id|nct_id|result_group_id|ctgov_group_code|title|period|description|count|milestone_description|count_units
60000417|NCT02177812|76116158|FG000|STARTED|Part 1 (Median of 4 Weeks)||1||
60000418|NCT02177812|76116159|FG001|STARTED|Part 1 (Median of 4 Weeks)||2||
59600871|NCT03844321|75710747|FG000|STARTED|Overall Study||2220||
59867317|NCT04526574|75991703|FG000|STARTED|Overall Study||898||
59867318|NCT04526574|75991704|FG001|STARTED|Overall Study||898||
60000419|NCT02177812|76116160|FG002|STARTED|Part 1 (Median of 4 Weeks)||7||
60000420|NCT02177812|76116161|FG003|STARTED|Part 1 (Median of 4 Weeks)||5||
60000421|NCT02177812|76116162|FG004|STARTED|Part 1 (Median of 4 Weeks)||6||
60000422|NCT02177812|76116163|FG005|STARTED|Part 1 (Median of 4 Weeks)||4||
60000423|NCT02177812|76116164|FG006|STARTED|Part 1 (Median of 4 Weeks)||10||
60000424|NCT02177812|76116165|FG007|STARTED|Part 1 (Median of 4 Weeks)||6||
60000425|NCT02177812|76116166|FG008|STARTED|Part 1 (Median of 4 Weeks)||0||
60000426|NCT02177812|76116158|FG000|COMPLETED|Part 1 (Median of 4 Weeks)||1||
60000427|NCT02177812|76116159|FG001|COMPLETED|Part 1 (Median of 4 Weeks)||2||
60000428|NCT02177812|76116160|FG002|COMPLETED|Part 1 (Median of 4 Weeks)||7||
60000429|NCT02177812|76116161|FG003|COMPLETED|Part 1 (Median of 4 Weeks)||4||
60000430|NCT02177812|76116162|FG004|COMPLETED|Part 1 (Median of 4 Weeks)||5||
60000431|NCT02177812|76116163|FG005|COMPLETED|Part 1 (Median of 4 Weeks)||1||
60000432|NCT02177812|76116164|FG006|COMPLETED|Part 1 (Median of 4 Weeks)||1||
60000433|NCT02177812|76116165|FG007|COMPLETED|Part 1 (Median of 4 Weeks)||4||
60000434|NCT02177812|76116166|FG008|COMPLETED|Part 1 (Median of 4 Weeks)||0||
60000435|NCT02177812|76116158|FG000|NOT COMPLETED|Part 1 (Median of 4 Weeks)||0||
60000436|NCT02177812|76116159|FG001|NOT COMPLETED|Part 1 (Median of 4 Weeks)||0||
60000437|NCT02177812|76116160|FG002|NOT COMPLETED|Part 1 (Median of 4 Weeks)||0||
60133658|NCT01411085|76256613|FG000|STARTED|Overall Study||10||
60133659|NCT01411085|76256613|FG000|COMPLETED|Overall Study||7||
60133660|NCT01411085|76256613|FG000|NOT COMPLETED|Overall Study||3||
60133661|NCT01543490|76256619|FG000|STARTED|Overall Study||368||
60133662|NCT01543490|76256620|FG001|STARTED|Overall Study||190||
60133663|NCT01543490|76256619|FG000|COMPLETED|Overall Study||352||
60133664|NCT01543490|76256620|FG001|COMPLETED|Overall Study||185||
60133665|NCT01543490|76256619|FG000|NOT COMPLETED|Overall Study||16||
60133666|NCT01543490|76256620|FG001|NOT COMPLETED|Overall Study||5||
60133667|NCT01404949|76256626|FG000|STARTED|Overall Study||17||
60133668|NCT01404949|76256626|FG000|COMPLETED|Overall Study||16||
60133669|NCT01404949|76256626|FG000|NOT COMPLETED|Overall Study||1||
60133670|NCT01431521|76256634|FG000|STARTED|Overall Study||10||
60133671|NCT01431521|76256635|FG001|STARTED|Overall Study||5||
60133672|NCT01431521|76256636|FG002|STARTED|Overall Study||11||
60133673|NCT01431521|76256637|FG003|STARTED|Overall Study||5||
60133674|NCT01431521|76256634|FG000|Treated|Overall Study||10||
60133675|NCT01431521|76256635|FG001|Treated|Overall Study||5||
60133676|NCT01431521|76256636|FG002|Treated|Overall Study||10||
60133677|NCT01431521|76256637|FG003|Treated|Overall Study||5||
60133678|NCT01431521|76256634|FG000|COMPLETED|Overall Study||10||
60133679|NCT01431521|76256635|FG001|COMPLETED|Overall Study||5||
60133680|NCT01431521|76256636|FG002|COMPLETED|Overall Study||10||
60133681|NCT01431521|76256637|FG003|COMPLETED|Overall Study||5||
60133682|NCT01431521|76256634|FG000|NOT COMPLETED|Overall Study||0||
59600872|NCT03844321|75710748|FG001|STARTED|Overall Study||2192||
59600873|NCT03844321|75710747|FG000|COMPLETED|Overall Study||579||
60000438|NCT02177812|76116161|FG003|NOT COMPLETED|Part 1 (Median of 4 Weeks)||1||
60000439|NCT02177812|76116162|FG004|NOT COMPLETED|Part 1 (Median of 4 Weeks)||1||
60000440|NCT02177812|76116163|FG005|NOT COMPLETED|Part 1 (Median of 4 Weeks)||3||
60000441|NCT02177812|76116164|FG006|NOT COMPLETED|Part 1 (Median of 4 Weeks)||9||
60000442|NCT02177812|76116165|FG007|NOT COMPLETED|Part 1 (Median of 4 Weeks)||2||
60000443|NCT02177812|76116166|FG008|NOT COMPLETED|Part 1 (Median of 4 Weeks)||0||
60000444|NCT02177812|76116158|FG000|STARTED|Part 2 (Up to 14 Months)||0||
60000445|NCT02177812|76116159|FG001|STARTED|Part 2 (Up to 14 Months)||0||
60000446|NCT02177812|76116160|FG002|STARTED|Part 2 (Up to 14 Months)||0||
60000447|NCT02177812|76116161|FG003|STARTED|Part 2 (Up to 14 Months)||0||
60000448|NCT02177812|76116162|FG004|STARTED|Part 2 (Up to 14 Months)||0||
60000449|NCT02177812|76116163|FG005|STARTED|Part 2 (Up to 14 Months)||0||
60000450|NCT02177812|76116164|FG006|STARTED|Part 2 (Up to 14 Months)||0||
60000451|NCT02177812|76116165|FG007|STARTED|Part 2 (Up to 14 Months)||0||
60000452|NCT02177812|76116166|FG008|STARTED|Part 2 (Up to 14 Months)||0||
60000453|NCT02177812|76116158|FG000|COMPLETED|Part 2 (Up to 14 Months)||0||
60000454|NCT02177812|76116159|FG001|COMPLETED|Part 2 (Up to 14 Months)||0||
60000455|NCT02177812|76116160|FG002|COMPLETED|Part 2 (Up to 14 Months)||0||
60000456|NCT02177812|76116161|FG003|COMPLETED|Part 2 (Up to 14 Months)||0||
60000457|NCT02177812|76116162|FG004|COMPLETED|Part 2 (Up to 14 Months)||0||
60000458|NCT02177812|76116163|FG005|COMPLETED|Part 2 (Up to 14 Months)||0||
60000459|NCT02177812|76116164|FG006|COMPLETED|Part 2 (Up to 14 Months)||0||
60000460|NCT02177812|76116165|FG007|COMPLETED|Part 2 (Up to 14 Months)||0||
60000461|NCT02177812|76116166|FG008|COMPLETED|Part 2 (Up to 14 Months)||0||
60000462|NCT02177812|76116158|FG000|NOT COMPLETED|Part 2 (Up to 14 Months)||0||
60000463|NCT02177812|76116159|FG001|NOT COMPLETED|Part 2 (Up to 14 Months)||0||
60000464|NCT02177812|76116160|FG002|NOT COMPLETED|Part 2 (Up to 14 Months)||0||
60000465|NCT02177812|76116161|FG003|NOT COMPLETED|Part 2 (Up to 14 Months)||0||
60000466|NCT02177812|76116162|FG004|NOT COMPLETED|Part 2 (Up to 14 Months)||0||
60133683|NCT01431521|76256635|FG001|NOT COMPLETED|Overall Study||0||
60133684|NCT01431521|76256636|FG002|NOT COMPLETED|Overall Study||1||
59867319|NCT04526574|75991703|FG000|Vaccination 1|Overall Study||895||
59867320|NCT04526574|75991704|FG001|Vaccination 1|Overall Study||896||
60133685|NCT01431521|76256637|FG003|NOT COMPLETED|Overall Study||0||
60133686|NCT00601731|76256658|FG000|STARTED|Overall Study||143||
60133687|NCT00601731|76256659|FG001|STARTED|Overall Study||43||
60133688|NCT00601731|76256660|FG002|STARTED|Overall Study||166||
60133689|NCT00601731|76256661|FG003|STARTED|Overall Study||30||
60133690|NCT00601731|76256658|FG000|COMPLETED|Overall Study||120||
60133691|NCT00601731|76256659|FG001|COMPLETED|Overall Study||43||
60133692|NCT00601731|76256660|FG002|COMPLETED|Overall Study||151||
60133693|NCT00601731|76256661|FG003|COMPLETED|Overall Study||29||
60133694|NCT00601731|76256658|FG000|NOT COMPLETED|Overall Study||23||
60133695|NCT00601731|76256659|FG001|NOT COMPLETED|Overall Study||0||
60133696|NCT00601731|76256660|FG002|NOT COMPLETED|Overall Study||15||
60133697|NCT00601731|76256661|FG003|NOT COMPLETED|Overall Study||1||
60133698|NCT00601965|76256691|FG000|STARTED|Overall Study||18||
60133699|NCT00601965|76256692|FG001|STARTED|Overall Study||18||
60133700|NCT00601965|76256693|FG002|STARTED|Overall Study||19||
60133701|NCT00601965|76256694|FG003|STARTED|Overall Study||18||
60133702|NCT00601965|76256691|FG000|COMPLETED|Overall Study||18||
60133703|NCT00601965|76256692|FG001|COMPLETED|Overall Study||16||
60133704|NCT00601965|76256693|FG002|COMPLETED|Overall Study||19||
60133705|NCT00601965|76256694|FG003|COMPLETED|Overall Study||17||
60133706|NCT00601965|76256691|FG000|NOT COMPLETED|Overall Study||0||
60133707|NCT00601965|76256692|FG001|NOT COMPLETED|Overall Study||2||
60133708|NCT00601965|76256693|FG002|NOT COMPLETED|Overall Study||0||
60133709|NCT00601965|76256694|FG003|NOT COMPLETED|Overall Study||1||
60133710|NCT00602043|76256704|FG000|STARTED|Overall Study||20||
60133711|NCT00602043|76256704|FG000|COMPLETED|Overall Study||15||
60133712|NCT00602043|76256704|FG000|NOT COMPLETED|Overall Study||5||
60133713|NCT01404325|76256713|FG000|STARTED|Overall Study||67||
60133714|NCT01404325|76256714|FG001|STARTED|Overall Study||63||
60133715|NCT01404325|76256713|FG000|COMPLETED|Overall Study||63||
60133716|NCT01404325|76256714|FG001|COMPLETED|Overall Study||61||
60133717|NCT01404325|76256713|FG000|NOT COMPLETED|Overall Study||4||
59867321|NCT04526574|75991703|FG000|Vaccination 2|Overall Study||874||
60133718|NCT01404325|76256714|FG001|NOT COMPLETED|Overall Study||2||
60133719|NCT00602355|76256723|FG000|STARTED|Overall Study||53||
60133720|NCT00602355|76256724|FG001|STARTED|Overall Study||56||
60133721|NCT00602355|76256725|FG002|STARTED|Overall Study||53||
60133722|NCT00602355|76256723|FG000|COMPLETED|Overall Study||44||
60133723|NCT00602355|76256724|FG001|COMPLETED|Overall Study||38||
59600874|NCT03844321|75710748|FG001|COMPLETED|Overall Study||533||
59867322|NCT04526574|75991704|FG001|Vaccination 2|Overall Study||878||
59867323|NCT04526574|75991703|FG000|COMPLETED|Overall Study||862||
60000467|NCT02177812|76116163|FG005|NOT COMPLETED|Part 2 (Up to 14 Months)||0||
60000468|NCT02177812|76116164|FG006|NOT COMPLETED|Part 2 (Up to 14 Months)||0||
60000469|NCT02177812|76116165|FG007|NOT COMPLETED|Part 2 (Up to 14 Months)||0||
60000470|NCT02177812|76116166|FG008|NOT COMPLETED|Part 2 (Up to 14 Months)||0||
60000471|NCT02203305|76116198|FG000|STARTED|Overall Study||20||
60000472|NCT02203305|76116199|FG001|STARTED|Overall Study||3||
60000473|NCT02203305|76116200|FG002|STARTED|Overall Study||20||
60000474|NCT02203305|76116198|FG000|COMPLETED|Overall Study||20||
60133724|NCT00602355|76256725|FG002|COMPLETED|Overall Study||43||
60133725|NCT00602355|76256723|FG000|NOT COMPLETED|Overall Study||9||
60133726|NCT00602355|76256724|FG001|NOT COMPLETED|Overall Study||18||
60133727|NCT00602355|76256725|FG002|NOT COMPLETED|Overall Study||10||
60133728|NCT01425463|76256735|FG000|STARTED|Overall Study||130||
60133729|NCT01425463|76256736|FG001|STARTED|Overall Study||126||
60133730|NCT01425463|76256735|FG000|Safety Set|Overall Study||126||
60133731|NCT01425463|76256736|FG001|Safety Set|Overall Study||122||
60133732|NCT01425463|76256735|FG000|Full Analysis Set|Overall Study||122||
60133733|NCT01425463|76256736|FG001|Full Analysis Set|Overall Study||116||
60133734|NCT01425463|76256735|FG000|COMPLETED|Overall Study||106||
60133735|NCT01425463|76256736|FG001|COMPLETED|Overall Study||102||
60133736|NCT01425463|76256735|FG000|NOT COMPLETED|Overall Study||24||
60133737|NCT01425463|76256736|FG001|NOT COMPLETED|Overall Study||24||
60133738|NCT02144259|76256745|FG000|STARTED|Overall Study||33||
60133739|NCT02144259|76256746|FG001|STARTED|Overall Study||33||
60000475|NCT02203305|76116199|FG001|COMPLETED|Overall Study||3||
60000476|NCT02203305|76116200|FG002|COMPLETED|Overall Study||19||
60000477|NCT02203305|76116198|FG000|NOT COMPLETED|Overall Study||0||
60000478|NCT02203305|76116199|FG001|NOT COMPLETED|Overall Study||0||
60000479|NCT02203305|76116200|FG002|NOT COMPLETED|Overall Study||1||
60000480|NCT01626352|76116210|FG000|STARTED|Overall Study||22||
60000481|NCT01626352|76116210|FG000|COMPLETED|Overall Study||12||
60000482|NCT01626352|76116210|FG000|NOT COMPLETED|Overall Study||10||
60000483|NCT01626118|76116221|FG000|STARTED|Overall Study||94||
60000484|NCT01626118|76116222|FG001|STARTED|Overall Study||93||
60000485|NCT01626118|76116223|FG002|STARTED|Overall Study||92||
60000486|NCT01626118|76116224|FG003|STARTED|Overall Study||94||
60000487|NCT01626118|76116221|FG000|COMPLETED|Overall Study||92||
60133740|NCT02144259|76256747|FG002|STARTED|Overall Study||34||
60133741|NCT02144259|76256745|FG000|COMPLETED|Overall Study||23||
60133742|NCT02144259|76256746|FG001|COMPLETED|Overall Study||28||
60133743|NCT02144259|76256747|FG002|COMPLETED|Overall Study||16||
60133744|NCT02144259|76256745|FG000|NOT COMPLETED|Overall Study||10||
60133745|NCT02144259|76256746|FG001|NOT COMPLETED|Overall Study||5||
60133746|NCT02144259|76256747|FG002|NOT COMPLETED|Overall Study||18||
60133747|NCT04655586|76256758|FG000|STARTED|Overall Study||40||
60133748|NCT04655586|76256759|FG001|STARTED|Overall Study||40||
60133749|NCT04655586|76256760|FG002|STARTED|Overall Study||80||
60133750|NCT04655586|76256758|FG000|COMPLETED|Overall Study||38|The primary reason for participants not receiving all three doses of drug and completing the study were hospital discharges.|
60133751|NCT04655586|76256759|FG001|COMPLETED|Overall Study||34|The primary reason for participants not receiving all three doses of drug and completing the study were hospital discharges.|
60133752|NCT04655586|76256760|FG002|COMPLETED|Overall Study||75|The primary reason for participants not receiving all three doses of drug and completing the study were hospital discharges.|
60133753|NCT04655586|76256758|FG000|NOT COMPLETED|Overall Study||2||
60133754|NCT04655586|76256759|FG001|NOT COMPLETED|Overall Study||6||
60133755|NCT04655586|76256760|FG002|NOT COMPLETED|Overall Study||5||
60133756|NCT00689091|76256770|FG000|STARTED|Overall Study||10831||
60133757|NCT00689091|76256771|FG001|STARTED|Overall Study||10770||
60133758|NCT00689091|76256770|FG000|COMPLETED|Overall Study||9460||
60133759|NCT00689091|76256771|FG001|COMPLETED|Overall Study||9376||
60133760|NCT00689091|76256770|FG000|NOT COMPLETED|Overall Study||1371||
60133761|NCT00689091|76256771|FG001|NOT COMPLETED|Overall Study||1394||
60133762|NCT01388647|76256783|FG000|STARTED|Overall Study||6||
60133763|NCT01388647|76256784|FG001|STARTED|Overall Study||6||
60133764|NCT01388647|76256783|FG000|COMPLETED|Overall Study|one subject ended study treatment due to adverse events|5||
60133765|NCT01388647|76256784|FG001|COMPLETED|Overall Study|two subjects ended study treatment due to adverse events|4||
60133766|NCT01388647|76256783|FG000|NOT COMPLETED|Overall Study||1||
60133767|NCT01388647|76256784|FG001|NOT COMPLETED|Overall Study||2||
60133768|NCT00603291|76256794|FG000|STARTED|Overall Study||95||
60133769|NCT00603291|76256795|FG001|STARTED|Overall Study||256||
60133770|NCT00603291|76256796|FG002|STARTED|Overall Study||253||
60133771|NCT00603291|76256794|FG000|COMPLETED|Overall Study||75||
60133772|NCT00603291|76256795|FG001|COMPLETED|Overall Study||169||
60133773|NCT00603291|76256796|FG002|COMPLETED|Overall Study||157||
60133774|NCT00603291|76256794|FG000|NOT COMPLETED|Overall Study||20||
60133775|NCT00603291|76256795|FG001|NOT COMPLETED|Overall Study||87||
60133776|NCT00603291|76256796|FG002|NOT COMPLETED|Overall Study||96||
60133777|NCT00705003|76256807|FG000|STARTED|Enrolled||71||
60133778|NCT00705003|76256808|FG001|STARTED|Enrolled||37||
60133779|NCT00705003|76256809|FG002|STARTED|Enrolled||34||
60133780|NCT00705003|76256807|FG000|COMPLETED|Enrolled||67||
60133781|NCT00705003|76256808|FG001|COMPLETED|Enrolled||34||
60133782|NCT00705003|76256809|FG002|COMPLETED|Enrolled||33||
60133783|NCT00705003|76256807|FG000|NOT COMPLETED|Enrolled||4||
60133784|NCT00705003|76256808|FG001|NOT COMPLETED|Enrolled||3||
59867324|NCT04526574|75991704|FG001|COMPLETED|Overall Study||865||
59867325|NCT04526574|75991703|FG000|NOT COMPLETED|Overall Study||36||
59867326|NCT04526574|75991704|FG001|NOT COMPLETED|Overall Study||33||
59867327|NCT03993392|75991714|FG000|STARTED|Overall Study||26||
60133785|NCT00705003|76256809|FG002|NOT COMPLETED|Enrolled||1||
59867328|NCT03993392|75991714|FG000|Treated With SUBLOCADE|Overall Study||24|Safety and Full Analysis Sets|
59867329|NCT03993392|75991714|FG000|COMPLETED|Overall Study||20||
60133786|NCT00705003|76256807|FG000|STARTED|Treated||67||
60133787|NCT00705003|76256808|FG001|STARTED|Treated||34||
60133788|NCT00705003|76256809|FG002|STARTED|Treated||33||
60133789|NCT00705003|76256807|FG000|COMPLETED|Treated||54||
60133790|NCT00705003|76256808|FG001|COMPLETED|Treated||28||
60133791|NCT00705003|76256809|FG002|COMPLETED|Treated||30||
59600875|NCT03844321|75710747|FG000|NOT COMPLETED|Overall Study||1641||
59600876|NCT03844321|75710748|FG001|NOT COMPLETED|Overall Study||1659||
59600877|NCT04332991|75710756|FG000|STARTED|Overall Study||242||
59600878|NCT04332991|75710757|FG001|STARTED|Overall Study||237||
60133792|NCT00705003|76256807|FG000|NOT COMPLETED|Treated||13||
60133793|NCT00705003|76256808|FG001|NOT COMPLETED|Treated||6||
60133794|NCT00705003|76256809|FG002|NOT COMPLETED|Treated||3||
60133795|NCT00690339|76256822|FG000|STARTED|Overall Study||492||
60133796|NCT00690339|76256823|FG001|STARTED|Overall Study||225||
60133797|NCT00690339|76256824|FG002|STARTED|Overall Study||156||
60133798|NCT00690339|76256825|FG003|STARTED|Overall Study||68||
60133799|NCT00690339|76256822|FG000|COMPLETED|Overall Study||375||
60133800|NCT00690339|76256823|FG001|COMPLETED|Overall Study||144||
60133801|NCT00690339|76256824|FG002|COMPLETED|Overall Study||99||
60133802|NCT00690339|76256825|FG003|COMPLETED|Overall Study||43||
60133803|NCT00690339|76256822|FG000|NOT COMPLETED|Overall Study||117||
60133804|NCT00690339|76256823|FG001|NOT COMPLETED|Overall Study||81||
60133805|NCT00690339|76256824|FG002|NOT COMPLETED|Overall Study||57||
60133806|NCT00690339|76256825|FG003|NOT COMPLETED|Overall Study||25||
59600879|NCT04332991|75710756|FG000|COMPLETED|Overall Study||242||
59867330|NCT03993392|75991714|FG000|NOT COMPLETED|Overall Study||6||
59867331|NCT04422990|75991721|FG000|STARTED|Overall Study||50||100
59867332|NCT04422990|75991722|FG001|STARTED|Overall Study||97||194
59867333|NCT04422990|75991721|FG000|COMPLETED|Overall Study||47||94
60133807|NCT00690495|76256837|FG000|STARTED|Overall Study||50||
60133808|NCT00690495|76256838|FG001|STARTED|Overall Study||50||
60133809|NCT00690495|76256837|FG000|Primary Endpoint|Overall Study||50||
60133810|NCT00690495|76256838|FG001|Primary Endpoint|Overall Study||50||
60133811|NCT00690495|76256837|FG000|COMPLETED|Overall Study||50||
60133812|NCT00690495|76256838|FG001|COMPLETED|Overall Study||50||
60133813|NCT00690495|76256837|FG000|NOT COMPLETED|Overall Study||0||
60133814|NCT00690495|76256838|FG001|NOT COMPLETED|Overall Study||0||
60133815|NCT00691197|76256846|FG000|STARTED|Overall Study||166||
60133816|NCT00691197|76256847|FG001|STARTED|Overall Study||80||
60133817|NCT00691197|76256846|FG000|COMPLETED|Overall Study||155||
60133818|NCT00691197|76256847|FG001|COMPLETED|Overall Study||75||
60133819|NCT00691197|76256846|FG000|NOT COMPLETED|Overall Study||11||
60133820|NCT00691197|76256847|FG001|NOT COMPLETED|Overall Study||5||
60133821|NCT00713427|76256853|FG000|STARTED|Overall Study||70||
59600880|NCT04332991|75710757|FG001|COMPLETED|Overall Study||237||
59600881|NCT04332991|75710756|FG000|NOT COMPLETED|Overall Study||0||
59600882|NCT04332991|75710757|FG001|NOT COMPLETED|Overall Study||0||
59867334|NCT04422990|75991722|FG001|COMPLETED|Overall Study||96||192
60133822|NCT00713427|76256853|FG000|COMPLETED|Overall Study||66||
60133823|NCT00713427|76256853|FG000|NOT COMPLETED|Overall Study||4||
60133824|NCT01402063|76256859|FG000|STARTED|Overall Study||42||
60133825|NCT01402063|76256860|FG001|STARTED|Overall Study||21||
60133826|NCT01402063|76256859|FG000|COMPLETED|Overall Study||39||
60133827|NCT01402063|76256860|FG001|COMPLETED|Overall Study||18||
60133828|NCT01402063|76256859|FG000|NOT COMPLETED|Overall Study||3||
60133829|NCT01402063|76256860|FG001|NOT COMPLETED|Overall Study||3||
60133830|NCT01796301|76256868|FG000|STARTED|Overall Study||218||
60133831|NCT01796301|76256869|FG001|STARTED|Overall Study||218||
60133832|NCT01796301|76256868|FG000|Received Treatment|Overall Study||214||
60133833|NCT01796301|76256869|FG001|Received Treatment|Overall Study||218||
60133834|NCT01796301|76256868|FG000|COMPLETED|Overall Study||200||
60133835|NCT01796301|76256869|FG001|COMPLETED|Overall Study||198||
60133836|NCT01796301|76256868|FG000|NOT COMPLETED|Overall Study||18||
60133837|NCT01796301|76256869|FG001|NOT COMPLETED|Overall Study||20||
60133838|NCT01204905|76256875|FG000|STARTED|Overall Study||7||
60133839|NCT01204905|76256875|FG000|COMPLETED|Overall Study||5||
60133840|NCT01204905|76256875|FG000|NOT COMPLETED|Overall Study||2||
60133841|NCT00691665|76256881|FG000|STARTED|Overall Study||65||
60133842|NCT00691665|76256882|FG001|STARTED|Overall Study||65||
60133843|NCT00691665|76256881|FG000|COMPLETED|Overall Study||65||
60133844|NCT00691665|76256882|FG001|COMPLETED|Overall Study||65||
60133845|NCT00691665|76256881|FG000|NOT COMPLETED|Overall Study||0||
60133846|NCT00691665|76256882|FG001|NOT COMPLETED|Overall Study||0||
60133847|NCT01388335|76256888|FG000|STARTED|Period 1||13||
60133848|NCT01388335|76256888|FG000|Received at Least 1 Dose of Study Drug|Period 1||13||
60133849|NCT01388335|76256888|FG000|COMPLETED|Period 1||12||
60133850|NCT01388335|76256888|FG000|NOT COMPLETED|Period 1||1||
60133851|NCT01388335|76256888|FG000|STARTED|Period 2||12||
60133852|NCT01388335|76256888|FG000|Received at Least 1 Dose of Study Drug|Period 2||12||
60133853|NCT01388335|76256888|FG000|COMPLETED|Period 2|Only 6 participants who completed Period 2 entered Safety Extension.|9||
60133854|NCT01388335|76256888|FG000|NOT COMPLETED|Period 2||3||
60133855|NCT01388335|76256888|FG000|STARTED|Safety Extension|Six completed Period 2 and 1 participant who discontinued Period 2 entered Safety Extension.|7||
60133856|NCT01388335|76256888|FG000|COMPLETED|Safety Extension||0||
60133857|NCT01388335|76256888|FG000|NOT COMPLETED|Safety Extension||7||
60133858|NCT00713583|76256902|FG000|STARTED|Overall Study||45||
60133859|NCT00713583|76256903|FG001|STARTED|Overall Study||40||
60133860|NCT00713583|76256902|FG000|COMPLETED|Overall Study||45||
60133861|NCT00713583|76256903|FG001|COMPLETED|Overall Study||40||
60133862|NCT00713583|76256902|FG000|NOT COMPLETED|Overall Study||0||
60133863|NCT00713583|76256903|FG001|NOT COMPLETED|Overall Study||0||
60133864|NCT00692211|76256911|FG000|STARTED|Overall Study||202||
60133865|NCT00692211|76256912|FG001|STARTED|Overall Study||202||
59600883|NCT03719677|75710763|FG000|STARTED|Overall Study||7||
59600884|NCT03719677|75710763|FG000|COMPLETED|Overall Study||7||
59600885|NCT03719677|75710763|FG000|NOT COMPLETED|Overall Study||0||
59600886|NCT03831451|75710769|FG000|STARTED|Overall Study||74||
59867335|NCT04422990|75991721|FG000|NOT COMPLETED|Overall Study||3||6
60133866|NCT00692211|76256911|FG000|COMPLETED|Overall Study||202||
60133867|NCT00692211|76256912|FG001|COMPLETED|Overall Study||202||
60133868|NCT00692211|76256911|FG000|NOT COMPLETED|Overall Study||0||
60133869|NCT00692211|76256912|FG001|NOT COMPLETED|Overall Study||0||
60133870|NCT00713661|76256922|FG000|STARTED|Overall Study||7||
60133871|NCT00713661|76256923|FG001|STARTED|Overall Study||9||
60133872|NCT00713661|76256924|FG002|STARTED|Overall Study||4||
60133873|NCT00713661|76256925|FG003|STARTED|Overall Study||5||
60133874|NCT00713661|76256922|FG000|COMPLETED|Overall Study||7||
60133875|NCT00713661|76256923|FG001|COMPLETED|Overall Study||9||
60133876|NCT00713661|76256924|FG002|COMPLETED|Overall Study||4||
60133877|NCT00713661|76256925|FG003|COMPLETED|Overall Study||5||
60133878|NCT00713661|76256922|FG000|NOT COMPLETED|Overall Study||0||
60133879|NCT00713661|76256923|FG001|NOT COMPLETED|Overall Study||0||
60133880|NCT00713661|76256924|FG002|NOT COMPLETED|Overall Study||0||
60133881|NCT00713661|76256925|FG003|NOT COMPLETED|Overall Study||0||
59600887|NCT03831451|75710770|FG001|STARTED|Overall Study||55||
59600888|NCT03831451|75710769|FG000|COMPLETED|Overall Study||74||
59600889|NCT03831451|75710770|FG001|COMPLETED|Overall Study||55||
59600890|NCT03831451|75710769|FG000|NOT COMPLETED|Overall Study||0||
59600891|NCT03831451|75710770|FG001|NOT COMPLETED|Overall Study||0||
59600892|NCT03721549|75710778|FG000|STARTED|Overall Study||8||
59600893|NCT03721549|75710779|FG001|STARTED|Overall Study||8||
59600894|NCT03721549|75710778|FG000|COMPLETED|Overall Study||7||
59600895|NCT03721549|75710779|FG001|COMPLETED|Overall Study||8||
59600896|NCT03721549|75710778|FG000|NOT COMPLETED|Overall Study||1||
59600897|NCT03721549|75710779|FG001|NOT COMPLETED|Overall Study||0||
59600898|NCT03834025|75710792|FG000|STARTED|Sent Recruitment Letter (Phase 1)||4150||
59600899|NCT03834025|75710793|FG001|STARTED|Sent Recruitment Letter (Phase 1)||3871||
59600900|NCT03834025|75710794|FG002|STARTED|Sent Recruitment Letter (Phase 1)||4121||
59600901|NCT03834025|75710795|FG003|STARTED|Sent Recruitment Letter (Phase 1)||3693||
59600902|NCT03834025|75710796|FG004|STARTED|Sent Recruitment Letter (Phase 1)||0||
59600903|NCT03834025|75710797|FG005|STARTED|Sent Recruitment Letter (Phase 1)||0||
59600904|NCT03834025|75710798|FG006|STARTED|Sent Recruitment Letter (Phase 1)||0||
59600905|NCT03834025|75710792|FG000|Sent Letter|Sent Recruitment Letter (Phase 1)||4150||
59600906|NCT03834025|75710793|FG001|Sent Letter|Sent Recruitment Letter (Phase 1)||3871||
59600907|NCT03834025|75710794|FG002|Sent Letter|Sent Recruitment Letter (Phase 1)||4121||
59600908|NCT03834025|75710795|FG003|Sent Letter|Sent Recruitment Letter (Phase 1)||3693||
59600909|NCT03834025|75710796|FG004|Sent Letter|Sent Recruitment Letter (Phase 1)||0||
59600910|NCT03834025|75710797|FG005|Sent Letter|Sent Recruitment Letter (Phase 1)||0||
59600911|NCT03834025|75710798|FG006|Sent Letter|Sent Recruitment Letter (Phase 1)||0||
59600912|NCT03834025|75710792|FG000|Responded to Letter|Sent Recruitment Letter (Phase 1)||36||
59600913|NCT03834025|75710793|FG001|Responded to Letter|Sent Recruitment Letter (Phase 1)||36||
59600914|NCT03834025|75710794|FG002|Responded to Letter|Sent Recruitment Letter (Phase 1)||44||
59600915|NCT03834025|75710795|FG003|Responded to Letter|Sent Recruitment Letter (Phase 1)||44||
59600916|NCT03834025|75710796|FG004|Responded to Letter|Sent Recruitment Letter (Phase 1)||0||
59600917|NCT03834025|75710797|FG005|Responded to Letter|Sent Recruitment Letter (Phase 1)||0||
59867336|NCT04422990|75991722|FG001|NOT COMPLETED|Overall Study||1||2
59600918|NCT03834025|75710798|FG006|Responded to Letter|Sent Recruitment Letter (Phase 1)||0||
59600919|NCT03834025|75710792|FG000|COMPLETED|Sent Recruitment Letter (Phase 1)||36||
59600920|NCT03834025|75710793|FG001|COMPLETED|Sent Recruitment Letter (Phase 1)||36||
59600921|NCT03834025|75710794|FG002|COMPLETED|Sent Recruitment Letter (Phase 1)||44||
59600922|NCT03834025|75710795|FG003|COMPLETED|Sent Recruitment Letter (Phase 1)||44||
59600923|NCT03834025|75710796|FG004|COMPLETED|Sent Recruitment Letter (Phase 1)||0||
59600924|NCT03834025|75710797|FG005|COMPLETED|Sent Recruitment Letter (Phase 1)||0||
59600925|NCT03834025|75710798|FG006|COMPLETED|Sent Recruitment Letter (Phase 1)||0||
59600926|NCT03834025|75710792|FG000|NOT COMPLETED|Sent Recruitment Letter (Phase 1)||4114||
59600927|NCT03834025|75710793|FG001|NOT COMPLETED|Sent Recruitment Letter (Phase 1)||3835||
59600928|NCT03834025|75710794|FG002|NOT COMPLETED|Sent Recruitment Letter (Phase 1)||4077||
59600929|NCT03834025|75710795|FG003|NOT COMPLETED|Sent Recruitment Letter (Phase 1)||3649||
59600930|NCT03834025|75710796|FG004|NOT COMPLETED|Sent Recruitment Letter (Phase 1)||0||
59600931|NCT03834025|75710797|FG005|NOT COMPLETED|Sent Recruitment Letter (Phase 1)||0||
59600932|NCT03834025|75710798|FG006|NOT COMPLETED|Sent Recruitment Letter (Phase 1)||0||
59600933|NCT03834025|75710792|FG000|STARTED|Randomized to Payment Condition(Phase 2)||0||
59600934|NCT03834025|75710793|FG001|STARTED|Randomized to Payment Condition(Phase 2)||0||
59600935|NCT03834025|75710794|FG002|STARTED|Randomized to Payment Condition(Phase 2)||0||
59600936|NCT03834025|75710795|FG003|STARTED|Randomized to Payment Condition(Phase 2)||0||
59600937|NCT03834025|75710796|FG004|STARTED|Randomized to Payment Condition(Phase 2)||24||
59600938|NCT03834025|75710797|FG005|STARTED|Randomized to Payment Condition(Phase 2)||21||
59600939|NCT03834025|75710798|FG006|STARTED|Randomized to Payment Condition(Phase 2)||28||
59600940|NCT03834025|75710792|FG000|COMPLETED|Randomized to Payment Condition(Phase 2)||0||
59600941|NCT03834025|75710793|FG001|COMPLETED|Randomized to Payment Condition(Phase 2)||0||
59600942|NCT03834025|75710794|FG002|COMPLETED|Randomized to Payment Condition(Phase 2)||0||
59600943|NCT03834025|75710795|FG003|COMPLETED|Randomized to Payment Condition(Phase 2)||0||
59600944|NCT03834025|75710796|FG004|COMPLETED|Randomized to Payment Condition(Phase 2)||24||
59600945|NCT03834025|75710797|FG005|COMPLETED|Randomized to Payment Condition(Phase 2)||21||
59600946|NCT03834025|75710798|FG006|COMPLETED|Randomized to Payment Condition(Phase 2)||27||
59600947|NCT03834025|75710792|FG000|NOT COMPLETED|Randomized to Payment Condition(Phase 2)||0||
59600948|NCT03834025|75710793|FG001|NOT COMPLETED|Randomized to Payment Condition(Phase 2)||0||
59600949|NCT03834025|75710794|FG002|NOT COMPLETED|Randomized to Payment Condition(Phase 2)||0||
59600950|NCT03834025|75710795|FG003|NOT COMPLETED|Randomized to Payment Condition(Phase 2)||0||
59867337|NCT04377308|75991733|FG000|STARTED|Overall Study||4||
59600951|NCT03834025|75710796|FG004|NOT COMPLETED|Randomized to Payment Condition(Phase 2)||0||
59600952|NCT03834025|75710797|FG005|NOT COMPLETED|Randomized to Payment Condition(Phase 2)||0||
59600953|NCT03834025|75710798|FG006|NOT COMPLETED|Randomized to Payment Condition(Phase 2)||1||
59600954|NCT03748771|75710814|FG000|STARTED|Overall Study||20||
59600955|NCT03748771|75710814|FG000|COMPLETED|Overall Study||20||
59600956|NCT03748771|75710814|FG000|NOT COMPLETED|Overall Study||0||
59600957|NCT03836989|75710820|FG000|STARTED|Overall Study||4||
59600958|NCT03836989|75710821|FG001|STARTED|Overall Study||0||
59600959|NCT03836989|75710820|FG000|Subjects > 60 Years Old With Complete Paralysis|Overall Study||1||
59600960|NCT03836989|75710821|FG001|Subjects > 60 Years Old With Complete Paralysis|Overall Study||0||
59600961|NCT03836989|75710820|FG000|Subjects > 60 Years Old With Incomplete Paralysis|Overall Study||1||
59600962|NCT03836989|75710821|FG001|Subjects > 60 Years Old With Incomplete Paralysis|Overall Study||0||
59600963|NCT03836989|75710820|FG000|Subject < 60 Years Old + Complete Paralysis < 15 Days Duration|Overall Study||1||
59600964|NCT03836989|75710821|FG001|Subject < 60 Years Old + Complete Paralysis < 15 Days Duration|Overall Study||0||
59600965|NCT03836989|75710820|FG000|Subjects < 60 Years Old + Complete Paralysis > 15 Days|Overall Study||1||
59600966|NCT03836989|75710821|FG001|Subjects < 60 Years Old + Complete Paralysis > 15 Days|Overall Study||0||
59600967|NCT03836989|75710820|FG000|COMPLETED|Overall Study||4||
59600968|NCT03836989|75710821|FG001|COMPLETED|Overall Study||0||
59600969|NCT03836989|75710820|FG000|NOT COMPLETED|Overall Study||0||
59600970|NCT03836989|75710821|FG001|NOT COMPLETED|Overall Study||0||
59600971|NCT03811951|75710832|FG000|STARTED|First Intervention (1 Day)||2||
59600972|NCT03811951|75710833|FG001|STARTED|First Intervention (1 Day)||2||
59600973|NCT03811951|75710832|FG000|COMPLETED|First Intervention (1 Day)||2||
59600974|NCT03811951|75710833|FG001|COMPLETED|First Intervention (1 Day)||2||
59600975|NCT03811951|75710832|FG000|NOT COMPLETED|First Intervention (1 Day)||0||
59600976|NCT03811951|75710833|FG001|NOT COMPLETED|First Intervention (1 Day)||0||
59600977|NCT03811951|75710832|FG000|STARTED|Washout (1 Week)||2||
59600978|NCT03811951|75710833|FG001|STARTED|Washout (1 Week)||2||
59600979|NCT03811951|75710832|FG000|COMPLETED|Washout (1 Week)||2||
59600980|NCT03811951|75710833|FG001|COMPLETED|Washout (1 Week)||2||
59600981|NCT03811951|75710832|FG000|NOT COMPLETED|Washout (1 Week)||0||
59600982|NCT03811951|75710833|FG001|NOT COMPLETED|Washout (1 Week)||0||
59600983|NCT03811951|75710832|FG000|STARTED|Second Intervention (1 Day)||2||
59600984|NCT03811951|75710833|FG001|STARTED|Second Intervention (1 Day)||2||
59600985|NCT03811951|75710832|FG000|COMPLETED|Second Intervention (1 Day)||2||
59600986|NCT03811951|75710833|FG001|COMPLETED|Second Intervention (1 Day)||2||
59600987|NCT03811951|75710832|FG000|NOT COMPLETED|Second Intervention (1 Day)||0||
59600988|NCT03811951|75710833|FG001|NOT COMPLETED|Second Intervention (1 Day)||0||
59600989|NCT03816709|75710841|FG000|STARTED|Overall Study||25||
59600990|NCT03816709|75710841|FG000|COMPLETED|Overall Study||25||
59600991|NCT03816709|75710841|FG000|NOT COMPLETED|Overall Study||0||
59600992|NCT04183231|75710845|FG000|STARTED|Overall Study||16||
59600993|NCT04183231|75710845|FG000|COMPLETED|Overall Study||16||
59600994|NCT04183231|75710845|FG000|NOT COMPLETED|Overall Study||0||
59600995|NCT03890419|75710852|FG000|STARTED|Overall Study||34||
59600996|NCT03890419|75710853|FG001|STARTED|Overall Study||30||
59600997|NCT03890419|75710854|FG002|STARTED|Overall Study||30||
59600998|NCT03890419|75710852|FG000|COMPLETED|Overall Study||27||
59600999|NCT03890419|75710853|FG001|COMPLETED|Overall Study||27||
59601000|NCT03890419|75710854|FG002|COMPLETED|Overall Study||25||
59601001|NCT03890419|75710852|FG000|NOT COMPLETED|Overall Study||7||
59601002|NCT03890419|75710853|FG001|NOT COMPLETED|Overall Study||3||
59601003|NCT03890419|75710854|FG002|NOT COMPLETED|Overall Study||5||
59601004|NCT03907033|75710864|FG000|STARTED|Overall Study||14||
59601005|NCT03907033|75710865|FG001|STARTED|Overall Study||14||
59601006|NCT03907033|75710864|FG000|COMPLETED|Overall Study||14||
59601007|NCT03907033|75710865|FG001|COMPLETED|Overall Study||14||
59601008|NCT03907033|75710864|FG000|NOT COMPLETED|Overall Study||0||
59601009|NCT03907033|75710865|FG001|NOT COMPLETED|Overall Study||0||
59601010|NCT03818815|75710873|FG000|STARTED|Overall Study||56||
59601011|NCT03818815|75710874|FG001|STARTED|Overall Study||47||
59601012|NCT03818815|75710873|FG000|COMPLETED|Overall Study||48||
59601013|NCT03818815|75710874|FG001|COMPLETED|Overall Study||42||
59601014|NCT03818815|75710873|FG000|NOT COMPLETED|Overall Study||8||
59601015|NCT03818815|75710874|FG001|NOT COMPLETED|Overall Study||5||
59601016|NCT03801265|75710882|FG000|STARTED|Overall Study||23||
59601017|NCT03801265|75710883|FG001|STARTED|Overall Study||23||
59601018|NCT03801265|75710882|FG000|COMPLETED|Overall Study||23||
59601019|NCT03801265|75710883|FG001|COMPLETED|Overall Study||23||
59601020|NCT03801265|75710882|FG000|NOT COMPLETED|Overall Study||0||
59601021|NCT03801265|75710883|FG001|NOT COMPLETED|Overall Study||0||
59601022|NCT03950167|75710891|FG000|STARTED|Overall Study||25||
59601023|NCT03950167|75710892|FG001|STARTED|Overall Study||25||
59601024|NCT03950167|75710891|FG000|COMPLETED|Overall Study||24||
59601025|NCT03950167|75710892|FG001|COMPLETED|Overall Study||22||
59601026|NCT03950167|75710891|FG000|NOT COMPLETED|Overall Study||1||
59601027|NCT03950167|75710892|FG001|NOT COMPLETED|Overall Study||3||
59601028|NCT03968965|75710900|FG000|STARTED|Overall Study||32||
59601029|NCT03968965|75710901|FG001|STARTED|Overall Study||32||
59601030|NCT03968965|75710900|FG000|COMPLETED|Overall Study||32||
59867338|NCT04377308|75991734|FG001|STARTED|Overall Study||12||
59867339|NCT04377308|75991733|FG000|COMPLETED|Overall Study||4||
59601031|NCT03968965|75710901|FG001|COMPLETED|Overall Study||30||
60000488|NCT01626118|76116222|FG001|COMPLETED|Overall Study||91||
60000489|NCT01626118|76116223|FG002|COMPLETED|Overall Study||90||
59601032|NCT03968965|75710900|FG000|NOT COMPLETED|Overall Study||0||
59867340|NCT04377308|75991734|FG001|COMPLETED|Overall Study||11||
59867341|NCT04377308|75991733|FG000|NOT COMPLETED|Overall Study||0||
59867342|NCT04377308|75991734|FG001|NOT COMPLETED|Overall Study||1||
59867343|NCT04447404|75991742|FG000|STARTED|Overall Study||2||
59867344|NCT04447404|75991743|FG001|STARTED|Overall Study||0||
59867345|NCT04447404|75991742|FG000|COMPLETED|Overall Study||0||
59867346|NCT04447404|75991743|FG001|COMPLETED|Overall Study||0||
59867347|NCT04447404|75991742|FG000|NOT COMPLETED|Overall Study||2||
59867348|NCT04447404|75991743|FG001|NOT COMPLETED|Overall Study||0||
59867349|NCT03988166|75991749|FG000|STARTED|Overall Study||150||
59601033|NCT03968965|75710901|FG001|NOT COMPLETED|Overall Study||2||
59601034|NCT03978403|75710911|FG000|STARTED|Overall Study||6||
59601035|NCT03978403|75710912|FG001|STARTED|Overall Study||6||
59867350|NCT03988166|75991749|FG000|COMPLETED|Overall Study||147||
59867351|NCT03988166|75991749|FG000|NOT COMPLETED|Overall Study||3||
59867352|NCT03988088|75991758|FG000|STARTED|Single-Dose Pharmacokinetic Study||11||
59867353|NCT03988088|75991759|FG001|STARTED|Single-Dose Pharmacokinetic Study||7||
59867354|NCT03988088|75991760|FG002|STARTED|Single-Dose Pharmacokinetic Study||0||
59867355|NCT03988088|75991761|FG003|STARTED|Single-Dose Pharmacokinetic Study||0||
59867356|NCT03988088|75991758|FG000|COMPLETED|Single-Dose Pharmacokinetic Study||11||
59867357|NCT03988088|75991759|FG001|COMPLETED|Single-Dose Pharmacokinetic Study||6||
59867358|NCT03988088|75991760|FG002|COMPLETED|Single-Dose Pharmacokinetic Study||0||
59867359|NCT03988088|75991761|FG003|COMPLETED|Single-Dose Pharmacokinetic Study||0||
59867360|NCT03988088|75991758|FG000|NOT COMPLETED|Single-Dose Pharmacokinetic Study||0||
59867361|NCT03988088|75991759|FG001|NOT COMPLETED|Single-Dose Pharmacokinetic Study||1||
59867362|NCT03988088|75991760|FG002|NOT COMPLETED|Single-Dose Pharmacokinetic Study||0||
59867363|NCT03988088|75991761|FG003|NOT COMPLETED|Single-Dose Pharmacokinetic Study||0||
59867364|NCT03988088|75991758|FG000|STARTED|Open-Label Addendum||0||
59867365|NCT03988088|75991759|FG001|STARTED|Open-Label Addendum||0||
59867366|NCT03988088|75991760|FG002|STARTED|Open-Label Addendum|The US participants had the option to enter this optional 3-month open-label extension addendum.|2||
59867367|NCT03988088|75991761|FG003|STARTED|Open-Label Addendum|The US participants had the option to enter this optional 3-month open-label extension addendum.|2||
60000490|NCT01626118|76116224|FG003|COMPLETED|Overall Study||91||
60000491|NCT01626118|76116221|FG000|NOT COMPLETED|Overall Study||2||
60000492|NCT01626118|76116222|FG001|NOT COMPLETED|Overall Study||2||
60000493|NCT01626118|76116223|FG002|NOT COMPLETED|Overall Study||2||
60000494|NCT01626118|76116224|FG003|NOT COMPLETED|Overall Study||3||
59601036|NCT03978403|75710913|FG002|STARTED|Overall Study||6||
59601037|NCT03978403|75710914|FG003|STARTED|Overall Study||6||
59601038|NCT03978403|75710911|FG000|COMPLETED|Overall Study||6||
59601039|NCT03978403|75710912|FG001|COMPLETED|Overall Study||6||
59601040|NCT03978403|75710913|FG002|COMPLETED|Overall Study||6||
59867368|NCT03988088|75991758|FG000|COMPLETED|Open-Label Addendum||0||
59867369|NCT03988088|75991759|FG001|COMPLETED|Open-Label Addendum||0||
59867370|NCT03988088|75991760|FG002|COMPLETED|Open-Label Addendum||1||
59867371|NCT03988088|75991761|FG003|COMPLETED|Open-Label Addendum||2||
59867372|NCT03988088|75991758|FG000|NOT COMPLETED|Open-Label Addendum||0||
59867373|NCT03988088|75991759|FG001|NOT COMPLETED|Open-Label Addendum||0||
59867374|NCT03988088|75991760|FG002|NOT COMPLETED|Open-Label Addendum||1||
59867375|NCT03988088|75991761|FG003|NOT COMPLETED|Open-Label Addendum||0||
59867376|NCT03987932|75991772|FG000|STARTED|Overall Study||4|Study stopped due to COVID-19|
59867377|NCT03987932|75991773|FG001|STARTED|Overall Study||3|Study stopped due to COVID-19|
59867378|NCT03987932|75991774|FG002|STARTED|Overall Study||4|Study stopped due to COVID-19|
59867379|NCT03987932|75991772|FG000|1 Month|Overall Study||4||
59867380|NCT03987932|75991773|FG001|1 Month|Overall Study||2||
59867381|NCT03987932|75991774|FG002|1 Month|Overall Study||3||
59867382|NCT03987932|75991772|FG000|3 Months|Overall Study||4||
59867383|NCT03987932|75991773|FG001|3 Months|Overall Study||2||
59867384|NCT03987932|75991774|FG002|3 Months|Overall Study||3||
59867385|NCT03987932|75991772|FG000|6 Months|Overall Study||2||
59867386|NCT03987932|75991773|FG001|6 Months|Overall Study||2||
59867387|NCT03987932|75991774|FG002|6 Months|Overall Study||2||
59867388|NCT03987932|75991772|FG000|COMPLETED|Overall Study||2|Study stopped due to COVID-19|
59867389|NCT03987932|75991773|FG001|COMPLETED|Overall Study||2|Study stopped due to COVID-19|
59867390|NCT03987932|75991774|FG002|COMPLETED|Overall Study||2|Study stopped due to COVID-19|
59867391|NCT03987932|75991772|FG000|NOT COMPLETED|Overall Study||2||
59867392|NCT03987932|75991773|FG001|NOT COMPLETED|Overall Study||1||
59867393|NCT03987932|75991774|FG002|NOT COMPLETED|Overall Study||2||
59867394|NCT03987620|75991784|FG000|STARTED|Overall Study||303||
59867395|NCT03987620|75991785|FG001|STARTED|Overall Study||152||
60000495|NCT02152384|76116234|FG000|STARTED|Run In (1-5 Week Transition)||14||
60000496|NCT02152384|76116235|FG001|STARTED|Run In (1-5 Week Transition)||14||
60000497|NCT02152384|76116234|FG000|COMPLETED|Run In (1-5 Week Transition)||14||
60000498|NCT02152384|76116235|FG001|COMPLETED|Run In (1-5 Week Transition)||14||
60000499|NCT02152384|76116234|FG000|NOT COMPLETED|Run In (1-5 Week Transition)||0||
60000500|NCT02152384|76116235|FG001|NOT COMPLETED|Run In (1-5 Week Transition)||0||
60000501|NCT02152384|76116234|FG000|STARTED|Period 1||14||
60000502|NCT02152384|76116235|FG001|STARTED|Period 1||14||
60000503|NCT02152384|76116234|FG000|Received at Least 1 Dose of Study Drug|Period 1||14||
60000504|NCT02152384|76116235|FG001|Received at Least 1 Dose of Study Drug|Period 1||14||
60000505|NCT02152384|76116234|FG000|COMPLETED|Period 1||13||
60000506|NCT02152384|76116235|FG001|COMPLETED|Period 1||12||
60000507|NCT02152384|76116234|FG000|NOT COMPLETED|Period 1||1||
60000508|NCT02152384|76116235|FG001|NOT COMPLETED|Period 1||2||
60000509|NCT02152384|76116234|FG000|STARTED|Period 2||13||
60000510|NCT02152384|76116235|FG001|STARTED|Period 2||12||
60000511|NCT02152384|76116234|FG000|COMPLETED|Period 2||13||
60000512|NCT02152384|76116235|FG001|COMPLETED|Period 2||12||
60000513|NCT02152384|76116234|FG000|NOT COMPLETED|Period 2||0||
60000514|NCT02152384|76116235|FG001|NOT COMPLETED|Period 2||0||
60000515|NCT02177266|76116247|FG000|STARTED|Overall Study||1||
60000516|NCT02177266|76116248|FG001|STARTED|Overall Study||1||
60000517|NCT02177266|76116247|FG000|COMPLETED|Overall Study||0||
60000518|NCT02177266|76116248|FG001|COMPLETED|Overall Study||0||
60000519|NCT02177266|76116247|FG000|NOT COMPLETED|Overall Study||1||
60000520|NCT02177266|76116248|FG001|NOT COMPLETED|Overall Study||1||
60000521|NCT02177032|76116258|FG000|STARTED|Overall Study||355||
60000522|NCT02177032|76116259|FG001|STARTED|Overall Study||88||
60000523|NCT02177032|76116260|FG002|STARTED|Overall Study||354||
60000524|NCT02177032|76116261|FG003|STARTED|Overall Study||88||
60000525|NCT02177032|76116258|FG000|COMPLETED|Overall Study||350||
60000526|NCT02177032|76116259|FG001|COMPLETED|Overall Study||86||
60000527|NCT02177032|76116260|FG002|COMPLETED|Overall Study||351||
60000528|NCT02177032|76116261|FG003|COMPLETED|Overall Study||88||
60000529|NCT02177032|76116258|FG000|NOT COMPLETED|Overall Study||5||
60000530|NCT02177032|76116259|FG001|NOT COMPLETED|Overall Study||2||
60000531|NCT02177032|76116260|FG002|NOT COMPLETED|Overall Study||3||
60000532|NCT02177032|76116261|FG003|NOT COMPLETED|Overall Study||0||
60000533|NCT02176642|76116284|FG000|STARTED|Overall Study||18||
60000534|NCT02176642|76116285|FG001|STARTED|Overall Study||17||
60000535|NCT02176642|76116284|FG000|COMPLETED|Overall Study||18||
60000536|NCT02176642|76116285|FG001|COMPLETED|Overall Study||16||
60000537|NCT02176642|76116284|FG000|NOT COMPLETED|Overall Study||0||
60000538|NCT02176642|76116285|FG001|NOT COMPLETED|Overall Study||1||
60000539|NCT02116660|76116293|FG000|STARTED|Overall Study||6||
60000540|NCT02116660|76116294|FG001|STARTED|Overall Study||5||
60000541|NCT02116660|76116293|FG000|COMPLETED|Overall Study||4||
60000542|NCT02116660|76116294|FG001|COMPLETED|Overall Study||1||
60000543|NCT02116660|76116293|FG000|NOT COMPLETED|Overall Study||2||
60000544|NCT02116660|76116294|FG001|NOT COMPLETED|Overall Study||4||
60000545|NCT02589405|76116302|FG000|STARTED|Overall Study||50||
60000546|NCT02589405|76116302|FG000|COMPLETED|Overall Study||46||
60000547|NCT02589405|76116302|FG000|NOT COMPLETED|Overall Study||4||
60133882|NCT01401361|76256935|FG000|STARTED|Overall Study||150||
60000548|NCT02176018|76116308|FG000|STARTED|Overall Study||22||
60000549|NCT02176018|76116309|FG001|STARTED|Overall Study||23||
60000550|NCT02176018|76116308|FG000|COMPLETED|Overall Study||17||
60000551|NCT02176018|76116309|FG001|COMPLETED|Overall Study||17||
60000552|NCT02176018|76116308|FG000|NOT COMPLETED|Overall Study||5||
60000553|NCT02176018|76116309|FG001|NOT COMPLETED|Overall Study||6||
60000554|NCT02116582|76116315|FG000|STARTED|Overall Study||215||
60000555|NCT02116582|76116315|FG000|Treated|Overall Study||214||
60000556|NCT02116582|76116315|FG000|COMPLETED|Overall Study||0||
60000557|NCT02116582|76116315|FG000|NOT COMPLETED|Overall Study||215||
60000558|NCT02589639|76116322|FG000|STARTED|Overall Study||90||
60000559|NCT02589639|76116323|FG001|STARTED|Overall Study||89||
60000560|NCT02589639|76116324|FG002|STARTED|Overall Study||90||
60000561|NCT02589639|76116322|FG000|Treated|Overall Study||90||
60000562|NCT02589639|76116323|FG001|Treated|Overall Study||86||
60000563|NCT02589639|76116324|FG002|Treated|Overall Study||90||
60000564|NCT02589639|76116322|FG000|COMPLETED|Overall Study||80||
60000565|NCT02589639|76116323|FG001|COMPLETED|Overall Study||79||
60000566|NCT02589639|76116324|FG002|COMPLETED|Overall Study||86||
60000567|NCT02589639|76116322|FG000|NOT COMPLETED|Overall Study||10||
60000568|NCT02589639|76116323|FG001|NOT COMPLETED|Overall Study||10||
60000569|NCT02589639|76116324|FG002|NOT COMPLETED|Overall Study||4||
60000570|NCT02151682|76116334|FG000|STARTED|Part 1: 14 Days Morphine or Tapentadol||24||
60000571|NCT02151682|76116335|FG001|STARTED|Part 1: 14 Days Morphine or Tapentadol||45||
60000572|NCT02151682|76116336|FG002|STARTED|Part 1: 14 Days Morphine or Tapentadol|Group not defined for Part 1.|0||
60000573|NCT02151682|76116337|FG003|STARTED|Part 1: 14 Days Morphine or Tapentadol|Group not defined for Part 1.|0||
60000574|NCT02151682|76116338|FG004|STARTED|Part 1: 14 Days Morphine or Tapentadol|Group not defined for Part 1.|0||
60000575|NCT02151682|76116339|FG005|STARTED|Part 1: 14 Days Morphine or Tapentadol|Group not defined for Part 1.|0||
60000576|NCT02151682|76116334|FG000|COMPLETED|Part 1: 14 Days Morphine or Tapentadol|14-Day treatment and final post-treatment visit completed or tapentadol treatment in Part 2 entered.|22||
60000577|NCT02151682|76116335|FG001|COMPLETED|Part 1: 14 Days Morphine or Tapentadol|14-Day treatment and final post-treatment visit completed or tapentadol treatment in Part 2 entered.|40||
60000578|NCT02151682|76116336|FG002|COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0||
60000579|NCT02151682|76116337|FG003|COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0||
60000580|NCT02151682|76116338|FG004|COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0||
60000581|NCT02151682|76116339|FG005|COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0||
60000582|NCT02151682|76116334|FG000|NOT COMPLETED|Part 1: 14 Days Morphine or Tapentadol||2||
60000583|NCT02151682|76116335|FG001|NOT COMPLETED|Part 1: 14 Days Morphine or Tapentadol||5||
60000584|NCT02151682|76116336|FG002|NOT COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0||
60000585|NCT02151682|76116337|FG003|NOT COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0||
60000586|NCT02151682|76116338|FG004|NOT COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0||
60000587|NCT02151682|76116339|FG005|NOT COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0||
60000588|NCT02151682|76116334|FG000|STARTED|Part 2: Tapent. Extension or Observation|Group not defined for Part 2.|0||
60000589|NCT02151682|76116335|FG001|STARTED|Part 2: Tapent. Extension or Observation|Group not defined for Part 2.|0||
60000590|NCT02151682|76116336|FG002|STARTED|Part 2: Tapent. Extension or Observation|26 Completers on tapentadol PR and 10 completers on morphine PR from Part 1.|36||
60000591|NCT02151682|76116337|FG003|STARTED|Part 2: Tapent. Extension or Observation|14 Completers and 4 of 5 non-completers on tapentadol in Part 1.|18||
60000592|NCT02151682|76116338|FG004|STARTED|Part 2: Tapent. Extension or Observation|12 Completers and 2 non-completers from morphine treatment in Part 1.|14||
60000593|NCT02151682|76116339|FG005|STARTED|Part 2: Tapent. Extension or Observation||0||
60000594|NCT02151682|76116334|FG000|COMPLETED|Part 2: Tapent. Extension or Observation||0||
60000595|NCT02151682|76116335|FG001|COMPLETED|Part 2: Tapent. Extension or Observation||0||
60000596|NCT02151682|76116336|FG002|COMPLETED|Part 2: Tapent. Extension or Observation|12 Month of tapentadol treatment completed and final visit of Part 2 performed.|8||
60000597|NCT02151682|76116337|FG003|COMPLETED|Part 2: Tapent. Extension or Observation||14||
60000598|NCT02151682|76116338|FG004|COMPLETED|Part 2: Tapent. Extension or Observation||14||
60000599|NCT02151682|76116339|FG005|COMPLETED|Part 2: Tapent. Extension or Observation||0||
60000600|NCT02151682|76116334|FG000|NOT COMPLETED|Part 2: Tapent. Extension or Observation||0||
60000601|NCT02151682|76116335|FG001|NOT COMPLETED|Part 2: Tapent. Extension or Observation||0||
60000602|NCT02151682|76116336|FG002|NOT COMPLETED|Part 2: Tapent. Extension or Observation||28||
60000603|NCT02151682|76116337|FG003|NOT COMPLETED|Part 2: Tapent. Extension or Observation||4||
60000604|NCT02151682|76116338|FG004|NOT COMPLETED|Part 2: Tapent. Extension or Observation||0||
60000605|NCT02151682|76116339|FG005|NOT COMPLETED|Part 2: Tapent. Extension or Observation||0||
60000606|NCT02151682|76116334|FG000|STARTED|Part 2: Observ. Aft. Tapent. Extension|Group not defined for Part 2.|0||
60000607|NCT02151682|76116335|FG001|STARTED|Part 2: Observ. Aft. Tapent. Extension|Group not defined for Part 2.|0||
60000608|NCT02151682|76116336|FG002|STARTED|Part 2: Observ. Aft. Tapent. Extension|Not applicable for this period.|0||
60000609|NCT02151682|76116337|FG003|STARTED|Part 2: Observ. Aft. Tapent. Extension|Not applicable for this period.|0||
60000610|NCT02151682|76116338|FG004|STARTED|Part 2: Observ. Aft. Tapent. Extension|Not applicable for this period.|0||
60000611|NCT02151682|76116339|FG005|STARTED|Part 2: Observ. Aft. Tapent. Extension|19 tapentadol and 7 morphine completers (Part 1) who discontinued from tapentadol treatm. in Part 2.|26||
60000612|NCT02151682|76116334|FG000|COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0||
60000613|NCT02151682|76116335|FG001|COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0||
60000614|NCT02151682|76116336|FG002|COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0||
60000615|NCT02151682|76116337|FG003|COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0||
60133883|NCT01401361|76256935|FG000|COMPLETED|Overall Study|16 subjects were withdrawn prior to the use of the investigational device|122||
60133884|NCT01401361|76256935|FG000|NOT COMPLETED|Overall Study||28||
60133885|NCT01401283|76256941|FG000|STARTED|Overall Study||89||
60133886|NCT01401283|76256942|FG001|STARTED|Overall Study||91||
60133887|NCT01401283|76256941|FG000|COMPLETED|Overall Study||79||
60133888|NCT01401283|76256942|FG001|COMPLETED|Overall Study||81||
60133889|NCT01401283|76256941|FG000|NOT COMPLETED|Overall Study||10||
60133890|NCT01401283|76256942|FG001|NOT COMPLETED|Overall Study||10||
60133891|NCT00693303|76256948|FG000|STARTED|Overall Study||21||
60133892|NCT00693303|76256948|FG000|COMPLETED|Overall Study||21||
60133893|NCT00693303|76256948|FG000|NOT COMPLETED|Overall Study||0||
60133894|NCT00694473|76256952|FG000|STARTED|Overall Study|Aug 2008|76||
60133895|NCT00694473|76256952|FG000|COMPLETED|Overall Study|Dec 2010|69||
60133896|NCT00694473|76256952|FG000|NOT COMPLETED|Overall Study||7||
60133897|NCT00695097|76256958|FG000|STARTED|Overall Study||10||
60133898|NCT00695097|76256959|FG001|STARTED|Overall Study||5||
60133899|NCT00695097|76256958|FG000|COMPLETED|Overall Study||9||
60133900|NCT00695097|76256959|FG001|COMPLETED|Overall Study||5||
60133901|NCT00695097|76256958|FG000|NOT COMPLETED|Overall Study||1||
60133902|NCT00695097|76256959|FG001|NOT COMPLETED|Overall Study||0||
60133903|NCT01422889|76256965|FG000|STARTED|Overall Study||1120||
60133904|NCT01422889|76256965|FG000|COMPLETED|Overall Study|9 subjects did not receive a study stent therefore 1111 subjects were eligible for follow up.|1111||
60133905|NCT01422889|76256965|FG000|NOT COMPLETED|Overall Study||9||
60133906|NCT01400971|76256969|FG000|STARTED|Overall Study||4299||
60133907|NCT01400971|76256969|FG000|Complete Treatment Data|Overall Study||2528||
60133908|NCT01400971|76256969|FG000|COMPLETED|Overall Study||3382||
60133909|NCT01400971|76256969|FG000|NOT COMPLETED|Overall Study||917||
60133910|NCT01387789|76256973|FG000|STARTED|Overall Study||71||
60133911|NCT01387789|76256973|FG000|COMPLETED|Overall Study||63||
60133912|NCT01387789|76256973|FG000|NOT COMPLETED|Overall Study||8||
60133913|NCT00695409|76256977|FG000|STARTED|Overall Study||122||
60133914|NCT00695409|76256977|FG000|COMPLETED|Overall Study||122||
60133915|NCT00695409|76256977|FG000|NOT COMPLETED|Overall Study||0||
60133916|NCT01400893|76256984|FG000|STARTED|Overall Study||69||
60133917|NCT01400893|76256985|FG001|STARTED|Overall Study||65||
59867396|NCT03987620|75991784|FG000|Withdrawn Before Treatment|Overall Study||5||
59867397|NCT03987620|75991785|FG001|Withdrawn Before Treatment|Overall Study||1||
59867398|NCT03987620|75991784|FG000|Withdrawn Before TOC|Overall Study||48||
59867399|NCT03987620|75991785|FG001|Withdrawn Before TOC|Overall Study||45||
59867400|NCT03987620|75991784|FG000|Completed the TOC Visit|Overall Study||250||
59867401|NCT03987620|75991785|FG001|Completed the TOC Visit|Overall Study||106||
59867402|NCT03987620|75991784|FG000|Withdrawn At or After the TOC Visit|Overall Study||4||
59867403|NCT03987620|75991785|FG001|Withdrawn At or After the TOC Visit|Overall Study||4||
59867404|NCT03987620|75991784|FG000|COMPLETED|Overall Study||246||
59867405|NCT03987620|75991785|FG001|COMPLETED|Overall Study||102||
59867406|NCT03987620|75991784|FG000|NOT COMPLETED|Overall Study||57||
59867407|NCT03987620|75991785|FG001|NOT COMPLETED|Overall Study||50||
59867408|NCT04376060|75991791|FG000|STARTED|Overall Study||15||
59867409|NCT04376060|75991791|FG000|COMPLETED|Overall Study||14||
59867410|NCT04376060|75991791|FG000|NOT COMPLETED|Overall Study||1||
59867411|NCT04413552|75991805|FG000|STARTED|Overall Study||6||
59867412|NCT04413552|75991806|FG001|STARTED|Overall Study||6||
59867413|NCT04413552|75991807|FG002|STARTED|Overall Study||6||
59867414|NCT04413552|75991808|FG003|STARTED|Overall Study||6||
59867415|NCT04413552|75991809|FG004|STARTED|Overall Study||6||
59867416|NCT04413552|75991810|FG005|STARTED|Overall Study||6||
59867417|NCT04413552|75991811|FG006|STARTED|Overall Study||7||
59867418|NCT04413552|75991812|FG007|STARTED|Overall Study||6||
59867419|NCT04413552|75991813|FG008|STARTED|Overall Study||16||
59867420|NCT04413552|75991814|FG009|STARTED|Overall Study||8||
59867421|NCT04413552|75991805|FG000|Received Study Drug|Overall Study||6||
59867422|NCT04413552|75991806|FG001|Received Study Drug|Overall Study||6||
59867423|NCT04413552|75991807|FG002|Received Study Drug|Overall Study||6||
59867424|NCT04413552|75991808|FG003|Received Study Drug|Overall Study||6||
59867425|NCT04413552|75991809|FG004|Received Study Drug|Overall Study||6||
59867426|NCT04413552|75991810|FG005|Received Study Drug|Overall Study||6||
59867427|NCT04413552|75991811|FG006|Received Study Drug|Overall Study||6||
59867428|NCT04413552|75991812|FG007|Received Study Drug|Overall Study||6||
59867429|NCT04413552|75991813|FG008|Received Study Drug|Overall Study||16||
59867430|NCT04413552|75991814|FG009|Received Study Drug|Overall Study||8||
59867431|NCT04413552|75991805|FG000|COMPLETED|Overall Study||6||
59867432|NCT04413552|75991806|FG001|COMPLETED|Overall Study||6||
59867433|NCT04413552|75991807|FG002|COMPLETED|Overall Study||6||
59867434|NCT04413552|75991808|FG003|COMPLETED|Overall Study||6||
59867435|NCT04413552|75991809|FG004|COMPLETED|Overall Study||6||
59867436|NCT04413552|75991810|FG005|COMPLETED|Overall Study||6||
59867437|NCT04413552|75991811|FG006|COMPLETED|Overall Study||6||
59867438|NCT04413552|75991812|FG007|COMPLETED|Overall Study||6||
59867439|NCT04413552|75991813|FG008|COMPLETED|Overall Study||16||
59867440|NCT04413552|75991814|FG009|COMPLETED|Overall Study||8||
59867441|NCT04413552|75991805|FG000|NOT COMPLETED|Overall Study||0||
59867442|NCT04413552|75991806|FG001|NOT COMPLETED|Overall Study||0||
59867443|NCT04413552|75991807|FG002|NOT COMPLETED|Overall Study||0||
59867444|NCT04413552|75991808|FG003|NOT COMPLETED|Overall Study||0||
59867445|NCT04413552|75991809|FG004|NOT COMPLETED|Overall Study||0||
59867446|NCT04413552|75991810|FG005|NOT COMPLETED|Overall Study||0||
59867447|NCT04413552|75991811|FG006|NOT COMPLETED|Overall Study||1||
59867448|NCT04413552|75991812|FG007|NOT COMPLETED|Overall Study||0||
59867449|NCT04413552|75991813|FG008|NOT COMPLETED|Overall Study||0||
59867450|NCT04413552|75991814|FG009|NOT COMPLETED|Overall Study||0||
59867451|NCT03987074|75991845|FG000|STARTED|Overall Study||21||
59867452|NCT03987074|75991846|FG001|STARTED|Overall Study||22||
59867453|NCT03987074|75991847|FG002|STARTED|Overall Study||22||
59867454|NCT03987074|75991848|FG003|STARTED|Overall Study||22||
59867455|NCT03987074|75991849|FG004|STARTED|Overall Study||21||
60133918|NCT01400893|76256984|FG000|COMPLETED|Overall Study||42||
60133919|NCT01400893|76256985|FG001|COMPLETED|Overall Study||38||
60133920|NCT01400893|76256984|FG000|NOT COMPLETED|Overall Study||27||
59867456|NCT03987074|75991845|FG000|COMPLETED|Overall Study||18||
59867457|NCT03987074|75991846|FG001|COMPLETED|Overall Study||20||
59867458|NCT03987074|75991847|FG002|COMPLETED|Overall Study||21||
59867459|NCT03987074|75991848|FG003|COMPLETED|Overall Study||18||
59867460|NCT03987074|75991849|FG004|COMPLETED|Overall Study||19||
59867461|NCT03987074|75991845|FG000|NOT COMPLETED|Overall Study||3||
59867462|NCT03987074|75991846|FG001|NOT COMPLETED|Overall Study||2||
59867463|NCT03987074|75991847|FG002|NOT COMPLETED|Overall Study||1||
59867464|NCT03987074|75991848|FG003|NOT COMPLETED|Overall Study||4||
59867465|NCT03987074|75991849|FG004|NOT COMPLETED|Overall Study||2||
59867466|NCT04439214|75991861|FG000|STARTED|Overall Study||47||
59867467|NCT04439214|75991861|FG000|Eligible|Overall Study||42||
59867468|NCT04439214|75991861|FG000|Treated|Overall Study||47||
59867469|NCT04439214|75991861|FG000|Treated and Reported Adverse Event Data|Overall Study|One patient experienced disease progression in cycle 1 and an AE form was not submitted.|46||
59867470|NCT04439214|75991861|FG000|Eligible and Treated|Overall Study||42||
59867471|NCT04439214|75991861|FG000|COMPLETED|Overall Study||0|Treatment continued until progression or intolerability. At the time of the final analysis of the data, 9 patients were still receiving protocol treatment.|
59867472|NCT04439214|75991861|FG000|NOT COMPLETED|Overall Study||47||
59867473|NCT03696342|75991867|FG000|STARTED|Overall Study||23||23
60133921|NCT01400893|76256985|FG001|NOT COMPLETED|Overall Study||27||
60133922|NCT00697203|76256997|FG000|STARTED|Overall Study||76||
60133923|NCT00697203|76256998|FG001|STARTED|Overall Study||68||
60133924|NCT00697203|76256999|FG002|STARTED|Overall Study||74||
60133925|NCT00697203|76257000|FG003|STARTED|Overall Study||74||
60133926|NCT00697203|76256997|FG000|COMPLETED|Overall Study||67||
60133927|NCT00697203|76256998|FG001|COMPLETED|Overall Study||62||
60133928|NCT00697203|76256999|FG002|COMPLETED|Overall Study||66||
60133929|NCT00697203|76257000|FG003|COMPLETED|Overall Study||67||
60133930|NCT00697203|76256997|FG000|NOT COMPLETED|Overall Study||9||
60133931|NCT00697203|76256998|FG001|NOT COMPLETED|Overall Study||6||
60133932|NCT00697203|76256999|FG002|NOT COMPLETED|Overall Study||8||
60133933|NCT00697203|76257000|FG003|NOT COMPLETED|Overall Study||7||
60133934|NCT00698139|76257013|FG000|STARTED|Overall Study||1||
60133935|NCT00698139|76257014|FG001|STARTED|Overall Study||1||
60133936|NCT00698139|76257015|FG002|STARTED|Overall Study||1||
60133937|NCT00698139|76257013|FG000|2nd Visit|Overall Study||1||
60133938|NCT00698139|76257014|FG001|2nd Visit|Overall Study||1||
60133939|NCT00698139|76257015|FG002|2nd Visit|Overall Study|1 subject in the Intervention Group did not have a 2nd visit (per design).|0||
60133940|NCT00698139|76257013|FG000|COMPLETED|Overall Study||1||
60133941|NCT00698139|76257014|FG001|COMPLETED|Overall Study||1||
60133942|NCT00698139|76257015|FG002|COMPLETED|Overall Study||1||
60133943|NCT00698139|76257013|FG000|NOT COMPLETED|Overall Study||0||
60133944|NCT00698139|76257014|FG001|NOT COMPLETED|Overall Study||0||
60133945|NCT00698139|76257015|FG002|NOT COMPLETED|Overall Study||0||
60133946|NCT01400815|76257025|FG000|STARTED|Overall Study||118||
60133947|NCT01400815|76257026|FG001|STARTED|Overall Study||116||
60133948|NCT01400815|76257025|FG000|COMPLETED|Overall Study||80||
60133949|NCT01400815|76257026|FG001|COMPLETED|Overall Study||95||
60133950|NCT01400815|76257025|FG000|NOT COMPLETED|Overall Study||38||
60133951|NCT01400815|76257026|FG001|NOT COMPLETED|Overall Study||21||
60133952|NCT02990325|76257035|FG000|STARTED|Overall Study||11||
60133953|NCT02990325|76257036|FG001|STARTED|Overall Study||12||
60133954|NCT02990325|76257037|FG002|STARTED|Overall Study||13||
59762482|NCT02644525|75882211|FG002|NOT COMPLETED|Group 2||0||
59867474|NCT03696342|75991868|FG001|STARTED|Overall Study||23||23
59867475|NCT03696342|75991867|FG000|COMPLETED|Overall Study||22||22
59867476|NCT03696342|75991868|FG001|COMPLETED|Overall Study||23||23
59867477|NCT03696342|75991867|FG000|NOT COMPLETED|Overall Study||1||1
59867478|NCT03696342|75991868|FG001|NOT COMPLETED|Overall Study||0||0
59867479|NCT04411680|75991876|FG000|STARTED|Treatment Period||78||
59867480|NCT04411680|75991877|FG001|STARTED|Treatment Period||44||
59867481|NCT04411680|75991876|FG000|COMPLETED|Treatment Period||49||
59867482|NCT04411680|75991877|FG001|COMPLETED|Treatment Period||36||
59867483|NCT04411680|75991876|FG000|NOT COMPLETED|Treatment Period||29||
59867484|NCT04411680|75991877|FG001|NOT COMPLETED|Treatment Period||8||
59867485|NCT04411680|75991876|FG000|STARTED|Follow up Period||78||
59867486|NCT04411680|75991877|FG001|STARTED|Follow up Period||44||
59867487|NCT04411680|75991876|FG000|COMPLETED|Follow up Period||60||
59867488|NCT04411680|75991877|FG001|COMPLETED|Follow up Period||30||
59867489|NCT04411680|75991876|FG000|NOT COMPLETED|Follow up Period||18||
59867490|NCT04411680|75991877|FG001|NOT COMPLETED|Follow up Period||14||
59867491|NCT04410198|75991883|FG000|STARTED|Overall Study||203||
60000616|NCT02151682|76116338|FG004|COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0||
59867492|NCT04410198|75991883|FG000|Received at Least 1 Dose of Study Drug|Overall Study||203||
59950732|NCT03536884|76069560|FG004|COMPLETED|Maintenance Treatment Period Week 16-48||325||
60000617|NCT02151682|76116339|FG005|COMPLETED|Part 2: Observ. Aft. Tapent. Extension||19||
60000618|NCT02151682|76116334|FG000|NOT COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0||
60000619|NCT02151682|76116335|FG001|NOT COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0||
60000620|NCT02151682|76116336|FG002|NOT COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0||
60000621|NCT02151682|76116337|FG003|NOT COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0||
60000622|NCT02151682|76116338|FG004|NOT COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0||
60000623|NCT02151682|76116339|FG005|NOT COMPLETED|Part 2: Observ. Aft. Tapent. Extension||7||
60000624|NCT02174848|76116359|FG000|STARTED|Overall Study||24||
60000625|NCT02174848|76116360|FG001|STARTED|Overall Study||44||
60000626|NCT02174848|76116359|FG000|Provided Post-baseline Efficacy Data|Overall Study||19||
60000627|NCT02174848|76116360|FG001|Provided Post-baseline Efficacy Data|Overall Study||43||
60000628|NCT02174848|76116359|FG000|COMPLETED|Overall Study||17||
60000629|NCT02174848|76116360|FG001|COMPLETED|Overall Study||38||
60000630|NCT02174848|76116359|FG000|NOT COMPLETED|Overall Study||7||
60000631|NCT02174848|76116360|FG001|NOT COMPLETED|Overall Study||6||
60000632|NCT02151058|76116374|FG000|STARTED|Overall Study||45||
60000633|NCT02151058|76116375|FG001|STARTED|Overall Study||91||
60000634|NCT02151058|76116376|FG002|STARTED|Overall Study||91||
60000635|NCT02151058|76116374|FG000|COMPLETED|Overall Study||43||
60000636|NCT02151058|76116375|FG001|COMPLETED|Overall Study||90||
60000637|NCT02151058|76116376|FG002|COMPLETED|Overall Study||86||
60000638|NCT02151058|76116374|FG000|NOT COMPLETED|Overall Study||2||
60000639|NCT02151058|76116375|FG001|NOT COMPLETED|Overall Study||1||
60133955|NCT02990325|76257035|FG000|COMPLETED|Overall Study||11||
60133956|NCT02990325|76257036|FG001|COMPLETED|Overall Study||12||
60133957|NCT02990325|76257037|FG002|COMPLETED|Overall Study||13||
60133958|NCT02990325|76257035|FG000|NOT COMPLETED|Overall Study||0||
60133959|NCT02990325|76257036|FG001|NOT COMPLETED|Overall Study||0||
60133960|NCT02990325|76257037|FG002|NOT COMPLETED|Overall Study||0||
59867493|NCT04410198|75991883|FG000|Full Analysis Set|Overall Study||201|All enrolled participants who provided baseline Hb data and data for at least 1 postbaseline Hb time point.|
59867494|NCT04410198|75991883|FG000|COMPLETED|Overall Study||166||
59867495|NCT04410198|75991883|FG000|NOT COMPLETED|Overall Study||37||
59867496|NCT04161144|75991889|FG000|STARTED|Overall Study||12||
59867497|NCT04161144|75991890|FG001|STARTED|Overall Study||10||
59867498|NCT04161144|75991889|FG000|COMPLETED|Overall Study||11||
59867499|NCT04161144|75991890|FG001|COMPLETED|Overall Study||9||
59867500|NCT04161144|75991889|FG000|NOT COMPLETED|Overall Study||1||
59867501|NCT04161144|75991890|FG001|NOT COMPLETED|Overall Study||1||
59867502|NCT03984812|75991907|FG000|STARTED|Part 1 (Up to Day 28)||6||
59867503|NCT03984812|75991908|FG001|STARTED|Part 1 (Up to Day 28)||6||
59867504|NCT03984812|75991909|FG002|STARTED|Part 1 (Up to Day 28)||6||
59867505|NCT03984812|75991910|FG003|STARTED|Part 1 (Up to Day 28)||6||
59867506|NCT03984812|75991911|FG004|STARTED|Part 1 (Up to Day 28)|No participants were enrolled in this arm as the study was terminated due to non-safety reasons.|0||
59867507|NCT03984812|75991912|FG005|STARTED|Part 1 (Up to Day 28)|No participants were enrolled in this arm as the study was terminated due to non-safety reasons.|0||
59867508|NCT03984812|75991913|FG006|STARTED|Part 1 (Up to Day 28)|No participants were enrolled in this arm as the study was terminated due to non-safety reasons.|0||
59867509|NCT03984812|75991914|FG007|STARTED|Part 1 (Up to Day 28)||0||
59867510|NCT03984812|75991915|FG008|STARTED|Part 1 (Up to Day 28)||0||
60133961|NCT00706407|76257049|FG000|STARTED|Overall Study||42||
60133962|NCT00706407|76257049|FG000|COMPLETED|Overall Study||33||
60133963|NCT00706407|76257049|FG000|NOT COMPLETED|Overall Study||9||
60133964|NCT00706485|76257056|FG000|STARTED|Overall Study||5||
60133965|NCT00706485|76257056|FG000|COMPLETED|Overall Study||5||
60133966|NCT00706485|76257056|FG000|NOT COMPLETED|Overall Study||0||
60133967|NCT02339415|76257062|FG000|STARTED|First Period||22||
60133968|NCT02339415|76257063|FG001|STARTED|First Period||22||
60133969|NCT02339415|76257062|FG000|Received at Least One Dose|First Period||21||
60133970|NCT02339415|76257063|FG001|Received at Least One Dose|First Period||20||
60133971|NCT02339415|76257062|FG000|COMPLETED|First Period||20||
60133972|NCT02339415|76257063|FG001|COMPLETED|First Period||20||
60133973|NCT02339415|76257062|FG000|NOT COMPLETED|First Period||2||
60133974|NCT02339415|76257063|FG001|NOT COMPLETED|First Period||2||
60133975|NCT02339415|76257062|FG000|STARTED|Washout||20||
60133976|NCT02339415|76257063|FG001|STARTED|Washout||20||
60133977|NCT02339415|76257062|FG000|COMPLETED|Washout||20||
60133978|NCT02339415|76257063|FG001|COMPLETED|Washout||20||
60133979|NCT02339415|76257062|FG000|NOT COMPLETED|Washout||0||
60133980|NCT02339415|76257063|FG001|NOT COMPLETED|Washout||0||
60133981|NCT02339415|76257062|FG000|STARTED|Second Period||20||
60133982|NCT02339415|76257063|FG001|STARTED|Second Period||20||
60133983|NCT02339415|76257062|FG000|COMPLETED|Second Period||19||
60133984|NCT02339415|76257063|FG001|COMPLETED|Second Period||18||
60133985|NCT02339415|76257062|FG000|NOT COMPLETED|Second Period||1||
60133986|NCT02339415|76257063|FG001|NOT COMPLETED|Second Period||2||
60133987|NCT00706563|76257073|FG000|STARTED|Overall Study||61||
60133988|NCT00706563|76257074|FG001|STARTED|Overall Study||59||
60133989|NCT00706563|76257073|FG000|COMPLETED|Overall Study||61||
60133990|NCT00706563|76257074|FG001|COMPLETED|Overall Study||59||
60133991|NCT00706563|76257073|FG000|NOT COMPLETED|Overall Study||0||
60133992|NCT00706563|76257074|FG001|NOT COMPLETED|Overall Study||0||
60133993|NCT01400503|76257080|FG000|STARTED|Overall Study||60||
60133994|NCT01400503|76257080|FG000|COMPLETED|Overall Study||0||
60133995|NCT01400503|76257080|FG000|NOT COMPLETED|Overall Study||60||
60133996|NCT00706719|76257087|FG000|STARTED|Overall Study||5||
60133997|NCT00706719|76257088|FG001|STARTED|Overall Study||7||
60133998|NCT00706719|76257089|FG002|STARTED|Overall Study||5||
60133999|NCT00706719|76257087|FG000|COMPLETED|Overall Study||5||
60134000|NCT00706719|76257088|FG001|COMPLETED|Overall Study||6||
60134001|NCT00706719|76257089|FG002|COMPLETED|Overall Study||1||
60134002|NCT00706719|76257087|FG000|NOT COMPLETED|Overall Study||0||
60134003|NCT00706719|76257088|FG001|NOT COMPLETED|Overall Study||1||
60134004|NCT00706719|76257089|FG002|NOT COMPLETED|Overall Study||4||
60134005|NCT01400425|76257096|FG000|STARTED|Overall Study||239||
60134006|NCT01400425|76257096|FG000|COMPLETED|Overall Study||229||
60134007|NCT01400425|76257096|FG000|NOT COMPLETED|Overall Study||10||
60134008|NCT01421719|76257102|FG000|STARTED|Overall Study||20||
60134009|NCT01421719|76257102|FG000|COMPLETED|Overall Study||16||
60134010|NCT01421719|76257102|FG000|NOT COMPLETED|Overall Study||4||
60134011|NCT01421641|76257109|FG000|STARTED|Overall Study||37||
60134012|NCT01421641|76257110|FG001|STARTED|Overall Study||37||
60134013|NCT01421641|76257109|FG000|COMPLETED|Overall Study||35||
60134014|NCT01421641|76257110|FG001|COMPLETED|Overall Study||35||
60134015|NCT01421641|76257109|FG000|NOT COMPLETED|Overall Study||2||
60134016|NCT01421641|76257110|FG001|NOT COMPLETED|Overall Study||2||
60134017|NCT01385995|76257118|FG000|STARTED|Period 1, 2 Months||25||
60134018|NCT01385995|76257119|FG001|STARTED|Period 1, 2 Months||25||
60134019|NCT01385995|76257118|FG000|COMPLETED|Period 1, 2 Months||24||
60134020|NCT01385995|76257119|FG001|COMPLETED|Period 1, 2 Months||25||
60134021|NCT01385995|76257118|FG000|NOT COMPLETED|Period 1, 2 Months||1||
60134022|NCT01385995|76257119|FG001|NOT COMPLETED|Period 1, 2 Months||0||
60134023|NCT01385995|76257118|FG000|STARTED|Washout Period, 1 Month||24||
60134024|NCT01385995|76257119|FG001|STARTED|Washout Period, 1 Month||25||
60134025|NCT01385995|76257118|FG000|COMPLETED|Washout Period, 1 Month||24||
60134026|NCT01385995|76257119|FG001|COMPLETED|Washout Period, 1 Month||25||
60134027|NCT01385995|76257118|FG000|NOT COMPLETED|Washout Period, 1 Month||0||
60134028|NCT01385995|76257119|FG001|NOT COMPLETED|Washout Period, 1 Month||0||
60134029|NCT01385995|76257118|FG000|STARTED|Period 2, 2 Months||24||
60134030|NCT01385995|76257119|FG001|STARTED|Period 2, 2 Months||25||
60134031|NCT01385995|76257118|FG000|COMPLETED|Period 2, 2 Months||24||
60134032|NCT01385995|76257119|FG001|COMPLETED|Period 2, 2 Months||25||
60134033|NCT01385995|76257118|FG000|NOT COMPLETED|Period 2, 2 Months||0||
60134034|NCT01385995|76257119|FG001|NOT COMPLETED|Period 2, 2 Months||0||
60134035|NCT01421017|76257130|FG000|STARTED|Overall Study||12||
60134036|NCT01421017|76257131|FG001|STARTED|Overall Study||12||
60134037|NCT01421017|76257132|FG002|STARTED|Overall Study||7||
60134038|NCT01421017|76257130|FG000|COMPLETED|Overall Study||10||
60134039|NCT01421017|76257131|FG001|COMPLETED|Overall Study||6||
60134040|NCT01421017|76257132|FG002|COMPLETED|Overall Study||4||
60134041|NCT01421017|76257130|FG000|NOT COMPLETED|Overall Study||2||
60134042|NCT01421017|76257131|FG001|NOT COMPLETED|Overall Study||6||
60134043|NCT01421017|76257132|FG002|NOT COMPLETED|Overall Study||3||
60134044|NCT00703053|76257149|FG000|STARTED|Overall Study||27||
60134045|NCT00703053|76257150|FG001|STARTED|Overall Study||26||
60134046|NCT00703053|76257151|FG002|STARTED|Overall Study||51||
60134047|NCT00703053|76257152|FG003|STARTED|Overall Study||49||
60134048|NCT00703053|76257153|FG004|STARTED|Overall Study||51||
60134049|NCT00703053|76257154|FG005|STARTED|Overall Study||49||
60134050|NCT00703053|76257155|FG006|STARTED|Overall Study||52||
59762483|NCT02644525|75882212|FG003|NOT COMPLETED|Group 2||0||
60134051|NCT00703053|76257156|FG007|STARTED|Overall Study||97||
60134052|NCT00703053|76257157|FG008|STARTED|Overall Study||103||
60134053|NCT00703053|76257149|FG000|COMPLETED|Overall Study||26||
60134054|NCT00703053|76257150|FG001|COMPLETED|Overall Study||24||
60134055|NCT00703053|76257151|FG002|COMPLETED|Overall Study||48||
60134056|NCT00703053|76257152|FG003|COMPLETED|Overall Study||46||
60134057|NCT00703053|76257153|FG004|COMPLETED|Overall Study||50||
60134058|NCT00703053|76257154|FG005|COMPLETED|Overall Study||43||
60134059|NCT00703053|76257155|FG006|COMPLETED|Overall Study||45||
60134060|NCT00703053|76257156|FG007|COMPLETED|Overall Study||91||
60134061|NCT00703053|76257157|FG008|COMPLETED|Overall Study||102||
60134062|NCT00703053|76257149|FG000|NOT COMPLETED|Overall Study||1||
60134063|NCT00703053|76257150|FG001|NOT COMPLETED|Overall Study||2||
60134064|NCT00703053|76257151|FG002|NOT COMPLETED|Overall Study||3||
60134065|NCT00703053|76257152|FG003|NOT COMPLETED|Overall Study||3||
60134066|NCT00703053|76257153|FG004|NOT COMPLETED|Overall Study||1||
60134067|NCT00703053|76257154|FG005|NOT COMPLETED|Overall Study||6||
60134068|NCT00703053|76257155|FG006|NOT COMPLETED|Overall Study||7||
60134069|NCT00703053|76257156|FG007|NOT COMPLETED|Overall Study||6||
60134070|NCT00703053|76257157|FG008|NOT COMPLETED|Overall Study||1||
60134071|NCT01420627|76257179|FG000|STARTED|Adagen Lead-in Period||7|3 weeks, minimum|
60134072|NCT01420627|76257179|FG000|COMPLETED|Adagen Lead-in Period||7||
60134073|NCT01420627|76257179|FG000|NOT COMPLETED|Adagen Lead-in Period||0||
60134074|NCT01420627|76257179|FG000|STARTED|EZN-2279 Treatment Period||7|Weeks T-1 through T-21|
60134075|NCT01420627|76257179|FG000|COMPLETED|EZN-2279 Treatment Period||6||
60134076|NCT01420627|76257179|FG000|NOT COMPLETED|EZN-2279 Treatment Period||1||
60134077|NCT01420627|76257179|FG000|STARTED|EZN-2279 Maintenance Period||6|Continuing until end of study, at least 203 weeks|
60134078|NCT01420627|76257179|FG000|COMPLETED|EZN-2279 Maintenance Period||6||
60134079|NCT01420627|76257179|FG000|NOT COMPLETED|EZN-2279 Maintenance Period||0||
60134080|NCT01400113|76257189|FG000|STARTED|Overall Study||60||
60134081|NCT01400113|76257190|FG001|STARTED|Overall Study||60||
60134082|NCT01400113|76257189|FG000|COMPLETED|Overall Study||59||
60134083|NCT01400113|76257190|FG001|COMPLETED|Overall Study||59||
60134084|NCT01400113|76257189|FG000|NOT COMPLETED|Overall Study||1||
60134085|NCT01400113|76257190|FG001|NOT COMPLETED|Overall Study||1||
60134086|NCT01399723|76257198|FG000|STARTED|Overall Study||263||
60134087|NCT01399723|76257199|FG001|STARTED|Overall Study||264||
60134088|NCT01399723|76257198|FG000|COMPLETED|Overall Study||263||
60134089|NCT01399723|76257199|FG001|COMPLETED|Overall Study||263||
60134090|NCT01399723|76257198|FG000|NOT COMPLETED|Overall Study||0||
60134091|NCT01399723|76257199|FG001|NOT COMPLETED|Overall Study||1||
60134092|NCT01385371|76257208|FG000|STARTED|Overall Study||752||
60134093|NCT01385371|76257209|FG001|STARTED|Overall Study||749||
60134094|NCT01385371|76257208|FG000|COMPLETED|Overall Study||603||
60134095|NCT01385371|76257209|FG001|COMPLETED|Overall Study||652||
60134096|NCT01385371|76257208|FG000|NOT COMPLETED|Overall Study||149||
60134097|NCT01385371|76257209|FG001|NOT COMPLETED|Overall Study||97||
60134098|NCT01399099|76257215|FG000|STARTED|Overall Study||67||
60134099|NCT01399099|76257215|FG000|6 Months|Overall Study||47||
60134100|NCT01399099|76257215|FG000|COMPLETED|Overall Study||36||
60134101|NCT01399099|76257215|FG000|NOT COMPLETED|Overall Study||31||
60134102|NCT01398787|76257220|FG000|STARTED|Overall Study||198||
60134103|NCT01398787|76257220|FG000|COMPLETED|Overall Study||197||
60134104|NCT01398787|76257220|FG000|NOT COMPLETED|Overall Study||1||
60134105|NCT01383499|76257226|FG000|STARTED|Period 1 (4 Weeks)||27||
60134106|NCT01383499|76257227|FG001|STARTED|Period 1 (4 Weeks)||24||
60134107|NCT01383499|76257228|FG002|STARTED|Period 1 (4 Weeks)||25||
60134108|NCT01383499|76257229|FG003|STARTED|Period 1 (4 Weeks)||25||
60134109|NCT01383499|76257226|FG000|COMPLETED|Period 1 (4 Weeks)||26||
60134110|NCT01383499|76257227|FG001|COMPLETED|Period 1 (4 Weeks)||24||
60134111|NCT01383499|76257228|FG002|COMPLETED|Period 1 (4 Weeks)||25||
60134112|NCT01383499|76257229|FG003|COMPLETED|Period 1 (4 Weeks)||25||
60134113|NCT01383499|76257226|FG000|NOT COMPLETED|Period 1 (4 Weeks)||1||
60134114|NCT01383499|76257227|FG001|NOT COMPLETED|Period 1 (4 Weeks)||0||
60134115|NCT01383499|76257228|FG002|NOT COMPLETED|Period 1 (4 Weeks)||0||
60134116|NCT01383499|76257229|FG003|NOT COMPLETED|Period 1 (4 Weeks)||0||
60134117|NCT01383499|76257226|FG000|STARTED|Period 2 (4 Weeks)||26||
60134118|NCT01383499|76257227|FG001|STARTED|Period 2 (4 Weeks)||24||
60134119|NCT01383499|76257228|FG002|STARTED|Period 2 (4 Weeks)||25||
60134120|NCT01383499|76257229|FG003|STARTED|Period 2 (4 Weeks)||25||
60134121|NCT01383499|76257226|FG000|COMPLETED|Period 2 (4 Weeks)||26||
60134122|NCT01383499|76257227|FG001|COMPLETED|Period 2 (4 Weeks)||24||
60134123|NCT01383499|76257228|FG002|COMPLETED|Period 2 (4 Weeks)||25||
60134124|NCT01383499|76257229|FG003|COMPLETED|Period 2 (4 Weeks)||25||
60134125|NCT01383499|76257226|FG000|NOT COMPLETED|Period 2 (4 Weeks)||0||
60134126|NCT01383499|76257227|FG001|NOT COMPLETED|Period 2 (4 Weeks)||0||
60134127|NCT01383499|76257228|FG002|NOT COMPLETED|Period 2 (4 Weeks)||0||
60134128|NCT01383499|76257229|FG003|NOT COMPLETED|Period 2 (4 Weeks)||0||
60134129|NCT01383499|76257226|FG000|STARTED|Period 3 (4 Weeks)||26||
60134130|NCT01383499|76257227|FG001|STARTED|Period 3 (4 Weeks)||24||
60134131|NCT01383499|76257228|FG002|STARTED|Period 3 (4 Weeks)||25||
60134132|NCT01383499|76257229|FG003|STARTED|Period 3 (4 Weeks)||25||
60134133|NCT01383499|76257226|FG000|COMPLETED|Period 3 (4 Weeks)||26||
60134134|NCT01383499|76257227|FG001|COMPLETED|Period 3 (4 Weeks)||24||
60134135|NCT01383499|76257228|FG002|COMPLETED|Period 3 (4 Weeks)||25||
60134136|NCT01383499|76257229|FG003|COMPLETED|Period 3 (4 Weeks)||25||
60134137|NCT01383499|76257226|FG000|NOT COMPLETED|Period 3 (4 Weeks)||0||
60134138|NCT01383499|76257227|FG001|NOT COMPLETED|Period 3 (4 Weeks)||0||
60134139|NCT01383499|76257228|FG002|NOT COMPLETED|Period 3 (4 Weeks)||0||
60134140|NCT01383499|76257229|FG003|NOT COMPLETED|Period 3 (4 Weeks)||0||
60134141|NCT01397461|76257245|FG000|STARTED|Overall Study||155||
60134142|NCT01397461|76257246|FG001|STARTED|Overall Study||156||
60134143|NCT01397461|76257247|FG002|STARTED|Overall Study||154||
60134144|NCT01397461|76257245|FG000|COMPLETED|Overall Study||153||
60134145|NCT01397461|76257246|FG001|COMPLETED|Overall Study||150||
60134146|NCT01397461|76257247|FG002|COMPLETED|Overall Study||152||
60134147|NCT01397461|76257245|FG000|NOT COMPLETED|Overall Study||2||
60134148|NCT01397461|76257246|FG001|NOT COMPLETED|Overall Study||6||
60134149|NCT01397461|76257247|FG002|NOT COMPLETED|Overall Study||2||
60134150|NCT01382251|76257257|FG000|STARTED|Overall Study||123||
60134151|NCT01382251|76257258|FG001|STARTED|Overall Study||123||
59601041|NCT03978403|75710914|FG003|COMPLETED|Overall Study||6||
59601042|NCT03978403|75710911|FG000|NOT COMPLETED|Overall Study||0||
59601043|NCT03978403|75710912|FG001|NOT COMPLETED|Overall Study||0||
59601044|NCT03978403|75710913|FG002|NOT COMPLETED|Overall Study||0||
59762484|NCT02644525|75882209|FG000|STARTED|Group 3||1||
60134152|NCT01382251|76257257|FG000|COMPLETED|Overall Study||102||
60134153|NCT01382251|76257258|FG001|COMPLETED|Overall Study||102||
60134154|NCT01382251|76257257|FG000|NOT COMPLETED|Overall Study||21||
60134155|NCT01382251|76257258|FG001|NOT COMPLETED|Overall Study||21||
60134156|NCT01396525|76257263|FG000|STARTED|Overall Study||153||
60134157|NCT01396525|76257263|FG000|COMPLETED|Overall Study||127||
60134158|NCT01396525|76257263|FG000|NOT COMPLETED|Overall Study||26||
60134159|NCT02849652|76257275|FG000|STARTED|Overall Study||344||
60134160|NCT02849652|76257276|FG001|STARTED|Overall Study||131||
60134161|NCT02849652|76257277|FG002|STARTED|Overall Study||266||
60134162|NCT02849652|76257278|FG003|STARTED|Overall Study||91||
60134163|NCT02849652|76257275|FG000|Week 12|Overall Study||294||
60134164|NCT02849652|76257276|FG001|Week 12|Overall Study||120||
60134165|NCT02849652|76257277|FG002|Week 12|Overall Study||222||
60134166|NCT02849652|76257278|FG003|Week 12|Overall Study||78||
60134167|NCT02849652|76257275|FG000|Week 24|Overall Study||279||
60134168|NCT02849652|76257276|FG001|Week 24|Overall Study||112||
60134169|NCT02849652|76257277|FG002|Week 24|Overall Study||188||
60134170|NCT02849652|76257278|FG003|Week 24|Overall Study||74||
60134171|NCT02849652|76257275|FG000|Week 36|Overall Study||250||
60134172|NCT02849652|76257276|FG001|Week 36|Overall Study||104||
60134173|NCT02849652|76257277|FG002|Week 36|Overall Study||166||
60134174|NCT02849652|76257278|FG003|Week 36|Overall Study||66||
59601045|NCT03978403|75710914|FG003|NOT COMPLETED|Overall Study||0||
60134175|NCT02849652|76257275|FG000|Week 52|Overall Study||230||
60134176|NCT02849652|76257276|FG001|Week 52|Overall Study||94||
60134177|NCT02849652|76257277|FG002|Week 52|Overall Study||142||
60134178|NCT02849652|76257278|FG003|Week 52|Overall Study||65||
59601046|NCT03979807|75710927|FG000|STARTED|Overall Study||3876||
59601047|NCT03979807|75710928|FG001|STARTED|Overall Study||7420||
59601048|NCT03979807|75710927|FG000|COMPLETED|Overall Study||3876||
59601049|NCT03979807|75710928|FG001|COMPLETED|Overall Study||7420||
59601050|NCT03979807|75710927|FG000|NOT COMPLETED|Overall Study||0||
59601051|NCT03979807|75710928|FG001|NOT COMPLETED|Overall Study||0||
59601052|NCT04169113|75710936|FG000|STARTED|Overall Study||52||
59601053|NCT04169113|75710937|FG001|STARTED|Overall Study||59||
59601054|NCT04169113|75710936|FG000|COMPLETED|Overall Study||47||
59601055|NCT04169113|75710937|FG001|COMPLETED|Overall Study||53||
59601056|NCT04169113|75710936|FG000|NOT COMPLETED|Overall Study||5||
59601057|NCT04169113|75710937|FG001|NOT COMPLETED|Overall Study||6||
59601058|NCT04149925|75710945|FG000|STARTED|Overall Study||30||
59601059|NCT04149925|75710946|FG001|STARTED|Overall Study||30||
59601060|NCT04149925|75710945|FG000|COMPLETED|Overall Study||30||
59601061|NCT04149925|75710946|FG001|COMPLETED|Overall Study||30||
59601062|NCT04149925|75710945|FG000|NOT COMPLETED|Overall Study||0||
59601063|NCT04149925|75710946|FG001|NOT COMPLETED|Overall Study||0||
59601064|NCT03799783|75710952|FG000|STARTED|Overall Study||19||
59601065|NCT03799783|75710952|FG000|COMPLETED|Overall Study||19||
59601066|NCT03799783|75710952|FG000|NOT COMPLETED|Overall Study||0||
59601067|NCT04085341|75710958|FG000|STARTED|Overall Study||10||
59601068|NCT04085341|75710959|FG001|STARTED|Overall Study||11||
59601069|NCT04085341|75710958|FG000|COMPLETED|Overall Study||10||
59601070|NCT04085341|75710959|FG001|COMPLETED|Overall Study||11||
59601071|NCT04085341|75710958|FG000|NOT COMPLETED|Overall Study||0||
59601072|NCT04085341|75710959|FG001|NOT COMPLETED|Overall Study||0||
59601073|NCT04103515|75710967|FG000|STARTED|Overall Study||25||
59601074|NCT04103515|75710968|FG001|STARTED|Overall Study||25||
59601075|NCT04103515|75710967|FG000|COMPLETED|Overall Study||25||
59601076|NCT04103515|75710968|FG001|COMPLETED|Overall Study||25||
59601077|NCT04103515|75710967|FG000|NOT COMPLETED|Overall Study||0||
59601078|NCT04103515|75710968|FG001|NOT COMPLETED|Overall Study||0||
59601079|NCT03782701|75710974|FG000|STARTED|Overall Study||43||86
59601080|NCT03782701|75710974|FG000|Lumify|Overall Study||43||43
59601081|NCT03782701|75710974|FG000|Saline Solution|Overall Study||43||43
59601082|NCT03782701|75710974|FG000|COMPLETED|Overall Study||43||86
59601083|NCT03782701|75710974|FG000|NOT COMPLETED|Overall Study||0||0
59601084|NCT04143373|75710980|FG000|STARTED|Overall Study||20||20
59601085|NCT04143373|75710981|FG001|STARTED|Overall Study||20||20
59601086|NCT04143373|75710980|FG000|COMPLETED|Overall Study||20||20
59601087|NCT04143373|75710981|FG001|COMPLETED|Overall Study||20||20
59601088|NCT04143373|75710980|FG000|NOT COMPLETED|Overall Study||0||0
59601089|NCT04143373|75710981|FG001|NOT COMPLETED|Overall Study||0||0
59601090|NCT03789175|75710986|FG000|STARTED|Week 0 to Week 12 of NR||1||
59601091|NCT03789175|75710986|FG000|COMPLETED|Week 0 to Week 12 of NR||1||
59601092|NCT03789175|75710986|FG000|NOT COMPLETED|Week 0 to Week 12 of NR||0||
59601093|NCT03789175|75710986|FG000|STARTED|Week 12 to Week 24 of NR||1||
59601094|NCT03789175|75710986|FG000|COMPLETED|Week 12 to Week 24 of NR|Participant did not meet primary endpoint and completed study at week 24|1||
59601095|NCT03789175|75710986|FG000|NOT COMPLETED|Week 12 to Week 24 of NR||0||
59601096|NCT04130425|75710992|FG000|STARTED|Overall Study||30||
59601097|NCT04130425|75710992|FG000|COMPLETED|Overall Study||30||
59601098|NCT04130425|75710992|FG000|NOT COMPLETED|Overall Study||0||
59601099|NCT04131517|75711005|FG000|STARTED|Overall Study||7||
59601100|NCT04131517|75711006|FG001|STARTED|Overall Study||7||
59601101|NCT04131517|75711005|FG000|COMPLETED|Overall Study||7||
59601102|NCT04131517|75711006|FG001|COMPLETED|Overall Study||7||
59601103|NCT04131517|75711005|FG000|NOT COMPLETED|Overall Study||0||
59601104|NCT04131517|75711006|FG001|NOT COMPLETED|Overall Study||0||
59601105|NCT03782233|75711025|FG000|STARTED|Overall Study||50||
59601106|NCT03782233|75711026|FG001|STARTED|Overall Study||33||
59601107|NCT03782233|75711025|FG000|COMPLETED|Overall Study||46||
59601108|NCT03782233|75711026|FG001|COMPLETED|Overall Study||31||
59601109|NCT03782233|75711025|FG000|NOT COMPLETED|Overall Study||4||
59601110|NCT03782233|75711026|FG001|NOT COMPLETED|Overall Study||2||
59601111|NCT04285489|75711034|FG000|STARTED|Overall Study||130|The first subject was enrolled in May 2, 2020|
59601112|NCT04285489|75711034|FG000|COMPLETED|Overall Study|all subjects finished the study before Jul 1, 2020.|130|all subjects finished the study by Jul 1, 2020.|
59601113|NCT04285489|75711034|FG000|NOT COMPLETED|Overall Study||0||
59601114|NCT04317313|75711040|FG000|STARTED|Overall Study||100||
59601115|NCT04317313|75711041|FG001|STARTED|Overall Study||52||
59601116|NCT04317313|75711040|FG000|COMPLETED|Overall Study||100||
59601117|NCT04317313|75711041|FG001|COMPLETED|Overall Study||52||
59601118|NCT04317313|75711040|FG000|NOT COMPLETED|Overall Study||0||
59601119|NCT04317313|75711041|FG001|NOT COMPLETED|Overall Study||0||
59601120|NCT03777865|75711047|FG000|STARTED|Overall Study||100||
59601121|NCT03777865|75711047|FG000|COMPLETED|Overall Study||100||
59601122|NCT03777865|75711047|FG000|NOT COMPLETED|Overall Study||0||
59601123|NCT04109443|75711053|FG000|STARTED|Overall Study||77||
59601124|NCT04109443|75711054|FG001|STARTED|Overall Study||77||
59601125|NCT04109443|75711053|FG000|COMPLETED|Overall Study||67||
59601126|NCT04109443|75711054|FG001|COMPLETED|Overall Study||65||
59601127|NCT04109443|75711053|FG000|NOT COMPLETED|Overall Study||10||
59601128|NCT04109443|75711054|FG001|NOT COMPLETED|Overall Study||12||
59601129|NCT04107493|75711063|FG000|STARTED|First Intervention (1 Hour)||16||
59601130|NCT04107493|75711064|FG001|STARTED|First Intervention (1 Hour)||17||
59601131|NCT04107493|75711063|FG000|COMPLETED|First Intervention (1 Hour)||16||
59601132|NCT04107493|75711064|FG001|COMPLETED|First Intervention (1 Hour)||17||
59601133|NCT04107493|75711063|FG000|NOT COMPLETED|First Intervention (1 Hour)||0||
59601134|NCT04107493|75711064|FG001|NOT COMPLETED|First Intervention (1 Hour)||0||
59601135|NCT04107493|75711063|FG000|STARTED|Washout (One Hour)||16||
59601136|NCT04107493|75711064|FG001|STARTED|Washout (One Hour)||17||
59601137|NCT04107493|75711063|FG000|COMPLETED|Washout (One Hour)||16||
59601138|NCT04107493|75711064|FG001|COMPLETED|Washout (One Hour)||17||
59601139|NCT04107493|75711063|FG000|NOT COMPLETED|Washout (One Hour)||0||
59601140|NCT04107493|75711064|FG001|NOT COMPLETED|Washout (One Hour)||0||
59601141|NCT04107493|75711063|FG000|STARTED|Second Intervention||16||
59601142|NCT04107493|75711064|FG001|STARTED|Second Intervention||17||
59601143|NCT04107493|75711063|FG000|COMPLETED|Second Intervention||16||
59601144|NCT04107493|75711064|FG001|COMPLETED|Second Intervention||17||
59601145|NCT04107493|75711063|FG000|NOT COMPLETED|Second Intervention||0||
59601146|NCT04107493|75711064|FG001|NOT COMPLETED|Second Intervention||0||
59601147|NCT03231397|75711074|FG000|STARTED|Overall Study||0||
59601148|NCT03231397|75711075|FG001|STARTED|Overall Study||1||
59601149|NCT03231397|75711076|FG002|STARTED|Overall Study||1||
59601150|NCT03231397|75711077|FG003|STARTED|Overall Study||0||
59601151|NCT03231397|75711074|FG000|COMPLETED|Overall Study||0||
59601152|NCT03231397|75711075|FG001|COMPLETED|Overall Study||1||
59601153|NCT03231397|75711076|FG002|COMPLETED|Overall Study||1||
59601154|NCT03231397|75711077|FG003|COMPLETED|Overall Study||0||
59601155|NCT03231397|75711074|FG000|NOT COMPLETED|Overall Study||0||
59601156|NCT03231397|75711075|FG001|NOT COMPLETED|Overall Study||0||
59601157|NCT03231397|75711076|FG002|NOT COMPLETED|Overall Study||0||
59601158|NCT03231397|75711077|FG003|NOT COMPLETED|Overall Study||0||
59601159|NCT03189433|75711089|FG000|STARTED|Overall Study||2||
59601160|NCT03189433|75711090|FG001|STARTED|Overall Study||0||
59601161|NCT03189433|75711089|FG000|COMPLETED|Overall Study||0||
59601162|NCT03189433|75711090|FG001|COMPLETED|Overall Study||0||
59601163|NCT03189433|75711089|FG000|NOT COMPLETED|Overall Study||2||
59601164|NCT03189433|75711090|FG001|NOT COMPLETED|Overall Study||0||
59601165|NCT03776539|75711100|FG000|STARTED|Overall Study||6||
59601166|NCT03776539|75711101|FG001|STARTED|Overall Study||6||
59601167|NCT03776539|75711102|FG002|STARTED|Overall Study||6||
59601168|NCT03776539|75711103|FG003|STARTED|Overall Study||6||
59601169|NCT03776539|75711100|FG000|COMPLETED|Overall Study||6||
59601170|NCT03776539|75711101|FG001|COMPLETED|Overall Study||6||
59601171|NCT03776539|75711102|FG002|COMPLETED|Overall Study||6||
59601172|NCT03776539|75711103|FG003|COMPLETED|Overall Study||6||
59601173|NCT03776539|75711100|FG000|NOT COMPLETED|Overall Study||0||
59601174|NCT03776539|75711101|FG001|NOT COMPLETED|Overall Study||0||
59601175|NCT03776539|75711102|FG002|NOT COMPLETED|Overall Study||0||
59601176|NCT03776539|75711103|FG003|NOT COMPLETED|Overall Study||0||
59601177|NCT03774745|75711115|FG000|STARTED|Overall Study||6||
59601178|NCT03774745|75711116|FG001|STARTED|Overall Study||6||
59601179|NCT03774745|75711115|FG000|Follow-Up 1|Overall Study||5|3 +/- 1 day after enrollment|
59601180|NCT03774745|75711116|FG001|Follow-Up 1|Overall Study||6|3 +/- 1 day after enrollment|
59601181|NCT03774745|75711115|FG000|Follow-up 2|Overall Study||4|7 +/1 day after enrollment|
59601182|NCT03774745|75711116|FG001|Follow-up 2|Overall Study||2|7 +/1 day after enrollment|
59601183|NCT03774745|75711115|FG000|COMPLETED|Overall Study||4|15 +/- 1 day after enrollment|
59601184|NCT03774745|75711116|FG001|COMPLETED|Overall Study||2|15 +/- 1 day after enrollment|
59601185|NCT03774745|75711115|FG000|NOT COMPLETED|Overall Study||2||
59601186|NCT03774745|75711116|FG001|NOT COMPLETED|Overall Study||4||
59601187|NCT03769207|75711122|FG000|STARTED|Overall Study||17||
59601188|NCT03769207|75711122|FG000|Attended First Study Visit|Overall Study||11||
59601189|NCT03769207|75711122|FG000|ECG Patch Shipped|Overall Study||11||
59601190|NCT03769207|75711122|FG000|ECG Patch Returned and Readable|Overall Study||9||
59601191|NCT03769207|75711122|FG000|Attended Second Study Visit|Overall Study||6||
59601192|NCT03769207|75711122|FG000|COMPLETED|Overall Study||6||
59601193|NCT03769207|75711122|FG000|NOT COMPLETED|Overall Study||11||
59601194|NCT03766165|75711128|FG000|STARTED|Overall Study||19||
59601195|NCT03766165|75711129|FG001|STARTED|Overall Study||19||
59601196|NCT03766165|75711128|FG000|COMPLETED|Overall Study||19||
59601197|NCT03766165|75711129|FG001|COMPLETED|Overall Study||19||
59601198|NCT03766165|75711128|FG000|NOT COMPLETED|Overall Study||0||
59601199|NCT03766165|75711129|FG001|NOT COMPLETED|Overall Study||0||
59601200|NCT03109873|75711138|FG000|STARTED|Overall Study||5||
59601201|NCT03109873|75711139|FG001|STARTED|Overall Study||4||
59601202|NCT03109873|75711138|FG000|COMPLETED|Overall Study||5||
59867511|NCT03984812|75991916|FG009|STARTED|Part 1 (Up to Day 28)||0||
59601203|NCT03109873|75711139|FG001|COMPLETED|Overall Study||4||
59601204|NCT03109873|75711138|FG000|NOT COMPLETED|Overall Study||0||
59601205|NCT03109873|75711139|FG001|NOT COMPLETED|Overall Study||0||
59601206|NCT04092907|75711147|FG000|STARTED|Overall Study||50||
59601207|NCT04092907|75711148|FG001|STARTED|Overall Study||50||
59601208|NCT04092907|75711147|FG000|COMPLETED|Overall Study||48||
59601209|NCT04092907|75711148|FG001|COMPLETED|Overall Study||50||
59601210|NCT04092907|75711147|FG000|NOT COMPLETED|Overall Study||2||
59601211|NCT04092907|75711148|FG001|NOT COMPLETED|Overall Study||0||
59601212|NCT04086433|75711156|FG000|STARTED|Overall Study||17||
59601213|NCT04086433|75711157|FG001|STARTED|Overall Study||18||
59601214|NCT04086433|75711156|FG000|COMPLETED|Overall Study||17||
59601215|NCT04086433|75711157|FG001|COMPLETED|Overall Study||18||
59601216|NCT04086433|75711156|FG000|NOT COMPLETED|Overall Study||0||
59601217|NCT04086433|75711157|FG001|NOT COMPLETED|Overall Study||0||
59601218|NCT03764449|75711165|FG000|STARTED|Overall Study||8||
59601219|NCT03764449|75711166|FG001|STARTED|Overall Study||8||
59601220|NCT03764449|75711165|FG000|COMPLETED|Overall Study||8||
59601221|NCT03764449|75711166|FG001|COMPLETED|Overall Study||8||
59601222|NCT03764449|75711165|FG000|NOT COMPLETED|Overall Study||0||
59601223|NCT03764449|75711166|FG001|NOT COMPLETED|Overall Study||0||
59601224|NCT04084015|75711179|FG000|STARTED|Overall Study||2||
59601225|NCT04084015|75711179|FG000|COMPLETED|Overall Study||2||
59601226|NCT04084015|75711179|FG000|NOT COMPLETED|Overall Study||0||
59601227|NCT03061279|75711185|FG000|STARTED|Overall Study||0||
59601228|NCT03061279|75711186|FG001|STARTED|Overall Study||1||
59601229|NCT03061279|75711185|FG000|COMPLETED|Overall Study||0||
59601230|NCT03061279|75711186|FG001|COMPLETED|Overall Study||0||
59601231|NCT03061279|75711185|FG000|NOT COMPLETED|Overall Study||0||
59601232|NCT03061279|75711186|FG001|NOT COMPLETED|Overall Study||1||
59601233|NCT03763747|75711192|FG000|STARTED|Overall Study||200||
59601234|NCT03763747|75711192|FG000|COMPLETED|Overall Study||200||
59601235|NCT03763747|75711192|FG000|NOT COMPLETED|Overall Study||0||
59601236|NCT03758365|75711196|FG000|STARTED|Overall Study||36||
59601237|NCT03758365|75711196|FG000|MC2-01 Cream|Overall Study||36||
59601238|NCT03758365|75711196|FG000|Clobetasol Propionate 0.05% Lotion|Overall Study||36||
59601239|NCT03758365|75711196|FG000|Betamethasone Dipropionate 0.05% Cream|Overall Study||36||
59601240|NCT03758365|75711196|FG000|Triamcinolone Acetonide 0,1% Cream|Overall Study||36||
59601241|NCT03758365|75711196|FG000|Hydrocortisone Butyrate 0.1% Cream|Overall Study||36||
59601242|NCT03758365|75711196|FG000|Desonide 0.05% Cream|Overall Study||36||
59601243|NCT03758365|75711196|FG000|Vehicle Cream|Overall Study||36||
59601244|NCT03758365|75711196|FG000|COMPLETED|Overall Study||36||
59601245|NCT03758365|75711196|FG000|NOT COMPLETED|Overall Study||0||
59601246|NCT03757039|75711211|FG000|STARTED|Overall Study||32||
59601247|NCT03757039|75711212|FG001|STARTED|Overall Study||9||
59601248|NCT03757039|75711211|FG000|AOHG MF|Overall Study||11|AOHG MF = AIR OPTIX plus HydraGlyde Multifocal contact lenses|
59601249|NCT03757039|75711212|FG001|AOHG MF|Overall Study||0|AOHG MF = AIR OPTIX plus HydraGlyde Multifocal contact lenses|
59601250|NCT03757039|75711211|FG000|DT1 MF|Overall Study||11|DT1 MF = DAILIES TOTAL1 Multifocal contact lenses|
59601251|NCT03757039|75711212|FG001|DT1 MF|Overall Study||0|DT1 MF = DAILIES TOTAL1 Multifocal contact lenses|
59601252|NCT03757039|75711211|FG000|DACP MF|Overall Study||10|DACP MF = DAILIES AquaComfort Plus Multifocal contact lenses|
59601253|NCT03757039|75711212|FG001|DACP MF|Overall Study||0|DACP MF = DAILIES AquaComfort Plus Multifocal contact lenses|
59601254|NCT03757039|75711211|FG000|COMPLETED|Overall Study||32||
59601255|NCT03757039|75711212|FG001|COMPLETED|Overall Study||9||
59601256|NCT03757039|75711211|FG000|NOT COMPLETED|Overall Study||0||
59601257|NCT03757039|75711212|FG001|NOT COMPLETED|Overall Study||0||
59601258|NCT04072237|75711220|FG000|STARTED|Stage I: MarzAA 18 µg/kg IV||11||
59601259|NCT04072237|75711220|FG000|COMPLETED|Stage I: MarzAA 18 µg/kg IV||10||
59601260|NCT04072237|75711220|FG000|NOT COMPLETED|Stage I: MarzAA 18 µg/kg IV||1||
59601261|NCT04072237|75711220|FG000|STARTED|Stage 2: MarzAA 30 µg/kg SC||8||
59601262|NCT04072237|75711220|FG000|COMPLETED|Stage 2: MarzAA 30 µg/kg SC||8||
59601263|NCT04072237|75711220|FG000|NOT COMPLETED|Stage 2: MarzAA 30 µg/kg SC||0||
59601264|NCT04072237|75711220|FG000|STARTED|Stage 3: MarzAA 45 µg/kg SC||8||
59601265|NCT04072237|75711220|FG000|COMPLETED|Stage 3: MarzAA 45 µg/kg SC||8||
59601266|NCT04072237|75711220|FG000|NOT COMPLETED|Stage 3: MarzAA 45 µg/kg SC||0||
59601267|NCT04072237|75711220|FG000|STARTED|Stage 4: MarzAA 60 µg/kg SC||8||
59601268|NCT04072237|75711220|FG000|COMPLETED|Stage 4: MarzAA 60 µg/kg SC||8||
59601269|NCT04072237|75711220|FG000|NOT COMPLETED|Stage 4: MarzAA 60 µg/kg SC||0||
59601270|NCT04072237|75711220|FG000|STARTED|Stage 5: MarzAA 2 x 30 ug/kg SC||8||
59601271|NCT04072237|75711220|FG000|COMPLETED|Stage 5: MarzAA 2 x 30 ug/kg SC||8||
59601272|NCT04072237|75711220|FG000|NOT COMPLETED|Stage 5: MarzAA 2 x 30 ug/kg SC||0||
59601273|NCT04072237|75711220|FG000|STARTED|Stage 6: MarzAA 90 µg/kg SC||8||
59601274|NCT04072237|75711220|FG000|COMPLETED|Stage 6: MarzAA 90 µg/kg SC||8||
59601275|NCT04072237|75711220|FG000|NOT COMPLETED|Stage 6: MarzAA 90 µg/kg SC||0||
59601276|NCT04072237|75711220|FG000|STARTED|Stage 7: MarzAA 120 µg/kg SC||8||
59601277|NCT04072237|75711220|FG000|COMPLETED|Stage 7: MarzAA 120 µg/kg SC||8||
59601278|NCT04072237|75711220|FG000|NOT COMPLETED|Stage 7: MarzAA 120 µg/kg SC||0||
59601279|NCT04072237|75711220|FG000|STARTED|Stage 8: MarzAA 2 x 60 µg/kg Q3H SC||8||
59601280|NCT04072237|75711220|FG000|COMPLETED|Stage 8: MarzAA 2 x 60 µg/kg Q3H SC||8||
59601281|NCT04072237|75711220|FG000|NOT COMPLETED|Stage 8: MarzAA 2 x 60 µg/kg Q3H SC||0||
59601282|NCT04072237|75711220|FG000|STARTED|Stage 9: MarzAA 3 x 60 µg/kg Q3H SC||8||
59601283|NCT04072237|75711220|FG000|COMPLETED|Stage 9: MarzAA 3 x 60 µg/kg Q3H SC||8||
59601284|NCT04072237|75711220|FG000|NOT COMPLETED|Stage 9: MarzAA 3 x 60 µg/kg Q3H SC||0||
59601285|NCT03743311|75711250|FG000|STARTED|Overall Study||311||
59601286|NCT03743311|75711251|FG001|STARTED|Overall Study||298||
59601287|NCT03743311|75711252|FG002|STARTED|Overall Study||423||
59601288|NCT03743311|75711250|FG000|COMPLETED|Overall Study||311||
59601289|NCT03743311|75711251|FG001|COMPLETED|Overall Study||298||
59601290|NCT03743311|75711252|FG002|COMPLETED|Overall Study||423||
59601291|NCT03743311|75711250|FG000|NOT COMPLETED|Overall Study||0||
59601292|NCT03743311|75711251|FG001|NOT COMPLETED|Overall Study||0||
59601293|NCT03743311|75711252|FG002|NOT COMPLETED|Overall Study||0||
59601294|NCT03740659|75711264|FG000|STARTED|Overall Study||42||
59601295|NCT03740659|75711265|FG001|STARTED|Overall Study||42||
59601296|NCT03740659|75711266|FG002|STARTED|Overall Study||41||
59601297|NCT03740659|75711264|FG000|COMPLETED|Overall Study||42||
60134179|NCT02849652|76257275|FG000|COMPLETED|Overall Study||230||
60134180|NCT02849652|76257276|FG001|COMPLETED|Overall Study||94||
60134181|NCT02849652|76257277|FG002|COMPLETED|Overall Study||142||
60134182|NCT02849652|76257278|FG003|COMPLETED|Overall Study||65||
60134183|NCT02849652|76257275|FG000|NOT COMPLETED|Overall Study||114||
60134184|NCT02849652|76257276|FG001|NOT COMPLETED|Overall Study||37||
60134185|NCT02849652|76257277|FG002|NOT COMPLETED|Overall Study||124||
60134186|NCT02849652|76257278|FG003|NOT COMPLETED|Overall Study||26||
60134187|NCT01396447|76257290|FG000|STARTED|Overall Study||148||
60134188|NCT01396447|76257291|FG001|STARTED|Overall Study||143||
60134189|NCT01396447|76257292|FG002|STARTED|Overall Study||147||
60134190|NCT01396447|76257293|FG003|STARTED|Overall Study||146||
60134191|NCT01396447|76257290|FG000|Received Treatment|Overall Study||145||
60134192|NCT01396447|76257291|FG001|Received Treatment|Overall Study||141||
60134193|NCT01396447|76257292|FG002|Received Treatment|Overall Study||146||
60134194|NCT01396447|76257293|FG003|Received Treatment|Overall Study||146||
60134195|NCT01396447|76257290|FG000|COMPLETED|Overall Study||105||
60134196|NCT01396447|76257291|FG001|COMPLETED|Overall Study||103||
60134197|NCT01396447|76257292|FG002|COMPLETED|Overall Study||117||
60134198|NCT01396447|76257293|FG003|COMPLETED|Overall Study||94||
60134199|NCT01396447|76257290|FG000|NOT COMPLETED|Overall Study||43||
60134200|NCT01396447|76257291|FG001|NOT COMPLETED|Overall Study||40||
60134201|NCT01396447|76257292|FG002|NOT COMPLETED|Overall Study||30||
60134202|NCT01396447|76257293|FG003|NOT COMPLETED|Overall Study||52||
60134203|NCT00704379|76257305|FG000|STARTED|Overall Study||46||
60134204|NCT00704379|76257306|FG001|STARTED|Overall Study||48||
60134205|NCT00704379|76257305|FG000|COMPLETED|Overall Study||39||
60134206|NCT00704379|76257306|FG001|COMPLETED|Overall Study||41||
60134207|NCT00704379|76257305|FG000|NOT COMPLETED|Overall Study||7||
60134208|NCT00704379|76257306|FG001|NOT COMPLETED|Overall Study||7||
59601298|NCT03740659|75711265|FG001|COMPLETED|Overall Study||42||
59601299|NCT03740659|75711266|FG002|COMPLETED|Overall Study||41||
59601300|NCT03740659|75711264|FG000|NOT COMPLETED|Overall Study||0||
59601301|NCT03740659|75711265|FG001|NOT COMPLETED|Overall Study||0||
59601302|NCT03740659|75711266|FG002|NOT COMPLETED|Overall Study||0||
59601303|NCT03738163|75711274|FG000|STARTED|Overall Study||121||
59601304|NCT03738163|75711274|FG000|COMPLETED|Overall Study||114||
59601305|NCT03738163|75711274|FG000|NOT COMPLETED|Overall Study||7||
59601306|NCT02757547|75711278|FG000|STARTED|Overall Study||2||
59601307|NCT02757547|75711278|FG000|COMPLETED|Overall Study||2||
59601308|NCT02757547|75711278|FG000|NOT COMPLETED|Overall Study||0||
59601309|NCT02721277|75711283|FG000|STARTED|Overall Study||2||
59601310|NCT02721277|75711283|FG000|COMPLETED|Overall Study||2||
59601311|NCT02721277|75711283|FG000|NOT COMPLETED|Overall Study||0||
59601312|NCT03733483|75711287|FG000|STARTED|Overall Study||12||
59601313|NCT03733483|75711287|FG000|COMPLETED|Overall Study||12||
59601314|NCT03733483|75711287|FG000|NOT COMPLETED|Overall Study||0||
59601315|NCT02658877|75711293|FG000|STARTED|Overall Study||3||
59601316|NCT02658877|75711294|FG001|STARTED|Overall Study||0||
59601317|NCT02658877|75711293|FG000|COMPLETED|Overall Study||3||
59601318|NCT02658877|75711294|FG001|COMPLETED|Overall Study||0||
59601319|NCT02658877|75711293|FG000|NOT COMPLETED|Overall Study||0||
59601320|NCT02658877|75711294|FG001|NOT COMPLETED|Overall Study||0||
59601321|NCT02589145|75711303|FG000|STARTED|Overall Study||4||
59601322|NCT02589145|75711304|FG001|STARTED|Overall Study||2||
59601323|NCT02589145|75711305|FG002|STARTED|Overall Study||2||
59601324|NCT02589145|75711303|FG000|COMPLETED|Overall Study||4||
59601325|NCT02589145|75711304|FG001|COMPLETED|Overall Study||2||
59601326|NCT02589145|75711305|FG002|COMPLETED|Overall Study||2||
59601327|NCT02589145|75711303|FG000|NOT COMPLETED|Overall Study||0||
59601328|NCT02589145|75711304|FG001|NOT COMPLETED|Overall Study||0||
59601329|NCT02589145|75711305|FG002|NOT COMPLETED|Overall Study||0||
59601330|NCT02568007|75711316|FG000|STARTED|Overall Study||2||
59601331|NCT02568007|75711317|FG001|STARTED|Overall Study||2||
59601332|NCT02568007|75711318|FG002|STARTED|Overall Study||0||
59601333|NCT02568007|75711316|FG000|COMPLETED|Overall Study||2||
59601334|NCT02568007|75711317|FG001|COMPLETED|Overall Study||2||
59601335|NCT02568007|75711318|FG002|COMPLETED|Overall Study||0||
60134209|NCT00714753|76257314|FG000|STARTED|Overall Study||5||
60134210|NCT00714753|76257314|FG000|HDR Brachytherapy|Overall Study||5||
60134211|NCT00714753|76257314|FG000|External Beam Radiotherapy (EBRT)|Overall Study||1||
59601336|NCT02568007|75711316|FG000|NOT COMPLETED|Overall Study||0||
60134212|NCT00714753|76257314|FG000|COMPLETED|Overall Study||5||
60134213|NCT00714753|76257314|FG000|NOT COMPLETED|Overall Study||0||
60134214|NCT00707343|76257318|FG000|STARTED|Overall Study||15||
60134215|NCT00707343|76257318|FG000|COMPLETED|Overall Study||15||
60134216|NCT00707343|76257318|FG000|NOT COMPLETED|Overall Study||0||
60134217|NCT02076919|76257334|FG000|STARTED|Overall Study||24||
60134218|NCT02076919|76257335|FG001|STARTED|Overall Study||8||
60134219|NCT02076919|76257336|FG002|STARTED|Overall Study||36||
60134220|NCT02076919|76257337|FG003|STARTED|Overall Study||12||
60134221|NCT02076919|76257334|FG000|COMPLETED|Overall Study||24||
60134222|NCT02076919|76257335|FG001|COMPLETED|Overall Study||8||
60134223|NCT02076919|76257336|FG002|COMPLETED|Overall Study||36||
60134224|NCT02076919|76257337|FG003|COMPLETED|Overall Study||12||
60134225|NCT02076919|76257334|FG000|NOT COMPLETED|Overall Study||0||
60134226|NCT02076919|76257335|FG001|NOT COMPLETED|Overall Study||0||
60134227|NCT02076919|76257336|FG002|NOT COMPLETED|Overall Study||0||
60134228|NCT02076919|76257337|FG003|NOT COMPLETED|Overall Study||0||
60134229|NCT01678560|76257366|FG000|STARTED|Overall Study||26||
60134230|NCT01678560|76257367|FG001|STARTED|Overall Study||26||
60134231|NCT01678560|76257366|FG000|COMPLETED|Overall Study||22||
60134232|NCT01678560|76257367|FG001|COMPLETED|Overall Study||20||
60134233|NCT01678560|76257366|FG000|NOT COMPLETED|Overall Study||4||
60134234|NCT01678560|76257367|FG001|NOT COMPLETED|Overall Study||6||
60134235|NCT02076997|76257377|FG000|STARTED|Overall Study||23||
60134236|NCT02076997|76257377|FG000|COMPLETED|Overall Study||22||
60134237|NCT02076997|76257377|FG000|NOT COMPLETED|Overall Study||1||
60134238|NCT00707967|76257384|FG000|STARTED|Overall Study||22||
60134239|NCT00707967|76257385|FG001|STARTED|Overall Study||8||
60134240|NCT00707967|76257386|FG002|STARTED|Overall Study||7||
60134241|NCT00707967|76257384|FG000|COMPLETED|Overall Study||22||
60134242|NCT00707967|76257385|FG001|COMPLETED|Overall Study||8||
60134243|NCT00707967|76257386|FG002|COMPLETED|Overall Study||7||
60134244|NCT00707967|76257384|FG000|NOT COMPLETED|Overall Study||0||
60134245|NCT00707967|76257385|FG001|NOT COMPLETED|Overall Study||0||
60134246|NCT00707967|76257386|FG002|NOT COMPLETED|Overall Study||0||
60134247|NCT00716079|76257396|FG000|STARTED|Overall Study||1403||
60134248|NCT00716079|76257397|FG001|STARTED|Overall Study||1436||
60134249|NCT00716079|76257396|FG000|COMPLETED|Overall Study||1394||
60134250|NCT00716079|76257397|FG001|COMPLETED|Overall Study||1421||
60134251|NCT00716079|76257396|FG000|NOT COMPLETED|Overall Study||9||
60134252|NCT00716079|76257397|FG001|NOT COMPLETED|Overall Study||15||
60134253|NCT01381549|76257406|FG000|STARTED|Overall Study||6||
60134254|NCT01381549|76257407|FG001|STARTED|Overall Study||8||
60134255|NCT01381549|76257408|FG002|STARTED|Overall Study||6||
60134256|NCT01381549|76257406|FG000|COMPLETED|Overall Study||6||
60134257|NCT01381549|76257407|FG001|COMPLETED|Overall Study||8||
60134258|NCT01381549|76257408|FG002|COMPLETED|Overall Study||5||
60134259|NCT01381549|76257406|FG000|NOT COMPLETED|Overall Study||0||
60134260|NCT01381549|76257407|FG001|NOT COMPLETED|Overall Study||0||
60134261|NCT01381549|76257408|FG002|NOT COMPLETED|Overall Study||1||
60134262|NCT00159432|76257417|FG000|STARTED|Overall Study||63||
60134263|NCT00159432|76257417|FG000|COMPLETED|Overall Study||53||
60134264|NCT00159432|76257417|FG000|NOT COMPLETED|Overall Study||10||
60134265|NCT01396057|76257423|FG000|STARTED|Overall Study||126||
60134266|NCT01396057|76257424|FG001|STARTED|Overall Study||118||
60134267|NCT01396057|76257423|FG000|COMPLETED|Overall Study||115||
60134268|NCT01396057|76257424|FG001|COMPLETED|Overall Study||100||
60134269|NCT01396057|76257423|FG000|NOT COMPLETED|Overall Study||11||
60134270|NCT01396057|76257424|FG001|NOT COMPLETED|Overall Study||18||
60134271|NCT00704847|76257432|FG000|STARTED|Overall Study||521||
60134272|NCT00704847|76257433|FG001|STARTED|Overall Study||509||
60134273|NCT00704847|76257432|FG000|COMPLETED|Overall Study||300||
60134274|NCT00704847|76257433|FG001|COMPLETED|Overall Study||339||
60134275|NCT00704847|76257432|FG000|NOT COMPLETED|Overall Study||221||
60134276|NCT00704847|76257433|FG001|NOT COMPLETED|Overall Study||170||
60134277|NCT01380769|76257441|FG000|STARTED|Overall Study||100||
60134278|NCT01380769|76257442|FG001|STARTED|Overall Study||57||
60134279|NCT01380769|76257441|FG000|COMPLETED|Overall Study|subjects in ITT with reported date of death, alive with progression, or alive without progression|91||
60134280|NCT01380769|76257442|FG001|COMPLETED|Overall Study|subjects in ITT with reported date of death, alive with progression, or alive without progression|43||
60134281|NCT01380769|76257441|FG000|NOT COMPLETED|Overall Study||9||
60134282|NCT01380769|76257442|FG001|NOT COMPLETED|Overall Study||14||
60134283|NCT01395901|76257450|FG000|STARTED|Overall Study|Randomized Population|336||
60134284|NCT01395901|76257451|FG001|STARTED|Overall Study|Randomized Population|334||
60134285|NCT01395901|76257450|FG000|COMPLETED|Overall Study|Treated patients completing the study|326||
60134286|NCT01395901|76257451|FG001|COMPLETED|Overall Study|Treated patients completing the study|329||
60134287|NCT01395901|76257450|FG000|NOT COMPLETED|Overall Study||10||
60134288|NCT01395901|76257451|FG001|NOT COMPLETED|Overall Study||5||
60134289|NCT01395823|76257459|FG000|STARTED|Overall Study||137||
60134290|NCT01395823|76257460|FG001|STARTED|Overall Study||139||
60134291|NCT01395823|76257459|FG000|COMPLETED|Overall Study||122||
60134292|NCT01395823|76257460|FG001|COMPLETED|Overall Study||130||
60134293|NCT01395823|76257459|FG000|NOT COMPLETED|Overall Study||15||
60134294|NCT01395823|76257460|FG001|NOT COMPLETED|Overall Study||9||
60134295|NCT00158184|76257468|FG000|STARTED|Overall Study||16||
60134296|NCT00158184|76257469|FG001|STARTED|Overall Study||11||
60134297|NCT00158184|76257468|FG000|COMPLETED|Overall Study||10||
60134298|NCT00158184|76257469|FG001|COMPLETED|Overall Study||9||
60134299|NCT00158184|76257468|FG000|NOT COMPLETED|Overall Study||6||
60134300|NCT00158184|76257469|FG001|NOT COMPLETED|Overall Study||2||
60134301|NCT01380691|76257477|FG000|STARTED|Period 1||7||
60134302|NCT01380691|76257478|FG001|STARTED|Period 1||7||
60134303|NCT01380691|76257479|FG002|STARTED|Period 1||7||
60134304|NCT01380691|76257480|FG003|STARTED|Period 1||7||
60134305|NCT01380691|76257477|FG000|COMPLETED|Period 1||7||
60134306|NCT01380691|76257478|FG001|COMPLETED|Period 1||7||
60134307|NCT01380691|76257479|FG002|COMPLETED|Period 1||7||
60134308|NCT01380691|76257480|FG003|COMPLETED|Period 1||7||
60134309|NCT01380691|76257477|FG000|NOT COMPLETED|Period 1||0||
60134310|NCT01380691|76257478|FG001|NOT COMPLETED|Period 1||0||
60134311|NCT01380691|76257479|FG002|NOT COMPLETED|Period 1||0||
60134312|NCT01380691|76257480|FG003|NOT COMPLETED|Period 1||0||
60134313|NCT01380691|76257477|FG000|STARTED|Washout (7 Days)||7||
60134314|NCT01380691|76257478|FG001|STARTED|Washout (7 Days)||7||
60134315|NCT01380691|76257479|FG002|STARTED|Washout (7 Days)||7||
60134316|NCT01380691|76257480|FG003|STARTED|Washout (7 Days)||7||
60134317|NCT01380691|76257477|FG000|COMPLETED|Washout (7 Days)||7||
60134318|NCT01380691|76257478|FG001|COMPLETED|Washout (7 Days)||7||
60134319|NCT01380691|76257479|FG002|COMPLETED|Washout (7 Days)||6||
60134320|NCT01380691|76257480|FG003|COMPLETED|Washout (7 Days)||6||
60134321|NCT01380691|76257477|FG000|NOT COMPLETED|Washout (7 Days)||0||
60134322|NCT01380691|76257478|FG001|NOT COMPLETED|Washout (7 Days)||0||
60134323|NCT01380691|76257479|FG002|NOT COMPLETED|Washout (7 Days)||1||
60134324|NCT01380691|76257480|FG003|NOT COMPLETED|Washout (7 Days)||1||
60134325|NCT01380691|76257477|FG000|STARTED|Period 2||7||
60134326|NCT01380691|76257478|FG001|STARTED|Period 2||7||
60134327|NCT01380691|76257479|FG002|STARTED|Period 2||6||
60134328|NCT01380691|76257480|FG003|STARTED|Period 2||6||
60134329|NCT01380691|76257477|FG000|COMPLETED|Period 2||7||
60134330|NCT01380691|76257478|FG001|COMPLETED|Period 2||7||
60134331|NCT01380691|76257479|FG002|COMPLETED|Period 2||6||
60134332|NCT01380691|76257480|FG003|COMPLETED|Period 2||6||
60134333|NCT01380691|76257477|FG000|NOT COMPLETED|Period 2||0||
60134334|NCT01380691|76257478|FG001|NOT COMPLETED|Period 2||0||
60134335|NCT01380691|76257479|FG002|NOT COMPLETED|Period 2||0||
60134336|NCT01380691|76257480|FG003|NOT COMPLETED|Period 2||0||
60134337|NCT02114814|76257493|FG000|STARTED|Overall Study||103||
60134338|NCT02114814|76257494|FG001|STARTED|Overall Study||83||
60134339|NCT02114814|76257493|FG000|COMPLETED|Overall Study||88||
60134340|NCT02114814|76257494|FG001|COMPLETED|Overall Study||74||
60134341|NCT02114814|76257493|FG000|NOT COMPLETED|Overall Study||15||
60134342|NCT02114814|76257494|FG001|NOT COMPLETED|Overall Study||9||
60134343|NCT01380535|76257506|FG000|STARTED|Overall Study||29||
60134344|NCT01380535|76257507|FG001|STARTED|Overall Study||31||
60134345|NCT01380535|76257506|FG000|Baseline Population|Overall Study||29|All enrolled participants|
60134346|NCT01380535|76257507|FG001|Baseline Population|Overall Study||31|All enrolled participants|
60134347|NCT01380535|76257506|FG000|Safety Population|Overall Study||28|All randomized participants who received at least 1 dose of study treatment, per treatment received.|
60134348|NCT01380535|76257507|FG001|Safety Population|Overall Study||28|All randomized participants who received at least 1 dose of study treatment, per treatment received.|
60134349|NCT01380535|76257506|FG000|Intent-to-treat Population|Overall Study||29|All randomized subjects with baseline and post-treatment measurements, per assigned treatment|
60134350|NCT01380535|76257507|FG001|Intent-to-treat Population|Overall Study||24|All randomized subjects with baseline and post-treatment measurements, per assigned treatment|
60134351|NCT01380535|76257506|FG000|COMPLETED|Overall Study||22||
60134352|NCT01380535|76257507|FG001|COMPLETED|Overall Study||16||
60134353|NCT01380535|76257506|FG000|NOT COMPLETED|Overall Study||7||
60134354|NCT01380535|76257507|FG001|NOT COMPLETED|Overall Study||15||
60134355|NCT00725361|76257513|FG000|STARTED|Overall Study||20||
60134356|NCT00725361|76257513|FG000|COMPLETED|Overall Study||16||
60134357|NCT00725361|76257513|FG000|NOT COMPLETED|Overall Study||4||
60134358|NCT01380379|76257517|FG000|STARTED|Overall Study||9||
60134359|NCT01380379|76257517|FG000|COMPLETED|Overall Study||8||
60134360|NCT01380379|76257517|FG000|NOT COMPLETED|Overall Study||1||
60134361|NCT01380145|76257521|FG000|STARTED|Overall Study||13||
60134362|NCT01380145|76257521|FG000|COMPLETED|Overall Study||9||
60134363|NCT01380145|76257521|FG000|NOT COMPLETED|Overall Study||4||
60134364|NCT00725751|76257529|FG000|STARTED|Overall Study||90||
60134365|NCT00725751|76257530|FG001|STARTED|Overall Study||258||
60134366|NCT00725751|76257529|FG000|COMPLETED|Overall Study||56||
60134367|NCT00725751|76257530|FG001|COMPLETED|Overall Study||150||
60134368|NCT00725751|76257529|FG000|NOT COMPLETED|Overall Study||34||
60134369|NCT00725751|76257530|FG001|NOT COMPLETED|Overall Study||108||
60134370|NCT00726375|76257537|FG000|STARTED|Overall Study||34||
60134371|NCT00726375|76257537|FG000|COMPLETED|Overall Study||34||
60134372|NCT00726375|76257537|FG000|NOT COMPLETED|Overall Study||0||
60134373|NCT00710931|76257541|FG000|STARTED|Overall Study||34||
60134374|NCT00710931|76257541|FG000|COMPLETED|Overall Study||29||
60134375|NCT00710931|76257541|FG000|NOT COMPLETED|Overall Study||5||
60134376|NCT03420222|76257547|FG000|STARTED|Overall Study||8||
60134377|NCT03420222|76257548|FG001|STARTED|Overall Study||2||
60134378|NCT03420222|76257547|FG000|COMPLETED|Overall Study||3||
60134379|NCT03420222|76257548|FG001|COMPLETED|Overall Study||1||
60134380|NCT03420222|76257547|FG000|NOT COMPLETED|Overall Study||5||
60134381|NCT03420222|76257548|FG001|NOT COMPLETED|Overall Study||1||
60134382|NCT01394185|76257554|FG000|STARTED|Overall Study||8||
60134383|NCT01394185|76257555|FG001|STARTED|Overall Study||2||
60134384|NCT01394185|76257556|FG002|STARTED|Overall Study||2||
60134385|NCT01394185|76257557|FG003|STARTED|Overall Study||4||
60134386|NCT01394185|76257558|FG004|STARTED|Overall Study||6||
60134387|NCT01394185|76257559|FG005|STARTED|Overall Study||3||
60134388|NCT01394185|76257554|FG000|COMPLETED|Overall Study||2||
60134389|NCT01394185|76257555|FG001|COMPLETED|Overall Study||2||
60134390|NCT01394185|76257556|FG002|COMPLETED|Overall Study||2||
60134391|NCT01394185|76257557|FG003|COMPLETED|Overall Study||3||
60134392|NCT01394185|76257558|FG004|COMPLETED|Overall Study||2||
60134393|NCT01394185|76257559|FG005|COMPLETED|Overall Study||2||
60134394|NCT01394185|76257554|FG000|NOT COMPLETED|Overall Study||6||
60134395|NCT01394185|76257555|FG001|NOT COMPLETED|Overall Study||0||
60134396|NCT01394185|76257556|FG002|NOT COMPLETED|Overall Study||0||
60134397|NCT01394185|76257557|FG003|NOT COMPLETED|Overall Study||1||
60134398|NCT01394185|76257558|FG004|NOT COMPLETED|Overall Study||4||
59601337|NCT02568007|75711317|FG001|NOT COMPLETED|Overall Study||0||
59601338|NCT02568007|75711318|FG002|NOT COMPLETED|Overall Study||0||
59601339|NCT02549755|75711326|FG000|STARTED|Overall Study||1||
59601340|NCT02549755|75711326|FG000|COMPLETED|Overall Study||0||
59601341|NCT02549755|75711326|FG000|NOT COMPLETED|Overall Study||1||
59601342|NCT04024501|75711330|FG000|STARTED|Overall Study||25||
59601343|NCT04024501|75711330|FG000|COMPLETED|Overall Study||25||
59601344|NCT04024501|75711330|FG000|NOT COMPLETED|Overall Study||0||
59601345|NCT03538015|75711345|FG000|STARTED|Overall Study||0||
59601346|NCT03538015|75711346|FG001|STARTED|Overall Study||0||
59601347|NCT03538015|75711347|FG002|STARTED|Overall Study||1||
59601348|NCT03538015|75711345|FG000|COMPLETED|Overall Study||0||
59601349|NCT03538015|75711346|FG001|COMPLETED|Overall Study||0||
59601350|NCT03538015|75711347|FG002|COMPLETED|Overall Study||0||
59601351|NCT03538015|75711345|FG000|NOT COMPLETED|Overall Study||0||
59601352|NCT03538015|75711346|FG001|NOT COMPLETED|Overall Study||0||
59601353|NCT03538015|75711347|FG002|NOT COMPLETED|Overall Study||1||
59601354|NCT03342157|75711357|FG000|STARTED|Overall Study||1||
59601355|NCT03342157|75711358|FG001|STARTED|Overall Study||1||
59601356|NCT03342157|75711357|FG000|COMPLETED|Overall Study||1||
59601357|NCT03342157|75711358|FG001|COMPLETED|Overall Study||1||
59601358|NCT03342157|75711357|FG000|NOT COMPLETED|Overall Study||0||
59601359|NCT03342157|75711358|FG001|NOT COMPLETED|Overall Study||0||
59601360|NCT04016077|75711366|FG000|STARTED|Overall Study||10||
59601361|NCT04016077|75711367|FG001|STARTED|Overall Study||8||
59601362|NCT04016077|75711366|FG000|COMPLETED|Overall Study||10||
59601363|NCT04016077|75711367|FG001|COMPLETED|Overall Study||8||
59601364|NCT04016077|75711366|FG000|NOT COMPLETED|Overall Study||0||
59601365|NCT04016077|75711367|FG001|NOT COMPLETED|Overall Study||0||
59601366|NCT04021771|75711375|FG000|STARTED|Overall Study||55||
59601367|NCT04021771|75711376|FG001|STARTED|Overall Study||54||
59601368|NCT04021771|75711375|FG000|COMPLETED|Overall Study||55||
59601369|NCT04021771|75711376|FG001|COMPLETED|Overall Study||54||
59601370|NCT04021771|75711375|FG000|NOT COMPLETED|Overall Study||0||
59601371|NCT04021771|75711376|FG001|NOT COMPLETED|Overall Study||0||
60134399|NCT01394185|76257559|FG005|NOT COMPLETED|Overall Study||1||
60134400|NCT00711711|76257569|FG000|STARTED|Overall Study||30||
60134401|NCT00711711|76257570|FG001|STARTED|Overall Study||30||
59601372|NCT02487277|75711384|FG000|STARTED|Overall Study||3||
59601373|NCT02487277|75711385|FG001|STARTED|Overall Study||0||
59601374|NCT02487277|75711384|FG000|COMPLETED|Overall Study||3||
59601375|NCT02487277|75711385|FG001|COMPLETED|Overall Study||0||
59601376|NCT02487277|75711384|FG000|NOT COMPLETED|Overall Study||0||
59601377|NCT02487277|75711385|FG001|NOT COMPLETED|Overall Study||0||
59601378|NCT02436265|75711392|FG000|STARTED|Overall Study||3||
59601379|NCT02436265|75711393|FG001|STARTED|Overall Study||4||
59601380|NCT02436265|75711392|FG000|COMPLETED|Overall Study||3||
59601381|NCT02436265|75711393|FG001|COMPLETED|Overall Study||4||
59601382|NCT02436265|75711392|FG000|NOT COMPLETED|Overall Study||0||
59601383|NCT02436265|75711393|FG001|NOT COMPLETED|Overall Study||0||
59601384|NCT04016623|75711399|FG000|STARTED|Pair 1 Test / Control Dispense||10||20
59601385|NCT04016623|75711399|FG000|COMPLETED|Pair 1 Test / Control Dispense||10||20
59601386|NCT04016623|75711399|FG000|NOT COMPLETED|Pair 1 Test / Control Dispense||0||0
59601387|NCT04016623|75711399|FG000|STARTED|Pair 1 Test /Control Follow up||10||20
59601388|NCT04016623|75711399|FG000|COMPLETED|Pair 1 Test /Control Follow up||10||20
59601389|NCT04016623|75711399|FG000|NOT COMPLETED|Pair 1 Test /Control Follow up||0||0
59601390|NCT04016623|75711399|FG000|STARTED|Pair 2 Test / Control Dispense||10||20
59601391|NCT04016623|75711399|FG000|COMPLETED|Pair 2 Test / Control Dispense||10||20
59601392|NCT04016623|75711399|FG000|NOT COMPLETED|Pair 2 Test / Control Dispense||0||0
59601393|NCT04016623|75711399|FG000|STARTED|Pair 2 Test /Control Follow up||10||20
59601394|NCT04016623|75711399|FG000|COMPLETED|Pair 2 Test /Control Follow up||10||20
59601395|NCT04016623|75711399|FG000|NOT COMPLETED|Pair 2 Test /Control Follow up||0||0
59601396|NCT04016623|75711399|FG000|STARTED|Pair 3 Test / Control Dispense||10||20
59601397|NCT04016623|75711399|FG000|COMPLETED|Pair 3 Test / Control Dispense||10||20
59601398|NCT04016623|75711399|FG000|NOT COMPLETED|Pair 3 Test / Control Dispense||0||0
59601399|NCT04016623|75711399|FG000|STARTED|Pair 3 Test /Control Follow up||10||20
59601400|NCT04016623|75711399|FG000|COMPLETED|Pair 3 Test /Control Follow up||10||20
59601401|NCT04016623|75711399|FG000|NOT COMPLETED|Pair 3 Test /Control Follow up||0||0
59601402|NCT04016623|75711399|FG000|STARTED|Pair 4 Test / Control Dispense||10||20
59601403|NCT04016623|75711399|FG000|COMPLETED|Pair 4 Test / Control Dispense||10||20
59601404|NCT04016623|75711399|FG000|NOT COMPLETED|Pair 4 Test / Control Dispense||0||0
59601405|NCT04016623|75711399|FG000|STARTED|Pair 4 Test /Control Follow up||10||20
59601406|NCT04016623|75711399|FG000|COMPLETED|Pair 4 Test /Control Follow up||10||20
59601407|NCT04016623|75711399|FG000|NOT COMPLETED|Pair 4 Test /Control Follow up||0||0
59601408|NCT03316105|75711421|FG000|STARTED|Overall Study||9||
59601409|NCT03316105|75711422|FG001|STARTED|Overall Study||7||
59601410|NCT03316105|75711421|FG000|COMPLETED|Overall Study||9||
59601411|NCT03316105|75711422|FG001|COMPLETED|Overall Study||7||
59601412|NCT03316105|75711421|FG000|NOT COMPLETED|Overall Study||0||
59601413|NCT03316105|75711422|FG001|NOT COMPLETED|Overall Study||0||
59601414|NCT03277183|75711430|FG000|STARTED|Overall Study||3||
59601415|NCT03277183|75711431|FG001|STARTED|Overall Study||2||
59601416|NCT03277183|75711430|FG000|COMPLETED|Overall Study||0||
59601417|NCT03277183|75711431|FG001|COMPLETED|Overall Study||0||
59601418|NCT03277183|75711430|FG000|NOT COMPLETED|Overall Study||3||
59601419|NCT03277183|75711431|FG001|NOT COMPLETED|Overall Study||2||
59601420|NCT01525927|75711439|FG000|STARTED|Overall Study||0||
59601421|NCT01525927|75711439|FG000|COMPLETED|Overall Study||0||
59601422|NCT01525927|75711439|FG000|NOT COMPLETED|Overall Study||0||
59601423|NCT04013737|75711447|FG000|STARTED|Overall Study||18||
59601424|NCT04013737|75711448|FG001|STARTED|Overall Study||15||
59601425|NCT04013737|75711447|FG000|COMPLETED|Overall Study|12 participants declined to participate in the study|18||
59601426|NCT04013737|75711448|FG001|COMPLETED|Overall Study||15||
59601427|NCT04013737|75711447|FG000|NOT COMPLETED|Overall Study||0||
59601428|NCT04013737|75711448|FG001|NOT COMPLETED|Overall Study||0||
59601429|NCT04011631|75711453|FG000|STARTED|Overall Study||100||
59601430|NCT04011631|75711453|FG000|COMPLETED|Overall Study||100||
59601431|NCT04011631|75711453|FG000|NOT COMPLETED|Overall Study||0||
59601432|NCT02373865|75711459|FG000|STARTED|Overall Study||2||
59601433|NCT02373865|75711460|FG001|STARTED|Overall Study||2||
59601434|NCT02373865|75711459|FG000|COMPLETED|Overall Study||2||
59601435|NCT02373865|75711460|FG001|COMPLETED|Overall Study||2||
59601436|NCT02373865|75711459|FG000|NOT COMPLETED|Overall Study||0||
59601437|NCT02373865|75711460|FG001|NOT COMPLETED|Overall Study||0||
59601438|NCT02360059|75711468|FG000|STARTED|Overall Study||1||
59601439|NCT02360059|75711469|FG001|STARTED|Overall Study||0||
59601440|NCT02360059|75711468|FG000|COMPLETED|Overall Study||1||
59601441|NCT02360059|75711469|FG001|COMPLETED|Overall Study||0||
59601442|NCT02360059|75711468|FG000|NOT COMPLETED|Overall Study||0||
59601443|NCT02360059|75711469|FG001|NOT COMPLETED|Overall Study||0||
59601444|NCT04006795|75711475|FG000|STARTED|Induction Phase||37||
59601445|NCT04006795|75711475|FG000|COMPLETED|Induction Phase||37||
59601446|NCT04006795|75711475|FG000|NOT COMPLETED|Induction Phase||0||
59601447|NCT04006795|75711475|FG000|STARTED|Rest Phase||37||
59601448|NCT04006795|75711475|FG000|COMPLETED|Rest Phase||37||
59601449|NCT04006795|75711475|FG000|NOT COMPLETED|Rest Phase||0||
59601450|NCT04006795|75711475|FG000|STARTED|Challenge Phase||37||
59601451|NCT04006795|75711475|FG000|COMPLETED|Challenge Phase||37||
59601452|NCT04006795|75711475|FG000|NOT COMPLETED|Challenge Phase||0||
59601453|NCT01500109|75711489|FG000|STARTED|Overall Study||0||
59601454|NCT01500109|75711490|FG001|STARTED|Overall Study||0||
59601455|NCT01500109|75711491|FG002|STARTED|Overall Study||0||
59601456|NCT01500109|75711489|FG000|COMPLETED|Overall Study||0||
59601457|NCT01500109|75711490|FG001|COMPLETED|Overall Study||0||
59601458|NCT01500109|75711491|FG002|COMPLETED|Overall Study||0||
59601459|NCT01500109|75711489|FG000|NOT COMPLETED|Overall Study||0||
59601460|NCT01500109|75711490|FG001|NOT COMPLETED|Overall Study||0||
59601461|NCT01500109|75711491|FG002|NOT COMPLETED|Overall Study||0||
59601462|NCT02350777|75711501|FG000|STARTED|Overall Study||2||
59601463|NCT02350777|75711502|FG001|STARTED|Overall Study||2||
59601464|NCT02350777|75711501|FG000|COMPLETED|Overall Study||2||
59601465|NCT02350777|75711502|FG001|COMPLETED|Overall Study||2||
59601466|NCT02350777|75711501|FG000|NOT COMPLETED|Overall Study||0||
59601467|NCT02350777|75711502|FG001|NOT COMPLETED|Overall Study||0||
59601468|NCT01482325|75711508|FG000|STARTED|Overall Study||31||
59601469|NCT01482325|75711508|FG000|COMPLETED|Overall Study||31||
59601470|NCT01482325|75711508|FG000|NOT COMPLETED|Overall Study||0||
59601471|NCT02341495|75711512|FG000|STARTED|Overall Study||4||
59601472|NCT02341495|75711512|FG000|COMPLETED|Overall Study||4||
59601473|NCT02341495|75711512|FG000|NOT COMPLETED|Overall Study||0||
59601474|NCT02320825|75711518|FG000|STARTED|Overall Study||8||
59601475|NCT02320825|75711519|FG001|STARTED|Overall Study||8||
59601476|NCT02320825|75711518|FG000|COMPLETED|Overall Study||8||
59601477|NCT02320825|75711519|FG001|COMPLETED|Overall Study||8||
59601478|NCT02320825|75711518|FG000|NOT COMPLETED|Overall Study||0||
59601479|NCT02320825|75711519|FG001|NOT COMPLETED|Overall Study||0||
59601480|NCT01477177|75711525|FG000|STARTED|Overall Study||4||
59601481|NCT01477177|75711525|FG000|COMPLETED|Overall Study||4||
59601482|NCT01477177|75711525|FG000|NOT COMPLETED|Overall Study||0||
59601483|NCT04005391|75711531|FG000|STARTED|Overall Study|10/23/18|108||
59601484|NCT04005391|75711532|FG001|STARTED|Overall Study|10/23/18|100||
59601485|NCT04005391|75711531|FG000|COMPLETED|Overall Study||101|Primary Outcome Three Months|
59601486|NCT04005391|75711532|FG001|COMPLETED|Overall Study||100|Primary Outcome Three Months|
59601487|NCT04005391|75711531|FG000|NOT COMPLETED|Overall Study||7||
59601488|NCT04005391|75711532|FG001|NOT COMPLETED|Overall Study||0||
59601489|NCT03990415|75711545|FG000|STARTED|Overall Study||19||
59601490|NCT03990415|75711546|FG001|STARTED|Overall Study||19||
59601491|NCT03990415|75711547|FG002|STARTED|Overall Study||14||
59601492|NCT03990415|75711545|FG000|COMPLETED|Overall Study||15||
59601493|NCT03990415|75711546|FG001|COMPLETED|Overall Study||17||
59601494|NCT03990415|75711547|FG002|COMPLETED|Overall Study||14||
59601495|NCT03990415|75711545|FG000|NOT COMPLETED|Overall Study||4||
59867512|NCT03984812|75991917|FG010|STARTED|Part 1 (Up to Day 28)||0||
59867513|NCT03984812|75991907|FG000|COMPLETED|Part 1 (Up to Day 28)||6||
59867514|NCT03984812|75991908|FG001|COMPLETED|Part 1 (Up to Day 28)||6||
59601496|NCT03990415|75711546|FG001|NOT COMPLETED|Overall Study||2||
59601497|NCT03990415|75711547|FG002|NOT COMPLETED|Overall Study||0||
59601498|NCT04002973|75711555|FG000|STARTED|Overall Study||11||
59601499|NCT04002973|75711555|FG000|COMPLETED|Overall Study||11||
59601500|NCT04002973|75711555|FG000|NOT COMPLETED|Overall Study||0||
59601501|NCT03977935|75711561|FG000|STARTED|Overall Study||40||
59601502|NCT03977935|75711562|FG001|STARTED|Overall Study||40||
59601503|NCT03977935|75711561|FG000|COMPLETED|Overall Study||40||
59601504|NCT03977935|75711562|FG001|COMPLETED|Overall Study||40||
59601505|NCT03977935|75711561|FG000|NOT COMPLETED|Overall Study||0||
59601506|NCT03977935|75711562|FG001|NOT COMPLETED|Overall Study||0||
59601507|NCT03985657|75711568|FG000|STARTED|Intervention 1 (One Night)||20||
59601508|NCT03985657|75711569|FG001|STARTED|Intervention 1 (One Night)||11||
59601509|NCT03985657|75711568|FG000|COMPLETED|Intervention 1 (One Night)||20||
59601510|NCT03985657|75711569|FG001|COMPLETED|Intervention 1 (One Night)||10||
59601511|NCT03985657|75711568|FG000|NOT COMPLETED|Intervention 1 (One Night)||0||
59601512|NCT03985657|75711569|FG001|NOT COMPLETED|Intervention 1 (One Night)||1||
59601513|NCT03985657|75711568|FG000|STARTED|Washout (Up to 1 Week)||20||
59601514|NCT03985657|75711569|FG001|STARTED|Washout (Up to 1 Week)||10||
59601515|NCT03985657|75711568|FG000|COMPLETED|Washout (Up to 1 Week)||20||
59601516|NCT03985657|75711569|FG001|COMPLETED|Washout (Up to 1 Week)||10||
59601517|NCT03985657|75711568|FG000|NOT COMPLETED|Washout (Up to 1 Week)||0||
59601518|NCT03985657|75711569|FG001|NOT COMPLETED|Washout (Up to 1 Week)||0||
59601519|NCT03985657|75711568|FG000|STARTED|Intervention 2 (One Night)||20||
59601520|NCT03985657|75711569|FG001|STARTED|Intervention 2 (One Night)||10||
59601521|NCT03985657|75711568|FG000|COMPLETED|Intervention 2 (One Night)||20||
59601522|NCT03985657|75711569|FG001|COMPLETED|Intervention 2 (One Night)||10||
59601523|NCT03985657|75711568|FG000|NOT COMPLETED|Intervention 2 (One Night)||0||
59601524|NCT03985657|75711569|FG001|NOT COMPLETED|Intervention 2 (One Night)||0||
59601525|NCT02249377|75711577|FG000|STARTED|Overall Study||25||
59601526|NCT02249377|75711578|FG001|STARTED|Overall Study||25||
59601527|NCT02249377|75711577|FG000|COMPLETED|Overall Study||0||
59601528|NCT02249377|75711578|FG001|COMPLETED|Overall Study||1||
59601529|NCT02249377|75711577|FG000|NOT COMPLETED|Overall Study||25||
59601530|NCT02249377|75711578|FG001|NOT COMPLETED|Overall Study||24||
59867515|NCT03984812|75991909|FG002|COMPLETED|Part 1 (Up to Day 28)||5||
59867516|NCT03984812|75991910|FG003|COMPLETED|Part 1 (Up to Day 28)||6||
59601531|NCT02239627|75711586|FG000|STARTED|Overall Study||0||
59601532|NCT02239627|75711587|FG001|STARTED|Overall Study||0||
59601533|NCT02239627|75711586|FG000|COMPLETED|Overall Study||0||
59601534|NCT02239627|75711587|FG001|COMPLETED|Overall Study||0||
59601535|NCT02239627|75711586|FG000|NOT COMPLETED|Overall Study||0||
59601536|NCT02239627|75711587|FG001|NOT COMPLETED|Overall Study||0||
59601537|NCT02234011|75711593|FG000|STARTED|Overall Study||0||
59601538|NCT02234011|75711593|FG000|COMPLETED|Overall Study||0||
59601539|NCT02234011|75711593|FG000|NOT COMPLETED|Overall Study||0||
59601540|NCT02198833|75711599|FG000|STARTED|Overall Study|Unable to clear urine of bacteria for all but one patient therefore catheter not placed|1||
59601541|NCT02198833|75711600|FG001|STARTED|Overall Study|Unable to clear urine of bacteria for all but one patient therefore catheter not placed.|1||
59601542|NCT02198833|75711599|FG000|COMPLETED|Overall Study||1||
59601543|NCT02198833|75711600|FG001|COMPLETED|Overall Study||1||
59601544|NCT02198833|75711599|FG000|NOT COMPLETED|Overall Study||0||
59601545|NCT02198833|75711600|FG001|NOT COMPLETED|Overall Study||0||
59601546|NCT02177773|75711606|FG000|STARTED|Overall Study||300||
59601547|NCT02177773|75711606|FG000|COMPLETED|Overall Study||300||
59601548|NCT02177773|75711606|FG000|NOT COMPLETED|Overall Study||0||
59601549|NCT02144155|75711610|FG000|STARTED|Overall Study||14||
59601550|NCT02144155|75711610|FG000|COMPLETED|Overall Study||14||
59601551|NCT02144155|75711610|FG000|NOT COMPLETED|Overall Study||0||
59601552|NCT02145169|75711614|FG000|STARTED|Overall Study||0||
59601553|NCT02145169|75711614|FG000|COMPLETED|Overall Study||0||
59601554|NCT02145169|75711614|FG000|NOT COMPLETED|Overall Study||0||
59601555|NCT02047747|75711618|FG000|STARTED|Overall Study||4||
59601556|NCT02047747|75711618|FG000|COMPLETED|Overall Study||1||
59601557|NCT02047747|75711618|FG000|NOT COMPLETED|Overall Study||3||
59601558|NCT03983941|75711624|FG000|STARTED|Overall Study||2||
59601559|NCT03983941|75711625|FG001|STARTED|Overall Study||5||
59601560|NCT03983941|75711624|FG000|COMPLETED|Overall Study||2||
59601561|NCT03983941|75711625|FG001|COMPLETED|Overall Study||5||
59601562|NCT03983941|75711624|FG000|NOT COMPLETED|Overall Study||0||
59601563|NCT03983941|75711625|FG001|NOT COMPLETED|Overall Study||0||
59601564|NCT01434511|75711631|FG000|STARTED|Overall Study||1||
59601565|NCT01434511|75711631|FG000|COMPLETED|Overall Study||1||
59601566|NCT01434511|75711631|FG000|NOT COMPLETED|Overall Study||0||
59601567|NCT02020837|75711635|FG000|STARTED|Overall Study||2||
59601568|NCT02020837|75711635|FG000|COMPLETED|Overall Study||2||
59601569|NCT02020837|75711635|FG000|NOT COMPLETED|Overall Study||0||
59601570|NCT02006407|75711639|FG000|STARTED|Overall Study||5||
59601571|NCT02006407|75711639|FG000|COMPLETED|Overall Study||5||
59601572|NCT02006407|75711639|FG000|NOT COMPLETED|Overall Study||0||
59601573|NCT01426555|75711645|FG000|STARTED|Overall Study||35||
59601574|NCT01426555|75711646|FG001|STARTED|Overall Study||35||
59601575|NCT01426555|75711645|FG000|COMPLETED|Overall Study||17||
59601576|NCT01426555|75711646|FG001|COMPLETED|Overall Study||20||
59601577|NCT01426555|75711645|FG000|NOT COMPLETED|Overall Study||18||
59601578|NCT01426555|75711646|FG001|NOT COMPLETED|Overall Study||15||
59867517|NCT03984812|75991911|FG004|COMPLETED|Part 1 (Up to Day 28)||0||
59867518|NCT03984812|75991912|FG005|COMPLETED|Part 1 (Up to Day 28)||0||
59867519|NCT03984812|75991913|FG006|COMPLETED|Part 1 (Up to Day 28)||0||
59867520|NCT03984812|75991914|FG007|COMPLETED|Part 1 (Up to Day 28)||0||
59867521|NCT03984812|75991915|FG008|COMPLETED|Part 1 (Up to Day 28)||0||
59867522|NCT03984812|75991916|FG009|COMPLETED|Part 1 (Up to Day 28)||0||
59601579|NCT01434745|75711656|FG000|STARTED|Overall Study||0||
59601580|NCT01434745|75711657|FG001|STARTED|Overall Study||0||
59601581|NCT01434745|75711656|FG000|COMPLETED|Overall Study||0||
59601582|NCT01434745|75711657|FG001|COMPLETED|Overall Study||0||
59601583|NCT01434745|75711656|FG000|NOT COMPLETED|Overall Study||0||
59601584|NCT01434745|75711657|FG001|NOT COMPLETED|Overall Study||0||
59867523|NCT03984812|75991917|FG010|COMPLETED|Part 1 (Up to Day 28)||0||
59867524|NCT03984812|75991907|FG000|NOT COMPLETED|Part 1 (Up to Day 28)||0||
59601585|NCT01401049|75711665|FG000|STARTED|Overall Study|Due to flooding from Hurricane Sandy at our site, all files and pertinent patient data were lost.|0||
59601586|NCT01401049|75711666|FG001|STARTED|Overall Study|Due to flooding from Hurricane Sandy at our site, all files and pertinent patient data were lost.|0||
59867525|NCT03984812|75991908|FG001|NOT COMPLETED|Part 1 (Up to Day 28)||0||
59867526|NCT03984812|75991909|FG002|NOT COMPLETED|Part 1 (Up to Day 28)||1||
59601587|NCT01401049|75711665|FG000|COMPLETED|Overall Study||0||
59601588|NCT01401049|75711666|FG001|COMPLETED|Overall Study||0||
59601589|NCT01401049|75711665|FG000|NOT COMPLETED|Overall Study||0||
59601590|NCT01401049|75711666|FG001|NOT COMPLETED|Overall Study||0||
59601591|NCT01402531|75711672|FG000|STARTED|Overall Study||0||
59601592|NCT01402531|75711672|FG000|COMPLETED|Overall Study||0||
59601593|NCT01402531|75711672|FG000|NOT COMPLETED|Overall Study||0||
59601594|NCT01971853|75711678|FG000|STARTED|Overall Study||0||
59601595|NCT01971853|75711679|FG001|STARTED|Overall Study||0||
59601596|NCT01971853|75711678|FG000|COMPLETED|Overall Study||0||
59601597|NCT01971853|75711679|FG001|COMPLETED|Overall Study||0||
59601598|NCT01971853|75711678|FG000|NOT COMPLETED|Overall Study||0||
59601599|NCT01971853|75711679|FG001|NOT COMPLETED|Overall Study||0||
59867527|NCT03984812|75991910|FG003|NOT COMPLETED|Part 1 (Up to Day 28)||0||
59867528|NCT03984812|75991911|FG004|NOT COMPLETED|Part 1 (Up to Day 28)||0||
59601600|NCT01397695|75711685|FG000|STARTED|Overall Study||0||
59601601|NCT01397695|75711685|FG000|COMPLETED|Overall Study||0||
59601602|NCT01397695|75711685|FG000|NOT COMPLETED|Overall Study||0||
59601603|NCT01982383|75711691|FG000|STARTED|Overall Study||2||
59601604|NCT01982383|75711692|FG001|STARTED|Overall Study||0||
59601605|NCT01982383|75711691|FG000|COMPLETED|Overall Study||2||
59601606|NCT01982383|75711692|FG001|COMPLETED|Overall Study||0||
59601607|NCT01982383|75711691|FG000|NOT COMPLETED|Overall Study||0||
59601608|NCT01982383|75711692|FG001|NOT COMPLETED|Overall Study||0||
59601609|NCT01356667|75711700|FG000|STARTED|Overall Study||4||
59601610|NCT01356667|75711701|FG001|STARTED|Overall Study||6||
59601611|NCT01356667|75711700|FG000|COMPLETED|Overall Study||0||
59601612|NCT01356667|75711701|FG001|COMPLETED|Overall Study||0||
59601613|NCT01356667|75711700|FG000|NOT COMPLETED|Overall Study||4||
59601614|NCT01356667|75711701|FG001|NOT COMPLETED|Overall Study||6||
59601615|NCT01934647|75711712|FG000|STARTED|Overall Study||2||
59601616|NCT01934647|75711713|FG001|STARTED|Overall Study||2||
59601617|NCT01934647|75711714|FG002|STARTED|Overall Study||3||
59601618|NCT01934647|75711712|FG000|COMPLETED|Overall Study||2||
59601619|NCT01934647|75711713|FG001|COMPLETED|Overall Study||2||
59601620|NCT01934647|75711714|FG002|COMPLETED|Overall Study||3||
59601621|NCT01934647|75711712|FG000|NOT COMPLETED|Overall Study||0||
59601622|NCT01934647|75711713|FG001|NOT COMPLETED|Overall Study||0||
59601623|NCT01934647|75711714|FG002|NOT COMPLETED|Overall Study||0||
59601624|NCT01354951|75711722|FG000|STARTED|Overall Study||3||
59601625|NCT01354951|75711722|FG000|COMPLETED|Overall Study||1||
59601626|NCT01354951|75711722|FG000|NOT COMPLETED|Overall Study||2||
59601627|NCT01350583|75711726|FG000|STARTED|Overall Study||2||
59601628|NCT01350583|75711726|FG000|COMPLETED|Overall Study||2||
59601629|NCT01350583|75711726|FG000|NOT COMPLETED|Overall Study||0||
59601630|NCT01890577|75711730|FG000|STARTED|Overall Study||28||
59601631|NCT01890577|75711730|FG000|COMPLETED|Overall Study||0||
59601632|NCT01890577|75711730|FG000|NOT COMPLETED|Overall Study||28||
59601633|NCT01315873|75711734|FG000|STARTED|Overall Study||24||
59601634|NCT01315873|75711734|FG000|COMPLETED|Overall Study||24||
59601635|NCT01315873|75711734|FG000|NOT COMPLETED|Overall Study||0||
59601636|NCT01895959|75711738|FG000|STARTED|Overall Study||12||
59601637|NCT01895959|75711738|FG000|COMPLETED|Overall Study||10||
59734152|NCT00940602|75852711|FG000|STARTED|Overall Study||149|All patients to whom study treatment had been assigned by randomization (Full Analysis Set).|
59734153|NCT00940602|75852712|FG001|STARTED|Overall Study||76|All patients to whom study treatment had been assigned by randomization (Full Analysis Set).|
59734154|NCT00940602|75852711|FG000|Safety Analysis Set|Overall Study||148|All randomized patients who received at least one dose of study medication|
59734155|NCT00940602|75852712|FG001|Safety Analysis Set|Overall Study||76|All randomized patients who received at least one dose of study medication|
59734156|NCT00940602|75852711|FG000|Full Analysis Set|Overall Study||149|All patients to whom study treatment had been assigned by randomization|
59734157|NCT00940602|75852712|FG001|Full Analysis Set|Overall Study||76|All patients to whom study treatment had been assigned by randomization|
59734158|NCT00940602|75852711|FG000|Treated|Overall Study||148|Treated = Received study drug|
59734159|NCT00940602|75852712|FG001|Treated|Overall Study||76|Treated = Received study drug|
59734160|NCT00940602|75852711|FG000|Untreated|Overall Study||1|Untreated = Did not receive study drug|
59734161|NCT00940602|75852712|FG001|Untreated|Overall Study||0|Untreated = Did not receive study drug|
59734162|NCT00940602|75852711|FG000|COMPLETED|Overall Study||0||
59734163|NCT00940602|75852712|FG001|COMPLETED|Overall Study||0||
59734164|NCT00940602|75852711|FG000|NOT COMPLETED|Overall Study||149||
59734165|NCT00940602|75852712|FG001|NOT COMPLETED|Overall Study||76||
59734166|NCT00875524|75852721|FG000|STARTED|Overall Study||120||
59734167|NCT00875524|75852722|FG001|STARTED|Overall Study||60||
59734168|NCT00875524|75852721|FG000|Received Vaccination 1|Overall Study||120||
59734169|NCT00875524|75852722|FG001|Received Vaccination 1|Overall Study||60||
59734170|NCT00875524|75852721|FG000|Received Vaccination 2|Overall Study||116||
59734171|NCT00875524|75852722|FG001|Received Vaccination 2|Overall Study||58||
59734172|NCT00875524|75852721|FG000|Received Vaccination 3|Overall Study||114||
59734173|NCT00875524|75852722|FG001|Received Vaccination 3|Overall Study||58||
59734174|NCT00875524|75852721|FG000|COMPLETED|Overall Study||112||
59734175|NCT00875524|75852722|FG001|COMPLETED|Overall Study||54||
59734176|NCT00875524|75852721|FG000|NOT COMPLETED|Overall Study||8||
59734177|NCT00875524|75852722|FG001|NOT COMPLETED|Overall Study||6||
59734178|NCT01094288|75852736|FG000|STARTED|Overall Study||6||
59734179|NCT01094288|75852737|FG001|STARTED|Overall Study||15||
59734180|NCT01094288|75852738|FG002|STARTED|Overall Study||5||
59734181|NCT01094288|75852739|FG003|STARTED|Overall Study||3||
59734182|NCT01094288|75852740|FG004|STARTED|Overall Study||2||
59734183|NCT01094288|75852741|FG005|STARTED|Overall Study||4||
59734184|NCT01094288|75852742|FG006|STARTED|Overall Study||2||
59734185|NCT01094288|75852743|FG007|STARTED|Overall Study||4||
59867529|NCT03984812|75991912|FG005|NOT COMPLETED|Part 1 (Up to Day 28)||0||
59867530|NCT03984812|75991913|FG006|NOT COMPLETED|Part 1 (Up to Day 28)||0||
59867531|NCT03984812|75991914|FG007|NOT COMPLETED|Part 1 (Up to Day 28)||0||
59867532|NCT03984812|75991915|FG008|NOT COMPLETED|Part 1 (Up to Day 28)||0||
59734186|NCT01094288|75852736|FG000|COMPLETED|Overall Study|Completed=Completed Treatment|4||
59734187|NCT01094288|75852737|FG001|COMPLETED|Overall Study||5||
59734188|NCT01094288|75852738|FG002|COMPLETED|Overall Study||1||
59734189|NCT01094288|75852739|FG003|COMPLETED|Overall Study||1||
59734190|NCT01094288|75852740|FG004|COMPLETED|Overall Study||2||
59734191|NCT01094288|75852741|FG005|COMPLETED|Overall Study||4||
59734192|NCT01094288|75852742|FG006|COMPLETED|Overall Study||2||
59734193|NCT01094288|75852743|FG007|COMPLETED|Overall Study||2||
59734194|NCT01094288|75852736|FG000|NOT COMPLETED|Overall Study||2||
59734195|NCT01094288|75852737|FG001|NOT COMPLETED|Overall Study||10||
59734196|NCT01094288|75852738|FG002|NOT COMPLETED|Overall Study||4||
59734197|NCT01094288|75852739|FG003|NOT COMPLETED|Overall Study||2||
59734198|NCT01094288|75852740|FG004|NOT COMPLETED|Overall Study||0||
59734199|NCT01094288|75852741|FG005|NOT COMPLETED|Overall Study||0||
59734200|NCT01094288|75852742|FG006|NOT COMPLETED|Overall Study||0||
59734201|NCT01094288|75852743|FG007|NOT COMPLETED|Overall Study||2||
59734202|NCT00874120|75852767|FG000|STARTED|First Intervention||58||
59734203|NCT00874120|75852768|FG001|STARTED|First Intervention||58||
59734204|NCT00874120|75852767|FG000|COMPLETED|First Intervention||52||
59734205|NCT00874120|75852768|FG001|COMPLETED|First Intervention||56||
59734206|NCT00874120|75852767|FG000|NOT COMPLETED|First Intervention||6||
59734207|NCT00874120|75852768|FG001|NOT COMPLETED|First Intervention||2||
59734208|NCT00874120|75852767|FG000|STARTED|Wash-out Period||52||
59734209|NCT00874120|75852768|FG001|STARTED|Wash-out Period||56||
59734210|NCT00874120|75852767|FG000|COMPLETED|Wash-out Period||52||
59734211|NCT00874120|75852768|FG001|COMPLETED|Wash-out Period||56||
59734212|NCT00874120|75852767|FG000|NOT COMPLETED|Wash-out Period||0||
59734213|NCT00874120|75852768|FG001|NOT COMPLETED|Wash-out Period||0||
59734214|NCT00874120|75852767|FG000|STARTED|Second Intervention||52||
59734215|NCT00874120|75852768|FG001|STARTED|Second Intervention||56||
59734216|NCT00874120|75852767|FG000|COMPLETED|Second Intervention||50||
59734217|NCT00874120|75852768|FG001|COMPLETED|Second Intervention||56||
59734218|NCT00874120|75852767|FG000|NOT COMPLETED|Second Intervention||2||
59734219|NCT00874120|75852768|FG001|NOT COMPLETED|Second Intervention||0||
59734220|NCT00939822|75852776|FG000|STARTED|Overall Study||44||
59734221|NCT00939822|75852777|FG001|STARTED|Overall Study||44||
59734222|NCT00939822|75852776|FG000|COMPLETED|Overall Study||42||
59734223|NCT00939822|75852777|FG001|COMPLETED|Overall Study||41||
59734224|NCT00939822|75852776|FG000|NOT COMPLETED|Overall Study||2||
59734225|NCT00939822|75852777|FG001|NOT COMPLETED|Overall Study||3||
59734226|NCT00939510|75852783|FG000|STARTED|Overall Study||32||
59734227|NCT00939510|75852783|FG000|COMPLETED|Overall Study||31||
59734228|NCT00939510|75852783|FG000|NOT COMPLETED|Overall Study||1||
59734229|NCT01098266|75852789|FG000|STARTED|Overall Study||200||
59734230|NCT01098266|75852790|FG001|STARTED|Overall Study||200||
59734231|NCT01098266|75852789|FG000|COMPLETED|Overall Study||193||
59734232|NCT01098266|75852790|FG001|COMPLETED|Overall Study||193||
59734233|NCT01098266|75852789|FG000|NOT COMPLETED|Overall Study||7||
59734234|NCT01098266|75852790|FG001|NOT COMPLETED|Overall Study||7||
59734235|NCT00935532|75852798|FG000|STARTED|Overall Study||215||
59734236|NCT00935532|75852799|FG001|STARTED|Overall Study||212||
59734237|NCT00935532|75852798|FG000|COMPLETED|Overall Study||193||
59734238|NCT00935532|75852799|FG001|COMPLETED|Overall Study||201||
59734239|NCT00935532|75852798|FG000|NOT COMPLETED|Overall Study||22||
59734240|NCT00935532|75852799|FG001|NOT COMPLETED|Overall Study||11||
59734241|NCT01093586|75852805|FG000|STARTED|Overall Study||14||
59734242|NCT01093586|75852805|FG000|COMPLETED|Overall Study||11||
59734243|NCT01093586|75852805|FG000|NOT COMPLETED|Overall Study||3||
59734244|NCT00937404|75852809|FG000|STARTED|Overall Study||25||
59734245|NCT00937404|75852809|FG000|COMPLETED|Overall Study||23||
59734246|NCT00937404|75852809|FG000|NOT COMPLETED|Overall Study||2||
59734247|NCT01098110|75852816|FG000|STARTED|Overall Study|Randomized participants|176||
59734248|NCT01098110|75852817|FG001|STARTED|Overall Study|Randomized participants|182||
59734249|NCT01098110|75852818|FG002|STARTED|Overall Study|Randomized participants|174||
59734250|NCT01098110|75852816|FG000|Treated|Overall Study|Received at least one dose of trial medication|175||
59734251|NCT01098110|75852817|FG001|Treated|Overall Study|Received at least one dose of trial medication|181||
59734252|NCT01098110|75852818|FG002|Treated|Overall Study|Received at least one dose of trial medication|174||
59734253|NCT01098110|75852816|FG000|COMPLETED|Overall Study||114||
59734254|NCT01098110|75852817|FG001|COMPLETED|Overall Study||109||
59734255|NCT01098110|75852818|FG002|COMPLETED|Overall Study||80||
59734256|NCT01098110|75852816|FG000|NOT COMPLETED|Overall Study||62||
59734257|NCT01098110|75852817|FG001|NOT COMPLETED|Overall Study||73||
59734258|NCT01098110|75852818|FG002|NOT COMPLETED|Overall Study||94||
59734259|NCT01092728|75852828|FG000|STARTED|Overall Study||4||
59734260|NCT01092728|75852829|FG001|STARTED|Overall Study||14||
59734261|NCT01092728|75852828|FG000|COMPLETED|Overall Study||0||
59734262|NCT01092728|75852829|FG001|COMPLETED|Overall Study||0||
59734263|NCT01092728|75852828|FG000|NOT COMPLETED|Overall Study||4||
59734264|NCT01092728|75852829|FG001|NOT COMPLETED|Overall Study||14||
59734265|NCT01096550|75852837|FG000|STARTED|Overall Study||170||
59734266|NCT01096550|75852838|FG001|STARTED|Overall Study||175||
59734267|NCT01096550|75852837|FG000|COMPLETED|Overall Study||133||
59734268|NCT01096550|75852838|FG001|COMPLETED|Overall Study||146||
59734269|NCT01096550|75852837|FG000|NOT COMPLETED|Overall Study||37||
59734270|NCT01096550|75852838|FG001|NOT COMPLETED|Overall Study||29||
59734271|NCT01101542|75852844|FG000|STARTED|Year 3 Surveillance Period||105||
59734272|NCT01101542|75852844|FG000|COMPLETED|Year 3 Surveillance Period||94||
59734273|NCT01101542|75852844|FG000|NOT COMPLETED|Year 3 Surveillance Period||11||
59734274|NCT01101542|75852844|FG000|STARTED|Year 4 Surveillance Period||569||
59734275|NCT01101542|75852844|FG000|COMPLETED|Year 4 Surveillance Period||282||
59734276|NCT01101542|75852844|FG000|NOT COMPLETED|Year 4 Surveillance Period||287||
59734277|NCT01101542|75852844|FG000|STARTED|Year 5 Surveillance Period||809||
59734278|NCT01101542|75852844|FG000|COMPLETED|Year 5 Surveillance Period||668||
59734279|NCT01101542|75852844|FG000|NOT COMPLETED|Year 5 Surveillance Period||141||
59734280|NCT01101542|75852844|FG000|STARTED|Year 6 Surveillance Period||3091||
59734281|NCT01101542|75852844|FG000|COMPLETED|Year 6 Surveillance Period||2100||
59734282|NCT01101542|75852844|FG000|NOT COMPLETED|Year 6 Surveillance Period||991||
59734283|NCT00937326|75852853|FG000|STARTED|Overall Study||46||
59734284|NCT00937326|75852854|FG001|STARTED|Overall Study||45||
59734285|NCT00937326|75852855|FG002|STARTED|Overall Study||46||
59734286|NCT00937326|75852856|FG003|STARTED|Overall Study||45||
59734287|NCT00937326|75852857|FG004|STARTED|Overall Study||45||
59734288|NCT00937326|75852853|FG000|COMPLETED|Overall Study||43||
59734289|NCT00937326|75852854|FG001|COMPLETED|Overall Study||38||
59734290|NCT00937326|75852855|FG002|COMPLETED|Overall Study||42||
59734291|NCT00937326|75852856|FG003|COMPLETED|Overall Study||40||
59734292|NCT00937326|75852857|FG004|COMPLETED|Overall Study||40||
59734293|NCT00937326|75852853|FG000|NOT COMPLETED|Overall Study||3||
59734294|NCT00937326|75852854|FG001|NOT COMPLETED|Overall Study||7||
59734295|NCT00937326|75852855|FG002|NOT COMPLETED|Overall Study||4||
59734296|NCT00937326|75852856|FG003|NOT COMPLETED|Overall Study||5||
59734297|NCT00937326|75852857|FG004|NOT COMPLETED|Overall Study||5||
59734298|NCT00873730|75852876|FG000|STARTED|Overall Study||54||
59734299|NCT00873730|75852877|FG001|STARTED|Overall Study||54||
59734300|NCT00873730|75852876|FG000|COMPLETED|Overall Study||48||
59734301|NCT00873730|75852877|FG001|COMPLETED|Overall Study||49||
59734302|NCT00873730|75852876|FG000|NOT COMPLETED|Overall Study||6||
59734303|NCT00873730|75852877|FG001|NOT COMPLETED|Overall Study||5||
59734304|NCT00874432|75852887|FG000|STARTED|Overall Study||8||
59734305|NCT00874432|75852888|FG001|STARTED|Overall Study||4||
59734306|NCT00874432|75852889|FG002|STARTED|Overall Study||17||
59734307|NCT00874432|75852890|FG003|STARTED|Overall Study||14||
59734308|NCT00874432|75852887|FG000|COMPLETED|Overall Study||5||
59734309|NCT00874432|75852888|FG001|COMPLETED|Overall Study||2||
59734310|NCT00874432|75852889|FG002|COMPLETED|Overall Study||9||
59734311|NCT00874432|75852890|FG003|COMPLETED|Overall Study||11||
59734312|NCT00874432|75852887|FG000|NOT COMPLETED|Overall Study||3||
59734313|NCT00874432|75852888|FG001|NOT COMPLETED|Overall Study||2||
59734314|NCT00874432|75852889|FG002|NOT COMPLETED|Overall Study||8||
59734315|NCT00874432|75852890|FG003|NOT COMPLETED|Overall Study||3||
59734316|NCT00935220|75852902|FG000|STARTED|Overall Study||41||
59734317|NCT00935220|75852902|FG000|COMPLETED|Overall Study||39||
59734318|NCT00935220|75852902|FG000|NOT COMPLETED|Overall Study||2||
59734319|NCT00874276|75852908|FG000|STARTED|Overall Study||6||
59734320|NCT00874276|75852909|FG001|STARTED|Overall Study||8||
59734321|NCT00874276|75852908|FG000|COMPLETED|Overall Study||5||
59734322|NCT00874276|75852909|FG001|COMPLETED|Overall Study||7||
59734323|NCT00874276|75852908|FG000|NOT COMPLETED|Overall Study||1||
59734324|NCT00874276|75852909|FG001|NOT COMPLETED|Overall Study||1||
59734325|NCT00594958|75852920|FG000|STARTED|Overall Study||214||
59734326|NCT00594958|75852921|FG001|STARTED|Overall Study||213||
59734327|NCT00594958|75852922|FG002|STARTED|Overall Study||212||
59734328|NCT00594958|75852920|FG000|Randomized and at Least 1 Vaccination|Overall Study||212||
59734329|NCT00594958|75852921|FG001|Randomized and at Least 1 Vaccination|Overall Study||213||
59734330|NCT00594958|75852922|FG002|Randomized and at Least 1 Vaccination|Overall Study||211||
59734331|NCT00594958|75852920|FG000|COMPLETED|Overall Study||200||
59734332|NCT00594958|75852921|FG001|COMPLETED|Overall Study||210||
59734333|NCT00594958|75852922|FG002|COMPLETED|Overall Study||202||
59734334|NCT00594958|75852920|FG000|NOT COMPLETED|Overall Study||14||
59734335|NCT00594958|75852921|FG001|NOT COMPLETED|Overall Study||3||
59734336|NCT00594958|75852922|FG002|NOT COMPLETED|Overall Study||10||
59734337|NCT00594880|75852932|FG000|STARTED|Overall Study||12||
59734338|NCT00594880|75852933|FG001|STARTED|Overall Study||11||
59734339|NCT00594880|75852932|FG000|COMPLETED|Overall Study||10||
59734340|NCT00594880|75852933|FG001|COMPLETED|Overall Study||10||
59734341|NCT00594880|75852932|FG000|NOT COMPLETED|Overall Study||2||
59734342|NCT00594880|75852933|FG001|NOT COMPLETED|Overall Study||1||
59734343|NCT00871858|75852945|FG000|STARTED|Overall Study||61||
59734344|NCT00871858|75852946|FG001|STARTED|Overall Study||59||
59734345|NCT00871858|75852945|FG000|Evaluable for Safety|Overall Study|1 patient refused to continue study and therefore did not received treatment.|60||
59734346|NCT00871858|75852946|FG001|Evaluable for Safety|Overall Study|1 patient refused to continue study after randomization and therefore did not received treatment.|58||
59734347|NCT00871858|75852945|FG000|COMPLETED|Overall Study||56||
59734348|NCT00871858|75852946|FG001|COMPLETED|Overall Study||52||
59734349|NCT00871858|75852945|FG000|NOT COMPLETED|Overall Study||5||
59734350|NCT00871858|75852946|FG001|NOT COMPLETED|Overall Study||7||
59734351|NCT00871780|75852952|FG000|STARTED|Overall Study|number enrolled|224||
59734352|NCT00871780|75852952|FG000|Safety Analysis Population|Overall Study|participants who had ≥1 infusion of natalizumab during the study|218||
59734353|NCT00871780|75852952|FG000|Efficacy Analysis Population|Overall Study|participants who had ≥1 infusion of natalizumab and completed at least 1 on-treatment evaluation|215||
59734354|NCT00871780|75852952|FG000|COMPLETED|Overall Study||197||
59734355|NCT00871780|75852952|FG000|NOT COMPLETED|Overall Study||27||
59734356|NCT00594178|75852959|FG000|STARTED|Overall Study||17||
59734357|NCT00594178|75852959|FG000|COMPLETED|Overall Study||12||
59734358|NCT00594178|75852959|FG000|NOT COMPLETED|Overall Study||5||
59734359|NCT00933270|75852963|FG000|STARTED|Overall Study|ITT population|264||
59734360|NCT00933270|75852963|FG000|COMPLETED|Overall Study||177||
59734361|NCT00933270|75852963|FG000|NOT COMPLETED|Overall Study||87||
59734362|NCT00936858|75852968|FG000|STARTED|Overall Study||50||
59734363|NCT00936858|75852968|FG000|Participants With Medullary Thyroid Cancer|Overall Study||10||
59734364|NCT00936858|75852968|FG000|COMPLETED|Overall Study||0||
59734365|NCT00936858|75852968|FG000|NOT COMPLETED|Overall Study||50||
59734366|NCT00872170|75852975|FG000|STARTED|Overall Study||14||
59734367|NCT00872170|75852976|FG001|STARTED|Overall Study||13||
59734368|NCT00872170|75852975|FG000|COMPLETED|Overall Study|One patient withdrew from study at week 2.|13||
59734369|NCT00872170|75852976|FG001|COMPLETED|Overall Study||13||
59734370|NCT00872170|75852975|FG000|NOT COMPLETED|Overall Study||1||
59734371|NCT00872170|75852976|FG001|NOT COMPLETED|Overall Study||0||
59734372|NCT00936702|75852981|FG000|STARTED|Overall Study||46||
59734373|NCT00936702|75852981|FG000|COMPLETED|Overall Study||0||
59734374|NCT00936702|75852981|FG000|NOT COMPLETED|Overall Study||46||
59734375|NCT00594100|75852985|FG000|STARTED|Procedure||245||
59734376|NCT00594100|75852985|FG000|COMPLETED|Procedure||236||
59734377|NCT00594100|75852985|FG000|NOT COMPLETED|Procedure||9||
59734378|NCT00594100|75852985|FG000|STARTED|Follow-up Through 30 Days Post Procedure||236||
59734379|NCT00594100|75852985|FG000|COMPLETED|Follow-up Through 30 Days Post Procedure||224||
59734380|NCT00594100|75852985|FG000|NOT COMPLETED|Follow-up Through 30 Days Post Procedure||12||
59734381|NCT01092182|75852992|FG000|STARTED|Overall Study||15||
59734382|NCT01092182|75852993|FG001|STARTED|Overall Study||98||
59734383|NCT01092182|75852994|FG002|STARTED|Overall Study||81||
59734384|NCT01092182|75852992|FG000|COMPLETED|Overall Study||14||
59734385|NCT01092182|75852993|FG001|COMPLETED|Overall Study||80||
59734386|NCT01092182|75852994|FG002|COMPLETED|Overall Study||53||
59734387|NCT01092182|75852992|FG000|NOT COMPLETED|Overall Study||1||
59734388|NCT01092182|75852993|FG001|NOT COMPLETED|Overall Study||18||
59734389|NCT01092182|75852994|FG002|NOT COMPLETED|Overall Study||28||
59734390|NCT00932646|75853002|FG000|STARTED|Overall Study||25||
59734391|NCT00932646|75853003|FG001|STARTED|Overall Study||25||
59734392|NCT00932646|75853004|FG002|STARTED|Overall Study||25||
59734393|NCT00932646|75853005|FG003|STARTED|Overall Study||25||
59734394|NCT00932646|75853002|FG000|COMPLETED|Overall Study||20||
59734395|NCT00932646|75853003|FG001|COMPLETED|Overall Study||22||
59734396|NCT00932646|75853004|FG002|COMPLETED|Overall Study||21||
59734397|NCT00932646|75853005|FG003|COMPLETED|Overall Study||24||
59734398|NCT00932646|75853002|FG000|NOT COMPLETED|Overall Study||5||
59734399|NCT00932646|75853003|FG001|NOT COMPLETED|Overall Study||3||
59734400|NCT00932646|75853004|FG002|NOT COMPLETED|Overall Study||4||
59734401|NCT00932646|75853005|FG003|NOT COMPLETED|Overall Study||1||
59734402|NCT00871234|75853019|FG000|STARTED|Overall Study||28||
59734403|NCT00871234|75853019|FG000|COMPLETED|Overall Study||23||
59734404|NCT00871234|75853019|FG000|NOT COMPLETED|Overall Study||5||
59734405|NCT01091246|75853026|FG000|STARTED|Overall Study||1385||
59734406|NCT01091246|75853027|FG001|STARTED|Overall Study||464||
59734407|NCT01091246|75853028|FG002|STARTED|Overall Study||463||
59734408|NCT01091246|75853026|FG000|COMPLETED|Overall Study||1350||
59734409|NCT01091246|75853027|FG001|COMPLETED|Overall Study||448||
59734410|NCT01091246|75853028|FG002|COMPLETED|Overall Study||450||
59734411|NCT01091246|75853026|FG000|NOT COMPLETED|Overall Study||35||
59734412|NCT01091246|75853027|FG001|NOT COMPLETED|Overall Study||16||
59734413|NCT01091246|75853028|FG002|NOT COMPLETED|Overall Study||13||
59734414|NCT01097330|75853040|FG000|STARTED|Overall Study||7||
59734415|NCT01097330|75853041|FG001|STARTED|Overall Study||5||
59734416|NCT01097330|75853040|FG000|COMPLETED|Overall Study||0||
59734417|NCT01097330|75853041|FG001|COMPLETED|Overall Study||0||
59734418|NCT01097330|75853040|FG000|NOT COMPLETED|Overall Study||7||
59734419|NCT01097330|75853041|FG001|NOT COMPLETED|Overall Study||5||
59734420|NCT00934440|75853047|FG000|STARTED|Overall Study||11||
59734421|NCT00934440|75853047|FG000|COMPLETED|Overall Study||10||
59734422|NCT00934440|75853047|FG000|NOT COMPLETED|Overall Study||1||
59734423|NCT00934362|75853054|FG000|STARTED|Overall Study||8||
59734424|NCT00934362|75853055|FG001|STARTED|Overall Study||8||
59734425|NCT00934362|75853054|FG000|COMPLETED|Overall Study||7||
59734426|NCT00934362|75853055|FG001|COMPLETED|Overall Study||8||
59734427|NCT00934362|75853054|FG000|NOT COMPLETED|Overall Study||1||
59734428|NCT00934362|75853055|FG001|NOT COMPLETED|Overall Study||0||
59734429|NCT00934128|75853063|FG000|STARTED|First Intervention (2 Hours)||15||
59762485|NCT02644525|75882210|FG001|STARTED|Group 3||0||
59734430|NCT00934128|75853064|FG001|STARTED|First Intervention (2 Hours)||15||
59734431|NCT00934128|75853063|FG000|COMPLETED|First Intervention (2 Hours)||10||
59734432|NCT00934128|75853064|FG001|COMPLETED|First Intervention (2 Hours)||13||
59734433|NCT00934128|75853063|FG000|NOT COMPLETED|First Intervention (2 Hours)||5||
59734434|NCT00934128|75853064|FG001|NOT COMPLETED|First Intervention (2 Hours)||2||
59734435|NCT00934128|75853063|FG000|STARTED|Washout Period (1 Hour)||10||
59734436|NCT00934128|75853064|FG001|STARTED|Washout Period (1 Hour)||13||
59734437|NCT00934128|75853063|FG000|COMPLETED|Washout Period (1 Hour)||3||
59734438|NCT00934128|75853064|FG001|COMPLETED|Washout Period (1 Hour)||8||
59734439|NCT00934128|75853063|FG000|NOT COMPLETED|Washout Period (1 Hour)||7||
59734440|NCT00934128|75853064|FG001|NOT COMPLETED|Washout Period (1 Hour)||5||
59734441|NCT00934128|75853063|FG000|STARTED|Second Intervention (2 Hours)||3||
59734442|NCT00934128|75853064|FG001|STARTED|Second Intervention (2 Hours)||8||
59734443|NCT00934128|75853063|FG000|COMPLETED|Second Intervention (2 Hours)||3||
59734444|NCT00934128|75853064|FG001|COMPLETED|Second Intervention (2 Hours)||5||
59734445|NCT00934128|75853063|FG000|NOT COMPLETED|Second Intervention (2 Hours)||0||
59734446|NCT00934128|75853064|FG001|NOT COMPLETED|Second Intervention (2 Hours)||3||
59734447|NCT00871000|75853072|FG000|STARTED|Overall Study||151||
59734448|NCT00871000|75853073|FG001|STARTED|Overall Study||152||
59734449|NCT00871000|75853072|FG000|COMPLETED|Overall Study||150||
59734450|NCT00871000|75853073|FG001|COMPLETED|Overall Study||152||
59734451|NCT00871000|75853072|FG000|NOT COMPLETED|Overall Study||1||
59734452|NCT00871000|75853073|FG001|NOT COMPLETED|Overall Study||0||
59734453|NCT01096784|75853081|FG000|STARTED|Overall Study||61||
59734454|NCT01096784|75853082|FG001|STARTED|Overall Study||60||
59734455|NCT01096784|75853081|FG000|COMPLETED|Overall Study||46||
59734456|NCT01096784|75853082|FG001|COMPLETED|Overall Study||46||
59734457|NCT01096784|75853081|FG000|NOT COMPLETED|Overall Study||15||
59734458|NCT01096784|75853082|FG001|NOT COMPLETED|Overall Study||14||
59734459|NCT00934050|75853096|FG000|STARTED|Enrolled Prior to 15 Dec 2009||12||
59734460|NCT00934050|75853097|FG001|STARTED|Enrolled Prior to 15 Dec 2009||12||
59734461|NCT00934050|75853098|FG002|STARTED|Enrolled Prior to 15 Dec 2009||12||
59734462|NCT00934050|75853099|FG003|STARTED|Enrolled Prior to 15 Dec 2009||14||
59734463|NCT00934050|75853100|FG004|STARTED|Enrolled Prior to 15 Dec 2009||0||
59734464|NCT00934050|75853101|FG005|STARTED|Enrolled Prior to 15 Dec 2009||0||
59734465|NCT00934050|75853096|FG000|COMPLETED|Enrolled Prior to 15 Dec 2009||0||
59734466|NCT00934050|75853097|FG001|COMPLETED|Enrolled Prior to 15 Dec 2009||0||
59734467|NCT00934050|75853098|FG002|COMPLETED|Enrolled Prior to 15 Dec 2009||0||
59734468|NCT00934050|75853099|FG003|COMPLETED|Enrolled Prior to 15 Dec 2009||0||
59734469|NCT00934050|75853100|FG004|COMPLETED|Enrolled Prior to 15 Dec 2009||0||
59734470|NCT00934050|75853101|FG005|COMPLETED|Enrolled Prior to 15 Dec 2009||0||
59734471|NCT00934050|75853096|FG000|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||12||
59734472|NCT00934050|75853097|FG001|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||12||
59734473|NCT00934050|75853098|FG002|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||12||
59734474|NCT00934050|75853099|FG003|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||14||
59734475|NCT00934050|75853100|FG004|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||0||
59734476|NCT00934050|75853101|FG005|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||0||
59734477|NCT00934050|75853096|FG000|STARTED|Enrolled After 15 Dec 2009||0||
59734478|NCT00934050|75853097|FG001|STARTED|Enrolled After 15 Dec 2009||0||
59734479|NCT00934050|75853098|FG002|STARTED|Enrolled After 15 Dec 2009||0||
59734480|NCT00934050|75853099|FG003|STARTED|Enrolled After 15 Dec 2009||0||
59734481|NCT00934050|75853100|FG004|STARTED|Enrolled After 15 Dec 2009||26||
59734482|NCT00934050|75853101|FG005|STARTED|Enrolled After 15 Dec 2009||27||
59734483|NCT00934050|75853096|FG000|COMPLETED|Enrolled After 15 Dec 2009||0||
59734484|NCT00934050|75853097|FG001|COMPLETED|Enrolled After 15 Dec 2009||0||
59734485|NCT00934050|75853098|FG002|COMPLETED|Enrolled After 15 Dec 2009||0||
59734486|NCT00934050|75853099|FG003|COMPLETED|Enrolled After 15 Dec 2009||0||
59734487|NCT00934050|75853100|FG004|COMPLETED|Enrolled After 15 Dec 2009||19||
59734488|NCT00934050|75853101|FG005|COMPLETED|Enrolled After 15 Dec 2009||23||
59734489|NCT00934050|75853096|FG000|NOT COMPLETED|Enrolled After 15 Dec 2009||0||
59734490|NCT00934050|75853097|FG001|NOT COMPLETED|Enrolled After 15 Dec 2009||0||
59734491|NCT00934050|75853098|FG002|NOT COMPLETED|Enrolled After 15 Dec 2009||0||
59734492|NCT00934050|75853099|FG003|NOT COMPLETED|Enrolled After 15 Dec 2009||0||
59734493|NCT00934050|75853100|FG004|NOT COMPLETED|Enrolled After 15 Dec 2009||7||
59734494|NCT00934050|75853101|FG005|NOT COMPLETED|Enrolled After 15 Dec 2009||4||
59734495|NCT01091168|75853113|FG000|STARTED|Overall Study||298||
59734496|NCT01091168|75853114|FG001|STARTED|Overall Study||296||
59734497|NCT01091168|75853113|FG000|COMPLETED|Overall Study||0||
59734498|NCT01091168|75853114|FG001|COMPLETED|Overall Study||0||
59734499|NCT01091168|75853113|FG000|NOT COMPLETED|Overall Study||298||
59734500|NCT01091168|75853114|FG001|NOT COMPLETED|Overall Study||296||
59734501|NCT00864916|75853122|FG000|STARTED|Overall Study||10||
59734502|NCT00864916|75853123|FG001|STARTED|Overall Study||9||
59734503|NCT00864916|75853122|FG000|COMPLETED|Overall Study||4||
59734504|NCT00864916|75853123|FG001|COMPLETED|Overall Study||5||
59734505|NCT00864916|75853122|FG000|NOT COMPLETED|Overall Study||6||
59734506|NCT00864916|75853123|FG001|NOT COMPLETED|Overall Study||4||
59734507|NCT00864682|75853132|FG000|STARTED|Overall Study||52||
59734508|NCT00864682|75853133|FG001|STARTED|Overall Study||51||
59734509|NCT00864682|75853134|FG002|STARTED|Overall Study||53||
59734510|NCT00864682|75853132|FG000|COMPLETED|Overall Study||50||
59734511|NCT00864682|75853133|FG001|COMPLETED|Overall Study||50||
59734512|NCT00864682|75853134|FG002|COMPLETED|Overall Study||51||
59734513|NCT00864682|75853132|FG000|NOT COMPLETED|Overall Study||2||
59734514|NCT00864682|75853133|FG001|NOT COMPLETED|Overall Study||1||
59734515|NCT00864682|75853134|FG002|NOT COMPLETED|Overall Study||2||
59734516|NCT00931944|75853142|FG000|STARTED|Overall Study||74||
59734517|NCT00931944|75853142|FG000|COMPLETED|Overall Study||19||
59734518|NCT00931944|75853142|FG000|NOT COMPLETED|Overall Study||55||
59734519|NCT00929994|75853146|FG000|STARTED|Overall Study||20||
59734520|NCT00929994|75853146|FG000|COMPLETED|Overall Study||14||
59734521|NCT00929994|75853146|FG000|NOT COMPLETED|Overall Study||6||
59734522|NCT01090310|75853157|FG000|STARTED|Core Study||29||
59734523|NCT01090310|75853158|FG001|STARTED|Core Study||31||
59734524|NCT01090310|75853159|FG002|STARTED|Core Study||31||
59734525|NCT01090310|75853160|FG003|STARTED|Core Study||34||
59734526|NCT01090310|75853157|FG000|COMPLETED|Core Study||21||
59734527|NCT01090310|75853158|FG001|COMPLETED|Core Study||20||
59734528|NCT01090310|75853159|FG002|COMPLETED|Core Study||24||
59734529|NCT01090310|75853160|FG003|COMPLETED|Core Study||27||
59734530|NCT01090310|75853157|FG000|NOT COMPLETED|Core Study||8||
59734531|NCT01090310|75853158|FG001|NOT COMPLETED|Core Study||11||
59734532|NCT01090310|75853159|FG002|NOT COMPLETED|Core Study||7||
59734533|NCT01090310|75853160|FG003|NOT COMPLETED|Core Study||7||
59734534|NCT01090310|75853157|FG000|STARTED|Extension Study||17||
59734535|NCT01090310|75853158|FG001|STARTED|Extension Study||16||
59734536|NCT01090310|75853159|FG002|STARTED|Extension Study||16||
59734537|NCT01090310|75853160|FG003|STARTED|Extension Study||21||
59734538|NCT01090310|75853157|FG000|COMPLETED|Extension Study||3||
59734539|NCT01090310|75853158|FG001|COMPLETED|Extension Study||0||
59734540|NCT01090310|75853159|FG002|COMPLETED|Extension Study||1||
59734541|NCT01090310|75853160|FG003|COMPLETED|Extension Study||1||
59734542|NCT01090310|75853157|FG000|NOT COMPLETED|Extension Study||14||
59734543|NCT01090310|75853158|FG001|NOT COMPLETED|Extension Study||16||
59734544|NCT01090310|75853159|FG002|NOT COMPLETED|Extension Study||15||
59734545|NCT01090310|75853160|FG003|NOT COMPLETED|Extension Study||20||
59734546|NCT01090076|75853172|FG000|STARTED|Overall Study||12||
59734547|NCT01090076|75853173|FG001|STARTED|Overall Study||14||
59734548|NCT01090076|75853172|FG000|COMPLETED|Overall Study||11||
59734549|NCT01090076|75853173|FG001|COMPLETED|Overall Study||12||
59734550|NCT01090076|75853172|FG000|NOT COMPLETED|Overall Study||1||
59734551|NCT01090076|75853173|FG001|NOT COMPLETED|Overall Study||2||
59734552|NCT00869050|75853181|FG000|STARTED|Overall Study||41||
59734553|NCT00869050|75853181|FG000|COMPLETED|Overall Study||38||
59734554|NCT00869050|75853181|FG000|NOT COMPLETED|Overall Study||3||
59734555|NCT00927186|75853187|FG000|STARTED|12 Months Primary Study||34||
59734556|NCT00927186|75853188|FG001|STARTED|12 Months Primary Study||35||
59734557|NCT00927186|75853187|FG000|Completed 6 Months Double Blind Phase|12 Months Primary Study||28||
59734558|NCT00927186|75853188|FG001|Completed 6 Months Double Blind Phase|12 Months Primary Study||31||
59734559|NCT00927186|75853187|FG000|COMPLETED|12 Months Primary Study||27||
59734560|NCT00927186|75853188|FG001|COMPLETED|12 Months Primary Study||31||
59734561|NCT00927186|75853187|FG000|NOT COMPLETED|12 Months Primary Study||7||
59734562|NCT00927186|75853188|FG001|NOT COMPLETED|12 Months Primary Study||4||
59734563|NCT00927186|75853187|FG000|STARTED|12 - 24 Months Extension Treatment|Not all participants who completed 12 months of primary study chose to enter 12-month extension.|10||
59734564|NCT00927186|75853188|FG001|STARTED|12 - 24 Months Extension Treatment|Not all participants who completed 12 months of primary study chose to enter 12-month extension.|11||
59734565|NCT00927186|75853187|FG000|COMPLETED|12 - 24 Months Extension Treatment||10||
59734566|NCT00927186|75853188|FG001|COMPLETED|12 - 24 Months Extension Treatment||11||
59734567|NCT00927186|75853187|FG000|NOT COMPLETED|12 - 24 Months Extension Treatment||0||
59734568|NCT00927186|75853188|FG001|NOT COMPLETED|12 - 24 Months Extension Treatment||0||
59734569|NCT00593554|75853199|FG000|STARTED|Overall Study||3||
59734570|NCT00593554|75853200|FG001|STARTED|Overall Study||5||
59734571|NCT00593554|75853199|FG000|COMPLETED|Overall Study||0||
59734572|NCT00593554|75853200|FG001|COMPLETED|Overall Study||0||
59734573|NCT00593554|75853199|FG000|NOT COMPLETED|Overall Study||3||
59734574|NCT00593554|75853200|FG001|NOT COMPLETED|Overall Study||5||
59734575|NCT01101308|75853206|FG000|STARTED|Period 1||27||
59734576|NCT01101308|75853207|FG001|STARTED|Period 1||28||
59734577|NCT01101308|75853206|FG000|COMPLETED|Period 1||24||
59734578|NCT01101308|75853207|FG001|COMPLETED|Period 1||27||
59734579|NCT01101308|75853206|FG000|NOT COMPLETED|Period 1||3||
59734580|NCT01101308|75853207|FG001|NOT COMPLETED|Period 1||1||
59734581|NCT01101308|75853206|FG000|STARTED|Period 2||24||
59734582|NCT01101308|75853207|FG001|STARTED|Period 2||27||
59734583|NCT01101308|75853206|FG000|COMPLETED|Period 2||24||
59734584|NCT01101308|75853207|FG001|COMPLETED|Period 2||27||
59734585|NCT01101308|75853206|FG000|NOT COMPLETED|Period 2||0||
59734586|NCT01101308|75853207|FG001|NOT COMPLETED|Period 2||0||
59734587|NCT00926796|75853216|FG000|STARTED|Overall Study|Number randomized|309||
59734588|NCT00926796|75853217|FG001|STARTED|Overall Study|Number randomized|305||
59762486|NCT02644525|75882211|FG002|STARTED|Group 3||0||
59734589|NCT00926796|75853216|FG000|COMPLETED|Overall Study|Number eligible and in the full analysis set|202||
59734590|NCT00926796|75853217|FG001|COMPLETED|Overall Study|Number eligible and in the full analysis set|199||
59734591|NCT00926796|75853216|FG000|NOT COMPLETED|Overall Study||107||
59734592|NCT00926796|75853217|FG001|NOT COMPLETED|Overall Study||106||
59734593|NCT01087736|75853227|FG000|STARTED|Overall Study||14||
59734594|NCT01087736|75853228|FG001|STARTED|Overall Study||16||
59734595|NCT01087736|75853227|FG000|COMPLETED|Overall Study||13||
59734596|NCT01087736|75853228|FG001|COMPLETED|Overall Study||14||
59734597|NCT01087736|75853227|FG000|NOT COMPLETED|Overall Study||1||
59734598|NCT01087736|75853228|FG001|NOT COMPLETED|Overall Study||2||
59734599|NCT01079936|75853238|FG000|STARTED|Phase I: MTD||16||
59734600|NCT01079936|75853239|FG001|STARTED|Phase I: MTD||0||
59734601|NCT01079936|75853240|FG002|STARTED|Phase I: MTD||0||
59734602|NCT01079936|75853241|FG003|STARTED|Phase I: MTD||0||
59734603|NCT01079936|75853242|FG004|STARTED|Phase I: MTD||0||
59734604|NCT01079936|75853238|FG000|COMPLETED|Phase I: MTD|The 12 Phase I participants were randomized across 4 dose arms for Phase II.|12||
59734605|NCT01079936|75853239|FG001|COMPLETED|Phase I: MTD||0||
59734606|NCT01079936|75853240|FG002|COMPLETED|Phase I: MTD||0||
59734607|NCT01079936|75853241|FG003|COMPLETED|Phase I: MTD||0||
59734608|NCT01079936|75853242|FG004|COMPLETED|Phase I: MTD||0||
59734609|NCT01079936|75853238|FG000|NOT COMPLETED|Phase I: MTD||4||
59734610|NCT01079936|75853239|FG001|NOT COMPLETED|Phase I: MTD||0||
59734611|NCT01079936|75853240|FG002|NOT COMPLETED|Phase I: MTD||0||
59734612|NCT01079936|75853241|FG003|NOT COMPLETED|Phase I: MTD||0||
59734613|NCT01079936|75853242|FG004|NOT COMPLETED|Phase I: MTD||0||
59734614|NCT01079936|75853238|FG000|STARTED|Phase II||0||
59734615|NCT01079936|75853239|FG001|STARTED|Phase II||3||
59734616|NCT01079936|75853240|FG002|STARTED|Phase II||6||
59734617|NCT01079936|75853241|FG003|STARTED|Phase II||24||
59734618|NCT01079936|75853242|FG004|STARTED|Phase II||26||
59734619|NCT01079936|75853238|FG000|COMPLETED|Phase II||0||
59734620|NCT01079936|75853239|FG001|COMPLETED|Phase II||3||
59734621|NCT01079936|75853240|FG002|COMPLETED|Phase II||5||
59734622|NCT01079936|75853241|FG003|COMPLETED|Phase II||24||
59734623|NCT01079936|75853242|FG004|COMPLETED|Phase II||25||
59734624|NCT01079936|75853238|FG000|NOT COMPLETED|Phase II||0||
59734625|NCT01079936|75853239|FG001|NOT COMPLETED|Phase II||0||
59734626|NCT01079936|75853240|FG002|NOT COMPLETED|Phase II||1||
59734627|NCT01079936|75853241|FG003|NOT COMPLETED|Phase II||0||
59734628|NCT01079936|75853242|FG004|NOT COMPLETED|Phase II||1||
59734629|NCT00931710|75853255|FG000|STARTED|Overall Study||241||
59734630|NCT00931710|75853256|FG001|STARTED|Overall Study||247||
59734631|NCT00931710|75853255|FG000|COMPLETED|Overall Study||207||
59734632|NCT00931710|75853256|FG001|COMPLETED|Overall Study||209||
59734633|NCT00931710|75853255|FG000|NOT COMPLETED|Overall Study||34||
59734634|NCT00931710|75853256|FG001|NOT COMPLETED|Overall Study||38||
59734635|NCT01100528|75853262|FG000|STARTED|Overall Study||38||
59734636|NCT01100528|75853262|FG000|COMPLETED|Overall Study||35||
59734637|NCT01100528|75853262|FG000|NOT COMPLETED|Overall Study||3||
59734638|NCT01079234|75853269|FG000|STARTED|Main: Week 0 to 26||164||
59734639|NCT01079234|75853270|FG001|STARTED|Main: Week 0 to 26||165||
59734640|NCT01079234|75853271|FG002|STARTED|Main: Week 0 to 26||164||
59734641|NCT01079234|75853272|FG003|STARTED|Main: Week 0 to 26||0||
59734642|NCT01079234|75853269|FG000|Exposed|Main: Week 0 to 26||164||
59734643|NCT01079234|75853270|FG001|Exposed|Main: Week 0 to 26||165||
59734644|NCT01079234|75853271|FG002|Exposed|Main: Week 0 to 26|Three subjects withdrew prior to exposure to trial drug.|161||
59734645|NCT01079234|75853272|FG003|Exposed|Main: Week 0 to 26||0||
59734646|NCT01079234|75853269|FG000|COMPLETED|Main: Week 0 to 26||138||
59734647|NCT01079234|75853270|FG001|COMPLETED|Main: Week 0 to 26||139||
59734648|NCT01079234|75853271|FG002|COMPLETED|Main: Week 0 to 26||152||
59734649|NCT01079234|75853272|FG003|COMPLETED|Main: Week 0 to 26||0||
59734650|NCT01079234|75853269|FG000|NOT COMPLETED|Main: Week 0 to 26||26||
59734651|NCT01079234|75853270|FG001|NOT COMPLETED|Main: Week 0 to 26||26||
59734652|NCT01079234|75853271|FG002|NOT COMPLETED|Main: Week 0 to 26||12||
59734653|NCT01079234|75853272|FG003|NOT COMPLETED|Main: Week 0 to 26||0||
59734654|NCT01079234|75853269|FG000|STARTED|Extension: Week 27 to 52||0||
59734655|NCT01079234|75853270|FG001|STARTED|Extension: Week 27 to 52||0||
59734656|NCT01079234|75853271|FG002|STARTED|Extension: Week 27 to 52|Nineteen subjects from main trial did not continue into extension trial|133||
59734657|NCT01079234|75853272|FG003|STARTED|Extension: Week 27 to 52|Thirty eight subjects did not continue into extension trial.|239||
59734658|NCT01079234|75853269|FG000|COMPLETED|Extension: Week 27 to 52||0||
59734659|NCT01079234|75853270|FG001|COMPLETED|Extension: Week 27 to 52||0||
59734660|NCT01079234|75853271|FG002|COMPLETED|Extension: Week 27 to 52||122||
59734661|NCT01079234|75853272|FG003|COMPLETED|Extension: Week 27 to 52||223||
59734662|NCT01079234|75853269|FG000|NOT COMPLETED|Extension: Week 27 to 52||0||
59734663|NCT01079234|75853270|FG001|NOT COMPLETED|Extension: Week 27 to 52||0||
59734664|NCT01079234|75853271|FG002|NOT COMPLETED|Extension: Week 27 to 52||11||
59734665|NCT01079234|75853272|FG003|NOT COMPLETED|Extension: Week 27 to 52||16||
59734666|NCT00931632|75853283|FG000|STARTED|Overall Study|Randomized|229||
59734667|NCT00931632|75853284|FG001|STARTED|Overall Study|Randomized|222||
59734668|NCT00931632|75853283|FG000|COMPLETED|Overall Study|Completed at 36 weeks Postmenstrual Age (PMA)|208||
59734669|NCT00931632|75853284|FG001|COMPLETED|Overall Study|Completed at 36 weeks Postmenstrual Age (PMA)|204||
59734670|NCT00931632|75853283|FG000|NOT COMPLETED|Overall Study||21||
59734671|NCT00931632|75853284|FG001|NOT COMPLETED|Overall Study||18||
59734672|NCT01078922|75853290|FG000|STARTED|Overall Study||11||
59734673|NCT01078922|75853290|FG000|COMPLETED|Overall Study||10||
59734674|NCT01078922|75853290|FG000|NOT COMPLETED|Overall Study||1||
59734675|NCT00863746|75853297|FG000|STARTED|Treatment||350||
59734676|NCT00863746|75853298|FG001|STARTED|Treatment||353||
59734677|NCT00863746|75853297|FG000|Participants Received Treatment|Treatment|Safety population|346||
59734678|NCT00863746|75853298|FG001|Participants Received Treatment|Treatment|Safety population|351||
59734679|NCT00863746|75853297|FG000|COMPLETED|Treatment||279||
59734680|NCT00863746|75853298|FG001|COMPLETED|Treatment||318||
59734681|NCT00863746|75853297|FG000|NOT COMPLETED|Treatment||71||
59734682|NCT00863746|75853298|FG001|NOT COMPLETED|Treatment||35||
59734683|NCT00863746|75853297|FG000|STARTED|Survival Follow up|298 patients of 317 patients (= 346 randomized - 29 deaths) entered the survival follow-up|298||
59734684|NCT00863746|75853298|FG001|STARTED|Survival Follow up|331 patients of 339 patients (=353 randomized - 14 death) entered the survival follow-up.|331||
59734685|NCT00863746|75853297|FG000|COMPLETED|Survival Follow up||45||
59734686|NCT00863746|75853298|FG001|COMPLETED|Survival Follow up||51||
59734687|NCT00863746|75853297|FG000|NOT COMPLETED|Survival Follow up||253||
59734688|NCT00863746|75853298|FG001|NOT COMPLETED|Survival Follow up||280||
59734689|NCT00926328|75853306|FG000|STARTED|Overall Study||60||
59734690|NCT00926328|75853307|FG001|STARTED|Overall Study||60||
59734691|NCT00926328|75853306|FG000|COMPLETED|Overall Study||48||
59734692|NCT00926328|75853307|FG001|COMPLETED|Overall Study||46||
59734693|NCT00926328|75853306|FG000|NOT COMPLETED|Overall Study||12||
59734694|NCT00926328|75853307|FG001|NOT COMPLETED|Overall Study||14||
59734695|NCT00863512|75853315|FG000|STARTED|Overall Study||17||
59734696|NCT00863512|75853316|FG001|STARTED|Overall Study||17||
59734697|NCT00863512|75853315|FG000|COMPLETED|Overall Study||3||
59734698|NCT00863512|75853316|FG001|COMPLETED|Overall Study||17||
59734699|NCT00863512|75853315|FG000|NOT COMPLETED|Overall Study||14||
59734700|NCT00863512|75853316|FG001|NOT COMPLETED|Overall Study||0||
59734701|NCT00868192|75853322|FG000|STARTED|Overall Study||38||
59734702|NCT00868192|75853322|FG000|COMPLETED|Overall Study||34||
59734703|NCT00868192|75853322|FG000|NOT COMPLETED|Overall Study||4||
59734704|NCT00930930|75853328|FG000|STARTED|Overall Study||96||
59734705|NCT00930930|75853329|FG001|STARTED|Overall Study||49||
59734706|NCT00930930|75853328|FG000|COMPLETED|Overall Study||75||
59734707|NCT00930930|75853329|FG001|COMPLETED|Overall Study||40||
59734708|NCT00930930|75853328|FG000|NOT COMPLETED|Overall Study||21||
59734709|NCT00930930|75853329|FG001|NOT COMPLETED|Overall Study||9||
59734710|NCT00862654|75853339|FG000|STARTED|Overall Study||82||
59734711|NCT00862654|75853340|FG001|STARTED|Overall Study||82||
59734712|NCT00862654|75853341|FG002|STARTED|Overall Study||82||
59734713|NCT00862654|75853342|FG003|STARTED|Overall Study||80||
59734714|NCT00862654|75853339|FG000|COMPLETED|Overall Study||76||
59734715|NCT00862654|75853340|FG001|COMPLETED|Overall Study||74||
59734716|NCT00862654|75853341|FG002|COMPLETED|Overall Study||76||
59734717|NCT00862654|75853342|FG003|COMPLETED|Overall Study||74||
59734718|NCT00862654|75853339|FG000|NOT COMPLETED|Overall Study||6||
59734719|NCT00862654|75853340|FG001|NOT COMPLETED|Overall Study||8||
59734720|NCT00862654|75853341|FG002|NOT COMPLETED|Overall Study||6||
59734721|NCT00862654|75853342|FG003|NOT COMPLETED|Overall Study||6||
59734722|NCT00867490|75853352|FG000|STARTED|Phase 1 - Candesartan+HCTZ||186||
59734723|NCT00867490|75853352|FG000|COMPLETED|Phase 1 - Candesartan+HCTZ||176||
59734724|NCT00867490|75853352|FG000|NOT COMPLETED|Phase 1 - Candesartan+HCTZ||10||
59734725|NCT00867490|75853352|FG000|STARTED|Phase 2 - Aliskiren+HCTZ|Only patients with mean sitting diastolic BP ≥ 90 mmHg at the end of Phase 1 entered this phase.|123||
59734726|NCT00867490|75853352|FG000|COMPLETED|Phase 2 - Aliskiren+HCTZ||120||
59734727|NCT00867490|75853352|FG000|NOT COMPLETED|Phase 2 - Aliskiren+HCTZ||3||
59734728|NCT00867490|75853352|FG000|STARTED|Phase 3 - Aliskiren+HCTZ+Amlodipine|The first 60 patients with systolic BP ≥ 140 mmHg or diastolic BP ≥ 90 mmHg entered this phase.|61||
59734729|NCT00867490|75853352|FG000|COMPLETED|Phase 3 - Aliskiren+HCTZ+Amlodipine||61||
59734730|NCT00867490|75853352|FG000|NOT COMPLETED|Phase 3 - Aliskiren+HCTZ+Amlodipine||0||
59734731|NCT00930774|75853363|FG000|STARTED|Overall Study||25||
59734732|NCT00930774|75853364|FG001|STARTED|Overall Study||25||
59734733|NCT00930774|75853365|FG002|STARTED|Overall Study||24||
59734734|NCT00930774|75853366|FG003|STARTED|Overall Study||25||
59734735|NCT00930774|75853363|FG000|COMPLETED|Overall Study||24||
59734736|NCT00930774|75853364|FG001|COMPLETED|Overall Study||16||
59734737|NCT00930774|75853365|FG002|COMPLETED|Overall Study||22||
59734738|NCT00930774|75853366|FG003|COMPLETED|Overall Study||25||
59734739|NCT00930774|75853363|FG000|NOT COMPLETED|Overall Study||1||
59734740|NCT00930774|75853364|FG001|NOT COMPLETED|Overall Study||9||
59734741|NCT00930774|75853365|FG002|NOT COMPLETED|Overall Study||2||
59734742|NCT00930774|75853366|FG003|NOT COMPLETED|Overall Study||0||
59734743|NCT00867334|75853379|FG000|STARTED|Overall Study||6||
59734744|NCT00867334|75853380|FG001|STARTED|Overall Study||1||
59734745|NCT00867334|75853379|FG000|COMPLETED|Overall Study||4||
59734746|NCT00867334|75853380|FG001|COMPLETED|Overall Study||0||
59734747|NCT00867334|75853379|FG000|NOT COMPLETED|Overall Study||2||
59734748|NCT00867334|75853380|FG001|NOT COMPLETED|Overall Study||1||
59734749|NCT00925704|75853392|FG000|STARTED|First Intervention||6||
59734750|NCT00925704|75853393|FG001|STARTED|First Intervention||7||
59734751|NCT00925704|75853394|FG002|STARTED|First Intervention||7||
59734752|NCT00925704|75853395|FG003|STARTED|First Intervention||7||
59734753|NCT00925704|75853396|FG004|STARTED|First Intervention||7||
59734754|NCT00925704|75853397|FG005|STARTED|First Intervention||7||
59734755|NCT00925704|75853392|FG000|COMPLETED|First Intervention||6||
59734756|NCT00925704|75853393|FG001|COMPLETED|First Intervention||7||
59734757|NCT00925704|75853394|FG002|COMPLETED|First Intervention||7||
59734758|NCT00925704|75853395|FG003|COMPLETED|First Intervention||6||
59734759|NCT00925704|75853396|FG004|COMPLETED|First Intervention||6||
59734760|NCT00925704|75853397|FG005|COMPLETED|First Intervention||7||
59734761|NCT00925704|75853392|FG000|NOT COMPLETED|First Intervention||0||
59734762|NCT00925704|75853393|FG001|NOT COMPLETED|First Intervention||0||
59734763|NCT00925704|75853394|FG002|NOT COMPLETED|First Intervention||0||
59734764|NCT00925704|75853395|FG003|NOT COMPLETED|First Intervention||1||
59734765|NCT00925704|75853396|FG004|NOT COMPLETED|First Intervention||1||
59734766|NCT00925704|75853397|FG005|NOT COMPLETED|First Intervention||0||
59734767|NCT00925704|75853392|FG000|STARTED|Washout||6||
59734768|NCT00925704|75853393|FG001|STARTED|Washout||7||
59734769|NCT00925704|75853394|FG002|STARTED|Washout||7||
59734770|NCT00925704|75853395|FG003|STARTED|Washout||6||
59734771|NCT00925704|75853396|FG004|STARTED|Washout||6||
59734772|NCT00925704|75853397|FG005|STARTED|Washout||7||
59734773|NCT00925704|75853392|FG000|COMPLETED|Washout||6||
59734774|NCT00925704|75853393|FG001|COMPLETED|Washout||7||
59734775|NCT00925704|75853394|FG002|COMPLETED|Washout||7||
59734776|NCT00925704|75853395|FG003|COMPLETED|Washout||6||
59734777|NCT00925704|75853396|FG004|COMPLETED|Washout||6||
59734778|NCT00925704|75853397|FG005|COMPLETED|Washout||7||
59734779|NCT00925704|75853392|FG000|NOT COMPLETED|Washout||0||
59734780|NCT00925704|75853393|FG001|NOT COMPLETED|Washout||0||
59734781|NCT00925704|75853394|FG002|NOT COMPLETED|Washout||0||
59734782|NCT00925704|75853395|FG003|NOT COMPLETED|Washout||0||
59734783|NCT00925704|75853396|FG004|NOT COMPLETED|Washout||0||
59734784|NCT00925704|75853397|FG005|NOT COMPLETED|Washout||0||
59734785|NCT00925704|75853392|FG000|STARTED|Second Intervention||6||
59734786|NCT00925704|75853393|FG001|STARTED|Second Intervention||7||
59734787|NCT00925704|75853394|FG002|STARTED|Second Intervention||7||
59734788|NCT00925704|75853395|FG003|STARTED|Second Intervention||6||
59734789|NCT00925704|75853396|FG004|STARTED|Second Intervention||6||
59734790|NCT00925704|75853397|FG005|STARTED|Second Intervention||7||
59734791|NCT00925704|75853392|FG000|COMPLETED|Second Intervention||5||
59734792|NCT00925704|75853393|FG001|COMPLETED|Second Intervention||7||
59734793|NCT00925704|75853394|FG002|COMPLETED|Second Intervention||7||
59734794|NCT00925704|75853395|FG003|COMPLETED|Second Intervention||6||
59734795|NCT00925704|75853396|FG004|COMPLETED|Second Intervention||5||
59734796|NCT00925704|75853397|FG005|COMPLETED|Second Intervention||7||
59734797|NCT00925704|75853392|FG000|NOT COMPLETED|Second Intervention||1||
59734798|NCT00925704|75853393|FG001|NOT COMPLETED|Second Intervention||0||
59734799|NCT00925704|75853394|FG002|NOT COMPLETED|Second Intervention||0||
59734800|NCT00925704|75853395|FG003|NOT COMPLETED|Second Intervention||0||
59734801|NCT00925704|75853396|FG004|NOT COMPLETED|Second Intervention||1||
59734802|NCT00925704|75853397|FG005|NOT COMPLETED|Second Intervention||0||
59734803|NCT00925704|75853392|FG000|STARTED|Washout||5||
59734804|NCT00925704|75853393|FG001|STARTED|Washout||7||
59734805|NCT00925704|75853394|FG002|STARTED|Washout||7||
59734806|NCT00925704|75853395|FG003|STARTED|Washout||6||
59734807|NCT00925704|75853396|FG004|STARTED|Washout||5||
59734808|NCT00925704|75853397|FG005|STARTED|Washout||7||
59734809|NCT00925704|75853392|FG000|COMPLETED|Washout||5||
59734810|NCT00925704|75853393|FG001|COMPLETED|Washout||7||
59734811|NCT00925704|75853394|FG002|COMPLETED|Washout||7||
59734812|NCT00925704|75853395|FG003|COMPLETED|Washout||6||
59734813|NCT00925704|75853396|FG004|COMPLETED|Washout||5||
59734814|NCT00925704|75853397|FG005|COMPLETED|Washout||7||
59734815|NCT00925704|75853392|FG000|NOT COMPLETED|Washout||0||
59734816|NCT00925704|75853393|FG001|NOT COMPLETED|Washout||0||
59734817|NCT00925704|75853394|FG002|NOT COMPLETED|Washout||0||
59734818|NCT00925704|75853395|FG003|NOT COMPLETED|Washout||0||
59734819|NCT00925704|75853396|FG004|NOT COMPLETED|Washout||0||
59734820|NCT00925704|75853397|FG005|NOT COMPLETED|Washout||0||
59734821|NCT00925704|75853392|FG000|STARTED|Third Intervention||5||
59734822|NCT00925704|75853393|FG001|STARTED|Third Intervention||7||
59734823|NCT00925704|75853394|FG002|STARTED|Third Intervention||7||
59734824|NCT00925704|75853395|FG003|STARTED|Third Intervention||6||
59734825|NCT00925704|75853396|FG004|STARTED|Third Intervention||5||
59734826|NCT00925704|75853397|FG005|STARTED|Third Intervention||7||
59734827|NCT00925704|75853392|FG000|COMPLETED|Third Intervention||5||
59734828|NCT00925704|75853393|FG001|COMPLETED|Third Intervention||7||
59734829|NCT00925704|75853394|FG002|COMPLETED|Third Intervention||7||
59734830|NCT00925704|75853395|FG003|COMPLETED|Third Intervention||6||
59734831|NCT00925704|75853396|FG004|COMPLETED|Third Intervention||5||
59734832|NCT00925704|75853397|FG005|COMPLETED|Third Intervention||6||
59734833|NCT00925704|75853392|FG000|NOT COMPLETED|Third Intervention||0||
59734834|NCT00925704|75853393|FG001|NOT COMPLETED|Third Intervention||0||
59734835|NCT00925704|75853394|FG002|NOT COMPLETED|Third Intervention||0||
59734836|NCT00925704|75853395|FG003|NOT COMPLETED|Third Intervention||0||
59734837|NCT00925704|75853396|FG004|NOT COMPLETED|Third Intervention||0||
59734838|NCT00925704|75853397|FG005|NOT COMPLETED|Third Intervention||1||
59734839|NCT01076192|75853408|FG000|STARTED|Overall Study||547||
59734840|NCT01076192|75853408|FG000|COMPLETED|Overall Study||350||
59734841|NCT01076192|75853408|FG000|NOT COMPLETED|Overall Study||197||
59734842|NCT01076036|75853413|FG000|STARTED|Overall Study||10||
59734843|NCT01076036|75853413|FG000|# of Procedures|Overall Study||8||
59734844|NCT01076036|75853413|FG000|Complete CorPath Procedures|Overall Study||8||
59734845|NCT01076036|75853413|FG000|COMPLETED|Overall Study||8||
59734846|NCT01076036|75853413|FG000|NOT COMPLETED|Overall Study||2||
59734847|NCT01075958|75853417|FG000|STARTED|Overall Study||283||
59734848|NCT01075958|75853417|FG000|COMPLETED|Overall Study||239||
59734849|NCT01075958|75853417|FG000|NOT COMPLETED|Overall Study||44||
59734850|NCT01096316|75853423|FG000|STARTED|Overall Study||102||
59734851|NCT01096316|75853424|FG001|STARTED|Overall Study||103||
59734852|NCT01096316|75853423|FG000|COMPLETED|Overall Study||87||
59734853|NCT01096316|75853424|FG001|COMPLETED|Overall Study||94||
59734854|NCT01096316|75853423|FG000|NOT COMPLETED|Overall Study||15||
59734855|NCT01096316|75853424|FG001|NOT COMPLETED|Overall Study||9||
59734856|NCT00925548|75853432|FG000|STARTED|Overall Study||11||
59734857|NCT00925548|75853433|FG001|STARTED|Overall Study||5||
59734858|NCT00925548|75853432|FG000|COMPLETED|Overall Study||1||
59734859|NCT00925548|75853433|FG001|COMPLETED|Overall Study||0||
59734860|NCT00925548|75853432|FG000|NOT COMPLETED|Overall Study||10||
59734861|NCT00925548|75853433|FG001|NOT COMPLETED|Overall Study||5||
59734862|NCT00866788|75853444|FG000|STARTED|Overall Study||21||
59734863|NCT00866788|75853445|FG001|STARTED|Overall Study||23||
59734864|NCT00866788|75853446|FG002|STARTED|Overall Study||25||
59734865|NCT00866788|75853447|FG003|STARTED|Overall Study||21||
59734866|NCT00866788|75853444|FG000|COMPLETED|Overall Study||15||
59734867|NCT00866788|75853445|FG001|COMPLETED|Overall Study||17||
59734868|NCT00866788|75853446|FG002|COMPLETED|Overall Study||23||
59734869|NCT00866788|75853447|FG003|COMPLETED|Overall Study||16||
59734870|NCT00866788|75853444|FG000|NOT COMPLETED|Overall Study||6||
59734871|NCT00866788|75853445|FG001|NOT COMPLETED|Overall Study||6||
59734872|NCT00866788|75853446|FG002|NOT COMPLETED|Overall Study||2||
59734873|NCT00866788|75853447|FG003|NOT COMPLETED|Overall Study||5||
59734874|NCT00860470|75853462|FG000|STARTED|Overall Study||22162||
59734875|NCT00860470|75853463|FG001|STARTED|Overall Study||22405||
59734876|NCT00860470|75853462|FG000|COMPLETED|Overall Study||22114||
59734877|NCT00860470|75853463|FG001|COMPLETED|Overall Study||22346||
59734878|NCT00860470|75853462|FG000|NOT COMPLETED|Overall Study||48||
59734879|NCT00860470|75853463|FG001|NOT COMPLETED|Overall Study||59||
59734880|NCT00923364|75853469|FG000|STARTED|Overall Study||14||
59734881|NCT00923364|75853470|FG001|STARTED|Overall Study||5||
59734882|NCT00923364|75853469|FG000|COMPLETED|Overall Study||10||
59734883|NCT00923364|75853470|FG001|COMPLETED|Overall Study||5||
59734884|NCT00923364|75853469|FG000|NOT COMPLETED|Overall Study||4||
59734885|NCT00923364|75853470|FG001|NOT COMPLETED|Overall Study||0||
59734886|NCT01096160|75853485|FG000|STARTED|Overall Study||6||
59734887|NCT01096160|75853486|FG001|STARTED|Overall Study||2||
59734888|NCT01096160|75853487|FG002|STARTED|Overall Study||6||
59734889|NCT01096160|75853488|FG003|STARTED|Overall Study||2||
59734890|NCT01096160|75853489|FG004|STARTED|Overall Study||6||
59734891|NCT01096160|75853490|FG005|STARTED|Overall Study||2||
59867533|NCT03984812|75991916|FG009|NOT COMPLETED|Part 1 (Up to Day 28)||0||
59867534|NCT03984812|75991917|FG010|NOT COMPLETED|Part 1 (Up to Day 28)||0||
59734892|NCT01096160|75853491|FG006|STARTED|Overall Study||6||
59734893|NCT01096160|75853492|FG007|STARTED|Overall Study||2||
59734894|NCT01096160|75853493|FG008|STARTED|Overall Study||6||
59734895|NCT01096160|75853494|FG009|STARTED|Overall Study||2||
59734896|NCT01096160|75853485|FG000|COMPLETED|Overall Study||6||
59734897|NCT01096160|75853486|FG001|COMPLETED|Overall Study||2||
59734898|NCT01096160|75853487|FG002|COMPLETED|Overall Study||5||
59734899|NCT01096160|75853488|FG003|COMPLETED|Overall Study||2||
59734900|NCT01096160|75853489|FG004|COMPLETED|Overall Study||5||
59734901|NCT01096160|75853490|FG005|COMPLETED|Overall Study||2||
59734902|NCT01096160|75853491|FG006|COMPLETED|Overall Study||4||
59734903|NCT01096160|75853492|FG007|COMPLETED|Overall Study||2||
59734904|NCT01096160|75853493|FG008|COMPLETED|Overall Study||4||
59734905|NCT01096160|75853494|FG009|COMPLETED|Overall Study||1||
59734906|NCT01096160|75853485|FG000|NOT COMPLETED|Overall Study||0||
59734907|NCT01096160|75853486|FG001|NOT COMPLETED|Overall Study||0||
59734908|NCT01096160|75853487|FG002|NOT COMPLETED|Overall Study||1||
59734909|NCT01096160|75853488|FG003|NOT COMPLETED|Overall Study||0||
59734910|NCT01096160|75853489|FG004|NOT COMPLETED|Overall Study||1||
59734911|NCT01096160|75853490|FG005|NOT COMPLETED|Overall Study||0||
59734912|NCT01096160|75853491|FG006|NOT COMPLETED|Overall Study||2||
59734913|NCT01096160|75853492|FG007|NOT COMPLETED|Overall Study||0||
59734914|NCT01096160|75853493|FG008|NOT COMPLETED|Overall Study||2||
59734915|NCT01096160|75853494|FG009|NOT COMPLETED|Overall Study||1||
59734916|NCT00860158|75853529|FG000|STARTED|Overall Study||1||
59734917|NCT00860158|75853529|FG000|COMPLETED|Overall Study||0||
59734918|NCT00860158|75853529|FG000|NOT COMPLETED|Overall Study||1||
59734919|NCT00929526|75853535|FG000|STARTED|Overall Study||375||
59734920|NCT00929526|75853536|FG001|STARTED|Overall Study||377||
59734921|NCT00929526|75853535|FG000|COMPLETED|Overall Study||358||
59734922|NCT00929526|75853536|FG001|COMPLETED|Overall Study||348||
59734923|NCT00929526|75853535|FG000|NOT COMPLETED|Overall Study||17||
59734924|NCT00929526|75853536|FG001|NOT COMPLETED|Overall Study||29||
59734925|NCT00859456|75853542|FG000|STARTED|Overall Study||9||
59734926|NCT00859456|75853542|FG000|COMPLETED|Overall Study||1||
59734927|NCT00859456|75853542|FG000|NOT COMPLETED|Overall Study||8||
59734928|NCT01075646|75853550|FG000|STARTED|Overall Study||33||
59734929|NCT01075646|75853551|FG001|STARTED|Overall Study||34||
59734930|NCT01075646|75853552|FG002|STARTED|Overall Study||53||
59734931|NCT01075646|75853553|FG003|STARTED|Overall Study||46||
59734932|NCT01075646|75853550|FG000|COMPLETED|Overall Study||29||
59734933|NCT01075646|75853551|FG001|COMPLETED|Overall Study||31||
59734934|NCT01075646|75853552|FG002|COMPLETED|Overall Study||52||
59734935|NCT01075646|75853553|FG003|COMPLETED|Overall Study||44||
59734936|NCT01075646|75853550|FG000|NOT COMPLETED|Overall Study||4||
59734937|NCT01075646|75853551|FG001|NOT COMPLETED|Overall Study||3||
59734938|NCT01075646|75853552|FG002|NOT COMPLETED|Overall Study||1||
59734939|NCT01075646|75853553|FG003|NOT COMPLETED|Overall Study||2||
59734940|NCT01075412|75853565|FG000|STARTED|Overall Study||4||
59734941|NCT01075412|75853566|FG001|STARTED|Overall Study||2||
59734942|NCT01075412|75853565|FG000|COMPLETED|Overall Study||4||
59734943|NCT01075412|75853566|FG001|COMPLETED|Overall Study||1||
59734944|NCT01075412|75853565|FG000|NOT COMPLETED|Overall Study||0||
59734945|NCT01075412|75853566|FG001|NOT COMPLETED|Overall Study||1||
59734946|NCT00799903|75853573|FG000|STARTED|Overall Study||7904||
59734947|NCT00799903|75853574|FG001|STARTED|Overall Study||7924||
59734948|NCT00799903|75853573|FG000|COMPLETED|Overall Study||7631||
59734949|NCT00799903|75853574|FG001|COMPLETED|Overall Study||7646||
59734950|NCT00799903|75853573|FG000|NOT COMPLETED|Overall Study||273||
59734951|NCT00799903|75853574|FG001|NOT COMPLETED|Overall Study||278||
59734952|NCT01075256|75853583|FG000|STARTED|Overall Study||64||
59734953|NCT01075256|75853584|FG001|STARTED|Overall Study||66||
59734954|NCT01075256|75853585|FG002|STARTED|Overall Study||65||
59734955|NCT01075256|75853583|FG000|COMPLETED|Overall Study||63||
59734956|NCT01075256|75853584|FG001|COMPLETED|Overall Study||66||
59734957|NCT01075256|75853585|FG002|COMPLETED|Overall Study||65||
59734958|NCT01075256|75853583|FG000|NOT COMPLETED|Overall Study||1||
59734959|NCT01075256|75853584|FG001|NOT COMPLETED|Overall Study||0||
59734960|NCT01075256|75853585|FG002|NOT COMPLETED|Overall Study||0||
59734961|NCT00923130|75853598|FG000|STARTED|Overall Study||30||
59734962|NCT00923130|75853598|FG000|COMPLETED|Overall Study||5||
59734963|NCT00923130|75853598|FG000|NOT COMPLETED|Overall Study||25||
59734964|NCT03253627|75853604|FG000|STARTED|Overall Study||12||
59734965|NCT03253627|75853605|FG001|STARTED|Overall Study||11||
59734966|NCT03253627|75853604|FG000|Post-intervention|Overall Study||11||
59734967|NCT03253627|75853605|FG001|Post-intervention|Overall Study||9||
59734968|NCT03253627|75853604|FG000|COMPLETED|Overall Study||10||
59734969|NCT03253627|75853605|FG001|COMPLETED|Overall Study||7||
59734970|NCT03253627|75853604|FG000|NOT COMPLETED|Overall Study||2||
59734971|NCT03253627|75853605|FG001|NOT COMPLETED|Overall Study||4||
59734972|NCT01075178|75853613|FG000|STARTED|Subject Matching|eligible for matching|1148||
59734973|NCT01075178|75853614|FG001|STARTED|Subject Matching|eligible for matching|1421||
59734974|NCT01075178|75853613|FG000|COMPLETED|Subject Matching|subjects matched|1018||
59734975|NCT01075178|75853614|FG001|COMPLETED|Subject Matching|subjects matched|1018||
59734976|NCT01075178|75853613|FG000|NOT COMPLETED|Subject Matching||130||
59734977|NCT01075178|75853614|FG001|NOT COMPLETED|Subject Matching||403||
59734978|NCT01075178|75853613|FG000|STARTED|Subject Chart Review|subjects matched|1018||
59734979|NCT01075178|75853614|FG001|STARTED|Subject Chart Review|subjects matched|1018||
59734980|NCT01075178|75853613|FG000|COMPLETED|Subject Chart Review|subjects in full analysis set|1009||
59734981|NCT01075178|75853614|FG001|COMPLETED|Subject Chart Review|subjects in full analysis set|1009||
59734982|NCT01075178|75853613|FG000|NOT COMPLETED|Subject Chart Review||9||
59734983|NCT01075178|75853614|FG001|NOT COMPLETED|Subject Chart Review||9||
59734984|NCT00799825|75853620|FG000|STARTED|Overall Study||344||
59734985|NCT00799825|75853620|FG000|COMPLETED|Overall Study||296||
59734986|NCT00799825|75853620|FG000|NOT COMPLETED|Overall Study||48||
59734987|NCT00799591|75853624|FG000|STARTED|Overall Study||156||
59734988|NCT00799591|75853624|FG000|COMPLETED|Overall Study||90||
59734989|NCT00799591|75853624|FG000|NOT COMPLETED|Overall Study||66||
59734990|NCT01075100|75853630|FG000|STARTED|Overall Study||49||
59734991|NCT01075100|75853631|FG001|STARTED|Overall Study||54||
59734992|NCT01075100|75853630|FG000|COMPLETED|Overall Study||0||
59867535|NCT03984812|75991907|FG000|STARTED|Part 2 (Up to Day 49)||0||
59734993|NCT01075100|75853631|FG001|COMPLETED|Overall Study||1||
59734994|NCT01075100|75853630|FG000|NOT COMPLETED|Overall Study||49||
59734995|NCT01075100|75853631|FG001|NOT COMPLETED|Overall Study||53||
59734996|NCT00803023|75853643|FG000|STARTED|Overall Study||32||
59734997|NCT00803023|75853644|FG001|STARTED|Overall Study||33||
59734998|NCT00803023|75853645|FG002|STARTED|Overall Study||31||
59734999|NCT00803023|75853646|FG003|STARTED|Overall Study||33||
59735000|NCT00803023|75853643|FG000|COMPLETED|Overall Study||27||
59735001|NCT00803023|75853644|FG001|COMPLETED|Overall Study||25||
59735002|NCT00803023|75853645|FG002|COMPLETED|Overall Study||20||
59735003|NCT00803023|75853646|FG003|COMPLETED|Overall Study||25||
59735004|NCT00803023|75853643|FG000|NOT COMPLETED|Overall Study||5||
59735005|NCT00803023|75853644|FG001|NOT COMPLETED|Overall Study||8||
59735006|NCT00803023|75853645|FG002|NOT COMPLETED|Overall Study||11||
59735007|NCT00803023|75853646|FG003|NOT COMPLETED|Overall Study||8||
59735008|NCT00859222|75853659|FG000|STARTED|Overall Study||3||
59735009|NCT00859222|75853660|FG001|STARTED|Overall Study||3||
59735010|NCT00859222|75853661|FG002|STARTED|Overall Study||6||
59735011|NCT00859222|75853662|FG003|STARTED|Overall Study||24||
59735012|NCT00859222|75853663|FG004|STARTED|Overall Study||15||
59735013|NCT00859222|75853659|FG000|COMPLETED|Overall Study||0||
59735014|NCT00859222|75853660|FG001|COMPLETED|Overall Study||0||
59735015|NCT00859222|75853661|FG002|COMPLETED|Overall Study||0||
59735016|NCT00859222|75853662|FG003|COMPLETED|Overall Study||0||
59735017|NCT00859222|75853663|FG004|COMPLETED|Overall Study||0||
59735018|NCT00859222|75853659|FG000|NOT COMPLETED|Overall Study||3||
59735019|NCT00859222|75853660|FG001|NOT COMPLETED|Overall Study||3||
59735020|NCT00859222|75853661|FG002|NOT COMPLETED|Overall Study||6||
59735021|NCT00859222|75853662|FG003|NOT COMPLETED|Overall Study||24||
59735022|NCT00859222|75853663|FG004|NOT COMPLETED|Overall Study||15||
59735023|NCT01072448|75853680|FG000|STARTED|Overall Study||163||
59735024|NCT01072448|75853681|FG001|STARTED|Overall Study||160||
59867536|NCT03984812|75991908|FG001|STARTED|Part 2 (Up to Day 49)||0||
59867537|NCT03984812|75991909|FG002|STARTED|Part 2 (Up to Day 49)||0||
59867538|NCT03984812|75991910|FG003|STARTED|Part 2 (Up to Day 49)||0||
59867539|NCT03984812|75991911|FG004|STARTED|Part 2 (Up to Day 49)||0||
59867540|NCT03984812|75991912|FG005|STARTED|Part 2 (Up to Day 49)||0||
59867541|NCT03984812|75991913|FG006|STARTED|Part 2 (Up to Day 49)||0||
59867542|NCT03984812|75991914|FG007|STARTED|Part 2 (Up to Day 49)|No participants were enrolled in Part 2 as the study was terminated due to non-safety reasons.|0||
59867543|NCT03984812|75991915|FG008|STARTED|Part 2 (Up to Day 49)|No participants were enrolled in Part 2 as the study was terminated due to non-safety reasons.|0||
59867544|NCT03984812|75991916|FG009|STARTED|Part 2 (Up to Day 49)|No participants were enrolled in Part 2 as the study was terminated due to non-safety reasons.|0||
59867545|NCT03984812|75991917|FG010|STARTED|Part 2 (Up to Day 49)|No participants were enrolled in Part 2 as the study was terminated due to non-safety reasons.|0||
59867546|NCT03984812|75991907|FG000|COMPLETED|Part 2 (Up to Day 49)||0||
59867547|NCT03984812|75991908|FG001|COMPLETED|Part 2 (Up to Day 49)||0||
59867548|NCT03984812|75991909|FG002|COMPLETED|Part 2 (Up to Day 49)||0||
59867549|NCT03984812|75991910|FG003|COMPLETED|Part 2 (Up to Day 49)||0||
59867550|NCT03984812|75991911|FG004|COMPLETED|Part 2 (Up to Day 49)||0||
59867551|NCT03984812|75991912|FG005|COMPLETED|Part 2 (Up to Day 49)||0||
59867552|NCT03984812|75991913|FG006|COMPLETED|Part 2 (Up to Day 49)||0||
59867553|NCT03984812|75991914|FG007|COMPLETED|Part 2 (Up to Day 49)||0||
59867554|NCT03984812|75991915|FG008|COMPLETED|Part 2 (Up to Day 49)||0||
59867555|NCT03984812|75991916|FG009|COMPLETED|Part 2 (Up to Day 49)||0||
59867556|NCT03984812|75991917|FG010|COMPLETED|Part 2 (Up to Day 49)||0||
59867557|NCT03984812|75991907|FG000|NOT COMPLETED|Part 2 (Up to Day 49)||0||
59867558|NCT03984812|75991908|FG001|NOT COMPLETED|Part 2 (Up to Day 49)||0||
59867559|NCT03984812|75991909|FG002|NOT COMPLETED|Part 2 (Up to Day 49)||0||
59867560|NCT03984812|75991910|FG003|NOT COMPLETED|Part 2 (Up to Day 49)||0||
59867561|NCT03984812|75991911|FG004|NOT COMPLETED|Part 2 (Up to Day 49)||0||
59867562|NCT03984812|75991912|FG005|NOT COMPLETED|Part 2 (Up to Day 49)||0||
59867563|NCT03984812|75991913|FG006|NOT COMPLETED|Part 2 (Up to Day 49)||0||
59867564|NCT03984812|75991914|FG007|NOT COMPLETED|Part 2 (Up to Day 49)||0||
59867565|NCT03984812|75991915|FG008|NOT COMPLETED|Part 2 (Up to Day 49)||0||
59867566|NCT03984812|75991916|FG009|NOT COMPLETED|Part 2 (Up to Day 49)||0||
59867567|NCT03984812|75991917|FG010|NOT COMPLETED|Part 2 (Up to Day 49)||0||
59867568|NCT04160988|75991944|FG000|STARTED|Overall Study||703||
59867569|NCT04160988|75991944|FG000|COMPLETED|Overall Study||675||
59867570|NCT04160988|75991944|FG000|NOT COMPLETED|Overall Study||28||
59867571|NCT04764630|75991949|FG000|STARTED|Overall Study||3||
59867572|NCT04764630|75991950|FG001|STARTED|Overall Study||4||
59867573|NCT04764630|75991951|FG002|STARTED|Overall Study||3||
59867574|NCT04764630|75991952|FG003|STARTED|Overall Study||4||
59867575|NCT04764630|75991953|FG004|STARTED|Overall Study||3||
59867576|NCT04764630|75991954|FG005|STARTED|Overall Study||4||
59867577|NCT04764630|75991949|FG000|COMPLETED|Overall Study||3||
59867578|NCT04764630|75991950|FG001|COMPLETED|Overall Study||3||
59735025|NCT01072448|75853680|FG000|COMPLETED|Overall Study||144||
59735026|NCT01072448|75853681|FG001|COMPLETED|Overall Study||130||
59735027|NCT01072448|75853680|FG000|NOT COMPLETED|Overall Study||19||
59735028|NCT01072448|75853681|FG001|NOT COMPLETED|Overall Study||30||
59735029|NCT00922974|75853690|FG000|STARTED|Phase II Component||46||
59735030|NCT00922974|75853691|FG001|STARTED|Phase II Component||0||
59735031|NCT00922974|75853690|FG000|Eligible|Phase II Component||44||
59867579|NCT04764630|75991951|FG002|COMPLETED|Overall Study||3||
59867580|NCT04764630|75991952|FG003|COMPLETED|Overall Study||3||
59867581|NCT04764630|75991953|FG004|COMPLETED|Overall Study||3||
59867582|NCT04764630|75991954|FG005|COMPLETED|Overall Study||3||
59867583|NCT04764630|75991949|FG000|NOT COMPLETED|Overall Study||0||
59867584|NCT04764630|75991950|FG001|NOT COMPLETED|Overall Study||1||
59867585|NCT04764630|75991951|FG002|NOT COMPLETED|Overall Study||0||
59867586|NCT04764630|75991952|FG003|NOT COMPLETED|Overall Study||1||
59867587|NCT04764630|75991953|FG004|NOT COMPLETED|Overall Study||0||
59867588|NCT04764630|75991954|FG005|NOT COMPLETED|Overall Study||1||
59867589|NCT04153188|75991965|FG000|STARTED|Overall Study||17||
59867590|NCT04153188|75991966|FG001|STARTED|Overall Study||13||
59867591|NCT04153188|75991965|FG000|COMPLETED|Overall Study||14||
59867592|NCT04153188|75991966|FG001|COMPLETED|Overall Study||11||
59867593|NCT04153188|75991965|FG000|NOT COMPLETED|Overall Study||3||
59867594|NCT04153188|75991966|FG001|NOT COMPLETED|Overall Study||2||
59867595|NCT04113746|75991974|FG000|STARTED|Overall Study||13||
59867596|NCT04113746|75991975|FG001|STARTED|Overall Study||14||
59867597|NCT04113746|75991974|FG000|COMPLETED|Overall Study||9||
59867598|NCT04113746|75991975|FG001|COMPLETED|Overall Study||10||
59867599|NCT04113746|75991974|FG000|NOT COMPLETED|Overall Study||4||
59867600|NCT04113746|75991975|FG001|NOT COMPLETED|Overall Study||4||
59867601|NCT03611010|75991985|FG000|STARTED|Period 1: Lead-In||14||
59867602|NCT03611010|75991986|FG001|STARTED|Period 1: Lead-In||14||
59867603|NCT03611010|75991987|FG002|STARTED|Period 1: Lead-In||2||
59867604|NCT03611010|75991988|FG003|STARTED|Period 1: Lead-In||10||
59867605|NCT03611010|75991985|FG000|COMPLETED|Period 1: Lead-In||14||
59867606|NCT03611010|75991986|FG001|COMPLETED|Period 1: Lead-In||14||
59867607|NCT03611010|75991987|FG002|COMPLETED|Period 1: Lead-In||2||
59867608|NCT03611010|75991988|FG003|COMPLETED|Period 1: Lead-In||10||
59867609|NCT03611010|75991985|FG000|NOT COMPLETED|Period 1: Lead-In||0||
59867610|NCT03611010|75991986|FG001|NOT COMPLETED|Period 1: Lead-In||0||
59867611|NCT03611010|75991987|FG002|NOT COMPLETED|Period 1: Lead-In||0||
59867612|NCT03611010|75991988|FG003|NOT COMPLETED|Period 1: Lead-In||0||
59867613|NCT03611010|75991985|FG000|STARTED|Period 2: 15 Day Treatment||14||
59867614|NCT03611010|75991986|FG001|STARTED|Period 2: 15 Day Treatment||14||
59867615|NCT03611010|75991987|FG002|STARTED|Period 2: 15 Day Treatment||2||
59867616|NCT03611010|75991988|FG003|STARTED|Period 2: 15 Day Treatment||10||
59867617|NCT03611010|75991985|FG000|COMPLETED|Period 2: 15 Day Treatment||13||
59867618|NCT03611010|75991986|FG001|COMPLETED|Period 2: 15 Day Treatment||14||
59867619|NCT03611010|75991987|FG002|COMPLETED|Period 2: 15 Day Treatment||2||
59867620|NCT03611010|75991988|FG003|COMPLETED|Period 2: 15 Day Treatment||10||
59867621|NCT03611010|75991985|FG000|NOT COMPLETED|Period 2: 15 Day Treatment||1||
59867622|NCT03611010|75991986|FG001|NOT COMPLETED|Period 2: 15 Day Treatment||0||
59867623|NCT03611010|75991987|FG002|NOT COMPLETED|Period 2: 15 Day Treatment||0||
59867624|NCT03611010|75991988|FG003|NOT COMPLETED|Period 2: 15 Day Treatment||0||
59867625|NCT04357782|75992003|FG000|STARTED|Overall Study||10||
59867626|NCT04357782|75992004|FG001|STARTED|Overall Study||10||
59867627|NCT04357782|75992003|FG000|COMPLETED|Overall Study||9||
59867628|NCT04357782|75992004|FG001|COMPLETED|Overall Study||8||
59867629|NCT04357782|75992003|FG000|NOT COMPLETED|Overall Study||1||
59867630|NCT04357782|75992004|FG001|NOT COMPLETED|Overall Study||2||
59867631|NCT03980522|75992015|FG000|STARTED|Treatment Period||13||
59867632|NCT03980522|75992016|FG001|STARTED|Treatment Period||3||
59867633|NCT03980522|75992017|FG002|STARTED|Treatment Period||6||
59867634|NCT03980522|75992018|FG003|STARTED|Treatment Period||1||
59867635|NCT03980522|75992019|FG004|STARTED|Treatment Period||3||
59867636|NCT03980522|75992015|FG000|COMPLETED|Treatment Period||12||
59867637|NCT03980522|75992016|FG001|COMPLETED|Treatment Period||3||
59867638|NCT03980522|75992017|FG002|COMPLETED|Treatment Period||6||
59867639|NCT03980522|75992018|FG003|COMPLETED|Treatment Period||1||
59867640|NCT03980522|75992019|FG004|COMPLETED|Treatment Period||3||
59867641|NCT03980522|75992015|FG000|NOT COMPLETED|Treatment Period||1||
59867642|NCT03980522|75992016|FG001|NOT COMPLETED|Treatment Period||0||
59867643|NCT03980522|75992017|FG002|NOT COMPLETED|Treatment Period||0||
59867644|NCT03980522|75992018|FG003|NOT COMPLETED|Treatment Period||0||
59867645|NCT03980522|75992019|FG004|NOT COMPLETED|Treatment Period||0||
59867646|NCT03980522|75992015|FG000|STARTED|Extension Period||12||
59867647|NCT03980522|75992016|FG001|STARTED|Extension Period||3||
59867648|NCT03980522|75992017|FG002|STARTED|Extension Period|1 participant did not sign the optional Extension Period consent form.|5||
59867649|NCT03980522|75992018|FG003|STARTED|Extension Period||1||
59867650|NCT03980522|75992019|FG004|STARTED|Extension Period||3||
59867651|NCT03980522|75992015|FG000|COMPLETED|Extension Period||12||
59867652|NCT03980522|75992016|FG001|COMPLETED|Extension Period||3||
59867653|NCT03980522|75992017|FG002|COMPLETED|Extension Period||5||
59867654|NCT03980522|75992018|FG003|COMPLETED|Extension Period||1||
59867655|NCT03980522|75992019|FG004|COMPLETED|Extension Period||3||
59867656|NCT03980522|75992015|FG000|NOT COMPLETED|Extension Period||0||
59867657|NCT03980522|75992016|FG001|NOT COMPLETED|Extension Period||0||
59867658|NCT03980522|75992017|FG002|NOT COMPLETED|Extension Period||0||
59867659|NCT03980522|75992018|FG003|NOT COMPLETED|Extension Period||0||
59867660|NCT03980522|75992019|FG004|NOT COMPLETED|Extension Period||0||
59867661|NCT04402866|75992037|FG000|STARTED|Overall Study||6||
59867662|NCT04402866|75992038|FG001|STARTED|Overall Study||6||
59867663|NCT04402866|75992039|FG002|STARTED|Overall Study||7||
59867664|NCT04402866|75992040|FG003|STARTED|Overall Study||6||
59867665|NCT04402866|75992041|FG004|STARTED|Overall Study||104||
59867666|NCT04402866|75992042|FG005|STARTED|Overall Study||106||
59867667|NCT04402866|75992037|FG000|Randomized and Treated With Study Drug|Overall Study||6||
59867668|NCT04402866|75992038|FG001|Randomized and Treated With Study Drug|Overall Study||6||
59867669|NCT04402866|75992039|FG002|Randomized and Treated With Study Drug|Overall Study||7||
59867670|NCT04402866|75992040|FG003|Randomized and Treated With Study Drug|Overall Study||6||
59867671|NCT04402866|75992041|FG004|Randomized and Treated With Study Drug|Overall Study||102||
59867672|NCT04402866|75992042|FG005|Randomized and Treated With Study Drug|Overall Study||103||
59867673|NCT04402866|75992037|FG000|COMPLETED|Overall Study||4||
59867674|NCT04402866|75992038|FG001|COMPLETED|Overall Study||5||
59867675|NCT04402866|75992039|FG002|COMPLETED|Overall Study||6||
59867676|NCT04402866|75992040|FG003|COMPLETED|Overall Study||6||
59867677|NCT04402866|75992041|FG004|COMPLETED|Overall Study||89||
59867678|NCT04402866|75992042|FG005|COMPLETED|Overall Study||92||
59867679|NCT04402866|75992037|FG000|NOT COMPLETED|Overall Study||2||
59867680|NCT04402866|75992038|FG001|NOT COMPLETED|Overall Study||1||
59867681|NCT04402866|75992039|FG002|NOT COMPLETED|Overall Study||1||
59867682|NCT04402866|75992040|FG003|NOT COMPLETED|Overall Study||0||
59867683|NCT04402866|75992041|FG004|NOT COMPLETED|Overall Study||15||
59867684|NCT04402866|75992042|FG005|NOT COMPLETED|Overall Study||14||
59867685|NCT04400682|75992054|FG000|STARTED|Period 1||15||
59867686|NCT04400682|75992055|FG001|STARTED|Period 1||15||
59867687|NCT04400682|75992054|FG000|COMPLETED|Period 1||14||
59867688|NCT04400682|75992055|FG001|COMPLETED|Period 1||11||
59867689|NCT04400682|75992054|FG000|NOT COMPLETED|Period 1||1||
59867690|NCT04400682|75992055|FG001|NOT COMPLETED|Period 1||4||
59867691|NCT04400682|75992054|FG000|STARTED|Period 2||14||
59867692|NCT04400682|75992055|FG001|STARTED|Period 2||11||
59867693|NCT04400682|75992054|FG000|COMPLETED|Period 2||14||
59867694|NCT04400682|75992055|FG001|COMPLETED|Period 2||11||
59867695|NCT04400682|75992054|FG000|NOT COMPLETED|Period 2||0||
59867696|NCT04400682|75992055|FG001|NOT COMPLETED|Period 2||0||
59867697|NCT03066778|75992063|FG000|STARTED|Overall Study||228||
59867698|NCT03066778|75992064|FG001|STARTED|Overall Study||225||
59867699|NCT03066778|75992063|FG000|Treated|Overall Study|1 participant randomized to the pembrolizumab+EP arm was treated with placebo+EP.|223||
59867700|NCT03066778|75992064|FG001|Treated|Overall Study||223||
59867701|NCT03066778|75992063|FG000|Received Second Course of Pembrolizumab|Overall Study||1||
59867702|NCT03066778|75992064|FG001|Received Second Course of Pembrolizumab|Overall Study||0||
59867703|NCT03066778|75992063|FG000|COMPLETED|Overall Study||28||
59867704|NCT03066778|75992064|FG001|COMPLETED|Overall Study||13||
59867705|NCT03066778|75992063|FG000|NOT COMPLETED|Overall Study||200||
59867706|NCT03066778|75992064|FG001|NOT COMPLETED|Overall Study||212||
59867707|NCT04348656|75992073|FG000|STARTED|Overall Study||627||
59867708|NCT04348656|75992074|FG001|STARTED|Overall Study||313||
59867709|NCT04348656|75992073|FG000|Baseline Population|Overall Study||625||
59867710|NCT04348656|75992074|FG001|Baseline Population|Overall Study||313||
59867711|NCT04348656|75992073|FG000|Intention to Treat Analysis|Overall Study||614||
59867712|NCT04348656|75992074|FG001|Intention to Treat Analysis|Overall Study||307||
59867713|NCT04348656|75992073|FG000|Per Protocol Analysis|Overall Study||548||
59867714|NCT04348656|75992074|FG001|Per Protocol Analysis|Overall Study||303||
59867715|NCT04348656|75992073|FG000|COMPLETED|Overall Study||614||
59867716|NCT04348656|75992074|FG001|COMPLETED|Overall Study||307||
59867717|NCT04348656|75992073|FG000|NOT COMPLETED|Overall Study||13||
59867718|NCT04348656|75992074|FG001|NOT COMPLETED|Overall Study||6||
59867719|NCT04136548|75992080|FG000|STARTED|Enrolled & Randomized||19||
59867720|NCT04136548|75992081|FG001|STARTED|Enrolled & Randomized||19||
59867721|NCT04136548|75992080|FG000|COMPLETED|Enrolled & Randomized||13||
59867722|NCT04136548|75992081|FG001|COMPLETED|Enrolled & Randomized||15||
59867723|NCT04136548|75992080|FG000|NOT COMPLETED|Enrolled & Randomized||6||
59867724|NCT04136548|75992081|FG001|NOT COMPLETED|Enrolled & Randomized||4||
59867725|NCT04136548|75992080|FG000|STARTED|First Visit||13||
59867726|NCT04136548|75992081|FG001|STARTED|First Visit||15||
59867727|NCT04136548|75992080|FG000|COMPLETED|First Visit||13||
59867728|NCT04136548|75992081|FG001|COMPLETED|First Visit||15||
59867729|NCT04136548|75992080|FG000|NOT COMPLETED|First Visit||0||
59867730|NCT04136548|75992081|FG001|NOT COMPLETED|First Visit||0||
59867731|NCT04136548|75992080|FG000|STARTED|Washout (at Least 48 Hours)||13||
59867732|NCT04136548|75992081|FG001|STARTED|Washout (at Least 48 Hours)||15||
59867733|NCT04136548|75992080|FG000|COMPLETED|Washout (at Least 48 Hours)||13||
59867734|NCT04136548|75992081|FG001|COMPLETED|Washout (at Least 48 Hours)||15||
59867735|NCT04136548|75992080|FG000|NOT COMPLETED|Washout (at Least 48 Hours)||0||
59867736|NCT04136548|75992081|FG001|NOT COMPLETED|Washout (at Least 48 Hours)||0||
59867737|NCT04136548|75992080|FG000|STARTED|Second Visit||13||
59867738|NCT04136548|75992081|FG001|STARTED|Second Visit||15||
59867739|NCT04136548|75992080|FG000|COMPLETED|Second Visit||13||
59867740|NCT04136548|75992081|FG001|COMPLETED|Second Visit||15||
59867741|NCT04136548|75992080|FG000|NOT COMPLETED|Second Visit||0||
59867742|NCT04136548|75992081|FG001|NOT COMPLETED|Second Visit||0||
59867743|NCT04348500|75992089|FG000|STARTED|Overall Study||8||
59867744|NCT04348500|75992090|FG001|STARTED|Overall Study||9||
59867745|NCT04348500|75992089|FG000|Treated|Overall Study||8||
59867746|NCT04348500|75992090|FG001|Treated|Overall Study||8||
59867747|NCT04348500|75992089|FG000|COMPLETED|Overall Study||6||
59867748|NCT04348500|75992090|FG001|COMPLETED|Overall Study||6||
59867749|NCT04348500|75992089|FG000|NOT COMPLETED|Overall Study||2||
59867750|NCT04348500|75992090|FG001|NOT COMPLETED|Overall Study||3||
59867751|NCT04347954|75992099|FG000|STARTED|Overall Study||15||
59867752|NCT04347954|75992100|FG001|STARTED|Overall Study||15||
59867753|NCT04347954|75992101|FG002|STARTED|Overall Study||17||
59867754|NCT04347954|75992099|FG000|Received Allocated Intervention|Overall Study||12||
59867755|NCT04347954|75992100|FG001|Received Allocated Intervention|Overall Study||15||
59867756|NCT04347954|75992101|FG002|Received Allocated Intervention|Overall Study||14||
59867757|NCT04347954|75992099|FG000|Negative PCR Swab at Baseline|Overall Study||1||
59867758|NCT04347954|75992100|FG001|Negative PCR Swab at Baseline|Overall Study||3||
59867759|NCT04347954|75992101|FG002|Negative PCR Swab at Baseline|Overall Study||1||
59867760|NCT04347954|75992099|FG000|COMPLETED|Overall Study||12||
59867761|NCT04347954|75992100|FG001|COMPLETED|Overall Study||14||
59867762|NCT04347954|75992101|FG002|COMPLETED|Overall Study||14||
59867763|NCT04347954|75992099|FG000|NOT COMPLETED|Overall Study||3||
59867764|NCT04347954|75992100|FG001|NOT COMPLETED|Overall Study||1||
59867765|NCT04347954|75992101|FG002|NOT COMPLETED|Overall Study||3||
59867766|NCT03065530|75992113|FG000|STARTED|Overall Study||30||
59867767|NCT03065530|75992114|FG001|STARTED|Overall Study||30||
59867768|NCT03065530|75992115|FG002|STARTED|Overall Study||30||
59867769|NCT03065530|75992116|FG003|STARTED|Overall Study||30||
59867770|NCT03065530|75992113|FG000|COMPLETED|Overall Study||28||
59867771|NCT03065530|75992114|FG001|COMPLETED|Overall Study||29||
59867772|NCT03065530|75992115|FG002|COMPLETED|Overall Study||29||
59867773|NCT03065530|75992116|FG003|COMPLETED|Overall Study||28||
59867774|NCT03065530|75992113|FG000|NOT COMPLETED|Overall Study||2||
59867775|NCT03065530|75992114|FG001|NOT COMPLETED|Overall Study||1||
59867776|NCT03065530|75992115|FG002|NOT COMPLETED|Overall Study||1||
59867777|NCT03065530|75992116|FG003|NOT COMPLETED|Overall Study||2||
59867778|NCT03979820|75992138|FG000|STARTED|Overall Study||13||
59867779|NCT03979820|75992139|FG001|STARTED|Overall Study||14||
59867780|NCT03979820|75992140|FG002|STARTED|Overall Study||16||
59867781|NCT03979820|75992141|FG003|STARTED|Overall Study||10||
59867782|NCT03979820|75992138|FG000|COMPLETED|Overall Study||7||
59867783|NCT03979820|75992139|FG001|COMPLETED|Overall Study||14||
59867784|NCT03979820|75992140|FG002|COMPLETED|Overall Study||15||
59867785|NCT03979820|75992141|FG003|COMPLETED|Overall Study||0||
59867786|NCT03979820|75992138|FG000|NOT COMPLETED|Overall Study||6||
59867787|NCT03979820|75992139|FG001|NOT COMPLETED|Overall Study||0||
59867788|NCT03979820|75992140|FG002|NOT COMPLETED|Overall Study||1||
59867789|NCT03979820|75992141|FG003|NOT COMPLETED|Overall Study||10||
59867790|NCT03647488|75992158|FG000|STARTED|Overall Study||18||
59867791|NCT03647488|75992159|FG001|STARTED|Overall Study|Randomized part was not opened|0||
59867792|NCT03647488|75992160|FG002|STARTED|Overall Study|Randomized part was not opened|0||
59867793|NCT03647488|75992158|FG000|COMPLETED|Overall Study||0||
59867794|NCT03647488|75992159|FG001|COMPLETED|Overall Study||0||
59867795|NCT03647488|75992160|FG002|COMPLETED|Overall Study||0||
59867796|NCT03647488|75992158|FG000|NOT COMPLETED|Overall Study||18||
59867797|NCT03647488|75992159|FG001|NOT COMPLETED|Overall Study||0||
59867798|NCT03647488|75992160|FG002|NOT COMPLETED|Overall Study||0||
59867799|NCT03693950|75992168|FG000|STARTED|Overall Study||29||
59867800|NCT03693950|75992169|FG001|STARTED|Overall Study||28||
59867801|NCT03693950|75992168|FG000|COMPLETED|Overall Study||28||
59867802|NCT03693950|75992169|FG001|COMPLETED|Overall Study||28||
59867803|NCT03693950|75992168|FG000|NOT COMPLETED|Overall Study||1||
59867804|NCT03693950|75992169|FG001|NOT COMPLETED|Overall Study||0||
59867805|NCT04110314|75992181|FG000|STARTED|Overall Study||71781||
59867806|NCT04110314|75992182|FG001|STARTED|Overall Study||71492||
59867807|NCT04110314|75992183|FG002|STARTED|Overall Study||72177||
59867808|NCT04110314|75992184|FG003|STARTED|Overall Study||71512||
59867809|NCT04110314|75992185|FG004|STARTED|Overall Study||71536||
59867810|NCT04110314|75992186|FG005|STARTED|Overall Study||72138||
59867811|NCT04110314|75992181|FG000|Patients Who Met Inclusion|Overall Study||36526||
59867812|NCT04110314|75992182|FG001|Patients Who Met Inclusion|Overall Study||36388||
59867813|NCT04110314|75992183|FG002|Patients Who Met Inclusion|Overall Study||36541||
59867814|NCT04110314|75992184|FG003|Patients Who Met Inclusion|Overall Study||36377||
59867815|NCT04110314|75992185|FG004|Patients Who Met Inclusion|Overall Study||36289||
59867816|NCT04110314|75992186|FG005|Patients Who Met Inclusion|Overall Study||36411||
59867817|NCT04110314|75992181|FG000|COMPLETED|Overall Study||36526||
59867818|NCT04110314|75992182|FG001|COMPLETED|Overall Study||36388||
59867819|NCT04110314|75992183|FG002|COMPLETED|Overall Study||36541||
59867820|NCT04110314|75992184|FG003|COMPLETED|Overall Study||36377||
59867821|NCT04110314|75992185|FG004|COMPLETED|Overall Study||36289||
59867822|NCT04110314|75992186|FG005|COMPLETED|Overall Study||36411||
59867823|NCT04110314|75992181|FG000|NOT COMPLETED|Overall Study||35255||
59867824|NCT04110314|75992182|FG001|NOT COMPLETED|Overall Study||35104||
59867825|NCT04110314|75992183|FG002|NOT COMPLETED|Overall Study||35636||
59867826|NCT04110314|75992184|FG003|NOT COMPLETED|Overall Study||35135||
59867827|NCT04110314|75992185|FG004|NOT COMPLETED|Overall Study||35247||
59867828|NCT04110314|75992186|FG005|NOT COMPLETED|Overall Study||35727||
59867829|NCT04098458|75992198|FG000|STARTED|Overall Study||18||
59867830|NCT04098458|75992198|FG000|COMPLETED|Overall Study||14||
59867831|NCT04098458|75992198|FG000|NOT COMPLETED|Overall Study||4||
59867832|NCT03447262|75992203|FG000|STARTED|Overall Study||481||
59867833|NCT03447262|75992203|FG000|COMPLETED|Overall Study||2||
59867834|NCT03447262|75992203|FG000|NOT COMPLETED|Overall Study||479||
59867835|NCT04094870|75992212|FG000|STARTED|Overall Study||40||
59867836|NCT04094870|75992213|FG001|STARTED|Overall Study||40||
59867837|NCT04094870|75992212|FG000|COMPLETED|Overall Study||39||
59867838|NCT04094870|75992213|FG001|COMPLETED|Overall Study||39||
59867839|NCT04094870|75992212|FG000|NOT COMPLETED|Overall Study||1||
59867840|NCT04094870|75992213|FG001|NOT COMPLETED|Overall Study||1||
59867841|NCT04399356|75992228|FG000|STARTED|Overall Study||36||
59867842|NCT04399356|75992229|FG001|STARTED|Overall Study||37||
59867843|NCT04399356|75992228|FG000|COMPLETED|Overall Study||33||
59867844|NCT04399356|75992229|FG001|COMPLETED|Overall Study||34||
59867845|NCT04399356|75992228|FG000|NOT COMPLETED|Overall Study||3||
59867846|NCT04399356|75992229|FG001|NOT COMPLETED|Overall Study||3||
59867847|NCT03692676|75992239|FG000|STARTED|Overall Study||10365||
59867848|NCT03692676|75992240|FG001|STARTED|Overall Study||51142||
59867849|NCT03692676|75992241|FG002|STARTED|Overall Study||49479||
59867850|NCT03692676|75992242|FG003|STARTED|Overall Study||5147||
59867851|NCT03692676|75992239|FG000|COMPLETED|Overall Study||940||
59867852|NCT03692676|75992240|FG001|COMPLETED|Overall Study||3704||
59867853|NCT03692676|75992241|FG002|COMPLETED|Overall Study||11135||
59867854|NCT03692676|75992242|FG003|COMPLETED|Overall Study||1561||
59867855|NCT03692676|75992239|FG000|NOT COMPLETED|Overall Study||9425||
59867856|NCT03692676|75992240|FG001|NOT COMPLETED|Overall Study||47438||
59867857|NCT03692676|75992241|FG002|NOT COMPLETED|Overall Study||38344||
59867858|NCT03692676|75992242|FG003|NOT COMPLETED|Overall Study||3586||
59867859|NCT03691428|75992254|FG000|STARTED|Overall Study||48||
59867860|NCT03691428|75992255|FG001|STARTED|Overall Study||42||
59867861|NCT03691428|75992254|FG000|COMPLETED|Overall Study||42||
59867862|NCT03691428|75992255|FG001|COMPLETED|Overall Study||34||
59867863|NCT03691428|75992254|FG000|NOT COMPLETED|Overall Study||6||
59867864|NCT03691428|75992255|FG001|NOT COMPLETED|Overall Study||8||
59867865|NCT04122534|75992261|FG000|STARTED|Overall Study||48||
59867866|NCT04122534|75992261|FG000|COMPLETED|Overall Study||44||
59867867|NCT04122534|75992261|FG000|NOT COMPLETED|Overall Study||4||
59867868|NCT04091360|75992271|FG000|STARTED|Part A (R, PC, PG) Single Dose||6||
59867869|NCT04091360|75992272|FG001|STARTED|Part A (R, PC, PG) Single Dose||7||
59867870|NCT04091360|75992273|FG002|STARTED|Part A (R, PC, PG) Single Dose||6||
59867871|NCT04091360|75992274|FG003|STARTED|Part A (R, PC, PG) Single Dose||7||
59867872|NCT04091360|75992275|FG004|STARTED|Part A (R, PC, PG) Single Dose||7||
59867873|NCT04091360|75992276|FG005|STARTED|Part A (R, PC, PG) Single Dose||7||
59867874|NCT04091360|75992277|FG006|STARTED|Part A (R, PC, PG) Single Dose||0||
59867875|NCT04091360|75992278|FG007|STARTED|Part A (R, PC, PG) Single Dose||0||
59867876|NCT04091360|75992279|FG008|STARTED|Part A (R, PC, PG) Single Dose||0||
59867877|NCT04091360|75992280|FG009|STARTED|Part A (R, PC, PG) Single Dose||0||
59867878|NCT04091360|75992271|FG000|COMPLETED|Part A (R, PC, PG) Single Dose||6||
59867879|NCT04091360|75992272|FG001|COMPLETED|Part A (R, PC, PG) Single Dose||7||
59867880|NCT04091360|75992273|FG002|COMPLETED|Part A (R, PC, PG) Single Dose||6||
59867881|NCT04091360|75992274|FG003|COMPLETED|Part A (R, PC, PG) Single Dose||7||
59867882|NCT04091360|75992275|FG004|COMPLETED|Part A (R, PC, PG) Single Dose||7||
59867883|NCT04091360|75992276|FG005|COMPLETED|Part A (R, PC, PG) Single Dose||7||
59867884|NCT04091360|75992277|FG006|COMPLETED|Part A (R, PC, PG) Single Dose||0||
59867885|NCT04091360|75992278|FG007|COMPLETED|Part A (R, PC, PG) Single Dose||0||
59867886|NCT04091360|75992279|FG008|COMPLETED|Part A (R, PC, PG) Single Dose||0||
59867887|NCT04091360|75992280|FG009|COMPLETED|Part A (R, PC, PG) Single Dose||0||
59867888|NCT04091360|75992271|FG000|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0||
59867889|NCT04091360|75992272|FG001|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0||
59867890|NCT04091360|75992273|FG002|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0||
59867891|NCT04091360|75992274|FG003|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0||
59867892|NCT04091360|75992275|FG004|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0||
59867893|NCT04091360|75992276|FG005|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0||
59867894|NCT04091360|75992277|FG006|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0||
59867895|NCT04091360|75992278|FG007|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0||
59867896|NCT04091360|75992279|FG008|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0||
59867897|NCT04091360|75992280|FG009|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0||
59867898|NCT04091360|75992271|FG000|STARTED|Part B (R, PC, XO) Twice Daily for 7 Day||0||
59867899|NCT04091360|75992272|FG001|STARTED|Part B (R, PC, XO) Twice Daily for 7 Day||0||
59867900|NCT04091360|75992273|FG002|STARTED|Part B (R, PC, XO) Twice Daily for 7 Day||0||
59867901|NCT04091360|75992274|FG003|STARTED|Part B (R, PC, XO) Twice Daily for 7 Day||0||
59867902|NCT04091360|75992275|FG004|STARTED|Part B (R, PC, XO) Twice Daily for 7 Day||0||
59867903|NCT04091360|75992276|FG005|STARTED|Part B (R, PC, XO) Twice Daily for 7 Day||0||
59867904|NCT04091360|75992277|FG006|STARTED|Part B (R, PC, XO) Twice Daily for 7 Day||8||
59867905|NCT04091360|75992278|FG007|STARTED|Part B (R, PC, XO) Twice Daily for 7 Day||7||
59867906|NCT04091360|75992279|FG008|STARTED|Part B (R, PC, XO) Twice Daily for 7 Day||7||
59867907|NCT04091360|75992280|FG009|STARTED|Part B (R, PC, XO) Twice Daily for 7 Day||6||
59867908|NCT04091360|75992271|FG000|COMPLETED|Part B (R, PC, XO) Twice Daily for 7 Day||0||
59867909|NCT04091360|75992272|FG001|COMPLETED|Part B (R, PC, XO) Twice Daily for 7 Day||0||
59867910|NCT04091360|75992273|FG002|COMPLETED|Part B (R, PC, XO) Twice Daily for 7 Day||0||
59867911|NCT04091360|75992274|FG003|COMPLETED|Part B (R, PC, XO) Twice Daily for 7 Day||0||
59867912|NCT04091360|75992275|FG004|COMPLETED|Part B (R, PC, XO) Twice Daily for 7 Day||0||
59867913|NCT04091360|75992276|FG005|COMPLETED|Part B (R, PC, XO) Twice Daily for 7 Day||0||
59867914|NCT04091360|75992277|FG006|COMPLETED|Part B (R, PC, XO) Twice Daily for 7 Day||6||
59867915|NCT04091360|75992278|FG007|COMPLETED|Part B (R, PC, XO) Twice Daily for 7 Day||6||
59867916|NCT04091360|75992279|FG008|COMPLETED|Part B (R, PC, XO) Twice Daily for 7 Day||6||
59867917|NCT04091360|75992280|FG009|COMPLETED|Part B (R, PC, XO) Twice Daily for 7 Day||4||
59867918|NCT04091360|75992271|FG000|NOT COMPLETED|Part B (R, PC, XO) Twice Daily for 7 Day||0||
59867919|NCT04091360|75992272|FG001|NOT COMPLETED|Part B (R, PC, XO) Twice Daily for 7 Day||0||
59867920|NCT04091360|75992273|FG002|NOT COMPLETED|Part B (R, PC, XO) Twice Daily for 7 Day||0||
59867921|NCT04091360|75992274|FG003|NOT COMPLETED|Part B (R, PC, XO) Twice Daily for 7 Day||0||
59867922|NCT04091360|75992275|FG004|NOT COMPLETED|Part B (R, PC, XO) Twice Daily for 7 Day||0||
59867923|NCT04091360|75992276|FG005|NOT COMPLETED|Part B (R, PC, XO) Twice Daily for 7 Day||0||
59867924|NCT04091360|75992277|FG006|NOT COMPLETED|Part B (R, PC, XO) Twice Daily for 7 Day||2||
59867925|NCT04091360|75992278|FG007|NOT COMPLETED|Part B (R, PC, XO) Twice Daily for 7 Day||1||
59867926|NCT04091360|75992279|FG008|NOT COMPLETED|Part B (R, PC, XO) Twice Daily for 7 Day||1||
59867927|NCT04091360|75992280|FG009|NOT COMPLETED|Part B (R, PC, XO) Twice Daily for 7 Day||2||
59867928|NCT04346628|75992304|FG000|STARTED|Overall Study||74||
59867929|NCT04346628|75992305|FG001|STARTED|Overall Study||75||
59867930|NCT04346628|75992304|FG000|Intention-to-treat (ITT) Analysis Set|Overall Study||74||
59867931|NCT04346628|75992305|FG001|Intention-to-treat (ITT) Analysis Set|Overall Study||75||
59867932|NCT04346628|75992304|FG000|Symptomatic Modified ITT (smITT) Analysis Set|Overall Study||70|Participant reported at least one symptom other than mild cough, mild fatigue, or decreased taste/smell at baseline.|
59867933|NCT04346628|75992305|FG001|Symptomatic Modified ITT (smITT) Analysis Set|Overall Study||65|Participant reported at least one symptom other than mild cough, mild fatigue, or decreased taste/smell at baseline.|
59867934|NCT04346628|75992304|FG000|Modified ITT (mITT) Analysis|Overall Study||57|Participant was symptomatic with positive RT-PCR result at baseline.|
59867935|NCT04346628|75992305|FG001|Modified ITT (mITT) Analysis|Overall Study||59|Participant was symptomatic with positive RT-PCR result at baseline.|
59867936|NCT04346628|75992304|FG000|COMPLETED|Overall Study||68||
59867937|NCT04346628|75992305|FG001|COMPLETED|Overall Study||62||
59867938|NCT04346628|75992304|FG000|NOT COMPLETED|Overall Study||6||
59867939|NCT04346628|75992305|FG001|NOT COMPLETED|Overall Study||13||
59867940|NCT03681470|75992311|FG000|STARTED|Overall Study||20||
59867941|NCT03681470|75992311|FG000|COMPLETED|Overall Study||12||
59867942|NCT03681470|75992311|FG000|NOT COMPLETED|Overall Study||8||
59867943|NCT04343976|75992317|FG000|STARTED|Overall Study||7||
59867944|NCT04343976|75992318|FG001|STARTED|Overall Study||7||
59867945|NCT04343976|75992317|FG000|COMPLETED|Overall Study||7||
59867946|NCT04343976|75992318|FG001|COMPLETED|Overall Study||6||
59867947|NCT04343976|75992317|FG000|NOT COMPLETED|Overall Study||0||
59867948|NCT04343976|75992318|FG001|NOT COMPLETED|Overall Study||1||
59867949|NCT03322540|75992326|FG000|STARTED|Overall Study||77||
59867950|NCT03322540|75992327|FG001|STARTED|Overall Study||77||
59867951|NCT03322540|75992326|FG000|Number of Subjects Received Treatment (Actual Treatment) (ASaT)|Overall Study||75||
59867952|NCT03322540|75992327|FG001|Number of Subjects Received Treatment (Actual Treatment) (ASaT)|Overall Study||77||
59867953|NCT03322540|75992326|FG000|COMPLETED|Overall Study||46||
59867954|NCT03322540|75992327|FG001|COMPLETED|Overall Study||40||
59867955|NCT03322540|75992326|FG000|NOT COMPLETED|Overall Study||31||
59867956|NCT03322540|75992327|FG001|NOT COMPLETED|Overall Study||37||
59867957|NCT04339296|75992337|FG000|STARTED|Overall Study||24||
59867958|NCT04339296|75992338|FG001|STARTED|Overall Study||26||
59867959|NCT04339296|75992337|FG000|Completed Baseline|Overall Study||23||
59867960|NCT04339296|75992338|FG001|Completed Baseline|Overall Study||25||
59867961|NCT04339296|75992337|FG000|Received Allocated Intervention|Overall Study||21||
59867962|NCT04339296|75992338|FG001|Received Allocated Intervention|Overall Study||24||
59867963|NCT04339296|75992337|FG000|COMPLETED|Overall Study||16||
59867964|NCT04339296|75992338|FG001|COMPLETED|Overall Study||17||
59867965|NCT04339296|75992337|FG000|NOT COMPLETED|Overall Study||8||
59867966|NCT04339296|75992338|FG001|NOT COMPLETED|Overall Study||9||
59867967|NCT02025556|75992347|FG000|STARTED|Overall Study||104|All randomized participants|
59867968|NCT02025556|75992348|FG001|STARTED|Overall Study||96|All randomized participants|
59867969|NCT02025556|75992349|FG002|STARTED|Overall Study||97|All randomized participants|
59867970|NCT02025556|75992347|FG000|Safety Analysis Set|Overall Study||104|All randomized participants who received at least one dose of study drug|
59867971|NCT02025556|75992348|FG001|Safety Analysis Set|Overall Study||96|All randomized participants who received at least one dose of study drug|
59867972|NCT02025556|75992349|FG002|Safety Analysis Set|Overall Study||96|All randomized participants who received at least one dose of study drug|
59867973|NCT02025556|75992347|FG000|Intent-to-treat (ITT) Set|Overall Study||104|Received at least one dose of study drug and obtained at least one efficacy measurement|
59867974|NCT02025556|75992348|FG001|Intent-to-treat (ITT) Set|Overall Study||95|Received at least one dose of study drug and obtained at least one efficacy measurement|
59867975|NCT02025556|75992349|FG002|Intent-to-treat (ITT) Set|Overall Study||96|Received at least one dose of study drug and obtained at least one efficacy measurement|
59867976|NCT02025556|75992347|FG000|COMPLETED|Overall Study||98||
59867977|NCT02025556|75992348|FG001|COMPLETED|Overall Study||83||
59867978|NCT02025556|75992349|FG002|COMPLETED|Overall Study||88||
59867979|NCT02025556|75992347|FG000|NOT COMPLETED|Overall Study||6||
59867980|NCT02025556|75992348|FG001|NOT COMPLETED|Overall Study||13||
59867981|NCT02025556|75992349|FG002|NOT COMPLETED|Overall Study||9||
59867982|NCT04334460|75992359|FG000|STARTED|Full Enrollment||81||
59867983|NCT04334460|75992360|FG001|STARTED|Full Enrollment||39||
59867984|NCT04334460|75992359|FG000|COMPLETED|Full Enrollment||81||
59867985|NCT04334460|75992360|FG001|COMPLETED|Full Enrollment||39||
59867986|NCT04334460|75992359|FG000|NOT COMPLETED|Full Enrollment||0||
59867987|NCT04334460|75992360|FG001|NOT COMPLETED|Full Enrollment||0||
59867988|NCT04334460|75992359|FG000|STARTED|Full Analysis Set (FAS)||81||
59867989|NCT04334460|75992360|FG001|STARTED|Full Analysis Set (FAS)||39||
59867990|NCT04334460|75992359|FG000|COMPLETED|Full Analysis Set (FAS)||77||
59867991|NCT04334460|75992360|FG001|COMPLETED|Full Analysis Set (FAS)||38||
59867992|NCT04334460|75992359|FG000|NOT COMPLETED|Full Analysis Set (FAS)||4||
59867993|NCT04334460|75992360|FG001|NOT COMPLETED|Full Analysis Set (FAS)||1||
59867994|NCT04334460|75992359|FG000|STARTED|Safety Analysis Population||81||
59867995|NCT04334460|75992360|FG001|STARTED|Safety Analysis Population||39||
59867996|NCT04334460|75992359|FG000|COMPLETED|Safety Analysis Population||77||
59867997|NCT04334460|75992360|FG001|COMPLETED|Safety Analysis Population||38||
59867998|NCT04334460|75992359|FG000|NOT COMPLETED|Safety Analysis Population||4||
59867999|NCT04334460|75992360|FG001|NOT COMPLETED|Safety Analysis Population||1||
59868000|NCT04334148|75992369|FG000|STARTED|Overall Study||683||
59868001|NCT04334148|75992370|FG001|STARTED|Overall Study||677||
59868002|NCT04334148|75992369|FG000|COMPLETED|Overall Study||683||
59868003|NCT04334148|75992370|FG001|COMPLETED|Overall Study||676||
59868004|NCT04334148|75992369|FG000|NOT COMPLETED|Overall Study||0||
59868005|NCT04334148|75992370|FG001|NOT COMPLETED|Overall Study||1||
59868006|NCT04399122|75992378|FG000|STARTED|Overall Study||100||
59868007|NCT04399122|75992379|FG001|STARTED|Overall Study||100||
59868008|NCT04399122|75992378|FG000|COMPLETED|Overall Study||97||
59868009|NCT04399122|75992379|FG001|COMPLETED|Overall Study||100||
59868010|NCT04399122|75992378|FG000|NOT COMPLETED|Overall Study||3||
59868011|NCT04399122|75992379|FG001|NOT COMPLETED|Overall Study||0||
59868012|NCT00826462|75992388|FG000|STARTED|Overall Study||59||
59868013|NCT00826462|75992389|FG001|STARTED|Overall Study||58||
59868014|NCT00826462|75992390|FG002|STARTED|Overall Study||60||
59868015|NCT00826462|75992388|FG000|COMPLETED|Overall Study||52||
59868016|NCT00826462|75992389|FG001|COMPLETED|Overall Study||53||
59868017|NCT00826462|75992390|FG002|COMPLETED|Overall Study||52||
59868018|NCT00826462|75992388|FG000|NOT COMPLETED|Overall Study||7||
59868019|NCT00826462|75992389|FG001|NOT COMPLETED|Overall Study||5||
59868020|NCT00826462|75992390|FG002|NOT COMPLETED|Overall Study||8||
59868021|NCT04398732|75992400|FG000|STARTED|Overall Study||486||
59868022|NCT04398732|75992400|FG000|COMPLETED|Overall Study||436||
59868023|NCT04398732|75992400|FG000|NOT COMPLETED|Overall Study||50||
59868024|NCT04398030|75992406|FG000|STARTED|Treatment Period 1 (1 Week)||3||
59868025|NCT04398030|75992407|FG001|STARTED|Treatment Period 1 (1 Week)||4||
59868026|NCT04398030|75992406|FG000|COMPLETED|Treatment Period 1 (1 Week)||3||
59868027|NCT04398030|75992407|FG001|COMPLETED|Treatment Period 1 (1 Week)||3||
59868028|NCT04398030|75992406|FG000|NOT COMPLETED|Treatment Period 1 (1 Week)||0||
59868029|NCT04398030|75992407|FG001|NOT COMPLETED|Treatment Period 1 (1 Week)||1||
59868030|NCT04398030|75992406|FG000|STARTED|Washout (2 Weeks)||3||
59868031|NCT04398030|75992407|FG001|STARTED|Washout (2 Weeks)||3||
59868032|NCT04398030|75992406|FG000|COMPLETED|Washout (2 Weeks)||3||
59868033|NCT04398030|75992407|FG001|COMPLETED|Washout (2 Weeks)||3||
59868034|NCT04398030|75992406|FG000|NOT COMPLETED|Washout (2 Weeks)||0||
59868035|NCT04398030|75992407|FG001|NOT COMPLETED|Washout (2 Weeks)||0||
59868036|NCT04398030|75992406|FG000|STARTED|Treatment Period 2 (1 Week)||3||
59868037|NCT04398030|75992407|FG001|STARTED|Treatment Period 2 (1 Week)||3||
59868038|NCT04398030|75992406|FG000|COMPLETED|Treatment Period 2 (1 Week)||2||
59868039|NCT04398030|75992407|FG001|COMPLETED|Treatment Period 2 (1 Week)||3||
59868040|NCT04398030|75992406|FG000|NOT COMPLETED|Treatment Period 2 (1 Week)||1||
59868041|NCT04398030|75992407|FG001|NOT COMPLETED|Treatment Period 2 (1 Week)||0||
59868042|NCT03064438|75992415|FG000|STARTED|Overall Study||27||
59868043|NCT03064438|75992416|FG001|STARTED|Overall Study||13||
59868044|NCT03064438|75992415|FG000|COMPLETED|Overall Study||26||
59868045|NCT03064438|75992416|FG001|COMPLETED|Overall Study||12||
59868046|NCT03064438|75992415|FG000|NOT COMPLETED|Overall Study||1||
59868047|NCT03064438|75992416|FG001|NOT COMPLETED|Overall Study||1||
59868048|NCT04327986|75992422|FG000|STARTED|Overall Study||3||
59868049|NCT04327986|75992423|FG001|STARTED|Overall Study||0||
59868050|NCT04327986|75992424|FG002|STARTED|Overall Study||0||
59868051|NCT04327986|75992422|FG000|COMPLETED|Overall Study||0||
59868052|NCT04327986|75992423|FG001|COMPLETED|Overall Study||0||
59868053|NCT04327986|75992424|FG002|COMPLETED|Overall Study||0||
59868054|NCT04327986|75992422|FG000|NOT COMPLETED|Overall Study||3||
59868055|NCT04327986|75992423|FG001|NOT COMPLETED|Overall Study||0||
59868056|NCT04327986|75992424|FG002|NOT COMPLETED|Overall Study||0||
59868057|NCT04322682|75992430|FG000|STARTED|Overall Study||2235||
59868058|NCT04322682|75992431|FG001|STARTED|Overall Study||2253||
59868059|NCT04322682|75992430|FG000|COMPLETED|Overall Study||2192||
59868060|NCT04322682|75992431|FG001|COMPLETED|Overall Study||2189||
59868061|NCT04322682|75992430|FG000|NOT COMPLETED|Overall Study||43||
59868062|NCT04322682|75992431|FG001|NOT COMPLETED|Overall Study||64||
59868063|NCT04322526|75992439|FG000|STARTED|First Intervention (1 Day)||13||
59868064|NCT04322526|75992440|FG001|STARTED|First Intervention (1 Day)||12||
59868065|NCT04322526|75992439|FG000|COMPLETED|First Intervention (1 Day)||12||
59868066|NCT04322526|75992440|FG001|COMPLETED|First Intervention (1 Day)||11||
59868067|NCT04322526|75992439|FG000|NOT COMPLETED|First Intervention (1 Day)||1||
59868068|NCT04322526|75992440|FG001|NOT COMPLETED|First Intervention (1 Day)||1||
59868069|NCT04322526|75992439|FG000|STARTED|Washout (1 Week)||12||
59868070|NCT04322526|75992440|FG001|STARTED|Washout (1 Week)||11||
59868071|NCT04322526|75992439|FG000|COMPLETED|Washout (1 Week)||11||
59868072|NCT04322526|75992440|FG001|COMPLETED|Washout (1 Week)||9||
59868073|NCT04322526|75992439|FG000|NOT COMPLETED|Washout (1 Week)||1||
59868074|NCT04322526|75992440|FG001|NOT COMPLETED|Washout (1 Week)||2||
59868075|NCT04322526|75992439|FG000|STARTED|Second Intervention (1day)||11||
59868076|NCT04322526|75992440|FG001|STARTED|Second Intervention (1day)||9||
59868077|NCT04322526|75992439|FG000|COMPLETED|Second Intervention (1day)||11||
59868078|NCT04322526|75992440|FG001|COMPLETED|Second Intervention (1day)||9||
59868079|NCT04322526|75992439|FG000|NOT COMPLETED|Second Intervention (1day)||0||
59868080|NCT04322526|75992440|FG001|NOT COMPLETED|Second Intervention (1day)||0||
59868081|NCT04115358|75992449|FG000|STARTED|Overall Study||34||51
59868082|NCT04115358|75992450|FG001|STARTED|Overall Study||33||40
59868083|NCT04115358|75992451|FG002|STARTED|Overall Study||34||39
59868084|NCT04115358|75992449|FG000|COMPLETED|Overall Study|34 participants 48 teeth for clinical assessment, 28 participants 35 teeth for radiographic assessment.|34|In the 12th month follow-up, the dropouts increased due to the Covid-19 pandemic and periapical radiographs could not be taken in a total of eight children.|48
59868085|NCT04115358|75992450|FG001|COMPLETED|Overall Study|33 participants 40 teeth for clinical assessment, 26 participants 32 teeth for radiographic assessment.|33|In the 12th month follow-up, the dropouts increased due to the Covid-19 pandemic and periapical radiographs could not be taken in a total of eight children.|40
59868086|NCT04115358|75992451|FG002|COMPLETED|Overall Study|34 participants 38 teeth for clinical assessment, 26 participants 31 teeth for radiographic assessment.|33|In the 12th month follow-up, the dropouts increased due to the Covid-19 pandemic and periapical radiographs could not be taken in a total of eight children.|38
59868087|NCT04115358|75992449|FG000|NOT COMPLETED|Overall Study||0||3
59868088|NCT04115358|75992450|FG001|NOT COMPLETED|Overall Study||0||0
59868089|NCT04115358|75992451|FG002|NOT COMPLETED|Overall Study||1||1
59868090|NCT04109118|75992460|FG000|STARTED|Overall Study||4||
59868091|NCT04109118|75992460|FG000|COMPLETED|Overall Study||1||
59868092|NCT04109118|75992460|FG000|NOT COMPLETED|Overall Study||3||
59868093|NCT04105998|75992467|FG000|STARTED|First Study Day||12||
59868094|NCT04105998|75992468|FG001|STARTED|First Study Day||10||
59868095|NCT04105998|75992467|FG000|COMPLETED|First Study Day||12||
59868096|NCT04105998|75992468|FG001|COMPLETED|First Study Day||10||
59868097|NCT04105998|75992467|FG000|NOT COMPLETED|First Study Day||0||
59868098|NCT04105998|75992468|FG001|NOT COMPLETED|First Study Day||0||
59868099|NCT04105998|75992467|FG000|STARTED|Second Study Day||12||
59868100|NCT04105998|75992468|FG001|STARTED|Second Study Day||10||
59868101|NCT04105998|75992467|FG000|COMPLETED|Second Study Day||10||
59868102|NCT04105998|75992468|FG001|COMPLETED|Second Study Day||10||
59868103|NCT04105998|75992467|FG000|NOT COMPLETED|Second Study Day||2||
59868104|NCT04105998|75992468|FG001|NOT COMPLETED|Second Study Day||0||
59868105|NCT04397718|75992476|FG000|STARTED|Overall Study||34||
59868106|NCT04397718|75992477|FG001|STARTED|Overall Study||62||
59868107|NCT04397718|75992476|FG000|COMPLETED|Overall Study||27||
59868108|NCT04397718|75992477|FG001|COMPLETED|Overall Study||47||
59868109|NCT04397718|75992476|FG000|NOT COMPLETED|Overall Study||7||
59868110|NCT04397718|75992477|FG001|NOT COMPLETED|Overall Study||15||
59868111|NCT04105218|75992485|FG000|STARTED|Overall Study||6||
59868112|NCT04105218|75992486|FG001|STARTED|Overall Study||6||
59868113|NCT04105218|75992485|FG000|Completed First Condition|Overall Study||0||
59868114|NCT04105218|75992486|FG001|Completed First Condition|Overall Study||1||
59868115|NCT04105218|75992485|FG000|Completed Second Condition|Overall Study||0||
59868116|NCT04105218|75992486|FG001|Completed Second Condition|Overall Study||0||
59868117|NCT04105218|75992485|FG000|COMPLETED|Overall Study||0||
59868118|NCT04105218|75992486|FG001|COMPLETED|Overall Study||0||
59868119|NCT04105218|75992485|FG000|NOT COMPLETED|Overall Study||6||
59868120|NCT04105218|75992486|FG001|NOT COMPLETED|Overall Study||6||
59868121|NCT04317690|75992497|FG000|STARTED|Overall Study||100||
59868122|NCT04317690|75992498|FG001|STARTED|Overall Study||100||
59868123|NCT04317690|75992499|FG002|STARTED|Overall Study||140||
59868124|NCT04317690|75992500|FG003|STARTED|Overall Study||100||
59868125|NCT04317690|75992501|FG004|STARTED|Overall Study||99||
59868126|NCT04317690|75992497|FG000|COMPLETED|Overall Study||100||
59868127|NCT04317690|75992498|FG001|COMPLETED|Overall Study||96||
59868128|NCT04317690|75992499|FG002|COMPLETED|Overall Study||140||
59868129|NCT04317690|75992500|FG003|COMPLETED|Overall Study||98||
59868130|NCT04317690|75992501|FG004|COMPLETED|Overall Study||99||
59868131|NCT04317690|75992497|FG000|NOT COMPLETED|Overall Study||0||
59868132|NCT04317690|75992498|FG001|NOT COMPLETED|Overall Study||4||
59868133|NCT04317690|75992499|FG002|NOT COMPLETED|Overall Study||0||
59868134|NCT04317690|75992500|FG003|NOT COMPLETED|Overall Study||2||
59868135|NCT04317690|75992501|FG004|NOT COMPLETED|Overall Study||0||
59868136|NCT04368910|75992515|FG000|STARTED|Overall Study||15||
59868137|NCT04368910|75992516|FG001|STARTED|Overall Study||15||
59868138|NCT04368910|75992515|FG000|COMPLETED|Overall Study||15||
59868139|NCT04368910|75992516|FG001|COMPLETED|Overall Study||15||
59868140|NCT04368910|75992515|FG000|NOT COMPLETED|Overall Study||0||
59868141|NCT04368910|75992516|FG001|NOT COMPLETED|Overall Study||0||
59868142|NCT03781726|75992522|FG000|STARTED|Overall Study||30||
59868143|NCT03781726|75992522|FG000|COMPLETED|Overall Study||28||
59868144|NCT03781726|75992522|FG000|NOT COMPLETED|Overall Study||2||
59868145|NCT03721276|75992528|FG000|STARTED|Overall Study||30||
59868146|NCT03721276|75992529|FG001|STARTED|Overall Study||30||
59868147|NCT03721276|75992528|FG000|Three-month Pre-intervention|Overall Study|Participants in this arm started therapy immediately after randomization, and therefore, did not have a three-month waiting period prior to receiving the intervention.|0||
59868148|NCT03721276|75992529|FG001|Three-month Pre-intervention|Overall Study||30||
59868149|NCT03721276|75992528|FG000|Immediate Pre-intervention|Overall Study||30||
59868150|NCT03721276|75992529|FG001|Immediate Pre-intervention|Overall Study||29||
59868151|NCT03721276|75992528|FG000|Post-intervention|Overall Study||25||
59868152|NCT03721276|75992529|FG001|Post-intervention|Overall Study||26||
59868153|NCT03721276|75992528|FG000|Three-month Follow-up (Post Intervention)|Overall Study||25||
59868154|NCT03721276|75992529|FG001|Three-month Follow-up (Post Intervention)|Overall Study|Participants in this arm started therapy three months after randomization (waitlist) and therefore, were not assessed at the three-month follow-up time point due to completion of the study|0||
59868155|NCT03721276|75992528|FG000|COMPLETED|Overall Study||25||
59868156|NCT03721276|75992529|FG001|COMPLETED|Overall Study||26||
59868157|NCT03721276|75992528|FG000|NOT COMPLETED|Overall Study||5||
59868158|NCT03721276|75992529|FG001|NOT COMPLETED|Overall Study||4||
59868159|NCT03311854|75992535|FG000|STARTED|Overall Study||14||
59868160|NCT03311854|75992535|FG000|COMPLETED|Overall Study||14||
59868161|NCT03311854|75992535|FG000|NOT COMPLETED|Overall Study||0||
59868162|NCT03269344|75992544|FG000|STARTED|Overall Study||33||
59868163|NCT03269344|75992545|FG001|STARTED|Overall Study||32||
59868164|NCT03269344|75992544|FG000|COMPLETED|Overall Study||29||
59868165|NCT03269344|75992545|FG001|COMPLETED|Overall Study||29||
59868166|NCT03269344|75992544|FG000|NOT COMPLETED|Overall Study||4||
59868167|NCT03269344|75992545|FG001|NOT COMPLETED|Overall Study||3||
59868168|NCT04389840|75992557|FG000|STARTED|Overall Study||6||
59868169|NCT04389840|75992558|FG001|STARTED|Overall Study||6||
59868170|NCT04389840|75992559|FG002|STARTED|Overall Study||8||
59868171|NCT04389840|75992560|FG003|STARTED|Overall Study||4||
59868172|NCT04389840|75992561|FG004|STARTED|Overall Study||2||
59868173|NCT04389840|75992562|FG005|STARTED|Overall Study||1||
59868174|NCT04389840|75992557|FG000|Intent-to-Treat Analysis Set|Overall Study||6||
59868175|NCT04389840|75992558|FG001|Intent-to-Treat Analysis Set|Overall Study||6||
59868176|NCT04389840|75992559|FG002|Intent-to-Treat Analysis Set|Overall Study||8||
59868177|NCT04389840|75992560|FG003|Intent-to-Treat Analysis Set|Overall Study||4||
59868178|NCT04389840|75992561|FG004|Intent-to-Treat Analysis Set|Overall Study||2||
59868179|NCT04389840|75992562|FG005|Intent-to-Treat Analysis Set|Overall Study||1||
59868180|NCT04389840|75992557|FG000|Safety Analysis Set|Overall Study||6||
59868181|NCT04389840|75992558|FG001|Safety Analysis Set|Overall Study||6||
59868182|NCT04389840|75992559|FG002|Safety Analysis Set|Overall Study||8||
59868183|NCT04389840|75992560|FG003|Safety Analysis Set|Overall Study|The excluded subject was randomized to receive placebo but never received treatment due to consent withdrawal.|3||
59868184|NCT04389840|75992561|FG004|Safety Analysis Set|Overall Study||2||
59868185|NCT04389840|75992562|FG005|Safety Analysis Set|Overall Study||1||
59868186|NCT04389840|75992557|FG000|COMPLETED|Overall Study||4||
59868187|NCT04389840|75992558|FG001|COMPLETED|Overall Study||5||
59868188|NCT04389840|75992559|FG002|COMPLETED|Overall Study||8||
59868189|NCT04389840|75992560|FG003|COMPLETED|Overall Study||3||
59868190|NCT04389840|75992561|FG004|COMPLETED|Overall Study||1||
59868191|NCT04389840|75992562|FG005|COMPLETED|Overall Study||1||
59868192|NCT04389840|75992557|FG000|NOT COMPLETED|Overall Study||2||
59868193|NCT04389840|75992558|FG001|NOT COMPLETED|Overall Study||1||
59868194|NCT04389840|75992559|FG002|NOT COMPLETED|Overall Study||0||
59868195|NCT04389840|75992560|FG003|NOT COMPLETED|Overall Study||1||
59868196|NCT04389840|75992561|FG004|NOT COMPLETED|Overall Study||1||
59868197|NCT04389840|75992562|FG005|NOT COMPLETED|Overall Study||0||
59868198|NCT02933944|75992576|FG000|STARTED|Overall Study||6||
59868199|NCT02933944|75992576|FG000|COMPLETED|Overall Study||6||
59868200|NCT02933944|75992576|FG000|NOT COMPLETED|Overall Study||0||
59868201|NCT04307940|75992585|FG000|STARTED|Overall Study||90||
59868202|NCT04307940|75992586|FG001|STARTED|Overall Study||87||
59868203|NCT04307940|75992587|FG002|STARTED|Overall Study||44||
59868204|NCT04307940|75992585|FG000|COMPLETED|Overall Study||85||
59868205|NCT04307940|75992586|FG001|COMPLETED|Overall Study||84||
59868206|NCT04307940|75992587|FG002|COMPLETED|Overall Study||42||
59868207|NCT04307940|75992585|FG000|NOT COMPLETED|Overall Study||5||
59868208|NCT04307940|75992586|FG001|NOT COMPLETED|Overall Study||3||
59868209|NCT04307940|75992587|FG002|NOT COMPLETED|Overall Study||2||
59868210|NCT02054104|75992597|FG000|STARTED|Overall Study||10||
59868211|NCT02054104|75992598|FG001|STARTED|Overall Study||11||
59868212|NCT02054104|75992597|FG000|COMPLETED|Overall Study||2||
59868213|NCT02054104|75992598|FG001|COMPLETED|Overall Study||2||
59868214|NCT02054104|75992597|FG000|NOT COMPLETED|Overall Study||8||
59868215|NCT02054104|75992598|FG001|NOT COMPLETED|Overall Study||9||
59868216|NCT04090242|75992606|FG000|STARTED|Overall Study||28||
59868217|NCT04090242|75992607|FG001|STARTED|Overall Study||30||
59868218|NCT04090242|75992606|FG000|COMPLETED|Overall Study||27||
59868219|NCT04090242|75992607|FG001|COMPLETED|Overall Study||30||
59868220|NCT04090242|75992606|FG000|NOT COMPLETED|Overall Study||1||
59868221|NCT04090242|75992607|FG001|NOT COMPLETED|Overall Study||0||
59868222|NCT04090164|75992616|FG000|STARTED|Overall Study|Number of patients retrivied from the hospital files.|650||
59868223|NCT04090164|75992617|FG001|STARTED|Overall Study||145||
59868224|NCT04090164|75992616|FG000|COMPLETED|Overall Study|Number of patients analyzed.|405||
59868225|NCT04090164|75992617|FG001|COMPLETED|Overall Study||145||
59868226|NCT04090164|75992616|FG000|NOT COMPLETED|Overall Study||245||
59868227|NCT04090164|75992617|FG001|NOT COMPLETED|Overall Study||0||
59868228|NCT04068142|75992626|FG000|STARTED|Overall Study||17||
59868229|NCT04068142|75992627|FG001|STARTED|Overall Study||20||
59868230|NCT04068142|75992626|FG000|COMPLETED|Overall Study||15||
59868231|NCT04068142|75992627|FG001|COMPLETED|Overall Study||16||
59868232|NCT04068142|75992626|FG000|NOT COMPLETED|Overall Study||2||
59868233|NCT04068142|75992627|FG001|NOT COMPLETED|Overall Study||4||
59868234|NCT04292730|75992637|FG000|STARTED|Overall Study||199||
59868235|NCT04292730|75992638|FG001|STARTED|Overall Study||197||
59868236|NCT04292730|75992639|FG002|STARTED|Overall Study||200||
59868237|NCT04292730|75992640|FG003|STARTED|Overall Study||517||
59868238|NCT04292730|75992637|FG000|COMPLETED|Overall Study||179||
59868239|NCT04292730|75992638|FG001|COMPLETED|Overall Study||176||
59868240|NCT04292730|75992639|FG002|COMPLETED|Overall Study||178||
59868241|NCT04292730|75992640|FG003|COMPLETED|Overall Study||437||
59868242|NCT04292730|75992637|FG000|NOT COMPLETED|Overall Study||20||
59868243|NCT04292730|75992638|FG001|NOT COMPLETED|Overall Study||21||
59868244|NCT04292730|75992639|FG002|NOT COMPLETED|Overall Study||22||
59868245|NCT04292730|75992640|FG003|NOT COMPLETED|Overall Study||80||
59868246|NCT02861014|75992649|FG000|STARTED|Primary Analysis||680||
59868247|NCT02861014|75992649|FG000|COMPLETED|Primary Analysis||641||
59868248|NCT02861014|75992649|FG000|NOT COMPLETED|Primary Analysis||39||
59868249|NCT02861014|75992649|FG000|STARTED|Safety Follow-up||64||
59868250|NCT02861014|75992649|FG000|COMPLETED|Safety Follow-up||14||
59868251|NCT02861014|75992649|FG000|NOT COMPLETED|Safety Follow-up||50||
59868252|NCT04382586|75992657|FG000|STARTED|Overall Study||30||
59868253|NCT04382586|75992658|FG001|STARTED|Overall Study||33||
59868254|NCT04382586|75992657|FG000|COMPLETED|Overall Study||13||
59868255|NCT04382586|75992658|FG001|COMPLETED|Overall Study||17||
59868256|NCT04382586|75992657|FG000|NOT COMPLETED|Overall Study||17||
59868257|NCT04382586|75992658|FG001|NOT COMPLETED|Overall Study||16||
59868258|NCT04480710|75992668|FG000|STARTED|Overall Study||6||
59868259|NCT04480710|75992669|FG001|STARTED|Overall Study||15||
59868260|NCT04480710|75992670|FG002|STARTED|Overall Study||9||
59868261|NCT04480710|75992671|FG003|STARTED|Overall Study||17||
59868262|NCT04480710|75992668|FG000|COMPLETED|Overall Study||6||
59868263|NCT04480710|75992669|FG001|COMPLETED|Overall Study||12||
59868264|NCT04480710|75992670|FG002|COMPLETED|Overall Study||8||
59868265|NCT04480710|75992671|FG003|COMPLETED|Overall Study||17||
59868266|NCT04480710|75992668|FG000|NOT COMPLETED|Overall Study||0||
59868267|NCT04480710|75992669|FG001|NOT COMPLETED|Overall Study||3||
59868268|NCT04480710|75992670|FG002|NOT COMPLETED|Overall Study||1||
59868269|NCT04480710|75992671|FG003|NOT COMPLETED|Overall Study||0||
59868270|NCT04268316|75992690|FG000|STARTED|Overall Study||5||
59868271|NCT04268316|75992691|FG001|STARTED|Overall Study||4||
59868272|NCT04268316|75992692|FG002|STARTED|Overall Study||4||
59868273|NCT04268316|75992690|FG000|COMPLETED|Overall Study||3||
59868274|NCT04268316|75992691|FG001|COMPLETED|Overall Study||3||
59868275|NCT04268316|75992692|FG002|COMPLETED|Overall Study||4||
59868276|NCT04268316|75992690|FG000|NOT COMPLETED|Overall Study||2||
59868277|NCT04268316|75992691|FG001|NOT COMPLETED|Overall Study||1||
59868278|NCT04268316|75992692|FG002|NOT COMPLETED|Overall Study||0||
59868279|NCT01971970|75992702|FG000|STARTED|Baseline Until Week 6||24||
59868280|NCT01971970|75992703|FG001|STARTED|Baseline Until Week 6||21||
59868281|NCT01971970|75992702|FG000|Receiving Standard Therapy|Baseline Until Week 6||23||
59868282|NCT01971970|75992703|FG001|Receiving Standard Therapy|Baseline Until Week 6||21||
59868283|NCT01971970|75992702|FG000|Therapy Escalation|Baseline Until Week 6||1|Therapy escalation defined as either increasing anti-TNF dose or shortening interval between doses|
59868284|NCT01971970|75992703|FG001|Therapy Escalation|Baseline Until Week 6||0|Therapy escalation defined as either increasing anti-TNF dose or shortening interval between doses|
59868285|NCT01971970|75992702|FG000|COMPLETED|Baseline Until Week 6||23||
59868286|NCT01971970|75992703|FG001|COMPLETED|Baseline Until Week 6||21||
59868287|NCT01971970|75992702|FG000|NOT COMPLETED|Baseline Until Week 6||1||
59868288|NCT01971970|75992703|FG001|NOT COMPLETED|Baseline Until Week 6||0||
59868289|NCT01971970|75992702|FG000|STARTED|Week 6 Until Week 8||23||
59868290|NCT01971970|75992703|FG001|STARTED|Week 6 Until Week 8||21||
59868291|NCT01971970|75992702|FG000|Receiving Standard Therapy|Week 6 Until Week 8||23||
59868292|NCT01971970|75992703|FG001|Receiving Standard Therapy|Week 6 Until Week 8||20||
59868293|NCT01971970|75992702|FG000|COMPLETED|Week 6 Until Week 8||23||
59868294|NCT01971970|75992703|FG001|COMPLETED|Week 6 Until Week 8||20||
59868295|NCT01971970|75992702|FG000|NOT COMPLETED|Week 6 Until Week 8||0||
59868296|NCT01971970|75992703|FG001|NOT COMPLETED|Week 6 Until Week 8||1||
59868297|NCT01971970|75992702|FG000|STARTED|Week 8 Until Week 14||23||
59868298|NCT01971970|75992703|FG001|STARTED|Week 8 Until Week 14||20||
59868299|NCT01971970|75992702|FG000|Receiving Standard Therapy|Week 8 Until Week 14||16||
59868300|NCT01971970|75992703|FG001|Receiving Standard Therapy|Week 8 Until Week 14||19||
59868301|NCT01971970|75992702|FG000|Therapy Escalation|Week 8 Until Week 14||7|Therapy escalation defined as either increasing anti-TNF dose or shortening interval between doses|
59868302|NCT01971970|75992703|FG001|Therapy Escalation|Week 8 Until Week 14||1|Therapy escalation defined as either increasing anti-TNF dose or shortening interval between doses|
59868303|NCT01971970|75992702|FG000|COMPLETED|Week 8 Until Week 14||23||
59868304|NCT01971970|75992703|FG001|COMPLETED|Week 8 Until Week 14||20||
59868305|NCT01971970|75992702|FG000|NOT COMPLETED|Week 8 Until Week 14||0||
59868306|NCT01971970|75992703|FG001|NOT COMPLETED|Week 8 Until Week 14||0||
59868307|NCT01971970|75992702|FG000|STARTED|Week 14 Until Week 22||23||
59868308|NCT01971970|75992703|FG001|STARTED|Week 14 Until Week 22||20||
59868309|NCT01971970|75992702|FG000|Receiving Standard Therapy|Week 14 Until Week 22||12||
59868310|NCT01971970|75992703|FG001|Receiving Standard Therapy|Week 14 Until Week 22||16||
59868311|NCT01971970|75992702|FG000|Therapy Escalation|Week 14 Until Week 22||3|Therapy escalation defined as either increasing anti-TNF dose or shortening interval between doses|
59868312|NCT01971970|75992703|FG001|Therapy Escalation|Week 14 Until Week 22||2|Therapy escalation defined as either increasing anti-TNF dose or shortening interval between doses|
59868313|NCT01971970|75992702|FG000|COMPLETED|Week 14 Until Week 22||23||
59868314|NCT01971970|75992703|FG001|COMPLETED|Week 14 Until Week 22||19||
59868315|NCT01971970|75992702|FG000|NOT COMPLETED|Week 14 Until Week 22||0||
59868316|NCT01971970|75992703|FG001|NOT COMPLETED|Week 14 Until Week 22||1||
59868317|NCT01971970|75992702|FG000|STARTED|Week 22 Until Week 52||23||
59868318|NCT01971970|75992703|FG001|STARTED|Week 22 Until Week 52||19||
59868319|NCT01971970|75992702|FG000|Receiving Standard Therapy|Week 22 Until Week 52||5|Therapy escalation defined as either increasing anti-TNF dose or shortening interval between doses|
59868320|NCT01971970|75992703|FG001|Receiving Standard Therapy|Week 22 Until Week 52||9|Therapy escalation defined as either increasing anti-TNF dose or shortening interval between doses|
59868321|NCT01971970|75992702|FG000|Therapy Escalation|Week 22 Until Week 52||6|Therapy escalation defined as either increasing anti-TNF dose or shortening interval between doses|
59868322|NCT01971970|75992703|FG001|Therapy Escalation|Week 22 Until Week 52||6|Therapy escalation defined as either increasing anti-TNF dose or shortening interval between doses|
59868323|NCT01971970|75992702|FG000|COMPLETED|Week 22 Until Week 52||15||
59868324|NCT01971970|75992703|FG001|COMPLETED|Week 22 Until Week 52||15||
59868325|NCT01971970|75992702|FG000|NOT COMPLETED|Week 22 Until Week 52||8||
59868326|NCT01971970|75992703|FG001|NOT COMPLETED|Week 22 Until Week 52||4||
59868327|NCT01971970|75992702|FG000|STARTED|Week 52 Until Week 78||15||
59868328|NCT01971970|75992703|FG001|STARTED|Week 52 Until Week 78||15||
59868329|NCT01971970|75992702|FG000|COMPLETED|Week 52 Until Week 78||14||
59868330|NCT01971970|75992703|FG001|COMPLETED|Week 52 Until Week 78||12||
59868331|NCT01971970|75992702|FG000|NOT COMPLETED|Week 52 Until Week 78||1||
59868332|NCT01971970|75992703|FG001|NOT COMPLETED|Week 52 Until Week 78||3||
59868333|NCT04079790|75992718|FG000|STARTED|Part 1, Period 1(Day 1 to Day 4)||14||
59868334|NCT04079790|75992719|FG001|STARTED|Part 1, Period 1(Day 1 to Day 4)||2||
59868335|NCT04079790|75992720|FG002|STARTED|Part 1, Period 1(Day 1 to Day 4)||0||
59868336|NCT04079790|75992721|FG003|STARTED|Part 1, Period 1(Day 1 to Day 4)||0||
59868337|NCT04079790|75992718|FG000|COMPLETED|Part 1, Period 1(Day 1 to Day 4)||13||
59868338|NCT04079790|75992719|FG001|COMPLETED|Part 1, Period 1(Day 1 to Day 4)||2||
59868339|NCT04079790|75992720|FG002|COMPLETED|Part 1, Period 1(Day 1 to Day 4)||0||
59868340|NCT04079790|75992721|FG003|COMPLETED|Part 1, Period 1(Day 1 to Day 4)||0||
59868341|NCT04079790|75992718|FG000|NOT COMPLETED|Part 1, Period 1(Day 1 to Day 4)||1||
59868342|NCT04079790|75992719|FG001|NOT COMPLETED|Part 1, Period 1(Day 1 to Day 4)||0||
59868343|NCT04079790|75992720|FG002|NOT COMPLETED|Part 1, Period 1(Day 1 to Day 4)||0||
59868344|NCT04079790|75992721|FG003|NOT COMPLETED|Part 1, Period 1(Day 1 to Day 4)||0||
59868345|NCT04079790|75992718|FG000|STARTED|Part 1, Period 2 (Day 5 to Day 8)||13||
59868346|NCT04079790|75992719|FG001|STARTED|Part 1, Period 2 (Day 5 to Day 8)||2||
59868347|NCT04079790|75992720|FG002|STARTED|Part 1, Period 2 (Day 5 to Day 8)||0||
59868348|NCT04079790|75992721|FG003|STARTED|Part 1, Period 2 (Day 5 to Day 8)||0||
59868349|NCT04079790|75992718|FG000|COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||13||
59868350|NCT04079790|75992719|FG001|COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||2||
59868351|NCT04079790|75992720|FG002|COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||0||
59868352|NCT04079790|75992721|FG003|COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||0||
59868353|NCT04079790|75992718|FG000|NOT COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||0||
59868354|NCT04079790|75992719|FG001|NOT COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||0||
59951244|NCT03743415|76070175|FG000|COMPLETED|Overall Study||158||
59868355|NCT04079790|75992720|FG002|NOT COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||0||
59868356|NCT04079790|75992721|FG003|NOT COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||0||
59868357|NCT04079790|75992718|FG000|STARTED|Part 1, Period 3 (Day 9 to Day 11)||13||
59868358|NCT04079790|75992719|FG001|STARTED|Part 1, Period 3 (Day 9 to Day 11)||2||
59868359|NCT04079790|75992720|FG002|STARTED|Part 1, Period 3 (Day 9 to Day 11)||0||
59868360|NCT04079790|75992721|FG003|STARTED|Part 1, Period 3 (Day 9 to Day 11)||0||
59868361|NCT04079790|75992718|FG000|COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||13||
59868362|NCT04079790|75992719|FG001|COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||2||
59868363|NCT04079790|75992720|FG002|COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||0||
59868364|NCT04079790|75992721|FG003|COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||0||
59868365|NCT04079790|75992718|FG000|NOT COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||0||
59868366|NCT04079790|75992719|FG001|NOT COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||0||
59868367|NCT04079790|75992720|FG002|NOT COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||0||
59868368|NCT04079790|75992721|FG003|NOT COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||0||
59868369|NCT04079790|75992718|FG000|STARTED|Part 2, Period 1 (Day 1 to Day 3)||0||
59868370|NCT04079790|75992719|FG001|STARTED|Part 2, Period 1 (Day 1 to Day 3)||0||
59868371|NCT04079790|75992720|FG002|STARTED|Part 2, Period 1 (Day 1 to Day 3)||15||
59868372|NCT04079790|75992721|FG003|STARTED|Part 2, Period 1 (Day 1 to Day 3)||3||
59868373|NCT04079790|75992718|FG000|COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||0||
59868374|NCT04079790|75992719|FG001|COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||0||
59868375|NCT04079790|75992720|FG002|COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||12||
59868376|NCT04079790|75992721|FG003|COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||3||
59868377|NCT04079790|75992718|FG000|NOT COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||0||
59868378|NCT04079790|75992719|FG001|NOT COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||0||
59868379|NCT04079790|75992720|FG002|NOT COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||3||
59868380|NCT04079790|75992721|FG003|NOT COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||0||
59868381|NCT04079790|75992718|FG000|STARTED|Part 2, Period 2 (Day 1 to Day 3)||0||
59868382|NCT04079790|75992719|FG001|STARTED|Part 2, Period 2 (Day 1 to Day 3)||0||
59868383|NCT04079790|75992720|FG002|STARTED|Part 2, Period 2 (Day 1 to Day 3)||12||
59868384|NCT04079790|75992721|FG003|STARTED|Part 2, Period 2 (Day 1 to Day 3)||3||
59868385|NCT04079790|75992718|FG000|COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||0||
59868386|NCT04079790|75992719|FG001|COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||0||
59868387|NCT04079790|75992720|FG002|COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||12||
59868388|NCT04079790|75992721|FG003|COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||3||
59868389|NCT04079790|75992718|FG000|NOT COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||0||
59868390|NCT04079790|75992719|FG001|NOT COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||0||
59868391|NCT04079790|75992720|FG002|NOT COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||0||
59868392|NCT04079790|75992721|FG003|NOT COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||0||
59868393|NCT04259346|75992749|FG000|STARTED|Overall Study||126||
59868394|NCT04259346|75992750|FG001|STARTED|Overall Study||119||
59868395|NCT04259346|75992749|FG000|Received at Least One Dose of Study Drug|Overall Study||126||
59868396|NCT04259346|75992750|FG001|Received at Least One Dose of Study Drug|Overall Study||119||
59868397|NCT04259346|75992749|FG000|COMPLETED|Overall Study||122||
59868398|NCT04259346|75992750|FG001|COMPLETED|Overall Study||115||
59868399|NCT04259346|75992749|FG000|NOT COMPLETED|Overall Study||4||
59868400|NCT04259346|75992750|FG001|NOT COMPLETED|Overall Study||4||
59868401|NCT04230876|75992758|FG000|STARTED|Overall Study||15||
59868402|NCT04230876|75992759|FG001|STARTED|Overall Study||15||
59868403|NCT04230876|75992758|FG000|COMPLETED|Overall Study||14||
59868404|NCT04230876|75992759|FG001|COMPLETED|Overall Study||14||
59868405|NCT04230876|75992758|FG000|NOT COMPLETED|Overall Study||1||
59868406|NCT04230876|75992759|FG001|NOT COMPLETED|Overall Study||1||
59868407|NCT04228302|75992771|FG000|STARTED|Overall Study||6||
59868408|NCT04228302|75992772|FG001|STARTED|Overall Study||6||
59868409|NCT04228302|75992773|FG002|STARTED|Overall Study||6||
59868410|NCT04228302|75992774|FG003|STARTED|Overall Study||6||
59868411|NCT04228302|75992775|FG004|STARTED|Overall Study||6||
59868412|NCT04228302|75992776|FG005|STARTED|Overall Study||10||
59868413|NCT04228302|75992771|FG000|COMPLETED|Overall Study||6||
59868414|NCT04228302|75992772|FG001|COMPLETED|Overall Study||6||
59868415|NCT04228302|75992773|FG002|COMPLETED|Overall Study||6||
59868416|NCT04228302|75992774|FG003|COMPLETED|Overall Study||6||
59868417|NCT04228302|75992775|FG004|COMPLETED|Overall Study||5||
59868418|NCT04228302|75992776|FG005|COMPLETED|Overall Study||10||
59868419|NCT04228302|75992771|FG000|NOT COMPLETED|Overall Study||0||
59868420|NCT04228302|75992772|FG001|NOT COMPLETED|Overall Study||0||
59868421|NCT04228302|75992773|FG002|NOT COMPLETED|Overall Study||0||
59868422|NCT04228302|75992774|FG003|NOT COMPLETED|Overall Study||0||
59868423|NCT04228302|75992775|FG004|NOT COMPLETED|Overall Study||1||
59868424|NCT04228302|75992776|FG005|NOT COMPLETED|Overall Study||0||
59868425|NCT01348100|75992797|FG000|STARTED|Overall Study||2||
59868426|NCT01348100|75992798|FG001|STARTED|Overall Study||2||
59868427|NCT01348100|75992799|FG002|STARTED|Overall Study||15||
59868428|NCT01348100|75992800|FG003|STARTED|Overall Study||15||
59868429|NCT01348100|75992801|FG004|STARTED|Overall Study||15||
59868430|NCT01348100|75992802|FG005|STARTED|Overall Study||16||
59868431|NCT01348100|75992803|FG006|STARTED|Overall Study||16||
59868432|NCT01348100|75992797|FG000|COMPLETED|Overall Study||2||
59868433|NCT01348100|75992798|FG001|COMPLETED|Overall Study||2||
59868434|NCT01348100|75992799|FG002|COMPLETED|Overall Study||13||
59868435|NCT01348100|75992800|FG003|COMPLETED|Overall Study||14||
59868436|NCT01348100|75992801|FG004|COMPLETED|Overall Study||14||
59868437|NCT01348100|75992802|FG005|COMPLETED|Overall Study||14||
59868438|NCT01348100|75992803|FG006|COMPLETED|Overall Study||13||
59868439|NCT01348100|75992797|FG000|NOT COMPLETED|Overall Study||0||
59868440|NCT01348100|75992798|FG001|NOT COMPLETED|Overall Study||0||
59868441|NCT01348100|75992799|FG002|NOT COMPLETED|Overall Study||2||
59868442|NCT01348100|75992800|FG003|NOT COMPLETED|Overall Study||1||
59868443|NCT01348100|75992801|FG004|NOT COMPLETED|Overall Study||1||
59868444|NCT01348100|75992802|FG005|NOT COMPLETED|Overall Study||2||
59868445|NCT01348100|75992803|FG006|NOT COMPLETED|Overall Study||3||
59868446|NCT03676634|75992824|FG000|STARTED|Overall Study||32||
59868447|NCT03676634|75992824|FG000|Screening|Overall Study||32||
59868448|NCT03676634|75992824|FG000|Participants Received rBV A/B Injection|Overall Study||32||
59868449|NCT03676634|75992824|FG000|Participants Included in the Plasma-donating Population|Overall Study||32||
59868450|NCT03676634|75992824|FG000|Participants Completed Follow up|Overall Study||32||
59868451|NCT03676634|75992824|FG000|COMPLETED|Overall Study||29||
59868452|NCT03676634|75992824|FG000|NOT COMPLETED|Overall Study||3||
59868453|NCT03675776|75992831|FG000|STARTED|Double Blind Treatment Period||15||
59868454|NCT03675776|75992832|FG001|STARTED|Double Blind Treatment Period||17||
59868455|NCT03675776|75992833|FG002|STARTED|Double Blind Treatment Period||18||
59868456|NCT03675776|75992831|FG000|COMPLETED|Double Blind Treatment Period||9||
59868457|NCT03675776|75992832|FG001|COMPLETED|Double Blind Treatment Period||11||
59868458|NCT03675776|75992833|FG002|COMPLETED|Double Blind Treatment Period||10||
59868459|NCT03675776|75992831|FG000|NOT COMPLETED|Double Blind Treatment Period||6||
59868460|NCT03675776|75992832|FG001|NOT COMPLETED|Double Blind Treatment Period||6||
59868461|NCT03675776|75992833|FG002|NOT COMPLETED|Double Blind Treatment Period||8||
59868462|NCT03675776|75992831|FG000|STARTED|Safety Follow-up Period||6||
59868463|NCT03675776|75992832|FG001|STARTED|Safety Follow-up Period||8||
59868464|NCT03675776|75992833|FG002|STARTED|Safety Follow-up Period||7||
59868465|NCT03675776|75992831|FG000|COMPLETED|Safety Follow-up Period||6||
59868466|NCT03675776|75992832|FG001|COMPLETED|Safety Follow-up Period||8||
59868467|NCT03675776|75992833|FG002|COMPLETED|Safety Follow-up Period||7||
59868468|NCT03675776|75992831|FG000|NOT COMPLETED|Safety Follow-up Period||0||
59868469|NCT03675776|75992832|FG001|NOT COMPLETED|Safety Follow-up Period||0||
59868470|NCT03675776|75992833|FG002|NOT COMPLETED|Safety Follow-up Period||0||
59868471|NCT03673670|75992847|FG000|STARTED|Treatment Period 1 (3 Days)||14||
59868472|NCT03673670|75992848|FG001|STARTED|Treatment Period 1 (3 Days)||14||
59868473|NCT03673670|75992849|FG002|STARTED|Treatment Period 1 (3 Days)||13||
59868474|NCT03673670|75992850|FG003|STARTED|Treatment Period 1 (3 Days)||12||
59868475|NCT03673670|75992851|FG004|STARTED|Treatment Period 1 (3 Days)||13||
59868476|NCT03673670|75992852|FG005|STARTED|Treatment Period 1 (3 Days)||13||
59868477|NCT03673670|75992847|FG000|COMPLETED|Treatment Period 1 (3 Days)||13||
59868478|NCT03673670|75992848|FG001|COMPLETED|Treatment Period 1 (3 Days)||14||
59868479|NCT03673670|75992849|FG002|COMPLETED|Treatment Period 1 (3 Days)||12||
59868480|NCT03673670|75992850|FG003|COMPLETED|Treatment Period 1 (3 Days)||12||
59868481|NCT03673670|75992851|FG004|COMPLETED|Treatment Period 1 (3 Days)||13||
59868482|NCT03673670|75992852|FG005|COMPLETED|Treatment Period 1 (3 Days)||11||
59868483|NCT03673670|75992847|FG000|NOT COMPLETED|Treatment Period 1 (3 Days)||1||
59868484|NCT03673670|75992848|FG001|NOT COMPLETED|Treatment Period 1 (3 Days)||0||
59868485|NCT03673670|75992849|FG002|NOT COMPLETED|Treatment Period 1 (3 Days)||1||
59868486|NCT03673670|75992850|FG003|NOT COMPLETED|Treatment Period 1 (3 Days)||0||
59868487|NCT03673670|75992851|FG004|NOT COMPLETED|Treatment Period 1 (3 Days)||0||
59868488|NCT03673670|75992852|FG005|NOT COMPLETED|Treatment Period 1 (3 Days)||2||
59868489|NCT03673670|75992847|FG000|STARTED|Washout Period 1 (7-14 Days)||13||
59868490|NCT03673670|75992848|FG001|STARTED|Washout Period 1 (7-14 Days)||14||
59868491|NCT03673670|75992849|FG002|STARTED|Washout Period 1 (7-14 Days)||12||
59868492|NCT03673670|75992850|FG003|STARTED|Washout Period 1 (7-14 Days)||12||
59868493|NCT03673670|75992851|FG004|STARTED|Washout Period 1 (7-14 Days)||13||
59868494|NCT03673670|75992852|FG005|STARTED|Washout Period 1 (7-14 Days)||11||
59868495|NCT03673670|75992847|FG000|COMPLETED|Washout Period 1 (7-14 Days)||13||
59868496|NCT03673670|75992848|FG001|COMPLETED|Washout Period 1 (7-14 Days)||14||
59868497|NCT03673670|75992849|FG002|COMPLETED|Washout Period 1 (7-14 Days)||12||
59868498|NCT03673670|75992850|FG003|COMPLETED|Washout Period 1 (7-14 Days)||12||
59868499|NCT03673670|75992851|FG004|COMPLETED|Washout Period 1 (7-14 Days)||13||
59868500|NCT03673670|75992852|FG005|COMPLETED|Washout Period 1 (7-14 Days)||11||
59868501|NCT03673670|75992847|FG000|NOT COMPLETED|Washout Period 1 (7-14 Days)||0||
59868502|NCT03673670|75992848|FG001|NOT COMPLETED|Washout Period 1 (7-14 Days)||0||
59868503|NCT03673670|75992849|FG002|NOT COMPLETED|Washout Period 1 (7-14 Days)||0||
59868504|NCT03673670|75992850|FG003|NOT COMPLETED|Washout Period 1 (7-14 Days)||0||
59868505|NCT03673670|75992851|FG004|NOT COMPLETED|Washout Period 1 (7-14 Days)||0||
59868506|NCT03673670|75992852|FG005|NOT COMPLETED|Washout Period 1 (7-14 Days)||0||
59868507|NCT03673670|75992847|FG000|STARTED|Treatment Period 2 (3 Days)||13||
59868508|NCT03673670|75992848|FG001|STARTED|Treatment Period 2 (3 Days)||14||
59868509|NCT03673670|75992849|FG002|STARTED|Treatment Period 2 (3 Days)||12||
59868510|NCT03673670|75992850|FG003|STARTED|Treatment Period 2 (3 Days)||12||
59868511|NCT03673670|75992851|FG004|STARTED|Treatment Period 2 (3 Days)||13||
59868512|NCT03673670|75992852|FG005|STARTED|Treatment Period 2 (3 Days)||11||
59868513|NCT03673670|75992847|FG000|COMPLETED|Treatment Period 2 (3 Days)||13||
59868514|NCT03673670|75992848|FG001|COMPLETED|Treatment Period 2 (3 Days)||14||
59868515|NCT03673670|75992849|FG002|COMPLETED|Treatment Period 2 (3 Days)||11||
59868516|NCT03673670|75992850|FG003|COMPLETED|Treatment Period 2 (3 Days)||12||
59868517|NCT03673670|75992851|FG004|COMPLETED|Treatment Period 2 (3 Days)||12||
59868518|NCT03673670|75992852|FG005|COMPLETED|Treatment Period 2 (3 Days)||11||
59868519|NCT03673670|75992847|FG000|NOT COMPLETED|Treatment Period 2 (3 Days)||0||
59868520|NCT03673670|75992848|FG001|NOT COMPLETED|Treatment Period 2 (3 Days)||0||
59868521|NCT03673670|75992849|FG002|NOT COMPLETED|Treatment Period 2 (3 Days)||1||
59868522|NCT03673670|75992850|FG003|NOT COMPLETED|Treatment Period 2 (3 Days)||0||
59868523|NCT03673670|75992851|FG004|NOT COMPLETED|Treatment Period 2 (3 Days)||1||
59868524|NCT03673670|75992852|FG005|NOT COMPLETED|Treatment Period 2 (3 Days)||0||
59868525|NCT03673670|75992847|FG000|STARTED|Washout Period 2 (7-14 Days)||13||
59868526|NCT03673670|75992848|FG001|STARTED|Washout Period 2 (7-14 Days)||14||
59868527|NCT03673670|75992849|FG002|STARTED|Washout Period 2 (7-14 Days)||11||
59868528|NCT03673670|75992850|FG003|STARTED|Washout Period 2 (7-14 Days)||12||
59868529|NCT03673670|75992851|FG004|STARTED|Washout Period 2 (7-14 Days)||12||
59868530|NCT03673670|75992852|FG005|STARTED|Washout Period 2 (7-14 Days)||11||
59868531|NCT03673670|75992847|FG000|COMPLETED|Washout Period 2 (7-14 Days)||13||
59868532|NCT03673670|75992848|FG001|COMPLETED|Washout Period 2 (7-14 Days)||14||
59868533|NCT03673670|75992849|FG002|COMPLETED|Washout Period 2 (7-14 Days)||11||
59868534|NCT03673670|75992850|FG003|COMPLETED|Washout Period 2 (7-14 Days)||12||
59868535|NCT03673670|75992851|FG004|COMPLETED|Washout Period 2 (7-14 Days)||11||
59868536|NCT03673670|75992852|FG005|COMPLETED|Washout Period 2 (7-14 Days)||11||
59868537|NCT03673670|75992847|FG000|NOT COMPLETED|Washout Period 2 (7-14 Days)||0||
59868538|NCT03673670|75992848|FG001|NOT COMPLETED|Washout Period 2 (7-14 Days)||0||
59868539|NCT03673670|75992849|FG002|NOT COMPLETED|Washout Period 2 (7-14 Days)||0||
59868540|NCT03673670|75992850|FG003|NOT COMPLETED|Washout Period 2 (7-14 Days)||0||
59868541|NCT03673670|75992851|FG004|NOT COMPLETED|Washout Period 2 (7-14 Days)||1||
59868542|NCT03673670|75992852|FG005|NOT COMPLETED|Washout Period 2 (7-14 Days)||0||
59868543|NCT03673670|75992847|FG000|STARTED|Treatment Period 3 (3 Days)||13||
59868544|NCT03673670|75992848|FG001|STARTED|Treatment Period 3 (3 Days)||14||
59868545|NCT03673670|75992849|FG002|STARTED|Treatment Period 3 (3 Days)||11||
59868546|NCT03673670|75992850|FG003|STARTED|Treatment Period 3 (3 Days)||12||
59868547|NCT03673670|75992851|FG004|STARTED|Treatment Period 3 (3 Days)||11||
59868548|NCT03673670|75992852|FG005|STARTED|Treatment Period 3 (3 Days)||11||
59868549|NCT03673670|75992847|FG000|COMPLETED|Treatment Period 3 (3 Days)||13||
59868550|NCT03673670|75992848|FG001|COMPLETED|Treatment Period 3 (3 Days)||14||
59868551|NCT03673670|75992849|FG002|COMPLETED|Treatment Period 3 (3 Days)||11||
59868552|NCT03673670|75992850|FG003|COMPLETED|Treatment Period 3 (3 Days)||12||
59868553|NCT03673670|75992851|FG004|COMPLETED|Treatment Period 3 (3 Days)||10||
59868554|NCT03673670|75992852|FG005|COMPLETED|Treatment Period 3 (3 Days)||11||
59868555|NCT03673670|75992847|FG000|NOT COMPLETED|Treatment Period 3 (3 Days)||0||
59868556|NCT03673670|75992848|FG001|NOT COMPLETED|Treatment Period 3 (3 Days)||0||
59868557|NCT03673670|75992849|FG002|NOT COMPLETED|Treatment Period 3 (3 Days)||0||
59868558|NCT03673670|75992850|FG003|NOT COMPLETED|Treatment Period 3 (3 Days)||0||
59868559|NCT03673670|75992851|FG004|NOT COMPLETED|Treatment Period 3 (3 Days)||1||
59868560|NCT03673670|75992852|FG005|NOT COMPLETED|Treatment Period 3 (3 Days)||0||
59868561|NCT04369742|75992871|FG000|STARTED|Overall Study||67||
59868562|NCT04369742|75992872|FG001|STARTED|Overall Study||61||
59868563|NCT04369742|75992871|FG000|COMPLETED|Overall Study||53||
59868564|NCT04369742|75992872|FG001|COMPLETED|Overall Study||50||
59868565|NCT04369742|75992871|FG000|NOT COMPLETED|Overall Study||14||
59868566|NCT04369742|75992872|FG001|NOT COMPLETED|Overall Study||11||
59601638|NCT01895959|75711738|FG000|NOT COMPLETED|Overall Study||2||
59601639|NCT01303003|75711744|FG000|STARTED|Overall Study||0||
59601640|NCT01303003|75711745|FG001|STARTED|Overall Study||0||
59601641|NCT01303003|75711744|FG000|COMPLETED|Overall Study||0||
59868567|NCT04369430|75992880|FG000|STARTED|Overall Study||55||
59868568|NCT04369430|75992881|FG001|STARTED|Overall Study||55||
59868569|NCT04369430|75992880|FG000|COMPLETED|Overall Study||46||
59868570|NCT04369430|75992881|FG001|COMPLETED|Overall Study||47||
59868571|NCT04369430|75992880|FG000|NOT COMPLETED|Overall Study||9||
59868572|NCT04369430|75992881|FG001|NOT COMPLETED|Overall Study||8||
59868573|NCT04363736|75992889|FG000|STARTED|Overall Study||49||
59868574|NCT04363736|75992890|FG001|STARTED|Overall Study||48||
59868575|NCT04363736|75992889|FG000|COMPLETED|Overall Study||30||
59868576|NCT04363736|75992890|FG001|COMPLETED|Overall Study||35||
59868577|NCT04363736|75992889|FG000|NOT COMPLETED|Overall Study||19||
59868578|NCT04363736|75992890|FG001|NOT COMPLETED|Overall Study||13||
59868579|NCT04362176|75992898|FG000|STARTED|Overall Study||495||
59868580|NCT04362176|75992899|FG001|STARTED|Overall Study||479||
59868581|NCT04362176|75992898|FG000|COMPLETED|Overall Study||482||
59601642|NCT01303003|75711745|FG001|COMPLETED|Overall Study||0||
59868582|NCT04362176|75992899|FG001|COMPLETED|Overall Study||465||
59868583|NCT04362176|75992898|FG000|NOT COMPLETED|Overall Study||13||
59868584|NCT04362176|75992899|FG001|NOT COMPLETED|Overall Study||14||
59868585|NCT04079816|75992905|FG000|STARTED|Overall Study||29||
59868586|NCT04079816|75992905|FG000|COMPLETED|Overall Study||26||
59868587|NCT04079816|75992905|FG000|NOT COMPLETED|Overall Study||3||
59868588|NCT04079114|75992909|FG000|STARTED|Overall Study||166||
59868589|NCT04079114|75992909|FG000|COMPLETED|Overall Study|Study prematurely terminated.|0||
59868590|NCT04079114|75992909|FG000|NOT COMPLETED|Overall Study||166||
59868591|NCT03055936|75992917|FG000|STARTED|Overall Study||14||
59868592|NCT03055936|75992918|FG001|STARTED|Overall Study||14||
59868593|NCT03055936|75992919|FG002|STARTED|Overall Study||14||
59868594|NCT03055936|75992920|FG003|STARTED|Overall Study||14||
59868595|NCT03055936|75992917|FG000|COMPLETED|Overall Study||12||
59868596|NCT03055936|75992918|FG001|COMPLETED|Overall Study||13||
59868597|NCT03055936|75992919|FG002|COMPLETED|Overall Study||12||
59868598|NCT03055936|75992920|FG003|COMPLETED|Overall Study||13||
59868599|NCT03055936|75992917|FG000|NOT COMPLETED|Overall Study||2||
59868600|NCT03055936|75992918|FG001|NOT COMPLETED|Overall Study||1||
59868601|NCT03055936|75992919|FG002|NOT COMPLETED|Overall Study||2||
59868602|NCT03055936|75992920|FG003|NOT COMPLETED|Overall Study||1||
59868603|NCT03891524|75992962|FG000|STARTED|Overall Study||34||
59868604|NCT03891524|75992963|FG001|STARTED|Overall Study||150||
59868605|NCT03891524|75992964|FG002|STARTED|Overall Study||153||
59868606|NCT03891524|75992965|FG003|STARTED|Overall Study||150||
59868607|NCT03891524|75992966|FG004|STARTED|Overall Study||149||
59868608|NCT03891524|75992967|FG005|STARTED|Overall Study||152||
59868609|NCT03891524|75992968|FG006|STARTED|Overall Study||153||
59868610|NCT03891524|75992969|FG007|STARTED|Overall Study||301||
59868611|NCT03891524|75992962|FG000|Safety Analysis Set|Overall Study||33||
59868612|NCT03891524|75992963|FG001|Safety Analysis Set|Overall Study||150||
59868613|NCT03891524|75992964|FG002|Safety Analysis Set|Overall Study||148||
59868614|NCT03891524|75992965|FG003|Safety Analysis Set|Overall Study||148||
59868615|NCT03891524|75992966|FG004|Safety Analysis Set|Overall Study||147||
59868616|NCT03891524|75992967|FG005|Safety Analysis Set|Overall Study||149||
59868617|NCT03891524|75992968|FG006|Safety Analysis Set|Overall Study||148||
59868618|NCT03891524|75992969|FG007|Safety Analysis Set|Overall Study||296||
59868619|NCT03891524|75992962|FG000|COMPLETED|Overall Study||34||
59868620|NCT03891524|75992963|FG001|COMPLETED|Overall Study||149||
59868621|NCT03891524|75992964|FG002|COMPLETED|Overall Study||151||
59868622|NCT03891524|75992965|FG003|COMPLETED|Overall Study||149||
59868623|NCT03891524|75992966|FG004|COMPLETED|Overall Study||147||
59868624|NCT03891524|75992967|FG005|COMPLETED|Overall Study||150||
59868625|NCT03891524|75992968|FG006|COMPLETED|Overall Study||151||
59868626|NCT03891524|75992969|FG007|COMPLETED|Overall Study||299||
59868627|NCT03891524|75992962|FG000|NOT COMPLETED|Overall Study||0||
59868628|NCT03891524|75992963|FG001|NOT COMPLETED|Overall Study||1||
59868629|NCT03891524|75992964|FG002|NOT COMPLETED|Overall Study||2||
59868630|NCT03891524|75992965|FG003|NOT COMPLETED|Overall Study||1||
59868631|NCT03891524|75992966|FG004|NOT COMPLETED|Overall Study||2||
59868632|NCT03891524|75992967|FG005|NOT COMPLETED|Overall Study||2||
59868633|NCT03891524|75992968|FG006|NOT COMPLETED|Overall Study||2||
59868634|NCT03891524|75992969|FG007|NOT COMPLETED|Overall Study||2||
59868635|NCT03055624|75993004|FG000|STARTED|Overall Study||9|9 patients enrolled in the study and underwent the PAE procedure.|
59868636|NCT03055624|75993004|FG000|COMPLETED|Overall Study||0|The device received FDA IDE approval during the study. The study was closed at that time.|
59868637|NCT03055624|75993004|FG000|NOT COMPLETED|Overall Study||9||
59868638|NCT01346176|75993011|FG000|STARTED|Recruited||49||
59868639|NCT01346176|75993012|FG001|STARTED|Recruited||40||
59868640|NCT01346176|75993013|FG002|STARTED|Recruited||43||
59868641|NCT01346176|75993011|FG000|COMPLETED|Recruited||48||
59868642|NCT01346176|75993012|FG001|COMPLETED|Recruited||40||
59868643|NCT01346176|75993013|FG002|COMPLETED|Recruited||43||
59868644|NCT01346176|75993011|FG000|NOT COMPLETED|Recruited||1||
59868645|NCT01346176|75993012|FG001|NOT COMPLETED|Recruited||0||
59868646|NCT01346176|75993013|FG002|NOT COMPLETED|Recruited||0||
59868647|NCT01346176|75993011|FG000|STARTED|Completed Advance Directive||48||
59868648|NCT01346176|75993012|FG001|STARTED|Completed Advance Directive||40||
59868649|NCT01346176|75993013|FG002|STARTED|Completed Advance Directive||43||
59868650|NCT01346176|75993011|FG000|COMPLETED|Completed Advance Directive||35||
59868651|NCT01346176|75993012|FG001|COMPLETED|Completed Advance Directive||26||
59868652|NCT01346176|75993013|FG002|COMPLETED|Completed Advance Directive||33||
59868653|NCT01346176|75993011|FG000|NOT COMPLETED|Completed Advance Directive||13||
59868654|NCT01346176|75993012|FG001|NOT COMPLETED|Completed Advance Directive||14||
59868655|NCT01346176|75993013|FG002|NOT COMPLETED|Completed Advance Directive||10||
59868656|NCT01346176|75993011|FG000|STARTED|Completed Satisfaction Survey||35||
59868657|NCT01346176|75993012|FG001|STARTED|Completed Satisfaction Survey||26||
59868658|NCT01346176|75993013|FG002|STARTED|Completed Satisfaction Survey||33||
59868659|NCT01346176|75993011|FG000|COMPLETED|Completed Satisfaction Survey||29||
59868660|NCT01346176|75993012|FG001|COMPLETED|Completed Satisfaction Survey||22||
59868661|NCT01346176|75993013|FG002|COMPLETED|Completed Satisfaction Survey||27||
60000640|NCT02151058|76116376|FG002|NOT COMPLETED|Overall Study||5||
60000641|NCT02149810|76116386|FG000|STARTED|Overall Study||48||
59868662|NCT01346176|75993011|FG000|NOT COMPLETED|Completed Satisfaction Survey||6||
59868663|NCT01346176|75993012|FG001|NOT COMPLETED|Completed Satisfaction Survey||4||
59868664|NCT01346176|75993013|FG002|NOT COMPLETED|Completed Satisfaction Survey||6||
59868665|NCT04075604|75993024|FG000|STARTED|Overall Study||2||
59868666|NCT04075604|75993025|FG001|STARTED|Overall Study||9||
59868667|NCT04075604|75993026|FG002|STARTED|Overall Study||12||
59868668|NCT04075604|75993024|FG000|COMPLETED|Overall Study||1||
59868669|NCT04075604|75993025|FG001|COMPLETED|Overall Study||3||
59868670|NCT04075604|75993026|FG002|COMPLETED|Overall Study||6||
59868671|NCT04075604|75993024|FG000|NOT COMPLETED|Overall Study||1||
59868672|NCT04075604|75993025|FG001|NOT COMPLETED|Overall Study||6||
59868673|NCT04075604|75993026|FG002|NOT COMPLETED|Overall Study||6||
59868674|NCT03796208|75993036|FG000|STARTED|Overall Study||40||
59868675|NCT03796208|75993037|FG001|STARTED|Overall Study||38||
59868676|NCT03796208|75993036|FG000|COMPLETED|Overall Study||16||
59868677|NCT03796208|75993037|FG001|COMPLETED|Overall Study||16||
59868678|NCT03796208|75993036|FG000|NOT COMPLETED|Overall Study||24||
59868679|NCT03796208|75993037|FG001|NOT COMPLETED|Overall Study||22||
59868680|NCT01318876|75993043|FG000|STARTED|Day 8 Survey||7645||
59868681|NCT01318876|75993043|FG000|COMPLETED|Day 8 Survey||5825||
59868682|NCT01318876|75993043|FG000|NOT COMPLETED|Day 8 Survey||1820||
59868683|NCT01318876|75993043|FG000|STARTED|Day 29 Survey|All participants with a valid e-mail, have received the second survey|7549||
59868684|NCT01318876|75993043|FG000|COMPLETED|Day 29 Survey||5724||
59868685|NCT01318876|75993043|FG000|NOT COMPLETED|Day 29 Survey||1825||
59868686|NCT03668600|75993047|FG000|STARTED|Overall Study||230||
59868687|NCT03668600|75993047|FG000|COMPLETED|Overall Study||0||
59868688|NCT03668600|75993047|FG000|NOT COMPLETED|Overall Study||230||
59868689|NCT04073186|75993051|FG000|STARTED|First Wearing Cycle||86||
59868690|NCT04073186|75993051|FG000|COMPLETED|First Wearing Cycle||80||
59868691|NCT04073186|75993051|FG000|NOT COMPLETED|First Wearing Cycle||6||
59868692|NCT04073186|75993051|FG000|STARTED|Second Wearing Cycle||80||
59868693|NCT04073186|75993051|FG000|COMPLETED|Second Wearing Cycle||79||
59868694|NCT04073186|75993051|FG000|NOT COMPLETED|Second Wearing Cycle||1||
59868695|NCT03054064|75993056|FG000|STARTED|Overall Study||48||
59868696|NCT03054064|75993056|FG000|Screen Failure|Overall Study||2||
59868697|NCT03054064|75993056|FG000|COMPLETED|Overall Study||42||
59868698|NCT03054064|75993056|FG000|NOT COMPLETED|Overall Study||6||
59868699|NCT03053518|75993060|FG000|STARTED|Overall Study||22||
59868700|NCT03053518|75993060|FG000|COMPLETED|Overall Study||12||
59868701|NCT03053518|75993060|FG000|NOT COMPLETED|Overall Study||10||
59868702|NCT04015336|75993064|FG000|STARTED|Overall Study||1||
59868703|NCT04015336|75993064|FG000|COMPLETED|Overall Study||0||
59868704|NCT04015336|75993064|FG000|NOT COMPLETED|Overall Study||1||
59868705|NCT04957732|75993070|FG000|STARTED|Overall Study||19||
59868706|NCT04957732|75993071|FG001|STARTED|Overall Study||16||
59868707|NCT04957732|75993070|FG000|COMPLETED|Overall Study||18||
59868708|NCT04957732|75993071|FG001|COMPLETED|Overall Study||12||
59868709|NCT04957732|75993070|FG000|NOT COMPLETED|Overall Study||1||
59868710|NCT04957732|75993071|FG001|NOT COMPLETED|Overall Study||4||
59868711|NCT04071158|75993087|FG000|STARTED|Overall Study||143||
59868712|NCT04071158|75993088|FG001|STARTED|Overall Study||143||
59868713|NCT04071158|75993089|FG002|STARTED|Overall Study||143||
59868714|NCT04071158|75993090|FG003|STARTED|Overall Study||143||
59868715|NCT04071158|75993091|FG004|STARTED|Overall Study||141||
59868716|NCT04071158|75993087|FG000|Treated|Overall Study||141||
59868717|NCT04071158|75993088|FG001|Treated|Overall Study||141||
59868718|NCT04071158|75993089|FG002|Treated|Overall Study||143||
59868719|NCT04071158|75993090|FG003|Treated|Overall Study||143||
59868720|NCT04071158|75993091|FG004|Treated|Overall Study||141||
59868721|NCT04071158|75993087|FG000|Safety Population|Overall Study||141|Safety analysis set included all randomized participants who received investigational product. Participants were analyzed according to the investigational product they actually received.|
59868722|NCT04071158|75993088|FG001|Safety Population|Overall Study||141|Safety analysis set included all randomized participants who received investigational product. Participants were analyzed according to the investigational product they actually received.|
59868723|NCT04071158|75993089|FG002|Safety Population|Overall Study|1 participant randomized to this arm received RSV vaccine 240 mcg with aluminum hydroxide withTdap|142|Safety analysis set included all randomized participants who received investigational product. Participants were analyzed according to the investigational product they actually received.|
59868724|NCT04071158|75993090|FG003|Safety Population|Overall Study|1 participant of this arm actually received RSV vaccine 240 mcg with aluminum hydroxide with Tdap|144|Safety analysis set included all randomized participants who received investigational product. Participants were analyzed according to the investigational product they actually received.|
59868725|NCT04071158|75993091|FG004|Safety Population|Overall Study||141|Safety analysis set included all randomized participants who received investigational product. Participants were analyzed according to the investigational product they actually received.|
59868726|NCT04071158|75993087|FG000|COMPLETED|Overall Study||140||
60000642|NCT02149810|76116387|FG001|STARTED|Overall Study||47||
59868727|NCT04071158|75993088|FG001|COMPLETED|Overall Study||139||
59868728|NCT04071158|75993089|FG002|COMPLETED|Overall Study||140||
59868729|NCT04071158|75993090|FG003|COMPLETED|Overall Study||140||
59868730|NCT04071158|75993091|FG004|COMPLETED|Overall Study||136||
59868731|NCT04071158|75993087|FG000|NOT COMPLETED|Overall Study||3||
59868732|NCT04071158|75993088|FG001|NOT COMPLETED|Overall Study||4||
59868733|NCT04071158|75993089|FG002|NOT COMPLETED|Overall Study||3||
59868734|NCT04071158|75993090|FG003|NOT COMPLETED|Overall Study||3||
59868735|NCT04071158|75993091|FG004|NOT COMPLETED|Overall Study||5||
59868736|NCT01317940|75993115|FG000|STARTED|Overall Study||19||
59868737|NCT01317940|75993116|FG001|STARTED|Overall Study||10||
59868738|NCT01317940|75993117|FG002|STARTED|Overall Study||20||
59868739|NCT01317940|75993118|FG003|STARTED|Overall Study||6||
59868740|NCT01317940|75993119|FG004|STARTED|Overall Study||13||
59868741|NCT01317940|75993120|FG005|STARTED|Overall Study||4||
59868742|NCT01317940|75993115|FG000|COMPLETED|Overall Study||18||
59868743|NCT01317940|75993116|FG001|COMPLETED|Overall Study||10||
59868744|NCT01317940|75993117|FG002|COMPLETED|Overall Study||15||
59868745|NCT01317940|75993118|FG003|COMPLETED|Overall Study||5||
59868746|NCT01317940|75993119|FG004|COMPLETED|Overall Study||12||
59868747|NCT01317940|75993120|FG005|COMPLETED|Overall Study||4||
59868748|NCT01317940|75993115|FG000|NOT COMPLETED|Overall Study||1||
59868749|NCT01317940|75993116|FG001|NOT COMPLETED|Overall Study||0||
59868750|NCT01317940|75993117|FG002|NOT COMPLETED|Overall Study||5||
59868751|NCT01317940|75993118|FG003|NOT COMPLETED|Overall Study||1||
59868752|NCT01317940|75993119|FG004|NOT COMPLETED|Overall Study||1||
59868753|NCT01317940|75993120|FG005|NOT COMPLETED|Overall Study||0||
59868754|NCT01345786|75993139|FG000|STARTED|Overall Study|Number randomized|41||
59868755|NCT01345786|75993140|FG001|STARTED|Overall Study|Number randomized|41||
59868756|NCT01345786|75993141|FG002|STARTED|Overall Study|Number randomized|38||
59868757|NCT01345786|75993142|FG003|STARTED|Overall Study|Number randomized|38||
59868758|NCT01345786|75993139|FG000|Treated|Overall Study||41||
59868759|NCT01345786|75993140|FG001|Treated|Overall Study||41||
59868760|NCT01345786|75993141|FG002|Treated|Overall Study||37||
59868761|NCT01345786|75993142|FG003|Treated|Overall Study||37||
59868762|NCT01345786|75993139|FG000|COMPLETED|Overall Study||35||
59868763|NCT01345786|75993140|FG001|COMPLETED|Overall Study||33||
59868764|NCT01345786|75993141|FG002|COMPLETED|Overall Study||33||
59868765|NCT01345786|75993142|FG003|COMPLETED|Overall Study||35||
59868766|NCT01345786|75993139|FG000|NOT COMPLETED|Overall Study||6||
59868767|NCT01345786|75993140|FG001|NOT COMPLETED|Overall Study||8||
59868768|NCT01345786|75993141|FG002|NOT COMPLETED|Overall Study||5||
59868769|NCT01345786|75993142|FG003|NOT COMPLETED|Overall Study||3||
59868770|NCT01317550|75993156|FG000|STARTED|Overall Study||5||
59868771|NCT01317550|75993157|FG001|STARTED|Overall Study||3||
59868772|NCT01317550|75993158|FG002|STARTED|Overall Study||3||
59868773|NCT01317550|75993159|FG003|STARTED|Overall Study||3||
59868774|NCT01317550|75993156|FG000|COMPLETED|Overall Study||3||
59868775|NCT01317550|75993157|FG001|COMPLETED|Overall Study||3||
59868776|NCT01317550|75993158|FG002|COMPLETED|Overall Study||3||
59868777|NCT01317550|75993159|FG003|COMPLETED|Overall Study||3||
59868778|NCT01317550|75993156|FG000|NOT COMPLETED|Overall Study||2||
59868779|NCT01317550|75993157|FG001|NOT COMPLETED|Overall Study||0||
59868780|NCT01317550|75993158|FG002|NOT COMPLETED|Overall Study||0||
59868781|NCT01317550|75993159|FG003|NOT COMPLETED|Overall Study||0||
59868782|NCT01317472|75993171|FG000|STARTED|Overall Study||9||
59868783|NCT01317472|75993172|FG001|STARTED|Overall Study||2||
59868784|NCT01317472|75993171|FG000|COMPLETED|Overall Study||7||
59868785|NCT01317472|75993172|FG001|COMPLETED|Overall Study||2||
59868786|NCT01317472|75993171|FG000|NOT COMPLETED|Overall Study||2||
59868787|NCT01317472|75993172|FG001|NOT COMPLETED|Overall Study||0||
59868788|NCT01345630|75993180|FG000|STARTED|Overall Study||396||
59868789|NCT01345630|75993181|FG001|STARTED|Overall Study||401||
59868790|NCT01345630|75993180|FG000|COMPLETED|Overall Study||35||
59868791|NCT01345630|75993181|FG001|COMPLETED|Overall Study||42||
59868792|NCT01345630|75993180|FG000|NOT COMPLETED|Overall Study||361||
59868793|NCT01345630|75993181|FG001|NOT COMPLETED|Overall Study||359||
59868794|NCT03693612|75993198|FG000|STARTED|Overall Study||1||
60000643|NCT02149810|76116386|FG000|Baseline|Overall Study||47||
59868795|NCT03693612|75993199|FG001|STARTED|Overall Study||1||
59868796|NCT03693612|75993200|FG002|STARTED|Overall Study||5||
59868797|NCT03693612|75993201|FG003|STARTED|Overall Study||3||
59868798|NCT03693612|75993202|FG004|STARTED|Overall Study||16||
59868799|NCT03693612|75993203|FG005|STARTED|Overall Study||0||
59868800|NCT03693612|75993204|FG006|STARTED|Overall Study||0||
59868801|NCT03693612|75993198|FG000|COMPLETED|Overall Study||1||
59868802|NCT03693612|75993199|FG001|COMPLETED|Overall Study||0||
59868803|NCT03693612|75993200|FG002|COMPLETED|Overall Study||4||
59868804|NCT03693612|75993201|FG003|COMPLETED|Overall Study||3||
59868805|NCT03693612|75993202|FG004|COMPLETED|Overall Study||10||
59868806|NCT03693612|75993203|FG005|COMPLETED|Overall Study||0||
59868807|NCT03693612|75993204|FG006|COMPLETED|Overall Study||0||
59868808|NCT03693612|75993198|FG000|NOT COMPLETED|Overall Study||0||
59868809|NCT03693612|75993199|FG001|NOT COMPLETED|Overall Study||1||
59868810|NCT03693612|75993200|FG002|NOT COMPLETED|Overall Study||1||
59868811|NCT03693612|75993201|FG003|NOT COMPLETED|Overall Study||0||
59868812|NCT03693612|75993202|FG004|NOT COMPLETED|Overall Study||6||
59868813|NCT03693612|75993203|FG005|NOT COMPLETED|Overall Study||0||
59868814|NCT03693612|75993204|FG006|NOT COMPLETED|Overall Study||0||
59868815|NCT04223232|75993220|FG000|STARTED|Overall Study||6||
59868816|NCT04223232|75993220|FG000|COMPLETED|Overall Study||5||
59601643|NCT01303003|75711744|FG000|NOT COMPLETED|Overall Study||0||
59601644|NCT01303003|75711745|FG001|NOT COMPLETED|Overall Study||0||
59601645|NCT01256281|75711751|FG000|STARTED|Overall Study||2||
59601646|NCT01256281|75711751|FG000|COMPLETED|Overall Study||2||
59601647|NCT01256281|75711751|FG000|NOT COMPLETED|Overall Study||0||
59601648|NCT01821859|75711755|FG000|STARTED|Overall Study||5||
59601649|NCT01821859|75711755|FG000|COMPLETED|Overall Study||0||
59601650|NCT01821859|75711755|FG000|NOT COMPLETED|Overall Study||5||
59601651|NCT01194427|75711759|FG000|STARTED|Overall Study||2||
59601652|NCT01194427|75711759|FG000|COMPLETED|Overall Study||2||
59601653|NCT01194427|75711759|FG000|NOT COMPLETED|Overall Study||0||
59601654|NCT01788475|75711766|FG000|STARTED|Overall Study||3||
59601655|NCT01788475|75711767|FG001|STARTED|Overall Study||0||
59601656|NCT01788475|75711768|FG002|STARTED|Overall Study||0||
59601657|NCT01788475|75711766|FG000|COMPLETED|Overall Study||0||
59601658|NCT01788475|75711767|FG001|COMPLETED|Overall Study||0||
59601659|NCT01788475|75711768|FG002|COMPLETED|Overall Study||0||
59601660|NCT01788475|75711766|FG000|NOT COMPLETED|Overall Study||3||
59601661|NCT01788475|75711767|FG001|NOT COMPLETED|Overall Study||0||
59601662|NCT01788475|75711768|FG002|NOT COMPLETED|Overall Study||0||
59601663|NCT01183897|75711776|FG000|STARTED|Overall Study||31||
59601664|NCT01183897|75711776|FG000|COMPLETED|Overall Study||31||
59601665|NCT01183897|75711776|FG000|NOT COMPLETED|Overall Study||0||
59601666|NCT01183429|75711780|FG000|STARTED|Overall Study||39||
59601667|NCT01183429|75711780|FG000|COMPLETED|Overall Study||39||
59601668|NCT01183429|75711780|FG000|NOT COMPLETED|Overall Study||0||
59601669|NCT01157533|75711784|FG000|STARTED|Overall Study||1||
59601670|NCT01157533|75711784|FG000|COMPLETED|Overall Study||1||
59601671|NCT01157533|75711784|FG000|NOT COMPLETED|Overall Study||0||
59601672|NCT01760941|75711788|FG000|STARTED|Overall Study||1||
59601673|NCT01760941|75711788|FG000|COMPLETED|Overall Study||1||
59601674|NCT01760941|75711788|FG000|NOT COMPLETED|Overall Study||0||
59601675|NCT01756573|75711795|FG000|STARTED|Overall Study||3||
59601676|NCT01756573|75711796|FG001|STARTED|Overall Study||1||
59601677|NCT01756573|75711797|FG002|STARTED|Overall Study||1||
59601678|NCT01756573|75711795|FG000|COMPLETED|Overall Study||3||
59601679|NCT01756573|75711796|FG001|COMPLETED|Overall Study||1||
59601680|NCT01756573|75711797|FG002|COMPLETED|Overall Study||1||
59601681|NCT01756573|75711795|FG000|NOT COMPLETED|Overall Study||0||
59601682|NCT01756573|75711796|FG001|NOT COMPLETED|Overall Study||0||
59601683|NCT01756573|75711797|FG002|NOT COMPLETED|Overall Study||0||
59601684|NCT01126801|75711807|FG000|STARTED|Overall Study||1||
59601685|NCT01126801|75711808|FG001|STARTED|Overall Study||1||
59601686|NCT01126801|75711807|FG000|COMPLETED|Overall Study||1||
59601687|NCT01126801|75711808|FG001|COMPLETED|Overall Study||1||
59601688|NCT01126801|75711807|FG000|NOT COMPLETED|Overall Study||0||
59601689|NCT01126801|75711808|FG001|NOT COMPLETED|Overall Study||0||
59601690|NCT01727167|75711816|FG000|STARTED|Overall Study||1||
59601691|NCT01727167|75711817|FG001|STARTED|Overall Study||0||
59601692|NCT01727167|75711816|FG000|COMPLETED|Overall Study||1||
59601693|NCT01727167|75711817|FG001|COMPLETED|Overall Study||0||
59601694|NCT01727167|75711816|FG000|NOT COMPLETED|Overall Study||0||
59601695|NCT01727167|75711817|FG001|NOT COMPLETED|Overall Study||0||
59601696|NCT01702909|75711823|FG000|STARTED|Overall Study||7||
59601697|NCT01702909|75711823|FG000|COMPLETED|Overall Study||7||
59601698|NCT01702909|75711823|FG000|NOT COMPLETED|Overall Study||0||
59601699|NCT01692691|75711827|FG000|STARTED|Overall Study||1||
59601700|NCT01692691|75711827|FG000|COMPLETED|Overall Study||1||
59601701|NCT01692691|75711827|FG000|NOT COMPLETED|Overall Study||0||
59601702|NCT01127503|75711835|FG000|STARTED|Overall Study||1||
59601703|NCT01127503|75711836|FG001|STARTED|Overall Study||1||
59601704|NCT01127503|75711835|FG000|COMPLETED|Overall Study||1||
59601705|NCT01127503|75711836|FG001|COMPLETED|Overall Study||1||
59601706|NCT01127503|75711835|FG000|NOT COMPLETED|Overall Study||0||
59601707|NCT01127503|75711836|FG001|NOT COMPLETED|Overall Study||0||
59601708|NCT01122511|75711844|FG000|STARTED|Overall Study||2||
59601709|NCT01122511|75711845|FG001|STARTED|Overall Study||2||
59601710|NCT01122511|75711844|FG000|COMPLETED|Overall Study||0||
59601711|NCT01122511|75711845|FG001|COMPLETED|Overall Study||0||
59601712|NCT01122511|75711844|FG000|NOT COMPLETED|Overall Study||2||
59601713|NCT01122511|75711845|FG001|NOT COMPLETED|Overall Study||2||
59601714|NCT01663285|75711851|FG000|STARTED|Overall Study||1||
59601715|NCT01663285|75711851|FG000|COMPLETED|Overall Study||1||
59601716|NCT01663285|75711851|FG000|NOT COMPLETED|Overall Study||0||
59601717|NCT01673425|75711855|FG000|STARTED|Overall Study||5||
59601718|NCT01673425|75711855|FG000|COMPLETED|Overall Study||4||
59601719|NCT01673425|75711855|FG000|NOT COMPLETED|Overall Study||1||
59601720|NCT01090141|75711861|FG000|STARTED|Overall Study||0||
59601721|NCT01090141|75711862|FG001|STARTED|Overall Study||0||
59601722|NCT01090141|75711861|FG000|COMPLETED|Overall Study||0||
59601723|NCT01090141|75711862|FG001|COMPLETED|Overall Study||0||
59601724|NCT01090141|75711861|FG000|NOT COMPLETED|Overall Study||0||
59601725|NCT01090141|75711862|FG001|NOT COMPLETED|Overall Study||0||
59601726|NCT01048723|75711868|FG000|STARTED|Overall Study||2||
59601727|NCT01048723|75711868|FG000|COMPLETED|Overall Study||2||
59601728|NCT01048723|75711868|FG000|NOT COMPLETED|Overall Study||0||
59601729|NCT01583647|75711872|FG000|STARTED|Overall Study||10||
59601730|NCT01583647|75711873|FG001|STARTED|Overall Study|Study terminated prior to Panel B being conducted.|0||
59601731|NCT01583647|75711872|FG000|COMPLETED|Overall Study||10||
59601732|NCT01583647|75711873|FG001|COMPLETED|Overall Study||0||
59601733|NCT01583647|75711872|FG000|NOT COMPLETED|Overall Study||0||
59601734|NCT01583647|75711873|FG001|NOT COMPLETED|Overall Study||0||
59601735|NCT01555489|75711879|FG000|STARTED|Overall Study||11||
59868817|NCT04223232|75993220|FG000|NOT COMPLETED|Overall Study||1||
59868818|NCT04206384|75993224|FG000|STARTED|Overall Study||52||
59868819|NCT04206384|75993224|FG000|COMPLETED|Overall Study||42||
59868820|NCT04206384|75993224|FG000|NOT COMPLETED|Overall Study||10||
59868821|NCT04051944|75993230|FG000|STARTED|Overall Study||11||
59868822|NCT04051944|75993231|FG001|STARTED|Overall Study||10||
59868823|NCT04051944|75993230|FG000|COMPLETED|Overall Study||3||
59868824|NCT04051944|75993231|FG001|COMPLETED|Overall Study||6||
60000644|NCT02149810|76116387|FG001|Baseline|Overall Study||44||
60000645|NCT02149810|76116386|FG000|Week 4|Overall Study||43||
60000646|NCT02149810|76116387|FG001|Week 4|Overall Study||42||
60000647|NCT02149810|76116386|FG000|Week 8|Overall Study||40||
60000648|NCT02149810|76116387|FG001|Week 8|Overall Study||43||
60000649|NCT02149810|76116386|FG000|Week 12|Overall Study||40||
60000650|NCT02149810|76116387|FG001|Week 12|Overall Study||43||
60000651|NCT02149810|76116386|FG000|Week 24|Overall Study||31||
60000652|NCT02149810|76116387|FG001|Week 24|Overall Study|Not applicable study was amended such that week 24 data was not collected for TAU participants.|0||
60000653|NCT02149810|76116386|FG000|COMPLETED|Overall Study||40||
60000654|NCT02149810|76116387|FG001|COMPLETED|Overall Study||43||
60000655|NCT02149810|76116386|FG000|NOT COMPLETED|Overall Study||8||
60000656|NCT02149810|76116387|FG001|NOT COMPLETED|Overall Study||4||
60000657|NCT02149420|76116396|FG000|STARTED|Core Study||9||
60000658|NCT02149420|76116397|FG001|STARTED|Core Study||6||
60000659|NCT02149420|76116398|FG002|STARTED|Core Study||12||
60000660|NCT02149420|76116396|FG000|Safety Analysis Set|Core Study||9|all patients that received study drug|
60000661|NCT02149420|76116397|FG001|Safety Analysis Set|Core Study||6|all patients that received study drug|
60000662|NCT02149420|76116398|FG002|Safety Analysis Set|Core Study||12|all patients that received study drug|
59601736|NCT01555489|75711879|FG000|COMPLETED|Overall Study||11||
59601737|NCT01555489|75711879|FG000|NOT COMPLETED|Overall Study||0||
59601738|NCT01035073|75711883|FG000|STARTED|Overall Study||0||
59601739|NCT01035073|75711883|FG000|COMPLETED|Overall Study||0||
59601740|NCT01035073|75711883|FG000|NOT COMPLETED|Overall Study||0||
59601741|NCT01561495|75711887|FG000|STARTED|Overall Study||1||
59601742|NCT01561495|75711887|FG000|COMPLETED|Overall Study||1||
59601743|NCT01561495|75711887|FG000|NOT COMPLETED|Overall Study||0||
59601744|NCT01532635|75711891|FG000|STARTED|Overall Study||4||
59601745|NCT01532635|75711891|FG000|COMPLETED|Overall Study||4||
59601746|NCT01532635|75711891|FG000|NOT COMPLETED|Overall Study||0||
59601747|NCT00986947|75711895|FG000|STARTED|Overall Study||20||
60000663|NCT02149420|76116396|FG000|PK Analysis Set|Core Study|for patients entering open label VAY736 10 mg/kg at Week 24|5|at least one valid PK concentration measurement|
60000664|NCT02149420|76116397|FG001|PK Analysis Set|Core Study||6|at least one valid PK concentration measurement|
60000665|NCT02149420|76116398|FG002|PK Analysis Set|Core Study||12|at least one valid PK concentration measurement|
60000666|NCT02149420|76116396|FG000|PD (Pharmacodynamics) Analysis Set|Core Study||9|all patients with PD data, who received at least one dose of study drug.|
60000667|NCT02149420|76116397|FG001|PD (Pharmacodynamics) Analysis Set|Core Study||6|all patients with PD data, who received at least one dose of study drug.|
60067696|NCT01788423|76182877|FG000|STARTED|Overall Study||53||
59601748|NCT00986947|75711895|FG000|COMPLETED|Overall Study||0||
59601749|NCT00986947|75711895|FG000|NOT COMPLETED|Overall Study||20||
59601750|NCT00559897|75711899|FG000|STARTED|Overall Study||6||
59601751|NCT00559897|75711899|FG000|COMPLETED|Overall Study||6||
59601752|NCT00559897|75711899|FG000|NOT COMPLETED|Overall Study||0||
59601753|NCT00979147|75711905|FG000|STARTED|Overall Study||0||
59601754|NCT00979147|75711906|FG001|STARTED|Overall Study||0||
59601755|NCT00979147|75711905|FG000|COMPLETED|Overall Study||0||
59601756|NCT00979147|75711906|FG001|COMPLETED|Overall Study||0||
59601757|NCT00979147|75711905|FG000|NOT COMPLETED|Overall Study||0||
59601758|NCT00979147|75711906|FG001|NOT COMPLETED|Overall Study||0||
59868825|NCT04051944|75993230|FG000|NOT COMPLETED|Overall Study||8||
59868826|NCT04051944|75993231|FG001|NOT COMPLETED|Overall Study||4||
59868827|NCT04050618|75993239|FG000|STARTED|First Intervention||58||
59868828|NCT04050618|75993240|FG001|STARTED|First Intervention||56||
59868829|NCT04050618|75993239|FG000|COMPLETED|First Intervention||56||
59868830|NCT04050618|75993240|FG001|COMPLETED|First Intervention||56||
59868831|NCT04050618|75993239|FG000|NOT COMPLETED|First Intervention||2||
59868832|NCT04050618|75993240|FG001|NOT COMPLETED|First Intervention||0||
59868833|NCT04050618|75993239|FG000|STARTED|Second Intervention||56||
59868834|NCT04050618|75993240|FG001|STARTED|Second Intervention||56||
59868835|NCT04050618|75993239|FG000|COMPLETED|Second Intervention||55||
59868836|NCT04050618|75993240|FG001|COMPLETED|Second Intervention||56||
59868837|NCT04050618|75993239|FG000|NOT COMPLETED|Second Intervention||1||
59868838|NCT04050618|75993240|FG001|NOT COMPLETED|Second Intervention||0||
60000668|NCT02149420|76116398|FG002|PD (Pharmacodynamics) Analysis Set|Core Study||12|all patients with PD data, who received at least one dose of study drug.|
60000669|NCT02149420|76116396|FG000|COMPLETED|Core Study||9||
60000670|NCT02149420|76116397|FG001|COMPLETED|Core Study||5||
60000671|NCT02149420|76116398|FG002|COMPLETED|Core Study||10||
59601759|NCT00539617|75711912|FG000|STARTED|Pre-screening Period||7||
59601760|NCT00539617|75711912|FG000|COMPLETED|Pre-screening Period||4||
59601761|NCT00539617|75711912|FG000|NOT COMPLETED|Pre-screening Period||3||
59601762|NCT00539617|75711912|FG000|STARTED|Run-In Period||4||
59601763|NCT00539617|75711912|FG000|COMPLETED|Run-In Period||3||
59601764|NCT00539617|75711912|FG000|NOT COMPLETED|Run-In Period||1||
59601765|NCT00539617|75711912|FG000|STARTED|Treatment Period||3||
59601766|NCT00539617|75711912|FG000|COMPLETED|Treatment Period||3||
59601767|NCT00539617|75711912|FG000|NOT COMPLETED|Treatment Period||0||
59601768|NCT00967447|75711916|FG000|STARTED|Overall Study|there are no collected data in CRF|2||
59601769|NCT00967447|75711916|FG000|COMPLETED|Overall Study|there are no collected data in CRF|2||
59601770|NCT00967447|75711916|FG000|NOT COMPLETED|Overall Study||0||
59601771|NCT00976339|75711922|FG000|STARTED|Overall Study||10||
59601772|NCT00976339|75711923|FG001|STARTED|Overall Study||10||
59601773|NCT00976339|75711922|FG000|COMPLETED|Overall Study||10||
59601774|NCT00976339|75711923|FG001|COMPLETED|Overall Study||10||
59601775|NCT00976339|75711922|FG000|NOT COMPLETED|Overall Study||0||
59601776|NCT00976339|75711923|FG001|NOT COMPLETED|Overall Study||0||
59601777|NCT00517075|75711935|FG000|STARTED|Overall Study||0||
59601778|NCT00517075|75711936|FG001|STARTED|Overall Study||0||
59601779|NCT00517075|75711937|FG002|STARTED|Overall Study||0||
59601780|NCT00517075|75711938|FG003|STARTED|Overall Study||0||
59601781|NCT00517075|75711935|FG000|COMPLETED|Overall Study||0||
59601782|NCT00517075|75711936|FG001|COMPLETED|Overall Study||0||
59601783|NCT00517075|75711937|FG002|COMPLETED|Overall Study||0||
59601784|NCT00517075|75711938|FG003|COMPLETED|Overall Study||0||
59601785|NCT00517075|75711935|FG000|NOT COMPLETED|Overall Study||0||
59601786|NCT00517075|75711936|FG001|NOT COMPLETED|Overall Study||0||
59601787|NCT00517075|75711937|FG002|NOT COMPLETED|Overall Study||0||
59601788|NCT00517075|75711938|FG003|NOT COMPLETED|Overall Study||0||
59601789|NCT00523939|75711950|FG000|STARTED|Overall Study||2||
59601790|NCT00523939|75711951|FG001|STARTED|Overall Study||2||
59601791|NCT00523939|75711950|FG000|COMPLETED|Overall Study||2||
59601792|NCT00523939|75711951|FG001|COMPLETED|Overall Study||2||
59601793|NCT00523939|75711950|FG000|NOT COMPLETED|Overall Study||0||
59601794|NCT00523939|75711951|FG001|NOT COMPLETED|Overall Study||0||
59601795|NCT00954187|75711958|FG000|STARTED|Overall Study|No subjects were assigned treatment and no study procedures were performed|0||
59601796|NCT00954187|75711959|FG001|STARTED|Overall Study|No subjects were assigned treatment and no study procedures were performed|0||
59601797|NCT00954187|75711958|FG000|COMPLETED|Overall Study||0||
59601798|NCT00954187|75711959|FG001|COMPLETED|Overall Study||0||
59601799|NCT00954187|75711958|FG000|NOT COMPLETED|Overall Study||0||
59601800|NCT00954187|75711959|FG001|NOT COMPLETED|Overall Study||0||
59601801|NCT00947791|75711967|FG000|STARTED|Overall Study||0||
59601802|NCT00947791|75711968|FG001|STARTED|Overall Study||1||
59601803|NCT00947791|75711967|FG000|COMPLETED|Overall Study||0||
59601804|NCT00947791|75711968|FG001|COMPLETED|Overall Study||1||
59601805|NCT00947791|75711967|FG000|NOT COMPLETED|Overall Study||0||
59601806|NCT00947791|75711968|FG001|NOT COMPLETED|Overall Study||0||
59601807|NCT00504985|75711974|FG000|STARTED|Overall Study||14||
59601808|NCT00504985|75711974|FG000|COMPLETED|Overall Study||14||
59601809|NCT00504985|75711974|FG000|NOT COMPLETED|Overall Study||0||
59601810|NCT00930787|75711980|FG000|STARTED|Overall Study||14||
59601811|NCT00930787|75711981|FG001|STARTED|Overall Study||9||
59601812|NCT00930787|75711980|FG000|COMPLETED|Overall Study||14||
59601813|NCT00930787|75711981|FG001|COMPLETED|Overall Study||9||
59601814|NCT00930787|75711980|FG000|NOT COMPLETED|Overall Study||0||
59601815|NCT00930787|75711981|FG001|NOT COMPLETED|Overall Study||0||
59601816|NCT00911053|75711992|FG000|STARTED|Overall Study||0||
59601817|NCT00911053|75711993|FG001|STARTED|Overall Study||0||
59601818|NCT00911053|75711994|FG002|STARTED|Overall Study||0||
59601819|NCT00911053|75711995|FG003|STARTED|Overall Study||0||
59601820|NCT00911053|75711996|FG004|STARTED|Overall Study||0||
59601821|NCT00911053|75711992|FG000|COMPLETED|Overall Study||0||
59601822|NCT00911053|75711993|FG001|COMPLETED|Overall Study||0||
59601823|NCT00911053|75711994|FG002|COMPLETED|Overall Study||0||
59601824|NCT00911053|75711995|FG003|COMPLETED|Overall Study||0||
59601825|NCT00911053|75711996|FG004|COMPLETED|Overall Study||0||
59601826|NCT00911053|75711992|FG000|NOT COMPLETED|Overall Study||0||
59601827|NCT00911053|75711993|FG001|NOT COMPLETED|Overall Study||0||
59601828|NCT00911053|75711994|FG002|NOT COMPLETED|Overall Study||0||
59601829|NCT00911053|75711995|FG003|NOT COMPLETED|Overall Study||0||
59601830|NCT00911053|75711996|FG004|NOT COMPLETED|Overall Study||0||
59601831|NCT00476827|75712014|FG000|STARTED|Overall Study||3||
59601832|NCT00476827|75712015|FG001|STARTED|Overall Study||0||
59601833|NCT00476827|75712016|FG002|STARTED|Overall Study||1||
59601834|NCT00476827|75712017|FG003|STARTED|Overall Study||0||
59601835|NCT00476827|75712018|FG004|STARTED|Overall Study||2||
59601836|NCT00476827|75712019|FG005|STARTED|Overall Study||2||
59601837|NCT00476827|75712014|FG000|COMPLETED|Overall Study||3||
59601838|NCT00476827|75712015|FG001|COMPLETED|Overall Study||0||
59601839|NCT00476827|75712016|FG002|COMPLETED|Overall Study||1||
59601840|NCT00476827|75712017|FG003|COMPLETED|Overall Study||0||
59601841|NCT00476827|75712018|FG004|COMPLETED|Overall Study||2||
59601842|NCT00476827|75712019|FG005|COMPLETED|Overall Study||2||
59735032|NCT00922974|75853691|FG001|Eligible|Phase II Component||0||
59735033|NCT00922974|75853690|FG000|Eligible and Started Treatment|Phase II Component||39||
59735034|NCT00922974|75853691|FG001|Eligible and Started Treatment|Phase II Component||0||
59762487|NCT02644525|75882212|FG003|STARTED|Group 3||5||
60000672|NCT02149420|76116396|FG000|NOT COMPLETED|Core Study||0||
60000673|NCT02149420|76116397|FG001|NOT COMPLETED|Core Study||1||
59601843|NCT00476827|75712014|FG000|NOT COMPLETED|Overall Study||0||
59601844|NCT00476827|75712015|FG001|NOT COMPLETED|Overall Study||0||
59601845|NCT00476827|75712016|FG002|NOT COMPLETED|Overall Study||0||
59601846|NCT00476827|75712017|FG003|NOT COMPLETED|Overall Study||0||
59601847|NCT00476827|75712018|FG004|NOT COMPLETED|Overall Study||0||
59601848|NCT00476827|75712019|FG005|NOT COMPLETED|Overall Study||0||
59601849|NCT00901303|75712033|FG000|STARTED|Overall Study||5||
59601850|NCT00901303|75712034|FG001|STARTED|Overall Study||1||
59601851|NCT00901303|75712033|FG000|COMPLETED|Overall Study||5||
59601852|NCT00901303|75712034|FG001|COMPLETED|Overall Study||1||
59601853|NCT00901303|75712033|FG000|NOT COMPLETED|Overall Study||0||
59601854|NCT00901303|75712034|FG001|NOT COMPLETED|Overall Study||0||
59601855|NCT00459121|75712040|FG000|STARTED|Overall Study||2||
59601856|NCT00459121|75712040|FG000|COMPLETED|Overall Study||2||
59601857|NCT00459121|75712040|FG000|NOT COMPLETED|Overall Study||0||
59601858|NCT00432445|75712045|FG000|STARTED|Overall Study||2||
59601859|NCT00432445|75712045|FG000|COMPLETED|Overall Study||2||
59601860|NCT00432445|75712045|FG000|NOT COMPLETED|Overall Study||0||
59601861|NCT00904423|75712049|FG000|STARTED|Overall Study||8||
59601862|NCT00904423|75712049|FG000|COMPLETED|Overall Study||8||
60000674|NCT02149420|76116398|FG002|NOT COMPLETED|Core Study||2||
60000675|NCT02149420|76116396|FG000|STARTED|Open Label VAY736 10 mg/kg Extension|Patients received single dose of VAY736 10mg/kg at Week 24.|5||
59601863|NCT00904423|75712049|FG000|NOT COMPLETED|Overall Study||0||
59601864|NCT00904189|75712053|FG000|STARTED|Overall Study||2||
59601865|NCT00904189|75712053|FG000|COMPLETED|Overall Study||2||
59601866|NCT00904189|75712053|FG000|NOT COMPLETED|Overall Study||0||
59601867|NCT00399841|75712058|FG000|STARTED|Overall Study||13||
59601868|NCT00399841|75712059|FG001|STARTED|Overall Study|# of participants unknown. Efforts were made to locate data. No data are available|0||
59601869|NCT00399841|75712060|FG002|STARTED|Overall Study|# of participants unknown. Efforts were made to locate data. No data are available|0||
59601870|NCT00399841|75712058|FG000|Permanent Implant|Overall Study||6||
59601871|NCT00399841|75712059|FG001|Permanent Implant|Overall Study|# of participants unknown. Efforts were made to locate data. No data are available|0||
59601872|NCT00399841|75712060|FG002|Permanent Implant|Overall Study|# of participants unknown. Efforts were made to locate data. No data are available|0||
59601873|NCT00399841|75712058|FG000|12-week|Overall Study||2||
59601874|NCT00399841|75712059|FG001|12-week|Overall Study|# of participants unknown. Efforts were made to locate data. No data are available|0||
59601875|NCT00399841|75712060|FG002|12-week|Overall Study|# of participants unknown. Efforts were made to locate data. No data are available|0||
59601876|NCT00399841|75712058|FG000|COMPLETED|Overall Study||1||
59601877|NCT00399841|75712059|FG001|COMPLETED|Overall Study|# of participants unknown. Efforts were made to locate data. No data are available|0||
59601878|NCT00399841|75712060|FG002|COMPLETED|Overall Study|# of participants unknown. Efforts were made to locate data. No data are available|0||
59601879|NCT00399841|75712058|FG000|NOT COMPLETED|Overall Study||12||
59601880|NCT00399841|75712059|FG001|NOT COMPLETED|Overall Study||0||
59601881|NCT00399841|75712060|FG002|NOT COMPLETED|Overall Study||0||
59601882|NCT00387673|75712065|FG000|STARTED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0||
59601883|NCT00387673|75712066|FG001|STARTED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0||
59601884|NCT00387673|75712067|FG002|STARTED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0||
59601885|NCT00387673|75712065|FG000|COMPLETED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0||
59601886|NCT00387673|75712066|FG001|COMPLETED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0||
59601887|NCT00387673|75712067|FG002|COMPLETED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0||
59601888|NCT00387673|75712065|FG000|NOT COMPLETED|Overall Study||0||
59601889|NCT00387673|75712066|FG001|NOT COMPLETED|Overall Study||0||
59601890|NCT00387673|75712067|FG002|NOT COMPLETED|Overall Study||0||
59601891|NCT00879619|75712073|FG000|STARTED|Overall Study||4||
59601892|NCT00879619|75712073|FG000|COMPLETED|Overall Study||4||
59601893|NCT00879619|75712073|FG000|NOT COMPLETED|Overall Study||0||
59601894|NCT00878605|75712081|FG000|STARTED|Overall Study||10||
60000676|NCT02149420|76116397|FG001|STARTED|Open Label VAY736 10 mg/kg Extension|Only patients origianally randomized to Placebo were allowed to enter this Period.|0||
60000677|NCT02149420|76116398|FG002|STARTED|Open Label VAY736 10 mg/kg Extension|Only patients origianally randomized to Placebo were allowed to enter this Period.|0||
60000678|NCT02149420|76116396|FG000|COMPLETED|Open Label VAY736 10 mg/kg Extension||4||
59601895|NCT00878605|75712082|FG001|STARTED|Overall Study||10||
59601896|NCT00878605|75712083|FG002|STARTED|Overall Study||9||
59601897|NCT00878605|75712084|FG003|STARTED|Overall Study||9||
59601898|NCT00878605|75712081|FG000|COMPLETED|Overall Study||7||
59601899|NCT00878605|75712082|FG001|COMPLETED|Overall Study||7||
59601900|NCT00878605|75712083|FG002|COMPLETED|Overall Study||8||
59601901|NCT00878605|75712084|FG003|COMPLETED|Overall Study||6||
59601902|NCT00878605|75712081|FG000|NOT COMPLETED|Overall Study||3||
59601903|NCT00878605|75712082|FG001|NOT COMPLETED|Overall Study||3||
59601904|NCT00878605|75712083|FG002|NOT COMPLETED|Overall Study||1||
59601905|NCT00878605|75712084|FG003|NOT COMPLETED|Overall Study||3||
59601906|NCT00353275|75712096|FG000|STARTED|Overall Study||2||
59601907|NCT00353275|75712097|FG001|STARTED|Overall Study||3||
59601908|NCT00353275|75712096|FG000|COMPLETED|Overall Study||2||
59601909|NCT00353275|75712097|FG001|COMPLETED|Overall Study||3||
59601910|NCT00353275|75712096|FG000|NOT COMPLETED|Overall Study||0||
59601911|NCT00353275|75712097|FG001|NOT COMPLETED|Overall Study||0||
59601912|NCT00822679|75712105|FG000|STARTED|Overall Study||0||
59601913|NCT00822679|75712106|FG001|STARTED|Overall Study||0||
59601914|NCT00822679|75712105|FG000|COMPLETED|Overall Study||0||
59601915|NCT00822679|75712106|FG001|COMPLETED|Overall Study||0||
59601916|NCT00822679|75712105|FG000|NOT COMPLETED|Overall Study||0||
59601917|NCT00822679|75712106|FG001|NOT COMPLETED|Overall Study||0||
59601918|NCT00322855|75712112|FG000|STARTED|Overall Study||1||
59601919|NCT00322855|75712112|FG000|COMPLETED|Overall Study||1||
59601920|NCT00322855|75712112|FG000|NOT COMPLETED|Overall Study||0||
59601921|NCT05034614|75712118|FG000|STARTED|Overall Study||357||
59601922|NCT05034614|75712119|FG001|STARTED|Overall Study||399||
59601923|NCT05034614|75712118|FG000|COMPLETED|Overall Study||357||
59601924|NCT05034614|75712119|FG001|COMPLETED|Overall Study||399||
59601925|NCT05034614|75712118|FG000|NOT COMPLETED|Overall Study||0||
59601926|NCT05034614|75712119|FG001|NOT COMPLETED|Overall Study||0||
59601927|NCT00323635|75712127|FG000|STARTED|Overall Study||10||
59601928|NCT00323635|75712128|FG001|STARTED|Overall Study||9||
59601929|NCT00323635|75712127|FG000|COMPLETED|Overall Study||10||
59601930|NCT00323635|75712128|FG001|COMPLETED|Overall Study||9||
59601931|NCT00323635|75712127|FG000|NOT COMPLETED|Overall Study||0||
59601932|NCT00323635|75712128|FG001|NOT COMPLETED|Overall Study||0||
59601933|NCT00314353|75712138|FG000|STARTED|Protocol Therapy (8 Cycles)||4||
59601934|NCT00314353|75712139|FG001|STARTED|Protocol Therapy (8 Cycles)||3||
59601935|NCT00314353|75712138|FG000|COMPLETED|Protocol Therapy (8 Cycles)|COMPLETED refers to the participants completing 8 cycles of therapy.|2||
59601936|NCT00314353|75712139|FG001|COMPLETED|Protocol Therapy (8 Cycles)|COMPLETED refers to the participants completing 8 cycles of therapy.|0||
59601937|NCT00314353|75712138|FG000|NOT COMPLETED|Protocol Therapy (8 Cycles)||2||
59601938|NCT00314353|75712139|FG001|NOT COMPLETED|Protocol Therapy (8 Cycles)||3||
59601939|NCT00314353|75712138|FG000|STARTED|Follow-up|2 participants who completed 8 cycles plus 1 participant who did not complete 8 cycles therapy.|3||
59601940|NCT00314353|75712139|FG001|STARTED|Follow-up||0||
59601941|NCT00314353|75712138|FG000|COMPLETED|Follow-up||3||
59601942|NCT00314353|75712139|FG001|COMPLETED|Follow-up||0||
59601943|NCT00314353|75712138|FG000|NOT COMPLETED|Follow-up||0||
59601944|NCT00314353|75712139|FG001|NOT COMPLETED|Follow-up||0||
59601945|NCT00279409|75712147|FG000|STARTED|Overall Study||0||
59601946|NCT00279409|75712148|FG001|STARTED|Overall Study||0||
59601947|NCT00279409|75712147|FG000|COMPLETED|Overall Study||0||
59601948|NCT00279409|75712148|FG001|COMPLETED|Overall Study||0||
59601949|NCT00279409|75712147|FG000|NOT COMPLETED|Overall Study||0||
59601950|NCT00279409|75712148|FG001|NOT COMPLETED|Overall Study||0||
59601951|NCT00253981|75712156|FG000|STARTED|Overall Study||16||
59601952|NCT00253981|75712157|FG001|STARTED|Overall Study||14||
59601953|NCT00253981|75712156|FG000|COMPLETED|Overall Study||16||
59601954|NCT00253981|75712157|FG001|COMPLETED|Overall Study||14||
59601955|NCT00253981|75712156|FG000|NOT COMPLETED|Overall Study||0||
59601956|NCT00253981|75712157|FG001|NOT COMPLETED|Overall Study||0||
59601957|NCT00804349|75712165|FG000|STARTED|Overall Study|0 analyzed PI no longer at institution;PI contacted, information not added; No data available.|0||
59601958|NCT00804349|75712166|FG001|STARTED|Overall Study|0 analyzed PI no longer at institution;PI contacted, information not added; No data available|0||
59601959|NCT00804349|75712165|FG000|COMPLETED|Overall Study|0 analyzed PI no longer at institution;PI contacted, information not added; No data available|0||
59601960|NCT00804349|75712166|FG001|COMPLETED|Overall Study|0 analyzed PI no longer at institution;PI contacted, information not added; No data available|0||
59601961|NCT00804349|75712165|FG000|NOT COMPLETED|Overall Study||0||
59601962|NCT00804349|75712166|FG001|NOT COMPLETED|Overall Study||0||
59601963|NCT00178477|75712172|FG000|STARTED|Overall Study||10||
59601964|NCT00178477|75712172|FG000|COMPLETED|Overall Study||5||
59601965|NCT00178477|75712172|FG000|NOT COMPLETED|Overall Study||5||
59601966|NCT00801931|75712176|FG000|STARTED|Overall Study||1||
59601967|NCT00801931|75712176|FG000|COMPLETED|Overall Study||1||
59601968|NCT00801931|75712176|FG000|NOT COMPLETED|Overall Study||0||
59601969|NCT00780481|75712180|FG000|STARTED|Overall Study||13||
59601970|NCT00780481|75712180|FG000|COMPLETED|Overall Study||13||
59601971|NCT00780481|75712180|FG000|NOT COMPLETED|Overall Study||0||
59601972|NCT00019747|75712186|FG000|STARTED|Overall Study||23||
59601973|NCT00019747|75712187|FG001|STARTED|Overall Study||16||
59601974|NCT00019747|75712186|FG000|COMPLETED|Overall Study||23||
59601975|NCT00019747|75712187|FG001|COMPLETED|Overall Study||16||
59601976|NCT00019747|75712186|FG000|NOT COMPLETED|Overall Study||0||
59601977|NCT00019747|75712187|FG001|NOT COMPLETED|Overall Study||0||
59601978|NCT02970799|75712195|FG000|STARTED|Overall Study||0||
59601979|NCT02970799|75712196|FG001|STARTED|Overall Study||0||
59601980|NCT02970799|75712195|FG000|COMPLETED|Overall Study||0||
59601981|NCT02970799|75712196|FG001|COMPLETED|Overall Study||0||
59601982|NCT02970799|75712195|FG000|NOT COMPLETED|Overall Study||0||
59601983|NCT02970799|75712196|FG001|NOT COMPLETED|Overall Study||0||
59601984|NCT00759577|75712202|FG000|STARTED|Overall Study||36||
59601985|NCT00759577|75712202|FG000|COMPLETED|Overall Study||36||
59601986|NCT00759577|75712202|FG000|NOT COMPLETED|Overall Study||0||
59601987|NCT00748579|75712208|FG000|STARTED|Overall Study||2||
59601988|NCT00748579|75712209|FG001|STARTED|Overall Study||0||
59601989|NCT00748579|75712208|FG000|COMPLETED|Overall Study||2||
59601990|NCT00748579|75712209|FG001|COMPLETED|Overall Study||0||
59601991|NCT00748579|75712208|FG000|NOT COMPLETED|Overall Study||0||
59601992|NCT00748579|75712209|FG001|NOT COMPLETED|Overall Study||0||
59601993|NCT00746239|75712215|FG000|STARTED|Overall Study||11||
59601994|NCT00746239|75712215|FG000|COMPLETED|Overall Study|11 subjects total were enrolled - 6 withdrew from study and 5 competed|5||
59601995|NCT00746239|75712215|FG000|NOT COMPLETED|Overall Study||6||
59735035|NCT00922974|75853690|FG000|Eligible, Treated, Adverse Event Data|Phase II Component||34|Eligible, started protocol treatment, and has adverse event data|
59735036|NCT00922974|75853691|FG001|Eligible, Treated, Adverse Event Data|Phase II Component||0|Eligible, started protocol treatment, and has adverse event data|
59735037|NCT00922974|75853690|FG000|COMPLETED|Phase II Component|These subjects do not participate in the phase III component.|39|Subjects contributing any data to analysis are considered to have completed the study|
59735038|NCT00922974|75853691|FG001|COMPLETED|Phase II Component||0|Subjects contributing any data to analysis are considered to have completed the study|
59735039|NCT00922974|75853690|FG000|NOT COMPLETED|Phase II Component||7||
59735040|NCT00922974|75853691|FG001|NOT COMPLETED|Phase II Component||0||
59735041|NCT00922974|75853690|FG000|STARTED|Phase III Component|The phase III component accrues new subjects; these are not continuing phase II subjects.|217||
59735042|NCT00922974|75853691|FG001|STARTED|Phase III Component||136||
59735043|NCT00922974|75853690|FG000|Eligible|Phase III Component||209||
59735044|NCT00922974|75853691|FG001|Eligible|Phase III Component||130||
59735045|NCT00922974|75853690|FG000|Eligible With 3 mo. NRPS Data|Phase III Component||139|All eligible randomized patients with both baseline and 3 month NRPS scores|
59735046|NCT00922974|75853691|FG001|Eligible With 3 mo. NRPS Data|Phase III Component||76|All eligible randomized patients with both baseline and 3 month NRPS scores|
59735047|NCT00922974|75853690|FG000|Eligible With 3 mo. FACT-G Data|Phase III Component||87|Eligible and QOL consented patients with both baseline and follow up 3 month FACT-G total Score|
59735048|NCT00922974|75853691|FG001|Eligible With 3 mo. FACT-G Data|Phase III Component||58|Eligible and QOL consented patients with both baseline and follow up 3 month FACT-G total Score|
59735049|NCT00922974|75853690|FG000|Eligible With Adverse Event Data|Phase III Component||202||
59735050|NCT00922974|75853691|FG001|Eligible With Adverse Event Data|Phase III Component||117||
59735051|NCT00922974|75853690|FG000|Eligible, Treated, Adverse Event Data|Phase III Component||148|Eligible, started protocol treatment, and has adverse event data|
59735052|NCT00922974|75853691|FG001|Eligible, Treated, Adverse Event Data|Phase III Component||83|Eligible, started protocol treatment, and has adverse event data|
59735053|NCT00922974|75853690|FG000|Eligible and Consented to Quality of Life Participate in Quality of Life (QOL) Study Component|Phase III Component||152||
59735054|NCT00922974|75853691|FG001|Eligible and Consented to Quality of Life Participate in Quality of Life (QOL) Study Component|Phase III Component||100||
59735055|NCT00922974|75853690|FG000|COMPLETED|Phase III Component||209|Subjects contributing any data to analysis are considered to have completed the study|
59735056|NCT00922974|75853691|FG001|COMPLETED|Phase III Component||130|Subjects contributing any data to analysis are considered to have completed the study|
59735057|NCT00922974|75853690|FG000|NOT COMPLETED|Phase III Component||8||
59735058|NCT00922974|75853691|FG001|NOT COMPLETED|Phase III Component||6||
59735059|NCT00858988|75853701|FG000|STARTED|Randomized and Allocation||74||
59735060|NCT00858988|75853702|FG001|STARTED|Randomized and Allocation||73||
59735061|NCT00858988|75853701|FG000|COMPLETED|Randomized and Allocation||74||
59735062|NCT00858988|75853702|FG001|COMPLETED|Randomized and Allocation||73||
59735063|NCT00858988|75853701|FG000|NOT COMPLETED|Randomized and Allocation||0||
59735064|NCT00858988|75853702|FG001|NOT COMPLETED|Randomized and Allocation||0||
59735065|NCT00858988|75853701|FG000|STARTED|Analysis||74||
59735066|NCT00858988|75853702|FG001|STARTED|Analysis||73||
59735067|NCT00858988|75853701|FG000|COMPLETED|Analysis||72||
59735068|NCT00858988|75853702|FG001|COMPLETED|Analysis||72||
59735069|NCT00858988|75853701|FG000|NOT COMPLETED|Analysis||2||
59735070|NCT00858988|75853702|FG001|NOT COMPLETED|Analysis||1||
59735071|NCT00858832|75853710|FG000|STARTED|Overall Study|study terminated early due to enrollment deficiencies|21||
59735072|NCT00858832|75853711|FG001|STARTED|Overall Study||23||
59735073|NCT00858832|75853710|FG000|COMPLETED|Overall Study||20||
59601996|NCT00402883|75712219|FG000|STARTED|Induction Therapy||5||
59601997|NCT00402883|75712219|FG000|COMPLETED|Induction Therapy||5||
59601998|NCT00402883|75712219|FG000|NOT COMPLETED|Induction Therapy||0||
59601999|NCT00402883|75712219|FG000|STARTED|Consolidation Therapy||5||
59602000|NCT00402883|75712219|FG000|COMPLETED|Consolidation Therapy||5||
59735074|NCT00858832|75853711|FG001|COMPLETED|Overall Study||22||
59735075|NCT00858832|75853710|FG000|NOT COMPLETED|Overall Study||1||
59735076|NCT00858832|75853711|FG001|NOT COMPLETED|Overall Study||1||
59735077|NCT01071512|75853717|FG000|STARTED|Overall Study||20||
59735078|NCT01071512|75853717|FG000|COMPLETED|Overall Study||15||
59735079|NCT01071512|75853717|FG000|NOT COMPLETED|Overall Study||5||
59735080|NCT00858442|75853723|FG000|STARTED|From Surgery to Start Compression;||21||
59735081|NCT00858442|75853724|FG001|STARTED|From Surgery to Start Compression;||23||
59735082|NCT00858442|75853723|FG000|COMPLETED|From Surgery to Start Compression;||21||
59735083|NCT00858442|75853724|FG001|COMPLETED|From Surgery to Start Compression;||23||
59735084|NCT00858442|75853723|FG000|NOT COMPLETED|From Surgery to Start Compression;||0||
59735085|NCT00858442|75853724|FG001|NOT COMPLETED|From Surgery to Start Compression;||0||
59735086|NCT00858442|75853723|FG000|STARTED|Compression:Start to Finish||21||
59735087|NCT00858442|75853724|FG001|STARTED|Compression:Start to Finish||23||
59735088|NCT00858442|75853723|FG000|COMPLETED|Compression:Start to Finish||20||
59735089|NCT00858442|75853724|FG001|COMPLETED|Compression:Start to Finish||20||
59735090|NCT00858442|75853723|FG000|NOT COMPLETED|Compression:Start to Finish||1||
59735091|NCT00858442|75853724|FG001|NOT COMPLETED|Compression:Start to Finish||3||
59735092|NCT01071278|75853731|FG000|STARTED|Overall Study||2390||
59735093|NCT01071278|75853731|FG000|COMPLETED|Overall Study||1677||
59735094|NCT01071278|75853731|FG000|NOT COMPLETED|Overall Study||713||
59735095|NCT00858208|75853737|FG000|STARTED|Overall Study||85||
59735096|NCT00858208|75853737|FG000|COMPLETED|Overall Study||6||
59735097|NCT00858208|75853737|FG000|NOT COMPLETED|Overall Study||79||
59735098|NCT01071200|75853743|FG000|STARTED|Overall Study||67||
59735099|NCT01071200|75853744|FG001|STARTED|Overall Study||66||
59735100|NCT01071200|75853743|FG000|COMPLETED|Overall Study||60||
59735101|NCT01071200|75853744|FG001|COMPLETED|Overall Study||63||
59735102|NCT01071200|75853743|FG000|NOT COMPLETED|Overall Study||7||
59735103|NCT01071200|75853744|FG001|NOT COMPLETED|Overall Study||3||
59735104|NCT02207569|75853750|FG000|STARTED|Implant|241 Attempted Implant|241||
59735105|NCT02207569|75853750|FG000|COMPLETED|Implant|237 Implanted|241||
59735106|NCT02207569|75853750|FG000|NOT COMPLETED|Implant||0||
59735107|NCT02207569|75853750|FG000|STARTED|1-Month|241 Attempted Implant|241||
59735108|NCT02207569|75853750|FG000|COMPLETED|1-Month||232||
59735109|NCT02207569|75853750|FG000|NOT COMPLETED|1-Month||9||
59735110|NCT02207569|75853750|FG000|STARTED|6-Month||232||
59735111|NCT02207569|75853750|FG000|COMPLETED|6-Month||222||
59735112|NCT02207569|75853750|FG000|NOT COMPLETED|6-Month||10||
59735113|NCT02207569|75853750|FG000|STARTED|12-Month||213||
59735114|NCT02207569|75853750|FG000|COMPLETED|12-Month||197||
59735115|NCT02207569|75853750|FG000|NOT COMPLETED|12-Month||16||
59735116|NCT02207569|75853750|FG000|STARTED|24-Month||197||
59735117|NCT02207569|75853750|FG000|COMPLETED|24-Month||171||
59735118|NCT02207569|75853750|FG000|NOT COMPLETED|24-Month||26||
59735119|NCT02207569|75853750|FG000|STARTED|36-Month||171||
59735120|NCT02207569|75853750|FG000|COMPLETED|36-Month||144||
59735121|NCT02207569|75853750|FG000|NOT COMPLETED|36-Month||27||
59735122|NCT02207569|75853750|FG000|STARTED|48-Month||144||
59735123|NCT02207569|75853750|FG000|COMPLETED|48-Month||113||
59735124|NCT02207569|75853750|FG000|NOT COMPLETED|48-Month||31||
59735125|NCT02207569|75853750|FG000|STARTED|60-Month||113||
59735126|NCT02207569|75853750|FG000|COMPLETED|60-Month||109||
59735127|NCT02207569|75853750|FG000|NOT COMPLETED|60-Month||4||
59735128|NCT01070966|75853754|FG000|STARTED|Participants for Safety Evaluation||2089||
59735129|NCT01070966|75853754|FG000|COMPLETED|Participants for Safety Evaluation||2011||
59735130|NCT01070966|75853754|FG000|NOT COMPLETED|Participants for Safety Evaluation||78||
59735131|NCT01070966|75853754|FG000|STARTED|Participants for Efficacy Evaluation||2011||
59735132|NCT01070966|75853754|FG000|COMPLETED|Participants for Efficacy Evaluation||1929||
59735133|NCT01070966|75853754|FG000|NOT COMPLETED|Participants for Efficacy Evaluation||82||
59735134|NCT01070888|75853767|FG000|STARTED|First Intervention (14 Days)||2||
59735135|NCT01070888|75853768|FG001|STARTED|First Intervention (14 Days)||4||
59735136|NCT01070888|75853767|FG000|COMPLETED|First Intervention (14 Days)||2||
59735137|NCT01070888|75853768|FG001|COMPLETED|First Intervention (14 Days)||2||
59735138|NCT01070888|75853767|FG000|NOT COMPLETED|First Intervention (14 Days)||0||
59735139|NCT01070888|75853768|FG001|NOT COMPLETED|First Intervention (14 Days)||2||
59735140|NCT01070888|75853767|FG000|STARTED|Washout (14 Days)||2||
59735141|NCT01070888|75853768|FG001|STARTED|Washout (14 Days)||2||
59735142|NCT01070888|75853767|FG000|COMPLETED|Washout (14 Days)||1||
59735143|NCT01070888|75853768|FG001|COMPLETED|Washout (14 Days)||2||
59868839|NCT04067492|75993257|FG000|STARTED|Overall Study||15||
59735144|NCT01070888|75853767|FG000|NOT COMPLETED|Washout (14 Days)||1||
59735145|NCT01070888|75853768|FG001|NOT COMPLETED|Washout (14 Days)||0||
59735146|NCT01070888|75853767|FG000|STARTED|Second Intervention (14 Days)||1||
59735147|NCT01070888|75853768|FG001|STARTED|Second Intervention (14 Days)||2||
59735148|NCT01070888|75853767|FG000|COMPLETED|Second Intervention (14 Days)||1||
59735149|NCT01070888|75853768|FG001|COMPLETED|Second Intervention (14 Days)||2||
59735150|NCT01070888|75853767|FG000|NOT COMPLETED|Second Intervention (14 Days)||0||
59735151|NCT01070888|75853768|FG001|NOT COMPLETED|Second Intervention (14 Days)||0||
59735152|NCT00857896|75853774|FG000|STARTED|Baseline to Week 4||21||
59735153|NCT00857896|75853774|FG000|COMPLETED|Baseline to Week 4||20||
59735154|NCT00857896|75853774|FG000|NOT COMPLETED|Baseline to Week 4||1||
59735155|NCT00857896|75853774|FG000|STARTED|Week 5 to Week 8||20||
59735156|NCT00857896|75853774|FG000|COMPLETED|Week 5 to Week 8||20||
59735157|NCT00857896|75853774|FG000|NOT COMPLETED|Week 5 to Week 8||0||
59735158|NCT00857818|75853781|FG000|STARTED|Overall Study||14||
59735159|NCT00857818|75853782|FG001|STARTED|Overall Study||14||
59735160|NCT00857818|75853781|FG000|Received Treatment|Overall Study||14||
59735161|NCT00857818|75853782|FG001|Received Treatment|Overall Study||12||
59735162|NCT00857818|75853781|FG000|COMPLETED|Overall Study||3||
59735163|NCT00857818|75853782|FG001|COMPLETED|Overall Study||6||
59735164|NCT00857818|75853781|FG000|NOT COMPLETED|Overall Study||11||
59735165|NCT00857818|75853782|FG001|NOT COMPLETED|Overall Study||8||
59735166|NCT01074944|75853788|FG000|STARTED|Lead-in Period (up to 78 Weeks)|LIP conducted to assess randomization criteria of all participants in single reporting arm.|170||
59735167|NCT01074944|75853789|FG001|STARTED|Lead-in Period (up to 78 Weeks)||0||
59735168|NCT01074944|75853790|FG002|STARTED|Lead-in Period (up to 78 Weeks)||0||
59735169|NCT01074944|75853791|FG003|STARTED|Lead-in Period (up to 78 Weeks)||0||
59735170|NCT01074944|75853792|FG004|STARTED|Lead-in Period (up to 78 Weeks)||0||
59735171|NCT01074944|75853788|FG000|COMPLETED|Lead-in Period (up to 78 Weeks)||157||
59735172|NCT01074944|75853789|FG001|COMPLETED|Lead-in Period (up to 78 Weeks)||0||
59735173|NCT01074944|75853790|FG002|COMPLETED|Lead-in Period (up to 78 Weeks)||0||
59735174|NCT01074944|75853791|FG003|COMPLETED|Lead-in Period (up to 78 Weeks)||0||
59735175|NCT01074944|75853792|FG004|COMPLETED|Lead-in Period (up to 78 Weeks)||0||
60000679|NCT02149420|76116397|FG001|COMPLETED|Open Label VAY736 10 mg/kg Extension||0||
60000680|NCT02149420|76116398|FG002|COMPLETED|Open Label VAY736 10 mg/kg Extension||0||
60000681|NCT02149420|76116396|FG000|NOT COMPLETED|Open Label VAY736 10 mg/kg Extension||1||
60000682|NCT02149420|76116397|FG001|NOT COMPLETED|Open Label VAY736 10 mg/kg Extension||0||
60000683|NCT02149420|76116398|FG002|NOT COMPLETED|Open Label VAY736 10 mg/kg Extension||0||
60000684|NCT02149264|76116411|FG000|STARTED|Overall Study|Of the 160 enrolled subjects, one discontinued before receiving treatment.|159||
60000685|NCT02149264|76116411|FG000|COMPLETED|Overall Study||139||
60000686|NCT02149264|76116411|FG000|NOT COMPLETED|Overall Study||20||
60000687|NCT02115256|76116417|FG000|STARTED|Overall Study||3||
60000688|NCT02115256|76116418|FG001|STARTED|Overall Study||3||
59735176|NCT01074944|75853788|FG000|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||13||
59735177|NCT01074944|75853789|FG001|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||0||
59735178|NCT01074944|75853790|FG002|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||0||
59735179|NCT01074944|75853791|FG003|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||0||
59735180|NCT01074944|75853792|FG004|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||0||
59735181|NCT01074944|75853788|FG000|STARTED|Primary Analysis Period (up to 52 Weeks)||0||
59735182|NCT01074944|75853789|FG001|STARTED|Primary Analysis Period (up to 52 Weeks)|Participants who were randomized after LIP received treatment in PAP.|65||
59735183|NCT01074944|75853790|FG002|STARTED|Primary Analysis Period (up to 52 Weeks)|Participants who were randomized after LIP received treatment in PAP.|66||
59735184|NCT01074944|75853791|FG003|STARTED|Primary Analysis Period (up to 52 Weeks)||0||
59735185|NCT01074944|75853792|FG004|STARTED|Primary Analysis Period (up to 52 Weeks)||0||
59735186|NCT01074944|75853788|FG000|COMPLETED|Primary Analysis Period (up to 52 Weeks)||0||
59735187|NCT01074944|75853789|FG001|COMPLETED|Primary Analysis Period (up to 52 Weeks)||54||
59735188|NCT01074944|75853790|FG002|COMPLETED|Primary Analysis Period (up to 52 Weeks)||60||
59735189|NCT01074944|75853791|FG003|COMPLETED|Primary Analysis Period (up to 52 Weeks)||0||
59735190|NCT01074944|75853792|FG004|COMPLETED|Primary Analysis Period (up to 52 Weeks)||0||
59735191|NCT01074944|75853788|FG000|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||0||
59735192|NCT01074944|75853789|FG001|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||11||
59735193|NCT01074944|75853790|FG002|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||6||
59735194|NCT01074944|75853791|FG003|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||0||
59735195|NCT01074944|75853792|FG004|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||0||
59735196|NCT01074944|75853788|FG000|STARTED|Long Term Treatment||0||
59735197|NCT01074944|75853789|FG001|STARTED|Long Term Treatment||0||
59735198|NCT01074944|75853790|FG002|STARTED|Long Term Treatment||0||
59735199|NCT01074944|75853791|FG003|STARTED|Long Term Treatment|Participants who completed PAP (114) including those who considered as treatment failure in PAP (7).|121||
59735200|NCT01074944|75853792|FG004|STARTED|Long Term Treatment||0||
59735201|NCT01074944|75853788|FG000|COMPLETED|Long Term Treatment||0||
59735202|NCT01074944|75853789|FG001|COMPLETED|Long Term Treatment||0||
59735203|NCT01074944|75853790|FG002|COMPLETED|Long Term Treatment||0||
59735204|NCT01074944|75853791|FG003|COMPLETED|Long Term Treatment||95||
59735205|NCT01074944|75853792|FG004|COMPLETED|Long Term Treatment||0||
59735206|NCT01074944|75853788|FG000|NOT COMPLETED|Long Term Treatment||0||
59735207|NCT01074944|75853789|FG001|NOT COMPLETED|Long Term Treatment||0||
59735208|NCT01074944|75853790|FG002|NOT COMPLETED|Long Term Treatment||0||
59735209|NCT01074944|75853791|FG003|NOT COMPLETED|Long Term Treatment||26||
59735210|NCT01074944|75853792|FG004|NOT COMPLETED|Long Term Treatment||0||
59735211|NCT01074944|75853788|FG000|STARTED|Extended Treatment (up to 42 Months)||0||
59762488|NCT02644525|75882209|FG000|COMPLETED|Group 3||1||
60000689|NCT02115256|76116417|FG000|COMPLETED|Overall Study||3||
60000690|NCT02115256|76116418|FG001|COMPLETED|Overall Study||2||
60000691|NCT02115256|76116417|FG000|NOT COMPLETED|Overall Study||0||
59735212|NCT01074944|75853789|FG001|STARTED|Extended Treatment (up to 42 Months)||0||
59735213|NCT01074944|75853790|FG002|STARTED|Extended Treatment (up to 42 Months)||0||
59735214|NCT01074944|75853791|FG003|STARTED|Extended Treatment (up to 42 Months)||0||
59735215|NCT01074944|75853792|FG004|STARTED|Extended Treatment (up to 42 Months)|Participants who were failed to meet the randomization criteria during the lead-in period.|25||
59735216|NCT01074944|75853788|FG000|COMPLETED|Extended Treatment (up to 42 Months)||0||
59735217|NCT01074944|75853789|FG001|COMPLETED|Extended Treatment (up to 42 Months)||0||
59735218|NCT01074944|75853790|FG002|COMPLETED|Extended Treatment (up to 42 Months)||0||
59735219|NCT01074944|75853791|FG003|COMPLETED|Extended Treatment (up to 42 Months)||0||
59735220|NCT01074944|75853792|FG004|COMPLETED|Extended Treatment (up to 42 Months)||20||
59735221|NCT01074944|75853788|FG000|NOT COMPLETED|Extended Treatment (up to 42 Months)||0||
59735222|NCT01074944|75853789|FG001|NOT COMPLETED|Extended Treatment (up to 42 Months)||0||
59735223|NCT01074944|75853790|FG002|NOT COMPLETED|Extended Treatment (up to 42 Months)||0||
59735224|NCT01074944|75853791|FG003|NOT COMPLETED|Extended Treatment (up to 42 Months)||0||
59735225|NCT01074944|75853792|FG004|NOT COMPLETED|Extended Treatment (up to 42 Months)||5||
59735226|NCT00802945|75853802|FG000|STARTED|Overall Study||35||
59735227|NCT00802945|75853803|FG001|STARTED|Overall Study||35||
59735228|NCT00802945|75853802|FG000|COMPLETED|Overall Study||0||
59735229|NCT00802945|75853803|FG001|COMPLETED|Overall Study||0||
59735230|NCT00802945|75853802|FG000|NOT COMPLETED|Overall Study||35||
59735231|NCT00802945|75853803|FG001|NOT COMPLETED|Overall Study||35||
59735232|NCT01074554|75853813|FG000|STARTED|Overall Study||14||
59735233|NCT01074554|75853814|FG001|STARTED|Overall Study||15||
59735234|NCT01074554|75853813|FG000|COMPLETED|Overall Study||11||
59735235|NCT01074554|75853814|FG001|COMPLETED|Overall Study||11||
59735236|NCT01074554|75853813|FG000|NOT COMPLETED|Overall Study||3||
59735237|NCT01074554|75853814|FG001|NOT COMPLETED|Overall Study||4||
59735238|NCT00857584|75853822|FG000|STARTED|Overall Study||14||
59735239|NCT00857584|75853823|FG001|STARTED|Overall Study||13||
59735240|NCT00857584|75853822|FG000|Week 1|Overall Study||14||
59735241|NCT00857584|75853823|FG001|Week 1|Overall Study||13||
59735242|NCT00857584|75853822|FG000|Week 2|Overall Study||14||
59735243|NCT00857584|75853823|FG001|Week 2|Overall Study||11||
59735244|NCT00857584|75853822|FG000|Week 4|Overall Study||11||
59735245|NCT00857584|75853823|FG001|Week 4|Overall Study||9||
59735246|NCT00857584|75853822|FG000|Week 8|Overall Study||10||
59735247|NCT00857584|75853823|FG001|Week 8|Overall Study||8||
59735248|NCT00857584|75853822|FG000|COMPLETED|Overall Study||10||
59735249|NCT00857584|75853823|FG001|COMPLETED|Overall Study||8||
59735250|NCT00857584|75853822|FG000|NOT COMPLETED|Overall Study||4||
59735251|NCT00857584|75853823|FG001|NOT COMPLETED|Overall Study||5||
59735252|NCT00798967|75853831|FG000|STARTED|Overall Study||43||
59735253|NCT00798967|75853832|FG001|STARTED|Overall Study||43||
59735254|NCT00798967|75853831|FG000|Discontinued During Dosing Period|Overall Study||4||
59735255|NCT00798967|75853832|FG001|Discontinued During Dosing Period|Overall Study||4||
59735256|NCT00798967|75853831|FG000|COMPLETED|Overall Study||39||
59735257|NCT00798967|75853832|FG001|COMPLETED|Overall Study||39||
59735258|NCT00798967|75853831|FG000|NOT COMPLETED|Overall Study||4||
59735259|NCT00798967|75853832|FG001|NOT COMPLETED|Overall Study||4||
59735260|NCT01074242|75853839|FG000|STARTED|Overall Study||3798||
59735261|NCT01074242|75853839|FG000|Received at Least 1 Dose of Vaccine|Overall Study||3395||
59735262|NCT01074242|75853839|FG000|COMPLETED|Overall Study||3395||
59735263|NCT01074242|75853839|FG000|NOT COMPLETED|Overall Study||403||
59735264|NCT00798889|75853843|FG000|STARTED|Overall Study||314||
59735265|NCT00798889|75853843|FG000|Treated|Overall Study||311||
59735266|NCT00798889|75853843|FG000|COMPLETED|Overall Study||0||
59735267|NCT00798889|75853843|FG000|NOT COMPLETED|Overall Study||314||
59735268|NCT00796861|75853847|FG000|STARTED|Overall Study||4||
59735269|NCT00796861|75853847|FG000|COMPLETED|Overall Study||0||
59735270|NCT00796861|75853847|FG000|NOT COMPLETED|Overall Study||4||
59735271|NCT00802867|75853851|FG000|STARTED|Overall Study||989||
59735272|NCT00802867|75853851|FG000|COMPLETED|Overall Study||976||
59735273|NCT00802867|75853851|FG000|NOT COMPLETED|Overall Study||13||
59735274|NCT00798655|75853855|FG000|STARTED|Overall Study||46||
59735275|NCT00798655|75853855|FG000|COMPLETED|Overall Study||44||
59735276|NCT00798655|75853855|FG000|NOT COMPLETED|Overall Study||2||
59735277|NCT00796549|75853859|FG000|STARTED|Overall Study|Excluding duplicate records for 5 patients who were screened twice|218||
59735278|NCT00796549|75853859|FG000|Entered|Overall Study|entered and treated|69||
59735279|NCT00796549|75853859|FG000|COMPLETED|Overall Study||0||
59735280|NCT00796549|75853859|FG000|NOT COMPLETED|Overall Study||218||
59735281|NCT00856492|75853868|FG000|STARTED|Overall Study||99||
59735282|NCT00856492|75853869|FG001|STARTED|Overall Study||63||
59735283|NCT00856492|75853870|FG002|STARTED|Overall Study||53||
59735284|NCT00856492|75853868|FG000|Toxicity Eval|Overall Study||96|Fewer pts evaluable for toxicity vs arm totals b/c 2 pts on each arm did not receive any treatment|
59735285|NCT00856492|75853869|FG001|Toxicity Eval|Overall Study||60|Fewer pts evaluable for toxicity vs arm totals b/c 2 pts on each arm did not receive any treatment|
59735286|NCT00856492|75853870|FG002|Toxicity Eval|Overall Study||51|Fewer pts evaluable for toxicity vs arm totals b/c 2 pts on each arm did not receive any treatment|
59735287|NCT00856492|75853868|FG000|COMPLETED|Overall Study||98||
59735288|NCT00856492|75853869|FG001|COMPLETED|Overall Study||62||
59735289|NCT00856492|75853870|FG002|COMPLETED|Overall Study||51||
59735290|NCT00856492|75853868|FG000|NOT COMPLETED|Overall Study||1||
59735291|NCT00856492|75853869|FG001|NOT COMPLETED|Overall Study||1||
59735292|NCT00856492|75853870|FG002|NOT COMPLETED|Overall Study||2||
59735293|NCT00856180|75853881|FG000|STARTED|Overall Study||20||
59735294|NCT00856180|75853881|FG000|COMPLETED|Overall Study||0||
59735295|NCT00856180|75853881|FG000|NOT COMPLETED|Overall Study||20||
59735296|NCT00900627|75853893|FG000|STARTED|Overall Study||6||
59735297|NCT00900627|75853894|FG001|STARTED|Overall Study||2||
59735298|NCT00900627|75853895|FG002|STARTED|Overall Study||6||
59735299|NCT00900627|75853896|FG003|STARTED|Overall Study||6||
59735300|NCT00900627|75853897|FG004|STARTED|Overall Study|The values under 'Not Completed' are based on the time of the primary analysis|94||
59735301|NCT00900627|75853898|FG005|STARTED|Overall Study|The values under 'Not Completed' are based on the time of the primary analysis|96||
59735302|NCT00900627|75853893|FG000|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|0||
59735303|NCT00900627|75853894|FG001|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|0||
59735304|NCT00900627|75853895|FG002|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|0||
59735305|NCT00900627|75853896|FG003|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|0||
59735306|NCT00900627|75853897|FG004|COMPLETED|Overall Study|No set completion, pts were to remain in study until withdrawn|65||
59735307|NCT00900627|75853898|FG005|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|70||
59735308|NCT00900627|75853893|FG000|NOT COMPLETED|Overall Study||6||
59735309|NCT00900627|75853894|FG001|NOT COMPLETED|Overall Study||2||
59735310|NCT00900627|75853895|FG002|NOT COMPLETED|Overall Study||6||
59735311|NCT00900627|75853896|FG003|NOT COMPLETED|Overall Study||6||
59735312|NCT00900627|75853897|FG004|NOT COMPLETED|Overall Study||29||
59735313|NCT00900627|75853898|FG005|NOT COMPLETED|Overall Study||26||
59735314|NCT00866320|75853912|FG000|STARTED|Overall Study||49||
59735315|NCT00866320|75853912|FG000|COMPLETED|Overall Study|All patients that received treatment were analyzed.|43||
59735316|NCT00866320|75853912|FG000|NOT COMPLETED|Overall Study||6||
59735317|NCT00869518|75853920|FG000|STARTED|Overall Study||6||
59735318|NCT00869518|75853921|FG001|STARTED|Overall Study||6||
59735319|NCT00869518|75853920|FG000|COMPLETED|Overall Study||5||
59735320|NCT00869518|75853921|FG001|COMPLETED|Overall Study||5||
59735321|NCT00869518|75853920|FG000|NOT COMPLETED|Overall Study||1||
59735322|NCT00869518|75853921|FG001|NOT COMPLETED|Overall Study||1||
59735323|NCT00797563|75853927|FG000|STARTED|Overall Study|number of subjects|102||
59735324|NCT00797563|75853927|FG000|COMPLETED|Overall Study||101||
59735325|NCT00797563|75853927|FG000|NOT COMPLETED|Overall Study||1||
59735326|NCT00869440|75853935|FG000|STARTED|Overall Study||25||
59735327|NCT00869440|75853936|FG001|STARTED|Overall Study||25||
59735328|NCT00869440|75853937|FG002|STARTED|Overall Study||25||
59735329|NCT00869440|75853938|FG003|STARTED|Overall Study||25||
59735330|NCT00869440|75853935|FG000|COMPLETED|Overall Study||23||
59735331|NCT00869440|75853936|FG001|COMPLETED|Overall Study||24||
59735332|NCT00869440|75853937|FG002|COMPLETED|Overall Study||25||
59735333|NCT00869440|75853938|FG003|COMPLETED|Overall Study||25||
59735334|NCT00869440|75853935|FG000|NOT COMPLETED|Overall Study||2||
59735335|NCT00869440|75853936|FG001|NOT COMPLETED|Overall Study||1||
59735336|NCT00869440|75853937|FG002|NOT COMPLETED|Overall Study||0||
59735337|NCT00869440|75853938|FG003|NOT COMPLETED|Overall Study||0||
59735338|NCT00895947|75853950|FG000|STARTED|Overall Study||100||
59735339|NCT00895947|75853951|FG001|STARTED|Overall Study||100||
59735340|NCT00895947|75853950|FG000|COMPLETED|Overall Study||88||
59735341|NCT00895947|75853951|FG001|COMPLETED|Overall Study||90||
59735342|NCT00895947|75853950|FG000|NOT COMPLETED|Overall Study||12||
59735343|NCT00895947|75853951|FG001|NOT COMPLETED|Overall Study||10||
59735344|NCT00869362|75853959|FG000|STARTED|Overall Study||15||
59735345|NCT00869362|75853960|FG001|STARTED|Overall Study||16||
59735346|NCT00869362|75853959|FG000|COMPLETED|Overall Study||14||
59735347|NCT00869362|75853960|FG001|COMPLETED|Overall Study||11||
59735348|NCT00869362|75853959|FG000|NOT COMPLETED|Overall Study||1||
59735349|NCT00869362|75853960|FG001|NOT COMPLETED|Overall Study||5||
59735350|NCT00588445|75853967|FG000|STARTED|Overall Study||65||
59735351|NCT00588445|75853967|FG000|COMPLETED|Overall Study||50||
59735352|NCT00588445|75853967|FG000|NOT COMPLETED|Overall Study||15||
59735353|NCT00796315|75853973|FG000|STARTED|Overall Study||9||
59735354|NCT00796315|75853974|FG001|STARTED|Overall Study||17||
59735355|NCT00796315|75853975|FG002|STARTED|Overall Study||15||
59735356|NCT00796315|75853973|FG000|COMPLETED|Overall Study||9||
59735357|NCT00796315|75853974|FG001|COMPLETED|Overall Study||16||
59735358|NCT00796315|75853975|FG002|COMPLETED|Overall Study||15||
59735359|NCT00796315|75853973|FG000|NOT COMPLETED|Overall Study||0||
59735360|NCT00796315|75853974|FG001|NOT COMPLETED|Overall Study||1||
59735361|NCT00796315|75853975|FG002|NOT COMPLETED|Overall Study||0||
59735362|NCT00855166|75853988|FG000|STARTED|Overall Study||91||
59735363|NCT00855166|75853989|FG001|STARTED|Overall Study|Of the 91 randomized participants only 89 were included in the full analysis set.|91||
59735364|NCT00855166|75853988|FG000|COMPLETED|Overall Study||86||
59735365|NCT00855166|75853989|FG001|COMPLETED|Overall Study||83||
59735366|NCT00855166|75853988|FG000|NOT COMPLETED|Overall Study||5||
59735367|NCT00855166|75853989|FG001|NOT COMPLETED|Overall Study||8||
59735368|NCT00587587|75853999|FG000|STARTED|Overall Study||17||
59735369|NCT00587587|75854000|FG001|STARTED|Overall Study||13||
59735370|NCT00587587|75853999|FG000|COMPLETED|Overall Study||11||
59735371|NCT00587587|75854000|FG001|COMPLETED|Overall Study||12||
59735372|NCT00587587|75853999|FG000|NOT COMPLETED|Overall Study||6||
59735373|NCT00587587|75854000|FG001|NOT COMPLETED|Overall Study||1||
59735374|NCT00854620|75854008|FG000|STARTED|Overall Study||9||
59735375|NCT00854620|75854008|FG000|COMPLETED|Overall Study||8||
59735376|NCT00854620|75854008|FG000|NOT COMPLETED|Overall Study||1||
59735377|NCT00793585|75854014|FG000|STARTED|Overall Study||19||
59735378|NCT00793585|75854015|FG001|STARTED|Overall Study||21||
59735379|NCT00793585|75854014|FG000|COMPLETED|Overall Study||17||
59735380|NCT00793585|75854015|FG001|COMPLETED|Overall Study||18||
59735381|NCT00793585|75854014|FG000|NOT COMPLETED|Overall Study||2||
59735382|NCT00793585|75854015|FG001|NOT COMPLETED|Overall Study||3||
60000692|NCT02115256|76116418|FG001|NOT COMPLETED|Overall Study||1||
60000693|NCT02173054|76116427|FG000|STARTED|Overall Study||40||
60000694|NCT02173054|76116428|FG001|STARTED|Overall Study||40||
60000695|NCT02173054|76116429|FG002|STARTED|Overall Study||40||
60000696|NCT02173054|76116427|FG000|COMPLETED|Overall Study||39||
60000697|NCT02173054|76116428|FG001|COMPLETED|Overall Study||40||
60000698|NCT02173054|76116429|FG002|COMPLETED|Overall Study||39||
60000699|NCT02173054|76116427|FG000|NOT COMPLETED|Overall Study||1||
60000700|NCT02173054|76116428|FG001|NOT COMPLETED|Overall Study||0||
60000701|NCT02173054|76116429|FG002|NOT COMPLETED|Overall Study||1||
60000702|NCT04225221|76116439|FG000|STARTED|Lupron and Placebo Baseline (6 Weeks)||6|One participant experienced a topical skin reaction to the Lupron injection and received only 1 Lupron injection and no placebo during the first period. The participant completed a shortened phase of Lupron alone for 2 weeks and proceeded directly to the first intervention followed by the second intervention (with no washout in between). Because this participant did not complete the full 6-weeks, they are counted as not complete.|
60000703|NCT04225221|76116440|FG001|STARTED|Lupron and Placebo Baseline (6 Weeks)||4|One participant experienced a topical skin reaction to the Lupron injection and received only 1 Lupron injection and no placebo during the first period. The participant completed a shortened phase of Lupron alone for 2 weeks and proceeded directly to the first intervention followed by the second intervention (with no washout in between). Because this participant did not complete the full 6-weeks, they are counted as not complete.|
60000704|NCT04225221|76116439|FG000|COMPLETED|Lupron and Placebo Baseline (6 Weeks)||5||
60000705|NCT04225221|76116440|FG001|COMPLETED|Lupron and Placebo Baseline (6 Weeks)||4||
60000706|NCT04225221|76116439|FG000|NOT COMPLETED|Lupron and Placebo Baseline (6 Weeks)||1||
60000707|NCT04225221|76116440|FG001|NOT COMPLETED|Lupron and Placebo Baseline (6 Weeks)||0||
60000708|NCT04225221|76116439|FG000|STARTED|First Intervention (2 Weeks)||6||
60000709|NCT04225221|76116440|FG001|STARTED|First Intervention (2 Weeks)||4||
60000710|NCT04225221|76116439|FG000|COMPLETED|First Intervention (2 Weeks)||6||
60000711|NCT04225221|76116440|FG001|COMPLETED|First Intervention (2 Weeks)||4||
60000712|NCT04225221|76116439|FG000|NOT COMPLETED|First Intervention (2 Weeks)||0||
60000713|NCT04225221|76116440|FG001|NOT COMPLETED|First Intervention (2 Weeks)||0||
60000714|NCT04225221|76116439|FG000|STARTED|Washout (2 Weeks)||5|One participant experienced a topical skin reaction to the Lupron injection and received only 1 Lupron injection. The participant remained on Lupron alone for 2 weeks and proceeded directly to the first intervention followed by the second intervention (with no washout in between).|
60000715|NCT04225221|76116440|FG001|STARTED|Washout (2 Weeks)||4|One participant experienced a topical skin reaction to the Lupron injection and received only 1 Lupron injection. The participant remained on Lupron alone for 2 weeks and proceeded directly to the first intervention followed by the second intervention (with no washout in between).|
60000716|NCT04225221|76116439|FG000|COMPLETED|Washout (2 Weeks)||4||
60000717|NCT04225221|76116440|FG001|COMPLETED|Washout (2 Weeks)||4||
60000718|NCT04225221|76116439|FG000|NOT COMPLETED|Washout (2 Weeks)||1||
60000719|NCT04225221|76116440|FG001|NOT COMPLETED|Washout (2 Weeks)||0||
60000720|NCT04225221|76116439|FG000|STARTED|Second Intervention (2 Weeks)||5||
60000721|NCT04225221|76116440|FG001|STARTED|Second Intervention (2 Weeks)||4||
60000722|NCT04225221|76116439|FG000|COMPLETED|Second Intervention (2 Weeks)||5||
60000723|NCT04225221|76116440|FG001|COMPLETED|Second Intervention (2 Weeks)||4||
60000724|NCT04225221|76116439|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||0||
60000725|NCT04225221|76116440|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||0||
59735383|NCT00898443|75854023|FG000|STARTED|Overall Study||10||
59735384|NCT00898443|75854024|FG001|STARTED|Overall Study||8||
59735385|NCT00898443|75854023|FG000|COMPLETED|Overall Study||9||
59735386|NCT00898443|75854024|FG001|COMPLETED|Overall Study||8||
59735387|NCT00898443|75854023|FG000|NOT COMPLETED|Overall Study||1||
59735388|NCT00898443|75854024|FG001|NOT COMPLETED|Overall Study||0||
59735389|NCT00900159|75854032|FG000|STARTED|First Intervention||11||
60000726|NCT03971643|76116450|FG000|STARTED|Overall Study||6||
60000727|NCT03971643|76116451|FG001|STARTED|Overall Study||6||
60000728|NCT03971643|76116452|FG002|STARTED|Overall Study||7||
60000729|NCT03971643|76116450|FG000|Completed Until Day 99 (Evaluable)|Overall Study||6||
60000730|NCT03971643|76116451|FG001|Completed Until Day 99 (Evaluable)|Overall Study||4||
60000731|NCT03971643|76116452|FG002|Completed Until Day 99 (Evaluable)|Overall Study||7||
60000732|NCT03971643|76116450|FG000|COMPLETED|Overall Study||1||
60000733|NCT03971643|76116451|FG001|COMPLETED|Overall Study||3||
60000734|NCT03971643|76116452|FG002|COMPLETED|Overall Study||6||
60000735|NCT03971643|76116450|FG000|NOT COMPLETED|Overall Study||5||
60000736|NCT03971643|76116451|FG001|NOT COMPLETED|Overall Study||3||
60000737|NCT03971643|76116452|FG002|NOT COMPLETED|Overall Study||1||
60000738|NCT04480749|76116465|FG000|STARTED|Overall Study||50||
60000739|NCT04480749|76116466|FG001|STARTED|Overall Study||50||
60000740|NCT04480749|76116465|FG000|COMPLETED|Overall Study||50||
60000741|NCT04480749|76116466|FG001|COMPLETED|Overall Study||50||
60000742|NCT04480749|76116465|FG000|NOT COMPLETED|Overall Study||0||
60000743|NCT04480749|76116466|FG001|NOT COMPLETED|Overall Study||0||
60000744|NCT02149108|76116474|FG000|STARTED|Overall Study|Randomised patients.|382||
60000745|NCT02149108|76116475|FG001|STARTED|Overall Study|Randomised patients.|386||
60000746|NCT02149108|76116474|FG000|COMPLETED|Overall Study|On-treatment at analysis cut-off date (14JUN2016).|2||
60000747|NCT02149108|76116475|FG001|COMPLETED|Overall Study|On-treatment at analysis cut-off date (14JUN2016).|3||
60000748|NCT02149108|76116474|FG000|NOT COMPLETED|Overall Study||380||
60000749|NCT02149108|76116475|FG001|NOT COMPLETED|Overall Study||383||
60000750|NCT02148952|76116483|FG000|STARTED|Assessing Eligibility and Consent||83166|This includes all women who registered for delivery.|60
60000751|NCT02148952|76116484|FG001|STARTED|Assessing Eligibility and Consent||80773|This includes all women who registered for delivery.|60
60000752|NCT02148952|76116483|FG000|COMPLETED|Assessing Eligibility and Consent||80063|This includes all women who were eligible for inclusion and consented to follow-up.|60
60000753|NCT02148952|76116484|FG001|COMPLETED|Assessing Eligibility and Consent||77626|This includes all women who were eligible for inclusion and consented to follow-up.|60
60000754|NCT02148952|76116483|FG000|NOT COMPLETED|Assessing Eligibility and Consent||3103||0
60000755|NCT02148952|76116484|FG001|NOT COMPLETED|Assessing Eligibility and Consent||3147||0
60000756|NCT02148952|76116483|FG000|STARTED|Follow-Up||80063||60
60000757|NCT02148952|76116484|FG001|STARTED|Follow-Up||77626||60
60000758|NCT02148952|76116483|FG000|COMPLETED|Follow-Up||79798||60
60000759|NCT02148952|76116484|FG001|COMPLETED|Follow-Up||77347||60
60000760|NCT02148952|76116483|FG000|NOT COMPLETED|Follow-Up||265||0
60000761|NCT02148952|76116484|FG001|NOT COMPLETED|Follow-Up||279||0
60000762|NCT03653091|76116500|FG000|STARTED|First 24 Weeks||6||
60000763|NCT03653091|76116501|FG001|STARTED|First 24 Weeks||3||
60000764|NCT03653091|76116500|FG000|Intent-to-Treat|First 24 Weeks||6||
60000765|NCT03653091|76116501|FG001|Intent-to-Treat|First 24 Weeks||3||
60000766|NCT03653091|76116500|FG000|As-Treated|First 24 Weeks||5|One participant randomized to the DMR arm received Sham, had the option to crossover, and was included in the Sham arm.|
60000767|NCT03653091|76116501|FG001|As-Treated|First 24 Weeks||4|One participant randomized to the DMR arm received Sham, had the option to crossover, and was included in the Sham arm.|
60000768|NCT03653091|76116500|FG000|Safety|First 24 Weeks||5||
60000769|NCT03653091|76116501|FG001|Safety|First 24 Weeks||4||
60000770|NCT03653091|76116500|FG000|COMPLETED|First 24 Weeks||6||
60000771|NCT03653091|76116501|FG001|COMPLETED|First 24 Weeks||3||
60000772|NCT03653091|76116500|FG000|NOT COMPLETED|First 24 Weeks||0||
60000773|NCT03653091|76116501|FG001|NOT COMPLETED|First 24 Weeks||0||
60000774|NCT03653091|76116500|FG000|STARTED|Second 24 Weeks||5|The As-Treated population is being used|
60000775|NCT03653091|76116501|FG001|STARTED|Second 24 Weeks||4|The As-Treated population is being used|
60000776|NCT03653091|76116500|FG000|Crossed Over to DMR at Week 24|Second 24 Weeks||0||
60000777|NCT03653091|76116501|FG001|Crossed Over to DMR at Week 24|Second 24 Weeks||3||
60000778|NCT03653091|76116500|FG000|COMPLETED|Second 24 Weeks||5||
60000779|NCT03653091|76116501|FG001|COMPLETED|Second 24 Weeks||3||
60000780|NCT03653091|76116500|FG000|NOT COMPLETED|Second 24 Weeks||0||
60000781|NCT03653091|76116501|FG001|NOT COMPLETED|Second 24 Weeks||1||
60000782|NCT02148718|76116508|FG000|STARTED|Overall Study||86|Intent to Treat (ITT) population: all enrolled participants who received ≥ 1 dose of study drug|
60000783|NCT02148718|76116508|FG000|COMPLETED|Overall Study||55||
60000784|NCT02148718|76116508|FG000|NOT COMPLETED|Overall Study||31||
60000785|NCT02148250|76116512|FG000|STARTED|Screening||17||
60000786|NCT02148250|76116513|FG001|STARTED|Screening||0||
60000787|NCT02148250|76116512|FG000|COMPLETED|Screening||12||
60000788|NCT02148250|76116513|FG001|COMPLETED|Screening||0||
60000789|NCT02148250|76116512|FG000|NOT COMPLETED|Screening||5||
60000790|NCT02148250|76116513|FG001|NOT COMPLETED|Screening||0||
60000791|NCT02148250|76116512|FG000|STARTED|Period 1||6||
60000792|NCT02148250|76116513|FG001|STARTED|Period 1||6||
60000793|NCT02148250|76116512|FG000|COMPLETED|Period 1||6||
60000794|NCT02148250|76116513|FG001|COMPLETED|Period 1||6||
60000795|NCT02148250|76116512|FG000|NOT COMPLETED|Period 1||0||
60000796|NCT02148250|76116513|FG001|NOT COMPLETED|Period 1||0||
60000797|NCT02148250|76116512|FG000|STARTED|Period 2||6||
60000798|NCT02148250|76116513|FG001|STARTED|Period 2||6||
60000799|NCT02148250|76116512|FG000|COMPLETED|Period 2||6||
60000800|NCT02148250|76116513|FG001|COMPLETED|Period 2||6||
60000801|NCT02148250|76116512|FG000|NOT COMPLETED|Period 2||0||
60000802|NCT02148250|76116513|FG001|NOT COMPLETED|Period 2||0||
60000803|NCT02147626|76116522|FG000|STARTED|Overall Study||75||
60000804|NCT02147626|76116523|FG001|STARTED|Overall Study||76||
60000805|NCT02147626|76116522|FG000|COMPLETED|Overall Study||70||
60000806|NCT02147626|76116523|FG001|COMPLETED|Overall Study||69||
60000807|NCT02147626|76116522|FG000|NOT COMPLETED|Overall Study||5||
60000808|NCT02147626|76116523|FG001|NOT COMPLETED|Overall Study||7||
60000809|NCT02172664|76116529|FG000|STARTED|Overall Study||33||40
60000810|NCT02172664|76116530|FG001|STARTED|Overall Study||33||41
60000811|NCT02172664|76116529|FG000|COMPLETED|Overall Study||27||35
60000812|NCT02172664|76116530|FG001|COMPLETED|Overall Study||27||31
60000813|NCT02172664|76116529|FG000|NOT COMPLETED|Overall Study||6||5
60000814|NCT02172664|76116530|FG001|NOT COMPLETED|Overall Study||6||10
60000815|NCT02172040|76116539|FG000|STARTED|Overall Study||49||
60000816|NCT02172040|76116540|FG001|STARTED|Overall Study||45||
60000817|NCT02172040|76116541|FG002|STARTED|Overall Study||31||
60000818|NCT02172040|76116542|FG003|STARTED|Overall Study||27||
60000819|NCT02172040|76116539|FG000|COMPLETED|Overall Study||49||
60000820|NCT02172040|76116540|FG001|COMPLETED|Overall Study||42||
60000821|NCT02172040|76116541|FG002|COMPLETED|Overall Study||29||
60000822|NCT02172040|76116542|FG003|COMPLETED|Overall Study||26||
60000823|NCT02172040|76116539|FG000|NOT COMPLETED|Overall Study||0||
60000824|NCT02172040|76116540|FG001|NOT COMPLETED|Overall Study||3||
60000825|NCT02172040|76116541|FG002|NOT COMPLETED|Overall Study||2||
60000826|NCT02172040|76116542|FG003|NOT COMPLETED|Overall Study||1||
60000827|NCT02367105|76116555|FG000|STARTED|Overall Study||41||
60000828|NCT02367105|76116556|FG001|STARTED|Overall Study||42||
60000829|NCT02367105|76116555|FG000|COMPLETED|Overall Study||36||
60000830|NCT02367105|76116556|FG001|COMPLETED|Overall Study||34||
60000831|NCT02367105|76116555|FG000|NOT COMPLETED|Overall Study||5||
60000832|NCT02367105|76116556|FG001|NOT COMPLETED|Overall Study||8||
60000833|NCT02112994|76116568|FG000|STARTED|Overall Study||6||
60000834|NCT02112994|76116569|FG001|STARTED|Overall Study||16||
60000835|NCT02112994|76116570|FG002|STARTED|Overall Study||9||
60000836|NCT02112994|76116568|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6||
60000837|NCT02112994|76116569|FG001|Received at Least 1 Dose of Study Drug|Overall Study||16||
60000838|NCT02112994|76116570|FG002|Received at Least 1 Dose of Study Drug|Overall Study||9||
60000839|NCT02112994|76116568|FG000|Received 0.35 mg/kg QOW|Overall Study||0||
60000840|NCT02112994|76116569|FG001|Received 0.35 mg/kg QOW|Overall Study||0||
60000841|NCT02112994|76116570|FG002|Received 0.35 mg/kg QOW|Overall Study||1||
60000842|NCT02112994|76116568|FG000|Received 1 mg/kg QOW|Overall Study||6|All participants started the study at this dose.|
60000843|NCT02112994|76116569|FG001|Received 1 mg/kg QOW|Overall Study||16|All participants started the study at this dose.|
60000844|NCT02112994|76116570|FG002|Received 1 mg/kg QOW|Overall Study||9|All participants started the study at this dose.|
60000845|NCT02112994|76116568|FG000|Received 1 mg/kg QW|Overall Study||1||
60000846|NCT02112994|76116569|FG001|Received 1 mg/kg QW|Overall Study||1||
60000847|NCT02112994|76116570|FG002|Received 1 mg/kg QW|Overall Study||0||
60000848|NCT02112994|76116568|FG000|Received 3 mg/kg QOW|Overall Study||3||
60000849|NCT02112994|76116569|FG001|Received 3 mg/kg QOW|Overall Study||5||
60000850|NCT02112994|76116570|FG002|Received 3 mg/kg QOW|Overall Study||3||
60000851|NCT02112994|76116568|FG000|Received 3 mg/kg QW|Overall Study||2||
60000852|NCT02112994|76116569|FG001|Received 3 mg/kg QW|Overall Study||1||
60000853|NCT02112994|76116570|FG002|Received 3 mg/kg QW|Overall Study||1||
60000854|NCT02112994|76116568|FG000|Completed 96-week Treatment Period|Overall Study||6||
60000855|NCT02112994|76116569|FG001|Completed 96-week Treatment Period|Overall Study||14||
60000856|NCT02112994|76116570|FG002|Completed 96-week Treatment Period|Overall Study||8||
60000857|NCT02112994|76116568|FG000|COMPLETED|Overall Study||6|Participants who transitioned to commercial product are displayed as having completed the study.|
60000858|NCT02112994|76116569|FG001|COMPLETED|Overall Study||14|Participants who transitioned to commercial product are displayed as having completed the study.|
60000859|NCT02112994|76116570|FG002|COMPLETED|Overall Study||6|Participants who transitioned to commercial product are displayed as having completed the study.|
60000860|NCT02112994|76116568|FG000|NOT COMPLETED|Overall Study||0||
60000861|NCT02112994|76116569|FG001|NOT COMPLETED|Overall Study||2||
60000862|NCT02112994|76116570|FG002|NOT COMPLETED|Overall Study||3||
60000863|NCT02147158|76116588|FG000|STARTED|Treatment Course 1||55||
60000864|NCT02147158|76116589|FG001|STARTED|Treatment Course 1||47||
60000865|NCT02147158|76116590|FG002|STARTED|Treatment Course 1||107||
60000866|NCT02147158|76116591|FG003|STARTED|Treatment Course 1||110||
60000867|NCT02147158|76116592|FG004|STARTED|Treatment Course 1||55||
60000868|NCT02147158|76116593|FG005|STARTED|Treatment Course 1||58||
60000869|NCT02147158|76116588|FG000|COMPLETED|Treatment Course 1||51||
60000870|NCT02147158|76116589|FG001|COMPLETED|Treatment Course 1||38||
60000871|NCT02147158|76116590|FG002|COMPLETED|Treatment Course 1||99||
60000872|NCT02147158|76116591|FG003|COMPLETED|Treatment Course 1||97||
60000873|NCT02147158|76116592|FG004|COMPLETED|Treatment Course 1||49||
60000874|NCT02147158|76116593|FG005|COMPLETED|Treatment Course 1||50||
60000875|NCT02147158|76116588|FG000|NOT COMPLETED|Treatment Course 1||4||
60000876|NCT02147158|76116589|FG001|NOT COMPLETED|Treatment Course 1||9||
60000877|NCT02147158|76116590|FG002|NOT COMPLETED|Treatment Course 1||8||
60000878|NCT02147158|76116591|FG003|NOT COMPLETED|Treatment Course 1||13||
60000879|NCT02147158|76116592|FG004|NOT COMPLETED|Treatment Course 1||6||
60000880|NCT02147158|76116593|FG005|NOT COMPLETED|Treatment Course 1||8||
60000881|NCT02147158|76116588|FG000|STARTED|Off-Treatment Interval 1||51||
60000882|NCT02147158|76116589|FG001|STARTED|Off-Treatment Interval 1||38||
60000883|NCT02147158|76116590|FG002|STARTED|Off-Treatment Interval 1||99||
60000884|NCT02147158|76116591|FG003|STARTED|Off-Treatment Interval 1||97||
60000885|NCT02147158|76116592|FG004|STARTED|Off-Treatment Interval 1||49||
60000886|NCT02147158|76116593|FG005|STARTED|Off-Treatment Interval 1||50||
60000887|NCT02147158|76116588|FG000|COMPLETED|Off-Treatment Interval 1||41||
60000888|NCT02147158|76116589|FG001|COMPLETED|Off-Treatment Interval 1||34||
60000889|NCT02147158|76116590|FG002|COMPLETED|Off-Treatment Interval 1||84||
60000890|NCT02147158|76116591|FG003|COMPLETED|Off-Treatment Interval 1||82||
60000891|NCT02147158|76116592|FG004|COMPLETED|Off-Treatment Interval 1||41||
60000892|NCT02147158|76116593|FG005|COMPLETED|Off-Treatment Interval 1||45||
60000893|NCT02147158|76116588|FG000|NOT COMPLETED|Off-Treatment Interval 1||10||
60000894|NCT02147158|76116589|FG001|NOT COMPLETED|Off-Treatment Interval 1||4||
60000895|NCT02147158|76116590|FG002|NOT COMPLETED|Off-Treatment Interval 1||15||
60000896|NCT02147158|76116591|FG003|NOT COMPLETED|Off-Treatment Interval 1||15||
60000897|NCT02147158|76116592|FG004|NOT COMPLETED|Off-Treatment Interval 1||8||
60000898|NCT02147158|76116593|FG005|NOT COMPLETED|Off-Treatment Interval 1||5||
60000899|NCT02147158|76116588|FG000|STARTED|Treatment Course 2||41||
60000900|NCT02147158|76116589|FG001|STARTED|Treatment Course 2||34||
60000901|NCT02147158|76116590|FG002|STARTED|Treatment Course 2||84||
60000902|NCT02147158|76116591|FG003|STARTED|Treatment Course 2||82||
60000903|NCT02147158|76116592|FG004|STARTED|Treatment Course 2||41||
60000904|NCT02147158|76116593|FG005|STARTED|Treatment Course 2||45||
60000905|NCT02147158|76116588|FG000|COMPLETED|Treatment Course 2||40||
60000906|NCT02147158|76116589|FG001|COMPLETED|Treatment Course 2||29||
60000907|NCT02147158|76116590|FG002|COMPLETED|Treatment Course 2||79||
60000908|NCT02147158|76116591|FG003|COMPLETED|Treatment Course 2||77||
60000909|NCT02147158|76116592|FG004|COMPLETED|Treatment Course 2||41||
60000910|NCT02147158|76116593|FG005|COMPLETED|Treatment Course 2||43||
60000911|NCT02147158|76116588|FG000|NOT COMPLETED|Treatment Course 2||1||
60000912|NCT02147158|76116589|FG001|NOT COMPLETED|Treatment Course 2||5||
60000913|NCT02147158|76116590|FG002|NOT COMPLETED|Treatment Course 2||5||
60000914|NCT02147158|76116591|FG003|NOT COMPLETED|Treatment Course 2||5||
60000915|NCT02147158|76116592|FG004|NOT COMPLETED|Treatment Course 2||0||
60000916|NCT02147158|76116593|FG005|NOT COMPLETED|Treatment Course 2||2||
60000917|NCT02147158|76116588|FG000|STARTED|Off-Treatment Interval 2||40||
60000918|NCT02147158|76116589|FG001|STARTED|Off-Treatment Interval 2||29||
60000919|NCT02147158|76116590|FG002|STARTED|Off-Treatment Interval 2||79||
60000920|NCT02147158|76116591|FG003|STARTED|Off-Treatment Interval 2||77||
60000921|NCT02147158|76116592|FG004|STARTED|Off-Treatment Interval 2||41||
60000922|NCT02147158|76116593|FG005|STARTED|Off-Treatment Interval 2||43||
60000923|NCT02147158|76116588|FG000|COMPLETED|Off-Treatment Interval 2||36||
60000924|NCT02147158|76116589|FG001|COMPLETED|Off-Treatment Interval 2||25||
60000925|NCT02147158|76116590|FG002|COMPLETED|Off-Treatment Interval 2||69||
60000926|NCT02147158|76116591|FG003|COMPLETED|Off-Treatment Interval 2||66||
60000927|NCT02147158|76116592|FG004|COMPLETED|Off-Treatment Interval 2||39||
60000928|NCT02147158|76116593|FG005|COMPLETED|Off-Treatment Interval 2||39||
60000929|NCT02147158|76116588|FG000|NOT COMPLETED|Off-Treatment Interval 2||4||
60000930|NCT02147158|76116589|FG001|NOT COMPLETED|Off-Treatment Interval 2||4||
60000931|NCT02147158|76116590|FG002|NOT COMPLETED|Off-Treatment Interval 2||10||
60000932|NCT02147158|76116591|FG003|NOT COMPLETED|Off-Treatment Interval 2||11||
60000933|NCT02147158|76116592|FG004|NOT COMPLETED|Off-Treatment Interval 2||2||
60000934|NCT02147158|76116593|FG005|NOT COMPLETED|Off-Treatment Interval 2||4||
60000935|NCT02112448|76116612|FG000|STARTED|Overall Study||38||
60000936|NCT02112448|76116613|FG001|STARTED|Overall Study||40||
60000937|NCT02112448|76116612|FG000|COMPLETED|Overall Study||30||
60000938|NCT02112448|76116613|FG001|COMPLETED|Overall Study||30||
60000939|NCT02112448|76116612|FG000|NOT COMPLETED|Overall Study||8||
60000940|NCT02112448|76116613|FG001|NOT COMPLETED|Overall Study||10||
60000941|NCT02171260|76116625|FG000|STARTED|Overall Study||6||
60000942|NCT02171260|76116626|FG001|STARTED|Overall Study||6||
60000943|NCT02171260|76116627|FG002|STARTED|Overall Study||5||
60000944|NCT02171260|76116628|FG003|STARTED|Overall Study||5||
60000945|NCT02171260|76116625|FG000|COMPLETED|Overall Study||0||
60000946|NCT02171260|76116626|FG001|COMPLETED|Overall Study||0||
60000947|NCT02171260|76116627|FG002|COMPLETED|Overall Study||0||
60000948|NCT02171260|76116628|FG003|COMPLETED|Overall Study||0||
60000949|NCT02171260|76116625|FG000|NOT COMPLETED|Overall Study||6||
60000950|NCT02171260|76116626|FG001|NOT COMPLETED|Overall Study||6||
60000951|NCT02171260|76116627|FG002|NOT COMPLETED|Overall Study||5||
60000952|NCT02171260|76116628|FG003|NOT COMPLETED|Overall Study||5||
60000953|NCT02110732|76116646|FG000|STARTED|Overall Study||20||
60000954|NCT02110732|76116647|FG001|STARTED|Overall Study||20||
60000955|NCT02110732|76116646|FG000|COMPLETED|Overall Study||14||
60000956|NCT02110732|76116647|FG001|COMPLETED|Overall Study||17||
60000957|NCT02110732|76116646|FG000|NOT COMPLETED|Overall Study||6||
60000958|NCT02110732|76116647|FG001|NOT COMPLETED|Overall Study||3||
60000959|NCT02109562|76116656|FG000|STARTED|Overall Study||116||
60000960|NCT02109562|76116657|FG001|STARTED|Overall Study||119||
60000961|NCT02109562|76116658|FG002|STARTED|Overall Study||119||
60000962|NCT02109562|76116656|FG000|Safety|Overall Study||115|Randomized and received at least one dose of study drug|
60000963|NCT02109562|76116657|FG001|Safety|Overall Study||117|Randomized and received at least one dose of study drug|
60000964|NCT02109562|76116658|FG002|Safety|Overall Study||118|Randomized and received at least one dose of study drug|
60067697|NCT01788423|76182878|FG001|STARTED|Overall Study||55||
60067698|NCT01788423|76182879|FG002|STARTED|Overall Study||55||
60000965|NCT02109562|76116656|FG000|Intent to Treat (ITT)|Overall Study||111|Randomized, dosed, had a baseline and 1 or more post baseline efficacy measurements.|
60000966|NCT02109562|76116657|FG001|Intent to Treat (ITT)|Overall Study||114|Randomized, dosed, had a baseline and 1 or more post baseline efficacy measurements.|
60000967|NCT02109562|76116658|FG002|Intent to Treat (ITT)|Overall Study||112|Randomized, dosed, had a baseline and 1 or more post baseline efficacy measurements.|
60000968|NCT02109562|76116656|FG000|COMPLETED|Overall Study||90||
60000969|NCT02109562|76116657|FG001|COMPLETED|Overall Study||85||
60000970|NCT02109562|76116658|FG002|COMPLETED|Overall Study||84||
60000971|NCT02109562|76116656|FG000|NOT COMPLETED|Overall Study||26||
60000972|NCT02109562|76116657|FG001|NOT COMPLETED|Overall Study||34||
60000973|NCT02109562|76116658|FG002|NOT COMPLETED|Overall Study||35||
60000974|NCT02109484|76116674|FG000|STARTED|Overall Study||5||
60000975|NCT02109484|76116675|FG001|STARTED|Overall Study||13||
60000976|NCT02109484|76116676|FG002|STARTED|Overall Study||12||
60000977|NCT02109484|76116677|FG003|STARTED|Overall Study||12||
60000978|NCT02109484|76116678|FG004|STARTED|Overall Study||50||
60000979|NCT02109484|76116679|FG005|STARTED|Overall Study||12||
60000980|NCT02109484|76116680|FG006|STARTED|Overall Study||50||
60000981|NCT02109484|76116681|FG007|STARTED|Overall Study||50||
60000982|NCT02109484|76116674|FG000|COMPLETED|Overall Study||5||
60000983|NCT02109484|76116675|FG001|COMPLETED|Overall Study||13||
60000984|NCT02109484|76116676|FG002|COMPLETED|Overall Study||12||
60000985|NCT02109484|76116677|FG003|COMPLETED|Overall Study||11||
60000986|NCT02109484|76116678|FG004|COMPLETED|Overall Study||46||
60000987|NCT02109484|76116679|FG005|COMPLETED|Overall Study||11||
60000988|NCT02109484|76116680|FG006|COMPLETED|Overall Study||47||
60000989|NCT02109484|76116681|FG007|COMPLETED|Overall Study||47||
60000990|NCT02109484|76116674|FG000|NOT COMPLETED|Overall Study||0||
60000991|NCT02109484|76116675|FG001|NOT COMPLETED|Overall Study||0||
60000992|NCT02109484|76116676|FG002|NOT COMPLETED|Overall Study||0||
60000993|NCT02109484|76116677|FG003|NOT COMPLETED|Overall Study||1||
60000994|NCT02109484|76116678|FG004|NOT COMPLETED|Overall Study||4||
60000995|NCT02109484|76116679|FG005|NOT COMPLETED|Overall Study||1||
60000996|NCT02109484|76116680|FG006|NOT COMPLETED|Overall Study||3||
60000997|NCT02109484|76116681|FG007|NOT COMPLETED|Overall Study||3||
60000998|NCT02105974|76116718|FG000|STARTED|2 Week Run-in Period||2423||
60000999|NCT02105974|76116719|FG001|STARTED|2 Week Run-in Period||0||
60001000|NCT02105974|76116720|FG002|STARTED|2 Week Run-in Period||0||
60001001|NCT02105974|76116718|FG000|COMPLETED|2 Week Run-in Period||1622||
60001002|NCT02105974|76116719|FG001|COMPLETED|2 Week Run-in Period||0||
60001003|NCT02105974|76116720|FG002|COMPLETED|2 Week Run-in Period||0||
60001004|NCT02105974|76116718|FG000|NOT COMPLETED|2 Week Run-in Period||801||
60001005|NCT02105974|76116719|FG001|NOT COMPLETED|2 Week Run-in Period||0||
60001006|NCT02105974|76116720|FG002|NOT COMPLETED|2 Week Run-in Period||0||
60001007|NCT02105974|76116718|FG000|STARTED|12 Week (Wk) Treatment Period (TP)||0||
60001008|NCT02105974|76116719|FG001|STARTED|12 Week (Wk) Treatment Period (TP)||806||
60001009|NCT02105974|76116720|FG002|STARTED|12 Week (Wk) Treatment Period (TP)||814||
60001010|NCT02105974|76116718|FG000|Completed the Treatment(Trt) Period|12 Week (Wk) Treatment Period (TP)||0||
60001011|NCT02105974|76116719|FG001|Completed the Treatment(Trt) Period|12 Week (Wk) Treatment Period (TP)|Par completed TP if attended Visit (V7, Wk12), did not withdraw at V7 and did not stop trt before V7|764||
60001012|NCT02105974|76116720|FG002|Completed the Treatment(Trt) Period|12 Week (Wk) Treatment Period (TP)|Par completed TP if attended Visit (V7, Wk12), did not withdraw at V7 and did not stop trt before V7|754||
60001013|NCT02105974|76116718|FG000|COMPLETED|12 Week (Wk) Treatment Period (TP)||0||
60001014|NCT02105974|76116719|FG001|COMPLETED|12 Week (Wk) Treatment Period (TP)|Par. completed study if attended visit 7, had follow-up contact and no early withdrawal|764||
59735390|NCT00900159|75854033|FG001|STARTED|First Intervention||13||
60001015|NCT02105974|76116720|FG002|COMPLETED|12 Week (Wk) Treatment Period (TP)|Par. completed study if attended visit 7, had follow-up contact and no early withdrawal|756||
60001016|NCT02105974|76116718|FG000|NOT COMPLETED|12 Week (Wk) Treatment Period (TP)||0||
60001017|NCT02105974|76116719|FG001|NOT COMPLETED|12 Week (Wk) Treatment Period (TP)||42||
60001018|NCT02105974|76116720|FG002|NOT COMPLETED|12 Week (Wk) Treatment Period (TP)||58||
60001019|NCT02105662|76116726|FG000|STARTED|Overall Study||218||
60001020|NCT02105662|76116726|FG000|COMPLETED|Overall Study||212||
60001021|NCT02105662|76116726|FG000|NOT COMPLETED|Overall Study||6||
60001022|NCT02143102|76116732|FG000|STARTED|Overall Study||97||
60001023|NCT02143102|76116733|FG001|STARTED|Overall Study||28||
60001024|NCT02143102|76116732|FG000|COMPLETED|Overall Study||86||
60001025|NCT02143102|76116733|FG001|COMPLETED|Overall Study||28||
60001026|NCT02143102|76116732|FG000|NOT COMPLETED|Overall Study||11||
60001027|NCT02143102|76116733|FG001|NOT COMPLETED|Overall Study||0||
60001028|NCT02143024|76116741|FG000|STARTED|Overall Study||15||
60001029|NCT02143024|76116742|FG001|STARTED|Overall Study||8||
60001030|NCT02143024|76116741|FG000|Received Treatment|Overall Study||13|These people were randomized and received at least 1 session before dropping out of the study.|
60001031|NCT02143024|76116742|FG001|Received Treatment|Overall Study||7|These people were randomized and received at least 1 session before dropping out of the study.|
60001032|NCT02143024|76116741|FG000|COMPLETED|Overall Study||13||
60001033|NCT02143024|76116742|FG001|COMPLETED|Overall Study||7||
60001034|NCT02143024|76116741|FG000|NOT COMPLETED|Overall Study||2||
60001035|NCT02143024|76116742|FG001|NOT COMPLETED|Overall Study||1||
60001036|NCT02142712|76116751|FG000|STARTED|Overall Study||1||
60001037|NCT02142712|76116752|FG001|STARTED|Overall Study||1||
60001038|NCT02142712|76116753|FG002|STARTED|Overall Study||1||
60001039|NCT02142712|76116754|FG003|STARTED|Overall Study||0||
60001040|NCT02142712|76116751|FG000|COMPLETED|Overall Study||0||
60001041|NCT02142712|76116752|FG001|COMPLETED|Overall Study||0||
60001042|NCT02142712|76116753|FG002|COMPLETED|Overall Study||0||
60001043|NCT02142712|76116754|FG003|COMPLETED|Overall Study||0||
60001044|NCT02142712|76116751|FG000|NOT COMPLETED|Overall Study||1||
60001045|NCT02142712|76116752|FG001|NOT COMPLETED|Overall Study||1||
60001046|NCT02142712|76116753|FG002|NOT COMPLETED|Overall Study||1||
60001047|NCT02142712|76116754|FG003|NOT COMPLETED|Overall Study||0||
60001048|NCT02105272|76116765|FG000|STARTED|Overall Study||118||
60001049|NCT02105272|76116766|FG001|STARTED|Overall Study||119||
60001050|NCT02105272|76116765|FG000|COMPLETED|Overall Study||113||
60001051|NCT02105272|76116766|FG001|COMPLETED|Overall Study||116||
60001052|NCT02105272|76116765|FG000|NOT COMPLETED|Overall Study||5||
60001053|NCT02105272|76116766|FG001|NOT COMPLETED|Overall Study||3||
60001054|NCT02141854|76116777|FG000|STARTED|Run-In Period (Pre-assignment)||882||
60001055|NCT02141854|76116778|FG001|STARTED|Run-In Period (Pre-assignment)||0||
60001056|NCT02141854|76116779|FG002|STARTED|Run-In Period (Pre-assignment)||0||
60001057|NCT02141854|76116780|FG003|STARTED|Run-In Period (Pre-assignment)||0||
60001058|NCT02141854|76116781|FG004|STARTED|Run-In Period (Pre-assignment)||0||
60001059|NCT02141854|76116782|FG005|STARTED|Run-In Period (Pre-assignment)||0||
60001060|NCT02141854|76116777|FG000|COMPLETED|Run-In Period (Pre-assignment)||728||
60001061|NCT02141854|76116778|FG001|COMPLETED|Run-In Period (Pre-assignment)||0||
60001062|NCT02141854|76116779|FG002|COMPLETED|Run-In Period (Pre-assignment)||0||
60001063|NCT02141854|76116780|FG003|COMPLETED|Run-In Period (Pre-assignment)||0||
60001064|NCT02141854|76116781|FG004|COMPLETED|Run-In Period (Pre-assignment)||0||
60001065|NCT02141854|76116782|FG005|COMPLETED|Run-In Period (Pre-assignment)||0||
60001066|NCT02141854|76116777|FG000|NOT COMPLETED|Run-In Period (Pre-assignment)||154||
60001067|NCT02141854|76116778|FG001|NOT COMPLETED|Run-In Period (Pre-assignment)||0||
60001068|NCT02141854|76116779|FG002|NOT COMPLETED|Run-In Period (Pre-assignment)||0||
60001069|NCT02141854|76116780|FG003|NOT COMPLETED|Run-In Period (Pre-assignment)||0||
60001070|NCT02141854|76116781|FG004|NOT COMPLETED|Run-In Period (Pre-assignment)||0||
60001071|NCT02141854|76116782|FG005|NOT COMPLETED|Run-In Period (Pre-assignment)||0||
60001072|NCT02141854|76116777|FG000|STARTED|Treatment Period||0||
60001073|NCT02141854|76116778|FG001|STARTED|Treatment Period||146||
60001074|NCT02141854|76116779|FG002|STARTED|Treatment Period||145||
60001075|NCT02141854|76116780|FG003|STARTED|Treatment Period||146||
60001076|NCT02141854|76116781|FG004|STARTED|Treatment Period||146||
60001077|NCT02141854|76116782|FG005|STARTED|Treatment Period||145||
60001078|NCT02141854|76116777|FG000|Intent to Treat Population|Treatment Period||0||
60001079|NCT02141854|76116778|FG001|Intent to Treat Population|Treatment Period||146||
60001080|NCT02141854|76116779|FG002|Intent to Treat Population|Treatment Period||145||
60001081|NCT02141854|76116780|FG003|Intent to Treat Population|Treatment Period||146||
60001082|NCT02141854|76116781|FG004|Intent to Treat Population|Treatment Period||146||
60001083|NCT02141854|76116782|FG005|Intent to Treat Population|Treatment Period||145||
60001084|NCT02141854|76116777|FG000|Safety Population|Treatment Period||0||
60001085|NCT02141854|76116778|FG001|Safety Population|Treatment Period||145||
60001086|NCT02141854|76116779|FG002|Safety Population|Treatment Period||143||
60001087|NCT02141854|76116780|FG003|Safety Population|Treatment Period||146||
60001088|NCT02141854|76116781|FG004|Safety Population|Treatment Period||145||
60001089|NCT02141854|76116782|FG005|Safety Population|Treatment Period||144||
60001090|NCT02141854|76116777|FG000|Full Analysis Set|Treatment Period||0||
60001091|NCT02141854|76116778|FG001|Full Analysis Set|Treatment Period||145||
60001092|NCT02141854|76116779|FG002|Full Analysis Set|Treatment Period||141||
60001093|NCT02141854|76116780|FG003|Full Analysis Set|Treatment Period||146||
60001094|NCT02141854|76116781|FG004|Full Analysis Set|Treatment Period||145||
60001095|NCT02141854|76116782|FG005|Full Analysis Set|Treatment Period||143||
60001096|NCT02141854|76116777|FG000|COMPLETED|Treatment Period||0||
60001097|NCT02141854|76116778|FG001|COMPLETED|Treatment Period||136||
60001098|NCT02141854|76116779|FG002|COMPLETED|Treatment Period||136||
60001099|NCT02141854|76116780|FG003|COMPLETED|Treatment Period||135||
60001100|NCT02141854|76116781|FG004|COMPLETED|Treatment Period||136||
60001101|NCT02141854|76116782|FG005|COMPLETED|Treatment Period||107||
60001102|NCT02141854|76116777|FG000|NOT COMPLETED|Treatment Period||0||
60001103|NCT02141854|76116778|FG001|NOT COMPLETED|Treatment Period||10||
60001104|NCT02141854|76116779|FG002|NOT COMPLETED|Treatment Period||9||
60001105|NCT02141854|76116780|FG003|NOT COMPLETED|Treatment Period||11||
60001106|NCT02141854|76116781|FG004|NOT COMPLETED|Treatment Period||10||
60001107|NCT02141854|76116782|FG005|NOT COMPLETED|Treatment Period||38||
60001108|NCT02587221|76116796|FG000|STARTED|Overall Study||3394||
60001109|NCT02587221|76116797|FG001|STARTED|Overall Study||3396||
60001110|NCT02587221|76116796|FG000|Treated|Overall Study||3379||
60001111|NCT02587221|76116797|FG001|Treated|Overall Study||3382||
60001112|NCT02587221|76116796|FG000|COMPLETED|Overall Study||3263||
60001113|NCT02587221|76116797|FG001|COMPLETED|Overall Study||3273||
60001114|NCT02587221|76116796|FG000|NOT COMPLETED|Overall Study||131||
60001115|NCT02587221|76116797|FG001|NOT COMPLETED|Overall Study||123||
60001116|NCT02141620|76116803|FG000|STARTED|Treatment Condition 1 (7 Days)||8||
60001117|NCT02141620|76116804|FG001|STARTED|Treatment Condition 1 (7 Days)||7||
60001118|NCT02141620|76116803|FG000|COMPLETED|Treatment Condition 1 (7 Days)|7 completing subjects switched to n-acetylcysteine for Condition 2.|7||
60001119|NCT02141620|76116804|FG001|COMPLETED|Treatment Condition 1 (7 Days)|7 completing subjects switched to placebo for Condition 2.|7||
60001120|NCT02141620|76116803|FG000|NOT COMPLETED|Treatment Condition 1 (7 Days)||1||
60001121|NCT02141620|76116804|FG001|NOT COMPLETED|Treatment Condition 1 (7 Days)||0||
60001122|NCT02141620|76116803|FG000|STARTED|Treatment Condition 2 (7 Days)||7||
60001123|NCT02141620|76116804|FG001|STARTED|Treatment Condition 2 (7 Days)||7||
60001124|NCT02141620|76116803|FG000|COMPLETED|Treatment Condition 2 (7 Days)||7||
60001125|NCT02141620|76116804|FG001|COMPLETED|Treatment Condition 2 (7 Days)||7||
60001126|NCT02141620|76116803|FG000|NOT COMPLETED|Treatment Condition 2 (7 Days)||0||
60001127|NCT02141620|76116804|FG001|NOT COMPLETED|Treatment Condition 2 (7 Days)||0||
60001128|NCT02106910|76116812|FG000|STARTED|Overall Study||49||
60001129|NCT02106910|76116813|FG001|STARTED|Overall Study||89||
60001130|NCT02106910|76116812|FG000|COMPLETED|Overall Study||48||
60001131|NCT02106910|76116813|FG001|COMPLETED|Overall Study||88||
60001132|NCT02106910|76116812|FG000|NOT COMPLETED|Overall Study||1||
60001133|NCT02106910|76116813|FG001|NOT COMPLETED|Overall Study||1||
60001134|NCT01664949|76116822|FG000|STARTED|Overall Study||224||
60001135|NCT01664949|76116823|FG001|STARTED|Overall Study||236||
60001136|NCT01664949|76116822|FG000|COMPLETED|Overall Study||200||
60001137|NCT01664949|76116823|FG001|COMPLETED|Overall Study||211||
60001138|NCT01664949|76116822|FG000|NOT COMPLETED|Overall Study||24||
60001139|NCT01664949|76116823|FG001|NOT COMPLETED|Overall Study||25||
60001140|NCT02587143|76116831|FG000|STARTED|Overall Study||66||
60001141|NCT02587143|76116832|FG001|STARTED|Overall Study||60||
60001142|NCT02587143|76116831|FG000|COMPLETED|Overall Study||65||
60001143|NCT02587143|76116832|FG001|COMPLETED|Overall Study||60||
59735391|NCT00900159|75854032|FG000|COMPLETED|First Intervention||11||
59735392|NCT00900159|75854033|FG001|COMPLETED|First Intervention||13||
59735393|NCT00900159|75854032|FG000|NOT COMPLETED|First Intervention||0||
59735394|NCT00900159|75854033|FG001|NOT COMPLETED|First Intervention||0||
59735395|NCT00900159|75854032|FG000|STARTED|Washout||11||
59735396|NCT00900159|75854033|FG001|STARTED|Washout||13||
59735397|NCT00900159|75854032|FG000|COMPLETED|Washout||11||
59735398|NCT00900159|75854033|FG001|COMPLETED|Washout||13||
59735399|NCT00900159|75854032|FG000|NOT COMPLETED|Washout||0||
59735400|NCT00900159|75854033|FG001|NOT COMPLETED|Washout||0||
59735401|NCT00900159|75854032|FG000|STARTED|Second Intervention||11||
59735402|NCT00900159|75854033|FG001|STARTED|Second Intervention||13||
59735403|NCT00900159|75854032|FG000|COMPLETED|Second Intervention||10||
59735404|NCT00900159|75854033|FG001|COMPLETED|Second Intervention||13||
59735405|NCT00900159|75854032|FG000|NOT COMPLETED|Second Intervention||1||
59735406|NCT00900159|75854033|FG001|NOT COMPLETED|Second Intervention||0||
59735407|NCT01689909|75854041|FG000|STARTED|Overall Study||51||
59735408|NCT01689909|75854042|FG001|STARTED|Overall Study||52||
59735409|NCT01689909|75854041|FG000|COMPLETED|Overall Study||51||
59735410|NCT01689909|75854042|FG001|COMPLETED|Overall Study||52||
59735411|NCT01689909|75854041|FG000|NOT COMPLETED|Overall Study||0||
59735412|NCT01689909|75854042|FG001|NOT COMPLETED|Overall Study||0||
59735413|NCT00854308|75854052|FG000|STARTED|Overall Study||69||
59735414|NCT00854308|75854053|FG001|STARTED|Overall Study||68||
59735415|NCT00854308|75854052|FG000|Received Study Drug|Overall Study||69||
59735416|NCT00854308|75854053|FG001|Received Study Drug|Overall Study||67||
59735417|NCT00854308|75854052|FG000|COMPLETED|Overall Study|Completed participants in both arms were still receiving study drug when analyses were performed.|7||
59735418|NCT00854308|75854053|FG001|COMPLETED|Overall Study||1||
59735419|NCT00854308|75854052|FG000|NOT COMPLETED|Overall Study||62||
59735420|NCT00854308|75854053|FG001|NOT COMPLETED|Overall Study||67||
59735421|NCT00592852|75854059|FG000|STARTED|Overall Study||13||
59735422|NCT00592852|75854059|FG000|COMPLETED|Overall Study||7||
59735423|NCT00592852|75854059|FG000|NOT COMPLETED|Overall Study||6||
59735424|NCT00895245|75854063|FG000|STARTED|Overall Study||6||
59735425|NCT00895245|75854063|FG000|COMPLETED|Overall Study||0||
59735426|NCT00895245|75854063|FG000|NOT COMPLETED|Overall Study||6||
59735427|NCT00865306|75854069|FG000|STARTED|Controlled Trial|35 assigned to CBT. One child in trial had 0 anxiety disorders, so we excluded her from analysis.|34||
59735428|NCT00865306|75854070|FG001|STARTED|Controlled Trial||30||
59735429|NCT00865306|75854069|FG000|COMPLETED|Controlled Trial||29||
59735430|NCT00865306|75854070|FG001|COMPLETED|Controlled Trial||28||
59735431|NCT00865306|75854069|FG000|NOT COMPLETED|Controlled Trial||5||
59735432|NCT00865306|75854070|FG001|NOT COMPLETED|Controlled Trial||2||
59735433|NCT00865306|75854069|FG000|STARTED|One-Year Follow-Up||29||
59735434|NCT00865306|75854070|FG001|STARTED|One-Year Follow-Up|Only controls who opted for CBT after the waitlist (n=17) were included. 2 were lost (15 included).|15||
59735435|NCT00865306|75854069|FG000|COMPLETED|One-Year Follow-Up||29||
59735436|NCT00865306|75854070|FG001|COMPLETED|One-Year Follow-Up||15||
60001144|NCT02587143|76116831|FG000|NOT COMPLETED|Overall Study||1||
60001145|NCT02587143|76116832|FG001|NOT COMPLETED|Overall Study||0||
60001146|NCT02106832|76116842|FG000|STARTED|Overall Study||171||
60001147|NCT02106832|76116843|FG001|STARTED|Overall Study||176||
59735437|NCT00865306|75854069|FG000|NOT COMPLETED|One-Year Follow-Up||0||
59735438|NCT00865306|75854070|FG001|NOT COMPLETED|One-Year Follow-Up||0||
59735439|NCT00896649|75854076|FG000|STARTED|Overall Study||193||
59735440|NCT00896649|75854076|FG000|COMPLETED|Overall Study||188||
59735441|NCT00896649|75854076|FG000|NOT COMPLETED|Overall Study||5||
59735442|NCT00796003|75854083|FG000|STARTED|Overall Study|Number of participants enrolled|3||
59735443|NCT00796003|75854084|FG001|STARTED|Overall Study|Number of participants enrolled. Includes 6 participants from Phase I (20 mg/m2) group|36||
59735444|NCT00796003|75854083|FG000|Treated|Overall Study|Number of participants treated|3||
59735445|NCT00796003|75854084|FG001|Treated|Overall Study|Number of participants treated|34||
59735446|NCT00796003|75854083|FG000|COMPLETED|Overall Study||0||
59735447|NCT00796003|75854084|FG001|COMPLETED|Overall Study|Includes 2 participants from Phase I (20 mg/m2) group|7||
59735448|NCT00796003|75854083|FG000|NOT COMPLETED|Overall Study||3||
59735449|NCT00796003|75854084|FG001|NOT COMPLETED|Overall Study||29||
59735450|NCT00895011|75854096|FG000|STARTED|Overall Study||100||
59735451|NCT00895011|75854097|FG001|STARTED|Overall Study||99||
59735452|NCT00895011|75854098|FG002|STARTED|Overall Study||99||
59735453|NCT00895011|75854096|FG000|COMPLETED|Overall Study||76||
59735454|NCT00895011|75854097|FG001|COMPLETED|Overall Study||85||
59735455|NCT00895011|75854098|FG002|COMPLETED|Overall Study||91||
59735456|NCT00895011|75854096|FG000|NOT COMPLETED|Overall Study||24||
59735457|NCT00895011|75854097|FG001|NOT COMPLETED|Overall Study||14||
59735458|NCT00895011|75854098|FG002|NOT COMPLETED|Overall Study||8||
59735459|NCT00899847|75854107|FG000|STARTED|Overall Study||9||
59735460|NCT00899847|75854107|FG000|COMPLETED|Overall Study||7||
59735461|NCT00899847|75854107|FG000|NOT COMPLETED|Overall Study||2||
59735462|NCT00795535|75854113|FG000|STARTED|Overall Study||95||
59735463|NCT00795535|75854113|FG000|COMPLETED|Overall Study||75||
59735464|NCT00795535|75854113|FG000|NOT COMPLETED|Overall Study||20||
59735465|NCT00853762|75854121|FG000|STARTED|Overall Study||16||
59735466|NCT00853762|75854122|FG001|STARTED|Overall Study||19||
59735467|NCT00853762|75854123|FG002|STARTED|Overall Study||17||
59735468|NCT00853762|75854124|FG003|STARTED|Overall Study||22||
59735469|NCT00853762|75854121|FG000|COMPLETED|Overall Study||0||
59735470|NCT00853762|75854122|FG001|COMPLETED|Overall Study||0||
59735471|NCT00853762|75854123|FG002|COMPLETED|Overall Study||0||
59735472|NCT00853762|75854124|FG003|COMPLETED|Overall Study||0||
59735473|NCT00853762|75854121|FG000|NOT COMPLETED|Overall Study||16||
59735474|NCT00853762|75854122|FG001|NOT COMPLETED|Overall Study||19||
59735475|NCT00853762|75854123|FG002|NOT COMPLETED|Overall Study||17||
59735476|NCT00853762|75854124|FG003|NOT COMPLETED|Overall Study||22||
59735477|NCT00789529|75854136|FG000|STARTED|Overall Study||16||
59735478|NCT00789529|75854137|FG001|STARTED|Overall Study||16||
59735479|NCT00789529|75854136|FG000|COMPLETED|Overall Study||15||
59735480|NCT00789529|75854137|FG001|COMPLETED|Overall Study||15||
59735481|NCT00789529|75854136|FG000|NOT COMPLETED|Overall Study||1||
59735482|NCT00789529|75854137|FG001|NOT COMPLETED|Overall Study||1||
59735483|NCT00894933|75854143|FG000|STARTED|Overall Study||33||
59735484|NCT00894933|75854143|FG000|COMPLETED|Overall Study||29||
59735485|NCT00894933|75854143|FG000|NOT COMPLETED|Overall Study||4||
59735486|NCT00792805|75854150|FG000|STARTED|Overall Study||188||
59735487|NCT00792805|75854151|FG001|STARTED|Overall Study||188||
59735488|NCT00792805|75854152|FG002|STARTED|Overall Study||187||
59735489|NCT00792805|75854150|FG000|Exposed to Study Medication or Placebo|Overall Study|One patient in this group did not receive any study treatment.|187||
59735490|NCT00792805|75854151|FG001|Exposed to Study Medication or Placebo|Overall Study||188||
59735491|NCT00792805|75854152|FG002|Exposed to Study Medication or Placebo|Overall Study|One patient in this group did not receive any study treatment.|186||
59735492|NCT00792805|75854150|FG000|COMPLETED|Overall Study||166||
59735493|NCT00792805|75854151|FG001|COMPLETED|Overall Study||162||
59735494|NCT00792805|75854152|FG002|COMPLETED|Overall Study||154||
59735495|NCT00792805|75854150|FG000|NOT COMPLETED|Overall Study||22||
59735496|NCT00792805|75854151|FG001|NOT COMPLETED|Overall Study||26||
59735497|NCT00792805|75854152|FG002|NOT COMPLETED|Overall Study||33||
59735498|NCT00925002|75854163|FG000|STARTED|Overall Study||38||
59735499|NCT00925002|75854164|FG001|STARTED|Overall Study||37||
59735500|NCT00925002|75854165|FG002|STARTED|Overall Study||18||
59735501|NCT00925002|75854163|FG000|Treated|Overall Study||38||
59735502|NCT00925002|75854164|FG001|Treated|Overall Study||37||
59735503|NCT00925002|75854165|FG002|Treated|Overall Study||18||
59735504|NCT00925002|75854163|FG000|COMPLETED|Overall Study||32||
59735505|NCT00925002|75854164|FG001|COMPLETED|Overall Study||28||
59735506|NCT00925002|75854165|FG002|COMPLETED|Overall Study||8||
59735507|NCT00925002|75854163|FG000|NOT COMPLETED|Overall Study||6||
59735508|NCT00925002|75854164|FG001|NOT COMPLETED|Overall Study||9||
59735509|NCT00925002|75854165|FG002|NOT COMPLETED|Overall Study||10||
59735510|NCT00928746|75854174|FG000|STARTED|Overall Study||142||
59735511|NCT00928746|75854174|FG000|COMPLETED|Overall Study||136||
59735512|NCT00928746|75854174|FG000|NOT COMPLETED|Overall Study||6||
59735513|NCT00922428|75854180|FG000|STARTED|Overall Study|13 patients were completely not analysed, 2 not for demographic or efficacy but for safety|1389||
59735514|NCT00922428|75854180|FG000|COMPLETED|Overall Study|for 11 participants no gender was given|1374||
59735515|NCT00922428|75854180|FG000|NOT COMPLETED|Overall Study||15||
59735516|NCT00894543|75854192|FG000|STARTED|Baseline||104||
59735517|NCT00894543|75854193|FG001|STARTED|Baseline||101||
59735518|NCT00894543|75854192|FG000|COMPLETED|Baseline||104||
59735519|NCT00894543|75854193|FG001|COMPLETED|Baseline||101||
59735520|NCT00894543|75854192|FG000|NOT COMPLETED|Baseline||0||
59735521|NCT00894543|75854193|FG001|NOT COMPLETED|Baseline||0||
59735522|NCT00894543|75854192|FG000|STARTED|Baseline to Week 4||104||
59735523|NCT00894543|75854193|FG001|STARTED|Baseline to Week 4||101||
59735524|NCT00894543|75854192|FG000|COMPLETED|Baseline to Week 4||101||
59735525|NCT00894543|75854193|FG001|COMPLETED|Baseline to Week 4||99||
59735526|NCT00894543|75854192|FG000|NOT COMPLETED|Baseline to Week 4||3||
59735527|NCT00894543|75854193|FG001|NOT COMPLETED|Baseline to Week 4||2||
59735528|NCT00894543|75854192|FG000|STARTED|Week 4 to Week 8||101||
59735529|NCT00894543|75854193|FG001|STARTED|Week 4 to Week 8||99||
59735530|NCT00894543|75854192|FG000|COMPLETED|Week 4 to Week 8||97||
59735531|NCT00894543|75854193|FG001|COMPLETED|Week 4 to Week 8||97||
59735532|NCT00894543|75854192|FG000|NOT COMPLETED|Week 4 to Week 8||4||
59735533|NCT00894543|75854193|FG001|NOT COMPLETED|Week 4 to Week 8||2||
59735534|NCT00922272|75854199|FG000|STARTED|Open-label Phase||92||
59735535|NCT00922272|75854200|FG001|STARTED|Open-label Phase||0||
59735536|NCT00922272|75854199|FG000|COMPLETED|Open-label Phase||69||
59735537|NCT00922272|75854200|FG001|COMPLETED|Open-label Phase||0||
59735538|NCT00922272|75854199|FG000|NOT COMPLETED|Open-label Phase||23||
59735539|NCT00922272|75854200|FG001|NOT COMPLETED|Open-label Phase||0||
59735540|NCT00922272|75854199|FG000|STARTED|Double-blind Phase||34||
59735541|NCT00922272|75854200|FG001|STARTED|Double-blind Phase||35||
59735542|NCT00922272|75854199|FG000|COMPLETED|Double-blind Phase||27||
59735543|NCT00922272|75854200|FG001|COMPLETED|Double-blind Phase||29||
59735544|NCT00922272|75854199|FG000|NOT COMPLETED|Double-blind Phase||7||
59735545|NCT00922272|75854200|FG001|NOT COMPLETED|Double-blind Phase||6||
59735546|NCT00853372|75854210|FG000|STARTED|Overall Study||43||
59735547|NCT00853372|75854211|FG001|STARTED|Overall Study||42||
59735548|NCT00853372|75854210|FG000|COMPLETED|Overall Study||11||
59735549|NCT00853372|75854211|FG001|COMPLETED|Overall Study||13||
59735550|NCT00853372|75854210|FG000|NOT COMPLETED|Overall Study||32||
59735551|NCT00853372|75854211|FG001|NOT COMPLETED|Overall Study||29||
59735552|NCT00848536|75854219|FG000|STARTED|Overall Study||185||
59735553|NCT00848536|75854220|FG001|STARTED|Overall Study||186||
59735554|NCT00848536|75854219|FG000|COMPLETED|Overall Study||181||
59735555|NCT00848536|75854220|FG001|COMPLETED|Overall Study||179||
59735556|NCT00848536|75854219|FG000|NOT COMPLETED|Overall Study||4||
59735557|NCT00848536|75854220|FG001|NOT COMPLETED|Overall Study||7||
59735558|NCT00922116|75854226|FG000|STARTED|Overall Study||191||
59735559|NCT00922116|75854226|FG000|COMPLETED|Overall Study||176||
59735560|NCT00922116|75854226|FG000|NOT COMPLETED|Overall Study||15||
59735561|NCT00921024|75854232|FG000|STARTED|Overall Study||85||
59735562|NCT00921024|75854233|FG001|STARTED|Overall Study||42||
59735563|NCT00921024|75854232|FG000|COMPLETED|Overall Study||81||
59735564|NCT00921024|75854233|FG001|COMPLETED|Overall Study||39||
59735565|NCT00921024|75854232|FG000|NOT COMPLETED|Overall Study||4||
59735566|NCT00921024|75854233|FG001|NOT COMPLETED|Overall Study||3||
59735567|NCT00928668|75854239|FG000|STARTED|Overall Study||7||
59735568|NCT00928668|75854240|FG001|STARTED|Overall Study||7||
59735569|NCT00928668|75854241|FG002|STARTED|Overall Study||7||
59735570|NCT00928668|75854242|FG003|STARTED|Overall Study||4||
59735571|NCT00928668|75854243|FG004|STARTED|Overall Study||6||
59735572|NCT00928668|75854239|FG000|COMPLETED|Overall Study||6||
59735573|NCT00928668|75854240|FG001|COMPLETED|Overall Study||6||
59735574|NCT00928668|75854241|FG002|COMPLETED|Overall Study||6||
59735575|NCT00928668|75854242|FG003|COMPLETED|Overall Study||3||
59735576|NCT00928668|75854243|FG004|COMPLETED|Overall Study||5||
59735577|NCT00928668|75854239|FG000|NOT COMPLETED|Overall Study||1||
59735578|NCT00928668|75854240|FG001|NOT COMPLETED|Overall Study||1||
59735579|NCT00928668|75854241|FG002|NOT COMPLETED|Overall Study||1||
59735580|NCT00928668|75854242|FG003|NOT COMPLETED|Overall Study||1||
59735581|NCT00928668|75854243|FG004|NOT COMPLETED|Overall Study||1||
59735582|NCT00592774|75854265|FG000|STARTED|Overall Study||26||
59735583|NCT00592774|75854266|FG001|STARTED|Overall Study||53||
59735584|NCT00592774|75854267|FG002|STARTED|Overall Study||22||
59735585|NCT00592774|75854268|FG003|STARTED|Overall Study||22||
59735586|NCT00592774|75854269|FG004|STARTED|Overall Study||23||
59735587|NCT00592774|75854265|FG000|COMPLETED|Overall Study||15||
59735588|NCT00592774|75854266|FG001|COMPLETED|Overall Study||21||
59735589|NCT00592774|75854267|FG002|COMPLETED|Overall Study||18||
59735590|NCT00592774|75854268|FG003|COMPLETED|Overall Study||8||
59735591|NCT00592774|75854269|FG004|COMPLETED|Overall Study||9||
59735592|NCT00592774|75854265|FG000|NOT COMPLETED|Overall Study||11||
59735593|NCT00592774|75854266|FG001|NOT COMPLETED|Overall Study||32||
59735594|NCT00592774|75854267|FG002|NOT COMPLETED|Overall Study||4||
59735595|NCT00592774|75854268|FG003|NOT COMPLETED|Overall Study||14||
59735596|NCT00592774|75854269|FG004|NOT COMPLETED|Overall Study||14||
59735597|NCT00837694|75854287|FG000|STARTED|Overall Study||10||
59735598|NCT00837694|75854288|FG001|STARTED|Overall Study||11||
59735599|NCT00837694|75854289|FG002|STARTED|Overall Study||10||
59735600|NCT00837694|75854290|FG003|STARTED|Overall Study||11||
59735601|NCT00837694|75854291|FG004|STARTED|Overall Study||12||
59735602|NCT00837694|75854292|FG005|STARTED|Overall Study||11||
59735603|NCT00837694|75854287|FG000|COMPLETED|Overall Study||8||
59735604|NCT00837694|75854288|FG001|COMPLETED|Overall Study||11||
59735605|NCT00837694|75854289|FG002|COMPLETED|Overall Study||8||
59735606|NCT00837694|75854290|FG003|COMPLETED|Overall Study||10||
59735607|NCT00837694|75854291|FG004|COMPLETED|Overall Study||11||
59735608|NCT00837694|75854292|FG005|COMPLETED|Overall Study||10||
59735609|NCT00837694|75854287|FG000|NOT COMPLETED|Overall Study||2||
59735610|NCT00837694|75854288|FG001|NOT COMPLETED|Overall Study||0||
59735611|NCT00837694|75854289|FG002|NOT COMPLETED|Overall Study||2||
59735612|NCT00837694|75854290|FG003|NOT COMPLETED|Overall Study||1||
59735613|NCT00837694|75854291|FG004|NOT COMPLETED|Overall Study||1||
59735614|NCT00837694|75854292|FG005|NOT COMPLETED|Overall Study||1||
59735615|NCT00852202|75854309|FG000|STARTED|Overall Study||77||
59735616|NCT00852202|75854310|FG001|STARTED|Overall Study||75||
59735617|NCT00852202|75854311|FG002|STARTED|Overall Study||75||
59735618|NCT00852202|75854309|FG000|COMPLETED|Overall Study||60||
59735619|NCT00852202|75854310|FG001|COMPLETED|Overall Study||63||
59735620|NCT00852202|75854311|FG002|COMPLETED|Overall Study||49||
59735621|NCT00852202|75854309|FG000|NOT COMPLETED|Overall Study||17||
59735622|NCT00852202|75854310|FG001|NOT COMPLETED|Overall Study||12||
59735623|NCT00852202|75854311|FG002|NOT COMPLETED|Overall Study||26||
59735624|NCT01074008|75854329|FG000|STARTED|Overall Study||8||
59735625|NCT01074008|75854330|FG001|STARTED|Overall Study||8||
59735626|NCT01074008|75854331|FG002|STARTED|Overall Study||8||
59735627|NCT01074008|75854332|FG003|STARTED|Overall Study||8||
59735628|NCT01074008|75854333|FG004|STARTED|Overall Study||8||
59735629|NCT01074008|75854334|FG005|STARTED|Overall Study||7||
59735630|NCT01074008|75854335|FG006|STARTED|Overall Study||8||
59735631|NCT01074008|75854336|FG007|STARTED|Overall Study||8||
59735632|NCT01074008|75854337|FG008|STARTED|Overall Study||11||
59735633|NCT01074008|75854329|FG000|Completed Direct-acting Antiviral Agent|Overall Study||8||
59735634|NCT01074008|75854330|FG001|Completed Direct-acting Antiviral Agent|Overall Study||7||
59735635|NCT01074008|75854331|FG002|Completed Direct-acting Antiviral Agent|Overall Study||7||
59735636|NCT01074008|75854332|FG003|Completed Direct-acting Antiviral Agent|Overall Study||8||
59735637|NCT01074008|75854333|FG004|Completed Direct-acting Antiviral Agent|Overall Study||8||
59735638|NCT01074008|75854334|FG005|Completed Direct-acting Antiviral Agent|Overall Study||5||
59735639|NCT01074008|75854335|FG006|Completed Direct-acting Antiviral Agent|Overall Study||8||
59735640|NCT01074008|75854336|FG007|Completed Direct-acting Antiviral Agent|Overall Study||7||
59735641|NCT01074008|75854337|FG008|Completed Direct-acting Antiviral Agent|Overall Study||5||
59735642|NCT01074008|75854329|FG000|COMPLETED|Overall Study||7||
59735643|NCT01074008|75854330|FG001|COMPLETED|Overall Study||5||
59735644|NCT01074008|75854331|FG002|COMPLETED|Overall Study||6||
59735645|NCT01074008|75854332|FG003|COMPLETED|Overall Study||7||
59735646|NCT01074008|75854333|FG004|COMPLETED|Overall Study||6||
59735647|NCT01074008|75854334|FG005|COMPLETED|Overall Study||7||
59735648|NCT01074008|75854335|FG006|COMPLETED|Overall Study||7||
59735649|NCT01074008|75854336|FG007|COMPLETED|Overall Study||8||
59735650|NCT01074008|75854337|FG008|COMPLETED|Overall Study||7||
59735651|NCT01074008|75854329|FG000|NOT COMPLETED|Overall Study||1||
59735652|NCT01074008|75854330|FG001|NOT COMPLETED|Overall Study||3||
59735653|NCT01074008|75854331|FG002|NOT COMPLETED|Overall Study||2||
59735654|NCT01074008|75854332|FG003|NOT COMPLETED|Overall Study||1||
59735655|NCT01074008|75854333|FG004|NOT COMPLETED|Overall Study||2||
59735656|NCT01074008|75854334|FG005|NOT COMPLETED|Overall Study||0||
59735657|NCT01074008|75854335|FG006|NOT COMPLETED|Overall Study||1||
59735658|NCT01074008|75854336|FG007|NOT COMPLETED|Overall Study||0||
59735659|NCT01074008|75854337|FG008|NOT COMPLETED|Overall Study||4||
59735660|NCT01073930|75854368|FG000|STARTED|Overall Study||307||
59735661|NCT01073930|75854369|FG001|STARTED|Overall Study||301||
59735662|NCT01073930|75854368|FG000|Safety Population (Treated)|Overall Study||305||
59735663|NCT01073930|75854369|FG001|Safety Population (Treated)|Overall Study||298||
59735664|NCT01073930|75854368|FG000|Intent to Treat Population|Overall Study|One treated participant did not have an efficacy assessment performed.|304||
59735665|NCT01073930|75854369|FG001|Intent to Treat Population|Overall Study|One treated participant did not have an efficacy assessment performed.|297||
59735666|NCT01073930|75854368|FG000|COMPLETED|Overall Study||304||
59735667|NCT01073930|75854369|FG001|COMPLETED|Overall Study||295||
59735668|NCT01073930|75854368|FG000|NOT COMPLETED|Overall Study||3||
59735669|NCT01073930|75854369|FG001|NOT COMPLETED|Overall Study||6||
59735670|NCT01073618|75854375|FG000|STARTED|Overall Study||692||
59735671|NCT01073618|75854375|FG000|COMPLETED|Overall Study||385||
59735672|NCT01073618|75854375|FG000|NOT COMPLETED|Overall Study||307||
59735673|NCT01073462|75854379|FG000|STARTED|Overall Study||67||
59735674|NCT01073462|75854379|FG000|COMPLETED|Overall Study||26||
59735675|NCT01073462|75854379|FG000|NOT COMPLETED|Overall Study||41||
59735676|NCT00789373|75854383|FG000|STARTED|Induction||939||
59735677|NCT00789373|75854384|FG001|STARTED|Induction||0||
59735678|NCT00789373|75854385|FG002|STARTED|Induction||0||
59735679|NCT00789373|75854383|FG000|COMPLETED|Induction|1 patient received maintenance therapy post-induction but was never randomized.|540||
59735680|NCT00789373|75854384|FG001|COMPLETED|Induction||0||
59735681|NCT00789373|75854385|FG002|COMPLETED|Induction||0||
59735682|NCT00789373|75854383|FG000|NOT COMPLETED|Induction||399||
59735683|NCT00789373|75854384|FG001|NOT COMPLETED|Induction||0||
59735684|NCT00789373|75854385|FG002|NOT COMPLETED|Induction||0||
59735685|NCT00789373|75854383|FG000|STARTED|Maintenance||0||
59735686|NCT00789373|75854384|FG001|STARTED|Maintenance||359||
59735687|NCT00789373|75854385|FG002|STARTED|Maintenance||180||
59735688|NCT00789373|75854383|FG000|COMPLETED|Maintenance||0||
59735689|NCT00789373|75854384|FG001|COMPLETED|Maintenance||0||
59735690|NCT00789373|75854385|FG002|COMPLETED|Maintenance||0||
59735691|NCT00789373|75854383|FG000|NOT COMPLETED|Maintenance||0||
59735692|NCT00789373|75854384|FG001|NOT COMPLETED|Maintenance||359||
59735693|NCT00789373|75854385|FG002|NOT COMPLETED|Maintenance||180||
59735694|NCT00851890|75854400|FG000|STARTED|Overall Study||8||
59735695|NCT00851890|75854401|FG001|STARTED|Overall Study||8||
59735696|NCT00851890|75854402|FG002|STARTED|Overall Study||8||
59735697|NCT00851890|75854403|FG003|STARTED|Overall Study||6||
59735698|NCT00851890|75854400|FG000|COMPLETED|Overall Study||8||
59735699|NCT00851890|75854401|FG001|COMPLETED|Overall Study||7||
59735700|NCT00851890|75854402|FG002|COMPLETED|Overall Study||8||
59735701|NCT00851890|75854403|FG003|COMPLETED|Overall Study||5||
59735702|NCT00851890|75854400|FG000|NOT COMPLETED|Overall Study||0||
59735703|NCT00851890|75854401|FG001|NOT COMPLETED|Overall Study||1||
59735704|NCT00851890|75854402|FG002|NOT COMPLETED|Overall Study||0||
59735705|NCT00851890|75854403|FG003|NOT COMPLETED|Overall Study||1||
59735706|NCT00788827|75854413|FG000|STARTED|Overall Study||7||
59735707|NCT00788827|75854413|FG000|COMPLETED|Overall Study||5||
59735708|NCT00788827|75854413|FG000|NOT COMPLETED|Overall Study||2||
59735709|NCT00592072|75854419|FG000|STARTED|First Sequence||6||
59735710|NCT00592072|75854420|FG001|STARTED|First Sequence||6||
59735711|NCT00592072|75854419|FG000|COMPLETED|First Sequence||6||
59735712|NCT00592072|75854420|FG001|COMPLETED|First Sequence||6||
59735713|NCT00592072|75854419|FG000|NOT COMPLETED|First Sequence||0||
59735714|NCT00592072|75854420|FG001|NOT COMPLETED|First Sequence||0||
59735715|NCT00592072|75854419|FG000|STARTED|Wash Out Period||6||
59735716|NCT00592072|75854420|FG001|STARTED|Wash Out Period||6||
59735717|NCT00592072|75854419|FG000|COMPLETED|Wash Out Period||5||
59735718|NCT00592072|75854420|FG001|COMPLETED|Wash Out Period||5||
59735719|NCT00592072|75854419|FG000|NOT COMPLETED|Wash Out Period||1||
59735720|NCT00592072|75854420|FG001|NOT COMPLETED|Wash Out Period||1||
59735721|NCT00592072|75854419|FG000|STARTED|Second Sequence||5||
59735722|NCT00592072|75854420|FG001|STARTED|Second Sequence||5||
59735723|NCT00592072|75854419|FG000|COMPLETED|Second Sequence||5||
59735724|NCT00592072|75854420|FG001|COMPLETED|Second Sequence||5||
59735725|NCT00592072|75854419|FG000|NOT COMPLETED|Second Sequence||0||
59735726|NCT00592072|75854420|FG001|NOT COMPLETED|Second Sequence||0||
60001148|NCT02106832|76116844|FG002|STARTED|Overall Study||86||
60001149|NCT02106832|76116845|FG003|STARTED|Overall Study||88||
59735727|NCT00792571|75854426|FG000|STARTED|Overall Study||18||
59735728|NCT00792571|75854426|FG000|COMPLETED|Overall Study||8||
59735729|NCT00792571|75854426|FG000|NOT COMPLETED|Overall Study||10||
59735730|NCT01069484|75854432|FG000|STARTED|Overall Study|27 in the stratum with major levator ani muscle defects and 60 in the stratum without such defects.|87||
59735731|NCT01069484|75854433|FG001|STARTED|Overall Study|28 in the stratum with major levator ani muscle defects and 60 in the stratum without such defects.|88||
59735732|NCT01069484|75854432|FG000|COMPLETED|Overall Study|24 in the stratum with major levator ani muscle defects and 51 in the stratum without such defects.|75||
59735733|NCT01069484|75854433|FG001|COMPLETED|Overall Study|27 in the stratum with major levator ani muscle defects and 58 in the stratum without such defects.|85||
59735734|NCT01069484|75854432|FG000|NOT COMPLETED|Overall Study||12||
59735735|NCT01069484|75854433|FG001|NOT COMPLETED|Overall Study||3||
59735736|NCT00794365|75854440|FG000|STARTED|Overall Study||330||
59735737|NCT00794365|75854440|FG000|COMPLETED|Overall Study||251||
59735738|NCT00794365|75854440|FG000|NOT COMPLETED|Overall Study||79||
59735739|NCT01067144|75854446|FG000|STARTED|Treatment||207||
59735740|NCT01067144|75854447|FG001|STARTED|Treatment||215||
59735741|NCT01067144|75854446|FG000|COMPLETED|Treatment||203||
59735742|NCT01067144|75854447|FG001|COMPLETED|Treatment||208||
59735743|NCT01067144|75854446|FG000|NOT COMPLETED|Treatment||4||
59735744|NCT01067144|75854447|FG001|NOT COMPLETED|Treatment||7||
59735745|NCT01067144|75854446|FG000|STARTED|Follow-up||203||
59735746|NCT01067144|75854447|FG001|STARTED|Follow-up||208||
59735747|NCT01067144|75854446|FG000|Intention-to-Treat Analysis Set|Follow-up||202|Received allocated treatment and had follow-up data.|
59735748|NCT01067144|75854447|FG001|Intention-to-Treat Analysis Set|Follow-up||208|Received allocated treatment and had follow-up data.|
59735749|NCT01067144|75854446|FG000|COMPLETED|Follow-up||144||
59735750|NCT01067144|75854447|FG001|COMPLETED|Follow-up||152||
59735751|NCT01067144|75854446|FG000|NOT COMPLETED|Follow-up||59||
59735752|NCT01067144|75854447|FG001|NOT COMPLETED|Follow-up||56||
59735753|NCT01078298|75854455|FG000|STARTED|Overall Study||256||
59735754|NCT01078298|75854456|FG001|STARTED|Overall Study||269||
60001150|NCT02106832|76116842|FG000|Participants Received Treatment|Overall Study||171||
59735755|NCT01078298|75854455|FG000|COMPLETED|Overall Study||175||
59735756|NCT01078298|75854456|FG001|COMPLETED|Overall Study||179||
59735757|NCT01078298|75854455|FG000|NOT COMPLETED|Overall Study||81||
59735758|NCT01078298|75854456|FG001|NOT COMPLETED|Overall Study||90||
59735759|NCT00788593|75854462|FG000|STARTED|Placebo Run-in Phase||82||
59735760|NCT00788593|75854463|FG001|STARTED|Placebo Run-in Phase||0||
59735761|NCT00788593|75854464|FG002|STARTED|Placebo Run-in Phase||0||
59735762|NCT00788593|75854462|FG000|COMPLETED|Placebo Run-in Phase||76||
59735763|NCT00788593|75854463|FG001|COMPLETED|Placebo Run-in Phase||0||
59735764|NCT00788593|75854464|FG002|COMPLETED|Placebo Run-in Phase||0||
59735765|NCT00788593|75854462|FG000|NOT COMPLETED|Placebo Run-in Phase||6||
59735766|NCT00788593|75854463|FG001|NOT COMPLETED|Placebo Run-in Phase||0||
59735767|NCT00788593|75854464|FG002|NOT COMPLETED|Placebo Run-in Phase||0||
59735768|NCT00788593|75854462|FG000|STARTED|First Intervention Period||0||
59735769|NCT00788593|75854463|FG001|STARTED|First Intervention Period||39||
59735770|NCT00788593|75854464|FG002|STARTED|First Intervention Period||37||
59735771|NCT00788593|75854462|FG000|COMPLETED|First Intervention Period||0||
59735772|NCT00788593|75854463|FG001|COMPLETED|First Intervention Period||38||
59735773|NCT00788593|75854464|FG002|COMPLETED|First Intervention Period||37||
59735774|NCT00788593|75854462|FG000|NOT COMPLETED|First Intervention Period||0||
59735775|NCT00788593|75854463|FG001|NOT COMPLETED|First Intervention Period||1||
59735776|NCT00788593|75854464|FG002|NOT COMPLETED|First Intervention Period||0||
59735777|NCT00788593|75854462|FG000|STARTED|Second Intervention Period||0||
59735778|NCT00788593|75854463|FG001|STARTED|Second Intervention Period||38||
59735779|NCT00788593|75854464|FG002|STARTED|Second Intervention Period||37||
59735780|NCT00788593|75854462|FG000|COMPLETED|Second Intervention Period||0||
59735781|NCT00788593|75854463|FG001|COMPLETED|Second Intervention Period||37||
59735782|NCT00788593|75854464|FG002|COMPLETED|Second Intervention Period||36||
59735783|NCT00788593|75854462|FG000|NOT COMPLETED|Second Intervention Period||0||
59735784|NCT00788593|75854463|FG001|NOT COMPLETED|Second Intervention Period||1||
59735785|NCT00788593|75854464|FG002|NOT COMPLETED|Second Intervention Period||1||
59735786|NCT00793819|75854476|FG000|STARTED|Overall Study||111||
60001151|NCT02106832|76116843|FG001|Participants Received Treatment|Overall Study||174||
59735787|NCT00793819|75854477|FG001|STARTED|Overall Study||98||
59735788|NCT00793819|75854476|FG000|COMPLETED|Overall Study||97||
59735789|NCT00793819|75854477|FG001|COMPLETED|Overall Study||89||
59735790|NCT00793819|75854476|FG000|NOT COMPLETED|Overall Study||14||
59735791|NCT00793819|75854477|FG001|NOT COMPLETED|Overall Study||9||
59735792|NCT00792259|75854486|FG000|STARTED|Overall Study||15||
59735793|NCT00792259|75854487|FG001|STARTED|Overall Study||20||
59735794|NCT00792259|75854488|FG002|STARTED|Overall Study||13||
59735795|NCT00792259|75854486|FG000|COMPLETED|Overall Study||14||
59735796|NCT00792259|75854487|FG001|COMPLETED|Overall Study||20||
59735797|NCT00792259|75854488|FG002|COMPLETED|Overall Study||13||
59735798|NCT00792259|75854486|FG000|NOT COMPLETED|Overall Study||1||
59735799|NCT00792259|75854487|FG001|NOT COMPLETED|Overall Study||0||
59735800|NCT00792259|75854488|FG002|NOT COMPLETED|Overall Study||0||
59735801|NCT00894387|75854498|FG000|STARTED|Overall Study|"Started indicates all randomized patients"|821||
59735802|NCT00894387|75854499|FG001|STARTED|Overall Study||818||
59735803|NCT00894387|75854498|FG000|Safety Set|Overall Study||808||
59735804|NCT00894387|75854499|FG001|Safety Set|Overall Study||810||
59735805|NCT00894387|75854498|FG000|Full Analysis Set|Overall Study||808||
59735806|NCT00894387|75854499|FG001|Full Analysis Set|Overall Study||807||
59735807|NCT00894387|75854498|FG000|Completed Primary Efficacy Phase (6 m)|Overall Study||717||
59735808|NCT00894387|75854499|FG001|Completed Primary Efficacy Phase (6 m)|Overall Study||707||
59735809|NCT00894387|75854498|FG000|Completed Secondary Efficacy Phase (12m)|Overall Study||654||
59735810|NCT00894387|75854499|FG001|Completed Secondary Efficacy Phase (12m)|Overall Study||640||
59735811|NCT00894387|75854498|FG000|COMPLETED|Overall Study|"Completed indicates patients whose treatment duration completed as per protocol"|646||
59735812|NCT00894387|75854499|FG001|COMPLETED|Overall Study||643||
59735813|NCT00894387|75854498|FG000|NOT COMPLETED|Overall Study||175||
59735814|NCT00894387|75854499|FG001|NOT COMPLETED|Overall Study||175||
59735815|NCT00928512|75854510|FG000|STARTED|Overall Study||41||
59735816|NCT00928512|75854511|FG001|STARTED|Overall Study||43||
59735817|NCT00928512|75854512|FG002|STARTED|Overall Study||49||
59735818|NCT00928512|75854513|FG003|STARTED|Overall Study||54||
59735819|NCT00928512|75854514|FG004|STARTED|Overall Study||50||
59735820|NCT00928512|75854510|FG000|Discontinued Prior to Week 16|Overall Study||3||
59735821|NCT00928512|75854511|FG001|Discontinued Prior to Week 16|Overall Study||0||
59735822|NCT00928512|75854512|FG002|Discontinued Prior to Week 16|Overall Study||2||
59735823|NCT00928512|75854513|FG003|Discontinued Prior to Week 16|Overall Study||6||
59735824|NCT00928512|75854514|FG004|Discontinued Prior to Week 16|Overall Study||5||
59735825|NCT00928512|75854510|FG000|Reassigned at Week 20 (Non-responders)|Overall Study|All patients in the 300 mg group at Week 20 remained at this dose in this group.|0||
59735826|NCT00928512|75854511|FG001|Reassigned at Week 20 (Non-responders)|Overall Study|Non-responders in the AIN457 150 mg group were reassigned treatment to the 300 mg group.|23||
59735827|NCT00928512|75854512|FG002|Reassigned at Week 20 (Non-responders)|Overall Study|Non-responders in the AIN457 75 mg group were reassigned treatment to the 150 mg group.|23||
59735828|NCT00928512|75854513|FG003|Reassigned at Week 20 (Non-responders)|Overall Study|Non-responders in the AIN457 25 mg group were reassigned treatment to the 150 mg group.|27||
59735829|NCT00928512|75854514|FG004|Reassigned at Week 20 (Non-responders)|Overall Study|All placebo patients (responders & non-responders) were reassigned treatment to the 150 mg group.|45||
59735830|NCT00928512|75854510|FG000|Not Reassigned at Week 20 (Responders)|Overall Study||37||
59735831|NCT00928512|75854511|FG001|Not Reassigned at Week 20 (Responders)|Overall Study||20||
59735832|NCT00928512|75854512|FG002|Not Reassigned at Week 20 (Responders)|Overall Study||23||
59735833|NCT00928512|75854513|FG003|Not Reassigned at Week 20 (Responders)|Overall Study||18||
59735834|NCT00928512|75854514|FG004|Not Reassigned at Week 20 (Responders)|Overall Study||0||
59735835|NCT00928512|75854510|FG000|New Groups After Reassignment|Overall Study|1 patient in this group continued at Week 16 but did not receive any study drug at Week 20.|60||
59735836|NCT00928512|75854511|FG001|New Groups After Reassignment|Overall Study||115||
59735837|NCT00928512|75854512|FG002|New Groups After Reassignment|Overall Study|1 patient in this group continued at Week 16 but did not receive any study drug at Week 20.|23||
59735838|NCT00928512|75854513|FG003|New Groups After Reassignment|Overall Study|2 patients in this group continued at Week 16 but did not receive any study drug at Week 20|18||
59735839|NCT00928512|75854514|FG004|New Groups After Reassignment|Overall Study||0||
59735840|NCT00928512|75854510|FG000|Completed Week 16|Overall Study||38||
59735841|NCT00928512|75854511|FG001|Completed Week 16|Overall Study||43||
59735842|NCT00928512|75854512|FG002|Completed Week 16|Overall Study||47||
59735843|NCT00928512|75854513|FG003|Completed Week 16|Overall Study||48||
59735844|NCT00928512|75854514|FG004|Completed Week 16|Overall Study||45||
59735845|NCT00928512|75854510|FG000|Entered/Continued to Week 20 (All)|Overall Study||37||
59735846|NCT00928512|75854511|FG001|Entered/Continued to Week 20 (All)|Overall Study||43||
59735847|NCT00928512|75854512|FG002|Entered/Continued to Week 20 (All)|Overall Study||46||
59735848|NCT00928512|75854513|FG003|Entered/Continued to Week 20 (All)|Overall Study||45||
59735849|NCT00928512|75854514|FG004|Entered/Continued to Week 20 (All)|Overall Study||45||
59735850|NCT00928512|75854510|FG000|COMPLETED|Overall Study||31||
59735851|NCT00928512|75854511|FG001|COMPLETED|Overall Study||37||
59735852|NCT00928512|75854512|FG002|COMPLETED|Overall Study||38||
59735853|NCT00928512|75854513|FG003|COMPLETED|Overall Study||33||
59735854|NCT00928512|75854514|FG004|COMPLETED|Overall Study||35||
59735855|NCT00928512|75854510|FG000|NOT COMPLETED|Overall Study||10||
59735856|NCT00928512|75854511|FG001|NOT COMPLETED|Overall Study||6||
59735857|NCT00928512|75854512|FG002|NOT COMPLETED|Overall Study||11||
59735858|NCT00928512|75854513|FG003|NOT COMPLETED|Overall Study||21||
59735859|NCT00928512|75854514|FG004|NOT COMPLETED|Overall Study||15||
59735860|NCT00787891|75854532|FG000|STARTED|Short-term Double-blind Phase (Part 1)||65||
59735861|NCT00787891|75854533|FG001|STARTED|Short-term Double-blind Phase (Part 1)||62||
59735862|NCT00787891|75854532|FG000|COMPLETED|Short-term Double-blind Phase (Part 1)||55||
59735863|NCT00787891|75854533|FG001|COMPLETED|Short-term Double-blind Phase (Part 1)||53||
59735864|NCT00787891|75854532|FG000|NOT COMPLETED|Short-term Double-blind Phase (Part 1)||10||
59735865|NCT00787891|75854533|FG001|NOT COMPLETED|Short-term Double-blind Phase (Part 1)||9||
59735866|NCT00787891|75854532|FG000|STARTED|Maintenance Double-blind Phase (Part 2)||33||
59735867|NCT00787891|75854533|FG001|STARTED|Maintenance Double-blind Phase (Part 2)||31||
59735868|NCT00787891|75854532|FG000|COMPLETED|Maintenance Double-blind Phase (Part 2)||26||
59735869|NCT00787891|75854533|FG001|COMPLETED|Maintenance Double-blind Phase (Part 2)||24||
59735870|NCT00787891|75854532|FG000|NOT COMPLETED|Maintenance Double-blind Phase (Part 2)||7||
59735871|NCT00787891|75854533|FG001|NOT COMPLETED|Maintenance Double-blind Phase (Part 2)||7||
59735872|NCT00892437|75854543|FG000|STARTED|Randomized Phase||56||
59735873|NCT00892437|75854544|FG001|STARTED|Randomized Phase||29||
59735874|NCT00892437|75854543|FG000|Randomized and Treated|Randomized Phase||50||
59735875|NCT00892437|75854544|FG001|Randomized and Treated|Randomized Phase||29||
59735876|NCT00892437|75854543|FG000|COMPLETED|Randomized Phase||45||
59735877|NCT00892437|75854544|FG001|COMPLETED|Randomized Phase||24||
59735878|NCT00892437|75854543|FG000|NOT COMPLETED|Randomized Phase||11||
59735879|NCT00892437|75854544|FG001|NOT COMPLETED|Randomized Phase||5||
59735880|NCT00892437|75854543|FG000|STARTED|Open-Label Extension Phase|1 participant completed the randomized phase but did not enter the open-label extension phase.|44||
59735881|NCT00892437|75854544|FG001|STARTED|Open-Label Extension Phase|5 participants completed the randomized phase but did not enter the open-label extension phase.|19||
59735882|NCT00892437|75854543|FG000|COMPLETED|Open-Label Extension Phase||32||
59735883|NCT00892437|75854544|FG001|COMPLETED|Open-Label Extension Phase||15||
59735884|NCT00892437|75854543|FG000|NOT COMPLETED|Open-Label Extension Phase||12||
59735885|NCT00892437|75854544|FG001|NOT COMPLETED|Open-Label Extension Phase||4||
59735886|NCT00792103|75854551|FG000|STARTED|Overall Study|15 subjects were enrolled but did not treat for a total of 183 subjects in the safety population|198||
59735887|NCT00792103|75854551|FG000|COMPLETED|Overall Study||65||
59735888|NCT00792103|75854551|FG000|NOT COMPLETED|Overall Study||133||
59735889|NCT00892281|75854557|FG000|STARTED|Overall Study||1197||
59735890|NCT00892281|75854558|FG001|STARTED|Overall Study||224||
59735891|NCT00892281|75854557|FG000|COMPLETED|Overall Study||930||
59735892|NCT00892281|75854558|FG001|COMPLETED|Overall Study||187||
59735893|NCT00892281|75854557|FG000|NOT COMPLETED|Overall Study||267||
59735894|NCT00892281|75854558|FG001|NOT COMPLETED|Overall Study||37||
59735895|NCT00784693|75854566|FG000|STARTED|Overall Study||23||
59735896|NCT00784693|75854567|FG001|STARTED|Overall Study||25||
59735897|NCT00784693|75854566|FG000|Treated|Overall Study||22||
59735898|NCT00784693|75854567|FG001|Treated|Overall Study||25||
59735899|NCT00784693|75854566|FG000|COMPLETED|Overall Study||20||
59735900|NCT00784693|75854567|FG001|COMPLETED|Overall Study||19||
59735901|NCT00784693|75854566|FG000|NOT COMPLETED|Overall Study||3||
59735902|NCT00784693|75854567|FG001|NOT COMPLETED|Overall Study||6||
59735903|NCT00893763|75854575|FG000|STARTED|Overall Study||157||
59735904|NCT00893763|75854576|FG001|STARTED|Overall Study||157||
59735905|NCT00893763|75854575|FG000|COMPLETED|Overall Study||47||
59735906|NCT00893763|75854576|FG001|COMPLETED|Overall Study||47||
59735907|NCT00893763|75854575|FG000|NOT COMPLETED|Overall Study||110||
59735908|NCT00893763|75854576|FG001|NOT COMPLETED|Overall Study||110||
59735909|NCT00892047|75854586|FG000|STARTED|Overall Study||91||
59735910|NCT00892047|75854587|FG001|STARTED|Overall Study||90||
59735911|NCT00892047|75854586|FG000|COMPLETED|Overall Study||87||
59735912|NCT00892047|75854587|FG001|COMPLETED|Overall Study||83||
59735913|NCT00892047|75854586|FG000|NOT COMPLETED|Overall Study||4||
59735914|NCT00892047|75854587|FG001|NOT COMPLETED|Overall Study||7||
59735915|NCT00787267|75854595|FG000|STARTED|Overall Study|Signed a consent form|37||
59735916|NCT00787267|75854595|FG000|COMPLETED|Overall Study|Received at least one dose of study drug|25||
59735917|NCT00787267|75854595|FG000|NOT COMPLETED|Overall Study||12||
59735918|NCT00928434|75854602|FG000|STARTED|Overall Study|Full Analysis Set Patients|175||
59735919|NCT00928434|75854603|FG001|STARTED|Overall Study|Full Analysis Set Patients|50||
59735920|NCT00928434|75854604|FG002|STARTED|Overall Study|Full Analysis Set Patients|178||
59735921|NCT00928434|75854602|FG000|Full Phase B Analysis Set|Overall Study|Patients completing 7 months treatment with PSA<2 ng/mL, and having one primary efficacy assessment.|137||
59735922|NCT00928434|75854603|FG001|Full Phase B Analysis Set|Overall Study|Patients completing 7 months treatment with PSA<2 ng/mL, and having one primary efficacy assessment.|41||
59735923|NCT00928434|75854604|FG002|Full Phase B Analysis Set|Overall Study|Patients completing 7 months treatment with PSA<2 ng/mL, and having one primary efficacy assessment.|150||
59735924|NCT00928434|75854602|FG000|COMPLETED|Overall Study||131||
59735925|NCT00928434|75854603|FG001|COMPLETED|Overall Study||36||
59735926|NCT00928434|75854604|FG002|COMPLETED|Overall Study||134||
59735927|NCT00928434|75854602|FG000|NOT COMPLETED|Overall Study||44||
59735928|NCT00928434|75854603|FG001|NOT COMPLETED|Overall Study||14||
59735929|NCT00928434|75854604|FG002|NOT COMPLETED|Overall Study||44||
59735930|NCT00787189|75854622|FG000|STARTED|Overall Study||32||
59735931|NCT00787189|75854623|FG001|STARTED|Overall Study||32||
59735932|NCT00787189|75854622|FG000|COMPLETED|Overall Study|To study end point.|30||
59735933|NCT00787189|75854623|FG001|COMPLETED|Overall Study|To study end point.|30||
59735934|NCT00787189|75854622|FG000|NOT COMPLETED|Overall Study||2||
59735935|NCT00787189|75854623|FG001|NOT COMPLETED|Overall Study||2||
59735936|NCT00784459|75854631|FG000|STARTED|Overall Study||11||
59735937|NCT00784459|75854632|FG001|STARTED|Overall Study||13||
59735938|NCT00784459|75854631|FG000|COMPLETED|Overall Study||11||
59735939|NCT00784459|75854632|FG001|COMPLETED|Overall Study||11||
59735940|NCT00784459|75854631|FG000|NOT COMPLETED|Overall Study||0||
59735941|NCT00784459|75854632|FG001|NOT COMPLETED|Overall Study||2||
59735942|NCT00786799|75854640|FG000|STARTED|Overall Study||14||
59735943|NCT00786799|75854641|FG001|STARTED|Overall Study||13||
59735944|NCT00786799|75854640|FG000|COMPLETED|Overall Study||13||
59735945|NCT00786799|75854641|FG001|COMPLETED|Overall Study||12||
59735946|NCT00786799|75854640|FG000|NOT COMPLETED|Overall Study||1||
59735947|NCT00786799|75854641|FG001|NOT COMPLETED|Overall Study||1||
59735948|NCT00786565|75854652|FG000|STARTED|Enrollment Prior to Surgery||75||
59735949|NCT00786565|75854652|FG000|COMPLETED|Enrollment Prior to Surgery|69 participants - Akreos Advanced Optic Lens in one eye and Akreos Adapt Lens in the fellow eye.|69||
59735950|NCT00786565|75854652|FG000|NOT COMPLETED|Enrollment Prior to Surgery||6||
59735951|NCT00786565|75854652|FG000|STARTED|Post Surgery||69||
59735952|NCT00786565|75854652|FG000|COMPLETED|Post Surgery|67 Participants (134 eyes) completed the study.|67||
59735953|NCT00786565|75854652|FG000|NOT COMPLETED|Post Surgery||2||
59735954|NCT00784147|75854660|FG000|STARTED|Overall Study||59||
59735955|NCT00784147|75854661|FG001|STARTED|Overall Study||54||
59735956|NCT00784147|75854660|FG000|COMPLETED|Overall Study||51||
59735957|NCT00784147|75854661|FG001|COMPLETED|Overall Study||45||
59735958|NCT00784147|75854660|FG000|NOT COMPLETED|Overall Study||8||
59735959|NCT00784147|75854661|FG001|NOT COMPLETED|Overall Study||9||
59735960|NCT00891813|75854667|FG000|STARTED|Overall Study||100||
59735961|NCT00891813|75854667|FG000|COMPLETED|Overall Study||88||
59735962|NCT00891813|75854667|FG000|NOT COMPLETED|Overall Study||12||
59735963|NCT02833311|75854674|FG000|STARTED|Overall Study||15||
59735964|NCT02833311|75854675|FG001|STARTED|Overall Study||16||
59735965|NCT02833311|75854676|FG002|STARTED|Overall Study||15||
59735966|NCT02833311|75854674|FG000|COMPLETED|Overall Study||13||
59735967|NCT02833311|75854675|FG001|COMPLETED|Overall Study||15||
59735968|NCT02833311|75854676|FG002|COMPLETED|Overall Study||15||
59735969|NCT02833311|75854674|FG000|NOT COMPLETED|Overall Study||2||
59735970|NCT02833311|75854675|FG001|NOT COMPLETED|Overall Study||1||
59735971|NCT02833311|75854676|FG002|NOT COMPLETED|Overall Study||0||
59735972|NCT00783835|75854684|FG000|STARTED|Overall Study||60||
59735973|NCT00783835|75854684|FG000|COMPLETED|Overall Study||50||
59735974|NCT00783835|75854684|FG000|NOT COMPLETED|Overall Study||10||
59735975|NCT00783289|75854692|FG000|STARTED|Overall Study||6||
59735976|NCT00783289|75854693|FG001|STARTED|Overall Study||7||
59735977|NCT00783289|75854694|FG002|STARTED|Overall Study||6||
59735978|NCT00783289|75854695|FG003|STARTED|Overall Study||6||
59735979|NCT00783289|75854692|FG000|COMPLETED|Overall Study||6||
59735980|NCT00783289|75854693|FG001|COMPLETED|Overall Study||6||
59735981|NCT00783289|75854694|FG002|COMPLETED|Overall Study||6||
59735982|NCT00783289|75854695|FG003|COMPLETED|Overall Study||6||
59735983|NCT00783289|75854692|FG000|NOT COMPLETED|Overall Study||0||
59735984|NCT00783289|75854693|FG001|NOT COMPLETED|Overall Study||1||
59735985|NCT00783289|75854694|FG002|NOT COMPLETED|Overall Study||0||
59735986|NCT00783289|75854695|FG003|NOT COMPLETED|Overall Study||0||
59735987|NCT00847912|75854710|FG000|STARTED|Overall Study||477||
59735988|NCT00847912|75854711|FG001|STARTED|Overall Study||477||
59735989|NCT00847912|75854710|FG000|COMPLETED|Overall Study||468||
59735990|NCT00847912|75854711|FG001|COMPLETED|Overall Study||464||
59735991|NCT00847912|75854710|FG000|NOT COMPLETED|Overall Study||9||
59735992|NCT00847912|75854711|FG001|NOT COMPLETED|Overall Study||13||
59735993|NCT00850564|75854718|FG000|STARTED|Overall Study||15||
59735994|NCT00850564|75854718|FG000|COMPLETED|Overall Study||13||
59735995|NCT00850564|75854718|FG000|NOT COMPLETED|Overall Study||2||
59735996|NCT00837148|75854722|FG000|STARTED|Overall Study||37||
59735997|NCT00837148|75854722|FG000|COMPLETED|Overall Study||35||
59735998|NCT00837148|75854722|FG000|NOT COMPLETED|Overall Study||2||
59735999|NCT00849940|75854726|FG000|STARTED|Overall Study||72||
59736000|NCT00849940|75854726|FG000|COMPLETED|Overall Study||68||
59736001|NCT00849940|75854726|FG000|NOT COMPLETED|Overall Study||4||
59736002|NCT00849472|75854730|FG000|STARTED|Doxorubicin and Cyclophosphamide (AC)||101||
59736003|NCT00849472|75854730|FG000|COMPLETED|Doxorubicin and Cyclophosphamide (AC)||95||
59736004|NCT00849472|75854730|FG000|NOT COMPLETED|Doxorubicin and Cyclophosphamide (AC)||6||
59736005|NCT00849472|75854730|FG000|STARTED|Weekly Paclitaxel|One par. was deemed ineligible after completing AC therapy and did not start paclitaxel+pazopanib.|94||
59736006|NCT00849472|75854730|FG000|COMPLETED|Weekly Paclitaxel||78||
59736007|NCT00849472|75854730|FG000|NOT COMPLETED|Weekly Paclitaxel||16||
59736008|NCT00849472|75854730|FG000|STARTED|Pazopanib Presurgery Treatment (PPT)||94||
59736009|NCT00849472|75854730|FG000|COMPLETED|Pazopanib Presurgery Treatment (PPT)||36||
59736010|NCT00849472|75854730|FG000|NOT COMPLETED|Pazopanib Presurgery Treatment (PPT)||58||
59736011|NCT00849472|75854730|FG000|STARTED|Pazopanib Postsurgery Treatment|36 participants completed PPT; 7 participants who discontinued PPT resumed treatment postsurgery.|42||
59736012|NCT00849472|75854730|FG000|COMPLETED|Pazopanib Postsurgery Treatment||16||
59736013|NCT00849472|75854730|FG000|NOT COMPLETED|Pazopanib Postsurgery Treatment||26||
59736014|NCT00782509|75854738|FG000|STARTED|Overall Study||216||
59736015|NCT00782509|75854739|FG001|STARTED|Overall Study||209||
59736016|NCT00782509|75854740|FG002|STARTED|Overall Study||217||
59736017|NCT00782509|75854738|FG000|COMPLETED|Overall Study||175||
59736018|NCT00782509|75854739|FG001|COMPLETED|Overall Study||185||
59736019|NCT00782509|75854740|FG002|COMPLETED|Overall Study||181||
59736020|NCT00782509|75854738|FG000|NOT COMPLETED|Overall Study||41||
59736021|NCT00782509|75854739|FG001|NOT COMPLETED|Overall Study||24||
59736022|NCT00782509|75854740|FG002|NOT COMPLETED|Overall Study||36||
59736023|NCT00927810|75854759|FG000|STARTED|Overall Study||75||
59736024|NCT00927810|75854760|FG001|STARTED|Overall Study||181||
59736025|NCT00927810|75854761|FG002|STARTED|Overall Study||25||
59736026|NCT00927810|75854762|FG003|STARTED|Overall Study||60||
59736027|NCT00927810|75854759|FG000|COMPLETED|Overall Study||75||
59736028|NCT00927810|75854760|FG001|COMPLETED|Overall Study||173||
59736029|NCT00927810|75854761|FG002|COMPLETED|Overall Study||24||
59736030|NCT00927810|75854762|FG003|COMPLETED|Overall Study||58||
59736031|NCT00927810|75854759|FG000|NOT COMPLETED|Overall Study||0||
59736032|NCT00927810|75854760|FG001|NOT COMPLETED|Overall Study||8||
59736033|NCT00927810|75854761|FG002|NOT COMPLETED|Overall Study||1||
59736034|NCT00927810|75854762|FG003|NOT COMPLETED|Overall Study||2||
59736035|NCT00848926|75854780|FG000|STARTED|Treatment Period||102||
59736036|NCT00848926|75854780|FG000|COMPLETED|Treatment Period|Number who completed 16 cycles of treatment|18||
59736037|NCT00848926|75854780|FG000|NOT COMPLETED|Treatment Period||84||
59736038|NCT00848926|75854780|FG000|STARTED|Follow-up Period|All participants were to be followed after treatment|102||
59736039|NCT00848926|75854780|FG000|COMPLETED|Follow-up Period|Completed survival follow-up due to death [57] or study termination by sponsor [33]|90||
59736040|NCT00848926|75854780|FG000|NOT COMPLETED|Follow-up Period||12||
59736041|NCT00847132|75854786|FG000|STARTED|Overall Study||90||
59736042|NCT00847132|75854787|FG001|STARTED|Overall Study||85||
59736043|NCT00847132|75854786|FG000|COMPLETED|Overall Study||89||
59736044|NCT00847132|75854787|FG001|COMPLETED|Overall Study||84||
59736045|NCT00847132|75854786|FG000|NOT COMPLETED|Overall Study||1||
59736046|NCT00847132|75854787|FG001|NOT COMPLETED|Overall Study||1||
59736047|NCT00918138|75854795|FG000|STARTED|Overall Study||46||
59736048|NCT00918138|75854796|FG001|STARTED|Overall Study||47||
59736049|NCT00918138|75854795|FG000|COMPLETED|Overall Study||44||
59736050|NCT00918138|75854796|FG001|COMPLETED|Overall Study||46||
59736051|NCT00918138|75854795|FG000|NOT COMPLETED|Overall Study||2||
59736052|NCT00918138|75854796|FG001|NOT COMPLETED|Overall Study||1||
59736053|NCT00782275|75854802|FG000|STARTED|Overall Study||41||
59736054|NCT00782275|75854802|FG000|Treated|Overall Study||40||
59736055|NCT00782275|75854802|FG000|Prior VEGFR Response Evaluable|Overall Study|One patient was unevaluable and therefore excluded from related subgroup analyses.|39|Pts were classified by response to previous VEGFR TKI therapy at baseline: refractory or responsive.|
59736056|NCT00782275|75854802|FG000|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0||
59736057|NCT00782275|75854802|FG000|NOT COMPLETED|Overall Study||41||
59736058|NCT00791557|75854806|FG000|STARTED|Overall Study||2||
59736059|NCT00791557|75854806|FG000|COMPLETED|Overall Study||1||
59736060|NCT00791557|75854806|FG000|NOT COMPLETED|Overall Study||1||
59736061|NCT00920790|75854810|FG000|STARTED|Overall Study||27||
59736062|NCT00920790|75854810|FG000|COMPLETED|Overall Study||13||
59736063|NCT00920790|75854810|FG000|NOT COMPLETED|Overall Study||14||
59736064|NCT00781963|75854816|FG000|STARTED|Overall Study||106||
59736065|NCT00781963|75854817|FG001|STARTED|Overall Study||53||
59736066|NCT00781963|75854816|FG000|COMPLETED|Overall Study||89||
59736067|NCT00781963|75854817|FG001|COMPLETED|Overall Study||51||
59736068|NCT00781963|75854816|FG000|NOT COMPLETED|Overall Study||17||
59736069|NCT00781963|75854817|FG001|NOT COMPLETED|Overall Study||2||
59736070|NCT00920556|75854823|FG000|STARTED|Overall Study||24||
59736071|NCT00920556|75854823|FG000|COMPLETED|Overall Study||0||
59736072|NCT00920556|75854823|FG000|NOT COMPLETED|Overall Study||24||
59736073|NCT00781885|75854831|FG000|STARTED|Overall Study||19||
59736074|NCT00781885|75854831|FG000|Received at Least 1 Dose of Study Drug|Overall Study||19||
59736075|NCT00781885|75854831|FG000|COMPLETED|Overall Study||18||
59736076|NCT00781885|75854831|FG000|NOT COMPLETED|Overall Study||1||
59736077|NCT00918684|75854835|FG000|STARTED|Two Week Drug Washout and Placebo Phase||106||
59736078|NCT00918684|75854835|FG000|COMPLETED|Two Week Drug Washout and Placebo Phase||90||
59736079|NCT00918684|75854835|FG000|NOT COMPLETED|Two Week Drug Washout and Placebo Phase||16||
59736080|NCT00918684|75854835|FG000|STARTED|Treatment Phase||90||
59736081|NCT00918684|75854835|FG000|COMPLETED|Treatment Phase||65||
59736082|NCT00918684|75854835|FG000|NOT COMPLETED|Treatment Phase||25||
59736083|NCT00786409|75854839|FG000|STARTED|Overall Study||27||
59736084|NCT00786409|75854839|FG000|COMPLETED|Overall Study||20||
59736085|NCT00786409|75854839|FG000|NOT COMPLETED|Overall Study||7||
59736086|NCT00919854|75854843|FG000|STARTED|Overall Study||21||
59736087|NCT00919854|75854843|FG000|COMPLETED|Overall Study|'Completed' represents the patients that are ongoing at the time of cut-off for the Week 24 analysis|20||
59736088|NCT00919854|75854843|FG000|NOT COMPLETED|Overall Study||1||
59736089|NCT00891735|75854851|FG000|STARTED|Overall Study||275||
59736090|NCT00891735|75854852|FG001|STARTED|Overall Study||274||
59736091|NCT00891735|75854853|FG002|STARTED|Overall Study||275||
59736092|NCT00891735|75854854|FG003|STARTED|Overall Study||273||
59736093|NCT00891735|75854851|FG000|COMPLETED|Overall Study||258||
59736094|NCT00891735|75854852|FG001|COMPLETED|Overall Study||258||
59736095|NCT00891735|75854853|FG002|COMPLETED|Overall Study||263||
59736096|NCT00891735|75854854|FG003|COMPLETED|Overall Study||258||
59736097|NCT00891735|75854851|FG000|NOT COMPLETED|Overall Study||17||
59736098|NCT00891735|75854852|FG001|NOT COMPLETED|Overall Study||16||
59736099|NCT00891735|75854853|FG002|NOT COMPLETED|Overall Study||12||
59736100|NCT00891735|75854854|FG003|NOT COMPLETED|Overall Study||15||
59736101|NCT00891657|75854866|FG000|STARTED|Overall Study||9||
59736102|NCT00891657|75854867|FG001|STARTED|Overall Study||6||
59736103|NCT00891657|75854866|FG000|COMPLETED|Overall Study||8||
59736104|NCT00891657|75854867|FG001|COMPLETED|Overall Study||5||
59736105|NCT00891657|75854866|FG000|NOT COMPLETED|Overall Study||1||
59736106|NCT00891657|75854867|FG001|NOT COMPLETED|Overall Study||1||
59736107|NCT00917124|75854875|FG000|STARTED|Overall Study||100||
59736108|NCT00917124|75854876|FG001|STARTED|Overall Study||100||
59736109|NCT00917124|75854875|FG000|COMPLETED|Overall Study||96||
59736110|NCT00917124|75854876|FG001|COMPLETED|Overall Study||94||
59736111|NCT00917124|75854875|FG000|NOT COMPLETED|Overall Study||4||
59736112|NCT00917124|75854876|FG001|NOT COMPLETED|Overall Study||6||
59736113|NCT00889863|75854882|FG000|STARTED|Part I: Open Label||177||
59736114|NCT00889863|75854883|FG001|STARTED|Part I: Open Label|No participants received placebo in Part I.|0||
59736115|NCT00889863|75854882|FG000|Entered Part Ia|Part I: Open Label||145||
59736116|NCT00889863|75854883|FG001|Entered Part Ia|Part I: Open Label||0||
59868840|NCT04067492|75993258|FG001|STARTED|Overall Study||6||
59868841|NCT04067492|75993259|FG002|STARTED|Overall Study||6||
59736117|NCT00889863|75854882|FG000|Entered Part Ib|Part I: Open Label||142||
59736118|NCT00889863|75854883|FG001|Entered Part Ib|Part I: Open Label||0||
59736119|NCT00889863|75854882|FG000|Entered Part Ic|Part I: Open Label|Patients steroid free at study entry entered Part Id directly and did not participate in Part Ic.|92||
59736120|NCT00889863|75854883|FG001|Entered Part Ic|Part I: Open Label||0||
59736121|NCT00889863|75854882|FG000|Entered Part 1d|Part I: Open Label||103||
59736122|NCT00889863|75854883|FG001|Entered Part 1d|Part I: Open Label||0||
59736123|NCT00889863|75854882|FG000|COMPLETED|Part I: Open Label||100||
59736124|NCT00889863|75854883|FG001|COMPLETED|Part I: Open Label||0||
59736125|NCT00889863|75854882|FG000|NOT COMPLETED|Part I: Open Label||77||
59736126|NCT00889863|75854883|FG001|NOT COMPLETED|Part I: Open Label||0||
59736127|NCT00889863|75854882|FG000|STARTED|Part II: Randomized Double Blind||50||
59736128|NCT00889863|75854883|FG001|STARTED|Part II: Randomized Double Blind||50||
59736129|NCT00889863|75854882|FG000|COMPLETED|Part II: Randomized Double Blind||39||
59736130|NCT00889863|75854883|FG001|COMPLETED|Part II: Randomized Double Blind||24||
59736131|NCT00889863|75854882|FG000|NOT COMPLETED|Part II: Randomized Double Blind||11||
59736132|NCT00889863|75854883|FG001|NOT COMPLETED|Part II: Randomized Double Blind||26||
59736133|NCT00915018|75854893|FG000|STARTED|Overall Study||242||
59868842|NCT04067492|75993260|FG003|STARTED|Overall Study||6||
59736134|NCT00915018|75854894|FG001|STARTED|Overall Study||237||
59736135|NCT00915018|75854893|FG000|Received Treatment|Overall Study||240||
59736136|NCT00915018|75854894|FG001|Received Treatment|Overall Study||234||
59736137|NCT00915018|75854893|FG000|COMPLETED|Overall Study||27||
59736138|NCT00915018|75854894|FG001|COMPLETED|Overall Study||30||
59736139|NCT00915018|75854893|FG000|NOT COMPLETED|Overall Study||215||
59736140|NCT00915018|75854894|FG001|NOT COMPLETED|Overall Study||207||
59736141|NCT00916578|75854900|FG000|STARTED|Overall Study||33||
59736142|NCT00916578|75854900|FG000|COMPLETED|Overall Study||26||
59736143|NCT00916578|75854900|FG000|NOT COMPLETED|Overall Study||7||
59736144|NCT00889707|75854906|FG000|STARTED|Overall Study||61||
59736145|NCT00889707|75854907|FG001|STARTED|Overall Study||31||
59736146|NCT00889707|75854906|FG000|COMPLETED|Overall Study||54||
59736147|NCT00889707|75854907|FG001|COMPLETED|Overall Study||21||
59736148|NCT00889707|75854906|FG000|NOT COMPLETED|Overall Study||7||
59736149|NCT00889707|75854907|FG001|NOT COMPLETED|Overall Study||10||
59736150|NCT00914940|75854913|FG000|STARTED|D0 to D100 Post-transplant||41||
59736151|NCT00914940|75854913|FG000|COMPLETED|D0 to D100 Post-transplant||39||
59736152|NCT00914940|75854913|FG000|NOT COMPLETED|D0 to D100 Post-transplant||2||
59736153|NCT00914940|75854913|FG000|STARTED|D101 to 2 Years Post-transplant||39||
59736154|NCT00914940|75854913|FG000|COMPLETED|D101 to 2 Years Post-transplant||31||
59736155|NCT00914940|75854913|FG000|NOT COMPLETED|D101 to 2 Years Post-transplant||8||
59736156|NCT00914940|75854913|FG000|STARTED|2 Years to 5 Years Post-transplant||31||
59736157|NCT00914940|75854913|FG000|COMPLETED|2 Years to 5 Years Post-transplant||28||
59736158|NCT00914940|75854913|FG000|NOT COMPLETED|2 Years to 5 Years Post-transplant||3||
59736159|NCT00835978|75854921|FG000|STARTED|Overall Study||56||
59736160|NCT00835978|75854922|FG001|STARTED|Overall Study||56||
59736161|NCT00835978|75854923|FG002|STARTED|Overall Study||91||
59736162|NCT00835978|75854924|FG003|STARTED|Overall Study||10||
59736163|NCT00835978|75854921|FG000|Treated|Overall Study||56||
59736164|NCT00835978|75854922|FG001|Treated|Overall Study||56||
59736165|NCT00835978|75854923|FG002|Treated|Overall Study||91||
59736166|NCT00835978|75854924|FG003|Treated|Overall Study||10||
59736167|NCT00835978|75854921|FG000|COMPLETED|Overall Study|Study Completion: 29 Feb 2016. Treatment discontinued due to objective progression/relapse & death|0||
59736168|NCT00835978|75854922|FG001|COMPLETED|Overall Study|Study Completion: 29 Feb 2016. Treatment discontinued due to objective progression/relapse & death|0||
59736169|NCT00835978|75854923|FG002|COMPLETED|Overall Study|Study Completion: 29 Feb 2016. Treatment discontinued due to objective progression/relapse & death|0||
59736170|NCT00835978|75854924|FG003|COMPLETED|Overall Study|Study Completion: 29 Feb 2016. Treatment discontinued due to objective progression/relapse & death|0||
59736171|NCT00835978|75854921|FG000|NOT COMPLETED|Overall Study||56||
59736172|NCT00835978|75854922|FG001|NOT COMPLETED|Overall Study||56||
59736173|NCT00835978|75854923|FG002|NOT COMPLETED|Overall Study||91||
59736174|NCT00835978|75854924|FG003|NOT COMPLETED|Overall Study||10||
59736175|NCT00914628|75854941|FG000|STARTED|Overall Study|Referred to all randomized patient|64||
59736176|NCT00914628|75854942|FG001|STARTED|Overall Study|Referred to all randomized patient|28||
59736177|NCT00914628|75854941|FG000|COMPLETED|Overall Study|Early termination of the Study|0||
59736178|NCT00914628|75854942|FG001|COMPLETED|Overall Study|Early termination of the Study|0||
59736179|NCT00914628|75854941|FG000|NOT COMPLETED|Overall Study||64||
59736180|NCT00914628|75854942|FG001|NOT COMPLETED|Overall Study||28||
59736181|NCT01077518|75854954|FG000|STARTED|Treatment Phase - no Optional Ofa||173||
59736182|NCT01077518|75854955|FG001|STARTED|Treatment Phase - no Optional Ofa||173||
60001152|NCT02106832|76116844|FG002|Participants Received Treatment|Overall Study||86||
60001153|NCT02106832|76116845|FG003|Participants Received Treatment|Overall Study||88||
60001154|NCT02106832|76116842|FG000|COMPLETED|Overall Study||148||
60001155|NCT02106832|76116843|FG001|COMPLETED|Overall Study||151||
60001156|NCT02106832|76116844|FG002|COMPLETED|Overall Study||70||
60001157|NCT02106832|76116845|FG003|COMPLETED|Overall Study||73||
60001158|NCT02106832|76116842|FG000|NOT COMPLETED|Overall Study||23||
60001159|NCT02106832|76116843|FG001|NOT COMPLETED|Overall Study||25||
60001160|NCT02106832|76116844|FG002|NOT COMPLETED|Overall Study||16||
60001161|NCT02106832|76116845|FG003|NOT COMPLETED|Overall Study||15||
59736183|NCT01077518|75854956|FG002|STARTED|Treatment Phase - no Optional Ofa||0||
59736184|NCT01077518|75854954|FG000|Completed 5-year Follow-up|Treatment Phase - no Optional Ofa||64||
59736185|NCT01077518|75854955|FG001|Completed 5-year Follow-up|Treatment Phase - no Optional Ofa||64||
59736186|NCT01077518|75854956|FG002|Completed 5-year Follow-up|Treatment Phase - no Optional Ofa||0||
59736187|NCT01077518|75854954|FG000|Safety Population|Treatment Phase - no Optional Ofa||172||
59736188|NCT01077518|75854955|FG001|Safety Population|Treatment Phase - no Optional Ofa||170||
59736189|NCT01077518|75854956|FG002|Safety Population|Treatment Phase - no Optional Ofa||0||
59736190|NCT01077518|75854954|FG000|COMPLETED|Treatment Phase - no Optional Ofa||95||
59736191|NCT01077518|75854955|FG001|COMPLETED|Treatment Phase - no Optional Ofa||108||
59736192|NCT01077518|75854956|FG002|COMPLETED|Treatment Phase - no Optional Ofa||0||
59736193|NCT01077518|75854954|FG000|NOT COMPLETED|Treatment Phase - no Optional Ofa||78||
59736194|NCT01077518|75854955|FG001|NOT COMPLETED|Treatment Phase - no Optional Ofa||65||
59736195|NCT01077518|75854956|FG002|NOT COMPLETED|Treatment Phase - no Optional Ofa||0||
59736196|NCT01077518|75854954|FG000|STARTED|Optional Ofa Phase||0||
60001162|NCT02106442|76116857|FG000|STARTED|Overall Study||579||
59736197|NCT01077518|75854955|FG001|STARTED|Optional Ofa Phase||0||
59736198|NCT01077518|75854956|FG002|STARTED|Optional Ofa Phase||32||
59736199|NCT01077518|75854954|FG000|Completed 5-year Follow-up|Optional Ofa Phase||0||
59736200|NCT01077518|75854955|FG001|Completed 5-year Follow-up|Optional Ofa Phase||0||
59736201|NCT01077518|75854956|FG002|Completed 5-year Follow-up|Optional Ofa Phase||12||
59736202|NCT01077518|75854954|FG000|COMPLETED|Optional Ofa Phase||0||
59736203|NCT01077518|75854955|FG001|COMPLETED|Optional Ofa Phase||0||
59736204|NCT01077518|75854956|FG002|COMPLETED|Optional Ofa Phase||16||
59736205|NCT01077518|75854954|FG000|NOT COMPLETED|Optional Ofa Phase||0||
59736206|NCT01077518|75854955|FG001|NOT COMPLETED|Optional Ofa Phase||0||
59736207|NCT01077518|75854956|FG002|NOT COMPLETED|Optional Ofa Phase||16||
59736208|NCT00835120|75854965|FG000|STARTED|Overall Study||34||
59736209|NCT00835120|75854965|FG000|COMPLETED|Overall Study||26||
59736210|NCT00835120|75854965|FG000|NOT COMPLETED|Overall Study||8||
59736211|NCT00914316|75854973|FG000|STARTED|Phase 1||7||
59736212|NCT00914316|75854974|FG001|STARTED|Phase 1||6||
59736213|NCT00914316|75854975|FG002|STARTED|Phase 1||8||
59736214|NCT00914316|75854976|FG003|STARTED|Phase 1||8||
59736215|NCT00914316|75854973|FG000|COMPLETED|Phase 1||2||
59736216|NCT00914316|75854974|FG001|COMPLETED|Phase 1||4||
59736217|NCT00914316|75854975|FG002|COMPLETED|Phase 1||3||
59736218|NCT00914316|75854976|FG003|COMPLETED|Phase 1||6||
59736219|NCT00914316|75854973|FG000|NOT COMPLETED|Phase 1||5||
59736220|NCT00914316|75854974|FG001|NOT COMPLETED|Phase 1||2||
59736221|NCT00914316|75854975|FG002|NOT COMPLETED|Phase 1||5||
59736222|NCT00914316|75854976|FG003|NOT COMPLETED|Phase 1||2||
59736223|NCT00914316|75854973|FG000|STARTED|Phase 2||2||
59736224|NCT00914316|75854974|FG001|STARTED|Phase 2||4||
59736225|NCT00914316|75854975|FG002|STARTED|Phase 2||3||
59736226|NCT00914316|75854976|FG003|STARTED|Phase 2||6||
59736227|NCT00914316|75854973|FG000|COMPLETED|Phase 2||1||
59736228|NCT00914316|75854974|FG001|COMPLETED|Phase 2||4||
59736229|NCT00914316|75854975|FG002|COMPLETED|Phase 2||2||
59736230|NCT00914316|75854976|FG003|COMPLETED|Phase 2||6||
59736231|NCT00914316|75854973|FG000|NOT COMPLETED|Phase 2||1||
59736232|NCT00914316|75854974|FG001|NOT COMPLETED|Phase 2||0||
59736233|NCT00914316|75854975|FG002|NOT COMPLETED|Phase 2||1||
59736234|NCT00914316|75854976|FG003|NOT COMPLETED|Phase 2||0||
59736235|NCT00827632|75854988|FG000|STARTED|Overall Study||128||
59736236|NCT00827632|75854989|FG001|STARTED|Overall Study||98||
59736237|NCT00827632|75854988|FG000|COMPLETED|Overall Study||106||
59736238|NCT00827632|75854989|FG001|COMPLETED|Overall Study||75||
59736239|NCT00827632|75854988|FG000|NOT COMPLETED|Overall Study||22||
59736240|NCT00827632|75854989|FG001|NOT COMPLETED|Overall Study||23||
59736241|NCT00827242|75854997|FG000|STARTED|Overall Study||161||
59736242|NCT00827242|75854998|FG001|STARTED|Overall Study||164||
59736243|NCT00827242|75854997|FG000|COMPLETED|Overall Study||148||
59736244|NCT00827242|75854998|FG001|COMPLETED|Overall Study||152||
59736245|NCT00827242|75854997|FG000|NOT COMPLETED|Overall Study||13||
59736246|NCT00827242|75854998|FG001|NOT COMPLETED|Overall Study||12||
59736247|NCT01077362|75855007|FG000|STARTED|Overall Study||104||
59736248|NCT01077362|75855008|FG001|STARTED|Overall Study||103||
59736249|NCT01077362|75855009|FG002|STARTED|Overall Study||105||
59736250|NCT01077362|75855007|FG000|COMPLETED|Overall Study||73||
59736251|NCT01077362|75855008|FG001|COMPLETED|Overall Study||84||
59736252|NCT01077362|75855009|FG002|COMPLETED|Overall Study||81||
59736253|NCT01077362|75855007|FG000|NOT COMPLETED|Overall Study||31||
59736254|NCT01077362|75855008|FG001|NOT COMPLETED|Overall Study||19||
59736255|NCT01077362|75855009|FG002|NOT COMPLETED|Overall Study||24||
59736256|NCT00846586|75855024|FG000|STARTED|Overall Study||570||
59736257|NCT00846586|75855025|FG001|STARTED|Overall Study||564||
59736258|NCT00846586|75855024|FG000|Received Study Drug|Overall Study||570||
59736259|NCT00846586|75855025|FG001|Received Study Drug|Overall Study|Three patients were not exposed to study treatment in this group.|561||
59736260|NCT00846586|75855024|FG000|COMPLETED|Overall Study||531||
59736261|NCT00846586|75855025|FG001|COMPLETED|Overall Study||529||
59736262|NCT00846586|75855024|FG000|NOT COMPLETED|Overall Study||39||
59736263|NCT00846586|75855025|FG001|NOT COMPLETED|Overall Study||35||
59736264|NCT00785785|75855033|FG000|STARTED|Core Phase up to 36 Months||324||
59736265|NCT00785785|75855034|FG001|STARTED|Core Phase up to 36 Months||320||
59736266|NCT00785785|75855033|FG000|COMPLETED|Core Phase up to 36 Months||0||
59736267|NCT00785785|75855034|FG001|COMPLETED|Core Phase up to 36 Months||0||
59736268|NCT00785785|75855033|FG000|NOT COMPLETED|Core Phase up to 36 Months||324||
59736269|NCT00785785|75855034|FG001|NOT COMPLETED|Core Phase up to 36 Months||320||
59736270|NCT00785785|75855033|FG000|STARTED|Optional Extension Phase|crossover extension phase was optional|39||
59736271|NCT00785785|75855034|FG001|STARTED|Optional Extension Phase|crossover extension phase was optional|125||
59736272|NCT00785785|75855033|FG000|COMPLETED|Optional Extension Phase||0||
59736273|NCT00785785|75855034|FG001|COMPLETED|Optional Extension Phase||0||
59736274|NCT00785785|75855033|FG000|NOT COMPLETED|Optional Extension Phase||39||
59736275|NCT00785785|75855034|FG001|NOT COMPLETED|Optional Extension Phase||125||
59736276|NCT01077284|75855045|FG000|STARTED|Overall Study||33||
59736277|NCT01077284|75855046|FG001|STARTED|Overall Study||33||
59736278|NCT01077284|75855047|FG002|STARTED|Overall Study||33||
59736279|NCT01077284|75855045|FG000|COMPLETED|Overall Study||28||
59736280|NCT01077284|75855046|FG001|COMPLETED|Overall Study||28||
59736281|NCT01077284|75855047|FG002|COMPLETED|Overall Study||30||
59736282|NCT01077284|75855045|FG000|NOT COMPLETED|Overall Study||5||
59736283|NCT01077284|75855046|FG001|NOT COMPLETED|Overall Study||5||
59736284|NCT01077284|75855047|FG002|NOT COMPLETED|Overall Study||3||
59736285|NCT00826618|75855055|FG000|STARTED|Overall Study||6||
59736286|NCT00826618|75855055|FG000|COMPLETED|Overall Study||5||
59736287|NCT00826618|75855055|FG000|NOT COMPLETED|Overall Study||1||
59736288|NCT01077128|75855059|FG000|STARTED|Overall Study||500||
59736289|NCT01077128|75855059|FG000|COMPLETED|Overall Study||433||
59736290|NCT01077128|75855059|FG000|NOT COMPLETED|Overall Study||67||
59736291|NCT00826540|75855113|FG000|STARTED|Overall Study||83||
59736292|NCT00826540|75855113|FG000|COMPLETED|Overall Study||79||
59736293|NCT00826540|75855113|FG000|NOT COMPLETED|Overall Study||4||
59736294|NCT01077050|75855117|FG000|STARTED|Overall Study||1951||
59736295|NCT01077050|75855117|FG000|COMPLETED|Overall Study||1942||
59736296|NCT01077050|75855117|FG000|NOT COMPLETED|Overall Study||9||
59736297|NCT00592384|75855123|FG000|STARTED|Overall Study||64||
59736298|NCT00592384|75855124|FG001|STARTED|Overall Study||69||
59736299|NCT00592384|75855123|FG000|COMPLETED|Overall Study||59||
59736300|NCT00592384|75855124|FG001|COMPLETED|Overall Study||63||
59736301|NCT00592384|75855123|FG000|NOT COMPLETED|Overall Study||5||
59736302|NCT00592384|75855124|FG001|NOT COMPLETED|Overall Study||6||
59736303|NCT00846040|75855133|FG000|STARTED|Baseline: Days 1-5||10||
59736304|NCT00846040|75855134|FG001|STARTED|Baseline: Days 1-5||10||
59736305|NCT00846040|75855135|FG002|STARTED|Baseline: Days 1-5||23||
59736306|NCT00846040|75855133|FG000|COMPLETED|Baseline: Days 1-5||9||
59736307|NCT00846040|75855134|FG001|COMPLETED|Baseline: Days 1-5||10||
59736308|NCT00846040|75855135|FG002|COMPLETED|Baseline: Days 1-5||23||
59736309|NCT00846040|75855133|FG000|NOT COMPLETED|Baseline: Days 1-5||1||
59736310|NCT00846040|75855134|FG001|NOT COMPLETED|Baseline: Days 1-5||0||
59736311|NCT00846040|75855135|FG002|NOT COMPLETED|Baseline: Days 1-5||0||
59736312|NCT00846040|75855133|FG000|STARTED|First Treatment Period: Days 6-14||9||
59736313|NCT00846040|75855134|FG001|STARTED|First Treatment Period: Days 6-14||10||
59736314|NCT00846040|75855135|FG002|STARTED|First Treatment Period: Days 6-14|This group participated in only the baseline period|0||
59736315|NCT00846040|75855133|FG000|COMPLETED|First Treatment Period: Days 6-14||9||
59736316|NCT00846040|75855134|FG001|COMPLETED|First Treatment Period: Days 6-14||10||
59736317|NCT00846040|75855135|FG002|COMPLETED|First Treatment Period: Days 6-14||0||
59736318|NCT00846040|75855133|FG000|NOT COMPLETED|First Treatment Period: Days 6-14||0||
59736319|NCT00846040|75855134|FG001|NOT COMPLETED|First Treatment Period: Days 6-14||0||
59736320|NCT00846040|75855135|FG002|NOT COMPLETED|First Treatment Period: Days 6-14||0||
59736321|NCT00846040|75855133|FG000|STARTED|Washout: 2 Weeks to 10 Weeks||9||
59736322|NCT00846040|75855134|FG001|STARTED|Washout: 2 Weeks to 10 Weeks||10||
59736323|NCT00846040|75855135|FG002|STARTED|Washout: 2 Weeks to 10 Weeks||0||
59736324|NCT00846040|75855133|FG000|COMPLETED|Washout: 2 Weeks to 10 Weeks||9||
59736325|NCT00846040|75855134|FG001|COMPLETED|Washout: 2 Weeks to 10 Weeks||8||
59736326|NCT00846040|75855135|FG002|COMPLETED|Washout: 2 Weeks to 10 Weeks||0||
59736327|NCT00846040|75855133|FG000|NOT COMPLETED|Washout: 2 Weeks to 10 Weeks||0||
59736328|NCT00846040|75855134|FG001|NOT COMPLETED|Washout: 2 Weeks to 10 Weeks||2||
59736329|NCT00846040|75855135|FG002|NOT COMPLETED|Washout: 2 Weeks to 10 Weeks||0||
59736330|NCT00846040|75855133|FG000|STARTED|Second Treatment: After Washout, 14 Day||9||
59736331|NCT00846040|75855134|FG001|STARTED|Second Treatment: After Washout, 14 Day||8||
59736332|NCT00846040|75855135|FG002|STARTED|Second Treatment: After Washout, 14 Day||0||
59736333|NCT00846040|75855133|FG000|COMPLETED|Second Treatment: After Washout, 14 Day||9||
59736334|NCT00846040|75855134|FG001|COMPLETED|Second Treatment: After Washout, 14 Day||8||
59736335|NCT00846040|75855135|FG002|COMPLETED|Second Treatment: After Washout, 14 Day||0||
59736336|NCT00846040|75855133|FG000|NOT COMPLETED|Second Treatment: After Washout, 14 Day||0||
59736337|NCT00846040|75855134|FG001|NOT COMPLETED|Second Treatment: After Washout, 14 Day||0||
59736338|NCT00846040|75855135|FG002|NOT COMPLETED|Second Treatment: After Washout, 14 Day||0||
59736339|NCT00826228|75855144|FG000|STARTED|Overall Study||12||
59736340|NCT00826228|75855144|FG000|COMPLETED|Overall Study||11||
59736341|NCT00826228|75855144|FG000|NOT COMPLETED|Overall Study||1||
59736342|NCT00825994|75855149|FG000|STARTED|Overall Study||24||
59736343|NCT00825994|75855149|FG000|COMPLETED|Overall Study||19||
59736344|NCT00825994|75855149|FG000|NOT COMPLETED|Overall Study||5||
59736345|NCT00825916|75855156|FG000|STARTED|Overall Study||19||
59736346|NCT00825916|75855157|FG001|STARTED|Overall Study||20||
59736347|NCT00825916|75855158|FG002|STARTED|Overall Study||20||
59736348|NCT00825916|75855156|FG000|COMPLETED|Overall Study||15||
59736349|NCT00825916|75855157|FG001|COMPLETED|Overall Study||18||
59736350|NCT00825916|75855158|FG002|COMPLETED|Overall Study||19||
59736351|NCT00825916|75855156|FG000|NOT COMPLETED|Overall Study||4||
59736352|NCT00825916|75855157|FG001|NOT COMPLETED|Overall Study||2||
59736353|NCT00825916|75855158|FG002|NOT COMPLETED|Overall Study||1||
59736354|NCT00791479|75855205|FG000|STARTED|Overall Study||35||
59736355|NCT00791479|75855206|FG001|STARTED|Overall Study||34||
59736356|NCT00791479|75855207|FG002|STARTED|Overall Study||34||
59736357|NCT00791479|75855208|FG003|STARTED|Overall Study||29||
59736358|NCT00791479|75855209|FG004|STARTED|Overall Study|3mg LY2189265 discont. Replaced with 1.5mg dose based on dose finding Study H9X-MC-GBCF; NCT00734474|3||
59736359|NCT00791479|75855210|FG005|STARTED|Overall Study||32||
59736360|NCT00791479|75855205|FG000|Received at Least One Dose of Study Drug|Overall Study||35||
59736361|NCT00791479|75855206|FG001|Received at Least One Dose of Study Drug|Overall Study||34||
59736362|NCT00791479|75855207|FG002|Received at Least One Dose of Study Drug|Overall Study||34||
59736363|NCT00791479|75855208|FG003|Received at Least One Dose of Study Drug|Overall Study||29||
59736364|NCT00791479|75855209|FG004|Received at Least One Dose of Study Drug|Overall Study||3||
59736365|NCT00791479|75855210|FG005|Received at Least One Dose of Study Drug|Overall Study||32||
59736366|NCT00791479|75855205|FG000|COMPLETED|Overall Study||33||
59736367|NCT00791479|75855206|FG001|COMPLETED|Overall Study||31||
59736368|NCT00791479|75855207|FG002|COMPLETED|Overall Study||34||
59736369|NCT00791479|75855208|FG003|COMPLETED|Overall Study||25||
59736370|NCT00791479|75855209|FG004|COMPLETED|Overall Study||0||
59736371|NCT00791479|75855210|FG005|COMPLETED|Overall Study||29||
59736372|NCT00791479|75855205|FG000|NOT COMPLETED|Overall Study||2||
59736373|NCT00791479|75855206|FG001|NOT COMPLETED|Overall Study||3||
59736374|NCT00791479|75855207|FG002|NOT COMPLETED|Overall Study||0||
59736375|NCT00791479|75855208|FG003|NOT COMPLETED|Overall Study||4||
59736376|NCT00791479|75855209|FG004|NOT COMPLETED|Overall Study||3||
59736377|NCT00791479|75855210|FG005|NOT COMPLETED|Overall Study||3||
59736378|NCT00890097|75855234|FG000|STARTED|Overall Study||252||
59736379|NCT00890097|75855235|FG001|STARTED|Overall Study||259||
59736380|NCT00890097|75855236|FG002|STARTED|Overall Study||261||
59736381|NCT00890097|75855234|FG000|COMPLETED|Overall Study||184||
59736382|NCT00890097|75855235|FG001|COMPLETED|Overall Study||173||
59736383|NCT00890097|75855236|FG002|COMPLETED|Overall Study||184||
59736384|NCT00890097|75855234|FG000|NOT COMPLETED|Overall Study||68||
59736385|NCT00890097|75855235|FG001|NOT COMPLETED|Overall Study||86||
59736386|NCT00890097|75855236|FG002|NOT COMPLETED|Overall Study||77||
59736387|NCT00913458|75855244|FG000|STARTED|Phase 1||306||
59736388|NCT00913458|75855245|FG001|STARTED|Phase 1|This arm is part of Phase 2 study|0||
59736389|NCT00913458|75855246|FG002|STARTED|Phase 1|This arm is part of Phase 2 study|0||
59736390|NCT00913458|75855247|FG003|STARTED|Phase 1|This arm is part of Phase 2 study|0||
59736391|NCT00913458|75855248|FG004|STARTED|Phase 1|This arm is part of Phase 3 study|0||
59736392|NCT00913458|75855249|FG005|STARTED|Phase 1|This arm is part of Phase 3 study|0||
59736393|NCT00913458|75855250|FG006|STARTED|Phase 1|This arm is part of Phase 3 study|0||
59736394|NCT00913458|75855244|FG000|COMPLETED|Phase 1|194 continued to Phase 2 but 1 was randomized in error leaving 193 in the phase 2 analysis.|194||
59736395|NCT00913458|75855245|FG001|COMPLETED|Phase 1|This arm is part of Phase 2 study|0||
59736396|NCT00913458|75855246|FG002|COMPLETED|Phase 1|This arm is part of Phase 2 study|0||
59736397|NCT00913458|75855247|FG003|COMPLETED|Phase 1|This arm is part of Phase 2 study|0||
59736398|NCT00913458|75855248|FG004|COMPLETED|Phase 1|This arm is part of Phase 3 study|0||
59736399|NCT00913458|75855249|FG005|COMPLETED|Phase 1|This arm is part of Phase 3 study|0||
59736400|NCT00913458|75855250|FG006|COMPLETED|Phase 1|This arm is part of Phase 3 study|0||
59736401|NCT00913458|75855244|FG000|NOT COMPLETED|Phase 1||112||
59736402|NCT00913458|75855245|FG001|NOT COMPLETED|Phase 1||0||
59736403|NCT00913458|75855246|FG002|NOT COMPLETED|Phase 1||0||
59736404|NCT00913458|75855247|FG003|NOT COMPLETED|Phase 1||0||
59736405|NCT00913458|75855248|FG004|NOT COMPLETED|Phase 1||0||
59736406|NCT00913458|75855249|FG005|NOT COMPLETED|Phase 1||0||
59736407|NCT00913458|75855250|FG006|NOT COMPLETED|Phase 1||0||
59736408|NCT00913458|75855244|FG000|STARTED|Phase 2|This arm is part of Phase 1 of the study.|0||
59736409|NCT00913458|75855245|FG001|STARTED|Phase 2||63||
59736410|NCT00913458|75855246|FG002|STARTED|Phase 2||65||
59736411|NCT00913458|75855247|FG003|STARTED|Phase 2||65||
59736412|NCT00913458|75855248|FG004|STARTED|Phase 2||0||
59736413|NCT00913458|75855249|FG005|STARTED|Phase 2||0||
59736414|NCT00913458|75855250|FG006|STARTED|Phase 2||0||
59736415|NCT00913458|75855244|FG000|COMPLETED|Phase 2|This arm is part of Phase 1 of the study.|0||
59736416|NCT00913458|75855245|FG001|COMPLETED|Phase 2|Participants randomized into Phase 3 of study.|53||
59736417|NCT00913458|75855246|FG002|COMPLETED|Phase 2|Participants randomized into Phase 3 of study.|46||
59736418|NCT00913458|75855247|FG003|COMPLETED|Phase 2|Participants randomized into Phase 3 of study.|32||
59736419|NCT00913458|75855248|FG004|COMPLETED|Phase 2||0||
59736420|NCT00913458|75855249|FG005|COMPLETED|Phase 2||0||
59736421|NCT00913458|75855250|FG006|COMPLETED|Phase 2||0||
59736422|NCT00913458|75855244|FG000|NOT COMPLETED|Phase 2||0||
59736423|NCT00913458|75855245|FG001|NOT COMPLETED|Phase 2||10||
59736424|NCT00913458|75855246|FG002|NOT COMPLETED|Phase 2||19||
59736425|NCT00913458|75855247|FG003|NOT COMPLETED|Phase 2||33||
59736426|NCT00913458|75855248|FG004|NOT COMPLETED|Phase 2||0||
59736427|NCT00913458|75855249|FG005|NOT COMPLETED|Phase 2||0||
59736428|NCT00913458|75855250|FG006|NOT COMPLETED|Phase 2||0||
59736429|NCT00913458|75855244|FG000|STARTED|Phase 3|This arm is part of Phase 1 of the study.|0||
59736430|NCT00913458|75855245|FG001|STARTED|Phase 3||0||
59736431|NCT00913458|75855246|FG002|STARTED|Phase 3||0||
59736432|NCT00913458|75855247|FG003|STARTED|Phase 3||0||
59736433|NCT00913458|75855248|FG004|STARTED|Phase 3|Participants who completed Phase 2 study|53||
59736434|NCT00913458|75855249|FG005|STARTED|Phase 3|Participants who completed Phase 2 study|46||
59736435|NCT00913458|75855250|FG006|STARTED|Phase 3|Participants who completed Phase 2 study|32||
59736436|NCT00913458|75855244|FG000|COMPLETED|Phase 3|This arm is part of Phase 1 of the study.|0||
59736437|NCT00913458|75855245|FG001|COMPLETED|Phase 3||0||
59736438|NCT00913458|75855246|FG002|COMPLETED|Phase 3||0||
59736439|NCT00913458|75855247|FG003|COMPLETED|Phase 3||0||
59736440|NCT00913458|75855248|FG004|COMPLETED|Phase 3||31||
59736441|NCT00913458|75855249|FG005|COMPLETED|Phase 3||28||
59736442|NCT00913458|75855250|FG006|COMPLETED|Phase 3||24||
59736443|NCT00913458|75855244|FG000|NOT COMPLETED|Phase 3||0||
59736444|NCT00913458|75855245|FG001|NOT COMPLETED|Phase 3||0||
59736445|NCT00913458|75855246|FG002|NOT COMPLETED|Phase 3||0||
59736446|NCT00913458|75855247|FG003|NOT COMPLETED|Phase 3||0||
59736447|NCT00913458|75855248|FG004|NOT COMPLETED|Phase 3||22||
59736448|NCT00913458|75855249|FG005|NOT COMPLETED|Phase 3||18||
59736449|NCT00913458|75855250|FG006|NOT COMPLETED|Phase 3||8||
59736450|NCT00785707|75855267|FG000|STARTED|Overall Study||31||
59736451|NCT00785707|75855267|FG000|COMPLETED|Overall Study||24||
59736452|NCT00785707|75855267|FG000|NOT COMPLETED|Overall Study||7||
59736453|NCT00913380|75855273|FG000|STARTED|CT Examination||444||
59736454|NCT00913380|75855274|FG001|STARTED|CT Examination||447||
59736455|NCT00913380|75855273|FG000|COMPLETED|CT Examination||444||
59736456|NCT00913380|75855274|FG001|COMPLETED|CT Examination||447||
59736457|NCT00913380|75855273|FG000|NOT COMPLETED|CT Examination||0||
59736458|NCT00913380|75855274|FG001|NOT COMPLETED|CT Examination||0||
59736459|NCT00913380|75855273|FG000|STARTED|Clinical Outcomes||444||
59736460|NCT00913380|75855274|FG001|STARTED|Clinical Outcomes||447||
59736461|NCT00913380|75855273|FG000|COMPLETED|Clinical Outcomes||438||
59736462|NCT00913380|75855274|FG001|COMPLETED|Clinical Outcomes||441||
59736463|NCT00913380|75855273|FG000|NOT COMPLETED|Clinical Outcomes||6||
59736464|NCT00913380|75855274|FG001|NOT COMPLETED|Clinical Outcomes||6||
59736465|NCT00785629|75855284|FG000|STARTED|Overall Study||30||
59736466|NCT00785629|75855285|FG001|STARTED|Overall Study||30||
60001163|NCT02106442|76116857|FG000|COMPLETED|Overall Study||542||
60001164|NCT02106442|76116857|FG000|NOT COMPLETED|Overall Study||37||
60001165|NCT02105116|76116861|FG000|STARTED|Overall Study||6||
59736467|NCT00785629|75855286|FG002|STARTED|Overall Study||28||
59736468|NCT00785629|75855287|FG003|STARTED|Overall Study||57||
59736469|NCT00785629|75855284|FG000|COMPLETED|Overall Study|8 not completed|22||
59736470|NCT00785629|75855285|FG001|COMPLETED|Overall Study|5 not completed|25||
59736471|NCT00785629|75855286|FG002|COMPLETED|Overall Study|10 not completed|18||
59736472|NCT00785629|75855287|FG003|COMPLETED|Overall Study|16 not completed|41||
59736473|NCT00785629|75855284|FG000|NOT COMPLETED|Overall Study||8||
59736474|NCT00785629|75855285|FG001|NOT COMPLETED|Overall Study||5||
59736475|NCT00785629|75855286|FG002|NOT COMPLETED|Overall Study||10||
59736476|NCT00785629|75855287|FG003|NOT COMPLETED|Overall Study||16||
59736477|NCT00916344|75855295|FG000|STARTED|Overall Study||175||
59736478|NCT00916344|75855295|FG000|COMPLETED|Overall Study||167||
59736479|NCT00916344|75855295|FG000|NOT COMPLETED|Overall Study||8||
59736480|NCT00913770|75855302|FG000|STARTED|Overall Study||104||
59736481|NCT00913770|75855303|FG001|STARTED|Overall Study||111||
59736482|NCT00913770|75855304|FG002|STARTED|Overall Study||114||
59736483|NCT00913770|75855302|FG000|COMPLETED|Overall Study||69||
59736484|NCT00913770|75855303|FG001|COMPLETED|Overall Study||82||
59736485|NCT00913770|75855304|FG002|COMPLETED|Overall Study||93||
59736486|NCT00913770|75855302|FG000|NOT COMPLETED|Overall Study||35||
59736487|NCT00913770|75855303|FG001|NOT COMPLETED|Overall Study||29||
59736488|NCT00913770|75855304|FG002|NOT COMPLETED|Overall Study||21||
59736489|NCT00780559|75855314|FG000|STARTED|Overall Study||32||
59736490|NCT00780559|75855315|FG001|STARTED|Overall Study||40||
59736491|NCT00780559|75855314|FG000|COMPLETED|Overall Study||29||
59736492|NCT00780559|75855315|FG001|COMPLETED|Overall Study||33||
59736493|NCT00780559|75855314|FG000|NOT COMPLETED|Overall Study||3||
59736494|NCT00780559|75855315|FG001|NOT COMPLETED|Overall Study||7||
59736495|NCT00912912|75855323|FG000|STARTED|Overall Study||5||
59736496|NCT00912912|75855323|FG000|COMPLETED|Overall Study||1||
59736497|NCT00912912|75855323|FG000|NOT COMPLETED|Overall Study||4||
59736498|NCT00889005|75855329|FG000|STARTED|Overall Study||65||
59736499|NCT00889005|75855330|FG001|STARTED|Overall Study||74||
59736500|NCT00889005|75855329|FG000|COMPLETED|Overall Study||57||
59736501|NCT00889005|75855330|FG001|COMPLETED|Overall Study||72||
59736502|NCT00889005|75855329|FG000|NOT COMPLETED|Overall Study||8||
59736503|NCT00889005|75855330|FG001|NOT COMPLETED|Overall Study||2||
59736504|NCT00779857|75855336|FG000|STARTED|Overall Study|70 patients treated|70||
59736505|NCT00779857|75855336|FG000|30 Day Post Procedure|Overall Study|2 missed Visit|68||
59736506|NCT00779857|75855336|FG000|3 Month Post Procedure|Overall Study|3 month follow-up, 65 of the subjects were available for evaluation.|65||
59736507|NCT00779857|75855336|FG000|COMPLETED|Overall Study|12 Month Post procedure, 64 subjects available for evaluation|64||
59736508|NCT00779857|75855336|FG000|NOT COMPLETED|Overall Study||6||
59736509|NCT00913692|75855340|FG000|STARTED|Screening (4 Months)||11||
59736510|NCT00913692|75855340|FG000|COMPLETED|Screening (4 Months)||2||
59736511|NCT00913692|75855340|FG000|NOT COMPLETED|Screening (4 Months)||9||
59736512|NCT00913692|75855340|FG000|STARTED|Treatment Phase 1 (5 Months)||2||
59736513|NCT00913692|75855340|FG000|COMPLETED|Treatment Phase 1 (5 Months)||1||
59736514|NCT00913692|75855340|FG000|NOT COMPLETED|Treatment Phase 1 (5 Months)||1||
59736515|NCT00913692|75855340|FG000|STARTED|Washout (2 Weeks)||1||
59736516|NCT00913692|75855340|FG000|COMPLETED|Washout (2 Weeks)||1||
59736517|NCT00913692|75855340|FG000|NOT COMPLETED|Washout (2 Weeks)||0||
59736518|NCT00913692|75855340|FG000|STARTED|Treatment Phase 2 (5 Months)||1||
59736519|NCT00913692|75855340|FG000|COMPLETED|Treatment Phase 2 (5 Months)||1||
59736520|NCT00913692|75855340|FG000|NOT COMPLETED|Treatment Phase 2 (5 Months)||0||
59736521|NCT00784927|75855347|FG000|STARTED|Overall Study||36||
59736522|NCT00784927|75855347|FG000|COMPLETED|Overall Study||33||
59736523|NCT00784927|75855347|FG000|NOT COMPLETED|Overall Study||3||
59736524|NCT00779779|75855352|FG000|STARTED|Overall Study||522||
59736525|NCT00779779|75855352|FG000|COMPLETED|Overall Study||498||
59736526|NCT00779779|75855352|FG000|NOT COMPLETED|Overall Study||24||
59736527|NCT00845728|75855358|FG000|STARTED|Overall Study||1723||
59736528|NCT00845728|75855359|FG001|STARTED|Overall Study||1721||
59736529|NCT00845728|75855358|FG000|Exposed|Overall Study||1721||
59736530|NCT00845728|75855359|FG001|Exposed|Overall Study||1718||
59736531|NCT00845728|75855358|FG000|COMPLETED|Overall Study||1337||
59736532|NCT00845728|75855359|FG001|COMPLETED|Overall Study||1379||
59736533|NCT00845728|75855358|FG000|NOT COMPLETED|Overall Study||386||
59736534|NCT00845728|75855359|FG001|NOT COMPLETED|Overall Study||342||
59736535|NCT00779467|75855369|FG000|STARTED|Overall Study||53||
59736536|NCT00779467|75855370|FG001|STARTED|Overall Study||45||
59736537|NCT00779467|75855371|FG002|STARTED|Overall Study||48||
59736538|NCT00779467|75855372|FG003|STARTED|Overall Study||54||
59736539|NCT00779467|75855369|FG000|COMPLETED|Overall Study||38||
59736540|NCT00779467|75855370|FG001|COMPLETED|Overall Study||40||
59736541|NCT00779467|75855371|FG002|COMPLETED|Overall Study||38||
59736542|NCT00779467|75855372|FG003|COMPLETED|Overall Study||35||
59736543|NCT00779467|75855369|FG000|NOT COMPLETED|Overall Study||15||
59736544|NCT00779467|75855370|FG001|NOT COMPLETED|Overall Study||5||
59736545|NCT00779467|75855371|FG002|NOT COMPLETED|Overall Study||10||
59736546|NCT00779467|75855372|FG003|NOT COMPLETED|Overall Study||19||
59736547|NCT00778921|75855385|FG000|STARTED|Overall Study||279||
59736548|NCT00778921|75855386|FG001|STARTED|Overall Study||285||
59736549|NCT00778921|75855387|FG002|STARTED|Overall Study||283||
59736550|NCT00778921|75855385|FG000|COMPLETED|Overall Study||261||
59736551|NCT00778921|75855386|FG001|COMPLETED|Overall Study||266||
59736552|NCT00778921|75855387|FG002|COMPLETED|Overall Study||255||
59736553|NCT00778921|75855385|FG000|NOT COMPLETED|Overall Study||18||
59736554|NCT00778921|75855386|FG001|NOT COMPLETED|Overall Study||19||
59736555|NCT00778921|75855387|FG002|NOT COMPLETED|Overall Study||28||
59736556|NCT00915876|75855397|FG000|STARTED|Overall Study||20||
59736557|NCT00915876|75855398|FG001|STARTED|Overall Study||21||
59736558|NCT00915876|75855397|FG000|Moving Beyond First Dose|Overall Study||20||
59736559|NCT00915876|75855398|FG001|Moving Beyond First Dose|Overall Study||20||
59736560|NCT00915876|75855397|FG000|COMPLETED|Overall Study||20||
59736561|NCT00915876|75855398|FG001|COMPLETED|Overall Study||20||
59736562|NCT00915876|75855397|FG000|NOT COMPLETED|Overall Study||0||
59736563|NCT00915876|75855398|FG001|NOT COMPLETED|Overall Study||1||
59736564|NCT00776659|75855404|FG000|STARTED|Overall Study||39||
59736565|NCT00776659|75855404|FG000|COMPLETED|Overall Study||13||
59736566|NCT00776659|75855404|FG000|NOT COMPLETED|Overall Study||26||
59736567|NCT00825682|75855410|FG000|STARTED|Overall Study||47||
59736568|NCT00825682|75855411|FG001|STARTED|Overall Study||25||
59736569|NCT00825682|75855410|FG000|COMPLETED|Overall Study||34||
59736570|NCT00825682|75855411|FG001|COMPLETED|Overall Study||20||
59736571|NCT00825682|75855410|FG000|NOT COMPLETED|Overall Study||13||
59736572|NCT00825682|75855411|FG001|NOT COMPLETED|Overall Study||5||
59736573|NCT00833794|75855420|FG000|STARTED|Open-label Phase|Enrolled. Population described in the baseline characteristics is 1023 patients (Open-Label safety).|1028||
59736574|NCT00833794|75855421|FG001|STARTED|Open-label Phase|No Placebo arm during open-label phase.|0||
59736575|NCT00833794|75855420|FG000|Entered run-in Period|Open-label Phase||1027||
59736576|NCT00833794|75855421|FG001|Entered run-in Period|Open-label Phase||0||
59736577|NCT00833794|75855420|FG000|Received Open-Label Treatment|Open-label Phase||1023||
59736578|NCT00833794|75855421|FG001|Received Open-Label Treatment|Open-label Phase||0||
59736579|NCT00833794|75855420|FG000|COMPLETED|Open-label Phase|Randomized in double-blind phase|646||
59736580|NCT00833794|75855421|FG001|COMPLETED|Open-label Phase||0||
59736581|NCT00833794|75855420|FG000|NOT COMPLETED|Open-label Phase||382||
59736582|NCT00833794|75855421|FG001|NOT COMPLETED|Open-label Phase||0||
59736583|NCT00833794|75855420|FG000|STARTED|Double-blind Phase|Of the 646 patients who completed the Open-Label phase, 432 were randomized to Tramadol Once A Day|432||
59736584|NCT00833794|75855421|FG001|STARTED|Double-blind Phase|Of the 646 patients who completed the Open-Label phase, 214 were randomized to Placebo|214||
59736585|NCT00833794|75855420|FG000|COMPLETED|Double-blind Phase||326||
59736586|NCT00833794|75855421|FG001|COMPLETED|Double-blind Phase||165||
59736587|NCT00833794|75855420|FG000|NOT COMPLETED|Double-blind Phase||106||
59736588|NCT00833794|75855421|FG001|NOT COMPLETED|Double-blind Phase||49||
59736589|NCT00912288|75855431|FG000|STARTED|Overall Study||44||
59736590|NCT00912288|75855432|FG001|STARTED|Overall Study||42||
59736591|NCT00912288|75855431|FG000|COMPLETED|Overall Study||3||
59736592|NCT00912288|75855432|FG001|COMPLETED|Overall Study||2||
59736593|NCT00912288|75855431|FG000|NOT COMPLETED|Overall Study||41||
59736594|NCT00912288|75855432|FG001|NOT COMPLETED|Overall Study||40||
59736595|NCT00778375|75855438|FG000|STARTED|Overall Study||122||
59736596|NCT00778375|75855438|FG000|COMPLETED|Overall Study||119||
59736597|NCT00778375|75855438|FG000|NOT COMPLETED|Overall Study||3||
59736598|NCT00777829|75855444|FG000|STARTED|Overall Study||15||
59736599|NCT00777829|75855445|FG001|STARTED|Overall Study||15||
59736600|NCT00777829|75855444|FG000|Study Orientation|Overall Study||15||
59736601|NCT00777829|75855445|FG001|Study Orientation|Overall Study||13||
59736602|NCT00777829|75855444|FG000|COMPLETED|Overall Study||15||
59736603|NCT00777829|75855445|FG001|COMPLETED|Overall Study||13||
59736604|NCT00777829|75855444|FG000|NOT COMPLETED|Overall Study||0||
59736605|NCT00777829|75855445|FG001|NOT COMPLETED|Overall Study||2||
59736606|NCT00775021|75855453|FG000|STARTED|First Intervention||63||
59736607|NCT00775021|75855454|FG001|STARTED|First Intervention||60||
59736608|NCT00775021|75855453|FG000|COMPLETED|First Intervention||62||
59736609|NCT00775021|75855454|FG001|COMPLETED|First Intervention||60||
59736610|NCT00775021|75855453|FG000|NOT COMPLETED|First Intervention||1||
59736611|NCT00775021|75855454|FG001|NOT COMPLETED|First Intervention||0||
59736612|NCT00775021|75855453|FG000|STARTED|Second Intervention||62||
59736613|NCT00775021|75855454|FG001|STARTED|Second Intervention||60||
59736614|NCT00775021|75855453|FG000|COMPLETED|Second Intervention||62||
59736615|NCT00775021|75855454|FG001|COMPLETED|Second Intervention||59||
59736616|NCT00775021|75855453|FG000|NOT COMPLETED|Second Intervention||0||
59736617|NCT00775021|75855454|FG001|NOT COMPLETED|Second Intervention||1||
59736618|NCT00777205|75855462|FG000|STARTED|Overall Study||243||
59736619|NCT00777205|75855463|FG001|STARTED|Overall Study||200||
59736620|NCT00777205|75855462|FG000|Intervention Interruption|Overall Study||0||
59736621|NCT00777205|75855463|FG001|Intervention Interruption|Overall Study|56 participants excluded from main analyses due to 2 mos interruption in study intervention|56||
59868843|NCT04067492|75993261|FG004|STARTED|Overall Study||5||
59868844|NCT04067492|75993262|FG005|STARTED|Overall Study||9||
59868845|NCT04067492|75993257|FG000|COMPLETED|Overall Study||15||
59868846|NCT04067492|75993258|FG001|COMPLETED|Overall Study||5||
59868847|NCT04067492|75993259|FG002|COMPLETED|Overall Study||6||
59868848|NCT04067492|75993260|FG003|COMPLETED|Overall Study||5||
59868849|NCT04067492|75993261|FG004|COMPLETED|Overall Study||5||
59868850|NCT04067492|75993262|FG005|COMPLETED|Overall Study||8||
59868851|NCT04067492|75993257|FG000|NOT COMPLETED|Overall Study||0||
59868852|NCT04067492|75993258|FG001|NOT COMPLETED|Overall Study||1||
59868853|NCT04067492|75993259|FG002|NOT COMPLETED|Overall Study||0||
59868854|NCT04067492|75993260|FG003|NOT COMPLETED|Overall Study||1||
59868855|NCT04067492|75993261|FG004|NOT COMPLETED|Overall Study||0||
59868856|NCT04067492|75993262|FG005|NOT COMPLETED|Overall Study||1||
59868857|NCT04375878|75993280|FG000|STARTED|Crossover First and Second Interventions||7||
59868858|NCT04375878|75993281|FG001|STARTED|Crossover First and Second Interventions||7||
59868859|NCT04375878|75993282|FG002|STARTED|Crossover First and Second Interventions||6||
59868860|NCT04375878|75993283|FG003|STARTED|Crossover First and Second Interventions||7||
59868861|NCT04375878|75993284|FG004|STARTED|Crossover First and Second Interventions||0||
59868862|NCT04375878|75993285|FG005|STARTED|Crossover First and Second Interventions||0||
59868863|NCT04375878|75993280|FG000|COMPLETED|Crossover First and Second Interventions||6||
59868864|NCT04375878|75993281|FG001|COMPLETED|Crossover First and Second Interventions||6||
59868865|NCT04375878|75993282|FG002|COMPLETED|Crossover First and Second Interventions||5||
59868866|NCT04375878|75993283|FG003|COMPLETED|Crossover First and Second Interventions||7||
59868867|NCT04375878|75993284|FG004|COMPLETED|Crossover First and Second Interventions||0||
59868868|NCT04375878|75993285|FG005|COMPLETED|Crossover First and Second Interventions||0||
59868869|NCT04375878|75993280|FG000|NOT COMPLETED|Crossover First and Second Interventions||1||
59868870|NCT04375878|75993281|FG001|NOT COMPLETED|Crossover First and Second Interventions||1||
59868871|NCT04375878|75993282|FG002|NOT COMPLETED|Crossover First and Second Interventions||1||
59868872|NCT04375878|75993283|FG003|NOT COMPLETED|Crossover First and Second Interventions||0||
59868873|NCT04375878|75993284|FG004|NOT COMPLETED|Crossover First and Second Interventions||0||
59868874|NCT04375878|75993285|FG005|NOT COMPLETED|Crossover First and Second Interventions||0||
59868875|NCT04375878|75993280|FG000|STARTED|Extension Phase|Only patients who completed period 1(Crossover: First and Second interventions) were eligible for participation in period 2.|0||
59868876|NCT04375878|75993281|FG001|STARTED|Extension Phase|Only patients who completed period 1(Crossover: First and Second interventions) were eligible for participation in period 2.|0||
59868877|NCT04375878|75993282|FG002|STARTED|Extension Phase|Only patients who completed period 1(Crossover: First and Second interventions) were eligible for participation in period 2.|0||
59868878|NCT04375878|75993283|FG003|STARTED|Extension Phase|Only patients who completed period 1(Crossover: First and Second interventions) were eligible for participation in period 2.|0||
59868879|NCT04375878|75993284|FG004|STARTED|Extension Phase|Although 24 participants were eligible for the Extension, not all elected to participate.|9||
59868880|NCT04375878|75993285|FG005|STARTED|Extension Phase|Although 24 participants were eligible for the Extension, not all elected to participate.|8||
59868881|NCT04375878|75993280|FG000|COMPLETED|Extension Phase||0||
59868882|NCT04375878|75993281|FG001|COMPLETED|Extension Phase||0||
59868883|NCT04375878|75993282|FG002|COMPLETED|Extension Phase||0||
59868884|NCT04375878|75993283|FG003|COMPLETED|Extension Phase||0||
59868885|NCT04375878|75993284|FG004|COMPLETED|Extension Phase||8||
59868886|NCT04375878|75993285|FG005|COMPLETED|Extension Phase||8||
59736622|NCT00777205|75855462|FG000|COMPLETED|Overall Study||212||
59736623|NCT00777205|75855463|FG001|COMPLETED|Overall Study||129||
59868887|NCT04375878|75993280|FG000|NOT COMPLETED|Extension Phase||0||
59868888|NCT04375878|75993281|FG001|NOT COMPLETED|Extension Phase||0||
59868889|NCT04375878|75993282|FG002|NOT COMPLETED|Extension Phase||0||
59868890|NCT04375878|75993283|FG003|NOT COMPLETED|Extension Phase||0||
59868891|NCT04375878|75993284|FG004|NOT COMPLETED|Extension Phase||1||
59868892|NCT04375878|75993285|FG005|NOT COMPLETED|Extension Phase||0||
59868893|NCT04189224|75993305|FG000|STARTED|Period 1||23||
59868894|NCT04189224|75993306|FG001|STARTED|Period 1||21||
59868895|NCT04189224|75993305|FG000|COMPLETED|Period 1||23||
59868896|NCT04189224|75993306|FG001|COMPLETED|Period 1||21||
59868897|NCT04189224|75993305|FG000|NOT COMPLETED|Period 1||0||
59868898|NCT04189224|75993306|FG001|NOT COMPLETED|Period 1||0||
59868899|NCT04189224|75993305|FG000|STARTED|Period 2||23||
59868900|NCT04189224|75993306|FG001|STARTED|Period 2||21||
59868901|NCT04189224|75993305|FG000|COMPLETED|Period 2||23||
59868902|NCT04189224|75993306|FG001|COMPLETED|Period 2||20||
59868903|NCT04189224|75993305|FG000|NOT COMPLETED|Period 2||0||
59868904|NCT04189224|75993306|FG001|NOT COMPLETED|Period 2||1||
59868905|NCT04186806|75993314|FG000|STARTED|Period 1: 7 Days||20||
59868906|NCT04186806|75993315|FG001|STARTED|Period 1: 7 Days||20||
59868907|NCT04186806|75993314|FG000|COMPLETED|Period 1: 7 Days||19||
59868908|NCT04186806|75993315|FG001|COMPLETED|Period 1: 7 Days||20||
59868909|NCT04186806|75993314|FG000|NOT COMPLETED|Period 1: 7 Days||1||
59868910|NCT04186806|75993315|FG001|NOT COMPLETED|Period 1: 7 Days||0||
59868911|NCT04186806|75993314|FG000|STARTED|Washout Period: at Least 2 Days||19||
59868912|NCT04186806|75993315|FG001|STARTED|Washout Period: at Least 2 Days||20||
59868913|NCT04186806|75993314|FG000|COMPLETED|Washout Period: at Least 2 Days||19||
59868914|NCT04186806|75993315|FG001|COMPLETED|Washout Period: at Least 2 Days||20||
59868915|NCT04186806|75993314|FG000|NOT COMPLETED|Washout Period: at Least 2 Days||0||
59868916|NCT04186806|75993315|FG001|NOT COMPLETED|Washout Period: at Least 2 Days||0||
59868917|NCT04186806|75993314|FG000|STARTED|Period 2: 7 Days||19||
59868918|NCT04186806|75993315|FG001|STARTED|Period 2: 7 Days||20||
59868919|NCT04186806|75993314|FG000|COMPLETED|Period 2: 7 Days||19||
59868920|NCT04186806|75993315|FG001|COMPLETED|Period 2: 7 Days||20||
59868921|NCT04186806|75993314|FG000|NOT COMPLETED|Period 2: 7 Days||0||
59868922|NCT04186806|75993315|FG001|NOT COMPLETED|Period 2: 7 Days||0||
59868923|NCT04041414|75993324|FG000|STARTED|Overall Study||27||
59868924|NCT04041414|75993325|FG001|STARTED|Overall Study||20||
59868925|NCT04041414|75993324|FG000|COMPLETED|Overall Study||26||
59868926|NCT04041414|75993325|FG001|COMPLETED|Overall Study||18||
59868927|NCT04041414|75993324|FG000|NOT COMPLETED|Overall Study||1||
59868928|NCT04041414|75993325|FG001|NOT COMPLETED|Overall Study||2||
59868929|NCT04370028|75993334|FG000|STARTED|Overall Study||2583||
59868930|NCT04370028|75993334|FG000|COMPLETED|Overall Study||1876||
59868931|NCT04370028|75993334|FG000|NOT COMPLETED|Overall Study||707||
59868932|NCT04037748|75993347|FG000|STARTED|Treatment Period 1||36||
59868933|NCT04037748|75993348|FG001|STARTED|Treatment Period 1||36||
59868934|NCT04037748|75993347|FG000|COMPLETED|Treatment Period 1||28||
59868935|NCT04037748|75993348|FG001|COMPLETED|Treatment Period 1||30||
59868936|NCT04037748|75993347|FG000|NOT COMPLETED|Treatment Period 1||8||
59868937|NCT04037748|75993348|FG001|NOT COMPLETED|Treatment Period 1||6||
59868938|NCT04037748|75993347|FG000|STARTED|Treatment Period 2||28||
59868939|NCT04037748|75993348|FG001|STARTED|Treatment Period 2||30||
59868940|NCT04037748|75993347|FG000|COMPLETED|Treatment Period 2||26||
59868941|NCT04037748|75993348|FG001|COMPLETED|Treatment Period 2||29||
59868942|NCT04037748|75993347|FG000|NOT COMPLETED|Treatment Period 2||2||
59868943|NCT04037748|75993348|FG001|NOT COMPLETED|Treatment Period 2||1||
59868944|NCT04036110|75993357|FG000|STARTED|Overall Study||12||
59868945|NCT04036110|75993358|FG001|STARTED|Overall Study||12||
59868946|NCT04036110|75993359|FG002|STARTED|Overall Study||12||
59868947|NCT04036110|75993357|FG000|COMPLETED|Overall Study||5||
59868948|NCT04036110|75993358|FG001|COMPLETED|Overall Study||5||
59868949|NCT04036110|75993359|FG002|COMPLETED|Overall Study||10||
59868950|NCT04036110|75993357|FG000|NOT COMPLETED|Overall Study||7||
59868951|NCT04036110|75993358|FG001|NOT COMPLETED|Overall Study||7||
59868952|NCT04036110|75993359|FG002|NOT COMPLETED|Overall Study||2||
59868953|NCT03053050|75993370|FG000|STARTED|Randomized Phase||324||
59868954|NCT03053050|75993371|FG001|STARTED|Randomized Phase||323||
59868955|NCT03053050|75993372|FG002|STARTED|Randomized Phase||161||
59868956|NCT03053050|75993373|FG003|STARTED|Randomized Phase||0||
59868957|NCT03053050|75993370|FG000|COMPLETED|Randomized Phase||0||
59868958|NCT03053050|75993371|FG001|COMPLETED|Randomized Phase||0||
59868959|NCT03053050|75993372|FG002|COMPLETED|Randomized Phase||0||
59868960|NCT03053050|75993373|FG003|COMPLETED|Randomized Phase||0||
59868961|NCT03053050|75993370|FG000|NOT COMPLETED|Randomized Phase||324||
59868962|NCT03053050|75993371|FG001|NOT COMPLETED|Randomized Phase||323||
59868963|NCT03053050|75993372|FG002|NOT COMPLETED|Randomized Phase||161||
59868964|NCT03053050|75993373|FG003|NOT COMPLETED|Randomized Phase||0||
59868965|NCT03053050|75993370|FG000|STARTED|Open-label Phase||0||
59868966|NCT03053050|75993371|FG001|STARTED|Open-label Phase||0||
59868967|NCT03053050|75993372|FG002|STARTED|Open-label Phase||0||
59868968|NCT03053050|75993373|FG003|STARTED|Open-label Phase|Participants with hepatic clinical event or progression to cirrhosis had option to go into OL Phase.|99||
59868969|NCT03053050|75993370|FG000|COMPLETED|Open-label Phase||0||
59868970|NCT03053050|75993371|FG001|COMPLETED|Open-label Phase||0||
59868971|NCT03053050|75993372|FG002|COMPLETED|Open-label Phase||0||
59868972|NCT03053050|75993373|FG003|COMPLETED|Open-label Phase||0||
59868973|NCT03053050|75993370|FG000|NOT COMPLETED|Open-label Phase||0||
59868974|NCT03053050|75993371|FG001|NOT COMPLETED|Open-label Phase||0||
59868975|NCT03053050|75993372|FG002|NOT COMPLETED|Open-label Phase||0||
59868976|NCT03053050|75993373|FG003|NOT COMPLETED|Open-label Phase||99||
59868977|NCT04369950|75993384|FG000|STARTED|Overall Study||22||
59868978|NCT04369950|75993385|FG001|STARTED|Overall Study||22||
59868979|NCT04369950|75993384|FG000|COMPLETED|Overall Study||20||
59868980|NCT04369950|75993385|FG001|COMPLETED|Overall Study||20||
59868981|NCT04369950|75993384|FG000|NOT COMPLETED|Overall Study||2||
59868982|NCT04369950|75993385|FG001|NOT COMPLETED|Overall Study||2||
59868983|NCT04035564|75993393|FG000|STARTED|Overall Study||27||
59868984|NCT04035564|75993394|FG001|STARTED|Overall Study||25||
59868985|NCT04035564|75993393|FG000|COMPLETED|Overall Study||23||
59868986|NCT04035564|75993394|FG001|COMPLETED|Overall Study||19||
59868987|NCT04035564|75993393|FG000|NOT COMPLETED|Overall Study||4||
59868988|NCT04035564|75993394|FG001|NOT COMPLETED|Overall Study||6||
59868989|NCT02955602|75993403|FG000|STARTED|Overall Study||11||
59868990|NCT02955602|75993404|FG001|STARTED|Overall Study||53||
59868991|NCT02955602|75993405|FG002|STARTED|Overall Study||55||
59868992|NCT02955602|75993403|FG000|COMPLETED|Overall Study||10||
59868993|NCT02955602|75993404|FG001|COMPLETED|Overall Study||46||
59868994|NCT02955602|75993405|FG002|COMPLETED|Overall Study||49||
59868995|NCT02955602|75993403|FG000|NOT COMPLETED|Overall Study||1||
59868996|NCT02955602|75993404|FG001|NOT COMPLETED|Overall Study||7||
59868997|NCT02955602|75993405|FG002|NOT COMPLETED|Overall Study||6||
59868998|NCT04179786|75993413|FG000|STARTED|Overall Study||91||
59868999|NCT04179786|75993413|FG000|COMPLETED|Overall Study||83||
59869000|NCT04179786|75993413|FG000|NOT COMPLETED|Overall Study||8||
59869001|NCT04175808|75993417|FG000|STARTED|Part A||70||
59869002|NCT04175808|75993418|FG001|STARTED|Part A||0||
59869003|NCT04175808|75993419|FG002|STARTED|Part A||0||
59869004|NCT04175808|75993420|FG003|STARTED|Part A||0||
59869005|NCT04175808|75993421|FG004|STARTED|Part A||0||
59869006|NCT04175808|75993422|FG005|STARTED|Part A||0||
59869007|NCT04175808|75993423|FG006|STARTED|Part A||0||
59869008|NCT04175808|75993417|FG000|COMPLETED|Part A||68||
59869009|NCT04175808|75993418|FG001|COMPLETED|Part A||0||
59869010|NCT04175808|75993419|FG002|COMPLETED|Part A||0||
59869011|NCT04175808|75993420|FG003|COMPLETED|Part A||0||
59869012|NCT04175808|75993421|FG004|COMPLETED|Part A||0||
59869013|NCT04175808|75993422|FG005|COMPLETED|Part A||0||
59869014|NCT04175808|75993423|FG006|COMPLETED|Part A||0||
59869015|NCT04175808|75993417|FG000|NOT COMPLETED|Part A||2||
59869016|NCT04175808|75993418|FG001|NOT COMPLETED|Part A||0||
59869017|NCT04175808|75993419|FG002|NOT COMPLETED|Part A||0||
59869018|NCT04175808|75993420|FG003|NOT COMPLETED|Part A||0||
59869019|NCT04175808|75993421|FG004|NOT COMPLETED|Part A||0||
59869020|NCT04175808|75993422|FG005|NOT COMPLETED|Part A||0||
59869021|NCT04175808|75993423|FG006|NOT COMPLETED|Part A||0||
59869022|NCT04175808|75993417|FG000|STARTED|Part B||0||
59869023|NCT04175808|75993418|FG001|STARTED|Part B||10||
59869024|NCT04175808|75993419|FG002|STARTED|Part B||10||
59869025|NCT04175808|75993420|FG003|STARTED|Part B||10||
59869026|NCT04175808|75993421|FG004|STARTED|Part B||10||
59869027|NCT04175808|75993422|FG005|STARTED|Part B||10||
59869028|NCT04175808|75993423|FG006|STARTED|Part B||10||
59869029|NCT04175808|75993417|FG000|COMPLETED|Part B||0||
59869030|NCT04175808|75993418|FG001|COMPLETED|Part B||10||
59869031|NCT04175808|75993419|FG002|COMPLETED|Part B||10||
59869032|NCT04175808|75993420|FG003|COMPLETED|Part B||10||
59869033|NCT04175808|75993421|FG004|COMPLETED|Part B||10||
59869034|NCT04175808|75993422|FG005|COMPLETED|Part B||10||
59869035|NCT04175808|75993423|FG006|COMPLETED|Part B||10||
59869036|NCT04175808|75993417|FG000|NOT COMPLETED|Part B||0||
59869037|NCT04175808|75993418|FG001|NOT COMPLETED|Part B||0||
59869038|NCT04175808|75993419|FG002|NOT COMPLETED|Part B||0||
59869039|NCT04175808|75993420|FG003|NOT COMPLETED|Part B||0||
59869040|NCT04175808|75993421|FG004|NOT COMPLETED|Part B||0||
59869041|NCT04175808|75993422|FG005|NOT COMPLETED|Part B||0||
59869042|NCT04175808|75993423|FG006|NOT COMPLETED|Part B||0||
59869043|NCT04057196|75993439|FG000|STARTED|Overall Study||30||
59869044|NCT04057196|75993439|FG000|COMPLETED|Overall Study||24||
59869045|NCT04057196|75993439|FG000|NOT COMPLETED|Overall Study||6||
59869046|NCT04027686|75993445|FG000|STARTED|Overall Study||17||
59869047|NCT04027686|75993446|FG001|STARTED|Overall Study||6||
59869048|NCT04027686|75993445|FG000|COMPLETED|Overall Study||15||
59869049|NCT04027686|75993446|FG001|COMPLETED|Overall Study||5||
59869050|NCT04027686|75993445|FG000|NOT COMPLETED|Overall Study||2||
59869051|NCT04027686|75993446|FG001|NOT COMPLETED|Overall Study||1||
59869052|NCT03052426|75993459|FG000|STARTED|Overall Study||6||
59869053|NCT03052426|75993460|FG001|STARTED|Overall Study||6||
59869054|NCT03052426|75993461|FG002|STARTED|Overall Study||6||
59869055|NCT03052426|75993459|FG000|COMPLETED|Overall Study||4||
59869056|NCT03052426|75993460|FG001|COMPLETED|Overall Study||5||
59869057|NCT03052426|75993461|FG002|COMPLETED|Overall Study||5||
59869058|NCT03052426|75993459|FG000|NOT COMPLETED|Overall Study||2||
59869059|NCT03052426|75993460|FG001|NOT COMPLETED|Overall Study||1||
59869060|NCT03052426|75993461|FG002|NOT COMPLETED|Overall Study||1||
59869061|NCT03688880|75993476|FG000|STARTED|Overall Study||29||
59869062|NCT03688880|75993477|FG001|STARTED|Overall Study||60||
59869063|NCT03688880|75993476|FG000|COMPLETED|Overall Study||15||
59869064|NCT03688880|75993477|FG001|COMPLETED|Overall Study||29||
59869065|NCT03688880|75993476|FG000|NOT COMPLETED|Overall Study||14||
59869066|NCT03688880|75993477|FG001|NOT COMPLETED|Overall Study||31||
59869067|NCT03051178|75993483|FG000|STARTED|Overall Study||17||
59869068|NCT03051178|75993483|FG000|Implementation of Responsive DBS Based on Wearable Sensors|Overall Study||12||
59869069|NCT03051178|75993483|FG000|COMPLETED|Overall Study||12||
59869070|NCT03051178|75993483|FG000|NOT COMPLETED|Overall Study||5||
59869071|NCT03051100|75993489|FG000|STARTED|Overall Study||20||
59869072|NCT03051100|75993490|FG001|STARTED|Overall Study||43||
59869073|NCT03051100|75993489|FG000|COMPLETED|Overall Study||19||
59869074|NCT03051100|75993490|FG001|COMPLETED|Overall Study||43||
59869075|NCT03051100|75993489|FG000|NOT COMPLETED|Overall Study||1||
59869076|NCT03051100|75993490|FG001|NOT COMPLETED|Overall Study||0||
59869077|NCT01343368|75993498|FG000|STARTED|Overall Study||9||
59869078|NCT01343368|75993499|FG001|STARTED|Overall Study||10||
59869079|NCT01343368|75993498|FG000|COMPLETED|Overall Study||7||
59869080|NCT01343368|75993499|FG001|COMPLETED|Overall Study||10||
59869081|NCT01343368|75993498|FG000|NOT COMPLETED|Overall Study||2||
59869082|NCT01343368|75993499|FG001|NOT COMPLETED|Overall Study||0||
59869083|NCT02955212|75993507|FG000|STARTED|Period 1: Double-blind Treatment Period||169||
59869084|NCT02955212|75993508|FG001|STARTED|Period 1: Double-blind Treatment Period||169||
59869085|NCT02955212|75993507|FG000|COMPLETED|Period 1: Double-blind Treatment Period||153|Completed Period 1 (Week 12) study drug|
59869086|NCT02955212|75993508|FG001|COMPLETED|Period 1: Double-blind Treatment Period||157|Completed Period 1 (Week 12) study drug|
59869087|NCT02955212|75993507|FG000|NOT COMPLETED|Period 1: Double-blind Treatment Period||16||
59869088|NCT02955212|75993508|FG001|NOT COMPLETED|Period 1: Double-blind Treatment Period||12||
59869089|NCT02955212|75993507|FG000|STARTED|Period 2: Open-label Extension||153||
59869090|NCT02955212|75993508|FG001|STARTED|Period 2: Open-label Extension||157||
59869091|NCT02955212|75993507|FG000|COMPLETED|Period 2: Open-label Extension||136||
59869092|NCT02955212|75993508|FG001|COMPLETED|Period 2: Open-label Extension||139||
59736624|NCT00777205|75855462|FG000|NOT COMPLETED|Overall Study||31||
59869093|NCT02955212|75993507|FG000|NOT COMPLETED|Period 2: Open-label Extension||17||
59869094|NCT02955212|75993508|FG001|NOT COMPLETED|Period 2: Open-label Extension||18||
59869095|NCT03050398|75993515|FG000|STARTED|Overall Study||8||
59869096|NCT03050398|75993515|FG000|COMPLETED|Overall Study||0||
59869097|NCT03050398|75993515|FG000|NOT COMPLETED|Overall Study||8||
59869098|NCT03662750|75993519|FG000|STARTED|Overall Study||3||
59869099|NCT03662750|75993519|FG000|COMPLETED|Overall Study||2||
59869100|NCT03662750|75993519|FG000|NOT COMPLETED|Overall Study||1||
59869101|NCT04052204|75993523|FG000|STARTED|Overall Study||3||
59869102|NCT04052204|75993524|FG001|STARTED|Overall Study|Arm was not tested due to study termination.|0||
59869103|NCT04052204|75993525|FG002|STARTED|Overall Study|Arm was not tested due to study termination.|0||
59869104|NCT04052204|75993523|FG000|COMPLETED|Overall Study||0||
59869105|NCT04052204|75993524|FG001|COMPLETED|Overall Study||0||
59869106|NCT04052204|75993525|FG002|COMPLETED|Overall Study||0||
59869107|NCT04052204|75993523|FG000|NOT COMPLETED|Overall Study||3||
59869108|NCT04052204|75993524|FG001|NOT COMPLETED|Overall Study||0||
59869109|NCT04052204|75993525|FG002|NOT COMPLETED|Overall Study||0||
59869110|NCT04050722|75993531|FG000|STARTED|Overall Study||65||
59869111|NCT04050722|75993532|FG001|STARTED|Overall Study||65||
59869112|NCT04050722|75993531|FG000|COMPLETED|Overall Study||64||
59869113|NCT04050722|75993532|FG001|COMPLETED|Overall Study||65||
59869114|NCT04050722|75993531|FG000|NOT COMPLETED|Overall Study||1||
59869115|NCT04050722|75993532|FG001|NOT COMPLETED|Overall Study||0||
59869116|NCT04049552|75993538|FG000|STARTED|Overall Study||4||8
59736625|NCT00777205|75855463|FG001|NOT COMPLETED|Overall Study||71||
59736626|NCT00833638|75855474|FG000|STARTED|Phase 2: Double-blind Treatment Phase||121||
59736627|NCT00833638|75855475|FG001|STARTED|Phase 2: Double-blind Treatment Phase||118||
59736628|NCT00833638|75855476|FG002|STARTED|Phase 2: Double-blind Treatment Phase||133||
59736629|NCT00833638|75855474|FG000|COMPLETED|Phase 2: Double-blind Treatment Phase||111||
59736630|NCT00833638|75855475|FG001|COMPLETED|Phase 2: Double-blind Treatment Phase||108||
59736631|NCT00833638|75855476|FG002|COMPLETED|Phase 2: Double-blind Treatment Phase||124||
59736632|NCT00833638|75855474|FG000|NOT COMPLETED|Phase 2: Double-blind Treatment Phase||10||
59736633|NCT00833638|75855475|FG001|NOT COMPLETED|Phase 2: Double-blind Treatment Phase||10||
59736634|NCT00833638|75855476|FG002|NOT COMPLETED|Phase 2: Double-blind Treatment Phase||9||
59736635|NCT00833638|75855474|FG000|STARTED|Phase 3: Open-label Extension Phase||111||
59736636|NCT00833638|75855475|FG001|STARTED|Phase 3: Open-label Extension Phase||108||
59736637|NCT00833638|75855476|FG002|STARTED|Phase 3: Open-label Extension Phase||124||
59736638|NCT00833638|75855474|FG000|COMPLETED|Phase 3: Open-label Extension Phase||110||
59736639|NCT00833638|75855475|FG001|COMPLETED|Phase 3: Open-label Extension Phase||105||
59736640|NCT00833638|75855476|FG002|COMPLETED|Phase 3: Open-label Extension Phase||122||
59736641|NCT00833638|75855474|FG000|NOT COMPLETED|Phase 3: Open-label Extension Phase||1||
59736642|NCT00833638|75855475|FG001|NOT COMPLETED|Phase 3: Open-label Extension Phase||3||
59869117|NCT04049552|75993538|FG000|COMPLETED|Overall Study||3||6
59869118|NCT04049552|75993538|FG000|NOT COMPLETED|Overall Study||1||2
59869119|NCT03048058|75993546|FG000|STARTED|Overall Study||10||
59869120|NCT03048058|75993547|FG001|STARTED|Overall Study||10||
59869121|NCT03048058|75993546|FG000|COMPLETED|Overall Study||6||
59869122|NCT03048058|75993547|FG001|COMPLETED|Overall Study||6||
59869123|NCT03048058|75993546|FG000|NOT COMPLETED|Overall Study||4||
59869124|NCT03048058|75993547|FG001|NOT COMPLETED|Overall Study||4||
59869125|NCT03047980|75993553|FG000|STARTED|Overall Study||10||
59869126|NCT03047980|75993553|FG000|COMPLETED|Overall Study||9||
59869127|NCT03047980|75993553|FG000|NOT COMPLETED|Overall Study||1||
59869128|NCT04048382|75993559|FG000|STARTED|3-Month Follow Up||28||
59869129|NCT04048382|75993560|FG001|STARTED|3-Month Follow Up||29||
59869130|NCT04048382|75993559|FG000|COMPLETED|3-Month Follow Up||26||
59869131|NCT04048382|75993560|FG001|COMPLETED|3-Month Follow Up||28||
59869132|NCT04048382|75993559|FG000|NOT COMPLETED|3-Month Follow Up||2||
59869133|NCT04048382|75993560|FG001|NOT COMPLETED|3-Month Follow Up||1||
59869134|NCT04048382|75993559|FG000|STARTED|6-Month Follow up||28||
59869135|NCT04048382|75993560|FG001|STARTED|6-Month Follow up||28||
59869136|NCT04048382|75993559|FG000|COMPLETED|6-Month Follow up||26||
59869137|NCT04048382|75993560|FG001|COMPLETED|6-Month Follow up||28||
59869138|NCT04048382|75993559|FG000|NOT COMPLETED|6-Month Follow up||2||
59869139|NCT04048382|75993560|FG001|NOT COMPLETED|6-Month Follow up||0||
59869140|NCT04047446|75993568|FG000|STARTED|Overall Study||56||
59869141|NCT04047446|75993569|FG001|STARTED|Overall Study||56||
59869142|NCT04047446|75993568|FG000|COMPLETED|Overall Study||55||
59869143|NCT04047446|75993569|FG001|COMPLETED|Overall Study||56||
59869144|NCT04047446|75993568|FG000|NOT COMPLETED|Overall Study||1||
59869145|NCT04047446|75993569|FG001|NOT COMPLETED|Overall Study||0||
59869146|NCT03655106|75993577|FG000|STARTED|Overall Study||135||
59869147|NCT03655106|75993578|FG001|STARTED|Overall Study||135||
59869148|NCT03655106|75993577|FG000|COMPLETED|Overall Study||126||
59869149|NCT03655106|75993578|FG001|COMPLETED|Overall Study||131||
59869150|NCT03655106|75993577|FG000|NOT COMPLETED|Overall Study||9||
59869151|NCT03655106|75993578|FG001|NOT COMPLETED|Overall Study||4||
59869152|NCT03630302|75993584|FG000|STARTED|Surgery||10||
59869153|NCT03630302|75993584|FG000|COMPLETED|Surgery||9||
59869154|NCT03630302|75993584|FG000|NOT COMPLETED|Surgery||1||
59869155|NCT03630302|75993584|FG000|STARTED|3 Month Visit||9||
59869156|NCT03630302|75993584|FG000|COMPLETED|3 Month Visit||7||
59869157|NCT03630302|75993584|FG000|NOT COMPLETED|3 Month Visit||2||
59869158|NCT03630302|75993584|FG000|STARTED|Data Post Analyses||7||
59869159|NCT03630302|75993584|FG000|COMPLETED|Data Post Analyses||5||
59869160|NCT03630302|75993584|FG000|NOT COMPLETED|Data Post Analyses||2||
59869161|NCT04041440|75993590|FG000|STARTED|Overall Study||12||
59869162|NCT04041440|75993591|FG001|STARTED|Overall Study||22||
59869163|NCT04041440|75993590|FG000|COMPLETED|Overall Study||12||
59869164|NCT04041440|75993591|FG001|COMPLETED|Overall Study||20||
59869165|NCT04041440|75993590|FG000|NOT COMPLETED|Overall Study||0||
59869166|NCT04041440|75993591|FG001|NOT COMPLETED|Overall Study||2||
59869167|NCT03654560|75993600|FG000|STARTED|Overall Study||118||
59869168|NCT03654560|75993601|FG001|STARTED|Overall Study||118||
59869169|NCT03654560|75993600|FG000|COMPLETED|Overall Study||114||
59869170|NCT03654560|75993601|FG001|COMPLETED|Overall Study||117||
59869171|NCT03654560|75993600|FG000|NOT COMPLETED|Overall Study||4||
59869172|NCT03654560|75993601|FG001|NOT COMPLETED|Overall Study||1||
59869173|NCT03629054|75993609|FG000|STARTED|Period 1 (4 Days)|Started this period|15|Started are treated|
59869174|NCT03629054|75993610|FG001|STARTED|Period 1 (4 Days)|Started this period|15|Started are treated|
59869175|NCT03629054|75993609|FG000|COMPLETED|Period 1 (4 Days)||15||
59869176|NCT03629054|75993610|FG001|COMPLETED|Period 1 (4 Days)||15||
59869177|NCT03629054|75993609|FG000|NOT COMPLETED|Period 1 (4 Days)||0||
59869178|NCT03629054|75993610|FG001|NOT COMPLETED|Period 1 (4 Days)||0||
59869179|NCT03629054|75993609|FG000|STARTED|Wasout Period (35 Days)|Started this period|15|Started are treated|
59869180|NCT03629054|75993610|FG001|STARTED|Wasout Period (35 Days)|Started this period|15|Started are treated|
59869181|NCT03629054|75993609|FG000|COMPLETED|Wasout Period (35 Days)||15||
59869182|NCT03629054|75993610|FG001|COMPLETED|Wasout Period (35 Days)||15||
59869183|NCT03629054|75993609|FG000|NOT COMPLETED|Wasout Period (35 Days)||0||
59869184|NCT03629054|75993610|FG001|NOT COMPLETED|Wasout Period (35 Days)||0||
59869185|NCT03629054|75993609|FG000|STARTED|Period 2 (4 Days)|Started this period|15||
59869186|NCT03629054|75993610|FG001|STARTED|Period 2 (4 Days)|Started this period|15||
59869187|NCT03629054|75993609|FG000|Treated|Period 2 (4 Days)||15||
59869188|NCT03629054|75993610|FG001|Treated|Period 2 (4 Days)||14||
59869189|NCT03629054|75993609|FG000|COMPLETED|Period 2 (4 Days)||15||
59869190|NCT03629054|75993610|FG001|COMPLETED|Period 2 (4 Days)||14||
59869191|NCT03629054|75993609|FG000|NOT COMPLETED|Period 2 (4 Days)||0||
59869192|NCT03629054|75993610|FG001|NOT COMPLETED|Period 2 (4 Days)||1||
59869193|NCT03628898|75993616|FG000|STARTED|Overall Study||27||
59869194|NCT03628898|75993616|FG000|COMPLETED|Overall Study||26||
59869195|NCT03628898|75993616|FG000|NOT COMPLETED|Overall Study||1||
59869196|NCT03628508|75993620|FG000|STARTED|Overall Study||40||
59869197|NCT03628508|75993620|FG000|COMPLETED|Overall Study||39||
59869198|NCT03628508|75993620|FG000|NOT COMPLETED|Overall Study||1||
59869199|NCT03045328|75993624|FG000|STARTED|Overall Study||22||
59869200|NCT03045328|75993624|FG000|COMPLETED|Overall Study||20||
59869201|NCT03045328|75993624|FG000|NOT COMPLETED|Overall Study||2||
59869202|NCT02154490|75993630|FG000|STARTED|Overall Study||1864||
59869203|NCT02154490|75993630|FG000|COMPLETED|Overall Study||655||
59869204|NCT02154490|75993630|FG000|NOT COMPLETED|Overall Study||1209||
59869205|NCT03627494|75993646|FG000|STARTED|Part A Period 1 (4 Days)||3||
59869206|NCT03627494|75993647|FG001|STARTED|Part A Period 1 (4 Days)||3||
59869207|NCT03627494|75993648|FG002|STARTED|Part A Period 1 (4 Days)||3||
59869208|NCT03627494|75993649|FG003|STARTED|Part A Period 1 (4 Days)||3||
59869209|NCT03627494|75993650|FG004|STARTED|Part A Period 1 (4 Days)||3||
59869210|NCT03627494|75993651|FG005|STARTED|Part A Period 1 (4 Days)||3||
59869211|NCT03627494|75993652|FG006|STARTED|Part A Period 1 (4 Days)||0||
59869212|NCT03627494|75993653|FG007|STARTED|Part A Period 1 (4 Days)||0||
59869213|NCT03627494|75993654|FG008|STARTED|Part A Period 1 (4 Days)||0||
59869214|NCT03627494|75993655|FG009|STARTED|Part A Period 1 (4 Days)||0||
59869215|NCT03627494|75993656|FG010|STARTED|Part A Period 1 (4 Days)||0||
59869216|NCT03627494|75993657|FG011|STARTED|Part A Period 1 (4 Days)||0||
59869217|NCT03627494|75993646|FG000|COMPLETED|Part A Period 1 (4 Days)||3|0|
59869218|NCT03627494|75993647|FG001|COMPLETED|Part A Period 1 (4 Days)||3|0|
59869219|NCT03627494|75993648|FG002|COMPLETED|Part A Period 1 (4 Days)||3|0|
59869220|NCT03627494|75993649|FG003|COMPLETED|Part A Period 1 (4 Days)||3|0|
59869221|NCT03627494|75993650|FG004|COMPLETED|Part A Period 1 (4 Days)||3|0|
59869222|NCT03627494|75993651|FG005|COMPLETED|Part A Period 1 (4 Days)||3|0|
59869223|NCT03627494|75993652|FG006|COMPLETED|Part A Period 1 (4 Days)||0|0|
59869224|NCT03627494|75993653|FG007|COMPLETED|Part A Period 1 (4 Days)||0|0|
59869225|NCT03627494|75993654|FG008|COMPLETED|Part A Period 1 (4 Days)||0|0|
59869226|NCT03627494|75993655|FG009|COMPLETED|Part A Period 1 (4 Days)||0|0|
59869227|NCT03627494|75993656|FG010|COMPLETED|Part A Period 1 (4 Days)||0|0|
59869228|NCT03627494|75993657|FG011|COMPLETED|Part A Period 1 (4 Days)||0|0|
59869229|NCT03627494|75993646|FG000|NOT COMPLETED|Part A Period 1 (4 Days)||0||
59869230|NCT03627494|75993647|FG001|NOT COMPLETED|Part A Period 1 (4 Days)||0||
59869231|NCT03627494|75993648|FG002|NOT COMPLETED|Part A Period 1 (4 Days)||0||
59869232|NCT03627494|75993649|FG003|NOT COMPLETED|Part A Period 1 (4 Days)||0||
59869233|NCT03627494|75993650|FG004|NOT COMPLETED|Part A Period 1 (4 Days)||0||
59869234|NCT03627494|75993651|FG005|NOT COMPLETED|Part A Period 1 (4 Days)||0||
59869235|NCT03627494|75993652|FG006|NOT COMPLETED|Part A Period 1 (4 Days)||0||
59869236|NCT03627494|75993653|FG007|NOT COMPLETED|Part A Period 1 (4 Days)||0||
59869237|NCT03627494|75993654|FG008|NOT COMPLETED|Part A Period 1 (4 Days)||0||
59869238|NCT03627494|75993655|FG009|NOT COMPLETED|Part A Period 1 (4 Days)||0||
59869239|NCT03627494|75993656|FG010|NOT COMPLETED|Part A Period 1 (4 Days)||0||
59869240|NCT03627494|75993657|FG011|NOT COMPLETED|Part A Period 1 (4 Days)||0||
59869241|NCT03627494|75993646|FG000|STARTED|Part A Washout 1 (7 Days)||3||
59869242|NCT03627494|75993647|FG001|STARTED|Part A Washout 1 (7 Days)||3||
59869243|NCT03627494|75993648|FG002|STARTED|Part A Washout 1 (7 Days)||3||
59869244|NCT03627494|75993649|FG003|STARTED|Part A Washout 1 (7 Days)||3||
59869245|NCT03627494|75993650|FG004|STARTED|Part A Washout 1 (7 Days)||3||
59869246|NCT03627494|75993651|FG005|STARTED|Part A Washout 1 (7 Days)||3||
59869247|NCT03627494|75993652|FG006|STARTED|Part A Washout 1 (7 Days)||0||
59869248|NCT03627494|75993653|FG007|STARTED|Part A Washout 1 (7 Days)||0||
59869249|NCT03627494|75993654|FG008|STARTED|Part A Washout 1 (7 Days)||0||
59869250|NCT03627494|75993655|FG009|STARTED|Part A Washout 1 (7 Days)||0||
59869251|NCT03627494|75993656|FG010|STARTED|Part A Washout 1 (7 Days)||0||
59869252|NCT03627494|75993657|FG011|STARTED|Part A Washout 1 (7 Days)||0||
59869253|NCT03627494|75993646|FG000|COMPLETED|Part A Washout 1 (7 Days)||3||
59869254|NCT03627494|75993647|FG001|COMPLETED|Part A Washout 1 (7 Days)||3||
59869255|NCT03627494|75993648|FG002|COMPLETED|Part A Washout 1 (7 Days)||3||
59869256|NCT03627494|75993649|FG003|COMPLETED|Part A Washout 1 (7 Days)||3||
59869257|NCT03627494|75993650|FG004|COMPLETED|Part A Washout 1 (7 Days)||3||
59869258|NCT03627494|75993651|FG005|COMPLETED|Part A Washout 1 (7 Days)||3||
59869259|NCT03627494|75993652|FG006|COMPLETED|Part A Washout 1 (7 Days)||0||
59869260|NCT03627494|75993653|FG007|COMPLETED|Part A Washout 1 (7 Days)||0||
59869261|NCT03627494|75993654|FG008|COMPLETED|Part A Washout 1 (7 Days)||0||
59869262|NCT03627494|75993655|FG009|COMPLETED|Part A Washout 1 (7 Days)||0||
59869263|NCT03627494|75993656|FG010|COMPLETED|Part A Washout 1 (7 Days)||0||
59869264|NCT03627494|75993657|FG011|COMPLETED|Part A Washout 1 (7 Days)||0||
59869265|NCT03627494|75993646|FG000|NOT COMPLETED|Part A Washout 1 (7 Days)||0||
59869266|NCT03627494|75993647|FG001|NOT COMPLETED|Part A Washout 1 (7 Days)||0||
59869267|NCT03627494|75993648|FG002|NOT COMPLETED|Part A Washout 1 (7 Days)||0||
59869268|NCT03627494|75993649|FG003|NOT COMPLETED|Part A Washout 1 (7 Days)||0||
59869269|NCT03627494|75993650|FG004|NOT COMPLETED|Part A Washout 1 (7 Days)||0||
59869270|NCT03627494|75993651|FG005|NOT COMPLETED|Part A Washout 1 (7 Days)||0||
59869271|NCT03627494|75993652|FG006|NOT COMPLETED|Part A Washout 1 (7 Days)||0||
59869272|NCT03627494|75993653|FG007|NOT COMPLETED|Part A Washout 1 (7 Days)||0||
59869273|NCT03627494|75993654|FG008|NOT COMPLETED|Part A Washout 1 (7 Days)||0||
59869274|NCT03627494|75993655|FG009|NOT COMPLETED|Part A Washout 1 (7 Days)||0||
59869275|NCT03627494|75993656|FG010|NOT COMPLETED|Part A Washout 1 (7 Days)||0||
59869276|NCT03627494|75993657|FG011|NOT COMPLETED|Part A Washout 1 (7 Days)||0||
59869277|NCT03627494|75993646|FG000|STARTED|Part A Period 2 (4 Days)||3||
59869278|NCT03627494|75993647|FG001|STARTED|Part A Period 2 (4 Days)||3||
59869279|NCT03627494|75993648|FG002|STARTED|Part A Period 2 (4 Days)||3||
59869280|NCT03627494|75993649|FG003|STARTED|Part A Period 2 (4 Days)||3||
59869281|NCT03627494|75993650|FG004|STARTED|Part A Period 2 (4 Days)||3||
59869282|NCT03627494|75993651|FG005|STARTED|Part A Period 2 (4 Days)||3||
59869283|NCT03627494|75993652|FG006|STARTED|Part A Period 2 (4 Days)||0||
59869284|NCT03627494|75993653|FG007|STARTED|Part A Period 2 (4 Days)||0||
59869285|NCT03627494|75993654|FG008|STARTED|Part A Period 2 (4 Days)||0||
59869286|NCT03627494|75993655|FG009|STARTED|Part A Period 2 (4 Days)||0||
59869287|NCT03627494|75993656|FG010|STARTED|Part A Period 2 (4 Days)||0||
59869288|NCT03627494|75993657|FG011|STARTED|Part A Period 2 (4 Days)||0||
59869289|NCT03627494|75993646|FG000|COMPLETED|Part A Period 2 (4 Days)||3||
59869290|NCT03627494|75993647|FG001|COMPLETED|Part A Period 2 (4 Days)||3||
59869291|NCT03627494|75993648|FG002|COMPLETED|Part A Period 2 (4 Days)||3||
59869292|NCT03627494|75993649|FG003|COMPLETED|Part A Period 2 (4 Days)||3||
59869293|NCT03627494|75993650|FG004|COMPLETED|Part A Period 2 (4 Days)||3||
59869294|NCT03627494|75993651|FG005|COMPLETED|Part A Period 2 (4 Days)||3||
59869295|NCT03627494|75993652|FG006|COMPLETED|Part A Period 2 (4 Days)||0||
59869296|NCT03627494|75993653|FG007|COMPLETED|Part A Period 2 (4 Days)||0||
59869297|NCT03627494|75993654|FG008|COMPLETED|Part A Period 2 (4 Days)||0||
59869298|NCT03627494|75993655|FG009|COMPLETED|Part A Period 2 (4 Days)||0||
59869299|NCT03627494|75993656|FG010|COMPLETED|Part A Period 2 (4 Days)||0||
59869300|NCT03627494|75993657|FG011|COMPLETED|Part A Period 2 (4 Days)||0||
59869301|NCT03627494|75993646|FG000|NOT COMPLETED|Part A Period 2 (4 Days)||0||
59869302|NCT03627494|75993647|FG001|NOT COMPLETED|Part A Period 2 (4 Days)||0||
59869303|NCT03627494|75993648|FG002|NOT COMPLETED|Part A Period 2 (4 Days)||0||
59869304|NCT03627494|75993649|FG003|NOT COMPLETED|Part A Period 2 (4 Days)||0||
59869305|NCT03627494|75993650|FG004|NOT COMPLETED|Part A Period 2 (4 Days)||0||
59869306|NCT03627494|75993651|FG005|NOT COMPLETED|Part A Period 2 (4 Days)||0||
59869307|NCT03627494|75993652|FG006|NOT COMPLETED|Part A Period 2 (4 Days)||0||
59869308|NCT03627494|75993653|FG007|NOT COMPLETED|Part A Period 2 (4 Days)||0||
59869309|NCT03627494|75993654|FG008|NOT COMPLETED|Part A Period 2 (4 Days)||0||
59869310|NCT03627494|75993655|FG009|NOT COMPLETED|Part A Period 2 (4 Days)||0||
59869311|NCT03627494|75993656|FG010|NOT COMPLETED|Part A Period 2 (4 Days)||0||
59869312|NCT03627494|75993657|FG011|NOT COMPLETED|Part A Period 2 (4 Days)||0||
59869313|NCT03627494|75993646|FG000|STARTED|Part A Washout 2 (7 Days)||3||
59869314|NCT03627494|75993647|FG001|STARTED|Part A Washout 2 (7 Days)||3||
59869315|NCT03627494|75993648|FG002|STARTED|Part A Washout 2 (7 Days)||3||
59869316|NCT03627494|75993649|FG003|STARTED|Part A Washout 2 (7 Days)||3||
59869317|NCT03627494|75993650|FG004|STARTED|Part A Washout 2 (7 Days)||3||
59869318|NCT03627494|75993651|FG005|STARTED|Part A Washout 2 (7 Days)||3||
59869319|NCT03627494|75993652|FG006|STARTED|Part A Washout 2 (7 Days)||0||
59869320|NCT03627494|75993653|FG007|STARTED|Part A Washout 2 (7 Days)||0||
59869321|NCT03627494|75993654|FG008|STARTED|Part A Washout 2 (7 Days)||0||
59869322|NCT03627494|75993655|FG009|STARTED|Part A Washout 2 (7 Days)||0||
59869323|NCT03627494|75993656|FG010|STARTED|Part A Washout 2 (7 Days)||0||
59869324|NCT03627494|75993657|FG011|STARTED|Part A Washout 2 (7 Days)||0||
59869325|NCT03627494|75993646|FG000|COMPLETED|Part A Washout 2 (7 Days)||2||
59869326|NCT03627494|75993647|FG001|COMPLETED|Part A Washout 2 (7 Days)||3||
59869327|NCT03627494|75993648|FG002|COMPLETED|Part A Washout 2 (7 Days)||2||
59869328|NCT03627494|75993649|FG003|COMPLETED|Part A Washout 2 (7 Days)||3||
59869329|NCT03627494|75993650|FG004|COMPLETED|Part A Washout 2 (7 Days)||3||
59869330|NCT03627494|75993651|FG005|COMPLETED|Part A Washout 2 (7 Days)||3||
59869331|NCT03627494|75993652|FG006|COMPLETED|Part A Washout 2 (7 Days)||0||
59869332|NCT03627494|75993653|FG007|COMPLETED|Part A Washout 2 (7 Days)||0||
59869333|NCT03627494|75993654|FG008|COMPLETED|Part A Washout 2 (7 Days)||0||
59869334|NCT03627494|75993655|FG009|COMPLETED|Part A Washout 2 (7 Days)||0||
59869335|NCT03627494|75993656|FG010|COMPLETED|Part A Washout 2 (7 Days)||0||
59869336|NCT03627494|75993657|FG011|COMPLETED|Part A Washout 2 (7 Days)||0||
59869337|NCT03627494|75993646|FG000|NOT COMPLETED|Part A Washout 2 (7 Days)||1||
59869338|NCT03627494|75993647|FG001|NOT COMPLETED|Part A Washout 2 (7 Days)||0||
59869339|NCT03627494|75993648|FG002|NOT COMPLETED|Part A Washout 2 (7 Days)||1||
59869340|NCT03627494|75993649|FG003|NOT COMPLETED|Part A Washout 2 (7 Days)||0||
59869341|NCT03627494|75993650|FG004|NOT COMPLETED|Part A Washout 2 (7 Days)||0||
59869342|NCT03627494|75993651|FG005|NOT COMPLETED|Part A Washout 2 (7 Days)||0||
59869343|NCT03627494|75993652|FG006|NOT COMPLETED|Part A Washout 2 (7 Days)||0||
59869344|NCT03627494|75993653|FG007|NOT COMPLETED|Part A Washout 2 (7 Days)||0||
59869345|NCT03627494|75993654|FG008|NOT COMPLETED|Part A Washout 2 (7 Days)||0||
59869346|NCT03627494|75993655|FG009|NOT COMPLETED|Part A Washout 2 (7 Days)||0||
59869347|NCT03627494|75993656|FG010|NOT COMPLETED|Part A Washout 2 (7 Days)||0||
59869348|NCT03627494|75993657|FG011|NOT COMPLETED|Part A Washout 2 (7 Days)||0||
59869349|NCT03627494|75993646|FG000|STARTED|Part A Period3(4days)+Follow-up(14days)||2||
59869350|NCT03627494|75993647|FG001|STARTED|Part A Period3(4days)+Follow-up(14days)||3||
59869351|NCT03627494|75993648|FG002|STARTED|Part A Period3(4days)+Follow-up(14days)||2||
59869352|NCT03627494|75993649|FG003|STARTED|Part A Period3(4days)+Follow-up(14days)||3||
59869353|NCT03627494|75993650|FG004|STARTED|Part A Period3(4days)+Follow-up(14days)||3||
59869354|NCT03627494|75993651|FG005|STARTED|Part A Period3(4days)+Follow-up(14days)||3||
59869355|NCT03627494|75993652|FG006|STARTED|Part A Period3(4days)+Follow-up(14days)||0||
59869356|NCT03627494|75993653|FG007|STARTED|Part A Period3(4days)+Follow-up(14days)||0||
59869357|NCT03627494|75993654|FG008|STARTED|Part A Period3(4days)+Follow-up(14days)||0||
59869358|NCT03627494|75993655|FG009|STARTED|Part A Period3(4days)+Follow-up(14days)||0||
59869359|NCT03627494|75993656|FG010|STARTED|Part A Period3(4days)+Follow-up(14days)||0||
59869360|NCT03627494|75993657|FG011|STARTED|Part A Period3(4days)+Follow-up(14days)||0||
59869361|NCT03627494|75993646|FG000|COMPLETED|Part A Period3(4days)+Follow-up(14days)||2||
59869362|NCT03627494|75993647|FG001|COMPLETED|Part A Period3(4days)+Follow-up(14days)||3||
59869363|NCT03627494|75993648|FG002|COMPLETED|Part A Period3(4days)+Follow-up(14days)||2||
59869364|NCT03627494|75993649|FG003|COMPLETED|Part A Period3(4days)+Follow-up(14days)||3||
59869365|NCT03627494|75993650|FG004|COMPLETED|Part A Period3(4days)+Follow-up(14days)||3||
59869366|NCT03627494|75993651|FG005|COMPLETED|Part A Period3(4days)+Follow-up(14days)||3||
59869367|NCT03627494|75993652|FG006|COMPLETED|Part A Period3(4days)+Follow-up(14days)||0||
59869368|NCT03627494|75993653|FG007|COMPLETED|Part A Period3(4days)+Follow-up(14days)||0||
59869369|NCT03627494|75993654|FG008|COMPLETED|Part A Period3(4days)+Follow-up(14days)||0||
59869370|NCT03627494|75993655|FG009|COMPLETED|Part A Period3(4days)+Follow-up(14days)||0||
59869371|NCT03627494|75993656|FG010|COMPLETED|Part A Period3(4days)+Follow-up(14days)||0||
59869372|NCT03627494|75993657|FG011|COMPLETED|Part A Period3(4days)+Follow-up(14days)||0||
59869373|NCT03627494|75993646|FG000|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0||
59869374|NCT03627494|75993647|FG001|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0||
59869375|NCT03627494|75993648|FG002|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0||
59869376|NCT03627494|75993649|FG003|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0||
59869377|NCT03627494|75993650|FG004|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0||
59869378|NCT03627494|75993651|FG005|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0||
59869379|NCT03627494|75993652|FG006|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0||
59869380|NCT03627494|75993653|FG007|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0||
59869381|NCT03627494|75993654|FG008|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0||
59869382|NCT03627494|75993655|FG009|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0||
59869383|NCT03627494|75993656|FG010|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0||
59869384|NCT03627494|75993657|FG011|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0||
59869385|NCT03627494|75993646|FG000|STARTED|Part B (Maximum of 34 Days)||0||
59869386|NCT03627494|75993647|FG001|STARTED|Part B (Maximum of 34 Days)||0||
59869387|NCT03627494|75993648|FG002|STARTED|Part B (Maximum of 34 Days)||0||
59869388|NCT03627494|75993649|FG003|STARTED|Part B (Maximum of 34 Days)||0||
59869389|NCT03627494|75993650|FG004|STARTED|Part B (Maximum of 34 Days)||0||
59869390|NCT03627494|75993651|FG005|STARTED|Part B (Maximum of 34 Days)||0||
59869391|NCT03627494|75993652|FG006|STARTED|Part B (Maximum of 34 Days)||9||
59869392|NCT03627494|75993653|FG007|STARTED|Part B (Maximum of 34 Days)||9||
59869393|NCT03627494|75993654|FG008|STARTED|Part B (Maximum of 34 Days)||9||
59869394|NCT03627494|75993655|FG009|STARTED|Part B (Maximum of 34 Days)||9||
59869395|NCT03627494|75993656|FG010|STARTED|Part B (Maximum of 34 Days)||0||
59869396|NCT03627494|75993657|FG011|STARTED|Part B (Maximum of 34 Days)||0||
59869397|NCT03627494|75993646|FG000|COMPLETED|Part B (Maximum of 34 Days)||0||
59869398|NCT03627494|75993647|FG001|COMPLETED|Part B (Maximum of 34 Days)||0||
59869399|NCT03627494|75993648|FG002|COMPLETED|Part B (Maximum of 34 Days)||0||
59869400|NCT03627494|75993649|FG003|COMPLETED|Part B (Maximum of 34 Days)||0||
59869401|NCT03627494|75993650|FG004|COMPLETED|Part B (Maximum of 34 Days)||0||
59869402|NCT03627494|75993651|FG005|COMPLETED|Part B (Maximum of 34 Days)||0||
59869403|NCT03627494|75993652|FG006|COMPLETED|Part B (Maximum of 34 Days)||9||
59869404|NCT03627494|75993653|FG007|COMPLETED|Part B (Maximum of 34 Days)||9||
59869405|NCT03627494|75993654|FG008|COMPLETED|Part B (Maximum of 34 Days)||7||
59869406|NCT03627494|75993655|FG009|COMPLETED|Part B (Maximum of 34 Days)||9||
59869407|NCT03627494|75993656|FG010|COMPLETED|Part B (Maximum of 34 Days)||0||
59869408|NCT03627494|75993657|FG011|COMPLETED|Part B (Maximum of 34 Days)||0||
59869409|NCT03627494|75993646|FG000|NOT COMPLETED|Part B (Maximum of 34 Days)||0||
59869410|NCT03627494|75993647|FG001|NOT COMPLETED|Part B (Maximum of 34 Days)||0||
59869411|NCT03627494|75993648|FG002|NOT COMPLETED|Part B (Maximum of 34 Days)||0||
59869412|NCT03627494|75993649|FG003|NOT COMPLETED|Part B (Maximum of 34 Days)||0||
59869413|NCT03627494|75993650|FG004|NOT COMPLETED|Part B (Maximum of 34 Days)||0||
59869414|NCT03627494|75993651|FG005|NOT COMPLETED|Part B (Maximum of 34 Days)||0||
59869415|NCT03627494|75993652|FG006|NOT COMPLETED|Part B (Maximum of 34 Days)||0||
59869416|NCT03627494|75993653|FG007|NOT COMPLETED|Part B (Maximum of 34 Days)||0||
59869417|NCT03627494|75993654|FG008|NOT COMPLETED|Part B (Maximum of 34 Days)||2||
59869418|NCT03627494|75993655|FG009|NOT COMPLETED|Part B (Maximum of 34 Days)||0||
59869419|NCT03627494|75993656|FG010|NOT COMPLETED|Part B (Maximum of 34 Days)||0||
59869420|NCT03627494|75993657|FG011|NOT COMPLETED|Part B (Maximum of 34 Days)||0||
59869421|NCT03627494|75993646|FG000|STARTED|Part C Period 1 (4 Days)||0||
59869422|NCT03627494|75993647|FG001|STARTED|Part C Period 1 (4 Days)||0||
59869423|NCT03627494|75993648|FG002|STARTED|Part C Period 1 (4 Days)||0||
59869424|NCT03627494|75993649|FG003|STARTED|Part C Period 1 (4 Days)||0||
59869425|NCT03627494|75993650|FG004|STARTED|Part C Period 1 (4 Days)||0||
59869426|NCT03627494|75993651|FG005|STARTED|Part C Period 1 (4 Days)||0||
59869427|NCT03627494|75993652|FG006|STARTED|Part C Period 1 (4 Days)||0||
59869428|NCT03627494|75993653|FG007|STARTED|Part C Period 1 (4 Days)||0||
59869429|NCT03627494|75993654|FG008|STARTED|Part C Period 1 (4 Days)||0||
59869430|NCT03627494|75993655|FG009|STARTED|Part C Period 1 (4 Days)||0||
59869431|NCT03627494|75993656|FG010|STARTED|Part C Period 1 (4 Days)||6||
59869432|NCT03627494|75993657|FG011|STARTED|Part C Period 1 (4 Days)||6||
59869433|NCT03627494|75993646|FG000|COMPLETED|Part C Period 1 (4 Days)||0||
59869434|NCT03627494|75993647|FG001|COMPLETED|Part C Period 1 (4 Days)||0||
59869435|NCT03627494|75993648|FG002|COMPLETED|Part C Period 1 (4 Days)||0||
59869436|NCT03627494|75993649|FG003|COMPLETED|Part C Period 1 (4 Days)||0||
59869437|NCT03627494|75993650|FG004|COMPLETED|Part C Period 1 (4 Days)||0||
59869438|NCT03627494|75993651|FG005|COMPLETED|Part C Period 1 (4 Days)||0||
59869439|NCT03627494|75993652|FG006|COMPLETED|Part C Period 1 (4 Days)||0||
59869440|NCT03627494|75993653|FG007|COMPLETED|Part C Period 1 (4 Days)||0||
59869441|NCT03627494|75993654|FG008|COMPLETED|Part C Period 1 (4 Days)||0||
59869442|NCT03627494|75993655|FG009|COMPLETED|Part C Period 1 (4 Days)||0||
59869443|NCT03627494|75993656|FG010|COMPLETED|Part C Period 1 (4 Days)||6||
59869444|NCT03627494|75993657|FG011|COMPLETED|Part C Period 1 (4 Days)||6||
59869445|NCT03627494|75993646|FG000|NOT COMPLETED|Part C Period 1 (4 Days)||0||
59869446|NCT03627494|75993647|FG001|NOT COMPLETED|Part C Period 1 (4 Days)||0||
59869447|NCT03627494|75993648|FG002|NOT COMPLETED|Part C Period 1 (4 Days)||0||
59869448|NCT03627494|75993649|FG003|NOT COMPLETED|Part C Period 1 (4 Days)||0||
59869449|NCT03627494|75993650|FG004|NOT COMPLETED|Part C Period 1 (4 Days)||0||
59869450|NCT03627494|75993651|FG005|NOT COMPLETED|Part C Period 1 (4 Days)||0||
59869451|NCT03627494|75993652|FG006|NOT COMPLETED|Part C Period 1 (4 Days)||0||
59869452|NCT03627494|75993653|FG007|NOT COMPLETED|Part C Period 1 (4 Days)||0||
59869453|NCT03627494|75993654|FG008|NOT COMPLETED|Part C Period 1 (4 Days)||0||
59869454|NCT03627494|75993655|FG009|NOT COMPLETED|Part C Period 1 (4 Days)||0||
59869455|NCT03627494|75993656|FG010|NOT COMPLETED|Part C Period 1 (4 Days)||0||
59869456|NCT03627494|75993657|FG011|NOT COMPLETED|Part C Period 1 (4 Days)||0||
59869457|NCT03627494|75993646|FG000|STARTED|Part C Washout 1 (7 Days)||0||
59869458|NCT03627494|75993647|FG001|STARTED|Part C Washout 1 (7 Days)||0||
59869459|NCT03627494|75993648|FG002|STARTED|Part C Washout 1 (7 Days)||0||
59869460|NCT03627494|75993649|FG003|STARTED|Part C Washout 1 (7 Days)||0||
59869461|NCT03627494|75993650|FG004|STARTED|Part C Washout 1 (7 Days)||0||
59869462|NCT03627494|75993651|FG005|STARTED|Part C Washout 1 (7 Days)||0||
59869463|NCT03627494|75993652|FG006|STARTED|Part C Washout 1 (7 Days)||0||
59869464|NCT03627494|75993653|FG007|STARTED|Part C Washout 1 (7 Days)||0||
59869465|NCT03627494|75993654|FG008|STARTED|Part C Washout 1 (7 Days)||0||
59869466|NCT03627494|75993655|FG009|STARTED|Part C Washout 1 (7 Days)||0||
59869467|NCT03627494|75993656|FG010|STARTED|Part C Washout 1 (7 Days)||6||
59869468|NCT03627494|75993657|FG011|STARTED|Part C Washout 1 (7 Days)||6||
59869469|NCT03627494|75993646|FG000|COMPLETED|Part C Washout 1 (7 Days)||0||
59869470|NCT03627494|75993647|FG001|COMPLETED|Part C Washout 1 (7 Days)||0||
59869471|NCT03627494|75993648|FG002|COMPLETED|Part C Washout 1 (7 Days)||0||
59869472|NCT03627494|75993649|FG003|COMPLETED|Part C Washout 1 (7 Days)||0||
59869473|NCT03627494|75993650|FG004|COMPLETED|Part C Washout 1 (7 Days)||0||
59869474|NCT03627494|75993651|FG005|COMPLETED|Part C Washout 1 (7 Days)||0||
59869475|NCT03627494|75993652|FG006|COMPLETED|Part C Washout 1 (7 Days)||0||
59869476|NCT03627494|75993653|FG007|COMPLETED|Part C Washout 1 (7 Days)||0||
59869477|NCT03627494|75993654|FG008|COMPLETED|Part C Washout 1 (7 Days)||0||
59869478|NCT03627494|75993655|FG009|COMPLETED|Part C Washout 1 (7 Days)||0||
59869479|NCT03627494|75993656|FG010|COMPLETED|Part C Washout 1 (7 Days)||5||
59869480|NCT03627494|75993657|FG011|COMPLETED|Part C Washout 1 (7 Days)||5||
59869481|NCT03627494|75993646|FG000|NOT COMPLETED|Part C Washout 1 (7 Days)||0||
59869482|NCT03627494|75993647|FG001|NOT COMPLETED|Part C Washout 1 (7 Days)||0||
59869483|NCT03627494|75993648|FG002|NOT COMPLETED|Part C Washout 1 (7 Days)||0||
59869484|NCT03627494|75993649|FG003|NOT COMPLETED|Part C Washout 1 (7 Days)||0||
59869485|NCT03627494|75993650|FG004|NOT COMPLETED|Part C Washout 1 (7 Days)||0||
59869486|NCT03627494|75993651|FG005|NOT COMPLETED|Part C Washout 1 (7 Days)||0||
59869487|NCT03627494|75993652|FG006|NOT COMPLETED|Part C Washout 1 (7 Days)||0||
59869488|NCT03627494|75993653|FG007|NOT COMPLETED|Part C Washout 1 (7 Days)||0||
59869489|NCT03627494|75993654|FG008|NOT COMPLETED|Part C Washout 1 (7 Days)||0||
59869490|NCT03627494|75993655|FG009|NOT COMPLETED|Part C Washout 1 (7 Days)||0||
59869491|NCT03627494|75993656|FG010|NOT COMPLETED|Part C Washout 1 (7 Days)||1||
59869492|NCT03627494|75993657|FG011|NOT COMPLETED|Part C Washout 1 (7 Days)||1||
59869493|NCT03627494|75993646|FG000|STARTED|Part C Period2(4days)+Follow-up(14days)||0||
59869494|NCT03627494|75993647|FG001|STARTED|Part C Period2(4days)+Follow-up(14days)||0||
59869495|NCT03627494|75993648|FG002|STARTED|Part C Period2(4days)+Follow-up(14days)||0||
59869496|NCT03627494|75993649|FG003|STARTED|Part C Period2(4days)+Follow-up(14days)||0||
59869497|NCT03627494|75993650|FG004|STARTED|Part C Period2(4days)+Follow-up(14days)||0||
59869498|NCT03627494|75993651|FG005|STARTED|Part C Period2(4days)+Follow-up(14days)||0||
59869499|NCT03627494|75993652|FG006|STARTED|Part C Period2(4days)+Follow-up(14days)||0||
59869500|NCT03627494|75993653|FG007|STARTED|Part C Period2(4days)+Follow-up(14days)||0||
59869501|NCT03627494|75993654|FG008|STARTED|Part C Period2(4days)+Follow-up(14days)||0||
59869502|NCT03627494|75993655|FG009|STARTED|Part C Period2(4days)+Follow-up(14days)||0||
59869503|NCT03627494|75993656|FG010|STARTED|Part C Period2(4days)+Follow-up(14days)||5||
59869504|NCT03627494|75993657|FG011|STARTED|Part C Period2(4days)+Follow-up(14days)||5||
59869505|NCT03627494|75993646|FG000|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0||
59869506|NCT03627494|75993647|FG001|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0||
59869507|NCT03627494|75993648|FG002|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0||
59869508|NCT03627494|75993649|FG003|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0||
59869509|NCT03627494|75993650|FG004|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0||
59869510|NCT03627494|75993651|FG005|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0||
59869511|NCT03627494|75993652|FG006|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0||
59869512|NCT03627494|75993653|FG007|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0||
59869513|NCT03627494|75993654|FG008|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0||
59869514|NCT03627494|75993655|FG009|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0||
59869515|NCT03627494|75993656|FG010|COMPLETED|Part C Period2(4days)+Follow-up(14days)||5||
59869516|NCT03627494|75993657|FG011|COMPLETED|Part C Period2(4days)+Follow-up(14days)||5||
59869517|NCT03627494|75993646|FG000|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0||
59869518|NCT03627494|75993647|FG001|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0||
59869519|NCT03627494|75993648|FG002|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0||
59869520|NCT03627494|75993649|FG003|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0||
59869521|NCT03627494|75993650|FG004|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0||
59869522|NCT03627494|75993651|FG005|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0||
59869523|NCT03627494|75993652|FG006|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0||
59869524|NCT03627494|75993653|FG007|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0||
59869525|NCT03627494|75993654|FG008|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0||
59869526|NCT03627494|75993655|FG009|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0||
59869527|NCT03627494|75993656|FG010|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0||
59869528|NCT03627494|75993657|FG011|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0||
59869529|NCT03627416|75993698|FG000|STARTED|Overall Study||8||
59869530|NCT03627416|75993699|FG001|STARTED|Overall Study||7||
59869531|NCT03627416|75993698|FG000|COMPLETED|Overall Study||8||
59869532|NCT03627416|75993699|FG001|COMPLETED|Overall Study||6||
59869533|NCT03627416|75993698|FG000|NOT COMPLETED|Overall Study||0||
59869534|NCT03627416|75993699|FG001|NOT COMPLETED|Overall Study||1||
59869535|NCT00097539|75993712|FG000|STARTED|Overall Study||27286||
59736643|NCT00833638|75855476|FG002|NOT COMPLETED|Phase 3: Open-label Extension Phase||2||
59736644|NCT01041404|75855494|FG000|STARTED|Overall Study||290||
59736645|NCT01041404|75855495|FG001|STARTED|Overall Study||294||
59869536|NCT00097539|75993713|FG001|STARTED|Overall Study||9356||
59869537|NCT00097539|75993714|FG002|STARTED|Overall Study||12519||
59869538|NCT00097539|75993715|FG003|STARTED|Overall Study||5651||
59869539|NCT00097539|75993716|FG004|STARTED|Overall Study||2144||
59869540|NCT00097539|75993717|FG005|STARTED|Overall Study||8010||
59869541|NCT00097539|75993718|FG006|STARTED|Overall Study||239||
59869542|NCT00097539|75993712|FG000|COMPLETED|Overall Study||8220||
59869543|NCT00097539|75993713|FG001|COMPLETED|Overall Study||2825||
59869544|NCT00097539|75993714|FG002|COMPLETED|Overall Study||3411||
59869545|NCT00097539|75993715|FG003|COMPLETED|Overall Study||2066||
59869546|NCT00097539|75993716|FG004|COMPLETED|Overall Study||386||
59869547|NCT00097539|75993717|FG005|COMPLETED|Overall Study||2118||
59869548|NCT00097539|75993718|FG006|COMPLETED|Overall Study||68||
59869549|NCT00097539|75993712|FG000|NOT COMPLETED|Overall Study||19066||
59869550|NCT00097539|75993713|FG001|NOT COMPLETED|Overall Study||6531||
59869551|NCT00097539|75993714|FG002|NOT COMPLETED|Overall Study||9108||
59869552|NCT00097539|75993715|FG003|NOT COMPLETED|Overall Study||3585||
59869553|NCT00097539|75993716|FG004|NOT COMPLETED|Overall Study||1758||
59869554|NCT00097539|75993717|FG005|NOT COMPLETED|Overall Study||5892||
59869555|NCT00097539|75993718|FG006|NOT COMPLETED|Overall Study||171||
59869556|NCT03925324|75993736|FG000|STARTED|Overall Study||2||
59869557|NCT03925324|75993737|FG001|STARTED|Overall Study||2||
59869558|NCT03925324|75993736|FG000|COMPLETED|Overall Study||1||
59869559|NCT03925324|75993737|FG001|COMPLETED|Overall Study||1||
59736646|NCT01041404|75855494|FG000|Entered Follow-Up|Overall Study||251||
59736647|NCT01041404|75855495|FG001|Entered Follow-Up|Overall Study||251||
59736648|NCT01041404|75855494|FG000|Died in Follow-up|Overall Study||199||
59736649|NCT01041404|75855495|FG001|Died in Follow-up|Overall Study||200||
59736650|NCT01041404|75855494|FG000|Lost to Follow-up|Overall Study||12||
59736651|NCT01041404|75855495|FG001|Lost to Follow-up|Overall Study||10||
59736652|NCT01041404|75855494|FG000|Alive in Follow-up|Overall Study||40||
59869560|NCT03925324|75993736|FG000|NOT COMPLETED|Overall Study||1||
59869561|NCT03925324|75993737|FG001|NOT COMPLETED|Overall Study||1||
59869562|NCT03042910|75993743|FG000|STARTED|Overall Study||38||
59869563|NCT03042910|75993743|FG000|Treated|Overall Study||37||
59869564|NCT03042910|75993743|FG000|COMPLETED|Overall Study||31||
59869565|NCT03042910|75993743|FG000|NOT COMPLETED|Overall Study||7||
59869566|NCT03059446|75993747|FG000|STARTED|Overall Study||167||
59736653|NCT01041404|75855495|FG001|Alive in Follow-up|Overall Study||41||
59736654|NCT01041404|75855494|FG000|COMPLETED|Overall Study|Summary of withdrawals represents withdrawals from treatment, rather than withdrawals from study.|0||
59869567|NCT03059446|75993747|FG000|COMPLETED|Overall Study||0||
59869568|NCT03059446|75993747|FG000|NOT COMPLETED|Overall Study||167||
59869569|NCT00090519|75993753|FG000|STARTED|Overall Study||371||
59869570|NCT00090519|75993754|FG001|STARTED|Overall Study||360||
59869571|NCT00090519|75993753|FG000|COMPLETED|Overall Study||298||
59869572|NCT00090519|75993754|FG001|COMPLETED|Overall Study||285||
59869573|NCT00090519|75993753|FG000|NOT COMPLETED|Overall Study||73||
59869574|NCT00090519|75993754|FG001|NOT COMPLETED|Overall Study||75||
59869575|NCT02980666|75993762|FG000|STARTED|Overall Study||8||
59869576|NCT02980666|75993763|FG001|STARTED|Overall Study||2||
59869577|NCT02980666|75993762|FG000|COMPLETED|Overall Study||8||
59869578|NCT02980666|75993763|FG001|COMPLETED|Overall Study||2||
59869579|NCT02980666|75993762|FG000|NOT COMPLETED|Overall Study||0||
59869580|NCT02980666|75993763|FG001|NOT COMPLETED|Overall Study||0||
59869581|NCT02962102|75993772|FG000|STARTED|Overall Study||51||
59869582|NCT02962102|75993773|FG001|STARTED|Overall Study||50||
59869583|NCT02962102|75993774|FG002|STARTED|Overall Study||49||
59869584|NCT02962102|75993772|FG000|COMPLETED|Overall Study||51||
59869585|NCT02962102|75993773|FG001|COMPLETED|Overall Study||50||
59869586|NCT02962102|75993774|FG002|COMPLETED|Overall Study||49||
59869587|NCT02962102|75993772|FG000|NOT COMPLETED|Overall Study||0||
59869588|NCT02962102|75993773|FG001|NOT COMPLETED|Overall Study||0||
59869589|NCT02962102|75993774|FG002|NOT COMPLETED|Overall Study||0||
59869590|NCT00096993|75993784|FG000|STARTED|Overall Study||66||
59869591|NCT00096993|75993785|FG001|STARTED|Overall Study||65||
59869592|NCT00096993|75993784|FG000|COMPLETED|Overall Study||1||
59869593|NCT00096993|75993785|FG001|COMPLETED|Overall Study||0||
59869594|NCT00096993|75993784|FG000|NOT COMPLETED|Overall Study||65||
59869595|NCT00096993|75993785|FG001|NOT COMPLETED|Overall Study||65||
59869596|NCT03040336|75993793|FG000|STARTED|Overall Study||10||
59869597|NCT03040336|75993794|FG001|STARTED|Overall Study||7||
59869598|NCT03040336|75993793|FG000|COMPLETED|Overall Study||7||
59869599|NCT03040336|75993794|FG001|COMPLETED|Overall Study||4||
59869600|NCT03040336|75993793|FG000|NOT COMPLETED|Overall Study||3||
59869601|NCT03040336|75993794|FG001|NOT COMPLETED|Overall Study||3||
59869602|NCT00072189|75993801|FG000|STARTED|Overall Study||17||
59869603|NCT00072189|75993801|FG000|COMPLETED|Overall Study||16||
59869604|NCT00072189|75993801|FG000|NOT COMPLETED|Overall Study||1||
59869605|NCT03040024|75993808|FG000|STARTED|Overall Study||21||
59869606|NCT03040024|75993809|FG001|STARTED|Overall Study||26||
59869607|NCT03040024|75993810|FG002|STARTED|Overall Study||24||
59869608|NCT03040024|75993808|FG000|COMPLETED|Overall Study||21||
59869609|NCT03040024|75993809|FG001|COMPLETED|Overall Study||24||
59869610|NCT03040024|75993810|FG002|COMPLETED|Overall Study||23||
59869611|NCT03040024|75993808|FG000|NOT COMPLETED|Overall Study||0||
59869612|NCT03040024|75993809|FG001|NOT COMPLETED|Overall Study||2||
59869613|NCT03040024|75993810|FG002|NOT COMPLETED|Overall Study||1||
59869614|NCT03039790|75993838|FG000|STARTED|Overall Study||25||
59869615|NCT03039790|75993839|FG001|STARTED|Overall Study||19||
59869616|NCT03039790|75993840|FG002|STARTED|Overall Study||27||
59869617|NCT03039790|75993841|FG003|STARTED|Overall Study||27||
59869618|NCT03039790|75993842|FG004|STARTED|Overall Study||23||
59869619|NCT03039790|75993843|FG005|STARTED|Overall Study||27||
59869620|NCT03039790|75993844|FG006|STARTED|Overall Study||25||
59869621|NCT03039790|75993845|FG007|STARTED|Overall Study||28||
59869622|NCT03039790|75993846|FG008|STARTED|Overall Study||22||
59869623|NCT03039790|75993847|FG009|STARTED|Overall Study||28||
59869624|NCT03039790|75993848|FG010|STARTED|Overall Study||21||
59869625|NCT03039790|75993849|FG011|STARTED|Overall Study||25||
59869626|NCT03039790|75993850|FG012|STARTED|Overall Study||24||
59869627|NCT03039790|75993851|FG013|STARTED|Overall Study||24||
59869628|NCT03039790|75993852|FG014|STARTED|Overall Study||24||
59869629|NCT03039790|75993853|FG015|STARTED|Overall Study||29||
59869630|NCT03039790|75993854|FG016|STARTED|Overall Study||39||
59869631|NCT03039790|75993855|FG017|STARTED|Overall Study||14||
59869632|NCT03039790|75993856|FG018|STARTED|Overall Study||35||
59869633|NCT03039790|75993857|FG019|STARTED|Overall Study||42||
59869634|NCT03039790|75993838|FG000|Per Protocol Set (PPS)|Overall Study||25|PPS included all participants in the FAS who had no major or critical protocol violations that potentially confound the primary endpoint.|
59869635|NCT03039790|75993839|FG001|Per Protocol Set (PPS)|Overall Study||19|PPS included all participants in the FAS who had no major or critical protocol violations that potentially confound the primary endpoint.|
59869636|NCT03039790|75993840|FG002|Per Protocol Set (PPS)|Overall Study||27|PPS included all participants in the FAS who had no major or critical protocol violations that potentially confound the primary endpoint.|
59869637|NCT03039790|75993841|FG003|Per Protocol Set (PPS)|Overall Study||26|PPS included all participants in the FAS who had no major or critical protocol violations that potentially confound the primary endpoint.|
59869638|NCT03039790|75993842|FG004|Per Protocol Set (PPS)|Overall Study||23|PPS included all participants in the FAS who had no major or critical protocol violations that potentially confound the primary endpoint.|
59869639|NCT03039790|75993843|FG005|Per Protocol Set (PPS)|Overall Study||27|PPS included all participants in the FAS who had no major or critical protocol violations that potentially confound the primary endpoint.|
59869640|NCT03039790|75993844|FG006|Per Protocol Set (PPS)|Overall Study||25|PPS included all participants in the FAS who had no major or critical protocol violations that potentially confound the primary endpoint.|
59951245|NCT03743415|76070176|FG001|COMPLETED|Overall Study||41||
59869641|NCT03039790|75993845|FG007|Per Protocol Set (PPS)|Overall Study||28|PPS included all participants in the FAS who had no major or critical protocol violations that potentially confound the primary endpoint.|
59869642|NCT03039790|75993846|FG008|Per Protocol Set (PPS)|Overall Study||22|PPS included all participants in the FAS who had no major or critical protocol violations that potentially confound the primary endpoint.|
59869643|NCT03039790|75993847|FG009|Per Protocol Set (PPS)|Overall Study||28|PPS included all participants in the FAS who had no major or critical protocol violations that potentially confound the primary endpoint.|
59869644|NCT03039790|75993848|FG010|Per Protocol Set (PPS)|Overall Study||19|PPS included all participants in the FAS who had no major or critical protocol violations that potentially confound the primary endpoint.|
59869645|NCT03039790|75993849|FG011|Per Protocol Set (PPS)|Overall Study||25|PPS included all participants in the FAS who had no major or critical protocol violations that potentially confound the primary endpoint.|
59869646|NCT03039790|75993850|FG012|Per Protocol Set (PPS)|Overall Study||24|PPS included all participants in the FAS who had no major or critical protocol violations that potentially confound the primary endpoint.|
59869647|NCT03039790|75993851|FG013|Per Protocol Set (PPS)|Overall Study||24|PPS included all participants in the FAS who had no major or critical protocol violations that potentially confound the primary endpoint.|
59869648|NCT03039790|75993852|FG014|Per Protocol Set (PPS)|Overall Study||24|PPS included all participants in the FAS who had no major or critical protocol violations that potentially confound the primary endpoint.|
59869649|NCT03039790|75993853|FG015|Per Protocol Set (PPS)|Overall Study||29|PPS included all participants in the FAS who had no major or critical protocol violations that potentially confound the primary endpoint.|
59869650|NCT03039790|75993854|FG016|Per Protocol Set (PPS)|Overall Study||39|PPS included all participants in the FAS who had no major or critical protocol violations that potentially confound the primary endpoint.|
59869651|NCT03039790|75993855|FG017|Per Protocol Set (PPS)|Overall Study||14|PPS included all participants in the FAS who had no major or critical protocol violations that potentially confound the primary endpoint.|
59869652|NCT03039790|75993856|FG018|Per Protocol Set (PPS)|Overall Study||35|PPS included all participants in the FAS who had no major or critical protocol violations that potentially confound the primary endpoint.|
59869653|NCT03039790|75993857|FG019|Per Protocol Set (PPS)|Overall Study||42|PPS included all participants in the FAS who had no major or critical protocol violations that potentially confound the primary endpoint.|
59869654|NCT03039790|75993838|FG000|COMPLETED|Overall Study||21||
59869655|NCT03039790|75993839|FG001|COMPLETED|Overall Study||19||
59869656|NCT03039790|75993840|FG002|COMPLETED|Overall Study||26||
59869657|NCT03039790|75993841|FG003|COMPLETED|Overall Study||25||
59869658|NCT03039790|75993842|FG004|COMPLETED|Overall Study||23||
59869659|NCT03039790|75993843|FG005|COMPLETED|Overall Study||26||
59869660|NCT03039790|75993844|FG006|COMPLETED|Overall Study||24||
59869661|NCT03039790|75993845|FG007|COMPLETED|Overall Study||27||
59869662|NCT03039790|75993846|FG008|COMPLETED|Overall Study||22||
59869663|NCT03039790|75993847|FG009|COMPLETED|Overall Study||26||
59869664|NCT03039790|75993848|FG010|COMPLETED|Overall Study||20||
59869665|NCT03039790|75993849|FG011|COMPLETED|Overall Study||25||
59869666|NCT03039790|75993850|FG012|COMPLETED|Overall Study||21||
59869667|NCT03039790|75993851|FG013|COMPLETED|Overall Study||24||
59869668|NCT03039790|75993852|FG014|COMPLETED|Overall Study||20||
59869669|NCT03039790|75993853|FG015|COMPLETED|Overall Study||22||
59869670|NCT03039790|75993854|FG016|COMPLETED|Overall Study||29||
59869671|NCT03039790|75993855|FG017|COMPLETED|Overall Study||12||
59869672|NCT03039790|75993856|FG018|COMPLETED|Overall Study||29||
59869673|NCT03039790|75993857|FG019|COMPLETED|Overall Study||34||
59869674|NCT03039790|75993838|FG000|NOT COMPLETED|Overall Study||4||
59869675|NCT03039790|75993839|FG001|NOT COMPLETED|Overall Study||0||
59869676|NCT03039790|75993840|FG002|NOT COMPLETED|Overall Study||1||
59869677|NCT03039790|75993841|FG003|NOT COMPLETED|Overall Study||2||
59869678|NCT03039790|75993842|FG004|NOT COMPLETED|Overall Study||0||
59869679|NCT03039790|75993843|FG005|NOT COMPLETED|Overall Study||1||
59869680|NCT03039790|75993844|FG006|NOT COMPLETED|Overall Study||1||
59869681|NCT03039790|75993845|FG007|NOT COMPLETED|Overall Study||1||
59869682|NCT03039790|75993846|FG008|NOT COMPLETED|Overall Study||0||
59869683|NCT03039790|75993847|FG009|NOT COMPLETED|Overall Study||2||
59869684|NCT03039790|75993848|FG010|NOT COMPLETED|Overall Study||1||
59869685|NCT03039790|75993849|FG011|NOT COMPLETED|Overall Study||0||
59869686|NCT03039790|75993850|FG012|NOT COMPLETED|Overall Study||3||
59869687|NCT03039790|75993851|FG013|NOT COMPLETED|Overall Study||0||
59869688|NCT03039790|75993852|FG014|NOT COMPLETED|Overall Study||4||
59869689|NCT03039790|75993853|FG015|NOT COMPLETED|Overall Study||7||
59869690|NCT03039790|75993854|FG016|NOT COMPLETED|Overall Study||10||
59869691|NCT03039790|75993855|FG017|NOT COMPLETED|Overall Study||2||
59869692|NCT03039790|75993856|FG018|NOT COMPLETED|Overall Study||6||
59869693|NCT03039790|75993857|FG019|NOT COMPLETED|Overall Study||8||
59869694|NCT05264116|75993922|FG000|STARTED|Overall Study||12||
59869695|NCT05264116|75993922|FG000|COMPLETED|Overall Study||12||
59869696|NCT05264116|75993922|FG000|NOT COMPLETED|Overall Study||0||
59869697|NCT03038620|75993930|FG000|STARTED|Overall Study||92||
59869698|NCT03038620|75993931|FG001|STARTED|Overall Study||93||
59869699|NCT03038620|75993930|FG000|COMPLETED|Overall Study||73||
59869700|NCT03038620|75993931|FG001|COMPLETED|Overall Study||55||
59869701|NCT03038620|75993930|FG000|NOT COMPLETED|Overall Study||19||
59869702|NCT03038620|75993931|FG001|NOT COMPLETED|Overall Study||38||
59869703|NCT02032810|75993939|FG000|STARTED|Overall Study||6||
59869704|NCT02032810|75993940|FG001|STARTED|Overall Study||11||
59869705|NCT02032810|75993939|FG000|COMPLETED|Overall Study||6||
59869706|NCT02032810|75993940|FG001|COMPLETED|Overall Study||11||
59869707|NCT02032810|75993939|FG000|NOT COMPLETED|Overall Study||0||
59869708|NCT02032810|75993940|FG001|NOT COMPLETED|Overall Study||0||
59869709|NCT01350934|75993952|FG000|STARTED|Base Study||111||
59869710|NCT01350934|75993953|FG001|STARTED|Base Study||108||
59869711|NCT01350934|75993952|FG000|COMPLETED|Base Study||100||
59869712|NCT01350934|75993953|FG001|COMPLETED|Base Study||105||
59869713|NCT01350934|75993952|FG000|NOT COMPLETED|Base Study||11||
59869714|NCT01350934|75993953|FG001|NOT COMPLETED|Base Study||3||
59869715|NCT01350934|75993952|FG000|STARTED|Extension Study||100||
59869716|NCT01350934|75993953|FG001|STARTED|Extension Study||105||
59869717|NCT01350934|75993952|FG000|COMPLETED|Extension Study||95||
59869718|NCT01350934|75993953|FG001|COMPLETED|Extension Study||101||
59869719|NCT01350934|75993952|FG000|NOT COMPLETED|Extension Study||5||
59869720|NCT01350934|75993953|FG001|NOT COMPLETED|Extension Study||4||
59869721|NCT01146418|75993961|FG000|STARTED|Base Study P06029 (NCT01144416)||694||
59869722|NCT01146418|75993962|FG001|STARTED|Base Study P06029 (NCT01144416)||696||
59869723|NCT01146418|75993963|FG002|STARTED|Base Study P06029 (NCT01144416)||0||
59869724|NCT01146418|75993964|FG003|STARTED|Base Study P06029 (NCT01144416)||0||
59869725|NCT01146418|75993961|FG000|COMPLETED|Base Study P06029 (NCT01144416)|Participants who underwent ET in base study|632||
59869726|NCT01146418|75993962|FG001|COMPLETED|Base Study P06029 (NCT01144416)|Participants who underwent ET in base study|647||
59869727|NCT01146418|75993963|FG002|COMPLETED|Base Study P06029 (NCT01144416)||0||
59869728|NCT01146418|75993964|FG003|COMPLETED|Base Study P06029 (NCT01144416)||0||
59869729|NCT01146418|75993961|FG000|NOT COMPLETED|Base Study P06029 (NCT01144416)||62||
59869730|NCT01146418|75993962|FG001|NOT COMPLETED|Base Study P06029 (NCT01144416)||49||
59869731|NCT01146418|75993963|FG002|NOT COMPLETED|Base Study P06029 (NCT01144416)||0||
59869732|NCT01146418|75993964|FG003|NOT COMPLETED|Base Study P06029 (NCT01144416)||0||
59869733|NCT01146418|75993961|FG000|STARTED|Women/Expectant Mother Follow Up|Participants from Base Study P06029 with at least one embryo thawed for use in FTET cycle.|157||
59869734|NCT01146418|75993962|FG001|STARTED|Women/Expectant Mother Follow Up|Participants from base study P06029 with at least one embryo thawed for use in FTET cycle.|150||
59869735|NCT01146418|75993963|FG002|STARTED|Women/Expectant Mother Follow Up||0||
59869736|NCT01146418|75993964|FG003|STARTED|Women/Expectant Mother Follow Up||0||
59869737|NCT01146418|75993961|FG000|Participants With Embryo Transfer (ET)|Women/Expectant Mother Follow Up||151||
59869738|NCT01146418|75993962|FG001|Participants With Embryo Transfer (ET)|Women/Expectant Mother Follow Up||147||
59869739|NCT01146418|75993963|FG002|Participants With Embryo Transfer (ET)|Women/Expectant Mother Follow Up||0||
59869740|NCT01146418|75993964|FG003|Participants With Embryo Transfer (ET)|Women/Expectant Mother Follow Up||0||
59869741|NCT01146418|75993961|FG000|Participants With an Ongoing Pregnancy|Women/Expectant Mother Follow Up|Ongoing pregnancy defined as intra-uterine pregnancy with fetal heart beat on USS 10 weeks after ET|52||
59869742|NCT01146418|75993962|FG001|Participants With an Ongoing Pregnancy|Women/Expectant Mother Follow Up|Ongoing pregnancy defined as intra-uterine pregnancy with fetal heart beat on USS 10 weeks after ET|50||
59869743|NCT01146418|75993963|FG002|Participants With an Ongoing Pregnancy|Women/Expectant Mother Follow Up||0||
59869744|NCT01146418|75993964|FG003|Participants With an Ongoing Pregnancy|Women/Expectant Mother Follow Up||0||
59869745|NCT01146418|75993961|FG000|COMPLETED|Women/Expectant Mother Follow Up|Participants with ET transfer who completed follow-up study|113||
59869746|NCT01146418|75993962|FG001|COMPLETED|Women/Expectant Mother Follow Up|Participants with ET transfer who completed follow-up study|110||
59869747|NCT01146418|75993963|FG002|COMPLETED|Women/Expectant Mother Follow Up||0||
59869748|NCT01146418|75993964|FG003|COMPLETED|Women/Expectant Mother Follow Up||0||
59869749|NCT01146418|75993961|FG000|NOT COMPLETED|Women/Expectant Mother Follow Up||44||
59869750|NCT01146418|75993962|FG001|NOT COMPLETED|Women/Expectant Mother Follow Up||40||
59869751|NCT01146418|75993963|FG002|NOT COMPLETED|Women/Expectant Mother Follow Up||0||
59869752|NCT01146418|75993964|FG003|NOT COMPLETED|Women/Expectant Mother Follow Up||0||
59869753|NCT01146418|75993961|FG000|STARTED|Live-Born Infant Follow Up||0||
59869754|NCT01146418|75993962|FG001|STARTED|Live-Born Infant Follow Up||0||
59869755|NCT01146418|75993963|FG002|STARTED|Live-Born Infant Follow Up||61||
59869756|NCT01146418|75993964|FG003|STARTED|Live-Born Infant Follow Up||56||
59869757|NCT01146418|75993961|FG000|COMPLETED|Live-Born Infant Follow Up||0||
59869758|NCT01146418|75993962|FG001|COMPLETED|Live-Born Infant Follow Up||0||
59869759|NCT01146418|75993963|FG002|COMPLETED|Live-Born Infant Follow Up|Infants who completed follow up|55||
59869760|NCT01146418|75993964|FG003|COMPLETED|Live-Born Infant Follow Up|Infants who completed follow up|51||
59869761|NCT01146418|75993961|FG000|NOT COMPLETED|Live-Born Infant Follow Up||0||
59869762|NCT01146418|75993962|FG001|NOT COMPLETED|Live-Born Infant Follow Up||0||
59869763|NCT01146418|75993963|FG002|NOT COMPLETED|Live-Born Infant Follow Up||6||
59869764|NCT01146418|75993964|FG003|NOT COMPLETED|Live-Born Infant Follow Up||5||
59869765|NCT03622580|75993977|FG000|STARTED|Overall Study||315|Intent-to-Treat (ITT) Population|
59869766|NCT03622580|75993978|FG001|STARTED|Overall Study||313|Intent-to-Treat (ITT) Population|
59869767|NCT03622580|75993979|FG002|STARTED|Overall Study||312|Intent-to-Treat (ITT) Population|
59869768|NCT03622580|75993977|FG000|Received at Least One Dose of Study Drug|Overall Study||313|Safety-Evaluable Population|
59869769|NCT03622580|75993978|FG001|Received at Least One Dose of Study Drug|Overall Study||313|Safety-Evaluable Population|
59869770|NCT03622580|75993979|FG002|Received at Least One Dose of Study Drug|Overall Study||311|Safety-Evaluable Population|
59869771|NCT03622580|75993977|FG000|Completed up to Week 56|Overall Study||291|Primary Completion Date Cutoff|
59869772|NCT03622580|75993978|FG001|Completed up to Week 56|Overall Study||289|Primary Completion Date Cutoff|
59869773|NCT03622580|75993979|FG002|Completed up to Week 56|Overall Study||292|Primary Completion Date Cutoff|
59869774|NCT03622580|75993977|FG000|COMPLETED|Overall Study||263||
59869775|NCT03622580|75993978|FG001|COMPLETED|Overall Study||269||
59869776|NCT03622580|75993979|FG002|COMPLETED|Overall Study||260||
59869777|NCT03622580|75993977|FG000|NOT COMPLETED|Overall Study||52||
59869778|NCT03622580|75993978|FG001|NOT COMPLETED|Overall Study||44||
59869779|NCT03622580|75993979|FG002|NOT COMPLETED|Overall Study||52||
59869780|NCT00461032|75993990|FG000|STARTED|Overall Study||582||
59869781|NCT00461032|75993991|FG001|STARTED|Overall Study||580||
59869782|NCT00461032|75993990|FG000|COMPLETED|Overall Study||545||
59869783|NCT00461032|75993991|FG001|COMPLETED|Overall Study||536||
59869784|NCT00461032|75993990|FG000|NOT COMPLETED|Overall Study||37||
59869785|NCT00461032|75993991|FG001|NOT COMPLETED|Overall Study||44||
59869786|NCT00090142|75993997|FG000|STARTED|Treatment Period I|1 patient was lost to follow-up after randomization and did not receive any study drug.|31||
59869787|NCT00090142|75993998|FG001|STARTED|Treatment Period I||31||
59869788|NCT00090142|75993997|FG000|COMPLETED|Treatment Period I||26||
59869789|NCT00090142|75993998|FG001|COMPLETED|Treatment Period I||28||
59869790|NCT00090142|75993997|FG000|NOT COMPLETED|Treatment Period I||5||
59869791|NCT00090142|75993998|FG001|NOT COMPLETED|Treatment Period I||3||
59869792|NCT00090142|75993997|FG000|STARTED|Treatment Period II||26||
59869793|NCT00090142|75993998|FG001|STARTED|Treatment Period II||28||
59869794|NCT00090142|75993997|FG000|COMPLETED|Treatment Period II||25||
59869795|NCT00090142|75993998|FG001|COMPLETED|Treatment Period II||28||
59869796|NCT00090142|75993997|FG000|NOT COMPLETED|Treatment Period II||1||
59869797|NCT00090142|75993998|FG001|NOT COMPLETED|Treatment Period II||0||
59869798|NCT00043108|75994004|FG000|STARTED|Overall Study||19||
59869799|NCT00043108|75994004|FG000|COMPLETED|Overall Study||19||
59869800|NCT00043108|75994004|FG000|NOT COMPLETED|Overall Study||0||
59869801|NCT03622112|75994015|FG000|STARTED|Overall Study||110|One patient in the AZD7594 50 μg treatment arm did not receive any treatment and was randomised in error (protocol deviation).|
59869802|NCT03622112|75994016|FG001|STARTED|Overall Study||112|One patient in the AZD7594 50 μg treatment arm did not receive any treatment and was randomised in error (protocol deviation).|
59869803|NCT03622112|75994017|FG002|STARTED|Overall Study||111|One patient in the AZD7594 50 μg treatment arm did not receive any treatment and was randomised in error (protocol deviation).|
59869804|NCT03622112|75994018|FG003|STARTED|Overall Study||113|One patient in the AZD7594 50 μg treatment arm did not receive any treatment and was randomised in error (protocol deviation).|
59869805|NCT03622112|75994019|FG004|STARTED|Overall Study||134|One patient in the AZD7594 50 μg treatment arm did not receive any treatment and was randomised in error (protocol deviation).|
59869806|NCT03622112|75994020|FG005|STARTED|Overall Study||113|One patient in the AZD7594 50 μg treatment arm did not receive any treatment and was randomised in error (protocol deviation).|
59869807|NCT03622112|75994021|FG006|STARTED|Overall Study||112|One patient in the AZD7594 50 μg treatment arm did not receive any treatment and was randomised in error (protocol deviation).|
59869808|NCT03622112|75994015|FG000|COMPLETED|Overall Study||85||
59869809|NCT03622112|75994016|FG001|COMPLETED|Overall Study||92||
59869810|NCT03622112|75994017|FG002|COMPLETED|Overall Study||95||
59869811|NCT03622112|75994018|FG003|COMPLETED|Overall Study||91||
59869812|NCT03622112|75994019|FG004|COMPLETED|Overall Study||124||
59869813|NCT03622112|75994020|FG005|COMPLETED|Overall Study||71||
59869814|NCT03622112|75994021|FG006|COMPLETED|Overall Study||103||
59869815|NCT03622112|75994015|FG000|NOT COMPLETED|Overall Study||25||
59869816|NCT03622112|75994016|FG001|NOT COMPLETED|Overall Study||20||
59869817|NCT03622112|75994017|FG002|NOT COMPLETED|Overall Study||16||
59869818|NCT03622112|75994018|FG003|NOT COMPLETED|Overall Study||22||
59869819|NCT03622112|75994019|FG004|NOT COMPLETED|Overall Study||10||
59869820|NCT03622112|75994020|FG005|NOT COMPLETED|Overall Study||42||
59869821|NCT03622112|75994021|FG006|NOT COMPLETED|Overall Study||9||
59869822|NCT04032158|75994039|FG000|STARTED|Overall Study||2||
59869823|NCT04032158|75994040|FG001|STARTED|Overall Study||1||
59869824|NCT04032158|75994039|FG000|COMPLETED|Overall Study||0||
59869825|NCT04032158|75994040|FG001|COMPLETED|Overall Study||0||
59869826|NCT04032158|75994039|FG000|NOT COMPLETED|Overall Study||2||
59869827|NCT04032158|75994040|FG001|NOT COMPLETED|Overall Study||1||
59869828|NCT03620708|75994049|FG000|STARTED|Overall Study||19||
59869829|NCT03620708|75994050|FG001|STARTED|Overall Study||19||
59869830|NCT03620708|75994051|FG002|STARTED|Overall Study||20||
59869831|NCT03620708|75994049|FG000|COMPLETED|Overall Study||18||
59869832|NCT03620708|75994050|FG001|COMPLETED|Overall Study||18||
59869833|NCT03620708|75994051|FG002|COMPLETED|Overall Study||17||
59869834|NCT03620708|75994049|FG000|NOT COMPLETED|Overall Study||1||
59869835|NCT03620708|75994050|FG001|NOT COMPLETED|Overall Study||1||
59869836|NCT03620708|75994051|FG002|NOT COMPLETED|Overall Study||3||
59869837|NCT03654326|75994061|FG000|STARTED|Overall Study||94||
59869838|NCT03654326|75994062|FG001|STARTED|Overall Study||93||
59869839|NCT03654326|75994061|FG000|COMPLETED|Overall Study||88||
59869840|NCT03654326|75994062|FG001|COMPLETED|Overall Study||87||
59869841|NCT03654326|75994061|FG000|NOT COMPLETED|Overall Study||6||
59869842|NCT03654326|75994062|FG001|NOT COMPLETED|Overall Study||6||
59869843|NCT04025684|75994072|FG000|STARTED|Overall Study||20||
59869844|NCT04025684|75994073|FG001|STARTED|Overall Study||19||
59869845|NCT04025684|75994074|FG002|STARTED|Overall Study||20||
59869846|NCT04025684|75994075|FG003|STARTED|Overall Study||21||
59869847|NCT04025684|75994072|FG000|COMPLETED|Overall Study||18||
59869848|NCT04025684|75994073|FG001|COMPLETED|Overall Study||15||
59869849|NCT04025684|75994074|FG002|COMPLETED|Overall Study||20||
59869850|NCT04025684|75994075|FG003|COMPLETED|Overall Study||20||
59869851|NCT04025684|75994072|FG000|NOT COMPLETED|Overall Study||2||
59869852|NCT04025684|75994073|FG001|NOT COMPLETED|Overall Study||4||
59869853|NCT04025684|75994074|FG002|NOT COMPLETED|Overall Study||0||
59869854|NCT04025684|75994075|FG003|NOT COMPLETED|Overall Study||1||
59869855|NCT03617588|75994087|FG000|STARTED|Overall Study||20||
59869856|NCT03617588|75994088|FG001|STARTED|Overall Study||29||
59869857|NCT03617588|75994087|FG000|COMPLETED|Overall Study||19||
59869858|NCT03617588|75994088|FG001|COMPLETED|Overall Study||29||
59869859|NCT03617588|75994087|FG000|NOT COMPLETED|Overall Study||1||
59869860|NCT03617588|75994088|FG001|NOT COMPLETED|Overall Study||0||
59869861|NCT03616106|75994100|FG000|STARTED|Overall Study||56||
59869862|NCT03616106|75994101|FG001|STARTED|Overall Study||3||
59869863|NCT03616106|75994100|FG000|COMPLETED|Overall Study||42||
59869864|NCT03616106|75994101|FG001|COMPLETED|Overall Study||2||
59869865|NCT03616106|75994100|FG000|NOT COMPLETED|Overall Study||14||
59869866|NCT03616106|75994101|FG001|NOT COMPLETED|Overall Study||1||
59869867|NCT04019054|75994108|FG000|STARTED|Overall Study||11||
59869868|NCT04019054|75994109|FG001|STARTED|Overall Study||11||
59869869|NCT04019054|75994108|FG000|COMPLETED|Overall Study||8||
59869870|NCT04019054|75994109|FG001|COMPLETED|Overall Study||9||
59869871|NCT04019054|75994108|FG000|NOT COMPLETED|Overall Study||3||
59869872|NCT04019054|75994109|FG001|NOT COMPLETED|Overall Study||2||
59869873|NCT00071799|75994117|FG000|STARTED|Overall Study||179||
59869874|NCT00071799|75994118|FG001|STARTED|Overall Study|Best supportive care: 105, Low-dose cytarabine: 49, Standard chemotherapy: 25 patients|179||
59869875|NCT00071799|75994117|FG000|COMPLETED|Overall Study|Includes those who died or transformed to AML, or receiving drug + eligible for extension period.|109||
59869876|NCT00071799|75994118|FG001|COMPLETED|Overall Study|Includes patients who died or transformed to AML during treatment, or were still receiving drug.|81||
59869877|NCT00071799|75994117|FG000|NOT COMPLETED|Overall Study||70||
59869878|NCT00071799|75994118|FG001|NOT COMPLETED|Overall Study||98||
59869879|NCT03615482|75994132|FG000|STARTED|Overall Study||600||
59869880|NCT03615482|75994133|FG001|STARTED|Overall Study||600||
59869881|NCT03615482|75994132|FG000|Vaccinated|Overall Study||599||
59869882|NCT03615482|75994133|FG001|Vaccinated|Overall Study||598||
59869883|NCT03615482|75994132|FG000|COMPLETED|Overall Study||583||
59869884|NCT03615482|75994133|FG001|COMPLETED|Overall Study||583||
59869885|NCT03615482|75994132|FG000|NOT COMPLETED|Overall Study||17||
59869886|NCT03615482|75994133|FG001|NOT COMPLETED|Overall Study||17||
59869887|NCT00090363|75994142|FG000|STARTED|Overall Study||107||
59869888|NCT00090363|75994143|FG001|STARTED|Overall Study||107||
59869889|NCT00090363|75994144|FG002|STARTED|Overall Study||98||
59869890|NCT00090363|75994142|FG000|Received Study Treatment.|Overall Study||107||
59869891|NCT00090363|75994143|FG001|Received Study Treatment.|Overall Study||107||
59869892|NCT00090363|75994144|FG002|Received Study Treatment.|Overall Study||98||
59869893|NCT00090363|75994142|FG000|COMPLETED|Overall Study|Number of patients receiving study treatment at data cut-off (18th December 2008).|1||
59869894|NCT00090363|75994143|FG001|COMPLETED|Overall Study|Number of patients receiving study treatment at data cut-off (18th December 2008).|0||
59869895|NCT00090363|75994144|FG002|COMPLETED|Overall Study|Number of patients receiving study treatment at data cut-off (18th December 2008).|2||
59869896|NCT00090363|75994142|FG000|NOT COMPLETED|Overall Study||106||
59869897|NCT00090363|75994143|FG001|NOT COMPLETED|Overall Study||107||
59869898|NCT00090363|75994144|FG002|NOT COMPLETED|Overall Study||96||
59869899|NCT03652610|75994154|FG000|STARTED|Overall Study||490||
59869900|NCT03652610|75994155|FG001|STARTED|Overall Study||489||
59869901|NCT03652610|75994154|FG000|COMPLETED|Overall Study||486||
59869902|NCT03652610|75994155|FG001|COMPLETED|Overall Study||484||
59869903|NCT03652610|75994154|FG000|NOT COMPLETED|Overall Study||4||
59869904|NCT03652610|75994155|FG001|NOT COMPLETED|Overall Study||5||
59869905|NCT03615404|75994161|FG000|STARTED|Overall Study||11||
59869906|NCT03615404|75994161|FG000|COMPLETED|Overall Study||9||
59869907|NCT03615404|75994161|FG000|NOT COMPLETED|Overall Study||2||
59869908|NCT03614156|75994168|FG000|STARTED|Open-Label Treatment Period||363||
59869909|NCT03614156|75994169|FG001|STARTED|Open-Label Treatment Period||0||
59869910|NCT03614156|75994170|FG002|STARTED|Open-Label Treatment Period||0||
59869911|NCT03614156|75994171|FG003|STARTED|Open-Label Treatment Period||0||
59869912|NCT03614156|75994168|FG000|COMPLETED|Open-Label Treatment Period||209||
59869913|NCT03614156|75994169|FG001|COMPLETED|Open-Label Treatment Period||0||
59869914|NCT03614156|75994170|FG002|COMPLETED|Open-Label Treatment Period||0||
59869915|NCT03614156|75994171|FG003|COMPLETED|Open-Label Treatment Period||0||
59869916|NCT03614156|75994168|FG000|NOT COMPLETED|Open-Label Treatment Period||154||
59869917|NCT03614156|75994169|FG001|NOT COMPLETED|Open-Label Treatment Period||0||
59869918|NCT03614156|75994170|FG002|NOT COMPLETED|Open-Label Treatment Period||0||
59869919|NCT03614156|75994171|FG003|NOT COMPLETED|Open-Label Treatment Period||0||
59869920|NCT03614156|75994168|FG000|STARTED|Double-Blind Treatment Period (DBTP)||0||
59869921|NCT03614156|75994169|FG001|STARTED|Double-Blind Treatment Period (DBTP)||40||
59869922|NCT03614156|75994170|FG002|STARTED|Double-Blind Treatment Period (DBTP)||42||
59869923|NCT03614156|75994171|FG003|STARTED|Double-Blind Treatment Period (DBTP)||55||
59869924|NCT03614156|75994168|FG000|COMPLETED|Double-Blind Treatment Period (DBTP)||0||
59869925|NCT03614156|75994169|FG001|COMPLETED|Double-Blind Treatment Period (DBTP)||10||
59869926|NCT03614156|75994170|FG002|COMPLETED|Double-Blind Treatment Period (DBTP)||11||
59869927|NCT03614156|75994171|FG003|COMPLETED|Double-Blind Treatment Period (DBTP)||10||
59869928|NCT03614156|75994168|FG000|NOT COMPLETED|Double-Blind Treatment Period (DBTP)||0||
59869929|NCT03614156|75994169|FG001|NOT COMPLETED|Double-Blind Treatment Period (DBTP)||30||
59869930|NCT03614156|75994170|FG002|NOT COMPLETED|Double-Blind Treatment Period (DBTP)||31||
59869931|NCT03614156|75994171|FG003|NOT COMPLETED|Double-Blind Treatment Period (DBTP)||45||
59869932|NCT03614156|75994168|FG000|STARTED|Safety Follow-Up Period||165||
59869933|NCT03614156|75994169|FG001|STARTED|Safety Follow-Up Period||26||
59869934|NCT03614156|75994170|FG002|STARTED|Safety Follow-Up Period||30||
59869935|NCT03614156|75994171|FG003|STARTED|Safety Follow-Up Period||35||
59869936|NCT03614156|75994168|FG000|COMPLETED|Safety Follow-Up Period||162||
59869937|NCT03614156|75994169|FG001|COMPLETED|Safety Follow-Up Period||26||
59869938|NCT03614156|75994170|FG002|COMPLETED|Safety Follow-Up Period||29||
59869939|NCT03614156|75994171|FG003|COMPLETED|Safety Follow-Up Period||34||
59869940|NCT03614156|75994168|FG000|NOT COMPLETED|Safety Follow-Up Period||3||
59869941|NCT03614156|75994169|FG001|NOT COMPLETED|Safety Follow-Up Period||0||
59869942|NCT03614156|75994170|FG002|NOT COMPLETED|Safety Follow-Up Period||1||
59869943|NCT03614156|75994171|FG003|NOT COMPLETED|Safety Follow-Up Period||1||
59869944|NCT03614078|75994183|FG000|STARTED|Overall Study||31||
59869945|NCT03614078|75994184|FG001|STARTED|Overall Study||30||
59869946|NCT03614078|75994185|FG002|STARTED|Overall Study||31||
59869947|NCT03614078|75994183|FG000|COMPLETED|Overall Study||28||
59869948|NCT03614078|75994184|FG001|COMPLETED|Overall Study||23||
59869949|NCT03614078|75994185|FG002|COMPLETED|Overall Study||26||
59869950|NCT03614078|75994183|FG000|NOT COMPLETED|Overall Study||3||
59869951|NCT03614078|75994184|FG001|NOT COMPLETED|Overall Study||7||
59869952|NCT03614078|75994185|FG002|NOT COMPLETED|Overall Study||5||
59869953|NCT03613454|75994195|FG000|STARTED|Overall Study||24||
59869954|NCT03613454|75994196|FG001|STARTED|Overall Study||24||
59869955|NCT03613454|75994195|FG000|COMPLETED|Overall Study||23||
59869956|NCT03613454|75994196|FG001|COMPLETED|Overall Study||23||
59869957|NCT03613454|75994195|FG000|NOT COMPLETED|Overall Study||1||
59869958|NCT03613454|75994196|FG001|NOT COMPLETED|Overall Study||1||
59869959|NCT03581786|75994204|FG000|STARTED|Overall Study||143||
59869960|NCT03581786|75994205|FG001|STARTED|Overall Study||146||
59869961|NCT03581786|75994204|FG000|COMPLETED|Overall Study||0||
59869962|NCT03581786|75994205|FG001|COMPLETED|Overall Study||0||
59869963|NCT03581786|75994204|FG000|NOT COMPLETED|Overall Study||143||
59869964|NCT03581786|75994205|FG001|NOT COMPLETED|Overall Study||146||
59736655|NCT01041404|75855495|FG001|COMPLETED|Overall Study|Summary of withdrawals represents withdrawals from treatment, rather than withdrawals from study.|0||
59736656|NCT01041404|75855494|FG000|NOT COMPLETED|Overall Study||290||
59736657|NCT01041404|75855495|FG001|NOT COMPLETED|Overall Study||294||
59736658|NCT00777049|75855506|FG000|STARTED|Overall Study||33||
59736659|NCT00777049|75855507|FG001|STARTED|Overall Study||21||
59736660|NCT00777049|75855506|FG000|COMPLETED|Overall Study||32||
59736661|NCT00777049|75855507|FG001|COMPLETED|Overall Study||20||
59736662|NCT00777049|75855506|FG000|NOT COMPLETED|Overall Study||1||
59736663|NCT00777049|75855507|FG001|NOT COMPLETED|Overall Study||1||
59736664|NCT00774787|75855513|FG000|STARTED|Overall Study||27||
59736665|NCT00774787|75855513|FG000|COMPLETED|Overall Study||26||
59736666|NCT00774787|75855513|FG000|NOT COMPLETED|Overall Study||1||
59736667|NCT00888927|75855521|FG000|STARTED|Overall Study||3||
59736668|NCT00888927|75855522|FG001|STARTED|Overall Study||3||
59736669|NCT00888927|75855523|FG002|STARTED|Overall Study||3||
59736670|NCT00888927|75855524|FG003|STARTED|Overall Study||33||
59736671|NCT00888927|75855521|FG000|COMPLETED|Overall Study||3||
59736672|NCT00888927|75855522|FG001|COMPLETED|Overall Study||3||
59736673|NCT00888927|75855523|FG002|COMPLETED|Overall Study||3||
59736674|NCT00888927|75855524|FG003|COMPLETED|Overall Study||31||
59736675|NCT00888927|75855521|FG000|NOT COMPLETED|Overall Study||0||
59736676|NCT00888927|75855522|FG001|NOT COMPLETED|Overall Study||0||
59736677|NCT00888927|75855523|FG002|NOT COMPLETED|Overall Study||0||
59736678|NCT00888927|75855524|FG003|NOT COMPLETED|Overall Study||2||
59736679|NCT01040780|75855536|FG000|STARTED|Overall Study||200||
59736680|NCT01040780|75855537|FG001|STARTED|Overall Study||199||
59736681|NCT01040780|75855536|FG000|COMPLETED|Overall Study||199||
59736682|NCT01040780|75855537|FG001|COMPLETED|Overall Study||196||
59736683|NCT01040780|75855536|FG000|NOT COMPLETED|Overall Study||1||
59736684|NCT01040780|75855537|FG001|NOT COMPLETED|Overall Study||3||
59736685|NCT00888849|75855548|FG000|STARTED|Overall Study||142||
59736686|NCT00888849|75855549|FG001|STARTED|Overall Study||138||
59736687|NCT00888849|75855548|FG000|COMPLETED|Overall Study||137||
59736688|NCT00888849|75855549|FG001|COMPLETED|Overall Study||129||
59869965|NCT03580382|75994213|FG000|STARTED|Overall Study||0||
59869966|NCT03580382|75994214|FG001|STARTED|Overall Study||3||
59869967|NCT03580382|75994213|FG000|COMPLETED|Overall Study||0||
59869968|NCT03580382|75994214|FG001|COMPLETED|Overall Study||0||
59869969|NCT03580382|75994213|FG000|NOT COMPLETED|Overall Study||0||
59869970|NCT03580382|75994214|FG001|NOT COMPLETED|Overall Study||3||
59869971|NCT03579290|75994219|FG000|STARTED|Overall Study||40||
59869972|NCT03579290|75994219|FG000|COMPLETED|Overall Study||31||
59869973|NCT03579290|75994219|FG000|NOT COMPLETED|Overall Study||9||
59869974|NCT03611582|75994225|FG000|STARTED|Overall Study||407||
59869975|NCT03611582|75994226|FG001|STARTED|Overall Study||204||
59869976|NCT03611582|75994225|FG000|Full Analysis Set (FAS)|Overall Study||407||
59869977|NCT03611582|75994226|FG001|Full Analysis Set (FAS)|Overall Study||204||
59869978|NCT03611582|75994225|FG000|Safety Analysis Set (SAS)|Overall Study||407||
59869979|NCT03611582|75994226|FG001|Safety Analysis Set (SAS)|Overall Study||204||
59869980|NCT03611582|75994225|FG000|COMPLETED|Overall Study||339||
59869981|NCT03611582|75994226|FG001|COMPLETED|Overall Study||166||
59869982|NCT03611582|75994225|FG000|NOT COMPLETED|Overall Study||68||
59869983|NCT03611582|75994226|FG001|NOT COMPLETED|Overall Study||38||
59869984|NCT04015518|75994237|FG000|STARTED|Overall Study||43||
59869985|NCT04015518|75994238|FG001|STARTED|Overall Study||22||
59869986|NCT04015518|75994239|FG002|STARTED|Overall Study||21||
59869987|NCT04015518|75994240|FG003|STARTED|Overall Study||22||
59869988|NCT04015518|75994241|FG004|STARTED|Overall Study||44||
59869989|NCT04015518|75994237|FG000|Full Analysis Set (FAS)|Overall Study||43||
59869990|NCT04015518|75994238|FG001|Full Analysis Set (FAS)|Overall Study||22||
59869991|NCT04015518|75994239|FG002|Full Analysis Set (FAS)|Overall Study||21||
59869992|NCT04015518|75994240|FG003|Full Analysis Set (FAS)|Overall Study||22||
59869993|NCT04015518|75994241|FG004|Full Analysis Set (FAS)|Overall Study||44||
59869994|NCT04015518|75994237|FG000|COMPLETED|Overall Study||32||
59869995|NCT04015518|75994238|FG001|COMPLETED|Overall Study||19||
59869996|NCT04015518|75994239|FG002|COMPLETED|Overall Study||18||
59869997|NCT04015518|75994240|FG003|COMPLETED|Overall Study||17||
59869998|NCT04015518|75994241|FG004|COMPLETED|Overall Study||32||
59869999|NCT04015518|75994237|FG000|NOT COMPLETED|Overall Study||11||
59870000|NCT04015518|75994238|FG001|NOT COMPLETED|Overall Study||3||
59870001|NCT04015518|75994239|FG002|NOT COMPLETED|Overall Study||3||
59870002|NCT04015518|75994240|FG003|NOT COMPLETED|Overall Study||5||
59870003|NCT04015518|75994241|FG004|NOT COMPLETED|Overall Study||12||
59870004|NCT03577730|75994258|FG000|STARTED|Overall Study||34|Started is defined as randomized (n=65). Six participants were withdrawn prior to randomization.|
59870005|NCT03577730|75994259|FG001|STARTED|Overall Study||31|Started is defined as randomized (n=65). Six participants were withdrawn prior to randomization.|
59870006|NCT03577730|75994258|FG000|Received Treatment|Overall Study||33||
59870007|NCT03577730|75994259|FG001|Received Treatment|Overall Study||31||
59870008|NCT03577730|75994258|FG000|COMPLETED|Overall Study||30||
59870009|NCT03577730|75994259|FG001|COMPLETED|Overall Study||30||
59870010|NCT03577730|75994258|FG000|NOT COMPLETED|Overall Study||4||
59870011|NCT03577730|75994259|FG001|NOT COMPLETED|Overall Study||1||
59870012|NCT03608774|75994267|FG000|STARTED|Overall Study||89||
59870013|NCT03608774|75994268|FG001|STARTED|Overall Study||88||
59870014|NCT03608774|75994267|FG000|COMPLETED|Overall Study||82||
59870015|NCT03608774|75994268|FG001|COMPLETED|Overall Study||81||
59870016|NCT03608774|75994267|FG000|NOT COMPLETED|Overall Study||7||
59870017|NCT03608774|75994268|FG001|NOT COMPLETED|Overall Study||7||
59870018|NCT04021524|75994276|FG000|STARTED|Overall Study||25||
59870019|NCT04021524|75994277|FG001|STARTED|Overall Study||25||
59870020|NCT04021524|75994276|FG000|COMPLETED|Overall Study||25||
59870021|NCT04021524|75994277|FG001|COMPLETED|Overall Study||24||
59870022|NCT04021524|75994276|FG000|NOT COMPLETED|Overall Study||0||
59870023|NCT04021524|75994277|FG001|NOT COMPLETED|Overall Study||1||
59870024|NCT03607682|75994283|FG000|STARTED|Overall Study||2||
59870025|NCT03607682|75994283|FG000|COMPLETED|Overall Study||0||
59870026|NCT03607682|75994283|FG000|NOT COMPLETED|Overall Study||2||
59870027|NCT03606668|75994287|FG000|STARTED|Overall Study||20||
59870028|NCT03606668|75994287|FG000|COMPLETED|Overall Study||18||
59870029|NCT03606668|75994287|FG000|NOT COMPLETED|Overall Study||2||
59870030|NCT03601052|75994291|FG000|STARTED|Overall Study||14||
59870031|NCT03601052|75994291|FG000|COMPLETED|Overall Study||12||
59870032|NCT03601052|75994291|FG000|NOT COMPLETED|Overall Study||2||
59870033|NCT03600740|75994300|FG000|STARTED|Overall Study||1||
59870034|NCT03600740|75994300|FG000|COMPLETED|Overall Study||0||
59870035|NCT03600740|75994300|FG000|NOT COMPLETED|Overall Study||1||
59870036|NCT03600428|75994306|FG000|STARTED|Overall Study||79||
59870037|NCT03600428|75994307|FG001|STARTED|Overall Study||73||
59870038|NCT03600428|75994306|FG000|15-day Follow-up|Overall Study||76||
59870039|NCT03600428|75994307|FG001|15-day Follow-up|Overall Study||70||
59870040|NCT03600428|75994306|FG000|43-day Follow-up|Overall Study||74||
59870041|NCT03600428|75994307|FG001|43-day Follow-up|Overall Study||68||
59870042|NCT03600428|75994306|FG000|COMPLETED|Overall Study||74||
59870043|NCT03600428|75994307|FG001|COMPLETED|Overall Study||68||
59870044|NCT03600428|75994306|FG000|NOT COMPLETED|Overall Study||5||
59870045|NCT03600428|75994307|FG001|NOT COMPLETED|Overall Study||5||
59870046|NCT03575702|75994315|FG000|STARTED|Overall Study||149||
59870047|NCT03575702|75994316|FG001|STARTED|Overall Study||150||
59870048|NCT03575702|75994315|FG000|COMPLETED|Overall Study||143||
59870049|NCT03575702|75994316|FG001|COMPLETED|Overall Study||146||
59870050|NCT03575702|75994315|FG000|NOT COMPLETED|Overall Study||6||
59870051|NCT03575702|75994316|FG001|NOT COMPLETED|Overall Study||4||
59870052|NCT03573908|75994324|FG000|STARTED|Treatment Period||308||
59870053|NCT03573908|75994325|FG001|STARTED|Treatment Period||306||
59870054|NCT03573908|75994326|FG002|STARTED|Treatment Period||0||
59870055|NCT03573908|75994327|FG003|STARTED|Treatment Period||0||
59870056|NCT03573908|75994328|FG004|STARTED|Treatment Period||0||
59870057|NCT03573908|75994324|FG000|COMPLETED|Treatment Period||284|Completed 12-week Treatment Period|
59870058|NCT03573908|75994325|FG001|COMPLETED|Treatment Period||280|Completed 12-week Treatment Period|
59870059|NCT03573908|75994326|FG002|COMPLETED|Treatment Period||0|Completed 12-week Treatment Period|
59870060|NCT03573908|75994327|FG003|COMPLETED|Treatment Period||0|Completed 12-week Treatment Period|
59870061|NCT03573908|75994328|FG004|COMPLETED|Treatment Period||0|Completed 12-week Treatment Period|
59870062|NCT03573908|75994324|FG000|NOT COMPLETED|Treatment Period||24||
59870063|NCT03573908|75994325|FG001|NOT COMPLETED|Treatment Period||26||
59870064|NCT03573908|75994326|FG002|NOT COMPLETED|Treatment Period||0||
59870065|NCT03573908|75994327|FG003|NOT COMPLETED|Treatment Period||0||
59870066|NCT03573908|75994328|FG004|NOT COMPLETED|Treatment Period||0||
59870067|NCT03573908|75994324|FG000|STARTED|Randomized Withdrawal Period||0||
59870068|NCT03573908|75994325|FG001|STARTED|Randomized Withdrawal Period||0||
59870069|NCT03573908|75994326|FG002|STARTED|Randomized Withdrawal Period||280||
59870070|NCT03573908|75994327|FG003|STARTED|Randomized Withdrawal Period||138||
59870071|NCT03573908|75994328|FG004|STARTED|Randomized Withdrawal Period||139||
59870072|NCT03573908|75994324|FG000|COMPLETED|Randomized Withdrawal Period||0||
59870073|NCT03573908|75994325|FG001|COMPLETED|Randomized Withdrawal Period||0||
59870074|NCT03573908|75994326|FG002|COMPLETED|Randomized Withdrawal Period||272||
59870075|NCT03573908|75994327|FG003|COMPLETED|Randomized Withdrawal Period||136||
59870076|NCT03573908|75994328|FG004|COMPLETED|Randomized Withdrawal Period||137||
59870077|NCT03573908|75994324|FG000|NOT COMPLETED|Randomized Withdrawal Period||0||
59870078|NCT03573908|75994325|FG001|NOT COMPLETED|Randomized Withdrawal Period||0||
59870079|NCT03573908|75994326|FG002|NOT COMPLETED|Randomized Withdrawal Period||8||
59870080|NCT03573908|75994327|FG003|NOT COMPLETED|Randomized Withdrawal Period||2||
59870081|NCT03573908|75994328|FG004|NOT COMPLETED|Randomized Withdrawal Period||2||
59870082|NCT03573830|75994339|FG000|STARTED|Overall Study||364||
59870083|NCT03573830|75994340|FG001|STARTED|Overall Study||367||
59870084|NCT03573830|75994339|FG000|Reviewed Assigned Material|Overall Study|All participants assigned to this arm reviewed their assigned material.|364|Whether participants completed their assigned intervention.|
59870085|NCT03573830|75994340|FG001|Reviewed Assigned Material|Overall Study|360 reviewed their assigned material:Transport Canada information plus the enhanced material.|360|Whether participants completed their assigned intervention.|
59870086|NCT03573830|75994339|FG000|COMPLETED|Overall Study||360||
59870087|NCT03573830|75994340|FG001|COMPLETED|Overall Study||360||
59870088|NCT03573830|75994339|FG000|NOT COMPLETED|Overall Study||4||
59870089|NCT03573830|75994340|FG001|NOT COMPLETED|Overall Study||7||
59870090|NCT03595904|75994347|FG000|STARTED|Overall Study||39||
59870091|NCT03595904|75994348|FG001|STARTED|Overall Study||39||
59870092|NCT03595904|75994347|FG000|COMPLETED|Overall Study||29||
59870093|NCT03595904|75994348|FG001|COMPLETED|Overall Study||34||
59870094|NCT03595904|75994347|FG000|NOT COMPLETED|Overall Study||10||
59870095|NCT03595904|75994348|FG001|NOT COMPLETED|Overall Study||5||
59870096|NCT03595280|75994357|FG000|STARTED|Overall Study||119||
59870097|NCT03595280|75994358|FG001|STARTED|Overall Study||117||
59870098|NCT03595280|75994359|FG002|STARTED|Overall Study||113||
59870099|NCT03595280|75994357|FG000|COMPLETED|Overall Study||113||
59870100|NCT03595280|75994358|FG001|COMPLETED|Overall Study||108||
59870101|NCT03595280|75994359|FG002|COMPLETED|Overall Study||98||
59870102|NCT03595280|75994357|FG000|NOT COMPLETED|Overall Study||6||
59870103|NCT03595280|75994358|FG001|NOT COMPLETED|Overall Study||9||
59870104|NCT03595280|75994359|FG002|NOT COMPLETED|Overall Study||15||
59870105|NCT03593876|75994367|FG000|STARTED|Overall Study||16||
59870106|NCT03593876|75994367|FG000|COMPLETED|Overall Study||13||
59870107|NCT03593876|75994367|FG000|NOT COMPLETED|Overall Study||3||
59870108|NCT00071487|75994375|FG000|STARTED|52-Week Double-Blind Period||113||
59870109|NCT00071487|75994376|FG001|STARTED|52-Week Double-Blind Period||114||
59870110|NCT00071487|75994377|FG002|STARTED|52-Week Double-Blind Period||111||
59870111|NCT00071487|75994378|FG003|STARTED|52-Week Double-Blind Period||111||
59870112|NCT00071487|75994375|FG000|COMPLETED|52-Week Double-Blind Period||93||
59870113|NCT00071487|75994376|FG001|COMPLETED|52-Week Double-Blind Period||87||
59870114|NCT00071487|75994377|FG002|COMPLETED|52-Week Double-Blind Period||94||
59870115|NCT00071487|75994378|FG003|COMPLETED|52-Week Double-Blind Period||90||
59870116|NCT00071487|75994375|FG000|NOT COMPLETED|52-Week Double-Blind Period||20||
59870117|NCT00071487|75994376|FG001|NOT COMPLETED|52-Week Double-Blind Period||27||
59870118|NCT00071487|75994377|FG002|NOT COMPLETED|52-Week Double-Blind Period||17||
59870119|NCT00071487|75994378|FG003|NOT COMPLETED|52-Week Double-Blind Period||21||
59870120|NCT00071487|75994375|FG000|STARTED|24-Week Open-Label Extension Period|Of 93: 88 switched to 10 mg/kg; 5 elected not to continue in the open-label extension period.|0||
59870121|NCT00071487|75994376|FG001|STARTED|24-Week Open-Label Extension Period|Of 87: 65 switched to 10 mg/kg; 3 elected not to continue in the open-label extension period.|19||
59870122|NCT00071487|75994377|FG002|STARTED|24-Week Open-Label Extension Period|Of 94: 64 switched to 10 mg/kg; 6 elected not to continue in the open-label extension period.|24||
59870123|NCT00071487|75994378|FG003|STARTED|24-Week Open-Label Extension Period|Of 90: 85 continued with 10 mg/kg; 5 elected not to continue in the open-label extension period.|302||
59870124|NCT00071487|75994375|FG000|COMPLETED|24-Week Open-Label Extension Period||0||
59870125|NCT00071487|75994376|FG001|COMPLETED|24-Week Open-Label Extension Period||19||
59870126|NCT00071487|75994377|FG002|COMPLETED|24-Week Open-Label Extension Period||23||
59870127|NCT00071487|75994378|FG003|COMPLETED|24-Week Open-Label Extension Period||279||
59870128|NCT00071487|75994375|FG000|NOT COMPLETED|24-Week Open-Label Extension Period||0||
59870129|NCT00071487|75994376|FG001|NOT COMPLETED|24-Week Open-Label Extension Period||0||
59870130|NCT00071487|75994377|FG002|NOT COMPLETED|24-Week Open-Label Extension Period||1||
59870131|NCT00071487|75994378|FG003|NOT COMPLETED|24-Week Open-Label Extension Period||23||
59870132|NCT03591146|75994395|FG000|STARTED|TLC590 190mg and Naropin 150mg||12||
59870133|NCT03591146|75994396|FG001|STARTED|TLC590 190mg and Naropin 150mg||0||
59870134|NCT03591146|75994397|FG002|STARTED|TLC590 190mg and Naropin 150mg||0||
59870135|NCT03591146|75994398|FG003|STARTED|TLC590 190mg and Naropin 150mg||0||
59870136|NCT03591146|75994399|FG004|STARTED|TLC590 190mg and Naropin 150mg||4||
59870137|NCT03591146|75994395|FG000|COMPLETED|TLC590 190mg and Naropin 150mg||12||
59870138|NCT03591146|75994396|FG001|COMPLETED|TLC590 190mg and Naropin 150mg||0||
59870139|NCT03591146|75994397|FG002|COMPLETED|TLC590 190mg and Naropin 150mg||0||
59870140|NCT03591146|75994398|FG003|COMPLETED|TLC590 190mg and Naropin 150mg||0||
59870141|NCT03591146|75994399|FG004|COMPLETED|TLC590 190mg and Naropin 150mg||3||
59870142|NCT03591146|75994395|FG000|NOT COMPLETED|TLC590 190mg and Naropin 150mg||0||
59870143|NCT03591146|75994396|FG001|NOT COMPLETED|TLC590 190mg and Naropin 150mg||0||
59870144|NCT03591146|75994397|FG002|NOT COMPLETED|TLC590 190mg and Naropin 150mg||0||
59870145|NCT03591146|75994398|FG003|NOT COMPLETED|TLC590 190mg and Naropin 150mg||0||
59870146|NCT03591146|75994399|FG004|NOT COMPLETED|TLC590 190mg and Naropin 150mg||1||
59870147|NCT03591146|75994395|FG000|STARTED|TLC590 380mg and Naropin 150mg||0||
59870148|NCT03591146|75994396|FG001|STARTED|TLC590 380mg and Naropin 150mg||12||
59870149|NCT03591146|75994397|FG002|STARTED|TLC590 380mg and Naropin 150mg||0||
59870150|NCT03591146|75994398|FG003|STARTED|TLC590 380mg and Naropin 150mg||0||
59870151|NCT03591146|75994399|FG004|STARTED|TLC590 380mg and Naropin 150mg||5||
59870152|NCT03591146|75994395|FG000|COMPLETED|TLC590 380mg and Naropin 150mg||0||
59870153|NCT03591146|75994396|FG001|COMPLETED|TLC590 380mg and Naropin 150mg||11||
59870154|NCT03591146|75994397|FG002|COMPLETED|TLC590 380mg and Naropin 150mg||0||
59870155|NCT03591146|75994398|FG003|COMPLETED|TLC590 380mg and Naropin 150mg||0||
59870156|NCT03591146|75994399|FG004|COMPLETED|TLC590 380mg and Naropin 150mg||4||
59870157|NCT03591146|75994395|FG000|NOT COMPLETED|TLC590 380mg and Naropin 150mg||0||
59870158|NCT03591146|75994396|FG001|NOT COMPLETED|TLC590 380mg and Naropin 150mg||1||
59870159|NCT03591146|75994397|FG002|NOT COMPLETED|TLC590 380mg and Naropin 150mg||0||
59870160|NCT03591146|75994398|FG003|NOT COMPLETED|TLC590 380mg and Naropin 150mg||0||
59870161|NCT03591146|75994399|FG004|NOT COMPLETED|TLC590 380mg and Naropin 150mg||1||
59870162|NCT03591146|75994395|FG000|STARTED|TLC590 570mg and Naropin 150mg||0||
59870163|NCT03591146|75994396|FG001|STARTED|TLC590 570mg and Naropin 150mg||0||
59870164|NCT03591146|75994397|FG002|STARTED|TLC590 570mg and Naropin 150mg||12||
59870165|NCT03591146|75994398|FG003|STARTED|TLC590 570mg and Naropin 150mg||0||
59870166|NCT03591146|75994399|FG004|STARTED|TLC590 570mg and Naropin 150mg||4||
59870167|NCT03591146|75994395|FG000|COMPLETED|TLC590 570mg and Naropin 150mg||0||
59870168|NCT03591146|75994396|FG001|COMPLETED|TLC590 570mg and Naropin 150mg||0||
59870169|NCT03591146|75994397|FG002|COMPLETED|TLC590 570mg and Naropin 150mg||11||
59870170|NCT03591146|75994398|FG003|COMPLETED|TLC590 570mg and Naropin 150mg||0||
59870171|NCT03591146|75994399|FG004|COMPLETED|TLC590 570mg and Naropin 150mg||3||
59870172|NCT03591146|75994395|FG000|NOT COMPLETED|TLC590 570mg and Naropin 150mg||0||
59870173|NCT03591146|75994396|FG001|NOT COMPLETED|TLC590 570mg and Naropin 150mg||0||
59870174|NCT03591146|75994397|FG002|NOT COMPLETED|TLC590 570mg and Naropin 150mg||1||
59870175|NCT03591146|75994398|FG003|NOT COMPLETED|TLC590 570mg and Naropin 150mg||0||
59870176|NCT03591146|75994399|FG004|NOT COMPLETED|TLC590 570mg and Naropin 150mg||1||
59870177|NCT03591146|75994395|FG000|STARTED|TLC590 475mg and Naropin 150mg||0||
59870178|NCT03591146|75994396|FG001|STARTED|TLC590 475mg and Naropin 150mg||0||
59870179|NCT03591146|75994397|FG002|STARTED|TLC590 475mg and Naropin 150mg||0||
59870180|NCT03591146|75994398|FG003|STARTED|TLC590 475mg and Naropin 150mg||12||
59870181|NCT03591146|75994399|FG004|STARTED|TLC590 475mg and Naropin 150mg||4||
59870182|NCT03591146|75994395|FG000|COMPLETED|TLC590 475mg and Naropin 150mg||0||
59870183|NCT03591146|75994396|FG001|COMPLETED|TLC590 475mg and Naropin 150mg||0||
59870184|NCT03591146|75994397|FG002|COMPLETED|TLC590 475mg and Naropin 150mg||0||
59870185|NCT03591146|75994398|FG003|COMPLETED|TLC590 475mg and Naropin 150mg||12||
59870186|NCT03591146|75994399|FG004|COMPLETED|TLC590 475mg and Naropin 150mg||4||
59870187|NCT03591146|75994395|FG000|NOT COMPLETED|TLC590 475mg and Naropin 150mg||0||
59870188|NCT03591146|75994396|FG001|NOT COMPLETED|TLC590 475mg and Naropin 150mg||0||
59870189|NCT03591146|75994397|FG002|NOT COMPLETED|TLC590 475mg and Naropin 150mg||0||
59870190|NCT03591146|75994398|FG003|NOT COMPLETED|TLC590 475mg and Naropin 150mg||0||
59870191|NCT03591146|75994399|FG004|NOT COMPLETED|TLC590 475mg and Naropin 150mg||0||
59870192|NCT00096447|75994411|FG000|STARTED|Overall Study||31||
59870193|NCT00096447|75994411|FG000|COMPLETED|Overall Study|Eligible and treated patients.|30||
59870194|NCT00096447|75994411|FG000|NOT COMPLETED|Overall Study||1||
59870195|NCT03590366|75994422|FG000|STARTED|Overall Study||73||
59870196|NCT03590366|75994423|FG001|STARTED|Overall Study||67||
59870197|NCT03590366|75994422|FG000|COMPLETED|Overall Study||70||
59870198|NCT03590366|75994423|FG001|COMPLETED|Overall Study||59||
59870199|NCT03590366|75994422|FG000|NOT COMPLETED|Overall Study||3||
59870200|NCT03590366|75994423|FG001|NOT COMPLETED|Overall Study||8||
59870201|NCT03588572|75994431|FG000|STARTED|Visitation 1||22||
59870202|NCT03588572|75994432|FG001|STARTED|Visitation 1||21||
59870203|NCT03588572|75994431|FG000|COMPLETED|Visitation 1||21||
59870204|NCT03588572|75994432|FG001|COMPLETED|Visitation 1||20||
59870205|NCT03588572|75994431|FG000|NOT COMPLETED|Visitation 1||1||
59870206|NCT03588572|75994432|FG001|NOT COMPLETED|Visitation 1||1||
59870207|NCT03588572|75994431|FG000|STARTED|Visitation 2||21||
59870208|NCT03588572|75994432|FG001|STARTED|Visitation 2||20||
59870209|NCT03588572|75994431|FG000|COMPLETED|Visitation 2||19||
59870210|NCT03588572|75994432|FG001|COMPLETED|Visitation 2||18||
59870211|NCT03588572|75994431|FG000|NOT COMPLETED|Visitation 2||2||
59870212|NCT03588572|75994432|FG001|NOT COMPLETED|Visitation 2||2||
59870213|NCT03588572|75994431|FG000|STARTED|Visitation 3||19||
59870214|NCT03588572|75994432|FG001|STARTED|Visitation 3||18||
59870215|NCT03588572|75994431|FG000|COMPLETED|Visitation 3||16||
59870216|NCT03588572|75994432|FG001|COMPLETED|Visitation 3||16||
59870217|NCT03588572|75994431|FG000|NOT COMPLETED|Visitation 3||3||
59870218|NCT03588572|75994432|FG001|NOT COMPLETED|Visitation 3||2||
59870219|NCT00090285|75994440|FG000|STARTED|Base Study Vaccination Period||2032||
59870220|NCT00090285|75994441|FG001|STARTED|Base Study Vaccination Period||2033||
59870221|NCT00090285|75994442|FG002|STARTED|Base Study Vaccination Period||0||
59870222|NCT00090285|75994443|FG003|STARTED|Base Study Vaccination Period||0||
59870223|NCT00090285|75994444|FG004|STARTED|Base Study Vaccination Period||0||
59870224|NCT00090285|75994445|FG005|STARTED|Base Study Vaccination Period||0||
59870225|NCT00090285|75994440|FG000|Vaccinated|Base Study Vaccination Period||2025||
59870226|NCT00090285|75994441|FG001|Vaccinated|Base Study Vaccination Period||2030||
59870227|NCT00090285|75994442|FG002|Vaccinated|Base Study Vaccination Period||0||
59870228|NCT00090285|75994443|FG003|Vaccinated|Base Study Vaccination Period||0||
59870229|NCT00090285|75994444|FG004|Vaccinated|Base Study Vaccination Period||0||
59870230|NCT00090285|75994445|FG005|Vaccinated|Base Study Vaccination Period||0||
59870231|NCT00090285|75994440|FG000|COMPLETED|Base Study Vaccination Period||1818||
59870232|NCT00090285|75994441|FG001|COMPLETED|Base Study Vaccination Period||1814||
59870233|NCT00090285|75994442|FG002|COMPLETED|Base Study Vaccination Period||0||
59870234|NCT00090285|75994443|FG003|COMPLETED|Base Study Vaccination Period||0||
59870235|NCT00090285|75994444|FG004|COMPLETED|Base Study Vaccination Period||0||
59870236|NCT00090285|75994445|FG005|COMPLETED|Base Study Vaccination Period||0||
59870237|NCT00090285|75994440|FG000|NOT COMPLETED|Base Study Vaccination Period||214||
59870238|NCT00090285|75994441|FG001|NOT COMPLETED|Base Study Vaccination Period||219||
59870239|NCT00090285|75994442|FG002|NOT COMPLETED|Base Study Vaccination Period||0||
59870240|NCT00090285|75994443|FG003|NOT COMPLETED|Base Study Vaccination Period||0||
59870241|NCT00090285|75994444|FG004|NOT COMPLETED|Base Study Vaccination Period||0||
59870242|NCT00090285|75994445|FG005|NOT COMPLETED|Base Study Vaccination Period||0||
59870243|NCT00090285|75994440|FG000|STARTED|Base Study Follow-up Period|4 subjects who did not receive 3 doses of vaccine in base study continued into the Follow-up Period|1822||
59870244|NCT00090285|75994441|FG001|STARTED|Base Study Follow-up Period|7 subjects who did not receive 3 doses of placebo in base study continued into the Follow-up Period|1821||
59870245|NCT00090285|75994442|FG002|STARTED|Base Study Follow-up Period||0||
59870246|NCT00090285|75994443|FG003|STARTED|Base Study Follow-up Period||0||
59870247|NCT00090285|75994444|FG004|STARTED|Base Study Follow-up Period||0||
59870248|NCT00090285|75994445|FG005|STARTED|Base Study Follow-up Period||0||
59870249|NCT00090285|75994440|FG000|COMPLETED|Base Study Follow-up Period||1487||
59870250|NCT00090285|75994441|FG001|COMPLETED|Base Study Follow-up Period||1479||
59870251|NCT00090285|75994442|FG002|COMPLETED|Base Study Follow-up Period||0||
59870252|NCT00090285|75994443|FG003|COMPLETED|Base Study Follow-up Period||0||
59870253|NCT00090285|75994444|FG004|COMPLETED|Base Study Follow-up Period||0||
59870254|NCT00090285|75994445|FG005|COMPLETED|Base Study Follow-up Period||0||
59870255|NCT00090285|75994440|FG000|NOT COMPLETED|Base Study Follow-up Period||335||
59870256|NCT00090285|75994441|FG001|NOT COMPLETED|Base Study Follow-up Period||342||
59870257|NCT00090285|75994442|FG002|NOT COMPLETED|Base Study Follow-up Period||0||
59870258|NCT00090285|75994443|FG003|NOT COMPLETED|Base Study Follow-up Period||0||
59870259|NCT00090285|75994444|FG004|NOT COMPLETED|Base Study Follow-up Period||0||
59870260|NCT00090285|75994445|FG005|NOT COMPLETED|Base Study Follow-up Period||0||
59870261|NCT00090285|75994440|FG000|STARTED|Extension 1||0||
59870262|NCT00090285|75994441|FG001|STARTED|Extension 1||0||
59870263|NCT00090285|75994442|FG002|STARTED|Extension 1|Participation in EXT1 was voluntary; not all participants eligible for EXT1 enrolled.|1098||
59870264|NCT00090285|75994443|FG003|STARTED|Extension 1|Participation in EXT1 was voluntary; not all participants eligible for EXT1 enrolled.|16||
59870265|NCT00090285|75994444|FG004|STARTED|Extension 1||0||
59870266|NCT00090285|75994445|FG005|STARTED|Extension 1||0||
59870267|NCT00090285|75994440|FG000|COMPLETED|Extension 1||0||
59870268|NCT00090285|75994441|FG001|COMPLETED|Extension 1||0||
59870269|NCT00090285|75994442|FG002|COMPLETED|Extension 1||1041||
59870270|NCT00090285|75994443|FG003|COMPLETED|Extension 1||15||
59870271|NCT00090285|75994444|FG004|COMPLETED|Extension 1||0||
59870272|NCT00090285|75994445|FG005|COMPLETED|Extension 1||0||
59870273|NCT00090285|75994440|FG000|NOT COMPLETED|Extension 1||0||
59870274|NCT00090285|75994441|FG001|NOT COMPLETED|Extension 1||0||
59870275|NCT00090285|75994442|FG002|NOT COMPLETED|Extension 1||57||
59870276|NCT00090285|75994443|FG003|NOT COMPLETED|Extension 1||1||
59870277|NCT00090285|75994444|FG004|NOT COMPLETED|Extension 1||0||
59870278|NCT00090285|75994445|FG005|NOT COMPLETED|Extension 1||0||
59870279|NCT00090285|75994440|FG000|STARTED|Long-term Follow-up (EXT2)||0||
59870280|NCT00090285|75994441|FG001|STARTED|Long-term Follow-up (EXT2)||0||
59870281|NCT00090285|75994442|FG002|STARTED|Long-term Follow-up (EXT2)||0||
59870282|NCT00090285|75994443|FG003|STARTED|Long-term Follow-up (EXT2)||0||
59870283|NCT00090285|75994444|FG004|STARTED|Long-term Follow-up (EXT2)|Not all eligible participants enrolled in LTFU (EXT2)|936||
59870284|NCT00090285|75994445|FG005|STARTED|Long-term Follow-up (EXT2)|Not all eligible participants enrolled in LTFU (EXT2)|867||
59870285|NCT00090285|75994440|FG000|COMPLETED|Long-term Follow-up (EXT2)||0||
59870286|NCT00090285|75994441|FG001|COMPLETED|Long-term Follow-up (EXT2)||0||
59870287|NCT00090285|75994442|FG002|COMPLETED|Long-term Follow-up (EXT2)||0||
59870288|NCT00090285|75994443|FG003|COMPLETED|Long-term Follow-up (EXT2)||0||
59870289|NCT00090285|75994444|FG004|COMPLETED|Long-term Follow-up (EXT2)||709||
59870290|NCT00090285|75994445|FG005|COMPLETED|Long-term Follow-up (EXT2)||664||
59870291|NCT00090285|75994440|FG000|NOT COMPLETED|Long-term Follow-up (EXT2)||0||
59870292|NCT00090285|75994441|FG001|NOT COMPLETED|Long-term Follow-up (EXT2)||0||
59870293|NCT00090285|75994442|FG002|NOT COMPLETED|Long-term Follow-up (EXT2)||0||
59870294|NCT00090285|75994443|FG003|NOT COMPLETED|Long-term Follow-up (EXT2)||0||
59870295|NCT00090285|75994444|FG004|NOT COMPLETED|Long-term Follow-up (EXT2)||227||
59870296|NCT00090285|75994445|FG005|NOT COMPLETED|Long-term Follow-up (EXT2)||203||
59870297|NCT00070941|75994463|FG000|STARTED|Overall Study||12||
59870298|NCT00070941|75994464|FG001|STARTED|Overall Study||11||
59870299|NCT00070941|75994465|FG002|STARTED|Overall Study||6||
59870300|NCT00070941|75994463|FG000|COMPLETED|Overall Study||2||
59870301|NCT00070941|75994464|FG001|COMPLETED|Overall Study||3||
59870302|NCT00070941|75994465|FG002|COMPLETED|Overall Study||2||
59870303|NCT00070941|75994463|FG000|NOT COMPLETED|Overall Study||10||
59870304|NCT00070941|75994464|FG001|NOT COMPLETED|Overall Study||8||
59870305|NCT00070941|75994465|FG002|NOT COMPLETED|Overall Study||4||
59870306|NCT00070707|75994475|FG000|STARTED|Overall Study||113||
59870307|NCT00070707|75994476|FG001|STARTED|Overall Study||75||
59870308|NCT00070707|75994475|FG000|COMPLETED|Overall Study||99||
59870309|NCT00070707|75994476|FG001|COMPLETED|Overall Study||68||
59870310|NCT00070707|75994475|FG000|NOT COMPLETED|Overall Study||14||
59870311|NCT00070707|75994476|FG001|NOT COMPLETED|Overall Study||7||
59870312|NCT03036124|75994484|FG000|STARTED|Overall Study||2373||
59870313|NCT03036124|75994485|FG001|STARTED|Overall Study||2371||
59870314|NCT03036124|75994484|FG000|COMPLETED|Overall Study||2368||
59870315|NCT03036124|75994485|FG001|COMPLETED|Overall Study||2365||
59870316|NCT03036124|75994484|FG000|NOT COMPLETED|Overall Study||5||
59870317|NCT03036124|75994485|FG001|NOT COMPLETED|Overall Study||6||
59870318|NCT00070317|75994491|FG000|STARTED|Overall Study||102||
59870319|NCT00070317|75994491|FG000|COMPLETED|Overall Study||89||
59870320|NCT00070317|75994491|FG000|NOT COMPLETED|Overall Study||13||
59870321|NCT03649412|75994497|FG000|STARTED|Part A, Period 1 (4 Days)||16||
59870322|NCT03649412|75994498|FG001|STARTED|Part A, Period 1 (4 Days)||0||
59870323|NCT03649412|75994497|FG000|COMPLETED|Part A, Period 1 (4 Days)||16||
59870324|NCT03649412|75994498|FG001|COMPLETED|Part A, Period 1 (4 Days)||0||
59870325|NCT03649412|75994497|FG000|NOT COMPLETED|Part A, Period 1 (4 Days)||0||
59870326|NCT03649412|75994498|FG001|NOT COMPLETED|Part A, Period 1 (4 Days)||0||
59870327|NCT03649412|75994497|FG000|STARTED|Part A, Washout Period 1 (7 Days)||16||
59870328|NCT03649412|75994498|FG001|STARTED|Part A, Washout Period 1 (7 Days)||0||
59870329|NCT03649412|75994497|FG000|COMPLETED|Part A, Washout Period 1 (7 Days)||15||
59870330|NCT03649412|75994498|FG001|COMPLETED|Part A, Washout Period 1 (7 Days)||0||
59870331|NCT03649412|75994497|FG000|NOT COMPLETED|Part A, Washout Period 1 (7 Days)||1||
59870332|NCT03649412|75994498|FG001|NOT COMPLETED|Part A, Washout Period 1 (7 Days)||0||
59870333|NCT03649412|75994497|FG000|STARTED|Part A, Period 2 (3 Days)|1 Replacement par. was enrolled & dosed|16||
59870334|NCT03649412|75994498|FG001|STARTED|Part A, Period 2 (3 Days)||0||
59870335|NCT03649412|75994497|FG000|COMPLETED|Part A, Period 2 (3 Days)||16||
59870336|NCT03649412|75994498|FG001|COMPLETED|Part A, Period 2 (3 Days)||0||
59870337|NCT03649412|75994497|FG000|NOT COMPLETED|Part A, Period 2 (3 Days)||0||
59870338|NCT03649412|75994498|FG001|NOT COMPLETED|Part A, Period 2 (3 Days)||0||
59870339|NCT03649412|75994497|FG000|STARTED|Part A, Washout Period 2 (7 Days)||16||
59870340|NCT03649412|75994498|FG001|STARTED|Part A, Washout Period 2 (7 Days)||0||
59870341|NCT03649412|75994497|FG000|COMPLETED|Part A, Washout Period 2 (7 Days)||16||
59870342|NCT03649412|75994498|FG001|COMPLETED|Part A, Washout Period 2 (7 Days)||0||
59870343|NCT03649412|75994497|FG000|NOT COMPLETED|Part A, Washout Period 2 (7 Days)||0||
59870344|NCT03649412|75994498|FG001|NOT COMPLETED|Part A, Washout Period 2 (7 Days)||0||
59870345|NCT03649412|75994497|FG000|STARTED|Part A, Period 3 (4 Days)||16||
59870346|NCT03649412|75994498|FG001|STARTED|Part A, Period 3 (4 Days)||0||
59870347|NCT03649412|75994497|FG000|COMPLETED|Part A, Period 3 (4 Days)||16||
59870348|NCT03649412|75994498|FG001|COMPLETED|Part A, Period 3 (4 Days)||0||
59870349|NCT03649412|75994497|FG000|NOT COMPLETED|Part A, Period 3 (4 Days)||0||
59870350|NCT03649412|75994498|FG001|NOT COMPLETED|Part A, Period 3 (4 Days)||0||
59870351|NCT03649412|75994497|FG000|STARTED|Part A, Washout Period 3 (7 Days)||16||
59870352|NCT03649412|75994498|FG001|STARTED|Part A, Washout Period 3 (7 Days)||0||
59870353|NCT03649412|75994497|FG000|COMPLETED|Part A, Washout Period 3 (7 Days)||16||
59870354|NCT03649412|75994498|FG001|COMPLETED|Part A, Washout Period 3 (7 Days)||0||
59870355|NCT03649412|75994497|FG000|NOT COMPLETED|Part A, Washout Period 3 (7 Days)||0||
59870356|NCT03649412|75994498|FG001|NOT COMPLETED|Part A, Washout Period 3 (7 Days)||0||
59870357|NCT03649412|75994497|FG000|STARTED|Part A, Period 4 (4 Days)||16||
59870358|NCT03649412|75994498|FG001|STARTED|Part A, Period 4 (4 Days)||0||
59870359|NCT03649412|75994497|FG000|COMPLETED|Part A, Period 4 (4 Days)||16||
59870360|NCT03649412|75994498|FG001|COMPLETED|Part A, Period 4 (4 Days)||0||
59870361|NCT03649412|75994497|FG000|NOT COMPLETED|Part A, Period 4 (4 Days)||0||
59870362|NCT03649412|75994498|FG001|NOT COMPLETED|Part A, Period 4 (4 Days)||0||
59870363|NCT03649412|75994497|FG000|STARTED|Part A, Washout Period 4 (7 Days)||16||
59870364|NCT03649412|75994498|FG001|STARTED|Part A, Washout Period 4 (7 Days)||0||
59870365|NCT03649412|75994497|FG000|COMPLETED|Part A, Washout Period 4 (7 Days)||14||
59870366|NCT03649412|75994498|FG001|COMPLETED|Part A, Washout Period 4 (7 Days)||0||
59870367|NCT03649412|75994497|FG000|NOT COMPLETED|Part A, Washout Period 4 (7 Days)||2||
59870368|NCT03649412|75994498|FG001|NOT COMPLETED|Part A, Washout Period 4 (7 Days)||0||
59870369|NCT03649412|75994497|FG000|STARTED|Part A, Period 5 (4 Days)|Two participant did not start in Period 5|12||
59870370|NCT03649412|75994498|FG001|STARTED|Part A, Period 5 (4 Days)||0||
59870371|NCT03649412|75994497|FG000|COMPLETED|Part A, Period 5 (4 Days)||12||
59870372|NCT03649412|75994498|FG001|COMPLETED|Part A, Period 5 (4 Days)||0||
59870373|NCT03649412|75994497|FG000|NOT COMPLETED|Part A, Period 5 (4 Days)||0||
59870374|NCT03649412|75994498|FG001|NOT COMPLETED|Part A, Period 5 (4 Days)||0||
59870375|NCT03649412|75994497|FG000|STARTED|Part A, Washout Period 5 (7 Days)||12||
59870376|NCT03649412|75994498|FG001|STARTED|Part A, Washout Period 5 (7 Days)||0||
59870377|NCT03649412|75994497|FG000|COMPLETED|Part A, Washout Period 5 (7 Days)||11||
59870378|NCT03649412|75994498|FG001|COMPLETED|Part A, Washout Period 5 (7 Days)||0||
59870379|NCT03649412|75994497|FG000|NOT COMPLETED|Part A, Washout Period 5 (7 Days)||1||
59870380|NCT03649412|75994498|FG001|NOT COMPLETED|Part A, Washout Period 5 (7 Days)||0||
59870381|NCT03649412|75994497|FG000|STARTED|Part A, Period 6 (4 Days)|1 of the participant who did not start Period 5 directly joined into Period 6|12||
59870382|NCT03649412|75994498|FG001|STARTED|Part A, Period 6 (4 Days)||0||
59870383|NCT03649412|75994497|FG000|COMPLETED|Part A, Period 6 (4 Days)||12||
59870384|NCT03649412|75994498|FG001|COMPLETED|Part A, Period 6 (4 Days)||0||
59870385|NCT03649412|75994497|FG000|NOT COMPLETED|Part A, Period 6 (4 Days)||0||
59870386|NCT03649412|75994498|FG001|NOT COMPLETED|Part A, Period 6 (4 Days)||0||
59870387|NCT03649412|75994497|FG000|STARTED|Part B, Period 1 (4 Days)|Participants in Part A did not enter Part B|0||
59870388|NCT03649412|75994498|FG001|STARTED|Part B, Period 1 (4 Days)|16 new participants enrolled in Part B|16||
59870389|NCT03649412|75994497|FG000|COMPLETED|Part B, Period 1 (4 Days)||0||
59870390|NCT03649412|75994498|FG001|COMPLETED|Part B, Period 1 (4 Days)||16||
59870391|NCT03649412|75994497|FG000|NOT COMPLETED|Part B, Period 1 (4 Days)||0||
59870392|NCT03649412|75994498|FG001|NOT COMPLETED|Part B, Period 1 (4 Days)||0||
59870393|NCT03649412|75994497|FG000|STARTED|Part B, Washout Period 1 (7 Days)||0||
59870394|NCT03649412|75994498|FG001|STARTED|Part B, Washout Period 1 (7 Days)||16||
59870395|NCT03649412|75994497|FG000|COMPLETED|Part B, Washout Period 1 (7 Days)||0||
59870396|NCT03649412|75994498|FG001|COMPLETED|Part B, Washout Period 1 (7 Days)||15||
59870397|NCT03649412|75994497|FG000|NOT COMPLETED|Part B, Washout Period 1 (7 Days)||0||
59870398|NCT03649412|75994498|FG001|NOT COMPLETED|Part B, Washout Period 1 (7 Days)||1||
59870399|NCT03649412|75994497|FG000|STARTED|Part B, Period 2 (4 Days)||0||
59870400|NCT03649412|75994498|FG001|STARTED|Part B, Period 2 (4 Days)||15||
59870401|NCT03649412|75994497|FG000|COMPLETED|Part B, Period 2 (4 Days)||0||
59870402|NCT03649412|75994498|FG001|COMPLETED|Part B, Period 2 (4 Days)||15||
59870403|NCT03649412|75994497|FG000|NOT COMPLETED|Part B, Period 2 (4 Days)||0||
59870404|NCT03649412|75994498|FG001|NOT COMPLETED|Part B, Period 2 (4 Days)||0||
59870405|NCT03649412|75994497|FG000|STARTED|Part B, Washout Period 2 (7 Days)||0||
59870406|NCT03649412|75994498|FG001|STARTED|Part B, Washout Period 2 (7 Days)||15||
59870407|NCT03649412|75994497|FG000|COMPLETED|Part B, Washout Period 2 (7 Days)||0||
59870408|NCT03649412|75994498|FG001|COMPLETED|Part B, Washout Period 2 (7 Days)||15||
59870409|NCT03649412|75994497|FG000|NOT COMPLETED|Part B, Washout Period 2 (7 Days)||0||
59870410|NCT03649412|75994498|FG001|NOT COMPLETED|Part B, Washout Period 2 (7 Days)||0||
59870411|NCT03649412|75994497|FG000|STARTED|Part B, Period 3 (4 Days)||0||
59870412|NCT03649412|75994498|FG001|STARTED|Part B, Period 3 (4 Days)||15||
59870413|NCT03649412|75994497|FG000|COMPLETED|Part B, Period 3 (4 Days)||0||
59870414|NCT03649412|75994498|FG001|COMPLETED|Part B, Period 3 (4 Days)||15||
59870415|NCT03649412|75994497|FG000|NOT COMPLETED|Part B, Period 3 (4 Days)||0||
59870416|NCT03649412|75994498|FG001|NOT COMPLETED|Part B, Period 3 (4 Days)||0||
59870417|NCT03649412|75994497|FG000|STARTED|Part B, Washout Period 3 (7 Days)||0||
59870418|NCT03649412|75994498|FG001|STARTED|Part B, Washout Period 3 (7 Days)||15||
59870419|NCT03649412|75994497|FG000|COMPLETED|Part B, Washout Period 3 (7 Days)||0||
59870420|NCT03649412|75994498|FG001|COMPLETED|Part B, Washout Period 3 (7 Days)||15||
59870421|NCT03649412|75994497|FG000|NOT COMPLETED|Part B, Washout Period 3 (7 Days)||0||
59870422|NCT03649412|75994498|FG001|NOT COMPLETED|Part B, Washout Period 3 (7 Days)||0||
59870423|NCT03649412|75994497|FG000|STARTED|Part B, Period 4 (4 Days)||0||
59870424|NCT03649412|75994498|FG001|STARTED|Part B, Period 4 (4 Days)||15||
59870425|NCT03649412|75994497|FG000|COMPLETED|Part B, Period 4 (4 Days)||0||
59870426|NCT03649412|75994498|FG001|COMPLETED|Part B, Period 4 (4 Days)||15||
59870427|NCT03649412|75994497|FG000|NOT COMPLETED|Part B, Period 4 (4 Days)||0||
59870428|NCT03649412|75994498|FG001|NOT COMPLETED|Part B, Period 4 (4 Days)||0||
59870429|NCT03649412|75994497|FG000|STARTED|Part B, Washout Period 4 (7 Days)||0||
59870430|NCT03649412|75994498|FG001|STARTED|Part B, Washout Period 4 (7 Days)||15||
59870431|NCT03649412|75994497|FG000|COMPLETED|Part B, Washout Period 4 (7 Days)||0||
59870432|NCT03649412|75994498|FG001|COMPLETED|Part B, Washout Period 4 (7 Days)||15||
59870433|NCT03649412|75994497|FG000|NOT COMPLETED|Part B, Washout Period 4 (7 Days)||0||
59870434|NCT03649412|75994498|FG001|NOT COMPLETED|Part B, Washout Period 4 (7 Days)||0||
59870435|NCT03649412|75994497|FG000|STARTED|Part B, Period 5 (4 Days)||0||
59870436|NCT03649412|75994498|FG001|STARTED|Part B, Period 5 (4 Days)|One participant did not start in Period 5|14||
59870437|NCT03649412|75994497|FG000|COMPLETED|Part B, Period 5 (4 Days)||0||
59870438|NCT03649412|75994498|FG001|COMPLETED|Part B, Period 5 (4 Days)||14||
59870439|NCT03649412|75994497|FG000|NOT COMPLETED|Part B, Period 5 (4 Days)||0||
59870440|NCT03649412|75994498|FG001|NOT COMPLETED|Part B, Period 5 (4 Days)||0||
59870441|NCT03649412|75994497|FG000|STARTED|Part B, Washout Period 5 (7 Days)||0||
59870442|NCT03649412|75994498|FG001|STARTED|Part B, Washout Period 5 (7 Days)||14||
59870443|NCT03649412|75994497|FG000|COMPLETED|Part B, Washout Period 5 (7 Days)||0||
59870444|NCT03649412|75994498|FG001|COMPLETED|Part B, Washout Period 5 (7 Days)||13||
59870445|NCT03649412|75994497|FG000|NOT COMPLETED|Part B, Washout Period 5 (7 Days)||0||
59870446|NCT03649412|75994498|FG001|NOT COMPLETED|Part B, Washout Period 5 (7 Days)||1||
59870447|NCT03649412|75994497|FG000|STARTED|Part B, Period 6 (4days)||0||
59870448|NCT03649412|75994498|FG001|STARTED|Part B, Period 6 (4days)|Participant who did not start Period 5 directly joined into Period 6|14||
59870449|NCT03649412|75994497|FG000|COMPLETED|Part B, Period 6 (4days)||0||
59870450|NCT03649412|75994498|FG001|COMPLETED|Part B, Period 6 (4days)||14||
59870451|NCT03649412|75994497|FG000|NOT COMPLETED|Part B, Period 6 (4days)||0||
59870452|NCT03649412|75994498|FG001|NOT COMPLETED|Part B, Period 6 (4days)||0||
59870453|NCT03587636|75994543|FG000|STARTED|Overall Study||39||
59870454|NCT03587636|75994544|FG001|STARTED|Overall Study||38||
59870455|NCT03587636|75994543|FG000|COMPLETED|Overall Study||37||
59870456|NCT03587636|75994544|FG001|COMPLETED|Overall Study||33||
59870457|NCT03587636|75994543|FG000|NOT COMPLETED|Overall Study||2||
59870458|NCT03587636|75994544|FG001|NOT COMPLETED|Overall Study||5||
59870459|NCT03053362|75994552|FG000|STARTED|Overall Study||100||
59870460|NCT03053362|75994553|FG001|STARTED|Overall Study||58||
59870461|NCT03053362|75994552|FG000|COMPLETED|Overall Study||83||
59870462|NCT03053362|75994553|FG001|COMPLETED|Overall Study||50||
59870463|NCT03053362|75994552|FG000|NOT COMPLETED|Overall Study||17||
59870464|NCT03053362|75994553|FG001|NOT COMPLETED|Overall Study||8||
59870465|NCT03586544|75994562|FG000|STARTED|First Intervention||6||
59870466|NCT03586544|75994563|FG001|STARTED|First Intervention||12||
59870467|NCT03586544|75994562|FG000|COMPLETED|First Intervention||6||
59870468|NCT03586544|75994563|FG001|COMPLETED|First Intervention||11||
59870469|NCT03586544|75994562|FG000|NOT COMPLETED|First Intervention||0||
59870470|NCT03586544|75994563|FG001|NOT COMPLETED|First Intervention||1||
59870471|NCT03586544|75994562|FG000|STARTED|Second Intervention||6||
59870472|NCT03586544|75994563|FG001|STARTED|Second Intervention||11||
59870473|NCT03586544|75994562|FG000|COMPLETED|Second Intervention||6||
59870474|NCT03586544|75994563|FG001|COMPLETED|Second Intervention||10||
59870475|NCT03586544|75994562|FG000|NOT COMPLETED|Second Intervention||0||
59870476|NCT03586544|75994563|FG001|NOT COMPLETED|Second Intervention||1||
59870477|NCT03585296|75994569|FG000|STARTED|Overall Study||22||
59870478|NCT03585296|75994569|FG000|COMPLETED|Overall Study||17||
59870479|NCT03585296|75994569|FG000|NOT COMPLETED|Overall Study||5||
59870480|NCT03589768|75994577|FG000|STARTED|Overall Study||134||
59870481|NCT03589768|75994578|FG001|STARTED|Overall Study||67||
59870482|NCT03589768|75994579|FG002|STARTED|Overall Study||131||
59870483|NCT03589768|75994580|FG003|STARTED|Overall Study||67||
59870484|NCT03589768|75994577|FG000|COMPLETED|Overall Study||130||
59870485|NCT03589768|75994578|FG001|COMPLETED|Overall Study||67||
59870486|NCT03589768|75994579|FG002|COMPLETED|Overall Study||123||
59870487|NCT03589768|75994580|FG003|COMPLETED|Overall Study||64||
59870488|NCT03589768|75994577|FG000|NOT COMPLETED|Overall Study||4||
59870489|NCT03589768|75994578|FG001|NOT COMPLETED|Overall Study||0||
59870490|NCT03589768|75994579|FG002|NOT COMPLETED|Overall Study||8||
59870491|NCT03589768|75994580|FG003|NOT COMPLETED|Overall Study||3||
59870492|NCT02892422|75994590|FG000|STARTED|Overall Study|528 participants were enrolled, 524 from study 16159A and 4 from study 16323A|528||
59870493|NCT02892422|75994590|FG000|COMPLETED|Overall Study||318||
59870494|NCT02892422|75994590|FG000|NOT COMPLETED|Overall Study||210||
59870495|NCT03571646|75994596|FG000|STARTED|Overall Study||3||
59870496|NCT03571646|75994597|FG001|STARTED|Overall Study||3||
59870497|NCT03571646|75994596|FG000|COMPLETED|Overall Study||1||
59870498|NCT03571646|75994597|FG001|COMPLETED|Overall Study||2||
59870499|NCT03571646|75994596|FG000|NOT COMPLETED|Overall Study||2||
59870500|NCT03571646|75994597|FG001|NOT COMPLETED|Overall Study||1||
59870501|NCT03645434|75994603|FG000|STARTED|Period 1||12||
59870502|NCT03645434|75994604|FG001|STARTED|Period 1||13||
59870503|NCT03645434|75994605|FG002|STARTED|Period 1||13||
59870504|NCT03645434|75994606|FG003|STARTED|Period 1||11||
59870505|NCT03645434|75994607|FG004|STARTED|Period 1||12||
59870506|NCT03645434|75994608|FG005|STARTED|Period 1||12||
59870507|NCT03645434|75994603|FG000|COMPLETED|Period 1||12||
59870508|NCT03645434|75994604|FG001|COMPLETED|Period 1||13||
59870509|NCT03645434|75994605|FG002|COMPLETED|Period 1||13||
59870510|NCT03645434|75994606|FG003|COMPLETED|Period 1||10||
59870511|NCT03645434|75994607|FG004|COMPLETED|Period 1||11||
59870512|NCT03645434|75994608|FG005|COMPLETED|Period 1||12||
59870513|NCT03645434|75994603|FG000|NOT COMPLETED|Period 1||0||
59870514|NCT03645434|75994604|FG001|NOT COMPLETED|Period 1||0||
59870515|NCT03645434|75994605|FG002|NOT COMPLETED|Period 1||0||
59870516|NCT03645434|75994606|FG003|NOT COMPLETED|Period 1||1||
59870517|NCT03645434|75994607|FG004|NOT COMPLETED|Period 1||1||
59870518|NCT03645434|75994608|FG005|NOT COMPLETED|Period 1||0||
59870519|NCT03645434|75994603|FG000|STARTED|Period 2|2 subject discontinued as they did not meet stability or FEV1 variability.|10||
59870520|NCT03645434|75994604|FG001|STARTED|Period 2||13||
59870521|NCT03645434|75994605|FG002|STARTED|Period 2||13||
59870522|NCT03645434|75994606|FG003|STARTED|Period 2||10||
59870523|NCT03645434|75994607|FG004|STARTED|Period 2||11||
59870524|NCT03645434|75994608|FG005|STARTED|Period 2|1 subject completed Period 1 but not allowed to enter Period 2 due to physician decision.|11||
59870525|NCT03645434|75994603|FG000|COMPLETED|Period 2||10||
59870526|NCT03645434|75994604|FG001|COMPLETED|Period 2||13||
59870527|NCT03645434|75994605|FG002|COMPLETED|Period 2||13||
59870528|NCT03645434|75994606|FG003|COMPLETED|Period 2||10||
59870529|NCT03645434|75994607|FG004|COMPLETED|Period 2||11||
59870530|NCT03645434|75994608|FG005|COMPLETED|Period 2||11||
59870531|NCT03645434|75994603|FG000|NOT COMPLETED|Period 2||0||
59870532|NCT03645434|75994604|FG001|NOT COMPLETED|Period 2||0||
59870533|NCT03645434|75994605|FG002|NOT COMPLETED|Period 2||0||
59870534|NCT03645434|75994606|FG003|NOT COMPLETED|Period 2||0||
59870535|NCT03645434|75994607|FG004|NOT COMPLETED|Period 2||0||
59870536|NCT03645434|75994608|FG005|NOT COMPLETED|Period 2||0||
59870537|NCT03645434|75994603|FG000|STARTED|Period 3||10||
59870538|NCT03645434|75994604|FG001|STARTED|Period 3||13||
59870539|NCT03645434|75994605|FG002|STARTED|Period 3|2 subjects discontinued as they did not meet FEV1 stability criteria or pfts variability criteria.|11||
59870540|NCT03645434|75994606|FG003|STARTED|Period 3||10||
59870541|NCT03645434|75994607|FG004|STARTED|Period 3||11||
59870542|NCT03645434|75994608|FG005|STARTED|Period 3||11||
59870543|NCT03645434|75994603|FG000|COMPLETED|Period 3||10||
59870544|NCT03645434|75994604|FG001|COMPLETED|Period 3||13||
59870545|NCT03645434|75994605|FG002|COMPLETED|Period 3||11||
59870546|NCT03645434|75994606|FG003|COMPLETED|Period 3||10||
59870547|NCT03645434|75994607|FG004|COMPLETED|Period 3||11||
59870548|NCT03645434|75994608|FG005|COMPLETED|Period 3||11||
59870549|NCT03645434|75994603|FG000|NOT COMPLETED|Period 3||0||
59870550|NCT03645434|75994604|FG001|NOT COMPLETED|Period 3||0||
59870551|NCT03645434|75994605|FG002|NOT COMPLETED|Period 3||0||
59870552|NCT03645434|75994606|FG003|NOT COMPLETED|Period 3||0||
59870553|NCT03645434|75994607|FG004|NOT COMPLETED|Period 3||0||
59870554|NCT03645434|75994608|FG005|NOT COMPLETED|Period 3||0||
59870555|NCT00089505|75994620|FG000|STARTED|Overall Study|2 women never started treatment and per protocol, were not followed and not included in analysis.|121||
59870556|NCT00089505|75994621|FG001|STARTED|Overall Study||120||
59870557|NCT00089505|75994622|FG002|STARTED|Overall Study|2 women never started treatment and per protocol, were not followed and not included in analysis.|249||
59870558|NCT00089505|75994623|FG003|STARTED|Overall Study||251||
59870559|NCT00089505|75994620|FG000|COMPLETED|Overall Study|The results for NVP/NVP were through database cutoff for DSMB review (by 6 October 2008).|112||
59870560|NCT00089505|75994621|FG001|COMPLETED|Overall Study|The results for NVP/LPV_r were through database cutoff for DSMB review (by 6 October 2008).|118||
59870561|NCT00089505|75994622|FG002|COMPLETED|Overall Study||228||
59870562|NCT00089505|75994623|FG003|COMPLETED|Overall Study||230||
59870563|NCT00089505|75994620|FG000|NOT COMPLETED|Overall Study||9||
59870564|NCT00089505|75994621|FG001|NOT COMPLETED|Overall Study||2||
59870565|NCT00089505|75994622|FG002|NOT COMPLETED|Overall Study||21||
59870566|NCT00089505|75994623|FG003|NOT COMPLETED|Overall Study||21||
59870567|NCT04009824|75994638|FG000|STARTED|Overall Study||10||
59870568|NCT04009824|75994639|FG001|STARTED|Overall Study||10||
59870569|NCT04009824|75994640|FG002|STARTED|Overall Study||11||
59870570|NCT04009824|75994641|FG003|STARTED|Overall Study||10||
59870571|NCT04009824|75994642|FG004|STARTED|Overall Study||10||
59870572|NCT04009824|75994638|FG000|COMPLETED|Overall Study||8||
59870573|NCT04009824|75994639|FG001|COMPLETED|Overall Study||7||
59870574|NCT04009824|75994640|FG002|COMPLETED|Overall Study||6||
59870575|NCT04009824|75994641|FG003|COMPLETED|Overall Study||8||
59870576|NCT04009824|75994642|FG004|COMPLETED|Overall Study||7||
59870577|NCT04009824|75994638|FG000|NOT COMPLETED|Overall Study||2||
59870578|NCT04009824|75994639|FG001|NOT COMPLETED|Overall Study||3||
59870579|NCT04009824|75994640|FG002|NOT COMPLETED|Overall Study||5||
59870580|NCT04009824|75994641|FG003|NOT COMPLETED|Overall Study||2||
59870581|NCT04009824|75994642|FG004|NOT COMPLETED|Overall Study||3||
59870582|NCT03555890|75994658|FG000|STARTED|Part 1:Treatment Period 1 (3 Days)||12||
59870583|NCT03555890|75994659|FG001|STARTED|Part 1:Treatment Period 1 (3 Days)||12||
59870584|NCT03555890|75994660|FG002|STARTED|Part 1:Treatment Period 1 (3 Days)||0||
59870585|NCT03555890|75994661|FG003|STARTED|Part 1:Treatment Period 1 (3 Days)||0||
59870586|NCT03555890|75994658|FG000|COMPLETED|Part 1:Treatment Period 1 (3 Days)||12||
59870587|NCT03555890|75994659|FG001|COMPLETED|Part 1:Treatment Period 1 (3 Days)||12||
59870588|NCT03555890|75994660|FG002|COMPLETED|Part 1:Treatment Period 1 (3 Days)||0||
59870589|NCT03555890|75994661|FG003|COMPLETED|Part 1:Treatment Period 1 (3 Days)||0||
59870590|NCT03555890|75994658|FG000|NOT COMPLETED|Part 1:Treatment Period 1 (3 Days)||0||
59870591|NCT03555890|75994659|FG001|NOT COMPLETED|Part 1:Treatment Period 1 (3 Days)||0||
59870592|NCT03555890|75994660|FG002|NOT COMPLETED|Part 1:Treatment Period 1 (3 Days)||0||
59870593|NCT03555890|75994661|FG003|NOT COMPLETED|Part 1:Treatment Period 1 (3 Days)||0||
59870594|NCT03555890|75994658|FG000|STARTED|Part 1:Washout Period (at Least 5 Days)||12||
59870595|NCT03555890|75994659|FG001|STARTED|Part 1:Washout Period (at Least 5 Days)||12||
59870596|NCT03555890|75994660|FG002|STARTED|Part 1:Washout Period (at Least 5 Days)||0||
59870597|NCT03555890|75994661|FG003|STARTED|Part 1:Washout Period (at Least 5 Days)||0||
59870598|NCT03555890|75994658|FG000|COMPLETED|Part 1:Washout Period (at Least 5 Days)||12||
59870599|NCT03555890|75994659|FG001|COMPLETED|Part 1:Washout Period (at Least 5 Days)||12||
59870600|NCT03555890|75994660|FG002|COMPLETED|Part 1:Washout Period (at Least 5 Days)||0||
59870601|NCT03555890|75994661|FG003|COMPLETED|Part 1:Washout Period (at Least 5 Days)||0||
59870602|NCT03555890|75994658|FG000|NOT COMPLETED|Part 1:Washout Period (at Least 5 Days)||0||
59870603|NCT03555890|75994659|FG001|NOT COMPLETED|Part 1:Washout Period (at Least 5 Days)||0||
59870604|NCT03555890|75994660|FG002|NOT COMPLETED|Part 1:Washout Period (at Least 5 Days)||0||
59870605|NCT03555890|75994661|FG003|NOT COMPLETED|Part 1:Washout Period (at Least 5 Days)||0||
59870606|NCT03555890|75994658|FG000|STARTED|Part 1:Treatment Period 2 (10 Days)||12||
59870607|NCT03555890|75994659|FG001|STARTED|Part 1:Treatment Period 2 (10 Days)||12||
59870608|NCT03555890|75994660|FG002|STARTED|Part 1:Treatment Period 2 (10 Days)||0||
59870609|NCT03555890|75994661|FG003|STARTED|Part 1:Treatment Period 2 (10 Days)||0||
59870610|NCT03555890|75994658|FG000|COMPLETED|Part 1:Treatment Period 2 (10 Days)||12||
59870611|NCT03555890|75994659|FG001|COMPLETED|Part 1:Treatment Period 2 (10 Days)||12||
59870612|NCT03555890|75994660|FG002|COMPLETED|Part 1:Treatment Period 2 (10 Days)||0||
59870613|NCT03555890|75994661|FG003|COMPLETED|Part 1:Treatment Period 2 (10 Days)||0||
59870614|NCT03555890|75994658|FG000|NOT COMPLETED|Part 1:Treatment Period 2 (10 Days)||0||
59870615|NCT03555890|75994659|FG001|NOT COMPLETED|Part 1:Treatment Period 2 (10 Days)||0||
59870616|NCT03555890|75994660|FG002|NOT COMPLETED|Part 1:Treatment Period 2 (10 Days)||0||
59870617|NCT03555890|75994661|FG003|NOT COMPLETED|Part 1:Treatment Period 2 (10 Days)||0||
59870618|NCT03555890|75994658|FG000|STARTED|Part 2:Treatment Period 1 (3 Days)||0||
59870619|NCT03555890|75994659|FG001|STARTED|Part 2:Treatment Period 1 (3 Days)||0||
59870620|NCT03555890|75994660|FG002|STARTED|Part 2:Treatment Period 1 (3 Days)||24||
59870621|NCT03555890|75994661|FG003|STARTED|Part 2:Treatment Period 1 (3 Days)||24||
59870622|NCT03555890|75994658|FG000|COMPLETED|Part 2:Treatment Period 1 (3 Days)||0||
59870623|NCT03555890|75994659|FG001|COMPLETED|Part 2:Treatment Period 1 (3 Days)||0||
59870624|NCT03555890|75994660|FG002|COMPLETED|Part 2:Treatment Period 1 (3 Days)||24||
59870625|NCT03555890|75994661|FG003|COMPLETED|Part 2:Treatment Period 1 (3 Days)||24||
59870626|NCT03555890|75994658|FG000|NOT COMPLETED|Part 2:Treatment Period 1 (3 Days)||0||
59870627|NCT03555890|75994659|FG001|NOT COMPLETED|Part 2:Treatment Period 1 (3 Days)||0||
59870628|NCT03555890|75994660|FG002|NOT COMPLETED|Part 2:Treatment Period 1 (3 Days)||0||
59870629|NCT03555890|75994661|FG003|NOT COMPLETED|Part 2:Treatment Period 1 (3 Days)||0||
59870630|NCT03555890|75994658|FG000|STARTED|Part 2:Washout Period (at Least 5 Days)||0||
59870631|NCT03555890|75994659|FG001|STARTED|Part 2:Washout Period (at Least 5 Days)||0||
59870632|NCT03555890|75994660|FG002|STARTED|Part 2:Washout Period (at Least 5 Days)||24||
59870633|NCT03555890|75994661|FG003|STARTED|Part 2:Washout Period (at Least 5 Days)||24||
59870634|NCT03555890|75994658|FG000|COMPLETED|Part 2:Washout Period (at Least 5 Days)||0||
59870635|NCT03555890|75994659|FG001|COMPLETED|Part 2:Washout Period (at Least 5 Days)||0||
59870636|NCT03555890|75994660|FG002|COMPLETED|Part 2:Washout Period (at Least 5 Days)||24||
59870637|NCT03555890|75994661|FG003|COMPLETED|Part 2:Washout Period (at Least 5 Days)||23||
59870638|NCT03555890|75994658|FG000|NOT COMPLETED|Part 2:Washout Period (at Least 5 Days)||0||
59870639|NCT03555890|75994659|FG001|NOT COMPLETED|Part 2:Washout Period (at Least 5 Days)||0||
59870640|NCT03555890|75994660|FG002|NOT COMPLETED|Part 2:Washout Period (at Least 5 Days)||0||
59870641|NCT03555890|75994661|FG003|NOT COMPLETED|Part 2:Washout Period (at Least 5 Days)||1||
59870642|NCT03555890|75994658|FG000|STARTED|Part 2:Treatment Period 2 (10 Days)||0||
59870643|NCT03555890|75994659|FG001|STARTED|Part 2:Treatment Period 2 (10 Days)||0||
59870644|NCT03555890|75994660|FG002|STARTED|Part 2:Treatment Period 2 (10 Days)||24||
59870645|NCT03555890|75994661|FG003|STARTED|Part 2:Treatment Period 2 (10 Days)||23||
59870646|NCT03555890|75994658|FG000|COMPLETED|Part 2:Treatment Period 2 (10 Days)||0||
59870647|NCT03555890|75994659|FG001|COMPLETED|Part 2:Treatment Period 2 (10 Days)||0||
59870648|NCT03555890|75994660|FG002|COMPLETED|Part 2:Treatment Period 2 (10 Days)||24||
59870649|NCT03555890|75994661|FG003|COMPLETED|Part 2:Treatment Period 2 (10 Days)||23||
59870650|NCT03555890|75994658|FG000|NOT COMPLETED|Part 2:Treatment Period 2 (10 Days)||0||
59870651|NCT03555890|75994659|FG001|NOT COMPLETED|Part 2:Treatment Period 2 (10 Days)||0||
59870652|NCT03555890|75994660|FG002|NOT COMPLETED|Part 2:Treatment Period 2 (10 Days)||0||
59870653|NCT03555890|75994661|FG003|NOT COMPLETED|Part 2:Treatment Period 2 (10 Days)||0||
59870654|NCT03688074|75994673|FG000|STARTED|Overall Study||59||
59870655|NCT03688074|75994674|FG001|STARTED|Overall Study||57||
59870656|NCT03688074|75994673|FG000|COMPLETED|Overall Study||58||
59870657|NCT03688074|75994674|FG001|COMPLETED|Overall Study||56||
59870658|NCT03688074|75994673|FG000|NOT COMPLETED|Overall Study||1||
59870659|NCT03688074|75994674|FG001|NOT COMPLETED|Overall Study||1||
59870660|NCT03630120|75994684|FG000|STARTED|Overall Study||2||
59870661|NCT03630120|75994685|FG001|STARTED|Overall Study||2||
59870662|NCT03630120|75994686|FG002|STARTED|Overall Study||1||
59870663|NCT03630120|75994687|FG003|STARTED|Overall Study||1||
59870664|NCT03630120|75994684|FG000|COMPLETED|Overall Study||2||
59870665|NCT03630120|75994685|FG001|COMPLETED|Overall Study||1||
59870666|NCT03630120|75994686|FG002|COMPLETED|Overall Study||0||
59870667|NCT03630120|75994687|FG003|COMPLETED|Overall Study||0||
59870668|NCT03630120|75994684|FG000|NOT COMPLETED|Overall Study||0||
59870669|NCT03630120|75994685|FG001|NOT COMPLETED|Overall Study||1||
59870670|NCT03630120|75994686|FG002|NOT COMPLETED|Overall Study||1||
59870671|NCT03630120|75994687|FG003|NOT COMPLETED|Overall Study||1||
59870672|NCT03555266|75994699|FG000|STARTED|Overall Study||32||
59870673|NCT03555266|75994700|FG001|STARTED|Overall Study||31||
59870674|NCT03555266|75994699|FG000|COMPLETED|Overall Study||26||
59870675|NCT03555266|75994700|FG001|COMPLETED|Overall Study||27||
59870676|NCT03555266|75994699|FG000|NOT COMPLETED|Overall Study||6||
59870677|NCT03555266|75994700|FG001|NOT COMPLETED|Overall Study||4||
59870678|NCT03629886|75994708|FG000|STARTED|Overall Study||1671||
59870679|NCT03629886|75994709|FG001|STARTED|Overall Study||1866||
59870680|NCT03629886|75994708|FG000|COMPLETED|Overall Study||1671||
59870681|NCT03629886|75994709|FG001|COMPLETED|Overall Study||1686||
59870682|NCT03629886|75994708|FG000|NOT COMPLETED|Overall Study||0||
59870683|NCT03629886|75994709|FG001|NOT COMPLETED|Overall Study||180||
59870684|NCT03656874|75994718|FG000|STARTED|Overall Study||13|Patient Participants|4
59870685|NCT03656874|75994719|FG001|STARTED|Overall Study||43|Patient Participants|6
59870686|NCT03656874|75994718|FG000|COMPLETED|Overall Study||10|Patient participants|2
59870687|NCT03656874|75994719|FG001|COMPLETED|Overall Study||26|Patient participants|5
59870688|NCT03656874|75994718|FG000|NOT COMPLETED|Overall Study||3||2
59870689|NCT03656874|75994719|FG001|NOT COMPLETED|Overall Study||17||1
59870690|NCT03554486|75994727|FG000|STARTED|Run-in Period (2 Weeks)||24||
59870691|NCT03554486|75994728|FG001|STARTED|Run-in Period (2 Weeks)||0||
59870692|NCT03554486|75994729|FG002|STARTED|Run-in Period (2 Weeks)||0||
59870693|NCT03554486|75994727|FG000|COMPLETED|Run-in Period (2 Weeks)||21||
59870694|NCT03554486|75994728|FG001|COMPLETED|Run-in Period (2 Weeks)||0||
59870695|NCT03554486|75994729|FG002|COMPLETED|Run-in Period (2 Weeks)||0||
59870696|NCT03554486|75994727|FG000|NOT COMPLETED|Run-in Period (2 Weeks)||3||
59870697|NCT03554486|75994728|FG001|NOT COMPLETED|Run-in Period (2 Weeks)||0||
59870698|NCT03554486|75994729|FG002|NOT COMPLETED|Run-in Period (2 Weeks)||0||
59870699|NCT03554486|75994727|FG000|STARTED|Treatment Period 1 (2 Weeks)||0||
59870700|NCT03554486|75994728|FG001|STARTED|Treatment Period 1 (2 Weeks)||11||
59870701|NCT03554486|75994729|FG002|STARTED|Treatment Period 1 (2 Weeks)||10||
59870702|NCT03554486|75994727|FG000|COMPLETED|Treatment Period 1 (2 Weeks)||0||
59870703|NCT03554486|75994728|FG001|COMPLETED|Treatment Period 1 (2 Weeks)||10||
59870704|NCT03554486|75994729|FG002|COMPLETED|Treatment Period 1 (2 Weeks)||9||
59870705|NCT03554486|75994727|FG000|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0||
59870706|NCT03554486|75994728|FG001|NOT COMPLETED|Treatment Period 1 (2 Weeks)||1||
59870707|NCT03554486|75994729|FG002|NOT COMPLETED|Treatment Period 1 (2 Weeks)||1||
59870708|NCT03554486|75994727|FG000|STARTED|Treatment Period 2 (2 Weeks)||0||
59870709|NCT03554486|75994728|FG001|STARTED|Treatment Period 2 (2 Weeks)||10||
59870710|NCT03554486|75994729|FG002|STARTED|Treatment Period 2 (2 Weeks)||9||
59870711|NCT03554486|75994727|FG000|COMPLETED|Treatment Period 2 (2 Weeks)||0||
59870712|NCT03554486|75994728|FG001|COMPLETED|Treatment Period 2 (2 Weeks)||10||
59870713|NCT03554486|75994729|FG002|COMPLETED|Treatment Period 2 (2 Weeks)||9||
59870714|NCT03554486|75994727|FG000|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0||
59870715|NCT03554486|75994728|FG001|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0||
59870716|NCT03554486|75994729|FG002|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0||
59870717|NCT03554018|75994738|FG000|STARTED|Overall Study||60||
59870718|NCT03554018|75994739|FG001|STARTED|Overall Study||60||
59870719|NCT03554018|75994738|FG000|COMPLETED|Overall Study||57||
59870720|NCT03554018|75994739|FG001|COMPLETED|Overall Study||53||
59870721|NCT03554018|75994738|FG000|NOT COMPLETED|Overall Study||3||
59870722|NCT03554018|75994739|FG001|NOT COMPLETED|Overall Study||7||
59870723|NCT03571256|75994748|FG000|STARTED|Overall Study||52|Intent-to-treat (ITT) analysis set: all randomized participants|
59870724|NCT03571256|75994749|FG001|STARTED|Overall Study||54|Intent-to-treat (ITT) analysis set: all randomized participants|
59870725|NCT03571256|75994750|FG002|STARTED|Overall Study||52|Intent-to-treat (ITT) analysis set: all randomized participants|
59870726|NCT03571256|75994748|FG000|Safety Analysis Set|Overall Study||52|Received at least 1 dose of study drug|
59870727|NCT03571256|75994749|FG001|Safety Analysis Set|Overall Study||54|Received at least 1 dose of study drug|
59870728|NCT03571256|75994750|FG002|Safety Analysis Set|Overall Study||51|Received at least 1 dose of study drug|
59870729|NCT03571256|75994748|FG000|Modified ITT (mITT) Analysis Set|Overall Study||49|Received at least 1 dose of study drug; had both baseline & at least 1 postbaseline YGTSS assessment|
59870730|NCT03571256|75994749|FG001|Modified ITT (mITT) Analysis Set|Overall Study||53|Received at least 1 dose of study drug; had both baseline & at least 1 postbaseline YGTSS assessment|
59870731|NCT03571256|75994750|FG002|Modified ITT (mITT) Analysis Set|Overall Study||51|Received at least 1 dose of study drug; had both baseline & at least 1 postbaseline YGTSS assessment|
59870732|NCT03571256|75994748|FG000|COMPLETED|Overall Study||46||
59870733|NCT03571256|75994749|FG001|COMPLETED|Overall Study||51||
59870734|NCT03571256|75994750|FG002|COMPLETED|Overall Study||48||
59870735|NCT03571256|75994748|FG000|NOT COMPLETED|Overall Study||6||
59870736|NCT03571256|75994749|FG001|NOT COMPLETED|Overall Study||3||
59870737|NCT03571256|75994750|FG002|NOT COMPLETED|Overall Study||4||
59870738|NCT03570554|75994764|FG000|STARTED|Overall Study||10||
59870739|NCT03570554|75994765|FG001|STARTED|Overall Study||10||
59870740|NCT03570554|75994766|FG002|STARTED|Overall Study||11||
59870741|NCT03570554|75994767|FG003|STARTED|Overall Study||10||
59870742|NCT03570554|75994764|FG000|COMPLETED|Overall Study||10||
59870743|NCT03570554|75994765|FG001|COMPLETED|Overall Study||10||
59870744|NCT03570554|75994766|FG002|COMPLETED|Overall Study||10||
59870745|NCT03570554|75994767|FG003|COMPLETED|Overall Study||9||
59870746|NCT03570554|75994764|FG000|NOT COMPLETED|Overall Study||0||
59870747|NCT03570554|75994765|FG001|NOT COMPLETED|Overall Study||0||
59870748|NCT03570554|75994766|FG002|NOT COMPLETED|Overall Study||1||
59870749|NCT03570554|75994767|FG003|NOT COMPLETED|Overall Study||1||
59870750|NCT04004208|75994779|FG000|STARTED|Overall Study||75|All randomized participants who received any study treatment and had a baseline and at least one post-baseline assessment of efficacy (FAS)|
59870751|NCT04004208|75994780|FG001|STARTED|Overall Study||38|All randomized participants who received any study treatment and had a baseline and at least one post-baseline assessment of efficacy (FAS)|
59870752|NCT04004208|75994779|FG000|SAF|Overall Study||75|The safety analysis set (SAF) included all participants who received any type of study treatment.|
59870753|NCT04004208|75994780|FG001|SAF|Overall Study||38|The safety analysis set (SAF) included all participants who received any type of study treatment.|
59870754|NCT04004208|75994779|FG000|PKS|Overall Study||75|The pharmacokinetic analysis set (PKS) included all participants who received aflibercept treatment at the baseline visit and who had at least one nonmissing PK assessment following the first dose of study drug.|
59870755|NCT04004208|75994780|FG001|PKS|Overall Study||0|The pharmacokinetic analysis set (PKS) included all participants who received aflibercept treatment at the baseline visit and who had at least one nonmissing PK assessment following the first dose of study drug.|
59870756|NCT04004208|75994779|FG000|AAS|Overall Study||75|The anti-drug antibody (ADA) analysis set (AAS) included all participants who received aflibercept at baseline and had at least 1 nonmissing result in the ADA assay following the first study dose.|
59870757|NCT04004208|75994780|FG001|AAS|Overall Study||0|The anti-drug antibody (ADA) analysis set (AAS) included all participants who received aflibercept at baseline and had at least 1 nonmissing result in the ADA assay following the first study dose.|
59870758|NCT04004208|75994779|FG000|COMPLETED|Overall Study||68||
59870759|NCT04004208|75994780|FG001|COMPLETED|Overall Study||36||
59870760|NCT04004208|75994779|FG000|NOT COMPLETED|Overall Study||7||
59870761|NCT04004208|75994780|FG001|NOT COMPLETED|Overall Study||2||
59870762|NCT03643952|75994786|FG000|STARTED|Overall Study||18||
59870763|NCT03643952|75994786|FG000|COMPLETED|Overall Study||17||
59870764|NCT03643952|75994786|FG000|NOT COMPLETED|Overall Study||1||
59870765|NCT03035032|75994798|FG000|STARTED|Overall Study||107||
59870766|NCT03035032|75994798|FG000|COMPLETED|Overall Study||64||
59870767|NCT03035032|75994798|FG000|NOT COMPLETED|Overall Study||43||
59870768|NCT03629184|75994804|FG000|STARTED|Overall Study||115||
59870769|NCT03629184|75994805|FG001|STARTED|Overall Study||58||
59870770|NCT03629184|75994804|FG000|COMPLETED|Overall Study||112||
59870771|NCT03629184|75994805|FG001|COMPLETED|Overall Study||57||
59870772|NCT03629184|75994804|FG000|NOT COMPLETED|Overall Study||3||
59870773|NCT03629184|75994805|FG001|NOT COMPLETED|Overall Study||1||
59870774|NCT04105738|75994813|FG000|STARTED|Overall Study||13||
59870775|NCT04105738|75994814|FG001|STARTED|Overall Study||0||
59870776|NCT04105738|75994813|FG000|COMPLETED|Overall Study||13||
59870777|NCT04105738|75994814|FG001|COMPLETED|Overall Study||0||
59870778|NCT04105738|75994813|FG000|NOT COMPLETED|Overall Study||0||
59870779|NCT04105738|75994814|FG001|NOT COMPLETED|Overall Study||0||
59870780|NCT03549338|75994823|FG000|STARTED|Overall Study||1||
59870781|NCT03549338|75994824|FG001|STARTED|Overall Study||1||
59870782|NCT03549338|75994825|FG002|STARTED|Overall Study||0||
59870783|NCT03549338|75994823|FG000|COMPLETED|Overall Study||0||
59870784|NCT03549338|75994824|FG001|COMPLETED|Overall Study|Patient crossed-over to Sym004 at the EOC1 per Sponsor decision following trial termination.|0||
59870785|NCT03549338|75994825|FG002|COMPLETED|Overall Study||0||
59870786|NCT03549338|75994823|FG000|NOT COMPLETED|Overall Study||1||
59870787|NCT03549338|75994824|FG001|NOT COMPLETED|Overall Study||1||
59870788|NCT03549338|75994825|FG002|NOT COMPLETED|Overall Study||0||
59870789|NCT03629028|75994833|FG000|STARTED|Overall Study||141|18/08/2018|
59870790|NCT03629028|75994834|FG001|STARTED|Overall Study||141|18/08/2018|
59870791|NCT03629028|75994833|FG000|COMPLETED|Overall Study||109||
59870792|NCT03629028|75994834|FG001|COMPLETED|Overall Study||116||
59870793|NCT03629028|75994833|FG000|NOT COMPLETED|Overall Study||32||
59870794|NCT03629028|75994834|FG001|NOT COMPLETED|Overall Study||25||
59870795|NCT03549104|75994852|FG000|STARTED|Overall Study||26||
59870796|NCT03549104|75994853|FG001|STARTED|Overall Study||25||
59870797|NCT03549104|75994852|FG000|COMPLETED|Overall Study||18||
59870798|NCT03549104|75994853|FG001|COMPLETED|Overall Study||21||
59870799|NCT03549104|75994852|FG000|NOT COMPLETED|Overall Study||8||
59870800|NCT03549104|75994853|FG001|NOT COMPLETED|Overall Study||4||
59870801|NCT02892344|75994861|FG000|STARTED|Overall Study||398||
59870802|NCT02892344|75994862|FG001|STARTED|Overall Study||404||
59870803|NCT02892344|75994861|FG000|Full Analysis Set|Overall Study||395||
59870804|NCT02892344|75994862|FG001|Full Analysis Set|Overall Study||399||
59870805|NCT02892344|75994861|FG000|COMPLETED|Overall Study||394||
59870806|NCT02892344|75994862|FG001|COMPLETED|Overall Study||383||
59870807|NCT02892344|75994861|FG000|NOT COMPLETED|Overall Study||4||
59870808|NCT02892344|75994862|FG001|NOT COMPLETED|Overall Study||21||
59870809|NCT03567980|75994868|FG000|STARTED|Overall Study||30||
59870810|NCT03567980|75994868|FG000|COMPLETED|Overall Study||29||
59870811|NCT03567980|75994868|FG000|NOT COMPLETED|Overall Study||1||
59870812|NCT02894840|75994876|FG000|STARTED|Overall Study||20||
59870813|NCT02894840|75994877|FG001|STARTED|Overall Study||20||
59870814|NCT02894840|75994878|FG002|STARTED|Overall Study||200||
59870815|NCT02894840|75994879|FG003|STARTED|Overall Study||100||
59870816|NCT02894840|75994876|FG000|COMPLETED|Overall Study||19||
59870817|NCT02894840|75994877|FG001|COMPLETED|Overall Study||20||
59870818|NCT02894840|75994878|FG002|COMPLETED|Overall Study||197||
59870819|NCT02894840|75994879|FG003|COMPLETED|Overall Study||100||
59870820|NCT02894840|75994876|FG000|NOT COMPLETED|Overall Study||1||
59870821|NCT02894840|75994877|FG001|NOT COMPLETED|Overall Study||0||
59870822|NCT02894840|75994878|FG002|NOT COMPLETED|Overall Study||3||
59870823|NCT02894840|75994879|FG003|NOT COMPLETED|Overall Study||0||
59870824|NCT03358030|75994898|FG000|STARTED|Overall Study||53||
59870825|NCT03358030|75994899|FG001|STARTED|Overall Study||53||
59870826|NCT03358030|75994900|FG002|STARTED|Overall Study||55||
59870827|NCT03358030|75994901|FG003|STARTED|Overall Study||52||
59870828|NCT03358030|75994898|FG000|Treated|Overall Study||53|Safety population: All participants randomized who have received at least 1 dose of the study drug.|
59870829|NCT03358030|75994899|FG001|Treated|Overall Study||53|Safety population: All participants randomized who have received at least 1 dose of the study drug.|
59870830|NCT03358030|75994900|FG002|Treated|Overall Study||54|Safety population: All participants randomized who have received at least 1 dose of the study drug.|
59870831|NCT03358030|75994901|FG003|Treated|Overall Study||50|Safety population: All participants randomized who have received at least 1 dose of the study drug.|
59870832|NCT03358030|75994898|FG000|Per-protocol (PP) Population|Overall Study||49||
59870833|NCT03358030|75994899|FG001|Per-protocol (PP) Population|Overall Study||45||
59870834|NCT03358030|75994900|FG002|Per-protocol (PP) Population|Overall Study||43||
59870835|NCT03358030|75994901|FG003|Per-protocol (PP) Population|Overall Study||35||
59870836|NCT03358030|75994898|FG000|COMPLETED|Overall Study||50||
59870837|NCT03358030|75994899|FG001|COMPLETED|Overall Study||52||
59870838|NCT03358030|75994900|FG002|COMPLETED|Overall Study||46||
59870839|NCT03358030|75994901|FG003|COMPLETED|Overall Study||48||
59870840|NCT03358030|75994898|FG000|NOT COMPLETED|Overall Study||3||
59870841|NCT03358030|75994899|FG001|NOT COMPLETED|Overall Study||1||
59870842|NCT03358030|75994900|FG002|NOT COMPLETED|Overall Study||9||
59870843|NCT03358030|75994901|FG003|NOT COMPLETED|Overall Study||4||
59870844|NCT03566810|75994915|FG000|STARTED|Treatment Period 1 (Day 1-Day 3)||19||
59870845|NCT03566810|75994916|FG001|STARTED|Treatment Period 1 (Day 1-Day 3)||19||
59870846|NCT03566810|75994917|FG002|STARTED|Treatment Period 1 (Day 1-Day 3)||8||
59870847|NCT03566810|75994918|FG003|STARTED|Treatment Period 1 (Day 1-Day 3)||8||
59870848|NCT03566810|75994915|FG000|Treated|Treatment Period 1 (Day 1-Day 3)||19||
59870849|NCT03566810|75994916|FG001|Treated|Treatment Period 1 (Day 1-Day 3)||18||
59870850|NCT03566810|75994917|FG002|Treated|Treatment Period 1 (Day 1-Day 3)||8||
59870851|NCT03566810|75994918|FG003|Treated|Treatment Period 1 (Day 1-Day 3)||8||
59870852|NCT03566810|75994915|FG000|COMPLETED|Treatment Period 1 (Day 1-Day 3)||19||
59870853|NCT03566810|75994916|FG001|COMPLETED|Treatment Period 1 (Day 1-Day 3)||18||
59870854|NCT03566810|75994917|FG002|COMPLETED|Treatment Period 1 (Day 1-Day 3)||8||
59870855|NCT03566810|75994918|FG003|COMPLETED|Treatment Period 1 (Day 1-Day 3)||8||
59870856|NCT03566810|75994915|FG000|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0||
59870857|NCT03566810|75994916|FG001|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||1||
59870858|NCT03566810|75994917|FG002|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0||
59870859|NCT03566810|75994918|FG003|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0||
59870860|NCT03566810|75994915|FG000|STARTED|Treatment Period 2 (Day 8- Day 10)||19||
59870861|NCT03566810|75994916|FG001|STARTED|Treatment Period 2 (Day 8- Day 10)||18||
59870862|NCT03566810|75994917|FG002|STARTED|Treatment Period 2 (Day 8- Day 10)||8||
59870863|NCT03566810|75994918|FG003|STARTED|Treatment Period 2 (Day 8- Day 10)||8||
59870864|NCT03566810|75994915|FG000|COMPLETED|Treatment Period 2 (Day 8- Day 10)||19||
59870865|NCT03566810|75994916|FG001|COMPLETED|Treatment Period 2 (Day 8- Day 10)||18||
59870866|NCT03566810|75994917|FG002|COMPLETED|Treatment Period 2 (Day 8- Day 10)||8||
59870867|NCT03566810|75994918|FG003|COMPLETED|Treatment Period 2 (Day 8- Day 10)||8||
59870868|NCT03566810|75994915|FG000|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0||
59870869|NCT03566810|75994916|FG001|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0||
59951246|NCT03743415|76070177|FG002|COMPLETED|Overall Study||37||
59870870|NCT03566810|75994917|FG002|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0||
59870871|NCT03566810|75994918|FG003|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0||
59870872|NCT04013932|75994930|FG000|STARTED|Overall Study||33||
59870873|NCT04013932|75994931|FG001|STARTED|Overall Study||33||
59870874|NCT04013932|75994930|FG000|COMPLETED|Overall Study||33||
59870875|NCT04013932|75994931|FG001|COMPLETED|Overall Study||28||
59870876|NCT04013932|75994930|FG000|NOT COMPLETED|Overall Study||0||
59870877|NCT04013932|75994931|FG001|NOT COMPLETED|Overall Study||5||
59870878|NCT03628716|75994941|FG000|STARTED|Overall Study||19||
59870879|NCT03628716|75994942|FG001|STARTED|Overall Study||24||
59870880|NCT03628716|75994941|FG000|COMPLETED|Overall Study||0||
59870881|NCT03628716|75994942|FG001|COMPLETED|Overall Study||1||
59870882|NCT03628716|75994941|FG000|NOT COMPLETED|Overall Study||19||
59870883|NCT03628716|75994942|FG001|NOT COMPLETED|Overall Study||23||
59870884|NCT04002960|75994950|FG000|STARTED|Overall Study||23||
59870885|NCT04002960|75994950|FG000|COMPLETED|Overall Study||21||
59870886|NCT04002960|75994950|FG000|NOT COMPLETED|Overall Study||2||
59870887|NCT04002648|75994956|FG000|STARTED|Overall Study||104||
59870888|NCT04002648|75994957|FG001|STARTED|Overall Study||104||
59870889|NCT04002648|75994956|FG000|COMPLETED|Overall Study||102||
59870890|NCT04002648|75994957|FG001|COMPLETED|Overall Study||104||
59870891|NCT04002648|75994956|FG000|NOT COMPLETED|Overall Study||2||
59870892|NCT04002648|75994957|FG001|NOT COMPLETED|Overall Study||0||
59870893|NCT03840616|75994965|FG000|STARTED|2-Week Induction Phase||147||
59870894|NCT03840616|75994966|FG001|STARTED|2-Week Induction Phase||72||
59870895|NCT03840616|75994965|FG000|COMPLETED|2-Week Induction Phase||123||
59870896|NCT03840616|75994966|FG001|COMPLETED|2-Week Induction Phase||62||
59870897|NCT03840616|75994965|FG000|NOT COMPLETED|2-Week Induction Phase||24||
59870898|NCT03840616|75994966|FG001|NOT COMPLETED|2-Week Induction Phase||10||
59870899|NCT03840616|75994965|FG000|STARTED|48-Week Maintenance Phase||123||
59870900|NCT03840616|75994966|FG001|STARTED|48-Week Maintenance Phase||62||
59870901|NCT03840616|75994965|FG000|COMPLETED|48-Week Maintenance Phase||112||
59870902|NCT03840616|75994966|FG001|COMPLETED|48-Week Maintenance Phase||55||
59870903|NCT03840616|75994965|FG000|NOT COMPLETED|48-Week Maintenance Phase||11||
59870904|NCT03840616|75994966|FG001|NOT COMPLETED|48-Week Maintenance Phase||7||
59870905|NCT00088413|75994978|FG000|STARTED|Overall Study||10||
59870906|NCT00088413|75994979|FG001|STARTED|Overall Study||15||
59870907|NCT00088413|75994980|FG002|STARTED|Overall Study||12||
59870908|NCT00088413|75994981|FG003|STARTED|Overall Study||14||
59870909|NCT00088413|75994978|FG000|COMPLETED|Overall Study||0||
59870910|NCT00088413|75994979|FG001|COMPLETED|Overall Study||0||
59870911|NCT00088413|75994980|FG002|COMPLETED|Overall Study||0||
59870912|NCT00088413|75994981|FG003|COMPLETED|Overall Study||0||
59870913|NCT00088413|75994978|FG000|NOT COMPLETED|Overall Study||10||
59870914|NCT00088413|75994979|FG001|NOT COMPLETED|Overall Study||15||
59870915|NCT00088413|75994980|FG002|NOT COMPLETED|Overall Study||12||
59870916|NCT00088413|75994981|FG003|NOT COMPLETED|Overall Study||14||
59870917|NCT03995784|75994993|FG000|STARTED|Overall Study||6||
59870918|NCT03995784|75994993|FG000|COMPLETED|Overall Study||5||
59870919|NCT03995784|75994993|FG000|NOT COMPLETED|Overall Study||1||
59870920|NCT00086385|75995008|FG000|STARTED|Overall Study||100||
59870921|NCT00086385|75995009|FG001|STARTED|Overall Study||99||
59870922|NCT00086385|75995010|FG002|STARTED|Overall Study||104||
59870923|NCT00086385|75995011|FG003|STARTED|Overall Study||99||
59870924|NCT00086385|75995008|FG000|COMPLETED|Overall Study||98||
59870925|NCT00086385|75995009|FG001|COMPLETED|Overall Study||97||
59870926|NCT00086385|75995010|FG002|COMPLETED|Overall Study||103||
59870927|NCT00086385|75995011|FG003|COMPLETED|Overall Study||98||
59870928|NCT00086385|75995008|FG000|NOT COMPLETED|Overall Study||2||
59870929|NCT00086385|75995009|FG001|NOT COMPLETED|Overall Study||2||
59870930|NCT00086385|75995010|FG002|NOT COMPLETED|Overall Study||1||
59870931|NCT00086385|75995011|FG003|NOT COMPLETED|Overall Study||1||
59870932|NCT03993288|75995023|FG000|STARTED|Overall Study||133|All randomized participants|
59870933|NCT03993288|75995024|FG001|STARTED|Overall Study||134|All randomized participants|
59870934|NCT03993288|75995023|FG000|Intention-to-treat (ITT) Population|Overall Study||123|All randomized participants who received at least one dose of the investigational product or comparator and had hemoglobin data both before and after treatment|
59870935|NCT03993288|75995024|FG001|Intention-to-treat (ITT) Population|Overall Study||129|All randomized participants who received at least one dose of the investigational product or comparator and had hemoglobin data both before and after treatment|
59870936|NCT03993288|75995023|FG000|Safety Analysis Set|Overall Study||133|All randomized participants who received at least one dose of the test drug/comparator drug|
59870937|NCT03993288|75995024|FG001|Safety Analysis Set|Overall Study||134|All randomized participants who received at least one dose of the test drug/comparator drug|
59870938|NCT03993288|75995023|FG000|COMPLETED|Overall Study||123||
59870939|NCT03993288|75995024|FG001|COMPLETED|Overall Study||129||
59870940|NCT03993288|75995023|FG000|NOT COMPLETED|Overall Study||10||
59870941|NCT03993288|75995024|FG001|NOT COMPLETED|Overall Study||5||
59870942|NCT03991494|75995030|FG000|STARTED|Overall Study||4||
59870943|NCT03991494|75995030|FG000|COMPLETED|Overall Study||0||
59870944|NCT03991494|75995030|FG000|NOT COMPLETED|Overall Study||4||
59870945|NCT00086307|75995039|FG000|STARTED|Overall Study||13||
59870946|NCT00086307|75995040|FG001|STARTED|Overall Study||13||
59870947|NCT00086307|75995041|FG002|STARTED|Overall Study||13||
59870948|NCT00086307|75995039|FG000|COMPLETED|Overall Study||11||
59870949|NCT00086307|75995040|FG001|COMPLETED|Overall Study||12||
59870950|NCT00086307|75995041|FG002|COMPLETED|Overall Study||5||
59870951|NCT00086307|75995039|FG000|NOT COMPLETED|Overall Study||2||
59870952|NCT00086307|75995040|FG001|NOT COMPLETED|Overall Study||1||
59870953|NCT00086307|75995041|FG002|NOT COMPLETED|Overall Study||8||
59870954|NCT03624972|75995052|FG000|STARTED|Overall Study||71||
59870955|NCT03624972|75995053|FG001|STARTED|Overall Study||73||
59870956|NCT03624972|75995054|FG002|STARTED|Overall Study||9||
59870957|NCT03624972|75995052|FG000|COMPLETED|Overall Study||69||
59870958|NCT03624972|75995053|FG001|COMPLETED|Overall Study||71||
59870959|NCT03624972|75995054|FG002|COMPLETED|Overall Study||9||
59870960|NCT03624972|75995052|FG000|NOT COMPLETED|Overall Study||2||
59870961|NCT03624972|75995053|FG001|NOT COMPLETED|Overall Study||2||
59870962|NCT03624972|75995054|FG002|NOT COMPLETED|Overall Study||0||
59870963|NCT03988842|75995063|FG000|STARTED|Overall Study||4||
59870964|NCT03988842|75995063|FG000|COMPLETED|Overall Study||3||
59870965|NCT03988842|75995063|FG000|NOT COMPLETED|Overall Study||1||
59870966|NCT02668822|75995070|FG000|STARTED|Overall Study||9||
59870967|NCT02668822|75995071|FG001|STARTED|Overall Study||9||
59870968|NCT02668822|75995070|FG000|COMPLETED|Overall Study||0||
59870969|NCT02668822|75995071|FG001|COMPLETED|Overall Study||0||
59870970|NCT02668822|75995070|FG000|NOT COMPLETED|Overall Study||9||
59870971|NCT02668822|75995071|FG001|NOT COMPLETED|Overall Study||9||
59870972|NCT02524288|75995077|FG000|STARTED|Overall Study||1941||
59870973|NCT02524288|75995077|FG000|Treated|Overall Study||1936||
59870974|NCT02524288|75995077|FG000|COMPLETED|Overall Study||0||
59870975|NCT02524288|75995077|FG000|NOT COMPLETED|Overall Study||1941||
59870976|NCT03624504|75995081|FG000|STARTED|Overall Study||82||
59870977|NCT03624504|75995081|FG000|COMPLETED|Overall Study||81||
59870978|NCT03624504|75995081|FG000|NOT COMPLETED|Overall Study||1||
59870979|NCT02954952|75995088|FG000|STARTED|Overall Study||36||
59870980|NCT02954952|75995089|FG001|STARTED|Overall Study||5||
59870981|NCT02954952|75995090|FG002|STARTED|Overall Study||3||
59870982|NCT02954952|75995088|FG000|COMPLETED|Overall Study||35||
59870983|NCT02954952|75995089|FG001|COMPLETED|Overall Study||4||
59870984|NCT02954952|75995090|FG002|COMPLETED|Overall Study||3||
59870985|NCT02954952|75995088|FG000|NOT COMPLETED|Overall Study||1||
59870986|NCT02954952|75995089|FG001|NOT COMPLETED|Overall Study||1||
59870987|NCT02954952|75995090|FG002|NOT COMPLETED|Overall Study||0||
59870988|NCT03547154|75995100|FG000|STARTED|Overall Study||173||
59870989|NCT03547154|75995101|FG001|STARTED|Overall Study||171||
59870990|NCT03547154|75995100|FG000|COMPLETED|Overall Study||50||
59870991|NCT03547154|75995101|FG001|COMPLETED|Overall Study||55||
59870992|NCT03547154|75995100|FG000|NOT COMPLETED|Overall Study||123||
59870993|NCT03547154|75995101|FG001|NOT COMPLETED|Overall Study||116||
59870994|NCT02275546|75995107|FG000|STARTED|Treatment Period 1||81||
59870995|NCT02275546|75995108|FG001|STARTED|Treatment Period 1||83||
59870996|NCT02275546|75995107|FG000|COMPLETED|Treatment Period 1||81||
59870997|NCT02275546|75995108|FG001|COMPLETED|Treatment Period 1||83||
59870998|NCT02275546|75995107|FG000|NOT COMPLETED|Treatment Period 1||0||
59870999|NCT02275546|75995108|FG001|NOT COMPLETED|Treatment Period 1||0||
59871000|NCT02275546|75995107|FG000|STARTED|Treatment Period 2||81||
59871001|NCT02275546|75995108|FG001|STARTED|Treatment Period 2||83||
59871002|NCT02275546|75995107|FG000|COMPLETED|Treatment Period 2||79||
59871003|NCT02275546|75995108|FG001|COMPLETED|Treatment Period 2||81||
59871004|NCT02275546|75995107|FG000|NOT COMPLETED|Treatment Period 2||2||
59871005|NCT02275546|75995108|FG001|NOT COMPLETED|Treatment Period 2||2||
59871006|NCT03624192|75995114|FG000|STARTED|Overall Study||3||3
59871007|NCT03624192|75995115|FG001|STARTED|Overall Study||3||3
59871008|NCT03624192|75995114|FG000|COMPLETED|Overall Study||2||2
59871009|NCT03624192|75995115|FG001|COMPLETED|Overall Study||2||2
59871010|NCT03624192|75995114|FG000|NOT COMPLETED|Overall Study||1||1
59871011|NCT03624192|75995115|FG001|NOT COMPLETED|Overall Study||1||1
59871012|NCT03034954|75995125|FG000|STARTED|Overall Study||21||
59871013|NCT03034954|75995126|FG001|STARTED|Overall Study||21||
59871014|NCT03034954|75995125|FG000|COMPLETED|Overall Study||20||
59871015|NCT03034954|75995126|FG001|COMPLETED|Overall Study||21||
59871016|NCT03034954|75995125|FG000|NOT COMPLETED|Overall Study||1||
59871017|NCT03034954|75995126|FG001|NOT COMPLETED|Overall Study||0||
59871018|NCT03546842|75995132|FG000|STARTED|Overall Study||201||
59871019|NCT03546842|75995132|FG000|Vaccination 1|Overall Study||200||
59871020|NCT03546842|75995132|FG000|Vaccination 2|Overall Study||200||
59871021|NCT03546842|75995132|FG000|Vaccination 3|Overall Study||198||
59871022|NCT03546842|75995132|FG000|COMPLETED|Overall Study||198||
59871023|NCT03546842|75995132|FG000|NOT COMPLETED|Overall Study||3||
59871024|NCT03640052|75995136|FG000|STARTED|Overall Study||2||
59871025|NCT03640052|75995137|FG001|STARTED|Overall Study||1||
59871026|NCT03640052|75995138|FG002|STARTED|Overall Study||1||
59871027|NCT03640052|75995139|FG003|STARTED|Overall Study||1||
59871028|NCT03640052|75995140|FG004|STARTED|Overall Study||1||
59871029|NCT03640052|75995136|FG000|COMPLETED|Overall Study||2||
59871030|NCT03640052|75995137|FG001|COMPLETED|Overall Study|the patient performed 4 out of 5 nights|0||
59871031|NCT03640052|75995138|FG002|COMPLETED|Overall Study||1||
59871032|NCT03640052|75995139|FG003|COMPLETED|Overall Study||1||
59871033|NCT03640052|75995140|FG004|COMPLETED|Overall Study||1||
59871034|NCT03640052|75995136|FG000|NOT COMPLETED|Overall Study||0||
59871035|NCT03640052|75995137|FG001|NOT COMPLETED|Overall Study||1||
59871036|NCT03640052|75995138|FG002|NOT COMPLETED|Overall Study||0||
59871037|NCT03640052|75995139|FG003|NOT COMPLETED|Overall Study||0||
59871038|NCT03640052|75995140|FG004|NOT COMPLETED|Overall Study||0||
59871039|NCT00068601|75995154|FG000|STARTED|Overall Study||131||
59871040|NCT00068601|75995155|FG001|STARTED|Overall Study||126||
59871041|NCT00068601|75995154|FG000|COMPLETED|Overall Study||69||
59871042|NCT00068601|75995155|FG001|COMPLETED|Overall Study||66||
59871043|NCT00068601|75995154|FG000|NOT COMPLETED|Overall Study||62||
59871044|NCT00068601|75995155|FG001|NOT COMPLETED|Overall Study||60||
59871045|NCT03638258|75995164|FG000|STARTED|Overall Study||109||
59871046|NCT03638258|75995165|FG001|STARTED|Overall Study||113||
59871047|NCT03638258|75995166|FG002|STARTED|Overall Study||109||
59871048|NCT03638258|75995164|FG000|COMPLETED|Overall Study||102||
59871049|NCT03638258|75995165|FG001|COMPLETED|Overall Study||104||
59871050|NCT03638258|75995166|FG002|COMPLETED|Overall Study||86||
59871051|NCT03638258|75995164|FG000|NOT COMPLETED|Overall Study||7||
59871052|NCT03638258|75995165|FG001|NOT COMPLETED|Overall Study||9||
59871053|NCT03638258|75995166|FG002|NOT COMPLETED|Overall Study||23||
59871054|NCT01670656|75995180|FG000|STARTED|Overall Study||86||
59871055|NCT01670656|75995181|FG001|STARTED|Overall Study||91||
59871056|NCT01670656|75995182|FG002|STARTED|Overall Study||87||
59871057|NCT01670656|75995183|FG003|STARTED|Overall Study||85||
59871058|NCT01670656|75995184|FG004|STARTED|Overall Study||90||
59871059|NCT01670656|75995180|FG000|Treated|Overall Study||86||
59871060|NCT01670656|75995181|FG001|Treated|Overall Study||91||
59871061|NCT01670656|75995182|FG002|Treated|Overall Study||86||
59871062|NCT01670656|75995183|FG003|Treated|Overall Study||85||
59871063|NCT01670656|75995184|FG004|Treated|Overall Study||90||
59871064|NCT01670656|75995180|FG000|COMPLETED|Overall Study||83||
59871065|NCT01670656|75995181|FG001|COMPLETED|Overall Study||84||
59871066|NCT01670656|75995182|FG002|COMPLETED|Overall Study||79||
59871067|NCT01670656|75995183|FG003|COMPLETED|Overall Study||79||
59871068|NCT01670656|75995184|FG004|COMPLETED|Overall Study||79||
59871069|NCT01670656|75995180|FG000|NOT COMPLETED|Overall Study||3||
59871070|NCT01670656|75995181|FG001|NOT COMPLETED|Overall Study||7||
59871071|NCT01670656|75995182|FG002|NOT COMPLETED|Overall Study||8||
59871072|NCT01670656|75995183|FG003|NOT COMPLETED|Overall Study||6||
59871073|NCT01670656|75995184|FG004|NOT COMPLETED|Overall Study||11||
59871074|NCT00068445|75995198|FG000|STARTED|Randomization||65||
59871075|NCT00068445|75995199|FG001|STARTED|Randomization||66||
59871076|NCT00068445|75995198|FG000|COMPLETED|Randomization||63||
59871077|NCT00068445|75995199|FG001|COMPLETED|Randomization||62||
59871078|NCT00068445|75995198|FG000|NOT COMPLETED|Randomization||2||
59871079|NCT00068445|75995199|FG001|NOT COMPLETED|Randomization||4||
59871080|NCT00068445|75995198|FG000|STARTED|Treatment||63||
59871081|NCT00068445|75995199|FG001|STARTED|Treatment||62||
59871082|NCT00068445|75995198|FG000|COMPLETED|Treatment||34||
59871083|NCT00068445|75995199|FG001|COMPLETED|Treatment||46||
59871084|NCT00068445|75995198|FG000|NOT COMPLETED|Treatment||29||
59871085|NCT00068445|75995199|FG001|NOT COMPLETED|Treatment||16||
59871086|NCT03653208|75995214|FG000|STARTED|Overall Study||3||
59871087|NCT03653208|75995215|FG001|STARTED|Overall Study||3||
59871088|NCT03653208|75995216|FG002|STARTED|Overall Study||6||
59871089|NCT03653208|75995217|FG003|STARTED|Overall Study||6||
59871090|NCT03653208|75995218|FG004|STARTED|Overall Study||6||
59871091|NCT03653208|75995219|FG005|STARTED|Overall Study||6||
59871092|NCT03653208|75995220|FG006|STARTED|Overall Study||6||
59871093|NCT03653208|75995221|FG007|STARTED|Overall Study||6||
59871094|NCT03653208|75995222|FG008|STARTED|Overall Study||14||
59871095|NCT03653208|75995214|FG000|COMPLETED|Overall Study||3||
59871096|NCT03653208|75995215|FG001|COMPLETED|Overall Study||3||
59871097|NCT03653208|75995216|FG002|COMPLETED|Overall Study||6||
59871098|NCT03653208|75995217|FG003|COMPLETED|Overall Study||6||
59871099|NCT03653208|75995218|FG004|COMPLETED|Overall Study||5||
59871100|NCT03653208|75995219|FG005|COMPLETED|Overall Study||6||
59871101|NCT03653208|75995220|FG006|COMPLETED|Overall Study||6||
59871102|NCT03653208|75995221|FG007|COMPLETED|Overall Study||5||
59871103|NCT03653208|75995222|FG008|COMPLETED|Overall Study||13||
59871104|NCT03653208|75995214|FG000|NOT COMPLETED|Overall Study||0||
59871105|NCT03653208|75995215|FG001|NOT COMPLETED|Overall Study||0||
59871106|NCT03653208|75995216|FG002|NOT COMPLETED|Overall Study||0||
59871107|NCT03653208|75995217|FG003|NOT COMPLETED|Overall Study||0||
59871108|NCT03653208|75995218|FG004|NOT COMPLETED|Overall Study||1||
59871109|NCT03653208|75995219|FG005|NOT COMPLETED|Overall Study||0||
59871110|NCT03653208|75995220|FG006|NOT COMPLETED|Overall Study||0||
59871111|NCT03653208|75995221|FG007|NOT COMPLETED|Overall Study||1||
59871112|NCT03653208|75995222|FG008|NOT COMPLETED|Overall Study||1||
59871113|NCT03545984|75995244|FG000|STARTED|Overall Study||24||
59871114|NCT03545984|75995245|FG001|STARTED|Overall Study||24||
59871115|NCT03545984|75995244|FG000|COMPLETED|Overall Study||13||
59871116|NCT03545984|75995245|FG001|COMPLETED|Overall Study||15||
59871117|NCT03545984|75995244|FG000|NOT COMPLETED|Overall Study||11||
59871118|NCT03545984|75995245|FG001|NOT COMPLETED|Overall Study||9||
59871119|NCT03033784|75995253|FG000|STARTED|Overall Study||9|Clinical visit 1|
59871120|NCT03033784|75995254|FG001|STARTED|Overall Study||2|Clinical visit 1|
59871121|NCT03033784|75995255|FG002|STARTED|Overall Study||4|Clinical visit 1|
59871122|NCT03033784|75995256|FG003|STARTED|Overall Study||4|Clinical visit 1|
59871123|NCT03033784|75995257|FG004|STARTED|Overall Study||3|Clinical visit 1|
59871124|NCT03033784|75995258|FG005|STARTED|Overall Study||2|Clinical visit 1|
59871125|NCT03033784|75995259|FG006|STARTED|Overall Study||2|Clinical visit 1|
59871126|NCT03033784|75995260|FG007|STARTED|Overall Study||2|Clinical visit 1|
59871127|NCT03033784|75995261|FG008|STARTED|Overall Study||1|Clinical visit 1|
59871128|NCT03033784|75995262|FG009|STARTED|Overall Study||1|Clinical visit 1|
59871129|NCT03033784|75995263|FG010|STARTED|Overall Study||1|Clinical visit 1|
59871130|NCT03033784|75995264|FG011|STARTED|Overall Study||1|Clinical visit 1|
59871131|NCT03033784|75995265|FG012|STARTED|Overall Study||19|Clinical visit 1|
59871132|NCT03033784|75995253|FG000|Clinical Visit 2|Overall Study||9||
59871133|NCT03033784|75995254|FG001|Clinical Visit 2|Overall Study||2||
59871134|NCT03033784|75995255|FG002|Clinical Visit 2|Overall Study||4||
59871135|NCT03033784|75995256|FG003|Clinical Visit 2|Overall Study||4||
59871136|NCT03033784|75995257|FG004|Clinical Visit 2|Overall Study||3||
59871137|NCT03033784|75995258|FG005|Clinical Visit 2|Overall Study||2||
59871138|NCT03033784|75995259|FG006|Clinical Visit 2|Overall Study||2||
59871139|NCT03033784|75995260|FG007|Clinical Visit 2|Overall Study||2||
59871140|NCT03033784|75995261|FG008|Clinical Visit 2|Overall Study||1||
59871141|NCT03033784|75995262|FG009|Clinical Visit 2|Overall Study||1||
59871142|NCT03033784|75995263|FG010|Clinical Visit 2|Overall Study||1||
59871143|NCT03033784|75995264|FG011|Clinical Visit 2|Overall Study||1||
59871144|NCT03033784|75995265|FG012|Clinical Visit 2|Overall Study||17||
59871145|NCT03033784|75995253|FG000|Clinical Visit 3|Overall Study||9||
59871146|NCT03033784|75995254|FG001|Clinical Visit 3|Overall Study||1||
59871147|NCT03033784|75995255|FG002|Clinical Visit 3|Overall Study||4||
59871148|NCT03033784|75995256|FG003|Clinical Visit 3|Overall Study||4||
59871149|NCT03033784|75995257|FG004|Clinical Visit 3|Overall Study||3||
59871150|NCT03033784|75995258|FG005|Clinical Visit 3|Overall Study||2||
59871151|NCT03033784|75995259|FG006|Clinical Visit 3|Overall Study||2||
59871152|NCT03033784|75995260|FG007|Clinical Visit 3|Overall Study||2||
59871153|NCT03033784|75995261|FG008|Clinical Visit 3|Overall Study||1||
59871154|NCT03033784|75995262|FG009|Clinical Visit 3|Overall Study||1||
59871155|NCT03033784|75995263|FG010|Clinical Visit 3|Overall Study||1||
59871156|NCT03033784|75995264|FG011|Clinical Visit 3|Overall Study||1||
59871157|NCT03033784|75995265|FG012|Clinical Visit 3|Overall Study||0||
59871158|NCT03033784|75995253|FG000|Clinical Visit 4|Overall Study||9||
59871159|NCT03033784|75995254|FG001|Clinical Visit 4|Overall Study||1||
59871160|NCT03033784|75995255|FG002|Clinical Visit 4|Overall Study||4||
59871161|NCT03033784|75995256|FG003|Clinical Visit 4|Overall Study||4||
59871162|NCT03033784|75995257|FG004|Clinical Visit 4|Overall Study||3||
59871163|NCT03033784|75995258|FG005|Clinical Visit 4|Overall Study||2||
59871164|NCT03033784|75995259|FG006|Clinical Visit 4|Overall Study||2||
59871165|NCT03033784|75995260|FG007|Clinical Visit 4|Overall Study||2||
59871166|NCT03033784|75995261|FG008|Clinical Visit 4|Overall Study||1||
59871167|NCT03033784|75995262|FG009|Clinical Visit 4|Overall Study||1||
59871168|NCT03033784|75995263|FG010|Clinical Visit 4|Overall Study||1||
59871169|NCT03033784|75995264|FG011|Clinical Visit 4|Overall Study||1||
59871170|NCT03033784|75995265|FG012|Clinical Visit 4|Overall Study||0||
59871171|NCT03033784|75995253|FG000|COMPLETED|Overall Study||9|Clinical Visit 4|
59871172|NCT03033784|75995254|FG001|COMPLETED|Overall Study||1|Clinical Visit 4|
59871173|NCT03033784|75995255|FG002|COMPLETED|Overall Study||4|Clinical Visit 4|
59871174|NCT03033784|75995256|FG003|COMPLETED|Overall Study||4|Clinical Visit 4|
59871175|NCT03033784|75995257|FG004|COMPLETED|Overall Study||3|Clinical Visit 4|
59871176|NCT03033784|75995258|FG005|COMPLETED|Overall Study||2|Clinical Visit 4|
59871177|NCT03033784|75995259|FG006|COMPLETED|Overall Study||2|Clinical Visit 4|
59871178|NCT03033784|75995260|FG007|COMPLETED|Overall Study||2|Clinical Visit 4|
59871179|NCT03033784|75995261|FG008|COMPLETED|Overall Study||1|Clinical Visit 4|
59871180|NCT03033784|75995262|FG009|COMPLETED|Overall Study||1|Clinical Visit 4|
59871181|NCT03033784|75995263|FG010|COMPLETED|Overall Study||1|Clinical Visit 4|
59871182|NCT03033784|75995264|FG011|COMPLETED|Overall Study||1|Clinical Visit 4|
59871183|NCT03033784|75995265|FG012|COMPLETED|Overall Study||17|Clinical Visit 4|
59871184|NCT03033784|75995253|FG000|NOT COMPLETED|Overall Study||0||
59871185|NCT03033784|75995254|FG001|NOT COMPLETED|Overall Study||1||
59871186|NCT03033784|75995255|FG002|NOT COMPLETED|Overall Study||0||
59871187|NCT03033784|75995256|FG003|NOT COMPLETED|Overall Study||0||
59871188|NCT03033784|75995257|FG004|NOT COMPLETED|Overall Study||0||
59871189|NCT03033784|75995258|FG005|NOT COMPLETED|Overall Study||0||
59871190|NCT03033784|75995259|FG006|NOT COMPLETED|Overall Study||0||
59871191|NCT03033784|75995260|FG007|NOT COMPLETED|Overall Study||0||
59871192|NCT03033784|75995261|FG008|NOT COMPLETED|Overall Study||0||
59871193|NCT03033784|75995262|FG009|NOT COMPLETED|Overall Study||0||
59871194|NCT03033784|75995263|FG010|NOT COMPLETED|Overall Study||0||
59871195|NCT03033784|75995264|FG011|NOT COMPLETED|Overall Study||0||
59871196|NCT03033784|75995265|FG012|NOT COMPLETED|Overall Study||2||
59871197|NCT00038649|75995276|FG000|STARTED|Overall Study||114||
59871198|NCT00038649|75995276|FG000|COMPLETED|Overall Study||105||
59871199|NCT00038649|75995276|FG000|NOT COMPLETED|Overall Study||9||
59871200|NCT03544268|75995282|FG000|STARTED|Overall Study||5||
59871201|NCT03544268|75995283|FG001|STARTED|Overall Study||15||
59871202|NCT03544268|75995282|FG000|COMPLETED|Overall Study||3||
59871203|NCT03544268|75995283|FG001|COMPLETED|Overall Study||15||
59871204|NCT03544268|75995282|FG000|NOT COMPLETED|Overall Study||2||
59871205|NCT03544268|75995283|FG001|NOT COMPLETED|Overall Study||0||
59871206|NCT03652818|75995294|FG000|STARTED|Overall Study||24||
59871207|NCT03652818|75995295|FG001|STARTED|Overall Study||23||
59871208|NCT03652818|75995296|FG002|STARTED|Overall Study||22||
59871209|NCT03652818|75995297|FG003|STARTED|Overall Study||23||
59871210|NCT03652818|75995298|FG004|STARTED|Overall Study||23||
59871211|NCT03652818|75995294|FG000|COMPLETED|Overall Study||22||
59871212|NCT03652818|75995295|FG001|COMPLETED|Overall Study||22||
59871213|NCT03652818|75995296|FG002|COMPLETED|Overall Study||20||
59871214|NCT03652818|75995297|FG003|COMPLETED|Overall Study||22||
59871215|NCT03652818|75995298|FG004|COMPLETED|Overall Study||22||
59871216|NCT03652818|75995294|FG000|NOT COMPLETED|Overall Study||2||
59871217|NCT03652818|75995295|FG001|NOT COMPLETED|Overall Study||1||
59871218|NCT03652818|75995296|FG002|NOT COMPLETED|Overall Study||2||
59871219|NCT03652818|75995297|FG003|NOT COMPLETED|Overall Study||1||
59871220|NCT03652818|75995298|FG004|NOT COMPLETED|Overall Study||1||
59871221|NCT03619902|75995310|FG000|STARTED|Overall Study||8||
59871222|NCT03619902|75995310|FG000|COMPLETED|Overall Study||6||
59871223|NCT03619902|75995310|FG000|NOT COMPLETED|Overall Study||2||
59871224|NCT00620464|75995316|FG000|STARTED|Overall Study||52||
59871225|NCT00620464|75995317|FG001|STARTED|Overall Study||56||
59871226|NCT00620464|75995316|FG000|COMPLETED|Overall Study||32||
59871227|NCT00620464|75995317|FG001|COMPLETED|Overall Study||32||
59871228|NCT00620464|75995316|FG000|NOT COMPLETED|Overall Study||20||
59871229|NCT00620464|75995317|FG001|NOT COMPLETED|Overall Study||24||
59871230|NCT03652662|75995325|FG000|STARTED|Overall Study||18||
59871231|NCT03652662|75995326|FG001|STARTED|Overall Study||16||
59871232|NCT03652662|75995325|FG000|COMPLETED|Overall Study||15||
59871233|NCT03652662|75995326|FG001|COMPLETED|Overall Study||15||
59871234|NCT03652662|75995325|FG000|NOT COMPLETED|Overall Study||3||
59871235|NCT03652662|75995326|FG001|NOT COMPLETED|Overall Study||1||
59871236|NCT03560258|75995335|FG000|STARTED|Overall Study||22||
59871237|NCT03560258|75995336|FG001|STARTED|Overall Study||11||
59871238|NCT03560258|75995337|FG002|STARTED|Overall Study||12||
59871239|NCT03560258|75995335|FG000|Received at Least 1 Dose of Treatment|Overall Study||22||
59871240|NCT03560258|75995336|FG001|Received at Least 1 Dose of Treatment|Overall Study||10||
59871241|NCT03560258|75995337|FG002|Received at Least 1 Dose of Treatment|Overall Study||12||
59871242|NCT03560258|75995335|FG000|COMPLETED|Overall Study||19||
59871243|NCT03560258|75995336|FG001|COMPLETED|Overall Study||10||
59871244|NCT03560258|75995337|FG002|COMPLETED|Overall Study||11||
59871245|NCT03560258|75995335|FG000|NOT COMPLETED|Overall Study||3||
59871246|NCT03560258|75995336|FG001|NOT COMPLETED|Overall Study||1||
59871247|NCT03560258|75995337|FG002|NOT COMPLETED|Overall Study||1||
59871248|NCT02768662|75995345|FG000|STARTED|Overall Study||142||
59871249|NCT02768662|75995345|FG000|COMPLETED|Overall Study||56||
59871250|NCT02768662|75995345|FG000|NOT COMPLETED|Overall Study||86||
59871251|NCT03539432|75995351|FG000|STARTED|Overall Study||2||
59871252|NCT03539432|75995352|FG001|STARTED|Overall Study||1||
59871253|NCT03539432|75995351|FG000|COMPLETED|Overall Study||2||
59871254|NCT03539432|75995352|FG001|COMPLETED|Overall Study||0||
59871255|NCT03539432|75995351|FG000|NOT COMPLETED|Overall Study||0||
59871256|NCT03539432|75995352|FG001|NOT COMPLETED|Overall Study||1||
59871257|NCT03615924|75995360|FG000|STARTED|Overall Study||101|Randomized to treatment.|
59871258|NCT03615924|75995361|FG001|STARTED|Overall Study||92|Randomized to treatment.|
59871259|NCT03615924|75995360|FG000|Received Treatment|Overall Study||101||
59871260|NCT03615924|75995361|FG001|Received Treatment|Overall Study||92||
59871261|NCT03615924|75995360|FG000|COMPLETED|Overall Study||0|Completed the study.|
59871262|NCT03615924|75995361|FG001|COMPLETED|Overall Study||0|Completed the study.|
59871263|NCT03615924|75995360|FG000|NOT COMPLETED|Overall Study||101||
59871264|NCT03615924|75995361|FG001|NOT COMPLETED|Overall Study||92||
59871265|NCT03535844|75995369|FG000|STARTED|Overall Study||22||
59871266|NCT03535844|75995370|FG001|STARTED|Overall Study||19||
59871267|NCT03535844|75995369|FG000|COMPLETED|Overall Study||22||
59871268|NCT03535844|75995370|FG001|COMPLETED|Overall Study||18||
59871269|NCT03535844|75995369|FG000|NOT COMPLETED|Overall Study||0||
59871270|NCT03535844|75995370|FG001|NOT COMPLETED|Overall Study||1||
59871271|NCT03533114|75995378|FG000|STARTED|Overall||88||
59871272|NCT03533114|75995379|FG001|STARTED|Overall||66||
59871273|NCT03533114|75995378|FG000|COMPLETED|Overall||57||
59871274|NCT03533114|75995379|FG001|COMPLETED|Overall||38||
59871275|NCT03533114|75995378|FG000|NOT COMPLETED|Overall||31||
59871276|NCT03533114|75995379|FG001|NOT COMPLETED|Overall||28||
59871277|NCT03533114|75995378|FG000|STARTED|Open Label Titration and Optimization||88||
59871278|NCT03533114|75995379|FG001|STARTED|Open Label Titration and Optimization||66||
59871279|NCT03533114|75995378|FG000|COMPLETED|Open Label Titration and Optimization||72||
59951247|NCT03743415|76070178|FG003|COMPLETED|Overall Study||87||
59871280|NCT03533114|75995379|FG001|COMPLETED|Open Label Titration and Optimization||53||
59871281|NCT03533114|75995378|FG000|NOT COMPLETED|Open Label Titration and Optimization||16||
59871282|NCT03533114|75995379|FG001|NOT COMPLETED|Open Label Titration and Optimization||13||
59871283|NCT03533114|75995378|FG000|STARTED|Stable Dose||71||
59871284|NCT03533114|75995379|FG001|STARTED|Stable Dose||52||
59871285|NCT03533114|75995378|FG000|COMPLETED|Stable Dose||69||
59871286|NCT03533114|75995379|FG001|COMPLETED|Stable Dose||50||
59871287|NCT03533114|75995378|FG000|NOT COMPLETED|Stable Dose||2||
59871288|NCT03533114|75995379|FG001|NOT COMPLETED|Stable Dose||2||
59871289|NCT03533114|75995378|FG000|STARTED|Double Blind Randomized-Withdrawal||69||
59871290|NCT03533114|75995379|FG001|STARTED|Double Blind Randomized-Withdrawal||47||
59871291|NCT03533114|75995378|FG000|JZP-258|Double Blind Randomized-Withdrawal||57||
59871292|NCT03533114|75995379|FG001|JZP-258|Double Blind Randomized-Withdrawal||0||
59871293|NCT03533114|75995378|FG000|Placebo|Double Blind Randomized-Withdrawal||0||
59871294|NCT03533114|75995379|FG001|Placebo|Double Blind Randomized-Withdrawal||59||
59871295|NCT03533114|75995378|FG000|COMPLETED|Double Blind Randomized-Withdrawal||67||
59871296|NCT03533114|75995379|FG001|COMPLETED|Double Blind Randomized-Withdrawal||46||
59871297|NCT03533114|75995378|FG000|NOT COMPLETED|Double Blind Randomized-Withdrawal||2||
59871298|NCT03533114|75995379|FG001|NOT COMPLETED|Double Blind Randomized-Withdrawal||1||
59871299|NCT03533114|75995378|FG000|STARTED|Open-Label Safety Extension||65||
59871300|NCT03533114|75995379|FG001|STARTED|Open-Label Safety Extension||41||
59871301|NCT03533114|75995378|FG000|COMPLETED|Open-Label Safety Extension||57||
59871302|NCT03533114|75995379|FG001|COMPLETED|Open-Label Safety Extension||38||
59871303|NCT03533114|75995378|FG000|NOT COMPLETED|Open-Label Safety Extension||8||
59871304|NCT03533114|75995379|FG001|NOT COMPLETED|Open-Label Safety Extension||3||
59871305|NCT03033394|75995387|FG000|STARTED|Completed Sampling||65||
59871306|NCT03033394|75995387|FG000|COMPLETED|Completed Sampling||65||
59871307|NCT03033394|75995387|FG000|NOT COMPLETED|Completed Sampling||0||
59871308|NCT03033394|75995387|FG000|STARTED|Completed Pharmacokinetic Analysis||65||
59871309|NCT03033394|75995387|FG000|COMPLETED|Completed Pharmacokinetic Analysis||59||
59871310|NCT03033394|75995387|FG000|NOT COMPLETED|Completed Pharmacokinetic Analysis||6||
59871311|NCT03033394|75995387|FG000|STARTED|Completed Final Analysis||59||
59871312|NCT03033394|75995387|FG000|COMPLETED|Completed Final Analysis||58||
59871313|NCT03033394|75995387|FG000|NOT COMPLETED|Completed Final Analysis||1||
59871314|NCT03981822|75995404|FG000|STARTED|Overall Study||5||
59871315|NCT03981822|75995405|FG001|STARTED|Overall Study||5||
59871316|NCT03981822|75995406|FG002|STARTED|Overall Study||5||
59871317|NCT03981822|75995407|FG003|STARTED|Overall Study||3||
59871318|NCT03981822|75995408|FG004|STARTED|Overall Study||25||
59871319|NCT03981822|75995409|FG005|STARTED|Overall Study||23||
59871320|NCT03981822|75995410|FG006|STARTED|Overall Study||22||
59871321|NCT03981822|75995411|FG007|STARTED|Overall Study||17||
59871322|NCT03981822|75995404|FG000|COMPLETED|Overall Study||5||
59871323|NCT03981822|75995405|FG001|COMPLETED|Overall Study||3||
59871324|NCT03981822|75995406|FG002|COMPLETED|Overall Study||4||
59871325|NCT03981822|75995407|FG003|COMPLETED|Overall Study||3||
59871326|NCT03981822|75995408|FG004|COMPLETED|Overall Study||17||
59871327|NCT03981822|75995409|FG005|COMPLETED|Overall Study||17||
59871328|NCT03981822|75995410|FG006|COMPLETED|Overall Study||16||
59871329|NCT03981822|75995411|FG007|COMPLETED|Overall Study||12||
59871330|NCT03981822|75995404|FG000|NOT COMPLETED|Overall Study||0||
59871331|NCT03981822|75995405|FG001|NOT COMPLETED|Overall Study||2||
59871332|NCT03981822|75995406|FG002|NOT COMPLETED|Overall Study||1||
59871333|NCT03981822|75995407|FG003|NOT COMPLETED|Overall Study||0||
59871334|NCT03981822|75995408|FG004|NOT COMPLETED|Overall Study||8||
59871335|NCT03981822|75995409|FG005|NOT COMPLETED|Overall Study||6||
59871336|NCT03981822|75995410|FG006|NOT COMPLETED|Overall Study||6||
59871337|NCT03981822|75995411|FG007|NOT COMPLETED|Overall Study||5||
59871338|NCT03650556|75995423|FG000|STARTED|Overall Study||224||
59871339|NCT03650556|75995423|FG000|Ablation Procedure|Overall Study||223||
59871340|NCT03650556|75995423|FG000|Pre-Discharge|Overall Study||223||
59871341|NCT03650556|75995423|FG000|7-day Follow-Up|Overall Study||223||
59871342|NCT03650556|75995423|FG000|3-month Follow-Up|Overall Study||210||
59871343|NCT03650556|75995423|FG000|6-month Follow-up|Overall Study||197||
59871344|NCT03650556|75995423|FG000|12-month Follow-Up|Overall Study||189||
59871345|NCT03650556|75995423|FG000|15-month Follow-Up|Overall Study||187||
59871346|NCT03650556|75995423|FG000|COMPLETED|Overall Study||187||
59871347|NCT03650556|75995423|FG000|NOT COMPLETED|Overall Study||37||
59871348|NCT03531632|75995431|FG000|STARTED|Overall Study||5||
59871349|NCT03531632|75995432|FG001|STARTED|Overall Study||3||
59871350|NCT03531632|75995433|FG002|STARTED|Overall Study||28||
59871351|NCT03531632|75995431|FG000|Safety Population|Overall Study|At least 1 dose of study drug|5||
59871352|NCT03531632|75995432|FG001|Safety Population|Overall Study||3||
59871353|NCT03531632|75995433|FG002|Safety Population|Overall Study||28||
59871354|NCT03531632|75995431|FG000|Response Evaluable Population|Overall Study|All patients who received at least one dose of any study drug, had baseline measurable disease, and had at least one post-baseline radiographic tumor assessment or discontinued treatment due to clearly documented, clinically progressive disease or death.|5||
59871355|NCT03531632|75995432|FG001|Response Evaluable Population|Overall Study||3||
59871356|NCT03531632|75995433|FG002|Response Evaluable Population|Overall Study||24||
59871357|NCT03531632|75995431|FG000|COMPLETED|Overall Study||0||
59871358|NCT03531632|75995432|FG001|COMPLETED|Overall Study||0||
59871359|NCT03531632|75995433|FG002|COMPLETED|Overall Study||2||
59871360|NCT03531632|75995431|FG000|NOT COMPLETED|Overall Study||5||
59871361|NCT03531632|75995432|FG001|NOT COMPLETED|Overall Study||3||
59871362|NCT03531632|75995433|FG002|NOT COMPLETED|Overall Study||26||
59871363|NCT03979638|75995444|FG000|STARTED|Period 1||33||
59871364|NCT03979638|75995445|FG001|STARTED|Period 1||35||
59871365|NCT03979638|75995444|FG000|COMPLETED|Period 1||26||
59871366|NCT03979638|75995445|FG001|COMPLETED|Period 1||28||
59871367|NCT03979638|75995444|FG000|NOT COMPLETED|Period 1||7||
59871368|NCT03979638|75995445|FG001|NOT COMPLETED|Period 1||7||
59871369|NCT03979638|75995444|FG000|STARTED|Period 2||26||
59871370|NCT03979638|75995445|FG001|STARTED|Period 2||28||
59871371|NCT03979638|75995444|FG000|COMPLETED|Period 2||25||
59871372|NCT03979638|75995445|FG001|COMPLETED|Period 2||27||
59871373|NCT03979638|75995444|FG000|NOT COMPLETED|Period 2||1||
59871374|NCT03979638|75995445|FG001|NOT COMPLETED|Period 2||1||
59871375|NCT03655054|75995460|FG000|STARTED|Overall Study||23||
59871376|NCT03655054|75995460|FG000|COMPLETED|Overall Study||22||
59871377|NCT03655054|75995460|FG000|NOT COMPLETED|Overall Study||1||
59871378|NCT03615144|75995466|FG000|STARTED|Overall Study||1||
59871379|NCT03615144|75995467|FG001|STARTED|Overall Study||0||
59871380|NCT03615144|75995466|FG000|COMPLETED|Overall Study||0||
59871381|NCT03615144|75995467|FG001|COMPLETED|Overall Study||0||
59871382|NCT03615144|75995466|FG000|NOT COMPLETED|Overall Study||1||
59871383|NCT03615144|75995467|FG001|NOT COMPLETED|Overall Study||0||
59871384|NCT03682302|75995477|FG000|STARTED|Overall Study||31||
59871385|NCT03682302|75995478|FG001|STARTED|Overall Study||30||
59871386|NCT03682302|75995479|FG002|STARTED|Overall Study|1 subject enrolled in Group 2, not treated, and surgery type unknown. Subject is not counted here.|6||
59871387|NCT03682302|75995480|FG003|STARTED|Overall Study|1 subject enrolled in Group 2, not treated, and surgery type unknown. Subject is not counted here.|30||
59871388|NCT03682302|75995477|FG000|COMPLETED|Overall Study||30||
59871389|NCT03682302|75995478|FG001|COMPLETED|Overall Study||28||
59871390|NCT03682302|75995479|FG002|COMPLETED|Overall Study||5||
59871391|NCT03682302|75995480|FG003|COMPLETED|Overall Study||28||
59871392|NCT03682302|75995477|FG000|NOT COMPLETED|Overall Study||1||
59871393|NCT03682302|75995478|FG001|NOT COMPLETED|Overall Study||2||
59871394|NCT03682302|75995479|FG002|NOT COMPLETED|Overall Study||1||
59871395|NCT03682302|75995480|FG003|NOT COMPLETED|Overall Study||2||
59871396|NCT03522506|75995494|FG000|STARTED|Treatment Period 1 (2 Days)||5||
59871397|NCT03522506|75995495|FG001|STARTED|Treatment Period 1 (2 Days)||5||
59871398|NCT03522506|75995496|FG002|STARTED|Treatment Period 1 (2 Days)||5||
59871399|NCT03522506|75995497|FG003|STARTED|Treatment Period 1 (2 Days)||5||
59871400|NCT03522506|75995494|FG000|COMPLETED|Treatment Period 1 (2 Days)||5||
59871401|NCT03522506|75995495|FG001|COMPLETED|Treatment Period 1 (2 Days)||5||
59871402|NCT03522506|75995496|FG002|COMPLETED|Treatment Period 1 (2 Days)||5||
59871403|NCT03522506|75995497|FG003|COMPLETED|Treatment Period 1 (2 Days)||5||
59871404|NCT03522506|75995494|FG000|NOT COMPLETED|Treatment Period 1 (2 Days)||0||
59871405|NCT03522506|75995495|FG001|NOT COMPLETED|Treatment Period 1 (2 Days)||0||
59871406|NCT03522506|75995496|FG002|NOT COMPLETED|Treatment Period 1 (2 Days)||0||
59871407|NCT03522506|75995497|FG003|NOT COMPLETED|Treatment Period 1 (2 Days)||0||
59871408|NCT03522506|75995494|FG000|STARTED|Washout Period 1 (7 Days)||5||
59871409|NCT03522506|75995495|FG001|STARTED|Washout Period 1 (7 Days)||5||
59871410|NCT03522506|75995496|FG002|STARTED|Washout Period 1 (7 Days)||5||
59871411|NCT03522506|75995497|FG003|STARTED|Washout Period 1 (7 Days)||5||
59871412|NCT03522506|75995494|FG000|COMPLETED|Washout Period 1 (7 Days)||5||
59871413|NCT03522506|75995495|FG001|COMPLETED|Washout Period 1 (7 Days)||5||
59871414|NCT03522506|75995496|FG002|COMPLETED|Washout Period 1 (7 Days)||5||
59871415|NCT03522506|75995497|FG003|COMPLETED|Washout Period 1 (7 Days)||4||
59871416|NCT03522506|75995494|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0||
59871417|NCT03522506|75995495|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0||
59871418|NCT03522506|75995496|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0||
59871419|NCT03522506|75995497|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||1||
59871420|NCT03522506|75995494|FG000|STARTED|Treatment Period 2 (2 Days)||5||
59871421|NCT03522506|75995495|FG001|STARTED|Treatment Period 2 (2 Days)||5||
59871422|NCT03522506|75995496|FG002|STARTED|Treatment Period 2 (2 Days)||5||
59871423|NCT03522506|75995497|FG003|STARTED|Treatment Period 2 (2 Days)||4||
59871424|NCT03522506|75995494|FG000|COMPLETED|Treatment Period 2 (2 Days)||5||
59871425|NCT03522506|75995495|FG001|COMPLETED|Treatment Period 2 (2 Days)||5||
59871426|NCT03522506|75995496|FG002|COMPLETED|Treatment Period 2 (2 Days)||5||
59871427|NCT03522506|75995497|FG003|COMPLETED|Treatment Period 2 (2 Days)||4||
59871428|NCT03522506|75995494|FG000|NOT COMPLETED|Treatment Period 2 (2 Days)||0||
59871429|NCT03522506|75995495|FG001|NOT COMPLETED|Treatment Period 2 (2 Days)||0||
59871430|NCT03522506|75995496|FG002|NOT COMPLETED|Treatment Period 2 (2 Days)||0||
59871431|NCT03522506|75995497|FG003|NOT COMPLETED|Treatment Period 2 (2 Days)||0||
59871432|NCT03522506|75995494|FG000|STARTED|Washout Period 2 (7 Days)||5||
59871433|NCT03522506|75995495|FG001|STARTED|Washout Period 2 (7 Days)||5||
59871434|NCT03522506|75995496|FG002|STARTED|Washout Period 2 (7 Days)||5||
59871435|NCT03522506|75995497|FG003|STARTED|Washout Period 2 (7 Days)||4||
59871436|NCT03522506|75995494|FG000|COMPLETED|Washout Period 2 (7 Days)||5||
59871437|NCT03522506|75995495|FG001|COMPLETED|Washout Period 2 (7 Days)||5||
59871438|NCT03522506|75995496|FG002|COMPLETED|Washout Period 2 (7 Days)||5||
59871439|NCT03522506|75995497|FG003|COMPLETED|Washout Period 2 (7 Days)||3||
59871440|NCT03522506|75995494|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0||
59871441|NCT03522506|75995495|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0||
59871442|NCT03522506|75995496|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0||
59871443|NCT03522506|75995497|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||1||
59871444|NCT03522506|75995494|FG000|STARTED|Treatment Period 3 (2 Days)||5||
59871445|NCT03522506|75995495|FG001|STARTED|Treatment Period 3 (2 Days)||5||
59871446|NCT03522506|75995496|FG002|STARTED|Treatment Period 3 (2 Days)||5||
59871447|NCT03522506|75995497|FG003|STARTED|Treatment Period 3 (2 Days)||3||
59871448|NCT03522506|75995494|FG000|COMPLETED|Treatment Period 3 (2 Days)||5||
59871449|NCT03522506|75995495|FG001|COMPLETED|Treatment Period 3 (2 Days)||5||
59871450|NCT03522506|75995496|FG002|COMPLETED|Treatment Period 3 (2 Days)||5||
59871451|NCT03522506|75995497|FG003|COMPLETED|Treatment Period 3 (2 Days)||3||
59871452|NCT03522506|75995494|FG000|NOT COMPLETED|Treatment Period 3 (2 Days)||0||
59871453|NCT03522506|75995495|FG001|NOT COMPLETED|Treatment Period 3 (2 Days)||0||
59871454|NCT03522506|75995496|FG002|NOT COMPLETED|Treatment Period 3 (2 Days)||0||
59871455|NCT03522506|75995497|FG003|NOT COMPLETED|Treatment Period 3 (2 Days)||0||
59871456|NCT03522506|75995494|FG000|STARTED|Washout Period 3 (7 Days)||5||
59871457|NCT03522506|75995495|FG001|STARTED|Washout Period 3 (7 Days)||5||
59871458|NCT03522506|75995496|FG002|STARTED|Washout Period 3 (7 Days)||5||
59871459|NCT03522506|75995497|FG003|STARTED|Washout Period 3 (7 Days)||3||
59871460|NCT03522506|75995494|FG000|COMPLETED|Washout Period 3 (7 Days)||5||
59871461|NCT03522506|75995495|FG001|COMPLETED|Washout Period 3 (7 Days)||5||
59871462|NCT03522506|75995496|FG002|COMPLETED|Washout Period 3 (7 Days)||5||
59871463|NCT03522506|75995497|FG003|COMPLETED|Washout Period 3 (7 Days)||3||
59871464|NCT03522506|75995494|FG000|NOT COMPLETED|Washout Period 3 (7 Days)||0||
59871465|NCT03522506|75995495|FG001|NOT COMPLETED|Washout Period 3 (7 Days)||0||
59871466|NCT03522506|75995496|FG002|NOT COMPLETED|Washout Period 3 (7 Days)||0||
59871467|NCT03522506|75995497|FG003|NOT COMPLETED|Washout Period 3 (7 Days)||0||
59871468|NCT03522506|75995494|FG000|STARTED|Treatment Period 4 (2 Days)||5||
59871469|NCT03522506|75995495|FG001|STARTED|Treatment Period 4 (2 Days)||5||
59871470|NCT03522506|75995496|FG002|STARTED|Treatment Period 4 (2 Days)||5||
59871471|NCT03522506|75995497|FG003|STARTED|Treatment Period 4 (2 Days)||3||
59871472|NCT03522506|75995494|FG000|COMPLETED|Treatment Period 4 (2 Days)||5||
59871473|NCT03522506|75995495|FG001|COMPLETED|Treatment Period 4 (2 Days)||5||
59871474|NCT03522506|75995496|FG002|COMPLETED|Treatment Period 4 (2 Days)||5||
59871475|NCT03522506|75995497|FG003|COMPLETED|Treatment Period 4 (2 Days)||3||
59871476|NCT03522506|75995494|FG000|NOT COMPLETED|Treatment Period 4 (2 Days)||0||
59871477|NCT03522506|75995495|FG001|NOT COMPLETED|Treatment Period 4 (2 Days)||0||
59871478|NCT03522506|75995496|FG002|NOT COMPLETED|Treatment Period 4 (2 Days)||0||
59871479|NCT03522506|75995497|FG003|NOT COMPLETED|Treatment Period 4 (2 Days)||0||
59871480|NCT03320434|75995515|FG000|STARTED|Overall Study||32||
59871481|NCT03320434|75995516|FG001|STARTED|Overall Study||29||
59871482|NCT03320434|75995517|FG002|STARTED|Overall Study||30||
59871483|NCT03320434|75995518|FG003|STARTED|Overall Study||29||
59871484|NCT03320434|75995515|FG000|COMPLETED|Overall Study||25||
59871485|NCT03320434|75995516|FG001|COMPLETED|Overall Study||23||
59871486|NCT03320434|75995517|FG002|COMPLETED|Overall Study||28||
59871487|NCT03320434|75995518|FG003|COMPLETED|Overall Study||23||
59871488|NCT03320434|75995515|FG000|NOT COMPLETED|Overall Study||7||
59871489|NCT03320434|75995516|FG001|NOT COMPLETED|Overall Study||6||
59871490|NCT03320434|75995517|FG002|NOT COMPLETED|Overall Study||2||
59871491|NCT03320434|75995518|FG003|NOT COMPLETED|Overall Study||6||
59871492|NCT02892734|75995528|FG000|STARTED|Treatment on Study||3||
59871493|NCT02892734|75995528|FG000|Completed 1st Cycle/Response at 12 Weeks|Treatment on Study||1||
59871494|NCT02892734|75995528|FG000|Went on to Start Cycle 2|Treatment on Study||1||
59871495|NCT02892734|75995528|FG000|COMPLETED|Treatment on Study||1||
59871496|NCT02892734|75995528|FG000|NOT COMPLETED|Treatment on Study||2||
59871497|NCT02892734|75995528|FG000|STARTED|Follow up for 2 Years||3|All patients that are treated with at least one dose of study drug go into follow-up.|
59871498|NCT02892734|75995528|FG000|COMPLETED|Follow up for 2 Years||0||
59871499|NCT02892734|75995528|FG000|NOT COMPLETED|Follow up for 2 Years||3||
59871500|NCT00055497|75995536|FG000|STARTED|Overall Study||18||
59871501|NCT00055497|75995537|FG001|STARTED|Overall Study||19||
59871502|NCT00055497|75995538|FG002|STARTED|Overall Study||18||
59871503|NCT00055497|75995539|FG003|STARTED|Overall Study|17 participants who discontinued at/before Week 4 are counted here because they were not randomized.|221||
59871504|NCT00055497|75995536|FG000|COMPLETED|Overall Study|Participants may have continued to the open-label extension study. See NCT01070303.|13||
59871505|NCT00055497|75995537|FG001|COMPLETED|Overall Study|Participants may have continued to the open-label extension study. See NCT01070303.|16||
59871506|NCT00055497|75995538|FG002|COMPLETED|Overall Study|Participants may have continued to the open-label extension study. See NCT01070303.|16||
59871507|NCT00055497|75995539|FG003|COMPLETED|Overall Study|Participants may have continued to the open-label extension study. See NCT01070303.|131||
59871508|NCT00055497|75995536|FG000|NOT COMPLETED|Overall Study||5||
59871509|NCT00055497|75995537|FG001|NOT COMPLETED|Overall Study||3||
59871510|NCT00055497|75995538|FG002|NOT COMPLETED|Overall Study||2||
59871511|NCT00055497|75995539|FG003|NOT COMPLETED|Overall Study||90||
59871512|NCT03520400|75995556|FG000|STARTED|Overall Study||37||
59871513|NCT03520400|75995557|FG001|STARTED|Overall Study||14||
59871514|NCT03520400|75995556|FG000|COMPLETED|Overall Study||22||
59871515|NCT03520400|75995557|FG001|COMPLETED|Overall Study||7||
59871516|NCT03520400|75995556|FG000|NOT COMPLETED|Overall Study||15||
59871517|NCT03520400|75995557|FG001|NOT COMPLETED|Overall Study||7||
59871518|NCT03615066|75995566|FG000|STARTED|Main Study||26||
59871519|NCT03615066|75995567|FG001|STARTED|Main Study||28||
59871520|NCT03615066|75995568|FG002|STARTED|Main Study||13||
59871521|NCT03615066|75995566|FG000|COMPLETED|Main Study|2 participants did not receive all doses of study treatments but were considered to have completed the Main Study because the participants entered the TFFU Phase.|26||
59871522|NCT03615066|75995567|FG001|COMPLETED|Main Study|1 participant did not receive all doses of study treatments but was considered to have completed the Main Study because the participant entered the TFFU Phase.|27||
59871523|NCT03615066|75995568|FG002|COMPLETED|Main Study||11||
59871524|NCT03615066|75995566|FG000|NOT COMPLETED|Main Study||0||
59871525|NCT03615066|75995567|FG001|NOT COMPLETED|Main Study||1||
59871526|NCT03615066|75995568|FG002|NOT COMPLETED|Main Study||2||
59871527|NCT03615066|75995566|FG000|STARTED|Treatment-free Follow-up (TFFU) Phase|13 participants who completed Main study did not enter TFFU phase.|13||
59871528|NCT03615066|75995567|FG001|STARTED|Treatment-free Follow-up (TFFU) Phase|15 participants who completed Main study did not enter TFFU phase.|12||
59871529|NCT03615066|75995568|FG002|STARTED|Treatment-free Follow-up (TFFU) Phase|9 participants who completed Main study did not enter TFFU phase.|2||
59871530|NCT03615066|75995566|FG000|COMPLETED|Treatment-free Follow-up (TFFU) Phase||11||
59871531|NCT03615066|75995567|FG001|COMPLETED|Treatment-free Follow-up (TFFU) Phase||11||
59871532|NCT03615066|75995568|FG002|COMPLETED|Treatment-free Follow-up (TFFU) Phase||2||
59871533|NCT03615066|75995566|FG000|NOT COMPLETED|Treatment-free Follow-up (TFFU) Phase||2||
59871534|NCT03615066|75995567|FG001|NOT COMPLETED|Treatment-free Follow-up (TFFU) Phase||1||
59871535|NCT03615066|75995568|FG002|NOT COMPLETED|Treatment-free Follow-up (TFFU) Phase||0||
59871536|NCT03527966|75995582|FG000|STARTED|Overall Study||3||
59871537|NCT03527966|75995583|FG001|STARTED|Overall Study||0||
59871538|NCT03527966|75995582|FG000|COMPLETED|Overall Study||0||
59871539|NCT03527966|75995583|FG001|COMPLETED|Overall Study||0||
59871540|NCT03527966|75995582|FG000|NOT COMPLETED|Overall Study||3||
59871541|NCT03527966|75995583|FG001|NOT COMPLETED|Overall Study||0||
59871542|NCT03808545|75995591|FG000|STARTED|Overall Study||6||
59871543|NCT03808545|75995592|FG001|STARTED|Overall Study||5||
59871544|NCT03808545|75995591|FG000|COMPLETED|Overall Study||5||
59871545|NCT03808545|75995592|FG001|COMPLETED|Overall Study||4||
59736689|NCT00888849|75855548|FG000|NOT COMPLETED|Overall Study||5||
59736690|NCT00888849|75855549|FG001|NOT COMPLETED|Overall Study||9||
59736691|NCT01059812|75855557|FG000|STARTED|Overall Study||282||
59736692|NCT01059812|75855558|FG001|STARTED|Overall Study||142||
59736693|NCT01059812|75855557|FG000|Exposed|Overall Study|Three subjects withdrew prior to exposure to trial drug|279||
59871546|NCT03808545|75995591|FG000|NOT COMPLETED|Overall Study||1||
59871547|NCT03808545|75995592|FG001|NOT COMPLETED|Overall Study||1||
59871548|NCT03807843|75995601|FG000|STARTED|Overall Study||21||
59871549|NCT03807843|75995602|FG001|STARTED|Overall Study||20||
59871550|NCT03807843|75995601|FG000|COMPLETED|Overall Study||20||
59871551|NCT03807843|75995602|FG001|COMPLETED|Overall Study||20||
59871552|NCT03807843|75995601|FG000|NOT COMPLETED|Overall Study||1||
59871553|NCT03807843|75995602|FG001|NOT COMPLETED|Overall Study||0||
59871554|NCT03519932|75995608|FG000|STARTED|First Intervention||24||
59871555|NCT03519932|75995609|FG001|STARTED|First Intervention||25||
59871556|NCT03519932|75995608|FG000|COMPLETED|First Intervention|One subject had non-significant adverse event and data not included in the analysis|23||
59871557|NCT03519932|75995609|FG001|COMPLETED|First Intervention|3 subjects had non-significant adverse events and data not included in analysis.|22||
59871558|NCT03519932|75995608|FG000|NOT COMPLETED|First Intervention||1||
59871559|NCT03519932|75995609|FG001|NOT COMPLETED|First Intervention||3||
59871560|NCT03519932|75995608|FG000|STARTED|Second Intervention|Subjects who wore samfilcon A toric at 1st intervention wear comfilcon A toric at 2nd intervention|22||
59871561|NCT03519932|75995609|FG001|STARTED|Second Intervention|Subjects who wore comfilcon A toric at 1st intervention wear Samfilcon A toric at 2nd intervention|23||
59871562|NCT03519932|75995608|FG000|COMPLETED|Second Intervention||22||
59871563|NCT03519932|75995609|FG001|COMPLETED|Second Intervention||23||
59871564|NCT03519932|75995608|FG000|NOT COMPLETED|Second Intervention||0||
59871565|NCT03519932|75995609|FG001|NOT COMPLETED|Second Intervention||0||
59871566|NCT03806127|75995622|FG000|STARTED|Overall Study||111||
59871567|NCT03806127|75995623|FG001|STARTED|Overall Study||111||
59871568|NCT03806127|75995622|FG000|COMPLETED|Overall Study||90||
59871569|NCT03806127|75995623|FG001|COMPLETED|Overall Study||99||
59871570|NCT03806127|75995622|FG000|NOT COMPLETED|Overall Study||21||
59871571|NCT03806127|75995623|FG001|NOT COMPLETED|Overall Study||12||
59871572|NCT03650400|75995631|FG000|STARTED|Overall Study||6||
59871573|NCT03650400|75995632|FG001|STARTED|Overall Study||5||
59871574|NCT03650400|75995631|FG000|COMPLETED|Overall Study||6||
59736694|NCT01059812|75855558|FG001|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|141||
59871575|NCT03650400|75995632|FG001|COMPLETED|Overall Study||0||
59871576|NCT03650400|75995631|FG000|NOT COMPLETED|Overall Study||0||
59871577|NCT03650400|75995632|FG001|NOT COMPLETED|Overall Study||5||
59871578|NCT00038103|75995640|FG000|STARTED|Overall Study||55||
59871579|NCT00038103|75995641|FG001|STARTED|Overall Study||56||
59871580|NCT00038103|75995640|FG000|End of Treatment|Overall Study|patients remained on treatment until discontinued|53||
59871581|NCT00038103|75995641|FG001|End of Treatment|Overall Study|patients remained on treatment until discontinued|56||
59871582|NCT00038103|75995640|FG000|COMPLETED|Overall Study||0||
59871583|NCT00038103|75995641|FG001|COMPLETED|Overall Study||0||
59871584|NCT00038103|75995640|FG000|NOT COMPLETED|Overall Study||55||
59871585|NCT00038103|75995641|FG001|NOT COMPLETED|Overall Study||56||
59871586|NCT03680742|75995647|FG000|STARTED|Overall Study||34||
59871587|NCT03680742|75995647|FG000|COMPLETED|Overall Study||32||
59871588|NCT03680742|75995647|FG000|NOT COMPLETED|Overall Study||2||
59871589|NCT03678870|75995653|FG000|STARTED|Overall Study||97||
59871590|NCT03678870|75995654|FG001|STARTED|Overall Study||99||
59871591|NCT03678870|75995653|FG000|COMPLETED|Overall Study||84||
59871592|NCT03678870|75995654|FG001|COMPLETED|Overall Study||91||
59871593|NCT03678870|75995653|FG000|NOT COMPLETED|Overall Study||13||
59871594|NCT03678870|75995654|FG001|NOT COMPLETED|Overall Study||8||
59871595|NCT03805971|75995660|FG000|STARTED|Overall Study||65||
59871596|NCT03805971|75995660|FG000|COMPLETED|Overall Study||62||
59871597|NCT03805971|75995660|FG000|NOT COMPLETED|Overall Study||3||
59871598|NCT03032380|75995667|FG000|STARTED|Overall Study||148||
59871599|NCT03032380|75995668|FG001|STARTED|Overall Study||152||
59871600|NCT03032380|75995667|FG000|Received Treatment|Overall Study||148||
59871601|NCT03032380|75995668|FG001|Received Treatment|Overall Study||150||
59871602|NCT03032380|75995667|FG000|COMPLETED|Overall Study||106||
59871603|NCT03032380|75995668|FG001|COMPLETED|Overall Study||112||
59871604|NCT03032380|75995667|FG000|NOT COMPLETED|Overall Study||42||
59871605|NCT03032380|75995668|FG001|NOT COMPLETED|Overall Study||40||
59871606|NCT03519854|75995692|FG000|STARTED|Overall Study|N=3 randomized to Arm A. An additional N=1 (randomized to Arm C) is counted as Started in Arm A|4||
59871607|NCT03519854|75995693|FG001|STARTED|Overall Study||6||
59871608|NCT03519854|75995694|FG002|STARTED|Overall Study||5||
59871609|NCT03519854|75995695|FG003|STARTED|Overall Study||6||
59871610|NCT03519854|75995696|FG004|STARTED|Overall Study||6||
59871611|NCT03519854|75995697|FG005|STARTED|Overall Study||6||
59871612|NCT03519854|75995698|FG006|STARTED|Overall Study||3||
59871613|NCT03519854|75995699|FG007|STARTED|Overall Study||6||
59871614|NCT03519854|75995700|FG008|STARTED|Overall Study||6||
59871615|NCT03519854|75995701|FG009|STARTED|Overall Study||6||
59871616|NCT03519854|75995702|FG010|STARTED|Overall Study||6||
59871617|NCT03519854|75995703|FG011|STARTED|Overall Study||6||
59871618|NCT03519854|75995704|FG012|STARTED|Overall Study||3||
59871619|NCT03519854|75995705|FG013|STARTED|Overall Study||6||
59871620|NCT03519854|75995706|FG014|STARTED|Overall Study||6||
59871621|NCT03519854|75995707|FG015|STARTED|Overall Study||6||
59871622|NCT03519854|75995708|FG016|STARTED|Overall Study||6||
59871623|NCT03519854|75995709|FG017|STARTED|Overall Study||6||
59871624|NCT03519854|75995692|FG000|Treated|Overall Study|N=1 (randomized to Arm C) received placebo, 3 min after 1.2 mg/kg Esmeron®|4||
59871625|NCT03519854|75995693|FG001|Treated|Overall Study||6||
59871626|NCT03519854|75995694|FG002|Treated|Overall Study||4||
59871627|NCT03519854|75995695|FG003|Treated|Overall Study||6||
59871628|NCT03519854|75995696|FG004|Treated|Overall Study||6||
59871629|NCT03519854|75995697|FG005|Treated|Overall Study||6||
59871630|NCT03519854|75995698|FG006|Treated|Overall Study||3||
59871631|NCT03519854|75995699|FG007|Treated|Overall Study||6||
59871632|NCT03519854|75995700|FG008|Treated|Overall Study||6||
59871633|NCT03519854|75995701|FG009|Treated|Overall Study||6||
59871634|NCT03519854|75995702|FG010|Treated|Overall Study||6||
59871635|NCT03519854|75995703|FG011|Treated|Overall Study||6||
59871636|NCT03519854|75995704|FG012|Treated|Overall Study||3||
59871637|NCT03519854|75995705|FG013|Treated|Overall Study||6||
59871638|NCT03519854|75995706|FG014|Treated|Overall Study||6||
59871639|NCT03519854|75995707|FG015|Treated|Overall Study||6||
59871640|NCT03519854|75995708|FG016|Treated|Overall Study||6||
59871641|NCT03519854|75995709|FG017|Treated|Overall Study||6||
59871642|NCT03519854|75995692|FG000|COMPLETED|Overall Study||4||
59871643|NCT03519854|75995693|FG001|COMPLETED|Overall Study||6||
59871644|NCT03519854|75995694|FG002|COMPLETED|Overall Study||4||
59871645|NCT03519854|75995695|FG003|COMPLETED|Overall Study||6||
59871646|NCT03519854|75995696|FG004|COMPLETED|Overall Study||6||
59871647|NCT03519854|75995697|FG005|COMPLETED|Overall Study||6||
59871648|NCT03519854|75995698|FG006|COMPLETED|Overall Study||3||
59871649|NCT03519854|75995699|FG007|COMPLETED|Overall Study||6||
59871650|NCT03519854|75995700|FG008|COMPLETED|Overall Study||6||
59871651|NCT03519854|75995701|FG009|COMPLETED|Overall Study||6||
59871652|NCT03519854|75995702|FG010|COMPLETED|Overall Study||6||
59871653|NCT03519854|75995703|FG011|COMPLETED|Overall Study||6||
59871654|NCT03519854|75995704|FG012|COMPLETED|Overall Study||3||
59871655|NCT03519854|75995705|FG013|COMPLETED|Overall Study||6||
59871656|NCT03519854|75995706|FG014|COMPLETED|Overall Study||6||
59871657|NCT03519854|75995707|FG015|COMPLETED|Overall Study||6||
59871658|NCT03519854|75995708|FG016|COMPLETED|Overall Study||6||
59871659|NCT03519854|75995709|FG017|COMPLETED|Overall Study||6||
59871660|NCT03519854|75995692|FG000|NOT COMPLETED|Overall Study||0||
59871661|NCT03519854|75995693|FG001|NOT COMPLETED|Overall Study||0||
59871662|NCT03519854|75995694|FG002|NOT COMPLETED|Overall Study||1||
59871663|NCT03519854|75995695|FG003|NOT COMPLETED|Overall Study||0||
59871664|NCT03519854|75995696|FG004|NOT COMPLETED|Overall Study||0||
59871665|NCT03519854|75995697|FG005|NOT COMPLETED|Overall Study||0||
59871666|NCT03519854|75995698|FG006|NOT COMPLETED|Overall Study||0||
59871667|NCT03519854|75995699|FG007|NOT COMPLETED|Overall Study||0||
59871668|NCT03519854|75995700|FG008|NOT COMPLETED|Overall Study||0||
59871669|NCT03519854|75995701|FG009|NOT COMPLETED|Overall Study||0||
59871670|NCT03519854|75995702|FG010|NOT COMPLETED|Overall Study||0||
59871671|NCT03519854|75995703|FG011|NOT COMPLETED|Overall Study||0||
59871672|NCT03519854|75995704|FG012|NOT COMPLETED|Overall Study||0||
59871673|NCT03519854|75995705|FG013|NOT COMPLETED|Overall Study||0||
59871674|NCT03519854|75995706|FG014|NOT COMPLETED|Overall Study||0||
59871675|NCT03519854|75995707|FG015|NOT COMPLETED|Overall Study||0||
59871676|NCT03519854|75995708|FG016|NOT COMPLETED|Overall Study||0||
59871677|NCT03519854|75995709|FG017|NOT COMPLETED|Overall Study||0||
59871678|NCT03479216|75995749|FG000|STARTED|Overall Study||31||
59871679|NCT03479216|75995750|FG001|STARTED|Overall Study||31||
59871680|NCT03479216|75995749|FG000|COMPLETED|Overall Study||26||
59871681|NCT03479216|75995750|FG001|COMPLETED|Overall Study||26||
59871682|NCT03479216|75995749|FG000|NOT COMPLETED|Overall Study||5||
59871683|NCT03479216|75995750|FG001|NOT COMPLETED|Overall Study||5||
59871684|NCT03518840|75995756|FG000|STARTED|Overall Study||63||
59871685|NCT03518840|75995756|FG000|COMPLETED|Overall Study||57||
59871686|NCT03518840|75995756|FG000|NOT COMPLETED|Overall Study||6||
59871687|NCT03436082|75995765|FG000|STARTED|Overall Study||30||
59871688|NCT03436082|75995766|FG001|STARTED|Overall Study||30||
59871689|NCT03436082|75995765|FG000|COMPLETED|Overall Study|Had procedure|29||
59871690|NCT03436082|75995766|FG001|COMPLETED|Overall Study|Had procedure|30||
59871691|NCT03436082|75995765|FG000|NOT COMPLETED|Overall Study||1||
59871692|NCT03436082|75995766|FG001|NOT COMPLETED|Overall Study||0||
59871693|NCT03677934|75995774|FG000|STARTED|Overall Study||248||
59871694|NCT03677934|75995775|FG001|STARTED|Overall Study||167||
59871695|NCT03677934|75995774|FG000|COMPLETED|Overall Study||234||
59871696|NCT03677934|75995775|FG001|COMPLETED|Overall Study||154||
59871697|NCT03677934|75995774|FG000|NOT COMPLETED|Overall Study||14||
59871698|NCT03677934|75995775|FG001|NOT COMPLETED|Overall Study||13||
59871699|NCT03435692|75995787|FG000|STARTED|Overall Study||17||
59871700|NCT03435692|75995788|FG001|STARTED|Overall Study||18||
59871701|NCT03435692|75995789|FG002|STARTED|Overall Study||7||
59871702|NCT03435692|75995787|FG000|COMPLETED|Overall Study|Discontinued intervention (n=2). 1) Lumbar Epidural Catheter (LEC) not working Post-Operative Day (POD) 0, Lumbar Epidural Catheter (LEC) removed and morphine infusion started - patient 1 year old. 2) Lumbar Epidural Catheter (LEC) not working Post-Operative Day (POD) 1, Lumbar Epidural Catheter (LEC) removed and Patient Controlled Analgesia (PCA) started.|15||
59871703|NCT03435692|75995788|FG001|COMPLETED|Overall Study|Discontinued intervention (n=2). 1) Successful lumbar plexus injection, but unable to thread catheter, morphine infusion started (patient 1 year old). 2) Lumbar Plexus Catheter (LPC) catheter (10 cm) not long enough to reach lumbar plexus in patient weighing 136kg, Lumbar Epidural Catheter (LEC) placed instead.|16||
59871704|NCT03435692|75995789|FG002|COMPLETED|Overall Study||7||
59871705|NCT03435692|75995787|FG000|NOT COMPLETED|Overall Study||2||
59871706|NCT03435692|75995788|FG001|NOT COMPLETED|Overall Study||2||
59871707|NCT03435692|75995789|FG002|NOT COMPLETED|Overall Study||0||
59871708|NCT03475316|75995803|FG000|STARTED|6 Month Intervention||13||
59871709|NCT03475316|75995804|FG001|STARTED|6 Month Intervention||12||
59871710|NCT03475316|75995803|FG000|COMPLETED|6 Month Intervention||8||
59871711|NCT03475316|75995804|FG001|COMPLETED|6 Month Intervention||8||
59871712|NCT03475316|75995803|FG000|NOT COMPLETED|6 Month Intervention||5||
59871713|NCT03475316|75995804|FG001|NOT COMPLETED|6 Month Intervention||4||
59871714|NCT03475316|75995803|FG000|STARTED|9 Months||8||
59871715|NCT03475316|75995804|FG001|STARTED|9 Months||8||
59871716|NCT03475316|75995803|FG000|COMPLETED|9 Months||5||
59871717|NCT03475316|75995804|FG001|COMPLETED|9 Months||4||
59871718|NCT03475316|75995803|FG000|NOT COMPLETED|9 Months||3||
59871719|NCT03475316|75995804|FG001|NOT COMPLETED|9 Months||4||
59871720|NCT03673956|75995814|FG000|STARTED|Overall Study||12||
59871721|NCT03673956|75995815|FG001|STARTED|Overall Study||1||
59871722|NCT03673956|75995816|FG002|STARTED|Overall Study||5||
59871723|NCT03673956|75995817|FG003|STARTED|Overall Study||1||
59871724|NCT03673956|75995814|FG000|COMPLETED|Overall Study||10||
59871725|NCT03673956|75995815|FG001|COMPLETED|Overall Study||1||
59871726|NCT03673956|75995816|FG002|COMPLETED|Overall Study||5||
59871727|NCT03673956|75995817|FG003|COMPLETED|Overall Study||1||
59871728|NCT03673956|75995814|FG000|NOT COMPLETED|Overall Study||2||
59871729|NCT03673956|75995815|FG001|NOT COMPLETED|Overall Study||0||
59871730|NCT03673956|75995816|FG002|NOT COMPLETED|Overall Study||0||
59871731|NCT03673956|75995817|FG003|NOT COMPLETED|Overall Study||0||
59871732|NCT03673098|75995829|FG000|STARTED|Overall Study||23||
59871733|NCT03673098|75995830|FG001|STARTED|Overall Study||21||
59871734|NCT03673098|75995829|FG000|COMPLETED|Overall Study||13||
59871735|NCT03673098|75995830|FG001|COMPLETED|Overall Study||17||
59871736|NCT03673098|75995829|FG000|NOT COMPLETED|Overall Study||10||
59871737|NCT03673098|75995830|FG001|NOT COMPLETED|Overall Study||4||
59871738|NCT03435224|75995843|FG000|STARTED|Overall Study||29||
59871739|NCT03435224|75995843|FG000|COMPLETED|Overall Study||25||
59871740|NCT03435224|75995843|FG000|NOT COMPLETED|Overall Study||4||
59871741|NCT03672396|75995847|FG000|STARTED|Overall Study||22||
59871742|NCT03672396|75995847|FG000|COMPLETED|Overall Study||16||
59871743|NCT03672396|75995847|FG000|NOT COMPLETED|Overall Study||6||
59871744|NCT03434834|75995851|FG000|STARTED|Overall Study||53||
59871745|NCT03434834|75995851|FG000|COMPLETED|Overall Study||37||
59871746|NCT03434834|75995851|FG000|NOT COMPLETED|Overall Study||16||
59871747|NCT03605862|75995857|FG000|STARTED|Overall Study||872||
59871748|NCT03605862|75995858|FG001|STARTED|Overall Study||884||
59871749|NCT03605862|75995857|FG000|COMPLETED|Overall Study||844||
59871750|NCT03605862|75995858|FG001|COMPLETED|Overall Study||858||
59871751|NCT03605862|75995857|FG000|NOT COMPLETED|Overall Study||28||
59871752|NCT03605862|75995858|FG001|NOT COMPLETED|Overall Study||26||
59871753|NCT03672006|75995867|FG000|STARTED|Overall Study||10||
59871754|NCT03672006|75995868|FG001|STARTED|Overall Study||10||
59871755|NCT03672006|75995867|FG000|COMPLETED|Overall Study||10||
59871756|NCT03672006|75995868|FG001|COMPLETED|Overall Study||9||
59871757|NCT03672006|75995867|FG000|NOT COMPLETED|Overall Study||0||
59871758|NCT03672006|75995868|FG001|NOT COMPLETED|Overall Study||1||
59871759|NCT03512288|75995878|FG000|STARTED|Overall Study||232||
59871760|NCT03512288|75995879|FG001|STARTED|Overall Study||228||
59871761|NCT03512288|75995878|FG000|Vaccination 1|Overall Study||231||
59871762|NCT03512288|75995879|FG001|Vaccination 1|Overall Study||227||
59871763|NCT03512288|75995878|FG000|Vaccination 2|Overall Study||222||
59871764|NCT03512288|75995879|FG001|Vaccination 2|Overall Study||213||
59871765|NCT03512288|75995878|FG000|Vaccination 3|Overall Study||210||
59871766|NCT03512288|75995879|FG001|Vaccination 3|Overall Study||206||
59871767|NCT03512288|75995878|FG000|Vaccination 4|Overall Study||197||
59871768|NCT03512288|75995879|FG001|Vaccination 4|Overall Study||194||
59871769|NCT03512288|75995878|FG000|COMPLETED|Overall Study||191||
59871770|NCT03512288|75995879|FG001|COMPLETED|Overall Study||185||
59871771|NCT03512288|75995878|FG000|NOT COMPLETED|Overall Study||41||
59871772|NCT03512288|75995879|FG001|NOT COMPLETED|Overall Study||43||
59871773|NCT03031678|75995885|FG000|STARTED|Overall Study||50||
59871774|NCT03031678|75995885|FG000|EAS Test Condition Complete|Overall Study||39||
59871775|NCT03031678|75995885|FG000|CI Alone Test Condition Complete|Overall Study||10||
59871776|NCT03031678|75995885|FG000|COMPLETED|Overall Study||49||
59871777|NCT03031678|75995885|FG000|NOT COMPLETED|Overall Study||1||
59871778|NCT03669588|75995895|FG000|STARTED|Overall Study||84||
59871779|NCT03669588|75995896|FG001|STARTED|Overall Study||83||
59871780|NCT03669588|75995895|FG000|COMPLETED|Overall Study||80||
59871781|NCT03669588|75995896|FG001|COMPLETED|Overall Study||76||
59871782|NCT03669588|75995895|FG000|NOT COMPLETED|Overall Study||4||
59871783|NCT03669588|75995896|FG001|NOT COMPLETED|Overall Study||7||
59871784|NCT03598140|75995904|FG000|STARTED|Overall Study||10||
59871785|NCT03598140|75995905|FG001|STARTED|Overall Study||11||
59871786|NCT03598140|75995904|FG000|COMPLETED|Overall Study||9||
59871787|NCT03598140|75995905|FG001|COMPLETED|Overall Study||11||
59871788|NCT03598140|75995904|FG000|NOT COMPLETED|Overall Study||1||
59871789|NCT03598140|75995905|FG001|NOT COMPLETED|Overall Study||0||
59871790|NCT03644550|75995911|FG000|STARTED|Overall Study||18||
59871791|NCT03644550|75995911|FG000|COMPLETED|Overall Study||0||
59871792|NCT03644550|75995911|FG000|NOT COMPLETED|Overall Study||18||
59871793|NCT00054717|75995918|FG000|STARTED|Overall Study||313||
59871794|NCT00054717|75995919|FG001|STARTED|Overall Study||317||
59871795|NCT00054717|75995918|FG000|COMPLETED|Overall Study||51||
59871796|NCT00054717|75995919|FG001|COMPLETED|Overall Study||18||
59871797|NCT00054717|75995918|FG000|NOT COMPLETED|Overall Study||262||
59871798|NCT00054717|75995919|FG001|NOT COMPLETED|Overall Study||299||
59871799|NCT03430856|75995928|FG000|STARTED|Overall Study||31||
59871800|NCT03430856|75995929|FG001|STARTED|Overall Study||30||
59871801|NCT03430856|75995930|FG002|STARTED|Overall Study||30||
59871802|NCT03430856|75995928|FG000|Exposed|Overall Study||31||
59871803|NCT03430856|75995929|FG001|Exposed|Overall Study||30||
59871804|NCT03430856|75995930|FG002|Exposed|Overall Study||30||
59871805|NCT03430856|75995928|FG000|COMPLETED|Overall Study||29||
59871806|NCT03430856|75995929|FG001|COMPLETED|Overall Study||27||
59871807|NCT03430856|75995930|FG002|COMPLETED|Overall Study||29||
59871808|NCT03430856|75995928|FG000|NOT COMPLETED|Overall Study||2||
59871809|NCT03430856|75995929|FG001|NOT COMPLETED|Overall Study||3||
59871810|NCT03430856|75995930|FG002|NOT COMPLETED|Overall Study||1||
59871811|NCT03731364|75995946|FG000|STARTED|Overall Study||9||
59871812|NCT03731364|75995947|FG001|STARTED|Overall Study||9||
59871813|NCT03731364|75995948|FG002|STARTED|Overall Study||13||
59871814|NCT03731364|75995949|FG003|STARTED|Overall Study||13||
59871815|NCT03731364|75995950|FG004|STARTED|Overall Study||11||
59871816|NCT03731364|75995946|FG000|COMPLETED|Overall Study||9||
59871817|NCT03731364|75995947|FG001|COMPLETED|Overall Study||9||
59871818|NCT03731364|75995948|FG002|COMPLETED|Overall Study||12||
59871819|NCT03731364|75995949|FG003|COMPLETED|Overall Study||11||
59871820|NCT03731364|75995950|FG004|COMPLETED|Overall Study||10||
59871821|NCT03731364|75995946|FG000|NOT COMPLETED|Overall Study||0||
59871822|NCT03731364|75995947|FG001|NOT COMPLETED|Overall Study||0||
59871823|NCT03731364|75995948|FG002|NOT COMPLETED|Overall Study||1||
59871824|NCT03731364|75995949|FG003|NOT COMPLETED|Overall Study||2||
59871825|NCT03731364|75995950|FG004|NOT COMPLETED|Overall Study||1||
59871826|NCT03510182|75995962|FG000|STARTED|Overall Study||25||
59871827|NCT03510182|75995962|FG000|COMPLETED|Overall Study||23||
59871828|NCT03510182|75995962|FG000|NOT COMPLETED|Overall Study||2||
59871829|NCT00066807|75995968|FG000|STARTED|Overall Study||14||
59871830|NCT00066807|75995969|FG001|STARTED|Overall Study||15||
59871831|NCT00066807|75995968|FG000|COMPLETED|Overall Study||0||
59871832|NCT00066807|75995969|FG001|COMPLETED|Overall Study||0||
59871833|NCT00066807|75995968|FG000|NOT COMPLETED|Overall Study||14||
59871834|NCT00066807|75995969|FG001|NOT COMPLETED|Overall Study||15||
59871835|NCT03428750|75995977|FG000|STARTED|Overall Study||210||
59871836|NCT03428750|75995978|FG001|STARTED|Overall Study||213||
59871837|NCT03428750|75995977|FG000|COMPLETED|Overall Study||186||
59871838|NCT03428750|75995978|FG001|COMPLETED|Overall Study||192||
59871839|NCT03428750|75995977|FG000|NOT COMPLETED|Overall Study||24||
59871840|NCT03428750|75995978|FG001|NOT COMPLETED|Overall Study||21||
59871841|NCT03666858|75996007|FG000|STARTED|Cohort 1|All participants with TTH who had reported at least one headache and Neosaldina intake.|216||
59871842|NCT03666858|75996008|FG001|STARTED|Cohort 1||0||
59871843|NCT03666858|75996007|FG000|COMPLETED|Cohort 1||215||
59871844|NCT03666858|75996008|FG001|COMPLETED|Cohort 1||0||
59871845|NCT03666858|75996007|FG000|NOT COMPLETED|Cohort 1||1||
59871846|NCT03666858|75996008|FG001|NOT COMPLETED|Cohort 1||0||
59871847|NCT03666858|75996007|FG000|STARTED|Cohort 2||0||
59871848|NCT03666858|75996008|FG001|STARTED|Cohort 2|Cohort 1 participants with pain intensity at 0,120minutes after Neosaldina/0 pain before 120minutes.|138||
59871849|NCT03666858|75996007|FG000|COMPLETED|Cohort 2||0||
59871850|NCT03666858|75996008|FG001|COMPLETED|Cohort 2||137||
59871851|NCT03666858|75996007|FG000|NOT COMPLETED|Cohort 2||0||
59871852|NCT03666858|75996008|FG001|NOT COMPLETED|Cohort 2||1||
59871853|NCT00054639|75996014|FG000|STARTED|Overall Study||48||
59871854|NCT00054639|75996014|FG000|COMPLETED|Overall Study||46||
59871855|NCT00054639|75996014|FG000|NOT COMPLETED|Overall Study||2||
59871856|NCT03428360|75996018|FG000|STARTED|Overall Study||130||
59871857|NCT03428360|75996018|FG000|COMPLETED|Overall Study||90||
59871858|NCT03428360|75996018|FG000|NOT COMPLETED|Overall Study||40||
59871859|NCT03427892|75996026|FG000|STARTED|Overall Study||21|Open Label (baseline to week 8)|
59871860|NCT03427892|75996026|FG000|COMPLETED|Overall Study|Of the 21 recruited, 19 completed at least one post baseline visit, included in the analysis.|19||
59871861|NCT03427892|75996026|FG000|NOT COMPLETED|Overall Study||2||
59871862|NCT03595332|75996032|FG000|STARTED|Overall Study||92||
59871863|NCT03595332|75996033|FG001|STARTED|Overall Study||130||
59871864|NCT03595332|75996032|FG000|COMPLETED|Overall Study||76||
59871865|NCT03595332|75996033|FG001|COMPLETED|Overall Study||106||
59871866|NCT03595332|75996032|FG000|NOT COMPLETED|Overall Study||16||
59871867|NCT03595332|75996033|FG001|NOT COMPLETED|Overall Study||24||
59871868|NCT03427268|75996042|FG000|STARTED|Overall Study||32||
59871869|NCT03427268|75996042|FG000|COMPLETED|Overall Study||0||
59871870|NCT03427268|75996042|FG000|NOT COMPLETED|Overall Study||32||
59871871|NCT03509948|75996046|FG000|STARTED|Overall Study||6||
59871872|NCT03509948|75996047|FG001|STARTED|Overall Study||7||
59871873|NCT03509948|75996046|FG000|COMPLETED|Overall Study||6||
59871874|NCT03509948|75996047|FG001|COMPLETED|Overall Study||6||
59871875|NCT03509948|75996046|FG000|NOT COMPLETED|Overall Study||0||
59871876|NCT03509948|75996047|FG001|NOT COMPLETED|Overall Study||1||
59871877|NCT03466658|75996053|FG000|STARTED|Overall Study||17||34
59871878|NCT03466658|75996053|FG000|COMPLETED|Overall Study||14||28
59871879|NCT03466658|75996053|FG000|NOT COMPLETED|Overall Study||3||6
59871880|NCT03425396|75996064|FG000|STARTED|Overall Study||55||
59871881|NCT03425396|75996065|FG001|STARTED|Overall Study||54||
59871882|NCT03425396|75996066|FG002|STARTED|Overall Study||54||
59871883|NCT03425396|75996067|FG003|STARTED|Overall Study||8||
59871884|NCT03425396|75996068|FG004|STARTED|Overall Study||54||
59871885|NCT03425396|75996064|FG000|Completed End of Treatment Visit|Overall Study||53||
59871886|NCT03425396|75996065|FG001|Completed End of Treatment Visit|Overall Study||52||
59871887|NCT03425396|75996066|FG002|Completed End of Treatment Visit|Overall Study||51||
59871888|NCT03425396|75996067|FG003|Completed End of Treatment Visit|Overall Study||7||
59871889|NCT03425396|75996068|FG004|Completed End of Treatment Visit|Overall Study||53||
59871890|NCT03425396|75996064|FG000|Completed Post-therapy Evaluation Visit|Overall Study||53||
59871891|NCT03425396|75996065|FG001|Completed Post-therapy Evaluation Visit|Overall Study||49||
59871892|NCT03425396|75996066|FG002|Completed Post-therapy Evaluation Visit|Overall Study||51||
59871893|NCT03425396|75996067|FG003|Completed Post-therapy Evaluation Visit|Overall Study||7||
59871894|NCT03425396|75996068|FG004|Completed Post-therapy Evaluation Visit|Overall Study||54||
59871895|NCT03425396|75996064|FG000|Completed Final Follow-up Visit|Overall Study||53||
59871896|NCT03425396|75996065|FG001|Completed Final Follow-up Visit|Overall Study||47||
59871897|NCT03425396|75996066|FG002|Completed Final Follow-up Visit|Overall Study||51||
59871898|NCT03425396|75996067|FG003|Completed Final Follow-up Visit|Overall Study||7||
59871899|NCT03425396|75996068|FG004|Completed Final Follow-up Visit|Overall Study||53||
59871900|NCT03425396|75996064|FG000|COMPLETED|Overall Study||53||
59871901|NCT03425396|75996065|FG001|COMPLETED|Overall Study||47||
59871902|NCT03425396|75996066|FG002|COMPLETED|Overall Study||51||
59871903|NCT03425396|75996067|FG003|COMPLETED|Overall Study||7||
59871904|NCT03425396|75996068|FG004|COMPLETED|Overall Study||53||
59871905|NCT03425396|75996064|FG000|NOT COMPLETED|Overall Study||2||
59871906|NCT03425396|75996065|FG001|NOT COMPLETED|Overall Study||7||
59871907|NCT03425396|75996066|FG002|NOT COMPLETED|Overall Study||3||
59871908|NCT03425396|75996067|FG003|NOT COMPLETED|Overall Study||1||
59871909|NCT03425396|75996068|FG004|NOT COMPLETED|Overall Study||1||
59871910|NCT00032487|75996082|FG000|STARTED|Overall Study||899||
59871911|NCT00032487|75996083|FG001|STARTED|Overall Study||892||
59871912|NCT00032487|75996082|FG000|COMPLETED|Overall Study||760||
59871913|NCT00032487|75996083|FG001|COMPLETED|Overall Study||772||
59871914|NCT00032487|75996082|FG000|NOT COMPLETED|Overall Study||139||
59871915|NCT00032487|75996083|FG001|NOT COMPLETED|Overall Study||120||
59871916|NCT03641508|75996091|FG000|STARTED|First Injection||37||
59871917|NCT03641508|75996092|FG001|STARTED|First Injection||32||
59871918|NCT03641508|75996091|FG000|COMPLETED|First Injection||35||
59871919|NCT03641508|75996092|FG001|COMPLETED|First Injection||32||
59871920|NCT03641508|75996091|FG000|NOT COMPLETED|First Injection||2||
59871921|NCT03641508|75996092|FG001|NOT COMPLETED|First Injection||0||
59871922|NCT03641508|75996091|FG000|STARTED|Follow-up/Second Injection||2|Only those who had symptoms at the six-week follow-up received the second injection|
59871923|NCT03641508|75996092|FG001|STARTED|Follow-up/Second Injection|Only those who had symptoms at the six-week follow-up received the second injection|10|Only those who had symptoms at the six-week follow-up received the second injection|
59871924|NCT03641508|75996091|FG000|COMPLETED|Follow-up/Second Injection|Only those who had symptoms at the six-week follow-up received the second injection|2||
59871925|NCT03641508|75996092|FG001|COMPLETED|Follow-up/Second Injection|Only those who had symptoms at the six-week follow-up received the second injection|10||
59871926|NCT03641508|75996091|FG000|NOT COMPLETED|Follow-up/Second Injection||0||
59871927|NCT03641508|75996092|FG001|NOT COMPLETED|Follow-up/Second Injection||0||
59871928|NCT03465878|75996100|FG000|STARTED|Period 1-Part A First Intervention Day 1||21||
59871929|NCT03465878|75996101|FG001|STARTED|Period 1-Part A First Intervention Day 1||21||
59871930|NCT03465878|75996102|FG002|STARTED|Period 1-Part A First Intervention Day 1||0||
59871931|NCT03465878|75996103|FG003|STARTED|Period 1-Part A First Intervention Day 1||0||
59871932|NCT03465878|75996100|FG000|Received at Least 1 Dose of Study Drug|Period 1-Part A First Intervention Day 1||21||
59871933|NCT03465878|75996101|FG001|Received at Least 1 Dose of Study Drug|Period 1-Part A First Intervention Day 1||21||
59871934|NCT03465878|75996102|FG002|Received at Least 1 Dose of Study Drug|Period 1-Part A First Intervention Day 1||0||
59871935|NCT03465878|75996103|FG003|Received at Least 1 Dose of Study Drug|Period 1-Part A First Intervention Day 1||0||
59871936|NCT03465878|75996100|FG000|Children (2-11 Years)|Period 1-Part A First Intervention Day 1||7||
59871937|NCT03465878|75996101|FG001|Children (2-11 Years)|Period 1-Part A First Intervention Day 1||6||
59871938|NCT03465878|75996102|FG002|Children (2-11 Years)|Period 1-Part A First Intervention Day 1||0||
59871939|NCT03465878|75996103|FG003|Children (2-11 Years)|Period 1-Part A First Intervention Day 1||0||
59871940|NCT03465878|75996100|FG000|Adolescents (12-17 Years)|Period 1-Part A First Intervention Day 1||7||
59871941|NCT03465878|75996101|FG001|Adolescents (12-17 Years)|Period 1-Part A First Intervention Day 1||7||
59871942|NCT03465878|75996102|FG002|Adolescents (12-17 Years)|Period 1-Part A First Intervention Day 1||0||
59871943|NCT03465878|75996103|FG003|Adolescents (12-17 Years)|Period 1-Part A First Intervention Day 1||0||
59871944|NCT03465878|75996100|FG000|Adults (18-64 Years)|Period 1-Part A First Intervention Day 1||7||
59871945|NCT03465878|75996101|FG001|Adults (18-64 Years)|Period 1-Part A First Intervention Day 1||8||
59871946|NCT03465878|75996102|FG002|Adults (18-64 Years)|Period 1-Part A First Intervention Day 1||0||
59871947|NCT03465878|75996103|FG003|Adults (18-64 Years)|Period 1-Part A First Intervention Day 1||0||
59871948|NCT03465878|75996100|FG000|COMPLETED|Period 1-Part A First Intervention Day 1||21||
59871949|NCT03465878|75996101|FG001|COMPLETED|Period 1-Part A First Intervention Day 1||20||
59871950|NCT03465878|75996102|FG002|COMPLETED|Period 1-Part A First Intervention Day 1||0||
59871951|NCT03465878|75996103|FG003|COMPLETED|Period 1-Part A First Intervention Day 1||0||
59871952|NCT03465878|75996100|FG000|NOT COMPLETED|Period 1-Part A First Intervention Day 1||0||
59871953|NCT03465878|75996101|FG001|NOT COMPLETED|Period 1-Part A First Intervention Day 1||1||
59871954|NCT03465878|75996102|FG002|NOT COMPLETED|Period 1-Part A First Intervention Day 1||0||
59871955|NCT03465878|75996103|FG003|NOT COMPLETED|Period 1-Part A First Intervention Day 1||0||
59871956|NCT03465878|75996100|FG000|STARTED|Period2-Part A Second Intervention Day 1||21||
59871957|NCT03465878|75996101|FG001|STARTED|Period2-Part A Second Intervention Day 1||20||
59871958|NCT03465878|75996102|FG002|STARTED|Period2-Part A Second Intervention Day 1||0||
59871959|NCT03465878|75996103|FG003|STARTED|Period2-Part A Second Intervention Day 1||0||
59871960|NCT03465878|75996100|FG000|Children (2-11 Years)|Period2-Part A Second Intervention Day 1||7||
59871961|NCT03465878|75996101|FG001|Children (2-11 Years)|Period2-Part A Second Intervention Day 1||6||
59871962|NCT03465878|75996102|FG002|Children (2-11 Years)|Period2-Part A Second Intervention Day 1||0||
59871963|NCT03465878|75996103|FG003|Children (2-11 Years)|Period2-Part A Second Intervention Day 1||0||
59871964|NCT03465878|75996100|FG000|Adolescents (12-17 Years)|Period2-Part A Second Intervention Day 1||7||
59871965|NCT03465878|75996101|FG001|Adolescents (12-17 Years)|Period2-Part A Second Intervention Day 1||7||
59871966|NCT03465878|75996102|FG002|Adolescents (12-17 Years)|Period2-Part A Second Intervention Day 1||0||
59871967|NCT03465878|75996103|FG003|Adolescents (12-17 Years)|Period2-Part A Second Intervention Day 1||0||
59871968|NCT03465878|75996100|FG000|Adults (18-64 Years)|Period2-Part A Second Intervention Day 1||7||
59871969|NCT03465878|75996101|FG001|Adults (18-64 Years)|Period2-Part A Second Intervention Day 1||7||
59871970|NCT03465878|75996102|FG002|Adults (18-64 Years)|Period2-Part A Second Intervention Day 1||0||
59871971|NCT03465878|75996103|FG003|Adults (18-64 Years)|Period2-Part A Second Intervention Day 1||0||
59871972|NCT03465878|75996100|FG000|COMPLETED|Period2-Part A Second Intervention Day 1||21||
59871973|NCT03465878|75996101|FG001|COMPLETED|Period2-Part A Second Intervention Day 1||20||
59871974|NCT03465878|75996102|FG002|COMPLETED|Period2-Part A Second Intervention Day 1||0||
59871975|NCT03465878|75996103|FG003|COMPLETED|Period2-Part A Second Intervention Day 1||0||
59871976|NCT03465878|75996100|FG000|NOT COMPLETED|Period2-Part A Second Intervention Day 1||0||
59871977|NCT03465878|75996101|FG001|NOT COMPLETED|Period2-Part A Second Intervention Day 1||0||
59871978|NCT03465878|75996102|FG002|NOT COMPLETED|Period2-Part A Second Intervention Day 1||0||
59871979|NCT03465878|75996103|FG003|NOT COMPLETED|Period2-Part A Second Intervention Day 1||0||
59871980|NCT03465878|75996100|FG000|STARTED|Period 1-Part B First Intervention Day 1|This period is for Part B group.|0||
59871981|NCT03465878|75996101|FG001|STARTED|Period 1-Part B First Intervention Day 1|This period is for Part B group.|0||
59871982|NCT03465878|75996102|FG002|STARTED|Period 1-Part B First Intervention Day 1|25 pts from Part A were re-randomized to Part B, 14 new pts were randomized in Part B.|20||
59871983|NCT03465878|75996103|FG003|STARTED|Period 1-Part B First Intervention Day 1|25 pts from Part A were re-randomized to Part B, 14 new pts were randomized in Part B.|19||
59871984|NCT03465878|75996100|FG000|Received at Least 1 Dose of Study Drug|Period 1-Part B First Intervention Day 1||0||
59871985|NCT03465878|75996101|FG001|Received at Least 1 Dose of Study Drug|Period 1-Part B First Intervention Day 1||0||
59871986|NCT03465878|75996102|FG002|Received at Least 1 Dose of Study Drug|Period 1-Part B First Intervention Day 1||20||
59871987|NCT03465878|75996103|FG003|Received at Least 1 Dose of Study Drug|Period 1-Part B First Intervention Day 1||17||
59871988|NCT03465878|75996100|FG000|Children (2-11 Years)|Period 1-Part B First Intervention Day 1||0||
59871989|NCT03465878|75996101|FG001|Children (2-11 Years)|Period 1-Part B First Intervention Day 1||0||
59871990|NCT03465878|75996102|FG002|Children (2-11 Years)|Period 1-Part B First Intervention Day 1||6||
59871991|NCT03465878|75996103|FG003|Children (2-11 Years)|Period 1-Part B First Intervention Day 1||6||
59871992|NCT03465878|75996100|FG000|Adolescents (12-17 Years)|Period 1-Part B First Intervention Day 1||0||
59871993|NCT03465878|75996101|FG001|Adolescents (12-17 Years)|Period 1-Part B First Intervention Day 1||0||
59871994|NCT03465878|75996102|FG002|Adolescents (12-17 Years)|Period 1-Part B First Intervention Day 1||7||
59871995|NCT03465878|75996103|FG003|Adolescents (12-17 Years)|Period 1-Part B First Intervention Day 1||6||
59871996|NCT03465878|75996100|FG000|Adults (18-64 Years)|Period 1-Part B First Intervention Day 1||0||
59871997|NCT03465878|75996101|FG001|Adults (18-64 Years)|Period 1-Part B First Intervention Day 1||0||
59871998|NCT03465878|75996102|FG002|Adults (18-64 Years)|Period 1-Part B First Intervention Day 1||7||
59871999|NCT03465878|75996103|FG003|Adults (18-64 Years)|Period 1-Part B First Intervention Day 1||5||
59872000|NCT03465878|75996100|FG000|COMPLETED|Period 1-Part B First Intervention Day 1||0||
59872001|NCT03465878|75996101|FG001|COMPLETED|Period 1-Part B First Intervention Day 1||0||
59872002|NCT03465878|75996102|FG002|COMPLETED|Period 1-Part B First Intervention Day 1||20||
59872003|NCT03465878|75996103|FG003|COMPLETED|Period 1-Part B First Intervention Day 1||17||
59872004|NCT03465878|75996100|FG000|NOT COMPLETED|Period 1-Part B First Intervention Day 1||0||
59872005|NCT03465878|75996101|FG001|NOT COMPLETED|Period 1-Part B First Intervention Day 1||0||
59872006|NCT03465878|75996102|FG002|NOT COMPLETED|Period 1-Part B First Intervention Day 1||0||
59872007|NCT03465878|75996103|FG003|NOT COMPLETED|Period 1-Part B First Intervention Day 1||2||
59872008|NCT03465878|75996100|FG000|STARTED|Period2-Part B Second Intervention Day 1||0||
59872009|NCT03465878|75996101|FG001|STARTED|Period2-Part B Second Intervention Day 1||0||
59872010|NCT03465878|75996102|FG002|STARTED|Period2-Part B Second Intervention Day 1||20||
59872011|NCT03465878|75996103|FG003|STARTED|Period2-Part B Second Intervention Day 1||17||
59951248|NCT03743415|76070179|FG004|COMPLETED|Overall Study||160||
59736695|NCT01059812|75855557|FG000|COMPLETED|Overall Study||245||
59736696|NCT01059812|75855558|FG001|COMPLETED|Overall Study||126||
59736697|NCT01059812|75855557|FG000|NOT COMPLETED|Overall Study||37||
59736698|NCT01059812|75855558|FG001|NOT COMPLETED|Overall Study||16||
59736699|NCT00888615|75855564|FG000|STARTED|Overall Study||58||
59736700|NCT00888615|75855564|FG000|COMPLETED|Overall Study||56||
59736701|NCT00888615|75855564|FG000|NOT COMPLETED|Overall Study||2||
59736702|NCT00845650|75855574|FG000|STARTED|Overall Study|1 subject not dosed|31||
59736703|NCT00845650|75855575|FG001|STARTED|Overall Study||5||
59736704|NCT00845650|75855576|FG002|STARTED|Overall Study||31||
59736705|NCT00845650|75855577|FG003|STARTED|Overall Study||14||
59736706|NCT00845650|75855578|FG004|STARTED|Overall Study|2 subjects not dosed|31||
59736707|NCT00845650|75855579|FG005|STARTED|Overall Study|1 subject not dosed|17||
59736708|NCT00845650|75855574|FG000|COMPLETED|Overall Study||30||
59736709|NCT00845650|75855575|FG001|COMPLETED|Overall Study||5||
59736710|NCT00845650|75855576|FG002|COMPLETED|Overall Study||28||
59736711|NCT00845650|75855577|FG003|COMPLETED|Overall Study||13||
59736712|NCT00845650|75855578|FG004|COMPLETED|Overall Study||28||
59736713|NCT00845650|75855579|FG005|COMPLETED|Overall Study||15||
59736714|NCT00845650|75855574|FG000|NOT COMPLETED|Overall Study||1||
59736715|NCT00845650|75855575|FG001|NOT COMPLETED|Overall Study||0||
59736716|NCT00845650|75855576|FG002|NOT COMPLETED|Overall Study||3||
59736717|NCT00845650|75855577|FG003|NOT COMPLETED|Overall Study||1||
59736718|NCT00845650|75855578|FG004|NOT COMPLETED|Overall Study||3||
59736719|NCT00845650|75855579|FG005|NOT COMPLETED|Overall Study||2||
59736720|NCT00888381|75855597|FG000|STARTED|Overall Study||60||
59736721|NCT00888381|75855598|FG001|STARTED|Overall Study||60||
59736722|NCT00888381|75855597|FG000|COMPLETED|Overall Study||60||
59736723|NCT00888381|75855598|FG001|COMPLETED|Overall Study||59||
59736724|NCT00888381|75855597|FG000|NOT COMPLETED|Overall Study||0||
59736725|NCT00888381|75855598|FG001|NOT COMPLETED|Overall Study||1||
59736726|NCT00887913|75855604|FG000|STARTED|Overall Study||69||
59736727|NCT00887913|75855604|FG000|COMPLETED|Overall Study||63||
59736728|NCT00887913|75855604|FG000|NOT COMPLETED|Overall Study||6||
59872012|NCT03465878|75996100|FG000|Children (2-11 Years)|Period2-Part B Second Intervention Day 1||0||
59872013|NCT03465878|75996101|FG001|Children (2-11 Years)|Period2-Part B Second Intervention Day 1||0||
59872014|NCT03465878|75996102|FG002|Children (2-11 Years)|Period2-Part B Second Intervention Day 1||6||
59872015|NCT03465878|75996103|FG003|Children (2-11 Years)|Period2-Part B Second Intervention Day 1||6||
59872016|NCT03465878|75996100|FG000|Adolescents (12-17 Years)|Period2-Part B Second Intervention Day 1||0||
59872017|NCT03465878|75996101|FG001|Adolescents (12-17 Years)|Period2-Part B Second Intervention Day 1||0||
59872018|NCT03465878|75996102|FG002|Adolescents (12-17 Years)|Period2-Part B Second Intervention Day 1||7||
59872019|NCT03465878|75996103|FG003|Adolescents (12-17 Years)|Period2-Part B Second Intervention Day 1||6||
59872020|NCT03465878|75996100|FG000|Adults (18-64 Years)|Period2-Part B Second Intervention Day 1||0||
59872021|NCT03465878|75996101|FG001|Adults (18-64 Years)|Period2-Part B Second Intervention Day 1||0||
59872022|NCT03465878|75996102|FG002|Adults (18-64 Years)|Period2-Part B Second Intervention Day 1||7||
59872023|NCT03465878|75996103|FG003|Adults (18-64 Years)|Period2-Part B Second Intervention Day 1||5||
59872024|NCT03465878|75996100|FG000|COMPLETED|Period2-Part B Second Intervention Day 1||0||
59872025|NCT03465878|75996101|FG001|COMPLETED|Period2-Part B Second Intervention Day 1||0||
59872026|NCT03465878|75996102|FG002|COMPLETED|Period2-Part B Second Intervention Day 1||20||
59872027|NCT03465878|75996103|FG003|COMPLETED|Period2-Part B Second Intervention Day 1||17||
59872028|NCT03465878|75996100|FG000|NOT COMPLETED|Period2-Part B Second Intervention Day 1||0||
59872029|NCT03465878|75996101|FG001|NOT COMPLETED|Period2-Part B Second Intervention Day 1||0||
59872030|NCT03465878|75996102|FG002|NOT COMPLETED|Period2-Part B Second Intervention Day 1||0||
59872031|NCT03465878|75996103|FG003|NOT COMPLETED|Period2-Part B Second Intervention Day 1||0||
59872032|NCT03637374|75996131|FG000|STARTED|Overall Study||2||
59872033|NCT03637374|75996132|FG001|STARTED|Overall Study||0||
59872034|NCT03637374|75996131|FG000|COMPLETED|Overall Study||0||
59872035|NCT03637374|75996132|FG001|COMPLETED|Overall Study||0||
59872036|NCT03637374|75996131|FG000|NOT COMPLETED|Overall Study||2||
59872037|NCT03637374|75996132|FG001|NOT COMPLETED|Overall Study||0||
59872038|NCT03421730|75996138|FG000|STARTED|First Intervention (Day 1, Visit 2)||1||
59872039|NCT03421730|75996139|FG001|STARTED|First Intervention (Day 1, Visit 2)||3||
59872040|NCT03421730|75996140|FG002|STARTED|First Intervention (Day 1, Visit 2)||1||
59872041|NCT03421730|75996141|FG003|STARTED|First Intervention (Day 1, Visit 2)||1||
59872042|NCT03421730|75996142|FG004|STARTED|First Intervention (Day 1, Visit 2)||3||
59872043|NCT03421730|75996143|FG005|STARTED|First Intervention (Day 1, Visit 2)||1||
59872044|NCT03421730|75996144|FG006|STARTED|First Intervention (Day 1, Visit 2)||1||
59872045|NCT03421730|75996145|FG007|STARTED|First Intervention (Day 1, Visit 2)||1||
59872046|NCT03421730|75996146|FG008|STARTED|First Intervention (Day 1, Visit 2)||1||
59872047|NCT03421730|75996147|FG009|STARTED|First Intervention (Day 1, Visit 2)||2||
59872048|NCT03421730|75996148|FG010|STARTED|First Intervention (Day 1, Visit 2)||1||
59872049|NCT03421730|75996149|FG011|STARTED|First Intervention (Day 1, Visit 2)||1||
59872050|NCT03421730|75996138|FG000|COMPLETED|First Intervention (Day 1, Visit 2)||1||
59872051|NCT03421730|75996139|FG001|COMPLETED|First Intervention (Day 1, Visit 2)|Two subjects withdrew without receiving treatment with either A or C.|1||
59872052|NCT03421730|75996140|FG002|COMPLETED|First Intervention (Day 1, Visit 2)||1||
59872053|NCT03421730|75996141|FG003|COMPLETED|First Intervention (Day 1, Visit 2)||1||
59872054|NCT03421730|75996142|FG004|COMPLETED|First Intervention (Day 1, Visit 2)||3||
59872055|NCT03421730|75996143|FG005|COMPLETED|First Intervention (Day 1, Visit 2)||1||
59872056|NCT03421730|75996144|FG006|COMPLETED|First Intervention (Day 1, Visit 2)||1||
59872057|NCT03421730|75996145|FG007|COMPLETED|First Intervention (Day 1, Visit 2)||1||
59872058|NCT03421730|75996146|FG008|COMPLETED|First Intervention (Day 1, Visit 2)||1||
59872059|NCT03421730|75996147|FG009|COMPLETED|First Intervention (Day 1, Visit 2)||2||
59736729|NCT00833560|75855608|FG000|STARTED|Overall Study||395||
59736730|NCT00833560|75855608|FG000|COMPLETED|Overall Study||353||
59736731|NCT00833560|75855608|FG000|NOT COMPLETED|Overall Study||42||
59736732|NCT00887679|75855612|FG000|STARTED|Overall Study||30||
59736733|NCT00887679|75855612|FG000|COMPLETED|Overall Study|20 subjects completed the study.|20||
59736734|NCT00887679|75855612|FG000|NOT COMPLETED|Overall Study||10||
59736735|NCT00833482|75855619|FG000|STARTED|Days 1-3|Participants who received treatment|24||
59736736|NCT00833482|75855620|FG001|STARTED|Days 1-3|Participants who received treatment|0||
59872060|NCT03421730|75996148|FG010|COMPLETED|First Intervention (Day 1, Visit 2)||1||
59872061|NCT03421730|75996149|FG011|COMPLETED|First Intervention (Day 1, Visit 2)||1||
59872062|NCT03421730|75996138|FG000|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0||
59872063|NCT03421730|75996139|FG001|NOT COMPLETED|First Intervention (Day 1, Visit 2)||2||
59872064|NCT03421730|75996140|FG002|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0||
59872065|NCT03421730|75996141|FG003|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0||
59872066|NCT03421730|75996142|FG004|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0||
59872067|NCT03421730|75996143|FG005|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0||
59872068|NCT03421730|75996144|FG006|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0||
59872069|NCT03421730|75996145|FG007|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0||
59872070|NCT03421730|75996146|FG008|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0||
59872071|NCT03421730|75996147|FG009|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0||
59872072|NCT03421730|75996148|FG010|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0||
59872073|NCT03421730|75996149|FG011|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0||
59872074|NCT03421730|75996138|FG000|STARTED|Washout (Days 4 to 10)||1||
59872075|NCT03421730|75996139|FG001|STARTED|Washout (Days 4 to 10)||1||
59872076|NCT03421730|75996140|FG002|STARTED|Washout (Days 4 to 10)||1||
59872077|NCT03421730|75996141|FG003|STARTED|Washout (Days 4 to 10)||1||
59872078|NCT03421730|75996142|FG004|STARTED|Washout (Days 4 to 10)||3||
59872079|NCT03421730|75996143|FG005|STARTED|Washout (Days 4 to 10)||1||
59872080|NCT03421730|75996144|FG006|STARTED|Washout (Days 4 to 10)||1||
59872081|NCT03421730|75996145|FG007|STARTED|Washout (Days 4 to 10)||1||
59872082|NCT03421730|75996146|FG008|STARTED|Washout (Days 4 to 10)||1||
59872083|NCT03421730|75996147|FG009|STARTED|Washout (Days 4 to 10)||2||
59872084|NCT03421730|75996148|FG010|STARTED|Washout (Days 4 to 10)||1||
59872085|NCT03421730|75996149|FG011|STARTED|Washout (Days 4 to 10)||1||
59872086|NCT03421730|75996138|FG000|COMPLETED|Washout (Days 4 to 10)||1||
59872087|NCT03421730|75996139|FG001|COMPLETED|Washout (Days 4 to 10)||1||
59872088|NCT03421730|75996140|FG002|COMPLETED|Washout (Days 4 to 10)||1||
59872089|NCT03421730|75996141|FG003|COMPLETED|Washout (Days 4 to 10)||1||
59872090|NCT03421730|75996142|FG004|COMPLETED|Washout (Days 4 to 10)|Two subjects withdrew after receiving treatment with B but before receiving treatment with C.|1||
59872091|NCT03421730|75996143|FG005|COMPLETED|Washout (Days 4 to 10)||1||
59872092|NCT03421730|75996144|FG006|COMPLETED|Washout (Days 4 to 10)||1||
59872093|NCT03421730|75996145|FG007|COMPLETED|Washout (Days 4 to 10)||1||
59872094|NCT03421730|75996146|FG008|COMPLETED|Washout (Days 4 to 10)||1||
59872095|NCT03421730|75996147|FG009|COMPLETED|Washout (Days 4 to 10)||2||
59872096|NCT03421730|75996148|FG010|COMPLETED|Washout (Days 4 to 10)||1||
59872097|NCT03421730|75996149|FG011|COMPLETED|Washout (Days 4 to 10)||1||
59872098|NCT03421730|75996138|FG000|NOT COMPLETED|Washout (Days 4 to 10)||0||
59872099|NCT03421730|75996139|FG001|NOT COMPLETED|Washout (Days 4 to 10)||0||
59872100|NCT03421730|75996140|FG002|NOT COMPLETED|Washout (Days 4 to 10)||0||
59872101|NCT03421730|75996141|FG003|NOT COMPLETED|Washout (Days 4 to 10)||0||
59872102|NCT03421730|75996142|FG004|NOT COMPLETED|Washout (Days 4 to 10)||2||
59872103|NCT03421730|75996143|FG005|NOT COMPLETED|Washout (Days 4 to 10)||0||
59872104|NCT03421730|75996144|FG006|NOT COMPLETED|Washout (Days 4 to 10)||0||
59872105|NCT03421730|75996145|FG007|NOT COMPLETED|Washout (Days 4 to 10)||0||
59872106|NCT03421730|75996146|FG008|NOT COMPLETED|Washout (Days 4 to 10)||0||
59872107|NCT03421730|75996147|FG009|NOT COMPLETED|Washout (Days 4 to 10)||0||
59872108|NCT03421730|75996148|FG010|NOT COMPLETED|Washout (Days 4 to 10)||0||
59872109|NCT03421730|75996149|FG011|NOT COMPLETED|Washout (Days 4 to 10)||0||
59872110|NCT03421730|75996138|FG000|STARTED|Second Intervention (Day 8±3, Visit 3)||1||
59872111|NCT03421730|75996139|FG001|STARTED|Second Intervention (Day 8±3, Visit 3)||1||
59872112|NCT03421730|75996140|FG002|STARTED|Second Intervention (Day 8±3, Visit 3)||1||
59872113|NCT03421730|75996141|FG003|STARTED|Second Intervention (Day 8±3, Visit 3)||1||
59872114|NCT03421730|75996142|FG004|STARTED|Second Intervention (Day 8±3, Visit 3)||1||
59872115|NCT03421730|75996143|FG005|STARTED|Second Intervention (Day 8±3, Visit 3)||1||
59872116|NCT03421730|75996144|FG006|STARTED|Second Intervention (Day 8±3, Visit 3)||1||
59872117|NCT03421730|75996145|FG007|STARTED|Second Intervention (Day 8±3, Visit 3)||1||
59872118|NCT03421730|75996146|FG008|STARTED|Second Intervention (Day 8±3, Visit 3)||1||
59872119|NCT03421730|75996147|FG009|STARTED|Second Intervention (Day 8±3, Visit 3)||2||
59872120|NCT03421730|75996148|FG010|STARTED|Second Intervention (Day 8±3, Visit 3)||1||
59872121|NCT03421730|75996149|FG011|STARTED|Second Intervention (Day 8±3, Visit 3)||1||
59872122|NCT03421730|75996138|FG000|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1||
59872123|NCT03421730|75996139|FG001|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1||
59872124|NCT03421730|75996140|FG002|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1||
59872125|NCT03421730|75996141|FG003|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1||
59872126|NCT03421730|75996142|FG004|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1||
59872127|NCT03421730|75996143|FG005|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1||
59872128|NCT03421730|75996144|FG006|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1||
59872129|NCT03421730|75996145|FG007|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1||
59872130|NCT03421730|75996146|FG008|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1||
59872131|NCT03421730|75996147|FG009|COMPLETED|Second Intervention (Day 8±3, Visit 3)||2||
59872132|NCT03421730|75996148|FG010|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1||
59872133|NCT03421730|75996149|FG011|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1||
59872134|NCT03421730|75996138|FG000|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0||
59872135|NCT03421730|75996139|FG001|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0||
59872136|NCT03421730|75996140|FG002|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0||
59872137|NCT03421730|75996141|FG003|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0||
59872138|NCT03421730|75996142|FG004|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0||
59872139|NCT03421730|75996143|FG005|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0||
59872140|NCT03421730|75996144|FG006|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0||
59872141|NCT03421730|75996145|FG007|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0||
59872142|NCT03421730|75996146|FG008|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0||
59872143|NCT03421730|75996147|FG009|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0||
59872144|NCT03421730|75996148|FG010|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0||
59872145|NCT03421730|75996149|FG011|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0||
59872146|NCT00054327|75996169|FG000|STARTED|Overall Study||11||
59872147|NCT00054327|75996170|FG001|STARTED|Overall Study||4||
59872148|NCT00054327|75996171|FG002|STARTED|Overall Study||3||
59872149|NCT00054327|75996172|FG003|STARTED|Overall Study||4||
59872150|NCT00054327|75996173|FG004|STARTED|Overall Study||10||
59872151|NCT00054327|75996174|FG005|STARTED|Overall Study||2||
59872152|NCT00054327|75996169|FG000|COMPLETED|Overall Study||10||
59872153|NCT00054327|75996170|FG001|COMPLETED|Overall Study||4||
59872154|NCT00054327|75996171|FG002|COMPLETED|Overall Study||3||
59872155|NCT00054327|75996172|FG003|COMPLETED|Overall Study||4||
59872156|NCT00054327|75996173|FG004|COMPLETED|Overall Study||10||
59872157|NCT00054327|75996174|FG005|COMPLETED|Overall Study||2||
59872158|NCT00054327|75996169|FG000|NOT COMPLETED|Overall Study||1||
59872159|NCT00054327|75996170|FG001|NOT COMPLETED|Overall Study||0||
59872160|NCT00054327|75996171|FG002|NOT COMPLETED|Overall Study||0||
59872161|NCT00054327|75996172|FG003|NOT COMPLETED|Overall Study||0||
59872162|NCT00054327|75996173|FG004|NOT COMPLETED|Overall Study||0||
59872163|NCT00054327|75996174|FG005|NOT COMPLETED|Overall Study||0||
59872164|NCT03503162|75996188|FG000|STARTED|Overall Study||95||
59872165|NCT03503162|75996188|FG000|COMPLETED|Overall Study||94||
59872166|NCT03503162|75996188|FG000|NOT COMPLETED|Overall Study||1||
59872167|NCT03029650|75996192|FG000|STARTED|First Intervention (3 - 6 Days)|More subjects not enrolled after consent in other group leaving uneven number.|14||
59872168|NCT03029650|75996193|FG001|STARTED|First Intervention (3 - 6 Days)||12||
59872169|NCT03029650|75996192|FG000|COMPLETED|First Intervention (3 - 6 Days)||14||
59872170|NCT03029650|75996193|FG001|COMPLETED|First Intervention (3 - 6 Days)||12||
59872171|NCT03029650|75996192|FG000|NOT COMPLETED|First Intervention (3 - 6 Days)||0||
59872172|NCT03029650|75996193|FG001|NOT COMPLETED|First Intervention (3 - 6 Days)||0||
59872173|NCT03029650|75996192|FG000|STARTED|Washout (1 Week)||14||
59872174|NCT03029650|75996193|FG001|STARTED|Washout (1 Week)||12||
59872175|NCT03029650|75996192|FG000|COMPLETED|Washout (1 Week)||13||
59872176|NCT03029650|75996193|FG001|COMPLETED|Washout (1 Week)||10||
59872177|NCT03029650|75996192|FG000|NOT COMPLETED|Washout (1 Week)||1||
59872178|NCT03029650|75996193|FG001|NOT COMPLETED|Washout (1 Week)||2||
59872179|NCT03029650|75996192|FG000|STARTED|2nd Intervention (3 - 6 Days)||13||
59872180|NCT03029650|75996193|FG001|STARTED|2nd Intervention (3 - 6 Days)||10||
59872181|NCT03029650|75996192|FG000|COMPLETED|2nd Intervention (3 - 6 Days)||13||
59872182|NCT03029650|75996193|FG001|COMPLETED|2nd Intervention (3 - 6 Days)||10||
59872183|NCT03029650|75996192|FG000|NOT COMPLETED|2nd Intervention (3 - 6 Days)||0||
59872184|NCT03029650|75996193|FG001|NOT COMPLETED|2nd Intervention (3 - 6 Days)||0||
59872185|NCT03462680|75996205|FG000|STARTED|Overall Study||21||
59872186|NCT03462680|75996206|FG001|STARTED|Overall Study||26||
59872187|NCT03462680|75996205|FG000|COMPLETED|Overall Study||18||
59872188|NCT03462680|75996206|FG001|COMPLETED|Overall Study||21||
59872189|NCT03462680|75996205|FG000|NOT COMPLETED|Overall Study||3||
59872190|NCT03462680|75996206|FG001|NOT COMPLETED|Overall Study||5||
59872191|NCT03636906|75996215|FG000|STARTED|Overall Study||65||
59872192|NCT03636906|75996216|FG001|STARTED|Overall Study||71||
59872193|NCT03636906|75996217|FG002|STARTED|Overall Study||65||
59872194|NCT03636906|75996215|FG000|COMPLETED|Overall Study||61||
59872195|NCT03636906|75996216|FG001|COMPLETED|Overall Study||71||
59872196|NCT03636906|75996217|FG002|COMPLETED|Overall Study||60||
59872197|NCT03636906|75996215|FG000|NOT COMPLETED|Overall Study||4||
59872198|NCT03636906|75996216|FG001|NOT COMPLETED|Overall Study||0||
59872199|NCT03636906|75996217|FG002|NOT COMPLETED|Overall Study||5||
59872200|NCT03028870|75996235|FG000|STARTED|Overall Study||74||
59872201|NCT03028870|75996236|FG001|STARTED|Overall Study||67||
59872202|NCT03028870|75996237|FG002|STARTED|Overall Study||76||
59872203|NCT03028870|75996238|FG003|STARTED|Overall Study||74||
59872204|NCT03028870|75996235|FG000|COMPLETED|Overall Study||57||
59872205|NCT03028870|75996236|FG001|COMPLETED|Overall Study||57||
59872206|NCT03028870|75996237|FG002|COMPLETED|Overall Study||60||
59872207|NCT03028870|75996238|FG003|COMPLETED|Overall Study||65||
59872208|NCT03028870|75996235|FG000|NOT COMPLETED|Overall Study||17||
59872209|NCT03028870|75996236|FG001|NOT COMPLETED|Overall Study||10||
59872210|NCT03028870|75996237|FG002|NOT COMPLETED|Overall Study||16||
59872211|NCT03028870|75996238|FG003|NOT COMPLETED|Overall Study||9||
59872212|NCT03663582|75996248|FG000|STARTED|Overall Study||7||
59872213|NCT03663582|75996248|FG000|COMPLETED|Overall Study||6||
59872214|NCT03663582|75996248|FG000|NOT COMPLETED|Overall Study||1||
59872215|NCT03502616|75996254|FG000|STARTED|Up to Week 16||134||
59872216|NCT03502616|75996255|FG001|STARTED|Up to Week 16||136||
59872217|NCT03502616|75996254|FG000|Treated|Up to Week 16||133||
59872218|NCT03502616|75996255|FG001|Treated|Up to Week 16||136||
59872219|NCT03502616|75996254|FG000|COMPLETED|Up to Week 16||132||
59872220|NCT03502616|75996255|FG001|COMPLETED|Up to Week 16||133||
59872221|NCT03502616|75996254|FG000|NOT COMPLETED|Up to Week 16||2||
59872222|NCT03502616|75996255|FG001|NOT COMPLETED|Up to Week 16||3||
59872223|NCT03502616|75996254|FG000|STARTED|Week 16 to Week 48||132||
59872224|NCT03502616|75996255|FG001|STARTED|Week 16 to Week 48||133||
59872225|NCT03502616|75996254|FG000|Treated|Week 16 to Week 48||132||
59872226|NCT03502616|75996255|FG001|Treated|Week 16 to Week 48||133||
59872227|NCT03502616|75996254|FG000|COMPLETED|Week 16 to Week 48||125||
59872228|NCT03502616|75996255|FG001|COMPLETED|Week 16 to Week 48||127||
59872229|NCT03502616|75996254|FG000|NOT COMPLETED|Week 16 to Week 48||7||
59872230|NCT03502616|75996255|FG001|NOT COMPLETED|Week 16 to Week 48||6||
59872231|NCT04003012|75996265|FG000|STARTED|Overall Study||5||
59872232|NCT04003012|75996266|FG001|STARTED|Overall Study||5||
59872233|NCT04003012|75996265|FG000|COMPLETED|Overall Study||5||
59872234|NCT04003012|75996266|FG001|COMPLETED|Overall Study||5||
59872235|NCT04003012|75996265|FG000|NOT COMPLETED|Overall Study||0||
59872236|NCT04003012|75996266|FG001|NOT COMPLETED|Overall Study||0||
59872237|NCT03028012|75996276|FG000|STARTED|Overall Study||4||
59872238|NCT03028012|75996277|FG001|STARTED|Overall Study||3||
59872239|NCT03028012|75996278|FG002|STARTED|Overall Study||3||
59872240|NCT03028012|75996276|FG000|COMPLETED|Overall Study||2||
59872241|NCT03028012|75996277|FG001|COMPLETED|Overall Study||0||
59872242|NCT03028012|75996278|FG002|COMPLETED|Overall Study||0||
59872243|NCT03028012|75996276|FG000|NOT COMPLETED|Overall Study||2||
59872244|NCT03028012|75996277|FG001|NOT COMPLETED|Overall Study||3||
59872245|NCT03028012|75996278|FG002|NOT COMPLETED|Overall Study||3||
59872246|NCT03635190|75996287|FG000|STARTED|Overall Study|Some endpoints were evaluated on a per patient basis and some on a per lesion basis|112||154
59872247|NCT03635190|75996287|FG000|COMPLETED|Overall Study|2 lesions were not evaluable or results not reported|103||152
59872248|NCT03635190|75996287|FG000|NOT COMPLETED|Overall Study||9||2
59872249|NCT03634800|75996294|FG000|STARTED|Overall Study||6||
59872250|NCT03634800|75996294|FG000|COMPLETED|Overall Study||0||
59872251|NCT03634800|75996294|FG000|NOT COMPLETED|Overall Study||6||
59872252|NCT03027466|75996302|FG000|STARTED|Overall Study||2027||
59872253|NCT03027466|75996303|FG001|STARTED|Overall Study||1984||
59872254|NCT03027466|75996304|FG002|STARTED|Overall Study||1903||
59872255|NCT03027466|75996305|FG003|STARTED|Overall Study||1985||
59872256|NCT03027466|75996302|FG000|COMPLETED|Overall Study||158||
59872257|NCT03027466|75996303|FG001|COMPLETED|Overall Study||165||
59872258|NCT03027466|75996304|FG002|COMPLETED|Overall Study||160||
59872259|NCT03027466|75996305|FG003|COMPLETED|Overall Study||164||
59872260|NCT03027466|75996302|FG000|NOT COMPLETED|Overall Study||1869||
59872261|NCT03027466|75996303|FG001|NOT COMPLETED|Overall Study||1819||
59872262|NCT03027466|75996304|FG002|NOT COMPLETED|Overall Study||1743||
59872263|NCT03027466|75996305|FG003|NOT COMPLETED|Overall Study||1821||
59872264|NCT03662334|75996317|FG000|STARTED|Part 1: Treatment Period 1||0||
59872265|NCT03662334|75996318|FG001|STARTED|Part 1: Treatment Period 1||0||
59872266|NCT03662334|75996317|FG000|COMPLETED|Part 1: Treatment Period 1||0||
59872267|NCT03662334|75996318|FG001|COMPLETED|Part 1: Treatment Period 1||0||
59872268|NCT03662334|75996317|FG000|NOT COMPLETED|Part 1: Treatment Period 1||0||
59872269|NCT03662334|75996318|FG001|NOT COMPLETED|Part 1: Treatment Period 1||0||
59872270|NCT03662334|75996317|FG000|STARTED|Part 1: Treatment Period 2||0||
59872271|NCT03662334|75996318|FG001|STARTED|Part 1: Treatment Period 2||0||
59872272|NCT03662334|75996317|FG000|COMPLETED|Part 1: Treatment Period 2||0||
59872273|NCT03662334|75996318|FG001|COMPLETED|Part 1: Treatment Period 2||0||
59872274|NCT03662334|75996317|FG000|NOT COMPLETED|Part 1: Treatment Period 2||0||
59872275|NCT03662334|75996318|FG001|NOT COMPLETED|Part 1: Treatment Period 2||0||
59872276|NCT03662334|75996317|FG000|STARTED|Part 2: Treatment Period 1 (2 Days)|Part 1 of the study was not conducted. Participants were enrolled starting with Part 2.|7||
59872277|NCT03662334|75996318|FG001|STARTED|Part 2: Treatment Period 1 (2 Days)|Part 1 of the study was not conducted. Participants were enrolled starting with Part 2.|7||
59872278|NCT03662334|75996317|FG000|COMPLETED|Part 2: Treatment Period 1 (2 Days)||7||
59872279|NCT03662334|75996318|FG001|COMPLETED|Part 2: Treatment Period 1 (2 Days)||7||
59872280|NCT03662334|75996317|FG000|NOT COMPLETED|Part 2: Treatment Period 1 (2 Days)||0||
59872281|NCT03662334|75996318|FG001|NOT COMPLETED|Part 2: Treatment Period 1 (2 Days)||0||
59872282|NCT03662334|75996317|FG000|STARTED|Part 2: Treatment Period 2 (2 Days)||7||
59872283|NCT03662334|75996318|FG001|STARTED|Part 2: Treatment Period 2 (2 Days)||7||
59872284|NCT03662334|75996317|FG000|COMPLETED|Part 2: Treatment Period 2 (2 Days)||6||
59872285|NCT03662334|75996318|FG001|COMPLETED|Part 2: Treatment Period 2 (2 Days)||7||
59872286|NCT03662334|75996317|FG000|NOT COMPLETED|Part 2: Treatment Period 2 (2 Days)||1||
59872287|NCT03662334|75996318|FG001|NOT COMPLETED|Part 2: Treatment Period 2 (2 Days)||0||
59950733|NCT03536884|76069556|FG000|NOT COMPLETED|Maintenance Treatment Period Week 16-48||0||
59872288|NCT03662334|75996317|FG000|STARTED|Part 3: Treatment Period 1|Part 3 of the study was not conducted. No participants were enrolled in this part of the study.|0||
59872289|NCT03662334|75996318|FG001|STARTED|Part 3: Treatment Period 1|Part 3 of the study was not conducted. No participants were enrolled in this part of the study.|0||
59872290|NCT03662334|75996317|FG000|COMPLETED|Part 3: Treatment Period 1||0||
59872291|NCT03662334|75996318|FG001|COMPLETED|Part 3: Treatment Period 1||0||
59872292|NCT03662334|75996317|FG000|NOT COMPLETED|Part 3: Treatment Period 1||0||
59872293|NCT03662334|75996318|FG001|NOT COMPLETED|Part 3: Treatment Period 1||0||
59872294|NCT03662334|75996317|FG000|STARTED|Part 3: Treatment Period 2||0||
59872295|NCT03662334|75996318|FG001|STARTED|Part 3: Treatment Period 2||0||
59872296|NCT03662334|75996317|FG000|COMPLETED|Part 3: Treatment Period 2||0||
59872297|NCT03662334|75996318|FG001|COMPLETED|Part 3: Treatment Period 2||0||
59872298|NCT03662334|75996317|FG000|NOT COMPLETED|Part 3: Treatment Period 2||0||
59872299|NCT03662334|75996318|FG001|NOT COMPLETED|Part 3: Treatment Period 2||0||
59872300|NCT02955186|75996326|FG000|STARTED|Overall Study||33||
59872301|NCT02955186|75996327|FG001|STARTED|Overall Study||17||
59872302|NCT02955186|75996326|FG000|COMPLETED|Overall Study||26||
59872303|NCT02955186|75996327|FG001|COMPLETED|Overall Study||15||
59872304|NCT02955186|75996326|FG000|NOT COMPLETED|Overall Study||7||
59872305|NCT02955186|75996327|FG001|NOT COMPLETED|Overall Study||2||
59872306|NCT03502070|75996333|FG000|STARTED|Overall Study||47||
59872307|NCT03502070|75996333|FG000|COMPLETED|Overall Study||45||
59872308|NCT03502070|75996333|FG000|NOT COMPLETED|Overall Study||2||
59872309|NCT03586830|75996341|FG000|STARTED|Overall Study||50||
59872310|NCT03586830|75996342|FG001|STARTED|Overall Study||48||
59872311|NCT03586830|75996343|FG002|STARTED|Overall Study||49||
59872312|NCT03586830|75996344|FG003|STARTED|Overall Study||49||
59872313|NCT03586830|75996341|FG000|Treated|Overall Study||49||
59872314|NCT03586830|75996342|FG001|Treated|Overall Study||48||
59872315|NCT03586830|75996343|FG002|Treated|Overall Study||49||
59872316|NCT03586830|75996344|FG003|Treated|Overall Study||49||
59872317|NCT03586830|75996341|FG000|COMPLETED|Overall Study||48||
59872318|NCT03586830|75996342|FG001|COMPLETED|Overall Study||42||
59872319|NCT03586830|75996343|FG002|COMPLETED|Overall Study||41||
59872320|NCT03586830|75996344|FG003|COMPLETED|Overall Study||44||
59872321|NCT03586830|75996341|FG000|NOT COMPLETED|Overall Study||2||
59872322|NCT03586830|75996342|FG001|NOT COMPLETED|Overall Study||6||
59872323|NCT03586830|75996343|FG002|NOT COMPLETED|Overall Study||8||
59872324|NCT03586830|75996344|FG003|NOT COMPLETED|Overall Study||5||
59872325|NCT03026530|75996356|FG000|STARTED|Overall Study||100||
59872326|NCT03026530|75996357|FG001|STARTED|Overall Study||100||
59872327|NCT03026530|75996356|FG000|COMPLETED|Overall Study||79||
59872328|NCT03026530|75996357|FG001|COMPLETED|Overall Study||71||
59872329|NCT03026530|75996356|FG000|NOT COMPLETED|Overall Study||21||
59872330|NCT03026530|75996357|FG001|NOT COMPLETED|Overall Study||29||
59872331|NCT03418376|75996367|FG000|STARTED|Overall Study||12||
59872332|NCT03418376|75996368|FG001|STARTED|Overall Study||11||
59872333|NCT03418376|75996369|FG002|STARTED|Overall Study||11||
59872334|NCT03418376|75996370|FG003|STARTED|Overall Study||11||
59872335|NCT03418376|75996367|FG000|COMPLETED|Overall Study||11||
59872336|NCT03418376|75996368|FG001|COMPLETED|Overall Study||6||
59872337|NCT03418376|75996369|FG002|COMPLETED|Overall Study||8||
59872338|NCT03418376|75996370|FG003|COMPLETED|Overall Study||10||
59872339|NCT03418376|75996367|FG000|NOT COMPLETED|Overall Study||1||
59872340|NCT03418376|75996368|FG001|NOT COMPLETED|Overall Study||5||
59872341|NCT03418376|75996369|FG002|NOT COMPLETED|Overall Study||3||
59872342|NCT03418376|75996370|FG003|NOT COMPLETED|Overall Study||1||
59872343|NCT03585504|75996382|FG000|STARTED|Overall Study||41||
59872344|NCT03585504|75996383|FG001|STARTED|Overall Study||40||
59872345|NCT03585504|75996382|FG000|COMPLETED|Overall Study||15||
59872346|NCT03585504|75996383|FG001|COMPLETED|Overall Study||11||
59872347|NCT03585504|75996382|FG000|NOT COMPLETED|Overall Study||26||
59872348|NCT03585504|75996383|FG001|NOT COMPLETED|Overall Study||29||
59872349|NCT03417830|75996391|FG000|STARTED|Part A (up to 26 Days)||2||
59872350|NCT03417830|75996392|FG001|STARTED|Part A (up to 26 Days)||0||
59872351|NCT03417830|75996391|FG000|COMPLETED|Part A (up to 26 Days)||1||
59872352|NCT03417830|75996392|FG001|COMPLETED|Part A (up to 26 Days)||0||
59872353|NCT03417830|75996391|FG000|NOT COMPLETED|Part A (up to 26 Days)||1||
59872354|NCT03417830|75996392|FG001|NOT COMPLETED|Part A (up to 26 Days)||0||
59872355|NCT03417830|75996391|FG000|STARTED|Part B (up to 26 Days)||0||
59872356|NCT03417830|75996392|FG001|STARTED|Part B (up to 26 Days)||0||
59872357|NCT03417830|75996391|FG000|COMPLETED|Part B (up to 26 Days)||0||
59872358|NCT03417830|75996392|FG001|COMPLETED|Part B (up to 26 Days)||0||
59872359|NCT03417830|75996391|FG000|NOT COMPLETED|Part B (up to 26 Days)||0||
59872360|NCT03417830|75996392|FG001|NOT COMPLETED|Part B (up to 26 Days)||0||
59872361|NCT03576768|75996403|FG000|STARTED|Overall Study||13||
59872362|NCT03576768|75996404|FG001|STARTED|Overall Study||12||
59872363|NCT03576768|75996405|FG002|STARTED|Overall Study|The study was ended before recruitment into this arm started.|0||
59872364|NCT03576768|75996406|FG003|STARTED|Overall Study|The study was ended before recruitment into this arm started.|0||
59872365|NCT03576768|75996403|FG000|COMPLETED|Overall Study||10||
59872366|NCT03576768|75996404|FG001|COMPLETED|Overall Study||9||
59872367|NCT03576768|75996405|FG002|COMPLETED|Overall Study||0||
59872368|NCT03576768|75996406|FG003|COMPLETED|Overall Study||0||
59872369|NCT03576768|75996403|FG000|NOT COMPLETED|Overall Study||3||
59872370|NCT03576768|75996404|FG001|NOT COMPLETED|Overall Study||3||
59872371|NCT03576768|75996405|FG002|NOT COMPLETED|Overall Study||0||
59872372|NCT03576768|75996406|FG003|NOT COMPLETED|Overall Study||0||
59872373|NCT03576066|75996418|FG000|STARTED|Overall Study||45||
59872374|NCT03576066|75996419|FG001|STARTED|Overall Study||28||
59872375|NCT03576066|75996418|FG000|COMPLETED|Overall Study||45||
59872376|NCT03576066|75996419|FG001|COMPLETED|Overall Study||27||
59872377|NCT03576066|75996418|FG000|NOT COMPLETED|Overall Study||0||
59872378|NCT03576066|75996419|FG001|NOT COMPLETED|Overall Study||1||
59872379|NCT03557034|75996431|FG000|STARTED|Overall Study||49||
59872380|NCT03557034|75996432|FG001|STARTED|Overall Study||51||
59872381|NCT03557034|75996431|FG000|Randomization|Overall Study||49||
59872382|NCT03557034|75996432|FG001|Randomization|Overall Study||51||
59872383|NCT03557034|75996431|FG000|COMPLETED|Overall Study||48||
59872384|NCT03557034|75996432|FG001|COMPLETED|Overall Study||51||
59872385|NCT03557034|75996431|FG000|NOT COMPLETED|Overall Study||1||
59872386|NCT03557034|75996432|FG001|NOT COMPLETED|Overall Study||0||
59872387|NCT03583554|75996438|FG000|STARTED|Period 1||4||
59872388|NCT03583554|75996439|FG001|STARTED|Period 1||4||
59872389|NCT03583554|75996440|FG002|STARTED|Period 1||4||
59872390|NCT03583554|75996438|FG000|COMPLETED|Period 1||4||
59872391|NCT03583554|75996439|FG001|COMPLETED|Period 1||4||
59872392|NCT03583554|75996440|FG002|COMPLETED|Period 1||4||
59872393|NCT03583554|75996438|FG000|NOT COMPLETED|Period 1||0||
59872394|NCT03583554|75996439|FG001|NOT COMPLETED|Period 1||0||
59872395|NCT03583554|75996440|FG002|NOT COMPLETED|Period 1||0||
59872396|NCT03583554|75996438|FG000|STARTED|Period 2||4||
59872397|NCT03583554|75996439|FG001|STARTED|Period 2||4||
59872398|NCT03583554|75996440|FG002|STARTED|Period 2||4||
59872399|NCT03583554|75996438|FG000|COMPLETED|Period 2||3||
59872400|NCT03583554|75996439|FG001|COMPLETED|Period 2||4||
59872401|NCT03583554|75996440|FG002|COMPLETED|Period 2||3||
59872402|NCT03583554|75996438|FG000|NOT COMPLETED|Period 2||1||
59872403|NCT03583554|75996439|FG001|NOT COMPLETED|Period 2||0||
59872404|NCT03583554|75996440|FG002|NOT COMPLETED|Period 2||1||
59872405|NCT03583554|75996438|FG000|STARTED|Period 3||3||
59872406|NCT03583554|75996439|FG001|STARTED|Period 3||4||
59872407|NCT03583554|75996440|FG002|STARTED|Period 3||3||
59872408|NCT03583554|75996438|FG000|COMPLETED|Period 3||3||
59872409|NCT03583554|75996439|FG001|COMPLETED|Period 3||4||
59872410|NCT03583554|75996440|FG002|COMPLETED|Period 3||3||
59872411|NCT03583554|75996438|FG000|NOT COMPLETED|Period 3||0||
59872412|NCT03583554|75996439|FG001|NOT COMPLETED|Period 3||0||
59872413|NCT03583554|75996440|FG002|NOT COMPLETED|Period 3||0||
59872414|NCT03948178|75996451|FG000|STARTED|Overall Study||227||
59872415|NCT03948178|75996451|FG000|COMPLETED|Overall Study||0||
59872416|NCT03948178|75996451|FG000|NOT COMPLETED|Overall Study||227||
59872417|NCT03520920|75996458|FG000|STARTED|Overall Study||20||
59872418|NCT03520920|75996459|FG001|STARTED|Overall Study||16||
59872419|NCT03520920|75996460|FG002|STARTED|Overall Study||5||
59872420|NCT03520920|75996458|FG000|Received at Least 1 Dose of Study Drug|Overall Study||20||
59872421|NCT03520920|75996459|FG001|Received at Least 1 Dose of Study Drug|Overall Study||16||
59872422|NCT03520920|75996460|FG002|Received at Least 1 Dose of Study Drug|Overall Study||5||
59872423|NCT03520920|75996458|FG000|COMPLETED|Overall Study||0||
59872424|NCT03520920|75996459|FG001|COMPLETED|Overall Study||0||
59872425|NCT03520920|75996460|FG002|COMPLETED|Overall Study||0||
59872426|NCT03520920|75996458|FG000|NOT COMPLETED|Overall Study||20||
59872427|NCT03520920|75996459|FG001|NOT COMPLETED|Overall Study||16||
59872428|NCT03520920|75996460|FG002|NOT COMPLETED|Overall Study||5||
59872429|NCT02953340|75996476|FG000|STARTED|Overall Study||118||
59872430|NCT02953340|75996477|FG001|STARTED|Overall Study||119||
59872431|NCT02953340|75996476|FG000|Safety Population|Overall Study||117|Safety Population includes all participants who receive at least one dose of any protocol-specified drug (TC, SPI-2012 or pegfilgrastim).|
59872432|NCT02953340|75996477|FG001|Safety Population|Overall Study||118|Safety Population includes all participants who receive at least one dose of any protocol-specified drug (TC, SPI-2012 or pegfilgrastim).|
59872433|NCT02953340|75996476|FG000|Entered Safety Follow-up Period|Overall Study||117|Safety Follow-up Period included all participants who received at least one dose of any protocol specified drug (TC or SPI-2012 or pegfilgrastim) and continued for 12 months after last study treatment.|
59872434|NCT02953340|75996477|FG001|Entered Safety Follow-up Period|Overall Study||118|Safety Follow-up Period included all participants who received at least one dose of any protocol specified drug (TC or SPI-2012 or pegfilgrastim) and continued for 12 months after last study treatment.|
59872435|NCT02953340|75996476|FG000|COMPLETED|Overall Study||96||
59872436|NCT02953340|75996477|FG001|COMPLETED|Overall Study||85||
59872437|NCT02953340|75996476|FG000|NOT COMPLETED|Overall Study||22||
59872438|NCT02953340|75996477|FG001|NOT COMPLETED|Overall Study||34||
59872439|NCT03554772|75996493|FG000|STARTED|Overall Study||30||
59872440|NCT03554772|75996494|FG001|STARTED|Overall Study||30||
59872441|NCT03554772|75996495|FG002|STARTED|Overall Study||29||
59872442|NCT03554772|75996496|FG003|STARTED|Overall Study||31||
59872443|NCT03554772|75996493|FG000|Completed Treatment Period (8 Hours Post Dose)|Overall Study||30||
59872444|NCT03554772|75996494|FG001|Completed Treatment Period (8 Hours Post Dose)|Overall Study||30||
59872445|NCT03554772|75996495|FG002|Completed Treatment Period (8 Hours Post Dose)|Overall Study||29||
59872446|NCT03554772|75996496|FG003|Completed Treatment Period (8 Hours Post Dose)|Overall Study||31||
59872447|NCT03554772|75996493|FG000|COMPLETED|Overall Study||30||
59872448|NCT03554772|75996494|FG001|COMPLETED|Overall Study||30||
59872449|NCT03554772|75996495|FG002|COMPLETED|Overall Study||29||
59872450|NCT03554772|75996496|FG003|COMPLETED|Overall Study||29||
59872451|NCT03554772|75996493|FG000|NOT COMPLETED|Overall Study||0||
59872452|NCT03554772|75996494|FG001|NOT COMPLETED|Overall Study||0||
59872453|NCT03554772|75996495|FG002|NOT COMPLETED|Overall Study||0||
59872454|NCT03554772|75996496|FG003|NOT COMPLETED|Overall Study||2||
59872455|NCT03573804|75996506|FG000|STARTED|Overall Study||72||
59872456|NCT03573804|75996506|FG000|COMPLETED|Overall Study||62||
59872457|NCT03573804|75996506|FG000|NOT COMPLETED|Overall Study||10||
59872458|NCT03417440|75996524|FG000|STARTED|Overall Study||13||
59872459|NCT03417440|75996525|FG001|STARTED|Overall Study||13||
59872460|NCT03417440|75996526|FG002|STARTED|Overall Study||14||
59872461|NCT03417440|75996527|FG003|STARTED|Overall Study||14||
59872462|NCT03417440|75996528|FG004|STARTED|Overall Study||14||
59872463|NCT03417440|75996529|FG005|STARTED|Overall Study||12||
59872464|NCT03417440|75996530|FG006|STARTED|Overall Study||15||
59872465|NCT03417440|75996531|FG007|STARTED|Overall Study||12||
59872466|NCT03417440|75996524|FG000|Non-completer But Included in ITT|Overall Study||1||
59872467|NCT03417440|75996525|FG001|Non-completer But Included in ITT|Overall Study||1||
59872468|NCT03417440|75996526|FG002|Non-completer But Included in ITT|Overall Study||1||
59872469|NCT03417440|75996527|FG003|Non-completer But Included in ITT|Overall Study||1||
59872470|NCT03417440|75996528|FG004|Non-completer But Included in ITT|Overall Study||2||
59872471|NCT03417440|75996529|FG005|Non-completer But Included in ITT|Overall Study||0||
59872472|NCT03417440|75996530|FG006|Non-completer But Included in ITT|Overall Study||0||
59872473|NCT03417440|75996531|FG007|Non-completer But Included in ITT|Overall Study||1||
59872474|NCT03417440|75996524|FG000|Non-completer But NOT Included in ITT|Overall Study||1||
59872475|NCT03417440|75996525|FG001|Non-completer But NOT Included in ITT|Overall Study||0||
59872476|NCT03417440|75996526|FG002|Non-completer But NOT Included in ITT|Overall Study||1||
59872477|NCT03417440|75996527|FG003|Non-completer But NOT Included in ITT|Overall Study||0||
59872478|NCT03417440|75996528|FG004|Non-completer But NOT Included in ITT|Overall Study||0||
59872479|NCT03417440|75996529|FG005|Non-completer But NOT Included in ITT|Overall Study||0||
59872480|NCT03417440|75996530|FG006|Non-completer But NOT Included in ITT|Overall Study||0||
59872481|NCT03417440|75996531|FG007|Non-completer But NOT Included in ITT|Overall Study||0||
59872482|NCT03417440|75996524|FG000|COMPLETED|Overall Study||11||
59872483|NCT03417440|75996525|FG001|COMPLETED|Overall Study||12||
59872484|NCT03417440|75996526|FG002|COMPLETED|Overall Study||12||
59872485|NCT03417440|75996527|FG003|COMPLETED|Overall Study||13||
59872486|NCT03417440|75996528|FG004|COMPLETED|Overall Study||12||
59872487|NCT03417440|75996529|FG005|COMPLETED|Overall Study||12||
59872488|NCT03417440|75996530|FG006|COMPLETED|Overall Study||15||
59872489|NCT03417440|75996531|FG007|COMPLETED|Overall Study||11||
59872490|NCT03417440|75996524|FG000|NOT COMPLETED|Overall Study||2||
59872491|NCT03417440|75996525|FG001|NOT COMPLETED|Overall Study||1||
59872492|NCT03417440|75996526|FG002|NOT COMPLETED|Overall Study||2||
59872493|NCT03417440|75996527|FG003|NOT COMPLETED|Overall Study||1||
59872494|NCT03417440|75996528|FG004|NOT COMPLETED|Overall Study||2||
59872495|NCT03417440|75996529|FG005|NOT COMPLETED|Overall Study||0||
59872496|NCT03417440|75996530|FG006|NOT COMPLETED|Overall Study||0||
59872497|NCT03417440|75996531|FG007|NOT COMPLETED|Overall Study||1||
59872498|NCT03458702|75996554|FG000|STARTED|Study Condition A (Yoga or Rest)||28||
59872499|NCT03458702|75996555|FG001|STARTED|Study Condition A (Yoga or Rest)||28||
59872500|NCT03458702|75996554|FG000|COMPLETED|Study Condition A (Yoga or Rest)||24||
59872501|NCT03458702|75996555|FG001|COMPLETED|Study Condition A (Yoga or Rest)||22||
59872502|NCT03458702|75996554|FG000|NOT COMPLETED|Study Condition A (Yoga or Rest)||4||
59872503|NCT03458702|75996555|FG001|NOT COMPLETED|Study Condition A (Yoga or Rest)||6||
59872504|NCT03458702|75996554|FG000|STARTED|Study Condition B (Yoga or Rest)||24||
59872505|NCT03458702|75996555|FG001|STARTED|Study Condition B (Yoga or Rest)||22||
59872506|NCT03458702|75996554|FG000|COMPLETED|Study Condition B (Yoga or Rest)||20||
59872507|NCT03458702|75996555|FG001|COMPLETED|Study Condition B (Yoga or Rest)||20||
59872508|NCT03458702|75996554|FG000|NOT COMPLETED|Study Condition B (Yoga or Rest)||4||
59872509|NCT03458702|75996555|FG001|NOT COMPLETED|Study Condition B (Yoga or Rest)||2||
59872510|NCT03458702|75996554|FG000|STARTED|Picture Rating/Body Composition||20||
59872511|NCT03458702|75996555|FG001|STARTED|Picture Rating/Body Composition||20||
59872512|NCT03458702|75996554|FG000|COMPLETED|Picture Rating/Body Composition||20||
59872513|NCT03458702|75996555|FG001|COMPLETED|Picture Rating/Body Composition||20||
59872514|NCT03458702|75996554|FG000|NOT COMPLETED|Picture Rating/Body Composition||0||
59872515|NCT03458702|75996555|FG001|NOT COMPLETED|Picture Rating/Body Composition||0||
59872516|NCT03454412|75996561|FG000|STARTED|Baseline Assesment||44||
59872517|NCT03454412|75996561|FG000|COMPLETED|Baseline Assesment||32||
59872518|NCT03454412|75996561|FG000|NOT COMPLETED|Baseline Assesment||12||
59872519|NCT03454412|75996561|FG000|STARTED|Treatment Course||32||
59872520|NCT03454412|75996561|FG000|COMPLETED|Treatment Course||32||
59872521|NCT03454412|75996561|FG000|NOT COMPLETED|Treatment Course||0||
59872522|NCT03454412|75996561|FG000|STARTED|Final Assesment||32||
59872523|NCT03454412|75996561|FG000|COMPLETED|Final Assesment||32||
59872524|NCT03454412|75996561|FG000|NOT COMPLETED|Final Assesment||0||
59872525|NCT03452540|75996565|FG000|STARTED|Overall Study||9||
59872526|NCT03452540|75996565|FG000|COMPLETED|Overall Study||5||
59872527|NCT03452540|75996565|FG000|NOT COMPLETED|Overall Study||4||
59872528|NCT03573336|75996572|FG000|STARTED|Overall Study||2||
59872529|NCT03573336|75996573|FG001|STARTED|Overall Study||4||
59872530|NCT03573336|75996574|FG002|STARTED|Overall Study||2||
59872531|NCT03573336|75996572|FG000|Treated|Overall Study||2||
59872532|NCT03573336|75996573|FG001|Treated|Overall Study||4||
59872533|NCT03573336|75996574|FG002|Treated|Overall Study||2||
59872534|NCT03573336|75996572|FG000|COMPLETED|Overall Study||0||
59872535|NCT03573336|75996573|FG001|COMPLETED|Overall Study||0||
59872536|NCT03573336|75996574|FG002|COMPLETED|Overall Study||0||
59872537|NCT03573336|75996572|FG000|NOT COMPLETED|Overall Study||2||
59872538|NCT03573336|75996573|FG001|NOT COMPLETED|Overall Study||4||
59872539|NCT03573336|75996574|FG002|NOT COMPLETED|Overall Study||2||
59872540|NCT03500198|75996584|FG000|STARTED|Overall Study||110||
59872541|NCT03500198|75996585|FG001|STARTED|Overall Study||108||
59872542|NCT03500198|75996584|FG000|First Eye|Overall Study||110||
59872543|NCT03500198|75996585|FG001|First Eye|Overall Study||108||
59872544|NCT03500198|75996584|FG000|Second Eye|Overall Study||109||
59872545|NCT03500198|75996585|FG001|Second Eye|Overall Study||108||
59872546|NCT03500198|75996584|FG000|COMPLETED|Overall Study||110||
59872547|NCT03500198|75996585|FG001|COMPLETED|Overall Study||107||
59872548|NCT03500198|75996584|FG000|NOT COMPLETED|Overall Study||0||
59872549|NCT03500198|75996585|FG001|NOT COMPLETED|Overall Study||1||
59872550|NCT03553758|75996593|FG000|STARTED|Overall Study||16||
59872551|NCT03553758|75996593|FG000|Completed Screening Visit|Overall Study||16||
59872552|NCT03553758|75996593|FG000|COMPLETED|Overall Study||15||
59872553|NCT03553758|75996593|FG000|NOT COMPLETED|Overall Study||1||
59872554|NCT03552198|75996603|FG000|STARTED|Overall Study||83||
59872555|NCT03552198|75996604|FG001|STARTED|Overall Study||84||
59872556|NCT03552198|75996605|FG002|STARTED|Overall Study||24||
59872557|NCT03552198|75996606|FG003|STARTED|Overall Study||34||
59872558|NCT03552198|75996603|FG000|Final Questionnaire 4 Weeks Follow-up|Overall Study||34||
59872559|NCT03552198|75996604|FG001|Final Questionnaire 4 Weeks Follow-up|Overall Study||29||
59872560|NCT03552198|75996605|FG002|Final Questionnaire 4 Weeks Follow-up|Overall Study||7||
59872561|NCT03552198|75996606|FG003|Final Questionnaire 4 Weeks Follow-up|Overall Study||12||
59872562|NCT03552198|75996603|FG000|COMPLETED|Overall Study||34||
59872563|NCT03552198|75996604|FG001|COMPLETED|Overall Study||29||
59872564|NCT03552198|75996605|FG002|COMPLETED|Overall Study||7||
59872565|NCT03552198|75996606|FG003|COMPLETED|Overall Study||12||
59872566|NCT03552198|75996603|FG000|NOT COMPLETED|Overall Study||49||
59872567|NCT03552198|75996604|FG001|NOT COMPLETED|Overall Study||55||
59872568|NCT03552198|75996605|FG002|NOT COMPLETED|Overall Study||17||
59872569|NCT03552198|75996606|FG003|NOT COMPLETED|Overall Study||22||
59872570|NCT02954354|75996619|FG000|STARTED|Overall Study||612||
59872571|NCT02954354|75996620|FG001|STARTED|Overall Study||310||
59872572|NCT02954354|75996621|FG002|STARTED|Overall Study||514||
59872573|NCT02954354|75996619|FG000|Received Study Drug|Overall Study||610||
59872574|NCT02954354|75996620|FG001|Received Study Drug|Overall Study||309||
59872575|NCT02954354|75996621|FG002|Received Study Drug|Overall Study||513||
59872576|NCT02954354|75996619|FG000|Intention to Treat Infected Population|Overall Study||456||
59872577|NCT02954354|75996620|FG001|Intention to Treat Infected Population|Overall Study||231||
59872578|NCT02954354|75996621|FG002|Intention to Treat Infected Population|Overall Study||377||
59872579|NCT02954354|75996619|FG000|COMPLETED|Overall Study||578||
59872580|NCT02954354|75996620|FG001|COMPLETED|Overall Study||290||
59872581|NCT02954354|75996621|FG002|COMPLETED|Overall Study||498||
59872582|NCT02954354|75996619|FG000|NOT COMPLETED|Overall Study||34||
59872583|NCT02954354|75996620|FG001|NOT COMPLETED|Overall Study||20||
59872584|NCT02954354|75996621|FG002|NOT COMPLETED|Overall Study||16||
59872585|NCT03519516|75996633|FG000|STARTED|Overall Study||15||
59872586|NCT03519516|75996634|FG001|STARTED|Overall Study||15||
59872587|NCT03519516|75996633|FG000|COMPLETED|Overall Study||15||
59872588|NCT03519516|75996634|FG001|COMPLETED|Overall Study||14||
59872589|NCT03519516|75996633|FG000|NOT COMPLETED|Overall Study||0||
59872590|NCT03519516|75996634|FG001|NOT COMPLETED|Overall Study||1||
59872591|NCT03519204|75996642|FG000|STARTED|Overall Study|3 control participants were treated in error; 29 participants received treatment after 3 months.|43||
59872592|NCT03519204|75996643|FG001|STARTED|Overall Study||133||
59872593|NCT03519204|75996642|FG000|mITT Population|Overall Study||33||
59872594|NCT03519204|75996643|FG001|mITT Population|Overall Study||130||
59872595|NCT03519204|75996642|FG000|Safety Population|Overall Study||40||
59872596|NCT03519204|75996643|FG001|Safety Population|Overall Study||136||
59872597|NCT03519204|75996642|FG000|COMPLETED|Overall Study||30||
59872598|NCT03519204|75996643|FG001|COMPLETED|Overall Study||118||
59872599|NCT03519204|75996642|FG000|NOT COMPLETED|Overall Study||13||
59872600|NCT03519204|75996643|FG001|NOT COMPLETED|Overall Study||15||
59872601|NCT03518658|75996655|FG000|STARTED|Overall Study|Number of patients completing device pairing survey|257||
59872602|NCT03518658|75996656|FG001|STARTED|Overall Study||128607||
59951249|NCT03743415|76070180|FG005|COMPLETED|Overall Study||42||
59872603|NCT03518658|75996655|FG000|COMPLETED|Overall Study|Number of patients completing annual survey|206||
59872604|NCT03518658|75996656|FG001|COMPLETED|Overall Study||128607||
59872605|NCT03518658|75996655|FG000|NOT COMPLETED|Overall Study||51||
59872606|NCT03518658|75996656|FG001|NOT COMPLETED|Overall Study||0||
59872607|NCT03518112|75996664|FG000|STARTED|Overall Study||6||
59872608|NCT03518112|75996664|FG000|COMPLETED|Overall Study||5||
59872609|NCT03518112|75996664|FG000|NOT COMPLETED|Overall Study||1||
59872610|NCT03517566|75996673|FG000|STARTED|Overall Study||74||
59872611|NCT03517566|75996674|FG001|STARTED|Overall Study||37||
59872612|NCT03517566|75996675|FG002|STARTED|Overall Study||36||
59872613|NCT03517566|75996676|FG003|STARTED|Overall Study||73||
59872614|NCT03517566|75996677|FG004|STARTED|Overall Study||73||
59872615|NCT03517566|75996673|FG000|COMPLETED|Overall Study||42||
59872616|NCT03517566|75996674|FG001|COMPLETED|Overall Study||16||
59872617|NCT03517566|75996675|FG002|COMPLETED|Overall Study||21||
59872618|NCT03517566|75996676|FG003|COMPLETED|Overall Study||39||
59872619|NCT03517566|75996677|FG004|COMPLETED|Overall Study||41||
59872620|NCT03517566|75996673|FG000|NOT COMPLETED|Overall Study||32||
59872621|NCT03517566|75996674|FG001|NOT COMPLETED|Overall Study||21||
59872622|NCT03517566|75996675|FG002|NOT COMPLETED|Overall Study||15||
59872623|NCT03517566|75996676|FG003|NOT COMPLETED|Overall Study||34||
59872624|NCT03517566|75996677|FG004|NOT COMPLETED|Overall Study||32||
59872625|NCT03916744|75996693|FG000|STARTED|Overall Study||17|Intent-to-Treat (ITT) Population|
59872626|NCT03916744|75996694|FG001|STARTED|Overall Study||40|Intent-to-Treat (ITT) Population|
59872627|NCT03916744|75996695|FG002|STARTED|Overall Study||18|Intent-to-Treat (ITT) Population|
59872628|NCT03916744|75996693|FG000|Received at Least One Dose of Study Drug|Overall Study||17|Safety Evaluable Population|
59872629|NCT03916744|75996694|FG001|Received at Least One Dose of Study Drug|Overall Study||40|Safety Evaluable Population|
59872630|NCT03916744|75996695|FG002|Received at Least One Dose of Study Drug|Overall Study||17|Safety Evaluable Population|
59872631|NCT03916744|75996693|FG000|COMPLETED|Overall Study||17||
59872632|NCT03916744|75996694|FG001|COMPLETED|Overall Study||39||
59872633|NCT03916744|75996695|FG002|COMPLETED|Overall Study||16||
59872634|NCT03916744|75996693|FG000|NOT COMPLETED|Overall Study||0||
59872635|NCT03916744|75996694|FG001|NOT COMPLETED|Overall Study||1||
59872636|NCT03916744|75996695|FG002|NOT COMPLETED|Overall Study||2||
59872637|NCT03639610|75996710|FG000|STARTED|Overall Study||21||
59872638|NCT03639610|75996711|FG001|STARTED|Overall Study||10||
59872639|NCT03639610|75996712|FG002|STARTED|Overall Study||4||
59872640|NCT03639610|75996710|FG000|COMPLETED|Overall Study||0||
59872641|NCT03639610|75996711|FG001|COMPLETED|Overall Study||0||
59872642|NCT03639610|75996712|FG002|COMPLETED|Overall Study||0||
59872643|NCT03639610|75996710|FG000|NOT COMPLETED|Overall Study||21||
59872644|NCT03639610|75996711|FG001|NOT COMPLETED|Overall Study||10||
59872645|NCT03639610|75996712|FG002|NOT COMPLETED|Overall Study||4||
59872646|NCT02954406|75996730|FG000|STARTED|Overall Study||3||
59872647|NCT02954406|75996731|FG001|STARTED|Overall Study||6||
59872648|NCT02954406|75996732|FG002|STARTED|Overall Study||6||
59872649|NCT02954406|75996733|FG003|STARTED|Overall Study||6||
59872650|NCT02954406|75996734|FG004|STARTED|Overall Study||7||
59872651|NCT02954406|75996735|FG005|STARTED|Overall Study||3||
59872652|NCT02954406|75996736|FG006|STARTED|Overall Study||3||
59872653|NCT02954406|75996737|FG007|STARTED|Overall Study||2||
59872654|NCT02954406|75996738|FG008|STARTED|Overall Study||4||
59872655|NCT02954406|75996739|FG009|STARTED|Overall Study||3||
59872656|NCT02954406|75996740|FG010|STARTED|Overall Study||0||
59872657|NCT02954406|75996730|FG000|COMPLETED|Overall Study||0||
59872658|NCT02954406|75996731|FG001|COMPLETED|Overall Study||0||
59872659|NCT02954406|75996732|FG002|COMPLETED|Overall Study||0||
59872660|NCT02954406|75996733|FG003|COMPLETED|Overall Study||0||
59872661|NCT02954406|75996734|FG004|COMPLETED|Overall Study||0||
59872662|NCT02954406|75996735|FG005|COMPLETED|Overall Study||0||
59872663|NCT02954406|75996736|FG006|COMPLETED|Overall Study||0||
59872664|NCT02954406|75996737|FG007|COMPLETED|Overall Study||0||
59872665|NCT02954406|75996738|FG008|COMPLETED|Overall Study||0||
59872666|NCT02954406|75996739|FG009|COMPLETED|Overall Study||0||
59872667|NCT02954406|75996740|FG010|COMPLETED|Overall Study||0||
59872668|NCT02954406|75996730|FG000|NOT COMPLETED|Overall Study||3||
59872669|NCT02954406|75996731|FG001|NOT COMPLETED|Overall Study||6||
59872670|NCT02954406|75996732|FG002|NOT COMPLETED|Overall Study||6||
59872671|NCT02954406|75996733|FG003|NOT COMPLETED|Overall Study||6||
59872672|NCT02954406|75996734|FG004|NOT COMPLETED|Overall Study||7||
59872673|NCT02954406|75996735|FG005|NOT COMPLETED|Overall Study||3||
59872674|NCT02954406|75996736|FG006|NOT COMPLETED|Overall Study||3||
59872675|NCT02954406|75996737|FG007|NOT COMPLETED|Overall Study||2||
59872676|NCT02954406|75996738|FG008|NOT COMPLETED|Overall Study||4||
59872677|NCT02954406|75996739|FG009|NOT COMPLETED|Overall Study||3||
59872678|NCT02954406|75996740|FG010|NOT COMPLETED|Overall Study||0||
59872679|NCT03514914|75996770|FG000|STARTED|Overall Study||1200||10
59872680|NCT03514914|75996771|FG001|STARTED|Overall Study||1202||10
59872681|NCT03514914|75996770|FG000|9 Month Follow-up|Overall Study||1091||10
59872682|NCT03514914|75996771|FG001|9 Month Follow-up|Overall Study||1114||10
59872683|NCT03514914|75996770|FG000|COMPLETED|Overall Study||1080||10
59872684|NCT03514914|75996771|FG001|COMPLETED|Overall Study||1110||10
59872685|NCT03514914|75996770|FG000|NOT COMPLETED|Overall Study||120||0
59872686|NCT03514914|75996771|FG001|NOT COMPLETED|Overall Study||92||0
59872687|NCT03513588|75996780|FG000|STARTED|Overall Study||16||
59872688|NCT03513588|75996781|FG001|STARTED|Overall Study||17||
59872689|NCT03513588|75996782|FG002|STARTED|Overall Study||15||
59872690|NCT03513588|75996780|FG000|COMPLETED|Overall Study||15||
59872691|NCT03513588|75996781|FG001|COMPLETED|Overall Study||15||
59872692|NCT03513588|75996782|FG002|COMPLETED|Overall Study||13||
59872693|NCT03513588|75996780|FG000|NOT COMPLETED|Overall Study||1||
59872694|NCT03513588|75996781|FG001|NOT COMPLETED|Overall Study||2||
59872695|NCT03513588|75996782|FG002|NOT COMPLETED|Overall Study||2||
59872696|NCT03512028|75996794|FG000|STARTED|Overall Study||19||
59872697|NCT03512028|75996795|FG001|STARTED|Overall Study||15||
59872698|NCT03512028|75996794|FG000|COMPLETED|Overall Study||15||
59872699|NCT03512028|75996795|FG001|COMPLETED|Overall Study||15||
59872700|NCT03512028|75996794|FG000|NOT COMPLETED|Overall Study||4||
59872701|NCT03512028|75996795|FG001|NOT COMPLETED|Overall Study||0||
59872702|NCT03511326|75996801|FG000|STARTED|Overall Study||50||
59872703|NCT03511326|75996801|FG000|COMPLETED|Overall Study||49||
59872704|NCT03511326|75996801|FG000|NOT COMPLETED|Overall Study||1||
59872705|NCT03508830|75996807|FG000|STARTED|Overall Study||46||
59872706|NCT03508830|75996808|FG001|STARTED|Overall Study||45||
59872707|NCT03508830|75996807|FG000|COMPLETED|Overall Study||41||
59872708|NCT03508830|75996808|FG001|COMPLETED|Overall Study||39||
59872709|NCT03508830|75996807|FG000|NOT COMPLETED|Overall Study||5||
59872710|NCT03508830|75996808|FG001|NOT COMPLETED|Overall Study||6||
59872711|NCT03508050|75996816|FG000|STARTED|Overall Study||20||
59872712|NCT03508050|75996817|FG001|STARTED|Overall Study||17||
59872713|NCT03508050|75996816|FG000|COMPLETED|Overall Study||15||
59872714|NCT03508050|75996817|FG001|COMPLETED|Overall Study||15||
59872715|NCT03508050|75996816|FG000|NOT COMPLETED|Overall Study||5||
59872716|NCT03508050|75996817|FG001|NOT COMPLETED|Overall Study||2||
59872717|NCT03569202|75996826|FG000|STARTED|Part 1|Emulsion Eye Drops were used on one eye only.|3||3
59872718|NCT03569202|75996827|FG001|STARTED|Part 1|Control Eye Drops were not used for Part 1.|0||0
59872719|NCT03569202|75996826|FG000|COMPLETED|Part 1|No participant completing Part 1 was allowed to continue to Parts 2 or 3.|3||3
59872720|NCT03569202|75996827|FG001|COMPLETED|Part 1||0||0
59872721|NCT03569202|75996826|FG000|NOT COMPLETED|Part 1||0||0
59872722|NCT03569202|75996827|FG001|NOT COMPLETED|Part 1||0||0
59872723|NCT03569202|75996826|FG000|STARTED|Part 2|Emulsion Eye Drops were used on one randomized eye. Participants were different from Part 1.|9||9
59872724|NCT03569202|75996827|FG001|STARTED|Part 2|Control Eye Drops were used on contralateral eye. Participants were different from Part 1.|9||9
59872725|NCT03569202|75996826|FG000|COMPLETED|Part 2|No participant completing Part 2 was allowed to continue to Part 3.|9||9
59872726|NCT03569202|75996827|FG001|COMPLETED|Part 2|No participant completing Part 2 was allowed to continue to Part 3.|9||9
59872727|NCT03569202|75996826|FG000|NOT COMPLETED|Part 2||0||0
59872728|NCT03569202|75996827|FG001|NOT COMPLETED|Part 2||0||0
59872729|NCT03569202|75996826|FG000|STARTED|Part 3|Emulsion Eye Drops were used on both eyes. Participants were different from Parts 1 and 2.|26||0
59872730|NCT03569202|75996827|FG001|STARTED|Part 3|Control Eye Drops were used on both eyes. Participants were different from Parts 1 and 2.|26||0
59872731|NCT03569202|75996826|FG000|COMPLETED|Part 3|Per-protocol (PP) dataset. 'Not Completed' participants are included in safety and ITT datasets.|24||0
59872732|NCT03569202|75996827|FG001|COMPLETED|Part 3|Per-protocol (PP) dataset. 'Not Completed' participants are included in safety and ITT datasets.|25||0
59872733|NCT03569202|75996826|FG000|NOT COMPLETED|Part 3||2||0
59872734|NCT03569202|75996827|FG001|NOT COMPLETED|Part 3||1||0
59872735|NCT03568500|75996836|FG000|STARTED|Overall Study||18||
59872736|NCT03568500|75996837|FG001|STARTED|Overall Study||20||
59872737|NCT03568500|75996838|FG002|STARTED|Overall Study||6||
59872738|NCT03568500|75996836|FG000|Received At Least 1 Dose of Study Drug|Overall Study||18|Safety Population: All participants who entered the trial and used the DMS.|
59872739|NCT03568500|75996837|FG001|Received At Least 1 Dose of Study Drug|Overall Study||19|Safety Population: All participants who entered the trial and used the DMS.|
59872740|NCT03568500|75996838|FG002|Received At Least 1 Dose of Study Drug|Overall Study||6|Safety Population: All participants who entered the trial and used the DMS.|
59872741|NCT03568500|75996836|FG000|COMPLETED|Overall Study||8||
59872742|NCT03568500|75996837|FG001|COMPLETED|Overall Study||14||
59872743|NCT03568500|75996838|FG002|COMPLETED|Overall Study||2||
59872744|NCT03568500|75996836|FG000|NOT COMPLETED|Overall Study||10||
59872745|NCT03568500|75996837|FG001|NOT COMPLETED|Overall Study||6||
59872746|NCT03568500|75996838|FG002|NOT COMPLETED|Overall Study||4||
59872747|NCT03724422|75996853|FG000|STARTED|Overall Study||1||
59872748|NCT03724422|75996854|FG001|STARTED|Overall Study||2||
59872749|NCT03724422|75996853|FG000|COMPLETED|Overall Study||1||
59872750|NCT03724422|75996854|FG001|COMPLETED|Overall Study|Patients had interval healing then lost follow up|0||
59872751|NCT03724422|75996853|FG000|NOT COMPLETED|Overall Study||0||
59872752|NCT03724422|75996854|FG001|NOT COMPLETED|Overall Study||2||
59872753|NCT03504852|75996863|FG000|STARTED|Overall Study||165||
59872754|NCT03504852|75996864|FG001|STARTED|Overall Study||135||
59872755|NCT03504852|75996865|FG002|STARTED|Overall Study||31||
59872756|NCT03504852|75996863|FG000|COMPLETED|Overall Study||148||
59872757|NCT03504852|75996864|FG001|COMPLETED|Overall Study||117||
59872758|NCT03504852|75996865|FG002|COMPLETED|Overall Study||28||
59872759|NCT03504852|75996863|FG000|NOT COMPLETED|Overall Study||17||
59872760|NCT03504852|75996864|FG001|NOT COMPLETED|Overall Study||18||
59872761|NCT03504852|75996865|FG002|NOT COMPLETED|Overall Study||3||
59872762|NCT03025828|75996875|FG000|STARTED|Overall Study||5||
59872763|NCT03025828|75996875|FG000|COMPLETED|Overall Study||4||
59872764|NCT03025828|75996875|FG000|NOT COMPLETED|Overall Study||1||
59872765|NCT03546816|75996881|FG000|STARTED|Overall Study||142||
59872766|NCT03546816|75996882|FG001|STARTED|Overall Study||143||
59872767|NCT03546816|75996881|FG000|COMPLETED|Overall Study||121||
59872768|NCT03546816|75996882|FG001|COMPLETED|Overall Study||124||
59872769|NCT03546816|75996881|FG000|NOT COMPLETED|Overall Study||21||
59872770|NCT03546816|75996882|FG001|NOT COMPLETED|Overall Study||19||
59872771|NCT03024970|75996890|FG000|STARTED|First Intervention||34||
59872772|NCT03024970|75996891|FG001|STARTED|First Intervention||38||
59872773|NCT03024970|75996890|FG000|COMPLETED|First Intervention||33||
59872774|NCT03024970|75996891|FG001|COMPLETED|First Intervention||38||
59872775|NCT03024970|75996890|FG000|NOT COMPLETED|First Intervention||1||
59872776|NCT03024970|75996891|FG001|NOT COMPLETED|First Intervention||0||
59872777|NCT03024970|75996890|FG000|STARTED|Second Intervention||33||
59872778|NCT03024970|75996891|FG001|STARTED|Second Intervention||38||
59872779|NCT03024970|75996890|FG000|COMPLETED|Second Intervention||32||
59872780|NCT03024970|75996891|FG001|COMPLETED|Second Intervention||38||
59872781|NCT03024970|75996890|FG000|NOT COMPLETED|Second Intervention||1||
59872782|NCT03024970|75996891|FG001|NOT COMPLETED|Second Intervention||0||
59872783|NCT03500094|75996897|FG000|STARTED|Overall Study||22||
59872784|NCT03500094|75996897|FG000|Received At Least 1 Dose of Study Drug|Overall Study||21||
59872785|NCT03500094|75996897|FG000|COMPLETED|Overall Study||19||
59872786|NCT03500094|75996897|FG000|NOT COMPLETED|Overall Study||3||
59872787|NCT03566550|75996905|FG000|STARTED|Overall Study||12||
59872788|NCT03566550|75996906|FG001|STARTED|Overall Study||13||
59872789|NCT03566550|75996905|FG000|COMPLETED|Overall Study||12||
59872790|NCT03566550|75996906|FG001|COMPLETED|Overall Study||12||
59872791|NCT03566550|75996905|FG000|NOT COMPLETED|Overall Study||0||
59872792|NCT03566550|75996906|FG001|NOT COMPLETED|Overall Study||1||
59872793|NCT03566238|75996915|FG000|STARTED|Overall Study||23||
59872794|NCT03566238|75996916|FG001|STARTED|Overall Study||19||
59872795|NCT03566238|75996917|FG002|STARTED|Overall Study||20||
59872796|NCT03566238|75996915|FG000|Received Treatment|Overall Study||23||
59872797|NCT03566238|75996916|FG001|Received Treatment|Overall Study||19||
59872798|NCT03566238|75996917|FG002|Received Treatment|Overall Study||20||
59872799|NCT03566238|75996915|FG000|COMPLETED|Overall Study||18||
59872800|NCT03566238|75996916|FG001|COMPLETED|Overall Study||16||
59872801|NCT03566238|75996917|FG002|COMPLETED|Overall Study||15||
59872802|NCT03566238|75996915|FG000|NOT COMPLETED|Overall Study||5||
59872803|NCT03566238|75996916|FG001|NOT COMPLETED|Overall Study||3||
59872804|NCT03566238|75996917|FG002|NOT COMPLETED|Overall Study||5||
59872805|NCT02894502|75996928|FG000|STARTED|Baseline||155||
59872806|NCT02894502|75996929|FG001|STARTED|Baseline||177||
59872807|NCT02894502|75996930|FG002|STARTED|Baseline||178||
59872808|NCT02894502|75996928|FG000|COMPLETED|Baseline||128||
59872809|NCT02894502|75996929|FG001|COMPLETED|Baseline||145||
59872810|NCT02894502|75996930|FG002|COMPLETED|Baseline||133||
59872811|NCT02894502|75996928|FG000|NOT COMPLETED|Baseline||27||
59872812|NCT02894502|75996929|FG001|NOT COMPLETED|Baseline||32||
59872813|NCT02894502|75996930|FG002|NOT COMPLETED|Baseline||45||
59872814|NCT02894502|75996928|FG000|STARTED|First Follow up||128||
59872815|NCT02894502|75996929|FG001|STARTED|First Follow up||145||
59872816|NCT02894502|75996930|FG002|STARTED|First Follow up||133||
59872817|NCT02894502|75996928|FG000|COMPLETED|First Follow up||94||
59872818|NCT02894502|75996929|FG001|COMPLETED|First Follow up||114||
59872819|NCT02894502|75996930|FG002|COMPLETED|First Follow up||93||
59872820|NCT02894502|75996928|FG000|NOT COMPLETED|First Follow up||34||
59872821|NCT02894502|75996929|FG001|NOT COMPLETED|First Follow up||31||
59872822|NCT02894502|75996930|FG002|NOT COMPLETED|First Follow up||40||
59872823|NCT02894502|75996928|FG000|STARTED|Second Follow up||94||
59872824|NCT02894502|75996929|FG001|STARTED|Second Follow up||114||
59872825|NCT02894502|75996930|FG002|STARTED|Second Follow up||93||
59872826|NCT02894502|75996928|FG000|COMPLETED|Second Follow up||79||
59872827|NCT02894502|75996929|FG001|COMPLETED|Second Follow up||96||
59872828|NCT02894502|75996930|FG002|COMPLETED|Second Follow up||79||
59872829|NCT02894502|75996928|FG000|NOT COMPLETED|Second Follow up||15||
59872830|NCT02894502|75996929|FG001|NOT COMPLETED|Second Follow up||18||
59872831|NCT02894502|75996930|FG002|NOT COMPLETED|Second Follow up||14||
59872832|NCT02894502|75996928|FG000|STARTED|Third Follow up||79||
59872833|NCT02894502|75996929|FG001|STARTED|Third Follow up||96||
59872834|NCT02894502|75996930|FG002|STARTED|Third Follow up||79||
59872835|NCT02894502|75996928|FG000|COMPLETED|Third Follow up||73||
59872836|NCT02894502|75996929|FG001|COMPLETED|Third Follow up||89||
59872837|NCT02894502|75996930|FG002|COMPLETED|Third Follow up||76||
59872838|NCT02894502|75996928|FG000|NOT COMPLETED|Third Follow up||6||
59872839|NCT02894502|75996929|FG001|NOT COMPLETED|Third Follow up||7||
59872840|NCT02894502|75996930|FG002|NOT COMPLETED|Third Follow up||3||
59872841|NCT03449030|75996951|FG000|STARTED|Overall Study||1||
59872842|NCT03449030|75996952|FG001|STARTED|Overall Study||1||
59872843|NCT03449030|75996953|FG002|STARTED|Overall Study||1||
59872844|NCT03449030|75996954|FG003|STARTED|Overall Study||5||
59872845|NCT03449030|75996955|FG004|STARTED|Overall Study||7||
59872846|NCT03449030|75996956|FG005|STARTED|Overall Study||7||
59872847|NCT03449030|75996957|FG006|STARTED|Overall Study||2||
59872848|NCT03449030|75996958|FG007|STARTED|Overall Study||3||
59872849|NCT03449030|75996959|FG008|STARTED|Overall Study||3||
59872850|NCT03449030|75996960|FG009|STARTED|Overall Study||1||
59872851|NCT03449030|75996951|FG000|COMPLETED|Overall Study||0||
59872852|NCT03449030|75996952|FG001|COMPLETED|Overall Study||0||
59872853|NCT03449030|75996953|FG002|COMPLETED|Overall Study||0||
59872854|NCT03449030|75996954|FG003|COMPLETED|Overall Study||0||
59872855|NCT03449030|75996955|FG004|COMPLETED|Overall Study||0||
59872856|NCT03449030|75996956|FG005|COMPLETED|Overall Study||0||
59872857|NCT03449030|75996957|FG006|COMPLETED|Overall Study||0||
59872858|NCT03449030|75996958|FG007|COMPLETED|Overall Study||0||
59872859|NCT03449030|75996959|FG008|COMPLETED|Overall Study||0||
59872860|NCT03449030|75996960|FG009|COMPLETED|Overall Study||0||
59872861|NCT03449030|75996951|FG000|NOT COMPLETED|Overall Study||1||
59872862|NCT03449030|75996952|FG001|NOT COMPLETED|Overall Study||1||
59872863|NCT03449030|75996953|FG002|NOT COMPLETED|Overall Study||1||
59872864|NCT03449030|75996954|FG003|NOT COMPLETED|Overall Study||5||
59872865|NCT03449030|75996955|FG004|NOT COMPLETED|Overall Study||7||
59872866|NCT03449030|75996956|FG005|NOT COMPLETED|Overall Study||7||
59872867|NCT03449030|75996957|FG006|NOT COMPLETED|Overall Study||2||
59872868|NCT03449030|75996958|FG007|NOT COMPLETED|Overall Study||3||
59872869|NCT03449030|75996959|FG008|NOT COMPLETED|Overall Study||3||
59872870|NCT03449030|75996960|FG009|NOT COMPLETED|Overall Study||1||
59872871|NCT03448406|75996985|FG000|STARTED|Overall Study||158||
59872872|NCT03448406|75996986|FG001|STARTED|Overall Study||157||
59872873|NCT03448406|75996985|FG000|COMPLETED|Overall Study||147||
59872874|NCT03448406|75996986|FG001|COMPLETED|Overall Study||144||
59872875|NCT03448406|75996985|FG000|NOT COMPLETED|Overall Study||11||
59872876|NCT03448406|75996986|FG001|NOT COMPLETED|Overall Study||13||
59872877|NCT03499028|75996994|FG000|STARTED|Overall Study||226||
59872878|NCT03499028|75996995|FG001|STARTED|Overall Study||220||
59872879|NCT03499028|75996994|FG000|COMPLETED|Overall Study||204||
59872880|NCT03499028|75996995|FG001|COMPLETED|Overall Study||195||
59872881|NCT03499028|75996994|FG000|NOT COMPLETED|Overall Study||22||
59872882|NCT03499028|75996995|FG001|NOT COMPLETED|Overall Study||25||
59872883|NCT03498560|75997003|FG000|STARTED|Overall Study||38||
59872884|NCT03498560|75997003|FG000|Completed Baseline Assessment|Overall Study||32||
59872885|NCT03498560|75997003|FG000|Completed PSG|Overall Study||25||
59872886|NCT03498560|75997003|FG000|COMPLETED|Overall Study||17||
59872887|NCT03498560|75997003|FG000|NOT COMPLETED|Overall Study||21||
59872888|NCT00064701|75997011|FG000|STARTED|One Year Post-transplant||219||
59872889|NCT00064701|75997012|FG001|STARTED|One Year Post-transplant||226||
59872890|NCT00064701|75997013|FG002|STARTED|One Year Post-transplant||223||
59872891|NCT00064701|75997011|FG000|Received Study Drug|One Year Post-transplant||212||
59872892|NCT00064701|75997012|FG001|Received Study Drug|One Year Post-transplant||214||
59872893|NCT00064701|75997013|FG002|Received Study Drug|One Year Post-transplant||212||
59872894|NCT00064701|75997011|FG000|COMPLETED|One Year Post-transplant||179||
59872895|NCT00064701|75997012|FG001|COMPLETED|One Year Post-transplant||183||
59872896|NCT00064701|75997013|FG002|COMPLETED|One Year Post-transplant||151||
59872897|NCT00064701|75997011|FG000|NOT COMPLETED|One Year Post-transplant||40||
59872898|NCT00064701|75997012|FG001|NOT COMPLETED|One Year Post-transplant||43||
59872899|NCT00064701|75997013|FG002|NOT COMPLETED|One Year Post-transplant||72||
59872900|NCT00064701|75997011|FG000|STARTED|Clinical Continuation Phase||179||
59872901|NCT00064701|75997012|FG001|STARTED|Clinical Continuation Phase|One participant did not enter the Clinical Continuation phase|182||
59872902|NCT00064701|75997013|FG002|STARTED|Clinical Continuation Phase||151||
59872903|NCT00064701|75997011|FG000|COMPLETED|Clinical Continuation Phase||9||
59872904|NCT00064701|75997012|FG001|COMPLETED|Clinical Continuation Phase||4||
59872905|NCT00064701|75997013|FG002|COMPLETED|Clinical Continuation Phase||11||
59872906|NCT00064701|75997011|FG000|NOT COMPLETED|Clinical Continuation Phase||170||
59872907|NCT00064701|75997012|FG001|NOT COMPLETED|Clinical Continuation Phase||178||
59872908|NCT00064701|75997013|FG002|NOT COMPLETED|Clinical Continuation Phase||140||
59872909|NCT00064077|75997025|FG000|STARTED|Overall Study||118||
59872910|NCT00064077|75997026|FG001|STARTED|Overall Study||117||
59872911|NCT00064077|75997027|FG002|STARTED|Overall Study||119||
59872912|NCT00064077|75997028|FG003|STARTED|Overall Study||118||
59872913|NCT00064077|75997025|FG000|COMPLETED|Overall Study|Evaluable (treatment)|103||
59872914|NCT00064077|75997026|FG001|COMPLETED|Overall Study|Evaluable (treatment)|108||
59872915|NCT00064077|75997027|FG002|COMPLETED|Overall Study|Evaluable (treatment)|112||
59872916|NCT00064077|75997028|FG003|COMPLETED|Overall Study|Evaluable (treatment)|111||
59872917|NCT00064077|75997025|FG000|NOT COMPLETED|Overall Study||15||
59872918|NCT00064077|75997026|FG001|NOT COMPLETED|Overall Study||9||
59872919|NCT00064077|75997027|FG002|NOT COMPLETED|Overall Study||7||
59872920|NCT00064077|75997028|FG003|NOT COMPLETED|Overall Study||7||
59872921|NCT00063999|75997040|FG000|STARTED|Overall Study||692||
59872922|NCT00063999|75997041|FG001|STARTED|Overall Study||689||
59872923|NCT00063999|75997040|FG000|COMPLETED|Overall Study||647||
59872924|NCT00063999|75997041|FG001|COMPLETED|Overall Study||665||
59872925|NCT00063999|75997040|FG000|NOT COMPLETED|Overall Study||45||
59872926|NCT00063999|75997041|FG001|NOT COMPLETED|Overall Study||24||
59872927|NCT03131440|75997086|FG000|STARTED|Overall Study||8||
59872928|NCT03131440|75997087|FG001|STARTED|Overall Study||9||
59872929|NCT03131440|75997088|FG002|STARTED|Overall Study||8||
59872930|NCT03131440|75997089|FG003|STARTED|Overall Study||8||
59872931|NCT03131440|75997090|FG004|STARTED|Overall Study||9||
59872932|NCT03131440|75997091|FG005|STARTED|Overall Study||9||
59872933|NCT03131440|75997092|FG006|STARTED|Overall Study||9||
59872934|NCT03131440|75997093|FG007|STARTED|Overall Study||9||
59872935|NCT03131440|75997094|FG008|STARTED|Overall Study||9||
59872936|NCT03131440|75997095|FG009|STARTED|Overall Study||8||
59872937|NCT03131440|75997096|FG010|STARTED|Overall Study||8||
59872938|NCT03131440|75997097|FG011|STARTED|Overall Study||8||
59872939|NCT03131440|75997098|FG012|STARTED|Overall Study||8||
59872940|NCT03131440|75997099|FG013|STARTED|Overall Study||8||
60001166|NCT02105116|76116861|FG000|COMPLETED|Overall Study||0||
59872941|NCT03131440|75997100|FG014|STARTED|Overall Study||8||
59872942|NCT03131440|75997101|FG015|STARTED|Overall Study||8||
59872943|NCT03131440|75997102|FG016|STARTED|Overall Study||8||
59872944|NCT03131440|75997103|FG017|STARTED|Overall Study||8||
59872945|NCT03131440|75997104|FG018|STARTED|Overall Study||8||
59872946|NCT03131440|75997105|FG019|STARTED|Overall Study||9||
59872947|NCT03131440|75997106|FG020|STARTED|Overall Study||8||
59872948|NCT03131440|75997107|FG021|STARTED|Overall Study||8||
59872949|NCT03131440|75997108|FG022|STARTED|Overall Study||9||
59872950|NCT03131440|75997109|FG023|STARTED|Overall Study||8||
59872951|NCT03131440|75997110|FG024|STARTED|Overall Study||9||
60001167|NCT02105116|76116861|FG000|NOT COMPLETED|Overall Study||6||
60001168|NCT02104804|76116867|FG000|STARTED|Overall Study|Number of patients who were randomized|234||
60001169|NCT02104804|76116868|FG001|STARTED|Overall Study|Number of patients who were randomized|232||
60001170|NCT02104804|76116867|FG000|COMPLETED|Overall Study|Number of patients who completed 24 weeks of treatment|218||
60001171|NCT02104804|76116868|FG001|COMPLETED|Overall Study|Of the 19 who did not complete, 1 did not take study medication after randomization.|213||
60001172|NCT02104804|76116867|FG000|NOT COMPLETED|Overall Study||16||
60001173|NCT02104804|76116868|FG001|NOT COMPLETED|Overall Study||19||
60001174|NCT02075008|76116874|FG000|STARTED|Overall Study||270||
60001175|NCT02075008|76116874|FG000|COMPLETED|Overall Study||94||
60001176|NCT02075008|76116874|FG000|NOT COMPLETED|Overall Study||176||
60001177|NCT05546229|76116881|FG000|STARTED|Overall Study||3||
60001178|NCT05546229|76116882|FG001|STARTED|Overall Study||6||
60001179|NCT05546229|76116883|FG002|STARTED|Overall Study||2||
60001180|NCT05546229|76116881|FG000|COMPLETED|Overall Study||3||
60001181|NCT05546229|76116882|FG001|COMPLETED|Overall Study||6||
60001182|NCT05546229|76116883|FG002|COMPLETED|Overall Study||2||
60001183|NCT05546229|76116881|FG000|NOT COMPLETED|Overall Study||0||
60001184|NCT05546229|76116882|FG001|NOT COMPLETED|Overall Study||0||
60001185|NCT05546229|76116883|FG002|NOT COMPLETED|Overall Study||0||
60001186|NCT01666119|76116905|FG000|STARTED|Overall Study||249||
60001187|NCT01666119|76116905|FG000|COMPLETED|Overall Study||197||
60001188|NCT01666119|76116905|FG000|NOT COMPLETED|Overall Study||52||
60001189|NCT05128773|76116909|FG000|STARTED|Overall Study||3||
60001190|NCT05128773|76116909|FG000|COMPLETED|Overall Study||0||
60001191|NCT05128773|76116909|FG000|NOT COMPLETED|Overall Study||3||
60001192|NCT01665807|76116917|FG000|STARTED|Overall Study||411||
60001193|NCT01665807|76116918|FG001|STARTED|Overall Study||58||
60001194|NCT01665807|76116919|FG002|STARTED|Overall Study||402||
60001195|NCT01665807|76116917|FG000|COMPLETED|Overall Study||409||
60001196|NCT01665807|76116918|FG001|COMPLETED|Overall Study||58||
60001197|NCT01665807|76116919|FG002|COMPLETED|Overall Study||401||
60001198|NCT01665807|76116917|FG000|NOT COMPLETED|Overall Study||2||
60001199|NCT01665807|76116918|FG001|NOT COMPLETED|Overall Study||0||
60001200|NCT01665807|76116919|FG002|NOT COMPLETED|Overall Study||1||
60001201|NCT02584959|76116930|FG000|STARTED|Period 1||31||
60001202|NCT02584959|76116931|FG001|STARTED|Period 1||29||
60001203|NCT02584959|76116932|FG002|STARTED|Period 1||15||
60001204|NCT02584959|76116930|FG000|COMPLETED|Period 1||28||
60001205|NCT02584959|76116931|FG001|COMPLETED|Period 1||25||
60001206|NCT02584959|76116932|FG002|COMPLETED|Period 1||15||
60001207|NCT02584959|76116930|FG000|NOT COMPLETED|Period 1||3||
60001208|NCT02584959|76116931|FG001|NOT COMPLETED|Period 1||4||
60001209|NCT02584959|76116932|FG002|NOT COMPLETED|Period 1||0||
60001210|NCT02584959|76116930|FG000|STARTED|Period 2||28||
59872952|NCT03131440|75997111|FG025|STARTED|Overall Study||8||
59872953|NCT03131440|75997112|FG026|STARTED|Overall Study||9||
59872954|NCT03131440|75997113|FG027|STARTED|Overall Study||9||
59872955|NCT03131440|75997114|FG028|STARTED|Overall Study||8||
59872956|NCT03131440|75997115|FG029|STARTED|Overall Study||9||
60001211|NCT02584959|76116931|FG001|STARTED|Period 2||25||
60001212|NCT02584959|76116932|FG002|STARTED|Period 2||15||
60001213|NCT02584959|76116930|FG000|COMPLETED|Period 2||22||
60001214|NCT02584959|76116931|FG001|COMPLETED|Period 2||24||
60001215|NCT02584959|76116932|FG002|COMPLETED|Period 2||13||
60001216|NCT02584959|76116930|FG000|NOT COMPLETED|Period 2||6||
60001217|NCT02584959|76116931|FG001|NOT COMPLETED|Period 2||1||
60001218|NCT02584959|76116932|FG002|NOT COMPLETED|Period 2||2||
60001219|NCT02584257|76116949|FG000|STARTED|Period 1||9||
60001220|NCT02584257|76116950|FG001|STARTED|Period 1||9||
60001221|NCT02584257|76116951|FG002|STARTED|Period 1||9||
60001222|NCT02584257|76116952|FG003|STARTED|Period 1||8||
60001223|NCT02584257|76116953|FG004|STARTED|Period 1||10||
60001224|NCT02584257|76116954|FG005|STARTED|Period 1||10||
60001225|NCT02584257|76116955|FG006|STARTED|Period 1||18||
60001226|NCT02584257|76116956|FG007|STARTED|Period 1||9||
60001227|NCT02584257|76116957|FG008|STARTED|Period 1||9||
60001228|NCT02584257|76116949|FG000|COMPLETED|Period 1||9||
60001229|NCT02584257|76116950|FG001|COMPLETED|Period 1||9||
60001230|NCT02584257|76116951|FG002|COMPLETED|Period 1||9||
60001231|NCT02584257|76116952|FG003|COMPLETED|Period 1||8||
60001232|NCT02584257|76116953|FG004|COMPLETED|Period 1||10||
60001233|NCT02584257|76116954|FG005|COMPLETED|Period 1||10||
60001234|NCT02584257|76116955|FG006|COMPLETED|Period 1||17||
60001235|NCT02584257|76116956|FG007|COMPLETED|Period 1||9||
60001236|NCT02584257|76116957|FG008|COMPLETED|Period 1||9||
60001237|NCT02584257|76116949|FG000|NOT COMPLETED|Period 1||0||
60001238|NCT02584257|76116950|FG001|NOT COMPLETED|Period 1||0||
60001239|NCT02584257|76116951|FG002|NOT COMPLETED|Period 1||0||
60001240|NCT02584257|76116952|FG003|NOT COMPLETED|Period 1||0||
60001241|NCT02584257|76116953|FG004|NOT COMPLETED|Period 1||0||
60001242|NCT02584257|76116954|FG005|NOT COMPLETED|Period 1||0||
60001243|NCT02584257|76116955|FG006|NOT COMPLETED|Period 1||1||
60001244|NCT02584257|76116956|FG007|NOT COMPLETED|Period 1||0||
60001245|NCT02584257|76116957|FG008|NOT COMPLETED|Period 1||0||
60001246|NCT02584257|76116949|FG000|STARTED|Period 2||9||
60001247|NCT02584257|76116950|FG001|STARTED|Period 2||9||
60001248|NCT02584257|76116951|FG002|STARTED|Period 2||9||
60001249|NCT02584257|76116952|FG003|STARTED|Period 2||8||
60001250|NCT02584257|76116953|FG004|STARTED|Period 2||10||
60001251|NCT02584257|76116954|FG005|STARTED|Period 2||10||
60001252|NCT02584257|76116955|FG006|STARTED|Period 2||17||
60001253|NCT02584257|76116956|FG007|STARTED|Period 2||9||
60001254|NCT02584257|76116957|FG008|STARTED|Period 2||9||
60001255|NCT02584257|76116949|FG000|COMPLETED|Period 2||8||
60001256|NCT02584257|76116950|FG001|COMPLETED|Period 2||8||
60001257|NCT02584257|76116951|FG002|COMPLETED|Period 2||9||
60001258|NCT02584257|76116952|FG003|COMPLETED|Period 2||8||
60001259|NCT02584257|76116953|FG004|COMPLETED|Period 2||10||
60001260|NCT02584257|76116954|FG005|COMPLETED|Period 2||10||
60001261|NCT02584257|76116955|FG006|COMPLETED|Period 2||17||
60001262|NCT02584257|76116956|FG007|COMPLETED|Period 2||9||
60001263|NCT02584257|76116957|FG008|COMPLETED|Period 2||9||
60001264|NCT02584257|76116949|FG000|NOT COMPLETED|Period 2||1||
60001265|NCT02584257|76116950|FG001|NOT COMPLETED|Period 2||1||
60001266|NCT02584257|76116951|FG002|NOT COMPLETED|Period 2||0||
60001267|NCT02584257|76116952|FG003|NOT COMPLETED|Period 2||0||
60001268|NCT02584257|76116953|FG004|NOT COMPLETED|Period 2||0||
60001269|NCT02584257|76116954|FG005|NOT COMPLETED|Period 2||0||
60001270|NCT02584257|76116955|FG006|NOT COMPLETED|Period 2||0||
60001271|NCT02584257|76116956|FG007|NOT COMPLETED|Period 2||0||
60001272|NCT02584257|76116957|FG008|NOT COMPLETED|Period 2||0||
60001273|NCT02584257|76116949|FG000|STARTED|Period 3||8||
60001274|NCT02584257|76116950|FG001|STARTED|Period 3||8||
60001275|NCT02584257|76116951|FG002|STARTED|Period 3||9||
60001276|NCT02584257|76116952|FG003|STARTED|Period 3||8||
60001277|NCT02584257|76116953|FG004|STARTED|Period 3||10||
60001278|NCT02584257|76116954|FG005|STARTED|Period 3||10||
60001279|NCT02584257|76116955|FG006|STARTED|Period 3||17||
60001280|NCT02584257|76116956|FG007|STARTED|Period 3||9||
60001281|NCT02584257|76116957|FG008|STARTED|Period 3||9||
60001282|NCT02584257|76116949|FG000|COMPLETED|Period 3||8||
60001283|NCT02584257|76116950|FG001|COMPLETED|Period 3||8||
60001284|NCT02584257|76116951|FG002|COMPLETED|Period 3||9||
60001285|NCT02584257|76116952|FG003|COMPLETED|Period 3||8||
60001286|NCT02584257|76116953|FG004|COMPLETED|Period 3||10||
60001287|NCT02584257|76116954|FG005|COMPLETED|Period 3||10||
60001288|NCT02584257|76116955|FG006|COMPLETED|Period 3||17||
60001289|NCT02584257|76116956|FG007|COMPLETED|Period 3||9||
60001290|NCT02584257|76116957|FG008|COMPLETED|Period 3||9||
60001291|NCT02584257|76116949|FG000|NOT COMPLETED|Period 3||0||
60001292|NCT02584257|76116950|FG001|NOT COMPLETED|Period 3||0||
60001293|NCT02584257|76116951|FG002|NOT COMPLETED|Period 3||0||
60001294|NCT02584257|76116952|FG003|NOT COMPLETED|Period 3||0||
60001295|NCT02584257|76116953|FG004|NOT COMPLETED|Period 3||0||
60001296|NCT02584257|76116954|FG005|NOT COMPLETED|Period 3||0||
60001297|NCT02584257|76116955|FG006|NOT COMPLETED|Period 3||0||
60001298|NCT02584257|76116956|FG007|NOT COMPLETED|Period 3||0||
60001299|NCT02584257|76116957|FG008|NOT COMPLETED|Period 3||0||
60001300|NCT02584257|76116949|FG000|STARTED|Period 4||8||
60001301|NCT02584257|76116950|FG001|STARTED|Period 4||8||
60001302|NCT02584257|76116951|FG002|STARTED|Period 4||9||
60001303|NCT02584257|76116952|FG003|STARTED|Period 4||8||
60001304|NCT02584257|76116953|FG004|STARTED|Period 4||10||
60001305|NCT02584257|76116954|FG005|STARTED|Period 4||10||
60001306|NCT02584257|76116955|FG006|STARTED|Period 4||17||
60001307|NCT02584257|76116956|FG007|STARTED|Period 4||9||
60001308|NCT02584257|76116957|FG008|STARTED|Period 4||9||
60001309|NCT02584257|76116949|FG000|COMPLETED|Period 4||8||
60001310|NCT02584257|76116950|FG001|COMPLETED|Period 4||8||
60001311|NCT02584257|76116951|FG002|COMPLETED|Period 4||9||
60001312|NCT02584257|76116952|FG003|COMPLETED|Period 4||8||
60001313|NCT02584257|76116953|FG004|COMPLETED|Period 4||10||
60001314|NCT02584257|76116954|FG005|COMPLETED|Period 4||10||
60001315|NCT02584257|76116955|FG006|COMPLETED|Period 4||17||
60001316|NCT02584257|76116956|FG007|COMPLETED|Period 4||9||
60001317|NCT02584257|76116957|FG008|COMPLETED|Period 4||9||
60001318|NCT02584257|76116949|FG000|NOT COMPLETED|Period 4||0||
60001319|NCT02584257|76116950|FG001|NOT COMPLETED|Period 4||0||
60001320|NCT02584257|76116951|FG002|NOT COMPLETED|Period 4||0||
60001321|NCT02584257|76116952|FG003|NOT COMPLETED|Period 4||0||
60001322|NCT02584257|76116953|FG004|NOT COMPLETED|Period 4||0||
60001323|NCT02584257|76116954|FG005|NOT COMPLETED|Period 4||0||
60001324|NCT02584257|76116955|FG006|NOT COMPLETED|Period 4||0||
60001325|NCT02584257|76116956|FG007|NOT COMPLETED|Period 4||0||
60001326|NCT02584257|76116957|FG008|NOT COMPLETED|Period 4||0||
60001327|NCT02584257|76116949|FG000|STARTED|Period 5||8||
60001328|NCT02584257|76116950|FG001|STARTED|Period 5||8||
60001329|NCT02584257|76116951|FG002|STARTED|Period 5||9||
60001330|NCT02584257|76116952|FG003|STARTED|Period 5||8||
60001331|NCT02584257|76116953|FG004|STARTED|Period 5||10||
60001332|NCT02584257|76116954|FG005|STARTED|Period 5||10||
60001333|NCT02584257|76116955|FG006|STARTED|Period 5||17||
60001334|NCT02584257|76116956|FG007|STARTED|Period 5||9||
60001335|NCT02584257|76116957|FG008|STARTED|Period 5||9||
60001336|NCT02584257|76116949|FG000|COMPLETED|Period 5||8||
60001337|NCT02584257|76116950|FG001|COMPLETED|Period 5||8||
60001338|NCT02584257|76116951|FG002|COMPLETED|Period 5||9||
60001339|NCT02584257|76116952|FG003|COMPLETED|Period 5||8||
60001340|NCT02584257|76116953|FG004|COMPLETED|Period 5||10||
60001341|NCT02584257|76116954|FG005|COMPLETED|Period 5||10||
60001342|NCT02584257|76116955|FG006|COMPLETED|Period 5||17||
60001343|NCT02584257|76116956|FG007|COMPLETED|Period 5||9||
60001344|NCT02584257|76116957|FG008|COMPLETED|Period 5||9||
60001345|NCT02584257|76116949|FG000|NOT COMPLETED|Period 5||0||
60001346|NCT02584257|76116950|FG001|NOT COMPLETED|Period 5||0||
60001347|NCT02584257|76116951|FG002|NOT COMPLETED|Period 5||0||
60001348|NCT02584257|76116952|FG003|NOT COMPLETED|Period 5||0||
60001349|NCT02584257|76116953|FG004|NOT COMPLETED|Period 5||0||
60001350|NCT02584257|76116954|FG005|NOT COMPLETED|Period 5||0||
60001351|NCT02584257|76116955|FG006|NOT COMPLETED|Period 5||0||
60001352|NCT02584257|76116956|FG007|NOT COMPLETED|Period 5||0||
60001353|NCT02584257|76116957|FG008|NOT COMPLETED|Period 5||0||
60001354|NCT02583711|76116972|FG000|STARTED|Overall Study||11||
60001355|NCT02583711|76116973|FG001|STARTED|Overall Study||38||
60001356|NCT02583711|76116974|FG002|STARTED|Overall Study||10||
60001357|NCT02583711|76116972|FG000|COMPLETED|Overall Study||11||
60001358|NCT02583711|76116973|FG001|COMPLETED|Overall Study||28||
60001359|NCT02583711|76116974|FG002|COMPLETED|Overall Study||10||
60001360|NCT02583711|76116972|FG000|NOT COMPLETED|Overall Study||0||
60001361|NCT02583711|76116973|FG001|NOT COMPLETED|Overall Study||10||
60001362|NCT02583711|76116974|FG002|NOT COMPLETED|Overall Study||0||
60001363|NCT02583477|76116986|FG000|STARTED|Overall Study||3||
60001364|NCT02583477|76116987|FG001|STARTED|Overall Study||20||
60001365|NCT02583477|76116986|FG000|Received Treatment|Overall Study||3||
60001366|NCT02583477|76116987|FG001|Received Treatment|Overall Study||20||
60001367|NCT02583477|76116986|FG000|Completed Treatment|Overall Study||0||
60001368|NCT02583477|76116987|FG001|Completed Treatment|Overall Study||0||
60001369|NCT02583477|76116986|FG000|COMPLETED|Overall Study||0|Completed study|
60001370|NCT02583477|76116987|FG001|COMPLETED|Overall Study||0|Completed study|
60001371|NCT02583477|76116986|FG000|NOT COMPLETED|Overall Study||3||
59872957|NCT03131440|75997116|FG030|STARTED|Overall Study||9||
59872958|NCT03131440|75997117|FG031|STARTED|Overall Study||8||
60001372|NCT02583477|76116987|FG001|NOT COMPLETED|Overall Study||20||
60001373|NCT02583399|76116994|FG000|STARTED|Overall Study||30||
60001374|NCT02583399|76116994|FG000|COMPLETED|Overall Study||24||
59872959|NCT03131440|75997086|FG000|COMPLETED|Overall Study||7|Completed the 24 week questionnaires OR had valid data on the accelerometer at 24 weeks|
60001375|NCT02583399|76116994|FG000|NOT COMPLETED|Overall Study||6||
60001376|NCT02580591|76117002|FG000|STARTED|Overall Study||242||
60001377|NCT02580591|76117003|FG001|STARTED|Overall Study||242||
60001378|NCT02580591|76117004|FG002|STARTED|Overall Study||248||
60001379|NCT02580591|76117005|FG003|STARTED|Overall Study||245||
60001380|NCT02580591|76117002|FG000|Treated|Overall Study||241||
60001381|NCT02580591|76117003|FG001|Treated|Overall Study||241||
60001382|NCT02580591|76117004|FG002|Treated|Overall Study||248||
60001383|NCT02580591|76117005|FG003|Treated|Overall Study||245||
60001384|NCT02580591|76117002|FG000|COMPLETED|Overall Study||224||
60001385|NCT02580591|76117003|FG001|COMPLETED|Overall Study||232||
60001386|NCT02580591|76117004|FG002|COMPLETED|Overall Study||235||
60001387|NCT02580591|76117005|FG003|COMPLETED|Overall Study||233||
60001388|NCT02580591|76117002|FG000|NOT COMPLETED|Overall Study||18||
60001389|NCT02580591|76117003|FG001|NOT COMPLETED|Overall Study||10||
60001390|NCT02580591|76117004|FG002|NOT COMPLETED|Overall Study||13||
60001391|NCT02580591|76117005|FG003|NOT COMPLETED|Overall Study||12||
60001392|NCT02580357|76117018|FG000|STARTED|Overall Study||18||
60001393|NCT02580357|76117019|FG001|STARTED|Overall Study||18||
60001394|NCT02580357|76117020|FG002|STARTED|Overall Study||18||
60001395|NCT02580357|76117018|FG000|COMPLETED|Overall Study||15||
60001396|NCT02580357|76117019|FG001|COMPLETED|Overall Study||18||
60001397|NCT02580357|76117020|FG002|COMPLETED|Overall Study||18||
59736737|NCT00833482|75855621|FG002|STARTED|Days 1-3||0||
59736738|NCT00833482|75855622|FG003|STARTED|Days 1-3||8||
59736739|NCT00833482|75855623|FG004|STARTED|Days 1-3||0||
59736740|NCT00833482|75855624|FG005|STARTED|Days 1-3||0||
59736741|NCT00833482|75855619|FG000|COMPLETED|Days 1-3||24||
59736742|NCT00833482|75855620|FG001|COMPLETED|Days 1-3||0||
59736743|NCT00833482|75855621|FG002|COMPLETED|Days 1-3||0||
60001398|NCT02580357|76117018|FG000|NOT COMPLETED|Overall Study||3||
60001399|NCT02580357|76117019|FG001|NOT COMPLETED|Overall Study||0||
60001400|NCT02580357|76117020|FG002|NOT COMPLETED|Overall Study||0||
60001401|NCT01664091|76117028|FG000|STARTED|Overall Study||32||
60001402|NCT01664091|76117028|FG000|COMPLETED|Overall Study||26||
60001403|NCT01664091|76117028|FG000|NOT COMPLETED|Overall Study||6||
60001404|NCT02577315|76117035|FG000|STARTED|Treatment Period 1 (4 Days)||12||
60001405|NCT02577315|76117036|FG001|STARTED|Treatment Period 1 (4 Days)||13||
60001406|NCT02577315|76117035|FG000|COMPLETED|Treatment Period 1 (4 Days)||12||
60001407|NCT02577315|76117036|FG001|COMPLETED|Treatment Period 1 (4 Days)||12||
60001408|NCT02577315|76117035|FG000|NOT COMPLETED|Treatment Period 1 (4 Days)||0||
60001409|NCT02577315|76117036|FG001|NOT COMPLETED|Treatment Period 1 (4 Days)||1||
60001410|NCT02577315|76117035|FG000|STARTED|Washout Period (5 Days)||12||
60001411|NCT02577315|76117036|FG001|STARTED|Washout Period (5 Days)||12||
60001412|NCT02577315|76117035|FG000|COMPLETED|Washout Period (5 Days)||12||
60001413|NCT02577315|76117036|FG001|COMPLETED|Washout Period (5 Days)||12||
60001414|NCT02577315|76117035|FG000|NOT COMPLETED|Washout Period (5 Days)||0||
60001415|NCT02577315|76117036|FG001|NOT COMPLETED|Washout Period (5 Days)||0||
60001416|NCT02577315|76117035|FG000|STARTED|Treatment Period 2 (4 Days)||12||
60001417|NCT02577315|76117036|FG001|STARTED|Treatment Period 2 (4 Days)||12||
60001418|NCT02577315|76117035|FG000|COMPLETED|Treatment Period 2 (4 Days)||12||
60001419|NCT02577315|76117036|FG001|COMPLETED|Treatment Period 2 (4 Days)||12||
60001420|NCT02577315|76117035|FG000|NOT COMPLETED|Treatment Period 2 (4 Days)||0||
60001421|NCT02577315|76117036|FG001|NOT COMPLETED|Treatment Period 2 (4 Days)||0||
60001422|NCT02711345|76117052|FG000|STARTED|Overall Study||2||
60001423|NCT02711345|76117053|FG001|STARTED|Overall Study||3||
60001424|NCT02711345|76117054|FG002|STARTED|Overall Study||6||
60001425|NCT02711345|76117055|FG003|STARTED|Overall Study||4||
60001426|NCT02711345|76117056|FG004|STARTED|Overall Study||8||
60001427|NCT02711345|76117057|FG005|STARTED|Overall Study||6||
60001428|NCT02711345|76117058|FG006|STARTED|Overall Study||12||
60001429|NCT02711345|76117059|FG007|STARTED|Overall Study||6||
60001430|NCT02711345|76117060|FG008|STARTED|Overall Study||6||
60001431|NCT02711345|76117061|FG009|STARTED|Overall Study||12||
60001432|NCT02711345|76117052|FG000|COMPLETED|Overall Study||0||
60001433|NCT02711345|76117053|FG001|COMPLETED|Overall Study||0||
60001434|NCT02711345|76117054|FG002|COMPLETED|Overall Study||0||
60001435|NCT02711345|76117055|FG003|COMPLETED|Overall Study||0||
60001436|NCT02711345|76117056|FG004|COMPLETED|Overall Study||0||
60001437|NCT02711345|76117057|FG005|COMPLETED|Overall Study||0||
60001438|NCT02711345|76117058|FG006|COMPLETED|Overall Study||0||
60001439|NCT02711345|76117059|FG007|COMPLETED|Overall Study||0||
60001440|NCT02711345|76117060|FG008|COMPLETED|Overall Study||0||
60001441|NCT02711345|76117061|FG009|COMPLETED|Overall Study||0||
60001442|NCT02711345|76117052|FG000|NOT COMPLETED|Overall Study||2||
60001443|NCT02711345|76117053|FG001|NOT COMPLETED|Overall Study||3||
60001444|NCT02711345|76117054|FG002|NOT COMPLETED|Overall Study||6||
60001445|NCT02711345|76117055|FG003|NOT COMPLETED|Overall Study||4||
60001446|NCT02711345|76117056|FG004|NOT COMPLETED|Overall Study||8||
60001447|NCT02711345|76117057|FG005|NOT COMPLETED|Overall Study||6||
60001448|NCT02711345|76117058|FG006|NOT COMPLETED|Overall Study||12||
60001449|NCT02711345|76117059|FG007|NOT COMPLETED|Overall Study||6||
60001450|NCT02711345|76117060|FG008|NOT COMPLETED|Overall Study||6||
60001451|NCT02711345|76117061|FG009|NOT COMPLETED|Overall Study||12||
60001452|NCT00591227|76117090|FG000|STARTED|Overall Study||89||
60001453|NCT00591227|76117091|FG001|STARTED|Overall Study||87||
60001454|NCT00591227|76117090|FG000|COMPLETED|Overall Study||89||
60001455|NCT00591227|76117091|FG001|COMPLETED|Overall Study||87||
60001456|NCT00591227|76117090|FG000|NOT COMPLETED|Overall Study||0||
60001457|NCT00591227|76117091|FG001|NOT COMPLETED|Overall Study||0||
60001458|NCT02581995|76117098|FG000|STARTED|Overall Study||560||
60001459|NCT02581995|76117098|FG000|Treated|Overall Study||560||
60001460|NCT02581995|76117098|FG000|COMPLETED|Overall Study||529||
60001461|NCT02581995|76117098|FG000|NOT COMPLETED|Overall Study||31||
60001462|NCT02577003|76117104|FG000|STARTED|Overall Study||73||
60001463|NCT02577003|76117105|FG001|STARTED|Overall Study||70||
60001464|NCT02577003|76117104|FG000|COMPLETED|Overall Study||71||
60001465|NCT02577003|76117105|FG001|COMPLETED|Overall Study||65||
60001466|NCT02577003|76117104|FG000|NOT COMPLETED|Overall Study||2||
60001467|NCT02577003|76117105|FG001|NOT COMPLETED|Overall Study||5||
60001468|NCT02446899|76117113|FG000|STARTED|Overall Study||181||
59736744|NCT00833482|75855622|FG003|COMPLETED|Days 1-3||8||
59736745|NCT00833482|75855623|FG004|COMPLETED|Days 1-3||0||
60001469|NCT02446899|76117114|FG001|STARTED|Overall Study||184||
60001470|NCT02446899|76117113|FG000|Received Study Drug|Overall Study||180||
60001471|NCT02446899|76117114|FG001|Received Study Drug|Overall Study||182||
60001472|NCT02446899|76117113|FG000|COMPLETED|Overall Study||156||
60001473|NCT02446899|76117114|FG001|COMPLETED|Overall Study||136||
60001474|NCT02446899|76117113|FG000|NOT COMPLETED|Overall Study||25||
60001475|NCT02446899|76117114|FG001|NOT COMPLETED|Overall Study||48||
60001476|NCT02709785|76117123|FG000|STARTED|Overall Study||24||
60001477|NCT02709785|76117124|FG001|STARTED|Overall Study||28||
60001478|NCT02709785|76117125|FG002|STARTED|Overall Study||28||
60001479|NCT02709785|76117123|FG000|3 Weeks|Overall Study||23||
60001480|NCT02709785|76117124|FG001|3 Weeks|Overall Study||27||
60001481|NCT02709785|76117125|FG002|3 Weeks|Overall Study||27||
60001482|NCT02709785|76117123|FG000|6 Weeks|Overall Study||23||
60001483|NCT02709785|76117124|FG001|6 Weeks|Overall Study||26||
60001484|NCT02709785|76117125|FG002|6 Weeks|Overall Study||27||
60001485|NCT02709785|76117123|FG000|COMPLETED|Overall Study||23||
60001486|NCT02709785|76117124|FG001|COMPLETED|Overall Study||26||
60001487|NCT02709785|76117125|FG002|COMPLETED|Overall Study||27||
60001488|NCT02709785|76117123|FG000|NOT COMPLETED|Overall Study||1||
60001489|NCT02709785|76117124|FG001|NOT COMPLETED|Overall Study||2||
60001490|NCT02709785|76117125|FG002|NOT COMPLETED|Overall Study||1||
60001491|NCT02356887|76117133|FG000|STARTED|Overall Study||12||
60001492|NCT02356887|76117133|FG000|COMPLETED|Overall Study||10||
60001493|NCT02356887|76117133|FG000|NOT COMPLETED|Overall Study||2||
60001494|NCT01604265|76117145|FG000|STARTED|Overall Study||34||
60001495|NCT01604265|76117146|FG001|STARTED|Overall Study||32||
60001496|NCT01604265|76117145|FG000|COMPLETED|Overall Study||32||
60001497|NCT01604265|76117146|FG001|COMPLETED|Overall Study||32||
60001498|NCT01604265|76117145|FG000|NOT COMPLETED|Overall Study||2||
60001499|NCT01604265|76117146|FG001|NOT COMPLETED|Overall Study||0||
60001500|NCT01664247|76117154|FG000|STARTED|Overall Study||174||
60001501|NCT01664247|76117155|FG001|STARTED|Overall Study||172||
60001502|NCT01664247|76117154|FG000|Exposed|Overall Study|1 subject was randomised in error and withdrew before exposure to the drug|173||
60001503|NCT01664247|76117155|FG001|Exposed|Overall Study|Two subjects were randomised in error and withdrew prior to exposure to drug|170||
60001504|NCT01664247|76117154|FG000|COMPLETED|Overall Study||160||
60001505|NCT01664247|76117155|FG001|COMPLETED|Overall Study||131||
60001506|NCT01664247|76117154|FG000|NOT COMPLETED|Overall Study||14||
60001507|NCT01664247|76117155|FG001|NOT COMPLETED|Overall Study||41||
60001508|NCT04655703|76117165|FG000|STARTED|Overall Study||8||
60001509|NCT04655703|76117166|FG001|STARTED|Overall Study||8||
60001510|NCT04655703|76117167|FG002|STARTED|Overall Study||0||
60001511|NCT04655703|76117168|FG003|STARTED|Overall Study||0||
60001512|NCT04655703|76117165|FG000|COMPLETED|Overall Study||5||
60001513|NCT04655703|76117166|FG001|COMPLETED|Overall Study||8||
60001514|NCT04655703|76117167|FG002|COMPLETED|Overall Study||0||
60001515|NCT04655703|76117168|FG003|COMPLETED|Overall Study||0||
60001516|NCT04655703|76117165|FG000|NOT COMPLETED|Overall Study||3||
60001517|NCT04655703|76117166|FG001|NOT COMPLETED|Overall Study||0||
60001518|NCT04655703|76117167|FG002|NOT COMPLETED|Overall Study||0||
60001519|NCT04655703|76117168|FG003|NOT COMPLETED|Overall Study||0||
60001520|NCT03191903|76117179|FG000|STARTED|Overall Study||251|Safety Population|
60001521|NCT03191903|76117180|FG001|STARTED|Overall Study||251|Safety Population|
60001522|NCT03191903|76117181|FG002|STARTED|Overall Study||74|Safety Population|
60001523|NCT03191903|76117179|FG000|Intent to Treat Population|Overall Study||251||
60001524|NCT03191903|76117180|FG001|Intent to Treat Population|Overall Study||251||
60001525|NCT03191903|76117181|FG002|Intent to Treat Population|Overall Study||74||
60001526|NCT03191903|76117179|FG000|COMPLETED|Overall Study||244||
60001527|NCT03191903|76117180|FG001|COMPLETED|Overall Study||246||
60001528|NCT03191903|76117181|FG002|COMPLETED|Overall Study||70||
60001529|NCT03191903|76117179|FG000|NOT COMPLETED|Overall Study||7||
60001530|NCT03191903|76117180|FG001|NOT COMPLETED|Overall Study||5||
60001531|NCT03191903|76117181|FG002|NOT COMPLETED|Overall Study||4||
60001532|NCT02576145|76117196|FG000|STARTED|Overall Study||6||
60001533|NCT02576145|76117197|FG001|STARTED|Overall Study||5||
60001534|NCT02576145|76117196|FG000|COMPLETED|Overall Study||3||
60001535|NCT02576145|76117197|FG001|COMPLETED|Overall Study||4||
60001536|NCT02576145|76117196|FG000|NOT COMPLETED|Overall Study||3||
60001537|NCT02576145|76117197|FG001|NOT COMPLETED|Overall Study||1||
60001538|NCT02440685|76117212|FG000|STARTED|Overall Study||3||
60001539|NCT02440685|76117213|FG001|STARTED|Overall Study||4||
60001540|NCT02440685|76117214|FG002|STARTED|Overall Study||3||
60001541|NCT02440685|76117215|FG003|STARTED|Overall Study||4||
60001542|NCT02440685|76117216|FG004|STARTED|Overall Study||7||
60001543|NCT02440685|76117217|FG005|STARTED|Overall Study||15||
60001544|NCT02440685|76117218|FG006|STARTED|Overall Study||5||
60001545|NCT02440685|76117219|FG007|STARTED|Overall Study||7||
60001546|NCT02440685|76117220|FG008|STARTED|Overall Study||3||
60001547|NCT02440685|76117212|FG000|COMPLETED|Overall Study||0||
60001548|NCT02440685|76117213|FG001|COMPLETED|Overall Study||0||
60001549|NCT02440685|76117214|FG002|COMPLETED|Overall Study||0||
60001550|NCT02440685|76117215|FG003|COMPLETED|Overall Study||0||
60001551|NCT02440685|76117216|FG004|COMPLETED|Overall Study||0||
60001552|NCT02440685|76117217|FG005|COMPLETED|Overall Study||0||
60001553|NCT02440685|76117218|FG006|COMPLETED|Overall Study||0||
60001554|NCT02440685|76117219|FG007|COMPLETED|Overall Study||0||
60001555|NCT02440685|76117220|FG008|COMPLETED|Overall Study||0||
60001556|NCT02440685|76117212|FG000|NOT COMPLETED|Overall Study||3||
60001557|NCT02440685|76117213|FG001|NOT COMPLETED|Overall Study||4||
59736746|NCT00833482|75855624|FG005|COMPLETED|Days 1-3||0||
59736747|NCT00833482|75855619|FG000|NOT COMPLETED|Days 1-3||0||
59736748|NCT00833482|75855620|FG001|NOT COMPLETED|Days 1-3||0||
59736749|NCT00833482|75855621|FG002|NOT COMPLETED|Days 1-3||0||
59736750|NCT00833482|75855622|FG003|NOT COMPLETED|Days 1-3||0||
59736751|NCT00833482|75855623|FG004|NOT COMPLETED|Days 1-3||0||
59736752|NCT00833482|75855624|FG005|NOT COMPLETED|Days 1-3||0||
59736753|NCT00833482|75855619|FG000|STARTED|Days 11-20||0||
59736754|NCT00833482|75855620|FG001|STARTED|Days 11-20|Participants who received treatment.|24||
59736755|NCT00833482|75855621|FG002|STARTED|Days 11-20||0||
59736756|NCT00833482|75855622|FG003|STARTED|Days 11-20||0||
59736757|NCT00833482|75855623|FG004|STARTED|Days 11-20||0||
59736758|NCT00833482|75855624|FG005|STARTED|Days 11-20|Participants who received treatment.|8||
59736759|NCT00833482|75855619|FG000|COMPLETED|Days 11-20||0||
59736760|NCT00833482|75855620|FG001|COMPLETED|Days 11-20||21||
59736761|NCT00833482|75855621|FG002|COMPLETED|Days 11-20||0||
59736762|NCT00833482|75855622|FG003|COMPLETED|Days 11-20||0||
59736763|NCT00833482|75855623|FG004|COMPLETED|Days 11-20||0||
59736764|NCT00833482|75855624|FG005|COMPLETED|Days 11-20||8||
59736765|NCT00833482|75855619|FG000|NOT COMPLETED|Days 11-20||0||
59736766|NCT00833482|75855620|FG001|NOT COMPLETED|Days 11-20||3||
59736767|NCT00833482|75855621|FG002|NOT COMPLETED|Days 11-20||0||
59736768|NCT00833482|75855622|FG003|NOT COMPLETED|Days 11-20||0||
59736769|NCT00833482|75855623|FG004|NOT COMPLETED|Days 11-20||0||
59736770|NCT00833482|75855624|FG005|NOT COMPLETED|Days 11-20||0||
59736771|NCT00833482|75855619|FG000|STARTED|Days 21-30||0||
59736772|NCT00833482|75855620|FG001|STARTED|Days 21-30||0||
59736773|NCT00833482|75855621|FG002|STARTED|Days 21-30||21||
59736774|NCT00833482|75855622|FG003|STARTED|Days 21-30||0||
59736775|NCT00833482|75855623|FG004|STARTED|Days 21-30||8||
59736776|NCT00833482|75855624|FG005|STARTED|Days 21-30||0||
59736777|NCT00833482|75855619|FG000|COMPLETED|Days 21-30||0||
59736778|NCT00833482|75855620|FG001|COMPLETED|Days 21-30||0||
59736779|NCT00833482|75855621|FG002|COMPLETED|Days 21-30||20||
59736780|NCT00833482|75855622|FG003|COMPLETED|Days 21-30||0||
59736781|NCT00833482|75855623|FG004|COMPLETED|Days 21-30||7||
59736782|NCT00833482|75855624|FG005|COMPLETED|Days 21-30||0||
59736783|NCT00833482|75855619|FG000|NOT COMPLETED|Days 21-30||0||
59736784|NCT00833482|75855620|FG001|NOT COMPLETED|Days 21-30||0||
59736785|NCT00833482|75855621|FG002|NOT COMPLETED|Days 21-30||1||
59736786|NCT00833482|75855622|FG003|NOT COMPLETED|Days 21-30||0||
59736787|NCT00833482|75855623|FG004|NOT COMPLETED|Days 21-30||1||
59736788|NCT00833482|75855624|FG005|NOT COMPLETED|Days 21-30||0||
59736789|NCT00845182|75855649|FG000|STARTED|Overall Study||13||
59736790|NCT00845182|75855650|FG001|STARTED|Overall Study||15||
59736791|NCT00845182|75855651|FG002|STARTED|Overall Study||15||
59736792|NCT00845182|75855649|FG000|COMPLETED|Overall Study||10||
59736793|NCT00845182|75855650|FG001|COMPLETED|Overall Study||11||
59736794|NCT00845182|75855651|FG002|COMPLETED|Overall Study||9||
59736795|NCT00845182|75855649|FG000|NOT COMPLETED|Overall Study||3||
59736796|NCT00845182|75855650|FG001|NOT COMPLETED|Overall Study||4||
59736797|NCT00845182|75855651|FG002|NOT COMPLETED|Overall Study||6||
59736798|NCT00833248|75855665|FG000|STARTED|Overall Study||181||
59736799|NCT00833248|75855666|FG001|STARTED|Overall Study||65||
59736800|NCT00833248|75855665|FG000|Full Analysis Set (FAS)|Overall Study||180||
59736801|NCT00833248|75855666|FG001|Full Analysis Set (FAS)|Overall Study||64||
59736802|NCT00833248|75855665|FG000|Per Protocol (PP) Analysis Set|Overall Study||164||
59736803|NCT00833248|75855666|FG001|Per Protocol (PP) Analysis Set|Overall Study||57||
59736804|NCT00833248|75855665|FG000|Safety Analysis Set|Overall Study||181||
59736805|NCT00833248|75855666|FG001|Safety Analysis Set|Overall Study||64||
59736806|NCT00833248|75855665|FG000|COMPLETED|Overall Study||177||
59736807|NCT00833248|75855666|FG001|COMPLETED|Overall Study||62||
59736808|NCT00833248|75855665|FG000|NOT COMPLETED|Overall Study||4||
59736809|NCT00833248|75855666|FG001|NOT COMPLETED|Overall Study||3||
59736810|NCT00887289|75855672|FG000|STARTED|Overall Study||1504||
59736811|NCT00887289|75855672|FG000|COMPLETED|Overall Study||1409||
59736812|NCT00887289|75855672|FG000|NOT COMPLETED|Overall Study||95||
59736813|NCT00833092|75855678|FG000|STARTED|Overall Study||54||
59736814|NCT00833092|75855679|FG001|STARTED|Overall Study||57||
59736815|NCT00833092|75855678|FG000|COMPLETED|Overall Study||50||
59736816|NCT00833092|75855679|FG001|COMPLETED|Overall Study||50||
59736817|NCT00833092|75855678|FG000|NOT COMPLETED|Overall Study||4||
59736818|NCT00833092|75855679|FG001|NOT COMPLETED|Overall Study||7||
59736819|NCT00823264|75855687|FG000|STARTED|Overall Study||10||
59736820|NCT00823264|75855688|FG001|STARTED|Overall Study||7||
59736821|NCT00823264|75855687|FG000|COMPLETED|Overall Study||8||
59736822|NCT00823264|75855688|FG001|COMPLETED|Overall Study||7||
59736823|NCT00823264|75855687|FG000|NOT COMPLETED|Overall Study||2||
59736824|NCT00823264|75855688|FG001|NOT COMPLETED|Overall Study||0||
59736825|NCT00832780|75855694|FG000|STARTED|Overall Study||44||
60001558|NCT02440685|76117214|FG002|NOT COMPLETED|Overall Study||3||
60001559|NCT02440685|76117215|FG003|NOT COMPLETED|Overall Study||4||
60001560|NCT02440685|76117216|FG004|NOT COMPLETED|Overall Study||7||
60001561|NCT02440685|76117217|FG005|NOT COMPLETED|Overall Study||15||
60001562|NCT02440685|76117218|FG006|NOT COMPLETED|Overall Study||5||
60001563|NCT02440685|76117219|FG007|NOT COMPLETED|Overall Study||7||
60001564|NCT02440685|76117220|FG008|NOT COMPLETED|Overall Study||3||
60001565|NCT02576067|76117242|FG000|STARTED|Overall Study||60||
60001566|NCT02576067|76117243|FG001|STARTED|Overall Study||63||
60001567|NCT02576067|76117242|FG000|COMPLETED|Overall Study||26||
60001568|NCT02576067|76117243|FG001|COMPLETED|Overall Study||27||
60001569|NCT02576067|76117242|FG000|NOT COMPLETED|Overall Study||34||
60001570|NCT02576067|76117243|FG001|NOT COMPLETED|Overall Study||36||
60001571|NCT02575911|76117249|FG000|STARTED|Overall Study||30||
60001572|NCT02575911|76117249|FG000|COMPLETED|Overall Study||29||
60001573|NCT02575911|76117249|FG000|NOT COMPLETED|Overall Study||1||
60001574|NCT02575833|76117263|FG000|STARTED|Overall Study||44||
60001575|NCT02575833|76117264|FG001|STARTED|Overall Study||45||
60001576|NCT02575833|76117263|FG000|Received Study Drug|Overall Study||44||
60001577|NCT02575833|76117264|FG001|Received Study Drug|Overall Study||44||
60001578|NCT02575833|76117263|FG000|COMPLETED|Overall Study||43||
60001579|NCT02575833|76117264|FG001|COMPLETED|Overall Study||44||
60001580|NCT02575833|76117263|FG000|NOT COMPLETED|Overall Study||1||
60001581|NCT02575833|76117264|FG001|NOT COMPLETED|Overall Study||1||
60001582|NCT02709083|76117270|FG000|STARTED|Overall Study||7||
60001583|NCT02709083|76117270|FG000|COMPLETED|Overall Study||0||
60001584|NCT02709083|76117270|FG000|NOT COMPLETED|Overall Study||7||
60001585|NCT02709005|76117276|FG000|STARTED|Overall Study||73||
60001586|NCT02709005|76117277|FG001|STARTED|Overall Study||36||
60001587|NCT02709005|76117276|FG000|COMPLETED|Overall Study||69||
60001588|NCT02709005|76117277|FG001|COMPLETED|Overall Study||35||
60001589|NCT02709005|76117276|FG000|NOT COMPLETED|Overall Study||4||
60001590|NCT02709005|76117277|FG001|NOT COMPLETED|Overall Study||1||
60001591|NCT02573883|76117285|FG000|STARTED|Six Month Follow Up||25||
60001592|NCT02573883|76117286|FG001|STARTED|Six Month Follow Up||27||
60001593|NCT02573883|76117287|FG002|STARTED|Six Month Follow Up||0||
60001594|NCT02573883|76117288|FG003|STARTED|Six Month Follow Up||0||
60001595|NCT02573883|76117285|FG000|COMPLETED|Six Month Follow Up||24||
60001596|NCT02573883|76117286|FG001|COMPLETED|Six Month Follow Up||27||
60001597|NCT02573883|76117287|FG002|COMPLETED|Six Month Follow Up||0||
60001598|NCT02573883|76117288|FG003|COMPLETED|Six Month Follow Up||0||
60001599|NCT02573883|76117285|FG000|NOT COMPLETED|Six Month Follow Up||1||
60001600|NCT02573883|76117286|FG001|NOT COMPLETED|Six Month Follow Up||0||
60001601|NCT02573883|76117287|FG002|NOT COMPLETED|Six Month Follow Up||0||
60001602|NCT02573883|76117288|FG003|NOT COMPLETED|Six Month Follow Up||0||
60001603|NCT02573883|76117285|FG000|STARTED|One Year Follow Up||13||
60001604|NCT02573883|76117286|FG001|STARTED|One Year Follow Up||17||
60001605|NCT02573883|76117287|FG002|STARTED|One Year Follow Up||11||
60001606|NCT02573883|76117288|FG003|STARTED|One Year Follow Up||10||
60001607|NCT02573883|76117285|FG000|COMPLETED|One Year Follow Up||11||
60001608|NCT02573883|76117286|FG001|COMPLETED|One Year Follow Up||16||
60001609|NCT02573883|76117287|FG002|COMPLETED|One Year Follow Up||11||
60001610|NCT02573883|76117288|FG003|COMPLETED|One Year Follow Up||10||
60001611|NCT02573883|76117285|FG000|NOT COMPLETED|One Year Follow Up||2||
60001612|NCT02573883|76117286|FG001|NOT COMPLETED|One Year Follow Up||1||
60001613|NCT02573883|76117287|FG002|NOT COMPLETED|One Year Follow Up||0||
60001614|NCT02573883|76117288|FG003|NOT COMPLETED|One Year Follow Up||0||
60001615|NCT02575365|76117303|FG000|STARTED|Overall Study||4||
60001616|NCT02575365|76117303|FG000|COMPLETED|Overall Study||0||
60001617|NCT02575365|76117303|FG000|NOT COMPLETED|Overall Study||4||
60001618|NCT02707991|76117309|FG000|STARTED|Overall Study||33||
60001619|NCT02707991|76117310|FG001|STARTED|Overall Study||35||
60001620|NCT02707991|76117309|FG000|Day 60 Data Collectio|Overall Study||32||
60001621|NCT02707991|76117310|FG001|Day 60 Data Collectio|Overall Study||34||
60001622|NCT02707991|76117309|FG000|Month 6 Data Collection|Overall Study||32||
60001623|NCT02707991|76117310|FG001|Month 6 Data Collection|Overall Study||34||
60001624|NCT02707991|76117309|FG000|COMPLETED|Overall Study||32||
60001625|NCT02707991|76117310|FG001|COMPLETED|Overall Study||34||
60001626|NCT02707991|76117309|FG000|NOT COMPLETED|Overall Study||1||
60001627|NCT02707991|76117310|FG001|NOT COMPLETED|Overall Study||1||
60001628|NCT02707757|76117318|FG000|STARTED|Overall Study||88|"This refers to the number of times to which a participant was allocated to each respective treatment.~A participant could be re-randomised 6 months following initial randomisation. Not all participants were randomised due to not meeting randomisation criteria."|
60001629|NCT02707757|76117319|FG001|STARTED|Overall Study||96|"This refers to the number of times to which a participant was allocated to each respective treatment.~A participant could be re-randomised 6 months following initial randomisation. Not all participants were randomised due to not meeting randomisation criteria."|
60001630|NCT02707757|76117318|FG000|COMPLETED|Overall Study||76||
60001631|NCT02707757|76117319|FG001|COMPLETED|Overall Study||84||
60001632|NCT02707757|76117318|FG000|NOT COMPLETED|Overall Study||12||
60001633|NCT02707757|76117319|FG001|NOT COMPLETED|Overall Study||12||
60001634|NCT02572401|76117329|FG000|STARTED|Overall Study||97||
60001635|NCT02572401|76117330|FG001|STARTED|Overall Study||98||
59736826|NCT00832780|75855694|FG000|COMPLETED|Overall Study||19||
59736827|NCT00832780|75855694|FG000|NOT COMPLETED|Overall Study||25||
59736828|NCT00591838|75855703|FG000|STARTED|Overall Study||5||
59736829|NCT00591838|75855704|FG001|STARTED|Overall Study||6||
59736830|NCT00591838|75855705|FG002|STARTED|Overall Study||6||
59736831|NCT00591838|75855706|FG003|STARTED|Overall Study||6||
59736832|NCT00591838|75855707|FG004|STARTED|Overall Study||51||
60001636|NCT02572401|76117331|FG002|STARTED|Overall Study||98||
60001637|NCT02572401|76117332|FG003|STARTED|Overall Study||98||
60001638|NCT02572401|76117329|FG000|COMPLETED|Overall Study||92||
60001639|NCT02572401|76117330|FG001|COMPLETED|Overall Study||90||
60001640|NCT02572401|76117331|FG002|COMPLETED|Overall Study||89||
60001641|NCT02572401|76117332|FG003|COMPLETED|Overall Study||88||
60001642|NCT02572401|76117329|FG000|NOT COMPLETED|Overall Study||5||
60001643|NCT02572401|76117330|FG001|NOT COMPLETED|Overall Study||8||
60001644|NCT02572401|76117331|FG002|NOT COMPLETED|Overall Study||9||
60001645|NCT02572401|76117332|FG003|NOT COMPLETED|Overall Study||10||
60001646|NCT02431325|76117344|FG000|STARTED|Overall Study||17||
60001647|NCT02431325|76117345|FG001|STARTED|Overall Study||15||
60001648|NCT02431325|76117344|FG000|COMPLETED|Overall Study||9||
60001649|NCT02431325|76117345|FG001|COMPLETED|Overall Study||12||
60001650|NCT02431325|76117344|FG000|NOT COMPLETED|Overall Study||8||
60001651|NCT02431325|76117345|FG001|NOT COMPLETED|Overall Study||3||
60001652|NCT02103478|76117358|FG000|STARTED|Overall Study||7||
60001653|NCT02103478|76117359|FG001|STARTED|Overall Study||6||
60001654|NCT02103478|76117360|FG002|STARTED|Overall Study||6||
60001655|NCT02103478|76117361|FG003|STARTED|Overall Study||6||
60001656|NCT02103478|76117362|FG004|STARTED|Overall Study||19||
60001657|NCT02103478|76117363|FG005|STARTED|Overall Study||25||
60001658|NCT02103478|76117364|FG006|STARTED|Overall Study||25||
60001659|NCT02103478|76117365|FG007|STARTED|Overall Study||16||
60001660|NCT02103478|76117366|FG008|STARTED|Overall Study||14||
60001661|NCT02103478|76117358|FG000|COMPLETED|Overall Study||0||
60001662|NCT02103478|76117359|FG001|COMPLETED|Overall Study||0||
60001663|NCT02103478|76117360|FG002|COMPLETED|Overall Study||0||
60001664|NCT02103478|76117361|FG003|COMPLETED|Overall Study||0||
60001665|NCT02103478|76117362|FG004|COMPLETED|Overall Study||0||
60001666|NCT02103478|76117363|FG005|COMPLETED|Overall Study||0||
60001667|NCT02103478|76117364|FG006|COMPLETED|Overall Study||0||
60001668|NCT02103478|76117365|FG007|COMPLETED|Overall Study||0||
60001669|NCT02103478|76117366|FG008|COMPLETED|Overall Study||0||
60001670|NCT02103478|76117358|FG000|NOT COMPLETED|Overall Study||7||
60001671|NCT02103478|76117359|FG001|NOT COMPLETED|Overall Study||6||
60001672|NCT02103478|76117360|FG002|NOT COMPLETED|Overall Study||6||
60001673|NCT02103478|76117361|FG003|NOT COMPLETED|Overall Study||6||
60001674|NCT02103478|76117362|FG004|NOT COMPLETED|Overall Study||19||
60001675|NCT02103478|76117363|FG005|NOT COMPLETED|Overall Study||25||
60001676|NCT02103478|76117364|FG006|NOT COMPLETED|Overall Study||25||
60001677|NCT02103478|76117365|FG007|NOT COMPLETED|Overall Study||16||
59736833|NCT00591838|75855703|FG000|COMPLETED|Overall Study||5||
60001678|NCT02103478|76117366|FG008|NOT COMPLETED|Overall Study||14||
60001679|NCT02102464|76117398|FG000|STARTED|Randomized Study||29||58
60001680|NCT02102464|76117399|FG001|STARTED|Randomized Study||26||52
60001681|NCT02102464|76117400|FG002|STARTED|Randomized Study||0||0
60001682|NCT02102464|76117398|FG000|COMPLETED|Randomized Study||29||58
60001683|NCT02102464|76117399|FG001|COMPLETED|Randomized Study||25||50
60001684|NCT02102464|76117400|FG002|COMPLETED|Randomized Study||0||0
60001685|NCT02102464|76117398|FG000|NOT COMPLETED|Randomized Study||0||0
60001686|NCT02102464|76117399|FG001|NOT COMPLETED|Randomized Study||1||2
60001687|NCT02102464|76117400|FG002|NOT COMPLETED|Randomized Study||0||0
60001688|NCT02102464|76117398|FG000|STARTED|Crossover LipiFlow Treatment of Control||0||0
60001689|NCT02102464|76117399|FG001|STARTED|Crossover LipiFlow Treatment of Control||0||0
60001690|NCT02102464|76117400|FG002|STARTED|Crossover LipiFlow Treatment of Control||25||50
60001691|NCT02102464|76117398|FG000|COMPLETED|Crossover LipiFlow Treatment of Control||0||0
60001692|NCT02102464|76117399|FG001|COMPLETED|Crossover LipiFlow Treatment of Control||0||0
60001693|NCT02102464|76117400|FG002|COMPLETED|Crossover LipiFlow Treatment of Control||25||50
60001694|NCT02102464|76117398|FG000|NOT COMPLETED|Crossover LipiFlow Treatment of Control||0||0
60001695|NCT02102464|76117399|FG001|NOT COMPLETED|Crossover LipiFlow Treatment of Control||0||0
60001696|NCT02102464|76117400|FG002|NOT COMPLETED|Crossover LipiFlow Treatment of Control||0||0
60001697|NCT02707601|76117411|FG000|STARTED|Overall Study||76||
60134402|NCT00711711|76257569|FG000|Second Postsurgical Day|Overall Study||30||
60134403|NCT00711711|76257570|FG001|Second Postsurgical Day|Overall Study||30||
59736834|NCT00591838|75855704|FG001|COMPLETED|Overall Study||6||
59736835|NCT00591838|75855705|FG002|COMPLETED|Overall Study||6||
60001698|NCT02707601|76117412|FG001|STARTED|Overall Study||74||
60001699|NCT02707601|76117411|FG000|COMPLETED|Overall Study||72||
60001700|NCT02707601|76117412|FG001|COMPLETED|Overall Study||70||
60001701|NCT02707601|76117411|FG000|NOT COMPLETED|Overall Study||4||
60001702|NCT02707601|76117412|FG001|NOT COMPLETED|Overall Study||4||
60001703|NCT02707055|76117424|FG000|STARTED|Phase 1||18||
60001704|NCT02707055|76117425|FG001|STARTED|Phase 1||19||
60001705|NCT02707055|76117424|FG000|COMPLETED|Phase 1||17||
60001706|NCT02707055|76117425|FG001|COMPLETED|Phase 1||16||
60001707|NCT02707055|76117424|FG000|NOT COMPLETED|Phase 1||1||
60001708|NCT02707055|76117425|FG001|NOT COMPLETED|Phase 1||3||
60001709|NCT02707055|76117424|FG000|STARTED|Washout Period||17||
60001710|NCT02707055|76117425|FG001|STARTED|Washout Period||16||
60001711|NCT02707055|76117424|FG000|COMPLETED|Washout Period||17||
60001712|NCT02707055|76117425|FG001|COMPLETED|Washout Period||16||
60001713|NCT02707055|76117424|FG000|NOT COMPLETED|Washout Period||0||
60001714|NCT02707055|76117425|FG001|NOT COMPLETED|Washout Period||0||
60001715|NCT02707055|76117424|FG000|STARTED|Phase 2||17||
60001716|NCT02707055|76117425|FG001|STARTED|Phase 2||16||
60001717|NCT02707055|76117424|FG000|COMPLETED|Phase 2||16||
60001718|NCT02707055|76117425|FG001|COMPLETED|Phase 2||14||
60001719|NCT02707055|76117424|FG000|NOT COMPLETED|Phase 2||1||
60001720|NCT02707055|76117425|FG001|NOT COMPLETED|Phase 2||2||
60001721|NCT02073682|76117433|FG000|STARTED|Overall Study||522||
60001722|NCT02073682|76117434|FG001|STARTED|Overall Study||524||
60001723|NCT02073682|76117433|FG000|COMPLETED|Overall Study||200|In reasons not completed, acronyms are used: Investigator Decision (ID) and Patient Decision (PD)|
60001724|NCT02073682|76117434|FG001|COMPLETED|Overall Study||154|In reasons not completed, acronyms are used: Investigator Decision (ID) and Patient Decision (PD)|
60001725|NCT02073682|76117433|FG000|NOT COMPLETED|Overall Study||322||
60001726|NCT02073682|76117434|FG001|NOT COMPLETED|Overall Study||370||
60001727|NCT02072980|76117440|FG000|STARTED|Period 1, First Wear||7||
60001728|NCT02072980|76117441|FG001|STARTED|Period 1, First Wear||8||
60001729|NCT02072980|76117440|FG000|COMPLETED|Period 1, First Wear||7||
60001730|NCT02072980|76117441|FG001|COMPLETED|Period 1, First Wear||8||
60001731|NCT02072980|76117440|FG000|NOT COMPLETED|Period 1, First Wear||0||
60001732|NCT02072980|76117441|FG001|NOT COMPLETED|Period 1, First Wear||0||
60001733|NCT02072980|76117440|FG000|STARTED|Period 2, Second Wear||7||
60001734|NCT02072980|76117441|FG001|STARTED|Period 2, Second Wear||8||
60001735|NCT02072980|76117440|FG000|COMPLETED|Period 2, Second Wear||7||
60001736|NCT02072980|76117441|FG001|COMPLETED|Period 2, Second Wear||7||
60001737|NCT02072980|76117440|FG000|NOT COMPLETED|Period 2, Second Wear||0||
60001738|NCT02072980|76117441|FG001|NOT COMPLETED|Period 2, Second Wear||1||
60001739|NCT02706899|76117449|FG000|STARTED|Overall Study||13||
60001740|NCT02706899|76117450|FG001|STARTED|Overall Study||6||
60001741|NCT02706899|76117449|FG000|COMPLETED|Overall Study||0||
60001742|NCT02706899|76117450|FG001|COMPLETED|Overall Study||0||
60001743|NCT02706899|76117449|FG000|NOT COMPLETED|Overall Study||13||
60001744|NCT02706899|76117450|FG001|NOT COMPLETED|Overall Study||6||
60001745|NCT02072824|76117459|FG000|STARTED|Overall Study||71||
60001746|NCT02072824|76117460|FG001|STARTED|Overall Study||34||
60001747|NCT02072824|76117461|FG002|STARTED|Overall Study||70||
60001748|NCT02072824|76117459|FG000|COMPLETED|Overall Study||69||
60001749|NCT02072824|76117460|FG001|COMPLETED|Overall Study||33||
60001750|NCT02072824|76117461|FG002|COMPLETED|Overall Study||67||
60001751|NCT02072824|76117459|FG000|NOT COMPLETED|Overall Study||2||
60001752|NCT02072824|76117460|FG001|NOT COMPLETED|Overall Study||1||
60001753|NCT02072824|76117461|FG002|NOT COMPLETED|Overall Study||3||
60001754|NCT02072668|76117469|FG000|STARTED|First Intervention||7||
60001755|NCT02072668|76117470|FG001|STARTED|First Intervention||7||
60001756|NCT02072668|76117469|FG000|COMPLETED|First Intervention||7||
60001757|NCT02072668|76117470|FG001|COMPLETED|First Intervention||7||
60001758|NCT02072668|76117469|FG000|NOT COMPLETED|First Intervention||0||
60001759|NCT02072668|76117470|FG001|NOT COMPLETED|First Intervention||0||
60001760|NCT02072668|76117469|FG000|STARTED|Washout (2 Weeks)||7||
60001761|NCT02072668|76117470|FG001|STARTED|Washout (2 Weeks)||7||
60001762|NCT02072668|76117469|FG000|COMPLETED|Washout (2 Weeks)||7||
60001763|NCT02072668|76117470|FG001|COMPLETED|Washout (2 Weeks)||7||
60001764|NCT02072668|76117469|FG000|NOT COMPLETED|Washout (2 Weeks)||0||
60001765|NCT02072668|76117470|FG001|NOT COMPLETED|Washout (2 Weeks)||0||
60001766|NCT02072668|76117469|FG000|STARTED|Second Intervention||7||
60001767|NCT02072668|76117470|FG001|STARTED|Second Intervention||7||
60001768|NCT02072668|76117469|FG000|COMPLETED|Second Intervention||6||
60001769|NCT02072668|76117470|FG001|COMPLETED|Second Intervention||7||
60001770|NCT02072668|76117469|FG000|NOT COMPLETED|Second Intervention||1||
60001771|NCT02072668|76117470|FG001|NOT COMPLETED|Second Intervention||0||
60001772|NCT02140762|76117480|FG000|STARTED|Overall Study||154||
60001773|NCT02140762|76117481|FG001|STARTED|Overall Study||151||
60001774|NCT02140762|76117480|FG000|COMPLETED|Overall Study||137||
60001775|NCT02140762|76117481|FG001|COMPLETED|Overall Study||139||
60001776|NCT02140762|76117480|FG000|NOT COMPLETED|Overall Study||17||
60001777|NCT02140762|76117481|FG001|NOT COMPLETED|Overall Study||12||
60001778|NCT02101294|76117492|FG000|STARTED|Overall Study||31||
60001779|NCT02101294|76117492|FG000|COMPLETED|Overall Study||20||
60001780|NCT02101294|76117492|FG000|NOT COMPLETED|Overall Study||11||
60001781|NCT01598506|76117499|FG000|STARTED|Overall Study||22||
60001782|NCT01598506|76117499|FG000|COMPLETED|Overall Study||20||
60001783|NCT01598506|76117499|FG000|NOT COMPLETED|Overall Study||2||
60001784|NCT02140060|76117510|FG000|STARTED|Overall Study||44||
60001785|NCT02140060|76117511|FG001|STARTED|Overall Study||44||
60001786|NCT02140060|76117512|FG002|STARTED|Overall Study||44||
60001787|NCT02140060|76117513|FG003|STARTED|Overall Study||45||
60001788|NCT02140060|76117514|FG004|STARTED|Overall Study||45||
60001789|NCT02140060|76117515|FG005|STARTED|Overall Study||44||
60001790|NCT02140060|76117510|FG000|COMPLETED|Overall Study||44||
60001791|NCT02140060|76117511|FG001|COMPLETED|Overall Study||44||
60001792|NCT02140060|76117512|FG002|COMPLETED|Overall Study||44||
60001793|NCT02140060|76117513|FG003|COMPLETED|Overall Study||43||
60001794|NCT02140060|76117514|FG004|COMPLETED|Overall Study||44||
60001795|NCT02140060|76117515|FG005|COMPLETED|Overall Study||43||
60001796|NCT02140060|76117510|FG000|NOT COMPLETED|Overall Study||0||
60001797|NCT02140060|76117511|FG001|NOT COMPLETED|Overall Study||0||
60001798|NCT02140060|76117512|FG002|NOT COMPLETED|Overall Study||0||
60001799|NCT02140060|76117513|FG003|NOT COMPLETED|Overall Study||2||
60001800|NCT02140060|76117514|FG004|NOT COMPLETED|Overall Study||1||
60001801|NCT02140060|76117515|FG005|NOT COMPLETED|Overall Study||1||
60001802|NCT02139982|76117540|FG000|STARTED|Overall Study||8||
60001803|NCT02139982|76117541|FG001|STARTED|Overall Study||8||
60001804|NCT02139982|76117542|FG002|STARTED|Overall Study||8||
60001805|NCT02139982|76117543|FG003|STARTED|Overall Study||8||
60001806|NCT02139982|76117544|FG004|STARTED|Overall Study||13||
60001807|NCT02139982|76117545|FG005|STARTED|Overall Study||13||
60001808|NCT02139982|76117546|FG006|STARTED|Overall Study||13||
60001809|NCT02139982|76117547|FG007|STARTED|Overall Study||13||
60001810|NCT02139982|76117548|FG008|STARTED|Overall Study||13||
60001811|NCT02139982|76117549|FG009|STARTED|Overall Study||13||
60001812|NCT02139982|76117540|FG000|COMPLETED|Overall Study||8||
60001813|NCT02139982|76117541|FG001|COMPLETED|Overall Study||7||
60001814|NCT02139982|76117542|FG002|COMPLETED|Overall Study||8||
60001815|NCT02139982|76117543|FG003|COMPLETED|Overall Study||7||
60001816|NCT02139982|76117544|FG004|COMPLETED|Overall Study||13||
60001817|NCT02139982|76117545|FG005|COMPLETED|Overall Study||13||
60001818|NCT02139982|76117546|FG006|COMPLETED|Overall Study||13||
60001819|NCT02139982|76117547|FG007|COMPLETED|Overall Study||13||
60001820|NCT02139982|76117548|FG008|COMPLETED|Overall Study||13||
60001821|NCT02139982|76117549|FG009|COMPLETED|Overall Study||13||
60001822|NCT02139982|76117540|FG000|NOT COMPLETED|Overall Study||0||
60001823|NCT02139982|76117541|FG001|NOT COMPLETED|Overall Study||1||
60001824|NCT02139982|76117542|FG002|NOT COMPLETED|Overall Study||0||
60001825|NCT02139982|76117543|FG003|NOT COMPLETED|Overall Study||1||
60001826|NCT02139982|76117544|FG004|NOT COMPLETED|Overall Study||0||
60001827|NCT02139982|76117545|FG005|NOT COMPLETED|Overall Study||0||
60001828|NCT02139982|76117546|FG006|NOT COMPLETED|Overall Study||0||
60001829|NCT02139982|76117547|FG007|NOT COMPLETED|Overall Study||0||
60001830|NCT02139982|76117548|FG008|NOT COMPLETED|Overall Study||0||
60001831|NCT02139982|76117549|FG009|NOT COMPLETED|Overall Study||0||
60001832|NCT02139826|76117571|FG000|STARTED|Overall Study||12||
60001833|NCT02139826|76117571|FG000|COMPLETED|Overall Study||11||
60001834|NCT02139826|76117571|FG000|NOT COMPLETED|Overall Study||1||
60001835|NCT02139592|76117581|FG000|STARTED|Overall Study||292||
60001836|NCT02139592|76117581|FG000|COMPLETED|Overall Study||284||
60001837|NCT02139592|76117581|FG000|NOT COMPLETED|Overall Study||8||
60001838|NCT02139280|76117587|FG000|STARTED|Overall Study||34||
60001839|NCT02139280|76117588|FG001|STARTED|Overall Study||20||
60001840|NCT02139280|76117587|FG000|COMPLETED|Overall Study||32||
60001841|NCT02139280|76117588|FG001|COMPLETED|Overall Study||20||
60001842|NCT02139280|76117587|FG000|NOT COMPLETED|Overall Study||2||
60001843|NCT02139280|76117588|FG001|NOT COMPLETED|Overall Study||0||
60001844|NCT02072434|76117596|FG000|STARTED|Overall Study||1095||
60001845|NCT02072434|76117597|FG001|STARTED|Overall Study||1104||
60001846|NCT02072434|76117596|FG000|Intent to Treat Analysis Set|Overall Study||1095||
60001847|NCT02072434|76117597|FG001|Intent to Treat Analysis Set|Overall Study||1104||
60001848|NCT02072434|76117596|FG000|Received Study Drug|Overall Study||1067||
60001849|NCT02072434|76117597|FG001|Received Study Drug|Overall Study||1082||
60001850|NCT02072434|76117596|FG000|Safety Analysis Set|Overall Study||1067||
60001851|NCT02072434|76117597|FG001|Safety Analysis Set|Overall Study||1082||
60001852|NCT02072434|76117596|FG000|COMPLETED|Overall Study||1041||
60001853|NCT02072434|76117597|FG001|COMPLETED|Overall Study||1014||
60001854|NCT02072434|76117596|FG000|NOT COMPLETED|Overall Study||54||
60001855|NCT02072434|76117597|FG001|NOT COMPLETED|Overall Study||90||
60001856|NCT02101060|76117605|FG000|STARTED|Overall Study||17||
60001857|NCT02101060|76117606|FG001|STARTED|Overall Study||16||
60001858|NCT02101060|76117605|FG000|COMPLETED|Overall Study||12||
60001859|NCT02101060|76117606|FG001|COMPLETED|Overall Study||12||
60001860|NCT02101060|76117605|FG000|NOT COMPLETED|Overall Study||5||
60001861|NCT02101060|76117606|FG001|NOT COMPLETED|Overall Study||4||
60001862|NCT02139124|76117617|FG000|STARTED|Overall Study||78||
60001863|NCT02139124|76117618|FG001|STARTED|Overall Study||77||
60001864|NCT02139124|76117619|FG002|STARTED|Overall Study||73||
60001865|NCT02139124|76117620|FG003|STARTED|Overall Study||73||
60001866|NCT02139124|76117621|FG004|STARTED|Overall Study||74||
60001867|NCT02139124|76117617|FG000|COMPLETED|Overall Study||69||
60001868|NCT02139124|76117618|FG001|COMPLETED|Overall Study||73||
60001869|NCT02139124|76117619|FG002|COMPLETED|Overall Study||69||
60001870|NCT02139124|76117620|FG003|COMPLETED|Overall Study||61||
60001871|NCT02139124|76117621|FG004|COMPLETED|Overall Study||61||
60001872|NCT02139124|76117617|FG000|NOT COMPLETED|Overall Study||9||
60001873|NCT02139124|76117618|FG001|NOT COMPLETED|Overall Study||4||
60001874|NCT02139124|76117619|FG002|NOT COMPLETED|Overall Study||4||
60001875|NCT02139124|76117620|FG003|NOT COMPLETED|Overall Study||12||
60001876|NCT02139124|76117621|FG004|NOT COMPLETED|Overall Study||13||
60001877|NCT02139046|76117638|FG000|STARTED|Overall Study||358||
60001878|NCT02139046|76117639|FG001|STARTED|Overall Study||359||
60001879|NCT02139046|76117640|FG002|STARTED|Overall Study||357||
60001880|NCT02139046|76117641|FG003|STARTED|Overall Study||358||
60001881|NCT02139046|76117642|FG004|STARTED|Overall Study||358||
60001882|NCT02139046|76117638|FG000|Safety Analysis Set|Overall Study||356||
60001883|NCT02139046|76117639|FG001|Safety Analysis Set|Overall Study||358||
60001884|NCT02139046|76117640|FG002|Safety Analysis Set|Overall Study||355||
60001885|NCT02139046|76117641|FG003|Safety Analysis Set|Overall Study||357||
60001886|NCT02139046|76117642|FG004|Safety Analysis Set|Overall Study||357||
60001887|NCT02139046|76117638|FG000|Full Analysis Set|Overall Study||357||
60001888|NCT02139046|76117639|FG001|Full Analysis Set|Overall Study||357||
60001889|NCT02139046|76117640|FG002|Full Analysis Set|Overall Study||355||
60001890|NCT02139046|76117641|FG003|Full Analysis Set|Overall Study||357||
60001891|NCT02139046|76117642|FG004|Full Analysis Set|Overall Study||357||
60001892|NCT02139046|76117638|FG000|COMPLETED|Overall Study|Completed=Completed Study Drug|296||
60001893|NCT02139046|76117639|FG001|COMPLETED|Overall Study||305||
60001894|NCT02139046|76117640|FG002|COMPLETED|Overall Study||298||
60001895|NCT02139046|76117641|FG003|COMPLETED|Overall Study||290||
60001896|NCT02139046|76117642|FG004|COMPLETED|Overall Study||301||
60001897|NCT02139046|76117638|FG000|NOT COMPLETED|Overall Study||62||
60001898|NCT02139046|76117639|FG001|NOT COMPLETED|Overall Study||54||
60001899|NCT02139046|76117640|FG002|NOT COMPLETED|Overall Study||59||
60001900|NCT02139046|76117641|FG003|NOT COMPLETED|Overall Study||68||
60001901|NCT02139046|76117642|FG004|NOT COMPLETED|Overall Study||57||
60001902|NCT02138890|76117656|FG000|STARTED|Overall Study||31|Subjects were followed up for 12 months and if they consent, for a long term follow-up of 5 years.|
60001903|NCT02138890|76117657|FG001|STARTED|Overall Study||15|Subjects were followed up for 12 months and if they consent, for a long term follow-up of 5 years.|
60001904|NCT02138890|76117656|FG000|COMPLETED|Overall Study||30||
60001905|NCT02138890|76117657|FG001|COMPLETED|Overall Study||15||
60001906|NCT02138890|76117656|FG000|NOT COMPLETED|Overall Study||1||
60001907|NCT02138890|76117657|FG001|NOT COMPLETED|Overall Study||0||
60001908|NCT02100670|76117668|FG000|STARTED|Overall Study||118||
60001909|NCT02100670|76117669|FG001|STARTED|Overall Study||113||
60001910|NCT02100670|76117670|FG002|STARTED|Overall Study||78||
60001911|NCT02100670|76117671|FG003|STARTED|Overall Study||76||
60001912|NCT02100670|76117668|FG000|COMPLETED|Overall Study||105||
60001913|NCT02100670|76117669|FG001|COMPLETED|Overall Study||106||
60001914|NCT02100670|76117670|FG002|COMPLETED|Overall Study||74||
60001915|NCT02100670|76117671|FG003|COMPLETED|Overall Study||75||
60001916|NCT02100670|76117668|FG000|NOT COMPLETED|Overall Study||13||
60001917|NCT02100670|76117669|FG001|NOT COMPLETED|Overall Study||7||
60001918|NCT02100670|76117670|FG002|NOT COMPLETED|Overall Study||4||
60001919|NCT02100670|76117671|FG003|NOT COMPLETED|Overall Study||1||
60001920|NCT02070484|76117690|FG000|STARTED|Overall Study||3||
60001921|NCT02070484|76117691|FG001|STARTED|Overall Study||3||
60001922|NCT02070484|76117690|FG000|COMPLETED|Overall Study||2||
60001923|NCT02070484|76117691|FG001|COMPLETED|Overall Study||3||
60001924|NCT02070484|76117690|FG000|NOT COMPLETED|Overall Study||1||
60001925|NCT02070484|76117691|FG001|NOT COMPLETED|Overall Study||0||
60001926|NCT02100514|76117699|FG000|STARTED|Treatment Period||247||
60001927|NCT02100514|76117700|FG001|STARTED|Treatment Period||499||
60001928|NCT02100514|76117701|FG002|STARTED|Treatment Period||0||
60001929|NCT02100514|76117702|FG003|STARTED|Treatment Period||0||
60001930|NCT02100514|76117703|FG004|STARTED|Treatment Period||0||
60001931|NCT02100514|76117699|FG000|COMPLETED|Treatment Period||218||
60001932|NCT02100514|76117700|FG001|COMPLETED|Treatment Period||425||
60001933|NCT02100514|76117701|FG002|COMPLETED|Treatment Period||0||
60001934|NCT02100514|76117702|FG003|COMPLETED|Treatment Period||0||
60001935|NCT02100514|76117703|FG004|COMPLETED|Treatment Period||0||
60001936|NCT02100514|76117699|FG000|NOT COMPLETED|Treatment Period||29||
60001937|NCT02100514|76117700|FG001|NOT COMPLETED|Treatment Period||74||
60001938|NCT02100514|76117701|FG002|NOT COMPLETED|Treatment Period||0||
60001939|NCT02100514|76117702|FG003|NOT COMPLETED|Treatment Period||0||
60001940|NCT02100514|76117703|FG004|NOT COMPLETED|Treatment Period||0||
60001941|NCT02100514|76117699|FG000|STARTED|Extension Period||0||
60001942|NCT02100514|76117700|FG001|STARTED|Extension Period||0||
60001943|NCT02100514|76117701|FG002|STARTED|Extension Period||44||
60001944|NCT02100514|76117702|FG003|STARTED|Extension Period||33||
60001945|NCT02100514|76117703|FG004|STARTED|Extension Period||56||
60001946|NCT02100514|76117699|FG000|COMPLETED|Extension Period||0||
60001947|NCT02100514|76117700|FG001|COMPLETED|Extension Period||0||
60001948|NCT02100514|76117701|FG002|COMPLETED|Extension Period||42||
60001949|NCT02100514|76117702|FG003|COMPLETED|Extension Period||33||
60001950|NCT02100514|76117703|FG004|COMPLETED|Extension Period||56||
60001951|NCT02100514|76117699|FG000|NOT COMPLETED|Extension Period||0||
60001952|NCT02100514|76117700|FG001|NOT COMPLETED|Extension Period||0||
60001953|NCT02100514|76117701|FG002|NOT COMPLETED|Extension Period||2||
60001954|NCT02100514|76117702|FG003|NOT COMPLETED|Extension Period||0||
60001955|NCT02100514|76117703|FG004|NOT COMPLETED|Extension Period||0||
60001956|NCT02069392|76117719|FG000|STARTED|Overall Study||14||
60001957|NCT02069392|76117720|FG001|STARTED|Overall Study||17||
60001958|NCT02069392|76117719|FG000|COMPLETED|Overall Study||10||
60001959|NCT02069392|76117720|FG001|COMPLETED|Overall Study||15||
60001960|NCT02069392|76117719|FG000|NOT COMPLETED|Overall Study||4||
60001961|NCT02069392|76117720|FG001|NOT COMPLETED|Overall Study||2||
60001962|NCT02047318|76117728|FG000|STARTED|Core Study Period||19||
60001963|NCT02047318|76117728|FG000|Received MRX 14 ug/kg/Day|Core Study Period||6|Only participants who received PBO in the previous study, LUM001-302, went through dose escalation.|
60001964|NCT02047318|76117728|FG000|Received MRX 35 ug/kg/Day|Core Study Period||6|Only participants who received PBO in the previous study, LUM001-302, went through dose escalation.|
60001965|NCT02047318|76117728|FG000|Received MRX 70 ug/kg/Day|Core Study Period||6|Only participants who received PBO in the previous study, LUM001-302, went through dose escalation.|
60001966|NCT02047318|76117728|FG000|Received MRX 140 ug/kg/Day|Core Study Period||11|Only participants who received PBO in the previous study, LUM001-302, went through dose escalation. Additionally, participants who were randomized to receive 140 ug/kg/day in LUM001-302 were kept at their previous dose when entering this study.|
60001967|NCT02047318|76117728|FG000|Received MRX 280 ug/kg/Day|Core Study Period||19|All participants reached the 280 ug/kg/day dose, either through dose escalated or by continuing their previous dose from LUM001-302.|
60001968|NCT02047318|76117728|FG000|COMPLETED|Core Study Period||7||
60001969|NCT02047318|76117728|FG000|NOT COMPLETED|Core Study Period||12||
60001970|NCT02047318|76117728|FG000|STARTED|52-week Follow-up Treatment Period||6||
60001971|NCT02047318|76117728|FG000|COMPLETED|52-week Follow-up Treatment Period||6||
60001972|NCT02047318|76117728|FG000|NOT COMPLETED|52-week Follow-up Treatment Period||0||
60001973|NCT02047318|76117728|FG000|STARTED|Long-term Follow-up Treatment Period||7||
60001974|NCT02047318|76117728|FG000|Received MRX 280 ug/kg/Day|Long-term Follow-up Treatment Period||7||
60001975|NCT02047318|76117728|FG000|Received 420 ug/kg/Day|Long-term Follow-up Treatment Period||5|Participants who received 420ug/kg/day, received 280ug/kg dose in the morning and 140ug/kg in the afternoon during the long term extension period.|
60001976|NCT02047318|76117728|FG000|Received 560 ug/kg/Day|Long-term Follow-up Treatment Period||5|Participants who received 560ug/kg/day, received 280ug/kg dose in the morning and 280ug/kg in the afternoon during the long term extension period.|
60001977|NCT02047318|76117728|FG000|COMPLETED|Long-term Follow-up Treatment Period||6||
60001978|NCT02047318|76117728|FG000|NOT COMPLETED|Long-term Follow-up Treatment Period||1||
60001979|NCT02100124|76117746|FG000|STARTED|Overall Study||329||
60001980|NCT02100124|76117747|FG001|STARTED|Overall Study||329||
60001981|NCT02100124|76117748|FG002|STARTED|Overall Study||326||
60001982|NCT02100124|76117746|FG000|COMPLETED|Overall Study||323||
60001983|NCT02100124|76117747|FG001|COMPLETED|Overall Study||318||
60001984|NCT02100124|76117748|FG002|COMPLETED|Overall Study||323||
60001985|NCT02100124|76117746|FG000|NOT COMPLETED|Overall Study||6||
60001986|NCT02100124|76117747|FG001|NOT COMPLETED|Overall Study||11||
60001987|NCT02100124|76117748|FG002|NOT COMPLETED|Overall Study||3||
60001988|NCT02068768|76117756|FG000|STARTED|Overall Study||13||
60001989|NCT02068768|76117756|FG000|COMPLETED|Overall Study||6||
60001990|NCT02068768|76117756|FG000|NOT COMPLETED|Overall Study||7||
60001991|NCT02046616|76117760|FG000|STARTED|24-Week Treatment Period||133||
60001992|NCT02046616|76117760|FG000|COMPLETED|24-Week Treatment Period||114||
60001993|NCT02046616|76117760|FG000|NOT COMPLETED|24-Week Treatment Period||19||
60001994|NCT02046616|76117760|FG000|STARTED|8-Week FU Period||114||
60001995|NCT02046616|76117760|FG000|COMPLETED|8-Week FU Period||113||
60001996|NCT02046616|76117760|FG000|NOT COMPLETED|8-Week FU Period||1||
60001997|NCT02099344|76117766|FG000|STARTED|Overall Study||1||
60001998|NCT02099344|76117767|FG001|STARTED|Overall Study||0||
60001999|NCT02099344|76117766|FG000|COMPLETED|Overall Study||0||
60002000|NCT02099344|76117767|FG001|COMPLETED|Overall Study||0||
60002001|NCT02099344|76117766|FG000|NOT COMPLETED|Overall Study||1||
60002002|NCT02099344|76117767|FG001|NOT COMPLETED|Overall Study||0||
60002003|NCT02068222|76117775|FG000|STARTED|Overall Study||10||
60002004|NCT02068222|76117775|FG000|COMPLETED|Overall Study||9||
60002005|NCT02068222|76117775|FG000|NOT COMPLETED|Overall Study||1||
60002006|NCT02099110|76117784|FG000|STARTED|Overall Study||250||
60002007|NCT02099110|76117785|FG001|STARTED|Overall Study||248||
60002008|NCT02099110|76117786|FG002|STARTED|Overall Study||247||
60002009|NCT02099110|76117787|FG003|STARTED|Overall Study||243||
60002010|NCT02099110|76117788|FG004|STARTED|Overall Study||245||
60002011|NCT02099110|76117784|FG000|Treated|Overall Study||250||
60002012|NCT02099110|76117785|FG001|Treated|Overall Study||248||
60002013|NCT02099110|76117786|FG002|Treated|Overall Study||247||
60002014|NCT02099110|76117787|FG003|Treated|Overall Study||243||
60002015|NCT02099110|76117788|FG004|Treated|Overall Study||244||
60002016|NCT02099110|76117784|FG000|COMPLETED|Overall Study||226||
60002017|NCT02099110|76117785|FG001|COMPLETED|Overall Study||217||
60002018|NCT02099110|76117786|FG002|COMPLETED|Overall Study||219||
60002019|NCT02099110|76117787|FG003|COMPLETED|Overall Study||221||
60002020|NCT02099110|76117788|FG004|COMPLETED|Overall Study||218||
60002021|NCT02099110|76117784|FG000|NOT COMPLETED|Overall Study||24||
60002022|NCT02099110|76117785|FG001|NOT COMPLETED|Overall Study||31||
60002023|NCT02099110|76117786|FG002|NOT COMPLETED|Overall Study||28||
60002024|NCT02099110|76117787|FG003|NOT COMPLETED|Overall Study||22||
60002025|NCT02099110|76117788|FG004|NOT COMPLETED|Overall Study||27||
60002026|NCT02098876|76117802|FG000|STARTED|Overall Study||45||
60002027|NCT02098876|76117803|FG001|STARTED|Overall Study||41||
60002028|NCT02098876|76117802|FG000|COMPLETED|Overall Study||40||
60002029|NCT02098876|76117803|FG001|COMPLETED|Overall Study||36||
60002030|NCT02098876|76117802|FG000|NOT COMPLETED|Overall Study||5||
60002031|NCT02098876|76117803|FG001|NOT COMPLETED|Overall Study||5||
60002032|NCT01624090|76117813|FG000|STARTED|Overall Study||2||
60002033|NCT01624090|76117814|FG001|STARTED|Overall Study||2||
60002034|NCT01624090|76117815|FG002|STARTED|Overall Study||10||
60002035|NCT01624090|76117816|FG003|STARTED|Overall Study||2||
60002036|NCT01624090|76117813|FG000|COMPLETED|Overall Study||2||
60002037|NCT01624090|76117814|FG001|COMPLETED|Overall Study||0||
60002038|NCT01624090|76117815|FG002|COMPLETED|Overall Study||3||
60002039|NCT01624090|76117816|FG003|COMPLETED|Overall Study||2||
60002040|NCT01624090|76117813|FG000|NOT COMPLETED|Overall Study||0||
60002041|NCT01624090|76117814|FG001|NOT COMPLETED|Overall Study||2||
60002042|NCT01624090|76117815|FG002|NOT COMPLETED|Overall Study||7||
60002043|NCT01624090|76117816|FG003|NOT COMPLETED|Overall Study||0||
60002044|NCT02571777|76117831|FG000|STARTED|Overall Study||619|All patients who were assigned a randomization number|
60002045|NCT02571777|76117832|FG001|STARTED|Overall Study||620|All patients who were assigned a randomization number|
60002046|NCT02571777|76117833|FG002|STARTED|Overall Study||618|All patients who were assigned a randomization number|
60002047|NCT02571777|76117834|FG003|STARTED|Overall Study||617|All patients who were assigned a randomization number|
60002048|NCT02571777|76117835|FG004|STARTED|Overall Study||618|All patients who were assigned a randomization number|
60002049|NCT02571777|76117831|FG000|Full Analysis Set (FAS)|Overall Study||615|All patients in the randomization set who received at least one dose of study medication|
60002050|NCT02571777|76117832|FG001|Full Analysis Set (FAS)|Overall Study||616|All patients in the randomization set who received at least one dose of study medication|
60002051|NCT02571777|76117833|FG002|Full Analysis Set (FAS)|Overall Study||611|All patients in the randomization set who received at least one dose of study medication|
60002052|NCT02571777|76117834|FG003|Full Analysis Set (FAS)|Overall Study||607|All patients in the randomization set who received at least one dose of study medication|
60002053|NCT02571777|76117835|FG004|Full Analysis Set (FAS)|Overall Study||612|All patients in the randomization set who received at least one dose of study medication|
60002054|NCT02571777|76117831|FG000|Safety Set (SAF)|Overall Study||616|All patients who received at least one dose of study medication whether or not being randomized|
60002055|NCT02571777|76117832|FG001|Safety Set (SAF)|Overall Study||617|All patients who received at least one dose of study medication whether or not being randomized|
60002056|NCT02571777|76117833|FG002|Safety Set (SAF)|Overall Study||613|All patients who received at least one dose of study medication whether or not being randomized|
60002057|NCT02571777|76117834|FG003|Safety Set (SAF)|Overall Study||608|All patients who received at least one dose of study medication whether or not being randomized|
60002058|NCT02571777|76117835|FG004|Safety Set (SAF)|Overall Study||618|All patients who received at least one dose of study medication whether or not being randomized|
60002059|NCT02571777|76117831|FG000|COMPLETED|Overall Study||580||
60002060|NCT02571777|76117832|FG001|COMPLETED|Overall Study||582||
60002061|NCT02571777|76117833|FG002|COMPLETED|Overall Study||577||
60002062|NCT02571777|76117834|FG003|COMPLETED|Overall Study||580||
60002063|NCT02571777|76117835|FG004|COMPLETED|Overall Study||582||
60002064|NCT02571777|76117831|FG000|NOT COMPLETED|Overall Study||39||
60002065|NCT02571777|76117832|FG001|NOT COMPLETED|Overall Study||38||
60002066|NCT02571777|76117833|FG002|NOT COMPLETED|Overall Study||41||
60002067|NCT02571777|76117834|FG003|NOT COMPLETED|Overall Study||37||
60002068|NCT02571777|76117835|FG004|NOT COMPLETED|Overall Study||36||
60002069|NCT02571075|76117849|FG000|STARTED|Overall Study||45||
60002070|NCT02571075|76117850|FG001|STARTED|Overall Study||50||
60002071|NCT02571075|76117849|FG000|COMPLETED|Overall Study||25||
60002072|NCT02571075|76117850|FG001|COMPLETED|Overall Study||26||
60002073|NCT02571075|76117849|FG000|NOT COMPLETED|Overall Study||20||
60002074|NCT02571075|76117850|FG001|NOT COMPLETED|Overall Study||24||
60002075|NCT02705105|76117864|FG000|STARTED|Treatment||4||
60002076|NCT02705105|76117865|FG001|STARTED|Treatment||110||
60002077|NCT02705105|76117864|FG000|Subjects Who Were Replaced|Treatment||1||
60002078|NCT02705105|76117865|FG001|Subjects Who Were Replaced|Treatment||0||
60002079|NCT02705105|76117864|FG000|D/C From Treatment Phase|Treatment||4||
60002080|NCT02705105|76117865|FG001|D/C From Treatment Phase|Treatment||107||
60002081|NCT02705105|76117864|FG000|D/C From Follow-Up|Treatment||4||
60002082|NCT02705105|76117865|FG001|D/C From Follow-Up|Treatment||110||
60002083|NCT02705105|76117864|FG000|COMPLETED|Treatment||0||
60002084|NCT02705105|76117865|FG001|COMPLETED|Treatment||1||
60002085|NCT02705105|76117864|FG000|NOT COMPLETED|Treatment||4||
60002086|NCT02705105|76117865|FG001|NOT COMPLETED|Treatment||109||
60002087|NCT02705105|76117864|FG000|STARTED|Follow-Up||4||
60002088|NCT02705105|76117865|FG001|STARTED|Follow-Up||110||
60002089|NCT02705105|76117864|FG000|COMPLETED|Follow-Up||0||
60002090|NCT02705105|76117865|FG001|COMPLETED|Follow-Up||0||
60002091|NCT02705105|76117864|FG000|NOT COMPLETED|Follow-Up||4||
60002092|NCT02705105|76117865|FG001|NOT COMPLETED|Follow-Up||110||
60002093|NCT02097472|76117891|FG000|STARTED|Received Vaccination 1||18||
60002094|NCT02097472|76117892|FG001|STARTED|Received Vaccination 1||18||
60002095|NCT02097472|76117893|FG002|STARTED|Received Vaccination 1||18||
60002096|NCT02097472|76117894|FG003|STARTED|Received Vaccination 1||50||
60002097|NCT02097472|76117895|FG004|STARTED|Received Vaccination 1||50||
60002098|NCT02097472|76117896|FG005|STARTED|Received Vaccination 1||50||
60002099|NCT02097472|76117897|FG006|STARTED|Received Vaccination 1||50||
60002100|NCT02097472|76117898|FG007|STARTED|Received Vaccination 1||50||
60002101|NCT02097472|76117891|FG000|COMPLETED|Received Vaccination 1||18||
60002102|NCT02097472|76117892|FG001|COMPLETED|Received Vaccination 1||18||
60002103|NCT02097472|76117893|FG002|COMPLETED|Received Vaccination 1||18||
60002104|NCT02097472|76117894|FG003|COMPLETED|Received Vaccination 1||50||
60002105|NCT02097472|76117895|FG004|COMPLETED|Received Vaccination 1||50||
60002106|NCT02097472|76117896|FG005|COMPLETED|Received Vaccination 1||50||
60002107|NCT02097472|76117897|FG006|COMPLETED|Received Vaccination 1||50||
60002108|NCT02097472|76117898|FG007|COMPLETED|Received Vaccination 1||50||
60002109|NCT02097472|76117891|FG000|NOT COMPLETED|Received Vaccination 1||0||
60002110|NCT02097472|76117892|FG001|NOT COMPLETED|Received Vaccination 1||0||
60002111|NCT02097472|76117893|FG002|NOT COMPLETED|Received Vaccination 1||0||
60002112|NCT02097472|76117894|FG003|NOT COMPLETED|Received Vaccination 1||0||
60002113|NCT02097472|76117895|FG004|NOT COMPLETED|Received Vaccination 1||0||
60002114|NCT02097472|76117896|FG005|NOT COMPLETED|Received Vaccination 1||0||
60002115|NCT02097472|76117897|FG006|NOT COMPLETED|Received Vaccination 1||0||
60002116|NCT02097472|76117898|FG007|NOT COMPLETED|Received Vaccination 1||0||
60002117|NCT02097472|76117891|FG000|STARTED|Received Vaccination 2||18||
60002118|NCT02097472|76117892|FG001|STARTED|Received Vaccination 2||18||
60002119|NCT02097472|76117893|FG002|STARTED|Received Vaccination 2||18||
60002120|NCT02097472|76117894|FG003|STARTED|Received Vaccination 2||50||
60002121|NCT02097472|76117895|FG004|STARTED|Received Vaccination 2||50||
60002122|NCT02097472|76117896|FG005|STARTED|Received Vaccination 2||50||
60002123|NCT02097472|76117897|FG006|STARTED|Received Vaccination 2||50||
60002124|NCT02097472|76117898|FG007|STARTED|Received Vaccination 2||50||
60002125|NCT02097472|76117891|FG000|COMPLETED|Received Vaccination 2||18||
60002126|NCT02097472|76117892|FG001|COMPLETED|Received Vaccination 2||18||
60002127|NCT02097472|76117893|FG002|COMPLETED|Received Vaccination 2||18||
60002128|NCT02097472|76117894|FG003|COMPLETED|Received Vaccination 2||50||
60002129|NCT02097472|76117895|FG004|COMPLETED|Received Vaccination 2||50||
60002130|NCT02097472|76117896|FG005|COMPLETED|Received Vaccination 2||50||
60002131|NCT02097472|76117897|FG006|COMPLETED|Received Vaccination 2||49||
60002132|NCT02097472|76117898|FG007|COMPLETED|Received Vaccination 2||50||
60002133|NCT02097472|76117891|FG000|NOT COMPLETED|Received Vaccination 2||0||
60002134|NCT02097472|76117892|FG001|NOT COMPLETED|Received Vaccination 2||0||
60002135|NCT02097472|76117893|FG002|NOT COMPLETED|Received Vaccination 2||0||
60002136|NCT02097472|76117894|FG003|NOT COMPLETED|Received Vaccination 2||0||
60002137|NCT02097472|76117895|FG004|NOT COMPLETED|Received Vaccination 2||0||
60002138|NCT02097472|76117896|FG005|NOT COMPLETED|Received Vaccination 2||0||
60002139|NCT02097472|76117897|FG006|NOT COMPLETED|Received Vaccination 2||1||
60002140|NCT02097472|76117898|FG007|NOT COMPLETED|Received Vaccination 2||0||
60002141|NCT02097472|76117891|FG000|STARTED|Assessed for Immunogenicity||18||
60002142|NCT02097472|76117892|FG001|STARTED|Assessed for Immunogenicity||18||
60002143|NCT02097472|76117893|FG002|STARTED|Assessed for Immunogenicity||18||
60002144|NCT02097472|76117894|FG003|STARTED|Assessed for Immunogenicity||50||
60002145|NCT02097472|76117895|FG004|STARTED|Assessed for Immunogenicity||50||
60002146|NCT02097472|76117896|FG005|STARTED|Assessed for Immunogenicity||50||
60002147|NCT02097472|76117897|FG006|STARTED|Assessed for Immunogenicity||49||
60002148|NCT02097472|76117898|FG007|STARTED|Assessed for Immunogenicity||50||
60002149|NCT02097472|76117891|FG000|COMPLETED|Assessed for Immunogenicity||18||
60002150|NCT02097472|76117892|FG001|COMPLETED|Assessed for Immunogenicity||18||
60002151|NCT02097472|76117893|FG002|COMPLETED|Assessed for Immunogenicity||17||
60002152|NCT02097472|76117894|FG003|COMPLETED|Assessed for Immunogenicity||48||
60002153|NCT02097472|76117895|FG004|COMPLETED|Assessed for Immunogenicity||50||
60002154|NCT02097472|76117896|FG005|COMPLETED|Assessed for Immunogenicity||48||
60002155|NCT02097472|76117897|FG006|COMPLETED|Assessed for Immunogenicity||47||
60002156|NCT02097472|76117898|FG007|COMPLETED|Assessed for Immunogenicity||49||
60002157|NCT02097472|76117891|FG000|NOT COMPLETED|Assessed for Immunogenicity||0||
60002158|NCT02097472|76117892|FG001|NOT COMPLETED|Assessed for Immunogenicity||0||
60002159|NCT02097472|76117893|FG002|NOT COMPLETED|Assessed for Immunogenicity||1||
60002160|NCT02097472|76117894|FG003|NOT COMPLETED|Assessed for Immunogenicity||2||
60002161|NCT02097472|76117895|FG004|NOT COMPLETED|Assessed for Immunogenicity||0||
60002162|NCT02097472|76117896|FG005|NOT COMPLETED|Assessed for Immunogenicity||2||
60002163|NCT02097472|76117897|FG006|NOT COMPLETED|Assessed for Immunogenicity||2||
60002164|NCT02097472|76117898|FG007|NOT COMPLETED|Assessed for Immunogenicity||1||
60002165|NCT01623310|76117982|FG000|STARTED|Overall Study||223||
60002166|NCT01623310|76117982|FG000|COMPLETED|Overall Study||144||
60002167|NCT01623310|76117982|FG000|NOT COMPLETED|Overall Study||79||
60002168|NCT02046226|76117986|FG000|STARTED|Overall Study||7||
60002169|NCT02046226|76117986|FG000|COMPLETED|Overall Study||0||
60002170|NCT02046226|76117986|FG000|NOT COMPLETED|Overall Study||7||
60002171|NCT02046148|76117993|FG000|STARTED|Overall Study||49||
60002172|NCT02046148|76117994|FG001|STARTED|Overall Study||26||
60002173|NCT02046148|76117993|FG000|COMPLETED|Overall Study||48||
60002174|NCT02046148|76117994|FG001|COMPLETED|Overall Study||23||
60002175|NCT02046148|76117993|FG000|NOT COMPLETED|Overall Study||1||
60002176|NCT02046148|76117994|FG001|NOT COMPLETED|Overall Study||3||
60002177|NCT02097238|76118000|FG000|STARTED|Overall Study||19||
60002178|NCT02097238|76118000|FG000|COMPLETED|Overall Study||0||
60002179|NCT02097238|76118000|FG000|NOT COMPLETED|Overall Study||19||
60002180|NCT02704091|76118007|FG000|STARTED|Overall Study||430||
60002181|NCT02704091|76118008|FG001|STARTED|Overall Study||423||
60002182|NCT02704091|76118007|FG000|COMPLETED|Overall Study||402||
60002183|NCT02704091|76118008|FG001|COMPLETED|Overall Study||400||
60002184|NCT02704091|76118007|FG000|NOT COMPLETED|Overall Study||28||
60002185|NCT02704091|76118008|FG001|NOT COMPLETED|Overall Study||23||
60002186|NCT02702609|76118016|FG000|STARTED|Overall Study||24||
60002187|NCT02702609|76118017|FG001|STARTED|Overall Study||21||
60002188|NCT02702609|76118016|FG000|Implant Placement|Overall Study||23||
60002189|NCT02702609|76118017|FG001|Implant Placement|Overall Study||21||
60002190|NCT02702609|76118016|FG000|Crown Delivery|Overall Study||16||
60002191|NCT02702609|76118017|FG001|Crown Delivery|Overall Study||18||
60002192|NCT02702609|76118016|FG000|COMPLETED|Overall Study||15||
60002193|NCT02702609|76118017|FG001|COMPLETED|Overall Study||17||
60002194|NCT02702609|76118016|FG000|NOT COMPLETED|Overall Study||9||
60002195|NCT02702609|76118017|FG001|NOT COMPLETED|Overall Study||4||
60002196|NCT02046070|76118026|FG000|STARTED|Overall Study||36||
60002197|NCT02046070|76118027|FG001|STARTED|Overall Study||34||
60002198|NCT02046070|76118028|FG002|STARTED|Overall Study||78||
60002199|NCT02046070|76118026|FG000|COMPLETED|Overall Study||4|Completed=Completed Study Treatment|
60002200|NCT02046070|76118027|FG001|COMPLETED|Overall Study||6|Completed=Completed Study Treatment|
60002201|NCT02046070|76118028|FG002|COMPLETED|Overall Study||8|Completed=Completed Study Treatment|
60002202|NCT02046070|76118026|FG000|NOT COMPLETED|Overall Study||32||
60002203|NCT02046070|76118027|FG001|NOT COMPLETED|Overall Study||28||
60002204|NCT02046070|76118028|FG002|NOT COMPLETED|Overall Study||70||
60002205|NCT01663857|76118040|FG000|STARTED|Overall Study||6||
60002206|NCT01663857|76118041|FG001|STARTED|Overall Study||2||
60002207|NCT01663857|76118042|FG002|STARTED|Overall Study||58||
59518872|NCT03537274|75612754|FG001|NOT COMPLETED|Overall Study||69||
60002208|NCT01663857|76118043|FG003|STARTED|Overall Study||52||
60002209|NCT01663857|76118040|FG000|Received at Least One Dose of Study Drug|Overall Study||6||
60002210|NCT01663857|76118041|FG001|Received at Least One Dose of Study Drug|Overall Study||2||
60002211|NCT01663857|76118042|FG002|Received at Least One Dose of Study Drug|Overall Study||58||
60002212|NCT01663857|76118043|FG003|Received at Least One Dose of Study Drug|Overall Study||52||
60002213|NCT01663857|76118040|FG000|COMPLETED|Overall Study||6||
60002214|NCT01663857|76118041|FG001|COMPLETED|Overall Study||1||
60002215|NCT01663857|76118042|FG002|COMPLETED|Overall Study||48||
60002216|NCT01663857|76118043|FG003|COMPLETED|Overall Study||48||
60002217|NCT01663857|76118040|FG000|NOT COMPLETED|Overall Study||0||
60002218|NCT01663857|76118041|FG001|NOT COMPLETED|Overall Study||1||
60002219|NCT01663857|76118042|FG002|NOT COMPLETED|Overall Study||10||
60002220|NCT01663857|76118043|FG003|NOT COMPLETED|Overall Study||4||
60002221|NCT02094898|76118059|FG000|STARTED|Overall Study||12||
60002222|NCT02094898|76118059|FG000|COMPLETED|Overall Study||7||
60002223|NCT02094898|76118059|FG000|NOT COMPLETED|Overall Study||5||
60002224|NCT02045836|76118067|FG000|STARTED|Overall Study||432||
60002225|NCT02045836|76118068|FG001|STARTED|Overall Study||433||
60002226|NCT02045836|76118067|FG000|COMPLETED|Overall Study||423||
60002227|NCT02045836|76118068|FG001|COMPLETED|Overall Study||419||
60002228|NCT02045836|76118067|FG000|NOT COMPLETED|Overall Study||9||
60002229|NCT02045836|76118068|FG001|NOT COMPLETED|Overall Study||14||
60002230|NCT02569437|76118077|FG000|STARTED|Overall Study||24||
60002231|NCT02569437|76118078|FG001|STARTED|Overall Study||25||
60002232|NCT02569437|76118077|FG000|COMPLETED|Overall Study||12||
60002233|NCT02569437|76118078|FG001|COMPLETED|Overall Study||11||
60002234|NCT02569437|76118077|FG000|NOT COMPLETED|Overall Study||12||
60002235|NCT02569437|76118078|FG001|NOT COMPLETED|Overall Study||14||
60002236|NCT02045212|76118086|FG000|STARTED|Overall Study||13||
60002237|NCT02045212|76118087|FG001|STARTED|Overall Study||9||
60002238|NCT02045212|76118086|FG000|COMPLETED|Overall Study||11||
60002239|NCT02045212|76118087|FG001|COMPLETED|Overall Study||8||
60002240|NCT02045212|76118086|FG000|NOT COMPLETED|Overall Study||2||
60002241|NCT02045212|76118087|FG001|NOT COMPLETED|Overall Study||1||
60002242|NCT02044822|76118097|FG000|STARTED|Overall Study||102||
60002243|NCT02044822|76118097|FG000|COMPLETED|Overall Study|Completed = reached primary efficacy endpoint of progressive disease or death.|9||
60002244|NCT02044822|76118097|FG000|NOT COMPLETED|Overall Study||93||
60002245|NCT02044510|76118103|FG000|STARTED|Overall Study||16||
60002246|NCT02044510|76118104|FG001|STARTED|Overall Study||16||
60002247|NCT02044510|76118103|FG000|COMPLETED|Overall Study||15||
60002248|NCT02044510|76118104|FG001|COMPLETED|Overall Study||14||
60002249|NCT02044510|76118103|FG000|NOT COMPLETED|Overall Study||1||
60002250|NCT02044510|76118104|FG001|NOT COMPLETED|Overall Study||2||
60002251|NCT02067676|76118116|FG000|STARTED|Overall Study||8||
60002252|NCT02067676|76118117|FG001|STARTED|Overall Study||8||
60002253|NCT02067676|76118118|FG002|STARTED|Overall Study||8||
60002254|NCT02067676|76118119|FG003|STARTED|Overall Study||8||
60002255|NCT02067676|76118120|FG004|STARTED|Overall Study||8||
60002256|NCT02067676|76118121|FG005|STARTED|Overall Study||8||
60002257|NCT02067676|76118116|FG000|COMPLETED|Overall Study||7||
60002258|NCT02067676|76118117|FG001|COMPLETED|Overall Study||8||
60002259|NCT02067676|76118118|FG002|COMPLETED|Overall Study||8||
60002260|NCT02067676|76118119|FG003|COMPLETED|Overall Study||8||
60002261|NCT02067676|76118120|FG004|COMPLETED|Overall Study||8||
60002262|NCT02067676|76118121|FG005|COMPLETED|Overall Study||8||
60002263|NCT02067676|76118116|FG000|NOT COMPLETED|Overall Study||1||
60002264|NCT02067676|76118117|FG001|NOT COMPLETED|Overall Study||0||
60002265|NCT02067676|76118118|FG002|NOT COMPLETED|Overall Study||0||
60002266|NCT02067676|76118119|FG003|NOT COMPLETED|Overall Study||0||
60002267|NCT02067676|76118120|FG004|NOT COMPLETED|Overall Study||0||
60002268|NCT02067676|76118121|FG005|NOT COMPLETED|Overall Study||0||
60002269|NCT01623154|76118140|FG000|STARTED|Overall Study||99||
60002270|NCT01623154|76118140|FG000|Available for Analysis|Overall Study||95||
60002271|NCT01623154|76118140|FG000|COMPLETED|Overall Study||95||
60002272|NCT01623154|76118140|FG000|NOT COMPLETED|Overall Study||4||
60002273|NCT00702689|76118146|FG000|STARTED|Overall Study||20||
60002274|NCT00702689|76118146|FG000|COMPLETED|Overall Study||14||
60002275|NCT00702689|76118146|FG000|NOT COMPLETED|Overall Study||6||
60002276|NCT02065570|76118152|FG000|STARTED|Induction Study||206||
60002277|NCT02065570|76118153|FG001|STARTED|Induction Study||308||
60002278|NCT02065570|76118154|FG002|STARTED|Induction Study||0||
60002279|NCT02065570|76118155|FG003|STARTED|Induction Study||0||
60002280|NCT02065570|76118152|FG000|COMPLETED|Induction Study||192||
60002281|NCT02065570|76118153|FG001|COMPLETED|Induction Study||287||
60002282|NCT02065570|76118154|FG002|COMPLETED|Induction Study||0||
60002283|NCT02065570|76118155|FG003|COMPLETED|Induction Study||0||
60002284|NCT02065570|76118152|FG000|NOT COMPLETED|Induction Study||14||
60002285|NCT02065570|76118153|FG001|NOT COMPLETED|Induction Study||21||
60002286|NCT02065570|76118154|FG002|NOT COMPLETED|Induction Study||0||
60002287|NCT02065570|76118155|FG003|NOT COMPLETED|Induction Study||0||
60002288|NCT02065570|76118152|FG000|STARTED|Maintenance Study||0||
60002289|NCT02065570|76118153|FG001|STARTED|Maintenance Study||0||
60002290|NCT02065570|76118154|FG002|STARTED|Maintenance Study||109||
60002291|NCT02065570|76118155|FG003|STARTED|Maintenance Study||109||
60002292|NCT02065570|76118152|FG000|COMPLETED|Maintenance Study||0||
60002293|NCT02065570|76118153|FG001|COMPLETED|Maintenance Study||0||
60002294|NCT02065570|76118154|FG002|COMPLETED|Maintenance Study||87||
60002295|NCT02065570|76118155|FG003|COMPLETED|Maintenance Study||90||
60002296|NCT02065570|76118152|FG000|NOT COMPLETED|Maintenance Study||0||
60002297|NCT02065570|76118153|FG001|NOT COMPLETED|Maintenance Study||0||
60002298|NCT02065570|76118154|FG002|NOT COMPLETED|Maintenance Study||22||
60002299|NCT02065570|76118155|FG003|NOT COMPLETED|Maintenance Study||19||
60002300|NCT02566005|76118168|FG000|STARTED|Overall Study||100||
60002301|NCT02566005|76118169|FG001|STARTED|Overall Study||100||
59872960|NCT03131440|75997087|FG001|COMPLETED|Overall Study||6|Completed the 24 week questionnaires OR had valid data on the accelerometer at 24 weeks|
59872961|NCT03131440|75997088|FG002|COMPLETED|Overall Study||8|Completed the 24 week questionnaires OR had valid data on the accelerometer at 24 weeks|
60002302|NCT02566005|76118168|FG000|COMPLETED|Overall Study||92||
60002303|NCT02566005|76118169|FG001|COMPLETED|Overall Study||94||
60002304|NCT02566005|76118168|FG000|NOT COMPLETED|Overall Study||8||
60002305|NCT02566005|76118169|FG001|NOT COMPLETED|Overall Study||6||
60002306|NCT04757805|76118175|FG000|STARTED|Overall Study||50||
60002307|NCT04757805|76118175|FG000|COMPLETED|Overall Study||50||
60002308|NCT04757805|76118175|FG000|NOT COMPLETED|Overall Study||0||
60002309|NCT02065336|76118187|FG000|STARTED|Main Study||6||
60002310|NCT02065336|76118188|FG001|STARTED|Main Study||6||
60002311|NCT02065336|76118189|FG002|STARTED|Main Study||6||
60002312|NCT02065336|76118190|FG003|STARTED|Main Study||6||
60002313|NCT02065336|76118191|FG004|STARTED|Main Study||6||
60002314|NCT02065336|76118192|FG005|STARTED|Main Study||6||
60002315|NCT02065336|76118193|FG006|STARTED|Main Study||12||
60002316|NCT02065336|76118194|FG007|STARTED|Main Study||10||
60002317|NCT02065336|76118195|FG008|STARTED|Main Study||0||
60002318|NCT02065336|76118196|FG009|STARTED|Main Study||0||
60002319|NCT02065336|76118187|FG000|COMPLETED|Main Study||6||
60002320|NCT02065336|76118188|FG001|COMPLETED|Main Study||6||
60002321|NCT02065336|76118189|FG002|COMPLETED|Main Study||6||
60002322|NCT02065336|76118190|FG003|COMPLETED|Main Study||6||
60002323|NCT02065336|76118191|FG004|COMPLETED|Main Study||6||
60002324|NCT02065336|76118192|FG005|COMPLETED|Main Study||6||
60002325|NCT02065336|76118193|FG006|COMPLETED|Main Study||12||
60002326|NCT02065336|76118194|FG007|COMPLETED|Main Study||10||
59872962|NCT03131440|75997089|FG003|COMPLETED|Overall Study||8|Completed the 24 week questionnaires OR had valid data on the accelerometer at 24 weeks|
59872963|NCT03131440|75997090|FG004|COMPLETED|Overall Study||8|Completed the 24 week questionnaires OR had valid data on the accelerometer at 24 weeks|
59872964|NCT03131440|75997091|FG005|COMPLETED|Overall Study||8|Completed the 24 week questionnaires OR had valid data on the accelerometer at 24 weeks|
59872965|NCT03131440|75997092|FG006|COMPLETED|Overall Study||9|Completed the 24 week questionnaires OR had valid data on the accelerometer at 24 weeks|
59872966|NCT03131440|75997093|FG007|COMPLETED|Overall Study||8|Completed the 24 week questionnaires OR had valid data on the accelerometer at 24 weeks|
59872967|NCT03131440|75997094|FG008|COMPLETED|Overall Study||8|Completed the 24 week questionnaires OR had valid data on the accelerometer at 24 weeks|
59872968|NCT03131440|75997095|FG009|COMPLETED|Overall Study||7|Completed the 24 week questionnaires OR had valid data on the accelerometer at 24 weeks|
59872969|NCT03131440|75997096|FG010|COMPLETED|Overall Study||8|Completed the 24 week questionnaires OR had valid data on the accelerometer at 24 weeks|
60002327|NCT02065336|76118195|FG008|COMPLETED|Main Study||0||
60002328|NCT02065336|76118196|FG009|COMPLETED|Main Study||0||
60002329|NCT02065336|76118187|FG000|NOT COMPLETED|Main Study||0||
60002330|NCT02065336|76118188|FG001|NOT COMPLETED|Main Study||0||
60002331|NCT02065336|76118189|FG002|NOT COMPLETED|Main Study||0||
60002332|NCT02065336|76118190|FG003|NOT COMPLETED|Main Study||0||
60002333|NCT02065336|76118191|FG004|NOT COMPLETED|Main Study||0||
60002334|NCT02065336|76118192|FG005|NOT COMPLETED|Main Study||0||
60002335|NCT02065336|76118193|FG006|NOT COMPLETED|Main Study||0||
60002336|NCT02065336|76118194|FG007|NOT COMPLETED|Main Study||0||
60002337|NCT02065336|76118195|FG008|NOT COMPLETED|Main Study||0||
60002338|NCT02065336|76118196|FG009|NOT COMPLETED|Main Study||0||
60002339|NCT02065336|76118187|FG000|STARTED|Extension Phase||0||
60002340|NCT02065336|76118188|FG001|STARTED|Extension Phase||0||
60002341|NCT02065336|76118189|FG002|STARTED|Extension Phase||0||
60002342|NCT02065336|76118190|FG003|STARTED|Extension Phase||0||
60002343|NCT02065336|76118191|FG004|STARTED|Extension Phase||0||
60002344|NCT02065336|76118192|FG005|STARTED|Extension Phase||0||
60002345|NCT02065336|76118193|FG006|STARTED|Extension Phase||0||
60002346|NCT02065336|76118194|FG007|STARTED|Extension Phase||0||
60002347|NCT02065336|76118195|FG008|STARTED|Extension Phase||2||
60002348|NCT02065336|76118196|FG009|STARTED|Extension Phase||8||
60002349|NCT02065336|76118187|FG000|COMPLETED|Extension Phase||0||
60002350|NCT02065336|76118188|FG001|COMPLETED|Extension Phase||0||
60002351|NCT02065336|76118189|FG002|COMPLETED|Extension Phase||0||
60002352|NCT02065336|76118190|FG003|COMPLETED|Extension Phase||0||
60002353|NCT02065336|76118191|FG004|COMPLETED|Extension Phase||0||
60002354|NCT02065336|76118192|FG005|COMPLETED|Extension Phase||0||
60002355|NCT02065336|76118193|FG006|COMPLETED|Extension Phase||0||
60002356|NCT02065336|76118194|FG007|COMPLETED|Extension Phase||0||
60002357|NCT02065336|76118195|FG008|COMPLETED|Extension Phase||0||
60002358|NCT02065336|76118196|FG009|COMPLETED|Extension Phase||0||
60002359|NCT02065336|76118187|FG000|NOT COMPLETED|Extension Phase||0||
60002360|NCT02065336|76118188|FG001|NOT COMPLETED|Extension Phase||0||
60002361|NCT02065336|76118189|FG002|NOT COMPLETED|Extension Phase||0||
60134404|NCT00711711|76257569|FG000|Seventh Postsurgical Day|Overall Study||29||
60134405|NCT00711711|76257570|FG001|Seventh Postsurgical Day|Overall Study||27||
60134406|NCT00711711|76257569|FG000|COMPLETED|Overall Study||29||
60134407|NCT00711711|76257570|FG001|COMPLETED|Overall Study||24||
60134408|NCT00711711|76257569|FG000|NOT COMPLETED|Overall Study||1||
60134409|NCT00711711|76257570|FG001|NOT COMPLETED|Overall Study||6||
60134410|NCT04000399|76257580|FG000|STARTED|Overall Study||38||
60134411|NCT04000399|76257581|FG001|STARTED|Overall Study||5||
60134412|NCT04000399|76257580|FG000|COMPLETED|Overall Study||38||
60134413|NCT04000399|76257581|FG001|COMPLETED|Overall Study||5||
60134414|NCT04000399|76257580|FG000|NOT COMPLETED|Overall Study||0||
60134415|NCT04000399|76257581|FG001|NOT COMPLETED|Overall Study||0||
60134416|NCT01677936|76257592|FG000|STARTED|Overall Study|31 randomized to raisins; 4 excluded due to lack of post-baseline evaluation; 27 = full dataset|31||
60134417|NCT01677936|76257593|FG001|STARTED|Overall Study|20 randomized to snacks; 1 excluded due to lack of post-baseline evaluation; 19 = full dataset|20||
60134418|NCT01677936|76257592|FG000|COMPLETED|Overall Study|Full analysis dataset completers|22||
60134419|NCT01677936|76257593|FG001|COMPLETED|Overall Study|Full analysis dataset completers|15||
60134420|NCT01677936|76257592|FG000|NOT COMPLETED|Overall Study||9||
60134421|NCT01677936|76257593|FG001|NOT COMPLETED|Overall Study||5||
60134422|NCT00727857|76257602|FG000|STARTED|Overall Study||201||
60134423|NCT00727857|76257603|FG001|STARTED|Overall Study||189||
60134424|NCT00727857|76257604|FG002|STARTED|Overall Study||210||
60134425|NCT00727857|76257602|FG000|COMPLETED|Overall Study||157||
60134426|NCT00727857|76257603|FG001|COMPLETED|Overall Study||125||
60134427|NCT00727857|76257604|FG002|COMPLETED|Overall Study||142||
60134428|NCT00727857|76257602|FG000|NOT COMPLETED|Overall Study||44||
60134429|NCT00727857|76257603|FG001|NOT COMPLETED|Overall Study||64||
60134430|NCT00727857|76257604|FG002|NOT COMPLETED|Overall Study||68||
60134431|NCT00711867|76257615|FG000|STARTED|Overall Study||30||
60134432|NCT00711867|76257616|FG001|STARTED|Overall Study||25||
60134433|NCT00711867|76257615|FG000|COMPLETED|Overall Study|2 received additional warming. 3 missing primary measure.|25||
60134434|NCT00711867|76257616|FG001|COMPLETED|Overall Study|3 received additional warming. 1 missing primary measure.|21||
60134435|NCT00711867|76257615|FG000|NOT COMPLETED|Overall Study||5||
60134436|NCT00711867|76257616|FG001|NOT COMPLETED|Overall Study||4||
60134437|NCT01525550|76257624|FG000|STARTED|Overall Study||61||
60134438|NCT01525550|76257625|FG001|STARTED|Overall Study||45||
60134439|NCT01525550|76257624|FG000|COMPLETED|Overall Study||0||
60134440|NCT01525550|76257625|FG001|COMPLETED|Overall Study||0||
60134441|NCT01525550|76257624|FG000|NOT COMPLETED|Overall Study||61||
60134442|NCT01525550|76257625|FG001|NOT COMPLETED|Overall Study||45||
60134443|NCT04699032|76257633|FG000|STARTED|Overall Study||8||
60134444|NCT04699032|76257634|FG001|STARTED|Overall Study||8||
60134445|NCT04699032|76257633|FG000|COMPLETED|Overall Study||8||
60134446|NCT04699032|76257634|FG001|COMPLETED|Overall Study||8||
60134447|NCT04699032|76257633|FG000|NOT COMPLETED|Overall Study||0||
60134448|NCT04699032|76257634|FG001|NOT COMPLETED|Overall Study||0||
60134449|NCT00712179|76257640|FG000|STARTED|Overall Study||49||
60134450|NCT00712179|76257640|FG000|COMPLETED|Overall Study|Data from 4 subjects was excluded due to noise in recorded EMG signal, so 33 subjects were analysed.|37||
60134451|NCT00712179|76257640|FG000|NOT COMPLETED|Overall Study||12||
60134452|NCT00211237|76257646|FG000|STARTED|Baseline||70||
60134453|NCT00211237|76257647|FG001|STARTED|Baseline||64||
60134454|NCT00211237|76257648|FG002|STARTED|Baseline||0||
60134455|NCT00211237|76257646|FG000|COMPLETED|Baseline||68||
60134456|NCT00211237|76257647|FG001|COMPLETED|Baseline||61||
60134457|NCT00211237|76257648|FG002|COMPLETED|Baseline||0||
60134458|NCT00211237|76257646|FG000|NOT COMPLETED|Baseline||2||
60134459|NCT00211237|76257647|FG001|NOT COMPLETED|Baseline||3||
60134460|NCT00211237|76257648|FG002|NOT COMPLETED|Baseline||0||
60134461|NCT00211237|76257646|FG000|STARTED|1 Month||68||
60134462|NCT00211237|76257647|FG001|STARTED|1 Month||61||
60134463|NCT00211237|76257648|FG002|STARTED|1 Month||0||
60134464|NCT00211237|76257646|FG000|COMPLETED|1 Month||65||
60134465|NCT00211237|76257647|FG001|COMPLETED|1 Month||52||
60134466|NCT00211237|76257648|FG002|COMPLETED|1 Month||0||
60134467|NCT00211237|76257646|FG000|NOT COMPLETED|1 Month||3||
60134468|NCT00211237|76257647|FG001|NOT COMPLETED|1 Month||9||
60134469|NCT00211237|76257648|FG002|NOT COMPLETED|1 Month||0||
60134470|NCT00211237|76257646|FG000|STARTED|3 Months||65||
60134471|NCT00211237|76257647|FG001|STARTED|3 Months|34 patients crossed over to Balloon Kyphoplasty.|18||
60134472|NCT00211237|76257648|FG002|STARTED|3 Months||34||
60134473|NCT00211237|76257646|FG000|COMPLETED|3 Months||57||
60134474|NCT00211237|76257647|FG001|COMPLETED|3 Months||14||
60134475|NCT00211237|76257648|FG002|COMPLETED|3 Months||33||
60134476|NCT00211237|76257646|FG000|NOT COMPLETED|3 Months||8||
60134477|NCT00211237|76257647|FG001|NOT COMPLETED|3 Months||4||
60134478|NCT00211237|76257648|FG002|NOT COMPLETED|3 Months||1||
60134479|NCT00211237|76257646|FG000|STARTED|6 Months||57||
60134480|NCT00211237|76257647|FG001|STARTED|6 Months|3 patients crossed over Balloon Kyphoplasty|11||
60134481|NCT00211237|76257648|FG002|STARTED|6 Months||36||
60134482|NCT00211237|76257646|FG000|COMPLETED|6 Months||49||
60134483|NCT00211237|76257647|FG001|COMPLETED|6 Months||9||
60134484|NCT00211237|76257648|FG002|COMPLETED|6 Months||33||
60134485|NCT00211237|76257646|FG000|NOT COMPLETED|6 Months||8||
60134486|NCT00211237|76257647|FG001|NOT COMPLETED|6 Months||2||
60134487|NCT00211237|76257648|FG002|NOT COMPLETED|6 Months||3||
60134488|NCT00211237|76257646|FG000|STARTED|12 Months||49||
60134489|NCT00211237|76257647|FG001|STARTED|12 Months|1 patient crossed over Balloon Kyphoplasty|8||
60134490|NCT00211237|76257648|FG002|STARTED|12 Months||34||
60134491|NCT00211237|76257646|FG000|COMPLETED|12 Months||40||
60134492|NCT00211237|76257647|FG001|COMPLETED|12 Months||6||
60134493|NCT00211237|76257648|FG002|COMPLETED|12 Months||28||
60134494|NCT00211237|76257646|FG000|NOT COMPLETED|12 Months||9||
60134495|NCT00211237|76257647|FG001|NOT COMPLETED|12 Months||2||
60134496|NCT00211237|76257648|FG002|NOT COMPLETED|12 Months||6||
60134497|NCT01489358|76257668|FG000|STARTED|Overall Study||5||
60134498|NCT01489358|76257669|FG001|STARTED|Overall Study||10||
60134499|NCT01489358|76257670|FG002|STARTED|Overall Study||10||
60134500|NCT01489358|76257668|FG000|COMPLETED|Overall Study||5||
60134501|NCT01489358|76257669|FG001|COMPLETED|Overall Study||10||
60134502|NCT01489358|76257670|FG002|COMPLETED|Overall Study||8||
60134503|NCT01489358|76257668|FG000|NOT COMPLETED|Overall Study||0||
60134504|NCT01489358|76257669|FG001|NOT COMPLETED|Overall Study||0||
60134505|NCT01489358|76257670|FG002|NOT COMPLETED|Overall Study||2||
60134506|NCT01525238|76257681|FG000|STARTED|Overall Study||8||
60134507|NCT01525238|76257682|FG001|STARTED|Overall Study||8||
60134508|NCT01525238|76257683|FG002|STARTED|Overall Study||8||
60134509|NCT01525238|76257681|FG000|COMPLETED|Overall Study||7||
60134510|NCT01525238|76257682|FG001|COMPLETED|Overall Study||8||
60134511|NCT01525238|76257683|FG002|COMPLETED|Overall Study||8||
60134512|NCT01525238|76257681|FG000|NOT COMPLETED|Overall Study||1||
60134513|NCT01525238|76257682|FG001|NOT COMPLETED|Overall Study||0||
60134514|NCT01525238|76257683|FG002|NOT COMPLETED|Overall Study||0||
60134515|NCT00717405|76257691|FG000|STARTED|Overall Study||52||
60134516|NCT00717405|76257691|FG000|COMPLETED|Overall Study||52||
60134517|NCT00717405|76257691|FG000|NOT COMPLETED|Overall Study||0||
60134518|NCT00717873|76257697|FG000|STARTED|Overall Study||46||
60134519|NCT00717873|76257698|FG001|STARTED|Overall Study||59||
59602001|NCT00402883|75712219|FG000|NOT COMPLETED|Consolidation Therapy||0||
59602002|NCT00402883|75712219|FG000|STARTED|Maintenance Therapy||5||
59602003|NCT00402883|75712219|FG000|COMPLETED|Maintenance Therapy|All 5 patients received limited maintenance therapy due to early trial closure.|5||
59602004|NCT00402883|75712219|FG000|NOT COMPLETED|Maintenance Therapy||0||
59602005|NCT00728845|75712226|FG000|STARTED|Overall Study||8||
59602006|NCT00728845|75712227|FG001|STARTED|Overall Study||0||
59602007|NCT00728845|75712226|FG000|COMPLETED|Overall Study||8||
59602008|NCT00728845|75712227|FG001|COMPLETED|Overall Study||0||
60134520|NCT00717873|76257697|FG000|COMPLETED|Overall Study||46||
60134521|NCT00717873|76257698|FG001|COMPLETED|Overall Study||59||
60134522|NCT00717873|76257697|FG000|NOT COMPLETED|Overall Study||0||
60134523|NCT00717873|76257698|FG001|NOT COMPLETED|Overall Study||0||
60134524|NCT01525082|76257704|FG000|STARTED|Overall Study||20||
60134525|NCT01525082|76257704|FG000|COMPLETED|Overall Study||19|Completion defined as assessment for clinical response after 3 cycles of treatment.|
60134526|NCT01525082|76257704|FG000|NOT COMPLETED|Overall Study||1||
60134527|NCT01488578|76257711|FG000|STARTED|Overall Study||11157||
60134528|NCT01488578|76257711|FG000|COMPLETED|Overall Study||9321||
60134529|NCT01488578|76257711|FG000|NOT COMPLETED|Overall Study||1836||
60134530|NCT00720369|76257743|FG000|STARTED|Overall Study||11||
60134531|NCT00720369|76257744|FG001|STARTED|Overall Study||8||
60134532|NCT00720369|76257743|FG000|COMPLETED|Overall Study|one subject discontinued due to an adverse event.|10||
60134533|NCT00720369|76257744|FG001|COMPLETED|Overall Study||8||
60134534|NCT00720369|76257743|FG000|NOT COMPLETED|Overall Study||1||
60134535|NCT00720369|76257744|FG001|NOT COMPLETED|Overall Study||0||
60134536|NCT01524770|76257752|FG000|STARTED|First Intervention||26||
60134537|NCT01524770|76257753|FG001|STARTED|First Intervention||24||
60134538|NCT01524770|76257752|FG000|Received at Least 1 Dose of Study Drug|First Intervention||26||
60134539|NCT01524770|76257753|FG001|Received at Least 1 Dose of Study Drug|First Intervention||24||
60134540|NCT01524770|76257752|FG000|COMPLETED|First Intervention||23||
60134541|NCT01524770|76257753|FG001|COMPLETED|First Intervention||23||
60134542|NCT01524770|76257752|FG000|NOT COMPLETED|First Intervention||3||
60134543|NCT01524770|76257753|FG001|NOT COMPLETED|First Intervention||1||
60134544|NCT01524770|76257752|FG000|STARTED|Washout Period of at Least 28 Days||23||
60134545|NCT01524770|76257753|FG001|STARTED|Washout Period of at Least 28 Days||23||
60134546|NCT01524770|76257752|FG000|COMPLETED|Washout Period of at Least 28 Days||23||
60134547|NCT01524770|76257753|FG001|COMPLETED|Washout Period of at Least 28 Days||23||
60134548|NCT01524770|76257752|FG000|NOT COMPLETED|Washout Period of at Least 28 Days||0||
60134549|NCT01524770|76257753|FG001|NOT COMPLETED|Washout Period of at Least 28 Days||0||
60134550|NCT01524770|76257752|FG000|STARTED|Second Intervention||23||
60134551|NCT01524770|76257753|FG001|STARTED|Second Intervention||23||
60134552|NCT01524770|76257752|FG000|COMPLETED|Second Intervention||23||
60134553|NCT01524770|76257753|FG001|COMPLETED|Second Intervention||23||
60134554|NCT01524770|76257752|FG000|NOT COMPLETED|Second Intervention||0||
60134555|NCT01524770|76257753|FG001|NOT COMPLETED|Second Intervention||0||
60134556|NCT05387889|76257761|FG000|STARTED|Overall Study||9||
60134557|NCT05387889|76257762|FG001|STARTED|Overall Study||6||
60134558|NCT05387889|76257761|FG000|COMPLETED|Overall Study||9||
60134559|NCT05387889|76257762|FG001|COMPLETED|Overall Study||6||
60134560|NCT05387889|76257761|FG000|NOT COMPLETED|Overall Study||0||
60134561|NCT05387889|76257762|FG001|NOT COMPLETED|Overall Study||0||
60134562|NCT05253755|76257768|FG000|STARTED|Overall Study||10||20
60134563|NCT05253755|76257768|FG000|COMPLETED|Overall Study||9||18
60134564|NCT05253755|76257768|FG000|NOT COMPLETED|Overall Study||1||2
60134565|NCT05166876|76257777|FG000|STARTED|Overall Study||7||
60134566|NCT05166876|76257778|FG001|STARTED|Overall Study||6||
60134567|NCT05166876|76257779|FG002|STARTED|Overall Study||13||
60134568|NCT05166876|76257777|FG000|COMPLETED|Overall Study||6||
60134569|NCT05166876|76257778|FG001|COMPLETED|Overall Study||6||
60134570|NCT05166876|76257779|FG002|COMPLETED|Overall Study||13||
60134571|NCT05166876|76257777|FG000|NOT COMPLETED|Overall Study||1||
60134572|NCT05166876|76257778|FG001|NOT COMPLETED|Overall Study||0||
60134573|NCT05166876|76257779|FG002|NOT COMPLETED|Overall Study||0||
60134574|NCT05096156|76257787|FG000|STARTED|Overall Study||30||
60134575|NCT05096156|76257787|FG000|COMPLETED|Overall Study||30||
60134576|NCT05096156|76257787|FG000|NOT COMPLETED|Overall Study||0||
60134577|NCT05065619|76257793|FG000|STARTED|Up to Day 42||102||
60134578|NCT05065619|76257794|FG001|STARTED|Up to Day 42||26||
60134579|NCT05065619|76257793|FG000|COMPLETED|Up to Day 42||100||
60134580|NCT05065619|76257794|FG001|COMPLETED|Up to Day 42||26||
60134581|NCT05065619|76257793|FG000|NOT COMPLETED|Up to Day 42||2||
60134582|NCT05065619|76257794|FG001|NOT COMPLETED|Up to Day 42||0||
60134583|NCT05065619|76257793|FG000|STARTED|After Day 43||100||
60134584|NCT05065619|76257794|FG001|STARTED|After Day 43||26||
60134585|NCT05065619|76257793|FG000|COMPLETED|After Day 43||0||
60134586|NCT05065619|76257794|FG001|COMPLETED|After Day 43||0||
60134587|NCT05065619|76257793|FG000|NOT COMPLETED|After Day 43||100||
60134588|NCT05065619|76257794|FG001|NOT COMPLETED|After Day 43||26||
60134589|NCT04987372|76257802|FG000|STARTED|Overall Study||50||
60134590|NCT04987372|76257803|FG001|STARTED|Overall Study||50||
60134591|NCT04987372|76257802|FG000|COMPLETED|Overall Study||50||
60134592|NCT04987372|76257803|FG001|COMPLETED|Overall Study||46||
60134593|NCT04987372|76257802|FG000|NOT COMPLETED|Overall Study||0||
60134594|NCT04987372|76257803|FG001|NOT COMPLETED|Overall Study||4||
60134595|NCT04802187|76257812|FG000|STARTED|Overall Study|No participants were enrolled. 6 CHCs were in the primary analysis and completed the control and intervention milestones. Primary outcome was number of COVID tests. 186,171 Testing Intervention Strategy tests and 109,911 Usual Care tests collected.|||6
60134596|NCT04802187|76257812|FG000|COMPLETED|Overall Study|No participants were enrolled. 6 CHCs were in the primary analysis and completed the control and intervention milestones. Primary outcome was number of COVID tests. 186,171 Testing Intervention Strategy tests and 109,911 Usual Care tests collected.|||6
60134597|NCT04802187|76257812|FG000|NOT COMPLETED|Overall Study||||0
60134598|NCT04581200|76257820|FG000|STARTED|Overall Study||29||
60134599|NCT04581200|76257821|FG001|STARTED|Overall Study||27||
60134600|NCT04581200|76257820|FG000|COMPLETED|Overall Study||23||
60134601|NCT04581200|76257821|FG001|COMPLETED|Overall Study||22||
60134602|NCT04581200|76257820|FG000|NOT COMPLETED|Overall Study||6||
60134603|NCT04581200|76257821|FG001|NOT COMPLETED|Overall Study||5||
60134604|NCT04576455|76257830|FG000|STARTED|Overall Study||151||
60134605|NCT04576455|76257831|FG001|STARTED|Overall Study||152||
60134606|NCT04576455|76257830|FG000|Safety-Evaluable Population|Overall Study|1 participant randomized to the giredestrant arm received fulvestrant in error thus was counted in PCET arm for safety analysis.|150|Safety-Evaluable Population included all participants who received at least one dose of the study treatment (giredestrant or PCET).|
60134607|NCT04576455|76257831|FG001|Safety-Evaluable Population|Overall Study|1 participant randomized to the giredestrant arm received fulvestrant in error thus counted in this arm for safety analysis and 1 participant randomized to this arm discontinued the study before receiving any study drug.|152|Safety-Evaluable Population included all participants who received at least one dose of the study treatment (giredestrant or PCET).|
60134608|NCT04576455|76257830|FG000|COMPLETED|Overall Study||0||
60134609|NCT04576455|76257831|FG001|COMPLETED|Overall Study||0||
60134610|NCT04576455|76257830|FG000|NOT COMPLETED|Overall Study||151||
60134611|NCT04576455|76257831|FG001|NOT COMPLETED|Overall Study||152||
60134612|NCT04503616|76257838|FG000|STARTED|Overall Study||46||
60134613|NCT04503616|76257838|FG000|COMPLETED|Overall Study||46||
60134614|NCT04503616|76257838|FG000|NOT COMPLETED|Overall Study||0||
60134615|NCT04481243|76257842|FG000|STARTED|Overall Study||29||
60134616|NCT04481243|76257842|FG000|COMPLETED|Overall Study||25||
60134617|NCT04481243|76257842|FG000|NOT COMPLETED|Overall Study||4||
60134618|NCT04468230|76257846|FG000|STARTED|Overall Study||4||
60134619|NCT04468230|76257846|FG000|COMPLETED|Overall Study||2||
60134620|NCT04468230|76257846|FG000|NOT COMPLETED|Overall Study||2||
60134621|NCT04457362|76257850|FG000|STARTED|Overall Study||20||
60134622|NCT04457362|76257850|FG000|COMPLETED|Overall Study||20||
60134623|NCT04457362|76257850|FG000|NOT COMPLETED|Overall Study||0||
60134624|NCT04446299|76257856|FG000|STARTED|Overall Study||259||
60134625|NCT04446299|76257857|FG001|STARTED|Overall Study||260||
60134626|NCT04446299|76257856|FG000|COMPLETED|Overall Study||220||
60134627|NCT04446299|76257857|FG001|COMPLETED|Overall Study||230||
60134628|NCT04446299|76257856|FG000|NOT COMPLETED|Overall Study||39||
60134629|NCT04446299|76257857|FG001|NOT COMPLETED|Overall Study||30||
60134630|NCT04439175|76257863|FG000|STARTED|Overall Study||70||
60134631|NCT04439175|76257863|FG000|Started Protocol Therapy|Overall Study||66||
60134632|NCT04439175|76257863|FG000|Eligible and Started Protocol Therapy|Overall Study||61|Four patients did not initiate protocol therapy and five patients initiated therapy but were subsequently found to be ineligible by central review. This is the primary analysis population.|
60134633|NCT04439175|76257863|FG000|COMPLETED|Overall Study||0|Treatment continued until disease progression or intolerability.|
60134634|NCT04439175|76257863|FG000|NOT COMPLETED|Overall Study||70||
60134635|NCT04439136|76257867|FG000|STARTED|Overall Study||40||
60134636|NCT04439136|76257867|FG000|Eligible|Overall Study||39||
60134637|NCT04439136|76257867|FG000|Eligible and Started Protocol Therapy|Overall Study||37|One patient ineligible, 2 patients never started treatment. This is the primary analysis population.|
60134638|NCT04439136|76257867|FG000|Reported Adverse Events Data|Overall Study||37|Excluding two who did not receive afatinib treatment and one who was not assessed for toxicity|
60134639|NCT04439136|76257867|FG000|COMPLETED|Overall Study||0|Treatment continued until disease progression or intolerability.|
60134640|NCT04439136|76257867|FG000|NOT COMPLETED|Overall Study||40||
60134641|NCT04208321|76257878|FG000|STARTED|Overall Study||6||
60134642|NCT04208321|76257879|FG001|STARTED|Overall Study||6||
60134643|NCT04208321|76257880|FG002|STARTED|Overall Study||6||
60134644|NCT04208321|76257881|FG003|STARTED|Overall Study||6||
60134645|NCT04208321|76257882|FG004|STARTED|Overall Study||6||
60134646|NCT04208321|76257883|FG005|STARTED|Overall Study||6||
60134647|NCT04208321|76257884|FG006|STARTED|Overall Study||12||
60134648|NCT04208321|76257878|FG000|COMPLETED|Overall Study||6||
60134649|NCT04208321|76257879|FG001|COMPLETED|Overall Study||6||
60134650|NCT04208321|76257880|FG002|COMPLETED|Overall Study||6||
60134651|NCT04208321|76257881|FG003|COMPLETED|Overall Study||6||
60134652|NCT04208321|76257882|FG004|COMPLETED|Overall Study||6||
60134653|NCT04208321|76257883|FG005|COMPLETED|Overall Study||6||
60134654|NCT04208321|76257884|FG006|COMPLETED|Overall Study||12||
60134655|NCT04208321|76257878|FG000|NOT COMPLETED|Overall Study||0||
60134656|NCT04208321|76257879|FG001|NOT COMPLETED|Overall Study||0||
60134657|NCT04208321|76257880|FG002|NOT COMPLETED|Overall Study||0||
60134658|NCT04208321|76257881|FG003|NOT COMPLETED|Overall Study||0||
60134659|NCT04208321|76257882|FG004|NOT COMPLETED|Overall Study||0||
60134660|NCT04208321|76257883|FG005|NOT COMPLETED|Overall Study||0||
60134661|NCT04208321|76257884|FG006|NOT COMPLETED|Overall Study||0||
60134662|NCT04204902|76257900|FG000|STARTED|Treatment Period 1 (Day 1)||9||
60134663|NCT04204902|76257901|FG001|STARTED|Treatment Period 1 (Day 1)||9||
60134664|NCT04204902|76257900|FG000|COMPLETED|Treatment Period 1 (Day 1)||9||
60134665|NCT04204902|76257901|FG001|COMPLETED|Treatment Period 1 (Day 1)||9||
60134666|NCT04204902|76257900|FG000|NOT COMPLETED|Treatment Period 1 (Day 1)||0||
60134667|NCT04204902|76257901|FG001|NOT COMPLETED|Treatment Period 1 (Day 1)||0||
60134668|NCT04204902|76257900|FG000|STARTED|Washout Period (21 Days)||9||
60134669|NCT04204902|76257901|FG001|STARTED|Washout Period (21 Days)||9||
60134670|NCT04204902|76257900|FG000|COMPLETED|Washout Period (21 Days)||9||
60134671|NCT04204902|76257901|FG001|COMPLETED|Washout Period (21 Days)||9||
60134672|NCT04204902|76257900|FG000|NOT COMPLETED|Washout Period (21 Days)||0||
60134673|NCT04204902|76257901|FG001|NOT COMPLETED|Washout Period (21 Days)||0||
60134674|NCT04204902|76257900|FG000|STARTED|Treatment Period 2 (Day 22)||9||
60134675|NCT04204902|76257901|FG001|STARTED|Treatment Period 2 (Day 22)||9||
60134676|NCT04204902|76257900|FG000|COMPLETED|Treatment Period 2 (Day 22)||9||
60134677|NCT04204902|76257901|FG001|COMPLETED|Treatment Period 2 (Day 22)||8||
60134678|NCT04204902|76257900|FG000|NOT COMPLETED|Treatment Period 2 (Day 22)||0||
60134679|NCT04204902|76257901|FG001|NOT COMPLETED|Treatment Period 2 (Day 22)||1||
60134680|NCT04191616|76257907|FG000|STARTED|Overall Study||54||
60134681|NCT04191616|76257907|FG000|Received Carfilzomib|Overall Study||52||
60134682|NCT04191616|76257907|FG000|Received Pomalidomide|Overall Study||52||
60134683|NCT04191616|76257907|FG000|Received Dexamethasone|Overall Study||52||
60134684|NCT04191616|76257907|FG000|COMPLETED|Overall Study||0||
60134685|NCT04191616|76257907|FG000|NOT COMPLETED|Overall Study||54||
60134686|NCT04166383|76257911|FG000|STARTED|Drug Administration||14||
60134687|NCT04166383|76257911|FG000|COMPLETED|Drug Administration||13||
60134688|NCT04166383|76257911|FG000|NOT COMPLETED|Drug Administration||1||
60134689|NCT04166383|76257911|FG000|STARTED|TAC 1 - Second Biopsy Cycle 2 Day 1||9||
60134690|NCT04166383|76257911|FG000|COMPLETED|TAC 1 - Second Biopsy Cycle 2 Day 1||7||
60134691|NCT04166383|76257911|FG000|NOT COMPLETED|TAC 1 - Second Biopsy Cycle 2 Day 1||2||
60134692|NCT04166383|76257911|FG000|STARTED|TAC 2 - Second Biopsy Cycle 4 Day 1||5||
60134693|NCT04166383|76257911|FG000|COMPLETED|TAC 2 - Second Biopsy Cycle 4 Day 1||4||
60134694|NCT04166383|76257911|FG000|NOT COMPLETED|TAC 2 - Second Biopsy Cycle 4 Day 1||1||
60134695|NCT04163458|76257932|FG000|STARTED|Overall Study||204||
59872970|NCT03131440|75997097|FG011|COMPLETED|Overall Study||7|Completed the 24 week questionnaires OR had valid data on the accelerometer at 24 weeks|
59872971|NCT03131440|75997098|FG012|COMPLETED|Overall Study||7|Completed the 24 week questionnaires OR had valid data on the accelerometer at 24 weeks|
59872972|NCT03131440|75997099|FG013|COMPLETED|Overall Study||8|Completed the 24 week questionnaires OR had valid data on the accelerometer at 24 weeks|
59872973|NCT03131440|75997100|FG014|COMPLETED|Overall Study||7|Completed the 24 week questionnaires OR had valid data on the accelerometer at 24 weeks|
59872974|NCT03131440|75997101|FG015|COMPLETED|Overall Study||8|Completed the 24 week questionnaires OR had valid data on the accelerometer at 24 weeks|
59951250|NCT03743415|76070181|FG006|COMPLETED|Overall Study||41||
59518873|NCT03537274|75612755|FG002|NOT COMPLETED|Overall Study||76||
59518874|NCT03537274|75612756|FG003|NOT COMPLETED|Overall Study||76||
59602009|NCT00728845|75712226|FG000|NOT COMPLETED|Overall Study||0||
59602010|NCT00728845|75712227|FG001|NOT COMPLETED|Overall Study||0||
59602011|NCT00726037|75712233|FG000|STARTED|Overall Study||7||
59602012|NCT00726037|75712233|FG000|COMPLETED|Overall Study||7||
59602013|NCT00726037|75712233|FG000|NOT COMPLETED|Overall Study||0||
59602014|NCT00703885|75712237|FG000|STARTED|Overall Study||16||
59602015|NCT00703885|75712237|FG000|COMPLETED|Overall Study||16||
59602016|NCT00703885|75712237|FG000|NOT COMPLETED|Overall Study||0||
59602017|NCT00703339|75712242|FG000|STARTED|Overall Study||1||
59602018|NCT00703339|75712242|FG000|COMPLETED|Overall Study||1||
59602019|NCT00703339|75712242|FG000|NOT COMPLETED|Overall Study||0||
59602020|NCT00668785|75712246|FG000|STARTED|Overall Study||6||
59602021|NCT00668785|75712246|FG000|COMPLETED|Overall Study||6||
59602022|NCT00668785|75712246|FG000|NOT COMPLETED|Overall Study||0||
59602023|NCT00655057|75712255|FG000|STARTED|Overall Study||0||
59602024|NCT00655057|75712256|FG001|STARTED|Overall Study||0||
59602025|NCT00655057|75712257|FG002|STARTED|Overall Study||0||
59602026|NCT00655057|75712255|FG000|COMPLETED|Overall Study||0||
59602027|NCT00655057|75712256|FG001|COMPLETED|Overall Study||0||
59602028|NCT00655057|75712257|FG002|COMPLETED|Overall Study||0||
59602029|NCT00655057|75712255|FG000|NOT COMPLETED|Overall Study||0||
59602030|NCT00655057|75712256|FG001|NOT COMPLETED|Overall Study||0||
59602031|NCT00655057|75712257|FG002|NOT COMPLETED|Overall Study||0||
59602032|NCT00635167|75712265|FG000|STARTED|Overall Study||1||
59602033|NCT00635167|75712265|FG000|COMPLETED|Overall Study||1||
59602034|NCT00635167|75712265|FG000|NOT COMPLETED|Overall Study||0||
59602035|NCT00630487|75712271|FG000|STARTED|Overall Study||0||
59602036|NCT00630487|75712272|FG001|STARTED|Overall Study||0||
59602037|NCT00630487|75712271|FG000|COMPLETED|Overall Study||0||
59602038|NCT00630487|75712272|FG001|COMPLETED|Overall Study||0||
59602039|NCT00630487|75712271|FG000|NOT COMPLETED|Overall Study||0||
59602040|NCT00630487|75712272|FG001|NOT COMPLETED|Overall Study||0||
59602041|NCT00607477|75712280|FG000|STARTED|Overall Study||0||
59602042|NCT00607477|75712281|FG001|STARTED|Overall Study||2||
59602043|NCT00607477|75712280|FG000|COMPLETED|Overall Study||0||
59602044|NCT00607477|75712281|FG001|COMPLETED|Overall Study||2||
59602045|NCT00607477|75712280|FG000|NOT COMPLETED|Overall Study||0||
59602046|NCT00607477|75712281|FG001|NOT COMPLETED|Overall Study||0||
59602047|NCT03603314|75712290|FG000|STARTED|Overall Study||38||
59602048|NCT03603314|75712291|FG001|STARTED|Overall Study||39||
59602049|NCT03603314|75712292|FG002|STARTED|Overall Study||38||
59602050|NCT03603314|75712290|FG000|COMPLETED|Overall Study||31||
59602051|NCT03603314|75712291|FG001|COMPLETED|Overall Study||28||
59602052|NCT03603314|75712292|FG002|COMPLETED|Overall Study||35||
59602053|NCT03603314|75712290|FG000|NOT COMPLETED|Overall Study||7||
59602054|NCT03603314|75712291|FG001|NOT COMPLETED|Overall Study||11||
59602055|NCT03603314|75712292|FG002|NOT COMPLETED|Overall Study||3||
59602056|NCT00599131|75712300|FG000|STARTED|Overall Study||4||
59602057|NCT00599131|75712300|FG000|COMPLETED|Overall Study||4||
59602058|NCT00599131|75712300|FG000|NOT COMPLETED|Overall Study||0||
59602059|NCT04302350|75712307|FG000|STARTED|Overall Study||26||
59602060|NCT04302350|75712308|FG001|STARTED|Overall Study||26||
59602061|NCT04302350|75712309|FG002|STARTED|Overall Study||26||
59602062|NCT04302350|75712307|FG000|COMPLETED|Overall Study||24||
59602063|NCT04302350|75712308|FG001|COMPLETED|Overall Study||23||
59602064|NCT04302350|75712309|FG002|COMPLETED|Overall Study||18||
59602065|NCT04302350|75712307|FG000|NOT COMPLETED|Overall Study||2||
59602066|NCT04302350|75712308|FG001|NOT COMPLETED|Overall Study||3||
59602067|NCT04302350|75712309|FG002|NOT COMPLETED|Overall Study||8||
59602068|NCT00584935|75712317|FG000|STARTED|Overall Study||3||
59602069|NCT00584935|75712317|FG000|COMPLETED|Overall Study||3||
59602070|NCT00584935|75712317|FG000|NOT COMPLETED|Overall Study||0||
59602071|NCT03521102|75712324|FG000|STARTED|Overall Study||81||
59602072|NCT03521102|75712325|FG001|STARTED|Overall Study||81||
59602073|NCT03521102|75712324|FG000|COMPLETED|Overall Study||81||
59602074|NCT03521102|75712325|FG001|COMPLETED|Overall Study||81||
59602075|NCT03521102|75712324|FG000|NOT COMPLETED|Overall Study||0||
59602076|NCT03521102|75712325|FG001|NOT COMPLETED|Overall Study||0||
59602077|NCT02341807|75712334|FG000|STARTED|Overall Study||5||
59602078|NCT02341807|75712335|FG001|STARTED|Overall Study||5||
59602079|NCT02341807|75712336|FG002|STARTED|Overall Study||5||
59602080|NCT02341807|75712334|FG000|Received at Least 1 Dose of Study Drug|Overall Study||5||
59602081|NCT02341807|75712335|FG001|Received at Least 1 Dose of Study Drug|Overall Study||5||
59602082|NCT02341807|75712336|FG002|Received at Least 1 Dose of Study Drug|Overall Study||5||
59602083|NCT02341807|75712334|FG000|COMPLETED|Overall Study||5||
59602084|NCT02341807|75712335|FG001|COMPLETED|Overall Study||4||
59602085|NCT02341807|75712336|FG002|COMPLETED|Overall Study||5||
59602086|NCT02341807|75712334|FG000|NOT COMPLETED|Overall Study||0||
59602087|NCT02341807|75712335|FG001|NOT COMPLETED|Overall Study||1||
59602088|NCT02341807|75712336|FG002|NOT COMPLETED|Overall Study||0||
59602089|NCT02335424|75712344|FG000|STARTED|Overall Study||374||
59602090|NCT02335424|75712344|FG000|Treated|Overall Study||370||
59602091|NCT02335424|75712344|FG000|Received Second Course Treatment|Overall Study||13||
59602092|NCT02335424|75712344|FG000|COMPLETED|Overall Study||0||
59602093|NCT02335424|75712344|FG000|NOT COMPLETED|Overall Study||374||
59602094|NCT03805412|75712351|FG000|STARTED|Overall Study||15||
59602095|NCT03805412|75712352|FG001|STARTED|Overall Study||8||
59602096|NCT03805412|75712351|FG000|COMPLETED|Overall Study||15||
59602097|NCT03805412|75712352|FG001|COMPLETED|Overall Study||7||
59602098|NCT03805412|75712351|FG000|NOT COMPLETED|Overall Study||0||
59602099|NCT03805412|75712352|FG001|NOT COMPLETED|Overall Study||1||
59602100|NCT04600375|75712361|FG000|STARTED|Overall Study||12||
59602101|NCT04600375|75712362|FG001|STARTED|Overall Study||10||
59602102|NCT04600375|75712361|FG000|COMPLETED|Overall Study||12||
59602103|NCT04600375|75712362|FG001|COMPLETED|Overall Study||10||
59602104|NCT04600375|75712361|FG000|NOT COMPLETED|Overall Study||0||
59602105|NCT04600375|75712362|FG001|NOT COMPLETED|Overall Study||0||
59602106|NCT04791319|75712372|FG000|STARTED|Placebo Controlled Period (Week 0-15)||33||
59602107|NCT04791319|75712373|FG001|STARTED|Placebo Controlled Period (Week 0-15)||33||
59602108|NCT04791319|75712374|FG002|STARTED|Placebo Controlled Period (Week 0-15)||67||
59602109|NCT04791319|75712375|FG003|STARTED|Placebo Controlled Period (Week 0-15)||66||
59602110|NCT04791319|75712376|FG004|STARTED|Placebo Controlled Period (Week 0-15)||0||
59602111|NCT04791319|75712377|FG005|STARTED|Placebo Controlled Period (Week 0-15)||0||
59602112|NCT04791319|75712378|FG006|STARTED|Placebo Controlled Period (Week 0-15)||0||
59602113|NCT04791319|75712379|FG007|STARTED|Placebo Controlled Period (Week 0-15)||0||
59602114|NCT04791319|75712380|FG008|STARTED|Placebo Controlled Period (Week 0-15)||0||
59602115|NCT04791319|75712381|FG009|STARTED|Placebo Controlled Period (Week 0-15)||0||
59602116|NCT04791319|75712382|FG010|STARTED|Placebo Controlled Period (Week 0-15)||0||
59602117|NCT04791319|75712372|FG000|Treated|Placebo Controlled Period (Week 0-15)||33||
59602118|NCT04791319|75712373|FG001|Treated|Placebo Controlled Period (Week 0-15)||33||
59602119|NCT04791319|75712374|FG002|Treated|Placebo Controlled Period (Week 0-15)||67||
59602120|NCT04791319|75712375|FG003|Treated|Placebo Controlled Period (Week 0-15)||65||
59602121|NCT04791319|75712376|FG004|Treated|Placebo Controlled Period (Week 0-15)||0||
59602122|NCT04791319|75712377|FG005|Treated|Placebo Controlled Period (Week 0-15)||0||
59602123|NCT04791319|75712378|FG006|Treated|Placebo Controlled Period (Week 0-15)||0||
59602124|NCT04791319|75712379|FG007|Treated|Placebo Controlled Period (Week 0-15)||0||
59602125|NCT04791319|75712380|FG008|Treated|Placebo Controlled Period (Week 0-15)||0||
59602126|NCT04791319|75712381|FG009|Treated|Placebo Controlled Period (Week 0-15)||0||
59602127|NCT04791319|75712382|FG010|Treated|Placebo Controlled Period (Week 0-15)||0||
59602128|NCT04791319|75712372|FG000|COMPLETED|Placebo Controlled Period (Week 0-15)||19||
59602129|NCT04791319|75712373|FG001|COMPLETED|Placebo Controlled Period (Week 0-15)||21||
59602130|NCT04791319|75712374|FG002|COMPLETED|Placebo Controlled Period (Week 0-15)||30||
59602131|NCT04791319|75712375|FG003|COMPLETED|Placebo Controlled Period (Week 0-15)||38||
59602132|NCT04791319|75712376|FG004|COMPLETED|Placebo Controlled Period (Week 0-15)||0||
59602133|NCT04791319|75712377|FG005|COMPLETED|Placebo Controlled Period (Week 0-15)||0||
59602134|NCT04791319|75712378|FG006|COMPLETED|Placebo Controlled Period (Week 0-15)||0||
59602135|NCT04791319|75712379|FG007|COMPLETED|Placebo Controlled Period (Week 0-15)||0||
59602136|NCT04791319|75712380|FG008|COMPLETED|Placebo Controlled Period (Week 0-15)||0||
59602137|NCT04791319|75712381|FG009|COMPLETED|Placebo Controlled Period (Week 0-15)||0||
59602138|NCT04791319|75712382|FG010|COMPLETED|Placebo Controlled Period (Week 0-15)||0||
59602139|NCT04791319|75712372|FG000|NOT COMPLETED|Placebo Controlled Period (Week 0-15)||14||
59602140|NCT04791319|75712373|FG001|NOT COMPLETED|Placebo Controlled Period (Week 0-15)||12||
59602141|NCT04791319|75712374|FG002|NOT COMPLETED|Placebo Controlled Period (Week 0-15)||37||
59602142|NCT04791319|75712375|FG003|NOT COMPLETED|Placebo Controlled Period (Week 0-15)||28||
59602143|NCT04791319|75712376|FG004|NOT COMPLETED|Placebo Controlled Period (Week 0-15)||0||
59602144|NCT04791319|75712377|FG005|NOT COMPLETED|Placebo Controlled Period (Week 0-15)||0||
59602145|NCT04791319|75712378|FG006|NOT COMPLETED|Placebo Controlled Period (Week 0-15)||0||
59602146|NCT04791319|75712379|FG007|NOT COMPLETED|Placebo Controlled Period (Week 0-15)||0||
59602147|NCT04791319|75712380|FG008|NOT COMPLETED|Placebo Controlled Period (Week 0-15)||0||
59602148|NCT04791319|75712381|FG009|NOT COMPLETED|Placebo Controlled Period (Week 0-15)||0||
59602149|NCT04791319|75712382|FG010|NOT COMPLETED|Placebo Controlled Period (Week 0-15)||0||
59602150|NCT04791319|75712372|FG000|STARTED|Active Treatment Period (Week 16-31)||0||
59602151|NCT04791319|75712373|FG001|STARTED|Active Treatment Period (Week 16-31)||0||
59602152|NCT04791319|75712374|FG002|STARTED|Active Treatment Period (Week 16-31)||0||
59602153|NCT04791319|75712375|FG003|STARTED|Active Treatment Period (Week 16-31)||0||
59602154|NCT04791319|75712376|FG004|STARTED|Active Treatment Period (Week 16-31)||19||
59602155|NCT04791319|75712377|FG005|STARTED|Active Treatment Period (Week 16-31)||21||
59602156|NCT04791319|75712378|FG006|STARTED|Active Treatment Period (Week 16-31)||22||
59602157|NCT04791319|75712379|FG007|STARTED|Active Treatment Period (Week 16-31)||3||
59602158|NCT04791319|75712380|FG008|STARTED|Active Treatment Period (Week 16-31)||5||
59602159|NCT04791319|75712381|FG009|STARTED|Active Treatment Period (Week 16-31)||27||
59602160|NCT04791319|75712382|FG010|STARTED|Active Treatment Period (Week 16-31)||11||
59602161|NCT04791319|75712372|FG000|COMPLETED|Active Treatment Period (Week 16-31)||0||
59602162|NCT04791319|75712373|FG001|COMPLETED|Active Treatment Period (Week 16-31)||0||
59602163|NCT04791319|75712374|FG002|COMPLETED|Active Treatment Period (Week 16-31)||0||
59602164|NCT04791319|75712375|FG003|COMPLETED|Active Treatment Period (Week 16-31)||0||
59602165|NCT04791319|75712376|FG004|COMPLETED|Active Treatment Period (Week 16-31)||1||
59602166|NCT04791319|75712377|FG005|COMPLETED|Active Treatment Period (Week 16-31)||6||
59602167|NCT04791319|75712378|FG006|COMPLETED|Active Treatment Period (Week 16-31)||3||
59602168|NCT04791319|75712379|FG007|COMPLETED|Active Treatment Period (Week 16-31)||1||
59602169|NCT04791319|75712380|FG008|COMPLETED|Active Treatment Period (Week 16-31)||1||
59602170|NCT04791319|75712381|FG009|COMPLETED|Active Treatment Period (Week 16-31)||6||
59602171|NCT04791319|75712382|FG010|COMPLETED|Active Treatment Period (Week 16-31)||2||
59602172|NCT04791319|75712372|FG000|NOT COMPLETED|Active Treatment Period (Week 16-31)||0||
59602173|NCT04791319|75712373|FG001|NOT COMPLETED|Active Treatment Period (Week 16-31)||0||
59602174|NCT04791319|75712374|FG002|NOT COMPLETED|Active Treatment Period (Week 16-31)||0||
59602175|NCT04791319|75712375|FG003|NOT COMPLETED|Active Treatment Period (Week 16-31)||0||
59602176|NCT04791319|75712376|FG004|NOT COMPLETED|Active Treatment Period (Week 16-31)||18||
59602177|NCT04791319|75712377|FG005|NOT COMPLETED|Active Treatment Period (Week 16-31)||15||
59602178|NCT04791319|75712378|FG006|NOT COMPLETED|Active Treatment Period (Week 16-31)||19||
59602179|NCT04791319|75712379|FG007|NOT COMPLETED|Active Treatment Period (Week 16-31)||2||
59602180|NCT04791319|75712380|FG008|NOT COMPLETED|Active Treatment Period (Week 16-31)||4||
59602181|NCT04791319|75712381|FG009|NOT COMPLETED|Active Treatment Period (Week 16-31)||21||
59602182|NCT04791319|75712382|FG010|NOT COMPLETED|Active Treatment Period (Week 16-31)||9||
59602183|NCT04971031|75712421|FG000|STARTED|Overall Study||80||
59602184|NCT04971031|75712422|FG001|STARTED|Overall Study||78||
59602185|NCT04971031|75712421|FG000|COMPLETED|Overall Study||79||
59602186|NCT04971031|75712422|FG001|COMPLETED|Overall Study||75||
59602187|NCT04971031|75712421|FG000|NOT COMPLETED|Overall Study||1||
59602188|NCT04971031|75712422|FG001|NOT COMPLETED|Overall Study||3||
59602189|NCT03539887|75712430|FG000|STARTED|Overall Study||17||
59602190|NCT03539887|75712431|FG001|STARTED|Overall Study||11||
59602191|NCT03539887|75712430|FG000|COMPLETED|Overall Study||17||
59602192|NCT03539887|75712431|FG001|COMPLETED|Overall Study||11||
59602193|NCT03539887|75712430|FG000|NOT COMPLETED|Overall Study||0||
59602194|NCT03539887|75712431|FG001|NOT COMPLETED|Overall Study||0||
59602195|NCT03472495|75712439|FG000|STARTED|Overall Study||9||
59602196|NCT03472495|75712440|FG001|STARTED|Overall Study||10||
59602197|NCT03472495|75712439|FG000|COMPLETED|Overall Study||8||
59602198|NCT03472495|75712440|FG001|COMPLETED|Overall Study||6||
59602199|NCT03472495|75712439|FG000|NOT COMPLETED|Overall Study||1||
59602200|NCT03472495|75712440|FG001|NOT COMPLETED|Overall Study||4||
59602201|NCT03234907|75712448|FG000|STARTED|Induction Phase (Week 0 to Week 10)||71||
59602202|NCT03234907|75712449|FG001|STARTED|Induction Phase (Week 0 to Week 10)||144||
59602203|NCT03234907|75712450|FG002|STARTED|Induction Phase (Week 0 to Week 10)||0||
59602204|NCT03234907|75712451|FG003|STARTED|Induction Phase (Week 0 to Week 10)||0||
59602205|NCT03234907|75712452|FG004|STARTED|Induction Phase (Week 0 to Week 10)||0||
59602206|NCT03234907|75712453|FG005|STARTED|Induction Phase (Week 0 to Week 10)||0||
59602207|NCT03234907|75712448|FG000|Treated|Induction Phase (Week 0 to Week 10)||70|Full Analysis Set (FAS) for the induction phase study included all randomized participants who received any amount of blinded study drug during the Induction Phase.|
59602208|NCT03234907|75712449|FG001|Treated|Induction Phase (Week 0 to Week 10)||144|Full Analysis Set (FAS) for the induction phase study included all randomized participants who received any amount of blinded study drug during the Induction Phase.|
59602209|NCT03234907|75712450|FG002|Treated|Induction Phase (Week 0 to Week 10)||0|Full Analysis Set (FAS) for the induction phase study included all randomized participants who received any amount of blinded study drug during the Induction Phase.|
59602210|NCT03234907|75712451|FG003|Treated|Induction Phase (Week 0 to Week 10)||0|Full Analysis Set (FAS) for the induction phase study included all randomized participants who received any amount of blinded study drug during the Induction Phase.|
59602211|NCT03234907|75712452|FG004|Treated|Induction Phase (Week 0 to Week 10)||0|Full Analysis Set (FAS) for the induction phase study included all randomized participants who received any amount of blinded study drug during the Induction Phase.|
59602212|NCT03234907|75712453|FG005|Treated|Induction Phase (Week 0 to Week 10)||0|Full Analysis Set (FAS) for the induction phase study included all randomized participants who received any amount of blinded study drug during the Induction Phase.|
59602213|NCT03234907|75712448|FG000|COMPLETED|Induction Phase (Week 0 to Week 10)||61|Completed = Participants who completed the treatment.|
59602214|NCT03234907|75712449|FG001|COMPLETED|Induction Phase (Week 0 to Week 10)||138|Completed = Participants who completed the treatment.|
59602215|NCT03234907|75712450|FG002|COMPLETED|Induction Phase (Week 0 to Week 10)||0|Completed = Participants who completed the treatment.|
59602216|NCT03234907|75712451|FG003|COMPLETED|Induction Phase (Week 0 to Week 10)||0|Completed = Participants who completed the treatment.|
59602217|NCT03234907|75712452|FG004|COMPLETED|Induction Phase (Week 0 to Week 10)||0|Completed = Participants who completed the treatment.|
59602218|NCT03234907|75712453|FG005|COMPLETED|Induction Phase (Week 0 to Week 10)||0|Completed = Participants who completed the treatment.|
59602219|NCT03234907|75712448|FG000|NOT COMPLETED|Induction Phase (Week 0 to Week 10)||10||
59602220|NCT03234907|75712449|FG001|NOT COMPLETED|Induction Phase (Week 0 to Week 10)||6||
59602221|NCT03234907|75712450|FG002|NOT COMPLETED|Induction Phase (Week 0 to Week 10)||0||
59602222|NCT03234907|75712451|FG003|NOT COMPLETED|Induction Phase (Week 0 to Week 10)||0||
59602223|NCT03234907|75712452|FG004|NOT COMPLETED|Induction Phase (Week 0 to Week 10)||0||
59602224|NCT03234907|75712453|FG005|NOT COMPLETED|Induction Phase (Week 0 to Week 10)||0||
59602225|NCT03234907|75712448|FG000|STARTED|Maintenance Phase (Week 10 to Week 60)||0||
59602226|NCT03234907|75712449|FG001|STARTED|Maintenance Phase (Week 10 to Week 60)||0||
59602227|NCT03234907|75712450|FG002|STARTED|Maintenance Phase (Week 10 to Week 60)||18||
59602228|NCT03234907|75712451|FG003|STARTED|Maintenance Phase (Week 10 to Week 60)||38||
59602229|NCT03234907|75712452|FG004|STARTED|Maintenance Phase (Week 10 to Week 60)||46||
59602230|NCT03234907|75712453|FG005|STARTED|Maintenance Phase (Week 10 to Week 60)||88||
59602231|NCT03234907|75712448|FG000|COMPLETED|Maintenance Phase (Week 10 to Week 60)||0||
59602232|NCT03234907|75712449|FG001|COMPLETED|Maintenance Phase (Week 10 to Week 60)||0||
59602233|NCT03234907|75712450|FG002|COMPLETED|Maintenance Phase (Week 10 to Week 60)||17||
59602234|NCT03234907|75712451|FG003|COMPLETED|Maintenance Phase (Week 10 to Week 60)||27||
59602235|NCT03234907|75712452|FG004|COMPLETED|Maintenance Phase (Week 10 to Week 60)||36||
59602236|NCT03234907|75712453|FG005|COMPLETED|Maintenance Phase (Week 10 to Week 60)||67||
59602237|NCT03234907|75712448|FG000|NOT COMPLETED|Maintenance Phase (Week 10 to Week 60)||0||
59602238|NCT03234907|75712449|FG001|NOT COMPLETED|Maintenance Phase (Week 10 to Week 60)||0||
59602239|NCT03234907|75712450|FG002|NOT COMPLETED|Maintenance Phase (Week 10 to Week 60)||1||
59602240|NCT03234907|75712451|FG003|NOT COMPLETED|Maintenance Phase (Week 10 to Week 60)||11||
59602241|NCT03234907|75712452|FG004|NOT COMPLETED|Maintenance Phase (Week 10 to Week 60)||10||
59602242|NCT03234907|75712453|FG005|NOT COMPLETED|Maintenance Phase (Week 10 to Week 60)||21||
59602243|NCT03818581|75712467|FG000|STARTED|Overall Study||24||
59602244|NCT03818581|75712468|FG001|STARTED|Overall Study||7||
59602245|NCT03818581|75712469|FG002|STARTED|Overall Study||16||
59602246|NCT03818581|75712470|FG003|STARTED|Overall Study||18||
59602247|NCT03818581|75712471|FG004|STARTED|Overall Study||4||
59602248|NCT03818581|75712467|FG000|COMPLETED|Overall Study||20||
59602249|NCT03818581|75712468|FG001|COMPLETED|Overall Study||7||
59602250|NCT03818581|75712469|FG002|COMPLETED|Overall Study||16||
59602251|NCT03818581|75712470|FG003|COMPLETED|Overall Study||18||
59602252|NCT03818581|75712471|FG004|COMPLETED|Overall Study||0||
59602253|NCT03818581|75712467|FG000|NOT COMPLETED|Overall Study||4||
59602254|NCT03818581|75712468|FG001|NOT COMPLETED|Overall Study||0||
59602255|NCT03818581|75712469|FG002|NOT COMPLETED|Overall Study||0||
59602256|NCT03818581|75712470|FG003|NOT COMPLETED|Overall Study||0||
59602257|NCT03818581|75712471|FG004|NOT COMPLETED|Overall Study||4||
59602258|NCT03736447|75712485|FG000|STARTED|Overall Study||98||
59602259|NCT03736447|75712486|FG001|STARTED|Overall Study||48||
59602260|NCT03736447|75712485|FG000|COMPLETED|Overall Study||83||
59602261|NCT03736447|75712486|FG001|COMPLETED|Overall Study||45||
59602262|NCT03736447|75712485|FG000|NOT COMPLETED|Overall Study||15||
59602263|NCT03736447|75712486|FG001|NOT COMPLETED|Overall Study||3||
59602264|NCT01338649|75712494|FG000|STARTED|Overall Study||13||
59602265|NCT01338649|75712495|FG001|STARTED|Overall Study||14||
59602266|NCT01338649|75712494|FG000|COMPLETED|Overall Study||13||
59602267|NCT01338649|75712495|FG001|COMPLETED|Overall Study||14||
59602268|NCT01338649|75712494|FG000|NOT COMPLETED|Overall Study||0||
59602269|NCT01338649|75712495|FG001|NOT COMPLETED|Overall Study||0||
59602270|NCT02132754|75712535|FG000|STARTED|Overall Study||1||
59602271|NCT02132754|75712536|FG001|STARTED|Overall Study||1||
59602272|NCT02132754|75712537|FG002|STARTED|Overall Study||1||
59602273|NCT02132754|75712538|FG003|STARTED|Overall Study||1||
59602274|NCT02132754|75712539|FG004|STARTED|Overall Study||1||
59602275|NCT02132754|75712540|FG005|STARTED|Overall Study||1||
59602276|NCT02132754|75712541|FG006|STARTED|Overall Study||1||
59602277|NCT02132754|75712542|FG007|STARTED|Overall Study||1||
59602278|NCT02132754|75712543|FG008|STARTED|Overall Study||1||
59602279|NCT02132754|75712544|FG009|STARTED|Overall Study||6||
59602280|NCT02132754|75712545|FG010|STARTED|Overall Study||3||
59602281|NCT02132754|75712546|FG011|STARTED|Overall Study||3||
59602282|NCT02132754|75712547|FG012|STARTED|Overall Study||4||
59602283|NCT02132754|75712548|FG013|STARTED|Overall Study||3||
59602284|NCT02132754|75712549|FG014|STARTED|Overall Study||3||
59602285|NCT02132754|75712550|FG015|STARTED|Overall Study||5||
59602286|NCT02132754|75712551|FG016|STARTED|Overall Study||4||
59602287|NCT02132754|75712552|FG017|STARTED|Overall Study||3||
59602288|NCT02132754|75712553|FG018|STARTED|Overall Study||3||
59602289|NCT02132754|75712554|FG019|STARTED|Overall Study||4||
59602290|NCT02132754|75712555|FG020|STARTED|Overall Study||3||
59602291|NCT02132754|75712556|FG021|STARTED|Overall Study||5||
59602292|NCT02132754|75712557|FG022|STARTED|Overall Study||3||
59602293|NCT02132754|75712558|FG023|STARTED|Overall Study||3||
59602294|NCT02132754|75712559|FG024|STARTED|Overall Study||3||
59602295|NCT02132754|75712560|FG025|STARTED|Overall Study||3||
59602296|NCT02132754|75712561|FG026|STARTED|Overall Study||4||
59602297|NCT02132754|75712562|FG027|STARTED|Overall Study||3||
59602298|NCT02132754|75712563|FG028|STARTED|Overall Study||3||
59602299|NCT02132754|75712564|FG029|STARTED|Overall Study||3||
59602300|NCT02132754|75712565|FG030|STARTED|Overall Study||3||
59602301|NCT02132754|75712566|FG031|STARTED|Overall Study||3||
59602302|NCT02132754|75712567|FG032|STARTED|Overall Study||4||
59602303|NCT02132754|75712568|FG033|STARTED|Overall Study||23||
59602304|NCT02132754|75712535|FG000|Treated|Overall Study||1||
59602305|NCT02132754|75712536|FG001|Treated|Overall Study||1||
59602306|NCT02132754|75712537|FG002|Treated|Overall Study||1||
59602307|NCT02132754|75712538|FG003|Treated|Overall Study||1||
59602308|NCT02132754|75712539|FG004|Treated|Overall Study||1||
59602309|NCT02132754|75712540|FG005|Treated|Overall Study||1||
59602310|NCT02132754|75712541|FG006|Treated|Overall Study||1||
59602311|NCT02132754|75712542|FG007|Treated|Overall Study||1||
59602312|NCT02132754|75712543|FG008|Treated|Overall Study||1||
59602313|NCT02132754|75712544|FG009|Treated|Overall Study||6||
59602314|NCT02132754|75712545|FG010|Treated|Overall Study||3||
59602315|NCT02132754|75712546|FG011|Treated|Overall Study||3||
59602316|NCT02132754|75712547|FG012|Treated|Overall Study||3||
59602317|NCT02132754|75712548|FG013|Treated|Overall Study||3||
59602318|NCT02132754|75712549|FG014|Treated|Overall Study||3||
59602319|NCT02132754|75712550|FG015|Treated|Overall Study||5||
59602320|NCT02132754|75712551|FG016|Treated|Overall Study||4||
59602321|NCT02132754|75712552|FG017|Treated|Overall Study||3||
59602322|NCT02132754|75712553|FG018|Treated|Overall Study||3||
59602323|NCT02132754|75712554|FG019|Treated|Overall Study||3||
59602324|NCT02132754|75712555|FG020|Treated|Overall Study||3||
59602325|NCT02132754|75712556|FG021|Treated|Overall Study||4||
59602326|NCT02132754|75712557|FG022|Treated|Overall Study||3||
59602327|NCT02132754|75712558|FG023|Treated|Overall Study||3||
59602328|NCT02132754|75712559|FG024|Treated|Overall Study||3||
59602329|NCT02132754|75712560|FG025|Treated|Overall Study||3||
59602330|NCT02132754|75712561|FG026|Treated|Overall Study||4||
59602331|NCT02132754|75712562|FG027|Treated|Overall Study||3||
59602332|NCT02132754|75712563|FG028|Treated|Overall Study||3||
59602333|NCT02132754|75712564|FG029|Treated|Overall Study||3||
59736836|NCT00591838|75855706|FG003|COMPLETED|Overall Study||5||
59602334|NCT02132754|75712565|FG030|Treated|Overall Study||3||
59602335|NCT02132754|75712566|FG031|Treated|Overall Study||3||
59602336|NCT02132754|75712567|FG032|Treated|Overall Study||4||
59602337|NCT02132754|75712568|FG033|Treated|Overall Study||23||
59602338|NCT02132754|75712535|FG000|COMPLETED|Overall Study||0||
59602339|NCT02132754|75712536|FG001|COMPLETED|Overall Study||0||
59602340|NCT02132754|75712537|FG002|COMPLETED|Overall Study||0||
59602341|NCT02132754|75712538|FG003|COMPLETED|Overall Study||0||
59602342|NCT02132754|75712539|FG004|COMPLETED|Overall Study||0||
59602343|NCT02132754|75712540|FG005|COMPLETED|Overall Study||0||
59602344|NCT02132754|75712541|FG006|COMPLETED|Overall Study||0||
59602345|NCT02132754|75712542|FG007|COMPLETED|Overall Study||0||
59602346|NCT02132754|75712543|FG008|COMPLETED|Overall Study||0||
59602347|NCT02132754|75712544|FG009|COMPLETED|Overall Study||0||
59602348|NCT02132754|75712545|FG010|COMPLETED|Overall Study||0||
59602349|NCT02132754|75712546|FG011|COMPLETED|Overall Study||0||
59602350|NCT02132754|75712547|FG012|COMPLETED|Overall Study||0||
59602351|NCT02132754|75712548|FG013|COMPLETED|Overall Study||0||
59602352|NCT02132754|75712549|FG014|COMPLETED|Overall Study||0||
59602353|NCT02132754|75712550|FG015|COMPLETED|Overall Study||0||
59602354|NCT02132754|75712551|FG016|COMPLETED|Overall Study||0||
59602355|NCT02132754|75712552|FG017|COMPLETED|Overall Study||0||
59602356|NCT02132754|75712553|FG018|COMPLETED|Overall Study||0||
59602357|NCT02132754|75712554|FG019|COMPLETED|Overall Study||0||
59602358|NCT02132754|75712555|FG020|COMPLETED|Overall Study||0||
59602359|NCT02132754|75712556|FG021|COMPLETED|Overall Study||0||
59602360|NCT02132754|75712557|FG022|COMPLETED|Overall Study||0||
59602361|NCT02132754|75712558|FG023|COMPLETED|Overall Study||0||
59602362|NCT02132754|75712559|FG024|COMPLETED|Overall Study||0||
59602363|NCT02132754|75712560|FG025|COMPLETED|Overall Study||0||
59602364|NCT02132754|75712561|FG026|COMPLETED|Overall Study||0||
59602365|NCT02132754|75712562|FG027|COMPLETED|Overall Study||0||
59602366|NCT02132754|75712563|FG028|COMPLETED|Overall Study||0||
59602367|NCT02132754|75712564|FG029|COMPLETED|Overall Study||0||
59602368|NCT02132754|75712565|FG030|COMPLETED|Overall Study||0||
59602369|NCT02132754|75712566|FG031|COMPLETED|Overall Study||0||
59602370|NCT02132754|75712567|FG032|COMPLETED|Overall Study||0||
59602371|NCT02132754|75712568|FG033|COMPLETED|Overall Study||0||
59602372|NCT02132754|75712535|FG000|NOT COMPLETED|Overall Study||1||
59602373|NCT02132754|75712536|FG001|NOT COMPLETED|Overall Study||1||
59602374|NCT02132754|75712537|FG002|NOT COMPLETED|Overall Study||1||
59602375|NCT02132754|75712538|FG003|NOT COMPLETED|Overall Study||1||
59602376|NCT02132754|75712539|FG004|NOT COMPLETED|Overall Study||1||
59602377|NCT02132754|75712540|FG005|NOT COMPLETED|Overall Study||1||
59602378|NCT02132754|75712541|FG006|NOT COMPLETED|Overall Study||1||
59602379|NCT02132754|75712542|FG007|NOT COMPLETED|Overall Study||1||
59602380|NCT02132754|75712543|FG008|NOT COMPLETED|Overall Study||1||
59602381|NCT02132754|75712544|FG009|NOT COMPLETED|Overall Study||6||
59602382|NCT02132754|75712545|FG010|NOT COMPLETED|Overall Study||3||
59602383|NCT02132754|75712546|FG011|NOT COMPLETED|Overall Study||3||
59602384|NCT02132754|75712547|FG012|NOT COMPLETED|Overall Study||4||
59602385|NCT02132754|75712548|FG013|NOT COMPLETED|Overall Study||3||
59602386|NCT02132754|75712549|FG014|NOT COMPLETED|Overall Study||3||
59602387|NCT02132754|75712550|FG015|NOT COMPLETED|Overall Study||5||
59602388|NCT02132754|75712551|FG016|NOT COMPLETED|Overall Study||4||
59602389|NCT02132754|75712552|FG017|NOT COMPLETED|Overall Study||3||
59602390|NCT02132754|75712553|FG018|NOT COMPLETED|Overall Study||3||
59602391|NCT02132754|75712554|FG019|NOT COMPLETED|Overall Study||4||
59602392|NCT02132754|75712555|FG020|NOT COMPLETED|Overall Study||3||
59602393|NCT02132754|75712556|FG021|NOT COMPLETED|Overall Study||5||
59602394|NCT02132754|75712557|FG022|NOT COMPLETED|Overall Study||3||
59602395|NCT02132754|75712558|FG023|NOT COMPLETED|Overall Study||3||
59602396|NCT02132754|75712559|FG024|NOT COMPLETED|Overall Study||3||
59602397|NCT02132754|75712560|FG025|NOT COMPLETED|Overall Study||3||
59602398|NCT02132754|75712561|FG026|NOT COMPLETED|Overall Study||4||
59602399|NCT02132754|75712562|FG027|NOT COMPLETED|Overall Study||3||
59602400|NCT02132754|75712563|FG028|NOT COMPLETED|Overall Study||3||
59602401|NCT02132754|75712564|FG029|NOT COMPLETED|Overall Study||3||
59602402|NCT02132754|75712565|FG030|NOT COMPLETED|Overall Study||3||
59602403|NCT02132754|75712566|FG031|NOT COMPLETED|Overall Study||3||
59602404|NCT02132754|75712567|FG032|NOT COMPLETED|Overall Study||4||
59602405|NCT02132754|75712568|FG033|NOT COMPLETED|Overall Study||23||
59602406|NCT02151786|75712678|FG000|STARTED|Overall Study||1120||
59602407|NCT02151786|75712678|FG000|COMPLETED|Overall Study||1084||
59602408|NCT02151786|75712678|FG000|NOT COMPLETED|Overall Study||36||
59602409|NCT02132130|75712686|FG000|STARTED|Overall Study||3||
59602410|NCT02132130|75712687|FG001|STARTED|Overall Study||12||
59602411|NCT02132130|75712688|FG002|STARTED|Overall Study||4||
59602412|NCT02132130|75712689|FG003|STARTED|Overall Study||3||
59602413|NCT02132130|75712686|FG000|COMPLETED|Overall Study||3||
59602414|NCT02132130|75712687|FG001|COMPLETED|Overall Study||10||
59602415|NCT02132130|75712688|FG002|COMPLETED|Overall Study||4||
59602416|NCT02132130|75712689|FG003|COMPLETED|Overall Study||2||
59602417|NCT02132130|75712686|FG000|NOT COMPLETED|Overall Study||0||
59602418|NCT02132130|75712687|FG001|NOT COMPLETED|Overall Study||2||
59602419|NCT02132130|75712688|FG002|NOT COMPLETED|Overall Study||0||
59602420|NCT02132130|75712689|FG003|NOT COMPLETED|Overall Study||1||
59602421|NCT02131662|75712708|FG000|STARTED|Overall Study||62||
59602422|NCT02131662|75712709|FG001|STARTED|Overall Study||61||
59602423|NCT02131662|75712710|FG002|STARTED|Overall Study||63||
59602424|NCT02131662|75712711|FG003|STARTED|Overall Study||62||
59602425|NCT02131662|75712712|FG004|STARTED|Overall Study||61||
59602426|NCT02131662|75712708|FG000|Treated|Overall Study||60||
59602427|NCT02131662|75712709|FG001|Treated|Overall Study||61||
59602428|NCT02131662|75712710|FG002|Treated|Overall Study||61||
59602429|NCT02131662|75712711|FG003|Treated|Overall Study||60||
59602430|NCT02131662|75712712|FG004|Treated|Overall Study||58||
59602431|NCT02131662|75712708|FG000|Completed Treatment|Overall Study||57||
59602432|NCT02131662|75712709|FG001|Completed Treatment|Overall Study||60||
59602433|NCT02131662|75712710|FG002|Completed Treatment|Overall Study||61||
59602434|NCT02131662|75712711|FG003|Completed Treatment|Overall Study||56||
59602435|NCT02131662|75712712|FG004|Completed Treatment|Overall Study||52||
59602436|NCT02131662|75712708|FG000|Completed Follow-up|Overall Study||54||
59602437|NCT02131662|75712709|FG001|Completed Follow-up|Overall Study||47||
59602438|NCT02131662|75712710|FG002|Completed Follow-up|Overall Study||56||
59602439|NCT02131662|75712711|FG003|Completed Follow-up|Overall Study||42||
59602440|NCT02131662|75712712|FG004|Completed Follow-up|Overall Study||44||
59602441|NCT02131662|75712708|FG000|COMPLETED|Overall Study||54||
59602442|NCT02131662|75712709|FG001|COMPLETED|Overall Study||47||
59602443|NCT02131662|75712710|FG002|COMPLETED|Overall Study||56||
59602444|NCT02131662|75712711|FG003|COMPLETED|Overall Study||41||
59602445|NCT02131662|75712712|FG004|COMPLETED|Overall Study||43||
59602446|NCT02131662|75712708|FG000|NOT COMPLETED|Overall Study||8||
59602447|NCT02131662|75712709|FG001|NOT COMPLETED|Overall Study||14||
59602448|NCT02131662|75712710|FG002|NOT COMPLETED|Overall Study||7||
59602449|NCT02131662|75712711|FG003|NOT COMPLETED|Overall Study||21||
59602450|NCT02131662|75712712|FG004|NOT COMPLETED|Overall Study||18||
59602451|NCT02106156|75712731|FG000|STARTED|Overall Study||9620||
59602452|NCT02106156|75712732|FG001|STARTED|Overall Study||90||
59602453|NCT02106156|75712733|FG002|STARTED|Overall Study||518||
59602454|NCT02106156|75712731|FG000|COMPLETED|Overall Study||7071||
59602455|NCT02106156|75712732|FG001|COMPLETED|Overall Study||50||
59602456|NCT02106156|75712733|FG002|COMPLETED|Overall Study||518||
59602457|NCT02106156|75712731|FG000|NOT COMPLETED|Overall Study||2549||
59602458|NCT02106156|75712732|FG001|NOT COMPLETED|Overall Study||40||
59602459|NCT02106156|75712733|FG002|NOT COMPLETED|Overall Study||0||
59602460|NCT05137002|75712744|FG000|STARTED|Part I (8 Weeks)||64||
59602461|NCT05137002|75712745|FG001|STARTED|Part I (8 Weeks)||63||
59602462|NCT05137002|75712746|FG002|STARTED|Part I (8 Weeks)||62||
59602463|NCT05137002|75712747|FG003|STARTED|Part I (8 Weeks)||60||
59602464|NCT05137002|75712748|FG004|STARTED|Part I (8 Weeks)||0||
59602465|NCT05137002|75712744|FG000|COMPLETED|Part I (8 Weeks)||60||
59602466|NCT05137002|75712745|FG001|COMPLETED|Part I (8 Weeks)||55||
59602467|NCT05137002|75712746|FG002|COMPLETED|Part I (8 Weeks)||58||
59602468|NCT05137002|75712747|FG003|COMPLETED|Part I (8 Weeks)||54||
59602469|NCT05137002|75712748|FG004|COMPLETED|Part I (8 Weeks)||0||
59602470|NCT05137002|75712744|FG000|NOT COMPLETED|Part I (8 Weeks)||4||
59602471|NCT05137002|75712745|FG001|NOT COMPLETED|Part I (8 Weeks)||8||
59602472|NCT05137002|75712746|FG002|NOT COMPLETED|Part I (8 Weeks)||4||
59602473|NCT05137002|75712747|FG003|NOT COMPLETED|Part I (8 Weeks)||6||
59602474|NCT05137002|75712748|FG004|NOT COMPLETED|Part I (8 Weeks)||0||
59602475|NCT05137002|75712744|FG000|STARTED|Part II (4 Weeks)||0||
59602476|NCT05137002|75712745|FG001|STARTED|Part II (4 Weeks)||0||
59602477|NCT05137002|75712746|FG002|STARTED|Part II (4 Weeks)||0||
59602478|NCT05137002|75712747|FG003|STARTED|Part II (4 Weeks)||0||
59602479|NCT05137002|75712748|FG004|STARTED|Part II (4 Weeks)|A total of 227 participants completed Part I, but 14 (1 of 0.5mg CIN-107 Part I, 1 of 1mg CIN-107 Part I, and 12 of 2mg CIN-107 Part I) of these participants did not enter Part II, 213 participants entered Part II.|213||
59602480|NCT05137002|75712744|FG000|COMPLETED|Part II (4 Weeks)||0||
59602481|NCT05137002|75712745|FG001|COMPLETED|Part II (4 Weeks)||0||
59602482|NCT05137002|75712746|FG002|COMPLETED|Part II (4 Weeks)||0||
59602483|NCT05137002|75712747|FG003|COMPLETED|Part II (4 Weeks)||0||
59602484|NCT05137002|75712748|FG004|COMPLETED|Part II (4 Weeks)||201||
59602485|NCT05137002|75712744|FG000|NOT COMPLETED|Part II (4 Weeks)||0||
59602486|NCT05137002|75712745|FG001|NOT COMPLETED|Part II (4 Weeks)||0||
59602487|NCT05137002|75712746|FG002|NOT COMPLETED|Part II (4 Weeks)||0||
59602488|NCT05137002|75712747|FG003|NOT COMPLETED|Part II (4 Weeks)||0||
59602489|NCT05137002|75712748|FG004|NOT COMPLETED|Part II (4 Weeks)||12||
59602490|NCT01598610|75712759|FG000|STARTED|Overall Study||220||
59602491|NCT01598610|75712759|FG000|COMPLETED|Overall Study||219||
59602492|NCT01598610|75712759|FG000|NOT COMPLETED|Overall Study||1||
59602493|NCT01625988|75712765|FG000|STARTED|Overall Study|One participant was randomized inappropriately and was discontinued before start of study treatment.|108||
59602494|NCT01625988|75712766|FG001|STARTED|Overall Study||110||
59602495|NCT01625988|75712765|FG000|Received at Least One Dose of Study Drug|Overall Study||107||
59602496|NCT01625988|75712766|FG001|Received at Least One Dose of Study Drug|Overall Study||110||
59602497|NCT01625988|75712765|FG000|COMPLETED|Overall Study||94||
59602498|NCT01625988|75712766|FG001|COMPLETED|Overall Study||97||
59602499|NCT01625988|75712765|FG000|NOT COMPLETED|Overall Study||14||
59602500|NCT01625988|75712766|FG001|NOT COMPLETED|Overall Study||13||
59602501|NCT02131272|75712777|FG000|STARTED|Overall Study||20||
59602502|NCT02131272|75712778|FG001|STARTED|Overall Study||22||
59602503|NCT02131272|75712777|FG000|COMPLETED|Overall Study||19||
59602504|NCT02131272|75712778|FG001|COMPLETED|Overall Study||20||
59602505|NCT02131272|75712777|FG000|NOT COMPLETED|Overall Study||1||
59602506|NCT02131272|75712778|FG001|NOT COMPLETED|Overall Study||2||
59602507|NCT02130882|75712786|FG000|STARTED|Overall Study||10||
59602508|NCT02130882|75712787|FG001|STARTED|Overall Study||10||
59602509|NCT02130882|75712786|FG000|COMPLETED|Overall Study||10||
59602510|NCT02130882|75712787|FG001|COMPLETED|Overall Study||9||
59602511|NCT02130882|75712786|FG000|NOT COMPLETED|Overall Study||0||
59602512|NCT02130882|75712787|FG001|NOT COMPLETED|Overall Study||1||
59602513|NCT02130570|75712795|FG000|STARTED|Overall Study||987||
59602514|NCT02130570|75712796|FG001|STARTED|Overall Study||692||
59602515|NCT02130570|75712795|FG000|COMPLETED|Overall Study|Participants enrolled, did not die during index admission, did not withdraw consent|978||
59602516|NCT02130570|75712796|FG001|COMPLETED|Overall Study|Participants enrolled, did not die during index admission, did not withdraw consent|679||
59602517|NCT02130570|75712795|FG000|NOT COMPLETED|Overall Study||9||
59602518|NCT02130570|75712796|FG001|NOT COMPLETED|Overall Study||13||
59602519|NCT02149836|75712803|FG000|STARTED|Overall Study||18||
59602520|NCT02149836|75712803|FG000|COMPLETED|Overall Study||17||
59602521|NCT02149836|75712803|FG000|NOT COMPLETED|Overall Study||1||
59602522|NCT02130024|75712809|FG000|STARTED|Overall Study||142||
59602523|NCT02130024|75712810|FG001|STARTED|Overall Study||139||
59602524|NCT02130024|75712809|FG000|Safety Set|Overall Study|One randomized patient did not receive treatment|141||
59602525|NCT02130024|75712810|FG001|Safety Set|Overall Study||139||
59602526|NCT02130024|75712809|FG000|Full Analysis Set (FAS)|Overall Study||141||
59602527|NCT02130024|75712810|FG001|Full Analysis Set (FAS)|Overall Study|2 patients had no post Baseline geographic atrophy (GA) data|137||
59602528|NCT02130024|75712809|FG000|COMPLETED|Overall Study||117||
59602529|NCT02130024|75712810|FG001|COMPLETED|Overall Study||108||
59602530|NCT02130024|75712809|FG000|NOT COMPLETED|Overall Study||25||
59602531|NCT02130024|75712810|FG001|NOT COMPLETED|Overall Study||31||
59602532|NCT02105688|75712818|FG000|STARTED|Part A: Double-Blind||201||
59602533|NCT02105688|75712819|FG001|STARTED|Part A: Double-Blind||100||
59602534|NCT02105688|75712818|FG000|COMPLETED|Part A: Double-Blind|Completed Part A|181||
59602535|NCT02105688|75712819|FG001|COMPLETED|Part A: Double-Blind|Completed Part A|83||
59602536|NCT02105688|75712818|FG000|NOT COMPLETED|Part A: Double-Blind||20||
59602537|NCT02105688|75712819|FG001|NOT COMPLETED|Part A: Double-Blind||17||
59602538|NCT02105688|75712818|FG000|STARTED|Part B: Observational Follow-up|Completed Part A and met Part B Extension criteria|131||
59602539|NCT02105688|75712819|FG001|STARTED|Part B: Observational Follow-up|Completed Part A and met Part B Extension criteria|68||
59602540|NCT02105688|75712818|FG000|COMPLETED|Part B: Observational Follow-up|Completed Part B extension|94||
59602541|NCT02105688|75712819|FG001|COMPLETED|Part B: Observational Follow-up|Completed Part B extension|48||
59602542|NCT02105688|75712818|FG000|NOT COMPLETED|Part B: Observational Follow-up||37||
59602543|NCT02105688|75712819|FG001|NOT COMPLETED|Part B: Observational Follow-up||20||
59602544|NCT02105454|75712826|FG000|STARTED|Overall Study||79||
59602545|NCT02105454|75712826|FG000|COMPLETED|Overall Study||78||
59602546|NCT02105454|75712826|FG000|NOT COMPLETED|Overall Study||1||
59602547|NCT01625910|75712832|FG000|STARTED|Overall Study||35||
59602548|NCT01625910|75712833|FG001|STARTED|Overall Study||37||
59602549|NCT01625910|75712832|FG000|COMPLETED|Overall Study||32||
59602550|NCT01625910|75712833|FG001|COMPLETED|Overall Study||33||
59602551|NCT01625910|75712832|FG000|NOT COMPLETED|Overall Study||3||
59602552|NCT01625910|75712833|FG001|NOT COMPLETED|Overall Study||4||
59602553|NCT02104752|75712843|FG000|STARTED|Overall Study||18||
59602554|NCT02104752|75712844|FG001|STARTED|Overall Study||21||
59602555|NCT02104752|75712843|FG000|COMPLETED|Overall Study||17||
59602556|NCT02104752|75712844|FG001|COMPLETED|Overall Study||19||
59602557|NCT02104752|75712843|FG000|NOT COMPLETED|Overall Study||1||
59602558|NCT02104752|75712844|FG001|NOT COMPLETED|Overall Study||2||
59602559|NCT02102724|75712852|FG000|STARTED|Overall Study||18||
59602560|NCT02102724|75712853|FG001|STARTED|Overall Study||19||
59602561|NCT02102724|75712852|FG000|COMPLETED|Overall Study||16||
59602562|NCT02102724|75712853|FG001|COMPLETED|Overall Study||18||
59602563|NCT02102724|75712852|FG000|NOT COMPLETED|Overall Study||2||
59602564|NCT02102724|75712853|FG001|NOT COMPLETED|Overall Study||1||
59602565|NCT02102490|75712859|FG000|STARTED|Overall Study||132||
59602566|NCT02102490|75712859|FG000|Received at Least 1 Dose of Study Drug|Overall Study||132||
59602567|NCT02102490|75712859|FG000|COMPLETED|Overall Study||125||
59602568|NCT02102490|75712859|FG000|NOT COMPLETED|Overall Study||7||
59602569|NCT02101554|75712866|FG000|STARTED|Overall Study||6||
59602570|NCT02101554|75712867|FG001|STARTED|Overall Study||10||
59602571|NCT02101554|75712868|FG002|STARTED|Overall Study||3||
59602572|NCT02101554|75712866|FG000|COMPLETED|Overall Study||3||
59602573|NCT02101554|75712867|FG001|COMPLETED|Overall Study||5||
59602574|NCT02101554|75712868|FG002|COMPLETED|Overall Study||2||
59602575|NCT02101554|75712866|FG000|NOT COMPLETED|Overall Study||3||
59602576|NCT02101554|75712867|FG001|NOT COMPLETED|Overall Study||5||
59602577|NCT02101554|75712868|FG002|NOT COMPLETED|Overall Study||1||
59602578|NCT02128932|75712879|FG000|STARTED|Overall Study||362||
59602579|NCT02128932|75712880|FG001|STARTED|Overall Study||360||
59602580|NCT02128932|75712881|FG002|STARTED|Overall Study||360||
59602581|NCT02128932|75712879|FG000|COMPLETED|Overall Study||335||
59602582|NCT02128932|75712880|FG001|COMPLETED|Overall Study||341||
59602583|NCT02128932|75712881|FG002|COMPLETED|Overall Study||342||
59602584|NCT02128932|75712879|FG000|NOT COMPLETED|Overall Study||27||
59602585|NCT02128932|75712880|FG001|NOT COMPLETED|Overall Study||19||
59602586|NCT02128932|75712881|FG002|NOT COMPLETED|Overall Study||18||
59602587|NCT02128542|75712891|FG000|STARTED|Overall Study||47||
59602588|NCT02128542|75712892|FG001|STARTED|Overall Study||19||
59602589|NCT02128542|75712891|FG000|COMPLETED|Overall Study||43||
59602590|NCT02128542|75712892|FG001|COMPLETED|Overall Study||19||
59602591|NCT02128542|75712891|FG000|NOT COMPLETED|Overall Study||4||
59602592|NCT02128542|75712892|FG001|NOT COMPLETED|Overall Study||0||
59602593|NCT02127372|75712902|FG000|STARTED|Overall Study|Signed Consent|15||
59602594|NCT02127372|75712903|FG001|STARTED|Overall Study|Signed Consent|28||
59602595|NCT02127372|75712902|FG000|Started Study Treatment|Overall Study||15||
59602596|NCT02127372|75712903|FG001|Started Study Treatment|Overall Study||28||
59602597|NCT02127372|75712902|FG000|COMPLETED|Overall Study|Completed at least one cycle and were available for dose limiting toxicity (DLT) evaluation.|14||
59602598|NCT02127372|75712903|FG001|COMPLETED|Overall Study||28||
59602599|NCT02127372|75712902|FG000|NOT COMPLETED|Overall Study||1||
59602600|NCT02127372|75712903|FG001|NOT COMPLETED|Overall Study||0||
59602601|NCT02126826|75712917|FG000|STARTED|Overall Study||9||
59602602|NCT02126826|75712918|FG001|STARTED|Overall Study||9||
59602603|NCT02126826|75712919|FG002|STARTED|Overall Study||9||
59602604|NCT02126826|75712920|FG003|STARTED|Overall Study||9||
59602605|NCT02126826|75712921|FG004|STARTED|Overall Study||5||
59602606|NCT02126826|75712922|FG005|STARTED|Overall Study||9||
59602607|NCT02126826|75712923|FG006|STARTED|Overall Study||8||
59602608|NCT02126826|75712917|FG000|COMPLETED|Overall Study||9||
59602609|NCT02126826|75712918|FG001|COMPLETED|Overall Study||9||
59602610|NCT02126826|75712919|FG002|COMPLETED|Overall Study||9||
59602611|NCT02126826|75712920|FG003|COMPLETED|Overall Study||8||
59602612|NCT02126826|75712921|FG004|COMPLETED|Overall Study||5||
59602613|NCT02126826|75712922|FG005|COMPLETED|Overall Study||9||
59602614|NCT02126826|75712923|FG006|COMPLETED|Overall Study||8||
59602615|NCT02126826|75712917|FG000|NOT COMPLETED|Overall Study||0||
59602616|NCT02126826|75712918|FG001|NOT COMPLETED|Overall Study||0||
59602617|NCT02126826|75712919|FG002|NOT COMPLETED|Overall Study||0||
59602618|NCT02126826|75712920|FG003|NOT COMPLETED|Overall Study||1||
59602619|NCT02126826|75712921|FG004|NOT COMPLETED|Overall Study||0||
59602620|NCT02126826|75712922|FG005|NOT COMPLETED|Overall Study||0||
59602621|NCT02126826|75712923|FG006|NOT COMPLETED|Overall Study||0||
59602622|NCT02126670|75712948|FG000|STARTED|Overall Study||26||
59602623|NCT02126670|75712949|FG001|STARTED|Overall Study||24||
59602624|NCT02126670|75712950|FG002|STARTED|Overall Study||25||
59602625|NCT02126670|75712951|FG003|STARTED|Overall Study||25||
59602626|NCT02126670|75712948|FG000|COMPLETED|Overall Study||25||
59602627|NCT02126670|75712949|FG001|COMPLETED|Overall Study||24||
59602628|NCT02126670|75712950|FG002|COMPLETED|Overall Study||25||
59602629|NCT02126670|75712951|FG003|COMPLETED|Overall Study||24||
59602630|NCT02126670|75712948|FG000|NOT COMPLETED|Overall Study||1||
59602631|NCT02126670|75712949|FG001|NOT COMPLETED|Overall Study||0||
59602632|NCT02126670|75712950|FG002|NOT COMPLETED|Overall Study||0||
59602633|NCT02126670|75712951|FG003|NOT COMPLETED|Overall Study||1||
59602634|NCT02125734|75712963|FG000|STARTED|Period 1||40||
59602635|NCT02125734|75712964|FG001|STARTED|Period 1||48||
59602636|NCT02125734|75712963|FG000|COMPLETED|Period 1||40||
59602637|NCT02125734|75712964|FG001|COMPLETED|Period 1||48||
59602638|NCT02125734|75712963|FG000|NOT COMPLETED|Period 1||0||
59602639|NCT02125734|75712964|FG001|NOT COMPLETED|Period 1||0||
59602640|NCT02125734|75712963|FG000|STARTED|Period 2||40||
59602641|NCT02125734|75712964|FG001|STARTED|Period 2||48||
59602642|NCT02125734|75712963|FG000|COMPLETED|Period 2||40||
59602643|NCT02125734|75712964|FG001|COMPLETED|Period 2||47||
59602644|NCT02125734|75712963|FG000|NOT COMPLETED|Period 2||0||
59602645|NCT02125734|75712964|FG001|NOT COMPLETED|Period 2||1||
59602646|NCT02124798|75712970|FG000|STARTED|Overall Study||95||
59602647|NCT02124798|75712970|FG000|COMPLETED|Overall Study||91||
59602648|NCT02124798|75712970|FG000|NOT COMPLETED|Overall Study||4||
59602649|NCT02146326|75712978|FG000|STARTED|Overall Study||89||
59602650|NCT02146326|75712979|FG001|STARTED|Overall Study||103||
59602651|NCT02146326|75712980|FG002|STARTED|Overall Study||211||
59602652|NCT02146326|75712981|FG003|STARTED|Overall Study||258||
59602653|NCT02146326|75712978|FG000|Baseline|Overall Study||89||
59602654|NCT02146326|75712979|FG001|Baseline|Overall Study||103||
59602655|NCT02146326|75712980|FG002|Baseline|Overall Study||211||
59602656|NCT02146326|75712981|FG003|Baseline|Overall Study||258||
59602657|NCT02146326|75712978|FG000|3 Months|Overall Study||71||
59602658|NCT02146326|75712979|FG001|3 Months|Overall Study||83||
59602659|NCT02146326|75712980|FG002|3 Months|Overall Study||0||
59602660|NCT02146326|75712981|FG003|3 Months|Overall Study||0||
59602661|NCT02146326|75712978|FG000|6 Months|Overall Study||71||
59602662|NCT02146326|75712979|FG001|6 Months|Overall Study||71||
59602663|NCT02146326|75712980|FG002|6 Months|Overall Study||186||
59602664|NCT02146326|75712981|FG003|6 Months|Overall Study||235||
59602665|NCT02146326|75712978|FG000|12 Months|Overall Study||61||
59602666|NCT02146326|75712979|FG001|12 Months|Overall Study||66||
59602667|NCT02146326|75712980|FG002|12 Months|Overall Study||168||
59602668|NCT02146326|75712981|FG003|12 Months|Overall Study||210||
59602669|NCT02146326|75712978|FG000|COMPLETED|Overall Study||61||
59602670|NCT02146326|75712979|FG001|COMPLETED|Overall Study||66||
59602671|NCT02146326|75712980|FG002|COMPLETED|Overall Study||168||
59602672|NCT02146326|75712981|FG003|COMPLETED|Overall Study||210||
59602673|NCT02146326|75712978|FG000|NOT COMPLETED|Overall Study||28||
59602674|NCT02146326|75712979|FG001|NOT COMPLETED|Overall Study||37||
59602675|NCT02146326|75712980|FG002|NOT COMPLETED|Overall Study||43||
59602676|NCT02146326|75712981|FG003|NOT COMPLETED|Overall Study||48||
59602677|NCT02146248|75712997|FG000|STARTED|Overall Study||11||
59602678|NCT02146248|75712997|FG000|Enrolled|Overall Study||11||
59602679|NCT02146248|75712997|FG000|Uterine Sounding|Overall Study|one subject dropped out after uterine sound before HSG #1|11||
59602680|NCT02146248|75712997|FG000|HSG 1|Overall Study||10||
59602681|NCT02146248|75712997|FG000|HSG 2|Overall Study||10||
59602682|NCT02146248|75712997|FG000|HSG 3|Overall Study||9||
59602683|NCT02146248|75712997|FG000|HSG 4|Overall Study||7||
59602684|NCT02146248|75712997|FG000|HSG 5|Overall Study||1||
59602685|NCT02146248|75712997|FG000|COMPLETED|Overall Study||9||
59602686|NCT02146248|75712997|FG000|NOT COMPLETED|Overall Study||2||
59602687|NCT02145468|75713007|FG000|STARTED|Overall Study||1758||
59602688|NCT02145468|75713008|FG001|STARTED|Overall Study||1731||
59602689|NCT02145468|75713007|FG000|COMPLETED|Overall Study||1753||
59602690|NCT02145468|75713008|FG001|COMPLETED|Overall Study||1723||
59602691|NCT02145468|75713007|FG000|NOT COMPLETED|Overall Study||5||
59602692|NCT02145468|75713008|FG001|NOT COMPLETED|Overall Study||8||
59602693|NCT02124564|75713014|FG000|STARTED|Treatment Period||19||
59602694|NCT02124564|75713014|FG000|Started Treatment Period|Treatment Period||19||
59602695|NCT02124564|75713014|FG000|Started Titration Period|Treatment Period||19||
59602696|NCT02124564|75713014|FG000|Started AED Withdrawal Period|Treatment Period||19||
59602697|NCT02124564|75713014|FG000|Started Monotherapy Period|Treatment Period||17||
59602698|NCT02124564|75713014|FG000|Started Evaluation Period|Treatment Period||17||
59602699|NCT02124564|75713014|FG000|Started Follow-Up Period|Treatment Period||13||
59602700|NCT02124564|75713014|FG000|COMPLETED|Treatment Period||12||
59602701|NCT02124564|75713014|FG000|NOT COMPLETED|Treatment Period||7||
59602702|NCT02124564|75713014|FG000|STARTED|Taper Period||2|Subjects receiving LCM >200mg/day at the End-of-Study/Early Withdrawal Visit should be tapered off.|
59602703|NCT02124564|75713014|FG000|COMPLETED|Taper Period||2||
59602704|NCT02124564|75713014|FG000|NOT COMPLETED|Taper Period||0||
59602705|NCT02145390|75713019|FG000|STARTED|Overall Study||1||
59602706|NCT02145390|75713019|FG000|COMPLETED|Overall Study||0||
59602707|NCT02145390|75713019|FG000|NOT COMPLETED|Overall Study||1||
59602708|NCT02100696|75713029|FG000|STARTED|Induction Phase||130||
59602709|NCT02100696|75713030|FG001|STARTED|Induction Phase||95||
59602710|NCT02100696|75713031|FG002|STARTED|Induction Phase||384||
59602711|NCT02100696|75713032|FG003|STARTED|Induction Phase||0||
59602712|NCT02100696|75713033|FG004|STARTED|Induction Phase||0||
59602713|NCT02100696|75713034|FG005|STARTED|Induction Phase||0||
59602714|NCT02100696|75713029|FG000|COMPLETED|Induction Phase||115||
59602715|NCT02100696|75713030|FG001|COMPLETED|Induction Phase||90||
59602716|NCT02100696|75713031|FG002|COMPLETED|Induction Phase||358||
59602717|NCT02100696|75713032|FG003|COMPLETED|Induction Phase||0||
59602718|NCT02100696|75713033|FG004|COMPLETED|Induction Phase||0||
59602719|NCT02100696|75713034|FG005|COMPLETED|Induction Phase||0||
59602720|NCT02100696|75713029|FG000|NOT COMPLETED|Induction Phase||15||
59602721|NCT02100696|75713030|FG001|NOT COMPLETED|Induction Phase||5||
59602722|NCT02100696|75713031|FG002|NOT COMPLETED|Induction Phase||26||
59602723|NCT02100696|75713032|FG003|NOT COMPLETED|Induction Phase||0||
59602724|NCT02100696|75713033|FG004|NOT COMPLETED|Induction Phase||0||
59602725|NCT02100696|75713034|FG005|NOT COMPLETED|Induction Phase||0||
59602726|NCT02100696|75713029|FG000|STARTED|Maintenance Phase||0||
59602727|NCT02100696|75713030|FG001|STARTED|Maintenance Phase||0||
59602728|NCT02100696|75713031|FG002|STARTED|Maintenance Phase||0||
59602729|NCT02100696|75713032|FG003|STARTED|Maintenance Phase||27||
59602730|NCT02100696|75713033|FG004|STARTED|Maintenance Phase||115||
59602731|NCT02100696|75713034|FG005|STARTED|Maintenance Phase||117||
59602732|NCT02100696|75713029|FG000|COMPLETED|Maintenance Phase||0||
59602733|NCT02100696|75713030|FG001|COMPLETED|Maintenance Phase||0||
59602734|NCT02100696|75713031|FG002|COMPLETED|Maintenance Phase||0||
59602735|NCT02100696|75713032|FG003|COMPLETED|Maintenance Phase||26||
59602736|NCT02100696|75713033|FG004|COMPLETED|Maintenance Phase||106||
59602737|NCT02100696|75713034|FG005|COMPLETED|Maintenance Phase||112||
59602738|NCT02100696|75713029|FG000|NOT COMPLETED|Maintenance Phase||0||
59602739|NCT02100696|75713030|FG001|NOT COMPLETED|Maintenance Phase||0||
59602740|NCT02100696|75713031|FG002|NOT COMPLETED|Maintenance Phase||0||
59602741|NCT02100696|75713032|FG003|NOT COMPLETED|Maintenance Phase||1||
59602742|NCT02100696|75713033|FG004|NOT COMPLETED|Maintenance Phase||9||
59602743|NCT02100696|75713034|FG005|NOT COMPLETED|Maintenance Phase||5||
59602744|NCT02145156|75713058|FG000|STARTED|Overall Study||430||
59602745|NCT02145156|75713059|FG001|STARTED|Overall Study||425||
59602746|NCT02145156|75713060|FG002|STARTED|Overall Study||439||
59602747|NCT02145156|75713058|FG000|COMPLETED|Overall Study||370||
59602748|NCT02145156|75713059|FG001|COMPLETED|Overall Study||373||
59602749|NCT02145156|75713060|FG002|COMPLETED|Overall Study||398||
59602750|NCT02145156|75713058|FG000|NOT COMPLETED|Overall Study||60||
59602751|NCT02145156|75713059|FG001|NOT COMPLETED|Overall Study||52||
59602752|NCT02145156|75713060|FG002|NOT COMPLETED|Overall Study||41||
59602753|NCT02123472|75713068|FG000|STARTED|Period 1 (7 Days)||14||
59602754|NCT02123472|75713069|FG001|STARTED|Period 1 (7 Days)||14||
59602755|NCT02123472|75713068|FG000|COMPLETED|Period 1 (7 Days)||14||
59602756|NCT02123472|75713069|FG001|COMPLETED|Period 1 (7 Days)||14||
59602757|NCT02123472|75713068|FG000|NOT COMPLETED|Period 1 (7 Days)||0||
59602758|NCT02123472|75713069|FG001|NOT COMPLETED|Period 1 (7 Days)||0||
59602759|NCT02123472|75713068|FG000|STARTED|Washout Period (1 Day)||14||
59602760|NCT02123472|75713069|FG001|STARTED|Washout Period (1 Day)||14||
59602761|NCT02123472|75713068|FG000|COMPLETED|Washout Period (1 Day)||14||
59602762|NCT02123472|75713069|FG001|COMPLETED|Washout Period (1 Day)||14||
59602763|NCT02123472|75713068|FG000|NOT COMPLETED|Washout Period (1 Day)||0||
59602764|NCT02123472|75713069|FG001|NOT COMPLETED|Washout Period (1 Day)||0||
59602765|NCT02123472|75713068|FG000|STARTED|Period 2 (7 Days)||14||
59602766|NCT02123472|75713069|FG001|STARTED|Period 2 (7 Days)||14||
59602767|NCT02123472|75713068|FG000|COMPLETED|Period 2 (7 Days)||14||
59602768|NCT02123472|75713069|FG001|COMPLETED|Period 2 (7 Days)||13||
59602769|NCT02123472|75713068|FG000|NOT COMPLETED|Period 2 (7 Days)||0||
59602770|NCT02123472|75713069|FG001|NOT COMPLETED|Period 2 (7 Days)||1||
59602771|NCT02145078|75713075|FG000|STARTED|Overall Study||4||
59602772|NCT02145078|75713075|FG000|COMPLETED|Overall Study||0||
59602773|NCT02145078|75713075|FG000|NOT COMPLETED|Overall Study||4||
59602774|NCT02144610|75713081|FG000|STARTED|Overall Study||23||
59602775|NCT02144610|75713082|FG001|STARTED|Overall Study||23||
59602776|NCT02144610|75713081|FG000|COMPLETED|Overall Study||0||
59602777|NCT02144610|75713082|FG001|COMPLETED|Overall Study||1||
59602778|NCT02144610|75713081|FG000|NOT COMPLETED|Overall Study||23||
59602779|NCT02144610|75713082|FG001|NOT COMPLETED|Overall Study||22||
59602780|NCT02100228|75713090|FG000|STARTED|Overall Study|735 treated with Apixaban|753||
59602781|NCT02100228|75713091|FG001|STARTED|Overall Study|721 treated with Usual Care|747||
59602782|NCT02100228|75713090|FG000|COMPLETED|Overall Study||678||
59602783|NCT02100228|75713091|FG001|COMPLETED|Overall Study||657||
59602784|NCT02100228|75713090|FG000|NOT COMPLETED|Overall Study||75||
59602785|NCT02100228|75713091|FG001|NOT COMPLETED|Overall Study||90||
59602786|NCT02099838|75713099|FG000|STARTED|Overall Study||47||
59602787|NCT02099838|75713100|FG001|STARTED|Overall Study||51||
59602788|NCT02099838|75713099|FG000|COMPLETED|Overall Study||43||
59602789|NCT02099838|75713100|FG001|COMPLETED|Overall Study||49||
59602790|NCT02099838|75713099|FG000|NOT COMPLETED|Overall Study||4||
59602791|NCT02099838|75713100|FG001|NOT COMPLETED|Overall Study||2||
59602792|NCT02144220|75713106|FG000|STARTED|Overall Study||277||
59602793|NCT02144220|75713106|FG000|COMPLETED|Overall Study||258||
59602794|NCT02144220|75713106|FG000|NOT COMPLETED|Overall Study||19||
59602795|NCT02099682|75713110|FG000|STARTED|Overall Study|Number of cases.|3366||
59602796|NCT02099682|75713110|FG000|Safety Analysis Set (SAS)|Overall Study|All participants who took the study drug at least once.|3255||
59602797|NCT02099682|75713110|FG000|COMPLETED|Overall Study||3255||
59602798|NCT02099682|75713110|FG000|NOT COMPLETED|Overall Study||111||
59602799|NCT02142894|75713114|FG000|STARTED|Overall Study||33||
59602800|NCT02142894|75713114|FG000|COMPLETED|Overall Study||25||
59602801|NCT02142894|75713114|FG000|NOT COMPLETED|Overall Study||8||
59602802|NCT02098746|75713118|FG000|STARTED|Overall Study||294||
59602803|NCT02098746|75713118|FG000|COMPLETED|Overall Study||289||
59602804|NCT02098746|75713118|FG000|NOT COMPLETED|Overall Study||5||
59602805|NCT02122770|75713126|FG000|STARTED|Part A: Drug-drug Interaction 2||13||
59602806|NCT02122770|75713127|FG001|STARTED|Part A: Drug-drug Interaction 2||13||
59602807|NCT02122770|75713128|FG002|STARTED|Part A: Drug-drug Interaction 2||6||
59602808|NCT02122770|75713129|FG003|STARTED|Part A: Drug-drug Interaction 2||19||
59602809|NCT02122770|75713130|FG004|STARTED|Part A: Drug-drug Interaction 2||0||
59602810|NCT02122770|75713131|FG005|STARTED|Part A: Drug-drug Interaction 2||0||
59602811|NCT02122770|75713126|FG000|COMPLETED|Part A: Drug-drug Interaction 2||9|Completed Part A, ongoing to Part B|
59602812|NCT02122770|75713127|FG001|COMPLETED|Part A: Drug-drug Interaction 2||7|Completed Part A, ongoing to Part B|
59602813|NCT02122770|75713128|FG002|COMPLETED|Part A: Drug-drug Interaction 2||4|Completed Part A, ongoing to Part B|
59602814|NCT02122770|75713129|FG003|COMPLETED|Part A: Drug-drug Interaction 2||16|Completed Part A, ongoing to Part B|
59602815|NCT02122770|75713130|FG004|COMPLETED|Part A: Drug-drug Interaction 2||0|Completed Part A, ongoing to Part B|
59602816|NCT02122770|75713131|FG005|COMPLETED|Part A: Drug-drug Interaction 2||0|Completed Part A, ongoing to Part B|
59602817|NCT02122770|75713126|FG000|NOT COMPLETED|Part A: Drug-drug Interaction 2||4||
59602818|NCT02122770|75713127|FG001|NOT COMPLETED|Part A: Drug-drug Interaction 2||6||
59602819|NCT02122770|75713128|FG002|NOT COMPLETED|Part A: Drug-drug Interaction 2||2||
59602820|NCT02122770|75713129|FG003|NOT COMPLETED|Part A: Drug-drug Interaction 2||3||
59602821|NCT02122770|75713130|FG004|NOT COMPLETED|Part A: Drug-drug Interaction 2||0||
59602822|NCT02122770|75713131|FG005|NOT COMPLETED|Part A: Drug-drug Interaction 2||0||
59602823|NCT02122770|75713126|FG000|STARTED|Part B: Standard of Care||0||
59602824|NCT02122770|75713127|FG001|STARTED|Part B: Standard of Care||0||
59602825|NCT02122770|75713128|FG002|STARTED|Part B: Standard of Care||0||
59602826|NCT02122770|75713129|FG003|STARTED|Part B: Standard of Care||0||
59602827|NCT02122770|75713130|FG004|STARTED|Part B: Standard of Care||23||
59602828|NCT02122770|75713131|FG005|STARTED|Part B: Standard of Care||13||
59602829|NCT02122770|75713126|FG000|COMPLETED|Part B: Standard of Care||0||
59602830|NCT02122770|75713127|FG001|COMPLETED|Part B: Standard of Care||0||
59602831|NCT02122770|75713128|FG002|COMPLETED|Part B: Standard of Care||0||
59602832|NCT02122770|75713129|FG003|COMPLETED|Part B: Standard of Care||0||
59602833|NCT02122770|75713130|FG004|COMPLETED|Part B: Standard of Care||0||
59602834|NCT02122770|75713131|FG005|COMPLETED|Part B: Standard of Care||0||
59602835|NCT02122770|75713126|FG000|NOT COMPLETED|Part B: Standard of Care||0||
59602836|NCT02122770|75713127|FG001|NOT COMPLETED|Part B: Standard of Care||0||
59602837|NCT02122770|75713128|FG002|NOT COMPLETED|Part B: Standard of Care||0||
59602838|NCT02122770|75713129|FG003|NOT COMPLETED|Part B: Standard of Care||0||
59602839|NCT02122770|75713130|FG004|NOT COMPLETED|Part B: Standard of Care||23||
59602840|NCT02122770|75713131|FG005|NOT COMPLETED|Part B: Standard of Care||13||
59602841|NCT02122380|75713156|FG000|STARTED|First Intervention (30 Days)||11||
59602842|NCT02122380|75713157|FG001|STARTED|First Intervention (30 Days)||12||
59602843|NCT02122380|75713156|FG000|COMPLETED|First Intervention (30 Days)||10||
59602844|NCT02122380|75713157|FG001|COMPLETED|First Intervention (30 Days)||11||
59602845|NCT02122380|75713156|FG000|NOT COMPLETED|First Intervention (30 Days)||1||
59602846|NCT02122380|75713157|FG001|NOT COMPLETED|First Intervention (30 Days)||1||
59602847|NCT02122380|75713156|FG000|STARTED|Washout (8 Weeks)||10||
59602848|NCT02122380|75713157|FG001|STARTED|Washout (8 Weeks)||11||
59602849|NCT02122380|75713156|FG000|COMPLETED|Washout (8 Weeks)||9||
59602850|NCT02122380|75713157|FG001|COMPLETED|Washout (8 Weeks)||9||
59602851|NCT02122380|75713156|FG000|NOT COMPLETED|Washout (8 Weeks)||1||
59602852|NCT02122380|75713157|FG001|NOT COMPLETED|Washout (8 Weeks)||2||
59602853|NCT02122380|75713156|FG000|STARTED|Second Intervention (30 Days)||9||
59602854|NCT02122380|75713157|FG001|STARTED|Second Intervention (30 Days)||9||
59602855|NCT02122380|75713156|FG000|COMPLETED|Second Intervention (30 Days)||9||
59602856|NCT02122380|75713157|FG001|COMPLETED|Second Intervention (30 Days)||7||
59602857|NCT02122380|75713156|FG000|NOT COMPLETED|Second Intervention (30 Days)||0||
59602858|NCT02122380|75713157|FG001|NOT COMPLETED|Second Intervention (30 Days)||2||
59602859|NCT02122146|75713172|FG000|STARTED|Part 1: Dose Escalation||2||
59602860|NCT02122146|75713173|FG001|STARTED|Part 1: Dose Escalation||2||
59602861|NCT02122146|75713174|FG002|STARTED|Part 1: Dose Escalation||4||
59602862|NCT02122146|75713175|FG003|STARTED|Part 1: Dose Escalation||4||
59602863|NCT02122146|75713176|FG004|STARTED|Part 1: Dose Escalation||4||
59602864|NCT02122146|75713177|FG005|STARTED|Part 1: Dose Escalation||6||
59602865|NCT02122146|75713178|FG006|STARTED|Part 1: Dose Escalation||1||
59602866|NCT02122146|75713179|FG007|STARTED|Part 1: Dose Escalation||8||
59602867|NCT02122146|75713172|FG000|COMPLETED|Part 1: Dose Escalation||1||
59602868|NCT02122146|75713173|FG001|COMPLETED|Part 1: Dose Escalation||1||
59602869|NCT02122146|75713174|FG002|COMPLETED|Part 1: Dose Escalation||2||
59602870|NCT02122146|75713175|FG003|COMPLETED|Part 1: Dose Escalation||3||
59602871|NCT02122146|75713176|FG004|COMPLETED|Part 1: Dose Escalation||3||
59602872|NCT02122146|75713177|FG005|COMPLETED|Part 1: Dose Escalation||5||
59602873|NCT02122146|75713178|FG006|COMPLETED|Part 1: Dose Escalation||0||
59602874|NCT02122146|75713179|FG007|COMPLETED|Part 1: Dose Escalation||6||
59602875|NCT02122146|75713172|FG000|NOT COMPLETED|Part 1: Dose Escalation||1||
59602876|NCT02122146|75713173|FG001|NOT COMPLETED|Part 1: Dose Escalation||1||
59602877|NCT02122146|75713174|FG002|NOT COMPLETED|Part 1: Dose Escalation||2||
59602878|NCT02122146|75713175|FG003|NOT COMPLETED|Part 1: Dose Escalation||1||
59602879|NCT02122146|75713176|FG004|NOT COMPLETED|Part 1: Dose Escalation||1||
59602880|NCT02122146|75713177|FG005|NOT COMPLETED|Part 1: Dose Escalation||1||
59602881|NCT02122146|75713178|FG006|NOT COMPLETED|Part 1: Dose Escalation||1||
59602882|NCT02122146|75713179|FG007|NOT COMPLETED|Part 1: Dose Escalation||2||
59602883|NCT02122146|75713172|FG000|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0||
59602884|NCT02122146|75713173|FG001|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0||
59602885|NCT02122146|75713174|FG002|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0||
59602886|NCT02122146|75713175|FG003|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0||
59602887|NCT02122146|75713176|FG004|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0||
59602888|NCT02122146|75713177|FG005|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0||
59602889|NCT02122146|75713178|FG006|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0||
59602890|NCT02122146|75713179|FG007|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0||
59602891|NCT02122146|75713172|FG000|COMPLETED|Part 2: Maximum Tolerated Dose||0||
59602892|NCT02122146|75713173|FG001|COMPLETED|Part 2: Maximum Tolerated Dose||0||
59602893|NCT02122146|75713174|FG002|COMPLETED|Part 2: Maximum Tolerated Dose||0||
59602894|NCT02122146|75713175|FG003|COMPLETED|Part 2: Maximum Tolerated Dose||0||
59602895|NCT02122146|75713176|FG004|COMPLETED|Part 2: Maximum Tolerated Dose||0||
59602896|NCT02122146|75713177|FG005|COMPLETED|Part 2: Maximum Tolerated Dose||0||
59602897|NCT02122146|75713178|FG006|COMPLETED|Part 2: Maximum Tolerated Dose||0||
59602898|NCT02122146|75713179|FG007|COMPLETED|Part 2: Maximum Tolerated Dose||0||
59602899|NCT02122146|75713172|FG000|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0||
59602900|NCT02122146|75713173|FG001|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0||
59602901|NCT02122146|75713174|FG002|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0||
59602902|NCT02122146|75713175|FG003|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0||
59602903|NCT02122146|75713176|FG004|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0||
59602904|NCT02122146|75713177|FG005|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0||
59602905|NCT02122146|75713178|FG006|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0||
59602906|NCT02122146|75713179|FG007|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0||
59602907|NCT02122146|75713172|FG000|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0||
59602908|NCT02122146|75713173|FG001|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0||
59602909|NCT02122146|75713174|FG002|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0||
59602910|NCT02122146|75713175|FG003|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0||
59602911|NCT02122146|75713176|FG004|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0||
59602912|NCT02122146|75713177|FG005|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0||
59602913|NCT02122146|75713178|FG006|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0||
59602914|NCT02122146|75713179|FG007|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0||
59602915|NCT02122146|75713172|FG000|COMPLETED|Part 3: Expansion||0||
59602916|NCT02122146|75713173|FG001|COMPLETED|Part 3: Expansion||0||
59602917|NCT02122146|75713174|FG002|COMPLETED|Part 3: Expansion||0||
59602918|NCT02122146|75713175|FG003|COMPLETED|Part 3: Expansion||0||
59602919|NCT02122146|75713176|FG004|COMPLETED|Part 3: Expansion||0||
59602920|NCT02122146|75713177|FG005|COMPLETED|Part 3: Expansion||0||
59602921|NCT02122146|75713178|FG006|COMPLETED|Part 3: Expansion||0||
59602922|NCT02122146|75713179|FG007|COMPLETED|Part 3: Expansion||0||
59602923|NCT02122146|75713172|FG000|NOT COMPLETED|Part 3: Expansion||0||
59602924|NCT02122146|75713173|FG001|NOT COMPLETED|Part 3: Expansion||0||
59602925|NCT02122146|75713174|FG002|NOT COMPLETED|Part 3: Expansion||0||
59602926|NCT02122146|75713175|FG003|NOT COMPLETED|Part 3: Expansion||0||
59602927|NCT02122146|75713176|FG004|NOT COMPLETED|Part 3: Expansion||0||
59602928|NCT02122146|75713177|FG005|NOT COMPLETED|Part 3: Expansion||0||
59602929|NCT02122146|75713178|FG006|NOT COMPLETED|Part 3: Expansion||0||
59602930|NCT02122146|75713179|FG007|NOT COMPLETED|Part 3: Expansion||0||
59602931|NCT02121834|75713205|FG000|STARTED|Overall Study||12||
59602932|NCT02121834|75713206|FG001|STARTED|Overall Study||11||
59602933|NCT02121834|75713207|FG002|STARTED|Overall Study||9||
59602934|NCT02121834|75713208|FG003|STARTED|Overall Study||10||
59602935|NCT02121834|75713209|FG004|STARTED|Overall Study||9||
59602936|NCT02121834|75713210|FG005|STARTED|Overall Study||9||
59602937|NCT02121834|75713211|FG006|STARTED|Overall Study||3||
59602938|NCT02121834|75713205|FG000|Received at Least One Dose of Study Drug|Overall Study||12||
59602939|NCT02121834|75713206|FG001|Received at Least One Dose of Study Drug|Overall Study||11||
59602940|NCT02121834|75713207|FG002|Received at Least One Dose of Study Drug|Overall Study||9||
59602941|NCT02121834|75713208|FG003|Received at Least One Dose of Study Drug|Overall Study||10||
59602942|NCT02121834|75713209|FG004|Received at Least One Dose of Study Drug|Overall Study||9||
59602943|NCT02121834|75713210|FG005|Received at Least One Dose of Study Drug|Overall Study||9||
59602944|NCT02121834|75713211|FG006|Received at Least One Dose of Study Drug|Overall Study||3||
59602945|NCT02121834|75713205|FG000|COMPLETED|Overall Study||12||
59602946|NCT02121834|75713206|FG001|COMPLETED|Overall Study||9||
59602947|NCT02121834|75713207|FG002|COMPLETED|Overall Study||7||
59602948|NCT02121834|75713208|FG003|COMPLETED|Overall Study||10||
59602949|NCT02121834|75713209|FG004|COMPLETED|Overall Study||9||
59602950|NCT02121834|75713210|FG005|COMPLETED|Overall Study||9||
59602951|NCT02121834|75713211|FG006|COMPLETED|Overall Study||3||
59602952|NCT02121834|75713205|FG000|NOT COMPLETED|Overall Study||0||
59602953|NCT02121834|75713206|FG001|NOT COMPLETED|Overall Study||2||
59602954|NCT02121834|75713207|FG002|NOT COMPLETED|Overall Study||2||
59602955|NCT02121834|75713208|FG003|NOT COMPLETED|Overall Study||0||
59602956|NCT02121834|75713209|FG004|NOT COMPLETED|Overall Study||0||
59602957|NCT02121834|75713210|FG005|NOT COMPLETED|Overall Study||0||
59602958|NCT02121834|75713211|FG006|NOT COMPLETED|Overall Study||0||
59602959|NCT02121756|75713239|FG000|STARTED|Overall Study||21||
59602960|NCT02121756|75713240|FG001|STARTED|Overall Study||19||
59602961|NCT02121756|75713239|FG000|COMPLETED|Overall Study||15||
59602962|NCT02121756|75713240|FG001|COMPLETED|Overall Study||17||
59602963|NCT02121756|75713239|FG000|NOT COMPLETED|Overall Study||6||
59602964|NCT02121756|75713240|FG001|NOT COMPLETED|Overall Study||2||
59602965|NCT02142504|75713252|FG000|STARTED|Overall Study||153||
59602966|NCT02142504|75713253|FG001|STARTED|Overall Study||147||
59602967|NCT02142504|75713254|FG002|STARTED|Overall Study||154||
59602968|NCT02142504|75713252|FG000|Randomized and Received Treatment|Overall Study||153||
59602969|NCT02142504|75713253|FG001|Randomized and Received Treatment|Overall Study||145||
59602970|NCT02142504|75713254|FG002|Randomized and Received Treatment|Overall Study||154||
59602971|NCT02142504|75713252|FG000|Received Booster (Second Vaccination)|Overall Study||126||
59602972|NCT02142504|75713253|FG001|Received Booster (Second Vaccination)|Overall Study||109||
59602973|NCT02142504|75713254|FG002|Received Booster (Second Vaccination)|Overall Study||116||
59602974|NCT02142504|75713252|FG000|COMPLETED|Overall Study||122||
59602975|NCT02142504|75713253|FG001|COMPLETED|Overall Study||105||
59602976|NCT02142504|75713254|FG002|COMPLETED|Overall Study||111||
59602977|NCT02142504|75713252|FG000|NOT COMPLETED|Overall Study||31||
59602978|NCT02142504|75713253|FG001|NOT COMPLETED|Overall Study||42||
59602979|NCT02142504|75713254|FG002|NOT COMPLETED|Overall Study||43||
59602980|NCT02121522|75713262|FG000|STARTED|Overall Study||14||
59602981|NCT02121522|75713262|FG000|COMPLETED|Overall Study||13||
59602982|NCT02121522|75713262|FG000|NOT COMPLETED|Overall Study||1||
59602983|NCT02121210|75713268|FG000|STARTED|Overall Study||65||
59602984|NCT02121210|75713269|FG001|STARTED|Overall Study||67||
59602985|NCT02121210|75713268|FG000|COMPLETED|Overall Study||58||
59602986|NCT02121210|75713269|FG001|COMPLETED|Overall Study||58||
59602987|NCT02121210|75713268|FG000|NOT COMPLETED|Overall Study||7||
59602988|NCT02121210|75713269|FG001|NOT COMPLETED|Overall Study||9||
59602989|NCT02141490|75713278|FG000|STARTED|Overall Study||34||
59602990|NCT02141490|75713279|FG001|STARTED|Overall Study||6||
59602991|NCT02141490|75713280|FG002|STARTED|Overall Study||3||
59602992|NCT02141490|75713278|FG000|COMPLETED|Overall Study||30||
59602993|NCT02141490|75713279|FG001|COMPLETED|Overall Study||6||
59602994|NCT02141490|75713280|FG002|COMPLETED|Overall Study||3||
59602995|NCT02141490|75713278|FG000|NOT COMPLETED|Overall Study||4||
59602996|NCT02141490|75713279|FG001|NOT COMPLETED|Overall Study||0||
59602997|NCT02141490|75713280|FG002|NOT COMPLETED|Overall Study||0||
59602998|NCT02097108|75713290|FG000|STARTED|Overall Study||11||
59602999|NCT02097108|75713290|FG000|COMPLETED|Overall Study||9||
59603000|NCT02097108|75713290|FG000|NOT COMPLETED|Overall Study||2||
59603001|NCT02097030|75713296|FG000|STARTED|First Intervention (3 Days)||15||
59603002|NCT02097030|75713297|FG001|STARTED|First Intervention (3 Days)||17||
59603003|NCT02097030|75713296|FG000|COMPLETED|First Intervention (3 Days)||14||
59603004|NCT02097030|75713297|FG001|COMPLETED|First Intervention (3 Days)||16||
59603005|NCT02097030|75713296|FG000|NOT COMPLETED|First Intervention (3 Days)||1||
59603006|NCT02097030|75713297|FG001|NOT COMPLETED|First Intervention (3 Days)||1||
59603007|NCT02097030|75713296|FG000|STARTED|Second Intervention (3 Days)||14||
59603008|NCT02097030|75713297|FG001|STARTED|Second Intervention (3 Days)||16||
59603009|NCT02097030|75713296|FG000|COMPLETED|Second Intervention (3 Days)||14||
59603010|NCT02097030|75713297|FG001|COMPLETED|Second Intervention (3 Days)||16||
59603011|NCT02097030|75713296|FG000|NOT COMPLETED|Second Intervention (3 Days)||0||
59603012|NCT02097030|75713297|FG001|NOT COMPLETED|Second Intervention (3 Days)||0||
59603013|NCT02096952|75713307|FG000|STARTED|Overall Study||15||
59603014|NCT02096952|75713307|FG000|COMPLETED|Overall Study||14||
59603015|NCT02096952|75713307|FG000|NOT COMPLETED|Overall Study||1||
59603016|NCT02120898|75713314|FG000|STARTED|Overall Study||187||
59603017|NCT02120898|75713315|FG001|STARTED|Overall Study||187||
59603018|NCT02120898|75713316|FG002|STARTED|Overall Study||93||
59603019|NCT02120898|75713314|FG000|Safety Population|Overall Study||187|All randomized participants who received study drug.|
59603020|NCT02120898|75713315|FG001|Safety Population|Overall Study||187|All randomized participants who received study drug.|
59603021|NCT02120898|75713316|FG002|Safety Population|Overall Study||93|All randomized participants who received study drug.|
59603022|NCT02120898|75713314|FG000|Intent-to-Treat (ITT) Population|Overall Study||183|Applied at least 1 dose of study drug, and returned for at least 1 post-baseline evaluation.|
59603023|NCT02120898|75713315|FG001|Intent-to-Treat (ITT) Population|Overall Study||185|Applied at least 1 dose of study drug, and returned for at least 1 post-baseline evaluation.|
59603024|NCT02120898|75713316|FG002|Intent-to-Treat (ITT) Population|Overall Study||93|Applied at least 1 dose of study drug, and returned for at least 1 post-baseline evaluation.|
59603025|NCT02120898|75713314|FG000|COMPLETED|Overall Study||178||
59603026|NCT02120898|75713315|FG001|COMPLETED|Overall Study||181||
59603027|NCT02120898|75713316|FG002|COMPLETED|Overall Study||89||
59603028|NCT02120898|75713314|FG000|NOT COMPLETED|Overall Study||9||
59603029|NCT02120898|75713315|FG001|NOT COMPLETED|Overall Study||6||
59603030|NCT02120898|75713316|FG002|NOT COMPLETED|Overall Study||4||
59603031|NCT02120664|75713329|FG000|STARTED|Overall Study||10||
59603032|NCT02120664|75713330|FG001|STARTED|Overall Study||4||
59603033|NCT02120664|75713331|FG002|STARTED|Overall Study||7||
59603034|NCT02120664|75713332|FG003|STARTED|Overall Study||4||
59603035|NCT02120664|75713333|FG004|STARTED|Overall Study||10||
59603036|NCT02120664|75713329|FG000|COMPLETED|Overall Study||10||
59603037|NCT02120664|75713330|FG001|COMPLETED|Overall Study||4||
59603038|NCT02120664|75713331|FG002|COMPLETED|Overall Study||7||
59603039|NCT02120664|75713332|FG003|COMPLETED|Overall Study||3||
59603040|NCT02120664|75713333|FG004|COMPLETED|Overall Study||10||
59603041|NCT02120664|75713329|FG000|NOT COMPLETED|Overall Study||0||
59603042|NCT02120664|75713330|FG001|NOT COMPLETED|Overall Study||0||
59603043|NCT02120664|75713331|FG002|NOT COMPLETED|Overall Study||0||
59603044|NCT02120664|75713332|FG003|NOT COMPLETED|Overall Study||1||
59603045|NCT02120664|75713333|FG004|NOT COMPLETED|Overall Study||0||
59603046|NCT01627860|75713348|FG000|STARTED|Overall Study||35||
59603047|NCT01627860|75713349|FG001|STARTED|Overall Study||20||
59603048|NCT01627860|75713348|FG000|COMPLETED|Overall Study||23||
59603049|NCT01627860|75713349|FG001|COMPLETED|Overall Study||14||
59603050|NCT01627860|75713348|FG000|NOT COMPLETED|Overall Study||12||
59603051|NCT01627860|75713349|FG001|NOT COMPLETED|Overall Study||6||
59603052|NCT01627782|75713359|FG000|STARTED|Overall Study||17||
59603053|NCT01627782|75713360|FG001|STARTED|Overall Study||18||
59603054|NCT01627782|75713361|FG002|STARTED|Overall Study||16||
59603055|NCT01627782|75713362|FG003|STARTED|Overall Study||17||
59603056|NCT01627782|75713359|FG000|Treated|Overall Study||16||
59603057|NCT01627782|75713360|FG001|Treated|Overall Study||18||
59603058|NCT01627782|75713361|FG002|Treated|Overall Study||16||
59603059|NCT01627782|75713362|FG003|Treated|Overall Study||17||
59603060|NCT01627782|75713359|FG000|COMPLETED|Overall Study||1||
59603061|NCT01627782|75713360|FG001|COMPLETED|Overall Study||12||
59603062|NCT01627782|75713361|FG002|COMPLETED|Overall Study||1||
59603063|NCT01627782|75713362|FG003|COMPLETED|Overall Study||11||
59603064|NCT01627782|75713359|FG000|NOT COMPLETED|Overall Study||16||
59603065|NCT01627782|75713360|FG001|NOT COMPLETED|Overall Study||6||
59603066|NCT01627782|75713361|FG002|NOT COMPLETED|Overall Study||15||
59603067|NCT01627782|75713362|FG003|NOT COMPLETED|Overall Study||6||
59603068|NCT01598532|75713374|FG000|STARTED|Overall Study||22||
59603069|NCT01598532|75713374|FG000|COMPLETED|Overall Study||11||
59603070|NCT01598532|75713374|FG000|NOT COMPLETED|Overall Study||11||
59603071|NCT02119650|75713383|FG000|STARTED|Overall Study||39||
59603072|NCT02119650|75713384|FG001|STARTED|Overall Study||37||
59603073|NCT02119650|75713383|FG000|COMPLETED|Overall Study|Participants with treatment ongoing when the study was terminated.|14||
59603074|NCT02119650|75713384|FG001|COMPLETED|Overall Study|Participants with treatment ongoing when the study was terminated.|11||
59603075|NCT02119650|75713383|FG000|NOT COMPLETED|Overall Study||25||
59603076|NCT02119650|75713384|FG001|NOT COMPLETED|Overall Study||26||
59603077|NCT02119416|75713393|FG000|STARTED|Overall Study||32||
59603078|NCT02119416|75713394|FG001|STARTED|Overall Study||36||
59603079|NCT02119416|75713395|FG002|STARTED|Overall Study||33||
59603080|NCT02119416|75713393|FG000|COMPLETED|Overall Study||30||
59603081|NCT02119416|75713394|FG001|COMPLETED|Overall Study||35||
59603082|NCT02119416|75713395|FG002|COMPLETED|Overall Study||31||
59603083|NCT02119416|75713393|FG000|NOT COMPLETED|Overall Study||2||
59603084|NCT02119416|75713394|FG001|NOT COMPLETED|Overall Study||1||
59603085|NCT02119416|75713395|FG002|NOT COMPLETED|Overall Study||2||
59603086|NCT02140164|75713406|FG000|STARTED|Overall Study||7||
59603087|NCT02140164|75713406|FG000|COMPLETED|Overall Study||5||
59603088|NCT02140164|75713406|FG000|NOT COMPLETED|Overall Study||2||
59603089|NCT02119260|75713417|FG000|STARTED|Overall Study||9||
59603090|NCT02119260|75713418|FG001|STARTED|Overall Study||12||
59603091|NCT02119260|75713419|FG002|STARTED|Overall Study||8||
59603092|NCT02119260|75713420|FG003|STARTED|Overall Study||10||
59603093|NCT02119260|75713421|FG004|STARTED|Overall Study||13||
59603094|NCT02119260|75713422|FG005|STARTED|Overall Study||6||
59603095|NCT02119260|75713423|FG006|STARTED|Overall Study||2||
59603096|NCT02119260|75713417|FG000|COMPLETED|Overall Study||8||
59603097|NCT02119260|75713418|FG001|COMPLETED|Overall Study||11||
59603098|NCT02119260|75713419|FG002|COMPLETED|Overall Study||7||
59603099|NCT02119260|75713420|FG003|COMPLETED|Overall Study||10||
59603100|NCT02119260|75713421|FG004|COMPLETED|Overall Study||13||
59603101|NCT02119260|75713422|FG005|COMPLETED|Overall Study||6||
59603102|NCT02119260|75713423|FG006|COMPLETED|Overall Study||2||
59603103|NCT02119260|75713417|FG000|NOT COMPLETED|Overall Study||1||
59603104|NCT02119260|75713418|FG001|NOT COMPLETED|Overall Study||1||
59603105|NCT02119260|75713419|FG002|NOT COMPLETED|Overall Study||1||
59603106|NCT02119260|75713420|FG003|NOT COMPLETED|Overall Study||0||
59603107|NCT02119260|75713421|FG004|NOT COMPLETED|Overall Study||0||
59603108|NCT02119260|75713422|FG005|NOT COMPLETED|Overall Study||0||
59603109|NCT02119260|75713423|FG006|NOT COMPLETED|Overall Study||0||
59603110|NCT02119104|75713448|FG000|STARTED|Overall Study||1087||
59603111|NCT02119104|75713448|FG000|COMPLETED|Overall Study||1071||
59603112|NCT02119104|75713448|FG000|NOT COMPLETED|Overall Study||16||
59603113|NCT02119026|75713454|FG000|STARTED|1st-line Treatment||58||
59603114|NCT02119026|75713455|FG001|STARTED|1st-line Treatment||62||
59603115|NCT02119026|75713454|FG000|COMPLETED|1st-line Treatment||32||
59603116|NCT02119026|75713455|FG001|COMPLETED|1st-line Treatment||24||
59603117|NCT02119026|75713454|FG000|NOT COMPLETED|1st-line Treatment||26||
59603118|NCT02119026|75713455|FG001|NOT COMPLETED|1st-line Treatment||38||
59603119|NCT02119026|75713454|FG000|STARTED|2nd-line Treatment||32||
59603120|NCT02119026|75713455|FG001|STARTED|2nd-line Treatment||24||
59603121|NCT02119026|75713454|FG000|COMPLETED|2nd-line Treatment||23||
59603122|NCT02119026|75713455|FG001|COMPLETED|2nd-line Treatment||22||
59603123|NCT02119026|75713454|FG000|NOT COMPLETED|2nd-line Treatment||9||
59603124|NCT02119026|75713455|FG001|NOT COMPLETED|2nd-line Treatment||2||
59603125|NCT02095158|75713461|FG000|STARTED|Overall Study||440||
59603126|NCT02095158|75713461|FG000|COMPLETED|Overall Study||365||
59603127|NCT02095158|75713461|FG000|NOT COMPLETED|Overall Study||75||
59603128|NCT02094612|75713467|FG000|STARTED|Overall Study||112||
59603129|NCT02094612|75713468|FG001|STARTED|Overall Study||95||
59603130|NCT02094612|75713467|FG000|1 Month Follow up|Overall Study||67||
59603131|NCT02094612|75713468|FG001|1 Month Follow up|Overall Study||50||
59603132|NCT02094612|75713467|FG000|3 Month Follow up|Overall Study||50||
59603133|NCT02094612|75713468|FG001|3 Month Follow up|Overall Study||43||
59603134|NCT02094612|75713467|FG000|6 Month Follow up|Overall Study||33||
59603135|NCT02094612|75713468|FG001|6 Month Follow up|Overall Study||25||
59603136|NCT02094612|75713467|FG000|COMPLETED|Overall Study||33||
59603137|NCT02094612|75713468|FG001|COMPLETED|Overall Study||25||
59603138|NCT02094612|75713467|FG000|NOT COMPLETED|Overall Study||79||
59603139|NCT02094612|75713468|FG001|NOT COMPLETED|Overall Study||70||
59603140|NCT02139306|75713476|FG000|STARTED|Overall Study||140||
59603141|NCT02139306|75713477|FG001|STARTED|Overall Study||139||
59603142|NCT02139306|75713476|FG000|COMPLETED|Overall Study||127||
59603143|NCT02139306|75713477|FG001|COMPLETED|Overall Study||125||
59603144|NCT02139306|75713476|FG000|NOT COMPLETED|Overall Study||13||
59603145|NCT02139306|75713477|FG001|NOT COMPLETED|Overall Study||14||
59603146|NCT02094300|75713484|FG000|STARTED|Overall Study||26||
59603147|NCT02094300|75713484|FG000|30 Days|Overall Study||24||
59603148|NCT02094300|75713484|FG000|COMPLETED|Overall Study||6||
59603149|NCT02094300|75713484|FG000|NOT COMPLETED|Overall Study||20||
59603150|NCT02118792|75713490|FG000|STARTED|Overall Study||514||
59603151|NCT02118792|75713491|FG001|STARTED|Overall Study||250||
59603152|NCT02118792|75713490|FG000|Treated|Overall Study||513||
59603153|NCT02118792|75713491|FG001|Treated|Overall Study||250||
59603154|NCT02118792|75713490|FG000|COMPLETED|Overall Study||483||
59603155|NCT02118792|75713491|FG001|COMPLETED|Overall Study||213||
59603156|NCT02118792|75713490|FG000|NOT COMPLETED|Overall Study||31||
59603157|NCT02118792|75713491|FG001|NOT COMPLETED|Overall Study||37||
59603158|NCT02118714|75713499|FG000|STARTED|Overall Study||20||
59603159|NCT02118714|75713499|FG000|COMPLETED|Overall Study||17||
59603160|NCT02118714|75713499|FG000|NOT COMPLETED|Overall Study||3||
59603161|NCT02138916|75713506|FG000|STARTED|Overall Study||554||
59603162|NCT02138916|75713507|FG001|STARTED|Overall Study||552||
59603163|NCT02138916|75713508|FG002|STARTED|Overall Study||550||
59603164|NCT02138916|75713506|FG000|COMPLETED|Overall Study||497||
59603165|NCT02138916|75713507|FG001|COMPLETED|Overall Study||492||
59603166|NCT02138916|75713508|FG002|COMPLETED|Overall Study||491||
59603167|NCT02138916|75713506|FG000|NOT COMPLETED|Overall Study||57||
59603168|NCT02138916|75713507|FG001|NOT COMPLETED|Overall Study||60||
59603169|NCT02138916|75713508|FG002|NOT COMPLETED|Overall Study||59||
59603170|NCT02118012|75713518|FG000|STARTED|Overall Study||12||
59603171|NCT02118012|75713519|FG001|STARTED|Overall Study||12||
59603172|NCT02118012|75713518|FG000|Day 5|Overall Study||12||
59603173|NCT02118012|75713519|FG001|Day 5|Overall Study||11||
59603174|NCT02118012|75713518|FG000|Day 14|Overall Study||12||
59603175|NCT02118012|75713519|FG001|Day 14|Overall Study||10||
59603176|NCT02118012|75713518|FG000|COMPLETED|Overall Study||12||
59603177|NCT02118012|75713519|FG001|COMPLETED|Overall Study||10||
59603178|NCT02118012|75713518|FG000|NOT COMPLETED|Overall Study||0||
59603179|NCT02118012|75713519|FG001|NOT COMPLETED|Overall Study||2||
59603180|NCT02093520|75713527|FG000|STARTED|Overall Study||149||
59603181|NCT02093520|75713528|FG001|STARTED|Overall Study||153||
59603182|NCT02093520|75713527|FG000|COMPLETED|Overall Study||143||
59603183|NCT02093520|75713528|FG001|COMPLETED|Overall Study||131||
59603184|NCT02093520|75713527|FG000|NOT COMPLETED|Overall Study||6||
59603185|NCT02093520|75713528|FG001|NOT COMPLETED|Overall Study||22||
59603186|NCT02138838|75713536|FG000|STARTED|Overall Study||28||
59603187|NCT02138838|75713537|FG001|STARTED|Overall Study||27||
59603188|NCT02138838|75713536|FG000|Received Study Drug|Overall Study||28||
59603189|NCT02138838|75713537|FG001|Received Study Drug|Overall Study||25||
59603190|NCT02138838|75713536|FG000|COMPLETED|Overall Study||20||
59603191|NCT02138838|75713537|FG001|COMPLETED|Overall Study||16||
59603192|NCT02138838|75713536|FG000|NOT COMPLETED|Overall Study||8||
59603193|NCT02138838|75713537|FG001|NOT COMPLETED|Overall Study||11||
59603194|NCT02138214|75713546|FG000|STARTED|Overall Study||30||
59603195|NCT02138214|75713547|FG001|STARTED|Overall Study||30||
59603196|NCT02138214|75713548|FG002|STARTED|Overall Study||30||
59603197|NCT02138214|75713546|FG000|Analyzed for Baseline Measures|Overall Study||30||
59603198|NCT02138214|75713547|FG001|Analyzed for Baseline Measures|Overall Study||29||
59603199|NCT02138214|75713548|FG002|Analyzed for Baseline Measures|Overall Study||30||
59603200|NCT02138214|75713546|FG000|COMPLETED|Overall Study||30||
59603201|NCT02138214|75713547|FG001|COMPLETED|Overall Study||26||
59603202|NCT02138214|75713548|FG002|COMPLETED|Overall Study||26||
59603203|NCT02138214|75713546|FG000|NOT COMPLETED|Overall Study||0||
59603204|NCT02138214|75713547|FG001|NOT COMPLETED|Overall Study||4||
59603205|NCT02138214|75713548|FG002|NOT COMPLETED|Overall Study||4||
59603206|NCT02092662|75713557|FG000|STARTED|Overall Study||38||
59603207|NCT02092662|75713558|FG001|STARTED|Overall Study||19||
59603208|NCT02092662|75713557|FG000|Recruited|Overall Study||38||
59603209|NCT02092662|75713558|FG001|Recruited|Overall Study||19||
59603210|NCT02092662|75713557|FG000|COMPLETED|Overall Study||25||
59603211|NCT02092662|75713558|FG001|COMPLETED|Overall Study||19||
59603212|NCT02092662|75713557|FG000|NOT COMPLETED|Overall Study||13||
59603213|NCT02092662|75713558|FG001|NOT COMPLETED|Overall Study||0||
59603214|NCT02092350|75713567|FG000|STARTED|Overall Study||123||
59603215|NCT02092350|75713568|FG001|STARTED|Overall Study||114||
59603216|NCT02092350|75713567|FG000|COMPLETED|Overall Study||113||
59603217|NCT02092350|75713568|FG001|COMPLETED|Overall Study||102||
59603218|NCT02092350|75713567|FG000|NOT COMPLETED|Overall Study||10||
59603219|NCT02092350|75713568|FG001|NOT COMPLETED|Overall Study||12||
59603220|NCT02117544|75713576|FG000|STARTED|Period 1||54||
59603221|NCT02117544|75713577|FG001|STARTED|Period 1||55||
59603222|NCT02117544|75713576|FG000|Treated|Period 1||52||
59603223|NCT02117544|75713577|FG001|Treated|Period 1||55||
59603224|NCT02117544|75713576|FG000|COMPLETED|Period 1||52||
59603225|NCT02117544|75713577|FG001|COMPLETED|Period 1||55||
59603226|NCT02117544|75713576|FG000|NOT COMPLETED|Period 1||2||
59603227|NCT02117544|75713577|FG001|NOT COMPLETED|Period 1||0||
59603228|NCT02117544|75713576|FG000|STARTED|Period 2||52||
59603229|NCT02117544|75713577|FG001|STARTED|Period 2||55||
59603230|NCT02117544|75713576|FG000|COMPLETED|Period 2||52||
59603231|NCT02117544|75713577|FG001|COMPLETED|Period 2||55||
59603232|NCT02117544|75713576|FG000|NOT COMPLETED|Period 2||0||
59603233|NCT02117544|75713577|FG001|NOT COMPLETED|Period 2||0||
59603234|NCT02138136|75713584|FG000|STARTED|Overall Study||419||
59603235|NCT02138136|75713584|FG000|Safety Analysis Set|Overall Study||419||
59603236|NCT02138136|75713584|FG000|Modified Intent to Treat (mITT)|Overall Study||418|One participant excluded for serious compliance issues with potential data integrity impact|
59603237|NCT02138136|75713584|FG000|COMPLETED|Overall Study||280||
59603238|NCT02138136|75713584|FG000|NOT COMPLETED|Overall Study||139||
59603239|NCT01626690|75713591|FG000|STARTED|Overall Study||49||
59603240|NCT01626690|75713592|FG001|STARTED|Overall Study||51||
59603241|NCT01626690|75713591|FG000|COMPLETED|Overall Study||47||
59603242|NCT01626690|75713592|FG001|COMPLETED|Overall Study||51||
59603243|NCT01626690|75713591|FG000|NOT COMPLETED|Overall Study||2||
59603244|NCT01626690|75713592|FG001|NOT COMPLETED|Overall Study||0||
59603245|NCT01626456|75713602|FG000|STARTED|Overall Study||110||
59603246|NCT01626456|75713603|FG001|STARTED|Overall Study||368||
59603247|NCT01626456|75713602|FG000|COMPLETED|Overall Study||75||
59603248|NCT01626456|75713603|FG001|COMPLETED|Overall Study||251||
59603249|NCT01626456|75713602|FG000|NOT COMPLETED|Overall Study||35||
59603250|NCT01626456|75713603|FG001|NOT COMPLETED|Overall Study||117||
59603251|NCT02116608|75713621|FG000|STARTED|Overall Study||9||
59603252|NCT02116608|75713622|FG001|STARTED|Overall Study||9||
59603253|NCT02116608|75713623|FG002|STARTED|Overall Study||8||
59603254|NCT02116608|75713621|FG000|COMPLETED|Overall Study||9||
59603255|NCT02116608|75713622|FG001|COMPLETED|Overall Study||7||
59603256|NCT02116608|75713623|FG002|COMPLETED|Overall Study||7||
59603257|NCT02116608|75713621|FG000|NOT COMPLETED|Overall Study||0||
59603258|NCT02116608|75713622|FG001|NOT COMPLETED|Overall Study||2||
59603259|NCT02116608|75713623|FG002|NOT COMPLETED|Overall Study||1||
59603260|NCT02092116|75713633|FG000|STARTED|Overall Study||6||
59603261|NCT02092116|75713634|FG001|STARTED|Overall Study||20||
59603262|NCT02092116|75713633|FG000|COMPLETED|Overall Study||6||
59603263|NCT02092116|75713634|FG001|COMPLETED|Overall Study||16||
59603264|NCT02092116|75713633|FG000|NOT COMPLETED|Overall Study||0||
59603265|NCT02092116|75713634|FG001|NOT COMPLETED|Overall Study||4||
59603266|NCT02091726|75713640|FG000|STARTED|Overall Study||110||
59603267|NCT02091726|75713640|FG000|1 Week Followup|Overall Study||110||
59603268|NCT02091726|75713640|FG000|4 Week Followup|Overall Study||104||
59603269|NCT02091726|75713640|FG000|COMPLETED|Overall Study||104||
59603270|NCT02091726|75713640|FG000|NOT COMPLETED|Overall Study||6||
59603271|NCT02091414|75713644|FG000|STARTED|Overall Study||36||
59603272|NCT02091414|75713644|FG000|COMPLETED|Overall Study||32||
59603273|NCT02091414|75713644|FG000|NOT COMPLETED|Overall Study||4||
59603274|NCT02116530|75713650|FG000|STARTED|Overall Study||192||
59603275|NCT02116530|75713651|FG001|STARTED|Overall Study||188||
59603276|NCT02116530|75713650|FG000|COMPLETED|Overall Study||183||
59603277|NCT02116530|75713651|FG001|COMPLETED|Overall Study||184||
59603278|NCT02116530|75713650|FG000|NOT COMPLETED|Overall Study||9||
59603279|NCT02116530|75713651|FG001|NOT COMPLETED|Overall Study||4||
59603280|NCT02072226|75713659|FG000|STARTED|Overall Study||156||
59603281|NCT02072226|75713660|FG001|STARTED|Overall Study||157||
59603282|NCT02072226|75713659|FG000|COMPLETED|Overall Study||141||
59603283|NCT02072226|75713660|FG001|COMPLETED|Overall Study||147||
59603284|NCT02072226|75713659|FG000|NOT COMPLETED|Overall Study||15||
59603285|NCT02072226|75713660|FG001|NOT COMPLETED|Overall Study||10||
59603286|NCT02090634|75713668|FG000|STARTED|Overall Study||30||
59603287|NCT02090634|75713669|FG001|STARTED|Overall Study||28||
59603288|NCT02090634|75713668|FG000|COMPLETED|Overall Study||25||
59603289|NCT02090634|75713669|FG001|COMPLETED|Overall Study||25||
59603290|NCT02090634|75713668|FG000|NOT COMPLETED|Overall Study||5||
59603291|NCT02090634|75713669|FG001|NOT COMPLETED|Overall Study||3||
59603292|NCT02114892|75713677|FG000|STARTED|Overall Study||12||
59603293|NCT02114892|75713678|FG001|STARTED|Overall Study||12||
59603294|NCT02114892|75713677|FG000|COMPLETED|Overall Study|One patient did not complete the study due to early withdrawl|11||
59603295|NCT02114892|75713678|FG001|COMPLETED|Overall Study|Two patients did not complete the study due to early withdrawl|10||
59603296|NCT02114892|75713677|FG000|NOT COMPLETED|Overall Study||1||
59603297|NCT02114892|75713678|FG001|NOT COMPLETED|Overall Study||2||
59603298|NCT02070978|75713687|FG000|STARTED|Overall Study||83||
59603299|NCT02070978|75713688|FG001|STARTED|Overall Study||82||
59603300|NCT02070978|75713689|FG002|STARTED|Overall Study||88||
59603301|NCT02070978|75713687|FG000|COMPLETED|Overall Study||36||
59603302|NCT02070978|75713688|FG001|COMPLETED|Overall Study||29||
59603303|NCT02070978|75713689|FG002|COMPLETED|Overall Study||35||
59603304|NCT02070978|75713687|FG000|NOT COMPLETED|Overall Study||47||
59603305|NCT02070978|75713688|FG001|NOT COMPLETED|Overall Study||53||
59603306|NCT02070978|75713689|FG002|NOT COMPLETED|Overall Study||53||
59603307|NCT02114268|75713703|FG000|STARTED|Overall Study||34||
59603308|NCT02114268|75713704|FG001|STARTED|Overall Study||6||
59603309|NCT02114268|75713705|FG002|STARTED|Overall Study||6||
59603310|NCT02114268|75713706|FG003|STARTED|Overall Study||6||
59603311|NCT02114268|75713707|FG004|STARTED|Overall Study||6||
59603312|NCT02114268|75713708|FG005|STARTED|Overall Study||78||
59603313|NCT02114268|75713703|FG000|COMPLETED|Overall Study||28||
59603314|NCT02114268|75713704|FG001|COMPLETED|Overall Study||5||
59603315|NCT02114268|75713705|FG002|COMPLETED|Overall Study||5||
59603316|NCT02114268|75713706|FG003|COMPLETED|Overall Study||6||
59603317|NCT02114268|75713707|FG004|COMPLETED|Overall Study||6||
59603318|NCT02114268|75713708|FG005|COMPLETED|Overall Study||75||
59603319|NCT02114268|75713703|FG000|NOT COMPLETED|Overall Study||6||
59603320|NCT02114268|75713704|FG001|NOT COMPLETED|Overall Study||1||
59603321|NCT02114268|75713705|FG002|NOT COMPLETED|Overall Study||1||
59603322|NCT02114268|75713706|FG003|NOT COMPLETED|Overall Study||0||
59603323|NCT02114268|75713707|FG004|NOT COMPLETED|Overall Study||0||
59603324|NCT02114268|75713708|FG005|NOT COMPLETED|Overall Study||3||
59603325|NCT02089230|75713730|FG000|STARTED|Overall Study||3||
59603326|NCT02089230|75713731|FG001|STARTED|Overall Study||4||
59603327|NCT02089230|75713732|FG002|STARTED|Overall Study||12||
59603328|NCT02089230|75713730|FG000|COMPLETED|Overall Study||3||
59603329|NCT02089230|75713731|FG001|COMPLETED|Overall Study||4||
59603330|NCT02089230|75713732|FG002|COMPLETED|Overall Study||6||
59603331|NCT02089230|75713730|FG000|NOT COMPLETED|Overall Study||0||
59603332|NCT02089230|75713731|FG001|NOT COMPLETED|Overall Study||0||
59603333|NCT02089230|75713732|FG002|NOT COMPLETED|Overall Study||6||
59603334|NCT02070744|75713744|FG000|STARTED|PC Phase (12 Weeks)||6||
59603335|NCT02070744|75713745|FG001|STARTED|PC Phase (12 Weeks)||5||
59603336|NCT02070744|75713746|FG002|STARTED|PC Phase (12 Weeks)||15||
59603337|NCT02070744|75713747|FG003|STARTED|PC Phase (12 Weeks)||14||
59603338|NCT02070744|75713748|FG004|STARTED|PC Phase (12 Weeks)||0||
59603339|NCT02070744|75713744|FG000|Treated|PC Phase (12 Weeks)||6||
59603340|NCT02070744|75713745|FG001|Treated|PC Phase (12 Weeks)||5||
59603341|NCT02070744|75713746|FG002|Treated|PC Phase (12 Weeks)||15||
59603342|NCT02070744|75713747|FG003|Treated|PC Phase (12 Weeks)||13||
59603343|NCT02070744|75713748|FG004|Treated|PC Phase (12 Weeks)||0||
59603344|NCT02070744|75713744|FG000|COMPLETED|PC Phase (12 Weeks)||6||
59603345|NCT02070744|75713745|FG001|COMPLETED|PC Phase (12 Weeks)||5||
59603346|NCT02070744|75713746|FG002|COMPLETED|PC Phase (12 Weeks)||15||
59603347|NCT02070744|75713747|FG003|COMPLETED|PC Phase (12 Weeks)||13||
59603348|NCT02070744|75713748|FG004|COMPLETED|PC Phase (12 Weeks)||0||
59603349|NCT02070744|75713744|FG000|NOT COMPLETED|PC Phase (12 Weeks)||0||
59603350|NCT02070744|75713745|FG001|NOT COMPLETED|PC Phase (12 Weeks)||0||
59603351|NCT02070744|75713746|FG002|NOT COMPLETED|PC Phase (12 Weeks)||0||
59603352|NCT02070744|75713747|FG003|NOT COMPLETED|PC Phase (12 Weeks)||1||
59603353|NCT02070744|75713748|FG004|NOT COMPLETED|PC Phase (12 Weeks)||0||
59603354|NCT02070744|75713744|FG000|STARTED|OLE Phase (48 Weeks)||0||
59603355|NCT02070744|75713745|FG001|STARTED|OLE Phase (48 Weeks)||0||
59603356|NCT02070744|75713746|FG002|STARTED|OLE Phase (48 Weeks)||0||
59603357|NCT02070744|75713747|FG003|STARTED|OLE Phase (48 Weeks)||0||
59603358|NCT02070744|75713748|FG004|STARTED|OLE Phase (48 Weeks)|12 participants completed PC phase, but did not enter OLE phase.|27||
59603359|NCT02070744|75713744|FG000|COMPLETED|OLE Phase (48 Weeks)||0||
59603360|NCT02070744|75713745|FG001|COMPLETED|OLE Phase (48 Weeks)||0||
59603361|NCT02070744|75713746|FG002|COMPLETED|OLE Phase (48 Weeks)||0||
59603362|NCT02070744|75713747|FG003|COMPLETED|OLE Phase (48 Weeks)||0||
59603363|NCT02070744|75713748|FG004|COMPLETED|OLE Phase (48 Weeks)||24||
59603364|NCT02070744|75713744|FG000|NOT COMPLETED|OLE Phase (48 Weeks)||0||
59603365|NCT02070744|75713745|FG001|NOT COMPLETED|OLE Phase (48 Weeks)||0||
59603366|NCT02070744|75713746|FG002|NOT COMPLETED|OLE Phase (48 Weeks)||0||
59603367|NCT02070744|75713747|FG003|NOT COMPLETED|OLE Phase (48 Weeks)||0||
59603368|NCT02070744|75713748|FG004|NOT COMPLETED|OLE Phase (48 Weeks)||3||
59603369|NCT02113956|75713765|FG000|STARTED|Intervention End (5 Weeks Post Baseline)||150||
59603370|NCT02113956|75713766|FG001|STARTED|Intervention End (5 Weeks Post Baseline)||152||
59603371|NCT02113956|75713765|FG000|COMPLETED|Intervention End (5 Weeks Post Baseline)||141||
59603372|NCT02113956|75713766|FG001|COMPLETED|Intervention End (5 Weeks Post Baseline)||148||
59603373|NCT02113956|75713765|FG000|NOT COMPLETED|Intervention End (5 Weeks Post Baseline)||9||
59603374|NCT02113956|75713766|FG001|NOT COMPLETED|Intervention End (5 Weeks Post Baseline)||4||
59603375|NCT02113956|75713765|FG000|STARTED|3 Month Post-intervention||141||
59603376|NCT02113956|75713766|FG001|STARTED|3 Month Post-intervention||148||
59603377|NCT02113956|75713765|FG000|COMPLETED|3 Month Post-intervention||137||
59603378|NCT02113956|75713766|FG001|COMPLETED|3 Month Post-intervention||146||
59603379|NCT02113956|75713765|FG000|NOT COMPLETED|3 Month Post-intervention||4||
59603380|NCT02113956|75713766|FG001|NOT COMPLETED|3 Month Post-intervention||2||
59603381|NCT02070588|75713775|FG000|STARTED|Overall Study||86||
59603382|NCT02070588|75713776|FG001|STARTED|Overall Study||26||
59603383|NCT02070588|75713777|FG002|STARTED|Overall Study||0||
59603384|NCT02070588|75713775|FG000|COMPLETED|Overall Study||47||
59603385|NCT02070588|75713776|FG001|COMPLETED|Overall Study||25||
59603386|NCT02070588|75713777|FG002|COMPLETED|Overall Study||0||
59603387|NCT02070588|75713775|FG000|NOT COMPLETED|Overall Study||39||
59603388|NCT02070588|75713776|FG001|NOT COMPLETED|Overall Study||1||
59603389|NCT02070588|75713777|FG002|NOT COMPLETED|Overall Study||0||
59603390|NCT02111850|75713796|FG000|STARTED|Phase 1 Dose Escalation||1||
59603391|NCT02111850|75713797|FG001|STARTED|Phase 1 Dose Escalation||1||
59603392|NCT02111850|75713798|FG002|STARTED|Phase 1 Dose Escalation||1||
59603393|NCT02111850|75713799|FG003|STARTED|Phase 1 Dose Escalation||1||
59603394|NCT02111850|75713800|FG004|STARTED|Phase 1 Dose Escalation||2||
59603395|NCT02111850|75713801|FG005|STARTED|Phase 1 Dose Escalation||1||
59603396|NCT02111850|75713802|FG006|STARTED|Phase 1 Dose Escalation||1||
59603397|NCT02111850|75713803|FG007|STARTED|Phase 1 Dose Escalation||1||
59603398|NCT02111850|75713804|FG008|STARTED|Phase 1 Dose Escalation||6||
59603399|NCT02111850|75713805|FG009|STARTED|Phase 1 Dose Escalation||0||
59603400|NCT02111850|75713806|FG010|STARTED|Phase 1 Dose Escalation||0||
59603401|NCT02111850|75713796|FG000|COMPLETED|Phase 1 Dose Escalation||1||
59603402|NCT02111850|75713797|FG001|COMPLETED|Phase 1 Dose Escalation||1||
59603403|NCT02111850|75713798|FG002|COMPLETED|Phase 1 Dose Escalation||1||
59603404|NCT02111850|75713799|FG003|COMPLETED|Phase 1 Dose Escalation||1||
59603405|NCT02111850|75713800|FG004|COMPLETED|Phase 1 Dose Escalation||1||
59603406|NCT02111850|75713801|FG005|COMPLETED|Phase 1 Dose Escalation||1||
59603407|NCT02111850|75713802|FG006|COMPLETED|Phase 1 Dose Escalation||1||
59603408|NCT02111850|75713803|FG007|COMPLETED|Phase 1 Dose Escalation||1||
59603409|NCT02111850|75713804|FG008|COMPLETED|Phase 1 Dose Escalation||6||
59603410|NCT02111850|75713805|FG009|COMPLETED|Phase 1 Dose Escalation||0||
59603411|NCT02111850|75713806|FG010|COMPLETED|Phase 1 Dose Escalation||0||
59603412|NCT02111850|75713796|FG000|NOT COMPLETED|Phase 1 Dose Escalation||0||
59603413|NCT02111850|75713797|FG001|NOT COMPLETED|Phase 1 Dose Escalation||0||
59603414|NCT02111850|75713798|FG002|NOT COMPLETED|Phase 1 Dose Escalation||0||
59603415|NCT02111850|75713799|FG003|NOT COMPLETED|Phase 1 Dose Escalation||0||
59603416|NCT02111850|75713800|FG004|NOT COMPLETED|Phase 1 Dose Escalation||1||
59603417|NCT02111850|75713801|FG005|NOT COMPLETED|Phase 1 Dose Escalation||0||
59603418|NCT02111850|75713802|FG006|NOT COMPLETED|Phase 1 Dose Escalation||0||
59603419|NCT02111850|75713803|FG007|NOT COMPLETED|Phase 1 Dose Escalation||0||
59603420|NCT02111850|75713804|FG008|NOT COMPLETED|Phase 1 Dose Escalation||0||
59603421|NCT02111850|75713805|FG009|NOT COMPLETED|Phase 1 Dose Escalation||0||
59603422|NCT02111850|75713806|FG010|NOT COMPLETED|Phase 1 Dose Escalation||0||
59603423|NCT02111850|75713796|FG000|STARTED|Phase 2 Maximum Tolerated Dose||0||
59603424|NCT02111850|75713797|FG001|STARTED|Phase 2 Maximum Tolerated Dose||0||
59603425|NCT02111850|75713798|FG002|STARTED|Phase 2 Maximum Tolerated Dose||0||
59603426|NCT02111850|75713799|FG003|STARTED|Phase 2 Maximum Tolerated Dose||0||
59603427|NCT02111850|75713800|FG004|STARTED|Phase 2 Maximum Tolerated Dose||0||
59603428|NCT02111850|75713801|FG005|STARTED|Phase 2 Maximum Tolerated Dose||0||
59603429|NCT02111850|75713802|FG006|STARTED|Phase 2 Maximum Tolerated Dose||0||
59603430|NCT02111850|75713803|FG007|STARTED|Phase 2 Maximum Tolerated Dose||0||
59603431|NCT02111850|75713804|FG008|STARTED|Phase 2 Maximum Tolerated Dose||0||
59603432|NCT02111850|75713805|FG009|STARTED|Phase 2 Maximum Tolerated Dose||5||
59603433|NCT02111850|75713806|FG010|STARTED|Phase 2 Maximum Tolerated Dose||1||
59603434|NCT02111850|75713796|FG000|COMPLETED|Phase 2 Maximum Tolerated Dose||0||
59603435|NCT02111850|75713797|FG001|COMPLETED|Phase 2 Maximum Tolerated Dose||0||
59603436|NCT02111850|75713798|FG002|COMPLETED|Phase 2 Maximum Tolerated Dose||0||
59603437|NCT02111850|75713799|FG003|COMPLETED|Phase 2 Maximum Tolerated Dose||0||
59603438|NCT02111850|75713800|FG004|COMPLETED|Phase 2 Maximum Tolerated Dose||0||
59603439|NCT02111850|75713801|FG005|COMPLETED|Phase 2 Maximum Tolerated Dose||0||
59603440|NCT02111850|75713802|FG006|COMPLETED|Phase 2 Maximum Tolerated Dose||0||
59603441|NCT02111850|75713803|FG007|COMPLETED|Phase 2 Maximum Tolerated Dose||0||
59603442|NCT02111850|75713804|FG008|COMPLETED|Phase 2 Maximum Tolerated Dose||0||
59603443|NCT02111850|75713805|FG009|COMPLETED|Phase 2 Maximum Tolerated Dose||5||
59603444|NCT02111850|75713806|FG010|COMPLETED|Phase 2 Maximum Tolerated Dose||1||
59603445|NCT02111850|75713796|FG000|NOT COMPLETED|Phase 2 Maximum Tolerated Dose||0||
59603446|NCT02111850|75713797|FG001|NOT COMPLETED|Phase 2 Maximum Tolerated Dose||0||
59603447|NCT02111850|75713798|FG002|NOT COMPLETED|Phase 2 Maximum Tolerated Dose||0||
59603448|NCT02111850|75713799|FG003|NOT COMPLETED|Phase 2 Maximum Tolerated Dose||0||
59603449|NCT02111850|75713800|FG004|NOT COMPLETED|Phase 2 Maximum Tolerated Dose||0||
59603450|NCT02111850|75713801|FG005|NOT COMPLETED|Phase 2 Maximum Tolerated Dose||0||
59603451|NCT02111850|75713802|FG006|NOT COMPLETED|Phase 2 Maximum Tolerated Dose||0||
59603452|NCT02111850|75713803|FG007|NOT COMPLETED|Phase 2 Maximum Tolerated Dose||0||
59603453|NCT02111850|75713804|FG008|NOT COMPLETED|Phase 2 Maximum Tolerated Dose||0||
59603454|NCT02111850|75713805|FG009|NOT COMPLETED|Phase 2 Maximum Tolerated Dose||0||
59603455|NCT02111850|75713806|FG010|NOT COMPLETED|Phase 2 Maximum Tolerated Dose||0||
59603456|NCT02087904|75713836|FG000|STARTED|Overall Study||85||
59603457|NCT02087904|75713837|FG001|STARTED|Overall Study||89||
59603458|NCT02087904|75713838|FG002|STARTED|Overall Study||87||
59603459|NCT02087904|75713839|FG003|STARTED|Overall Study||89||
59603460|NCT02087904|75713836|FG000|COMPLETED|Overall Study||60||
59603461|NCT02087904|75713837|FG001|COMPLETED|Overall Study||70||
59603462|NCT02087904|75713838|FG002|COMPLETED|Overall Study||65||
59603463|NCT02087904|75713839|FG003|COMPLETED|Overall Study||64||
59603464|NCT02087904|75713836|FG000|NOT COMPLETED|Overall Study||25||
59603465|NCT02087904|75713837|FG001|NOT COMPLETED|Overall Study||19||
59603466|NCT02087904|75713838|FG002|NOT COMPLETED|Overall Study||22||
59603467|NCT02087904|75713839|FG003|NOT COMPLETED|Overall Study||25||
59603468|NCT02087670|75713851|FG000|STARTED|Overall Study||20||
59603469|NCT02087670|75713852|FG001|STARTED|Overall Study||22||
59603470|NCT02087670|75713851|FG000|COMPLETED|Overall Study||17||
59603471|NCT02087670|75713852|FG001|COMPLETED|Overall Study||20||
59603472|NCT02087670|75713851|FG000|NOT COMPLETED|Overall Study||3||
59603473|NCT02087670|75713852|FG001|NOT COMPLETED|Overall Study||2||
59603474|NCT02086968|75713860|FG000|STARTED|Overall Study||100||
59603475|NCT02086968|75713861|FG001|STARTED|Overall Study||98||
59603476|NCT02086968|75713860|FG000|COMPLETED|Overall Study||92||
59603477|NCT02086968|75713861|FG001|COMPLETED|Overall Study||85||
59603478|NCT02086968|75713860|FG000|NOT COMPLETED|Overall Study||8||
59603479|NCT02086968|75713861|FG001|NOT COMPLETED|Overall Study||13||
59603480|NCT02086110|75713869|FG000|STARTED|Overall Study||5||
59603481|NCT02086110|75713870|FG001|STARTED|Overall Study||6||
59603482|NCT02086110|75713869|FG000|COMPLETED|Overall Study||4||
59603483|NCT02086110|75713870|FG001|COMPLETED|Overall Study||5||
59603484|NCT02086110|75713869|FG000|NOT COMPLETED|Overall Study||1||
59603485|NCT02086110|75713870|FG001|NOT COMPLETED|Overall Study||1||
59603486|NCT02085252|75713879|FG000|STARTED|Overall Study||58||
59603487|NCT02085252|75713880|FG001|STARTED|Overall Study||57||
59603488|NCT02085252|75713879|FG000|COMPLETED|Overall Study||57||
59603489|NCT02085252|75713880|FG001|COMPLETED|Overall Study||53||
59603490|NCT02085252|75713879|FG000|NOT COMPLETED|Overall Study||1||
59603491|NCT02085252|75713880|FG001|NOT COMPLETED|Overall Study||4||
59603492|NCT02084238|75713886|FG000|STARTED|Overall Study||40||
59603493|NCT02084238|75713886|FG000|COMPLETED|Overall Study||38||
59603494|NCT02084238|75713886|FG000|NOT COMPLETED|Overall Study||2||
59603495|NCT02084082|75713899|FG000|STARTED|Treatment Period 1 (4 Days)||26||
59603496|NCT02084082|75713900|FG001|STARTED|Treatment Period 1 (4 Days)||26||
59603497|NCT02084082|75713901|FG002|STARTED|Treatment Period 1 (4 Days)||8||
59603498|NCT02084082|75713902|FG003|STARTED|Treatment Period 1 (4 Days)||8||
59603499|NCT02084082|75713899|FG000|COMPLETED|Treatment Period 1 (4 Days)||26||
59603500|NCT02084082|75713900|FG001|COMPLETED|Treatment Period 1 (4 Days)||26||
59603501|NCT02084082|75713901|FG002|COMPLETED|Treatment Period 1 (4 Days)||8||
59603502|NCT02084082|75713902|FG003|COMPLETED|Treatment Period 1 (4 Days)||8||
59603503|NCT02084082|75713899|FG000|NOT COMPLETED|Treatment Period 1 (4 Days)||0||
59603504|NCT02084082|75713900|FG001|NOT COMPLETED|Treatment Period 1 (4 Days)||0||
59603505|NCT02084082|75713901|FG002|NOT COMPLETED|Treatment Period 1 (4 Days)||0||
59603506|NCT02084082|75713902|FG003|NOT COMPLETED|Treatment Period 1 (4 Days)||0||
59603507|NCT02084082|75713899|FG000|STARTED|Washout Period 1 (35 Days)||26||
59603508|NCT02084082|75713900|FG001|STARTED|Washout Period 1 (35 Days)||26||
59603509|NCT02084082|75713901|FG002|STARTED|Washout Period 1 (35 Days)||8||
59603510|NCT02084082|75713902|FG003|STARTED|Washout Period 1 (35 Days)||8||
59603511|NCT02084082|75713899|FG000|COMPLETED|Washout Period 1 (35 Days)||26||
59603512|NCT02084082|75713900|FG001|COMPLETED|Washout Period 1 (35 Days)||26||
59603513|NCT02084082|75713901|FG002|COMPLETED|Washout Period 1 (35 Days)||7||
59603514|NCT02084082|75713902|FG003|COMPLETED|Washout Period 1 (35 Days)||6||
59603515|NCT02084082|75713899|FG000|NOT COMPLETED|Washout Period 1 (35 Days)||0||
59603516|NCT02084082|75713900|FG001|NOT COMPLETED|Washout Period 1 (35 Days)||0||
59603517|NCT02084082|75713901|FG002|NOT COMPLETED|Washout Period 1 (35 Days)||1||
59603518|NCT02084082|75713902|FG003|NOT COMPLETED|Washout Period 1 (35 Days)||2||
59603519|NCT02084082|75713899|FG000|STARTED|Treatment Period 2 (4 Days)||26||
59603520|NCT02084082|75713900|FG001|STARTED|Treatment Period 2 (4 Days)||26||
59603521|NCT02084082|75713901|FG002|STARTED|Treatment Period 2 (4 Days)||7||
59603522|NCT02084082|75713902|FG003|STARTED|Treatment Period 2 (4 Days)||6||
59603523|NCT02084082|75713899|FG000|COMPLETED|Treatment Period 2 (4 Days)||26||
59603524|NCT02084082|75713900|FG001|COMPLETED|Treatment Period 2 (4 Days)||26||
59603525|NCT02084082|75713901|FG002|COMPLETED|Treatment Period 2 (4 Days)||7||
59603526|NCT02084082|75713902|FG003|COMPLETED|Treatment Period 2 (4 Days)||6||
59603527|NCT02084082|75713899|FG000|NOT COMPLETED|Treatment Period 2 (4 Days)||0||
59603528|NCT02084082|75713900|FG001|NOT COMPLETED|Treatment Period 2 (4 Days)||0||
59603529|NCT02084082|75713901|FG002|NOT COMPLETED|Treatment Period 2 (4 Days)||0||
59603530|NCT02084082|75713902|FG003|NOT COMPLETED|Treatment Period 2 (4 Days)||0||
59603531|NCT02083926|75713914|FG000|STARTED|Overall Study||9||
59603532|NCT02083926|75713915|FG001|STARTED|Overall Study||9||
59603533|NCT02083926|75713914|FG000|COMPLETED|Overall Study||8||
59603534|NCT02083926|75713915|FG001|COMPLETED|Overall Study||9||
59603535|NCT02083926|75713914|FG000|NOT COMPLETED|Overall Study||1||
59603536|NCT02083926|75713915|FG001|NOT COMPLETED|Overall Study||0||
59603537|NCT02083380|75713925|FG000|STARTED|Overall Study|5 subjects excluded from safety / ITT population - no drug administered|148||
59603538|NCT02083380|75713926|FG001|STARTED|Overall Study|3 subjects excluded from safety / ITT population - no drug administered|151||
59603539|NCT02083380|75713927|FG002|STARTED|Overall Study|3 subjects excluded from safety / ITT population - no drug administered|149||
59603540|NCT02083380|75713925|FG000|COMPLETED|Overall Study||57|Lack of Efficacy = Received rescue treatment therefore linked with the efficacy endpoint ACPR|
59603541|NCT02083380|75713926|FG001|COMPLETED|Overall Study||56|Lack of Efficacy = Received rescue treatment therefore linked with the efficacy endpoint ACPR|
59603542|NCT02083380|75713927|FG002|COMPLETED|Overall Study||65|Lack of Efficacy = Received rescue treatment therefore linked with the efficacy endpoint ACPR|
59603543|NCT02083380|75713925|FG000|NOT COMPLETED|Overall Study||91||
60134696|NCT04163458|76257933|FG001|STARTED|Overall Study||201||
60134697|NCT04163458|76257932|FG000|mITT|Overall Study||202||
60134698|NCT04163458|76257933|FG001|mITT|Overall Study||199||
60134699|NCT04163458|76257932|FG000|COMPLETED|Overall Study||180||
60134700|NCT04163458|76257933|FG001|COMPLETED|Overall Study||171||
60134701|NCT04163458|76257932|FG000|NOT COMPLETED|Overall Study||24||
60134702|NCT04163458|76257933|FG001|NOT COMPLETED|Overall Study||30||
60134703|NCT04118348|76257943|FG000|STARTED|Overall Study||3416||
59603544|NCT02083380|75713926|FG001|NOT COMPLETED|Overall Study||95||
59603545|NCT02083380|75713927|FG002|NOT COMPLETED|Overall Study||84||
59603546|NCT02109744|75713942|FG000|STARTED|Overall Study||26||
59603547|NCT02109744|75713943|FG001|STARTED|Overall Study||1||
59603548|NCT02109744|75713942|FG000|COMPLETED|Overall Study||24||
59603549|NCT02109744|75713943|FG001|COMPLETED|Overall Study||0||
59603550|NCT02109744|75713942|FG000|NOT COMPLETED|Overall Study||2||
59603551|NCT02109744|75713943|FG001|NOT COMPLETED|Overall Study||1||
59603552|NCT02109432|75713949|FG000|STARTED|Overall Study||7||
59603553|NCT02109432|75713949|FG000|COMPLETED|Overall Study||6||
59603554|NCT02109432|75713949|FG000|NOT COMPLETED|Overall Study||1||
59603555|NCT02109042|75713953|FG000|STARTED|Overall Study||15||
59603556|NCT02109042|75713953|FG000|Received at Least 1 Dose of Study Drug|Overall Study||15||
59603557|NCT02109042|75713953|FG000|Received 180 mg Loading Dose|Overall Study||15||
59603558|NCT02109042|75713953|FG000|Receive at Least 1 Subsequent 90 mg Dose|Overall Study||15||
59603559|NCT02109042|75713953|FG000|COMPLETED|Overall Study||0||
59603560|NCT02109042|75713953|FG000|NOT COMPLETED|Overall Study||15||
59603561|NCT02066922|75713958|FG000|STARTED|Overall Study||15||
59603562|NCT02066922|75713958|FG000|COMPLETED|Overall Study||14||
59603563|NCT02066922|75713958|FG000|NOT COMPLETED|Overall Study||1||
59603564|NCT02108262|75713969|FG000|STARTED|Overall Study||9||
59603565|NCT02108262|75713970|FG001|STARTED|Overall Study||419||
59603566|NCT02108262|75713971|FG002|STARTED|Overall Study||421||
59603567|NCT02108262|75713972|FG003|STARTED|Overall Study||418||
59603568|NCT02108262|75713969|FG000|COMPLETED|Overall Study||9||
59603569|NCT02108262|75713970|FG001|COMPLETED|Overall Study||375||
59603570|NCT02108262|75713971|FG002|COMPLETED|Overall Study||379||
59603571|NCT02108262|75713972|FG003|COMPLETED|Overall Study||376||
59603572|NCT02108262|75713969|FG000|NOT COMPLETED|Overall Study||0||
59603573|NCT02108262|75713970|FG001|NOT COMPLETED|Overall Study||44||
59603574|NCT02108262|75713971|FG002|NOT COMPLETED|Overall Study||42||
59603575|NCT02108262|75713972|FG003|NOT COMPLETED|Overall Study||42||
59603576|NCT02107482|75713981|FG000|STARTED|Overall Study|21 participants enrolled. Total of 21 participants recvd both active and sham|21||
59603577|NCT02107482|75713981|FG000|COMPLETED|Overall Study||17||
59603578|NCT02107482|75713981|FG000|NOT COMPLETED|Overall Study||4||
59603579|NCT02066298|75713991|FG000|STARTED|Overall Study||49||
59603580|NCT02066298|75713992|FG001|STARTED|Overall Study||48||
59603581|NCT02066298|75713993|FG002|STARTED|Overall Study||50||
59603582|NCT02066298|75713994|FG003|STARTED|Overall Study||51||
59603583|NCT02066298|75713995|FG004|STARTED|Overall Study||47||
59603584|NCT02066298|75713996|FG005|STARTED|Overall Study||50||
59603585|NCT02066298|75713991|FG000|Completed 1st Period|Overall Study||44||
59603586|NCT02066298|75713992|FG001|Completed 1st Period|Overall Study||47||
59603587|NCT02066298|75713993|FG002|Completed 1st Period|Overall Study||45||
59603588|NCT02066298|75713994|FG003|Completed 1st Period|Overall Study||48||
59603589|NCT02066298|75713995|FG004|Completed 1st Period|Overall Study||46||
59603590|NCT02066298|75713996|FG005|Completed 1st Period|Overall Study||45||
59603591|NCT02066298|75713991|FG000|Completed 2nd Period|Overall Study||41||
59603592|NCT02066298|75713992|FG001|Completed 2nd Period|Overall Study||41||
59603593|NCT02066298|75713993|FG002|Completed 2nd Period|Overall Study||41||
59603594|NCT02066298|75713994|FG003|Completed 2nd Period|Overall Study||46||
59603595|NCT02066298|75713995|FG004|Completed 2nd Period|Overall Study||42||
59603596|NCT02066298|75713996|FG005|Completed 2nd Period|Overall Study||41||
59603597|NCT02066298|75713991|FG000|Completed 3rd Period|Overall Study||40||
59603598|NCT02066298|75713992|FG001|Completed 3rd Period|Overall Study||40||
59603599|NCT02066298|75713993|FG002|Completed 3rd Period|Overall Study||40||
59603600|NCT02066298|75713994|FG003|Completed 3rd Period|Overall Study||45||
59603601|NCT02066298|75713995|FG004|Completed 3rd Period|Overall Study||38||
59603602|NCT02066298|75713996|FG005|Completed 3rd Period|Overall Study||38||
59603603|NCT02066298|75713991|FG000|COMPLETED|Overall Study||40||
59603604|NCT02066298|75713992|FG001|COMPLETED|Overall Study||40||
59603605|NCT02066298|75713993|FG002|COMPLETED|Overall Study||40||
59603606|NCT02066298|75713994|FG003|COMPLETED|Overall Study||45||
60134704|NCT04118348|76257944|FG001|STARTED|Overall Study||3265||
60134705|NCT04118348|76257945|FG002|STARTED|Overall Study||3441||
59603607|NCT02066298|75713995|FG004|COMPLETED|Overall Study||38||
59603608|NCT02066298|75713996|FG005|COMPLETED|Overall Study||38||
59603609|NCT02066298|75713991|FG000|NOT COMPLETED|Overall Study||9||
59603610|NCT02066298|75713992|FG001|NOT COMPLETED|Overall Study||8||
59603611|NCT02066298|75713993|FG002|NOT COMPLETED|Overall Study||10||
59603612|NCT02066298|75713994|FG003|NOT COMPLETED|Overall Study||6||
59603613|NCT02066298|75713995|FG004|NOT COMPLETED|Overall Study||9||
59603614|NCT02066298|75713996|FG005|NOT COMPLETED|Overall Study||12||
59603615|NCT02082912|75714010|FG000|STARTED|Overall Study||7||
59603616|NCT02082912|75714011|FG001|STARTED|Overall Study||7||
59603617|NCT02082912|75714010|FG000|COMPLETED|Overall Study||7||
59603618|NCT02082912|75714011|FG001|COMPLETED|Overall Study||6||
59603619|NCT02082912|75714010|FG000|NOT COMPLETED|Overall Study||0||
59603620|NCT02082912|75714011|FG001|NOT COMPLETED|Overall Study||1||
59603621|NCT02082522|75714019|FG000|STARTED|Overall Study||15||
59603622|NCT02082522|75714020|FG001|STARTED|Overall Study||13||
59603623|NCT02082522|75714019|FG000|COMPLETED|Overall Study||0||
59603624|NCT02082522|75714020|FG001|COMPLETED|Overall Study||0||
59603625|NCT02082522|75714019|FG000|NOT COMPLETED|Overall Study||15||
59603626|NCT02082522|75714020|FG001|NOT COMPLETED|Overall Study||13||
59603627|NCT02082210|75714032|FG000|STARTED|Overall Study||3||
59603628|NCT02082210|75714033|FG001|STARTED|Overall Study||3||
59603629|NCT02082210|75714034|FG002|STARTED|Overall Study||16||
59603630|NCT02082210|75714035|FG003|STARTED|Overall Study||45||
59603631|NCT02082210|75714036|FG004|STARTED|Overall Study||15||
59603632|NCT02082210|75714037|FG005|STARTED|Overall Study||15||
59603633|NCT02082210|75714032|FG000|Received at Least One Dose of Study Drug|Overall Study||3||
59603634|NCT02082210|75714033|FG001|Received at Least One Dose of Study Drug|Overall Study||3||
59603635|NCT02082210|75714034|FG002|Received at Least One Dose of Study Drug|Overall Study||16||
59603636|NCT02082210|75714035|FG003|Received at Least One Dose of Study Drug|Overall Study||45||
59603637|NCT02082210|75714036|FG004|Received at Least One Dose of Study Drug|Overall Study||15||
59603638|NCT02082210|75714037|FG005|Received at Least One Dose of Study Drug|Overall Study||15||
59603639|NCT02082210|75714032|FG000|COMPLETED|Overall Study||3||
59603640|NCT02082210|75714033|FG001|COMPLETED|Overall Study||3||
59603641|NCT02082210|75714034|FG002|COMPLETED|Overall Study||13||
59603642|NCT02082210|75714035|FG003|COMPLETED|Overall Study||39||
59603643|NCT02082210|75714036|FG004|COMPLETED|Overall Study||12||
59603644|NCT02082210|75714037|FG005|COMPLETED|Overall Study||13||
59603645|NCT02082210|75714032|FG000|NOT COMPLETED|Overall Study||0||
59603646|NCT02082210|75714033|FG001|NOT COMPLETED|Overall Study||0||
59603647|NCT02082210|75714034|FG002|NOT COMPLETED|Overall Study||3||
59603648|NCT02082210|75714035|FG003|NOT COMPLETED|Overall Study||6||
59603649|NCT02082210|75714036|FG004|NOT COMPLETED|Overall Study||3||
59603650|NCT02082210|75714037|FG005|NOT COMPLETED|Overall Study||2||
59603651|NCT02107092|75714063|FG000|STARTED|Overall Study||123||
59603652|NCT02107092|75714063|FG000|COMPLETED|Overall Study||79||
59603653|NCT02107092|75714063|FG000|NOT COMPLETED|Overall Study||44||
59603654|NCT02107014|75714067|FG000|STARTED|Overall Study||9||
59603655|NCT02107014|75714067|FG000|COMPLETED|Overall Study||8||
59603656|NCT02107014|75714067|FG000|NOT COMPLETED|Overall Study||1||
59603657|NCT01624974|75714073|FG000|STARTED|Period III of Treatment (4 Weeks)||54||
59603658|NCT01624974|75714074|FG001|STARTED|Period III of Treatment (4 Weeks)||53||
59603659|NCT01624974|75714073|FG000|COMPLETED|Period III of Treatment (4 Weeks)||47||
59603660|NCT01624974|75714074|FG001|COMPLETED|Period III of Treatment (4 Weeks)||45||
59603661|NCT01624974|75714073|FG000|NOT COMPLETED|Period III of Treatment (4 Weeks)||7||
59603662|NCT01624974|75714074|FG001|NOT COMPLETED|Period III of Treatment (4 Weeks)||8||
59603663|NCT01624974|75714073|FG000|STARTED|Period IV Washout (4 Weeks)||47||
59603664|NCT01624974|75714074|FG001|STARTED|Period IV Washout (4 Weeks)||45||
59603665|NCT01624974|75714073|FG000|COMPLETED|Period IV Washout (4 Weeks)||44||
59603666|NCT01624974|75714074|FG001|COMPLETED|Period IV Washout (4 Weeks)||42||
59603667|NCT01624974|75714073|FG000|NOT COMPLETED|Period IV Washout (4 Weeks)||3||
59603668|NCT01624974|75714074|FG001|NOT COMPLETED|Period IV Washout (4 Weeks)||3||
59603669|NCT01624974|75714073|FG000|STARTED|Period V of Treatment (4 Weeks)||44||
59603670|NCT01624974|75714074|FG001|STARTED|Period V of Treatment (4 Weeks)||42||
59603671|NCT01624974|75714073|FG000|COMPLETED|Period V of Treatment (4 Weeks)||39||
59603672|NCT01624974|75714074|FG001|COMPLETED|Period V of Treatment (4 Weeks)||42||
59603673|NCT01624974|75714073|FG000|NOT COMPLETED|Period V of Treatment (4 Weeks)||5||
59603674|NCT01624974|75714074|FG001|NOT COMPLETED|Period V of Treatment (4 Weeks)||0||
59603675|NCT02065518|75714085|FG000|STARTED|Overall Study||19||
59603676|NCT02065518|75714086|FG001|STARTED|Overall Study||19||
59603677|NCT02065518|75714087|FG002|STARTED|Overall Study||20||
59603678|NCT02065518|75714088|FG003|STARTED|Overall Study||20||
59603679|NCT02065518|75714085|FG000|COMPLETED|Overall Study||13||
59603680|NCT02065518|75714086|FG001|COMPLETED|Overall Study||11||
59603681|NCT02065518|75714087|FG002|COMPLETED|Overall Study||11||
59603682|NCT02065518|75714088|FG003|COMPLETED|Overall Study||15||
59603683|NCT02065518|75714085|FG000|NOT COMPLETED|Overall Study||6||
59603684|NCT02065518|75714086|FG001|NOT COMPLETED|Overall Study||8||
59603685|NCT02065518|75714087|FG002|NOT COMPLETED|Overall Study||9||
59603686|NCT02065518|75714088|FG003|NOT COMPLETED|Overall Study||5||
59736837|NCT00591838|75855707|FG004|COMPLETED|Overall Study||51||
59603687|NCT01624662|75714102|FG000|STARTED|Double-Blind Treatment Phase (Wks 1-16)||80||
59603688|NCT01624662|75714103|FG001|STARTED|Double-Blind Treatment Phase (Wks 1-16)||81||
59603689|NCT01624662|75714104|FG002|STARTED|Double-Blind Treatment Phase (Wks 1-16)||80||
59603690|NCT01624662|75714105|FG003|STARTED|Double-Blind Treatment Phase (Wks 1-16)||82||
59603691|NCT01624662|75714102|FG000|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||70||
59603692|NCT01624662|75714103|FG001|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||78||
59603693|NCT01624662|75714104|FG002|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||76||
59603694|NCT01624662|75714105|FG003|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||82||
59603695|NCT01624662|75714102|FG000|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||10||
59603696|NCT01624662|75714103|FG001|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||3||
59603697|NCT01624662|75714104|FG002|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||4||
59603698|NCT01624662|75714105|FG003|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||0||
59603699|NCT01624662|75714102|FG000|STARTED|Open-Label Extension Phase (Wks 17-24)||70||
59603700|NCT01624662|75714103|FG001|STARTED|Open-Label Extension Phase (Wks 17-24)||78||
59603701|NCT01624662|75714104|FG002|STARTED|Open-Label Extension Phase (Wks 17-24)||72||
59603702|NCT01624662|75714105|FG003|STARTED|Open-Label Extension Phase (Wks 17-24)||79||
59603703|NCT01624662|75714102|FG000|COMPLETED|Open-Label Extension Phase (Wks 17-24)||69||
59603704|NCT01624662|75714103|FG001|COMPLETED|Open-Label Extension Phase (Wks 17-24)||76||
59603705|NCT01624662|75714104|FG002|COMPLETED|Open-Label Extension Phase (Wks 17-24)||71||
59603706|NCT01624662|75714105|FG003|COMPLETED|Open-Label Extension Phase (Wks 17-24)||78||
59603707|NCT01624662|75714102|FG000|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||1||
59603708|NCT01624662|75714103|FG001|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||2||
59603709|NCT01624662|75714104|FG002|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||1||
59603710|NCT01624662|75714105|FG003|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||1||
59603711|NCT01624506|75714128|FG000|STARTED|Overall Study||530||
59603712|NCT01624506|75714129|FG001|STARTED|Overall Study||230||
59603713|NCT01624506|75714128|FG000|COMPLETED|Overall Study||465||
59603714|NCT01624506|75714129|FG001|COMPLETED|Overall Study||213||
59603715|NCT01624506|75714128|FG000|NOT COMPLETED|Overall Study||65||
59603716|NCT01624506|75714129|FG001|NOT COMPLETED|Overall Study||17||
59603717|NCT02106390|75714138|FG000|STARTED|Overall Study||252||
59603718|NCT02106390|75714139|FG001|STARTED|Overall Study||250||
59603719|NCT02106390|75714140|FG002|STARTED|Overall Study||248||
59603720|NCT02106390|75714138|FG000|COMPLETED|Overall Study||203||
59603721|NCT02106390|75714139|FG001|COMPLETED|Overall Study||202||
59603722|NCT02106390|75714140|FG002|COMPLETED|Overall Study||205||
59603723|NCT02106390|75714138|FG000|NOT COMPLETED|Overall Study||49||
59603724|NCT02106390|75714139|FG001|NOT COMPLETED|Overall Study||48||
59603725|NCT02106390|75714140|FG002|NOT COMPLETED|Overall Study||43||
59603726|NCT02064894|75714154|FG000|STARTED|Overall Study|"Received allocated intervention (n=98)~Did not receive intervention (n=1)"|99||
59603727|NCT02064894|75714155|FG001|STARTED|Overall Study|"Received allocated intervention (n=198)~Did not receive allocated intervention (n=3)"|201||
59603728|NCT02064894|75714156|FG002|STARTED|Overall Study|"Received allocated intervention (n=199)~Did not receive allocated intervention (n=2)"|201||
59603729|NCT02064894|75714154|FG000|Available at T-60|Overall Study||91||
59603730|NCT02064894|75714155|FG001|Available at T-60|Overall Study||188||
59603731|NCT02064894|75714156|FG002|Available at T-60|Overall Study||177||
59603732|NCT02064894|75714154|FG000|Avalaible at T-90|Overall Study||74||
59603733|NCT02064894|75714155|FG001|Avalaible at T-90|Overall Study||134||
59603734|NCT02064894|75714156|FG002|Avalaible at T-90|Overall Study||129||
59603735|NCT02064894|75714154|FG000|COMPLETED|Overall Study||56|T-120|
59603736|NCT02064894|75714155|FG001|COMPLETED|Overall Study||99|T-120|
59603737|NCT02064894|75714156|FG002|COMPLETED|Overall Study||86|T-120|
59603738|NCT02064894|75714154|FG000|NOT COMPLETED|Overall Study||43||
59603739|NCT02064894|75714155|FG001|NOT COMPLETED|Overall Study||102||
59603740|NCT02064894|75714156|FG002|NOT COMPLETED|Overall Study||115||
59603741|NCT02081586|75714168|FG000|STARTED|Overall Study||3||
59603742|NCT02081586|75714169|FG001|STARTED|Overall Study||3||
59603743|NCT02081586|75714170|FG002|STARTED|Overall Study||4||
59603744|NCT02081586|75714171|FG003|STARTED|Overall Study||3||
59603745|NCT02081586|75714168|FG000|COMPLETED|Overall Study||3||
59603746|NCT02081586|75714169|FG001|COMPLETED|Overall Study||2||
59603747|NCT02081586|75714170|FG002|COMPLETED|Overall Study||3||
59603748|NCT02081586|75714171|FG003|COMPLETED|Overall Study||2||
59603749|NCT02081586|75714168|FG000|NOT COMPLETED|Overall Study||0||
59603750|NCT02081586|75714169|FG001|NOT COMPLETED|Overall Study||1||
59603751|NCT02081586|75714170|FG002|NOT COMPLETED|Overall Study||1||
59603752|NCT02081586|75714171|FG003|NOT COMPLETED|Overall Study||1||
59603753|NCT02081196|75714183|FG000|STARTED|Overall Study|Treatment on one flank. Contralateral flank was untreated control.|45|Forty-five participants were enrolled. Subjects had 1 flank treated and 1 untreated.|
59603754|NCT02081196|75714183|FG000|Untreated Control Flank|Overall Study||45|Each subject had one treated flank and one untreated flank.|
59603755|NCT02081196|75714183|FG000|COMPLETED|Overall Study|One (1) subject was lost to FU.|44||
59603756|NCT02081196|75714183|FG000|NOT COMPLETED|Overall Study||1||
59603757|NCT02064816|75714191|FG000|STARTED|Overall Study||104||
59603758|NCT02064816|75714192|FG001|STARTED|Overall Study||96||
59603759|NCT02064816|75714191|FG000|COMPLETED|Overall Study||96||
59603760|NCT02064816|75714192|FG001|COMPLETED|Overall Study||88||
59603761|NCT02064816|75714191|FG000|NOT COMPLETED|Overall Study||8||
59603762|NCT02064816|75714192|FG001|NOT COMPLETED|Overall Study||8||
59603763|NCT02080260|75714198|FG000|STARTED|Overall Study||20||
59603764|NCT02080260|75714198|FG000|COMPLETED|Overall Study|Defined as still alive in follow-up when the study was terminated and the database was locked.|1||
59603765|NCT02080260|75714198|FG000|NOT COMPLETED|Overall Study||19||
59603766|NCT01624194|75714204|FG000|STARTED|Overall Study||16||
59603767|NCT01624194|75714205|FG001|STARTED|Overall Study||18||
59603768|NCT01624194|75714204|FG000|COMPLETED|Overall Study||14||
59603769|NCT01624194|75714205|FG001|COMPLETED|Overall Study||18||
59603770|NCT01624194|75714204|FG000|NOT COMPLETED|Overall Study||2||
59603771|NCT01624194|75714205|FG001|NOT COMPLETED|Overall Study||0||
59603772|NCT02079636|75714227|FG000|STARTED|Overall Study||8||
59603773|NCT02079636|75714228|FG001|STARTED|Overall Study||15||
59603774|NCT02079636|75714229|FG002|STARTED|Overall Study||3||
59603775|NCT02079636|75714230|FG003|STARTED|Overall Study||21||
59603776|NCT02079636|75714231|FG004|STARTED|Overall Study||4||
59603777|NCT02079636|75714232|FG005|STARTED|Overall Study||19||
59603778|NCT02079636|75714233|FG006|STARTED|Overall Study||12||
59603779|NCT02079636|75714234|FG007|STARTED|Overall Study||4||
59603780|NCT02079636|75714235|FG008|STARTED|Overall Study||3||
59603781|NCT02079636|75714236|FG009|STARTED|Overall Study||9||
59603782|NCT02079636|75714237|FG010|STARTED|Overall Study||10||
59603783|NCT02079636|75714238|FG011|STARTED|Overall Study||6||
59603784|NCT02079636|75714239|FG012|STARTED|Overall Study||8||
59603785|NCT02079636|75714240|FG013|STARTED|Overall Study||3||
59603786|NCT02079636|75714241|FG014|STARTED|Overall Study||17||
59603787|NCT02079636|75714227|FG000|Received at Least One Dose of Study Drug|Overall Study||8||
59603788|NCT02079636|75714228|FG001|Received at Least One Dose of Study Drug|Overall Study||15||
59603789|NCT02079636|75714229|FG002|Received at Least One Dose of Study Drug|Overall Study||3||
59603790|NCT02079636|75714230|FG003|Received at Least One Dose of Study Drug|Overall Study||21||
59603791|NCT02079636|75714231|FG004|Received at Least One Dose of Study Drug|Overall Study||4||
59603792|NCT02079636|75714232|FG005|Received at Least One Dose of Study Drug|Overall Study||19||
59603793|NCT02079636|75714233|FG006|Received at Least One Dose of Study Drug|Overall Study||12||
59603794|NCT02079636|75714234|FG007|Received at Least One Dose of Study Drug|Overall Study||4||
59603795|NCT02079636|75714235|FG008|Received at Least One Dose of Study Drug|Overall Study||3||
59603796|NCT02079636|75714236|FG009|Received at Least One Dose of Study Drug|Overall Study||9||
59603797|NCT02079636|75714237|FG010|Received at Least One Dose of Study Drug|Overall Study||10||
59603798|NCT02079636|75714238|FG011|Received at Least One Dose of Study Drug|Overall Study||6||
59603799|NCT02079636|75714239|FG012|Received at Least One Dose of Study Drug|Overall Study||8||
59603800|NCT02079636|75714240|FG013|Received at Least One Dose of Study Drug|Overall Study||3||
59603801|NCT02079636|75714241|FG014|Received at Least One Dose of Study Drug|Overall Study||17||
59603802|NCT02079636|75714227|FG000|COMPLETED|Overall Study||5||
59603803|NCT02079636|75714228|FG001|COMPLETED|Overall Study||13||
59603804|NCT02079636|75714229|FG002|COMPLETED|Overall Study||3||
59603805|NCT02079636|75714230|FG003|COMPLETED|Overall Study||9||
59603806|NCT02079636|75714231|FG004|COMPLETED|Overall Study||2||
59603807|NCT02079636|75714232|FG005|COMPLETED|Overall Study||13||
59603808|NCT02079636|75714233|FG006|COMPLETED|Overall Study||11||
59603809|NCT02079636|75714234|FG007|COMPLETED|Overall Study||3||
59603810|NCT02079636|75714235|FG008|COMPLETED|Overall Study||3||
59603811|NCT02079636|75714236|FG009|COMPLETED|Overall Study||6||
59603812|NCT02079636|75714237|FG010|COMPLETED|Overall Study||8||
59603813|NCT02079636|75714238|FG011|COMPLETED|Overall Study||4||
59603814|NCT02079636|75714239|FG012|COMPLETED|Overall Study||5||
59603815|NCT02079636|75714240|FG013|COMPLETED|Overall Study||3||
59603816|NCT02079636|75714241|FG014|COMPLETED|Overall Study||12||
59603817|NCT02079636|75714227|FG000|NOT COMPLETED|Overall Study||3||
59603818|NCT02079636|75714228|FG001|NOT COMPLETED|Overall Study||2||
59603819|NCT02079636|75714229|FG002|NOT COMPLETED|Overall Study||0||
59603820|NCT02079636|75714230|FG003|NOT COMPLETED|Overall Study||12||
59603821|NCT02079636|75714231|FG004|NOT COMPLETED|Overall Study||2||
59603822|NCT02079636|75714232|FG005|NOT COMPLETED|Overall Study||6||
59603823|NCT02079636|75714233|FG006|NOT COMPLETED|Overall Study||1||
59603824|NCT02079636|75714234|FG007|NOT COMPLETED|Overall Study||1||
59603825|NCT02079636|75714235|FG008|NOT COMPLETED|Overall Study||0||
59603826|NCT02079636|75714236|FG009|NOT COMPLETED|Overall Study||3||
59603827|NCT02079636|75714237|FG010|NOT COMPLETED|Overall Study||2||
59603828|NCT02079636|75714238|FG011|NOT COMPLETED|Overall Study||2||
59603829|NCT02079636|75714239|FG012|NOT COMPLETED|Overall Study||3||
59603830|NCT02079636|75714240|FG013|NOT COMPLETED|Overall Study||0||
59603831|NCT02079636|75714241|FG014|NOT COMPLETED|Overall Study||5||
59603832|NCT02079246|75714305|FG000|STARTED|OLEX||1463||
59603833|NCT02079246|75714306|FG001|STARTED|OLEX||0||
59603834|NCT02079246|75714305|FG000|COMPLETED|OLEX||1235||
59603835|NCT02079246|75714306|FG001|COMPLETED|OLEX||0||
59603836|NCT02079246|75714305|FG000|NOT COMPLETED|OLEX||228||
59603837|NCT02079246|75714306|FG001|NOT COMPLETED|OLEX||0||
59603838|NCT02079246|75714305|FG000|STARTED|OLEX-MEM||0||
59603839|NCT02079246|75714306|FG001|STARTED|OLEX-MEM||101||
59603840|NCT02079246|75714305|FG000|COMPLETED|OLEX-MEM||0||
59603841|NCT02079246|75714306|FG001|COMPLETED|OLEX-MEM||82||
59603842|NCT02079246|75714305|FG000|NOT COMPLETED|OLEX-MEM||0||
59603843|NCT02079246|75714306|FG001|NOT COMPLETED|OLEX-MEM||19||
59603844|NCT02077374|75714317|FG000|STARTED|Overall Study||19||
59603845|NCT02077374|75714318|FG001|STARTED|Overall Study||19||
59603846|NCT02077374|75714317|FG000|COMPLETED|Overall Study||19||
59603847|NCT02077374|75714318|FG001|COMPLETED|Overall Study||17||
59603848|NCT02077374|75714317|FG000|NOT COMPLETED|Overall Study||0||
59603849|NCT02077374|75714318|FG001|NOT COMPLETED|Overall Study||2||
59603850|NCT02077140|75714332|FG000|STARTED|Overall Study||36||
59603851|NCT02077140|75714333|FG001|STARTED|Overall Study||36||
59603852|NCT02077140|75714334|FG002|STARTED|Overall Study||36||
59603853|NCT02077140|75714335|FG003|STARTED|Overall Study||36||
59603854|NCT02077140|75714336|FG004|STARTED|Overall Study||48||
59603855|NCT02077140|75714332|FG000|COMPLETED|Overall Study||32||
59603856|NCT02077140|75714333|FG001|COMPLETED|Overall Study||34||
59603857|NCT02077140|75714334|FG002|COMPLETED|Overall Study||34||
59603858|NCT02077140|75714335|FG003|COMPLETED|Overall Study||32||
59603859|NCT02077140|75714336|FG004|COMPLETED|Overall Study||43||
59603860|NCT02077140|75714332|FG000|NOT COMPLETED|Overall Study||4||
59603861|NCT02077140|75714333|FG001|NOT COMPLETED|Overall Study||2||
59603862|NCT02077140|75714334|FG002|NOT COMPLETED|Overall Study||2||
59603863|NCT02077140|75714335|FG003|NOT COMPLETED|Overall Study||4||
59603864|NCT02077140|75714336|FG004|NOT COMPLETED|Overall Study||5||
59603865|NCT02047110|75714355|FG000|STARTED|DB Treatment Period up to Week 24|Started are the treated patients|40||
59603866|NCT02047110|75714356|FG001|STARTED|DB Treatment Period up to Week 24|Started are the treated patients|40||
59603867|NCT02047110|75714357|FG002|STARTED|DB Treatment Period up to Week 24|Started are the treated patients|39||
59603868|NCT02047110|75714358|FG003|STARTED|DB Treatment Period up to Week 24|Started are the treated patients|40||
59603869|NCT02047110|75714355|FG000|COMPLETED|DB Treatment Period up to Week 24||35||
59603870|NCT02047110|75714356|FG001|COMPLETED|DB Treatment Period up to Week 24||38||
59603871|NCT02047110|75714357|FG002|COMPLETED|DB Treatment Period up to Week 24||36||
59603872|NCT02047110|75714358|FG003|COMPLETED|DB Treatment Period up to Week 24||38||
59603873|NCT02047110|75714355|FG000|NOT COMPLETED|DB Treatment Period up to Week 24||5||
59603874|NCT02047110|75714356|FG001|NOT COMPLETED|DB Treatment Period up to Week 24||2||
59603875|NCT02047110|75714357|FG002|NOT COMPLETED|DB Treatment Period up to Week 24||3||
59603876|NCT02047110|75714358|FG003|NOT COMPLETED|DB Treatment Period up to Week 24||2||
59603877|NCT02047110|75714355|FG000|STARTED|DB (Week 12 up to Week 24)|Patients who continued treatment in the DB treatment period up to Week 24|9||
59603878|NCT02047110|75714356|FG001|STARTED|DB (Week 12 up to Week 24)|Patients who continued treatment in the DB treatment period up to Week 24|17||
59603879|NCT02047110|75714357|FG002|STARTED|DB (Week 12 up to Week 24)|Patients who continued treatment in the DB treatment period up to Week 24|13||
59603880|NCT02047110|75714358|FG003|STARTED|DB (Week 12 up to Week 24)|Patients who continued treatment in the DB treatment period up to Week 24|12||
59603881|NCT02047110|75714355|FG000|COMPLETED|DB (Week 12 up to Week 24)||9||
59603882|NCT02047110|75714356|FG001|COMPLETED|DB (Week 12 up to Week 24)||15||
59603883|NCT02047110|75714357|FG002|COMPLETED|DB (Week 12 up to Week 24)||12||
59603884|NCT02047110|75714358|FG003|COMPLETED|DB (Week 12 up to Week 24)||12||
59603885|NCT02047110|75714355|FG000|NOT COMPLETED|DB (Week 12 up to Week 24)||0||
59603886|NCT02047110|75714356|FG001|NOT COMPLETED|DB (Week 12 up to Week 24)||2||
59603887|NCT02047110|75714357|FG002|NOT COMPLETED|DB (Week 12 up to Week 24)||1||
59603888|NCT02047110|75714358|FG003|NOT COMPLETED|DB (Week 12 up to Week 24)||0||
59603889|NCT02047110|75714355|FG000|STARTED|Escape Treatment Period|Assessment in SpondyloArthritis international Society (ASAS) 20 nonresponders|26||
59603890|NCT02047110|75714356|FG001|STARTED|Escape Treatment Period|ASAS 20 nonresponders|21||
59603891|NCT02047110|75714357|FG002|STARTED|Escape Treatment Period|ASAS 20 nonresponders|23||
59603892|NCT02047110|75714358|FG003|STARTED|Escape Treatment Period|ASAS 20 nonresponders|26||
59603893|NCT02047110|75714355|FG000|COMPLETED|Escape Treatment Period||23||
59603894|NCT02047110|75714356|FG001|COMPLETED|Escape Treatment Period||15||
59603895|NCT02047110|75714357|FG002|COMPLETED|Escape Treatment Period||20||
59603896|NCT02047110|75714358|FG003|COMPLETED|Escape Treatment Period||24||
59603897|NCT02047110|75714355|FG000|NOT COMPLETED|Escape Treatment Period||3||
59603898|NCT02047110|75714356|FG001|NOT COMPLETED|Escape Treatment Period||6||
59603899|NCT02047110|75714357|FG002|NOT COMPLETED|Escape Treatment Period||3||
59603900|NCT02047110|75714358|FG003|NOT COMPLETED|Escape Treatment Period||2||
59603901|NCT02047110|75714355|FG000|STARTED|OLE Treatment Period|Patients with loss of ASAS 20 response compared with baseline|4||
59603902|NCT02047110|75714356|FG001|STARTED|OLE Treatment Period|Patients with loss of ASAS 20 response compared with baseline|8||
59603903|NCT02047110|75714357|FG002|STARTED|OLE Treatment Period|Patients with loss of ASAS 20 response compared with baseline|5||
59603904|NCT02047110|75714358|FG003|STARTED|OLE Treatment Period|Patients with loss of ASAS 20 response compared with baseline|9||
59603905|NCT02047110|75714355|FG000|COMPLETED|OLE Treatment Period||4||
59603906|NCT02047110|75714356|FG001|COMPLETED|OLE Treatment Period||8||
59603907|NCT02047110|75714357|FG002|COMPLETED|OLE Treatment Period||4||
59603908|NCT02047110|75714358|FG003|COMPLETED|OLE Treatment Period||9||
59603909|NCT02047110|75714355|FG000|NOT COMPLETED|OLE Treatment Period||0||
59603910|NCT02047110|75714356|FG001|NOT COMPLETED|OLE Treatment Period||0||
59603911|NCT02047110|75714357|FG002|NOT COMPLETED|OLE Treatment Period||1||
59603912|NCT02047110|75714358|FG003|NOT COMPLETED|OLE Treatment Period||0||
59603913|NCT02046564|75714377|FG000|STARTED|Overall Study||209||
59603914|NCT02046564|75714378|FG001|STARTED|Overall Study||203||
59603915|NCT02046564|75714377|FG000|COMPLETED|Overall Study||194||
59603916|NCT02046564|75714378|FG001|COMPLETED|Overall Study||183||
59603917|NCT02046564|75714377|FG000|NOT COMPLETED|Overall Study||15||
59603918|NCT02046564|75714378|FG001|NOT COMPLETED|Overall Study||20||
59603919|NCT02046174|75714384|FG000|STARTED|Overall Study||42||
59603920|NCT02046174|75714385|FG001|STARTED|Overall Study||3||
59603921|NCT02046174|75714384|FG000|COMPLETED|Overall Study||41||
59603922|NCT02046174|75714385|FG001|COMPLETED|Overall Study||3||
59603923|NCT02046174|75714384|FG000|NOT COMPLETED|Overall Study||1||
59603924|NCT02046174|75714385|FG001|NOT COMPLETED|Overall Study||0||
59603925|NCT02045862|75714473|FG000|STARTED|Overall Study||306||
59603926|NCT02045862|75714474|FG001|STARTED|Overall Study||305||
59603927|NCT02045862|75714475|FG002|STARTED|Overall Study||1218||
59603928|NCT02045862|75714473|FG000|Treated|Overall Study||306||
59603929|NCT02045862|75714474|FG001|Treated|Overall Study||303||
59603930|NCT02045862|75714475|FG002|Treated|Overall Study||1210||
59603931|NCT02045862|75714473|FG000|COMPLETED|Overall Study||267||
59603932|NCT02045862|75714474|FG001|COMPLETED|Overall Study||265||
59603933|NCT02045862|75714475|FG002|COMPLETED|Overall Study||1092||
59603934|NCT02045862|75714473|FG000|NOT COMPLETED|Overall Study||39||
59603935|NCT02045862|75714474|FG001|NOT COMPLETED|Overall Study||40||
59603936|NCT02045862|75714475|FG002|NOT COMPLETED|Overall Study||126||
59603937|NCT02075658|75714485|FG000|STARTED|Overall Study||30||
59603938|NCT02075658|75714486|FG001|STARTED|Overall Study||30||
59603939|NCT02075658|75714485|FG000|COMPLETED|Overall Study||28||
59603940|NCT02075658|75714486|FG001|COMPLETED|Overall Study||28||
59603941|NCT02075658|75714485|FG000|NOT COMPLETED|Overall Study||2||
59603942|NCT02075658|75714486|FG001|NOT COMPLETED|Overall Study||2||
59603943|NCT02063880|75714494|FG000|STARTED|Overall Study||90||
59872975|NCT03131440|75997102|FG016|COMPLETED|Overall Study||8|Completed the 24 week questionnaires OR had valid data on the accelerometer at 24 weeks|
59872976|NCT03131440|75997103|FG017|COMPLETED|Overall Study||8|Completed the 24 week questionnaires OR had valid data on the accelerometer at 24 weeks|
59872977|NCT03131440|75997104|FG018|COMPLETED|Overall Study||7|Completed the 24 week questionnaires OR had valid data on the accelerometer at 24 weeks|
59603944|NCT02063880|75714495|FG001|STARTED|Overall Study||93||
59603945|NCT02063880|75714494|FG000|COMPLETED|Overall Study||62||
59603946|NCT02063880|75714495|FG001|COMPLETED|Overall Study||66||
59603947|NCT02063880|75714494|FG000|NOT COMPLETED|Overall Study||28||
59603948|NCT02063880|75714495|FG001|NOT COMPLETED|Overall Study||27||
59603949|NCT02044848|75714503|FG000|STARTED|Overall Study||2||
59603950|NCT02044848|75714504|FG001|STARTED|Overall Study||3||
59603951|NCT02044848|75714503|FG000|COMPLETED|Overall Study||0||
59603952|NCT02044848|75714504|FG001|COMPLETED|Overall Study||0||
59603953|NCT02044848|75714503|FG000|NOT COMPLETED|Overall Study||2||
59603954|NCT02044848|75714504|FG001|NOT COMPLETED|Overall Study||3||
59603955|NCT02044458|75714512|FG000|STARTED|Overall Study||65||
59603956|NCT02044458|75714513|FG001|STARTED|Overall Study||69||
59603957|NCT02044458|75714512|FG000|COMPLETED|Overall Study||62||
59603958|NCT02044458|75714513|FG001|COMPLETED|Overall Study||61||
59603959|NCT02044458|75714512|FG000|NOT COMPLETED|Overall Study||3||
59603960|NCT02044458|75714513|FG001|NOT COMPLETED|Overall Study||8||
59603961|NCT02044302|75714521|FG000|STARTED|Overall Study||2||
59603962|NCT02044302|75714522|FG001|STARTED|Overall Study||0||
59603963|NCT02044302|75714521|FG000|COMPLETED|Overall Study||0||
59603964|NCT02044302|75714522|FG001|COMPLETED|Overall Study||0||
59603965|NCT02044302|75714521|FG000|NOT COMPLETED|Overall Study||2||
59603966|NCT02044302|75714522|FG001|NOT COMPLETED|Overall Study||0||
59603967|NCT02062944|75714526|FG000|STARTED|Overall Study||21||
59603968|NCT02062944|75714526|FG000|COMPLETED|Overall Study||15||
59603969|NCT02062944|75714526|FG000|NOT COMPLETED|Overall Study||6||
59603970|NCT02062632|75714531|FG000|STARTED|Overall Study||3||
59603971|NCT02062632|75714531|FG000|COMPLETED|Overall Study||2||
59603972|NCT02062632|75714531|FG000|NOT COMPLETED|Overall Study||1||
59603973|NCT02062398|75714535|FG000|STARTED|Overall Study||13||
59603974|NCT02062398|75714535|FG000|COMPLETED|Overall Study||12||
59603975|NCT02062398|75714535|FG000|NOT COMPLETED|Overall Study||1||
59603976|NCT02061540|75714539|FG000|STARTED|Overall Study||27||
59603977|NCT02061540|75714539|FG000|Down-Titrated on LUM001 During the Study|Overall Study||5||
59603978|NCT02061540|75714539|FG000|COMPLETED|Overall Study||23||
59603979|NCT02061540|75714539|FG000|NOT COMPLETED|Overall Study||4||
59603980|NCT02043366|75714554|FG000|STARTED|Overall Study||30||
59603981|NCT02043366|75714555|FG001|STARTED|Overall Study||30||
59603982|NCT02043366|75714556|FG002|STARTED|Overall Study||30||
59603983|NCT02043366|75714557|FG003|STARTED|Overall Study||30||
59603984|NCT02043366|75714558|FG004|STARTED|Overall Study||30||
59603985|NCT02043366|75714559|FG005|STARTED|Overall Study||30||
59603986|NCT02043366|75714554|FG000|COMPLETED|Overall Study||28||
59603987|NCT02043366|75714555|FG001|COMPLETED|Overall Study||28||
59603988|NCT02043366|75714556|FG002|COMPLETED|Overall Study||28||
59603989|NCT02043366|75714557|FG003|COMPLETED|Overall Study||28||
59603990|NCT02043366|75714558|FG004|COMPLETED|Overall Study||28||
59603991|NCT02043366|75714559|FG005|COMPLETED|Overall Study||28||
59603992|NCT02043366|75714554|FG000|NOT COMPLETED|Overall Study||2||
59603993|NCT02043366|75714555|FG001|NOT COMPLETED|Overall Study||2||
59603994|NCT02043366|75714556|FG002|NOT COMPLETED|Overall Study||2||
59603995|NCT02043366|75714557|FG003|NOT COMPLETED|Overall Study||2||
59603996|NCT02043366|75714558|FG004|NOT COMPLETED|Overall Study||2||
59603997|NCT02043366|75714559|FG005|NOT COMPLETED|Overall Study||2||
59603998|NCT02060370|75714575|FG000|STARTED|Overall Study||60||
59603999|NCT02060370|75714575|FG000|COMPLETED|Overall Study||59||
59604000|NCT02060370|75714575|FG000|NOT COMPLETED|Overall Study||1||
59604001|NCT01622088|75714579|FG000|STARTED|Overall Study||616||
59604002|NCT01622088|75714579|FG000|COMPLETED|Overall Study||0||
59604003|NCT01622088|75714579|FG000|NOT COMPLETED|Overall Study||616||
59604004|NCT01621542|75714590|FG000|STARTED|Overall Study||5||
59604005|NCT01621542|75714591|FG001|STARTED|Overall Study||5||
59604006|NCT01621542|75714592|FG002|STARTED|Overall Study||6||
59604007|NCT01621542|75714593|FG003|STARTED|Overall Study||28||
59604008|NCT01621542|75714594|FG004|STARTED|Overall Study||9||
59604009|NCT01621542|75714595|FG005|STARTED|Overall Study||9||
59604010|NCT01621542|75714590|FG000|COMPLETED|Overall Study||0||
59604011|NCT01621542|75714591|FG001|COMPLETED|Overall Study||0||
59604012|NCT01621542|75714592|FG002|COMPLETED|Overall Study||0||
59604013|NCT01621542|75714593|FG003|COMPLETED|Overall Study||0||
59604014|NCT01621542|75714594|FG004|COMPLETED|Overall Study||0||
59604015|NCT01621542|75714595|FG005|COMPLETED|Overall Study||0||
59604016|NCT01621542|75714590|FG000|NOT COMPLETED|Overall Study||5||
59604017|NCT01621542|75714591|FG001|NOT COMPLETED|Overall Study||5||
59604018|NCT01621542|75714592|FG002|NOT COMPLETED|Overall Study||6||
59604019|NCT01621542|75714593|FG003|NOT COMPLETED|Overall Study||28||
59604020|NCT01621542|75714594|FG004|NOT COMPLETED|Overall Study||9||
59604021|NCT01621542|75714595|FG005|NOT COMPLETED|Overall Study||9||
59604022|NCT02021292|75714611|FG000|STARTED|Overall Study||40||
59604023|NCT02021292|75714612|FG001|STARTED|Overall Study||40||
59604024|NCT02021292|75714611|FG000|COMPLETED|Overall Study||40||
59604025|NCT02021292|75714612|FG001|COMPLETED|Overall Study||37||
59604026|NCT02021292|75714611|FG000|NOT COMPLETED|Overall Study||0||
59604027|NCT02021292|75714612|FG001|NOT COMPLETED|Overall Study||3||
59604028|NCT02059980|75714622|FG000|STARTED|Overall Study||18||
59604029|NCT02059980|75714623|FG001|STARTED|Overall Study||15||
59604030|NCT02059980|75714622|FG000|COMPLETED|Overall Study||16||
59604031|NCT02059980|75714623|FG001|COMPLETED|Overall Study||14||
59604032|NCT02059980|75714622|FG000|NOT COMPLETED|Overall Study||2||
59604033|NCT02059980|75714623|FG001|NOT COMPLETED|Overall Study||1||
59604034|NCT02043132|75714631|FG000|STARTED|Overall Study||58||
59604035|NCT02043132|75714632|FG001|STARTED|Overall Study||58||
59604036|NCT02043132|75714631|FG000|COMPLETED|Overall Study||53||
59604037|NCT02043132|75714632|FG001|COMPLETED|Overall Study||49||
59604038|NCT02043132|75714631|FG000|NOT COMPLETED|Overall Study||5||
59604039|NCT02043132|75714632|FG001|NOT COMPLETED|Overall Study||9||
59604040|NCT02059434|75714647|FG000|STARTED|Period 1 (After Screening/run-in Period)||2||
59604041|NCT02059434|75714648|FG001|STARTED|Period 1 (After Screening/run-in Period)||2||
59604042|NCT02059434|75714649|FG002|STARTED|Period 1 (After Screening/run-in Period)||2||
59604043|NCT02059434|75714650|FG003|STARTED|Period 1 (After Screening/run-in Period)||2||
59604044|NCT02059434|75714651|FG004|STARTED|Period 1 (After Screening/run-in Period)||2||
59604045|NCT02059434|75714652|FG005|STARTED|Period 1 (After Screening/run-in Period)||2||
59604046|NCT02059434|75714653|FG006|STARTED|Period 1 (After Screening/run-in Period)||2||
59604047|NCT02059434|75714654|FG007|STARTED|Period 1 (After Screening/run-in Period)||3||
59604048|NCT02059434|75714655|FG008|STARTED|Period 1 (After Screening/run-in Period)|Part 2 followed Part 1, and comprised 5 treatment periods|0||
59604049|NCT02059434|75714647|FG000|COMPLETED|Period 1 (After Screening/run-in Period)||2||
59604050|NCT02059434|75714648|FG001|COMPLETED|Period 1 (After Screening/run-in Period)||2||
59604051|NCT02059434|75714649|FG002|COMPLETED|Period 1 (After Screening/run-in Period)||2||
59604052|NCT02059434|75714650|FG003|COMPLETED|Period 1 (After Screening/run-in Period)||2||
59604053|NCT02059434|75714651|FG004|COMPLETED|Period 1 (After Screening/run-in Period)||2||
59604054|NCT02059434|75714652|FG005|COMPLETED|Period 1 (After Screening/run-in Period)||2||
59604055|NCT02059434|75714653|FG006|COMPLETED|Period 1 (After Screening/run-in Period)||2||
59604056|NCT02059434|75714654|FG007|COMPLETED|Period 1 (After Screening/run-in Period)||3||
59604057|NCT02059434|75714655|FG008|COMPLETED|Period 1 (After Screening/run-in Period)|Part 2 followed Part 1, and comprised 5 treatment periods|0||
59604058|NCT02059434|75714647|FG000|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0||
59604059|NCT02059434|75714648|FG001|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0||
59604060|NCT02059434|75714649|FG002|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0||
59604061|NCT02059434|75714650|FG003|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0||
59604062|NCT02059434|75714651|FG004|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0||
59604063|NCT02059434|75714652|FG005|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0||
59604064|NCT02059434|75714653|FG006|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0||
59604065|NCT02059434|75714654|FG007|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0||
59604066|NCT02059434|75714655|FG008|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0||
59604067|NCT02059434|75714647|FG000|STARTED|Washout Between Periods 1 and 2||2||
59604068|NCT02059434|75714648|FG001|STARTED|Washout Between Periods 1 and 2||2||
59604069|NCT02059434|75714649|FG002|STARTED|Washout Between Periods 1 and 2||2||
59604070|NCT02059434|75714650|FG003|STARTED|Washout Between Periods 1 and 2||2||
59736838|NCT00591838|75855703|FG000|NOT COMPLETED|Overall Study||0||
59736839|NCT00591838|75855704|FG001|NOT COMPLETED|Overall Study||0||
59736840|NCT00591838|75855705|FG002|NOT COMPLETED|Overall Study||0||
59736841|NCT00591838|75855706|FG003|NOT COMPLETED|Overall Study||1||
59736842|NCT00591838|75855707|FG004|NOT COMPLETED|Overall Study||0||
59736843|NCT00832624|75855720|FG000|STARTED|Overall Study||10||
59736844|NCT00832624|75855720|FG000|COMPLETED|Overall Study||0||
59736845|NCT00832624|75855720|FG000|NOT COMPLETED|Overall Study||10||
59736846|NCT00832078|75855724|FG000|STARTED|Test Day 1- 1 Period||13||
59736847|NCT00832078|75855725|FG001|STARTED|Test Day 1- 1 Period||12||
59736848|NCT00832078|75855724|FG000|COMPLETED|Test Day 1- 1 Period||13||
59736849|NCT00832078|75855725|FG001|COMPLETED|Test Day 1- 1 Period||12||
59736850|NCT00832078|75855724|FG000|NOT COMPLETED|Test Day 1- 1 Period||0||
59736851|NCT00832078|75855725|FG001|NOT COMPLETED|Test Day 1- 1 Period||0||
59736852|NCT00832078|75855724|FG000|STARTED|Test Day 1-2 Period||13||
59736853|NCT00832078|75855725|FG001|STARTED|Test Day 1-2 Period||12||
59736854|NCT00832078|75855724|FG000|COMPLETED|Test Day 1-2 Period||13||
59736855|NCT00832078|75855725|FG001|COMPLETED|Test Day 1-2 Period||10||
59736856|NCT00832078|75855724|FG000|NOT COMPLETED|Test Day 1-2 Period||0||
59736857|NCT00832078|75855725|FG001|NOT COMPLETED|Test Day 1-2 Period||2||
59736858|NCT00832078|75855724|FG000|STARTED|Test Day 2 - 1 Period||13||
59736859|NCT00832078|75855725|FG001|STARTED|Test Day 2 - 1 Period||10||
59736860|NCT00832078|75855724|FG000|COMPLETED|Test Day 2 - 1 Period||13||
59736861|NCT00832078|75855725|FG001|COMPLETED|Test Day 2 - 1 Period||10||
59736862|NCT00832078|75855724|FG000|NOT COMPLETED|Test Day 2 - 1 Period||0||
59736863|NCT00832078|75855725|FG001|NOT COMPLETED|Test Day 2 - 1 Period||0||
59736864|NCT00832078|75855724|FG000|STARTED|Test Day 2 - 2 Period||13||
59736865|NCT00832078|75855725|FG001|STARTED|Test Day 2 - 2 Period||10||
59736866|NCT00832078|75855724|FG000|COMPLETED|Test Day 2 - 2 Period||12||
59736867|NCT00832078|75855725|FG001|COMPLETED|Test Day 2 - 2 Period||10||
59736868|NCT00832078|75855724|FG000|NOT COMPLETED|Test Day 2 - 2 Period||1||
59736869|NCT00832078|75855725|FG001|NOT COMPLETED|Test Day 2 - 2 Period||0||
59736870|NCT00822172|75855733|FG000|STARTED|Overall Study||80||
59736871|NCT00822172|75855734|FG001|STARTED|Overall Study||83||
59736872|NCT00822172|75855733|FG000|COMPLETED|Overall Study||65||
59736873|NCT00822172|75855734|FG001|COMPLETED|Overall Study||64||
59736874|NCT00822172|75855733|FG000|NOT COMPLETED|Overall Study||15||
59736875|NCT00822172|75855734|FG001|NOT COMPLETED|Overall Study||19||
59736876|NCT00832000|75855740|FG000|STARTED|Overall Study|Mexiletine 200 mg orally three times daily|29||
59736877|NCT00832000|75855741|FG001|STARTED|Overall Study|Placebo|30||
59736878|NCT00832000|75855740|FG000|Crossed Over to Opposite Intervention|Overall Study|Placebo|25||
59736879|NCT00832000|75855741|FG001|Crossed Over to Opposite Intervention|Overall Study|Mexiletine 200 mg orally three times daily|29||
59736880|NCT00832000|75855740|FG000|COMPLETED|Overall Study||23||
59736881|NCT00832000|75855741|FG001|COMPLETED|Overall Study||29||
59736882|NCT00832000|75855740|FG000|NOT COMPLETED|Overall Study||6||
59736883|NCT00832000|75855741|FG001|NOT COMPLETED|Overall Study||1||
59736884|NCT00911508|75855778|FG000|STARTED|Overall Study||1108||
59736885|NCT00911508|75855779|FG001|STARTED|Overall Study||1096||
59736886|NCT00911508|75855778|FG000|COMPLETED|Overall Study||1002||
59736887|NCT00911508|75855779|FG001|COMPLETED|Overall Study||966||
59736888|NCT00911508|75855778|FG000|NOT COMPLETED|Overall Study||106||
59736889|NCT00911508|75855779|FG001|NOT COMPLETED|Overall Study||130||
59736890|NCT04394286|75855788|FG000|STARTED|Overall Study||0||
59736891|NCT04394286|75855789|FG001|STARTED|Overall Study||0||
59736892|NCT04394286|75855790|FG002|STARTED|Overall Study||0||
59736893|NCT04394286|75855788|FG000|COMPLETED|Overall Study||0||
59736894|NCT04394286|75855789|FG001|COMPLETED|Overall Study||0||
59872978|NCT03131440|75997105|FG019|COMPLETED|Overall Study||7|Completed the 24 week questionnaires OR had valid data on the accelerometer at 24 weeks|
59872979|NCT03131440|75997106|FG020|COMPLETED|Overall Study||6|Completed the 24 week questionnaires OR had valid data on the accelerometer at 24 weeks|
59604071|NCT02059434|75714651|FG004|STARTED|Washout Between Periods 1 and 2||2||
59604072|NCT02059434|75714652|FG005|STARTED|Washout Between Periods 1 and 2||2||
59604073|NCT02059434|75714653|FG006|STARTED|Washout Between Periods 1 and 2||2||
59604074|NCT02059434|75714654|FG007|STARTED|Washout Between Periods 1 and 2||3||
59604075|NCT02059434|75714655|FG008|STARTED|Washout Between Periods 1 and 2|Part 2 followed Part 1, and comprised 5 treatment periods|0||
59604076|NCT02059434|75714647|FG000|COMPLETED|Washout Between Periods 1 and 2||2||
59604077|NCT02059434|75714648|FG001|COMPLETED|Washout Between Periods 1 and 2||2||
59604078|NCT02059434|75714649|FG002|COMPLETED|Washout Between Periods 1 and 2||2||
59736895|NCT04394286|75855790|FG002|COMPLETED|Overall Study||0||
59736896|NCT04394286|75855788|FG000|NOT COMPLETED|Overall Study||0||
59736897|NCT04394286|75855789|FG001|NOT COMPLETED|Overall Study||0||
59736898|NCT04394286|75855790|FG002|NOT COMPLETED|Overall Study||0||
59736899|NCT00774397|75855805|FG000|STARTED|Overall Study||71||
59736900|NCT00774397|75855806|FG001|STARTED|Overall Study||69||
59736901|NCT00774397|75855807|FG002|STARTED|Overall Study||143||
59736902|NCT00774397|75855808|FG003|STARTED|Overall Study||146||
59736903|NCT00774397|75855809|FG004|STARTED|Overall Study||143||
59736904|NCT00774397|75855810|FG005|STARTED|Overall Study||76||
59736905|NCT00774397|75855811|FG006|STARTED|Overall Study||71||
59736906|NCT00774397|75855805|FG000|COMPLETED|Overall Study||57||
59736907|NCT00774397|75855806|FG001|COMPLETED|Overall Study||56||
59736908|NCT00774397|75855807|FG002|COMPLETED|Overall Study||113||
59736909|NCT00774397|75855808|FG003|COMPLETED|Overall Study||129||
59736910|NCT00774397|75855809|FG004|COMPLETED|Overall Study||97||
59736911|NCT00774397|75855810|FG005|COMPLETED|Overall Study||54||
59736912|NCT00774397|75855811|FG006|COMPLETED|Overall Study||41||
59736913|NCT00774397|75855805|FG000|NOT COMPLETED|Overall Study||14||
59736914|NCT00774397|75855806|FG001|NOT COMPLETED|Overall Study||13||
59736915|NCT00774397|75855807|FG002|NOT COMPLETED|Overall Study||30||
59736916|NCT00774397|75855808|FG003|NOT COMPLETED|Overall Study||17||
59736917|NCT00774397|75855809|FG004|NOT COMPLETED|Overall Study||46||
59736918|NCT00774397|75855810|FG005|NOT COMPLETED|Overall Study||22||
59736919|NCT00774397|75855811|FG006|NOT COMPLETED|Overall Study||30||
59736920|NCT03576144|75855840|FG000|STARTED|Overall Study||10|Started are treated|
59736921|NCT03576144|75855841|FG001|STARTED|Overall Study||8|Started are treated|
59736922|NCT03576144|75855842|FG002|STARTED|Overall Study||8|Started are treated|
59736923|NCT03576144|75855843|FG003|STARTED|Overall Study||8|Started are treated|
59736924|NCT03576144|75855844|FG004|STARTED|Overall Study||8|Started are treated|
59736925|NCT03576144|75855845|FG005|STARTED|Overall Study||8|Started are treated|
59736926|NCT03576144|75855840|FG000|COMPLETED|Overall Study||10||
59736927|NCT03576144|75855841|FG001|COMPLETED|Overall Study||8||
59736928|NCT03576144|75855842|FG002|COMPLETED|Overall Study||8||
59736929|NCT03576144|75855843|FG003|COMPLETED|Overall Study||8||
59736930|NCT03576144|75855844|FG004|COMPLETED|Overall Study||8||
59736931|NCT03576144|75855845|FG005|COMPLETED|Overall Study||8||
59736932|NCT03576144|75855840|FG000|NOT COMPLETED|Overall Study||0||
59736933|NCT03576144|75855841|FG001|NOT COMPLETED|Overall Study||0||
59736934|NCT03576144|75855842|FG002|NOT COMPLETED|Overall Study||0||
59736935|NCT03576144|75855843|FG003|NOT COMPLETED|Overall Study||0||
59736936|NCT03576144|75855844|FG004|NOT COMPLETED|Overall Study||0||
59736937|NCT03576144|75855845|FG005|NOT COMPLETED|Overall Study||0||
59736938|NCT00909870|75855866|FG000|STARTED|Overall Study||274||
59736939|NCT00909870|75855867|FG001|STARTED|Overall Study||263||
59736940|NCT00909870|75855866|FG000|COMPLETED|Overall Study||251||
59736941|NCT00909870|75855867|FG001|COMPLETED|Overall Study||236||
59736942|NCT00909870|75855866|FG000|NOT COMPLETED|Overall Study||23||
59736943|NCT00909870|75855867|FG001|NOT COMPLETED|Overall Study||27||
59736944|NCT00768469|75855876|FG000|STARTED|Overall Study||3||
59736945|NCT00768469|75855877|FG001|STARTED|Overall Study||7||
59736946|NCT00768469|75855876|FG000|COMPLETED|Overall Study||0||
59736947|NCT00768469|75855877|FG001|COMPLETED|Overall Study||0||
59736948|NCT00768469|75855876|FG000|NOT COMPLETED|Overall Study||3||
59736949|NCT00768469|75855877|FG001|NOT COMPLETED|Overall Study||7||
59736950|NCT00886821|75855898|FG000|STARTED|Stage 1||7||
59736951|NCT00886821|75855899|FG001|STARTED|Stage 1||6||
59736952|NCT00886821|75855900|FG002|STARTED|Stage 1||6||
59736953|NCT00886821|75855901|FG003|STARTED|Stage 1||7||
59736954|NCT00886821|75855902|FG004|STARTED|Stage 1||6||
59736955|NCT00886821|75855903|FG005|STARTED|Stage 1||6||
59736956|NCT00886821|75855904|FG006|STARTED|Stage 1||6||
59736957|NCT00886821|75855905|FG007|STARTED|Stage 1||6||
59736958|NCT00886821|75855906|FG008|STARTED|Stage 1||6||
59736959|NCT00886821|75855907|FG009|STARTED|Stage 1||18||
59736960|NCT00886821|75855908|FG010|STARTED|Stage 1||0||
59736961|NCT00886821|75855909|FG011|STARTED|Stage 1||0||
59736962|NCT00886821|75855910|FG012|STARTED|Stage 1||0||
59736963|NCT00886821|75855911|FG013|STARTED|Stage 1||0||
60134706|NCT04118348|76257946|FG003|STARTED|Overall Study||3218||
60134707|NCT04118348|76257943|FG000|COMPLETED|Overall Study||3416|Random assignment happened at the patient encounter|
60134708|NCT04118348|76257944|FG001|COMPLETED|Overall Study||3265|Random assignment happened at the patient encounter|
59736964|NCT00886821|75855898|FG000|COMPLETED|Stage 1||7||
60134709|NCT04118348|76257945|FG002|COMPLETED|Overall Study||3441|Random assignment happened at the patient encounter|
59736965|NCT00886821|75855899|FG001|COMPLETED|Stage 1||6||
59736966|NCT00886821|75855900|FG002|COMPLETED|Stage 1||6||
59736967|NCT00886821|75855901|FG003|COMPLETED|Stage 1||7||
59736968|NCT00886821|75855902|FG004|COMPLETED|Stage 1||6||
59736969|NCT00886821|75855903|FG005|COMPLETED|Stage 1||6||
59736970|NCT00886821|75855904|FG006|COMPLETED|Stage 1||6||
59736971|NCT00886821|75855905|FG007|COMPLETED|Stage 1||6||
59736972|NCT00886821|75855906|FG008|COMPLETED|Stage 1||6||
59736973|NCT00886821|75855907|FG009|COMPLETED|Stage 1||18||
59736974|NCT00886821|75855908|FG010|COMPLETED|Stage 1||0||
59736975|NCT00886821|75855909|FG011|COMPLETED|Stage 1||0||
59736976|NCT00886821|75855910|FG012|COMPLETED|Stage 1||0||
60134710|NCT04118348|76257946|FG003|COMPLETED|Overall Study||3218|Random assignment happened at the patient encounter|
59736977|NCT00886821|75855911|FG013|COMPLETED|Stage 1||0||
59736978|NCT00886821|75855898|FG000|NOT COMPLETED|Stage 1||0||
59736979|NCT00886821|75855899|FG001|NOT COMPLETED|Stage 1||0||
59736980|NCT00886821|75855900|FG002|NOT COMPLETED|Stage 1||0||
59736981|NCT00886821|75855901|FG003|NOT COMPLETED|Stage 1||0||
59736982|NCT00886821|75855902|FG004|NOT COMPLETED|Stage 1||0||
59736983|NCT00886821|75855903|FG005|NOT COMPLETED|Stage 1||0||
59736984|NCT00886821|75855904|FG006|NOT COMPLETED|Stage 1||0||
59736985|NCT00886821|75855905|FG007|NOT COMPLETED|Stage 1||0||
59736986|NCT00886821|75855906|FG008|NOT COMPLETED|Stage 1||0||
59736987|NCT00886821|75855907|FG009|NOT COMPLETED|Stage 1||0||
59736988|NCT00886821|75855908|FG010|NOT COMPLETED|Stage 1||0||
59736989|NCT00886821|75855909|FG011|NOT COMPLETED|Stage 1||0||
59736990|NCT00886821|75855910|FG012|NOT COMPLETED|Stage 1||0||
59736991|NCT00886821|75855911|FG013|NOT COMPLETED|Stage 1||0||
59736992|NCT00886821|75855898|FG000|STARTED|Stage 2||0||
59736993|NCT00886821|75855899|FG001|STARTED|Stage 2||0||
59736994|NCT00886821|75855900|FG002|STARTED|Stage 2||0||
59736995|NCT00886821|75855901|FG003|STARTED|Stage 2||0||
59736996|NCT00886821|75855902|FG004|STARTED|Stage 2||0||
59736997|NCT00886821|75855903|FG005|STARTED|Stage 2||0||
59736998|NCT00886821|75855904|FG006|STARTED|Stage 2||0||
59736999|NCT00886821|75855905|FG007|STARTED|Stage 2||0||
59737000|NCT00886821|75855906|FG008|STARTED|Stage 2||0||
59737001|NCT00886821|75855907|FG009|STARTED|Stage 2||0||
59737002|NCT00886821|75855908|FG010|STARTED|Stage 2||9||
59737003|NCT00886821|75855909|FG011|STARTED|Stage 2||9||
59737004|NCT00886821|75855910|FG012|STARTED|Stage 2||13||
59737005|NCT00886821|75855911|FG013|STARTED|Stage 2||9||
59737006|NCT00886821|75855898|FG000|COMPLETED|Stage 2||0||
59737007|NCT00886821|75855899|FG001|COMPLETED|Stage 2||0||
59737008|NCT00886821|75855900|FG002|COMPLETED|Stage 2||0||
59737009|NCT00886821|75855901|FG003|COMPLETED|Stage 2||0||
59737010|NCT00886821|75855902|FG004|COMPLETED|Stage 2||0||
59737011|NCT00886821|75855903|FG005|COMPLETED|Stage 2||0||
59737012|NCT00886821|75855904|FG006|COMPLETED|Stage 2||0||
59737013|NCT00886821|75855905|FG007|COMPLETED|Stage 2||0||
59737014|NCT00886821|75855906|FG008|COMPLETED|Stage 2||0||
59737015|NCT00886821|75855907|FG009|COMPLETED|Stage 2||0||
59737016|NCT00886821|75855908|FG010|COMPLETED|Stage 2||9||
59737017|NCT00886821|75855909|FG011|COMPLETED|Stage 2||8||
59737018|NCT00886821|75855910|FG012|COMPLETED|Stage 2||8||
59737019|NCT00886821|75855911|FG013|COMPLETED|Stage 2||8||
59737020|NCT00886821|75855898|FG000|NOT COMPLETED|Stage 2||0||
59737021|NCT00886821|75855899|FG001|NOT COMPLETED|Stage 2||0||
59737022|NCT00886821|75855900|FG002|NOT COMPLETED|Stage 2||0||
59737023|NCT00886821|75855901|FG003|NOT COMPLETED|Stage 2||0||
59737024|NCT00886821|75855902|FG004|NOT COMPLETED|Stage 2||0||
59737025|NCT00886821|75855903|FG005|NOT COMPLETED|Stage 2||0||
59737026|NCT00886821|75855904|FG006|NOT COMPLETED|Stage 2||0||
59737027|NCT00886821|75855905|FG007|NOT COMPLETED|Stage 2||0||
59737028|NCT00886821|75855906|FG008|NOT COMPLETED|Stage 2||0||
59737029|NCT00886821|75855907|FG009|NOT COMPLETED|Stage 2||0||
59737030|NCT00886821|75855908|FG010|NOT COMPLETED|Stage 2||0||
59737031|NCT00886821|75855909|FG011|NOT COMPLETED|Stage 2||1||
59737032|NCT00886821|75855910|FG012|NOT COMPLETED|Stage 2||5||
59737033|NCT00886821|75855911|FG013|NOT COMPLETED|Stage 2||1||
59737034|NCT00886743|75855955|FG000|STARTED|Overall Study|Received treatment|19||
59737035|NCT00886743|75855955|FG000|COMPLETED|Overall Study||15||
59737036|NCT00886743|75855955|FG000|NOT COMPLETED|Overall Study||4||
59737037|NCT00886587|75855961|FG000|STARTED|Overall Study||41||
59737038|NCT00886587|75855962|FG001|STARTED|Overall Study||41||
59737039|NCT00886587|75855961|FG000|COMPLETED|Overall Study||37||
59737040|NCT00886587|75855962|FG001|COMPLETED|Overall Study||39||
59737041|NCT00886587|75855961|FG000|NOT COMPLETED|Overall Study||4||
59737042|NCT00886587|75855962|FG001|NOT COMPLETED|Overall Study||2||
59737043|NCT00886119|75855968|FG000|STARTED|Period 1||24||
59737044|NCT00886119|75855969|FG001|STARTED|Period 1||22||
59737045|NCT00886119|75855968|FG000|COMPLETED|Period 1||23||
59737046|NCT00886119|75855969|FG001|COMPLETED|Period 1||22||
59737047|NCT00886119|75855968|FG000|NOT COMPLETED|Period 1||1||
59737048|NCT00886119|75855969|FG001|NOT COMPLETED|Period 1||0||
59737049|NCT00886119|75855968|FG000|STARTED|Period 2||23||
59737050|NCT00886119|75855969|FG001|STARTED|Period 2||22||
59737051|NCT00886119|75855968|FG000|COMPLETED|Period 2||23||
59737052|NCT00886119|75855969|FG001|COMPLETED|Period 2||22||
59737053|NCT00886119|75855968|FG000|NOT COMPLETED|Period 2||0||
59737054|NCT00886119|75855969|FG001|NOT COMPLETED|Period 2||0||
59737055|NCT00768079|75855978|FG000|STARTED|Overall Study||38||
59737056|NCT00768079|75855979|FG001|STARTED|Overall Study||36||
59737057|NCT00768079|75855980|FG002|STARTED|Overall Study||36||
59737058|NCT00768079|75855978|FG000|COMPLETED|Overall Study||36||
59737059|NCT00768079|75855979|FG001|COMPLETED|Overall Study||35||
59737060|NCT00768079|75855980|FG002|COMPLETED|Overall Study||32||
59737061|NCT00768079|75855978|FG000|NOT COMPLETED|Overall Study||2||
59737062|NCT00768079|75855979|FG001|NOT COMPLETED|Overall Study||1||
59737063|NCT00768079|75855980|FG002|NOT COMPLETED|Overall Study||4||
59737064|NCT00767455|75855990|FG000|STARTED|Overall Study||59||
59737065|NCT00767455|75855990|FG000|COMPLETED|Overall Study||40||
59737066|NCT00767455|75855990|FG000|NOT COMPLETED|Overall Study||19||
59737067|NCT00766831|75855996|FG000|STARTED|Overall Study||190||
59737068|NCT00766831|75855996|FG000|COMPLETED|Overall Study||75||
59737069|NCT00766831|75855996|FG000|NOT COMPLETED|Overall Study||115||
59737070|NCT00766675|75856000|FG000|STARTED|Overall Study||80||
59737071|NCT00766675|75856000|FG000|COMPLETED|Overall Study||40||
59737072|NCT00766675|75856000|FG000|NOT COMPLETED|Overall Study||40||
59737073|NCT00766597|75856004|FG000|STARTED|Overall Study|Screened participants who were evaluated for co-receptor tropism|9||
59737074|NCT00766597|75856004|FG000|With CCR5-tropic Virus|Overall Study|Evaluable participants, received the study drug|4||
59737075|NCT00766597|75856004|FG000|Without CCR5-tropic Virus|Overall Study|Not evaluable participants, did not receive the study drug|5||
59737076|NCT00766597|75856004|FG000|Completed Week 24|Overall Study|Week 24 is the first primary time point of analysis|1||
59737077|NCT00766597|75856004|FG000|Completed Week 48|Overall Study|Week 48 is the second primary time point of analysis|0||
59737078|NCT00766597|75856004|FG000|COMPLETED|Overall Study|Treatment duration is 48 weeks plus 5 years of follow-up|0||
59737079|NCT00766597|75856004|FG000|NOT COMPLETED|Overall Study||9||
59737080|NCT00910962|75856013|FG000|STARTED|Overall Study||135||
59737081|NCT00910962|75856014|FG001|STARTED|Overall Study||199||
59737082|NCT00910962|75856015|FG002|STARTED|Overall Study||192||
59737083|NCT00910962|75856013|FG000|COMPLETED|Overall Study||92||
59737084|NCT00910962|75856014|FG001|COMPLETED|Overall Study||121||
59737085|NCT00910962|75856015|FG002|COMPLETED|Overall Study||116||
59737086|NCT00910962|75856013|FG000|NOT COMPLETED|Overall Study||43||
59737087|NCT00910962|75856014|FG001|NOT COMPLETED|Overall Study||78||
59737088|NCT00910962|75856015|FG002|NOT COMPLETED|Overall Study||76||
59737089|NCT00773461|75856027|FG000|STARTED|Overall Study||70||
59737090|NCT00773461|75856028|FG001|STARTED|Overall Study||139||
59737091|NCT00773461|75856027|FG000|COMPLETED|Overall Study||65||
59737092|NCT00773461|75856028|FG001|COMPLETED|Overall Study||135||
59737093|NCT00773461|75856027|FG000|NOT COMPLETED|Overall Study||5||
59737094|NCT00773461|75856028|FG001|NOT COMPLETED|Overall Study||4||
59737095|NCT00773383|75856035|FG000|STARTED|Overall Study||35||
59737096|NCT00773383|75856035|FG000|Received Study Drug|Overall Study||34||
59737097|NCT00773383|75856035|FG000|COMPLETED|Overall Study|this includes at the time of clinical cut-off (2/23/2010) there were 4 patients ongoing|4||
59737098|NCT00773383|75856035|FG000|NOT COMPLETED|Overall Study||31||
59737099|NCT00757003|75856043|FG000|STARTED|Overall Study||100||
59737100|NCT00757003|75856043|FG000|COMPLETED|Overall Study||51||
59737101|NCT00757003|75856043|FG000|NOT COMPLETED|Overall Study||49||
59737102|NCT00766363|75856052|FG000|STARTED|Overall Study||12||
59737103|NCT00766363|75856053|FG001|STARTED|Overall Study||13||
59737104|NCT00766363|75856054|FG002|STARTED|Overall Study|Number randomized.|12||
59737105|NCT00766363|75856055|FG003|STARTED|Overall Study|Number randomized.|12||
59737106|NCT00766363|75856052|FG000|SAFETY POPULATION|Overall Study||12||
59737107|NCT00766363|75856053|FG001|SAFETY POPULATION|Overall Study||13||
59737108|NCT00766363|75856054|FG002|SAFETY POPULATION|Overall Study|Decreased by one subject who took placebo instead due to treatment assignment error.|11||
59737109|NCT00766363|75856055|FG003|SAFETY POPULATION|Overall Study|Increased by one subject who took placebo due to treatment assignment error.|13||
59737110|NCT00766363|75856052|FG000|PK POPULATION|Overall Study||12||
59737111|NCT00766363|75856053|FG001|PK POPULATION|Overall Study||13||
59737112|NCT00766363|75856054|FG002|PK POPULATION|Overall Study||10||
59737113|NCT00766363|75856055|FG003|PK POPULATION|Overall Study||13||
59737114|NCT00766363|75856052|FG000|COMPLETED|Overall Study||11||
59737115|NCT00766363|75856053|FG001|COMPLETED|Overall Study||12||
59737116|NCT00766363|75856054|FG002|COMPLETED|Overall Study||12||
59737117|NCT00766363|75856055|FG003|COMPLETED|Overall Study||12||
59737118|NCT00766363|75856052|FG000|NOT COMPLETED|Overall Study||1||
59737119|NCT00766363|75856053|FG001|NOT COMPLETED|Overall Study||1||
59737120|NCT00766363|75856054|FG002|NOT COMPLETED|Overall Study||0||
59737121|NCT00766363|75856055|FG003|NOT COMPLETED|Overall Study||0||
59737122|NCT02636946|75856068|FG000|STARTED|Cycle 1 (Day 1 to Week 15)||72||
59737123|NCT02636946|75856069|FG001|STARTED|Cycle 1 (Day 1 to Week 15)||72||
59737124|NCT02636946|75856068|FG000|Received Treatment in Either Eye|Cycle 1 (Day 1 to Week 15)||72||
59737125|NCT02636946|75856069|FG001|Received Treatment in Either Eye|Cycle 1 (Day 1 to Week 15)||70||
59737126|NCT02636946|75856068|FG000|COMPLETED|Cycle 1 (Day 1 to Week 15)||71||
59737127|NCT02636946|75856069|FG001|COMPLETED|Cycle 1 (Day 1 to Week 15)||67||
59737128|NCT02636946|75856068|FG000|NOT COMPLETED|Cycle 1 (Day 1 to Week 15)||1||
59737129|NCT02636946|75856069|FG001|NOT COMPLETED|Cycle 1 (Day 1 to Week 15)||5||
59737130|NCT02636946|75856068|FG000|STARTED|Cycle 2 (Week 16 to Week 31)||65|Started=received administration (Sham or Bimatoprost SR) in the cycle|
59737131|NCT02636946|75856069|FG001|STARTED|Cycle 2 (Week 16 to Week 31)||62|Started=received administration (Sham or Bimatoprost SR) in the cycle|
59737132|NCT02636946|75856068|FG000|COMPLETED|Cycle 2 (Week 16 to Week 31)||63||
59737133|NCT02636946|75856069|FG001|COMPLETED|Cycle 2 (Week 16 to Week 31)||61||
59737134|NCT02636946|75856068|FG000|NOT COMPLETED|Cycle 2 (Week 16 to Week 31)||2||
59737135|NCT02636946|75856069|FG001|NOT COMPLETED|Cycle 2 (Week 16 to Week 31)||1||
59737136|NCT02636946|75856068|FG000|STARTED|Cycle 3 (Week 32 to Week 52)||17|Started=received administration (Sham or Bimatoprost SR) in the cycle|
59737137|NCT02636946|75856069|FG001|STARTED|Cycle 3 (Week 32 to Week 52)||16|Started=received administration (Sham or Bimatoprost SR) in the cycle|
59737138|NCT02636946|75856068|FG000|COMPLETED|Cycle 3 (Week 32 to Week 52)||17||
59737139|NCT02636946|75856069|FG001|COMPLETED|Cycle 3 (Week 32 to Week 52)||16||
59737140|NCT02636946|75856068|FG000|NOT COMPLETED|Cycle 3 (Week 32 to Week 52)||0||
59737141|NCT02636946|75856069|FG001|NOT COMPLETED|Cycle 3 (Week 32 to Week 52)||0||
59737142|NCT00766051|75856077|FG000|STARTED|Overall Study||12||
59737143|NCT00766051|75856078|FG001|STARTED|Overall Study||10||
59737144|NCT00766051|75856077|FG000|COMPLETED|Overall Study||10||
59737145|NCT00766051|75856078|FG001|COMPLETED|Overall Study||10||
59737146|NCT00766051|75856077|FG000|NOT COMPLETED|Overall Study||2||
59737147|NCT00766051|75856078|FG001|NOT COMPLETED|Overall Study||0||
59737148|NCT00909792|75856086|FG000|STARTED|Period 1||130||
59737149|NCT00909792|75856087|FG001|STARTED|Period 1||128||
59737150|NCT00909792|75856086|FG000|COMPLETED|Period 1||130||
59737151|NCT00909792|75856087|FG001|COMPLETED|Period 1||127||
59737152|NCT00909792|75856086|FG000|NOT COMPLETED|Period 1||0||
59737153|NCT00909792|75856087|FG001|NOT COMPLETED|Period 1||1||
59737154|NCT00909792|75856086|FG000|STARTED|Period 2|One participant discontinued between Period 1 and Period 2 due to lack of efficacy.|129||
59737155|NCT00909792|75856087|FG001|STARTED|Period 2|Two discontinuations between P1 & P2: 1 for fail inc/exc criteria; 1 for lack of efficacy.|125||
59737156|NCT00909792|75856086|FG000|COMPLETED|Period 2||128||
59737157|NCT00909792|75856087|FG001|COMPLETED|Period 2||124||
59737158|NCT00909792|75856086|FG000|NOT COMPLETED|Period 2||1||
59737159|NCT00909792|75856087|FG001|NOT COMPLETED|Period 2||1||
59737160|NCT00765817|75856095|FG000|STARTED|Overall Study|One subject withdrew prior to receiving study medication, not included in analysis set|138||
59737161|NCT00765817|75856096|FG001|STARTED|Overall Study|One subject withdrew prior to receiving study medication, not included in analysis set|123||
59737162|NCT00765817|75856095|FG000|COMPLETED|Overall Study||112||
59737163|NCT00765817|75856096|FG001|COMPLETED|Overall Study||101||
59737164|NCT00765817|75856095|FG000|NOT COMPLETED|Overall Study||26||
59737165|NCT00765817|75856096|FG001|NOT COMPLETED|Overall Study||22||
59737166|NCT00772603|75856105|FG000|STARTED|Overall Study||123||
59737167|NCT00772603|75856106|FG001|STARTED|Overall Study||122||
59737168|NCT00772603|75856107|FG002|STARTED|Overall Study||121||
59737169|NCT00772603|75856105|FG000|COMPLETED|Overall Study||71||
59737170|NCT00772603|75856106|FG001|COMPLETED|Overall Study||82||
59737171|NCT00772603|75856107|FG002|COMPLETED|Overall Study||95||
59737172|NCT00772603|75856105|FG000|NOT COMPLETED|Overall Study||52||
59737173|NCT00772603|75856106|FG001|NOT COMPLETED|Overall Study||40||
59737174|NCT00772603|75856107|FG002|NOT COMPLETED|Overall Study||26||
59737175|NCT00772447|75856120|FG000|STARTED|Overall Study||131||
59737176|NCT00772447|75856121|FG001|STARTED|Overall Study||134||
59737177|NCT00772447|75856120|FG000|COMPLETED|Overall Study||111||
59737178|NCT00772447|75856121|FG001|COMPLETED|Overall Study||110||
59737179|NCT00772447|75856120|FG000|NOT COMPLETED|Overall Study||20||
59737180|NCT00772447|75856121|FG001|NOT COMPLETED|Overall Study||24||
59737181|NCT00765037|75856128|FG000|STARTED|Overall Study|Original number of eligible subjects who signed a consent form.|19||
59737182|NCT00765037|75856128|FG000|COMPLETED|Overall Study|Subjects who came in for 1 year visit.|13||
59737183|NCT00765037|75856128|FG000|NOT COMPLETED|Overall Study||6||
59737184|NCT00831844|75856142|FG000|STARTED|Overall Study||10||
59737185|NCT00831844|75856143|FG001|STARTED|Overall Study||12||
59737186|NCT00831844|75856144|FG002|STARTED|Overall Study||21||
59737187|NCT00831844|75856145|FG003|STARTED|Overall Study||10||
59737188|NCT00831844|75856146|FG004|STARTED|Overall Study||14||
59737189|NCT00831844|75856147|FG005|STARTED|Overall Study||20||
59737190|NCT00831844|75856148|FG006|STARTED|Overall Study||10||
59737191|NCT00831844|75856149|FG007|STARTED|Overall Study||10||
59737192|NCT00831844|75856150|FG008|STARTED|Overall Study||9||
59737193|NCT00831844|75856151|FG009|STARTED|Overall Study||0||
59737194|NCT00831844|75856142|FG000|COMPLETED|Overall Study||0||
59737195|NCT00831844|75856143|FG001|COMPLETED|Overall Study||0||
59737196|NCT00831844|75856144|FG002|COMPLETED|Overall Study||1||
59737197|NCT00831844|75856145|FG003|COMPLETED|Overall Study||0||
59737198|NCT00831844|75856146|FG004|COMPLETED|Overall Study||0||
59737199|NCT00831844|75856147|FG005|COMPLETED|Overall Study||1||
59737200|NCT00831844|75856148|FG006|COMPLETED|Overall Study||0||
59737201|NCT00831844|75856149|FG007|COMPLETED|Overall Study||0||
59951251|NCT03743415|76070182|FG007|COMPLETED|Overall Study||88||
59737202|NCT00831844|75856150|FG008|COMPLETED|Overall Study||0||
59737203|NCT00831844|75856151|FG009|COMPLETED|Overall Study||0||
59737204|NCT00831844|75856142|FG000|NOT COMPLETED|Overall Study||10||
59737205|NCT00831844|75856143|FG001|NOT COMPLETED|Overall Study||12||
59737206|NCT00831844|75856144|FG002|NOT COMPLETED|Overall Study||20||
59737207|NCT00831844|75856145|FG003|NOT COMPLETED|Overall Study||10||
59737208|NCT00831844|75856146|FG004|NOT COMPLETED|Overall Study||14||
59737209|NCT00831844|75856147|FG005|NOT COMPLETED|Overall Study||19||
59737210|NCT00831844|75856148|FG006|NOT COMPLETED|Overall Study||10||
59737211|NCT00831844|75856149|FG007|NOT COMPLETED|Overall Study||10||
59737212|NCT00831844|75856150|FG008|NOT COMPLETED|Overall Study||9||
59737213|NCT00831844|75856151|FG009|NOT COMPLETED|Overall Study||0||
59737214|NCT00764881|75856175|FG000|STARTED|Overall Study||108||
59737215|NCT00764881|75856176|FG001|STARTED|Overall Study||109||
59737216|NCT00764881|75856175|FG000|Subjects Received Treatment|Overall Study|Full Analysis Set (FAS)|106||
59737217|NCT00764881|75856176|FG001|Subjects Received Treatment|Overall Study|Full Analysis Set (FAS)|107||
59737218|NCT00764881|75856175|FG000|COMPLETED|Overall Study||92||
59737219|NCT00764881|75856176|FG001|COMPLETED|Overall Study||99||
59737220|NCT00764881|75856175|FG000|NOT COMPLETED|Overall Study||16||
59737221|NCT00764881|75856176|FG001|NOT COMPLETED|Overall Study||10||
59737222|NCT00844558|75856184|FG000|STARTED|Overall Study|"Received allocated intervention (n=33)~Did not receive allocated intervention (n=3)"|36||
59737223|NCT00844558|75856185|FG001|STARTED|Overall Study|"Received allocated intervention (n=21)~Did not receive allocated intervention (n=1)"|22||
59737224|NCT00844558|75856184|FG000|Received Allocated Intervention|Overall Study||33||
59737225|NCT00844558|75856185|FG001|Received Allocated Intervention|Overall Study||21||
59737226|NCT00844558|75856184|FG000|3 Month Visit|Overall Study|Discontinued intervention (n=4)|29||
59737227|NCT00844558|75856185|FG001|3 Month Visit|Overall Study|"Lost to follow-up (n=1)~Discontinued Intervention (n=1)"|19||
59737228|NCT00844558|75856184|FG000|6 Month Visit|Overall Study|Discontinued intervention (n=1)|28||
59737229|NCT00844558|75856185|FG001|6 Month Visit|Overall Study|-Discontinued intervention (n=1)|18||
59737230|NCT00844558|75856184|FG000|12 Month Visit|Overall Study|Discontinued intervention (n=4)|24||
59737231|NCT00844558|75856185|FG001|12 Month Visit|Overall Study|-Discontinued intervention (n=0)|18||
59737232|NCT00844558|75856184|FG000|COMPLETED|Overall Study||24||
59737233|NCT00844558|75856185|FG001|COMPLETED|Overall Study||18||
59737234|NCT00844558|75856184|FG000|NOT COMPLETED|Overall Study||12||
59737235|NCT00844558|75856185|FG001|NOT COMPLETED|Overall Study||4||
60134711|NCT04118348|76257943|FG000|NOT COMPLETED|Overall Study||0||
60134712|NCT04118348|76257944|FG001|NOT COMPLETED|Overall Study||0||
60134713|NCT04118348|76257945|FG002|NOT COMPLETED|Overall Study||0||
60134714|NCT04118348|76257946|FG003|NOT COMPLETED|Overall Study||0||
60134715|NCT04108988|76257958|FG000|STARTED|Overall Study|61 were randomized to this arm.|61||
60134716|NCT04108988|76257959|FG001|STARTED|Overall Study|56 were randomized to this arm.|56||
59737236|NCT00772369|75856196|FG000|STARTED|Overall Study||3214||
59737237|NCT00772369|75856196|FG000|COMPLETED|Overall Study||3213||
59737238|NCT00772369|75856196|FG000|NOT COMPLETED|Overall Study||1||
59737239|NCT00821236|75856203|FG000|STARTED|Overall Study||40||
59737240|NCT00821236|75856203|FG000|COMPLETED|Overall Study||37||
59737241|NCT00821236|75856203|FG000|NOT COMPLETED|Overall Study||3||
59737242|NCT00756457|75856213|FG000|STARTED|Overall Study||20||
59737243|NCT00756457|75856214|FG001|STARTED|Overall Study||19||
59737244|NCT00756457|75856213|FG000|COMPLETED|Overall Study|One participant in the Active treatment group decided to have surgery after the 2 week follow-up.|19||
59737245|NCT00756457|75856214|FG001|COMPLETED|Overall Study|One participant moved overseas; the other participant resumed cancer treatment|17||
59737246|NCT00756457|75856213|FG000|NOT COMPLETED|Overall Study||1||
59737247|NCT00756457|75856214|FG001|NOT COMPLETED|Overall Study||2||
59737248|NCT00844480|75856238|FG000|STARTED|Overall Study||8||
59737249|NCT00844480|75856239|FG001|STARTED|Overall Study||9||
59737250|NCT00844480|75856238|FG000|COMPLETED|Overall Study||6||
59737251|NCT00844480|75856239|FG001|COMPLETED|Overall Study||6||
59737252|NCT00844480|75856238|FG000|NOT COMPLETED|Overall Study||2||
59737253|NCT00844480|75856239|FG001|NOT COMPLETED|Overall Study||3||
60134717|NCT04108988|76257958|FG000|Consent and Baseline|Overall Study||40|Excluded participants did not attend initial meeting for consenting, baseline and gameplay.|
60134718|NCT04108988|76257959|FG001|Consent and Baseline|Overall Study||39|Excluded participants did not attend initial meeting for consenting, baseline and gameplay.|
59737254|NCT00771901|75856248|FG000|STARTED|Overall Study||10||
59737255|NCT00771901|75856249|FG001|STARTED|Overall Study||10||
59737256|NCT00771901|75856250|FG002|STARTED|Overall Study||10||
59737257|NCT00771901|75856248|FG000|COMPLETED|Overall Study||10||
59737258|NCT00771901|75856249|FG001|COMPLETED|Overall Study||10||
59737259|NCT00771901|75856250|FG002|COMPLETED|Overall Study||6||
59737260|NCT00771901|75856248|FG000|NOT COMPLETED|Overall Study||0||
59737261|NCT00771901|75856249|FG001|NOT COMPLETED|Overall Study||0||
59737262|NCT00771901|75856250|FG002|NOT COMPLETED|Overall Study||4||
59737263|NCT00843856|75856260|FG000|STARTED|Overall Study||20||
59737264|NCT00843856|75856261|FG001|STARTED|Overall Study||20||
59737265|NCT00843856|75856260|FG000|COMPLETED|Overall Study||19||
59737266|NCT00843856|75856261|FG001|COMPLETED|Overall Study||18||
59737267|NCT00843856|75856260|FG000|NOT COMPLETED|Overall Study||1||
59737268|NCT00843856|75856261|FG001|NOT COMPLETED|Overall Study||2||
59737269|NCT00764491|75856269|FG000|STARTED|Overall Study||123||
59737270|NCT00764491|75856270|FG001|STARTED|Overall Study||33||
59737271|NCT00764491|75856269|FG000|COMPLETED|Overall Study||88||
59737272|NCT00764491|75856270|FG001|COMPLETED|Overall Study||16||
59737273|NCT00764491|75856269|FG000|NOT COMPLETED|Overall Study||35||
59737274|NCT00764491|75856270|FG001|NOT COMPLETED|Overall Study||17||
60134719|NCT04108988|76257958|FG000|Completed Post Gameplay Survey|Overall Study||40||
59737275|NCT00843778|75856276|FG000|STARTED|Overall Study||131||
59737276|NCT00843778|75856276|FG000|COMPLETED|Overall Study||96||
59737277|NCT00843778|75856276|FG000|NOT COMPLETED|Overall Study||35||
59737278|NCT00910728|75856289|FG000|STARTED|Overall Study||6||
59737279|NCT00910728|75856290|FG001|STARTED|Overall Study||3||
59737280|NCT00910728|75856291|FG002|STARTED|Overall Study||3||
59737281|NCT00910728|75856292|FG003|STARTED|Overall Study||3||
59737282|NCT00910728|75856293|FG004|STARTED|Overall Study||6||
59737283|NCT00910728|75856294|FG005|STARTED|Overall Study||1||
59737284|NCT00910728|75856295|FG006|STARTED|Overall Study||6||
59737285|NCT00910728|75856296|FG007|STARTED|Overall Study||4||
59737286|NCT00910728|75856297|FG008|STARTED|Overall Study||3||
59737287|NCT00910728|75856289|FG000|COMPLETED|Overall Study||0||
59737288|NCT00910728|75856290|FG001|COMPLETED|Overall Study||0||
60134720|NCT04108988|76257959|FG001|Completed Post Gameplay Survey|Overall Study|One participant did not attend the session.|38||
59737289|NCT00910728|75856291|FG002|COMPLETED|Overall Study||0||
59737290|NCT00910728|75856292|FG003|COMPLETED|Overall Study||0||
59737291|NCT00910728|75856293|FG004|COMPLETED|Overall Study||1||
59737292|NCT00910728|75856294|FG005|COMPLETED|Overall Study||0||
59737293|NCT00910728|75856295|FG006|COMPLETED|Overall Study||0||
59737294|NCT00910728|75856296|FG007|COMPLETED|Overall Study||1||
59737295|NCT00910728|75856297|FG008|COMPLETED|Overall Study||0||
59737296|NCT00910728|75856289|FG000|NOT COMPLETED|Overall Study||6||
59737297|NCT00910728|75856290|FG001|NOT COMPLETED|Overall Study||3||
59737298|NCT00910728|75856291|FG002|NOT COMPLETED|Overall Study||3||
59737299|NCT00910728|75856292|FG003|NOT COMPLETED|Overall Study||3||
59737300|NCT00910728|75856293|FG004|NOT COMPLETED|Overall Study||5||
59737301|NCT00910728|75856294|FG005|NOT COMPLETED|Overall Study||1||
59737302|NCT00910728|75856295|FG006|NOT COMPLETED|Overall Study||6||
59737303|NCT00910728|75856296|FG007|NOT COMPLETED|Overall Study||3||
59737304|NCT00910728|75856297|FG008|NOT COMPLETED|Overall Study||3||
59737305|NCT00820222|75856319|FG000|STARTED|Overall Study||271||
59737306|NCT00820222|75856320|FG001|STARTED|Overall Study||269||
59737307|NCT00820222|75856319|FG000|COMPLETED|Overall Study||95||
59737308|NCT00820222|75856320|FG001|COMPLETED|Overall Study||79||
59737309|NCT00820222|75856319|FG000|NOT COMPLETED|Overall Study||176||
60134721|NCT04108988|76257958|FG000|Completed One Month Follow-up|Overall Study||40||
60134722|NCT04108988|76257959|FG001|Completed One Month Follow-up|Overall Study||39||
60134723|NCT04108988|76257958|FG000|Completed Four Month Follow-up|Overall Study|Two participants did not respond within the collection window.|38||
59737310|NCT00820222|75856320|FG001|NOT COMPLETED|Overall Study||190||
59737311|NCT01039688|75856329|FG000|STARTED|Overall Study||373||
59737312|NCT01039688|75856330|FG001|STARTED|Overall Study||397||
59737313|NCT01039688|75856331|FG002|STARTED|Overall Study||186||
59737314|NCT01039688|75856329|FG000|COMPLETED|Overall Study||266||
59737315|NCT01039688|75856330|FG001|COMPLETED|Overall Study||286||
59737316|NCT01039688|75856331|FG002|COMPLETED|Overall Study||106||
59737317|NCT01039688|75856329|FG000|NOT COMPLETED|Overall Study||107||
59737318|NCT01039688|75856330|FG001|NOT COMPLETED|Overall Study||111||
59737319|NCT01039688|75856331|FG002|NOT COMPLETED|Overall Study||80||
59737320|NCT02237508|75856352|FG000|STARTED|Overall Study||9||
59737321|NCT02237508|75856353|FG001|STARTED|Overall Study||9||
59737322|NCT02237508|75856354|FG002|STARTED|Overall Study||9||
59737323|NCT02237508|75856355|FG003|STARTED|Overall Study||9||
59737324|NCT02237508|75856356|FG004|STARTED|Overall Study||9||
59737325|NCT02237508|75856357|FG005|STARTED|Overall Study||9||
59737326|NCT02237508|75856358|FG006|STARTED|Overall Study||9||
59737327|NCT02237508|75856359|FG007|STARTED|Overall Study||9||
59737328|NCT02237508|75856360|FG008|STARTED|Overall Study||9||
59737329|NCT02237508|75856361|FG009|STARTED|Overall Study||9||
59737330|NCT02237508|75856352|FG000|A|Overall Study||9||
59737331|NCT02237508|75856353|FG001|A|Overall Study||6||
59737332|NCT02237508|75856354|FG002|A|Overall Study||8||
59737333|NCT02237508|75856355|FG003|A|Overall Study||8||
59737334|NCT02237508|75856356|FG004|A|Overall Study||9||
59737335|NCT02237508|75856357|FG005|A|Overall Study||8||
59737336|NCT02237508|75856358|FG006|A|Overall Study||8||
59737337|NCT02237508|75856359|FG007|A|Overall Study||9||
59737338|NCT02237508|75856360|FG008|A|Overall Study||9||
59737339|NCT02237508|75856361|FG009|A|Overall Study||9||
59737340|NCT02237508|75856352|FG000|B1|Overall Study||9||
59737341|NCT02237508|75856353|FG001|B1|Overall Study||9||
59737342|NCT02237508|75856354|FG002|B1|Overall Study||9||
59737343|NCT02237508|75856355|FG003|B1|Overall Study||8||
59737344|NCT02237508|75856356|FG004|B1|Overall Study||9||
59737345|NCT02237508|75856357|FG005|B1|Overall Study||9||
59737346|NCT02237508|75856358|FG006|B1|Overall Study||9||
59737347|NCT02237508|75856359|FG007|B1|Overall Study||9||
59737348|NCT02237508|75856360|FG008|B1|Overall Study||9||
59737349|NCT02237508|75856361|FG009|B1|Overall Study||9||
59737350|NCT02237508|75856352|FG000|B2|Overall Study||9||
59737351|NCT02237508|75856353|FG001|B2|Overall Study||6||
59737352|NCT02237508|75856354|FG002|B2|Overall Study||9||
59737353|NCT02237508|75856355|FG003|B2|Overall Study||9||
59737354|NCT02237508|75856356|FG004|B2|Overall Study||9||
59737355|NCT02237508|75856357|FG005|B2|Overall Study||9||
59737356|NCT02237508|75856358|FG006|B2|Overall Study||9||
59737357|NCT02237508|75856359|FG007|B2|Overall Study||9||
59737358|NCT02237508|75856360|FG008|B2|Overall Study||8||
59737359|NCT02237508|75856361|FG009|B2|Overall Study||9||
59737360|NCT02237508|75856352|FG000|C|Overall Study||9||
59737361|NCT02237508|75856353|FG001|C|Overall Study||8||
59737362|NCT02237508|75856354|FG002|C|Overall Study||9||
59737363|NCT02237508|75856355|FG003|C|Overall Study||8||
59737364|NCT02237508|75856356|FG004|C|Overall Study||9||
59737365|NCT02237508|75856357|FG005|C|Overall Study||9||
59737366|NCT02237508|75856358|FG006|C|Overall Study||9||
59737367|NCT02237508|75856359|FG007|C|Overall Study||9||
59737368|NCT02237508|75856360|FG008|C|Overall Study||9||
59737369|NCT02237508|75856361|FG009|C|Overall Study||9||
59737370|NCT02237508|75856352|FG000|D|Overall Study||9||
59737371|NCT02237508|75856353|FG001|D|Overall Study||6||
59737372|NCT02237508|75856354|FG002|D|Overall Study||9||
59737373|NCT02237508|75856355|FG003|D|Overall Study||9||
59737374|NCT02237508|75856356|FG004|D|Overall Study||9||
59737375|NCT02237508|75856357|FG005|D|Overall Study||9||
59737376|NCT02237508|75856358|FG006|D|Overall Study||9||
59604079|NCT02059434|75714650|FG003|COMPLETED|Washout Between Periods 1 and 2||2||
59604080|NCT02059434|75714651|FG004|COMPLETED|Washout Between Periods 1 and 2||2||
59604081|NCT02059434|75714652|FG005|COMPLETED|Washout Between Periods 1 and 2||2||
59604082|NCT02059434|75714653|FG006|COMPLETED|Washout Between Periods 1 and 2||2||
59604083|NCT02059434|75714654|FG007|COMPLETED|Washout Between Periods 1 and 2||2||
59604084|NCT02059434|75714655|FG008|COMPLETED|Washout Between Periods 1 and 2|Part 2 followed Part 1, and comprised 5 treatment periods|0||
59604085|NCT02059434|75714647|FG000|NOT COMPLETED|Washout Between Periods 1 and 2||0||
59604086|NCT02059434|75714648|FG001|NOT COMPLETED|Washout Between Periods 1 and 2||0||
59604087|NCT02059434|75714649|FG002|NOT COMPLETED|Washout Between Periods 1 and 2||0||
59604088|NCT02059434|75714650|FG003|NOT COMPLETED|Washout Between Periods 1 and 2||0||
59604089|NCT02059434|75714651|FG004|NOT COMPLETED|Washout Between Periods 1 and 2||0||
59604090|NCT02059434|75714652|FG005|NOT COMPLETED|Washout Between Periods 1 and 2||0||
59604091|NCT02059434|75714653|FG006|NOT COMPLETED|Washout Between Periods 1 and 2||0||
59604092|NCT02059434|75714654|FG007|NOT COMPLETED|Washout Between Periods 1 and 2||1||
59604093|NCT02059434|75714655|FG008|NOT COMPLETED|Washout Between Periods 1 and 2||0||
59604094|NCT02059434|75714647|FG000|STARTED|Period 2||2||
59604095|NCT02059434|75714648|FG001|STARTED|Period 2||2||
59604096|NCT02059434|75714649|FG002|STARTED|Period 2||2||
59604097|NCT02059434|75714650|FG003|STARTED|Period 2||2||
59604098|NCT02059434|75714651|FG004|STARTED|Period 2||2||
59604099|NCT02059434|75714652|FG005|STARTED|Period 2||2||
59604100|NCT02059434|75714653|FG006|STARTED|Period 2||2||
59604101|NCT02059434|75714654|FG007|STARTED|Period 2||2||
59604102|NCT02059434|75714655|FG008|STARTED|Period 2|Part 2 followed Part 1, and comprised 5 treatment periods|0||
59604103|NCT02059434|75714647|FG000|COMPLETED|Period 2||2||
59604104|NCT02059434|75714648|FG001|COMPLETED|Period 2||2||
59604105|NCT02059434|75714649|FG002|COMPLETED|Period 2||2||
59604106|NCT02059434|75714650|FG003|COMPLETED|Period 2||2||
59604107|NCT02059434|75714651|FG004|COMPLETED|Period 2||2||
59604108|NCT02059434|75714652|FG005|COMPLETED|Period 2||2||
59604109|NCT02059434|75714653|FG006|COMPLETED|Period 2||2||
59604110|NCT02059434|75714654|FG007|COMPLETED|Period 2||2||
59604111|NCT02059434|75714655|FG008|COMPLETED|Period 2|Part 2 followed Part 1, and comprised 5 treatment periods|0||
59604112|NCT02059434|75714647|FG000|NOT COMPLETED|Period 2||0||
59604113|NCT02059434|75714648|FG001|NOT COMPLETED|Period 2||0||
59604114|NCT02059434|75714649|FG002|NOT COMPLETED|Period 2||0||
59604115|NCT02059434|75714650|FG003|NOT COMPLETED|Period 2||0||
59604116|NCT02059434|75714651|FG004|NOT COMPLETED|Period 2||0||
59604117|NCT02059434|75714652|FG005|NOT COMPLETED|Period 2||0||
59604118|NCT02059434|75714653|FG006|NOT COMPLETED|Period 2||0||
59604119|NCT02059434|75714654|FG007|NOT COMPLETED|Period 2||0||
59604120|NCT02059434|75714655|FG008|NOT COMPLETED|Period 2||0||
59604121|NCT02059434|75714647|FG000|STARTED|Washout Between Periods 2 and 3||2||
59737377|NCT02237508|75856359|FG007|D|Overall Study||9||
59604122|NCT02059434|75714648|FG001|STARTED|Washout Between Periods 2 and 3||2||
59604123|NCT02059434|75714649|FG002|STARTED|Washout Between Periods 2 and 3||2||
59604124|NCT02059434|75714650|FG003|STARTED|Washout Between Periods 2 and 3||2||
59604125|NCT02059434|75714651|FG004|STARTED|Washout Between Periods 2 and 3||2||
59604126|NCT02059434|75714652|FG005|STARTED|Washout Between Periods 2 and 3||2||
59604127|NCT02059434|75714653|FG006|STARTED|Washout Between Periods 2 and 3||2||
59604128|NCT02059434|75714654|FG007|STARTED|Washout Between Periods 2 and 3||2||
59604129|NCT02059434|75714655|FG008|STARTED|Washout Between Periods 2 and 3|Part 2 followed Part 1, and comprised 5 treatment periods|0||
59604130|NCT02059434|75714647|FG000|COMPLETED|Washout Between Periods 2 and 3||2||
59604131|NCT02059434|75714648|FG001|COMPLETED|Washout Between Periods 2 and 3||2||
59604132|NCT02059434|75714649|FG002|COMPLETED|Washout Between Periods 2 and 3||2||
59604133|NCT02059434|75714650|FG003|COMPLETED|Washout Between Periods 2 and 3||2||
59604134|NCT02059434|75714651|FG004|COMPLETED|Washout Between Periods 2 and 3||2||
59604135|NCT02059434|75714652|FG005|COMPLETED|Washout Between Periods 2 and 3||2||
59604136|NCT02059434|75714653|FG006|COMPLETED|Washout Between Periods 2 and 3||2||
59604137|NCT02059434|75714654|FG007|COMPLETED|Washout Between Periods 2 and 3||2||
59604138|NCT02059434|75714655|FG008|COMPLETED|Washout Between Periods 2 and 3|Part 2 followed Part 1, and comprised 5 treatment periods|0||
59604139|NCT02059434|75714647|FG000|NOT COMPLETED|Washout Between Periods 2 and 3||0||
59604140|NCT02059434|75714648|FG001|NOT COMPLETED|Washout Between Periods 2 and 3||0||
59604141|NCT02059434|75714649|FG002|NOT COMPLETED|Washout Between Periods 2 and 3||0||
59604142|NCT02059434|75714650|FG003|NOT COMPLETED|Washout Between Periods 2 and 3||0||
59737378|NCT02237508|75856360|FG008|D|Overall Study||8||
59604143|NCT02059434|75714651|FG004|NOT COMPLETED|Washout Between Periods 2 and 3||0||
59604144|NCT02059434|75714652|FG005|NOT COMPLETED|Washout Between Periods 2 and 3||0||
59604145|NCT02059434|75714653|FG006|NOT COMPLETED|Washout Between Periods 2 and 3||0||
59604146|NCT02059434|75714654|FG007|NOT COMPLETED|Washout Between Periods 2 and 3||0||
59604147|NCT02059434|75714655|FG008|NOT COMPLETED|Washout Between Periods 2 and 3||0||
59604148|NCT02059434|75714647|FG000|STARTED|Period 3||2||
59737379|NCT02237508|75856361|FG009|D|Overall Study||9||
59737380|NCT02237508|75856352|FG000|COMPLETED|Overall Study||9||
59737381|NCT02237508|75856353|FG001|COMPLETED|Overall Study||6||
59737382|NCT02237508|75856354|FG002|COMPLETED|Overall Study||8||
59737383|NCT02237508|75856355|FG003|COMPLETED|Overall Study||8||
59737384|NCT02237508|75856356|FG004|COMPLETED|Overall Study||9||
59737385|NCT02237508|75856357|FG005|COMPLETED|Overall Study||8||
59737386|NCT02237508|75856358|FG006|COMPLETED|Overall Study||8||
59737387|NCT02237508|75856359|FG007|COMPLETED|Overall Study||9||
59737388|NCT02237508|75856360|FG008|COMPLETED|Overall Study||8||
59737389|NCT02237508|75856361|FG009|COMPLETED|Overall Study||9||
59737390|NCT02237508|75856352|FG000|NOT COMPLETED|Overall Study||0||
59737391|NCT02237508|75856353|FG001|NOT COMPLETED|Overall Study||3||
59737392|NCT02237508|75856354|FG002|NOT COMPLETED|Overall Study||1||
59737393|NCT02237508|75856355|FG003|NOT COMPLETED|Overall Study||1||
59737394|NCT02237508|75856356|FG004|NOT COMPLETED|Overall Study||0||
59737395|NCT02237508|75856357|FG005|NOT COMPLETED|Overall Study||1||
59737396|NCT02237508|75856358|FG006|NOT COMPLETED|Overall Study||1||
59737397|NCT02237508|75856359|FG007|NOT COMPLETED|Overall Study||0||
59737398|NCT02237508|75856360|FG008|NOT COMPLETED|Overall Study||1||
59737399|NCT02237508|75856361|FG009|NOT COMPLETED|Overall Study||0||
59737400|NCT00909090|75856381|FG000|STARTED|Overall Study||53||
59737401|NCT00909090|75856382|FG001|STARTED|Overall Study||56||
59737402|NCT00909090|75856381|FG000|COMPLETED|Overall Study||36||
59737403|NCT00909090|75856382|FG001|COMPLETED|Overall Study||39||
59737404|NCT00909090|75856381|FG000|NOT COMPLETED|Overall Study||17||
59737405|NCT00909090|75856382|FG001|NOT COMPLETED|Overall Study||17||
59737406|NCT00909480|75856393|FG000|STARTED|Overall Study||228||
59737407|NCT00909480|75856394|FG001|STARTED|Overall Study||229||
59737408|NCT00909480|75856393|FG000|Exposed|Overall Study|2 subjects withdrew before exposure to trial insulin|226||
59737409|NCT00909480|75856394|FG001|Exposed|Overall Study|2 subjects withdrew before exposure to trial insulin|227||
59737410|NCT00909480|75856393|FG000|COMPLETED|Overall Study||190||
59737411|NCT00909480|75856394|FG001|COMPLETED|Overall Study||188||
59737412|NCT00909480|75856393|FG000|NOT COMPLETED|Overall Study||38||
59737413|NCT00909480|75856394|FG001|NOT COMPLETED|Overall Study||41||
59737414|NCT01058096|75856402|FG000|STARTED|Double-blind Treatment Phase||154||
59737415|NCT01058096|75856403|FG001|STARTED|Double-blind Treatment Phase||158||
59737416|NCT01058096|75856402|FG000|COMPLETED|Double-blind Treatment Phase||106||
59737417|NCT01058096|75856403|FG001|COMPLETED|Double-blind Treatment Phase||108||
59737418|NCT01058096|75856402|FG000|NOT COMPLETED|Double-blind Treatment Phase||48||
59737419|NCT01058096|75856403|FG001|NOT COMPLETED|Double-blind Treatment Phase||50||
59737420|NCT01058096|75856402|FG000|STARTED|Safety Follow-up|Not all participants continued to Safety Follow-up.|133||
59737421|NCT01058096|75856403|FG001|STARTED|Safety Follow-up||134||
59737422|NCT01058096|75856402|FG000|COMPLETED|Safety Follow-up||129||
59737423|NCT01058096|75856403|FG001|COMPLETED|Safety Follow-up||130||
59737424|NCT01058096|75856402|FG000|NOT COMPLETED|Safety Follow-up||4||
59737425|NCT01058096|75856403|FG001|NOT COMPLETED|Safety Follow-up||4||
59737426|NCT01057862|75856411|FG000|STARTED|Overall Study||5||
59737427|NCT01057862|75856412|FG001|STARTED|Overall Study||4||
59737428|NCT01057862|75856411|FG000|COMPLETED|Overall Study||4||
59737429|NCT01057862|75856412|FG001|COMPLETED|Overall Study||2||
59737430|NCT01057862|75856411|FG000|NOT COMPLETED|Overall Study||1||
59737431|NCT01057862|75856412|FG001|NOT COMPLETED|Overall Study||2||
59737432|NCT01038128|75856418|FG000|STARTED|Overall Study||5||
59737433|NCT01038128|75856418|FG000|Baseline Visit|Overall Study||3||
59737434|NCT01038128|75856418|FG000|COMPLETED|Overall Study||1||
59737435|NCT01038128|75856418|FG000|NOT COMPLETED|Overall Study||4||
59737436|NCT02562378|75856427|FG000|STARTED|Overall Study||3||
59737437|NCT02562378|75856428|FG001|STARTED|Overall Study||3||
59737438|NCT02562378|75856429|FG002|STARTED|Overall Study||9||
59737439|NCT02562378|75856427|FG000|COMPLETED|Overall Study||3||
59737440|NCT02562378|75856428|FG001|COMPLETED|Overall Study||3||
59737441|NCT02562378|75856429|FG002|COMPLETED|Overall Study||9||
59737442|NCT02562378|75856427|FG000|NOT COMPLETED|Overall Study||0||
59737443|NCT02562378|75856428|FG001|NOT COMPLETED|Overall Study||0||
59737444|NCT02562378|75856429|FG002|NOT COMPLETED|Overall Study||0||
59737445|NCT00842530|75856439|FG000|STARTED|Overall Study||2669||
59737446|NCT00842530|75856440|FG001|STARTED|Overall Study||1333||
59737447|NCT00842530|75856439|FG000|Received Vaccination 1|Overall Study||2666||
59737448|NCT00842530|75856440|FG001|Received Vaccination 1|Overall Study||1331||
59737449|NCT00842530|75856439|FG000|Received Vaccination 2|Overall Study||2584||
59737450|NCT00842530|75856440|FG001|Received Vaccination 2|Overall Study||1300||
59737451|NCT00842530|75856439|FG000|Received Vaccination 3|Overall Study||2557||
59737452|NCT00842530|75856440|FG001|Received Vaccination 3|Overall Study||1282||
59737453|NCT00842530|75856439|FG000|COMPLETED|Overall Study||2552||
59737454|NCT00842530|75856440|FG001|COMPLETED|Overall Study||1276||
59737455|NCT00842530|75856439|FG000|NOT COMPLETED|Overall Study||117||
59737456|NCT00842530|75856440|FG001|NOT COMPLETED|Overall Study||57||
59737457|NCT00819910|75856451|FG000|STARTED|Overall Study||10||
59737458|NCT00819910|75856452|FG001|STARTED|Overall Study||10||
59737459|NCT00819910|75856453|FG002|STARTED|Overall Study||10||
59737460|NCT00819910|75856454|FG003|STARTED|Overall Study||11||
59737461|NCT00819910|75856451|FG000|COMPLETED|Overall Study||8||
59737462|NCT00819910|75856452|FG001|COMPLETED|Overall Study||9||
59737463|NCT00819910|75856453|FG002|COMPLETED|Overall Study||7||
59737464|NCT00819910|75856454|FG003|COMPLETED|Overall Study||10||
59737465|NCT00819910|75856451|FG000|NOT COMPLETED|Overall Study||2||
59737466|NCT00819910|75856452|FG001|NOT COMPLETED|Overall Study||1||
59737467|NCT00819910|75856453|FG002|NOT COMPLETED|Overall Study||3||
59737468|NCT00819910|75856454|FG003|NOT COMPLETED|Overall Study||1||
59737469|NCT00830518|75856468|FG000|STARTED|Overall Study||46||
59737470|NCT00830518|75856469|FG001|STARTED|Overall Study||11||
59737471|NCT00830518|75856468|FG000|COMPLETED|Overall Study|Completed = participants who completed study treatment.|0||
59737472|NCT00830518|75856469|FG001|COMPLETED|Overall Study||0||
59737473|NCT00830518|75856468|FG000|NOT COMPLETED|Overall Study||46||
59737474|NCT00830518|75856469|FG001|NOT COMPLETED|Overall Study||11||
59737475|NCT00908544|75856478|FG000|STARTED|Overall Study||20||
59737476|NCT00908544|75856479|FG001|STARTED|Overall Study||22||
59737477|NCT00908544|75856478|FG000|COMPLETED|Overall Study||15||
59737478|NCT00908544|75856479|FG001|COMPLETED|Overall Study||16||
59737479|NCT00908544|75856478|FG000|NOT COMPLETED|Overall Study||5||
59737480|NCT00908544|75856479|FG001|NOT COMPLETED|Overall Study||6||
59737481|NCT00830440|75856487|FG000|STARTED|Overall Study||32||
59737482|NCT00830440|75856488|FG001|STARTED|Overall Study||11||
59737483|NCT00830440|75856487|FG000|Received Device|Overall Study||26||
59737484|NCT00830440|75856488|FG001|Received Device|Overall Study||0||
59737485|NCT00830440|75856487|FG000|Completed 12 Week Follow up|Overall Study||24||
59737486|NCT00830440|75856488|FG001|Completed 12 Week Follow up|Overall Study||11||
59737487|NCT00830440|75856487|FG000|Completed 16 Week Follow up|Overall Study||4||
59737488|NCT00830440|75856488|FG001|Completed 16 Week Follow up|Overall Study||0||
59737489|NCT00830440|75856487|FG000|Completed 24 Week Follow up|Overall Study||3||
59737490|NCT00830440|75856488|FG001|Completed 24 Week Follow up|Overall Study||0||
59737491|NCT00830440|75856487|FG000|COMPLETED|Overall Study||24||
59737492|NCT00830440|75856488|FG001|COMPLETED|Overall Study||11||
59737493|NCT00830440|75856487|FG000|NOT COMPLETED|Overall Study||8||
59737494|NCT00830440|75856488|FG001|NOT COMPLETED|Overall Study||0||
59737495|NCT00908310|75856495|FG000|STARTED|Overall Study||213||
59737496|NCT00908310|75856495|FG000|COMPLETED|Overall Study||153||
59737497|NCT00908310|75856495|FG000|NOT COMPLETED|Overall Study||60||
59604149|NCT02059434|75714648|FG001|STARTED|Period 3||2||
59604150|NCT02059434|75714649|FG002|STARTED|Period 3||2||
59604151|NCT02059434|75714650|FG003|STARTED|Period 3||2||
59604152|NCT02059434|75714651|FG004|STARTED|Period 3||2||
59604153|NCT02059434|75714652|FG005|STARTED|Period 3||2||
59604154|NCT02059434|75714653|FG006|STARTED|Period 3||2||
59604155|NCT02059434|75714654|FG007|STARTED|Period 3||2||
59604156|NCT02059434|75714655|FG008|STARTED|Period 3|Part 2 followed Part 1, and comprised 5 treatment periods|0||
59604157|NCT02059434|75714647|FG000|COMPLETED|Period 3||2||
59604158|NCT02059434|75714648|FG001|COMPLETED|Period 3||2||
59604159|NCT02059434|75714649|FG002|COMPLETED|Period 3||2||
59604160|NCT02059434|75714650|FG003|COMPLETED|Period 3||2||
59604161|NCT02059434|75714651|FG004|COMPLETED|Period 3||2||
59604162|NCT02059434|75714652|FG005|COMPLETED|Period 3||2||
59604163|NCT02059434|75714653|FG006|COMPLETED|Period 3||2||
59737498|NCT00830128|75856499|FG000|STARTED|Overall Study||106||
59737499|NCT00830128|75856499|FG000|COMPLETED|Overall Study||87||
59737500|NCT00830128|75856499|FG000|NOT COMPLETED|Overall Study||19||
59737501|NCT00841906|75856505|FG000|STARTED|Overall Study||18||
59737502|NCT00841906|75856506|FG001|STARTED|Overall Study||14||
59737503|NCT00841906|75856505|FG000|COMPLETED|Overall Study||16||
59737504|NCT00841906|75856506|FG001|COMPLETED|Overall Study||14||
59737505|NCT00841906|75856505|FG000|NOT COMPLETED|Overall Study||2||
59604164|NCT02059434|75714654|FG007|COMPLETED|Period 3||2||
59604165|NCT02059434|75714655|FG008|COMPLETED|Period 3|Part 2 followed Part 1, and comprised 5 treatment periods|0||
59604166|NCT02059434|75714647|FG000|NOT COMPLETED|Period 3||0||
59737506|NCT00841906|75856506|FG001|NOT COMPLETED|Overall Study||0||
59737507|NCT00771667|75856518|FG000|STARTED|Induction Phase||132||
59737508|NCT00771667|75856519|FG001|STARTED|Induction Phase||131||
59737509|NCT00771667|75856520|FG002|STARTED|Induction Phase||132||
59737510|NCT00771667|75856521|FG003|STARTED|Induction Phase||131||
59737511|NCT00771667|75856522|FG004|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0||
59737512|NCT00771667|75856523|FG005|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0||
59737513|NCT00771667|75856524|FG006|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0||
59737514|NCT00771667|75856525|FG007|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0||
59737515|NCT00771667|75856526|FG008|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0||
59737516|NCT00771667|75856527|FG009|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0||
59737517|NCT00771667|75856518|FG000|COMPLETED|Induction Phase||113||
59737518|NCT00771667|75856519|FG001|COMPLETED|Induction Phase||121||
59737519|NCT00771667|75856520|FG002|COMPLETED|Induction Phase||120||
59604167|NCT02059434|75714648|FG001|NOT COMPLETED|Period 3||0||
59604168|NCT02059434|75714649|FG002|NOT COMPLETED|Period 3||0||
59604169|NCT02059434|75714650|FG003|NOT COMPLETED|Period 3||0||
59604170|NCT02059434|75714651|FG004|NOT COMPLETED|Period 3||0||
59604171|NCT02059434|75714652|FG005|NOT COMPLETED|Period 3||0||
59737520|NCT00771667|75856521|FG003|COMPLETED|Induction Phase||123||
59737521|NCT00771667|75856522|FG004|COMPLETED|Induction Phase||0||
59737522|NCT00771667|75856523|FG005|COMPLETED|Induction Phase||0||
59737523|NCT00771667|75856524|FG006|COMPLETED|Induction Phase||0||
59737524|NCT00771667|75856525|FG007|COMPLETED|Induction Phase||0||
59737525|NCT00771667|75856526|FG008|COMPLETED|Induction Phase||0||
59737526|NCT00771667|75856527|FG009|COMPLETED|Induction Phase||0||
59737527|NCT00771667|75856518|FG000|NOT COMPLETED|Induction Phase||19||
59737528|NCT00771667|75856519|FG001|NOT COMPLETED|Induction Phase||10||
59737529|NCT00771667|75856520|FG002|NOT COMPLETED|Induction Phase||12||
59737530|NCT00771667|75856521|FG003|NOT COMPLETED|Induction Phase||8||
59737531|NCT00771667|75856522|FG004|NOT COMPLETED|Induction Phase||0||
59737532|NCT00771667|75856523|FG005|NOT COMPLETED|Induction Phase||0||
59737533|NCT00771667|75856524|FG006|NOT COMPLETED|Induction Phase||0||
59737534|NCT00771667|75856525|FG007|NOT COMPLETED|Induction Phase||0||
59737535|NCT00771667|75856526|FG008|NOT COMPLETED|Induction Phase||0||
59737536|NCT00771667|75856527|FG009|NOT COMPLETED|Induction Phase||0||
59737537|NCT00771667|75856518|FG000|STARTED|Maintenance Phase|"0 in column indicates this reporting group is not relevant to Maintenance period."|0||
59737538|NCT00771667|75856519|FG001|STARTED|Maintenance Phase|"0 in column indicates this reporting group is not relevant to Maintenance period."|0||
59737539|NCT00771667|75856520|FG002|STARTED|Maintenance Phase|"0 in column indicates this reporting group is not relevant to Maintenance period."|0||
59737540|NCT00771667|75856521|FG003|STARTED|Maintenance Phase|"0 in column indicates this reporting group is not relevant to Maintenance period."|0||
59737541|NCT00771667|75856522|FG004|STARTED|Maintenance Phase||28||
59737542|NCT00771667|75856523|FG005|STARTED|Maintenance Phase||85||
59737543|NCT00771667|75856524|FG006|STARTED|Maintenance Phase||73||
59737544|NCT00771667|75856525|FG007|STARTED|Maintenance Phase||72||
59737545|NCT00771667|75856526|FG008|STARTED|Maintenance Phase||110||
59737546|NCT00771667|75856527|FG009|STARTED|Maintenance Phase||109||
59737547|NCT00771667|75856518|FG000|COMPLETED|Maintenance Phase||0||
59737548|NCT00771667|75856519|FG001|COMPLETED|Maintenance Phase||0||
59737549|NCT00771667|75856520|FG002|COMPLETED|Maintenance Phase||0||
59737550|NCT00771667|75856521|FG003|COMPLETED|Maintenance Phase||0||
59737551|NCT00771667|75856522|FG004|COMPLETED|Maintenance Phase||26||
59737552|NCT00771667|75856523|FG005|COMPLETED|Maintenance Phase||78||
59737553|NCT00771667|75856524|FG006|COMPLETED|Maintenance Phase||63||
59737554|NCT00771667|75856525|FG007|COMPLETED|Maintenance Phase||67||
59737555|NCT00771667|75856526|FG008|COMPLETED|Maintenance Phase||88||
59737556|NCT00771667|75856527|FG009|COMPLETED|Maintenance Phase||92||
59737557|NCT00771667|75856518|FG000|NOT COMPLETED|Maintenance Phase||0||
59737558|NCT00771667|75856519|FG001|NOT COMPLETED|Maintenance Phase||0||
59737559|NCT00771667|75856520|FG002|NOT COMPLETED|Maintenance Phase||0||
59737560|NCT00771667|75856521|FG003|NOT COMPLETED|Maintenance Phase||0||
59737561|NCT00771667|75856522|FG004|NOT COMPLETED|Maintenance Phase||2||
59737562|NCT00771667|75856523|FG005|NOT COMPLETED|Maintenance Phase||7||
59737563|NCT00771667|75856524|FG006|NOT COMPLETED|Maintenance Phase||10||
59737564|NCT00771667|75856525|FG007|NOT COMPLETED|Maintenance Phase||5||
59737565|NCT00771667|75856526|FG008|NOT COMPLETED|Maintenance Phase||22||
59737566|NCT00771667|75856527|FG009|NOT COMPLETED|Maintenance Phase||17||
59737567|NCT00770965|75856549|FG000|STARTED|Safety Set||2||
59737568|NCT00770965|75856550|FG001|STARTED|Safety Set||4||
59737569|NCT00770965|75856551|FG002|STARTED|Safety Set||4||
59737570|NCT00770965|75856552|FG003|STARTED|Safety Set||5||
59737571|NCT00770965|75856549|FG000|COMPLETED|Safety Set||2||
59737572|NCT00770965|75856550|FG001|COMPLETED|Safety Set||4||
59737573|NCT00770965|75856551|FG002|COMPLETED|Safety Set||3||
59737574|NCT00770965|75856552|FG003|COMPLETED|Safety Set||4||
59737575|NCT00770965|75856549|FG000|NOT COMPLETED|Safety Set||0||
59737576|NCT00770965|75856550|FG001|NOT COMPLETED|Safety Set||0||
59737577|NCT00770965|75856551|FG002|NOT COMPLETED|Safety Set||1||
59737578|NCT00770965|75856552|FG003|NOT COMPLETED|Safety Set||1||
59737579|NCT00770965|75856549|FG000|STARTED|Excluded Set||18||
59737580|NCT00770965|75856550|FG001|STARTED|Excluded Set||16||
59737581|NCT00770965|75856551|FG002|STARTED|Excluded Set||16||
59737582|NCT00770965|75856552|FG003|STARTED|Excluded Set||15||
59737583|NCT00770965|75856549|FG000|COMPLETED|Excluded Set||3||
59737584|NCT00770965|75856550|FG001|COMPLETED|Excluded Set||3||
59737585|NCT00770965|75856551|FG002|COMPLETED|Excluded Set||2||
59737586|NCT00770965|75856552|FG003|COMPLETED|Excluded Set||2||
59737587|NCT00770965|75856549|FG000|NOT COMPLETED|Excluded Set||15||
59737588|NCT00770965|75856550|FG001|NOT COMPLETED|Excluded Set||13||
59737589|NCT00770965|75856551|FG002|NOT COMPLETED|Excluded Set||14||
59737590|NCT00770965|75856552|FG003|NOT COMPLETED|Excluded Set||13||
59737591|NCT00763555|75856564|FG000|STARTED|Overall Study||44||
59737592|NCT00763555|75856565|FG001|STARTED|Overall Study||44||
59737593|NCT00763555|75856564|FG000|COMPLETED|Overall Study||40||
59737594|NCT00763555|75856565|FG001|COMPLETED|Overall Study||34||
59737595|NCT00763555|75856564|FG000|NOT COMPLETED|Overall Study||4||
59737596|NCT00763555|75856565|FG001|NOT COMPLETED|Overall Study||10||
59737597|NCT00763321|75856574|FG000|STARTED|Open-label Period||285||
59737598|NCT00763321|75856575|FG001|STARTED|Open-label Period||0||
59737599|NCT00763321|75856576|FG002|STARTED|Open-label Period||0||
59737600|NCT00763321|75856574|FG000|COMPLETED|Open-label Period||222||
59737601|NCT00763321|75856575|FG001|COMPLETED|Open-label Period||0||
59737602|NCT00763321|75856576|FG002|COMPLETED|Open-label Period||0||
59737603|NCT00763321|75856574|FG000|NOT COMPLETED|Open-label Period||63||
59737604|NCT00763321|75856575|FG001|NOT COMPLETED|Open-label Period||0||
59737605|NCT00763321|75856576|FG002|NOT COMPLETED|Open-label Period||0||
59737606|NCT00763321|75856574|FG000|STARTED|Double-blind Period||0||
59737607|NCT00763321|75856575|FG001|STARTED|Double-blind Period||109||
59737608|NCT00763321|75856576|FG002|STARTED|Double-blind Period||113||
59737609|NCT00763321|75856574|FG000|COMPLETED|Double-blind Period||0||
59737610|NCT00763321|75856575|FG001|COMPLETED|Double-blind Period||88||
59737611|NCT00763321|75856576|FG002|COMPLETED|Double-blind Period||84||
59737612|NCT00763321|75856574|FG000|NOT COMPLETED|Double-blind Period||0||
59737613|NCT00763321|75856575|FG001|NOT COMPLETED|Double-blind Period||21||
59737614|NCT00763321|75856576|FG002|NOT COMPLETED|Double-blind Period||29||
59737615|NCT00770653|75856585|FG000|STARTED|Overall Study||155||
59737616|NCT00770653|75856586|FG001|STARTED|Overall Study||150||
59737617|NCT00770653|75856585|FG000|COMPLETED|Overall Study||123||
59737618|NCT00770653|75856586|FG001|COMPLETED|Overall Study||121||
59737619|NCT00770653|75856585|FG000|NOT COMPLETED|Overall Study||32||
59737620|NCT00770653|75856586|FG001|NOT COMPLETED|Overall Study||29||
59737621|NCT00819052|75856594|FG000|STARTED|Overall Study||148||
59737622|NCT00819052|75856595|FG001|STARTED|Overall Study||295||
59737623|NCT00819052|75856594|FG000|COMPLETED|Overall Study||142||
59737624|NCT00819052|75856595|FG001|COMPLETED|Overall Study||281||
59737625|NCT00819052|75856594|FG000|NOT COMPLETED|Overall Study||6||
59737626|NCT00819052|75856595|FG001|NOT COMPLETED|Overall Study||14||
59737627|NCT00763009|75856604|FG000|STARTED|Overall Study||8||
59737628|NCT00763009|75856604|FG000|COMPLETED|Overall Study||7||
59737629|NCT00763009|75856604|FG000|NOT COMPLETED|Overall Study||1||
59737630|NCT00841672|75856611|FG000|STARTED|Overall Study|One patient was mis-randomized and was not treated in the double-blind treatment period.|244||
59737631|NCT00841672|75856612|FG001|STARTED|Overall Study||241||
59737632|NCT00841672|75856611|FG000|COMPLETED|Overall Study||224||
59737633|NCT00841672|75856612|FG001|COMPLETED|Overall Study||209||
59737634|NCT00841672|75856611|FG000|NOT COMPLETED|Overall Study||20||
59737635|NCT00841672|75856612|FG001|NOT COMPLETED|Overall Study||32||
59737636|NCT00908232|75856618|FG000|STARTED|Cycle 1 to 4|All participants started VD treatment for 4 cycles prior to local site response assessments|163||
59737637|NCT00908232|75856619|FG001|STARTED|Cycle 1 to 4||0||
59737638|NCT00908232|75856620|FG002|STARTED|Cycle 1 to 4||0||
59737639|NCT00908232|75856621|FG003|STARTED|Cycle 1 to 4||0||
59737640|NCT00908232|75856618|FG000|COMPLETED|Cycle 1 to 4|Of those completed, 120 subjects were assessed for response, 117 w/ Response or SD continued.|135||
59737641|NCT00908232|75856619|FG001|COMPLETED|Cycle 1 to 4||0||
59737642|NCT00908232|75856620|FG002|COMPLETED|Cycle 1 to 4||0||
59737643|NCT00908232|75856621|FG003|COMPLETED|Cycle 1 to 4||0||
59737644|NCT00908232|75856618|FG000|NOT COMPLETED|Cycle 1 to 4||28||
59737645|NCT00908232|75856619|FG001|NOT COMPLETED|Cycle 1 to 4||0||
59737646|NCT00908232|75856620|FG002|NOT COMPLETED|Cycle 1 to 4||0||
59737647|NCT00908232|75856621|FG003|NOT COMPLETED|Cycle 1 to 4||0||
59737648|NCT00908232|75856618|FG000|STARTED|Randomization (Cycle 5) to Cycle 8|Responding patients (not randomized) who received 4 more cycles of VD|98||
59737649|NCT00908232|75856619|FG001|STARTED|Randomization (Cycle 5) to Cycle 8||7||
59737650|NCT00908232|75856620|FG002|STARTED|Randomization (Cycle 5) to Cycle 8||8||
59737651|NCT00908232|75856621|FG003|STARTED|Randomization (Cycle 5) to Cycle 8||4||
59737652|NCT00908232|75856618|FG000|COMPLETED|Randomization (Cycle 5) to Cycle 8||63||
59737653|NCT00908232|75856619|FG001|COMPLETED|Randomization (Cycle 5) to Cycle 8||4||
59737654|NCT00908232|75856620|FG002|COMPLETED|Randomization (Cycle 5) to Cycle 8||7||
59737655|NCT00908232|75856621|FG003|COMPLETED|Randomization (Cycle 5) to Cycle 8||4||
59737656|NCT00908232|75856618|FG000|NOT COMPLETED|Randomization (Cycle 5) to Cycle 8||35||
59737657|NCT00908232|75856619|FG001|NOT COMPLETED|Randomization (Cycle 5) to Cycle 8||3||
59737658|NCT00908232|75856620|FG002|NOT COMPLETED|Randomization (Cycle 5) to Cycle 8||1||
59737659|NCT00908232|75856621|FG003|NOT COMPLETED|Randomization (Cycle 5) to Cycle 8||0||
59737660|NCT00770341|75856630|FG000|STARTED|Overall Study|Number randomized|89||
59737661|NCT00770341|75856631|FG001|STARTED|Overall Study|Number randomized|22||
59737662|NCT00770341|75856632|FG002|STARTED|Overall Study|Number randomized|11||
59737663|NCT00770341|75856630|FG000|COMPLETED|Overall Study||77||
59737664|NCT00770341|75856631|FG001|COMPLETED|Overall Study||17||
59737665|NCT00770341|75856632|FG002|COMPLETED|Overall Study||8||
59737666|NCT00770341|75856630|FG000|NOT COMPLETED|Overall Study||12||
59737667|NCT00770341|75856631|FG001|NOT COMPLETED|Overall Study||5||
59737668|NCT00770341|75856632|FG002|NOT COMPLETED|Overall Study||3||
59737669|NCT03793608|75856641|FG000|STARTED|Overall Study||1||
59737670|NCT03793608|75856642|FG001|STARTED|Overall Study||24||
59737671|NCT03793608|75856641|FG000|Treated|Overall Study||1||
59737672|NCT03793608|75856642|FG001|Treated|Overall Study||24||
59737673|NCT03793608|75856641|FG000|Safety Analysis Set (SAF)|Overall Study|1 participant randomized to placebo was not analyzed and thus excluded from analyses.|0|The safety analysis set (SAF) included all participants who received dupilumab. All efficacy and safety variables were analyzed using SAF.|
59737674|NCT03793608|75856642|FG001|Safety Analysis Set (SAF)|Overall Study||24|The safety analysis set (SAF) included all participants who received dupilumab. All efficacy and safety variables were analyzed using SAF.|
59737675|NCT03793608|75856641|FG000|COMPLETED|Overall Study||1||
59737676|NCT03793608|75856642|FG001|COMPLETED|Overall Study||24||
59737677|NCT03793608|75856641|FG000|NOT COMPLETED|Overall Study||0||
59737678|NCT03793608|75856642|FG001|NOT COMPLETED|Overall Study||0||
59737679|NCT00762463|75856649|FG000|STARTED|Double-blind Phase (Baseline to Week 6)||120||
59737680|NCT00762463|75856650|FG001|STARTED|Double-blind Phase (Baseline to Week 6)||120||
59737681|NCT00762463|75856651|FG002|STARTED|Double-blind Phase (Baseline to Week 6)||0||
59737682|NCT00762463|75856652|FG003|STARTED|Double-blind Phase (Baseline to Week 6)||0||
59737683|NCT00762463|75856649|FG000|COMPLETED|Double-blind Phase (Baseline to Week 6)||113||
59737684|NCT00762463|75856650|FG001|COMPLETED|Double-blind Phase (Baseline to Week 6)||110||
59737685|NCT00762463|75856651|FG002|COMPLETED|Double-blind Phase (Baseline to Week 6)||0||
59737686|NCT00762463|75856652|FG003|COMPLETED|Double-blind Phase (Baseline to Week 6)||0||
59737687|NCT00762463|75856649|FG000|NOT COMPLETED|Double-blind Phase (Baseline to Week 6)||7||
59737688|NCT00762463|75856650|FG001|NOT COMPLETED|Double-blind Phase (Baseline to Week 6)||10||
59737689|NCT00762463|75856651|FG002|NOT COMPLETED|Double-blind Phase (Baseline to Week 6)||0||
59737690|NCT00762463|75856652|FG003|NOT COMPLETED|Double-blind Phase (Baseline to Week 6)||0||
59737691|NCT00762463|75856649|FG000|STARTED|Enrollment in Extension Phase (Week 6)||113||
59737692|NCT00762463|75856650|FG001|STARTED|Enrollment in Extension Phase (Week 6)||110||
59737693|NCT00762463|75856651|FG002|STARTED|Enrollment in Extension Phase (Week 6)||0||
59737694|NCT00762463|75856652|FG003|STARTED|Enrollment in Extension Phase (Week 6)||0||
59737695|NCT00762463|75856649|FG000|COMPLETED|Enrollment in Extension Phase (Week 6)||109||
59737696|NCT00762463|75856650|FG001|COMPLETED|Enrollment in Extension Phase (Week 6)||109||
59737697|NCT00762463|75856651|FG002|COMPLETED|Enrollment in Extension Phase (Week 6)||0||
59737698|NCT00762463|75856652|FG003|COMPLETED|Enrollment in Extension Phase (Week 6)||0||
59737699|NCT00762463|75856649|FG000|NOT COMPLETED|Enrollment in Extension Phase (Week 6)||4||
59737700|NCT00762463|75856650|FG001|NOT COMPLETED|Enrollment in Extension Phase (Week 6)||1||
59737701|NCT00762463|75856651|FG002|NOT COMPLETED|Enrollment in Extension Phase (Week 6)||0||
59737702|NCT00762463|75856652|FG003|NOT COMPLETED|Enrollment in Extension Phase (Week 6)||0||
59737703|NCT00762463|75856649|FG000|STARTED|Extension Phase (Week 6 to Week 12)||55||
59737704|NCT00762463|75856650|FG001|STARTED|Extension Phase (Week 6 to Week 12)||55||
59737705|NCT00762463|75856651|FG002|STARTED|Extension Phase (Week 6 to Week 12)||54||
59737706|NCT00762463|75856652|FG003|STARTED|Extension Phase (Week 6 to Week 12)||54||
59737707|NCT00762463|75856649|FG000|COMPLETED|Extension Phase (Week 6 to Week 12)||52||
59737708|NCT00762463|75856650|FG001|COMPLETED|Extension Phase (Week 6 to Week 12)||54||
59737709|NCT00762463|75856651|FG002|COMPLETED|Extension Phase (Week 6 to Week 12)||50||
59737710|NCT00762463|75856652|FG003|COMPLETED|Extension Phase (Week 6 to Week 12)||52||
59737711|NCT00762463|75856649|FG000|NOT COMPLETED|Extension Phase (Week 6 to Week 12)||3||
59737712|NCT00762463|75856650|FG001|NOT COMPLETED|Extension Phase (Week 6 to Week 12)||1||
59737713|NCT00762463|75856651|FG002|NOT COMPLETED|Extension Phase (Week 6 to Week 12)||4||
59737714|NCT00762463|75856652|FG003|NOT COMPLETED|Extension Phase (Week 6 to Week 12)||2||
59737715|NCT00762385|75856665|FG000|STARTED|First Intervention||51||
59737716|NCT00762385|75856666|FG001|STARTED|First Intervention||46||
59737717|NCT00762385|75856665|FG000|COMPLETED|First Intervention||49||
59737718|NCT00762385|75856666|FG001|COMPLETED|First Intervention||42||
59737719|NCT00762385|75856665|FG000|NOT COMPLETED|First Intervention||2||
59737720|NCT00762385|75856666|FG001|NOT COMPLETED|First Intervention||4||
59737721|NCT00762385|75856665|FG000|STARTED|Second Intervention||49||
59737722|NCT00762385|75856666|FG001|STARTED|Second Intervention||42||
59737723|NCT00762385|75856665|FG000|COMPLETED|Second Intervention||46||
59737724|NCT00762385|75856666|FG001|COMPLETED|Second Intervention||39||
59737725|NCT00762385|75856665|FG000|NOT COMPLETED|Second Intervention||3||
59737726|NCT00762385|75856666|FG001|NOT COMPLETED|Second Intervention||3||
59737727|NCT00906282|75856675|FG000|STARTED|Preoperative Chemotherapy||46||
59737728|NCT00906282|75856675|FG000|COMPLETED|Preoperative Chemotherapy|2 of 27 patients completed less than 4 cycles and were deemed surgical candidates.|27||
59737729|NCT00906282|75856675|FG000|NOT COMPLETED|Preoperative Chemotherapy||19||
59737730|NCT00906282|75856675|FG000|STARTED|Surgical Resection||27||
59737731|NCT00906282|75856675|FG000|COMPLETED|Surgical Resection||27||
59737732|NCT00906282|75856675|FG000|NOT COMPLETED|Surgical Resection||0||
59737733|NCT00762229|75856682|FG000|STARTED|Overall Study||15||
59737734|NCT00762229|75856683|FG001|STARTED|Overall Study||24||
59737735|NCT00762229|75856682|FG000|COMPLETED|Overall Study||14||
59737736|NCT00762229|75856683|FG001|COMPLETED|Overall Study||22||
59737737|NCT00762229|75856682|FG000|NOT COMPLETED|Overall Study||1||
59737738|NCT00762229|75856683|FG001|NOT COMPLETED|Overall Study||2||
59737739|NCT00907374|75856691|FG000|STARTED|Overall Study||14||
59737740|NCT00907374|75856692|FG001|STARTED|Overall Study||13||
59737741|NCT00907374|75856691|FG000|COMPLETED|Overall Study||12||
59737742|NCT00907374|75856692|FG001|COMPLETED|Overall Study||11||
59737743|NCT00907374|75856691|FG000|NOT COMPLETED|Overall Study||2||
59737744|NCT00907374|75856692|FG001|NOT COMPLETED|Overall Study||2||
59737745|NCT00818662|75856702|FG000|STARTED|Overall Study||127||
59737746|NCT00818662|75856703|FG001|STARTED|Overall Study||135||
59737747|NCT00818662|75856704|FG002|STARTED|Overall Study||58||
59737748|NCT00818662|75856705|FG003|STARTED|Overall Study||63||
59737749|NCT00818662|75856702|FG000|COMPLETED|Overall Study||104||
59737750|NCT00818662|75856703|FG001|COMPLETED|Overall Study||102||
59737751|NCT00818662|75856704|FG002|COMPLETED|Overall Study||49||
59737752|NCT00818662|75856705|FG003|COMPLETED|Overall Study||47||
59737753|NCT00818662|75856702|FG000|NOT COMPLETED|Overall Study||23||
59737754|NCT00818662|75856703|FG001|NOT COMPLETED|Overall Study||33||
59737755|NCT00818662|75856704|FG002|NOT COMPLETED|Overall Study||9||
59737756|NCT00818662|75856705|FG003|NOT COMPLETED|Overall Study||16||
59737757|NCT00903786|75856716|FG000|STARTED|Overall Study||21||
59737758|NCT00903786|75856716|FG000|COMPLETED|Overall Study||6||
59737759|NCT00903786|75856716|FG000|NOT COMPLETED|Overall Study||15||
59737760|NCT00762073|75856725|FG000|STARTED|Overall Study||21||
59737761|NCT00762073|75856726|FG001|STARTED|Overall Study||21||
59737762|NCT00762073|75856727|FG002|STARTED|Overall Study||20||
59737763|NCT00762073|75856728|FG003|STARTED|Overall Study||20||
59737764|NCT00762073|75856725|FG000|COMPLETED|Overall Study||17||
59737765|NCT00762073|75856726|FG001|COMPLETED|Overall Study||17||
59737766|NCT00762073|75856727|FG002|COMPLETED|Overall Study|One participant was enrolled and randomized then withdrew consent and did not receive study drug.|18||
59737767|NCT00762073|75856728|FG003|COMPLETED|Overall Study||17||
59737768|NCT00762073|75856725|FG000|NOT COMPLETED|Overall Study||4||
59737769|NCT00762073|75856726|FG001|NOT COMPLETED|Overall Study||4||
59737770|NCT00762073|75856727|FG002|NOT COMPLETED|Overall Study||2||
59737771|NCT00762073|75856728|FG003|NOT COMPLETED|Overall Study||3||
59737772|NCT00761761|75856747|FG000|STARTED|Overall Study||30||
59737773|NCT00761761|75856748|FG001|STARTED|Overall Study||30||
59737774|NCT00761761|75856747|FG000|COMPLETED|Overall Study||24||
59737775|NCT00761761|75856748|FG001|COMPLETED|Overall Study||29||
59737776|NCT00761761|75856747|FG000|NOT COMPLETED|Overall Study||6||
59737777|NCT00761761|75856748|FG001|NOT COMPLETED|Overall Study||1||
59737778|NCT00761605|75856756|FG000|STARTED|Overall Study||387||
59737779|NCT00761605|75856756|FG000|COMPLETED|Overall Study||246||
59737780|NCT00761605|75856756|FG000|NOT COMPLETED|Overall Study||141||
59737781|NCT00761527|75856764|FG000|STARTED|Overall Study||2980||
59737782|NCT00761527|75856764|FG000|Received One Dose of Study Medication|Overall Study||2978||
59737783|NCT00761527|75856764|FG000|COMPLETED|Overall Study||2958||
59737784|NCT00761527|75856764|FG000|NOT COMPLETED|Overall Study||22||
59737785|NCT00770029|75856770|FG000|STARTED|Overall Study||184||
59737786|NCT00770029|75856771|FG001|STARTED|Overall Study||92||
59737787|NCT00770029|75856770|FG000|COMPLETED|Overall Study||178||
59737788|NCT00770029|75856771|FG001|COMPLETED|Overall Study||89||
59737789|NCT00770029|75856770|FG000|NOT COMPLETED|Overall Study||6||
59737790|NCT00770029|75856771|FG001|NOT COMPLETED|Overall Study||3||
59737791|NCT00817414|75856782|FG000|STARTED|Overall Study||12||
59737792|NCT00817414|75856783|FG001|STARTED|Overall Study||12||
59737793|NCT00817414|75856784|FG002|STARTED|Overall Study||13||
59737794|NCT00817414|75856785|FG003|STARTED|Overall Study||13||
59737795|NCT00817414|75856786|FG004|STARTED|Overall Study||13||
59737796|NCT00817414|75856782|FG000|COMPLETED|Overall Study||10||
59737797|NCT00817414|75856783|FG001|COMPLETED|Overall Study||9||
59737798|NCT00817414|75856784|FG002|COMPLETED|Overall Study||9||
59737799|NCT00817414|75856785|FG003|COMPLETED|Overall Study||1||
59737800|NCT00817414|75856786|FG004|COMPLETED|Overall Study||11||
59737801|NCT00817414|75856782|FG000|NOT COMPLETED|Overall Study||2||
59737802|NCT00817414|75856783|FG001|NOT COMPLETED|Overall Study||3||
59737803|NCT00817414|75856784|FG002|NOT COMPLETED|Overall Study||4||
59737804|NCT00817414|75856785|FG003|NOT COMPLETED|Overall Study||12||
59737805|NCT00817414|75856786|FG004|NOT COMPLETED|Overall Study||2||
59737806|NCT00769561|75856805|FG000|STARTED|Overall Study||29||
59737807|NCT00769561|75856806|FG001|STARTED|Overall Study||29||
59737808|NCT00769561|75856805|FG000|COMPLETED|Overall Study||26||
59737809|NCT00769561|75856806|FG001|COMPLETED|Overall Study||24||
59737810|NCT00769561|75856805|FG000|NOT COMPLETED|Overall Study||3||
59737811|NCT00769561|75856806|FG001|NOT COMPLETED|Overall Study||5||
59737812|NCT00817336|75856814|FG000|STARTED|Overall Study||8||
59737813|NCT00817336|75856815|FG001|STARTED|Overall Study||8||
59737814|NCT00817336|75856814|FG000|COMPLETED|Overall Study||7||
59737815|NCT00817336|75856815|FG001|COMPLETED|Overall Study||7||
59737816|NCT00817336|75856814|FG000|NOT COMPLETED|Overall Study||1||
59737817|NCT00817336|75856815|FG001|NOT COMPLETED|Overall Study||1||
59737818|NCT00761215|75856823|FG000|STARTED|Overall Study||64||
59737819|NCT00761215|75856824|FG001|STARTED|Overall Study||64||
59737820|NCT00761215|75856825|FG002|STARTED|Overall Study||64||
59737821|NCT00761215|75856823|FG000|COMPLETED|Overall Study||55||
59737822|NCT00761215|75856824|FG001|COMPLETED|Overall Study||60||
59737823|NCT00761215|75856825|FG002|COMPLETED|Overall Study||56||
59737824|NCT00761215|75856823|FG000|NOT COMPLETED|Overall Study||9||
59737825|NCT00761215|75856824|FG001|NOT COMPLETED|Overall Study||4||
59737826|NCT00761215|75856825|FG002|NOT COMPLETED|Overall Study||8||
59737827|NCT05175170|75856838|FG000|STARTED|Overall Study||10||
59737828|NCT05175170|75856839|FG001|STARTED|Overall Study||10||
59737829|NCT05175170|75856838|FG000|COMPLETED|Overall Study||10||
59737830|NCT05175170|75856839|FG001|COMPLETED|Overall Study||10||
59737831|NCT05175170|75856838|FG000|NOT COMPLETED|Overall Study||0||
59737832|NCT05175170|75856839|FG001|NOT COMPLETED|Overall Study||0||
59737833|NCT05169905|75856848|FG000|STARTED|Overall Study||1||
59737834|NCT05169905|75856849|FG001|STARTED|Overall Study||3||
59737835|NCT05169905|75856850|FG002|STARTED|Overall Study||4||
59737836|NCT05169905|75856848|FG000|COMPLETED|Overall Study||1||
59737837|NCT05169905|75856849|FG001|COMPLETED|Overall Study||3||
59737838|NCT05169905|75856850|FG002|COMPLETED|Overall Study||4||
59737839|NCT05169905|75856848|FG000|NOT COMPLETED|Overall Study||0||
59737840|NCT05169905|75856849|FG001|NOT COMPLETED|Overall Study||0||
59737841|NCT05169905|75856850|FG002|NOT COMPLETED|Overall Study||0||
59737842|NCT05101122|75856858|FG000|STARTED|Atomoxetine Only||15||
59737843|NCT05101122|75856858|FG000|COMPLETED|Atomoxetine Only||14||
59737844|NCT05101122|75856858|FG000|NOT COMPLETED|Atomoxetine Only||1||
59737845|NCT05101122|75856858|FG000|STARTED|AD313 40/2.5||14||
59737846|NCT05101122|75856858|FG000|COMPLETED|AD313 40/2.5||12||
59737847|NCT05101122|75856858|FG000|NOT COMPLETED|AD313 40/2.5||2||
59737848|NCT05101122|75856858|FG000|STARTED|AD313 80/5||12||
59737849|NCT05101122|75856858|FG000|COMPLETED|AD313 80/5||11||
59737850|NCT05101122|75856858|FG000|NOT COMPLETED|AD313 80/5||1||
59737851|NCT05101122|75856858|FG000|STARTED|AD313 80/10||11||
59737852|NCT05101122|75856858|FG000|COMPLETED|AD313 80/10||10||
59737853|NCT05101122|75856858|FG000|NOT COMPLETED|AD313 80/10||1||
59737854|NCT05038163|75856871|FG000|STARTED|Stage 1||4033||
59737855|NCT05038163|75856872|FG001|STARTED|Stage 1||0||
59737856|NCT05038163|75856873|FG002|STARTED|Stage 1||0||
59737857|NCT05038163|75856874|FG003|STARTED|Stage 1||0||
59737858|NCT05038163|75856875|FG004|STARTED|Stage 1||0||
59737859|NCT05038163|75856876|FG005|STARTED|Stage 1||0||
59737860|NCT05038163|75856871|FG000|COMPLETED|Stage 1||3659||
59737861|NCT05038163|75856872|FG001|COMPLETED|Stage 1||0||
59737862|NCT05038163|75856873|FG002|COMPLETED|Stage 1||0||
59737863|NCT05038163|75856874|FG003|COMPLETED|Stage 1||0||
59737864|NCT05038163|75856875|FG004|COMPLETED|Stage 1||0||
59737865|NCT05038163|75856876|FG005|COMPLETED|Stage 1||0||
59737866|NCT05038163|75856871|FG000|NOT COMPLETED|Stage 1||374||
59737867|NCT05038163|75856872|FG001|NOT COMPLETED|Stage 1||0||
59737868|NCT05038163|75856873|FG002|NOT COMPLETED|Stage 1||0||
59737869|NCT05038163|75856874|FG003|NOT COMPLETED|Stage 1||0||
59737870|NCT05038163|75856875|FG004|NOT COMPLETED|Stage 1||0||
59737871|NCT05038163|75856876|FG005|NOT COMPLETED|Stage 1||0||
59737872|NCT05038163|75856871|FG000|STARTED|Stage 2||0||
59737873|NCT05038163|75856872|FG001|STARTED|Stage 2||696||
59737874|NCT05038163|75856873|FG002|STARTED|Stage 2||683||
59737875|NCT05038163|75856874|FG003|STARTED|Stage 2||668||
59737876|NCT05038163|75856875|FG004|STARTED|Stage 2||683||
59737877|NCT05038163|75856876|FG005|STARTED|Stage 2||100||
59737878|NCT05038163|75856871|FG000|COMPLETED|Stage 2||0||
59737879|NCT05038163|75856872|FG001|COMPLETED|Stage 2||667||
59737880|NCT05038163|75856873|FG002|COMPLETED|Stage 2||653||
59737881|NCT05038163|75856874|FG003|COMPLETED|Stage 2||644||
59737882|NCT05038163|75856875|FG004|COMPLETED|Stage 2||662||
59737883|NCT05038163|75856876|FG005|COMPLETED|Stage 2||0||
59737884|NCT05038163|75856871|FG000|NOT COMPLETED|Stage 2||0||
59737885|NCT05038163|75856872|FG001|NOT COMPLETED|Stage 2||29||
59737886|NCT05038163|75856873|FG002|NOT COMPLETED|Stage 2||30||
59737887|NCT05038163|75856874|FG003|NOT COMPLETED|Stage 2||24||
59737888|NCT05038163|75856875|FG004|NOT COMPLETED|Stage 2||21||
59737889|NCT05038163|75856876|FG005|NOT COMPLETED|Stage 2||100||
59737890|NCT04860804|75856890|FG000|STARTED|Overall Study||30||
59737891|NCT04860804|75856891|FG001|STARTED|Overall Study||30||
59737892|NCT04860804|75856890|FG000|COMPLETED|Overall Study||28||
59737893|NCT04860804|75856891|FG001|COMPLETED|Overall Study||28||
59737894|NCT04860804|75856890|FG000|NOT COMPLETED|Overall Study||2||
59737895|NCT04860804|75856891|FG001|NOT COMPLETED|Overall Study||2||
59737896|NCT04812080|75856897|FG000|STARTED|Overall Study||20||
59737897|NCT04812080|75856897|FG000|COMPLETED|Overall Study||20||
59737898|NCT04812080|75856897|FG000|NOT COMPLETED|Overall Study||0||
59737899|NCT04516746|75856904|FG000|STARTED|Overall Study||21635|Participants randomized.|
59737900|NCT04516746|75856905|FG001|STARTED|Overall Study||10816|Participants randomized.|
59737901|NCT04516746|75856904|FG000|Participants Who Received First Dose|Overall Study||21583||
59737902|NCT04516746|75856905|FG001|Participants Who Received First Dose|Overall Study||10796||
59737903|NCT04516746|75856904|FG000|Participants Who Received Second Dose|Overall Study||20769||
59737904|NCT04516746|75856905|FG001|Participants Who Received Second Dose|Overall Study||9951||
59737905|NCT04516746|75856904|FG000|COMPLETED|Overall Study||0||
59737906|NCT04516746|75856905|FG001|COMPLETED|Overall Study||0||
59737907|NCT04516746|75856904|FG000|NOT COMPLETED|Overall Study||21635||
59737908|NCT04516746|75856905|FG001|NOT COMPLETED|Overall Study||10816||
59737909|NCT04502524|75856913|FG000|STARTED|Overall Study||25||
59737910|NCT04502524|75856914|FG001|STARTED|Overall Study||24||
59737911|NCT04502524|75856913|FG000|COMPLETED|Overall Study||18||
59737912|NCT04502524|75856914|FG001|COMPLETED|Overall Study||20||
59737913|NCT04502524|75856913|FG000|NOT COMPLETED|Overall Study||7||
59737914|NCT04502524|75856914|FG001|NOT COMPLETED|Overall Study||4||
59737915|NCT04487886|75856922|FG000|STARTED|Overall Study||25||
59737916|NCT04487886|75856923|FG001|STARTED|Overall Study||22||
59737917|NCT04487886|75856922|FG000|COMPLETED|Overall Study||25||
59737918|NCT04487886|75856923|FG001|COMPLETED|Overall Study||22||
59737919|NCT04487886|75856922|FG000|NOT COMPLETED|Overall Study||0||
59737920|NCT04487886|75856923|FG001|NOT COMPLETED|Overall Study||0||
59737921|NCT04413617|75856935|FG000|STARTED|Overall Study||102||
59737922|NCT04413617|75856936|FG001|STARTED|Overall Study||77||
59737923|NCT04413617|75856937|FG002|STARTED|Overall Study||77||
59737924|NCT04413617|75856938|FG003|STARTED|Overall Study||103||
59737925|NCT04413617|75856939|FG004|STARTED|Overall Study||101||
59737926|NCT04413617|75856935|FG000|COMPLETED|Overall Study||95||
59737927|NCT04413617|75856936|FG001|COMPLETED|Overall Study||71||
59737928|NCT04413617|75856937|FG002|COMPLETED|Overall Study||73||
59737929|NCT04413617|75856938|FG003|COMPLETED|Overall Study||95||
59737930|NCT04413617|75856939|FG004|COMPLETED|Overall Study||96||
59737931|NCT04413617|75856935|FG000|NOT COMPLETED|Overall Study||7||
59737932|NCT04413617|75856936|FG001|NOT COMPLETED|Overall Study||6||
59737933|NCT04413617|75856937|FG002|NOT COMPLETED|Overall Study||4||
59737934|NCT04413617|75856938|FG003|NOT COMPLETED|Overall Study||8||
59737935|NCT04413617|75856939|FG004|NOT COMPLETED|Overall Study||5||
59737936|NCT04112940|75856958|FG000|STARTED|Overall Study||12||
59737937|NCT04112940|75856958|FG000|COMPLETED|Overall Study||12||
59737938|NCT04112940|75856958|FG000|NOT COMPLETED|Overall Study||0||
59737939|NCT04055116|75856971|FG000|STARTED|First Intervention||30||
59737940|NCT04055116|75856972|FG001|STARTED|First Intervention||34||
59737941|NCT04055116|75856971|FG000|Recieved Intervention|First Intervention||28||
59737942|NCT04055116|75856972|FG001|Recieved Intervention|First Intervention||27||
59737943|NCT04055116|75856971|FG000|COMPLETED|First Intervention||28||
59737944|NCT04055116|75856972|FG001|COMPLETED|First Intervention||27||
59737945|NCT04055116|75856971|FG000|NOT COMPLETED|First Intervention||2||
59737946|NCT04055116|75856972|FG001|NOT COMPLETED|First Intervention||7||
59737947|NCT04055116|75856971|FG000|STARTED|Washout (14 Days)||28||
59737948|NCT04055116|75856972|FG001|STARTED|Washout (14 Days)||27||
59737949|NCT04055116|75856971|FG000|COMPLETED|Washout (14 Days)||28||
59737950|NCT04055116|75856972|FG001|COMPLETED|Washout (14 Days)||27||
59737951|NCT04055116|75856971|FG000|NOT COMPLETED|Washout (14 Days)||0||
59737952|NCT04055116|75856972|FG001|NOT COMPLETED|Washout (14 Days)||0||
59737953|NCT04055116|75856971|FG000|STARTED|Second Intervention (After 14 Days)||28||
59737954|NCT04055116|75856972|FG001|STARTED|Second Intervention (After 14 Days)||27||
59737955|NCT04055116|75856971|FG000|COMPLETED|Second Intervention (After 14 Days)||28||
59737956|NCT04055116|75856972|FG001|COMPLETED|Second Intervention (After 14 Days)||27||
59737957|NCT04055116|75856971|FG000|NOT COMPLETED|Second Intervention (After 14 Days)||0||
59737958|NCT04055116|75856972|FG001|NOT COMPLETED|Second Intervention (After 14 Days)||0||
59737959|NCT04010747|75856981|FG000|STARTED|Overall Study||53||
59737960|NCT04010747|75856982|FG001|STARTED|Overall Study||18||
59737961|NCT04010747|75856981|FG000|COMPLETED|Overall Study||53||
59737962|NCT04010747|75856982|FG001|COMPLETED|Overall Study||18||
59737963|NCT04010747|75856981|FG000|NOT COMPLETED|Overall Study||0||
59737964|NCT04010747|75856982|FG001|NOT COMPLETED|Overall Study||0||
59737965|NCT03743402|75856990|FG000|STARTED|Overall Study||79||
59737966|NCT03743402|75856991|FG001|STARTED|Overall Study||74||
59737967|NCT03743402|75856990|FG000|Availability of at Least One Primary Outcome Measure at 6 Months Post-baseline|Overall Study||79||
59737968|NCT03743402|75856991|FG001|Availability of at Least One Primary Outcome Measure at 6 Months Post-baseline|Overall Study||74||
59737969|NCT03743402|75856990|FG000|COMPLETED|Overall Study||78|Defined to be availability of at least one primary outcome measure at 12 months post-baseline.|
59737970|NCT03743402|75856991|FG001|COMPLETED|Overall Study||73|Defined to be availability of at least one primary outcome measure at 12 months post-baseline.|
59737971|NCT03743402|75856990|FG000|NOT COMPLETED|Overall Study||1||
59737972|NCT03743402|75856991|FG001|NOT COMPLETED|Overall Study||1||
59737973|NCT03734861|75856999|FG000|STARTED|Overall Study||50||
59737974|NCT03734861|75857000|FG001|STARTED|Overall Study||25||
59737975|NCT03734861|75856999|FG000|COMPLETED|Overall Study||50||
59737976|NCT03734861|75857000|FG001|COMPLETED|Overall Study||25||
59737977|NCT03734861|75856999|FG000|NOT COMPLETED|Overall Study||0||
59737978|NCT03734861|75857000|FG001|NOT COMPLETED|Overall Study||0||
59737979|NCT03646487|75857009|FG000|STARTED|Overall Study||12||
59737980|NCT03646487|75857010|FG001|STARTED|Overall Study||8||
59737981|NCT03646487|75857009|FG000|COMPLETED|Overall Study||7||
59737982|NCT03646487|75857010|FG001|COMPLETED|Overall Study||6||
59737983|NCT03646487|75857009|FG000|NOT COMPLETED|Overall Study||5||
59737984|NCT03646487|75857010|FG001|NOT COMPLETED|Overall Study||2||
59737985|NCT03512262|75857018|FG000|STARTED|Overall Study||149||
59737986|NCT03512262|75857019|FG001|STARTED|Overall Study||79||
59737987|NCT03512262|75857018|FG000|Received at Least 1 Dose of Study Drug|Overall Study||149||
59737988|NCT03512262|75857019|FG001|Received at Least 1 Dose of Study Drug|Overall Study||79||
59737989|NCT03512262|75857018|FG000|COMPLETED|Overall Study||114||
59737990|NCT03512262|75857019|FG001|COMPLETED|Overall Study||64||
59737991|NCT03512262|75857018|FG000|NOT COMPLETED|Overall Study||35||
59737992|NCT03512262|75857019|FG001|NOT COMPLETED|Overall Study||15||
59737993|NCT03499600|75857027|FG000|STARTED|Overall Study|1. Caregivers=39, Children=39|39||
59737994|NCT03499600|75857028|FG001|STARTED|Overall Study|Caregivers=50, Children=50|50||
59737995|NCT03499600|75857027|FG000|COMPLETED|Overall Study|Caregivers=18, Children=18|18||
59737996|NCT03499600|75857028|FG001|COMPLETED|Overall Study|Caregivers=50, children=50|20||
59737997|NCT03499600|75857027|FG000|NOT COMPLETED|Overall Study||21||
59737998|NCT03499600|75857028|FG001|NOT COMPLETED|Overall Study||30||
59737999|NCT03382665|75857034|FG000|STARTED|Overall Study||70|signed the informed consent|
59738000|NCT03382665|75857034|FG000|Actual Enrollment|Overall Study||59|11 patients were excluded from the study for different reasons|
59738001|NCT03382665|75857034|FG000|5 Year Follow up|Overall Study||25||
59738002|NCT03382665|75857034|FG000|COMPLETED|Overall Study||25|= longest FUP (Study completion was never reached since the study was terminated earlier).|
59738003|NCT03382665|75857034|FG000|NOT COMPLETED|Overall Study||45||
59738004|NCT03007979|75857042|FG000|STARTED|Overall Study||55||
59738005|NCT03007979|75857042|FG000|COMPLETED|Overall Study||54||
59738006|NCT03007979|75857042|FG000|NOT COMPLETED|Overall Study||1||
59738007|NCT02960893|75857048|FG000|STARTED|Randomization Phase (8-week)||71||
59738008|NCT02960893|75857049|FG001|STARTED|Randomization Phase (8-week)||70||
60134724|NCT04108988|76257959|FG001|Completed Four Month Follow-up|Overall Study||39||
59738009|NCT02960893|75857048|FG000|COMPLETED|Randomization Phase (8-week)||64|Completed the Randomization Phase|
59738010|NCT02960893|75857049|FG001|COMPLETED|Randomization Phase (8-week)||68|Completed the Randomization Phase|
59738011|NCT02960893|75857048|FG000|NOT COMPLETED|Randomization Phase (8-week)||7||
59738012|NCT02960893|75857049|FG001|NOT COMPLETED|Randomization Phase (8-week)||2||
60002362|NCT02065336|76118190|FG003|NOT COMPLETED|Extension Phase||0||
60002363|NCT02065336|76118191|FG004|NOT COMPLETED|Extension Phase||0||
60002364|NCT02065336|76118192|FG005|NOT COMPLETED|Extension Phase||0||
60002365|NCT02065336|76118193|FG006|NOT COMPLETED|Extension Phase||0||
60002366|NCT02065336|76118194|FG007|NOT COMPLETED|Extension Phase||0||
60002367|NCT02065336|76118195|FG008|NOT COMPLETED|Extension Phase||2||
60002368|NCT02065336|76118196|FG009|NOT COMPLETED|Extension Phase||8||
60134725|NCT04108988|76257958|FG000|COMPLETED|Overall Study||40||
60134726|NCT04108988|76257959|FG001|COMPLETED|Overall Study||39||
59738013|NCT02960893|75857048|FG000|STARTED|Extension Phase (48-week)||64||
59738014|NCT02960893|75857049|FG001|STARTED|Extension Phase (48-week)|One participant in placebo arm who completed Randomization Phase did not continue to Extension Phase|67||
59738015|NCT02960893|75857048|FG000|COMPLETED|Extension Phase (48-week)||50|Completed the 48-week Extension Phase|
59738016|NCT02960893|75857049|FG001|COMPLETED|Extension Phase (48-week)||54|Completed the 48-week Extension Phase|
59738017|NCT02960893|75857048|FG000|NOT COMPLETED|Extension Phase (48-week)||14||
59738018|NCT02960893|75857049|FG001|NOT COMPLETED|Extension Phase (48-week)||13||
59738019|NCT02867813|75857064|FG000|STARTED|Overall Study||2535||
59738020|NCT02867813|75857065|FG001|STARTED|Overall Study||2500||
59738021|NCT02867813|75857064|FG000|COMPLETED|Overall Study||2084||
59738022|NCT02867813|75857065|FG001|COMPLETED|Overall Study||2090||
59738023|NCT02867813|75857064|FG000|NOT COMPLETED|Overall Study||451||
59738024|NCT02867813|75857065|FG001|NOT COMPLETED|Overall Study||410||
59738025|NCT02494570|75857071|FG000|STARTED|Overall Study||34||
59738026|NCT02494570|75857071|FG000|COMPLETED|Overall Study||34||
59738027|NCT02494570|75857071|FG000|NOT COMPLETED|Overall Study||0||
59738028|NCT02278055|75857077|FG000|STARTED|Overall Study||29||
59738029|NCT02278055|75857077|FG000|COMPLETED|Overall Study||21||
59872980|NCT03131440|75997107|FG021|COMPLETED|Overall Study||7|Completed the 24 week questionnaires OR had valid data on the accelerometer at 24 weeks|
59872981|NCT03131440|75997108|FG022|COMPLETED|Overall Study||7|Completed the 24 week questionnaires OR had valid data on the accelerometer at 24 weeks|
59872982|NCT03131440|75997109|FG023|COMPLETED|Overall Study||8|Completed the 24 week questionnaires OR had valid data on the accelerometer at 24 weeks|
59872983|NCT03131440|75997110|FG024|COMPLETED|Overall Study||8|Completed the 24 week questionnaires OR had valid data on the accelerometer at 24 weeks|
59872984|NCT03131440|75997111|FG025|COMPLETED|Overall Study||7|Completed the 24 week questionnaires OR had valid data on the accelerometer at 24 weeks|
59872985|NCT03131440|75997112|FG026|COMPLETED|Overall Study||9|Completed the 24 week questionnaires OR had valid data on the accelerometer at 24 weeks|
59872986|NCT03131440|75997113|FG027|COMPLETED|Overall Study||7|Completed the 24 week questionnaires OR had valid data on the accelerometer at 24 weeks|
60002369|NCT02701985|76118229|FG000|STARTED|Overall Study||37||
60134727|NCT04108988|76257958|FG000|NOT COMPLETED|Overall Study||21||
60134728|NCT04108988|76257959|FG001|NOT COMPLETED|Overall Study||17||
59738030|NCT02278055|75857077|FG000|NOT COMPLETED|Overall Study||8||
59738031|NCT02231879|75857083|FG000|STARTED|Overall Study||10||
59738032|NCT02231879|75857084|FG001|STARTED|Overall Study||9||
59738033|NCT02231879|75857083|FG000|COMPLETED|Overall Study||8||
59738034|NCT02231879|75857084|FG001|COMPLETED|Overall Study||7||
59738035|NCT02231879|75857083|FG000|NOT COMPLETED|Overall Study||2||
59738036|NCT02231879|75857084|FG001|NOT COMPLETED|Overall Study||2||
59738037|NCT01968460|75857095|FG000|STARTED|Overall Study||49||
59738038|NCT01968460|75857096|FG001|STARTED|Overall Study||50||
59738039|NCT01968460|75857097|FG002|STARTED|Overall Study||50||
59738040|NCT01968460|75857095|FG000|COMPLETED|Overall Study||43||
59738041|NCT01968460|75857096|FG001|COMPLETED|Overall Study||45||
59738042|NCT01968460|75857097|FG002|COMPLETED|Overall Study||48||
59738043|NCT01968460|75857095|FG000|NOT COMPLETED|Overall Study||6||
59738044|NCT01968460|75857096|FG001|NOT COMPLETED|Overall Study||5||
59738045|NCT01968460|75857097|FG002|NOT COMPLETED|Overall Study||2||
59738046|NCT01833806|75857105|FG000|STARTED|Overall Study||32||
59738047|NCT01833806|75857105|FG000|COMPLETED|Overall Study||23||
59738048|NCT01833806|75857105|FG000|NOT COMPLETED|Overall Study||9||
59738049|NCT01712490|75857111|FG000|STARTED|Overall Study||664||
59738050|NCT01712490|75857112|FG001|STARTED|Overall Study||670||
59738051|NCT01712490|75857111|FG000|Treated|Overall Study||662||
59738052|NCT01712490|75857112|FG001|Treated|Overall Study||659||
59738053|NCT01712490|75857111|FG000|COMPLETED|Overall Study||0||
59738054|NCT01712490|75857112|FG001|COMPLETED|Overall Study||0||
59738055|NCT01712490|75857111|FG000|NOT COMPLETED|Overall Study||664||
59738056|NCT01712490|75857112|FG001|NOT COMPLETED|Overall Study||670||
59738057|NCT01439802|75857118|FG000|STARTED|6 Weeks Postpartum Status||90||
59738058|NCT01439802|75857118|FG000|COMPLETED|6 Weeks Postpartum Status||54||
59738059|NCT01439802|75857118|FG000|NOT COMPLETED|6 Weeks Postpartum Status||36||
59738060|NCT01439802|75857118|FG000|STARTED|6 Months Postpartum Status||54||
59738061|NCT01439802|75857118|FG000|COMPLETED|6 Months Postpartum Status||42||
59738062|NCT01439802|75857118|FG000|NOT COMPLETED|6 Months Postpartum Status||12||
59738063|NCT00544414|75857122|FG000|STARTED|Overall Study||31||
59738064|NCT00544414|75857122|FG000|COMPLETED|Overall Study||31||
59738065|NCT00544414|75857122|FG000|NOT COMPLETED|Overall Study||0||
59738066|NCT00816556|75857129|FG000|STARTED|Overall Study||20||
59738067|NCT00816556|75857130|FG001|STARTED|Overall Study||21||
59738068|NCT00816556|75857131|FG002|STARTED|Overall Study||22||
59738069|NCT00816556|75857129|FG000|COMPLETED|Overall Study||18||
59738070|NCT00816556|75857130|FG001|COMPLETED|Overall Study||19||
59738071|NCT00816556|75857131|FG002|COMPLETED|Overall Study||19||
59738072|NCT00816556|75857129|FG000|NOT COMPLETED|Overall Study||2||
59738073|NCT00816556|75857130|FG001|NOT COMPLETED|Overall Study||2||
59738074|NCT00816556|75857131|FG002|NOT COMPLETED|Overall Study||3||
59738075|NCT00760747|75857141|FG000|STARTED|Study Period II||57||
59738076|NCT00760747|75857142|FG001|STARTED|Study Period II||55||
59738077|NCT00760747|75857141|FG000|Received at Least One Dose of Study Drug|Study Period II||57||
59738078|NCT00760747|75857142|FG001|Received at Least One Dose of Study Drug|Study Period II||54||
59738079|NCT00760747|75857141|FG000|COMPLETED|Study Period II||44||
59738080|NCT00760747|75857142|FG001|COMPLETED|Study Period II||41||
59738081|NCT00760747|75857141|FG000|NOT COMPLETED|Study Period II||13||
59738082|NCT00760747|75857142|FG001|NOT COMPLETED|Study Period II||14||
59738083|NCT00760747|75857141|FG000|STARTED|Study Period III||44||
59738084|NCT00760747|75857142|FG001|STARTED|Study Period III||41||
59738085|NCT00760747|75857141|FG000|COMPLETED|Study Period III||41||
59738086|NCT00760747|75857142|FG001|COMPLETED|Study Period III||38||
59738087|NCT00760747|75857141|FG000|NOT COMPLETED|Study Period III||3||
59738088|NCT00760747|75857142|FG001|NOT COMPLETED|Study Period III||3||
59738089|NCT00760669|75857148|FG000|STARTED|Overall Study||1061||
59738090|NCT00760669|75857148|FG000|COMPLETED|Overall Study||1031||
59738091|NCT00760669|75857148|FG000|NOT COMPLETED|Overall Study||30||
59738092|NCT00769483|75857158|FG000|STARTED|Overall Study||9||
59738093|NCT00769483|75857159|FG001|STARTED|Overall Study||13||
59738094|NCT00769483|75857160|FG002|STARTED|Overall Study||15||
59738095|NCT00769483|75857161|FG003|STARTED|Overall Study||15||
59738096|NCT00769483|75857162|FG004|STARTED|Overall Study||16||
59738097|NCT00769483|75857163|FG005|STARTED|Overall Study||9||
59738098|NCT00769483|75857158|FG000|COMPLETED|Overall Study||9||
59738099|NCT00769483|75857159|FG001|COMPLETED|Overall Study||12||
59738100|NCT00769483|75857160|FG002|COMPLETED|Overall Study||15||
59738101|NCT00769483|75857161|FG003|COMPLETED|Overall Study||15||
59738102|NCT00769483|75857162|FG004|COMPLETED|Overall Study||15||
59738103|NCT00769483|75857163|FG005|COMPLETED|Overall Study||9||
59738104|NCT00769483|75857158|FG000|NOT COMPLETED|Overall Study||0||
59738105|NCT00769483|75857159|FG001|NOT COMPLETED|Overall Study||1||
59738106|NCT00769483|75857160|FG002|NOT COMPLETED|Overall Study||0||
59738107|NCT00769483|75857161|FG003|NOT COMPLETED|Overall Study||0||
59738108|NCT00769483|75857162|FG004|NOT COMPLETED|Overall Study||1||
59738109|NCT00769483|75857163|FG005|NOT COMPLETED|Overall Study||0||
59738110|NCT00760513|75857181|FG000|STARTED|Overall Study||51||
59738111|NCT00760513|75857182|FG001|STARTED|Overall Study||52||
59738112|NCT00760513|75857181|FG000|COMPLETED|Overall Study||46||
59738113|NCT00760513|75857182|FG001|COMPLETED|Overall Study||45||
59738114|NCT00760513|75857181|FG000|NOT COMPLETED|Overall Study||5||
59738115|NCT00760513|75857182|FG001|NOT COMPLETED|Overall Study||7||
59738116|NCT00907296|75857200|FG000|STARTED|Overall Study||103||
59738117|NCT00907296|75857201|FG001|STARTED|Overall Study||34||
59738118|NCT00907296|75857202|FG002|STARTED|Overall Study||34||
59738119|NCT00907296|75857203|FG003|STARTED|Overall Study||33||
59738120|NCT00907296|75857204|FG004|STARTED|Overall Study||33||
59738121|NCT00907296|75857205|FG005|STARTED|Overall Study||33||
59738122|NCT00907296|75857206|FG006|STARTED|Overall Study||33||
59738123|NCT00907296|75857207|FG007|STARTED|Overall Study||33||
59738124|NCT00907296|75857208|FG008|STARTED|Overall Study||31||
59738125|NCT00907296|75857209|FG009|STARTED|Overall Study||35||
59738126|NCT00907296|75857200|FG000|Received Treatment|Overall Study||100||
59738127|NCT00907296|75857201|FG001|Received Treatment|Overall Study||34||
59738128|NCT00907296|75857202|FG002|Received Treatment|Overall Study||34||
59738129|NCT00907296|75857203|FG003|Received Treatment|Overall Study||32||
59738130|NCT00907296|75857204|FG004|Received Treatment|Overall Study||33||
59738131|NCT00907296|75857205|FG005|Received Treatment|Overall Study||32||
59738132|NCT00907296|75857206|FG006|Received Treatment|Overall Study||31||
59738133|NCT00907296|75857207|FG007|Received Treatment|Overall Study||32||
59738134|NCT00907296|75857208|FG008|Received Treatment|Overall Study||30||
59738135|NCT00907296|75857209|FG009|Received Treatment|Overall Study||35||
59738136|NCT00907296|75857200|FG000|COMPLETED|Overall Study||83||
59738137|NCT00907296|75857201|FG001|COMPLETED|Overall Study||29||
59738138|NCT00907296|75857202|FG002|COMPLETED|Overall Study||32||
59738139|NCT00907296|75857203|FG003|COMPLETED|Overall Study||29||
59738140|NCT00907296|75857204|FG004|COMPLETED|Overall Study||32||
59738141|NCT00907296|75857205|FG005|COMPLETED|Overall Study||24||
59738142|NCT00907296|75857206|FG006|COMPLETED|Overall Study||27||
59738143|NCT00907296|75857207|FG007|COMPLETED|Overall Study||26||
59738144|NCT00907296|75857208|FG008|COMPLETED|Overall Study||27||
59738145|NCT00907296|75857209|FG009|COMPLETED|Overall Study||28||
59738146|NCT00907296|75857200|FG000|NOT COMPLETED|Overall Study||20||
59738147|NCT00907296|75857201|FG001|NOT COMPLETED|Overall Study||5||
59738148|NCT00907296|75857202|FG002|NOT COMPLETED|Overall Study||2||
59738149|NCT00907296|75857203|FG003|NOT COMPLETED|Overall Study||4||
59738150|NCT00907296|75857204|FG004|NOT COMPLETED|Overall Study||1||
59738151|NCT00907296|75857205|FG005|NOT COMPLETED|Overall Study||9||
59738152|NCT00907296|75857206|FG006|NOT COMPLETED|Overall Study||6||
59738153|NCT00907296|75857207|FG007|NOT COMPLETED|Overall Study||7||
59738154|NCT00907296|75857208|FG008|NOT COMPLETED|Overall Study||4||
59738155|NCT00907296|75857209|FG009|NOT COMPLETED|Overall Study||7||
59738156|NCT00816400|75857240|FG000|STARTED|Overall Study||3||
59738157|NCT00816400|75857241|FG001|STARTED|Overall Study||3||
59738158|NCT00816400|75857242|FG002|STARTED|Overall Study||5||
59738159|NCT00816400|75857243|FG003|STARTED|Overall Study||3||
59738160|NCT00816400|75857244|FG004|STARTED|Overall Study||3||
59738161|NCT00816400|75857245|FG005|STARTED|Overall Study||3||
59738162|NCT00816400|75857246|FG006|STARTED|Overall Study||3||
59738163|NCT00816400|75857247|FG007|STARTED|Overall Study||6||
59738164|NCT00816400|75857248|FG008|STARTED|Overall Study||6||
59738165|NCT00816400|75857240|FG000|COMPLETED|Overall Study||1||
59738166|NCT00816400|75857241|FG001|COMPLETED|Overall Study||0||
59738167|NCT00816400|75857242|FG002|COMPLETED|Overall Study||0||
59738168|NCT00816400|75857243|FG003|COMPLETED|Overall Study||0||
59738169|NCT00816400|75857244|FG004|COMPLETED|Overall Study||1||
59738170|NCT00816400|75857245|FG005|COMPLETED|Overall Study||0||
59738171|NCT00816400|75857246|FG006|COMPLETED|Overall Study||1||
59738172|NCT00816400|75857247|FG007|COMPLETED|Overall Study||1||
59738173|NCT00816400|75857248|FG008|COMPLETED|Overall Study||0||
59738174|NCT00816400|75857240|FG000|NOT COMPLETED|Overall Study||2||
59738175|NCT00816400|75857241|FG001|NOT COMPLETED|Overall Study||3||
59738176|NCT00816400|75857242|FG002|NOT COMPLETED|Overall Study||5||
59738177|NCT00816400|75857243|FG003|NOT COMPLETED|Overall Study||3||
59738178|NCT00816400|75857244|FG004|NOT COMPLETED|Overall Study||2||
59738179|NCT00816400|75857245|FG005|NOT COMPLETED|Overall Study||3||
59738180|NCT00816400|75857246|FG006|NOT COMPLETED|Overall Study||2||
59738181|NCT00816400|75857247|FG007|NOT COMPLETED|Overall Study||5||
59738182|NCT00816400|75857248|FG008|NOT COMPLETED|Overall Study||6||
59738183|NCT00906204|75857271|FG000|STARTED|Primary Endpoint (Early Safety)||45||
59738184|NCT00906204|75857272|FG001|STARTED|Primary Endpoint (Early Safety)||52||
59738185|NCT00906204|75857271|FG000|COMPLETED|Primary Endpoint (Early Safety)||43||
59738186|NCT00906204|75857272|FG001|COMPLETED|Primary Endpoint (Early Safety)||51||
59738187|NCT00906204|75857271|FG000|NOT COMPLETED|Primary Endpoint (Early Safety)||2||
59738188|NCT00906204|75857272|FG001|NOT COMPLETED|Primary Endpoint (Early Safety)||1||
59738189|NCT00906204|75857271|FG000|STARTED|Secondary Endpoints (Long-term Safety)||43||
59738190|NCT00906204|75857272|FG001|STARTED|Secondary Endpoints (Long-term Safety)||51||
59738191|NCT00906204|75857271|FG000|COMPLETED|Secondary Endpoints (Long-term Safety)||41||
59738192|NCT00906204|75857272|FG001|COMPLETED|Secondary Endpoints (Long-term Safety)||48||
59738193|NCT00906204|75857271|FG000|NOT COMPLETED|Secondary Endpoints (Long-term Safety)||2||
59738194|NCT00906204|75857272|FG001|NOT COMPLETED|Secondary Endpoints (Long-term Safety)||3||
59738195|NCT02389374|75857281|FG000|STARTED|Overall Study||55||
59738196|NCT02389374|75857282|FG001|STARTED|Overall Study||115||
59738197|NCT02389374|75857283|FG002|STARTED|Overall Study||11||
59738198|NCT02389374|75857281|FG000|COMPLETED|Overall Study||46||
59738199|NCT02389374|75857282|FG001|COMPLETED|Overall Study||87||
59738200|NCT02389374|75857283|FG002|COMPLETED|Overall Study||10||
59738201|NCT02389374|75857281|FG000|NOT COMPLETED|Overall Study||9||
59738202|NCT02389374|75857282|FG001|NOT COMPLETED|Overall Study||28||
59738203|NCT02389374|75857283|FG002|NOT COMPLETED|Overall Study||1||
59738204|NCT03649347|75857296|FG000|STARTED|Overall Study||13||
59738205|NCT03649347|75857297|FG001|STARTED|Overall Study||12||
59738206|NCT03649347|75857298|FG002|STARTED|Overall Study||0||
59738207|NCT03649347|75857299|FG003|STARTED|Overall Study||0||
59738208|NCT03649347|75857296|FG000|COMPLETED|Overall Study||13||
59738209|NCT03649347|75857297|FG001|COMPLETED|Overall Study||12||
59738210|NCT03649347|75857298|FG002|COMPLETED|Overall Study||0||
59738211|NCT03649347|75857299|FG003|COMPLETED|Overall Study||0||
59738212|NCT03649347|75857296|FG000|NOT COMPLETED|Overall Study||0||
59738213|NCT03649347|75857297|FG001|NOT COMPLETED|Overall Study||0||
59738214|NCT03649347|75857298|FG002|NOT COMPLETED|Overall Study||0||
59738215|NCT03649347|75857299|FG003|NOT COMPLETED|Overall Study||0||
59738216|NCT00905424|75857309|FG000|STARTED|Overall Study||89||
59738217|NCT00905424|75857310|FG001|STARTED|Overall Study||88||
59738218|NCT00905424|75857309|FG000|COMPLETED|Overall Study||78||
59738219|NCT00905424|75857310|FG001|COMPLETED|Overall Study||79||
59738220|NCT00905424|75857309|FG000|NOT COMPLETED|Overall Study||11||
59604172|NCT02059434|75714653|FG006|NOT COMPLETED|Period 3||0||
59604173|NCT02059434|75714654|FG007|NOT COMPLETED|Period 3||0||
59604174|NCT02059434|75714655|FG008|NOT COMPLETED|Period 3||0||
59604175|NCT02059434|75714647|FG000|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0||
59604176|NCT02059434|75714648|FG001|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0||
59604177|NCT02059434|75714649|FG002|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0||
59604178|NCT02059434|75714650|FG003|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0||
59604179|NCT02059434|75714651|FG004|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0||
59604180|NCT02059434|75714652|FG005|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0||
59604181|NCT02059434|75714653|FG006|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0||
59604182|NCT02059434|75714654|FG007|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0||
59604183|NCT02059434|75714655|FG008|STARTED|Period 4 (After Screening/run-in Period)||38||
59604184|NCT02059434|75714647|FG000|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0||
59604185|NCT02059434|75714648|FG001|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0||
59604186|NCT02059434|75714649|FG002|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0||
59604187|NCT02059434|75714650|FG003|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0||
59604188|NCT02059434|75714651|FG004|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0||
59604189|NCT02059434|75714652|FG005|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0||
59604190|NCT02059434|75714653|FG006|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0||
59604191|NCT02059434|75714654|FG007|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0||
59604192|NCT02059434|75714655|FG008|COMPLETED|Period 4 (After Screening/run-in Period)||38||
59604193|NCT02059434|75714647|FG000|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0||
59604194|NCT02059434|75714648|FG001|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0||
59604195|NCT02059434|75714649|FG002|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0||
59604196|NCT02059434|75714650|FG003|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0||
59604197|NCT02059434|75714651|FG004|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0||
59604198|NCT02059434|75714652|FG005|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0||
59604199|NCT02059434|75714653|FG006|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0||
59604200|NCT02059434|75714654|FG007|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0||
59604201|NCT02059434|75714655|FG008|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0||
59604202|NCT02059434|75714647|FG000|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0||
59604203|NCT02059434|75714648|FG001|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0||
59604204|NCT02059434|75714649|FG002|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0||
59604205|NCT02059434|75714650|FG003|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0||
59604206|NCT02059434|75714651|FG004|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0||
59604207|NCT02059434|75714652|FG005|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0||
59604208|NCT02059434|75714653|FG006|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0||
59604209|NCT02059434|75714654|FG007|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0||
59604210|NCT02059434|75714655|FG008|STARTED|Washout Between Periods 4 and 5||38||
59604211|NCT02059434|75714647|FG000|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0||
59604212|NCT02059434|75714648|FG001|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0||
59604213|NCT02059434|75714649|FG002|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0||
59604214|NCT02059434|75714650|FG003|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0||
59604215|NCT02059434|75714651|FG004|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0||
59738221|NCT00905424|75857310|FG001|NOT COMPLETED|Overall Study||9||
59738222|NCT00816166|75857320|FG000|STARTED|Overall Study|Of 59 randomized to Stent Arm, 4 were treated with Medical Therapy Only|59||
59738223|NCT00816166|75857321|FG001|STARTED|Overall Study|Of 53 randomized to Medical Therapy Arm, 9 were treated with Stent+Medical Therapy|53||
59738224|NCT00816166|75857320|FG000|ITT Population (Met Eligibility)|Overall Study|Of 59 randomized to Stent Arm, 1 subject failed to meet eligibility and was excluded from the ITT|58||
59738225|NCT00816166|75857321|FG001|ITT Population (Met Eligibility)|Overall Study||53||
59738226|NCT00816166|75857320|FG000|COMPLETED|Overall Study||49||
59738227|NCT00816166|75857321|FG001|COMPLETED|Overall Study||41||
59738228|NCT00816166|75857320|FG000|NOT COMPLETED|Overall Study||10||
59738229|NCT00816166|75857321|FG001|NOT COMPLETED|Overall Study||12||
59738230|NCT00815308|75857327|FG000|STARTED|Overall Study||55||
59738231|NCT00815308|75857327|FG000|COMPLETED|Overall Study||45||
59738232|NCT00815308|75857327|FG000|NOT COMPLETED|Overall Study||10||
59738233|NCT01039376|75857333|FG000|STARTED|Overall Study||240||
59738234|NCT01039376|75857334|FG001|STARTED|Overall Study||240||
59738235|NCT01039376|75857333|FG000|COMPLETED|Overall Study||110||
59738236|NCT01039376|75857334|FG001|COMPLETED|Overall Study||114||
59738237|NCT01039376|75857333|FG000|NOT COMPLETED|Overall Study||130||
59738238|NCT01039376|75857334|FG001|NOT COMPLETED|Overall Study||126||
59738239|NCT00905034|75857341|FG000|STARTED|Overall Study||37||
59738240|NCT00905034|75857341|FG000|COMPLETED|Overall Study||36||
59738241|NCT00905034|75857341|FG000|NOT COMPLETED|Overall Study||1||
59738242|NCT00828568|75857348|FG000|STARTED|Randomized||184||
59738243|NCT00828568|75857349|FG001|STARTED|Randomized||179||
59738244|NCT00828568|75857350|FG002|STARTED|Randomized||62||
59738245|NCT00828568|75857348|FG000|COMPLETED|Randomized||183||
59738246|NCT00828568|75857349|FG001|COMPLETED|Randomized||179||
59738247|NCT00828568|75857350|FG002|COMPLETED|Randomized||60||
59738248|NCT00828568|75857348|FG000|NOT COMPLETED|Randomized||1||
59738249|NCT00828568|75857349|FG001|NOT COMPLETED|Randomized||0||
59738250|NCT00828568|75857350|FG002|NOT COMPLETED|Randomized||2||
59738251|NCT00828568|75857348|FG000|STARTED|Treated - Received at Least One Dose||183||
59738252|NCT00828568|75857349|FG001|STARTED|Treated - Received at Least One Dose||179||
59738253|NCT00828568|75857350|FG002|STARTED|Treated - Received at Least One Dose||60||
59738254|NCT00828568|75857348|FG000|COMPLETED|Treated - Received at Least One Dose||153||
59738255|NCT00828568|75857349|FG001|COMPLETED|Treated - Received at Least One Dose||150||
59738256|NCT00828568|75857350|FG002|COMPLETED|Treated - Received at Least One Dose||55||
59738257|NCT00828568|75857348|FG000|NOT COMPLETED|Treated - Received at Least One Dose||30||
59738258|NCT00828568|75857349|FG001|NOT COMPLETED|Treated - Received at Least One Dose||29||
59738259|NCT00828568|75857350|FG002|NOT COMPLETED|Treated - Received at Least One Dose||5||
59738260|NCT01038752|75857361|FG000|STARTED|Overall Study||8||
59738261|NCT01038752|75857362|FG001|STARTED|Overall Study||6||
59738262|NCT01038752|75857361|FG000|COMPLETED|Overall Study||3||
59738263|NCT01038752|75857362|FG001|COMPLETED|Overall Study||1||
59738264|NCT01038752|75857361|FG000|NOT COMPLETED|Overall Study||5||
59738265|NCT01038752|75857362|FG001|NOT COMPLETED|Overall Study||5||
59738266|NCT00903630|75857371|FG000|STARTED|Phase l||6||
59738267|NCT00903630|75857372|FG001|STARTED|Phase l||5||
59738268|NCT00903630|75857373|FG002|STARTED|Phase l||0||
59738269|NCT00903630|75857371|FG000|COMPLETED|Phase l||6||
59738270|NCT00903630|75857372|FG001|COMPLETED|Phase l||5||
59738271|NCT00903630|75857373|FG002|COMPLETED|Phase l||0||
59738272|NCT00903630|75857371|FG000|NOT COMPLETED|Phase l||0||
59738273|NCT00903630|75857372|FG001|NOT COMPLETED|Phase l||0||
59738274|NCT00903630|75857373|FG002|NOT COMPLETED|Phase l||0||
59738275|NCT00903630|75857371|FG000|STARTED|Phase 2||6||
59738276|NCT00903630|75857372|FG001|STARTED|Phase 2||0||
59738277|NCT00903630|75857373|FG002|STARTED|Phase 2||4||
59738278|NCT00903630|75857371|FG000|COMPLETED|Phase 2||6||
59738279|NCT00903630|75857372|FG001|COMPLETED|Phase 2||0||
59738280|NCT00903630|75857373|FG002|COMPLETED|Phase 2|One participant was removed from the study after 2 weeks of treatment due to skin toxicity.|3||
59738281|NCT00903630|75857371|FG000|NOT COMPLETED|Phase 2||0||
59738282|NCT00903630|75857372|FG001|NOT COMPLETED|Phase 2||0||
59738283|NCT00903630|75857373|FG002|NOT COMPLETED|Phase 2||1||
59738284|NCT01037114|75857383|FG000|STARTED|Year 16||49||
59738285|NCT01037114|75857383|FG000|COMPLETED|Year 16||49||
59738286|NCT01037114|75857383|FG000|NOT COMPLETED|Year 16||0||
59738287|NCT01037114|75857383|FG000|STARTED|Year 17||48||
59738288|NCT01037114|75857383|FG000|COMPLETED|Year 17||48||
59738289|NCT01037114|75857383|FG000|NOT COMPLETED|Year 17||0||
59738290|NCT01037114|75857383|FG000|STARTED|Year 18||44||
59738291|NCT01037114|75857383|FG000|COMPLETED|Year 18||44||
59738292|NCT01037114|75857383|FG000|NOT COMPLETED|Year 18||0||
59738293|NCT01037114|75857383|FG000|STARTED|Year 19||45||
59738294|NCT01037114|75857383|FG000|COMPLETED|Year 19||45||
59738295|NCT01037114|75857383|FG000|NOT COMPLETED|Year 19||0||
59738296|NCT01037114|75857383|FG000|STARTED|Year 20||45||
59738297|NCT01037114|75857383|FG000|COMPLETED|Year 20|One subject returned at Y20 but did not do lab test because subject met a study exclusion criteria.|44||
59738298|NCT01037114|75857383|FG000|NOT COMPLETED|Year 20||1||
59738299|NCT00840970|75857387|FG000|STARTED|Overall Study||7||14
59738300|NCT00840970|75857388|FG001|STARTED|Overall Study||38||76
59738301|NCT00840970|75857389|FG002|STARTED|Overall Study||5||10
59738302|NCT00840970|75857387|FG000|COMPLETED|Overall Study||7||14
59738303|NCT00840970|75857388|FG001|COMPLETED|Overall Study||38||76
59738304|NCT00840970|75857389|FG002|COMPLETED|Overall Study||4||8
59738305|NCT00840970|75857387|FG000|NOT COMPLETED|Overall Study||0||0
59738306|NCT00840970|75857388|FG001|NOT COMPLETED|Overall Study||0||0
59738307|NCT00840970|75857389|FG002|NOT COMPLETED|Overall Study||1||2
59738308|NCT01054820|75857399|FG000|STARTED|Overall Study||123||
59738309|NCT01054820|75857399|FG000|COMPLETED|Overall Study||121||
59738310|NCT01054820|75857399|FG000|NOT COMPLETED|Overall Study||2||
59738311|NCT00840658|75857407|FG000|STARTED|Overall Study||144||
59738312|NCT00840658|75857408|FG001|STARTED|Overall Study||146||
59738313|NCT00840658|75857409|FG002|STARTED|Overall Study||148||
59738314|NCT00840658|75857410|FG003|STARTED|Overall Study||146||
59738315|NCT00840658|75857407|FG000|COMPLETED|Overall Study|"We defined completed as having at least one follow-up visit"|139||
59738316|NCT00840658|75857408|FG001|COMPLETED|Overall Study|"We defined completed as having at least one follow-up visit"|143||
59738317|NCT00840658|75857409|FG002|COMPLETED|Overall Study|"We defined completed as having at least one follow-up visit"|143||
59738318|NCT00840658|75857410|FG003|COMPLETED|Overall Study|"We defined completed as having at least one follow-up visit"|142||
59738319|NCT00840658|75857407|FG000|NOT COMPLETED|Overall Study||5||
59738320|NCT00840658|75857408|FG001|NOT COMPLETED|Overall Study||3||
59738321|NCT00840658|75857409|FG002|NOT COMPLETED|Overall Study||5||
59738322|NCT00840658|75857410|FG003|NOT COMPLETED|Overall Study||4||
59738323|NCT01036724|75857426|FG000|STARTED|Overall Study||52||
59738324|NCT01036724|75857427|FG001|STARTED|Overall Study||55||
59738325|NCT01036724|75857426|FG000|COMPLETED|Overall Study||46||
59738326|NCT01036724|75857427|FG001|COMPLETED|Overall Study||47||
59738327|NCT01036724|75857426|FG000|NOT COMPLETED|Overall Study||6||
59738328|NCT01036724|75857427|FG001|NOT COMPLETED|Overall Study||8||
59738329|NCT01052714|75857435|FG000|STARTED|Overall Study||42||
59738330|NCT01052714|75857436|FG001|STARTED|Overall Study||62||
59738331|NCT01052714|75857437|FG002|STARTED|Overall Study||17||
59738332|NCT01052714|75857435|FG000|COMPLETED|Overall Study||17||
59738333|NCT01052714|75857436|FG001|COMPLETED|Overall Study||33||
59738334|NCT01052714|75857437|FG002|COMPLETED|Overall Study||15||
59738335|NCT01052714|75857435|FG000|NOT COMPLETED|Overall Study||25||
59738336|NCT01052714|75857436|FG001|NOT COMPLETED|Overall Study||29||
59738337|NCT01052714|75857437|FG002|NOT COMPLETED|Overall Study||2||
59738338|NCT01372254|75857445|FG000|STARTED|Overall Study||47||
59738339|NCT01372254|75857446|FG001|STARTED|Overall Study||49||
59738340|NCT01372254|75857445|FG000|COMPLETED|Overall Study||43||
59738341|NCT01372254|75857446|FG001|COMPLETED|Overall Study||46||
59738342|NCT01372254|75857445|FG000|NOT COMPLETED|Overall Study||4||
59738343|NCT01372254|75857446|FG001|NOT COMPLETED|Overall Study||3||
59738344|NCT01052480|75857454|FG000|STARTED|Overall Study||49||
59738345|NCT01052480|75857455|FG001|STARTED|Overall Study||49||
59738346|NCT01052480|75857454|FG000|COMPLETED|Overall Study||41||
59738347|NCT01052480|75857455|FG001|COMPLETED|Overall Study||32||
59738348|NCT01052480|75857454|FG000|NOT COMPLETED|Overall Study||8||
59738349|NCT01052480|75857455|FG001|NOT COMPLETED|Overall Study||17||
60134729|NCT03904550|76257968|FG000|STARTED|Overall Study||23||
60134730|NCT03904550|76257969|FG001|STARTED|Overall Study||26||
59738350|NCT00904722|75857461|FG000|STARTED|Overall Study||30||
59738351|NCT00904722|75857461|FG000|COMPLETED|Overall Study||29||
59738352|NCT00904722|75857461|FG000|NOT COMPLETED|Overall Study||1||
59738353|NCT01029782|75857467|FG000|STARTED|Overall Study||102|All patients randomized were allocated to study arms|
59738354|NCT01029782|75857468|FG001|STARTED|Overall Study||104|All patients randomized were allocated to study arms|
59738355|NCT01029782|75857467|FG000|COMPLETED|Overall Study||99|All patients remaining in the study arms at the 72 hour endpoint|
59738356|NCT01029782|75857468|FG001|COMPLETED|Overall Study||96|All patients remaining in the study arms at the 72 hour endpoint|
59738357|NCT01029782|75857467|FG000|NOT COMPLETED|Overall Study||3||
59738358|NCT01029782|75857468|FG001|NOT COMPLETED|Overall Study||8||
59738359|NCT01029704|75857483|FG000|STARTED|Overall Study||5||
59738360|NCT01029704|75857484|FG001|STARTED|Overall Study||5||
59738361|NCT01029704|75857485|FG002|STARTED|Overall Study||5||
59738362|NCT01029704|75857486|FG003|STARTED|Overall Study||5||
59738363|NCT01029704|75857487|FG004|STARTED|Overall Study||28||
59738364|NCT01029704|75857488|FG005|STARTED|Overall Study||24||
59738365|NCT01029704|75857489|FG006|STARTED|Overall Study||23||
59738366|NCT01029704|75857490|FG007|STARTED|Overall Study||28||
59738367|NCT01029704|75857491|FG008|STARTED|Overall Study||26||
59738368|NCT01029704|75857483|FG000|COMPLETED|Overall Study||5||
59738369|NCT01029704|75857484|FG001|COMPLETED|Overall Study||5||
60134731|NCT03904550|76257968|FG000|COMPLETED|Overall Study||23||
60134732|NCT03904550|76257969|FG001|COMPLETED|Overall Study||26||
59738370|NCT01029704|75857485|FG002|COMPLETED|Overall Study||5||
59738371|NCT01029704|75857486|FG003|COMPLETED|Overall Study||5||
59738372|NCT01029704|75857487|FG004|COMPLETED|Overall Study||23||
59738373|NCT01029704|75857488|FG005|COMPLETED|Overall Study||20||
59738374|NCT01029704|75857489|FG006|COMPLETED|Overall Study||19||
59738375|NCT01029704|75857490|FG007|COMPLETED|Overall Study||22||
59738376|NCT01029704|75857491|FG008|COMPLETED|Overall Study||25||
59738377|NCT01029704|75857483|FG000|NOT COMPLETED|Overall Study||0||
59738378|NCT01029704|75857484|FG001|NOT COMPLETED|Overall Study||0||
59738379|NCT01029704|75857485|FG002|NOT COMPLETED|Overall Study||0||
59738380|NCT01029704|75857486|FG003|NOT COMPLETED|Overall Study||0||
59738381|NCT01029704|75857487|FG004|NOT COMPLETED|Overall Study||5||
59738382|NCT01029704|75857488|FG005|NOT COMPLETED|Overall Study||4||
59738383|NCT01029704|75857489|FG006|NOT COMPLETED|Overall Study||4||
59738384|NCT01029704|75857490|FG007|NOT COMPLETED|Overall Study||6||
59738385|NCT01029704|75857491|FG008|NOT COMPLETED|Overall Study||1||
59738386|NCT00840034|75857513|FG000|STARTED|Acute Treatment Phase||111||
59738387|NCT00840034|75857514|FG001|STARTED|Acute Treatment Phase||116||
59738388|NCT00840034|75857513|FG000|COMPLETED|Acute Treatment Phase||90||
59738389|NCT00840034|75857514|FG001|COMPLETED|Acute Treatment Phase||80||
59738390|NCT00840034|75857513|FG000|NOT COMPLETED|Acute Treatment Phase||21||
59738391|NCT00840034|75857514|FG001|NOT COMPLETED|Acute Treatment Phase||36||
59738392|NCT00840034|75857513|FG000|STARTED|Taper Phase|Completed Acute Treatment (AT) or discontinued ≥4 weeks of AT and chose to participate in Taper.|90||
59738393|NCT00840034|75857514|FG001|STARTED|Taper Phase|Completed Acute Treatment (AT) or discontinued ≥4 weeks of AT and chose to participate in Taper.|82||
59738394|NCT00840034|75857513|FG000|COMPLETED|Taper Phase||87||
59738395|NCT00840034|75857514|FG001|COMPLETED|Taper Phase||80||
59738396|NCT00840034|75857513|FG000|NOT COMPLETED|Taper Phase||3||
59738397|NCT00840034|75857514|FG001|NOT COMPLETED|Taper Phase||2||
59738398|NCT00813904|75857522|FG000|STARTED|Overall Study||31||
59738399|NCT00813904|75857522|FG000|COMPLETED|Overall Study||30||
59738400|NCT00813904|75857522|FG000|NOT COMPLETED|Overall Study||1||
59738401|NCT00839956|75857526|FG000|STARTED|Overall Study||31||
59738402|NCT00839956|75857526|FG000|COMPLETED|Overall Study||19||
59738403|NCT00839956|75857526|FG000|NOT COMPLETED|Overall Study||12||
59738404|NCT00839800|75857532|FG000|STARTED|Overall Study||1049||
59738405|NCT00839800|75857533|FG001|STARTED|Overall Study||1042||
59738406|NCT00839800|75857532|FG000|COMPLETED|Overall Study||956||
59738407|NCT00839800|75857533|FG001|COMPLETED|Overall Study||932||
59738408|NCT00839800|75857532|FG000|NOT COMPLETED|Overall Study||93||
59738409|NCT00839800|75857533|FG001|NOT COMPLETED|Overall Study||110||
59738410|NCT00867321|75857542|FG000|STARTED|Overall Study||4||
59738411|NCT00867321|75857543|FG001|STARTED|Overall Study||3||
59738412|NCT00867321|75857544|FG002|STARTED|Overall Study||3||
59738413|NCT00867321|75857545|FG003|STARTED|Overall Study||6||
59738414|NCT00867321|75857546|FG004|STARTED|Overall Study||5||
59738415|NCT00867321|75857547|FG005|STARTED|Overall Study||3||
59738416|NCT00867321|75857542|FG000|COMPLETED|Overall Study||4||
59738417|NCT00867321|75857543|FG001|COMPLETED|Overall Study||2||
59738418|NCT00867321|75857544|FG002|COMPLETED|Overall Study||3||
59738419|NCT00867321|75857545|FG003|COMPLETED|Overall Study||6||
59738420|NCT00867321|75857546|FG004|COMPLETED|Overall Study||5||
59738421|NCT00867321|75857547|FG005|COMPLETED|Overall Study||3||
59738422|NCT00867321|75857542|FG000|NOT COMPLETED|Overall Study||0||
59738423|NCT00867321|75857543|FG001|NOT COMPLETED|Overall Study||1||
59738424|NCT00867321|75857544|FG002|NOT COMPLETED|Overall Study||0||
59738425|NCT00867321|75857545|FG003|NOT COMPLETED|Overall Study||0||
60134733|NCT03904550|76257968|FG000|NOT COMPLETED|Overall Study||0||
60134734|NCT03904550|76257969|FG001|NOT COMPLETED|Overall Study||0||
60134735|NCT03838978|76257977|FG000|STARTED|Overall Study||81||
60134736|NCT03838978|76257978|FG001|STARTED|Overall Study||81||
60134737|NCT03838978|76257977|FG000|COMPLETED|Overall Study||73||
60134738|NCT03838978|76257978|FG001|COMPLETED|Overall Study||65||
60134739|NCT03838978|76257977|FG000|NOT COMPLETED|Overall Study||8||
59738426|NCT00867321|75857546|FG004|NOT COMPLETED|Overall Study||0||
59738427|NCT00867321|75857547|FG005|NOT COMPLETED|Overall Study||0||
59738428|NCT00753415|75857567|FG000|STARTED|Part A||3||
59738429|NCT00753415|75857568|FG001|STARTED|Part A||3||
59738430|NCT00753415|75857569|FG002|STARTED|Part A||10||
59738431|NCT00753415|75857570|FG003|STARTED|Part A||11||
59738432|NCT00753415|75857571|FG004|STARTED|Part A||10||
59738433|NCT00753415|75857572|FG005|STARTED|Part A||0||
59738434|NCT00753415|75857573|FG006|STARTED|Part A||0||
59738435|NCT00753415|75857574|FG007|STARTED|Part A||0||
59738436|NCT00753415|75857575|FG008|STARTED|Part A||0||
59738437|NCT00753415|75857576|FG009|STARTED|Part A||0||
59738438|NCT00753415|75857567|FG000|COMPLETED|Part A||2||
59738439|NCT00753415|75857568|FG001|COMPLETED|Part A||3||
59738440|NCT00753415|75857569|FG002|COMPLETED|Part A||8||
59738441|NCT00753415|75857570|FG003|COMPLETED|Part A||9||
59738442|NCT00753415|75857571|FG004|COMPLETED|Part A||10||
59738443|NCT00753415|75857572|FG005|COMPLETED|Part A||0||
59738444|NCT00753415|75857573|FG006|COMPLETED|Part A||0||
59738445|NCT00753415|75857574|FG007|COMPLETED|Part A||0||
59738446|NCT00753415|75857575|FG008|COMPLETED|Part A||0||
59738447|NCT00753415|75857576|FG009|COMPLETED|Part A||0||
59738448|NCT00753415|75857567|FG000|NOT COMPLETED|Part A||1||
60134740|NCT03838978|76257978|FG001|NOT COMPLETED|Overall Study||16||
59738449|NCT00753415|75857568|FG001|NOT COMPLETED|Part A||0||
59738450|NCT00753415|75857569|FG002|NOT COMPLETED|Part A||2||
59738451|NCT00753415|75857570|FG003|NOT COMPLETED|Part A||2||
59738452|NCT00753415|75857571|FG004|NOT COMPLETED|Part A||0||
59738453|NCT00753415|75857572|FG005|NOT COMPLETED|Part A||0||
59738454|NCT00753415|75857573|FG006|NOT COMPLETED|Part A||0||
59738455|NCT00753415|75857574|FG007|NOT COMPLETED|Part A||0||
59738456|NCT00753415|75857575|FG008|NOT COMPLETED|Part A||0||
60134741|NCT03834519|76257986|FG000|STARTED|Overall Study||529||
60134742|NCT03834519|76257987|FG001|STARTED|Overall Study||264||
60134743|NCT03834519|76257986|FG000|COMPLETED|Overall Study||0||
60134744|NCT03834519|76257987|FG001|COMPLETED|Overall Study||0||
60134745|NCT03834519|76257986|FG000|NOT COMPLETED|Overall Study||529||
60134746|NCT03834519|76257987|FG001|NOT COMPLETED|Overall Study||264||
59738457|NCT00753415|75857576|FG009|NOT COMPLETED|Part A||0||
59738458|NCT00753415|75857567|FG000|STARTED|Part B||0||
59738459|NCT00753415|75857568|FG001|STARTED|Part B||0||
59738460|NCT00753415|75857569|FG002|STARTED|Part B||0||
59738461|NCT00753415|75857570|FG003|STARTED|Part B||0||
59738462|NCT00753415|75857571|FG004|STARTED|Part B||0||
59738463|NCT00753415|75857572|FG005|STARTED|Part B|Of 2 eligible participants who completed Part A, 1 chose to enter Part B|1||
59738464|NCT00753415|75857573|FG006|STARTED|Part B|Of 3 eligible participants who completed Part A, 2 chose to enter Part B|2||
59738465|NCT00753415|75857574|FG007|STARTED|Part B|Of 8 eligible participants who completed Part A, 7 chose to enter Part B|7||
59738466|NCT00753415|75857575|FG008|STARTED|Part B|9 participants who completed Part A were eligible and enrolled in Part B|9||
59738467|NCT00753415|75857576|FG009|STARTED|Part B|Of 10 eligible participants who completed Part A, 9 chose to enter Part B|9||
59738468|NCT00753415|75857567|FG000|COMPLETED|Part B||0||
59738469|NCT00753415|75857568|FG001|COMPLETED|Part B||0||
59738470|NCT00753415|75857569|FG002|COMPLETED|Part B||0||
59738471|NCT00753415|75857570|FG003|COMPLETED|Part B||0||
59738472|NCT00753415|75857571|FG004|COMPLETED|Part B||0||
59738473|NCT00753415|75857572|FG005|COMPLETED|Part B||1||
59738474|NCT00753415|75857573|FG006|COMPLETED|Part B||2||
59738475|NCT00753415|75857574|FG007|COMPLETED|Part B||6||
59738476|NCT00753415|75857575|FG008|COMPLETED|Part B||6||
59738477|NCT00753415|75857576|FG009|COMPLETED|Part B||8||
59738478|NCT00753415|75857567|FG000|NOT COMPLETED|Part B||0||
59738479|NCT00753415|75857568|FG001|NOT COMPLETED|Part B||0||
59738480|NCT00753415|75857569|FG002|NOT COMPLETED|Part B||0||
59738481|NCT00753415|75857570|FG003|NOT COMPLETED|Part B||0||
59738482|NCT00753415|75857571|FG004|NOT COMPLETED|Part B||0||
59738483|NCT00753415|75857572|FG005|NOT COMPLETED|Part B||0||
59738484|NCT00753415|75857573|FG006|NOT COMPLETED|Part B||0||
59738485|NCT00753415|75857574|FG007|NOT COMPLETED|Part B||1||
59738486|NCT00753415|75857575|FG008|NOT COMPLETED|Part B||3||
59738487|NCT00753415|75857576|FG009|NOT COMPLETED|Part B||1||
59738488|NCT00754741|75857603|FG000|STARTED|Overall Study||567||
59738489|NCT00754741|75857604|FG001|STARTED|Overall Study||569||
59738490|NCT00754741|75857605|FG002|STARTED|Overall Study||556||
60134747|NCT03783442|76257995|FG000|STARTED|Overall Study||326||
60134748|NCT03783442|76257996|FG001|STARTED|Overall Study||323||
59738491|NCT00754741|75857603|FG000|COMPLETED|Overall Study||510||
59738492|NCT00754741|75857604|FG001|COMPLETED|Overall Study||500||
59738493|NCT00754741|75857605|FG002|COMPLETED|Overall Study||502||
59738494|NCT00754741|75857603|FG000|NOT COMPLETED|Overall Study||57||
59738495|NCT00754741|75857604|FG001|NOT COMPLETED|Overall Study||69||
59738496|NCT00754741|75857605|FG002|NOT COMPLETED|Overall Study||54||
59738497|NCT00752791|75857613|FG000|STARTED|Overall Study||59||
59738498|NCT00752791|75857613|FG000|COMPLETED|Overall Study||43||
59738499|NCT00752791|75857613|FG000|NOT COMPLETED|Overall Study||16||
59738500|NCT02163681|75857617|FG000|STARTED|Overall Study||45||
59738501|NCT02163681|75857617|FG000|COMPLETED|Overall Study||44||
59738502|NCT02163681|75857617|FG000|NOT COMPLETED|Overall Study||1||
59738503|NCT00902304|75857624|FG000|STARTED|Overall Study||524||
59738504|NCT00902304|75857625|FG001|STARTED|Overall Study||360||
59738505|NCT00902304|75857626|FG002|STARTED|Overall Study||678||
59738506|NCT00902304|75857624|FG000|COMPLETED|Overall Study||466||
59738507|NCT00902304|75857625|FG001|COMPLETED|Overall Study||289||
59738508|NCT00902304|75857626|FG002|COMPLETED|Overall Study||568||
59738509|NCT00902304|75857624|FG000|NOT COMPLETED|Overall Study||58||
59738510|NCT00902304|75857625|FG001|NOT COMPLETED|Overall Study||71||
59738511|NCT00902304|75857626|FG002|NOT COMPLETED|Overall Study||110||
59738512|NCT00759109|75857637|FG000|STARTED|Overall Study||74||
59738513|NCT00759109|75857638|FG001|STARTED|Overall Study||76||
59738514|NCT00759109|75857637|FG000|COMPLETED|Overall Study|From both arms combined, 7 discontinued due to death and there were 8 deaths during follow up.|35||
59738515|NCT00759109|75857638|FG001|COMPLETED|Overall Study|From both arms combined, 7 discontinued due to death and there were 8 deaths during follow up.|41||
59738516|NCT00759109|75857637|FG000|NOT COMPLETED|Overall Study||39||
59738517|NCT00759109|75857638|FG001|NOT COMPLETED|Overall Study||35||
59738518|NCT00759031|75857646|FG000|STARTED|First Intervention (1 Day)||10||
59738519|NCT00759031|75857647|FG001|STARTED|First Intervention (1 Day)||9||
59738520|NCT00759031|75857646|FG000|COMPLETED|First Intervention (1 Day)||8||
59738521|NCT00759031|75857647|FG001|COMPLETED|First Intervention (1 Day)||8||
59738522|NCT00759031|75857646|FG000|NOT COMPLETED|First Intervention (1 Day)||2||
59738523|NCT00759031|75857647|FG001|NOT COMPLETED|First Intervention (1 Day)||1||
59738524|NCT00759031|75857646|FG000|STARTED|Washout After 1st Intervention (1 Week)||8||
59738525|NCT00759031|75857647|FG001|STARTED|Washout After 1st Intervention (1 Week)||8||
59738526|NCT00759031|75857646|FG000|COMPLETED|Washout After 1st Intervention (1 Week)||8||
59738527|NCT00759031|75857647|FG001|COMPLETED|Washout After 1st Intervention (1 Week)||8||
60134749|NCT03783442|76257995|FG000|Treated|Overall Study||324||
60134750|NCT03783442|76257996|FG001|Treated|Overall Study||321||
60134751|NCT03783442|76257995|FG000|COMPLETED|Overall Study||0||
59738528|NCT00759031|75857646|FG000|NOT COMPLETED|Washout After 1st Intervention (1 Week)||0||
59738529|NCT00759031|75857647|FG001|NOT COMPLETED|Washout After 1st Intervention (1 Week)||0||
59738530|NCT00759031|75857646|FG000|STARTED|Second Intervention (1 Day)||8||
60134752|NCT03783442|76257996|FG001|COMPLETED|Overall Study||0||
59738531|NCT00759031|75857647|FG001|STARTED|Second Intervention (1 Day)||8||
59738532|NCT00759031|75857646|FG000|COMPLETED|Second Intervention (1 Day)||8||
59738533|NCT00759031|75857647|FG001|COMPLETED|Second Intervention (1 Day)||8||
59738534|NCT00759031|75857646|FG000|NOT COMPLETED|Second Intervention (1 Day)||0||
59738535|NCT00759031|75857647|FG001|NOT COMPLETED|Second Intervention (1 Day)||0||
59738536|NCT00758485|75857655|FG000|STARTED|Overall Study||70||
59738537|NCT00758485|75857656|FG001|STARTED|Overall Study||70||
59738538|NCT00758485|75857655|FG000|TREATED|Overall Study||69||
59738539|NCT00758485|75857656|FG001|TREATED|Overall Study||68||
59738540|NCT00758485|75857655|FG000|COMPLETED|Overall Study||69||
59738541|NCT00758485|75857656|FG001|COMPLETED|Overall Study||67||
59738542|NCT00758485|75857655|FG000|NOT COMPLETED|Overall Study||1||
59738543|NCT00758485|75857656|FG001|NOT COMPLETED|Overall Study||3||
59738544|NCT00757783|75857665|FG000|STARTED|Overall Study||34||
59738545|NCT00757783|75857666|FG001|STARTED|Overall Study||31||
59738546|NCT00757783|75857665|FG000|COMPLETED|Overall Study||29||
59738547|NCT00757783|75857666|FG001|COMPLETED|Overall Study||25||
59738548|NCT00757783|75857665|FG000|NOT COMPLETED|Overall Study||5||
59738549|NCT00757783|75857666|FG001|NOT COMPLETED|Overall Study||6||
59738550|NCT00757705|75857672|FG000|STARTED|Overall Study||299||
59738551|NCT00757705|75857672|FG000|COMPLETED|Overall Study||178||
59738552|NCT00757705|75857672|FG000|NOT COMPLETED|Overall Study||121||
59738553|NCT00757627|75857676|FG000|STARTED|Overall Study||500||
59738554|NCT00757627|75857676|FG000|COMPLETED|Overall Study||419||
59738555|NCT00757627|75857676|FG000|NOT COMPLETED|Overall Study||81||
59738556|NCT01023308|75857687|FG000|STARTED|Overall Study||387||
59738557|NCT01023308|75857688|FG001|STARTED|Overall Study||381||
59738558|NCT01023308|75857687|FG000|COMPLETED|Overall Study|completed all planned cycles of study treatment as per protocol|102||
59738559|NCT01023308|75857688|FG001|COMPLETED|Overall Study|completed all planned cycles of study treatment as per protocol|102||
59738560|NCT01023308|75857687|FG000|NOT COMPLETED|Overall Study||285||
59738561|NCT01023308|75857688|FG001|NOT COMPLETED|Overall Study||279||
59738562|NCT01022996|75857694|FG000|STARTED|Overall Study||57||
59738563|NCT01022996|75857694|FG000|COMPLETED|Overall Study||0||
59738564|NCT01022996|75857694|FG000|NOT COMPLETED|Overall Study||57||
59738565|NCT00757237|75857700|FG000|STARTED|Overall Study||137||
59738566|NCT00757237|75857701|FG001|STARTED|Overall Study||136||
59738567|NCT00757237|75857700|FG000|Treated|Overall Study||136||
59738568|NCT00757237|75857701|FG001|Treated|Overall Study||132||
59738569|NCT00757237|75857700|FG000|COMPLETED|Overall Study||124||
59738570|NCT00757237|75857701|FG001|COMPLETED|Overall Study||111||
59738571|NCT00757237|75857700|FG000|NOT COMPLETED|Overall Study||13||
59738572|NCT00757237|75857701|FG001|NOT COMPLETED|Overall Study||25||
59738573|NCT01029392|75857709|FG000|STARTED|Overall Study||37||
59738574|NCT01029392|75857710|FG001|STARTED|Overall Study||38||
59738575|NCT01029392|75857709|FG000|COMPLETED|Overall Study||17||
59738576|NCT01029392|75857710|FG001|COMPLETED|Overall Study||27||
59738577|NCT01029392|75857709|FG000|NOT COMPLETED|Overall Study||20||
59738578|NCT01029392|75857710|FG001|NOT COMPLETED|Overall Study||11||
59738579|NCT00903006|75857722|FG000|STARTED|Overall Study||2||
59738580|NCT00903006|75857723|FG001|STARTED|Overall Study||3||
59738581|NCT00903006|75857724|FG002|STARTED|Overall Study||1||
59738582|NCT00903006|75857725|FG003|STARTED|Overall Study|Zero participants started due to smaller sample size.|0||
59738583|NCT00903006|75857722|FG000|COMPLETED|Overall Study||0||
59738584|NCT00903006|75857723|FG001|COMPLETED|Overall Study||0||
59738585|NCT00903006|75857724|FG002|COMPLETED|Overall Study||0||
59738586|NCT00903006|75857725|FG003|COMPLETED|Overall Study||0||
59738587|NCT00903006|75857722|FG000|NOT COMPLETED|Overall Study||2||
59738588|NCT00903006|75857723|FG001|NOT COMPLETED|Overall Study||3||
59738589|NCT00903006|75857724|FG002|NOT COMPLETED|Overall Study||1||
59738590|NCT00903006|75857725|FG003|NOT COMPLETED|Overall Study||0||
59738591|NCT00839332|75857738|FG000|STARTED|Phase 1||50||
59738592|NCT00839332|75857739|FG001|STARTED|Phase 1|Participants in Phase 2 did not participate in Phase 1.|0||
59738593|NCT00839332|75857740|FG002|STARTED|Phase 1|Participants in Phase 2 did not participate in Phase 1.|0||
59738594|NCT00839332|75857738|FG000|Received at Least 1 Dose of Study Drug|Phase 1||50||
59738595|NCT00839332|75857739|FG001|Received at Least 1 Dose of Study Drug|Phase 1||0||
59738596|NCT00839332|75857740|FG002|Received at Least 1 Dose of Study Drug|Phase 1||0||
59738597|NCT00839332|75857738|FG000|COMPLETED|Phase 1||0||
59738598|NCT00839332|75857739|FG001|COMPLETED|Phase 1||0||
59738599|NCT00839332|75857740|FG002|COMPLETED|Phase 1||0||
59738600|NCT00839332|75857738|FG000|NOT COMPLETED|Phase 1||50||
59738601|NCT00839332|75857739|FG001|NOT COMPLETED|Phase 1||0||
59738602|NCT00839332|75857740|FG002|NOT COMPLETED|Phase 1||0||
59738603|NCT00839332|75857738|FG000|STARTED|Phase 2|Participants in Phase 1 did not participate in Phase 2.|0||
59738604|NCT00839332|75857739|FG001|STARTED|Phase 2||68||
59738605|NCT00839332|75857740|FG002|STARTED|Phase 2||39||
59738606|NCT00839332|75857738|FG000|Received at Least 1 Dose of Study Drug|Phase 2||0||
59738607|NCT00839332|75857739|FG001|Received at Least 1 Dose of Study Drug|Phase 2||65||
59738608|NCT00839332|75857740|FG002|Received at Least 1 Dose of Study Drug|Phase 2||34||
59738609|NCT00839332|75857738|FG000|COMPLETED|Phase 2||0||
59738610|NCT00839332|75857739|FG001|COMPLETED|Phase 2||0||
59738611|NCT00839332|75857740|FG002|COMPLETED|Phase 2||0||
59738612|NCT00839332|75857738|FG000|NOT COMPLETED|Phase 2||0||
59738613|NCT00839332|75857739|FG001|NOT COMPLETED|Phase 2||68||
59738614|NCT00839332|75857740|FG002|NOT COMPLETED|Phase 2||39||
59738615|NCT00902850|75857751|FG000|STARTED|Overall Study||14||
59738616|NCT00902850|75857752|FG001|STARTED|Overall Study||14||
59738617|NCT00902850|75857751|FG000|COMPLETED|Overall Study||12||
59738618|NCT00902850|75857752|FG001|COMPLETED|Overall Study||12||
59738619|NCT00902850|75857751|FG000|NOT COMPLETED|Overall Study||2||
59738620|NCT00902850|75857752|FG001|NOT COMPLETED|Overall Study||2||
59738621|NCT00902538|75857761|FG000|STARTED|1-Single-blind, Run-in, Single-Treatment||2204||
59738622|NCT00902538|75857762|FG001|STARTED|1-Single-blind, Run-in, Single-Treatment||0||
59738623|NCT00902538|75857763|FG002|STARTED|1-Single-blind, Run-in, Single-Treatment||0||
59738624|NCT00902538|75857764|FG003|STARTED|1-Single-blind, Run-in, Single-Treatment||0||
59738625|NCT00902538|75857765|FG004|STARTED|1-Single-blind, Run-in, Single-Treatment||0||
59738626|NCT00902538|75857766|FG005|STARTED|1-Single-blind, Run-in, Single-Treatment||0||
59738627|NCT00902538|75857761|FG000|COMPLETED|1-Single-blind, Run-in, Single-Treatment||2086||
59738628|NCT00902538|75857762|FG001|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0||
59738629|NCT00902538|75857763|FG002|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0||
59738630|NCT00902538|75857764|FG003|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0||
59738631|NCT00902538|75857765|FG004|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0||
59738632|NCT00902538|75857766|FG005|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0||
59738633|NCT00902538|75857761|FG000|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||118||
59738634|NCT00902538|75857762|FG001|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0||
59738635|NCT00902538|75857763|FG002|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0||
60134753|NCT03783442|76257995|FG000|NOT COMPLETED|Overall Study||326||
60134754|NCT03783442|76257996|FG001|NOT COMPLETED|Overall Study||323||
60134755|NCT03734016|76258004|FG000|STARTED|Overall Study||327||
59738636|NCT00902538|75857764|FG003|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0||
59738637|NCT00902538|75857765|FG004|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0||
59738638|NCT00902538|75857766|FG005|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0||
59738639|NCT00902538|75857761|FG000|STARTED|2-Randomized Double-blind 3 Treatments|Only 808 began Period 2 because the others finishing Period 1 did not meet the entry criteria.|269||
59738640|NCT00902538|75857762|FG001|STARTED|2-Randomized Double-blind 3 Treatments||269||
59738641|NCT00902538|75857763|FG002|STARTED|2-Randomized Double-blind 3 Treatments||270||
59738642|NCT00902538|75857764|FG003|STARTED|2-Randomized Double-blind 3 Treatments||0||
59738643|NCT00902538|75857765|FG004|STARTED|2-Randomized Double-blind 3 Treatments||0||
59738644|NCT00902538|75857766|FG005|STARTED|2-Randomized Double-blind 3 Treatments||0||
59738645|NCT00902538|75857761|FG000|COMPLETED|2-Randomized Double-blind 3 Treatments||260||
59738646|NCT00902538|75857762|FG001|COMPLETED|2-Randomized Double-blind 3 Treatments||263||
59738647|NCT00902538|75857763|FG002|COMPLETED|2-Randomized Double-blind 3 Treatments||262||
59738648|NCT00902538|75857764|FG003|COMPLETED|2-Randomized Double-blind 3 Treatments||0||
59738649|NCT00902538|75857765|FG004|COMPLETED|2-Randomized Double-blind 3 Treatments||0||
59738650|NCT00902538|75857766|FG005|COMPLETED|2-Randomized Double-blind 3 Treatments||0||
59738651|NCT00902538|75857761|FG000|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||9||
59738652|NCT00902538|75857762|FG001|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||6||
59738653|NCT00902538|75857763|FG002|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||8||
59738654|NCT00902538|75857764|FG003|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||0||
59738655|NCT00902538|75857765|FG004|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||0||
59738656|NCT00902538|75857766|FG005|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||0||
59738657|NCT00902538|75857761|FG000|STARTED|3-Single-blind, Single Treatment||0||
59738658|NCT00902538|75857762|FG001|STARTED|3-Single-blind, Single Treatment|Number starting is < total completing previous arm since 3 subjects did not receive at least 1 dose.|782||
59738659|NCT00902538|75857763|FG002|STARTED|3-Single-blind, Single Treatment||0||
59738660|NCT00902538|75857764|FG003|STARTED|3-Single-blind, Single Treatment||0||
59738661|NCT00902538|75857765|FG004|STARTED|3-Single-blind, Single Treatment||0||
59738662|NCT00902538|75857766|FG005|STARTED|3-Single-blind, Single Treatment||0||
59738663|NCT00902538|75857761|FG000|COMPLETED|3-Single-blind, Single Treatment||0||
59738664|NCT00902538|75857762|FG001|COMPLETED|3-Single-blind, Single Treatment||767||
59738665|NCT00902538|75857763|FG002|COMPLETED|3-Single-blind, Single Treatment||0||
59738666|NCT00902538|75857764|FG003|COMPLETED|3-Single-blind, Single Treatment||0||
59738667|NCT00902538|75857765|FG004|COMPLETED|3-Single-blind, Single Treatment||0||
59738668|NCT00902538|75857766|FG005|COMPLETED|3-Single-blind, Single Treatment||0||
59738669|NCT00902538|75857761|FG000|NOT COMPLETED|3-Single-blind, Single Treatment||0||
59738670|NCT00902538|75857762|FG001|NOT COMPLETED|3-Single-blind, Single Treatment||15||
59738671|NCT00902538|75857763|FG002|NOT COMPLETED|3-Single-blind, Single Treatment||0||
59738672|NCT00902538|75857764|FG003|NOT COMPLETED|3-Single-blind, Single Treatment||0||
59738673|NCT00902538|75857765|FG004|NOT COMPLETED|3-Single-blind, Single Treatment||0||
59762489|NCT02644525|75882210|FG001|COMPLETED|Group 3||0||
60134756|NCT03734016|76258005|FG001|STARTED|Overall Study||325||
60134757|NCT03734016|76258004|FG000|COMPLETED|Overall Study||0||
60134758|NCT03734016|76258005|FG001|COMPLETED|Overall Study||0||
60134759|NCT03734016|76258004|FG000|NOT COMPLETED|Overall Study||327||
60134760|NCT03734016|76258005|FG001|NOT COMPLETED|Overall Study||325||
60134761|NCT03693300|76258014|FG000|STARTED|Overall Study||114||
59738674|NCT00902538|75857766|FG005|NOT COMPLETED|3-Single-blind, Single Treatment||0||
59738675|NCT00902538|75857761|FG000|STARTED|4-Randomized Double-blind 2 Treatments||0||
59738676|NCT00902538|75857762|FG001|STARTED|4-Randomized Double-blind 2 Treatments||0||
59738677|NCT00902538|75857763|FG002|STARTED|4-Randomized Double-blind 2 Treatments||0||
59738678|NCT00902538|75857764|FG003|STARTED|4-Randomized Double-blind 2 Treatments|Period 3 responders were continued on OLM 40-AML 10-HCTZ 12.5|467||
59738679|NCT00902538|75857765|FG004|STARTED|4-Randomized Double-blind 2 Treatments|Period 3 non-responders were randomized to OLM 40-AML 10-HCTZ 12.5 or 25 in a 2:1 ratio|97||
59738680|NCT00902538|75857766|FG005|STARTED|4-Randomized Double-blind 2 Treatments||197||
59738681|NCT00902538|75857761|FG000|COMPLETED|4-Randomized Double-blind 2 Treatments||0||
59738682|NCT00902538|75857762|FG001|COMPLETED|4-Randomized Double-blind 2 Treatments||0||
59738683|NCT00902538|75857763|FG002|COMPLETED|4-Randomized Double-blind 2 Treatments||0||
59738684|NCT00902538|75857764|FG003|COMPLETED|4-Randomized Double-blind 2 Treatments||458||
59738685|NCT00902538|75857765|FG004|COMPLETED|4-Randomized Double-blind 2 Treatments||95||
59738686|NCT00902538|75857766|FG005|COMPLETED|4-Randomized Double-blind 2 Treatments||196||
59738687|NCT00902538|75857761|FG000|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||0||
59738688|NCT00902538|75857762|FG001|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||0||
59738689|NCT00902538|75857763|FG002|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||0||
59738690|NCT00902538|75857764|FG003|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||9||
59738691|NCT00902538|75857765|FG004|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||2||
59738692|NCT00902538|75857766|FG005|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||1||
59738693|NCT01979211|75857778|FG000|STARTED|Overall Study||24||
59738694|NCT01979211|75857778|FG000|COMPLETED|Overall Study||24||
59738695|NCT01979211|75857778|FG000|NOT COMPLETED|Overall Study||0||
59738696|NCT01036022|75857788|FG000|STARTED|Overall Study||15||
59738697|NCT01036022|75857789|FG001|STARTED|Overall Study||11||
59738698|NCT01036022|75857790|FG002|STARTED|Overall Study||12||
59738699|NCT01036022|75857791|FG003|STARTED|Overall Study||12||
59738700|NCT01036022|75857792|FG004|STARTED|Overall Study||12||
59738701|NCT01036022|75857793|FG005|STARTED|Overall Study||16||
59738702|NCT01036022|75857788|FG000|COMPLETED|Overall Study||13||
59738703|NCT01036022|75857789|FG001|COMPLETED|Overall Study||7||
59738704|NCT01036022|75857790|FG002|COMPLETED|Overall Study||8||
59738705|NCT01036022|75857791|FG003|COMPLETED|Overall Study||10||
59738706|NCT01036022|75857792|FG004|COMPLETED|Overall Study||9||
59738707|NCT01036022|75857793|FG005|COMPLETED|Overall Study||13||
59604216|NCT02059434|75714652|FG005|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0||
59604217|NCT02059434|75714653|FG006|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0||
59604218|NCT02059434|75714654|FG007|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0||
59604219|NCT02059434|75714655|FG008|COMPLETED|Washout Between Periods 4 and 5||37||
59604220|NCT02059434|75714647|FG000|NOT COMPLETED|Washout Between Periods 4 and 5||0||
59604221|NCT02059434|75714648|FG001|NOT COMPLETED|Washout Between Periods 4 and 5||0||
59604222|NCT02059434|75714649|FG002|NOT COMPLETED|Washout Between Periods 4 and 5||0||
59604223|NCT02059434|75714650|FG003|NOT COMPLETED|Washout Between Periods 4 and 5||0||
59604224|NCT02059434|75714651|FG004|NOT COMPLETED|Washout Between Periods 4 and 5||0||
59604225|NCT02059434|75714652|FG005|NOT COMPLETED|Washout Between Periods 4 and 5||0||
59604226|NCT02059434|75714653|FG006|NOT COMPLETED|Washout Between Periods 4 and 5||0||
59604227|NCT02059434|75714654|FG007|NOT COMPLETED|Washout Between Periods 4 and 5||0||
59738708|NCT01036022|75857788|FG000|NOT COMPLETED|Overall Study||2||
59738709|NCT01036022|75857789|FG001|NOT COMPLETED|Overall Study||4||
59738710|NCT01036022|75857790|FG002|NOT COMPLETED|Overall Study||4||
59738711|NCT01036022|75857791|FG003|NOT COMPLETED|Overall Study||2||
59738712|NCT01036022|75857792|FG004|NOT COMPLETED|Overall Study||3||
59738713|NCT01036022|75857793|FG005|NOT COMPLETED|Overall Study||3||
59738714|NCT00752557|75857818|FG000|STARTED|Overall Study||17||
59738715|NCT00752557|75857819|FG001|STARTED|Overall Study||16||
59604228|NCT02059434|75714655|FG008|NOT COMPLETED|Washout Between Periods 4 and 5||1||
59604229|NCT02059434|75714647|FG000|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0||
59604230|NCT02059434|75714648|FG001|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0||
59738716|NCT00752557|75857820|FG002|STARTED|Overall Study||17||
59604231|NCT02059434|75714649|FG002|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0||
59604232|NCT02059434|75714650|FG003|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0||
59604233|NCT02059434|75714651|FG004|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0||
59604234|NCT02059434|75714652|FG005|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0||
59604235|NCT02059434|75714653|FG006|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0||
59604236|NCT02059434|75714654|FG007|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0||
59604237|NCT02059434|75714655|FG008|STARTED|Period 5||37||
59604238|NCT02059434|75714647|FG000|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0||
59604239|NCT02059434|75714648|FG001|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0||
59604240|NCT02059434|75714649|FG002|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0||
59604241|NCT02059434|75714650|FG003|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0||
59604242|NCT02059434|75714651|FG004|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0||
59738717|NCT00752557|75857818|FG000|COMPLETED|Overall Study||12||
59738718|NCT00752557|75857819|FG001|COMPLETED|Overall Study||11||
59738719|NCT00752557|75857820|FG002|COMPLETED|Overall Study||11||
59738720|NCT00752557|75857818|FG000|NOT COMPLETED|Overall Study||5||
59738721|NCT00752557|75857819|FG001|NOT COMPLETED|Overall Study||5||
59738722|NCT00752557|75857820|FG002|NOT COMPLETED|Overall Study||6||
59738723|NCT00747643|75857832|FG000|STARTED|Overall Study||82||
59738724|NCT00747643|75857833|FG001|STARTED|Overall Study||81||
59738725|NCT00747643|75857832|FG000|COMPLETED|Overall Study||46||
59738726|NCT00747643|75857833|FG001|COMPLETED|Overall Study||54||
59738727|NCT00747643|75857832|FG000|NOT COMPLETED|Overall Study||36||
59738728|NCT00747643|75857833|FG001|NOT COMPLETED|Overall Study||27||
59738729|NCT01022762|75857841|FG000|STARTED|Overall Study||218||
59738730|NCT01022762|75857842|FG001|STARTED|Overall Study||222||
59738731|NCT01022762|75857841|FG000|Exposed to Trial Drug|Overall Study|One participant was not exposed to the treatment due to fulfillment of exclusion criteria|217||
59738732|NCT01022762|75857842|FG001|Exposed to Trial Drug|Overall Study|Four participants were not exposed to the treatment due to non-compliance or lost to follow-up|218||
59738733|NCT01022762|75857841|FG000|COMPLETED|Overall Study||196||
59738734|NCT01022762|75857842|FG001|COMPLETED|Overall Study||194||
59738735|NCT01022762|75857841|FG000|NOT COMPLETED|Overall Study||22||
59738736|NCT01022762|75857842|FG001|NOT COMPLETED|Overall Study||28||
59738737|NCT01028378|75857848|FG000|STARTED|Overall Study|212 participants (249 eyes) with myopia|212||
59738738|NCT01028378|75857848|FG000|COMPLETED|Overall Study|195 participants (230 eyes) with myopia|195||
59738739|NCT01028378|75857848|FG000|NOT COMPLETED|Overall Study||17||
59738740|NCT00747565|75857854|FG000|STARTED|Overall Study|125 multifocal subjects in original study plus 222 multifocal subjects in the expansion study.|347||
59738741|NCT00747565|75857855|FG001|STARTED|Overall Study||123||
59738742|NCT00747565|75857854|FG000|COMPLETED|Overall Study|118 multifocal subjects in the original study plus 215 multifocal subejcts in the expansion study.|333||
59738743|NCT00747565|75857855|FG001|COMPLETED|Overall Study||116||
59738744|NCT00747565|75857854|FG000|NOT COMPLETED|Overall Study||14||
59738745|NCT00747565|75857855|FG001|NOT COMPLETED|Overall Study||7||
59738746|NCT01028300|75857861|FG000|STARTED|Overall Study||4||
59738747|NCT01028300|75857861|FG000|COMPLETED|Overall Study||0||
60134762|NCT03693300|76258015|FG001|STARTED|Overall Study||3||
60134763|NCT03693300|76258014|FG000|COMPLETED|Overall Study||71||
60134764|NCT03693300|76258015|FG001|COMPLETED|Overall Study||2||
60134765|NCT03693300|76258014|FG000|NOT COMPLETED|Overall Study||43||
59738748|NCT01028300|75857861|FG000|NOT COMPLETED|Overall Study||4||
59738749|NCT00752089|75857865|FG000|STARTED|Overall Study||20||
59738750|NCT00752089|75857865|FG000|Received NaF/ KNO3/ 2% Isopentane|Overall Study||19||
59738751|NCT00752089|75857865|FG000|Received NaF/KNO3/ 0% Isopentane|Overall Study||17||
59738752|NCT00752089|75857865|FG000|Received NaF|Overall Study||18||
59738753|NCT00752089|75857865|FG000|Received Placebo|Overall Study||18||
59738754|NCT00752089|75857865|FG000|COMPLETED|Overall Study||14||
59738755|NCT00752089|75857865|FG000|NOT COMPLETED|Overall Study||6||
59738756|NCT00751933|75857876|FG000|STARTED|Overall Study||0||
59738757|NCT00751933|75857877|FG001|STARTED|Overall Study||1||
59738758|NCT00751933|75857878|FG002|STARTED|Overall Study||1||
59738759|NCT00751933|75857879|FG003|STARTED|Overall Study||1||
59738760|NCT00751933|75857876|FG000|COMPLETED|Overall Study||0||
59738761|NCT00751933|75857877|FG001|COMPLETED|Overall Study||0||
59738762|NCT00751933|75857878|FG002|COMPLETED|Overall Study||0||
59738763|NCT00751933|75857879|FG003|COMPLETED|Overall Study||0||
59738764|NCT00751933|75857876|FG000|NOT COMPLETED|Overall Study||0||
59738765|NCT00751933|75857877|FG001|NOT COMPLETED|Overall Study||1||
59738766|NCT00751933|75857878|FG002|NOT COMPLETED|Overall Study||1||
59738767|NCT00751933|75857879|FG003|NOT COMPLETED|Overall Study||1||
59738768|NCT00751621|75857883|FG000|STARTED|Overall Study||40||
59738769|NCT00751621|75857883|FG000|COMPLETED|Overall Study||36||
59738770|NCT00751621|75857883|FG000|NOT COMPLETED|Overall Study||4||
59738771|NCT01028222|75857891|FG000|STARTED|Overall Study||42||
60134766|NCT03693300|76258015|FG001|NOT COMPLETED|Overall Study||1||
60134767|NCT03671564|76258026|FG000|STARTED|Overall Study||4||
60134768|NCT03671564|76258027|FG001|STARTED|Overall Study||6||
60134769|NCT03671564|76258028|FG002|STARTED|Overall Study||4||
60134770|NCT03671564|76258026|FG000|COMPLETED|Overall Study||0||
60134771|NCT03671564|76258027|FG001|COMPLETED|Overall Study||0||
60134772|NCT03671564|76258028|FG002|COMPLETED|Overall Study||0||
60134773|NCT03671564|76258026|FG000|NOT COMPLETED|Overall Study||4||
60134774|NCT03671564|76258027|FG001|NOT COMPLETED|Overall Study||6||
60134775|NCT03671564|76258028|FG002|NOT COMPLETED|Overall Study||4||
60134776|NCT03671213|76258038|FG000|STARTED|Overall Study||81||
60134777|NCT03671213|76258039|FG001|STARTED|Overall Study||81||
60134778|NCT03671213|76258038|FG000|COMPLETED|Overall Study||73||
59738772|NCT01028222|75857892|FG001|STARTED|Overall Study||13||
59738773|NCT01028222|75857891|FG000|Cross Over From DTIC to Nilotinib|Overall Study||0||
59738774|NCT01028222|75857892|FG001|Cross Over From DTIC to Nilotinib|Overall Study||10||
59738775|NCT01028222|75857891|FG000|COMPLETED|Overall Study||4||
59738776|NCT01028222|75857892|FG001|COMPLETED|Overall Study||0||
59738777|NCT01028222|75857891|FG000|NOT COMPLETED|Overall Study||38||
60134779|NCT03671213|76258039|FG001|COMPLETED|Overall Study||65||
60134780|NCT03671213|76258038|FG000|NOT COMPLETED|Overall Study||8||
59738778|NCT01028222|75857892|FG001|NOT COMPLETED|Overall Study||13||
59738779|NCT00586495|75857899|FG000|STARTED|Treatment Period||95||
59738780|NCT00586495|75857899|FG000|COMPLETED|Treatment Period||0||
59738781|NCT00586495|75857899|FG000|NOT COMPLETED|Treatment Period||95||
59738782|NCT00586495|75857899|FG000|STARTED|Follow-up||92||
59738783|NCT00586495|75857899|FG000|COMPLETED|Follow-up||0||
59738784|NCT00586495|75857899|FG000|NOT COMPLETED|Follow-up||92||
59738785|NCT01027754|75857905|FG000|STARTED|Overall Study||57||
59738786|NCT01027754|75857906|FG001|STARTED|Overall Study||55||
59738787|NCT01027754|75857905|FG000|COMPLETED|Overall Study||55||
59738788|NCT01027754|75857906|FG001|COMPLETED|Overall Study||47||
59738789|NCT01027754|75857905|FG000|NOT COMPLETED|Overall Study||2||
59738790|NCT01027754|75857906|FG001|NOT COMPLETED|Overall Study||8||
59738791|NCT03976531|75857912|FG000|STARTED|Overall Study||42||
59738792|NCT03976531|75857912|FG000|COMPLETED|Overall Study||42||
59738793|NCT03976531|75857912|FG000|NOT COMPLETED|Overall Study||0||
59738794|NCT01034540|75857918|FG000|STARTED|Overall Study||11||
59738795|NCT01034540|75857919|FG001|STARTED|Overall Study||12||
59738796|NCT01034540|75857918|FG000|Completed 1st Treatment Intervention|Overall Study||11||
59738797|NCT01034540|75857919|FG001|Completed 1st Treatment Intervention|Overall Study||11||
59738798|NCT01034540|75857918|FG000|COMPLETED|Overall Study||11||
59738799|NCT01034540|75857919|FG001|COMPLETED|Overall Study||11||
59738800|NCT01034540|75857918|FG000|NOT COMPLETED|Overall Study||0||
59738801|NCT01034540|75857919|FG001|NOT COMPLETED|Overall Study||1||
59738802|NCT00774930|75857929|FG000|STARTED|DB Phase|One subject was randomised to receive lanreotide Autogel, but erroneously received placebo.|59||
59738803|NCT00774930|75857930|FG001|STARTED|DB Phase|One subject was randomised to receive lanreotide Autogel, but erroneously received placebo.|56||
59738804|NCT00774930|75857929|FG000|COMPLETED|DB Phase|Received 4 DB study injections AND continued to IOL phase OR|45||
59738805|NCT00774930|75857930|FG001|COMPLETED|DB Phase|had diary data at least up to day 21 after 4th dose, regardless of missing diary data before day 21.|34||
59738806|NCT00774930|75857929|FG000|NOT COMPLETED|DB Phase||14||
59738807|NCT00774930|75857930|FG001|NOT COMPLETED|DB Phase||22||
59738808|NCT00774930|75857929|FG000|STARTED|IOL Phase||56||
59738809|NCT00774930|75857930|FG001|STARTED|IOL Phase|Includes 1 subject listed as completing and withdrawing from the DB phase due to brain radiation|46||
59738810|NCT00774930|75857929|FG000|COMPLETED|IOL Phase||43||
59738811|NCT00774930|75857930|FG001|COMPLETED|IOL Phase||37||
59738812|NCT00774930|75857929|FG000|NOT COMPLETED|IOL Phase||13||
59738813|NCT00774930|75857930|FG001|NOT COMPLETED|IOL Phase||9||
59738814|NCT00774930|75857929|FG000|STARTED|LTOLE Phase|24 subjects from IOL did not enter LTOLE (11 completed IOL, 13 did not complete IOL).|32||
59738815|NCT00774930|75857930|FG001|STARTED|LTOLE Phase|20 subjects from IOL did not enter LTOLE (12 completed IOL, 8 did not complete IOL).|25||
59738816|NCT00774930|75857929|FG000|COMPLETED|LTOLE Phase||17||
59738817|NCT00774930|75857930|FG001|COMPLETED|LTOLE Phase||8||
59738818|NCT00774930|75857929|FG000|NOT COMPLETED|LTOLE Phase||15||
59738819|NCT00774930|75857930|FG001|NOT COMPLETED|LTOLE Phase||17||
59738820|NCT02841774|75857940|FG000|STARTED|Overall Study||6||
60134781|NCT03671213|76258039|FG001|NOT COMPLETED|Overall Study||16||
60134782|NCT03632720|76258048|FG000|STARTED|Overall Study||314||
60134783|NCT03632720|76258049|FG001|STARTED|Overall Study||316||
60134784|NCT03632720|76258050|FG002|STARTED|Overall Study||158||
60134785|NCT03632720|76258048|FG000|Safety Analysis Set|Overall Study||314|Safety analysis set included all participants who had received at least 1 dose of study vaccines and had any safety data available. All participants had their safety analyzed after each dose according to the vaccine they actually received at each visit, and after any dose according to the vaccine received.|
59738821|NCT02841774|75857941|FG001|STARTED|Overall Study||4||
59738822|NCT02841774|75857940|FG000|COMPLETED|Overall Study||6||
59738823|NCT02841774|75857941|FG001|COMPLETED|Overall Study||4||
59738824|NCT02841774|75857940|FG000|NOT COMPLETED|Overall Study||0||
59738825|NCT02841774|75857941|FG001|NOT COMPLETED|Overall Study||0||
59738826|NCT01027364|75857951|FG000|STARTED|Overall Study||63||
59738827|NCT01027364|75857952|FG001|STARTED|Overall Study||29||
59738828|NCT01027364|75857953|FG002|STARTED|Overall Study||27||
59738829|NCT01027364|75857954|FG003|STARTED|Overall Study|12 total participants in Arm 4 (6 started in Arm 4; 5 joined from Arm 1; 1 joined from Arm 3)|4||
59738830|NCT01027364|75857951|FG000|Enrolled in Sequential PK Subgroup|Overall Study||22||
59738831|NCT01027364|75857952|FG001|Enrolled in Sequential PK Subgroup|Overall Study||0||
59738832|NCT01027364|75857953|FG002|Enrolled in Sequential PK Subgroup|Overall Study||0||
59738833|NCT01027364|75857954|FG003|Enrolled in Sequential PK Subgroup|Overall Study||0||
59738834|NCT01027364|75857951|FG000|Joined Arm 4 for Surgery Then Returned|Overall Study||5||
60134786|NCT03632720|76258049|FG001|Safety Analysis Set|Overall Study||314|Safety analysis set included all participants who had received at least 1 dose of study vaccines and had any safety data available. All participants had their safety analyzed after each dose according to the vaccine they actually received at each visit, and after any dose according to the vaccine received.|
59738835|NCT01027364|75857952|FG001|Joined Arm 4 for Surgery Then Returned|Overall Study||0||
59738836|NCT01027364|75857953|FG002|Joined Arm 4 for Surgery Then Returned|Overall Study||1||
59738837|NCT01027364|75857954|FG003|Joined Arm 4 for Surgery Then Returned|Overall Study||0||
59738838|NCT01027364|75857951|FG000|Started Arm 4 Then Joined Another Arm|Overall Study||2||
59738839|NCT01027364|75857952|FG001|Started Arm 4 Then Joined Another Arm|Overall Study||0||
59738840|NCT01027364|75857953|FG002|Started Arm 4 Then Joined Another Arm|Overall Study||0||
59738841|NCT01027364|75857954|FG003|Started Arm 4 Then Joined Another Arm|Overall Study||0||
59738842|NCT01027364|75857951|FG000|COMPLETED|Overall Study||59||
59738843|NCT01027364|75857952|FG001|COMPLETED|Overall Study||27||
59738844|NCT01027364|75857953|FG002|COMPLETED|Overall Study||26||
59738845|NCT01027364|75857954|FG003|COMPLETED|Overall Study|11 participants total completed Arm 4 (3: compl. Arm 4 only; 7: cont. to Arm 1; 1: cont. to Arm 3)|3||
59738846|NCT01027364|75857951|FG000|NOT COMPLETED|Overall Study||4||
59738847|NCT01027364|75857952|FG001|NOT COMPLETED|Overall Study||2||
59738848|NCT01027364|75857953|FG002|NOT COMPLETED|Overall Study||1||
59738849|NCT01027364|75857954|FG003|NOT COMPLETED|Overall Study||1||
59738850|NCT01027286|75857982|FG000|STARTED|Overall Study||50||
59738851|NCT01027286|75857983|FG001|STARTED|Overall Study||50||
59738852|NCT01027286|75857982|FG000|Preoperative|Overall Study||50||
59738853|NCT01027286|75857983|FG001|Preoperative|Overall Study||50||
59738854|NCT01027286|75857982|FG000|Day of Surgery|Overall Study||50||
59738855|NCT01027286|75857983|FG001|Day of Surgery|Overall Study||50||
59738856|NCT01027286|75857982|FG000|4 Week Postoperative|Overall Study||49||
59738857|NCT01027286|75857983|FG001|4 Week Postoperative|Overall Study||50||
59738858|NCT01027286|75857982|FG000|12 Week Postoperative|Overall Study||49||
59738859|NCT01027286|75857983|FG001|12 Week Postoperative|Overall Study||49||
59738860|NCT01027286|75857982|FG000|COMPLETED|Overall Study||49||
59738861|NCT01027286|75857983|FG001|COMPLETED|Overall Study||49||
59738862|NCT01027286|75857982|FG000|NOT COMPLETED|Overall Study||1||
59738863|NCT01027286|75857983|FG001|NOT COMPLETED|Overall Study||1||
59738864|NCT01026974|75857993|FG000|STARTED|Overall Study||16||
59738865|NCT01026974|75857994|FG001|STARTED|Overall Study||14||
59738866|NCT01026974|75857995|FG002|STARTED|Overall Study||41||
59738867|NCT01026974|75857996|FG003|STARTED|Overall Study||49||
59738868|NCT01026974|75857993|FG000|COMPLETED|Overall Study||15||
59738869|NCT01026974|75857994|FG001|COMPLETED|Overall Study||12||
59738870|NCT01026974|75857995|FG002|COMPLETED|Overall Study||29||
59738871|NCT01026974|75857996|FG003|COMPLETED|Overall Study||46||
59738872|NCT01026974|75857993|FG000|NOT COMPLETED|Overall Study||1||
59738873|NCT01026974|75857994|FG001|NOT COMPLETED|Overall Study||2||
59738874|NCT01026974|75857995|FG002|NOT COMPLETED|Overall Study||12||
59738875|NCT01026974|75857996|FG003|NOT COMPLETED|Overall Study||3||
59738876|NCT00897390|75858011|FG000|STARTED|Overall Study||24||
59738877|NCT00897390|75858011|FG000|COMPLETED|Overall Study||18||
59738878|NCT00897390|75858011|FG000|NOT COMPLETED|Overall Study||6||
59738879|NCT01034462|75858024|FG000|STARTED|Overall Study||217||
59738880|NCT01034462|75858025|FG001|STARTED|Overall Study||217||
59738881|NCT01034462|75858024|FG000|COMPLETED|Overall Study||172||
59738882|NCT01034462|75858025|FG001|COMPLETED|Overall Study||163||
59738883|NCT01034462|75858024|FG000|NOT COMPLETED|Overall Study||45||
59738884|NCT01034462|75858025|FG001|NOT COMPLETED|Overall Study||54||
59738885|NCT01033448|75858033|FG000|STARTED|Overall Study||59||
59738886|NCT01033448|75858033|FG000|COMPLETED|Overall Study||47||
59738887|NCT01033448|75858033|FG000|NOT COMPLETED|Overall Study||12||
59738888|NCT00746941|75858043|FG000|STARTED|Overall Study||7||
59738889|NCT00746941|75858044|FG001|STARTED|Overall Study||5||
59738890|NCT00746941|75858045|FG002|STARTED|Overall Study||5||
59738891|NCT00746941|75858046|FG003|STARTED|Overall Study||20||
59738892|NCT00746941|75858043|FG000|COMPLETED|Overall Study||0||
59738893|NCT00746941|75858044|FG001|COMPLETED|Overall Study||1||
59738894|NCT00746941|75858045|FG002|COMPLETED|Overall Study||3||
59738895|NCT00746941|75858046|FG003|COMPLETED|Overall Study||7||
59738896|NCT00746941|75858043|FG000|NOT COMPLETED|Overall Study||7||
59738897|NCT00746941|75858044|FG001|NOT COMPLETED|Overall Study||4||
59738898|NCT00746941|75858045|FG002|NOT COMPLETED|Overall Study||2||
59738899|NCT00746941|75858046|FG003|NOT COMPLETED|Overall Study||13||
60002370|NCT02701985|76118230|FG001|STARTED|Overall Study||38||
60002371|NCT02701985|76118229|FG000|COMPLETED|Overall Study||34||
60002372|NCT02701985|76118230|FG001|COMPLETED|Overall Study||32||
59738900|NCT00746785|75858058|FG000|STARTED|Overall Study||43||
59738901|NCT00746785|75858059|FG001|STARTED|Overall Study||46||
59738902|NCT00746785|75858060|FG002|STARTED|Overall Study||40||
59738903|NCT00746785|75858058|FG000|COMPLETED|Overall Study||14||
59738904|NCT00746785|75858059|FG001|COMPLETED|Overall Study||21||
59738905|NCT00746785|75858060|FG002|COMPLETED|Overall Study||13||
59738906|NCT00746785|75858058|FG000|NOT COMPLETED|Overall Study||29||
59738907|NCT00746785|75858059|FG001|NOT COMPLETED|Overall Study||25||
59738908|NCT00746785|75858060|FG002|NOT COMPLETED|Overall Study||27||
59738909|NCT00750919|75858068|FG000|STARTED|Overall Study||184||
60002373|NCT02701985|76118229|FG000|NOT COMPLETED|Overall Study||3||
59738910|NCT00750919|75858068|FG000|COMPLETED|Overall Study||126||
59738911|NCT00750919|75858068|FG000|NOT COMPLETED|Overall Study||58||
59738912|NCT00746551|75858074|FG000|STARTED|At Gestational Age of 36 Weeks||40||
59738913|NCT00746551|75858075|FG001|STARTED|At Gestational Age of 36 Weeks||40||
59738914|NCT00746551|75858074|FG000|COMPLETED|At Gestational Age of 36 Weeks||38||
59738915|NCT00746551|75858075|FG001|COMPLETED|At Gestational Age of 36 Weeks||36||
59738916|NCT00746551|75858074|FG000|NOT COMPLETED|At Gestational Age of 36 Weeks||2||
59738917|NCT00746551|75858075|FG001|NOT COMPLETED|At Gestational Age of 36 Weeks||4||
59738918|NCT00746551|75858074|FG000|STARTED|At Delivery (GA of 39 Weeks)||40||
59738919|NCT00746551|75858075|FG001|STARTED|At Delivery (GA of 39 Weeks)||40||
59738920|NCT00746551|75858074|FG000|COMPLETED|At Delivery (GA of 39 Weeks)||25||
59738921|NCT00746551|75858075|FG001|COMPLETED|At Delivery (GA of 39 Weeks)||25||
59738922|NCT00746551|75858074|FG000|NOT COMPLETED|At Delivery (GA of 39 Weeks)||15||
59738923|NCT00746551|75858075|FG001|NOT COMPLETED|At Delivery (GA of 39 Weeks)||15||
59738924|NCT00753649|75858083|FG000|STARTED|Overall Study||112||
60134787|NCT03632720|76258050|FG002|Safety Analysis Set|Overall Study||157|Safety analysis set included all participants who had received at least 1 dose of study vaccines and had any safety data available. All participants had their safety analyzed after each dose according to the vaccine they actually received at each visit, and after any dose according to the vaccine received.|
60134788|NCT03632720|76258048|FG000|COMPLETED|Overall Study||301||
60134789|NCT03632720|76258049|FG001|COMPLETED|Overall Study||305||
59738925|NCT00753649|75858084|FG001|STARTED|Overall Study||112||
59738926|NCT00753649|75858083|FG000|COMPLETED|Overall Study||105||
59738927|NCT00753649|75858084|FG001|COMPLETED|Overall Study||112||
59738928|NCT00753649|75858083|FG000|NOT COMPLETED|Overall Study||7||
59738929|NCT00753649|75858084|FG001|NOT COMPLETED|Overall Study||0||
59738930|NCT00750139|75858094|FG000|STARTED|Overall Study||234||
59738931|NCT00750139|75858095|FG001|STARTED|Overall Study||118||
59738932|NCT00750139|75858096|FG002|STARTED|Overall Study||236||
59738933|NCT00750139|75858097|FG003|STARTED|Overall Study||119||
59738934|NCT00750139|75858094|FG000|COMPLETED|Overall Study||145||
59738935|NCT00750139|75858095|FG001|COMPLETED|Overall Study||59||
59738936|NCT00750139|75858096|FG002|COMPLETED|Overall Study||135||
59738937|NCT00750139|75858097|FG003|COMPLETED|Overall Study||73||
59738938|NCT00750139|75858094|FG000|NOT COMPLETED|Overall Study||89||
59738939|NCT00750139|75858095|FG001|NOT COMPLETED|Overall Study||59||
59738940|NCT00750139|75858096|FG002|NOT COMPLETED|Overall Study||101||
59738941|NCT00750139|75858097|FG003|NOT COMPLETED|Overall Study||46||
59738942|NCT00750061|75858111|FG000|STARTED|Overall Study||20||
59738943|NCT00750061|75858112|FG001|STARTED|Overall Study||20||
59738944|NCT00750061|75858111|FG000|COMPLETED|Overall Study||18||
59738945|NCT00750061|75858112|FG001|COMPLETED|Overall Study||18||
59738946|NCT00750061|75858111|FG000|NOT COMPLETED|Overall Study||2||
59738947|NCT00750061|75858112|FG001|NOT COMPLETED|Overall Study||2||
59738948|NCT00744757|75858118|FG000|STARTED|Overall Study||37||
59738949|NCT00744757|75858118|FG000|COMPLETED|Overall Study||16||
59738950|NCT00744757|75858118|FG000|NOT COMPLETED|Overall Study||21||
59738951|NCT00745849|75858122|FG000|STARTED|First Intervention||21||
59738952|NCT00745849|75858123|FG001|STARTED|First Intervention||22||
59738953|NCT00745849|75858122|FG000|COMPLETED|First Intervention||20||
59738954|NCT00745849|75858123|FG001|COMPLETED|First Intervention||20||
59738955|NCT00745849|75858122|FG000|NOT COMPLETED|First Intervention||1||
59738956|NCT00745849|75858123|FG001|NOT COMPLETED|First Intervention||2||
59738957|NCT00745849|75858122|FG000|STARTED|Washout Period||20||
59738958|NCT00745849|75858123|FG001|STARTED|Washout Period||20||
59738959|NCT00745849|75858122|FG000|COMPLETED|Washout Period||20||
59738960|NCT00745849|75858123|FG001|COMPLETED|Washout Period||20||
59738961|NCT00745849|75858122|FG000|NOT COMPLETED|Washout Period||0||
59950734|NCT03536884|76069557|FG001|NOT COMPLETED|Maintenance Treatment Period Week 16-48||0||
59738962|NCT00745849|75858123|FG001|NOT COMPLETED|Washout Period||0||
59738963|NCT00745849|75858122|FG000|STARTED|Second Intervention||20||
59738964|NCT00745849|75858123|FG001|STARTED|Second Intervention||20||
59738965|NCT00745849|75858122|FG000|COMPLETED|Second Intervention||18||
59738966|NCT00745849|75858123|FG001|COMPLETED|Second Intervention||19||
59738967|NCT00745849|75858122|FG000|NOT COMPLETED|Second Intervention||2||
59738968|NCT00745849|75858123|FG001|NOT COMPLETED|Second Intervention||1||
59738969|NCT02599051|75858131|FG000|STARTED|Overall Study||49||
59738970|NCT02599051|75858132|FG001|STARTED|Overall Study||49||
59738971|NCT02599051|75858131|FG000|COMPLETED|Overall Study||42||
59738972|NCT02599051|75858132|FG001|COMPLETED|Overall Study||41||
59738973|NCT02599051|75858131|FG000|NOT COMPLETED|Overall Study||7||
59738974|NCT02599051|75858132|FG001|NOT COMPLETED|Overall Study||8||
59738975|NCT00749203|75858140|FG000|STARTED|First Infusion Day 1||22||
59738976|NCT00749203|75858141|FG001|STARTED|First Infusion Day 1||19||
59738977|NCT00749203|75858140|FG000|COMPLETED|First Infusion Day 1||22||
59738978|NCT00749203|75858141|FG001|COMPLETED|First Infusion Day 1||19||
59738979|NCT00749203|75858140|FG000|NOT COMPLETED|First Infusion Day 1||0||
59738980|NCT00749203|75858141|FG001|NOT COMPLETED|First Infusion Day 1||0||
59738981|NCT00749203|75858140|FG000|STARTED|no Infusion at Week 1||22||
59738982|NCT00749203|75858141|FG001|STARTED|no Infusion at Week 1||19||
59738983|NCT00749203|75858140|FG000|COMPLETED|no Infusion at Week 1||22||
59738984|NCT00749203|75858141|FG001|COMPLETED|no Infusion at Week 1||15||
59738985|NCT00749203|75858140|FG000|NOT COMPLETED|no Infusion at Week 1||0||
59738986|NCT00749203|75858141|FG001|NOT COMPLETED|no Infusion at Week 1||4||
59738987|NCT00749203|75858140|FG000|STARTED|Second Infusion at 2 Weeks|N=6 completed the study at 2 wks due to CAPS scores < 50, precluding 2nd infusion.|16||
59738988|NCT00749203|75858141|FG001|STARTED|Second Infusion at 2 Weeks||15||
59738989|NCT00749203|75858140|FG000|COMPLETED|Second Infusion at 2 Weeks||16||
59738990|NCT00749203|75858141|FG001|COMPLETED|Second Infusion at 2 Weeks||13||
59738991|NCT00749203|75858140|FG000|NOT COMPLETED|Second Infusion at 2 Weeks||0||
59738992|NCT00749203|75858141|FG001|NOT COMPLETED|Second Infusion at 2 Weeks||2||
59738993|NCT00748969|75858149|FG000|STARTED|Overall Study|Subject withdrew from study due to worsening sleep apnea|1||
59738994|NCT00748969|75858150|FG001|STARTED|Overall Study|Subject withdrew from study due to randomization to no treatment|1||
59738995|NCT00748969|75858149|FG000|COMPLETED|Overall Study||0||
59738996|NCT00748969|75858150|FG001|COMPLETED|Overall Study||0||
59738997|NCT00748969|75858149|FG000|NOT COMPLETED|Overall Study||1||
59738998|NCT00748969|75858150|FG001|NOT COMPLETED|Overall Study||1||
59738999|NCT00745615|75858160|FG000|STARTED|Double-Blind Extension (36 Weeks)||80||
59739000|NCT00745615|75858161|FG001|STARTED|Double-Blind Extension (36 Weeks)||94||
59739001|NCT00745615|75858162|FG002|STARTED|Double-Blind Extension (36 Weeks)||39||
59739002|NCT00745615|75858163|FG003|STARTED|Double-Blind Extension (36 Weeks)||44||
59739003|NCT00745615|75858164|FG004|STARTED|Double-Blind Extension (36 Weeks)||0||
59739004|NCT00745615|75858165|FG005|STARTED|Double-Blind Extension (36 Weeks)||0||
59739005|NCT00745615|75858160|FG000|COMPLETED|Double-Blind Extension (36 Weeks)||75||
59739006|NCT00745615|75858161|FG001|COMPLETED|Double-Blind Extension (36 Weeks)||87||
59739007|NCT00745615|75858162|FG002|COMPLETED|Double-Blind Extension (36 Weeks)||38||
59739008|NCT00745615|75858163|FG003|COMPLETED|Double-Blind Extension (36 Weeks)||39||
59739009|NCT00745615|75858164|FG004|COMPLETED|Double-Blind Extension (36 Weeks)||0||
59739010|NCT00745615|75858165|FG005|COMPLETED|Double-Blind Extension (36 Weeks)||0||
59739011|NCT00745615|75858160|FG000|NOT COMPLETED|Double-Blind Extension (36 Weeks)||5||
59739012|NCT00745615|75858161|FG001|NOT COMPLETED|Double-Blind Extension (36 Weeks)||7||
59739013|NCT00745615|75858162|FG002|NOT COMPLETED|Double-Blind Extension (36 Weeks)||1||
59739014|NCT00745615|75858163|FG003|NOT COMPLETED|Double-Blind Extension (36 Weeks)||5||
59739015|NCT00745615|75858164|FG004|NOT COMPLETED|Double-Blind Extension (36 Weeks)||0||
59739016|NCT00745615|75858165|FG005|NOT COMPLETED|Double-Blind Extension (36 Weeks)||0||
59604243|NCT02059434|75714652|FG005|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0||
59604244|NCT02059434|75714653|FG006|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0||
59604245|NCT02059434|75714654|FG007|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0||
59604246|NCT02059434|75714655|FG008|COMPLETED|Period 5||37||
59604247|NCT02059434|75714647|FG000|NOT COMPLETED|Period 5||0||
59604248|NCT02059434|75714648|FG001|NOT COMPLETED|Period 5||0||
59604249|NCT02059434|75714649|FG002|NOT COMPLETED|Period 5||0||
59604250|NCT02059434|75714650|FG003|NOT COMPLETED|Period 5||0||
59604251|NCT02059434|75714651|FG004|NOT COMPLETED|Period 5||0||
59604252|NCT02059434|75714652|FG005|NOT COMPLETED|Period 5||0||
59604253|NCT02059434|75714653|FG006|NOT COMPLETED|Period 5||0||
59604254|NCT02059434|75714654|FG007|NOT COMPLETED|Period 5||0||
59604255|NCT02059434|75714655|FG008|NOT COMPLETED|Period 5||0||
59604256|NCT02059434|75714647|FG000|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0||
59604257|NCT02059434|75714648|FG001|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0||
59604258|NCT02059434|75714649|FG002|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0||
59604259|NCT02059434|75714650|FG003|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0||
59604260|NCT02059434|75714651|FG004|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0||
59604261|NCT02059434|75714652|FG005|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0||
59604262|NCT02059434|75714653|FG006|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0||
59604263|NCT02059434|75714654|FG007|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0||
59604264|NCT02059434|75714655|FG008|STARTED|Washout Between Periods 5 and 6||37||
59604265|NCT02059434|75714647|FG000|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0||
59604266|NCT02059434|75714648|FG001|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0||
59604267|NCT02059434|75714649|FG002|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0||
59604268|NCT02059434|75714650|FG003|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0||
59604269|NCT02059434|75714651|FG004|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0||
59604270|NCT02059434|75714652|FG005|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0||
59739017|NCT00745615|75858160|FG000|STARTED|Open-Label (up to Approx 10.5 Years)||0||
59739018|NCT00745615|75858161|FG001|STARTED|Open-Label (up to Approx 10.5 Years)||0||
59739019|NCT00745615|75858162|FG002|STARTED|Open-Label (up to Approx 10.5 Years)||0||
59739020|NCT00745615|75858163|FG003|STARTED|Open-Label (up to Approx 10.5 Years)||0||
59739021|NCT00745615|75858164|FG004|STARTED|Open-Label (up to Approx 10.5 Years)||96||
59739022|NCT00745615|75858165|FG005|STARTED|Open-Label (up to Approx 10.5 Years)||113||
59739023|NCT00745615|75858160|FG000|COMPLETED|Open-Label (up to Approx 10.5 Years)||0||
59604271|NCT02059434|75714653|FG006|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0||
59604272|NCT02059434|75714654|FG007|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0||
59604273|NCT02059434|75714655|FG008|COMPLETED|Washout Between Periods 5 and 6||37||
59604274|NCT02059434|75714647|FG000|NOT COMPLETED|Washout Between Periods 5 and 6||0||
59604275|NCT02059434|75714648|FG001|NOT COMPLETED|Washout Between Periods 5 and 6||0||
59739024|NCT00745615|75858161|FG001|COMPLETED|Open-Label (up to Approx 10.5 Years)||0||
59739025|NCT00745615|75858162|FG002|COMPLETED|Open-Label (up to Approx 10.5 Years)||0||
59739026|NCT00745615|75858163|FG003|COMPLETED|Open-Label (up to Approx 10.5 Years)||0||
59739027|NCT00745615|75858164|FG004|COMPLETED|Open-Label (up to Approx 10.5 Years)||5||
59739028|NCT00745615|75858165|FG005|COMPLETED|Open-Label (up to Approx 10.5 Years)||5||
59739029|NCT00745615|75858160|FG000|NOT COMPLETED|Open-Label (up to Approx 10.5 Years)||0||
59739030|NCT00745615|75858161|FG001|NOT COMPLETED|Open-Label (up to Approx 10.5 Years)||0||
59739031|NCT00745615|75858162|FG002|NOT COMPLETED|Open-Label (up to Approx 10.5 Years)||0||
59739032|NCT00745615|75858163|FG003|NOT COMPLETED|Open-Label (up to Approx 10.5 Years)||0||
59739033|NCT00745615|75858164|FG004|NOT COMPLETED|Open-Label (up to Approx 10.5 Years)||91||
59739034|NCT00745615|75858165|FG005|NOT COMPLETED|Open-Label (up to Approx 10.5 Years)||108||
59739035|NCT02755545|75858179|FG000|STARTED|Overall Study||62||
59739036|NCT02755545|75858180|FG001|STARTED|Overall Study||65||
59739037|NCT02755545|75858179|FG000|COMPLETED|Overall Study||43||
59739038|NCT02755545|75858180|FG001|COMPLETED|Overall Study||44||
59739039|NCT02755545|75858179|FG000|NOT COMPLETED|Overall Study||19||
59739040|NCT02755545|75858180|FG001|NOT COMPLETED|Overall Study||21||
59739041|NCT00744523|75858188|FG000|STARTED|Procedure||37||
59739042|NCT00744523|75858189|FG001|STARTED|Procedure||225||
59739043|NCT00744523|75858188|FG000|COMPLETED|Procedure||37||
60134790|NCT03632720|76258050|FG002|COMPLETED|Overall Study||150||
60134791|NCT03632720|76258048|FG000|NOT COMPLETED|Overall Study||13||
60134792|NCT03632720|76258049|FG001|NOT COMPLETED|Overall Study||11||
60134793|NCT03632720|76258050|FG002|NOT COMPLETED|Overall Study||8||
59739044|NCT00744523|75858189|FG001|COMPLETED|Procedure||225||
59739045|NCT00744523|75858188|FG000|NOT COMPLETED|Procedure||0||
59739046|NCT00744523|75858189|FG001|NOT COMPLETED|Procedure||0||
59739047|NCT00744523|75858188|FG000|STARTED|30 Days After the Procedure||37||
59739048|NCT00744523|75858189|FG001|STARTED|30 Days After the Procedure||225||
59739049|NCT00744523|75858188|FG000|COMPLETED|30 Days After the Procedure||37||
59739050|NCT00744523|75858189|FG001|COMPLETED|30 Days After the Procedure||220||
59739051|NCT00744523|75858188|FG000|NOT COMPLETED|30 Days After the Procedure||0||
59739052|NCT00744523|75858189|FG001|NOT COMPLETED|30 Days After the Procedure||5||
59739053|NCT00744991|75858197|FG000|STARTED|Overall Study||25||
59739054|NCT00744991|75858197|FG000|Received at Least 1 Dose|Overall Study||25||
59739055|NCT00744991|75858197|FG000|COMPLETED|Overall Study||0||
59739056|NCT00744991|75858197|FG000|NOT COMPLETED|Overall Study||25||
59739057|NCT02414607|75858206|FG000|STARTED|Overall Study||11||
59739058|NCT02414607|75858207|FG001|STARTED|Overall Study||13||
59739059|NCT02414607|75858206|FG000|COMPLETED|Overall Study||9||
59739060|NCT02414607|75858207|FG001|COMPLETED|Overall Study||11||
59739061|NCT02414607|75858206|FG000|NOT COMPLETED|Overall Study||2||
59739062|NCT02414607|75858207|FG001|NOT COMPLETED|Overall Study||2||
59739063|NCT00839254|75858221|FG000|STARTED|Overall Study||1849||
59739064|NCT00839254|75858222|FG001|STARTED|Overall Study||1316||
59739065|NCT00839254|75858223|FG002|STARTED|Overall Study||1069||
59739066|NCT00839254|75858224|FG003|STARTED|Overall Study||859||
59739067|NCT00839254|75858225|FG004|STARTED|Overall Study||241||
59739068|NCT00839254|75858226|FG005|STARTED|Overall Study||204||
59739069|NCT00839254|75858227|FG006|STARTED|Overall Study||368||
59739070|NCT00839254|75858228|FG007|STARTED|Overall Study||271||
59739071|NCT00839254|75858221|FG000|COMPLETED|Overall Study||1696||
59739072|NCT00839254|75858222|FG001|COMPLETED|Overall Study||1224||
59739073|NCT00839254|75858223|FG002|COMPLETED|Overall Study||979||
59739074|NCT00839254|75858224|FG003|COMPLETED|Overall Study||797||
59739075|NCT00839254|75858225|FG004|COMPLETED|Overall Study||204||
59739076|NCT00839254|75858226|FG005|COMPLETED|Overall Study||178||
59739077|NCT00839254|75858227|FG006|COMPLETED|Overall Study||340||
59739078|NCT00839254|75858228|FG007|COMPLETED|Overall Study||256||
60134794|NCT03606512|76258062|FG000|STARTED|Overall Study||18||
59739079|NCT00839254|75858221|FG000|NOT COMPLETED|Overall Study||153||
59739080|NCT00839254|75858222|FG001|NOT COMPLETED|Overall Study||92||
59739081|NCT00839254|75858223|FG002|NOT COMPLETED|Overall Study||90||
59739082|NCT00839254|75858224|FG003|NOT COMPLETED|Overall Study||62||
60134795|NCT03606512|76258063|FG001|STARTED|Overall Study||20||
60134796|NCT03606512|76258062|FG000|Participants Received Placebo on Day 57|Overall Study||6||
60134797|NCT03606512|76258063|FG001|Participants Received Placebo on Day 57|Overall Study||0||
59739083|NCT00839254|75858225|FG004|NOT COMPLETED|Overall Study||37||
59739084|NCT00839254|75858226|FG005|NOT COMPLETED|Overall Study||26||
59739085|NCT00839254|75858227|FG006|NOT COMPLETED|Overall Study||28||
59739086|NCT00839254|75858228|FG007|NOT COMPLETED|Overall Study||15||
59739087|NCT00586339|75858280|FG000|STARTED|Overall Study||61||
59739088|NCT00586339|75858281|FG001|STARTED|Overall Study||59||
59739089|NCT00586339|75858282|FG002|STARTED|Overall Study||30||
59739090|NCT00586339|75858280|FG000|COMPLETED|Overall Study||54||
59739091|NCT00586339|75858281|FG001|COMPLETED|Overall Study||52||
59739092|NCT00586339|75858282|FG002|COMPLETED|Overall Study||24||
59739093|NCT00586339|75858280|FG000|NOT COMPLETED|Overall Study||7||
59739094|NCT00586339|75858281|FG001|NOT COMPLETED|Overall Study||7||
60134798|NCT03606512|76258062|FG000|Participants Received Nimenrix on Day 57|Overall Study||12||
60134799|NCT03606512|76258063|FG001|Participants Received Nimenrix on Day 57|Overall Study||0||
59739095|NCT00586339|75858282|FG002|NOT COMPLETED|Overall Study||6||
59739096|NCT00812968|75858290|FG000|STARTED|Overall Study||11||
59739097|NCT00812968|75858290|FG000|COMPLETED|Overall Study||0||
59739098|NCT00812968|75858290|FG000|NOT COMPLETED|Overall Study||11||
59739099|NCT00839098|75858299|FG000|STARTED|Overall Study||3||
59739100|NCT00839098|75858300|FG001|STARTED|Overall Study||12||
59739101|NCT00839098|75858301|FG002|STARTED|Overall Study||13||
59739102|NCT00839098|75858299|FG000|COMPLETED|Overall Study||1||
59739103|NCT00839098|75858300|FG001|COMPLETED|Overall Study||11||
59739104|NCT00839098|75858301|FG002|COMPLETED|Overall Study||6||
59739105|NCT00839098|75858299|FG000|NOT COMPLETED|Overall Study||2||
59739106|NCT00839098|75858300|FG001|NOT COMPLETED|Overall Study||1||
59739107|NCT00839098|75858301|FG002|NOT COMPLETED|Overall Study||7||
59739108|NCT00813748|75858311|FG000|STARTED|Main Observational Study||30||
59739109|NCT00813748|75858312|FG001|STARTED|Main Observational Study||88||
59739110|NCT00813748|75858311|FG000|COMPLETED|Main Observational Study||30||
59739111|NCT00813748|75858312|FG001|COMPLETED|Main Observational Study||88||
59739112|NCT00813748|75858311|FG000|NOT COMPLETED|Main Observational Study||0||
59739113|NCT00813748|75858312|FG001|NOT COMPLETED|Main Observational Study||0||
59739114|NCT00813748|75858311|FG000|STARTED|Skin Test Substudy|Included participants who discontinued omalizumab for at least 16 weeks but not more than 18 months.|3||
59739115|NCT00813748|75858312|FG001|STARTED|Skin Test Substudy|Included participants who discontinued omalizumab for at least 16 weeks but not more than 18 months.|8||
59739116|NCT00813748|75858311|FG000|COMPLETED|Skin Test Substudy||3||
59739117|NCT00813748|75858312|FG001|COMPLETED|Skin Test Substudy||7||
59739118|NCT00813748|75858311|FG000|NOT COMPLETED|Skin Test Substudy||0||
59739119|NCT00813748|75858312|FG001|NOT COMPLETED|Skin Test Substudy||1||
59739120|NCT00813592|75858320|FG000|STARTED|Overall Study||2||
59739121|NCT00813592|75858320|FG000|Treated|Overall Study|Two patients were treated.|2||
59739122|NCT00813592|75858320|FG000|Response Assessment|Overall Study|One patient met the response assessment.|1||
59739123|NCT00813592|75858320|FG000|COMPLETED|Overall Study||0||
59739124|NCT00813592|75858320|FG000|NOT COMPLETED|Overall Study||2||
59739125|NCT05067647|75858325|FG000|STARTED|Overall Study||94||
59739126|NCT05067647|75858325|FG000|COMPLETED|Overall Study||93||
59739127|NCT05067647|75858325|FG000|NOT COMPLETED|Overall Study||1||
59739128|NCT04795323|75858331|FG000|STARTED|Overall Study||4|Entered set (ES)|
59739129|NCT04795323|75858332|FG001|STARTED|Overall Study||1|Entered set (ES)|
59739130|NCT04795323|75858331|FG000|COMPLETED|Overall Study||3||
59739131|NCT04795323|75858332|FG001|COMPLETED|Overall Study||1||
59739132|NCT04795323|75858331|FG000|NOT COMPLETED|Overall Study||1||
59739133|NCT04795323|75858332|FG001|NOT COMPLETED|Overall Study||0||
59739134|NCT04784091|75858340|FG000|STARTED|Overall Study||203||
59739135|NCT04784091|75858341|FG001|STARTED|Overall Study||209||
59739136|NCT04784091|75858340|FG000|COMPLETED|Overall Study||193||
59739137|NCT04784091|75858341|FG001|COMPLETED|Overall Study||200||
59739138|NCT04784091|75858340|FG000|NOT COMPLETED|Overall Study||10||
59739139|NCT04784091|75858341|FG001|NOT COMPLETED|Overall Study||9||
59739140|NCT04732871|75858350|FG000|STARTED|Overall Study||993||
59739141|NCT04732871|75858351|FG001|STARTED|Overall Study||329||
59739142|NCT04732871|75858352|FG002|STARTED|Overall Study||331||
59739143|NCT04732871|75858350|FG000|COMPLETED|Overall Study||938||
59739144|NCT04732871|75858351|FG001|COMPLETED|Overall Study||317||
59739145|NCT04732871|75858352|FG002|COMPLETED|Overall Study||317||
59739146|NCT04732871|75858350|FG000|NOT COMPLETED|Overall Study||55||
59739147|NCT04732871|75858351|FG001|NOT COMPLETED|Overall Study||12||
59739148|NCT04732871|75858352|FG002|NOT COMPLETED|Overall Study||14||
59739149|NCT04718779|75858360|FG000|STARTED|Overall Study||2||
59739150|NCT04718779|75858361|FG001|STARTED|Overall Study||2||
59739151|NCT04718779|75858360|FG000|COMPLETED|Overall Study||2||
59739152|NCT04718779|75858361|FG001|COMPLETED|Overall Study||2||
59739153|NCT04718779|75858360|FG000|NOT COMPLETED|Overall Study||0||
59739154|NCT04718779|75858361|FG001|NOT COMPLETED|Overall Study||0||
59739155|NCT04498377|75858369|FG000|STARTED|Overall Study||1||
59739156|NCT04498377|75858370|FG001|STARTED|Overall Study||0||
59739157|NCT04498377|75858369|FG000|COMPLETED|Overall Study||1||
59739158|NCT04498377|75858370|FG001|COMPLETED|Overall Study||0||
59739159|NCT04498377|75858369|FG000|NOT COMPLETED|Overall Study||0||
59739160|NCT04498377|75858370|FG001|NOT COMPLETED|Overall Study||0||
59739161|NCT04497389|75858378|FG000|STARTED|Overall Study||23||
59739162|NCT04497389|75858379|FG001|STARTED|Overall Study||24||
59739163|NCT04497389|75858378|FG000|COMPLETED|Overall Study||22||
59739164|NCT04497389|75858379|FG001|COMPLETED|Overall Study||24||
59739165|NCT04497389|75858378|FG000|NOT COMPLETED|Overall Study||1||
59739166|NCT04497389|75858379|FG001|NOT COMPLETED|Overall Study||0||
59739167|NCT04475432|75858419|FG000|STARTED|Overall Study||212||
59739168|NCT04475432|75858420|FG001|STARTED|Overall Study||209||
59739169|NCT04475432|75858419|FG000|COMPLETED|Overall Study||208||
59739170|NCT04475432|75858420|FG001|COMPLETED|Overall Study||203||
59739171|NCT04475432|75858419|FG000|NOT COMPLETED|Overall Study||4||
59739172|NCT04475432|75858420|FG001|NOT COMPLETED|Overall Study||6||
59739173|NCT04425629|75858447|FG000|STARTED|Overall Study||24||
59739174|NCT04425629|75858448|FG001|STARTED|Overall Study||24||
59739175|NCT04425629|75858449|FG002|STARTED|Overall Study||24||
59739176|NCT04425629|75858450|FG003|STARTED|Overall Study||242||
59739177|NCT04425629|75858451|FG004|STARTED|Overall Study||242||
59739178|NCT04425629|75858452|FG005|STARTED|Overall Study||243||
59739179|NCT04425629|75858453|FG006|STARTED|Overall Study||76||
59739180|NCT04425629|75858454|FG007|STARTED|Overall Study||76||
59739181|NCT04425629|75858455|FG008|STARTED|Overall Study||76||
59739182|NCT04425629|75858456|FG009|STARTED|Overall Study||2378||
59739183|NCT04425629|75858457|FG010|STARTED|Overall Study||2156||
59739184|NCT04425629|75858458|FG011|STARTED|Overall Study||3189||
59739185|NCT04425629|75858459|FG012|STARTED|Overall Study||1027||
59739186|NCT04425629|75858460|FG013|STARTED|Overall Study||2||
59739187|NCT04425629|75858461|FG014|STARTED|Overall Study||129||
59739188|NCT04425629|75858462|FG015|STARTED|Overall Study||75||
59739189|NCT04425629|75858463|FG016|STARTED|Overall Study||3||
59739190|NCT04425629|75858464|FG017|STARTED|Overall Study||43||
59739191|NCT04425629|75858465|FG018|STARTED|Overall Study||36||
59739192|NCT04425629|75858447|FG000|COMPLETED|Overall Study||23||
59739193|NCT04425629|75858448|FG001|COMPLETED|Overall Study||19||
59739194|NCT04425629|75858449|FG002|COMPLETED|Overall Study||22||
59739195|NCT04425629|75858450|FG003|COMPLETED|Overall Study||230||
59739196|NCT04425629|75858451|FG004|COMPLETED|Overall Study||232||
59739197|NCT04425629|75858452|FG005|COMPLETED|Overall Study||233||
59739198|NCT04425629|75858453|FG006|COMPLETED|Overall Study||71||
59739199|NCT04425629|75858454|FG007|COMPLETED|Overall Study||73||
59739200|NCT04425629|75858455|FG008|COMPLETED|Overall Study||74||
59739201|NCT04425629|75858456|FG009|COMPLETED|Overall Study||2217||
59739202|NCT04425629|75858457|FG010|COMPLETED|Overall Study||1974||
59739203|NCT04425629|75858458|FG011|COMPLETED|Overall Study||2947||
59739204|NCT04425629|75858459|FG012|COMPLETED|Overall Study||962||
59739205|NCT04425629|75858460|FG013|COMPLETED|Overall Study||2||
59739206|NCT04425629|75858461|FG014|COMPLETED|Overall Study||123||
59739207|NCT04425629|75858462|FG015|COMPLETED|Overall Study||65||
59739208|NCT04425629|75858463|FG016|COMPLETED|Overall Study||2||
59739209|NCT04425629|75858464|FG017|COMPLETED|Overall Study||40||
59739210|NCT04425629|75858465|FG018|COMPLETED|Overall Study||33||
59739211|NCT04425629|75858447|FG000|NOT COMPLETED|Overall Study||1||
59739212|NCT04425629|75858448|FG001|NOT COMPLETED|Overall Study||5||
59739213|NCT04425629|75858449|FG002|NOT COMPLETED|Overall Study||2||
59739214|NCT04425629|75858450|FG003|NOT COMPLETED|Overall Study||12||
59739215|NCT04425629|75858451|FG004|NOT COMPLETED|Overall Study||10||
59739216|NCT04425629|75858452|FG005|NOT COMPLETED|Overall Study||10||
59739217|NCT04425629|75858453|FG006|NOT COMPLETED|Overall Study||5||
59739218|NCT04425629|75858454|FG007|NOT COMPLETED|Overall Study||3||
59739219|NCT04425629|75858455|FG008|NOT COMPLETED|Overall Study||2||
59739220|NCT04425629|75858456|FG009|NOT COMPLETED|Overall Study||161||
59739221|NCT04425629|75858457|FG010|NOT COMPLETED|Overall Study||182||
59739222|NCT04425629|75858458|FG011|NOT COMPLETED|Overall Study||242||
59739223|NCT04425629|75858459|FG012|NOT COMPLETED|Overall Study||65||
59739224|NCT04425629|75858460|FG013|NOT COMPLETED|Overall Study||0||
59739225|NCT04425629|75858461|FG014|NOT COMPLETED|Overall Study||6||
59739226|NCT04425629|75858462|FG015|NOT COMPLETED|Overall Study||10||
59739227|NCT04425629|75858463|FG016|NOT COMPLETED|Overall Study||1||
59739228|NCT04425629|75858464|FG017|NOT COMPLETED|Overall Study||3||
59739229|NCT04425629|75858465|FG018|NOT COMPLETED|Overall Study||3||
59739230|NCT04417218|75858615|FG000|STARTED|First Intervention (1 Week))||25||
59739231|NCT04417218|75858616|FG001|STARTED|First Intervention (1 Week))||22||
59739232|NCT04417218|75858615|FG000|COMPLETED|First Intervention (1 Week))||24||
59739233|NCT04417218|75858616|FG001|COMPLETED|First Intervention (1 Week))||22||
59739234|NCT04417218|75858615|FG000|NOT COMPLETED|First Intervention (1 Week))||1||
59739235|NCT04417218|75858616|FG001|NOT COMPLETED|First Intervention (1 Week))||0||
59739236|NCT04417218|75858615|FG000|STARTED|Washout (2 Weeks)||24||
59739237|NCT04417218|75858616|FG001|STARTED|Washout (2 Weeks)||22||
59739238|NCT04417218|75858615|FG000|COMPLETED|Washout (2 Weeks)||24||
59739239|NCT04417218|75858616|FG001|COMPLETED|Washout (2 Weeks)||22||
59739240|NCT04417218|75858615|FG000|NOT COMPLETED|Washout (2 Weeks)||0||
59739241|NCT04417218|75858616|FG001|NOT COMPLETED|Washout (2 Weeks)||0||
59739242|NCT04417218|75858615|FG000|STARTED|Second Intervention (1 Week)||24||
59739243|NCT04417218|75858616|FG001|STARTED|Second Intervention (1 Week)||22||
59739244|NCT04417218|75858615|FG000|COMPLETED|Second Intervention (1 Week)||24||
59739245|NCT04417218|75858616|FG001|COMPLETED|Second Intervention (1 Week)||22||
59739246|NCT04417218|75858615|FG000|NOT COMPLETED|Second Intervention (1 Week)||0||
59739247|NCT04417218|75858616|FG001|NOT COMPLETED|Second Intervention (1 Week)||0||
59739248|NCT04134767|75858624|FG000|STARTED|Overall Study||111||6
59739249|NCT04134767|75858625|FG001|STARTED|Overall Study||123||6
59739250|NCT04134767|75858624|FG000|COMPLETED|Overall Study||67||6
59739251|NCT04134767|75858625|FG001|COMPLETED|Overall Study||81||6
59739252|NCT04134767|75858624|FG000|NOT COMPLETED|Overall Study||44||0
59739253|NCT04134767|75858625|FG001|NOT COMPLETED|Overall Study||42||0
59739254|NCT04070287|75858637|FG000|STARTED|Overall Study||114|Youth (aged 14-24 years) enrolled in the study|
59739255|NCT04070287|75858638|FG001|STARTED|Overall Study||86|Youth (aged 14-24 years) enrolled in the study|
59739256|NCT04070287|75858639|FG002|STARTED|Overall Study||81|Youth (aged 14-24 years) enrolled in the study|
59739257|NCT04070287|75858640|FG003|STARTED|Overall Study||11|Youth (aged 14-24 years) enrolled in the study|
59739258|NCT04070287|75858641|FG004|STARTED|Overall Study||96|Youth (aged 14-24 years) enrolled in the study|
59739259|NCT04070287|75858637|FG000|COMPLETED|Overall Study||103|Youth retained through a 6-month follow-up period|
59739260|NCT04070287|75858638|FG001|COMPLETED|Overall Study||44|Youth retained through a 6-month follow-up period|
59739261|NCT04070287|75858639|FG002|COMPLETED|Overall Study||75|Youth retained through a 6-month follow-up period|
59739262|NCT04070287|75858640|FG003|COMPLETED|Overall Study||7|Youth retained through a 6-month follow-up period|
59739263|NCT04070287|75858641|FG004|COMPLETED|Overall Study||95|Youth retained through a 6-month follow-up period|
59739264|NCT04070287|75858637|FG000|NOT COMPLETED|Overall Study||11||
59739265|NCT04070287|75858638|FG001|NOT COMPLETED|Overall Study||42||
59739266|NCT04070287|75858639|FG002|NOT COMPLETED|Overall Study||6||
59739267|NCT04070287|75858640|FG003|NOT COMPLETED|Overall Study||4||
59739268|NCT04070287|75858641|FG004|NOT COMPLETED|Overall Study||1||
59739269|NCT04024462|75858655|FG000|STARTED|Overall Study||101|Intent-to-Treat (ITT) Population|
59739270|NCT04024462|75858656|FG001|STARTED|Overall Study||99|Intent-to-Treat (ITT) Population|
59739271|NCT04024462|75858655|FG000|Completed Neoadjuvant Treatment (24 Weeks)|Overall Study||96||
59739272|NCT04024462|75858656|FG001|Completed Neoadjuvant Treatment (24 Weeks)|Overall Study||95||
59739273|NCT04024462|75858655|FG000|Completed Surgery (<9 Weeks)|Overall Study||94||
59739274|NCT04024462|75858656|FG001|Completed Surgery (<9 Weeks)|Overall Study||93||
59739275|NCT04024462|75858655|FG000|Started Adjuvant Treatment|Overall Study||89||
59739276|NCT04024462|75858656|FG001|Started Adjuvant Treatment|Overall Study||89||
59739277|NCT04024462|75858655|FG000|Completed Adjuvant Treatment (42 Weeks)|Overall Study||12||
59739278|NCT04024462|75858656|FG001|Completed Adjuvant Treatment (42 Weeks)|Overall Study||14||
59739279|NCT04024462|75858655|FG000|Started Follow-Up (≥3 Years)|Overall Study||23|Participants who completed treatment or prematurely withdrew from treatment entered the follow-up phase.|
59739280|NCT04024462|75858656|FG001|Started Follow-Up (≥3 Years)|Overall Study||20|Participants who completed treatment or prematurely withdrew from treatment entered the follow-up phase.|
59739281|NCT04024462|75858655|FG000|COMPLETED|Overall Study||0||
59739282|NCT04024462|75858656|FG001|COMPLETED|Overall Study||0||
59739283|NCT04024462|75858655|FG000|NOT COMPLETED|Overall Study||101||
59739284|NCT04024462|75858656|FG001|NOT COMPLETED|Overall Study||99||
59739285|NCT03960580|75858665|FG000|STARTED|Overall Study||75||
59739286|NCT03960580|75858666|FG001|STARTED|Overall Study||74||
59739287|NCT03960580|75858667|FG002|STARTED|Overall Study||74||
59739288|NCT03960580|75858665|FG000|COMPLETED|Overall Study||69||
59739289|NCT03960580|75858666|FG001|COMPLETED|Overall Study||70||
59739290|NCT03960580|75858667|FG002|COMPLETED|Overall Study||71||
59739291|NCT03960580|75858665|FG000|NOT COMPLETED|Overall Study||6||
59739292|NCT03960580|75858666|FG001|NOT COMPLETED|Overall Study||4||
59739293|NCT03960580|75858667|FG002|NOT COMPLETED|Overall Study||3||
59739294|NCT03803202|75858684|FG000|STARTED|Overall Study||30|Started = All enrolled participants|
59739295|NCT03803202|75858685|FG001|STARTED|Overall Study||32|Started = All enrolled participants|
59739296|NCT03803202|75858686|FG002|STARTED|Overall Study||32|Started = All enrolled participants|
59739297|NCT03803202|75858687|FG003|STARTED|Overall Study||33|Started = All enrolled participants|
59739298|NCT03803202|75858688|FG004|STARTED|Overall Study||100|Started = All enrolled participants|
59739299|NCT03803202|75858689|FG005|STARTED|Overall Study||107|Started = All enrolled participants|
59739300|NCT03803202|75858690|FG006|STARTED|Overall Study||86|Started = All enrolled participants|
59739301|NCT03803202|75858691|FG007|STARTED|Overall Study||97|Started = All enrolled participants|
59739302|NCT03803202|75858692|FG008|STARTED|Overall Study||113|Started = All enrolled participants|
59739303|NCT03803202|75858684|FG000|Vaccinated|Overall Study||30|Vaccinated = number of participants who completed the vaccination|
59739304|NCT03803202|75858685|FG001|Vaccinated|Overall Study||31|Vaccinated = number of participants who completed the vaccination|
59739305|NCT03803202|75858686|FG002|Vaccinated|Overall Study||32|Vaccinated = number of participants who completed the vaccination|
59739306|NCT03803202|75858687|FG003|Vaccinated|Overall Study||33|Vaccinated = number of participants who completed the vaccination|
59739307|NCT03803202|75858688|FG004|Vaccinated|Overall Study||100|Vaccinated = number of participants who completed the vaccination|
59739308|NCT03803202|75858689|FG005|Vaccinated|Overall Study||107|Vaccinated = number of participants who completed the vaccination|
59739309|NCT03803202|75858690|FG006|Vaccinated|Overall Study||86|Vaccinated = number of participants who completed the vaccination|
59739310|NCT03803202|75858691|FG007|Vaccinated|Overall Study||97|Vaccinated = number of participants who completed the vaccination|
59739311|NCT03803202|75858692|FG008|Vaccinated|Overall Study||113|Vaccinated = number of participants who completed the vaccination|
59739312|NCT03803202|75858684|FG000|COMPLETED|Overall Study||30||
59739313|NCT03803202|75858685|FG001|COMPLETED|Overall Study||31||
59739314|NCT03803202|75858686|FG002|COMPLETED|Overall Study||31||
59739315|NCT03803202|75858687|FG003|COMPLETED|Overall Study||32||
59739316|NCT03803202|75858688|FG004|COMPLETED|Overall Study||99||
59739317|NCT03803202|75858689|FG005|COMPLETED|Overall Study||106||
59739318|NCT03803202|75858690|FG006|COMPLETED|Overall Study||85||
59739319|NCT03803202|75858691|FG007|COMPLETED|Overall Study||96||
59739320|NCT03803202|75858692|FG008|COMPLETED|Overall Study||113||
59739321|NCT03803202|75858684|FG000|NOT COMPLETED|Overall Study||0||
59739322|NCT03803202|75858685|FG001|NOT COMPLETED|Overall Study||1||
59739323|NCT03803202|75858686|FG002|NOT COMPLETED|Overall Study||1||
59739324|NCT03803202|75858687|FG003|NOT COMPLETED|Overall Study||1||
59739325|NCT03803202|75858688|FG004|NOT COMPLETED|Overall Study||1||
59739326|NCT03803202|75858689|FG005|NOT COMPLETED|Overall Study||1||
59739327|NCT03803202|75858690|FG006|NOT COMPLETED|Overall Study||1||
59739328|NCT03803202|75858691|FG007|NOT COMPLETED|Overall Study||1||
59739329|NCT03803202|75858692|FG008|NOT COMPLETED|Overall Study||0||
59739330|NCT03782727|75858726|FG000|STARTED|Overall Study||148||
59739331|NCT03782727|75858726|FG000|COMPLETED|Overall Study||116||
59739332|NCT03782727|75858726|FG000|NOT COMPLETED|Overall Study||32||
59739333|NCT03737812|75858733|FG000|STARTED|Overall Study||43||
59739334|NCT03737812|75858734|FG001|STARTED|Overall Study||40||
59739335|NCT03737812|75858735|FG002|STARTED|Overall Study||40||
59739336|NCT03737812|75858733|FG000|COMPLETED|Overall Study||38||
59739337|NCT03737812|75858734|FG001|COMPLETED|Overall Study||34||
59739338|NCT03737812|75858735|FG002|COMPLETED|Overall Study||36||
59739339|NCT03737812|75858733|FG000|NOT COMPLETED|Overall Study||5||
59739340|NCT03737812|75858734|FG001|NOT COMPLETED|Overall Study||6||
59739341|NCT03737812|75858735|FG002|NOT COMPLETED|Overall Study||4||
59739342|NCT03662659|75858745|FG000|STARTED|Pre-treatment||138|Started = Randomized|
59739343|NCT03662659|75858746|FG001|STARTED|Pre-treatment||136|Started = Randomized|
59739344|NCT03662659|75858745|FG000|COMPLETED|Pre-treatment||136|Completed = Treated|
59739345|NCT03662659|75858746|FG001|COMPLETED|Pre-treatment||135|Completed = Treated|
59739346|NCT03662659|75858745|FG000|NOT COMPLETED|Pre-treatment||2||
59739347|NCT03662659|75858746|FG001|NOT COMPLETED|Pre-treatment||1||
59739348|NCT03662659|75858745|FG000|STARTED|Treatment||136|Started = Treated|
59739349|NCT03662659|75858746|FG001|STARTED|Treatment||135|Started = Treated|
59739350|NCT03662659|75858745|FG000|COMPLETED|Treatment||21|Completed = Continuing treatment|
59739351|NCT03662659|75858746|FG001|COMPLETED|Treatment||29|Completed = Continuing treatment|
59739352|NCT03662659|75858745|FG000|NOT COMPLETED|Treatment||115||
59739353|NCT03662659|75858746|FG001|NOT COMPLETED|Treatment||106||
59739354|NCT03646123|75858755|FG000|STARTED|Overall Study||41||
59739355|NCT03646123|75858756|FG001|STARTED|Overall Study||58||
59739356|NCT03646123|75858757|FG002|STARTED|Overall Study||156||
59739357|NCT03646123|75858755|FG000|COMPLETED|Overall Study||31||
59739358|NCT03646123|75858756|FG001|COMPLETED|Overall Study||0||
59739359|NCT03646123|75858757|FG002|COMPLETED|Overall Study||0||
59739360|NCT03646123|75858755|FG000|NOT COMPLETED|Overall Study||10||
59739361|NCT03646123|75858756|FG001|NOT COMPLETED|Overall Study||58||
59739362|NCT03646123|75858757|FG002|NOT COMPLETED|Overall Study||156||
59739363|NCT03635424|75858765|FG000|STARTED|Overall Study||150||
59739364|NCT03635424|75858765|FG000|COMPLETED|Overall Study||147||
59739365|NCT03635424|75858765|FG000|NOT COMPLETED|Overall Study||3||
59739366|NCT03565367|75858771|FG000|STARTED|Overall Study||7||
59739367|NCT03565367|75858772|FG001|STARTED|Overall Study||2||
59739368|NCT03565367|75858771|FG000|Received Interventions|Overall Study||3||
59739369|NCT03565367|75858772|FG001|Received Interventions|Overall Study||2||
59739370|NCT03565367|75858771|FG000|COMPLETED|Overall Study||3||
59739371|NCT03565367|75858772|FG001|COMPLETED|Overall Study||2||
59739372|NCT03565367|75858771|FG000|NOT COMPLETED|Overall Study||4||
59739373|NCT03565367|75858772|FG001|NOT COMPLETED|Overall Study||0||
59739374|NCT03554317|75858778|FG000|STARTED|Overall Study||45||
59739375|NCT03554317|75858778|FG000|COMPLETED|Overall Study||37||
59739376|NCT03554317|75858778|FG000|NOT COMPLETED|Overall Study||8||
59739377|NCT03443687|75858784|FG000|STARTED|Overall Study||27||
59739378|NCT03443687|75858785|FG001|STARTED|Overall Study||27||
59739379|NCT03443687|75858784|FG000|COMPLETED|Overall Study||22||
59739380|NCT03443687|75858785|FG001|COMPLETED|Overall Study||21||
59739381|NCT03443687|75858784|FG000|NOT COMPLETED|Overall Study||5||
59739382|NCT03443687|75858785|FG001|NOT COMPLETED|Overall Study||6||
59739383|NCT03384654|75858795|FG000|STARTED|Overall Study||7||
59739384|NCT03384654|75858796|FG001|STARTED|Overall Study||24||
59739385|NCT03384654|75858797|FG002|STARTED|Overall Study||5||
59739386|NCT03384654|75858798|FG003|STARTED|Overall Study||10||
59739387|NCT03384654|75858795|FG000|COMPLETED|Overall Study||7||
59739388|NCT03384654|75858796|FG001|COMPLETED|Overall Study||24||
59739389|NCT03384654|75858797|FG002|COMPLETED|Overall Study||4||
59739390|NCT03384654|75858798|FG003|COMPLETED|Overall Study||10||
59739391|NCT03384654|75858795|FG000|NOT COMPLETED|Overall Study||0||
59739392|NCT03384654|75858796|FG001|NOT COMPLETED|Overall Study||0||
59739393|NCT03384654|75858797|FG002|NOT COMPLETED|Overall Study||1||
59739394|NCT03384654|75858798|FG003|NOT COMPLETED|Overall Study||0||
59739395|NCT03379168|75858814|FG000|STARTED|Overall Study||22||
59739396|NCT03379168|75858815|FG001|STARTED|Overall Study||23||
59739397|NCT03379168|75858816|FG002|STARTED|Overall Study||23||
59739398|NCT03379168|75858814|FG000|COMPLETED|Overall Study||18||
59739399|NCT03379168|75858815|FG001|COMPLETED|Overall Study||16||
59739400|NCT03379168|75858816|FG002|COMPLETED|Overall Study||18||
59739401|NCT03379168|75858814|FG000|NOT COMPLETED|Overall Study||4||
59739402|NCT03379168|75858815|FG001|NOT COMPLETED|Overall Study||7||
59739403|NCT03379168|75858816|FG002|NOT COMPLETED|Overall Study||5||
59739404|NCT03085485|75858826|FG000|STARTED|Overall Study||30||
59739405|NCT03085485|75858827|FG001|STARTED|Overall Study||10||
59739406|NCT03085485|75858826|FG000|COMPLETED|Overall Study||28||
59739407|NCT03085485|75858827|FG001|COMPLETED|Overall Study||10||
59739408|NCT03085485|75858826|FG000|NOT COMPLETED|Overall Study||2||
59739409|NCT03085485|75858827|FG001|NOT COMPLETED|Overall Study||0||
59739410|NCT03071861|75858835|FG000|STARTED|Overall Study||13||
59739411|NCT03071861|75858836|FG001|STARTED|Overall Study||15||
59739412|NCT03071861|75858835|FG000|COMPLETED|Overall Study||12||
59739413|NCT03071861|75858836|FG001|COMPLETED|Overall Study||14||
59739414|NCT03071861|75858835|FG000|NOT COMPLETED|Overall Study||1||
59739415|NCT03071861|75858836|FG001|NOT COMPLETED|Overall Study||1||
59739416|NCT03043872|75858845|FG000|STARTED|Overall Study||329|Randomized in overall study|
59739417|NCT03043872|75858846|FG001|STARTED|Overall Study||328|Randomized in overall study|
59739418|NCT03043872|75858847|FG002|STARTED|Overall Study||330|Randomized in overall study|
59739419|NCT03043872|75858845|FG000|Randomized and Included in Global Cohort Analysis|Overall Study||268||
59739420|NCT03043872|75858846|FG001|Randomized and Included in Global Cohort Analysis|Overall Study||268||
59739421|NCT03043872|75858847|FG002|Randomized and Included in Global Cohort Analysis|Overall Study||269||
59739422|NCT03043872|75858845|FG000|Received Treatment in Global Cohort|Overall Study||266||
59739423|NCT03043872|75858846|FG001|Received Treatment in Global Cohort|Overall Study||265||
59739424|NCT03043872|75858847|FG002|Received Treatment in Global Cohort|Overall Study||266||
59739425|NCT03043872|75858845|FG000|Randomized and Included in China Cohort Analysis|Overall Study||65||
59739426|NCT03043872|75858846|FG001|Randomized and Included in China Cohort Analysis|Overall Study||61||
59739427|NCT03043872|75858847|FG002|Randomized and Included in China Cohort Analysis|Overall Study||62||
59739428|NCT03043872|75858845|FG000|Received Treatment in China Cohort|Overall Study||65||
59739429|NCT03043872|75858846|FG001|Received Treatment in China Cohort|Overall Study||61||
59739430|NCT03043872|75858847|FG002|Received Treatment in China Cohort|Overall Study||62||
59739431|NCT03043872|75858845|FG000|Included in Both Cohorts (Global + China)|Overall Study||4||
59739432|NCT03043872|75858846|FG001|Included in Both Cohorts (Global + China)|Overall Study||1||
59739433|NCT03043872|75858847|FG002|Included in Both Cohorts (Global + China)|Overall Study||1||
59739434|NCT03043872|75858845|FG000|Ongoing Study at Global Cohort Final Analysis Data Cut-off (DCO)|Overall Study||56||
59739435|NCT03043872|75858846|FG001|Ongoing Study at Global Cohort Final Analysis Data Cut-off (DCO)|Overall Study||56||
59739436|NCT03043872|75858847|FG002|Ongoing Study at Global Cohort Final Analysis Data Cut-off (DCO)|Overall Study||31||
59739437|NCT03043872|75858845|FG000|Ongoing Study at China Cohort Second (Final) Analysis DCO|Overall Study||16||
59739438|NCT03043872|75858846|FG001|Ongoing Study at China Cohort Second (Final) Analysis DCO|Overall Study||11||
59739439|NCT03043872|75858847|FG002|Ongoing Study at China Cohort Second (Final) Analysis DCO|Overall Study||7||
59739440|NCT03043872|75858845|FG000|COMPLETED|Overall Study||51|Ongoing in overall study at long-term follow-up (LTFU) analysis DCO|
59739441|NCT03043872|75858846|FG001|COMPLETED|Overall Study||52|Ongoing in overall study at long-term follow-up (LTFU) analysis DCO|
59739442|NCT03043872|75858847|FG002|COMPLETED|Overall Study||18|Ongoing in overall study at long-term follow-up (LTFU) analysis DCO|
59739443|NCT03043872|75858845|FG000|NOT COMPLETED|Overall Study||278||
59739444|NCT03043872|75858846|FG001|NOT COMPLETED|Overall Study||276||
59739445|NCT03043872|75858847|FG002|NOT COMPLETED|Overall Study||312||
59739446|NCT02928224|75858869|FG000|STARTED|Overall Study||37||
59739447|NCT02928224|75858870|FG001|STARTED|Overall Study||224||
59739448|NCT02928224|75858871|FG002|STARTED|Overall Study||220||
59739449|NCT02928224|75858872|FG003|STARTED|Overall Study||221||
59739450|NCT02928224|75858869|FG000|Crossover Participants|Overall Study||0||
59739451|NCT02928224|75858870|FG001|Crossover Participants|Overall Study||0||
59739452|NCT02928224|75858871|FG002|Crossover Participants|Overall Study||0||
59739453|NCT02928224|75858872|FG003|Crossover Participants|Overall Study|Participants from control arm received triplet therapy.|3||
59739454|NCT02928224|75858869|FG000|COMPLETED|Overall Study||0||
59739455|NCT02928224|75858870|FG001|COMPLETED|Overall Study||0||
59739456|NCT02928224|75858871|FG002|COMPLETED|Overall Study||0||
59739457|NCT02928224|75858872|FG003|COMPLETED|Overall Study||0||
59739458|NCT02928224|75858869|FG000|NOT COMPLETED|Overall Study||37||
59739459|NCT02928224|75858870|FG001|NOT COMPLETED|Overall Study||224||
59739460|NCT02928224|75858871|FG002|NOT COMPLETED|Overall Study||220||
59739461|NCT02928224|75858872|FG003|NOT COMPLETED|Overall Study||221||
59739462|NCT02842086|75858891|FG000|STARTED|Overall Study||2700||
59739463|NCT02842086|75858892|FG001|STARTED|Overall Study||2699||
59739464|NCT02842086|75858891|FG000|COMPLETED|Overall Study||2156|Completed the Double Blind Phase|
59739465|NCT02842086|75858892|FG001|COMPLETED|Overall Study||2206|Completed the Double Blind Phase|
59739466|NCT02842086|75858891|FG000|NOT COMPLETED|Overall Study||544||
59739467|NCT02842086|75858892|FG001|NOT COMPLETED|Overall Study||493||
59739468|NCT02788474|75858900|FG000|STARTED|Double Blind Treatment Period||231|Randomised|
59739469|NCT02788474|75858901|FG001|STARTED|Double Blind Treatment Period||116|Randomised|
59739470|NCT02788474|75858900|FG000|Treated|Double Blind Treatment Period||230||
59739471|NCT02788474|75858901|FG001|Treated|Double Blind Treatment Period||116||
59739472|NCT02788474|75858900|FG000|COMPLETED|Double Blind Treatment Period||221||
59739473|NCT02788474|75858901|FG001|COMPLETED|Double Blind Treatment Period||112||
59739474|NCT02788474|75858900|FG000|NOT COMPLETED|Double Blind Treatment Period||10||
59739475|NCT02788474|75858901|FG001|NOT COMPLETED|Double Blind Treatment Period||4||
59739476|NCT02788474|75858900|FG000|STARTED|Open Label Treatment Period||221||
59739477|NCT02788474|75858901|FG001|STARTED|Open Label Treatment Period||112||
59739478|NCT02788474|75858900|FG000|COMPLETED|Open Label Treatment Period||189||
59739479|NCT02788474|75858901|FG001|COMPLETED|Open Label Treatment Period||100||
59739480|NCT02788474|75858900|FG000|NOT COMPLETED|Open Label Treatment Period||32||
59739481|NCT02788474|75858901|FG001|NOT COMPLETED|Open Label Treatment Period||12||
59739482|NCT02631746|75858908|FG000|STARTED|Overall Study||3||
59739483|NCT02631746|75858908|FG000|COMPLETED|Overall Study||0||
59739484|NCT02631746|75858908|FG000|NOT COMPLETED|Overall Study||3||
59739485|NCT02293655|75858914|FG000|STARTED|Overall Study||92||
59739486|NCT02293655|75858915|FG001|STARTED|Overall Study||17||
59739487|NCT02293655|75858914|FG000|COMPLETED|Overall Study||85||
59739488|NCT02293655|75858915|FG001|COMPLETED|Overall Study||15||
59739489|NCT02293655|75858914|FG000|NOT COMPLETED|Overall Study||7||
59739490|NCT02293655|75858915|FG001|NOT COMPLETED|Overall Study||2||
59739491|NCT02166463|75858925|FG000|STARTED|Overall Study||300||
59739492|NCT02166463|75858926|FG001|STARTED|Overall Study||300||
59739493|NCT02166463|75858925|FG000|COMPLETED|Overall Study||262||
59739494|NCT02166463|75858926|FG001|COMPLETED|Overall Study||273||
59739495|NCT02166463|75858925|FG000|NOT COMPLETED|Overall Study||38||
59739496|NCT02166463|75858926|FG001|NOT COMPLETED|Overall Study||27||
59739497|NCT02101034|75858937|FG000|STARTED|Overall Study||3||
59739498|NCT02101034|75858938|FG001|STARTED|Overall Study||6||
59739499|NCT02101034|75858939|FG002|STARTED|Overall Study||31||
59739500|NCT02101034|75858940|FG003|STARTED|Overall Study||32||
59739501|NCT02101034|75858941|FG004|STARTED|Overall Study||24||
59739502|NCT02101034|75858937|FG000|COMPLETED|Overall Study||3||
59739503|NCT02101034|75858938|FG001|COMPLETED|Overall Study||6||
59739504|NCT02101034|75858939|FG002|COMPLETED|Overall Study||30||
59739505|NCT02101034|75858940|FG003|COMPLETED|Overall Study||32||
59739506|NCT02101034|75858941|FG004|COMPLETED|Overall Study||24||
59739507|NCT02101034|75858937|FG000|NOT COMPLETED|Overall Study||0||
59739508|NCT02101034|75858938|FG001|NOT COMPLETED|Overall Study||0||
59739509|NCT02101034|75858939|FG002|NOT COMPLETED|Overall Study||1||
59739510|NCT02101034|75858940|FG003|NOT COMPLETED|Overall Study||0||
59739511|NCT02101034|75858941|FG004|NOT COMPLETED|Overall Study||0||
59739512|NCT02000622|75858964|FG000|STARTED|Overall Study||205||
59739513|NCT02000622|75858965|FG001|STARTED|Overall Study||97||
59739514|NCT02000622|75858964|FG000|COMPLETED|Overall Study||36||
59739515|NCT02000622|75858965|FG001|COMPLETED|Overall Study||17||
59739516|NCT02000622|75858964|FG000|NOT COMPLETED|Overall Study||169||
59739517|NCT02000622|75858965|FG001|NOT COMPLETED|Overall Study||80||
59739518|NCT00965991|75858973|FG000|STARTED|Overall Study||75||
59739519|NCT00965991|75858974|FG001|STARTED|Overall Study||74||
59739520|NCT00965991|75858973|FG000|COMPLETED|Overall Study||75||
59739521|NCT00965991|75858974|FG001|COMPLETED|Overall Study||74||
59739522|NCT00965991|75858973|FG000|NOT COMPLETED|Overall Study||0||
59739523|NCT00965991|75858974|FG001|NOT COMPLETED|Overall Study||0||
59739524|NCT00798135|75858980|FG000|STARTED|Overall Study||13||
59739525|NCT00798135|75858980|FG000|COMPLETED|Overall Study||0||
59739526|NCT00798135|75858980|FG000|NOT COMPLETED|Overall Study||13||
59739527|NCT00135226|75858988|FG000|STARTED|Overall Study||3870||
59739528|NCT00135226|75858989|FG001|STARTED|Overall Study||3870||
59739529|NCT00135226|75858990|FG002|STARTED|Overall Study||3870||
59739530|NCT00135226|75858991|FG003|STARTED|Overall Study||3870||
59739531|NCT00135226|75858988|FG000|COMPLETED|Overall Study||3836||
59739532|NCT00135226|75858989|FG001|COMPLETED|Overall Study||3835||
59739533|NCT00135226|75858990|FG002|COMPLETED|Overall Study||3836||
59739534|NCT00135226|75858991|FG003|COMPLETED|Overall Study||3834||
59739535|NCT00135226|75858988|FG000|NOT COMPLETED|Overall Study||34||
59739536|NCT00135226|75858989|FG001|NOT COMPLETED|Overall Study||35||
59739537|NCT00135226|75858990|FG002|NOT COMPLETED|Overall Study||34||
59739538|NCT00135226|75858991|FG003|NOT COMPLETED|Overall Study||36||
59739539|NCT00813358|75859003|FG000|STARTED|Overall Study||115||
59739540|NCT00813358|75859003|FG000|COMPLETED|Overall Study||46||
59739541|NCT00813358|75859003|FG000|NOT COMPLETED|Overall Study||69||
59739542|NCT00812812|75859009|FG000|STARTED|Overall Study||27||
59739543|NCT00812812|75859010|FG001|STARTED|Overall Study||29||
59739544|NCT00812812|75859009|FG000|COMPLETED|Overall Study||24||
59739545|NCT00812812|75859010|FG001|COMPLETED|Overall Study||25||
59739546|NCT00812812|75859009|FG000|NOT COMPLETED|Overall Study||3||
59739547|NCT00812812|75859010|FG001|NOT COMPLETED|Overall Study||4||
59739548|NCT00810082|75859020|FG000|STARTED|Overall Study||34||
59739549|NCT00810082|75859021|FG001|STARTED|Overall Study||31||
59739550|NCT00810082|75859020|FG000|COMPLETED|Overall Study||34||
59739551|NCT00810082|75859021|FG001|COMPLETED|Overall Study||27||
59739552|NCT00810082|75859020|FG000|NOT COMPLETED|Overall Study||0||
59739553|NCT00810082|75859021|FG001|NOT COMPLETED|Overall Study||4||
59739554|NCT00748189|75859029|FG000|STARTED|Overall Study||226||
59739555|NCT00748189|75859030|FG001|STARTED|Overall Study||221||
59739556|NCT00748189|75859029|FG000|COMPLETED|Overall Study||10||
59739557|NCT00748189|75859030|FG001|COMPLETED|Overall Study||9||
59739558|NCT00748189|75859029|FG000|NOT COMPLETED|Overall Study||216||
59739559|NCT00748189|75859030|FG001|NOT COMPLETED|Overall Study||212||
59739560|NCT00744055|75859043|FG000|STARTED|Overall Study||50||
59739561|NCT00744055|75859044|FG001|STARTED|Overall Study||46||
59739562|NCT00744055|75859043|FG000|COMPLETED|Overall Study||43||
59739563|NCT00744055|75859044|FG001|COMPLETED|Overall Study||32||
59739564|NCT00744055|75859043|FG000|NOT COMPLETED|Overall Study||7||
59739565|NCT00744055|75859044|FG001|NOT COMPLETED|Overall Study||14||
59739566|NCT00748033|75859052|FG000|STARTED|Overall Study||12||
59739567|NCT00748033|75859053|FG001|STARTED|Overall Study||13||
59739568|NCT00748033|75859052|FG000|COMPLETED|Overall Study||12||
59739569|NCT00748033|75859053|FG001|COMPLETED|Overall Study|One subject participated only in 2 arms due to an adverse event.|12||
59739570|NCT00748033|75859052|FG000|NOT COMPLETED|Overall Study||0||
59739571|NCT00748033|75859053|FG001|NOT COMPLETED|Overall Study||1||
59739572|NCT00735553|75859070|FG000|STARTED|Overall Study||77||
59739573|NCT00735553|75859070|FG000|COMPLETED|Overall Study||0||
59739574|NCT00735553|75859070|FG000|NOT COMPLETED|Overall Study||77||
59739575|NCT00740779|75859081|FG000|STARTED|Overall Study||52||
59739576|NCT00740779|75859082|FG001|STARTED|Overall Study||45||
59739577|NCT00740779|75859083|FG002|STARTED|Overall Study||54||
59604276|NCT02059434|75714649|FG002|NOT COMPLETED|Washout Between Periods 5 and 6||0||
59604277|NCT02059434|75714650|FG003|NOT COMPLETED|Washout Between Periods 5 and 6||0||
59604278|NCT02059434|75714651|FG004|NOT COMPLETED|Washout Between Periods 5 and 6||0||
59604279|NCT02059434|75714652|FG005|NOT COMPLETED|Washout Between Periods 5 and 6||0||
59604280|NCT02059434|75714653|FG006|NOT COMPLETED|Washout Between Periods 5 and 6||0||
59604281|NCT02059434|75714654|FG007|NOT COMPLETED|Washout Between Periods 5 and 6||0||
59604282|NCT02059434|75714655|FG008|NOT COMPLETED|Washout Between Periods 5 and 6||0||
59604283|NCT02059434|75714647|FG000|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0||
59604284|NCT02059434|75714648|FG001|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0||
59604285|NCT02059434|75714649|FG002|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0||
59604286|NCT02059434|75714650|FG003|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0||
59604287|NCT02059434|75714651|FG004|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0||
59604288|NCT02059434|75714652|FG005|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0||
59604289|NCT02059434|75714653|FG006|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0||
59604290|NCT02059434|75714654|FG007|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0||
59604291|NCT02059434|75714655|FG008|STARTED|Period 6||37||
59604292|NCT02059434|75714647|FG000|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0||
59604293|NCT02059434|75714648|FG001|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0||
59604294|NCT02059434|75714649|FG002|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0||
59604295|NCT02059434|75714650|FG003|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0||
59604296|NCT02059434|75714651|FG004|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0||
59604297|NCT02059434|75714652|FG005|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0||
59604298|NCT02059434|75714653|FG006|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0||
59604299|NCT02059434|75714654|FG007|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0||
59604300|NCT02059434|75714655|FG008|COMPLETED|Period 6||37||
59604301|NCT02059434|75714647|FG000|NOT COMPLETED|Period 6||0||
59604302|NCT02059434|75714648|FG001|NOT COMPLETED|Period 6||0||
59604303|NCT02059434|75714649|FG002|NOT COMPLETED|Period 6||0||
59604304|NCT02059434|75714650|FG003|NOT COMPLETED|Period 6||0||
59604305|NCT02059434|75714651|FG004|NOT COMPLETED|Period 6||0||
59604306|NCT02059434|75714652|FG005|NOT COMPLETED|Period 6||0||
59604307|NCT02059434|75714653|FG006|NOT COMPLETED|Period 6||0||
59604308|NCT02059434|75714654|FG007|NOT COMPLETED|Period 6||0||
59604309|NCT02059434|75714655|FG008|NOT COMPLETED|Period 6||0||
59604310|NCT02059434|75714647|FG000|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0||
59604311|NCT02059434|75714648|FG001|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0||
59604312|NCT02059434|75714649|FG002|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0||
59604313|NCT02059434|75714650|FG003|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0||
59604314|NCT02059434|75714651|FG004|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0||
59604315|NCT02059434|75714652|FG005|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0||
59604316|NCT02059434|75714653|FG006|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0||
59604317|NCT02059434|75714654|FG007|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0||
59604318|NCT02059434|75714655|FG008|STARTED|Washout Between Periods 6 and 7||37||
59604319|NCT02059434|75714647|FG000|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0||
59604320|NCT02059434|75714648|FG001|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0||
59604321|NCT02059434|75714649|FG002|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0||
59604322|NCT02059434|75714650|FG003|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0||
59613440|NCT01592760|75724573|FG002|NOT COMPLETED|Perioperative to Discharge||0||
59613441|NCT01592760|75724571|FG000|STARTED|24-hour Follow-Up||90||
59613442|NCT01592760|75724572|FG001|STARTED|24-hour Follow-Up||90||
59613443|NCT01592760|75724573|FG002|STARTED|24-hour Follow-Up||45||
59613444|NCT01592760|75724571|FG000|COMPLETED|24-hour Follow-Up||86||
59613445|NCT01592760|75724572|FG001|COMPLETED|24-hour Follow-Up||87||
59613446|NCT01592760|75724573|FG002|COMPLETED|24-hour Follow-Up||43||
59613447|NCT01592760|75724571|FG000|NOT COMPLETED|24-hour Follow-Up||4||
59613448|NCT01592760|75724572|FG001|NOT COMPLETED|24-hour Follow-Up||3||
59613449|NCT01592760|75724573|FG002|NOT COMPLETED|24-hour Follow-Up||2||
59613450|NCT01696188|75724586|FG000|STARTED|Overall Study||41||
59739578|NCT00740779|75859081|FG000|COMPLETED|Overall Study||43||
59739579|NCT00740779|75859082|FG001|COMPLETED|Overall Study||31||
59739580|NCT00740779|75859083|FG002|COMPLETED|Overall Study||41||
59739581|NCT00740779|75859081|FG000|NOT COMPLETED|Overall Study||9||
59739582|NCT00740779|75859082|FG001|NOT COMPLETED|Overall Study||14||
59739583|NCT00740779|75859083|FG002|NOT COMPLETED|Overall Study||13||
59739584|NCT00735475|75859093|FG000|STARTED|Overall Study||631||
59739585|NCT00735475|75859094|FG001|STARTED|Overall Study||637||
59739586|NCT00735475|75859093|FG000|COMPLETED|Overall Study||623||
59739587|NCT00735475|75859094|FG001|COMPLETED|Overall Study||626||
59739588|NCT00735475|75859093|FG000|NOT COMPLETED|Overall Study||8||
59739589|NCT00735475|75859094|FG001|NOT COMPLETED|Overall Study||11||
59739590|NCT01026818|75859103|FG000|STARTED|Screening Period||583||
59739591|NCT01026818|75859104|FG001|STARTED|Screening Period||0||
59739592|NCT01026818|75859105|FG002|STARTED|Screening Period||0||
59739593|NCT01026818|75859106|FG003|STARTED|Screening Period||0||
59739594|NCT01026818|75859103|FG000|COMPLETED|Screening Period||423||
59739595|NCT01026818|75859104|FG001|COMPLETED|Screening Period||0||
59739596|NCT01026818|75859105|FG002|COMPLETED|Screening Period||0||
59739597|NCT01026818|75859106|FG003|COMPLETED|Screening Period||0||
59739598|NCT01026818|75859103|FG000|NOT COMPLETED|Screening Period||160||
59739599|NCT01026818|75859104|FG001|NOT COMPLETED|Screening Period||0||
59739600|NCT01026818|75859105|FG002|NOT COMPLETED|Screening Period||0||
59739601|NCT01026818|75859106|FG003|NOT COMPLETED|Screening Period||0||
59739602|NCT01026818|75859103|FG000|STARTED|DB Treatment Period (Month 0 - 9)||0||
59739603|NCT01026818|75859104|FG001|STARTED|DB Treatment Period (Month 0 - 9)||139||
59739604|NCT01026818|75859105|FG002|STARTED|DB Treatment Period (Month 0 - 9)||143||
59739605|NCT01026818|75859106|FG003|STARTED|DB Treatment Period (Month 0 - 9)||141||
59739606|NCT01026818|75859103|FG000|Received at Least 1 Dose of Study Drug|DB Treatment Period (Month 0 - 9)||0||
59739607|NCT01026818|75859104|FG001|Received at Least 1 Dose of Study Drug|DB Treatment Period (Month 0 - 9)||139||
59739608|NCT01026818|75859105|FG002|Received at Least 1 Dose of Study Drug|DB Treatment Period (Month 0 - 9)||143||
59739609|NCT01026818|75859106|FG003|Received at Least 1 Dose of Study Drug|DB Treatment Period (Month 0 - 9)||141||
59739610|NCT01026818|75859103|FG000|COMPLETED|DB Treatment Period (Month 0 - 9)||0||
59739611|NCT01026818|75859104|FG001|COMPLETED|DB Treatment Period (Month 0 - 9)||114||
59739612|NCT01026818|75859105|FG002|COMPLETED|DB Treatment Period (Month 0 - 9)||122||
59739613|NCT01026818|75859106|FG003|COMPLETED|DB Treatment Period (Month 0 - 9)||115||
59739614|NCT01026818|75859103|FG000|NOT COMPLETED|DB Treatment Period (Month 0 - 9)||0||
59739615|NCT01026818|75859104|FG001|NOT COMPLETED|DB Treatment Period (Month 0 - 9)||25||
59739616|NCT01026818|75859105|FG002|NOT COMPLETED|DB Treatment Period (Month 0 - 9)||21||
59739617|NCT01026818|75859106|FG003|NOT COMPLETED|DB Treatment Period (Month 0 - 9)||26||
59739618|NCT01026818|75859103|FG000|STARTED|Drug-Free Washout Period (Month 9-10.5)||0||
59739619|NCT01026818|75859104|FG001|STARTED|Drug-Free Washout Period (Month 9-10.5)||114||
59739620|NCT01026818|75859105|FG002|STARTED|Drug-Free Washout Period (Month 9-10.5)||122||
59739621|NCT01026818|75859106|FG003|STARTED|Drug-Free Washout Period (Month 9-10.5)||115||
59739622|NCT01026818|75859103|FG000|COMPLETED|Drug-Free Washout Period (Month 9-10.5)||0||
59739623|NCT01026818|75859104|FG001|COMPLETED|Drug-Free Washout Period (Month 9-10.5)||105||
59739624|NCT01026818|75859105|FG002|COMPLETED|Drug-Free Washout Period (Month 9-10.5)||117||
59739625|NCT01026818|75859106|FG003|COMPLETED|Drug-Free Washout Period (Month 9-10.5)||108||
59739626|NCT01026818|75859103|FG000|NOT COMPLETED|Drug-Free Washout Period (Month 9-10.5)||0||
59739627|NCT01026818|75859104|FG001|NOT COMPLETED|Drug-Free Washout Period (Month 9-10.5)||9||
59739628|NCT01026818|75859105|FG002|NOT COMPLETED|Drug-Free Washout Period (Month 9-10.5)||5||
59739629|NCT01026818|75859106|FG003|NOT COMPLETED|Drug-Free Washout Period (Month 9-10.5)||7||
59739630|NCT01026818|75859103|FG000|STARTED|OL Period (Month 10.5 - 13.5)||0||
59739631|NCT01026818|75859104|FG001|STARTED|OL Period (Month 10.5 - 13.5)||105||
59739632|NCT01026818|75859105|FG002|STARTED|OL Period (Month 10.5 - 13.5)||117||
59739633|NCT01026818|75859106|FG003|STARTED|OL Period (Month 10.5 - 13.5)||108||
59739634|NCT01026818|75859103|FG000|COMPLETED|OL Period (Month 10.5 - 13.5)||0||
59739635|NCT01026818|75859104|FG001|COMPLETED|OL Period (Month 10.5 - 13.5)||98||
59739636|NCT01026818|75859105|FG002|COMPLETED|OL Period (Month 10.5 - 13.5)||112||
59739637|NCT01026818|75859106|FG003|COMPLETED|OL Period (Month 10.5 - 13.5)||105||
59739638|NCT01026818|75859103|FG000|NOT COMPLETED|OL Period (Month 10.5 - 13.5)||0||
59739639|NCT01026818|75859104|FG001|NOT COMPLETED|OL Period (Month 10.5 - 13.5)||7||
59739640|NCT01026818|75859105|FG002|NOT COMPLETED|OL Period (Month 10.5 - 13.5)||5||
59739641|NCT01026818|75859106|FG003|NOT COMPLETED|OL Period (Month 10.5 - 13.5)||3||
59739642|NCT00735397|75859118|FG000|STARTED|Overall Study||1218||
59739643|NCT00735397|75859118|FG000|COMPLETED|Overall Study||35||
59739644|NCT00735397|75859118|FG000|NOT COMPLETED|Overall Study||1183||
59739645|NCT00735007|75859125|FG000|STARTED|Overall Study||106||
59739646|NCT00735007|75859125|FG000|COMPLETED|Overall Study||101||
59739647|NCT00735007|75859125|FG000|NOT COMPLETED|Overall Study||5||
59739648|NCT00743509|75859129|FG000|STARTED|Overall Study||49||
59739649|NCT00743509|75859129|FG000|COMPLETED|Overall Study||47||
59739650|NCT00743509|75859129|FG000|NOT COMPLETED|Overall Study||2||
59739651|NCT00734929|75859135|FG000|STARTED|Overall Study||57||
59739652|NCT00734929|75859136|FG001|STARTED|Overall Study||58||
59739653|NCT00734929|75859135|FG000|COMPLETED|Overall Study||51||
59739654|NCT00734929|75859136|FG001|COMPLETED|Overall Study||53||
59739655|NCT00734929|75859135|FG000|NOT COMPLETED|Overall Study||6||
59739656|NCT00734929|75859136|FG001|NOT COMPLETED|Overall Study||5||
59739657|NCT00734851|75859144|FG000|STARTED|Overall Study||34||
59739658|NCT00734851|75859144|FG000|COMPLETED|Overall Study||13||
59739659|NCT00734851|75859144|FG000|NOT COMPLETED|Overall Study||21||
59739660|NCT00734617|75859150|FG000|STARTED|Overall Study||249||
59739661|NCT00734617|75859151|FG001|STARTED|Overall Study||230||
59739662|NCT00734617|75859150|FG000|COMPLETED|Overall Study||142||
59739663|NCT00734617|75859151|FG001|COMPLETED|Overall Study||128||
59739664|NCT00734617|75859150|FG000|NOT COMPLETED|Overall Study||107||
59739665|NCT00734617|75859151|FG001|NOT COMPLETED|Overall Study||102||
59739666|NCT00743431|75859157|FG000|STARTED|Overall Study||224||
59739667|NCT00743431|75859157|FG000|COMPLETED|Overall Study||98||
59739668|NCT00743431|75859157|FG000|NOT COMPLETED|Overall Study||126||
59739669|NCT00734539|75859163|FG000|STARTED|Main Study||189||
59739670|NCT00734539|75859164|FG001|STARTED|Main Study||173||
59739671|NCT00734539|75859163|FG000|COMPLETED|Main Study|Number of subjects who participated through hospital discharge or study end|152||
59739672|NCT00734539|75859164|FG001|COMPLETED|Main Study|Number of subjects who participated through hospital discharge or study end|138||
59739673|NCT00734539|75859163|FG000|NOT COMPLETED|Main Study||37||
59739674|NCT00734539|75859164|FG001|NOT COMPLETED|Main Study||35||
59739675|NCT00734539|75859163|FG000|STARTED|Long Term Follow up||152||
59739676|NCT00734539|75859164|FG001|STARTED|Long Term Follow up||138||
59739677|NCT00734539|75859163|FG000|COMPLETED|Long Term Follow up|Number of participants who completed the 18-22 months follow-up|118||
59739678|NCT00734539|75859164|FG001|COMPLETED|Long Term Follow up|Number of participants who completed the 18-22 months follow-up|107||
59739679|NCT00734539|75859163|FG000|NOT COMPLETED|Long Term Follow up||34||
59739680|NCT00734539|75859164|FG001|NOT COMPLETED|Long Term Follow up||31||
59739681|NCT00743275|75859175|FG000|STARTED|Overall Study||59||
59739682|NCT00743275|75859176|FG001|STARTED|Overall Study||61||
59739683|NCT00743275|75859175|FG000|COMPLETED|Overall Study||59||
59739684|NCT00743275|75859176|FG001|COMPLETED|Overall Study||60||
59739685|NCT00743275|75859175|FG000|NOT COMPLETED|Overall Study||0||
59739686|NCT00743275|75859176|FG001|NOT COMPLETED|Overall Study||1||
59739687|NCT00743197|75859184|FG000|STARTED|Overall Study||1||
59739688|NCT00743197|75859185|FG001|STARTED|Overall Study||2||
59739689|NCT00743197|75859184|FG000|COMPLETED|Overall Study||0||
59739690|NCT00743197|75859185|FG001|COMPLETED|Overall Study||0||
59739691|NCT00743197|75859184|FG000|NOT COMPLETED|Overall Study||1||
59739692|NCT00743197|75859185|FG001|NOT COMPLETED|Overall Study||2||
59739693|NCT00734071|75859193|FG000|STARTED|Overall Study||152||
59739694|NCT00734071|75859194|FG001|STARTED|Overall Study||152||
59739695|NCT00734071|75859193|FG000|Treated|Overall Study||151||
59739696|NCT00734071|75859194|FG001|Treated|Overall Study||148||
59739697|NCT00734071|75859193|FG000|COMPLETED|Overall Study||114||
59739698|NCT00734071|75859194|FG001|COMPLETED|Overall Study||125||
59739699|NCT00734071|75859193|FG000|NOT COMPLETED|Overall Study||38||
59739700|NCT00734071|75859194|FG001|NOT COMPLETED|Overall Study||27||
59739701|NCT00739297|75859200|FG000|STARTED|First Intervention (Visit 3 to Visit 4)||17||
60134800|NCT03606512|76258062|FG000|COMPLETED|Overall Study||18||
60134801|NCT03606512|76258063|FG001|COMPLETED|Overall Study||18||
60134802|NCT03606512|76258062|FG000|NOT COMPLETED|Overall Study||0||
59739702|NCT00739297|75859201|FG001|STARTED|First Intervention (Visit 3 to Visit 4)||11||
60134803|NCT03606512|76258063|FG001|NOT COMPLETED|Overall Study||2||
60134804|NCT03490344|76258076|FG000|STARTED|Overall Study||10||
60134805|NCT03490344|76258076|FG000|COMPLETED|Overall Study||10||
60134806|NCT03490344|76258076|FG000|NOT COMPLETED|Overall Study||0||
60134807|NCT03417739|76258080|FG000|STARTED|Overall Study||13||
60134808|NCT03417739|76258080|FG000|COMPLETED|Overall Study||13||
59739703|NCT00739297|75859202|FG002|STARTED|First Intervention (Visit 3 to Visit 4)||6||
59739704|NCT00739297|75859203|FG003|STARTED|First Intervention (Visit 3 to Visit 4)||19||
59739705|NCT00739297|75859204|FG004|STARTED|First Intervention (Visit 3 to Visit 4)||6||
59739706|NCT00739297|75859205|FG005|STARTED|First Intervention (Visit 3 to Visit 4)||9||
59739707|NCT00739297|75859206|FG006|STARTED|First Intervention (Visit 3 to Visit 4)||68||
59739708|NCT00739297|75859200|FG000|COMPLETED|First Intervention (Visit 3 to Visit 4)||17||
59739709|NCT00739297|75859201|FG001|COMPLETED|First Intervention (Visit 3 to Visit 4)||11||
59739710|NCT00739297|75859202|FG002|COMPLETED|First Intervention (Visit 3 to Visit 4)||6||
59739711|NCT00739297|75859203|FG003|COMPLETED|First Intervention (Visit 3 to Visit 4)||19||
59739712|NCT00739297|75859204|FG004|COMPLETED|First Intervention (Visit 3 to Visit 4)||6||
59739713|NCT00739297|75859205|FG005|COMPLETED|First Intervention (Visit 3 to Visit 4)||9||
59739714|NCT00739297|75859206|FG006|COMPLETED|First Intervention (Visit 3 to Visit 4)||68||
59739715|NCT00739297|75859200|FG000|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0||
59739716|NCT00739297|75859201|FG001|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0||
59739717|NCT00739297|75859202|FG002|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0||
59739718|NCT00739297|75859203|FG003|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0||
59739719|NCT00739297|75859204|FG004|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0||
59739720|NCT00739297|75859205|FG005|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0||
60134809|NCT03417739|76258080|FG000|NOT COMPLETED|Overall Study||0||
60134810|NCT03398200|76258086|FG000|STARTED|Overall Study||52||
60134811|NCT03398200|76258087|FG001|STARTED|Overall Study||47||
59739721|NCT00739297|75859206|FG006|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0||
59739722|NCT00739297|75859200|FG000|STARTED|First Washout Period of 4-7 Days||17||
59739723|NCT00739297|75859201|FG001|STARTED|First Washout Period of 4-7 Days||11||
59739724|NCT00739297|75859202|FG002|STARTED|First Washout Period of 4-7 Days||6||
59739725|NCT00739297|75859203|FG003|STARTED|First Washout Period of 4-7 Days||19||
59739726|NCT00739297|75859204|FG004|STARTED|First Washout Period of 4-7 Days||6||
59739727|NCT00739297|75859205|FG005|STARTED|First Washout Period of 4-7 Days||9||
59739728|NCT00739297|75859206|FG006|STARTED|First Washout Period of 4-7 Days||68||
59739729|NCT00739297|75859200|FG000|COMPLETED|First Washout Period of 4-7 Days||17||
59739730|NCT00739297|75859201|FG001|COMPLETED|First Washout Period of 4-7 Days||11||
59739731|NCT00739297|75859202|FG002|COMPLETED|First Washout Period of 4-7 Days||6||
59739732|NCT00739297|75859203|FG003|COMPLETED|First Washout Period of 4-7 Days||17||
59739733|NCT00739297|75859204|FG004|COMPLETED|First Washout Period of 4-7 Days||6||
59739734|NCT00739297|75859205|FG005|COMPLETED|First Washout Period of 4-7 Days||9||
59739735|NCT00739297|75859206|FG006|COMPLETED|First Washout Period of 4-7 Days||66||
59739736|NCT00739297|75859200|FG000|NOT COMPLETED|First Washout Period of 4-7 Days||0||
59739737|NCT00739297|75859201|FG001|NOT COMPLETED|First Washout Period of 4-7 Days||0||
59739738|NCT00739297|75859202|FG002|NOT COMPLETED|First Washout Period of 4-7 Days||0||
59739739|NCT00739297|75859203|FG003|NOT COMPLETED|First Washout Period of 4-7 Days||2||
59739740|NCT00739297|75859204|FG004|NOT COMPLETED|First Washout Period of 4-7 Days||0||
59739741|NCT00739297|75859205|FG005|NOT COMPLETED|First Washout Period of 4-7 Days||0||
59739742|NCT00739297|75859206|FG006|NOT COMPLETED|First Washout Period of 4-7 Days||2||
59739743|NCT00739297|75859200|FG000|STARTED|Second Intervention (Visit 5 to Visit 6)||18||
59739744|NCT00739297|75859201|FG001|STARTED|Second Intervention (Visit 5 to Visit 6)||8||
59739745|NCT00739297|75859202|FG002|STARTED|Second Intervention (Visit 5 to Visit 6)||10||
59739746|NCT00739297|75859203|FG003|STARTED|Second Intervention (Visit 5 to Visit 6)||14||
59739747|NCT00739297|75859204|FG004|STARTED|Second Intervention (Visit 5 to Visit 6)||6||
59739748|NCT00739297|75859205|FG005|STARTED|Second Intervention (Visit 5 to Visit 6)||10||
59739749|NCT00739297|75859206|FG006|STARTED|Second Intervention (Visit 5 to Visit 6)||66||
59739750|NCT00739297|75859200|FG000|COMPLETED|Second Intervention (Visit 5 to Visit 6)||18||
59739751|NCT00739297|75859201|FG001|COMPLETED|Second Intervention (Visit 5 to Visit 6)||8||
59739752|NCT00739297|75859202|FG002|COMPLETED|Second Intervention (Visit 5 to Visit 6)||10||
59739753|NCT00739297|75859203|FG003|COMPLETED|Second Intervention (Visit 5 to Visit 6)||14||
59739754|NCT00739297|75859204|FG004|COMPLETED|Second Intervention (Visit 5 to Visit 6)||6||
59739755|NCT00739297|75859205|FG005|COMPLETED|Second Intervention (Visit 5 to Visit 6)||10||
59739756|NCT00739297|75859206|FG006|COMPLETED|Second Intervention (Visit 5 to Visit 6)||66||
59739757|NCT00739297|75859200|FG000|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0||
59739758|NCT00739297|75859201|FG001|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0||
59739759|NCT00739297|75859202|FG002|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0||
59739760|NCT00739297|75859203|FG003|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0||
59739761|NCT00739297|75859204|FG004|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0||
59739762|NCT00739297|75859205|FG005|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0||
59739763|NCT00739297|75859206|FG006|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0||
59739764|NCT00739297|75859200|FG000|STARTED|Second Washout Period of 4-7 Days||18||
59739765|NCT00739297|75859201|FG001|STARTED|Second Washout Period of 4-7 Days||8||
59739766|NCT00739297|75859202|FG002|STARTED|Second Washout Period of 4-7 Days||10||
59739767|NCT00739297|75859203|FG003|STARTED|Second Washout Period of 4-7 Days||14||
59739768|NCT00739297|75859204|FG004|STARTED|Second Washout Period of 4-7 Days||6||
59739769|NCT00739297|75859205|FG005|STARTED|Second Washout Period of 4-7 Days||10||
59739770|NCT00739297|75859206|FG006|STARTED|Second Washout Period of 4-7 Days||66||
59739771|NCT00739297|75859200|FG000|COMPLETED|Second Washout Period of 4-7 Days||18||
59739772|NCT00739297|75859201|FG001|COMPLETED|Second Washout Period of 4-7 Days||8||
59739773|NCT00739297|75859202|FG002|COMPLETED|Second Washout Period of 4-7 Days||10||
59739774|NCT00739297|75859203|FG003|COMPLETED|Second Washout Period of 4-7 Days||14||
59739775|NCT00739297|75859204|FG004|COMPLETED|Second Washout Period of 4-7 Days||6||
59739776|NCT00739297|75859205|FG005|COMPLETED|Second Washout Period of 4-7 Days||10||
59739777|NCT00739297|75859206|FG006|COMPLETED|Second Washout Period of 4-7 Days||66||
60134812|NCT03398200|76258086|FG000|COMPLETED|Overall Study||52||
60134813|NCT03398200|76258087|FG001|COMPLETED|Overall Study||46||
59739778|NCT00739297|75859200|FG000|NOT COMPLETED|Second Washout Period of 4-7 Days||0||
59739779|NCT00739297|75859201|FG001|NOT COMPLETED|Second Washout Period of 4-7 Days||0||
59739780|NCT00739297|75859202|FG002|NOT COMPLETED|Second Washout Period of 4-7 Days||0||
59739781|NCT00739297|75859203|FG003|NOT COMPLETED|Second Washout Period of 4-7 Days||0||
59739782|NCT00739297|75859204|FG004|NOT COMPLETED|Second Washout Period of 4-7 Days||0||
59739783|NCT00739297|75859205|FG005|NOT COMPLETED|Second Washout Period of 4-7 Days||0||
59739784|NCT00739297|75859206|FG006|NOT COMPLETED|Second Washout Period of 4-7 Days||0||
59739785|NCT00739297|75859200|FG000|STARTED|Third Intervention (Visit 7 to Visit 8)||16||
59739786|NCT00739297|75859201|FG001|STARTED|Third Intervention (Visit 7 to Visit 8)||12||
60134814|NCT03398200|76258086|FG000|NOT COMPLETED|Overall Study||0||
59739787|NCT00739297|75859202|FG002|STARTED|Third Intervention (Visit 7 to Visit 8)||6||
59739788|NCT00739297|75859203|FG003|STARTED|Third Intervention (Visit 7 to Visit 8)||18||
59739789|NCT00739297|75859204|FG004|STARTED|Third Intervention (Visit 7 to Visit 8)||6||
59739790|NCT00739297|75859205|FG005|STARTED|Third Intervention (Visit 7 to Visit 8)||8||
59739791|NCT00739297|75859206|FG006|STARTED|Third Intervention (Visit 7 to Visit 8)||66||
59739792|NCT00739297|75859200|FG000|COMPLETED|Third Intervention (Visit 7 to Visit 8)||16||
59739793|NCT00739297|75859201|FG001|COMPLETED|Third Intervention (Visit 7 to Visit 8)||12||
59739794|NCT00739297|75859202|FG002|COMPLETED|Third Intervention (Visit 7 to Visit 8)||6||
60134815|NCT03398200|76258087|FG001|NOT COMPLETED|Overall Study||1||
60134816|NCT03338621|76258096|FG000|STARTED|Overall Study||150||
60134817|NCT03338621|76258097|FG001|STARTED|Overall Study||153||
60134818|NCT03338621|76258098|FG002|STARTED|Overall Study||152||
59739795|NCT00739297|75859203|FG003|COMPLETED|Third Intervention (Visit 7 to Visit 8)||18||
59739796|NCT00739297|75859204|FG004|COMPLETED|Third Intervention (Visit 7 to Visit 8)||6||
59739797|NCT00739297|75859205|FG005|COMPLETED|Third Intervention (Visit 7 to Visit 8)||8||
59739798|NCT00739297|75859206|FG006|COMPLETED|Third Intervention (Visit 7 to Visit 8)||66||
59739799|NCT00739297|75859200|FG000|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0||
59739800|NCT00739297|75859201|FG001|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0||
59739801|NCT00739297|75859202|FG002|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0||
59739802|NCT00739297|75859203|FG003|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0||
59739803|NCT00739297|75859204|FG004|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0||
59739804|NCT00739297|75859205|FG005|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0||
59739805|NCT00739297|75859206|FG006|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0||
59739806|NCT00739297|75859200|FG000|STARTED|Third Washout Period of 4-7 Days||16||
60134819|NCT03338621|76258096|FG000|COMPLETED|Overall Study||121||
59739807|NCT00739297|75859201|FG001|STARTED|Third Washout Period of 4-7 Days||12||
59739808|NCT00739297|75859202|FG002|STARTED|Third Washout Period of 4-7 Days||6||
59739809|NCT00739297|75859203|FG003|STARTED|Third Washout Period of 4-7 Days||18||
59739810|NCT00739297|75859204|FG004|STARTED|Third Washout Period of 4-7 Days||6||
59739811|NCT00739297|75859205|FG005|STARTED|Third Washout Period of 4-7 Days||8||
59739812|NCT00739297|75859206|FG006|STARTED|Third Washout Period of 4-7 Days||66||
59739813|NCT00739297|75859200|FG000|COMPLETED|Third Washout Period of 4-7 Days||16||
59739814|NCT00739297|75859201|FG001|COMPLETED|Third Washout Period of 4-7 Days||12||
59739815|NCT00739297|75859202|FG002|COMPLETED|Third Washout Period of 4-7 Days||6||
59739816|NCT00739297|75859203|FG003|COMPLETED|Third Washout Period of 4-7 Days||18||
59739817|NCT00739297|75859204|FG004|COMPLETED|Third Washout Period of 4-7 Days||6||
59739818|NCT00739297|75859205|FG005|COMPLETED|Third Washout Period of 4-7 Days||8||
59739819|NCT00739297|75859206|FG006|COMPLETED|Third Washout Period of 4-7 Days||66||
59739820|NCT00739297|75859200|FG000|NOT COMPLETED|Third Washout Period of 4-7 Days||0||
59739821|NCT00739297|75859201|FG001|NOT COMPLETED|Third Washout Period of 4-7 Days||0||
59739822|NCT00739297|75859202|FG002|NOT COMPLETED|Third Washout Period of 4-7 Days||0||
59739823|NCT00739297|75859203|FG003|NOT COMPLETED|Third Washout Period of 4-7 Days||0||
59739824|NCT00739297|75859204|FG004|NOT COMPLETED|Third Washout Period of 4-7 Days||0||
59739825|NCT00739297|75859205|FG005|NOT COMPLETED|Third Washout Period of 4-7 Days||0||
59739826|NCT00739297|75859206|FG006|NOT COMPLETED|Third Washout Period of 4-7 Days||0||
59739827|NCT00739297|75859200|FG000|STARTED|Fourth Intervention(Visit 9 to Visit 10)||16||
59739828|NCT00739297|75859201|FG001|STARTED|Fourth Intervention(Visit 9 to Visit 10)||11||
59739829|NCT00739297|75859202|FG002|STARTED|Fourth Intervention(Visit 9 to Visit 10)||8||
59739830|NCT00739297|75859203|FG003|STARTED|Fourth Intervention(Visit 9 to Visit 10)||15||
59739831|NCT00739297|75859204|FG004|STARTED|Fourth Intervention(Visit 9 to Visit 10)||7||
59739832|NCT00739297|75859205|FG005|STARTED|Fourth Intervention(Visit 9 to Visit 10)||9||
59739833|NCT00739297|75859206|FG006|STARTED|Fourth Intervention(Visit 9 to Visit 10)||66||
59739834|NCT00739297|75859200|FG000|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||16||
59739835|NCT00739297|75859201|FG001|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||11||
59739836|NCT00739297|75859202|FG002|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||8||
59739837|NCT00739297|75859203|FG003|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||15||
59739838|NCT00739297|75859204|FG004|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||7||
59739839|NCT00739297|75859205|FG005|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||8||
59739840|NCT00739297|75859206|FG006|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||65||
59739841|NCT00739297|75859200|FG000|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0||
59739842|NCT00739297|75859201|FG001|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0||
59739843|NCT00739297|75859202|FG002|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0||
59739844|NCT00739297|75859203|FG003|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0||
60134820|NCT03338621|76258097|FG001|COMPLETED|Overall Study||134||
60134821|NCT03338621|76258098|FG002|COMPLETED|Overall Study||117||
60134822|NCT03338621|76258096|FG000|NOT COMPLETED|Overall Study||29||
60134823|NCT03338621|76258097|FG001|NOT COMPLETED|Overall Study||19||
60134824|NCT03338621|76258098|FG002|NOT COMPLETED|Overall Study||35||
60134825|NCT03323099|76258113|FG000|STARTED|Overall Study||251||
59739845|NCT00739297|75859204|FG004|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0||
60134826|NCT03323099|76258114|FG001|STARTED|Overall Study||248||
60134827|NCT03323099|76258113|FG000|COMPLETED|Overall Study||136||
59739846|NCT00739297|75859205|FG005|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||1||
59739847|NCT00739297|75859206|FG006|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||1||
59739848|NCT00739063|75859222|FG000|STARTED|Overall Study||11||
59739849|NCT00739063|75859222|FG000|COMPLETED|Overall Study||3||
59739850|NCT00739063|75859222|FG000|NOT COMPLETED|Overall Study||8||
59739851|NCT01026194|75859228|FG000|STARTED|Period 1：Double Blind Period||101||
59739852|NCT01026194|75859229|FG001|STARTED|Period 1：Double Blind Period||103||
59739853|NCT01026194|75859228|FG000|COMPLETED|Period 1：Double Blind Period||98||
59739854|NCT01026194|75859229|FG001|COMPLETED|Period 1：Double Blind Period||98||
59739855|NCT01026194|75859228|FG000|NOT COMPLETED|Period 1：Double Blind Period||3||
59739856|NCT01026194|75859229|FG001|NOT COMPLETED|Period 1：Double Blind Period||5||
59739857|NCT01026194|75859228|FG000|STARTED|Period 2：Open-label Period||98||
59739858|NCT01026194|75859229|FG001|STARTED|Period 2：Open-label Period||98||
59739859|NCT01026194|75859228|FG000|COMPLETED|Period 2：Open-label Period||91||
59739860|NCT01026194|75859229|FG001|COMPLETED|Period 2：Open-label Period||88||
59739861|NCT01026194|75859228|FG000|NOT COMPLETED|Period 2：Open-label Period||7||
59739862|NCT01026194|75859229|FG001|NOT COMPLETED|Period 2：Open-label Period||10||
59739863|NCT01033136|75859239|FG000|STARTED|Baseline Assessment||36||
59739864|NCT01033136|75859240|FG001|STARTED|Baseline Assessment||32||
59739865|NCT01033136|75859239|FG000|COMPLETED|Baseline Assessment||30||
59739866|NCT01033136|75859240|FG001|COMPLETED|Baseline Assessment||26||
59739867|NCT01033136|75859239|FG000|NOT COMPLETED|Baseline Assessment||6||
59739868|NCT01033136|75859240|FG001|NOT COMPLETED|Baseline Assessment||6||
59739869|NCT01033136|75859239|FG000|STARTED|Post-Treatment (1 Week)||30||
59739870|NCT01033136|75859240|FG001|STARTED|Post-Treatment (1 Week)||26||
59739871|NCT01033136|75859239|FG000|COMPLETED|Post-Treatment (1 Week)||16||
59739872|NCT01033136|75859240|FG001|COMPLETED|Post-Treatment (1 Week)||15||
59739873|NCT01033136|75859239|FG000|NOT COMPLETED|Post-Treatment (1 Week)||14||
59739874|NCT01033136|75859240|FG001|NOT COMPLETED|Post-Treatment (1 Week)||11||
59739875|NCT01033136|75859239|FG000|STARTED|Follow-Up (3 Month)||16||
59739876|NCT01033136|75859240|FG001|STARTED|Follow-Up (3 Month)||15||
59739877|NCT01033136|75859239|FG000|COMPLETED|Follow-Up (3 Month)||14||
59739878|NCT01033136|75859240|FG001|COMPLETED|Follow-Up (3 Month)||13||
59739879|NCT01033136|75859239|FG000|NOT COMPLETED|Follow-Up (3 Month)||2||
59739880|NCT01033136|75859240|FG001|NOT COMPLETED|Follow-Up (3 Month)||2||
59739881|NCT00738673|75859250|FG000|STARTED|Overall Study||25||
59739882|NCT00738673|75859251|FG001|STARTED|Overall Study||12||
59739883|NCT00738673|75859250|FG000|Intent to Treat Population|Overall Study||24||
59739884|NCT00738673|75859251|FG001|Intent to Treat Population|Overall Study||12||
59739885|NCT00738673|75859250|FG000|COMPLETED|Overall Study||1||
59739886|NCT00738673|75859251|FG001|COMPLETED|Overall Study||1||
59739887|NCT00738673|75859250|FG000|NOT COMPLETED|Overall Study||24||
59739888|NCT00738673|75859251|FG001|NOT COMPLETED|Overall Study||11||
59739889|NCT00811954|75859260|FG000|STARTED|Overall Study||605||
59739890|NCT00811954|75859261|FG001|STARTED|Overall Study||603||
59739891|NCT00811954|75859262|FG002|STARTED|Overall Study||601||
59739892|NCT00811954|75859260|FG000|COMPLETED|Overall Study||516||
59739893|NCT00811954|75859261|FG001|COMPLETED|Overall Study||531||
59739894|NCT00811954|75859262|FG002|COMPLETED|Overall Study||500||
59739895|NCT00811954|75859260|FG000|NOT COMPLETED|Overall Study||89||
59739896|NCT00811954|75859261|FG001|NOT COMPLETED|Overall Study||72||
59739897|NCT00811954|75859262|FG002|NOT COMPLETED|Overall Study||101||
59739898|NCT01032200|75859272|FG000|STARTED|Overall Study||26||
59739899|NCT01032200|75859273|FG001|STARTED|Overall Study||28||
59739900|NCT01032200|75859272|FG000|COMPLETED|Overall Study||22||
59739901|NCT01032200|75859273|FG001|COMPLETED|Overall Study||21||
59739902|NCT01032200|75859272|FG000|NOT COMPLETED|Overall Study||4||
59739903|NCT01032200|75859273|FG001|NOT COMPLETED|Overall Study||7||
59739904|NCT00738283|75859279|FG000|STARTED|Overall Study||17||
59739905|NCT00738283|75859279|FG000|COMPLETED|Overall Study||13||
59739906|NCT00738283|75859279|FG000|NOT COMPLETED|Overall Study||4||
59739907|NCT03345771|75859285|FG000|STARTED|Overall Study||115||
59739908|NCT03345771|75859286|FG001|STARTED|Overall Study||115||
59739909|NCT03345771|75859285|FG000|COMPLETED|Overall Study||115||
59739910|NCT03345771|75859286|FG001|COMPLETED|Overall Study||115||
59739911|NCT03345771|75859285|FG000|NOT COMPLETED|Overall Study||0||
59739912|NCT03345771|75859286|FG001|NOT COMPLETED|Overall Study||0||
59739913|NCT00586105|75859292|FG000|STARTED|Overall Study||39||
59739914|NCT00586105|75859292|FG000|COMPLETED|Overall Study||0||
59739915|NCT00586105|75859292|FG000|NOT COMPLETED|Overall Study||39||
59739916|NCT00743119|75859296|FG000|STARTED|Overall Study||34||
59739917|NCT00743119|75859296|FG000|COMPLETED|Overall Study||30||
59739918|NCT00743119|75859296|FG000|NOT COMPLETED|Overall Study||4||
59739919|NCT00733369|75859310|FG000|STARTED|Overall Study||50||
59739920|NCT00733369|75859311|FG001|STARTED|Overall Study||56||
59739921|NCT00733369|75859310|FG000|COMPLETED|Overall Study||40||
59739922|NCT00733369|75859311|FG001|COMPLETED|Overall Study||47||
59739923|NCT00733369|75859310|FG000|NOT COMPLETED|Overall Study||10||
59739924|NCT00733369|75859311|FG001|NOT COMPLETED|Overall Study||9||
59739925|NCT00813124|75859317|FG000|STARTED|Overall Study||24||
59739926|NCT00813124|75859317|FG000|COMPLETED|Overall Study||12||
59739927|NCT00813124|75859317|FG000|NOT COMPLETED|Overall Study||12||
59739928|NCT00733291|75859323|FG000|STARTED|First Intervention, 2 Hrs (+/- 30 Min)||13||
59739929|NCT00733291|75859324|FG001|STARTED|First Intervention, 2 Hrs (+/- 30 Min)||17||
59739930|NCT00733291|75859325|FG002|STARTED|First Intervention, 2 Hrs (+/- 30 Min)||17||
59739931|NCT00733291|75859326|FG003|STARTED|First Intervention, 2 Hrs (+/- 30 Min)||17||
59739932|NCT00733291|75859323|FG000|COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||13||
59739933|NCT00733291|75859324|FG001|COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||17||
59739934|NCT00733291|75859325|FG002|COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||17||
59739935|NCT00733291|75859326|FG003|COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||17||
59739936|NCT00733291|75859323|FG000|NOT COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||0||
59739937|NCT00733291|75859324|FG001|NOT COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||0||
59739938|NCT00733291|75859325|FG002|NOT COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||0||
60134828|NCT03323099|76258114|FG001|COMPLETED|Overall Study||184||
60134829|NCT03323099|76258113|FG000|NOT COMPLETED|Overall Study||115||
59739939|NCT00733291|75859326|FG003|NOT COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||0||
59739940|NCT00733291|75859323|FG000|STARTED|Washout Period, 3 Days (+/-1 Day)||13||
59739941|NCT00733291|75859324|FG001|STARTED|Washout Period, 3 Days (+/-1 Day)||17||
59739942|NCT00733291|75859325|FG002|STARTED|Washout Period, 3 Days (+/-1 Day)||17||
59739943|NCT00733291|75859326|FG003|STARTED|Washout Period, 3 Days (+/-1 Day)||17||
59739944|NCT00733291|75859323|FG000|COMPLETED|Washout Period, 3 Days (+/-1 Day)||12||
59739945|NCT00733291|75859324|FG001|COMPLETED|Washout Period, 3 Days (+/-1 Day)||17||
59739946|NCT00733291|75859325|FG002|COMPLETED|Washout Period, 3 Days (+/-1 Day)||17||
59739947|NCT00733291|75859326|FG003|COMPLETED|Washout Period, 3 Days (+/-1 Day)||17||
59739948|NCT00733291|75859323|FG000|NOT COMPLETED|Washout Period, 3 Days (+/-1 Day)||1||
59739949|NCT00733291|75859324|FG001|NOT COMPLETED|Washout Period, 3 Days (+/-1 Day)||0||
59739950|NCT00733291|75859325|FG002|NOT COMPLETED|Washout Period, 3 Days (+/-1 Day)||0||
59739951|NCT00733291|75859326|FG003|NOT COMPLETED|Washout Period, 3 Days (+/-1 Day)||0||
59739952|NCT00733291|75859323|FG000|STARTED|Second Intervention, 2 Hrs (+/- 30 Min)||12||
59739953|NCT00733291|75859324|FG001|STARTED|Second Intervention, 2 Hrs (+/- 30 Min)||17||
59739954|NCT00733291|75859325|FG002|STARTED|Second Intervention, 2 Hrs (+/- 30 Min)||17||
59739955|NCT00733291|75859326|FG003|STARTED|Second Intervention, 2 Hrs (+/- 30 Min)||17||
59739956|NCT00733291|75859323|FG000|COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||12||
59739957|NCT00733291|75859324|FG001|COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||17||
59739958|NCT00733291|75859325|FG002|COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||17||
60134830|NCT03323099|76258114|FG001|NOT COMPLETED|Overall Study||64||
60134831|NCT03323034|76258125|FG000|STARTED|Overall Study||6||
60134832|NCT03323034|76258126|FG001|STARTED|Overall Study||6||
60134833|NCT03323034|76258127|FG002|STARTED|Overall Study||6||
59739959|NCT00733291|75859326|FG003|COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||17||
59739960|NCT00733291|75859323|FG000|NOT COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||0||
59739961|NCT00733291|75859324|FG001|NOT COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||0||
59739962|NCT00733291|75859325|FG002|NOT COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||0||
59739963|NCT00733291|75859326|FG003|NOT COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||0||
59739964|NCT00732199|75859339|FG000|STARTED|Overall Study||50||
59739965|NCT00732199|75859340|FG001|STARTED|Overall Study||42||
59739966|NCT00732199|75859339|FG000|COMPLETED|Overall Study||16||
59739967|NCT00732199|75859340|FG001|COMPLETED|Overall Study||16||
59739968|NCT00732199|75859339|FG000|NOT COMPLETED|Overall Study||34||
59739969|NCT00732199|75859340|FG001|NOT COMPLETED|Overall Study||26||
59739970|NCT00807040|75859351|FG000|STARTED|Overall Study||126||
59739971|NCT00807040|75859352|FG001|STARTED|Overall Study||125||
59739972|NCT00807040|75859351|FG000|COMPLETED|Overall Study||90||
59739973|NCT00807040|75859352|FG001|COMPLETED|Overall Study||84||
59739974|NCT00807040|75859351|FG000|NOT COMPLETED|Overall Study||36||
59739975|NCT00807040|75859352|FG001|NOT COMPLETED|Overall Study||41||
59739976|NCT00811720|75859360|FG000|STARTED|All Randomised Patients||298||
59739977|NCT00811720|75859361|FG001|STARTED|All Randomised Patients||306||
59739978|NCT00811720|75859360|FG000|COMPLETED|All Randomised Patients||296||
59739979|NCT00811720|75859361|FG001|COMPLETED|All Randomised Patients||302||
59739980|NCT00811720|75859360|FG000|NOT COMPLETED|All Randomised Patients||2||
59739981|NCT00811720|75859361|FG001|NOT COMPLETED|All Randomised Patients||4||
59739982|NCT00811720|75859360|FG000|STARTED|All Treated Patients||296||
59739983|NCT00811720|75859361|FG001|STARTED|All Treated Patients||302||
59739984|NCT00811720|75859360|FG000|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|200||
59739985|NCT00811720|75859361|FG001|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|138||
59739986|NCT00811720|75859360|FG000|NOT COMPLETED|All Treated Patients||96||
59739987|NCT00811720|75859361|FG001|NOT COMPLETED|All Treated Patients||164||
59739988|NCT04202679|75859369|FG000|STARTED|Overall Study||82||
59739989|NCT04202679|75859370|FG001|STARTED|Overall Study||78||
59739990|NCT04202679|75859369|FG000|Treated|Overall Study||82||
59739991|NCT04202679|75859370|FG001|Treated|Overall Study||77||
59739992|NCT04202679|75859369|FG000|COMPLETED|Overall Study||56||
60134834|NCT03323034|76258128|FG003|STARTED|Overall Study||6||
60134835|NCT03323034|76258129|FG004|STARTED|Overall Study||6||
60134836|NCT03323034|76258125|FG000|COMPLETED|Overall Study||0||
60134837|NCT03323034|76258126|FG001|COMPLETED|Overall Study||0||
59739993|NCT04202679|75859370|FG001|COMPLETED|Overall Study||72||
59739994|NCT04202679|75859369|FG000|NOT COMPLETED|Overall Study||26||
59739995|NCT04202679|75859370|FG001|NOT COMPLETED|Overall Study||6||
59739996|NCT00811642|75859377|FG000|STARTED|Overall Study|63 participants were screened and enrolled; 62 participants from Safety Set (SS) started study drug.|62||
59739997|NCT00811642|75859377|FG000|COMPLETED|Overall Study|The Per Protocol Set (PPS) includes the 47 participants who completed the study per protocol.|47||
59739998|NCT00811642|75859377|FG000|NOT COMPLETED|Overall Study||15||
59739999|NCT00809926|75859383|FG000|STARTED|Overall Study||232||
59740000|NCT00809926|75859384|FG001|STARTED|Overall Study||219||
59740001|NCT00809926|75859383|FG000|COMPLETED|Overall Study||201||
59740002|NCT00809926|75859384|FG001|COMPLETED|Overall Study||196||
60134838|NCT03323034|76258127|FG002|COMPLETED|Overall Study||0||
60134839|NCT03323034|76258128|FG003|COMPLETED|Overall Study||0||
60134840|NCT03323034|76258129|FG004|COMPLETED|Overall Study||0||
60134841|NCT03323034|76258125|FG000|NOT COMPLETED|Overall Study||6||
60134842|NCT03323034|76258126|FG001|NOT COMPLETED|Overall Study||6||
60134843|NCT03323034|76258127|FG002|NOT COMPLETED|Overall Study||6||
60134844|NCT03323034|76258128|FG003|NOT COMPLETED|Overall Study||6||
60134845|NCT03323034|76258129|FG004|NOT COMPLETED|Overall Study||6||
60134846|NCT03307252|76258153|FG000|STARTED|Part 1, Period 1|Participants randomised in Part 1|4||
60134847|NCT03307252|76258154|FG001|STARTED|Part 1, Period 1|Participants randomised in Part 1|4||
60134848|NCT03307252|76258155|FG002|STARTED|Part 1, Period 1|Participants randomised in Part 1|4||
60134849|NCT03307252|76258156|FG003|STARTED|Part 1, Period 1||0||
60134850|NCT03307252|76258157|FG004|STARTED|Part 1, Period 1||0||
59604323|NCT02059434|75714651|FG004|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0||
59604324|NCT02059434|75714652|FG005|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0||
59604325|NCT02059434|75714653|FG006|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0||
59604326|NCT02059434|75714654|FG007|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0||
59604327|NCT02059434|75714655|FG008|COMPLETED|Washout Between Periods 6 and 7||36||
59604328|NCT02059434|75714647|FG000|NOT COMPLETED|Washout Between Periods 6 and 7||0||
59604329|NCT02059434|75714648|FG001|NOT COMPLETED|Washout Between Periods 6 and 7||0||
59604330|NCT02059434|75714649|FG002|NOT COMPLETED|Washout Between Periods 6 and 7||0||
59604331|NCT02059434|75714650|FG003|NOT COMPLETED|Washout Between Periods 6 and 7||0||
59604332|NCT02059434|75714651|FG004|NOT COMPLETED|Washout Between Periods 6 and 7||0||
59604333|NCT02059434|75714652|FG005|NOT COMPLETED|Washout Between Periods 6 and 7||0||
59604334|NCT02059434|75714653|FG006|NOT COMPLETED|Washout Between Periods 6 and 7||0||
59604335|NCT02059434|75714654|FG007|NOT COMPLETED|Washout Between Periods 6 and 7||0||
59604336|NCT02059434|75714655|FG008|NOT COMPLETED|Washout Between Periods 6 and 7||1||
59604337|NCT02059434|75714647|FG000|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0||
59604338|NCT02059434|75714648|FG001|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0||
59604339|NCT02059434|75714649|FG002|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0||
59604340|NCT02059434|75714650|FG003|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0||
59604341|NCT02059434|75714651|FG004|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0||
59604342|NCT02059434|75714652|FG005|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0||
59604343|NCT02059434|75714653|FG006|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0||
59604344|NCT02059434|75714654|FG007|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0||
59740003|NCT00809926|75859383|FG000|NOT COMPLETED|Overall Study||31||
59740004|NCT00809926|75859384|FG001|NOT COMPLETED|Overall Study||23||
59740005|NCT00590980|75859390|FG000|STARTED|Overall Study||82||
59740006|NCT00590980|75859390|FG000|COMPLETED|Overall Study||72||
59740007|NCT00590980|75859390|FG000|NOT COMPLETED|Overall Study||10||
59740008|NCT00590824|75859398|FG000|STARTED|Overall Study||11||
59740009|NCT00590824|75859399|FG001|STARTED|Overall Study||9||
59740010|NCT00590824|75859400|FG002|STARTED|Overall Study||2||
59740011|NCT00590824|75859401|FG003|STARTED|Overall Study||1||
59740012|NCT00590824|75859398|FG000|COMPLETED|Overall Study||11||
59740013|NCT00590824|75859399|FG001|COMPLETED|Overall Study||7||
59740014|NCT00590824|75859400|FG002|COMPLETED|Overall Study||1||
59740015|NCT00590824|75859401|FG003|COMPLETED|Overall Study||0||
59740016|NCT00590824|75859398|FG000|NOT COMPLETED|Overall Study||0||
59740017|NCT00590824|75859399|FG001|NOT COMPLETED|Overall Study||2||
60134851|NCT03307252|76258158|FG005|STARTED|Part 1, Period 1||0||
60134852|NCT03307252|76258159|FG006|STARTED|Part 1, Period 1||0||
59604345|NCT02059434|75714655|FG008|STARTED|Period 7||36||
59604346|NCT02059434|75714647|FG000|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0||
59740018|NCT00590824|75859400|FG002|NOT COMPLETED|Overall Study||1||
59740019|NCT00590824|75859401|FG003|NOT COMPLETED|Overall Study||1||
59740020|NCT00590590|75859414|FG000|STARTED|Overall Study||39||
59740021|NCT00590590|75859415|FG001|STARTED|Overall Study||39||
59740022|NCT00590590|75859416|FG002|STARTED|Overall Study||27||
59740023|NCT00590590|75859414|FG000|COMPLETED|Overall Study||32||
59740024|NCT00590590|75859415|FG001|COMPLETED|Overall Study||33||
59740025|NCT00590590|75859416|FG002|COMPLETED|Overall Study||21||
59740026|NCT00590590|75859414|FG000|NOT COMPLETED|Overall Study||7||
59740027|NCT00590590|75859415|FG001|NOT COMPLETED|Overall Study||6||
59740028|NCT00590590|75859416|FG002|NOT COMPLETED|Overall Study||6||
59740029|NCT00809614|75859426|FG000|STARTED|Overall Study||28||
59740030|NCT00809614|75859427|FG001|STARTED|Overall Study||14||
59740031|NCT00809614|75859426|FG000|Pharmacokinetic Safety Set|Overall Study||27||
59740032|NCT00809614|75859427|FG001|Pharmacokinetic Safety Set|Overall Study||14||
59740033|NCT00809614|75859426|FG000|Pharmacodynamic (PD) Set|Overall Study||24||
59740034|NCT00809614|75859427|FG001|Pharmacodynamic (PD) Set|Overall Study||13||
59740035|NCT00809614|75859426|FG000|COMPLETED|Overall Study||25||
59740036|NCT00809614|75859427|FG001|COMPLETED|Overall Study||10||
59740037|NCT00809614|75859426|FG000|NOT COMPLETED|Overall Study||3||
59740038|NCT00809614|75859427|FG001|NOT COMPLETED|Overall Study||4||
59740039|NCT00731731|75859436|FG000|STARTED|Overall Study||12||
59740040|NCT00731731|75859437|FG001|STARTED|Overall Study||3||
59740041|NCT00731731|75859438|FG002|STARTED|Overall Study||110||
59740042|NCT00731731|75859436|FG000|COMPLETED|Overall Study||12||
59740043|NCT00731731|75859437|FG001|COMPLETED|Overall Study||3||
59740044|NCT00731731|75859438|FG002|COMPLETED|Overall Study||107||
59740045|NCT00731731|75859436|FG000|NOT COMPLETED|Overall Study||0||
59740046|NCT00731731|75859437|FG001|NOT COMPLETED|Overall Study||0||
59740047|NCT00731731|75859438|FG002|NOT COMPLETED|Overall Study||3||
59740048|NCT00806494|75859451|FG000|STARTED|Overall Study||331||
59740049|NCT00806494|75859451|FG000|COMPLETED|Overall Study||251||
59740050|NCT00806494|75859451|FG000|NOT COMPLETED|Overall Study||80||
59740051|NCT00806416|75859458|FG000|STARTED|Period 1 - Part I||107||
59740052|NCT00806416|75859459|FG001|STARTED|Period 1 - Part I||107||
59740053|NCT00806416|75859460|FG002|STARTED|Period 1 - Part I||0||
59740054|NCT00806416|75859461|FG003|STARTED|Period 1 - Part I||0||
59740055|NCT00806416|75859458|FG000|COMPLETED|Period 1 - Part I||104||
59740056|NCT00806416|75859459|FG001|COMPLETED|Period 1 - Part I||103||
59740057|NCT00806416|75859460|FG002|COMPLETED|Period 1 - Part I||0||
59740058|NCT00806416|75859461|FG003|COMPLETED|Period 1 - Part I||0||
59740059|NCT00806416|75859458|FG000|NOT COMPLETED|Period 1 - Part I||3||
59740060|NCT00806416|75859459|FG001|NOT COMPLETED|Period 1 - Part I||4||
59740061|NCT00806416|75859460|FG002|NOT COMPLETED|Period 1 - Part I||0||
59740062|NCT00806416|75859461|FG003|NOT COMPLETED|Period 1 - Part I||0||
59740063|NCT00806416|75859458|FG000|STARTED|Period 2 - Part I||104||
59740064|NCT00806416|75859459|FG001|STARTED|Period 2 - Part I||103||
59740065|NCT00806416|75859460|FG002|STARTED|Period 2 - Part I||0||
59740066|NCT00806416|75859461|FG003|STARTED|Period 2 - Part I||0||
59740067|NCT00806416|75859458|FG000|COMPLETED|Period 2 - Part I||104||
59740068|NCT00806416|75859459|FG001|COMPLETED|Period 2 - Part I||103||
59740069|NCT00806416|75859460|FG002|COMPLETED|Period 2 - Part I||0||
59740070|NCT00806416|75859461|FG003|COMPLETED|Period 2 - Part I||0||
59740071|NCT00806416|75859458|FG000|NOT COMPLETED|Period 2 - Part I||0||
59740072|NCT00806416|75859459|FG001|NOT COMPLETED|Period 2 - Part I||0||
59740073|NCT00806416|75859460|FG002|NOT COMPLETED|Period 2 - Part I||0||
59740074|NCT00806416|75859461|FG003|NOT COMPLETED|Period 2 - Part I||0||
59740075|NCT00806416|75859458|FG000|STARTED|Period 1 - Part II||0||
59740076|NCT00806416|75859459|FG001|STARTED|Period 1 - Part II||0||
59740077|NCT00806416|75859460|FG002|STARTED|Period 1 - Part II||14||
59740078|NCT00806416|75859461|FG003|STARTED|Period 1 - Part II||16||
59740079|NCT00806416|75859458|FG000|COMPLETED|Period 1 - Part II||0||
59740080|NCT00806416|75859459|FG001|COMPLETED|Period 1 - Part II||0||
59740081|NCT00806416|75859460|FG002|COMPLETED|Period 1 - Part II||14||
59740082|NCT00806416|75859461|FG003|COMPLETED|Period 1 - Part II||14||
59740083|NCT00806416|75859458|FG000|NOT COMPLETED|Period 1 - Part II||0||
59740084|NCT00806416|75859459|FG001|NOT COMPLETED|Period 1 - Part II||0||
59740085|NCT00806416|75859460|FG002|NOT COMPLETED|Period 1 - Part II||0||
59740086|NCT00806416|75859461|FG003|NOT COMPLETED|Period 1 - Part II||2||
59740087|NCT00806416|75859458|FG000|STARTED|Period 2 - Part II||0||
59740088|NCT00806416|75859459|FG001|STARTED|Period 2 - Part II||0||
59740089|NCT00806416|75859460|FG002|STARTED|Period 2 - Part II||14||
59740090|NCT00806416|75859461|FG003|STARTED|Period 2 - Part II||14||
59740091|NCT00806416|75859458|FG000|COMPLETED|Period 2 - Part II||0||
59740092|NCT00806416|75859459|FG001|COMPLETED|Period 2 - Part II||0||
59740093|NCT00806416|75859460|FG002|COMPLETED|Period 2 - Part II||14||
59740094|NCT00806416|75859461|FG003|COMPLETED|Period 2 - Part II||14||
59740095|NCT00806416|75859458|FG000|NOT COMPLETED|Period 2 - Part II||0||
59740096|NCT00806416|75859459|FG001|NOT COMPLETED|Period 2 - Part II||0||
59740097|NCT00806416|75859460|FG002|NOT COMPLETED|Period 2 - Part II||0||
59740098|NCT00806416|75859461|FG003|NOT COMPLETED|Period 2 - Part II||0||
59740099|NCT02724969|75859471|FG000|STARTED|Overall Study||126||
59740100|NCT02724969|75859472|FG001|STARTED|Overall Study||124||
59740101|NCT02724969|75859471|FG000|COMPLETED|Overall Study||111||
59740102|NCT02724969|75859472|FG001|COMPLETED|Overall Study||113||
59740103|NCT02724969|75859471|FG000|NOT COMPLETED|Overall Study||15||
59740104|NCT02724969|75859472|FG001|NOT COMPLETED|Overall Study||11||
59740105|NCT00811252|75859481|FG000|STARTED|Overall Study||145||
59740106|NCT00811252|75859482|FG001|STARTED|Overall Study||156||
59740107|NCT00811252|75859483|FG002|STARTED|Overall Study||151||
59740108|NCT00811252|75859481|FG000|COMPLETED|Overall Study||128||
59740109|NCT00811252|75859482|FG001|COMPLETED|Overall Study||136||
59740110|NCT00811252|75859483|FG002|COMPLETED|Overall Study||128||
59740111|NCT00811252|75859481|FG000|NOT COMPLETED|Overall Study||17||
59740112|NCT00811252|75859482|FG001|NOT COMPLETED|Overall Study||20||
59740113|NCT00811252|75859483|FG002|NOT COMPLETED|Overall Study||23||
59740114|NCT04114617|75859491|FG000|STARTED|Overall Study||80||
59740115|NCT04114617|75859491|FG000|COMPLETED|Overall Study||80||
59740116|NCT04114617|75859491|FG000|NOT COMPLETED|Overall Study||0||
59740117|NCT00736957|75859500|FG000|STARTED|Overall Study||219||
59740118|NCT00736957|75859500|FG000|Treated|Overall Study||190||
59740119|NCT00736957|75859500|FG000|COMPLETED|Overall Study||97||
59740120|NCT00736957|75859500|FG000|NOT COMPLETED|Overall Study||122||
59740121|NCT00736879|75859508|FG000|STARTED|Double Blind Treatment Period||68||
59740122|NCT00736879|75859509|FG001|STARTED|Double Blind Treatment Period||72||
59740123|NCT00736879|75859510|FG002|STARTED|Double Blind Treatment Period||74||
59740124|NCT00736879|75859511|FG003|STARTED|Double Blind Treatment Period||68||
59740125|NCT00736879|75859508|FG000|COMPLETED|Double Blind Treatment Period||65||
59740126|NCT00736879|75859509|FG001|COMPLETED|Double Blind Treatment Period||68||
59740127|NCT00736879|75859510|FG002|COMPLETED|Double Blind Treatment Period||67||
59740128|NCT00736879|75859511|FG003|COMPLETED|Double Blind Treatment Period||63||
59740129|NCT00736879|75859508|FG000|NOT COMPLETED|Double Blind Treatment Period||3||
59740130|NCT00736879|75859509|FG001|NOT COMPLETED|Double Blind Treatment Period||4||
59740131|NCT00736879|75859510|FG002|NOT COMPLETED|Double Blind Treatment Period||7||
59740132|NCT00736879|75859511|FG003|NOT COMPLETED|Double Blind Treatment Period||5||
59740133|NCT00736879|75859508|FG000|STARTED|Follow up Period - No Drug Treatment|Those not completing 24 weeks of treatment can still remain in the trial for 4 weeks of follow up.|66||
59740134|NCT00736879|75859509|FG001|STARTED|Follow up Period - No Drug Treatment|Those not completing 24 weeks of treatment can still remain in the trial for 4 weeks of follow up.|70||
59740135|NCT00736879|75859510|FG002|STARTED|Follow up Period - No Drug Treatment|Those not completing 24 weeks of treatment can still remain in the trial for 4 weeks of follow up.|66||
59740136|NCT00736879|75859511|FG003|STARTED|Follow up Period - No Drug Treatment|Those not completing 24 weeks of treatment can still remain in the trial for 4 weeks of follow up.|62||
59740137|NCT00736879|75859508|FG000|COMPLETED|Follow up Period - No Drug Treatment||65||
59740138|NCT00736879|75859509|FG001|COMPLETED|Follow up Period - No Drug Treatment||67||
59740139|NCT00736879|75859510|FG002|COMPLETED|Follow up Period - No Drug Treatment||66||
59740140|NCT00736879|75859511|FG003|COMPLETED|Follow up Period - No Drug Treatment||62||
59740141|NCT00736879|75859508|FG000|NOT COMPLETED|Follow up Period - No Drug Treatment||1||
59740142|NCT00736879|75859509|FG001|NOT COMPLETED|Follow up Period - No Drug Treatment||3||
59740143|NCT00736879|75859510|FG002|NOT COMPLETED|Follow up Period - No Drug Treatment||0||
59740144|NCT00736879|75859511|FG003|NOT COMPLETED|Follow up Period - No Drug Treatment||0||
59740145|NCT00806260|75859530|FG000|STARTED|Period 1 (1 Day)||15||
59740146|NCT00806260|75859531|FG001|STARTED|Period 1 (1 Day)||8||
59740147|NCT00806260|75859532|FG002|STARTED|Period 1 (1 Day)||8||
59740148|NCT00806260|75859533|FG003|STARTED|Period 1 (1 Day)||14||
59740149|NCT00806260|75859534|FG004|STARTED|Period 1 (1 Day)||18||
59740150|NCT00806260|75859535|FG005|STARTED|Period 1 (1 Day)||17||
59740151|NCT00806260|75859530|FG000|COMPLETED|Period 1 (1 Day)||15||
59740152|NCT00806260|75859531|FG001|COMPLETED|Period 1 (1 Day)||8||
59740153|NCT00806260|75859532|FG002|COMPLETED|Period 1 (1 Day)||8||
59740154|NCT00806260|75859533|FG003|COMPLETED|Period 1 (1 Day)||14||
59740155|NCT00806260|75859534|FG004|COMPLETED|Period 1 (1 Day)|did not move onto Periods 2 and 3 due to adjusted design of study|15||
59740156|NCT00806260|75859535|FG005|COMPLETED|Period 1 (1 Day)|did not move onto Periods 2 and 3 due to adjusted design of study|17||
59740157|NCT00806260|75859530|FG000|NOT COMPLETED|Period 1 (1 Day)||0||
59740158|NCT00806260|75859531|FG001|NOT COMPLETED|Period 1 (1 Day)||0||
59740159|NCT00806260|75859532|FG002|NOT COMPLETED|Period 1 (1 Day)||0||
59740160|NCT00806260|75859533|FG003|NOT COMPLETED|Period 1 (1 Day)||0||
59740161|NCT00806260|75859534|FG004|NOT COMPLETED|Period 1 (1 Day)||3||
59740162|NCT00806260|75859535|FG005|NOT COMPLETED|Period 1 (1 Day)||0||
59740163|NCT00806260|75859530|FG000|STARTED|Period 2||15||
59740164|NCT00806260|75859531|FG001|STARTED|Period 2||8||
59740165|NCT00806260|75859532|FG002|STARTED|Period 2||8||
59740166|NCT00806260|75859533|FG003|STARTED|Period 2||14||
59740167|NCT00806260|75859534|FG004|STARTED|Period 2||0||
59740168|NCT00806260|75859535|FG005|STARTED|Period 2||0||
59740169|NCT00806260|75859530|FG000|COMPLETED|Period 2||13||
59740170|NCT00806260|75859531|FG001|COMPLETED|Period 2||8||
59740171|NCT00806260|75859532|FG002|COMPLETED|Period 2||6||
59740172|NCT00806260|75859533|FG003|COMPLETED|Period 2||12||
59740173|NCT00806260|75859534|FG004|COMPLETED|Period 2||0||
59872987|NCT03131440|75997114|FG028|COMPLETED|Overall Study||8|Completed the 24 week questionnaires OR had valid data on the accelerometer at 24 weeks|
59951252|NCT03743415|76070183|FG008|COMPLETED|Overall Study||0||
59740174|NCT00806260|75859535|FG005|COMPLETED|Period 2||0||
59740175|NCT00806260|75859530|FG000|NOT COMPLETED|Period 2||2||
59740176|NCT00806260|75859531|FG001|NOT COMPLETED|Period 2||0||
59740177|NCT00806260|75859532|FG002|NOT COMPLETED|Period 2||2||
59740178|NCT00806260|75859533|FG003|NOT COMPLETED|Period 2||2||
59740179|NCT00806260|75859534|FG004|NOT COMPLETED|Period 2||0||
59740180|NCT00806260|75859535|FG005|NOT COMPLETED|Period 2||0||
59740181|NCT00806260|75859530|FG000|STARTED|Period 3||13||
59740182|NCT00806260|75859531|FG001|STARTED|Period 3||8||
59740183|NCT00806260|75859532|FG002|STARTED|Period 3||6||
59740184|NCT00806260|75859533|FG003|STARTED|Period 3||12||
59740185|NCT00806260|75859534|FG004|STARTED|Period 3||0||
59740186|NCT00806260|75859535|FG005|STARTED|Period 3||0||
59740187|NCT00806260|75859530|FG000|COMPLETED|Period 3||12||
59740188|NCT00806260|75859531|FG001|COMPLETED|Period 3||7||
59740189|NCT00806260|75859532|FG002|COMPLETED|Period 3||5||
59740190|NCT00806260|75859533|FG003|COMPLETED|Period 3||12||
59740191|NCT00806260|75859534|FG004|COMPLETED|Period 3||0||
59740192|NCT00806260|75859535|FG005|COMPLETED|Period 3||0||
59740193|NCT00806260|75859530|FG000|NOT COMPLETED|Period 3||1||
59740194|NCT00806260|75859531|FG001|NOT COMPLETED|Period 3||1||
59740195|NCT00806260|75859532|FG002|NOT COMPLETED|Period 3||1||
59740196|NCT00806260|75859533|FG003|NOT COMPLETED|Period 3||0||
59740197|NCT00806260|75859534|FG004|NOT COMPLETED|Period 3||0||
59740198|NCT00806260|75859535|FG005|NOT COMPLETED|Period 3||0||
59740199|NCT00742885|75859549|FG000|STARTED|Overall Study||50||
59740200|NCT00742885|75859550|FG001|STARTED|Overall Study||50||
59740201|NCT00742885|75859549|FG000|COMPLETED|Overall Study|to Day 182|49||
59740202|NCT00742885|75859550|FG001|COMPLETED|Overall Study|to Day 182|50||
59740203|NCT00742885|75859549|FG000|NOT COMPLETED|Overall Study||1||
59740204|NCT00742885|75859550|FG001|NOT COMPLETED|Overall Study||0||
59740205|NCT00811174|75859559|FG000|STARTED|Overall Study||5||
59740206|NCT00811174|75859559|FG000|COMPLETED|Overall Study||2||
59740207|NCT00811174|75859559|FG000|NOT COMPLETED|Overall Study||3||
59740208|NCT00730405|75859568|FG000|STARTED|Overall Study-Treatment Phase||116||
59740209|NCT00730405|75859569|FG001|STARTED|Overall Study-Treatment Phase||117||
59740210|NCT00730405|75859570|FG002|STARTED|Overall Study-Treatment Phase||117||
59740211|NCT00730405|75859571|FG003|STARTED|Overall Study-Treatment Phase||117||
59740212|NCT00730405|75859572|FG004|STARTED|Overall Study-Treatment Phase||115||
59740213|NCT00730405|75859568|FG000|COMPLETED|Overall Study-Treatment Phase||97||
59740214|NCT00730405|75859569|FG001|COMPLETED|Overall Study-Treatment Phase||96||
59740215|NCT00730405|75859570|FG002|COMPLETED|Overall Study-Treatment Phase||96||
59740216|NCT00730405|75859571|FG003|COMPLETED|Overall Study-Treatment Phase||98||
59740217|NCT00730405|75859572|FG004|COMPLETED|Overall Study-Treatment Phase||95||
59740218|NCT00730405|75859568|FG000|NOT COMPLETED|Overall Study-Treatment Phase||19||
59740219|NCT00730405|75859569|FG001|NOT COMPLETED|Overall Study-Treatment Phase||21||
59740220|NCT00730405|75859570|FG002|NOT COMPLETED|Overall Study-Treatment Phase||21||
59740221|NCT00730405|75859571|FG003|NOT COMPLETED|Overall Study-Treatment Phase||19||
59740222|NCT00730405|75859572|FG004|NOT COMPLETED|Overall Study-Treatment Phase||20||
59740223|NCT00730405|75859568|FG000|STARTED|Overall Study-follow-up Phase||116||
59740224|NCT00730405|75859569|FG001|STARTED|Overall Study-follow-up Phase||117||
59740225|NCT00730405|75859570|FG002|STARTED|Overall Study-follow-up Phase||117||
59740226|NCT00730405|75859571|FG003|STARTED|Overall Study-follow-up Phase||117||
59740227|NCT00730405|75859572|FG004|STARTED|Overall Study-follow-up Phase||115||
59740228|NCT00730405|75859568|FG000|COMPLETED|Overall Study-follow-up Phase||95||
59740229|NCT00730405|75859569|FG001|COMPLETED|Overall Study-follow-up Phase||96||
59740230|NCT00730405|75859570|FG002|COMPLETED|Overall Study-follow-up Phase||94||
59740231|NCT00730405|75859571|FG003|COMPLETED|Overall Study-follow-up Phase||100||
59740232|NCT00730405|75859572|FG004|COMPLETED|Overall Study-follow-up Phase||93||
59740233|NCT00730405|75859568|FG000|NOT COMPLETED|Overall Study-follow-up Phase||21||
59740234|NCT00730405|75859569|FG001|NOT COMPLETED|Overall Study-follow-up Phase||21||
59740235|NCT00730405|75859570|FG002|NOT COMPLETED|Overall Study-follow-up Phase||23||
59740236|NCT00730405|75859571|FG003|NOT COMPLETED|Overall Study-follow-up Phase||17||
59740237|NCT00730405|75859572|FG004|NOT COMPLETED|Overall Study-follow-up Phase||22||
59740238|NCT00736723|75859588|FG000|STARTED|Overall Study||30||
59740239|NCT00736723|75859589|FG001|STARTED|Overall Study||21||
59740240|NCT00736723|75859588|FG000|COMPLETED|Overall Study||26||
59740241|NCT00736723|75859589|FG001|COMPLETED|Overall Study||18||
59740242|NCT00736723|75859588|FG000|NOT COMPLETED|Overall Study||4||
59740243|NCT00736723|75859589|FG001|NOT COMPLETED|Overall Study||3||
59740244|NCT00736645|75859599|FG000|STARTED|Overall Study||13||
59740245|NCT00736645|75859600|FG001|STARTED|Overall Study||15||
59740246|NCT00736645|75859601|FG002|STARTED|Overall Study||14||
59740247|NCT00736645|75859602|FG003|STARTED|Overall Study||13||
59740248|NCT00736645|75859599|FG000|COMPLETED|Overall Study||13||
59740249|NCT00736645|75859600|FG001|COMPLETED|Overall Study||13||
59740250|NCT00736645|75859601|FG002|COMPLETED|Overall Study||14||
59740251|NCT00736645|75859602|FG003|COMPLETED|Overall Study||13||
59740252|NCT00736645|75859599|FG000|NOT COMPLETED|Overall Study||0||
59740253|NCT00736645|75859600|FG001|NOT COMPLETED|Overall Study||2||
59740254|NCT00736645|75859601|FG002|NOT COMPLETED|Overall Study||0||
59740255|NCT00736645|75859602|FG003|NOT COMPLETED|Overall Study||0||
59740256|NCT00736489|75859612|FG000|STARTED|Period 1|Cross-over study|6||
59740257|NCT00736489|75859613|FG001|STARTED|Period 1||5||
59740258|NCT00736489|75859614|FG002|STARTED|Period 1||6||
59740259|NCT00736489|75859615|FG003|STARTED|Period 1||7||
59740260|NCT00736489|75859616|FG004|STARTED|Period 1||7||
59740261|NCT00736489|75859617|FG005|STARTED|Period 1||6||
59740262|NCT00736489|75859612|FG000|COMPLETED|Period 1||5||
59740263|NCT00736489|75859613|FG001|COMPLETED|Period 1||5||
59740264|NCT00736489|75859614|FG002|COMPLETED|Period 1||6||
59740265|NCT00736489|75859615|FG003|COMPLETED|Period 1||7||
59740266|NCT00736489|75859616|FG004|COMPLETED|Period 1||7||
59740267|NCT00736489|75859617|FG005|COMPLETED|Period 1||5||
59740268|NCT00736489|75859612|FG000|NOT COMPLETED|Period 1||1||
59740269|NCT00736489|75859613|FG001|NOT COMPLETED|Period 1||0||
59740270|NCT00736489|75859614|FG002|NOT COMPLETED|Period 1||0||
59740271|NCT00736489|75859615|FG003|NOT COMPLETED|Period 1||0||
59740272|NCT00736489|75859616|FG004|NOT COMPLETED|Period 1||0||
59740273|NCT00736489|75859617|FG005|NOT COMPLETED|Period 1||1||
59740274|NCT00736489|75859612|FG000|STARTED|Period 2||5||
59740275|NCT00736489|75859613|FG001|STARTED|Period 2||5||
59740276|NCT00736489|75859614|FG002|STARTED|Period 2||6||
59740277|NCT00736489|75859615|FG003|STARTED|Period 2||7||
59740278|NCT00736489|75859616|FG004|STARTED|Period 2||7||
59740279|NCT00736489|75859617|FG005|STARTED|Period 2||5||
59740280|NCT00736489|75859612|FG000|COMPLETED|Period 2||5||
59740281|NCT00736489|75859613|FG001|COMPLETED|Period 2||5||
59740282|NCT00736489|75859614|FG002|COMPLETED|Period 2||6||
59740283|NCT00736489|75859615|FG003|COMPLETED|Period 2||7||
59740284|NCT00736489|75859616|FG004|COMPLETED|Period 2||7||
59740285|NCT00736489|75859617|FG005|COMPLETED|Period 2||5||
59740286|NCT00736489|75859612|FG000|NOT COMPLETED|Period 2||0||
59740287|NCT00736489|75859613|FG001|NOT COMPLETED|Period 2||0||
59740288|NCT00736489|75859614|FG002|NOT COMPLETED|Period 2||0||
59740289|NCT00736489|75859615|FG003|NOT COMPLETED|Period 2||0||
59740290|NCT00736489|75859616|FG004|NOT COMPLETED|Period 2||0||
59740291|NCT00736489|75859617|FG005|NOT COMPLETED|Period 2||0||
59740292|NCT00736489|75859612|FG000|STARTED|Period 3||5||
59740293|NCT00736489|75859613|FG001|STARTED|Period 3||5||
59740294|NCT00736489|75859614|FG002|STARTED|Period 3||6||
59740295|NCT00736489|75859615|FG003|STARTED|Period 3||7||
59740296|NCT00736489|75859616|FG004|STARTED|Period 3||7||
59740297|NCT00736489|75859617|FG005|STARTED|Period 3||5||
59740298|NCT00736489|75859612|FG000|COMPLETED|Period 3||5||
59740299|NCT00736489|75859613|FG001|COMPLETED|Period 3||5||
59740300|NCT00736489|75859614|FG002|COMPLETED|Period 3||6||
59740301|NCT00736489|75859615|FG003|COMPLETED|Period 3||7||
59740302|NCT00736489|75859616|FG004|COMPLETED|Period 3||7||
59740303|NCT00736489|75859617|FG005|COMPLETED|Period 3||5||
59740304|NCT00736489|75859612|FG000|NOT COMPLETED|Period 3||0||
59740305|NCT00736489|75859613|FG001|NOT COMPLETED|Period 3||0||
59740306|NCT00736489|75859614|FG002|NOT COMPLETED|Period 3||0||
59740307|NCT00736489|75859615|FG003|NOT COMPLETED|Period 3||0||
59740308|NCT00736489|75859616|FG004|NOT COMPLETED|Period 3||0||
59740309|NCT00736489|75859617|FG005|NOT COMPLETED|Period 3||0||
59740310|NCT00736489|75859612|FG000|STARTED|Period 4||5||
59740311|NCT00736489|75859613|FG001|STARTED|Period 4||5||
59740312|NCT00736489|75859614|FG002|STARTED|Period 4||6||
59740313|NCT00736489|75859615|FG003|STARTED|Period 4||7||
59740314|NCT00736489|75859616|FG004|STARTED|Period 4||7||
59740315|NCT00736489|75859617|FG005|STARTED|Period 4||5||
59740316|NCT00736489|75859612|FG000|COMPLETED|Period 4||5||
59740317|NCT00736489|75859613|FG001|COMPLETED|Period 4||5||
59740318|NCT00736489|75859614|FG002|COMPLETED|Period 4||6||
59740319|NCT00736489|75859615|FG003|COMPLETED|Period 4||7||
59740320|NCT00736489|75859616|FG004|COMPLETED|Period 4||7||
59740321|NCT00736489|75859617|FG005|COMPLETED|Period 4||5||
59740322|NCT00736489|75859612|FG000|NOT COMPLETED|Period 4||0||
59740323|NCT00736489|75859613|FG001|NOT COMPLETED|Period 4||0||
59740324|NCT00736489|75859614|FG002|NOT COMPLETED|Period 4||0||
59740325|NCT00736489|75859615|FG003|NOT COMPLETED|Period 4||0||
59740326|NCT00736489|75859616|FG004|NOT COMPLETED|Period 4||0||
60134853|NCT03307252|76258160|FG007|STARTED|Part 1, Period 1||0||
59740327|NCT00736489|75859617|FG005|NOT COMPLETED|Period 4||0||
59740328|NCT00736489|75859612|FG000|STARTED|Period 5||5||
59740329|NCT00736489|75859613|FG001|STARTED|Period 5||5||
59740330|NCT00736489|75859614|FG002|STARTED|Period 5||6||
59740331|NCT00736489|75859615|FG003|STARTED|Period 5||7||
59740332|NCT00736489|75859616|FG004|STARTED|Period 5||7||
59740333|NCT00736489|75859617|FG005|STARTED|Period 5||5||
59740334|NCT00736489|75859612|FG000|COMPLETED|Period 5||5||
59740335|NCT00736489|75859613|FG001|COMPLETED|Period 5||5||
59740336|NCT00736489|75859614|FG002|COMPLETED|Period 5||6||
59740337|NCT00736489|75859615|FG003|COMPLETED|Period 5||7||
59740338|NCT00736489|75859616|FG004|COMPLETED|Period 5||7||
59740339|NCT00736489|75859617|FG005|COMPLETED|Period 5||5||
59740340|NCT00736489|75859612|FG000|NOT COMPLETED|Period 5||0||
59740341|NCT00736489|75859613|FG001|NOT COMPLETED|Period 5||0||
59740342|NCT00736489|75859614|FG002|NOT COMPLETED|Period 5||0||
59740343|NCT00736489|75859615|FG003|NOT COMPLETED|Period 5||0||
59740344|NCT00736489|75859616|FG004|NOT COMPLETED|Period 5||0||
59740345|NCT00736489|75859617|FG005|NOT COMPLETED|Period 5||0||
59740346|NCT00736489|75859612|FG000|STARTED|Period 6||5||
59740347|NCT00736489|75859613|FG001|STARTED|Period 6||5||
59740348|NCT00736489|75859614|FG002|STARTED|Period 6||6||
59740349|NCT00736489|75859615|FG003|STARTED|Period 6||7||
59740350|NCT00736489|75859616|FG004|STARTED|Period 6||7||
59740351|NCT00736489|75859617|FG005|STARTED|Period 6||5||
59740352|NCT00736489|75859612|FG000|COMPLETED|Period 6||5||
59740353|NCT00736489|75859613|FG001|COMPLETED|Period 6||5||
59740354|NCT00736489|75859614|FG002|COMPLETED|Period 6||6||
59740355|NCT00736489|75859615|FG003|COMPLETED|Period 6||7||
59740356|NCT00736489|75859616|FG004|COMPLETED|Period 6||7||
59740357|NCT00736489|75859617|FG005|COMPLETED|Period 6||5||
59740358|NCT00736489|75859612|FG000|NOT COMPLETED|Period 6||0||
59740359|NCT00736489|75859613|FG001|NOT COMPLETED|Period 6||0||
59740360|NCT00736489|75859614|FG002|NOT COMPLETED|Period 6||0||
59740361|NCT00736489|75859615|FG003|NOT COMPLETED|Period 6||0||
59740362|NCT00736489|75859616|FG004|NOT COMPLETED|Period 6||0||
59740363|NCT00736489|75859617|FG005|NOT COMPLETED|Period 6||0||
59740364|NCT02047929|75859634|FG000|STARTED|Overall Study||1503||10
59740365|NCT02047929|75859635|FG001|STARTED|Overall Study||2523||10
59740366|NCT02047929|75859636|FG002|STARTED|Overall Study||2248||10
59740367|NCT02047929|75859634|FG000|Practice Rollout|Overall Study||1503||10
59740368|NCT02047929|75859635|FG001|Practice Rollout|Overall Study||2523||10
59740369|NCT02047929|75859636|FG002|Practice Rollout|Overall Study|Per protocol, practice did not receive any intervention from practice facilitator|0||0
59740370|NCT02047929|75859634|FG000|Practice Refresher|Overall Study||1503||10
59740371|NCT02047929|75859635|FG001|Practice Refresher|Overall Study||2523||10
59740372|NCT02047929|75859636|FG002|Practice Refresher|Overall Study|Per protocol, practices did not receive any interaction from practice facilitator|0||0
59740373|NCT02047929|75859634|FG000|Surveys Collected|Overall Study||1503||10
59740374|NCT02047929|75859635|FG001|Surveys Collected|Overall Study||2523||10
59740375|NCT02047929|75859636|FG002|Surveys Collected|Overall Study|Per protocol, practice did not receive any interaction from practice facilitator|0||0
59740376|NCT02047929|75859634|FG000|COMPLETED|Overall Study||1503||10
59740377|NCT02047929|75859635|FG001|COMPLETED|Overall Study||2523||10
59740378|NCT02047929|75859636|FG002|COMPLETED|Overall Study||2248||10
59740379|NCT02047929|75859634|FG000|NOT COMPLETED|Overall Study||0||0
59740380|NCT02047929|75859635|FG001|NOT COMPLETED|Overall Study||0||0
59740381|NCT02047929|75859636|FG002|NOT COMPLETED|Overall Study||0||0
59740382|NCT00730327|75859649|FG000|STARTED|Overall Study|Started is defined as subjects that began treatment.|125||
59740383|NCT00730327|75859650|FG001|STARTED|Overall Study||130||
59740384|NCT00730327|75859649|FG000|Completed Week 26|Overall Study|Week 26 was halfway through the study, at which point the BIB group had their balloon removed.|125||
59740385|NCT00730327|75859650|FG001|Completed Week 26|Overall Study||99||
59740386|NCT00730327|75859649|FG000|COMPLETED|Overall Study|Completed defined as subjects who completed the Week 52 follow-up visit.|98||
59740387|NCT00730327|75859650|FG001|COMPLETED|Overall Study||93||
60134854|NCT03307252|76258161|FG008|STARTED|Part 1, Period 1||0||
60134855|NCT03307252|76258162|FG009|STARTED|Part 1, Period 1||0||
60134856|NCT03307252|76258163|FG010|STARTED|Part 1, Period 1||0||
60134857|NCT03307252|76258153|FG000|COMPLETED|Part 1, Period 1||4||
60134858|NCT03307252|76258154|FG001|COMPLETED|Part 1, Period 1||4||
60134859|NCT03307252|76258155|FG002|COMPLETED|Part 1, Period 1||4||
60134860|NCT03307252|76258156|FG003|COMPLETED|Part 1, Period 1||0||
60134861|NCT03307252|76258157|FG004|COMPLETED|Part 1, Period 1||0||
60134862|NCT03307252|76258158|FG005|COMPLETED|Part 1, Period 1||0||
60134863|NCT03307252|76258159|FG006|COMPLETED|Part 1, Period 1||0||
60134864|NCT03307252|76258160|FG007|COMPLETED|Part 1, Period 1||0||
60134865|NCT03307252|76258161|FG008|COMPLETED|Part 1, Period 1||0||
60134866|NCT03307252|76258162|FG009|COMPLETED|Part 1, Period 1||0||
60134867|NCT03307252|76258163|FG010|COMPLETED|Part 1, Period 1||0||
60134868|NCT03307252|76258153|FG000|NOT COMPLETED|Part 1, Period 1||0||
60134869|NCT03307252|76258154|FG001|NOT COMPLETED|Part 1, Period 1||0||
60134870|NCT03307252|76258155|FG002|NOT COMPLETED|Part 1, Period 1||0||
60134871|NCT03307252|76258156|FG003|NOT COMPLETED|Part 1, Period 1||0||
60134872|NCT03307252|76258157|FG004|NOT COMPLETED|Part 1, Period 1||0||
60134873|NCT03307252|76258158|FG005|NOT COMPLETED|Part 1, Period 1||0||
60134874|NCT03307252|76258159|FG006|NOT COMPLETED|Part 1, Period 1||0||
60134875|NCT03307252|76258160|FG007|NOT COMPLETED|Part 1, Period 1||0||
60134876|NCT03307252|76258161|FG008|NOT COMPLETED|Part 1, Period 1||0||
60134877|NCT03307252|76258162|FG009|NOT COMPLETED|Part 1, Period 1||0||
60134878|NCT03307252|76258163|FG010|NOT COMPLETED|Part 1, Period 1||0||
60134879|NCT03307252|76258153|FG000|STARTED|Part 1, Washout Period 1 (13 Days)||4||
60134880|NCT03307252|76258154|FG001|STARTED|Part 1, Washout Period 1 (13 Days)||4||
60134881|NCT03307252|76258155|FG002|STARTED|Part 1, Washout Period 1 (13 Days)||4||
60134882|NCT03307252|76258156|FG003|STARTED|Part 1, Washout Period 1 (13 Days)||0||
59740388|NCT00730327|75859649|FG000|NOT COMPLETED|Overall Study||27||
59740389|NCT00730327|75859650|FG001|NOT COMPLETED|Overall Study||37||
59740390|NCT01999569|75859656|FG000|STARTED|Control Cycle|First cycle no meds|10||
59740391|NCT01999569|75859656|FG000|COMPLETED|Control Cycle||10||
59740392|NCT01999569|75859656|FG000|NOT COMPLETED|Control Cycle||0||
59740393|NCT01999569|75859656|FG000|STARTED|Letrozole Treatment Cycle||10||
59740394|NCT01999569|75859656|FG000|COMPLETED|Letrozole Treatment Cycle||10||
59740395|NCT01999569|75859656|FG000|NOT COMPLETED|Letrozole Treatment Cycle||0||
60134883|NCT03307252|76258157|FG004|STARTED|Part 1, Washout Period 1 (13 Days)||0||
60134884|NCT03307252|76258158|FG005|STARTED|Part 1, Washout Period 1 (13 Days)||0||
60134885|NCT03307252|76258159|FG006|STARTED|Part 1, Washout Period 1 (13 Days)||0||
59740396|NCT00742417|75859665|FG000|STARTED|Randomized||21||
59740397|NCT00742417|75859666|FG001|STARTED|Randomized||21||
59740398|NCT00742417|75859665|FG000|COMPLETED|Randomized||19||
59740399|NCT00742417|75859666|FG001|COMPLETED|Randomized||20||
59740400|NCT00742417|75859665|FG000|NOT COMPLETED|Randomized||2||
59740401|NCT00742417|75859666|FG001|NOT COMPLETED|Randomized||1||
59740402|NCT00742417|75859665|FG000|STARTED|Intensive Period||19||
59740403|NCT00742417|75859666|FG001|STARTED|Intensive Period||20||
59740404|NCT00742417|75859665|FG000|COMPLETED|Intensive Period|16 patients completed all the 6 plasma exchange with Albutein 5% during the Intensive Period|16||
59740405|NCT00742417|75859666|FG001|COMPLETED|Intensive Period|19 control patients completed all the 6 plasma exchange during the Intensive Period|19||
59740406|NCT00742417|75859665|FG000|NOT COMPLETED|Intensive Period||3||
59740407|NCT00742417|75859666|FG001|NOT COMPLETED|Intensive Period||1||
59740408|NCT00742417|75859665|FG000|STARTED|Maintenance I||16||
59740409|NCT00742417|75859666|FG001|STARTED|Maintenance I||19||
59740410|NCT00742417|75859665|FG000|COMPLETED|Maintenance I||16||
59740411|NCT00742417|75859666|FG001|COMPLETED|Maintenance I||19||
59740412|NCT00742417|75859665|FG000|NOT COMPLETED|Maintenance I||0||
59740413|NCT00742417|75859666|FG001|NOT COMPLETED|Maintenance I||0||
59740414|NCT00742417|75859665|FG000|STARTED|Maintenance II||16||
59740415|NCT00742417|75859666|FG001|STARTED|Maintenance II||19||
59740416|NCT00742417|75859665|FG000|COMPLETED|Maintenance II||16||
59740417|NCT00742417|75859666|FG001|COMPLETED|Maintenance II||19||
59740418|NCT00742417|75859665|FG000|NOT COMPLETED|Maintenance II||0||
59740419|NCT00742417|75859666|FG001|NOT COMPLETED|Maintenance II||0||
59740420|NCT00811018|75859674|FG000|STARTED|Overall Study||1192||
59740421|NCT00811018|75859674|FG000|COMPLETED|Overall Study||224||
59740422|NCT00811018|75859674|FG000|NOT COMPLETED|Overall Study||968||
59740423|NCT04037085|75859678|FG000|STARTED|Overall Study||8||
59740424|NCT04037085|75859678|FG000|COMPLETED|Overall Study||8||
59740425|NCT04037085|75859678|FG000|NOT COMPLETED|Overall Study||0||
59740426|NCT00730171|75859683|FG000|STARTED|Overall Study||1725||
59740427|NCT00730171|75859683|FG000|CC Safety Population|Overall Study||607|met the modified Rome II criteria for chronic constipation (CC)|
59740428|NCT00730171|75859683|FG000|IBS-C Safety Population|Overall Study||1119|met the modified Rome II criteria for irritable bowel syndrome with constipation (IBS-C)|
59740429|NCT00730171|75859683|FG000|COMPLETED|Overall Study||954||
59740430|NCT00730171|75859683|FG000|NOT COMPLETED|Overall Study||771||
59740431|NCT00730015|75859694|FG000|STARTED|Overall Study||217||
59740432|NCT00730015|75859695|FG001|STARTED|Overall Study||217||
59740433|NCT00730015|75859696|FG002|STARTED|Overall Study||209||
59740434|NCT00730015|75859694|FG000|COMPLETED|Overall Study||186||
59740435|NCT00730015|75859695|FG001|COMPLETED|Overall Study||177||
59740436|NCT00730015|75859696|FG002|COMPLETED|Overall Study||177||
59740437|NCT00730015|75859694|FG000|NOT COMPLETED|Overall Study||31||
59740438|NCT00730015|75859695|FG001|NOT COMPLETED|Overall Study||40||
59740439|NCT00730015|75859696|FG002|NOT COMPLETED|Overall Study||32||
60134886|NCT03307252|76258160|FG007|STARTED|Part 1, Washout Period 1 (13 Days)||0||
60134887|NCT03307252|76258161|FG008|STARTED|Part 1, Washout Period 1 (13 Days)||0||
60134888|NCT03307252|76258162|FG009|STARTED|Part 1, Washout Period 1 (13 Days)||0||
59740440|NCT00806026|75859715|FG000|STARTED|Overall Study||185||
59740441|NCT00806026|75859716|FG001|STARTED|Overall Study||183||
59740442|NCT00806026|75859717|FG002|STARTED|Overall Study||182||
59740443|NCT00806026|75859718|FG003|STARTED|Overall Study||61||
59740444|NCT00806026|75859719|FG004|STARTED|Overall Study||59||
59740445|NCT00806026|75859720|FG005|STARTED|Overall Study||61||
59740446|NCT00806026|75859715|FG000|Treated|Overall Study||182||
59740447|NCT00806026|75859716|FG001|Treated|Overall Study||178||
59740448|NCT00806026|75859717|FG002|Treated|Overall Study||180||
59740449|NCT00806026|75859718|FG003|Treated|Overall Study||59||
59740450|NCT00806026|75859719|FG004|Treated|Overall Study||59||
59740451|NCT00806026|75859720|FG005|Treated|Overall Study||61||
60134889|NCT03307252|76258163|FG010|STARTED|Part 1, Washout Period 1 (13 Days)||0||
60134890|NCT03307252|76258153|FG000|COMPLETED|Part 1, Washout Period 1 (13 Days)||4||
60134891|NCT03307252|76258154|FG001|COMPLETED|Part 1, Washout Period 1 (13 Days)||4||
60134892|NCT03307252|76258155|FG002|COMPLETED|Part 1, Washout Period 1 (13 Days)||4||
60134893|NCT03307252|76258156|FG003|COMPLETED|Part 1, Washout Period 1 (13 Days)||0||
60134894|NCT03307252|76258157|FG004|COMPLETED|Part 1, Washout Period 1 (13 Days)||0||
60134895|NCT03307252|76258158|FG005|COMPLETED|Part 1, Washout Period 1 (13 Days)||0||
60134896|NCT03307252|76258159|FG006|COMPLETED|Part 1, Washout Period 1 (13 Days)||0||
59740452|NCT00806026|75859715|FG000|COMPLETED|Overall Study||93||
59740453|NCT00806026|75859716|FG001|COMPLETED|Overall Study||82||
59740454|NCT00806026|75859717|FG002|COMPLETED|Overall Study||89||
59740455|NCT00806026|75859718|FG003|COMPLETED|Overall Study||32||
59740456|NCT00806026|75859719|FG004|COMPLETED|Overall Study||29||
60134897|NCT03307252|76258160|FG007|COMPLETED|Part 1, Washout Period 1 (13 Days)||0||
59740457|NCT00806026|75859720|FG005|COMPLETED|Overall Study||29||
59740458|NCT00806026|75859715|FG000|NOT COMPLETED|Overall Study||92||
59740459|NCT00806026|75859716|FG001|NOT COMPLETED|Overall Study||101||
59740460|NCT00806026|75859717|FG002|NOT COMPLETED|Overall Study||93||
59740461|NCT00806026|75859718|FG003|NOT COMPLETED|Overall Study||29||
59740462|NCT00806026|75859719|FG004|NOT COMPLETED|Overall Study||30||
59740463|NCT00806026|75859720|FG005|NOT COMPLETED|Overall Study||32||
59740464|NCT04026165|75859735|FG000|STARTED|Run-in Placebo Period|Following the screening period, eligible participants were enrolled into Run-in Placebo period for at least one week.|384||
59740465|NCT04026165|75859736|FG001|STARTED|Run-in Placebo Period||0||
59740466|NCT04026165|75859737|FG002|STARTED|Run-in Placebo Period||0||
59740467|NCT04026165|75859738|FG003|STARTED|Run-in Placebo Period||0||
59740468|NCT04026165|75859735|FG000|COMPLETED|Run-in Placebo Period||362||
59740469|NCT04026165|75859736|FG001|COMPLETED|Run-in Placebo Period||0||
59740470|NCT04026165|75859737|FG002|COMPLETED|Run-in Placebo Period||0||
59740471|NCT04026165|75859738|FG003|COMPLETED|Run-in Placebo Period||0||
59740472|NCT04026165|75859735|FG000|NOT COMPLETED|Run-in Placebo Period||22||
59740473|NCT04026165|75859736|FG001|NOT COMPLETED|Run-in Placebo Period||0||
59740474|NCT04026165|75859737|FG002|NOT COMPLETED|Run-in Placebo Period||0||
59740475|NCT04026165|75859738|FG003|NOT COMPLETED|Run-in Placebo Period||0||
59740476|NCT04026165|75859735|FG000|STARTED|Run-in SEL Period|Following the Run-in Placebo period, participants took SEL (18 mg) for at least 4 weeks in Run-in SEL period.|0||
59740477|NCT04026165|75859736|FG001|STARTED|Run-in SEL Period|Following the Run-in Placebo period, participants took SEL (18 mg) for at least 4 weeks in Run-in SEL period.|357||
59740478|NCT04026165|75859737|FG002|STARTED|Run-in SEL Period||0||
59740479|NCT04026165|75859738|FG003|STARTED|Run-in SEL Period||0||
59740480|NCT04026165|75859735|FG000|COMPLETED|Run-in SEL Period||0||
59740481|NCT04026165|75859736|FG001|COMPLETED|Run-in SEL Period||311||
59740482|NCT04026165|75859737|FG002|COMPLETED|Run-in SEL Period||0||
59740483|NCT04026165|75859738|FG003|COMPLETED|Run-in SEL Period||0||
59740484|NCT04026165|75859735|FG000|NOT COMPLETED|Run-in SEL Period||0||
59740485|NCT04026165|75859736|FG001|NOT COMPLETED|Run-in SEL Period||46||
59740486|NCT04026165|75859737|FG002|NOT COMPLETED|Run-in SEL Period||0||
59740487|NCT04026165|75859738|FG003|NOT COMPLETED|Run-in SEL Period||0||
59740488|NCT04026165|75859735|FG000|STARTED|Randomized Period||0||
59740489|NCT04026165|75859736|FG001|STARTED|Randomized Period|Following the Run-in period, eligible participants were randomized to receive either SEL (18 mg) or placebo.|0||
59740490|NCT04026165|75859737|FG002|STARTED|Randomized Period|Following the Run-in period, eligible participants were randomized to receive either SEL (18 mg) or placebo.|154||
59740491|NCT04026165|75859738|FG003|STARTED|Randomized Period|Following the Run-in period, eligible participants were randomized to receive either SEL (18 mg) or placebo.|156||
59740492|NCT04026165|75859735|FG000|COMPLETED|Randomized Period||0||
59740493|NCT04026165|75859736|FG001|COMPLETED|Randomized Period||0||
59740494|NCT04026165|75859737|FG002|COMPLETED|Randomized Period||140||
59740495|NCT04026165|75859738|FG003|COMPLETED|Randomized Period||137||
59740496|NCT04026165|75859735|FG000|NOT COMPLETED|Randomized Period||0||
59740497|NCT04026165|75859736|FG001|NOT COMPLETED|Randomized Period||0||
59740498|NCT04026165|75859737|FG002|NOT COMPLETED|Randomized Period||14||
59740499|NCT04026165|75859738|FG003|NOT COMPLETED|Randomized Period||19||
59740500|NCT00805792|75859746|FG000|STARTED|Overall Study||33||
59740501|NCT00805792|75859746|FG000|COMPLETED|Overall Study||28||
59740502|NCT00805792|75859746|FG000|NOT COMPLETED|Overall Study||5||
59740503|NCT00590044|75859752|FG000|STARTED|Overall Study||38||
59740504|NCT00590044|75859753|FG001|STARTED|Overall Study||36||
59740505|NCT00590044|75859752|FG000|COMPLETED|Overall Study||34||
59740506|NCT00590044|75859753|FG001|COMPLETED|Overall Study||34||
59740507|NCT00590044|75859752|FG000|NOT COMPLETED|Overall Study||4||
59740508|NCT00590044|75859753|FG001|NOT COMPLETED|Overall Study||2||
59740509|NCT00805480|75859766|FG000|STARTED|Overall Study||30||
59740510|NCT00805480|75859767|FG001|STARTED|Overall Study||29||
59740511|NCT00805480|75859768|FG002|STARTED|Overall Study||31||
59740512|NCT00805480|75859769|FG003|STARTED|Overall Study||10||
59740513|NCT00805480|75859766|FG000|Pharmacodynamic Analysis Set|Overall Study||30||
59740514|NCT00805480|75859767|FG001|Pharmacodynamic Analysis Set|Overall Study||25||
59740515|NCT00805480|75859768|FG002|Pharmacodynamic Analysis Set|Overall Study||29||
59740516|NCT00805480|75859769|FG003|Pharmacodynamic Analysis Set|Overall Study||10||
59740517|NCT00805480|75859766|FG000|COMPLETED|Overall Study||16||
59740518|NCT00805480|75859767|FG001|COMPLETED|Overall Study||22||
59740519|NCT00805480|75859768|FG002|COMPLETED|Overall Study||19||
59740520|NCT00805480|75859769|FG003|COMPLETED|Overall Study||5||
59740521|NCT00805480|75859766|FG000|NOT COMPLETED|Overall Study||14||
59740522|NCT00805480|75859767|FG001|NOT COMPLETED|Overall Study||7||
59740523|NCT00805480|75859768|FG002|NOT COMPLETED|Overall Study||12||
59740524|NCT00805480|75859769|FG003|NOT COMPLETED|Overall Study||5||
59740525|NCT00729937|75859785|FG000|STARTED|Overall Study||629||
59740526|NCT00729937|75859786|FG001|STARTED|Overall Study||636||
59740527|NCT00729937|75859787|FG002|STARTED|Overall Study||251||
59740528|NCT00729937|75859788|FG003|STARTED|Overall Study||249||
59740529|NCT00729937|75859789|FG004|STARTED|Overall Study||249||
59740530|NCT00729937|75859790|FG005|STARTED|Overall Study||251||
59740531|NCT00729937|75859785|FG000|COMPLETED|Overall Study||555||
59740532|NCT00729937|75859786|FG001|COMPLETED|Overall Study||548||
59740533|NCT00729937|75859787|FG002|COMPLETED|Overall Study||222||
59740534|NCT00729937|75859788|FG003|COMPLETED|Overall Study||215||
59740535|NCT00729937|75859789|FG004|COMPLETED|Overall Study||221||
59740536|NCT00729937|75859790|FG005|COMPLETED|Overall Study||214||
59740537|NCT00729937|75859785|FG000|NOT COMPLETED|Overall Study||74||
59740538|NCT00729937|75859786|FG001|NOT COMPLETED|Overall Study||88||
59740539|NCT00729937|75859787|FG002|NOT COMPLETED|Overall Study||29||
59740540|NCT00729937|75859788|FG003|NOT COMPLETED|Overall Study||34||
59740541|NCT00729937|75859789|FG004|NOT COMPLETED|Overall Study||28||
59740542|NCT00729937|75859790|FG005|NOT COMPLETED|Overall Study||37||
59740543|NCT00729859|75859807|FG000|STARTED|Overall Study||8||
59740544|NCT00729859|75859808|FG001|STARTED|Overall Study||8||
59740545|NCT00729859|75859809|FG002|STARTED|Overall Study||8||
59740546|NCT00729859|75859807|FG000|COMPLETED|Overall Study||8||
59740547|NCT00729859|75859808|FG001|COMPLETED|Overall Study||6||
59740548|NCT00729859|75859809|FG002|COMPLETED|Overall Study||8||
59740549|NCT00729859|75859807|FG000|NOT COMPLETED|Overall Study||0||
59740550|NCT00729859|75859808|FG001|NOT COMPLETED|Overall Study||2||
59740551|NCT00729859|75859809|FG002|NOT COMPLETED|Overall Study||0||
59740552|NCT00810394|75859825|FG000|STARTED|Overall Study||50||
59740553|NCT00810394|75859825|FG000|Cycle 2 600mg Twice Daily|Overall Study||13||
59740554|NCT00810394|75859825|FG000|Cycle 2 400mg Once Daily|Overall Study||22||
59740555|NCT00810394|75859825|FG000|Cycle 3 800 mg Twice Daily|Overall Study||4||
59740556|NCT00810394|75859825|FG000|Cycle 3 400mg Twice Daily|Overall Study||5||
59740557|NCT00810394|75859825|FG000|COMPLETED|Overall Study||47||
59740558|NCT00810394|75859825|FG000|NOT COMPLETED|Overall Study||3||
59740559|NCT00736333|75859829|FG000|STARTED|Overall Study||167||
59740560|NCT00736333|75859829|FG000|COMPLETED|Overall Study||56||
59740561|NCT00736333|75859829|FG000|NOT COMPLETED|Overall Study||111||
59740562|NCT00736255|75859835|FG000|STARTED|Overall Study||17||
59740563|NCT00736255|75859836|FG001|STARTED|Overall Study||15||
59740564|NCT00736255|75859835|FG000|COMPLETED|Overall Study||14||
59740565|NCT00736255|75859836|FG001|COMPLETED|Overall Study||14||
59740566|NCT00736255|75859835|FG000|NOT COMPLETED|Overall Study||3||
59740567|NCT00736255|75859836|FG001|NOT COMPLETED|Overall Study||1||
59740568|NCT03920254|75859845|FG000|STARTED|Overall Study||13||
59740569|NCT03920254|75859846|FG001|STARTED|Overall Study||18||
59740570|NCT03920254|75859847|FG002|STARTED|Overall Study||15||
59740571|NCT03920254|75859845|FG000|COMPLETED|Overall Study||0||
59740572|NCT03920254|75859846|FG001|COMPLETED|Overall Study||0||
59740573|NCT03920254|75859847|FG002|COMPLETED|Overall Study||0||
59740574|NCT03920254|75859845|FG000|NOT COMPLETED|Overall Study||13||
59740575|NCT03920254|75859846|FG001|NOT COMPLETED|Overall Study||18||
59740576|NCT03920254|75859847|FG002|NOT COMPLETED|Overall Study||15||
59740577|NCT00729469|75859857|FG000|STARTED|Overall Study||456||
59740578|NCT00729469|75859858|FG001|STARTED|Overall Study||463||
59740579|NCT00729469|75859857|FG000|COMPLETED|Overall Study||403||
59740580|NCT00729469|75859858|FG001|COMPLETED|Overall Study||416||
59740581|NCT00729469|75859857|FG000|NOT COMPLETED|Overall Study||53||
59740582|NCT00729469|75859858|FG001|NOT COMPLETED|Overall Study||47||
59740583|NCT00742183|75859866|FG000|STARTED|Overall Study|50 subjects randomised, one of them did not receive any treatment.|49||
59740584|NCT00742183|75859867|FG001|STARTED|Overall Study||51||
59740585|NCT00742183|75859866|FG000|COMPLETED|Overall Study||40||
59740586|NCT00742183|75859867|FG001|COMPLETED|Overall Study||39||
59740587|NCT00742183|75859866|FG000|NOT COMPLETED|Overall Study||9||
59740588|NCT00742183|75859867|FG001|NOT COMPLETED|Overall Study||12||
59740589|NCT00808444|75859875|FG000|STARTED|Overall Study||233||
59740590|NCT00808444|75859876|FG001|STARTED|Overall Study||233||
59740591|NCT00808444|75859875|FG000|COMPLETED|Overall Study||232||
59740592|NCT00808444|75859876|FG001|COMPLETED|Overall Study||232||
59740593|NCT00808444|75859875|FG000|NOT COMPLETED|Overall Study||1||
59740594|NCT00808444|75859876|FG001|NOT COMPLETED|Overall Study||1||
59740595|NCT00742027|75859882|FG000|STARTED|Overall Study||129||
59740596|NCT00742027|75859882|FG000|COMPLETED|Overall Study||0|Deaths reported included deaths that occurred more than 28 days after treatment discontinuation.|
59740597|NCT00742027|75859882|FG000|NOT COMPLETED|Overall Study||129||
59740598|NCT03996369|75859888|FG000|STARTED|Overall Study||238||
59740599|NCT03996369|75859889|FG001|STARTED|Overall Study||116||
59740600|NCT03996369|75859888|FG000|COMPLETED|Overall Study||213||
59740601|NCT03996369|75859889|FG001|COMPLETED|Overall Study||103||
59740602|NCT03996369|75859888|FG000|NOT COMPLETED|Overall Study||25||
59740603|NCT03996369|75859889|FG001|NOT COMPLETED|Overall Study||13||
59740604|NCT00808210|75859897|FG000|STARTED|Study Period + 48 Weeks of Follow-up||15||
59740605|NCT00808210|75859898|FG001|STARTED|Study Period + 48 Weeks of Follow-up||13||
59740606|NCT00808210|75859897|FG000|COMPLETED|Study Period + 48 Weeks of Follow-up||6||
59740607|NCT00808210|75859898|FG001|COMPLETED|Study Period + 48 Weeks of Follow-up||4||
59740608|NCT00808210|75859897|FG000|NOT COMPLETED|Study Period + 48 Weeks of Follow-up||9||
59740609|NCT00808210|75859898|FG001|NOT COMPLETED|Study Period + 48 Weeks of Follow-up||9||
59740610|NCT00808210|75859897|FG000|STARTED|Double-Blind TX Period||15||
59740611|NCT00808210|75859898|FG001|STARTED|Double-Blind TX Period||13||
59740612|NCT00808210|75859897|FG000|COMPLETED|Double-Blind TX Period||13||
59740613|NCT00808210|75859898|FG001|COMPLETED|Double-Blind TX Period||10||
59740614|NCT00808210|75859897|FG000|NOT COMPLETED|Double-Blind TX Period||2||
59740615|NCT00808210|75859898|FG001|NOT COMPLETED|Double-Blind TX Period||3||
59740616|NCT00808210|75859897|FG000|STARTED|Open Label Ocrelizumab Treatment Period||9||
59740617|NCT00808210|75859898|FG001|STARTED|Open Label Ocrelizumab Treatment Period||4||
59740618|NCT00808210|75859897|FG000|COMPLETED|Open Label Ocrelizumab Treatment Period||0||
59740619|NCT00808210|75859898|FG001|COMPLETED|Open Label Ocrelizumab Treatment Period||0||
59740620|NCT00808210|75859897|FG000|NOT COMPLETED|Open Label Ocrelizumab Treatment Period||9||
59740621|NCT00808210|75859898|FG001|NOT COMPLETED|Open Label Ocrelizumab Treatment Period||4||
59740622|NCT00736099|75859906|FG000|STARTED|Overall Study|Number who started treatment.|1532||
59740623|NCT00736099|75859907|FG001|STARTED|Overall Study|Number who started treatment.|589||
59740624|NCT00736099|75859906|FG000|COMPLETED|Overall Study|Number who completed treatment.|1349||
59740625|NCT00736099|75859907|FG001|COMPLETED|Overall Study|Number who completed treatment.|531||
59740626|NCT00736099|75859906|FG000|NOT COMPLETED|Overall Study||183||
59740627|NCT00736099|75859907|FG001|NOT COMPLETED|Overall Study||58||
59740628|NCT00735943|75859913|FG000|STARTED|Overall Study||22||
59740629|NCT00735943|75859913|FG000|COMPLETED|Overall Study||20||
59740630|NCT00735943|75859913|FG000|NOT COMPLETED|Overall Study||2||
59740631|NCT00735709|75859921|FG000|STARTED|Overall Study||140||
59740632|NCT00735709|75859922|FG001|STARTED|Overall Study||140||
59740633|NCT00735709|75859923|FG002|STARTED|Overall Study||140||
59740634|NCT00735709|75859924|FG003|STARTED|Overall Study||140||
59740635|NCT00735709|75859921|FG000|Treated|Overall Study||140||
59740636|NCT00735709|75859922|FG001|Treated|Overall Study||140||
59740637|NCT00735709|75859923|FG002|Treated|Overall Study||140||
59740638|NCT00735709|75859924|FG003|Treated|Overall Study||139||
59740639|NCT00735709|75859921|FG000|COMPLETED|Overall Study||127||
59740640|NCT00735709|75859922|FG001|COMPLETED|Overall Study||127||
59740641|NCT00735709|75859923|FG002|COMPLETED|Overall Study||129||
59740642|NCT00735709|75859924|FG003|COMPLETED|Overall Study||122||
59740643|NCT00735709|75859921|FG000|NOT COMPLETED|Overall Study||13||
59740644|NCT00735709|75859922|FG001|NOT COMPLETED|Overall Study||13||
59740645|NCT00735709|75859923|FG002|NOT COMPLETED|Overall Study||11||
59740646|NCT00735709|75859924|FG003|NOT COMPLETED|Overall Study||18||
59740647|NCT00729157|75859934|FG000|STARTED|Overall Study||41||
59740648|NCT00729157|75859934|FG000|COMPLETED|Overall Study||40||
59740649|NCT00729157|75859934|FG000|NOT COMPLETED|Overall Study||1||
59740650|NCT00728689|75859940|FG000|STARTED|First Intervention (Days 1 - 3)||6||
59740651|NCT00728689|75859941|FG001|STARTED|First Intervention (Days 1 - 3)||6||
59740652|NCT00728689|75859940|FG000|COMPLETED|First Intervention (Days 1 - 3)||6||
59740653|NCT00728689|75859941|FG001|COMPLETED|First Intervention (Days 1 - 3)||6||
59740654|NCT00728689|75859940|FG000|NOT COMPLETED|First Intervention (Days 1 - 3)||0||
59740655|NCT00728689|75859941|FG001|NOT COMPLETED|First Intervention (Days 1 - 3)||0||
59740656|NCT00728689|75859940|FG000|STARTED|Washout Period (Days 4 - 10)||6||
59740657|NCT00728689|75859941|FG001|STARTED|Washout Period (Days 4 - 10)||6||
59740658|NCT00728689|75859940|FG000|COMPLETED|Washout Period (Days 4 - 10)|Death in family during the Washout period. Completed First Intervention period with ST-246 Form I.|5||
59740659|NCT00728689|75859941|FG001|COMPLETED|Washout Period (Days 4 - 10)||6||
59740660|NCT00728689|75859940|FG000|NOT COMPLETED|Washout Period (Days 4 - 10)||1||
59740661|NCT00728689|75859941|FG001|NOT COMPLETED|Washout Period (Days 4 - 10)||0||
59740662|NCT00728689|75859940|FG000|STARTED|Second Intervention (Days 11 - 13)||5||
59740663|NCT00728689|75859941|FG001|STARTED|Second Intervention (Days 11 - 13)||6||
59740664|NCT00728689|75859940|FG000|COMPLETED|Second Intervention (Days 11 - 13)||5||
59740665|NCT00728689|75859941|FG001|COMPLETED|Second Intervention (Days 11 - 13)||6||
59740666|NCT00728689|75859940|FG000|NOT COMPLETED|Second Intervention (Days 11 - 13)||0||
59740667|NCT00728689|75859941|FG001|NOT COMPLETED|Second Intervention (Days 11 - 13)||0||
59740668|NCT00727909|75859949|FG000|STARTED|Overall Study||65||
59740669|NCT00727909|75859950|FG001|STARTED|Overall Study||72||
59740670|NCT00727909|75859951|FG002|STARTED|Overall Study||67||
59740671|NCT00727909|75859952|FG003|STARTED|Overall Study||75||
59740672|NCT00727909|75859949|FG000|COMPLETED|Overall Study||60||
59872988|NCT03131440|75997115|FG029|COMPLETED|Overall Study||7|Completed the 24 week questionnaires OR had valid data on the accelerometer at 24 weeks|
59872989|NCT03131440|75997116|FG030|COMPLETED|Overall Study||8|Completed the 24 week questionnaires OR had valid data on the accelerometer at 24 weeks|
59740673|NCT00727909|75859950|FG001|COMPLETED|Overall Study||61||
59740674|NCT00727909|75859951|FG002|COMPLETED|Overall Study||58||
59740675|NCT00727909|75859952|FG003|COMPLETED|Overall Study||70||
59740676|NCT00727909|75859949|FG000|NOT COMPLETED|Overall Study||5||
59740677|NCT00727909|75859950|FG001|NOT COMPLETED|Overall Study||11||
59740678|NCT00727909|75859951|FG002|NOT COMPLETED|Overall Study||9||
59740679|NCT00727909|75859952|FG003|NOT COMPLETED|Overall Study||5||
59740680|NCT00726895|75859956|FG000|STARTED|First Intervention||12||
59740681|NCT00726895|75859957|FG001|STARTED|First Intervention||12||
59740682|NCT00726895|75859956|FG000|COMPLETED|First Intervention||12||
59740683|NCT00726895|75859957|FG001|COMPLETED|First Intervention||12||
59740684|NCT00726895|75859956|FG000|NOT COMPLETED|First Intervention||0||
59740685|NCT00726895|75859957|FG001|NOT COMPLETED|First Intervention||0||
59740686|NCT00726895|75859956|FG000|STARTED|Washout Period of 7 Days||12||
59950735|NCT03536884|76069558|FG002|NOT COMPLETED|Maintenance Treatment Period Week 16-48||10||
59740687|NCT00726895|75859957|FG001|STARTED|Washout Period of 7 Days||12||
59740688|NCT00726895|75859956|FG000|COMPLETED|Washout Period of 7 Days||12||
59740689|NCT00726895|75859957|FG001|COMPLETED|Washout Period of 7 Days||11||
59740690|NCT00726895|75859956|FG000|NOT COMPLETED|Washout Period of 7 Days||0||
59740691|NCT00726895|75859957|FG001|NOT COMPLETED|Washout Period of 7 Days||1||
59740692|NCT00726895|75859956|FG000|STARTED|Second Intervention||12||
59740693|NCT00726895|75859957|FG001|STARTED|Second Intervention||11||
59740694|NCT00726895|75859956|FG000|COMPLETED|Second Intervention||12||
59740695|NCT00726895|75859957|FG001|COMPLETED|Second Intervention||11||
59740696|NCT00726895|75859956|FG000|NOT COMPLETED|Second Intervention||0||
59740697|NCT00726895|75859957|FG001|NOT COMPLETED|Second Intervention||0||
59740698|NCT00585325|75859966|FG000|STARTED|Overall Study||10||20
59740699|NCT00585325|75859967|FG001|STARTED|Overall Study||13||21
59740700|NCT00585325|75859966|FG000|COMPLETED|Overall Study||9||14
59740701|NCT00585325|75859967|FG001|COMPLETED|Overall Study||12||18
59740702|NCT00585325|75859966|FG000|NOT COMPLETED|Overall Study||1||6
59740703|NCT00585325|75859967|FG001|NOT COMPLETED|Overall Study||1||3
59740704|NCT00726661|75859975|FG000|STARTED|Overall Study||832||
59740705|NCT00726661|75859976|FG001|STARTED|Overall Study||435||
59740706|NCT00726661|75859975|FG000|COMPLETED|Overall Study||18||
59740707|NCT00726661|75859976|FG001|COMPLETED|Overall Study||17||
59740708|NCT00726661|75859975|FG000|NOT COMPLETED|Overall Study||814||
59740709|NCT00726661|75859976|FG001|NOT COMPLETED|Overall Study||418||
59740710|NCT03821337|75859985|FG000|STARTED|Overall Study||1||
59740711|NCT03821337|75859986|FG001|STARTED|Overall Study||0||
59740712|NCT03821337|75859985|FG000|COMPLETED|Overall Study||1||
59740713|NCT03821337|75859986|FG001|COMPLETED|Overall Study||0||
59740714|NCT03821337|75859985|FG000|NOT COMPLETED|Overall Study||0||
59740715|NCT03821337|75859986|FG001|NOT COMPLETED|Overall Study||0||
59740716|NCT00741091|75859992|FG000|STARTED|Overall Study||1097||
59740717|NCT00741091|75859992|FG000|COMPLETED|Overall Study||1040||
59740718|NCT00741091|75859992|FG000|NOT COMPLETED|Overall Study||57||
59740719|NCT00741013|75859999|FG000|STARTED|Overall Study||7||
59740720|NCT00741013|75860000|FG001|STARTED|Overall Study||8||
59740721|NCT00741013|75860001|FG002|STARTED|Overall Study||7||
59740722|NCT00741013|75859999|FG000|COMPLETED|Overall Study||6||
59740723|NCT00741013|75860000|FG001|COMPLETED|Overall Study||6||
59740724|NCT00741013|75860001|FG002|COMPLETED|Overall Study||6||
59740725|NCT00741013|75859999|FG000|NOT COMPLETED|Overall Study||1||
59740726|NCT00741013|75860000|FG001|NOT COMPLETED|Overall Study||2||
59740727|NCT00741013|75860001|FG002|NOT COMPLETED|Overall Study||1||
59740728|NCT00740857|75860012|FG000|STARTED|Overall Study||33||
59740729|NCT00740857|75860013|FG001|STARTED|Overall Study||88||
59740730|NCT00740857|75860014|FG002|STARTED|Overall Study||90||
59740731|NCT00740857|75860012|FG000|COMPLETED|Overall Study||32||
59740732|NCT00740857|75860013|FG001|COMPLETED|Overall Study||88||
59740733|NCT00740857|75860014|FG002|COMPLETED|Overall Study||90||
59740734|NCT00740857|75860012|FG000|NOT COMPLETED|Overall Study||1||
59740735|NCT00740857|75860013|FG001|NOT COMPLETED|Overall Study||0||
59740736|NCT00740857|75860014|FG002|NOT COMPLETED|Overall Study||0||
59740737|NCT00808132|75860027|FG000|STARTED|Overall Study||455||
59740738|NCT00808132|75860028|FG001|STARTED|Overall Study||481||
59740739|NCT00808132|75860029|FG002|STARTED|Overall Study||239||
59740740|NCT00808132|75860030|FG003|STARTED|Overall Study||228||
59740741|NCT00808132|75860031|FG004|STARTED|Overall Study||483||
59740742|NCT00808132|75860027|FG000|Treated|Overall Study||445||
59740743|NCT00808132|75860028|FG001|Treated|Overall Study||474||
59740744|NCT00808132|75860029|FG002|Treated|Overall Study||230||
59740745|NCT00808132|75860030|FG003|Treated|Overall Study||220||
59740746|NCT00808132|75860031|FG004|Treated|Overall Study||474||
59740747|NCT00808132|75860027|FG000|COMPLETED|Overall Study||357||
59740748|NCT00808132|75860028|FG001|COMPLETED|Overall Study||393||
59740749|NCT00808132|75860029|FG002|COMPLETED|Overall Study||185||
59740750|NCT00808132|75860030|FG003|COMPLETED|Overall Study||159||
59740751|NCT00808132|75860031|FG004|COMPLETED|Overall Study||383||
59740752|NCT00808132|75860027|FG000|NOT COMPLETED|Overall Study||98||
59740753|NCT00808132|75860028|FG001|NOT COMPLETED|Overall Study||88||
59740754|NCT00808132|75860029|FG002|NOT COMPLETED|Overall Study||54||
59740755|NCT00808132|75860030|FG003|NOT COMPLETED|Overall Study||69||
59740756|NCT00808132|75860031|FG004|NOT COMPLETED|Overall Study||100||
59740757|NCT00727441|75860046|FG000|STARTED|Overall Study||29||
59740758|NCT00727441|75860047|FG001|STARTED|Overall Study||28||
59740759|NCT00727441|75860048|FG002|STARTED|Overall Study||30||
59740760|NCT00727441|75860046|FG000|COMPLETED|Overall Study||11||
59740761|NCT00727441|75860047|FG001|COMPLETED|Overall Study||6||
59740762|NCT00727441|75860048|FG002|COMPLETED|Overall Study||5||
59740763|NCT00727441|75860046|FG000|NOT COMPLETED|Overall Study||18||
59740764|NCT00727441|75860047|FG001|NOT COMPLETED|Overall Study||22||
59740765|NCT00727441|75860048|FG002|NOT COMPLETED|Overall Study||25||
59740766|NCT00717769|75860062|FG000|STARTED|Overall Study||120||
59740767|NCT00717769|75860063|FG001|STARTED|Overall Study||120||
59740768|NCT00717769|75860064|FG002|STARTED|Overall Study||30||
59740769|NCT00717769|75860062|FG000|COMPLETED|Overall Study||104||
59740770|NCT00717769|75860063|FG001|COMPLETED|Overall Study||102||
59740771|NCT00717769|75860064|FG002|COMPLETED|Overall Study||19||
59740772|NCT00717769|75860062|FG000|NOT COMPLETED|Overall Study||16||
59740773|NCT00717769|75860063|FG001|NOT COMPLETED|Overall Study||18||
59740774|NCT00717769|75860064|FG002|NOT COMPLETED|Overall Study||11||
59740775|NCT04153929|75860082|FG000|STARTED|Overall Study||60|Entered/Randomized|
59740776|NCT04153929|75860083|FG001|STARTED|Overall Study||50|Entered/Randomized|
59740777|NCT04153929|75860084|FG002|STARTED|Overall Study||50|Entered/Randomized|
59740778|NCT04153929|75860085|FG003|STARTED|Overall Study||52|Entered/Randomized|
59740779|NCT04153929|75860086|FG004|STARTED|Overall Study||50|Entered/Randomized|
59740780|NCT04153929|75860087|FG005|STARTED|Overall Study||51|Entered/Randomized|
59740781|NCT04153929|75860088|FG006|STARTED|Overall Study||50|Entered/Randomized|
59740782|NCT04153929|75860089|FG007|STARTED|Overall Study||50|Entered/Randomized|
59740783|NCT04153929|75860082|FG000|Treated|Overall Study||59||
59740784|NCT04153929|75860083|FG001|Treated|Overall Study||50||
59740785|NCT04153929|75860084|FG002|Treated|Overall Study||50||
59740786|NCT04153929|75860085|FG003|Treated|Overall Study||52||
59740787|NCT04153929|75860086|FG004|Treated|Overall Study||50||
59740788|NCT04153929|75860087|FG005|Treated|Overall Study||51||
59740789|NCT04153929|75860088|FG006|Treated|Overall Study||49||
59740790|NCT04153929|75860089|FG007|Treated|Overall Study||50||
59740791|NCT04153929|75860082|FG000|COMPLETED|Overall Study||49|Completed planned treatment|
59740792|NCT04153929|75860083|FG001|COMPLETED|Overall Study||41|Completed planned treatment|
59740793|NCT04153929|75860084|FG002|COMPLETED|Overall Study||45|Completed planned treatment|
59740794|NCT04153929|75860085|FG003|COMPLETED|Overall Study||36|Completed planned treatment|
59740795|NCT04153929|75860086|FG004|COMPLETED|Overall Study||33|Completed planned treatment|
60134898|NCT03307252|76258161|FG008|COMPLETED|Part 1, Washout Period 1 (13 Days)||0||
60134899|NCT03307252|76258162|FG009|COMPLETED|Part 1, Washout Period 1 (13 Days)||0||
59604347|NCT02059434|75714648|FG001|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0||
59740796|NCT04153929|75860087|FG005|COMPLETED|Overall Study||45|Completed planned treatment|
59740797|NCT04153929|75860088|FG006|COMPLETED|Overall Study||37|Completed planned treatment|
59740798|NCT04153929|75860089|FG007|COMPLETED|Overall Study||45|Completed planned treatment|
59740799|NCT04153929|75860082|FG000|NOT COMPLETED|Overall Study||11||
59740800|NCT04153929|75860083|FG001|NOT COMPLETED|Overall Study||9||
59740801|NCT04153929|75860084|FG002|NOT COMPLETED|Overall Study||5||
59740802|NCT04153929|75860085|FG003|NOT COMPLETED|Overall Study||16||
59740803|NCT04153929|75860086|FG004|NOT COMPLETED|Overall Study||17||
59740804|NCT04153929|75860087|FG005|NOT COMPLETED|Overall Study||6||
59740805|NCT04153929|75860088|FG006|NOT COMPLETED|Overall Study||13||
60134900|NCT03307252|76258163|FG010|COMPLETED|Part 1, Washout Period 1 (13 Days)||0||
60134901|NCT03307252|76258153|FG000|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0||
60134902|NCT03307252|76258154|FG001|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0||
60134903|NCT03307252|76258155|FG002|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0||
60134904|NCT03307252|76258156|FG003|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0||
60134905|NCT03307252|76258157|FG004|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0||
60134906|NCT03307252|76258158|FG005|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0||
60134907|NCT03307252|76258159|FG006|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0||
60134908|NCT03307252|76258160|FG007|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0||
60134909|NCT03307252|76258161|FG008|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0||
60134910|NCT03307252|76258162|FG009|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0||
60134911|NCT03307252|76258163|FG010|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0||
59604348|NCT02059434|75714649|FG002|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0||
59604349|NCT02059434|75714650|FG003|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0||
59604350|NCT02059434|75714651|FG004|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0||
59604351|NCT02059434|75714652|FG005|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0||
59604352|NCT02059434|75714653|FG006|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0||
59604353|NCT02059434|75714654|FG007|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0||
59604354|NCT02059434|75714655|FG008|COMPLETED|Period 7||36||
59604355|NCT02059434|75714647|FG000|NOT COMPLETED|Period 7||0||
59604356|NCT02059434|75714648|FG001|NOT COMPLETED|Period 7||0||
59604357|NCT02059434|75714649|FG002|NOT COMPLETED|Period 7||0||
59604358|NCT02059434|75714650|FG003|NOT COMPLETED|Period 7||0||
59604359|NCT02059434|75714651|FG004|NOT COMPLETED|Period 7||0||
59604360|NCT02059434|75714652|FG005|NOT COMPLETED|Period 7||0||
59740806|NCT04153929|75860089|FG007|NOT COMPLETED|Overall Study||5||
59740807|NCT00591214|75860107|FG000|STARTED|Overall Study||10||
59740808|NCT00591214|75860107|FG000|COMPLETED|Overall Study||2||
59740809|NCT00591214|75860107|FG000|NOT COMPLETED|Overall Study||8||
59740810|NCT00725725|75860114|FG000|STARTED|Overall Study||14||
59740811|NCT00725725|75860115|FG001|STARTED|Overall Study||15||
59740812|NCT00725725|75860116|FG002|STARTED|Overall Study||17||
59740813|NCT00725725|75860114|FG000|Treated|Overall Study||11||
59740814|NCT00725725|75860115|FG001|Treated|Overall Study||15||
59740815|NCT00725725|75860116|FG002|Treated|Overall Study||14||
59740816|NCT00725725|75860114|FG000|COMPLETED|Overall Study||10||
59740817|NCT00725725|75860115|FG001|COMPLETED|Overall Study||11||
59604361|NCT02059434|75714653|FG006|NOT COMPLETED|Period 7||0||
59740818|NCT00725725|75860116|FG002|COMPLETED|Overall Study||12||
59740819|NCT00725725|75860114|FG000|NOT COMPLETED|Overall Study||4||
60134912|NCT03307252|76258153|FG000|STARTED|Part 1, Period 2|Participants randomised in Part 1|4||
59740820|NCT00725725|75860115|FG001|NOT COMPLETED|Overall Study||4||
59740821|NCT00725725|75860116|FG002|NOT COMPLETED|Overall Study||5||
59740822|NCT00725101|75860124|FG000|STARTED|Overall Study||1700||
59740823|NCT00725101|75860124|FG000|COMPLETED|Overall Study||1205||
59740824|NCT00725101|75860124|FG000|NOT COMPLETED|Overall Study||495||
59740825|NCT00585169|75860128|FG000|STARTED|Overall Study||29||
59740826|NCT00585169|75860128|FG000|COMPLETED|Overall Study||28||
59740827|NCT00585169|75860128|FG000|NOT COMPLETED|Overall Study||1||
59740828|NCT00807742|75860136|FG000|STARTED|Overall Study||172||
59740829|NCT00807742|75860137|FG001|STARTED|Overall Study||168||
59740830|NCT00807742|75860136|FG000|COMPLETED|Overall Study||126||
59740831|NCT00807742|75860137|FG001|COMPLETED|Overall Study||114||
59740832|NCT00807742|75860136|FG000|NOT COMPLETED|Overall Study||46||
59740833|NCT00807742|75860137|FG001|NOT COMPLETED|Overall Study||54||
59740834|NCT00724945|75860143|FG000|STARTED|Period 1||58||
59740835|NCT00724945|75860144|FG001|STARTED|Period 1||55||
59740836|NCT00724945|75860143|FG000|COMPLETED|Period 1||55||
59740837|NCT00724945|75860144|FG001|COMPLETED|Period 1||54||
59740838|NCT00724945|75860143|FG000|NOT COMPLETED|Period 1||3||
59740839|NCT00724945|75860144|FG001|NOT COMPLETED|Period 1||1||
59740840|NCT00724945|75860143|FG000|STARTED|Period 2||55||
59740841|NCT00724945|75860144|FG001|STARTED|Period 2||54||
59740842|NCT00724945|75860143|FG000|COMPLETED|Period 2||51||
59740843|NCT00724945|75860144|FG001|COMPLETED|Period 2||54||
59740844|NCT00724945|75860143|FG000|NOT COMPLETED|Period 2||4||
59740845|NCT00724945|75860144|FG001|NOT COMPLETED|Period 2||0||
59740846|NCT00803452|75860152|FG000|STARTED|Overall Study||9||
59740847|NCT00803452|75860153|FG001|STARTED|Overall Study||22||
59740848|NCT00803452|75860152|FG000|COMPLETED|Overall Study||9||
59740849|NCT00803452|75860153|FG001|COMPLETED|Overall Study||17||
59740850|NCT00803452|75860152|FG000|NOT COMPLETED|Overall Study||0||
59740851|NCT00803452|75860153|FG001|NOT COMPLETED|Overall Study||5||
59740852|NCT00589108|75860162|FG000|STARTED|Overall Study||80||
59740853|NCT00589108|75860163|FG001|STARTED|Overall Study||80||
59740854|NCT00589108|75860164|FG002|STARTED|Overall Study||80||
59740855|NCT00589108|75860162|FG000|COMPLETED|Overall Study||76||
59740856|NCT00589108|75860163|FG001|COMPLETED|Overall Study||76||
59740857|NCT00589108|75860164|FG002|COMPLETED|Overall Study||75||
59740858|NCT00589108|75860162|FG000|NOT COMPLETED|Overall Study||4||
59740859|NCT00589108|75860163|FG001|NOT COMPLETED|Overall Study||4||
59740860|NCT00589108|75860164|FG002|NOT COMPLETED|Overall Study||5||
59740861|NCT00717067|75860177|FG000|STARTED|Part 1a: Normal/Mild/Moderate Group||6||
59740862|NCT00717067|75860178|FG001|STARTED|Part 1a: Normal/Mild/Moderate Group||6||
59740863|NCT00717067|75860179|FG002|STARTED|Part 1a: Normal/Mild/Moderate Group||6||
59740864|NCT00717067|75860180|FG003|STARTED|Part 1a: Normal/Mild/Moderate Group||0||
59740865|NCT00717067|75860181|FG004|STARTED|Part 1a: Normal/Mild/Moderate Group||0||
59740866|NCT00717067|75860177|FG000|COMPLETED|Part 1a: Normal/Mild/Moderate Group||6||
59740867|NCT00717067|75860178|FG001|COMPLETED|Part 1a: Normal/Mild/Moderate Group||6||
59740868|NCT00717067|75860179|FG002|COMPLETED|Part 1a: Normal/Mild/Moderate Group||5||
59740869|NCT00717067|75860180|FG003|COMPLETED|Part 1a: Normal/Mild/Moderate Group||0||
59740870|NCT00717067|75860181|FG004|COMPLETED|Part 1a: Normal/Mild/Moderate Group||0||
59740871|NCT00717067|75860177|FG000|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||0||
59740872|NCT00717067|75860178|FG001|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||0||
59740873|NCT00717067|75860179|FG002|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||1||
59740874|NCT00717067|75860180|FG003|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||0||
59740875|NCT00717067|75860181|FG004|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||0||
59740876|NCT00717067|75860177|FG000|STARTED|Part 1b: Severe Renal Impairment||0||
59740877|NCT00717067|75860178|FG001|STARTED|Part 1b: Severe Renal Impairment||0||
59740878|NCT00717067|75860179|FG002|STARTED|Part 1b: Severe Renal Impairment||0||
59740879|NCT00717067|75860180|FG003|STARTED|Part 1b: Severe Renal Impairment||6||
59740880|NCT00717067|75860181|FG004|STARTED|Part 1b: Severe Renal Impairment||0||
59740881|NCT00717067|75860177|FG000|COMPLETED|Part 1b: Severe Renal Impairment||0||
59740882|NCT00717067|75860178|FG001|COMPLETED|Part 1b: Severe Renal Impairment||0||
59740883|NCT00717067|75860179|FG002|COMPLETED|Part 1b: Severe Renal Impairment||0||
59740884|NCT00717067|75860180|FG003|COMPLETED|Part 1b: Severe Renal Impairment||6||
59740885|NCT00717067|75860181|FG004|COMPLETED|Part 1b: Severe Renal Impairment||0||
59740886|NCT00717067|75860177|FG000|NOT COMPLETED|Part 1b: Severe Renal Impairment||0||
59740887|NCT00717067|75860178|FG001|NOT COMPLETED|Part 1b: Severe Renal Impairment||0||
59740888|NCT00717067|75860179|FG002|NOT COMPLETED|Part 1b: Severe Renal Impairment||0||
59740889|NCT00717067|75860180|FG003|NOT COMPLETED|Part 1b: Severe Renal Impairment||0||
59740890|NCT00717067|75860181|FG004|NOT COMPLETED|Part 1b: Severe Renal Impairment||0||
59740891|NCT00717067|75860177|FG000|STARTED|Part 2: End Stage Renal Disease||0||
59740892|NCT00717067|75860178|FG001|STARTED|Part 2: End Stage Renal Disease||0||
59740893|NCT00717067|75860179|FG002|STARTED|Part 2: End Stage Renal Disease||0||
59740894|NCT00717067|75860180|FG003|STARTED|Part 2: End Stage Renal Disease||0||
59740895|NCT00717067|75860181|FG004|STARTED|Part 2: End Stage Renal Disease||6||
59740896|NCT00717067|75860177|FG000|COMPLETED|Part 2: End Stage Renal Disease||0||
59740897|NCT00717067|75860178|FG001|COMPLETED|Part 2: End Stage Renal Disease||0||
59740898|NCT00717067|75860179|FG002|COMPLETED|Part 2: End Stage Renal Disease||0||
59740899|NCT00717067|75860180|FG003|COMPLETED|Part 2: End Stage Renal Disease||0||
59740900|NCT00717067|75860181|FG004|COMPLETED|Part 2: End Stage Renal Disease||6||
59740901|NCT00717067|75860177|FG000|NOT COMPLETED|Part 2: End Stage Renal Disease||0||
59740902|NCT00717067|75860178|FG001|NOT COMPLETED|Part 2: End Stage Renal Disease||0||
59740903|NCT00717067|75860179|FG002|NOT COMPLETED|Part 2: End Stage Renal Disease||0||
59740904|NCT00717067|75860180|FG003|NOT COMPLETED|Part 2: End Stage Renal Disease||0||
59740905|NCT00717067|75860181|FG004|NOT COMPLETED|Part 2: End Stage Renal Disease||0||
59740906|NCT00802438|75860203|FG000|STARTED|Overall Study||38||
59740907|NCT00802438|75860203|FG000|COMPLETED|Overall Study||10||
59740908|NCT00802438|75860203|FG000|NOT COMPLETED|Overall Study||28||
59740909|NCT04283253|75860207|FG000|STARTED|Overall Study||1||
59740910|NCT04283253|75860207|FG000|COMPLETED|Overall Study||1||
59740911|NCT04283253|75860207|FG000|NOT COMPLETED|Overall Study||0||
59740912|NCT00588952|75860213|FG000|STARTED|Overall Study||29||
59740913|NCT00588952|75860214|FG001|STARTED|Overall Study||70||
59740914|NCT00588952|75860213|FG000|COMPLETED|Overall Study||26||
59740915|NCT00588952|75860214|FG001|COMPLETED|Overall Study||63||
59740916|NCT00588952|75860213|FG000|NOT COMPLETED|Overall Study||3||
59740917|NCT00588952|75860214|FG001|NOT COMPLETED|Overall Study||7||
59740918|NCT01021748|75860229|FG000|STARTED|Overall Study||6||
59740919|NCT01021748|75860230|FG001|STARTED|Overall Study||5||
59740920|NCT01021748|75860231|FG002|STARTED|Overall Study||7||
59740921|NCT01021748|75860232|FG003|STARTED|Overall Study||7||
59740922|NCT01021748|75860233|FG004|STARTED|Overall Study||9||
59740923|NCT01021748|75860234|FG005|STARTED|Overall Study||3||
59740924|NCT01021748|75860235|FG006|STARTED|Overall Study||3||
59740925|NCT01021748|75860236|FG007|STARTED|Overall Study||6||
59740926|NCT01021748|75860237|FG008|STARTED|Overall Study||17||
59740927|NCT01021748|75860229|FG000|Treated|Overall Study||6||
59740928|NCT01021748|75860230|FG001|Treated|Overall Study|One participant was allocated, but not treated.|4||
59740929|NCT01021748|75860231|FG002|Treated|Overall Study||7||
59740930|NCT01021748|75860232|FG003|Treated|Overall Study||7||
59740931|NCT01021748|75860233|FG004|Treated|Overall Study||9||
59740932|NCT01021748|75860234|FG005|Treated|Overall Study||3||
59740933|NCT01021748|75860235|FG006|Treated|Overall Study||3||
59740934|NCT01021748|75860236|FG007|Treated|Overall Study||6||
59740935|NCT01021748|75860237|FG008|Treated|Overall Study||17||
59740936|NCT01021748|75860229|FG000|COMPLETED|Overall Study||0||
59740937|NCT01021748|75860230|FG001|COMPLETED|Overall Study||0||
59740938|NCT01021748|75860231|FG002|COMPLETED|Overall Study||0||
59740939|NCT01021748|75860232|FG003|COMPLETED|Overall Study||0||
59740940|NCT01021748|75860233|FG004|COMPLETED|Overall Study||0||
59872990|NCT03131440|75997117|FG031|COMPLETED|Overall Study||8|Completed the 24 week questionnaires OR had valid data on the accelerometer at 24 weeks|
59872991|NCT03131440|75997086|FG000|NOT COMPLETED|Overall Study||1||
59872992|NCT03131440|75997087|FG001|NOT COMPLETED|Overall Study||3||
59872993|NCT03131440|75997088|FG002|NOT COMPLETED|Overall Study||0||
59872994|NCT03131440|75997089|FG003|NOT COMPLETED|Overall Study||0||
59872995|NCT03131440|75997090|FG004|NOT COMPLETED|Overall Study||1||
59872996|NCT03131440|75997091|FG005|NOT COMPLETED|Overall Study||1||
60134913|NCT03307252|76258154|FG001|STARTED|Part 1, Period 2|Participants randomised in Part 1|4||
59740941|NCT01021748|75860234|FG005|COMPLETED|Overall Study||0||
59740942|NCT01021748|75860235|FG006|COMPLETED|Overall Study||0||
59740943|NCT01021748|75860236|FG007|COMPLETED|Overall Study||0||
59740944|NCT01021748|75860237|FG008|COMPLETED|Overall Study||1||
59740945|NCT01021748|75860229|FG000|NOT COMPLETED|Overall Study||6||
59740946|NCT01021748|75860230|FG001|NOT COMPLETED|Overall Study||5||
59740947|NCT01021748|75860231|FG002|NOT COMPLETED|Overall Study||7||
59740948|NCT01021748|75860232|FG003|NOT COMPLETED|Overall Study||7||
59740949|NCT01021748|75860233|FG004|NOT COMPLETED|Overall Study||9||
59740950|NCT01021748|75860234|FG005|NOT COMPLETED|Overall Study||3||
59740951|NCT01021748|75860235|FG006|NOT COMPLETED|Overall Study||3||
59740952|NCT01021748|75860236|FG007|NOT COMPLETED|Overall Study||6||
59740953|NCT01021748|75860237|FG008|NOT COMPLETED|Overall Study||16||
59740954|NCT00802360|75860261|FG000|STARTED|Overall Study||42||
59740955|NCT00802360|75860262|FG001|STARTED|Overall Study||42||
59740956|NCT00802360|75860263|FG002|STARTED|Overall Study||42||
59740957|NCT00802360|75860264|FG003|STARTED|Overall Study||39||
59740958|NCT00802360|75860261|FG000|COMPLETED|Overall Study||18||
59740959|NCT00802360|75860262|FG001|COMPLETED|Overall Study||16||
59740960|NCT00802360|75860263|FG002|COMPLETED|Overall Study||17||
59740961|NCT00802360|75860264|FG003|COMPLETED|Overall Study||17||
59740962|NCT00802360|75860261|FG000|NOT COMPLETED|Overall Study||24||
59740963|NCT00802360|75860262|FG001|NOT COMPLETED|Overall Study||26||
59740964|NCT00802360|75860263|FG002|NOT COMPLETED|Overall Study||25||
59740965|NCT00802360|75860264|FG003|NOT COMPLETED|Overall Study||22||
59872997|NCT03131440|75997092|FG006|NOT COMPLETED|Overall Study||0||
60134914|NCT03307252|76258155|FG002|STARTED|Part 1, Period 2|Participants randomised in Part 1|4||
59740966|NCT01026038|75860279|FG000|STARTED|Overall Study||130||
59740967|NCT01026038|75860280|FG001|STARTED|Overall Study||65||
59740968|NCT01026038|75860281|FG002|STARTED|Overall Study||67||
59740969|NCT01026038|75860279|FG000|COMPLETED|Overall Study||129||
59740970|NCT01026038|75860280|FG001|COMPLETED|Overall Study||64||
59740971|NCT01026038|75860281|FG002|COMPLETED|Overall Study||67||
59740972|NCT01026038|75860279|FG000|NOT COMPLETED|Overall Study||1||
59740973|NCT01026038|75860280|FG001|NOT COMPLETED|Overall Study||1||
59740974|NCT01026038|75860281|FG002|NOT COMPLETED|Overall Study||0||
59740975|NCT02720211|75860291|FG000|STARTED|Overall Study||5||
59740976|NCT02720211|75860292|FG001|STARTED|Overall Study||5||
59740977|NCT02720211|75860291|FG000|COMPLETED|Overall Study||5||
59740978|NCT02720211|75860292|FG001|COMPLETED|Overall Study||5||
59740979|NCT02720211|75860291|FG000|NOT COMPLETED|Overall Study||0||
59740980|NCT02720211|75860292|FG001|NOT COMPLETED|Overall Study||0||
59740981|NCT00801892|75860300|FG000|STARTED|Main Study Period||12||
59740982|NCT00801892|75860301|FG001|STARTED|Main Study Period||11||
59740983|NCT00801892|75860300|FG000|COMPLETED|Main Study Period||12||
59740984|NCT00801892|75860301|FG001|COMPLETED|Main Study Period||10||
59740985|NCT00801892|75860300|FG000|NOT COMPLETED|Main Study Period||0||
59740986|NCT00801892|75860301|FG001|NOT COMPLETED|Main Study Period||1||
59740987|NCT00801892|75860300|FG000|STARTED|Sham Crossover Period||0||
59740988|NCT00801892|75860301|FG001|STARTED|Sham Crossover Period||7||
59740989|NCT00801892|75860300|FG000|COMPLETED|Sham Crossover Period||0||
59740990|NCT00801892|75860301|FG001|COMPLETED|Sham Crossover Period||5||
59740991|NCT00801892|75860300|FG000|NOT COMPLETED|Sham Crossover Period||0||
59740992|NCT00801892|75860301|FG001|NOT COMPLETED|Sham Crossover Period||2||
59740993|NCT03868839|75860309|FG000|STARTED|Overall Study||6||
59740994|NCT03868839|75860309|FG000|COMPLETED|Overall Study||5||
59740995|NCT03868839|75860309|FG000|NOT COMPLETED|Overall Study||1||
59740996|NCT02680587|75860315|FG000|STARTED|Overall Study||18||
59740997|NCT02680587|75860316|FG001|STARTED|Overall Study||36||
59740998|NCT02680587|75860315|FG000|COMPLETED|Overall Study||17||
59740999|NCT02680587|75860316|FG001|COMPLETED|Overall Study||36||
59741000|NCT02680587|75860315|FG000|NOT COMPLETED|Overall Study||1||
59741001|NCT02680587|75860316|FG001|NOT COMPLETED|Overall Study||0||
59741002|NCT00589420|75860326|FG000|STARTED|Overall Study||18||
59741003|NCT00589420|75860326|FG000|COMPLETED|Overall Study||17||
59741004|NCT00589420|75860326|FG000|NOT COMPLETED|Overall Study||1||
59741005|NCT01025336|75860335|FG000|STARTED|Overall Study||130||
59741006|NCT01025336|75860336|FG001|STARTED|Overall Study||210||
59741007|NCT01025336|75860337|FG002|STARTED|Overall Study||179||
59741008|NCT01025336|75860338|FG003|STARTED|Overall Study||221||
59741009|NCT01025336|75860339|FG004|STARTED|Overall Study||222||
59741010|NCT01025336|75860335|FG000|COMPLETED|Overall Study||130||
59741011|NCT01025336|75860336|FG001|COMPLETED|Overall Study||210||
59741012|NCT01025336|75860337|FG002|COMPLETED|Overall Study||179||
59741013|NCT01025336|75860338|FG003|COMPLETED|Overall Study||219||
59741014|NCT01025336|75860339|FG004|COMPLETED|Overall Study||222||
59741015|NCT01025336|75860335|FG000|NOT COMPLETED|Overall Study||0||
59741016|NCT01025336|75860336|FG001|NOT COMPLETED|Overall Study||0||
59741017|NCT01025336|75860337|FG002|NOT COMPLETED|Overall Study||0||
59741018|NCT01025336|75860338|FG003|NOT COMPLETED|Overall Study||2||
59741019|NCT01025336|75860339|FG004|NOT COMPLETED|Overall Study||0||
59741020|NCT03787095|75860365|FG000|STARTED|Overall Study||4||
59741021|NCT03787095|75860366|FG001|STARTED|Overall Study||1||
59741022|NCT03787095|75860365|FG000|COMPLETED|Overall Study||4||
59741023|NCT03787095|75860366|FG001|COMPLETED|Overall Study|Participant had final visit at study week 7 in accordance with decision from team after the study was closed.|1||
59741024|NCT03787095|75860365|FG000|NOT COMPLETED|Overall Study||0||
59741025|NCT03787095|75860366|FG001|NOT COMPLETED|Overall Study||0||
59741026|NCT00796978|75860373|FG000|STARTED|Overall Study||56||
59741027|NCT00796978|75860373|FG000|COMPLETED|Overall Study||44||
59741028|NCT00796978|75860373|FG000|NOT COMPLETED|Overall Study||12||
59741029|NCT00796822|75860379|FG000|STARTED|Overall Study||13||
59741030|NCT00796822|75860380|FG001|STARTED|Overall Study||13||
59741031|NCT00796822|75860379|FG000|COMPLETED|Overall Study||10||
59741032|NCT00796822|75860380|FG001|COMPLETED|Overall Study||13||
59741033|NCT00796822|75860379|FG000|NOT COMPLETED|Overall Study||3||
59741034|NCT00796822|75860380|FG001|NOT COMPLETED|Overall Study||0||
59741035|NCT01020812|75860386|FG000|STARTED|Overall Study||11||
59741036|NCT01020812|75860386|FG000|COMPLETED|Overall Study||8||
59741037|NCT01020812|75860386|FG000|NOT COMPLETED|Overall Study||3||
59741038|NCT01032044|75860392|FG000|STARTED|Overall Study||82||
59741039|NCT01032044|75860393|FG001|STARTED|Overall Study||82||
59741040|NCT01032044|75860392|FG000|Procedure|Overall Study||74||
59741041|NCT01032044|75860393|FG001|Procedure|Overall Study||75||
59741042|NCT01032044|75860392|FG000|COMPLETED|Overall Study||57||
59741043|NCT01032044|75860393|FG001|COMPLETED|Overall Study||62||
59741044|NCT01032044|75860392|FG000|NOT COMPLETED|Overall Study||25||
59741045|NCT01032044|75860393|FG001|NOT COMPLETED|Overall Study||20||
59741046|NCT01024946|75860399|FG000|STARTED|Overall Study||11||
59741047|NCT01024946|75860399|FG000|COMPLETED|Overall Study||6||
59741048|NCT01024946|75860399|FG000|NOT COMPLETED|Overall Study||5||
59741049|NCT00724867|75860403|FG000|STARTED|Overall Study||268||
59741050|NCT00724867|75860403|FG000|COMPLETED|Overall Study||140||
59741051|NCT00724867|75860403|FG000|NOT COMPLETED|Overall Study||128||
59741052|NCT00724711|75860412|FG000|STARTED|Overall Study||155||
59741053|NCT00724711|75860413|FG001|STARTED|Overall Study||156||
59741054|NCT00724711|75860412|FG000|COMPLETED|Overall Study||138||
59741055|NCT00724711|75860413|FG001|COMPLETED|Overall Study||139||
59741056|NCT00724711|75860412|FG000|NOT COMPLETED|Overall Study||17||
59741057|NCT00724711|75860413|FG001|NOT COMPLETED|Overall Study||17||
59741058|NCT01024244|75860424|FG000|STARTED|Overall Study||22||
59741059|NCT01024244|75860425|FG001|STARTED|Overall Study||12||
59741060|NCT01024244|75860426|FG002|STARTED|Overall Study||15||
59741061|NCT01024244|75860427|FG003|STARTED|Overall Study||14||
59741062|NCT01024244|75860428|FG004|STARTED|Overall Study||15||
59741063|NCT01024244|75860424|FG000|COMPLETED|Overall Study||5||
59741064|NCT01024244|75860425|FG001|COMPLETED|Overall Study||1||
59741065|NCT01024244|75860426|FG002|COMPLETED|Overall Study||1||
59741066|NCT01024244|75860427|FG003|COMPLETED|Overall Study||1||
59741067|NCT01024244|75860428|FG004|COMPLETED|Overall Study||1||
59741068|NCT01024244|75860424|FG000|NOT COMPLETED|Overall Study||17||
59741069|NCT01024244|75860425|FG001|NOT COMPLETED|Overall Study||11||
59741070|NCT01024244|75860426|FG002|NOT COMPLETED|Overall Study||14||
59741071|NCT01024244|75860427|FG003|NOT COMPLETED|Overall Study||13||
60134915|NCT03307252|76258156|FG003|STARTED|Part 1, Period 2||0||
60134916|NCT03307252|76258157|FG004|STARTED|Part 1, Period 2||0||
60134917|NCT03307252|76258158|FG005|STARTED|Part 1, Period 2||0||
60134918|NCT03307252|76258159|FG006|STARTED|Part 1, Period 2||0||
60134919|NCT03307252|76258160|FG007|STARTED|Part 1, Period 2||0||
60134920|NCT03307252|76258161|FG008|STARTED|Part 1, Period 2||0||
60134921|NCT03307252|76258162|FG009|STARTED|Part 1, Period 2||0||
60134922|NCT03307252|76258163|FG010|STARTED|Part 1, Period 2||0||
60134923|NCT03307252|76258153|FG000|COMPLETED|Part 1, Period 2||4||
60134924|NCT03307252|76258154|FG001|COMPLETED|Part 1, Period 2||4||
59741072|NCT01024244|75860428|FG004|NOT COMPLETED|Overall Study||14||
59741073|NCT00721279|75860442|FG000|STARTED|Overall Study||452||
59741074|NCT00721279|75860443|FG001|STARTED|Overall Study||97||
59741075|NCT00721279|75860442|FG000|COMPLETED|Overall Study||416||
59741076|NCT00721279|75860443|FG001|COMPLETED|Overall Study||73||
59741077|NCT00721279|75860442|FG000|NOT COMPLETED|Overall Study||36||
59741078|NCT00721279|75860443|FG001|NOT COMPLETED|Overall Study||24||
59741079|NCT01030952|75860452|FG000|STARTED|Overall Study||51||
59741080|NCT01030952|75860453|FG001|STARTED|Overall Study||52||
59741081|NCT01030952|75860452|FG000|COMPLETED|Overall Study||49||
59741082|NCT01030952|75860453|FG001|COMPLETED|Overall Study||49||
59741083|NCT01030952|75860452|FG000|NOT COMPLETED|Overall Study||2||
59741084|NCT01030952|75860453|FG001|NOT COMPLETED|Overall Study||3||
59741085|NCT01030874|75860463|FG000|STARTED|Overall Study|1 with impaired decision making capacity|178||
59741086|NCT01030874|75860464|FG001|STARTED|Overall Study|1 with impaired decision making capacity|178||
59741087|NCT01030874|75860463|FG000|COMPLETED|Overall Study||160||
59741088|NCT01030874|75860464|FG001|COMPLETED|Overall Study||162||
59741089|NCT01030874|75860463|FG000|NOT COMPLETED|Overall Study||18||
59741090|NCT01030874|75860464|FG001|NOT COMPLETED|Overall Study||16||
59741091|NCT03611751|75860473|FG000|STARTED|Pre-treatment||511||
59741092|NCT03611751|75860474|FG001|STARTED|Pre-treatment||255||
59741093|NCT03611751|75860475|FG002|STARTED|Pre-treatment||254||
59741094|NCT03611751|75860473|FG000|COMPLETED|Pre-treatment||510||
59741095|NCT03611751|75860474|FG001|COMPLETED|Pre-treatment||254||
59741096|NCT03611751|75860475|FG002|COMPLETED|Pre-treatment||254||
59741097|NCT03611751|75860473|FG000|NOT COMPLETED|Pre-treatment||1||
59741098|NCT03611751|75860474|FG001|NOT COMPLETED|Pre-treatment||1||
59741099|NCT03611751|75860475|FG002|NOT COMPLETED|Pre-treatment||0||
59741100|NCT03611751|75860473|FG000|STARTED|Treatment Week 0 - Week 16||510||
59741101|NCT03611751|75860474|FG001|STARTED|Treatment Week 0 - Week 16||254||
59741102|NCT03611751|75860475|FG002|STARTED|Treatment Week 0 - Week 16||254||
59741103|NCT03611751|75860473|FG000|COMPLETED|Treatment Week 0 - Week 16||456||
59741104|NCT03611751|75860474|FG001|COMPLETED|Treatment Week 0 - Week 16||212||
59741105|NCT03611751|75860475|FG002|COMPLETED|Treatment Week 0 - Week 16||217||
59741106|NCT03611751|75860473|FG000|NOT COMPLETED|Treatment Week 0 - Week 16||54||
59741107|NCT03611751|75860474|FG001|NOT COMPLETED|Treatment Week 0 - Week 16||42||
59741108|NCT03611751|75860475|FG002|NOT COMPLETED|Treatment Week 0 - Week 16||37||
59741109|NCT03611751|75860473|FG000|STARTED|Treatment Week 16 - Week 24||667||
59741110|NCT03611751|75860474|FG001|STARTED|Treatment Week 16 - Week 24||0||
59741111|NCT03611751|75860475|FG002|STARTED|Treatment Week 16 - Week 24||217||
59741112|NCT03611751|75860473|FG000|COMPLETED|Treatment Week 16 - Week 24||642||
59872998|NCT03131440|75997093|FG007|NOT COMPLETED|Overall Study||1||
59741113|NCT03611751|75860474|FG001|COMPLETED|Treatment Week 16 - Week 24||0||
59741114|NCT03611751|75860475|FG002|COMPLETED|Treatment Week 16 - Week 24||208||
59741115|NCT03611751|75860473|FG000|NOT COMPLETED|Treatment Week 16 - Week 24||25||
59872999|NCT03131440|75997094|FG008|NOT COMPLETED|Overall Study||1||
60134925|NCT03307252|76258155|FG002|COMPLETED|Part 1, Period 2||4||
60134926|NCT03307252|76258156|FG003|COMPLETED|Part 1, Period 2||0||
60134927|NCT03307252|76258157|FG004|COMPLETED|Part 1, Period 2||0||
60134928|NCT03307252|76258158|FG005|COMPLETED|Part 1, Period 2||0||
60134929|NCT03307252|76258159|FG006|COMPLETED|Part 1, Period 2||0||
60134930|NCT03307252|76258160|FG007|COMPLETED|Part 1, Period 2||0||
60134931|NCT03307252|76258161|FG008|COMPLETED|Part 1, Period 2||0||
60134932|NCT03307252|76258162|FG009|COMPLETED|Part 1, Period 2||0||
60134933|NCT03307252|76258163|FG010|COMPLETED|Part 1, Period 2||0||
59741116|NCT03611751|75860474|FG001|NOT COMPLETED|Treatment Week 16 - Week 24||0||
59741117|NCT03611751|75860475|FG002|NOT COMPLETED|Treatment Week 16 - Week 24||9||
59741118|NCT03611751|75860473|FG000|STARTED|Treatment Week 24 - Week 52||604||
59741119|NCT03611751|75860474|FG001|STARTED|Treatment Week 24 - Week 52||247||
59741120|NCT03611751|75860475|FG002|STARTED|Treatment Week 24 - Week 52||0||
59741121|NCT03611751|75860473|FG000|COMPLETED|Treatment Week 24 - Week 52||535||
59741122|NCT03611751|75860474|FG001|COMPLETED|Treatment Week 24 - Week 52||214||
60134934|NCT03307252|76258153|FG000|NOT COMPLETED|Part 1, Period 2||0||
60134935|NCT03307252|76258154|FG001|NOT COMPLETED|Part 1, Period 2||0||
60134936|NCT03307252|76258155|FG002|NOT COMPLETED|Part 1, Period 2||0||
60134937|NCT03307252|76258156|FG003|NOT COMPLETED|Part 1, Period 2||0||
60134938|NCT03307252|76258157|FG004|NOT COMPLETED|Part 1, Period 2||0||
60134939|NCT03307252|76258158|FG005|NOT COMPLETED|Part 1, Period 2||0||
60134940|NCT03307252|76258159|FG006|NOT COMPLETED|Part 1, Period 2||0||
60134941|NCT03307252|76258160|FG007|NOT COMPLETED|Part 1, Period 2||0||
60134942|NCT03307252|76258161|FG008|NOT COMPLETED|Part 1, Period 2||0||
60134943|NCT03307252|76258162|FG009|NOT COMPLETED|Part 1, Period 2||0||
60134944|NCT03307252|76258163|FG010|NOT COMPLETED|Part 1, Period 2||0||
59604362|NCT02059434|75714654|FG007|NOT COMPLETED|Period 7||0||
59604363|NCT02059434|75714655|FG008|NOT COMPLETED|Period 7||0||
59604364|NCT02059434|75714647|FG000|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0||
59604365|NCT02059434|75714648|FG001|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0||
59604366|NCT02059434|75714649|FG002|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0||
59604367|NCT02059434|75714650|FG003|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0||
59604368|NCT02059434|75714651|FG004|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0||
59604369|NCT02059434|75714652|FG005|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0||
59604370|NCT02059434|75714653|FG006|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0||
59604371|NCT02059434|75714654|FG007|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0||
59604372|NCT02059434|75714655|FG008|STARTED|Washout Between Periods 7 and 8||36||
59604373|NCT02059434|75714647|FG000|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0||
59604374|NCT02059434|75714648|FG001|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0||
59604375|NCT02059434|75714649|FG002|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0||
59604376|NCT02059434|75714650|FG003|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0||
59604377|NCT02059434|75714651|FG004|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0||
59604378|NCT02059434|75714652|FG005|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0||
59604379|NCT02059434|75714653|FG006|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0||
59604380|NCT02059434|75714654|FG007|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0||
59604381|NCT02059434|75714655|FG008|COMPLETED|Washout Between Periods 7 and 8||34||
59604382|NCT02059434|75714647|FG000|NOT COMPLETED|Washout Between Periods 7 and 8||0||
59604383|NCT02059434|75714648|FG001|NOT COMPLETED|Washout Between Periods 7 and 8||0||
59604384|NCT02059434|75714649|FG002|NOT COMPLETED|Washout Between Periods 7 and 8||0||
59604385|NCT02059434|75714650|FG003|NOT COMPLETED|Washout Between Periods 7 and 8||0||
59604386|NCT02059434|75714651|FG004|NOT COMPLETED|Washout Between Periods 7 and 8||0||
59604387|NCT02059434|75714652|FG005|NOT COMPLETED|Washout Between Periods 7 and 8||0||
59604388|NCT02059434|75714653|FG006|NOT COMPLETED|Washout Between Periods 7 and 8||0||
59604389|NCT02059434|75714654|FG007|NOT COMPLETED|Washout Between Periods 7 and 8||0||
59604390|NCT02059434|75714655|FG008|NOT COMPLETED|Washout Between Periods 7 and 8||2||
59604391|NCT02059434|75714647|FG000|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0||
59604392|NCT02059434|75714648|FG001|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0||
59604393|NCT02059434|75714649|FG002|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0||
59604394|NCT02059434|75714650|FG003|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0||
59604395|NCT02059434|75714651|FG004|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0||
59604396|NCT02059434|75714652|FG005|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0||
59604397|NCT02059434|75714653|FG006|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0||
59604398|NCT02059434|75714654|FG007|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0||
59604399|NCT02059434|75714655|FG008|STARTED|Period 8||34||
59604400|NCT02059434|75714647|FG000|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0||
59613451|NCT01696188|75724587|FG001|STARTED|Overall Study||43||
59613452|NCT01696188|75724586|FG000|COMPLETED|Overall Study||40||
59613453|NCT01696188|75724587|FG001|COMPLETED|Overall Study||42||
59613454|NCT01696188|75724586|FG000|NOT COMPLETED|Overall Study||1||
59613455|NCT01696188|75724587|FG001|NOT COMPLETED|Overall Study||1||
59613456|NCT01603602|75724596|FG000|STARTED|Overall Study||77||
59613457|NCT01603602|75724597|FG001|STARTED|Overall Study||78||
59613458|NCT01603602|75724598|FG002|STARTED|Overall Study||80||
59613459|NCT01603602|75724596|FG000|COMPLETED|Overall Study||75||
59613460|NCT01603602|75724597|FG001|COMPLETED|Overall Study||78||
59613461|NCT01603602|75724598|FG002|COMPLETED|Overall Study||79||
59741123|NCT03611751|75860475|FG002|COMPLETED|Treatment Week 24 - Week 52||0||
59741124|NCT03611751|75860473|FG000|NOT COMPLETED|Treatment Week 24 - Week 52||69||
59741125|NCT03611751|75860474|FG001|NOT COMPLETED|Treatment Week 24 - Week 52||33||
59741126|NCT03611751|75860475|FG002|NOT COMPLETED|Treatment Week 24 - Week 52||0||
59741127|NCT03492099|75860487|FG000|STARTED|Overall Study||47||
59741128|NCT03492099|75860487|FG000|COMPLETED|Overall Study||43||
59741129|NCT03492099|75860487|FG000|NOT COMPLETED|Overall Study||4||
59741130|NCT00721123|75860492|FG000|STARTED|Overall Study||538||
59741131|NCT00721123|75860492|FG000|COMPLETED|Overall Study||355||
59741132|NCT00721123|75860492|FG000|NOT COMPLETED|Overall Study||183||
59741133|NCT00720499|75860512|FG000|STARTED|Treatment Period 1 (4 Weeks)||69||
59741134|NCT00720499|75860513|FG001|STARTED|Treatment Period 1 (4 Weeks)||72||
59741135|NCT00720499|75860512|FG000|COMPLETED|Treatment Period 1 (4 Weeks)||66||
59741136|NCT00720499|75860513|FG001|COMPLETED|Treatment Period 1 (4 Weeks)||70||
59741137|NCT00720499|75860512|FG000|NOT COMPLETED|Treatment Period 1 (4 Weeks)||3||
59741138|NCT00720499|75860513|FG001|NOT COMPLETED|Treatment Period 1 (4 Weeks)||2||
59741139|NCT00720499|75860512|FG000|STARTED|Washout Period (2 Weeks)||66||
59741140|NCT00720499|75860513|FG001|STARTED|Washout Period (2 Weeks)||70||
59741141|NCT00720499|75860512|FG000|COMPLETED|Washout Period (2 Weeks)||66||
59741142|NCT00720499|75860513|FG001|COMPLETED|Washout Period (2 Weeks)||70||
59741143|NCT00720499|75860512|FG000|NOT COMPLETED|Washout Period (2 Weeks)||0||
59741144|NCT00720499|75860513|FG001|NOT COMPLETED|Washout Period (2 Weeks)||0||
59741145|NCT00720499|75860512|FG000|STARTED|Treatment Period 2 (4 Weeks)||66||
59741146|NCT00720499|75860513|FG001|STARTED|Treatment Period 2 (4 Weeks)||70||
59741147|NCT00720499|75860512|FG000|COMPLETED|Treatment Period 2 (4 Weeks)||64||
59741148|NCT00720499|75860513|FG001|COMPLETED|Treatment Period 2 (4 Weeks)||67||
59741149|NCT00720499|75860512|FG000|NOT COMPLETED|Treatment Period 2 (4 Weeks)||2||
59741150|NCT00720499|75860513|FG001|NOT COMPLETED|Treatment Period 2 (4 Weeks)||3||
59741151|NCT00724243|75860520|FG000|STARTED|Overall Study||33||
59741152|NCT00724243|75860520|FG000|COMPLETED|Overall Study||18||
59741153|NCT00724243|75860520|FG000|NOT COMPLETED|Overall Study||15||
59741154|NCT00720343|75860524|FG000|STARTED|Overall Study||54||
59741155|NCT00720343|75860524|FG000|COMPLETED|Overall Study|3 removed by physician. 3 unable to be determined; Columbia will never have access to this data.|48||
59741156|NCT00720343|75860524|FG000|NOT COMPLETED|Overall Study||6||
59741157|NCT00720109|75860530|FG000|STARTED|Induction Period||63||
59741158|NCT00720109|75860531|FG001|STARTED|Induction Period||0||
59741159|NCT00720109|75860532|FG002|STARTED|Induction Period||0||
59741160|NCT00720109|75860530|FG000|COMPLETED|Induction Period||57||
59741161|NCT00720109|75860531|FG001|COMPLETED|Induction Period||0||
59741162|NCT00720109|75860532|FG002|COMPLETED|Induction Period||0||
59741163|NCT00720109|75860530|FG000|NOT COMPLETED|Induction Period||6||
59741164|NCT00720109|75860531|FG001|NOT COMPLETED|Induction Period||0||
59741165|NCT00720109|75860532|FG002|NOT COMPLETED|Induction Period||0||
59741166|NCT00720109|75860530|FG000|STARTED|Risk Stratification Period||0||
59741167|NCT00720109|75860531|FG001|STARTED|Risk Stratification Period||48||
59741168|NCT00720109|75860532|FG002|STARTED|Risk Stratification Period||9||
59741169|NCT00720109|75860530|FG000|COMPLETED|Risk Stratification Period||0||
59741170|NCT00720109|75860531|FG001|COMPLETED|Risk Stratification Period||33||
59741171|NCT00720109|75860532|FG002|COMPLETED|Risk Stratification Period||1||
59741172|NCT00720109|75860530|FG000|NOT COMPLETED|Risk Stratification Period||0||
59741173|NCT00720109|75860531|FG001|NOT COMPLETED|Risk Stratification Period||15||
59741174|NCT00720109|75860532|FG002|NOT COMPLETED|Risk Stratification Period||8||
59741175|NCT01015118|75860543|FG000|STARTED|Overall Study||911||
59741176|NCT01015118|75860544|FG001|STARTED|Overall Study||455||
59741177|NCT01015118|75860543|FG000|COMPLETED|Overall Study|Patients who completed max trial therapy duration.|242||
59741178|NCT01015118|75860544|FG001|COMPLETED|Overall Study|Patients who completed max trial therapy duration.|128||
59741179|NCT01015118|75860543|FG000|NOT COMPLETED|Overall Study||669||
59741180|NCT01015118|75860544|FG001|NOT COMPLETED|Overall Study||327||
59741181|NCT00800176|75860556|FG000|STARTED|Overall Study||66||
59741182|NCT00800176|75860557|FG001|STARTED|Overall Study||66||
59741183|NCT00800176|75860558|FG002|STARTED|Overall Study||65||
59741184|NCT00800176|75860559|FG003|STARTED|Overall Study||66||
59741185|NCT00800176|75860560|FG004|STARTED|Overall Study||64||
59741186|NCT00800176|75860561|FG005|STARTED|Overall Study||67||
59741187|NCT00800176|75860556|FG000|COMPLETED|Overall Study||57||
59741188|NCT00800176|75860557|FG001|COMPLETED|Overall Study||60||
59741189|NCT00800176|75860558|FG002|COMPLETED|Overall Study||65||
59741190|NCT00800176|75860559|FG003|COMPLETED|Overall Study||62||
59741191|NCT00800176|75860560|FG004|COMPLETED|Overall Study||60||
59741192|NCT00800176|75860561|FG005|COMPLETED|Overall Study||62||
59741193|NCT00800176|75860556|FG000|NOT COMPLETED|Overall Study||9||
59741194|NCT00800176|75860557|FG001|NOT COMPLETED|Overall Study||6||
59741195|NCT00800176|75860558|FG002|NOT COMPLETED|Overall Study||0||
59741196|NCT00800176|75860559|FG003|NOT COMPLETED|Overall Study||4||
59741197|NCT00800176|75860560|FG004|NOT COMPLETED|Overall Study||4||
59741198|NCT00800176|75860561|FG005|NOT COMPLETED|Overall Study||5||
59741199|NCT00715429|75860577|FG000|STARTED|Overall Study||7||
59741200|NCT00715429|75860578|FG001|STARTED|Overall Study||7||
59741201|NCT00715429|75860577|FG000|COMPLETED|Overall Study||7||
59741202|NCT00715429|75860578|FG001|COMPLETED|Overall Study||6||
59741203|NCT00715429|75860577|FG000|NOT COMPLETED|Overall Study||0||
59741204|NCT00715429|75860578|FG001|NOT COMPLETED|Overall Study||1||
59741205|NCT02145507|75860586|FG000|STARTED|First Donation||82||
59741206|NCT02145507|75860587|FG001|STARTED|First Donation||88||
59741207|NCT02145507|75860586|FG000|Randomized to Have Blood Processed With SOLX (IP)|First Donation||52||
59741208|NCT02145507|75860587|FG001|Randomized to Have Blood Processed With SOLX (IP)|First Donation||51||
59741209|NCT02145507|75860586|FG000|Randomized to Have Blood Processed With AS-3 (CP)|First Donation||30||
59741210|NCT02145507|75860587|FG001|Randomized to Have Blood Processed With AS-3 (CP)|First Donation||37||
59741211|NCT02145507|75860586|FG000|COMPLETED|First Donation||70||
59741212|NCT02145507|75860587|FG001|COMPLETED|First Donation||67||
59741213|NCT02145507|75860586|FG000|NOT COMPLETED|First Donation||12||
59741214|NCT02145507|75860587|FG001|NOT COMPLETED|First Donation||21||
59741215|NCT02145507|75860586|FG000|STARTED|Second Donation||65||
59741216|NCT02145507|75860587|FG001|STARTED|Second Donation|Note: Of the 65 participants who started the second period in Arm 2, there were 3 screen failures, therefore only n=62 participants received their alternate procedure.|65||
59741217|NCT02145507|75860586|FG000|Blood Processed With AS-3 (CP)|Second Donation||39||
59741218|NCT02145507|75860587|FG001|Blood Processed With AS-3 (CP)|Second Donation||35||
59741219|NCT02145507|75860586|FG000|Blood Processed With SOLX (IP)|Second Donation||26||
59741220|NCT02145507|75860587|FG001|Blood Processed With SOLX (IP)|Second Donation||27||
59741221|NCT02145507|75860586|FG000|COMPLETED|Second Donation||63||
59741222|NCT02145507|75860587|FG001|COMPLETED|Second Donation||60||
59741223|NCT02145507|75860586|FG000|NOT COMPLETED|Second Donation||2||
59741224|NCT02145507|75860587|FG001|NOT COMPLETED|Second Donation||5||
59741225|NCT00715117|75860600|FG000|STARTED|Overall Study||6||
59741226|NCT00715117|75860601|FG001|STARTED|Overall Study||6||
59741227|NCT00715117|75860600|FG000|Completion fo 8 Week Study|Overall Study||6||
59741228|NCT00715117|75860601|FG001|Completion fo 8 Week Study|Overall Study||6||
59741229|NCT00715117|75860600|FG000|COMPLETED|Overall Study||6||
59741230|NCT00715117|75860601|FG001|COMPLETED|Overall Study|One subject flared and was rescued with steroids|5||
59741231|NCT00715117|75860600|FG000|NOT COMPLETED|Overall Study||0||
59741232|NCT00715117|75860601|FG001|NOT COMPLETED|Overall Study||1||
59741233|NCT00723229|75860614|FG000|STARTED|First Intervention||25||
59741234|NCT00723229|75860615|FG001|STARTED|First Intervention||23||
59741235|NCT00723229|75860614|FG000|COMPLETED|First Intervention||18||
59604401|NCT02059434|75714648|FG001|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0||
59604402|NCT02059434|75714649|FG002|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0||
59604403|NCT02059434|75714650|FG003|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0||
59604404|NCT02059434|75714651|FG004|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0||
59604405|NCT02059434|75714652|FG005|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0||
59741236|NCT00723229|75860615|FG001|COMPLETED|First Intervention||20||
59741237|NCT00723229|75860614|FG000|NOT COMPLETED|First Intervention||7||
59741238|NCT00723229|75860615|FG001|NOT COMPLETED|First Intervention||3||
59741239|NCT00723229|75860614|FG000|STARTED|Second Intervention||18||
59741240|NCT00723229|75860615|FG001|STARTED|Second Intervention||20||
59741241|NCT00723229|75860614|FG000|COMPLETED|Second Intervention||18||
59741242|NCT00723229|75860615|FG001|COMPLETED|Second Intervention||20||
59741243|NCT00723229|75860614|FG000|NOT COMPLETED|Second Intervention||0||
59741244|NCT00723229|75860615|FG001|NOT COMPLETED|Second Intervention||0||
59741245|NCT01093521|75860621|FG000|STARTED|Overall Study||20||
59741246|NCT01093521|75860621|FG000|COMPLETED|Overall Study||20||
59741247|NCT01093521|75860621|FG000|NOT COMPLETED|Overall Study||0||
59741248|NCT01030718|75860630|FG000|STARTED|Studies CA180-031 and -036 Combined||30||
59741249|NCT01030718|75860631|FG001|STARTED|Studies CA180-031 and -036 Combined||11||
59741250|NCT01030718|75860632|FG002|STARTED|Studies CA180-031 and -036 Combined||13||
59741251|NCT01030718|75860630|FG000|COMPLETED|Studies CA180-031 and -036 Combined||26||
59741252|NCT01030718|75860631|FG001|COMPLETED|Studies CA180-031 and -036 Combined||2||
59741253|NCT01030718|75860632|FG002|COMPLETED|Studies CA180-031 and -036 Combined||1||
59741254|NCT01030718|75860630|FG000|NOT COMPLETED|Studies CA180-031 and -036 Combined||4||
59741255|NCT01030718|75860631|FG001|NOT COMPLETED|Studies CA180-031 and -036 Combined||9||
59741256|NCT01030718|75860632|FG002|NOT COMPLETED|Studies CA180-031 and -036 Combined||12||
59604406|NCT02059434|75714653|FG006|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0||
59741257|NCT01030718|75860630|FG000|STARTED|Study CA180-036 Only||29||
59741258|NCT01030718|75860631|FG001|STARTED|Study CA180-036 Only||9||
59741259|NCT01030718|75860632|FG002|STARTED|Study CA180-036 Only||6||
59741260|NCT01030718|75860630|FG000|COMPLETED|Study CA180-036 Only||26||
59741261|NCT01030718|75860631|FG001|COMPLETED|Study CA180-036 Only||2||
59741262|NCT01030718|75860632|FG002|COMPLETED|Study CA180-036 Only||1||
59741263|NCT01030718|75860630|FG000|NOT COMPLETED|Study CA180-036 Only||3||
59741264|NCT01030718|75860631|FG001|NOT COMPLETED|Study CA180-036 Only||7||
59741265|NCT01030718|75860632|FG002|NOT COMPLETED|Study CA180-036 Only||5||
59741266|NCT00722761|75860652|FG000|STARTED|Overall Study||16||
59741267|NCT00722761|75860653|FG001|STARTED|Overall Study||14||
59741268|NCT00722761|75860652|FG000|COMPLETED AT LEAST 1 FOLLOW-UP VISIT|Overall Study||15||
59741269|NCT00722761|75860653|FG001|COMPLETED AT LEAST 1 FOLLOW-UP VISIT|Overall Study||10||
59741270|NCT00722761|75860652|FG000|COMPLETED|Overall Study||10||
59741271|NCT00722761|75860653|FG001|COMPLETED|Overall Study||8||
59741272|NCT00722761|75860652|FG000|NOT COMPLETED|Overall Study||6||
59741273|NCT00722761|75860653|FG001|NOT COMPLETED|Overall Study||6||
59741274|NCT00719953|75860659|FG000|STARTED|Overall Study||30||
59741275|NCT00719953|75860659|FG000|COMPLETED|Overall Study||26||
59741276|NCT00719953|75860659|FG000|NOT COMPLETED|Overall Study||4||
59741277|NCT01019486|75860666|FG000|STARTED|Overall Study||5||
59741278|NCT01019486|75860667|FG001|STARTED|Overall Study||5||
59741279|NCT01019486|75860668|FG002|STARTED|Overall Study||16||
59741280|NCT01019486|75860666|FG000|COMPLETED|Overall Study||4||
59741281|NCT01019486|75860667|FG001|COMPLETED|Overall Study||4||
59741282|NCT01019486|75860668|FG002|COMPLETED|Overall Study||15||
59741283|NCT01019486|75860666|FG000|NOT COMPLETED|Overall Study||1||
59741284|NCT01019486|75860667|FG001|NOT COMPLETED|Overall Study||1||
59741285|NCT01019486|75860668|FG002|NOT COMPLETED|Overall Study||1||
59741286|NCT02803203|75860677|FG000|STARTED|Overall Study||49||
59741287|NCT02803203|75860677|FG000|COMPLETED|Overall Study||0||
59741288|NCT02803203|75860677|FG000|NOT COMPLETED|Overall Study||49||
59741289|NCT00714493|75860682|FG000|STARTED|Overall Study||203||
59741290|NCT00714493|75860682|FG000|COMPLETED|Overall Study||154||
59741291|NCT00714493|75860682|FG000|NOT COMPLETED|Overall Study||49||
59741292|NCT01019252|75860688|FG000|STARTED|Initial CBT for ADHD vs. Wait List|Stratified based on biological sex and clinician-rated severity (CGI score)|24||
59741293|NCT01019252|75860689|FG001|STARTED|Initial CBT for ADHD vs. Wait List|Stratified based on biological sex and clinician-rated severity (CGI score)|22||
59741294|NCT01019252|75860688|FG000|COMPLETED|Initial CBT for ADHD vs. Wait List||21||
59741295|NCT01019252|75860689|FG001|COMPLETED|Initial CBT for ADHD vs. Wait List||22||
59741296|NCT01019252|75860688|FG000|NOT COMPLETED|Initial CBT for ADHD vs. Wait List||3||
59741297|NCT01019252|75860689|FG001|NOT COMPLETED|Initial CBT for ADHD vs. Wait List||0||
59741298|NCT01019252|75860688|FG000|STARTED|Wait List Cross-over to CBT for ADHD|Lost to follow up, did not start treatment following wait list completion (n=3)|21||
59741299|NCT01019252|75860689|FG001|STARTED|Wait List Cross-over to CBT for ADHD||22||
59741300|NCT01019252|75860688|FG000|COMPLETED|Wait List Cross-over to CBT for ADHD||21||
59741301|NCT01019252|75860689|FG001|COMPLETED|Wait List Cross-over to CBT for ADHD||15||
59741302|NCT01019252|75860688|FG000|NOT COMPLETED|Wait List Cross-over to CBT for ADHD||0||
59741303|NCT01019252|75860689|FG001|NOT COMPLETED|Wait List Cross-over to CBT for ADHD||7||
59741304|NCT01013870|75860697|FG000|STARTED|Overall Study||28||
59741305|NCT01013870|75860698|FG001|STARTED|Overall Study||24||
59741306|NCT01013870|75860697|FG000|COMPLETED|Overall Study||27||
59741307|NCT01013870|75860698|FG001|COMPLETED|Overall Study||21||
59741308|NCT01013870|75860697|FG000|NOT COMPLETED|Overall Study||1||
59741309|NCT01013870|75860698|FG001|NOT COMPLETED|Overall Study||3||
59741310|NCT01013792|75860706|FG000|STARTED|Overall Study||14||
59741311|NCT01013792|75860707|FG001|STARTED|Overall Study||16||
59741312|NCT01013792|75860706|FG000|COMPLETED|Overall Study||12||
59741313|NCT01013792|75860707|FG001|COMPLETED|Overall Study||11||
59741314|NCT01013792|75860706|FG000|NOT COMPLETED|Overall Study||2||
59741315|NCT01013792|75860707|FG001|NOT COMPLETED|Overall Study||5||
59741316|NCT01018862|75860716|FG000|STARTED|Overall Study||161||
59741317|NCT01018862|75860717|FG001|STARTED|Overall Study||166||
59741318|NCT01018862|75860718|FG002|STARTED|Overall Study||162||
59741319|NCT01018862|75860716|FG000|COMPLETED|Overall Study||148||
59741320|NCT01018862|75860717|FG001|COMPLETED|Overall Study||156||
59741321|NCT01018862|75860718|FG002|COMPLETED|Overall Study||146||
59741322|NCT01018862|75860716|FG000|NOT COMPLETED|Overall Study||13||
59741323|NCT01018862|75860717|FG001|NOT COMPLETED|Overall Study||10||
59741324|NCT01018862|75860718|FG002|NOT COMPLETED|Overall Study||16||
59741325|NCT01018394|75860728|FG000|STARTED|Overall Study||40||
59741326|NCT01018394|75860729|FG001|STARTED|Overall Study||41||
59741327|NCT01018394|75860728|FG000|COMPLETED|Overall Study||31||
59741328|NCT01018394|75860729|FG001|COMPLETED|Overall Study||33||
59741329|NCT01018394|75860728|FG000|NOT COMPLETED|Overall Study||9||
59741330|NCT01018394|75860729|FG001|NOT COMPLETED|Overall Study||8||
59741331|NCT01017146|75860737|FG000|STARTED|Overall Study||372||
59741332|NCT01017146|75860738|FG001|STARTED|Overall Study||372||
59741333|NCT01017146|75860737|FG000|COMPLETED|Overall Study||306||
59741334|NCT01017146|75860738|FG001|COMPLETED|Overall Study||333||
59741335|NCT01017146|75860737|FG000|NOT COMPLETED|Overall Study||66||
59741336|NCT01017146|75860738|FG001|NOT COMPLETED|Overall Study||39||
59741337|NCT01010750|75860750|FG000|STARTED|First Intervention||3||
59741338|NCT01010750|75860751|FG001|STARTED|First Intervention||4||
59741339|NCT01010750|75860752|FG002|STARTED|First Intervention||3||
59741340|NCT01010750|75860753|FG003|STARTED|First Intervention||3||
59741341|NCT01010750|75860754|FG004|STARTED|First Intervention||2||
59741342|NCT01010750|75860755|FG005|STARTED|First Intervention||3||
59741343|NCT01010750|75860750|FG000|COMPLETED|First Intervention||3||
59741344|NCT01010750|75860751|FG001|COMPLETED|First Intervention||4||
59741345|NCT01010750|75860752|FG002|COMPLETED|First Intervention||3||
59741346|NCT01010750|75860753|FG003|COMPLETED|First Intervention||3||
59741347|NCT01010750|75860754|FG004|COMPLETED|First Intervention||2||
59741348|NCT01010750|75860755|FG005|COMPLETED|First Intervention||3||
59741349|NCT01010750|75860750|FG000|NOT COMPLETED|First Intervention||0||
59741350|NCT01010750|75860751|FG001|NOT COMPLETED|First Intervention||0||
59741351|NCT01010750|75860752|FG002|NOT COMPLETED|First Intervention||0||
59741352|NCT01010750|75860753|FG003|NOT COMPLETED|First Intervention||0||
59741353|NCT01010750|75860754|FG004|NOT COMPLETED|First Intervention||0||
59741354|NCT01010750|75860755|FG005|NOT COMPLETED|First Intervention||0||
59741355|NCT01010750|75860750|FG000|STARTED|Second Intervention||3||
59741356|NCT01010750|75860751|FG001|STARTED|Second Intervention||4||
59741357|NCT01010750|75860752|FG002|STARTED|Second Intervention||3||
59741358|NCT01010750|75860753|FG003|STARTED|Second Intervention||3||
59741359|NCT01010750|75860754|FG004|STARTED|Second Intervention||2||
59741360|NCT01010750|75860755|FG005|STARTED|Second Intervention||3||
59741361|NCT01010750|75860750|FG000|COMPLETED|Second Intervention||3||
59741362|NCT01010750|75860751|FG001|COMPLETED|Second Intervention||3||
59741363|NCT01010750|75860752|FG002|COMPLETED|Second Intervention||3||
59741364|NCT01010750|75860753|FG003|COMPLETED|Second Intervention||3||
59741365|NCT01010750|75860754|FG004|COMPLETED|Second Intervention||2||
59741366|NCT01010750|75860755|FG005|COMPLETED|Second Intervention||3||
59741367|NCT01010750|75860750|FG000|NOT COMPLETED|Second Intervention||0||
59741368|NCT01010750|75860751|FG001|NOT COMPLETED|Second Intervention||1||
59741369|NCT01010750|75860752|FG002|NOT COMPLETED|Second Intervention||0||
59741370|NCT01010750|75860753|FG003|NOT COMPLETED|Second Intervention||0||
59741371|NCT01010750|75860754|FG004|NOT COMPLETED|Second Intervention||0||
59741372|NCT01010750|75860755|FG005|NOT COMPLETED|Second Intervention||0||
59741373|NCT01010750|75860750|FG000|STARTED|Third Intervention||3||
59741374|NCT01010750|75860751|FG001|STARTED|Third Intervention||3||
59741375|NCT01010750|75860752|FG002|STARTED|Third Intervention||3||
59741376|NCT01010750|75860753|FG003|STARTED|Third Intervention||3||
59741377|NCT01010750|75860754|FG004|STARTED|Third Intervention||2||
59741378|NCT01010750|75860755|FG005|STARTED|Third Intervention||3||
59741379|NCT01010750|75860750|FG000|COMPLETED|Third Intervention||3||
59741380|NCT01010750|75860751|FG001|COMPLETED|Third Intervention||3||
59741381|NCT01010750|75860752|FG002|COMPLETED|Third Intervention||3||
59741382|NCT01010750|75860753|FG003|COMPLETED|Third Intervention||3||
59741383|NCT01010750|75860754|FG004|COMPLETED|Third Intervention||2||
59741384|NCT01010750|75860755|FG005|COMPLETED|Third Intervention||3||
59741385|NCT01010750|75860750|FG000|NOT COMPLETED|Third Intervention||0||
59741386|NCT01010750|75860751|FG001|NOT COMPLETED|Third Intervention||0||
59741387|NCT01010750|75860752|FG002|NOT COMPLETED|Third Intervention||0||
59741388|NCT01010750|75860753|FG003|NOT COMPLETED|Third Intervention||0||
59741389|NCT01010750|75860754|FG004|NOT COMPLETED|Third Intervention||0||
59741390|NCT01010750|75860755|FG005|NOT COMPLETED|Third Intervention||0||
59741391|NCT01012622|75860763|FG000|STARTED|Overall Study||142||
59741392|NCT01012622|75860763|FG000|COMPLETED|Overall Study||111||
59741393|NCT01012622|75860763|FG000|NOT COMPLETED|Overall Study||31||
59741394|NCT00722371|75860774|FG000|STARTED|Overall Study||231||
59741395|NCT00722371|75860775|FG001|STARTED|Overall Study||230||
59741396|NCT00722371|75860776|FG002|STARTED|Overall Study||233||
59741397|NCT00722371|75860777|FG003|STARTED|Overall Study||230||
59741398|NCT00722371|75860778|FG004|STARTED|Overall Study||230||
59741399|NCT00722371|75860779|FG005|STARTED|Overall Study||231||
59741400|NCT00722371|75860780|FG006|STARTED|Overall Study||230||
59741401|NCT00722371|75860774|FG000|COMPLETED|Overall Study||175||
59741402|NCT00722371|75860775|FG001|COMPLETED|Overall Study||158||
59741403|NCT00722371|75860776|FG002|COMPLETED|Overall Study||168||
59741404|NCT00722371|75860777|FG003|COMPLETED|Overall Study||167||
59741405|NCT00722371|75860778|FG004|COMPLETED|Overall Study||182||
59741406|NCT00722371|75860779|FG005|COMPLETED|Overall Study||178||
59741407|NCT00722371|75860780|FG006|COMPLETED|Overall Study||179||
59741408|NCT00722371|75860774|FG000|NOT COMPLETED|Overall Study||56||
59741409|NCT00722371|75860775|FG001|NOT COMPLETED|Overall Study||72||
59741410|NCT00722371|75860776|FG002|NOT COMPLETED|Overall Study||65||
59741411|NCT00722371|75860777|FG003|NOT COMPLETED|Overall Study||63||
59741412|NCT00722371|75860778|FG004|NOT COMPLETED|Overall Study||48||
59741413|NCT00722371|75860779|FG005|NOT COMPLETED|Overall Study||53||
59741414|NCT00722371|75860780|FG006|NOT COMPLETED|Overall Study||51||
59741415|NCT00722137|75860798|FG000|STARTED|Overall Study||244||
59741416|NCT00722137|75860799|FG001|STARTED|Overall Study||243||
59741417|NCT00722137|75860798|FG000|COMPLETED|Overall Study||199|Completed participants are the participants who completed the treatment.|
59741418|NCT00722137|75860799|FG001|COMPLETED|Overall Study||195|Completed participants are the participants who completed the treatment.|
59741419|NCT00722137|75860798|FG000|NOT COMPLETED|Overall Study||45||
59741420|NCT00722137|75860799|FG001|NOT COMPLETED|Overall Study||48||
59741421|NCT01775722|75860805|FG000|STARTED|Overall Study||22||44
59741422|NCT01775722|75860805|FG000|COMPLETED|Overall Study||20||40
59741423|NCT01775722|75860805|FG000|NOT COMPLETED|Overall Study||2||4
59741424|NCT00796666|75860813|FG000|STARTED|Overall Study||67||
59741425|NCT00796666|75860814|FG001|STARTED|Overall Study||64||
59741426|NCT00796666|75860813|FG000|Treated|Overall Study||66||
59741427|NCT00796666|75860814|FG001|Treated|Overall Study||64||
59741428|NCT00796666|75860813|FG000|Randomized and Not Treated|Overall Study||1||
59741429|NCT00796666|75860814|FG001|Randomized and Not Treated|Overall Study||0||
59741430|NCT00796666|75860813|FG000|COMPLETED|Overall Study||0||
59741431|NCT00796666|75860814|FG001|COMPLETED|Overall Study||0||
59741432|NCT00796666|75860813|FG000|NOT COMPLETED|Overall Study||67||
59741433|NCT00796666|75860814|FG001|NOT COMPLETED|Overall Study||64||
59741434|NCT00799708|75860823|FG000|STARTED|Overall Study||10||
59741435|NCT00799708|75860824|FG001|STARTED|Overall Study||6||
59741436|NCT00799708|75860825|FG002|STARTED|Overall Study||11||
59741437|NCT00799708|75860823|FG000|COMPLETED|Overall Study||9||
59741438|NCT00799708|75860824|FG001|COMPLETED|Overall Study||6||
59741439|NCT00799708|75860825|FG002|COMPLETED|Overall Study||11||
59741440|NCT00799708|75860823|FG000|NOT COMPLETED|Overall Study||1||
59741441|NCT00799708|75860824|FG001|NOT COMPLETED|Overall Study||0||
59741442|NCT00799708|75860825|FG002|NOT COMPLETED|Overall Study||0||
59741443|NCT00796510|75860837|FG000|STARTED|Overall Study||3||
59741444|NCT00796510|75860838|FG001|STARTED|Overall Study||0||
59741445|NCT00796510|75860837|FG000|COMPLETED|Overall Study||0||
59741446|NCT00796510|75860838|FG001|COMPLETED|Overall Study||0||
59741447|NCT00796510|75860837|FG000|NOT COMPLETED|Overall Study||3||
59741448|NCT00796510|75860838|FG001|NOT COMPLETED|Overall Study||0||
59741449|NCT00588640|75860844|FG000|STARTED|Overall Study||10||
59741450|NCT00588640|75860844|FG000|COMPLETED|Overall Study||8||
59741451|NCT00588640|75860844|FG000|NOT COMPLETED|Overall Study||2||
59741452|NCT01016912|75860853|FG000|STARTED|End of Treatment Period||8||
59741453|NCT01016912|75860854|FG001|STARTED|End of Treatment Period||9||
59741454|NCT01016912|75860855|FG002|STARTED|End of Treatment Period||10||
59741455|NCT01016912|75860856|FG003|STARTED|End of Treatment Period||9||
59741456|NCT01016912|75860857|FG004|STARTED|End of Treatment Period||9||
59741457|NCT01016912|75860853|FG000|Received Treatment|End of Treatment Period||8||
59741458|NCT01016912|75860854|FG001|Received Treatment|End of Treatment Period||9||
59741459|NCT01016912|75860855|FG002|Received Treatment|End of Treatment Period||10||
59741460|NCT01016912|75860856|FG003|Received Treatment|End of Treatment Period||9||
59741461|NCT01016912|75860857|FG004|Received Treatment|End of Treatment Period||9||
59741462|NCT01016912|75860853|FG000|COMPLETED|End of Treatment Period||8||
59741463|NCT01016912|75860854|FG001|COMPLETED|End of Treatment Period||6||
59741464|NCT01016912|75860855|FG002|COMPLETED|End of Treatment Period||9||
59741465|NCT01016912|75860856|FG003|COMPLETED|End of Treatment Period||5||
59741466|NCT01016912|75860857|FG004|COMPLETED|End of Treatment Period||5||
59741467|NCT01016912|75860853|FG000|NOT COMPLETED|End of Treatment Period||0||
59741468|NCT01016912|75860854|FG001|NOT COMPLETED|End of Treatment Period||3||
59741469|NCT01016912|75860855|FG002|NOT COMPLETED|End of Treatment Period||1||
59741470|NCT01016912|75860856|FG003|NOT COMPLETED|End of Treatment Period||4||
59741471|NCT01016912|75860857|FG004|NOT COMPLETED|End of Treatment Period||4||
59741472|NCT01016912|75860853|FG000|STARTED|Follow-up Period||8||
59741473|NCT01016912|75860854|FG001|STARTED|Follow-up Period|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment|9||
59741474|NCT01016912|75860855|FG002|STARTED|Follow-up Period|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment|10||
59741475|NCT01016912|75860856|FG003|STARTED|Follow-up Period|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment|9||
59741476|NCT01016912|75860857|FG004|STARTED|Follow-up Period|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment|9||
59741477|NCT01016912|75860853|FG000|COMPLETED|Follow-up Period||8||
59741478|NCT01016912|75860854|FG001|COMPLETED|Follow-up Period||9||
59741479|NCT01016912|75860855|FG002|COMPLETED|Follow-up Period||9||
59741480|NCT01016912|75860856|FG003|COMPLETED|Follow-up Period||8||
59741481|NCT01016912|75860857|FG004|COMPLETED|Follow-up Period||9||
59741482|NCT01016912|75860853|FG000|NOT COMPLETED|Follow-up Period||0||
59741483|NCT01016912|75860854|FG001|NOT COMPLETED|Follow-up Period||0||
59741484|NCT01016912|75860855|FG002|NOT COMPLETED|Follow-up Period||1||
59741485|NCT01016912|75860856|FG003|NOT COMPLETED|Follow-up Period||1||
59741486|NCT01016912|75860857|FG004|NOT COMPLETED|Follow-up Period||0||
59741487|NCT00802672|75860892|FG000|STARTED|Overall Study||224||
59741488|NCT00802672|75860893|FG001|STARTED|Overall Study||226||
59741489|NCT00802672|75860894|FG002|STARTED|Overall Study||111||
59741490|NCT00802672|75860892|FG000|COMPLETED|Overall Study||156||
59741491|NCT00802672|75860893|FG001|COMPLETED|Overall Study||174||
59741492|NCT00802672|75860894|FG002|COMPLETED|Overall Study||77||
59741493|NCT00802672|75860892|FG000|NOT COMPLETED|Overall Study||68||
59741494|NCT00802672|75860893|FG001|NOT COMPLETED|Overall Study||52||
59741495|NCT00802672|75860894|FG002|NOT COMPLETED|Overall Study||34||
59741496|NCT00714415|75860904|FG000|STARTED|Overall Study||25||
59741497|NCT00714415|75860905|FG001|STARTED|Overall Study||55||
59741498|NCT00714415|75860904|FG000|COMPLETED|Overall Study||23||
59741499|NCT00714415|75860905|FG001|COMPLETED|Overall Study||55||
59741500|NCT00714415|75860904|FG000|NOT COMPLETED|Overall Study||2||
59741501|NCT00714415|75860905|FG001|NOT COMPLETED|Overall Study||0||
59741502|NCT00714259|75860911|FG000|STARTED|Overall Study||5||
59741503|NCT00714259|75860911|FG000|COMPLETED|Overall Study||3||
59741504|NCT00714259|75860911|FG000|NOT COMPLETED|Overall Study||2||
59741505|NCT00796120|75860917|FG000|STARTED|Overall Study||61||
59741506|NCT00796120|75860918|FG001|STARTED|Overall Study||60||
59741507|NCT00796120|75860917|FG000|Treated|Overall Study||61||
59741508|NCT00796120|75860918|FG001|Treated|Overall Study||57||
59741509|NCT00796120|75860917|FG000|COMPLETED|Overall Study||0||
59741510|NCT00796120|75860918|FG001|COMPLETED|Overall Study||0||
59741511|NCT00796120|75860917|FG000|NOT COMPLETED|Overall Study||61||
59741512|NCT00796120|75860918|FG001|NOT COMPLETED|Overall Study||60||
59741513|NCT00795886|75860924|FG000|STARTED|Overall Study||63||
59741514|NCT00795886|75860924|FG000|COMPLETED|Overall Study||53||
59741515|NCT00795886|75860924|FG000|NOT COMPLETED|Overall Study||10||
59741516|NCT00719563|75860931|FG000|STARTED|Overall Study||171||
59741517|NCT00719563|75860932|FG001|STARTED|Overall Study||170||
59741518|NCT00719563|75860931|FG000|COMPLETED|Overall Study||133||
59741519|NCT00719563|75860932|FG001|COMPLETED|Overall Study||128||
59741520|NCT00719563|75860931|FG000|NOT COMPLETED|Overall Study||38||
59741521|NCT00719563|75860932|FG001|NOT COMPLETED|Overall Study||42||
59741522|NCT00795184|75860939|FG000|STARTED|Overall Study||65||
59741523|NCT00795184|75860940|FG001|STARTED|Overall Study||57||
59741524|NCT00795184|75860939|FG000|COMPLETED|Overall Study|57 patients analysable, completed all 3 imaging procedures|57||
59741525|NCT00795184|75860940|FG001|COMPLETED|Overall Study|44 patients analysable, completed all 3 imaging procedures|44||
59741526|NCT00795184|75860939|FG000|NOT COMPLETED|Overall Study||8||
59741527|NCT00795184|75860940|FG001|NOT COMPLETED|Overall Study||13||
59741528|NCT00718861|75860951|FG000|STARTED|Overall Study|"Started indicates Randomized and Intent-to Treat (ITT) population"|95||
59741529|NCT00718861|75860952|FG001|STARTED|Overall Study||95||
59741530|NCT00718861|75860951|FG000|Safety Set|Overall Study|3 patients randomized but never received study drug|92||
59741531|NCT00718861|75860952|FG001|Safety Set|Overall Study||95||
59741532|NCT00718861|75860951|FG000|Modified Intent to Treat|Overall Study|ITT patients with DXA total hip measure at extension 2 baseline and year 9|67||
59741533|NCT00718861|75860952|FG001|Modified Intent to Treat|Overall Study|ITT patients with DXA total hip measure at extension 2 baseline and year 9|69||
59741534|NCT00718861|75860951|FG000|COMPLETED|Overall Study||74||
59741535|NCT00718861|75860952|FG001|COMPLETED|Overall Study||77||
59741536|NCT00718861|75860951|FG000|NOT COMPLETED|Overall Study||21||
59741537|NCT00718861|75860952|FG001|NOT COMPLETED|Overall Study||18||
59741538|NCT01016600|75860962|FG000|STARTED|Overall Study||9||
59741539|NCT01016600|75860963|FG001|STARTED|Overall Study||4||
59741540|NCT01016600|75860964|FG002|STARTED|Overall Study||6||
59741541|NCT01016600|75860965|FG003|STARTED|Overall Study||12||
59741542|NCT01016600|75860962|FG000|COMPLETED|Overall Study||8||
59741543|NCT01016600|75860963|FG001|COMPLETED|Overall Study||4||
59741544|NCT01016600|75860964|FG002|COMPLETED|Overall Study||6||
59741545|NCT01016600|75860965|FG003|COMPLETED|Overall Study||12||
59741546|NCT01016600|75860962|FG000|NOT COMPLETED|Overall Study||1||
59741547|NCT01016600|75860963|FG001|NOT COMPLETED|Overall Study||0||
59741548|NCT01016600|75860964|FG002|NOT COMPLETED|Overall Study||0||
59741549|NCT01016600|75860965|FG003|NOT COMPLETED|Overall Study||0||
59741550|NCT01016132|75860976|FG000|STARTED|Overall Study||152||
59741551|NCT01016132|75860976|FG000|COMPLETED|Overall Study||151||
59741552|NCT01016132|75860976|FG000|NOT COMPLETED|Overall Study||1||
59741553|NCT01015820|75860982|FG000|STARTED|Overall Study||15||
59741554|NCT01015820|75860983|FG001|STARTED|Overall Study||15||
59741555|NCT01015820|75860982|FG000|COMPLETED|Overall Study||14||
59741556|NCT01015820|75860983|FG001|COMPLETED|Overall Study||15||
59741557|NCT01015820|75860982|FG000|NOT COMPLETED|Overall Study||1||
59741558|NCT01015820|75860983|FG001|NOT COMPLETED|Overall Study||0||
59741559|NCT04424888|75860991|FG000|STARTED|First Intervention||3||
59741560|NCT04424888|75860992|FG001|STARTED|First Intervention||3||
59741561|NCT04424888|75860991|FG000|COMPLETED|First Intervention||3||
59741562|NCT04424888|75860992|FG001|COMPLETED|First Intervention||3||
59741563|NCT04424888|75860991|FG000|NOT COMPLETED|First Intervention||0||
59741564|NCT04424888|75860992|FG001|NOT COMPLETED|First Intervention||0||
59741565|NCT04424888|75860991|FG000|STARTED|Washout||3||
59741566|NCT04424888|75860992|FG001|STARTED|Washout||3||
59741567|NCT04424888|75860991|FG000|COMPLETED|Washout||3||
59741568|NCT04424888|75860992|FG001|COMPLETED|Washout||3||
59741569|NCT04424888|75860991|FG000|NOT COMPLETED|Washout||0||
59741570|NCT04424888|75860992|FG001|NOT COMPLETED|Washout||0||
59741571|NCT04424888|75860991|FG000|STARTED|Second Intervention||3||
59741572|NCT04424888|75860992|FG001|STARTED|Second Intervention||3||
59741573|NCT04424888|75860991|FG000|COMPLETED|Second Intervention||3||
59741574|NCT04424888|75860992|FG001|COMPLETED|Second Intervention||3||
59741575|NCT04424888|75860991|FG000|NOT COMPLETED|Second Intervention||0||
59741576|NCT04424888|75860992|FG001|NOT COMPLETED|Second Intervention||0||
59741577|NCT01010204|75861006|FG000|STARTED|Overall Study||31||
59741578|NCT01010204|75861007|FG001|STARTED|Overall Study||29||
59741579|NCT01010204|75861006|FG000|COMPLETED|Overall Study||24||
59741580|NCT01010204|75861007|FG001|COMPLETED|Overall Study||20||
59741581|NCT01010204|75861006|FG000|NOT COMPLETED|Overall Study||7||
59741582|NCT01010204|75861007|FG001|NOT COMPLETED|Overall Study||9||
59741583|NCT00718549|75861013|FG000|STARTED|Induction Phase||128||
59741584|NCT00718549|75861014|FG001|STARTED|Induction Phase||0||
59741585|NCT00718549|75861015|FG002|STARTED|Induction Phase||0||
59741586|NCT00718549|75861013|FG000|COMPLETED|Induction Phase||66||
59741587|NCT00718549|75861014|FG001|COMPLETED|Induction Phase||0||
59741588|NCT00718549|75861015|FG002|COMPLETED|Induction Phase||0||
59741589|NCT00718549|75861013|FG000|NOT COMPLETED|Induction Phase||62||
59741590|NCT00718549|75861014|FG001|NOT COMPLETED|Induction Phase||0||
59741591|NCT00718549|75861015|FG002|NOT COMPLETED|Induction Phase||0||
59741592|NCT00718549|75861013|FG000|STARTED|Maintenance/ Observation Phase||0||
59741593|NCT00718549|75861014|FG001|STARTED|Maintenance/ Observation Phase||33||
60134945|NCT03307252|76258153|FG000|STARTED|Part 1, Washout Period 2 (13 Days)||4||
59741594|NCT00718549|75861015|FG002|STARTED|Maintenance/ Observation Phase||33||
59741595|NCT00718549|75861013|FG000|COMPLETED|Maintenance/ Observation Phase||0||
59741596|NCT00718549|75861014|FG001|COMPLETED|Maintenance/ Observation Phase||5||
59741597|NCT00718549|75861015|FG002|COMPLETED|Maintenance/ Observation Phase||3||
59741598|NCT00718549|75861013|FG000|NOT COMPLETED|Maintenance/ Observation Phase||0||
59741599|NCT00718549|75861014|FG001|NOT COMPLETED|Maintenance/ Observation Phase||28||
59741600|NCT00718549|75861015|FG002|NOT COMPLETED|Maintenance/ Observation Phase||30||
59741601|NCT00793624|75861032|FG000|STARTED|Overall Study||225||
59741602|NCT00793624|75861033|FG001|STARTED|Overall Study||227||
59741603|NCT00793624|75861034|FG002|STARTED|Overall Study||225||
59741604|NCT00793624|75861035|FG003|STARTED|Overall Study||227||
59741605|NCT00793624|75861032|FG000|COMPLETED|Overall Study||168||
59741606|NCT00793624|75861033|FG001|COMPLETED|Overall Study||191||
59741607|NCT00793624|75861034|FG002|COMPLETED|Overall Study||186||
59741608|NCT00793624|75861035|FG003|COMPLETED|Overall Study||184||
59741609|NCT00793624|75861032|FG000|NOT COMPLETED|Overall Study||57||
59741610|NCT00793624|75861033|FG001|NOT COMPLETED|Overall Study||36||
59741611|NCT00793624|75861034|FG002|NOT COMPLETED|Overall Study||39||
59741612|NCT00793624|75861035|FG003|NOT COMPLETED|Overall Study||43||
59741613|NCT00794950|75861053|FG000|STARTED|BCG Induction||43||
59741614|NCT00794950|75861053|FG000|COMPLETED|BCG Induction||36||
59741615|NCT00794950|75861053|FG000|NOT COMPLETED|BCG Induction||7||
59741616|NCT00794950|75861053|FG000|STARTED|Beginning Sunitinib Treatment||36||
59741617|NCT00794950|75861053|FG000|COMPLETED|Beginning Sunitinib Treatment||24||
59741618|NCT00794950|75861053|FG000|NOT COMPLETED|Beginning Sunitinib Treatment||12||
59741619|NCT00793546|75861060|FG000|STARTED|Overall Study||14||
59741620|NCT00793546|75861061|FG001|STARTED|Overall Study||28||
59741621|NCT00793546|75861060|FG000|COMPLETED|Overall Study||0||
59741622|NCT00793546|75861061|FG001|COMPLETED|Overall Study||0||
59741623|NCT00793546|75861060|FG000|NOT COMPLETED|Overall Study||14||
59741624|NCT00793546|75861061|FG001|NOT COMPLETED|Overall Study||28||
59741625|NCT00798694|75861071|FG000|STARTED|Overall Study||30||
59741626|NCT00798694|75861072|FG001|STARTED|Overall Study||28||
59741627|NCT00798694|75861071|FG000|COMPLETED|Overall Study||28||
59741628|NCT00798694|75861072|FG001|COMPLETED|Overall Study||27||
59741629|NCT00798694|75861071|FG000|NOT COMPLETED|Overall Study||2||
59741630|NCT00798694|75861072|FG001|NOT COMPLETED|Overall Study||1||
59741631|NCT00718315|75861087|FG000|STARTED|Overall Study||67||
59741632|NCT00718315|75861088|FG001|STARTED|Overall Study||67||
59741633|NCT00718315|75861089|FG002|STARTED|Overall Study||67||
59741634|NCT00718315|75861087|FG000|COMPLETED|Overall Study||48||
59741635|NCT00718315|75861088|FG001|COMPLETED|Overall Study||45||
59741636|NCT00718315|75861089|FG002|COMPLETED|Overall Study||46||
59741637|NCT00718315|75861087|FG000|NOT COMPLETED|Overall Study||19||
59741638|NCT00718315|75861088|FG001|NOT COMPLETED|Overall Study||22||
59741639|NCT00718315|75861089|FG002|NOT COMPLETED|Overall Study||21||
59741640|NCT00798304|75861100|FG000|STARTED|Overall Study||14||
59741641|NCT00798304|75861101|FG001|STARTED|Overall Study||22||
59741642|NCT00798304|75861102|FG002|STARTED|Overall Study||10||
59741643|NCT00798304|75861100|FG000|COMPLETED|Overall Study||0||
59741644|NCT00798304|75861101|FG001|COMPLETED|Overall Study||0||
59741645|NCT00798304|75861102|FG002|COMPLETED|Overall Study||0||
59741646|NCT00798304|75861100|FG000|NOT COMPLETED|Overall Study||14||
59741647|NCT00798304|75861101|FG001|NOT COMPLETED|Overall Study||22||
59741648|NCT00798304|75861102|FG002|NOT COMPLETED|Overall Study||10||
59741649|NCT00718237|75861112|FG000|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized into the study|381||
59741650|NCT00718237|75861113|FG001|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized into the study|381||
59741651|NCT00718237|75861112|FG000|Vaccinated at Visit 1|Overall Study||380||
59741652|NCT00718237|75861113|FG001|Vaccinated at Visit 1|Overall Study||381||
59741653|NCT00718237|75861112|FG000|Vaccinated at Visit 2|Overall Study||373||
59741654|NCT00718237|75861113|FG001|Vaccinated at Visit 2|Overall Study||374||
59741655|NCT00718237|75861112|FG000|Vaccinated at Visit 3|Overall Study||371||
59741656|NCT00718237|75861113|FG001|Vaccinated at Visit 3|Overall Study||369||
59741657|NCT00718237|75861112|FG000|COMPLETED|Overall Study|Subjects who continued follow-up until the last visit, regardless of number of vaccinations received|368||
59741658|NCT00718237|75861113|FG001|COMPLETED|Overall Study|Subjects who continued follow-up until the last visit, regardless of number of vaccinations received|366||
59741659|NCT00718237|75861112|FG000|NOT COMPLETED|Overall Study||13||
59741660|NCT00718237|75861113|FG001|NOT COMPLETED|Overall Study||15||
59741661|NCT00793780|75861123|FG000|STARTED|Overall Study||12||
59741662|NCT00793780|75861124|FG001|STARTED|Overall Study||12||
59741663|NCT00793780|75861123|FG000|Randomization|Overall Study||12||
59741664|NCT00793780|75861124|FG001|Randomization|Overall Study||12||
59741665|NCT00793780|75861123|FG000|Collected Baseline Data|Overall Study||11||
59741666|NCT00793780|75861124|FG001|Collected Baseline Data|Overall Study||12||
59741667|NCT00793780|75861123|FG000|COMPLETED|Overall Study||10||
59741668|NCT00793780|75861124|FG001|COMPLETED|Overall Study||11||
59741669|NCT00793780|75861123|FG000|NOT COMPLETED|Overall Study||2||
59741670|NCT00793780|75861124|FG001|NOT COMPLETED|Overall Study||1||
59741671|NCT02643303|75861139|FG000|STARTED|Overall Study||4|Subjects who started treatment.|
59741672|NCT02643303|75861140|FG001|STARTED|Overall Study||5|Subjects who started treatment.|
59741673|NCT02643303|75861141|FG002|STARTED|Overall Study||1|Subjects who started treatment.|
59741674|NCT02643303|75861142|FG003|STARTED|Overall Study||15|Subjects who started treatment.|
59741675|NCT02643303|75861143|FG004|STARTED|Overall Study||7|Subjects who started treatment.|
59741676|NCT02643303|75861144|FG005|STARTED|Overall Study||4|Subjects who started treatment.|
59741677|NCT02643303|75861145|FG006|STARTED|Overall Study||10|Subjects who started treatment.|
59741678|NCT02643303|75861146|FG007|STARTED|Overall Study||3|Subjects who started treatment.|
59741679|NCT02643303|75861147|FG008|STARTED|Overall Study||7|Subjects who started treatment.|
59741680|NCT02643303|75861139|FG000|COMPLETED|Overall Study||0|Subjects who completed 12 cycles of treatment.|
59741681|NCT02643303|75861140|FG001|COMPLETED|Overall Study||0|Subjects who completed 12 cycles of treatment.|
59741682|NCT02643303|75861141|FG002|COMPLETED|Overall Study||0|Subjects who completed 12 cycles of treatment.|
59741683|NCT02643303|75861142|FG003|COMPLETED|Overall Study||2|Subjects who completed 12 cycles of treatment.|
59741684|NCT02643303|75861143|FG004|COMPLETED|Overall Study||0|Subjects who completed 12 cycles of treatment.|
59741685|NCT02643303|75861144|FG005|COMPLETED|Overall Study||0|Subjects who completed 12 cycles of treatment.|
59741686|NCT02643303|75861145|FG006|COMPLETED|Overall Study||1|Subjects who completed 12 cycles of treatment.|
59741687|NCT02643303|75861146|FG007|COMPLETED|Overall Study||0|Subjects who completed 12 cycles of treatment.|
59741688|NCT02643303|75861147|FG008|COMPLETED|Overall Study||0|Subjects who completed 12 cycles of treatment.|
59741689|NCT02643303|75861139|FG000|NOT COMPLETED|Overall Study||4||
59741690|NCT02643303|75861140|FG001|NOT COMPLETED|Overall Study||5||
59741691|NCT02643303|75861141|FG002|NOT COMPLETED|Overall Study||1||
59741692|NCT02643303|75861142|FG003|NOT COMPLETED|Overall Study||13||
59741693|NCT02643303|75861143|FG004|NOT COMPLETED|Overall Study||7||
59741694|NCT02643303|75861144|FG005|NOT COMPLETED|Overall Study||4||
59741695|NCT02643303|75861145|FG006|NOT COMPLETED|Overall Study||9||
59741696|NCT02643303|75861146|FG007|NOT COMPLETED|Overall Study||3||
59741697|NCT02643303|75861147|FG008|NOT COMPLETED|Overall Study||7||
59741698|NCT00790036|75861169|FG000|STARTED|Overall Study||372||
59741699|NCT00790036|75861170|FG001|STARTED|Overall Study||370||
59741700|NCT00790036|75861169|FG000|Untreated Participants|Overall Study|not treated due to administrative problems, protocol deviation, and subject withdrawal of consent.|4||
59741701|NCT00790036|75861170|FG001|Untreated Participants|Overall Study|not treated due to administrative problems and subject withdrawal of consent.|6||
59741702|NCT00790036|75861169|FG000|COMPLETED|Overall Study|completed = treatment duration completed as per protocol|177||
59741703|NCT00790036|75861170|FG001|COMPLETED|Overall Study|completed = treatment duration completed as per protocol|249||
59741704|NCT00790036|75861169|FG000|NOT COMPLETED|Overall Study||195||
59741705|NCT00790036|75861170|FG001|NOT COMPLETED|Overall Study||121||
59741706|NCT00789958|75861177|FG000|STARTED|Overall Study||105||
59741707|NCT00789958|75861177|FG000|Eligible and Analyzable|Overall Study||79||
59741708|NCT00789958|75861177|FG000|COMPLETED|Overall Study||68||
59741709|NCT00789958|75861177|FG000|NOT COMPLETED|Overall Study||37||
59741710|NCT00789880|75861189|FG000|STARTED|Overall Study||16||
59741711|NCT00789880|75861190|FG001|STARTED|Overall Study||16||
59741712|NCT00789880|75861191|FG002|STARTED|Overall Study||8||
59741713|NCT00789880|75861192|FG003|STARTED|Overall Study||16||
59741714|NCT00789880|75861193|FG004|STARTED|Overall Study||18||
59741715|NCT00789880|75861194|FG005|STARTED|Overall Study||8||
59741716|NCT00789880|75861189|FG000|COMPLETED|Overall Study||15||
59741717|NCT00789880|75861190|FG001|COMPLETED|Overall Study||15||
59741718|NCT00789880|75861191|FG002|COMPLETED|Overall Study||8||
59741719|NCT00789880|75861192|FG003|COMPLETED|Overall Study||15||
59741720|NCT00789880|75861193|FG004|COMPLETED|Overall Study||15||
59741721|NCT00789880|75861194|FG005|COMPLETED|Overall Study||8||
59741722|NCT00789880|75861189|FG000|NOT COMPLETED|Overall Study||1||
59741723|NCT00789880|75861190|FG001|NOT COMPLETED|Overall Study||1||
59741724|NCT00789880|75861191|FG002|NOT COMPLETED|Overall Study||0||
59741725|NCT00789880|75861192|FG003|NOT COMPLETED|Overall Study||1||
59741726|NCT00789880|75861193|FG004|NOT COMPLETED|Overall Study||3||
59741727|NCT00789880|75861194|FG005|NOT COMPLETED|Overall Study||0||
59741728|NCT00792298|75861208|FG000|STARTED|Treatment Period 1||31||
59741729|NCT00792298|75861209|FG001|STARTED|Treatment Period 1||32||
59741730|NCT00792298|75861210|FG002|STARTED|Treatment Period 1||33||
59741731|NCT00792298|75861211|FG003|STARTED|Treatment Period 1||32||
59741732|NCT00792298|75861212|FG004|STARTED|Treatment Period 1||32||
59741733|NCT00792298|75861213|FG005|STARTED|Treatment Period 1||32||
59741734|NCT00792298|75861214|FG006|STARTED|Treatment Period 1||31||
59741735|NCT00792298|75861215|FG007|STARTED|Treatment Period 1||31||
59741736|NCT00792298|75861208|FG000|COMPLETED|Treatment Period 1||30||
59741737|NCT00792298|75861209|FG001|COMPLETED|Treatment Period 1||31||
59741738|NCT00792298|75861210|FG002|COMPLETED|Treatment Period 1||31||
59741739|NCT00792298|75861211|FG003|COMPLETED|Treatment Period 1||28||
59741740|NCT00792298|75861212|FG004|COMPLETED|Treatment Period 1||32||
59741741|NCT00792298|75861213|FG005|COMPLETED|Treatment Period 1||29||
59741742|NCT00792298|75861214|FG006|COMPLETED|Treatment Period 1||27||
59741743|NCT00792298|75861215|FG007|COMPLETED|Treatment Period 1||30||
59741744|NCT00792298|75861208|FG000|NOT COMPLETED|Treatment Period 1||1||
59741745|NCT00792298|75861209|FG001|NOT COMPLETED|Treatment Period 1||1||
59741746|NCT00792298|75861210|FG002|NOT COMPLETED|Treatment Period 1||2||
59741747|NCT00792298|75861211|FG003|NOT COMPLETED|Treatment Period 1||4||
59741748|NCT00792298|75861212|FG004|NOT COMPLETED|Treatment Period 1||0||
59741749|NCT00792298|75861213|FG005|NOT COMPLETED|Treatment Period 1||3||
59741750|NCT00792298|75861214|FG006|NOT COMPLETED|Treatment Period 1||4||
59741751|NCT00792298|75861215|FG007|NOT COMPLETED|Treatment Period 1||1||
59741752|NCT00792298|75861208|FG000|STARTED|Washout||30||
59741753|NCT00792298|75861209|FG001|STARTED|Washout||31||
59741754|NCT00792298|75861210|FG002|STARTED|Washout|1 participant discontinued therapy during Period 1 but entered the Washout as allowed per protocol|32||
59741755|NCT00792298|75861211|FG003|STARTED|Washout||28||
59741756|NCT00792298|75861212|FG004|STARTED|Washout||32||
59741757|NCT00792298|75861213|FG005|STARTED|Washout||29||
59741758|NCT00792298|75861214|FG006|STARTED|Washout|2 participants discontinued therapy during Period 1 but entered the Washout as allowed per protocol|29||
59741759|NCT00792298|75861215|FG007|STARTED|Washout||30||
59741760|NCT00792298|75861208|FG000|COMPLETED|Washout||30||
59741761|NCT00792298|75861209|FG001|COMPLETED|Washout||31||
59741762|NCT00792298|75861210|FG002|COMPLETED|Washout||31||
59741763|NCT00792298|75861211|FG003|COMPLETED|Washout||28||
59741764|NCT00792298|75861212|FG004|COMPLETED|Washout||32||
59741765|NCT00792298|75861213|FG005|COMPLETED|Washout||27||
59741766|NCT00792298|75861214|FG006|COMPLETED|Washout||29||
59741767|NCT00792298|75861215|FG007|COMPLETED|Washout||30||
59741768|NCT00792298|75861208|FG000|NOT COMPLETED|Washout||0||
59741769|NCT00792298|75861209|FG001|NOT COMPLETED|Washout||0||
60134946|NCT03307252|76258154|FG001|STARTED|Part 1, Washout Period 2 (13 Days)||4||
59741770|NCT00792298|75861210|FG002|NOT COMPLETED|Washout||1||
59741771|NCT00792298|75861211|FG003|NOT COMPLETED|Washout||0||
59741772|NCT00792298|75861212|FG004|NOT COMPLETED|Washout||0||
59741773|NCT00792298|75861213|FG005|NOT COMPLETED|Washout||2||
59741774|NCT00792298|75861214|FG006|NOT COMPLETED|Washout||0||
59741775|NCT00792298|75861215|FG007|NOT COMPLETED|Washout||0||
59741776|NCT00792298|75861208|FG000|STARTED|Treatment Period 2||30||
59741777|NCT00792298|75861209|FG001|STARTED|Treatment Period 2||31||
59741778|NCT00792298|75861210|FG002|STARTED|Treatment Period 2||31||
59741779|NCT00792298|75861211|FG003|STARTED|Treatment Period 2||28||
59741780|NCT00792298|75861212|FG004|STARTED|Treatment Period 2||32||
60134947|NCT03307252|76258155|FG002|STARTED|Part 1, Washout Period 2 (13 Days)||4||
60134948|NCT03307252|76258156|FG003|STARTED|Part 1, Washout Period 2 (13 Days)||0||
60134949|NCT03307252|76258157|FG004|STARTED|Part 1, Washout Period 2 (13 Days)||0||
59741781|NCT00792298|75861213|FG005|STARTED|Treatment Period 2||27||
59741782|NCT00792298|75861214|FG006|STARTED|Treatment Period 2||29||
59741783|NCT00792298|75861215|FG007|STARTED|Treatment Period 2||30||
59741784|NCT00792298|75861208|FG000|COMPLETED|Treatment Period 2||29||
59741785|NCT00792298|75861209|FG001|COMPLETED|Treatment Period 2||30||
59741786|NCT00792298|75861210|FG002|COMPLETED|Treatment Period 2||30||
59741787|NCT00792298|75861211|FG003|COMPLETED|Treatment Period 2||26||
59741788|NCT00792298|75861212|FG004|COMPLETED|Treatment Period 2||30||
59741789|NCT00792298|75861213|FG005|COMPLETED|Treatment Period 2||27||
59741790|NCT00792298|75861214|FG006|COMPLETED|Treatment Period 2||28||
59741791|NCT00792298|75861215|FG007|COMPLETED|Treatment Period 2||28||
59741792|NCT00792298|75861208|FG000|NOT COMPLETED|Treatment Period 2||1||
59741793|NCT00792298|75861209|FG001|NOT COMPLETED|Treatment Period 2||1||
59741794|NCT00792298|75861210|FG002|NOT COMPLETED|Treatment Period 2||1||
59741795|NCT00792298|75861211|FG003|NOT COMPLETED|Treatment Period 2||2||
59741796|NCT00792298|75861212|FG004|NOT COMPLETED|Treatment Period 2||2||
59741797|NCT00792298|75861213|FG005|NOT COMPLETED|Treatment Period 2||0||
59741798|NCT00792298|75861214|FG006|NOT COMPLETED|Treatment Period 2||1||
59741799|NCT00792298|75861215|FG007|NOT COMPLETED|Treatment Period 2||2||
59741800|NCT00718159|75861239|FG000|STARTED|Overall Study||3||
59741801|NCT00718159|75861240|FG001|STARTED|Overall Study||3||
59741802|NCT00718159|75861241|FG002|STARTED|Overall Study||3||
59741803|NCT00718159|75861242|FG003|STARTED|Overall Study||4||
59741804|NCT00718159|75861243|FG004|STARTED|Overall Study||8||
60134950|NCT03307252|76258158|FG005|STARTED|Part 1, Washout Period 2 (13 Days)||0||
60134951|NCT03307252|76258159|FG006|STARTED|Part 1, Washout Period 2 (13 Days)||0||
60134952|NCT03307252|76258160|FG007|STARTED|Part 1, Washout Period 2 (13 Days)||0||
59741805|NCT00718159|75861244|FG005|STARTED|Overall Study||1||
59741806|NCT00718159|75861245|FG006|STARTED|Overall Study||1||
59741807|NCT00718159|75861239|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3||
59741808|NCT00718159|75861240|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3||
59741809|NCT00718159|75861241|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3||
59741810|NCT00718159|75861242|FG003|Received at Least 1 Dose of Study Drug|Overall Study||4||
59741811|NCT00718159|75861243|FG004|Received at Least 1 Dose of Study Drug|Overall Study||8||
59741812|NCT00718159|75861244|FG005|Received at Least 1 Dose of Study Drug|Overall Study||1||
60134953|NCT03307252|76258161|FG008|STARTED|Part 1, Washout Period 2 (13 Days)||0||
60134954|NCT03307252|76258162|FG009|STARTED|Part 1, Washout Period 2 (13 Days)||0||
59741813|NCT00718159|75861245|FG006|Received at Least 1 Dose of Study Drug|Overall Study||1||
59741814|NCT00718159|75861239|FG000|COMPLETED|Overall Study||0||
59741815|NCT00718159|75861240|FG001|COMPLETED|Overall Study||0||
59741816|NCT00718159|75861241|FG002|COMPLETED|Overall Study||0||
59741817|NCT00718159|75861242|FG003|COMPLETED|Overall Study||0||
59741818|NCT00718159|75861243|FG004|COMPLETED|Overall Study||0||
59741819|NCT00718159|75861244|FG005|COMPLETED|Overall Study||0||
59741820|NCT00718159|75861245|FG006|COMPLETED|Overall Study||0||
59741821|NCT00718159|75861239|FG000|NOT COMPLETED|Overall Study||3||
59741822|NCT00718159|75861240|FG001|NOT COMPLETED|Overall Study||3||
59741823|NCT00718159|75861241|FG002|NOT COMPLETED|Overall Study||3||
59741824|NCT00718159|75861242|FG003|NOT COMPLETED|Overall Study||4||
59741825|NCT00718159|75861243|FG004|NOT COMPLETED|Overall Study||8||
59741826|NCT00718159|75861244|FG005|NOT COMPLETED|Overall Study||1||
59741827|NCT00718159|75861245|FG006|NOT COMPLETED|Overall Study||1||
59741828|NCT00718081|75861264|FG000|STARTED|Overall Study||29||
59741829|NCT00718081|75861265|FG001|STARTED|Overall Study||29||
59741830|NCT00718081|75861266|FG002|STARTED|Overall Study||30||
59741831|NCT00718081|75861264|FG000|COMPLETED|Overall Study||22||
59741832|NCT00718081|75861265|FG001|COMPLETED|Overall Study||25||
59741833|NCT00718081|75861266|FG002|COMPLETED|Overall Study||9||
59741834|NCT00718081|75861264|FG000|NOT COMPLETED|Overall Study||7||
59741835|NCT00718081|75861265|FG001|NOT COMPLETED|Overall Study||4||
59741836|NCT00718081|75861266|FG002|NOT COMPLETED|Overall Study||21||
59741837|NCT00788710|75861277|FG000|STARTED|Overall Study||144||
59741838|NCT00788710|75861278|FG001|STARTED|Overall Study||142||
59741839|NCT00788710|75861279|FG002|STARTED|Overall Study||144||
59741840|NCT00788710|75861277|FG000|COMPLETED|Overall Study||139||
59741841|NCT00788710|75861278|FG001|COMPLETED|Overall Study||134||
59741842|NCT00788710|75861279|FG002|COMPLETED|Overall Study||138||
59741843|NCT00788710|75861277|FG000|NOT COMPLETED|Overall Study||5||
59741844|NCT00788710|75861278|FG001|NOT COMPLETED|Overall Study||8||
59741845|NCT00788710|75861279|FG002|NOT COMPLETED|Overall Study||6||
59741846|NCT00787930|75861287|FG000|STARTED|Acute Treatment -- 3 Weeks||19||
59741847|NCT00787930|75861287|FG000|COMPLETED|Acute Treatment -- 3 Weeks||19||
59741848|NCT00787930|75861287|FG000|NOT COMPLETED|Acute Treatment -- 3 Weeks||0||
59741849|NCT00787930|75861287|FG000|STARTED|Continuation Treatment -- up to 12 Month||19||
59741850|NCT00787930|75861287|FG000|COMPLETED|Continuation Treatment -- up to 12 Month||16||
59741851|NCT00787930|75861287|FG000|NOT COMPLETED|Continuation Treatment -- up to 12 Month||3||
59741852|NCT00588094|75861297|FG000|STARTED|Overall Study||20||
59741853|NCT00588094|75861297|FG000|COMPLETED|Overall Study||15||
59741854|NCT00588094|75861297|FG000|NOT COMPLETED|Overall Study||5||
59741855|NCT00784654|75861301|FG000|STARTED|Open-Label Period (Non-Randomized)||276||
59741856|NCT00784654|75861302|FG001|STARTED|Open-Label Period (Non-Randomized)||0||
59741857|NCT00784654|75861303|FG002|STARTED|Open-Label Period (Non-Randomized)||0||
59741858|NCT00784654|75861301|FG000|COMPLETED|Open-Label Period (Non-Randomized)||165||
59741859|NCT00784654|75861302|FG001|COMPLETED|Open-Label Period (Non-Randomized)||0||
59741860|NCT00784654|75861303|FG002|COMPLETED|Open-Label Period (Non-Randomized)||0||
59741861|NCT00784654|75861301|FG000|NOT COMPLETED|Open-Label Period (Non-Randomized)||111||
59741862|NCT00784654|75861302|FG001|NOT COMPLETED|Open-Label Period (Non-Randomized)||0||
59741863|NCT00784654|75861303|FG002|NOT COMPLETED|Open-Label Period (Non-Randomized)||0||
59741864|NCT00784654|75861301|FG000|STARTED|Randomized Withdrawal Period||0||
59741865|NCT00784654|75861302|FG001|STARTED|Randomized Withdrawal Period||78||
59741866|NCT00784654|75861303|FG002|STARTED|Randomized Withdrawal Period||79||
59741867|NCT00784654|75861301|FG000|COMPLETED|Randomized Withdrawal Period||0||
59741868|NCT00784654|75861302|FG001|COMPLETED|Randomized Withdrawal Period||60||
59741869|NCT00784654|75861303|FG002|COMPLETED|Randomized Withdrawal Period||16||
59741870|NCT00784654|75861301|FG000|NOT COMPLETED|Randomized Withdrawal Period||0||
59741871|NCT00784654|75861302|FG001|NOT COMPLETED|Randomized Withdrawal Period||18||
59741872|NCT00784654|75861303|FG002|NOT COMPLETED|Randomized Withdrawal Period||63||
59741873|NCT00787150|75861317|FG000|STARTED|Overall Study|Of 222 participants enrolled 4 discontinued before dosing, made a total of 218 participants started.|75||
59741874|NCT00787150|75861318|FG001|STARTED|Overall Study|Of 222 participants enrolled 4 discontinued before dosing, made a total of 218 participants started.|72||
59741875|NCT00787150|75861319|FG002|STARTED|Overall Study|Of 222 participants enrolled 4 discontinued before dosing, made a total of 218 participants started.|71||
59741876|NCT00787150|75861317|FG000|COMPLETED|Overall Study||66||
59741877|NCT00787150|75861318|FG001|COMPLETED|Overall Study||65||
59741878|NCT00787150|75861319|FG002|COMPLETED|Overall Study||66||
59741879|NCT00787150|75861317|FG000|NOT COMPLETED|Overall Study||9||
59741880|NCT00787150|75861318|FG001|NOT COMPLETED|Overall Study||7||
59741881|NCT00787150|75861319|FG002|NOT COMPLETED|Overall Study||5||
59741882|NCT00786838|75861329|FG000|STARTED|Overall Study||75||
59741883|NCT00786838|75861329|FG000|COMPLETED|Overall Study||26||
59741884|NCT00786838|75861329|FG000|NOT COMPLETED|Overall Study||49||
59741885|NCT00785980|75861338|FG000|STARTED|Quinine Sulfate Alone||24||
59741886|NCT00785980|75861338|FG000|COMPLETED|Quinine Sulfate Alone||24||
59741887|NCT00785980|75861338|FG000|NOT COMPLETED|Quinine Sulfate Alone||0||
59741888|NCT00785980|75861338|FG000|STARTED|7 Day Washout Period||24||
59741889|NCT00785980|75861338|FG000|COMPLETED|7 Day Washout Period||21||
59741890|NCT00785980|75861338|FG000|NOT COMPLETED|7 Day Washout Period||3||
59741891|NCT00785980|75861338|FG000|STARTED|Ciprofloxacin Alone||21||
59741892|NCT00785980|75861338|FG000|COMPLETED|Ciprofloxacin Alone||21||
59741893|NCT00785980|75861338|FG000|NOT COMPLETED|Ciprofloxacin Alone||0||
59741894|NCT00785980|75861338|FG000|STARTED|Quinine Sulfate With Ciprofloxacin||21||
59873000|NCT03131440|75997095|FG009|NOT COMPLETED|Overall Study||1||
60134955|NCT03307252|76258163|FG010|STARTED|Part 1, Washout Period 2 (13 Days)||0||
60134956|NCT03307252|76258153|FG000|COMPLETED|Part 1, Washout Period 2 (13 Days)||4||
60134957|NCT03307252|76258154|FG001|COMPLETED|Part 1, Washout Period 2 (13 Days)||4||
60134958|NCT03307252|76258155|FG002|COMPLETED|Part 1, Washout Period 2 (13 Days)||4||
60134959|NCT03307252|76258156|FG003|COMPLETED|Part 1, Washout Period 2 (13 Days)||0||
60134960|NCT03307252|76258157|FG004|COMPLETED|Part 1, Washout Period 2 (13 Days)||0||
60134961|NCT03307252|76258158|FG005|COMPLETED|Part 1, Washout Period 2 (13 Days)||0||
60134962|NCT03307252|76258159|FG006|COMPLETED|Part 1, Washout Period 2 (13 Days)||0||
60134963|NCT03307252|76258160|FG007|COMPLETED|Part 1, Washout Period 2 (13 Days)||0||
60134964|NCT03307252|76258161|FG008|COMPLETED|Part 1, Washout Period 2 (13 Days)||0||
60134965|NCT03307252|76258162|FG009|COMPLETED|Part 1, Washout Period 2 (13 Days)||0||
60134966|NCT03307252|76258163|FG010|COMPLETED|Part 1, Washout Period 2 (13 Days)||0||
60134967|NCT03307252|76258153|FG000|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0||
60134968|NCT03307252|76258154|FG001|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0||
60134969|NCT03307252|76258155|FG002|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0||
60134970|NCT03307252|76258156|FG003|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0||
60134971|NCT03307252|76258157|FG004|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0||
60134972|NCT03307252|76258158|FG005|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0||
60134973|NCT03307252|76258159|FG006|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0||
60134974|NCT03307252|76258160|FG007|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0||
60134975|NCT03307252|76258161|FG008|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0||
60134976|NCT03307252|76258162|FG009|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0||
60134977|NCT03307252|76258163|FG010|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0||
59741895|NCT00785980|75861338|FG000|COMPLETED|Quinine Sulfate With Ciprofloxacin||21||
59741896|NCT00785980|75861338|FG000|NOT COMPLETED|Quinine Sulfate With Ciprofloxacin||0||
60134978|NCT03307252|76258153|FG000|STARTED|Part 1, Period 3|Participants randomised in Part 1|4||
60134979|NCT03307252|76258154|FG001|STARTED|Part 1, Period 3|Participants randomised in Part 1|4||
60134980|NCT03307252|76258155|FG002|STARTED|Part 1, Period 3|Participants randomised in Part 1|4||
60134981|NCT03307252|76258156|FG003|STARTED|Part 1, Period 3||0||
60134982|NCT03307252|76258157|FG004|STARTED|Part 1, Period 3||0||
60134983|NCT03307252|76258158|FG005|STARTED|Part 1, Period 3||0||
60134984|NCT03307252|76258159|FG006|STARTED|Part 1, Period 3||0||
60134985|NCT03307252|76258160|FG007|STARTED|Part 1, Period 3||0||
60134986|NCT03307252|76258161|FG008|STARTED|Part 1, Period 3||0||
60134987|NCT03307252|76258162|FG009|STARTED|Part 1, Period 3||0||
60134988|NCT03307252|76258163|FG010|STARTED|Part 1, Period 3||0||
60134989|NCT03307252|76258153|FG000|COMPLETED|Part 1, Period 3||4||
60134990|NCT03307252|76258154|FG001|COMPLETED|Part 1, Period 3||4||
60134991|NCT03307252|76258155|FG002|COMPLETED|Part 1, Period 3||4||
60134992|NCT03307252|76258156|FG003|COMPLETED|Part 1, Period 3||0||
60134993|NCT03307252|76258157|FG004|COMPLETED|Part 1, Period 3||0||
60134994|NCT03307252|76258158|FG005|COMPLETED|Part 1, Period 3||0||
60134995|NCT03307252|76258159|FG006|COMPLETED|Part 1, Period 3||0||
60134996|NCT03307252|76258160|FG007|COMPLETED|Part 1, Period 3||0||
60134997|NCT03307252|76258161|FG008|COMPLETED|Part 1, Period 3||0||
60134998|NCT03307252|76258162|FG009|COMPLETED|Part 1, Period 3||0||
60134999|NCT03307252|76258163|FG010|COMPLETED|Part 1, Period 3||0||
60135000|NCT03307252|76258153|FG000|NOT COMPLETED|Part 1, Period 3||0||
60135001|NCT03307252|76258154|FG001|NOT COMPLETED|Part 1, Period 3||0||
60135002|NCT03307252|76258155|FG002|NOT COMPLETED|Part 1, Period 3||0||
60135003|NCT03307252|76258156|FG003|NOT COMPLETED|Part 1, Period 3||0||
60135004|NCT03307252|76258157|FG004|NOT COMPLETED|Part 1, Period 3||0||
60135005|NCT03307252|76258158|FG005|NOT COMPLETED|Part 1, Period 3||0||
60135006|NCT03307252|76258159|FG006|NOT COMPLETED|Part 1, Period 3||0||
60135007|NCT03307252|76258160|FG007|NOT COMPLETED|Part 1, Period 3||0||
60135008|NCT03307252|76258161|FG008|NOT COMPLETED|Part 1, Period 3||0||
60135009|NCT03307252|76258162|FG009|NOT COMPLETED|Part 1, Period 3||0||
60135010|NCT03307252|76258163|FG010|NOT COMPLETED|Part 1, Period 3||0||
60135011|NCT03307252|76258153|FG000|STARTED|Part 2, Period 1||0||
60135012|NCT03307252|76258154|FG001|STARTED|Part 2, Period 1||0||
60135013|NCT03307252|76258155|FG002|STARTED|Part 2, Period 1||0||
59741897|NCT00791518|75861345|FG000|STARTED|Overall Study||1084||
59741898|NCT00791518|75861345|FG000|COMPLETED|Overall Study||991||
59741899|NCT00791518|75861345|FG000|NOT COMPLETED|Overall Study||93||
59741900|NCT00785512|75861366|FG000|STARTED|Overall Study||102||
59741901|NCT00785512|75861367|FG001|STARTED|Overall Study||105||
59741902|NCT00785512|75861366|FG000|COMPLETED|Overall Study||99||
59741903|NCT00785512|75861367|FG001|COMPLETED|Overall Study||101||
59741904|NCT00785512|75861366|FG000|NOT COMPLETED|Overall Study||3||
59741905|NCT00785512|75861367|FG001|NOT COMPLETED|Overall Study||4||
59741906|NCT00785356|75861377|FG000|STARTED|Overall Study||8||
59741907|NCT00785356|75861377|FG000|COMPLETED|Overall Study||0||
59741908|NCT00785356|75861377|FG000|NOT COMPLETED|Overall Study||8||
59741909|NCT00785044|75861385|FG000|STARTED|Overall Study|Eligible to participate in MBG313|964||
59741910|NCT00785044|75861385|FG000|Enrolled Participants|Overall Study|Out of 964 from MBG311 and MBG312 HF participants, 471 enrolled into the extension MBG313 study.|471||
59741911|NCT00785044|75861385|FG000|COMPLETED|Overall Study|Data for 471 participants (MBG313) combined with data from MBG311 and MBG312 for efficacy analysis|468||
59741912|NCT00785044|75861385|FG000|NOT COMPLETED|Overall Study||496||
59741913|NCT00784810|75861392|FG000|STARTED|Overall Study||124||
59741914|NCT00784810|75861393|FG001|STARTED|Overall Study||123||
59741915|NCT00784810|75861392|FG000|COMPLETED|Overall Study||61||
59741916|NCT00784810|75861393|FG001|COMPLETED|Overall Study||74||
59741917|NCT00784810|75861392|FG000|NOT COMPLETED|Overall Study||63||
59741918|NCT00784810|75861393|FG001|NOT COMPLETED|Overall Study||49||
59741919|NCT00791128|75861399|FG000|STARTED|Overall Study||22||
59741920|NCT00791128|75861399|FG000|COMPLETED|Overall Study||13||
59741921|NCT00791128|75861399|FG000|NOT COMPLETED|Overall Study||9||
59741922|NCT03262701|75861406|FG000|STARTED|Overall Study||14||
59741923|NCT03262701|75861407|FG001|STARTED|Overall Study||17||
59604407|NCT02059434|75714654|FG007|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0||
59604408|NCT02059434|75714655|FG008|COMPLETED|Period 8||34||
59604409|NCT02059434|75714647|FG000|NOT COMPLETED|Period 8||0||
59741924|NCT03262701|75861408|FG002|STARTED|Overall Study||9||
59741925|NCT03262701|75861406|FG000|COMPLETED|Overall Study||11||
59741926|NCT03262701|75861407|FG001|COMPLETED|Overall Study||13||
59741927|NCT03262701|75861408|FG002|COMPLETED|Overall Study||8||
59741928|NCT03262701|75861406|FG000|NOT COMPLETED|Overall Study||3||
59741929|NCT03262701|75861407|FG001|NOT COMPLETED|Overall Study||4||
59741930|NCT03262701|75861408|FG002|NOT COMPLETED|Overall Study||1||
59741931|NCT00776230|75861419|FG000|STARTED|Overall Study||99||
59741932|NCT00776230|75861420|FG001|STARTED|Overall Study||103||
59741933|NCT00776230|75861421|FG002|STARTED|Overall Study||102||
59741934|NCT00776230|75861419|FG000|Enrolled and Vaccinated at Day 0|Overall Study||98||
59741935|NCT00776230|75861420|FG001|Enrolled and Vaccinated at Day 0|Overall Study||103||
59741936|NCT00776230|75861421|FG002|Enrolled and Vaccinated at Day 0|Overall Study||102||
59741937|NCT00776230|75861419|FG000|COMPLETED|Overall Study||96||
59741938|NCT00776230|75861420|FG001|COMPLETED|Overall Study||100||
59741939|NCT00776230|75861421|FG002|COMPLETED|Overall Study||97||
59741940|NCT00776230|75861419|FG000|NOT COMPLETED|Overall Study||3||
59741941|NCT00776230|75861420|FG001|NOT COMPLETED|Overall Study||3||
59741942|NCT00776230|75861421|FG002|NOT COMPLETED|Overall Study||5||
59741943|NCT00775606|75861431|FG000|STARTED|Overall Study||8||
59741944|NCT00775606|75861432|FG001|STARTED|Overall Study||5||
59741945|NCT00775606|75861431|FG000|COMPLETED|Overall Study||5||
59741946|NCT00775606|75861432|FG001|COMPLETED|Overall Study||5||
59741947|NCT00775606|75861431|FG000|NOT COMPLETED|Overall Study||3||
59741948|NCT00775606|75861432|FG001|NOT COMPLETED|Overall Study||0||
59741949|NCT02960763|75861451|FG000|STARTED|Step 1||211||
59741950|NCT02960763|75861452|FG001|STARTED|Step 1||206||
59741951|NCT02960763|75861453|FG002|STARTED|Step 1||202||
59741952|NCT02960763|75861454|FG003|STARTED|Step 1||0||
59741953|NCT02960763|75861455|FG004|STARTED|Step 1||0||
59741954|NCT02960763|75861451|FG000|COMPLETED|Step 1||192|"Step 1 only includes: Aripiprazole Augmentation Bupropion Augmentation Switch to Bupropion"|
59741955|NCT02960763|75861452|FG001|COMPLETED|Step 1||188|"Step 1 only includes: Aripiprazole Augmentation Bupropion Augmentation Switch to Bupropion"|
59741956|NCT02960763|75861453|FG002|COMPLETED|Step 1||174|"Step 1 only includes: Aripiprazole Augmentation Bupropion Augmentation Switch to Bupropion"|
59741957|NCT02960763|75861454|FG003|COMPLETED|Step 1||0|"Step 1 only includes: Aripiprazole Augmentation Bupropion Augmentation Switch to Bupropion"|
59741958|NCT02960763|75861455|FG004|COMPLETED|Step 1||0|"Step 1 only includes: Aripiprazole Augmentation Bupropion Augmentation Switch to Bupropion"|
59741959|NCT02960763|75861451|FG000|NOT COMPLETED|Step 1||19||
59741960|NCT02960763|75861452|FG001|NOT COMPLETED|Step 1||18||
59741961|NCT02960763|75861453|FG002|NOT COMPLETED|Step 1||28||
59741962|NCT02960763|75861454|FG003|NOT COMPLETED|Step 1||0||
59741963|NCT02960763|75861455|FG004|NOT COMPLETED|Step 1||0||
59741964|NCT02960763|75861451|FG000|STARTED|Step 2||0||
59741965|NCT02960763|75861452|FG001|STARTED|Step 2||0||
59741966|NCT02960763|75861453|FG002|STARTED|Step 2||0||
59741967|NCT02960763|75861454|FG003|STARTED|Step 2||127||
59741968|NCT02960763|75861455|FG004|STARTED|Step 2||121||
59741969|NCT02960763|75861451|FG000|People Who Participated in Step 1 and Continued to Participate in Step 2|Step 2||43||
59741970|NCT02960763|75861452|FG001|People Who Participated in Step 1 and Continued to Participate in Step 2|Step 2||44||
59741971|NCT02960763|75861453|FG002|People Who Participated in Step 1 and Continued to Participate in Step 2|Step 2||38||
59741972|NCT02960763|75861454|FG003|People Who Participated in Step 1 and Continued to Participate in Step 2|Step 2||0||
59741973|NCT02960763|75861455|FG004|People Who Participated in Step 1 and Continued to Participate in Step 2|Step 2||0||
59741974|NCT02960763|75861451|FG000|People Who Began Step 2 Without Having Participated in Step 1|Step 2||0||
59741975|NCT02960763|75861452|FG001|People Who Began Step 2 Without Having Participated in Step 1|Step 2||0||
59741976|NCT02960763|75861453|FG002|People Who Began Step 2 Without Having Participated in Step 1|Step 2||0||
59741977|NCT02960763|75861454|FG003|People Who Began Step 2 Without Having Participated in Step 1|Step 2||63||
59741978|NCT02960763|75861455|FG004|People Who Began Step 2 Without Having Participated in Step 1|Step 2||60||
59741979|NCT02960763|75861451|FG000|COMPLETED|Step 2||0|"Step 2 only includes: Lithium Augmentation Switch to Nortriptyline"|
59741980|NCT02960763|75861452|FG001|COMPLETED|Step 2||0|"Step 2 only includes: Lithium Augmentation Switch to Nortriptyline"|
59741981|NCT02960763|75861453|FG002|COMPLETED|Step 2||0|"Step 2 only includes: Lithium Augmentation Switch to Nortriptyline"|
59741982|NCT02960763|75861454|FG003|COMPLETED|Step 2||116|"Step 2 only includes: Lithium Augmentation Switch to Nortriptyline"|
59741983|NCT02960763|75861455|FG004|COMPLETED|Step 2||116|"Step 2 only includes: Lithium Augmentation Switch to Nortriptyline"|
59741984|NCT02960763|75861451|FG000|NOT COMPLETED|Step 2||0||
59741985|NCT02960763|75861452|FG001|NOT COMPLETED|Step 2||0||
59741986|NCT02960763|75861453|FG002|NOT COMPLETED|Step 2||0||
59741987|NCT02960763|75861454|FG003|NOT COMPLETED|Step 2||11||
59741988|NCT02960763|75861455|FG004|NOT COMPLETED|Step 2||5||
59741989|NCT00775528|75861467|FG000|STARTED|Overall Study|Started means number of patients who consented|19||
59741990|NCT00775528|75861467|FG000|COMPLETED|Overall Study||18||
59741991|NCT00775528|75861467|FG000|NOT COMPLETED|Overall Study||1||
59741992|NCT00775450|75861476|FG000|STARTED|Overall Study||295||
59741993|NCT00775450|75861477|FG001|STARTED|Overall Study||98||
59741994|NCT00775450|75861478|FG002|STARTED|Overall Study||105||
59741995|NCT00775450|75861479|FG003|STARTED|Overall Study||108||
59741996|NCT00775450|75861480|FG004|STARTED|Overall Study||201||
59741997|NCT00775450|75861476|FG000|COMPLETED|Overall Study||292||
59741998|NCT00775450|75861477|FG001|COMPLETED|Overall Study||98||
59741999|NCT00775450|75861478|FG002|COMPLETED|Overall Study||105||
59742000|NCT00775450|75861479|FG003|COMPLETED|Overall Study||108||
59742001|NCT00775450|75861480|FG004|COMPLETED|Overall Study||199||
59742002|NCT00775450|75861476|FG000|NOT COMPLETED|Overall Study||3||
59742003|NCT00775450|75861477|FG001|NOT COMPLETED|Overall Study||0||
59742004|NCT00775450|75861478|FG002|NOT COMPLETED|Overall Study||0||
59742005|NCT00775450|75861479|FG003|NOT COMPLETED|Overall Study||0||
59742006|NCT00775450|75861480|FG004|NOT COMPLETED|Overall Study||2||
59742007|NCT00775138|75861496|FG000|STARTED|Overall Study||24||
59742008|NCT00775138|75861497|FG001|STARTED|Overall Study||10||
59742009|NCT00775138|75861498|FG002|STARTED|Overall Study||20||
59742010|NCT00775138|75861499|FG003|STARTED|Overall Study||10||
59742011|NCT00775138|75861496|FG000|COMPLETED|Overall Study||24||
59742012|NCT00775138|75861497|FG001|COMPLETED|Overall Study||10||
59742013|NCT00775138|75861498|FG002|COMPLETED|Overall Study||17||
59742014|NCT00775138|75861499|FG003|COMPLETED|Overall Study||8||
59742015|NCT00775138|75861496|FG000|NOT COMPLETED|Overall Study||0||
59742016|NCT00775138|75861497|FG001|NOT COMPLETED|Overall Study||0||
59742017|NCT00775138|75861498|FG002|NOT COMPLETED|Overall Study||3||
59742018|NCT00775138|75861499|FG003|NOT COMPLETED|Overall Study||2||
59742019|NCT04605991|75861511|FG000|STARTED|Overall Study||187||
59742020|NCT04605991|75861511|FG000|Received at Least 1 Dose of Study Drug|Overall Study||176||
59742021|NCT04605991|75861511|FG000|COMPLETED|Overall Study||154||
59742022|NCT04605991|75861511|FG000|NOT COMPLETED|Overall Study||33||
59742023|NCT00783796|75861515|FG000|STARTED|Overall Study||150||
59742024|NCT00783796|75861515|FG000|COMPLETED|Overall Study||144||
59742025|NCT00783796|75861515|FG000|NOT COMPLETED|Overall Study||6||
59742026|NCT00783718|75861524|FG000|STARTED|Induction Phase||149||
59742027|NCT00783718|75861525|FG001|STARTED|Induction Phase||225||
59742028|NCT00783718|75861526|FG002|STARTED|Induction Phase||521||
59742029|NCT00783718|75861527|FG003|STARTED|Induction Phase||0||
59742030|NCT00783718|75861528|FG004|STARTED|Induction Phase||0||
59742031|NCT00783718|75861529|FG005|STARTED|Induction Phase||0||
59742032|NCT00783718|75861530|FG006|STARTED|Induction Phase||0||
59742033|NCT00783718|75861524|FG000|COMPLETED|Induction Phase||135||
59742034|NCT00783718|75861525|FG001|COMPLETED|Induction Phase||218||
59742035|NCT00783718|75861526|FG002|COMPLETED|Induction Phase||485||
59742036|NCT00783718|75861527|FG003|COMPLETED|Induction Phase||0||
59742037|NCT00783718|75861528|FG004|COMPLETED|Induction Phase||0||
59742038|NCT00783718|75861529|FG005|COMPLETED|Induction Phase||0||
59742039|NCT00783718|75861530|FG006|COMPLETED|Induction Phase||0||
59742040|NCT00783718|75861524|FG000|NOT COMPLETED|Induction Phase||14||
59742041|NCT00783718|75861525|FG001|NOT COMPLETED|Induction Phase||7||
59742042|NCT00783718|75861526|FG002|NOT COMPLETED|Induction Phase||36||
59742043|NCT00783718|75861527|FG003|NOT COMPLETED|Induction Phase||0||
59742044|NCT00783718|75861528|FG004|NOT COMPLETED|Induction Phase||0||
59742045|NCT00783718|75861529|FG005|NOT COMPLETED|Induction Phase||0||
59742046|NCT00783718|75861530|FG006|NOT COMPLETED|Induction Phase||0||
59742047|NCT00783718|75861524|FG000|STARTED|Maintenance Phase||135||
59742048|NCT00783718|75861525|FG001|STARTED|Maintenance Phase||0||
59742049|NCT00783718|75861526|FG002|STARTED|Maintenance Phase||0||
59742050|NCT00783718|75861527|FG003|STARTED|Maintenance Phase||126||
59742051|NCT00783718|75861528|FG004|STARTED|Maintenance Phase||122||
59742052|NCT00783718|75861529|FG005|STARTED|Maintenance Phase||125||
59742053|NCT00783718|75861530|FG006|STARTED|Maintenance Phase||330||
59742054|NCT00783718|75861524|FG000|COMPLETED|Maintenance Phase||30||
59742055|NCT00783718|75861525|FG001|COMPLETED|Maintenance Phase||0||
59742056|NCT00783718|75861526|FG002|COMPLETED|Maintenance Phase||0||
59742057|NCT00783718|75861527|FG003|COMPLETED|Maintenance Phase||48||
59742058|NCT00783718|75861528|FG004|COMPLETED|Maintenance Phase||77||
59742059|NCT00783718|75861529|FG005|COMPLETED|Maintenance Phase||84||
59742060|NCT00783718|75861530|FG006|COMPLETED|Maintenance Phase||135||
59742061|NCT00783718|75861524|FG000|NOT COMPLETED|Maintenance Phase||105||
59742062|NCT00783718|75861525|FG001|NOT COMPLETED|Maintenance Phase||0||
59742063|NCT00783718|75861526|FG002|NOT COMPLETED|Maintenance Phase||0||
59742064|NCT00783718|75861527|FG003|NOT COMPLETED|Maintenance Phase||78||
59742065|NCT00783718|75861528|FG004|NOT COMPLETED|Maintenance Phase||45||
59742066|NCT00783718|75861529|FG005|NOT COMPLETED|Maintenance Phase||41||
59742067|NCT00783718|75861530|FG006|NOT COMPLETED|Maintenance Phase||195||
59742068|NCT02528721|75861542|FG000|STARTED|Overall Study||203||
59742069|NCT02528721|75861543|FG001|STARTED|Overall Study||79||
59742070|NCT02528721|75861542|FG000|COMPLETED|Overall Study||196||
59742071|NCT02528721|75861543|FG001|COMPLETED|Overall Study||76||
59742072|NCT02528721|75861542|FG000|NOT COMPLETED|Overall Study||7||
59742073|NCT02528721|75861543|FG001|NOT COMPLETED|Overall Study||3||
59742074|NCT00774748|75861549|FG000|STARTED|Overall Study||21||
59742075|NCT00774748|75861549|FG000|COMPLETED|Overall Study||18||
59742076|NCT00774748|75861549|FG000|NOT COMPLETED|Overall Study||3||
59742077|NCT00587860|75861559|FG000|STARTED|Overall Study||35||
59742078|NCT00587860|75861560|FG001|STARTED|Overall Study||35||
59742079|NCT00587860|75861559|FG000|COMPLETED|Overall Study||30||
59742080|NCT00587860|75861560|FG001|COMPLETED|Overall Study||30||
59742081|NCT00587860|75861559|FG000|NOT COMPLETED|Overall Study||5||
59742082|NCT00587860|75861560|FG001|NOT COMPLETED|Overall Study||5||
59742083|NCT00583453|75861568|FG000|STARTED|Overall Study||9||
59742084|NCT00583453|75861569|FG001|STARTED|Overall Study||8||
59742085|NCT00583453|75861568|FG000|COMPLETED|Overall Study||9||
59742086|NCT00583453|75861569|FG001|COMPLETED|Overall Study||6||
59742087|NCT00583453|75861568|FG000|NOT COMPLETED|Overall Study||0||
59742088|NCT00583453|75861569|FG001|NOT COMPLETED|Overall Study||2||
59742089|NCT00583219|75861577|FG000|STARTED|Phase 1|First 3 subjects in Phase 1 received 200 units Botox. The remaining subjects got 300 units Botox.|9||
59742090|NCT00583219|75861577|FG000|COMPLETED|Phase 1||9||
59742091|NCT00583219|75861577|FG000|NOT COMPLETED|Phase 1||0||
59742092|NCT00583219|75861577|FG000|STARTED|Phase 2|6 subjects from P1 continued in P2; plus 16 new subjects. All subjects in P2 got 300 units Botox.|22||
59742093|NCT00583219|75861577|FG000|COMPLETED|Phase 2||21||
59742094|NCT00583219|75861577|FG000|NOT COMPLETED|Phase 2||1||
59742095|NCT04296877|75861581|FG000|STARTED|Overall Study||30||
59742096|NCT04296877|75861581|FG000|COMPLETED|Overall Study||30||
59742097|NCT04296877|75861581|FG000|NOT COMPLETED|Overall Study||0||
59742098|NCT01072175|75861597|FG000|STARTED|Part A (Drug-Drug Interaction)||8||
59742099|NCT01072175|75861598|FG001|STARTED|Part A (Drug-Drug Interaction)||0||
59742100|NCT01072175|75861599|FG002|STARTED|Part A (Drug-Drug Interaction)||0||
59742101|NCT01072175|75861600|FG003|STARTED|Part A (Drug-Drug Interaction)||0||
59742102|NCT01072175|75861601|FG004|STARTED|Part A (Drug-Drug Interaction)||0||
59742103|NCT01072175|75861602|FG005|STARTED|Part A (Drug-Drug Interaction)||0||
59742104|NCT01072175|75861603|FG006|STARTED|Part A (Drug-Drug Interaction)||0||
59742105|NCT01072175|75861604|FG007|STARTED|Part A (Drug-Drug Interaction)||0||
59742106|NCT01072175|75861605|FG008|STARTED|Part A (Drug-Drug Interaction)||0||
59742107|NCT01072175|75861606|FG009|STARTED|Part A (Drug-Drug Interaction)||0||
59742108|NCT01072175|75861607|FG010|STARTED|Part A (Drug-Drug Interaction)||0||
59742109|NCT01072175|75861608|FG011|STARTED|Part A (Drug-Drug Interaction)||0||
59742110|NCT01072175|75861609|FG012|STARTED|Part A (Drug-Drug Interaction)||0||
59742111|NCT01072175|75861597|FG000|COMPLETED|Part A (Drug-Drug Interaction)||0||
59742112|NCT01072175|75861598|FG001|COMPLETED|Part A (Drug-Drug Interaction)||0||
59742113|NCT01072175|75861599|FG002|COMPLETED|Part A (Drug-Drug Interaction)||0||
59742114|NCT01072175|75861600|FG003|COMPLETED|Part A (Drug-Drug Interaction)||0||
59742115|NCT01072175|75861601|FG004|COMPLETED|Part A (Drug-Drug Interaction)||0||
59742116|NCT01072175|75861602|FG005|COMPLETED|Part A (Drug-Drug Interaction)||0||
59742117|NCT01072175|75861603|FG006|COMPLETED|Part A (Drug-Drug Interaction)||0||
59742118|NCT01072175|75861604|FG007|COMPLETED|Part A (Drug-Drug Interaction)||0||
59742119|NCT01072175|75861605|FG008|COMPLETED|Part A (Drug-Drug Interaction)||0||
59742120|NCT01072175|75861606|FG009|COMPLETED|Part A (Drug-Drug Interaction)||0||
59742121|NCT01072175|75861607|FG010|COMPLETED|Part A (Drug-Drug Interaction)||0||
59742122|NCT01072175|75861608|FG011|COMPLETED|Part A (Drug-Drug Interaction)||0||
59742123|NCT01072175|75861609|FG012|COMPLETED|Part A (Drug-Drug Interaction)||0||
59742124|NCT01072175|75861597|FG000|NOT COMPLETED|Part A (Drug-Drug Interaction)||8||
59742125|NCT01072175|75861598|FG001|NOT COMPLETED|Part A (Drug-Drug Interaction)||0||
59742126|NCT01072175|75861599|FG002|NOT COMPLETED|Part A (Drug-Drug Interaction)||0||
59742127|NCT01072175|75861600|FG003|NOT COMPLETED|Part A (Drug-Drug Interaction)||0||
59742128|NCT01072175|75861601|FG004|NOT COMPLETED|Part A (Drug-Drug Interaction)||0||
59742129|NCT01072175|75861602|FG005|NOT COMPLETED|Part A (Drug-Drug Interaction)||0||
59742130|NCT01072175|75861603|FG006|NOT COMPLETED|Part A (Drug-Drug Interaction)||0||
59742131|NCT01072175|75861604|FG007|NOT COMPLETED|Part A (Drug-Drug Interaction)||0||
59742132|NCT01072175|75861605|FG008|NOT COMPLETED|Part A (Drug-Drug Interaction)||0||
59742133|NCT01072175|75861606|FG009|NOT COMPLETED|Part A (Drug-Drug Interaction)||0||
59742134|NCT01072175|75861607|FG010|NOT COMPLETED|Part A (Drug-Drug Interaction)||0||
59742135|NCT01072175|75861608|FG011|NOT COMPLETED|Part A (Drug-Drug Interaction)||0||
59742136|NCT01072175|75861609|FG012|NOT COMPLETED|Part A (Drug-Drug Interaction)||0||
59742137|NCT01072175|75861597|FG000|STARTED|Part B (Dose Escalation and Expansion)||0||
59742138|NCT01072175|75861598|FG001|STARTED|Part B (Dose Escalation and Expansion)||6||
59742139|NCT01072175|75861599|FG002|STARTED|Part B (Dose Escalation and Expansion)||23||
59742140|NCT01072175|75861600|FG003|STARTED|Part B (Dose Escalation and Expansion)||27||
59742141|NCT01072175|75861601|FG004|STARTED|Part B (Dose Escalation and Expansion)||94||
59742142|NCT01072175|75861602|FG005|STARTED|Part B (Dose Escalation and Expansion)||0||
59742143|NCT01072175|75861603|FG006|STARTED|Part B (Dose Escalation and Expansion)||0||
59742144|NCT01072175|75861604|FG007|STARTED|Part B (Dose Escalation and Expansion)||0||
59742145|NCT01072175|75861605|FG008|STARTED|Part B (Dose Escalation and Expansion)||0||
59742146|NCT01072175|75861606|FG009|STARTED|Part B (Dose Escalation and Expansion)||0||
59742147|NCT01072175|75861607|FG010|STARTED|Part B (Dose Escalation and Expansion)||0||
59742148|NCT01072175|75861608|FG011|STARTED|Part B (Dose Escalation and Expansion)||0||
59742149|NCT01072175|75861609|FG012|STARTED|Part B (Dose Escalation and Expansion)||0||
59742150|NCT01072175|75861597|FG000|COMPLETED|Part B (Dose Escalation and Expansion)||0||
59742151|NCT01072175|75861598|FG001|COMPLETED|Part B (Dose Escalation and Expansion)||0||
59742152|NCT01072175|75861599|FG002|COMPLETED|Part B (Dose Escalation and Expansion)||0||
59742153|NCT01072175|75861600|FG003|COMPLETED|Part B (Dose Escalation and Expansion)||0||
59742154|NCT01072175|75861601|FG004|COMPLETED|Part B (Dose Escalation and Expansion)||0||
59742155|NCT01072175|75861602|FG005|COMPLETED|Part B (Dose Escalation and Expansion)||0||
59742156|NCT01072175|75861603|FG006|COMPLETED|Part B (Dose Escalation and Expansion)||0||
59742157|NCT01072175|75861604|FG007|COMPLETED|Part B (Dose Escalation and Expansion)||0||
59742158|NCT01072175|75861605|FG008|COMPLETED|Part B (Dose Escalation and Expansion)||0||
59742159|NCT01072175|75861606|FG009|COMPLETED|Part B (Dose Escalation and Expansion)||0||
59742160|NCT01072175|75861607|FG010|COMPLETED|Part B (Dose Escalation and Expansion)||0||
59742161|NCT01072175|75861608|FG011|COMPLETED|Part B (Dose Escalation and Expansion)||0||
59742162|NCT01072175|75861609|FG012|COMPLETED|Part B (Dose Escalation and Expansion)||0||
59742163|NCT01072175|75861597|FG000|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0||
59742164|NCT01072175|75861598|FG001|NOT COMPLETED|Part B (Dose Escalation and Expansion)||6||
59742165|NCT01072175|75861599|FG002|NOT COMPLETED|Part B (Dose Escalation and Expansion)||23||
59742166|NCT01072175|75861600|FG003|NOT COMPLETED|Part B (Dose Escalation and Expansion)||27||
59742167|NCT01072175|75861601|FG004|NOT COMPLETED|Part B (Dose Escalation and Expansion)||94||
59742168|NCT01072175|75861602|FG005|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0||
59742169|NCT01072175|75861603|FG006|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0||
59742170|NCT01072175|75861604|FG007|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0||
59742171|NCT01072175|75861605|FG008|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0||
59742172|NCT01072175|75861606|FG009|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0||
59742173|NCT01072175|75861607|FG010|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0||
59742174|NCT01072175|75861608|FG011|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0||
59742175|NCT01072175|75861609|FG012|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0||
59742176|NCT01072175|75861597|FG000|STARTED|Part C (Phase II: Randomized Phase)||0||
59742177|NCT01072175|75861598|FG001|STARTED|Part C (Phase II: Randomized Phase)||0||
59742178|NCT01072175|75861599|FG002|STARTED|Part C (Phase II: Randomized Phase)||0||
59742179|NCT01072175|75861600|FG003|STARTED|Part C (Phase II: Randomized Phase)||0||
59742180|NCT01072175|75861601|FG004|STARTED|Part C (Phase II: Randomized Phase)||0||
59742181|NCT01072175|75861602|FG005|STARTED|Part C (Phase II: Randomized Phase)||54||
59742182|NCT01072175|75861603|FG006|STARTED|Part C (Phase II: Randomized Phase)||54||
59742183|NCT01072175|75861604|FG007|STARTED|Part C (Phase II: Randomized Phase)||54||
59742184|NCT01072175|75861605|FG008|STARTED|Part C (Phase II: Randomized Phase)||0||
59742185|NCT01072175|75861606|FG009|STARTED|Part C (Phase II: Randomized Phase)||0||
59742186|NCT01072175|75861607|FG010|STARTED|Part C (Phase II: Randomized Phase)||0||
59742187|NCT01072175|75861608|FG011|STARTED|Part C (Phase II: Randomized Phase)||0||
59742188|NCT01072175|75861609|FG012|STARTED|Part C (Phase II: Randomized Phase)||0||
59742189|NCT01072175|75861597|FG000|COMPLETED|Part C (Phase II: Randomized Phase)||0||
59742190|NCT01072175|75861598|FG001|COMPLETED|Part C (Phase II: Randomized Phase)||0||
59742191|NCT01072175|75861599|FG002|COMPLETED|Part C (Phase II: Randomized Phase)||0||
59742192|NCT01072175|75861600|FG003|COMPLETED|Part C (Phase II: Randomized Phase)||0||
59742193|NCT01072175|75861601|FG004|COMPLETED|Part C (Phase II: Randomized Phase)||0||
59742194|NCT01072175|75861602|FG005|COMPLETED|Part C (Phase II: Randomized Phase)||0||
59742195|NCT01072175|75861603|FG006|COMPLETED|Part C (Phase II: Randomized Phase)||0||
59742196|NCT01072175|75861604|FG007|COMPLETED|Part C (Phase II: Randomized Phase)||0||
59742197|NCT01072175|75861605|FG008|COMPLETED|Part C (Phase II: Randomized Phase)||0||
59742198|NCT01072175|75861606|FG009|COMPLETED|Part C (Phase II: Randomized Phase)||0||
59742199|NCT01072175|75861607|FG010|COMPLETED|Part C (Phase II: Randomized Phase)||0||
59742200|NCT01072175|75861608|FG011|COMPLETED|Part C (Phase II: Randomized Phase)||0||
59742201|NCT01072175|75861609|FG012|COMPLETED|Part C (Phase II: Randomized Phase)||0||
59742202|NCT01072175|75861597|FG000|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0||
59742203|NCT01072175|75861598|FG001|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0||
59742204|NCT01072175|75861599|FG002|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0||
59742205|NCT01072175|75861600|FG003|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0||
59742206|NCT01072175|75861601|FG004|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0||
60135014|NCT03307252|76258156|FG003|STARTED|Part 2, Period 1|Participants randomized in Part 2|4||
60135015|NCT03307252|76258157|FG004|STARTED|Part 2, Period 1|Participants randomized in Part 2|4||
60135016|NCT03307252|76258158|FG005|STARTED|Part 2, Period 1|Participants randomized in Part 2|4||
59742207|NCT01072175|75861602|FG005|NOT COMPLETED|Part C (Phase II: Randomized Phase)||54||
59742208|NCT01072175|75861603|FG006|NOT COMPLETED|Part C (Phase II: Randomized Phase)||54||
59742209|NCT01072175|75861604|FG007|NOT COMPLETED|Part C (Phase II: Randomized Phase)||54||
59742210|NCT01072175|75861605|FG008|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0||
59742211|NCT01072175|75861606|FG009|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0||
59742212|NCT01072175|75861607|FG010|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0||
59742213|NCT01072175|75861608|FG011|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0||
59742214|NCT01072175|75861609|FG012|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0||
59742215|NCT01072175|75861597|FG000|STARTED|Part C (Phase II: Crossover Phase [CP])||0||
59742216|NCT01072175|75861598|FG001|STARTED|Part C (Phase II: Crossover Phase [CP])||0||
59742217|NCT01072175|75861599|FG002|STARTED|Part C (Phase II: Crossover Phase [CP])||0||
59742218|NCT01072175|75861600|FG003|STARTED|Part C (Phase II: Crossover Phase [CP])||0||
59742219|NCT01072175|75861601|FG004|STARTED|Part C (Phase II: Crossover Phase [CP])||0||
59742220|NCT01072175|75861602|FG005|STARTED|Part C (Phase II: Crossover Phase [CP])||0||
59742221|NCT01072175|75861603|FG006|STARTED|Part C (Phase II: Crossover Phase [CP])||0||
59742222|NCT01072175|75861604|FG007|STARTED|Part C (Phase II: Crossover Phase [CP])||0||
59742223|NCT01072175|75861605|FG008|STARTED|Part C (Phase II: Crossover Phase [CP])||45||
59742224|NCT01072175|75861606|FG009|STARTED|Part C (Phase II: Crossover Phase [CP])||0||
59742225|NCT01072175|75861607|FG010|STARTED|Part C (Phase II: Crossover Phase [CP])||0||
59742226|NCT01072175|75861608|FG011|STARTED|Part C (Phase II: Crossover Phase [CP])||0||
59742227|NCT01072175|75861609|FG012|STARTED|Part C (Phase II: Crossover Phase [CP])||0||
59742228|NCT01072175|75861597|FG000|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0||
59742229|NCT01072175|75861598|FG001|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0||
59742230|NCT01072175|75861599|FG002|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0||
59742231|NCT01072175|75861600|FG003|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0||
59742232|NCT01072175|75861601|FG004|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0||
59742233|NCT01072175|75861602|FG005|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0||
59742234|NCT01072175|75861603|FG006|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0||
59742235|NCT01072175|75861604|FG007|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0||
59742236|NCT01072175|75861605|FG008|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0||
59742237|NCT01072175|75861606|FG009|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0||
59742238|NCT01072175|75861607|FG010|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0||
59742239|NCT01072175|75861608|FG011|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0||
59742240|NCT01072175|75861609|FG012|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0||
59742241|NCT01072175|75861597|FG000|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0||
59742242|NCT01072175|75861598|FG001|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0||
59742243|NCT01072175|75861599|FG002|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0||
59742244|NCT01072175|75861600|FG003|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0||
59742245|NCT01072175|75861601|FG004|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0||
59742246|NCT01072175|75861602|FG005|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0||
60135017|NCT03307252|76258159|FG006|STARTED|Part 2, Period 1|Participants randomized in Part 2|5||
60135018|NCT03307252|76258160|FG007|STARTED|Part 2, Period 1||0||
60135019|NCT03307252|76258161|FG008|STARTED|Part 2, Period 1||0||
60135020|NCT03307252|76258162|FG009|STARTED|Part 2, Period 1||0||
60135021|NCT03307252|76258163|FG010|STARTED|Part 2, Period 1||0||
60135022|NCT03307252|76258153|FG000|COMPLETED|Part 2, Period 1||0||
59742247|NCT01072175|75861603|FG006|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0||
59742248|NCT01072175|75861604|FG007|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0||
59742249|NCT01072175|75861605|FG008|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||45||
59762490|NCT02644525|75882211|FG002|COMPLETED|Group 3||0||
60135023|NCT03307252|76258154|FG001|COMPLETED|Part 2, Period 1||0||
60135024|NCT03307252|76258155|FG002|COMPLETED|Part 2, Period 1||0||
60135025|NCT03307252|76258156|FG003|COMPLETED|Part 2, Period 1||4||
60135026|NCT03307252|76258157|FG004|COMPLETED|Part 2, Period 1||4||
59742250|NCT01072175|75861606|FG009|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0||
59742251|NCT01072175|75861607|FG010|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0||
59742252|NCT01072175|75861608|FG011|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0||
59742253|NCT01072175|75861609|FG012|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0||
59742254|NCT01072175|75861597|FG000|STARTED|Part D (HPMC Capsules)||0||
59742255|NCT01072175|75861598|FG001|STARTED|Part D (HPMC Capsules)||0||
59742256|NCT01072175|75861599|FG002|STARTED|Part D (HPMC Capsules)||0||
59742257|NCT01072175|75861600|FG003|STARTED|Part D (HPMC Capsules)||0||
59742258|NCT01072175|75861601|FG004|STARTED|Part D (HPMC Capsules)||0||
59742259|NCT01072175|75861602|FG005|STARTED|Part D (HPMC Capsules)||0||
59742260|NCT01072175|75861603|FG006|STARTED|Part D (HPMC Capsules)||0||
59742261|NCT01072175|75861604|FG007|STARTED|Part D (HPMC Capsules)||0||
59742262|NCT01072175|75861605|FG008|STARTED|Part D (HPMC Capsules)||0||
59742263|NCT01072175|75861606|FG009|STARTED|Part D (HPMC Capsules)||12||
59742264|NCT01072175|75861607|FG010|STARTED|Part D (HPMC Capsules)||16||
59742265|NCT01072175|75861608|FG011|STARTED|Part D (HPMC Capsules)||43||
59742266|NCT01072175|75861609|FG012|STARTED|Part D (HPMC Capsules)||39||
59742267|NCT01072175|75861597|FG000|COMPLETED|Part D (HPMC Capsules)||0||
59742268|NCT01072175|75861598|FG001|COMPLETED|Part D (HPMC Capsules)||0||
59742269|NCT01072175|75861599|FG002|COMPLETED|Part D (HPMC Capsules)||0||
59742270|NCT01072175|75861600|FG003|COMPLETED|Part D (HPMC Capsules)||0||
59742271|NCT01072175|75861601|FG004|COMPLETED|Part D (HPMC Capsules)||0||
59742272|NCT01072175|75861602|FG005|COMPLETED|Part D (HPMC Capsules)||0||
59742273|NCT01072175|75861603|FG006|COMPLETED|Part D (HPMC Capsules)||0||
59742274|NCT01072175|75861604|FG007|COMPLETED|Part D (HPMC Capsules)||0||
59742275|NCT01072175|75861605|FG008|COMPLETED|Part D (HPMC Capsules)||0||
59742276|NCT01072175|75861606|FG009|COMPLETED|Part D (HPMC Capsules)||0||
59742277|NCT01072175|75861607|FG010|COMPLETED|Part D (HPMC Capsules)||0||
59742278|NCT01072175|75861608|FG011|COMPLETED|Part D (HPMC Capsules)||0||
59742279|NCT01072175|75861609|FG012|COMPLETED|Part D (HPMC Capsules)||0||
59742280|NCT01072175|75861597|FG000|NOT COMPLETED|Part D (HPMC Capsules)||0||
59742281|NCT01072175|75861598|FG001|NOT COMPLETED|Part D (HPMC Capsules)||0||
59742282|NCT01072175|75861599|FG002|NOT COMPLETED|Part D (HPMC Capsules)||0||
59742283|NCT01072175|75861600|FG003|NOT COMPLETED|Part D (HPMC Capsules)||0||
59742284|NCT01072175|75861601|FG004|NOT COMPLETED|Part D (HPMC Capsules)||0||
59742285|NCT01072175|75861602|FG005|NOT COMPLETED|Part D (HPMC Capsules)||0||
59742286|NCT01072175|75861603|FG006|NOT COMPLETED|Part D (HPMC Capsules)||0||
59742287|NCT01072175|75861604|FG007|NOT COMPLETED|Part D (HPMC Capsules)||0||
59742288|NCT01072175|75861605|FG008|NOT COMPLETED|Part D (HPMC Capsules)||0||
59742289|NCT01072175|75861606|FG009|NOT COMPLETED|Part D (HPMC Capsules)||12||
59742290|NCT01072175|75861607|FG010|NOT COMPLETED|Part D (HPMC Capsules)||16||
59742291|NCT01072175|75861608|FG011|NOT COMPLETED|Part D (HPMC Capsules)||43||
59742292|NCT01072175|75861609|FG012|NOT COMPLETED|Part D (HPMC Capsules)||39||
59742293|NCT01071317|75861643|FG000|STARTED|Overall Study||25||
59742294|NCT01071317|75861644|FG001|STARTED|Overall Study||25||
59742295|NCT01071317|75861643|FG000|COMPLETED|Overall Study||23||
59742296|NCT01071317|75861644|FG001|COMPLETED|Overall Study||23||
59742297|NCT01071317|75861643|FG000|NOT COMPLETED|Overall Study||2||
59742298|NCT01071317|75861644|FG001|NOT COMPLETED|Overall Study||2||
59742299|NCT04283149|75861650|FG000|STARTED|Overall Study||327||327
59742300|NCT04283149|75861651|FG001|STARTED|Overall Study||327||302
59742301|NCT04283149|75861650|FG000|Postoperative Month 6|Overall Study||321||321
59742302|NCT04283149|75861651|FG001|Postoperative Month 6|Overall Study||321||298
59742303|NCT04283149|75861650|FG000|COMPLETED|Overall Study||0||0
59742304|NCT04283149|75861651|FG001|COMPLETED|Overall Study||0||0
59742305|NCT04283149|75861650|FG000|NOT COMPLETED|Overall Study||327||327
59742306|NCT04283149|75861651|FG001|NOT COMPLETED|Overall Study||327||302
59742307|NCT00783094|75861661|FG000|STARTED|Randomized Double-Blind Treatment Period||142||
59742308|NCT00783094|75861662|FG001|STARTED|Randomized Double-Blind Treatment Period||140||
59742309|NCT00783094|75861663|FG002|STARTED|Randomized Double-Blind Treatment Period||140||
59742310|NCT00783094|75861661|FG000|COMPLETED|Randomized Double-Blind Treatment Period||135||
59742311|NCT00783094|75861662|FG001|COMPLETED|Randomized Double-Blind Treatment Period||128||
59742312|NCT00783094|75861663|FG002|COMPLETED|Randomized Double-Blind Treatment Period||131||
59742313|NCT00783094|75861661|FG000|NOT COMPLETED|Randomized Double-Blind Treatment Period||7||
59742314|NCT00783094|75861662|FG001|NOT COMPLETED|Randomized Double-Blind Treatment Period||12||
59742315|NCT00783094|75861663|FG002|NOT COMPLETED|Randomized Double-Blind Treatment Period||9||
59742316|NCT00783094|75861661|FG000|STARTED|Open-Label Extension Period||135||
59742317|NCT00783094|75861662|FG001|STARTED|Open-Label Extension Period||128||
59742318|NCT00783094|75861663|FG002|STARTED|Open-Label Extension Period||131||
59742319|NCT00783094|75861661|FG000|COMPLETED|Open-Label Extension Period||113||
59742320|NCT00783094|75861662|FG001|COMPLETED|Open-Label Extension Period||109||
59742321|NCT00783094|75861663|FG002|COMPLETED|Open-Label Extension Period||101||
59742322|NCT00783094|75861661|FG000|NOT COMPLETED|Open-Label Extension Period||22||
59742323|NCT00783094|75861662|FG001|NOT COMPLETED|Open-Label Extension Period||19||
59742324|NCT00783094|75861663|FG002|NOT COMPLETED|Open-Label Extension Period||30||
59742325|NCT00790582|75861676|FG000|STARTED|Overall Study||109||
59742326|NCT00790582|75861677|FG001|STARTED|Overall Study||249||
60135027|NCT03307252|76258158|FG005|COMPLETED|Part 2, Period 1||3||
60135028|NCT03307252|76258159|FG006|COMPLETED|Part 2, Period 1||5||
60135029|NCT03307252|76258160|FG007|COMPLETED|Part 2, Period 1||0||
59742327|NCT00790582|75861676|FG000|COMPLETED|Overall Study||78||
59742328|NCT00790582|75861677|FG001|COMPLETED|Overall Study||162||
59742329|NCT00790582|75861676|FG000|NOT COMPLETED|Overall Study||31||
59742330|NCT00790582|75861677|FG001|NOT COMPLETED|Overall Study||87||
59742331|NCT01048541|75861685|FG000|STARTED|Overall Study||18||
59742332|NCT01048541|75861686|FG001|STARTED|Overall Study||19||
59742333|NCT01048541|75861685|FG000|COMPLETED|Overall Study||17||
59742334|NCT01048541|75861686|FG001|COMPLETED|Overall Study||19||
59742335|NCT01048541|75861685|FG000|NOT COMPLETED|Overall Study||1||
59742336|NCT01048541|75861686|FG001|NOT COMPLETED|Overall Study||0||
59742337|NCT00774046|75861692|FG000|STARTED|Screening||116||
59742338|NCT00774046|75861692|FG000|COMPLETED|Screening||60||
59742339|NCT00774046|75861692|FG000|NOT COMPLETED|Screening||56||
60135030|NCT03307252|76258161|FG008|COMPLETED|Part 2, Period 1||0||
60135031|NCT03307252|76258162|FG009|COMPLETED|Part 2, Period 1||0||
60135032|NCT03307252|76258163|FG010|COMPLETED|Part 2, Period 1||0||
60135033|NCT03307252|76258153|FG000|NOT COMPLETED|Part 2, Period 1||0||
59742340|NCT00774046|75861692|FG000|STARTED|Enrollment||60||
59742341|NCT00774046|75861692|FG000|COMPLETED|Enrollment||32||
59742342|NCT00774046|75861692|FG000|NOT COMPLETED|Enrollment||28||
59742343|NCT00774046|75861692|FG000|STARTED|Induction Therapy||32||
59742344|NCT00774046|75861692|FG000|COMPLETED|Induction Therapy||32||
59742345|NCT00774046|75861692|FG000|NOT COMPLETED|Induction Therapy||0||
59742346|NCT00774046|75861692|FG000|STARTED|Stem Cell Mobilization|For mobilization, the patient must have had a CR and not been a candidate for allogeneic transplant|10||
59742347|NCT00774046|75861692|FG000|COMPLETED|Stem Cell Mobilization||7||
59742348|NCT00774046|75861692|FG000|NOT COMPLETED|Stem Cell Mobilization||3||
59742349|NCT00774046|75861692|FG000|STARTED|Autologous Transplant|2 patients died in remission and 1 relapsed without having received transplant|4||
59742350|NCT00774046|75861692|FG000|COMPLETED|Autologous Transplant||4||
59742351|NCT00774046|75861692|FG000|NOT COMPLETED|Autologous Transplant||0||
59742352|NCT01046903|75861696|FG000|STARTED|Overall Study||503||
59742353|NCT01046903|75861696|FG000|COMPLETED|Overall Study||475||
59742354|NCT01046903|75861696|FG000|NOT COMPLETED|Overall Study||28||
59742355|NCT00773968|75861700|FG000|STARTED|Overall Study||140||
59742356|NCT00773968|75861700|FG000|Treated|Overall Study||111||
59742357|NCT00773968|75861700|FG000|COMPLETED|Overall Study||95||
59742358|NCT00773968|75861700|FG000|NOT COMPLETED|Overall Study||45||
59742359|NCT00782626|75861704|FG000|STARTED|Overall Study||23||
59742360|NCT00782626|75861704|FG000|COMPLETED|Overall Study||16||
59742361|NCT00782626|75861704|FG000|NOT COMPLETED|Overall Study||7||
59742362|NCT01071083|75861713|FG000|STARTED|Overall Study||42||
59742363|NCT01071083|75861714|FG001|STARTED|Overall Study||45||
59742364|NCT01071083|75861715|FG002|STARTED|Overall Study||17||
59742365|NCT01071083|75861716|FG003|STARTED|Overall Study||17||
59742366|NCT01071083|75861717|FG004|STARTED|Overall Study||54||
59742367|NCT01071083|75861713|FG000|COMPLETED|Overall Study||35||
59742368|NCT01071083|75861714|FG001|COMPLETED|Overall Study||43||
59742369|NCT01071083|75861715|FG002|COMPLETED|Overall Study||12||
59742370|NCT01071083|75861716|FG003|COMPLETED|Overall Study||15||
59742371|NCT01071083|75861717|FG004|COMPLETED|Overall Study||46||
59742372|NCT01071083|75861713|FG000|NOT COMPLETED|Overall Study||7||
59742373|NCT01071083|75861714|FG001|NOT COMPLETED|Overall Study||2||
59742374|NCT01071083|75861715|FG002|NOT COMPLETED|Overall Study||5||
59742375|NCT01071083|75861716|FG003|NOT COMPLETED|Overall Study||2||
60135034|NCT03307252|76258154|FG001|NOT COMPLETED|Part 2, Period 1||0||
60135035|NCT03307252|76258155|FG002|NOT COMPLETED|Part 2, Period 1||0||
60135036|NCT03307252|76258156|FG003|NOT COMPLETED|Part 2, Period 1||0||
60135037|NCT03307252|76258157|FG004|NOT COMPLETED|Part 2, Period 1||0||
60135038|NCT03307252|76258158|FG005|NOT COMPLETED|Part 2, Period 1||1||
60135039|NCT03307252|76258159|FG006|NOT COMPLETED|Part 2, Period 1||0||
60135040|NCT03307252|76258160|FG007|NOT COMPLETED|Part 2, Period 1||0||
60135041|NCT03307252|76258161|FG008|NOT COMPLETED|Part 2, Period 1||0||
60135042|NCT03307252|76258162|FG009|NOT COMPLETED|Part 2, Period 1||0||
59742376|NCT01071083|75861717|FG004|NOT COMPLETED|Overall Study||8||
59742377|NCT01070771|75861729|FG000|STARTED|Overall Study|September 2008|203||
59742378|NCT01070771|75861729|FG000|COMPLETED|Overall Study|August 2012|200||
59742379|NCT01070771|75861729|FG000|NOT COMPLETED|Overall Study||3||
59742380|NCT01070381|75861734|FG000|STARTED|Period 1, 1 Week of Wear|One subject could not be dispensed into Period 1 product. Subject started Period 2 wear.|109||
59742381|NCT01070381|75861735|FG001|STARTED|Period 1, 1 Week of Wear||107||
59742382|NCT01070381|75861734|FG000|COMPLETED|Period 1, 1 Week of Wear|One subject could not continue into Period 2 due to product unavailability.|109||
59742383|NCT01070381|75861735|FG001|COMPLETED|Period 1, 1 Week of Wear||107||
59742384|NCT01070381|75861734|FG000|NOT COMPLETED|Period 1, 1 Week of Wear||0||
59742385|NCT01070381|75861735|FG001|NOT COMPLETED|Period 1, 1 Week of Wear||0||
59742386|NCT01070381|75861734|FG000|STARTED|Period 2, 1 Week of Wear||109||
59742387|NCT01070381|75861735|FG001|STARTED|Period 2, 1 Week of Wear||107||
59742388|NCT01070381|75861734|FG000|COMPLETED|Period 2, 1 Week of Wear||108||
59742389|NCT01070381|75861735|FG001|COMPLETED|Period 2, 1 Week of Wear||106||
59742390|NCT01070381|75861734|FG000|NOT COMPLETED|Period 2, 1 Week of Wear||1||
59742391|NCT01070381|75861735|FG001|NOT COMPLETED|Period 2, 1 Week of Wear||1||
59742392|NCT03897751|75861743|FG000|STARTED|Overall Study||127||
59742393|NCT03897751|75861744|FG001|STARTED|Overall Study||125||
59742394|NCT03897751|75861743|FG000|COMPLETED|Overall Study||121||
59742395|NCT03897751|75861744|FG001|COMPLETED|Overall Study||119||
59742396|NCT03897751|75861743|FG000|NOT COMPLETED|Overall Study||6||
59742397|NCT03897751|75861744|FG001|NOT COMPLETED|Overall Study||6||
59742398|NCT01010126|75861756|FG000|STARTED|Overall Study||27||
59742399|NCT01010126|75861757|FG001|STARTED|Overall Study||58||
59742400|NCT01010126|75861758|FG002|STARTED|Overall Study||28||
59742401|NCT01010126|75861759|FG003|STARTED|Overall Study||57||
59742402|NCT01010126|75861760|FG004|STARTED|Overall Study||58||
59742403|NCT01010126|75861761|FG005|STARTED|Overall Study||24||
59742404|NCT01010126|75861756|FG000|COMPLETED|Overall Study||26||
59742405|NCT01010126|75861757|FG001|COMPLETED|Overall Study||58||
59742406|NCT01010126|75861758|FG002|COMPLETED|Overall Study||27||
59742407|NCT01010126|75861759|FG003|COMPLETED|Overall Study||57||
59742408|NCT01010126|75861760|FG004|COMPLETED|Overall Study||55||
59742409|NCT01010126|75861761|FG005|COMPLETED|Overall Study||24||
59742410|NCT01010126|75861756|FG000|NOT COMPLETED|Overall Study||1||
59742411|NCT01010126|75861757|FG001|NOT COMPLETED|Overall Study||0||
59742412|NCT01010126|75861758|FG002|NOT COMPLETED|Overall Study||1||
59742413|NCT01010126|75861759|FG003|NOT COMPLETED|Overall Study||0||
59742414|NCT01010126|75861760|FG004|NOT COMPLETED|Overall Study||3||
59742415|NCT01010126|75861761|FG005|NOT COMPLETED|Overall Study||0||
59742416|NCT01043705|75861778|FG000|STARTED|Overall Study||459||
59742417|NCT01043705|75861779|FG001|STARTED|Overall Study||578||
59742418|NCT01043705|75861780|FG002|STARTED|Overall Study||578||
59742419|NCT01043705|75861778|FG000|COMPLETED|Overall Study||352||
59742420|NCT01043705|75861779|FG001|COMPLETED|Overall Study||447||
59742421|NCT01043705|75861780|FG002|COMPLETED|Overall Study||498||
59742422|NCT01043705|75861778|FG000|NOT COMPLETED|Overall Study||107||
59742423|NCT01043705|75861779|FG001|NOT COMPLETED|Overall Study||131||
59742424|NCT01043705|75861780|FG002|NOT COMPLETED|Overall Study||80||
59742425|NCT03837379|75861790|FG000|STARTED|Overall Study||50||
59742426|NCT03837379|75861791|FG001|STARTED|Overall Study||114||
59742427|NCT03837379|75861790|FG000|COMPLETED|Overall Study||47||
59742428|NCT03837379|75861791|FG001|COMPLETED|Overall Study||103||
59742429|NCT03837379|75861790|FG000|NOT COMPLETED|Overall Study||3||
59742430|NCT03837379|75861791|FG001|NOT COMPLETED|Overall Study||11||
59742431|NCT01070303|75861799|FG000|STARTED|Overall Study||177||
59742432|NCT01070303|75861799|FG000|COMPLETED|Overall Study||88||
59742433|NCT01070303|75861799|FG000|NOT COMPLETED|Overall Study||89||
59742434|NCT01009814|75861814|FG000|STARTED|Overall Study||10||
59742435|NCT01009814|75861815|FG001|STARTED|Overall Study||10||
59742436|NCT01009814|75861816|FG002|STARTED|Overall Study||10||
59742437|NCT01009814|75861817|FG003|STARTED|Overall Study||10||
59742438|NCT01009814|75861818|FG004|STARTED|Overall Study||10||
59742439|NCT01009814|75861814|FG000|COMPLETED|Overall Study||9||
59742440|NCT01009814|75861815|FG001|COMPLETED|Overall Study||9||
59742441|NCT01009814|75861816|FG002|COMPLETED|Overall Study||10||
59742442|NCT01009814|75861817|FG003|COMPLETED|Overall Study||10||
59742443|NCT01009814|75861818|FG004|COMPLETED|Overall Study||10||
60135043|NCT03307252|76258163|FG010|NOT COMPLETED|Part 2, Period 1||0||
59742444|NCT01009814|75861814|FG000|NOT COMPLETED|Overall Study||1||
59742445|NCT01009814|75861815|FG001|NOT COMPLETED|Overall Study||1||
59742446|NCT01009814|75861816|FG002|NOT COMPLETED|Overall Study||0||
59742447|NCT01009814|75861817|FG003|NOT COMPLETED|Overall Study||0||
59742448|NCT01009814|75861818|FG004|NOT COMPLETED|Overall Study||0||
59742449|NCT03824587|75861836|FG000|STARTED|Run-in Period|No subjects were on treatment during this period|0||
59742450|NCT03824587|75861837|FG001|STARTED|Run-in Period||511||
59742451|NCT03824587|75861836|FG000|COMPLETED|Run-in Period|No subjects were on treatment during this period|0||
59742452|NCT03824587|75861837|FG001|COMPLETED|Run-in Period||236||
59742453|NCT03824587|75861836|FG000|NOT COMPLETED|Run-in Period||0||
59742454|NCT03824587|75861837|FG001|NOT COMPLETED|Run-in Period||275||
59742455|NCT03824587|75861836|FG000|STARTED|Treatment Period||117||
59742456|NCT03824587|75861837|FG001|STARTED|Treatment Period||119||
60135044|NCT03307252|76258153|FG000|STARTED|Part 2, Washout Period 1 (7 Days)||0||
60135045|NCT03307252|76258154|FG001|STARTED|Part 2, Washout Period 1 (7 Days)||0||
60135046|NCT03307252|76258155|FG002|STARTED|Part 2, Washout Period 1 (7 Days)||0||
59742457|NCT03824587|75861836|FG000|COMPLETED|Treatment Period||112||
59742458|NCT03824587|75861837|FG001|COMPLETED|Treatment Period||116||
59742459|NCT03824587|75861836|FG000|NOT COMPLETED|Treatment Period||5||
59742460|NCT03824587|75861837|FG001|NOT COMPLETED|Treatment Period||3||
59742461|NCT00773734|75861847|FG000|STARTED|Core: Placebo Controlled Phase Week 0-16||88||
59742462|NCT00773734|75861848|FG001|STARTED|Core: Placebo Controlled Phase Week 0-16||89||
59742463|NCT00773734|75861849|FG002|STARTED|Core: Placebo Controlled Phase Week 0-16||87||
59742464|NCT00773734|75861850|FG003|STARTED|Core: Placebo Controlled Phase Week 0-16||88||
59742465|NCT00773734|75861851|FG004|STARTED|Core: Placebo Controlled Phase Week 0-16||0||
59762491|NCT02644525|75882212|FG003|COMPLETED|Group 3||5||
60135047|NCT03307252|76258156|FG003|STARTED|Part 2, Washout Period 1 (7 Days)||4||
59742466|NCT00773734|75861852|FG005|STARTED|Core: Placebo Controlled Phase Week 0-16||0||
59742467|NCT00773734|75861847|FG000|COMPLETED|Core: Placebo Controlled Phase Week 0-16|2 participants completed placebo controlled phase but elected not to continue|72||
59742468|NCT00773734|75861848|FG001|COMPLETED|Core: Placebo Controlled Phase Week 0-16|2 participants completed placebo controlled phase but elected not to continue|79||
59742469|NCT00773734|75861849|FG002|COMPLETED|Core: Placebo Controlled Phase Week 0-16||66||
59742470|NCT00773734|75861850|FG003|COMPLETED|Core: Placebo Controlled Phase Week 0-16|3 participants completed placebo controlled phase but elected not to continue|70||
59742471|NCT00773734|75861851|FG004|COMPLETED|Core: Placebo Controlled Phase Week 0-16||0||
59742472|NCT00773734|75861852|FG005|COMPLETED|Core: Placebo Controlled Phase Week 0-16||0||
59742473|NCT00773734|75861847|FG000|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||16||
59742474|NCT00773734|75861848|FG001|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||10||
59742475|NCT00773734|75861849|FG002|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||21||
59742476|NCT00773734|75861850|FG003|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||18||
59742477|NCT00773734|75861851|FG004|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||0||
59742478|NCT00773734|75861852|FG005|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||0||
59742479|NCT00773734|75861847|FG000|STARTED|Core: Active Treatment Phase Week 16-24|Placebo participants were re-randomized at Week 16 to receive apremilast 20mg or 30mg PO BID.|0||
59742480|NCT00773734|75861848|FG001|STARTED|Core: Active Treatment Phase Week 16-24|2 participants elected not to continue from previous period|77||
59742481|NCT00773734|75861849|FG002|STARTED|Core: Active Treatment Phase Week 16-24||66||
59742482|NCT00773734|75861850|FG003|STARTED|Core: Active Treatment Phase Week 16-24|3 participants elected not to continue from previous period|67||
59742483|NCT00773734|75861851|FG004|STARTED|Core: Active Treatment Phase Week 16-24||34||
59742484|NCT00773734|75861852|FG005|STARTED|Core: Active Treatment Phase Week 16-24||36||
59742485|NCT00773734|75861847|FG000|COMPLETED|Core: Active Treatment Phase Week 16-24||0||
59742486|NCT00773734|75861848|FG001|COMPLETED|Core: Active Treatment Phase Week 16-24||65||
59742487|NCT00773734|75861849|FG002|COMPLETED|Core: Active Treatment Phase Week 16-24||59||
59742488|NCT00773734|75861850|FG003|COMPLETED|Core: Active Treatment Phase Week 16-24||65||
59742489|NCT00773734|75861851|FG004|COMPLETED|Core: Active Treatment Phase Week 16-24||33||
59742490|NCT00773734|75861852|FG005|COMPLETED|Core: Active Treatment Phase Week 16-24||31||
59742491|NCT00773734|75861847|FG000|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||0||
59742492|NCT00773734|75861848|FG001|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||12||
59742493|NCT00773734|75861849|FG002|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||7||
59742494|NCT00773734|75861850|FG003|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||2||
59742495|NCT00773734|75861851|FG004|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||1||
59742496|NCT00773734|75861852|FG005|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||5||
59742497|NCT00773734|75861847|FG000|STARTED|Extension: Active Treatment Week 24-52||0||
59742498|NCT00773734|75861848|FG001|STARTED|Extension: Active Treatment Week 24-52||47||
59742499|NCT00773734|75861849|FG002|STARTED|Extension: Active Treatment Week 24-52||50||
59742500|NCT00773734|75861850|FG003|STARTED|Extension: Active Treatment Week 24-52||58||
59742501|NCT00773734|75861851|FG004|STARTED|Extension: Active Treatment Week 24-52||27||
59742502|NCT00773734|75861852|FG005|STARTED|Extension: Active Treatment Week 24-52||27||
59742503|NCT00773734|75861847|FG000|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||0||
59742504|NCT00773734|75861848|FG001|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||5||
59742505|NCT00773734|75861849|FG002|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||10||
59742506|NCT00773734|75861850|FG003|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||10||
59742507|NCT00773734|75861851|FG004|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||4||
59742508|NCT00773734|75861852|FG005|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||4||
59742509|NCT00773734|75861847|FG000|COMPLETED|Extension: Active Treatment Week 24-52||0||
59742510|NCT00773734|75861848|FG001|COMPLETED|Extension: Active Treatment Week 24-52|Those dosed APR 10 mg BID in extension study were randomly assigned APR 20 mg or 30 mg BID in LTE|34||
59742511|NCT00773734|75861849|FG002|COMPLETED|Extension: Active Treatment Week 24-52||33||
59742512|NCT00773734|75861850|FG003|COMPLETED|Extension: Active Treatment Week 24-52||48||
59742513|NCT00773734|75861851|FG004|COMPLETED|Extension: Active Treatment Week 24-52||22||
59742514|NCT00773734|75861852|FG005|COMPLETED|Extension: Active Treatment Week 24-52||19||
59742515|NCT00773734|75861847|FG000|NOT COMPLETED|Extension: Active Treatment Week 24-52||0||
59742516|NCT00773734|75861848|FG001|NOT COMPLETED|Extension: Active Treatment Week 24-52||13||
59742517|NCT00773734|75861849|FG002|NOT COMPLETED|Extension: Active Treatment Week 24-52||17||
59742518|NCT00773734|75861850|FG003|NOT COMPLETED|Extension: Active Treatment Week 24-52||10||
59742519|NCT00773734|75861851|FG004|NOT COMPLETED|Extension: Active Treatment Week 24-52||5||
59742520|NCT00773734|75861852|FG005|NOT COMPLETED|Extension: Active Treatment Week 24-52||8||
59742521|NCT00773734|75861847|FG000|STARTED|LTE Period: Week 52 to 6 Years||0||
59742522|NCT00773734|75861848|FG001|STARTED|LTE Period: Week 52 to 6 Years||0||
59742523|NCT00773734|75861849|FG002|STARTED|LTE Period: Week 52 to 6 Years|Those dosed APR 10 mg BID in extension study were randomly assigned APR 20 mg or 30 mg BID in LTE|16||
59742524|NCT00773734|75861850|FG003|STARTED|LTE Period: Week 52 to 6 Years|Those dosed APR 10 mg BID in extension study were randomly assigned APR 20 mg or 30 mg BID in LTE|17||
59742525|NCT00773734|75861851|FG004|STARTED|LTE Period: Week 52 to 6 Years||0||
59742526|NCT00773734|75861852|FG005|STARTED|LTE Period: Week 52 to 6 Years||0||
59742527|NCT00773734|75861847|FG000|COMPLETED|LTE Period: Week 52 to 6 Years||0||
59742528|NCT00773734|75861848|FG001|COMPLETED|LTE Period: Week 52 to 6 Years||0||
59742529|NCT00773734|75861849|FG002|COMPLETED|LTE Period: Week 52 to 6 Years|Completed = Completed Long Term Extension study|4||
59742530|NCT00773734|75861850|FG003|COMPLETED|LTE Period: Week 52 to 6 Years|Completed = Completed Long Term Extension study|5||
59742531|NCT00773734|75861851|FG004|COMPLETED|LTE Period: Week 52 to 6 Years||0||
59742532|NCT00773734|75861852|FG005|COMPLETED|LTE Period: Week 52 to 6 Years||0||
59742533|NCT00773734|75861847|FG000|NOT COMPLETED|LTE Period: Week 52 to 6 Years||0||
59742534|NCT00773734|75861848|FG001|NOT COMPLETED|LTE Period: Week 52 to 6 Years||0||
59742535|NCT00773734|75861849|FG002|NOT COMPLETED|LTE Period: Week 52 to 6 Years||12||
59742536|NCT00773734|75861850|FG003|NOT COMPLETED|LTE Period: Week 52 to 6 Years||12||
59742537|NCT00773734|75861851|FG004|NOT COMPLETED|LTE Period: Week 52 to 6 Years||0||
59742538|NCT00773734|75861852|FG005|NOT COMPLETED|LTE Period: Week 52 to 6 Years||0||
59742539|NCT01009580|75861911|FG000|STARTED|Overall Study||224||
59742540|NCT01009580|75861912|FG001|STARTED|Overall Study||223||
59742541|NCT01009580|75861911|FG000|Exposed|Overall Study||224||
59742542|NCT01009580|75861912|FG001|Exposed|Overall Study|One subject was randomised in error and withdrew prior to exposure to drug|222||
59742543|NCT01009580|75861911|FG000|COMPLETED|Overall Study||197||
59742544|NCT01009580|75861912|FG001|COMPLETED|Overall Study||188||
59742545|NCT01009580|75861911|FG000|NOT COMPLETED|Overall Study||27||
59742546|NCT01009580|75861912|FG001|NOT COMPLETED|Overall Study||35||
59742547|NCT01009346|75861918|FG000|STARTED|Overall Study||9||
59742548|NCT01009346|75861918|FG000|COMPLETED|Overall Study||5||
59742549|NCT01009346|75861918|FG000|NOT COMPLETED|Overall Study||4||
59742550|NCT01001702|75861923|FG000|STARTED|Overall Study||85||
59742551|NCT01001702|75861923|FG000|COMPLETED|Overall Study||13||
59742552|NCT01001702|75861923|FG000|NOT COMPLETED|Overall Study||72||
59742553|NCT01070069|75861932|FG000|STARTED|Overall Study||50||
59742554|NCT01070069|75861933|FG001|STARTED|Overall Study||50||
59742555|NCT01070069|75861934|FG002|STARTED|Overall Study||51||
59742556|NCT01070069|75861935|FG003|STARTED|Overall Study||19||
59742557|NCT01070069|75861936|FG004|STARTED|Overall Study||22||
59742558|NCT01070069|75861932|FG000|COMPLETED|Overall Study||44||
59742559|NCT01070069|75861933|FG001|COMPLETED|Overall Study||48||
59742560|NCT01070069|75861934|FG002|COMPLETED|Overall Study||45||
59742561|NCT01070069|75861935|FG003|COMPLETED|Overall Study||19||
59742562|NCT01070069|75861936|FG004|COMPLETED|Overall Study||18||
59742563|NCT01070069|75861932|FG000|NOT COMPLETED|Overall Study||6||
59742564|NCT01070069|75861933|FG001|NOT COMPLETED|Overall Study||2||
59742565|NCT01070069|75861934|FG002|NOT COMPLETED|Overall Study||6||
59742566|NCT01070069|75861935|FG003|NOT COMPLETED|Overall Study||0||
59742567|NCT01070069|75861936|FG004|NOT COMPLETED|Overall Study||4||
59742568|NCT01068665|75861953|FG000|STARTED|Overall Study||230||
59742569|NCT01068665|75861954|FG001|STARTED|Overall Study||230||
59742570|NCT01068665|75861953|FG000|Full Analysis Set|Overall Study|Two subjects were withdrawn because the subjects were randomised in error.|228||
59742571|NCT01068665|75861954|FG001|Full Analysis Set|Overall Study|One subject was withdrawn because the subject was randomised in error.|229||
59742572|NCT01068665|75861953|FG000|Exposed|Overall Study||228||
59742573|NCT01068665|75861954|FG001|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug.|228||
59742574|NCT01068665|75861953|FG000|COMPLETED|Overall Study||200||
59742575|NCT01068665|75861954|FG001|COMPLETED|Overall Study||201||
59742576|NCT01068665|75861953|FG000|NOT COMPLETED|Overall Study||30||
59742577|NCT01068665|75861954|FG001|NOT COMPLETED|Overall Study||29||
59742578|NCT01001390|75861960|FG000|STARTED|Overall Study||2||
59742579|NCT01001390|75861961|FG001|STARTED|Overall Study||0||
59742580|NCT01001390|75861960|FG000|COMPLETED|Overall Study||0||
59742581|NCT01001390|75861961|FG001|COMPLETED|Overall Study||0||
59742582|NCT01001390|75861960|FG000|NOT COMPLETED|Overall Study||2||
59742583|NCT01001390|75861961|FG001|NOT COMPLETED|Overall Study||0||
59742584|NCT00772954|75861969|FG000|STARTED|Overall Study||12||
59742585|NCT00772954|75861970|FG001|STARTED|Overall Study||12||
59742586|NCT00772954|75861971|FG002|STARTED|Overall Study||12||
59742587|NCT00772954|75861969|FG000|COMPLETED|Overall Study||12||
59742588|NCT00772954|75861970|FG001|COMPLETED|Overall Study||12||
59742589|NCT00772954|75861971|FG002|COMPLETED|Overall Study||11||
59742590|NCT00772954|75861969|FG000|NOT COMPLETED|Overall Study||0||
59742591|NCT00772954|75861970|FG001|NOT COMPLETED|Overall Study||0||
59742592|NCT00772954|75861971|FG002|NOT COMPLETED|Overall Study||1||
59742593|NCT04214301|75861979|FG000|STARTED|Overall Study||40||
59742594|NCT04214301|75861979|FG000|COMPLETED|Overall Study||38||
59742595|NCT04214301|75861979|FG000|NOT COMPLETED|Overall Study||2||
59742596|NCT00781768|75861985|FG000|STARTED|Overall Study||89||
59742597|NCT00781768|75861986|FG001|STARTED|Overall Study||92||
59742598|NCT00781768|75861985|FG000|COMPLETED|Overall Study||89||
59742599|NCT00781768|75861986|FG001|COMPLETED|Overall Study||90||
59742600|NCT00781768|75861985|FG000|NOT COMPLETED|Overall Study||0||
59742601|NCT00781768|75861986|FG001|NOT COMPLETED|Overall Study||2||
59742602|NCT01005680|75861994|FG000|STARTED|Overall Study||126||
59742603|NCT01005680|75861995|FG001|STARTED|Overall Study||130||
59742604|NCT01005680|75861994|FG000|Received at Least 1 Dose of Study Drug|Overall Study||125||
59742605|NCT01005680|75861995|FG001|Received at Least 1 Dose of Study Drug|Overall Study||127||
59742606|NCT01005680|75861994|FG000|COMPLETED|Overall Study||120||
59742607|NCT01005680|75861995|FG001|COMPLETED|Overall Study||119||
59742608|NCT01005680|75861994|FG000|NOT COMPLETED|Overall Study||6||
59742609|NCT01005680|75861995|FG001|NOT COMPLETED|Overall Study||11||
59742610|NCT01005602|75862004|FG000|STARTED|Overall Study||66||
59742611|NCT01005602|75862005|FG001|STARTED|Overall Study||66||
59742612|NCT01005602|75862004|FG000|COMPLETED|Overall Study|One patient completed the trial but was excluded from data analyses due to unreliable clinical data.|65||
59742613|NCT01005602|75862005|FG001|COMPLETED|Overall Study||66||
59742614|NCT01005602|75862004|FG000|NOT COMPLETED|Overall Study||1||
59742615|NCT01005602|75862005|FG001|NOT COMPLETED|Overall Study||0||
59742616|NCT01068509|75862021|FG000|STARTED|Overall Study||7||
59742617|NCT01068509|75862022|FG001|STARTED|Overall Study||29||
59742618|NCT01068509|75862023|FG002|STARTED|Overall Study||27||
59742619|NCT01068509|75862021|FG000|COMPLETED|Overall Study||1||
59742620|NCT01068509|75862022|FG001|COMPLETED|Overall Study||7||
59742621|NCT01068509|75862023|FG002|COMPLETED|Overall Study||6||
59742622|NCT01068509|75862021|FG000|NOT COMPLETED|Overall Study||6||
59742623|NCT01068509|75862022|FG001|NOT COMPLETED|Overall Study||22||
59742624|NCT01068509|75862023|FG002|NOT COMPLETED|Overall Study||21||
59742625|NCT01009034|75862030|FG000|STARTED|Overall Study||14||
59742626|NCT01009034|75862030|FG000|COMPLETED|Overall Study||10||
59742627|NCT01009034|75862030|FG000|NOT COMPLETED|Overall Study||4||
59742628|NCT00768430|75862036|FG000|STARTED|24 Hour Endpoint||48||
59742629|NCT00768430|75862037|FG001|STARTED|24 Hour Endpoint||25||
59742630|NCT00768430|75862036|FG000|COMPLETED|24 Hour Endpoint||47||
59742631|NCT00768430|75862037|FG001|COMPLETED|24 Hour Endpoint||25||
59742632|NCT00768430|75862036|FG000|NOT COMPLETED|24 Hour Endpoint||1||
59742633|NCT00768430|75862037|FG001|NOT COMPLETED|24 Hour Endpoint||0||
59742634|NCT00768430|75862036|FG000|STARTED|7 Day Endpoint||47||
59742635|NCT00768430|75862037|FG001|STARTED|7 Day Endpoint||25||
59742636|NCT00768430|75862036|FG000|COMPLETED|7 Day Endpoint||45||
59742637|NCT00768430|75862037|FG001|COMPLETED|7 Day Endpoint||22||
59742638|NCT00768430|75862036|FG000|NOT COMPLETED|7 Day Endpoint||2||
59742639|NCT00768430|75862037|FG001|NOT COMPLETED|7 Day Endpoint||3||
59742640|NCT01064297|75862046|FG000|STARTED|Overall Study||2567||
59742641|NCT01064297|75862047|FG001|STARTED|Overall Study||219||
59742642|NCT01064297|75862048|FG002|STARTED|Overall Study||630||
59742643|NCT01064297|75862046|FG000|COMPLETED|Overall Study||1776||
59742644|NCT01064297|75862047|FG001|COMPLETED|Overall Study||171||
59742645|NCT01064297|75862048|FG002|COMPLETED|Overall Study||497||
59742646|NCT01064297|75862046|FG000|NOT COMPLETED|Overall Study||791||
59742647|NCT01064297|75862047|FG001|NOT COMPLETED|Overall Study||48||
59742648|NCT01064297|75862048|FG002|NOT COMPLETED|Overall Study||133||
59742649|NCT00781456|75862065|FG000|STARTED|Overall Study||58||
59742650|NCT00781456|75862066|FG001|STARTED|Overall Study||51||
59742651|NCT00781456|75862065|FG000|Received Study Drug|Overall Study||57||
59742652|NCT00781456|75862066|FG001|Received Study Drug|Overall Study||49||
59742653|NCT00781456|75862065|FG000|COMPLETED|Overall Study||37||
59742654|NCT00781456|75862066|FG001|COMPLETED|Overall Study||35||
59742655|NCT00781456|75862065|FG000|NOT COMPLETED|Overall Study||21||
59742656|NCT00781456|75862066|FG001|NOT COMPLETED|Overall Study||16||
59742657|NCT00587158|75862074|FG000|STARTED|Overall Study||49||
59742658|NCT00587158|75862075|FG001|STARTED|Overall Study||51||
59742659|NCT00587158|75862074|FG000|Continued in Study|Overall Study||45||
59742660|NCT00587158|75862075|FG001|Continued in Study|Overall Study||46||
59742661|NCT00587158|75862074|FG000|COMPLETED|Overall Study||44||
59742662|NCT00587158|75862075|FG001|COMPLETED|Overall Study||43||
59742663|NCT00587158|75862074|FG000|NOT COMPLETED|Overall Study||5||
59742664|NCT00587158|75862075|FG001|NOT COMPLETED|Overall Study||8||
59742665|NCT00582907|75862081|FG000|STARTED|1st Course||4||
59742666|NCT00582907|75862082|FG001|STARTED|1st Course||3||
59742667|NCT00582907|75862083|FG002|STARTED|1st Course||3||
59742668|NCT00582907|75862084|FG003|STARTED|1st Course||4||
59742669|NCT00582907|75862081|FG000|COMPLETED|1st Course|1 left after 1st course (transportation issues)|3||
59742670|NCT00582907|75862082|FG001|COMPLETED|1st Course||3||
59742671|NCT00582907|75862083|FG002|COMPLETED|1st Course||3||
59742672|NCT00582907|75862084|FG003|COMPLETED|1st Course|Patient lost to follow-up towards end of 1st course|3||
59742673|NCT00582907|75862081|FG000|NOT COMPLETED|1st Course||1||
59742674|NCT00582907|75862082|FG001|NOT COMPLETED|1st Course||0||
59742675|NCT00582907|75862083|FG002|NOT COMPLETED|1st Course||0||
59742676|NCT00582907|75862084|FG003|NOT COMPLETED|1st Course||1||
59742677|NCT00582907|75862081|FG000|STARTED|2nd Course||3||
59742678|NCT00582907|75862082|FG001|STARTED|2nd Course||3||
59742679|NCT00582907|75862083|FG002|STARTED|2nd Course||3||
59742680|NCT00582907|75862084|FG003|STARTED|2nd Course||3||
59742681|NCT00582907|75862081|FG000|COMPLETED|2nd Course||2||
59742682|NCT00582907|75862082|FG001|COMPLETED|2nd Course||3||
59742683|NCT00582907|75862083|FG002|COMPLETED|2nd Course||3||
59742684|NCT00582907|75862084|FG003|COMPLETED|2nd Course||3||
59742685|NCT00582907|75862081|FG000|NOT COMPLETED|2nd Course||1||
59742686|NCT00582907|75862082|FG001|NOT COMPLETED|2nd Course||0||
59742687|NCT00582907|75862083|FG002|NOT COMPLETED|2nd Course||0||
59742688|NCT00582907|75862084|FG003|NOT COMPLETED|2nd Course||0||
59742689|NCT00582907|75862081|FG000|STARTED|3rd Course||2||
59742690|NCT00582907|75862082|FG001|STARTED|3rd Course||3||
59742691|NCT00582907|75862083|FG002|STARTED|3rd Course||3||
59742692|NCT00582907|75862084|FG003|STARTED|3rd Course||3||
59742693|NCT00582907|75862081|FG000|COMPLETED|3rd Course||2||
59742694|NCT00582907|75862082|FG001|COMPLETED|3rd Course||3||
59742695|NCT00582907|75862083|FG002|COMPLETED|3rd Course||3||
59742696|NCT00582907|75862084|FG003|COMPLETED|3rd Course||3||
59742697|NCT00582907|75862081|FG000|NOT COMPLETED|3rd Course||0||
59742698|NCT00582907|75862082|FG001|NOT COMPLETED|3rd Course||0||
59742699|NCT00582907|75862083|FG002|NOT COMPLETED|3rd Course||0||
59742700|NCT00582907|75862084|FG003|NOT COMPLETED|3rd Course||0||
59742701|NCT00582907|75862081|FG000|STARTED|4th Course||2||
59742702|NCT00582907|75862082|FG001|STARTED|4th Course||3||
59742703|NCT00582907|75862083|FG002|STARTED|4th Course||3||
59742704|NCT00582907|75862084|FG003|STARTED|4th Course||3||
59742705|NCT00582907|75862081|FG000|COMPLETED|4th Course||2||
59742706|NCT00582907|75862082|FG001|COMPLETED|4th Course||3||
59742707|NCT00582907|75862083|FG002|COMPLETED|4th Course||3||
59742708|NCT00582907|75862084|FG003|COMPLETED|4th Course||3||
59742709|NCT00582907|75862081|FG000|NOT COMPLETED|4th Course||0||
59742710|NCT00582907|75862082|FG001|NOT COMPLETED|4th Course||0||
59742711|NCT00582907|75862083|FG002|NOT COMPLETED|4th Course||0||
59742712|NCT00582907|75862084|FG003|NOT COMPLETED|4th Course||0||
59742713|NCT01062113|75862093|FG000|STARTED|Overall Study||133||
59742714|NCT01062113|75862094|FG001|STARTED|Overall Study||64||
59742715|NCT01062113|75862095|FG002|STARTED|Overall Study||58||
59742716|NCT01062113|75862093|FG000|COMPLETED|Overall Study||93||
59742717|NCT01062113|75862094|FG001|COMPLETED|Overall Study||42||
59742718|NCT01062113|75862095|FG002|COMPLETED|Overall Study||27||
59742719|NCT01062113|75862093|FG000|NOT COMPLETED|Overall Study||40||
59742720|NCT01062113|75862094|FG001|NOT COMPLETED|Overall Study||22||
59742721|NCT01062113|75862095|FG002|NOT COMPLETED|Overall Study||31||
59742722|NCT00772330|75862103|FG000|STARTED|Overall Study||23||
59742723|NCT00772330|75862103|FG000|COMPLETED|Overall Study||20||
59742724|NCT00772330|75862103|FG000|NOT COMPLETED|Overall Study||3||
59742725|NCT01038869|75862110|FG000|STARTED|Overall Study||20||
59742726|NCT01038869|75862110|FG000|COMPLETED|Overall Study||13||
59742727|NCT01038869|75862110|FG000|NOT COMPLETED|Overall Study||7||
59742728|NCT01038713|75862121|FG000|STARTED|Overall Study||26||
59742729|NCT01038713|75862122|FG001|STARTED|Overall Study||20||
59742730|NCT01038713|75862123|FG002|STARTED|Overall Study||17||
59742731|NCT01038713|75862121|FG000|COMPLETED|Overall Study||21||
59742732|NCT01038713|75862122|FG001|COMPLETED|Overall Study||17||
59742733|NCT01038713|75862123|FG002|COMPLETED|Overall Study||16||
59742734|NCT01038713|75862121|FG000|NOT COMPLETED|Overall Study||5||
59742735|NCT01038713|75862122|FG001|NOT COMPLETED|Overall Study||3||
59742736|NCT01038713|75862123|FG002|NOT COMPLETED|Overall Study||1||
59742737|NCT00768040|75862133|FG000|STARTED|Overall Study|"Started indicates randomized, safety and full analysis set."|20||
59742738|NCT00768040|75862134|FG001|STARTED|Overall Study||19||
59742739|NCT00768040|75862133|FG000|COMPLETED|Overall Study||16||
59742740|NCT00768040|75862134|FG001|COMPLETED|Overall Study||16||
59742741|NCT00768040|75862133|FG000|NOT COMPLETED|Overall Study||4||
59742742|NCT00768040|75862134|FG001|NOT COMPLETED|Overall Study||3||
59742743|NCT00767806|75862142|FG000|STARTED|Overall Study||198||
59742744|NCT00767806|75862143|FG001|STARTED|Overall Study||203||
59742745|NCT00767806|75862142|FG000|COMPLETED|Overall Study||147||
59742746|NCT00767806|75862143|FG001|COMPLETED|Overall Study||156||
59742747|NCT00767806|75862142|FG000|NOT COMPLETED|Overall Study||51||
59742748|NCT00767806|75862143|FG001|NOT COMPLETED|Overall Study||47||
59742749|NCT00780910|75862149|FG000|STARTED|Overall Study||109||
59742750|NCT00780910|75862149|FG000|COMPLETED|Overall Study||107||
59742751|NCT00780910|75862149|FG000|NOT COMPLETED|Overall Study||2||
59742752|NCT00767104|75862155|FG000|STARTED|Overall Study||20||
59742753|NCT00767104|75862156|FG001|STARTED|Overall Study||20||
59742754|NCT00767104|75862155|FG000|COMPLETED|Overall Study||19||
59742755|NCT00767104|75862156|FG001|COMPLETED|Overall Study||18||
59742756|NCT00767104|75862155|FG000|NOT COMPLETED|Overall Study||1||
59742757|NCT00767104|75862156|FG001|NOT COMPLETED|Overall Study||2||
59742758|NCT00771472|75862164|FG000|STARTED|Overall Study||6||
59742759|NCT00771472|75862165|FG001|STARTED|Overall Study||4||
59742760|NCT00771472|75862164|FG000|COMPLETED|Overall Study||0||
59742761|NCT00771472|75862165|FG001|COMPLETED|Overall Study||0||
59742762|NCT00771472|75862164|FG000|NOT COMPLETED|Overall Study||6||
59742763|NCT00771472|75862165|FG001|NOT COMPLETED|Overall Study||4||
59742764|NCT00771316|75862172|FG000|STARTED|Overall Study||4||
59742765|NCT00771316|75862173|FG001|STARTED|Overall Study||2||
59742766|NCT00771316|75862172|FG000|COMPLETED|Overall Study||2||
59742767|NCT00771316|75862173|FG001|COMPLETED|Overall Study||1||
59742768|NCT00771316|75862172|FG000|NOT COMPLETED|Overall Study||2||
59742769|NCT00771316|75862173|FG001|NOT COMPLETED|Overall Study||1||
59742770|NCT05209867|75862179|FG000|STARTED|Overall Study||4||
59742771|NCT05209867|75862179|FG000|Completed 1 Month of Intervention|Overall Study||4|The individual completed one month of intervention and attended the second visit|
59742772|NCT05209867|75862179|FG000|Completed 2 Months of Intervention|Overall Study||3|The individual completed two months of intervention and attended the third visit|
59742773|NCT05209867|75862179|FG000|COMPLETED|Overall Study|Four individuals completed the assigned intervention. One individual completed one month only. Two individuals completed two months. A fourth individual completed two months but, after protocol and data review, the quality of the provided data was deemed not sufficient (single-cell RNA was not sequenced, gene expression not measured for that individual).|4||
59742774|NCT05209867|75862179|FG000|NOT COMPLETED|Overall Study||0||
59742775|NCT05066165|75862185|FG000|STARTED|C1:DoseLevel1 Assignment||1||
59742776|NCT05066165|75862186|FG001|STARTED|C1:DoseLevel1 Assignment||5||
59742777|NCT05066165|75862185|FG000|COMPLETED|C1:DoseLevel1 Assignment||1||
59742778|NCT05066165|75862186|FG001|COMPLETED|C1:DoseLevel1 Assignment||1||
59742779|NCT05066165|75862185|FG000|NOT COMPLETED|C1:DoseLevel1 Assignment||0||
59742780|NCT05066165|75862186|FG001|NOT COMPLETED|C1:DoseLevel1 Assignment||4||
59742781|NCT05066165|75862185|FG000|STARTED|C1:DoseLevel1 Dosed Participants (W1-16)||1||
59742782|NCT05066165|75862186|FG001|STARTED|C1:DoseLevel1 Dosed Participants (W1-16)||1||
59742783|NCT05066165|75862185|FG000|COMPLETED|C1:DoseLevel1 Dosed Participants (W1-16)||0||
59742784|NCT05066165|75862186|FG001|COMPLETED|C1:DoseLevel1 Dosed Participants (W1-16)||0||
59742785|NCT05066165|75862185|FG000|NOT COMPLETED|C1:DoseLevel1 Dosed Participants (W1-16)||1||
59742786|NCT05066165|75862186|FG001|NOT COMPLETED|C1:DoseLevel1 Dosed Participants (W1-16)||1||
59742787|NCT05066165|75862185|FG000|STARTED|Cohort2:Dose Level 2||0||
59742788|NCT05066165|75862186|FG001|STARTED|Cohort2:Dose Level 2||0||
59742789|NCT05066165|75862185|FG000|COMPLETED|Cohort2:Dose Level 2||0||
59742790|NCT05066165|75862186|FG001|COMPLETED|Cohort2:Dose Level 2||0||
59742791|NCT05066165|75862185|FG000|NOT COMPLETED|Cohort2:Dose Level 2||0||
59742792|NCT05066165|75862186|FG001|NOT COMPLETED|Cohort2:Dose Level 2||0||
59742793|NCT04846400|75862192|FG000|STARTED|Overall Study||2||
59742794|NCT04846400|75862192|FG000|COMPLETED|Overall Study||2||
59742795|NCT04846400|75862192|FG000|NOT COMPLETED|Overall Study||0||
59742796|NCT04731298|75862198|FG000|STARTED|Allogeneic HSCT (Day 0)||0||
59742797|NCT04731298|75862199|FG001|STARTED|Allogeneic HSCT (Day 0)||2||
59742798|NCT04731298|75862198|FG000|COMPLETED|Allogeneic HSCT (Day 0)||0||
59742799|NCT04731298|75862199|FG001|COMPLETED|Allogeneic HSCT (Day 0)||2||
59742800|NCT04731298|75862198|FG000|NOT COMPLETED|Allogeneic HSCT (Day 0)||0||
59742801|NCT04731298|75862199|FG001|NOT COMPLETED|Allogeneic HSCT (Day 0)||0||
59742802|NCT04731298|75862198|FG000|STARTED|Monitoring - Primary GF (Day 1 to 42)||0||
59742803|NCT04731298|75862199|FG001|STARTED|Monitoring - Primary GF (Day 1 to 42)||2||
59742804|NCT04731298|75862198|FG000|COMPLETED|Monitoring - Primary GF (Day 1 to 42)||0||
59742805|NCT04731298|75862199|FG001|COMPLETED|Monitoring - Primary GF (Day 1 to 42)||2||
59742806|NCT04731298|75862198|FG000|NOT COMPLETED|Monitoring - Primary GF (Day 1 to 42)||0||
59742807|NCT04731298|75862199|FG001|NOT COMPLETED|Monitoring - Primary GF (Day 1 to 42)||0||
59742808|NCT04731298|75862198|FG000|STARTED|Monitoring - Secondary GF (Up to Day 98)||0||
59742809|NCT04731298|75862199|FG001|STARTED|Monitoring - Secondary GF (Up to Day 98)||2||
59742810|NCT04731298|75862198|FG000|COMPLETED|Monitoring - Secondary GF (Up to Day 98)||0||
59742811|NCT04731298|75862199|FG001|COMPLETED|Monitoring - Secondary GF (Up to Day 98)||2||
59742812|NCT04731298|75862198|FG000|NOT COMPLETED|Monitoring - Secondary GF (Up to Day 98)||0||
59742813|NCT04731298|75862199|FG001|NOT COMPLETED|Monitoring - Secondary GF (Up to Day 98)||0||
59742814|NCT04731298|75862198|FG000|STARTED|Follow-up (3 Years From HSCT)||0||
59742815|NCT04731298|75862199|FG001|STARTED|Follow-up (3 Years From HSCT)||2||
59742816|NCT04731298|75862198|FG000|COMPLETED|Follow-up (3 Years From HSCT)||0||
59742817|NCT04731298|75862199|FG001|COMPLETED|Follow-up (3 Years From HSCT)||0||
59742818|NCT04731298|75862198|FG000|NOT COMPLETED|Follow-up (3 Years From HSCT)||0||
59742819|NCT04731298|75862199|FG001|NOT COMPLETED|Follow-up (3 Years From HSCT)||2||
59742820|NCT04676412|75862208|FG000|STARTED|Overall Study||49||
59742821|NCT04676412|75862209|FG001|STARTED|Overall Study||58||
59742822|NCT04676412|75862208|FG000|COMPLETED|Overall Study||0||
59742823|NCT04676412|75862209|FG001|COMPLETED|Overall Study||0||
59742824|NCT04676412|75862208|FG000|NOT COMPLETED|Overall Study||49||
59604410|NCT02059434|75714648|FG001|NOT COMPLETED|Period 8||0||
59604411|NCT02059434|75714649|FG002|NOT COMPLETED|Period 8||0||
59604412|NCT02059434|75714650|FG003|NOT COMPLETED|Period 8||0||
59604413|NCT02059434|75714651|FG004|NOT COMPLETED|Period 8||0||
59604414|NCT02059434|75714652|FG005|NOT COMPLETED|Period 8||0||
59742825|NCT04676412|75862209|FG001|NOT COMPLETED|Overall Study||58||
59742826|NCT04641975|75862219|FG000|STARTED|Overall Study||11||
59742827|NCT04641975|75862220|FG001|STARTED|Overall Study||12||
59742828|NCT04641975|75862221|FG002|STARTED|Overall Study||2||
59742829|NCT04641975|75862222|FG003|STARTED|Overall Study||1||
59742830|NCT04641975|75862219|FG000|COMPLETED|Overall Study||9||
59742831|NCT04641975|75862220|FG001|COMPLETED|Overall Study||10||
59742832|NCT04641975|75862221|FG002|COMPLETED|Overall Study||1||
59742833|NCT04641975|75862222|FG003|COMPLETED|Overall Study||0||
59742834|NCT04641975|75862219|FG000|NOT COMPLETED|Overall Study||2||
59742835|NCT04641975|75862220|FG001|NOT COMPLETED|Overall Study||2||
59742836|NCT04641975|75862221|FG002|NOT COMPLETED|Overall Study||1||
59742837|NCT04641975|75862222|FG003|NOT COMPLETED|Overall Study||1||
59742838|NCT04633200|75862237|FG000|STARTED|Overall Study||57||
59742839|NCT04633200|75862238|FG001|STARTED|Overall Study||51||
59742840|NCT04633200|75862237|FG000|COMPLETED|Overall Study||54||
59604415|NCT02059434|75714653|FG006|NOT COMPLETED|Period 8||0||
59604416|NCT02059434|75714654|FG007|NOT COMPLETED|Period 8||0||
59742841|NCT04633200|75862238|FG001|COMPLETED|Overall Study||46||
59742842|NCT04633200|75862237|FG000|NOT COMPLETED|Overall Study||3||
59742843|NCT04633200|75862238|FG001|NOT COMPLETED|Overall Study||5||
59742844|NCT04603560|75862250|FG000|STARTED|Overall Study||173|Providers Randomized|
59742845|NCT04603560|75862251|FG001|STARTED|Overall Study||143|Providers Randomized|
59742846|NCT04603560|75862252|FG002|STARTED|Overall Study||150|Providers Randomized|
59742847|NCT04603560|75862253|FG003|STARTED|Overall Study||16|Providers Randomized|
59742848|NCT04603560|75862254|FG004|STARTED|Overall Study||15|Providers Randomized|
59742849|NCT04603560|75862255|FG005|STARTED|Overall Study||14|Providers Randomized|
59742850|NCT04603560|75862250|FG000|COMPLETED|Overall Study||173|Providers Completed Study|
59742851|NCT04603560|75862251|FG001|COMPLETED|Overall Study||143|Providers Completed Study|
59742852|NCT04603560|75862252|FG002|COMPLETED|Overall Study||150|Providers Completed Study|
59742853|NCT04603560|75862253|FG003|COMPLETED|Overall Study||16|Providers Completed Study|
59742854|NCT04603560|75862254|FG004|COMPLETED|Overall Study||15|Providers Completed Study|
59742855|NCT04603560|75862255|FG005|COMPLETED|Overall Study||14|Providers Completed Study|
59742856|NCT04603560|75862250|FG000|NOT COMPLETED|Overall Study||0||
59742857|NCT04603560|75862251|FG001|NOT COMPLETED|Overall Study||0||
59742858|NCT04603560|75862252|FG002|NOT COMPLETED|Overall Study||0||
59742859|NCT04603560|75862253|FG003|NOT COMPLETED|Overall Study||0||
59742860|NCT04603560|75862254|FG004|NOT COMPLETED|Overall Study||0||
59742861|NCT04603560|75862255|FG005|NOT COMPLETED|Overall Study||0||
59742862|NCT04435366|75862265|FG000|STARTED|Overall Study||225||
59742863|NCT04435366|75862266|FG001|STARTED|Overall Study|223 participants were randomized to the Sham Treatment Group, but 1 participant was never treated|222||
59742864|NCT04435366|75862265|FG000|Month 12|Overall Study||200||
59742865|NCT04435366|75862266|FG001|Month 12|Overall Study||205||
59742866|NCT04435366|75862265|FG000|COMPLETED|Overall Study||200|Completed up to Month 12 (Year 1); Month 24 (Year 2) data availability pending Year 2 Clinical Study Report finalization and submission (anticipated no later than August 22, 2024)|
59742867|NCT04435366|75862266|FG001|COMPLETED|Overall Study||205|Completed up to Month 12 (Year 1); Month 24 (Year 2) data availability pending Year 2 Clinical Study Report finalization and submission (anticipated no later than August 22, 2024)|
59742868|NCT04435366|75862265|FG000|NOT COMPLETED|Overall Study||25||
59742869|NCT04435366|75862266|FG001|NOT COMPLETED|Overall Study||17||
59742870|NCT03439137|75862274|FG000|STARTED|Overall Study||162||
59742871|NCT03439137|75862275|FG001|STARTED|Overall Study||161||
59742872|NCT03439137|75862274|FG000|COMPLETED|Overall Study||120||
59742873|NCT03439137|75862275|FG001|COMPLETED|Overall Study||135||
59742874|NCT03439137|75862274|FG000|NOT COMPLETED|Overall Study||42||
59742875|NCT03439137|75862275|FG001|NOT COMPLETED|Overall Study||26||
59742876|NCT03402386|75862281|FG000|STARTED|Overall Study||42||
59742877|NCT03402386|75862281|FG000|Correction Group|Overall Study||2||
59742878|NCT03402386|75862281|FG000|Conversion Group|Overall Study||40||
59742879|NCT03402386|75862281|FG000|COMPLETED|Overall Study||36||
59742880|NCT03402386|75862281|FG000|NOT COMPLETED|Overall Study||6||
59742881|NCT03329196|75862287|FG000|STARTED|Overall Study||151||
59742882|NCT03329196|75862288|FG001|STARTED|Overall Study||153||
59742883|NCT03329196|75862287|FG000|COMPLETED|Overall Study||111||
59742884|NCT03329196|75862288|FG001|COMPLETED|Overall Study||123||
59742885|NCT03329196|75862287|FG000|NOT COMPLETED|Overall Study||40||
59742886|NCT03329196|75862288|FG001|NOT COMPLETED|Overall Study||30||
59742887|NCT02967692|75862298|FG000|STARTED|Overall Study||9||
59742888|NCT02967692|75862299|FG001|STARTED|Overall Study||27||
59742889|NCT02967692|75862300|FG002|STARTED|Overall Study||267||
59742890|NCT02967692|75862301|FG003|STARTED|Overall Study||265||
59742891|NCT02967692|75862298|FG000|Treated|Overall Study||9|1 subject in the placebo arm (Part 3) was not treated as the subject died due to disease progression before receiving any treatment|
59742892|NCT02967692|75862299|FG001|Treated|Overall Study||27|1 subject in the placebo arm (Part 3) was not treated as the subject died due to disease progression before receiving any treatment|
59742893|NCT02967692|75862300|FG002|Treated|Overall Study||267|1 subject in the placebo arm (Part 3) was not treated as the subject died due to disease progression before receiving any treatment|
59742894|NCT02967692|75862301|FG003|Treated|Overall Study||264|1 subject in the placebo arm (Part 3) was not treated as the subject died due to disease progression before receiving any treatment|
59742895|NCT02967692|75862298|FG000|COMPLETED|Overall Study||0||
59742896|NCT02967692|75862299|FG001|COMPLETED|Overall Study||0||
59742897|NCT02967692|75862300|FG002|COMPLETED|Overall Study||0||
59742898|NCT02967692|75862301|FG003|COMPLETED|Overall Study||0||
59742899|NCT02967692|75862298|FG000|NOT COMPLETED|Overall Study||9||
59742900|NCT02967692|75862299|FG001|NOT COMPLETED|Overall Study||27||
59742901|NCT02967692|75862300|FG002|NOT COMPLETED|Overall Study||267||
59742902|NCT02967692|75862301|FG003|NOT COMPLETED|Overall Study||265||
59742903|NCT02949219|75862319|FG000|STARTED|Overall Study||41||
59742904|NCT02949219|75862319|FG000|COMPLETED|Overall Study||40||
59742905|NCT02949219|75862319|FG000|NOT COMPLETED|Overall Study||1||
59742906|NCT02892201|75862323|FG000|STARTED|Overall Study|For purpose of the primary endpoint of the study, the overall response will be measured during the post pembrolizumab, in comparison to the most immediate pre-pembrolizumab imaging.|9||
59742907|NCT02892201|75862323|FG000|COMPLETED|Overall Study||9||
59742908|NCT02892201|75862323|FG000|NOT COMPLETED|Overall Study||0||
59742909|NCT02873195|75862329|FG000|STARTED|Overall Study||87||
59742910|NCT02873195|75862330|FG001|STARTED|Overall Study||46||
59742911|NCT02873195|75862329|FG000|Never Began Treatment (Cancel)|Overall Study||1|Participants who never began treatment are not evaluable for adverse events.|
59742912|NCT02873195|75862330|FG001|Never Began Treatment (Cancel)|Overall Study||0|Participants who never began treatment are not evaluable for adverse events.|
59742913|NCT02873195|75862329|FG000|COMPLETED|Overall Study||82|Modified Intent-to-treat (ITT) population|
59742914|NCT02873195|75862330|FG001|COMPLETED|Overall Study||46|Modified Intent-to-treat (ITT) population|
59742915|NCT02873195|75862329|FG000|NOT COMPLETED|Overall Study||5||
59742916|NCT02873195|75862330|FG001|NOT COMPLETED|Overall Study||0||
59742917|NCT02136238|75862338|FG000|STARTED|Overall Study||4||
59742918|NCT02136238|75862339|FG001|STARTED|Overall Study||4||
59742919|NCT02136238|75862340|FG002|STARTED|Overall Study||10||
59742920|NCT02136238|75862338|FG000|COMPLETED|Overall Study||4||
59742921|NCT02136238|75862339|FG001|COMPLETED|Overall Study||4||
59742922|NCT02136238|75862340|FG002|COMPLETED|Overall Study||10||
59742923|NCT02136238|75862338|FG000|NOT COMPLETED|Overall Study||0||
59742924|NCT02136238|75862339|FG001|NOT COMPLETED|Overall Study||0||
59742925|NCT02136238|75862340|FG002|NOT COMPLETED|Overall Study||0||
59742926|NCT02026232|75862353|FG000|STARTED|Overall Study||10||
59742927|NCT02026232|75862354|FG001|STARTED|Overall Study||11||
59742928|NCT02026232|75862353|FG000|COMPLETED|Overall Study||7||
59742929|NCT02026232|75862354|FG001|COMPLETED|Overall Study||9||
59742930|NCT02026232|75862353|FG000|NOT COMPLETED|Overall Study||3||
59742931|NCT02026232|75862354|FG001|NOT COMPLETED|Overall Study||2||
59742932|NCT02008357|75862362|FG000|STARTED|Double-blind (Placebo Controlled) Period||578||
59742933|NCT02008357|75862363|FG001|STARTED|Double-blind (Placebo Controlled) Period||591||
59742934|NCT02008357|75862362|FG000|COMPLETED|Double-blind (Placebo Controlled) Period||406||
59742935|NCT02008357|75862363|FG001|COMPLETED|Double-blind (Placebo Controlled) Period||424||
59742936|NCT02008357|75862362|FG000|NOT COMPLETED|Double-blind (Placebo Controlled) Period||172||
59742937|NCT02008357|75862363|FG001|NOT COMPLETED|Double-blind (Placebo Controlled) Period||167||
59742938|NCT02008357|75862362|FG000|STARTED|Open-label Extension Period|Not all Participants who completed the Double-blind (Placebo Controlled) Period entered into Open-label Extension Period.|383||
59742939|NCT02008357|75862363|FG001|STARTED|Open-label Extension Period|Not all Participants who completed the Double-blind (Placebo Controlled) Period entered into Open-label Extension Period.|401||
59742940|NCT02008357|75862362|FG000|COMPLETED|Open-label Extension Period||1||
59742941|NCT02008357|75862363|FG001|COMPLETED|Open-label Extension Period||1||
59742942|NCT02008357|75862362|FG000|NOT COMPLETED|Open-label Extension Period||382||
59742943|NCT02008357|75862363|FG001|NOT COMPLETED|Open-label Extension Period||400||
59742944|NCT01784068|75862373|FG000|STARTED|NTCS Phase||215||
59742945|NCT01784068|75862374|FG001|STARTED|NTCS Phase||0||
59742946|NCT01784068|75862373|FG000|NTRI Phase|NTCS Phase||86||
59742947|NCT01784068|75862374|FG001|NTRI Phase|NTCS Phase||0||
59742948|NCT01784068|75862373|FG000|NTCT Phase|NTCS Phase||13||
59742949|NCT01784068|75862374|FG001|NTCT Phase|NTCS Phase||0||
59742950|NCT01784068|75862373|FG000|TFR-2 Phase|NTCS Phase||8||
59742951|NCT01784068|75862374|FG001|TFR-2 Phase|NTCS Phase||0||
59742952|NCT01784068|75862373|FG000|NTCT-P Phase|NTCS Phase||2||
59742953|NCT01784068|75862374|FG001|NTCT-P Phase|NTCS Phase||0||
59742954|NCT01784068|75862373|FG000|NTRI-2|NTCS Phase||0||
59742955|NCT01784068|75862374|FG001|NTRI-2|NTCS Phase||0||
59742956|NCT01784068|75862373|FG000|COMPLETED|NTCS Phase||0|Completed = Still on Study Phase which means a patient has no end of study phase completion CRF page as of data Cut-off date: 30-NOV-2015|
59742957|NCT01784068|75862374|FG001|COMPLETED|NTCS Phase||0|Completed = Still on Study Phase which means a patient has no end of study phase completion CRF page as of data Cut-off date: 30-NOV-2015|
59742958|NCT01784068|75862373|FG000|NOT COMPLETED|NTCS Phase||215||
59742959|NCT01784068|75862374|FG001|NOT COMPLETED|NTCS Phase||0||
60135048|NCT03307252|76258157|FG004|STARTED|Part 2, Washout Period 1 (7 Days)||4||
60135049|NCT03307252|76258158|FG005|STARTED|Part 2, Washout Period 1 (7 Days)||3||
60135050|NCT03307252|76258159|FG006|STARTED|Part 2, Washout Period 1 (7 Days)||5||
60135051|NCT03307252|76258160|FG007|STARTED|Part 2, Washout Period 1 (7 Days)||0||
60135052|NCT03307252|76258161|FG008|STARTED|Part 2, Washout Period 1 (7 Days)||0||
60135053|NCT03307252|76258162|FG009|STARTED|Part 2, Washout Period 1 (7 Days)||0||
59604417|NCT02059434|75714655|FG008|NOT COMPLETED|Period 8||0||
59604418|NCT02059278|75714685|FG000|STARTED|Overall Study||165||
59604419|NCT02059278|75714686|FG001|STARTED|Overall Study||170||
59604420|NCT02059278|75714685|FG000|COMPLETED|Overall Study||162||
59604421|NCT02059278|75714686|FG001|COMPLETED|Overall Study||166||
59604422|NCT02059278|75714685|FG000|NOT COMPLETED|Overall Study||3||
59604423|NCT02059278|75714686|FG001|NOT COMPLETED|Overall Study||4||
59604424|NCT02020512|75714692|FG000|STARTED|Overall Study||87||
59604425|NCT02020512|75714692|FG000|COMPLETED|Overall Study||79||
59604426|NCT02020512|75714692|FG000|NOT COMPLETED|Overall Study||8||
59604427|NCT02041962|75714698|FG000|STARTED|Overall Study||123|Completed baseline and randomized|
59604428|NCT02041962|75714699|FG001|STARTED|Overall Study||115|Completed baseline and randomized|
59604429|NCT02041962|75714698|FG000|Participants Completing 6 mo. f/up|Overall Study||69||
59604430|NCT02041962|75714699|FG001|Participants Completing 6 mo. f/up|Overall Study||44||
59604431|NCT02041962|75714698|FG000|Participants Completing 12 mo. f/up|Overall Study||42||
59604432|NCT02041962|75714699|FG001|Participants Completing 12 mo. f/up|Overall Study||31||
59604433|NCT02041962|75714698|FG000|COMPLETED|Overall Study||42||
59604434|NCT02041962|75714699|FG001|COMPLETED|Overall Study||31||
59604435|NCT02041962|75714698|FG000|NOT COMPLETED|Overall Study||81||
59604436|NCT02041962|75714699|FG001|NOT COMPLETED|Overall Study||84||
59604437|NCT02041494|75714707|FG000|STARTED|Overall Study||82||
59604438|NCT02041494|75714708|FG001|STARTED|Overall Study||83||
59604439|NCT02041494|75714707|FG000|COMPLETED|Overall Study||63||
59604440|NCT02041494|75714708|FG001|COMPLETED|Overall Study||63||
59604441|NCT02041494|75714707|FG000|NOT COMPLETED|Overall Study||19||
59604442|NCT02041494|75714708|FG001|NOT COMPLETED|Overall Study||20||
59604443|NCT04699812|75714719|FG000|STARTED|Overall Study||78||
59604444|NCT04699812|75714720|FG001|STARTED|Overall Study||82||
59604445|NCT04699812|75714721|FG002|STARTED|Overall Study||366||
59604446|NCT04699812|75714722|FG003|STARTED|Overall Study||47||
59604447|NCT04699812|75714719|FG000|COMPLETED|Overall Study||70||
59604448|NCT04699812|75714720|FG001|COMPLETED|Overall Study||64||
59604449|NCT04699812|75714721|FG002|COMPLETED|Overall Study||304||
59604450|NCT04699812|75714722|FG003|COMPLETED|Overall Study||45||
59604451|NCT04699812|75714719|FG000|NOT COMPLETED|Overall Study||8||
59604452|NCT04699812|75714720|FG001|NOT COMPLETED|Overall Study||18||
59604453|NCT04699812|75714721|FG002|NOT COMPLETED|Overall Study||62||
59604454|NCT04699812|75714722|FG003|NOT COMPLETED|Overall Study||2||
59604455|NCT02041104|75714739|FG000|STARTED|Overall Study||28||
59604456|NCT02041104|75714740|FG001|STARTED|Overall Study||23||
59604457|NCT02041104|75714739|FG000|COMPLETED|Overall Study||27||
59604458|NCT02041104|75714740|FG001|COMPLETED|Overall Study||16||
59604459|NCT02041104|75714739|FG000|NOT COMPLETED|Overall Study||1||
59604460|NCT02041104|75714740|FG001|NOT COMPLETED|Overall Study||7||
59604461|NCT02019420|75714750|FG000|STARTED|Overall Study||366|Randomized|
59604462|NCT02019420|75714751|FG001|STARTED|Overall Study||360|Randomized|
59604463|NCT02019420|75714750|FG000|Treated|Overall Study||361||
59604464|NCT02019420|75714751|FG001|Treated|Overall Study||357||
59604465|NCT02019420|75714750|FG000|COMPLETED|Overall Study||258||
59604466|NCT02019420|75714751|FG001|COMPLETED|Overall Study||254||
59604467|NCT02019420|75714750|FG000|NOT COMPLETED|Overall Study||108||
59604468|NCT02019420|75714751|FG001|NOT COMPLETED|Overall Study||106||
59604469|NCT02019264|75714759|FG000|STARTED|Overall Study||6000||
59604470|NCT02019264|75714760|FG001|STARTED|Overall Study||6000||
59604471|NCT02019264|75714759|FG000|Safety Analysis Set|Overall Study||5992||
59604472|NCT02019264|75714760|FG001|Safety Analysis Set|Overall Study||5995||
59604473|NCT02019264|75714759|FG000|COMPLETED|Overall Study||5752|Participants who died on trial were considered completed.|
59604474|NCT02019264|75714760|FG001|COMPLETED|Overall Study||5793|Participants who died on trial were considered completed.|
59604475|NCT02019264|75714759|FG000|NOT COMPLETED|Overall Study||248||
59604476|NCT02019264|75714760|FG001|NOT COMPLETED|Overall Study||207||
59604477|NCT02019108|75714768|FG000|STARTED|Overall Study||40||
59604478|NCT02019108|75714769|FG001|STARTED|Overall Study||39||
59604479|NCT02019108|75714768|FG000|Baseline (Week 0)|Overall Study||40||
59604480|NCT02019108|75714769|FG001|Baseline (Week 0)|Overall Study||39||
59604481|NCT02019108|75714768|FG000|Follow-up (Week 17)|Overall Study||38||
59604482|NCT02019108|75714769|FG001|Follow-up (Week 17)|Overall Study||36||
59604483|NCT02019108|75714768|FG000|Retention (Week 21)|Overall Study||35||
59604484|NCT02019108|75714769|FG001|Retention (Week 21)|Overall Study||32||
59604485|NCT02019108|75714768|FG000|COMPLETED|Overall Study||35||
59604486|NCT02019108|75714769|FG001|COMPLETED|Overall Study||32||
59604487|NCT02019108|75714768|FG000|NOT COMPLETED|Overall Study||5||
59604488|NCT02019108|75714769|FG001|NOT COMPLETED|Overall Study||7||
59604489|NCT02018562|75714777|FG000|STARTED|Overall Study||25||
59604490|NCT02018562|75714778|FG001|STARTED|Overall Study||25||
59604491|NCT02018562|75714777|FG000|COMPLETED|Overall Study||22||
59604492|NCT02018562|75714778|FG001|COMPLETED|Overall Study||25||
59604493|NCT02018562|75714777|FG000|NOT COMPLETED|Overall Study||3||
59604494|NCT02018562|75714778|FG001|NOT COMPLETED|Overall Study||0||
59604495|NCT02058966|75714784|FG000|STARTED|Open-Label Methamphetamine||19||
59604496|NCT02058966|75714784|FG000|Received Methamphetamine|Open-Label Methamphetamine||18||
59742960|NCT01784068|75862373|FG000|STARTED|TFR Phase||0||
59742961|NCT01784068|75862374|FG001|STARTED|TFR Phase||190||
59742962|NCT01784068|75862373|FG000|COMPLETED|TFR Phase||0||
59742963|NCT01784068|75862374|FG001|COMPLETED|TFR Phase||97||
59742964|NCT01784068|75862373|FG000|NOT COMPLETED|TFR Phase||0||
59742965|NCT01784068|75862374|FG001|NOT COMPLETED|TFR Phase||93||
59604497|NCT02058966|75714784|FG000|COMPLETED|Open-Label Methamphetamine||18||
59604498|NCT02058966|75714784|FG000|NOT COMPLETED|Open-Label Methamphetamine||1||
59604499|NCT02058966|75714784|FG000|STARTED|First Intervention||15|3 subjects dropped out between Open-Label Methamphetamine and First Intervention.|
59604500|NCT02058966|75714784|FG000|Received Placebo-Placebo|First Intervention||3||
59604501|NCT02058966|75714784|FG000|Received Placebo-Meth|First Intervention||4||
59604502|NCT02058966|75714784|FG000|Received Entacapone-Placebo|First Intervention||2||
59604503|NCT02058966|75714784|FG000|Received Entacapone-Meth|First Intervention||5||
59604504|NCT02058966|75714784|FG000|COMPLETED|First Intervention||14||
59604505|NCT02058966|75714784|FG000|NOT COMPLETED|First Intervention||1||
59604506|NCT02058966|75714784|FG000|STARTED|Second Intervention||13|1 subject dropped out between First and Second Intervention.|
59613462|NCT01603602|75724596|FG000|NOT COMPLETED|Overall Study||2||
59742966|NCT01065454|75862389|FG000|STARTED|Treatment||67||
59742967|NCT01065454|75862390|FG001|STARTED|Treatment||33||
59742968|NCT01065454|75862391|FG002|STARTED|Treatment||32||
59742969|NCT01065454|75862392|FG003|STARTED|Treatment||69||
59742970|NCT01065454|75862389|FG000|COMPLETED|Treatment||54||
59742971|NCT01065454|75862390|FG001|COMPLETED|Treatment||28||
59742972|NCT01065454|75862391|FG002|COMPLETED|Treatment||23||
59742973|NCT01065454|75862392|FG003|COMPLETED|Treatment||57||
59742974|NCT01065454|75862389|FG000|NOT COMPLETED|Treatment||13||
59742975|NCT01065454|75862390|FG001|NOT COMPLETED|Treatment||5||
59742976|NCT01065454|75862391|FG002|NOT COMPLETED|Treatment||9||
59742977|NCT01065454|75862392|FG003|NOT COMPLETED|Treatment||12||
59742978|NCT01065454|75862389|FG000|STARTED|Follow up||54||
59742979|NCT01065454|75862390|FG001|STARTED|Follow up||28||
59742980|NCT01065454|75862391|FG002|STARTED|Follow up||23||
59742981|NCT01065454|75862392|FG003|STARTED|Follow up||57||
59742982|NCT01065454|75862389|FG000|Entering Follow-up|Follow up||49||
59742983|NCT01065454|75862390|FG001|Entering Follow-up|Follow up||27||
59742984|NCT01065454|75862391|FG002|Entering Follow-up|Follow up||23||
59742985|NCT01065454|75862392|FG003|Entering Follow-up|Follow up||51||
59742986|NCT01065454|75862389|FG000|COMPLETED|Follow up||15||
59742987|NCT01065454|75862390|FG001|COMPLETED|Follow up||4||
59742988|NCT01065454|75862391|FG002|COMPLETED|Follow up||6||
59742989|NCT01065454|75862392|FG003|COMPLETED|Follow up||13||
59742990|NCT01065454|75862389|FG000|NOT COMPLETED|Follow up||39||
59742991|NCT01065454|75862390|FG001|NOT COMPLETED|Follow up||24||
59742992|NCT01065454|75862391|FG002|NOT COMPLETED|Follow up||17||
59742993|NCT01065454|75862392|FG003|NOT COMPLETED|Follow up||44||
59742994|NCT00775463|75862404|FG000|STARTED|Overall Study||76||
59742995|NCT00775463|75862405|FG001|STARTED|Overall Study||72||
59742996|NCT00775463|75862404|FG000|COMPLETED|Overall Study||65||
59742997|NCT00775463|75862405|FG001|COMPLETED|Overall Study||59||
59742998|NCT00775463|75862404|FG000|NOT COMPLETED|Overall Study||11||
59742999|NCT00775463|75862405|FG001|NOT COMPLETED|Overall Study||13||
59743000|NCT00406640|75862419|FG000|STARTED|Acute Phase||296||
59743001|NCT00406640|75862420|FG001|STARTED|Acute Phase||299||
59743002|NCT00406640|75862419|FG000|COMPLETED|Acute Phase||245||
59743003|NCT00406640|75862420|FG001|COMPLETED|Acute Phase||256||
59743004|NCT00406640|75862419|FG000|NOT COMPLETED|Acute Phase||51||
59743005|NCT00406640|75862420|FG001|NOT COMPLETED|Acute Phase||43||
59743006|NCT00406640|75862419|FG000|STARTED|DB Continuation Phase for Responders||172||
59743007|NCT00406640|75862420|FG001|STARTED|DB Continuation Phase for Responders||188||
59743008|NCT00406640|75862419|FG000|COMPLETED|DB Continuation Phase for Responders||139||
59743009|NCT00406640|75862420|FG001|COMPLETED|DB Continuation Phase for Responders||151||
59743010|NCT00406640|75862419|FG000|NOT COMPLETED|DB Continuation Phase for Responders||33||
59743011|NCT00406640|75862420|FG001|NOT COMPLETED|DB Continuation Phase for Responders||37||
59743012|NCT00406640|75862419|FG000|STARTED|OL Extension Phase for Non-Responders||69||
59743013|NCT00406640|75862420|FG001|STARTED|OL Extension Phase for Non-Responders||60||
59743014|NCT00406640|75862419|FG000|COMPLETED|OL Extension Phase for Non-Responders||47||
59743015|NCT00406640|75862420|FG001|COMPLETED|OL Extension Phase for Non-Responders||36||
59743016|NCT00406640|75862419|FG000|NOT COMPLETED|OL Extension Phase for Non-Responders||22||
59743017|NCT00406640|75862420|FG001|NOT COMPLETED|OL Extension Phase for Non-Responders||24||
59743018|NCT00229931|75862434|FG000|STARTED|Overall Study||6||
59743019|NCT00229931|75862435|FG001|STARTED|Overall Study||5||
59743020|NCT00229931|75862434|FG000|COMPLETED|Overall Study||2||
59743021|NCT00229931|75862435|FG001|COMPLETED|Overall Study||3||
59743022|NCT00229931|75862434|FG000|NOT COMPLETED|Overall Study||4||
59743023|NCT00229931|75862435|FG001|NOT COMPLETED|Overall Study||2||
59743024|NCT00150969|75862443|FG000|STARTED|24 Month Main Study||217||
59743025|NCT00150969|75862444|FG001|STARTED|24 Month Main Study||223||
59743026|NCT00150969|75862443|FG000|COMPLETED|24 Month Main Study||198||
59743027|NCT00150969|75862444|FG001|COMPLETED|24 Month Main Study||202||
59743028|NCT00150969|75862443|FG000|NOT COMPLETED|24 Month Main Study||19||
59743029|NCT00150969|75862444|FG001|NOT COMPLETED|24 Month Main Study||21||
59743030|NCT00150969|75862443|FG000|STARTED|24-48 Month Extension||121||
59873001|NCT03131440|75997096|FG010|NOT COMPLETED|Overall Study||0||
59873002|NCT03131440|75997097|FG011|NOT COMPLETED|Overall Study||1||
59873003|NCT03131440|75997098|FG012|NOT COMPLETED|Overall Study||1||
59743031|NCT00150969|75862444|FG001|STARTED|24-48 Month Extension||140||
59743032|NCT00150969|75862443|FG000|COMPLETED|24-48 Month Extension||33||
59743033|NCT00150969|75862444|FG001|COMPLETED|24-48 Month Extension||40||
59743034|NCT00150969|75862443|FG000|NOT COMPLETED|24-48 Month Extension||88||
59743035|NCT00150969|75862444|FG001|NOT COMPLETED|24-48 Month Extension||100||
59743036|NCT00770770|75862453|FG000|STARTED|Overall Study||14||
59743037|NCT00770770|75862454|FG001|STARTED|Overall Study||6||
59743038|NCT00770770|75862453|FG000|COMPLETED|Overall Study||4||
59743039|NCT00770770|75862454|FG001|COMPLETED|Overall Study||5||
59743040|NCT00770770|75862453|FG000|NOT COMPLETED|Overall Study||10||
59743041|NCT00770770|75862454|FG001|NOT COMPLETED|Overall Study||1||
59743042|NCT00766636|75862462|FG000|STARTED|Overall Study||3||
59743043|NCT00766636|75862463|FG001|STARTED|Overall Study||2||
59743044|NCT00766636|75862462|FG000|COMPLETED|Overall Study|Number that completed pre- and post-operative therapy as well as surgery.|0||
59743045|NCT00766636|75862463|FG001|COMPLETED|Overall Study||0||
59873004|NCT03131440|75997099|FG013|NOT COMPLETED|Overall Study||0||
59743046|NCT00766636|75862462|FG000|NOT COMPLETED|Overall Study||3||
59743047|NCT00766636|75862463|FG001|NOT COMPLETED|Overall Study||2||
59743048|NCT00770692|75862473|FG000|STARTED|Overall Study|"1 participant whose compliance was unknown, was regarded as a treatment compliance unknown"|81||
59743049|NCT00770692|75862474|FG001|STARTED|Overall Study||83||
59743050|NCT00770692|75862475|FG002|STARTED|Overall Study||84||
59743051|NCT00770692|75862476|FG003|STARTED|Overall Study||77||
59743052|NCT00770692|75862473|FG000|COMPLETED|Overall Study||69||
59743053|NCT00770692|75862474|FG001|COMPLETED|Overall Study||74||
59743054|NCT00770692|75862475|FG002|COMPLETED|Overall Study||70||
59743055|NCT00770692|75862476|FG003|COMPLETED|Overall Study||66||
59743056|NCT00770692|75862473|FG000|NOT COMPLETED|Overall Study||12||
59743057|NCT00770692|75862474|FG001|NOT COMPLETED|Overall Study||9||
59743058|NCT00770692|75862475|FG002|NOT COMPLETED|Overall Study||14||
59743059|NCT00770692|75862476|FG003|NOT COMPLETED|Overall Study||11||
59743060|NCT02743897|75862486|FG000|STARTED|Overall Study||62||
59743061|NCT02743897|75862486|FG000|COMPLETED|Overall Study||62||
59743062|NCT02743897|75862486|FG000|NOT COMPLETED|Overall Study||0||
59743063|NCT02743819|75862490|FG000|STARTED|Overall Study||70|70 patients enrolled in the study and received at least one dose of study treatment.|
59743064|NCT02743819|75862490|FG000|COMPLETED|Overall Study||62||
59743065|NCT02743819|75862490|FG000|NOT COMPLETED|Overall Study||8||
59743066|NCT01004822|75862502|FG000|STARTED|Overall Study||3||
59743067|NCT01004822|75862503|FG001|STARTED|Overall Study||3||
59743068|NCT01004822|75862504|FG002|STARTED|Overall Study||4||
59743069|NCT01004822|75862505|FG003|STARTED|Overall Study||4||
59743070|NCT01004822|75862506|FG004|STARTED|Overall Study||4||
59743071|NCT01004822|75862507|FG005|STARTED|Overall Study||4||
59743072|NCT01004822|75862508|FG006|STARTED|Overall Study||4||
59743073|NCT01004822|75862509|FG007|STARTED|Overall Study||5||
59743074|NCT01004822|75862502|FG000|Treated|Overall Study||3||
59743075|NCT01004822|75862503|FG001|Treated|Overall Study||3||
59743076|NCT01004822|75862504|FG002|Treated|Overall Study||3||
59743077|NCT01004822|75862505|FG003|Treated|Overall Study||4||
59743078|NCT01004822|75862506|FG004|Treated|Overall Study||4||
59743079|NCT01004822|75862507|FG005|Treated|Overall Study||4||
59743080|NCT01004822|75862508|FG006|Treated|Overall Study||4||
59743081|NCT01004822|75862509|FG007|Treated|Overall Study||5||
59743082|NCT01004822|75862502|FG000|COMPLETED|Overall Study||0||
59873005|NCT03131440|75997100|FG014|NOT COMPLETED|Overall Study||1||
59873006|NCT03131440|75997101|FG015|NOT COMPLETED|Overall Study||0||
59873007|NCT03131440|75997102|FG016|NOT COMPLETED|Overall Study||0||
59873008|NCT03131440|75997103|FG017|NOT COMPLETED|Overall Study||0||
59873009|NCT03131440|75997104|FG018|NOT COMPLETED|Overall Study||1||
59873010|NCT03131440|75997105|FG019|NOT COMPLETED|Overall Study||2||
59873011|NCT03131440|75997106|FG020|NOT COMPLETED|Overall Study||2||
59873012|NCT03131440|75997107|FG021|NOT COMPLETED|Overall Study||1||
59873013|NCT03131440|75997108|FG022|NOT COMPLETED|Overall Study||2||
59873014|NCT03131440|75997109|FG023|NOT COMPLETED|Overall Study||0||
59873015|NCT03131440|75997110|FG024|NOT COMPLETED|Overall Study||1||
59873016|NCT03131440|75997111|FG025|NOT COMPLETED|Overall Study||1||
59873017|NCT03131440|75997112|FG026|NOT COMPLETED|Overall Study||0||
59873018|NCT03131440|75997113|FG027|NOT COMPLETED|Overall Study||2||
59873019|NCT03131440|75997114|FG028|NOT COMPLETED|Overall Study||0||
59873020|NCT03131440|75997115|FG029|NOT COMPLETED|Overall Study||2||
59873021|NCT03131440|75997116|FG030|NOT COMPLETED|Overall Study||1||
59743083|NCT01004822|75862503|FG001|COMPLETED|Overall Study||0||
59743084|NCT01004822|75862504|FG002|COMPLETED|Overall Study||0||
59743085|NCT01004822|75862505|FG003|COMPLETED|Overall Study||0||
59743086|NCT01004822|75862506|FG004|COMPLETED|Overall Study||0||
59743087|NCT01004822|75862507|FG005|COMPLETED|Overall Study||0||
59743088|NCT01004822|75862508|FG006|COMPLETED|Overall Study||0||
59743089|NCT01004822|75862509|FG007|COMPLETED|Overall Study||0||
59743090|NCT01004822|75862502|FG000|NOT COMPLETED|Overall Study||3||
59743091|NCT01004822|75862503|FG001|NOT COMPLETED|Overall Study||3||
59743092|NCT01004822|75862504|FG002|NOT COMPLETED|Overall Study||4||
59743093|NCT01004822|75862505|FG003|NOT COMPLETED|Overall Study||4||
59743094|NCT01004822|75862506|FG004|NOT COMPLETED|Overall Study||4||
59743095|NCT01004822|75862507|FG005|NOT COMPLETED|Overall Study||4||
59743096|NCT01004822|75862508|FG006|NOT COMPLETED|Overall Study||4||
59743097|NCT01004822|75862509|FG007|NOT COMPLETED|Overall Study||5||
59743098|NCT01001234|75862534|FG000|STARTED|Overall Study|Participants who were randomized to study drug|492||
59743099|NCT01001234|75862535|FG001|STARTED|Overall Study|Participants who were randomized to study drug|31||
59743100|NCT01001234|75862536|FG002|STARTED|Overall Study|Participants who were randomized to study drug|409||
59743101|NCT01001234|75862537|FG003|STARTED|Overall Study|Participants who were randomized to study drug|410||
59743102|NCT01001234|75862538|FG004|STARTED|Overall Study|Participants who were randomized to study drug|40||
59743103|NCT01001234|75862534|FG000|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|124||
59743104|NCT01001234|75862535|FG001|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|8||
59743105|NCT01001234|75862536|FG002|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|400||
59762492|NCT02644525|75882209|FG000|NOT COMPLETED|Group 3||0||
59743106|NCT01001234|75862537|FG003|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|405||
59743107|NCT01001234|75862538|FG004|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|40||
59743108|NCT01001234|75862534|FG000|Participants Not Treated|Overall Study|Participants who did not take study drug|368||
59743109|NCT01001234|75862535|FG001|Participants Not Treated|Overall Study|Participants who did not take study drug|23||
59743110|NCT01001234|75862536|FG002|Participants Not Treated|Overall Study|Participants who did not take study drug|9||
59743111|NCT01001234|75862537|FG003|Participants Not Treated|Overall Study|Participants who did not take study drug|5||
59743112|NCT01001234|75862538|FG004|Participants Not Treated|Overall Study|Participants who did not take study drug|0||
59743113|NCT01001234|75862534|FG000|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|87||
59743114|NCT01001234|75862535|FG001|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|5||
59743115|NCT01001234|75862536|FG002|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|377||
59743116|NCT01001234|75862537|FG003|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|385||
59743117|NCT01001234|75862538|FG004|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|40||
59743118|NCT01001234|75862534|FG000|NOT COMPLETED|Overall Study||405||
59743119|NCT01001234|75862535|FG001|NOT COMPLETED|Overall Study||26||
59743120|NCT01001234|75862536|FG002|NOT COMPLETED|Overall Study||32||
59743121|NCT01001234|75862537|FG003|NOT COMPLETED|Overall Study||25||
59743122|NCT01001234|75862538|FG004|NOT COMPLETED|Overall Study||0||
59743123|NCT01004510|75862544|FG000|STARTED|Overall Study||3||
59743124|NCT01004510|75862544|FG000|COMPLETED|Overall Study||2||
59743125|NCT01004510|75862544|FG000|NOT COMPLETED|Overall Study||1||
59743126|NCT01004432|75862548|FG000|STARTED|Open-label (OL) Period (Week 0 - 16)||433||
59743127|NCT01004432|75862549|FG001|STARTED|Open-label (OL) Period (Week 0 - 16)||0||
59743128|NCT01004432|75862550|FG002|STARTED|Open-label (OL) Period (Week 0 - 16)||0||
59743129|NCT01004432|75862551|FG003|STARTED|Open-label (OL) Period (Week 0 - 16)||0||
59743130|NCT01004432|75862552|FG004|STARTED|Open-label (OL) Period (Week 0 - 16)||0||
59743131|NCT01004432|75862548|FG000|COMPLETED|Open-label (OL) Period (Week 0 - 16)|1 Participant died after completing open-label period. Discontinuation was noted as adverse event.|350||
59743132|NCT01004432|75862549|FG001|COMPLETED|Open-label (OL) Period (Week 0 - 16)||0||
59743133|NCT01004432|75862550|FG002|COMPLETED|Open-label (OL) Period (Week 0 - 16)||0||
59743134|NCT01004432|75862551|FG003|COMPLETED|Open-label (OL) Period (Week 0 - 16)||0||
59743135|NCT01004432|75862552|FG004|COMPLETED|Open-label (OL) Period (Week 0 - 16)||0||
59743136|NCT01004432|75862548|FG000|NOT COMPLETED|Open-label (OL) Period (Week 0 - 16)||83||
59743137|NCT01004432|75862549|FG001|NOT COMPLETED|Open-label (OL) Period (Week 0 - 16)||0||
59743138|NCT01004432|75862550|FG002|NOT COMPLETED|Open-label (OL) Period (Week 0 - 16)||0||
59743139|NCT01004432|75862551|FG003|NOT COMPLETED|Open-label (OL) Period (Week 0 - 16)||0||
59743140|NCT01004432|75862552|FG004|NOT COMPLETED|Open-label (OL) Period (Week 0 - 16)||0||
59743141|NCT01004432|75862548|FG000|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||0||
59743142|NCT01004432|75862549|FG001|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||75||
59743143|NCT01004432|75862550|FG002|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||91||
59743144|NCT01004432|75862551|FG003|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||184||
59743145|NCT01004432|75862552|FG004|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||0||
59743146|NCT01004432|75862548|FG000|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||0||
59743147|NCT01004432|75862549|FG001|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||65||
59743148|NCT01004432|75862550|FG002|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||54||
59743149|NCT01004432|75862551|FG003|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||126||
59743150|NCT01004432|75862552|FG004|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||0||
59743151|NCT01004432|75862548|FG000|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||0||
59743152|NCT01004432|75862549|FG001|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||10||
59743153|NCT01004432|75862550|FG002|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||37||
59743154|NCT01004432|75862551|FG003|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||58||
59743155|NCT01004432|75862552|FG004|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||0||
59743156|NCT01004432|75862548|FG000|STARTED|OL Study Extension (Week 52 - 76)||0||
59743157|NCT01004432|75862549|FG001|STARTED|OL Study Extension (Week 52 - 76)||0||
59743158|NCT01004432|75862550|FG002|STARTED|OL Study Extension (Week 52 - 76)||0||
59743159|NCT01004432|75862551|FG003|STARTED|OL Study Extension (Week 52 - 76)||0||
59743160|NCT01004432|75862552|FG004|STARTED|OL Study Extension (Week 52 - 76)||212||
59743161|NCT01004432|75862548|FG000|COMPLETED|OL Study Extension (Week 52 - 76)||0||
59743162|NCT01004432|75862549|FG001|COMPLETED|OL Study Extension (Week 52 - 76)||0||
59743163|NCT01004432|75862550|FG002|COMPLETED|OL Study Extension (Week 52 - 76)||0||
59743164|NCT01004432|75862551|FG003|COMPLETED|OL Study Extension (Week 52 - 76)||0||
59743165|NCT01004432|75862552|FG004|COMPLETED|OL Study Extension (Week 52 - 76)||194||
59743166|NCT01004432|75862548|FG000|NOT COMPLETED|OL Study Extension (Week 52 - 76)||0||
59743167|NCT01004432|75862549|FG001|NOT COMPLETED|OL Study Extension (Week 52 - 76)||0||
59743168|NCT01004432|75862550|FG002|NOT COMPLETED|OL Study Extension (Week 52 - 76)||0||
59743169|NCT01004432|75862551|FG003|NOT COMPLETED|OL Study Extension (Week 52 - 76)||0||
59743170|NCT01004432|75862552|FG004|NOT COMPLETED|OL Study Extension (Week 52 - 76)||18||
59743171|NCT01000610|75862566|FG000|STARTED|Overall Study||18||
59743172|NCT01000610|75862566|FG000|COMPLETED|Overall Study||12||
59743173|NCT01000610|75862566|FG000|NOT COMPLETED|Overall Study||6||
59743174|NCT01877655|75862572|FG000|STARTED|Overall Study||263||
59743175|NCT01877655|75862573|FG001|STARTED|Overall Study||251||
59743176|NCT01877655|75862572|FG000|Received Treatment|Overall Study||255||
59743177|NCT01877655|75862573|FG001|Received Treatment|Overall Study||246||
59743178|NCT01877655|75862572|FG000|COMPLETED|Overall Study||165||
59743179|NCT01877655|75862573|FG001|COMPLETED|Overall Study||154||
59743180|NCT01877655|75862572|FG000|NOT COMPLETED|Overall Study||98||
59743181|NCT01877655|75862573|FG001|NOT COMPLETED|Overall Study||97||
59743182|NCT00586924|75862585|FG000|STARTED|Overall Study||3||
59743183|NCT00586924|75862586|FG001|STARTED|Overall Study||3||
59743184|NCT00586924|75862587|FG002|STARTED|Overall Study||3||
59743185|NCT00586924|75862588|FG003|STARTED|Overall Study||3||
59743186|NCT00586924|75862589|FG004|STARTED|Overall Study||4||
59743187|NCT00586924|75862590|FG005|STARTED|Overall Study||33||
59743188|NCT00586924|75862585|FG000|COMPLETED|Overall Study||0||
59743189|NCT00586924|75862586|FG001|COMPLETED|Overall Study||0||
59743190|NCT00586924|75862587|FG002|COMPLETED|Overall Study||0||
59743191|NCT00586924|75862588|FG003|COMPLETED|Overall Study||0||
59743192|NCT00586924|75862589|FG004|COMPLETED|Overall Study||0||
59743193|NCT00586924|75862590|FG005|COMPLETED|Overall Study||0||
59743194|NCT00586924|75862585|FG000|NOT COMPLETED|Overall Study||3||
59743195|NCT00586924|75862586|FG001|NOT COMPLETED|Overall Study||3||
59743196|NCT00586924|75862587|FG002|NOT COMPLETED|Overall Study||3||
59743197|NCT00586924|75862588|FG003|NOT COMPLETED|Overall Study||3||
59743198|NCT00586924|75862589|FG004|NOT COMPLETED|Overall Study||4||
59743199|NCT00586924|75862590|FG005|NOT COMPLETED|Overall Study||33||
59743200|NCT01000376|75862606|FG000|STARTED|Cycle 1 Day 1||6||
59743201|NCT01000376|75862607|FG001|STARTED|Cycle 1 Day 1||6||
59743202|NCT01000376|75862606|FG000|COMPLETED|Cycle 1 Day 1||4||
59743203|NCT01000376|75862607|FG001|COMPLETED|Cycle 1 Day 1||6||
59743204|NCT01000376|75862606|FG000|NOT COMPLETED|Cycle 1 Day 1||2||
59743205|NCT01000376|75862607|FG001|NOT COMPLETED|Cycle 1 Day 1||0||
59743206|NCT01000376|75862606|FG000|STARTED|Cycle 1 Day 15||4||
59743207|NCT01000376|75862607|FG001|STARTED|Cycle 1 Day 15||6||
59743208|NCT01000376|75862606|FG000|COMPLETED|Cycle 1 Day 15||4||
59743209|NCT01000376|75862607|FG001|COMPLETED|Cycle 1 Day 15||6||
59743210|NCT01000376|75862606|FG000|NOT COMPLETED|Cycle 1 Day 15||0||
59743211|NCT01000376|75862607|FG001|NOT COMPLETED|Cycle 1 Day 15||0||
59743212|NCT01038635|75862622|FG000|STARTED|Overall Study||5||
59743213|NCT01038635|75862623|FG001|STARTED|Overall Study||3||
59743214|NCT01038635|75862624|FG002|STARTED|Overall Study||3||
59743215|NCT01038635|75862625|FG003|STARTED|Overall Study||3||
59743216|NCT01038635|75862626|FG004|STARTED|Overall Study||4||
59743217|NCT01038635|75862627|FG005|STARTED|Overall Study||3||
59743218|NCT01038635|75862628|FG006|STARTED|Overall Study||7||
59743219|NCT01038635|75862629|FG007|STARTED|Overall Study||20||
59743220|NCT01038635|75862630|FG008|STARTED|Overall Study||40||
59743221|NCT01038635|75862622|FG000|COMPLETED|Overall Study||3||
59743222|NCT01038635|75862623|FG001|COMPLETED|Overall Study||3||
59743223|NCT01038635|75862624|FG002|COMPLETED|Overall Study||3||
59743224|NCT01038635|75862625|FG003|COMPLETED|Overall Study||3||
59743225|NCT01038635|75862626|FG004|COMPLETED|Overall Study||3||
59743226|NCT01038635|75862627|FG005|COMPLETED|Overall Study||3||
59743227|NCT01038635|75862628|FG006|COMPLETED|Overall Study||5||
59743228|NCT01038635|75862629|FG007|COMPLETED|Overall Study||15||
59743229|NCT01038635|75862630|FG008|COMPLETED|Overall Study||38||
59743230|NCT01038635|75862622|FG000|NOT COMPLETED|Overall Study||2||
59743231|NCT01038635|75862623|FG001|NOT COMPLETED|Overall Study||0||
59743232|NCT01038635|75862624|FG002|NOT COMPLETED|Overall Study||0||
59743233|NCT01038635|75862625|FG003|NOT COMPLETED|Overall Study||0||
59743234|NCT01038635|75862626|FG004|NOT COMPLETED|Overall Study||1||
59743235|NCT01038635|75862627|FG005|NOT COMPLETED|Overall Study||0||
59743236|NCT01038635|75862628|FG006|NOT COMPLETED|Overall Study||2||
59743237|NCT01038635|75862629|FG007|NOT COMPLETED|Overall Study||5||
59743238|NCT01038635|75862630|FG008|NOT COMPLETED|Overall Study||2||
59743239|NCT01000064|75862651|FG000|STARTED|Overall Study||7||
59743240|NCT01000064|75862652|FG001|STARTED|Overall Study||6||
59743241|NCT01000064|75862651|FG000|COMPLETED|Overall Study||6||
59743242|NCT01000064|75862652|FG001|COMPLETED|Overall Study||5||
59743243|NCT01000064|75862651|FG000|NOT COMPLETED|Overall Study||1||
59743244|NCT01000064|75862652|FG001|NOT COMPLETED|Overall Study||1||
59743245|NCT00766090|75862663|FG000|STARTED|Treatment Period 1 (28 Days)||25||
59743246|NCT00766090|75862664|FG001|STARTED|Treatment Period 1 (28 Days)||27||
59743247|NCT00766090|75862665|FG002|STARTED|Treatment Period 1 (28 Days)||23||
59743248|NCT00766090|75862666|FG003|STARTED|Treatment Period 1 (28 Days)||26||
59743249|NCT00766090|75862667|FG004|STARTED|Treatment Period 1 (28 Days)||23||
59743250|NCT00766090|75862668|FG005|STARTED|Treatment Period 1 (28 Days)||23||
59743251|NCT00766090|75862669|FG006|STARTED|Treatment Period 1 (28 Days)||6||
59743252|NCT00766090|75862670|FG007|STARTED|Treatment Period 1 (28 Days)||8||
59743253|NCT00766090|75862671|FG008|STARTED|Treatment Period 1 (28 Days)||7||
59743254|NCT00766090|75862672|FG009|STARTED|Treatment Period 1 (28 Days)||8||
59743255|NCT00766090|75862673|FG010|STARTED|Treatment Period 1 (28 Days)||7||
59743256|NCT00766090|75862674|FG011|STARTED|Treatment Period 1 (28 Days)||7||
59743257|NCT00766090|75862663|FG000|COMPLETED|Treatment Period 1 (28 Days)||22||
59743258|NCT00766090|75862664|FG001|COMPLETED|Treatment Period 1 (28 Days)||27||
59743259|NCT00766090|75862665|FG002|COMPLETED|Treatment Period 1 (28 Days)||23||
59743260|NCT00766090|75862666|FG003|COMPLETED|Treatment Period 1 (28 Days)||25||
59743261|NCT00766090|75862667|FG004|COMPLETED|Treatment Period 1 (28 Days)||23||
59743262|NCT00766090|75862668|FG005|COMPLETED|Treatment Period 1 (28 Days)||23||
59743263|NCT00766090|75862669|FG006|COMPLETED|Treatment Period 1 (28 Days)||6||
59743264|NCT00766090|75862670|FG007|COMPLETED|Treatment Period 1 (28 Days)||8||
59743265|NCT00766090|75862671|FG008|COMPLETED|Treatment Period 1 (28 Days)||6||
59743266|NCT00766090|75862672|FG009|COMPLETED|Treatment Period 1 (28 Days)||8||
59743267|NCT00766090|75862673|FG010|COMPLETED|Treatment Period 1 (28 Days)||7||
59743268|NCT00766090|75862674|FG011|COMPLETED|Treatment Period 1 (28 Days)||7||
59743269|NCT00766090|75862663|FG000|NOT COMPLETED|Treatment Period 1 (28 Days)||3||
59743270|NCT00766090|75862664|FG001|NOT COMPLETED|Treatment Period 1 (28 Days)||0||
59743271|NCT00766090|75862665|FG002|NOT COMPLETED|Treatment Period 1 (28 Days)||0||
59743272|NCT00766090|75862666|FG003|NOT COMPLETED|Treatment Period 1 (28 Days)||1||
59743273|NCT00766090|75862667|FG004|NOT COMPLETED|Treatment Period 1 (28 Days)||0||
59743274|NCT00766090|75862668|FG005|NOT COMPLETED|Treatment Period 1 (28 Days)||0||
59743275|NCT00766090|75862669|FG006|NOT COMPLETED|Treatment Period 1 (28 Days)||0||
59743276|NCT00766090|75862670|FG007|NOT COMPLETED|Treatment Period 1 (28 Days)||0||
59743277|NCT00766090|75862671|FG008|NOT COMPLETED|Treatment Period 1 (28 Days)||1||
59743278|NCT00766090|75862672|FG009|NOT COMPLETED|Treatment Period 1 (28 Days)||0||
59743279|NCT00766090|75862673|FG010|NOT COMPLETED|Treatment Period 1 (28 Days)||0||
59743280|NCT00766090|75862674|FG011|NOT COMPLETED|Treatment Period 1 (28 Days)||0||
59743281|NCT00766090|75862663|FG000|STARTED|Washout Period 1 (14 Days)||22||
59743282|NCT00766090|75862664|FG001|STARTED|Washout Period 1 (14 Days)||27||
59743283|NCT00766090|75862665|FG002|STARTED|Washout Period 1 (14 Days)||23||
59743284|NCT00766090|75862666|FG003|STARTED|Washout Period 1 (14 Days)||25||
59743285|NCT00766090|75862667|FG004|STARTED|Washout Period 1 (14 Days)||23||
59743286|NCT00766090|75862668|FG005|STARTED|Washout Period 1 (14 Days)||23||
59743287|NCT00766090|75862669|FG006|STARTED|Washout Period 1 (14 Days)||6||
59743288|NCT00766090|75862670|FG007|STARTED|Washout Period 1 (14 Days)||8||
59743289|NCT00766090|75862671|FG008|STARTED|Washout Period 1 (14 Days)||6||
59743290|NCT00766090|75862672|FG009|STARTED|Washout Period 1 (14 Days)||8||
59743291|NCT00766090|75862673|FG010|STARTED|Washout Period 1 (14 Days)||7||
59743292|NCT00766090|75862674|FG011|STARTED|Washout Period 1 (14 Days)||7||
59743293|NCT00766090|75862663|FG000|COMPLETED|Washout Period 1 (14 Days)||22||
59743294|NCT00766090|75862664|FG001|COMPLETED|Washout Period 1 (14 Days)||27||
59743295|NCT00766090|75862665|FG002|COMPLETED|Washout Period 1 (14 Days)||22||
59743296|NCT00766090|75862666|FG003|COMPLETED|Washout Period 1 (14 Days)||25||
59743297|NCT00766090|75862667|FG004|COMPLETED|Washout Period 1 (14 Days)||23||
59743298|NCT00766090|75862668|FG005|COMPLETED|Washout Period 1 (14 Days)||23||
59743299|NCT00766090|75862669|FG006|COMPLETED|Washout Period 1 (14 Days)||6||
59743300|NCT00766090|75862670|FG007|COMPLETED|Washout Period 1 (14 Days)||8||
59743301|NCT00766090|75862671|FG008|COMPLETED|Washout Period 1 (14 Days)||6||
59743302|NCT00766090|75862672|FG009|COMPLETED|Washout Period 1 (14 Days)||8||
59743303|NCT00766090|75862673|FG010|COMPLETED|Washout Period 1 (14 Days)||7||
59743304|NCT00766090|75862674|FG011|COMPLETED|Washout Period 1 (14 Days)||7||
59743305|NCT00766090|75862663|FG000|NOT COMPLETED|Washout Period 1 (14 Days)||0||
59743306|NCT00766090|75862664|FG001|NOT COMPLETED|Washout Period 1 (14 Days)||0||
59743307|NCT00766090|75862665|FG002|NOT COMPLETED|Washout Period 1 (14 Days)||1||
59743308|NCT00766090|75862666|FG003|NOT COMPLETED|Washout Period 1 (14 Days)||0||
59743309|NCT00766090|75862667|FG004|NOT COMPLETED|Washout Period 1 (14 Days)||0||
59873022|NCT03131440|75997117|FG031|NOT COMPLETED|Overall Study||0||
59873023|NCT02915302|75997162|FG000|STARTED|Overall Study||955||
59743310|NCT00766090|75862668|FG005|NOT COMPLETED|Washout Period 1 (14 Days)||0||
59743311|NCT00766090|75862669|FG006|NOT COMPLETED|Washout Period 1 (14 Days)||0||
59743312|NCT00766090|75862670|FG007|NOT COMPLETED|Washout Period 1 (14 Days)||0||
59743313|NCT00766090|75862671|FG008|NOT COMPLETED|Washout Period 1 (14 Days)||0||
59743314|NCT00766090|75862672|FG009|NOT COMPLETED|Washout Period 1 (14 Days)||0||
59743315|NCT00766090|75862673|FG010|NOT COMPLETED|Washout Period 1 (14 Days)||0||
59743316|NCT00766090|75862674|FG011|NOT COMPLETED|Washout Period 1 (14 Days)||0||
59743317|NCT00766090|75862663|FG000|STARTED|Treatment Period 2 (28 Days)||22||
59743318|NCT00766090|75862664|FG001|STARTED|Treatment Period 2 (28 Days)||27||
59743319|NCT00766090|75862665|FG002|STARTED|Treatment Period 2 (28 Days)||22||
59743320|NCT00766090|75862666|FG003|STARTED|Treatment Period 2 (28 Days)||25||
59743321|NCT00766090|75862667|FG004|STARTED|Treatment Period 2 (28 Days)||23||
59743322|NCT00766090|75862668|FG005|STARTED|Treatment Period 2 (28 Days)||23||
59873024|NCT02915302|75997163|FG001|STARTED|Overall Study||995||
59743323|NCT00766090|75862669|FG006|STARTED|Treatment Period 2 (28 Days)||6||
59743324|NCT00766090|75862670|FG007|STARTED|Treatment Period 2 (28 Days)||8||
59743325|NCT00766090|75862671|FG008|STARTED|Treatment Period 2 (28 Days)||6||
59743326|NCT00766090|75862672|FG009|STARTED|Treatment Period 2 (28 Days)||8||
59743327|NCT00766090|75862673|FG010|STARTED|Treatment Period 2 (28 Days)||7||
59743328|NCT00766090|75862674|FG011|STARTED|Treatment Period 2 (28 Days)||7||
59743329|NCT00766090|75862663|FG000|COMPLETED|Treatment Period 2 (28 Days)||22||
59743330|NCT00766090|75862664|FG001|COMPLETED|Treatment Period 2 (28 Days)||27||
59743331|NCT00766090|75862665|FG002|COMPLETED|Treatment Period 2 (28 Days)||21||
59743332|NCT00766090|75862666|FG003|COMPLETED|Treatment Period 2 (28 Days)||25||
59743333|NCT00766090|75862667|FG004|COMPLETED|Treatment Period 2 (28 Days)||21||
59743334|NCT00766090|75862668|FG005|COMPLETED|Treatment Period 2 (28 Days)||23||
59743335|NCT00766090|75862669|FG006|COMPLETED|Treatment Period 2 (28 Days)||6||
59743336|NCT00766090|75862670|FG007|COMPLETED|Treatment Period 2 (28 Days)||8||
59743337|NCT00766090|75862671|FG008|COMPLETED|Treatment Period 2 (28 Days)||6||
59743338|NCT00766090|75862672|FG009|COMPLETED|Treatment Period 2 (28 Days)||8||
59743339|NCT00766090|75862673|FG010|COMPLETED|Treatment Period 2 (28 Days)||7||
59743340|NCT00766090|75862674|FG011|COMPLETED|Treatment Period 2 (28 Days)||7||
59743341|NCT00766090|75862663|FG000|NOT COMPLETED|Treatment Period 2 (28 Days)||0||
59743342|NCT00766090|75862664|FG001|NOT COMPLETED|Treatment Period 2 (28 Days)||0||
59743343|NCT00766090|75862665|FG002|NOT COMPLETED|Treatment Period 2 (28 Days)||1||
59743344|NCT00766090|75862666|FG003|NOT COMPLETED|Treatment Period 2 (28 Days)||0||
59743345|NCT00766090|75862667|FG004|NOT COMPLETED|Treatment Period 2 (28 Days)||2||
59743346|NCT00766090|75862668|FG005|NOT COMPLETED|Treatment Period 2 (28 Days)||0||
59743347|NCT00766090|75862669|FG006|NOT COMPLETED|Treatment Period 2 (28 Days)||0||
59743348|NCT00766090|75862670|FG007|NOT COMPLETED|Treatment Period 2 (28 Days)||0||
59743349|NCT00766090|75862671|FG008|NOT COMPLETED|Treatment Period 2 (28 Days)||0||
59743350|NCT00766090|75862672|FG009|NOT COMPLETED|Treatment Period 2 (28 Days)||0||
59743351|NCT00766090|75862673|FG010|NOT COMPLETED|Treatment Period 2 (28 Days)||0||
59743352|NCT00766090|75862674|FG011|NOT COMPLETED|Treatment Period 2 (28 Days)||0||
59743353|NCT00766090|75862663|FG000|STARTED|Washout Period 2 (14 Days)||22||
59743354|NCT00766090|75862664|FG001|STARTED|Washout Period 2 (14 Days)||27||
59743355|NCT00766090|75862665|FG002|STARTED|Washout Period 2 (14 Days)||21||
59743356|NCT00766090|75862666|FG003|STARTED|Washout Period 2 (14 Days)||25||
59743357|NCT00766090|75862667|FG004|STARTED|Washout Period 2 (14 Days)||21||
59743358|NCT00766090|75862668|FG005|STARTED|Washout Period 2 (14 Days)||23||
59743359|NCT00766090|75862669|FG006|STARTED|Washout Period 2 (14 Days)||6||
59743360|NCT00766090|75862670|FG007|STARTED|Washout Period 2 (14 Days)||8||
59743361|NCT00766090|75862671|FG008|STARTED|Washout Period 2 (14 Days)||6||
59743362|NCT00766090|75862672|FG009|STARTED|Washout Period 2 (14 Days)||8||
59743363|NCT00766090|75862673|FG010|STARTED|Washout Period 2 (14 Days)||7||
59743364|NCT00766090|75862674|FG011|STARTED|Washout Period 2 (14 Days)||7||
59743365|NCT00766090|75862663|FG000|COMPLETED|Washout Period 2 (14 Days)||22||
59743366|NCT00766090|75862664|FG001|COMPLETED|Washout Period 2 (14 Days)||27||
59743367|NCT00766090|75862665|FG002|COMPLETED|Washout Period 2 (14 Days)||20||
59743368|NCT00766090|75862666|FG003|COMPLETED|Washout Period 2 (14 Days)||25||
59743369|NCT00766090|75862667|FG004|COMPLETED|Washout Period 2 (14 Days)||21||
59743370|NCT00766090|75862668|FG005|COMPLETED|Washout Period 2 (14 Days)||23||
59743371|NCT00766090|75862669|FG006|COMPLETED|Washout Period 2 (14 Days)||6||
59743372|NCT00766090|75862670|FG007|COMPLETED|Washout Period 2 (14 Days)||8||
59743373|NCT00766090|75862671|FG008|COMPLETED|Washout Period 2 (14 Days)||6||
59743374|NCT00766090|75862672|FG009|COMPLETED|Washout Period 2 (14 Days)||8||
59743375|NCT00766090|75862673|FG010|COMPLETED|Washout Period 2 (14 Days)||7||
59743376|NCT00766090|75862674|FG011|COMPLETED|Washout Period 2 (14 Days)||7||
59743377|NCT00766090|75862663|FG000|NOT COMPLETED|Washout Period 2 (14 Days)||0||
59743378|NCT00766090|75862664|FG001|NOT COMPLETED|Washout Period 2 (14 Days)||0||
59743379|NCT00766090|75862665|FG002|NOT COMPLETED|Washout Period 2 (14 Days)||1||
59743380|NCT00766090|75862666|FG003|NOT COMPLETED|Washout Period 2 (14 Days)||0||
59743381|NCT00766090|75862667|FG004|NOT COMPLETED|Washout Period 2 (14 Days)||0||
59743382|NCT00766090|75862668|FG005|NOT COMPLETED|Washout Period 2 (14 Days)||0||
59743383|NCT00766090|75862669|FG006|NOT COMPLETED|Washout Period 2 (14 Days)||0||
59743384|NCT00766090|75862670|FG007|NOT COMPLETED|Washout Period 2 (14 Days)||0||
59743385|NCT00766090|75862671|FG008|NOT COMPLETED|Washout Period 2 (14 Days)||0||
59743386|NCT00766090|75862672|FG009|NOT COMPLETED|Washout Period 2 (14 Days)||0||
59743387|NCT00766090|75862673|FG010|NOT COMPLETED|Washout Period 2 (14 Days)||0||
59743388|NCT00766090|75862674|FG011|NOT COMPLETED|Washout Period 2 (14 Days)||0||
59743389|NCT00766090|75862663|FG000|STARTED|Treatment Period 3 (28 Days)||22||
59743390|NCT00766090|75862664|FG001|STARTED|Treatment Period 3 (28 Days)||27||
59743391|NCT00766090|75862665|FG002|STARTED|Treatment Period 3 (28 Days)||20||
59743392|NCT00766090|75862666|FG003|STARTED|Treatment Period 3 (28 Days)||25||
59743393|NCT00766090|75862667|FG004|STARTED|Treatment Period 3 (28 Days)||21||
59743394|NCT00766090|75862668|FG005|STARTED|Treatment Period 3 (28 Days)||23||
59743395|NCT00766090|75862669|FG006|STARTED|Treatment Period 3 (28 Days)||6||
59743396|NCT00766090|75862670|FG007|STARTED|Treatment Period 3 (28 Days)||8||
59743397|NCT00766090|75862671|FG008|STARTED|Treatment Period 3 (28 Days)||6||
59743398|NCT00766090|75862672|FG009|STARTED|Treatment Period 3 (28 Days)||8||
59743399|NCT00766090|75862673|FG010|STARTED|Treatment Period 3 (28 Days)||7||
59743400|NCT00766090|75862674|FG011|STARTED|Treatment Period 3 (28 Days)||7||
59743401|NCT00766090|75862663|FG000|COMPLETED|Treatment Period 3 (28 Days)||22||
59743402|NCT00766090|75862664|FG001|COMPLETED|Treatment Period 3 (28 Days)||26||
59743403|NCT00766090|75862665|FG002|COMPLETED|Treatment Period 3 (28 Days)||20||
59743404|NCT00766090|75862666|FG003|COMPLETED|Treatment Period 3 (28 Days)||24||
59743405|NCT00766090|75862667|FG004|COMPLETED|Treatment Period 3 (28 Days)||20||
59743406|NCT00766090|75862668|FG005|COMPLETED|Treatment Period 3 (28 Days)||22||
59743407|NCT00766090|75862669|FG006|COMPLETED|Treatment Period 3 (28 Days)||6||
59743408|NCT00766090|75862670|FG007|COMPLETED|Treatment Period 3 (28 Days)||8||
59743409|NCT00766090|75862671|FG008|COMPLETED|Treatment Period 3 (28 Days)||6||
59743410|NCT00766090|75862672|FG009|COMPLETED|Treatment Period 3 (28 Days)||8||
59743411|NCT00766090|75862673|FG010|COMPLETED|Treatment Period 3 (28 Days)||7||
59743412|NCT00766090|75862674|FG011|COMPLETED|Treatment Period 3 (28 Days)||6||
59743413|NCT00766090|75862663|FG000|NOT COMPLETED|Treatment Period 3 (28 Days)||0||
59743414|NCT00766090|75862664|FG001|NOT COMPLETED|Treatment Period 3 (28 Days)||1||
59743415|NCT00766090|75862665|FG002|NOT COMPLETED|Treatment Period 3 (28 Days)||0||
59743416|NCT00766090|75862666|FG003|NOT COMPLETED|Treatment Period 3 (28 Days)||1||
59743417|NCT00766090|75862667|FG004|NOT COMPLETED|Treatment Period 3 (28 Days)||1||
59743418|NCT00766090|75862668|FG005|NOT COMPLETED|Treatment Period 3 (28 Days)||1||
59743419|NCT00766090|75862669|FG006|NOT COMPLETED|Treatment Period 3 (28 Days)||0||
59743420|NCT00766090|75862670|FG007|NOT COMPLETED|Treatment Period 3 (28 Days)||0||
59743421|NCT00766090|75862671|FG008|NOT COMPLETED|Treatment Period 3 (28 Days)||0||
59743422|NCT00766090|75862672|FG009|NOT COMPLETED|Treatment Period 3 (28 Days)||0||
59743423|NCT00766090|75862673|FG010|NOT COMPLETED|Treatment Period 3 (28 Days)||0||
59743424|NCT00766090|75862674|FG011|NOT COMPLETED|Treatment Period 3 (28 Days)||1||
59743425|NCT00580801|75862691|FG000|STARTED|Overall Study||8||
59743426|NCT00580801|75862692|FG001|STARTED|Overall Study||8||
59743427|NCT00580801|75862693|FG002|STARTED|Overall Study||8||
59743428|NCT00580801|75862691|FG000|COMPLETED|Overall Study||2||
59743429|NCT00580801|75862692|FG001|COMPLETED|Overall Study||7||
59743430|NCT00580801|75862693|FG002|COMPLETED|Overall Study||5||
59743431|NCT00580801|75862691|FG000|NOT COMPLETED|Overall Study||6||
59743432|NCT00580801|75862692|FG001|NOT COMPLETED|Overall Study||1||
59743433|NCT00580801|75862693|FG002|NOT COMPLETED|Overall Study||3||
59743434|NCT01059539|75862701|FG000|STARTED|Overall Study||403||
59743435|NCT01059539|75862701|FG000|COMPLETED|Overall Study||132||
59743436|NCT01059539|75862701|FG000|NOT COMPLETED|Overall Study||271||
59743437|NCT00999908|75862705|FG000|STARTED|Treatment Period 1||19||
59743438|NCT00999908|75862706|FG001|STARTED|Treatment Period 1||16||
59743439|NCT00999908|75862707|FG002|STARTED|Treatment Period 1||19||
59743440|NCT00999908|75862705|FG000|COMPLETED|Treatment Period 1||17||
59743441|NCT00999908|75862706|FG001|COMPLETED|Treatment Period 1||16||
59743442|NCT00999908|75862707|FG002|COMPLETED|Treatment Period 1||19||
59743443|NCT00999908|75862705|FG000|NOT COMPLETED|Treatment Period 1||2||
59743444|NCT00999908|75862706|FG001|NOT COMPLETED|Treatment Period 1||0||
59743445|NCT00999908|75862707|FG002|NOT COMPLETED|Treatment Period 1||0||
59743446|NCT00999908|75862705|FG000|STARTED|Treatment Period 2||17||
59743447|NCT00999908|75862706|FG001|STARTED|Treatment Period 2||16||
59743448|NCT00999908|75862707|FG002|STARTED|Treatment Period 2||19||
59743449|NCT00999908|75862705|FG000|COMPLETED|Treatment Period 2||16||
59743450|NCT00999908|75862706|FG001|COMPLETED|Treatment Period 2||16||
59743451|NCT00999908|75862707|FG002|COMPLETED|Treatment Period 2||19||
59743452|NCT00999908|75862705|FG000|NOT COMPLETED|Treatment Period 2||1||
59743453|NCT00999908|75862706|FG001|NOT COMPLETED|Treatment Period 2||0||
59743454|NCT00999908|75862707|FG002|NOT COMPLETED|Treatment Period 2||0||
59743455|NCT00999908|75862705|FG000|STARTED|Treatment Period 3||16||
59743456|NCT00999908|75862706|FG001|STARTED|Treatment Period 3||16||
59743457|NCT00999908|75862707|FG002|STARTED|Treatment Period 3||19||
59743458|NCT00999908|75862705|FG000|COMPLETED|Treatment Period 3||16||
59743459|NCT00999908|75862706|FG001|COMPLETED|Treatment Period 3||16||
59743460|NCT00999908|75862707|FG002|COMPLETED|Treatment Period 3||19||
59743461|NCT00999908|75862705|FG000|NOT COMPLETED|Treatment Period 3||0||
59743462|NCT00999908|75862706|FG001|NOT COMPLETED|Treatment Period 3||0||
59743463|NCT00999908|75862707|FG002|NOT COMPLETED|Treatment Period 3||0||
59743464|NCT00580723|75862715|FG000|STARTED|Overall Study||24||
59743465|NCT00580723|75862715|FG000|COMPLETED|Overall Study||16||
59743466|NCT00580723|75862715|FG000|NOT COMPLETED|Overall Study||8||
59743467|NCT00999596|75862719|FG000|STARTED|Overall Study||107||
59743468|NCT00999596|75862719|FG000|New FDA Guideline Released|Overall Study|FDA Guidance: Class II Special Controls Guidance Document: Full-Field Digital Mammography System|6||
59743469|NCT00999596|75862719|FG000|COMPLETED|Overall Study|Not all patient images were used for the reader evaluation based on new FDA Guidelines|6||
59743470|NCT00999596|75862719|FG000|NOT COMPLETED|Overall Study||101||
59743471|NCT04676867|75862728|FG000|STARTED|Overall Study|Medication never taken n=3|56||
59743472|NCT04676867|75862729|FG001|STARTED|Overall Study|Medication never taken n=1|56||
59743473|NCT04676867|75862730|FG002|STARTED|Overall Study|Medication never taken n=8|56||
59743474|NCT04676867|75862731|FG003|STARTED|Overall Study|Medication never taken n=5|57||
59743475|NCT04676867|75862728|FG000|Entered Study and Received at Least 1 Dose of Study Medication|Overall Study||53||
59743476|NCT04676867|75862729|FG001|Entered Study and Received at Least 1 Dose of Study Medication|Overall Study||55||
59743477|NCT04676867|75862730|FG002|Entered Study and Received at Least 1 Dose of Study Medication|Overall Study||48||
59743478|NCT04676867|75862731|FG003|Entered Study and Received at Least 1 Dose of Study Medication|Overall Study||52||
59743479|NCT04676867|75862728|FG000|COMPLETED|Overall Study||53||
59743480|NCT04676867|75862729|FG001|COMPLETED|Overall Study||54||
59743481|NCT04676867|75862730|FG002|COMPLETED|Overall Study||45||
59743482|NCT04676867|75862731|FG003|COMPLETED|Overall Study||51||
59743483|NCT04676867|75862728|FG000|NOT COMPLETED|Overall Study||3||
59743484|NCT04676867|75862729|FG001|NOT COMPLETED|Overall Study||2||
59743485|NCT04676867|75862730|FG002|NOT COMPLETED|Overall Study||11||
59743486|NCT04676867|75862731|FG003|NOT COMPLETED|Overall Study||6||
59743487|NCT00770224|75862741|FG000|STARTED|Step 1: Induction||87||
59743488|NCT00770224|75862742|FG001|STARTED|Step 1: Induction||0||
59743489|NCT00770224|75862741|FG000|Eligible and Evaluable|Step 1: Induction||84||
59743490|NCT00770224|75862742|FG001|Eligible and Evaluable|Step 1: Induction||0||
59743491|NCT00770224|75862741|FG000|COMPLETED|Step 1: Induction||73||
59743492|NCT00770224|75862742|FG001|COMPLETED|Step 1: Induction||0||
59743493|NCT00770224|75862741|FG000|NOT COMPLETED|Step 1: Induction||14||
59743494|NCT00770224|75862742|FG001|NOT COMPLETED|Step 1: Induction||0||
59743495|NCT00770224|75862741|FG000|STARTED|Step 2: Maintenance||0||
59743496|NCT00770224|75862742|FG001|STARTED|Step 2: Maintenance||71||
59743497|NCT00770224|75862741|FG000|Eligible and Evaluable|Step 2: Maintenance||0||
59743498|NCT00770224|75862742|FG001|Eligible and Evaluable|Step 2: Maintenance||69||
59743499|NCT00770224|75862741|FG000|COMPLETED|Step 2: Maintenance||0||
59743500|NCT00770224|75862742|FG001|COMPLETED|Step 2: Maintenance||41||
59743501|NCT00770224|75862741|FG000|NOT COMPLETED|Step 2: Maintenance||0||
59743502|NCT00770224|75862742|FG001|NOT COMPLETED|Step 2: Maintenance||30||
59743503|NCT02389465|75862753|FG000|STARTED|Overall Study||30||
59743504|NCT02389465|75862754|FG001|STARTED|Overall Study||20||
59743505|NCT02389465|75862755|FG002|STARTED|Overall Study||29||
59743506|NCT02389465|75862756|FG003|STARTED|Overall Study||16||
59743507|NCT02389465|75862753|FG000|COMPLETED|Overall Study||29||
59743508|NCT02389465|75862754|FG001|COMPLETED|Overall Study||16||
59743509|NCT02389465|75862755|FG002|COMPLETED|Overall Study||24||
59743510|NCT02389465|75862756|FG003|COMPLETED|Overall Study||13||
59743511|NCT02389465|75862753|FG000|NOT COMPLETED|Overall Study||1||
59743512|NCT02389465|75862754|FG001|NOT COMPLETED|Overall Study||4||
59743513|NCT02389465|75862755|FG002|NOT COMPLETED|Overall Study||5||
59743514|NCT02389465|75862756|FG003|NOT COMPLETED|Overall Study||3||
59743515|NCT01057589|75862766|FG000|STARTED|Overall Study||66||
59743516|NCT01057589|75862766|FG000|COMPLETED|Overall Study||0||
59743517|NCT01057589|75862766|FG000|NOT COMPLETED|Overall Study||66||
59743518|NCT01716117|75862772|FG000|STARTED|Overall Study||180||
59743519|NCT01716117|75862773|FG001|STARTED|Overall Study||33||
59743520|NCT01716117|75862772|FG000|Discharge|Overall Study||177||
59743521|NCT01716117|75862773|FG001|Discharge|Overall Study||33||
59743522|NCT01716117|75862772|FG000|1-Month Visit|Overall Study||176||
59743523|NCT01716117|75862773|FG001|1-Month Visit|Overall Study||33||
59743524|NCT01716117|75862772|FG000|6-Month Visit|Overall Study||174||
59743525|NCT01716117|75862773|FG001|6-Month Visit|Overall Study||32||
59743526|NCT01716117|75862772|FG000|COMPLETED|Overall Study||173||
59743527|NCT01716117|75862773|FG001|COMPLETED|Overall Study||31||
59743528|NCT01716117|75862772|FG000|NOT COMPLETED|Overall Study||7||
59743529|NCT01716117|75862773|FG001|NOT COMPLETED|Overall Study||2||
59743530|NCT00579553|75862789|FG000|STARTED|Overall Study||82||
59743531|NCT00579553|75862790|FG001|STARTED|Overall Study||92||
59743532|NCT00579553|75862789|FG000|COMPLETED|Overall Study||66||
59743533|NCT00579553|75862790|FG001|COMPLETED|Overall Study||79||
59743534|NCT00579553|75862789|FG000|NOT COMPLETED|Overall Study||16||
59743535|NCT00579553|75862790|FG001|NOT COMPLETED|Overall Study||13||
59743536|NCT01650831|75862796|FG000|STARTED|Overall Study||113||
59743537|NCT01650831|75862796|FG000|COMPLETED|Overall Study||112||
59743538|NCT01650831|75862796|FG000|NOT COMPLETED|Overall Study||1||
59743539|NCT00581893|75862804|FG000|STARTED|First Intervention (1 Month)||10||
59743540|NCT00581893|75862805|FG001|STARTED|First Intervention (1 Month)||10||
59743541|NCT00581893|75862804|FG000|COMPLETED|First Intervention (1 Month)||10||
59743542|NCT00581893|75862805|FG001|COMPLETED|First Intervention (1 Month)||10||
59743543|NCT00581893|75862804|FG000|NOT COMPLETED|First Intervention (1 Month)||0||
59743544|NCT00581893|75862805|FG001|NOT COMPLETED|First Intervention (1 Month)||0||
59743545|NCT00581893|75862804|FG000|STARTED|Washout (14 Days)||10||
59743546|NCT00581893|75862805|FG001|STARTED|Washout (14 Days)||10||
59743547|NCT00581893|75862804|FG000|COMPLETED|Washout (14 Days)||10||
59743548|NCT00581893|75862805|FG001|COMPLETED|Washout (14 Days)||10||
59743549|NCT00581893|75862804|FG000|NOT COMPLETED|Washout (14 Days)||0||
59743550|NCT00581893|75862805|FG001|NOT COMPLETED|Washout (14 Days)||0||
59743551|NCT00581893|75862804|FG000|STARTED|Second Intervention (1 Month)||10||
59743552|NCT00581893|75862805|FG001|STARTED|Second Intervention (1 Month)||10||
59743553|NCT00581893|75862804|FG000|COMPLETED|Second Intervention (1 Month)||7||
59743554|NCT00581893|75862805|FG001|COMPLETED|Second Intervention (1 Month)||8||
59743555|NCT00581893|75862804|FG000|NOT COMPLETED|Second Intervention (1 Month)||3||
59743556|NCT00581893|75862805|FG001|NOT COMPLETED|Second Intervention (1 Month)||2||
59743557|NCT00770146|75862813|FG000|STARTED|Treatment Period||53||
59743558|NCT00770146|75862814|FG001|STARTED|Treatment Period||105||
59743559|NCT00770146|75862813|FG000|Treated|Treatment Period||52||
59743560|NCT00770146|75862814|FG001|Treated|Treatment Period||105||
59743561|NCT00770146|75862813|FG000|Full Analysis Set|Treatment Period|Treated patients with a valid baseline & post-baseline LDL-C measurement|50||
59743562|NCT00770146|75862814|FG001|Full Analysis Set|Treatment Period|Treated patients with a valid baseline & post-baseline LDL-C measurement|101||
59743563|NCT00770146|75862813|FG000|COMPLETED|Treatment Period||44||
59743564|NCT00770146|75862814|FG001|COMPLETED|Treatment Period||60||
59743565|NCT00770146|75862813|FG000|NOT COMPLETED|Treatment Period||9||
59743566|NCT00770146|75862814|FG001|NOT COMPLETED|Treatment Period||45||
59743567|NCT00770146|75862813|FG000|STARTED|Follow-up Period||53||
59743568|NCT00770146|75862814|FG001|STARTED|Follow-up Period||105||
59743569|NCT00770146|75862813|FG000|COMPLETED|Follow-up Period||42||
59743570|NCT00770146|75862814|FG001|COMPLETED|Follow-up Period||85||
59743571|NCT00770146|75862813|FG000|NOT COMPLETED|Follow-up Period||11||
59743572|NCT00770146|75862814|FG001|NOT COMPLETED|Follow-up Period||20||
59743573|NCT01056341|75862825|FG000|STARTED|Overall Study||55||
59743574|NCT01056341|75862826|FG001|STARTED|Overall Study||99||
59743575|NCT01056341|75862827|FG002|STARTED|Overall Study||103||
59743576|NCT01056341|75862828|FG003|STARTED|Overall Study||101||
59743577|NCT01056341|75862829|FG004|STARTED|Overall Study||102||
59743578|NCT01056341|75862825|FG000|Interim Analysis|Overall Study||25||
59743579|NCT01056341|75862826|FG001|Interim Analysis|Overall Study||41||
59743580|NCT01056341|75862827|FG002|Interim Analysis|Overall Study||41||
59743581|NCT01056341|75862828|FG003|Interim Analysis|Overall Study||40||
59743582|NCT01056341|75862829|FG004|Interim Analysis|Overall Study||43||
59743583|NCT01056341|75862825|FG000|COMPLETED|Overall Study||19||
59743584|NCT01056341|75862826|FG001|COMPLETED|Overall Study||63||
59743585|NCT01056341|75862827|FG002|COMPLETED|Overall Study||88||
59743586|NCT01056341|75862828|FG003|COMPLETED|Overall Study||65||
59743587|NCT01056341|75862829|FG004|COMPLETED|Overall Study||88||
59743588|NCT01056341|75862825|FG000|NOT COMPLETED|Overall Study||36||
59743589|NCT01056341|75862826|FG001|NOT COMPLETED|Overall Study||36||
59743590|NCT01056341|75862827|FG002|NOT COMPLETED|Overall Study||15||
59743591|NCT01056341|75862828|FG003|NOT COMPLETED|Overall Study||36||
59743592|NCT01056341|75862829|FG004|NOT COMPLETED|Overall Study||14||
59743593|NCT00999518|75862852|FG000|STARTED|Overall Study||43||
59743594|NCT00999518|75862853|FG001|STARTED|Overall Study||42||
59743595|NCT00999518|75862854|FG002|STARTED|Overall Study||39||
59743596|NCT00999518|75862855|FG003|STARTED|Overall Study||40||
59743597|NCT00999518|75862856|FG004|STARTED|Overall Study||41||
59743598|NCT00999518|75862852|FG000|Treated|Overall Study||42||
59743599|NCT00999518|75862853|FG001|Treated|Overall Study||41||
59743600|NCT00999518|75862854|FG002|Treated|Overall Study||37||
59743601|NCT00999518|75862855|FG003|Treated|Overall Study||40||
59743602|NCT00999518|75862856|FG004|Treated|Overall Study||40||
59743603|NCT00999518|75862852|FG000|COMPLETED|Overall Study||19||
59743604|NCT00999518|75862853|FG001|COMPLETED|Overall Study||17||
59743605|NCT00999518|75862854|FG002|COMPLETED|Overall Study||17||
59743606|NCT00999518|75862855|FG003|COMPLETED|Overall Study||18||
59743607|NCT00999518|75862856|FG004|COMPLETED|Overall Study||17||
59743608|NCT00999518|75862852|FG000|NOT COMPLETED|Overall Study||24||
59743609|NCT00999518|75862853|FG001|NOT COMPLETED|Overall Study||25||
59743610|NCT00999518|75862854|FG002|NOT COMPLETED|Overall Study||22||
59743611|NCT00999518|75862855|FG003|NOT COMPLETED|Overall Study||22||
59743612|NCT00999518|75862856|FG004|NOT COMPLETED|Overall Study||24||
59743613|NCT01056263|75862872|FG000|STARTED|Overall Study||52||
59743614|NCT01056263|75862872|FG000|COMPLETED|Overall Study||0||
59743615|NCT01056263|75862872|FG000|NOT COMPLETED|Overall Study||52||
59743616|NCT01056107|75862880|FG000|STARTED|Overall Study||11||
59743617|NCT01056107|75862881|FG001|STARTED|Overall Study||11||
59743618|NCT01056107|75862882|FG002|STARTED|Overall Study||12||
60002374|NCT02701985|76118230|FG001|NOT COMPLETED|Overall Study||6||
59743619|NCT01056107|75862883|FG003|STARTED|Overall Study||12||
59743620|NCT01056107|75862880|FG000|COMPLETED|Overall Study||11||
59743621|NCT01056107|75862881|FG001|COMPLETED|Overall Study||10||
59743622|NCT01056107|75862882|FG002|COMPLETED|Overall Study||9||
59743623|NCT01056107|75862883|FG003|COMPLETED|Overall Study||12||
59743624|NCT01056107|75862880|FG000|NOT COMPLETED|Overall Study||0||
59743625|NCT01056107|75862881|FG001|NOT COMPLETED|Overall Study||1||
59743626|NCT01056107|75862882|FG002|NOT COMPLETED|Overall Study||3||
59743627|NCT01056107|75862883|FG003|NOT COMPLETED|Overall Study||0||
59743628|NCT01003886|75862893|FG000|STARTED|Overall Study||989||
59743629|NCT01003886|75862893|FG000|COMPLETED|Overall Study||759||
59743630|NCT01003886|75862893|FG000|NOT COMPLETED|Overall Study||230||
59743631|NCT01003184|75862899|FG000|STARTED|Overall Study||111||
59743632|NCT01003184|75862900|FG001|STARTED|Overall Study||111||
59743633|NCT01003184|75862899|FG000|Full Analysis Set (FAS)|Overall Study||111||
59743634|NCT01003184|75862900|FG001|Full Analysis Set (FAS)|Overall Study||105||
60067699|NCT01788423|76182877|FG000|COMPLETED|Overall Study||53||
59743635|NCT01003184|75862899|FG000|COMPLETED|Overall Study||92||
59743636|NCT01003184|75862900|FG001|COMPLETED|Overall Study||99||
59743637|NCT01003184|75862899|FG000|NOT COMPLETED|Overall Study||19||
59743638|NCT01003184|75862900|FG001|NOT COMPLETED|Overall Study||12||
59743639|NCT01029353|75862910|FG000|STARTED|Overall Study||148|Five infants in the preference cohort never received a Lap or Drain. These five infants are excluded from the summarization and analysis of preference cohort data.|
59743640|NCT01029353|75862911|FG001|STARTED|Overall Study||162|Five infants in the preference cohort never received a Lap or Drain. These five infants are excluded from the summarization and analysis of preference cohort data.|
59743641|NCT01029353|75862912|FG002|STARTED|Overall Study||100|Five infants in the preference cohort never received a Lap or Drain. These five infants are excluded from the summarization and analysis of preference cohort data.|
59743642|NCT01029353|75862913|FG003|STARTED|Overall Study||119|Five infants in the preference cohort never received a Lap or Drain. These five infants are excluded from the summarization and analysis of preference cohort data.|
59743643|NCT01029353|75862910|FG000|Included in ITT Analysis|Overall Study||146||
59743644|NCT01029353|75862911|FG001|Included in ITT Analysis|Overall Study||162||
59743645|NCT01029353|75862912|FG002|Included in ITT Analysis|Overall Study||100||
59743646|NCT01029353|75862913|FG003|Included in ITT Analysis|Overall Study||119||
59743647|NCT01029353|75862910|FG000|Reached Network Status|Overall Study||146||
59743648|NCT01029353|75862911|FG001|Reached Network Status|Overall Study||162||
59743649|NCT01029353|75862912|FG002|Reached Network Status|Overall Study||100||
59743650|NCT01029353|75862913|FG003|Reached Network Status|Overall Study||119||
59743651|NCT01029353|75862910|FG000|COMPLETED|Overall Study||141|Primary Outcome Observed|
59743652|NCT01029353|75862911|FG001|COMPLETED|Overall Study||154|Primary Outcome Observed|
59743653|NCT01029353|75862912|FG002|COMPLETED|Overall Study||93|Primary Outcome Observed|
59743654|NCT01029353|75862913|FG003|COMPLETED|Overall Study||115|Primary Outcome Observed|
59743655|NCT01029353|75862910|FG000|NOT COMPLETED|Overall Study||7||
59743656|NCT01029353|75862911|FG001|NOT COMPLETED|Overall Study||8||
59743657|NCT01029353|75862912|FG002|NOT COMPLETED|Overall Study||7||
59743658|NCT01029353|75862913|FG003|NOT COMPLETED|Overall Study||4||
59743659|NCT01008410|75862925|FG000|STARTED|Overall Study||133||
59743660|NCT01008410|75862926|FG001|STARTED|Overall Study||132||
59743661|NCT01008410|75862925|FG000|Received at Least 1 Dose of Study Drug|Overall Study||133||
59743662|NCT01008410|75862926|FG001|Received at Least 1 Dose of Study Drug|Overall Study||132||
59743663|NCT01008410|75862925|FG000|COMPLETED|Overall Study||108||
59743664|NCT01008410|75862926|FG001|COMPLETED|Overall Study||116||
59743665|NCT01008410|75862925|FG000|NOT COMPLETED|Overall Study||25||
59743666|NCT01008410|75862926|FG001|NOT COMPLETED|Overall Study||16||
59743667|NCT01023269|75862932|FG000|STARTED|Overall Study||3||
59743668|NCT01023269|75862933|FG001|STARTED|Overall Study||2||
59743669|NCT01023269|75862932|FG000|COMPLETED|Overall Study||1||
59743670|NCT01023269|75862933|FG001|COMPLETED|Overall Study||2||
59743671|NCT01023269|75862932|FG000|NOT COMPLETED|Overall Study||2||
59743672|NCT01023269|75862933|FG001|NOT COMPLETED|Overall Study||0||
59743673|NCT02347917|75862939|FG000|STARTED|Overall Study||4||
59743674|NCT02347917|75862940|FG001|STARTED|Overall Study||24||
59743675|NCT02347917|75862939|FG000|Discontinued beforeBBI608 Administration|Overall Study||0||
59743676|NCT02347917|75862940|FG001|Discontinued beforeBBI608 Administration|Overall Study||0||
59743677|NCT02347917|75862939|FG000|Start BBI608 Administration|Overall Study||4||
59743678|NCT02347917|75862940|FG001|Start BBI608 Administration|Overall Study||24||
59743679|NCT02347917|75862939|FG000|Discontinued in DLT Evaluation Period|Overall Study||1|DLT was assessed in Phase 1 part only.|
59743680|NCT02347917|75862940|FG001|Discontinued in DLT Evaluation Period|Overall Study||0|DLT was assessed in Phase 1 part only.|
59743681|NCT02347917|75862939|FG000|Complete DLT Evaluation Period|Overall Study||3|DLT was assessed in Phase 1 part only.|
59743682|NCT02347917|75862940|FG001|Complete DLT Evaluation Period|Overall Study||0|DLT was assessed in Phase 1 part only.|
59743683|NCT02347917|75862939|FG000|Discontinued After BBI608 Administration|Overall Study||4||
59743684|NCT02347917|75862940|FG001|Discontinued After BBI608 Administration|Overall Study||24||
59743685|NCT02347917|75862939|FG000|Discontinued Before Survival Observation|Overall Study||0||
59743686|NCT02347917|75862940|FG001|Discontinued Before Survival Observation|Overall Study||1||
59743687|NCT02347917|75862939|FG000|COMPLETED|Overall Study||4|Complete survival observation|
59743688|NCT02347917|75862940|FG001|COMPLETED|Overall Study||23|Complete survival observation|
59743689|NCT02347917|75862939|FG000|NOT COMPLETED|Overall Study||0||
59743690|NCT02347917|75862940|FG001|NOT COMPLETED|Overall Study||1||
59743691|NCT01972035|75862956|FG000|STARTED|Overall Study||66||
59743692|NCT01972035|75862957|FG001|STARTED|Overall Study||71||
59743693|NCT01972035|75862956|FG000|COMPLETED|Overall Study||27||
59743694|NCT01972035|75862957|FG001|COMPLETED|Overall Study||44||
59743695|NCT01972035|75862956|FG000|NOT COMPLETED|Overall Study||39||
59743696|NCT01972035|75862957|FG001|NOT COMPLETED|Overall Study||27||
59743697|NCT01007942|75862965|FG000|STARTED|Overall Study||284||
59743698|NCT01007942|75862966|FG001|STARTED|Overall Study||285||
59762493|NCT02644525|75882210|FG001|NOT COMPLETED|Group 3||0||
59951253|NCT03743415|76070184|FG009|COMPLETED|Overall Study||0||
59743699|NCT01007942|75862965|FG000|COMPLETED|Overall Study|Pts completed= on treatment at time of DCO. Not Completed = ended treatment as per protocol.|3||
59743700|NCT01007942|75862966|FG001|COMPLETED|Overall Study|Pts completed= on treatment at time of DCO. Not Completed = ended treatment as per protocol.|7||
59743701|NCT01007942|75862965|FG000|NOT COMPLETED|Overall Study||281||
59743702|NCT01007942|75862966|FG001|NOT COMPLETED|Overall Study||278||
59743703|NCT01023035|75862979|FG000|STARTED|Treatment Period||249||
59743704|NCT01023035|75862980|FG001|STARTED|Treatment Period||251||
59743705|NCT01023035|75862981|FG002|STARTED|Treatment Period||187||
59743706|NCT01023035|75862979|FG000|COMPLETED|Treatment Period||177||
59743707|NCT01023035|75862980|FG001|COMPLETED|Treatment Period||166||
59743708|NCT01023035|75862981|FG002|COMPLETED|Treatment Period||69||
59743709|NCT01023035|75862979|FG000|NOT COMPLETED|Treatment Period||72||
59743710|NCT01023035|75862980|FG001|NOT COMPLETED|Treatment Period||85||
59743711|NCT01023035|75862981|FG002|NOT COMPLETED|Treatment Period||118||
59743712|NCT01023035|75862979|FG000|STARTED|Follow-up Period (up to Week 72)||238||
59743713|NCT01023035|75862980|FG001|STARTED|Follow-up Period (up to Week 72)||235||
59743714|NCT01023035|75862981|FG002|STARTED|Follow-up Period (up to Week 72)||147||
59743715|NCT01023035|75862979|FG000|COMPLETED|Follow-up Period (up to Week 72)||210||
59743716|NCT01023035|75862980|FG001|COMPLETED|Follow-up Period (up to Week 72)||207||
59743717|NCT01023035|75862981|FG002|COMPLETED|Follow-up Period (up to Week 72)||108||
59743718|NCT01023035|75862979|FG000|NOT COMPLETED|Follow-up Period (up to Week 72)||28||
59743719|NCT01023035|75862980|FG001|NOT COMPLETED|Follow-up Period (up to Week 72)||28||
59743720|NCT01023035|75862981|FG002|NOT COMPLETED|Follow-up Period (up to Week 72)||39||
59743721|NCT01028651|75862991|FG000|STARTED|Overall Study||13||
59743722|NCT01028651|75862991|FG000|COMPLETED|Overall Study||10||
59743723|NCT01028651|75862991|FG000|NOT COMPLETED|Overall Study||3||
59743724|NCT01028027|75862999|FG000|STARTED|Overall Study||180||
59743725|NCT01028027|75863000|FG001|STARTED|Overall Study||177||
59743726|NCT01028027|75862999|FG000|COMPLETED|Overall Study||164||
59743727|NCT01028027|75863000|FG001|COMPLETED|Overall Study||164||
59743728|NCT01028027|75862999|FG000|NOT COMPLETED|Overall Study||16||
59743729|NCT01028027|75863000|FG001|NOT COMPLETED|Overall Study||13||
59743730|NCT01007552|75863006|FG000|STARTED|Overall Study||50||
59743731|NCT01007552|75863006|FG000|COMPLETED|Overall Study||49||
59743732|NCT01007552|75863006|FG000|NOT COMPLETED|Overall Study||1||
59743733|NCT01007396|75863010|FG000|STARTED|Overall Study||322||
59743734|NCT01007396|75863010|FG000|COMPLETED|Overall Study||275||
59743735|NCT01007396|75863010|FG000|NOT COMPLETED|Overall Study||47||
59743736|NCT00998738|75863014|FG000|STARTED|Overall Study||1||
59743737|NCT00998738|75863014|FG000|COMPLETED|Overall Study||0||
59743738|NCT00998738|75863014|FG000|NOT COMPLETED|Overall Study||1||
59743739|NCT00997334|75863018|FG000|STARTED|Overall Study||60||
59743740|NCT00997334|75863018|FG000|Eligible for Repeat Biopsy|Overall Study|Patients who experience disease progression on treatment were eligible for repeat biopsy|44||
59743741|NCT00997334|75863018|FG000|Evaluable|Overall Study|Patients with tissue available for re-biopsy at time of progression|35||
59743742|NCT00997334|75863018|FG000|COMPLETED|Overall Study||35||
59743743|NCT00997334|75863018|FG000|NOT COMPLETED|Overall Study||25||
59743744|NCT00996944|75863024|FG000|STARTED|Double-blind Treatment Period||22||
59743745|NCT00996944|75863025|FG001|STARTED|Double-blind Treatment Period||12||
59743746|NCT00996944|75863024|FG000|COMPLETED|Double-blind Treatment Period||12||
59743747|NCT00996944|75863025|FG001|COMPLETED|Double-blind Treatment Period||5||
59743748|NCT00996944|75863024|FG000|NOT COMPLETED|Double-blind Treatment Period||10||
59743749|NCT00996944|75863025|FG001|NOT COMPLETED|Double-blind Treatment Period||7||
59743750|NCT00996944|75863024|FG000|STARTED|Long-term Treatment Period||12||
59743751|NCT00996944|75863025|FG001|STARTED|Long-term Treatment Period||5||
59743752|NCT00996944|75863024|FG000|COMPLETED|Long-term Treatment Period||0||
59743753|NCT00996944|75863025|FG001|COMPLETED|Long-term Treatment Period||0||
59743754|NCT00996944|75863024|FG000|NOT COMPLETED|Long-term Treatment Period||12||
59743755|NCT00996944|75863025|FG001|NOT COMPLETED|Long-term Treatment Period||5||
59743756|NCT01002482|75863035|FG000|STARTED|Overall Study||1351||
59743757|NCT01002482|75863036|FG001|STARTED|Overall Study||1333||
59743758|NCT01002482|75863035|FG000|COMPLETED|Overall Study||1336||
59743759|NCT01002482|75863036|FG001|COMPLETED|Overall Study||1312||
59743760|NCT01002482|75863035|FG000|NOT COMPLETED|Overall Study||15||
59743761|NCT01002482|75863036|FG001|NOT COMPLETED|Overall Study||21||
59743762|NCT01027949|75863042|FG000|STARTED|Overall Study||894||
59743763|NCT01027949|75863042|FG000|COMPLETED|Overall Study||208||
59743764|NCT01027949|75863042|FG000|NOT COMPLETED|Overall Study||686||
59743765|NCT01038323|75863049|FG000|STARTED|Overall Study||20||
59743766|NCT01038323|75863050|FG001|STARTED|Overall Study||19||
59743767|NCT01038323|75863051|FG002|STARTED|Overall Study||19||
59743768|NCT01038323|75863049|FG000|COMPLETED|Overall Study||17||
59743769|NCT01038323|75863050|FG001|COMPLETED|Overall Study||17||
59743770|NCT01038323|75863051|FG002|COMPLETED|Overall Study||15||
59743771|NCT01038323|75863049|FG000|NOT COMPLETED|Overall Study||3||
59743772|NCT01038323|75863050|FG001|NOT COMPLETED|Overall Study||2||
59743773|NCT01038323|75863051|FG002|NOT COMPLETED|Overall Study||4||
59743774|NCT01027871|75863062|FG000|STARTED|Overall Study||93||
59743775|NCT01027871|75863063|FG001|STARTED|Overall Study||98||
59743776|NCT01027871|75863064|FG002|STARTED|Overall Study||98||
59743777|NCT01027871|75863062|FG000|Received at Least One Dose of Study Drug|Overall Study||93||
59743778|NCT01027871|75863063|FG001|Received at Least One Dose of Study Drug|Overall Study||98||
59743779|NCT01027871|75863064|FG002|Received at Least One Dose of Study Drug|Overall Study||97||
59743780|NCT01027871|75863062|FG000|COMPLETED|Overall Study||91||
59743781|NCT01027871|75863063|FG001|COMPLETED|Overall Study||85||
59743782|NCT01027871|75863064|FG002|COMPLETED|Overall Study||91||
59743783|NCT01027871|75863062|FG000|NOT COMPLETED|Overall Study||2||
59743784|NCT01027871|75863063|FG001|NOT COMPLETED|Overall Study||13||
59743785|NCT01027871|75863064|FG002|NOT COMPLETED|Overall Study||7||
59743786|NCT01021553|75863080|FG000|STARTED|Overall Study||27||
59743787|NCT01021553|75863081|FG001|STARTED|Overall Study||22||
59743788|NCT01021553|75863082|FG002|STARTED|Overall Study||28||
59743789|NCT01021553|75863080|FG000|COMPLETED|Overall Study||23||
59743790|NCT01021553|75863081|FG001|COMPLETED|Overall Study||17||
59743791|NCT01021553|75863082|FG002|COMPLETED|Overall Study||25||
59743792|NCT01021553|75863080|FG000|NOT COMPLETED|Overall Study||4||
59743793|NCT01021553|75863081|FG001|NOT COMPLETED|Overall Study||5||
59743794|NCT01021553|75863082|FG002|NOT COMPLETED|Overall Study||3||
59743795|NCT01026389|75863097|FG000|STARTED|Overall Study||93||
59743796|NCT01026389|75863098|FG001|STARTED|Overall Study||93||
59743797|NCT01026389|75863097|FG000|COMPLETED|Overall Study||88||
59743798|NCT01026389|75863098|FG001|COMPLETED|Overall Study||88||
60135054|NCT03307252|76258163|FG010|STARTED|Part 2, Washout Period 1 (7 Days)||0||
59743799|NCT01026389|75863097|FG000|NOT COMPLETED|Overall Study||5||
59743800|NCT01026389|75863098|FG001|NOT COMPLETED|Overall Study||5||
59743801|NCT01006616|75863108|FG000|STARTED|Period 1 (6 Months)||152||
59743802|NCT01006616|75863109|FG001|STARTED|Period 1 (6 Months)||156||
59743803|NCT01006616|75863110|FG002|STARTED|Period 1 (6 Months)||153||
59743804|NCT01006616|75863111|FG003|STARTED|Period 1 (6 Months)||155||
59743805|NCT01006616|75863108|FG000|Treated|Period 1 (6 Months)||152||
59743806|NCT01006616|75863109|FG001|Treated|Period 1 (6 Months)||156||
59743807|NCT01006616|75863110|FG002|Treated|Period 1 (6 Months)||152||
59743808|NCT01006616|75863111|FG003|Treated|Period 1 (6 Months)||154||
59743809|NCT01006616|75863108|FG000|COMPLETED|Period 1 (6 Months)||126||
59743810|NCT01006616|75863109|FG001|COMPLETED|Period 1 (6 Months)||102||
59743811|NCT01006616|75863110|FG002|COMPLETED|Period 1 (6 Months)||102||
59743812|NCT01006616|75863111|FG003|COMPLETED|Period 1 (6 Months)||128||
59743813|NCT01006616|75863108|FG000|NOT COMPLETED|Period 1 (6 Months)||26||
59743814|NCT01006616|75863109|FG001|NOT COMPLETED|Period 1 (6 Months)||54||
59743815|NCT01006616|75863110|FG002|NOT COMPLETED|Period 1 (6 Months)||51||
59743816|NCT01006616|75863111|FG003|NOT COMPLETED|Period 1 (6 Months)||27||
59743817|NCT01006616|75863108|FG000|STARTED|Period 2 (18 Months)|Period 2 was optional. Not all participants completing Period 1 continued into Period 2.|75||
59743818|NCT01006616|75863109|FG001|STARTED|Period 2 (18 Months)|Period 2 was optional. Not all participants completing Period 1 continued into Period 2.|63||
59743819|NCT01006616|75863110|FG002|STARTED|Period 2 (18 Months)|Period 2 was optional. Not all participants completing Period 1 continued into Period 2.|55||
59743820|NCT01006616|75863111|FG003|STARTED|Period 2 (18 Months)|Period 2 was optional. Not all participants completing Period 1 continued into Period 2.|82||
59743821|NCT01006616|75863108|FG000|Treated|Period 2 (18 Months)||75||
59743822|NCT01006616|75863109|FG001|Treated|Period 2 (18 Months)||63||
59743823|NCT01006616|75863110|FG002|Treated|Period 2 (18 Months)||55||
59743824|NCT01006616|75863111|FG003|Treated|Period 2 (18 Months)||82||
59743825|NCT01006616|75863108|FG000|COMPLETED|Period 2 (18 Months)||0||
59743826|NCT01006616|75863109|FG001|COMPLETED|Period 2 (18 Months)||0||
59743827|NCT01006616|75863110|FG002|COMPLETED|Period 2 (18 Months)||0||
59743828|NCT01006616|75863111|FG003|COMPLETED|Period 2 (18 Months)||0||
59743829|NCT01006616|75863108|FG000|NOT COMPLETED|Period 2 (18 Months)||75||
59743830|NCT01006616|75863109|FG001|NOT COMPLETED|Period 2 (18 Months)||63||
59743831|NCT01006616|75863110|FG002|NOT COMPLETED|Period 2 (18 Months)||55||
59743832|NCT01006616|75863111|FG003|NOT COMPLETED|Period 2 (18 Months)||82||
59743833|NCT00996632|75863123|FG000|STARTED|Overall Study||38||
59743834|NCT00996632|75863124|FG001|STARTED|Overall Study||56||
59743835|NCT00996632|75863123|FG000|COMPLETED|Overall Study||38||
59743836|NCT00996632|75863124|FG001|COMPLETED|Overall Study||56||
59743837|NCT00996632|75863123|FG000|NOT COMPLETED|Overall Study||0||
59743838|NCT00996632|75863124|FG001|NOT COMPLETED|Overall Study||0||
59743839|NCT01025843|75863140|FG000|STARTED|Period 1||2||
59743840|NCT01025843|75863141|FG001|STARTED|Period 1||2||
59743841|NCT01025843|75863142|FG002|STARTED|Period 1||2||
59743842|NCT01025843|75863143|FG003|STARTED|Period 1||2||
59743843|NCT01025843|75863144|FG004|STARTED|Period 1||2||
59743844|NCT01025843|75863145|FG005|STARTED|Period 1||2||
59743845|NCT01025843|75863146|FG006|STARTED|Period 1||2||
59743846|NCT01025843|75863147|FG007|STARTED|Period 1||2||
59743847|NCT01025843|75863148|FG008|STARTED|Period 1||2||
59743848|NCT01025843|75863149|FG009|STARTED|Period 1||2||
59743849|NCT01025843|75863140|FG000|COMPLETED|Period 1||2||
59743850|NCT01025843|75863141|FG001|COMPLETED|Period 1||2||
59743851|NCT01025843|75863142|FG002|COMPLETED|Period 1||2||
59743852|NCT01025843|75863143|FG003|COMPLETED|Period 1||2||
59743853|NCT01025843|75863144|FG004|COMPLETED|Period 1||2||
59743854|NCT01025843|75863145|FG005|COMPLETED|Period 1||2||
60135055|NCT03307252|76258153|FG000|COMPLETED|Part 2, Washout Period 1 (7 Days)||0||
59743855|NCT01025843|75863146|FG006|COMPLETED|Period 1||2||
59743856|NCT01025843|75863147|FG007|COMPLETED|Period 1||2||
59743857|NCT01025843|75863148|FG008|COMPLETED|Period 1||2||
59743858|NCT01025843|75863149|FG009|COMPLETED|Period 1||2||
59743859|NCT01025843|75863140|FG000|NOT COMPLETED|Period 1||0||
59743860|NCT01025843|75863141|FG001|NOT COMPLETED|Period 1||0||
59743861|NCT01025843|75863142|FG002|NOT COMPLETED|Period 1||0||
59743862|NCT01025843|75863143|FG003|NOT COMPLETED|Period 1||0||
59743863|NCT01025843|75863144|FG004|NOT COMPLETED|Period 1||0||
59743864|NCT01025843|75863145|FG005|NOT COMPLETED|Period 1||0||
59743865|NCT01025843|75863146|FG006|NOT COMPLETED|Period 1||0||
59743866|NCT01025843|75863147|FG007|NOT COMPLETED|Period 1||0||
59743867|NCT01025843|75863148|FG008|NOT COMPLETED|Period 1||0||
59743868|NCT01025843|75863149|FG009|NOT COMPLETED|Period 1||0||
59743869|NCT01025843|75863140|FG000|STARTED|Washout 1||2||
59743870|NCT01025843|75863141|FG001|STARTED|Washout 1||2||
59743871|NCT01025843|75863142|FG002|STARTED|Washout 1||2||
59743872|NCT01025843|75863143|FG003|STARTED|Washout 1||2||
59743873|NCT01025843|75863144|FG004|STARTED|Washout 1||2||
59604507|NCT02058966|75714784|FG000|Received Placebo-Placebo|Second Intervention||2||
59604508|NCT02058966|75714784|FG000|Received Placebo-Meth|Second Intervention||2||
59743874|NCT01025843|75863145|FG005|STARTED|Washout 1||2||
59743875|NCT01025843|75863146|FG006|STARTED|Washout 1||2||
59743876|NCT01025843|75863147|FG007|STARTED|Washout 1||2||
59743877|NCT01025843|75863148|FG008|STARTED|Washout 1||2||
59743878|NCT01025843|75863149|FG009|STARTED|Washout 1||2||
59743879|NCT01025843|75863140|FG000|COMPLETED|Washout 1||2||
59743880|NCT01025843|75863141|FG001|COMPLETED|Washout 1||2||
59743881|NCT01025843|75863142|FG002|COMPLETED|Washout 1||2||
59743882|NCT01025843|75863143|FG003|COMPLETED|Washout 1||2||
59743883|NCT01025843|75863144|FG004|COMPLETED|Washout 1||2||
59743884|NCT01025843|75863145|FG005|COMPLETED|Washout 1||2||
59743885|NCT01025843|75863146|FG006|COMPLETED|Washout 1||2||
59743886|NCT01025843|75863147|FG007|COMPLETED|Washout 1||2||
59604509|NCT02058966|75714784|FG000|Received Entacapone-Placebo|Second Intervention||6||
59604510|NCT02058966|75714784|FG000|Received Entacapone-Meth|Second Intervention||3||
59604511|NCT02058966|75714784|FG000|COMPLETED|Second Intervention||13||
59604512|NCT02058966|75714784|FG000|NOT COMPLETED|Second Intervention||0||
59604513|NCT02058966|75714784|FG000|STARTED|Third Intervention||12|1 subjects dropped out between Second and Third Intervention.|
59604514|NCT02058966|75714784|FG000|Received Placebo-Placebo|Third Intervention||4||
59604515|NCT02058966|75714784|FG000|Received Placebo-Meth|Third Intervention||4||
59604516|NCT02058966|75714784|FG000|Received Entacapone-Placebo|Third Intervention||1||
59604517|NCT02058966|75714784|FG000|Received Entacapone-Meth|Third Intervention||3||
59604518|NCT02058966|75714784|FG000|COMPLETED|Third Intervention||12||
59604519|NCT02058966|75714784|FG000|NOT COMPLETED|Third Intervention||0||
59604520|NCT02058966|75714784|FG000|STARTED|Fourth Intervention||12||
59604521|NCT02058966|75714784|FG000|Received Placebo-Placebo|Fourth Intervention||4||
59604522|NCT02058966|75714784|FG000|Received Placebo-Meth|Fourth Intervention||3||
59604523|NCT02058966|75714784|FG000|Received Entacapone-Placebo|Fourth Intervention||3||
59604524|NCT02058966|75714784|FG000|Received Entacapone-Meth|Fourth Intervention||2||
59604525|NCT02058966|75714784|FG000|COMPLETED|Fourth Intervention||12||
59604526|NCT02058966|75714784|FG000|NOT COMPLETED|Fourth Intervention||0||
59604527|NCT02017860|75714796|FG000|STARTED|Overall Study||4||
59604528|NCT02017860|75714796|FG000|COMPLETED|Overall Study||2||
59604529|NCT02017860|75714796|FG000|NOT COMPLETED|Overall Study||2||
59604530|NCT02040870|75714800|FG000|STARTED|Overall Study||103|Treatment Phase|
59604531|NCT02040870|75714800|FG000|Entered Post-treatment Follow-up|Overall Study||2||
59604532|NCT02040870|75714800|FG000|Entered Survival Follow-up|Overall Study||75||
59604533|NCT02040870|75714800|FG000|Discontinue From Study|Overall Study||26||
59604534|NCT02040870|75714800|FG000|COMPLETED|Overall Study||0||
59604535|NCT02040870|75714800|FG000|NOT COMPLETED|Overall Study||103||
59604536|NCT02016690|75714804|FG000|STARTED|Overall Study||312||
59604537|NCT02016690|75714804|FG000|Treated|Overall Study||312||
59604538|NCT02016690|75714804|FG000|Safety Analysis Set (SAS)|Overall Study||304||
59743887|NCT01025843|75863148|FG008|COMPLETED|Washout 1||2||
59743888|NCT01025843|75863149|FG009|COMPLETED|Washout 1||2||
59743889|NCT01025843|75863140|FG000|NOT COMPLETED|Washout 1||0||
59613463|NCT01603602|75724597|FG001|NOT COMPLETED|Overall Study||0||
59613464|NCT01603602|75724598|FG002|NOT COMPLETED|Overall Study||1||
59613465|NCT01684878|75724610|FG000|STARTED|Part 1: Safety Run in Phase||22||
59613466|NCT01684878|75724611|FG001|STARTED|Part 1: Safety Run in Phase||28||
59613467|NCT01684878|75724612|FG002|STARTED|Part 1: Safety Run in Phase||0||
59613468|NCT01684878|75724613|FG003|STARTED|Part 1: Safety Run in Phase||0||
59613469|NCT01684878|75724610|FG000|COMPLETED|Part 1: Safety Run in Phase||6||
59613470|NCT01684878|75724611|FG001|COMPLETED|Part 1: Safety Run in Phase||5||
59613471|NCT01684878|75724612|FG002|COMPLETED|Part 1: Safety Run in Phase||0||
59613472|NCT01684878|75724613|FG003|COMPLETED|Part 1: Safety Run in Phase||0||
59613473|NCT01684878|75724610|FG000|NOT COMPLETED|Part 1: Safety Run in Phase||16||
59613474|NCT01684878|75724611|FG001|NOT COMPLETED|Part 1: Safety Run in Phase||23||
59613475|NCT01684878|75724612|FG002|NOT COMPLETED|Part 1: Safety Run in Phase||0||
59613476|NCT01684878|75724613|FG003|NOT COMPLETED|Part 1: Safety Run in Phase||0||
59743890|NCT01025843|75863141|FG001|NOT COMPLETED|Washout 1||0||
59743891|NCT01025843|75863142|FG002|NOT COMPLETED|Washout 1||0||
59743892|NCT01025843|75863143|FG003|NOT COMPLETED|Washout 1||0||
59743893|NCT01025843|75863144|FG004|NOT COMPLETED|Washout 1||0||
59743894|NCT01025843|75863145|FG005|NOT COMPLETED|Washout 1||0||
59743895|NCT01025843|75863146|FG006|NOT COMPLETED|Washout 1||0||
59743896|NCT01025843|75863147|FG007|NOT COMPLETED|Washout 1||0||
59743897|NCT01025843|75863148|FG008|NOT COMPLETED|Washout 1||0||
59743898|NCT01025843|75863149|FG009|NOT COMPLETED|Washout 1||0||
59743899|NCT01025843|75863140|FG000|STARTED|Period 2||2||
59743900|NCT01025843|75863141|FG001|STARTED|Period 2||2||
59743901|NCT01025843|75863142|FG002|STARTED|Period 2||2||
59743902|NCT01025843|75863143|FG003|STARTED|Period 2||2||
59743903|NCT01025843|75863144|FG004|STARTED|Period 2||2||
59743904|NCT01025843|75863145|FG005|STARTED|Period 2||2||
59743905|NCT01025843|75863146|FG006|STARTED|Period 2||2||
59743906|NCT01025843|75863147|FG007|STARTED|Period 2||2||
59743907|NCT01025843|75863148|FG008|STARTED|Period 2||2||
59743908|NCT01025843|75863149|FG009|STARTED|Period 2||2||
59743909|NCT01025843|75863140|FG000|COMPLETED|Period 2||2||
59743910|NCT01025843|75863141|FG001|COMPLETED|Period 2||2||
59743911|NCT01025843|75863142|FG002|COMPLETED|Period 2||2||
59743912|NCT01025843|75863143|FG003|COMPLETED|Period 2||2||
59743913|NCT01025843|75863144|FG004|COMPLETED|Period 2||2||
59743914|NCT01025843|75863145|FG005|COMPLETED|Period 2||2||
60135056|NCT03307252|76258154|FG001|COMPLETED|Part 2, Washout Period 1 (7 Days)||0||
60135057|NCT03307252|76258155|FG002|COMPLETED|Part 2, Washout Period 1 (7 Days)||0||
60135058|NCT03307252|76258156|FG003|COMPLETED|Part 2, Washout Period 1 (7 Days)||4||
59743915|NCT01025843|75863146|FG006|COMPLETED|Period 2||2||
59743916|NCT01025843|75863147|FG007|COMPLETED|Period 2||2||
59743917|NCT01025843|75863148|FG008|COMPLETED|Period 2||2||
59743918|NCT01025843|75863149|FG009|COMPLETED|Period 2||2||
59743919|NCT01025843|75863140|FG000|NOT COMPLETED|Period 2||0||
59743920|NCT01025843|75863141|FG001|NOT COMPLETED|Period 2||0||
59743921|NCT01025843|75863142|FG002|NOT COMPLETED|Period 2||0||
59743922|NCT01025843|75863143|FG003|NOT COMPLETED|Period 2||0||
59743923|NCT01025843|75863144|FG004|NOT COMPLETED|Period 2||0||
59743924|NCT01025843|75863145|FG005|NOT COMPLETED|Period 2||0||
59743925|NCT01025843|75863146|FG006|NOT COMPLETED|Period 2||0||
59743926|NCT01025843|75863147|FG007|NOT COMPLETED|Period 2||0||
59743927|NCT01025843|75863148|FG008|NOT COMPLETED|Period 2||0||
59743928|NCT01025843|75863149|FG009|NOT COMPLETED|Period 2||0||
59743929|NCT01025843|75863140|FG000|STARTED|Washout 2||2||
59743930|NCT01025843|75863141|FG001|STARTED|Washout 2||2||
59743931|NCT01025843|75863142|FG002|STARTED|Washout 2||2||
59743932|NCT01025843|75863143|FG003|STARTED|Washout 2||2||
59743933|NCT01025843|75863144|FG004|STARTED|Washout 2||2||
59743934|NCT01025843|75863145|FG005|STARTED|Washout 2||2||
59743935|NCT01025843|75863146|FG006|STARTED|Washout 2||2||
59743936|NCT01025843|75863147|FG007|STARTED|Washout 2||2||
59743937|NCT01025843|75863148|FG008|STARTED|Washout 2||2||
59743938|NCT01025843|75863149|FG009|STARTED|Washout 2||2||
59743939|NCT01025843|75863140|FG000|COMPLETED|Washout 2||2||
59743940|NCT01025843|75863141|FG001|COMPLETED|Washout 2||2||
59743941|NCT01025843|75863142|FG002|COMPLETED|Washout 2||2||
59743942|NCT01025843|75863143|FG003|COMPLETED|Washout 2||2||
59743943|NCT01025843|75863144|FG004|COMPLETED|Washout 2||2||
59743944|NCT01025843|75863145|FG005|COMPLETED|Washout 2||2||
59743945|NCT01025843|75863146|FG006|COMPLETED|Washout 2||2||
59743946|NCT01025843|75863147|FG007|COMPLETED|Washout 2||2||
59743947|NCT01025843|75863148|FG008|COMPLETED|Washout 2||2||
59743948|NCT01025843|75863149|FG009|COMPLETED|Washout 2||2||
59743949|NCT01025843|75863140|FG000|NOT COMPLETED|Washout 2||0||
59743950|NCT01025843|75863141|FG001|NOT COMPLETED|Washout 2||0||
59743951|NCT01025843|75863142|FG002|NOT COMPLETED|Washout 2||0||
59743952|NCT01025843|75863143|FG003|NOT COMPLETED|Washout 2||0||
59743953|NCT01025843|75863144|FG004|NOT COMPLETED|Washout 2||0||
59743954|NCT01025843|75863145|FG005|NOT COMPLETED|Washout 2||0||
59743955|NCT01025843|75863146|FG006|NOT COMPLETED|Washout 2||0||
59743956|NCT01025843|75863147|FG007|NOT COMPLETED|Washout 2||0||
59743957|NCT01025843|75863148|FG008|NOT COMPLETED|Washout 2||0||
59743958|NCT01025843|75863149|FG009|NOT COMPLETED|Washout 2||0||
59743959|NCT01025843|75863140|FG000|STARTED|Period 3||2||
59743960|NCT01025843|75863141|FG001|STARTED|Period 3||2||
59743961|NCT01025843|75863142|FG002|STARTED|Period 3||2||
59743962|NCT01025843|75863143|FG003|STARTED|Period 3||2||
59743963|NCT01025843|75863144|FG004|STARTED|Period 3||2||
59743964|NCT01025843|75863145|FG005|STARTED|Period 3||2||
59743965|NCT01025843|75863146|FG006|STARTED|Period 3||2||
59743966|NCT01025843|75863147|FG007|STARTED|Period 3||2||
59743967|NCT01025843|75863148|FG008|STARTED|Period 3||2||
59743968|NCT01025843|75863149|FG009|STARTED|Period 3||2||
59743969|NCT01025843|75863140|FG000|COMPLETED|Period 3||2||
59743970|NCT01025843|75863141|FG001|COMPLETED|Period 3||2||
59743971|NCT01025843|75863142|FG002|COMPLETED|Period 3||2||
59743972|NCT01025843|75863143|FG003|COMPLETED|Period 3||2||
59743973|NCT01025843|75863144|FG004|COMPLETED|Period 3||2||
59743974|NCT01025843|75863145|FG005|COMPLETED|Period 3||2||
60135059|NCT03307252|76258157|FG004|COMPLETED|Part 2, Washout Period 1 (7 Days)||4||
59743975|NCT01025843|75863146|FG006|COMPLETED|Period 3||2||
59743976|NCT01025843|75863147|FG007|COMPLETED|Period 3||2||
59743977|NCT01025843|75863148|FG008|COMPLETED|Period 3||2||
59743978|NCT01025843|75863149|FG009|COMPLETED|Period 3||2||
59743979|NCT01025843|75863140|FG000|NOT COMPLETED|Period 3||0||
59743980|NCT01025843|75863141|FG001|NOT COMPLETED|Period 3||0||
59743981|NCT01025843|75863142|FG002|NOT COMPLETED|Period 3||0||
59743982|NCT01025843|75863143|FG003|NOT COMPLETED|Period 3||0||
59743983|NCT01025843|75863144|FG004|NOT COMPLETED|Period 3||0||
59743984|NCT01025843|75863145|FG005|NOT COMPLETED|Period 3||0||
59743985|NCT01025843|75863146|FG006|NOT COMPLETED|Period 3||0||
59743986|NCT01025843|75863147|FG007|NOT COMPLETED|Period 3||0||
59743987|NCT01025843|75863148|FG008|NOT COMPLETED|Period 3||0||
59743988|NCT01025843|75863149|FG009|NOT COMPLETED|Period 3||0||
59743989|NCT01025843|75863140|FG000|STARTED|Washout 3||2||
59743990|NCT01025843|75863141|FG001|STARTED|Washout 3||2||
59743991|NCT01025843|75863142|FG002|STARTED|Washout 3||2||
59743992|NCT01025843|75863143|FG003|STARTED|Washout 3||2||
59743993|NCT01025843|75863144|FG004|STARTED|Washout 3||2||
59743994|NCT01025843|75863145|FG005|STARTED|Washout 3||2||
59743995|NCT01025843|75863146|FG006|STARTED|Washout 3||2||
59743996|NCT01025843|75863147|FG007|STARTED|Washout 3||2||
59743997|NCT01025843|75863148|FG008|STARTED|Washout 3||2||
59743998|NCT01025843|75863149|FG009|STARTED|Washout 3||2||
59743999|NCT01025843|75863140|FG000|COMPLETED|Washout 3||2||
59744000|NCT01025843|75863141|FG001|COMPLETED|Washout 3||2||
59744001|NCT01025843|75863142|FG002|COMPLETED|Washout 3||2||
59744002|NCT01025843|75863143|FG003|COMPLETED|Washout 3||2||
59744003|NCT01025843|75863144|FG004|COMPLETED|Washout 3||2||
59744004|NCT01025843|75863145|FG005|COMPLETED|Washout 3||2||
59744005|NCT01025843|75863146|FG006|COMPLETED|Washout 3||2||
59744006|NCT01025843|75863147|FG007|COMPLETED|Washout 3||2||
59744007|NCT01025843|75863148|FG008|COMPLETED|Washout 3||2||
59744008|NCT01025843|75863149|FG009|COMPLETED|Washout 3||2||
59744009|NCT01025843|75863140|FG000|NOT COMPLETED|Washout 3||0||
59744010|NCT01025843|75863141|FG001|NOT COMPLETED|Washout 3||0||
59744011|NCT01025843|75863142|FG002|NOT COMPLETED|Washout 3||0||
59744012|NCT01025843|75863143|FG003|NOT COMPLETED|Washout 3||0||
59744013|NCT01025843|75863144|FG004|NOT COMPLETED|Washout 3||0||
59744014|NCT01025843|75863145|FG005|NOT COMPLETED|Washout 3||0||
59744015|NCT01025843|75863146|FG006|NOT COMPLETED|Washout 3||0||
59744016|NCT01025843|75863147|FG007|NOT COMPLETED|Washout 3||0||
59744017|NCT01025843|75863148|FG008|NOT COMPLETED|Washout 3||0||
59744018|NCT01025843|75863149|FG009|NOT COMPLETED|Washout 3||0||
59744019|NCT01025843|75863140|FG000|STARTED|Period 4||2||
59744020|NCT01025843|75863141|FG001|STARTED|Period 4||2||
59744021|NCT01025843|75863142|FG002|STARTED|Period 4||2||
59744022|NCT01025843|75863143|FG003|STARTED|Period 4||2||
59744023|NCT01025843|75863144|FG004|STARTED|Period 4||2||
59744024|NCT01025843|75863145|FG005|STARTED|Period 4||2||
59744025|NCT01025843|75863146|FG006|STARTED|Period 4||2||
59744026|NCT01025843|75863147|FG007|STARTED|Period 4||2||
59744027|NCT01025843|75863148|FG008|STARTED|Period 4||2||
59744028|NCT01025843|75863149|FG009|STARTED|Period 4||2||
59744029|NCT01025843|75863140|FG000|COMPLETED|Period 4||2||
59744030|NCT01025843|75863141|FG001|COMPLETED|Period 4||2||
59744031|NCT01025843|75863142|FG002|COMPLETED|Period 4||2||
59744032|NCT01025843|75863143|FG003|COMPLETED|Period 4||2||
59744033|NCT01025843|75863144|FG004|COMPLETED|Period 4||2||
59744034|NCT01025843|75863145|FG005|COMPLETED|Period 4||2||
59744035|NCT01025843|75863146|FG006|COMPLETED|Period 4||2||
59744036|NCT01025843|75863147|FG007|COMPLETED|Period 4||2||
59744037|NCT01025843|75863148|FG008|COMPLETED|Period 4||2||
59744038|NCT01025843|75863149|FG009|COMPLETED|Period 4||2||
59744039|NCT01025843|75863140|FG000|NOT COMPLETED|Period 4||0||
59744040|NCT01025843|75863141|FG001|NOT COMPLETED|Period 4||0||
59744041|NCT01025843|75863142|FG002|NOT COMPLETED|Period 4||0||
59744042|NCT01025843|75863143|FG003|NOT COMPLETED|Period 4||0||
59744043|NCT01025843|75863144|FG004|NOT COMPLETED|Period 4||0||
59744044|NCT01025843|75863145|FG005|NOT COMPLETED|Period 4||0||
59744045|NCT01025843|75863146|FG006|NOT COMPLETED|Period 4||0||
59744046|NCT01025843|75863147|FG007|NOT COMPLETED|Period 4||0||
59744047|NCT01025843|75863148|FG008|NOT COMPLETED|Period 4||0||
59744048|NCT01025843|75863149|FG009|NOT COMPLETED|Period 4||0||
59744049|NCT01025843|75863140|FG000|STARTED|Washout 4||2||
59744050|NCT01025843|75863141|FG001|STARTED|Washout 4||2||
59744051|NCT01025843|75863142|FG002|STARTED|Washout 4||2||
59744052|NCT01025843|75863143|FG003|STARTED|Washout 4||2||
59744053|NCT01025843|75863144|FG004|STARTED|Washout 4||2||
59744054|NCT01025843|75863145|FG005|STARTED|Washout 4||2||
59744055|NCT01025843|75863146|FG006|STARTED|Washout 4||2||
59744056|NCT01025843|75863147|FG007|STARTED|Washout 4||2||
59744057|NCT01025843|75863148|FG008|STARTED|Washout 4||2||
59744058|NCT01025843|75863149|FG009|STARTED|Washout 4||2||
59744059|NCT01025843|75863140|FG000|COMPLETED|Washout 4||2||
59744060|NCT01025843|75863141|FG001|COMPLETED|Washout 4||2||
59744061|NCT01025843|75863142|FG002|COMPLETED|Washout 4||1||
59744062|NCT01025843|75863143|FG003|COMPLETED|Washout 4||1||
59744063|NCT01025843|75863144|FG004|COMPLETED|Washout 4||2||
59744064|NCT01025843|75863145|FG005|COMPLETED|Washout 4||2||
59744065|NCT01025843|75863146|FG006|COMPLETED|Washout 4||2||
59744066|NCT01025843|75863147|FG007|COMPLETED|Washout 4||2||
59744067|NCT01025843|75863148|FG008|COMPLETED|Washout 4||2||
59744068|NCT01025843|75863149|FG009|COMPLETED|Washout 4||2||
59744069|NCT01025843|75863140|FG000|NOT COMPLETED|Washout 4||0||
59744070|NCT01025843|75863141|FG001|NOT COMPLETED|Washout 4||0||
59744071|NCT01025843|75863142|FG002|NOT COMPLETED|Washout 4||1||
59744072|NCT01025843|75863143|FG003|NOT COMPLETED|Washout 4||1||
59744073|NCT01025843|75863144|FG004|NOT COMPLETED|Washout 4||0||
59744074|NCT01025843|75863145|FG005|NOT COMPLETED|Washout 4||0||
59744075|NCT01025843|75863146|FG006|NOT COMPLETED|Washout 4||0||
59744076|NCT01025843|75863147|FG007|NOT COMPLETED|Washout 4||0||
59744077|NCT01025843|75863148|FG008|NOT COMPLETED|Washout 4||0||
59744078|NCT01025843|75863149|FG009|NOT COMPLETED|Washout 4||0||
59744079|NCT01025843|75863140|FG000|STARTED|Period 5||2||
59744080|NCT01025843|75863141|FG001|STARTED|Period 5||2||
59744081|NCT01025843|75863142|FG002|STARTED|Period 5||1||
59744082|NCT01025843|75863143|FG003|STARTED|Period 5||1||
59744083|NCT01025843|75863144|FG004|STARTED|Period 5||2||
59744084|NCT01025843|75863145|FG005|STARTED|Period 5||2||
59744085|NCT01025843|75863146|FG006|STARTED|Period 5||2||
59744086|NCT01025843|75863147|FG007|STARTED|Period 5||2||
59744087|NCT01025843|75863148|FG008|STARTED|Period 5||2||
59744088|NCT01025843|75863149|FG009|STARTED|Period 5||2||
59744089|NCT01025843|75863140|FG000|COMPLETED|Period 5||2||
59744090|NCT01025843|75863141|FG001|COMPLETED|Period 5||2||
59744091|NCT01025843|75863142|FG002|COMPLETED|Period 5||1||
59744092|NCT01025843|75863143|FG003|COMPLETED|Period 5||1||
59744093|NCT01025843|75863144|FG004|COMPLETED|Period 5||2||
59744094|NCT01025843|75863145|FG005|COMPLETED|Period 5||2||
59744095|NCT01025843|75863146|FG006|COMPLETED|Period 5||2||
59744096|NCT01025843|75863147|FG007|COMPLETED|Period 5||2||
59744097|NCT01025843|75863148|FG008|COMPLETED|Period 5||2||
59744098|NCT01025843|75863149|FG009|COMPLETED|Period 5||2||
59744099|NCT01025843|75863140|FG000|NOT COMPLETED|Period 5||0||
59744100|NCT01025843|75863141|FG001|NOT COMPLETED|Period 5||0||
59744101|NCT01025843|75863142|FG002|NOT COMPLETED|Period 5||0||
59744102|NCT01025843|75863143|FG003|NOT COMPLETED|Period 5||0||
59744103|NCT01025843|75863144|FG004|NOT COMPLETED|Period 5||0||
59744104|NCT01025843|75863145|FG005|NOT COMPLETED|Period 5||0||
59744105|NCT01025843|75863146|FG006|NOT COMPLETED|Period 5||0||
59744106|NCT01025843|75863147|FG007|NOT COMPLETED|Period 5||0||
59744107|NCT01025843|75863148|FG008|NOT COMPLETED|Period 5||0||
59744108|NCT01025843|75863149|FG009|NOT COMPLETED|Period 5||0||
59744109|NCT01036763|75863177|FG000|STARTED|Overall Study||1264||
59744110|NCT01036763|75863177|FG000|COMPLETED|Overall Study||1171||
59744111|NCT01036763|75863177|FG000|NOT COMPLETED|Overall Study||93||
59744112|NCT01021007|75863183|FG000|STARTED|Overall Study||36||
59744113|NCT01021007|75863184|FG001|STARTED|Overall Study||37||
59744114|NCT01021007|75863183|FG000|COMPLETED|Overall Study||34||
59744115|NCT01021007|75863184|FG001|COMPLETED|Overall Study||33||
59744116|NCT01021007|75863183|FG000|NOT COMPLETED|Overall Study||2||
59744117|NCT01021007|75863184|FG001|NOT COMPLETED|Overall Study||4||
59744118|NCT01020773|75863192|FG000|STARTED|Overall Study||35||
59744119|NCT01020773|75863193|FG001|STARTED|Overall Study||32||
59744120|NCT01020773|75863192|FG000|COMPLETED|Overall Study||31||
59744121|NCT01020773|75863193|FG001|COMPLETED|Overall Study||29||
59744122|NCT01020773|75863192|FG000|NOT COMPLETED|Overall Study||4||
59744123|NCT01020773|75863193|FG001|NOT COMPLETED|Overall Study||3||
59744124|NCT01020305|75863199|FG000|STARTED|Overall Study||5||
59744125|NCT01020305|75863199|FG000|COMPLETED|Overall Study||3||
59744126|NCT01020305|75863199|FG000|NOT COMPLETED|Overall Study||2||
59744127|NCT01036529|75863205|FG000|STARTED|Overall Study||13||
59744128|NCT01036529|75863206|FG001|STARTED|Overall Study||15||
59744129|NCT01036529|75863205|FG000|Baseline Visit|Overall Study||10||
59744130|NCT01036529|75863206|FG001|Baseline Visit|Overall Study||13||
59744131|NCT01036529|75863205|FG000|Index Procedure|Overall Study|Index Procedure: Trial Stimulation|10||
59744132|NCT01036529|75863206|FG001|Index Procedure|Overall Study|Index Procedure: Surgery|11||
59744133|NCT01036529|75863205|FG000|3 Month Follow-up|Overall Study||7||
59744134|NCT01036529|75863206|FG001|3 Month Follow-up|Overall Study||9||
59744135|NCT01036529|75863205|FG000|6 Month Follow-up|Overall Study||6||
59744136|NCT01036529|75863206|FG001|6 Month Follow-up|Overall Study||7||
59744137|NCT01036529|75863205|FG000|12 Month Follow-up|Overall Study||4||
59744138|NCT01036529|75863206|FG001|12 Month Follow-up|Overall Study||3||
59744139|NCT01036529|75863205|FG000|Requested Crossover|Overall Study||1||
59744140|NCT01036529|75863206|FG001|Requested Crossover|Overall Study||2||
59744141|NCT01036529|75863205|FG000|Crossover to Other Group|Overall Study||1||
59744142|NCT01036529|75863206|FG001|Crossover to Other Group|Overall Study||1||
59744143|NCT01036529|75863205|FG000|COMPLETED|Overall Study||0||
59744144|NCT01036529|75863206|FG001|COMPLETED|Overall Study||0||
59744145|NCT01036529|75863205|FG000|NOT COMPLETED|Overall Study||13||
59744146|NCT01036529|75863206|FG001|NOT COMPLETED|Overall Study||15||
59744147|NCT01024751|75863214|FG000|STARTED|Enrolled Participants||156||
59744148|NCT01024751|75863215|FG001|STARTED|Enrolled Participants||156||
59744149|NCT01024751|75863214|FG000|COMPLETED|Enrolled Participants||153||
59744150|NCT01024751|75863215|FG001|COMPLETED|Enrolled Participants||152||
59744151|NCT01024751|75863214|FG000|NOT COMPLETED|Enrolled Participants||3||
59744152|NCT01024751|75863215|FG001|NOT COMPLETED|Enrolled Participants||4||
59744153|NCT01024751|75863214|FG000|STARTED|Eligible Participants||153||
59744154|NCT01024751|75863215|FG001|STARTED|Eligible Participants||152||
59744155|NCT01024751|75863214|FG000|COMPLETED|Eligible Participants||153||
59744156|NCT01024751|75863215|FG001|COMPLETED|Eligible Participants||149||
59744157|NCT01024751|75863214|FG000|NOT COMPLETED|Eligible Participants||0||
59744158|NCT01024751|75863215|FG001|NOT COMPLETED|Eligible Participants||3||
59744159|NCT01019369|75863223|FG000|STARTED|Overall Study||86||
59744160|NCT01019369|75863224|FG001|STARTED|Overall Study||46||
59744161|NCT01019369|75863223|FG000|COMPLETED|Overall Study||76||
59744162|NCT01019369|75863224|FG001|COMPLETED|Overall Study||39||
59744163|NCT01019369|75863223|FG000|NOT COMPLETED|Overall Study||10||
59744164|NCT01019369|75863224|FG001|NOT COMPLETED|Overall Study||7||
59744165|NCT01019135|75863234|FG000|STARTED|Overall Study||55||
59744166|NCT01019135|75863235|FG001|STARTED|Overall Study||59||
59744167|NCT01019135|75863236|FG002|STARTED|Overall Study||55||
59744168|NCT01019135|75863234|FG000|COMPLETED|Overall Study||35||
59744169|NCT01019135|75863235|FG001|COMPLETED|Overall Study||40||
59744170|NCT01019135|75863236|FG002|COMPLETED|Overall Study||24||
59744171|NCT01019135|75863234|FG000|NOT COMPLETED|Overall Study||20||
59744172|NCT01019135|75863235|FG001|NOT COMPLETED|Overall Study||19||
59744173|NCT01019135|75863236|FG002|NOT COMPLETED|Overall Study||31||
59744174|NCT01018979|75863246|FG000|STARTED|Overall Study||7||
59744175|NCT01018979|75863247|FG001|STARTED|Overall Study|A total of 20 subjects were randomized.|13||
59744176|NCT01018979|75863246|FG000|Received at Least One Dose|Overall Study||7||
59744177|NCT01018979|75863247|FG001|Received at Least One Dose|Overall Study||12||
59744178|NCT01018979|75863246|FG000|COMPLETED|Overall Study||4||
59744179|NCT01018979|75863247|FG001|COMPLETED|Overall Study||3||
59744180|NCT01018979|75863246|FG000|NOT COMPLETED|Overall Study||3||
59744181|NCT01018979|75863247|FG001|NOT COMPLETED|Overall Study||10||
59744182|NCT01572493|75863265|FG000|STARTED|Overall Study||4||
59744183|NCT01572493|75863266|FG001|STARTED|Overall Study||3||
59744184|NCT01572493|75863267|FG002|STARTED|Overall Study||3||
59744185|NCT01572493|75863268|FG003|STARTED|Overall Study||6||
59744186|NCT01572493|75863269|FG004|STARTED|Overall Study||9||
59744187|NCT01572493|75863270|FG005|STARTED|Overall Study||2||
59744188|NCT01572493|75863271|FG006|STARTED|Overall Study||4||
59744189|NCT01572493|75863272|FG007|STARTED|Overall Study||3||
59744190|NCT01572493|75863273|FG008|STARTED|Overall Study||4||
59744191|NCT01572493|75863265|FG000|COMPLETED|Overall Study||3||
59744192|NCT01572493|75863266|FG001|COMPLETED|Overall Study||2||
59744193|NCT01572493|75863267|FG002|COMPLETED|Overall Study||1||
59744194|NCT01572493|75863268|FG003|COMPLETED|Overall Study||4||
59744195|NCT01572493|75863269|FG004|COMPLETED|Overall Study||7||
59744196|NCT01572493|75863270|FG005|COMPLETED|Overall Study||1||
59744197|NCT01572493|75863271|FG006|COMPLETED|Overall Study||1||
59744198|NCT01572493|75863272|FG007|COMPLETED|Overall Study||3||
59744199|NCT01572493|75863273|FG008|COMPLETED|Overall Study||2||
59744200|NCT01572493|75863265|FG000|NOT COMPLETED|Overall Study||1||
59744201|NCT01572493|75863266|FG001|NOT COMPLETED|Overall Study||1||
59744202|NCT01572493|75863267|FG002|NOT COMPLETED|Overall Study||2||
59744203|NCT01572493|75863268|FG003|NOT COMPLETED|Overall Study||2||
59744204|NCT01572493|75863269|FG004|NOT COMPLETED|Overall Study||2||
59744205|NCT01572493|75863270|FG005|NOT COMPLETED|Overall Study||1||
59744206|NCT01572493|75863271|FG006|NOT COMPLETED|Overall Study||3||
59744207|NCT01572493|75863272|FG007|NOT COMPLETED|Overall Study||0||
59744208|NCT01572493|75863273|FG008|NOT COMPLETED|Overall Study||2||
59744209|NCT01018511|75863300|FG000|STARTED|Overall Study||341||
59744210|NCT01018511|75863301|FG001|STARTED|Overall Study||327||
59744211|NCT01018511|75863302|FG002|STARTED|Overall Study||339||
59744212|NCT01018511|75863303|FG003|STARTED|Overall Study||327||
59744213|NCT01018511|75863300|FG000|Randomized and Treated|Overall Study||341||
59744214|NCT01018511|75863301|FG001|Randomized and Treated|Overall Study||326||
59744215|NCT01018511|75863302|FG002|Randomized and Treated|Overall Study||338||
59744216|NCT01018511|75863303|FG003|Randomized and Treated|Overall Study||324||
59744217|NCT01018511|75863300|FG000|COMPLETED|Overall Study||315||
59744218|NCT01018511|75863301|FG001|COMPLETED|Overall Study||295||
59744219|NCT01018511|75863302|FG002|COMPLETED|Overall Study||299||
59744220|NCT01018511|75863303|FG003|COMPLETED|Overall Study||294||
59744221|NCT01018511|75863300|FG000|NOT COMPLETED|Overall Study||26||
59744222|NCT01018511|75863301|FG001|NOT COMPLETED|Overall Study||32||
59744223|NCT01018511|75863302|FG002|NOT COMPLETED|Overall Study||40||
59744224|NCT01018511|75863303|FG003|NOT COMPLETED|Overall Study||33||
59744225|NCT00996476|75863324|FG000|STARTED|Overall Study||27||
59744226|NCT00996476|75863325|FG001|STARTED|Overall Study||26||
59744227|NCT00996476|75863326|FG002|STARTED|Overall Study||13||
59744228|NCT00996476|75863327|FG003|STARTED|Overall Study||13||
59744229|NCT00996476|75863328|FG004|STARTED|Overall Study||13||
59744230|NCT00996476|75863324|FG000|COMPLETED|Overall Study||26||
59744231|NCT00996476|75863325|FG001|COMPLETED|Overall Study||23||
59744232|NCT00996476|75863326|FG002|COMPLETED|Overall Study||12||
59744233|NCT00996476|75863327|FG003|COMPLETED|Overall Study||13||
59744234|NCT00996476|75863328|FG004|COMPLETED|Overall Study||11||
59744235|NCT00996476|75863324|FG000|NOT COMPLETED|Overall Study||1||
59744236|NCT00996476|75863325|FG001|NOT COMPLETED|Overall Study||3||
59744237|NCT00996476|75863326|FG002|NOT COMPLETED|Overall Study||1||
59744238|NCT00996476|75863327|FG003|NOT COMPLETED|Overall Study||0||
59744239|NCT00996476|75863328|FG004|NOT COMPLETED|Overall Study||2||
59744240|NCT02269267|75863345|FG000|STARTED|Overall Study|One subject expired prior to achieving an appropriate response for suspension of TKI therapy. Total evaluable subjects = 172 for subsequent analyses.|173||
59744241|NCT02269267|75863345|FG000|COMPLETED|Overall Study||168||
59744242|NCT02269267|75863345|FG000|NOT COMPLETED|Overall Study||5||
59744243|NCT01017731|75863349|FG000|STARTED|Overall Study||68||
59744244|NCT01017731|75863349|FG000|Received at Least 1 Dose of Study Drug|Overall Study||66||
59744245|NCT01017731|75863349|FG000|COMPLETED|Overall Study||60||
59744246|NCT01017731|75863349|FG000|NOT COMPLETED|Overall Study||8||
59744247|NCT01035905|75863356|FG000|STARTED|Overall Study||32||
59744248|NCT01035905|75863357|FG001|STARTED|Overall Study||31||
59744249|NCT01035905|75863356|FG000|COMPLETED|Overall Study||31||
60135060|NCT03307252|76258158|FG005|COMPLETED|Part 2, Washout Period 1 (7 Days)||3||
59744250|NCT01035905|75863357|FG001|COMPLETED|Overall Study||30||
59744251|NCT01035905|75863356|FG000|NOT COMPLETED|Overall Study||1||
59744252|NCT01035905|75863357|FG001|NOT COMPLETED|Overall Study||1||
59744253|NCT02255305|75863365|FG000|STARTED|Overall Study||2||
59744254|NCT02255305|75863366|FG001|STARTED|Overall Study||4||
59744255|NCT02255305|75863365|FG000|COMPLETED|Overall Study||1||
59744256|NCT02255305|75863366|FG001|COMPLETED|Overall Study||0||
59744257|NCT02255305|75863365|FG000|NOT COMPLETED|Overall Study||1||
59744258|NCT02255305|75863366|FG001|NOT COMPLETED|Overall Study||4||
59744259|NCT00779584|75863381|FG000|STARTED|Overall Study||3||
59744260|NCT00779584|75863382|FG001|STARTED|Overall Study||3||
59744261|NCT00779584|75863383|FG002|STARTED|Overall Study||7||
59744262|NCT00779584|75863384|FG003|STARTED|Overall Study||6||
59744263|NCT00779584|75863385|FG004|STARTED|Overall Study||7||
59744264|NCT00779584|75863386|FG005|STARTED|Overall Study||6||
59744265|NCT00779584|75863387|FG006|STARTED|Overall Study||8||
59744266|NCT00779584|75863388|FG007|STARTED|Overall Study||3||
59744267|NCT00779584|75863389|FG008|STARTED|Overall Study||2||
59744268|NCT00779584|75863381|FG000|Treated|Overall Study||3||
59744269|NCT00779584|75863382|FG001|Treated|Overall Study||3||
59744270|NCT00779584|75863383|FG002|Treated|Overall Study||7||
59744271|NCT00779584|75863384|FG003|Treated|Overall Study||6||
59744272|NCT00779584|75863385|FG004|Treated|Overall Study||7||
59744273|NCT00779584|75863386|FG005|Treated|Overall Study||4||
59744274|NCT00779584|75863387|FG006|Treated|Overall Study||8||
59744275|NCT00779584|75863388|FG007|Treated|Overall Study||3||
59744276|NCT00779584|75863389|FG008|Treated|Overall Study||2||
59744277|NCT00779584|75863381|FG000|COMPLETED|Overall Study||0||
59744278|NCT00779584|75863382|FG001|COMPLETED|Overall Study||0||
59744279|NCT00779584|75863383|FG002|COMPLETED|Overall Study||0||
59744280|NCT00779584|75863384|FG003|COMPLETED|Overall Study||0||
59744281|NCT00779584|75863385|FG004|COMPLETED|Overall Study||0||
59744282|NCT00779584|75863386|FG005|COMPLETED|Overall Study||0||
59744283|NCT00779584|75863387|FG006|COMPLETED|Overall Study||0||
59744284|NCT00779584|75863388|FG007|COMPLETED|Overall Study||0||
59744285|NCT00779584|75863389|FG008|COMPLETED|Overall Study||0||
59744286|NCT00779584|75863381|FG000|NOT COMPLETED|Overall Study||3||
59744287|NCT00779584|75863382|FG001|NOT COMPLETED|Overall Study||3||
59744288|NCT00779584|75863383|FG002|NOT COMPLETED|Overall Study||7||
59744289|NCT00779584|75863384|FG003|NOT COMPLETED|Overall Study||6||
59744290|NCT00779584|75863385|FG004|NOT COMPLETED|Overall Study||7||
59744291|NCT00779584|75863386|FG005|NOT COMPLETED|Overall Study||6||
59744292|NCT00779584|75863387|FG006|NOT COMPLETED|Overall Study||8||
59744293|NCT00779584|75863388|FG007|NOT COMPLETED|Overall Study||3||
59744294|NCT00779584|75863389|FG008|NOT COMPLETED|Overall Study||2||
59744295|NCT00995930|75863411|FG000|STARTED|Overall Study||94||
59744296|NCT00995930|75863412|FG001|STARTED|Overall Study||95||
59744297|NCT00995930|75863411|FG000|Safety Analysis Set|Overall Study||94||
59744298|NCT00995930|75863412|FG001|Safety Analysis Set|Overall Study||95||
59744299|NCT00995930|75863411|FG000|Pharmacokinetic (PK) Analysis Set|Overall Study||0||
59744300|NCT00995930|75863412|FG001|Pharmacokinetic (PK) Analysis Set|Overall Study||95||
59744301|NCT00995930|75863411|FG000|Pharmacodynamic (PD) Analysis Set|Overall Study||92||
59744302|NCT00995930|75863412|FG001|Pharmacodynamic (PD) Analysis Set|Overall Study||92||
59744303|NCT00995930|75863411|FG000|Imaging Analysis Set|Overall Study||92||
59744304|NCT00995930|75863412|FG001|Imaging Analysis Set|Overall Study||92||
60135061|NCT03307252|76258159|FG006|COMPLETED|Part 2, Washout Period 1 (7 Days)||5||
60135062|NCT03307252|76258160|FG007|COMPLETED|Part 2, Washout Period 1 (7 Days)||0||
60135063|NCT03307252|76258161|FG008|COMPLETED|Part 2, Washout Period 1 (7 Days)||0||
60135064|NCT03307252|76258162|FG009|COMPLETED|Part 2, Washout Period 1 (7 Days)||0||
59744305|NCT00995930|75863411|FG000|COMPLETED|Overall Study||73||
59744306|NCT00995930|75863412|FG001|COMPLETED|Overall Study||67||
59744307|NCT00995930|75863411|FG000|NOT COMPLETED|Overall Study||21||
59744308|NCT00995930|75863412|FG001|NOT COMPLETED|Overall Study||28||
59744309|NCT00779506|75863419|FG000|STARTED|Overall Study||96||
59744310|NCT00779506|75863419|FG000|Enrolled|Overall Study||96||
59744311|NCT00779506|75863419|FG000|Screen Failed|Overall Study||2||
59744312|NCT00779506|75863419|FG000|Assigned|Overall Study||94||
59744313|NCT00779506|75863419|FG000|MITT|Overall Study||89||
59744314|NCT00779506|75863419|FG000|Treatment Complete|Overall Study||67||
59744315|NCT00779506|75863419|FG000|Withdrawal Treatment|Overall Study||27||
59744316|NCT00779506|75863419|FG000|COMPLETED|Overall Study||67||
59744317|NCT00779506|75863419|FG000|NOT COMPLETED|Overall Study||29||
59744318|NCT00995774|75863425|FG000|STARTED|Training Period 1||7||
59744319|NCT00995774|75863426|FG001|STARTED|Training Period 1||5||
59744320|NCT00995774|75863425|FG000|COMPLETED|Training Period 1||7||
59744321|NCT00995774|75863426|FG001|COMPLETED|Training Period 1||5||
59744322|NCT00995774|75863425|FG000|NOT COMPLETED|Training Period 1||0||
59744323|NCT00995774|75863426|FG001|NOT COMPLETED|Training Period 1||0||
59744324|NCT00995774|75863425|FG000|STARTED|Washout Period||7||
59744325|NCT00995774|75863426|FG001|STARTED|Washout Period||5||
59744326|NCT00995774|75863425|FG000|COMPLETED|Washout Period||7||
59744327|NCT00995774|75863426|FG001|COMPLETED|Washout Period||5||
59744328|NCT00995774|75863425|FG000|NOT COMPLETED|Washout Period||0||
59744329|NCT00995774|75863426|FG001|NOT COMPLETED|Washout Period||0||
59744330|NCT00995774|75863425|FG000|STARTED|Training Period 2||7||
59744331|NCT00995774|75863426|FG001|STARTED|Training Period 2||5||
59744332|NCT00995774|75863425|FG000|COMPLETED|Training Period 2||5||
59744333|NCT00995774|75863426|FG001|COMPLETED|Training Period 2||5||
59744334|NCT00995774|75863425|FG000|NOT COMPLETED|Training Period 2||2||
59744335|NCT00995774|75863426|FG001|NOT COMPLETED|Training Period 2||0||
59744336|NCT00765388|75863432|FG000|STARTED|Period 1|A cross-over study|16||
59744337|NCT00765388|75863433|FG001|STARTED|Period 1||11||
59744338|NCT00765388|75863432|FG000|COMPLETED|Period 1||15||
59744339|NCT00765388|75863433|FG001|COMPLETED|Period 1||6||
59744340|NCT00765388|75863432|FG000|NOT COMPLETED|Period 1||1||
59744341|NCT00765388|75863433|FG001|NOT COMPLETED|Period 1||5||
59744342|NCT00765388|75863432|FG000|STARTED|Period 2||15||
59744343|NCT00765388|75863433|FG001|STARTED|Period 2||6||
59744344|NCT00765388|75863432|FG000|COMPLETED|Period 2||15||
59744345|NCT00765388|75863433|FG001|COMPLETED|Period 2||6||
59744346|NCT00765388|75863432|FG000|NOT COMPLETED|Period 2||0||
59744347|NCT00765388|75863433|FG001|NOT COMPLETED|Period 2||0||
59744348|NCT01385059|75863441|FG000|STARTED|Overall Study||4||
59744349|NCT01385059|75863442|FG001|STARTED|Overall Study||7||
59744350|NCT01385059|75863441|FG000|COMPLETED|Overall Study||4||
59744351|NCT01385059|75863442|FG001|COMPLETED|Overall Study||7||
59744352|NCT01385059|75863441|FG000|NOT COMPLETED|Overall Study||0||
59744353|NCT01385059|75863442|FG001|NOT COMPLETED|Overall Study||0||
59873025|NCT02915302|75997162|FG000|Vaccinated (Safety Analysis Set)|Overall Study||949||
59873026|NCT02915302|75997163|FG001|Vaccinated (Safety Analysis Set)|Overall Study||992||
59873027|NCT02915302|75997162|FG000|COMPLETED|Overall Study||890||
60135065|NCT03307252|76258163|FG010|COMPLETED|Part 2, Washout Period 1 (7 Days)||0||
60135066|NCT03307252|76258153|FG000|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0||
60135067|NCT03307252|76258154|FG001|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0||
60135068|NCT03307252|76258155|FG002|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0||
60135069|NCT03307252|76258156|FG003|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0||
60135070|NCT03307252|76258157|FG004|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0||
60135071|NCT03307252|76258158|FG005|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0||
59744354|NCT00769132|75863448|FG000|STARTED|Period 1||7||
59744355|NCT00769132|75863449|FG001|STARTED|Period 1||6||
59744356|NCT00769132|75863450|FG002|STARTED|Period 1||6||
59744357|NCT00769132|75863451|FG003|STARTED|Period 1||7||
59744358|NCT00769132|75863448|FG000|COMPLETED|Period 1||6||
59744359|NCT00769132|75863449|FG001|COMPLETED|Period 1||6||
59744360|NCT00769132|75863450|FG002|COMPLETED|Period 1||6||
59744361|NCT00769132|75863451|FG003|COMPLETED|Period 1||6||
59744362|NCT00769132|75863448|FG000|NOT COMPLETED|Period 1||1||
59744363|NCT00769132|75863449|FG001|NOT COMPLETED|Period 1||0||
59744364|NCT00769132|75863450|FG002|NOT COMPLETED|Period 1||0||
59744365|NCT00769132|75863451|FG003|NOT COMPLETED|Period 1||1||
59744366|NCT00769132|75863448|FG000|STARTED|Period 2||6||
59744367|NCT00769132|75863449|FG001|STARTED|Period 2||6||
59744368|NCT00769132|75863450|FG002|STARTED|Period 2||6||
59744369|NCT00769132|75863451|FG003|STARTED|Period 2||6||
59744370|NCT00769132|75863448|FG000|COMPLETED|Period 2||6||
59744371|NCT00769132|75863449|FG001|COMPLETED|Period 2||6||
59744372|NCT00769132|75863450|FG002|COMPLETED|Period 2||6||
59744373|NCT00769132|75863451|FG003|COMPLETED|Period 2||5||
59744374|NCT00769132|75863448|FG000|NOT COMPLETED|Period 2||0||
59744375|NCT00769132|75863449|FG001|NOT COMPLETED|Period 2||0||
59744376|NCT00769132|75863450|FG002|NOT COMPLETED|Period 2||0||
59744377|NCT00769132|75863451|FG003|NOT COMPLETED|Period 2||1||
59744378|NCT00769132|75863448|FG000|STARTED|Period 3||6||
59744379|NCT00769132|75863449|FG001|STARTED|Period 3||6||
59744380|NCT00769132|75863450|FG002|STARTED|Period 3||6||
59744381|NCT00769132|75863451|FG003|STARTED|Period 3||5||
59744382|NCT00769132|75863448|FG000|COMPLETED|Period 3||5||
59744383|NCT00769132|75863449|FG001|COMPLETED|Period 3||6||
59744384|NCT00769132|75863450|FG002|COMPLETED|Period 3||6||
59744385|NCT00769132|75863451|FG003|COMPLETED|Period 3||5||
59744386|NCT00769132|75863448|FG000|NOT COMPLETED|Period 3||1||
59744387|NCT00769132|75863449|FG001|NOT COMPLETED|Period 3||0||
59744388|NCT00769132|75863450|FG002|NOT COMPLETED|Period 3||0||
59744389|NCT00769132|75863451|FG003|NOT COMPLETED|Period 3||0||
59744390|NCT00769132|75863448|FG000|STARTED|Period 4||5||
59744391|NCT00769132|75863449|FG001|STARTED|Period 4||6||
59744392|NCT00769132|75863450|FG002|STARTED|Period 4||6||
59744393|NCT00769132|75863451|FG003|STARTED|Period 4||5||
59744394|NCT00769132|75863448|FG000|COMPLETED|Period 4||5||
59744395|NCT00769132|75863449|FG001|COMPLETED|Period 4||5||
59744396|NCT00769132|75863450|FG002|COMPLETED|Period 4||6||
59744397|NCT00769132|75863451|FG003|COMPLETED|Period 4||5||
59744398|NCT00769132|75863448|FG000|NOT COMPLETED|Period 4||0||
59744399|NCT00769132|75863449|FG001|NOT COMPLETED|Period 4||1||
59744400|NCT00769132|75863450|FG002|NOT COMPLETED|Period 4||0||
59744401|NCT00769132|75863451|FG003|NOT COMPLETED|Period 4||0||
59744402|NCT00991952|75863463|FG000|STARTED|Overall Study||13||
59744403|NCT00991952|75863464|FG001|STARTED|Overall Study||6||
59744404|NCT00991952|75863463|FG000|COMPLETED|Overall Study||13||
59744405|NCT00991952|75863464|FG001|COMPLETED|Overall Study||5||
59744406|NCT00991952|75863463|FG000|NOT COMPLETED|Overall Study||0||
59744407|NCT00991952|75863464|FG001|NOT COMPLETED|Overall Study||1||
59744408|NCT00779038|75863470|FG000|STARTED|Overall Study||13||
59744409|NCT00779038|75863470|FG000|COMPLETED|Overall Study||0||
59744410|NCT00779038|75863470|FG000|NOT COMPLETED|Overall Study||13||
59744411|NCT00765076|75863477|FG000|STARTED|Overall Study||69||
59744412|NCT00765076|75863478|FG001|STARTED|Overall Study||73||
59744413|NCT00765076|75863479|FG002|STARTED|Overall Study||50||
59744414|NCT00765076|75863477|FG000|COMPLETED|Overall Study||68||
59744415|NCT00765076|75863478|FG001|COMPLETED|Overall Study||73||
59744416|NCT00765076|75863479|FG002|COMPLETED|Overall Study||49||
59744417|NCT00765076|75863477|FG000|NOT COMPLETED|Overall Study||1||
59744418|NCT00765076|75863478|FG001|NOT COMPLETED|Overall Study||0||
59744419|NCT00765076|75863479|FG002|NOT COMPLETED|Overall Study||1||
59744420|NCT00994682|75863489|FG000|STARTED|Double Bilnd||51||
59744421|NCT00994682|75863490|FG001|STARTED|Double Bilnd||50||
59873028|NCT02915302|75997163|FG001|COMPLETED|Overall Study||917||
59873029|NCT02915302|75997162|FG000|NOT COMPLETED|Overall Study||65||
59873030|NCT02915302|75997163|FG001|NOT COMPLETED|Overall Study||78||
59744422|NCT00994682|75863489|FG000|COMPLETED|Double Bilnd||42||
59744423|NCT00994682|75863490|FG001|COMPLETED|Double Bilnd||41||
59744424|NCT00994682|75863489|FG000|NOT COMPLETED|Double Bilnd||9||
59744425|NCT00994682|75863490|FG001|NOT COMPLETED|Double Bilnd||9||
59744426|NCT00994682|75863489|FG000|STARTED|Pioglitazone Open Label||42||
59744427|NCT00994682|75863490|FG001|STARTED|Pioglitazone Open Label||41||
59744428|NCT00994682|75863489|FG000|COMPLETED|Pioglitazone Open Label||29||
59744429|NCT00994682|75863490|FG001|COMPLETED|Pioglitazone Open Label||34||
59744430|NCT00994682|75863489|FG000|NOT COMPLETED|Pioglitazone Open Label||13||
59873031|NCT03023878|75997169|FG000|STARTED|Pre-Study Run-In Period||47|Standard of Care (SOC) rituximab (R)-chemotherapy Analysis Set.|
59873032|NCT03023878|75997169|FG000|COMPLETED|Pre-Study Run-In Period||30||
59873033|NCT03023878|75997169|FG000|NOT COMPLETED|Pre-Study Run-In Period||17||
59873034|NCT03023878|75997169|FG000|STARTED|Between Run-In and Treatment Periods||30||
59873035|NCT03023878|75997169|FG000|COMPLETED|Between Run-In and Treatment Periods||28||
59873036|NCT03023878|75997169|FG000|NOT COMPLETED|Between Run-In and Treatment Periods||2||
59873037|NCT03023878|75997169|FG000|STARTED|Treatment Period||28||
59873038|NCT03023878|75997169|FG000|Started Cycle 1|Treatment Period||28|Full analysis set (FAS)|
59873039|NCT03023878|75997169|FG000|Started Cycle 2|Treatment Period||11||
59744431|NCT00994682|75863490|FG001|NOT COMPLETED|Pioglitazone Open Label||7||
59744432|NCT00768898|75863500|FG000|STARTED|Overall Study||30||
59744433|NCT00768898|75863500|FG000|COMPLETED|Overall Study||28||
59744434|NCT00768898|75863500|FG000|NOT COMPLETED|Overall Study||2||
59744435|NCT00994448|75863511|FG000|STARTED|Overall Study||12||
59744436|NCT00994448|75863512|FG001|STARTED|Overall Study||7||
59744437|NCT00994448|75863511|FG000|COMPLETED|Overall Study||4||
59744438|NCT00994448|75863512|FG001|COMPLETED|Overall Study||5||
59744439|NCT00994448|75863511|FG000|NOT COMPLETED|Overall Study||8||
59873040|NCT03023878|75997169|FG000|COMPLETED|Treatment Period||25||
59744440|NCT00994448|75863512|FG001|NOT COMPLETED|Overall Study||2||
59744441|NCT00991406|75863518|FG000|STARTED|Overall Study||9||
59744442|NCT00991406|75863518|FG000|COMPLETED|Overall Study|One participant did not respond to FES due to tone.|8||
59744443|NCT00991406|75863518|FG000|NOT COMPLETED|Overall Study||1||
59744444|NCT01017575|75863527|FG000|STARTED|Overall Study||8||
59744445|NCT01017575|75863528|FG001|STARTED|Overall Study||9||
59744446|NCT01017575|75863529|FG002|STARTED|Overall Study||8||
59744447|NCT01017575|75863530|FG003|STARTED|Overall Study||8||
59744448|NCT01017575|75863531|FG004|STARTED|Overall Study||9||
59744449|NCT01017575|75863527|FG000|COMPLETED|Overall Study||7||
59744450|NCT01017575|75863528|FG001|COMPLETED|Overall Study||7||
59744451|NCT01017575|75863529|FG002|COMPLETED|Overall Study||8||
59744452|NCT01017575|75863530|FG003|COMPLETED|Overall Study||7||
59744453|NCT01017575|75863531|FG004|COMPLETED|Overall Study||6||
59744454|NCT01017575|75863527|FG000|NOT COMPLETED|Overall Study||1||
59744455|NCT01017575|75863528|FG001|NOT COMPLETED|Overall Study||2||
59744456|NCT01017575|75863529|FG002|NOT COMPLETED|Overall Study||0||
59744457|NCT01017575|75863530|FG003|NOT COMPLETED|Overall Study||1||
59744458|NCT01017575|75863531|FG004|NOT COMPLETED|Overall Study||3||
59744459|NCT01017263|75863543|FG000|STARTED|Overall Study||14||
59744460|NCT01017263|75863543|FG000|COMPLETED|Overall Study|A total of 14 participants screened: 2 qualified and received drug the remaining 12 failed screen|2||
59744461|NCT01017263|75863543|FG000|NOT COMPLETED|Overall Study||12||
59744462|NCT00768664|75863547|FG000|STARTED|Overall Study||69||
59744463|NCT00768664|75863547|FG000|COMPLETED|Overall Study||0||
59744464|NCT00768664|75863547|FG000|NOT COMPLETED|Overall Study||69||
59744465|NCT00778336|75863555|FG000|STARTED|Index Procedure-Discharge||198||
59744466|NCT00778336|75863556|FG001|STARTED|Index Procedure-Discharge||170||
59744467|NCT00778336|75863557|FG002|STARTED|Index Procedure-Discharge||72||
59744468|NCT00778336|75863558|FG003|STARTED|Index Procedure-Discharge||12||
59873041|NCT03023878|75997169|FG000|NOT COMPLETED|Treatment Period||3||
60135072|NCT03307252|76258159|FG006|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0||
59744469|NCT00778336|75863555|FG000|COMPLETED|Index Procedure-Discharge||192||
59744470|NCT00778336|75863556|FG001|COMPLETED|Index Procedure-Discharge||167||
59744471|NCT00778336|75863557|FG002|COMPLETED|Index Procedure-Discharge||70||
59744472|NCT00778336|75863558|FG003|COMPLETED|Index Procedure-Discharge||12||
59744473|NCT00778336|75863555|FG000|NOT COMPLETED|Index Procedure-Discharge||6||
59744474|NCT00778336|75863556|FG001|NOT COMPLETED|Index Procedure-Discharge||3||
59744475|NCT00778336|75863557|FG002|NOT COMPLETED|Index Procedure-Discharge||2||
59744476|NCT00778336|75863558|FG003|NOT COMPLETED|Index Procedure-Discharge||0||
59744477|NCT00778336|75863555|FG000|STARTED|3 Month Follow Up||192||
59744478|NCT00778336|75863556|FG001|STARTED|3 Month Follow Up||167||
59744479|NCT00778336|75863557|FG002|STARTED|3 Month Follow Up||70||
59744480|NCT00778336|75863558|FG003|STARTED|3 Month Follow Up||12||
59744481|NCT00778336|75863555|FG000|COMPLETED|3 Month Follow Up||169||
59744482|NCT00778336|75863556|FG001|COMPLETED|3 Month Follow Up||144||
59744483|NCT00778336|75863557|FG002|COMPLETED|3 Month Follow Up||65||
59744484|NCT00778336|75863558|FG003|COMPLETED|3 Month Follow Up||12||
59744485|NCT00778336|75863555|FG000|NOT COMPLETED|3 Month Follow Up||23||
59744486|NCT00778336|75863556|FG001|NOT COMPLETED|3 Month Follow Up||23||
59744487|NCT00778336|75863557|FG002|NOT COMPLETED|3 Month Follow Up||5||
59744488|NCT00778336|75863558|FG003|NOT COMPLETED|3 Month Follow Up||0||
59744489|NCT01253161|75863568|FG000|STARTED|Overall Study||29||
59744490|NCT01253161|75863568|FG000|COMPLETED|Overall Study||28||
59744491|NCT01253161|75863568|FG000|NOT COMPLETED|Overall Study||1||
59744492|NCT00581113|75863574|FG000|STARTED|Overall Study||4||
59744493|NCT00581113|75863575|FG001|STARTED|Overall Study||4||
59744494|NCT00581113|75863574|FG000|COMPLETED|Overall Study||4||
59744495|NCT00581113|75863575|FG001|COMPLETED|Overall Study||3||
59744496|NCT00581113|75863574|FG000|NOT COMPLETED|Overall Study||0||
59744497|NCT00581113|75863575|FG001|NOT COMPLETED|Overall Study||1||
59744498|NCT01016015|75863581|FG000|STARTED|Overall Study||178||
59744499|NCT01016015|75863581|FG000|COMPLETED|Overall Study||159||
59744500|NCT01016015|75863581|FG000|NOT COMPLETED|Overall Study||19||
59744501|NCT01015703|75863590|FG000|STARTED|Overall Study||10||
59744502|NCT01015703|75863591|FG001|STARTED|Overall Study||10||
59744503|NCT01015703|75863592|FG002|STARTED|Overall Study||10||
59744504|NCT01015703|75863593|FG003|STARTED|Overall Study||10||
59744505|NCT01015703|75863594|FG004|STARTED|Overall Study||10||
59744506|NCT01015703|75863590|FG000|COMPLETED|Overall Study||8||
60135073|NCT03307252|76258160|FG007|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0||
60135074|NCT03307252|76258161|FG008|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0||
60135075|NCT03307252|76258162|FG009|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0||
59744507|NCT01015703|75863591|FG001|COMPLETED|Overall Study||9||
59744508|NCT01015703|75863592|FG002|COMPLETED|Overall Study||10||
59744509|NCT01015703|75863593|FG003|COMPLETED|Overall Study||10||
59744510|NCT01015703|75863594|FG004|COMPLETED|Overall Study||10||
59744511|NCT01015703|75863590|FG000|NOT COMPLETED|Overall Study||2||
59744512|NCT01015703|75863591|FG001|NOT COMPLETED|Overall Study||1||
59744513|NCT01015703|75863592|FG002|NOT COMPLETED|Overall Study||0||
59744514|NCT01015703|75863593|FG003|NOT COMPLETED|Overall Study||0||
59744515|NCT01015703|75863594|FG004|NOT COMPLETED|Overall Study||0||
59744516|NCT04439071|75863608|FG000|STARTED|Overall Study||94||
59744517|NCT04439071|75863609|FG001|STARTED|Overall Study||95||
59744518|NCT04439071|75863608|FG000|Received at Least 1 Dose of Study Drug|Overall Study||92||
59744519|NCT04439071|75863609|FG001|Received at Least 1 Dose of Study Drug|Overall Study||95||
59744520|NCT04439071|75863608|FG000|COMPLETED|Overall Study||80||
59744521|NCT04439071|75863609|FG001|COMPLETED|Overall Study||77||
59744522|NCT04439071|75863608|FG000|NOT COMPLETED|Overall Study||14||
59744523|NCT04439071|75863609|FG001|NOT COMPLETED|Overall Study||18||
59744524|NCT01017029|75863617|FG000|STARTED|Overall Study||89||
59744525|NCT01017029|75863618|FG001|STARTED|Overall Study||92||
59744526|NCT01017029|75863617|FG000|COMPLETED|Overall Study||85||
59744527|NCT01017029|75863618|FG001|COMPLETED|Overall Study||90||
59744528|NCT01017029|75863617|FG000|NOT COMPLETED|Overall Study||4||
59744529|NCT01017029|75863618|FG001|NOT COMPLETED|Overall Study||2||
59744530|NCT00994214|75863628|FG000|STARTED|ITT (Intention-to-Treat) - Part A||19||
59744531|NCT00994214|75863629|FG001|STARTED|ITT (Intention-to-Treat) - Part A||19||
59744532|NCT00994214|75863630|FG002|STARTED|ITT (Intention-to-Treat) - Part A||18||
59744533|NCT00994214|75863631|FG003|STARTED|ITT (Intention-to-Treat) - Part A||20||
59744534|NCT00994214|75863628|FG000|COMPLETED|ITT (Intention-to-Treat) - Part A||5||
59744535|NCT00994214|75863629|FG001|COMPLETED|ITT (Intention-to-Treat) - Part A||6||
59744536|NCT00994214|75863630|FG002|COMPLETED|ITT (Intention-to-Treat) - Part A||5||
59744537|NCT00994214|75863631|FG003|COMPLETED|ITT (Intention-to-Treat) - Part A||5||
59744538|NCT00994214|75863628|FG000|NOT COMPLETED|ITT (Intention-to-Treat) - Part A||14||
59744539|NCT00994214|75863629|FG001|NOT COMPLETED|ITT (Intention-to-Treat) - Part A||13||
59744540|NCT00994214|75863630|FG002|NOT COMPLETED|ITT (Intention-to-Treat) - Part A||13||
59744541|NCT00994214|75863631|FG003|NOT COMPLETED|ITT (Intention-to-Treat) - Part A||15||
59744542|NCT00994214|75863628|FG000|STARTED|ITT (Intention-to-Treat) - Part B|1 subject did not enter Part B Arm A|4||
59744543|NCT00994214|75863629|FG001|STARTED|ITT (Intention-to-Treat) - Part B|3 subjects did not enter Part B Arm B|3||
59744544|NCT00994214|75863630|FG002|STARTED|ITT (Intention-to-Treat) - Part B|3 subjects did not enter Part B Arm C|2||
59744545|NCT00994214|75863631|FG003|STARTED|ITT (Intention-to-Treat) - Part B|2 subjects did not enter Part B Arm D|3||
59744546|NCT00994214|75863628|FG000|Received Maximum Dose of 1mg|ITT (Intention-to-Treat) - Part B||0||
59744547|NCT00994214|75863629|FG001|Received Maximum Dose of 1mg|ITT (Intention-to-Treat) - Part B||0||
59744548|NCT00994214|75863630|FG002|Received Maximum Dose of 1mg|ITT (Intention-to-Treat) - Part B||0||
59744549|NCT00994214|75863631|FG003|Received Maximum Dose of 1mg|ITT (Intention-to-Treat) - Part B||0||
59744550|NCT00994214|75863628|FG000|Received Maximum Dose of 2mg|ITT (Intention-to-Treat) - Part B||3||
59744551|NCT00994214|75863629|FG001|Received Maximum Dose of 2mg|ITT (Intention-to-Treat) - Part B||0||
59744552|NCT00994214|75863630|FG002|Received Maximum Dose of 2mg|ITT (Intention-to-Treat) - Part B||0||
59744553|NCT00994214|75863631|FG003|Received Maximum Dose of 2mg|ITT (Intention-to-Treat) - Part B||0||
59744554|NCT00994214|75863628|FG000|Received Maximum Dose of 4mg|ITT (Intention-to-Treat) - Part B||1||
59744555|NCT00994214|75863629|FG001|Received Maximum Dose of 4mg|ITT (Intention-to-Treat) - Part B||3||
59744556|NCT00994214|75863630|FG002|Received Maximum Dose of 4mg|ITT (Intention-to-Treat) - Part B||0||
59744557|NCT00994214|75863631|FG003|Received Maximum Dose of 4mg|ITT (Intention-to-Treat) - Part B||0||
59744558|NCT00994214|75863628|FG000|Received Maximum Dose of 6mg|ITT (Intention-to-Treat) - Part B||0||
59744559|NCT00994214|75863629|FG001|Received Maximum Dose of 6mg|ITT (Intention-to-Treat) - Part B||0||
59744560|NCT00994214|75863630|FG002|Received Maximum Dose of 6mg|ITT (Intention-to-Treat) - Part B||2||
59744561|NCT00994214|75863631|FG003|Received Maximum Dose of 6mg|ITT (Intention-to-Treat) - Part B||3||
59744562|NCT00994214|75863628|FG000|COMPLETED|ITT (Intention-to-Treat) - Part B||0||
59744563|NCT00994214|75863629|FG001|COMPLETED|ITT (Intention-to-Treat) - Part B||0||
59744564|NCT00994214|75863630|FG002|COMPLETED|ITT (Intention-to-Treat) - Part B||0||
59744565|NCT00994214|75863631|FG003|COMPLETED|ITT (Intention-to-Treat) - Part B||0||
59744566|NCT00994214|75863628|FG000|NOT COMPLETED|ITT (Intention-to-Treat) - Part B||4||
59744567|NCT00994214|75863629|FG001|NOT COMPLETED|ITT (Intention-to-Treat) - Part B||3||
59744568|NCT00994214|75863630|FG002|NOT COMPLETED|ITT (Intention-to-Treat) - Part B||2||
59744569|NCT00994214|75863631|FG003|NOT COMPLETED|ITT (Intention-to-Treat) - Part B||3||
59744570|NCT01034657|75863659|FG000|STARTED|Core Phase||34||
59744571|NCT01034657|75863660|FG001|STARTED|Core Phase||0||
59744572|NCT01034657|75863661|FG002|STARTED|Core Phase||0||
59744573|NCT01034657|75863659|FG000|COMPLETED|Core Phase||20||
59744574|NCT01034657|75863660|FG001|COMPLETED|Core Phase||0||
59744575|NCT01034657|75863661|FG002|COMPLETED|Core Phase||0||
59744576|NCT01034657|75863659|FG000|NOT COMPLETED|Core Phase||14||
59744577|NCT01034657|75863660|FG001|NOT COMPLETED|Core Phase||0||
59744578|NCT01034657|75863661|FG002|NOT COMPLETED|Core Phase||0||
59744579|NCT01034657|75863659|FG000|STARTED|Randomized Phase||6||
59744580|NCT01034657|75863660|FG001|STARTED|Randomized Phase||6||
59744581|NCT01034657|75863661|FG002|STARTED|Randomized Phase||1||
59744582|NCT01034657|75863659|FG000|COMPLETED|Randomized Phase||1||
59744583|NCT01034657|75863660|FG001|COMPLETED|Randomized Phase||0||
59744584|NCT01034657|75863661|FG002|COMPLETED|Randomized Phase||0||
59744585|NCT01034657|75863659|FG000|NOT COMPLETED|Randomized Phase||5||
59744586|NCT01034657|75863660|FG001|NOT COMPLETED|Randomized Phase||6||
59744587|NCT01034657|75863661|FG002|NOT COMPLETED|Randomized Phase||1||
59744588|NCT01014767|75863675|FG000|STARTED|Overall Study||12||
59744589|NCT01014767|75863676|FG001|STARTED|Overall Study||1||
59744590|NCT01014767|75863677|FG002|STARTED|Overall Study||4||
59744591|NCT01014767|75863678|FG003|STARTED|Overall Study||1||
59744592|NCT01014767|75863675|FG000|COMPLETED|Overall Study||0||
59744593|NCT01014767|75863676|FG001|COMPLETED|Overall Study||0||
59744594|NCT01014767|75863677|FG002|COMPLETED|Overall Study||0||
59744595|NCT01014767|75863678|FG003|COMPLETED|Overall Study||0||
59744596|NCT01014767|75863675|FG000|NOT COMPLETED|Overall Study||12||
59744597|NCT01014767|75863676|FG001|NOT COMPLETED|Overall Study||1||
59744598|NCT01014767|75863677|FG002|NOT COMPLETED|Overall Study||4||
59744599|NCT01014767|75863678|FG003|NOT COMPLETED|Overall Study||1||
59744600|NCT02016781|75863690|FG000|STARTED|Interim Look for Primary Analysis||260|Interim look uses data cutoff as of February 18, 2020|
59744601|NCT02016781|75863691|FG001|STARTED|Interim Look for Primary Analysis||124|Interim look uses data cutoff as of February 18, 2020|
59744602|NCT02016781|75863690|FG000|COMPLETED|Interim Look for Primary Analysis||187|Patients completed 3 years of follow up or died.|
59744603|NCT02016781|75863691|FG001|COMPLETED|Interim Look for Primary Analysis||100|Patients completed 3 years of follow up or died.|
59744604|NCT02016781|75863690|FG000|NOT COMPLETED|Interim Look for Primary Analysis||73||
59744605|NCT02016781|75863691|FG001|NOT COMPLETED|Interim Look for Primary Analysis||24||
59744606|NCT02016781|75863690|FG000|STARTED|Final Database Lock||261|Final database lock was on May 24, 2022. One patient was categorized in the non-HCT arm at interim analysis data look. The site corrected data to assign this patient to HCT arm after interim analysis data cutoff date and confirmed that the patient did receive transplant. Patients missing visits or data was unable to be obtained are categorized as not completing the study due to missing data.|
59744607|NCT02016781|75863691|FG001|STARTED|Final Database Lock||123|Final database lock was on May 24, 2022. One patient was categorized in the non-HCT arm at interim analysis data look. The site corrected data to assign this patient to HCT arm after interim analysis data cutoff date and confirmed that the patient did receive transplant. Patients missing visits or data was unable to be obtained are categorized as not completing the study due to missing data.|
59744608|NCT02016781|75863690|FG000|COMPLETED|Final Database Lock||248||
59744609|NCT02016781|75863691|FG001|COMPLETED|Final Database Lock||115||
59744610|NCT02016781|75863690|FG000|NOT COMPLETED|Final Database Lock||13||
59744611|NCT02016781|75863691|FG001|NOT COMPLETED|Final Database Lock||8||
59744612|NCT01014689|75863699|FG000|STARTED|Overall Study||191||
59744613|NCT01014689|75863700|FG001|STARTED|Overall Study||187||
59744614|NCT01014689|75863699|FG000|COMPLETED|Overall Study||178||
59744615|NCT01014689|75863700|FG001|COMPLETED|Overall Study||174||
59744616|NCT01014689|75863699|FG000|NOT COMPLETED|Overall Study||13||
59744617|NCT01014689|75863700|FG001|NOT COMPLETED|Overall Study||13||
59744618|NCT01014533|75863708|FG000|STARTED|Overall Study||29||
59744619|NCT01014533|75863709|FG001|STARTED|Overall Study||30||
59744620|NCT01014533|75863708|FG000|COMPLETED|Overall Study||24||
60135076|NCT03307252|76258163|FG010|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0||
60135077|NCT03307252|76258153|FG000|STARTED|Part 2, Period 2||0||
60135078|NCT03307252|76258154|FG001|STARTED|Part 2, Period 2||0||
60135079|NCT03307252|76258155|FG002|STARTED|Part 2, Period 2||0||
59744621|NCT01014533|75863709|FG001|COMPLETED|Overall Study||25||
59744622|NCT01014533|75863708|FG000|NOT COMPLETED|Overall Study||5||
59744623|NCT01014533|75863709|FG001|NOT COMPLETED|Overall Study||5||
59873042|NCT03023878|75997169|FG000|STARTED|Long Term Follow-Up Period||28|Treatment period participants are followed|
59873043|NCT03023878|75997169|FG000|COMPLETED|Long Term Follow-Up Period||26||
59873044|NCT03023878|75997169|FG000|NOT COMPLETED|Long Term Follow-Up Period||2||
59873045|NCT03022630|75997175|FG000|STARTED|Overall Study||31||
59744624|NCT02013427|75863719|FG000|STARTED|Overall Study||25||
59744625|NCT02013427|75863720|FG001|STARTED|Overall Study||5||
59744626|NCT02013427|75863721|FG002|STARTED|Overall Study||52||
59744627|NCT02013427|75863719|FG000|COMPLETED|Overall Study||20||
59744628|NCT02013427|75863720|FG001|COMPLETED|Overall Study||4||
59744629|NCT02013427|75863721|FG002|COMPLETED|Overall Study||43||
59744630|NCT02013427|75863719|FG000|NOT COMPLETED|Overall Study||5||
59744631|NCT02013427|75863720|FG001|NOT COMPLETED|Overall Study||1||
59744632|NCT02013427|75863721|FG002|NOT COMPLETED|Overall Study||9||
59744633|NCT01014143|75863732|FG000|STARTED|First Intervention||10||
59744634|NCT01014143|75863733|FG001|STARTED|First Intervention||9||
59744635|NCT01014143|75863734|FG002|STARTED|First Intervention||9||
59744636|NCT01014143|75863732|FG000|COMPLETED|First Intervention||10||
59873046|NCT03022630|75997176|FG001|STARTED|Overall Study||32||
60002375|NCT02064868|76118239|FG000|STARTED|Overall Study||1756|All Randomized Participants|
60002376|NCT02064868|76118240|FG001|STARTED|Overall Study||894|All Randomized Participants|
60002377|NCT02064868|76118239|FG000|Full Analysis Set|Overall Study||1756||
60002378|NCT02064868|76118240|FG001|Full Analysis Set|Overall Study||894||
60002379|NCT02064868|76118239|FG000|Safety Set|Overall Study|The Safety Set includes one patient not randomized but treated with serelaxin|1729||
60002380|NCT02064868|76118240|FG001|Safety Set|Overall Study||894||
60002381|NCT02064868|76118239|FG000|Per Protocol Set|Overall Study||1155||
60002382|NCT02064868|76118240|FG001|Per Protocol Set|Overall Study||627||
60002383|NCT02064868|76118239|FG000|COMPLETED|Overall Study||1722||
60002384|NCT02064868|76118240|FG001|COMPLETED|Overall Study||881||
60002385|NCT02064868|76118239|FG000|NOT COMPLETED|Overall Study||34||
60002386|NCT02064868|76118240|FG001|NOT COMPLETED|Overall Study||13||
60002387|NCT02064166|76118248|FG000|STARTED|Overall Study||9||
60002388|NCT02064166|76118249|FG001|STARTED|Overall Study||6||
60002389|NCT02064166|76118248|FG000|COMPLETED|Overall Study||8||
60002390|NCT02064166|76118249|FG001|COMPLETED|Overall Study||6||
60002391|NCT02064166|76118248|FG000|NOT COMPLETED|Overall Study||1||
60002392|NCT02064166|76118249|FG001|NOT COMPLETED|Overall Study||0||
60135080|NCT03307252|76258156|FG003|STARTED|Part 2, Period 2||4||
60135081|NCT03307252|76258157|FG004|STARTED|Part 2, Period 2||4||
59744637|NCT01014143|75863733|FG001|COMPLETED|First Intervention||9||
59744638|NCT01014143|75863734|FG002|COMPLETED|First Intervention||9||
59744639|NCT01014143|75863732|FG000|NOT COMPLETED|First Intervention||0||
59744640|NCT01014143|75863733|FG001|NOT COMPLETED|First Intervention||0||
59744641|NCT01014143|75863734|FG002|NOT COMPLETED|First Intervention||0||
59744642|NCT01014143|75863732|FG000|STARTED|Washout Period After 1st Intervention||10||
59744643|NCT01014143|75863733|FG001|STARTED|Washout Period After 1st Intervention||9||
59744644|NCT01014143|75863734|FG002|STARTED|Washout Period After 1st Intervention||9||
59744645|NCT01014143|75863732|FG000|COMPLETED|Washout Period After 1st Intervention||10||
59744646|NCT01014143|75863733|FG001|COMPLETED|Washout Period After 1st Intervention||9||
59744647|NCT01014143|75863734|FG002|COMPLETED|Washout Period After 1st Intervention||9||
59744648|NCT01014143|75863732|FG000|NOT COMPLETED|Washout Period After 1st Intervention||0||
59744649|NCT01014143|75863733|FG001|NOT COMPLETED|Washout Period After 1st Intervention||0||
59744650|NCT01014143|75863734|FG002|NOT COMPLETED|Washout Period After 1st Intervention||0||
59744651|NCT01014143|75863732|FG000|STARTED|Second Intervention||10||
59744652|NCT01014143|75863733|FG001|STARTED|Second Intervention||9||
59744653|NCT01014143|75863734|FG002|STARTED|Second Intervention||9||
59744654|NCT01014143|75863732|FG000|COMPLETED|Second Intervention||8||
59744655|NCT01014143|75863733|FG001|COMPLETED|Second Intervention||9||
59744656|NCT01014143|75863734|FG002|COMPLETED|Second Intervention||9||
59744657|NCT01014143|75863732|FG000|NOT COMPLETED|Second Intervention||2||
59744658|NCT01014143|75863733|FG001|NOT COMPLETED|Second Intervention||0||
59744659|NCT01014143|75863734|FG002|NOT COMPLETED|Second Intervention||0||
59744660|NCT01014143|75863732|FG000|STARTED|Washout After 2nd Intervention||8||
59744661|NCT01014143|75863733|FG001|STARTED|Washout After 2nd Intervention||9||
59744662|NCT01014143|75863734|FG002|STARTED|Washout After 2nd Intervention||9||
59744663|NCT01014143|75863732|FG000|COMPLETED|Washout After 2nd Intervention||8||
59744664|NCT01014143|75863733|FG001|COMPLETED|Washout After 2nd Intervention||9||
59744665|NCT01014143|75863734|FG002|COMPLETED|Washout After 2nd Intervention||9||
59744666|NCT01014143|75863732|FG000|NOT COMPLETED|Washout After 2nd Intervention||0||
59744667|NCT01014143|75863733|FG001|NOT COMPLETED|Washout After 2nd Intervention||0||
59744668|NCT01014143|75863734|FG002|NOT COMPLETED|Washout After 2nd Intervention||0||
59744669|NCT01014143|75863732|FG000|STARTED|Third Intervention||8||
59744670|NCT01014143|75863733|FG001|STARTED|Third Intervention||9||
59744671|NCT01014143|75863734|FG002|STARTED|Third Intervention||9||
59744672|NCT01014143|75863732|FG000|COMPLETED|Third Intervention||8||
59744673|NCT01014143|75863733|FG001|COMPLETED|Third Intervention||9||
59744674|NCT01014143|75863734|FG002|COMPLETED|Third Intervention||9||
59744675|NCT01014143|75863732|FG000|NOT COMPLETED|Third Intervention||0||
59744676|NCT01014143|75863733|FG001|NOT COMPLETED|Third Intervention||0||
59744677|NCT01014143|75863734|FG002|NOT COMPLETED|Third Intervention||0||
59744678|NCT01013753|75863742|FG000|STARTED|Overall Study|Entered and treated|198||
59744679|NCT01013753|75863742|FG000|Received Placebo|Overall Study||125||
59744680|NCT01013753|75863742|FG000|Received Olo 2 mcg qd|Overall Study||121||
59744681|NCT01013753|75863742|FG000|Received Olo 5 mcg qd|Overall Study||130||
59744682|NCT01013753|75863742|FG000|Received Olo 10 mcg qd|Overall Study||127||
59744683|NCT01013753|75863742|FG000|Received Olo 20 mcg qd|Overall Study||124||
59744684|NCT01013753|75863742|FG000|Received Form 12 mcg Bid|Overall Study||125||
59744685|NCT01013753|75863742|FG000|COMPLETED|Overall Study||182||
59744686|NCT01013753|75863742|FG000|NOT COMPLETED|Overall Study||16||
59744687|NCT00757042|75863767|FG000|STARTED|Overall Study||6||
59744688|NCT00757042|75863768|FG001|STARTED|Overall Study||6||
59744689|NCT00757042|75863769|FG002|STARTED|Overall Study||6||
59744690|NCT00757042|75863770|FG003|STARTED|Overall Study||6||
59744691|NCT00757042|75863771|FG004|STARTED|Overall Study||6||
59744692|NCT00757042|75863772|FG005|STARTED|Overall Study||6||
59744693|NCT00757042|75863773|FG006|STARTED|Overall Study||6||
59744694|NCT00757042|75863774|FG007|STARTED|Overall Study||6||
59744695|NCT00757042|75863775|FG008|STARTED|Overall Study||16||
59744696|NCT00757042|75863776|FG009|STARTED|Overall Study||10||
59744697|NCT00757042|75863777|FG010|STARTED|Overall Study||4||
59744698|NCT00757042|75863767|FG000|Received Study Drug|Overall Study||6||
59744699|NCT00757042|75863768|FG001|Received Study Drug|Overall Study||6||
59744700|NCT00757042|75863769|FG002|Received Study Drug|Overall Study||6||
59744701|NCT00757042|75863770|FG003|Received Study Drug|Overall Study||6||
59744702|NCT00757042|75863771|FG004|Received Study Drug|Overall Study||6||
59744703|NCT00757042|75863772|FG005|Received Study Drug|Overall Study||6||
59744704|NCT00757042|75863773|FG006|Received Study Drug|Overall Study||6||
59744705|NCT00757042|75863774|FG007|Received Study Drug|Overall Study||6||
59744706|NCT00757042|75863775|FG008|Received Study Drug|Overall Study||16||
59744707|NCT00757042|75863776|FG009|Received Study Drug|Overall Study||9||
59744708|NCT00757042|75863777|FG010|Received Study Drug|Overall Study||3||
59744709|NCT00757042|75863767|FG000|COMPLETED|Overall Study||6||
59744710|NCT00757042|75863768|FG001|COMPLETED|Overall Study||6||
59744711|NCT00757042|75863769|FG002|COMPLETED|Overall Study||6||
59744712|NCT00757042|75863770|FG003|COMPLETED|Overall Study||6||
59744713|NCT00757042|75863771|FG004|COMPLETED|Overall Study||6||
59744714|NCT00757042|75863772|FG005|COMPLETED|Overall Study||6||
59744715|NCT00757042|75863773|FG006|COMPLETED|Overall Study||6||
59744716|NCT00757042|75863774|FG007|COMPLETED|Overall Study||6||
59744717|NCT00757042|75863775|FG008|COMPLETED|Overall Study||15||
59744718|NCT00757042|75863776|FG009|COMPLETED|Overall Study||9||
59744719|NCT00757042|75863777|FG010|COMPLETED|Overall Study||3||
59744720|NCT00757042|75863767|FG000|NOT COMPLETED|Overall Study||0||
59744721|NCT00757042|75863768|FG001|NOT COMPLETED|Overall Study||0||
59744722|NCT00757042|75863769|FG002|NOT COMPLETED|Overall Study||0||
59744723|NCT00757042|75863770|FG003|NOT COMPLETED|Overall Study||0||
59744724|NCT00757042|75863771|FG004|NOT COMPLETED|Overall Study||0||
59744725|NCT00757042|75863772|FG005|NOT COMPLETED|Overall Study||0||
59744726|NCT00757042|75863773|FG006|NOT COMPLETED|Overall Study||0||
59744727|NCT00757042|75863774|FG007|NOT COMPLETED|Overall Study||0||
59744728|NCT00757042|75863775|FG008|NOT COMPLETED|Overall Study||1||
59744729|NCT00757042|75863776|FG009|NOT COMPLETED|Overall Study||1||
59744730|NCT00757042|75863777|FG010|NOT COMPLETED|Overall Study||1||
59744731|NCT01013597|75863808|FG000|STARTED|Overall Study||13||
59744732|NCT01013597|75863808|FG000|COMPLETED|Overall Study||12||
59744733|NCT01013597|75863808|FG000|NOT COMPLETED|Overall Study||1||
59744734|NCT00715273|75863815|FG000|STARTED|Overall Study||71||
59744735|NCT00715273|75863816|FG001|STARTED|Overall Study||73||
59744736|NCT00715273|75863817|FG002|STARTED|Overall Study||73||
59744737|NCT00715273|75863815|FG000|COMPLETED|Overall Study||63||
59744738|NCT00715273|75863816|FG001|COMPLETED|Overall Study||65||
59744739|NCT00715273|75863817|FG002|COMPLETED|Overall Study||68||
59744740|NCT00715273|75863815|FG000|NOT COMPLETED|Overall Study||8||
59744741|NCT00715273|75863816|FG001|NOT COMPLETED|Overall Study||8||
59744742|NCT00715273|75863817|FG002|NOT COMPLETED|Overall Study||5||
59744743|NCT01013285|75863827|FG000|STARTED|Overall Study||70||
59744744|NCT01013285|75863828|FG001|STARTED|Overall Study||110||
59744745|NCT01013285|75863827|FG000|COMPLETED|Overall Study||22||
59744746|NCT01013285|75863828|FG001|COMPLETED|Overall Study||21||
59744747|NCT01013285|75863827|FG000|NOT COMPLETED|Overall Study||48||
59744748|NCT01013285|75863828|FG001|NOT COMPLETED|Overall Study||89||
59744749|NCT01033643|75863838|FG000|STARTED|Overall Study||6||
59744750|NCT01033643|75863839|FG001|STARTED|Overall Study||6||
59744751|NCT01033643|75863840|FG002|STARTED|Overall Study||6||
59744752|NCT01033643|75863841|FG003|STARTED|Overall Study||4||
59744753|NCT01033643|75863842|FG004|STARTED|Overall Study||0||
59744754|NCT01033643|75863843|FG005|STARTED|Overall Study||8||
59744755|NCT01033643|75863838|FG000|COMPLETED|Overall Study||6||
59744756|NCT01033643|75863839|FG001|COMPLETED|Overall Study||3||
59744757|NCT01033643|75863840|FG002|COMPLETED|Overall Study||6||
60135082|NCT03307252|76258158|FG005|STARTED|Part 2, Period 2||3||
60135083|NCT03307252|76258159|FG006|STARTED|Part 2, Period 2||5||
59744758|NCT01033643|75863841|FG003|COMPLETED|Overall Study||4||
59744759|NCT01033643|75863842|FG004|COMPLETED|Overall Study||0||
59744760|NCT01033643|75863843|FG005|COMPLETED|Overall Study||7||
59744761|NCT01033643|75863838|FG000|NOT COMPLETED|Overall Study||0||
59744762|NCT01033643|75863839|FG001|NOT COMPLETED|Overall Study||3||
59744763|NCT01033643|75863840|FG002|NOT COMPLETED|Overall Study||0||
59744764|NCT01033643|75863841|FG003|NOT COMPLETED|Overall Study||0||
59744765|NCT01033643|75863842|FG004|NOT COMPLETED|Overall Study||0||
59744766|NCT01033643|75863843|FG005|NOT COMPLETED|Overall Study||1||
59744767|NCT01013207|75863857|FG000|STARTED|CPAP Pre Nexus (S9)||50||
59744768|NCT01013207|75863857|FG000|COMPLETED|CPAP Pre Nexus (S9)||50||
59744769|NCT01013207|75863857|FG000|NOT COMPLETED|CPAP Pre Nexus (S9)||0||
59744770|NCT01013207|75863857|FG000|STARTED|Nexus (S9)||50||
59744771|NCT01013207|75863857|FG000|COMPLETED|Nexus (S9)||50||
59744772|NCT01013207|75863857|FG000|NOT COMPLETED|Nexus (S9)||0||
59744773|NCT01013207|75863857|FG000|STARTED|CPAP Post Nexus (S9)||50||
59744774|NCT01013207|75863857|FG000|COMPLETED|CPAP Post Nexus (S9)||44||
59744775|NCT01013207|75863857|FG000|NOT COMPLETED|CPAP Post Nexus (S9)||6||
59744776|NCT01033487|75863861|FG000|STARTED|First Intervention Period||2||
59744777|NCT01033487|75863862|FG001|STARTED|First Intervention Period||3||
59744778|NCT01033487|75863863|FG002|STARTED|First Intervention Period||2||
59744779|NCT01033487|75863864|FG003|STARTED|First Intervention Period||2||
59744780|NCT01033487|75863865|FG004|STARTED|First Intervention Period||2||
59744781|NCT01033487|75863866|FG005|STARTED|First Intervention Period||2||
59744782|NCT01033487|75863867|FG006|STARTED|First Intervention Period||2||
59744783|NCT01033487|75863868|FG007|STARTED|First Intervention Period||3||
59744784|NCT01033487|75863869|FG008|STARTED|First Intervention Period||2||
59744785|NCT01033487|75863870|FG009|STARTED|First Intervention Period||2||
59744786|NCT01033487|75863861|FG000|COMPLETED|First Intervention Period||2||
59744787|NCT01033487|75863862|FG001|COMPLETED|First Intervention Period||3||
59744788|NCT01033487|75863863|FG002|COMPLETED|First Intervention Period||2||
59744789|NCT01033487|75863864|FG003|COMPLETED|First Intervention Period||2||
59744790|NCT01033487|75863865|FG004|COMPLETED|First Intervention Period||2||
59744791|NCT01033487|75863866|FG005|COMPLETED|First Intervention Period||2||
59744792|NCT01033487|75863867|FG006|COMPLETED|First Intervention Period||2||
59744793|NCT01033487|75863868|FG007|COMPLETED|First Intervention Period||3||
60135084|NCT03307252|76258160|FG007|STARTED|Part 2, Period 2||0||
59744794|NCT01033487|75863869|FG008|COMPLETED|First Intervention Period||2||
59744795|NCT01033487|75863870|FG009|COMPLETED|First Intervention Period||2||
59744796|NCT01033487|75863861|FG000|NOT COMPLETED|First Intervention Period||0||
59744797|NCT01033487|75863862|FG001|NOT COMPLETED|First Intervention Period||0||
59744798|NCT01033487|75863863|FG002|NOT COMPLETED|First Intervention Period||0||
59744799|NCT01033487|75863864|FG003|NOT COMPLETED|First Intervention Period||0||
59744800|NCT01033487|75863865|FG004|NOT COMPLETED|First Intervention Period||0||
59744801|NCT01033487|75863866|FG005|NOT COMPLETED|First Intervention Period||0||
59744802|NCT01033487|75863867|FG006|NOT COMPLETED|First Intervention Period||0||
59744803|NCT01033487|75863868|FG007|NOT COMPLETED|First Intervention Period||0||
59744804|NCT01033487|75863869|FG008|NOT COMPLETED|First Intervention Period||0||
59744805|NCT01033487|75863870|FG009|NOT COMPLETED|First Intervention Period||0||
59744806|NCT01033487|75863861|FG000|STARTED|Between Period 1 and 2 (At Least 7 Days)||2||
59744807|NCT01033487|75863862|FG001|STARTED|Between Period 1 and 2 (At Least 7 Days)||3||
59744808|NCT01033487|75863863|FG002|STARTED|Between Period 1 and 2 (At Least 7 Days)||2||
59744809|NCT01033487|75863864|FG003|STARTED|Between Period 1 and 2 (At Least 7 Days)||2||
59744810|NCT01033487|75863865|FG004|STARTED|Between Period 1 and 2 (At Least 7 Days)||2||
59744811|NCT01033487|75863866|FG005|STARTED|Between Period 1 and 2 (At Least 7 Days)||2||
59744812|NCT01033487|75863867|FG006|STARTED|Between Period 1 and 2 (At Least 7 Days)||2||
59744813|NCT01033487|75863868|FG007|STARTED|Between Period 1 and 2 (At Least 7 Days)||3||
59744814|NCT01033487|75863869|FG008|STARTED|Between Period 1 and 2 (At Least 7 Days)||2||
59744815|NCT01033487|75863870|FG009|STARTED|Between Period 1 and 2 (At Least 7 Days)||2||
59744816|NCT01033487|75863861|FG000|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2||
59744817|NCT01033487|75863862|FG001|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||3||
59744818|NCT01033487|75863863|FG002|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2||
59744819|NCT01033487|75863864|FG003|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2||
59744820|NCT01033487|75863865|FG004|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2||
59744821|NCT01033487|75863866|FG005|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2||
59744822|NCT01033487|75863867|FG006|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2||
59744823|NCT01033487|75863868|FG007|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||3||
59744824|NCT01033487|75863869|FG008|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2||
59744825|NCT01033487|75863870|FG009|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2||
59744826|NCT01033487|75863861|FG000|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0||
59744827|NCT01033487|75863862|FG001|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0||
59744828|NCT01033487|75863863|FG002|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0||
59744829|NCT01033487|75863864|FG003|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0||
59744830|NCT01033487|75863865|FG004|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0||
59744831|NCT01033487|75863866|FG005|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0||
59744832|NCT01033487|75863867|FG006|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0||
59744833|NCT01033487|75863868|FG007|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0||
59744834|NCT01033487|75863869|FG008|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0||
59744835|NCT01033487|75863870|FG009|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0||
59744836|NCT01033487|75863861|FG000|STARTED|Second Intervention Period||2||
59744837|NCT01033487|75863862|FG001|STARTED|Second Intervention Period||3||
59744838|NCT01033487|75863863|FG002|STARTED|Second Intervention Period||2||
59744839|NCT01033487|75863864|FG003|STARTED|Second Intervention Period||2||
59744840|NCT01033487|75863865|FG004|STARTED|Second Intervention Period||2||
59744841|NCT01033487|75863866|FG005|STARTED|Second Intervention Period||2||
59744842|NCT01033487|75863867|FG006|STARTED|Second Intervention Period||2||
59744843|NCT01033487|75863868|FG007|STARTED|Second Intervention Period||3||
59744844|NCT01033487|75863869|FG008|STARTED|Second Intervention Period||2||
59744845|NCT01033487|75863870|FG009|STARTED|Second Intervention Period||2||
59744846|NCT01033487|75863861|FG000|COMPLETED|Second Intervention Period||2||
59744847|NCT01033487|75863862|FG001|COMPLETED|Second Intervention Period||3||
59744848|NCT01033487|75863863|FG002|COMPLETED|Second Intervention Period||2||
59744849|NCT01033487|75863864|FG003|COMPLETED|Second Intervention Period||2||
59744850|NCT01033487|75863865|FG004|COMPLETED|Second Intervention Period||2||
59744851|NCT01033487|75863866|FG005|COMPLETED|Second Intervention Period||2||
59744852|NCT01033487|75863867|FG006|COMPLETED|Second Intervention Period||2||
59744853|NCT01033487|75863868|FG007|COMPLETED|Second Intervention Period||3||
59744854|NCT01033487|75863869|FG008|COMPLETED|Second Intervention Period||2||
59744855|NCT01033487|75863870|FG009|COMPLETED|Second Intervention Period||2||
59744856|NCT01033487|75863861|FG000|NOT COMPLETED|Second Intervention Period||0||
59744857|NCT01033487|75863862|FG001|NOT COMPLETED|Second Intervention Period||0||
59744858|NCT01033487|75863863|FG002|NOT COMPLETED|Second Intervention Period||0||
59744859|NCT01033487|75863864|FG003|NOT COMPLETED|Second Intervention Period||0||
59744860|NCT01033487|75863865|FG004|NOT COMPLETED|Second Intervention Period||0||
59744861|NCT01033487|75863866|FG005|NOT COMPLETED|Second Intervention Period||0||
59744862|NCT01033487|75863867|FG006|NOT COMPLETED|Second Intervention Period||0||
59744863|NCT01033487|75863868|FG007|NOT COMPLETED|Second Intervention Period||0||
59744864|NCT01033487|75863869|FG008|NOT COMPLETED|Second Intervention Period||0||
59744865|NCT01033487|75863870|FG009|NOT COMPLETED|Second Intervention Period||0||
59744866|NCT01033487|75863861|FG000|STARTED|Between Period 2 and 3 (At Least 7 Days)||2||
59744867|NCT01033487|75863862|FG001|STARTED|Between Period 2 and 3 (At Least 7 Days)||3||
59744868|NCT01033487|75863863|FG002|STARTED|Between Period 2 and 3 (At Least 7 Days)||2||
59744869|NCT01033487|75863864|FG003|STARTED|Between Period 2 and 3 (At Least 7 Days)||2||
59744870|NCT01033487|75863865|FG004|STARTED|Between Period 2 and 3 (At Least 7 Days)||2||
59744871|NCT01033487|75863866|FG005|STARTED|Between Period 2 and 3 (At Least 7 Days)||2||
59744872|NCT01033487|75863867|FG006|STARTED|Between Period 2 and 3 (At Least 7 Days)||2||
59744873|NCT01033487|75863868|FG007|STARTED|Between Period 2 and 3 (At Least 7 Days)||3||
59744874|NCT01033487|75863869|FG008|STARTED|Between Period 2 and 3 (At Least 7 Days)||2||
59744875|NCT01033487|75863870|FG009|STARTED|Between Period 2 and 3 (At Least 7 Days)||2||
59744876|NCT01033487|75863861|FG000|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2||
59744877|NCT01033487|75863862|FG001|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||3||
59744878|NCT01033487|75863863|FG002|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2||
59744879|NCT01033487|75863864|FG003|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2||
59744880|NCT01033487|75863865|FG004|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2||
59744881|NCT01033487|75863866|FG005|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2||
59744882|NCT01033487|75863867|FG006|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2||
59744883|NCT01033487|75863868|FG007|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||3||
59744884|NCT01033487|75863869|FG008|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2||
59744885|NCT01033487|75863870|FG009|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2||
59744886|NCT01033487|75863861|FG000|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0||
59744887|NCT01033487|75863862|FG001|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0||
59744888|NCT01033487|75863863|FG002|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0||
59744889|NCT01033487|75863864|FG003|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0||
59744890|NCT01033487|75863865|FG004|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0||
60135085|NCT03307252|76258161|FG008|STARTED|Part 2, Period 2||0||
60135086|NCT03307252|76258162|FG009|STARTED|Part 2, Period 2||0||
60135087|NCT03307252|76258163|FG010|STARTED|Part 2, Period 2||0||
60135088|NCT03307252|76258153|FG000|COMPLETED|Part 2, Period 2||0||
60135089|NCT03307252|76258154|FG001|COMPLETED|Part 2, Period 2||0||
59744891|NCT01033487|75863866|FG005|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0||
59744892|NCT01033487|75863867|FG006|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0||
59744893|NCT01033487|75863868|FG007|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0||
59744894|NCT01033487|75863869|FG008|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0||
59744895|NCT01033487|75863870|FG009|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0||
59744896|NCT01033487|75863861|FG000|STARTED|Third Intervention Period||2||
59744897|NCT01033487|75863862|FG001|STARTED|Third Intervention Period||3||
59744898|NCT01033487|75863863|FG002|STARTED|Third Intervention Period||2||
59744899|NCT01033487|75863864|FG003|STARTED|Third Intervention Period||2||
59744900|NCT01033487|75863865|FG004|STARTED|Third Intervention Period||2||
59744901|NCT01033487|75863866|FG005|STARTED|Third Intervention Period||2||
59744902|NCT01033487|75863867|FG006|STARTED|Third Intervention Period||2||
59744903|NCT01033487|75863868|FG007|STARTED|Third Intervention Period||3||
59744904|NCT01033487|75863869|FG008|STARTED|Third Intervention Period||2||
59744905|NCT01033487|75863870|FG009|STARTED|Third Intervention Period||2||
59744906|NCT01033487|75863861|FG000|COMPLETED|Third Intervention Period||2||
60135090|NCT03307252|76258155|FG002|COMPLETED|Part 2, Period 2||0||
59744907|NCT01033487|75863862|FG001|COMPLETED|Third Intervention Period||3||
59744908|NCT01033487|75863863|FG002|COMPLETED|Third Intervention Period||2||
60135091|NCT03307252|76258156|FG003|COMPLETED|Part 2, Period 2||4||
60135092|NCT03307252|76258157|FG004|COMPLETED|Part 2, Period 2||4||
60135093|NCT03307252|76258158|FG005|COMPLETED|Part 2, Period 2||3||
60135094|NCT03307252|76258159|FG006|COMPLETED|Part 2, Period 2||5||
60135095|NCT03307252|76258160|FG007|COMPLETED|Part 2, Period 2||0||
59744909|NCT01033487|75863864|FG003|COMPLETED|Third Intervention Period||2||
59873047|NCT03022630|75997175|FG000|COMPLETED|Overall Study||22||
60135096|NCT03307252|76258161|FG008|COMPLETED|Part 2, Period 2||0||
60135097|NCT03307252|76258162|FG009|COMPLETED|Part 2, Period 2||0||
59744910|NCT01033487|75863865|FG004|COMPLETED|Third Intervention Period||2||
59744911|NCT01033487|75863866|FG005|COMPLETED|Third Intervention Period||2||
59744912|NCT01033487|75863867|FG006|COMPLETED|Third Intervention Period||2||
59744913|NCT01033487|75863868|FG007|COMPLETED|Third Intervention Period||3||
59744914|NCT01033487|75863869|FG008|COMPLETED|Third Intervention Period||2||
59744915|NCT01033487|75863870|FG009|COMPLETED|Third Intervention Period||2||
59744916|NCT01033487|75863861|FG000|NOT COMPLETED|Third Intervention Period||0||
59744917|NCT01033487|75863862|FG001|NOT COMPLETED|Third Intervention Period||0||
59744918|NCT01033487|75863863|FG002|NOT COMPLETED|Third Intervention Period||0||
60135098|NCT03307252|76258163|FG010|COMPLETED|Part 2, Period 2||0||
60135099|NCT03307252|76258153|FG000|NOT COMPLETED|Part 2, Period 2||0||
60135100|NCT03307252|76258154|FG001|NOT COMPLETED|Part 2, Period 2||0||
60135101|NCT03307252|76258155|FG002|NOT COMPLETED|Part 2, Period 2||0||
60135102|NCT03307252|76258156|FG003|NOT COMPLETED|Part 2, Period 2||0||
60135103|NCT03307252|76258157|FG004|NOT COMPLETED|Part 2, Period 2||0||
60135104|NCT03307252|76258158|FG005|NOT COMPLETED|Part 2, Period 2||0||
60135105|NCT03307252|76258159|FG006|NOT COMPLETED|Part 2, Period 2||0||
60135106|NCT03307252|76258160|FG007|NOT COMPLETED|Part 2, Period 2||0||
59744919|NCT01033487|75863864|FG003|NOT COMPLETED|Third Intervention Period||0||
59744920|NCT01033487|75863865|FG004|NOT COMPLETED|Third Intervention Period||0||
59744921|NCT01033487|75863866|FG005|NOT COMPLETED|Third Intervention Period||0||
59744922|NCT01033487|75863867|FG006|NOT COMPLETED|Third Intervention Period||0||
59744923|NCT01033487|75863868|FG007|NOT COMPLETED|Third Intervention Period||0||
59744924|NCT01033487|75863869|FG008|NOT COMPLETED|Third Intervention Period||0||
59744925|NCT01033487|75863870|FG009|NOT COMPLETED|Third Intervention Period||0||
59744926|NCT01033487|75863861|FG000|STARTED|Between Period 3 and 4 (At Least 7 Days)||2||
59744927|NCT01033487|75863862|FG001|STARTED|Between Period 3 and 4 (At Least 7 Days)||3||
59744928|NCT01033487|75863863|FG002|STARTED|Between Period 3 and 4 (At Least 7 Days)||2||
59744929|NCT01033487|75863864|FG003|STARTED|Between Period 3 and 4 (At Least 7 Days)||2||
59744930|NCT01033487|75863865|FG004|STARTED|Between Period 3 and 4 (At Least 7 Days)||2||
59744931|NCT01033487|75863866|FG005|STARTED|Between Period 3 and 4 (At Least 7 Days)||2||
59744932|NCT01033487|75863867|FG006|STARTED|Between Period 3 and 4 (At Least 7 Days)||2||
59744933|NCT01033487|75863868|FG007|STARTED|Between Period 3 and 4 (At Least 7 Days)||3||
59744934|NCT01033487|75863869|FG008|STARTED|Between Period 3 and 4 (At Least 7 Days)||2||
59744935|NCT01033487|75863870|FG009|STARTED|Between Period 3 and 4 (At Least 7 Days)||2||
59744936|NCT01033487|75863861|FG000|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2||
59744937|NCT01033487|75863862|FG001|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||3||
59744938|NCT01033487|75863863|FG002|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2||
59744939|NCT01033487|75863864|FG003|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2||
59744940|NCT01033487|75863865|FG004|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2||
59744941|NCT01033487|75863866|FG005|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2||
59744942|NCT01033487|75863867|FG006|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2||
59744943|NCT01033487|75863868|FG007|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||3||
59744944|NCT01033487|75863869|FG008|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2||
59744945|NCT01033487|75863870|FG009|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2||
59744946|NCT01033487|75863861|FG000|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0||
59744947|NCT01033487|75863862|FG001|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0||
59744948|NCT01033487|75863863|FG002|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0||
59744949|NCT01033487|75863864|FG003|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0||
59744950|NCT01033487|75863865|FG004|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0||
59744951|NCT01033487|75863866|FG005|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0||
59744952|NCT01033487|75863867|FG006|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0||
59744953|NCT01033487|75863868|FG007|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0||
59744954|NCT01033487|75863869|FG008|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0||
59744955|NCT01033487|75863870|FG009|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0||
59744956|NCT01033487|75863861|FG000|STARTED|Fourth Intervention Period||2||
59744957|NCT01033487|75863862|FG001|STARTED|Fourth Intervention Period||3||
59744958|NCT01033487|75863863|FG002|STARTED|Fourth Intervention Period||2||
60002393|NCT02565615|76118282|FG000|STARTED|Overall Study||291||
60002394|NCT02565615|76118283|FG001|STARTED|Overall Study||3080||
60002395|NCT02565615|76118284|FG002|STARTED|Overall Study||21||
60002396|NCT02565615|76118285|FG003|STARTED|Overall Study||101||
60002397|NCT02565615|76118286|FG004|STARTED|Overall Study||1622||
60002398|NCT02565615|76118282|FG000|Treated|Overall Study||291||
60002399|NCT02565615|76118283|FG001|Treated|Overall Study||3080||
60002400|NCT02565615|76118284|FG002|Treated|Overall Study||21||
60002401|NCT02565615|76118285|FG003|Treated|Overall Study||101||
60135107|NCT03307252|76258161|FG008|NOT COMPLETED|Part 2, Period 2||0||
60135108|NCT03307252|76258162|FG009|NOT COMPLETED|Part 2, Period 2||0||
60135109|NCT03307252|76258163|FG010|NOT COMPLETED|Part 2, Period 2||0||
60135110|NCT03307252|76258153|FG000|STARTED|Part 2, Washout Period 2 (7 Days)||0||
60135111|NCT03307252|76258154|FG001|STARTED|Part 2, Washout Period 2 (7 Days)||0||
60135112|NCT03307252|76258155|FG002|STARTED|Part 2, Washout Period 2 (7 Days)||0||
60135113|NCT03307252|76258156|FG003|STARTED|Part 2, Washout Period 2 (7 Days)||4||
60135114|NCT03307252|76258157|FG004|STARTED|Part 2, Washout Period 2 (7 Days)||4||
59744959|NCT01033487|75863864|FG003|STARTED|Fourth Intervention Period||2||
59744960|NCT01033487|75863865|FG004|STARTED|Fourth Intervention Period||2||
59744961|NCT01033487|75863866|FG005|STARTED|Fourth Intervention Period||2||
59744962|NCT01033487|75863867|FG006|STARTED|Fourth Intervention Period||2||
59744963|NCT01033487|75863868|FG007|STARTED|Fourth Intervention Period||3||
59744964|NCT01033487|75863869|FG008|STARTED|Fourth Intervention Period||2||
59744965|NCT01033487|75863870|FG009|STARTED|Fourth Intervention Period||2||
59744966|NCT01033487|75863861|FG000|COMPLETED|Fourth Intervention Period||2||
59744967|NCT01033487|75863862|FG001|COMPLETED|Fourth Intervention Period||3||
59762494|NCT02644525|75882211|FG002|NOT COMPLETED|Group 3||0||
60002402|NCT02565615|76118286|FG004|Treated|Overall Study||1055||
60002403|NCT02565615|76118282|FG000|COMPLETED|Overall Study||288||
60002404|NCT02565615|76118283|FG001|COMPLETED|Overall Study||3044||
60135115|NCT03307252|76258158|FG005|STARTED|Part 2, Washout Period 2 (7 Days)||3||
60002405|NCT02565615|76118284|FG002|COMPLETED|Overall Study||21||
60002406|NCT02565615|76118285|FG003|COMPLETED|Overall Study||98||
60002407|NCT02565615|76118286|FG004|COMPLETED|Overall Study||21||
59744968|NCT01033487|75863863|FG002|COMPLETED|Fourth Intervention Period||2||
59744969|NCT01033487|75863864|FG003|COMPLETED|Fourth Intervention Period||2||
59744970|NCT01033487|75863865|FG004|COMPLETED|Fourth Intervention Period||2||
59744971|NCT01033487|75863866|FG005|COMPLETED|Fourth Intervention Period||2||
59744972|NCT01033487|75863867|FG006|COMPLETED|Fourth Intervention Period||2||
59744973|NCT01033487|75863868|FG007|COMPLETED|Fourth Intervention Period||3||
59744974|NCT01033487|75863869|FG008|COMPLETED|Fourth Intervention Period||1||
59744975|NCT01033487|75863870|FG009|COMPLETED|Fourth Intervention Period||2||
60135116|NCT03307252|76258159|FG006|STARTED|Part 2, Washout Period 2 (7 Days)||5||
59744976|NCT01033487|75863861|FG000|NOT COMPLETED|Fourth Intervention Period||0||
59744977|NCT01033487|75863862|FG001|NOT COMPLETED|Fourth Intervention Period||0||
59744978|NCT01033487|75863863|FG002|NOT COMPLETED|Fourth Intervention Period||0||
59744979|NCT01033487|75863864|FG003|NOT COMPLETED|Fourth Intervention Period||0||
59744980|NCT01033487|75863865|FG004|NOT COMPLETED|Fourth Intervention Period||0||
59744981|NCT01033487|75863866|FG005|NOT COMPLETED|Fourth Intervention Period||0||
59744982|NCT01033487|75863867|FG006|NOT COMPLETED|Fourth Intervention Period||0||
59744983|NCT01033487|75863868|FG007|NOT COMPLETED|Fourth Intervention Period||0||
59744984|NCT01033487|75863869|FG008|NOT COMPLETED|Fourth Intervention Period||1||
59744985|NCT01033487|75863870|FG009|NOT COMPLETED|Fourth Intervention Period||0||
59744986|NCT01033487|75863861|FG000|STARTED|Between Period 4 and 5 (At Least 7 Days)||2||
59744987|NCT01033487|75863862|FG001|STARTED|Between Period 4 and 5 (At Least 7 Days)||3||
59744988|NCT01033487|75863863|FG002|STARTED|Between Period 4 and 5 (At Least 7 Days)||2||
59744989|NCT01033487|75863864|FG003|STARTED|Between Period 4 and 5 (At Least 7 Days)||2||
59744990|NCT01033487|75863865|FG004|STARTED|Between Period 4 and 5 (At Least 7 Days)||2||
59744991|NCT01033487|75863866|FG005|STARTED|Between Period 4 and 5 (At Least 7 Days)||2||
59744992|NCT01033487|75863867|FG006|STARTED|Between Period 4 and 5 (At Least 7 Days)||2||
59744993|NCT01033487|75863868|FG007|STARTED|Between Period 4 and 5 (At Least 7 Days)||3||
59744994|NCT01033487|75863869|FG008|STARTED|Between Period 4 and 5 (At Least 7 Days)||1||
59744995|NCT01033487|75863870|FG009|STARTED|Between Period 4 and 5 (At Least 7 Days)||2||
59744996|NCT01033487|75863861|FG000|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2||
59744997|NCT01033487|75863862|FG001|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||3||
59744998|NCT01033487|75863863|FG002|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2||
59744999|NCT01033487|75863864|FG003|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2||
59745000|NCT01033487|75863865|FG004|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2||
59745001|NCT01033487|75863866|FG005|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2||
59745002|NCT01033487|75863867|FG006|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2||
59745003|NCT01033487|75863868|FG007|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||3||
59745004|NCT01033487|75863869|FG008|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||1||
59745005|NCT01033487|75863870|FG009|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2||
59745006|NCT01033487|75863861|FG000|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0||
59745007|NCT01033487|75863862|FG001|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0||
59745008|NCT01033487|75863863|FG002|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0||
59745009|NCT01033487|75863864|FG003|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0||
59745010|NCT01033487|75863865|FG004|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0||
59745011|NCT01033487|75863866|FG005|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0||
59745012|NCT01033487|75863867|FG006|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0||
59745013|NCT01033487|75863868|FG007|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0||
59745014|NCT01033487|75863869|FG008|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0||
59745015|NCT01033487|75863870|FG009|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0||
59745016|NCT01033487|75863861|FG000|STARTED|Fifth Intervention Period||2||
59745017|NCT01033487|75863862|FG001|STARTED|Fifth Intervention Period||3||
59745018|NCT01033487|75863863|FG002|STARTED|Fifth Intervention Period||2||
60135117|NCT03307252|76258160|FG007|STARTED|Part 2, Washout Period 2 (7 Days)||0||
60135118|NCT03307252|76258161|FG008|STARTED|Part 2, Washout Period 2 (7 Days)||0||
60135119|NCT03307252|76258162|FG009|STARTED|Part 2, Washout Period 2 (7 Days)||0||
60135120|NCT03307252|76258163|FG010|STARTED|Part 2, Washout Period 2 (7 Days)||0||
59745019|NCT01033487|75863864|FG003|STARTED|Fifth Intervention Period||2||
59745020|NCT01033487|75863865|FG004|STARTED|Fifth Intervention Period||2||
59745021|NCT01033487|75863866|FG005|STARTED|Fifth Intervention Period||2||
59745022|NCT01033487|75863867|FG006|STARTED|Fifth Intervention Period||2||
59745023|NCT01033487|75863868|FG007|STARTED|Fifth Intervention Period||3||
59745024|NCT01033487|75863869|FG008|STARTED|Fifth Intervention Period||1||
59745025|NCT01033487|75863870|FG009|STARTED|Fifth Intervention Period||2||
59745026|NCT01033487|75863861|FG000|COMPLETED|Fifth Intervention Period||2||
59745027|NCT01033487|75863862|FG001|COMPLETED|Fifth Intervention Period||3||
59745028|NCT01033487|75863863|FG002|COMPLETED|Fifth Intervention Period||2||
59745029|NCT01033487|75863864|FG003|COMPLETED|Fifth Intervention Period||2||
59745030|NCT01033487|75863865|FG004|COMPLETED|Fifth Intervention Period||2||
59745031|NCT01033487|75863866|FG005|COMPLETED|Fifth Intervention Period||2||
59745032|NCT01033487|75863867|FG006|COMPLETED|Fifth Intervention Period||2||
59745033|NCT01033487|75863868|FG007|COMPLETED|Fifth Intervention Period||3||
59745034|NCT01033487|75863869|FG008|COMPLETED|Fifth Intervention Period||1||
59745035|NCT01033487|75863870|FG009|COMPLETED|Fifth Intervention Period||2||
59745036|NCT01033487|75863861|FG000|NOT COMPLETED|Fifth Intervention Period||0||
59745037|NCT01033487|75863862|FG001|NOT COMPLETED|Fifth Intervention Period||0||
59745038|NCT01033487|75863863|FG002|NOT COMPLETED|Fifth Intervention Period||0||
59745039|NCT01033487|75863864|FG003|NOT COMPLETED|Fifth Intervention Period||0||
59745040|NCT01033487|75863865|FG004|NOT COMPLETED|Fifth Intervention Period||0||
59745041|NCT01033487|75863866|FG005|NOT COMPLETED|Fifth Intervention Period||0||
59745042|NCT01033487|75863867|FG006|NOT COMPLETED|Fifth Intervention Period||0||
59745043|NCT01033487|75863868|FG007|NOT COMPLETED|Fifth Intervention Period||0||
59745044|NCT01033487|75863869|FG008|NOT COMPLETED|Fifth Intervention Period||0||
59745045|NCT01033487|75863870|FG009|NOT COMPLETED|Fifth Intervention Period||0||
59745046|NCT01033019|75863886|FG000|STARTED|Overall Study||16||
59745047|NCT01033019|75863887|FG001|STARTED|Overall Study||8||
59745048|NCT01033019|75863886|FG000|COMPLETED|Overall Study||15||
59745049|NCT01033019|75863887|FG001|COMPLETED|Overall Study||8||
59745050|NCT01033019|75863886|FG000|NOT COMPLETED|Overall Study||1||
59745051|NCT01033019|75863887|FG001|NOT COMPLETED|Overall Study||0||
59745052|NCT00603447|75863901|FG000|STARTED|Overall Study||6||
59745053|NCT00603447|75863902|FG001|STARTED|Overall Study||6||
59745054|NCT00603447|75863903|FG002|STARTED|Overall Study||8||
59745055|NCT00603447|75863904|FG003|STARTED|Overall Study||6||
59745056|NCT00603447|75863905|FG004|STARTED|Overall Study||6||
59745057|NCT00603447|75863906|FG005|STARTED|Overall Study||8||
59745058|NCT00603447|75863907|FG006|STARTED|Overall Study||44||
59745059|NCT00603447|75863901|FG000|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|6||
59745060|NCT00603447|75863902|FG001|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|3||
59745061|NCT00603447|75863903|FG002|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|6||
59745062|NCT00603447|75863904|FG003|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|4||
59745063|NCT00603447|75863905|FG004|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|1||
59745064|NCT00603447|75863906|FG005|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|6||
59745065|NCT00603447|75863907|FG006|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|20||
59745066|NCT00603447|75863901|FG000|NOT COMPLETED|Overall Study||0||
59745067|NCT00603447|75863902|FG001|NOT COMPLETED|Overall Study||3||
59745068|NCT00603447|75863903|FG002|NOT COMPLETED|Overall Study||2||
59745069|NCT00603447|75863904|FG003|NOT COMPLETED|Overall Study||2||
59745070|NCT00603447|75863905|FG004|NOT COMPLETED|Overall Study||5||
59745071|NCT00603447|75863906|FG005|NOT COMPLETED|Overall Study||2||
59745072|NCT00603447|75863907|FG006|NOT COMPLETED|Overall Study||24||
59745073|NCT00778258|75863932|FG000|STARTED|Overall Study||16||
59745074|NCT00778258|75863933|FG001|STARTED|Overall Study||5||
59745075|NCT00778258|75863934|FG002|STARTED|Overall Study||20||
59745076|NCT00778258|75863935|FG003|STARTED|Overall Study||15||
59745077|NCT00778258|75863936|FG004|STARTED|Overall Study||6||
59745078|NCT00778258|75863937|FG005|STARTED|Overall Study||23||
59745079|NCT00778258|75863938|FG006|STARTED|Overall Study||34||
59745080|NCT00778258|75863939|FG007|STARTED|Overall Study||41||
59745081|NCT00778258|75863940|FG008|STARTED|Overall Study||10||
59745082|NCT00778258|75863932|FG000|COMPLETED|Overall Study||9||
59745083|NCT00778258|75863933|FG001|COMPLETED|Overall Study||3||
59745084|NCT00778258|75863934|FG002|COMPLETED|Overall Study||10||
59745085|NCT00778258|75863935|FG003|COMPLETED|Overall Study||12||
59745086|NCT00778258|75863936|FG004|COMPLETED|Overall Study||6||
59745087|NCT00778258|75863937|FG005|COMPLETED|Overall Study||13||
59745088|NCT00778258|75863938|FG006|COMPLETED|Overall Study||19||
59745089|NCT00778258|75863939|FG007|COMPLETED|Overall Study||26||
59745090|NCT00778258|75863940|FG008|COMPLETED|Overall Study||6||
59745091|NCT00778258|75863932|FG000|NOT COMPLETED|Overall Study||7||
59745092|NCT00778258|75863933|FG001|NOT COMPLETED|Overall Study||2||
59745093|NCT00778258|75863934|FG002|NOT COMPLETED|Overall Study||10||
59745094|NCT00778258|75863935|FG003|NOT COMPLETED|Overall Study||3||
59745095|NCT00778258|75863936|FG004|NOT COMPLETED|Overall Study||0||
59745096|NCT00778258|75863937|FG005|NOT COMPLETED|Overall Study||10||
59745097|NCT00778258|75863938|FG006|NOT COMPLETED|Overall Study||15||
59745098|NCT00778258|75863939|FG007|NOT COMPLETED|Overall Study||15||
59745099|NCT00778258|75863940|FG008|NOT COMPLETED|Overall Study||4||
59745100|NCT00988208|75863968|FG000|STARTED|Overall Study||526||
59745101|NCT00988208|75863969|FG001|STARTED|Overall Study||533||
59745102|NCT00988208|75863968|FG000|Treated|Overall Study||521||
59745103|NCT00988208|75863969|FG001|Treated|Overall Study||525||
59745104|NCT00988208|75863968|FG000|COMPLETED|Overall Study|DP Completed = kept on treatment with docetaxel/prednisone; Placebo was discontinued in DP arm|95||
59745105|NCT00988208|75863969|FG001|COMPLETED|Overall Study|DPL Completed = kept on treatment with docetaxel/prednisone; Lenalidomide discontinued in DPL arm|95||
59745106|NCT00988208|75863968|FG000|NOT COMPLETED|Overall Study||431||
59745107|NCT00988208|75863969|FG001|NOT COMPLETED|Overall Study||438||
59745108|NCT00990704|75863977|FG000|STARTED|Overall Study||14||
59745109|NCT00990704|75863978|FG001|STARTED|Overall Study||33||
59745110|NCT00990704|75863977|FG000|COMPLETED|Overall Study||13||
59745111|NCT00990704|75863978|FG001|COMPLETED|Overall Study||31||
59745112|NCT00990704|75863977|FG000|NOT COMPLETED|Overall Study||1||
59745113|NCT00990704|75863978|FG001|NOT COMPLETED|Overall Study||2||
59745114|NCT04089553|75863986|FG000|STARTED|Overall Study||29||
59745115|NCT04089553|75863987|FG001|STARTED|Overall Study||30||
59745116|NCT04089553|75863986|FG000|COMPLETED|Overall Study||4||
59745117|NCT04089553|75863987|FG001|COMPLETED|Overall Study||12||
59745118|NCT04089553|75863986|FG000|NOT COMPLETED|Overall Study||25||
59745119|NCT04089553|75863987|FG001|NOT COMPLETED|Overall Study||18||
59745120|NCT00993668|75863996|FG000|STARTED|Single-Blind Period||114||
59745121|NCT00993668|75863997|FG001|STARTED|Single-Blind Period||110||
59745122|NCT00993668|75863996|FG000|COMPLETED|Single-Blind Period||110||
59745123|NCT00993668|75863997|FG001|COMPLETED|Single-Blind Period||107||
59745124|NCT00993668|75863996|FG000|NOT COMPLETED|Single-Blind Period||4||
59745125|NCT00993668|75863997|FG001|NOT COMPLETED|Single-Blind Period||3||
59745126|NCT00993668|75863996|FG000|STARTED|Open-Label Period|1 subject chose not to enter the optional open-label period|109||
59745127|NCT00993668|75863997|FG001|STARTED|Open-Label Period|1 subject chose not to enter the optional open-label period|106||
59745128|NCT00993668|75863996|FG000|COMPLETED|Open-Label Period||86||
59745129|NCT00993668|75863997|FG001|COMPLETED|Open-Label Period||91||
59745130|NCT00993668|75863996|FG000|NOT COMPLETED|Open-Label Period||23||
59745131|NCT00993668|75863997|FG001|NOT COMPLETED|Open-Label Period||15||
59745132|NCT00778102|75864006|FG000|STARTED|Overall Study||39||
59745133|NCT00778102|75864007|FG001|STARTED|Overall Study||41||
59745134|NCT00778102|75864006|FG000|COMPLETED|Overall Study||18||
59745135|NCT00778102|75864007|FG001|COMPLETED|Overall Study||19||
59745136|NCT00778102|75864006|FG000|NOT COMPLETED|Overall Study||21||
59745137|NCT00778102|75864007|FG001|NOT COMPLETED|Overall Study||22||
59745138|NCT00756886|75864015|FG000|STARTED|Overall Study||41||
59745139|NCT00756886|75864016|FG001|STARTED|Overall Study||32||
59745140|NCT00756886|75864015|FG000|COMPLETED|Overall Study||30||
59745141|NCT00756886|75864016|FG001|COMPLETED|Overall Study||25||
59745142|NCT00756886|75864015|FG000|NOT COMPLETED|Overall Study||11||
59745143|NCT00756886|75864016|FG001|NOT COMPLETED|Overall Study||7||
59745144|NCT00756730|75864024|FG000|STARTED|Overall Study||25||
59745145|NCT00756730|75864025|FG001|STARTED|Overall Study||24||
59745146|NCT00756730|75864024|FG000|COMPLETED|Overall Study||25||
59745147|NCT00756730|75864025|FG001|COMPLETED|Overall Study||22||
59745148|NCT00756730|75864024|FG000|NOT COMPLETED|Overall Study||0||
59745149|NCT00756730|75864025|FG001|NOT COMPLETED|Overall Study||2||
59745150|NCT00984620|75864033|FG000|STARTED|Overall Study||81||
59745151|NCT00984620|75864034|FG001|STARTED|Overall Study||79||
59745152|NCT00984620|75864033|FG000|COMPLETED|Overall Study||75||
59745153|NCT00984620|75864034|FG001|COMPLETED|Overall Study||67||
59745154|NCT00984620|75864033|FG000|NOT COMPLETED|Overall Study||6||
59745155|NCT00984620|75864034|FG001|NOT COMPLETED|Overall Study||12||
59745156|NCT00777946|75864045|FG000|STARTED|Overall Study|1 patient in the Aliskiren 300 mg/Amlodipine 10 mg group was randomized in error.|283||
59745157|NCT00777946|75864046|FG001|STARTED|Overall Study|1 patient in the Aliskiren 300 mg/Amlodipine 5 mg group was randomized in error.|277||
59745158|NCT00777946|75864047|FG002|STARTED|Overall Study||260||
59745159|NCT00777946|75864045|FG000|Safety & Full Analysis Sets|Overall Study||282||
59745160|NCT00777946|75864046|FG001|Safety & Full Analysis Sets|Overall Study||276||
59745161|NCT00777946|75864047|FG002|Safety & Full Analysis Sets|Overall Study||260||
59745162|NCT00777946|75864045|FG000|COMPLETED|Overall Study||262||
59745163|NCT00777946|75864046|FG001|COMPLETED|Overall Study||271||
59745164|NCT00777946|75864047|FG002|COMPLETED|Overall Study||244||
59745165|NCT00777946|75864045|FG000|NOT COMPLETED|Overall Study||21||
59745166|NCT00777946|75864046|FG001|NOT COMPLETED|Overall Study||6||
59745167|NCT00777946|75864047|FG002|NOT COMPLETED|Overall Study||16||
59745168|NCT00990314|75864055|FG000|STARTED|Overall Study||31||
59745169|NCT00990314|75864055|FG000|COMPLETED|Overall Study||19||
59745170|NCT00990314|75864055|FG000|NOT COMPLETED|Overall Study||12||
59745171|NCT00756652|75864061|FG000|STARTED|Original Phase||41452||
59745172|NCT00756652|75864062|FG001|STARTED|Original Phase||1039||
59762495|NCT02644525|75882212|FG003|NOT COMPLETED|Group 3||0||
59745173|NCT00756652|75864061|FG000|COMPLETED|Original Phase|At Year 7|6063||
59745174|NCT00756652|75864062|FG001|COMPLETED|Original Phase||118||
59745175|NCT00756652|75864061|FG000|NOT COMPLETED|Original Phase||35389||
59745176|NCT00756652|75864062|FG001|NOT COMPLETED|Original Phase||921||
59745177|NCT00756652|75864061|FG000|STARTED|Re-Op Phase||11101||
59745178|NCT00756652|75864062|FG001|STARTED|Re-Op Phase|NA - The Re-Op Phase was limited in scope to data collection for only MemoryGel participants.|0||
59745179|NCT00756652|75864061|FG000|COMPLETED|Re-Op Phase||8225||
59745180|NCT00756652|75864062|FG001|COMPLETED|Re-Op Phase||0||
59745181|NCT00756652|75864061|FG000|NOT COMPLETED|Re-Op Phase||2876||
59745182|NCT00756652|75864062|FG001|NOT COMPLETED|Re-Op Phase||0||
59745183|NCT00777556|75864066|FG000|STARTED|Overall Study|Enrolled; signed informed consent|343||
59745184|NCT00777556|75864066|FG000|Dispensed Product|Overall Study||307||
59745185|NCT00777556|75864066|FG000|Safety Population|Overall Study|Participants who used the product; two were given product in error (inappropriately self-selected)|299||
59745186|NCT00777556|75864066|FG000|Used Product|Overall Study||297||
59745187|NCT00777556|75864066|FG000|COMPLETED|Overall Study|Completed all 3 follow-up visits|277||
59745188|NCT00777556|75864066|FG000|NOT COMPLETED|Overall Study||66||
59745189|NCT00602979|75864075|FG000|STARTED|Overall Study||48||
59745190|NCT00602979|75864076|FG001|STARTED|Overall Study||48||
59745191|NCT00602979|75864077|FG002|STARTED|Overall Study||48||
59745192|NCT00602979|75864078|FG003|STARTED|Overall Study||48||
59745193|NCT00602979|75864079|FG004|STARTED|Overall Study||48||
59745194|NCT00602979|75864075|FG000|COMPLETED|Overall Study||45||
59745195|NCT00602979|75864076|FG001|COMPLETED|Overall Study||45||
59745196|NCT00602979|75864077|FG002|COMPLETED|Overall Study||45||
59745197|NCT00602979|75864078|FG003|COMPLETED|Overall Study||45||
59745198|NCT00602979|75864079|FG004|COMPLETED|Overall Study||45||
59745199|NCT00602979|75864075|FG000|NOT COMPLETED|Overall Study||3||
59745200|NCT00602979|75864076|FG001|NOT COMPLETED|Overall Study||3||
59745201|NCT00602979|75864077|FG002|NOT COMPLETED|Overall Study||3||
59745202|NCT00602979|75864078|FG003|NOT COMPLETED|Overall Study||3||
59745203|NCT00602979|75864079|FG004|NOT COMPLETED|Overall Study||3||
59745204|NCT04081363|75864093|FG000|STARTED|Overall Study||7||
59745205|NCT04081363|75864094|FG001|STARTED|Overall Study||6||
59745206|NCT04081363|75864093|FG000|COMPLETED|Overall Study||6||
59745207|NCT04081363|75864094|FG001|COMPLETED|Overall Study||6||
59745208|NCT04081363|75864093|FG000|NOT COMPLETED|Overall Study||1||
59745209|NCT04081363|75864094|FG001|NOT COMPLETED|Overall Study||0||
59745210|NCT03352011|75864102|FG000|STARTED|Overall Study||28||
59745211|NCT03352011|75864103|FG001|STARTED|Overall Study||27||
59745212|NCT03352011|75864102|FG000|COMPLETED|Overall Study||21||
59745213|NCT03352011|75864103|FG001|COMPLETED|Overall Study||20||
59745214|NCT03352011|75864102|FG000|NOT COMPLETED|Overall Study||7||
59745215|NCT03352011|75864103|FG001|NOT COMPLETED|Overall Study||7||
59745216|NCT00777088|75864109|FG000|STARTED|Overall Study||108||
59745217|NCT00777088|75864109|FG000|COMPLETED|Overall Study||107||
59745218|NCT00777088|75864109|FG000|NOT COMPLETED|Overall Study||1||
59745219|NCT03292809|75864116|FG000|STARTED|Overall Study||162||
59745220|NCT03292809|75864117|FG001|STARTED|Overall Study||166||
59745221|NCT03292809|75864116|FG000|COMPLETED|Overall Study||155||
59745222|NCT03292809|75864117|FG001|COMPLETED|Overall Study||163||
59745223|NCT03292809|75864116|FG000|NOT COMPLETED|Overall Study||7||
59745224|NCT03292809|75864117|FG001|NOT COMPLETED|Overall Study||3||
59745225|NCT00763282|75864125|FG000|STARTED|Overall Study||72||
59745226|NCT00763282|75864126|FG001|STARTED|Overall Study||72||
59745227|NCT00763282|75864125|FG000|COMPLETED|Overall Study||40||
59745228|NCT00763282|75864126|FG001|COMPLETED|Overall Study||38||
59745229|NCT00763282|75864125|FG000|NOT COMPLETED|Overall Study||32||
59745230|NCT00763282|75864126|FG001|NOT COMPLETED|Overall Study||34||
59745231|NCT00988598|75864136|FG000|STARTED|Overall Study||10||
59745232|NCT00988598|75864137|FG001|STARTED|Overall Study||5||
59745233|NCT00988598|75864136|FG000|COMPLETED|Overall Study||8||
59745234|NCT00988598|75864137|FG001|COMPLETED|Overall Study||5||
59745235|NCT00988598|75864136|FG000|NOT COMPLETED|Overall Study||2||
59745236|NCT00988598|75864137|FG001|NOT COMPLETED|Overall Study||0||
59745237|NCT00979628|75864146|FG000|STARTED|Overall Study||153||
59745238|NCT00979628|75864147|FG001|STARTED|Overall Study||142||
59745239|NCT00979628|75864148|FG002|STARTED|Overall Study||80||
59745240|NCT00979628|75864146|FG000|COMPLETED|Overall Study||144||
59745241|NCT00979628|75864147|FG001|COMPLETED|Overall Study||133||
59745242|NCT00979628|75864148|FG002|COMPLETED|Overall Study||74||
59745243|NCT00979628|75864146|FG000|NOT COMPLETED|Overall Study||9||
59745244|NCT00979628|75864147|FG001|NOT COMPLETED|Overall Study||9||
59745245|NCT00979628|75864148|FG002|NOT COMPLETED|Overall Study||6||
59745246|NCT00762970|75864162|FG000|STARTED|Overall Study||46||
59745247|NCT00762970|75864163|FG001|STARTED|Overall Study||44||
59745248|NCT00762970|75864164|FG002|STARTED|Overall Study||47||
59745249|NCT00762970|75864162|FG000|COMPLETED|Overall Study||34||
59745250|NCT00762970|75864163|FG001|COMPLETED|Overall Study||35||
59745251|NCT00762970|75864164|FG002|COMPLETED|Overall Study||46||
59745252|NCT00762970|75864162|FG000|NOT COMPLETED|Overall Study||12||
59745253|NCT00762970|75864163|FG001|NOT COMPLETED|Overall Study||9||
59745254|NCT00762970|75864164|FG002|NOT COMPLETED|Overall Study||1||
59745255|NCT00988442|75864174|FG000|STARTED|Overall Study||30||
59745256|NCT00988442|75864175|FG001|STARTED|Overall Study||29||
59745257|NCT00988442|75864174|FG000|COMPLETED|Overall Study||0||
59745258|NCT00988442|75864175|FG001|COMPLETED|Overall Study||1||
59745259|NCT00988442|75864174|FG000|NOT COMPLETED|Overall Study||30||
59745260|NCT00988442|75864175|FG001|NOT COMPLETED|Overall Study||28||
59745261|NCT03258723|75864184|FG000|STARTED|Overall Study||114||
59745262|NCT03258723|75864184|FG000|6 Month Follow up|Overall Study||80||
59745263|NCT03258723|75864184|FG000|12 Month Follow up|Overall Study||52||
59745264|NCT03258723|75864184|FG000|COMPLETED|Overall Study||52||
59745265|NCT03258723|75864184|FG000|NOT COMPLETED|Overall Study||62||
59745266|NCT00992186|75864188|FG000|STARTED|Overall Study||46||
59745267|NCT00992186|75864188|FG000|COMPLETED|Overall Study||0||
59745268|NCT00992186|75864188|FG000|NOT COMPLETED|Overall Study||46||
59745269|NCT00992108|75864195|FG000|STARTED|Overall Study||7||
59745270|NCT00992108|75864196|FG001|STARTED|Overall Study||10||
59745271|NCT00992108|75864195|FG000|COMPLETED|Overall Study||7||
59745272|NCT00992108|75864196|FG001|COMPLETED|Overall Study||9||
59745273|NCT00992108|75864195|FG000|NOT COMPLETED|Overall Study||0||
59745274|NCT00992108|75864196|FG001|NOT COMPLETED|Overall Study||1||
59745275|NCT00752986|75864205|FG000|STARTED|Overall Study||16||
59745276|NCT00752986|75864206|FG001|STARTED|Overall Study||12||
59745277|NCT00752986|75864207|FG002|STARTED|Overall Study||11||
59745278|NCT00752986|75864205|FG000|COMPLETED|Overall Study||11||
59745279|NCT00752986|75864206|FG001|COMPLETED|Overall Study||11||
59745280|NCT00752986|75864207|FG002|COMPLETED|Overall Study||9||
59745281|NCT00752986|75864205|FG000|NOT COMPLETED|Overall Study||5||
59745282|NCT00752986|75864206|FG001|NOT COMPLETED|Overall Study||1||
59745283|NCT00752986|75864207|FG002|NOT COMPLETED|Overall Study||2||
59745284|NCT00762892|75864217|FG000|STARTED|Overall Study||14||
59745285|NCT00762892|75864218|FG001|STARTED|Overall Study||14||
59745286|NCT00762892|75864217|FG000|COMPLETED|Overall Study||9||
59745287|NCT00762892|75864218|FG001|COMPLETED|Overall Study||8||
59745288|NCT00762892|75864217|FG000|NOT COMPLETED|Overall Study||5||
59745289|NCT00762892|75864218|FG001|NOT COMPLETED|Overall Study||6||
59745290|NCT00755716|75864227|FG000|STARTED|Overall Study||19||
59745291|NCT00755716|75864228|FG001|STARTED|Overall Study||19||
59745292|NCT00755716|75864229|FG002|STARTED|Overall Study||19||
59745293|NCT00755716|75864227|FG000|COMPLETED|Overall Study||11||
59745294|NCT00755716|75864228|FG001|COMPLETED|Overall Study||11||
59745295|NCT00755716|75864229|FG002|COMPLETED|Overall Study||16||
59745296|NCT00755716|75864227|FG000|NOT COMPLETED|Overall Study||8||
60135121|NCT03307252|76258153|FG000|COMPLETED|Part 2, Washout Period 2 (7 Days)||0||
60135122|NCT03307252|76258154|FG001|COMPLETED|Part 2, Washout Period 2 (7 Days)||0||
60135123|NCT03307252|76258155|FG002|COMPLETED|Part 2, Washout Period 2 (7 Days)||0||
60135124|NCT03307252|76258156|FG003|COMPLETED|Part 2, Washout Period 2 (7 Days)||4||
60135125|NCT03307252|76258157|FG004|COMPLETED|Part 2, Washout Period 2 (7 Days)||4||
60135126|NCT03307252|76258158|FG005|COMPLETED|Part 2, Washout Period 2 (7 Days)||3||
60135127|NCT03307252|76258159|FG006|COMPLETED|Part 2, Washout Period 2 (7 Days)||5||
60135128|NCT03307252|76258160|FG007|COMPLETED|Part 2, Washout Period 2 (7 Days)||0||
60135129|NCT03307252|76258161|FG008|COMPLETED|Part 2, Washout Period 2 (7 Days)||0||
60135130|NCT03307252|76258162|FG009|COMPLETED|Part 2, Washout Period 2 (7 Days)||0||
60135131|NCT03307252|76258163|FG010|COMPLETED|Part 2, Washout Period 2 (7 Days)||0||
60135132|NCT03307252|76258153|FG000|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0||
59745297|NCT00755716|75864228|FG001|NOT COMPLETED|Overall Study||8||
59745298|NCT00755716|75864229|FG002|NOT COMPLETED|Overall Study||3||
59745299|NCT00755326|75864239|FG000|STARTED|Overall Study||47||
59745300|NCT00755326|75864240|FG001|STARTED|Overall Study||45||
59745301|NCT00755326|75864239|FG000|COMPLETED|Overall Study||45||
59745302|NCT00755326|75864240|FG001|COMPLETED|Overall Study||42||
59745303|NCT00755326|75864239|FG000|NOT COMPLETED|Overall Study||2||
59745304|NCT00755326|75864240|FG001|NOT COMPLETED|Overall Study||3||
59873048|NCT03022630|75997176|FG001|COMPLETED|Overall Study||20||
59873049|NCT03022630|75997175|FG000|NOT COMPLETED|Overall Study||9||
59873050|NCT03022630|75997176|FG001|NOT COMPLETED|Overall Study||12||
60135133|NCT03307252|76258154|FG001|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0||
60135134|NCT03307252|76258155|FG002|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0||
60135135|NCT03307252|76258156|FG003|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0||
60135136|NCT03307252|76258157|FG004|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0||
60135137|NCT03307252|76258158|FG005|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0||
59745305|NCT03084471|75864247|FG000|STARTED|Overall Study||867||
59745306|NCT03084471|75864247|FG000|COMPLETED|Overall Study||0||
59745307|NCT03084471|75864247|FG000|NOT COMPLETED|Overall Study||867||
59745308|NCT00754936|75864254|FG000|STARTED|Overall Study||71||
59745309|NCT00754936|75864254|FG000|COMPLETED|Overall Study||59||
59745310|NCT00754936|75864254|FG000|NOT COMPLETED|Overall Study||12||
59745311|NCT00762502|75864261|FG000|STARTED|Baseline to Month 3 (Period 1)||36||
59745312|NCT00762502|75864262|FG001|STARTED|Baseline to Month 3 (Period 1)||25||
59745313|NCT00762502|75864263|FG002|STARTED|Baseline to Month 3 (Period 1)||51||
59745314|NCT00762502|75864261|FG000|COMPLETED|Baseline to Month 3 (Period 1)||26||
59745315|NCT00762502|75864262|FG001|COMPLETED|Baseline to Month 3 (Period 1)||19||
59873051|NCT03023722|75997187|FG000|STARTED|Overall Study||18||
59873052|NCT03023722|75997187|FG000|COMPLETED|Overall Study||14||
59745316|NCT00762502|75864263|FG002|COMPLETED|Baseline to Month 3 (Period 1)||32||
59745317|NCT00762502|75864261|FG000|NOT COMPLETED|Baseline to Month 3 (Period 1)||10||
59745318|NCT00762502|75864262|FG001|NOT COMPLETED|Baseline to Month 3 (Period 1)||6||
59745319|NCT00762502|75864263|FG002|NOT COMPLETED|Baseline to Month 3 (Period 1)||19||
59745320|NCT00762502|75864261|FG000|STARTED|Month 3 to Month 6 (Period 2)||9||
59745321|NCT00762502|75864262|FG001|STARTED|Month 3 to Month 6 (Period 2)||5||
59745322|NCT00762502|75864263|FG002|STARTED|Month 3 to Month 6 (Period 2)||23||
59745323|NCT00762502|75864261|FG000|COMPLETED|Month 3 to Month 6 (Period 2)||9||
59745324|NCT00762502|75864262|FG001|COMPLETED|Month 3 to Month 6 (Period 2)||4||
59745325|NCT00762502|75864263|FG002|COMPLETED|Month 3 to Month 6 (Period 2)||23||
59745326|NCT00762502|75864261|FG000|NOT COMPLETED|Month 3 to Month 6 (Period 2)||0||
59745327|NCT00762502|75864262|FG001|NOT COMPLETED|Month 3 to Month 6 (Period 2)||1||
59745328|NCT00762502|75864263|FG002|NOT COMPLETED|Month 3 to Month 6 (Period 2)||0||
59745329|NCT00762268|75864271|FG000|STARTED|Overall Study||12||
59745330|NCT00762268|75864272|FG001|STARTED|Overall Study||11||
59745331|NCT00762268|75864271|FG000|COMPLETED|Overall Study||9||
59745332|NCT00762268|75864272|FG001|COMPLETED|Overall Study||8||
59745333|NCT00762268|75864271|FG000|NOT COMPLETED|Overall Study||3||
59745334|NCT00762268|75864272|FG001|NOT COMPLETED|Overall Study||3||
59745335|NCT00975884|75864280|FG000|STARTED|Overall Study||184||
59745336|NCT00975884|75864281|FG001|STARTED|Overall Study||122||
59745337|NCT00975884|75864280|FG000|COMPLETED|Overall Study||168||
59745338|NCT00975884|75864281|FG001|COMPLETED|Overall Study||107||
59745339|NCT00975884|75864280|FG000|NOT COMPLETED|Overall Study||16||
59745340|NCT00975884|75864281|FG001|NOT COMPLETED|Overall Study||15||
59745341|NCT00578227|75864300|FG000|STARTED|Overall Study||272||
59745342|NCT00578227|75864301|FG001|STARTED|Overall Study||270||
59745343|NCT00578227|75864302|FG002|STARTED|Overall Study||271||
59745344|NCT00578227|75864300|FG000|COMPLETED|Overall Study||267||
59745345|NCT00578227|75864301|FG001|COMPLETED|Overall Study||268||
59745346|NCT00578227|75864302|FG002|COMPLETED|Overall Study||267||
59745347|NCT00578227|75864300|FG000|NOT COMPLETED|Overall Study||5||
59745348|NCT00578227|75864301|FG001|NOT COMPLETED|Overall Study||2||
59745349|NCT00578227|75864302|FG002|NOT COMPLETED|Overall Study||4||
59745350|NCT00978380|75864312|FG000|STARTED|Overall Study||63||
59745351|NCT00978380|75864312|FG000|COMPLETED|Overall Study||44||
59745352|NCT00978380|75864312|FG000|NOT COMPLETED|Overall Study||19||
59745353|NCT00577993|75864320|FG000|STARTED|Overall Study||85||
59745354|NCT00577993|75864321|FG001|STARTED|Overall Study||90||
59745355|NCT00577993|75864322|FG002|STARTED|Overall Study||35||
59745356|NCT00577993|75864320|FG000|COMPLETED|Overall Study||78||
59745357|NCT00577993|75864321|FG001|COMPLETED|Overall Study||80||
59745358|NCT00577993|75864322|FG002|COMPLETED|Overall Study||32||
59745359|NCT00577993|75864320|FG000|NOT COMPLETED|Overall Study||7||
59745360|NCT00577993|75864321|FG001|NOT COMPLETED|Overall Study||10||
59745361|NCT00577993|75864322|FG002|NOT COMPLETED|Overall Study||3||
59745362|NCT00975806|75864331|FG000|STARTED|Overall Study||5||
59745363|NCT00975806|75864332|FG001|STARTED|Overall Study||7||
59745364|NCT00975806|75864333|FG002|STARTED|Overall Study||4||
59745365|NCT00975806|75864331|FG000|COMPLETED|Overall Study|Participants were prematurely discontinued|0||
59745366|NCT00975806|75864332|FG001|COMPLETED|Overall Study|Participants were prematurely discontinued|0||
59745367|NCT00975806|75864333|FG002|COMPLETED|Overall Study|Participants were prematurely discontinued|0||
59745368|NCT00975806|75864331|FG000|NOT COMPLETED|Overall Study||5||
59745369|NCT00975806|75864332|FG001|NOT COMPLETED|Overall Study||7||
59745370|NCT00975806|75864333|FG002|NOT COMPLETED|Overall Study||4||
59745371|NCT00978068|75864345|FG000|STARTED|Overall Study||87||
59745372|NCT00978068|75864346|FG001|STARTED|Overall Study||89||
59745373|NCT00978068|75864345|FG000|Initiated Study Drugs|Overall Study||84||
59745374|NCT00978068|75864346|FG001|Initiated Study Drugs|Overall Study||86||
59745375|NCT00978068|75864345|FG000|COMPLETED|Overall Study||83||
59745376|NCT00978068|75864346|FG001|COMPLETED|Overall Study||80||
59873053|NCT03023722|75997187|FG000|NOT COMPLETED|Overall Study||4||
59873054|NCT03022084|75997193|FG000|STARTED|Overall Study||29||
59745377|NCT00978068|75864345|FG000|NOT COMPLETED|Overall Study||4||
59745378|NCT00978068|75864346|FG001|NOT COMPLETED|Overall Study||9||
59873055|NCT03022084|75997194|FG001|STARTED|Overall Study||32||
59745379|NCT00603525|75864358|FG000|STARTED|DB Treatment Period (24 Weeks)||84||
59745380|NCT00603525|75864359|FG001|STARTED|DB Treatment Period (24 Weeks)||85||
59745381|NCT00603525|75864360|FG002|STARTED|DB Treatment Period (24 Weeks)||0||
59745382|NCT00603525|75864358|FG000|COMPLETED|DB Treatment Period (24 Weeks)||67||
59745383|NCT00603525|75864359|FG001|COMPLETED|DB Treatment Period (24 Weeks)||63||
59745384|NCT00603525|75864360|FG002|COMPLETED|DB Treatment Period (24 Weeks)||0||
59745385|NCT00603525|75864358|FG000|NOT COMPLETED|DB Treatment Period (24 Weeks)||17||
59745386|NCT00603525|75864359|FG001|NOT COMPLETED|DB Treatment Period (24 Weeks)||22||
59745387|NCT00603525|75864360|FG002|NOT COMPLETED|DB Treatment Period (24 Weeks)||0||
59745388|NCT00603525|75864358|FG000|STARTED|OL Treatment Period (120 Weeks)||0||
59762496|NCT00866619|75882226|FG000|STARTED|Overall Study||5948||
59873056|NCT03022084|75997193|FG000|COMPLETED|Overall Study||27||
59873057|NCT03022084|75997194|FG001|COMPLETED|Overall Study||29||
59745389|NCT00603525|75864359|FG001|STARTED|OL Treatment Period (120 Weeks)|61 participants received OFA during the DB Period; 64 received placebo during the DB Period.|125||
59745390|NCT00603525|75864360|FG002|STARTED|OL Treatment Period (120 Weeks)||0||
59745391|NCT00603525|75864358|FG000|COMPLETED|OL Treatment Period (120 Weeks)||0||
59745392|NCT00603525|75864359|FG001|COMPLETED|OL Treatment Period (120 Weeks)||13||
59745393|NCT00603525|75864360|FG002|COMPLETED|OL Treatment Period (120 Weeks)||0||
59745394|NCT00603525|75864358|FG000|NOT COMPLETED|OL Treatment Period (120 Weeks)||0||
59745395|NCT00603525|75864359|FG001|NOT COMPLETED|OL Treatment Period (120 Weeks)||112||
59745396|NCT00603525|75864360|FG002|NOT COMPLETED|OL Treatment Period (120 Weeks)||0||
59745397|NCT00603525|75864358|FG000|STARTED|Follow-up Period (Approximately 2 Years)||0||
59745398|NCT00603525|75864359|FG001|STARTED|Follow-up Period (Approximately 2 Years)||0||
59745399|NCT00603525|75864360|FG002|STARTED|Follow-up Period (Approximately 2 Years)|124 participants (par) completing/withdrawing from the DB or OL Periods attended >=1 follow-up visit|124||
59745400|NCT00603525|75864358|FG000|Unknown Reason for Withdrawal|Follow-up Period (Approximately 2 Years)||0||
59745401|NCT00603525|75864359|FG001|Unknown Reason for Withdrawal|Follow-up Period (Approximately 2 Years)||0||
59745402|NCT00603525|75864360|FG002|Unknown Reason for Withdrawal|Follow-up Period (Approximately 2 Years)|As par. were not on active drug during the Follow-up Period, withdrawal reasons were not collected.|111||
59745403|NCT00603525|75864358|FG000|COMPLETED|Follow-up Period (Approximately 2 Years)||0||
59745404|NCT00603525|75864359|FG001|COMPLETED|Follow-up Period (Approximately 2 Years)||0||
59745405|NCT00603525|75864360|FG002|COMPLETED|Follow-up Period (Approximately 2 Years)||13||
59745406|NCT00603525|75864358|FG000|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||0||
59745407|NCT00603525|75864359|FG001|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||0||
59873058|NCT03022084|75997193|FG000|NOT COMPLETED|Overall Study||2||
59873059|NCT03022084|75997194|FG001|NOT COMPLETED|Overall Study||3||
59745408|NCT00603525|75864360|FG002|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||111||
59745409|NCT00762034|75864373|FG000|STARTED|Induction Period||472||
59745410|NCT00762034|75864374|FG001|STARTED|Induction Period||467||
59745411|NCT00762034|75864373|FG000|Received at Least 1 Dose of Study Drug|Induction Period||442||
59745412|NCT00762034|75864374|FG001|Received at Least 1 Dose of Study Drug|Induction Period||443||
59745413|NCT00762034|75864373|FG000|COMPLETED|Induction Period||294||
59745414|NCT00762034|75864374|FG001|COMPLETED|Induction Period||298||
59745415|NCT00762034|75864373|FG000|NOT COMPLETED|Induction Period||178||
59745416|NCT00762034|75864374|FG001|NOT COMPLETED|Induction Period||169||
59745417|NCT00762034|75864373|FG000|STARTED|Maintenance Period||294||
59745418|NCT00762034|75864374|FG001|STARTED|Maintenance Period||298||
59745419|NCT00762034|75864373|FG000|Received at Least 1 Dose of Study Drug|Maintenance Period||294||
59745420|NCT00762034|75864374|FG001|Received at Least 1 Dose of Study Drug|Maintenance Period||298||
59745421|NCT00762034|75864373|FG000|COMPLETED|Maintenance Period||0||
59745422|NCT00762034|75864374|FG001|COMPLETED|Maintenance Period||0||
59745423|NCT00762034|75864373|FG000|NOT COMPLETED|Maintenance Period||294||
59745424|NCT00762034|75864374|FG001|NOT COMPLETED|Maintenance Period||298||
59745425|NCT02386995|75864388|FG000|STARTED|Overall Study||30||
59745426|NCT02386995|75864388|FG000|COMPLETED|Overall Study||30||
59745427|NCT02386995|75864388|FG000|NOT COMPLETED|Overall Study||0||
59745428|NCT02360085|75864393|FG000|STARTED|Overall Study||65||
59745429|NCT02360085|75864393|FG000|COMPLETED|Overall Study||49||
59745430|NCT02360085|75864393|FG000|NOT COMPLETED|Overall Study||16||
59745431|NCT00761956|75864406|FG000|STARTED|Overall Study||87||
59745432|NCT00761956|75864407|FG001|STARTED|Overall Study||102||
59745433|NCT00761956|75864406|FG000|COMPLETED|Overall Study||52||
59745434|NCT00761956|75864407|FG001|COMPLETED|Overall Study||48||
59745435|NCT00761956|75864406|FG000|NOT COMPLETED|Overall Study||35||
59745436|NCT00761956|75864407|FG001|NOT COMPLETED|Overall Study||54||
59873060|NCT03021304|75997200|FG000|STARTED|Overall Study||56||
60135138|NCT03307252|76258159|FG006|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0||
60135139|NCT03307252|76258160|FG007|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0||
60135140|NCT03307252|76258161|FG008|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0||
59745437|NCT00754624|75864413|FG000|STARTED|Overall Study||229||
60135141|NCT03307252|76258162|FG009|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0||
60135142|NCT03307252|76258163|FG010|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0||
60135143|NCT03307252|76258153|FG000|STARTED|Part 2, Period 3||0||
60135144|NCT03307252|76258154|FG001|STARTED|Part 2, Period 3||0||
60135145|NCT03307252|76258155|FG002|STARTED|Part 2, Period 3||0||
59745438|NCT00754624|75864413|FG000|COMPLETED|Overall Study||160||
59745439|NCT00754624|75864413|FG000|NOT COMPLETED|Overall Study||69||
59745440|NCT04237207|75864419|FG000|STARTED|Overall Study|Due to differences in speed of enrollment between the two cohorts and the delay in enrollment due to the Coronavirus (COVID-19) pandemic, enrollment for the electric only cohort was capped at 10 subjects, which exceeds the minimum sample size of 8 subjects per cohort.|10||
59745441|NCT04237207|75864420|FG001|STARTED|Overall Study||12||
59745442|NCT04237207|75864419|FG000|COMPLETED|Overall Study||10||
59745443|NCT04237207|75864420|FG001|COMPLETED|Overall Study||12||
59745444|NCT04237207|75864419|FG000|NOT COMPLETED|Overall Study||0||
60135146|NCT03307252|76258156|FG003|STARTED|Part 2, Period 3||4||
60135147|NCT03307252|76258157|FG004|STARTED|Part 2, Period 3||4||
59745445|NCT04237207|75864420|FG001|NOT COMPLETED|Overall Study||0||
59745446|NCT00586846|75864426|FG000|STARTED|Overall Study||40||
59745447|NCT00586846|75864426|FG000|COMPLETED|Overall Study||34||
59745448|NCT00586846|75864426|FG000|NOT COMPLETED|Overall Study||6||
59745449|NCT00973700|75864435|FG000|STARTED|Overall Study||56||
59745450|NCT00973700|75864436|FG001|STARTED|Overall Study||56||
59745451|NCT00973700|75864437|FG002|STARTED|Overall Study||168||
59745452|NCT00973700|75864438|FG003|STARTED|Overall Study||336||
59745453|NCT00973700|75864439|FG004|STARTED|Overall Study||168||
59745454|NCT00973700|75864435|FG000|COMPLETED|Overall Study||49||
59745455|NCT00973700|75864436|FG001|COMPLETED|Overall Study||54||
59745456|NCT00973700|75864437|FG002|COMPLETED|Overall Study||158||
59745457|NCT00973700|75864438|FG003|COMPLETED|Overall Study||318||
59745458|NCT00973700|75864439|FG004|COMPLETED|Overall Study||158||
59745459|NCT00973700|75864435|FG000|NOT COMPLETED|Overall Study||7||
59745460|NCT00973700|75864436|FG001|NOT COMPLETED|Overall Study||2||
59745461|NCT00973700|75864437|FG002|NOT COMPLETED|Overall Study||10||
59745462|NCT00973700|75864438|FG003|NOT COMPLETED|Overall Study||18||
59745463|NCT00973700|75864439|FG004|NOT COMPLETED|Overall Study||10||
59745464|NCT00754390|75864466|FG000|STARTED|Ca/Phytate Test Meal 1 (Randomized)||17||
59745465|NCT00754390|75864466|FG000|COMPLETED|Ca/Phytate Test Meal 1 (Randomized)||12||
59745466|NCT00754390|75864466|FG000|NOT COMPLETED|Ca/Phytate Test Meal 1 (Randomized)||5||
59745467|NCT00754390|75864466|FG000|STARTED|Ca/Phytate Test Meal 2 (Randomized)||12||
59745468|NCT00754390|75864466|FG000|COMPLETED|Ca/Phytate Test Meal 2 (Randomized)||12||
59745469|NCT00754390|75864466|FG000|NOT COMPLETED|Ca/Phytate Test Meal 2 (Randomized)||0||
59745470|NCT00754390|75864466|FG000|STARTED|Ca/Phytate Test Meal 3 (Randomized)||12||
59745471|NCT00754390|75864466|FG000|COMPLETED|Ca/Phytate Test Meal 3 (Randomized)||11||
59745472|NCT00754390|75864466|FG000|NOT COMPLETED|Ca/Phytate Test Meal 3 (Randomized)||1||
59745473|NCT00754390|75864466|FG000|STARTED|Ca/Phytate Test Meal 4 (Randomized)||11||
59745474|NCT00754390|75864466|FG000|COMPLETED|Ca/Phytate Test Meal 4 (Randomized)||10||
59745475|NCT00754390|75864466|FG000|NOT COMPLETED|Ca/Phytate Test Meal 4 (Randomized)||1||
59745476|NCT00754234|75864473|FG000|STARTED|Overall Study|7 Menus were consumed in randomized order|16||
59745477|NCT00754234|75864473|FG000|COMPLETED|Overall Study|2 participants did not receive the Day 1,4,5,6 menu and 1 did not receive the Day 2 menu|13||
59745478|NCT00754234|75864473|FG000|NOT COMPLETED|Overall Study||3||
59745479|NCT00753922|75864481|FG000|STARTED|Overall Study||552||
59745480|NCT00753922|75864482|FG001|STARTED|Overall Study||251||
59745481|NCT00753922|75864483|FG002|STARTED|Overall Study||145||
59745482|NCT00753922|75864484|FG003|STARTED|Overall Study||60||
59745483|NCT00753922|75864481|FG000|COMPLETED|Overall Study||306||
59745484|NCT00753922|75864482|FG001|COMPLETED|Overall Study||157||
59745485|NCT00753922|75864483|FG002|COMPLETED|Overall Study||82||
59745486|NCT00753922|75864484|FG003|COMPLETED|Overall Study||37||
59745487|NCT00753922|75864481|FG000|NOT COMPLETED|Overall Study||246||
59745488|NCT00753922|75864482|FG001|NOT COMPLETED|Overall Study||94||
59745489|NCT00753922|75864483|FG002|NOT COMPLETED|Overall Study||63||
59745490|NCT00753922|75864484|FG003|NOT COMPLETED|Overall Study||23||
59745491|NCT00761176|75864496|FG000|STARTED|Overall Study||4||
59745492|NCT00761176|75864497|FG001|STARTED|Overall Study||4||
59745493|NCT00761176|75864496|FG000|COMPLETED|Overall Study||2||
60135148|NCT03307252|76258158|FG005|STARTED|Part 2, Period 3||3||
60135149|NCT03307252|76258159|FG006|STARTED|Part 2, Period 3||5||
59745494|NCT00761176|75864497|FG001|COMPLETED|Overall Study||3||
59745495|NCT00761176|75864496|FG000|NOT COMPLETED|Overall Study||2||
59745496|NCT00761176|75864497|FG001|NOT COMPLETED|Overall Study||1||
59745497|NCT00760552|75864505|FG000|STARTED|Overall Study||61||
59745498|NCT00760552|75864506|FG001|STARTED|Overall Study||62||
59745499|NCT00760552|75864505|FG000|COMPLETED|Overall Study||48||
59745500|NCT00760552|75864506|FG001|COMPLETED|Overall Study||52||
59745501|NCT00760552|75864505|FG000|NOT COMPLETED|Overall Study||13||
59745502|NCT00760552|75864506|FG001|NOT COMPLETED|Overall Study||10||
59745503|NCT00753766|75864514|FG000|STARTED|Overall Study||1||
59745504|NCT00753766|75864515|FG001|STARTED|Overall Study||0||
59745505|NCT00753766|75864514|FG000|COMPLETED|Overall Study||0||
59745506|NCT00753766|75864515|FG001|COMPLETED|Overall Study||0||
59745507|NCT00753766|75864514|FG000|NOT COMPLETED|Overall Study||1||
59745508|NCT00753766|75864515|FG001|NOT COMPLETED|Overall Study||0||
59745509|NCT00976898|75864522|FG000|STARTED|Overall Study||83||
59745510|NCT00976898|75864522|FG000|COMPLETED|Overall Study||78||
60135150|NCT03307252|76258160|FG007|STARTED|Part 2, Period 3||0||
59745511|NCT00976898|75864522|FG000|NOT COMPLETED|Overall Study||5||
59745512|NCT01648959|75864526|FG000|STARTED|Overall Study||5||
59745513|NCT01648959|75864526|FG000|COMPLETED|Overall Study||5||
59745514|NCT01648959|75864526|FG000|NOT COMPLETED|Overall Study||0||
59745515|NCT02620579|75864534|FG000|STARTED|Overall Study||62||
59745516|NCT02620579|75864535|FG001|STARTED|Overall Study||57||
59745517|NCT02620579|75864536|FG002|STARTED|Overall Study||57||
60135151|NCT03307252|76258161|FG008|STARTED|Part 2, Period 3||0||
59745518|NCT02620579|75864537|FG003|STARTED|Overall Study||57||
59745519|NCT02620579|75864534|FG000|COMPLETED|Overall Study||62||
59745520|NCT02620579|75864535|FG001|COMPLETED|Overall Study||56||
59745521|NCT02620579|75864536|FG002|COMPLETED|Overall Study||56||
59745522|NCT02620579|75864537|FG003|COMPLETED|Overall Study||56||
59745523|NCT02620579|75864534|FG000|NOT COMPLETED|Overall Study||0||
59745524|NCT02620579|75864535|FG001|NOT COMPLETED|Overall Study||1||
59745525|NCT02620579|75864536|FG002|NOT COMPLETED|Overall Study||1||
59745526|NCT02620579|75864537|FG003|NOT COMPLETED|Overall Study||1||
59745527|NCT03702283|75864547|FG000|STARTED|Overall Study|Recruitment and observation began on March 31, 2019|205||
59745528|NCT03702283|75864547|FG000|COMPLETED|Overall Study|Recruitment and observation ended on March 31, 2021|205||
59745529|NCT03702283|75864547|FG000|NOT COMPLETED|Overall Study||0||
59745530|NCT00753688|75864553|FG000|STARTED|Overall Study||123||
59745531|NCT00753688|75864554|FG001|STARTED|Overall Study||246||
59745532|NCT00753688|75864553|FG000|Ongoing - in Follow-up|Overall Study||15||
59745533|NCT00753688|75864554|FG001|Ongoing - in Follow-up|Overall Study||31||
59745534|NCT00753688|75864553|FG000|COMPLETED|Overall Study||0||
59745535|NCT00753688|75864554|FG001|COMPLETED|Overall Study||0||
59745536|NCT00753688|75864553|FG000|NOT COMPLETED|Overall Study||123||
59745537|NCT00753688|75864554|FG001|NOT COMPLETED|Overall Study||246||
59745538|NCT00586612|75864562|FG000|STARTED|Primary Phase||163||
59745539|NCT00586612|75864563|FG001|STARTED|Primary Phase||150||
59745540|NCT00586612|75864562|FG000|COMPLETED|Primary Phase||162||
59745541|NCT00586612|75864563|FG001|COMPLETED|Primary Phase||147||
59745542|NCT00586612|75864562|FG000|NOT COMPLETED|Primary Phase||1||
59745543|NCT00586612|75864563|FG001|NOT COMPLETED|Primary Phase||3||
59745544|NCT00586612|75864562|FG000|STARTED|Booster Phase||154||
59745545|NCT00586612|75864563|FG001|STARTED|Booster Phase||144||
59745546|NCT00586612|75864562|FG000|COMPLETED|Booster Phase||151||
59745547|NCT00586612|75864563|FG001|COMPLETED|Booster Phase||143||
59745548|NCT00586612|75864562|FG000|NOT COMPLETED|Booster Phase||3||
59745549|NCT00586612|75864563|FG001|NOT COMPLETED|Booster Phase||1||
59745550|NCT00586690|75864571|FG000|STARTED|Overall Study|Four consented subjects were screen failures.|21||
59745551|NCT00586690|75864572|FG001|STARTED|Overall Study||22||
59745552|NCT00586690|75864571|FG000|COMPLETED|Overall Study||5||
59745553|NCT00586690|75864572|FG001|COMPLETED|Overall Study||22||
59745554|NCT00586690|75864571|FG000|NOT COMPLETED|Overall Study||16||
59745555|NCT00586690|75864572|FG001|NOT COMPLETED|Overall Study||0||
59745556|NCT00976820|75864581|FG000|STARTED|Overall Study||67||
59745557|NCT00976820|75864582|FG001|STARTED|Overall Study||128||
59745558|NCT00976820|75864583|FG002|STARTED|Overall Study||64||
59745559|NCT00976820|75864584|FG003|STARTED|Overall Study||63||
59745560|NCT00976820|75864581|FG000|COMPLETED|Overall Study||59||
59745561|NCT00976820|75864582|FG001|COMPLETED|Overall Study||108||
59745562|NCT00976820|75864583|FG002|COMPLETED|Overall Study||60||
59745563|NCT00976820|75864584|FG003|COMPLETED|Overall Study||56||
59745564|NCT00976820|75864581|FG000|NOT COMPLETED|Overall Study||8||
59745565|NCT00976820|75864582|FG001|NOT COMPLETED|Overall Study||20||
59745566|NCT00976820|75864583|FG002|NOT COMPLETED|Overall Study||4||
59745567|NCT00976820|75864584|FG003|NOT COMPLETED|Overall Study||7||
59745568|NCT00760474|75864635|FG000|STARTED|Period 1 (P1)||13||
59745569|NCT00760474|75864636|FG001|STARTED|Period 1 (P1)||14||
59745570|NCT00760474|75864635|FG000|Treated|Period 1 (P1)|1 participant discontinued in P1; re-entered with new identification number and completed P1, P2.|13||
59745571|NCT00760474|75864636|FG001|Treated|Period 1 (P1)|1 participant discontinued in P1; re-entered with new identification number and completed P1, P2.|14||
59745572|NCT00760474|75864635|FG000|Overall Number of Unique Participants|Period 1 (P1)||12||
59745573|NCT00760474|75864636|FG001|Overall Number of Unique Participants|Period 1 (P1)||13||
59745574|NCT00760474|75864635|FG000|COMPLETED|Period 1 (P1)||12||
59745575|NCT00760474|75864636|FG001|COMPLETED|Period 1 (P1)||13||
59745576|NCT00760474|75864635|FG000|NOT COMPLETED|Period 1 (P1)||1||
59745577|NCT00760474|75864636|FG001|NOT COMPLETED|Period 1 (P1)||1||
59745578|NCT00760474|75864635|FG000|STARTED|Placebo Washout Period||12||
59745579|NCT00760474|75864636|FG001|STARTED|Placebo Washout Period||13||
59745580|NCT00760474|75864635|FG000|COMPLETED|Placebo Washout Period||12||
59745581|NCT00760474|75864636|FG001|COMPLETED|Placebo Washout Period||12||
59745582|NCT00760474|75864635|FG000|NOT COMPLETED|Placebo Washout Period||0||
59745583|NCT00760474|75864636|FG001|NOT COMPLETED|Placebo Washout Period||1||
59745584|NCT00760474|75864635|FG000|STARTED|Period 2 (P2)||12||
59745585|NCT00760474|75864636|FG001|STARTED|Period 2 (P2)||12||
59745586|NCT00760474|75864635|FG000|COMPLETED|Period 2 (P2)||11||
59745587|NCT00760474|75864636|FG001|COMPLETED|Period 2 (P2)||11||
59745588|NCT00760474|75864635|FG000|NOT COMPLETED|Period 2 (P2)||1||
59745589|NCT00760474|75864636|FG001|NOT COMPLETED|Period 2 (P2)||1||
59745590|NCT00975416|75864645|FG000|STARTED|Overall Study||14||
59745591|NCT00975416|75864646|FG001|STARTED|Overall Study||16||
59745592|NCT00975416|75864645|FG000|COMPLETED|Overall Study||11||
59745593|NCT00975416|75864646|FG001|COMPLETED|Overall Study||11||
59745594|NCT00975416|75864645|FG000|NOT COMPLETED|Overall Study||3||
59745595|NCT00975416|75864646|FG001|NOT COMPLETED|Overall Study||5||
59745596|NCT00760084|75864653|FG000|STARTED|Overall Study||10||
59745597|NCT00760084|75864653|FG000|COMPLETED|Overall Study||0||
59745598|NCT00760084|75864653|FG000|NOT COMPLETED|Overall Study||10||
59745599|NCT00752206|75864659|FG000|STARTED|Overall Study||19||
59745600|NCT00752206|75864660|FG001|STARTED|Overall Study||19||
59745601|NCT00752206|75864659|FG000|COMPLETED|Overall Study||10||
59745602|NCT00752206|75864660|FG001|COMPLETED|Overall Study||8||
59745603|NCT00752206|75864659|FG000|NOT COMPLETED|Overall Study||9||
59745604|NCT00752206|75864660|FG001|NOT COMPLETED|Overall Study||11||
59745605|NCT00752128|75864666|FG000|STARTED|Overall Study||2349||
59745606|NCT00752128|75864666|FG000|COMPLETED|Overall Study||2345||
59745607|NCT00752128|75864666|FG000|NOT COMPLETED|Overall Study||4||
59745608|NCT00976508|75864673|FG000|STARTED|Overall Study|18 subjects were enrolled; 17 subjects were treated; 1 subject was not eligible.|17||
59745609|NCT00976508|75864674|FG001|STARTED|Overall Study||6||
59745610|NCT00976508|75864673|FG000|COMPLETED|Overall Study|These subjects withdrew from last study treatment due to progressive disease.|3||
59745611|NCT00976508|75864674|FG001|COMPLETED|Overall Study||0||
59745612|NCT00976508|75864673|FG000|NOT COMPLETED|Overall Study||14||
59745613|NCT00976508|75864674|FG001|NOT COMPLETED|Overall Study||6||
59745614|NCT00973622|75864685|FG000|STARTED|Overall Study|75 passed telephone interview; 28 passed in-person interview, were enrolled, and sent for MRI.|47||
59745615|NCT00973622|75864686|FG001|STARTED|Overall Study|21 passed telephone interview; 19 passed the in-person interview, were enrolled, and sent for MRI.|19||
59745616|NCT00973622|75864685|FG000|COMPLETED|Overall Study|Completed three sessions of rTMS|16||
59745617|NCT00973622|75864686|FG001|COMPLETED|Overall Study|Completed three sessions of rTMS|14||
59745618|NCT00973622|75864685|FG000|NOT COMPLETED|Overall Study||31||
59745619|NCT00973622|75864686|FG001|NOT COMPLETED|Overall Study||5||
59745620|NCT04044716|75864694|FG000|STARTED|Overall Study||30||
59745621|NCT04044716|75864695|FG001|STARTED|Overall Study||30||
59745622|NCT04044716|75864696|FG002|STARTED|Overall Study||5||
59745623|NCT04044716|75864694|FG000|COMPLETED|Overall Study||27||
59745624|NCT04044716|75864695|FG001|COMPLETED|Overall Study||27||
59745625|NCT04044716|75864696|FG002|COMPLETED|Overall Study||5||
59745626|NCT04044716|75864694|FG000|NOT COMPLETED|Overall Study||3||
59745627|NCT04044716|75864695|FG001|NOT COMPLETED|Overall Study||3||
59745628|NCT04044716|75864696|FG002|NOT COMPLETED|Overall Study||0||
59745629|NCT04041284|75864705|FG000|STARTED|DB Phase (12 Weeks)||178||
59745630|NCT04041284|75864706|FG001|STARTED|DB Phase (12 Weeks)||175||
59745631|NCT04041284|75864705|FG000|DB Safety Analysis Set|DB Phase (12 Weeks)||177|All randomized participants who received at least 1 dose of study drug during the DB treatment period.|
59745632|NCT04041284|75864706|FG001|DB Safety Analysis Set|DB Phase (12 Weeks)|One participant was randomized to Placebo and received placebo in the DB period but was summarized in the Fremanezumab treatment group in all safety summaries due to an error in recording treatment.|176|All randomized participants who received at least 1 dose of study drug during the DB treatment period.|
60135152|NCT03307252|76258162|FG009|STARTED|Part 2, Period 3||0||
60135153|NCT03307252|76258163|FG010|STARTED|Part 2, Period 3||0||
60135154|NCT03307252|76258153|FG000|COMPLETED|Part 2, Period 3||0||
60135155|NCT03307252|76258154|FG001|COMPLETED|Part 2, Period 3||0||
60135156|NCT03307252|76258155|FG002|COMPLETED|Part 2, Period 3||0||
60135157|NCT03307252|76258156|FG003|COMPLETED|Part 2, Period 3||4||
59745633|NCT04041284|75864705|FG000|DB Modified Intent-to-treat (mITT) Analysis Set|DB Phase (12 Weeks)||178|All randomized participants who received at least 1 dose of study drug and had at least 10 days of postrandomization efficacy assessment on the primary endpoint.|
59745634|NCT04041284|75864706|FG001|DB Modified Intent-to-treat (mITT) Analysis Set|DB Phase (12 Weeks)||175|All randomized participants who received at least 1 dose of study drug and had at least 10 days of postrandomization efficacy assessment on the primary endpoint.|
59745635|NCT04041284|75864705|FG000|COMPLETED|DB Phase (12 Weeks)||166||
59745636|NCT04041284|75864706|FG001|COMPLETED|DB Phase (12 Weeks)||164||
59745637|NCT04041284|75864705|FG000|NOT COMPLETED|DB Phase (12 Weeks)||12||
59745638|NCT04041284|75864706|FG001|NOT COMPLETED|DB Phase (12 Weeks)||11||
60135158|NCT03307252|76258157|FG004|COMPLETED|Part 2, Period 3||3||
60135159|NCT03307252|76258158|FG005|COMPLETED|Part 2, Period 3||3||
60135160|NCT03307252|76258159|FG006|COMPLETED|Part 2, Period 3||5||
60135161|NCT03307252|76258160|FG007|COMPLETED|Part 2, Period 3||0||
60135162|NCT03307252|76258161|FG008|COMPLETED|Part 2, Period 3||0||
60135163|NCT03307252|76258162|FG009|COMPLETED|Part 2, Period 3||0||
60135164|NCT03307252|76258163|FG010|COMPLETED|Part 2, Period 3||0||
60135165|NCT03307252|76258153|FG000|NOT COMPLETED|Part 2, Period 3||0||
60135166|NCT03307252|76258154|FG001|NOT COMPLETED|Part 2, Period 3||0||
60135167|NCT03307252|76258155|FG002|NOT COMPLETED|Part 2, Period 3||0||
60135168|NCT03307252|76258156|FG003|NOT COMPLETED|Part 2, Period 3||0||
60135169|NCT03307252|76258157|FG004|NOT COMPLETED|Part 2, Period 3||1||
60135170|NCT03307252|76258158|FG005|NOT COMPLETED|Part 2, Period 3||0||
60135171|NCT03307252|76258159|FG006|NOT COMPLETED|Part 2, Period 3||0||
59873061|NCT03021304|75997200|FG000|COMPLETED|Overall Study||55||
60135172|NCT03307252|76258160|FG007|NOT COMPLETED|Part 2, Period 3||0||
60135173|NCT03307252|76258161|FG008|NOT COMPLETED|Part 2, Period 3||0||
60135174|NCT03307252|76258162|FG009|NOT COMPLETED|Part 2, Period 3||0||
60135175|NCT03307252|76258163|FG010|NOT COMPLETED|Part 2, Period 3||0||
60135176|NCT03307252|76258153|FG000|STARTED|Part 2, Washout Period 3 (7 Days)||0||
60135177|NCT03307252|76258154|FG001|STARTED|Part 2, Washout Period 3 (7 Days)||0||
59745639|NCT04041284|75864705|FG000|STARTED|OL Phase (12 Weeks)||166||
59745640|NCT04041284|75864706|FG001|STARTED|OL Phase (12 Weeks)||164||
59762497|NCT00866619|75882227|FG001|STARTED|Overall Study||4358||
60135178|NCT03307252|76258155|FG002|STARTED|Part 2, Washout Period 3 (7 Days)||0||
60135179|NCT03307252|76258156|FG003|STARTED|Part 2, Washout Period 3 (7 Days)||4||
60135180|NCT03307252|76258157|FG004|STARTED|Part 2, Washout Period 3 (7 Days)||3||
60135181|NCT03307252|76258158|FG005|STARTED|Part 2, Washout Period 3 (7 Days)||3||
60135182|NCT03307252|76258159|FG006|STARTED|Part 2, Washout Period 3 (7 Days)||5||
59745641|NCT04041284|75864705|FG000|OL Safety Analysis Set|OL Phase (12 Weeks)||165|All participants who received at least 1 of dose of study drug during the OL treatment period.|
59745642|NCT04041284|75864706|FG001|OL Safety Analysis Set|OL Phase (12 Weeks)|One participant was randomized to Placebo and received placebo in the DB period but was summarized in the Fremanezumab treatment group in all safety summaries due to an error in recording treatment.|165|All participants who received at least 1 of dose of study drug during the OL treatment period.|
59745643|NCT04041284|75864705|FG000|OL mITT Analysis Set|OL Phase (12 Weeks)||165|All participants who received at least 1 dose of study drug during the OL treatment period and had at least 10 days of diary entries during the OL period.|
59745644|NCT04041284|75864706|FG001|OL mITT Analysis Set|OL Phase (12 Weeks)||161|All participants who received at least 1 dose of study drug during the OL treatment period and had at least 10 days of diary entries during the OL period.|
59745645|NCT04041284|75864705|FG000|COMPLETED|OL Phase (12 Weeks)||154||
59745646|NCT04041284|75864706|FG001|COMPLETED|OL Phase (12 Weeks)||155||
59745647|NCT04041284|75864705|FG000|NOT COMPLETED|OL Phase (12 Weeks)||12||
59745648|NCT04041284|75864706|FG001|NOT COMPLETED|OL Phase (12 Weeks)||9||
59745649|NCT00753454|75864716|FG000|STARTED|Overall Study||168||
59745650|NCT00753454|75864716|FG000|COMPLETED|Overall Study||154||
59745651|NCT00753454|75864716|FG000|NOT COMPLETED|Overall Study||14||
59745652|NCT00976274|75864722|FG000|STARTED|Overall Study||31||
59745653|NCT00976274|75864723|FG001|STARTED|Overall Study||29||
59745654|NCT00976274|75864722|FG000|COMPLETED|Overall Study||24||
59745655|NCT00976274|75864723|FG001|COMPLETED|Overall Study||21||
59745656|NCT00976274|75864722|FG000|NOT COMPLETED|Overall Study||7||
59745657|NCT00976274|75864723|FG001|NOT COMPLETED|Overall Study||8||
59745658|NCT00759148|75864731|FG000|STARTED|Overall Study||593||
59745659|NCT00759148|75864732|FG001|STARTED|Overall Study||586||
59745660|NCT00759148|75864731|FG000|COMPLETED|Overall Study||579||
59745661|NCT00759148|75864732|FG001|COMPLETED|Overall Study||554||
59745662|NCT00759148|75864731|FG000|NOT COMPLETED|Overall Study||14||
59745663|NCT00759148|75864732|FG001|NOT COMPLETED|Overall Study||32||
59745664|NCT02794285|75864742|FG000|STARTED|Overall Study||257|12 participants were enrolled but excluded due to site non-compliance or lack of source documentation.|
59745665|NCT02794285|75864743|FG001|STARTED|Overall Study||112|12 participants were enrolled but excluded due to site non-compliance or lack of source documentation.|
59745666|NCT02794285|75864744|FG002|STARTED|Overall Study||111|12 participants were enrolled but excluded due to site non-compliance or lack of source documentation.|
59745667|NCT02794285|75864745|FG003|STARTED|Overall Study||67|12 participants were enrolled but excluded due to site non-compliance or lack of source documentation.|
59745668|NCT02794285|75864742|FG000|COMPLETED|Overall Study||178||
59745669|NCT02794285|75864743|FG001|COMPLETED|Overall Study||54||
59745670|NCT02794285|75864744|FG002|COMPLETED|Overall Study||69||
59745671|NCT02794285|75864745|FG003|COMPLETED|Overall Study||41||
59745672|NCT02794285|75864742|FG000|NOT COMPLETED|Overall Study||79||
59745673|NCT02794285|75864743|FG001|NOT COMPLETED|Overall Study||58||
59745674|NCT02794285|75864744|FG002|NOT COMPLETED|Overall Study||42||
59745675|NCT02794285|75864745|FG003|NOT COMPLETED|Overall Study||26||
59745676|NCT00970268|75864757|FG000|STARTED|Overall Study||139||
59745677|NCT00970268|75864758|FG001|STARTED|Overall Study||152||
59745678|NCT00970268|75864757|FG000|COMPLETED|Overall Study||96||
59745679|NCT00970268|75864758|FG001|COMPLETED|Overall Study||103||
59745680|NCT00970268|75864757|FG000|NOT COMPLETED|Overall Study||43||
59745681|NCT00970268|75864758|FG001|NOT COMPLETED|Overall Study||49||
59745682|NCT00969332|75864770|FG000|STARTED|Overall Study||62||
59745683|NCT00969332|75864770|FG000|COMPLETED|Overall Study||51||
59745684|NCT00969332|75864770|FG000|NOT COMPLETED|Overall Study||11||
59745685|NCT00968864|75864775|FG000|STARTED|Overall Study|One patient, FDA and IRB approved to enroll as an exception, was not evaluable for study endpoints.|53||
59745686|NCT00968864|75864775|FG000|COMPLETED|Overall Study||52||
59745687|NCT00968864|75864775|FG000|NOT COMPLETED|Overall Study||1||
59745688|NCT00758680|75864784|FG000|STARTED|Overall Study||6||
59745689|NCT00758680|75864785|FG001|STARTED|Overall Study||6||
59745690|NCT00758680|75864786|FG002|STARTED|Overall Study||6||
59745691|NCT00758680|75864787|FG003|STARTED|Overall Study||6||
59745692|NCT00758680|75864788|FG004|STARTED|Overall Study||6||
59745693|NCT00758680|75864789|FG005|STARTED|Overall Study||6||
59745694|NCT00758680|75864790|FG006|STARTED|Overall Study||7||
59745695|NCT00758680|75864791|FG007|STARTED|Overall Study||20||
59745696|NCT00758680|75864792|FG008|STARTED|Overall Study||20||
59745697|NCT00758680|75864793|FG009|STARTED|Overall Study||29||
59745698|NCT00758680|75864784|FG000|COMPLETED|Overall Study||6||
59745699|NCT00758680|75864785|FG001|COMPLETED|Overall Study||6||
59745700|NCT00758680|75864786|FG002|COMPLETED|Overall Study||6||
59745701|NCT00758680|75864787|FG003|COMPLETED|Overall Study||6||
59745702|NCT00758680|75864788|FG004|COMPLETED|Overall Study||6||
59745703|NCT00758680|75864789|FG005|COMPLETED|Overall Study||6||
59745704|NCT00758680|75864790|FG006|COMPLETED|Overall Study||6||
59873062|NCT03021304|75997200|FG000|NOT COMPLETED|Overall Study||1||
59873063|NCT01330966|75997204|FG000|STARTED|Overall Study||47||
59745705|NCT00758680|75864791|FG007|COMPLETED|Overall Study||19||
59745706|NCT00758680|75864792|FG008|COMPLETED|Overall Study||18||
59745707|NCT00758680|75864793|FG009|COMPLETED|Overall Study||28||
59745708|NCT00758680|75864784|FG000|NOT COMPLETED|Overall Study||0||
59745709|NCT00758680|75864785|FG001|NOT COMPLETED|Overall Study||0||
59745710|NCT00758680|75864786|FG002|NOT COMPLETED|Overall Study||0||
59745711|NCT00758680|75864787|FG003|NOT COMPLETED|Overall Study||0||
59745712|NCT00758680|75864788|FG004|NOT COMPLETED|Overall Study||0||
59745713|NCT00758680|75864789|FG005|NOT COMPLETED|Overall Study||0||
59745714|NCT00758680|75864790|FG006|NOT COMPLETED|Overall Study||1||
59745715|NCT00758680|75864791|FG007|NOT COMPLETED|Overall Study||1||
59745716|NCT00758680|75864792|FG008|NOT COMPLETED|Overall Study||2||
59745717|NCT00758680|75864793|FG009|NOT COMPLETED|Overall Study||1||
59745718|NCT00758602|75864818|FG000|STARTED|Overall Study||104||
59745719|NCT00758602|75864819|FG001|STARTED|Overall Study||106||
59745720|NCT00758602|75864818|FG000|COMPLETED|Overall Study||85||
59745721|NCT00758602|75864819|FG001|COMPLETED|Overall Study||84||
59745722|NCT00758602|75864818|FG000|NOT COMPLETED|Overall Study||19||
59745723|NCT00758602|75864819|FG001|NOT COMPLETED|Overall Study||22||
59745724|NCT00711529|75864828|FG000|STARTED|Overall Study||13||
59745725|NCT00711529|75864829|FG001|STARTED|Overall Study||14||
59745726|NCT00711529|75864828|FG000|COMPLETED|Overall Study|2 women lost their hot flash diary, so only 7 patients were evaluable for primary endpoint.|9||
59745727|NCT00711529|75864829|FG001|COMPLETED|Overall Study||8||
59745728|NCT00711529|75864828|FG000|NOT COMPLETED|Overall Study||4||
59745729|NCT00711529|75864829|FG001|NOT COMPLETED|Overall Study||6||
59745730|NCT00601419|75864835|FG000|STARTED|Overall Study||230||
59745731|NCT00601419|75864835|FG000|COMPLETED|Overall Study||226||
59745732|NCT00601419|75864835|FG000|NOT COMPLETED|Overall Study||4||
59745733|NCT00712933|75864855|FG000|STARTED|Overall Study||735||
59745734|NCT00712933|75864855|FG000|COMPLETED|Overall Study||368||
59745735|NCT00712933|75864855|FG000|NOT COMPLETED|Overall Study||367||
59745736|NCT00712543|75864865|FG000|STARTED|Day 1-7||23||
59745737|NCT00712543|75864866|FG001|STARTED|Day 1-7||27||
59745738|NCT00712543|75864865|FG000|COMPLETED|Day 1-7||23||
59745739|NCT00712543|75864866|FG001|COMPLETED|Day 1-7||27||
59745740|NCT00712543|75864865|FG000|NOT COMPLETED|Day 1-7||0||
59745741|NCT00712543|75864866|FG001|NOT COMPLETED|Day 1-7||0||
59745742|NCT00712543|75864865|FG000|STARTED|Day 8-14||23||
59745743|NCT00712543|75864866|FG001|STARTED|Day 8-14||27||
59745744|NCT00712543|75864865|FG000|COMPLETED|Day 8-14||23||
59745745|NCT00712543|75864866|FG001|COMPLETED|Day 8-14||25||
59745746|NCT00712543|75864865|FG000|NOT COMPLETED|Day 8-14||0||
59745747|NCT00712543|75864866|FG001|NOT COMPLETED|Day 8-14||2||
59745748|NCT00709111|75864872|FG000|STARTED|Overall Study||34||
59745749|NCT00709111|75864872|FG000|Week 22/24|Overall Study||33||
59745750|NCT00709111|75864872|FG000|COMPLETED|Overall Study||32||
59745751|NCT00709111|75864872|FG000|NOT COMPLETED|Overall Study||2||
59745752|NCT00710749|75864876|FG000|STARTED|Clinic Baseline Recording||30||
59745753|NCT00710749|75864877|FG001|STARTED|Clinic Baseline Recording||30||
59745754|NCT00710749|75864876|FG000|COMPLETED|Clinic Baseline Recording||30||
59745755|NCT00710749|75864877|FG001|COMPLETED|Clinic Baseline Recording||30||
59745756|NCT00710749|75864876|FG000|NOT COMPLETED|Clinic Baseline Recording||0||
59745757|NCT00710749|75864877|FG001|NOT COMPLETED|Clinic Baseline Recording||0||
59745758|NCT00710749|75864876|FG000|STARTED|First Intervention||30||
59745759|NCT00710749|75864877|FG001|STARTED|First Intervention||30||
59745760|NCT00710749|75864876|FG000|COMPLETED|First Intervention||29||
59745761|NCT00710749|75864877|FG001|COMPLETED|First Intervention||30||
59745762|NCT00710749|75864876|FG000|NOT COMPLETED|First Intervention||1||
59745763|NCT00710749|75864877|FG001|NOT COMPLETED|First Intervention||0||
59745764|NCT00710749|75864876|FG000|STARTED|Second Intervention||29||
59745765|NCT00710749|75864877|FG001|STARTED|Second Intervention||30||
59745766|NCT00710749|75864876|FG000|COMPLETED|Second Intervention||29||
59745767|NCT00710749|75864877|FG001|COMPLETED|Second Intervention||30||
59745768|NCT00710749|75864876|FG000|NOT COMPLETED|Second Intervention||0||
59745769|NCT00710749|75864877|FG001|NOT COMPLETED|Second Intervention||0||
59745770|NCT03628287|75864887|FG000|STARTED|Overall Study||531||
59745771|NCT03628287|75864888|FG001|STARTED|Overall Study||429||
59745772|NCT03628287|75864887|FG000|Period 0: No Revised Program Delivery|Overall Study||83|(November 2017-March 2018, follow-up through July 2018)|
59745773|NCT03628287|75864888|FG001|Period 0: No Revised Program Delivery|Overall Study||93|(November 2017-March 2018, follow-up through July 2018)|
59745774|NCT03628287|75864887|FG000|Period 1: Revised Program Delivery Only at Sites Assigned to Early Implementation|Overall Study||286|(August-December 2018, follow-up through April 2019)|
59745775|NCT03628287|75864888|FG001|Period 1: Revised Program Delivery Only at Sites Assigned to Early Implementation|Overall Study||104|(August-December 2018, follow-up through April 2019)|
59745776|NCT03628287|75864887|FG000|Period 2: Revised Program Delivery at All Sites|Overall Study||162|(May-September 2019, follow-up through January 2020)|
59745777|NCT03628287|75864888|FG001|Period 2: Revised Program Delivery at All Sites|Overall Study||232|(May-September 2019, follow-up through January 2020)|
59745778|NCT03628287|75864887|FG000|COMPLETED|Overall Study||531||
59745779|NCT03628287|75864888|FG001|COMPLETED|Overall Study||429||
59873064|NCT01330966|75997204|FG000|COMPLETED|Overall Study|Tumor responses evaluable in 42 of 47 pts; 5 pts discontinued prior to first tumor assessment.|42||
59745780|NCT03628287|75864887|FG000|NOT COMPLETED|Overall Study||0||
59745781|NCT03628287|75864888|FG001|NOT COMPLETED|Overall Study||0||
59745782|NCT00699907|75864897|FG000|STARTED|Overall Study||14||
59745783|NCT00699907|75864898|FG001|STARTED|Overall Study||57||
59745784|NCT00699907|75864899|FG002|STARTED|Overall Study||56||
59745785|NCT00699907|75864897|FG000|COMPLETED|Overall Study||12||
59745786|NCT00699907|75864898|FG001|COMPLETED|Overall Study||47||
59745787|NCT00699907|75864899|FG002|COMPLETED|Overall Study||48||
59745788|NCT00699907|75864897|FG000|NOT COMPLETED|Overall Study||2||
59745789|NCT00699907|75864898|FG001|NOT COMPLETED|Overall Study||10||
59745790|NCT00699907|75864899|FG002|NOT COMPLETED|Overall Study||8||
59745791|NCT00710593|75864909|FG000|STARTED|Overall Study||69||
59745792|NCT00710593|75864910|FG001|STARTED|Overall Study||30||
59745793|NCT00710593|75864909|FG000|COMPLETED|Overall Study|54 completed study and vaccine. 6 did not receive all vaccine, but completed all study visits.|54||
59745794|NCT00710593|75864910|FG001|COMPLETED|Overall Study|25 completed study and vaccine. 2 did not receive all vaccine, but completed all study visits.|25||
59745795|NCT00710593|75864909|FG000|NOT COMPLETED|Overall Study||15||
59745796|NCT00710593|75864910|FG001|NOT COMPLETED|Overall Study||5||
59745797|NCT00599313|75864932|FG000|STARTED|Overall Study||36||
59745798|NCT00599313|75864932|FG000|COMPLETED|Overall Study||0||
59745799|NCT00599313|75864932|FG000|NOT COMPLETED|Overall Study||36||
59745800|NCT00708175|75864938|FG000|STARTED|Overall Study||78||
59745801|NCT00708175|75864939|FG001|STARTED|Overall Study||78||
59745802|NCT00708175|75864938|FG000|COMPLETED|Overall Study||60||
59745803|NCT00708175|75864939|FG001|COMPLETED|Overall Study||57||
59745804|NCT00708175|75864938|FG000|NOT COMPLETED|Overall Study||18||
59745805|NCT00708175|75864939|FG001|NOT COMPLETED|Overall Study||21||
59745806|NCT00707239|75864948|FG000|STARTED|Overall Study||37||
59745807|NCT00707239|75864949|FG001|STARTED|Overall Study||36||
59745808|NCT00707239|75864950|FG002|STARTED|Overall Study||35||
59745809|NCT00707239|75864948|FG000|Treated|Overall Study||36||
59745810|NCT00707239|75864949|FG001|Treated|Overall Study||35||
59745811|NCT00707239|75864950|FG002|Treated|Overall Study||34||
59745812|NCT00707239|75864948|FG000|COMPLETED|Overall Study||18||
59745813|NCT00707239|75864949|FG001|COMPLETED|Overall Study||25||
59745814|NCT00707239|75864950|FG002|COMPLETED|Overall Study||21||
59745815|NCT00707239|75864948|FG000|NOT COMPLETED|Overall Study||19||
59745816|NCT00707239|75864949|FG001|NOT COMPLETED|Overall Study||11||
59745817|NCT00707239|75864950|FG002|NOT COMPLETED|Overall Study||14||
59745818|NCT00968708|75864963|FG000|STARTED|Overall Study||2679||
59745819|NCT00968708|75864964|FG001|STARTED|Overall Study||2701||
59745820|NCT00968708|75864963|FG000|Treated|Overall Study||2676||
59745821|NCT00968708|75864964|FG001|Treated|Overall Study||2698||
59745822|NCT00968708|75864963|FG000|COMPLETED|Overall Study||2361||
59745823|NCT00968708|75864964|FG001|COMPLETED|Overall Study||2403||
59745824|NCT00968708|75864963|FG000|NOT COMPLETED|Overall Study||318||
59745825|NCT00968708|75864964|FG001|NOT COMPLETED|Overall Study||298||
59745826|NCT00967694|75864970|FG000|STARTED|Overall Study||26||
59745827|NCT00967694|75864970|FG000|COMPLETED|Overall Study|5 discontinued during N2O administration due to agitation ⁄ dysphoria, one due to nausea⁄vomiting.|20||
59745828|NCT00967694|75864970|FG000|NOT COMPLETED|Overall Study||6||
59745829|NCT00967616|75864976|FG000|STARTED|Overall Study||50||
60135183|NCT03307252|76258160|FG007|STARTED|Part 2, Washout Period 3 (7 Days)||0||
59745830|NCT00967616|75864977|FG001|STARTED|Overall Study||50||
59745831|NCT00967616|75864976|FG000|COMPLETED|Overall Study||0||
59745832|NCT00967616|75864977|FG001|COMPLETED|Overall Study||0||
59745833|NCT00967616|75864976|FG000|NOT COMPLETED|Overall Study||50||
59745834|NCT00967616|75864977|FG001|NOT COMPLETED|Overall Study||50||
59745835|NCT04270292|75864983|FG000|STARTED|Overall Study||164||
59745836|NCT04270292|75864983|FG000|COMPLETED|Overall Study||164||
59745837|NCT04270292|75864983|FG000|NOT COMPLETED|Overall Study||0||
59745838|NCT00971204|75864987|FG000|STARTED|Overall Study|100 enrolled participants|100||
59745839|NCT00971204|75864987|FG000|Treated|Overall Study||86||
59745840|NCT00971204|75864987|FG000|COMPLETED|Overall Study|86 participants were treated and of these 86, 76 completed the study.|76||
59745841|NCT00971204|75864987|FG000|NOT COMPLETED|Overall Study||24||
59745842|NCT00974090|75864993|FG000|STARTED|Period 1: Double Blind Period||98||
59745843|NCT00974090|75864994|FG001|STARTED|Period 1: Double Blind Period||96||
59873065|NCT01330966|75997204|FG000|NOT COMPLETED|Overall Study||5||
59873066|NCT03496298|75997211|FG000|STARTED|Overall Study||1359|Randomized.|
59873067|NCT03496298|75997212|FG001|STARTED|Overall Study||1359|Randomized.|
59873068|NCT03496298|75997213|FG002|STARTED|Overall Study||1358|Randomized.|
59873069|NCT03496298|75997211|FG000|Randomized and Treated|Overall Study||1358||
59873070|NCT03496298|75997212|FG001|Randomized and Treated|Overall Study||1358||
59873071|NCT03496298|75997213|FG002|Randomized and Treated|Overall Study||1357||
59950736|NCT03536884|76069559|FG003|NOT COMPLETED|Maintenance Treatment Period Week 16-48||9||
59950737|NCT03536884|76069560|FG004|NOT COMPLETED|Maintenance Treatment Period Week 16-48||29||
59950738|NCT03515213|76069577|FG000|STARTED|Overall Study||9||
59950739|NCT03515213|76069578|FG001|STARTED|Overall Study||1||
60135184|NCT03307252|76258161|FG008|STARTED|Part 2, Washout Period 3 (7 Days)||0||
60135185|NCT03307252|76258162|FG009|STARTED|Part 2, Washout Period 3 (7 Days)||0||
60135186|NCT03307252|76258163|FG010|STARTED|Part 2, Washout Period 3 (7 Days)||0||
59745844|NCT00974090|75864993|FG000|COMPLETED|Period 1: Double Blind Period||95||
59745845|NCT00974090|75864994|FG001|COMPLETED|Period 1: Double Blind Period||95||
59745846|NCT00974090|75864993|FG000|NOT COMPLETED|Period 1: Double Blind Period||3||
59745847|NCT00974090|75864994|FG001|NOT COMPLETED|Period 1: Double Blind Period||1||
59745848|NCT00974090|75864993|FG000|STARTED|Period 2: Open-label Period||95||
59745849|NCT00974090|75864994|FG001|STARTED|Period 2: Open-label Period||95||
59745850|NCT00974090|75864993|FG000|COMPLETED|Period 2: Open-label Period||87||
59745851|NCT00974090|75864994|FG001|COMPLETED|Period 2: Open-label Period||85||
59745852|NCT00974090|75864993|FG000|NOT COMPLETED|Period 2: Open-label Period||8||
59745853|NCT00974090|75864994|FG001|NOT COMPLETED|Period 2: Open-label Period||10||
59745854|NCT00971048|75865006|FG000|STARTED|Overall Study||30||
59745855|NCT00971048|75865007|FG001|STARTED|Overall Study||33||
59745856|NCT00971048|75865008|FG002|STARTED|Overall Study||12||
59745857|NCT00971048|75865009|FG003|STARTED|Overall Study||13||
59745858|NCT00971048|75865006|FG000|COMPLETED|Overall Study||29||
59745859|NCT00971048|75865007|FG001|COMPLETED|Overall Study||31||
59745860|NCT00971048|75865008|FG002|COMPLETED|Overall Study||11||
59745861|NCT00971048|75865009|FG003|COMPLETED|Overall Study||11||
59745862|NCT00971048|75865006|FG000|NOT COMPLETED|Overall Study||1||
59745863|NCT00971048|75865007|FG001|NOT COMPLETED|Overall Study||2||
59745864|NCT00971048|75865008|FG002|NOT COMPLETED|Overall Study||1||
59745865|NCT00971048|75865009|FG003|NOT COMPLETED|Overall Study||2||
59745866|NCT00699751|75865023|FG000|STARTED|Period 1: Without/Before Drug Switch||614||
59745867|NCT00699751|75865024|FG001|STARTED|Period 1: Without/Before Drug Switch||307||
59745868|NCT00699751|75865023|FG000|Participants Received Treatment|Period 1: Without/Before Drug Switch||600||
59745869|NCT00699751|75865024|FG001|Participants Received Treatment|Period 1: Without/Before Drug Switch||301||
59745870|NCT00699751|75865023|FG000|Entered 3-Year Follow-up Period|Period 1: Without/Before Drug Switch|Participants were not required to complete all 6 injections to enter to 3-year follow-up period.|407||
59745871|NCT00699751|75865024|FG001|Entered 3-Year Follow-up Period|Period 1: Without/Before Drug Switch|Participants were not required to complete all 6 injections to enter to 3-year follow-up period.|168||
59745872|NCT00699751|75865023|FG000|Completed 3-Year Follow-up Period|Period 1: Without/Before Drug Switch||49||
59745873|NCT00699751|75865024|FG001|Completed 3-Year Follow-up Period|Period 1: Without/Before Drug Switch||12||
59745874|NCT00699751|75865023|FG000|COMPLETED|Period 1: Without/Before Drug Switch|Completed all 6 injections|389||
59745875|NCT00699751|75865024|FG001|COMPLETED|Period 1: Without/Before Drug Switch|Completed all 6 injections|145||
59745876|NCT00699751|75865023|FG000|NOT COMPLETED|Period 1: Without/Before Drug Switch||225||
59745877|NCT00699751|75865024|FG001|NOT COMPLETED|Period 1: Without/Before Drug Switch||162||
59745878|NCT00699751|75865023|FG000|STARTED|Period 2:Switched From Placebo to Xofigo||0||
59745879|NCT00699751|75865024|FG001|STARTED|Period 2:Switched From Placebo to Xofigo|Participants in the placebo group switched to Xofigo treatment|26||
59745880|NCT00699751|75865023|FG000|Participants Received Treatment|Period 2:Switched From Placebo to Xofigo||0||
59745881|NCT00699751|75865024|FG001|Participants Received Treatment|Period 2:Switched From Placebo to Xofigo||24||
59745882|NCT00699751|75865023|FG000|Entered 3-Year Follow-up Period|Period 2:Switched From Placebo to Xofigo||0||
59745883|NCT00699751|75865024|FG001|Entered 3-Year Follow-up Period|Period 2:Switched From Placebo to Xofigo||15||
59745884|NCT00699751|75865023|FG000|Completed 3-Year Follow-up Period|Period 2:Switched From Placebo to Xofigo||0||
59745885|NCT00699751|75865024|FG001|Completed 3-Year Follow-up Period|Period 2:Switched From Placebo to Xofigo||0||
59745886|NCT00699751|75865023|FG000|COMPLETED|Period 2:Switched From Placebo to Xofigo||0||
59745887|NCT00699751|75865024|FG001|COMPLETED|Period 2:Switched From Placebo to Xofigo|Completed all 6 injections|17||
59745888|NCT00699751|75865023|FG000|NOT COMPLETED|Period 2:Switched From Placebo to Xofigo||0||
59745889|NCT00699751|75865024|FG001|NOT COMPLETED|Period 2:Switched From Placebo to Xofigo||9||
59745890|NCT00970502|75865031|FG000|STARTED|Overall Study||15||
59745891|NCT00970502|75865031|FG000|COMPLETED|Overall Study||14||
59745892|NCT00970502|75865031|FG000|NOT COMPLETED|Overall Study||1||
59745893|NCT00967226|75865041|FG000|STARTED|Overall Study||11||
59745894|NCT00967226|75865042|FG001|STARTED|Overall Study||8||
59745895|NCT00967226|75865041|FG000|COMPLETED|Overall Study||9||
59745896|NCT00967226|75865042|FG001|COMPLETED|Overall Study||2||
59745897|NCT00967226|75865041|FG000|NOT COMPLETED|Overall Study||2||
59745898|NCT00967226|75865042|FG001|NOT COMPLETED|Overall Study||6||
59745899|NCT00706381|75865076|FG000|STARTED|Overall Study||10||
59745900|NCT00706381|75865077|FG001|STARTED|Overall Study||6||
59745901|NCT00706381|75865078|FG002|STARTED|Overall Study||6||
59745902|NCT00706381|75865079|FG003|STARTED|Overall Study||9||
59745903|NCT00706381|75865076|FG000|Intervention 1 (1 Day)|Overall Study||10||
59745904|NCT00706381|75865077|FG001|Intervention 1 (1 Day)|Overall Study||6||
59745905|NCT00706381|75865078|FG002|Intervention 1 (1 Day)|Overall Study||6||
59745906|NCT00706381|75865079|FG003|Intervention 1 (1 Day)|Overall Study||9||
59745907|NCT00706381|75865076|FG000|Intervention 2 (1 Day)|Overall Study||10||
59745908|NCT00706381|75865077|FG001|Intervention 2 (1 Day)|Overall Study||6||
59745909|NCT00706381|75865078|FG002|Intervention 2 (1 Day)|Overall Study||6||
59745910|NCT00706381|75865079|FG003|Intervention 2 (1 Day)|Overall Study||9||
59745911|NCT00706381|75865076|FG000|Intervention 3 (1 Day)|Overall Study||10||
59745912|NCT00706381|75865077|FG001|Intervention 3 (1 Day)|Overall Study||6||
59745913|NCT00706381|75865078|FG002|Intervention 3 (1 Day)|Overall Study||6||
59745914|NCT00706381|75865079|FG003|Intervention 3 (1 Day)|Overall Study||9||
59950740|NCT03515213|76069577|FG000|COMPLETED|Overall Study||9||
59950741|NCT03515213|76069578|FG001|COMPLETED|Overall Study||1||
59745915|NCT00706381|75865076|FG000|Intervention 4 (1 Day)|Overall Study||10||
59745916|NCT00706381|75865077|FG001|Intervention 4 (1 Day)|Overall Study||5||
59950742|NCT03515213|76069577|FG000|NOT COMPLETED|Overall Study||0||
59950743|NCT03515213|76069578|FG001|NOT COMPLETED|Overall Study||0||
59745917|NCT00706381|75865078|FG002|Intervention 4 (1 Day)|Overall Study||6||
59745918|NCT00706381|75865079|FG003|Intervention 4 (1 Day)|Overall Study||9||
59745919|NCT00706381|75865076|FG000|Intervention 5 (1 Day)|Overall Study||10||
59745920|NCT00706381|75865077|FG001|Intervention 5 (1 Day)|Overall Study||5||
59745921|NCT00706381|75865078|FG002|Intervention 5 (1 Day)|Overall Study||5||
59745922|NCT00706381|75865079|FG003|Intervention 5 (1 Day)|Overall Study||9||
59745923|NCT00706381|75865076|FG000|COMPLETED|Overall Study||10||
59745924|NCT00706381|75865077|FG001|COMPLETED|Overall Study||5||
59745925|NCT00706381|75865078|FG002|COMPLETED|Overall Study||5||
59745926|NCT00706381|75865079|FG003|COMPLETED|Overall Study||9||
59745927|NCT00706381|75865076|FG000|NOT COMPLETED|Overall Study||0||
59745928|NCT00706381|75865077|FG001|NOT COMPLETED|Overall Study||1||
59745929|NCT00706381|75865078|FG002|NOT COMPLETED|Overall Study||1||
59745930|NCT00706381|75865079|FG003|NOT COMPLETED|Overall Study||0||
59745931|NCT00964886|75865096|FG000|STARTED|Overall Study||38||
59745932|NCT00964886|75865097|FG001|STARTED|Overall Study||34||
59745933|NCT00964886|75865098|FG002|STARTED|Overall Study||37||
59745934|NCT00964886|75865099|FG003|STARTED|Overall Study||33||
59745935|NCT00964886|75865096|FG000|COMPLETED|Overall Study||27||
59745936|NCT00964886|75865097|FG001|COMPLETED|Overall Study||27||
59745937|NCT00964886|75865098|FG002|COMPLETED|Overall Study||21||
59745938|NCT00964886|75865099|FG003|COMPLETED|Overall Study||24||
59745939|NCT00964886|75865096|FG000|NOT COMPLETED|Overall Study||11||
59745940|NCT00964886|75865097|FG001|NOT COMPLETED|Overall Study||7||
59745941|NCT00964886|75865098|FG002|NOT COMPLETED|Overall Study||16||
59745942|NCT00964886|75865099|FG003|NOT COMPLETED|Overall Study||9||
59745943|NCT00705757|75865116|FG000|STARTED|Overall Study||32||
59745944|NCT00705757|75865117|FG001|STARTED|Overall Study||29||
59745945|NCT00705757|75865118|FG002|STARTED|Overall Study||28||
59745946|NCT00705757|75865116|FG000|COMPLETED|Overall Study||19||
59745947|NCT00705757|75865117|FG001|COMPLETED|Overall Study||21||
59745948|NCT00705757|75865118|FG002|COMPLETED|Overall Study||17||
59745949|NCT00705757|75865116|FG000|NOT COMPLETED|Overall Study||13||
59745950|NCT00705757|75865117|FG001|NOT COMPLETED|Overall Study||8||
59745951|NCT00705757|75865118|FG002|NOT COMPLETED|Overall Study||11||
59745952|NCT03588884|75865130|FG000|STARTED|Overall Study||18||
59745953|NCT03588884|75865131|FG001|STARTED|Overall Study||18||
59745954|NCT03588884|75865132|FG002|STARTED|Overall Study||18||
59745955|NCT03588884|75865133|FG003|STARTED|Overall Study||15||
59745956|NCT03588884|75865130|FG000|COMPLETED|Overall Study||18||
59745957|NCT03588884|75865131|FG001|COMPLETED|Overall Study||15||
59745958|NCT03588884|75865132|FG002|COMPLETED|Overall Study||15||
59745959|NCT03588884|75865133|FG003|COMPLETED|Overall Study||14||
59745960|NCT03588884|75865130|FG000|NOT COMPLETED|Overall Study||0||
59745961|NCT03588884|75865131|FG001|NOT COMPLETED|Overall Study||3||
59745962|NCT03588884|75865132|FG002|NOT COMPLETED|Overall Study||3||
59745963|NCT03588884|75865133|FG003|NOT COMPLETED|Overall Study||1||
59745964|NCT00960752|75865146|FG000|STARTED|Overall Study||13||
59745965|NCT00960752|75865147|FG001|STARTED|Overall Study||13||
59745966|NCT00960752|75865148|FG002|STARTED|Overall Study||19||
59745967|NCT00960752|75865146|FG000|COMPLETED|Overall Study||13||
59745968|NCT00960752|75865147|FG001|COMPLETED|Overall Study||13||
59745969|NCT00960752|75865148|FG002|COMPLETED|Overall Study||17||
59745970|NCT00960752|75865146|FG000|NOT COMPLETED|Overall Study||0||
59745971|NCT00960752|75865147|FG001|NOT COMPLETED|Overall Study||0||
59745972|NCT00960752|75865148|FG002|NOT COMPLETED|Overall Study||2||
59745973|NCT00758524|75865162|FG000|STARTED|Core Period (Week 0 to Week 8)||92||
59745974|NCT00758524|75865163|FG001|STARTED|Core Period (Week 0 to Week 8)||88||
59745975|NCT00758524|75865164|FG002|STARTED|Core Period (Week 0 to Week 8)||86||
59745976|NCT00758524|75865165|FG003|STARTED|Core Period (Week 0 to Week 8)|One participant in this arm group was randomized twice and was excluded from Full Analysis Set.|97||
59745977|NCT00758524|75865166|FG004|STARTED|Core Period (Week 0 to Week 8)||84||
59745978|NCT00758524|75865167|FG005|STARTED|Core Period (Week 0 to Week 8)||77||
59745979|NCT00758524|75865168|FG006|STARTED|Core Period (Week 0 to Week 8)||0||
59745980|NCT00758524|75865169|FG007|STARTED|Core Period (Week 0 to Week 8)||0||
59745981|NCT00758524|75865170|FG008|STARTED|Core Period (Week 0 to Week 8)||0||
59745982|NCT00758524|75865171|FG009|STARTED|Core Period (Week 0 to Week 8)||0||
59745983|NCT00758524|75865172|FG010|STARTED|Core Period (Week 0 to Week 8)||0||
59745984|NCT00758524|75865173|FG011|STARTED|Core Period (Week 0 to Week 8)||0||
59745985|NCT00758524|75865174|FG012|STARTED|Core Period (Week 0 to Week 8)||0||
59745986|NCT00758524|75865175|FG013|STARTED|Core Period (Week 0 to Week 8)||0||
59745987|NCT00758524|75865176|FG014|STARTED|Core Period (Week 0 to Week 8)||0||
59745988|NCT00758524|75865177|FG015|STARTED|Core Period (Week 0 to Week 8)||0||
59745989|NCT00758524|75865178|FG016|STARTED|Core Period (Week 0 to Week 8)||0||
59745990|NCT00758524|75865162|FG000|Treated|Core Period (Week 0 to Week 8)||92|Safety Set included participants who received at least 1 dose of study drug.|
59745991|NCT00758524|75865163|FG001|Treated|Core Period (Week 0 to Week 8)||87|Safety Set included participants who received at least 1 dose of study drug.|
59745992|NCT00758524|75865164|FG002|Treated|Core Period (Week 0 to Week 8)|One participant from LCI699 0.5 mg QD was randomized to LCI699 1.0 mg QD and received LCI699 1.0 mg QD, thus was included in this arm in the Safety Set.|87|Safety Set included participants who received at least 1 dose of study drug.|
59762498|NCT00866619|75882228|FG002|STARTED|Overall Study||2974||
59745993|NCT00758524|75865165|FG003|Treated|Core Period (Week 0 to Week 8)||97|Safety Set included participants who received at least 1 dose of study drug.|
59745994|NCT00758524|75865166|FG004|Treated|Core Period (Week 0 to Week 8)||84|Safety Set included participants who received at least 1 dose of study drug.|
59745995|NCT00758524|75865167|FG005|Treated|Core Period (Week 0 to Week 8)||76|Safety Set included participants who received at least 1 dose of study drug.|
59745996|NCT00758524|75865168|FG006|Treated|Core Period (Week 0 to Week 8)||0|Safety Set included participants who received at least 1 dose of study drug.|
59745997|NCT00758524|75865169|FG007|Treated|Core Period (Week 0 to Week 8)||0|Safety Set included participants who received at least 1 dose of study drug.|
59745998|NCT00758524|75865170|FG008|Treated|Core Period (Week 0 to Week 8)||0|Safety Set included participants who received at least 1 dose of study drug.|
59745999|NCT00758524|75865171|FG009|Treated|Core Period (Week 0 to Week 8)||0|Safety Set included participants who received at least 1 dose of study drug.|
59746000|NCT00758524|75865172|FG010|Treated|Core Period (Week 0 to Week 8)||0|Safety Set included participants who received at least 1 dose of study drug.|
59746001|NCT00758524|75865173|FG011|Treated|Core Period (Week 0 to Week 8)||0|Safety Set included participants who received at least 1 dose of study drug.|
59746002|NCT00758524|75865174|FG012|Treated|Core Period (Week 0 to Week 8)||0|Safety Set included participants who received at least 1 dose of study drug.|
59746003|NCT00758524|75865175|FG013|Treated|Core Period (Week 0 to Week 8)||0|Safety Set included participants who received at least 1 dose of study drug.|
59746004|NCT00758524|75865176|FG014|Treated|Core Period (Week 0 to Week 8)||0|Safety Set included participants who received at least 1 dose of study drug.|
59746005|NCT00758524|75865177|FG015|Treated|Core Period (Week 0 to Week 8)||0|Safety Set included participants who received at least 1 dose of study drug.|
59746006|NCT00758524|75865178|FG016|Treated|Core Period (Week 0 to Week 8)||0|Safety Set included participants who received at least 1 dose of study drug.|
59746007|NCT00758524|75865162|FG000|COMPLETED|Core Period (Week 0 to Week 8)||84||
59746008|NCT00758524|75865163|FG001|COMPLETED|Core Period (Week 0 to Week 8)||81||
59746009|NCT00758524|75865164|FG002|COMPLETED|Core Period (Week 0 to Week 8)||77||
59746010|NCT00758524|75865165|FG003|COMPLETED|Core Period (Week 0 to Week 8)||90||
59746011|NCT00758524|75865166|FG004|COMPLETED|Core Period (Week 0 to Week 8)||75||
59746012|NCT00758524|75865167|FG005|COMPLETED|Core Period (Week 0 to Week 8)||67||
59746013|NCT00758524|75865168|FG006|COMPLETED|Core Period (Week 0 to Week 8)||0||
59746014|NCT00758524|75865169|FG007|COMPLETED|Core Period (Week 0 to Week 8)||0||
59746015|NCT00758524|75865170|FG008|COMPLETED|Core Period (Week 0 to Week 8)||0||
59746016|NCT00758524|75865171|FG009|COMPLETED|Core Period (Week 0 to Week 8)||0||
59746017|NCT00758524|75865172|FG010|COMPLETED|Core Period (Week 0 to Week 8)||0||
59746018|NCT00758524|75865173|FG011|COMPLETED|Core Period (Week 0 to Week 8)||0||
59746019|NCT00758524|75865174|FG012|COMPLETED|Core Period (Week 0 to Week 8)||0||
59746020|NCT00758524|75865175|FG013|COMPLETED|Core Period (Week 0 to Week 8)||0||
59746021|NCT00758524|75865176|FG014|COMPLETED|Core Period (Week 0 to Week 8)||0||
59746022|NCT00758524|75865177|FG015|COMPLETED|Core Period (Week 0 to Week 8)||0||
59746023|NCT00758524|75865178|FG016|COMPLETED|Core Period (Week 0 to Week 8)||0||
59746024|NCT00758524|75865162|FG000|NOT COMPLETED|Core Period (Week 0 to Week 8)||8||
59746025|NCT00758524|75865163|FG001|NOT COMPLETED|Core Period (Week 0 to Week 8)||7||
59746026|NCT00758524|75865164|FG002|NOT COMPLETED|Core Period (Week 0 to Week 8)||9||
59746027|NCT00758524|75865165|FG003|NOT COMPLETED|Core Period (Week 0 to Week 8)||7||
60135187|NCT03307252|76258153|FG000|COMPLETED|Part 2, Washout Period 3 (7 Days)||0||
60135188|NCT03307252|76258154|FG001|COMPLETED|Part 2, Washout Period 3 (7 Days)||0||
60135189|NCT03307252|76258155|FG002|COMPLETED|Part 2, Washout Period 3 (7 Days)||0||
60135190|NCT03307252|76258156|FG003|COMPLETED|Part 2, Washout Period 3 (7 Days)||4||
60135191|NCT03307252|76258157|FG004|COMPLETED|Part 2, Washout Period 3 (7 Days)||3||
60135192|NCT03307252|76258158|FG005|COMPLETED|Part 2, Washout Period 3 (7 Days)||3||
60135193|NCT03307252|76258159|FG006|COMPLETED|Part 2, Washout Period 3 (7 Days)||4||
60135194|NCT03307252|76258160|FG007|COMPLETED|Part 2, Washout Period 3 (7 Days)||0||
60135195|NCT03307252|76258161|FG008|COMPLETED|Part 2, Washout Period 3 (7 Days)||0||
60135196|NCT03307252|76258162|FG009|COMPLETED|Part 2, Washout Period 3 (7 Days)||0||
60135197|NCT03307252|76258163|FG010|COMPLETED|Part 2, Washout Period 3 (7 Days)||0||
60135198|NCT03307252|76258153|FG000|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0||
59746028|NCT00758524|75865166|FG004|NOT COMPLETED|Core Period (Week 0 to Week 8)||9||
59762499|NCT00866619|75882229|FG003|STARTED|Overall Study||2179||
60135199|NCT03307252|76258154|FG001|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0||
60135200|NCT03307252|76258155|FG002|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0||
60135201|NCT03307252|76258156|FG003|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0||
60135202|NCT03307252|76258157|FG004|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0||
60135203|NCT03307252|76258158|FG005|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0||
60135204|NCT03307252|76258159|FG006|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||1||
60135205|NCT03307252|76258160|FG007|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0||
60135206|NCT03307252|76258161|FG008|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0||
60135207|NCT03307252|76258162|FG009|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0||
60135208|NCT03307252|76258163|FG010|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0||
60135209|NCT03307252|76258153|FG000|STARTED|Part 2, Period 4||0||
60135210|NCT03307252|76258154|FG001|STARTED|Part 2, Period 4||0||
59746029|NCT00758524|75865167|FG005|NOT COMPLETED|Core Period (Week 0 to Week 8)||10||
59746030|NCT00758524|75865168|FG006|NOT COMPLETED|Core Period (Week 0 to Week 8)||0||
59746031|NCT00758524|75865169|FG007|NOT COMPLETED|Core Period (Week 0 to Week 8)||0||
59746032|NCT00758524|75865170|FG008|NOT COMPLETED|Core Period (Week 0 to Week 8)||0||
59746033|NCT00758524|75865171|FG009|NOT COMPLETED|Core Period (Week 0 to Week 8)||0||
59746034|NCT00758524|75865172|FG010|NOT COMPLETED|Core Period (Week 0 to Week 8)||0||
59746035|NCT00758524|75865173|FG011|NOT COMPLETED|Core Period (Week 0 to Week 8)||0||
59746036|NCT00758524|75865174|FG012|NOT COMPLETED|Core Period (Week 0 to Week 8)||0||
59746037|NCT00758524|75865175|FG013|NOT COMPLETED|Core Period (Week 0 to Week 8)||0||
59746038|NCT00758524|75865176|FG014|NOT COMPLETED|Core Period (Week 0 to Week 8)||0||
59746039|NCT00758524|75865177|FG015|NOT COMPLETED|Core Period (Week 0 to Week 8)||0||
59746040|NCT00758524|75865178|FG016|NOT COMPLETED|Core Period (Week 0 to Week 8)||0||
59746041|NCT00758524|75865162|FG000|STARTED|Withdrawal Period (Week 8 to Week 9)||0|Participants that started the withdrawal period included those who received at least one dose of the study drug from Week 8 to Week 9 (Randomized Withdrawal Safety Set).|
59746042|NCT00758524|75865163|FG001|STARTED|Withdrawal Period (Week 8 to Week 9)||0|Participants that started the withdrawal period included those who received at least one dose of the study drug from Week 8 to Week 9 (Randomized Withdrawal Safety Set).|
59746043|NCT00758524|75865164|FG002|STARTED|Withdrawal Period (Week 8 to Week 9)||0|Participants that started the withdrawal period included those who received at least one dose of the study drug from Week 8 to Week 9 (Randomized Withdrawal Safety Set).|
59746044|NCT00758524|75865165|FG003|STARTED|Withdrawal Period (Week 8 to Week 9)||0|Participants that started the withdrawal period included those who received at least one dose of the study drug from Week 8 to Week 9 (Randomized Withdrawal Safety Set).|
59746045|NCT00758524|75865166|FG004|STARTED|Withdrawal Period (Week 8 to Week 9)||0|Participants that started the withdrawal period included those who received at least one dose of the study drug from Week 8 to Week 9 (Randomized Withdrawal Safety Set).|
59746046|NCT00758524|75865167|FG005|STARTED|Withdrawal Period (Week 8 to Week 9)||0|Participants that started the withdrawal period included those who received at least one dose of the study drug from Week 8 to Week 9 (Randomized Withdrawal Safety Set).|
59746047|NCT00758524|75865168|FG006|STARTED|Withdrawal Period (Week 8 to Week 9)||46|Participants that started the withdrawal period included those who received at least one dose of the study drug from Week 8 to Week 9 (Randomized Withdrawal Safety Set).|
59746048|NCT00758524|75865169|FG007|STARTED|Withdrawal Period (Week 8 to Week 9)||38|Participants that started the withdrawal period included those who received at least one dose of the study drug from Week 8 to Week 9 (Randomized Withdrawal Safety Set).|
59746049|NCT00758524|75865170|FG008|STARTED|Withdrawal Period (Week 8 to Week 9)||44|Participants that started the withdrawal period included those who received at least one dose of the study drug from Week 8 to Week 9 (Randomized Withdrawal Safety Set).|
59746050|NCT00758524|75865171|FG009|STARTED|Withdrawal Period (Week 8 to Week 9)|One participant randomized to Placebo arm in Withdrawal Period received LCI699 0.5 mg QD and was counted in LCI699 0.5 mg QD arm in the Randomized Withdrawal Safety Set.|37|Participants that started the withdrawal period included those who received at least one dose of the study drug from Week 8 to Week 9 (Randomized Withdrawal Safety Set).|
59746051|NCT00758524|75865172|FG010|STARTED|Withdrawal Period (Week 8 to Week 9)||41|Participants that started the withdrawal period included those who received at least one dose of the study drug from Week 8 to Week 9 (Randomized Withdrawal Safety Set).|
59746052|NCT00758524|75865173|FG011|STARTED|Withdrawal Period (Week 8 to Week 9)|One participant randomized to LCI699 0.5 mg BID in the core period received LCI699 1.0 mg QD and was considered in the LCI699 1.0 mg QD arm in Randomized Withdrawal Safety Set.|37|Participants that started the withdrawal period included those who received at least one dose of the study drug from Week 8 to Week 9 (Randomized Withdrawal Safety Set).|
59746053|NCT00758524|75865174|FG012|STARTED|Withdrawal Period (Week 8 to Week 9)||45|Participants that started the withdrawal period included those who received at least one dose of the study drug from Week 8 to Week 9 (Randomized Withdrawal Safety Set).|
59746054|NCT00758524|75865175|FG013|STARTED|Withdrawal Period (Week 8 to Week 9)||45|Participants that started the withdrawal period included those who received at least one dose of the study drug from Week 8 to Week 9 (Randomized Withdrawal Safety Set).|
59746055|NCT00758524|75865176|FG014|STARTED|Withdrawal Period (Week 8 to Week 9)||39|Participants that started the withdrawal period included those who received at least one dose of the study drug from Week 8 to Week 9 (Randomized Withdrawal Safety Set).|
59746056|NCT00758524|75865177|FG015|STARTED|Withdrawal Period (Week 8 to Week 9)||36|Participants that started the withdrawal period included those who received at least one dose of the study drug from Week 8 to Week 9 (Randomized Withdrawal Safety Set).|
59746057|NCT00758524|75865178|FG016|STARTED|Withdrawal Period (Week 8 to Week 9)||66|Participants that started the withdrawal period included those who received at least one dose of the study drug from Week 8 to Week 9 (Randomized Withdrawal Safety Set).|
59746058|NCT00758524|75865162|FG000|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||0|Randomized Withdrawal Set included all participants with post-baseline blood pressure measurements from Week 8 to Week 9 only.|
59746059|NCT00758524|75865163|FG001|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||0|Randomized Withdrawal Set included all participants with post-baseline blood pressure measurements from Week 8 to Week 9 only.|
59746060|NCT00758524|75865164|FG002|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||0|Randomized Withdrawal Set included all participants with post-baseline blood pressure measurements from Week 8 to Week 9 only.|
59746061|NCT00758524|75865165|FG003|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||0|Randomized Withdrawal Set included all participants with post-baseline blood pressure measurements from Week 8 to Week 9 only.|
59746062|NCT00758524|75865166|FG004|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||0|Randomized Withdrawal Set included all participants with post-baseline blood pressure measurements from Week 8 to Week 9 only.|
59762500|NCT00866619|75882226|FG000|COMPLETED|Overall Study||4102||
59746063|NCT00758524|75865167|FG005|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||0|Randomized Withdrawal Set included all participants with post-baseline blood pressure measurements from Week 8 to Week 9 only.|
59746064|NCT00758524|75865168|FG006|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||45|Randomized Withdrawal Set included all participants with post-baseline blood pressure measurements from Week 8 to Week 9 only.|
59746065|NCT00758524|75865169|FG007|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||38|Randomized Withdrawal Set included all participants with post-baseline blood pressure measurements from Week 8 to Week 9 only.|
59746066|NCT00758524|75865170|FG008|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||43|Randomized Withdrawal Set included all participants with post-baseline blood pressure measurements from Week 8 to Week 9 only.|
59746067|NCT00758524|75865171|FG009|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||37|Randomized Withdrawal Set included all participants with post-baseline blood pressure measurements from Week 8 to Week 9 only.|
59746068|NCT00758524|75865172|FG010|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||41|Randomized Withdrawal Set included all participants with post-baseline blood pressure measurements from Week 8 to Week 9 only.|
59746069|NCT00758524|75865173|FG011|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||36|Randomized Withdrawal Set included all participants with post-baseline blood pressure measurements from Week 8 to Week 9 only.|
59746070|NCT00758524|75865174|FG012|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||45|Randomized Withdrawal Set included all participants with post-baseline blood pressure measurements from Week 8 to Week 9 only.|
59746071|NCT00758524|75865175|FG013|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||44|Randomized Withdrawal Set included all participants with post-baseline blood pressure measurements from Week 8 to Week 9 only.|
59746072|NCT00758524|75865176|FG014|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||39|Randomized Withdrawal Set included all participants with post-baseline blood pressure measurements from Week 8 to Week 9 only.|
59746073|NCT00758524|75865177|FG015|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||36|Randomized Withdrawal Set included all participants with post-baseline blood pressure measurements from Week 8 to Week 9 only.|
59746074|NCT00758524|75865178|FG016|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)|One participant randomized to Placebo arm in Withdrawal Period received LCI699 0.5 mg QD and was counted in LCI699 0.5 mg QD arm in the Randomized Withdrawal Safety Set. However, this participant was counted in the Placebo arm (N=67) in the Randomized Withdrawal Set.|67|Randomized Withdrawal Set included all participants with post-baseline blood pressure measurements from Week 8 to Week 9 only.|
59746075|NCT00758524|75865162|FG000|COMPLETED|Withdrawal Period (Week 8 to Week 9)||0||
59746076|NCT00758524|75865163|FG001|COMPLETED|Withdrawal Period (Week 8 to Week 9)||0||
59746077|NCT00758524|75865164|FG002|COMPLETED|Withdrawal Period (Week 8 to Week 9)||0||
59746078|NCT00758524|75865165|FG003|COMPLETED|Withdrawal Period (Week 8 to Week 9)||0||
59746079|NCT00758524|75865166|FG004|COMPLETED|Withdrawal Period (Week 8 to Week 9)||0||
59746080|NCT00758524|75865167|FG005|COMPLETED|Withdrawal Period (Week 8 to Week 9)||0||
59746081|NCT00758524|75865168|FG006|COMPLETED|Withdrawal Period (Week 8 to Week 9)||45||
59746082|NCT00758524|75865169|FG007|COMPLETED|Withdrawal Period (Week 8 to Week 9)||38||
59746083|NCT00758524|75865170|FG008|COMPLETED|Withdrawal Period (Week 8 to Week 9)||42||
59746084|NCT00758524|75865171|FG009|COMPLETED|Withdrawal Period (Week 8 to Week 9)||37||
59746085|NCT00758524|75865172|FG010|COMPLETED|Withdrawal Period (Week 8 to Week 9)||41||
59746086|NCT00758524|75865173|FG011|COMPLETED|Withdrawal Period (Week 8 to Week 9)||37||
59746087|NCT00758524|75865174|FG012|COMPLETED|Withdrawal Period (Week 8 to Week 9)||45||
59746088|NCT00758524|75865175|FG013|COMPLETED|Withdrawal Period (Week 8 to Week 9)||45||
59746089|NCT00758524|75865176|FG014|COMPLETED|Withdrawal Period (Week 8 to Week 9)||39||
59746090|NCT00758524|75865177|FG015|COMPLETED|Withdrawal Period (Week 8 to Week 9)||36||
59746091|NCT00758524|75865178|FG016|COMPLETED|Withdrawal Period (Week 8 to Week 9)||66||
59746092|NCT00758524|75865162|FG000|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0||
59746093|NCT00758524|75865163|FG001|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0||
59746094|NCT00758524|75865164|FG002|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0||
59746095|NCT00758524|75865165|FG003|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0||
59746096|NCT00758524|75865166|FG004|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0||
59746097|NCT00758524|75865167|FG005|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0||
59746098|NCT00758524|75865168|FG006|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||1||
59746099|NCT00758524|75865169|FG007|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0||
59746100|NCT00758524|75865170|FG008|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||2||
60135211|NCT03307252|76258155|FG002|STARTED|Part 2, Period 4||0||
60135212|NCT03307252|76258156|FG003|STARTED|Part 2, Period 4||4||
60135213|NCT03307252|76258157|FG004|STARTED|Part 2, Period 4||3||
60135214|NCT03307252|76258158|FG005|STARTED|Part 2, Period 4||3||
60135215|NCT03307252|76258159|FG006|STARTED|Part 2, Period 4||5||
60135216|NCT03307252|76258160|FG007|STARTED|Part 2, Period 4||0||
59746101|NCT00758524|75865171|FG009|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0||
59950744|NCT03308058|76069586|FG000|STARTED|Overall Study||23||
60135217|NCT03307252|76258161|FG008|STARTED|Part 2, Period 4||0||
60135218|NCT03307252|76258162|FG009|STARTED|Part 2, Period 4||0||
60135219|NCT03307252|76258163|FG010|STARTED|Part 2, Period 4||0||
60135220|NCT03307252|76258153|FG000|COMPLETED|Part 2, Period 4||0||
60135221|NCT03307252|76258154|FG001|COMPLETED|Part 2, Period 4||0||
60135222|NCT03307252|76258155|FG002|COMPLETED|Part 2, Period 4||0||
60135223|NCT03307252|76258156|FG003|COMPLETED|Part 2, Period 4||4||
60135224|NCT03307252|76258157|FG004|COMPLETED|Part 2, Period 4||3||
60135225|NCT03307252|76258158|FG005|COMPLETED|Part 2, Period 4||3||
59746102|NCT00758524|75865172|FG010|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0||
59746103|NCT00758524|75865173|FG011|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0||
59746104|NCT00758524|75865174|FG012|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0||
59746105|NCT00758524|75865175|FG013|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0||
59746106|NCT00758524|75865176|FG014|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0||
59746107|NCT00758524|75865177|FG015|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0||
59746108|NCT00758524|75865178|FG016|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0||
59746109|NCT00757588|75865218|FG000|STARTED|Period 1: Short-term (24-week) Phase||304||
59746110|NCT00757588|75865219|FG001|STARTED|Period 1: Short-term (24-week) Phase||151||
59746111|NCT00757588|75865218|FG000|COMPLETED|Period 1: Short-term (24-week) Phase|Does not include 2 who completed Period 1 but were erroneously reported in the CSR as noncompleters.|268||
59746112|NCT00757588|75865219|FG001|COMPLETED|Period 1: Short-term (24-week) Phase||134||
59746113|NCT00757588|75865218|FG000|NOT COMPLETED|Period 1: Short-term (24-week) Phase||36||
59746114|NCT00757588|75865219|FG001|NOT COMPLETED|Period 1: Short-term (24-week) Phase||17||
59746115|NCT00757588|75865218|FG000|STARTED|Period 2: Long-term (52-week) Phase|270 participants completed short-term phase; 2 of these did not enter long-term phase.|268||
59746116|NCT00757588|75865219|FG001|STARTED|Period 2: Long-term (52-week) Phase||134||
59746117|NCT00757588|75865218|FG000|COMPLETED|Period 2: Long-term (52-week) Phase||246||
59746118|NCT00757588|75865219|FG001|COMPLETED|Period 2: Long-term (52-week) Phase||125||
59746119|NCT00757588|75865218|FG000|NOT COMPLETED|Period 2: Long-term (52-week) Phase||22||
59746120|NCT00757588|75865219|FG001|NOT COMPLETED|Period 2: Long-term (52-week) Phase||9||
59746121|NCT00744796|75865225|FG000|STARTED|Pre-operative||21||
59746122|NCT00744796|75865225|FG000|COMPLETED|Pre-operative||21||
59746123|NCT00744796|75865225|FG000|NOT COMPLETED|Pre-operative||0||
59746124|NCT00744796|75865225|FG000|STARTED|Post-Operative Day 1||21||
59746125|NCT00744796|75865225|FG000|COMPLETED|Post-Operative Day 1||21||
59746126|NCT00744796|75865225|FG000|NOT COMPLETED|Post-Operative Day 1||0||
59746127|NCT00744796|75865225|FG000|STARTED|Post-Operative 3-6 Months||21||
59746128|NCT00744796|75865225|FG000|COMPLETED|Post-Operative 3-6 Months||21||
59746129|NCT00744796|75865225|FG000|NOT COMPLETED|Post-Operative 3-6 Months||0||
59746130|NCT00744796|75865225|FG000|STARTED|Post-Operative 6-9 Months||21||
59746131|NCT00744796|75865225|FG000|COMPLETED|Post-Operative 6-9 Months||9||
59746132|NCT00744796|75865225|FG000|NOT COMPLETED|Post-Operative 6-9 Months||12||
59746133|NCT00705679|75865234|FG000|STARTED|Overall Study||1007||
59746134|NCT00705679|75865235|FG001|STARTED|Overall Study||1003||
59746135|NCT00705679|75865236|FG002|STARTED|Overall Study||1009||
59746136|NCT00705679|75865237|FG003|STARTED|Overall Study||1007||
59746137|NCT00705679|75865238|FG004|STARTED|Overall Study||1003||
59746138|NCT00705679|75865234|FG000|COMPLETED|Overall Study||942||
59746139|NCT00705679|75865235|FG001|COMPLETED|Overall Study||864||
59746140|NCT00705679|75865236|FG002|COMPLETED|Overall Study||894||
59746141|NCT00705679|75865237|FG003|COMPLETED|Overall Study||927||
59746142|NCT00705679|75865238|FG004|COMPLETED|Overall Study||934||
59746143|NCT00705679|75865234|FG000|NOT COMPLETED|Overall Study||65||
59746144|NCT00705679|75865235|FG001|NOT COMPLETED|Overall Study||139||
59746145|NCT00705679|75865236|FG002|NOT COMPLETED|Overall Study||115||
59746146|NCT00705679|75865237|FG003|NOT COMPLETED|Overall Study||80||
59746147|NCT00705679|75865238|FG004|NOT COMPLETED|Overall Study||69||
59746148|NCT03977818|75865255|FG000|STARTED|Overall Study||2165||
59746149|NCT03977818|75865255|FG000|COMPLETED|Overall Study||2165||
59746150|NCT03977818|75865255|FG000|NOT COMPLETED|Overall Study||0||
59746151|NCT00751348|75865261|FG000|STARTED|Overall Study||313||
59746152|NCT00751348|75865262|FG001|STARTED|Overall Study||161||
59746153|NCT00751348|75865261|FG000|COMPLETED|Overall Study||307||
59746154|NCT00751348|75865262|FG001|COMPLETED|Overall Study||159||
59746155|NCT00751348|75865261|FG000|NOT COMPLETED|Overall Study||6||
59746156|NCT00751348|75865262|FG001|NOT COMPLETED|Overall Study||2||
59746157|NCT00751114|75865270|FG000|STARTED|Overall Study|randomized|250||
59746158|NCT00751114|75865271|FG001|STARTED|Overall Study||265||
59746159|NCT00751114|75865270|FG000|TREATED = Safety Population|Overall Study|safety population: randomized patients who received at least one dose of investigational product|237||
59746160|NCT00751114|75865271|FG001|TREATED = Safety Population|Overall Study||264||
59746161|NCT00751114|75865270|FG000|mITT Population|Overall Study|modified Intent-To-Treat population: treated patients with at least 1 on-treatment efficacy measure|227||
59746162|NCT00751114|75865271|FG001|mITT Population|Overall Study||253||
59746163|NCT00751114|75865270|FG000|COMPLETED|Overall Study||212||
59746164|NCT00751114|75865271|FG001|COMPLETED|Overall Study||233||
59746165|NCT00751114|75865270|FG000|NOT COMPLETED|Overall Study||38||
59746166|NCT00751114|75865271|FG001|NOT COMPLETED|Overall Study||32||
59746167|NCT00960440|75865281|FG000|STARTED|Overall Study||133||
59746168|NCT00960440|75865282|FG001|STARTED|Overall Study||134||
59746169|NCT00960440|75865283|FG002|STARTED|Overall Study||66||
59746170|NCT00960440|75865284|FG003|STARTED|Overall Study||66||
59746171|NCT00960440|75865281|FG000|COMPLETED|Overall Study||107||
59746172|NCT00960440|75865282|FG001|COMPLETED|Overall Study||103||
59746173|NCT00960440|75865283|FG002|COMPLETED|Overall Study||53||
59746174|NCT00960440|75865284|FG003|COMPLETED|Overall Study||48||
59746175|NCT00960440|75865281|FG000|NOT COMPLETED|Overall Study||26||
59746176|NCT00960440|75865282|FG001|NOT COMPLETED|Overall Study||31||
59746177|NCT00960440|75865283|FG002|NOT COMPLETED|Overall Study||13||
59746178|NCT00960440|75865284|FG003|NOT COMPLETED|Overall Study||18||
59746179|NCT05434013|75865299|FG000|STARTED|Overall Study||526||
59746180|NCT05434013|75865300|FG001|STARTED|Overall Study||526||
59746181|NCT05434013|75865301|FG002|STARTED|Overall Study||526||
59746182|NCT05434013|75865299|FG000|COMPLETED|Overall Study||526||
59746183|NCT05434013|75865300|FG001|COMPLETED|Overall Study||526||
59746184|NCT05434013|75865301|FG002|COMPLETED|Overall Study||526||
59746185|NCT05434013|75865299|FG000|NOT COMPLETED|Overall Study||0||
59746186|NCT05434013|75865300|FG001|NOT COMPLETED|Overall Study||0||
59746187|NCT05434013|75865301|FG002|NOT COMPLETED|Overall Study||0||
59746188|NCT05303324|75865311|FG000|STARTED|Treatment Period 1||25||
59746189|NCT05303324|75865312|FG001|STARTED|Treatment Period 1||23||
59746190|NCT05303324|75865311|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 1||25||
59746191|NCT05303324|75865312|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 1||23||
59746192|NCT05303324|75865311|FG000|COMPLETED|Treatment Period 1||25||
59746193|NCT05303324|75865312|FG001|COMPLETED|Treatment Period 1||23||
59746194|NCT05303324|75865311|FG000|NOT COMPLETED|Treatment Period 1||0||
59746195|NCT05303324|75865312|FG001|NOT COMPLETED|Treatment Period 1||0||
59746196|NCT05303324|75865311|FG000|STARTED|Treatment Period 2||25||
59746197|NCT05303324|75865312|FG001|STARTED|Treatment Period 2||23||
59746198|NCT05303324|75865311|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 2||25||
59746199|NCT05303324|75865312|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 2||23||
59746200|NCT05303324|75865311|FG000|COMPLETED|Treatment Period 2||25||
59746201|NCT05303324|75865312|FG001|COMPLETED|Treatment Period 2||23||
59746202|NCT05303324|75865311|FG000|NOT COMPLETED|Treatment Period 2||0||
59746203|NCT05303324|75865312|FG001|NOT COMPLETED|Treatment Period 2||0||
59746204|NCT04909853|75865328|FG000|STARTED|Part 1||10||
59746205|NCT04909853|75865329|FG001|STARTED|Part 1||8||
59746206|NCT04909853|75865330|FG002|STARTED|Part 1||9||
59746207|NCT04909853|75865331|FG003|STARTED|Part 1||0||
59746208|NCT04909853|75865328|FG000|Treated|Part 1||10||
60135226|NCT03307252|76258159|FG006|COMPLETED|Part 2, Period 4||4||
60135227|NCT03307252|76258160|FG007|COMPLETED|Part 2, Period 4||0||
60135228|NCT03307252|76258161|FG008|COMPLETED|Part 2, Period 4||0||
60135229|NCT03307252|76258162|FG009|COMPLETED|Part 2, Period 4||0||
60135230|NCT03307252|76258163|FG010|COMPLETED|Part 2, Period 4||0||
60135231|NCT03307252|76258153|FG000|NOT COMPLETED|Part 2, Period 4||0||
60135232|NCT03307252|76258154|FG001|NOT COMPLETED|Part 2, Period 4||0||
60135233|NCT03307252|76258155|FG002|NOT COMPLETED|Part 2, Period 4||0||
60135234|NCT03307252|76258156|FG003|NOT COMPLETED|Part 2, Period 4||0||
60135235|NCT03307252|76258157|FG004|NOT COMPLETED|Part 2, Period 4||0||
60135236|NCT03307252|76258158|FG005|NOT COMPLETED|Part 2, Period 4||0||
60135237|NCT03307252|76258159|FG006|NOT COMPLETED|Part 2, Period 4||1||
60135238|NCT03307252|76258160|FG007|NOT COMPLETED|Part 2, Period 4||0||
60135239|NCT03307252|76258161|FG008|NOT COMPLETED|Part 2, Period 4||0||
59746209|NCT04909853|75865329|FG001|Treated|Part 1||8||
59746210|NCT04909853|75865330|FG002|Treated|Part 1||8||
59746211|NCT04909853|75865331|FG003|Treated|Part 1||0||
59746212|NCT04909853|75865328|FG000|COMPLETED|Part 1||10||
59746213|NCT04909853|75865329|FG001|COMPLETED|Part 1||8||
59746214|NCT04909853|75865330|FG002|COMPLETED|Part 1||8||
59746215|NCT04909853|75865331|FG003|COMPLETED|Part 1||0||
59746216|NCT04909853|75865328|FG000|NOT COMPLETED|Part 1||0||
59746217|NCT04909853|75865329|FG001|NOT COMPLETED|Part 1||0||
59746218|NCT04909853|75865330|FG002|NOT COMPLETED|Part 1||1||
59746219|NCT04909853|75865331|FG003|NOT COMPLETED|Part 1||0||
59746220|NCT04909853|75865328|FG000|STARTED|Part 2|Participants from Part 1 did not enter in Part 2. Enrollment was separate for Part 1 and 2.|0||
59746221|NCT04909853|75865329|FG001|STARTED|Part 2|Participants from Part 1 did not enter in Part 2. Enrollment was separate for Part 1 and 2.|0||
59746222|NCT04909853|75865330|FG002|STARTED|Part 2|Participants from Part 1 did not enter in Part 2. Enrollment was separate for Part 1 and 2.|0||
59746223|NCT04909853|75865331|FG003|STARTED|Part 2|Enrollment was separate for Part 1 and 2.|8||
59746224|NCT04909853|75865328|FG000|COMPLETED|Part 2||0||
59746225|NCT04909853|75865329|FG001|COMPLETED|Part 2||0||
59746226|NCT04909853|75865330|FG002|COMPLETED|Part 2||0||
59746227|NCT04909853|75865331|FG003|COMPLETED|Part 2||7||
59746228|NCT04909853|75865328|FG000|NOT COMPLETED|Part 2||0||
59746229|NCT04909853|75865329|FG001|NOT COMPLETED|Part 2||0||
59746230|NCT04909853|75865330|FG002|NOT COMPLETED|Part 2||0||
59746231|NCT04909853|75865331|FG003|NOT COMPLETED|Part 2||1||
59746232|NCT04811664|75865344|FG000|STARTED|Overall Study||725||
59746233|NCT04811664|75865345|FG001|STARTED|Overall Study||728||
59746234|NCT04811664|75865346|FG002|STARTED|Overall Study||470||
59746235|NCT04811664|75865344|FG000|Full Analysis Set (FAS)|Overall Study||725||
59746236|NCT04811664|75865345|FG001|Full Analysis Set (FAS)|Overall Study||728||
59746237|NCT04811664|75865346|FG002|Full Analysis Set (FAS)|Overall Study||470||
59746238|NCT04811664|75865344|FG000|Full Analysis Set With Study PCR (FAS-P)|Overall Study||701||
59746239|NCT04811664|75865345|FG001|Full Analysis Set With Study PCR (FAS-P)|Overall Study||646||
59746240|NCT04811664|75865346|FG002|Full Analysis Set With Study PCR (FAS-P)|Overall Study||454||
59746241|NCT04811664|75865344|FG000|FAS-P With Outside Vaccination Censored Incidence Rate Follow-up|Overall Study||563||
59746242|NCT04811664|75865345|FG001|FAS-P With Outside Vaccination Censored Incidence Rate Follow-up|Overall Study||622||
59746243|NCT04811664|75865346|FG002|FAS-P With Outside Vaccination Censored Incidence Rate Follow-up|Overall Study||452||
59746244|NCT04811664|75865344|FG000|Baseline Negative|Overall Study||600||
59746245|NCT04811664|75865345|FG001|Baseline Negative|Overall Study||549||
59746246|NCT04811664|75865346|FG002|Baseline Negative|Overall Study||311||
59746247|NCT04811664|75865344|FG000|Baseline Negative With Outside Vaccination Censored Incidence Rate Follow-up|Overall Study||489||
59746248|NCT04811664|75865345|FG001|Baseline Negative With Outside Vaccination Censored Incidence Rate Follow-up|Overall Study||531||
59746249|NCT04811664|75865346|FG002|Baseline Negative With Outside Vaccination Censored Incidence Rate Follow-up|Overall Study||311||
59746250|NCT04811664|75865344|FG000|FAS-P Viral Load|Overall Study||22||
59746251|NCT04811664|75865345|FG001|FAS-P Viral Load|Overall Study||23||
59746252|NCT04811664|75865346|FG002|FAS-P Viral Load|Overall Study||44||
59746253|NCT04811664|75865344|FG000|COMPLETED|Overall Study||571||
59746254|NCT04811664|75865345|FG001|COMPLETED|Overall Study||450||
59746255|NCT04811664|75865346|FG002|COMPLETED|Overall Study||255||
59746256|NCT04811664|75865344|FG000|NOT COMPLETED|Overall Study||154||
59746257|NCT04811664|75865345|FG001|NOT COMPLETED|Overall Study||278||
59746258|NCT04811664|75865346|FG002|NOT COMPLETED|Overall Study||215||
59746259|NCT04552704|75865357|FG000|STARTED|Overall Study||3||
59746260|NCT04552704|75865357|FG000|COMPLETED|Overall Study||3||
59746261|NCT04552704|75865357|FG000|NOT COMPLETED|Overall Study||0||
59746262|NCT04119414|75865363|FG000|STARTED|Overall Study||600||8
59746263|NCT04119414|75865363|FG000|COMPLETED|Overall Study||300||4
59746264|NCT04119414|75865363|FG000|NOT COMPLETED|Overall Study||300||4
59746265|NCT04026256|75865371|FG000|STARTED|Overall Study||13||
59746266|NCT04026256|75865372|FG001|STARTED|Overall Study||9||
59746267|NCT04026256|75865373|FG002|STARTED|Overall Study||12||
59746268|NCT04026256|75865371|FG000|COMPLETED|Overall Study||10||
59746269|NCT04026256|75865372|FG001|COMPLETED|Overall Study||8||
59746270|NCT04026256|75865373|FG002|COMPLETED|Overall Study||9||
59746271|NCT04026256|75865371|FG000|NOT COMPLETED|Overall Study||3||
59746272|NCT04026256|75865372|FG001|NOT COMPLETED|Overall Study||1||
59746273|NCT04026256|75865373|FG002|NOT COMPLETED|Overall Study||3||
59746274|NCT03955250|75865383|FG000|STARTED|Overall Study||19||
59746275|NCT03955250|75865384|FG001|STARTED|Overall Study||23||
59746276|NCT03955250|75865383|FG000|COMPLETED|Overall Study||17||
59746277|NCT03955250|75865384|FG001|COMPLETED|Overall Study||16||
59746278|NCT03955250|75865383|FG000|NOT COMPLETED|Overall Study||2||
59746279|NCT03955250|75865384|FG001|NOT COMPLETED|Overall Study||7||
59746280|NCT03762265|75865392|FG000|STARTED|BT Period: Weeks 1 to 37||66||
59746281|NCT03762265|75865393|FG001|STARTED|BT Period: Weeks 1 to 37||65||
59746282|NCT03762265|75865392|FG000|COMPLETED|BT Period: Weeks 1 to 37||51||
59746283|NCT03762265|75865393|FG001|COMPLETED|BT Period: Weeks 1 to 37||62||
59873072|NCT03496298|75997211|FG000|Safety Population|Overall Study|2 participants of Placebo arm received Efpeglenatide 4 mg treatment and 1 participant received Efpeglenatide 6 mg treatment. Hence, they were counted in the respective arm for safety analysis.|1355|Safety population included all randomized participants who had received at least 1 dose of double-blind treatment, regardless of the amount of treatment administered and were analyzed according to treatment actually received.|
59873073|NCT03496298|75997212|FG001|Safety Population|Overall Study|2 participants of Placebo arm received Efpeglenatide 4 mg treatment and thus counted in the 4 mg treatment arm for safety analysis.|1360|Safety population included all randomized participants who had received at least 1 dose of double-blind treatment, regardless of the amount of treatment administered and were analyzed according to treatment actually received.|
59873074|NCT03496298|75997213|FG002|Safety Population|Overall Study|1 participant of Placebo arm received Efpeglenatide 6 mg treatment and thus counted in the 6 mg treatment arm for safety analysis.|1358|Safety population included all randomized participants who had received at least 1 dose of double-blind treatment, regardless of the amount of treatment administered and were analyzed according to treatment actually received.|
59746284|NCT03762265|75865392|FG000|NOT COMPLETED|BT Period: Weeks 1 to 37||15||
59746285|NCT03762265|75865393|FG001|NOT COMPLETED|BT Period: Weeks 1 to 37||3||
59746286|NCT03762265|75865392|FG000|STARTED|OLE Period: Weeks 37 to 61||51||
59746287|NCT03762265|75865393|FG001|STARTED|OLE Period: Weeks 37 to 61|One participant did not enter OLE Period.|61||
59746288|NCT03762265|75865392|FG000|COMPLETED|OLE Period: Weeks 37 to 61||35||
59746289|NCT03762265|75865393|FG001|COMPLETED|OLE Period: Weeks 37 to 61||45||
59746290|NCT03762265|75865392|FG000|NOT COMPLETED|OLE Period: Weeks 37 to 61||16||
59746291|NCT03762265|75865393|FG001|NOT COMPLETED|OLE Period: Weeks 37 to 61||16||
59746292|NCT03762265|75865392|FG000|STARTED|LTE Period: Weeks 61 to 109||35||
59746293|NCT03762265|75865393|FG001|STARTED|LTE Period: Weeks 61 to 109|11 participants did not enter LTE Period.|34||
59746294|NCT03762265|75865392|FG000|COMPLETED|LTE Period: Weeks 61 to 109||6||
59746295|NCT03762265|75865393|FG001|COMPLETED|LTE Period: Weeks 61 to 109||6||
59746296|NCT03762265|75865392|FG000|NOT COMPLETED|LTE Period: Weeks 61 to 109||29||
59746297|NCT03762265|75865393|FG001|NOT COMPLETED|LTE Period: Weeks 61 to 109||28||
59746298|NCT03735420|75865417|FG000|STARTED|Overall Study||16||
59746299|NCT03735420|75865418|FG001|STARTED|Overall Study||14||
59746300|NCT03735420|75865417|FG000|COMPLETED|Overall Study||16||
59746301|NCT03735420|75865418|FG001|COMPLETED|Overall Study||14||
59746302|NCT03735420|75865417|FG000|NOT COMPLETED|Overall Study||0||
59746303|NCT03735420|75865418|FG001|NOT COMPLETED|Overall Study||0||
59746304|NCT03704051|75865426|FG000|STARTED|Overall Study|24 mother-infant dyads (24 mothers + 24 infants = 48 participants total) participated in the first visit|48||
60002408|NCT02565615|76118282|FG000|NOT COMPLETED|Overall Study||3||
60002409|NCT02565615|76118283|FG001|NOT COMPLETED|Overall Study||36||
60002410|NCT02565615|76118284|FG002|NOT COMPLETED|Overall Study||0||
60002411|NCT02565615|76118285|FG003|NOT COMPLETED|Overall Study||3||
60002412|NCT02565615|76118286|FG004|NOT COMPLETED|Overall Study||1601||
60002413|NCT02701361|76118301|FG000|STARTED|Overall Study||31||
59746305|NCT03704051|75865427|FG001|STARTED|Overall Study|23 mother-infant dyads (23 mothers + 23 infants = 48 participants total) participated in the first visit|46||
59746306|NCT03704051|75865426|FG000|COMPLETED|Overall Study|2 mother-infant dyads (2 mothers + 2 infants = 4 participants total) in this group dropped out of the study after the first visit|44||
59746307|NCT03704051|75865427|FG001|COMPLETED|Overall Study|0 mother-infant dyads in this group dropped out of the study after the first visit|46||
59746308|NCT03704051|75865426|FG000|NOT COMPLETED|Overall Study||4||
59746309|NCT03704051|75865427|FG001|NOT COMPLETED|Overall Study||0||
59746310|NCT03662074|75865435|FG000|STARTED|Overall Study||14||
59746311|NCT03662074|75865435|FG000|COMPLETED|Overall Study||14||
59746312|NCT03662074|75865435|FG000|NOT COMPLETED|Overall Study||0||
59746313|NCT03642938|75865443|FG000|STARTED|Overall Study||10||
59746314|NCT03642938|75865444|FG001|STARTED|Overall Study||10||
59746315|NCT03642938|75865445|FG002|STARTED|Overall Study||10||
59746316|NCT03642938|75865446|FG003|STARTED|Overall Study||11||
59746317|NCT03642938|75865443|FG000|COMPLETED|Overall Study||10||
59746318|NCT03642938|75865444|FG001|COMPLETED|Overall Study||10||
59746319|NCT03642938|75865445|FG002|COMPLETED|Overall Study||10||
59746320|NCT03642938|75865446|FG003|COMPLETED|Overall Study||10||
59746321|NCT03642938|75865443|FG000|NOT COMPLETED|Overall Study||0||
59746322|NCT03642938|75865444|FG001|NOT COMPLETED|Overall Study||0||
59746323|NCT03642938|75865445|FG002|NOT COMPLETED|Overall Study||0||
59746324|NCT03642938|75865446|FG003|NOT COMPLETED|Overall Study||1||
59746325|NCT03562767|75865459|FG000|STARTED|Overall Study||10||
59746326|NCT03562767|75865460|FG001|STARTED|Overall Study||10||
59746327|NCT03562767|75865461|FG002|STARTED|Overall Study||0||
59746328|NCT03562767|75865459|FG000|COMPLETED|Overall Study||7||
59746329|NCT03562767|75865460|FG001|COMPLETED|Overall Study||7||
59746330|NCT03562767|75865461|FG002|COMPLETED|Overall Study||0||
59746331|NCT03562767|75865459|FG000|NOT COMPLETED|Overall Study||3||
59746332|NCT03562767|75865460|FG001|NOT COMPLETED|Overall Study||3||
59746333|NCT03562767|75865461|FG002|NOT COMPLETED|Overall Study||0||
60002414|NCT02701361|76118302|FG001|STARTED|Overall Study||31||
60002415|NCT02701361|76118303|FG002|STARTED|Overall Study||18||
60002416|NCT02701361|76118301|FG000|COMPLETED|Overall Study||22||
60002417|NCT02701361|76118302|FG001|COMPLETED|Overall Study||28||
60002418|NCT02701361|76118303|FG002|COMPLETED|Overall Study||16||
60002419|NCT02701361|76118301|FG000|NOT COMPLETED|Overall Study||9||
59746340|NCT03333941|75865484|FG000|STARTED|Overall Study||76||
59746341|NCT03333941|75865484|FG000|COMPLETED|Overall Study||63||
59746342|NCT03333941|75865484|FG000|NOT COMPLETED|Overall Study||13||
59746343|NCT03315754|75865488|FG000|STARTED|Overall Study||50||
59746344|NCT03315754|75865488|FG000|COMPLETED|Overall Study||48||
59746345|NCT03315754|75865488|FG000|NOT COMPLETED|Overall Study||2||
59746346|NCT03182998|75865495|FG000|STARTED|Overall Study||37||
59746347|NCT03182998|75865496|FG001|STARTED|Overall Study||33||
59746348|NCT03182998|75865497|FG002|STARTED|Overall Study||33||
59746349|NCT03182998|75865495|FG000|COMPLETED|Overall Study||36||
59746350|NCT03182998|75865496|FG001|COMPLETED|Overall Study||33||
59746351|NCT03182998|75865497|FG002|COMPLETED|Overall Study||33||
59746352|NCT03182998|75865495|FG000|NOT COMPLETED|Overall Study||1||
59746353|NCT03182998|75865496|FG001|NOT COMPLETED|Overall Study||0||
59746354|NCT03182998|75865497|FG002|NOT COMPLETED|Overall Study||0||
59746355|NCT02440711|75865507|FG000|STARTED|First Intervention||16||
59746356|NCT02440711|75865508|FG001|STARTED|First Intervention||20||
59746357|NCT02440711|75865507|FG000|Unilateral Amputation|First Intervention|Number of participants with unilateral amputation in the mRSF-ESF sequence to complete the first period.|14||
59746358|NCT02440711|75865508|FG001|Unilateral Amputation|First Intervention|Number of participants with unilateral amputation in the ESF-mRSF sequence to complete the first period.|17||
59746359|NCT02440711|75865507|FG000|Bilateral Amputation|First Intervention|Number of participants with bilateral amputation in the mRSF-ESF sequence to complete the first period.|2||
59746360|NCT02440711|75865508|FG001|Bilateral Amputation|First Intervention|Number of participants with bilateral amputation in the ESF-mRSF sequence to complete the first period.|3||
59746361|NCT02440711|75865507|FG000|COMPLETED|First Intervention||16||
59746362|NCT02440711|75865508|FG001|COMPLETED|First Intervention||20||
59746363|NCT02440711|75865507|FG000|NOT COMPLETED|First Intervention||0||
60002420|NCT02701361|76118302|FG001|NOT COMPLETED|Overall Study||3||
59746364|NCT02440711|75865508|FG001|NOT COMPLETED|First Intervention||0||
59746365|NCT02440711|75865507|FG000|STARTED|Second Intervention||16||
59746366|NCT02440711|75865508|FG001|STARTED|Second Intervention||20||
60002421|NCT02701361|76118303|FG002|NOT COMPLETED|Overall Study||2||
59746367|NCT02440711|75865507|FG000|Unilateral Amputation|Second Intervention|Number of participants with unilateral amputation in the mRSF-ESF sequence to complete the second period.|14||
59746368|NCT02440711|75865508|FG001|Unilateral Amputation|Second Intervention|Number of participants with unilateral amputation in the ESF-mRSF sequence to complete the second period.|17||
59762501|NCT00866619|75882227|FG001|COMPLETED|Overall Study||3088||
59762502|NCT00866619|75882228|FG002|COMPLETED|Overall Study||2085||
59746369|NCT02440711|75865507|FG000|Bilateral Amputation|Second Intervention|Number of participants with bilateral amputation in the mRSF-ESF sequence to complete the second period.|2||
59746370|NCT02440711|75865508|FG001|Bilateral Amputation|Second Intervention|Number of participants with bilateral amputation in the ESF-mRSF sequence to complete the second period.|3||
59746371|NCT02440711|75865507|FG000|COMPLETED|Second Intervention||15||
59746372|NCT02440711|75865508|FG001|COMPLETED|Second Intervention||20||
59746373|NCT02440711|75865507|FG000|NOT COMPLETED|Second Intervention||1||
59746374|NCT02440711|75865508|FG001|NOT COMPLETED|Second Intervention||0||
59746375|NCT02358031|75865519|FG000|STARTED|Overall Study||301||
59746376|NCT02358031|75865520|FG001|STARTED|Overall Study||281||
59746377|NCT02358031|75865521|FG002|STARTED|Overall Study||300||
59746378|NCT02358031|75865519|FG000|Treated|Overall Study||300||
59746379|NCT02358031|75865520|FG001|Treated|Overall Study||276||
59746380|NCT02358031|75865521|FG002|Treated|Overall Study||287||
59746381|NCT02358031|75865519|FG000|Pembro Mono v Control Efficacy Analyses|Overall Study||301||
59746382|NCT02358031|75865520|FG001|Pembro Mono v Control Efficacy Analyses|Overall Study||0||
59746383|NCT02358031|75865521|FG002|Pembro Mono v Control Efficacy Analyses|Overall Study||300||
59746384|NCT02358031|75865519|FG000|Pembro Combo v Control Efficacy Analyses|Overall Study||0||
59746385|NCT02358031|75865520|FG001|Pembro Combo v Control Efficacy Analyses|Overall Study||281||
59746386|NCT02358031|75865521|FG002|Pembro Combo v Control Efficacy Analyses|Overall Study||278||
59746387|NCT02358031|75865519|FG000|COMPLETED|Overall Study||0||
59746388|NCT02358031|75865520|FG001|COMPLETED|Overall Study||0||
59746389|NCT02358031|75865521|FG002|COMPLETED|Overall Study||0||
59746390|NCT02358031|75865519|FG000|NOT COMPLETED|Overall Study||301||
59746391|NCT02358031|75865520|FG001|NOT COMPLETED|Overall Study||281||
59746392|NCT02358031|75865521|FG002|NOT COMPLETED|Overall Study||300||
59746393|NCT02223767|75865531|FG000|STARTED|Overall Study||24||
59746394|NCT02223767|75865532|FG001|STARTED|Overall Study||23||
59746395|NCT02223767|75865531|FG000|COMPLETED|Overall Study||20||
59746396|NCT02223767|75865532|FG001|COMPLETED|Overall Study||19||
59746397|NCT02223767|75865531|FG000|NOT COMPLETED|Overall Study||4||
59746398|NCT02223767|75865532|FG001|NOT COMPLETED|Overall Study||4||
59746399|NCT02177617|75865540|FG000|STARTED|Overall Study||8||
59746400|NCT02177617|75865541|FG001|STARTED|Overall Study||8||
59746401|NCT02177617|75865540|FG000|COMPLETED|Overall Study||8||
59746402|NCT02177617|75865541|FG001|COMPLETED|Overall Study||8||
59746403|NCT02177617|75865540|FG000|NOT COMPLETED|Overall Study||0||
59746404|NCT02177617|75865541|FG001|NOT COMPLETED|Overall Study||0||
59746405|NCT01956773|75865551|FG000|STARTED|Overall Study||2520||
59746406|NCT01956773|75865552|FG001|STARTED|Overall Study||100||
59746407|NCT01956773|75865551|FG000|COMPLETED|Overall Study||1892||
59746408|NCT01956773|75865552|FG001|COMPLETED|Overall Study||99||
59746409|NCT01956773|75865551|FG000|NOT COMPLETED|Overall Study||628||
59746410|NCT01956773|75865552|FG001|NOT COMPLETED|Overall Study||1||
59746411|NCT01946529|75865561|FG000|STARTED|End of Window Therapy (2 Courses)||1||
59746412|NCT01946529|75865562|FG001|STARTED|End of Window Therapy (2 Courses)||17||
59746413|NCT01946529|75865563|FG002|STARTED|End of Window Therapy (2 Courses)||6||
59746414|NCT01946529|75865561|FG000|COMPLETED|End of Window Therapy (2 Courses)||1||
59746415|NCT01946529|75865562|FG001|COMPLETED|End of Window Therapy (2 Courses)||16||
59746416|NCT01946529|75865563|FG002|COMPLETED|End of Window Therapy (2 Courses)||6||
59746417|NCT01946529|75865561|FG000|NOT COMPLETED|End of Window Therapy (2 Courses)||0||
59746418|NCT01946529|75865562|FG001|NOT COMPLETED|End of Window Therapy (2 Courses)||1||
59746419|NCT01946529|75865563|FG002|NOT COMPLETED|End of Window Therapy (2 Courses)||0||
59746420|NCT01946529|75865561|FG000|STARTED|Completion of All Therapy||1||
59746421|NCT01946529|75865562|FG001|STARTED|Completion of All Therapy||16||
59746422|NCT01946529|75865563|FG002|STARTED|Completion of All Therapy||6||
59746423|NCT01946529|75865561|FG000|COMPLETED|Completion of All Therapy||0||
59746424|NCT01946529|75865562|FG001|COMPLETED|Completion of All Therapy||0||
59746425|NCT01946529|75865563|FG002|COMPLETED|Completion of All Therapy||0||
59746426|NCT01946529|75865561|FG000|NOT COMPLETED|Completion of All Therapy||1||
59746427|NCT01946529|75865562|FG001|NOT COMPLETED|Completion of All Therapy||16||
59746428|NCT01946529|75865563|FG002|NOT COMPLETED|Completion of All Therapy||6||
59746429|NCT01695863|75865572|FG000|STARTED|Overall Study||62||
59746430|NCT01695863|75865573|FG001|STARTED|Overall Study||66||
59746431|NCT01695863|75865572|FG000|COMPLETED|Overall Study||62||
59746432|NCT01695863|75865573|FG001|COMPLETED|Overall Study||66||
59746433|NCT01695863|75865572|FG000|NOT COMPLETED|Overall Study||0||
59746434|NCT01695863|75865573|FG001|NOT COMPLETED|Overall Study||0||
59746435|NCT01666808|75865585|FG000|STARTED|Overall Study||83||
59746436|NCT01666808|75865586|FG001|STARTED|Overall Study||82||
59746437|NCT01666808|75865585|FG000|COMPLETED|Overall Study||67||
59746438|NCT01666808|75865586|FG001|COMPLETED|Overall Study||66||
59746439|NCT01666808|75865585|FG000|NOT COMPLETED|Overall Study||16||
59746440|NCT01666808|75865586|FG001|NOT COMPLETED|Overall Study||16||
59746441|NCT00017953|75865594|FG000|STARTED|Overall Study||2570||
59746442|NCT00017953|75865595|FG001|STARTED|Overall Study||2575||
59746443|NCT00017953|75865594|FG000|COMPLETED|Overall Study||2481||
59746444|NCT00017953|75865595|FG001|COMPLETED|Overall Study||2476||
59746445|NCT00017953|75865594|FG000|NOT COMPLETED|Overall Study||89||
59746446|NCT00017953|75865595|FG001|NOT COMPLETED|Overall Study||99||
59746447|NCT00964028|75865603|FG000|STARTED|Overall Study||25||
59746448|NCT00964028|75865604|FG001|STARTED|Overall Study||25||
59746449|NCT00964028|75865603|FG000|COMPLETED|Overall Study||25||
59746450|NCT00964028|75865604|FG001|COMPLETED|Overall Study||24||
59746451|NCT00964028|75865603|FG000|NOT COMPLETED|Overall Study||0||
59746452|NCT00964028|75865604|FG001|NOT COMPLETED|Overall Study||1||
59746453|NCT00960206|75865613|FG000|STARTED|Overall Study||190||
59746454|NCT00960206|75865614|FG001|STARTED|Overall Study||185||
59746455|NCT00960206|75865615|FG002|STARTED|Overall Study||89||
59746456|NCT00960206|75865613|FG000|COMPLETED|Overall Study||150||
59746457|NCT00960206|75865614|FG001|COMPLETED|Overall Study||158||
59746458|NCT00960206|75865615|FG002|COMPLETED|Overall Study||77||
59746459|NCT00960206|75865613|FG000|NOT COMPLETED|Overall Study||40||
59746460|NCT00960206|75865614|FG001|NOT COMPLETED|Overall Study||27||
59746461|NCT00960206|75865615|FG002|NOT COMPLETED|Overall Study||12||
59746462|NCT00751036|75865626|FG000|STARTED|Overall Study|Started = Treated|48||
59746463|NCT00751036|75865627|FG001|STARTED|Overall Study|Started = Treated|46||
59746464|NCT00751036|75865626|FG000|COMPLETED|Overall Study|Reason Not Completed = Reason for End of Treatment|0||
59746465|NCT00751036|75865627|FG001|COMPLETED|Overall Study|Reason Not Completed = Reason for End of Treatment|0||
59746466|NCT00751036|75865626|FG000|NOT COMPLETED|Overall Study||48||
59746467|NCT00751036|75865627|FG001|NOT COMPLETED|Overall Study||46||
59746468|NCT00961298|75865633|FG000|STARTED|Two Week Placebo Run in||15||
59746469|NCT00961298|75865633|FG000|COMPLETED|Two Week Placebo Run in||14||
59746470|NCT00961298|75865633|FG000|NOT COMPLETED|Two Week Placebo Run in||1||
60135240|NCT03307252|76258162|FG009|NOT COMPLETED|Part 2, Period 4||0||
60135241|NCT03307252|76258163|FG010|NOT COMPLETED|Part 2, Period 4||0||
60135242|NCT03307252|76258153|FG000|STARTED|Part 3, Period 1||0||
59746471|NCT00961298|75865633|FG000|STARTED|12 Weeks Duloxetine Treatment Phase||14||
59746472|NCT00961298|75865633|FG000|COMPLETED|12 Weeks Duloxetine Treatment Phase||11||
59746473|NCT00961298|75865633|FG000|NOT COMPLETED|12 Weeks Duloxetine Treatment Phase||3||
59746474|NCT00744328|75865640|FG000|STARTED|Overall Study||26||
59746475|NCT00744328|75865641|FG001|STARTED|Overall Study||30||
59746476|NCT00744328|75865642|FG002|STARTED|Overall Study||29||
59746477|NCT00744328|75865640|FG000|COMPLETED|Overall Study||19||
59746478|NCT00744328|75865641|FG001|COMPLETED|Overall Study||22||
59746479|NCT00744328|75865642|FG002|COMPLETED|Overall Study||21||
59746480|NCT00744328|75865640|FG000|NOT COMPLETED|Overall Study||7||
59746481|NCT00744328|75865641|FG001|NOT COMPLETED|Overall Study||8||
59746482|NCT00744328|75865642|FG002|NOT COMPLETED|Overall Study||8||
59746483|NCT03245840|75865652|FG000|STARTED|Overall Study||122||
59746484|NCT03245840|75865653|FG001|STARTED|Overall Study||11||
60135243|NCT03307252|76258154|FG001|STARTED|Part 3, Period 1||0||
60135244|NCT03307252|76258155|FG002|STARTED|Part 3, Period 1||0||
60135245|NCT03307252|76258156|FG003|STARTED|Part 3, Period 1||0||
60135246|NCT03307252|76258157|FG004|STARTED|Part 3, Period 1||0||
60135247|NCT03307252|76258158|FG005|STARTED|Part 3, Period 1||0||
60135248|NCT03307252|76258159|FG006|STARTED|Part 3, Period 1||0||
60135249|NCT03307252|76258160|FG007|STARTED|Part 3, Period 1||4||
60135250|NCT03307252|76258161|FG008|STARTED|Part 3, Period 1||4||
60135251|NCT03307252|76258162|FG009|STARTED|Part 3, Period 1||4||
60135252|NCT03307252|76258163|FG010|STARTED|Part 3, Period 1||4||
60135253|NCT03307252|76258153|FG000|COMPLETED|Part 3, Period 1||0||
60135254|NCT03307252|76258154|FG001|COMPLETED|Part 3, Period 1||0||
60135255|NCT03307252|76258155|FG002|COMPLETED|Part 3, Period 1||0||
59746485|NCT03245840|75865652|FG000|Treated|Overall Study||121||
59746486|NCT03245840|75865653|FG001|Treated|Overall Study||10||
59746487|NCT03245840|75865652|FG000|COMPLETED|Overall Study||0||
59746488|NCT03245840|75865653|FG001|COMPLETED|Overall Study||0||
59746489|NCT03245840|75865652|FG000|NOT COMPLETED|Overall Study||122||
59746490|NCT03245840|75865653|FG001|NOT COMPLETED|Overall Study||11||
59746491|NCT00959894|75865659|FG000|STARTED|Overall Study|One (1) additional subject became ineligible on the day of entry and never started study medication.|79||
59746492|NCT00959894|75865659|FG000|COMPLETED|Overall Study||63||
59746493|NCT00959894|75865659|FG000|NOT COMPLETED|Overall Study||16||
59746494|NCT00750880|75865664|FG000|STARTED|Overall Study||1681||
59746495|NCT00750880|75865664|FG000|COMPLETED|Overall Study||1466||
59746496|NCT00750880|75865664|FG000|NOT COMPLETED|Overall Study||215||
59746497|NCT00746590|75865669|FG000|STARTED|Overall Study||1||
59746498|NCT00746590|75865669|FG000|COMPLETED|Overall Study||0||
59746499|NCT00746590|75865669|FG000|NOT COMPLETED|Overall Study||1||
59746500|NCT01032629|75865676|FG000|STARTED|Overall Study||1442||
59746501|NCT01032629|75865677|FG001|STARTED|Overall Study||1445||
59746502|NCT01032629|75865678|FG002|STARTED|Overall Study||1443||
59746503|NCT01032629|75865676|FG000|Treated|Overall Study||1441||
59746504|NCT01032629|75865677|FG001|Treated|Overall Study||1445||
59746505|NCT01032629|75865678|FG002|Treated|Overall Study||1441||
59746506|NCT01032629|75865676|FG000|COMPLETED|Overall Study|Participants who died on trial were considered completed|1297||
60135256|NCT03307252|76258156|FG003|COMPLETED|Part 3, Period 1||0||
60135257|NCT03307252|76258157|FG004|COMPLETED|Part 3, Period 1||0||
59746507|NCT01032629|75865677|FG001|COMPLETED|Overall Study|Participants who died on trial were considered completed|1344||
59746508|NCT01032629|75865678|FG002|COMPLETED|Overall Study|Participants who died on trial were considered completed|1355||
59746509|NCT01032629|75865676|FG000|NOT COMPLETED|Overall Study||145||
59746510|NCT01032629|75865677|FG001|NOT COMPLETED|Overall Study||101||
59746511|NCT01032629|75865678|FG002|NOT COMPLETED|Overall Study||88||
59746512|NCT00749944|75865689|FG000|STARTED|Overall Study||55||
59746513|NCT00749944|75865690|FG001|STARTED|Overall Study||55||
59746514|NCT00749944|75865689|FG000|COMPLETED|Overall Study||50||
59746515|NCT00749944|75865690|FG001|COMPLETED|Overall Study||54||
59746516|NCT00749944|75865689|FG000|NOT COMPLETED|Overall Study||5||
59746517|NCT00749944|75865690|FG001|NOT COMPLETED|Overall Study||1||
59746518|NCT00749398|75865696|FG000|STARTED|Overall Study|Nine participants were excluded because they did not fulfill the inclusion criteria.|124||
59746519|NCT00749398|75865696|FG000|COMPLETED|Overall Study||71||
59746520|NCT00749398|75865696|FG000|NOT COMPLETED|Overall Study||53||
59746521|NCT00746356|75865700|FG000|STARTED|Overall Study||81||
59746522|NCT00746356|75865701|FG001|STARTED|Overall Study||47||
59746523|NCT00746356|75865700|FG000|COMPLETED|Overall Study||70||
59746524|NCT00746356|75865701|FG001|COMPLETED|Overall Study||40||
59746525|NCT00746356|75865700|FG000|NOT COMPLETED|Overall Study||11||
59746526|NCT00746356|75865701|FG001|NOT COMPLETED|Overall Study||7||
59746527|NCT01012973|75865711|FG000|STARTED|Overall Study||106||
59746528|NCT01012973|75865712|FG001|STARTED|Overall Study||71||
59746529|NCT01012973|75865711|FG000|Participants Received Treatment|Overall Study|Safety Population: Participants received treatment|104||
59746530|NCT01012973|75865712|FG001|Participants Received Treatment|Overall Study|Safety Population: Participants received treatment|68||
59746531|NCT01012973|75865711|FG000|Fulfilled Requirements of FAS Population|Overall Study|Full Analysis Set (FAS) Population: Participants received treatment with post baseline measurements|103||
59746532|NCT01012973|75865712|FG001|Fulfilled Requirements of FAS Population|Overall Study|Full Analysis Set (FAS) Population: Participants received treatment with post baseline measurements|68||
59746533|NCT01012973|75865711|FG000|Completed Week 24, From FAS|Overall Study||97||
59746534|NCT01012973|75865712|FG001|Completed Week 24, From FAS|Overall Study||57||
59746535|NCT01012973|75865711|FG000|Completed Week 52, From FAS|Overall Study||91||
59746536|NCT01012973|75865712|FG001|Completed Week 52, From FAS|Overall Study||52||
59746537|NCT01012973|75865711|FG000|COMPLETED|Overall Study||90||
59746538|NCT01012973|75865712|FG001|COMPLETED|Overall Study||52||
59746539|NCT01012973|75865711|FG000|NOT COMPLETED|Overall Study||16||
59746540|NCT01012973|75865712|FG001|NOT COMPLETED|Overall Study||19||
59746541|NCT00748540|75865722|FG000|STARTED|Overall Study||50||
59746542|NCT00748540|75865722|FG000|COMPLETED|Overall Study||49||
59746543|NCT00748540|75865722|FG000|NOT COMPLETED|Overall Study||1||
59746544|NCT01012739|75865726|FG000|STARTED|Treatment Period 1||9||
59746545|NCT01012739|75865727|FG001|STARTED|Treatment Period 1||8||
59746546|NCT01012739|75865728|FG002|STARTED|Treatment Period 1||9||
59746547|NCT01012739|75865729|FG003|STARTED|Treatment Period 1||9||
59746548|NCT01012739|75865726|FG000|COMPLETED|Treatment Period 1||9||
59746549|NCT01012739|75865727|FG001|COMPLETED|Treatment Period 1||8||
59746550|NCT01012739|75865728|FG002|COMPLETED|Treatment Period 1||9||
59746551|NCT01012739|75865729|FG003|COMPLETED|Treatment Period 1||8||
59746552|NCT01012739|75865726|FG000|NOT COMPLETED|Treatment Period 1||0||
59746553|NCT01012739|75865727|FG001|NOT COMPLETED|Treatment Period 1||0||
59746554|NCT01012739|75865728|FG002|NOT COMPLETED|Treatment Period 1||0||
59746555|NCT01012739|75865729|FG003|NOT COMPLETED|Treatment Period 1||1||
59746556|NCT01012739|75865726|FG000|STARTED|Treatment Period 2||9||
59746557|NCT01012739|75865727|FG001|STARTED|Treatment Period 2||8||
59746558|NCT01012739|75865728|FG002|STARTED|Treatment Period 2||9||
59746559|NCT01012739|75865729|FG003|STARTED|Treatment Period 2||8||
59746560|NCT01012739|75865726|FG000|COMPLETED|Treatment Period 2||9||
59746561|NCT01012739|75865727|FG001|COMPLETED|Treatment Period 2||8||
59746562|NCT01012739|75865728|FG002|COMPLETED|Treatment Period 2||9||
59746563|NCT01012739|75865729|FG003|COMPLETED|Treatment Period 2||7||
59746564|NCT01012739|75865726|FG000|NOT COMPLETED|Treatment Period 2||0||
59746565|NCT01012739|75865727|FG001|NOT COMPLETED|Treatment Period 2||0||
59746566|NCT01012739|75865728|FG002|NOT COMPLETED|Treatment Period 2||0||
59746567|NCT01012739|75865729|FG003|NOT COMPLETED|Treatment Period 2||1||
59746568|NCT01012739|75865726|FG000|STARTED|Treatment Period 3||9||
59746569|NCT01012739|75865727|FG001|STARTED|Treatment Period 3||8||
59746570|NCT01012739|75865728|FG002|STARTED|Treatment Period 3||9||
59746571|NCT01012739|75865729|FG003|STARTED|Treatment Period 3||7||
59746572|NCT01012739|75865726|FG000|COMPLETED|Treatment Period 3||9||
59746573|NCT01012739|75865727|FG001|COMPLETED|Treatment Period 3||8||
59746574|NCT01012739|75865728|FG002|COMPLETED|Treatment Period 3||9||
59746575|NCT01012739|75865729|FG003|COMPLETED|Treatment Period 3||7||
59746576|NCT01012739|75865726|FG000|NOT COMPLETED|Treatment Period 3||0||
59746577|NCT01012739|75865727|FG001|NOT COMPLETED|Treatment Period 3||0||
59746578|NCT01012739|75865728|FG002|NOT COMPLETED|Treatment Period 3||0||
59746579|NCT01012739|75865729|FG003|NOT COMPLETED|Treatment Period 3||0||
59746580|NCT01012739|75865726|FG000|STARTED|Treatment Period 4||9||
59746581|NCT01012739|75865727|FG001|STARTED|Treatment Period 4||8||
59746582|NCT01012739|75865728|FG002|STARTED|Treatment Period 4||9||
59873075|NCT03496298|75997211|FG000|COMPLETED|Overall Study||42||
59873076|NCT03496298|75997212|FG001|COMPLETED|Overall Study||36||
59746583|NCT01012739|75865729|FG003|STARTED|Treatment Period 4||7||
59746584|NCT01012739|75865726|FG000|COMPLETED|Treatment Period 4||9||
59746585|NCT01012739|75865727|FG001|COMPLETED|Treatment Period 4||8||
59746586|NCT01012739|75865728|FG002|COMPLETED|Treatment Period 4||9||
59746587|NCT01012739|75865729|FG003|COMPLETED|Treatment Period 4||7||
59746588|NCT01012739|75865726|FG000|NOT COMPLETED|Treatment Period 4||0||
59746589|NCT01012739|75865727|FG001|NOT COMPLETED|Treatment Period 4||0||
59746590|NCT01012739|75865728|FG002|NOT COMPLETED|Treatment Period 4||0||
59746591|NCT01012739|75865729|FG003|NOT COMPLETED|Treatment Period 4||0||
59746592|NCT00742924|75865744|FG000|STARTED|Overall Study||6||
59746593|NCT00742924|75865745|FG001|STARTED|Overall Study||6||
59746594|NCT00742924|75865746|FG002|STARTED|Overall Study||6||
59746595|NCT00742924|75865747|FG003|STARTED|Overall Study||6||
59746596|NCT00742924|75865744|FG000|COMPLETED|Overall Study||1||
59746597|NCT00742924|75865745|FG001|COMPLETED|Overall Study||4||
59746598|NCT00742924|75865746|FG002|COMPLETED|Overall Study||2||
59746599|NCT00742924|75865747|FG003|COMPLETED|Overall Study||0||
59746600|NCT00742924|75865744|FG000|NOT COMPLETED|Overall Study||5||
59746601|NCT00742924|75865745|FG001|NOT COMPLETED|Overall Study||2||
59746602|NCT00742924|75865746|FG002|NOT COMPLETED|Overall Study||4||
59746603|NCT00742924|75865747|FG003|NOT COMPLETED|Overall Study||6||
59746604|NCT00698815|75865760|FG000|STARTED|Overall Study||42||
59746605|NCT00698815|75865761|FG001|STARTED|Overall Study||47||
59746606|NCT00698815|75865762|FG002|STARTED|Overall Study||41||
59746607|NCT00698815|75865760|FG000|COMPLETED|Overall Study||32||
59746608|NCT00698815|75865761|FG001|COMPLETED|Overall Study||33||
59746609|NCT00698815|75865762|FG002|COMPLETED|Overall Study||31||
59746610|NCT00698815|75865760|FG000|NOT COMPLETED|Overall Study||10||
59746611|NCT00698815|75865761|FG001|NOT COMPLETED|Overall Study||14||
59746612|NCT00698815|75865762|FG002|NOT COMPLETED|Overall Study||10||
59746613|NCT00745498|75865773|FG000|STARTED|Overall Study||41||
59746614|NCT00745498|75865774|FG001|STARTED|Overall Study||43||
59746615|NCT00745498|75865775|FG002|STARTED|Overall Study||42||
59746616|NCT00745498|75865773|FG000|COMPLETED|Overall Study||36||
59746617|NCT00745498|75865774|FG001|COMPLETED|Overall Study||37||
59746618|NCT00745498|75865775|FG002|COMPLETED|Overall Study||34||
59746619|NCT00745498|75865773|FG000|NOT COMPLETED|Overall Study||5||
59746620|NCT00745498|75865774|FG001|NOT COMPLETED|Overall Study||6||
59746621|NCT00745498|75865775|FG002|NOT COMPLETED|Overall Study||8||
59746622|NCT00744874|75865783|FG000|STARTED|Overall Study||55||
59746623|NCT00744874|75865783|FG000|COMPLETED|Overall Study||51||
59746624|NCT00744874|75865783|FG000|NOT COMPLETED|Overall Study||4||
59746625|NCT00576901|75865794|FG000|STARTED|Overall Study||23||
59746626|NCT00576901|75865794|FG000|COMPLETED|Overall Study||20||
59746627|NCT00576901|75865794|FG000|NOT COMPLETED|Overall Study||3||
59746628|NCT00699283|75865800|FG000|STARTED|Overall Study||47||
59746629|NCT00699283|75865801|FG001|STARTED|Overall Study||15||
59746630|NCT00699283|75865800|FG000|COMPLETED|Overall Study||14||
59746631|NCT00699283|75865801|FG001|COMPLETED|Overall Study||7||
59746632|NCT00699283|75865800|FG000|NOT COMPLETED|Overall Study||33||
59746633|NCT00699283|75865801|FG001|NOT COMPLETED|Overall Study||8||
59746634|NCT00740584|75865806|FG000|STARTED|Overall Study||12||
59746635|NCT00740584|75865806|FG000|COMPLETED|Overall Study||11||
59746636|NCT00740584|75865806|FG000|NOT COMPLETED|Overall Study||1||
59746637|NCT01023815|75865815|FG000|STARTED|Pre-randomization Period (Day 1 to 90)|Out of 330 enrolled, 2 patients never received everolimus.|328||
59746638|NCT01023815|75865816|FG001|STARTED|Pre-randomization Period (Day 1 to 90)||0||
59746639|NCT01023815|75865817|FG002|STARTED|Pre-randomization Period (Day 1 to 90)||0||
59746640|NCT01023815|75865818|FG003|STARTED|Pre-randomization Period (Day 1 to 90)||0||
59746641|NCT01023815|75865815|FG000|COMPLETED|Pre-randomization Period (Day 1 to 90)||184||
59746642|NCT01023815|75865816|FG001|COMPLETED|Pre-randomization Period (Day 1 to 90)||0||
59746643|NCT01023815|75865817|FG002|COMPLETED|Pre-randomization Period (Day 1 to 90)||0||
59746644|NCT01023815|75865818|FG003|COMPLETED|Pre-randomization Period (Day 1 to 90)||0||
59746645|NCT01023815|75865815|FG000|NOT COMPLETED|Pre-randomization Period (Day 1 to 90)||144||
59746646|NCT01023815|75865816|FG001|NOT COMPLETED|Pre-randomization Period (Day 1 to 90)||0||
59746647|NCT01023815|75865817|FG002|NOT COMPLETED|Pre-randomization Period (Day 1 to 90)||0||
59746648|NCT01023815|75865818|FG003|NOT COMPLETED|Pre-randomization Period (Day 1 to 90)||0||
59746649|NCT01023815|75865815|FG000|STARTED|Randomized Period (Day 90 to Month 12)||0||
59746650|NCT01023815|75865816|FG001|STARTED|Randomized Period (Day 90 to Month 12)|Randomized patients to Group A, B and C are also intent to treat population.|45||
59746651|NCT01023815|75865817|FG002|STARTED|Randomized Period (Day 90 to Month 12)||68||
59746652|NCT01023815|75865818|FG003|STARTED|Randomized Period (Day 90 to Month 12)||71||
59746653|NCT01023815|75865815|FG000|COMPLETED|Randomized Period (Day 90 to Month 12)||0||
59746654|NCT01023815|75865816|FG001|COMPLETED|Randomized Period (Day 90 to Month 12)||42||
59746655|NCT01023815|75865817|FG002|COMPLETED|Randomized Period (Day 90 to Month 12)||60||
59746656|NCT01023815|75865818|FG003|COMPLETED|Randomized Period (Day 90 to Month 12)||68||
59746657|NCT01023815|75865815|FG000|NOT COMPLETED|Randomized Period (Day 90 to Month 12)||0||
59746658|NCT01023815|75865816|FG001|NOT COMPLETED|Randomized Period (Day 90 to Month 12)||3||
59746659|NCT01023815|75865817|FG002|NOT COMPLETED|Randomized Period (Day 90 to Month 12)||8||
59746660|NCT01023815|75865818|FG003|NOT COMPLETED|Randomized Period (Day 90 to Month 12)||3||
59746661|NCT01023659|75865832|FG000|STARTED|Overall Study||258||
59746662|NCT01023659|75865833|FG001|STARTED|Overall Study||365||
59746663|NCT01023659|75865834|FG002|STARTED|Overall Study||264||
60135258|NCT03307252|76258158|FG005|COMPLETED|Part 3, Period 1||0||
59746664|NCT01023659|75865832|FG000|COMPLETED|Overall Study||185||
59746665|NCT01023659|75865833|FG001|COMPLETED|Overall Study||137||
59746666|NCT01023659|75865834|FG002|COMPLETED|Overall Study||165||
59746667|NCT01023659|75865832|FG000|NOT COMPLETED|Overall Study||73||
59746668|NCT01023659|75865833|FG001|NOT COMPLETED|Overall Study||228||
59746669|NCT01023659|75865834|FG002|NOT COMPLETED|Overall Study||99||
59746670|NCT00740116|75865845|FG000|STARTED|Overall Study||50||
59746671|NCT00740116|75865846|FG001|STARTED|Overall Study||50||
59746672|NCT00740116|75865845|FG000|COMPLETED|Overall Study||48||
59746673|NCT00740116|75865846|FG001|COMPLETED|Overall Study||45||
59746674|NCT00740116|75865845|FG000|NOT COMPLETED|Overall Study||2||
59746675|NCT00740116|75865846|FG001|NOT COMPLETED|Overall Study||5||
59746676|NCT00698581|75865856|FG000|STARTED|Overall Study||68||
59746677|NCT00698581|75865857|FG001|STARTED|Overall Study||20||
59746678|NCT00698581|75865856|FG000|COMPLETED|Overall Study||23||
59746679|NCT00698581|75865857|FG001|COMPLETED|Overall Study||8||
59746680|NCT00698581|75865856|FG000|NOT COMPLETED|Overall Study||45||
59746681|NCT00698581|75865857|FG001|NOT COMPLETED|Overall Study||12||
59746682|NCT01023581|75865871|FG000|STARTED|Overall Study||109||
59746683|NCT01023581|75865872|FG001|STARTED|Overall Study||112||
59746684|NCT01023581|75865873|FG002|STARTED|Overall Study||113||
59746685|NCT01023581|75865874|FG003|STARTED|Overall Study||114||
59746686|NCT01023581|75865875|FG004|STARTED|Overall Study||111||
59746687|NCT01023581|75865876|FG005|STARTED|Overall Study||111||
59746688|NCT01023581|75865877|FG006|STARTED|Overall Study||114||
59604539|NCT02016690|75714804|FG000|COMPLETED|Overall Study|(Effectiveness analysis set)|288||
59604540|NCT02016690|75714804|FG000|NOT COMPLETED|Overall Study||24||
59746689|NCT01023581|75865871|FG000|Received Study Treatment|Overall Study||106||
59746690|NCT01023581|75865872|FG001|Received Study Treatment|Overall Study||112||
59746691|NCT01023581|75865873|FG002|Received Study Treatment|Overall Study||110||
59746692|NCT01023581|75865874|FG003|Received Study Treatment|Overall Study||109||
59746693|NCT01023581|75865875|FG004|Received Study Treatment|Overall Study||111||
59746694|NCT01023581|75865876|FG005|Received Study Treatment|Overall Study||106||
59746695|NCT01023581|75865877|FG006|Received Study Treatment|Overall Study||114||
59746696|NCT01023581|75865871|FG000|COMPLETED|Overall Study|The number of completed patients represents those who completed study drug.|74||
59746697|NCT01023581|75865872|FG001|COMPLETED|Overall Study||89||
59746698|NCT01023581|75865873|FG002|COMPLETED|Overall Study||71||
59746699|NCT01023581|75865874|FG003|COMPLETED|Overall Study||94||
59746700|NCT01023581|75865875|FG004|COMPLETED|Overall Study||95||
59746701|NCT01023581|75865876|FG005|COMPLETED|Overall Study||92||
59746702|NCT01023581|75865877|FG006|COMPLETED|Overall Study||94||
59746703|NCT01023581|75865871|FG000|NOT COMPLETED|Overall Study||35||
59746704|NCT01023581|75865872|FG001|NOT COMPLETED|Overall Study||23||
59746705|NCT01023581|75865873|FG002|NOT COMPLETED|Overall Study||42||
59746706|NCT01023581|75865874|FG003|NOT COMPLETED|Overall Study||20||
59746707|NCT01023581|75865875|FG004|NOT COMPLETED|Overall Study||16||
59746708|NCT01023581|75865876|FG005|NOT COMPLETED|Overall Study||19||
59746709|NCT01023581|75865877|FG006|NOT COMPLETED|Overall Study||20||
59746710|NCT00962780|75865895|FG000|STARTED|Overall Study||151||
59746711|NCT00962780|75865896|FG001|STARTED|Overall Study||152||
59746712|NCT00962780|75865895|FG000|Vaccinated 13vPnC Dose 1|Overall Study||150||
59746713|NCT00962780|75865896|FG001|Vaccinated 13vPnC Dose 1|Overall Study||151||
59746714|NCT00962780|75865895|FG000|Vaccinated 13vPnC Dose 2|Overall Study||145||
59746715|NCT00962780|75865896|FG001|Vaccinated 13vPnC Dose 2|Overall Study||145||
59746716|NCT00962780|75865895|FG000|Vaccinated 13vPnC Dose 3|Overall Study||144||
59746717|NCT00962780|75865896|FG001|Vaccinated 13vPnC Dose 3|Overall Study||142||
59746718|NCT00962780|75865895|FG000|Vaccinated 23vPS Dose|Overall Study||143||
59746719|NCT00962780|75865896|FG001|Vaccinated 23vPS Dose|Overall Study||139||
59746720|NCT00962780|75865895|FG000|COMPLETED|Overall Study||141||
59746721|NCT00962780|75865896|FG001|COMPLETED|Overall Study||138||
59746722|NCT00962780|75865895|FG000|NOT COMPLETED|Overall Study||10||
59746723|NCT00962780|75865896|FG001|NOT COMPLETED|Overall Study||14||
59746724|NCT00739882|75865910|FG000|STARTED|Double-blind Period||51||
59746725|NCT00739882|75865911|FG001|STARTED|Double-blind Period||25||
59746726|NCT00739882|75865910|FG000|COMPLETED|Double-blind Period||32||
59746727|NCT00739882|75865911|FG001|COMPLETED|Double-blind Period||14||
59746728|NCT00739882|75865910|FG000|NOT COMPLETED|Double-blind Period||19||
59746729|NCT00739882|75865911|FG001|NOT COMPLETED|Double-blind Period||11||
59746730|NCT00739882|75865910|FG000|STARTED|Open-label Period||17||
59746731|NCT00739882|75865911|FG001|STARTED|Open-label Period||14||
59746732|NCT00739882|75865910|FG000|COMPLETED|Open-label Period||7||
59746733|NCT00739882|75865911|FG001|COMPLETED|Open-label Period||9||
59746734|NCT00739882|75865910|FG000|NOT COMPLETED|Open-label Period||10||
59746735|NCT00739882|75865911|FG001|NOT COMPLETED|Open-label Period||5||
59746736|NCT00961220|75865919|FG000|STARTED|Overall Study||17||
60135259|NCT03307252|76258159|FG006|COMPLETED|Part 3, Period 1||0||
59746737|NCT00961220|75865919|FG000|COMPLETED|Overall Study||10||
59746738|NCT00961220|75865919|FG000|NOT COMPLETED|Overall Study||7||
59746739|NCT00734656|75865925|FG000|STARTED|Lab Session 1||24||
59746740|NCT00734656|75865926|FG001|STARTED|Lab Session 1||23||
59746741|NCT00734656|75865927|FG002|STARTED|Lab Session 1||26||
59746742|NCT00734656|75865928|FG003|STARTED|Lab Session 1||21||
59746743|NCT00734656|75865925|FG000|COMPLETED|Lab Session 1||22||
59746744|NCT00734656|75865926|FG001|COMPLETED|Lab Session 1||23||
59746745|NCT00734656|75865927|FG002|COMPLETED|Lab Session 1||26||
59746746|NCT00734656|75865928|FG003|COMPLETED|Lab Session 1||21||
59746747|NCT00734656|75865925|FG000|NOT COMPLETED|Lab Session 1||2||
59746748|NCT00734656|75865926|FG001|NOT COMPLETED|Lab Session 1||0||
59746749|NCT00734656|75865927|FG002|NOT COMPLETED|Lab Session 1||0||
59746750|NCT00734656|75865928|FG003|NOT COMPLETED|Lab Session 1||0||
59746751|NCT00734656|75865925|FG000|STARTED|Washout 1||22||
59746752|NCT00734656|75865926|FG001|STARTED|Washout 1||23||
59746753|NCT00734656|75865927|FG002|STARTED|Washout 1||26||
59746754|NCT00734656|75865928|FG003|STARTED|Washout 1||21||
59746755|NCT00734656|75865925|FG000|COMPLETED|Washout 1||21||
59746756|NCT00734656|75865926|FG001|COMPLETED|Washout 1||18||
59746757|NCT00734656|75865927|FG002|COMPLETED|Washout 1||24||
59746758|NCT00734656|75865928|FG003|COMPLETED|Washout 1||18||
59746759|NCT00734656|75865925|FG000|NOT COMPLETED|Washout 1||1||
59746760|NCT00734656|75865926|FG001|NOT COMPLETED|Washout 1||5||
59746761|NCT00734656|75865927|FG002|NOT COMPLETED|Washout 1||2||
59746762|NCT00734656|75865928|FG003|NOT COMPLETED|Washout 1||3||
59746763|NCT00734656|75865925|FG000|STARTED|Lab Session 2|subjects cross-over to different treatment condition with each lab session in factorial design,|19||
59746764|NCT00734656|75865926|FG001|STARTED|Lab Session 2|subjects cross-over to different treatment condition with each lab session in factorial design,|21||
59746765|NCT00734656|75865927|FG002|STARTED|Lab Session 2|subjects cross-over to different treatment condition with each lab session in factorial design,|21||
59746766|NCT00734656|75865928|FG003|STARTED|Lab Session 2|subjects cross-over to different treatment condition with each lab session in factorial design,|20||
59746767|NCT00734656|75865925|FG000|COMPLETED|Lab Session 2||18||
59746768|NCT00734656|75865926|FG001|COMPLETED|Lab Session 2||21||
59746769|NCT00734656|75865927|FG002|COMPLETED|Lab Session 2||21||
59746770|NCT00734656|75865928|FG003|COMPLETED|Lab Session 2||19||
59746771|NCT00734656|75865925|FG000|NOT COMPLETED|Lab Session 2||1||
59746772|NCT00734656|75865926|FG001|NOT COMPLETED|Lab Session 2||0||
59746773|NCT00734656|75865927|FG002|NOT COMPLETED|Lab Session 2||0||
59746774|NCT00734656|75865928|FG003|NOT COMPLETED|Lab Session 2||1||
59746775|NCT00734656|75865925|FG000|STARTED|Washout 2||18||
59746776|NCT00734656|75865926|FG001|STARTED|Washout 2||21||
59746777|NCT00734656|75865927|FG002|STARTED|Washout 2||21||
59746778|NCT00734656|75865928|FG003|STARTED|Washout 2||19||
59746779|NCT00734656|75865925|FG000|COMPLETED|Washout 2||17||
59746780|NCT00734656|75865926|FG001|COMPLETED|Washout 2||20||
59746781|NCT00734656|75865927|FG002|COMPLETED|Washout 2||20||
59746782|NCT00734656|75865928|FG003|COMPLETED|Washout 2||19||
59746783|NCT00734656|75865925|FG000|NOT COMPLETED|Washout 2||1||
59746784|NCT00734656|75865926|FG001|NOT COMPLETED|Washout 2||1||
59746785|NCT00734656|75865927|FG002|NOT COMPLETED|Washout 2||1||
59746786|NCT00734656|75865928|FG003|NOT COMPLETED|Washout 2||0||
59746787|NCT00734656|75865925|FG000|STARTED|Lab Session 3|subjects cross-over to different treatment condition with each lab session in factorial design,|18||
59746788|NCT00734656|75865926|FG001|STARTED|Lab Session 3|subjects cross-over to different treatment condition with each lab session in factorial design,|19||
59746789|NCT00734656|75865927|FG002|STARTED|Lab Session 3|subjects cross-over to different treatment condition with each lab session in factorial design,|20||
59746790|NCT00734656|75865928|FG003|STARTED|Lab Session 3|subjects cross-over to different treatment condition with each lab session in factorial design,|19||
59746791|NCT00734656|75865925|FG000|COMPLETED|Lab Session 3||18||
59746792|NCT00734656|75865926|FG001|COMPLETED|Lab Session 3||19||
59746793|NCT00734656|75865927|FG002|COMPLETED|Lab Session 3||20||
59746794|NCT00734656|75865928|FG003|COMPLETED|Lab Session 3||19||
59746795|NCT00734656|75865925|FG000|NOT COMPLETED|Lab Session 3||0||
59746796|NCT00734656|75865926|FG001|NOT COMPLETED|Lab Session 3||0||
59746797|NCT00734656|75865927|FG002|NOT COMPLETED|Lab Session 3||0||
59746798|NCT00734656|75865928|FG003|NOT COMPLETED|Lab Session 3||0||
59746799|NCT00734656|75865925|FG000|STARTED|Washout 3||18||
59746800|NCT00734656|75865926|FG001|STARTED|Washout 3||19||
59746801|NCT00734656|75865927|FG002|STARTED|Washout 3||20||
59746802|NCT00734656|75865928|FG003|STARTED|Washout 3||19||
59746803|NCT00734656|75865925|FG000|COMPLETED|Washout 3||17||
59746804|NCT00734656|75865926|FG001|COMPLETED|Washout 3||19||
59746805|NCT00734656|75865927|FG002|COMPLETED|Washout 3||20||
59746806|NCT00734656|75865928|FG003|COMPLETED|Washout 3||18||
59746807|NCT00734656|75865925|FG000|NOT COMPLETED|Washout 3||1||
59746808|NCT00734656|75865926|FG001|NOT COMPLETED|Washout 3||0||
59746809|NCT00734656|75865927|FG002|NOT COMPLETED|Washout 3||0||
59746810|NCT00734656|75865928|FG003|NOT COMPLETED|Washout 3||1||
59746811|NCT00734656|75865925|FG000|STARTED|Lab Session 4|subjects cross-over to different treatment condition with each lab session in factorial design,|20||
59746812|NCT00734656|75865926|FG001|STARTED|Lab Session 4|subjects cross-over to different treatment condition with each lab session in factorial design,|18||
59746813|NCT00734656|75865927|FG002|STARTED|Lab Session 4|subjects cross-over to different treatment condition with each lab session in factorial design,|16||
59746814|NCT00734656|75865928|FG003|STARTED|Lab Session 4|subjects cross-over to different treatment condition with each lab session in factorial design,|20||
59873077|NCT03496298|75997213|FG002|COMPLETED|Overall Study||23||
59746815|NCT00734656|75865925|FG000|COMPLETED|Lab Session 4||20||
59746816|NCT00734656|75865926|FG001|COMPLETED|Lab Session 4||18||
60135260|NCT03307252|76258160|FG007|COMPLETED|Part 3, Period 1|Participants randomized in Part 3|4||
60135261|NCT03307252|76258161|FG008|COMPLETED|Part 3, Period 1|Participants randomized in Part 3|4||
60135262|NCT03307252|76258162|FG009|COMPLETED|Part 3, Period 1|Participants randomized in Part 3|4||
60135263|NCT03307252|76258163|FG010|COMPLETED|Part 3, Period 1|Participants randomized in Part 3|4||
60135264|NCT03307252|76258153|FG000|NOT COMPLETED|Part 3, Period 1||0||
60135265|NCT03307252|76258154|FG001|NOT COMPLETED|Part 3, Period 1||0||
60135266|NCT03307252|76258155|FG002|NOT COMPLETED|Part 3, Period 1||0||
60135267|NCT03307252|76258156|FG003|NOT COMPLETED|Part 3, Period 1||0||
60135268|NCT03307252|76258157|FG004|NOT COMPLETED|Part 3, Period 1||0||
60135269|NCT03307252|76258158|FG005|NOT COMPLETED|Part 3, Period 1||0||
60135270|NCT03307252|76258159|FG006|NOT COMPLETED|Part 3, Period 1||0||
60135271|NCT03307252|76258160|FG007|NOT COMPLETED|Part 3, Period 1||0||
60135272|NCT03307252|76258161|FG008|NOT COMPLETED|Part 3, Period 1||0||
60135273|NCT03307252|76258162|FG009|NOT COMPLETED|Part 3, Period 1||0||
59604541|NCT02016300|75714810|FG000|STARTED|Overall Study||12||
59604542|NCT02016300|75714811|FG001|STARTED|Overall Study||12||
59604543|NCT02016300|75714810|FG000|COMPLETED|Overall Study||12||
59746817|NCT00734656|75865927|FG002|COMPLETED|Lab Session 4||16||
59746818|NCT00734656|75865928|FG003|COMPLETED|Lab Session 4||19||
59746819|NCT00734656|75865925|FG000|NOT COMPLETED|Lab Session 4||0||
59746820|NCT00734656|75865926|FG001|NOT COMPLETED|Lab Session 4||0||
59746821|NCT00734656|75865927|FG002|NOT COMPLETED|Lab Session 4||0||
59746822|NCT00734656|75865928|FG003|NOT COMPLETED|Lab Session 4||1||
59746823|NCT00739648|75865940|FG000|STARTED|Overall Study||108||
59746824|NCT00739648|75865941|FG001|STARTED|Overall Study||214||
59746825|NCT00739648|75865940|FG000|COMPLETED|Overall Study||82||
59746826|NCT00739648|75865941|FG001|COMPLETED|Overall Study||161||
59746827|NCT00739648|75865940|FG000|NOT COMPLETED|Overall Study||26||
59746828|NCT00739648|75865941|FG001|NOT COMPLETED|Overall Study||53||
59746829|NCT01032239|75865953|FG000|STARTED|Overall Study|randomized to ITB arm|31||
59746830|NCT01032239|75865954|FG001|STARTED|Overall Study|randomized to BMT arm|29||
59746831|NCT01032239|75865953|FG000|Implant|Overall Study|implanted|25||
59746832|NCT01032239|75865954|FG001|Implant|Overall Study||0||
59746833|NCT01032239|75865953|FG000|COMPLETED|Overall Study||24||
59746834|NCT01032239|75865954|FG001|COMPLETED|Overall Study||24||
59746835|NCT01032239|75865953|FG000|NOT COMPLETED|Overall Study||7||
59746836|NCT01032239|75865954|FG001|NOT COMPLETED|Overall Study||5||
59746837|NCT00734578|75865963|FG000|STARTED|Overall Study||154||
59746838|NCT00734578|75865964|FG001|STARTED|Overall Study||153||
59746839|NCT00734578|75865965|FG002|STARTED|Overall Study||154||
59746840|NCT00734578|75865963|FG000|COMPLETED|Overall Study||121||
59746841|NCT00734578|75865964|FG001|COMPLETED|Overall Study||128||
59746842|NCT00734578|75865965|FG002|COMPLETED|Overall Study||129||
59746843|NCT00734578|75865963|FG000|NOT COMPLETED|Overall Study||33||
60135274|NCT03307252|76258163|FG010|NOT COMPLETED|Part 3, Period 1||0||
60135275|NCT03307252|76258153|FG000|STARTED|Part 3, Washout Period 1 (7 Days)||0||
60135276|NCT03307252|76258154|FG001|STARTED|Part 3, Washout Period 1 (7 Days)||0||
60135277|NCT03307252|76258155|FG002|STARTED|Part 3, Washout Period 1 (7 Days)||0||
60135278|NCT03307252|76258156|FG003|STARTED|Part 3, Washout Period 1 (7 Days)||0||
60135279|NCT03307252|76258157|FG004|STARTED|Part 3, Washout Period 1 (7 Days)||0||
60135280|NCT03307252|76258158|FG005|STARTED|Part 3, Washout Period 1 (7 Days)||0||
60135281|NCT03307252|76258159|FG006|STARTED|Part 3, Washout Period 1 (7 Days)||0||
60135282|NCT03307252|76258160|FG007|STARTED|Part 3, Washout Period 1 (7 Days)||4||
59604544|NCT02016300|75714811|FG001|COMPLETED|Overall Study||9||
59604545|NCT02016300|75714810|FG000|NOT COMPLETED|Overall Study||0||
59604546|NCT02016300|75714811|FG001|NOT COMPLETED|Overall Study||3||
59604547|NCT02040090|75714819|FG000|STARTED|Overall Study||59||
59604548|NCT02040090|75714820|FG001|STARTED|Overall Study||59||
59604549|NCT02040090|75714819|FG000|COMPLETED|Overall Study||56||
59746844|NCT00734578|75865964|FG001|NOT COMPLETED|Overall Study||25||
59746845|NCT00734578|75865965|FG002|NOT COMPLETED|Overall Study||25||
59746846|NCT00739102|75865973|FG000|STARTED|Overall Study||250||
59604550|NCT02040090|75714820|FG001|COMPLETED|Overall Study||57||
59746847|NCT00739102|75865973|FG000|COMPLETED|Overall Study|Completed 12-Month Follow-up|235||
59746848|NCT00739102|75865973|FG000|NOT COMPLETED|Overall Study||15||
59746849|NCT00959192|75865981|FG000|STARTED|Overall Study||6||
59746850|NCT00959192|75865982|FG001|STARTED|Overall Study||9||
59746851|NCT00959192|75865983|FG002|STARTED|Overall Study||9||
59746852|NCT00959192|75865984|FG003|STARTED|Overall Study||8||
59604551|NCT02040090|75714819|FG000|NOT COMPLETED|Overall Study||3||
59604552|NCT02040090|75714820|FG001|NOT COMPLETED|Overall Study||2||
59746853|NCT00959192|75865981|FG000|COMPLETED|Overall Study||4||
59746854|NCT00959192|75865982|FG001|COMPLETED|Overall Study||8||
59746855|NCT00959192|75865983|FG002|COMPLETED|Overall Study||6||
59746856|NCT00959192|75865984|FG003|COMPLETED|Overall Study||7||
59746857|NCT00959192|75865981|FG000|NOT COMPLETED|Overall Study||2||
59746858|NCT00959192|75865982|FG001|NOT COMPLETED|Overall Study||1||
59746859|NCT00959192|75865983|FG002|NOT COMPLETED|Overall Study||3||
59746860|NCT00959192|75865984|FG003|NOT COMPLETED|Overall Study||1||
59746861|NCT00696787|75865998|FG000|STARTED|Overall Study||40||
59746862|NCT00696787|75865999|FG001|STARTED|Overall Study||42||
59746863|NCT00696787|75866000|FG002|STARTED|Overall Study||43||
59746864|NCT00696787|75865998|FG000|COMPLETED|Overall Study||25||
59746865|NCT00696787|75865999|FG001|COMPLETED|Overall Study||22||
59746866|NCT00696787|75866000|FG002|COMPLETED|Overall Study||17||
59746867|NCT00696787|75865998|FG000|NOT COMPLETED|Overall Study||15||
59746868|NCT00696787|75865999|FG001|NOT COMPLETED|Overall Study||20||
59746869|NCT00696787|75866000|FG002|NOT COMPLETED|Overall Study||26||
59746870|NCT01012037|75866011|FG000|STARTED|Overall Study||44||
59746871|NCT01012037|75866012|FG001|STARTED|Overall Study||223||
59746872|NCT01012037|75866013|FG002|STARTED|Overall Study||224||
59746873|NCT01012037|75866011|FG000|COMPLETED|Overall Study||43||
59746874|NCT01012037|75866012|FG001|COMPLETED|Overall Study||207||
59746875|NCT01012037|75866013|FG002|COMPLETED|Overall Study||214||
59746876|NCT01012037|75866011|FG000|NOT COMPLETED|Overall Study||1||
59746877|NCT01012037|75866012|FG001|NOT COMPLETED|Overall Study||16||
59746878|NCT01012037|75866013|FG002|NOT COMPLETED|Overall Study||10||
59746879|NCT00734032|75866025|FG000|STARTED|Overall Study||25||
59746880|NCT00734032|75866026|FG001|STARTED|Overall Study||28||
59746881|NCT00734032|75866027|FG002|STARTED|Overall Study||28||
59746882|NCT00734032|75866028|FG003|STARTED|Overall Study||26||
59746883|NCT00734032|75866025|FG000|COMPLETED|Overall Study||25||
59746884|NCT00734032|75866026|FG001|COMPLETED|Overall Study||27||
59746885|NCT00734032|75866027|FG002|COMPLETED|Overall Study||28||
59746886|NCT00734032|75866028|FG003|COMPLETED|Overall Study||26||
59746887|NCT00734032|75866025|FG000|NOT COMPLETED|Overall Study||0||
59746888|NCT00734032|75866026|FG001|NOT COMPLETED|Overall Study||1||
59746889|NCT00734032|75866027|FG002|NOT COMPLETED|Overall Study||0||
59746890|NCT00734032|75866028|FG003|NOT COMPLETED|Overall Study||0||
59746891|NCT01010633|75866040|FG000|STARTED|Overall Study||203||
59746892|NCT01010633|75866041|FG001|STARTED|Overall Study||203||
59746893|NCT01010633|75866040|FG000|COMPLETED|Overall Study||199||
59746894|NCT01010633|75866041|FG001|COMPLETED|Overall Study||198||
59746895|NCT01010633|75866040|FG000|NOT COMPLETED|Overall Study||4||
59746896|NCT01010633|75866041|FG001|NOT COMPLETED|Overall Study||5||
59746897|NCT00733954|75866049|FG000|STARTED|Overall Study||124||
59746898|NCT00733954|75866050|FG001|STARTED|Overall Study||125||
59746899|NCT00733954|75866049|FG000|COMPLETED|Overall Study||116||
59746900|NCT00733954|75866050|FG001|COMPLETED|Overall Study||123||
59746901|NCT00733954|75866049|FG000|NOT COMPLETED|Overall Study||8||
59746902|NCT00733954|75866050|FG001|NOT COMPLETED|Overall Study||2||
59746903|NCT00733408|75866056|FG000|STARTED|Overall Study||59||
59746904|NCT00733408|75866056|FG000|COMPLETED|Overall Study||55||
59746905|NCT00733408|75866056|FG000|NOT COMPLETED|Overall Study||4||
59746906|NCT01010867|75866060|FG000|STARTED|Overall Study||31||
59746907|NCT01010867|75866060|FG000|COMPLETED|Overall Study||30||
59746908|NCT01010867|75866060|FG000|NOT COMPLETED|Overall Study||1||
59746909|NCT00576823|75866067|FG000|STARTED|12-week Efficacy Phase||12||
59746910|NCT00576823|75866068|FG001|STARTED|12-week Efficacy Phase||6||
59746911|NCT00576823|75866069|FG002|STARTED|12-week Efficacy Phase||7||
59746912|NCT00576823|75866067|FG000|COMPLETED|12-week Efficacy Phase||11||
59746913|NCT00576823|75866068|FG001|COMPLETED|12-week Efficacy Phase||6||
59746914|NCT00576823|75866069|FG002|COMPLETED|12-week Efficacy Phase||7||
59746915|NCT00576823|75866067|FG000|NOT COMPLETED|12-week Efficacy Phase||1||
59746916|NCT00576823|75866068|FG001|NOT COMPLETED|12-week Efficacy Phase||0||
59746917|NCT00576823|75866069|FG002|NOT COMPLETED|12-week Efficacy Phase||0||
59746918|NCT00576823|75866067|FG000|STARTED|40-week Safety Extension Phase||11||
59746919|NCT00576823|75866068|FG001|STARTED|40-week Safety Extension Phase||6||
59746920|NCT00576823|75866069|FG002|STARTED|40-week Safety Extension Phase|One patient refused to continue in the extension phase.|6||
59746921|NCT00576823|75866067|FG000|COMPLETED|40-week Safety Extension Phase||10||
59746922|NCT00576823|75866068|FG001|COMPLETED|40-week Safety Extension Phase||6||
59746923|NCT00576823|75866069|FG002|COMPLETED|40-week Safety Extension Phase||6||
59746924|NCT00576823|75866067|FG000|NOT COMPLETED|40-week Safety Extension Phase||1||
59746925|NCT00576823|75866068|FG001|NOT COMPLETED|40-week Safety Extension Phase||0||
59746926|NCT00576823|75866069|FG002|NOT COMPLETED|40-week Safety Extension Phase||0||
59746927|NCT00732940|75866082|FG000|STARTED|Overall Study||28||
59746928|NCT00732940|75866083|FG001|STARTED|Overall Study||28||
59746929|NCT00732940|75866082|FG000|COMPLETED|Overall Study||26||
59746930|NCT00732940|75866083|FG001|COMPLETED|Overall Study||25||
59746931|NCT00732940|75866082|FG000|NOT COMPLETED|Overall Study||2||
59746932|NCT00732940|75866083|FG001|NOT COMPLETED|Overall Study||3||
59746933|NCT00962390|75866093|FG000|STARTED|Overall Study||29||
59746934|NCT00962390|75866094|FG001|STARTED|Overall Study||29||
59746935|NCT00962390|75866095|FG002|STARTED|Overall Study||29||
59746936|NCT00962390|75866096|FG003|STARTED|Overall Study||29||
59746937|NCT00962390|75866093|FG000|COMPLETED|Overall Study||25||
59746938|NCT00962390|75866094|FG001|COMPLETED|Overall Study||26||
59746939|NCT00962390|75866095|FG002|COMPLETED|Overall Study||25||
59746940|NCT00962390|75866096|FG003|COMPLETED|Overall Study||28||
59746941|NCT00962390|75866093|FG000|NOT COMPLETED|Overall Study||4||
59746942|NCT00962390|75866094|FG001|NOT COMPLETED|Overall Study||3||
59746943|NCT00962390|75866095|FG002|NOT COMPLETED|Overall Study||4||
59746944|NCT00962390|75866096|FG003|NOT COMPLETED|Overall Study||1||
59746945|NCT00732472|75866110|FG000|STARTED|Overall Study||9||
59746946|NCT00732472|75866111|FG001|STARTED|Overall Study|One par. (counted as 2 on outputs) was randomized/dosed with UMEC 250 µg on 2 separate occasions.|10||
59746947|NCT00732472|75866112|FG002|STARTED|Overall Study||10||
59746948|NCT00732472|75866113|FG003|STARTED|Overall Study||9||
59746949|NCT00732472|75866110|FG000|COMPLETED|Overall Study||9||
59746950|NCT00732472|75866111|FG001|COMPLETED|Overall Study||7||
59746951|NCT00732472|75866112|FG002|COMPLETED|Overall Study||9||
59746952|NCT00732472|75866113|FG003|COMPLETED|Overall Study||6||
59746953|NCT00732472|75866110|FG000|NOT COMPLETED|Overall Study||0||
59746954|NCT00732472|75866111|FG001|NOT COMPLETED|Overall Study||3||
59746955|NCT00732472|75866112|FG002|NOT COMPLETED|Overall Study||1||
59746956|NCT00732472|75866113|FG003|NOT COMPLETED|Overall Study||3||
59746957|NCT00960986|75866128|FG000|STARTED|Period 1 (Screening and Washout)||59||
59746958|NCT00960986|75866129|FG001|STARTED|Period 1 (Screening and Washout)||63||
59746959|NCT00960986|75866130|FG002|STARTED|Period 1 (Screening and Washout)||63||
59746960|NCT00960986|75866131|FG003|STARTED|Period 1 (Screening and Washout)||64||
59746961|NCT00960986|75866128|FG000|COMPLETED|Period 1 (Screening and Washout)||56||
59746962|NCT00960986|75866129|FG001|COMPLETED|Period 1 (Screening and Washout)||59||
59746963|NCT00960986|75866130|FG002|COMPLETED|Period 1 (Screening and Washout)||59||
59746964|NCT00960986|75866131|FG003|COMPLETED|Period 1 (Screening and Washout)||61||
59746965|NCT00960986|75866128|FG000|NOT COMPLETED|Period 1 (Screening and Washout)||3||
59746966|NCT00960986|75866129|FG001|NOT COMPLETED|Period 1 (Screening and Washout)||4||
59746967|NCT00960986|75866130|FG002|NOT COMPLETED|Period 1 (Screening and Washout)||4||
59746968|NCT00960986|75866131|FG003|NOT COMPLETED|Period 1 (Screening and Washout)||3||
59746969|NCT00960986|75866128|FG000|STARTED|Period 2 (1-week Initial Dosing Period)||56||
59746970|NCT00960986|75866129|FG001|STARTED|Period 2 (1-week Initial Dosing Period)||59||
59746971|NCT00960986|75866130|FG002|STARTED|Period 2 (1-week Initial Dosing Period)||59||
59746972|NCT00960986|75866131|FG003|STARTED|Period 2 (1-week Initial Dosing Period)||61||
59746973|NCT00960986|75866128|FG000|COMPLETED|Period 2 (1-week Initial Dosing Period)||56||
59746974|NCT00960986|75866129|FG001|COMPLETED|Period 2 (1-week Initial Dosing Period)||59||
59746975|NCT00960986|75866130|FG002|COMPLETED|Period 2 (1-week Initial Dosing Period)||59||
59746976|NCT00960986|75866131|FG003|COMPLETED|Period 2 (1-week Initial Dosing Period)||61||
59746977|NCT00960986|75866128|FG000|NOT COMPLETED|Period 2 (1-week Initial Dosing Period)||0||
59746978|NCT00960986|75866129|FG001|NOT COMPLETED|Period 2 (1-week Initial Dosing Period)||0||
59746979|NCT00960986|75866130|FG002|NOT COMPLETED|Period 2 (1-week Initial Dosing Period)||0||
59746980|NCT00960986|75866131|FG003|NOT COMPLETED|Period 2 (1-week Initial Dosing Period)||0||
59746981|NCT00960986|75866128|FG000|STARTED|Period 3 (7-week Therapy Period)||56||
59746982|NCT00960986|75866129|FG001|STARTED|Period 3 (7-week Therapy Period)||59||
59746983|NCT00960986|75866130|FG002|STARTED|Period 3 (7-week Therapy Period)||59||
59746984|NCT00960986|75866131|FG003|STARTED|Period 3 (7-week Therapy Period)||61||
59746985|NCT00960986|75866128|FG000|COMPLETED|Period 3 (7-week Therapy Period)||26||
59746986|NCT00960986|75866129|FG001|COMPLETED|Period 3 (7-week Therapy Period)||36||
59746987|NCT00960986|75866130|FG002|COMPLETED|Period 3 (7-week Therapy Period)||39||
59746988|NCT00960986|75866131|FG003|COMPLETED|Period 3 (7-week Therapy Period)||36||
59746989|NCT00960986|75866128|FG000|NOT COMPLETED|Period 3 (7-week Therapy Period)||30||
59746990|NCT00960986|75866129|FG001|NOT COMPLETED|Period 3 (7-week Therapy Period)||23||
59746991|NCT00960986|75866130|FG002|NOT COMPLETED|Period 3 (7-week Therapy Period)||20||
59746992|NCT00960986|75866131|FG003|NOT COMPLETED|Period 3 (7-week Therapy Period)||25||
59746993|NCT00732238|75866143|FG000|STARTED|Overall Study||33||
59746994|NCT00732238|75866144|FG001|STARTED|Overall Study||28||
59746995|NCT00732238|75866143|FG000|COMPLETED|Overall Study||28||
59746996|NCT00732238|75866144|FG001|COMPLETED|Overall Study||27||
59746997|NCT00732238|75866143|FG000|NOT COMPLETED|Overall Study||5||
59746998|NCT00732238|75866144|FG001|NOT COMPLETED|Overall Study||1||
59746999|NCT00958880|75866154|FG000|STARTED|Overall Study||20||
59747000|NCT00958880|75866155|FG001|STARTED|Overall Study||20||
59747001|NCT00958880|75866154|FG000|COMPLETED|Overall Study||18||
59747002|NCT00958880|75866155|FG001|COMPLETED|Overall Study||18||
59747003|NCT00958880|75866154|FG000|NOT COMPLETED|Overall Study||2||
59747004|NCT00958880|75866155|FG001|NOT COMPLETED|Overall Study||2||
59747005|NCT00732160|75866165|FG000|STARTED|Overall Study||7||
59747006|NCT00732160|75866166|FG001|STARTED|Overall Study||5||
59747007|NCT00732160|75866167|FG002|STARTED|Overall Study||6||
59747008|NCT00732160|75866168|FG003|STARTED|Overall Study||5||
59747009|NCT00732160|75866165|FG000|HS Vehicle|Overall Study||7||
59747010|NCT00732160|75866166|FG001|HS Vehicle|Overall Study||5||
59747011|NCT00732160|75866167|FG002|HS Vehicle|Overall Study||3||
59747012|NCT00732160|75866168|FG003|HS Vehicle|Overall Study||3||
59747013|NCT00732160|75866165|FG000|HS Aldosterone|Overall Study||7||
59747014|NCT00732160|75866166|FG001|HS Aldosterone|Overall Study||5||
59747015|NCT00732160|75866167|FG002|HS Aldosterone|Overall Study||3||
59747016|NCT00732160|75866168|FG003|HS Aldosterone|Overall Study||3||
59747017|NCT00732160|75866165|FG000|LS Vehicle|Overall Study||2||
59747018|NCT00732160|75866166|FG001|LS Vehicle|Overall Study||1||
59747019|NCT00732160|75866167|FG002|LS Vehicle|Overall Study||6||
59747020|NCT00732160|75866168|FG003|LS Vehicle|Overall Study||5||
59747021|NCT00732160|75866165|FG000|LS Aldosterone|Overall Study||2||
59747022|NCT00732160|75866166|FG001|LS Aldosterone|Overall Study||1||
59747023|NCT00732160|75866167|FG002|LS Aldosterone|Overall Study||6||
59747024|NCT00732160|75866168|FG003|LS Aldosterone|Overall Study||5||
59747025|NCT00732160|75866165|FG000|COMPLETED|Overall Study||2||
59747026|NCT00732160|75866166|FG001|COMPLETED|Overall Study||1||
59747027|NCT00732160|75866167|FG002|COMPLETED|Overall Study||3||
59747028|NCT00732160|75866168|FG003|COMPLETED|Overall Study||3||
59747029|NCT00732160|75866165|FG000|NOT COMPLETED|Overall Study||5||
59747030|NCT00732160|75866166|FG001|NOT COMPLETED|Overall Study||4||
59747031|NCT00732160|75866167|FG002|NOT COMPLETED|Overall Study||3||
59747032|NCT00732160|75866168|FG003|NOT COMPLETED|Overall Study||2||
59747033|NCT00958724|75866178|FG000|STARTED|Overall Study||6||
59747034|NCT00958724|75866178|FG000|COMPLETED|Overall Study||0||
59747035|NCT00958724|75866178|FG000|NOT COMPLETED|Overall Study||6||
59747036|NCT00738400|75866184|FG000|STARTED|Overall Study||76||
59747037|NCT00738400|75866185|FG001|STARTED|Overall Study||74||
59747038|NCT00738400|75866184|FG000|Received Treatment, Safety Population|Overall Study|One invalid participant (no evidence that this randomized participant took study medication).|75||
59747039|NCT00738400|75866185|FG001|Received Treatment, Safety Population|Overall Study|Two invalid participants (no evidence that these randomized participants took study medication).|72||
59747040|NCT00738400|75866184|FG000|ITT (Intent To Treatment) Population|Overall Study||75||
59747041|NCT00738400|75866185|FG001|ITT (Intent To Treatment) Population|Overall Study|No post-baseline efficacy measurement in 2 participants|70||
59747042|NCT00738400|75866184|FG000|COMPLETED|Overall Study||72||
59747043|NCT00738400|75866185|FG001|COMPLETED|Overall Study||67||
59747044|NCT00738400|75866184|FG000|NOT COMPLETED|Overall Study||4||
59747045|NCT00738400|75866185|FG001|NOT COMPLETED|Overall Study||7||
59747046|NCT01009463|75866195|FG000|STARTED|4-week, Open-label Run-In Period||2071||
59747047|NCT01009463|75866196|FG001|STARTED|4-week, Open-label Run-In Period||0||
59747048|NCT01009463|75866197|FG002|STARTED|4-week, Open-label Run-In Period||0||
59747049|NCT01009463|75866198|FG003|STARTED|4-week, Open-label Run-In Period||0||
59747050|NCT01009463|75866199|FG004|STARTED|4-week, Open-label Run-In Period||0||
59747051|NCT01009463|75866195|FG000|COMPLETED|4-week, Open-label Run-In Period||1622||
59747052|NCT01009463|75866196|FG001|COMPLETED|4-week, Open-label Run-In Period||0||
59747053|NCT01009463|75866197|FG002|COMPLETED|4-week, Open-label Run-In Period||0||
59747054|NCT01009463|75866198|FG003|COMPLETED|4-week, Open-label Run-In Period||0||
59747055|NCT01009463|75866199|FG004|COMPLETED|4-week, Open-label Run-In Period||0||
59747056|NCT01009463|75866195|FG000|NOT COMPLETED|4-week, Open-label Run-In Period||449||
59747057|NCT01009463|75866196|FG001|NOT COMPLETED|4-week, Open-label Run-In Period||0||
59747058|NCT01009463|75866197|FG002|NOT COMPLETED|4-week, Open-label Run-In Period||0||
59747059|NCT01009463|75866198|FG003|NOT COMPLETED|4-week, Open-label Run-In Period||0||
59747060|NCT01009463|75866199|FG004|NOT COMPLETED|4-week, Open-label Run-In Period||0||
59747061|NCT01009463|75866195|FG000|STARTED|52-week, Double-blind Treatment Period||0||
59747062|NCT01009463|75866196|FG001|STARTED|52-week, Double-blind Treatment Period||409||
59747063|NCT01009463|75866197|FG002|STARTED|52-week, Double-blind Treatment Period||408||
59747064|NCT01009463|75866198|FG003|STARTED|52-week, Double-blind Treatment Period||403||
59747065|NCT01009463|75866199|FG004|STARTED|52-week, Double-blind Treatment Period||402||
59747066|NCT01009463|75866195|FG000|Completed the Treatment Period|52-week, Double-blind Treatment Period||0||
59747067|NCT01009463|75866196|FG001|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|295||
59747068|NCT01009463|75866197|FG002|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|318||
59747069|NCT01009463|75866198|FG003|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|314||
59747070|NCT01009463|75866199|FG004|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|303||
59747071|NCT01009463|75866195|FG000|COMPLETED|52-week, Double-blind Treatment Period||0||
59747072|NCT01009463|75866196|FG001|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|294||
59747073|NCT01009463|75866197|FG002|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|315||
59747074|NCT01009463|75866198|FG003|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|312||
59747075|NCT01009463|75866199|FG004|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|301||
59747076|NCT01009463|75866195|FG000|NOT COMPLETED|52-week, Double-blind Treatment Period||0||
59747077|NCT01009463|75866196|FG001|NOT COMPLETED|52-week, Double-blind Treatment Period||115||
59747078|NCT01009463|75866197|FG002|NOT COMPLETED|52-week, Double-blind Treatment Period||93||
59747079|NCT01009463|75866198|FG003|NOT COMPLETED|52-week, Double-blind Treatment Period||91||
59747080|NCT01009463|75866199|FG004|NOT COMPLETED|52-week, Double-blind Treatment Period||101||
59747081|NCT00958568|75866210|FG000|STARTED|SPII (Wk 0-8, Acute Open-label)||892||
59747082|NCT00958568|75866211|FG001|STARTED|SPII (Wk 0-8, Acute Open-label)||0||
59747083|NCT00958568|75866212|FG002|STARTED|SPII (Wk 0-8, Acute Open-label)||0||
59747084|NCT00958568|75866213|FG003|STARTED|SPII (Wk 0-8, Acute Open-label)||0||
59747085|NCT00958568|75866210|FG000|COMPLETED|SPII (Wk 0-8, Acute Open-label)||655||
59747086|NCT00958568|75866211|FG001|COMPLETED|SPII (Wk 0-8, Acute Open-label)||0||
59747087|NCT00958568|75866212|FG002|COMPLETED|SPII (Wk 0-8, Acute Open-label)||0||
59747088|NCT00958568|75866213|FG003|COMPLETED|SPII (Wk 0-8, Acute Open-label)||0||
59747089|NCT00958568|75866210|FG000|NOT COMPLETED|SPII (Wk 0-8, Acute Open-label)||237||
59747090|NCT00958568|75866211|FG001|NOT COMPLETED|SPII (Wk 0-8, Acute Open-label)||0||
59747091|NCT00958568|75866212|FG002|NOT COMPLETED|SPII (Wk 0-8, Acute Open-label)||0||
59747092|NCT00958568|75866213|FG003|NOT COMPLETED|SPII (Wk 0-8, Acute Open-label)||0||
59747093|NCT00958568|75866210|FG000|STARTED|SPIII (Wk 9-20,Open-label Stabilization)||0||
59747094|NCT00958568|75866211|FG001|STARTED|SPIII (Wk 9-20,Open-label Stabilization)||655||
59747095|NCT00958568|75866212|FG002|STARTED|SPIII (Wk 9-20,Open-label Stabilization)||0||
59747096|NCT00958568|75866213|FG003|STARTED|SPIII (Wk 9-20,Open-label Stabilization)||0||
59747097|NCT00958568|75866210|FG000|COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0||
59747098|NCT00958568|75866211|FG001|COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||444||
59747099|NCT00958568|75866212|FG002|COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0||
59747100|NCT00958568|75866213|FG003|COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0||
59747101|NCT00958568|75866210|FG000|NOT COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0||
59747102|NCT00958568|75866211|FG001|NOT COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||211||
59747103|NCT00958568|75866212|FG002|NOT COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0||
59747104|NCT00958568|75866213|FG003|NOT COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0||
59747105|NCT00958568|75866210|FG000|STARTED|SPIV (Wk 21-47, DB Relapse Prevention)||0||
59747106|NCT00958568|75866211|FG001|STARTED|SPIV (Wk 21-47, DB Relapse Prevention)||0||
59747107|NCT00958568|75866212|FG002|STARTED|SPIV (Wk 21-47, DB Relapse Prevention)||221||
59747108|NCT00958568|75866213|FG003|STARTED|SPIV (Wk 21-47, DB Relapse Prevention)||223||
59747109|NCT00958568|75866210|FG000|COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||0||
59747110|NCT00958568|75866211|FG001|COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||0||
59747111|NCT00958568|75866212|FG002|COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||139||
59747112|NCT00958568|75866213|FG003|COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||117||
59747113|NCT00958568|75866210|FG000|NOT COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||0||
59747114|NCT00958568|75866211|FG001|NOT COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||0||
59747115|NCT00958568|75866212|FG002|NOT COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||82||
59747116|NCT00958568|75866213|FG003|NOT COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||106||
59747117|NCT00958412|75866224|FG000|STARTED|Overall Study||18||
59747118|NCT00958412|75866224|FG000|COMPLETED|Overall Study||0||
59747119|NCT00958412|75866224|FG000|NOT COMPLETED|Overall Study||18||
59747120|NCT00958256|75866228|FG000|STARTED|Overall Study||21||
59747121|NCT00958256|75866228|FG000|COMPLETED|Overall Study||18||
59747122|NCT00958256|75866228|FG000|NOT COMPLETED|Overall Study||3||
59747123|NCT00696709|75866237|FG000|STARTED|Overall Study||65||
59747124|NCT00696709|75866238|FG001|STARTED|Overall Study||63||
59747125|NCT00696709|75866239|FG002|STARTED|Overall Study||33||
59747126|NCT00696709|75866240|FG003|STARTED|Overall Study||64||
59747127|NCT00696709|75866241|FG004|STARTED|Overall Study||65||
60135283|NCT03307252|76258161|FG008|STARTED|Part 3, Washout Period 1 (7 Days)||4||
60135284|NCT03307252|76258162|FG009|STARTED|Part 3, Washout Period 1 (7 Days)||4||
59747128|NCT00696709|75866237|FG000|Vaccination 1 (Day 1)|Overall Study||65||
59747129|NCT00696709|75866238|FG001|Vaccination 1 (Day 1)|Overall Study||63||
59747130|NCT00696709|75866239|FG002|Vaccination 1 (Day 1)|Overall Study||32||
59747131|NCT00696709|75866240|FG003|Vaccination 1 (Day 1)|Overall Study||64||
59747132|NCT00696709|75866241|FG004|Vaccination 1 (Day 1)|Overall Study||65||
59747133|NCT00696709|75866237|FG000|Vaccination 2 (~Day 30)|Overall Study||64||
59747134|NCT00696709|75866238|FG001|Vaccination 2 (~Day 30)|Overall Study||60||
59747135|NCT00696709|75866239|FG002|Vaccination 2 (~Day 30)|Overall Study||32||
59747136|NCT00696709|75866240|FG003|Vaccination 2 (~Day 30)|Overall Study||61||
59747137|NCT00696709|75866241|FG004|Vaccination 2 (~Day 30)|Overall Study||64||
59747138|NCT00696709|75866237|FG000|Vaccination 3 (~Day 60)|Overall Study||64||
59747139|NCT00696709|75866238|FG001|Vaccination 3 (~Day 60)|Overall Study||60||
59747140|NCT00696709|75866239|FG002|Vaccination 3 (~Day 60)|Overall Study||32||
59747141|NCT00696709|75866240|FG003|Vaccination 3 (~Day 60)|Overall Study||59||
59747142|NCT00696709|75866241|FG004|Vaccination 3 (~Day 60)|Overall Study||63||
59747143|NCT00696709|75866237|FG000|Vaccination 4 (~Day 90)|Overall Study||62||
59747144|NCT00696709|75866238|FG001|Vaccination 4 (~Day 90)|Overall Study||60||
59747145|NCT00696709|75866239|FG002|Vaccination 4 (~Day 90)|Overall Study||32||
59747146|NCT00696709|75866240|FG003|Vaccination 4 (~Day 90)|Overall Study||59||
59747147|NCT00696709|75866241|FG004|Vaccination 4 (~Day 90)|Overall Study||63||
59747148|NCT00696709|75866237|FG000|COMPLETED|Overall Study||62||
60135285|NCT03307252|76258163|FG010|STARTED|Part 3, Washout Period 1 (7 Days)||4||
59747149|NCT00696709|75866238|FG001|COMPLETED|Overall Study||60||
59747150|NCT00696709|75866239|FG002|COMPLETED|Overall Study||32||
59747151|NCT00696709|75866240|FG003|COMPLETED|Overall Study||59||
59747152|NCT00696709|75866241|FG004|COMPLETED|Overall Study||62||
59747153|NCT00696709|75866237|FG000|NOT COMPLETED|Overall Study||3||
59747154|NCT00696709|75866238|FG001|NOT COMPLETED|Overall Study||3||
59747155|NCT00696709|75866239|FG002|NOT COMPLETED|Overall Study||1||
59747156|NCT00696709|75866240|FG003|NOT COMPLETED|Overall Study||5||
59747157|NCT00696709|75866241|FG004|NOT COMPLETED|Overall Study||3||
59747158|NCT01006265|75866261|FG000|STARTED|Overall Study||119||
59747159|NCT01006265|75866262|FG001|STARTED|Overall Study||116||
59747160|NCT01006265|75866263|FG002|STARTED|Overall Study||108||
59747161|NCT01006265|75866264|FG003|STARTED|Overall Study||121||
59747162|NCT01006265|75866261|FG000|Treated|Overall Study||119||
59747163|NCT01006265|75866262|FG001|Treated|Overall Study||114||
59747164|NCT01006265|75866263|FG002|Treated|Overall Study||108||
59747165|NCT01006265|75866264|FG003|Treated|Overall Study||121||
59747166|NCT01006265|75866261|FG000|COMPLETED|Overall Study||113||
59747167|NCT01006265|75866262|FG001|COMPLETED|Overall Study||107||
59747168|NCT01006265|75866263|FG002|COMPLETED|Overall Study||99||
59747169|NCT01006265|75866264|FG003|COMPLETED|Overall Study||116||
59747170|NCT01006265|75866261|FG000|NOT COMPLETED|Overall Study||6||
59747171|NCT01006265|75866262|FG001|NOT COMPLETED|Overall Study||9||
59747172|NCT01006265|75866263|FG002|NOT COMPLETED|Overall Study||9||
59747173|NCT01006265|75866264|FG003|NOT COMPLETED|Overall Study||5||
59747174|NCT01008995|75866276|FG000|STARTED|Controlled Period||162||
59747175|NCT01008995|75866277|FG001|STARTED|Controlled Period||160||
59747176|NCT01008995|75866278|FG002|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0||
59747177|NCT01008995|75866279|FG003|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0||
59747178|NCT01008995|75866276|FG000|COMPLETED|Controlled Period||159||
59747179|NCT01008995|75866277|FG001|COMPLETED|Controlled Period||157||
59747180|NCT01008995|75866278|FG002|COMPLETED|Controlled Period||0||
59747181|NCT01008995|75866279|FG003|COMPLETED|Controlled Period||0||
59747182|NCT01008995|75866276|FG000|NOT COMPLETED|Controlled Period||3||
59747183|NCT01008995|75866277|FG001|NOT COMPLETED|Controlled Period||3||
59747184|NCT01008995|75866278|FG002|NOT COMPLETED|Controlled Period||0||
59747185|NCT01008995|75866279|FG003|NOT COMPLETED|Controlled Period||0||
59747186|NCT01008995|75866276|FG000|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0||
59747187|NCT01008995|75866277|FG001|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0||
59747188|NCT01008995|75866278|FG002|STARTED|After Controlled Period|1 placebo participant discontinued after completing the CP and did not receive ustekinumab 45 mg.|158||
59747189|NCT01008995|75866279|FG003|STARTED|After Controlled Period|2 participants discontinued in CP, had follow-up, and are among frequent and serious adverse events.|157||
59747190|NCT01008995|75866276|FG000|COMPLETED|After Controlled Period||0||
59747191|NCT01008995|75866277|FG001|COMPLETED|After Controlled Period||0||
59747192|NCT01008995|75866278|FG002|COMPLETED|After Controlled Period||156||
59747193|NCT01008995|75866279|FG003|COMPLETED|After Controlled Period||156||
59747194|NCT01008995|75866276|FG000|NOT COMPLETED|After Controlled Period||0||
59747195|NCT01008995|75866277|FG001|NOT COMPLETED|After Controlled Period||0||
59747196|NCT01008995|75866278|FG002|NOT COMPLETED|After Controlled Period||2||
59747197|NCT01008995|75866279|FG003|NOT COMPLETED|After Controlled Period||1||
59747198|NCT00957944|75866289|FG000|STARTED|First Intervention- 24 Hours||20||
59747199|NCT00957944|75866290|FG001|STARTED|First Intervention- 24 Hours||20||
59747200|NCT00957944|75866289|FG000|COMPLETED|First Intervention- 24 Hours||20||
59747201|NCT00957944|75866290|FG001|COMPLETED|First Intervention- 24 Hours||19||
59747202|NCT00957944|75866289|FG000|NOT COMPLETED|First Intervention- 24 Hours||0||
59747203|NCT00957944|75866290|FG001|NOT COMPLETED|First Intervention- 24 Hours||1||
59747204|NCT00957944|75866289|FG000|STARTED|Washout Period of at Least 5 Days||20||
59747205|NCT00957944|75866290|FG001|STARTED|Washout Period of at Least 5 Days||19||
59747206|NCT00957944|75866289|FG000|COMPLETED|Washout Period of at Least 5 Days||20||
59747207|NCT00957944|75866290|FG001|COMPLETED|Washout Period of at Least 5 Days||19||
59747208|NCT00957944|75866289|FG000|NOT COMPLETED|Washout Period of at Least 5 Days||0||
59747209|NCT00957944|75866290|FG001|NOT COMPLETED|Washout Period of at Least 5 Days||0||
59747210|NCT00957944|75866289|FG000|STARTED|Second Intervention- 24 Hours||20||
59747211|NCT00957944|75866290|FG001|STARTED|Second Intervention- 24 Hours||19||
59747212|NCT00957944|75866289|FG000|Pharmacokinetic Set (PKS)|Second Intervention- 24 Hours||20||
59747213|NCT00957944|75866290|FG001|Pharmacokinetic Set (PKS)|Second Intervention- 24 Hours|One subject that fullfilled predefined criteria for patch adhesiveness was excluded from the PKS|18||
59747214|NCT00957944|75866289|FG000|COMPLETED|Second Intervention- 24 Hours||20||
59747215|NCT00957944|75866290|FG001|COMPLETED|Second Intervention- 24 Hours||19||
59747216|NCT00957944|75866289|FG000|NOT COMPLETED|Second Intervention- 24 Hours||0||
59747217|NCT00957944|75866290|FG001|NOT COMPLETED|Second Intervention- 24 Hours||0||
59747218|NCT01005875|75866296|FG000|STARTED|Overall Study||5||
60135286|NCT03307252|76258153|FG000|COMPLETED|Part 3, Washout Period 1 (7 Days)||0||
60135287|NCT03307252|76258154|FG001|COMPLETED|Part 3, Washout Period 1 (7 Days)||0||
59747219|NCT01005875|75866296|FG000|COMPLETED|Overall Study||2||
59747220|NCT01005875|75866296|FG000|NOT COMPLETED|Overall Study||3||
59747221|NCT01005719|75866300|FG000|STARTED|Period 1||10||
59747222|NCT01005719|75866301|FG001|STARTED|Period 1||10||
59747223|NCT01005719|75866302|FG002|STARTED|Period 1||10||
59747224|NCT01005719|75866303|FG003|STARTED|Period 1||11||
59747225|NCT01005719|75866304|FG004|STARTED|Period 1||11||
59747226|NCT01005719|75866305|FG005|STARTED|Period 1||11||
59747227|NCT01005719|75866300|FG000|COMPLETED|Period 1||10||
59747228|NCT01005719|75866301|FG001|COMPLETED|Period 1||10||
59747229|NCT01005719|75866302|FG002|COMPLETED|Period 1||10||
59747230|NCT01005719|75866303|FG003|COMPLETED|Period 1||10||
59747231|NCT01005719|75866304|FG004|COMPLETED|Period 1||11||
59747232|NCT01005719|75866305|FG005|COMPLETED|Period 1||10||
59747233|NCT01005719|75866300|FG000|NOT COMPLETED|Period 1||0||
59747234|NCT01005719|75866301|FG001|NOT COMPLETED|Period 1||0||
59747235|NCT01005719|75866302|FG002|NOT COMPLETED|Period 1||0||
59604553|NCT02058498|75714826|FG000|STARTED|Overall Study||12||
59604554|NCT02058498|75714826|FG000|6 Weeks|Overall Study||8||
59604555|NCT02058498|75714826|FG000|COMPLETED|Overall Study||8||
59747236|NCT01005719|75866303|FG003|NOT COMPLETED|Period 1||1||
59747237|NCT01005719|75866304|FG004|NOT COMPLETED|Period 1||0||
59747238|NCT01005719|75866305|FG005|NOT COMPLETED|Period 1||1||
59747239|NCT01005719|75866300|FG000|STARTED|Period 2||10||
59747240|NCT01005719|75866301|FG001|STARTED|Period 2||10||
59747241|NCT01005719|75866302|FG002|STARTED|Period 2||10||
59747242|NCT01005719|75866303|FG003|STARTED|Period 2||10||
59747243|NCT01005719|75866304|FG004|STARTED|Period 2||11||
59747244|NCT01005719|75866305|FG005|STARTED|Period 2||10||
59747245|NCT01005719|75866300|FG000|COMPLETED|Period 2||10||
59747246|NCT01005719|75866301|FG001|COMPLETED|Period 2||10||
59747247|NCT01005719|75866302|FG002|COMPLETED|Period 2||10||
59747248|NCT01005719|75866303|FG003|COMPLETED|Period 2||10||
59747249|NCT01005719|75866304|FG004|COMPLETED|Period 2||10||
59747250|NCT01005719|75866305|FG005|COMPLETED|Period 2||9||
59747251|NCT01005719|75866300|FG000|NOT COMPLETED|Period 2||0||
59747252|NCT01005719|75866301|FG001|NOT COMPLETED|Period 2||0||
59747253|NCT01005719|75866302|FG002|NOT COMPLETED|Period 2||0||
59747254|NCT01005719|75866303|FG003|NOT COMPLETED|Period 2||0||
59747255|NCT01005719|75866304|FG004|NOT COMPLETED|Period 2||1||
59747256|NCT01005719|75866305|FG005|NOT COMPLETED|Period 2||1||
59747257|NCT01005719|75866300|FG000|STARTED|Period 3||10||
59747258|NCT01005719|75866301|FG001|STARTED|Period 3||10||
59747259|NCT01005719|75866302|FG002|STARTED|Period 3||10||
59604556|NCT02058498|75714826|FG000|NOT COMPLETED|Overall Study||4||
59604557|NCT02039778|75714830|FG000|STARTED|Overall Study||4||
59604558|NCT02039778|75714830|FG000|COMPLETED|Overall Study||0||
59604559|NCT02039778|75714830|FG000|NOT COMPLETED|Overall Study||4||
59747260|NCT01005719|75866303|FG003|STARTED|Period 3||10||
59747261|NCT01005719|75866304|FG004|STARTED|Period 3||10||
59747262|NCT01005719|75866305|FG005|STARTED|Period 3||9||
60002422|NCT04742283|76118315|FG000|STARTED|Overall Study||161||
60002423|NCT04742283|76118316|FG001|STARTED|Overall Study||162||
60002424|NCT04742283|76118315|FG000|COMPLETED|Overall Study||148||
60002425|NCT04742283|76118316|FG001|COMPLETED|Overall Study||158||
60002426|NCT04742283|76118315|FG000|NOT COMPLETED|Overall Study||13||
60002427|NCT04742283|76118316|FG001|NOT COMPLETED|Overall Study||4||
60002428|NCT01662999|76118328|FG000|STARTED|Period 1||7||
60002429|NCT01662999|76118329|FG001|STARTED|Period 1||7||
60002430|NCT01662999|76118330|FG002|STARTED|Period 1||7||
60002431|NCT01662999|76118331|FG003|STARTED|Period 1||7||
60002432|NCT01662999|76118332|FG004|STARTED|Period 1||7||
60002433|NCT01662999|76118333|FG005|STARTED|Period 1||7||
59604560|NCT02015754|75714834|FG000|STARTED|Overall Study|17 participants were consented, but 3 participants were screened out prior to treatment|14||
59604561|NCT02015754|75714834|FG000|Completed First TACE|Overall Study||14|Number of patients who completed the first treatment on protocol and included in analysis.|
59604562|NCT02015754|75714834|FG000|Completed First Clinical and Imaging|Overall Study|1 patient exited prior to follow-up|13|Participants completing this milestone will be analyzed for image response outcomes|
59604563|NCT02015754|75714834|FG000|COMPLETED|Overall Study||3|Participants who have completed all 24 weeks of treatment on trial|
59604564|NCT02015754|75714834|FG000|NOT COMPLETED|Overall Study||11||
59604565|NCT02015676|75714841|FG000|STARTED|Overall Study||15||
59604566|NCT02015676|75714842|FG001|STARTED|Overall Study||48||
59604567|NCT02015676|75714843|FG002|STARTED|Overall Study||6||
59604568|NCT02015676|75714841|FG000|COMPLETED|Overall Study||6||
59604569|NCT02015676|75714842|FG001|COMPLETED|Overall Study||14||
59604570|NCT02015676|75714843|FG002|COMPLETED|Overall Study||3||
59747263|NCT01005719|75866300|FG000|COMPLETED|Period 3||10||
59747264|NCT01005719|75866301|FG001|COMPLETED|Period 3||10||
59747265|NCT01005719|75866302|FG002|COMPLETED|Period 3||10||
59747266|NCT01005719|75866303|FG003|COMPLETED|Period 3||10||
59747267|NCT01005719|75866304|FG004|COMPLETED|Period 3||10||
59747268|NCT01005719|75866305|FG005|COMPLETED|Period 3||9||
59747269|NCT01005719|75866300|FG000|NOT COMPLETED|Period 3||0||
59747270|NCT01005719|75866301|FG001|NOT COMPLETED|Period 3||0||
60002434|NCT01662999|76118328|FG000|COMPLETED|Period 1||7||
60002435|NCT01662999|76118329|FG001|COMPLETED|Period 1||7||
60002436|NCT01662999|76118330|FG002|COMPLETED|Period 1||7||
59747271|NCT01005719|75866302|FG002|NOT COMPLETED|Period 3||0||
59747272|NCT01005719|75866303|FG003|NOT COMPLETED|Period 3||0||
59747273|NCT01005719|75866304|FG004|NOT COMPLETED|Period 3||0||
59747274|NCT01005719|75866305|FG005|NOT COMPLETED|Period 3||0||
59747275|NCT00953576|75866316|FG000|STARTED|Overall Study||6||
59747276|NCT00953576|75866317|FG001|STARTED|Overall Study||5||
59747277|NCT00953576|75866316|FG000|DLT Evaluable|Overall Study||3|Participants were DLT evaluable if they received 1 cycle of KHLAD and full dose ketoconazole (KHAD).|
59747278|NCT00953576|75866317|FG001|DLT Evaluable|Overall Study||5|Participants were DLT evaluable if they received 1 cycle of KHLAD and full dose ketoconazole (KHAD).|
59747279|NCT00953576|75866316|FG000|Treated|Overall Study||4||
59747280|NCT00953576|75866317|FG001|Treated|Overall Study||5||
59747281|NCT00953576|75866316|FG000|Pharmacokinetic (PK) Evaluable|Overall Study||4|Participants with pre- and post KHLAD day 28 samples.|
59747282|NCT00953576|75866317|FG001|Pharmacokinetic (PK) Evaluable|Overall Study||3|Participants with pre- and post KHLAD day 28 samples.|
59747283|NCT00953576|75866316|FG000|COMPLETED|Overall Study|One participant enrolled on dose level 1 did not receive full dose ketoconazole and was replaced.|4||
59747284|NCT00953576|75866317|FG001|COMPLETED|Overall Study||4||
59747285|NCT00953576|75866316|FG000|NOT COMPLETED|Overall Study||2||
59747286|NCT00953576|75866317|FG001|NOT COMPLETED|Overall Study||1||
59747287|NCT01005329|75866326|FG000|STARTED|Overall Study||34||
59747288|NCT01005329|75866326|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|30||
59747289|NCT01005329|75866326|FG000|NOT COMPLETED|Overall Study||4||
59747290|NCT01005251|75866336|FG000|STARTED|Overall Study||134||
59747291|NCT01005251|75866337|FG001|STARTED|Overall Study||125||
59747292|NCT01005251|75866338|FG002|STARTED|Overall Study||136||
59747293|NCT01005251|75866339|FG003|STARTED|Overall Study||126||
59747294|NCT01005251|75866340|FG004|STARTED|Overall Study||140||
59747295|NCT01005251|75866336|FG000|COMPLETED|Overall Study||121||
59747296|NCT01005251|75866337|FG001|COMPLETED|Overall Study||109||
59747297|NCT01005251|75866338|FG002|COMPLETED|Overall Study||114||
59747298|NCT01005251|75866339|FG003|COMPLETED|Overall Study||114||
59747299|NCT01005251|75866340|FG004|COMPLETED|Overall Study||122||
59747300|NCT01005251|75866336|FG000|NOT COMPLETED|Overall Study||13||
59747301|NCT01005251|75866337|FG001|NOT COMPLETED|Overall Study||16||
59747302|NCT01005251|75866338|FG002|NOT COMPLETED|Overall Study||22||
59747303|NCT01005251|75866339|FG003|NOT COMPLETED|Overall Study||12||
59747304|NCT01005251|75866340|FG004|NOT COMPLETED|Overall Study||18||
59747305|NCT03048578|75866354|FG000|STARTED|Overall Study||89||
59747306|NCT03048578|75866355|FG001|STARTED|Overall Study||43||
59747307|NCT03048578|75866354|FG000|COMPLETED|Overall Study||58||
59747308|NCT03048578|75866355|FG001|COMPLETED|Overall Study||23||
59747309|NCT03048578|75866354|FG000|NOT COMPLETED|Overall Study||31||
59747310|NCT03048578|75866355|FG001|NOT COMPLETED|Overall Study||20||
59747311|NCT01008449|75866363|FG000|STARTED|Overall Study||200||
59747312|NCT01008449|75866364|FG001|STARTED|Overall Study||198||
59747313|NCT01008449|75866363|FG000|COMPLETED|Overall Study||171||
59747314|NCT01008449|75866364|FG001|COMPLETED|Overall Study||179||
59747315|NCT01008449|75866363|FG000|NOT COMPLETED|Overall Study||29||
59747316|NCT01008449|75866364|FG001|NOT COMPLETED|Overall Study||19||
59747317|NCT00696241|75866375|FG000|STARTED|Overall Study||283||
59747318|NCT00696241|75866376|FG001|STARTED|Overall Study||283||
59747319|NCT00696241|75866377|FG002|STARTED|Overall Study||285||
59747320|NCT00696241|75866378|FG003|STARTED|Overall Study||282||
59747321|NCT00696241|75866379|FG004|STARTED|Overall Study||142||
59747322|NCT00696241|75866375|FG000|COMPLETED|Overall Study||259||
59747323|NCT00696241|75866376|FG001|COMPLETED|Overall Study||261||
59747324|NCT00696241|75866377|FG002|COMPLETED|Overall Study||261||
59747325|NCT00696241|75866378|FG003|COMPLETED|Overall Study||268||
59747326|NCT00696241|75866379|FG004|COMPLETED|Overall Study||130||
59747327|NCT00696241|75866375|FG000|NOT COMPLETED|Overall Study||24||
59747328|NCT00696241|75866376|FG001|NOT COMPLETED|Overall Study||22||
59747329|NCT00696241|75866377|FG002|NOT COMPLETED|Overall Study||24||
59747330|NCT00696241|75866378|FG003|NOT COMPLETED|Overall Study||14||
59747331|NCT00696241|75866379|FG004|NOT COMPLETED|Overall Study||12||
59747332|NCT00957008|75866395|FG000|STARTED|Overall Study||49||
59747333|NCT00957008|75866396|FG001|STARTED|Overall Study||49||
59747334|NCT00957008|75866397|FG002|STARTED|Overall Study||49||
59747335|NCT00957008|75866398|FG003|STARTED|Overall Study||50||
59747336|NCT00957008|75866395|FG000|COMPLETED|Overall Study||28||
59747337|NCT00957008|75866396|FG001|COMPLETED|Overall Study||37||
59747338|NCT00957008|75866397|FG002|COMPLETED|Overall Study||32||
59747339|NCT00957008|75866398|FG003|COMPLETED|Overall Study||26||
59747340|NCT00957008|75866395|FG000|NOT COMPLETED|Overall Study||21||
59747341|NCT00957008|75866396|FG001|NOT COMPLETED|Overall Study||12||
59747342|NCT00957008|75866397|FG002|NOT COMPLETED|Overall Study||17||
59747343|NCT00957008|75866398|FG003|NOT COMPLETED|Overall Study||24||
59747344|NCT00952484|75866415|FG000|STARTED|Overall Study||6||
59747345|NCT00952484|75866416|FG001|STARTED|Overall Study||7||
59747346|NCT00952484|75866417|FG002|STARTED|Overall Study||16||
59747347|NCT00952484|75866415|FG000|COMPLETED|Overall Study||6||
59747348|NCT00952484|75866416|FG001|COMPLETED|Overall Study||6||
59747349|NCT00952484|75866417|FG002|COMPLETED|Overall Study||16||
59747350|NCT00952484|75866415|FG000|NOT COMPLETED|Overall Study||0||
59747351|NCT00952484|75866416|FG001|NOT COMPLETED|Overall Study||1||
60135288|NCT03307252|76258155|FG002|COMPLETED|Part 3, Washout Period 1 (7 Days)||0||
60135289|NCT03307252|76258156|FG003|COMPLETED|Part 3, Washout Period 1 (7 Days)||0||
60135290|NCT03307252|76258157|FG004|COMPLETED|Part 3, Washout Period 1 (7 Days)||0||
59747352|NCT00952484|75866417|FG002|NOT COMPLETED|Overall Study||0||
59747353|NCT00689611|75866428|FG000|STARTED|Overall Study||200||
59747354|NCT00689611|75866429|FG001|STARTED|Overall Study||192||
59747355|NCT00689611|75866428|FG000|COMPLETED|Overall Study||159||
59747356|NCT00689611|75866429|FG001|COMPLETED|Overall Study||146||
59747357|NCT00689611|75866428|FG000|NOT COMPLETED|Overall Study||41||
59747358|NCT00689611|75866429|FG001|NOT COMPLETED|Overall Study||46||
59747359|NCT00689299|75866438|FG000|STARTED|Overall Study||58||
59747360|NCT00689299|75866439|FG001|STARTED|Overall Study||57||
59747361|NCT00689299|75866440|FG002|STARTED|Overall Study||54||
59747362|NCT00689299|75866438|FG000|COMPLETED|Overall Study||51||
59747363|NCT00689299|75866439|FG001|COMPLETED|Overall Study||54||
59747364|NCT00689299|75866440|FG002|COMPLETED|Overall Study||49||
59747365|NCT00689299|75866438|FG000|NOT COMPLETED|Overall Study||7||
59747366|NCT00689299|75866439|FG001|NOT COMPLETED|Overall Study||3||
59747367|NCT00689299|75866440|FG002|NOT COMPLETED|Overall Study||5||
59747368|NCT02506244|75866451|FG000|STARTED|Overall Study||1366||
59747369|NCT02506244|75866452|FG001|STARTED|Overall Study||1293||
59747370|NCT02506244|75866453|FG002|STARTED|Overall Study||3476||
59747371|NCT02506244|75866451|FG000|COMPLETED|Overall Study||908||
59747372|NCT02506244|75866452|FG001|COMPLETED|Overall Study||834||
59747373|NCT02506244|75866453|FG002|COMPLETED|Overall Study||3476||
59747374|NCT02506244|75866451|FG000|NOT COMPLETED|Overall Study||458||
59747375|NCT02506244|75866452|FG001|NOT COMPLETED|Overall Study||459||
59747376|NCT02506244|75866453|FG002|NOT COMPLETED|Overall Study||0||
59747377|NCT00948974|75866463|FG000|STARTED|Overall Study||40||
59747378|NCT00948974|75866464|FG001|STARTED|Overall Study||48||
59747379|NCT00948974|75866463|FG000|COMPLETED|Overall Study||17||
59747380|NCT00948974|75866464|FG001|COMPLETED|Overall Study||28||
59747381|NCT00948974|75866463|FG000|NOT COMPLETED|Overall Study||23||
59747382|NCT00948974|75866464|FG001|NOT COMPLETED|Overall Study||20||
59747383|NCT01007435|75866474|FG000|STARTED|Overall Study||289||
59747384|NCT01007435|75866475|FG001|STARTED|Overall Study||290||
59747385|NCT01007435|75866476|FG002|STARTED|Overall Study||291||
59747386|NCT01007435|75866477|FG003|STARTED|Overall Study||292||
59747387|NCT01007435|75866474|FG000|COMPLETED|Overall Study||226||
59747388|NCT01007435|75866475|FG001|COMPLETED|Overall Study||231||
59747389|NCT01007435|75866476|FG002|COMPLETED|Overall Study||227||
59747390|NCT01007435|75866477|FG003|COMPLETED|Overall Study||236||
59747391|NCT01007435|75866474|FG000|NOT COMPLETED|Overall Study||63||
59747392|NCT01007435|75866475|FG001|NOT COMPLETED|Overall Study||59||
59747393|NCT01007435|75866476|FG002|NOT COMPLETED|Overall Study||64||
59747394|NCT01007435|75866477|FG003|NOT COMPLETED|Overall Study||56||
59747395|NCT00948896|75866495|FG000|STARTED|Randomization to 24 Months of Age||98||
59747396|NCT00948896|75866496|FG001|STARTED|Randomization to 24 Months of Age||98||
59747397|NCT00948896|75866497|FG002|STARTED|Randomization to 24 Months of Age||99||
59747398|NCT00948896|75866498|FG003|STARTED|Randomization to 24 Months of Age||98||
59747399|NCT00948896|75866499|FG004|STARTED|Randomization to 24 Months of Age||46||
59747400|NCT00948896|75866500|FG005|STARTED|Randomization to 24 Months of Age||46||
59747401|NCT00948896|75866501|FG006|STARTED|Randomization to 24 Months of Age||47||
59747402|NCT00948896|75866502|FG007|STARTED|Randomization to 24 Months of Age||47||
59747403|NCT00948896|75866495|FG000|COMPLETED|Randomization to 24 Months of Age||90||
59747404|NCT00948896|75866496|FG001|COMPLETED|Randomization to 24 Months of Age||85||
59747405|NCT00948896|75866497|FG002|COMPLETED|Randomization to 24 Months of Age||90||
59747406|NCT00948896|75866498|FG003|COMPLETED|Randomization to 24 Months of Age||87||
59747407|NCT00948896|75866499|FG004|COMPLETED|Randomization to 24 Months of Age||44||
59747408|NCT00948896|75866500|FG005|COMPLETED|Randomization to 24 Months of Age||42||
59873078|NCT03496298|75997211|FG000|NOT COMPLETED|Overall Study||1317||
59873079|NCT03496298|75997212|FG001|NOT COMPLETED|Overall Study||1323||
60135291|NCT03307252|76258158|FG005|COMPLETED|Part 3, Washout Period 1 (7 Days)||0||
60135292|NCT03307252|76258159|FG006|COMPLETED|Part 3, Washout Period 1 (7 Days)||0||
59747409|NCT00948896|75866501|FG006|COMPLETED|Randomization to 24 Months of Age||43||
59747410|NCT00948896|75866502|FG007|COMPLETED|Randomization to 24 Months of Age||45||
59747411|NCT00948896|75866495|FG000|NOT COMPLETED|Randomization to 24 Months of Age||8||
59747412|NCT00948896|75866496|FG001|NOT COMPLETED|Randomization to 24 Months of Age||13||
59747413|NCT00948896|75866497|FG002|NOT COMPLETED|Randomization to 24 Months of Age||9||
59747414|NCT00948896|75866498|FG003|NOT COMPLETED|Randomization to 24 Months of Age||11||
59747415|NCT00948896|75866499|FG004|NOT COMPLETED|Randomization to 24 Months of Age||2||
59747416|NCT00948896|75866500|FG005|NOT COMPLETED|Randomization to 24 Months of Age||4||
59747417|NCT00948896|75866501|FG006|NOT COMPLETED|Randomization to 24 Months of Age||4||
59747418|NCT00948896|75866502|FG007|NOT COMPLETED|Randomization to 24 Months of Age||2||
59747419|NCT00948896|75866495|FG000|STARTED|24 Months of Age to 36 Months of Age||90||
59873080|NCT03496298|75997213|FG002|NOT COMPLETED|Overall Study||1335||
59747420|NCT00948896|75866496|FG001|STARTED|24 Months of Age to 36 Months of Age||85||
59747421|NCT00948896|75866497|FG002|STARTED|24 Months of Age to 36 Months of Age||90||
59747422|NCT00948896|75866498|FG003|STARTED|24 Months of Age to 36 Months of Age||87||
59747423|NCT00948896|75866499|FG004|STARTED|24 Months of Age to 36 Months of Age||44||
59747424|NCT00948896|75866500|FG005|STARTED|24 Months of Age to 36 Months of Age||42||
59747425|NCT00948896|75866501|FG006|STARTED|24 Months of Age to 36 Months of Age||43||
59747426|NCT00948896|75866502|FG007|STARTED|24 Months of Age to 36 Months of Age||45||
59747427|NCT00948896|75866495|FG000|COMPLETED|24 Months of Age to 36 Months of Age||87||
59747428|NCT00948896|75866496|FG001|COMPLETED|24 Months of Age to 36 Months of Age||83||
59747429|NCT00948896|75866497|FG002|COMPLETED|24 Months of Age to 36 Months of Age||85||
59747430|NCT00948896|75866498|FG003|COMPLETED|24 Months of Age to 36 Months of Age||85||
59747431|NCT00948896|75866499|FG004|COMPLETED|24 Months of Age to 36 Months of Age||43||
59747432|NCT00948896|75866500|FG005|COMPLETED|24 Months of Age to 36 Months of Age||40||
59747433|NCT00948896|75866501|FG006|COMPLETED|24 Months of Age to 36 Months of Age||43||
59747434|NCT00948896|75866502|FG007|COMPLETED|24 Months of Age to 36 Months of Age||45||
59747435|NCT00948896|75866495|FG000|NOT COMPLETED|24 Months of Age to 36 Months of Age||3||
59747436|NCT00948896|75866496|FG001|NOT COMPLETED|24 Months of Age to 36 Months of Age||2||
59747437|NCT00948896|75866497|FG002|NOT COMPLETED|24 Months of Age to 36 Months of Age||5||
59747438|NCT00948896|75866498|FG003|NOT COMPLETED|24 Months of Age to 36 Months of Age||2||
59747439|NCT00948896|75866499|FG004|NOT COMPLETED|24 Months of Age to 36 Months of Age||1||
59747440|NCT00948896|75866500|FG005|NOT COMPLETED|24 Months of Age to 36 Months of Age||2||
59747441|NCT00948896|75866501|FG006|NOT COMPLETED|24 Months of Age to 36 Months of Age||0||
59747442|NCT00948896|75866502|FG007|NOT COMPLETED|24 Months of Age to 36 Months of Age||0||
59747443|NCT01004159|75866524|FG000|STARTED|Overall Study||20||
59747444|NCT01004159|75866524|FG000|COMPLETED|Overall Study||0||
59747445|NCT01004159|75866524|FG000|NOT COMPLETED|Overall Study||20||
59747446|NCT00948818|75866530|FG000|STARTED|Overall Study||397||
59747447|NCT00948818|75866531|FG001|STARTED|Overall Study||406||
59747448|NCT00948818|75866530|FG000|COMPLETED|Overall Study||335||
59747449|NCT00948818|75866531|FG001|COMPLETED|Overall Study||312||
59747450|NCT00948818|75866530|FG000|NOT COMPLETED|Overall Study||62||
59747451|NCT00948818|75866531|FG001|NOT COMPLETED|Overall Study||94||
59747452|NCT00948506|75866542|FG000|STARTED|Overall Study||11||
59747453|NCT00948506|75866543|FG001|STARTED|Overall Study||9||
59747454|NCT00948506|75866542|FG000|COMPLETED|Overall Study||8||
59747455|NCT00948506|75866543|FG001|COMPLETED|Overall Study||8||
59747456|NCT00948506|75866542|FG000|NOT COMPLETED|Overall Study||3||
59747457|NCT00948506|75866543|FG001|NOT COMPLETED|Overall Study||1||
59747458|NCT00955682|75866554|FG000|STARTED|Year 2 Period||253||
59747459|NCT00955682|75866555|FG001|STARTED|Year 2 Period||42||
59747460|NCT00955682|75866554|FG000|COMPLETED|Year 2 Period||253||
59747461|NCT00955682|75866555|FG001|COMPLETED|Year 2 Period||42||
59747462|NCT00955682|75866554|FG000|NOT COMPLETED|Year 2 Period||0||
59747463|NCT00955682|75866555|FG001|NOT COMPLETED|Year 2 Period||0||
59747464|NCT00955682|75866554|FG000|STARTED|Year 3 Period||273||
59747465|NCT00955682|75866555|FG001|STARTED|Year 3 Period||47||
59747466|NCT00955682|75866554|FG000|COMPLETED|Year 3 Period||273||
59747467|NCT00955682|75866555|FG001|COMPLETED|Year 3 Period||47||
59747468|NCT00955682|75866554|FG000|NOT COMPLETED|Year 3 Period||0||
59747469|NCT00955682|75866555|FG001|NOT COMPLETED|Year 3 Period||0||
59747470|NCT00955682|75866554|FG000|STARTED|Year 4 Period||246||
59747471|NCT00955682|75866555|FG001|STARTED|Year 4 Period||48||
59747472|NCT00955682|75866554|FG000|COMPLETED|Year 4 Period||246||
59747473|NCT00955682|75866555|FG001|COMPLETED|Year 4 Period||48||
59747474|NCT00955682|75866554|FG000|NOT COMPLETED|Year 4 Period||0||
59747475|NCT00955682|75866555|FG001|NOT COMPLETED|Year 4 Period||0||
59747476|NCT00955682|75866554|FG000|STARTED|Booster Period (Month 48- 49)||245||
59747477|NCT00955682|75866555|FG001|STARTED|Booster Period (Month 48- 49)||48||
59747478|NCT00955682|75866554|FG000|COMPLETED|Booster Period (Month 48- 49)||244||
59747479|NCT00955682|75866555|FG001|COMPLETED|Booster Period (Month 48- 49)||47||
59747480|NCT00955682|75866554|FG000|NOT COMPLETED|Booster Period (Month 48- 49)||1||
59747481|NCT00955682|75866555|FG001|NOT COMPLETED|Booster Period (Month 48- 49)||1||
59747482|NCT00955682|75866554|FG000|STARTED|Year 5 Period||239||
59747483|NCT00955682|75866555|FG001|STARTED|Year 5 Period||47||
59747484|NCT00955682|75866554|FG000|COMPLETED|Year 5 Period||239||
59747485|NCT00955682|75866555|FG001|COMPLETED|Year 5 Period||47||
59747486|NCT00955682|75866554|FG000|NOT COMPLETED|Year 5 Period||0||
59747487|NCT00955682|75866555|FG001|NOT COMPLETED|Year 5 Period||0||
59747488|NCT00689221|75866571|FG000|STARTED|Overall Study||272||
59747489|NCT00689221|75866572|FG001|STARTED|Overall Study||273||
59747490|NCT00689221|75866571|FG000|COMPLETED|Overall Study||233||
59747491|NCT00689221|75866572|FG001|COMPLETED|Overall Study||237||
59747492|NCT00689221|75866571|FG000|NOT COMPLETED|Overall Study||39||
59747493|NCT00689221|75866572|FG001|NOT COMPLETED|Overall Study||36||
59747494|NCT01875445|75866580|FG000|STARTED|Overall Study||19||
59747495|NCT01875445|75866581|FG001|STARTED|Overall Study||19||
59747496|NCT01875445|75866580|FG000|COMPLETED|Overall Study||12||
59747497|NCT01875445|75866581|FG001|COMPLETED|Overall Study||19||
59747498|NCT01875445|75866580|FG000|NOT COMPLETED|Overall Study||7||
59747499|NCT01875445|75866581|FG001|NOT COMPLETED|Overall Study||0||
59747500|NCT00688909|75866587|FG000|STARTED|Overall Study||261||
59747501|NCT00688909|75866587|FG000|COMPLETED|Overall Study||228||
59747502|NCT00688909|75866587|FG000|NOT COMPLETED|Overall Study||33||
59747503|NCT00948428|75866595|FG000|STARTED|Overall Study||185||
59747504|NCT00948428|75866596|FG001|STARTED|Overall Study||185||
59747505|NCT00948428|75866597|FG002|STARTED|Overall Study||92||
59747506|NCT00948428|75866595|FG000|COMPLETED|Overall Study||167||
59747507|NCT00948428|75866596|FG001|COMPLETED|Overall Study||167||
59747508|NCT00948428|75866597|FG002|COMPLETED|Overall Study||84||
59747509|NCT00948428|75866595|FG000|NOT COMPLETED|Overall Study||18||
59747510|NCT00948428|75866596|FG001|NOT COMPLETED|Overall Study||18||
59747511|NCT00948428|75866597|FG002|NOT COMPLETED|Overall Study||8||
59747512|NCT00948194|75866607|FG000|STARTED|Overall Study||6||
59747513|NCT00948194|75866608|FG001|STARTED|Overall Study||7||
59747514|NCT00948194|75866607|FG000|COMPLETED|Overall Study||5||
59747515|NCT00948194|75866608|FG001|COMPLETED|Overall Study||7||
59747516|NCT00948194|75866607|FG000|NOT COMPLETED|Overall Study||1||
59747517|NCT00948194|75866608|FG001|NOT COMPLETED|Overall Study||0||
59747518|NCT00691483|75866616|FG000|STARTED|Overall Study||493||
59747519|NCT00691483|75866617|FG001|STARTED|Overall Study||166||
59747520|NCT00691483|75866616|FG000|Received Treatment|Overall Study||486||
59747521|NCT00691483|75866617|FG001|Received Treatment|Overall Study||165||
59747522|NCT00691483|75866616|FG000|COMPLETED|Overall Study|Completed refers to completion of the study.|425||
59747523|NCT00691483|75866617|FG001|COMPLETED|Overall Study||141||
59747524|NCT00691483|75866616|FG000|NOT COMPLETED|Overall Study||68||
59747525|NCT00691483|75866617|FG001|NOT COMPLETED|Overall Study||25||
59747526|NCT00691093|75866623|FG000|STARTED|Overall Study||823||
59747527|NCT00691093|75866623|FG000|COMPLETED|Overall Study||816||
60135293|NCT03307252|76258160|FG007|COMPLETED|Part 3, Washout Period 1 (7 Days)||4||
60135294|NCT03307252|76258161|FG008|COMPLETED|Part 3, Washout Period 1 (7 Days)||4||
60135295|NCT03307252|76258162|FG009|COMPLETED|Part 3, Washout Period 1 (7 Days)||4||
60135296|NCT03307252|76258163|FG010|COMPLETED|Part 3, Washout Period 1 (7 Days)||4||
60135297|NCT03307252|76258153|FG000|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0||
60135298|NCT03307252|76258154|FG001|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0||
60135299|NCT03307252|76258155|FG002|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0||
60135300|NCT03307252|76258156|FG003|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0||
60135301|NCT03307252|76258157|FG004|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0||
60135302|NCT03307252|76258158|FG005|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0||
60135303|NCT03307252|76258159|FG006|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0||
60135304|NCT03307252|76258160|FG007|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0||
60135305|NCT03307252|76258161|FG008|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0||
60135306|NCT03307252|76258162|FG009|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0||
60135307|NCT03307252|76258163|FG010|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0||
60135308|NCT03307252|76258153|FG000|STARTED|Part 3, Period 2||0||
60135309|NCT03307252|76258154|FG001|STARTED|Part 3, Period 2||0||
60135310|NCT03307252|76258155|FG002|STARTED|Part 3, Period 2||0||
59747528|NCT00691093|75866623|FG000|NOT COMPLETED|Overall Study||7||
59747529|NCT00947882|75866636|FG000|STARTED|Overall Study|Started: Randomised.|100||
59747530|NCT00947882|75866637|FG001|STARTED|Overall Study||101||
59747531|NCT00947882|75866638|FG002|STARTED|Overall Study||101||
59747532|NCT00947882|75866639|FG003|STARTED|Overall Study||102||
59747533|NCT00947882|75866636|FG000|Full Analysis Set (FAS)|Overall Study|FAS: Received a dose of IMP and completed at least one post-baseline IPSS questionnaire.|100||
59747534|NCT00947882|75866637|FG001|Full Analysis Set (FAS)|Overall Study||101||
59747535|NCT00947882|75866638|FG002|Full Analysis Set (FAS)|Overall Study|1 patient received 20 mg degarelix but had no post-baseline IPSS value and was excluded from the FAS|100||
59747536|NCT00947882|75866639|FG003|Full Analysis Set (FAS)|Overall Study||102||
59747537|NCT00947882|75866636|FG000|Actual Treatment|Overall Study|2 placebo patients received 30 mg degarelix|98||
59747538|NCT00947882|75866637|FG001|Actual Treatment|Overall Study||101||
59747539|NCT00947882|75866638|FG002|Actual Treatment|Overall Study|1 patient randomised to 20 mg degarelix received 30 mg degarelix|100||
59747540|NCT00947882|75866639|FG003|Actual Treatment|Overall Study||105||
59747541|NCT00947882|75866636|FG000|Safety Analysis Set|Overall Study|Safety Analysis Set: Received a dose of Investigational Medicinal Product (IMP).|98||
60135311|NCT03307252|76258156|FG003|STARTED|Part 3, Period 2||0||
60135312|NCT03307252|76258157|FG004|STARTED|Part 3, Period 2||0||
60135313|NCT03307252|76258158|FG005|STARTED|Part 3, Period 2||0||
59747542|NCT00947882|75866637|FG001|Safety Analysis Set|Overall Study||101||
59747543|NCT00947882|75866638|FG002|Safety Analysis Set|Overall Study||100||
59747544|NCT00947882|75866639|FG003|Safety Analysis Set|Overall Study||105||
59950745|NCT03308058|76069587|FG001|STARTED|Overall Study||23||
59747545|NCT00947882|75866636|FG000|Visit 12, Month 6|Overall Study|The trial was stopped when all patients had completed Visit 12, scheduled 6 months after the dosing.|93||
59747546|NCT00947882|75866637|FG001|Visit 12, Month 6|Overall Study||91||
59747547|NCT00947882|75866638|FG002|Visit 12, Month 6|Overall Study||90||
59747548|NCT00947882|75866639|FG003|Visit 12, Month 6|Overall Study||95||
59747549|NCT00947882|75866636|FG000|COMPLETED|Overall Study|End of Trial, Month 12: Patients who had completed the 12-month period when the trial was stopped.|26||
59747550|NCT00947882|75866637|FG001|COMPLETED|Overall Study||24||
59747551|NCT00947882|75866638|FG002|COMPLETED|Overall Study||22||
59747552|NCT00947882|75866639|FG003|COMPLETED|Overall Study||20||
59747553|NCT00947882|75866636|FG000|NOT COMPLETED|Overall Study||74||
59747554|NCT00947882|75866637|FG001|NOT COMPLETED|Overall Study||77||
59747555|NCT00947882|75866638|FG002|NOT COMPLETED|Overall Study||79||
59747556|NCT00947882|75866639|FG003|NOT COMPLETED|Overall Study||82||
59747557|NCT00688753|75866650|FG000|STARTED|Overall Study||92||
59747558|NCT00688753|75866650|FG000|COMPLETED|Overall Study||0||
59747559|NCT00688753|75866650|FG000|NOT COMPLETED|Overall Study||92||
59747560|NCT00951080|75866656|FG000|STARTED|Overall Study||64||
59747561|NCT00951080|75866657|FG001|STARTED|Overall Study||68||
59873081|NCT02914522|75997226|FG000|STARTED|Induction Study: Up to Week 11||245||
59873082|NCT02914522|75997227|FG001|STARTED|Induction Study: Up to Week 11||278||
59873083|NCT02914522|75997228|FG002|STARTED|Induction Study: Up to Week 11||137||
59873084|NCT02914522|75997229|FG003|STARTED|Induction Study: Up to Week 11||262||
59873085|NCT02914522|75997230|FG004|STARTED|Induction Study: Up to Week 11||286||
59873086|NCT02914522|75997231|FG005|STARTED|Induction Study: Up to Week 11||143||
59873087|NCT02914522|75997232|FG006|STARTED|Induction Study: Up to Week 11||0||
59873088|NCT02914522|75997233|FG007|STARTED|Induction Study: Up to Week 11||0||
59873089|NCT02914522|75997234|FG008|STARTED|Induction Study: Up to Week 11||0||
59873090|NCT02914522|75997235|FG009|STARTED|Induction Study: Up to Week 11||0||
59873091|NCT02914522|75997236|FG010|STARTED|Induction Study: Up to Week 11||0||
59873092|NCT02914522|75997226|FG000|COMPLETED|Induction Study: Up to Week 11||235||
59873093|NCT02914522|75997227|FG001|COMPLETED|Induction Study: Up to Week 11||256||
59873094|NCT02914522|75997228|FG002|COMPLETED|Induction Study: Up to Week 11||127||
59873095|NCT02914522|75997229|FG003|COMPLETED|Induction Study: Up to Week 11||234||
59747562|NCT00951080|75866656|FG000|COMPLETED|Overall Study||38||
59747563|NCT00951080|75866657|FG001|COMPLETED|Overall Study||41||
59747564|NCT00951080|75866656|FG000|NOT COMPLETED|Overall Study||26||
59747565|NCT00951080|75866657|FG001|NOT COMPLETED|Overall Study||27||
59747566|NCT00946322|75866663|FG000|STARTED|Pre-treatment||12||
59873096|NCT02914522|75997230|FG004|COMPLETED|Induction Study: Up to Week 11||262||
59873097|NCT02914522|75997231|FG005|COMPLETED|Induction Study: Up to Week 11||127||
59873098|NCT02914522|75997232|FG006|COMPLETED|Induction Study: Up to Week 11||0||
59747567|NCT00946322|75866663|FG000|COMPLETED|Pre-treatment||11||
59747568|NCT00946322|75866663|FG000|NOT COMPLETED|Pre-treatment||1||
59747569|NCT00946322|75866663|FG000|STARTED|Post-treatment||11||
59747570|NCT00946322|75866663|FG000|COMPLETED|Post-treatment||9||
59747571|NCT00946322|75866663|FG000|NOT COMPLETED|Post-treatment||2||
59747572|NCT00950690|75866667|FG000|STARTED|Overall Study||1349||
59747573|NCT00950690|75866667|FG000|COMPLETED|Overall Study||1105||
59747574|NCT00950690|75866667|FG000|NOT COMPLETED|Overall Study||244||
59747575|NCT00694369|75866676|FG000|STARTED|Overall Study||46||
59747576|NCT00694369|75866677|FG001|STARTED|Overall Study||191||
59747577|NCT00694369|75866678|FG002|STARTED|Overall Study||97||
59747578|NCT00694369|75866679|FG003|STARTED|Overall Study||192||
59747579|NCT00694369|75866680|FG004|STARTED|Overall Study||62||
59747580|NCT00694369|75866676|FG000|COMPLETED|Overall Study||45||
59747581|NCT00694369|75866677|FG001|COMPLETED|Overall Study||188||
59747582|NCT00694369|75866678|FG002|COMPLETED|Overall Study||95||
59747583|NCT00694369|75866679|FG003|COMPLETED|Overall Study||189||
59747584|NCT00694369|75866680|FG004|COMPLETED|Overall Study||56||
59747585|NCT00694369|75866676|FG000|NOT COMPLETED|Overall Study||1||
59747586|NCT00694369|75866677|FG001|NOT COMPLETED|Overall Study||3||
59747587|NCT00694369|75866678|FG002|NOT COMPLETED|Overall Study||2||
59747588|NCT00694369|75866679|FG003|NOT COMPLETED|Overall Study||3||
59747589|NCT00694369|75866680|FG004|NOT COMPLETED|Overall Study||6||
59747590|NCT00513019|75866694|FG000|STARTED|Overall Study||17||
59747591|NCT00513019|75866695|FG001|STARTED|Overall Study||18||
59747592|NCT00513019|75866694|FG000|COMPLETED|Overall Study||12||
59747593|NCT00513019|75866695|FG001|COMPLETED|Overall Study||13||
59747594|NCT00513019|75866694|FG000|NOT COMPLETED|Overall Study||5||
59747595|NCT00513019|75866695|FG001|NOT COMPLETED|Overall Study||5||
59747596|NCT00053677|75866703|FG000|STARTED|Overall Study||58||
59747597|NCT00053677|75866704|FG001|STARTED|Overall Study||19||
59747598|NCT00053677|75866703|FG000|COMPLETED|Overall Study||36||
59747599|NCT00053677|75866704|FG001|COMPLETED|Overall Study||13||
59747600|NCT00053677|75866703|FG000|NOT COMPLETED|Overall Study||22||
59747601|NCT00053677|75866704|FG001|NOT COMPLETED|Overall Study||6||
59873099|NCT02914522|75997233|FG007|COMPLETED|Induction Study: Up to Week 11||0||
59873100|NCT02914522|75997234|FG008|COMPLETED|Induction Study: Up to Week 11||0||
59873101|NCT02914522|75997235|FG009|COMPLETED|Induction Study: Up to Week 11||0||
59873102|NCT02914522|75997236|FG010|COMPLETED|Induction Study: Up to Week 11||0||
59950746|NCT03308058|76069586|FG000|COMPLETED|Overall Study||23||
59747602|NCT00954512|75866716|FG000|STARTED|Overall Study||2||
59747603|NCT00954512|75866717|FG001|STARTED|Overall Study||3||
59747604|NCT00954512|75866718|FG002|STARTED|Overall Study||0||
59747605|NCT00954512|75866719|FG003|STARTED|Overall Study||2||
59747606|NCT00954512|75866720|FG004|STARTED|Overall Study||4||
59747607|NCT00954512|75866721|FG005|STARTED|Overall Study||4||
59747608|NCT00954512|75866716|FG000|COMPLETED|Overall Study||0||
59747609|NCT00954512|75866717|FG001|COMPLETED|Overall Study||0||
59747610|NCT00954512|75866718|FG002|COMPLETED|Overall Study||0||
59747611|NCT00954512|75866719|FG003|COMPLETED|Overall Study||0||
59747612|NCT00954512|75866720|FG004|COMPLETED|Overall Study||0||
59747613|NCT00954512|75866721|FG005|COMPLETED|Overall Study||0||
59747614|NCT00954512|75866716|FG000|NOT COMPLETED|Overall Study||2||
59747615|NCT00954512|75866717|FG001|NOT COMPLETED|Overall Study||3||
59747616|NCT00954512|75866718|FG002|NOT COMPLETED|Overall Study||0||
59747617|NCT00954512|75866719|FG003|NOT COMPLETED|Overall Study||2||
59747618|NCT00954512|75866720|FG004|NOT COMPLETED|Overall Study||4||
59747619|NCT00954512|75866721|FG005|NOT COMPLETED|Overall Study||4||
59747620|NCT00691015|75866734|FG000|STARTED|Overall Study||48||
59747621|NCT00691015|75866734|FG000|COMPLETED|Overall Study||47||
59747622|NCT00691015|75866734|FG000|NOT COMPLETED|Overall Study||1||
59747623|NCT00950300|75866740|FG000|STARTED|Neoadjuvant/Adjuvant Treatment Periods||299||
59747624|NCT00950300|75866741|FG001|STARTED|Neoadjuvant/Adjuvant Treatment Periods||297||
59747625|NCT00950300|75866740|FG000|Received Neoadjuvant Treatment|Neoadjuvant/Adjuvant Treatment Periods||298||
59747626|NCT00950300|75866741|FG001|Received Neoadjuvant Treatment|Neoadjuvant/Adjuvant Treatment Periods||297||
59747627|NCT00950300|75866740|FG000|Underwent Surgery|Neoadjuvant/Adjuvant Treatment Periods||277||
59747628|NCT00950300|75866741|FG001|Underwent Surgery|Neoadjuvant/Adjuvant Treatment Periods||273||
59747629|NCT00950300|75866740|FG000|Entered Adjuvant Treatment|Neoadjuvant/Adjuvant Treatment Periods||277||
59747630|NCT00950300|75866741|FG001|Entered Adjuvant Treatment|Neoadjuvant/Adjuvant Treatment Periods||274||
59747631|NCT00950300|75866740|FG000|COMPLETED|Neoadjuvant/Adjuvant Treatment Periods||257||
59747632|NCT00950300|75866741|FG001|COMPLETED|Neoadjuvant/Adjuvant Treatment Periods||255||
59747633|NCT00950300|75866740|FG000|NOT COMPLETED|Neoadjuvant/Adjuvant Treatment Periods||42||
59747634|NCT00950300|75866741|FG001|NOT COMPLETED|Neoadjuvant/Adjuvant Treatment Periods||42||
59747635|NCT00950300|75866740|FG000|STARTED|TFFU Period|Participants could withdraw from the study entirely or advance directly to the TFFU or SFU Period.|265||
59747636|NCT00950300|75866741|FG001|STARTED|TFFU Period|Participants could withdraw from the study entirely or advance directly to the TFFU or SFU Period.|268||
59747637|NCT00950300|75866740|FG000|COMPLETED|TFFU Period|Includes participants who completed either 2 years of follow-up or 5 years of follow-up.|165||
59747638|NCT00950300|75866741|FG001|COMPLETED|TFFU Period|Includes participants who completed either 2 years of follow-up or 5 years of follow-up.|161||
59747639|NCT00950300|75866740|FG000|NOT COMPLETED|TFFU Period||100||
59747640|NCT00950300|75866741|FG001|NOT COMPLETED|TFFU Period||107||
59747641|NCT00950300|75866740|FG000|STARTED|SFU Period|Participants could withdraw from the study entirely or advance directly to the SFU Period.|118||
59747642|NCT00950300|75866741|FG001|STARTED|SFU Period|Participants could withdraw from the study entirely or advance directly to the SFU Period.|123||
59747643|NCT00950300|75866740|FG000|COMPLETED|SFU Period|Includes participants who completed either 2 years of follow-up or 5 years of follow-up.|40||
59747644|NCT00950300|75866741|FG001|COMPLETED|SFU Period|Includes participants who completed either 2 years of follow-up or 5 years of follow-up.|45||
59747645|NCT00950300|75866740|FG000|NOT COMPLETED|SFU Period||78||
59747646|NCT00950300|75866741|FG001|NOT COMPLETED|SFU Period||78||
59747647|NCT00949988|75866748|FG000|STARTED|Overall Study||3||
59747648|NCT00949988|75866748|FG000|COMPLETED|Overall Study||0||
59747649|NCT00949988|75866748|FG000|NOT COMPLETED|Overall Study||3||
59747650|NCT00731692|75866755|FG000|STARTED|Core Study (36 Months)||147||
59747651|NCT00731692|75866756|FG001|STARTED|Core Study (36 Months)||336||
59747652|NCT00731692|75866757|FG002|STARTED|Core Study (36 Months)||487||
59747653|NCT00731692|75866755|FG000|Safety Set (SAF)|Core Study (36 Months)||0||
59747654|NCT00731692|75866756|FG001|Safety Set (SAF)|Core Study (36 Months)||336||
59747655|NCT00731692|75866757|FG002|Safety Set (SAF)|Core Study (36 Months)||487||
59747656|NCT00731692|75866755|FG000|Full Analysis Set (FAS)|Core Study (36 Months)||0||
59747657|NCT00731692|75866756|FG001|Full Analysis Set (FAS)|Core Study (36 Months)||336||
59747658|NCT00731692|75866757|FG002|Full Analysis Set (FAS)|Core Study (36 Months)||487||
59747659|NCT00731692|75866755|FG000|Pharmacokinetic Analysis Set|Core Study (36 Months)||102||
59747660|NCT00731692|75866756|FG001|Pharmacokinetic Analysis Set|Core Study (36 Months)||249||
59747661|NCT00731692|75866757|FG002|Pharmacokinetic Analysis Set|Core Study (36 Months)||0||
59747662|NCT00731692|75866755|FG000|Post Protocol Amendment 5 Switch|Core Study (36 Months)||0||
59747663|NCT00731692|75866756|FG001|Post Protocol Amendment 5 Switch|Core Study (36 Months)|post protocol amendment 121 patients switch to 0.5 mg dose from 125mg dose|121||
59747664|NCT00731692|75866757|FG002|Post Protocol Amendment 5 Switch|Core Study (36 Months)||0||
59747665|NCT00731692|75866755|FG000|COMPLETED|Core Study (36 Months)||79||
59747666|NCT00731692|75866756|FG001|COMPLETED|Core Study (36 Months)||220||
59747667|NCT00731692|75866757|FG002|COMPLETED|Core Study (36 Months)||317||
59747668|NCT00731692|75866755|FG000|NOT COMPLETED|Core Study (36 Months)||68||
59747669|NCT00731692|75866756|FG001|NOT COMPLETED|Core Study (36 Months)||116||
59747670|NCT00731692|75866757|FG002|NOT COMPLETED|Core Study (36 Months)||170||
59747671|NCT00731692|75866755|FG000|STARTED|Extension Phase||74||
59747672|NCT00731692|75866756|FG001|STARTED|Extension Phase||196||
59747673|NCT00731692|75866757|FG002|STARTED|Extension Phase||301||
59747674|NCT00731692|75866755|FG000|COMPLETED|Extension Phase||0||
59747675|NCT00731692|75866756|FG001|COMPLETED|Extension Phase||0||
59747676|NCT00731692|75866757|FG002|COMPLETED|Extension Phase||0||
59747677|NCT00731692|75866755|FG000|NOT COMPLETED|Extension Phase||74||
59747678|NCT00731692|75866756|FG001|NOT COMPLETED|Extension Phase||196||
59747679|NCT00731692|75866757|FG002|NOT COMPLETED|Extension Phase||301||
59747680|NCT00687193|75866779|FG000|STARTED|Overall Study||53||
59747681|NCT00687193|75866780|FG001|STARTED|Overall Study||53||
59747682|NCT00687193|75866781|FG002|STARTED|Overall Study||52||
59747683|NCT00687193|75866782|FG003|STARTED|Overall Study||53||
59747684|NCT00687193|75866783|FG004|STARTED|Overall Study||54||
59747685|NCT00687193|75866784|FG005|STARTED|Overall Study|One participant withdrew after randomization but prior to treatment.|52||
59747686|NCT00687193|75866779|FG000|COMPLETED|Overall Study||51||
59747687|NCT00687193|75866780|FG001|COMPLETED|Overall Study||49||
59747688|NCT00687193|75866781|FG002|COMPLETED|Overall Study||50||
60135314|NCT03307252|76258159|FG006|STARTED|Part 3, Period 2||0||
60135315|NCT03307252|76258160|FG007|STARTED|Part 3, Period 2||4||
60135316|NCT03307252|76258161|FG008|STARTED|Part 3, Period 2||4||
60135317|NCT03307252|76258162|FG009|STARTED|Part 3, Period 2||4||
60135318|NCT03307252|76258163|FG010|STARTED|Part 3, Period 2||4||
60135319|NCT03307252|76258153|FG000|COMPLETED|Part 3, Period 2||0||
60135320|NCT03307252|76258154|FG001|COMPLETED|Part 3, Period 2||0||
60135321|NCT03307252|76258155|FG002|COMPLETED|Part 3, Period 2||0||
60135322|NCT03307252|76258156|FG003|COMPLETED|Part 3, Period 2||0||
60135323|NCT03307252|76258157|FG004|COMPLETED|Part 3, Period 2||0||
60135324|NCT03307252|76258158|FG005|COMPLETED|Part 3, Period 2||0||
60135325|NCT03307252|76258159|FG006|COMPLETED|Part 3, Period 2||0||
60135326|NCT03307252|76258160|FG007|COMPLETED|Part 3, Period 2||4||
60135327|NCT03307252|76258161|FG008|COMPLETED|Part 3, Period 2||4||
60135328|NCT03307252|76258162|FG009|COMPLETED|Part 3, Period 2||4||
60135329|NCT03307252|76258163|FG010|COMPLETED|Part 3, Period 2||4||
60135330|NCT03307252|76258153|FG000|NOT COMPLETED|Part 3, Period 2||0||
60135331|NCT03307252|76258154|FG001|NOT COMPLETED|Part 3, Period 2||0||
60135332|NCT03307252|76258155|FG002|NOT COMPLETED|Part 3, Period 2||0||
60135333|NCT03307252|76258156|FG003|NOT COMPLETED|Part 3, Period 2||0||
59747689|NCT00687193|75866782|FG003|COMPLETED|Overall Study||49||
59747690|NCT00687193|75866783|FG004|COMPLETED|Overall Study||52||
59747691|NCT00687193|75866784|FG005|COMPLETED|Overall Study||48||
59747692|NCT00687193|75866779|FG000|NOT COMPLETED|Overall Study||2||
59747693|NCT00687193|75866780|FG001|NOT COMPLETED|Overall Study||4||
59747694|NCT00687193|75866781|FG002|NOT COMPLETED|Overall Study||2||
59747695|NCT00687193|75866782|FG003|NOT COMPLETED|Overall Study||4||
59747696|NCT00687193|75866783|FG004|NOT COMPLETED|Overall Study||2||
59747697|NCT00687193|75866784|FG005|NOT COMPLETED|Overall Study||4||
59747698|NCT00730912|75866804|FG000|STARTED|Overall Study||53||
59747699|NCT00730912|75866805|FG001|STARTED|Overall Study||104||
60135334|NCT03307252|76258157|FG004|NOT COMPLETED|Part 3, Period 2||0||
60135335|NCT03307252|76258158|FG005|NOT COMPLETED|Part 3, Period 2||0||
60135336|NCT03307252|76258159|FG006|NOT COMPLETED|Part 3, Period 2||0||
60135337|NCT03307252|76258160|FG007|NOT COMPLETED|Part 3, Period 2||0||
60135338|NCT03307252|76258161|FG008|NOT COMPLETED|Part 3, Period 2||0||
60135339|NCT03307252|76258162|FG009|NOT COMPLETED|Part 3, Period 2||0||
60135340|NCT03307252|76258163|FG010|NOT COMPLETED|Part 3, Period 2||0||
60135341|NCT03307252|76258153|FG000|STARTED|Part 3, Washout Period 2 (7 Days)||0||
60135342|NCT03307252|76258154|FG001|STARTED|Part 3, Washout Period 2 (7 Days)||0||
60135343|NCT03307252|76258155|FG002|STARTED|Part 3, Washout Period 2 (7 Days)||0||
59747700|NCT00730912|75866806|FG002|STARTED|Overall Study||104||
59747701|NCT00730912|75866804|FG000|COMPLETED|Overall Study||53||
59747702|NCT00730912|75866805|FG001|COMPLETED|Overall Study||104||
59747703|NCT00730912|75866806|FG002|COMPLETED|Overall Study||103||
59747704|NCT00730912|75866804|FG000|NOT COMPLETED|Overall Study||0||
59747705|NCT00730912|75866805|FG001|NOT COMPLETED|Overall Study||0||
59747706|NCT00730912|75866806|FG002|NOT COMPLETED|Overall Study||1||
59747707|NCT00730756|75866816|FG000|STARTED|Overall Study||49||
59873103|NCT02914522|75997226|FG000|NOT COMPLETED|Induction Study: Up to Week 11||10||
59873104|NCT02914522|75997227|FG001|NOT COMPLETED|Induction Study: Up to Week 11||22||
59873105|NCT02914522|75997228|FG002|NOT COMPLETED|Induction Study: Up to Week 11||10||
60135344|NCT03307252|76258156|FG003|STARTED|Part 3, Washout Period 2 (7 Days)||0||
60135345|NCT03307252|76258157|FG004|STARTED|Part 3, Washout Period 2 (7 Days)||0||
60135346|NCT03307252|76258158|FG005|STARTED|Part 3, Washout Period 2 (7 Days)||0||
59604571|NCT02015676|75714841|FG000|NOT COMPLETED|Overall Study||9||
59604572|NCT02015676|75714842|FG001|NOT COMPLETED|Overall Study||34||
59604573|NCT02015676|75714843|FG002|NOT COMPLETED|Overall Study||3||
59604574|NCT02015520|75714851|FG000|STARTED|Overall Study||40||
59604575|NCT02015520|75714852|FG001|STARTED|Overall Study||21||
59604576|NCT02015520|75714853|FG002|STARTED|Overall Study||42||
59604577|NCT02015520|75714854|FG003|STARTED|Overall Study||40||
59604578|NCT02015520|75714851|FG000|COMPLETED|Overall Study||35||
60135347|NCT03307252|76258159|FG006|STARTED|Part 3, Washout Period 2 (7 Days)||0||
60135348|NCT03307252|76258160|FG007|STARTED|Part 3, Washout Period 2 (7 Days)||4||
59604579|NCT02015520|75714852|FG001|COMPLETED|Overall Study||17||
59604580|NCT02015520|75714853|FG002|COMPLETED|Overall Study||35||
59604581|NCT02015520|75714854|FG003|COMPLETED|Overall Study||36||
59604582|NCT02015520|75714851|FG000|NOT COMPLETED|Overall Study||5||
59604583|NCT02015520|75714852|FG001|NOT COMPLETED|Overall Study||4||
59604584|NCT02015520|75714853|FG002|NOT COMPLETED|Overall Study||7||
59747708|NCT00730756|75866817|FG001|STARTED|Overall Study||53||
60135349|NCT03307252|76258161|FG008|STARTED|Part 3, Washout Period 2 (7 Days)||4||
60135350|NCT03307252|76258162|FG009|STARTED|Part 3, Washout Period 2 (7 Days)||4||
59747709|NCT00730756|75866816|FG000|COMPLETED|Overall Study||45||
59873106|NCT02914522|75997229|FG003|NOT COMPLETED|Induction Study: Up to Week 11||28||
59873107|NCT02914522|75997230|FG004|NOT COMPLETED|Induction Study: Up to Week 11||24||
59873108|NCT02914522|75997231|FG005|NOT COMPLETED|Induction Study: Up to Week 11||16||
59873109|NCT02914522|75997232|FG006|NOT COMPLETED|Induction Study: Up to Week 11||0||
59873110|NCT02914522|75997233|FG007|NOT COMPLETED|Induction Study: Up to Week 11||0||
59873111|NCT02914522|75997234|FG008|NOT COMPLETED|Induction Study: Up to Week 11||0||
59873112|NCT02914522|75997235|FG009|NOT COMPLETED|Induction Study: Up to Week 11||0||
59873113|NCT02914522|75997236|FG010|NOT COMPLETED|Induction Study: Up to Week 11||0||
59873114|NCT02914522|75997226|FG000|STARTED|Maintenance Study: Week 11 to Week 58|Participants achieved either EBS remission/MCS response at Week 10 continued into Maintenance Study.|0||
59873115|NCT02914522|75997227|FG001|STARTED|Maintenance Study: Week 11 to Week 58|Participants achieved either EBS remission/MCS response at Week 10 continued into Maintenance Study.|0||
59873116|NCT02914522|75997228|FG002|STARTED|Maintenance Study: Week 11 to Week 58|Participants achieved either EBS remission/MCS response at Week 10 continued into Maintenance Study.|0||
59873117|NCT02914522|75997229|FG003|STARTED|Maintenance Study: Week 11 to Week 58||0||
59873118|NCT02914522|75997230|FG004|STARTED|Maintenance Study: Week 11 to Week 58||0||
59873119|NCT02914522|75997231|FG005|STARTED|Maintenance Study: Week 11 to Week 58|Participants achieved either EBS remission/MCS response at Week 10 continued into Maintenance Study.|0||
59873120|NCT02914522|75997232|FG006|STARTED|Maintenance Study: Week 11 to Week 58|Participants achieved either EBS remission/MCS response at Week 10 continued into Maintenance Study.|202||
59873121|NCT02914522|75997233|FG007|STARTED|Maintenance Study: Week 11 to Week 58|Participants achieved either EBS remission/MCS response at Week 10 continued into Maintenance Study.|99||
59873122|NCT02914522|75997234|FG008|STARTED|Maintenance Study: Week 11 to Week 58|Participants achieved either EBS remission/MCS response at Week 10 continued into Maintenance Study.|179||
59873123|NCT02914522|75997235|FG009|STARTED|Maintenance Study: Week 11 to Week 58|Participants achieved either EBS remission/MCS response at Week 10 continued into Maintenance Study.|91||
59873124|NCT02914522|75997236|FG010|STARTED|Maintenance Study: Week 11 to Week 58||93||
59873125|NCT02914522|75997226|FG000|COMPLETED|Maintenance Study: Week 11 to Week 58||0||
59873126|NCT02914522|75997227|FG001|COMPLETED|Maintenance Study: Week 11 to Week 58||0||
59873127|NCT02914522|75997228|FG002|COMPLETED|Maintenance Study: Week 11 to Week 58||0||
59873128|NCT02914522|75997229|FG003|COMPLETED|Maintenance Study: Week 11 to Week 58||0||
59873129|NCT02914522|75997230|FG004|COMPLETED|Maintenance Study: Week 11 to Week 58||0||
59873130|NCT02914522|75997231|FG005|COMPLETED|Maintenance Study: Week 11 to Week 58||0||
59873131|NCT02914522|75997232|FG006|COMPLETED|Maintenance Study: Week 11 to Week 58||150||
59873132|NCT02914522|75997233|FG007|COMPLETED|Maintenance Study: Week 11 to Week 58||41||
59873133|NCT02914522|75997234|FG008|COMPLETED|Maintenance Study: Week 11 to Week 58||104||
59873134|NCT02914522|75997235|FG009|COMPLETED|Maintenance Study: Week 11 to Week 58||42||
59873135|NCT02914522|75997236|FG010|COMPLETED|Maintenance Study: Week 11 to Week 58||64||
59873136|NCT02914522|75997226|FG000|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||0||
59873137|NCT02914522|75997227|FG001|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||0||
59873138|NCT02914522|75997228|FG002|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||0||
59873139|NCT02914522|75997229|FG003|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||0||
59873140|NCT02914522|75997230|FG004|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||0||
59873141|NCT02914522|75997231|FG005|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||0||
59873142|NCT02914522|75997232|FG006|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||52||
59873143|NCT02914522|75997233|FG007|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||58||
59873144|NCT02914522|75997234|FG008|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||75||
59873145|NCT02914522|75997235|FG009|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||49||
59873146|NCT02914522|75997236|FG010|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||29||
59873147|NCT02924428|75997265|FG000|STARTED|Overall Study||20||
59873148|NCT02924428|75997266|FG001|STARTED|Overall Study||19||
59873149|NCT02924428|75997265|FG000|COMPLETED|Overall Study||16||
59873150|NCT02924428|75997266|FG001|COMPLETED|Overall Study||14||
59873151|NCT02924428|75997265|FG000|NOT COMPLETED|Overall Study||4||
59873152|NCT02924428|75997266|FG001|NOT COMPLETED|Overall Study||5||
59873153|NCT00062751|75997277|FG000|STARTED|Overall Study||33||
59873154|NCT00062751|75997278|FG001|STARTED|Overall Study||30||
59873155|NCT00062751|75997279|FG002|STARTED|Overall Study||33||
59873156|NCT00062751|75997280|FG003|STARTED|Overall Study||6||
59873157|NCT00062751|75997281|FG004|STARTED|Overall Study||6||
59873158|NCT00062751|75997277|FG000|COMPLETED|Overall Study||0||
59873159|NCT00062751|75997278|FG001|COMPLETED|Overall Study||0||
59873160|NCT00062751|75997279|FG002|COMPLETED|Overall Study||3||
59873161|NCT00062751|75997280|FG003|COMPLETED|Overall Study||1||
59873162|NCT00062751|75997281|FG004|COMPLETED|Overall Study||0||
59873163|NCT00062751|75997277|FG000|NOT COMPLETED|Overall Study||33||
59873164|NCT00062751|75997278|FG001|NOT COMPLETED|Overall Study||30||
59873165|NCT00062751|75997279|FG002|NOT COMPLETED|Overall Study||30||
59873166|NCT00062751|75997280|FG003|NOT COMPLETED|Overall Study||5||
59873167|NCT00062751|75997281|FG004|NOT COMPLETED|Overall Study||6||
59873168|NCT00258310|75997294|FG000|STARTED|Overall Study||35||
59873169|NCT00258310|75997294|FG000|COMPLETED|Overall Study||35||
59873170|NCT00258310|75997294|FG000|NOT COMPLETED|Overall Study||0||
59873171|NCT00062439|75997298|FG000|STARTED|Induction Chemotherapy + Radiotherapy||46||
59950747|NCT03308058|76069587|FG001|COMPLETED|Overall Study||23||
59873172|NCT00062439|75997298|FG000|COMPLETED|Induction Chemotherapy + Radiotherapy||38||
59873173|NCT00062439|75997298|FG000|NOT COMPLETED|Induction Chemotherapy + Radiotherapy||8||
59873174|NCT00062439|75997298|FG000|STARTED|Post Chemoradiation Assessment||38||
59873175|NCT00062439|75997298|FG000|COMPLETED|Post Chemoradiation Assessment||29||
59873176|NCT00062439|75997298|FG000|NOT COMPLETED|Post Chemoradiation Assessment||9||
59873177|NCT00062439|75997298|FG000|STARTED|Surgery||29||
59873178|NCT00062439|75997298|FG000|COMPLETED|Surgery||22||
59873179|NCT00062439|75997298|FG000|NOT COMPLETED|Surgery||7||
59873180|NCT00062439|75997298|FG000|STARTED|Consolidation Chemotherapy||22||
60135351|NCT03307252|76258163|FG010|STARTED|Part 3, Washout Period 2 (7 Days)||4||
60135352|NCT03307252|76258153|FG000|COMPLETED|Part 3, Washout Period 2 (7 Days)||0||
60135353|NCT03307252|76258154|FG001|COMPLETED|Part 3, Washout Period 2 (7 Days)||0||
60135354|NCT03307252|76258155|FG002|COMPLETED|Part 3, Washout Period 2 (7 Days)||0||
60135355|NCT03307252|76258156|FG003|COMPLETED|Part 3, Washout Period 2 (7 Days)||0||
60135356|NCT03307252|76258157|FG004|COMPLETED|Part 3, Washout Period 2 (7 Days)||0||
60135357|NCT03307252|76258158|FG005|COMPLETED|Part 3, Washout Period 2 (7 Days)||0||
60135358|NCT03307252|76258159|FG006|COMPLETED|Part 3, Washout Period 2 (7 Days)||0||
60135359|NCT03307252|76258160|FG007|COMPLETED|Part 3, Washout Period 2 (7 Days)||4||
60135360|NCT03307252|76258161|FG008|COMPLETED|Part 3, Washout Period 2 (7 Days)||4||
60135361|NCT03307252|76258162|FG009|COMPLETED|Part 3, Washout Period 2 (7 Days)||4||
60135362|NCT03307252|76258163|FG010|COMPLETED|Part 3, Washout Period 2 (7 Days)||4||
60135363|NCT03307252|76258153|FG000|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0||
60135364|NCT03307252|76258154|FG001|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0||
60135365|NCT03307252|76258155|FG002|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0||
60135366|NCT03307252|76258156|FG003|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0||
60135367|NCT03307252|76258157|FG004|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0||
60135368|NCT03307252|76258158|FG005|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0||
59873181|NCT00062439|75997298|FG000|COMPLETED|Consolidation Chemotherapy||20||
59873182|NCT00062439|75997298|FG000|NOT COMPLETED|Consolidation Chemotherapy||2||
59873183|NCT00051363|75997309|FG000|STARTED|Overall Study||558||
59873184|NCT00051363|75997310|FG001|STARTED|Overall Study||547||
59873185|NCT00051363|75997309|FG000|Randomized & Analyzed|Overall Study||556||
59873186|NCT00051363|75997310|FG001|Randomized & Analyzed|Overall Study||542||
59873187|NCT00051363|75997309|FG000|Completed 2M Visit On-Treatment|Overall Study||456||
59873188|NCT00051363|75997310|FG001|Completed 2M Visit On-Treatment|Overall Study||417||
59873189|NCT00051363|75997309|FG000|Completed 2M Visit On-Study|Overall Study||468||
59873190|NCT00051363|75997310|FG001|Completed 2M Visit On-Study|Overall Study||432||
59873191|NCT00051363|75997309|FG000|Completed 6M Visit On-Treatment|Overall Study||427||
59873192|NCT00051363|75997310|FG001|Completed 6M Visit On-Treatment|Overall Study||372||
59873193|NCT00051363|75997309|FG000|Completed 6M Vist On-Study|Overall Study||443||
59873194|NCT00051363|75997310|FG001|Completed 6M Vist On-Study|Overall Study||403||
59873195|NCT00051363|75997309|FG000|COMPLETED|Overall Study||443||
59873196|NCT00051363|75997310|FG001|COMPLETED|Overall Study||403||
59873197|NCT00051363|75997309|FG000|NOT COMPLETED|Overall Study||115||
59873198|NCT00051363|75997310|FG001|NOT COMPLETED|Overall Study||144||
59873199|NCT00031551|75997318|FG000|STARTED|Overall Study||2||
59873200|NCT00031551|75997319|FG001|STARTED|Overall Study||25||
59873201|NCT00031551|75997318|FG000|COMPLETED|Overall Study||0||
59873202|NCT00031551|75997319|FG001|COMPLETED|Overall Study||25||
59873203|NCT00031551|75997318|FG000|NOT COMPLETED|Overall Study||2||
59873204|NCT00031551|75997319|FG001|NOT COMPLETED|Overall Study||0||
59873205|NCT00049257|75997329|FG000|STARTED|Carboplatin, Paclitaxel||58||
59873206|NCT00049257|75997329|FG000|COMPLETED|Carboplatin, Paclitaxel|13 participants did not complete treatment|45||
59873207|NCT00049257|75997329|FG000|NOT COMPLETED|Carboplatin, Paclitaxel||13||
59873208|NCT00049257|75997329|FG000|STARTED|Follow-up Period for Survival Status||45||
59873209|NCT00049257|75997329|FG000|COMPLETED|Follow-up Period for Survival Status||41||
59873210|NCT00049257|75997329|FG000|NOT COMPLETED|Follow-up Period for Survival Status||4||
59873211|NCT03020992|75997333|FG000|STARTED|Overall Study||89||
59873212|NCT03020992|75997333|FG000|COMPLETED|Overall Study||83||
59873213|NCT03020992|75997333|FG000|NOT COMPLETED|Overall Study||6||
59873214|NCT03020914|75997340|FG000|STARTED|Overall Study||10||
59873215|NCT03020914|75997341|FG001|STARTED|Overall Study||9||
59873216|NCT03020914|75997340|FG000|COMPLETED|Overall Study||9||
60135369|NCT03307252|76258159|FG006|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0||
60135370|NCT03307252|76258160|FG007|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0||
60135371|NCT03307252|76258161|FG008|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0||
59873217|NCT03020914|75997341|FG001|COMPLETED|Overall Study||9||
59873218|NCT03020914|75997340|FG000|NOT COMPLETED|Overall Study||1||
59873219|NCT03020914|75997341|FG001|NOT COMPLETED|Overall Study||0||
59873220|NCT03018340|75997349|FG000|STARTED|Overall Study||52||
59873221|NCT03018340|75997350|FG001|STARTED|Overall Study||155||
59873222|NCT03018340|75997349|FG000|COMPLETED|Overall Study||44||
59873223|NCT03018340|75997350|FG001|COMPLETED|Overall Study||125||
59873224|NCT03018340|75997349|FG000|NOT COMPLETED|Overall Study||8||
59873225|NCT03018340|75997350|FG001|NOT COMPLETED|Overall Study||30||
59873226|NCT03016078|75997360|FG000|STARTED|Overall Study||21||
59873227|NCT03016078|75997360|FG000|COMPLETED|Overall Study||19||
59873228|NCT03016078|75997360|FG000|NOT COMPLETED|Overall Study||2||
59873229|NCT00048165|75997366|FG000|STARTED|Completed 6 Months Study||216||
59873230|NCT00048165|75997367|FG001|STARTED|Completed 6 Months Study||218||
59873231|NCT00048165|75997366|FG000|COMPLETED|Completed 6 Months Study||165||
59873232|NCT00048165|75997367|FG001|COMPLETED|Completed 6 Months Study||170||
59873233|NCT00048165|75997366|FG000|NOT COMPLETED|Completed 6 Months Study||51||
59873234|NCT00048165|75997367|FG001|NOT COMPLETED|Completed 6 Months Study||48||
59873235|NCT00048165|75997366|FG000|STARTED|Completed 12 Months Study||165||
59873236|NCT00048165|75997367|FG001|STARTED|Completed 12 Months Study||170||
59873237|NCT00048165|75997366|FG000|COMPLETED|Completed 12 Months Study||162||
59873238|NCT00048165|75997367|FG001|COMPLETED|Completed 12 Months Study||167||
59873239|NCT00048165|75997366|FG000|NOT COMPLETED|Completed 12 Months Study||3||
59873240|NCT00048165|75997367|FG001|NOT COMPLETED|Completed 12 Months Study||3||
59873241|NCT00059787|75997375|FG000|STARTED|Overall Study||56||
59873242|NCT00059787|75997375|FG000|COMPLETED|Overall Study||36||
59873243|NCT00059787|75997375|FG000|NOT COMPLETED|Overall Study||20||
59873244|NCT00058539|75997380|FG000|STARTED|Overall Study||42||
59873245|NCT00058539|75997380|FG000|COMPLETED|Overall Study||0||
59873246|NCT00058539|75997380|FG000|NOT COMPLETED|Overall Study||42||
59873247|NCT03015532|75997392|FG000|STARTED|Overall Study||20||
59873248|NCT03015532|75997393|FG001|STARTED|Overall Study||22||
59873249|NCT03015532|75997394|FG002|STARTED|Overall Study||11||
59873250|NCT03015532|75997395|FG003|STARTED|Overall Study||10||
59873251|NCT03015532|75997396|FG004|STARTED|Overall Study||58||
59873252|NCT03015532|75997397|FG005|STARTED|Overall Study||56||
59873253|NCT03015532|75997398|FG006|STARTED|Overall Study||53||
59873254|NCT03015532|75997399|FG007|STARTED|Overall Study||55||
59873255|NCT03015532|75997392|FG000|COMPLETED|Overall Study||20||
59873256|NCT03015532|75997393|FG001|COMPLETED|Overall Study||22||
59873257|NCT03015532|75997394|FG002|COMPLETED|Overall Study||11||
59873258|NCT03015532|75997395|FG003|COMPLETED|Overall Study||10||
59873259|NCT03015532|75997396|FG004|COMPLETED|Overall Study||58||
60002437|NCT01662999|76118331|FG003|COMPLETED|Period 1||7||
60002438|NCT01662999|76118332|FG004|COMPLETED|Period 1||7||
60002439|NCT01662999|76118333|FG005|COMPLETED|Period 1||7||
59747710|NCT00730756|75866817|FG001|COMPLETED|Overall Study||48||
59747711|NCT00730756|75866816|FG000|NOT COMPLETED|Overall Study||4||
59747712|NCT00730756|75866817|FG001|NOT COMPLETED|Overall Study||5||
59747713|NCT00730132|75866823|FG000|STARTED|Overall Study||712||
59747714|NCT00730132|75866823|FG000|COMPLETED|Overall Study||557||
59747715|NCT00730132|75866823|FG000|NOT COMPLETED|Overall Study||155||
59747716|NCT00737464|75866830|FG000|STARTED|Overall Study||132||
59873260|NCT03015532|75997397|FG005|COMPLETED|Overall Study||54||
59873261|NCT03015532|75997398|FG006|COMPLETED|Overall Study||51||
59873262|NCT03015532|75997399|FG007|COMPLETED|Overall Study||55||
59873263|NCT03015532|75997392|FG000|NOT COMPLETED|Overall Study||0||
59873264|NCT03015532|75997393|FG001|NOT COMPLETED|Overall Study||0||
59873265|NCT03015532|75997394|FG002|NOT COMPLETED|Overall Study||0||
59873266|NCT03015532|75997395|FG003|NOT COMPLETED|Overall Study||0||
59747717|NCT00737464|75866830|FG000|COMPLETED|Overall Study||114||
59747718|NCT00737464|75866830|FG000|NOT COMPLETED|Overall Study||18||
59747719|NCT00729586|75866836|FG000|STARTED|Overall Study||51||
59873267|NCT03015532|75997396|FG004|NOT COMPLETED|Overall Study||0||
59873268|NCT03015532|75997397|FG005|NOT COMPLETED|Overall Study||2||
59873269|NCT03015532|75997398|FG006|NOT COMPLETED|Overall Study||2||
59873270|NCT03015532|75997399|FG007|NOT COMPLETED|Overall Study||0||
59873271|NCT00047463|75997421|FG000|STARTED|Overall Study||13||
59873272|NCT00047463|75997422|FG001|STARTED|Overall Study||22||
59873273|NCT00047463|75997421|FG000|COMPLETED|Overall Study||13||
59873274|NCT00047463|75997422|FG001|COMPLETED|Overall Study||19||
59873275|NCT00047463|75997421|FG000|NOT COMPLETED|Overall Study||0||
59873276|NCT00047463|75997422|FG001|NOT COMPLETED|Overall Study||3||
60002440|NCT01662999|76118328|FG000|NOT COMPLETED|Period 1||0||
59747720|NCT00729586|75866837|FG001|STARTED|Overall Study||22||
59747721|NCT00729586|75866836|FG000|COMPLETED|Overall Study|Eligible and treated patients|50||
59747722|NCT00729586|75866837|FG001|COMPLETED|Overall Study|Eligible and treated patients|21||
59747723|NCT00729586|75866836|FG000|NOT COMPLETED|Overall Study||1||
59747724|NCT00729586|75866837|FG001|NOT COMPLETED|Overall Study||1||
59747725|NCT00949910|75866844|FG000|STARTED|Overall Study||6586||
59873277|NCT03015220|75997435|FG000|STARTED|Overall Study||131||
59873278|NCT03015220|75997436|FG001|STARTED|Overall Study||132||
59873279|NCT03015220|75997437|FG002|STARTED|Overall Study||130||
59873280|NCT03015220|75997438|FG003|STARTED|Overall Study||65||
59873281|NCT03015220|75997435|FG000|Full Analysis Set (FAS)|Overall Study||131||
59873282|NCT03015220|75997436|FG001|Full Analysis Set (FAS)|Overall Study||132||
59873283|NCT03015220|75997437|FG002|Full Analysis Set (FAS)|Overall Study||130||
59873284|NCT03015220|75997438|FG003|Full Analysis Set (FAS)|Overall Study||65||
59873285|NCT03015220|75997435|FG000|Safety Analysis Set (SAS)|Overall Study||131||
59873286|NCT03015220|75997436|FG001|Safety Analysis Set (SAS)|Overall Study||132||
59873287|NCT03015220|75997437|FG002|Safety Analysis Set (SAS)|Overall Study||130||
59747726|NCT00949910|75866844|FG000|COMPLETED|Overall Study||10||
60002441|NCT01662999|76118329|FG001|NOT COMPLETED|Period 1||0||
59873288|NCT03015220|75997438|FG003|Safety Analysis Set (SAS)|Overall Study||65||
59873289|NCT03015220|75997435|FG000|COMPLETED|Overall Study||128||
59873290|NCT03015220|75997436|FG001|COMPLETED|Overall Study||130||
59873291|NCT03015220|75997437|FG002|COMPLETED|Overall Study||127||
59873292|NCT03015220|75997438|FG003|COMPLETED|Overall Study||63||
59873293|NCT03015220|75997435|FG000|NOT COMPLETED|Overall Study||3||
59873294|NCT03015220|75997436|FG001|NOT COMPLETED|Overall Study||2||
59873295|NCT03015220|75997437|FG002|NOT COMPLETED|Overall Study||3||
59873296|NCT03015220|75997438|FG003|NOT COMPLETED|Overall Study||2||
59873297|NCT00022659|75997448|FG000|STARTED|Overall Study||64||
59873298|NCT00022659|75997448|FG000|COMPLETED|Overall Study|Eligible and treated patients.|62||
59873299|NCT00022659|75997448|FG000|NOT COMPLETED|Overall Study||2||
59873300|NCT03014674|75997459|FG000|STARTED|Overall Study||85||
59873301|NCT03014674|75997460|FG001|STARTED|Overall Study||79||
59873302|NCT03014674|75997461|FG002|STARTED|Overall Study||80||
59873303|NCT03014674|75997459|FG000|COMPLETED|Overall Study||84||
59873304|NCT03014674|75997460|FG001|COMPLETED|Overall Study||79||
59873305|NCT03014674|75997461|FG002|COMPLETED|Overall Study||80||
59873306|NCT03014674|75997459|FG000|NOT COMPLETED|Overall Study||1||
59873307|NCT03014674|75997460|FG001|NOT COMPLETED|Overall Study||0||
59873308|NCT03014674|75997461|FG002|NOT COMPLETED|Overall Study||0||
59873309|NCT03018106|75997471|FG000|STARTED|Overall Study||0||
59873310|NCT03018106|75997472|FG001|STARTED|Overall Study||1||
59873311|NCT03018106|75997471|FG000|COMPLETED|Overall Study||0||
59873312|NCT03018106|75997472|FG001|COMPLETED|Overall Study||0||
59873313|NCT03018106|75997471|FG000|NOT COMPLETED|Overall Study||0||
59873314|NCT03018106|75997472|FG001|NOT COMPLETED|Overall Study||1||
59873315|NCT03018028|75997481|FG000|STARTED|Overall Study||49||
59873316|NCT03018028|75997482|FG001|STARTED|Overall Study||49||
59873317|NCT03018028|75997483|FG002|STARTED|Overall Study||48||
59873318|NCT03018028|75997484|FG003|STARTED|Overall Study||48||
59873319|NCT03018028|75997485|FG004|STARTED|Overall Study||49||
59873320|NCT03018028|75997481|FG000|Full Analysis Set (FAS)|Overall Study||49||
59873321|NCT03018028|75997482|FG001|Full Analysis Set (FAS)|Overall Study||49||
59873322|NCT03018028|75997483|FG002|Full Analysis Set (FAS)|Overall Study||48||
59873323|NCT03018028|75997484|FG003|Full Analysis Set (FAS)|Overall Study||48||
59873324|NCT03018028|75997485|FG004|Full Analysis Set (FAS)|Overall Study||49||
59873325|NCT03018028|75997481|FG000|Safety Analysis Set (SAS)|Overall Study||49||
59873326|NCT03018028|75997482|FG001|Safety Analysis Set (SAS)|Overall Study||49||
59873327|NCT03018028|75997483|FG002|Safety Analysis Set (SAS)|Overall Study||48||
59873328|NCT03018028|75997484|FG003|Safety Analysis Set (SAS)|Overall Study||48||
59873329|NCT03018028|75997485|FG004|Safety Analysis Set (SAS)|Overall Study||49||
59873330|NCT03018028|75997481|FG000|COMPLETED|Overall Study||46||
59873331|NCT03018028|75997482|FG001|COMPLETED|Overall Study||49||
59873332|NCT03018028|75997483|FG002|COMPLETED|Overall Study||47||
59873333|NCT03018028|75997484|FG003|COMPLETED|Overall Study||46||
59873334|NCT03018028|75997485|FG004|COMPLETED|Overall Study||49||
59873335|NCT03018028|75997481|FG000|NOT COMPLETED|Overall Study||3||
59873336|NCT03018028|75997482|FG001|NOT COMPLETED|Overall Study||0||
59873337|NCT03018028|75997483|FG002|NOT COMPLETED|Overall Study||1||
59873338|NCT03018028|75997484|FG003|NOT COMPLETED|Overall Study||2||
59873339|NCT03018028|75997485|FG004|NOT COMPLETED|Overall Study||0||
59873340|NCT03010462|75997499|FG000|STARTED|Overall Study||31||
59873341|NCT03010462|75997500|FG001|STARTED|Overall Study||29||
59873342|NCT03010462|75997499|FG000|COMPLETED|Overall Study|1 subject withdrew consent before baseline visit. 2 subjects completed treatment but were lost during follow-up|28||
59873343|NCT03010462|75997500|FG001|COMPLETED|Overall Study|1 subject withdrew consent prior to baseline visit|28||
59873344|NCT03010462|75997499|FG000|NOT COMPLETED|Overall Study||3||
59873345|NCT03010462|75997500|FG001|NOT COMPLETED|Overall Study||1||
59873346|NCT00021255|75997509|FG000|STARTED|Overall Study|Randomized|1073||
59873347|NCT00021255|75997510|FG001|STARTED|Overall Study|Randomized|1074||
59873348|NCT00021255|75997511|FG002|STARTED|Overall Study|Randomized|1075||
59873349|NCT00021255|75997509|FG000|Treated|Overall Study||1045||
59873350|NCT00021255|75997510|FG001|Treated|Overall Study||1072||
59873351|NCT00021255|75997511|FG002|Treated|Overall Study||1057||
59873352|NCT00021255|75997509|FG000|Safety Population|Overall Study|1018 participants received AC-T (1012 from AC-T arm, 6 from AC-TH arm).|1018||
59873353|NCT00021255|75997510|FG001|Safety Population|Overall Study|1100 participants received AC-TH (1066 from AC-TH arm, 33 from AC-T arm and 1 from TCH arm).|1100||
59873354|NCT00021255|75997511|FG002|Safety Population|Overall Study|1056 participants received TCH.|1056||
59873355|NCT00021255|75997509|FG000|COMPLETED|Overall Study||952||
59873356|NCT00021255|75997510|FG001|COMPLETED|Overall Study||804||
59873357|NCT00021255|75997511|FG002|COMPLETED|Overall Study||926||
59873358|NCT00021255|75997509|FG000|NOT COMPLETED|Overall Study||121||
59873359|NCT00021255|75997510|FG001|NOT COMPLETED|Overall Study||270||
59873360|NCT00021255|75997511|FG002|NOT COMPLETED|Overall Study||149||
59873361|NCT03012334|75997529|FG000|STARTED|Period 1||9||
59873362|NCT03012334|75997530|FG001|STARTED|Period 1||9||
59873363|NCT03012334|75997531|FG002|STARTED|Period 1||9||
59873364|NCT03012334|75997532|FG003|STARTED|Period 1||9||
59873365|NCT03012334|75997533|FG004|STARTED|Period 1||9||
59873366|NCT03012334|75997534|FG005|STARTED|Period 1||9||
59873367|NCT03012334|75997535|FG006|STARTED|Period 1||9||
59873368|NCT03012334|75997536|FG007|STARTED|Period 1||9||
59747727|NCT00949910|75866844|FG000|NOT COMPLETED|Overall Study||6576||
59747728|NCT00686959|75866850|FG000|STARTED|Overall Study||301||
59747729|NCT00686959|75866851|FG001|STARTED|Overall Study||297||
59747730|NCT00686959|75866850|FG000|Received at Least One Dose of Study Drug|Overall Study||283||
59747731|NCT00686959|75866851|FG001|Received at Least One Dose of Study Drug|Overall Study||272||
59747732|NCT00686959|75866850|FG000|Entered Consolidation Phase|Overall Study||229||
59747733|NCT00686959|75866851|FG001|Entered Consolidation Phase|Overall Study||202||
59747734|NCT00686959|75866850|FG000|COMPLETED|Overall Study|Study completion includes death due to any cause|177||
59747735|NCT00686959|75866851|FG001|COMPLETED|Overall Study|Study completion includes death due to any cause.|180||
59747736|NCT00686959|75866850|FG000|NOT COMPLETED|Overall Study||124||
59747737|NCT00686959|75866851|FG001|NOT COMPLETED|Overall Study||117||
59747738|NCT00946088|75866859|FG000|STARTED|Overall Study||4||
59747739|NCT00946088|75866860|FG001|STARTED|Overall Study||3||
59747740|NCT00946088|75866859|FG000|COMPLETED|Overall Study|At least one dose administered and pre-term birth status known.|4||
59747741|NCT00946088|75866860|FG001|COMPLETED|Overall Study|At least one dose administered and pre-term birth status known.|2||
59747742|NCT00946088|75866859|FG000|NOT COMPLETED|Overall Study||0||
59747743|NCT00946088|75866860|FG001|NOT COMPLETED|Overall Study||1||
59747744|NCT00736996|75866871|FG000|STARTED|Overall Study||25||
59747745|NCT00736996|75866872|FG001|STARTED|Overall Study||26||
59747746|NCT00736996|75866873|FG002|STARTED|Overall Study||27||
59747747|NCT00736996|75866871|FG000|COMPLETED|Overall Study||24||
59747748|NCT00736996|75866872|FG001|COMPLETED|Overall Study||17||
59747749|NCT00736996|75866873|FG002|COMPLETED|Overall Study||25||
59747750|NCT00736996|75866871|FG000|NOT COMPLETED|Overall Study||1||
59747751|NCT00736996|75866872|FG001|NOT COMPLETED|Overall Study||9||
59747752|NCT00736996|75866873|FG002|NOT COMPLETED|Overall Study||2||
59747753|NCT01410344|75866881|FG000|STARTED|Overall Study||20||
59747754|NCT01410344|75866881|FG000|COMPLETED|Overall Study||17||
59747755|NCT01410344|75866881|FG000|NOT COMPLETED|Overall Study||3||
59747756|NCT00728962|75866887|FG000|STARTED|Implant Placement Surgery||75||
59747757|NCT00728962|75866887|FG000|COMPLETED|Implant Placement Surgery||65||
59747758|NCT00728962|75866887|FG000|NOT COMPLETED|Implant Placement Surgery||10||
59747759|NCT00728962|75866887|FG000|STARTED|Permanent Prosthesis Placement||65||
59747760|NCT00728962|75866887|FG000|COMPLETED|Permanent Prosthesis Placement||62||
59747761|NCT00728962|75866887|FG000|NOT COMPLETED|Permanent Prosthesis Placement||3||
59747762|NCT00728962|75866887|FG000|STARTED|One Year Post Placement Follow-up||62||
59747763|NCT00728962|75866887|FG000|COMPLETED|One Year Post Placement Follow-up||62||
59747764|NCT00728962|75866887|FG000|NOT COMPLETED|One Year Post Placement Follow-up||0||
59747765|NCT00728962|75866887|FG000|STARTED|Two Year Post Placement Follow-up||62||
59747766|NCT00728962|75866887|FG000|COMPLETED|Two Year Post Placement Follow-up||59||
59747767|NCT00728962|75866887|FG000|NOT COMPLETED|Two Year Post Placement Follow-up||3||
59747768|NCT00954122|75866891|FG000|STARTED|Overall Study||35||
59747769|NCT00954122|75866891|FG000|COMPLETED|Overall Study||28||
59747770|NCT00954122|75866891|FG000|NOT COMPLETED|Overall Study||7||
59747771|NCT00586066|75866898|FG000|STARTED|Overall Study||48||
59747772|NCT00586066|75866899|FG001|STARTED|Overall Study||24||
59747773|NCT00586066|75866898|FG000|COMPLETED|Overall Study||30||
59747774|NCT00586066|75866899|FG001|COMPLETED|Overall Study||14||
59747775|NCT00586066|75866898|FG000|NOT COMPLETED|Overall Study||18||
59747776|NCT00586066|75866899|FG001|NOT COMPLETED|Overall Study||10||
59747789|NCT00728494|75866911|FG000|STARTED|Overall Study||60||
59747790|NCT00728494|75866912|FG001|STARTED|Overall Study||39||
59747791|NCT00728494|75866911|FG000|COMPLETED|Overall Study||51||
59747792|NCT00728494|75866912|FG001|COMPLETED|Overall Study||32||
59747793|NCT00728494|75866911|FG000|NOT COMPLETED|Overall Study||9||
59747794|NCT00728494|75866912|FG001|NOT COMPLETED|Overall Study||7||
59747795|NCT00728416|75866920|FG000|STARTED|Overall Study||168||
59747796|NCT00728416|75866921|FG001|STARTED|Overall Study||165||
59747797|NCT00728416|75866920|FG000|COMPLETED|Overall Study||166||
59873369|NCT03012334|75997537|FG008|STARTED|Period 1||9||
59747798|NCT00728416|75866921|FG001|COMPLETED|Overall Study||163||
59747799|NCT00728416|75866920|FG000|NOT COMPLETED|Overall Study||2||
60135372|NCT03307252|76258162|FG009|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0||
60135373|NCT03307252|76258163|FG010|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0||
60135374|NCT03307252|76258153|FG000|STARTED|Part 3, Period 3||0||
60135375|NCT03307252|76258154|FG001|STARTED|Part 3, Period 3||0||
60135376|NCT03307252|76258155|FG002|STARTED|Part 3, Period 3||0||
60135377|NCT03307252|76258156|FG003|STARTED|Part 3, Period 3||0||
60135378|NCT03307252|76258157|FG004|STARTED|Part 3, Period 3||0||
60135379|NCT03307252|76258158|FG005|STARTED|Part 3, Period 3||0||
60135380|NCT03307252|76258159|FG006|STARTED|Part 3, Period 3||0||
60135381|NCT03307252|76258160|FG007|STARTED|Part 3, Period 3||4||
60135382|NCT03307252|76258161|FG008|STARTED|Part 3, Period 3||4||
60135383|NCT03307252|76258162|FG009|STARTED|Part 3, Period 3||4||
60135384|NCT03307252|76258163|FG010|STARTED|Part 3, Period 3||4||
60135385|NCT03307252|76258153|FG000|COMPLETED|Part 3, Period 3||0||
60135386|NCT03307252|76258154|FG001|COMPLETED|Part 3, Period 3||0||
60135387|NCT03307252|76258155|FG002|COMPLETED|Part 3, Period 3||0||
60135388|NCT03307252|76258156|FG003|COMPLETED|Part 3, Period 3||0||
60135389|NCT03307252|76258157|FG004|COMPLETED|Part 3, Period 3||0||
60135390|NCT03307252|76258158|FG005|COMPLETED|Part 3, Period 3||0||
60135391|NCT03307252|76258159|FG006|COMPLETED|Part 3, Period 3||0||
60135392|NCT03307252|76258160|FG007|COMPLETED|Part 3, Period 3||4||
60135393|NCT03307252|76258161|FG008|COMPLETED|Part 3, Period 3||4||
60135394|NCT03307252|76258162|FG009|COMPLETED|Part 3, Period 3||4||
60135395|NCT03307252|76258163|FG010|COMPLETED|Part 3, Period 3||4||
59747800|NCT00728416|75866921|FG001|NOT COMPLETED|Overall Study||2||
59747801|NCT00728182|75866929|FG000|STARTED|Overall Study||92||
59747802|NCT00728182|75866930|FG001|STARTED|Overall Study||93||
59747803|NCT00728182|75866929|FG000|COMPLETED|Overall Study||89||
59873370|NCT03012334|75997538|FG009|STARTED|Period 1||9||
59873371|NCT03012334|75997529|FG000|COMPLETED|Period 1||9||
59873372|NCT03012334|75997530|FG001|COMPLETED|Period 1||9||
59873373|NCT03012334|75997531|FG002|COMPLETED|Period 1||9||
59873374|NCT03012334|75997532|FG003|COMPLETED|Period 1||9||
59873375|NCT03012334|75997533|FG004|COMPLETED|Period 1||9||
59873376|NCT03012334|75997534|FG005|COMPLETED|Period 1||9||
59873377|NCT03012334|75997535|FG006|COMPLETED|Period 1||9||
59873378|NCT03012334|75997536|FG007|COMPLETED|Period 1||9||
59873379|NCT03012334|75997537|FG008|COMPLETED|Period 1||9||
59873380|NCT03012334|75997538|FG009|COMPLETED|Period 1||8||
59873381|NCT03012334|75997529|FG000|NOT COMPLETED|Period 1||0||
59873382|NCT03012334|75997530|FG001|NOT COMPLETED|Period 1||0||
59873383|NCT03012334|75997531|FG002|NOT COMPLETED|Period 1||0||
59873384|NCT03012334|75997532|FG003|NOT COMPLETED|Period 1||0||
59873385|NCT03012334|75997533|FG004|NOT COMPLETED|Period 1||0||
59873386|NCT03012334|75997534|FG005|NOT COMPLETED|Period 1||0||
60135396|NCT03307252|76258153|FG000|NOT COMPLETED|Part 3, Period 3||0||
60135397|NCT03307252|76258154|FG001|NOT COMPLETED|Part 3, Period 3||0||
60135398|NCT03307252|76258155|FG002|NOT COMPLETED|Part 3, Period 3||0||
59747804|NCT00728182|75866930|FG001|COMPLETED|Overall Study||90||
59747805|NCT00728182|75866929|FG000|NOT COMPLETED|Overall Study||3||
59747806|NCT00728182|75866930|FG001|NOT COMPLETED|Overall Study||3||
59747807|NCT00941330|75866940|FG000|STARTED|Overall Study||15||
59747808|NCT00941330|75866941|FG001|STARTED|Overall Study||11||
59747809|NCT00941330|75866940|FG000|COMPLETED|Overall Study||14||
59747810|NCT00941330|75866941|FG001|COMPLETED|Overall Study||9||
59747811|NCT00941330|75866940|FG000|NOT COMPLETED|Overall Study||1||
59747812|NCT00941330|75866941|FG001|NOT COMPLETED|Overall Study||2||
59747813|NCT00686881|75866949|FG000|STARTED|Overall Study|After randomization, 2 participants withdrew consent and did not receive study drug.|127||
59762503|NCT00866619|75882229|FG003|COMPLETED|Overall Study||1549||
59873387|NCT03012334|75997535|FG006|NOT COMPLETED|Period 1||0||
59873388|NCT03012334|75997536|FG007|NOT COMPLETED|Period 1||0||
59873389|NCT03012334|75997537|FG008|NOT COMPLETED|Period 1||0||
59873390|NCT03012334|75997538|FG009|NOT COMPLETED|Period 1||1||
59873391|NCT03012334|75997529|FG000|STARTED|Period 2||9||
59873392|NCT03012334|75997530|FG001|STARTED|Period 2||9||
60135399|NCT03307252|76258156|FG003|NOT COMPLETED|Part 3, Period 3||0||
60135400|NCT03307252|76258157|FG004|NOT COMPLETED|Part 3, Period 3||0||
60135401|NCT03307252|76258158|FG005|NOT COMPLETED|Part 3, Period 3||0||
60135402|NCT03307252|76258159|FG006|NOT COMPLETED|Part 3, Period 3||0||
60135403|NCT03307252|76258160|FG007|NOT COMPLETED|Part 3, Period 3||0||
60135404|NCT03307252|76258161|FG008|NOT COMPLETED|Part 3, Period 3||0||
60135405|NCT03307252|76258162|FG009|NOT COMPLETED|Part 3, Period 3||0||
60135406|NCT03307252|76258163|FG010|NOT COMPLETED|Part 3, Period 3||0||
59873393|NCT03012334|75997531|FG002|STARTED|Period 2||9||
59873394|NCT03012334|75997532|FG003|STARTED|Period 2||9||
59873395|NCT03012334|75997533|FG004|STARTED|Period 2||9||
59873396|NCT03012334|75997534|FG005|STARTED|Period 2||9||
59873397|NCT03012334|75997535|FG006|STARTED|Period 2||9||
59873398|NCT03012334|75997536|FG007|STARTED|Period 2||9||
59873399|NCT03012334|75997537|FG008|STARTED|Period 2||9||
59873400|NCT03012334|75997538|FG009|STARTED|Period 2||8||
59873401|NCT03012334|75997529|FG000|COMPLETED|Period 2||9||
59873402|NCT03012334|75997530|FG001|COMPLETED|Period 2||8||
59873403|NCT03012334|75997531|FG002|COMPLETED|Period 2||8||
59873404|NCT03012334|75997532|FG003|COMPLETED|Period 2||9||
59873405|NCT03012334|75997533|FG004|COMPLETED|Period 2||9||
59873406|NCT03012334|75997534|FG005|COMPLETED|Period 2||9||
59873407|NCT03012334|75997535|FG006|COMPLETED|Period 2||9||
59873408|NCT03012334|75997536|FG007|COMPLETED|Period 2||8||
59873409|NCT03012334|75997537|FG008|COMPLETED|Period 2||9||
59873410|NCT03012334|75997538|FG009|COMPLETED|Period 2||8||
59873411|NCT03012334|75997529|FG000|NOT COMPLETED|Period 2||0||
59873412|NCT03012334|75997530|FG001|NOT COMPLETED|Period 2||1||
59873413|NCT03012334|75997531|FG002|NOT COMPLETED|Period 2||1||
59873414|NCT03012334|75997532|FG003|NOT COMPLETED|Period 2||0||
59873415|NCT03012334|75997533|FG004|NOT COMPLETED|Period 2||0||
59873416|NCT03012334|75997534|FG005|NOT COMPLETED|Period 2||0||
59873417|NCT03012334|75997535|FG006|NOT COMPLETED|Period 2||0||
59873418|NCT03012334|75997536|FG007|NOT COMPLETED|Period 2||1||
59873419|NCT03012334|75997537|FG008|NOT COMPLETED|Period 2||0||
59873420|NCT03012334|75997538|FG009|NOT COMPLETED|Period 2||0||
59873421|NCT03012334|75997529|FG000|STARTED|Period 3||9||
59873422|NCT03012334|75997530|FG001|STARTED|Period 3||8||
59873423|NCT03012334|75997531|FG002|STARTED|Period 3||8||
59873424|NCT03012334|75997532|FG003|STARTED|Period 3||9||
59873425|NCT03012334|75997533|FG004|STARTED|Period 3||9||
59873426|NCT03012334|75997534|FG005|STARTED|Period 3||9||
59873427|NCT03012334|75997535|FG006|STARTED|Period 3||9||
59873428|NCT03012334|75997536|FG007|STARTED|Period 3||8||
59873429|NCT03012334|75997537|FG008|STARTED|Period 3||9||
59873430|NCT03012334|75997538|FG009|STARTED|Period 3||8||
59873431|NCT03012334|75997529|FG000|COMPLETED|Period 3||9||
59873432|NCT03012334|75997530|FG001|COMPLETED|Period 3||8||
59873433|NCT03012334|75997531|FG002|COMPLETED|Period 3||8||
59873434|NCT03012334|75997532|FG003|COMPLETED|Period 3||9||
59873435|NCT03012334|75997533|FG004|COMPLETED|Period 3||9||
59873436|NCT03012334|75997534|FG005|COMPLETED|Period 3||9||
59873437|NCT03012334|75997535|FG006|COMPLETED|Period 3||9||
59873438|NCT03012334|75997536|FG007|COMPLETED|Period 3||8||
59873439|NCT03012334|75997537|FG008|COMPLETED|Period 3||9||
59873440|NCT03012334|75997538|FG009|COMPLETED|Period 3||8||
59873441|NCT03012334|75997529|FG000|NOT COMPLETED|Period 3||0||
59873442|NCT03012334|75997530|FG001|NOT COMPLETED|Period 3||0||
59873443|NCT03012334|75997531|FG002|NOT COMPLETED|Period 3||0||
59873444|NCT03012334|75997532|FG003|NOT COMPLETED|Period 3||0||
59873445|NCT03012334|75997533|FG004|NOT COMPLETED|Period 3||0||
59873446|NCT03012334|75997534|FG005|NOT COMPLETED|Period 3||0||
59873447|NCT03012334|75997535|FG006|NOT COMPLETED|Period 3||0||
59873448|NCT03012334|75997536|FG007|NOT COMPLETED|Period 3||0||
59873449|NCT03012334|75997537|FG008|NOT COMPLETED|Period 3||0||
59873450|NCT03012334|75997538|FG009|NOT COMPLETED|Period 3||0||
59873451|NCT03012334|75997529|FG000|STARTED|Period 4||9||
59873452|NCT03012334|75997530|FG001|STARTED|Period 4||8||
59873453|NCT03012334|75997531|FG002|STARTED|Period 4||8||
59873454|NCT03012334|75997532|FG003|STARTED|Period 4||9||
59873455|NCT03012334|75997533|FG004|STARTED|Period 4||9||
59873456|NCT03012334|75997534|FG005|STARTED|Period 4||9||
59873457|NCT03012334|75997535|FG006|STARTED|Period 4||9||
59873458|NCT03012334|75997536|FG007|STARTED|Period 4||8||
59873459|NCT03012334|75997537|FG008|STARTED|Period 4||9||
59873460|NCT03012334|75997538|FG009|STARTED|Period 4||8||
59873461|NCT03012334|75997529|FG000|COMPLETED|Period 4||9||
59873462|NCT03012334|75997530|FG001|COMPLETED|Period 4||8||
59873463|NCT03012334|75997531|FG002|COMPLETED|Period 4||8||
59873464|NCT03012334|75997532|FG003|COMPLETED|Period 4||9||
59873465|NCT03012334|75997533|FG004|COMPLETED|Period 4||9||
59873466|NCT03012334|75997534|FG005|COMPLETED|Period 4||9||
59873467|NCT03012334|75997535|FG006|COMPLETED|Period 4||8||
59873468|NCT03012334|75997536|FG007|COMPLETED|Period 4||8||
59873469|NCT03012334|75997537|FG008|COMPLETED|Period 4||8||
59873470|NCT03012334|75997538|FG009|COMPLETED|Period 4||8||
59873471|NCT03012334|75997529|FG000|NOT COMPLETED|Period 4||0||
59873472|NCT03012334|75997530|FG001|NOT COMPLETED|Period 4||0||
59873473|NCT03012334|75997531|FG002|NOT COMPLETED|Period 4||0||
59873474|NCT03012334|75997532|FG003|NOT COMPLETED|Period 4||0||
59873475|NCT03012334|75997533|FG004|NOT COMPLETED|Period 4||0||
59873476|NCT03012334|75997534|FG005|NOT COMPLETED|Period 4||0||
59873477|NCT03012334|75997535|FG006|NOT COMPLETED|Period 4||1||
59873478|NCT03012334|75997536|FG007|NOT COMPLETED|Period 4||0||
59873479|NCT03012334|75997537|FG008|NOT COMPLETED|Period 4||1||
59873480|NCT03012334|75997538|FG009|NOT COMPLETED|Period 4||0||
59873481|NCT03012334|75997529|FG000|STARTED|Period 5||9||
59873482|NCT03012334|75997530|FG001|STARTED|Period 5||8||
59873483|NCT03012334|75997531|FG002|STARTED|Period 5||8||
59873484|NCT03012334|75997532|FG003|STARTED|Period 5||9||
59873485|NCT03012334|75997533|FG004|STARTED|Period 5||9||
59873486|NCT03012334|75997534|FG005|STARTED|Period 5||9||
59873487|NCT03012334|75997535|FG006|STARTED|Period 5||8||
59873488|NCT03012334|75997536|FG007|STARTED|Period 5||8||
59873489|NCT03012334|75997537|FG008|STARTED|Period 5||8||
59873490|NCT03012334|75997538|FG009|STARTED|Period 5||8||
59873491|NCT03012334|75997529|FG000|COMPLETED|Period 5||9||
59873492|NCT03012334|75997530|FG001|COMPLETED|Period 5||8||
59873493|NCT03012334|75997531|FG002|COMPLETED|Period 5||8||
59873494|NCT03012334|75997532|FG003|COMPLETED|Period 5||9||
59873495|NCT03012334|75997533|FG004|COMPLETED|Period 5||9||
59873496|NCT03012334|75997534|FG005|COMPLETED|Period 5||9||
59873497|NCT03012334|75997535|FG006|COMPLETED|Period 5||8||
59873498|NCT03012334|75997536|FG007|COMPLETED|Period 5||8||
59873499|NCT03012334|75997537|FG008|COMPLETED|Period 5||8||
59873500|NCT03012334|75997538|FG009|COMPLETED|Period 5||8||
59873501|NCT03012334|75997529|FG000|NOT COMPLETED|Period 5||0||
59873502|NCT03012334|75997530|FG001|NOT COMPLETED|Period 5||0||
59873503|NCT03012334|75997531|FG002|NOT COMPLETED|Period 5||0||
59873504|NCT03012334|75997532|FG003|NOT COMPLETED|Period 5||0||
59873505|NCT03012334|75997533|FG004|NOT COMPLETED|Period 5||0||
59873506|NCT03012334|75997534|FG005|NOT COMPLETED|Period 5||0||
59873507|NCT03012334|75997535|FG006|NOT COMPLETED|Period 5||0||
59873508|NCT03012334|75997536|FG007|NOT COMPLETED|Period 5||0||
59873509|NCT03012334|75997537|FG008|NOT COMPLETED|Period 5||0||
59873510|NCT03012334|75997538|FG009|NOT COMPLETED|Period 5||0||
59873511|NCT03565068|75997560|FG000|STARTED|Overall Study||12||
59873512|NCT03565068|75997561|FG001|STARTED|Overall Study||4||
59873513|NCT03565068|75997562|FG002|STARTED|Overall Study||12||
59873514|NCT03565068|75997563|FG003|STARTED|Overall Study||4||
59873515|NCT03565068|75997564|FG004|STARTED|Overall Study||12||
59873516|NCT03565068|75997565|FG005|STARTED|Overall Study||1||
59873517|NCT03565068|75997566|FG006|STARTED|Overall Study||4||
59873518|NCT03565068|75997567|FG007|STARTED|Overall Study||17||
59873519|NCT03565068|75997568|FG008|STARTED|Overall Study||9||
59873520|NCT03565068|75997560|FG000|COMPLETED|Overall Study||12||
59873521|NCT03565068|75997561|FG001|COMPLETED|Overall Study||4||
59873522|NCT03565068|75997562|FG002|COMPLETED|Overall Study||11||
59873523|NCT03565068|75997563|FG003|COMPLETED|Overall Study||4||
59873524|NCT03565068|75997564|FG004|COMPLETED|Overall Study||8||
59873525|NCT03565068|75997565|FG005|COMPLETED|Overall Study||0||
59873526|NCT03565068|75997566|FG006|COMPLETED|Overall Study||3||
59873527|NCT03565068|75997567|FG007|COMPLETED|Overall Study||9||
59873528|NCT03565068|75997568|FG008|COMPLETED|Overall Study||8||
59873529|NCT03565068|75997560|FG000|NOT COMPLETED|Overall Study||0||
59873530|NCT03565068|75997561|FG001|NOT COMPLETED|Overall Study||0||
59873531|NCT03565068|75997562|FG002|NOT COMPLETED|Overall Study||1||
60135407|NCT03307252|76258153|FG000|STARTED|Part 3, Washout Period 3 (7 Days)||0||
60135408|NCT03307252|76258154|FG001|STARTED|Part 3, Washout Period 3 (7 Days)||0||
60135409|NCT03307252|76258155|FG002|STARTED|Part 3, Washout Period 3 (7 Days)||0||
59873532|NCT03565068|75997563|FG003|NOT COMPLETED|Overall Study||0||
60135410|NCT03307252|76258156|FG003|STARTED|Part 3, Washout Period 3 (7 Days)||0||
60135411|NCT03307252|76258157|FG004|STARTED|Part 3, Washout Period 3 (7 Days)||0||
60135412|NCT03307252|76258158|FG005|STARTED|Part 3, Washout Period 3 (7 Days)||0||
60135413|NCT03307252|76258159|FG006|STARTED|Part 3, Washout Period 3 (7 Days)||0||
60135414|NCT03307252|76258160|FG007|STARTED|Part 3, Washout Period 3 (7 Days)||4||
60135415|NCT03307252|76258161|FG008|STARTED|Part 3, Washout Period 3 (7 Days)||4||
60135416|NCT03307252|76258162|FG009|STARTED|Part 3, Washout Period 3 (7 Days)||4||
60135417|NCT03307252|76258163|FG010|STARTED|Part 3, Washout Period 3 (7 Days)||4||
60135418|NCT03307252|76258153|FG000|COMPLETED|Part 3, Washout Period 3 (7 Days)||0||
59873533|NCT03565068|75997564|FG004|NOT COMPLETED|Overall Study||4||
59873534|NCT03565068|75997565|FG005|NOT COMPLETED|Overall Study||1||
59873535|NCT03565068|75997566|FG006|NOT COMPLETED|Overall Study||1||
60135419|NCT03307252|76258154|FG001|COMPLETED|Part 3, Washout Period 3 (7 Days)||0||
60135420|NCT03307252|76258155|FG002|COMPLETED|Part 3, Washout Period 3 (7 Days)||0||
60135421|NCT03307252|76258156|FG003|COMPLETED|Part 3, Washout Period 3 (7 Days)||0||
60135422|NCT03307252|76258157|FG004|COMPLETED|Part 3, Washout Period 3 (7 Days)||0||
60135423|NCT03307252|76258158|FG005|COMPLETED|Part 3, Washout Period 3 (7 Days)||0||
60135424|NCT03307252|76258159|FG006|COMPLETED|Part 3, Washout Period 3 (7 Days)||0||
60135425|NCT03307252|76258160|FG007|COMPLETED|Part 3, Washout Period 3 (7 Days)||4||
59873536|NCT03565068|75997567|FG007|NOT COMPLETED|Overall Study||8||
59873537|NCT03565068|75997568|FG008|NOT COMPLETED|Overall Study||1||
59873538|NCT00010803|75997627|FG000|STARTED|Overall Study|Randomized|1545||
59873539|NCT00010803|75997628|FG001|STARTED|Overall Study|Randomized|1524||
59873540|NCT00010803|75997627|FG000|COMPLETED|Overall Study|Reached endpoint of dementia, death or completion|1448||
59873541|NCT00010803|75997628|FG001|COMPLETED|Overall Study|Reached endpoint of dementia, death or completion|1426||
59873542|NCT00010803|75997627|FG000|NOT COMPLETED|Overall Study||97||
59873543|NCT00010803|75997628|FG001|NOT COMPLETED|Overall Study||98||
59873544|NCT02914834|75997636|FG000|STARTED|Overall Study||12||
59873545|NCT02914834|75997637|FG001|STARTED|Overall Study||15||
59873546|NCT02914834|75997636|FG000|COMPLETED|Overall Study||11||
60135426|NCT03307252|76258161|FG008|COMPLETED|Part 3, Washout Period 3 (7 Days)||4||
60135427|NCT03307252|76258162|FG009|COMPLETED|Part 3, Washout Period 3 (7 Days)||4||
60135428|NCT03307252|76258163|FG010|COMPLETED|Part 3, Washout Period 3 (7 Days)||3||
59873547|NCT02914834|75997637|FG001|COMPLETED|Overall Study||13||
59873548|NCT02914834|75997636|FG000|NOT COMPLETED|Overall Study||1||
59873549|NCT02914834|75997637|FG001|NOT COMPLETED|Overall Study||2||
59873550|NCT03497130|75997645|FG000|STARTED|Overall Study||40||
59873551|NCT03497130|75997646|FG001|STARTED|Overall Study||14||
59873552|NCT03497130|75997645|FG000|COMPLETED|Overall Study||39||
59873553|NCT03497130|75997646|FG001|COMPLETED|Overall Study||13||
59873554|NCT03497130|75997645|FG000|NOT COMPLETED|Overall Study||1||
59873555|NCT03497130|75997646|FG001|NOT COMPLETED|Overall Study||1||
59873556|NCT03006562|75997654|FG000|STARTED|Overall Study||251||
59873557|NCT03006562|75997655|FG001|STARTED|Overall Study||250||
59873558|NCT03006562|75997654|FG000|Voluntary Ultrasound at 30 Days|Overall Study||141||
59873559|NCT03006562|75997655|FG001|Voluntary Ultrasound at 30 Days|Overall Study||137||
59873560|NCT03006562|75997654|FG000|COMPLETED|Overall Study||251||
59873561|NCT03006562|75997655|FG001|COMPLETED|Overall Study||249||
59873562|NCT03006562|75997654|FG000|NOT COMPLETED|Overall Study||0||
59873563|NCT03006562|75997655|FG001|NOT COMPLETED|Overall Study||1||
59873564|NCT03007966|75997663|FG000|STARTED|Overall Study||30||
59873565|NCT03007966|75997664|FG001|STARTED|Overall Study||30||
59873566|NCT03007966|75997663|FG000|COMPLETED|Overall Study||29||
59873567|NCT03007966|75997664|FG001|COMPLETED|Overall Study||30||
59873568|NCT03007966|75997663|FG000|NOT COMPLETED|Overall Study||1||
59873569|NCT03007966|75997664|FG001|NOT COMPLETED|Overall Study||0||
59873570|NCT03007888|75997671|FG000|STARTED|First Intervention (14 Days)||15||
59873571|NCT03007888|75997672|FG001|STARTED|First Intervention (14 Days)||13||
59873572|NCT03007888|75997671|FG000|COMPLETED|First Intervention (14 Days)||14||
59873573|NCT03007888|75997672|FG001|COMPLETED|First Intervention (14 Days)||13||
59873574|NCT03007888|75997671|FG000|NOT COMPLETED|First Intervention (14 Days)||1||
59873575|NCT03007888|75997672|FG001|NOT COMPLETED|First Intervention (14 Days)||0||
59873576|NCT03007888|75997671|FG000|STARTED|Washout (7 Days)||14||
59873577|NCT03007888|75997672|FG001|STARTED|Washout (7 Days)||13||
59873578|NCT03007888|75997671|FG000|COMPLETED|Washout (7 Days)||14||
59873579|NCT03007888|75997672|FG001|COMPLETED|Washout (7 Days)||13||
59873580|NCT03007888|75997671|FG000|NOT COMPLETED|Washout (7 Days)||0||
59873581|NCT03007888|75997672|FG001|NOT COMPLETED|Washout (7 Days)||0||
59873582|NCT03007888|75997671|FG000|STARTED|Second Interventions (14 Days)||14||
59873583|NCT03007888|75997672|FG001|STARTED|Second Interventions (14 Days)||13||
59873584|NCT03007888|75997671|FG000|COMPLETED|Second Interventions (14 Days)||14||
59873585|NCT03007888|75997672|FG001|COMPLETED|Second Interventions (14 Days)||13||
59873586|NCT03007888|75997671|FG000|NOT COMPLETED|Second Interventions (14 Days)||0||
59873587|NCT03007888|75997672|FG001|NOT COMPLETED|Second Interventions (14 Days)||0||
59873588|NCT03541044|75997681|FG000|STARTED|Study Period 1: Up to Day 1||23||
59873589|NCT03541044|75997682|FG001|STARTED|Study Period 1: Up to Day 1||23||
59873590|NCT03541044|75997681|FG000|COMPLETED|Study Period 1: Up to Day 1||23||
59873591|NCT03541044|75997682|FG001|COMPLETED|Study Period 1: Up to Day 1||23||
59873592|NCT03541044|75997681|FG000|NOT COMPLETED|Study Period 1: Up to Day 1||0||
59873593|NCT03541044|75997682|FG001|NOT COMPLETED|Study Period 1: Up to Day 1||0||
59873594|NCT03541044|75997681|FG000|STARTED|Washout Period: 5 to 7 Days||23||
59873595|NCT03541044|75997682|FG001|STARTED|Washout Period: 5 to 7 Days||23||
59873596|NCT03541044|75997681|FG000|COMPLETED|Washout Period: 5 to 7 Days||23||
59873597|NCT03541044|75997682|FG001|COMPLETED|Washout Period: 5 to 7 Days||23||
59873598|NCT03541044|75997681|FG000|NOT COMPLETED|Washout Period: 5 to 7 Days||0||
59873599|NCT03541044|75997682|FG001|NOT COMPLETED|Washout Period: 5 to 7 Days||0||
59873600|NCT03541044|75997681|FG000|STARTED|Study Period 2: Up to Day 8||23||
59873601|NCT03541044|75997682|FG001|STARTED|Study Period 2: Up to Day 8||23||
59873602|NCT03541044|75997681|FG000|COMPLETED|Study Period 2: Up to Day 8||21||
59873603|NCT03541044|75997682|FG001|COMPLETED|Study Period 2: Up to Day 8||23||
59873604|NCT03541044|75997681|FG000|NOT COMPLETED|Study Period 2: Up to Day 8||2||
59873605|NCT03541044|75997682|FG001|NOT COMPLETED|Study Period 2: Up to Day 8||0||
59873606|NCT00009945|75997692|FG000|STARTED|Overall Study||1662||
59873607|NCT00009945|75997693|FG001|STARTED|Overall Study||1661||
59873608|NCT00009945|75997692|FG000|COMPLETED|Overall Study||1655||
60135429|NCT03307252|76258153|FG000|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0||
60135430|NCT03307252|76258154|FG001|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0||
60135431|NCT03307252|76258155|FG002|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0||
60135432|NCT03307252|76258156|FG003|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0||
60135433|NCT03307252|76258157|FG004|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0||
60135434|NCT03307252|76258158|FG005|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0||
59873609|NCT00009945|75997693|FG001|COMPLETED|Overall Study||1656||
59873610|NCT00009945|75997692|FG000|NOT COMPLETED|Overall Study||7||
59873611|NCT00009945|75997693|FG001|NOT COMPLETED|Overall Study||5||
59873612|NCT03540030|75997701|FG000|STARTED|Overall Study||48||
59873613|NCT03540030|75997702|FG001|STARTED|Overall Study||38||
59873614|NCT03540030|75997701|FG000|COMPLETED|Overall Study||30||
59873615|NCT03540030|75997702|FG001|COMPLETED|Overall Study||35||
59873616|NCT03540030|75997701|FG000|NOT COMPLETED|Overall Study||18||
59873617|NCT03540030|75997702|FG001|NOT COMPLETED|Overall Study||3||
59873618|NCT03003676|75997710|FG000|STARTED|Overall Study||9||
59873619|NCT03003676|75997711|FG001|STARTED|Overall Study||12||
59873620|NCT03003676|75997710|FG000|COMPLETED|Overall Study||3||
59873621|NCT03003676|75997711|FG001|COMPLETED|Overall Study||4||
59873622|NCT03003676|75997710|FG000|NOT COMPLETED|Overall Study||6||
59873623|NCT03003676|75997711|FG001|NOT COMPLETED|Overall Study||8||
59873624|NCT00047385|75997721|FG000|STARTED|Overall Study||26722||
59873625|NCT00047385|75997722|FG001|STARTED|Overall Study||26732||
59873626|NCT00047385|75997721|FG000|COMPLETED|Overall Study|Had at least one screening exam.|26455||
59873627|NCT00047385|75997722|FG001|COMPLETED|Overall Study||26232||
59873628|NCT00047385|75997721|FG000|NOT COMPLETED|Overall Study||267||
60135435|NCT03307252|76258159|FG006|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0||
60135436|NCT03307252|76258160|FG007|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0||
60135437|NCT03307252|76258161|FG008|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0||
60135438|NCT03307252|76258162|FG009|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0||
60135439|NCT03307252|76258163|FG010|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||1||
60135440|NCT03307252|76258153|FG000|STARTED|Part 3, Period 4||0||
59873629|NCT00047385|75997722|FG001|NOT COMPLETED|Overall Study||500||
59873630|NCT03002818|75997728|FG000|STARTED|Overall Study||41|eligible participants who received 3D regimen at least once|
59873631|NCT03002818|75997728|FG000|COMPLETED|Overall Study||40||
59873632|NCT03002818|75997728|FG000|NOT COMPLETED|Overall Study||1||
59873633|NCT03002194|75997732|FG000|STARTED|Overall Study||48||
59873634|NCT03002194|75997732|FG000|COMPLETED|Overall Study||38||
59873635|NCT03002194|75997732|FG000|NOT COMPLETED|Overall Study||10||
59873636|NCT02912650|75997740|FG000|STARTED|Overall Study||56||
59873637|NCT02912650|75997741|FG001|STARTED|Overall Study||172||
59873638|NCT02912650|75997742|FG002|STARTED|Overall Study||175||
59873639|NCT02912650|75997743|FG003|STARTED|Overall Study||165||
59873640|NCT02912650|75997740|FG000|COMPLETED|Overall Study||55||
59873641|NCT02912650|75997741|FG001|COMPLETED|Overall Study||172||
59873642|NCT02912650|75997742|FG002|COMPLETED|Overall Study||173||
59873643|NCT02912650|75997743|FG003|COMPLETED|Overall Study||160||
59873644|NCT02912650|75997740|FG000|NOT COMPLETED|Overall Study||1||
59873645|NCT02912650|75997741|FG001|NOT COMPLETED|Overall Study||0||
59873646|NCT02912650|75997742|FG002|NOT COMPLETED|Overall Study||2||
59873647|NCT02912650|75997743|FG003|NOT COMPLETED|Overall Study||5||
59873648|NCT03004924|75997756|FG000|STARTED|Overall Study||324||
59873649|NCT03004924|75997757|FG001|STARTED|Overall Study||108||
59873650|NCT03004924|75997758|FG002|STARTED|Overall Study||321||
59873651|NCT03004924|75997756|FG000|COMPLETED|Overall Study||297||
59873652|NCT03004924|75997757|FG001|COMPLETED|Overall Study||94||
59873653|NCT03004924|75997758|FG002|COMPLETED|Overall Study||293||
59873654|NCT03004924|75997756|FG000|NOT COMPLETED|Overall Study||27||
59873655|NCT03004924|75997757|FG001|NOT COMPLETED|Overall Study||14||
59873656|NCT03004924|75997758|FG002|NOT COMPLETED|Overall Study||28||
59873657|NCT03002038|75997769|FG000|STARTED|Overall Study||46||
59873658|NCT03002038|75997770|FG001|STARTED|Overall Study||40||
59873659|NCT03002038|75997769|FG000|COMPLETED|Overall Study||35||
59873660|NCT03002038|75997770|FG001|COMPLETED|Overall Study||33||
59873661|NCT03002038|75997769|FG000|NOT COMPLETED|Overall Study||11||
59873662|NCT03002038|75997770|FG001|NOT COMPLETED|Overall Study||7||
59873663|NCT02911948|75997778|FG000|STARTED|Overall Study||105||
59873664|NCT02911948|75997779|FG001|STARTED|Overall Study||105||
59873665|NCT02911948|75997778|FG000|COMPLETED|Overall Study||105||
59873666|NCT02911948|75997779|FG001|COMPLETED|Overall Study||98||
59873667|NCT02911948|75997778|FG000|NOT COMPLETED|Overall Study||0||
59873668|NCT02911948|75997779|FG001|NOT COMPLETED|Overall Study||7||
59873669|NCT02996968|75997787|FG000|STARTED|Overall Study||79||
59873670|NCT02996968|75997788|FG001|STARTED|Overall Study||79||
59873671|NCT02996968|75997787|FG000|COMPLETED|Overall Study||78||
59873672|NCT02996968|75997788|FG001|COMPLETED|Overall Study||79||
59873673|NCT02996968|75997787|FG000|NOT COMPLETED|Overall Study||1||
59873674|NCT02996968|75997788|FG001|NOT COMPLETED|Overall Study||0||
59873675|NCT00027027|75997799|FG000|STARTED|Overall Study||3||
59873676|NCT00027027|75997800|FG001|STARTED|Overall Study||3||
59873677|NCT00027027|75997801|FG002|STARTED|Overall Study||4||
59873678|NCT00027027|75997802|FG003|STARTED|Overall Study||3||
59873679|NCT00027027|75997803|FG004|STARTED|Overall Study||8||
59873680|NCT00027027|75997799|FG000|Discontinued Before 2 Treatment Cycles|Overall Study||0||
59873681|NCT00027027|75997800|FG001|Discontinued Before 2 Treatment Cycles|Overall Study||0||
60135441|NCT03307252|76258154|FG001|STARTED|Part 3, Period 4||0||
60135442|NCT03307252|76258155|FG002|STARTED|Part 3, Period 4||0||
60135443|NCT03307252|76258156|FG003|STARTED|Part 3, Period 4||0||
59873682|NCT00027027|75997801|FG002|Discontinued Before 2 Treatment Cycles|Overall Study||1||
59873683|NCT00027027|75997802|FG003|Discontinued Before 2 Treatment Cycles|Overall Study||0||
59873684|NCT00027027|75997803|FG004|Discontinued Before 2 Treatment Cycles|Overall Study||1||
59873685|NCT00027027|75997799|FG000|Completed 2 Cycles of Treatment|Overall Study||3||
59873686|NCT00027027|75997800|FG001|Completed 2 Cycles of Treatment|Overall Study||3||
59873687|NCT00027027|75997801|FG002|Completed 2 Cycles of Treatment|Overall Study||3||
59873688|NCT00027027|75997802|FG003|Completed 2 Cycles of Treatment|Overall Study||3||
59873689|NCT00027027|75997803|FG004|Completed 2 Cycles of Treatment|Overall Study||7||
59873690|NCT00027027|75997799|FG000|Discontinued at Cycle 2|Overall Study||2||
59873691|NCT00027027|75997800|FG001|Discontinued at Cycle 2|Overall Study||2||
59873692|NCT00027027|75997801|FG002|Discontinued at Cycle 2|Overall Study||1||
59873693|NCT00027027|75997802|FG003|Discontinued at Cycle 2|Overall Study||1||
59873694|NCT00027027|75997803|FG004|Discontinued at Cycle 2|Overall Study||3||
59873695|NCT00027027|75997799|FG000|Treated Beyond Cycle 2|Overall Study||1||
59873696|NCT00027027|75997800|FG001|Treated Beyond Cycle 2|Overall Study||1||
59873697|NCT00027027|75997801|FG002|Treated Beyond Cycle 2|Overall Study||2||
59873698|NCT00027027|75997802|FG003|Treated Beyond Cycle 2|Overall Study||2||
59873699|NCT00027027|75997803|FG004|Treated Beyond Cycle 2|Overall Study||4||
59873700|NCT00027027|75997799|FG000|COMPLETED|Overall Study||0||
59873701|NCT00027027|75997800|FG001|COMPLETED|Overall Study||0||
59873702|NCT00027027|75997801|FG002|COMPLETED|Overall Study||0||
59873703|NCT00027027|75997802|FG003|COMPLETED|Overall Study||0||
59873704|NCT00027027|75997803|FG004|COMPLETED|Overall Study||0||
59873705|NCT00027027|75997799|FG000|NOT COMPLETED|Overall Study||3||
59873706|NCT00027027|75997800|FG001|NOT COMPLETED|Overall Study||3||
59873707|NCT00027027|75997801|FG002|NOT COMPLETED|Overall Study||4||
59873708|NCT00027027|75997802|FG003|NOT COMPLETED|Overall Study||3||
59873709|NCT00027027|75997803|FG004|NOT COMPLETED|Overall Study||8||
59873710|NCT00046839|75997821|FG000|STARTED|Overall Study||8||
59873711|NCT00046839|75997822|FG001|STARTED|Overall Study||13||
59873712|NCT00046839|75997821|FG000|COMPLETED|Overall Study|Subjects contributing data to either primary analysis are considered to have completed the study.|7||
59873713|NCT00046839|75997822|FG001|COMPLETED|Overall Study|Subjects contributing data to either primary analysis are considered to have completed the study.|11||
59873714|NCT00046839|75997821|FG000|NOT COMPLETED|Overall Study||1||
59873715|NCT00046839|75997822|FG001|NOT COMPLETED|Overall Study||2||
59873716|NCT00006903|75997831|FG000|STARTED|Overall Study||10||
59873717|NCT00006903|75997832|FG001|STARTED|Overall Study||24||
59873718|NCT00006903|75997833|FG002|STARTED|Overall Study||33||
59873719|NCT00006903|75997831|FG000|COMPLETED|Overall Study||0||
59873720|NCT00006903|75997832|FG001|COMPLETED|Overall Study||20||
59873721|NCT00006903|75997833|FG002|COMPLETED|Overall Study||27||
59873722|NCT00006903|75997831|FG000|NOT COMPLETED|Overall Study||10||
59873723|NCT00006903|75997832|FG001|NOT COMPLETED|Overall Study||4||
59873724|NCT00006903|75997833|FG002|NOT COMPLETED|Overall Study||6||
59873725|NCT00026793|75997841|FG000|STARTED|Overall Study||29||
59873726|NCT00026793|75997841|FG000|COMPLETED|Overall Study||21||
59873727|NCT00026793|75997841|FG000|NOT COMPLETED|Overall Study||8||
59873728|NCT03539484|75997852|FG000|STARTED|Overall Study||1||
59873729|NCT03539484|75997853|FG001|STARTED|Overall Study||1||
59873730|NCT03539484|75997854|FG002|STARTED|Overall Study||1||
59873731|NCT03539484|75997855|FG003|STARTED|Overall Study||3||
59873732|NCT03539484|75997856|FG004|STARTED|Overall Study||13||
59873733|NCT03539484|75997857|FG005|STARTED|Overall Study||5||
59873734|NCT03539484|75997858|FG006|STARTED|Overall Study||2||
59873735|NCT03539484|75997852|FG000|COMPLETED|Overall Study||0||
59873736|NCT03539484|75997853|FG001|COMPLETED|Overall Study||0||
59873737|NCT03539484|75997854|FG002|COMPLETED|Overall Study||0||
59873738|NCT03539484|75997855|FG003|COMPLETED|Overall Study||0||
59873739|NCT03539484|75997856|FG004|COMPLETED|Overall Study||0||
59873740|NCT03539484|75997857|FG005|COMPLETED|Overall Study||0||
59873741|NCT03539484|75997858|FG006|COMPLETED|Overall Study||0||
59873742|NCT03539484|75997852|FG000|NOT COMPLETED|Overall Study||1||
59873743|NCT03539484|75997853|FG001|NOT COMPLETED|Overall Study||1||
59873744|NCT03539484|75997854|FG002|NOT COMPLETED|Overall Study||1||
59873745|NCT03539484|75997855|FG003|NOT COMPLETED|Overall Study||3||
59873746|NCT03539484|75997856|FG004|NOT COMPLETED|Overall Study||13||
59873747|NCT03539484|75997857|FG005|NOT COMPLETED|Overall Study||5||
59873748|NCT03539484|75997858|FG006|NOT COMPLETED|Overall Study||2||
59873749|NCT03561090|75997881|FG000|STARTED|Overall Study||247|Randomized|
59873750|NCT03561090|75997882|FG001|STARTED|Overall Study||248|Randomized|
59873751|NCT03561090|75997881|FG000|Randomized and Treated|Overall Study||246||
59873752|NCT03561090|75997882|FG001|Randomized and Treated|Overall Study||247||
59873753|NCT03561090|75997881|FG000|COMPLETED|Overall Study||207||
59873754|NCT03561090|75997882|FG001|COMPLETED|Overall Study||212||
59873755|NCT03561090|75997881|FG000|NOT COMPLETED|Overall Study||40||
59873756|NCT03561090|75997882|FG001|NOT COMPLETED|Overall Study||36||
59873757|NCT02996500|75997896|FG000|STARTED|Overall Study||39||
59873758|NCT02996500|75997897|FG001|STARTED|Overall Study||43||
59873759|NCT02996500|75997898|FG002|STARTED|Overall Study||39||
59873760|NCT02996500|75997899|FG003|STARTED|Overall Study||50||
59873761|NCT02996500|75997900|FG004|STARTED|Overall Study||50||
59873762|NCT02996500|75997901|FG005|STARTED|Overall Study||48||
59873763|NCT02996500|75997896|FG000|COMPLETED|Overall Study||31||
59873764|NCT02996500|75997897|FG001|COMPLETED|Overall Study||42||
59873765|NCT02996500|75997898|FG002|COMPLETED|Overall Study||29||
59873766|NCT02996500|75997899|FG003|COMPLETED|Overall Study||46||
59873767|NCT02996500|75997900|FG004|COMPLETED|Overall Study||45||
59873768|NCT02996500|75997901|FG005|COMPLETED|Overall Study||44||
59873769|NCT02996500|75997896|FG000|NOT COMPLETED|Overall Study||8||
59873770|NCT02996500|75997897|FG001|NOT COMPLETED|Overall Study||1||
59873771|NCT02996500|75997898|FG002|NOT COMPLETED|Overall Study||10||
59873772|NCT02996500|75997899|FG003|NOT COMPLETED|Overall Study||4||
59873773|NCT02996500|75997900|FG004|NOT COMPLETED|Overall Study||5||
59873774|NCT02996500|75997901|FG005|NOT COMPLETED|Overall Study||4||
59873775|NCT00006489|75997923|FG000|STARTED|Overall Study||42||
59873776|NCT00006489|75997924|FG001|STARTED|Overall Study||40||
59873777|NCT00006489|75997925|FG002|STARTED|Overall Study||40||
59873778|NCT00006489|75997926|FG003|STARTED|Overall Study||43||
59873779|NCT00006489|75997923|FG000|COMPLETED|Overall Study||29||
59873780|NCT00006489|75997924|FG001|COMPLETED|Overall Study||26||
59873781|NCT00006489|75997925|FG002|COMPLETED|Overall Study||25||
59873782|NCT00006489|75997926|FG003|COMPLETED|Overall Study||32||
59873783|NCT00006489|75997923|FG000|NOT COMPLETED|Overall Study||13||
59873784|NCT00006489|75997924|FG001|NOT COMPLETED|Overall Study||14||
59873785|NCT00006489|75997925|FG002|NOT COMPLETED|Overall Study||15||
59873786|NCT00006489|75997926|FG003|NOT COMPLETED|Overall Study||11||
59873787|NCT03535974|75997939|FG000|STARTED|First Intervention Weeks 0-6 (V1-V2)||14||
59873788|NCT03535974|75997940|FG001|STARTED|First Intervention Weeks 0-6 (V1-V2)||19||
59873789|NCT03535974|75997941|FG002|STARTED|First Intervention Weeks 0-6 (V1-V2)||5||
59873790|NCT03535974|75997939|FG000|COMPLETED|First Intervention Weeks 0-6 (V1-V2)||12||
59873791|NCT03535974|75997940|FG001|COMPLETED|First Intervention Weeks 0-6 (V1-V2)||17||
59873792|NCT03535974|75997941|FG002|COMPLETED|First Intervention Weeks 0-6 (V1-V2)||5||
59873793|NCT03535974|75997939|FG000|NOT COMPLETED|First Intervention Weeks 0-6 (V1-V2)||2||
59873794|NCT03535974|75997940|FG001|NOT COMPLETED|First Intervention Weeks 0-6 (V1-V2)||2||
59873795|NCT03535974|75997941|FG002|NOT COMPLETED|First Intervention Weeks 0-6 (V1-V2)||0||
59873796|NCT03535974|75997939|FG000|STARTED|Second Intervention Weeks 6-12 (V2-V3)||12||
59873797|NCT03535974|75997940|FG001|STARTED|Second Intervention Weeks 6-12 (V2-V3)||17||
59873798|NCT03535974|75997941|FG002|STARTED|Second Intervention Weeks 6-12 (V2-V3)||5||
59873799|NCT03535974|75997939|FG000|COMPLETED|Second Intervention Weeks 6-12 (V2-V3)||12||
59873800|NCT03535974|75997940|FG001|COMPLETED|Second Intervention Weeks 6-12 (V2-V3)||17||
59873801|NCT03535974|75997941|FG002|COMPLETED|Second Intervention Weeks 6-12 (V2-V3)||5||
59873802|NCT03535974|75997939|FG000|NOT COMPLETED|Second Intervention Weeks 6-12 (V2-V3)||0||
59873803|NCT03535974|75997940|FG001|NOT COMPLETED|Second Intervention Weeks 6-12 (V2-V3)||0||
59873804|NCT03535974|75997941|FG002|NOT COMPLETED|Second Intervention Weeks 6-12 (V2-V3)||0||
59873805|NCT00025233|75997949|FG000|STARTED|Overall Study||50||
59873806|NCT00025233|75997949|FG000|COMPLETED|Overall Study||46||
59873807|NCT00025233|75997949|FG000|NOT COMPLETED|Overall Study||4||
59873808|NCT00025155|75997959|FG000|STARTED|Overall Study||51||
59873809|NCT00025155|75997959|FG000|COMPLETED|Overall Study|Patients who were eligible and received any study treatment.|49||
59873810|NCT00025155|75997959|FG000|NOT COMPLETED|Overall Study||2||
59873811|NCT02998996|75997974|FG000|STARTED|Overall Study||36||
59873812|NCT02998996|75997975|FG001|STARTED|Overall Study||35||
59873813|NCT02998996|75997976|FG002|STARTED|Overall Study||36||
59873814|NCT02998996|75997977|FG003|STARTED|Overall Study||18||
59873815|NCT02998996|75997978|FG004|STARTED|Overall Study||18||
59873816|NCT02998996|75997979|FG005|STARTED|Overall Study||19||
59873817|NCT02998996|75997974|FG000|COMPLETED|Overall Study||36||
59873818|NCT02998996|75997975|FG001|COMPLETED|Overall Study||34||
59873819|NCT02998996|75997976|FG002|COMPLETED|Overall Study||35||
59873820|NCT02998996|75997977|FG003|COMPLETED|Overall Study||18||
59873821|NCT02998996|75997978|FG004|COMPLETED|Overall Study||17||
59873822|NCT02998996|75997979|FG005|COMPLETED|Overall Study||19||
59873823|NCT02998996|75997974|FG000|NOT COMPLETED|Overall Study||0||
59873824|NCT02998996|75997975|FG001|NOT COMPLETED|Overall Study||1||
59873825|NCT02998996|75997976|FG002|NOT COMPLETED|Overall Study||1||
59873826|NCT02998996|75997977|FG003|NOT COMPLETED|Overall Study||0||
59873827|NCT02998996|75997978|FG004|NOT COMPLETED|Overall Study||1||
59873828|NCT02998996|75997979|FG005|NOT COMPLETED|Overall Study||0||
59873829|NCT02994940|75997995|FG000|STARTED|Overall Study||37||
59873830|NCT02994940|75997996|FG001|STARTED|Overall Study||37||
59873831|NCT02994940|75997995|FG000|COMPLETED|Overall Study||30||
59873832|NCT02994940|75997996|FG001|COMPLETED|Overall Study||36||
59873833|NCT02994940|75997995|FG000|NOT COMPLETED|Overall Study||7||
59873834|NCT02994940|75997996|FG001|NOT COMPLETED|Overall Study||1||
59873835|NCT02994394|75998004|FG000|STARTED|Period 1 (Days 1 to 3)||14||
59873836|NCT02994394|75998005|FG001|STARTED|Period 1 (Days 1 to 3)||14||
59873837|NCT02994394|75998006|FG002|STARTED|Period 1 (Days 1 to 3)||14||
59873838|NCT02994394|75998007|FG003|STARTED|Period 1 (Days 1 to 3)||14||
59873839|NCT02994394|75998008|FG004|STARTED|Period 1 (Days 1 to 3)||14||
59873840|NCT02994394|75998009|FG005|STARTED|Period 1 (Days 1 to 3)||14||
59873841|NCT02994394|75998004|FG000|COMPLETED|Period 1 (Days 1 to 3)||14||
59873842|NCT02994394|75998005|FG001|COMPLETED|Period 1 (Days 1 to 3)||14||
59873843|NCT02994394|75998006|FG002|COMPLETED|Period 1 (Days 1 to 3)||13||
59873844|NCT02994394|75998007|FG003|COMPLETED|Period 1 (Days 1 to 3)||14||
59873845|NCT02994394|75998008|FG004|COMPLETED|Period 1 (Days 1 to 3)||14||
59873846|NCT02994394|75998009|FG005|COMPLETED|Period 1 (Days 1 to 3)||14||
59873847|NCT02994394|75998004|FG000|NOT COMPLETED|Period 1 (Days 1 to 3)||0||
59873848|NCT02994394|75998005|FG001|NOT COMPLETED|Period 1 (Days 1 to 3)||0||
59873849|NCT02994394|75998006|FG002|NOT COMPLETED|Period 1 (Days 1 to 3)||1||
59873850|NCT02994394|75998007|FG003|NOT COMPLETED|Period 1 (Days 1 to 3)||0||
59873851|NCT02994394|75998008|FG004|NOT COMPLETED|Period 1 (Days 1 to 3)||0||
59873852|NCT02994394|75998009|FG005|NOT COMPLETED|Period 1 (Days 1 to 3)||0||
59873853|NCT02994394|75998004|FG000|STARTED|Period 2 (Days 4 to 6)||14||
59873854|NCT02994394|75998005|FG001|STARTED|Period 2 (Days 4 to 6)||14||
59873855|NCT02994394|75998006|FG002|STARTED|Period 2 (Days 4 to 6)||13||
59873856|NCT02994394|75998007|FG003|STARTED|Period 2 (Days 4 to 6)||14||
59873857|NCT02994394|75998008|FG004|STARTED|Period 2 (Days 4 to 6)||14||
59873858|NCT02994394|75998009|FG005|STARTED|Period 2 (Days 4 to 6)||14||
59873859|NCT02994394|75998004|FG000|COMPLETED|Period 2 (Days 4 to 6)||14||
59873860|NCT02994394|75998005|FG001|COMPLETED|Period 2 (Days 4 to 6)||13||
59873861|NCT02994394|75998006|FG002|COMPLETED|Period 2 (Days 4 to 6)||13||
59873862|NCT02994394|75998007|FG003|COMPLETED|Period 2 (Days 4 to 6)||14||
59873863|NCT02994394|75998008|FG004|COMPLETED|Period 2 (Days 4 to 6)||13||
59873864|NCT02994394|75998009|FG005|COMPLETED|Period 2 (Days 4 to 6)||14||
59873865|NCT02994394|75998004|FG000|NOT COMPLETED|Period 2 (Days 4 to 6)||0||
59873866|NCT02994394|75998005|FG001|NOT COMPLETED|Period 2 (Days 4 to 6)||1||
59873867|NCT02994394|75998006|FG002|NOT COMPLETED|Period 2 (Days 4 to 6)||0||
59873868|NCT02994394|75998007|FG003|NOT COMPLETED|Period 2 (Days 4 to 6)||0||
59873869|NCT02994394|75998008|FG004|NOT COMPLETED|Period 2 (Days 4 to 6)||1||
59873870|NCT02994394|75998009|FG005|NOT COMPLETED|Period 2 (Days 4 to 6)||0||
59873871|NCT02994394|75998004|FG000|STARTED|Period 3 (Days 7 and 8)||14||
59873872|NCT02994394|75998005|FG001|STARTED|Period 3 (Days 7 and 8)||13||
59873873|NCT02994394|75998006|FG002|STARTED|Period 3 (Days 7 and 8)||13||
59873874|NCT02994394|75998007|FG003|STARTED|Period 3 (Days 7 and 8)||14||
59873875|NCT02994394|75998008|FG004|STARTED|Period 3 (Days 7 and 8)||13||
59873876|NCT02994394|75998009|FG005|STARTED|Period 3 (Days 7 and 8)||14||
59873877|NCT02994394|75998004|FG000|COMPLETED|Period 3 (Days 7 and 8)||14||
59873878|NCT02994394|75998005|FG001|COMPLETED|Period 3 (Days 7 and 8)||13||
59873879|NCT02994394|75998006|FG002|COMPLETED|Period 3 (Days 7 and 8)||13||
59873880|NCT02994394|75998007|FG003|COMPLETED|Period 3 (Days 7 and 8)||14||
59873881|NCT02994394|75998008|FG004|COMPLETED|Period 3 (Days 7 and 8)||13||
59873882|NCT02994394|75998009|FG005|COMPLETED|Period 3 (Days 7 and 8)||14||
59873883|NCT02994394|75998004|FG000|NOT COMPLETED|Period 3 (Days 7 and 8)||0||
59873884|NCT02994394|75998005|FG001|NOT COMPLETED|Period 3 (Days 7 and 8)||0||
59873885|NCT02994394|75998006|FG002|NOT COMPLETED|Period 3 (Days 7 and 8)||0||
59873886|NCT02994394|75998007|FG003|NOT COMPLETED|Period 3 (Days 7 and 8)||0||
59873887|NCT02994394|75998008|FG004|NOT COMPLETED|Period 3 (Days 7 and 8)||0||
59873888|NCT02994394|75998009|FG005|NOT COMPLETED|Period 3 (Days 7 and 8)||0||
59873889|NCT02998840|75998027|FG000|STARTED|Overall Study||33||
59873890|NCT02998840|75998028|FG001|STARTED|Overall Study||33||
59873891|NCT02998840|75998029|FG002|STARTED|Overall Study||33||
59873892|NCT02998840|75998030|FG003|STARTED|Overall Study||33||
59873893|NCT02998840|75998027|FG000|COMPLETED|Overall Study||29||
59873894|NCT02998840|75998028|FG001|COMPLETED|Overall Study||30||
59873895|NCT02998840|75998029|FG002|COMPLETED|Overall Study||31||
59873896|NCT02998840|75998030|FG003|COMPLETED|Overall Study||28||
59873897|NCT02998840|75998027|FG000|NOT COMPLETED|Overall Study||4||
59873898|NCT02998840|75998028|FG001|NOT COMPLETED|Overall Study||3||
59873899|NCT02998840|75998029|FG002|NOT COMPLETED|Overall Study||2||
60135444|NCT03307252|76258157|FG004|STARTED|Part 3, Period 4||0||
60135445|NCT03307252|76258158|FG005|STARTED|Part 3, Period 4||0||
60135446|NCT03307252|76258159|FG006|STARTED|Part 3, Period 4||0||
60135447|NCT03307252|76258160|FG007|STARTED|Part 3, Period 4||4||
60135448|NCT03307252|76258161|FG008|STARTED|Part 3, Period 4||4||
60135449|NCT03307252|76258162|FG009|STARTED|Part 3, Period 4||4||
60135450|NCT03307252|76258163|FG010|STARTED|Part 3, Period 4||3||
60135451|NCT03307252|76258153|FG000|COMPLETED|Part 3, Period 4||0||
60135452|NCT03307252|76258154|FG001|COMPLETED|Part 3, Period 4||0||
60135453|NCT03307252|76258155|FG002|COMPLETED|Part 3, Period 4||0||
60135454|NCT03307252|76258156|FG003|COMPLETED|Part 3, Period 4||0||
60135455|NCT03307252|76258157|FG004|COMPLETED|Part 3, Period 4||0||
60135456|NCT03307252|76258158|FG005|COMPLETED|Part 3, Period 4||0||
60135457|NCT03307252|76258159|FG006|COMPLETED|Part 3, Period 4||0||
60135458|NCT03307252|76258160|FG007|COMPLETED|Part 3, Period 4||4||
59873900|NCT02998840|75998030|FG003|NOT COMPLETED|Overall Study||5||
59873901|NCT00023673|75998041|FG000|STARTED|Overall Study||8||
59873902|NCT00023673|75998042|FG001|STARTED|Overall Study||9||
59873903|NCT00023673|75998043|FG002|STARTED|Overall Study||0||
59873904|NCT00023673|75998044|FG003|STARTED|Overall Study||46||
59873905|NCT00023673|75998041|FG000|COMPLETED|Overall Study|Phase I eligible patients starting protocol treatment are considered to have completed the study.|8||
59873906|NCT00023673|75998042|FG001|COMPLETED|Overall Study|Phase I eligible patients starting protocol treatment are considered to have completed the study.|9||
60135459|NCT03307252|76258161|FG008|COMPLETED|Part 3, Period 4||4||
59873907|NCT00023673|75998043|FG002|COMPLETED|Overall Study|This arm was not used since further de-escalation was not required.|0||
59873908|NCT00023673|75998044|FG003|COMPLETED|Overall Study|Phase II subjects contributing data to primary analysis are considered to have completed the study.|44||
60135460|NCT03307252|76258162|FG009|COMPLETED|Part 3, Period 4||4||
60135461|NCT03307252|76258163|FG010|COMPLETED|Part 3, Period 4||3||
60135462|NCT03307252|76258153|FG000|NOT COMPLETED|Part 3, Period 4||0||
60135463|NCT03307252|76258154|FG001|NOT COMPLETED|Part 3, Period 4||0||
59873909|NCT00023673|75998041|FG000|NOT COMPLETED|Overall Study||0||
59873910|NCT00023673|75998042|FG001|NOT COMPLETED|Overall Study||0||
59873911|NCT00023673|75998043|FG002|NOT COMPLETED|Overall Study||0||
60135464|NCT03307252|76258155|FG002|NOT COMPLETED|Part 3, Period 4||0||
60135465|NCT03307252|76258156|FG003|NOT COMPLETED|Part 3, Period 4||0||
60135466|NCT03307252|76258157|FG004|NOT COMPLETED|Part 3, Period 4||0||
60135467|NCT03307252|76258158|FG005|NOT COMPLETED|Part 3, Period 4||0||
59873912|NCT00023673|75998044|FG003|NOT COMPLETED|Overall Study||2||
59873913|NCT01069900|75998056|FG000|STARTED|Overall Study||305||
59873914|NCT01069900|75998057|FG001|STARTED|Overall Study||153||
59873915|NCT01069900|75998056|FG000|Treated|Overall Study||301||
59873916|NCT01069900|75998057|FG001|Treated|Overall Study||150||
59873917|NCT01069900|75998056|FG000|COMPLETED|Overall Study||287||
59873918|NCT01069900|75998057|FG001|COMPLETED|Overall Study||149||
59873919|NCT01069900|75998056|FG000|NOT COMPLETED|Overall Study||18||
59873920|NCT01069900|75998057|FG001|NOT COMPLETED|Overall Study||4||
59873921|NCT01069120|75998065|FG000|STARTED|Overall Study||27||
59873922|NCT01069120|75998065|FG000|COMPLETED|Overall Study||0||
59873923|NCT01069120|75998065|FG000|NOT COMPLETED|Overall Study||27||
59873924|NCT00006237|75998073|FG000|STARTED|Overall Study||212||
59873925|NCT00006237|75998074|FG001|STARTED|Overall Study||220||
59873926|NCT00006237|75998073|FG000|Eligible|Overall Study||203||
59873927|NCT00006237|75998074|FG001|Eligible|Overall Study||200||
59873928|NCT00006237|75998073|FG000|Eligible and Treated|Overall Study||203||
59873929|NCT00006237|75998074|FG001|Eligible and Treated|Overall Study||199||
59873930|NCT00006237|75998073|FG000|COMPLETED|Overall Study||87||
59873931|NCT00006237|75998074|FG001|COMPLETED|Overall Study||159||
59873932|NCT00006237|75998073|FG000|NOT COMPLETED|Overall Study||125||
59873933|NCT00006237|75998074|FG001|NOT COMPLETED|Overall Study||61||
59873934|NCT02993926|75998083|FG000|STARTED|Enantone Treatment Phase||108||
59873935|NCT02993926|75998084|FG001|STARTED|Enantone Treatment Phase||0||
59873936|NCT02993926|75998085|FG002|STARTED|Enantone Treatment Phase||0||
59873937|NCT02993926|75998083|FG000|COMPLETED|Enantone Treatment Phase||76||
59873938|NCT02993926|75998084|FG001|COMPLETED|Enantone Treatment Phase||0||
59873939|NCT02993926|75998085|FG002|COMPLETED|Enantone Treatment Phase||0||
59873940|NCT02993926|75998083|FG000|NOT COMPLETED|Enantone Treatment Phase||32||
59873941|NCT02993926|75998084|FG001|NOT COMPLETED|Enantone Treatment Phase||0||
59873942|NCT02993926|75998085|FG002|NOT COMPLETED|Enantone Treatment Phase||0||
59873943|NCT02993926|75998083|FG000|STARTED|Follow-Up Phase||0||
59873944|NCT02993926|75998084|FG001|STARTED|Follow-Up Phase||44||
59873945|NCT02993926|75998085|FG002|STARTED|Follow-Up Phase||26||
59873946|NCT02993926|75998083|FG000|COMPLETED|Follow-Up Phase||0||
59873947|NCT02993926|75998084|FG001|COMPLETED|Follow-Up Phase||44||
59873948|NCT02993926|75998085|FG002|COMPLETED|Follow-Up Phase||26||
59873949|NCT02993926|75998083|FG000|NOT COMPLETED|Follow-Up Phase||0||
59873950|NCT02993926|75998084|FG001|NOT COMPLETED|Follow-Up Phase||0||
59873951|NCT02993926|75998085|FG002|NOT COMPLETED|Follow-Up Phase||0||
59873952|NCT02993224|75998095|FG000|STARTED|Core Phase - Period 1||148||
59873953|NCT02993224|75998095|FG000|COMPLETED|Core Phase - Period 1||140||
59873954|NCT02993224|75998095|FG000|NOT COMPLETED|Core Phase - Period 1||8||
59873955|NCT02993224|75998095|FG000|STARTED|Core Phase- Period 2||140||
59873956|NCT02993224|75998095|FG000|COMPLETED|Core Phase- Period 2||136||
59873957|NCT02993224|75998095|FG000|NOT COMPLETED|Core Phase- Period 2||4||
59873958|NCT02993224|75998095|FG000|STARTED|Extension Phase||116|Participation in the extension phase was optional|
59873959|NCT02993224|75998095|FG000|COMPLETED|Extension Phase||80||
59873960|NCT02993224|75998095|FG000|NOT COMPLETED|Extension Phase||36||
59873961|NCT03495908|75998103|FG000|STARTED|Overall Study||69||
59873962|NCT03495908|75998104|FG001|STARTED|Overall Study||67||
59873963|NCT03495908|75998103|FG000|COMPLETED|Overall Study||59||
59873964|NCT03495908|75998104|FG001|COMPLETED|Overall Study||54||
59873965|NCT03495908|75998103|FG000|NOT COMPLETED|Overall Study||10||
59873966|NCT03495908|75998104|FG001|NOT COMPLETED|Overall Study||13||
59873967|NCT02992288|75998116|FG000|STARTED|Overall Study||106||
59873968|NCT02992288|75998117|FG001|STARTED|Overall Study||37||
59873969|NCT02992288|75998118|FG002|STARTED|Overall Study||70||
59873970|NCT02992288|75998119|FG003|STARTED|Overall Study||73||
59873971|NCT02992288|75998120|FG004|STARTED|Overall Study||69||
59873972|NCT02992288|75998121|FG005|STARTED|Overall Study||72||
59873973|NCT02992288|75998116|FG000|Treated|Overall Study||106||
59873974|NCT02992288|75998117|FG001|Treated|Overall Study||37||
59873975|NCT02992288|75998118|FG002|Treated|Overall Study||70||
59873976|NCT02992288|75998119|FG003|Treated|Overall Study||72||
59873977|NCT02992288|75998120|FG004|Treated|Overall Study||69||
59873978|NCT02992288|75998121|FG005|Treated|Overall Study||72||
59873979|NCT02992288|75998116|FG000|COMPLETED|Overall Study||89||
59873980|NCT02992288|75998117|FG001|COMPLETED|Overall Study||32||
59873981|NCT02992288|75998118|FG002|COMPLETED|Overall Study||63||
59873982|NCT02992288|75998119|FG003|COMPLETED|Overall Study||64||
59873983|NCT02992288|75998120|FG004|COMPLETED|Overall Study||61||
59873984|NCT02992288|75998121|FG005|COMPLETED|Overall Study||59||
59873985|NCT02992288|75998116|FG000|NOT COMPLETED|Overall Study||17||
59873986|NCT02992288|75998117|FG001|NOT COMPLETED|Overall Study||5||
59873987|NCT02992288|75998118|FG002|NOT COMPLETED|Overall Study||7||
59873988|NCT02992288|75998119|FG003|NOT COMPLETED|Overall Study||9||
59873989|NCT02992288|75998120|FG004|NOT COMPLETED|Overall Study||8||
59873990|NCT02992288|75998121|FG005|NOT COMPLETED|Overall Study||13||
59873991|NCT02992132|75998138|FG000|STARTED|Overall Study||40||
59873992|NCT02992132|75998139|FG001|STARTED|Overall Study||35||
59873993|NCT02992132|75998140|FG002|STARTED|Overall Study||36||
59873994|NCT02992132|75998138|FG000|COMPLETED|Overall Study||27||
59873995|NCT02992132|75998139|FG001|COMPLETED|Overall Study||27||
59873996|NCT02992132|75998140|FG002|COMPLETED|Overall Study||29||
59873997|NCT02992132|75998138|FG000|NOT COMPLETED|Overall Study||13||
59873998|NCT02992132|75998139|FG001|NOT COMPLETED|Overall Study||8||
59873999|NCT02992132|75998140|FG002|NOT COMPLETED|Overall Study||7||
59874000|NCT03444584|75998150|FG000|STARTED|Overall Study||24||
59874001|NCT03444584|75998151|FG001|STARTED|Overall Study||25||
59874002|NCT03444584|75998150|FG000|COMPLETED|Overall Study||24||
59874003|NCT03444584|75998151|FG001|COMPLETED|Overall Study||23||
59874004|NCT03444584|75998150|FG000|NOT COMPLETED|Overall Study||0||
59874005|NCT03444584|75998151|FG001|NOT COMPLETED|Overall Study||2||
59874006|NCT02989168|75998160|FG000|STARTED|Overall Study||11||
59874007|NCT02989168|75998161|FG001|STARTED|Overall Study||3||
59874008|NCT02989168|75998160|FG000|COMPLETED|Overall Study||7||
59874009|NCT02989168|75998161|FG001|COMPLETED|Overall Study||0||
59874010|NCT02989168|75998160|FG000|NOT COMPLETED|Overall Study||4||
59874011|NCT02989168|75998161|FG001|NOT COMPLETED|Overall Study||3||
59874012|NCT02988622|75998169|FG000|STARTED|Overall Study||100||
59874013|NCT02988622|75998169|FG000|COMPLETED|Overall Study||83||
59874014|NCT02988622|75998169|FG000|NOT COMPLETED|Overall Study||17||
59874015|NCT03412604|75998175|FG000|STARTED|Overall Study||5||
59874016|NCT03412604|75998175|FG000|COMPLETED|Overall Study||4||
59874017|NCT03412604|75998175|FG000|NOT COMPLETED|Overall Study||1||
59874018|NCT02991430|75998182|FG000|STARTED|Treatment Period 1||14||
59874019|NCT02991430|75998183|FG001|STARTED|Treatment Period 1||15||
59874020|NCT02991430|75998184|FG002|STARTED|Treatment Period 1||16||
59874021|NCT02991430|75998182|FG000|COMPLETED|Treatment Period 1||13||
59874022|NCT02991430|75998183|FG001|COMPLETED|Treatment Period 1||11||
59874023|NCT02991430|75998184|FG002|COMPLETED|Treatment Period 1||14||
59874024|NCT02991430|75998182|FG000|NOT COMPLETED|Treatment Period 1||1||
59874025|NCT02991430|75998183|FG001|NOT COMPLETED|Treatment Period 1||4||
59874026|NCT02991430|75998184|FG002|NOT COMPLETED|Treatment Period 1||2||
59874027|NCT02991430|75998182|FG000|STARTED|Treatment Period 2||13||
59874028|NCT02991430|75998183|FG001|STARTED|Treatment Period 2||11||
59874029|NCT02991430|75998184|FG002|STARTED|Treatment Period 2||14||
59874030|NCT02991430|75998182|FG000|COMPLETED|Treatment Period 2||7||
59874031|NCT02991430|75998183|FG001|COMPLETED|Treatment Period 2||8||
59874032|NCT02991430|75998184|FG002|COMPLETED|Treatment Period 2||10||
59874033|NCT02991430|75998182|FG000|NOT COMPLETED|Treatment Period 2||6||
59874034|NCT02991430|75998183|FG001|NOT COMPLETED|Treatment Period 2||3||
59874035|NCT02991430|75998184|FG002|NOT COMPLETED|Treatment Period 2||4||
59874036|NCT02991430|75998182|FG000|STARTED|Post-treatment Observation Period||7||
59874037|NCT02991430|75998183|FG001|STARTED|Post-treatment Observation Period||8||
59874038|NCT02991430|75998184|FG002|STARTED|Post-treatment Observation Period||10||
59874039|NCT02991430|75998182|FG000|COMPLETED|Post-treatment Observation Period||4||
59874040|NCT02991430|75998183|FG001|COMPLETED|Post-treatment Observation Period||2||
59874041|NCT02991430|75998184|FG002|COMPLETED|Post-treatment Observation Period||5||
59874042|NCT02991430|75998182|FG000|NOT COMPLETED|Post-treatment Observation Period||3||
59874043|NCT02991430|75998183|FG001|NOT COMPLETED|Post-treatment Observation Period||6||
59874044|NCT02991430|75998184|FG002|NOT COMPLETED|Post-treatment Observation Period||5||
59874045|NCT03411902|75998194|FG000|STARTED|Overall Study||11||
59874046|NCT03411902|75998195|FG001|STARTED|Overall Study||13||
59874047|NCT03411902|75998194|FG000|COMPLETED|Overall Study||8||
59874048|NCT03411902|75998195|FG001|COMPLETED|Overall Study||13||
59874049|NCT03411902|75998194|FG000|NOT COMPLETED|Overall Study||3||
59874050|NCT03411902|75998195|FG001|NOT COMPLETED|Overall Study||0||
59874051|NCT03494816|75998201|FG000|STARTED|Overall Study||24||
59874052|NCT03494816|75998201|FG000|COMPLETED|Overall Study||18||
59874053|NCT03494816|75998201|FG000|NOT COMPLETED|Overall Study||6||
59874054|NCT03492554|75998211|FG000|STARTED|Overall Study||301||
59874055|NCT03492554|75998212|FG001|STARTED|Overall Study||301||
59874056|NCT03492554|75998211|FG000|COMPLETED|Overall Study||301||
59874057|NCT03492554|75998212|FG001|COMPLETED|Overall Study||287||
59874058|NCT03492554|75998211|FG000|NOT COMPLETED|Overall Study||0||
59874059|NCT03492554|75998212|FG001|NOT COMPLETED|Overall Study||14||
59874060|NCT05428020|75998221|FG000|STARTED|Overall Study||194||
59874061|NCT05428020|75998222|FG001|STARTED|Overall Study||194||
59874062|NCT05428020|75998221|FG000|COMPLETED|Overall Study||194||
59874063|NCT05428020|75998222|FG001|COMPLETED|Overall Study||194||
59874064|NCT05428020|75998221|FG000|NOT COMPLETED|Overall Study||0||
59874065|NCT05428020|75998222|FG001|NOT COMPLETED|Overall Study||0||
59874066|NCT05022563|75998234|FG000|STARTED|Overall Study||11208||
59874067|NCT05022563|75998235|FG001|STARTED|Overall Study||5047||
60002442|NCT01662999|76118330|FG002|NOT COMPLETED|Period 1||0||
60002443|NCT01662999|76118331|FG003|NOT COMPLETED|Period 1||0||
60002444|NCT01662999|76118332|FG004|NOT COMPLETED|Period 1||0||
59874068|NCT05022563|75998236|FG002|STARTED|Overall Study||2103||
59874069|NCT05022563|75998237|FG003|STARTED|Overall Study||2342||
59874070|NCT05022563|75998238|FG004|STARTED|Overall Study||26276||
59874071|NCT05022563|75998239|FG005|STARTED|Overall Study||8783||
59874072|NCT05022563|75998234|FG000|Without Active Cancer|Overall Study||10390||
59874073|NCT05022563|75998235|FG001|Without Active Cancer|Overall Study||4543||
59874074|NCT05022563|75998236|FG002|Without Active Cancer|Overall Study||1894||
60002445|NCT01662999|76118333|FG005|NOT COMPLETED|Period 1||0||
59874075|NCT05022563|75998237|FG003|Without Active Cancer|Overall Study||2078||
59874076|NCT05022563|75998238|FG004|Without Active Cancer|Overall Study||23049||
59874077|NCT05022563|75998239|FG005|Without Active Cancer|Overall Study||6550||
59874078|NCT05022563|75998234|FG000|With Active Cancer (Diagnosis of Cancer Within Past 6 Months of Index Date)|Overall Study||818||
59874079|NCT05022563|75998235|FG001|With Active Cancer (Diagnosis of Cancer Within Past 6 Months of Index Date)|Overall Study||504||
59874080|NCT05022563|75998236|FG002|With Active Cancer (Diagnosis of Cancer Within Past 6 Months of Index Date)|Overall Study||209||
59874081|NCT05022563|75998237|FG003|With Active Cancer (Diagnosis of Cancer Within Past 6 Months of Index Date)|Overall Study||264||
59874082|NCT05022563|75998238|FG004|With Active Cancer (Diagnosis of Cancer Within Past 6 Months of Index Date)|Overall Study||3227||
59874083|NCT05022563|75998239|FG005|With Active Cancer (Diagnosis of Cancer Within Past 6 Months of Index Date)|Overall Study||2233||
59874084|NCT05022563|75998234|FG000|COMPLETED|Overall Study||11208||
59874085|NCT05022563|75998235|FG001|COMPLETED|Overall Study||5047||
59874086|NCT05022563|75998236|FG002|COMPLETED|Overall Study||2103||
59874087|NCT05022563|75998237|FG003|COMPLETED|Overall Study||2342||
59874088|NCT05022563|75998238|FG004|COMPLETED|Overall Study||26276||
59874089|NCT05022563|75998239|FG005|COMPLETED|Overall Study||8783||
59874090|NCT05022563|75998234|FG000|NOT COMPLETED|Overall Study||0||
59874091|NCT05022563|75998235|FG001|NOT COMPLETED|Overall Study||0||
59874092|NCT05022563|75998236|FG002|NOT COMPLETED|Overall Study||0||
59604585|NCT02015520|75714854|FG003|NOT COMPLETED|Overall Study||4||
59874093|NCT05022563|75998237|FG003|NOT COMPLETED|Overall Study||0||
59874094|NCT05022563|75998238|FG004|NOT COMPLETED|Overall Study||0||
60135468|NCT03307252|76258159|FG006|NOT COMPLETED|Part 3, Period 4||0||
60135469|NCT03307252|76258160|FG007|NOT COMPLETED|Part 3, Period 4||0||
60135470|NCT03307252|76258161|FG008|NOT COMPLETED|Part 3, Period 4||0||
60135471|NCT03307252|76258162|FG009|NOT COMPLETED|Part 3, Period 4||0||
60135472|NCT03307252|76258163|FG010|NOT COMPLETED|Part 3, Period 4||0||
60135473|NCT03286504|76258181|FG000|STARTED|Overall Study||60||
60135474|NCT03286504|76258182|FG001|STARTED|Overall Study||60||
60135475|NCT03286504|76258181|FG000|COMPLETED|Overall Study||41||
60135476|NCT03286504|76258182|FG001|COMPLETED|Overall Study||44||
60135477|NCT03286504|76258181|FG000|NOT COMPLETED|Overall Study||19||
60135478|NCT03286504|76258182|FG001|NOT COMPLETED|Overall Study||16||
60135479|NCT03275168|76258190|FG000|STARTED|Overall Study||34||
60135480|NCT03275168|76258191|FG001|STARTED|Overall Study||34||
60135481|NCT03275168|76258190|FG000|COMPLETED|Overall Study||27||
60135482|NCT03275168|76258191|FG001|COMPLETED|Overall Study||25||
60135483|NCT03275168|76258190|FG000|NOT COMPLETED|Overall Study||7||
60135484|NCT03275168|76258191|FG001|NOT COMPLETED|Overall Study||9||
60135485|NCT03191786|76258199|FG000|STARTED|Overall Study||302||
60135486|NCT03191786|76258200|FG001|STARTED|Overall Study||151||
60135487|NCT03191786|76258199|FG000|COMPLETED|Overall Study||15||
60135488|NCT03191786|76258200|FG001|COMPLETED|Overall Study||0||
59874095|NCT05022563|75998239|FG005|NOT COMPLETED|Overall Study||0||
59874096|NCT04936334|75998257|FG000|STARTED|Overall Study||51||102
59874097|NCT04936334|75998257|FG000|COMPLETED|Overall Study||50||100
59874098|NCT04936334|75998257|FG000|NOT COMPLETED|Overall Study||1||2
59874099|NCT04822597|75998267|FG000|STARTED|Overall Study||44||
59874100|NCT04822597|75998268|FG001|STARTED|Overall Study||39||
59874101|NCT04822597|75998269|FG002|STARTED|Overall Study||44||
59874102|NCT04822597|75998270|FG003|STARTED|Overall Study||40||
59874103|NCT04822597|75998267|FG000|On Treatment As Assigned|Overall Study||44||
59874104|NCT04822597|75998268|FG001|On Treatment As Assigned|Overall Study||37||
59874105|NCT04822597|75998269|FG002|On Treatment As Assigned|Overall Study||35||
59874106|NCT04822597|75998270|FG003|On Treatment As Assigned|Overall Study||34||
59874107|NCT04822597|75998267|FG000|Off Treatment As Assigned|Overall Study||44||
59874108|NCT04822597|75998268|FG001|Off Treatment As Assigned|Overall Study||37||
59874109|NCT04822597|75998269|FG002|Off Treatment As Assigned|Overall Study||35||
59874110|NCT04822597|75998270|FG003|Off Treatment As Assigned|Overall Study||34||
59874111|NCT04822597|75998267|FG000|Analyzed With Intent to Treat|Overall Study||43||
59874112|NCT04822597|75998268|FG001|Analyzed With Intent to Treat|Overall Study||37||
59874113|NCT04822597|75998269|FG002|Analyzed With Intent to Treat|Overall Study||42||
59874114|NCT04822597|75998270|FG003|Analyzed With Intent to Treat|Overall Study||38||
59874115|NCT04822597|75998267|FG000|COMPLETED|Overall Study||43||
59874116|NCT04822597|75998268|FG001|COMPLETED|Overall Study||37||
59874117|NCT04822597|75998269|FG002|COMPLETED|Overall Study||42||
59874118|NCT04822597|75998270|FG003|COMPLETED|Overall Study||38||
59874119|NCT04822597|75998267|FG000|NOT COMPLETED|Overall Study||1||
59874120|NCT04822597|75998268|FG001|NOT COMPLETED|Overall Study||2||
59874121|NCT04822597|75998269|FG002|NOT COMPLETED|Overall Study||2||
59874122|NCT04822597|75998270|FG003|NOT COMPLETED|Overall Study||2||
59874123|NCT04639245|75998280|FG000|STARTED|Overall Study||1||
59874124|NCT04639245|75998280|FG000|COMPLETED|Overall Study||0||
59874125|NCT04639245|75998280|FG000|NOT COMPLETED|Overall Study||1||
59874126|NCT04599465|75998284|FG000|STARTED|Overall Study||69||
59874127|NCT04599465|75998284|FG000|COMPLETED|Overall Study||66||
59874128|NCT04599465|75998284|FG000|NOT COMPLETED|Overall Study||3||
59874129|NCT04475198|75998295|FG000|STARTED|Overall Study||4||
59874130|NCT04475198|75998296|FG001|STARTED|Overall Study||4||
59874131|NCT04475198|75998297|FG002|STARTED|Overall Study||4||
59874132|NCT04475198|75998298|FG003|STARTED|Overall Study||4||
59874133|NCT04475198|75998299|FG004|STARTED|Overall Study||8||
59874134|NCT04475198|75998295|FG000|COMPLETED|Overall Study||4||
59874135|NCT04475198|75998296|FG001|COMPLETED|Overall Study||4||
59874136|NCT04475198|75998297|FG002|COMPLETED|Overall Study||4||
59874137|NCT04475198|75998298|FG003|COMPLETED|Overall Study||4||
59874138|NCT04475198|75998299|FG004|COMPLETED|Overall Study||8||
59874139|NCT04475198|75998295|FG000|NOT COMPLETED|Overall Study||0||
59874140|NCT04475198|75998296|FG001|NOT COMPLETED|Overall Study||0||
59874141|NCT04475198|75998297|FG002|NOT COMPLETED|Overall Study||0||
59874142|NCT04475198|75998298|FG003|NOT COMPLETED|Overall Study||0||
59874143|NCT04475198|75998299|FG004|NOT COMPLETED|Overall Study||0||
59874144|NCT04309370|75998313|FG000|STARTED|Overall Study||7||
59874145|NCT04309370|75998314|FG001|STARTED|Overall Study||7||
59874146|NCT04309370|75998313|FG000|COMPLETED|Overall Study||7||
59874147|NCT04309370|75998314|FG001|COMPLETED|Overall Study||7||
59874148|NCT04309370|75998313|FG000|NOT COMPLETED|Overall Study||0||
59874149|NCT04309370|75998314|FG001|NOT COMPLETED|Overall Study||0||
59874150|NCT04184362|75998322|FG000|STARTED|Overall Study||5||
59874151|NCT04184362|75998323|FG001|STARTED|Overall Study||5||
59874152|NCT04184362|75998322|FG000|COMPLETED|Overall Study||5||
59874153|NCT04184362|75998323|FG001|COMPLETED|Overall Study||5||
59874154|NCT04184362|75998322|FG000|NOT COMPLETED|Overall Study||0||
60135489|NCT03191786|76258199|FG000|NOT COMPLETED|Overall Study||287||
60135490|NCT03191786|76258200|FG001|NOT COMPLETED|Overall Study||151||
60135491|NCT03138733|76258208|FG000|STARTED|Overall Study||192|Intent-to-Treat (ITT) population|
60135492|NCT03138733|76258209|FG001|STARTED|Overall Study||198|Intent-to-Treat (ITT) population|
60135493|NCT03138733|76258208|FG000|Modified ITT (mITT)|Overall Study||189|Three patients were excluded from the mITT population in the ceftobiprole group: one patient discontinued prior to receiving study treatment, and two patients were determined by central laboratory results not to have a confirmed positive blood culture for Staphylococcus aureus at baseline|
60135494|NCT03138733|76258209|FG001|Modified ITT (mITT)|Overall Study||198|Three patients were excluded from the mITT population in the ceftobiprole group: one patient discontinued prior to receiving study treatment, and two patients were determined by central laboratory results not to have a confirmed positive blood culture for Staphylococcus aureus at baseline|
60135495|NCT03138733|76258208|FG000|COMPLETED|Overall Study||157||
60135496|NCT03138733|76258209|FG001|COMPLETED|Overall Study||169||
60135497|NCT03138733|76258208|FG000|NOT COMPLETED|Overall Study||35||
60135498|NCT03138733|76258209|FG001|NOT COMPLETED|Overall Study||29||
60135499|NCT03057054|76258217|FG000|STARTED|Overall Study||85||
60135500|NCT03057054|76258218|FG001|STARTED|Overall Study||88||
60135501|NCT03057054|76258217|FG000|Prior to Initial Stem Cell Infusion|Overall Study||83|Patients who started protocol therapy (either placebo or LBP, depending on randomization) after enrollment and prior to receiving their initial stem cell infusion.|
60135502|NCT03057054|76258218|FG001|Prior to Initial Stem Cell Infusion|Overall Study||86|Patients who started protocol therapy (either placebo or LBP, depending on randomization) after enrollment and prior to receiving their initial stem cell infusion.|
60135503|NCT03057054|76258217|FG000|Initial Stem Cell Infusion|Overall Study||78|Patients who received initial stem cell infusion within 6-months of study enrollment after initiating protocol therapy (LBP or placebo).|
60135504|NCT03057054|76258218|FG001|Initial Stem Cell Infusion|Overall Study||81|Patients who received initial stem cell infusion within 6-months of study enrollment after initiating protocol therapy (LBP or placebo).|
60135505|NCT03057054|76258217|FG000|COMPLETED|Overall Study||74||
60135506|NCT03057054|76258218|FG001|COMPLETED|Overall Study||80||
60135507|NCT03057054|76258217|FG000|NOT COMPLETED|Overall Study||11||
59874155|NCT04184362|75998323|FG001|NOT COMPLETED|Overall Study||0||
59874156|NCT04104646|75998331|FG000|STARTED|Overall Study||5||
59874157|NCT04104646|75998332|FG001|STARTED|Overall Study||2||
59874158|NCT04104646|75998331|FG000|COMPLETED|Overall Study||1||
59874159|NCT04104646|75998332|FG001|COMPLETED|Overall Study||1||
59874160|NCT04104646|75998331|FG000|NOT COMPLETED|Overall Study||4||
59874161|NCT04104646|75998332|FG001|NOT COMPLETED|Overall Study||1||
59874162|NCT03919669|75998343|FG000|STARTED|Overall Study||6||
59874163|NCT03919669|75998344|FG001|STARTED|Overall Study||8||
59874164|NCT03919669|75998345|FG002|STARTED|Overall Study||13||
59874165|NCT03919669|75998343|FG000|COMPLETED|Overall Study||5||
59874166|NCT03919669|75998344|FG001|COMPLETED|Overall Study||8||
59874167|NCT03919669|75998345|FG002|COMPLETED|Overall Study||13||
59874168|NCT03919669|75998343|FG000|NOT COMPLETED|Overall Study||1||
59874169|NCT03919669|75998344|FG001|NOT COMPLETED|Overall Study||0||
60135508|NCT03057054|76258218|FG001|NOT COMPLETED|Overall Study||8||
60135509|NCT03037528|76258232|FG000|STARTED|Overall Study||15||
60135510|NCT03037528|76258233|FG001|STARTED|Overall Study||15||
60135511|NCT03037528|76258234|FG002|STARTED|Overall Study||13||
60135512|NCT03037528|76258235|FG003|STARTED|Overall Study||14||
59874170|NCT03919669|75998345|FG002|NOT COMPLETED|Overall Study||0||
59874171|NCT03772665|75998356|FG000|STARTED|Overall Study||128||
59874172|NCT03772665|75998357|FG001|STARTED|Overall Study||66||
59874173|NCT03772665|75998356|FG000|COMPLETED|Overall Study||127||
59874174|NCT03772665|75998357|FG001|COMPLETED|Overall Study||66||
59874175|NCT03772665|75998356|FG000|NOT COMPLETED|Overall Study||1||
59874176|NCT03772665|75998357|FG001|NOT COMPLETED|Overall Study||0||
59874177|NCT03626701|75998365|FG000|STARTED|Overall Study||13||
59874178|NCT03626701|75998366|FG001|STARTED|Overall Study||6||
59874179|NCT03626701|75998365|FG000|COMPLETED|Overall Study||9||
59874180|NCT03626701|75998366|FG001|COMPLETED|Overall Study||5||
59874181|NCT03626701|75998365|FG000|NOT COMPLETED|Overall Study||4||
59874182|NCT03626701|75998366|FG001|NOT COMPLETED|Overall Study||1||
59874183|NCT03594110|75998374|FG000|STARTED|Overall Study||3305||
59874184|NCT03594110|75998375|FG001|STARTED|Overall Study||3304||
59874185|NCT03594110|75998374|FG000|Treated|Overall Study||3305||
59874186|NCT03594110|75998375|FG001|Treated|Overall Study||3304||
59874187|NCT03594110|75998374|FG000|COMPLETED|Overall Study||2457|Patients who did not prematurely discontinue study treatment.|
59874188|NCT03594110|75998375|FG001|COMPLETED|Overall Study||2549|Patients who did not prematurely discontinue study treatment.|
59874189|NCT03594110|75998374|FG000|NOT COMPLETED|Overall Study||848||
59874190|NCT03594110|75998375|FG001|NOT COMPLETED|Overall Study||755||
59874191|NCT03387137|75998385|FG000|STARTED|Overall Study||10||
59874192|NCT03387137|75998386|FG001|STARTED|Overall Study||5||
59874193|NCT03387137|75998387|FG002|STARTED|Overall Study||20||
59874194|NCT03387137|75998388|FG003|STARTED|Overall Study||10||
59874195|NCT03387137|75998385|FG000|COMPLETED|Overall Study||10||
59874196|NCT03387137|75998386|FG001|COMPLETED|Overall Study||5||
59874197|NCT03387137|75998387|FG002|COMPLETED|Overall Study||20||
59874198|NCT03387137|75998388|FG003|COMPLETED|Overall Study||10||
59874199|NCT03387137|75998385|FG000|NOT COMPLETED|Overall Study||0||
59874200|NCT03387137|75998386|FG001|NOT COMPLETED|Overall Study||0||
59874201|NCT03387137|75998387|FG002|NOT COMPLETED|Overall Study||0||
59874202|NCT03387137|75998388|FG003|NOT COMPLETED|Overall Study||0||
59874203|NCT03082963|75998398|FG000|STARTED|Overall Study||10||
59874204|NCT03082963|75998398|FG000|COMPLETED|Overall Study||10||
59874205|NCT03082963|75998398|FG000|NOT COMPLETED|Overall Study||0||
59874206|NCT03024996|75998404|FG000|STARTED|Overall Study||390||
59874207|NCT03024996|75998405|FG001|STARTED|Overall Study||388||
59874208|NCT03024996|75998404|FG000|COMPLETED|Overall Study||0||
59874209|NCT03024996|75998405|FG001|COMPLETED|Overall Study||0||
59874210|NCT03024996|75998404|FG000|NOT COMPLETED|Overall Study||390||
59874211|NCT03024996|75998405|FG001|NOT COMPLETED|Overall Study||388||
59874212|NCT02855203|75998411|FG000|STARTED|Overall Study||30||
59874213|NCT02855203|75998411|FG000|COMPLETED|Overall Study||30||
59874214|NCT02855203|75998411|FG000|NOT COMPLETED|Overall Study||0||
59874215|NCT02748564|75998418|FG000|STARTED|Overall Study||3||
59874216|NCT02748564|75998419|FG001|STARTED|Overall Study||3||
59874217|NCT02748564|75998420|FG002|STARTED|Overall Study||4||
59874218|NCT02748564|75998418|FG000|COMPLETED|Overall Study||3||
59874219|NCT02748564|75998419|FG001|COMPLETED|Overall Study||3||
59874220|NCT02748564|75998420|FG002|COMPLETED|Overall Study||4||
59874221|NCT02748564|75998418|FG000|NOT COMPLETED|Overall Study||0||
59874222|NCT02748564|75998419|FG001|NOT COMPLETED|Overall Study||0||
59874223|NCT02748564|75998420|FG002|NOT COMPLETED|Overall Study||0||
59874224|NCT02642965|75998429|FG000|STARTED|Overall Study||38||
59874225|NCT02642965|75998429|FG000|COMPLETED|Overall Study||25||
59874226|NCT02642965|75998429|FG000|NOT COMPLETED|Overall Study||13||
59874227|NCT02595892|75998435|FG000|STARTED|Overall Study||36||
59874228|NCT02595892|75998436|FG001|STARTED|Overall Study||34||
59874229|NCT02595892|75998435|FG000|Number of Participants From Arm I Who Crossed-over to Arm II|Overall Study||15||
59874230|NCT02595892|75998436|FG001|Number of Participants From Arm I Who Crossed-over to Arm II|Overall Study|Not applicable since Arm II patients were not able to cross-over to Arm I.|0||
59874231|NCT02595892|75998435|FG000|COMPLETED|Overall Study||36||
59874232|NCT02595892|75998436|FG001|COMPLETED|Overall Study||34||
59874233|NCT02595892|75998435|FG000|NOT COMPLETED|Overall Study||0||
59874234|NCT02595892|75998436|FG001|NOT COMPLETED|Overall Study||0||
59874235|NCT01054625|75998446|FG000|STARTED|Overall Study|A total of 31 participants were enrolled, 1 participant died before receiving any zalutumumab|8||
59874236|NCT01054625|75998447|FG001|STARTED|Overall Study||12||
59874237|NCT01054625|75998448|FG002|STARTED|Overall Study||10||
59874238|NCT01054625|75998446|FG000|COMPLETED|Overall Study||6||
59874239|NCT01054625|75998447|FG001|COMPLETED|Overall Study||9||
59874240|NCT01054625|75998448|FG002|COMPLETED|Overall Study||9||
59874241|NCT01054625|75998446|FG000|NOT COMPLETED|Overall Study||2||
59874242|NCT01054625|75998447|FG001|NOT COMPLETED|Overall Study||3||
59874243|NCT01054625|75998448|FG002|NOT COMPLETED|Overall Study||1||
59874244|NCT01038778|75998458|FG000|STARTED|Overall Study||3||
59874245|NCT01038778|75998459|FG001|STARTED|Overall Study||8||
59874246|NCT01038778|75998460|FG002|STARTED|Overall Study||36||
59874247|NCT01038778|75998458|FG000|COMPLETED|Overall Study||3||
59874248|NCT01038778|75998459|FG001|COMPLETED|Overall Study||6||
59874249|NCT01038778|75998460|FG002|COMPLETED|Overall Study||33||
59874250|NCT01038778|75998458|FG000|NOT COMPLETED|Overall Study||0||
59874251|NCT01038778|75998459|FG001|NOT COMPLETED|Overall Study||2||
59874252|NCT01038778|75998460|FG002|NOT COMPLETED|Overall Study||3||
59874253|NCT00707655|75998469|FG000|STARTED|Overall Study||3||
59874254|NCT00707655|75998470|FG001|STARTED|Overall Study||5||
59874255|NCT00707655|75998469|FG000|COMPLETED|Overall Study||3||
59874256|NCT00707655|75998470|FG001|COMPLETED|Overall Study||3||
59874257|NCT00707655|75998469|FG000|NOT COMPLETED|Overall Study||0||
59874258|NCT00707655|75998470|FG001|NOT COMPLETED|Overall Study||2||
59874259|NCT00542308|75998478|FG000|STARTED|Overall Study||90||
59874260|NCT00542308|75998478|FG000|COMPLETED|Overall Study||90||
60135513|NCT03037528|76258236|FG004|STARTED|Overall Study||13||
59874261|NCT00542308|75998478|FG000|NOT COMPLETED|Overall Study||0||
59874262|NCT03443414|75998487|FG000|STARTED|Overall Study||82||
59874263|NCT03443414|75998488|FG001|STARTED|Overall Study||81||
59874264|NCT03443414|75998489|FG002|STARTED|Overall Study||82||
60135514|NCT03037528|76258237|FG005|STARTED|Overall Study||14||
60135515|NCT03037528|76258238|FG006|STARTED|Overall Study||15||
60135516|NCT03037528|76258239|FG007|STARTED|Overall Study||13||
60135517|NCT03037528|76258232|FG000|COMPLETED|Overall Study||12||
60135518|NCT03037528|76258233|FG001|COMPLETED|Overall Study||12||
60135519|NCT03037528|76258234|FG002|COMPLETED|Overall Study||11||
60135520|NCT03037528|76258235|FG003|COMPLETED|Overall Study||10||
60135521|NCT03037528|76258236|FG004|COMPLETED|Overall Study||8||
60135522|NCT03037528|76258237|FG005|COMPLETED|Overall Study||7||
60135523|NCT03037528|76258238|FG006|COMPLETED|Overall Study||9||
60135524|NCT03037528|76258239|FG007|COMPLETED|Overall Study||5||
60135525|NCT03037528|76258232|FG000|NOT COMPLETED|Overall Study||3||
60135526|NCT03037528|76258233|FG001|NOT COMPLETED|Overall Study||3||
60135527|NCT03037528|76258234|FG002|NOT COMPLETED|Overall Study||2||
60135528|NCT03037528|76258235|FG003|NOT COMPLETED|Overall Study||4||
60135529|NCT03037528|76258236|FG004|NOT COMPLETED|Overall Study||5||
60135530|NCT03037528|76258237|FG005|NOT COMPLETED|Overall Study||7||
60135531|NCT03037528|76258238|FG006|NOT COMPLETED|Overall Study||6||
60135532|NCT03037528|76258239|FG007|NOT COMPLETED|Overall Study||8||
60135533|NCT03035292|76258257|FG000|STARTED|Overall Study||110||110
60135534|NCT03035292|76258257|FG000|COMPLETED|Overall Study||110||110
60135535|NCT03035292|76258257|FG000|NOT COMPLETED|Overall Study||0||0
60135536|NCT02905240|76258266|FG000|STARTED|Overall Study||172||
60135537|NCT02905240|76258267|FG001|STARTED|Overall Study||160||
60135538|NCT02905240|76258266|FG000|COMPLETED|Overall Study||154||
60135539|NCT02905240|76258267|FG001|COMPLETED|Overall Study||137||
60135540|NCT02905240|76258266|FG000|NOT COMPLETED|Overall Study||18||
60135541|NCT02905240|76258267|FG001|NOT COMPLETED|Overall Study||23||
60135542|NCT02901275|76258273|FG000|STARTED|Overall Study||29||
60135543|NCT02901275|76258273|FG000|Placebo + Placebo|Overall Study||29||
60135544|NCT02901275|76258273|FG000|Hydromorphone (Oral) 4mg + Placebo|Overall Study||29||
60135545|NCT02901275|76258273|FG000|Hydromorphone (Oral) 4mg + Dronabinol (Oral) 2.5mg|Overall Study||29||
60135546|NCT02901275|76258273|FG000|Hydromorphone (Oral) 4mg + Dronabinol (Oral) 5mg|Overall Study||29||
60135547|NCT02901275|76258273|FG000|Hydromorphone (Oral) 4mg + Dronabinol (Oral) 10mg|Overall Study||29||
60135548|NCT02901275|76258273|FG000|COMPLETED|Overall Study||29||
60135549|NCT02901275|76258273|FG000|NOT COMPLETED|Overall Study||0||
60135550|NCT02854527|76258295|FG000|STARTED|Overall Study||3||
60135551|NCT02854527|76258296|FG001|STARTED|Overall Study||3||
60135552|NCT02854527|76258297|FG002|STARTED|Overall Study||3||
60135553|NCT02854527|76258298|FG003|STARTED|Overall Study||3||
60135554|NCT02854527|76258299|FG004|STARTED|Overall Study||3||
60135555|NCT02854527|76258300|FG005|STARTED|Overall Study||3||
60135556|NCT02854527|76258301|FG006|STARTED|Overall Study||3||
60135557|NCT02854527|76258302|FG007|STARTED|Overall Study||3||
60135558|NCT02854527|76258303|FG008|STARTED|Overall Study||3||
60135559|NCT02854527|76258304|FG009|STARTED|Overall Study||3||
60135560|NCT02854527|76258295|FG000|Received R1|Overall Study||3||
59874265|NCT03443414|75998490|FG003|STARTED|Overall Study||80||
59874266|NCT03443414|75998491|FG004|STARTED|Overall Study||80||
59874267|NCT03443414|75998487|FG000|Received Treatment|Overall Study||81||
59874268|NCT03443414|75998488|FG001|Received Treatment|Overall Study||81||
60135561|NCT02854527|76258296|FG001|Received R1|Overall Study||3||
60135562|NCT02854527|76258297|FG002|Received R1|Overall Study||3||
60135563|NCT02854527|76258298|FG003|Received R1|Overall Study||2||
60135564|NCT02854527|76258299|FG004|Received R1|Overall Study||2||
60135565|NCT02854527|76258300|FG005|Received R1|Overall Study||3||
60135566|NCT02854527|76258301|FG006|Received R1|Overall Study||3||
60135567|NCT02854527|76258302|FG007|Received R1|Overall Study||3||
60135568|NCT02854527|76258303|FG008|Received R1|Overall Study||3||
60135569|NCT02854527|76258304|FG009|Received R1|Overall Study||3||
60135570|NCT02854527|76258295|FG000|Received R2|Overall Study||3||
60135571|NCT02854527|76258296|FG001|Received R2|Overall Study||3||
60135572|NCT02854527|76258297|FG002|Received R2|Overall Study||3||
60135573|NCT02854527|76258298|FG003|Received R2|Overall Study||3||
60135574|NCT02854527|76258299|FG004|Received R2|Overall Study||3||
60135575|NCT02854527|76258300|FG005|Received R2|Overall Study||3||
59874269|NCT03443414|75998489|FG002|Received Treatment|Overall Study||82||
59874270|NCT03443414|75998490|FG003|Received Treatment|Overall Study||80||
59874271|NCT03443414|75998491|FG004|Received Treatment|Overall Study||79||
59874272|NCT03443414|75998487|FG000|COMPLETED|Overall Study||71||
59874273|NCT03443414|75998488|FG001|COMPLETED|Overall Study||78||
59874274|NCT03443414|75998489|FG002|COMPLETED|Overall Study||76||
60135576|NCT02854527|76258301|FG006|Received R2|Overall Study||3||
60135577|NCT02854527|76258302|FG007|Received R2|Overall Study||3||
60135578|NCT02854527|76258303|FG008|Received R2|Overall Study||3||
60135579|NCT02854527|76258304|FG009|Received R2|Overall Study||3||
60135580|NCT02854527|76258295|FG000|Received R3|Overall Study||3||
59874275|NCT03443414|75998490|FG003|COMPLETED|Overall Study||75||
60135581|NCT02854527|76258296|FG001|Received R3|Overall Study||3||
60135582|NCT02854527|76258297|FG002|Received R3|Overall Study||3||
59874276|NCT03443414|75998491|FG004|COMPLETED|Overall Study||75||
59874277|NCT03443414|75998487|FG000|NOT COMPLETED|Overall Study||11||
59874278|NCT03443414|75998488|FG001|NOT COMPLETED|Overall Study||3||
59874279|NCT03443414|75998489|FG002|NOT COMPLETED|Overall Study||6||
59874280|NCT03443414|75998490|FG003|NOT COMPLETED|Overall Study||5||
59874281|NCT03443414|75998491|FG004|NOT COMPLETED|Overall Study||5||
59874282|NCT02991118|75998505|FG000|STARTED|Overall Study||257||
59874283|NCT02991118|75998506|FG001|STARTED|Overall Study||522||
59874284|NCT02991118|75998505|FG000|COMPLETED|Overall Study||250||
59874285|NCT02991118|75998506|FG001|COMPLETED|Overall Study||490||
59874286|NCT02991118|75998505|FG000|NOT COMPLETED|Overall Study||7||
59874287|NCT02991118|75998506|FG001|NOT COMPLETED|Overall Study||32||
59874288|NCT03491150|75998514|FG000|STARTED|Overall Study||76||
59874289|NCT03491150|75998515|FG001|STARTED|Overall Study||73||
59874290|NCT03491150|75998514|FG000|COMPLETED|Overall Study||0||
59874291|NCT03491150|75998515|FG001|COMPLETED|Overall Study||0||
59874292|NCT03491150|75998514|FG000|NOT COMPLETED|Overall Study||76||
59874293|NCT03491150|75998515|FG001|NOT COMPLETED|Overall Study||73||
59874294|NCT02991040|75998521|FG000|STARTED|Overall Study||100||
59874295|NCT02991040|75998521|FG000|COMPLETED|Overall Study||96||
59874296|NCT02991040|75998521|FG000|NOT COMPLETED|Overall Study||4||
59874297|NCT02910466|75998527|FG000|STARTED|Overall Study||39||
59874298|NCT02910466|75998527|FG000|Safety Set|Overall Study||39|The safety population consisted of all enrolled participants who received at least 1 dose of rhPTH(1-84) regardless of study (SHP634-402 or AAAE0544 [NCT01199614] core study).|
59874299|NCT02910466|75998527|FG000|Treated|Overall Study||36||
59874300|NCT02910466|75998527|FG000|COMPLETED|Overall Study||0||
59874301|NCT02910466|75998527|FG000|NOT COMPLETED|Overall Study||39||
59874302|NCT03415178|75998533|FG000|STARTED|Parallel-Arm Period (up to Week 4)|Randomized|34|Randomized|
59874303|NCT03415178|75998534|FG001|STARTED|Parallel-Arm Period (up to Week 4)|Randomized|35|Randomized|
59874304|NCT03415178|75998533|FG000|Treated|Parallel-Arm Period (up to Week 4)||34||
59874305|NCT03415178|75998534|FG001|Treated|Parallel-Arm Period (up to Week 4)||33||
59874306|NCT03415178|75998533|FG000|COMPLETED|Parallel-Arm Period (up to Week 4)|33 participants entered in single arm period & 1 participant decided not to enter single arm period.|34||
59874307|NCT03415178|75998534|FG001|COMPLETED|Parallel-Arm Period (up to Week 4)|32 participants entered in single arm period & 1 participant decided not to enter single arm period.|33||
59874308|NCT03415178|75998533|FG000|NOT COMPLETED|Parallel-Arm Period (up to Week 4)||0||
59874309|NCT03415178|75998534|FG001|NOT COMPLETED|Parallel-Arm Period (up to Week 4)||2||
59874310|NCT03415178|75998533|FG000|STARTED|Single Arm Period (up to Week 16)|Out of 34 participants from AI group, 33 participants entered entered in single arm period.|0||
59874311|NCT03415178|75998534|FG001|STARTED|Single Arm Period (up to Week 16)|65 (participants completed period 1) + 1 (randomized to SYDNEY arm but not treated in period 1).|66||
59874312|NCT03415178|75998533|FG000|COMPLETED|Single Arm Period (up to Week 16)||0||
59874313|NCT03415178|75998534|FG001|COMPLETED|Single Arm Period (up to Week 16)||65||
59874314|NCT03415178|75998533|FG000|NOT COMPLETED|Single Arm Period (up to Week 16)||0||
59874315|NCT03415178|75998534|FG001|NOT COMPLETED|Single Arm Period (up to Week 16)||1||
59874316|NCT01068730|75998544|FG000|STARTED|Period 1||7||
59874317|NCT01068730|75998545|FG001|STARTED|Period 1||7||
59874318|NCT01068730|75998546|FG002|STARTED|Period 1||7||
59874319|NCT01068730|75998547|FG003|STARTED|Period 1||7||
59874320|NCT01068730|75998544|FG000|COMPLETED|Period 1||7||
59874321|NCT01068730|75998545|FG001|COMPLETED|Period 1||7||
59874322|NCT01068730|75998546|FG002|COMPLETED|Period 1||7||
59874323|NCT01068730|75998547|FG003|COMPLETED|Period 1||7||
59874324|NCT01068730|75998544|FG000|NOT COMPLETED|Period 1||0||
59874325|NCT01068730|75998545|FG001|NOT COMPLETED|Period 1||0||
59874326|NCT01068730|75998546|FG002|NOT COMPLETED|Period 1||0||
59874327|NCT01068730|75998547|FG003|NOT COMPLETED|Period 1||0||
59874328|NCT01068730|75998544|FG000|STARTED|Period 2||7||
59874329|NCT01068730|75998545|FG001|STARTED|Period 2||7||
59874330|NCT01068730|75998546|FG002|STARTED|Period 2||7||
59874331|NCT01068730|75998547|FG003|STARTED|Period 2||7||
59874332|NCT01068730|75998544|FG000|COMPLETED|Period 2||7||
59874333|NCT01068730|75998545|FG001|COMPLETED|Period 2||7||
59874334|NCT01068730|75998546|FG002|COMPLETED|Period 2||7||
59874335|NCT01068730|75998547|FG003|COMPLETED|Period 2||7||
59874336|NCT01068730|75998544|FG000|NOT COMPLETED|Period 2||0||
59874337|NCT01068730|75998545|FG001|NOT COMPLETED|Period 2||0||
59874338|NCT01068730|75998546|FG002|NOT COMPLETED|Period 2||0||
59874339|NCT01068730|75998547|FG003|NOT COMPLETED|Period 2||0||
59874340|NCT01068730|75998544|FG000|STARTED|Period 3||7||
59874341|NCT01068730|75998545|FG001|STARTED|Period 3||7||
59874342|NCT01068730|75998546|FG002|STARTED|Period 3||7||
59874343|NCT01068730|75998547|FG003|STARTED|Period 3||7||
59874344|NCT01068730|75998544|FG000|COMPLETED|Period 3||6||
59874345|NCT01068730|75998545|FG001|COMPLETED|Period 3||7||
59874346|NCT01068730|75998546|FG002|COMPLETED|Period 3||7||
59874347|NCT01068730|75998547|FG003|COMPLETED|Period 3||7||
59874348|NCT01068730|75998544|FG000|NOT COMPLETED|Period 3||1||
59874349|NCT01068730|75998545|FG001|NOT COMPLETED|Period 3||0||
59874350|NCT01068730|75998546|FG002|NOT COMPLETED|Period 3||0||
59874351|NCT01068730|75998547|FG003|NOT COMPLETED|Period 3||0||
59874352|NCT01068730|75998544|FG000|STARTED|Period 4||6||
59874353|NCT01068730|75998545|FG001|STARTED|Period 4||7||
59874354|NCT01068730|75998546|FG002|STARTED|Period 4||7||
59874355|NCT01068730|75998547|FG003|STARTED|Period 4||7||
59874356|NCT01068730|75998544|FG000|COMPLETED|Period 4||6||
59874357|NCT01068730|75998545|FG001|COMPLETED|Period 4||6||
59874358|NCT01068730|75998546|FG002|COMPLETED|Period 4||7||
59874359|NCT01068730|75998547|FG003|COMPLETED|Period 4||7||
59874360|NCT01068730|75998544|FG000|NOT COMPLETED|Period 4||0||
59874361|NCT01068730|75998545|FG001|NOT COMPLETED|Period 4||1||
59874362|NCT01068730|75998546|FG002|NOT COMPLETED|Period 4||0||
59874363|NCT01068730|75998547|FG003|NOT COMPLETED|Period 4||0||
60135583|NCT02854527|76258298|FG003|Received R3|Overall Study||2||
60135584|NCT02854527|76258299|FG004|Received R3|Overall Study||3||
60135585|NCT02854527|76258300|FG005|Received R3|Overall Study||3||
59874364|NCT01068652|75998566|FG000|STARTED|Overall Study||200||
59874365|NCT01068652|75998567|FG001|STARTED|Overall Study||203||
59874366|NCT01068652|75998566|FG000|COMPLETED|Overall Study||182||
59874367|NCT01068652|75998567|FG001|COMPLETED|Overall Study||188||
59874368|NCT01068652|75998566|FG000|NOT COMPLETED|Overall Study||18||
59874369|NCT01068652|75998567|FG001|NOT COMPLETED|Overall Study||15||
59874370|NCT02921776|75998579|FG000|STARTED|Overall Study||13||
59874371|NCT02921776|75998580|FG001|STARTED|Overall Study||23||
59874372|NCT02921776|75998581|FG002|STARTED|Overall Study||7||
59874373|NCT02921776|75998582|FG003|STARTED|Overall Study||31||
59874374|NCT02921776|75998583|FG004|STARTED|Overall Study||32||
59874375|NCT02921776|75998584|FG005|STARTED|Overall Study||7||
59874376|NCT02921776|75998585|FG006|STARTED|Overall Study||18||
59874377|NCT02921776|75998586|FG007|STARTED|Overall Study||16||
59874378|NCT02921776|75998579|FG000|COMPLETED|Overall Study||11||
59874379|NCT02921776|75998580|FG001|COMPLETED|Overall Study||15||
59874380|NCT02921776|75998581|FG002|COMPLETED|Overall Study||7||
59874381|NCT02921776|75998582|FG003|COMPLETED|Overall Study|Completed Primary outcome (daily measures) = 27 Completed Secondary outcomes (@ICU discharge) = 23|23||
59874382|NCT02921776|75998583|FG004|COMPLETED|Overall Study|Completed Primary outcome (daily measures) = 27 Completed Secondary outcomes (@ICU discharge) = 26|26||
59874383|NCT02921776|75998584|FG005|COMPLETED|Overall Study||5||
59874384|NCT02921776|75998585|FG006|COMPLETED|Overall Study|"At discharge/ extubation =11~1-mos post-discharge = 8 3-mos post-discharge = 8"|7||
59874385|NCT02921776|75998586|FG007|COMPLETED|Overall Study|"At discharge/ extubation =15~1-mos post-discharge = 12 3-mos post-discharge = 11"|9||
59874386|NCT02921776|75998579|FG000|NOT COMPLETED|Overall Study||2||
59874387|NCT02921776|75998580|FG001|NOT COMPLETED|Overall Study||8||
59874388|NCT02921776|75998581|FG002|NOT COMPLETED|Overall Study||0||
59874389|NCT02921776|75998582|FG003|NOT COMPLETED|Overall Study||8||
59874390|NCT02921776|75998583|FG004|NOT COMPLETED|Overall Study||6||
59874391|NCT02921776|75998584|FG005|NOT COMPLETED|Overall Study||2||
59874392|NCT02921776|75998585|FG006|NOT COMPLETED|Overall Study||11||
59874393|NCT02921776|75998586|FG007|NOT COMPLETED|Overall Study||7||
59874394|NCT02922634|75998610|FG000|STARTED|Overall Study||229||
59874395|NCT02922634|75998610|FG000|COMPLETED|Overall Study||219||
59874396|NCT02922634|75998610|FG000|NOT COMPLETED|Overall Study||10||
59874397|NCT00023595|75998626|FG000|STARTED|5 Year Follow up||602||
59874398|NCT00023595|75998627|FG001|STARTED|5 Year Follow up||534||
60135586|NCT02854527|76258301|FG006|Received R3|Overall Study||3||
60135587|NCT02854527|76258302|FG007|Received R3|Overall Study||3||
60135588|NCT02854527|76258303|FG008|Received R3|Overall Study||3||
59613477|NCT01684878|75724610|FG000|STARTED|Part 2: Randomized Phase||0||
59747814|NCT00686881|75866950|FG001|STARTED|Overall Study|After randomization, 6 participants withdrew consent and did not receive study drug.|134||
59747815|NCT00686881|75866949|FG000|COMPLETED|Overall Study||45||
59747816|NCT00686881|75866950|FG001|COMPLETED|Overall Study||53||
59747817|NCT00686881|75866949|FG000|NOT COMPLETED|Overall Study||82||
59747818|NCT00686881|75866950|FG001|NOT COMPLETED|Overall Study||81||
59747819|NCT00727714|75866958|FG000|STARTED|Overall Study||95||
59747820|NCT00727714|75866958|FG000|COMPLETED|Overall Study||93||
59747821|NCT00727714|75866958|FG000|NOT COMPLETED|Overall Study||2||
59874399|NCT00023595|75998628|FG002|STARTED|5 Year Follow up||76||
59874400|NCT00023595|75998629|FG003|STARTED|5 Year Follow up|76 of stratum B pts who were randomized to med therapy + CABG group belong to both H01 and H02.|423||
59874401|NCT00023595|75998630|FG004|STARTED|5 Year Follow up||501||
60135589|NCT02854527|76258304|FG009|Received R3|Overall Study||3||
60135590|NCT02854527|76258295|FG000|Received R4|Overall Study||3||
59747822|NCT00727558|75866964|FG000|STARTED|Overall Study||127||
59747823|NCT00727558|75866965|FG001|STARTED|Overall Study||121||
59874402|NCT00023595|75998626|FG000|COMPLETED|5 Year Follow up||600||
59874403|NCT00023595|75998627|FG001|COMPLETED|5 Year Follow up||532||
59874404|NCT00023595|75998628|FG002|COMPLETED|5 Year Follow up||75||
59874405|NCT00023595|75998629|FG003|COMPLETED|5 Year Follow up||416||
59874406|NCT00023595|75998630|FG004|COMPLETED|5 Year Follow up||498||
59874407|NCT00023595|75998626|FG000|NOT COMPLETED|5 Year Follow up||2||
59874408|NCT00023595|75998627|FG001|NOT COMPLETED|5 Year Follow up||2||
59874409|NCT00023595|75998628|FG002|NOT COMPLETED|5 Year Follow up||1||
59874410|NCT00023595|75998629|FG003|NOT COMPLETED|5 Year Follow up||7||
59874411|NCT00023595|75998630|FG004|NOT COMPLETED|5 Year Follow up||3||
59874412|NCT00023595|75998626|FG000|STARTED|10 Year Follow up|all participants who started H01 were counted as starting the 10 year follow up.|602||
59874413|NCT00023595|75998627|FG001|STARTED|10 Year Follow up|all participants who started H01 were counted as starting the 10 year follow up.|534||
59874414|NCT00023595|75998628|FG002|STARTED|10 Year Follow up|all participants who started H01 were counted as starting the 10 year follow up.|76||
59874415|NCT00023595|75998629|FG003|STARTED|10 Year Follow up|H02 arm was not extended and ended at year 5|0||
60135591|NCT02854527|76258296|FG001|Received R4|Overall Study||3||
60135592|NCT02854527|76258297|FG002|Received R4|Overall Study||3||
60135593|NCT02854527|76258298|FG003|Received R4|Overall Study||2||
60135594|NCT02854527|76258299|FG004|Received R4|Overall Study||3||
60135595|NCT02854527|76258300|FG005|Received R4|Overall Study||3||
60135596|NCT02854527|76258301|FG006|Received R4|Overall Study||3||
60135597|NCT02854527|76258302|FG007|Received R4|Overall Study||3||
60135598|NCT02854527|76258303|FG008|Received R4|Overall Study||3||
60135599|NCT02854527|76258304|FG009|Received R4|Overall Study||3||
60135600|NCT02854527|76258295|FG000|Received T|Overall Study||3||
60135601|NCT02854527|76258296|FG001|Received T|Overall Study||3||
60135602|NCT02854527|76258297|FG002|Received T|Overall Study||3||
60135603|NCT02854527|76258298|FG003|Received T|Overall Study||2||
60135604|NCT02854527|76258299|FG004|Received T|Overall Study||2||
60135605|NCT02854527|76258300|FG005|Received T|Overall Study||3||
60135606|NCT02854527|76258301|FG006|Received T|Overall Study||3||
60135607|NCT02854527|76258302|FG007|Received T|Overall Study||3||
60135608|NCT02854527|76258303|FG008|Received T|Overall Study||3||
60135609|NCT02854527|76258304|FG009|Received T|Overall Study||3||
60135610|NCT02854527|76258295|FG000|COMPLETED|Overall Study||3||
60135611|NCT02854527|76258296|FG001|COMPLETED|Overall Study||3||
60135612|NCT02854527|76258297|FG002|COMPLETED|Overall Study||3||
60135613|NCT02854527|76258298|FG003|COMPLETED|Overall Study||2||
60135614|NCT02854527|76258299|FG004|COMPLETED|Overall Study||2||
60135615|NCT02854527|76258300|FG005|COMPLETED|Overall Study||3||
60135616|NCT02854527|76258301|FG006|COMPLETED|Overall Study||3||
60135617|NCT02854527|76258302|FG007|COMPLETED|Overall Study||3||
60135618|NCT02854527|76258303|FG008|COMPLETED|Overall Study||3||
60135619|NCT02854527|76258304|FG009|COMPLETED|Overall Study||3||
60135620|NCT02854527|76258295|FG000|NOT COMPLETED|Overall Study||0||
60135621|NCT02854527|76258296|FG001|NOT COMPLETED|Overall Study||0||
60135622|NCT02854527|76258297|FG002|NOT COMPLETED|Overall Study||0||
60135623|NCT02854527|76258298|FG003|NOT COMPLETED|Overall Study||1||
60135624|NCT02854527|76258299|FG004|NOT COMPLETED|Overall Study||1||
59874416|NCT00023595|75998630|FG004|STARTED|10 Year Follow up|H02 arm was not extended and ended at year 5|0||
59874417|NCT00023595|75998626|FG000|COMPLETED|10 Year Follow up||590||
59874418|NCT00023595|75998627|FG001|COMPLETED|10 Year Follow up||524||
59874419|NCT00023595|75998628|FG002|COMPLETED|10 Year Follow up||73||
59874420|NCT00023595|75998629|FG003|COMPLETED|10 Year Follow up|H02 arm was not extended and ended at year 5|0||
59874421|NCT00023595|75998630|FG004|COMPLETED|10 Year Follow up|H02 arm was not extended and ended at year 5|0||
59874422|NCT00023595|75998626|FG000|NOT COMPLETED|10 Year Follow up||12||
59874423|NCT00023595|75998627|FG001|NOT COMPLETED|10 Year Follow up||10||
59874424|NCT00023595|75998628|FG002|NOT COMPLETED|10 Year Follow up||3||
59874425|NCT00023595|75998629|FG003|NOT COMPLETED|10 Year Follow up||0||
59874426|NCT00023595|75998630|FG004|NOT COMPLETED|10 Year Follow up||0||
59874427|NCT02920528|75998656|FG000|STARTED|Overall Study||35||
59874428|NCT02920528|75998657|FG001|STARTED|Overall Study||36||
59874429|NCT02920528|75998658|FG002|STARTED|Overall Study||35||
59874430|NCT02920528|75998656|FG000|COMPLETED|Overall Study||32||
59874431|NCT02920528|75998657|FG001|COMPLETED|Overall Study||35||
59874432|NCT02920528|75998658|FG002|COMPLETED|Overall Study||30||
59874433|NCT02920528|75998656|FG000|NOT COMPLETED|Overall Study||3||
59874434|NCT02920528|75998657|FG001|NOT COMPLETED|Overall Study||1||
60135625|NCT02854527|76258300|FG005|NOT COMPLETED|Overall Study||0||
60135626|NCT02854527|76258301|FG006|NOT COMPLETED|Overall Study||0||
60135627|NCT02854527|76258302|FG007|NOT COMPLETED|Overall Study||0||
60135628|NCT02854527|76258303|FG008|NOT COMPLETED|Overall Study||0||
60135629|NCT02854527|76258304|FG009|NOT COMPLETED|Overall Study||0||
60135630|NCT02772081|76258318|FG000|STARTED|Overall Study||20||
59874435|NCT02920528|75998658|FG002|NOT COMPLETED|Overall Study||5||
59874436|NCT01068418|75998666|FG000|STARTED|Overall Study|26 participants found to be eligible|26||
59874437|NCT01068418|75998666|FG000|Medication Washout|Overall Study|9 participants were disempaneled during the medication washout phase due to noncompliance or high BP|17||
59874438|NCT01068418|75998666|FG000|COMPLETED|Overall Study|14 participants completed all study procedures.|14||
59874439|NCT01068418|75998666|FG000|NOT COMPLETED|Overall Study||12||
59874440|NCT01068262|75998674|FG000|STARTED|Overall Study||23||
59874441|NCT01068262|75998675|FG001|STARTED|Overall Study||9||
59874442|NCT01068262|75998676|FG002|STARTED|Overall Study||10||
59874443|NCT01068262|75998677|FG003|STARTED|Overall Study||2||
59874444|NCT01068262|75998674|FG000|COMPLETED|Overall Study||20||
59874445|NCT01068262|75998675|FG001|COMPLETED|Overall Study||8||
59874446|NCT01068262|75998676|FG002|COMPLETED|Overall Study||9||
60135631|NCT02772081|76258319|FG001|STARTED|Overall Study||13||
60135632|NCT02772081|76258318|FG000|COMPLETED|Overall Study||18||
60135633|NCT02772081|76258319|FG001|COMPLETED|Overall Study||11||
60135634|NCT02772081|76258318|FG000|NOT COMPLETED|Overall Study||2||
60135635|NCT02772081|76258319|FG001|NOT COMPLETED|Overall Study||2||
60135636|NCT02642744|76258327|FG000|STARTED|Overall Study||278||
60135637|NCT02642744|76258328|FG001|STARTED|Overall Study||392||
60135638|NCT02642744|76258327|FG000|COMPLETED|Overall Study||129||
59874447|NCT01068262|75998677|FG003|COMPLETED|Overall Study||2||
59874448|NCT01068262|75998674|FG000|NOT COMPLETED|Overall Study||3||
59874449|NCT01068262|75998675|FG001|NOT COMPLETED|Overall Study||1||
59874450|NCT01068262|75998676|FG002|NOT COMPLETED|Overall Study||1||
59874451|NCT01068262|75998677|FG003|NOT COMPLETED|Overall Study||0||
59874452|NCT02920450|75998690|FG000|STARTED|Overall Study||3||
59874453|NCT02920450|75998691|FG001|STARTED|Overall Study||0||
59874454|NCT02920450|75998692|FG002|STARTED|Overall Study||0||
59874455|NCT02920450|75998693|FG003|STARTED|Overall Study||0||
59874456|NCT02920450|75998690|FG000|COMPLETED|Overall Study||1||
59874457|NCT02920450|75998691|FG001|COMPLETED|Overall Study||0||
59874458|NCT02920450|75998692|FG002|COMPLETED|Overall Study||0||
59874459|NCT02920450|75998693|FG003|COMPLETED|Overall Study||0||
59874460|NCT02920450|75998690|FG000|NOT COMPLETED|Overall Study||2||
59874461|NCT02920450|75998691|FG001|NOT COMPLETED|Overall Study||0||
59874462|NCT02920450|75998692|FG002|NOT COMPLETED|Overall Study||0||
59874463|NCT02920450|75998693|FG003|NOT COMPLETED|Overall Study||0||
59874464|NCT02730130|75998700|FG000|STARTED|Overall Study||17||
59874465|NCT02730130|75998700|FG000|COMPLETED|Overall Study||17||
59874466|NCT02730130|75998700|FG000|NOT COMPLETED|Overall Study||0||
59874467|NCT01066936|75998704|FG000|STARTED|Overall Study||20||20
59874468|NCT01066936|75998704|FG000|COMPLETED|Overall Study||10||10
59874469|NCT01066936|75998704|FG000|NOT COMPLETED|Overall Study||10||10
59874470|NCT02919436|75998712|FG000|STARTED|Overall Study||305||
59874471|NCT02919436|75998713|FG001|STARTED|Overall Study||305||
59874472|NCT02919436|75998712|FG000|COMPLETED|Overall Study||245||
59874473|NCT02919436|75998713|FG001|COMPLETED|Overall Study||252||
59874474|NCT02919436|75998712|FG000|NOT COMPLETED|Overall Study||60||
59874475|NCT02919436|75998713|FG001|NOT COMPLETED|Overall Study||53||
59874476|NCT03804879|75998723|FG000|STARTED|Overall Study||41|All randomized participants.|
59874477|NCT03804879|75998724|FG001|STARTED|Overall Study||42|All randomized participants.|
59874478|NCT03804879|75998723|FG000|Pharmacokinetics (PK) Analysis Set|Overall Study||41|All randomized participants with at least one valid PK concentration measurement, who received LMB763 and no protocol deviations with relevant impact on PK data.|
59874479|NCT03804879|75998724|FG001|Pharmacokinetics (PK) Analysis Set|Overall Study||0|All randomized participants with at least one valid PK concentration measurement, who received LMB763 and no protocol deviations with relevant impact on PK data.|
59874480|NCT03804879|75998723|FG000|Pharmacodynamics (PD) Analysis Set|Overall Study||41|All randomized participants with no protocol deviations with relevant impact on PD data.|
59874481|NCT03804879|75998724|FG001|Pharmacodynamics (PD) Analysis Set|Overall Study||41|All randomized participants with no protocol deviations with relevant impact on PD data.|
59874482|NCT03804879|75998723|FG000|COMPLETED|Overall Study||25||
59874483|NCT03804879|75998724|FG001|COMPLETED|Overall Study||29||
59874484|NCT03804879|75998723|FG000|NOT COMPLETED|Overall Study||16||
59874485|NCT03804879|75998724|FG001|NOT COMPLETED|Overall Study||13||
59874486|NCT03803475|75998731|FG000|STARTED|Overall Study||485||
59874487|NCT03803475|75998731|FG000|COMPLETED|Overall Study||484||
59874488|NCT03803475|75998731|FG000|NOT COMPLETED|Overall Study||1||
59874489|NCT00005937|75998735|FG000|STARTED|Overall Study||42||
59874490|NCT00005937|75998735|FG000|COMPLETED|Overall Study||37||
59874491|NCT00005937|75998735|FG000|NOT COMPLETED|Overall Study||5||
59874492|NCT03443024|75998743|FG000|STARTED|Overall Study||73||
59874493|NCT03443024|75998744|FG001|STARTED|Overall Study||80||
59874494|NCT03443024|75998745|FG002|STARTED|Overall Study||75||
59874495|NCT03443024|75998746|FG003|STARTED|Overall Study||52||
59874496|NCT03443024|75998743|FG000|Received at Least One Dose of Study Drug|Overall Study||73||
59874497|NCT03443024|75998744|FG001|Received at Least One Dose of Study Drug|Overall Study||80||
59874498|NCT03443024|75998745|FG002|Received at Least One Dose of Study Drug|Overall Study||75||
59874499|NCT03443024|75998746|FG003|Received at Least One Dose of Study Drug|Overall Study||52||
59874500|NCT03443024|75998743|FG000|COMPLETED|Overall Study||52||
59874501|NCT03443024|75998744|FG001|COMPLETED|Overall Study||49||
59874502|NCT03443024|75998745|FG002|COMPLETED|Overall Study||56||
59874503|NCT03443024|75998746|FG003|COMPLETED|Overall Study||20||
59874504|NCT03443024|75998743|FG000|NOT COMPLETED|Overall Study||21||
59874505|NCT03443024|75998744|FG001|NOT COMPLETED|Overall Study||31||
59874506|NCT03443024|75998745|FG002|NOT COMPLETED|Overall Study||19||
59874507|NCT03443024|75998746|FG003|NOT COMPLETED|Overall Study||32||
59874508|NCT02908516|75998758|FG000|STARTED|Overall Study||3||
59874509|NCT02908516|75998759|FG001|STARTED|Overall Study||3||
59874510|NCT02908516|75998758|FG000|COMPLETED|Overall Study||0||
59874511|NCT02908516|75998759|FG001|COMPLETED|Overall Study||0||
59874512|NCT02908516|75998758|FG000|NOT COMPLETED|Overall Study||3||
59874513|NCT02908516|75998759|FG001|NOT COMPLETED|Overall Study||3||
59874514|NCT02907892|75998767|FG000|STARTED|Overall Study||277||
59874515|NCT02907892|75998768|FG001|STARTED|Overall Study||276||
59874516|NCT02907892|75998767|FG000|COMPLETED|Overall Study||250||
59874517|NCT02907892|75998768|FG001|COMPLETED|Overall Study||236||
59874518|NCT02907892|75998767|FG000|NOT COMPLETED|Overall Study||27||
59874519|NCT02907892|75998768|FG001|NOT COMPLETED|Overall Study||40||
59874520|NCT02906644|75998776|FG000|STARTED|First 2 Weeks||31||
59874521|NCT02906644|75998777|FG001|STARTED|First 2 Weeks||30||
59874522|NCT02906644|75998776|FG000|COMPLETED|First 2 Weeks||30||
59874523|NCT02906644|75998777|FG001|COMPLETED|First 2 Weeks||27||
59874524|NCT02906644|75998776|FG000|NOT COMPLETED|First 2 Weeks||1||
59874525|NCT02906644|75998777|FG001|NOT COMPLETED|First 2 Weeks||3||
59874526|NCT02906644|75998776|FG000|STARTED|Weeks 3 to 14|All participants receiving active Lorcaserin plus nicotine patches starting at the 2nd study visit.|30||
59874527|NCT02906644|75998777|FG001|STARTED|Weeks 3 to 14|All participants receiving active Lorcaserin plus nicotine patches starting at the 2nd study visit.|27||
59874528|NCT02906644|75998776|FG000|Final Study Visit|Weeks 3 to 14|All participants receiving only 1 week of 14mg & 1 week of 7mg nicotine patches at this visit.|17||
59874529|NCT02906644|75998777|FG001|Final Study Visit|Weeks 3 to 14|All participants receiving only 1 week of 14mg & 1 week of 7mg nicotine patches at this visit.|20||
59874530|NCT02906644|75998776|FG000|Follow-up (6 Months Post Quit Day)|Weeks 3 to 14||14||
59874531|NCT02906644|75998777|FG001|Follow-up (6 Months Post Quit Day)|Weeks 3 to 14||16||
59874532|NCT02906644|75998776|FG000|COMPLETED|Weeks 3 to 14||14||
59874533|NCT02906644|75998777|FG001|COMPLETED|Weeks 3 to 14||16||
59874534|NCT02906644|75998776|FG000|NOT COMPLETED|Weeks 3 to 14||16||
59874535|NCT02906644|75998777|FG001|NOT COMPLETED|Weeks 3 to 14||11||
59874536|NCT03410108|75998784|FG000|STARTED|Overall Study||104||
59874537|NCT03410108|75998784|FG000|Safety Evaluation Lead-in Part|Overall Study||9|Safety Evaluation Lead-in Part included participants with or without prior ALK-TKI treatment. Although the protocol allowed both refractory and TKI-naive participants to enroll in the Safety Evaluation Lead-in Part, all enrolled participants had history of prior ALK-TKI and were thus included in the efficacy evaluation in All Refractory Participants Cohort.|
59874538|NCT03410108|75998784|FG000|Refractory Expansion Part: Main Cohort|Overall Study||47|Main Cohort of the Refractory Expansion Part includes participants who had previously received alectinib (as their only ALK inhibitor) or both crizotinib and alectinib.|
59874539|NCT03410108|75998784|FG000|Refractory Expansion Part: Sub-Cohort|Overall Study||16|Sub-Cohort of the Refractory Expansion Part included participants with all sequences of ALK inhibitors other than the Main Cohort, and up to 2 prior ALK inhibitor(s).|
59874540|NCT03410108|75998784|FG000|Refractory Expansion Part|Overall Study||63|Refractory Expansion Part included participants from the Main Cohort and Sub-Cohort.|
59874541|NCT03410108|75998784|FG000|All Refractory Participants|Overall Study||72|All Refractory Participants included all participants from the Main Cohort and Sub-Cohort of the Refractory Expansion Part, and Safety Evaluation Lead-in Part.|
59874542|NCT03410108|75998784|FG000|TKI-Naive Expansion Cohort|Overall Study||32|TKI-Naive Expansion Cohort included participants with no prior ALK-TKI treatment.|
59874543|NCT03410108|75998784|FG000|Completed|Overall Study||0|Completed = Participants who completed the treatment.|
59874544|NCT03410108|75998784|FG000|COMPLETED|Overall Study||0||
59874545|NCT03410108|75998784|FG000|NOT COMPLETED|Overall Study||104||
59874546|NCT02982772|75998793|FG000|STARTED|Enrollment||245||
59874547|NCT02982772|75998794|FG001|STARTED|Enrollment||243||
59874548|NCT02982772|75998793|FG000|COMPLETED|Enrollment||245||
59874549|NCT02982772|75998794|FG001|COMPLETED|Enrollment||243||
59874550|NCT02982772|75998793|FG000|NOT COMPLETED|Enrollment||0||
59874551|NCT02982772|75998794|FG001|NOT COMPLETED|Enrollment||0||
59874552|NCT02982772|75998793|FG000|STARTED|Intervention||245||
59874553|NCT02982772|75998794|FG001|STARTED|Intervention||243||
59874554|NCT02982772|75998793|FG000|COMPLETED|Intervention||226||
59874555|NCT02982772|75998794|FG001|COMPLETED|Intervention||230||
59874556|NCT02982772|75998793|FG000|NOT COMPLETED|Intervention||19||
59874557|NCT02982772|75998794|FG001|NOT COMPLETED|Intervention||13||
59874558|NCT02982772|75998793|FG000|STARTED|1M Follow-Up||226||
59874559|NCT02982772|75998794|FG001|STARTED|1M Follow-Up||230||
59874560|NCT02982772|75998793|FG000|COMPLETED|1M Follow-Up||205||
59874561|NCT02982772|75998794|FG001|COMPLETED|1M Follow-Up||212||
59874562|NCT02982772|75998793|FG000|NOT COMPLETED|1M Follow-Up||21||
59874563|NCT02982772|75998794|FG001|NOT COMPLETED|1M Follow-Up||18||
59874564|NCT02982772|75998793|FG000|STARTED|3M Follow-Up||205||
59874565|NCT02982772|75998794|FG001|STARTED|3M Follow-Up||212||
59874566|NCT02982772|75998793|FG000|COMPLETED|3M Follow-Up||188||
59874567|NCT02982772|75998794|FG001|COMPLETED|3M Follow-Up||201||
59874568|NCT02982772|75998793|FG000|NOT COMPLETED|3M Follow-Up||17||
59874569|NCT02982772|75998794|FG001|NOT COMPLETED|3M Follow-Up||11||
59874570|NCT02982772|75998793|FG000|STARTED|6M Follow-Up||188||
59874571|NCT02982772|75998794|FG001|STARTED|6M Follow-Up||201||
59874572|NCT02982772|75998793|FG000|COMPLETED|6M Follow-Up||177||
59874573|NCT02982772|75998794|FG001|COMPLETED|6M Follow-Up||192||
59874574|NCT02982772|75998793|FG000|NOT COMPLETED|6M Follow-Up||11||
59874575|NCT02982772|75998794|FG001|NOT COMPLETED|6M Follow-Up||9||
59874576|NCT02982772|75998793|FG000|STARTED|12M Follow-Up||177||
59874577|NCT02982772|75998794|FG001|STARTED|12M Follow-Up||192||
59874578|NCT02982772|75998793|FG000|COMPLETED|12M Follow-Up||166||
59874579|NCT02982772|75998794|FG001|COMPLETED|12M Follow-Up||187||
59874580|NCT02982772|75998793|FG000|NOT COMPLETED|12M Follow-Up||11||
59874581|NCT02982772|75998794|FG001|NOT COMPLETED|12M Follow-Up||5||
59874582|NCT03488108|75998804|FG000|STARTED|First Intervention (12 Weeks)||10||
59874583|NCT03488108|75998805|FG001|STARTED|First Intervention (12 Weeks)||10||
59874584|NCT03488108|75998804|FG000|COMPLETED|First Intervention (12 Weeks)||10||
59874585|NCT03488108|75998805|FG001|COMPLETED|First Intervention (12 Weeks)||9||
59874586|NCT03488108|75998804|FG000|NOT COMPLETED|First Intervention (12 Weeks)||0||
59874587|NCT03488108|75998805|FG001|NOT COMPLETED|First Intervention (12 Weeks)||1||
59874588|NCT03488108|75998804|FG000|STARTED|Washout (2 Months)||10||
59874589|NCT03488108|75998805|FG001|STARTED|Washout (2 Months)||9||
59874590|NCT03488108|75998804|FG000|COMPLETED|Washout (2 Months)||10||
59874591|NCT03488108|75998805|FG001|COMPLETED|Washout (2 Months)||9||
59874592|NCT03488108|75998804|FG000|NOT COMPLETED|Washout (2 Months)||0||
59874593|NCT03488108|75998805|FG001|NOT COMPLETED|Washout (2 Months)||0||
59874594|NCT03488108|75998804|FG000|STARTED|Second Intervention (12 Weeks)||10||
59874595|NCT03488108|75998805|FG001|STARTED|Second Intervention (12 Weeks)||9||
59874596|NCT03488108|75998804|FG000|COMPLETED|Second Intervention (12 Weeks)||9||
59874597|NCT03488108|75998805|FG001|COMPLETED|Second Intervention (12 Weeks)||9||
59874598|NCT03488108|75998804|FG000|NOT COMPLETED|Second Intervention (12 Weeks)||1||
59874599|NCT03488108|75998805|FG001|NOT COMPLETED|Second Intervention (12 Weeks)||0||
59874600|NCT03440918|75998815|FG000|STARTED|Overall Study||133||
59874601|NCT03440918|75998816|FG001|STARTED|Overall Study||138||
59874602|NCT03440918|75998815|FG000|COMPLETED|Overall Study||133||
59874603|NCT03440918|75998816|FG001|COMPLETED|Overall Study||122||
59874604|NCT03440918|75998815|FG000|NOT COMPLETED|Overall Study||0||
59874605|NCT03440918|75998816|FG001|NOT COMPLETED|Overall Study||16||
59874606|NCT03486392|75998827|FG000|STARTED|Overall Study||60||
59874607|NCT03486392|75998828|FG001|STARTED|Overall Study||59||
59874608|NCT03486392|75998829|FG002|STARTED|Overall Study||118||
59874609|NCT03486392|75998830|FG003|STARTED|Overall Study||118||
59874610|NCT03486392|75998831|FG004|STARTED|Overall Study||119||
59874611|NCT03486392|75998827|FG000|COMPLETED|Overall Study||57||
59874612|NCT03486392|75998828|FG001|COMPLETED|Overall Study||59||
59874613|NCT03486392|75998829|FG002|COMPLETED|Overall Study||104||
59874614|NCT03486392|75998830|FG003|COMPLETED|Overall Study||109||
59874615|NCT03486392|75998831|FG004|COMPLETED|Overall Study||115||
59874616|NCT03486392|75998827|FG000|NOT COMPLETED|Overall Study||3||
59874617|NCT03486392|75998828|FG001|NOT COMPLETED|Overall Study||0||
59874618|NCT03486392|75998829|FG002|NOT COMPLETED|Overall Study||14||
59874619|NCT03486392|75998830|FG003|NOT COMPLETED|Overall Study||9||
59874620|NCT03486392|75998831|FG004|NOT COMPLETED|Overall Study||4||
59874621|NCT02981602|75998848|FG000|STARTED|Overall Study||6||
59874622|NCT02981602|75998849|FG001|STARTED|Overall Study||12||
59874623|NCT02981602|75998850|FG002|STARTED|Overall Study||6||
59874624|NCT02981602|75998851|FG003|STARTED|Overall Study||5||
59874625|NCT02981602|75998852|FG004|STARTED|Overall Study||2||
59874626|NCT02981602|75998848|FG000|COMPLETED|Overall Study||6||
59874627|NCT02981602|75998849|FG001|COMPLETED|Overall Study||12||
59874628|NCT02981602|75998850|FG002|COMPLETED|Overall Study||6||
59874629|NCT02981602|75998851|FG003|COMPLETED|Overall Study||4||
59874630|NCT02981602|75998852|FG004|COMPLETED|Overall Study||2||
59874631|NCT02981602|75998848|FG000|NOT COMPLETED|Overall Study||0||
59874632|NCT02981602|75998849|FG001|NOT COMPLETED|Overall Study||0||
59874633|NCT02981602|75998850|FG002|NOT COMPLETED|Overall Study||0||
59874634|NCT02981602|75998851|FG003|NOT COMPLETED|Overall Study||1||
59874635|NCT02981602|75998852|FG004|NOT COMPLETED|Overall Study||0||
59874636|NCT02981524|75998865|FG000|STARTED|Overall Study||17||
59874637|NCT02981524|75998865|FG000|COMPLETED|Overall Study||0||
59874638|NCT02981524|75998865|FG000|NOT COMPLETED|Overall Study||17||
59874639|NCT03486314|75998869|FG000|STARTED|Part A||20||
59874640|NCT03486314|75998870|FG001|STARTED|Part A||0||
59874641|NCT03486314|75998871|FG002|STARTED|Part A||0||
59874642|NCT03486314|75998869|FG000|COMPLETED|Part A||17||
59874643|NCT03486314|75998870|FG001|COMPLETED|Part A||0||
59874644|NCT03486314|75998871|FG002|COMPLETED|Part A||0||
59874645|NCT03486314|75998869|FG000|NOT COMPLETED|Part A||3||
59874646|NCT03486314|75998870|FG001|NOT COMPLETED|Part A||0||
59874647|NCT03486314|75998871|FG002|NOT COMPLETED|Part A||0||
59874648|NCT03486314|75998869|FG000|STARTED|Part B||0||
60002446|NCT01662999|76118328|FG000|STARTED|Period 2||7||
59874649|NCT03486314|75998870|FG001|STARTED|Part B|These are the participants who completed Part A, met eligibility criteria, and provided consent for Part B.|9||
59874650|NCT03486314|75998871|FG002|STARTED|Part B|These are the participants who completed Part A, met eligibility criteria, and provided consent for Part B.|8||
59874651|NCT03486314|75998869|FG000|COMPLETED|Part B||0||
59874652|NCT03486314|75998870|FG001|COMPLETED|Part B||9||
59874653|NCT03486314|75998871|FG002|COMPLETED|Part B||8||
59874654|NCT03486314|75998869|FG000|NOT COMPLETED|Part B||0||
60002447|NCT01662999|76118329|FG001|STARTED|Period 2||7||
59874655|NCT03486314|75998870|FG001|NOT COMPLETED|Part B||0||
59874656|NCT03486314|75998871|FG002|NOT COMPLETED|Part B||0||
59874657|NCT02905006|75998885|FG000|STARTED|Overall Study||42||
59874658|NCT02905006|75998886|FG001|STARTED|Overall Study||39||
59874659|NCT02905006|75998887|FG002|STARTED|Overall Study||43||
59874660|NCT02905006|75998888|FG003|STARTED|Overall Study||40||
60002448|NCT01662999|76118330|FG002|STARTED|Period 2||7||
59874661|NCT02905006|75998889|FG004|STARTED|Overall Study||43||
59874662|NCT02905006|75998890|FG005|STARTED|Overall Study||43||
59874663|NCT02905006|75998885|FG000|Completed Treatment Period|Overall Study||37||
59874664|NCT02905006|75998886|FG001|Completed Treatment Period|Overall Study||36||
59874665|NCT02905006|75998887|FG002|Completed Treatment Period|Overall Study||38||
59874666|NCT02905006|75998888|FG003|Completed Treatment Period|Overall Study||34||
59874667|NCT02905006|75998889|FG004|Completed Treatment Period|Overall Study||40||
59874668|NCT02905006|75998890|FG005|Completed Treatment Period|Overall Study||39||
59874669|NCT02905006|75998885|FG000|Enrolled in Extension Study (PS0011)|Overall Study||38||
60002449|NCT01662999|76118331|FG003|STARTED|Period 2||7||
59874670|NCT02905006|75998886|FG001|Enrolled in Extension Study (PS0011)|Overall Study||35||
59874671|NCT02905006|75998887|FG002|Enrolled in Extension Study (PS0011)|Overall Study||39||
59874672|NCT02905006|75998888|FG003|Enrolled in Extension Study (PS0011)|Overall Study||38||
59874673|NCT02905006|75998889|FG004|Enrolled in Extension Study (PS0011)|Overall Study||42||
59874674|NCT02905006|75998890|FG005|Enrolled in Extension Study (PS0011)|Overall Study||40||
59874675|NCT02905006|75998885|FG000|Entered Safety Follow-up Period|Overall Study||4||
59874676|NCT02905006|75998886|FG001|Entered Safety Follow-up Period|Overall Study||4||
59874677|NCT02905006|75998887|FG002|Entered Safety Follow-up Period|Overall Study||4||
59874678|NCT02905006|75998888|FG003|Entered Safety Follow-up Period|Overall Study||2||
59874679|NCT02905006|75998889|FG004|Entered Safety Follow-up Period|Overall Study||1||
59874680|NCT02905006|75998890|FG005|Entered Safety Follow-up Period|Overall Study||3||
59874681|NCT02905006|75998885|FG000|COMPLETED|Overall Study||37||
59874682|NCT02905006|75998886|FG001|COMPLETED|Overall Study||36||
59874683|NCT02905006|75998887|FG002|COMPLETED|Overall Study||38||
59874684|NCT02905006|75998888|FG003|COMPLETED|Overall Study||34||
59874685|NCT02905006|75998889|FG004|COMPLETED|Overall Study||40||
59874686|NCT02905006|75998890|FG005|COMPLETED|Overall Study||39||
59874687|NCT02905006|75998885|FG000|NOT COMPLETED|Overall Study||5||
59874688|NCT02905006|75998886|FG001|NOT COMPLETED|Overall Study||3||
59874689|NCT02905006|75998887|FG002|NOT COMPLETED|Overall Study||5||
59874690|NCT02905006|75998888|FG003|NOT COMPLETED|Overall Study||6||
59874691|NCT02905006|75998889|FG004|NOT COMPLETED|Overall Study||3||
59874692|NCT02905006|75998890|FG005|NOT COMPLETED|Overall Study||4||
59874693|NCT01066780|75998928|FG000|STARTED|Overall Study||24||
59874694|NCT01066780|75998929|FG001|STARTED|Overall Study||24||
59874695|NCT01066780|75998928|FG000|COMPLETED|Overall Study||23||
59874696|NCT01066780|75998929|FG001|COMPLETED|Overall Study||23||
59874697|NCT01066780|75998928|FG000|NOT COMPLETED|Overall Study||1||
59874698|NCT01066780|75998929|FG001|NOT COMPLETED|Overall Study||1||
60135639|NCT02642744|76258328|FG001|COMPLETED|Overall Study||169||
60135640|NCT02642744|76258327|FG000|NOT COMPLETED|Overall Study||149||
60135641|NCT02642744|76258328|FG001|NOT COMPLETED|Overall Study||223||
60135642|NCT02639559|76258336|FG000|STARTED|Overall Study||25||
60135643|NCT02639559|76258337|FG001|STARTED|Overall Study||25||
60135644|NCT02639559|76258336|FG000|COMPLETED|Overall Study||24||
60135645|NCT02639559|76258337|FG001|COMPLETED|Overall Study||22||
60135646|NCT02639559|76258336|FG000|NOT COMPLETED|Overall Study||1||
59874699|NCT02975206|75998936|FG000|STARTED|Overall Study||161||
59874700|NCT02975206|75998937|FG001|STARTED|Overall Study||161||
59874701|NCT02975206|75998938|FG002|STARTED|Overall Study||162||
59874702|NCT02975206|75998936|FG000|COMPLETED|Overall Study||134||
59874703|NCT02975206|75998937|FG001|COMPLETED|Overall Study||144||
59874704|NCT02975206|75998938|FG002|COMPLETED|Overall Study||145||
59874705|NCT02975206|75998936|FG000|NOT COMPLETED|Overall Study||27||
59874706|NCT02975206|75998937|FG001|NOT COMPLETED|Overall Study||17||
59874707|NCT02975206|75998938|FG002|NOT COMPLETED|Overall Study||17||
59874708|NCT01066156|75998946|FG000|STARTED|Overall Study||34||
59874709|NCT01066156|75998946|FG000|COMPLETED|Overall Study||24||
59874710|NCT01066156|75998946|FG000|NOT COMPLETED|Overall Study||10||
59874711|NCT02980042|75998952|FG000|STARTED|Overall Study||100||
59874712|NCT02980042|75998953|FG001|STARTED|Overall Study||100||
59874713|NCT02980042|75998952|FG000|COMPLETED|Overall Study|All 100 subjects completed their Week 24 infusion. 7 subjects did not complete the 12 month visit.|93||
59874714|NCT02980042|75998953|FG001|COMPLETED|Overall Study||100||
59874715|NCT02980042|75998952|FG000|NOT COMPLETED|Overall Study||7||
59874716|NCT02980042|75998953|FG001|NOT COMPLETED|Overall Study||0||
59874717|NCT01066000|75998971|FG000|STARTED|Overall Study||33||
59874718|NCT01066000|75998971|FG000|COMPLETED|Overall Study||24||
59874719|NCT01066000|75998971|FG000|NOT COMPLETED|Overall Study||9||
59874720|NCT01065844|75998975|FG000|STARTED|Overall Study||15||
59874721|NCT01065844|75998975|FG000|COMPLETED|Overall Study||10||
59874722|NCT01065844|75998975|FG000|NOT COMPLETED|Overall Study||5||
59874723|NCT00004635|75998981|FG000|STARTED|Period One||79||
59874724|NCT00004635|75998982|FG001|STARTED|Period One||80||
60135647|NCT02639559|76258337|FG001|NOT COMPLETED|Overall Study||3||
60135648|NCT02581891|76258345|FG000|STARTED|Overall Study||135|Randomized|
59874725|NCT00004635|75998981|FG000|Received Treatment|Period One||73||
59874726|NCT00004635|75998982|FG001|Received Treatment|Period One||75||
59874727|NCT00004635|75998981|FG000|COMPLETED|Period One||73||
59874728|NCT00004635|75998982|FG001|COMPLETED|Period One||74||
60135649|NCT02581891|76258346|FG001|STARTED|Overall Study||136|Randomized|
60135650|NCT02581891|76258345|FG000|Completed Treatment|Overall Study||120||
60135651|NCT02581891|76258346|FG001|Completed Treatment|Overall Study||117||
60135652|NCT02581891|76258345|FG000|COMPLETED|Overall Study||119|Completed Study|
59874729|NCT00004635|75998981|FG000|NOT COMPLETED|Period One||6||
59874730|NCT00004635|75998982|FG001|NOT COMPLETED|Period One||6||
59874731|NCT00004635|75998981|FG000|STARTED|Period Two||44||
60135653|NCT02581891|76258346|FG001|COMPLETED|Overall Study||117|Completed Study|
59874732|NCT00004635|75998982|FG001|STARTED|Period Two||59||
59874733|NCT00004635|75998981|FG000|COMPLETED|Period Two||38||
59874734|NCT00004635|75998982|FG001|COMPLETED|Period Two||50||
59874735|NCT00004635|75998981|FG000|NOT COMPLETED|Period Two||6||
59874736|NCT00004635|75998982|FG001|NOT COMPLETED|Period Two||9||
59874737|NCT00004563|75998993|FG000|STARTED|Overall Study||79||
59874738|NCT00004563|75998994|FG001|STARTED|Overall Study||79||
59874739|NCT00004563|75998993|FG000|COMPLETED|Overall Study||54||
59874740|NCT00004563|75998994|FG001|COMPLETED|Overall Study||55||
59874741|NCT00004563|75998993|FG000|NOT COMPLETED|Overall Study||25||
59874742|NCT00004563|75998994|FG001|NOT COMPLETED|Overall Study||24||
59874743|NCT00003645|75999002|FG000|STARTED|Overall Study||30||
59874744|NCT00003645|75999003|FG001|STARTED|Overall Study||34||
59874745|NCT00003645|75999002|FG000|COMPLETED|Overall Study||18||
59874746|NCT00003645|75999003|FG001|COMPLETED|Overall Study||22||
59874747|NCT00003645|75999002|FG000|NOT COMPLETED|Overall Study||12||
59874748|NCT00003645|75999003|FG001|NOT COMPLETED|Overall Study||12||
59874749|NCT00003537|75999011|FG000|STARTED|Overall Study||19||
59874750|NCT00003537|75999011|FG000|COMPLETED|Overall Study||18||
59874751|NCT00003537|75999011|FG000|NOT COMPLETED|Overall Study||1||
59874752|NCT00003531|75999015|FG000|STARTED|Overall Study||15||
59874753|NCT00003531|75999015|FG000|COMPLETED|Overall Study||5||
59874754|NCT00003531|75999015|FG000|NOT COMPLETED|Overall Study||10||
59874755|NCT02918968|75999021|FG000|STARTED|1st Line AAT||102||
59874756|NCT02918968|75999022|FG001|STARTED|1st Line AAT||104||
59874757|NCT02918968|75999021|FG000|Maintained 1st Line AAT Without Progression|1st Line AAT||25||
59874758|NCT02918968|75999022|FG001|Maintained 1st Line AAT Without Progression|1st Line AAT||8||
59874759|NCT02918968|75999021|FG000|COMPLETED|1st Line AAT||73||
59874760|NCT02918968|75999022|FG001|COMPLETED|1st Line AAT||93||
59874761|NCT02918968|75999021|FG000|NOT COMPLETED|1st Line AAT||29||
59874762|NCT02918968|75999022|FG001|NOT COMPLETED|1st Line AAT||11||
59874763|NCT02918968|75999021|FG000|STARTED|2nd Line AAT|Participants who maintained 1st line AAT without progression did not enter 2nd line AAT|48||
59874764|NCT02918968|75999022|FG001|STARTED|2nd Line AAT|Participants who maintained 1st line AAT without progression did not enter 2nd line AAT|85||
59874765|NCT02918968|75999021|FG000|COMPLETED|2nd Line AAT||23||
59874766|NCT02918968|75999022|FG001|COMPLETED|2nd Line AAT||73||
59874767|NCT02918968|75999021|FG000|NOT COMPLETED|2nd Line AAT||25||
59874768|NCT02918968|75999022|FG001|NOT COMPLETED|2nd Line AAT||12||
59874769|NCT01065766|75999030|FG000|STARTED|Overall Study||4065||
59874770|NCT01065766|75999030|FG000|COMPLETED|Overall Study||4033||
59874771|NCT01065766|75999030|FG000|NOT COMPLETED|Overall Study||32||
59874772|NCT01063972|75999036|FG000|STARTED|Overall Study||310||
59874773|NCT01063972|75999037|FG001|STARTED|Overall Study||296||
59874774|NCT01063972|75999036|FG000|COMPLETED|Overall Study|Participants who were deceased or incarcerated were excluded.|296||
59874775|NCT01063972|75999037|FG001|COMPLETED|Overall Study|Participants who were deceased or incarcerated were excluded.|284||
59874776|NCT01063972|75999036|FG000|NOT COMPLETED|Overall Study||14||
59874777|NCT01063972|75999037|FG001|NOT COMPLETED|Overall Study||12||
59874778|NCT00003483|75999043|FG000|STARTED|Overall Study||3||
59874779|NCT00003483|75999043|FG000|COMPLETED|Overall Study||2||
59874780|NCT00003483|75999043|FG000|NOT COMPLETED|Overall Study||1||
59874781|NCT00003477|75999047|FG000|STARTED|Overall Study||12||
59874782|NCT00003477|75999047|FG000|COMPLETED|Overall Study||8||
59874783|NCT00003477|75999047|FG000|NOT COMPLETED|Overall Study||4||
59874784|NCT00003471|75999051|FG000|STARTED|Overall Study||7||
59874785|NCT00003471|75999051|FG000|COMPLETED|Overall Study||3||
59874786|NCT00003471|75999051|FG000|NOT COMPLETED|Overall Study||4||
59874787|NCT04185220|75999057|FG000|STARTED|Dose Escalation||3||
59874788|NCT04185220|75999058|FG001|STARTED|Dose Escalation||3||
59874789|NCT04185220|75999057|FG000|COMPLETED|Dose Escalation||3||
59874790|NCT04185220|75999058|FG001|COMPLETED|Dose Escalation||1||
59874791|NCT04185220|75999057|FG000|NOT COMPLETED|Dose Escalation||0||
59874792|NCT04185220|75999058|FG001|NOT COMPLETED|Dose Escalation||2||
59874793|NCT04185220|75999057|FG000|STARTED|Dose Expansion||0||
59874794|NCT04185220|75999058|FG001|STARTED|Dose Expansion||0||
59874795|NCT04185220|75999057|FG000|COMPLETED|Dose Expansion||0||
59874796|NCT04185220|75999058|FG001|COMPLETED|Dose Expansion||0||
59874797|NCT04185220|75999057|FG000|NOT COMPLETED|Dose Expansion||0||
59874798|NCT04185220|75999058|FG001|NOT COMPLETED|Dose Expansion||0||
59874799|NCT00002931|75999065|FG000|STARTED|Overall Study||48||
59874800|NCT00002931|75999065|FG000|COMPLETED|Overall Study||46||
59874801|NCT00002931|75999065|FG000|NOT COMPLETED|Overall Study||2||
59874802|NCT02918266|75999080|FG000|STARTED|Part 1||6||
59874803|NCT02918266|75999081|FG001|STARTED|Part 1||0||
59874804|NCT02918266|75999082|FG002|STARTED|Part 1||0||
59874805|NCT02918266|75999083|FG003|STARTED|Part 1||0||
59874806|NCT02918266|75999084|FG004|STARTED|Part 1||0||
59874807|NCT02918266|75999085|FG005|STARTED|Part 1||0||
59874808|NCT02918266|75999086|FG006|STARTED|Part 1||0||
59874809|NCT02918266|75999087|FG007|STARTED|Part 1||0||
59874810|NCT02918266|75999088|FG008|STARTED|Part 1||0||
59874811|NCT02918266|75999089|FG009|STARTED|Part 1||0||
59874812|NCT02918266|75999090|FG010|STARTED|Part 1||0||
59874813|NCT02918266|75999080|FG000|COMPLETED|Part 1||6||
59874814|NCT02918266|75999081|FG001|COMPLETED|Part 1||0||
59874815|NCT02918266|75999082|FG002|COMPLETED|Part 1||0||
59874816|NCT02918266|75999083|FG003|COMPLETED|Part 1||0||
59874817|NCT02918266|75999084|FG004|COMPLETED|Part 1||0||
59874818|NCT02918266|75999085|FG005|COMPLETED|Part 1||0||
59874819|NCT02918266|75999086|FG006|COMPLETED|Part 1||0||
59874820|NCT02918266|75999087|FG007|COMPLETED|Part 1||0||
59874821|NCT02918266|75999088|FG008|COMPLETED|Part 1||0||
59874822|NCT02918266|75999089|FG009|COMPLETED|Part 1||0||
59874823|NCT02918266|75999090|FG010|COMPLETED|Part 1||0||
59874824|NCT02918266|75999080|FG000|NOT COMPLETED|Part 1||0||
59874825|NCT02918266|75999081|FG001|NOT COMPLETED|Part 1||0||
59874826|NCT02918266|75999082|FG002|NOT COMPLETED|Part 1||0||
59874827|NCT02918266|75999083|FG003|NOT COMPLETED|Part 1||0||
59874828|NCT02918266|75999084|FG004|NOT COMPLETED|Part 1||0||
59874829|NCT02918266|75999085|FG005|NOT COMPLETED|Part 1||0||
59874830|NCT02918266|75999086|FG006|NOT COMPLETED|Part 1||0||
59874831|NCT02918266|75999087|FG007|NOT COMPLETED|Part 1||0||
59874832|NCT02918266|75999088|FG008|NOT COMPLETED|Part 1||0||
59874833|NCT02918266|75999089|FG009|NOT COMPLETED|Part 1||0||
59874834|NCT02918266|75999090|FG010|NOT COMPLETED|Part 1||0||
59874835|NCT02918266|75999080|FG000|STARTED|Part 2: Intervention Period 1 (2 Days)||0||
59874836|NCT02918266|75999081|FG001|STARTED|Part 2: Intervention Period 1 (2 Days)||1||
59874837|NCT02918266|75999082|FG002|STARTED|Part 2: Intervention Period 1 (2 Days)||1||
59874838|NCT02918266|75999083|FG003|STARTED|Part 2: Intervention Period 1 (2 Days)||1||
59874839|NCT02918266|75999084|FG004|STARTED|Part 2: Intervention Period 1 (2 Days)||1||
59874840|NCT02918266|75999085|FG005|STARTED|Part 2: Intervention Period 1 (2 Days)||1||
59874841|NCT02918266|75999086|FG006|STARTED|Part 2: Intervention Period 1 (2 Days)||2||
59874842|NCT02918266|75999087|FG007|STARTED|Part 2: Intervention Period 1 (2 Days)||1||
59874843|NCT02918266|75999088|FG008|STARTED|Part 2: Intervention Period 1 (2 Days)||2||
59874844|NCT02918266|75999089|FG009|STARTED|Part 2: Intervention Period 1 (2 Days)||1||
59874845|NCT02918266|75999090|FG010|STARTED|Part 2: Intervention Period 1 (2 Days)||1||
59874846|NCT02918266|75999080|FG000|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0||
59874847|NCT02918266|75999081|FG001|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0||
59874848|NCT02918266|75999082|FG002|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0||
59874849|NCT02918266|75999083|FG003|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0||
59874850|NCT02918266|75999084|FG004|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0||
59874851|NCT02918266|75999085|FG005|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0||
59874852|NCT02918266|75999086|FG006|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0||
59874853|NCT02918266|75999087|FG007|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0||
59874854|NCT02918266|75999088|FG008|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0||
59874855|NCT02918266|75999089|FG009|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0||
59874856|NCT02918266|75999090|FG010|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0||
59874857|NCT02918266|75999080|FG000|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||0||
59874858|NCT02918266|75999081|FG001|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1||
59874859|NCT02918266|75999082|FG002|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1||
59874860|NCT02918266|75999083|FG003|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1||
59874861|NCT02918266|75999084|FG004|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1||
59874862|NCT02918266|75999085|FG005|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1||
59874863|NCT02918266|75999086|FG006|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||2||
59874864|NCT02918266|75999087|FG007|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1||
59874865|NCT02918266|75999088|FG008|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||2||
59874866|NCT02918266|75999089|FG009|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1||
59874867|NCT02918266|75999090|FG010|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1||
59874868|NCT02918266|75999080|FG000|STARTED|Part 2: Washout Period 1 (3 Weeks)||0||
59874869|NCT02918266|75999081|FG001|STARTED|Part 2: Washout Period 1 (3 Weeks)||0||
59874870|NCT02918266|75999082|FG002|STARTED|Part 2: Washout Period 1 (3 Weeks)||0||
59874871|NCT02918266|75999083|FG003|STARTED|Part 2: Washout Period 1 (3 Weeks)||0||
59874872|NCT02918266|75999084|FG004|STARTED|Part 2: Washout Period 1 (3 Weeks)||0||
59874873|NCT02918266|75999085|FG005|STARTED|Part 2: Washout Period 1 (3 Weeks)||0||
59874874|NCT02918266|75999086|FG006|STARTED|Part 2: Washout Period 1 (3 Weeks)||0||
59874875|NCT02918266|75999087|FG007|STARTED|Part 2: Washout Period 1 (3 Weeks)||0||
59874876|NCT02918266|75999088|FG008|STARTED|Part 2: Washout Period 1 (3 Weeks)||0||
59874877|NCT02918266|75999089|FG009|STARTED|Part 2: Washout Period 1 (3 Weeks)||0||
59874878|NCT02918266|75999090|FG010|STARTED|Part 2: Washout Period 1 (3 Weeks)||0||
59874879|NCT02918266|75999080|FG000|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0||
59874880|NCT02918266|75999081|FG001|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0||
59874881|NCT02918266|75999082|FG002|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0||
59874882|NCT02918266|75999083|FG003|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0||
60135654|NCT02581891|76258345|FG000|NOT COMPLETED|Overall Study||16||
60135655|NCT02581891|76258346|FG001|NOT COMPLETED|Overall Study||19||
59874883|NCT02918266|75999084|FG004|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0||
59874884|NCT02918266|75999085|FG005|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0||
59874885|NCT02918266|75999086|FG006|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0||
59874886|NCT02918266|75999087|FG007|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0||
59874887|NCT02918266|75999088|FG008|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0||
59874888|NCT02918266|75999089|FG009|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0||
59874889|NCT02918266|75999090|FG010|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0||
59874890|NCT02918266|75999080|FG000|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0||
60135656|NCT02576535|76258353|FG000|STARTED|Overall Study||18||
60135657|NCT02576535|76258353|FG000|COMPLETED|Overall Study||16||
60135658|NCT02576535|76258353|FG000|NOT COMPLETED|Overall Study||2||
60135659|NCT02574845|76258363|FG000|STARTED|Overall Study||3||
60135660|NCT02574845|76258364|FG001|STARTED|Overall Study||3||
60135661|NCT02574845|76258365|FG002|STARTED|Overall Study||3||
60135662|NCT02574845|76258366|FG003|STARTED|Overall Study||3||
59874891|NCT02918266|75999081|FG001|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0||
59874892|NCT02918266|75999082|FG002|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0||
59874893|NCT02918266|75999083|FG003|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0||
59874894|NCT02918266|75999084|FG004|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0||
59874895|NCT02918266|75999085|FG005|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0||
59874896|NCT02918266|75999086|FG006|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0||
59874897|NCT02918266|75999087|FG007|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0||
59874898|NCT02918266|75999088|FG008|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0||
59874899|NCT02918266|75999089|FG009|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0||
59874900|NCT02918266|75999090|FG010|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0||
59874901|NCT02918266|75999080|FG000|STARTED|Part 2: Intervention Period 2 (2 Days)||0||
59874902|NCT02918266|75999081|FG001|STARTED|Part 2: Intervention Period 2 (2 Days)||0||
59874903|NCT02918266|75999082|FG002|STARTED|Part 2: Intervention Period 2 (2 Days)||0||
59874904|NCT02918266|75999083|FG003|STARTED|Part 2: Intervention Period 2 (2 Days)||0||
59874905|NCT02918266|75999084|FG004|STARTED|Part 2: Intervention Period 2 (2 Days)||0||
59874906|NCT02918266|75999085|FG005|STARTED|Part 2: Intervention Period 2 (2 Days)||0||
59874907|NCT02918266|75999086|FG006|STARTED|Part 2: Intervention Period 2 (2 Days)||0||
59874908|NCT02918266|75999087|FG007|STARTED|Part 2: Intervention Period 2 (2 Days)||0||
59874909|NCT02918266|75999088|FG008|STARTED|Part 2: Intervention Period 2 (2 Days)||0||
60135663|NCT02574845|76258367|FG004|STARTED|Overall Study||3||
60135664|NCT02574845|76258368|FG005|STARTED|Overall Study||3||
60135665|NCT02574845|76258363|FG000|Received T1|Overall Study||3||
60135666|NCT02574845|76258364|FG001|Received T1|Overall Study||2||
59874910|NCT02918266|75999089|FG009|STARTED|Part 2: Intervention Period 2 (2 Days)||0||
59874911|NCT02918266|75999090|FG010|STARTED|Part 2: Intervention Period 2 (2 Days)||0||
59874912|NCT02918266|75999080|FG000|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0||
59874913|NCT02918266|75999081|FG001|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0||
59874914|NCT02918266|75999082|FG002|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0||
59874915|NCT02918266|75999083|FG003|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0||
59874916|NCT02918266|75999084|FG004|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0||
59874917|NCT02918266|75999085|FG005|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0||
59874918|NCT02918266|75999086|FG006|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0||
59874919|NCT02918266|75999087|FG007|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0||
59874920|NCT02918266|75999088|FG008|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0||
59874921|NCT02918266|75999089|FG009|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0||
59874922|NCT02918266|75999090|FG010|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0||
59874923|NCT02918266|75999080|FG000|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0||
59874924|NCT02918266|75999081|FG001|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0||
59874925|NCT02918266|75999082|FG002|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0||
59874926|NCT02918266|75999083|FG003|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0||
59874927|NCT02918266|75999084|FG004|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0||
59874928|NCT02918266|75999085|FG005|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0||
59874929|NCT02918266|75999086|FG006|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0||
59874930|NCT02918266|75999087|FG007|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0||
59874931|NCT02918266|75999088|FG008|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0||
59874932|NCT02918266|75999089|FG009|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0||
59874933|NCT02918266|75999090|FG010|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0||
59874934|NCT02918266|75999080|FG000|STARTED|Part 2: Washout Period 2 (3 Weeks)||0||
59874935|NCT02918266|75999081|FG001|STARTED|Part 2: Washout Period 2 (3 Weeks)||0||
59874936|NCT02918266|75999082|FG002|STARTED|Part 2: Washout Period 2 (3 Weeks)||0||
59874937|NCT02918266|75999083|FG003|STARTED|Part 2: Washout Period 2 (3 Weeks)||0||
59874938|NCT02918266|75999084|FG004|STARTED|Part 2: Washout Period 2 (3 Weeks)||0||
59874939|NCT02918266|75999085|FG005|STARTED|Part 2: Washout Period 2 (3 Weeks)||0||
59874940|NCT02918266|75999086|FG006|STARTED|Part 2: Washout Period 2 (3 Weeks)||0||
59874941|NCT02918266|75999087|FG007|STARTED|Part 2: Washout Period 2 (3 Weeks)||0||
59874942|NCT02918266|75999088|FG008|STARTED|Part 2: Washout Period 2 (3 Weeks)||0||
59874943|NCT02918266|75999089|FG009|STARTED|Part 2: Washout Period 2 (3 Weeks)||0||
60135667|NCT02574845|76258365|FG002|Received T1|Overall Study||3||
60135668|NCT02574845|76258366|FG003|Received T1|Overall Study||3||
60135669|NCT02574845|76258367|FG004|Received T1|Overall Study||2||
60135670|NCT02574845|76258368|FG005|Received T1|Overall Study|one subject missed treatment period 2|2||
60135671|NCT02574845|76258363|FG000|Received T2|Overall Study||3||
60135672|NCT02574845|76258364|FG001|Received T2|Overall Study||3||
60135673|NCT02574845|76258365|FG002|Received T2|Overall Study||3||
60135674|NCT02574845|76258366|FG003|Received T2|Overall Study||3||
60135675|NCT02574845|76258367|FG004|Received T2|Overall Study||2||
59874944|NCT02918266|75999090|FG010|STARTED|Part 2: Washout Period 2 (3 Weeks)||0||
59874945|NCT02918266|75999080|FG000|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0||
59874946|NCT02918266|75999081|FG001|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0||
59874947|NCT02918266|75999082|FG002|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0||
59874948|NCT02918266|75999083|FG003|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0||
59874949|NCT02918266|75999084|FG004|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0||
59874950|NCT02918266|75999085|FG005|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0||
59874951|NCT02918266|75999086|FG006|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0||
59874952|NCT02918266|75999087|FG007|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0||
59874953|NCT02918266|75999088|FG008|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0||
59874954|NCT02918266|75999089|FG009|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0||
59874955|NCT02918266|75999090|FG010|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0||
59874956|NCT02918266|75999080|FG000|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0||
59874957|NCT02918266|75999081|FG001|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0||
59874958|NCT02918266|75999082|FG002|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0||
59874959|NCT02918266|75999083|FG003|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0||
59874960|NCT02918266|75999084|FG004|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0||
59874961|NCT02918266|75999085|FG005|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0||
59874962|NCT02918266|75999086|FG006|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0||
59874963|NCT02918266|75999087|FG007|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0||
59874964|NCT02918266|75999088|FG008|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0||
59874965|NCT02918266|75999089|FG009|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0||
59874966|NCT02918266|75999090|FG010|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0||
59874967|NCT02918266|75999080|FG000|STARTED|Part 2: Intervention Period 3 (2 Days)||0||
59874968|NCT02918266|75999081|FG001|STARTED|Part 2: Intervention Period 3 (2 Days)||0||
59874969|NCT02918266|75999082|FG002|STARTED|Part 2: Intervention Period 3 (2 Days)||0||
59874970|NCT02918266|75999083|FG003|STARTED|Part 2: Intervention Period 3 (2 Days)||0||
59874971|NCT02918266|75999084|FG004|STARTED|Part 2: Intervention Period 3 (2 Days)||0||
59874972|NCT02918266|75999085|FG005|STARTED|Part 2: Intervention Period 3 (2 Days)||0||
59874973|NCT02918266|75999086|FG006|STARTED|Part 2: Intervention Period 3 (2 Days)||0||
59874974|NCT02918266|75999087|FG007|STARTED|Part 2: Intervention Period 3 (2 Days)||0||
59874975|NCT02918266|75999088|FG008|STARTED|Part 2: Intervention Period 3 (2 Days)||0||
59874976|NCT02918266|75999089|FG009|STARTED|Part 2: Intervention Period 3 (2 Days)||0||
59874977|NCT02918266|75999090|FG010|STARTED|Part 2: Intervention Period 3 (2 Days)||0||
59874978|NCT02918266|75999080|FG000|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0||
59874979|NCT02918266|75999081|FG001|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0||
59874980|NCT02918266|75999082|FG002|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0||
59874981|NCT02918266|75999083|FG003|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0||
59874982|NCT02918266|75999084|FG004|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0||
59874983|NCT02918266|75999085|FG005|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0||
59874984|NCT02918266|75999086|FG006|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0||
59874985|NCT02918266|75999087|FG007|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0||
59874986|NCT02918266|75999088|FG008|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0||
59874987|NCT02918266|75999089|FG009|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0||
59874988|NCT02918266|75999090|FG010|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0||
59874989|NCT02918266|75999080|FG000|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0||
59874990|NCT02918266|75999081|FG001|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0||
59874991|NCT02918266|75999082|FG002|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0||
59874992|NCT02918266|75999083|FG003|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0||
59874993|NCT02918266|75999084|FG004|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0||
59874994|NCT02918266|75999085|FG005|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0||
59874995|NCT02918266|75999086|FG006|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0||
59874996|NCT02918266|75999087|FG007|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0||
59874997|NCT02918266|75999088|FG008|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0||
59874998|NCT02918266|75999089|FG009|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0||
59874999|NCT02918266|75999090|FG010|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0||
59875000|NCT02918266|75999080|FG000|STARTED|Part 2: Washout Period 3 (3 Weeks)||0||
59875001|NCT02918266|75999081|FG001|STARTED|Part 2: Washout Period 3 (3 Weeks)||0||
59875002|NCT02918266|75999082|FG002|STARTED|Part 2: Washout Period 3 (3 Weeks)||0||
59875003|NCT02918266|75999083|FG003|STARTED|Part 2: Washout Period 3 (3 Weeks)||0||
59875004|NCT02918266|75999084|FG004|STARTED|Part 2: Washout Period 3 (3 Weeks)||0||
59875005|NCT02918266|75999085|FG005|STARTED|Part 2: Washout Period 3 (3 Weeks)||0||
59875006|NCT02918266|75999086|FG006|STARTED|Part 2: Washout Period 3 (3 Weeks)||0||
59875007|NCT02918266|75999087|FG007|STARTED|Part 2: Washout Period 3 (3 Weeks)||0||
59875008|NCT02918266|75999088|FG008|STARTED|Part 2: Washout Period 3 (3 Weeks)||0||
59875009|NCT02918266|75999089|FG009|STARTED|Part 2: Washout Period 3 (3 Weeks)||0||
59875010|NCT02918266|75999090|FG010|STARTED|Part 2: Washout Period 3 (3 Weeks)||0||
59875011|NCT02918266|75999080|FG000|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0||
59875012|NCT02918266|75999081|FG001|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0||
59875013|NCT02918266|75999082|FG002|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0||
59875014|NCT02918266|75999083|FG003|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0||
59875015|NCT02918266|75999084|FG004|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0||
59875016|NCT02918266|75999085|FG005|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0||
59875017|NCT02918266|75999086|FG006|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0||
59875018|NCT02918266|75999087|FG007|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0||
59875019|NCT02918266|75999088|FG008|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0||
59875020|NCT02918266|75999089|FG009|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0||
59875021|NCT02918266|75999090|FG010|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0||
59875022|NCT02918266|75999080|FG000|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0||
59875023|NCT02918266|75999081|FG001|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0||
59875024|NCT02918266|75999082|FG002|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0||
59875025|NCT02918266|75999083|FG003|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0||
59875026|NCT02918266|75999084|FG004|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0||
59875027|NCT02918266|75999085|FG005|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0||
59875028|NCT02918266|75999086|FG006|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0||
59875029|NCT02918266|75999087|FG007|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0||
59875030|NCT02918266|75999088|FG008|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0||
59875031|NCT02918266|75999089|FG009|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0||
59875032|NCT02918266|75999090|FG010|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0||
59875033|NCT02918266|75999080|FG000|STARTED|Part 2: Intervention Period 4 (2 Days)||0||
59875034|NCT02918266|75999081|FG001|STARTED|Part 2: Intervention Period 4 (2 Days)||0||
59875035|NCT02918266|75999082|FG002|STARTED|Part 2: Intervention Period 4 (2 Days)||0||
59875036|NCT02918266|75999083|FG003|STARTED|Part 2: Intervention Period 4 (2 Days)||0||
59875037|NCT02918266|75999084|FG004|STARTED|Part 2: Intervention Period 4 (2 Days)||0||
59875038|NCT02918266|75999085|FG005|STARTED|Part 2: Intervention Period 4 (2 Days)||0||
59875039|NCT02918266|75999086|FG006|STARTED|Part 2: Intervention Period 4 (2 Days)||0||
59875040|NCT02918266|75999087|FG007|STARTED|Part 2: Intervention Period 4 (2 Days)||0||
59604586|NCT02058108|75714866|FG000|STARTED|Overall Study||43|All randomized patients were included in the Full Analysis (FAS) and Safety Set|
59604587|NCT02058108|75714867|FG001|STARTED|Overall Study||10|All randomized patients were included in the Full Analysis (FAS) and Safety Set|
59604588|NCT02058108|75714866|FG000|Switched to Telbivudine After Week 24|Overall Study||0|Placebo randomized patients who switched to LdT after week 24|
59604589|NCT02058108|75714867|FG001|Switched to Telbivudine After Week 24|Overall Study||5|Placebo randomized patients who switched to LdT after week 24|
59604590|NCT02058108|75714866|FG000|COMPLETED|Overall Study||2||
59604591|NCT02058108|75714867|FG001|COMPLETED|Overall Study||0||
59875041|NCT02918266|75999088|FG008|STARTED|Part 2: Intervention Period 4 (2 Days)||0||
59875042|NCT02918266|75999089|FG009|STARTED|Part 2: Intervention Period 4 (2 Days)||0||
59875043|NCT02918266|75999090|FG010|STARTED|Part 2: Intervention Period 4 (2 Days)||0||
60135676|NCT02574845|76258368|FG005|Received T2|Overall Study||3||
59604592|NCT02058108|75714866|FG000|NOT COMPLETED|Overall Study||41||
59604593|NCT02058108|75714867|FG001|NOT COMPLETED|Overall Study||10||
59604594|NCT02057874|75714875|FG000|STARTED|Overall Study||2||
59604595|NCT02057874|75714875|FG000|COMPLETED|Overall Study||1||
59604596|NCT02057874|75714875|FG000|NOT COMPLETED|Overall Study||1||
59875044|NCT02918266|75999080|FG000|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0||
59875045|NCT02918266|75999081|FG001|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0||
59875046|NCT02918266|75999082|FG002|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0||
59875047|NCT02918266|75999083|FG003|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0||
59875048|NCT02918266|75999084|FG004|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0||
59875049|NCT02918266|75999085|FG005|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0||
59875050|NCT02918266|75999086|FG006|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0||
59875051|NCT02918266|75999087|FG007|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0||
59875052|NCT02918266|75999088|FG008|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0||
59875053|NCT02918266|75999089|FG009|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0||
59875054|NCT02918266|75999090|FG010|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0||
59875055|NCT02918266|75999080|FG000|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0||
59875056|NCT02918266|75999081|FG001|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0||
59875057|NCT02918266|75999082|FG002|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0||
59875058|NCT02918266|75999083|FG003|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0||
59875059|NCT02918266|75999084|FG004|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0||
59875060|NCT02918266|75999085|FG005|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0||
59875061|NCT02918266|75999086|FG006|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0||
59875062|NCT02918266|75999087|FG007|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0||
59875063|NCT02918266|75999088|FG008|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0||
59875064|NCT02918266|75999089|FG009|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0||
59875065|NCT02918266|75999090|FG010|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0||
59875066|NCT02918266|75999080|FG000|STARTED|Part 2: Washout Period 4 (3 Weeks)||0||
59875067|NCT02918266|75999081|FG001|STARTED|Part 2: Washout Period 4 (3 Weeks)||0||
59875068|NCT02918266|75999082|FG002|STARTED|Part 2: Washout Period 4 (3 Weeks)||0||
59875069|NCT02918266|75999083|FG003|STARTED|Part 2: Washout Period 4 (3 Weeks)||0||
59875070|NCT02918266|75999084|FG004|STARTED|Part 2: Washout Period 4 (3 Weeks)||0||
59875071|NCT02918266|75999085|FG005|STARTED|Part 2: Washout Period 4 (3 Weeks)||0||
59747824|NCT00727558|75866964|FG000|COMPLETED|Overall Study||125||
59747825|NCT00727558|75866965|FG001|COMPLETED|Overall Study||118||
59747826|NCT00727558|75866964|FG000|NOT COMPLETED|Overall Study||2||
59747827|NCT00727558|75866965|FG001|NOT COMPLETED|Overall Study||3||
59747828|NCT00688597|75866974|FG000|STARTED|Overall Study||3||
59747829|NCT00688597|75866975|FG001|STARTED|Overall Study||0||
59747830|NCT00688597|75866976|FG002|STARTED|Overall Study||0||
59747831|NCT00688597|75866974|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3||
59747832|NCT00688597|75866975|FG001|Received at Least 1 Dose of Study Drug|Overall Study||0||
59747833|NCT00688597|75866976|FG002|Received at Least 1 Dose of Study Drug|Overall Study||0||
59747834|NCT00688597|75866974|FG000|COMPLETED|Overall Study||0||
59747835|NCT00688597|75866975|FG001|COMPLETED|Overall Study||0||
59747836|NCT00688597|75866976|FG002|COMPLETED|Overall Study||0||
59747837|NCT00688597|75866974|FG000|NOT COMPLETED|Overall Study||3||
59747838|NCT00688597|75866975|FG001|NOT COMPLETED|Overall Study||0||
59747839|NCT00688597|75866976|FG002|NOT COMPLETED|Overall Study||0||
59747840|NCT00735904|75866984|FG000|STARTED|Overall Study||38||
59747841|NCT00735904|75866984|FG000|COMPLETED|Overall Study||0||
59747842|NCT00735904|75866984|FG000|NOT COMPLETED|Overall Study||38||
59747843|NCT00688519|75866990|FG000|STARTED|Overall Study||223||
59747844|NCT00688519|75866991|FG001|STARTED|Overall Study||113||
59747845|NCT00688519|75866990|FG000|COMPLETED|Overall Study||204||
59747846|NCT00688519|75866991|FG001|COMPLETED|Overall Study||98||
59747847|NCT00688519|75866990|FG000|NOT COMPLETED|Overall Study||19||
59747848|NCT00688519|75866991|FG001|NOT COMPLETED|Overall Study||15||
59747849|NCT00721630|75866997|FG000|STARTED|Overall Study||24||
59747850|NCT00721630|75866997|FG000|COMPLETED|Overall Study||23||
59747851|NCT00721630|75866997|FG000|NOT COMPLETED|Overall Study||1||
59747852|NCT00686725|75867003|FG000|STARTED|Overall Study||47||
59747853|NCT00686725|75867004|FG001|STARTED|Overall Study||52||
59747854|NCT00686725|75867003|FG000|COMPLETED|Overall Study|Completers were defined as those who completed the established treatment.|1||
59747855|NCT00686725|75867004|FG001|COMPLETED|Overall Study|Completers were defined as those who completed the established treatment.|10||
59747856|NCT00686725|75867003|FG000|NOT COMPLETED|Overall Study||46||
59747857|NCT00686725|75867004|FG001|NOT COMPLETED|Overall Study||42||
59747858|NCT00727402|75867010|FG000|STARTED|Overall Study||205||
59747859|NCT00727402|75867010|FG000|COMPLETED|Overall Study||89||
59747860|NCT00727402|75867010|FG000|NOT COMPLETED|Overall Study||116||
59747861|NCT00727246|75867018|FG000|STARTED|Overall Study||3||
59747862|NCT00727246|75867019|FG001|STARTED|Overall Study||3||
59747863|NCT00727246|75867020|FG002|STARTED|Overall Study||8||
59747864|NCT00727246|75867021|FG003|STARTED|Overall Study||5||
59747865|NCT00727246|75867018|FG000|COMPLETED|Overall Study||3||
59747866|NCT00727246|75867019|FG001|COMPLETED|Overall Study||2||
59747867|NCT00727246|75867020|FG002|COMPLETED|Overall Study||7||
59747868|NCT00727246|75867021|FG003|COMPLETED|Overall Study||3||
59747869|NCT00727246|75867018|FG000|NOT COMPLETED|Overall Study||0||
59747870|NCT00727246|75867019|FG001|NOT COMPLETED|Overall Study||1||
59747871|NCT00727246|75867020|FG002|NOT COMPLETED|Overall Study||1||
59747872|NCT00727246|75867021|FG003|NOT COMPLETED|Overall Study||2||
59747873|NCT00686647|75867031|FG000|STARTED|Overall Study||93||
59747874|NCT00686647|75867031|FG000|COMPLETED|Overall Study||91||
59747875|NCT00686647|75867031|FG000|NOT COMPLETED|Overall Study||2||
59747876|NCT00687973|75867038|FG000|STARTED|Overall Study||193||
59747877|NCT00687973|75867039|FG001|STARTED|Overall Study||200||
59747878|NCT00687973|75867038|FG000|COMPLETED|Overall Study||169||
59747879|NCT00687973|75867039|FG001|COMPLETED|Overall Study||162||
59518875|NCT01091155|75612766|FG000|STARTED|Overall Study||288||
59747880|NCT00687973|75867038|FG000|NOT COMPLETED|Overall Study||24||
59875072|NCT02918266|75999086|FG006|STARTED|Part 2: Washout Period 4 (3 Weeks)||0||
59518876|NCT01091155|75612766|FG000|COMPLETED|Overall Study||279||
59518877|NCT01091155|75612766|FG000|NOT COMPLETED|Overall Study||9||
59518878|NCT00939653|75612770|FG000|STARTED|Treatment Course 1||6||
59875073|NCT02918266|75999087|FG007|STARTED|Part 2: Washout Period 4 (3 Weeks)||0||
59875074|NCT02918266|75999088|FG008|STARTED|Part 2: Washout Period 4 (3 Weeks)||0||
59875075|NCT02918266|75999089|FG009|STARTED|Part 2: Washout Period 4 (3 Weeks)||0||
59875076|NCT02918266|75999090|FG010|STARTED|Part 2: Washout Period 4 (3 Weeks)||0||
59875077|NCT02918266|75999080|FG000|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0||
59875078|NCT02918266|75999081|FG001|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0||
59875079|NCT02918266|75999082|FG002|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0||
59875080|NCT02918266|75999083|FG003|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0||
59875081|NCT02918266|75999084|FG004|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0||
59875082|NCT02918266|75999085|FG005|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0||
59875083|NCT02918266|75999086|FG006|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0||
59875084|NCT02918266|75999087|FG007|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0||
59875085|NCT02918266|75999088|FG008|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0||
59875086|NCT02918266|75999089|FG009|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0||
59875087|NCT02918266|75999090|FG010|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0||
59875088|NCT02918266|75999080|FG000|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0||
59875089|NCT02918266|75999081|FG001|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0||
59875090|NCT02918266|75999082|FG002|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0||
59875091|NCT02918266|75999083|FG003|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0||
59875092|NCT02918266|75999084|FG004|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0||
59875093|NCT02918266|75999085|FG005|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0||
59875094|NCT02918266|75999086|FG006|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0||
59875095|NCT02918266|75999087|FG007|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0||
59875096|NCT02918266|75999088|FG008|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0||
60135677|NCT02574845|76258363|FG000|Received T3|Overall Study|one subject missed treatment period 2|2||
60135678|NCT02574845|76258364|FG001|Received T3|Overall Study||2||
60135679|NCT02574845|76258365|FG002|Received T3|Overall Study||3||
60135680|NCT02574845|76258366|FG003|Received T3|Overall Study||3||
60135681|NCT02574845|76258367|FG004|Received T3|Overall Study||2||
60135682|NCT02574845|76258368|FG005|Received T3|Overall Study||3||
59875097|NCT02918266|75999089|FG009|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0||
59875098|NCT02918266|75999090|FG010|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0||
59875099|NCT02918266|75999080|FG000|STARTED|Part 2: Intervention Period 5 (2 Days)||0||
59875100|NCT02918266|75999081|FG001|STARTED|Part 2: Intervention Period 5 (2 Days)||0||
59875101|NCT02918266|75999082|FG002|STARTED|Part 2: Intervention Period 5 (2 Days)||0||
59875102|NCT02918266|75999083|FG003|STARTED|Part 2: Intervention Period 5 (2 Days)||0||
59875103|NCT02918266|75999084|FG004|STARTED|Part 2: Intervention Period 5 (2 Days)||0||
60135683|NCT02574845|76258363|FG000|Received T4|Overall Study||3||
60135684|NCT02574845|76258364|FG001|Received T4|Overall Study||2||
60135685|NCT02574845|76258365|FG002|Received T4|Overall Study||3||
60135686|NCT02574845|76258366|FG003|Received T4|Overall Study||3||
60135687|NCT02574845|76258367|FG004|Received T4|Overall Study||2||
60135688|NCT02574845|76258368|FG005|Received T4|Overall Study||2||
60135689|NCT02574845|76258363|FG000|Received T5|Overall Study||3||
60135690|NCT02574845|76258364|FG001|Received T5|Overall Study||2||
60135691|NCT02574845|76258365|FG002|Received T5|Overall Study||3||
60135692|NCT02574845|76258366|FG003|Received T5|Overall Study||3||
59875104|NCT02918266|75999085|FG005|STARTED|Part 2: Intervention Period 5 (2 Days)||0||
59875105|NCT02918266|75999086|FG006|STARTED|Part 2: Intervention Period 5 (2 Days)||0||
59875106|NCT02918266|75999087|FG007|STARTED|Part 2: Intervention Period 5 (2 Days)||0||
59875107|NCT02918266|75999088|FG008|STARTED|Part 2: Intervention Period 5 (2 Days)||0||
59875108|NCT02918266|75999089|FG009|STARTED|Part 2: Intervention Period 5 (2 Days)||0||
59875109|NCT02918266|75999090|FG010|STARTED|Part 2: Intervention Period 5 (2 Days)||0||
59875110|NCT02918266|75999080|FG000|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0||
59875111|NCT02918266|75999081|FG001|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0||
59875112|NCT02918266|75999082|FG002|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0||
59875113|NCT02918266|75999083|FG003|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0||
59875114|NCT02918266|75999084|FG004|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0||
59875115|NCT02918266|75999085|FG005|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0||
59875116|NCT02918266|75999086|FG006|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0||
59875117|NCT02918266|75999087|FG007|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0||
60135693|NCT02574845|76258367|FG004|Received T5|Overall Study||3||
60135694|NCT02574845|76258368|FG005|Received T5|Overall Study||2||
60135695|NCT02574845|76258363|FG000|Received R|Overall Study||3||
60135696|NCT02574845|76258364|FG001|Received R|Overall Study||2||
60135697|NCT02574845|76258365|FG002|Received R|Overall Study||3||
60135698|NCT02574845|76258366|FG003|Received R|Overall Study||3||
60135699|NCT02574845|76258367|FG004|Received R|Overall Study||2||
60135700|NCT02574845|76258368|FG005|Received R|Overall Study||3||
60135701|NCT02574845|76258363|FG000|COMPLETED|Overall Study||3||
60135702|NCT02574845|76258364|FG001|COMPLETED|Overall Study||2||
60135703|NCT02574845|76258365|FG002|COMPLETED|Overall Study||3||
60135704|NCT02574845|76258366|FG003|COMPLETED|Overall Study||3||
60135705|NCT02574845|76258367|FG004|COMPLETED|Overall Study||2||
60135706|NCT02574845|76258368|FG005|COMPLETED|Overall Study||2||
60135707|NCT02574845|76258363|FG000|NOT COMPLETED|Overall Study||0||
59875118|NCT02918266|75999088|FG008|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0||
59875119|NCT02918266|75999089|FG009|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0||
59875120|NCT02918266|75999090|FG010|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0||
59875121|NCT02918266|75999080|FG000|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0||
59875122|NCT02918266|75999081|FG001|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0||
59875123|NCT02918266|75999082|FG002|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0||
59875124|NCT02918266|75999083|FG003|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0||
59875125|NCT02918266|75999084|FG004|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0||
59875126|NCT02918266|75999085|FG005|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0||
59875127|NCT02918266|75999086|FG006|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0||
59875128|NCT02918266|75999087|FG007|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0||
59875129|NCT02918266|75999088|FG008|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0||
59875130|NCT02918266|75999089|FG009|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0||
59875131|NCT02918266|75999090|FG010|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0||
59875132|NCT00041067|75999110|FG000|STARTED|Overall Study||76||
59875133|NCT00041067|75999110|FG000|Eligible|Overall Study||74||
59875134|NCT00041067|75999110|FG000|COMPLETED|Overall Study||0||
60002450|NCT01662999|76118332|FG004|STARTED|Period 2||7||
59747881|NCT00687973|75867039|FG001|NOT COMPLETED|Overall Study||38||
60002451|NCT01662999|76118333|FG005|STARTED|Period 2||7||
60002452|NCT01662999|76118328|FG000|COMPLETED|Period 2||7||
60002453|NCT01662999|76118329|FG001|COMPLETED|Period 2||7||
60002454|NCT01662999|76118330|FG002|COMPLETED|Period 2||7||
60002455|NCT01662999|76118331|FG003|COMPLETED|Period 2||7||
60002456|NCT01662999|76118332|FG004|COMPLETED|Period 2||7||
60002457|NCT01662999|76118333|FG005|COMPLETED|Period 2||7||
60002458|NCT01662999|76118328|FG000|NOT COMPLETED|Period 2||0||
60002459|NCT01662999|76118329|FG001|NOT COMPLETED|Period 2||0||
60002460|NCT01662999|76118330|FG002|NOT COMPLETED|Period 2||0||
60002461|NCT01662999|76118331|FG003|NOT COMPLETED|Period 2||0||
60002462|NCT01662999|76118332|FG004|NOT COMPLETED|Period 2||0||
60002463|NCT01662999|76118333|FG005|NOT COMPLETED|Period 2||0||
60002464|NCT01662999|76118328|FG000|STARTED|Period 3||7||
60002465|NCT01662999|76118329|FG001|STARTED|Period 3||7||
60002466|NCT01662999|76118330|FG002|STARTED|Period 3||7||
60002467|NCT01662999|76118331|FG003|STARTED|Period 3||7||
60002468|NCT01662999|76118332|FG004|STARTED|Period 3||7||
60002469|NCT01662999|76118333|FG005|STARTED|Period 3||7||
60002470|NCT01662999|76118328|FG000|COMPLETED|Period 3||7||
60002471|NCT01662999|76118329|FG001|COMPLETED|Period 3|Participant did not provide 36, 48, or 60 hour samples in this period for Treatment B.|6||
60002472|NCT01662999|76118330|FG002|COMPLETED|Period 3||7||
60002473|NCT01662999|76118331|FG003|COMPLETED|Period 3||7||
60002474|NCT01662999|76118332|FG004|COMPLETED|Period 3||7||
60002475|NCT01662999|76118333|FG005|COMPLETED|Period 3||7||
60002476|NCT01662999|76118328|FG000|NOT COMPLETED|Period 3||0||
60002477|NCT01662999|76118329|FG001|NOT COMPLETED|Period 3||1||
59747882|NCT00721396|75867050|FG000|STARTED|Overall Study||627||
59747883|NCT00721396|75867051|FG001|STARTED|Overall Study||628||
59747884|NCT00721396|75867052|FG002|STARTED|Overall Study||318||
59747885|NCT00721396|75867053|FG003|STARTED|Overall Study||312||
59747886|NCT00721396|75867050|FG000|COMPLETED|Overall Study||597||
59747887|NCT00721396|75867051|FG001|COMPLETED|Overall Study||592||
59747888|NCT00721396|75867052|FG002|COMPLETED|Overall Study||308||
59747889|NCT00721396|75867053|FG003|COMPLETED|Overall Study||302||
59747890|NCT00721396|75867050|FG000|NOT COMPLETED|Overall Study||30||
59747891|NCT00721396|75867051|FG001|NOT COMPLETED|Overall Study||36||
59747892|NCT00721396|75867052|FG002|NOT COMPLETED|Overall Study||10||
59747893|NCT00721396|75867053|FG003|NOT COMPLETED|Overall Study||10||
59747894|NCT00943826|75867070|FG000|STARTED|Concurrent Phase||458||
59747895|NCT00943826|75867071|FG001|STARTED|Concurrent Phase||463||
59747896|NCT00943826|75867070|FG000|Treated|Concurrent Phase||452||
59747897|NCT00943826|75867071|FG001|Treated|Concurrent Phase||459||
59747898|NCT00943826|75867070|FG000|COMPLETED|Concurrent Phase||397||
59747899|NCT00943826|75867071|FG001|COMPLETED|Concurrent Phase||421||
59747900|NCT00943826|75867070|FG000|NOT COMPLETED|Concurrent Phase||61||
59747901|NCT00943826|75867071|FG001|NOT COMPLETED|Concurrent Phase||42||
59747902|NCT00943826|75867070|FG000|STARTED|Maintenance Phase|Some who completed previous period had discontinued, progressed, or died prior to this period.|396||
59747903|NCT00943826|75867071|FG001|STARTED|Maintenance Phase|Some who completed previous period had discontinued, progressed, or died prior to this period.|370||
59747904|NCT00943826|75867070|FG000|COMPLETED|Maintenance Phase||353||
59747905|NCT00943826|75867071|FG001|COMPLETED|Maintenance Phase||331||
59747906|NCT00943826|75867070|FG000|NOT COMPLETED|Maintenance Phase||43||
59747907|NCT00943826|75867071|FG001|NOT COMPLETED|Maintenance Phase||39||
59747908|NCT00943826|75867070|FG000|STARTED|Monotherapy Phase|Some who completed previous period had discontinued, progressed, or died prior to this period.|269||
60002478|NCT01662999|76118330|FG002|NOT COMPLETED|Period 3||0||
60002479|NCT01662999|76118331|FG003|NOT COMPLETED|Period 3||0||
59747909|NCT00943826|75867071|FG001|STARTED|Monotherapy Phase|Some who completed previous period had discontinued, progressed, or died prior to this period.|159||
60002480|NCT01662999|76118332|FG004|NOT COMPLETED|Period 3||0||
60002481|NCT01662999|76118333|FG005|NOT COMPLETED|Period 3||0||
59875135|NCT00041067|75999110|FG000|NOT COMPLETED|Overall Study||76||
59875136|NCT01063036|75999115|FG000|STARTED|Participants Treated With Study Drug||92||
59875137|NCT01063036|75999115|FG000|COMPLETED|Participants Treated With Study Drug||86||
59875138|NCT01063036|75999115|FG000|NOT COMPLETED|Participants Treated With Study Drug||6||
59875139|NCT01063036|75999115|FG000|STARTED|Post Dosing Follow-up Through 24 Weeks|2 included did not complete treatment; 3 completed treatment but not included (lost to follow-up).|85||
59875140|NCT01063036|75999115|FG000|COMPLETED|Post Dosing Follow-up Through 24 Weeks||46||
59875141|NCT01063036|75999115|FG000|NOT COMPLETED|Post Dosing Follow-up Through 24 Weeks||39||
59875142|NCT00040365|75999119|FG000|STARTED|Overall Study||30||
60135708|NCT02574845|76258364|FG001|NOT COMPLETED|Overall Study||1||
60135709|NCT02574845|76258365|FG002|NOT COMPLETED|Overall Study||0||
60135710|NCT02574845|76258366|FG003|NOT COMPLETED|Overall Study||0||
59518879|NCT00939653|75612770|FG000|COMPLETED|Treatment Course 1||6||
59875143|NCT00040365|75999119|FG000|Completed Follow Up Phase|Overall Study||19||
59875144|NCT00040365|75999119|FG000|COMPLETED|Overall Study||19||
59875145|NCT00040365|75999119|FG000|NOT COMPLETED|Overall Study||11||
59875146|NCT02974114|75999126|FG000|STARTED|Overall Study||6||
59875147|NCT02974114|75999127|FG001|STARTED|Overall Study||7||
59875148|NCT02974114|75999128|FG002|STARTED|Overall Study||8||
59875149|NCT02974114|75999126|FG000|COMPLETED|Overall Study||6||
59875150|NCT02974114|75999127|FG001|COMPLETED|Overall Study||6||
59875151|NCT02974114|75999128|FG002|COMPLETED|Overall Study||6||
59875152|NCT02974114|75999126|FG000|NOT COMPLETED|Overall Study||0||
59875153|NCT02974114|75999127|FG001|NOT COMPLETED|Overall Study||1||
59875154|NCT02974114|75999128|FG002|NOT COMPLETED|Overall Study||2||
59875155|NCT00001959|75999138|FG000|STARTED|Overall Study||21||
59875156|NCT00001959|75999138|FG000|COMPLETED|Overall Study||18||
59875157|NCT00001959|75999138|FG000|NOT COMPLETED|Overall Study||3||
59875158|NCT00001941|75999142|FG000|STARTED|Overall Study||3||
59875159|NCT00001941|75999143|FG001|STARTED|Overall Study||5||
59875160|NCT00001941|75999144|FG002|STARTED|Overall Study||3||
59875161|NCT00001941|75999145|FG003|STARTED|Overall Study||3||
59875162|NCT00001941|75999146|FG004|STARTED|Overall Study||20||
59875163|NCT00001941|75999142|FG000|COMPLETED|Overall Study||3||
59875164|NCT00001941|75999143|FG001|COMPLETED|Overall Study||5||
59875165|NCT00001941|75999144|FG002|COMPLETED|Overall Study||3||
59875166|NCT00001941|75999145|FG003|COMPLETED|Overall Study||3||
60135711|NCT02574845|76258367|FG004|NOT COMPLETED|Overall Study||1||
60135712|NCT02574845|76258368|FG005|NOT COMPLETED|Overall Study||1||
60135713|NCT02404285|76258384|FG000|STARTED|Overall Study||33||
60135714|NCT02404285|76258385|FG001|STARTED|Overall Study||35||
59875167|NCT00001941|75999146|FG004|COMPLETED|Overall Study||19||
59875168|NCT00001941|75999142|FG000|NOT COMPLETED|Overall Study||0||
59875169|NCT00001941|75999143|FG001|NOT COMPLETED|Overall Study||0||
59875170|NCT00001941|75999144|FG002|NOT COMPLETED|Overall Study||0||
59875171|NCT00001941|75999145|FG003|NOT COMPLETED|Overall Study||0||
59875172|NCT00001941|75999146|FG004|NOT COMPLETED|Overall Study||1||
59875173|NCT01061866|75999151|FG000|STARTED|Overall Study||7||
59875174|NCT01061866|75999151|FG000|COMPLETED|Overall Study||5||
59875175|NCT01061866|75999151|FG000|NOT COMPLETED|Overall Study||2||
59875176|NCT01061008|75999157|FG000|STARTED|Overall Study||16||
59875177|NCT01061008|75999158|FG001|STARTED|Overall Study||15||
59875178|NCT01061008|75999157|FG000|COMPLETED|Overall Study||10||
59875179|NCT01061008|75999158|FG001|COMPLETED|Overall Study||9||
59875180|NCT01061008|75999157|FG000|NOT COMPLETED|Overall Study||6||
59875181|NCT01061008|75999158|FG001|NOT COMPLETED|Overall Study||6||
59875182|NCT00039741|75999168|FG000|STARTED|Overall Study||66||
59875183|NCT00039741|75999169|FG001|STARTED|Overall Study||68||
60135715|NCT02404285|76258384|FG000|COMPLETED|Overall Study||31||
60135716|NCT02404285|76258385|FG001|COMPLETED|Overall Study||33||
59875184|NCT00039741|75999170|FG002|STARTED|Overall Study||65||
60135717|NCT02404285|76258384|FG000|NOT COMPLETED|Overall Study||2||
60135718|NCT02404285|76258385|FG001|NOT COMPLETED|Overall Study||2||
60135719|NCT02048371|76258404|FG000|STARTED|Overall Study||24||
60135720|NCT02048371|76258405|FG001|STARTED|Overall Study||9||
60135721|NCT02048371|76258406|FG002|STARTED|Overall Study||15||
60135722|NCT02048371|76258407|FG003|STARTED|Overall Study||22||
60135723|NCT02048371|76258408|FG004|STARTED|Overall Study||9||
60135724|NCT02048371|76258409|FG005|STARTED|Overall Study||11||
60135725|NCT02048371|76258410|FG006|STARTED|Overall Study||30||
59875185|NCT00039741|75999171|FG003|STARTED|Overall Study||64||
59875186|NCT00039741|75999168|FG000|Death|Overall Study||0||
59875187|NCT00039741|75999169|FG001|Death|Overall Study||1||
59875188|NCT00039741|75999170|FG002|Death|Overall Study||0||
59875189|NCT00039741|75999171|FG003|Death|Overall Study||0||
59875190|NCT00039741|75999168|FG000|COMPLETED|Overall Study||51||
60135726|NCT02048371|76258411|FG007|STARTED|Overall Study||10||
60135727|NCT02048371|76258412|FG008|STARTED|Overall Study||1||
60135728|NCT02048371|76258404|FG000|COMPLETED|Overall Study||17||
59875191|NCT00039741|75999169|FG001|COMPLETED|Overall Study||56||
59875192|NCT00039741|75999170|FG002|COMPLETED|Overall Study||54||
59875193|NCT00039741|75999171|FG003|COMPLETED|Overall Study||50||
59875194|NCT00039741|75999168|FG000|NOT COMPLETED|Overall Study||15||
59875195|NCT00039741|75999169|FG001|NOT COMPLETED|Overall Study||12||
59875196|NCT00039741|75999170|FG002|NOT COMPLETED|Overall Study||11||
59875197|NCT00039741|75999171|FG003|NOT COMPLETED|Overall Study||14||
59875198|NCT02973802|75999181|FG000|STARTED|Overall Study||12||
59875199|NCT02973802|75999181|FG000|COMPLETED|Overall Study||10||
59875200|NCT02973802|75999181|FG000|NOT COMPLETED|Overall Study||2||
59875201|NCT02973100|75999190|FG000|STARTED|Overall Study||82||
59875202|NCT02973100|75999191|FG001|STARTED|Overall Study||81||
59875203|NCT02973100|75999192|FG002|STARTED|Overall Study||79||
59875204|NCT02973100|75999193|FG003|STARTED|Overall Study||76||
59875205|NCT02973100|75999190|FG000|Received at Least 1 Dose of Study Drug|Overall Study||81||
59875206|NCT02973100|75999191|FG001|Received at Least 1 Dose of Study Drug|Overall Study||81||
59875207|NCT02973100|75999192|FG002|Received at Least 1 Dose of Study Drug|Overall Study||79||
59875208|NCT02973100|75999193|FG003|Received at Least 1 Dose of Study Drug|Overall Study||76||
59875209|NCT02973100|75999190|FG000|COMPLETED|Overall Study||75||
59875210|NCT02973100|75999191|FG001|COMPLETED|Overall Study||73||
59875211|NCT02973100|75999192|FG002|COMPLETED|Overall Study||75||
59875212|NCT02973100|75999193|FG003|COMPLETED|Overall Study||69||
59875213|NCT02973100|75999190|FG000|NOT COMPLETED|Overall Study||7||
59875214|NCT02973100|75999191|FG001|NOT COMPLETED|Overall Study||8||
59875215|NCT02973100|75999192|FG002|NOT COMPLETED|Overall Study||4||
59875216|NCT02973100|75999193|FG003|NOT COMPLETED|Overall Study||7||
59875217|NCT01060540|75999208|FG000|STARTED|Overall Study||303||
59875218|NCT01060540|75999209|FG001|STARTED|Overall Study||298||
60135729|NCT02048371|76258405|FG001|COMPLETED|Overall Study||1||
60135730|NCT02048371|76258406|FG002|COMPLETED|Overall Study||9||
60135731|NCT02048371|76258407|FG003|COMPLETED|Overall Study||11||
60135732|NCT02048371|76258408|FG004|COMPLETED|Overall Study||3||
60135733|NCT02048371|76258409|FG005|COMPLETED|Overall Study||8||
60135734|NCT02048371|76258410|FG006|COMPLETED|Overall Study||22||
60135735|NCT02048371|76258411|FG007|COMPLETED|Overall Study||6||
60135736|NCT02048371|76258412|FG008|COMPLETED|Overall Study||1||
60135737|NCT02048371|76258404|FG000|NOT COMPLETED|Overall Study||7||
60135738|NCT02048371|76258405|FG001|NOT COMPLETED|Overall Study||8||
59875219|NCT01060540|75999208|FG000|COMPLETED|Overall Study||239||
59875220|NCT01060540|75999209|FG001|COMPLETED|Overall Study||233||
59875221|NCT01060540|75999208|FG000|NOT COMPLETED|Overall Study||64||
59875222|NCT01060540|75999209|FG001|NOT COMPLETED|Overall Study||65||
59875223|NCT01482286|75999221|FG000|STARTED|Overall Study||7||
59875224|NCT01482286|75999222|FG001|STARTED|Overall Study||7||
59875225|NCT01482286|75999223|FG002|STARTED|Overall Study||8||
59875226|NCT01482286|75999224|FG003|STARTED|Overall Study||10||
59875227|NCT01482286|75999221|FG000|COMPLETED|Overall Study||4||
59875228|NCT01482286|75999222|FG001|COMPLETED|Overall Study||4||
59875229|NCT01482286|75999223|FG002|COMPLETED|Overall Study||4||
59875230|NCT01482286|75999224|FG003|COMPLETED|Overall Study||5||
59875231|NCT01482286|75999221|FG000|NOT COMPLETED|Overall Study||3||
59875232|NCT01482286|75999222|FG001|NOT COMPLETED|Overall Study||3||
59875233|NCT01482286|75999223|FG002|NOT COMPLETED|Overall Study||4||
59875234|NCT01482286|75999224|FG003|NOT COMPLETED|Overall Study||5||
59875235|NCT02972632|75999234|FG000|STARTED|Overall Study||123||
59875236|NCT02972632|75999234|FG000|Safety Analysis Set|Overall Study||122|All participants who received at least one dose study drug.|
59875237|NCT02972632|75999234|FG000|COMPLETED|Overall Study||106||
59875238|NCT02972632|75999234|FG000|NOT COMPLETED|Overall Study||17||
59875239|NCT01060150|75999238|FG000|STARTED|Overall Study||115||
59875240|NCT01060150|75999238|FG000|Treated|Overall Study||113||
59875241|NCT01060150|75999238|FG000|COMPLETED|Overall Study||92||
59875242|NCT01060150|75999238|FG000|NOT COMPLETED|Overall Study||23||
59875243|NCT02972242|75999244|FG000|STARTED|Overall Study||82||
59875244|NCT02972242|75999245|FG001|STARTED|Overall Study||93||
59875245|NCT02972242|75999244|FG000|COMPLETED|Overall Study||81||
59875246|NCT02972242|75999245|FG001|COMPLETED|Overall Study||93||
59875247|NCT02972242|75999244|FG000|NOT COMPLETED|Overall Study||1||
59518880|NCT00939653|75612770|FG000|NOT COMPLETED|Treatment Course 1||0||
59875248|NCT02972242|75999245|FG001|NOT COMPLETED|Overall Study||0||
59875249|NCT02970292|75999253|FG000|STARTED|Overall Study||198||
59875250|NCT02970292|75999254|FG001|STARTED|Overall Study||198||
59875251|NCT02970292|75999253|FG000|COMPLETED|Overall Study||174||
59875252|NCT02970292|75999254|FG001|COMPLETED|Overall Study||190||
59875253|NCT02970292|75999253|FG000|NOT COMPLETED|Overall Study||24||
60135739|NCT02048371|76258406|FG002|NOT COMPLETED|Overall Study||6||
60135740|NCT02048371|76258407|FG003|NOT COMPLETED|Overall Study||11||
60135741|NCT02048371|76258408|FG004|NOT COMPLETED|Overall Study||6||
59518881|NCT00939653|75612770|FG000|STARTED|Treatment Course 2||2|Required for all patients who achieve Complete Remission (CR) or CRp, unless proceeding to HSCT|
59518882|NCT00939653|75612770|FG000|COMPLETED|Treatment Course 2||2||
59518883|NCT00939653|75612770|FG000|NOT COMPLETED|Treatment Course 2||0||
59518884|NCT00939653|75612770|FG000|STARTED|Treatment Course 3||0|Patients with CR or CRp and meeting other protocol-defined criteria may proceed to Courses 3 and 4.|
59518885|NCT00939653|75612770|FG000|COMPLETED|Treatment Course 3||0||
59518886|NCT00939653|75612770|FG000|NOT COMPLETED|Treatment Course 3||0||
59518887|NCT00939653|75612770|FG000|STARTED|Treatment Course 4||0||
59518888|NCT00939653|75612770|FG000|COMPLETED|Treatment Course 4||0||
59518889|NCT00939653|75612770|FG000|NOT COMPLETED|Treatment Course 4||0||
59875254|NCT02970292|75999254|FG001|NOT COMPLETED|Overall Study||8||
59875255|NCT02971228|75999260|FG000|STARTED|Overall Study||1|Enrolled|
59875256|NCT02971228|75999261|FG001|STARTED|Overall Study||7|Enrolled|
59875257|NCT02971228|75999262|FG002|STARTED|Overall Study||5|Enrolled|
59875258|NCT02971228|75999263|FG003|STARTED|Overall Study|Due to iLet unavailability, trial was stopped upon completion of Part 1. Part 2 was not conducted.|0|Enrolled|
59875259|NCT02971228|75999264|FG004|STARTED|Overall Study|Due to iLet unavailability, trial was stopped upon completion of Part 1. Part 2 was not conducted.|0|Enrolled|
59875260|NCT02971228|75999260|FG000|Randomized and Treated|Overall Study||0||
59875261|NCT02971228|75999261|FG001|Randomized and Treated|Overall Study||7||
59875262|NCT02971228|75999262|FG002|Randomized and Treated|Overall Study||5||
59875263|NCT02971228|75999263|FG003|Randomized and Treated|Overall Study||0||
59875264|NCT02971228|75999264|FG004|Randomized and Treated|Overall Study||0||
59875265|NCT02971228|75999260|FG000|COMPLETED|Overall Study||0||
59875266|NCT02971228|75999261|FG001|COMPLETED|Overall Study||5||
59875267|NCT02971228|75999262|FG002|COMPLETED|Overall Study||5||
59875268|NCT02971228|75999263|FG003|COMPLETED|Overall Study|Due to iLet unavailability, trial was stopped upon completion of Part 1. Part 2 was not conducted.|0||
59875269|NCT02971228|75999264|FG004|COMPLETED|Overall Study|Due to iLet unavailability, trial was stopped upon completion of Part 1. Part 2 was not conducted.|0||
59875270|NCT02971228|75999260|FG000|NOT COMPLETED|Overall Study||1||
59875271|NCT02971228|75999261|FG001|NOT COMPLETED|Overall Study||2||
59875272|NCT02971228|75999262|FG002|NOT COMPLETED|Overall Study||0||
59875273|NCT02971228|75999263|FG003|NOT COMPLETED|Overall Study||0||
59875274|NCT02971228|75999264|FG004|NOT COMPLETED|Overall Study||0||
59875275|NCT01060072|75999277|FG000|STARTED|Overall Study||206||
59875276|NCT01060072|75999278|FG001|STARTED|Overall Study||201||
59875277|NCT01060072|75999277|FG000|COMPLETED|Overall Study||204||
59875278|NCT01060072|75999278|FG001|COMPLETED|Overall Study||196||
59875279|NCT01060072|75999277|FG000|NOT COMPLETED|Overall Study||2||
59875280|NCT01060072|75999278|FG001|NOT COMPLETED|Overall Study||5||
59875281|NCT02969590|75999286|FG000|STARTED|Screening Period||5||
59875282|NCT02969590|75999287|FG001|STARTED|Screening Period||0||
59875283|NCT02969590|75999288|FG002|STARTED|Screening Period||0||
59875284|NCT02969590|75999286|FG000|COMPLETED|Screening Period||4||
59875285|NCT02969590|75999287|FG001|COMPLETED|Screening Period||0||
59875286|NCT02969590|75999288|FG002|COMPLETED|Screening Period||0||
59875287|NCT02969590|75999286|FG000|NOT COMPLETED|Screening Period||1||
59875288|NCT02969590|75999287|FG001|NOT COMPLETED|Screening Period||0||
59875289|NCT02969590|75999288|FG002|NOT COMPLETED|Screening Period||0||
59875290|NCT02969590|75999286|FG000|STARTED|Treatment Period 1||0||
59875291|NCT02969590|75999287|FG001|STARTED|Treatment Period 1||2||
59875292|NCT02969590|75999288|FG002|STARTED|Treatment Period 1||2||
59875293|NCT02969590|75999286|FG000|COMPLETED|Treatment Period 1||0||
59875294|NCT02969590|75999287|FG001|COMPLETED|Treatment Period 1||2||
59875295|NCT02969590|75999288|FG002|COMPLETED|Treatment Period 1||2||
59875296|NCT02969590|75999286|FG000|NOT COMPLETED|Treatment Period 1||0||
59875297|NCT02969590|75999287|FG001|NOT COMPLETED|Treatment Period 1||0||
59875298|NCT02969590|75999288|FG002|NOT COMPLETED|Treatment Period 1||0||
59875299|NCT02969590|75999286|FG000|STARTED|Treatment Period 2||0||
59875300|NCT02969590|75999287|FG001|STARTED|Treatment Period 2||2||
59875301|NCT02969590|75999288|FG002|STARTED|Treatment Period 2||2||
59875302|NCT02969590|75999286|FG000|COMPLETED|Treatment Period 2||0||
59875303|NCT02969590|75999287|FG001|COMPLETED|Treatment Period 2||2||
59875304|NCT02969590|75999288|FG002|COMPLETED|Treatment Period 2||2||
59875305|NCT02969590|75999286|FG000|NOT COMPLETED|Treatment Period 2||0||
59875306|NCT02969590|75999287|FG001|NOT COMPLETED|Treatment Period 2||0||
59875307|NCT02969590|75999288|FG002|NOT COMPLETED|Treatment Period 2||0||
59875308|NCT03345849|75999300|FG000|STARTED|Part 1: Induction Period (Weeks 1-12)||176||
59875309|NCT03345849|75999301|FG001|STARTED|Part 1: Induction Period (Weeks 1-12)||350||
59875310|NCT03345849|75999302|FG002|STARTED|Part 1: Induction Period (Weeks 1-12)||0||
59875311|NCT03345849|75999303|FG003|STARTED|Part 1: Induction Period (Weeks 1-12)||0||
59875312|NCT03345849|75999300|FG000|Received Study Drug|Part 1: Induction Period (Weeks 1-12)||176||
59875313|NCT03345849|75999301|FG001|Received Study Drug|Part 1: Induction Period (Weeks 1-12)||350||
59875314|NCT03345849|75999302|FG002|Received Study Drug|Part 1: Induction Period (Weeks 1-12)||0||
59875315|NCT03345849|75999303|FG003|Received Study Drug|Part 1: Induction Period (Weeks 1-12)||0||
59875316|NCT03345849|75999300|FG000|COMPLETED|Part 1: Induction Period (Weeks 1-12)||154||
59875317|NCT03345849|75999301|FG001|COMPLETED|Part 1: Induction Period (Weeks 1-12)||330||
59875318|NCT03345849|75999302|FG002|COMPLETED|Part 1: Induction Period (Weeks 1-12)||0||
59875319|NCT03345849|75999303|FG003|COMPLETED|Part 1: Induction Period (Weeks 1-12)||0||
59875320|NCT03345849|75999300|FG000|NOT COMPLETED|Part 1: Induction Period (Weeks 1-12)||22||
59875321|NCT03345849|75999301|FG001|NOT COMPLETED|Part 1: Induction Period (Weeks 1-12)||20||
59875322|NCT03345849|75999302|FG002|NOT COMPLETED|Part 1: Induction Period (Weeks 1-12)||0||
59875323|NCT03345849|75999303|FG003|NOT COMPLETED|Part 1: Induction Period (Weeks 1-12)||0||
59875324|NCT03345849|75999300|FG000|STARTED|Part 2: Extended Treatment (Weeks 12-24)||0|Participants who were clinical non-responders at the end of the induction period (Week 12) could enter Part 2.|
59875325|NCT03345849|75999301|FG001|STARTED|Part 2: Extended Treatment (Weeks 12-24)||0|Participants who were clinical non-responders at the end of the induction period (Week 12) could enter Part 2.|
59875326|NCT03345849|75999302|FG002|STARTED|Part 2: Extended Treatment (Weeks 12-24)||57|Participants who were clinical non-responders at the end of the induction period (Week 12) could enter Part 2.|
59875327|NCT03345849|75999303|FG003|STARTED|Part 2: Extended Treatment (Weeks 12-24)||59|Participants who were clinical non-responders at the end of the induction period (Week 12) could enter Part 2.|
59875328|NCT03345849|75999300|FG000|COMPLETED|Part 2: Extended Treatment (Weeks 12-24)||0||
59875329|NCT03345849|75999301|FG001|COMPLETED|Part 2: Extended Treatment (Weeks 12-24)||0||
59875330|NCT03345849|75999302|FG002|COMPLETED|Part 2: Extended Treatment (Weeks 12-24)||49||
59875331|NCT03345849|75999303|FG003|COMPLETED|Part 2: Extended Treatment (Weeks 12-24)||49||
59875332|NCT03345849|75999300|FG000|NOT COMPLETED|Part 2: Extended Treatment (Weeks 12-24)||0||
59875333|NCT03345849|75999301|FG001|NOT COMPLETED|Part 2: Extended Treatment (Weeks 12-24)||0||
59875334|NCT03345849|75999302|FG002|NOT COMPLETED|Part 2: Extended Treatment (Weeks 12-24)||8||
59875335|NCT03345849|75999303|FG003|NOT COMPLETED|Part 2: Extended Treatment (Weeks 12-24)||10||
59875336|NCT03011307|75999313|FG000|STARTED|Overall Study||50||
59875337|NCT03011307|75999314|FG001|STARTED|Overall Study||48||
59875338|NCT03011307|75999313|FG000|COMPLETED|Overall Study||44||
59875339|NCT03011307|75999314|FG001|COMPLETED|Overall Study||46||
59518890|NCT03537664|75612775|FG000|STARTED|Overall Study||20||
59518891|NCT03537664|75612776|FG001|STARTED|Overall Study||25||
59875340|NCT03011307|75999313|FG000|NOT COMPLETED|Overall Study||6||
59875341|NCT03011307|75999314|FG001|NOT COMPLETED|Overall Study||2||
59875342|NCT03798717|75999326|FG000|STARTED|Overall Study||4||
59875343|NCT03798717|75999327|FG001|STARTED|Overall Study||3||
59875344|NCT03798717|75999328|FG002|STARTED|Overall Study||3||
59875345|NCT03798717|75999329|FG003|STARTED|Overall Study||4||
59875346|NCT03798717|75999330|FG004|STARTED|Overall Study||3||
59875347|NCT03798717|75999331|FG005|STARTED|Overall Study||3||
59875348|NCT03798717|75999326|FG000|COMPLETED|Overall Study||2||
59875349|NCT03798717|75999327|FG001|COMPLETED|Overall Study||2||
59875350|NCT03798717|75999328|FG002|COMPLETED|Overall Study||2||
59875351|NCT03798717|75999329|FG003|COMPLETED|Overall Study||2||
59875352|NCT03798717|75999330|FG004|COMPLETED|Overall Study||2||
59875353|NCT03798717|75999331|FG005|COMPLETED|Overall Study||2||
59875354|NCT03798717|75999326|FG000|NOT COMPLETED|Overall Study||2||
59875355|NCT03798717|75999327|FG001|NOT COMPLETED|Overall Study||1||
59875356|NCT03798717|75999328|FG002|NOT COMPLETED|Overall Study||1||
59875357|NCT03798717|75999329|FG003|NOT COMPLETED|Overall Study||2||
59875358|NCT03798717|75999330|FG004|NOT COMPLETED|Overall Study||1||
59875359|NCT03798717|75999331|FG005|NOT COMPLETED|Overall Study||1||
59875360|NCT03798483|75999340|FG000|STARTED|Overall Study||15||
59875361|NCT03798483|75999340|FG000|Returned All Follow-up Outcome Data|Overall Study||11||
59875362|NCT03798483|75999340|FG000|COMPLETED|Overall Study||13|Completed participants were participants that returned Lysholm Knee Scoring Scale data. 2 participants returned Lysholm Knee Scoring Scale outcome data only.|
59875363|NCT03798483|75999340|FG000|NOT COMPLETED|Overall Study||2||
59875364|NCT03792477|75999353|FG000|STARTED|Overall Study||6||
59875365|NCT03792477|75999354|FG001|STARTED|Overall Study||6||
59875366|NCT03792477|75999355|FG002|STARTED|Overall Study||21||
59875367|NCT03792477|75999356|FG003|STARTED|Overall Study||21||
59875368|NCT03792477|75999357|FG004|STARTED|Overall Study||20||
59875369|NCT03792477|75999353|FG000|COMPLETED|Overall Study||6||
59875370|NCT03792477|75999354|FG001|COMPLETED|Overall Study||6||
59875371|NCT03792477|75999355|FG002|COMPLETED|Overall Study||19||
59875372|NCT03792477|75999356|FG003|COMPLETED|Overall Study||20||
59875373|NCT03792477|75999357|FG004|COMPLETED|Overall Study||19||
59875374|NCT03792477|75999353|FG000|NOT COMPLETED|Overall Study||0||
59875375|NCT03792477|75999354|FG001|NOT COMPLETED|Overall Study||0||
59875376|NCT03792477|75999355|FG002|NOT COMPLETED|Overall Study||2||
59875377|NCT03792477|75999356|FG003|NOT COMPLETED|Overall Study||1||
59875378|NCT03792477|75999357|FG004|NOT COMPLETED|Overall Study||1||
59875379|NCT03790917|75999363|FG000|STARTED|Overall Study||201||
59875380|NCT03790917|75999363|FG000|COMPLETED|Overall Study||200||
59875381|NCT03790917|75999363|FG000|NOT COMPLETED|Overall Study||1||
59875382|NCT03788967|75999370|FG000|STARTED|Overall Study||685||
59875383|NCT03788967|75999371|FG001|STARTED|Overall Study||687||
59875384|NCT03788967|75999370|FG000|Micro-Intent-to-Treat (ITT) Population|Overall Study||449|Micro-ITT=all randomized participants with a confirmed diagnosis of cUTI or AP and a positive Screening urine culture defined as growth of one or two uropathogens at ≥10^5 CFU/mL and/or positive Screening blood culture with isolation of one or more uropathogens.|
59875385|NCT03788967|75999371|FG001|Micro-Intent-to-Treat (ITT) Population|Overall Study||419|Micro-ITT=all randomized participants with a confirmed diagnosis of cUTI or AP and a positive Screening urine culture defined as growth of one or two uropathogens at ≥10^5 CFU/mL and/or positive Screening blood culture with isolation of one or more uropathogens.|
59875386|NCT03788967|75999370|FG000|COMPLETED|Overall Study||653||
59875387|NCT03788967|75999371|FG001|COMPLETED|Overall Study||663||
59875388|NCT03788967|75999370|FG000|NOT COMPLETED|Overall Study||32||
59875389|NCT03788967|75999371|FG001|NOT COMPLETED|Overall Study||24||
59875390|NCT03782571|75999379|FG000|STARTED|Period 1||6||
59875391|NCT03782571|75999380|FG001|STARTED|Period 1||6||
59875392|NCT03782571|75999381|FG002|STARTED|Period 1||6||
59875393|NCT03782571|75999382|FG003|STARTED|Period 1||7||
59875394|NCT03782571|75999379|FG000|COMPLETED|Period 1||5||
59875395|NCT03782571|75999380|FG001|COMPLETED|Period 1||6||
59875396|NCT03782571|75999381|FG002|COMPLETED|Period 1||6||
59875397|NCT03782571|75999382|FG003|COMPLETED|Period 1||7||
59875398|NCT03782571|75999379|FG000|NOT COMPLETED|Period 1||1||
59875399|NCT03782571|75999380|FG001|NOT COMPLETED|Period 1||0||
59875400|NCT03782571|75999381|FG002|NOT COMPLETED|Period 1||0||
59875401|NCT03782571|75999382|FG003|NOT COMPLETED|Period 1||0||
59875402|NCT03782571|75999379|FG000|STARTED|Period 2||5||
59875403|NCT03782571|75999380|FG001|STARTED|Period 2||6||
59875404|NCT03782571|75999381|FG002|STARTED|Period 2||6||
59875405|NCT03782571|75999382|FG003|STARTED|Period 2||7||
59875406|NCT03782571|75999379|FG000|COMPLETED|Period 2||5||
59875407|NCT03782571|75999380|FG001|COMPLETED|Period 2||6||
59875408|NCT03782571|75999381|FG002|COMPLETED|Period 2||6||
59875409|NCT03782571|75999382|FG003|COMPLETED|Period 2||7||
59875410|NCT03782571|75999379|FG000|NOT COMPLETED|Period 2||0||
59875411|NCT03782571|75999380|FG001|NOT COMPLETED|Period 2||0||
59875412|NCT03782571|75999381|FG002|NOT COMPLETED|Period 2||0||
59875413|NCT03782571|75999382|FG003|NOT COMPLETED|Period 2||0||
59875414|NCT03782571|75999379|FG000|STARTED|Period 3||5||
59875415|NCT03782571|75999380|FG001|STARTED|Period 3||6||
59604597|NCT02038920|75714882|FG000|STARTED|Induction Phase (Week 0 to 14)||79||
59875416|NCT03782571|75999381|FG002|STARTED|Period 3||6||
59875417|NCT03782571|75999382|FG003|STARTED|Period 3||7||
59875418|NCT03782571|75999379|FG000|COMPLETED|Period 3||3||
59875419|NCT03782571|75999380|FG001|COMPLETED|Period 3||6||
59875420|NCT03782571|75999381|FG002|COMPLETED|Period 3||6||
59875421|NCT03782571|75999382|FG003|COMPLETED|Period 3||7||
59875422|NCT03782571|75999379|FG000|NOT COMPLETED|Period 3||2||
59875423|NCT03782571|75999380|FG001|NOT COMPLETED|Period 3||0||
59875424|NCT03782571|75999381|FG002|NOT COMPLETED|Period 3||0||
59875425|NCT03782571|75999382|FG003|NOT COMPLETED|Period 3||0||
59875426|NCT03782571|75999379|FG000|STARTED|Period 4||3||
59604598|NCT02038920|75714883|FG001|STARTED|Induction Phase (Week 0 to 14)||78||
59875427|NCT03782571|75999380|FG001|STARTED|Period 4||6||
59875428|NCT03782571|75999381|FG002|STARTED|Period 4||6||
59875429|NCT03782571|75999382|FG003|STARTED|Period 4||7||
59875430|NCT03782571|75999379|FG000|COMPLETED|Period 4||3||
59875431|NCT03782571|75999380|FG001|COMPLETED|Period 4||6||
59875432|NCT03782571|75999381|FG002|COMPLETED|Period 4||6||
59875433|NCT03782571|75999382|FG003|COMPLETED|Period 4||7||
59875434|NCT03782571|75999379|FG000|NOT COMPLETED|Period 4||0||
59875435|NCT03782571|75999380|FG001|NOT COMPLETED|Period 4||0||
59875436|NCT03782571|75999381|FG002|NOT COMPLETED|Period 4||0||
59875437|NCT03782571|75999382|FG003|NOT COMPLETED|Period 4||0||
59875438|NCT03783039|75999396|FG000|STARTED|Overall Study||119||
59875439|NCT03783039|75999397|FG001|STARTED|Overall Study||115||
59875440|NCT03783039|75999396|FG000|COMPLETED|Overall Study||117|6 month follow-up|
59875441|NCT03783039|75999397|FG001|COMPLETED|Overall Study||114|6 month follow-up|
59875442|NCT03783039|75999396|FG000|NOT COMPLETED|Overall Study||2||
59875443|NCT03783039|75999397|FG001|NOT COMPLETED|Overall Study||1||
59875444|NCT03776175|75999407|FG000|STARTED|Treatment Period (42 Days)||14||
59875445|NCT03776175|75999408|FG001|STARTED|Treatment Period (42 Days)||29||
59875446|NCT03776175|75999409|FG002|STARTED|Treatment Period (42 Days)||28||
59875447|NCT03776175|75999410|FG003|STARTED|Treatment Period (42 Days)||28||
59875448|NCT03776175|75999407|FG000|Treated|Treatment Period (42 Days)||14||
59875449|NCT03776175|75999408|FG001|Treated|Treatment Period (42 Days)||29||
59875450|NCT03776175|75999409|FG002|Treated|Treatment Period (42 Days)||28||
59604599|NCT02038920|75714884|FG002|STARTED|Induction Phase (Week 0 to 14)||0||
59747910|NCT00943826|75867070|FG000|COMPLETED|Monotherapy Phase||204||
59604600|NCT02038920|75714885|FG003|STARTED|Induction Phase (Week 0 to 14)||0||
59875451|NCT03776175|75999410|FG003|Treated|Treatment Period (42 Days)||28||
59875452|NCT03776175|75999407|FG000|COMPLETED|Treatment Period (42 Days)||13||
59875453|NCT03776175|75999408|FG001|COMPLETED|Treatment Period (42 Days)||22||
59875454|NCT03776175|75999409|FG002|COMPLETED|Treatment Period (42 Days)||24||
59875455|NCT03776175|75999410|FG003|COMPLETED|Treatment Period (42 Days)||26||
59875456|NCT03776175|75999407|FG000|NOT COMPLETED|Treatment Period (42 Days)||1||
59875457|NCT03776175|75999408|FG001|NOT COMPLETED|Treatment Period (42 Days)||7||
59875458|NCT03776175|75999409|FG002|NOT COMPLETED|Treatment Period (42 Days)||4||
59875459|NCT03776175|75999410|FG003|NOT COMPLETED|Treatment Period (42 Days)||2||
59875460|NCT03776175|75999407|FG000|STARTED|Follow-Up Period (35 Days)||13||
59875461|NCT03776175|75999408|FG001|STARTED|Follow-Up Period (35 Days)||22||
59875462|NCT03776175|75999409|FG002|STARTED|Follow-Up Period (35 Days)||24||
59875463|NCT03776175|75999410|FG003|STARTED|Follow-Up Period (35 Days)||26||
59875464|NCT03776175|75999407|FG000|COMPLETED|Follow-Up Period (35 Days)||13||
59875465|NCT03776175|75999408|FG001|COMPLETED|Follow-Up Period (35 Days)||22||
59604601|NCT02038920|75714886|FG004|STARTED|Induction Phase (Week 0 to 14)||0||
59875466|NCT03776175|75999409|FG002|COMPLETED|Follow-Up Period (35 Days)||24||
59875467|NCT03776175|75999410|FG003|COMPLETED|Follow-Up Period (35 Days)||24||
59747911|NCT00943826|75867071|FG001|COMPLETED|Monotherapy Phase||143||
59747912|NCT00943826|75867070|FG000|NOT COMPLETED|Monotherapy Phase||65||
59747913|NCT00943826|75867071|FG001|NOT COMPLETED|Monotherapy Phase||16||
59875468|NCT03776175|75999407|FG000|NOT COMPLETED|Follow-Up Period (35 Days)||0||
59747914|NCT00943826|75867070|FG000|STARTED|After Primary Overall Survival Analysis|Some who completed previous period had discontinued, progressed, or died prior to this period.|27||
59747915|NCT00943826|75867071|FG001|STARTED|After Primary Overall Survival Analysis|Some who completed previous period had discontinued, progressed, or died prior to this period.|20||
59747916|NCT00943826|75867070|FG000|COMPLETED|After Primary Overall Survival Analysis||0||
59747917|NCT00943826|75867071|FG001|COMPLETED|After Primary Overall Survival Analysis||0||
59747918|NCT00943826|75867070|FG000|NOT COMPLETED|After Primary Overall Survival Analysis||27||
59747919|NCT00943826|75867071|FG001|NOT COMPLETED|After Primary Overall Survival Analysis||20||
59747920|NCT01004003|75867087|FG000|STARTED|Overall Study||6||
59875469|NCT03776175|75999408|FG001|NOT COMPLETED|Follow-Up Period (35 Days)||0||
59519064|NCT01116895|75612924|FG002|NOT COMPLETED|Overall Study||4||
59875470|NCT03776175|75999409|FG002|NOT COMPLETED|Follow-Up Period (35 Days)||0||
59875471|NCT03776175|75999410|FG003|NOT COMPLETED|Follow-Up Period (35 Days)||2||
59875472|NCT02903914|75999428|FG000|STARTED|Overall Study||8||
59875473|NCT02903914|75999429|FG001|STARTED|Overall Study||7||
59875474|NCT02903914|75999430|FG002|STARTED|Overall Study||85||
59875475|NCT02903914|75999431|FG003|STARTED|Overall Study||7||
59875476|NCT02903914|75999432|FG004|STARTED|Overall Study||10||
59875477|NCT02903914|75999433|FG005|STARTED|Overall Study||14||
59875478|NCT02903914|75999434|FG006|STARTED|Overall Study||123||
59875479|NCT02903914|75999435|FG007|STARTED|Overall Study||6||
59875480|NCT02903914|75999428|FG000|COMPLETED|Overall Study||0||
59875481|NCT02903914|75999429|FG001|COMPLETED|Overall Study||0||
59875482|NCT02903914|75999430|FG002|COMPLETED|Overall Study||0||
59875483|NCT02903914|75999431|FG003|COMPLETED|Overall Study||0||
59875484|NCT02903914|75999432|FG004|COMPLETED|Overall Study||0||
59875485|NCT02903914|75999433|FG005|COMPLETED|Overall Study||0||
59875486|NCT02903914|75999434|FG006|COMPLETED|Overall Study||6||
59875487|NCT02903914|75999435|FG007|COMPLETED|Overall Study||1||
59875488|NCT02903914|75999428|FG000|NOT COMPLETED|Overall Study||8||
59875489|NCT02903914|75999429|FG001|NOT COMPLETED|Overall Study||7||
59875490|NCT02903914|75999430|FG002|NOT COMPLETED|Overall Study||85||
59875491|NCT02903914|75999431|FG003|NOT COMPLETED|Overall Study||7||
59875492|NCT02903914|75999432|FG004|NOT COMPLETED|Overall Study||10||
59875493|NCT02903914|75999433|FG005|NOT COMPLETED|Overall Study||14||
59875494|NCT02903914|75999434|FG006|NOT COMPLETED|Overall Study||117||
59875495|NCT02903914|75999435|FG007|NOT COMPLETED|Overall Study||5||
59875496|NCT02969044|75999457|FG000|STARTED|Overall Study||42||
59875497|NCT02969044|75999458|FG001|STARTED|Overall Study||28||
59747921|NCT01004003|75867088|FG001|STARTED|Overall Study||3||
59747922|NCT01004003|75867089|FG002|STARTED|Overall Study||4||
59747923|NCT01004003|75867090|FG003|STARTED|Overall Study||3||
59747924|NCT01004003|75867091|FG004|STARTED|Overall Study||4||
59747925|NCT01004003|75867092|FG005|STARTED|Overall Study||4||
59747926|NCT01004003|75867093|FG006|STARTED|Overall Study||8||
59747927|NCT01004003|75867094|FG007|STARTED|Overall Study||62||
59747928|NCT01004003|75867095|FG008|STARTED|Overall Study||31||
59747929|NCT01004003|75867087|FG000|COMPLETED|Overall Study||0||
59747930|NCT01004003|75867088|FG001|COMPLETED|Overall Study||0||
59747931|NCT01004003|75867089|FG002|COMPLETED|Overall Study||0||
59747932|NCT01004003|75867090|FG003|COMPLETED|Overall Study||0||
59747933|NCT01004003|75867091|FG004|COMPLETED|Overall Study||0||
59747934|NCT01004003|75867092|FG005|COMPLETED|Overall Study||0||
59747935|NCT01004003|75867093|FG006|COMPLETED|Overall Study||0||
59747936|NCT01004003|75867094|FG007|COMPLETED|Overall Study|On-treatment at analysis cut-off date (15 July 2014).|2||
59875498|NCT02969044|75999457|FG000|COMPLETED|Overall Study||37||
59875499|NCT02969044|75999458|FG001|COMPLETED|Overall Study||22||
59875500|NCT02969044|75999457|FG000|NOT COMPLETED|Overall Study||5||
59875501|NCT02969044|75999458|FG001|NOT COMPLETED|Overall Study||6||
59875502|NCT02967562|75999466|FG000|STARTED|Overall Study||32||
59875503|NCT02967562|75999467|FG001|STARTED|Overall Study||31||
59875504|NCT02967562|75999466|FG000|COMPLETED|Overall Study||30||
59875505|NCT02967562|75999467|FG001|COMPLETED|Overall Study||30||
59875506|NCT02967562|75999466|FG000|NOT COMPLETED|Overall Study||2||
59747937|NCT01004003|75867095|FG008|COMPLETED|Overall Study|On-treatment at analysis cut-off date (15 July 2014).|1||
59747938|NCT01004003|75867087|FG000|NOT COMPLETED|Overall Study||6||
59747939|NCT01004003|75867088|FG001|NOT COMPLETED|Overall Study||3||
59747940|NCT01004003|75867089|FG002|NOT COMPLETED|Overall Study||4||
59747941|NCT01004003|75867090|FG003|NOT COMPLETED|Overall Study||3||
59875507|NCT02967562|75999467|FG001|NOT COMPLETED|Overall Study||1||
59875508|NCT02968576|75999473|FG000|STARTED|Overall Study||11||
59875509|NCT02968576|75999474|FG001|STARTED|Overall Study||14||
59875510|NCT02968576|75999473|FG000|COMPLETED|Overall Study||11||
59875511|NCT02968576|75999474|FG001|COMPLETED|Overall Study||13||
59875512|NCT02968576|75999473|FG000|NOT COMPLETED|Overall Study||0||
59875513|NCT02968576|75999474|FG001|NOT COMPLETED|Overall Study||1||
59875514|NCT02966002|75999478|FG000|STARTED|Overall Study||9||
59875515|NCT02966002|75999478|FG000|COMPLETED|Overall Study||5||
59875516|NCT02966002|75999478|FG000|NOT COMPLETED|Overall Study||4||
59875517|NCT02965846|75999485|FG000|STARTED|Overall Study||5||
59875518|NCT02965846|75999486|FG001|STARTED|Overall Study||5||
59875519|NCT02965846|75999487|FG002|STARTED|Overall Study||33||
59875520|NCT02965846|75999485|FG000|COMPLETED|Overall Study||0||
59875521|NCT02965846|75999486|FG001|COMPLETED|Overall Study||0||
59875522|NCT02965846|75999487|FG002|COMPLETED|Overall Study||0||
59875523|NCT02965846|75999485|FG000|NOT COMPLETED|Overall Study||5||
59875524|NCT02965846|75999486|FG001|NOT COMPLETED|Overall Study||5||
59875525|NCT02965846|75999487|FG002|NOT COMPLETED|Overall Study||33||
59875526|NCT02900170|75999493|FG000|STARTED|Overall Study||8||
59875527|NCT02900170|75999493|FG000|COMPLETED|Overall Study||0||
59875528|NCT02900170|75999493|FG000|NOT COMPLETED|Overall Study||8||
59875529|NCT02900092|75999497|FG000|STARTED|Overall Study||10||
59875530|NCT02900092|75999497|FG000|COMPLETED|Overall Study||9||
59875531|NCT02900092|75999497|FG000|NOT COMPLETED|Overall Study||1||
59875532|NCT04076644|75999501|FG000|STARTED|Overall Study||11||
59875533|NCT04076644|75999501|FG000|COMPLETED|Overall Study||7||
59875534|NCT04076644|75999501|FG000|NOT COMPLETED|Overall Study||4||
59875535|NCT02902120|75999505|FG000|STARTED|Overall Study||21||
59875536|NCT02902120|75999505|FG000|COMPLETED|Overall Study||20||
59875537|NCT02902120|75999505|FG000|NOT COMPLETED|Overall Study||1||
59875538|NCT02965456|75999511|FG000|STARTED|Overall Study||413||
59875539|NCT02965456|75999512|FG001|STARTED|Overall Study||407||
59875540|NCT02965456|75999511|FG000|Intent-to-treat (ITT) Population|Overall Study||413|All randomized participants who received study drug.|
59875541|NCT02965456|75999512|FG001|Intent-to-treat (ITT) Population|Overall Study||407|All randomized participants who received study drug.|
59950748|NCT03308058|76069586|FG000|NOT COMPLETED|Overall Study||0||
59604602|NCT02038920|75714887|FG005|STARTED|Induction Phase (Week 0 to 14)||0||
59604603|NCT02038920|75714882|FG000|COMPLETED|Induction Phase (Week 0 to 14)||73||
59604604|NCT02038920|75714883|FG001|COMPLETED|Induction Phase (Week 0 to 14)||66||
59604605|NCT02038920|75714884|FG002|COMPLETED|Induction Phase (Week 0 to 14)||0||
59604606|NCT02038920|75714885|FG003|COMPLETED|Induction Phase (Week 0 to 14)||0||
59604607|NCT02038920|75714886|FG004|COMPLETED|Induction Phase (Week 0 to 14)||0||
59604608|NCT02038920|75714887|FG005|COMPLETED|Induction Phase (Week 0 to 14)||0||
59604609|NCT02038920|75714882|FG000|NOT COMPLETED|Induction Phase (Week 0 to 14)||6||
59604610|NCT02038920|75714883|FG001|NOT COMPLETED|Induction Phase (Week 0 to 14)||12||
59604611|NCT02038920|75714884|FG002|NOT COMPLETED|Induction Phase (Week 0 to 14)||0||
59604612|NCT02038920|75714885|FG003|NOT COMPLETED|Induction Phase (Week 0 to 14)||0||
59604613|NCT02038920|75714886|FG004|NOT COMPLETED|Induction Phase (Week 0 to 14)||0||
59604614|NCT02038920|75714887|FG005|NOT COMPLETED|Induction Phase (Week 0 to 14)||0||
59604615|NCT02038920|75714882|FG000|STARTED|Maintenance Phase (Week 14 to 60)||0|Participants who achieved clinical response at Week 10 entered into the maintenance phase.|
59604616|NCT02038920|75714883|FG001|STARTED|Maintenance Phase (Week 14 to 60)||0|Participants who achieved clinical response at Week 10 entered into the maintenance phase.|
59604617|NCT02038920|75714884|FG002|STARTED|Maintenance Phase (Week 14 to 60)||12|Participants who achieved clinical response at Week 10 entered into the maintenance phase.|
59604618|NCT02038920|75714885|FG003|STARTED|Maintenance Phase (Week 14 to 60)||12|Participants who achieved clinical response at Week 10 entered into the maintenance phase.|
59604619|NCT02038920|75714886|FG004|STARTED|Maintenance Phase (Week 14 to 60)||17|Participants who achieved clinical response at Week 10 entered into the maintenance phase.|
59604620|NCT02038920|75714887|FG005|STARTED|Maintenance Phase (Week 14 to 60)||0|Participants who achieved clinical response at Week 10 entered into the maintenance phase.|
59604621|NCT02038920|75714882|FG000|COMPLETED|Maintenance Phase (Week 14 to 60)||0||
59604622|NCT02038920|75714883|FG001|COMPLETED|Maintenance Phase (Week 14 to 60)||0||
59604623|NCT02038920|75714884|FG002|COMPLETED|Maintenance Phase (Week 14 to 60)||7||
59604624|NCT02038920|75714885|FG003|COMPLETED|Maintenance Phase (Week 14 to 60)||4||
59604625|NCT02038920|75714886|FG004|COMPLETED|Maintenance Phase (Week 14 to 60)||5||
59604626|NCT02038920|75714887|FG005|COMPLETED|Maintenance Phase (Week 14 to 60)||0||
59604627|NCT02038920|75714882|FG000|NOT COMPLETED|Maintenance Phase (Week 14 to 60)||0||
59604628|NCT02038920|75714883|FG001|NOT COMPLETED|Maintenance Phase (Week 14 to 60)||0||
59604629|NCT02038920|75714884|FG002|NOT COMPLETED|Maintenance Phase (Week 14 to 60)||5||
59604630|NCT02038920|75714885|FG003|NOT COMPLETED|Maintenance Phase (Week 14 to 60)||8||
59604631|NCT02038920|75714886|FG004|NOT COMPLETED|Maintenance Phase (Week 14 to 60)||12||
59604632|NCT02038920|75714887|FG005|NOT COMPLETED|Maintenance Phase (Week 14 to 60)||0||
59604633|NCT02038920|75714882|FG000|STARTED|Open Label Cohort (Week 10 to 154)||0|23 out of 157 participants from induction/maintenance phase did not enter the open-label cohort.|
59604634|NCT02038920|75714883|FG001|STARTED|Open Label Cohort (Week 10 to 154)||0|23 out of 157 participants from induction/maintenance phase did not enter the open-label cohort.|
59604635|NCT02038920|75714884|FG002|STARTED|Open Label Cohort (Week 10 to 154)||0|23 out of 157 participants from induction/maintenance phase did not enter the open-label cohort.|
59604636|NCT02038920|75714885|FG003|STARTED|Open Label Cohort (Week 10 to 154)||0|23 out of 157 participants from induction/maintenance phase did not enter the open-label cohort.|
59604637|NCT02038920|75714886|FG004|STARTED|Open Label Cohort (Week 10 to 154)||0|23 out of 157 participants from induction/maintenance phase did not enter the open-label cohort.|
59604638|NCT02038920|75714887|FG005|STARTED|Open Label Cohort (Week 10 to 154)||134|23 out of 157 participants from induction/maintenance phase did not enter the open-label cohort.|
59604639|NCT02038920|75714882|FG000|COMPLETED|Open Label Cohort (Week 10 to 154)||0||
59604640|NCT02038920|75714883|FG001|COMPLETED|Open Label Cohort (Week 10 to 154)||0||
59604641|NCT02038920|75714884|FG002|COMPLETED|Open Label Cohort (Week 10 to 154)||0||
59604642|NCT02038920|75714885|FG003|COMPLETED|Open Label Cohort (Week 10 to 154)||0||
59604643|NCT02038920|75714886|FG004|COMPLETED|Open Label Cohort (Week 10 to 154)||0||
59604644|NCT02038920|75714887|FG005|COMPLETED|Open Label Cohort (Week 10 to 154)||57||
59604645|NCT02038920|75714882|FG000|NOT COMPLETED|Open Label Cohort (Week 10 to 154)||0||
59604646|NCT02038920|75714883|FG001|NOT COMPLETED|Open Label Cohort (Week 10 to 154)||0||
59604647|NCT02038920|75714884|FG002|NOT COMPLETED|Open Label Cohort (Week 10 to 154)||0||
59604648|NCT02038920|75714885|FG003|NOT COMPLETED|Open Label Cohort (Week 10 to 154)||0||
59604649|NCT02038920|75714886|FG004|NOT COMPLETED|Open Label Cohort (Week 10 to 154)||0||
59604650|NCT02038920|75714887|FG005|NOT COMPLETED|Open Label Cohort (Week 10 to 154)||77||
59604651|NCT02038764|75714909|FG000|STARTED|Overall Study||7||
59604652|NCT02038764|75714910|FG001|STARTED|Overall Study||8||
59604653|NCT02038764|75714911|FG002|STARTED|Overall Study||9||
59604654|NCT02038764|75714912|FG003|STARTED|Overall Study||5||
59604655|NCT02038764|75714913|FG004|STARTED|Overall Study||8||
59604656|NCT02038764|75714909|FG000|COMPLETED|Overall Study||6||
59875542|NCT02965456|75999511|FG000|Safety Population|Overall Study||389|All randomized participants with ≥1 confirmed dose of study drug and ≥1 post baseline evaluation.|
59875543|NCT02965456|75999512|FG001|Safety Population|Overall Study||398|All randomized participants with ≥1 confirmed dose of study drug and ≥1 post baseline evaluation.|
59875544|NCT02965456|75999511|FG000|COMPLETED|Overall Study||342||
59875545|NCT02965456|75999512|FG001|COMPLETED|Overall Study||364||
59875546|NCT02965456|75999511|FG000|NOT COMPLETED|Overall Study||71||
59875547|NCT02965456|75999512|FG001|NOT COMPLETED|Overall Study||43||
59875548|NCT02965378|75999520|FG000|STARTED|Overall Study||25||
59875549|NCT02965378|75999521|FG001|STARTED|Overall Study||9||
59875550|NCT02965378|75999520|FG000|Participants on Docetaxel Re-registered to AZD4547 After Progression.|Overall Study||0||
59875551|NCT02965378|75999521|FG001|Participants on Docetaxel Re-registered to AZD4547 After Progression.|Overall Study||2||
59875552|NCT02965378|75999520|FG000|COMPLETED|Overall Study||0|1 re-registered participant did not complete AZD4547 due to progression, and the other re-registered participant, due to adverse event|
59875553|NCT02965378|75999521|FG001|COMPLETED|Overall Study||0|1 re-registered participant did not complete AZD4547 due to progression, and the other re-registered participant, due to adverse event|
59875554|NCT02965378|75999520|FG000|NOT COMPLETED|Overall Study||25||
59875555|NCT02965378|75999521|FG001|NOT COMPLETED|Overall Study||9||
59875556|NCT03772041|75999529|FG000|STARTED|Overall Study||149||
59875557|NCT03772041|75999530|FG001|STARTED|Overall Study||145||
59875558|NCT03772041|75999529|FG000|COMPLETED|Overall Study||135||
59875559|NCT03772041|75999530|FG001|COMPLETED|Overall Study||135||
59875560|NCT03772041|75999529|FG000|NOT COMPLETED|Overall Study||14||
59875561|NCT03772041|75999530|FG001|NOT COMPLETED|Overall Study||10||
59875562|NCT02899156|75999538|FG000|STARTED|Overall Study||11||
59875563|NCT02899156|75999539|FG001|STARTED|Overall Study||11||
59875564|NCT02899156|75999538|FG000|COMPLETED|Overall Study||10||
59875565|NCT02899156|75999539|FG001|COMPLETED|Overall Study||10||
59875566|NCT02899156|75999538|FG000|NOT COMPLETED|Overall Study||1||
59875567|NCT02899156|75999539|FG001|NOT COMPLETED|Overall Study||1||
59875568|NCT03773133|75999545|FG000|STARTED|Overall Study||8||
59875569|NCT03773133|75999545|FG000|Received the Screening IIP|Overall Study||8||
59875570|NCT03773133|75999545|FG000|Received the Therapeutic IRPP|Overall Study||0||
59875571|NCT03773133|75999545|FG000|COMPLETED|Overall Study||0||
59875572|NCT03773133|75999545|FG000|NOT COMPLETED|Overall Study||8||
59875573|NCT02969356|75999550|FG000|STARTED|Overall Study||157||
59875574|NCT02969356|75999550|FG000|Intent-to-Treat (ITT) Population|Overall Study||153||
59875575|NCT02969356|75999550|FG000|COMPLETED|Overall Study||134||
59875576|NCT02969356|75999550|FG000|NOT COMPLETED|Overall Study||23||
59875577|NCT02898454|75999557|FG000|STARTED|Overall Study||153|Randomized population|
59875578|NCT02898454|75999558|FG001|STARTED|Overall Study||145|Randomized population|
59875579|NCT02898454|75999559|FG002|STARTED|Overall Study||150|Randomized population|
59875580|NCT02898454|75999557|FG000|Intent-to-Treat (ITT) Population|Overall Study||153|Randomized participants who were analyzed according to treatment group allocated by randomization.|
59875581|NCT02898454|75999558|FG001|Intent-to-Treat (ITT) Population|Overall Study||145|Randomized participants who were analyzed according to treatment group allocated by randomization.|
59875582|NCT02898454|75999559|FG002|Intent-to-Treat (ITT) Population|Overall Study||150|Randomized participants who were analyzed according to treatment group allocated by randomization.|
59875583|NCT02898454|75999557|FG000|Treated|Overall Study||152||
59875584|NCT02898454|75999558|FG001|Treated|Overall Study||145||
59875585|NCT02898454|75999559|FG002|Treated|Overall Study||150||
59950749|NCT03308058|76069587|FG001|NOT COMPLETED|Overall Study||0||
59604657|NCT02038764|75714910|FG001|COMPLETED|Overall Study||7||
59604658|NCT02038764|75714911|FG002|COMPLETED|Overall Study||7||
59604659|NCT02038764|75714912|FG003|COMPLETED|Overall Study||5||
59604660|NCT02038764|75714913|FG004|COMPLETED|Overall Study||7||
59604661|NCT02038764|75714909|FG000|NOT COMPLETED|Overall Study||1||
59604662|NCT02038764|75714910|FG001|NOT COMPLETED|Overall Study||1||
59604663|NCT02038764|75714911|FG002|NOT COMPLETED|Overall Study||2||
59604664|NCT02038764|75714912|FG003|NOT COMPLETED|Overall Study||0||
59604665|NCT02038764|75714913|FG004|NOT COMPLETED|Overall Study||1||
59604666|NCT02014740|75714931|FG000|STARTED|Overall Study||55||
59604667|NCT02014740|75714932|FG001|STARTED|Overall Study||45||
59604668|NCT02014740|75714931|FG000|COMPLETED|Overall Study||49||
59604669|NCT02014740|75714932|FG001|COMPLETED|Overall Study||40||
59604670|NCT02014740|75714931|FG000|NOT COMPLETED|Overall Study||6||
59604671|NCT02014740|75714932|FG001|NOT COMPLETED|Overall Study||5||
59604672|NCT02014584|75714940|FG000|STARTED|Double-Blind Period (24 Weeks)||59||
59604673|NCT02014584|75714941|FG001|STARTED|Double-Blind Period (24 Weeks)||58||
59604674|NCT02014584|75714942|FG002|STARTED|Double-Blind Period (24 Weeks)||0||
59604675|NCT02014584|75714943|FG003|STARTED|Double-Blind Period (24 Weeks)||0||
59604676|NCT02014584|75714944|FG004|STARTED|Double-Blind Period (24 Weeks)||0||
59604677|NCT02014584|75714945|FG005|STARTED|Double-Blind Period (24 Weeks)||0||
59604678|NCT02014584|75714940|FG000|COMPLETED|Double-Blind Period (24 Weeks)||57||
59604679|NCT02014584|75714941|FG001|COMPLETED|Double-Blind Period (24 Weeks)||52||
59604680|NCT02014584|75714942|FG002|COMPLETED|Double-Blind Period (24 Weeks)||0||
59604681|NCT02014584|75714943|FG003|COMPLETED|Double-Blind Period (24 Weeks)||0||
59604682|NCT02014584|75714944|FG004|COMPLETED|Double-Blind Period (24 Weeks)||0||
59604683|NCT02014584|75714945|FG005|COMPLETED|Double-Blind Period (24 Weeks)||0||
59604684|NCT02014584|75714940|FG000|NOT COMPLETED|Double-Blind Period (24 Weeks)||2||
59604685|NCT02014584|75714941|FG001|NOT COMPLETED|Double-Blind Period (24 Weeks)||6||
59604686|NCT02014584|75714942|FG002|NOT COMPLETED|Double-Blind Period (24 Weeks)||0||
59604687|NCT02014584|75714943|FG003|NOT COMPLETED|Double-Blind Period (24 Weeks)||0||
59604688|NCT02014584|75714944|FG004|NOT COMPLETED|Double-Blind Period (24 Weeks)||0||
59604689|NCT02014584|75714945|FG005|NOT COMPLETED|Double-Blind Period (24 Weeks)||0||
59604690|NCT02014584|75714940|FG000|STARTED|Open-Label Period (24 Weeks)||0||
59604691|NCT02014584|75714941|FG001|STARTED|Open-Label Period (24 Weeks)||0||
59604692|NCT02014584|75714942|FG002|STARTED|Open-Label Period (24 Weeks)||49||
59604693|NCT02014584|75714943|FG003|STARTED|Open-Label Period (24 Weeks)||48||
59604694|NCT02014584|75714944|FG004|STARTED|Open-Label Period (24 Weeks)||0||
59604695|NCT02014584|75714945|FG005|STARTED|Open-Label Period (24 Weeks)||0||
59604696|NCT02014584|75714940|FG000|COMPLETED|Open-Label Period (24 Weeks)||0||
59604697|NCT02014584|75714941|FG001|COMPLETED|Open-Label Period (24 Weeks)||0||
59604698|NCT02014584|75714942|FG002|COMPLETED|Open-Label Period (24 Weeks)||44||
59604699|NCT02014584|75714943|FG003|COMPLETED|Open-Label Period (24 Weeks)||47||
59604700|NCT02014584|75714944|FG004|COMPLETED|Open-Label Period (24 Weeks)||0||
59604701|NCT02014584|75714945|FG005|COMPLETED|Open-Label Period (24 Weeks)||0||
59604702|NCT02014584|75714940|FG000|NOT COMPLETED|Open-Label Period (24 Weeks)||0||
59604703|NCT02014584|75714941|FG001|NOT COMPLETED|Open-Label Period (24 Weeks)||0||
59604704|NCT02014584|75714942|FG002|NOT COMPLETED|Open-Label Period (24 Weeks)||5||
59604705|NCT02014584|75714943|FG003|NOT COMPLETED|Open-Label Period (24 Weeks)||1||
59604706|NCT02014584|75714944|FG004|NOT COMPLETED|Open-Label Period (24 Weeks)||0||
59604707|NCT02014584|75714945|FG005|NOT COMPLETED|Open-Label Period (24 Weeks)||0||
59604708|NCT02014584|75714940|FG000|STARTED|Target Follow-up (F/U) Period (24 Weeks)||0||
59604709|NCT02014584|75714941|FG001|STARTED|Target Follow-up (F/U) Period (24 Weeks)||0||
59604710|NCT02014584|75714942|FG002|STARTED|Target Follow-up (F/U) Period (24 Weeks)||0||
59604711|NCT02014584|75714943|FG003|STARTED|Target Follow-up (F/U) Period (24 Weeks)||0||
59604712|NCT02014584|75714944|FG004|STARTED|Target Follow-up (F/U) Period (24 Weeks)||3||
59604713|NCT02014584|75714945|FG005|STARTED|Target Follow-up (F/U) Period (24 Weeks)||2||
59604714|NCT02014584|75714940|FG000|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0||
59604715|NCT02014584|75714941|FG001|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0||
59604716|NCT02014584|75714942|FG002|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0||
59604717|NCT02014584|75714943|FG003|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0||
59604718|NCT02014584|75714944|FG004|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||2||
59604719|NCT02014584|75714945|FG005|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||2||
59604720|NCT02014584|75714940|FG000|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0||
59604721|NCT02014584|75714941|FG001|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0||
59604722|NCT02014584|75714942|FG002|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0||
59604723|NCT02014584|75714943|FG003|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0||
59604724|NCT02014584|75714944|FG004|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||1||
59604725|NCT02014584|75714945|FG005|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0||
59604726|NCT02014272|75714957|FG000|STARTED|Intervention Period 1||14||
59604727|NCT02014272|75714958|FG001|STARTED|Intervention Period 1||14||
59604728|NCT02014272|75714957|FG000|COMPLETED|Intervention Period 1||13||
59604729|NCT02014272|75714958|FG001|COMPLETED|Intervention Period 1||13||
59604730|NCT02014272|75714957|FG000|NOT COMPLETED|Intervention Period 1||1||
59604731|NCT02014272|75714958|FG001|NOT COMPLETED|Intervention Period 1||1||
59875586|NCT02898454|75999557|FG000|Safety Population|Overall Study|2 participants randomized to placebo received 1 dose of dupilumab:counted in 300 mg q2w then q4w arm|150||
59875587|NCT02898454|75999558|FG001|Safety Population|Overall Study|1 randomized to dupilumab q2w arm received 1dose of placebo: counted in 300 mg q2w then q4w arm.|148||
59875588|NCT02898454|75999559|FG002|Safety Population|Overall Study||149||
59875589|NCT02898454|75999557|FG000|COMPLETED|Overall Study||136||
59875590|NCT02898454|75999558|FG001|COMPLETED|Overall Study||140||
59875591|NCT02898454|75999559|FG002|COMPLETED|Overall Study||144||
59875592|NCT02898454|75999557|FG000|NOT COMPLETED|Overall Study||17||
59875593|NCT02898454|75999558|FG001|NOT COMPLETED|Overall Study||5||
59875594|NCT02898454|75999559|FG002|NOT COMPLETED|Overall Study||6||
59875595|NCT03772587|75999577|FG000|STARTED|Overall Study||14||
59875596|NCT03772587|75999578|FG001|STARTED|Overall Study||14||
59875597|NCT03772587|75999579|FG002|STARTED|Overall Study||13||
59875598|NCT03772587|75999580|FG003|STARTED|Overall Study||13||
59875599|NCT03772587|75999581|FG004|STARTED|Overall Study||14||
59875600|NCT03772587|75999577|FG000|COMPLETED|Overall Study||13||
59875601|NCT03772587|75999578|FG001|COMPLETED|Overall Study||14||
59875602|NCT03772587|75999579|FG002|COMPLETED|Overall Study||12||
60002482|NCT02565381|76118366|FG000|STARTED|Overall Study||25||
60002483|NCT02565381|76118367|FG001|STARTED|Overall Study||25||
59875603|NCT03772587|75999580|FG003|COMPLETED|Overall Study||12||
59875604|NCT03772587|75999581|FG004|COMPLETED|Overall Study||14||
59875605|NCT03772587|75999577|FG000|NOT COMPLETED|Overall Study||1||
59875606|NCT03772587|75999578|FG001|NOT COMPLETED|Overall Study||0||
59875607|NCT03772587|75999579|FG002|NOT COMPLETED|Overall Study||1||
59875608|NCT03772587|75999580|FG003|NOT COMPLETED|Overall Study||1||
59875609|NCT03772587|75999581|FG004|NOT COMPLETED|Overall Study||0||
59875610|NCT02963506|75999608|FG000|STARTED|Double-Blind Period||60||
59875611|NCT02963506|75999609|FG001|STARTED|Double-Blind Period||61||
59875612|NCT02963506|75999610|FG002|STARTED|Double-Blind Period||61||
59875613|NCT02963506|75999611|FG003|STARTED|Double-Blind Period||60||
59875614|NCT02963506|75999612|FG004|STARTED|Double-Blind Period||61||
59875615|NCT02963506|75999613|FG005|STARTED|Double-Blind Period||0||
59875616|NCT02963506|75999614|FG006|STARTED|Double-Blind Period||0||
60002484|NCT02565381|76118368|FG002|STARTED|Overall Study||25||
60002485|NCT02565381|76118366|FG000|COMPLETED|Overall Study||24||
60002486|NCT02565381|76118367|FG001|COMPLETED|Overall Study||25||
59604732|NCT02014272|75714957|FG000|STARTED|Washout Period 1 (7 Days)||13||
59875617|NCT02963506|75999615|FG007|STARTED|Double-Blind Period||0||
59875618|NCT02963506|75999616|FG008|STARTED|Double-Blind Period||0||
59875619|NCT02963506|75999617|FG009|STARTED|Double-Blind Period||0||
59875620|NCT02963506|75999618|FG010|STARTED|Double-Blind Period||0||
59875621|NCT02963506|75999619|FG011|STARTED|Double-Blind Period||0||
60002487|NCT02565381|76118368|FG002|COMPLETED|Overall Study||24||
59604733|NCT02014272|75714958|FG001|STARTED|Washout Period 1 (7 Days)||13||
59604734|NCT02014272|75714957|FG000|COMPLETED|Washout Period 1 (7 Days)||13||
59604735|NCT02014272|75714958|FG001|COMPLETED|Washout Period 1 (7 Days)||13||
59604736|NCT02014272|75714957|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0||
59604737|NCT02014272|75714958|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0||
59604738|NCT02014272|75714957|FG000|STARTED|Intervention Period 2||13||
59604739|NCT02014272|75714958|FG001|STARTED|Intervention Period 2||13||
59604740|NCT02014272|75714957|FG000|COMPLETED|Intervention Period 2||13||
59604741|NCT02014272|75714958|FG001|COMPLETED|Intervention Period 2||13||
59604742|NCT02014272|75714957|FG000|NOT COMPLETED|Intervention Period 2||0||
59604743|NCT02014272|75714958|FG001|NOT COMPLETED|Intervention Period 2||0||
59604744|NCT02037984|75714972|FG000|STARTED|Overall Study||20|Randomized|
59604745|NCT02037984|75714973|FG001|STARTED|Overall Study||20|Randomized|
59604746|NCT02037984|75714974|FG002|STARTED|Overall Study||50|Randomized|
59604747|NCT02037984|75714975|FG003|STARTED|Overall Study||51|Randomized|
59604748|NCT02037984|75714976|FG004|STARTED|Overall Study||50|Randomized|
59604749|NCT02037984|75714977|FG005|STARTED|Overall Study||49|Randomized|
59604750|NCT02037984|75714978|FG006|STARTED|Overall Study||50|Randomized|
59604751|NCT02037984|75714979|FG007|STARTED|Overall Study||51|Randomized|
59604752|NCT02037984|75714972|FG000|COMPLETED|Overall Study||19||
59604753|NCT02037984|75714973|FG001|COMPLETED|Overall Study||20||
59604754|NCT02037984|75714974|FG002|COMPLETED|Overall Study||38||
59604755|NCT02037984|75714975|FG003|COMPLETED|Overall Study||30||
59604756|NCT02037984|75714976|FG004|COMPLETED|Overall Study||38||
59604757|NCT02037984|75714977|FG005|COMPLETED|Overall Study||37||
59604758|NCT02037984|75714978|FG006|COMPLETED|Overall Study||33||
59604759|NCT02037984|75714979|FG007|COMPLETED|Overall Study||39||
59604760|NCT02037984|75714972|FG000|NOT COMPLETED|Overall Study||1||
59604761|NCT02037984|75714973|FG001|NOT COMPLETED|Overall Study||0||
59604762|NCT02037984|75714974|FG002|NOT COMPLETED|Overall Study||12||
59604763|NCT02037984|75714975|FG003|NOT COMPLETED|Overall Study||21||
59604764|NCT02037984|75714976|FG004|NOT COMPLETED|Overall Study||12||
59604765|NCT02037984|75714977|FG005|NOT COMPLETED|Overall Study||12||
59604766|NCT02037984|75714978|FG006|NOT COMPLETED|Overall Study||17||
59604767|NCT02037984|75714979|FG007|NOT COMPLETED|Overall Study||12||
59604768|NCT02057406|75715010|FG000|STARTED|Overall Study||36||
59604769|NCT02057406|75715011|FG001|STARTED|Overall Study||36||
59604770|NCT02057406|75715012|FG002|STARTED|Overall Study||36||
59604771|NCT02057406|75715010|FG000|COMPLETED|Overall Study||35||
59604772|NCT02057406|75715011|FG001|COMPLETED|Overall Study||33||
59604773|NCT02057406|75715012|FG002|COMPLETED|Overall Study||32||
59604774|NCT02057406|75715010|FG000|NOT COMPLETED|Overall Study||1||
59604775|NCT02057406|75715011|FG001|NOT COMPLETED|Overall Study||3||
59604776|NCT02057406|75715012|FG002|NOT COMPLETED|Overall Study||4||
59604777|NCT02036580|75715023|FG000|STARTED|Overall Study||8||
59604778|NCT02036580|75715024|FG001|STARTED|Overall Study||8||
59604779|NCT02036580|75715025|FG002|STARTED|Overall Study||4||
59604780|NCT02036580|75715023|FG000|COMPLETED|Overall Study||7||
59604781|NCT02036580|75715024|FG001|COMPLETED|Overall Study||7||
59604782|NCT02036580|75715025|FG002|COMPLETED|Overall Study||4||
59604783|NCT02036580|75715023|FG000|NOT COMPLETED|Overall Study||1||
59604784|NCT02036580|75715024|FG001|NOT COMPLETED|Overall Study||1||
59604785|NCT02036580|75715025|FG002|NOT COMPLETED|Overall Study||0||
59604786|NCT02014116|75715042|FG000|STARTED|Overall Study||3||
59604787|NCT02014116|75715043|FG001|STARTED|Overall Study||4||
59604788|NCT02014116|75715044|FG002|STARTED|Overall Study||3||
59604789|NCT02014116|75715045|FG003|STARTED|Overall Study||7||
59604790|NCT02014116|75715046|FG004|STARTED|Overall Study||2||
59604791|NCT02014116|75715047|FG005|STARTED|Overall Study||16||
59604792|NCT02014116|75715048|FG006|STARTED|Overall Study||1||
59604793|NCT02014116|75715049|FG007|STARTED|Overall Study||5||
59604794|NCT02014116|75715050|FG008|STARTED|Overall Study||10||
59604795|NCT02014116|75715042|FG000|Received at Least One Dose of Study Drug|Overall Study||3||
59604796|NCT02014116|75715043|FG001|Received at Least One Dose of Study Drug|Overall Study||4||
59604797|NCT02014116|75715044|FG002|Received at Least One Dose of Study Drug|Overall Study||3||
59604798|NCT02014116|75715045|FG003|Received at Least One Dose of Study Drug|Overall Study||7||
59604799|NCT02014116|75715046|FG004|Received at Least One Dose of Study Drug|Overall Study||2||
59604800|NCT02014116|75715047|FG005|Received at Least One Dose of Study Drug|Overall Study||16||
59604801|NCT02014116|75715048|FG006|Received at Least One Dose of Study Drug|Overall Study||1||
59604802|NCT02014116|75715049|FG007|Received at Least One Dose of Study Drug|Overall Study||5||
59604803|NCT02014116|75715050|FG008|Received at Least One Dose of Study Drug|Overall Study||10||
59604804|NCT02014116|75715042|FG000|COMPLETED|Overall Study||0||
59604805|NCT02014116|75715043|FG001|COMPLETED|Overall Study||0||
59604806|NCT02014116|75715044|FG002|COMPLETED|Overall Study||0||
59604807|NCT02014116|75715045|FG003|COMPLETED|Overall Study||0||
59604808|NCT02014116|75715046|FG004|COMPLETED|Overall Study||0||
59604809|NCT02014116|75715047|FG005|COMPLETED|Overall Study||0||
59604810|NCT02014116|75715048|FG006|COMPLETED|Overall Study||0||
59604811|NCT02014116|75715049|FG007|COMPLETED|Overall Study||0||
59604812|NCT02014116|75715050|FG008|COMPLETED|Overall Study||0||
59604813|NCT02014116|75715042|FG000|NOT COMPLETED|Overall Study||3||
59604814|NCT02014116|75715043|FG001|NOT COMPLETED|Overall Study||4||
59875622|NCT02963506|75999620|FG012|STARTED|Double-Blind Period||0||
59875623|NCT02963506|75999608|FG000|Completed Double-Blind Period|Double-Blind Period||60||
59875624|NCT02963506|75999609|FG001|Completed Double-Blind Period|Double-Blind Period||59||
59875625|NCT02963506|75999610|FG002|Completed Double-Blind Period|Double-Blind Period||59||
59875626|NCT02963506|75999611|FG003|Completed Double-Blind Period|Double-Blind Period||58||
59875627|NCT02963506|75999612|FG004|Completed Double-Blind Period|Double-Blind Period||61||
59875628|NCT02963506|75999613|FG005|Completed Double-Blind Period|Double-Blind Period||0||
59875629|NCT02963506|75999614|FG006|Completed Double-Blind Period|Double-Blind Period||0||
59875630|NCT02963506|75999615|FG007|Completed Double-Blind Period|Double-Blind Period||0||
59875631|NCT02963506|75999616|FG008|Completed Double-Blind Period|Double-Blind Period||0||
59875632|NCT02963506|75999617|FG009|Completed Double-Blind Period|Double-Blind Period||0||
59875633|NCT02963506|75999618|FG010|Completed Double-Blind Period|Double-Blind Period||0||
59875634|NCT02963506|75999619|FG011|Completed Double-Blind Period|Double-Blind Period||0||
59875635|NCT02963506|75999620|FG012|Completed Double-Blind Period|Double-Blind Period||0||
59875636|NCT02963506|75999608|FG000|Completed Week 12 - Started Dose-Blind|Double-Blind Period||60||
59875637|NCT02963506|75999609|FG001|Completed Week 12 - Started Dose-Blind|Double-Blind Period||58||
59875638|NCT02963506|75999610|FG002|Completed Week 12 - Started Dose-Blind|Double-Blind Period||59||
59875639|NCT02963506|75999611|FG003|Completed Week 12 - Started Dose-Blind|Double-Blind Period||58||
59875640|NCT02963506|75999612|FG004|Completed Week 12 - Started Dose-Blind|Double-Blind Period||61||
59875641|NCT02963506|75999613|FG005|Completed Week 12 - Started Dose-Blind|Double-Blind Period||0||
59875642|NCT02963506|75999614|FG006|Completed Week 12 - Started Dose-Blind|Double-Blind Period||0||
59875643|NCT02963506|75999615|FG007|Completed Week 12 - Started Dose-Blind|Double-Blind Period||0||
59875644|NCT02963506|75999616|FG008|Completed Week 12 - Started Dose-Blind|Double-Blind Period||0||
59875645|NCT02963506|75999617|FG009|Completed Week 12 - Started Dose-Blind|Double-Blind Period||0||
59875646|NCT02963506|75999618|FG010|Completed Week 12 - Started Dose-Blind|Double-Blind Period||0||
59875647|NCT02963506|75999619|FG011|Completed Week 12 - Started Dose-Blind|Double-Blind Period||0||
59875648|NCT02963506|75999620|FG012|Completed Week 12 - Started Dose-Blind|Double-Blind Period||0||
59875649|NCT02963506|75999608|FG000|COMPLETED|Double-Blind Period||60||
59875650|NCT02963506|75999609|FG001|COMPLETED|Double-Blind Period||58||
59875651|NCT02963506|75999610|FG002|COMPLETED|Double-Blind Period||59||
59875652|NCT02963506|75999611|FG003|COMPLETED|Double-Blind Period||58||
59875653|NCT02963506|75999612|FG004|COMPLETED|Double-Blind Period||61||
59875654|NCT02963506|75999613|FG005|COMPLETED|Double-Blind Period||0||
59875655|NCT02963506|75999614|FG006|COMPLETED|Double-Blind Period||0||
59875656|NCT02963506|75999615|FG007|COMPLETED|Double-Blind Period||0||
59875657|NCT02963506|75999616|FG008|COMPLETED|Double-Blind Period||0||
59875658|NCT02963506|75999617|FG009|COMPLETED|Double-Blind Period||0||
59875659|NCT02963506|75999618|FG010|COMPLETED|Double-Blind Period||0||
59875660|NCT02963506|75999619|FG011|COMPLETED|Double-Blind Period||0||
59875661|NCT02963506|75999620|FG012|COMPLETED|Double-Blind Period||0||
60002488|NCT02565381|76118366|FG000|NOT COMPLETED|Overall Study||1||
59604815|NCT02014116|75715044|FG002|NOT COMPLETED|Overall Study||3||
59604816|NCT02014116|75715045|FG003|NOT COMPLETED|Overall Study||7||
59604817|NCT02014116|75715046|FG004|NOT COMPLETED|Overall Study||2||
59604818|NCT02014116|75715047|FG005|NOT COMPLETED|Overall Study||16||
59604819|NCT02014116|75715048|FG006|NOT COMPLETED|Overall Study||1||
59604820|NCT02014116|75715049|FG007|NOT COMPLETED|Overall Study||5||
59604821|NCT02014116|75715050|FG008|NOT COMPLETED|Overall Study||10||
59604822|NCT02057250|75715077|FG000|STARTED|AID Assessment Phase||56||
59604823|NCT02057250|75715078|FG001|STARTED|AID Assessment Phase||53||
59604824|NCT02057250|75715079|FG002|STARTED|AID Assessment Phase||52||
59604825|NCT02057250|75715080|FG003|STARTED|AID Assessment Phase||56||
59604826|NCT02057250|75715081|FG004|STARTED|AID Assessment Phase||0||
59604827|NCT02057250|75715077|FG000|COMPLETED|AID Assessment Phase||52||
59604828|NCT02057250|75715078|FG001|COMPLETED|AID Assessment Phase||50||
59604829|NCT02057250|75715079|FG002|COMPLETED|AID Assessment Phase||45||
59604830|NCT02057250|75715080|FG003|COMPLETED|AID Assessment Phase||54||
59604831|NCT02057250|75715081|FG004|COMPLETED|AID Assessment Phase||0||
59604832|NCT02057250|75715077|FG000|NOT COMPLETED|AID Assessment Phase||4||
59604833|NCT02057250|75715078|FG001|NOT COMPLETED|AID Assessment Phase||3||
59604834|NCT02057250|75715079|FG002|NOT COMPLETED|AID Assessment Phase||7||
59604835|NCT02057250|75715080|FG003|NOT COMPLETED|AID Assessment Phase||2||
59604836|NCT02057250|75715081|FG004|NOT COMPLETED|AID Assessment Phase||0||
59604837|NCT02057250|75715077|FG000|STARTED|Extension Phase||0||
59604838|NCT02057250|75715078|FG001|STARTED|Extension Phase||0||
59604839|NCT02057250|75715079|FG002|STARTED|Extension Phase||0||
59604840|NCT02057250|75715080|FG003|STARTED|Extension Phase||0||
59604841|NCT02057250|75715081|FG004|STARTED|Extension Phase|9 participants who completed AID Assessment phase did not enter extension phase.|192||
59604842|NCT02057250|75715077|FG000|Treated|Extension Phase||0||
59604843|NCT02057250|75715078|FG001|Treated|Extension Phase||0||
59604844|NCT02057250|75715079|FG002|Treated|Extension Phase||0||
59604845|NCT02057250|75715080|FG003|Treated|Extension Phase||0||
59604846|NCT02057250|75715081|FG004|Treated|Extension Phase||188||
59604847|NCT02057250|75715077|FG000|COMPLETED|Extension Phase||0||
59604848|NCT02057250|75715078|FG001|COMPLETED|Extension Phase||0||
59604849|NCT02057250|75715079|FG002|COMPLETED|Extension Phase||0||
59604850|NCT02057250|75715080|FG003|COMPLETED|Extension Phase||0||
59604851|NCT02057250|75715081|FG004|COMPLETED|Extension Phase||156||
59604852|NCT02057250|75715077|FG000|NOT COMPLETED|Extension Phase||0||
59604853|NCT02057250|75715078|FG001|NOT COMPLETED|Extension Phase||0||
59604854|NCT02057250|75715079|FG002|NOT COMPLETED|Extension Phase||0||
59604855|NCT02057250|75715080|FG003|NOT COMPLETED|Extension Phase||0||
59604856|NCT02057250|75715081|FG004|NOT COMPLETED|Extension Phase||36||
59604857|NCT02036502|75715101|FG000|STARTED|Part 1:Dose Determination/Escalation||6||
59604858|NCT02036502|75715102|FG001|STARTED|Part 1:Dose Determination/Escalation||4||
59604859|NCT02036502|75715103|FG002|STARTED|Part 1:Dose Determination/Escalation||0||
59604860|NCT02036502|75715104|FG003|STARTED|Part 1:Dose Determination/Escalation||0||
59604861|NCT02036502|75715105|FG004|STARTED|Part 1:Dose Determination/Escalation||0||
59604862|NCT02036502|75715106|FG005|STARTED|Part 1:Dose Determination/Escalation||0||
59604863|NCT02036502|75715107|FG006|STARTED|Part 1:Dose Determination/Escalation||0||
59604864|NCT02036502|75715108|FG007|STARTED|Part 1:Dose Determination/Escalation||0||
59875662|NCT02963506|75999608|FG000|NOT COMPLETED|Double-Blind Period||0||
59604865|NCT02036502|75715101|FG000|Treated|Part 1:Dose Determination/Escalation||6||
59604866|NCT02036502|75715102|FG001|Treated|Part 1:Dose Determination/Escalation||3||
59604867|NCT02036502|75715103|FG002|Treated|Part 1:Dose Determination/Escalation||0||
59604868|NCT02036502|75715104|FG003|Treated|Part 1:Dose Determination/Escalation||0||
59604869|NCT02036502|75715105|FG004|Treated|Part 1:Dose Determination/Escalation||0||
59604870|NCT02036502|75715106|FG005|Treated|Part 1:Dose Determination/Escalation||0||
59604871|NCT02036502|75715107|FG006|Treated|Part 1:Dose Determination/Escalation||0||
59604872|NCT02036502|75715108|FG007|Treated|Part 1:Dose Determination/Escalation||0||
59604873|NCT02036502|75715101|FG000|COMPLETED|Part 1:Dose Determination/Escalation||0||
59604874|NCT02036502|75715102|FG001|COMPLETED|Part 1:Dose Determination/Escalation||0||
59604875|NCT02036502|75715103|FG002|COMPLETED|Part 1:Dose Determination/Escalation||0||
59604876|NCT02036502|75715104|FG003|COMPLETED|Part 1:Dose Determination/Escalation||0||
59604877|NCT02036502|75715105|FG004|COMPLETED|Part 1:Dose Determination/Escalation||0||
59604878|NCT02036502|75715106|FG005|COMPLETED|Part 1:Dose Determination/Escalation||0||
59604879|NCT02036502|75715107|FG006|COMPLETED|Part 1:Dose Determination/Escalation||0||
59604880|NCT02036502|75715108|FG007|COMPLETED|Part 1:Dose Determination/Escalation||0||
59604881|NCT02036502|75715101|FG000|NOT COMPLETED|Part 1:Dose Determination/Escalation||6||
59604882|NCT02036502|75715102|FG001|NOT COMPLETED|Part 1:Dose Determination/Escalation||4||
59604883|NCT02036502|75715103|FG002|NOT COMPLETED|Part 1:Dose Determination/Escalation||0||
59604884|NCT02036502|75715104|FG003|NOT COMPLETED|Part 1:Dose Determination/Escalation||0||
59604885|NCT02036502|75715105|FG004|NOT COMPLETED|Part 1:Dose Determination/Escalation||0||
59604886|NCT02036502|75715106|FG005|NOT COMPLETED|Part 1:Dose Determination/Escalation||0||
59604887|NCT02036502|75715107|FG006|NOT COMPLETED|Part 1:Dose Determination/Escalation||0||
59604888|NCT02036502|75715108|FG007|NOT COMPLETED|Part 1:Dose Determination/Escalation||0||
59875663|NCT02963506|75999609|FG001|NOT COMPLETED|Double-Blind Period||3||
59875664|NCT02963506|75999610|FG002|NOT COMPLETED|Double-Blind Period||2||
59875665|NCT02963506|75999611|FG003|NOT COMPLETED|Double-Blind Period||2||
59875666|NCT02963506|75999612|FG004|NOT COMPLETED|Double-Blind Period||0||
59875667|NCT02963506|75999613|FG005|NOT COMPLETED|Double-Blind Period||0||
59875668|NCT02963506|75999614|FG006|NOT COMPLETED|Double-Blind Period||0||
59875669|NCT02963506|75999615|FG007|NOT COMPLETED|Double-Blind Period||0||
59875670|NCT02963506|75999616|FG008|NOT COMPLETED|Double-Blind Period||0||
59875671|NCT02963506|75999617|FG009|NOT COMPLETED|Double-Blind Period||0||
59604889|NCT02036502|75715101|FG000|STARTED|Part 2:Dose Confirmation||0||
59604890|NCT02036502|75715102|FG001|STARTED|Part 2:Dose Confirmation||0||
59604891|NCT02036502|75715103|FG002|STARTED|Part 2:Dose Confirmation|Participants added to study for dose confirmation.|6||
59604892|NCT02036502|75715104|FG003|STARTED|Part 2:Dose Confirmation|Participants added to study for dose confirmation.|2||
59604893|NCT02036502|75715105|FG004|STARTED|Part 2:Dose Confirmation|Participants added to study for dose confirmation.|1||
59604894|NCT02036502|75715106|FG005|STARTED|Part 2:Dose Confirmation||0||
59604895|NCT02036502|75715107|FG006|STARTED|Part 2:Dose Confirmation||0||
59604896|NCT02036502|75715108|FG007|STARTED|Part 2:Dose Confirmation||0||
59604897|NCT02036502|75715101|FG000|Treated|Part 2:Dose Confirmation||0||
59604898|NCT02036502|75715102|FG001|Treated|Part 2:Dose Confirmation||0||
59604899|NCT02036502|75715103|FG002|Treated|Part 2:Dose Confirmation||6||
59604900|NCT02036502|75715104|FG003|Treated|Part 2:Dose Confirmation||1||
59604901|NCT02036502|75715105|FG004|Treated|Part 2:Dose Confirmation||1||
59604902|NCT02036502|75715106|FG005|Treated|Part 2:Dose Confirmation||0||
59604903|NCT02036502|75715107|FG006|Treated|Part 2:Dose Confirmation||0||
59604904|NCT02036502|75715108|FG007|Treated|Part 2:Dose Confirmation||0||
59604905|NCT02036502|75715101|FG000|COMPLETED|Part 2:Dose Confirmation||0||
59604906|NCT02036502|75715102|FG001|COMPLETED|Part 2:Dose Confirmation||0||
59604907|NCT02036502|75715103|FG002|COMPLETED|Part 2:Dose Confirmation||0||
59604908|NCT02036502|75715104|FG003|COMPLETED|Part 2:Dose Confirmation||0||
59604909|NCT02036502|75715105|FG004|COMPLETED|Part 2:Dose Confirmation||0||
59604910|NCT02036502|75715106|FG005|COMPLETED|Part 2:Dose Confirmation||0||
59604911|NCT02036502|75715107|FG006|COMPLETED|Part 2:Dose Confirmation||0||
59604912|NCT02036502|75715108|FG007|COMPLETED|Part 2:Dose Confirmation||0||
59604913|NCT02036502|75715101|FG000|NOT COMPLETED|Part 2:Dose Confirmation||0||
59604914|NCT02036502|75715102|FG001|NOT COMPLETED|Part 2:Dose Confirmation||0||
59604915|NCT02036502|75715103|FG002|NOT COMPLETED|Part 2:Dose Confirmation||6||
59604916|NCT02036502|75715104|FG003|NOT COMPLETED|Part 2:Dose Confirmation||2||
59604917|NCT02036502|75715105|FG004|NOT COMPLETED|Part 2:Dose Confirmation||1||
59604918|NCT02036502|75715106|FG005|NOT COMPLETED|Part 2:Dose Confirmation||0||
59604919|NCT02036502|75715107|FG006|NOT COMPLETED|Part 2:Dose Confirmation||0||
59604920|NCT02036502|75715108|FG007|NOT COMPLETED|Part 2:Dose Confirmation||0||
59604921|NCT02036502|75715101|FG000|STARTED|Part 3:Dose Expansion||0||
59604922|NCT02036502|75715102|FG001|STARTED|Part 3:Dose Expansion||0||
59604923|NCT02036502|75715103|FG002|STARTED|Part 3:Dose Expansion||0||
59604924|NCT02036502|75715104|FG003|STARTED|Part 3:Dose Expansion||0||
59604925|NCT02036502|75715105|FG004|STARTED|Part 3:Dose Expansion||0||
59604926|NCT02036502|75715106|FG005|STARTED|Part 3:Dose Expansion|Participants added to study for dose expansion|47||
59604927|NCT02036502|75715107|FG006|STARTED|Part 3:Dose Expansion|Participants added to study for dose expansion|1||
59604928|NCT02036502|75715108|FG007|STARTED|Part 3:Dose Expansion|Participants added to study for dose expansion|10||
59604929|NCT02036502|75715101|FG000|Treated|Part 3:Dose Expansion||0||
59604930|NCT02036502|75715102|FG001|Treated|Part 3:Dose Expansion||0||
59604931|NCT02036502|75715103|FG002|Treated|Part 3:Dose Expansion||0||
59604932|NCT02036502|75715104|FG003|Treated|Part 3:Dose Expansion||0||
59604933|NCT02036502|75715105|FG004|Treated|Part 3:Dose Expansion||0||
59604934|NCT02036502|75715106|FG005|Treated|Part 3:Dose Expansion||45||
59604935|NCT02036502|75715107|FG006|Treated|Part 3:Dose Expansion||1||
59604936|NCT02036502|75715108|FG007|Treated|Part 3:Dose Expansion||10||
59604937|NCT02036502|75715101|FG000|COMPLETED|Part 3:Dose Expansion||0||
59604938|NCT02036502|75715102|FG001|COMPLETED|Part 3:Dose Expansion||0||
59604939|NCT02036502|75715103|FG002|COMPLETED|Part 3:Dose Expansion||0||
59604940|NCT02036502|75715104|FG003|COMPLETED|Part 3:Dose Expansion||0||
59604941|NCT02036502|75715105|FG004|COMPLETED|Part 3:Dose Expansion||0||
59604942|NCT02036502|75715106|FG005|COMPLETED|Part 3:Dose Expansion||0||
59604943|NCT02036502|75715107|FG006|COMPLETED|Part 3:Dose Expansion||0||
59604944|NCT02036502|75715108|FG007|COMPLETED|Part 3:Dose Expansion||0||
59604945|NCT02036502|75715101|FG000|NOT COMPLETED|Part 3:Dose Expansion||0||
59604946|NCT02036502|75715102|FG001|NOT COMPLETED|Part 3:Dose Expansion||0||
59604947|NCT02036502|75715103|FG002|NOT COMPLETED|Part 3:Dose Expansion||0||
59604948|NCT02036502|75715104|FG003|NOT COMPLETED|Part 3:Dose Expansion||0||
59604949|NCT02036502|75715105|FG004|NOT COMPLETED|Part 3:Dose Expansion||0||
59604950|NCT02036502|75715106|FG005|NOT COMPLETED|Part 3:Dose Expansion||47||
59604951|NCT02036502|75715107|FG006|NOT COMPLETED|Part 3:Dose Expansion||1||
59604952|NCT02036502|75715108|FG007|NOT COMPLETED|Part 3:Dose Expansion||10||
59604953|NCT02056626|75715132|FG000|STARTED|Overall Study||13||
59604954|NCT02056626|75715133|FG001|STARTED|Overall Study||13||
59604955|NCT02056626|75715134|FG002|STARTED|Overall Study||4||
59604956|NCT02056626|75715135|FG003|STARTED|Overall Study||14||
59604957|NCT02056626|75715132|FG000|COMPLETED|Overall Study||10||
59604958|NCT02056626|75715133|FG001|COMPLETED|Overall Study||12||
59604959|NCT02056626|75715134|FG002|COMPLETED|Overall Study||4||
59604960|NCT02056626|75715135|FG003|COMPLETED|Overall Study||14||
59604961|NCT02056626|75715132|FG000|NOT COMPLETED|Overall Study||3||
59604962|NCT02056626|75715133|FG001|NOT COMPLETED|Overall Study||1||
59604963|NCT02056626|75715134|FG002|NOT COMPLETED|Overall Study||0||
59604964|NCT02056626|75715135|FG003|NOT COMPLETED|Overall Study||0||
59604965|NCT02035332|75715145|FG000|STARTED|Overall Study|Treatment Attempted|21||
59747942|NCT01004003|75867091|FG004|NOT COMPLETED|Overall Study||4||
59747943|NCT01004003|75867092|FG005|NOT COMPLETED|Overall Study||4||
59747944|NCT01004003|75867093|FG006|NOT COMPLETED|Overall Study||8||
59747945|NCT01004003|75867094|FG007|NOT COMPLETED|Overall Study||60||
59747946|NCT01004003|75867095|FG008|NOT COMPLETED|Overall Study||30||
59747947|NCT00943670|75867117|FG000|STARTED|Single-agent Trastuzumab Emtansine||51||
59875672|NCT02963506|75999618|FG010|NOT COMPLETED|Double-Blind Period||0||
59875673|NCT02963506|75999619|FG011|NOT COMPLETED|Double-Blind Period||0||
59875674|NCT02963506|75999620|FG012|NOT COMPLETED|Double-Blind Period||0||
59875675|NCT02963506|75999608|FG000|STARTED|Dose-Blind Period||0||
59875676|NCT02963506|75999609|FG001|STARTED|Dose-Blind Period||0||
59875677|NCT02963506|75999610|FG002|STARTED|Dose-Blind Period||0||
59875678|NCT02963506|75999611|FG003|STARTED|Dose-Blind Period||0||
59875679|NCT02963506|75999612|FG004|STARTED|Dose-Blind Period||0||
59875680|NCT02963506|75999613|FG005|STARTED|Dose-Blind Period||24||
59747948|NCT00943670|75867117|FG000|Treated|Single-agent Trastuzumab Emtansine||51||
59747949|NCT00943670|75867117|FG000|COMPLETED|Single-agent Trastuzumab Emtansine|Completed single-agent treatment defined as receiving 17 cycles of trastuzumab emtansine therapy.|9||
59747950|NCT00943670|75867117|FG000|NOT COMPLETED|Single-agent Trastuzumab Emtansine||42||
59875681|NCT02963506|75999614|FG006|STARTED|Dose-Blind Period||36||
59875682|NCT02963506|75999615|FG007|STARTED|Dose-Blind Period||31||
59875683|NCT02963506|75999616|FG008|STARTED|Dose-Blind Period||27||
59875684|NCT02963506|75999617|FG009|STARTED|Dose-Blind Period||34||
59875685|NCT02963506|75999618|FG010|STARTED|Dose-Blind Period||25||
59519065|NCT01116895|75612925|FG003|NOT COMPLETED|Overall Study||3||
59604966|NCT02035332|75715145|FG000|Treated|Overall Study|Treatment Completed|20||
59604967|NCT02035332|75715145|FG000|COMPLETED|Overall Study|Completed 12 Month Follow-up|20||
59604968|NCT02035332|75715145|FG000|NOT COMPLETED|Overall Study||1||
59604969|NCT02056392|75715155|FG000|STARTED|Overall Study||10||
59604970|NCT02056392|75715156|FG001|STARTED|Overall Study||9||
59604971|NCT02056392|75715157|FG002|STARTED|Overall Study||9||
59604972|NCT02056392|75715158|FG003|STARTED|Overall Study||9||
59604973|NCT02056392|75715159|FG004|STARTED|Overall Study||8||
59604974|NCT02056392|75715160|FG005|STARTED|Overall Study||9||
59604975|NCT02056392|75715155|FG000|COMPLETED|Overall Study||8||
59604976|NCT02056392|75715156|FG001|COMPLETED|Overall Study||8||
59604977|NCT02056392|75715157|FG002|COMPLETED|Overall Study||6||
59604978|NCT02056392|75715158|FG003|COMPLETED|Overall Study||9||
59604979|NCT02056392|75715159|FG004|COMPLETED|Overall Study||7||
59604980|NCT02056392|75715160|FG005|COMPLETED|Overall Study||9||
59604981|NCT02056392|75715155|FG000|NOT COMPLETED|Overall Study||2||
59604982|NCT02056392|75715156|FG001|NOT COMPLETED|Overall Study||1||
59604983|NCT02056392|75715157|FG002|NOT COMPLETED|Overall Study||3||
59604984|NCT02056392|75715158|FG003|NOT COMPLETED|Overall Study||0||
59604985|NCT02056392|75715159|FG004|NOT COMPLETED|Overall Study||1||
59604986|NCT02056392|75715160|FG005|NOT COMPLETED|Overall Study||0||
59604987|NCT02034708|75715170|FG000|STARTED|First Contrast Agent Injection (1 Day)||138||
59604988|NCT02034708|75715171|FG001|STARTED|First Contrast Agent Injection (1 Day)||130||
59604989|NCT02034708|75715170|FG000|COMPLETED|First Contrast Agent Injection (1 Day)||138||
59604990|NCT02034708|75715171|FG001|COMPLETED|First Contrast Agent Injection (1 Day)||130||
59604991|NCT02034708|75715170|FG000|NOT COMPLETED|First Contrast Agent Injection (1 Day)||0||
59604992|NCT02034708|75715171|FG001|NOT COMPLETED|First Contrast Agent Injection (1 Day)||0||
59604993|NCT02034708|75715170|FG000|STARTED|Wash-out (From 2 Days up to 14 Days)||138||
59604994|NCT02034708|75715171|FG001|STARTED|Wash-out (From 2 Days up to 14 Days)||130||
59604995|NCT02034708|75715170|FG000|COMPLETED|Wash-out (From 2 Days up to 14 Days)||129||
59604996|NCT02034708|75715171|FG001|COMPLETED|Wash-out (From 2 Days up to 14 Days)||120||
59604997|NCT02034708|75715170|FG000|NOT COMPLETED|Wash-out (From 2 Days up to 14 Days)||9||
59604998|NCT02034708|75715171|FG001|NOT COMPLETED|Wash-out (From 2 Days up to 14 Days)||10||
59604999|NCT02034708|75715170|FG000|STARTED|Second Contrast Agent Injection (1 Day)||129||
59605000|NCT02034708|75715171|FG001|STARTED|Second Contrast Agent Injection (1 Day)||120||
59605001|NCT02034708|75715170|FG000|COMPLETED|Second Contrast Agent Injection (1 Day)||129||
59605002|NCT02034708|75715171|FG001|COMPLETED|Second Contrast Agent Injection (1 Day)||120||
59605003|NCT02034708|75715170|FG000|NOT COMPLETED|Second Contrast Agent Injection (1 Day)||0||
59605004|NCT02034708|75715171|FG001|NOT COMPLETED|Second Contrast Agent Injection (1 Day)||0||
59605005|NCT02034552|75715185|FG000|STARTED|Overall Study||22||
59605006|NCT02034552|75715186|FG001|STARTED|Overall Study||24||
59605007|NCT02034552|75715187|FG002|STARTED|Overall Study||22||
59605008|NCT02034552|75715185|FG000|Received Treatment|Overall Study||19||
59605009|NCT02034552|75715186|FG001|Received Treatment|Overall Study||22||
59605010|NCT02034552|75715187|FG002|Received Treatment|Overall Study||22||
59605011|NCT02034552|75715185|FG000|COMPLETED|Overall Study||8||
59605012|NCT02034552|75715186|FG001|COMPLETED|Overall Study||4||
59605013|NCT02034552|75715187|FG002|COMPLETED|Overall Study||5||
59605014|NCT02034552|75715185|FG000|NOT COMPLETED|Overall Study||14||
59605015|NCT02034552|75715186|FG001|NOT COMPLETED|Overall Study||20||
59605016|NCT02034552|75715187|FG002|NOT COMPLETED|Overall Study||17||
59605017|NCT02034474|75715197|FG000|STARTED|Overall Study||19||
59605018|NCT02034474|75715198|FG001|STARTED|Overall Study||17||
59605019|NCT02034474|75715197|FG000|1 Dose|Overall Study||2||
59605020|NCT02034474|75715198|FG001|1 Dose|Overall Study||4||
59605021|NCT02034474|75715197|FG000|2 Doses|Overall Study||2||
59605022|NCT02034474|75715198|FG001|2 Doses|Overall Study||0||
59605023|NCT02034474|75715197|FG000|3 Doses|Overall Study||15||
59605024|NCT02034474|75715198|FG001|3 Doses|Overall Study||13||
59605025|NCT02034474|75715197|FG000|COMPLETED|Overall Study||15||
59605026|NCT02034474|75715198|FG001|COMPLETED|Overall Study||13||
59605027|NCT02034474|75715197|FG000|NOT COMPLETED|Overall Study||4||
59605028|NCT02034474|75715198|FG001|NOT COMPLETED|Overall Study||4||
59605029|NCT02011542|75715206|FG000|STARTED|Overall Study||30||
59605030|NCT02011542|75715206|FG000|COMPLETED|Overall Study||29||
59605031|NCT02011542|75715206|FG000|NOT COMPLETED|Overall Study||1||
59605032|NCT02011386|75715210|FG000|STARTED|Overall Study||53||
59605033|NCT02011386|75715210|FG000|COMPLETED|Overall Study||48||
59605034|NCT02011386|75715210|FG000|NOT COMPLETED|Overall Study||5||
59605035|NCT02010684|75715216|FG000|STARTED|Overall Study||39||
59605036|NCT02010684|75715217|FG001|STARTED|Overall Study||82||
59605037|NCT02010684|75715216|FG000|COMPLETED|Overall Study||27||
59605038|NCT02010684|75715217|FG001|COMPLETED|Overall Study||59||
59605039|NCT02010684|75715216|FG000|NOT COMPLETED|Overall Study||12||
59605040|NCT02010684|75715217|FG001|NOT COMPLETED|Overall Study||23||
59605041|NCT02034162|75715225|FG000|STARTED|Double-blind||146||
59605042|NCT02034162|75715226|FG001|STARTED|Double-blind||149||
59605043|NCT02034162|75715227|FG002|STARTED|Double-blind||0||
59605044|NCT02034162|75715225|FG000|COMPLETED|Double-blind||137||
59605045|NCT02034162|75715226|FG001|COMPLETED|Double-blind||141||
59605046|NCT02034162|75715227|FG002|COMPLETED|Double-blind||0||
59605047|NCT02034162|75715225|FG000|NOT COMPLETED|Double-blind||9||
59605048|NCT02034162|75715226|FG001|NOT COMPLETED|Double-blind||8||
59605049|NCT02034162|75715227|FG002|NOT COMPLETED|Double-blind||0||
59605050|NCT02034162|75715225|FG000|STARTED|Open-label||0||
59605051|NCT02034162|75715226|FG001|STARTED|Open-label||0||
59605052|NCT02034162|75715227|FG002|STARTED|Open-label||278||
59605053|NCT02034162|75715225|FG000|COMPLETED|Open-label||0||
59605054|NCT02034162|75715226|FG001|COMPLETED|Open-label||0||
59605055|NCT02034162|75715227|FG002|COMPLETED|Open-label||278||
59605056|NCT02034162|75715225|FG000|NOT COMPLETED|Open-label||0||
59605057|NCT02034162|75715226|FG001|NOT COMPLETED|Open-label||0||
59605058|NCT02034162|75715227|FG002|NOT COMPLETED|Open-label||0||
59605059|NCT02034006|75715240|FG000|STARTED|Overall Study||200||
59605060|NCT02034006|75715240|FG000|Once Treated Patients|Overall Study||70||
59605061|NCT02034006|75715240|FG000|Re-treated Patients|Overall Study||130||
59605062|NCT02034006|75715240|FG000|COMPLETED|Overall Study||186||
59605063|NCT02034006|75715240|FG000|NOT COMPLETED|Overall Study||14||
59605064|NCT02054910|75715249|FG000|STARTED|Overall Study||4||
59605065|NCT02054910|75715250|FG001|STARTED|Overall Study||1||
59605066|NCT02054910|75715249|FG000|COMPLETED|Overall Study||0||
59605067|NCT02054910|75715250|FG001|COMPLETED|Overall Study||0||
59605068|NCT02054910|75715249|FG000|NOT COMPLETED|Overall Study||4||
59605069|NCT02054910|75715250|FG001|NOT COMPLETED|Overall Study||1||
59605070|NCT02033850|75715260|FG000|STARTED|Overall Study||23||
59605071|NCT02033850|75715261|FG001|STARTED|Overall Study||23||
59605072|NCT02033850|75715260|FG000|COMPLETED|Overall Study||21||
59605073|NCT02033850|75715261|FG001|COMPLETED|Overall Study||22||
59605074|NCT02033850|75715260|FG000|NOT COMPLETED|Overall Study||2||
59605075|NCT02033850|75715261|FG001|NOT COMPLETED|Overall Study||1||
59605076|NCT02054130|75715271|FG000|STARTED|Overall Study||138||
59605077|NCT02054130|75715272|FG001|STARTED|Overall Study||138||
59605078|NCT02054130|75715273|FG002|STARTED|Overall Study||137||
59605079|NCT02054130|75715274|FG003|STARTED|Overall Study||137||
59605080|NCT02054130|75715271|FG000|COMPLETED|Overall Study||130||
59605081|NCT02054130|75715272|FG001|COMPLETED|Overall Study||127||
59605082|NCT02054130|75715273|FG002|COMPLETED|Overall Study||122||
59605083|NCT02054130|75715274|FG003|COMPLETED|Overall Study||115||
59605084|NCT02054130|75715271|FG000|NOT COMPLETED|Overall Study||8||
59605085|NCT02054130|75715272|FG001|NOT COMPLETED|Overall Study||11||
59605086|NCT02054130|75715273|FG002|NOT COMPLETED|Overall Study||15||
59605087|NCT02054130|75715274|FG003|NOT COMPLETED|Overall Study||22||
59605088|NCT02009046|75715289|FG000|STARTED|Overall Study||1025||
59605089|NCT02009046|75715290|FG001|STARTED|Overall Study||884||
59605090|NCT02009046|75715289|FG000|SEI Curriculum Only|Overall Study||461||
59605091|NCT02009046|75715290|FG001|SEI Curriculum Only|Overall Study||0||
59605092|NCT02009046|75715289|FG000|SEI Curriculum + 3 SchoolWide Components|Overall Study||544||
59605093|NCT02009046|75715290|FG001|SEI Curriculum + 3 SchoolWide Components|Overall Study||0||
59605094|NCT02009046|75715289|FG000|Ctrl Curriculum Only|Overall Study||0||
59605095|NCT02009046|75715290|FG001|Ctrl Curriculum Only|Overall Study||456||
59605096|NCT02009046|75715289|FG000|Ctrl Curriculm +1 SchoolWide Component|Overall Study||0||
59605097|NCT02009046|75715290|FG001|Ctrl Curriculm +1 SchoolWide Component|Overall Study||428||
59605098|NCT02009046|75715289|FG000|COMPLETED|Overall Study||769||
59605099|NCT02009046|75715290|FG001|COMPLETED|Overall Study||678||
59605100|NCT02009046|75715289|FG000|NOT COMPLETED|Overall Study||256||
59605101|NCT02009046|75715290|FG001|NOT COMPLETED|Overall Study||206||
59605102|NCT02052960|75715306|FG000|STARTED|Overall Study||117||
59605103|NCT02052960|75715307|FG001|STARTED|Overall Study||123||
59605104|NCT02052960|75715306|FG000|Treated Patients|Overall Study||115|Included all patients who received at least 1 dose of trial medication. This population was used for safety analyses (= Safety Population).|
59605105|NCT02052960|75715307|FG001|Treated Patients|Overall Study||122|Included all patients who received at least 1 dose of trial medication. This population was used for safety analyses (= Safety Population).|
59605106|NCT02052960|75715306|FG000|COMPLETED|Overall Study||63||
59605107|NCT02052960|75715307|FG001|COMPLETED|Overall Study||77||
59605108|NCT02052960|75715306|FG000|NOT COMPLETED|Overall Study||54||
59605109|NCT02052960|75715307|FG001|NOT COMPLETED|Overall Study||46||
59605110|NCT02008890|75715319|FG000|STARTED|Period 1||80||
59605111|NCT02008890|75715320|FG001|STARTED|Period 1||79||
59605112|NCT02008890|75715321|FG002|STARTED|Period 1||78||
59605113|NCT02008890|75715322|FG003|STARTED|Period 1||0||
59605114|NCT02008890|75715323|FG004|STARTED|Period 1||0||
59605115|NCT02008890|75715319|FG000|COMPLETED|Period 1||65||
59605116|NCT02008890|75715320|FG001|COMPLETED|Period 1||64||
59605117|NCT02008890|75715321|FG002|COMPLETED|Period 1||66||
59605118|NCT02008890|75715322|FG003|COMPLETED|Period 1||0||
59605119|NCT02008890|75715323|FG004|COMPLETED|Period 1||0||
59605120|NCT02008890|75715319|FG000|NOT COMPLETED|Period 1||15||
59605121|NCT02008890|75715320|FG001|NOT COMPLETED|Period 1||15||
59605122|NCT02008890|75715321|FG002|NOT COMPLETED|Period 1||12||
59605123|NCT02008890|75715322|FG003|NOT COMPLETED|Period 1||0||
59605124|NCT02008890|75715323|FG004|NOT COMPLETED|Period 1||0||
59605125|NCT02008890|75715319|FG000|STARTED|Period 2||65||
59605126|NCT02008890|75715320|FG001|STARTED|Period 2||64||
59605127|NCT02008890|75715321|FG002|STARTED|Period 2||10||
59605128|NCT02008890|75715322|FG003|STARTED|Period 2||27||
59605129|NCT02008890|75715323|FG004|STARTED|Period 2||28||
59605130|NCT02008890|75715319|FG000|COMPLETED|Period 2||38||
59605131|NCT02008890|75715320|FG001|COMPLETED|Period 2||49||
59605132|NCT02008890|75715321|FG002|COMPLETED|Period 2||9||
59605133|NCT02008890|75715322|FG003|COMPLETED|Period 2||13||
59605134|NCT02008890|75715323|FG004|COMPLETED|Period 2||20||
59875686|NCT02963506|75999619|FG011|STARTED|Dose-Blind Period||58||
59875687|NCT02963506|75999620|FG012|STARTED|Dose-Blind Period||61||
59875688|NCT02963506|75999608|FG000|COMPLETED|Dose-Blind Period||0||
59875689|NCT02963506|75999609|FG001|COMPLETED|Dose-Blind Period||0||
59875690|NCT02963506|75999610|FG002|COMPLETED|Dose-Blind Period||0||
59875691|NCT02963506|75999611|FG003|COMPLETED|Dose-Blind Period||0||
59875692|NCT02963506|75999612|FG004|COMPLETED|Dose-Blind Period||0||
59875693|NCT02963506|75999613|FG005|COMPLETED|Dose-Blind Period||20||
59875694|NCT02963506|75999614|FG006|COMPLETED|Dose-Blind Period||31||
59875695|NCT02963506|75999615|FG007|COMPLETED|Dose-Blind Period||26||
59875696|NCT02963506|75999616|FG008|COMPLETED|Dose-Blind Period||24||
59875697|NCT02963506|75999617|FG009|COMPLETED|Dose-Blind Period||30||
59875698|NCT02963506|75999618|FG010|COMPLETED|Dose-Blind Period||24||
59875699|NCT02963506|75999619|FG011|COMPLETED|Dose-Blind Period||56||
59875700|NCT02963506|75999620|FG012|COMPLETED|Dose-Blind Period||54||
59875701|NCT02963506|75999608|FG000|NOT COMPLETED|Dose-Blind Period||0||
59875702|NCT02963506|75999609|FG001|NOT COMPLETED|Dose-Blind Period||0||
59875703|NCT02963506|75999610|FG002|NOT COMPLETED|Dose-Blind Period||0||
59875704|NCT02963506|75999611|FG003|NOT COMPLETED|Dose-Blind Period||0||
59875705|NCT02963506|75999612|FG004|NOT COMPLETED|Dose-Blind Period||0||
59875706|NCT02963506|75999613|FG005|NOT COMPLETED|Dose-Blind Period||4||
59875707|NCT02963506|75999614|FG006|NOT COMPLETED|Dose-Blind Period||5||
59875708|NCT02963506|75999615|FG007|NOT COMPLETED|Dose-Blind Period||5||
59875709|NCT02963506|75999616|FG008|NOT COMPLETED|Dose-Blind Period||3||
59875710|NCT02963506|75999617|FG009|NOT COMPLETED|Dose-Blind Period||4||
59875711|NCT02963506|75999618|FG010|NOT COMPLETED|Dose-Blind Period||1||
59875712|NCT02963506|75999619|FG011|NOT COMPLETED|Dose-Blind Period||2||
59875713|NCT02963506|75999620|FG012|NOT COMPLETED|Dose-Blind Period||7||
59875714|NCT01345162|75999639|FG000|STARTED|Overall Study||100||
59875715|NCT01345162|75999640|FG001|STARTED|Overall Study||100||
59875716|NCT01345162|75999639|FG000|COMPLETED|Overall Study||98||
59875717|NCT01345162|75999640|FG001|COMPLETED|Overall Study||96||
59875718|NCT01345162|75999639|FG000|NOT COMPLETED|Overall Study||2||
59875719|NCT01345162|75999640|FG001|NOT COMPLETED|Overall Study||4||
59875720|NCT01345318|75999646|FG000|STARTED|Overall Study||191||
59875721|NCT01345318|75999646|FG000|COMPLETED|Overall Study||111||
59875722|NCT01345318|75999646|FG000|NOT COMPLETED|Overall Study||80||
59875723|NCT02961244|75999653|FG000|STARTED|Overall Study||64||
59875724|NCT02961244|75999654|FG001|STARTED|Overall Study||64||
59875725|NCT02961244|75999653|FG000|Patients Excluded During Randomization|Overall Study||0||
59875726|NCT02961244|75999654|FG001|Patients Excluded During Randomization|Overall Study||1||
59875727|NCT02961244|75999653|FG000|COMPLETED|Overall Study||63||
59875728|NCT02961244|75999654|FG001|COMPLETED|Overall Study||55||
60135742|NCT02048371|76258409|FG005|NOT COMPLETED|Overall Study||3||
60135743|NCT02048371|76258410|FG006|NOT COMPLETED|Overall Study||8||
60135744|NCT02048371|76258411|FG007|NOT COMPLETED|Overall Study||4||
60135745|NCT02048371|76258412|FG008|NOT COMPLETED|Overall Study||0||
60135746|NCT01946139|76258440|FG000|STARTED|Overall Study||276||
60135747|NCT01946139|76258440|FG000|COMPLETED|Overall Study||256||
60135748|NCT01946139|76258440|FG000|NOT COMPLETED|Overall Study||20||
60135749|NCT01685008|76258448|FG000|STARTED|Main Study Treatment (Cycles 1 - 2)||34||
60135750|NCT01685008|76258449|FG001|STARTED|Main Study Treatment (Cycles 1 - 2)||35||
60135751|NCT01685008|76258450|FG002|STARTED|Main Study Treatment (Cycles 1 - 2)||12||
60135752|NCT01685008|76258451|FG003|STARTED|Main Study Treatment (Cycles 1 - 2)||11||
60135753|NCT01685008|76258448|FG000|COMPLETED|Main Study Treatment (Cycles 1 - 2)||30|Patients were considered to have completed the study if they finished the first 2 cycles of treatment plus the end of cycle 2 assessments.|
59605135|NCT02008890|75715319|FG000|NOT COMPLETED|Period 2||27||
59605136|NCT02008890|75715320|FG001|NOT COMPLETED|Period 2||15||
59605137|NCT02008890|75715321|FG002|NOT COMPLETED|Period 2||1||
59605138|NCT02008890|75715322|FG003|NOT COMPLETED|Period 2||14||
59605139|NCT02008890|75715323|FG004|NOT COMPLETED|Period 2||8||
59605140|NCT02008890|75715319|FG000|STARTED|Extension Period||31||
59605141|NCT02008890|75715320|FG001|STARTED|Extension Period||36||
59875729|NCT02961244|75999653|FG000|NOT COMPLETED|Overall Study||1||
59875730|NCT02961244|75999654|FG001|NOT COMPLETED|Overall Study||9||
59875731|NCT03771963|75999660|FG000|STARTED|Overall Study||200||
59875732|NCT03771963|75999660|FG000|COMPLETED|Overall Study||168||
59875733|NCT03771963|75999660|FG000|NOT COMPLETED|Overall Study||32||
59875734|NCT02962648|75999664|FG000|STARTED|Overall Study||103||
59605142|NCT02008890|75715321|FG002|STARTED|Extension Period||0||
59605143|NCT02008890|75715322|FG003|STARTED|Extension Period||10||
59605144|NCT02008890|75715323|FG004|STARTED|Extension Period||17||
59605145|NCT02008890|75715319|FG000|COMPLETED|Extension Period||26||
59875735|NCT02962648|75999664|FG000|COMPLETED|Overall Study||94||
59605146|NCT02008890|75715320|FG001|COMPLETED|Extension Period||31||
59605147|NCT02008890|75715321|FG002|COMPLETED|Extension Period||0||
59605148|NCT02008890|75715322|FG003|COMPLETED|Extension Period||6||
59605149|NCT02008890|75715323|FG004|COMPLETED|Extension Period||13||
59605150|NCT02008890|75715319|FG000|NOT COMPLETED|Extension Period||5||
59605151|NCT02008890|75715320|FG001|NOT COMPLETED|Extension Period||5||
59605152|NCT02008890|75715321|FG002|NOT COMPLETED|Extension Period||0||
59605153|NCT02008890|75715322|FG003|NOT COMPLETED|Extension Period||4||
59605154|NCT02008890|75715323|FG004|NOT COMPLETED|Extension Period||4||
59605155|NCT02052414|75715338|FG000|STARTED|Overall Study||34||
59605156|NCT02052414|75715338|FG000|COMPLETED|Overall Study||17||
59605157|NCT02052414|75715338|FG000|NOT COMPLETED|Overall Study||17||
59605158|NCT02007954|75715343|FG000|STARTED|Overall Study|A total of 32 participants were consented, with 8 patients screened out prior to treatment.|24||
59605159|NCT02007954|75715343|FG000|Completed First TACE|Overall Study||24|Number of patients who completed the first treatment on protocol and included in analysis|
59605160|NCT02007954|75715343|FG000|Completed First Clinical and Imaging|Overall Study|1 patient exited prior to first imaging follow-up due to unrelated serious adverse event and death|23|Participants completing this milestone will be analyzed for image response outcomes|
59605161|NCT02007954|75715343|FG000|COMPLETED|Overall Study||17|Participants who have completed all 6 months of treatment on trial|
59605162|NCT02007954|75715343|FG000|NOT COMPLETED|Overall Study||7||
59605163|NCT02049450|75715347|FG000|STARTED|Overall Study||30||
59605164|NCT02049450|75715347|FG000|Discontinued Treatment Prior to Week 30|Overall Study||4||
59605165|NCT02049450|75715347|FG000|Entered Extension Phase|Overall Study|Of 26 who completed Core phase 18 moved into Ext. phase; All 18 eventually discontinued Ext. phase|18||
59605166|NCT02049450|75715347|FG000|COMPLETED|Overall Study|Completed = Completed Core phase of study|26||
59605167|NCT02049450|75715347|FG000|NOT COMPLETED|Overall Study||4||
59605168|NCT02031432|75715358|FG000|STARTED|Overall Study||76||
59605169|NCT02031432|75715358|FG000|Completing the Titration Phase|Overall Study||67||
59605170|NCT02031432|75715358|FG000|Completing the Treatment|Overall Study||39||
59605171|NCT02031432|75715358|FG000|COMPLETED|Overall Study||38||
59605172|NCT02031432|75715358|FG000|NOT COMPLETED|Overall Study||38||
59605173|NCT02031276|75715365|FG000|STARTED|Period 1 Double-blind IV||39||
59605174|NCT02031276|75715366|FG001|STARTED|Period 1 Double-blind IV||41||
59605175|NCT02031276|75715367|FG002|STARTED|Period 1 Double-blind IV||41||
59747951|NCT00943670|75867117|FG000|STARTED|Trastuzumab Emtansine + Pertuzumab|Patients with early progressive disease who elected to receive T-DM1 and pertuzumab.|20||
59747952|NCT00943670|75867117|FG000|COMPLETED|Trastuzumab Emtansine + Pertuzumab|Completed treatment defined as receiving a total of 17 cycles of therapy in both treatment periods.|2||
59747953|NCT00943670|75867117|FG000|NOT COMPLETED|Trastuzumab Emtansine + Pertuzumab||18||
59747954|NCT00938366|75867134|FG000|STARTED|Overall Study||9||
59747955|NCT00938366|75867135|FG001|STARTED|Overall Study||9||
59605176|NCT02031276|75715365|FG000|COMPLETED|Period 1 Double-blind IV||33||
59605177|NCT02031276|75715366|FG001|COMPLETED|Period 1 Double-blind IV||35||
59605178|NCT02031276|75715367|FG002|COMPLETED|Period 1 Double-blind IV||40||
59605179|NCT02031276|75715365|FG000|NOT COMPLETED|Period 1 Double-blind IV||6||
59605180|NCT02031276|75715366|FG001|NOT COMPLETED|Period 1 Double-blind IV||6||
59605181|NCT02031276|75715367|FG002|NOT COMPLETED|Period 1 Double-blind IV||1||
59605182|NCT02031276|75715365|FG000|STARTED|Period 2 Open-label Risankizumab IV||33||
59605183|NCT02031276|75715366|FG001|STARTED|Period 2 Open-label Risankizumab IV||35||
59605184|NCT02031276|75715367|FG002|STARTED|Period 2 Open-label Risankizumab IV|1 participant did not enter Period 2 (declined open-label treatment in Period 2)|39||
59605185|NCT02031276|75715365|FG000|COMPLETED|Period 2 Open-label Risankizumab IV||29||
59605186|NCT02031276|75715366|FG001|COMPLETED|Period 2 Open-label Risankizumab IV||33||
59605187|NCT02031276|75715367|FG002|COMPLETED|Period 2 Open-label Risankizumab IV||38||
59605188|NCT02031276|75715365|FG000|NOT COMPLETED|Period 2 Open-label Risankizumab IV||4||
59605189|NCT02031276|75715366|FG001|NOT COMPLETED|Period 2 Open-label Risankizumab IV||2||
59605190|NCT02031276|75715367|FG002|NOT COMPLETED|Period 2 Open-label Risankizumab IV||1||
59605191|NCT02031276|75715365|FG000|STARTED|Period 3 Open-label Risankizumab SC|10 participants did not enter period 3 (not in clinical remission)|19||
59605192|NCT02031276|75715366|FG001|STARTED|Period 3 Open-label Risankizumab SC|11 participants did not enter period 3 (not in clinical remission)|22||
59605193|NCT02031276|75715367|FG002|STARTED|Period 3 Open-label Risankizumab SC|17 participants did not enter period 3 (not in clinical remission)|21||
59605194|NCT02031276|75715365|FG000|COMPLETED|Period 3 Open-label Risankizumab SC||16||
59605195|NCT02031276|75715366|FG001|COMPLETED|Period 3 Open-label Risankizumab SC||19||
59605196|NCT02031276|75715367|FG002|COMPLETED|Period 3 Open-label Risankizumab SC||19||
59605197|NCT02031276|75715365|FG000|NOT COMPLETED|Period 3 Open-label Risankizumab SC||3||
59605198|NCT02031276|75715366|FG001|NOT COMPLETED|Period 3 Open-label Risankizumab SC||3||
59605199|NCT02031276|75715367|FG002|NOT COMPLETED|Period 3 Open-label Risankizumab SC||2||
59605200|NCT02007720|75715381|FG000|STARTED|Overall Study||436|876 participants were randomized|
59605201|NCT02007720|75715382|FG001|STARTED|Overall Study||440|876 participants were randomized|
59605202|NCT02007720|75715381|FG000|Full Analysis Set|Overall Study||433|6 patients were misrandomized and excluded from the fuoll analysis set|
59605203|NCT02007720|75715382|FG001|Full Analysis Set|Overall Study||437|6 patients were misrandomized and excluded from the fuoll analysis set|
59605204|NCT02007720|75715381|FG000|Safety Set|Overall Study||426|among these 858 had a least one dose of study drug and at least one post baseline assessment|
59605205|NCT02007720|75715382|FG001|Safety Set|Overall Study||432|among these 858 had a least one dose of study drug and at least one post baseline assessment|
59605206|NCT02007720|75715381|FG000|COMPLETED|Overall Study||354|Phase completion is defined as death or actual follow up greater or equal to Day 165|
59605207|NCT02007720|75715382|FG001|COMPLETED|Overall Study||368|Phase completion is defined as death or actual follow up greater or equal to Day 165|
59605208|NCT02007720|75715381|FG000|NOT COMPLETED|Overall Study||82||
59605209|NCT02007720|75715382|FG001|NOT COMPLETED|Overall Study||72||
59605210|NCT01363440|75715392|FG000|STARTED|Overall Study|randomized|156||
59605211|NCT01363440|75715393|FG001|STARTED|Overall Study|randomized|156||
59605212|NCT01363440|75715394|FG002|STARTED|Overall Study|randomized|154||
59605213|NCT01363440|75715392|FG000|Participants Received Treatment|Overall Study|safety analysis set (SAF)|154||
59605214|NCT01363440|75715393|FG001|Participants Received Treatment|Overall Study|safety analysis set (SAF)|155||
59605215|NCT01363440|75715394|FG002|Participants Received Treatment|Overall Study|safety analysis set (SAF)|152||
59605216|NCT01363440|75715392|FG000|Completed Week 52|Overall Study||145||
59605217|NCT01363440|75715393|FG001|Completed Week 52|Overall Study||146||
59605218|NCT01363440|75715394|FG002|Completed Week 52|Overall Study||144||
59605219|NCT01363440|75715392|FG000|Completed Week 100|Overall Study||133||
59605220|NCT01363440|75715393|FG001|Completed Week 100|Overall Study||125||
59605221|NCT01363440|75715394|FG002|Completed Week 100|Overall Study||127||
59605222|NCT01363440|75715392|FG000|COMPLETED|Overall Study|Completed Week 100|133||
59605223|NCT01363440|75715393|FG001|COMPLETED|Overall Study|Completed Week 100|125||
59605224|NCT01363440|75715394|FG002|COMPLETED|Overall Study|Completed Week 100|127||
59605225|NCT01363440|75715392|FG000|NOT COMPLETED|Overall Study||23||
59605226|NCT01363440|75715393|FG001|NOT COMPLETED|Overall Study||31||
59605227|NCT01363440|75715394|FG002|NOT COMPLETED|Overall Study||27||
59605228|NCT02007252|75715407|FG000|STARTED|Overall Study||31||
59605229|NCT02007252|75715408|FG001|STARTED|Overall Study||33||
59605230|NCT02007252|75715407|FG000|Safety Analysis Set|Overall Study||31||
59605231|NCT02007252|75715408|FG001|Safety Analysis Set|Overall Study||33||
59605232|NCT02007252|75715407|FG000|Pharmacodynamic Analysis Set|Overall Study||31||
59605233|NCT02007252|75715408|FG001|Pharmacodynamic Analysis Set|Overall Study||33||
59605234|NCT02007252|75715407|FG000|COMPLETED|Overall Study||20||
59605235|NCT02007252|75715408|FG001|COMPLETED|Overall Study||22||
59605236|NCT02007252|75715407|FG000|NOT COMPLETED|Overall Study||11||
59605237|NCT02007252|75715408|FG001|NOT COMPLETED|Overall Study||11||
59605238|NCT02007096|75715416|FG000|STARTED|Overall Study||63||
59605239|NCT02007096|75715417|FG001|STARTED|Overall Study||64||
59605240|NCT02007096|75715416|FG000|COMPLETED|Overall Study||52||
59605241|NCT02007096|75715417|FG001|COMPLETED|Overall Study||48||
59605242|NCT02007096|75715416|FG000|NOT COMPLETED|Overall Study||11||
59747956|NCT00938366|75867134|FG000|COMPLETED|Overall Study||8||
59875736|NCT02962648|75999664|FG000|NOT COMPLETED|Overall Study||9||
59875737|NCT02962882|75999668|FG000|STARTED|Overall Study||50||
59605243|NCT02007096|75715417|FG001|NOT COMPLETED|Overall Study||16||
59605244|NCT02006706|75715423|FG000|STARTED|Overall Study||15||
59605245|NCT02006706|75715423|FG000|COMPLETED|Overall Study||14||
59605246|NCT02006706|75715423|FG000|NOT COMPLETED|Overall Study||1||
59605247|NCT02049138|75715430|FG000|STARTED|Overall Study||306||
59605248|NCT02049138|75715431|FG001|STARTED|Overall Study||149||
59605249|NCT02049138|75715432|FG002|STARTED|Overall Study||38||
59605250|NCT02049138|75715430|FG000|Enrolled in Vaccine Sub-study|Overall Study||76||
59747957|NCT00938366|75867135|FG001|COMPLETED|Overall Study||9||
59747958|NCT00938366|75867134|FG000|NOT COMPLETED|Overall Study||1||
59747959|NCT00938366|75867135|FG001|NOT COMPLETED|Overall Study||0||
59747960|NCT00943592|75867141|FG000|STARTED|Overall Study||82||
59747961|NCT00943592|75867141|FG000|Maximum Tolerated Dose|Overall Study|74 patients received the Maximum Tolerated Dose|74||
59747962|NCT00943592|75867141|FG000|COMPLETED|Overall Study|None of the three deaths were attributed to the conditioning regimen|79||
59747963|NCT00943592|75867141|FG000|NOT COMPLETED|Overall Study||3||
59747964|NCT00943124|75867145|FG000|STARTED|Period 1||110||
59747965|NCT00943124|75867146|FG001|STARTED|Period 1||110||
59875738|NCT02962882|75999668|FG000|COMPLETED|Overall Study||14||
59875739|NCT02962882|75999668|FG000|NOT COMPLETED|Overall Study||36||
59875740|NCT02961790|75999677|FG000|STARTED|Overall Study||50||
59605251|NCT02049138|75715431|FG001|Enrolled in Vaccine Sub-study|Overall Study||24||
59605252|NCT02049138|75715432|FG002|Enrolled in Vaccine Sub-study|Overall Study||11||
59605253|NCT02049138|75715430|FG000|COMPLETED|Overall Study||142||
59605254|NCT02049138|75715431|FG001|COMPLETED|Overall Study||51||
59605255|NCT02049138|75715432|FG002|COMPLETED|Overall Study||30||
59605256|NCT02049138|75715430|FG000|NOT COMPLETED|Overall Study||164||
59605257|NCT02049138|75715431|FG001|NOT COMPLETED|Overall Study||98||
59605258|NCT02049138|75715432|FG002|NOT COMPLETED|Overall Study||8||
59605259|NCT02048904|75715443|FG000|STARTED|Overall Study||142||
59605260|NCT02048904|75715443|FG000|COMPLETED|Overall Study||65||
59605261|NCT02048904|75715443|FG000|NOT COMPLETED|Overall Study||77||
59605262|NCT02006628|75715449|FG000|STARTED|Overall Study||43||
59605263|NCT02006628|75715450|FG001|STARTED|Overall Study||45||
59605264|NCT02006628|75715449|FG000|Received at Least 1 Dose of Study Drug|Overall Study||43|Safety analysis set|
59605265|NCT02006628|75715450|FG001|Received at Least 1 Dose of Study Drug|Overall Study||45|Safety analysis set|
59613478|NCT01684878|75724611|FG001|STARTED|Part 2: Randomized Phase||0||
59605266|NCT02006628|75715449|FG000|Intention to Treat (ITT) Analysis Set|Overall Study||42|Provided informed consent, randomized, took at least 1 dose of IMP, had post-baseline efficacy data|
59605267|NCT02006628|75715450|FG001|Intention to Treat (ITT) Analysis Set|Overall Study||44|Provided informed consent, randomized, took at least 1 dose of IMP, had post-baseline efficacy data|
59605268|NCT02006628|75715449|FG000|COMPLETED|Overall Study||40||
59605269|NCT02006628|75715450|FG001|COMPLETED|Overall Study||43||
59605270|NCT02006628|75715449|FG000|NOT COMPLETED|Overall Study||3||
59605271|NCT02006628|75715450|FG001|NOT COMPLETED|Overall Study||2||
59605272|NCT02048826|75715458|FG000|STARTED|Overall Study||16||
59605273|NCT02048826|75715459|FG001|STARTED|Overall Study||15||
59605274|NCT02048826|75715458|FG000|COMPLETED|Overall Study||15||
59747966|NCT00943124|75867145|FG000|COMPLETED|Period 1||108||
59747967|NCT00943124|75867146|FG001|COMPLETED|Period 1||108||
59747968|NCT00943124|75867145|FG000|NOT COMPLETED|Period 1||2||
59747969|NCT00943124|75867146|FG001|NOT COMPLETED|Period 1||2||
59747970|NCT00943124|75867145|FG000|STARTED|Period 2||108||
59747971|NCT00943124|75867146|FG001|STARTED|Period 2||108||
59747972|NCT00943124|75867145|FG000|COMPLETED|Period 2||108||
59747973|NCT00943124|75867146|FG001|COMPLETED|Period 2||108||
59747974|NCT00943124|75867145|FG000|NOT COMPLETED|Period 2||0||
59747975|NCT00943124|75867146|FG001|NOT COMPLETED|Period 2||0||
59747976|NCT00726622|75867154|FG000|STARTED|Overall Study||243||
59747977|NCT00726622|75867155|FG001|STARTED|Overall Study||243||
59747978|NCT00726622|75867154|FG000|COMPLETED|Overall Study||225||
59747979|NCT00726622|75867155|FG001|COMPLETED|Overall Study||240||
59747980|NCT00726622|75867154|FG000|NOT COMPLETED|Overall Study||18||
59747981|NCT00726622|75867155|FG001|NOT COMPLETED|Overall Study||3||
59747982|NCT00940316|75867164|FG000|STARTED|Reached First Response at 8 Weeks||13||
59747983|NCT00940316|75867165|FG001|STARTED|Reached First Response at 8 Weeks||13||
59747984|NCT00940316|75867166|FG002|STARTED|Reached First Response at 8 Weeks||2||
59747985|NCT00940316|75867164|FG000|COMPLETED|Reached First Response at 8 Weeks||10||
59747986|NCT00940316|75867165|FG001|COMPLETED|Reached First Response at 8 Weeks||9||
59747987|NCT00940316|75867166|FG002|COMPLETED|Reached First Response at 8 Weeks||2||
59747988|NCT00940316|75867164|FG000|NOT COMPLETED|Reached First Response at 8 Weeks||3||
59747989|NCT00940316|75867165|FG001|NOT COMPLETED|Reached First Response at 8 Weeks||4||
59747990|NCT00940316|75867166|FG002|NOT COMPLETED|Reached First Response at 8 Weeks||0||
59747991|NCT00940316|75867164|FG000|STARTED|Moved on to be Treated Cycle 5||10||
59747992|NCT00940316|75867165|FG001|STARTED|Moved on to be Treated Cycle 5||9||
59747993|NCT00940316|75867166|FG002|STARTED|Moved on to be Treated Cycle 5||2||
59747994|NCT00940316|75867164|FG000|COMPLETED|Moved on to be Treated Cycle 5||8||
59747995|NCT00940316|75867165|FG001|COMPLETED|Moved on to be Treated Cycle 5||9||
59747996|NCT00940316|75867166|FG002|COMPLETED|Moved on to be Treated Cycle 5||2||
59747997|NCT00940316|75867164|FG000|NOT COMPLETED|Moved on to be Treated Cycle 5||2||
59747998|NCT00940316|75867165|FG001|NOT COMPLETED|Moved on to be Treated Cycle 5||0||
59605275|NCT02048826|75715459|FG001|COMPLETED|Overall Study||15||
59605276|NCT02048826|75715458|FG000|NOT COMPLETED|Overall Study||1||
59605277|NCT02048826|75715459|FG001|NOT COMPLETED|Overall Study||0||
59605278|NCT02006472|75715470|FG000|STARTED|Period 1 (Through Week 26)||82||
59605279|NCT02006472|75715471|FG001|STARTED|Period 1 (Through Week 26)||81||
59605280|NCT02006472|75715472|FG002|STARTED|Period 1 (Through Week 26)||82||
59605281|NCT02006472|75715473|FG003|STARTED|Period 1 (Through Week 26)||81||
59605282|NCT02006472|75715474|FG004|STARTED|Period 1 (Through Week 26)||82||
59605283|NCT02006472|75715470|FG000|ITT|Period 1 (Through Week 26)||82|Intention-to-treat: patients randomised into the study and dispensed study drug.|
59605284|NCT02006472|75715471|FG001|ITT|Period 1 (Through Week 26)||81|Intention-to-treat: patients randomised into the study and dispensed study drug.|
59605285|NCT02006472|75715472|FG002|ITT|Period 1 (Through Week 26)||82|Intention-to-treat: patients randomised into the study and dispensed study drug.|
59605286|NCT02006472|75715473|FG003|ITT|Period 1 (Through Week 26)||81|Intention-to-treat: patients randomised into the study and dispensed study drug.|
59605287|NCT02006472|75715474|FG004|ITT|Period 1 (Through Week 26)||82|Intention-to-treat: patients randomised into the study and dispensed study drug.|
59605288|NCT02006472|75715470|FG000|FAS|Period 1 (Through Week 26)||81|Full analysis set: patients from the ITT who received at least 1 dose of study drug and had at least 1 post-baseline efficacy assessment. The FAS included efficacy observations measured up to Week 52.|
59605289|NCT02006472|75715471|FG001|FAS|Period 1 (Through Week 26)||75|Full analysis set: patients from the ITT who received at least 1 dose of study drug and had at least 1 post-baseline efficacy assessment. The FAS included efficacy observations measured up to Week 52.|
59613479|NCT01684878|75724612|FG002|STARTED|Part 2: Randomized Phase||78||
59613480|NCT01684878|75724613|FG003|STARTED|Part 2: Randomized Phase||78||
59747999|NCT00940316|75867166|FG002|NOT COMPLETED|Moved on to be Treated Cycle 5||0||
59748000|NCT00940316|75867164|FG000|STARTED|Treated After Cycle 5||8||
59748001|NCT00940316|75867165|FG001|STARTED|Treated After Cycle 5||9||
59748002|NCT00940316|75867166|FG002|STARTED|Treated After Cycle 5||2||
59748003|NCT00940316|75867164|FG000|COMPLETED|Treated After Cycle 5||8||
59748004|NCT00940316|75867165|FG001|COMPLETED|Treated After Cycle 5||8||
59748005|NCT00940316|75867166|FG002|COMPLETED|Treated After Cycle 5||1||
59748006|NCT00940316|75867164|FG000|NOT COMPLETED|Treated After Cycle 5||0||
59748007|NCT00940316|75867165|FG001|NOT COMPLETED|Treated After Cycle 5||1||
59748008|NCT00940316|75867166|FG002|NOT COMPLETED|Treated After Cycle 5||1||
59605290|NCT02006472|75715472|FG002|FAS|Period 1 (Through Week 26)||79|Full analysis set: patients from the ITT who received at least 1 dose of study drug and had at least 1 post-baseline efficacy assessment. The FAS included efficacy observations measured up to Week 52.|
59605291|NCT02006472|75715473|FG003|FAS|Period 1 (Through Week 26)||81|Full analysis set: patients from the ITT who received at least 1 dose of study drug and had at least 1 post-baseline efficacy assessment. The FAS included efficacy observations measured up to Week 52.|
59605292|NCT02006472|75715474|FG004|FAS|Period 1 (Through Week 26)||81|Full analysis set: patients from the ITT who received at least 1 dose of study drug and had at least 1 post-baseline efficacy assessment. The FAS included efficacy observations measured up to Week 52.|
59605293|NCT02006472|75715470|FG000|Safety Set|Period 1 (Through Week 26)||82|Including all patients who took at least 1 dose of study drug. The analysis set included safety observations measured up to Week 52.|
59605294|NCT02006472|75715471|FG001|Safety Set|Period 1 (Through Week 26)||81|Including all patients who took at least 1 dose of study drug. The analysis set included safety observations measured up to Week 52.|
59605295|NCT02006472|75715472|FG002|Safety Set|Period 1 (Through Week 26)||82|Including all patients who took at least 1 dose of study drug. The analysis set included safety observations measured up to Week 52.|
59605296|NCT02006472|75715473|FG003|Safety Set|Period 1 (Through Week 26)||81|Including all patients who took at least 1 dose of study drug. The analysis set included safety observations measured up to Week 52.|
59605297|NCT02006472|75715474|FG004|Safety Set|Period 1 (Through Week 26)||82|Including all patients who took at least 1 dose of study drug. The analysis set included safety observations measured up to Week 52.|
59605298|NCT02006472|75715470|FG000|COMPLETED|Period 1 (Through Week 26)||70||
59605299|NCT02006472|75715471|FG001|COMPLETED|Period 1 (Through Week 26)||59||
59605300|NCT02006472|75715472|FG002|COMPLETED|Period 1 (Through Week 26)||65||
59605301|NCT02006472|75715473|FG003|COMPLETED|Period 1 (Through Week 26)||67||
59605302|NCT02006472|75715474|FG004|COMPLETED|Period 1 (Through Week 26)||62||
59605303|NCT02006472|75715470|FG000|NOT COMPLETED|Period 1 (Through Week 26)||12||
59605304|NCT02006472|75715471|FG001|NOT COMPLETED|Period 1 (Through Week 26)||22||
59605305|NCT02006472|75715472|FG002|NOT COMPLETED|Period 1 (Through Week 26)||17||
59748009|NCT00940316|75867164|FG000|STARTED|Crossed Over to Arm A After Progression||0|Patients on Arm B that progressed were able to cross over and be treated on arm A if still eligible.|
59748010|NCT00940316|75867165|FG001|STARTED|Crossed Over to Arm A After Progression||3|Patients on Arm B that progressed were able to cross over and be treated on arm A if still eligible.|
59748011|NCT00940316|75867166|FG002|STARTED|Crossed Over to Arm A After Progression||0|Patients on Arm B that progressed were able to cross over and be treated on arm A if still eligible.|
59748012|NCT00940316|75867164|FG000|Treated for Cycle One|Crossed Over to Arm A After Progression||0||
59605306|NCT02006472|75715473|FG003|NOT COMPLETED|Period 1 (Through Week 26)||14||
59605307|NCT02006472|75715474|FG004|NOT COMPLETED|Period 1 (Through Week 26)||20||
59605308|NCT02006472|75715470|FG000|STARTED|Period 2 (Through Week 52)||57|The trial was extended from 26 to 52 weeks to evaluate the effect of pridopidine on Total Functional Capacity (TFC). Approximately 20% of patients completed 26 weeks of the study before IRB approvals for this extension, and did not continue into the 2nd treatment period up to 52 weeks.|
59605309|NCT02006472|75715471|FG001|STARTED|Period 2 (Through Week 52)||49|The trial was extended from 26 to 52 weeks to evaluate the effect of pridopidine on Total Functional Capacity (TFC). Approximately 20% of patients completed 26 weeks of the study before IRB approvals for this extension, and did not continue into the 2nd treatment period up to 52 weeks.|
59605310|NCT02006472|75715472|FG002|STARTED|Period 2 (Through Week 52)||54|The trial was extended from 26 to 52 weeks to evaluate the effect of pridopidine on Total Functional Capacity (TFC). Approximately 20% of patients completed 26 weeks of the study before IRB approvals for this extension, and did not continue into the 2nd treatment period up to 52 weeks.|
59605311|NCT02006472|75715473|FG003|STARTED|Period 2 (Through Week 52)||56|The trial was extended from 26 to 52 weeks to evaluate the effect of pridopidine on Total Functional Capacity (TFC). Approximately 20% of patients completed 26 weeks of the study before IRB approvals for this extension, and did not continue into the 2nd treatment period up to 52 weeks.|
59605312|NCT02006472|75715474|FG004|STARTED|Period 2 (Through Week 52)||46|The trial was extended from 26 to 52 weeks to evaluate the effect of pridopidine on Total Functional Capacity (TFC). Approximately 20% of patients completed 26 weeks of the study before IRB approvals for this extension, and did not continue into the 2nd treatment period up to 52 weeks.|
59605313|NCT02006472|75715470|FG000|Started Treatment in Period 2|Period 2 (Through Week 52)||57||
59605314|NCT02006472|75715471|FG001|Started Treatment in Period 2|Period 2 (Through Week 52)||49||
59605315|NCT02006472|75715472|FG002|Started Treatment in Period 2|Period 2 (Through Week 52)||52||
59605316|NCT02006472|75715473|FG003|Started Treatment in Period 2|Period 2 (Through Week 52)||56||
59605317|NCT02006472|75715474|FG004|Started Treatment in Period 2|Period 2 (Through Week 52)||46||
59605318|NCT02006472|75715470|FG000|COMPLETED|Period 2 (Through Week 52)||52||
59605319|NCT02006472|75715471|FG001|COMPLETED|Period 2 (Through Week 52)||43||
59605320|NCT02006472|75715472|FG002|COMPLETED|Period 2 (Through Week 52)||44||
59605321|NCT02006472|75715473|FG003|COMPLETED|Period 2 (Through Week 52)||53||
59605322|NCT02006472|75715474|FG004|COMPLETED|Period 2 (Through Week 52)||44||
59605323|NCT02006472|75715470|FG000|NOT COMPLETED|Period 2 (Through Week 52)||5||
59605324|NCT02006472|75715471|FG001|NOT COMPLETED|Period 2 (Through Week 52)||6||
59605325|NCT02006472|75715472|FG002|NOT COMPLETED|Period 2 (Through Week 52)||10||
59605326|NCT02006472|75715473|FG003|NOT COMPLETED|Period 2 (Through Week 52)||3||
59605327|NCT02006472|75715474|FG004|NOT COMPLETED|Period 2 (Through Week 52)||2||
59748013|NCT00940316|75867165|FG001|Treated for Cycle One|Crossed Over to Arm A After Progression||3||
59748014|NCT00940316|75867166|FG002|Treated for Cycle One|Crossed Over to Arm A After Progression||0||
59748015|NCT00940316|75867164|FG000|COMPLETED|Crossed Over to Arm A After Progression||0||
59875741|NCT02961790|75999678|FG001|STARTED|Overall Study||51||
59875742|NCT02961790|75999679|FG002|STARTED|Overall Study||24||
59875743|NCT02961790|75999680|FG003|STARTED|Overall Study||25||
59875744|NCT02961790|75999677|FG000|COMPLETED|Overall Study||35||
59875745|NCT02961790|75999678|FG001|COMPLETED|Overall Study||40||
59875746|NCT02961790|75999679|FG002|COMPLETED|Overall Study||18||
59875747|NCT02961790|75999680|FG003|COMPLETED|Overall Study||20||
59875748|NCT02961790|75999677|FG000|NOT COMPLETED|Overall Study||15||
59875749|NCT02961790|75999678|FG001|NOT COMPLETED|Overall Study||11||
59875750|NCT02961790|75999679|FG002|NOT COMPLETED|Overall Study||6||
59875751|NCT02961790|75999680|FG003|NOT COMPLETED|Overall Study||5||
59875752|NCT01225341|75999693|FG000|STARTED|Overall Study||0||
59875753|NCT01225341|75999694|FG001|STARTED|Overall Study||0||
59875754|NCT01225341|75999693|FG000|COMPLETED|Overall Study||0||
59875755|NCT01225341|75999694|FG001|COMPLETED|Overall Study||0||
59875756|NCT01225341|75999693|FG000|NOT COMPLETED|Overall Study||0||
59875757|NCT01225341|75999694|FG001|NOT COMPLETED|Overall Study||0||
59875758|NCT02960854|75999702|FG000|STARTED|Overall Study||15||
59875759|NCT02960854|75999703|FG001|STARTED|Overall Study||16||
59875760|NCT02960854|75999702|FG000|COMPLETED|Overall Study||8||
59875761|NCT02960854|75999703|FG001|COMPLETED|Overall Study||7||
59875762|NCT02960854|75999702|FG000|NOT COMPLETED|Overall Study||7||
59875763|NCT02960854|75999703|FG001|NOT COMPLETED|Overall Study||9||
59875764|NCT01344538|75999711|FG000|STARTED|Overall Study||16||
59875765|NCT01344538|75999712|FG001|STARTED|Overall Study||17||
59875766|NCT01344538|75999711|FG000|COMPLETED|Overall Study||14||
59875767|NCT01344538|75999712|FG001|COMPLETED|Overall Study||16||
59875768|NCT01344538|75999711|FG000|NOT COMPLETED|Overall Study||2||
59875769|NCT01344538|75999712|FG001|NOT COMPLETED|Overall Study||1||
59875770|NCT01344460|75999718|FG000|STARTED|Overall Study|Participants received study drug; Safety analysis set|315||
59875771|NCT01344460|75999718|FG000|Fulfilled Requirements of FAS Population|Overall Study|Full analysis set (FAS)|292||
59875772|NCT01344460|75999718|FG000|COMPLETED|Overall Study||312||
59875773|NCT01344460|75999718|FG000|NOT COMPLETED|Overall Study||3||
59875774|NCT03764631|75999728|FG000|STARTED|Overall Study||751||
59875775|NCT03764631|75999729|FG001|STARTED|Overall Study||751||
59875776|NCT03764631|75999728|FG000|COMPLETED|Overall Study||710||
59875777|NCT03764631|75999729|FG001|COMPLETED|Overall Study||698||
59875778|NCT03764631|75999728|FG000|NOT COMPLETED|Overall Study||41||
59875779|NCT03764631|75999729|FG001|NOT COMPLETED|Overall Study||53||
59875780|NCT03674541|75999738|FG000|STARTED|Overall Study||23||
59875781|NCT03674541|75999739|FG001|STARTED|Overall Study||22||
59875782|NCT03674541|75999738|FG000|COMPLETED|Overall Study||23||
59875783|NCT03674541|75999739|FG001|COMPLETED|Overall Study||22||
59875784|NCT03674541|75999738|FG000|NOT COMPLETED|Overall Study||0||
59875785|NCT03674541|75999739|FG001|NOT COMPLETED|Overall Study||0||
59875786|NCT02956486|75999748|FG000|STARTED|Core Phase||1108||
59875787|NCT02956486|75999749|FG001|STARTED|Core Phase||1104||
59875788|NCT02956486|75999750|FG002|STARTED|Core Phase||0||
59875789|NCT02956486|75999748|FG000|Treated|Core Phase||1108||
59875790|NCT02956486|75999749|FG001|Treated|Core Phase||1101||
59875791|NCT02956486|75999750|FG002|Treated|Core Phase||0||
60002489|NCT02565381|76118367|FG001|NOT COMPLETED|Overall Study||0||
59875792|NCT02956486|75999748|FG000|Safety Analysis Set (SAS)|Core Phase||1105||
59875793|NCT02956486|75999749|FG001|Safety Analysis Set (SAS)|Core Phase||1099||
59875794|NCT02956486|75999750|FG002|Safety Analysis Set (SAS)|Core Phase||0||
59875795|NCT02956486|75999748|FG000|Full Analysis Set (FAS)|Core Phase||1084||
59875796|NCT02956486|75999749|FG001|Full Analysis Set (FAS)|Core Phase||1062||
59875797|NCT02956486|75999750|FG002|Full Analysis Set (FAS)|Core Phase||0||
59875798|NCT02956486|75999748|FG000|COMPLETED|Core Phase||29||
59875799|NCT02956486|75999749|FG001|COMPLETED|Core Phase||32||
59748016|NCT00940316|75867165|FG001|COMPLETED|Crossed Over to Arm A After Progression||3||
59748017|NCT00940316|75867166|FG002|COMPLETED|Crossed Over to Arm A After Progression||0||
59748018|NCT00940316|75867164|FG000|NOT COMPLETED|Crossed Over to Arm A After Progression||0||
59748019|NCT00940316|75867165|FG001|NOT COMPLETED|Crossed Over to Arm A After Progression||0||
59748020|NCT00940316|75867166|FG002|NOT COMPLETED|Crossed Over to Arm A After Progression||0||
59748021|NCT00940316|75867164|FG000|STARTED|Follow up Every 3 Months||13|All patients that receive treatment on the study go into follow up at treatment completion.|
59605328|NCT02005692|75715491|FG000|STARTED|Overall Study||70||
59605329|NCT02005692|75715491|FG000|COMPLETED|Overall Study||63||
59605330|NCT02005692|75715491|FG000|NOT COMPLETED|Overall Study||7||
59605331|NCT02029638|75715499|FG000|STARTED|Overall Study||2||
59605332|NCT02029638|75715500|FG001|STARTED|Overall Study||1||
59605333|NCT02029638|75715501|FG002|STARTED|Overall Study||1||
59748022|NCT00940316|75867165|FG001|STARTED|Follow up Every 3 Months||13|All patients that receive treatment on the study go into follow up at treatment completion.|
59748023|NCT00940316|75867166|FG002|STARTED|Follow up Every 3 Months||2|All patients that receive treatment on the study go into follow up at treatment completion.|
59748024|NCT00940316|75867164|FG000|COMPLETED|Follow up Every 3 Months||13||
59605334|NCT02029638|75715499|FG000|COMPLETED|Overall Study||0||
59605335|NCT02029638|75715500|FG001|COMPLETED|Overall Study||1||
59605336|NCT02029638|75715501|FG002|COMPLETED|Overall Study||0||
59605337|NCT02029638|75715499|FG000|NOT COMPLETED|Overall Study||2||
59605338|NCT02029638|75715500|FG001|NOT COMPLETED|Overall Study||0||
59605339|NCT02029638|75715501|FG002|NOT COMPLETED|Overall Study||1||
59748025|NCT00940316|75867165|FG001|COMPLETED|Follow up Every 3 Months||13||
59748026|NCT00940316|75867166|FG002|COMPLETED|Follow up Every 3 Months||2||
59605340|NCT02047734|75715512|FG000|STARTED|Overall Study||443||
59605341|NCT02047734|75715513|FG001|STARTED|Overall Study||443||
59605342|NCT02047734|75715514|FG002|STARTED|Overall Study||434||
59605343|NCT02047734|75715512|FG000|Received Treatment|Overall Study|One participant received ozanimod 0.5 mg in error|441||
59605344|NCT02047734|75715513|FG001|Received Treatment|Overall Study|One participant received ozanimod 1.0 mg in error|439||
59605345|NCT02047734|75715514|FG002|Received Treatment|Overall Study||433||
59605346|NCT02047734|75715512|FG000|COMPLETED|Overall Study||376|Completed study drug|
59605347|NCT02047734|75715513|FG001|COMPLETED|Overall Study||374|Completed study drug|
59605348|NCT02047734|75715514|FG002|COMPLETED|Overall Study||388|Completed study drug|
59605349|NCT02047734|75715512|FG000|NOT COMPLETED|Overall Study||67||
59605350|NCT02047734|75715513|FG001|NOT COMPLETED|Overall Study||69||
59605351|NCT02047734|75715514|FG002|NOT COMPLETED|Overall Study||46||
59605352|NCT02053350|75715522|FG000|STARTED|Overall Study||7||
59748027|NCT00940316|75867164|FG000|NOT COMPLETED|Follow up Every 3 Months||0||
59748028|NCT00940316|75867165|FG001|NOT COMPLETED|Follow up Every 3 Months||0||
59748029|NCT00940316|75867166|FG002|NOT COMPLETED|Follow up Every 3 Months||0||
59748030|NCT00726388|75867182|FG000|STARTED|Overall Study||1050||
59748031|NCT00726388|75867182|FG000|Treated|Overall Study||971||
59748032|NCT00726388|75867182|FG000|COMPLETED|Overall Study||943||
59605353|NCT02053350|75715522|FG000|COMPLETED|Overall Study||2||
59605354|NCT02053350|75715522|FG000|NOT COMPLETED|Overall Study||5||
59605355|NCT01994850|75715526|FG000|STARTED|Overall Study||32||
59605356|NCT01994850|75715526|FG000|COMPLETED|Overall Study||30||
59605357|NCT01994850|75715526|FG000|NOT COMPLETED|Overall Study||2||
59748033|NCT00726388|75867182|FG000|NOT COMPLETED|Overall Study||107||
59748034|NCT00572455|75867200|FG000|STARTED|Stage I (14 Days)||9||
59748035|NCT00572455|75867201|FG001|STARTED|Stage I (14 Days)||9||
59748036|NCT00572455|75867202|FG002|STARTED|Stage I (14 Days)||9||
59748037|NCT00572455|75867203|FG003|STARTED|Stage I (14 Days)||10||
59748038|NCT00572455|75867204|FG004|STARTED|Stage I (14 Days)||9||
59748039|NCT00572455|75867205|FG005|STARTED|Stage I (14 Days)||9||
59748040|NCT00572455|75867206|FG006|STARTED|Stage I (14 Days)||12||
59748041|NCT00572455|75867207|FG007|STARTED|Stage I (14 Days)||0||
59748042|NCT00572455|75867208|FG008|STARTED|Stage I (14 Days)||0||
59748043|NCT00572455|75867209|FG009|STARTED|Stage I (14 Days)||0||
59748044|NCT00572455|75867210|FG010|STARTED|Stage I (14 Days)||0||
59748045|NCT00572455|75867211|FG011|STARTED|Stage I (14 Days)||0||
59748046|NCT00572455|75867212|FG012|STARTED|Stage I (14 Days)||0||
59748047|NCT00572455|75867213|FG013|STARTED|Stage I (14 Days)||0||
59748048|NCT00572455|75867200|FG000|COMPLETED|Stage I (14 Days)||9||
59748049|NCT00572455|75867201|FG001|COMPLETED|Stage I (14 Days)||9||
59748050|NCT00572455|75867202|FG002|COMPLETED|Stage I (14 Days)||9||
59748051|NCT00572455|75867203|FG003|COMPLETED|Stage I (14 Days)||10||
59748052|NCT00572455|75867204|FG004|COMPLETED|Stage I (14 Days)||8||
59748053|NCT00572455|75867205|FG005|COMPLETED|Stage I (14 Days)||6||
59748054|NCT00572455|75867206|FG006|COMPLETED|Stage I (14 Days)||12||
59748055|NCT00572455|75867207|FG007|COMPLETED|Stage I (14 Days)||0||
59605358|NCT02027844|75715533|FG000|STARTED|Overall Study||39||
59605359|NCT02027844|75715534|FG001|STARTED|Overall Study||39||
59605360|NCT02027844|75715535|FG002|STARTED|Overall Study||39||
59605361|NCT02027844|75715533|FG000|COMPLETED|Overall Study||34||
59748056|NCT00572455|75867208|FG008|COMPLETED|Stage I (14 Days)||0||
59605362|NCT02027844|75715534|FG001|COMPLETED|Overall Study||33||
59605363|NCT02027844|75715535|FG002|COMPLETED|Overall Study||37||
59605364|NCT02027844|75715533|FG000|NOT COMPLETED|Overall Study||5||
59605365|NCT02027844|75715534|FG001|NOT COMPLETED|Overall Study||6||
59875800|NCT02956486|75999750|FG002|COMPLETED|Core Phase||0||
59875801|NCT02956486|75999748|FG000|NOT COMPLETED|Core Phase||1079||
59875802|NCT02956486|75999749|FG001|NOT COMPLETED|Core Phase||1072||
59875803|NCT02956486|75999750|FG002|NOT COMPLETED|Core Phase||0||
59875804|NCT02956486|75999748|FG000|STARTED|Extension Phase||0||
59875805|NCT02956486|75999749|FG001|STARTED|Extension Phase||0||
59875806|NCT02956486|75999750|FG002|STARTED|Extension Phase|Eligible participants who completed core and consented for extension phase, entered extension phase.|19||
59875807|NCT02956486|75999748|FG000|Treated|Extension Phase||0||
60135754|NCT01685008|76258449|FG001|COMPLETED|Main Study Treatment (Cycles 1 - 2)||25|Patients were considered to have completed the study if they finished the first 2 cycles of treatment plus the end of cycle 2 assessments.|
60135755|NCT01685008|76258450|FG002|COMPLETED|Main Study Treatment (Cycles 1 - 2)||10|Patients were considered to have completed the study if they finished the first 2 cycles of treatment plus the end of cycle 2 assessments.|
60135756|NCT01685008|76258451|FG003|COMPLETED|Main Study Treatment (Cycles 1 - 2)||10|Patients were considered to have completed the study if they finished the first 2 cycles of treatment plus the end of cycle 2 assessments.|
60135757|NCT01685008|76258448|FG000|NOT COMPLETED|Main Study Treatment (Cycles 1 - 2)||4||
60135758|NCT01685008|76258449|FG001|NOT COMPLETED|Main Study Treatment (Cycles 1 - 2)||10||
59605366|NCT02027844|75715535|FG002|NOT COMPLETED|Overall Study||2||
59875808|NCT02956486|75999749|FG001|Treated|Extension Phase||0||
59875809|NCT02956486|75999750|FG002|Treated|Extension Phase||18||
59875810|NCT02956486|75999748|FG000|Safety Analysis Set (SAS)|Extension Phase||0||
59875811|NCT02956486|75999749|FG001|Safety Analysis Set (SAS)|Extension Phase||0||
59875812|NCT02956486|75999750|FG002|Safety Analysis Set (SAS)|Extension Phase||18||
59875813|NCT02956486|75999748|FG000|COMPLETED|Extension Phase||0||
59875814|NCT02956486|75999749|FG001|COMPLETED|Extension Phase||0||
59875815|NCT02956486|75999750|FG002|COMPLETED|Extension Phase||0||
59875816|NCT02956486|75999748|FG000|NOT COMPLETED|Extension Phase||0||
59875817|NCT02956486|75999749|FG001|NOT COMPLETED|Extension Phase||0||
59875818|NCT02956486|75999750|FG002|NOT COMPLETED|Extension Phase||19||
59875819|NCT00001984|75999759|FG000|STARTED|Overall Study||5||
59875820|NCT00001984|75999759|FG000|COMPLETED|Overall Study||5||
59875821|NCT00001984|75999759|FG000|NOT COMPLETED|Overall Study||0||
59875822|NCT03445533|75999765|FG000|STARTED|Overall Study||243||
59875823|NCT03445533|75999766|FG001|STARTED|Overall Study||238||
59875824|NCT03445533|75999765|FG000|COMPLETED|Overall Study||115||
59875825|NCT03445533|75999766|FG001|COMPLETED|Overall Study||45||
59875826|NCT03445533|75999765|FG000|NOT COMPLETED|Overall Study||128||
59875827|NCT03445533|75999766|FG001|NOT COMPLETED|Overall Study||193||
59875828|NCT01337050|75999775|FG000|STARTED|Overall Study||4||
59875829|NCT01337050|75999776|FG001|STARTED|Overall Study||13||
59875830|NCT01337050|75999777|FG002|STARTED|Overall Study||19||
59875831|NCT01337050|75999775|FG000|COMPLETED|Overall Study||0||
59875832|NCT01337050|75999776|FG001|COMPLETED|Overall Study||0||
59875833|NCT01337050|75999777|FG002|COMPLETED|Overall Study||0||
59875834|NCT01337050|75999775|FG000|NOT COMPLETED|Overall Study||4||
59875835|NCT01337050|75999776|FG001|NOT COMPLETED|Overall Study||13||
59875836|NCT01337050|75999777|FG002|NOT COMPLETED|Overall Study||19||
59875837|NCT01336972|75999789|FG000|STARTED|Overall Study||10||
59875838|NCT01336972|75999790|FG001|STARTED|Overall Study||10||
59875839|NCT01336972|75999791|FG002|STARTED|Overall Study||9||
60135759|NCT01685008|76258450|FG002|NOT COMPLETED|Main Study Treatment (Cycles 1 - 2)||2||
60135760|NCT01685008|76258451|FG003|NOT COMPLETED|Main Study Treatment (Cycles 1 - 2)||1||
60135761|NCT01685008|76258448|FG000|STARTED|Cycle 3 and Maintenance Treatment||30|Includes all patients that completed the first 2 cycles of treatment.|
59875840|NCT01336972|75999789|FG000|COMPLETED|Overall Study||9||
59875841|NCT01336972|75999790|FG001|COMPLETED|Overall Study||9||
59875842|NCT01336972|75999791|FG002|COMPLETED|Overall Study||9||
59875843|NCT01336972|75999789|FG000|NOT COMPLETED|Overall Study||1||
59875844|NCT01336972|75999790|FG001|NOT COMPLETED|Overall Study||1||
59875845|NCT01336972|75999791|FG002|NOT COMPLETED|Overall Study||0||
59875846|NCT03762681|75999808|FG000|STARTED|Part 1||8||
59875847|NCT03762681|75999809|FG001|STARTED|Part 1||8||
59875848|NCT03762681|75999810|FG002|STARTED|Part 1||8||
59748057|NCT00572455|75867209|FG009|COMPLETED|Stage I (14 Days)||0||
59748058|NCT00572455|75867210|FG010|COMPLETED|Stage I (14 Days)||0||
59748059|NCT00572455|75867211|FG011|COMPLETED|Stage I (14 Days)||0||
59748060|NCT00572455|75867212|FG012|COMPLETED|Stage I (14 Days)||0||
59748061|NCT00572455|75867213|FG013|COMPLETED|Stage I (14 Days)||0||
59748062|NCT00572455|75867200|FG000|NOT COMPLETED|Stage I (14 Days)||0||
59748063|NCT00572455|75867201|FG001|NOT COMPLETED|Stage I (14 Days)||0||
59748064|NCT00572455|75867202|FG002|NOT COMPLETED|Stage I (14 Days)||0||
59748065|NCT00572455|75867203|FG003|NOT COMPLETED|Stage I (14 Days)||0||
59748066|NCT00572455|75867204|FG004|NOT COMPLETED|Stage I (14 Days)||1||
59748067|NCT00572455|75867205|FG005|NOT COMPLETED|Stage I (14 Days)||3||
59748068|NCT00572455|75867206|FG006|NOT COMPLETED|Stage I (14 Days)||0||
59748069|NCT00572455|75867207|FG007|NOT COMPLETED|Stage I (14 Days)||0||
59748070|NCT00572455|75867208|FG008|NOT COMPLETED|Stage I (14 Days)||0||
59748071|NCT00572455|75867209|FG009|NOT COMPLETED|Stage I (14 Days)||0||
59748072|NCT00572455|75867210|FG010|NOT COMPLETED|Stage I (14 Days)||0||
59875849|NCT03762681|75999811|FG003|STARTED|Part 1||8||
59875850|NCT03762681|75999812|FG004|STARTED|Part 1||8||
59875851|NCT03762681|75999813|FG005|STARTED|Part 1||0||
59875852|NCT03762681|75999814|FG006|STARTED|Part 1||0||
59875853|NCT03762681|75999815|FG007|STARTED|Part 1||0||
59875854|NCT03762681|75999808|FG000|COMPLETED|Part 1||8||
59875855|NCT03762681|75999809|FG001|COMPLETED|Part 1||8||
59875856|NCT03762681|75999810|FG002|COMPLETED|Part 1||8||
59875857|NCT03762681|75999811|FG003|COMPLETED|Part 1||7||
59875858|NCT03762681|75999812|FG004|COMPLETED|Part 1||8||
59748073|NCT00572455|75867211|FG011|NOT COMPLETED|Stage I (14 Days)||0||
59748074|NCT00572455|75867212|FG012|NOT COMPLETED|Stage I (14 Days)||0||
59748075|NCT00572455|75867213|FG013|NOT COMPLETED|Stage I (14 Days)||0||
59748076|NCT00572455|75867200|FG000|STARTED|Stage II (28 Days)||0||
59748077|NCT00572455|75867201|FG001|STARTED|Stage II (28 Days)||0||
59748078|NCT00572455|75867202|FG002|STARTED|Stage II (28 Days)||0||
59748079|NCT00572455|75867203|FG003|STARTED|Stage II (28 Days)||0||
59748080|NCT00572455|75867204|FG004|STARTED|Stage II (28 Days)||0||
59748081|NCT00572455|75867205|FG005|STARTED|Stage II (28 Days)||0||
59748082|NCT00572455|75867206|FG006|STARTED|Stage II (28 Days)||0||
59875859|NCT03762681|75999813|FG005|COMPLETED|Part 1||0||
59875860|NCT03762681|75999814|FG006|COMPLETED|Part 1||0||
59875861|NCT03762681|75999815|FG007|COMPLETED|Part 1||0||
59875862|NCT03762681|75999808|FG000|NOT COMPLETED|Part 1||0||
59875863|NCT03762681|75999809|FG001|NOT COMPLETED|Part 1||0||
59875864|NCT03762681|75999810|FG002|NOT COMPLETED|Part 1||0||
59875865|NCT03762681|75999811|FG003|NOT COMPLETED|Part 1||1||
59875866|NCT03762681|75999812|FG004|NOT COMPLETED|Part 1||0||
59875867|NCT03762681|75999813|FG005|NOT COMPLETED|Part 1||0||
59875868|NCT03762681|75999814|FG006|NOT COMPLETED|Part 1||0||
59875869|NCT03762681|75999815|FG007|NOT COMPLETED|Part 1||0||
59875870|NCT03762681|75999808|FG000|STARTED|Part 2a||0||
59875871|NCT03762681|75999809|FG001|STARTED|Part 2a||0||
59875872|NCT03762681|75999810|FG002|STARTED|Part 2a||0||
59748083|NCT00572455|75867207|FG007|STARTED|Stage II (28 Days)||35||
59748084|NCT00572455|75867208|FG008|STARTED|Stage II (28 Days)||36||
59748085|NCT00572455|75867209|FG009|STARTED|Stage II (28 Days)||36||
59748086|NCT00572455|75867210|FG010|STARTED|Stage II (28 Days)||36||
59748087|NCT00572455|75867211|FG011|STARTED|Stage II (28 Days)||36||
59748088|NCT00572455|75867212|FG012|STARTED|Stage II (28 Days)||36||
59875873|NCT03762681|75999811|FG003|STARTED|Part 2a||0||
59748089|NCT00572455|75867213|FG013|STARTED|Stage II (28 Days)||36||
59748090|NCT00572455|75867200|FG000|Treated|Stage II (28 Days)||0||
59748091|NCT00572455|75867201|FG001|Treated|Stage II (28 Days)||0||
59748092|NCT00572455|75867202|FG002|Treated|Stage II (28 Days)||0||
59748093|NCT00572455|75867203|FG003|Treated|Stage II (28 Days)||0||
59748094|NCT00572455|75867204|FG004|Treated|Stage II (28 Days)||0||
59748095|NCT00572455|75867205|FG005|Treated|Stage II (28 Days)||0||
59748096|NCT00572455|75867206|FG006|Treated|Stage II (28 Days)||0||
59748097|NCT00572455|75867207|FG007|Treated|Stage II (28 Days)||35||
59875874|NCT03762681|75999812|FG004|STARTED|Part 2a||0||
59875875|NCT03762681|75999813|FG005|STARTED|Part 2a||2||
59875876|NCT03762681|75999814|FG006|STARTED|Part 2a||8||
59748098|NCT00572455|75867208|FG008|Treated|Stage II (28 Days)||36||
59748099|NCT00572455|75867209|FG009|Treated|Stage II (28 Days)||36||
59748100|NCT00572455|75867210|FG010|Treated|Stage II (28 Days)||36||
59748101|NCT00572455|75867211|FG011|Treated|Stage II (28 Days)||36||
59748102|NCT00572455|75867212|FG012|Treated|Stage II (28 Days)||36||
59748103|NCT00572455|75867213|FG013|Treated|Stage II (28 Days)||35||
59748104|NCT00572455|75867200|FG000|COMPLETED|Stage II (28 Days)||0||
59748105|NCT00572455|75867201|FG001|COMPLETED|Stage II (28 Days)||0||
59748106|NCT00572455|75867202|FG002|COMPLETED|Stage II (28 Days)||0||
59748107|NCT00572455|75867203|FG003|COMPLETED|Stage II (28 Days)||0||
59748108|NCT00572455|75867204|FG004|COMPLETED|Stage II (28 Days)||0||
59748109|NCT00572455|75867205|FG005|COMPLETED|Stage II (28 Days)||0||
59748110|NCT00572455|75867206|FG006|COMPLETED|Stage II (28 Days)||0||
59748111|NCT00572455|75867207|FG007|COMPLETED|Stage II (28 Days)||34||
59748112|NCT00572455|75867208|FG008|COMPLETED|Stage II (28 Days)||33||
59748113|NCT00572455|75867209|FG009|COMPLETED|Stage II (28 Days)||33||
59748114|NCT00572455|75867210|FG010|COMPLETED|Stage II (28 Days)||31||
59748115|NCT00572455|75867211|FG011|COMPLETED|Stage II (28 Days)||32||
59748116|NCT00572455|75867212|FG012|COMPLETED|Stage II (28 Days)||31||
59748117|NCT00572455|75867213|FG013|COMPLETED|Stage II (28 Days)||34||
59748118|NCT00572455|75867200|FG000|NOT COMPLETED|Stage II (28 Days)||0||
59875877|NCT03762681|75999815|FG007|STARTED|Part 2a||5||
59875878|NCT03762681|75999808|FG000|COMPLETED|Part 2a||0||
59875879|NCT03762681|75999809|FG001|COMPLETED|Part 2a||0||
59875880|NCT03762681|75999810|FG002|COMPLETED|Part 2a||0||
59875881|NCT03762681|75999811|FG003|COMPLETED|Part 2a||0||
59748119|NCT00572455|75867201|FG001|NOT COMPLETED|Stage II (28 Days)||0||
59748120|NCT00572455|75867202|FG002|NOT COMPLETED|Stage II (28 Days)||0||
59748121|NCT00572455|75867203|FG003|NOT COMPLETED|Stage II (28 Days)||0||
59748122|NCT00572455|75867204|FG004|NOT COMPLETED|Stage II (28 Days)||0||
59748123|NCT00572455|75867205|FG005|NOT COMPLETED|Stage II (28 Days)||0||
59748124|NCT00572455|75867206|FG006|NOT COMPLETED|Stage II (28 Days)||0||
59748125|NCT00572455|75867207|FG007|NOT COMPLETED|Stage II (28 Days)||1||
59748126|NCT00572455|75867208|FG008|NOT COMPLETED|Stage II (28 Days)||3||
59748127|NCT00572455|75867209|FG009|NOT COMPLETED|Stage II (28 Days)||3||
59748128|NCT00572455|75867210|FG010|NOT COMPLETED|Stage II (28 Days)||5||
59748129|NCT00572455|75867211|FG011|NOT COMPLETED|Stage II (28 Days)||4||
59748130|NCT00572455|75867212|FG012|NOT COMPLETED|Stage II (28 Days)||5||
59748131|NCT00572455|75867213|FG013|NOT COMPLETED|Stage II (28 Days)||2||
59748132|NCT01003691|75867247|FG000|STARTED|Overall Study||6||
59748133|NCT01003691|75867248|FG001|STARTED|Overall Study||6||
59748134|NCT01003691|75867249|FG002|STARTED|Overall Study||6||
59748135|NCT01003691|75867250|FG003|STARTED|Overall Study||6||
59748136|NCT01003691|75867247|FG000|COMPLETED|Overall Study||6||
59748137|NCT01003691|75867248|FG001|COMPLETED|Overall Study||6||
59748138|NCT01003691|75867249|FG002|COMPLETED|Overall Study||6||
59748139|NCT01003691|75867250|FG003|COMPLETED|Overall Study||5||
59748140|NCT01003691|75867247|FG000|NOT COMPLETED|Overall Study||0||
59748141|NCT01003691|75867248|FG001|NOT COMPLETED|Overall Study||0||
59748142|NCT01003691|75867249|FG002|NOT COMPLETED|Overall Study||0||
59748143|NCT01003691|75867250|FG003|NOT COMPLETED|Overall Study||1||
59748144|NCT00686335|75867261|FG000|STARTED|Run-in Period||12||
59748145|NCT00686335|75867261|FG000|COMPLETED|Run-in Period||7||
59748146|NCT00686335|75867261|FG000|NOT COMPLETED|Run-in Period||5||
59748147|NCT00686335|75867261|FG000|STARTED|Treatment Period||7||
59875882|NCT03762681|75999812|FG004|COMPLETED|Part 2a||0||
59875883|NCT03762681|75999813|FG005|COMPLETED|Part 2a||2||
59875884|NCT03762681|75999814|FG006|COMPLETED|Part 2a||8||
59875885|NCT03762681|75999815|FG007|COMPLETED|Part 2a||4||
59875886|NCT03762681|75999808|FG000|NOT COMPLETED|Part 2a||0||
59875887|NCT03762681|75999809|FG001|NOT COMPLETED|Part 2a||0||
59748148|NCT00686335|75867261|FG000|COMPLETED|Treatment Period||7||
59875888|NCT03762681|75999810|FG002|NOT COMPLETED|Part 2a||0||
59748149|NCT00686335|75867261|FG000|NOT COMPLETED|Treatment Period||0||
59748150|NCT01002989|75867267|FG000|STARTED|Overall Study||98||
59748151|NCT01002989|75867267|FG000|COMPLETED|Overall Study||93||
59748152|NCT01002989|75867267|FG000|NOT COMPLETED|Overall Study||5||
59875889|NCT03762681|75999811|FG003|NOT COMPLETED|Part 2a||0||
59748153|NCT00685945|75867271|FG000|STARTED|Control (Bradykinin Infusion)|A total of 24 subjects received an infusion of bradykinin|24||
59748154|NCT00685945|75867271|FG000|COMPLETED|Control (Bradykinin Infusion)||24||
59748155|NCT00685945|75867271|FG000|NOT COMPLETED|Control (Bradykinin Infusion)||0||
59748156|NCT00685945|75867271|FG000|STARTED|L-NMMA + Bradykinin||24||
59748157|NCT00685945|75867271|FG000|COMPLETED|L-NMMA + Bradykinin||23||
59875890|NCT03762681|75999812|FG004|NOT COMPLETED|Part 2a||0||
59748158|NCT00685945|75867271|FG000|NOT COMPLETED|L-NMMA + Bradykinin||1||
59748159|NCT00685945|75867271|FG000|STARTED|Isosorbide + L-NMMA + Bradykinin||11||
59748160|NCT00685945|75867271|FG000|COMPLETED|Isosorbide + L-NMMA + Bradykinin||11||
59875891|NCT03762681|75999813|FG005|NOT COMPLETED|Part 2a||0||
59875892|NCT03762681|75999814|FG006|NOT COMPLETED|Part 2a||0||
59748161|NCT00685945|75867271|FG000|NOT COMPLETED|Isosorbide + L-NMMA + Bradykinin||0||
59748162|NCT00685945|75867271|FG000|STARTED|Sildenafil + L-NMMA + Bradykinin||12||
59748163|NCT00685945|75867271|FG000|COMPLETED|Sildenafil + L-NMMA + Bradykinin||12||
59748164|NCT00685945|75867271|FG000|NOT COMPLETED|Sildenafil + L-NMMA + Bradykinin||0||
59748165|NCT01007123|75867285|FG000|STARTED|Overall Study||48||
59748166|NCT01007123|75867286|FG001|STARTED|Overall Study||47||
59748167|NCT01007123|75867287|FG002|STARTED|Overall Study||48||
59748168|NCT01007123|75867288|FG003|STARTED|Overall Study||47||
59748169|NCT01007123|75867285|FG000|COMPLETED|Overall Study||42||
59748170|NCT01007123|75867286|FG001|COMPLETED|Overall Study||41||
59748171|NCT01007123|75867287|FG002|COMPLETED|Overall Study||37||
59748172|NCT01007123|75867288|FG003|COMPLETED|Overall Study||41||
59748173|NCT01007123|75867285|FG000|NOT COMPLETED|Overall Study||6||
59748174|NCT01007123|75867286|FG001|NOT COMPLETED|Overall Study||6||
59748175|NCT01007123|75867287|FG002|NOT COMPLETED|Overall Study||11||
59748176|NCT01007123|75867288|FG003|NOT COMPLETED|Overall Study||6||
59748177|NCT00687739|75867303|FG000|STARTED|Overall Study||25||
59748178|NCT00687739|75867304|FG001|STARTED|Overall Study||15||
59748179|NCT00687739|75867305|FG002|STARTED|Overall Study||25||
59748180|NCT00687739|75867306|FG003|STARTED|Overall Study||14||
59748181|NCT00687739|75867303|FG000|COMPLETED|Overall Study||23||
59748182|NCT00687739|75867304|FG001|COMPLETED|Overall Study||12||
59748183|NCT00687739|75867305|FG002|COMPLETED|Overall Study||23||
59748184|NCT00687739|75867306|FG003|COMPLETED|Overall Study||12||
59748185|NCT00687739|75867303|FG000|NOT COMPLETED|Overall Study||2||
59748186|NCT00687739|75867304|FG001|NOT COMPLETED|Overall Study||3||
59748187|NCT00687739|75867305|FG002|NOT COMPLETED|Overall Study||2||
59748188|NCT00687739|75867306|FG003|NOT COMPLETED|Overall Study||2||
59748189|NCT01006889|75867318|FG000|STARTED|Overall Study||20||
59748190|NCT01006889|75867318|FG000|COMPLETED|Overall Study||17||
59748191|NCT01006889|75867318|FG000|NOT COMPLETED|Overall Study||3||
59748192|NCT01001429|75867325|FG000|STARTED|Overall Study||39||
59748193|NCT01001429|75867326|FG001|STARTED|Overall Study||38||
59748194|NCT01001429|75867325|FG000|COMPLETED|Overall Study||39||
59748195|NCT01001429|75867326|FG001|COMPLETED|Overall Study||37||
59748196|NCT01001429|75867325|FG000|NOT COMPLETED|Overall Study||0||
59748197|NCT01001429|75867326|FG001|NOT COMPLETED|Overall Study||1||
59748198|NCT01000961|75867356|FG000|STARTED|Run-in Period of 2-3 Weeks on Cystagon|Part of the Safety analysis set|21||
59748199|NCT01000961|75867357|FG001|STARTED|Run-in Period of 2-3 Weeks on Cystagon|Part of the Safety analysis set|22||
59748200|NCT01000961|75867356|FG000|COMPLETED|Run-in Period of 2-3 Weeks on Cystagon||21||
59748201|NCT01000961|75867357|FG001|COMPLETED|Run-in Period of 2-3 Weeks on Cystagon||22||
59748202|NCT01000961|75867356|FG000|NOT COMPLETED|Run-in Period of 2-3 Weeks on Cystagon||0||
59748203|NCT01000961|75867357|FG001|NOT COMPLETED|Run-in Period of 2-3 Weeks on Cystagon||0||
59748204|NCT01000961|75867356|FG000|STARTED|First Intervention (3 Weeks)||21||
59748205|NCT01000961|75867357|FG001|STARTED|First Intervention (3 Weeks)||22||
59748206|NCT01000961|75867356|FG000|COMPLETED|First Intervention (3 Weeks)||21||
59748207|NCT01000961|75867357|FG001|COMPLETED|First Intervention (3 Weeks)||20||
59748208|NCT01000961|75867356|FG000|NOT COMPLETED|First Intervention (3 Weeks)||0||
59748209|NCT01000961|75867357|FG001|NOT COMPLETED|First Intervention (3 Weeks)||2||
59748210|NCT01000961|75867356|FG000|STARTED|Second Intervention (3 Weeks)||21||
59748211|NCT01000961|75867357|FG001|STARTED|Second Intervention (3 Weeks)||20||
59748212|NCT01000961|75867356|FG000|COMPLETED|Second Intervention (3 Weeks)|Part of Efficacy analysis set|21||
59748213|NCT01000961|75867357|FG001|COMPLETED|Second Intervention (3 Weeks)|Part of Efficacy analysis set|20||
59748214|NCT01000961|75867356|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||0||
59748215|NCT01000961|75867357|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0||
59748216|NCT01000805|75867367|FG000|STARTED|Overall Study||262||
59748217|NCT01000805|75867368|FG001|STARTED|Overall Study||266||
59748218|NCT01000805|75867367|FG000|COMPLETED|Overall Study||192||
59748219|NCT01000805|75867368|FG001|COMPLETED|Overall Study||204||
59748220|NCT01000805|75867367|FG000|NOT COMPLETED|Overall Study||70||
59748221|NCT01000805|75867368|FG001|NOT COMPLETED|Overall Study||62||
59748222|NCT00684307|75867380|FG000|STARTED|Overall Study|Patients who received treatment|164||
59748223|NCT00684307|75867381|FG001|STARTED|Overall Study||151||
59748224|NCT00684307|75867382|FG002|STARTED|Overall Study||156||
59748225|NCT00684307|75867383|FG003|STARTED|Overall Study||160||
59748226|NCT00684307|75867384|FG004|STARTED|Overall Study||318||
59748227|NCT00684307|75867380|FG000|On Treatment Period Started|Overall Study||164||
59748228|NCT00684307|75867381|FG001|On Treatment Period Started|Overall Study||151||
59748229|NCT00684307|75867382|FG002|On Treatment Period Started|Overall Study||156||
59748230|NCT00684307|75867383|FG003|On Treatment Period Started|Overall Study||160||
59875893|NCT03762681|75999815|FG007|NOT COMPLETED|Part 2a||1||
59875894|NCT03764475|75999844|FG000|STARTED|Overall Study||230||
59875895|NCT03764475|75999845|FG001|STARTED|Overall Study||102||
59875896|NCT03764475|75999844|FG000|COMPLETED|Overall Study||164||
59875897|NCT03764475|75999845|FG001|COMPLETED|Overall Study||80||
59875898|NCT03764475|75999844|FG000|NOT COMPLETED|Overall Study||66||
59748231|NCT00684307|75867384|FG004|On Treatment Period Started|Overall Study||318||
59748232|NCT00684307|75867380|FG000|On Treatment Period Completed|Overall Study|Patients who completed treatment|140||
59748233|NCT00684307|75867381|FG001|On Treatment Period Completed|Overall Study||129||
59748234|NCT00684307|75867382|FG002|On Treatment Period Completed|Overall Study||128||
59748235|NCT00684307|75867383|FG003|On Treatment Period Completed|Overall Study||128||
59748236|NCT00684307|75867384|FG004|On Treatment Period Completed|Overall Study||293||
59875899|NCT03764475|75999845|FG001|NOT COMPLETED|Overall Study||22||
59875900|NCT02872012|75999860|FG000|STARTED|Overall Study||4||
59875901|NCT02872012|75999861|FG001|STARTED|Overall Study||7||
59875902|NCT02872012|75999862|FG002|STARTED|Overall Study||4||
59875903|NCT02872012|75999863|FG003|STARTED|Overall Study||3||
59875904|NCT02872012|75999864|FG004|STARTED|Overall Study||5||
59875905|NCT02872012|75999860|FG000|COMPLETED|Overall Study||3||
59875906|NCT02872012|75999861|FG001|COMPLETED|Overall Study||7||
59875907|NCT02872012|75999862|FG002|COMPLETED|Overall Study||4||
59748237|NCT00684307|75867380|FG000|COMPLETED|Overall Study||140||
59748238|NCT00684307|75867381|FG001|COMPLETED|Overall Study||129||
59748239|NCT00684307|75867382|FG002|COMPLETED|Overall Study||128||
59748240|NCT00684307|75867383|FG003|COMPLETED|Overall Study||128||
59748241|NCT00684307|75867384|FG004|COMPLETED|Overall Study||293||
59748242|NCT00684307|75867380|FG000|NOT COMPLETED|Overall Study||24||
59748243|NCT00684307|75867381|FG001|NOT COMPLETED|Overall Study||22||
59875908|NCT02872012|75999863|FG003|COMPLETED|Overall Study||3||
59875909|NCT02872012|75999864|FG004|COMPLETED|Overall Study||5||
59875910|NCT02872012|75999860|FG000|NOT COMPLETED|Overall Study||1||
59875911|NCT02872012|75999861|FG001|NOT COMPLETED|Overall Study||0||
59875912|NCT02872012|75999862|FG002|NOT COMPLETED|Overall Study||0||
59748244|NCT00684307|75867382|FG002|NOT COMPLETED|Overall Study||28||
59748245|NCT00684307|75867383|FG003|NOT COMPLETED|Overall Study||32||
59748246|NCT00684307|75867384|FG004|NOT COMPLETED|Overall Study||25||
59748247|NCT00683917|75867399|FG000|STARTED|Overall Study||10||
59748248|NCT00683917|75867399|FG000|COMPLETED|Overall Study||0||
59748249|NCT00683917|75867399|FG000|NOT COMPLETED|Overall Study||10||
59748250|NCT00687271|75867411|FG000|STARTED|Overall Study||94||
59748251|NCT00687271|75867412|FG001|STARTED|Overall Study||96||
59748252|NCT00687271|75867413|FG002|STARTED|Overall Study||96||
59748253|NCT00687271|75867414|FG003|STARTED|Overall Study||48||
59748254|NCT00687271|75867411|FG000|Treated|Overall Study||94||
59748255|NCT00687271|75867412|FG001|Treated|Overall Study||95||
59748256|NCT00687271|75867413|FG002|Treated|Overall Study||96||
59748257|NCT00687271|75867414|FG003|Treated|Overall Study||48||
59748258|NCT00687271|75867411|FG000|COMPLETED|Overall Study||91||
59748259|NCT00687271|75867412|FG001|COMPLETED|Overall Study||90||
59875913|NCT02872012|75999863|FG003|NOT COMPLETED|Overall Study||0||
59748260|NCT00687271|75867413|FG002|COMPLETED|Overall Study||91||
59748261|NCT00687271|75867414|FG003|COMPLETED|Overall Study||48||
59748262|NCT00687271|75867411|FG000|NOT COMPLETED|Overall Study||3||
59748263|NCT00687271|75867412|FG001|NOT COMPLETED|Overall Study||6||
59748264|NCT00687271|75867413|FG002|NOT COMPLETED|Overall Study||5||
59875914|NCT02872012|75999864|FG004|NOT COMPLETED|Overall Study||0||
59875915|NCT02959138|75999881|FG000|STARTED|Overall Study||10||
59748265|NCT00687271|75867414|FG003|NOT COMPLETED|Overall Study||0||
59748266|NCT04617275|75867432|FG000|STARTED|Treatment Period||16||
59748267|NCT04617275|75867433|FG001|STARTED|Treatment Period||20||
59748268|NCT04617275|75867434|FG002|STARTED|Treatment Period||22||
59748269|NCT04617275|75867435|FG003|STARTED|Treatment Period||22||
59748270|NCT04617275|75867436|FG004|STARTED|Treatment Period||22||
59748271|NCT04617275|75867437|FG005|STARTED|Treatment Period||21||
59875916|NCT02959138|75999882|FG001|STARTED|Overall Study||10||
59875917|NCT02959138|75999883|FG002|STARTED|Overall Study||16||
59875918|NCT02959138|75999881|FG000|COMPLETED|Overall Study||10||
59875919|NCT02959138|75999882|FG001|COMPLETED|Overall Study||9||
59875920|NCT02959138|75999883|FG002|COMPLETED|Overall Study||16||
59875921|NCT02959138|75999881|FG000|NOT COMPLETED|Overall Study||0||
59875922|NCT02959138|75999882|FG001|NOT COMPLETED|Overall Study||1||
59875923|NCT02959138|75999883|FG002|NOT COMPLETED|Overall Study||0||
59748272|NCT04617275|75867438|FG006|STARTED|Treatment Period||6||
59748273|NCT04617275|75867439|FG007|STARTED|Treatment Period||22||
59748274|NCT04617275|75867432|FG000|COMPLETED|Treatment Period||13||
59748275|NCT04617275|75867433|FG001|COMPLETED|Treatment Period||13||
59748276|NCT04617275|75867434|FG002|COMPLETED|Treatment Period||16||
59748277|NCT04617275|75867435|FG003|COMPLETED|Treatment Period||13||
59748278|NCT04617275|75867436|FG004|COMPLETED|Treatment Period||13||
59748279|NCT04617275|75867437|FG005|COMPLETED|Treatment Period||10||
59748280|NCT04617275|75867438|FG006|COMPLETED|Treatment Period||5||
59748281|NCT04617275|75867439|FG007|COMPLETED|Treatment Period||6||
59748282|NCT04617275|75867432|FG000|NOT COMPLETED|Treatment Period||3||
59748283|NCT04617275|75867433|FG001|NOT COMPLETED|Treatment Period||7||
59748284|NCT04617275|75867434|FG002|NOT COMPLETED|Treatment Period||6||
59748285|NCT04617275|75867435|FG003|NOT COMPLETED|Treatment Period||9||
59748286|NCT04617275|75867436|FG004|NOT COMPLETED|Treatment Period||9||
59748287|NCT04617275|75867437|FG005|NOT COMPLETED|Treatment Period||11||
59748288|NCT04617275|75867438|FG006|NOT COMPLETED|Treatment Period||1||
59748289|NCT04617275|75867439|FG007|NOT COMPLETED|Treatment Period||16||
59748290|NCT04617275|75867432|FG000|STARTED|Follow-up Period||16||
59748291|NCT04617275|75867433|FG001|STARTED|Follow-up Period||20||
59748292|NCT04617275|75867434|FG002|STARTED|Follow-up Period||22||
59748293|NCT04617275|75867435|FG003|STARTED|Follow-up Period||22||
59748294|NCT04617275|75867436|FG004|STARTED|Follow-up Period||22||
59748295|NCT04617275|75867437|FG005|STARTED|Follow-up Period||21||
59748296|NCT04617275|75867438|FG006|STARTED|Follow-up Period||6||
59748297|NCT04617275|75867439|FG007|STARTED|Follow-up Period||22||
59748298|NCT04617275|75867432|FG000|COMPLETED|Follow-up Period||13||
59748299|NCT04617275|75867433|FG001|COMPLETED|Follow-up Period||17||
59748300|NCT04617275|75867434|FG002|COMPLETED|Follow-up Period||18||
59748301|NCT04617275|75867435|FG003|COMPLETED|Follow-up Period||16||
59748302|NCT04617275|75867436|FG004|COMPLETED|Follow-up Period||16||
59748303|NCT04617275|75867437|FG005|COMPLETED|Follow-up Period||14||
59748304|NCT04617275|75867438|FG006|COMPLETED|Follow-up Period||5||
59748305|NCT04617275|75867439|FG007|COMPLETED|Follow-up Period||14||
59748306|NCT04617275|75867432|FG000|NOT COMPLETED|Follow-up Period||3||
59748307|NCT04617275|75867433|FG001|NOT COMPLETED|Follow-up Period||3||
59748308|NCT04617275|75867434|FG002|NOT COMPLETED|Follow-up Period||4||
59748309|NCT04617275|75867435|FG003|NOT COMPLETED|Follow-up Period||6||
59748310|NCT04617275|75867436|FG004|NOT COMPLETED|Follow-up Period||6||
59748311|NCT04617275|75867437|FG005|NOT COMPLETED|Follow-up Period||7||
59748312|NCT04617275|75867438|FG006|NOT COMPLETED|Follow-up Period||1||
59748313|NCT04617275|75867439|FG007|NOT COMPLETED|Follow-up Period||8||
59748314|NCT04614545|75867467|FG000|STARTED|Overall Study||35||
59748315|NCT04614545|75867468|FG001|STARTED|Overall Study||35||
59748316|NCT04614545|75867467|FG000|COMPLETED|Overall Study||32||
59748317|NCT04614545|75867468|FG001|COMPLETED|Overall Study||32||
59748318|NCT04614545|75867467|FG000|NOT COMPLETED|Overall Study||3||
59748319|NCT04614545|75867468|FG001|NOT COMPLETED|Overall Study||3||
59748320|NCT01031537|75867474|FG000|STARTED|Overall Study||66||
59748321|NCT01031537|75867474|FG000|COMPLETED|Overall Study||34||
59748322|NCT01031537|75867474|FG000|NOT COMPLETED|Overall Study||32||
59748323|NCT01031381|75867478|FG000|STARTED|Overall Study||59||
59748324|NCT01031381|75867478|FG000|COMPLETED|Overall Study||50||
59748325|NCT01031381|75867478|FG000|NOT COMPLETED|Overall Study||9||
59748326|NCT00685399|75867490|FG000|STARTED|Treatment Period 1||16||
59748327|NCT00685399|75867491|FG001|STARTED|Treatment Period 1||0||
59748328|NCT00685399|75867492|FG002|STARTED|Treatment Period 1||0||
59748329|NCT00685399|75867493|FG003|STARTED|Treatment Period 1||0||
59748330|NCT00685399|75867494|FG004|STARTED|Treatment Period 1||0||
59748331|NCT00685399|75867495|FG005|STARTED|Treatment Period 1||0||
59748332|NCT00685399|75867496|FG006|STARTED|Treatment Period 1||0||
59748333|NCT00685399|75867497|FG007|STARTED|Treatment Period 1||0||
59748334|NCT00685399|75867490|FG000|COMPLETED|Treatment Period 1||10||
59748335|NCT00685399|75867491|FG001|COMPLETED|Treatment Period 1||0||
59748336|NCT00685399|75867492|FG002|COMPLETED|Treatment Period 1||0||
59748337|NCT00685399|75867493|FG003|COMPLETED|Treatment Period 1||0||
59748338|NCT00685399|75867494|FG004|COMPLETED|Treatment Period 1||0||
59748339|NCT00685399|75867495|FG005|COMPLETED|Treatment Period 1||0||
59748340|NCT00685399|75867496|FG006|COMPLETED|Treatment Period 1||0||
59748341|NCT00685399|75867497|FG007|COMPLETED|Treatment Period 1||0||
59748342|NCT00685399|75867490|FG000|NOT COMPLETED|Treatment Period 1||6||
59748343|NCT00685399|75867491|FG001|NOT COMPLETED|Treatment Period 1||0||
59748344|NCT00685399|75867492|FG002|NOT COMPLETED|Treatment Period 1||0||
59748345|NCT00685399|75867493|FG003|NOT COMPLETED|Treatment Period 1||0||
59748346|NCT00685399|75867494|FG004|NOT COMPLETED|Treatment Period 1||0||
59748347|NCT00685399|75867495|FG005|NOT COMPLETED|Treatment Period 1||0||
59748348|NCT00685399|75867496|FG006|NOT COMPLETED|Treatment Period 1||0||
59748349|NCT00685399|75867497|FG007|NOT COMPLETED|Treatment Period 1||0||
59748350|NCT00685399|75867490|FG000|STARTED|Treatment Period 2||0||
59748351|NCT00685399|75867491|FG001|STARTED|Treatment Period 2||14||
59748352|NCT00685399|75867492|FG002|STARTED|Treatment Period 2||5||
59748353|NCT00685399|75867493|FG003|STARTED|Treatment Period 2|in extension period only|0||
59748354|NCT00685399|75867494|FG004|STARTED|Treatment Period 2||4||
59748355|NCT00685399|75867495|FG005|STARTED|Treatment Period 2||12||
59748356|NCT00685399|75867496|FG006|STARTED|Treatment Period 2||13||
59748357|NCT00685399|75867497|FG007|STARTED|Treatment Period 2||12||
59748358|NCT00685399|75867490|FG000|COMPLETED|Treatment Period 2||0||
59748359|NCT00685399|75867491|FG001|COMPLETED|Treatment Period 2||2||
59748360|NCT00685399|75867492|FG002|COMPLETED|Treatment Period 2||2||
59748361|NCT00685399|75867493|FG003|COMPLETED|Treatment Period 2|in extension period only|0||
59748362|NCT00685399|75867494|FG004|COMPLETED|Treatment Period 2||4||
59748363|NCT00685399|75867495|FG005|COMPLETED|Treatment Period 2||10||
59748364|NCT00685399|75867496|FG006|COMPLETED|Treatment Period 2||13||
59748365|NCT00685399|75867497|FG007|COMPLETED|Treatment Period 2||10||
59748366|NCT00685399|75867490|FG000|NOT COMPLETED|Treatment Period 2||0||
59748367|NCT00685399|75867491|FG001|NOT COMPLETED|Treatment Period 2||12||
59748368|NCT00685399|75867492|FG002|NOT COMPLETED|Treatment Period 2||3||
59748369|NCT00685399|75867493|FG003|NOT COMPLETED|Treatment Period 2||0||
59748370|NCT00685399|75867494|FG004|NOT COMPLETED|Treatment Period 2||0||
59748371|NCT00685399|75867495|FG005|NOT COMPLETED|Treatment Period 2||2||
59748372|NCT00685399|75867496|FG006|NOT COMPLETED|Treatment Period 2||0||
59748373|NCT00685399|75867497|FG007|NOT COMPLETED|Treatment Period 2||2||
59748374|NCT00685399|75867490|FG000|STARTED|Extension||0||
59748375|NCT00685399|75867491|FG001|STARTED|Extension||0||
59748376|NCT00685399|75867492|FG002|STARTED|Extension||0||
59748377|NCT00685399|75867493|FG003|STARTED|Extension||28||
59748378|NCT00685399|75867494|FG004|STARTED|Extension||0||
59748379|NCT00685399|75867495|FG005|STARTED|Extension||0||
59748380|NCT00685399|75867496|FG006|STARTED|Extension||0||
59748381|NCT00685399|75867497|FG007|STARTED|Extension||0||
59748382|NCT00685399|75867490|FG000|COMPLETED|Extension||0||
59748383|NCT00685399|75867491|FG001|COMPLETED|Extension||0||
59748384|NCT00685399|75867492|FG002|COMPLETED|Extension||0||
59748385|NCT00685399|75867493|FG003|COMPLETED|Extension||21||
59748386|NCT00685399|75867494|FG004|COMPLETED|Extension||0||
59748387|NCT00685399|75867495|FG005|COMPLETED|Extension||0||
59748388|NCT00685399|75867496|FG006|COMPLETED|Extension||0||
59748389|NCT00685399|75867497|FG007|COMPLETED|Extension||0||
59748390|NCT00685399|75867490|FG000|NOT COMPLETED|Extension||0||
59748391|NCT00685399|75867491|FG001|NOT COMPLETED|Extension||0||
59748392|NCT00685399|75867492|FG002|NOT COMPLETED|Extension||0||
59748393|NCT00685399|75867493|FG003|NOT COMPLETED|Extension||7||
59748394|NCT00685399|75867494|FG004|NOT COMPLETED|Extension||0||
59748395|NCT00685399|75867495|FG005|NOT COMPLETED|Extension||0||
59748396|NCT00685399|75867496|FG006|NOT COMPLETED|Extension||0||
59748397|NCT00685399|75867497|FG007|NOT COMPLETED|Extension||0||
59748398|NCT00685165|75867524|FG000|STARTED|First Intervention||11||
59748399|NCT00685165|75867525|FG001|STARTED|First Intervention||11||
59748400|NCT00685165|75867524|FG000|COMPLETED|First Intervention||11||
59748401|NCT00685165|75867525|FG001|COMPLETED|First Intervention||11||
59748402|NCT00685165|75867524|FG000|NOT COMPLETED|First Intervention||0||
59748403|NCT00685165|75867525|FG001|NOT COMPLETED|First Intervention||0||
59748404|NCT00685165|75867524|FG000|STARTED|Washout Period of 14 Days||11||
59748405|NCT00685165|75867525|FG001|STARTED|Washout Period of 14 Days||11||
59748406|NCT00685165|75867524|FG000|COMPLETED|Washout Period of 14 Days|adverse event- possible upper respiratory infection|10||
59748407|NCT00685165|75867525|FG001|COMPLETED|Washout Period of 14 Days||11||
59748408|NCT00685165|75867524|FG000|NOT COMPLETED|Washout Period of 14 Days||1||
59748409|NCT00685165|75867525|FG001|NOT COMPLETED|Washout Period of 14 Days||0||
59748410|NCT00685165|75867524|FG000|STARTED|Second Intervention||10||
59748411|NCT00685165|75867525|FG001|STARTED|Second Intervention||11||
59748412|NCT00685165|75867524|FG000|COMPLETED|Second Intervention||10||
59748413|NCT00685165|75867525|FG001|COMPLETED|Second Intervention||11||
59748414|NCT00685165|75867524|FG000|NOT COMPLETED|Second Intervention||0||
59748415|NCT00685165|75867525|FG001|NOT COMPLETED|Second Intervention||0||
59748416|NCT00683449|75867536|FG000|STARTED|Overall Study||5||
59748417|NCT00683449|75867537|FG001|STARTED|Overall Study||13||
59748418|NCT00683449|75867538|FG002|STARTED|Overall Study||3||
59748419|NCT00683449|75867539|FG003|STARTED|Overall Study||6||
59748420|NCT00683449|75867540|FG004|STARTED|Overall Study||2||
59748421|NCT00683449|75867536|FG000|COMPLETED|Overall Study||5||
59748422|NCT00683449|75867537|FG001|COMPLETED|Overall Study||12||
59748423|NCT00683449|75867538|FG002|COMPLETED|Overall Study||3||
59748424|NCT00683449|75867539|FG003|COMPLETED|Overall Study||6||
59748425|NCT00683449|75867540|FG004|COMPLETED|Overall Study||2||
59748426|NCT00683449|75867536|FG000|NOT COMPLETED|Overall Study||0||
59748427|NCT00683449|75867537|FG001|NOT COMPLETED|Overall Study||1||
59748428|NCT00683449|75867538|FG002|NOT COMPLETED|Overall Study||0||
59748429|NCT00683449|75867539|FG003|NOT COMPLETED|Overall Study||0||
59748430|NCT00683449|75867540|FG004|NOT COMPLETED|Overall Study||0||
59748431|NCT00683293|75867559|FG000|STARTED|Overall Study||50||
59748432|NCT00683293|75867560|FG001|STARTED|Overall Study||50||
59748433|NCT00683293|75867559|FG000|COMPLETED|Overall Study||48||
59748434|NCT00683293|75867560|FG001|COMPLETED|Overall Study||47||
59748435|NCT00683293|75867559|FG000|NOT COMPLETED|Overall Study||2||
59748436|NCT00683293|75867560|FG001|NOT COMPLETED|Overall Study||3||
59748437|NCT00726232|75867572|FG000|STARTED|Initial Phase (Dose-finding)|The starting dose selected for the PV expansion cohort was 10 mg bid hence the sample size is larger|19||
59748438|NCT00726232|75867573|FG001|STARTED|Initial Phase (Dose-finding)||8||
59748439|NCT00726232|75867574|FG002|STARTED|Initial Phase (Dose-finding)||7||
59748440|NCT00726232|75867575|FG003|STARTED|Initial Phase (Dose-finding)||8||
59748441|NCT00726232|75867576|FG004|STARTED|Initial Phase (Dose-finding)|The starting dose selected for the ET expansion cohort was 25 mg bid hence the sample size is larger|22||
59748442|NCT00726232|75867577|FG005|STARTED|Initial Phase (Dose-finding)||9||
59748443|NCT00726232|75867578|FG006|STARTED|Initial Phase (Dose-finding)||0||
59748444|NCT00726232|75867579|FG007|STARTED|Initial Phase (Dose-finding)||0||
59748445|NCT00726232|75867572|FG000|Safety Evaluable Participants|Initial Phase (Dose-finding)||19||
59875924|NCT01344226|75999895|FG000|STARTED|Overall Study||49||
59875925|NCT01344226|75999895|FG000|COMPLETED|Overall Study||41||
59875926|NCT01344226|75999895|FG000|NOT COMPLETED|Overall Study||8||
59875927|NCT02869438|75999901|FG000|STARTED|Overall Study||118||
59875928|NCT02869438|75999902|FG001|STARTED|Overall Study||115||
59875929|NCT02869438|75999901|FG000|COMPLETED|Overall Study||115||
59748446|NCT00726232|75867573|FG001|Safety Evaluable Participants|Initial Phase (Dose-finding)||8||
59748447|NCT00726232|75867574|FG002|Safety Evaluable Participants|Initial Phase (Dose-finding)||7||
59748448|NCT00726232|75867575|FG003|Safety Evaluable Participants|Initial Phase (Dose-finding)||8||
59748449|NCT00726232|75867576|FG004|Safety Evaluable Participants|Initial Phase (Dose-finding)||22||
59748450|NCT00726232|75867577|FG005|Safety Evaluable Participants|Initial Phase (Dose-finding)||9||
59748451|NCT00726232|75867578|FG006|Safety Evaluable Participants|Initial Phase (Dose-finding)||0||
59875930|NCT02869438|75999902|FG001|COMPLETED|Overall Study||113||
59875931|NCT02869438|75999901|FG000|NOT COMPLETED|Overall Study||3||
59875932|NCT02869438|75999902|FG001|NOT COMPLETED|Overall Study||2||
59875933|NCT02868892|75999908|FG000|STARTED|Overall Study||6||
59875934|NCT02868892|75999908|FG000|COMPLETED|Overall Study||0||
59875935|NCT02868892|75999908|FG000|NOT COMPLETED|Overall Study||6||
59875936|NCT03352557|75999917|FG000|STARTED|PC Period: Day 1 to Week 78||214||
59875937|NCT03352557|75999918|FG001|STARTED|PC Period: Day 1 to Week 78||58||
59875938|NCT03352557|75999919|FG002|STARTED|PC Period: Day 1 to Week 78||58||
59748452|NCT00726232|75867579|FG007|Safety Evaluable Participants|Initial Phase (Dose-finding)||0||
59875939|NCT03352557|75999920|FG003|STARTED|PC Period: Day 1 to Week 78||106||
59748453|NCT00726232|75867572|FG000|ITT Participants|Initial Phase (Dose-finding)||19||
59748454|NCT00726232|75867573|FG001|ITT Participants|Initial Phase (Dose-finding)||8||
59748455|NCT00726232|75867574|FG002|ITT Participants|Initial Phase (Dose-finding)||7||
59748456|NCT00726232|75867575|FG003|ITT Participants|Initial Phase (Dose-finding)||8||
59748457|NCT00726232|75867576|FG004|ITT Participants|Initial Phase (Dose-finding)||22||
59748458|NCT00726232|75867577|FG005|ITT Participants|Initial Phase (Dose-finding)||9||
59748459|NCT00726232|75867578|FG006|ITT Participants|Initial Phase (Dose-finding)||0||
59748460|NCT00726232|75867579|FG007|ITT Participants|Initial Phase (Dose-finding)||0||
59748461|NCT00726232|75867572|FG000|COMPLETED|Initial Phase (Dose-finding)||6|Represents participants ongoing treatment.|
59748462|NCT00726232|75867573|FG001|COMPLETED|Initial Phase (Dose-finding)||2|Represents participants ongoing treatment.|
59762504|NCT00866619|75882226|FG000|NOT COMPLETED|Overall Study||1846||
59875940|NCT03352557|75999921|FG004|STARTED|PC Period: Day 1 to Week 78||218||
59875941|NCT03352557|75999922|FG005|STARTED|PC Period: Day 1 to Week 78||0||
59875942|NCT03352557|75999923|FG006|STARTED|PC Period: Day 1 to Week 78||0||
59875943|NCT03352557|75999924|FG007|STARTED|PC Period: Day 1 to Week 78||0||
59875944|NCT03352557|75999925|FG008|STARTED|PC Period: Day 1 to Week 78||0||
59748463|NCT00726232|75867574|FG002|COMPLETED|Initial Phase (Dose-finding)||2|Represents participants ongoing treatment.|
59748464|NCT00726232|75867575|FG003|COMPLETED|Initial Phase (Dose-finding)||0|Represents participants ongoing treatment.|
59748465|NCT00726232|75867576|FG004|COMPLETED|Initial Phase (Dose-finding)||1|Represents participants ongoing treatment.|
59748466|NCT00726232|75867577|FG005|COMPLETED|Initial Phase (Dose-finding)||0|Represents participants ongoing treatment.|
59748467|NCT00726232|75867578|FG006|COMPLETED|Initial Phase (Dose-finding)||0|Represents participants ongoing treatment.|
59748468|NCT00726232|75867579|FG007|COMPLETED|Initial Phase (Dose-finding)||0|Represents participants ongoing treatment.|
59748469|NCT00726232|75867572|FG000|NOT COMPLETED|Initial Phase (Dose-finding)||13||
59748470|NCT00726232|75867573|FG001|NOT COMPLETED|Initial Phase (Dose-finding)||6||
59748471|NCT00726232|75867574|FG002|NOT COMPLETED|Initial Phase (Dose-finding)||5||
59748472|NCT00726232|75867575|FG003|NOT COMPLETED|Initial Phase (Dose-finding)||8||
59748473|NCT00726232|75867576|FG004|NOT COMPLETED|Initial Phase (Dose-finding)||21||
59748474|NCT00726232|75867577|FG005|NOT COMPLETED|Initial Phase (Dose-finding)||9||
59748475|NCT00726232|75867578|FG006|NOT COMPLETED|Initial Phase (Dose-finding)||0||
59748476|NCT00726232|75867579|FG007|NOT COMPLETED|Initial Phase (Dose-finding)||0||
59748477|NCT00726232|75867572|FG000|STARTED|Expansion Phase||0||
59748478|NCT00726232|75867573|FG001|STARTED|Expansion Phase||0||
59748479|NCT00726232|75867574|FG002|STARTED|Expansion Phase||0||
59748480|NCT00726232|75867575|FG003|STARTED|Expansion Phase||0||
59748481|NCT00726232|75867576|FG004|STARTED|Expansion Phase||0||
59748482|NCT00726232|75867577|FG005|STARTED|Expansion Phase||0||
59748483|NCT00726232|75867578|FG006|STARTED|Expansion Phase||34||
59748484|NCT00726232|75867579|FG007|STARTED|Expansion Phase||39||
59748485|NCT00726232|75867572|FG000|Safety Evaluable Participants|Expansion Phase||0||
59748486|NCT00726232|75867573|FG001|Safety Evaluable Participants|Expansion Phase||0||
59748487|NCT00726232|75867574|FG002|Safety Evaluable Participants|Expansion Phase||0||
59748488|NCT00726232|75867575|FG003|Safety Evaluable Participants|Expansion Phase||0||
59748489|NCT00726232|75867576|FG004|Safety Evaluable Participants|Expansion Phase||0||
59748490|NCT00726232|75867577|FG005|Safety Evaluable Participants|Expansion Phase||0||
59748491|NCT00726232|75867578|FG006|Safety Evaluable Participants|Expansion Phase||34||
59748492|NCT00726232|75867579|FG007|Safety Evaluable Participants|Expansion Phase||39||
59748493|NCT00726232|75867572|FG000|ITT Participants|Expansion Phase||0||
59748494|NCT00726232|75867573|FG001|ITT Participants|Expansion Phase||0||
59748495|NCT00726232|75867574|FG002|ITT Participants|Expansion Phase||0||
59748496|NCT00726232|75867575|FG003|ITT Participants|Expansion Phase||0||
59748497|NCT00726232|75867576|FG004|ITT Participants|Expansion Phase||0||
59748498|NCT00726232|75867577|FG005|ITT Participants|Expansion Phase||0||
59748499|NCT00726232|75867578|FG006|ITT Participants|Expansion Phase||34||
59748500|NCT00726232|75867579|FG007|ITT Participants|Expansion Phase||39||
59748501|NCT00726232|75867572|FG000|COMPLETED|Expansion Phase||0|Participants ongoing: last patient last visit (LPLV) occurred 20AUG2018 following the data cutoff.|
59748502|NCT00726232|75867573|FG001|COMPLETED|Expansion Phase||0|Participants ongoing: last patient last visit (LPLV) occurred 20AUG2018 following the data cutoff.|
59748503|NCT00726232|75867574|FG002|COMPLETED|Expansion Phase||0|Participants ongoing: last patient last visit (LPLV) occurred 20AUG2018 following the data cutoff.|
59748504|NCT00726232|75867575|FG003|COMPLETED|Expansion Phase||0|Participants ongoing: last patient last visit (LPLV) occurred 20AUG2018 following the data cutoff.|
59748505|NCT00726232|75867576|FG004|COMPLETED|Expansion Phase||0|Participants ongoing: last patient last visit (LPLV) occurred 20AUG2018 following the data cutoff.|
59748506|NCT00726232|75867577|FG005|COMPLETED|Expansion Phase||0|Participants ongoing: last patient last visit (LPLV) occurred 20AUG2018 following the data cutoff.|
59748507|NCT00726232|75867578|FG006|COMPLETED|Expansion Phase||10|Participants ongoing: last patient last visit (LPLV) occurred 20AUG2018 following the data cutoff.|
59748508|NCT00726232|75867579|FG007|COMPLETED|Expansion Phase||1|Participants ongoing: last patient last visit (LPLV) occurred 20AUG2018 following the data cutoff.|
59748509|NCT00726232|75867572|FG000|NOT COMPLETED|Expansion Phase||0||
59748510|NCT00726232|75867573|FG001|NOT COMPLETED|Expansion Phase||0||
59748511|NCT00726232|75867574|FG002|NOT COMPLETED|Expansion Phase||0||
59748512|NCT00726232|75867575|FG003|NOT COMPLETED|Expansion Phase||0||
59748513|NCT00726232|75867576|FG004|NOT COMPLETED|Expansion Phase||0||
59748514|NCT00726232|75867577|FG005|NOT COMPLETED|Expansion Phase||0||
59748515|NCT00726232|75867578|FG006|NOT COMPLETED|Expansion Phase||24||
59748516|NCT00726232|75867579|FG007|NOT COMPLETED|Expansion Phase||38||
59748517|NCT00720382|75867600|FG000|STARTED|Overall Study||466||
59748518|NCT00720382|75867601|FG001|STARTED|Overall Study||237||
59748519|NCT00720382|75867600|FG000|COMPLETED|Overall Study||290||
59748520|NCT00720382|75867601|FG001|COMPLETED|Overall Study||178||
59748521|NCT00720382|75867600|FG000|NOT COMPLETED|Overall Study||176||
59748522|NCT00720382|75867601|FG001|NOT COMPLETED|Overall Study||59||
59748523|NCT00720226|75867609|FG000|STARTED|Overall Study||54||
59748524|NCT00720226|75867610|FG001|STARTED|Overall Study||52||
59748525|NCT00720226|75867609|FG000|COMPLETED|Overall Study|Participants not completing did not have 12 month CT scan|47||
59748526|NCT00720226|75867610|FG001|COMPLETED|Overall Study|Participants not completing did not have 12 month CT scan|48||
59748527|NCT00720226|75867609|FG000|NOT COMPLETED|Overall Study||7||
59748528|NCT00720226|75867610|FG001|NOT COMPLETED|Overall Study||4||
59748529|NCT00725920|75867618|FG000|STARTED|Overall Study||17||
59748530|NCT00725920|75867619|FG001|STARTED|Overall Study||18||
59875945|NCT03352557|75999926|FG009|STARTED|PC Period: Day 1 to Week 78||0||
59875946|NCT03352557|75999917|FG000|Safety Analysis Set|PC Period: Day 1 to Week 78||214|Safety Analysis Set = Dosed Participants|
59875947|NCT03352557|75999918|FG001|Safety Analysis Set|PC Period: Day 1 to Week 78||58|Safety Analysis Set = Dosed Participants|
59875948|NCT03352557|75999919|FG002|Safety Analysis Set|PC Period: Day 1 to Week 78||58|Safety Analysis Set = Dosed Participants|
59875949|NCT03352557|75999920|FG003|Safety Analysis Set|PC Period: Day 1 to Week 78||106|Safety Analysis Set = Dosed Participants|
59875950|NCT03352557|75999921|FG004|Safety Analysis Set|PC Period: Day 1 to Week 78||214|Safety Analysis Set = Dosed Participants|
59875951|NCT03352557|75999922|FG005|Safety Analysis Set|PC Period: Day 1 to Week 78||0|Safety Analysis Set = Dosed Participants|
59875952|NCT03352557|75999923|FG006|Safety Analysis Set|PC Period: Day 1 to Week 78||0|Safety Analysis Set = Dosed Participants|
59875953|NCT03352557|75999924|FG007|Safety Analysis Set|PC Period: Day 1 to Week 78||0|Safety Analysis Set = Dosed Participants|
59875954|NCT03352557|75999925|FG008|Safety Analysis Set|PC Period: Day 1 to Week 78||0|Safety Analysis Set = Dosed Participants|
59875955|NCT03352557|75999926|FG009|Safety Analysis Set|PC Period: Day 1 to Week 78||0|Safety Analysis Set = Dosed Participants|
59875956|NCT03352557|75999917|FG000|Full Analysis Set (FAS)|PC Period: Day 1 to Week 78||214||
59875957|NCT03352557|75999918|FG001|Full Analysis Set (FAS)|PC Period: Day 1 to Week 78||58||
59875958|NCT03352557|75999919|FG002|Full Analysis Set (FAS)|PC Period: Day 1 to Week 78||58||
59875959|NCT03352557|75999920|FG003|Full Analysis Set (FAS)|PC Period: Day 1 to Week 78||106||
59875960|NCT03352557|75999921|FG004|Full Analysis Set (FAS)|PC Period: Day 1 to Week 78||214||
59875961|NCT03352557|75999922|FG005|Full Analysis Set (FAS)|PC Period: Day 1 to Week 78||0||
59875962|NCT03352557|75999923|FG006|Full Analysis Set (FAS)|PC Period: Day 1 to Week 78||0||
59875963|NCT03352557|75999924|FG007|Full Analysis Set (FAS)|PC Period: Day 1 to Week 78||0||
59875964|NCT03352557|75999925|FG008|Full Analysis Set (FAS)|PC Period: Day 1 to Week 78||0||
59875965|NCT03352557|75999926|FG009|Full Analysis Set (FAS)|PC Period: Day 1 to Week 78||0||
59875966|NCT03352557|75999917|FG000|Antidrug Antibody (ADA) Evaluable Set|PC Period: Day 1 to Week 78||211||
59875967|NCT03352557|75999918|FG001|Antidrug Antibody (ADA) Evaluable Set|PC Period: Day 1 to Week 78||57||
59875968|NCT03352557|75999919|FG002|Antidrug Antibody (ADA) Evaluable Set|PC Period: Day 1 to Week 78||57||
59875969|NCT03352557|75999920|FG003|Antidrug Antibody (ADA) Evaluable Set|PC Period: Day 1 to Week 78||105||
59875970|NCT03352557|75999921|FG004|Antidrug Antibody (ADA) Evaluable Set|PC Period: Day 1 to Week 78||212||
59875971|NCT03352557|75999922|FG005|Antidrug Antibody (ADA) Evaluable Set|PC Period: Day 1 to Week 78||0||
59875972|NCT03352557|75999923|FG006|Antidrug Antibody (ADA) Evaluable Set|PC Period: Day 1 to Week 78||0||
59875973|NCT03352557|75999924|FG007|Antidrug Antibody (ADA) Evaluable Set|PC Period: Day 1 to Week 78||0||
59875974|NCT03352557|75999925|FG008|Antidrug Antibody (ADA) Evaluable Set|PC Period: Day 1 to Week 78||0||
59875975|NCT03352557|75999926|FG009|Antidrug Antibody (ADA) Evaluable Set|PC Period: Day 1 to Week 78||0||
59875976|NCT03352557|75999917|FG000|COMPLETED|PC Period: Day 1 to Week 78||172||
59875977|NCT03352557|75999918|FG001|COMPLETED|PC Period: Day 1 to Week 78||48||
59875978|NCT03352557|75999919|FG002|COMPLETED|PC Period: Day 1 to Week 78||50||
59875979|NCT03352557|75999920|FG003|COMPLETED|PC Period: Day 1 to Week 78||91||
59875980|NCT03352557|75999921|FG004|COMPLETED|PC Period: Day 1 to Week 78||175||
59875981|NCT03352557|75999922|FG005|COMPLETED|PC Period: Day 1 to Week 78||0||
59875982|NCT03352557|75999923|FG006|COMPLETED|PC Period: Day 1 to Week 78||0||
59875983|NCT03352557|75999924|FG007|COMPLETED|PC Period: Day 1 to Week 78||0||
59875984|NCT03352557|75999925|FG008|COMPLETED|PC Period: Day 1 to Week 78||0||
59875985|NCT03352557|75999926|FG009|COMPLETED|PC Period: Day 1 to Week 78||0||
59875986|NCT03352557|75999917|FG000|NOT COMPLETED|PC Period: Day 1 to Week 78||42||
59875987|NCT03352557|75999918|FG001|NOT COMPLETED|PC Period: Day 1 to Week 78||10||
59875988|NCT03352557|75999919|FG002|NOT COMPLETED|PC Period: Day 1 to Week 78||8||
59875989|NCT03352557|75999920|FG003|NOT COMPLETED|PC Period: Day 1 to Week 78||15||
59875990|NCT03352557|75999921|FG004|NOT COMPLETED|PC Period: Day 1 to Week 78||43||
59875991|NCT03352557|75999922|FG005|NOT COMPLETED|PC Period: Day 1 to Week 78||0||
59875992|NCT03352557|75999923|FG006|NOT COMPLETED|PC Period: Day 1 to Week 78||0||
59875993|NCT03352557|75999924|FG007|NOT COMPLETED|PC Period: Day 1 to Week 78||0||
59875994|NCT03352557|75999925|FG008|NOT COMPLETED|PC Period: Day 1 to Week 78||0||
59875995|NCT03352557|75999926|FG009|NOT COMPLETED|PC Period: Day 1 to Week 78||0||
59875996|NCT03352557|75999917|FG000|STARTED|LTE Period: Week 80 to Week 173||0||
59875997|NCT03352557|75999918|FG001|STARTED|LTE Period: Week 80 to Week 173||0||
59875998|NCT03352557|75999919|FG002|STARTED|LTE Period: Week 80 to Week 173||0||
59875999|NCT03352557|75999920|FG003|STARTED|LTE Period: Week 80 to Week 173||0||
59876000|NCT03352557|75999921|FG004|STARTED|LTE Period: Week 80 to Week 173||0||
59876001|NCT03352557|75999922|FG005|STARTED|LTE Period: Week 80 to Week 173|2 PC completers did not enter LTE.|46||
59876002|NCT03352557|75999923|FG006|STARTED|LTE Period: Week 80 to Week 173|1 PC completer did not enter LTE.|49||
59876003|NCT03352557|75999924|FG007|STARTED|LTE Period: Week 80 to Week 173|1 PC completer did not enter LTE.|90||
59876004|NCT03352557|75999925|FG008|STARTED|LTE Period: Week 80 to Week 173|6 PC completers did not enter LTE.|169||
59876005|NCT03352557|75999926|FG009|STARTED|LTE Period: Week 80 to Week 173|5 PC completers did not enter LTE.|167||
59876006|NCT03352557|75999917|FG000|Safety Analysis Set|LTE Period: Week 80 to Week 173||0|Safety Analysis Set = Dosed Participants|
59876007|NCT03352557|75999918|FG001|Safety Analysis Set|LTE Period: Week 80 to Week 173||0|Safety Analysis Set = Dosed Participants|
59950750|NCT03225287|76069596|FG000|STARTED|Overall Study||10||
59876008|NCT03352557|75999919|FG002|Safety Analysis Set|LTE Period: Week 80 to Week 173||0|Safety Analysis Set = Dosed Participants|
59876009|NCT03352557|75999920|FG003|Safety Analysis Set|LTE Period: Week 80 to Week 173||0|Safety Analysis Set = Dosed Participants|
59876010|NCT03352557|75999921|FG004|Safety Analysis Set|LTE Period: Week 80 to Week 173||0|Safety Analysis Set = Dosed Participants|
59876011|NCT03352557|75999922|FG005|Safety Analysis Set|LTE Period: Week 80 to Week 173||45|Safety Analysis Set = Dosed Participants|
59876012|NCT03352557|75999923|FG006|Safety Analysis Set|LTE Period: Week 80 to Week 173||49|Safety Analysis Set = Dosed Participants|
59876013|NCT03352557|75999924|FG007|Safety Analysis Set|LTE Period: Week 80 to Week 173||89|Safety Analysis Set = Dosed Participants|
59876014|NCT03352557|75999925|FG008|Safety Analysis Set|LTE Period: Week 80 to Week 173||168|Safety Analysis Set = Dosed Participants|
59876015|NCT03352557|75999926|FG009|Safety Analysis Set|LTE Period: Week 80 to Week 173||165|Safety Analysis Set = Dosed Participants|
59876016|NCT03352557|75999917|FG000|COMPLETED|LTE Period: Week 80 to Week 173||0||
59876017|NCT03352557|75999918|FG001|COMPLETED|LTE Period: Week 80 to Week 173||0||
59876018|NCT03352557|75999919|FG002|COMPLETED|LTE Period: Week 80 to Week 173||0||
59876019|NCT03352557|75999920|FG003|COMPLETED|LTE Period: Week 80 to Week 173||0||
59876020|NCT03352557|75999921|FG004|COMPLETED|LTE Period: Week 80 to Week 173||0||
59876021|NCT03352557|75999922|FG005|COMPLETED|LTE Period: Week 80 to Week 173||0||
59876022|NCT03352557|75999923|FG006|COMPLETED|LTE Period: Week 80 to Week 173||0||
59876023|NCT03352557|75999924|FG007|COMPLETED|LTE Period: Week 80 to Week 173||0||
59876024|NCT03352557|75999925|FG008|COMPLETED|LTE Period: Week 80 to Week 173||0||
59876025|NCT03352557|75999926|FG009|COMPLETED|LTE Period: Week 80 to Week 173||0||
59876026|NCT03352557|75999917|FG000|NOT COMPLETED|LTE Period: Week 80 to Week 173||0||
59876027|NCT03352557|75999918|FG001|NOT COMPLETED|LTE Period: Week 80 to Week 173||0||
59876028|NCT03352557|75999919|FG002|NOT COMPLETED|LTE Period: Week 80 to Week 173||0||
59876029|NCT03352557|75999920|FG003|NOT COMPLETED|LTE Period: Week 80 to Week 173||0||
59876030|NCT03352557|75999921|FG004|NOT COMPLETED|LTE Period: Week 80 to Week 173||0||
59876031|NCT03352557|75999922|FG005|NOT COMPLETED|LTE Period: Week 80 to Week 173||46||
59876032|NCT03352557|75999923|FG006|NOT COMPLETED|LTE Period: Week 80 to Week 173||49||
59876033|NCT03352557|75999924|FG007|NOT COMPLETED|LTE Period: Week 80 to Week 173||90||
59876034|NCT03352557|75999925|FG008|NOT COMPLETED|LTE Period: Week 80 to Week 173||169||
59876035|NCT03352557|75999926|FG009|NOT COMPLETED|LTE Period: Week 80 to Week 173||167||
59876036|NCT02866942|75999951|FG000|STARTED|Overall Study||479||
59876037|NCT02866942|75999951|FG000|COMPLETED|Overall Study||478||
59876038|NCT02866942|75999951|FG000|NOT COMPLETED|Overall Study||1||
59876039|NCT03059355|75999962|FG000|STARTED|Overall Study||3||
59876040|NCT03059355|75999963|FG001|STARTED|Overall Study||3||
59876041|NCT03059355|75999964|FG002|STARTED|Overall Study||3||
59876042|NCT03059355|75999965|FG003|STARTED|Overall Study||3||
59748531|NCT00725920|75867618|FG000|COMPLETED|Overall Study||14||
59748532|NCT00725920|75867619|FG001|COMPLETED|Overall Study||12||
59748533|NCT00725920|75867618|FG000|NOT COMPLETED|Overall Study||3||
59748534|NCT00725920|75867619|FG001|NOT COMPLETED|Overall Study||6||
59748535|NCT00725842|75867625|FG000|STARTED|Overall Study||97||
59876043|NCT03059355|75999966|FG004|STARTED|Overall Study||0||
59876044|NCT03059355|75999967|FG005|STARTED|Overall Study||2||
59876045|NCT03059355|75999968|FG006|STARTED|Overall Study||0||
59876046|NCT03059355|75999962|FG000|COMPLETED|Overall Study||3||
59876047|NCT03059355|75999963|FG001|COMPLETED|Overall Study||3||
59876048|NCT03059355|75999964|FG002|COMPLETED|Overall Study||3||
59605367|NCT01994382|75715560|FG000|STARTED|Overall Study||3||
59605368|NCT01994382|75715561|FG001|STARTED|Overall Study||6||
59748536|NCT00725842|75867625|FG000|Participants Eligible for Analysis|Overall Study||90||
59748537|NCT00725842|75867625|FG000|COMPLETED|Overall Study||57||
59876049|NCT03059355|75999965|FG003|COMPLETED|Overall Study||3||
59876050|NCT03059355|75999966|FG004|COMPLETED|Overall Study||0||
59605369|NCT01994382|75715562|FG002|STARTED|Overall Study||7||
59605370|NCT01994382|75715563|FG003|STARTED|Overall Study||3||
59876051|NCT03059355|75999967|FG005|COMPLETED|Overall Study||2||
59876052|NCT03059355|75999968|FG006|COMPLETED|Overall Study||0||
59876053|NCT03059355|75999962|FG000|NOT COMPLETED|Overall Study||0||
59876054|NCT03059355|75999963|FG001|NOT COMPLETED|Overall Study||0||
59876055|NCT03059355|75999964|FG002|NOT COMPLETED|Overall Study||0||
59876056|NCT03059355|75999965|FG003|NOT COMPLETED|Overall Study||0||
59876057|NCT03059355|75999966|FG004|NOT COMPLETED|Overall Study||0||
59876058|NCT03059355|75999967|FG005|NOT COMPLETED|Overall Study||0||
59876059|NCT03059355|75999968|FG006|NOT COMPLETED|Overall Study||0||
59748538|NCT00725842|75867625|FG000|NOT COMPLETED|Overall Study||40||
59748539|NCT00725764|75867629|FG000|STARTED|Overall Study||14||
59876060|NCT04974489|75999990|FG000|STARTED|Overall Study||285|Participants included in the sample sent from the panel provider to the study team.|
59876061|NCT04974489|75999991|FG001|STARTED|Overall Study||274|Participants included in the sample sent from the panel provider to the study team.|
59876062|NCT04974489|75999992|FG002|STARTED|Overall Study||288|Participants included in the sample sent from the panel provider to the study team.|
59876063|NCT04974489|75999993|FG003|STARTED|Overall Study||285|Participants included in the sample sent from the panel provider to the study team.|
59876064|NCT04974489|75999990|FG000|COMPLETED|Overall Study||262||
59876065|NCT04974489|75999991|FG001|COMPLETED|Overall Study||261||
59876066|NCT04974489|75999992|FG002|COMPLETED|Overall Study||263||
59748540|NCT00725764|75867629|FG000|COMPLETED|Overall Study||0||
59748541|NCT00725764|75867629|FG000|NOT COMPLETED|Overall Study||14||
59748542|NCT00725608|75867634|FG000|STARTED|Overall Study|339 patients enrolled, 32 non-eligible datasets excluded from final general and safety analysis|307||
59876067|NCT04974489|75999993|FG003|COMPLETED|Overall Study||267||
59876068|NCT04974489|75999990|FG000|NOT COMPLETED|Overall Study||23||
59876069|NCT04974489|75999991|FG001|NOT COMPLETED|Overall Study||13||
59876070|NCT04974489|75999992|FG002|NOT COMPLETED|Overall Study||25||
59876071|NCT04974489|75999993|FG003|NOT COMPLETED|Overall Study||18||
59876072|NCT01336894|76000005|FG000|STARTED|Protocol Interventions||4||
59876073|NCT01336894|76000006|FG001|STARTED|Protocol Interventions||7||
59876074|NCT01336894|76000005|FG000|COMPLETED|Protocol Interventions||4||
59876075|NCT01336894|76000006|FG001|COMPLETED|Protocol Interventions||7||
59876076|NCT01336894|76000005|FG000|NOT COMPLETED|Protocol Interventions||0||
59876077|NCT01336894|76000006|FG001|NOT COMPLETED|Protocol Interventions||0||
59876078|NCT01336894|76000005|FG000|STARTED|Follow-up||4||
59876079|NCT01336894|76000006|FG001|STARTED|Follow-up||7||
59876080|NCT01336894|76000005|FG000|COMPLETED|Follow-up||2||
59876081|NCT01336894|76000006|FG001|COMPLETED|Follow-up||0||
59876082|NCT01336894|76000005|FG000|NOT COMPLETED|Follow-up||2||
59876083|NCT01336894|76000006|FG001|NOT COMPLETED|Follow-up||7||
59876084|NCT02572167|76000015|FG000|STARTED|Overall Study||6||
59876085|NCT02572167|76000016|FG001|STARTED|Overall Study||56||
59876086|NCT02572167|76000017|FG002|STARTED|Overall Study||31||
59748543|NCT00725608|75867634|FG000|COMPLETED|Overall Study|1 patient terminated treatment at day 368 and was counted as dropout|140||
59748544|NCT00725608|75867634|FG000|NOT COMPLETED|Overall Study||167||
59748545|NCT00725452|75867638|FG000|STARTED|Overall Study||26||
59748546|NCT00725452|75867638|FG000|COMPLETED|Overall Study|Completed was defined as the number of participants who received 9 consecutive Infliximab infusions.|15||
59748547|NCT00725452|75867638|FG000|NOT COMPLETED|Overall Study||11||
59748548|NCT00725296|75867642|FG000|STARTED|Overall Study|163 of the 178 enrolled participants received at least one dose of Infliximab.|163||
59748549|NCT00725296|75867642|FG000|COMPLETED|Overall Study|Completed was defined as the number of participants who received 9 consecutive infusions.|101||
59748550|NCT00725296|75867642|FG000|NOT COMPLETED|Overall Study||62||
59748551|NCT00719680|75867647|FG000|STARTED|Overall Study||21||
59748552|NCT00719680|75867647|FG000|COMPLETED|Overall Study||16||
59748553|NCT00719680|75867647|FG000|NOT COMPLETED|Overall Study||5||
59748554|NCT00719212|75867651|FG000|STARTED|Overall Study||61||
59748555|NCT00719212|75867651|FG000|COMPLETED|Overall Study||17||
59748556|NCT00719212|75867651|FG000|NOT COMPLETED|Overall Study||44||
59876087|NCT02572167|76000015|FG000|COMPLETED|Overall Study||0||
59876088|NCT02572167|76000016|FG001|COMPLETED|Overall Study||0||
59876089|NCT02572167|76000017|FG002|COMPLETED|Overall Study||0||
59876090|NCT02572167|76000015|FG000|NOT COMPLETED|Overall Study||6||
59876091|NCT02572167|76000016|FG001|NOT COMPLETED|Overall Study||56||
59876092|NCT02572167|76000017|FG002|NOT COMPLETED|Overall Study||31||
59876093|NCT01336738|76000031|FG000|STARTED|Overall Study||52||
59876094|NCT01336738|76000032|FG001|STARTED|Overall Study||54||
59876095|NCT01336738|76000033|FG002|STARTED|Overall Study||53||
59876096|NCT01336738|76000034|FG003|STARTED|Overall Study||54||
59876097|NCT01336738|76000035|FG004|STARTED|Overall Study||53||
59876098|NCT01336738|76000031|FG000|COMPLETED|Overall Study||45||
59876099|NCT01336738|76000032|FG001|COMPLETED|Overall Study||45||
59876100|NCT01336738|76000033|FG002|COMPLETED|Overall Study||45||
59876101|NCT01336738|76000034|FG003|COMPLETED|Overall Study||47||
59876102|NCT01336738|76000035|FG004|COMPLETED|Overall Study||43||
59876103|NCT01336738|76000031|FG000|NOT COMPLETED|Overall Study||7||
59876104|NCT01336738|76000032|FG001|NOT COMPLETED|Overall Study||9||
59876105|NCT01336738|76000033|FG002|NOT COMPLETED|Overall Study||8||
59876106|NCT01336738|76000034|FG003|NOT COMPLETED|Overall Study||7||
59748557|NCT00585052|75867655|FG000|STARTED|Overall Study||11||
59748558|NCT00585052|75867655|FG000|COMPLETED|Overall Study||10||
59748559|NCT00585052|75867655|FG000|NOT COMPLETED|Overall Study||1||
59748560|NCT00724282|75867659|FG000|STARTED|Overall Study||20||
59748561|NCT00724282|75867659|FG000|COMPLETED|Overall Study||16||
59748562|NCT00724282|75867659|FG000|NOT COMPLETED|Overall Study||4||
59748563|NCT00724126|75867665|FG000|STARTED|Overall Study||321||
59876107|NCT01336738|76000035|FG004|NOT COMPLETED|Overall Study||10||
59876108|NCT02865538|76000052|FG000|STARTED|Overall Study||18|76|
59876109|NCT02865538|76000053|FG001|STARTED|Overall Study||15|76|
59876110|NCT02865538|76000054|FG002|STARTED|Overall Study||15|76|
59876111|NCT02865538|76000055|FG003|STARTED|Overall Study||15|76|
59876112|NCT02865538|76000056|FG004|STARTED|Overall Study||13|76|
59876113|NCT02865538|76000052|FG000|COMPLETED|Overall Study||17|74|
59876114|NCT02865538|76000053|FG001|COMPLETED|Overall Study||15|74|
59876115|NCT02865538|76000054|FG002|COMPLETED|Overall Study||14|74|
59876116|NCT02865538|76000055|FG003|COMPLETED|Overall Study||15|74|
59876117|NCT02865538|76000056|FG004|COMPLETED|Overall Study||13|74|
59876118|NCT02865538|76000052|FG000|NOT COMPLETED|Overall Study||1||
59876119|NCT02865538|76000053|FG001|NOT COMPLETED|Overall Study||0||
59876120|NCT02865538|76000054|FG002|NOT COMPLETED|Overall Study||1||
59876121|NCT02865538|76000055|FG003|NOT COMPLETED|Overall Study||0||
59876122|NCT02865538|76000056|FG004|NOT COMPLETED|Overall Study||0||
59876123|NCT02860546|76000068|FG000|STARTED|Overall Study||18||
59876124|NCT02860546|76000068|FG000|COMPLETED|Overall Study||0||
59876125|NCT02860546|76000068|FG000|NOT COMPLETED|Overall Study||18||
59876126|NCT01982955|76000077|FG000|STARTED|Overall Study||6||
59876127|NCT01982955|76000078|FG001|STARTED|Overall Study||12||
59876128|NCT01982955|76000079|FG002|STARTED|Overall Study||31||
59876129|NCT01982955|76000080|FG003|STARTED|Overall Study||24||
59876130|NCT01982955|76000081|FG004|STARTED|Overall Study||15||
59876131|NCT01982955|76000077|FG000|Treated|Overall Study||6||
59876132|NCT01982955|76000078|FG001|Treated|Overall Study||12||
59876133|NCT01982955|76000079|FG002|Treated|Overall Study||31||
59876134|NCT01982955|76000080|FG003|Treated|Overall Study||23||
59876135|NCT01982955|76000081|FG004|Treated|Overall Study||15||
59876136|NCT01982955|76000077|FG000|COMPLETED|Overall Study||6||
59876137|NCT01982955|76000078|FG001|COMPLETED|Overall Study||12||
59876138|NCT01982955|76000079|FG002|COMPLETED|Overall Study||31||
59876139|NCT01982955|76000080|FG003|COMPLETED|Overall Study||23||
59876140|NCT01982955|76000081|FG004|COMPLETED|Overall Study||15||
59876141|NCT01982955|76000077|FG000|NOT COMPLETED|Overall Study||0||
59876142|NCT01982955|76000078|FG001|NOT COMPLETED|Overall Study||0||
59876143|NCT01982955|76000079|FG002|NOT COMPLETED|Overall Study||0||
59876144|NCT01982955|76000080|FG003|NOT COMPLETED|Overall Study||1||
59876145|NCT01982955|76000081|FG004|NOT COMPLETED|Overall Study||0||
59876146|NCT00396279|76000094|FG000|STARTED|Overall Study||37||
59876147|NCT00396279|76000094|FG000|COMPLETED|Overall Study|Defined as participants with a complete resection|7||
59876148|NCT00396279|76000094|FG000|NOT COMPLETED|Overall Study||30||
59876149|NCT01347866|76000115|FG000|STARTED|Overall Study||5||
59876150|NCT01347866|76000116|FG001|STARTED|Overall Study||1||
59876151|NCT01347866|76000117|FG002|STARTED|Overall Study||1||
59876152|NCT01347866|76000118|FG003|STARTED|Overall Study||7||
59876153|NCT01347866|76000119|FG004|STARTED|Overall Study||7||
59876154|NCT01347866|76000120|FG005|STARTED|Overall Study||3||
59876155|NCT01347866|76000121|FG006|STARTED|Overall Study||6||
59876156|NCT01347866|76000122|FG007|STARTED|Overall Study||4||
59876157|NCT01347866|76000123|FG008|STARTED|Overall Study||31||
59876158|NCT01347866|76000124|FG009|STARTED|Overall Study||7||
59876159|NCT01347866|76000125|FG010|STARTED|Overall Study||3||
59876160|NCT01347866|76000126|FG011|STARTED|Overall Study||4||
59876161|NCT01347866|76000127|FG012|STARTED|Overall Study||7||
59876162|NCT01347866|76000128|FG013|STARTED|Overall Study||7||
59876163|NCT01347866|76000129|FG014|STARTED|Overall Study||3||
59876164|NCT01347866|76000130|FG015|STARTED|Overall Study||4||
59876165|NCT01347866|76000131|FG016|STARTED|Overall Study||2||
59876166|NCT01347866|76000115|FG000|COMPLETED|Overall Study||0||
59876167|NCT01347866|76000116|FG001|COMPLETED|Overall Study||0||
59876168|NCT01347866|76000117|FG002|COMPLETED|Overall Study||0||
59876169|NCT01347866|76000118|FG003|COMPLETED|Overall Study||0||
59876170|NCT01347866|76000119|FG004|COMPLETED|Overall Study||0||
59876171|NCT01347866|76000120|FG005|COMPLETED|Overall Study||0||
59876172|NCT01347866|76000121|FG006|COMPLETED|Overall Study||0||
59876173|NCT01347866|76000122|FG007|COMPLETED|Overall Study||0||
59876174|NCT01347866|76000123|FG008|COMPLETED|Overall Study||0||
59748564|NCT00724126|75867666|FG001|STARTED|Overall Study||316||
59748565|NCT00724126|75867665|FG000|COMPLETED|Overall Study||302||
59748566|NCT00724126|75867666|FG001|COMPLETED|Overall Study||301||
59748567|NCT00724126|75867665|FG000|NOT COMPLETED|Overall Study||19||
59748568|NCT00724126|75867666|FG001|NOT COMPLETED|Overall Study||15||
59748569|NCT00723892|75867674|FG000|STARTED|Overall Study||313||
59876175|NCT01347866|76000124|FG009|COMPLETED|Overall Study||0||
59876176|NCT01347866|76000125|FG010|COMPLETED|Overall Study||0||
59876177|NCT01347866|76000126|FG011|COMPLETED|Overall Study||0||
59876178|NCT01347866|76000127|FG012|COMPLETED|Overall Study||0||
59876179|NCT01347866|76000128|FG013|COMPLETED|Overall Study||0||
59876180|NCT01347866|76000129|FG014|COMPLETED|Overall Study||0||
59876181|NCT01347866|76000130|FG015|COMPLETED|Overall Study||0||
59876182|NCT01347866|76000131|FG016|COMPLETED|Overall Study||0||
59876183|NCT01347866|76000115|FG000|NOT COMPLETED|Overall Study||5||
59876184|NCT01347866|76000116|FG001|NOT COMPLETED|Overall Study||1||
59876185|NCT01347866|76000117|FG002|NOT COMPLETED|Overall Study||1||
59876186|NCT01347866|76000118|FG003|NOT COMPLETED|Overall Study||7||
59876187|NCT01347866|76000119|FG004|NOT COMPLETED|Overall Study||7||
59876188|NCT01347866|76000120|FG005|NOT COMPLETED|Overall Study||3||
59876189|NCT01347866|76000121|FG006|NOT COMPLETED|Overall Study||6||
59876190|NCT01347866|76000122|FG007|NOT COMPLETED|Overall Study||4||
59876191|NCT01347866|76000123|FG008|NOT COMPLETED|Overall Study||31||
59876192|NCT01347866|76000124|FG009|NOT COMPLETED|Overall Study||7||
59748570|NCT00723892|75867675|FG001|STARTED|Overall Study||255||
59876193|NCT01347866|76000125|FG010|NOT COMPLETED|Overall Study||3||
59876194|NCT01347866|76000126|FG011|NOT COMPLETED|Overall Study||4||
59876195|NCT01347866|76000127|FG012|NOT COMPLETED|Overall Study||7||
59876196|NCT01347866|76000128|FG013|NOT COMPLETED|Overall Study||7||
59876197|NCT01347866|76000129|FG014|NOT COMPLETED|Overall Study||3||
59876198|NCT01347866|76000130|FG015|NOT COMPLETED|Overall Study||4||
59876199|NCT01347866|76000131|FG016|NOT COMPLETED|Overall Study||2||
59876200|NCT01347710|76000202|FG000|STARTED|Overall Study||795||
59876201|NCT01347710|76000202|FG000|COMPLETED|Overall Study||764||
59876202|NCT01347710|76000202|FG000|NOT COMPLETED|Overall Study||31||
59876203|NCT03485222|76000212|FG000|STARTED|Overall Study||42||
59876204|NCT03485222|76000213|FG001|STARTED|Overall Study||42||
59876205|NCT03485222|76000212|FG000|COMPLETED|Overall Study||40||
59876206|NCT03485222|76000213|FG001|COMPLETED|Overall Study||40||
59876207|NCT03485222|76000212|FG000|NOT COMPLETED|Overall Study||2||
59876208|NCT03485222|76000213|FG001|NOT COMPLETED|Overall Study||2||
59876209|NCT01347554|76000221|FG000|STARTED|Overall Study||237||
59876210|NCT01347554|76000222|FG001|STARTED|Overall Study||242||
59748571|NCT00723892|75867674|FG000|COMPLETED|Overall Study||206||
59748572|NCT00723892|75867675|FG001|COMPLETED|Overall Study||168||
59876211|NCT01347554|76000221|FG000|COMPLETED|Overall Study|Final TIMI flow grade 0 or 1 patients or failed PCI cases (N=7) were excluded.|230||
59876212|NCT01347554|76000222|FG001|COMPLETED|Overall Study|Final TIMI flow grade 0 or 1 patients or failed PCI cases (N=11) were excluded.|231||
59748573|NCT00723892|75867674|FG000|NOT COMPLETED|Overall Study||107||
59876213|NCT01347554|76000221|FG000|NOT COMPLETED|Overall Study||7||
59876214|NCT01347554|76000222|FG001|NOT COMPLETED|Overall Study||11||
59876215|NCT03482882|76000228|FG000|STARTED|Overall Study||47||
59876216|NCT03482882|76000228|FG000|COMPLETED|Overall Study||40||
59876217|NCT03482882|76000228|FG000|NOT COMPLETED|Overall Study||7||
59876218|NCT03480932|76000235|FG000|STARTED|Overall Study||50||
59876219|NCT03480932|76000236|FG001|STARTED|Overall Study||50||
59876220|NCT03480932|76000237|FG002|STARTED|Overall Study||50||
59876221|NCT03480932|76000235|FG000|COMPLETED|Overall Study||47||
59748574|NCT00723892|75867675|FG001|NOT COMPLETED|Overall Study||87||
59748575|NCT00718666|75867684|FG000|STARTED|Persistence Phase Year 1||118||
59748576|NCT00718666|75867685|FG001|STARTED|Persistence Phase Year 1||130||
59748577|NCT00718666|75867686|FG002|STARTED|Persistence Phase Year 1||0||
59876222|NCT03480932|76000236|FG001|COMPLETED|Overall Study||45||
59876223|NCT03480932|76000237|FG002|COMPLETED|Overall Study||45||
59876224|NCT03480932|76000235|FG000|NOT COMPLETED|Overall Study||3||
59876225|NCT03480932|76000236|FG001|NOT COMPLETED|Overall Study||5||
59876226|NCT03480932|76000237|FG002|NOT COMPLETED|Overall Study||5||
59876227|NCT03387020|76000248|FG000|STARTED|Overall Study||13||
59876228|NCT03387020|76000249|FG001|STARTED|Overall Study||3||
59876229|NCT03387020|76000250|FG002|STARTED|Overall Study||5||
59876230|NCT03387020|76000248|FG000|Received Treatment|Overall Study||12||
59748578|NCT00718666|75867684|FG000|COMPLETED|Persistence Phase Year 1||118||
59748579|NCT00718666|75867685|FG001|COMPLETED|Persistence Phase Year 1||130||
59748580|NCT00718666|75867686|FG002|COMPLETED|Persistence Phase Year 1|Subjects enrolled to receive Nimenrix vaccine as primary vaccination only at Booster Phase-Year 5.|0||
59748581|NCT00718666|75867684|FG000|NOT COMPLETED|Persistence Phase Year 1||0||
59748582|NCT00718666|75867685|FG001|NOT COMPLETED|Persistence Phase Year 1||0||
59748583|NCT00718666|75867686|FG002|NOT COMPLETED|Persistence Phase Year 1||0||
59748584|NCT00718666|75867684|FG000|STARTED|Persistence Phase Year 3||98||
59748585|NCT00718666|75867685|FG001|STARTED|Persistence Phase Year 3||104||
59748586|NCT00718666|75867686|FG002|STARTED|Persistence Phase Year 3||0||
59748587|NCT00718666|75867684|FG000|COMPLETED|Persistence Phase Year 3||98||
59748588|NCT00718666|75867685|FG001|COMPLETED|Persistence Phase Year 3||104||
59748589|NCT00718666|75867686|FG002|COMPLETED|Persistence Phase Year 3|Subjects enrolled to receive Nimenrix vaccine as primary vaccination only at Booster Phase-Year 5.|0||
59748590|NCT00718666|75867684|FG000|NOT COMPLETED|Persistence Phase Year 3||0||
59748591|NCT00718666|75867685|FG001|NOT COMPLETED|Persistence Phase Year 3||0||
59748592|NCT00718666|75867686|FG002|NOT COMPLETED|Persistence Phase Year 3||0||
59748593|NCT00718666|75867684|FG000|STARTED|Persistence Phase Year 5||70||
59748594|NCT00718666|75867685|FG001|STARTED|Persistence Phase Year 5||82||
59748595|NCT00718666|75867686|FG002|STARTED|Persistence Phase Year 5||0||
59748596|NCT00718666|75867684|FG000|COMPLETED|Persistence Phase Year 5||70||
59748597|NCT00718666|75867685|FG001|COMPLETED|Persistence Phase Year 5||82||
59748598|NCT00718666|75867686|FG002|COMPLETED|Persistence Phase Year 5|Subjects enrolled to receive Nimenrix vaccine as primary vaccination only at Booster Phase-Year 5.|0||
59748599|NCT00718666|75867684|FG000|NOT COMPLETED|Persistence Phase Year 5||0||
59748600|NCT00718666|75867685|FG001|NOT COMPLETED|Persistence Phase Year 5||0||
59748601|NCT00718666|75867686|FG002|NOT COMPLETED|Persistence Phase Year 5||0||
59748602|NCT00718666|75867684|FG000|STARTED|Booster Phase Year 5||38||
59748603|NCT00718666|75867685|FG001|STARTED|Booster Phase Year 5||46||
59748604|NCT00718666|75867686|FG002|STARTED|Booster Phase Year 5||100||
59748605|NCT00718666|75867684|FG000|COMPLETED|Booster Phase Year 5||36||
59748606|NCT00718666|75867685|FG001|COMPLETED|Booster Phase Year 5||46||
59748607|NCT00718666|75867686|FG002|COMPLETED|Booster Phase Year 5||94||
59748608|NCT00718666|75867684|FG000|NOT COMPLETED|Booster Phase Year 5||2||
59748609|NCT00718666|75867685|FG001|NOT COMPLETED|Booster Phase Year 5||0||
59748610|NCT00718666|75867686|FG002|NOT COMPLETED|Booster Phase Year 5||6||
59748611|NCT03950440|75867707|FG000|STARTED|Overall Study||84||
59748612|NCT03950440|75867708|FG001|STARTED|Overall Study||82||
59748613|NCT03950440|75867709|FG002|STARTED|Overall Study||84||
59748614|NCT03950440|75867707|FG000|Primary Analysis|Overall Study||84||
59748615|NCT03950440|75867708|FG001|Primary Analysis|Overall Study||82||
59748616|NCT03950440|75867709|FG002|Primary Analysis|Overall Study||84||
59748617|NCT03950440|75867707|FG000|1 Month Follow-up|Overall Study||80||
59748618|NCT03950440|75867708|FG001|1 Month Follow-up|Overall Study||82||
59748619|NCT03950440|75867709|FG002|1 Month Follow-up|Overall Study||84||
59748620|NCT03950440|75867707|FG000|COMPLETED|Overall Study||76|6 month follow-up|
59748621|NCT03950440|75867708|FG001|COMPLETED|Overall Study||80|6 month follow-up|
59748622|NCT03950440|75867709|FG002|COMPLETED|Overall Study||83|6 month follow-up|
59748623|NCT03950440|75867707|FG000|NOT COMPLETED|Overall Study||8||
59748624|NCT03950440|75867708|FG001|NOT COMPLETED|Overall Study||2||
59748625|NCT03950440|75867709|FG002|NOT COMPLETED|Overall Study||1||
59748626|NCT00718510|75867719|FG000|STARTED|First Intervention (3 Weeks)||7||
59748627|NCT00718510|75867720|FG001|STARTED|First Intervention (3 Weeks)||8||
59748628|NCT00718510|75867719|FG000|Received Intervention|First Intervention (3 Weeks)||7|Received Intervention|
59748629|NCT00718510|75867720|FG001|Received Intervention|First Intervention (3 Weeks)||7|Received Intervention|
59748630|NCT00718510|75867719|FG000|COMPLETED|First Intervention (3 Weeks)||7||
59748631|NCT00718510|75867720|FG001|COMPLETED|First Intervention (3 Weeks)||7||
59748632|NCT00718510|75867719|FG000|NOT COMPLETED|First Intervention (3 Weeks)||0||
59748633|NCT00718510|75867720|FG001|NOT COMPLETED|First Intervention (3 Weeks)||1||
59748634|NCT00718510|75867719|FG000|STARTED|Washout (5 Days)||7||
59748635|NCT00718510|75867720|FG001|STARTED|Washout (5 Days)||7||
59748636|NCT00718510|75867719|FG000|COMPLETED|Washout (5 Days)||7||
59748637|NCT00718510|75867720|FG001|COMPLETED|Washout (5 Days)||7||
59748638|NCT00718510|75867719|FG000|NOT COMPLETED|Washout (5 Days)||0||
59748639|NCT00718510|75867720|FG001|NOT COMPLETED|Washout (5 Days)||0||
59748640|NCT00718510|75867719|FG000|STARTED|Second Intervention (3 Weeks)||7||
59748641|NCT00718510|75867720|FG001|STARTED|Second Intervention (3 Weeks)||7||
59748642|NCT00718510|75867719|FG000|COMPLETED|Second Intervention (3 Weeks)||6||
59748643|NCT00718510|75867720|FG001|COMPLETED|Second Intervention (3 Weeks)||7||
59876231|NCT03387020|76000249|FG001|Received Treatment|Overall Study||3||
59876232|NCT03387020|76000250|FG002|Received Treatment|Overall Study||5||
59876233|NCT03387020|76000248|FG000|COMPLETED|Overall Study||11||
59876234|NCT03387020|76000249|FG001|COMPLETED|Overall Study||1||
59876235|NCT03387020|76000250|FG002|COMPLETED|Overall Study||5||
59876236|NCT03387020|76000248|FG000|NOT COMPLETED|Overall Study||2||
59876237|NCT03387020|76000249|FG001|NOT COMPLETED|Overall Study||2||
59876238|NCT03387020|76000250|FG002|NOT COMPLETED|Overall Study||0||
59876239|NCT03386474|76000270|FG000|STARTED|Overall Study||107||
59876240|NCT03386474|76000271|FG001|STARTED|Overall Study||43||
59876241|NCT03386474|76000270|FG000|COMPLETED|Overall Study||106|Completed exWeek 24|
59876242|NCT03386474|76000271|FG001|COMPLETED|Overall Study||42|Completed exWeek 24|
59876243|NCT03386474|76000270|FG000|NOT COMPLETED|Overall Study||1||
59876244|NCT03386474|76000271|FG001|NOT COMPLETED|Overall Study||1||
59876245|NCT03405818|76000282|FG000|STARTED|Overall Study||55||
59876246|NCT03405818|76000282|FG000|COMPLETED|Overall Study||47||
59876247|NCT03405818|76000282|FG000|NOT COMPLETED|Overall Study||8||
59876248|NCT03403634|76000286|FG000|STARTED|Overall Study|19 patients were accrued and completed consent.|19||
59876249|NCT03403634|76000286|FG000|Treated|Overall Study|4 patients became ineligible prior to the start of treatment.|15||
59876250|NCT03403634|76000286|FG000|COMPLETED|Overall Study||12||
59876251|NCT03403634|76000286|FG000|NOT COMPLETED|Overall Study||7||
59876252|NCT03403400|76000293|FG000|STARTED|Overall Study||5||
59876253|NCT03403400|76000294|FG001|STARTED|Overall Study||6||
59876254|NCT03403400|76000295|FG002|STARTED|Overall Study||6||
59876255|NCT03403400|76000293|FG000|COMPLETED|Overall Study||3||
59876256|NCT03403400|76000294|FG001|COMPLETED|Overall Study||6||
59876257|NCT03403400|76000295|FG002|COMPLETED|Overall Study||4||
59876258|NCT03403400|76000293|FG000|NOT COMPLETED|Overall Study||2||
59876259|NCT03403400|76000294|FG001|NOT COMPLETED|Overall Study||0||
59876260|NCT03403400|76000295|FG002|NOT COMPLETED|Overall Study||2||
59876261|NCT02863354|76000320|FG000|STARTED|Year 1||23||23
59876262|NCT02863354|76000321|FG001|STARTED|Year 1||20||20
59876263|NCT02863354|76000320|FG000|COMPLETED|Year 1||19||19
59876264|NCT02863354|76000321|FG001|COMPLETED|Year 1||18||18
59876265|NCT02863354|76000320|FG000|NOT COMPLETED|Year 1||4||4
59876266|NCT02863354|76000321|FG001|NOT COMPLETED|Year 1||2||2
59876267|NCT02863354|76000320|FG000|STARTED|Year 2||19||19
59876268|NCT02863354|76000321|FG001|STARTED|Year 2||18||18
59876269|NCT02863354|76000320|FG000|COMPLETED|Year 2||17||17
59876270|NCT02863354|76000321|FG001|COMPLETED|Year 2||16||16
59876271|NCT02863354|76000320|FG000|NOT COMPLETED|Year 2||2||2
59876272|NCT02863354|76000321|FG001|NOT COMPLETED|Year 2||2||2
59876273|NCT03480152|76000329|FG000|STARTED|Phase I||3||
59876274|NCT03480152|76000330|FG001|STARTED|Phase I||2||
59876275|NCT03480152|76000331|FG002|STARTED|Phase I||0||
59876276|NCT03480152|76000329|FG000|Received Intervention|Phase I||2||
59876277|NCT03480152|76000330|FG001|Received Intervention|Phase I||2||
59876278|NCT03480152|76000331|FG002|Received Intervention|Phase I||0||
59876279|NCT03480152|76000329|FG000|COMPLETED|Phase I||2||
59876280|NCT03480152|76000330|FG001|COMPLETED|Phase I||2||
59876281|NCT03480152|76000331|FG002|COMPLETED|Phase I||0||
59876282|NCT03480152|76000329|FG000|NOT COMPLETED|Phase I||1||
59876283|NCT03480152|76000330|FG001|NOT COMPLETED|Phase I||0||
59876284|NCT03480152|76000331|FG002|NOT COMPLETED|Phase I||0||
59876285|NCT03480152|76000329|FG000|STARTED|Phase II||0||
59876286|NCT03480152|76000330|FG001|STARTED|Phase II||0||
59876287|NCT03480152|76000331|FG002|STARTED|Phase II||0||
59876288|NCT03480152|76000329|FG000|COMPLETED|Phase II||0||
59876289|NCT03480152|76000330|FG001|COMPLETED|Phase II||0||
59876290|NCT03480152|76000331|FG002|COMPLETED|Phase II||0||
59876291|NCT03480152|76000329|FG000|NOT COMPLETED|Phase II||0||
59876292|NCT03480152|76000330|FG001|NOT COMPLETED|Phase II||0||
59876293|NCT03480152|76000331|FG002|NOT COMPLETED|Phase II||0||
59876294|NCT02859454|76000339|FG000|STARTED|Overall Study||13||
59876295|NCT02859454|76000339|FG000|COMPLETED|Overall Study||12||
59876296|NCT02859454|76000339|FG000|NOT COMPLETED|Overall Study||1||
59876297|NCT02862730|76000346|FG000|STARTED|Tslim Training Visit (2 Weeks)||4||
59876298|NCT02862730|76000347|FG001|STARTED|Tslim Training Visit (2 Weeks)||1||
59876299|NCT02862730|76000348|FG002|STARTED|Tslim Training Visit (2 Weeks)||8||
59876300|NCT02862730|76000349|FG003|STARTED|Tslim Training Visit (2 Weeks)||5||
59876301|NCT02862730|76000350|FG004|STARTED|Tslim Training Visit (2 Weeks)||5||
59876302|NCT02862730|76000351|FG005|STARTED|Tslim Training Visit (2 Weeks)||1||
59876303|NCT02862730|76000352|FG006|STARTED|Tslim Training Visit (2 Weeks)||1||
59876304|NCT02862730|76000346|FG000|COMPLETED|Tslim Training Visit (2 Weeks)||4||
59876305|NCT02862730|76000347|FG001|COMPLETED|Tslim Training Visit (2 Weeks)||1||
59876306|NCT02862730|76000348|FG002|COMPLETED|Tslim Training Visit (2 Weeks)||7||
59876307|NCT02862730|76000349|FG003|COMPLETED|Tslim Training Visit (2 Weeks)||5||
59876308|NCT02862730|76000350|FG004|COMPLETED|Tslim Training Visit (2 Weeks)||5||
59876309|NCT02862730|76000351|FG005|COMPLETED|Tslim Training Visit (2 Weeks)||1||
59876310|NCT02862730|76000352|FG006|COMPLETED|Tslim Training Visit (2 Weeks)||1||
59876311|NCT02862730|76000346|FG000|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0||
59876312|NCT02862730|76000347|FG001|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0||
59876313|NCT02862730|76000348|FG002|NOT COMPLETED|Tslim Training Visit (2 Weeks)||1||
59876314|NCT02862730|76000349|FG003|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0||
59876315|NCT02862730|76000350|FG004|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0||
59876316|NCT02862730|76000351|FG005|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0||
59876317|NCT02862730|76000352|FG006|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0||
59876318|NCT02862730|76000346|FG000|STARTED|First Rest Period (1-12 Weeks)||4||
59876319|NCT02862730|76000347|FG001|STARTED|First Rest Period (1-12 Weeks)||1||
59876320|NCT02862730|76000348|FG002|STARTED|First Rest Period (1-12 Weeks)||7||
59876321|NCT02862730|76000349|FG003|STARTED|First Rest Period (1-12 Weeks)||5||
59876322|NCT02862730|76000350|FG004|STARTED|First Rest Period (1-12 Weeks)||5||
59876323|NCT02862730|76000351|FG005|STARTED|First Rest Period (1-12 Weeks)||1||
59876324|NCT02862730|76000352|FG006|STARTED|First Rest Period (1-12 Weeks)||1||
59876325|NCT02862730|76000346|FG000|COMPLETED|First Rest Period (1-12 Weeks)||4||
59876326|NCT02862730|76000347|FG001|COMPLETED|First Rest Period (1-12 Weeks)||1||
59876327|NCT02862730|76000348|FG002|COMPLETED|First Rest Period (1-12 Weeks)||7||
59876328|NCT02862730|76000349|FG003|COMPLETED|First Rest Period (1-12 Weeks)||5||
59876329|NCT02862730|76000350|FG004|COMPLETED|First Rest Period (1-12 Weeks)||5||
59876330|NCT02862730|76000351|FG005|COMPLETED|First Rest Period (1-12 Weeks)||1||
59876331|NCT02862730|76000352|FG006|COMPLETED|First Rest Period (1-12 Weeks)||1||
59876332|NCT02862730|76000346|FG000|NOT COMPLETED|First Rest Period (1-12 Weeks)||0||
59876333|NCT02862730|76000347|FG001|NOT COMPLETED|First Rest Period (1-12 Weeks)||0||
59876334|NCT02862730|76000348|FG002|NOT COMPLETED|First Rest Period (1-12 Weeks)||0||
59876335|NCT02862730|76000349|FG003|NOT COMPLETED|First Rest Period (1-12 Weeks)||0||
59876336|NCT02862730|76000350|FG004|NOT COMPLETED|First Rest Period (1-12 Weeks)||0||
59876337|NCT02862730|76000351|FG005|NOT COMPLETED|First Rest Period (1-12 Weeks)||0||
59876338|NCT02862730|76000352|FG006|NOT COMPLETED|First Rest Period (1-12 Weeks)||0||
59876339|NCT02862730|76000346|FG000|STARTED|First Intervention (84 Hours)||4||
59876340|NCT02862730|76000347|FG001|STARTED|First Intervention (84 Hours)||1||
59876341|NCT02862730|76000348|FG002|STARTED|First Intervention (84 Hours)||7||
59876342|NCT02862730|76000349|FG003|STARTED|First Intervention (84 Hours)||5||
59876343|NCT02862730|76000350|FG004|STARTED|First Intervention (84 Hours)||5||
59876344|NCT02862730|76000351|FG005|STARTED|First Intervention (84 Hours)||1||
59876345|NCT02862730|76000352|FG006|STARTED|First Intervention (84 Hours)||1||
59876346|NCT02862730|76000346|FG000|COMPLETED|First Intervention (84 Hours)||4||
59876347|NCT02862730|76000347|FG001|COMPLETED|First Intervention (84 Hours)||1||
59876348|NCT02862730|76000348|FG002|COMPLETED|First Intervention (84 Hours)||7||
59876349|NCT02862730|76000349|FG003|COMPLETED|First Intervention (84 Hours)||5||
59876350|NCT02862730|76000350|FG004|COMPLETED|First Intervention (84 Hours)||5||
59876351|NCT02862730|76000351|FG005|COMPLETED|First Intervention (84 Hours)||1||
59876352|NCT02862730|76000352|FG006|COMPLETED|First Intervention (84 Hours)||1||
59876353|NCT02862730|76000346|FG000|NOT COMPLETED|First Intervention (84 Hours)||0||
59876354|NCT02862730|76000347|FG001|NOT COMPLETED|First Intervention (84 Hours)||0||
59876355|NCT02862730|76000348|FG002|NOT COMPLETED|First Intervention (84 Hours)||0||
59876356|NCT02862730|76000349|FG003|NOT COMPLETED|First Intervention (84 Hours)||0||
59876357|NCT02862730|76000350|FG004|NOT COMPLETED|First Intervention (84 Hours)||0||
59876358|NCT02862730|76000351|FG005|NOT COMPLETED|First Intervention (84 Hours)||0||
59876359|NCT02862730|76000352|FG006|NOT COMPLETED|First Intervention (84 Hours)||0||
59876360|NCT02862730|76000346|FG000|STARTED|Second Rest Period (7-45 Days)||4||
59876361|NCT02862730|76000347|FG001|STARTED|Second Rest Period (7-45 Days)||1||
59876362|NCT02862730|76000348|FG002|STARTED|Second Rest Period (7-45 Days)||7||
59876363|NCT02862730|76000349|FG003|STARTED|Second Rest Period (7-45 Days)||5||
59876364|NCT02862730|76000350|FG004|STARTED|Second Rest Period (7-45 Days)||5||
59876365|NCT02862730|76000351|FG005|STARTED|Second Rest Period (7-45 Days)||1||
59876366|NCT02862730|76000352|FG006|STARTED|Second Rest Period (7-45 Days)||1||
59876367|NCT02862730|76000346|FG000|COMPLETED|Second Rest Period (7-45 Days)||4||
59876368|NCT02862730|76000347|FG001|COMPLETED|Second Rest Period (7-45 Days)||1||
59876369|NCT02862730|76000348|FG002|COMPLETED|Second Rest Period (7-45 Days)||7||
59876370|NCT02862730|76000349|FG003|COMPLETED|Second Rest Period (7-45 Days)||5||
59876371|NCT02862730|76000350|FG004|COMPLETED|Second Rest Period (7-45 Days)||5||
59876372|NCT02862730|76000351|FG005|COMPLETED|Second Rest Period (7-45 Days)||1||
59876373|NCT02862730|76000352|FG006|COMPLETED|Second Rest Period (7-45 Days)||1||
59876374|NCT02862730|76000346|FG000|NOT COMPLETED|Second Rest Period (7-45 Days)||0||
59876375|NCT02862730|76000347|FG001|NOT COMPLETED|Second Rest Period (7-45 Days)||0||
59876376|NCT02862730|76000348|FG002|NOT COMPLETED|Second Rest Period (7-45 Days)||0||
59876377|NCT02862730|76000349|FG003|NOT COMPLETED|Second Rest Period (7-45 Days)||0||
59876378|NCT02862730|76000350|FG004|NOT COMPLETED|Second Rest Period (7-45 Days)||0||
59876379|NCT02862730|76000351|FG005|NOT COMPLETED|Second Rest Period (7-45 Days)||0||
59876380|NCT02862730|76000352|FG006|NOT COMPLETED|Second Rest Period (7-45 Days)||0||
59748644|NCT00718510|75867719|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||1||
59748645|NCT00718510|75867720|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0||
59748646|NCT00585286|75867726|FG000|STARTED|Overall Study||15||
59748647|NCT00585286|75867726|FG000|COMPLETED|Overall Study||14||
59748648|NCT00585286|75867726|FG000|NOT COMPLETED|Overall Study||1||
59748649|NCT00723190|75867730|FG000|STARTED|Overall Study|Study CLON-301 (168 participants) and Study CLON-302 (135 participants)|303||
59748650|NCT00723190|75867730|FG000|SAFETY POPULATION|Overall Study||301||
59748651|NCT00723190|75867730|FG000|COMPLETED|Overall Study|53 participants completed 6-month protocol and 108 participants completed 12-month protocol|161||
59748652|NCT00723190|75867730|FG000|NOT COMPLETED|Overall Study||142||
59876381|NCT02862730|76000346|FG000|STARTED|Second Intervention (84 Hours)||4||
59876382|NCT02862730|76000347|FG001|STARTED|Second Intervention (84 Hours)||1||
59876383|NCT02862730|76000348|FG002|STARTED|Second Intervention (84 Hours)||7||
59876384|NCT02862730|76000349|FG003|STARTED|Second Intervention (84 Hours)||5||
59876385|NCT02862730|76000350|FG004|STARTED|Second Intervention (84 Hours)||5||
59876386|NCT02862730|76000351|FG005|STARTED|Second Intervention (84 Hours)||1||
59876387|NCT02862730|76000352|FG006|STARTED|Second Intervention (84 Hours)||1||
59876388|NCT02862730|76000346|FG000|COMPLETED|Second Intervention (84 Hours)||3||
59876389|NCT02862730|76000347|FG001|COMPLETED|Second Intervention (84 Hours)||1||
59876390|NCT02862730|76000348|FG002|COMPLETED|Second Intervention (84 Hours)||7||
59876391|NCT02862730|76000349|FG003|COMPLETED|Second Intervention (84 Hours)||5||
59876392|NCT02862730|76000350|FG004|COMPLETED|Second Intervention (84 Hours)||5||
59876393|NCT02862730|76000351|FG005|COMPLETED|Second Intervention (84 Hours)||1||
59876394|NCT02862730|76000352|FG006|COMPLETED|Second Intervention (84 Hours)||1||
59876395|NCT02862730|76000346|FG000|NOT COMPLETED|Second Intervention (84 Hours)||1||
59876396|NCT02862730|76000347|FG001|NOT COMPLETED|Second Intervention (84 Hours)||0||
59876397|NCT02862730|76000348|FG002|NOT COMPLETED|Second Intervention (84 Hours)||0||
59876398|NCT02862730|76000349|FG003|NOT COMPLETED|Second Intervention (84 Hours)||0||
59876399|NCT02862730|76000350|FG004|NOT COMPLETED|Second Intervention (84 Hours)||0||
59876400|NCT02862730|76000351|FG005|NOT COMPLETED|Second Intervention (84 Hours)||0||
59876401|NCT02862730|76000352|FG006|NOT COMPLETED|Second Intervention (84 Hours)||0||
59876402|NCT02862730|76000346|FG000|STARTED|Third Rest Period (7-45 Days)||3||
59876403|NCT02862730|76000347|FG001|STARTED|Third Rest Period (7-45 Days)||1||
59876404|NCT02862730|76000348|FG002|STARTED|Third Rest Period (7-45 Days)||7||
59876405|NCT02862730|76000349|FG003|STARTED|Third Rest Period (7-45 Days)||5||
59876406|NCT02862730|76000350|FG004|STARTED|Third Rest Period (7-45 Days)||5||
59876407|NCT02862730|76000351|FG005|STARTED|Third Rest Period (7-45 Days)||1||
59876408|NCT02862730|76000352|FG006|STARTED|Third Rest Period (7-45 Days)||1||
59876409|NCT02862730|76000346|FG000|COMPLETED|Third Rest Period (7-45 Days)||3||
59876410|NCT02862730|76000347|FG001|COMPLETED|Third Rest Period (7-45 Days)||1||
59876411|NCT02862730|76000348|FG002|COMPLETED|Third Rest Period (7-45 Days)||6||
59876412|NCT02862730|76000349|FG003|COMPLETED|Third Rest Period (7-45 Days)||5||
59876413|NCT02862730|76000350|FG004|COMPLETED|Third Rest Period (7-45 Days)||4||
59876414|NCT02862730|76000351|FG005|COMPLETED|Third Rest Period (7-45 Days)||1||
59876415|NCT02862730|76000352|FG006|COMPLETED|Third Rest Period (7-45 Days)||1||
59876416|NCT02862730|76000346|FG000|NOT COMPLETED|Third Rest Period (7-45 Days)||0||
59876417|NCT02862730|76000347|FG001|NOT COMPLETED|Third Rest Period (7-45 Days)||0||
59876418|NCT02862730|76000348|FG002|NOT COMPLETED|Third Rest Period (7-45 Days)||1||
59748653|NCT00722800|75867736|FG000|STARTED|Overall Study||2||
59748654|NCT00722800|75867737|FG001|STARTED|Overall Study||2||
59876419|NCT02862730|76000349|FG003|NOT COMPLETED|Third Rest Period (7-45 Days)||0||
59876420|NCT02862730|76000350|FG004|NOT COMPLETED|Third Rest Period (7-45 Days)||1||
59876421|NCT02862730|76000351|FG005|NOT COMPLETED|Third Rest Period (7-45 Days)||0||
59876422|NCT02862730|76000352|FG006|NOT COMPLETED|Third Rest Period (7-45 Days)||0||
59876423|NCT02862730|76000346|FG000|STARTED|Third Intervention (84 Hours)||3||
59876424|NCT02862730|76000347|FG001|STARTED|Third Intervention (84 Hours)||1||
59876425|NCT02862730|76000348|FG002|STARTED|Third Intervention (84 Hours)||6||
59876426|NCT02862730|76000349|FG003|STARTED|Third Intervention (84 Hours)||5||
59876427|NCT02862730|76000350|FG004|STARTED|Third Intervention (84 Hours)||4||
59876428|NCT02862730|76000351|FG005|STARTED|Third Intervention (84 Hours)||1||
59876429|NCT02862730|76000352|FG006|STARTED|Third Intervention (84 Hours)||1||
59876430|NCT02862730|76000346|FG000|COMPLETED|Third Intervention (84 Hours)||3||
59876431|NCT02862730|76000347|FG001|COMPLETED|Third Intervention (84 Hours)||1||
59876432|NCT02862730|76000348|FG002|COMPLETED|Third Intervention (84 Hours)||6||
59876433|NCT02862730|76000349|FG003|COMPLETED|Third Intervention (84 Hours)||4||
59876434|NCT02862730|76000350|FG004|COMPLETED|Third Intervention (84 Hours)||4||
59748655|NCT00722800|75867736|FG000|COMPLETED|Overall Study||0||
59748656|NCT00722800|75867737|FG001|COMPLETED|Overall Study||2||
59748657|NCT00722800|75867736|FG000|NOT COMPLETED|Overall Study||2||
59748658|NCT00722800|75867737|FG001|NOT COMPLETED|Overall Study||0||
59748659|NCT00718042|75867749|FG000|STARTED|ABBOTT PRISM Chagas Testing||16313||
59876435|NCT02862730|76000351|FG005|COMPLETED|Third Intervention (84 Hours)||1||
59876436|NCT02862730|76000352|FG006|COMPLETED|Third Intervention (84 Hours)||1||
59876437|NCT02862730|76000346|FG000|NOT COMPLETED|Third Intervention (84 Hours)||0||
59876438|NCT02862730|76000347|FG001|NOT COMPLETED|Third Intervention (84 Hours)||0||
59876439|NCT02862730|76000348|FG002|NOT COMPLETED|Third Intervention (84 Hours)||0||
59876440|NCT02862730|76000349|FG003|NOT COMPLETED|Third Intervention (84 Hours)||1||
59876441|NCT02862730|76000350|FG004|NOT COMPLETED|Third Intervention (84 Hours)||0||
59876442|NCT02862730|76000351|FG005|NOT COMPLETED|Third Intervention (84 Hours)||0||
59876443|NCT02862730|76000352|FG006|NOT COMPLETED|Third Intervention (84 Hours)||0||
59876444|NCT02862730|76000346|FG000|STARTED|Fourth Rest Period (7-45 Days)||3||
59876445|NCT02862730|76000347|FG001|STARTED|Fourth Rest Period (7-45 Days)||1||
59748660|NCT00718042|75867750|FG001|STARTED|ABBOTT PRISM Chagas Testing||289||
59748661|NCT00718042|75867751|FG002|STARTED|ABBOTT PRISM Chagas Testing||525||
59748662|NCT00718042|75867752|FG003|STARTED|ABBOTT PRISM Chagas Testing||110||
59748663|NCT00718042|75867753|FG004|STARTED|ABBOTT PRISM Chagas Testing||25549||
59748664|NCT00718042|75867754|FG005|STARTED|ABBOTT PRISM Chagas Testing|Specimens not screened with PRISM Chagas assay per protocol.|0||
59748665|NCT00718042|75867749|FG000|COMPLETED|ABBOTT PRISM Chagas Testing||16249||
59748666|NCT00718042|75867750|FG001|COMPLETED|ABBOTT PRISM Chagas Testing||287||
59748667|NCT00718042|75867751|FG002|COMPLETED|ABBOTT PRISM Chagas Testing||524||
59748668|NCT00718042|75867752|FG003|COMPLETED|ABBOTT PRISM Chagas Testing||110||
59748669|NCT00718042|75867753|FG004|COMPLETED|ABBOTT PRISM Chagas Testing||25511||
59748670|NCT00718042|75867754|FG005|COMPLETED|ABBOTT PRISM Chagas Testing||0||
59748671|NCT00718042|75867749|FG000|NOT COMPLETED|ABBOTT PRISM Chagas Testing||64||
59748672|NCT00718042|75867750|FG001|NOT COMPLETED|ABBOTT PRISM Chagas Testing||2||
59748673|NCT00718042|75867751|FG002|NOT COMPLETED|ABBOTT PRISM Chagas Testing||1||
59748674|NCT00718042|75867752|FG003|NOT COMPLETED|ABBOTT PRISM Chagas Testing||0||
59748675|NCT00718042|75867753|FG004|NOT COMPLETED|ABBOTT PRISM Chagas Testing||38||
59748676|NCT00718042|75867754|FG005|NOT COMPLETED|ABBOTT PRISM Chagas Testing||0||
59748677|NCT00718042|75867749|FG000|STARTED|ESA Chagas Testing|Only specimens repeatedly reactive by screening assay or PRISM grayzone tested with ESA Chagas|36||
59748678|NCT00718042|75867750|FG001|STARTED|ESA Chagas Testing||287||
59876446|NCT02862730|76000348|FG002|STARTED|Fourth Rest Period (7-45 Days)||6||
59876447|NCT02862730|76000349|FG003|STARTED|Fourth Rest Period (7-45 Days)||4||
59876448|NCT02862730|76000350|FG004|STARTED|Fourth Rest Period (7-45 Days)||4||
59876449|NCT02862730|76000351|FG005|STARTED|Fourth Rest Period (7-45 Days)||1||
59876450|NCT02862730|76000352|FG006|STARTED|Fourth Rest Period (7-45 Days)||1||
59876451|NCT02862730|76000346|FG000|COMPLETED|Fourth Rest Period (7-45 Days)||3||
59876452|NCT02862730|76000347|FG001|COMPLETED|Fourth Rest Period (7-45 Days)||1||
59876453|NCT02862730|76000348|FG002|COMPLETED|Fourth Rest Period (7-45 Days)||6||
59876454|NCT02862730|76000349|FG003|COMPLETED|Fourth Rest Period (7-45 Days)||4||
59876455|NCT02862730|76000350|FG004|COMPLETED|Fourth Rest Period (7-45 Days)||4||
59876456|NCT02862730|76000351|FG005|COMPLETED|Fourth Rest Period (7-45 Days)||1||
59876457|NCT02862730|76000352|FG006|COMPLETED|Fourth Rest Period (7-45 Days)||1||
59876458|NCT02862730|76000346|FG000|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0||
59876459|NCT02862730|76000347|FG001|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0||
59876460|NCT02862730|76000348|FG002|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0||
59876461|NCT02862730|76000349|FG003|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0||
59876462|NCT02862730|76000350|FG004|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0||
59876463|NCT02862730|76000351|FG005|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0||
59876464|NCT02862730|76000352|FG006|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0||
59876465|NCT02862730|76000346|FG000|STARTED|Fourth Intervention (84 Hours)||3||
59876466|NCT02862730|76000347|FG001|STARTED|Fourth Intervention (84 Hours)||1||
59876467|NCT02862730|76000348|FG002|STARTED|Fourth Intervention (84 Hours)||6||
59876468|NCT02862730|76000349|FG003|STARTED|Fourth Intervention (84 Hours)||4||
59876469|NCT02862730|76000350|FG004|STARTED|Fourth Intervention (84 Hours)||4||
59876470|NCT02862730|76000351|FG005|STARTED|Fourth Intervention (84 Hours)||1||
59876471|NCT02862730|76000352|FG006|STARTED|Fourth Intervention (84 Hours)||1||
59876472|NCT02862730|76000346|FG000|COMPLETED|Fourth Intervention (84 Hours)||3||
59876473|NCT02862730|76000347|FG001|COMPLETED|Fourth Intervention (84 Hours)||1||
59876474|NCT02862730|76000348|FG002|COMPLETED|Fourth Intervention (84 Hours)||6||
59876475|NCT02862730|76000349|FG003|COMPLETED|Fourth Intervention (84 Hours)||4||
59876476|NCT02862730|76000350|FG004|COMPLETED|Fourth Intervention (84 Hours)||4||
60002490|NCT02565381|76118368|FG002|NOT COMPLETED|Overall Study||1||
60002491|NCT02063854|76118383|FG000|STARTED|Overall Study||199||
59748679|NCT00718042|75867751|FG002|STARTED|ESA Chagas Testing||524||
59748680|NCT00718042|75867752|FG003|STARTED|ESA Chagas Testing||110||
59748681|NCT00718042|75867753|FG004|STARTED|ESA Chagas Testing|Only specimens repeatedly reactive by screening assay or PRISM grayzone tested with ESA Chagas|43||
59748682|NCT00718042|75867754|FG005|STARTED|ESA Chagas Testing|Specimens only tested with ESA Chagas|330||
59748683|NCT00718042|75867749|FG000|COMPLETED|ESA Chagas Testing||36||
59748684|NCT00718042|75867750|FG001|COMPLETED|ESA Chagas Testing||287||
59748685|NCT00718042|75867751|FG002|COMPLETED|ESA Chagas Testing||524||
59876477|NCT02862730|76000351|FG005|COMPLETED|Fourth Intervention (84 Hours)||1||
59876478|NCT02862730|76000352|FG006|COMPLETED|Fourth Intervention (84 Hours)||1||
59876479|NCT02862730|76000346|FG000|NOT COMPLETED|Fourth Intervention (84 Hours)||0||
59876480|NCT02862730|76000347|FG001|NOT COMPLETED|Fourth Intervention (84 Hours)||0||
59876481|NCT02862730|76000348|FG002|NOT COMPLETED|Fourth Intervention (84 Hours)||0||
59876482|NCT02862730|76000349|FG003|NOT COMPLETED|Fourth Intervention (84 Hours)||0||
60002492|NCT02063854|76118384|FG001|STARTED|Overall Study||66||
59876483|NCT02862730|76000350|FG004|NOT COMPLETED|Fourth Intervention (84 Hours)||0||
59876484|NCT02862730|76000351|FG005|NOT COMPLETED|Fourth Intervention (84 Hours)||0||
59876485|NCT02862730|76000352|FG006|NOT COMPLETED|Fourth Intervention (84 Hours)||0||
59876486|NCT03353792|76000369|FG000|STARTED|Overall Study||4||
59876487|NCT03353792|76000370|FG001|STARTED|Overall Study||3||
59876488|NCT03353792|76000369|FG000|COMPLETED|Overall Study||2||
59876489|NCT03353792|76000370|FG001|COMPLETED|Overall Study||3||
59876490|NCT03353792|76000369|FG000|NOT COMPLETED|Overall Study||2||
59876491|NCT03353792|76000370|FG001|NOT COMPLETED|Overall Study||0||
59876492|NCT02862574|76000379|FG000|STARTED|Double-Blind Treatment Period||5||
59876493|NCT02862574|76000380|FG001|STARTED|Double-Blind Treatment Period||5||
59876494|NCT02862574|76000381|FG002|STARTED|Double-Blind Treatment Period||5||
59876495|NCT02862574|76000379|FG000|COMPLETED|Double-Blind Treatment Period||2||
59876496|NCT02862574|76000380|FG001|COMPLETED|Double-Blind Treatment Period||3||
59876497|NCT02862574|76000381|FG002|COMPLETED|Double-Blind Treatment Period||1||
59876498|NCT02862574|76000379|FG000|NOT COMPLETED|Double-Blind Treatment Period||3||
59876499|NCT02862574|76000380|FG001|NOT COMPLETED|Double-Blind Treatment Period||2||
59876500|NCT02862574|76000381|FG002|NOT COMPLETED|Double-Blind Treatment Period||4||
59876501|NCT02862574|76000379|FG000|STARTED|Open-Label Treatment Period||2||
59876502|NCT02862574|76000380|FG001|STARTED|Open-Label Treatment Period||3||
59876503|NCT02862574|76000381|FG002|STARTED|Open-Label Treatment Period||1||
59876504|NCT02862574|76000379|FG000|COMPLETED|Open-Label Treatment Period||0||
59876505|NCT02862574|76000380|FG001|COMPLETED|Open-Label Treatment Period||0||
59876506|NCT02862574|76000381|FG002|COMPLETED|Open-Label Treatment Period||0||
59876507|NCT02862574|76000379|FG000|NOT COMPLETED|Open-Label Treatment Period||2||
59876508|NCT02862574|76000380|FG001|NOT COMPLETED|Open-Label Treatment Period||3||
59876509|NCT02862574|76000381|FG002|NOT COMPLETED|Open-Label Treatment Period||1||
59876510|NCT02862106|76000396|FG000|STARTED|Overall Study||183||
59876511|NCT02862106|76000397|FG001|STARTED|Overall Study||26||
59876512|NCT02862106|76000396|FG000|COMPLETED|Overall Study||145||
59876513|NCT02862106|76000397|FG001|COMPLETED|Overall Study||20||
59876514|NCT02862106|76000396|FG000|NOT COMPLETED|Overall Study||38||
59876515|NCT02862106|76000397|FG001|NOT COMPLETED|Overall Study||6||
59876516|NCT04157296|76000412|FG000|STARTED|Overall Study||6||
59876517|NCT04157296|76000413|FG001|STARTED|Overall Study||15||
59876518|NCT04157296|76000412|FG000|COMPLETED|Overall Study||6||
59876519|NCT04157296|76000413|FG001|COMPLETED|Overall Study||12||
59876520|NCT04157296|76000412|FG000|NOT COMPLETED|Overall Study||0||
59876521|NCT04157296|76000413|FG001|NOT COMPLETED|Overall Study||3||
59876522|NCT02859142|76000421|FG000|STARTED|Overall Study||61||
59876523|NCT02859142|76000422|FG001|STARTED|Overall Study||61||
59876524|NCT02859142|76000421|FG000|COMPLETED|Overall Study||57|Completed indicates the number of participants completing the study, including those who discontinued medication but opted to remain in the study.|
59876525|NCT02859142|76000422|FG001|COMPLETED|Overall Study||52|Completed indicates the number of participants completing the study, including those who discontinued medication but opted to remain in the study.|
59876526|NCT02859142|76000421|FG000|NOT COMPLETED|Overall Study||4||
59876527|NCT02859142|76000422|FG001|NOT COMPLETED|Overall Study||9||
59876528|NCT03351608|76000433|FG000|STARTED|Overall Study||19||
59876529|NCT03351608|76000434|FG001|STARTED|Overall Study||23||
59876530|NCT03351608|76000435|FG002|STARTED|Overall Study||35||
59876531|NCT03351608|76000436|FG003|STARTED|Overall Study||176||
59876532|NCT03351608|76000437|FG004|STARTED|Overall Study||35||
59876533|NCT03351608|76000433|FG000|Treated|Overall Study||18||
59876534|NCT03351608|76000434|FG001|Treated|Overall Study||22||
59876535|NCT03351608|76000435|FG002|Treated|Overall Study||33||
59876536|NCT03351608|76000436|FG003|Treated|Overall Study||169||
59876537|NCT03351608|76000437|FG004|Treated|Overall Study||34||
59876538|NCT03351608|76000433|FG000|COMPLETED|Overall Study||18||
59876539|NCT03351608|76000434|FG001|COMPLETED|Overall Study||21||
59876540|NCT03351608|76000435|FG002|COMPLETED|Overall Study||32||
59876541|NCT03351608|76000436|FG003|COMPLETED|Overall Study||168||
59876542|NCT03351608|76000437|FG004|COMPLETED|Overall Study||33||
59876543|NCT03351608|76000433|FG000|NOT COMPLETED|Overall Study||1||
59876544|NCT03351608|76000434|FG001|NOT COMPLETED|Overall Study||2||
59876545|NCT03351608|76000435|FG002|NOT COMPLETED|Overall Study||3||
59876546|NCT03351608|76000436|FG003|NOT COMPLETED|Overall Study||8||
59876547|NCT03351608|76000437|FG004|NOT COMPLETED|Overall Study||2||
59876548|NCT02857816|76000460|FG000|STARTED|Overall Study||154||
59876549|NCT02857816|76000460|FG000|Subjects Qualified and Treated With PTNM|Overall Study||120|This includes those subjects that met eligibility criteria and received PTNM therapy in the study.|
59876550|NCT02857816|76000460|FG000|COMPLETED|Overall Study||116||
59876551|NCT02857816|76000460|FG000|NOT COMPLETED|Overall Study||38||
59876552|NCT02858440|76000465|FG000|STARTED|Overall Study||235||
59876553|NCT02858440|76000465|FG000|COMPLETED|Overall Study||223||
59876554|NCT02858440|76000465|FG000|NOT COMPLETED|Overall Study||12||
59876555|NCT03382418|76000472|FG000|STARTED|Overall Study||25||
59876556|NCT03382418|76000473|FG001|STARTED|Overall Study||15||
59876557|NCT03382418|76000474|FG002|STARTED|Overall Study||5||
59876558|NCT03382418|76000472|FG000|Month .5 Immunogenicity Cohort|Overall Study||25|HIV uninfected at Month 0.5 and specimen available for assays|
59950751|NCT03225287|76069597|FG001|STARTED|Overall Study||6||
59748686|NCT00718042|75867752|FG003|COMPLETED|ESA Chagas Testing||110||
59748687|NCT00718042|75867753|FG004|COMPLETED|ESA Chagas Testing||43||
59748688|NCT00718042|75867754|FG005|COMPLETED|ESA Chagas Testing||330||
59748689|NCT00718042|75867749|FG000|NOT COMPLETED|ESA Chagas Testing||0||
59748690|NCT00718042|75867750|FG001|NOT COMPLETED|ESA Chagas Testing||0||
59748691|NCT00718042|75867751|FG002|NOT COMPLETED|ESA Chagas Testing||0||
59748692|NCT00718042|75867752|FG003|NOT COMPLETED|ESA Chagas Testing||0||
59748693|NCT00718042|75867753|FG004|NOT COMPLETED|ESA Chagas Testing||0||
59748694|NCT00718042|75867754|FG005|NOT COMPLETED|ESA Chagas Testing||0||
59748695|NCT00718042|75867749|FG000|STARTED|Donor Follow-up||36||
59748696|NCT00718042|75867750|FG001|STARTED|Donor Follow-up|Follow-up not performed for this specimen population.|0||
59748697|NCT00718042|75867751|FG002|STARTED|Donor Follow-up|Follow-up not performed for this specimen population.|0||
59748698|NCT00718042|75867752|FG003|STARTED|Donor Follow-up|Follow-up not performed for this specimen population.|0||
59748699|NCT00718042|75867753|FG004|STARTED|Donor Follow-up||43||
59748700|NCT00718042|75867754|FG005|STARTED|Donor Follow-up|Follow-up not performed for this specimen population.|0||
59748701|NCT00718042|75867749|FG000|COMPLETED|Donor Follow-up||23||
59748702|NCT00718042|75867750|FG001|COMPLETED|Donor Follow-up||0||
59748703|NCT00718042|75867751|FG002|COMPLETED|Donor Follow-up||0||
59748704|NCT00718042|75867752|FG003|COMPLETED|Donor Follow-up||0||
59748705|NCT00718042|75867753|FG004|COMPLETED|Donor Follow-up||24||
59748706|NCT00718042|75867754|FG005|COMPLETED|Donor Follow-up||0||
59748707|NCT00718042|75867749|FG000|NOT COMPLETED|Donor Follow-up||13||
59748708|NCT00718042|75867750|FG001|NOT COMPLETED|Donor Follow-up||0||
59748709|NCT00718042|75867751|FG002|NOT COMPLETED|Donor Follow-up||0||
59748710|NCT00718042|75867752|FG003|NOT COMPLETED|Donor Follow-up||0||
59748711|NCT00718042|75867753|FG004|NOT COMPLETED|Donor Follow-up||19||
59748712|NCT00718042|75867754|FG005|NOT COMPLETED|Donor Follow-up||0||
59748713|NCT00741598|75867768|FG000|STARTED|Overall Study||33||
59748714|NCT00741598|75867769|FG001|STARTED|Overall Study||39||
59748715|NCT00741598|75867768|FG000|COMPLETED|Overall Study||24||
59748716|NCT00741598|75867769|FG001|COMPLETED|Overall Study||30||
59748717|NCT00741598|75867768|FG000|NOT COMPLETED|Overall Study||9||
59748718|NCT00741598|75867769|FG001|NOT COMPLETED|Overall Study||9||
59748719|NCT00717886|75867776|FG000|STARTED|Overall Study||13||
59748720|NCT00717886|75867776|FG000|COMPLETED|Overall Study||9||
59748721|NCT00717886|75867776|FG000|NOT COMPLETED|Overall Study||4||
59748722|NCT00741286|75867782|FG000|STARTED|Overall Study||103||
59748723|NCT00741286|75867783|FG001|STARTED|Overall Study||100||
59748724|NCT00741286|75867782|FG000|COMPLETED|Overall Study||83||
59748725|NCT00741286|75867783|FG001|COMPLETED|Overall Study||81||
59748726|NCT00741286|75867782|FG000|NOT COMPLETED|Overall Study||20||
59748727|NCT00741286|75867783|FG001|NOT COMPLETED|Overall Study||19||
59748728|NCT00716482|75867789|FG000|STARTED|Overall Study||1681||
59748729|NCT00716482|75867789|FG000|COMPLETED|Overall Study||1562||
59748730|NCT00716482|75867789|FG000|NOT COMPLETED|Overall Study||119||
59748731|NCT00716092|75867802|FG000|STARTED|Overall Study||40||
59748732|NCT00716092|75867803|FG001|STARTED|Overall Study||40||
59748733|NCT00716092|75867804|FG002|STARTED|Overall Study||41||
59748734|NCT00716092|75867802|FG000|COMPLETED|Overall Study||38||
59748735|NCT00716092|75867803|FG001|COMPLETED|Overall Study||39||
59748736|NCT00716092|75867804|FG002|COMPLETED|Overall Study||41||
59748737|NCT00716092|75867802|FG000|NOT COMPLETED|Overall Study||2||
59748738|NCT00716092|75867803|FG001|NOT COMPLETED|Overall Study||1||
59748739|NCT00716092|75867804|FG002|NOT COMPLETED|Overall Study||0||
59748740|NCT00715624|75867814|FG000|STARTED|Overall Study|Randomized|167||
60002493|NCT02063854|76118385|FG002|STARTED|Overall Study||206||
59748741|NCT00715624|75867815|FG001|STARTED|Overall Study||329||
59748742|NCT00715624|75867814|FG000|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|167||
59748743|NCT00715624|75867815|FG001|Treated/Safety Population|Overall Study||328||
59748744|NCT00715624|75867814|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|166||
59748745|NCT00715624|75867815|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||327||
59748746|NCT00715624|75867814|FG000|COMPLETED|Overall Study||115||
59748747|NCT00715624|75867815|FG001|COMPLETED|Overall Study||213||
59748748|NCT00715624|75867814|FG000|NOT COMPLETED|Overall Study||52||
59748749|NCT00715624|75867815|FG001|NOT COMPLETED|Overall Study||116||
59748750|NCT00576199|75867821|FG000|STARTED|Overall Study||30||
59748751|NCT00576199|75867821|FG000|COMPLETED|Overall Study||0||
60002494|NCT02063854|76118386|FG003|STARTED|Overall Study||68||
60002495|NCT02063854|76118387|FG004|STARTED|Overall Study||65||
60002496|NCT02063854|76118388|FG005|STARTED|Overall Study||201||
59748752|NCT00576199|75867821|FG000|NOT COMPLETED|Overall Study||30||
59748753|NCT00715078|75867828|FG000|STARTED|Overall Study||41||
59748754|NCT00715078|75867829|FG001|STARTED|Overall Study||40||
59748755|NCT00715078|75867830|FG002|STARTED|Overall Study||41||
59748756|NCT00715078|75867828|FG000|Received ≥ 1 Study Infusion|Overall Study||40||
59748757|NCT00715078|75867829|FG001|Received ≥ 1 Study Infusion|Overall Study||40||
59748758|NCT00715078|75867830|FG002|Received ≥ 1 Study Infusion|Overall Study||39||
59748759|NCT00715078|75867828|FG000|Received ≥ 1 Leukapheresis|Overall Study||40||
60002497|NCT02063854|76118389|FG006|STARTED|Overall Study||66||
59748760|NCT00715078|75867829|FG001|Received ≥ 1 Leukapheresis|Overall Study||40||
59748761|NCT00715078|75867830|FG002|Received ≥ 1 Leukapheresis|Overall Study||40||
59748762|NCT00715078|75867828|FG000|COMPLETED|Overall Study||11||
59748763|NCT00715078|75867829|FG001|COMPLETED|Overall Study||4||
59748764|NCT00715078|75867830|FG002|COMPLETED|Overall Study||3||
59748765|NCT00715078|75867828|FG000|NOT COMPLETED|Overall Study||30||
59748766|NCT00715078|75867829|FG001|NOT COMPLETED|Overall Study||36||
59748767|NCT00715078|75867830|FG002|NOT COMPLETED|Overall Study||38||
59748768|NCT00679627|75867840|FG000|STARTED|Overall Study||1021||
59748769|NCT00679627|75867841|FG001|STARTED|Overall Study||1024||
59748770|NCT00679627|75867840|FG000|COMPLETED|Overall Study||322||
59748771|NCT00679627|75867841|FG001|COMPLETED|Overall Study||339||
59748772|NCT00679627|75867840|FG000|NOT COMPLETED|Overall Study||699||
59748773|NCT00679627|75867841|FG001|NOT COMPLETED|Overall Study||685||
59748774|NCT00714688|75867850|FG000|STARTED|Overall Study||97||
59748775|NCT00714688|75867851|FG001|STARTED|Overall Study||90||
59748776|NCT00714688|75867852|FG002|STARTED|Overall Study||92||
59748777|NCT00714688|75867850|FG000|COMPLETED|Overall Study||68||
59748778|NCT00714688|75867851|FG001|COMPLETED|Overall Study||55||
59748779|NCT00714688|75867852|FG002|COMPLETED|Overall Study||55||
59748780|NCT00714688|75867850|FG000|NOT COMPLETED|Overall Study||29||
59748781|NCT00714688|75867851|FG001|NOT COMPLETED|Overall Study||35||
59748782|NCT00714688|75867852|FG002|NOT COMPLETED|Overall Study||37||
59748783|NCT00679549|75867862|FG000|STARTED|Overall Study||75||
59748784|NCT00679549|75867863|FG001|STARTED|Overall Study||75||
59748785|NCT00679549|75867862|FG000|COMPLETED|Overall Study||69||
59748786|NCT00679549|75867863|FG001|COMPLETED|Overall Study|4 dropouts in the control arm; 5 missing echocardiograms in the control arm|66||
59748787|NCT00679549|75867862|FG000|NOT COMPLETED|Overall Study||6||
59748788|NCT00679549|75867863|FG001|NOT COMPLETED|Overall Study||9||
59748789|NCT01031069|75867873|FG000|STARTED|Overall Study||129||
59748790|NCT01031069|75867874|FG001|STARTED|Overall Study||128||
59748791|NCT01031069|75867875|FG002|STARTED|Overall Study||144||
59748792|NCT01031069|75867876|FG003|STARTED|Overall Study||145||
59748793|NCT01031069|75867873|FG000|COMPLETED|Overall Study||117||
59748794|NCT01031069|75867874|FG001|COMPLETED|Overall Study||117||
59748795|NCT01031069|75867875|FG002|COMPLETED|Overall Study||103||
59748796|NCT01031069|75867876|FG003|COMPLETED|Overall Study||111||
59748797|NCT01031069|75867873|FG000|NOT COMPLETED|Overall Study||12||
59748798|NCT01031069|75867874|FG001|NOT COMPLETED|Overall Study||11||
59748799|NCT01031069|75867875|FG002|NOT COMPLETED|Overall Study||41||
59748800|NCT01031069|75867876|FG003|NOT COMPLETED|Overall Study||34||
59748801|NCT00679081|75867888|FG000|STARTED|Overall Study|Study design was within-subject control.|15||
59748802|NCT00679081|75867888|FG000|COMPLETED|Overall Study||14||
59748803|NCT00679081|75867888|FG000|NOT COMPLETED|Overall Study||1||
59748804|NCT00682435|75867896|FG000|STARTED|Overall Study||230||
59748805|NCT00682435|75867896|FG000|Ensured Enrolled Only Once|Overall Study||228||
59748806|NCT00682435|75867896|FG000|Sufficient Data to Carry Out Analysis|Overall Study||223||
59748807|NCT00682435|75867896|FG000|COMPLETED|Overall Study||223||
59748808|NCT00682435|75867896|FG000|NOT COMPLETED|Overall Study||7||
59748809|NCT00713830|75867902|FG000|STARTED|Overall Study|Randomized.|286||
59748810|NCT00713830|75867903|FG001|STARTED|Overall Study||573||
59748811|NCT00713830|75867902|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|286||
59748812|NCT00713830|75867903|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||570||
59748813|NCT00713830|75867902|FG000|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|285||
59748814|NCT00713830|75867903|FG001|Safety Population|Overall Study|1 patient randomized to placebo received Lixisenatide (at least one dose)|574||
59748815|NCT00713830|75867902|FG000|Subgroup for Standardized Meal Test|Overall Study|Patients at selected sites where standardized meal challenge test was performed.|155||
59748816|NCT00713830|75867903|FG001|Subgroup for Standardized Meal Test|Overall Study||313||
59876559|NCT03382418|76000473|FG001|Month .5 Immunogenicity Cohort|Overall Study||14|HIV uninfected at Month 0.5 and specimen available for assays|
59876560|NCT03382418|76000474|FG002|Month .5 Immunogenicity Cohort|Overall Study||5|HIV uninfected at Month 0.5 and specimen available for assays|
59876561|NCT03382418|76000472|FG000|Month 6.5 Immunogenicity Cohort|Overall Study||21|HIV uninfected at Month 6.5 and specimen available for assays|
59748817|NCT00713830|75867902|FG000|COMPLETED|Overall Study||204||
59748818|NCT00713830|75867903|FG001|COMPLETED|Overall Study||396||
59748819|NCT00713830|75867902|FG000|NOT COMPLETED|Overall Study||82||
59748820|NCT00713830|75867903|FG001|NOT COMPLETED|Overall Study||177||
59748821|NCT00681811|75867911|FG000|STARTED|Overall Study||6||
59748822|NCT00681811|75867912|FG001|STARTED|Overall Study||5||
59748823|NCT00681811|75867911|FG000|COMPLETED|Overall Study||3||
59748824|NCT00681811|75867912|FG001|COMPLETED|Overall Study||1||
59748825|NCT00681811|75867911|FG000|NOT COMPLETED|Overall Study||3||
59748826|NCT00681811|75867912|FG001|NOT COMPLETED|Overall Study||4||
59748827|NCT00681187|75867931|FG000|STARTED|Overall Study||11||
59748828|NCT00681187|75867932|FG001|STARTED|Overall Study||15||
59748829|NCT00681187|75867931|FG000|COMPLETED|Overall Study||10||
59748830|NCT00681187|75867932|FG001|COMPLETED|Overall Study||13||
59748831|NCT00681187|75867931|FG000|NOT COMPLETED|Overall Study||1||
59748832|NCT00681187|75867932|FG001|NOT COMPLETED|Overall Study||2||
59748833|NCT00681109|75867954|FG000|STARTED|Overall Study||30||
59748834|NCT00681109|75867955|FG001|STARTED|Overall Study||30||
59748835|NCT00681109|75867956|FG002|STARTED|Overall Study||15||
59748836|NCT00681109|75867954|FG000|COMPLETED|Overall Study||28||
59748837|NCT00681109|75867955|FG001|COMPLETED|Overall Study||24||
59748838|NCT00681109|75867956|FG002|COMPLETED|Overall Study||15||
59748839|NCT00681109|75867954|FG000|NOT COMPLETED|Overall Study||2||
59748840|NCT00681109|75867955|FG001|NOT COMPLETED|Overall Study||6||
59748841|NCT00681109|75867956|FG002|NOT COMPLETED|Overall Study||0||
59748842|NCT02588950|75867967|FG000|STARTED|Period 1 (Part A)||3||
59748843|NCT02588950|75867968|FG001|STARTED|Period 1 (Part A)||2||
59748844|NCT02588950|75867969|FG002|STARTED|Period 1 (Part A)||3||
59748845|NCT02588950|75867970|FG003|STARTED|Period 1 (Part A)||3||
59748846|NCT02588950|75867967|FG000|Received at Least One Dose of Study Drug|Period 1 (Part A)||3||
59748847|NCT02588950|75867968|FG001|Received at Least One Dose of Study Drug|Period 1 (Part A)||2||
59748848|NCT02588950|75867969|FG002|Received at Least One Dose of Study Drug|Period 1 (Part A)||3||
59748849|NCT02588950|75867970|FG003|Received at Least One Dose of Study Drug|Period 1 (Part A)||3||
59748850|NCT02588950|75867967|FG000|COMPLETED|Period 1 (Part A)||3||
59748851|NCT02588950|75867968|FG001|COMPLETED|Period 1 (Part A)||2||
59748852|NCT02588950|75867969|FG002|COMPLETED|Period 1 (Part A)||3||
59748853|NCT02588950|75867970|FG003|COMPLETED|Period 1 (Part A)||3||
59748854|NCT02588950|75867967|FG000|NOT COMPLETED|Period 1 (Part A)||0||
59748855|NCT02588950|75867968|FG001|NOT COMPLETED|Period 1 (Part A)||0||
59748856|NCT02588950|75867969|FG002|NOT COMPLETED|Period 1 (Part A)||0||
59748857|NCT02588950|75867970|FG003|NOT COMPLETED|Period 1 (Part A)||0||
59748858|NCT02588950|75867967|FG000|STARTED|Period 2 (Part A)||3||
59748859|NCT02588950|75867968|FG001|STARTED|Period 2 (Part A)||2||
59748860|NCT02588950|75867969|FG002|STARTED|Period 2 (Part A)||3||
59748861|NCT02588950|75867970|FG003|STARTED|Period 2 (Part A)||3||
59748862|NCT02588950|75867967|FG000|COMPLETED|Period 2 (Part A)||3||
59748863|NCT02588950|75867968|FG001|COMPLETED|Period 2 (Part A)||2||
59748864|NCT02588950|75867969|FG002|COMPLETED|Period 2 (Part A)||2||
59748865|NCT02588950|75867970|FG003|COMPLETED|Period 2 (Part A)||3||
59748866|NCT02588950|75867967|FG000|NOT COMPLETED|Period 2 (Part A)||0||
59748867|NCT02588950|75867968|FG001|NOT COMPLETED|Period 2 (Part A)||0||
59748868|NCT02588950|75867969|FG002|NOT COMPLETED|Period 2 (Part A)||1||
59748869|NCT02588950|75867970|FG003|NOT COMPLETED|Period 2 (Part A)||0||
59748870|NCT02588950|75867967|FG000|STARTED|Period 3 (Part B)||3||
59748871|NCT02588950|75867968|FG001|STARTED|Period 3 (Part B)||2||
59748872|NCT02588950|75867969|FG002|STARTED|Period 3 (Part B)||2||
59876562|NCT03382418|76000473|FG001|Month 6.5 Immunogenicity Cohort|Overall Study||13|HIV uninfected at Month 6.5 and specimen available for assays|
59876563|NCT03382418|76000474|FG002|Month 6.5 Immunogenicity Cohort|Overall Study||5|HIV uninfected at Month 6.5 and specimen available for assays|
59876564|NCT03382418|76000472|FG000|COMPLETED|Overall Study||22||
59876565|NCT03382418|76000473|FG001|COMPLETED|Overall Study||12||
59876566|NCT03382418|76000474|FG002|COMPLETED|Overall Study||5||
59748873|NCT02588950|75867970|FG003|STARTED|Period 3 (Part B)||3||
59748874|NCT02588950|75867967|FG000|COMPLETED|Period 3 (Part B)||3||
59748875|NCT02588950|75867968|FG001|COMPLETED|Period 3 (Part B)||2||
59748876|NCT02588950|75867969|FG002|COMPLETED|Period 3 (Part B)||2||
59748877|NCT02588950|75867970|FG003|COMPLETED|Period 3 (Part B)||2||
59748878|NCT02588950|75867967|FG000|NOT COMPLETED|Period 3 (Part B)||0||
59748879|NCT02588950|75867968|FG001|NOT COMPLETED|Period 3 (Part B)||0||
59748880|NCT02588950|75867969|FG002|NOT COMPLETED|Period 3 (Part B)||0||
59748881|NCT02588950|75867970|FG003|NOT COMPLETED|Period 3 (Part B)||1||
59748882|NCT00680407|75867983|FG000|STARTED|Overall Study||26||
59748883|NCT00680407|75867984|FG001|STARTED|Overall Study||27||
59748884|NCT00680407|75867985|FG002|STARTED|Overall Study||25||
59748885|NCT00680407|75867983|FG000|COMPLETED|Overall Study||18||
59748886|NCT00680407|75867984|FG001|COMPLETED|Overall Study||22||
59748887|NCT00680407|75867985|FG002|COMPLETED|Overall Study||22||
59748888|NCT00680407|75867983|FG000|NOT COMPLETED|Overall Study||8||
59748889|NCT00680407|75867984|FG001|NOT COMPLETED|Overall Study||5||
59748890|NCT00680407|75867985|FG002|NOT COMPLETED|Overall Study||3||
59876567|NCT03382418|76000472|FG000|NOT COMPLETED|Overall Study||3||
59876568|NCT03382418|76000473|FG001|NOT COMPLETED|Overall Study||3||
59876569|NCT03382418|76000474|FG002|NOT COMPLETED|Overall Study||0||
59748891|NCT00677365|75867997|FG000|STARTED|Overall Study||37||
59748892|NCT00677365|75867998|FG001|STARTED|Overall Study||38||
59748893|NCT00677365|75867999|FG002|STARTED|Overall Study||37||
59748894|NCT00677365|75868000|FG003|STARTED|Overall Study||39||
59748895|NCT00677365|75867997|FG000|COMPLETED|Overall Study||35||
59748896|NCT00677365|75867998|FG001|COMPLETED|Overall Study||37||
59748897|NCT00677365|75867999|FG002|COMPLETED|Overall Study||35||
59748898|NCT00677365|75868000|FG003|COMPLETED|Overall Study||36||
59748899|NCT00677365|75867997|FG000|NOT COMPLETED|Overall Study||2||
59748900|NCT00677365|75867998|FG001|NOT COMPLETED|Overall Study||1||
59748901|NCT00677365|75867999|FG002|NOT COMPLETED|Overall Study||2||
59876570|NCT02858362|76000486|FG000|STARTED|Overall Study||30||
59748902|NCT00677365|75868000|FG003|NOT COMPLETED|Overall Study||3||
59748903|NCT00680017|75868012|FG000|STARTED|Overall Study||140||
59748904|NCT00680017|75868013|FG001|STARTED|Overall Study||140||
59748905|NCT00680017|75868012|FG000|COMPLETED|Overall Study||123||
59748906|NCT00680017|75868013|FG001|COMPLETED|Overall Study||128||
59748907|NCT00680017|75868012|FG000|NOT COMPLETED|Overall Study||17||
59748908|NCT00680017|75868013|FG001|NOT COMPLETED|Overall Study||12||
59748909|NCT00676663|75868021|FG000|STARTED|Overall Study||66||
59748910|NCT00676663|75868022|FG001|STARTED|Overall Study||64||
59748911|NCT00676663|75868021|FG000|COMPLETED|Overall Study||21||
59748912|NCT00676663|75868022|FG001|COMPLETED|Overall Study||26||
59748913|NCT00676663|75868021|FG000|NOT COMPLETED|Overall Study||45||
59748914|NCT00676663|75868022|FG001|NOT COMPLETED|Overall Study||38||
59748915|NCT00678691|75868032|FG000|STARTED|Overall Study||27||
59748916|NCT00678691|75868033|FG001|STARTED|Overall Study||28||
59748917|NCT00678691|75868032|FG000|COMPLETED|Overall Study||21||
59748918|NCT00678691|75868033|FG001|COMPLETED|Overall Study||24||
59748919|NCT00678691|75868032|FG000|NOT COMPLETED|Overall Study||6||
59748920|NCT00678691|75868033|FG001|NOT COMPLETED|Overall Study||4||
59748921|NCT00679939|75868041|FG000|STARTED|52-Week Double-Blind (DB) Period||114||
59748922|NCT00679939|75868042|FG001|STARTED|52-Week Double-Blind (DB) Period||112||
59748923|NCT00679939|75868041|FG000|COMPLETED|52-Week Double-Blind (DB) Period||77||
59748924|NCT00679939|75868042|FG001|COMPLETED|52-Week Double-Blind (DB) Period||85||
59748925|NCT00679939|75868041|FG000|NOT COMPLETED|52-Week Double-Blind (DB) Period||37||
59748926|NCT00679939|75868042|FG001|NOT COMPLETED|52-Week Double-Blind (DB) Period||27||
59748927|NCT00679939|75868041|FG000|STARTED|24-Week Open-Label (OL) Period|One participant who completed the DB Period did not receive the OL dose of MET.|76||
59748928|NCT00679939|75868042|FG001|STARTED|24-Week Open-Label (OL) Period|One participant who completed the DB Period did not receive the OL dose of MET.|84||
59748929|NCT00679939|75868041|FG000|COMPLETED|24-Week Open-Label (OL) Period||69||
59748930|NCT00679939|75868042|FG001|COMPLETED|24-Week Open-Label (OL) Period||80||
59748931|NCT00679939|75868041|FG000|NOT COMPLETED|24-Week Open-Label (OL) Period||7||
59748932|NCT00679939|75868042|FG001|NOT COMPLETED|24-Week Open-Label (OL) Period||4||
59748933|NCT00673933|75868052|FG000|STARTED|Overall Study||20||
59748934|NCT00673933|75868052|FG000|COMPLETED|Overall Study||17||
59748935|NCT00673933|75868052|FG000|NOT COMPLETED|Overall Study||3||
59748936|NCT00571519|75868065|FG000|STARTED|Overall Study||3||
59748937|NCT00571519|75868066|FG001|STARTED|Overall Study||9||
59748938|NCT00571519|75868067|FG002|STARTED|Overall Study||12||
59748939|NCT00571519|75868068|FG003|STARTED|Overall Study||27||
59748940|NCT00571519|75868069|FG004|STARTED|Overall Study||9||
59748941|NCT00571519|75868070|FG005|STARTED|Overall Study||10||
59748942|NCT00571519|75868071|FG006|STARTED|Overall Study||24||
59748943|NCT00571519|75868065|FG000|COMPLETED|Overall Study||0||
59748944|NCT00571519|75868066|FG001|COMPLETED|Overall Study||0||
59748945|NCT00571519|75868067|FG002|COMPLETED|Overall Study||0||
59748946|NCT00571519|75868068|FG003|COMPLETED|Overall Study||0||
59748947|NCT00571519|75868069|FG004|COMPLETED|Overall Study||0||
59748948|NCT00571519|75868070|FG005|COMPLETED|Overall Study||0||
59748949|NCT00571519|75868071|FG006|COMPLETED|Overall Study||0||
59748950|NCT00571519|75868065|FG000|NOT COMPLETED|Overall Study||3||
59748951|NCT00571519|75868066|FG001|NOT COMPLETED|Overall Study||9||
59748952|NCT00571519|75868067|FG002|NOT COMPLETED|Overall Study||12||
59748953|NCT00571519|75868068|FG003|NOT COMPLETED|Overall Study||27||
59748954|NCT00571519|75868069|FG004|NOT COMPLETED|Overall Study||9||
59748955|NCT00571519|75868070|FG005|NOT COMPLETED|Overall Study||10||
59748956|NCT00571519|75868071|FG006|NOT COMPLETED|Overall Study||24||
59748957|NCT00676195|75868087|FG000|STARTED|Overall Study||24||
59748958|NCT00676195|75868087|FG000|COMPLETED|Overall Study||21||
59748959|NCT00676195|75868087|FG000|NOT COMPLETED|Overall Study||3||
59748960|NCT00675103|75868092|FG000|STARTED|Overall Study||7||
59748961|NCT00675103|75868092|FG000|COMPLETED|Overall Study||4||
59748962|NCT00675103|75868092|FG000|NOT COMPLETED|Overall Study||3||
59748963|NCT00675025|75868098|FG000|STARTED|Overall Study||54||
59748964|NCT00675025|75868099|FG001|STARTED|Overall Study||63||
59748965|NCT00675025|75868098|FG000|COMPLETED|Overall Study||0||
59748966|NCT00675025|75868099|FG001|COMPLETED|Overall Study||0||
59748967|NCT00675025|75868098|FG000|NOT COMPLETED|Overall Study||54||
59748968|NCT00675025|75868099|FG001|NOT COMPLETED|Overall Study||63||
59748969|NCT01275313|75868107|FG000|STARTED|Overall Study||127||
59876571|NCT02858362|76000487|FG001|STARTED|Overall Study||10||
59748970|NCT01275313|75868108|FG001|STARTED|Overall Study||131||
59748971|NCT01275313|75868107|FG000|COMPLETED|Overall Study||102||
59748972|NCT01275313|75868108|FG001|COMPLETED|Overall Study||79||
59748973|NCT01275313|75868107|FG000|NOT COMPLETED|Overall Study||25||
59748974|NCT01275313|75868108|FG001|NOT COMPLETED|Overall Study||52||
59748975|NCT00678379|75868117|FG000|STARTED|Overall Study||40||
59748976|NCT00678379|75868118|FG001|STARTED|Overall Study||40||
59748977|NCT00678379|75868119|FG002|STARTED|Overall Study||40||
59748978|NCT00678379|75868117|FG000|COMPLETED|Overall Study||34||
59748979|NCT00678379|75868118|FG001|COMPLETED|Overall Study||37||
59748980|NCT00678379|75868119|FG002|COMPLETED|Overall Study||36||
59748981|NCT00678379|75868117|FG000|NOT COMPLETED|Overall Study||6||
59748982|NCT00678379|75868118|FG001|NOT COMPLETED|Overall Study||3||
59748983|NCT00678379|75868119|FG002|NOT COMPLETED|Overall Study||4||
59748984|NCT00674323|75868130|FG000|STARTED|Overall Study||19||
59876572|NCT02858362|76000488|FG002|STARTED|Overall Study||3||
59748985|NCT00674323|75868131|FG001|STARTED|Overall Study||21||
59748986|NCT00674323|75868132|FG002|STARTED|Overall Study||21||
59748987|NCT00674323|75868130|FG000|COMPLETED|Overall Study||18||
59748988|NCT00674323|75868131|FG001|COMPLETED|Overall Study||20||
59748989|NCT00674323|75868132|FG002|COMPLETED|Overall Study||21||
59748990|NCT00674323|75868130|FG000|NOT COMPLETED|Overall Study||1||
59748991|NCT00674323|75868131|FG001|NOT COMPLETED|Overall Study||1||
59748992|NCT00674323|75868132|FG002|NOT COMPLETED|Overall Study||0||
59748993|NCT00678301|75868142|FG000|STARTED|Overall Study||239||
59748994|NCT00678301|75868143|FG001|STARTED|Overall Study||118||
59748995|NCT00678301|75868142|FG000|COMPLETED|Overall Study||231||
59748996|NCT00678301|75868143|FG001|COMPLETED|Overall Study||116||
59748997|NCT00678301|75868142|FG000|NOT COMPLETED|Overall Study||8||
59748998|NCT00678301|75868143|FG001|NOT COMPLETED|Overall Study||2||
59748999|NCT00939770|75868157|FG000|STARTED|Overall Study||6||
59749000|NCT00939770|75868158|FG001|STARTED|Overall Study||8||
59749001|NCT00939770|75868159|FG002|STARTED|Overall Study||23||
59749002|NCT00939770|75868160|FG003|STARTED|Overall Study||12||
59749003|NCT00939770|75868161|FG004|STARTED|Overall Study||38||
59749004|NCT00939770|75868162|FG005|STARTED|Overall Study||11||
59749005|NCT00939770|75868163|FG006|STARTED|Overall Study||14||
59749006|NCT00939770|75868164|FG007|STARTED|Overall Study||10||
59749007|NCT00939770|75868157|FG000|COMPLETED|Overall Study||1||
59749008|NCT00939770|75868158|FG001|COMPLETED|Overall Study||0||
59749009|NCT00939770|75868159|FG002|COMPLETED|Overall Study||3||
59749010|NCT00939770|75868160|FG003|COMPLETED|Overall Study||1||
59749011|NCT00939770|75868161|FG004|COMPLETED|Overall Study||1||
59749012|NCT00939770|75868162|FG005|COMPLETED|Overall Study||0||
59749013|NCT00939770|75868163|FG006|COMPLETED|Overall Study||0||
59749014|NCT00939770|75868164|FG007|COMPLETED|Overall Study||0||
59749015|NCT00939770|75868157|FG000|NOT COMPLETED|Overall Study||5||
59749016|NCT00939770|75868158|FG001|NOT COMPLETED|Overall Study||8||
59749017|NCT00939770|75868159|FG002|NOT COMPLETED|Overall Study||20||
59749018|NCT00939770|75868160|FG003|NOT COMPLETED|Overall Study||11||
59749019|NCT00939770|75868161|FG004|NOT COMPLETED|Overall Study||37||
59749020|NCT00939770|75868162|FG005|NOT COMPLETED|Overall Study||11||
59749021|NCT00939770|75868163|FG006|NOT COMPLETED|Overall Study||14||
59749022|NCT00939770|75868164|FG007|NOT COMPLETED|Overall Study||10||
59749023|NCT00939692|75868197|FG000|STARTED|Period 1 - First Intervention - 5 Days||13||
59749024|NCT00939692|75868198|FG001|STARTED|Period 1 - First Intervention - 5 Days||13||
59749025|NCT00939692|75868197|FG000|COMPLETED|Period 1 - First Intervention - 5 Days||12||
59749026|NCT00939692|75868198|FG001|COMPLETED|Period 1 - First Intervention - 5 Days||13||
59749027|NCT00939692|75868197|FG000|NOT COMPLETED|Period 1 - First Intervention - 5 Days||1||
59749028|NCT00939692|75868198|FG001|NOT COMPLETED|Period 1 - First Intervention - 5 Days||0||
59749029|NCT00939692|75868197|FG000|STARTED|Period 2 - Second Intervent - 5 Days||12||
59749030|NCT00939692|75868198|FG001|STARTED|Period 2 - Second Intervent - 5 Days||13||
59749031|NCT00939692|75868197|FG000|COMPLETED|Period 2 - Second Intervent - 5 Days||12||
59749032|NCT00939692|75868198|FG001|COMPLETED|Period 2 - Second Intervent - 5 Days||12||
59749033|NCT00939692|75868197|FG000|NOT COMPLETED|Period 2 - Second Intervent - 5 Days||0||
59749034|NCT00939692|75868198|FG001|NOT COMPLETED|Period 2 - Second Intervent - 5 Days||1||
59749035|NCT04672252|75868206|FG000|STARTED|Overall Study||53||
59749036|NCT04672252|75868207|FG001|STARTED|Overall Study||47||
59749037|NCT04672252|75868206|FG000|COMPLETED|Overall Study||52||
59749038|NCT04672252|75868207|FG001|COMPLETED|Overall Study||47||
59749039|NCT04672252|75868206|FG000|NOT COMPLETED|Overall Study||1||
59749040|NCT04672252|75868207|FG001|NOT COMPLETED|Overall Study||0||
59749041|NCT00584740|75868215|FG000|STARTED|Overall Study||39||
59749042|NCT00584740|75868216|FG001|STARTED|Overall Study||20||
59749043|NCT00584740|75868215|FG000|COMPLETED|Overall Study||27||
59749044|NCT00584740|75868216|FG001|COMPLETED|Overall Study||14||
59749045|NCT00584740|75868215|FG000|NOT COMPLETED|Overall Study||12||
59749046|NCT00584740|75868216|FG001|NOT COMPLETED|Overall Study||6||
59749047|NCT00942968|75868222|FG000|STARTED|Overall Study||338||
59749048|NCT00942968|75868222|FG000|Treated|Overall Study||334||
59749049|NCT00942968|75868222|FG000|COMPLETED|Overall Study||109||
59749050|NCT00942968|75868222|FG000|NOT COMPLETED|Overall Study||229||
59749051|NCT00942734|75868226|FG000|STARTED|Overall Study||43||
59749052|NCT00942734|75868226|FG000|COMPLETED|Overall Study||35||
59749053|NCT00942734|75868226|FG000|NOT COMPLETED|Overall Study||8||
59749054|NCT00584194|75868230|FG000|STARTED|Overall Study||278||
59749055|NCT00584194|75868230|FG000|COMPLETED|Overall Study||143||
59749056|NCT00584194|75868230|FG000|NOT COMPLETED|Overall Study||135||
59749057|NCT00942422|75868234|FG000|STARTED|Overall Study||8||
59749058|NCT00942422|75868234|FG000|COMPLETED|Overall Study||5||
59749059|NCT00942422|75868234|FG000|NOT COMPLETED|Overall Study||3||
59749060|NCT00677833|75868242|FG000|STARTED|Overall Study||55||
59749061|NCT00677833|75868243|FG001|STARTED|Overall Study||51||
59749062|NCT00677833|75868244|FG002|STARTED|Overall Study||124||
59749063|NCT00677833|75868245|FG003|STARTED|Overall Study||131||
59749064|NCT00677833|75868242|FG000|COMPLETED|Overall Study||51||
59749065|NCT00677833|75868243|FG001|COMPLETED|Overall Study||51||
59749066|NCT00677833|75868244|FG002|COMPLETED|Overall Study||122||
59749067|NCT00677833|75868245|FG003|COMPLETED|Overall Study||128||
59749068|NCT00677833|75868242|FG000|NOT COMPLETED|Overall Study||4||
59749069|NCT00677833|75868243|FG001|NOT COMPLETED|Overall Study||0||
59749070|NCT00677833|75868244|FG002|NOT COMPLETED|Overall Study||2||
59749071|NCT00677833|75868245|FG003|NOT COMPLETED|Overall Study||3||
59749072|NCT00942266|75868255|FG000|STARTED|Overall Study||43||
59749073|NCT00942266|75868256|FG001|STARTED|Overall Study||15||
59749074|NCT00942266|75868255|FG000|COMPLETED|Overall Study||0||
59749075|NCT00942266|75868256|FG001|COMPLETED|Overall Study||0||
59749076|NCT00942266|75868255|FG000|NOT COMPLETED|Overall Study||43||
59749077|NCT00942266|75868256|FG001|NOT COMPLETED|Overall Study||15||
59749078|NCT00942188|75868266|FG000|STARTED|Overall Study||26||
59749079|NCT00942188|75868267|FG001|STARTED|Overall Study||26||
59749080|NCT00942188|75868268|FG002|STARTED|Overall Study||27||
59749081|NCT00942188|75868269|FG003|STARTED|Overall Study||27||
59749082|NCT00942188|75868266|FG000|COMPLETED|Overall Study||22||
59749083|NCT00942188|75868267|FG001|COMPLETED|Overall Study||16||
59749084|NCT00942188|75868268|FG002|COMPLETED|Overall Study||18||
59749085|NCT00942188|75868269|FG003|COMPLETED|Overall Study||23||
60135762|NCT01685008|76258449|FG001|STARTED|Cycle 3 and Maintenance Treatment||25|Includes all patients that completed the first 2 cycles of treatment.|
60135763|NCT01685008|76258450|FG002|STARTED|Cycle 3 and Maintenance Treatment||10|Includes all patients that completed the first 2 cycles of treatment.|
60135764|NCT01685008|76258451|FG003|STARTED|Cycle 3 and Maintenance Treatment||10|Includes all patients that completed the first 2 cycles of treatment.|
59749086|NCT00942188|75868266|FG000|NOT COMPLETED|Overall Study||4||
59749087|NCT00942188|75868267|FG001|NOT COMPLETED|Overall Study||10||
59749088|NCT00942188|75868268|FG002|NOT COMPLETED|Overall Study||9||
59749089|NCT00942188|75868269|FG003|NOT COMPLETED|Overall Study||4||
59749090|NCT00673231|75868283|FG000|STARTED|Overall Study|Of the 197 randomized participants only 193 were included in the full analysis set|197||
59749091|NCT00673231|75868284|FG001|STARTED|Overall Study|All 202 were included in the full analysis set|202||
59749092|NCT00673231|75868285|FG002|STARTED|Overall Study|Of the 212 randomized participants only 211 were included in the full analysis set|212||
59749093|NCT00673231|75868286|FG003|STARTED|Overall Study|Of the 196 randomized participants only 194 were included in the full analysis set|196||
59749094|NCT00673231|75868283|FG000|COMPLETED|Overall Study||168||
59749095|NCT00673231|75868284|FG001|COMPLETED|Overall Study||180||
59749096|NCT00673231|75868285|FG002|COMPLETED|Overall Study||186||
59749097|NCT00673231|75868286|FG003|COMPLETED|Overall Study||178||
59749098|NCT00673231|75868283|FG000|NOT COMPLETED|Overall Study||29||
59749099|NCT00673231|75868284|FG001|NOT COMPLETED|Overall Study||22||
59749100|NCT00673231|75868285|FG002|NOT COMPLETED|Overall Study||26||
59749101|NCT00673231|75868286|FG003|NOT COMPLETED|Overall Study||18||
59749102|NCT00672841|75868298|FG000|STARTED|Overall Study||17||
59749103|NCT00672841|75868299|FG001|STARTED|Overall Study||47||
59749104|NCT00672841|75868298|FG000|COMPLETED|Overall Study||16||
59749105|NCT00672841|75868299|FG001|COMPLETED|Overall Study||32||
59749106|NCT00672841|75868298|FG000|NOT COMPLETED|Overall Study||1||
59749107|NCT00672841|75868299|FG001|NOT COMPLETED|Overall Study||15||
59749108|NCT00673465|75868308|FG000|STARTED|Part 1/Period 1 (United States)||3||
59749109|NCT00673465|75868309|FG001|STARTED|Part 1/Period 1 (United States)||3||
59749110|NCT00673465|75868310|FG002|STARTED|Part 1/Period 1 (United States)||3||
59749111|NCT00673465|75868311|FG003|STARTED|Part 1/Period 1 (United States)||3||
59749112|NCT00673465|75868312|FG004|STARTED|Part 1/Period 1 (United States)||3||
59749113|NCT00673465|75868313|FG005|STARTED|Part 1/Period 1 (United States)||2||
59749114|NCT00673465|75868314|FG006|STARTED|Part 1/Period 1 (United States)||0||
59749115|NCT00673465|75868315|FG007|STARTED|Part 1/Period 1 (United States)||0||
59749116|NCT00673465|75868316|FG008|STARTED|Part 1/Period 1 (United States)||0||
59749117|NCT00673465|75868317|FG009|STARTED|Part 1/Period 1 (United States)||0||
59950752|NCT03225287|76069598|FG002|STARTED|Overall Study||3||
59749118|NCT00673465|75868318|FG010|STARTED|Part 1/Period 1 (United States)||0||
59749119|NCT00673465|75868319|FG011|STARTED|Part 1/Period 1 (United States)||0||
59749120|NCT00673465|75868308|FG000|COMPLETED|Part 1/Period 1 (United States)||3||
59749121|NCT00673465|75868309|FG001|COMPLETED|Part 1/Period 1 (United States)||3||
59749122|NCT00673465|75868310|FG002|COMPLETED|Part 1/Period 1 (United States)||3||
59749123|NCT00673465|75868311|FG003|COMPLETED|Part 1/Period 1 (United States)||3||
59749124|NCT00673465|75868312|FG004|COMPLETED|Part 1/Period 1 (United States)||2||
59749125|NCT00673465|75868313|FG005|COMPLETED|Part 1/Period 1 (United States)||1||
59749126|NCT00673465|75868314|FG006|COMPLETED|Part 1/Period 1 (United States)||0||
59749127|NCT00673465|75868315|FG007|COMPLETED|Part 1/Period 1 (United States)||0||
59749128|NCT00673465|75868316|FG008|COMPLETED|Part 1/Period 1 (United States)||0||
59749129|NCT00673465|75868317|FG009|COMPLETED|Part 1/Period 1 (United States)||0||
59749130|NCT00673465|75868318|FG010|COMPLETED|Part 1/Period 1 (United States)||0||
59749131|NCT00673465|75868319|FG011|COMPLETED|Part 1/Period 1 (United States)||0||
59749132|NCT00673465|75868308|FG000|NOT COMPLETED|Part 1/Period 1 (United States)||0||
59749133|NCT00673465|75868309|FG001|NOT COMPLETED|Part 1/Period 1 (United States)||0||
59749134|NCT00673465|75868310|FG002|NOT COMPLETED|Part 1/Period 1 (United States)||0||
59749135|NCT00673465|75868311|FG003|NOT COMPLETED|Part 1/Period 1 (United States)||0||
59749136|NCT00673465|75868312|FG004|NOT COMPLETED|Part 1/Period 1 (United States)||1||
59749137|NCT00673465|75868313|FG005|NOT COMPLETED|Part 1/Period 1 (United States)||1||
59749138|NCT00673465|75868314|FG006|NOT COMPLETED|Part 1/Period 1 (United States)||0||
59749139|NCT00673465|75868315|FG007|NOT COMPLETED|Part 1/Period 1 (United States)||0||
59749140|NCT00673465|75868316|FG008|NOT COMPLETED|Part 1/Period 1 (United States)||0||
59749141|NCT00673465|75868317|FG009|NOT COMPLETED|Part 1/Period 1 (United States)||0||
59749142|NCT00673465|75868318|FG010|NOT COMPLETED|Part 1/Period 1 (United States)||0||
59749143|NCT00673465|75868319|FG011|NOT COMPLETED|Part 1/Period 1 (United States)||0||
59749144|NCT00673465|75868308|FG000|STARTED|Part 1/Period 2 (United States)||3||
59749145|NCT00673465|75868309|FG001|STARTED|Part 1/Period 2 (United States)||3||
59749146|NCT00673465|75868310|FG002|STARTED|Part 1/Period 2 (United States)||3||
59749147|NCT00673465|75868311|FG003|STARTED|Part 1/Period 2 (United States)||3||
59749148|NCT00673465|75868312|FG004|STARTED|Part 1/Period 2 (United States)||2||
59749149|NCT00673465|75868313|FG005|STARTED|Part 1/Period 2 (United States)||1||
59749150|NCT00673465|75868314|FG006|STARTED|Part 1/Period 2 (United States)||0||
59749151|NCT00673465|75868315|FG007|STARTED|Part 1/Period 2 (United States)||0||
59749152|NCT00673465|75868316|FG008|STARTED|Part 1/Period 2 (United States)||0||
59749153|NCT00673465|75868317|FG009|STARTED|Part 1/Period 2 (United States)||0||
59749154|NCT00673465|75868318|FG010|STARTED|Part 1/Period 2 (United States)||0||
59749155|NCT00673465|75868319|FG011|STARTED|Part 1/Period 2 (United States)||0||
59749156|NCT00673465|75868308|FG000|COMPLETED|Part 1/Period 2 (United States)||3||
59749157|NCT00673465|75868309|FG001|COMPLETED|Part 1/Period 2 (United States)||3||
59749158|NCT00673465|75868310|FG002|COMPLETED|Part 1/Period 2 (United States)||3||
59749159|NCT00673465|75868311|FG003|COMPLETED|Part 1/Period 2 (United States)||3||
59749160|NCT00673465|75868312|FG004|COMPLETED|Part 1/Period 2 (United States)||1||
59749161|NCT00673465|75868313|FG005|COMPLETED|Part 1/Period 2 (United States)||1||
59749162|NCT00673465|75868314|FG006|COMPLETED|Part 1/Period 2 (United States)||0||
59749163|NCT00673465|75868315|FG007|COMPLETED|Part 1/Period 2 (United States)||0||
59749164|NCT00673465|75868316|FG008|COMPLETED|Part 1/Period 2 (United States)||0||
59749165|NCT00673465|75868317|FG009|COMPLETED|Part 1/Period 2 (United States)||0||
59749166|NCT00673465|75868318|FG010|COMPLETED|Part 1/Period 2 (United States)||0||
59749167|NCT00673465|75868319|FG011|COMPLETED|Part 1/Period 2 (United States)||0||
59749168|NCT00673465|75868308|FG000|NOT COMPLETED|Part 1/Period 2 (United States)||0||
59749169|NCT00673465|75868309|FG001|NOT COMPLETED|Part 1/Period 2 (United States)||0||
59749170|NCT00673465|75868310|FG002|NOT COMPLETED|Part 1/Period 2 (United States)||0||
59749171|NCT00673465|75868311|FG003|NOT COMPLETED|Part 1/Period 2 (United States)||0||
59749172|NCT00673465|75868312|FG004|NOT COMPLETED|Part 1/Period 2 (United States)||1||
59749173|NCT00673465|75868313|FG005|NOT COMPLETED|Part 1/Period 2 (United States)||0||
59749174|NCT00673465|75868314|FG006|NOT COMPLETED|Part 1/Period 2 (United States)||0||
59749175|NCT00673465|75868315|FG007|NOT COMPLETED|Part 1/Period 2 (United States)||0||
59749176|NCT00673465|75868316|FG008|NOT COMPLETED|Part 1/Period 2 (United States)||0||
59749177|NCT00673465|75868317|FG009|NOT COMPLETED|Part 1/Period 2 (United States)||0||
59749178|NCT00673465|75868318|FG010|NOT COMPLETED|Part 1/Period 2 (United States)||0||
59749179|NCT00673465|75868319|FG011|NOT COMPLETED|Part 1/Period 2 (United States)||0||
59749180|NCT00673465|75868308|FG000|STARTED|Part 1/Period 3 (United States)||3||
59749181|NCT00673465|75868309|FG001|STARTED|Part 1/Period 3 (United States)||3||
59749182|NCT00673465|75868310|FG002|STARTED|Part 1/Period 3 (United States)||3||
59749183|NCT00673465|75868311|FG003|STARTED|Part 1/Period 3 (United States)||3||
59749184|NCT00673465|75868312|FG004|STARTED|Part 1/Period 3 (United States)||1||
59749185|NCT00673465|75868313|FG005|STARTED|Part 1/Period 3 (United States)||1||
59749186|NCT00673465|75868314|FG006|STARTED|Part 1/Period 3 (United States)||0||
59749187|NCT00673465|75868315|FG007|STARTED|Part 1/Period 3 (United States)||0||
59749188|NCT00673465|75868316|FG008|STARTED|Part 1/Period 3 (United States)||0||
60002498|NCT02063854|76118383|FG000|Full Analysis Set: Received Study Drug|Overall Study||199||
60002499|NCT02063854|76118384|FG001|Full Analysis Set: Received Study Drug|Overall Study||66||
60002500|NCT02063854|76118385|FG002|Full Analysis Set: Received Study Drug|Overall Study||206||
60002501|NCT02063854|76118386|FG003|Full Analysis Set: Received Study Drug|Overall Study||68||
60002502|NCT02063854|76118387|FG004|Full Analysis Set: Received Study Drug|Overall Study||65||
60002503|NCT02063854|76118388|FG005|Full Analysis Set: Received Study Drug|Overall Study||200||
60002504|NCT02063854|76118389|FG006|Full Analysis Set: Received Study Drug|Overall Study||66||
60002505|NCT02063854|76118383|FG000|COMPLETED|Overall Study||178||
60002506|NCT02063854|76118384|FG001|COMPLETED|Overall Study||54||
60002507|NCT02063854|76118385|FG002|COMPLETED|Overall Study||176||
60002508|NCT02063854|76118386|FG003|COMPLETED|Overall Study||58||
60002509|NCT02063854|76118387|FG004|COMPLETED|Overall Study||54||
59749189|NCT00673465|75868317|FG009|STARTED|Part 1/Period 3 (United States)||0||
59749190|NCT00673465|75868318|FG010|STARTED|Part 1/Period 3 (United States)||0||
59749191|NCT00673465|75868319|FG011|STARTED|Part 1/Period 3 (United States)||0||
59749192|NCT00673465|75868308|FG000|COMPLETED|Part 1/Period 3 (United States)||3||
59749193|NCT00673465|75868309|FG001|COMPLETED|Part 1/Period 3 (United States)||3||
60002510|NCT02063854|76118388|FG005|COMPLETED|Overall Study||170||
60002511|NCT02063854|76118389|FG006|COMPLETED|Overall Study||60||
60002512|NCT02063854|76118383|FG000|NOT COMPLETED|Overall Study||21||
59749194|NCT00673465|75868310|FG002|COMPLETED|Part 1/Period 3 (United States)||3||
59749195|NCT00673465|75868311|FG003|COMPLETED|Part 1/Period 3 (United States)||3||
60002513|NCT02063854|76118384|FG001|NOT COMPLETED|Overall Study||12||
60002514|NCT02063854|76118385|FG002|NOT COMPLETED|Overall Study||30||
59749196|NCT00673465|75868312|FG004|COMPLETED|Part 1/Period 3 (United States)||1||
59749197|NCT00673465|75868313|FG005|COMPLETED|Part 1/Period 3 (United States)||1||
59749198|NCT00673465|75868314|FG006|COMPLETED|Part 1/Period 3 (United States)||0||
59749199|NCT00673465|75868315|FG007|COMPLETED|Part 1/Period 3 (United States)||0||
59749200|NCT00673465|75868316|FG008|COMPLETED|Part 1/Period 3 (United States)||0||
59749201|NCT00673465|75868317|FG009|COMPLETED|Part 1/Period 3 (United States)||0||
59749202|NCT00673465|75868318|FG010|COMPLETED|Part 1/Period 3 (United States)||0||
59749203|NCT00673465|75868319|FG011|COMPLETED|Part 1/Period 3 (United States)||0||
59749204|NCT00673465|75868308|FG000|NOT COMPLETED|Part 1/Period 3 (United States)||0||
59749205|NCT00673465|75868309|FG001|NOT COMPLETED|Part 1/Period 3 (United States)||0||
59749206|NCT00673465|75868310|FG002|NOT COMPLETED|Part 1/Period 3 (United States)||0||
59749207|NCT00673465|75868311|FG003|NOT COMPLETED|Part 1/Period 3 (United States)||0||
59749208|NCT00673465|75868312|FG004|NOT COMPLETED|Part 1/Period 3 (United States)||0||
59749209|NCT00673465|75868313|FG005|NOT COMPLETED|Part 1/Period 3 (United States)||0||
59749210|NCT00673465|75868314|FG006|NOT COMPLETED|Part 1/Period 3 (United States)||0||
59749211|NCT00673465|75868315|FG007|NOT COMPLETED|Part 1/Period 3 (United States)||0||
59749212|NCT00673465|75868316|FG008|NOT COMPLETED|Part 1/Period 3 (United States)||0||
59749213|NCT00673465|75868317|FG009|NOT COMPLETED|Part 1/Period 3 (United States)||0||
59749214|NCT00673465|75868318|FG010|NOT COMPLETED|Part 1/Period 3 (United States)||0||
59749215|NCT00673465|75868319|FG011|NOT COMPLETED|Part 1/Period 3 (United States)||0||
59749216|NCT00673465|75868308|FG000|STARTED|Part 2 (India)||0||
59749217|NCT00673465|75868309|FG001|STARTED|Part 2 (India)||0||
59749218|NCT00673465|75868310|FG002|STARTED|Part 2 (India)||0||
59749219|NCT00673465|75868311|FG003|STARTED|Part 2 (India)||0||
59749220|NCT00673465|75868312|FG004|STARTED|Part 2 (India)||0||
59749221|NCT00673465|75868313|FG005|STARTED|Part 2 (India)||0||
59749222|NCT00673465|75868314|FG006|STARTED|Part 2 (India)||0||
59749223|NCT00673465|75868315|FG007|STARTED|Part 2 (India)||0||
59749224|NCT00673465|75868316|FG008|STARTED|Part 2 (India)||0||
59749225|NCT00673465|75868317|FG009|STARTED|Part 2 (India)||0||
59749226|NCT00673465|75868318|FG010|STARTED|Part 2 (India)||0||
59749227|NCT00673465|75868319|FG011|STARTED|Part 2 (India)||0||
59749228|NCT00673465|75868308|FG000|COMPLETED|Part 2 (India)||0||
59749229|NCT00673465|75868309|FG001|COMPLETED|Part 2 (India)||0||
59749230|NCT00673465|75868310|FG002|COMPLETED|Part 2 (India)||0||
59749231|NCT00673465|75868311|FG003|COMPLETED|Part 2 (India)||0||
59749232|NCT00673465|75868312|FG004|COMPLETED|Part 2 (India)||0||
59749233|NCT00673465|75868313|FG005|COMPLETED|Part 2 (India)||0||
59749234|NCT00673465|75868314|FG006|COMPLETED|Part 2 (India)||0||
59749235|NCT00673465|75868315|FG007|COMPLETED|Part 2 (India)||0||
59749236|NCT00673465|75868316|FG008|COMPLETED|Part 2 (India)||0||
59749237|NCT00673465|75868317|FG009|COMPLETED|Part 2 (India)||0||
59749238|NCT00673465|75868318|FG010|COMPLETED|Part 2 (India)||0||
59749239|NCT00673465|75868319|FG011|COMPLETED|Part 2 (India)||0||
59749240|NCT00673465|75868308|FG000|NOT COMPLETED|Part 2 (India)||0||
59749241|NCT00673465|75868309|FG001|NOT COMPLETED|Part 2 (India)||0||
59749242|NCT00673465|75868310|FG002|NOT COMPLETED|Part 2 (India)||0||
59749243|NCT00673465|75868311|FG003|NOT COMPLETED|Part 2 (India)||0||
59749244|NCT00673465|75868312|FG004|NOT COMPLETED|Part 2 (India)||0||
59749245|NCT00673465|75868313|FG005|NOT COMPLETED|Part 2 (India)||0||
59749246|NCT00673465|75868314|FG006|NOT COMPLETED|Part 2 (India)||0||
59749247|NCT00673465|75868315|FG007|NOT COMPLETED|Part 2 (India)||0||
59749248|NCT00673465|75868316|FG008|NOT COMPLETED|Part 2 (India)||0||
59749249|NCT00673465|75868317|FG009|NOT COMPLETED|Part 2 (India)||0||
59749250|NCT00673465|75868318|FG010|NOT COMPLETED|Part 2 (India)||0||
59749251|NCT00673465|75868319|FG011|NOT COMPLETED|Part 2 (India)||0||
59749252|NCT00941798|75868329|FG000|STARTED|Overall Study||755||
59749253|NCT00941798|75868330|FG001|STARTED|Overall Study||763||
59749254|NCT00941798|75868329|FG000|Full Analysis Set|Overall Study||749||
59749255|NCT00941798|75868330|FG001|Full Analysis Set|Overall Study||759||
59749256|NCT00941798|75868329|FG000|COMPLETED|Overall Study||561||
59749257|NCT00941798|75868330|FG001|COMPLETED|Overall Study||578||
59749258|NCT00941798|75868329|FG000|NOT COMPLETED|Overall Study||194||
59749259|NCT00941798|75868330|FG001|NOT COMPLETED|Overall Study||185||
59749260|NCT00583102|75868336|FG000|STARTED|Overall Study||23||
59749261|NCT00583102|75868336|FG000|COMPLETED|Overall Study||20||
59749262|NCT00583102|75868336|FG000|NOT COMPLETED|Overall Study||3||
59749263|NCT05604794|75868340|FG000|STARTED|Overall Study||1806||
59749264|NCT05604794|75868340|FG000|COMPLETED|Overall Study||94||
59749265|NCT05604794|75868340|FG000|NOT COMPLETED|Overall Study||1712||
59749266|NCT05208866|75868344|FG000|STARTED|Lixivaptan Re-titration Period||1||
59749267|NCT05208866|75868344|FG000|COMPLETED|Lixivaptan Re-titration Period||1||
59749268|NCT05208866|75868344|FG000|NOT COMPLETED|Lixivaptan Re-titration Period||0||
59749269|NCT05208866|75868344|FG000|STARTED|Maintenance Treatment Period||1||
59749270|NCT05208866|75868344|FG000|COMPLETED|Maintenance Treatment Period||0||
59749271|NCT05208866|75868344|FG000|NOT COMPLETED|Maintenance Treatment Period||1||
59749272|NCT05208866|75868344|FG000|STARTED|Follow-up Period|All participants who were treated with lixivaptan completed the Follow-up Period, including those who did not complete the Maintenance Period.|1||
59749273|NCT05208866|75868344|FG000|COMPLETED|Follow-up Period||1||
59749274|NCT05208866|75868344|FG000|NOT COMPLETED|Follow-up Period||0||
59749275|NCT05158153|75868349|FG000|STARTED|Overall Study||1||
59749276|NCT05158153|75868349|FG000|COMPLETED|Overall Study||1||
59749277|NCT05158153|75868349|FG000|NOT COMPLETED|Overall Study||0||
59749278|NCT04839185|75868353|FG000|STARTED|Overall Study||3||
59749279|NCT04839185|75868353|FG000|COMPLETED|Overall Study||3||
59749280|NCT04839185|75868353|FG000|NOT COMPLETED|Overall Study||0||
59749281|NCT04745351|75868359|FG000|STARTED|Overall Study||166||
59749282|NCT04745351|75868360|FG001|STARTED|Overall Study||83||
59749283|NCT04745351|75868359|FG000|COMPLETED|Overall Study||95||
59749284|NCT04745351|75868360|FG001|COMPLETED|Overall Study||50||
59749285|NCT04745351|75868359|FG000|NOT COMPLETED|Overall Study||71||
59749286|NCT04745351|75868360|FG001|NOT COMPLETED|Overall Study||33||
59749287|NCT04704869|75868368|FG000|STARTED|Overall Study||805||
59749288|NCT04704869|75868369|FG001|STARTED|Overall Study||799||
59749289|NCT04704869|75868368|FG000|Completed 28-day Follow up|Overall Study||771||
59749290|NCT04704869|75868369|FG001|Completed 28-day Follow up|Overall Study||760||
59749291|NCT04704869|75868368|FG000|COMPLETED|Overall Study||771||
59749292|NCT04704869|75868369|FG001|COMPLETED|Overall Study||760||
59749293|NCT04704869|75868368|FG000|NOT COMPLETED|Overall Study||34||
59749294|NCT04704869|75868369|FG001|NOT COMPLETED|Overall Study||39||
59749295|NCT04427501|75868385|FG000|STARTED|Overall Study||156||
59749296|NCT04427501|75868386|FG001|STARTED|Overall Study||101||
59749297|NCT04427501|75868387|FG002|STARTED|Overall Study||107||
59749298|NCT04427501|75868388|FG003|STARTED|Overall Study||101||
59749299|NCT04427501|75868389|FG004|STARTED|Overall Study||112||
59749300|NCT04427501|75868390|FG005|STARTED|Overall Study|Participants in Placebo for Phase 3: 2800 mg Bamlanivimab + 2800 mg Etesevimab and Phase 3: 700 mg Bamlanivimab + 1400 mg Etesevimab were combined to avoid double counting.|776||
59749301|NCT04427501|75868391|FG006|STARTED|Overall Study||518||
59749302|NCT04427501|75868392|FG007|STARTED|Overall Study||513||
59749303|NCT04427501|75868393|FG008|STARTED|Overall Study||141||
59876573|NCT02858362|76000486|FG000|Did Not Enter Extension Phase|Overall Study||1|Completed the study (Week 48 treatment visit) but did not enter the optional extension phase.|
59876574|NCT02858362|76000487|FG001|Did Not Enter Extension Phase|Overall Study||2|Completed the study (Week 48 treatment visit) but did not enter the optional extension phase.|
59876575|NCT02858362|76000488|FG002|Did Not Enter Extension Phase|Overall Study||0|Completed the study (Week 48 treatment visit) but did not enter the optional extension phase.|
59876576|NCT02858362|76000486|FG000|COMPLETED|Overall Study||28||
60002515|NCT02063854|76118386|FG003|NOT COMPLETED|Overall Study||10||
59749304|NCT04427501|75868394|FG009|STARTED|Overall Study||213||
59749305|NCT04427501|75868385|FG000|Received at Least One Dose of Study Drug|Overall Study||156||
59749306|NCT04427501|75868386|FG001|Received at Least One Dose of Study Drug|Overall Study||101||
59749307|NCT04427501|75868387|FG002|Received at Least One Dose of Study Drug|Overall Study||107||
59749308|NCT04427501|75868388|FG003|Received at Least One Dose of Study Drug|Overall Study||101||
59749309|NCT04427501|75868389|FG004|Received at Least One Dose of Study Drug|Overall Study||112||
59749310|NCT04427501|75868390|FG005|Received at Least One Dose of Study Drug|Overall Study||776||
59749311|NCT04427501|75868391|FG006|Received at Least One Dose of Study Drug|Overall Study||518||
59749312|NCT04427501|75868392|FG007|Received at Least One Dose of Study Drug|Overall Study||513||
59749313|NCT04427501|75868393|FG008|Received at Least One Dose of Study Drug|Overall Study||141||
59749314|NCT04427501|75868394|FG009|Received at Least One Dose of Study Drug|Overall Study||213||
59749315|NCT04427501|75868385|FG000|Phase 3: Placebo For 2800 mg Bamlanivimab + 2800 mg Etesevimab|Overall Study||0||
59749316|NCT04427501|75868386|FG001|Phase 3: Placebo For 2800 mg Bamlanivimab + 2800 mg Etesevimab|Overall Study||0||
59749317|NCT04427501|75868387|FG002|Phase 3: Placebo For 2800 mg Bamlanivimab + 2800 mg Etesevimab|Overall Study||0||
59749318|NCT04427501|75868388|FG003|Phase 3: Placebo For 2800 mg Bamlanivimab + 2800 mg Etesevimab|Overall Study||0||
59749319|NCT04427501|75868389|FG004|Phase 3: Placebo For 2800 mg Bamlanivimab + 2800 mg Etesevimab|Overall Study||0||
59749320|NCT04427501|75868390|FG005|Phase 3: Placebo For 2800 mg Bamlanivimab + 2800 mg Etesevimab|Overall Study||517||
59749321|NCT04427501|75868391|FG006|Phase 3: Placebo For 2800 mg Bamlanivimab + 2800 mg Etesevimab|Overall Study||0||
59749322|NCT04427501|75868392|FG007|Phase 3: Placebo For 2800 mg Bamlanivimab + 2800 mg Etesevimab|Overall Study||0||
59749323|NCT04427501|75868393|FG008|Phase 3: Placebo For 2800 mg Bamlanivimab + 2800 mg Etesevimab|Overall Study||0||
59749324|NCT04427501|75868394|FG009|Phase 3: Placebo For 2800 mg Bamlanivimab + 2800 mg Etesevimab|Overall Study||0||
59749325|NCT04427501|75868385|FG000|Phase 3: Placebo For 700 mg Bamlanivimab + 1400 mg Etesevimab|Overall Study||0||
59749326|NCT04427501|75868386|FG001|Phase 3: Placebo For 700 mg Bamlanivimab + 1400 mg Etesevimab|Overall Study||0||
59749327|NCT04427501|75868387|FG002|Phase 3: Placebo For 700 mg Bamlanivimab + 1400 mg Etesevimab|Overall Study||0||
59749328|NCT04427501|75868388|FG003|Phase 3: Placebo For 700 mg Bamlanivimab + 1400 mg Etesevimab|Overall Study||0||
59749329|NCT04427501|75868389|FG004|Phase 3: Placebo For 700 mg Bamlanivimab + 1400 mg Etesevimab|Overall Study||0||
59749330|NCT04427501|75868390|FG005|Phase 3: Placebo For 700 mg Bamlanivimab + 1400 mg Etesevimab|Overall Study||776||
59749331|NCT04427501|75868391|FG006|Phase 3: Placebo For 700 mg Bamlanivimab + 1400 mg Etesevimab|Overall Study||0||
59749332|NCT04427501|75868392|FG007|Phase 3: Placebo For 700 mg Bamlanivimab + 1400 mg Etesevimab|Overall Study||0||
59749333|NCT04427501|75868393|FG008|Phase 3: Placebo For 700 mg Bamlanivimab + 1400 mg Etesevimab|Overall Study||0||
59749334|NCT04427501|75868394|FG009|Phase 3: Placebo For 700 mg Bamlanivimab + 1400 mg Etesevimab|Overall Study||0||
59749335|NCT04427501|75868385|FG000|COMPLETED|Overall Study||141||
59749336|NCT04427501|75868386|FG001|COMPLETED|Overall Study||95||
59749337|NCT04427501|75868387|FG002|COMPLETED|Overall Study||103||
59749338|NCT04427501|75868388|FG003|COMPLETED|Overall Study||98||
59749339|NCT04427501|75868389|FG004|COMPLETED|Overall Study||103||
59749340|NCT04427501|75868390|FG005|COMPLETED|Overall Study||719||
59749341|NCT04427501|75868391|FG006|COMPLETED|Overall Study||485||
59749342|NCT04427501|75868392|FG007|COMPLETED|Overall Study||496||
59749343|NCT04427501|75868393|FG008|COMPLETED|Overall Study||135||
59749344|NCT04427501|75868394|FG009|COMPLETED|Overall Study||207||
59749345|NCT04427501|75868385|FG000|NOT COMPLETED|Overall Study||15||
59749346|NCT04427501|75868386|FG001|NOT COMPLETED|Overall Study||6||
59749347|NCT04427501|75868387|FG002|NOT COMPLETED|Overall Study||4||
59749348|NCT04427501|75868388|FG003|NOT COMPLETED|Overall Study||3||
59749349|NCT04427501|75868389|FG004|NOT COMPLETED|Overall Study||9||
59749350|NCT04427501|75868390|FG005|NOT COMPLETED|Overall Study||57||
59749351|NCT04427501|75868391|FG006|NOT COMPLETED|Overall Study||33||
59749352|NCT04427501|75868392|FG007|NOT COMPLETED|Overall Study||17||
59749353|NCT04427501|75868393|FG008|NOT COMPLETED|Overall Study||6||
59749354|NCT04427501|75868394|FG009|NOT COMPLETED|Overall Study||6||
59749355|NCT04156802|75868431|FG000|STARTED|Overall Study||13||
59749356|NCT04156802|75868432|FG001|STARTED|Overall Study||6||
59749357|NCT04156802|75868433|FG002|STARTED|Overall Study||13||
59749358|NCT04156802|75868434|FG003|STARTED|Overall Study||6||
59749359|NCT04156802|75868431|FG000|COMPLETED|Overall Study||9||
59749360|NCT04156802|75868432|FG001|COMPLETED|Overall Study||5||
59749361|NCT04156802|75868433|FG002|COMPLETED|Overall Study||10||
59749362|NCT04156802|75868434|FG003|COMPLETED|Overall Study||5||
59749363|NCT04156802|75868431|FG000|NOT COMPLETED|Overall Study||4||
59749364|NCT04156802|75868432|FG001|NOT COMPLETED|Overall Study||1||
59749365|NCT04156802|75868433|FG002|NOT COMPLETED|Overall Study||3||
59749366|NCT04156802|75868434|FG003|NOT COMPLETED|Overall Study||1||
59749367|NCT03439124|75868446|FG000|STARTED|Overall Study||94||
59749368|NCT03439124|75868447|FG001|STARTED|Overall Study||44||
59749369|NCT03439124|75868446|FG000|COMPLETED|Overall Study||90||
59749370|NCT03439124|75868447|FG001|COMPLETED|Overall Study||44||
59749371|NCT03439124|75868446|FG000|NOT COMPLETED|Overall Study||4||
59749372|NCT03439124|75868447|FG001|NOT COMPLETED|Overall Study||0||
59749373|NCT03289052|75868456|FG000|STARTED|Overall Study||20||
59749374|NCT03289052|75868457|FG001|STARTED|Overall Study||111||
59749375|NCT03289052|75868458|FG002|STARTED|Overall Study||37||
59749376|NCT03289052|75868456|FG000|COMPLETED|Overall Study||20||
59749377|NCT03289052|75868457|FG001|COMPLETED|Overall Study||108||
59749378|NCT03289052|75868458|FG002|COMPLETED|Overall Study||32||
59749379|NCT03289052|75868456|FG000|NOT COMPLETED|Overall Study||0||
59749380|NCT03289052|75868457|FG001|NOT COMPLETED|Overall Study||3||
59749381|NCT03289052|75868458|FG002|NOT COMPLETED|Overall Study||5||
59749382|NCT03212989|75868466|FG000|STARTED|Overall Study||17||
59749383|NCT03212989|75868466|FG000|Completed Baseline Leukapheresis|Overall Study||17||
59749384|NCT03212989|75868466|FG000|First Intervention Series VOR/HXTC Infusion|Overall Study||9||
59749385|NCT03212989|75868466|FG000|Second Intervention Series VOR/HXTC Infusion|Overall Study||9||
59749386|NCT03212989|75868466|FG000|COMPLETED|Overall Study||9||
59749387|NCT03212989|75868466|FG000|NOT COMPLETED|Overall Study||8||
59749388|NCT03200548|75868474|FG000|STARTED|Overall Study||11||
59749389|NCT03200548|75868475|FG001|STARTED|Overall Study||14||
59749390|NCT03200548|75868476|FG002|STARTED|Overall Study||14||
59749391|NCT03200548|75868477|FG003|STARTED|Overall Study||13||
59749392|NCT03200548|75868474|FG000|COMPLETED|Overall Study||6||
59749393|NCT03200548|75868475|FG001|COMPLETED|Overall Study||3||
59749394|NCT03200548|75868476|FG002|COMPLETED|Overall Study||7||
59749395|NCT03200548|75868477|FG003|COMPLETED|Overall Study||7||
59749396|NCT03200548|75868474|FG000|NOT COMPLETED|Overall Study||5||
59749397|NCT03200548|75868475|FG001|NOT COMPLETED|Overall Study||11||
59749398|NCT03200548|75868476|FG002|NOT COMPLETED|Overall Study||7||
59749399|NCT03200548|75868477|FG003|NOT COMPLETED|Overall Study||6||
59749400|NCT03158688|75868489|FG000|STARTED|Overall Study||154||
59749401|NCT03158688|75868490|FG001|STARTED|Overall Study||312||
59749402|NCT03158688|75868489|FG000|Treated|Overall Study||153||
59749403|NCT03158688|75868490|FG001|Treated|Overall Study||308||
59749404|NCT03158688|75868489|FG000|COMPLETED|Overall Study||49||
59749405|NCT03158688|75868490|FG001|COMPLETED|Overall Study||102||
59749406|NCT03158688|75868489|FG000|NOT COMPLETED|Overall Study||105||
59749407|NCT03158688|75868490|FG001|NOT COMPLETED|Overall Study||210||
59749408|NCT03137173|75868498|FG000|STARTED|Overall Study||335||
59749409|NCT03137173|75868499|FG001|STARTED|Overall Study||344||
59749410|NCT03137173|75868498|FG000|COMPLETED|Overall Study||309||
59749411|NCT03137173|75868499|FG001|COMPLETED|Overall Study||308||
59749412|NCT03137173|75868498|FG000|NOT COMPLETED|Overall Study||26||
59749413|NCT03137173|75868499|FG001|NOT COMPLETED|Overall Study||36||
59749414|NCT02798120|75868508|FG000|STARTED|Overall Study||296||
59749415|NCT02798120|75868509|FG001|STARTED|Overall Study||305||
59749416|NCT02798120|75868508|FG000|COMPLETED|Overall Study||232||
59749417|NCT02798120|75868509|FG001|COMPLETED|Overall Study||216||
59749418|NCT02798120|75868508|FG000|NOT COMPLETED|Overall Study||64||
59749419|NCT02798120|75868509|FG001|NOT COMPLETED|Overall Study||89||
59749420|NCT02053077|75868522|FG000|STARTED|Overall Study||150||
59749421|NCT02053077|75868522|FG000|COMPLETED|Overall Study||150||
59749422|NCT02053077|75868522|FG000|NOT COMPLETED|Overall Study||0||
59749423|NCT01575808|75868528|FG000|STARTED|Overall Study||103||
59749424|NCT01575808|75868529|FG001|STARTED|Overall Study||68||
59749425|NCT01575808|75868528|FG000|COMPLETED|Overall Study|Study ongoing. All 103 assessed for primary invasiveness endpoints,100 for primary efficacy endpoint|100||
59749426|NCT01575808|75868529|FG001|COMPLETED|Overall Study||68||
59749427|NCT01575808|75868528|FG000|NOT COMPLETED|Overall Study||3||
59749428|NCT01575808|75868529|FG001|NOT COMPLETED|Overall Study||0||
59749429|NCT01546753|75868539|FG000|STARTED|Overall Study||10||
59749430|NCT01546753|75868540|FG001|STARTED|Overall Study||4||
59749431|NCT01546753|75868539|FG000|COMPLETED|Overall Study||8||
59749432|NCT01546753|75868540|FG001|COMPLETED|Overall Study||3||
59749433|NCT01546753|75868539|FG000|NOT COMPLETED|Overall Study||2||
59749434|NCT01546753|75868540|FG001|NOT COMPLETED|Overall Study||1||
59749435|NCT00941720|75868553|FG000|STARTED|Overall Study||71||
59749436|NCT00941720|75868553|FG000|COMPLETED|Overall Study||57||
59749437|NCT00941720|75868553|FG000|NOT COMPLETED|Overall Study||14||
59749438|NCT00933686|75868559|FG000|STARTED|Overall Study||55||
59749439|NCT00933686|75868560|FG001|STARTED|Overall Study||58||
59749440|NCT00933686|75868559|FG000|COMPLETED|Overall Study||45||
59749441|NCT00933686|75868560|FG001|COMPLETED|Overall Study||47||
59749442|NCT00933686|75868559|FG000|NOT COMPLETED|Overall Study||10||
59749443|NCT00933686|75868560|FG001|NOT COMPLETED|Overall Study||11||
59749444|NCT00937040|75868568|FG000|STARTED|Overall Study||179||
59749445|NCT00937040|75868569|FG001|STARTED|Overall Study||178||
59749446|NCT00937040|75868568|FG000|COMPLETED|Overall Study||138||
59749447|NCT00937040|75868569|FG001|COMPLETED|Overall Study||141||
59749448|NCT00937040|75868568|FG000|NOT COMPLETED|Overall Study||41||
59749449|NCT00937040|75868569|FG001|NOT COMPLETED|Overall Study||37||
59749450|NCT00673387|75868583|FG000|STARTED|Overall Study||75||
59749451|NCT00673387|75868584|FG001|STARTED|Overall Study||77||
59749452|NCT00673387|75868585|FG002|STARTED|Overall Study||72||
59749453|NCT00673387|75868586|FG003|STARTED|Overall Study||75||
59749454|NCT00673387|75868587|FG004|STARTED|Overall Study||78||
59749455|NCT00673387|75868588|FG005|STARTED|Overall Study||78||
59749456|NCT00673387|75868589|FG006|STARTED|Overall Study||78||
59749457|NCT00673387|75868590|FG007|STARTED|Overall Study||75||
59749458|NCT00673387|75868583|FG000|COMPLETED|Overall Study||46||
59749459|NCT00673387|75868584|FG001|COMPLETED|Overall Study||54||
59749460|NCT00673387|75868585|FG002|COMPLETED|Overall Study||41||
59749461|NCT00673387|75868586|FG003|COMPLETED|Overall Study||49||
59749462|NCT00673387|75868587|FG004|COMPLETED|Overall Study||48||
59749463|NCT00673387|75868588|FG005|COMPLETED|Overall Study||44||
59749464|NCT00673387|75868589|FG006|COMPLETED|Overall Study||48||
59749465|NCT00673387|75868590|FG007|COMPLETED|Overall Study||40||
59749466|NCT00673387|75868583|FG000|NOT COMPLETED|Overall Study||29||
59749467|NCT00673387|75868584|FG001|NOT COMPLETED|Overall Study||23||
59605371|NCT01994382|75715564|FG004|STARTED|Overall Study||3||
59605372|NCT01994382|75715565|FG005|STARTED|Overall Study||3||
59605373|NCT01994382|75715566|FG006|STARTED|Overall Study||4||
59605374|NCT01994382|75715567|FG007|STARTED|Overall Study||6||
59605375|NCT01994382|75715568|FG008|STARTED|Overall Study||3||
59605376|NCT01994382|75715569|FG009|STARTED|Overall Study||5||
59605377|NCT01994382|75715570|FG010|STARTED|Overall Study||42||
59605378|NCT01994382|75715571|FG011|STARTED|Overall Study||12||
59605379|NCT01994382|75715572|FG012|STARTED|Overall Study||26||
59605380|NCT01994382|75715573|FG013|STARTED|Overall Study||6||
59605381|NCT01994382|75715574|FG014|STARTED|Overall Study||28||
59605382|NCT01994382|75715575|FG015|STARTED|Overall Study||65||
59605383|NCT01994382|75715576|FG016|STARTED|Overall Study||41||
59605384|NCT01994382|75715560|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3|Safety Population|
59605385|NCT01994382|75715561|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6|Safety Population|
59605386|NCT01994382|75715562|FG002|Received at Least 1 Dose of Study Drug|Overall Study||7|Safety Population|
59605387|NCT01994382|75715563|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3|Safety Population|
59605388|NCT01994382|75715564|FG004|Received at Least 1 Dose of Study Drug|Overall Study||3|Safety Population|
59605389|NCT01994382|75715565|FG005|Received at Least 1 Dose of Study Drug|Overall Study||3|Safety Population|
59605390|NCT01994382|75715566|FG006|Received at Least 1 Dose of Study Drug|Overall Study||4|Safety Population|
59605391|NCT01994382|75715567|FG007|Received at Least 1 Dose of Study Drug|Overall Study||6|Safety Population|
59605392|NCT01994382|75715568|FG008|Received at Least 1 Dose of Study Drug|Overall Study||3|Safety Population|
59749468|NCT00673387|75868585|FG002|NOT COMPLETED|Overall Study||31||
59749469|NCT00673387|75868586|FG003|NOT COMPLETED|Overall Study||26||
59749470|NCT00673387|75868587|FG004|NOT COMPLETED|Overall Study||30||
59749471|NCT00673387|75868588|FG005|NOT COMPLETED|Overall Study||34||
59749472|NCT00673387|75868589|FG006|NOT COMPLETED|Overall Study||30||
59749473|NCT00673387|75868590|FG007|NOT COMPLETED|Overall Study||35||
59749474|NCT00933608|75868620|FG000|STARTED|Overall Study||7||
59749475|NCT00933608|75868621|FG001|STARTED|Overall Study||10||
59749476|NCT00933608|75868620|FG000|COMPLETED|Overall Study||2||
59749477|NCT00933608|75868621|FG001|COMPLETED|Overall Study||8||
59749478|NCT00933608|75868620|FG000|NOT COMPLETED|Overall Study||5||
59749479|NCT00933608|75868621|FG001|NOT COMPLETED|Overall Study||2||
59749480|NCT00574951|75868627|FG000|STARTED|Overall Study||23||
59749481|NCT00574951|75868627|FG000|COMPLETED|Overall Study||22|Eligible and treated patients.|
59749482|NCT00574951|75868627|FG000|NOT COMPLETED|Overall Study||1||
59749483|NCT01557751|75868631|FG000|STARTED|Overall Study||156||
59749484|NCT01557751|75868631|FG000|COMPLETED|Overall Study||153||
59749485|NCT01557751|75868631|FG000|NOT COMPLETED|Overall Study||3||
59749486|NCT00936884|75868637|FG000|STARTED|Double-blind|Twenty-five subjects received MNTX, and 24 had ≥ 1 post baseline diary assessment.|25||
59749487|NCT00936884|75868638|FG001|STARTED|Double-blind|Twenty-four subjects received placebo, and 23 had ≥ 1 post baseline diary assessment.|25||
59749488|NCT00936884|75868639|FG002|STARTED|Double-blind|Thirteen subjects from the MNTX group and 18 from the placebo group entered the 12-week extension.|0||
59749489|NCT00936884|75868637|FG000|COMPLETED|Double-blind||13||
59749490|NCT00936884|75868638|FG001|COMPLETED|Double-blind||18||
59749491|NCT00936884|75868639|FG002|COMPLETED|Double-blind||0||
59749492|NCT00936884|75868637|FG000|NOT COMPLETED|Double-blind||12||
59749493|NCT00936884|75868638|FG001|NOT COMPLETED|Double-blind||7||
59749494|NCT00936884|75868639|FG002|NOT COMPLETED|Double-blind||0||
59749495|NCT00936884|75868637|FG000|STARTED|Open-label||0|Thirteen subjects from the MNTX group and 18 from the placebo group entered the 12-week extension.|
59749496|NCT00936884|75868638|FG001|STARTED|Open-label||0|Thirteen subjects from the MNTX group and 18 from the placebo group entered the 12-week extension.|
59749497|NCT00936884|75868639|FG002|STARTED|Open-label||31|Thirteen subjects from the MNTX group and 18 from the placebo group entered the 12-week extension.|
59749498|NCT00936884|75868637|FG000|COMPLETED|Open-label||0||
59749499|NCT00936884|75868638|FG001|COMPLETED|Open-label||0||
59749500|NCT00936884|75868639|FG002|COMPLETED|Open-label||12||
59749501|NCT00936884|75868637|FG000|NOT COMPLETED|Open-label||0||
59749502|NCT00936884|75868638|FG001|NOT COMPLETED|Open-label||0||
59749503|NCT00936884|75868639|FG002|NOT COMPLETED|Open-label||19||
59749504|NCT04378426|75868648|FG000|STARTED|Overall Study||1||
59749505|NCT04378426|75868649|FG001|STARTED|Overall Study||0||
59749506|NCT04378426|75868648|FG000|COMPLETED|Overall Study||1||
59749507|NCT04378426|75868649|FG001|COMPLETED|Overall Study||0||
59749508|NCT04378426|75868648|FG000|NOT COMPLETED|Overall Study||0||
59749509|NCT04378426|75868649|FG001|NOT COMPLETED|Overall Study||0||
59749510|NCT00668863|75868655|FG000|STARTED|Overall Study||71||
59749511|NCT00668863|75868655|FG000|COMPLETED|Overall Study||0||
59749512|NCT00668863|75868655|FG000|NOT COMPLETED|Overall Study||71||
59749513|NCT00935012|75868659|FG000|STARTED|Overall Study||31||
59749514|NCT00935012|75868659|FG000|COMPLETED|Overall Study||2||
59749515|NCT00935012|75868659|FG000|NOT COMPLETED|Overall Study||29||
59749516|NCT00932360|75868663|FG000|STARTED|1: Visit 1/Week1||10||
59749517|NCT00932360|75868664|FG001|STARTED|1: Visit 1/Week1||6||
59749518|NCT00932360|75868665|FG002|STARTED|1: Visit 1/Week1||3||
59749519|NCT00932360|75868666|FG003|STARTED|1: Visit 1/Week1||13||
59749520|NCT00932360|75868667|FG004|STARTED|1: Visit 1/Week1||4||
59749521|NCT00932360|75868668|FG005|STARTED|1: Visit 1/Week1||7||
59749522|NCT00932360|75868663|FG000|COMPLETED|1: Visit 1/Week1||10||
59749523|NCT00932360|75868664|FG001|COMPLETED|1: Visit 1/Week1||6||
59749524|NCT00932360|75868665|FG002|COMPLETED|1: Visit 1/Week1||3||
59749525|NCT00932360|75868666|FG003|COMPLETED|1: Visit 1/Week1||13||
59749526|NCT00932360|75868667|FG004|COMPLETED|1: Visit 1/Week1||4||
59749527|NCT00932360|75868668|FG005|COMPLETED|1: Visit 1/Week1||7||
59749528|NCT00932360|75868663|FG000|NOT COMPLETED|1: Visit 1/Week1||0||
59749529|NCT00932360|75868664|FG001|NOT COMPLETED|1: Visit 1/Week1||0||
59749530|NCT00932360|75868665|FG002|NOT COMPLETED|1: Visit 1/Week1||0||
59749531|NCT00932360|75868666|FG003|NOT COMPLETED|1: Visit 1/Week1||0||
59749532|NCT00932360|75868667|FG004|NOT COMPLETED|1: Visit 1/Week1||0||
59749533|NCT00932360|75868668|FG005|NOT COMPLETED|1: Visit 1/Week1||0||
59749534|NCT00932360|75868663|FG000|STARTED|Washout (One Week)||10||
59749535|NCT00932360|75868664|FG001|STARTED|Washout (One Week)||6||
59749536|NCT00932360|75868665|FG002|STARTED|Washout (One Week)||3||
59749537|NCT00932360|75868666|FG003|STARTED|Washout (One Week)||13||
59749538|NCT00932360|75868667|FG004|STARTED|Washout (One Week)||4||
59749539|NCT00932360|75868668|FG005|STARTED|Washout (One Week)||7||
59749540|NCT00932360|75868663|FG000|COMPLETED|Washout (One Week)||10||
59749541|NCT00932360|75868664|FG001|COMPLETED|Washout (One Week)||6||
59749542|NCT00932360|75868665|FG002|COMPLETED|Washout (One Week)||3||
59749543|NCT00932360|75868666|FG003|COMPLETED|Washout (One Week)||13||
59749544|NCT00932360|75868667|FG004|COMPLETED|Washout (One Week)||2||
59749545|NCT00932360|75868668|FG005|COMPLETED|Washout (One Week)||7||
59749546|NCT00932360|75868663|FG000|NOT COMPLETED|Washout (One Week)||0||
59749547|NCT00932360|75868664|FG001|NOT COMPLETED|Washout (One Week)||0||
59749548|NCT00932360|75868665|FG002|NOT COMPLETED|Washout (One Week)||0||
59749549|NCT00932360|75868666|FG003|NOT COMPLETED|Washout (One Week)||0||
59749550|NCT00932360|75868667|FG004|NOT COMPLETED|Washout (One Week)||2||
59749551|NCT00932360|75868668|FG005|NOT COMPLETED|Washout (One Week)||0||
59749552|NCT00932360|75868663|FG000|STARTED|Visit 2/Week 2||10||
59749553|NCT00932360|75868664|FG001|STARTED|Visit 2/Week 2||6||
59749554|NCT00932360|75868665|FG002|STARTED|Visit 2/Week 2||3||
59749555|NCT00932360|75868666|FG003|STARTED|Visit 2/Week 2||13||
59749556|NCT00932360|75868667|FG004|STARTED|Visit 2/Week 2||2||
59749557|NCT00932360|75868668|FG005|STARTED|Visit 2/Week 2||7||
59749558|NCT00932360|75868663|FG000|COMPLETED|Visit 2/Week 2||10||
59749559|NCT00932360|75868664|FG001|COMPLETED|Visit 2/Week 2||6||
59749560|NCT00932360|75868665|FG002|COMPLETED|Visit 2/Week 2||3||
59749561|NCT00932360|75868666|FG003|COMPLETED|Visit 2/Week 2||13||
59749562|NCT00932360|75868667|FG004|COMPLETED|Visit 2/Week 2||2||
59749563|NCT00932360|75868668|FG005|COMPLETED|Visit 2/Week 2||7||
59749564|NCT00932360|75868663|FG000|NOT COMPLETED|Visit 2/Week 2||0||
59749565|NCT00932360|75868664|FG001|NOT COMPLETED|Visit 2/Week 2||0||
59749566|NCT00932360|75868665|FG002|NOT COMPLETED|Visit 2/Week 2||0||
59749567|NCT00932360|75868666|FG003|NOT COMPLETED|Visit 2/Week 2||0||
59749568|NCT00932360|75868667|FG004|NOT COMPLETED|Visit 2/Week 2||0||
59749569|NCT00932360|75868668|FG005|NOT COMPLETED|Visit 2/Week 2||0||
59749570|NCT00932360|75868663|FG000|STARTED|Washout (One Week)||10||
59749571|NCT00932360|75868664|FG001|STARTED|Washout (One Week)||6||
59749572|NCT00932360|75868665|FG002|STARTED|Washout (One Week)||3||
59749573|NCT00932360|75868666|FG003|STARTED|Washout (One Week)||13||
59749574|NCT00932360|75868667|FG004|STARTED|Washout (One Week)||2||
59749575|NCT00932360|75868668|FG005|STARTED|Washout (One Week)||7||
59749576|NCT00932360|75868663|FG000|COMPLETED|Washout (One Week)||10||
59749577|NCT00932360|75868664|FG001|COMPLETED|Washout (One Week)||6||
59749578|NCT00932360|75868665|FG002|COMPLETED|Washout (One Week)||3||
59749579|NCT00932360|75868666|FG003|COMPLETED|Washout (One Week)||13||
59749580|NCT00932360|75868667|FG004|COMPLETED|Washout (One Week)||2||
59749581|NCT00932360|75868668|FG005|COMPLETED|Washout (One Week)||7||
59749582|NCT00932360|75868663|FG000|NOT COMPLETED|Washout (One Week)||0||
59749583|NCT00932360|75868664|FG001|NOT COMPLETED|Washout (One Week)||0||
59749584|NCT00932360|75868665|FG002|NOT COMPLETED|Washout (One Week)||0||
59749585|NCT00932360|75868666|FG003|NOT COMPLETED|Washout (One Week)||0||
59749586|NCT00932360|75868667|FG004|NOT COMPLETED|Washout (One Week)||0||
59749587|NCT00932360|75868668|FG005|NOT COMPLETED|Washout (One Week)||0||
59749588|NCT00932360|75868663|FG000|STARTED|Visit 3/Week 3||10||
59749589|NCT00932360|75868664|FG001|STARTED|Visit 3/Week 3||6||
59749590|NCT00932360|75868665|FG002|STARTED|Visit 3/Week 3||3||
59749591|NCT00932360|75868666|FG003|STARTED|Visit 3/Week 3||13||
59749592|NCT00932360|75868667|FG004|STARTED|Visit 3/Week 3||2||
59749593|NCT00932360|75868668|FG005|STARTED|Visit 3/Week 3||7||
59749594|NCT00932360|75868663|FG000|COMPLETED|Visit 3/Week 3||10||
59749595|NCT00932360|75868664|FG001|COMPLETED|Visit 3/Week 3||6||
59749596|NCT00932360|75868665|FG002|COMPLETED|Visit 3/Week 3||3||
59749597|NCT00932360|75868666|FG003|COMPLETED|Visit 3/Week 3||13||
59749598|NCT00932360|75868667|FG004|COMPLETED|Visit 3/Week 3||2||
59749599|NCT00932360|75868668|FG005|COMPLETED|Visit 3/Week 3||7||
59749600|NCT00932360|75868663|FG000|NOT COMPLETED|Visit 3/Week 3||0||
59749601|NCT00932360|75868664|FG001|NOT COMPLETED|Visit 3/Week 3||0||
59749602|NCT00932360|75868665|FG002|NOT COMPLETED|Visit 3/Week 3||0||
59749603|NCT00932360|75868666|FG003|NOT COMPLETED|Visit 3/Week 3||0||
59749604|NCT00932360|75868667|FG004|NOT COMPLETED|Visit 3/Week 3||0||
59749605|NCT00932360|75868668|FG005|NOT COMPLETED|Visit 3/Week 3||0||
59749606|NCT00668707|75868684|FG000|STARTED|Overall Study||356||
59749607|NCT00668707|75868685|FG001|STARTED|Overall Study||353||
59749608|NCT00668707|75868684|FG000|COMPLETED|Overall Study||157||
59749609|NCT00668707|75868685|FG001|COMPLETED|Overall Study||173||
59749610|NCT00668707|75868684|FG000|NOT COMPLETED|Overall Study||199||
59749611|NCT00668707|75868685|FG001|NOT COMPLETED|Overall Study||180||
59749612|NCT00668395|75868699|FG000|STARTED|Overall Study||45||
59749613|NCT00668395|75868700|FG001|STARTED|Overall Study||22||
59749614|NCT00668395|75868701|FG002|STARTED|Overall Study||6||
59749615|NCT00668395|75868699|FG000|COMPLETED|Overall Study||39||
59749616|NCT00668395|75868700|FG001|COMPLETED|Overall Study||16||
59749617|NCT00668395|75868701|FG002|COMPLETED|Overall Study||5||
59749618|NCT00668395|75868699|FG000|NOT COMPLETED|Overall Study||6||
59749619|NCT00668395|75868700|FG001|NOT COMPLETED|Overall Study||6||
59749620|NCT00668395|75868701|FG002|NOT COMPLETED|Overall Study||1||
59749621|NCT00668317|75868709|FG000|STARTED|Overall Study||5||
59749622|NCT00668317|75868709|FG000|COMPLETED|Overall Study||3||
59749623|NCT00668317|75868709|FG000|NOT COMPLETED|Overall Study||2||
59749624|NCT04024072|75868715|FG000|STARTED|Overall Study||249||
59749625|NCT04024072|75868716|FG001|STARTED|Overall Study||246||
59749626|NCT04024072|75868715|FG000|COMPLETED|Overall Study||247||
59749627|NCT04024072|75868716|FG001|COMPLETED|Overall Study||237||
59749628|NCT04024072|75868715|FG000|NOT COMPLETED|Overall Study||2||
59749629|NCT04024072|75868716|FG001|NOT COMPLETED|Overall Study||9||
59749630|NCT03828214|75868722|FG000|STARTED|Overall Study||11||
59749631|NCT03828214|75868722|FG000|COMPLETED|Overall Study|11 participants completed this study, however, for some outcome variables, only data from 9 or 10 participants was available for analysis due to technical challenges during data collection.|11||
59749632|NCT03828214|75868722|FG000|NOT COMPLETED|Overall Study||0||
59749633|NCT00670111|75868730|FG000|STARTED|Enrollment to One Month||5||
59749634|NCT00670111|75868731|FG001|STARTED|Enrollment to One Month||8||
59749635|NCT00670111|75868732|FG002|STARTED|Enrollment to One Month||19||
59749636|NCT00670111|75868730|FG000|COMPLETED|Enrollment to One Month||4||
59749637|NCT00670111|75868731|FG001|COMPLETED|Enrollment to One Month||8||
59749638|NCT00670111|75868732|FG002|COMPLETED|Enrollment to One Month||0||
59749639|NCT00670111|75868730|FG000|NOT COMPLETED|Enrollment to One Month||1||
59749640|NCT00670111|75868731|FG001|NOT COMPLETED|Enrollment to One Month||0||
59749641|NCT00670111|75868732|FG002|NOT COMPLETED|Enrollment to One Month||19||
59749642|NCT00670111|75868730|FG000|STARTED|One Month Period A||4||
59749643|NCT00670111|75868731|FG001|STARTED|One Month Period A||8||
59749644|NCT00670111|75868732|FG002|STARTED|One Month Period A||0||
59749645|NCT00670111|75868730|FG000|COMPLETED|One Month Period A||4||
59876577|NCT02858362|76000487|FG001|COMPLETED|Overall Study||9||
59876578|NCT02858362|76000488|FG002|COMPLETED|Overall Study||0||
59876579|NCT02858362|76000486|FG000|NOT COMPLETED|Overall Study||2||
59876580|NCT02858362|76000487|FG001|NOT COMPLETED|Overall Study||1||
59876581|NCT02858362|76000488|FG002|NOT COMPLETED|Overall Study||3||
59876582|NCT03350750|76000503|FG000|STARTED|Overall Study||9||
59876583|NCT03350750|76000504|FG001|STARTED|Overall Study||9||
59876584|NCT03350750|76000503|FG000|4-month Follow-up (Randomized Evaluation)|Overall Study||8||
59876585|NCT03350750|76000504|FG001|4-month Follow-up (Randomized Evaluation)|Overall Study||8||
59876586|NCT03350750|76000503|FG000|12-Month Follow-up (Entire Study)|Overall Study||8||
59876587|NCT03350750|76000504|FG001|12-Month Follow-up (Entire Study)|Overall Study||8||
59876588|NCT03350750|76000503|FG000|COMPLETED|Overall Study||8||
59876589|NCT03350750|76000504|FG001|COMPLETED|Overall Study||8||
59876590|NCT03350750|76000503|FG000|NOT COMPLETED|Overall Study||1||
59876591|NCT03350750|76000504|FG001|NOT COMPLETED|Overall Study||1||
59876592|NCT03394508|76000514|FG000|STARTED|Overall Study||13||
59876593|NCT03394508|76000515|FG001|STARTED|Overall Study||17||
59876594|NCT03394508|76000514|FG000|COMPLETED|Overall Study||12||
59876595|NCT03394508|76000515|FG001|COMPLETED|Overall Study||14||
59876596|NCT03394508|76000514|FG000|NOT COMPLETED|Overall Study||1||
59876597|NCT03394508|76000515|FG001|NOT COMPLETED|Overall Study||3||
59876598|NCT02856880|76000525|FG000|STARTED|Overall Study||45||
59876599|NCT02856880|76000525|FG000|Received Test Zinc-IPMP|Overall Study||44||
59876600|NCT02856880|76000525|FG000|Received Test Zinc Non-IPMP|Overall Study||44||
59876601|NCT02856880|76000525|FG000|Received Positive Control|Overall Study||45||
59876602|NCT02856880|76000525|FG000|Received Non-SLS Negative Control|Overall Study||44||
59876603|NCT02856880|76000525|FG000|Received SLS Negative Control|Overall Study||44||
59876604|NCT02856880|76000525|FG000|COMPLETED|Overall Study||44||
59876605|NCT02856880|76000525|FG000|NOT COMPLETED|Overall Study||1||
59876606|NCT03393806|76000546|FG000|STARTED|Overall Study||9||
59876607|NCT03393806|76000547|FG001|STARTED|Overall Study||8||
59876608|NCT03393806|76000546|FG000|COMPLETED|Overall Study||8||
59876609|NCT03393806|76000547|FG001|COMPLETED|Overall Study||8||
59876610|NCT03393806|76000546|FG000|NOT COMPLETED|Overall Study||1||
59876611|NCT03393806|76000547|FG001|NOT COMPLETED|Overall Study||0||
59876612|NCT02856802|76000556|FG000|STARTED|Double-Blind Treatment Period 1|4 of 54 randomized subjects did not start; 2 had no migraines, 1 withdrew, 1 lost to follow-up.|50||
59876613|NCT02856802|76000557|FG001|STARTED|Double-Blind Treatment Period 1|10 of 53 randomized subjects did not start; 6 had no migraines, 3 withdrew, 1 sponsor terminated.|43||
59876614|NCT02856802|76000556|FG000|COMPLETED|Double-Blind Treatment Period 1||48||
59876615|NCT02856802|76000557|FG001|COMPLETED|Double-Blind Treatment Period 1||38||
59876616|NCT02856802|76000556|FG000|NOT COMPLETED|Double-Blind Treatment Period 1||2||
59876617|NCT02856802|76000557|FG001|NOT COMPLETED|Double-Blind Treatment Period 1||5||
59876618|NCT02856802|76000556|FG000|STARTED|Double-Blind Treatment Period 2|6 of 43 re-randomized subjects did not start; 5 had no migraines, for 1 protocol deviation.|37|86 subjects completing double-blind treatment period 1, and still eligible, were re-randomized into double-blind treatment period 2|
59876619|NCT02856802|76000557|FG001|STARTED|Double-Blind Treatment Period 2|5 of 43 re-randomized subjects did not start; 4 had no migraines, for 1 prohibited drug use.|38|86 subjects completing double-blind treatment period 1, and still eligible, were re-randomized into double-blind treatment period 2|
59876620|NCT02856802|76000556|FG000|COMPLETED|Double-Blind Treatment Period 2||36||
59876621|NCT02856802|76000557|FG001|COMPLETED|Double-Blind Treatment Period 2||38||
59876622|NCT02856802|76000556|FG000|NOT COMPLETED|Double-Blind Treatment Period 2||1||
59876623|NCT02856802|76000557|FG001|NOT COMPLETED|Double-Blind Treatment Period 2||0||
59876624|NCT03380390|76000567|FG000|STARTED|Overall Study||46||
59876625|NCT03380390|76000567|FG000|COMPLETED|Overall Study||43||
59876626|NCT03380390|76000567|FG000|NOT COMPLETED|Overall Study||3||
59876627|NCT03350672|76000574|FG000|STARTED|Overall Study||17||
59876628|NCT03350672|76000575|FG001|STARTED|Overall Study||10||
59876629|NCT03350672|76000576|FG002|STARTED|Overall Study||10||
59876630|NCT03350672|76000574|FG000|COMPLETED|Overall Study||10||
59876631|NCT03350672|76000575|FG001|COMPLETED|Overall Study||10||
59876632|NCT03350672|76000576|FG002|COMPLETED|Overall Study||10||
59876633|NCT03350672|76000574|FG000|NOT COMPLETED|Overall Study||7||
59876634|NCT03350672|76000575|FG001|NOT COMPLETED|Overall Study||0||
59876635|NCT03350672|76000576|FG002|NOT COMPLETED|Overall Study||0||
59876636|NCT03392168|76000588|FG000|STARTED|Period 1: Cohort 1||8||
59876637|NCT03392168|76000589|FG001|STARTED|Period 1: Cohort 1||0||
59876638|NCT03392168|76000590|FG002|STARTED|Period 1: Cohort 1||0||
59749646|NCT00670111|75868731|FG001|COMPLETED|One Month Period A||8||
59749647|NCT00670111|75868732|FG002|COMPLETED|One Month Period A||0||
59749648|NCT00670111|75868730|FG000|NOT COMPLETED|One Month Period A||0||
59749649|NCT00670111|75868731|FG001|NOT COMPLETED|One Month Period A||0||
59749650|NCT00670111|75868732|FG002|NOT COMPLETED|One Month Period A||0||
59749651|NCT00670111|75868730|FG000|STARTED|One Month Period B||4||
59876639|NCT03392168|76000591|FG003|STARTED|Period 1: Cohort 1||0||
59876640|NCT03392168|76000588|FG000|COMPLETED|Period 1: Cohort 1||8||
59876641|NCT03392168|76000589|FG001|COMPLETED|Period 1: Cohort 1||0||
59876642|NCT03392168|76000590|FG002|COMPLETED|Period 1: Cohort 1||0||
59876643|NCT03392168|76000591|FG003|COMPLETED|Period 1: Cohort 1||0||
59876644|NCT03392168|76000588|FG000|NOT COMPLETED|Period 1: Cohort 1||0||
59876645|NCT03392168|76000589|FG001|NOT COMPLETED|Period 1: Cohort 1||0||
59876646|NCT03392168|76000590|FG002|NOT COMPLETED|Period 1: Cohort 1||0||
59749652|NCT00670111|75868731|FG001|STARTED|One Month Period B||8||
59749653|NCT00670111|75868732|FG002|STARTED|One Month Period B||0||
59749654|NCT00670111|75868730|FG000|COMPLETED|One Month Period B|4 patients in this group completed the 1 month visit; 0 had data eligible for endpoint analysis.|4||
59749655|NCT00670111|75868731|FG001|COMPLETED|One Month Period B|8 patients in this group completed the 1 month visit; 6 had data eligible for endpoint analysis.|8||
59749656|NCT00670111|75868732|FG002|COMPLETED|One Month Period B||0||
59749657|NCT00670111|75868730|FG000|NOT COMPLETED|One Month Period B||0||
59749658|NCT00670111|75868731|FG001|NOT COMPLETED|One Month Period B||0||
59749659|NCT00670111|75868732|FG002|NOT COMPLETED|One Month Period B||0||
59749660|NCT00670111|75868730|FG000|STARTED|One Month to Six Months||4||
59749661|NCT00670111|75868731|FG001|STARTED|One Month to Six Months||8||
59749662|NCT00670111|75868732|FG002|STARTED|One Month to Six Months||0||
59749663|NCT00670111|75868730|FG000|COMPLETED|One Month to Six Months|4 patients in this group completed the 1 month visit; 0 had data eligible for endpoint analysis.|4||
59749664|NCT00670111|75868731|FG001|COMPLETED|One Month to Six Months|8 patients in this group completed the 1 month visit; 4 had data eligible for endpoint analysis.|8||
59749665|NCT00670111|75868732|FG002|COMPLETED|One Month to Six Months||0||
59876647|NCT03392168|76000591|FG003|NOT COMPLETED|Period 1: Cohort 1||0||
59876648|NCT03392168|76000588|FG000|STARTED|Period 2: Cohort 2||0||
59876649|NCT03392168|76000589|FG001|STARTED|Period 2: Cohort 2|Includes 2 participants from Cohort 1|30||
59876650|NCT03392168|76000590|FG002|STARTED|Period 2: Cohort 2|Includes 2 participants from Cohort 1|28||
59876651|NCT03392168|76000591|FG003|STARTED|Period 2: Cohort 2|Includes 2 participants from Cohort 1|31||
59876652|NCT03392168|76000588|FG000|COMPLETED|Period 2: Cohort 2||0||
59876653|NCT03392168|76000589|FG001|COMPLETED|Period 2: Cohort 2||28||
59876654|NCT03392168|76000590|FG002|COMPLETED|Period 2: Cohort 2||27||
59876655|NCT03392168|76000591|FG003|COMPLETED|Period 2: Cohort 2||30||
59876656|NCT03392168|76000588|FG000|NOT COMPLETED|Period 2: Cohort 2||0||
59876657|NCT03392168|76000589|FG001|NOT COMPLETED|Period 2: Cohort 2||2||
59876658|NCT03392168|76000590|FG002|NOT COMPLETED|Period 2: Cohort 2||1||
59876659|NCT03392168|76000591|FG003|NOT COMPLETED|Period 2: Cohort 2||1||
59876660|NCT03391232|76000602|FG000|STARTED|Part A - First Dose (1-12weeks)||5||
59876661|NCT03391232|76000603|FG001|STARTED|Part A - First Dose (1-12weeks)||6||
59876662|NCT03391232|76000602|FG000|COMPLETED|Part A - First Dose (1-12weeks)|This cohort finished the trial here after 12 weeks.|5||
59876663|NCT03391232|76000603|FG001|COMPLETED|Part A - First Dose (1-12weeks)|After interim analysis this cohort continued the trial.|6||
59876664|NCT03391232|76000602|FG000|NOT COMPLETED|Part A - First Dose (1-12weeks)||0||
59876665|NCT03391232|76000603|FG001|NOT COMPLETED|Part A - First Dose (1-12weeks)||0||
59876666|NCT03391232|76000602|FG000|STARTED|Part B - Additional 2 Doses (13-38weeks)||0||
59876667|NCT03391232|76000603|FG001|STARTED|Part B - Additional 2 Doses (13-38weeks)||6||
59876668|NCT03391232|76000602|FG000|COMPLETED|Part B - Additional 2 Doses (13-38weeks)||0||
59876669|NCT03391232|76000603|FG001|COMPLETED|Part B - Additional 2 Doses (13-38weeks)||3||
59876670|NCT03391232|76000602|FG000|NOT COMPLETED|Part B - Additional 2 Doses (13-38weeks)||0||
59876671|NCT03391232|76000603|FG001|NOT COMPLETED|Part B - Additional 2 Doses (13-38weeks)||3||
59876672|NCT03379376|76000611|FG000|STARTED|Overall Study||10||
59749666|NCT00670111|75868730|FG000|NOT COMPLETED|One Month to Six Months||0||
59749667|NCT00670111|75868731|FG001|NOT COMPLETED|One Month to Six Months||0||
59749668|NCT00670111|75868732|FG002|NOT COMPLETED|One Month to Six Months||0||
59749669|NCT00670111|75868730|FG000|STARTED|Six Months to Twelve Months||4||
59749670|NCT00670111|75868731|FG001|STARTED|Six Months to Twelve Months||8||
59749671|NCT00670111|75868732|FG002|STARTED|Six Months to Twelve Months||0||
59876673|NCT03379376|76000611|FG000|COMPLETED|Overall Study||5||
59876674|NCT03379376|76000611|FG000|NOT COMPLETED|Overall Study||5||
59876675|NCT03349034|76000617|FG000|STARTED|Overall Study||12||
59876676|NCT03349034|76000618|FG001|STARTED|Overall Study||12||
59876677|NCT03349034|76000617|FG000|COMPLETED|Overall Study||8||
59876678|NCT03349034|76000618|FG001|COMPLETED|Overall Study||10||
59876679|NCT03349034|76000617|FG000|NOT COMPLETED|Overall Study||4||
59876680|NCT03349034|76000618|FG001|NOT COMPLETED|Overall Study||2||
59876681|NCT00358215|76000628|FG000|STARTED|Overall Study||1142||
59876682|NCT00358215|76000629|FG001|STARTED|Overall Study||1136||
59876683|NCT00358215|76000628|FG000|Received Investigational Product|Overall Study||1140||
59876684|NCT00358215|76000629|FG001|Received Investigational Product|Overall Study||1133||
59876685|NCT00358215|76000628|FG000|COMPLETED|Overall Study|Participants who completed investigational product|463||
59876686|NCT00358215|76000629|FG001|COMPLETED|Overall Study|Participants who completed investigational product|484||
59876687|NCT00358215|76000628|FG000|NOT COMPLETED|Overall Study||679||
59876688|NCT00358215|76000629|FG001|NOT COMPLETED|Overall Study||652||
59876689|NCT02855164|76000643|FG000|STARTED|Parts A + B (Randomized Set)||14||
59876690|NCT02855164|76000644|FG001|STARTED|Parts A + B (Randomized Set)||16||
59876691|NCT02855164|76000645|FG002|STARTED|Parts A + B (Randomized Set)||37||
59876692|NCT02855164|76000646|FG003|STARTED|Parts A + B (Randomized Set)||85||
59876693|NCT02855164|76000647|FG004|STARTED|Parts A + B (Randomized Set)||46||
59876694|NCT02855164|76000648|FG005|STARTED|Parts A + B (Randomized Set)||0||
59876695|NCT02855164|76000649|FG006|STARTED|Parts A + B (Randomized Set)||0||
59876696|NCT02855164|76000650|FG007|STARTED|Parts A + B (Randomized Set)||0||
59749672|NCT00670111|75868730|FG000|COMPLETED|Six Months to Twelve Months||4||
59749673|NCT00670111|75868731|FG001|COMPLETED|Six Months to Twelve Months||8||
59749674|NCT00670111|75868732|FG002|COMPLETED|Six Months to Twelve Months||0||
59749675|NCT00670111|75868730|FG000|NOT COMPLETED|Six Months to Twelve Months||0||
59749676|NCT00670111|75868731|FG001|NOT COMPLETED|Six Months to Twelve Months||0||
59749677|NCT00670111|75868732|FG002|NOT COMPLETED|Six Months to Twelve Months||0||
59749678|NCT00672139|75868742|FG000|STARTED|Overall Study|Three of 60 enrolled subjects did not receive study drug.|57||
59749679|NCT00672139|75868743|FG001|STARTED|Overall Study|Four of 96 enrolled subjects did not receive study drug.|92||
59749680|NCT00672139|75868742|FG000|COMPLETED|Overall Study||27||
59749681|NCT00672139|75868743|FG001|COMPLETED|Overall Study||47||
59749682|NCT00672139|75868742|FG000|NOT COMPLETED|Overall Study||30||
59749683|NCT00672139|75868743|FG001|NOT COMPLETED|Overall Study||45||
59749684|NCT00570739|75868753|FG000|STARTED|Overall Study||141||
59749685|NCT00570739|75868754|FG001|STARTED|Overall Study||145||
59749686|NCT00570739|75868755|FG002|STARTED|Overall Study||108||
59749687|NCT00570739|75868756|FG003|STARTED|Overall Study||108||
59749688|NCT00570739|75868753|FG000|COMPLETED|Overall Study||120||
59749689|NCT00570739|75868754|FG001|COMPLETED|Overall Study||124||
59749690|NCT00570739|75868755|FG002|COMPLETED|Overall Study||92||
59749691|NCT00570739|75868756|FG003|COMPLETED|Overall Study||96||
59749692|NCT00570739|75868753|FG000|NOT COMPLETED|Overall Study||21||
59749693|NCT00570739|75868754|FG001|NOT COMPLETED|Overall Study||21||
59749694|NCT00570739|75868755|FG002|NOT COMPLETED|Overall Study||16||
59749695|NCT00570739|75868756|FG003|NOT COMPLETED|Overall Study||12||
59749696|NCT03689530|75868788|FG000|STARTED|Overall Study||272||
59749697|NCT03689530|75868789|FG001|STARTED|Overall Study||178||
59749698|NCT03689530|75868788|FG000|6-month Follow-up|Overall Study||223||
59605393|NCT01994382|75715569|FG009|Received at Least 1 Dose of Study Drug|Overall Study||5|Safety Population|
59605394|NCT01994382|75715570|FG010|Received at Least 1 Dose of Study Drug|Overall Study||42|Safety Population|
59749699|NCT03689530|75868789|FG001|6-month Follow-up|Overall Study||169||
59749700|NCT03689530|75868788|FG000|12-month Follow-up|Overall Study||212||
59749701|NCT03689530|75868789|FG001|12-month Follow-up|Overall Study||162||
59749702|NCT03689530|75868788|FG000|COMPLETED|Overall Study||219||
59749703|NCT03689530|75868789|FG001|COMPLETED|Overall Study||162||
59749704|NCT03689530|75868788|FG000|NOT COMPLETED|Overall Study||53||
59749705|NCT03689530|75868789|FG001|NOT COMPLETED|Overall Study||16||
59749706|NCT04188106|75868795|FG000|STARTED|Overall Study||26||
59749707|NCT04188106|75868795|FG000|COMPLETED|Overall Study||20||
59749708|NCT04188106|75868795|FG000|NOT COMPLETED|Overall Study||6||
59749709|NCT00669955|75868803|FG000|STARTED|Overall Study|216 patients received study drug. 2 patients were dispensed study drug but did not take it|218||
59749710|NCT00669955|75868804|FG001|STARTED|Overall Study||222||
59749711|NCT00669955|75868803|FG000|COMPLETED|Overall Study||204||
59749712|NCT00669955|75868804|FG001|COMPLETED|Overall Study||195||
59749713|NCT00669955|75868803|FG000|NOT COMPLETED|Overall Study||14||
59749714|NCT00669955|75868804|FG001|NOT COMPLETED|Overall Study||27||
59749715|NCT00671749|75868810|FG000|STARTED|Overall Study||100||
59749716|NCT00671749|75868810|FG000|COMPLETED|Overall Study||92||
59749717|NCT00671749|75868810|FG000|NOT COMPLETED|Overall Study||8||
59749718|NCT00669877|75868814|FG000|STARTED|Overall Study||56||
59749719|NCT00669877|75868814|FG000|COMPLETED|Overall Study||52||
59749720|NCT00669877|75868814|FG000|NOT COMPLETED|Overall Study||4||
59749721|NCT00882999|75868825|FG000|STARTED|Overall Study||35||
59749722|NCT00882999|75868826|FG001|STARTED|Overall Study||34||
59749723|NCT00882999|75868827|FG002|STARTED|Overall Study||34||
59749724|NCT00882999|75868828|FG003|STARTED|Overall Study||36||
59749725|NCT00882999|75868829|FG004|STARTED|Overall Study||36||
59749726|NCT00882999|75868830|FG005|STARTED|Overall Study||35||
59876697|NCT02855164|76000643|FG000|COMPLETED|Parts A + B (Randomized Set)||14||
59876698|NCT02855164|76000644|FG001|COMPLETED|Parts A + B (Randomized Set)||16||
59605395|NCT01994382|75715571|FG011|Received at Least 1 Dose of Study Drug|Overall Study||12|Safety Population|
59749727|NCT00882999|75868831|FG006|STARTED|Overall Study||35||
59749728|NCT00882999|75868825|FG000|Received Any Amount of Study Drug|Overall Study||35||
59749729|NCT00882999|75868826|FG001|Received Any Amount of Study Drug|Overall Study||34||
59749730|NCT00882999|75868827|FG002|Received Any Amount of Study Drug|Overall Study||34||
59749731|NCT00882999|75868828|FG003|Received Any Amount of Study Drug|Overall Study||36||
59749732|NCT00882999|75868829|FG004|Received Any Amount of Study Drug|Overall Study||36||
59749733|NCT00882999|75868830|FG005|Received Any Amount of Study Drug|Overall Study||35||
59749734|NCT00882999|75868831|FG006|Received Any Amount of Study Drug|Overall Study||35||
59749735|NCT00882999|75868825|FG000|Completed Study Treatment|Overall Study||29||
59876699|NCT02855164|76000645|FG002|COMPLETED|Parts A + B (Randomized Set)||36||
59876700|NCT02855164|76000646|FG003|COMPLETED|Parts A + B (Randomized Set)||77||
59876701|NCT02855164|76000647|FG004|COMPLETED|Parts A + B (Randomized Set)||45||
59749736|NCT00882999|75868826|FG001|Completed Study Treatment|Overall Study||29||
59749737|NCT00882999|75868827|FG002|Completed Study Treatment|Overall Study||31||
59749738|NCT00882999|75868828|FG003|Completed Study Treatment|Overall Study||33||
59749739|NCT00882999|75868829|FG004|Completed Study Treatment|Overall Study||29||
59876702|NCT02855164|76000648|FG005|COMPLETED|Parts A + B (Randomized Set)||0||
59876703|NCT02855164|76000649|FG006|COMPLETED|Parts A + B (Randomized Set)||0||
59876704|NCT02855164|76000650|FG007|COMPLETED|Parts A + B (Randomized Set)||0||
59876705|NCT02855164|76000643|FG000|NOT COMPLETED|Parts A + B (Randomized Set)||0||
59876706|NCT02855164|76000644|FG001|NOT COMPLETED|Parts A + B (Randomized Set)||0||
59876707|NCT02855164|76000645|FG002|NOT COMPLETED|Parts A + B (Randomized Set)||1||
59876708|NCT02855164|76000646|FG003|NOT COMPLETED|Parts A + B (Randomized Set)||8||
59876709|NCT02855164|76000647|FG004|NOT COMPLETED|Parts A + B (Randomized Set)||1||
59876710|NCT02855164|76000648|FG005|NOT COMPLETED|Parts A + B (Randomized Set)||0||
59876711|NCT02855164|76000649|FG006|NOT COMPLETED|Parts A + B (Randomized Set)||0||
59876712|NCT02855164|76000650|FG007|NOT COMPLETED|Parts A + B (Randomized Set)||0||
59876713|NCT02855164|76000643|FG000|STARTED|Part C (Randomized Set)||0||
59876714|NCT02855164|76000644|FG001|STARTED|Part C (Randomized Set)||0||
59876715|NCT02855164|76000645|FG002|STARTED|Part C (Randomized Set)||0||
59876716|NCT02855164|76000646|FG003|STARTED|Part C (Randomized Set)||0||
59876717|NCT02855164|76000647|FG004|STARTED|Part C (Randomized Set)||0||
59876718|NCT02855164|76000648|FG005|STARTED|Part C (Randomized Set)||50||
59876719|NCT02855164|76000649|FG006|STARTED|Part C (Randomized Set)||51||
59876720|NCT02855164|76000650|FG007|STARTED|Part C (Randomized Set)||51||
59876721|NCT02855164|76000643|FG000|COMPLETED|Part C (Randomized Set)||0||
59876722|NCT02855164|76000644|FG001|COMPLETED|Part C (Randomized Set)||0||
59876723|NCT02855164|76000645|FG002|COMPLETED|Part C (Randomized Set)||0||
59876724|NCT02855164|76000646|FG003|COMPLETED|Part C (Randomized Set)||0||
59876725|NCT02855164|76000647|FG004|COMPLETED|Part C (Randomized Set)||0||
59876726|NCT02855164|76000648|FG005|COMPLETED|Part C (Randomized Set)||38||
59876727|NCT02855164|76000649|FG006|COMPLETED|Part C (Randomized Set)||37||
59749740|NCT00882999|75868830|FG005|Completed Study Treatment|Overall Study||30||
59876728|NCT02855164|76000650|FG007|COMPLETED|Part C (Randomized Set)||44||
59876729|NCT02855164|76000643|FG000|NOT COMPLETED|Part C (Randomized Set)||0||
59876730|NCT02855164|76000644|FG001|NOT COMPLETED|Part C (Randomized Set)||0||
59876731|NCT02855164|76000645|FG002|NOT COMPLETED|Part C (Randomized Set)||0||
59876732|NCT02855164|76000646|FG003|NOT COMPLETED|Part C (Randomized Set)||0||
59876733|NCT02855164|76000647|FG004|NOT COMPLETED|Part C (Randomized Set)||0||
59876734|NCT02855164|76000648|FG005|NOT COMPLETED|Part C (Randomized Set)||12||
59876735|NCT02855164|76000649|FG006|NOT COMPLETED|Part C (Randomized Set)||14||
59876736|NCT02855164|76000650|FG007|NOT COMPLETED|Part C (Randomized Set)||7||
59876737|NCT01002742|76000690|FG000|STARTED|Overall Study||119||
59876738|NCT01002742|76000691|FG001|STARTED|Overall Study||117||
59876739|NCT01002742|76000690|FG000|COMPLETED|Overall Study||119||
59876740|NCT01002742|76000691|FG001|COMPLETED|Overall Study||116||
59876741|NCT01002742|76000690|FG000|NOT COMPLETED|Overall Study||0||
59876742|NCT01002742|76000691|FG001|NOT COMPLETED|Overall Study||1||
59876743|NCT02853760|76000697|FG000|STARTED|First Intervention (3 Hours)||7||
59876744|NCT02853760|76000698|FG001|STARTED|First Intervention (3 Hours)||10||
59876745|NCT02853760|76000699|FG002|STARTED|First Intervention (3 Hours)||7||
59876746|NCT02853760|76000700|FG003|STARTED|First Intervention (3 Hours)||8||
59876747|NCT02853760|76000701|FG004|STARTED|First Intervention (3 Hours)||8||
59876748|NCT02853760|76000702|FG005|STARTED|First Intervention (3 Hours)||7||
59876749|NCT02853760|76000697|FG000|COMPLETED|First Intervention (3 Hours)||7||
59876750|NCT02853760|76000698|FG001|COMPLETED|First Intervention (3 Hours)||10||
59876751|NCT02853760|76000699|FG002|COMPLETED|First Intervention (3 Hours)||7||
59876752|NCT02853760|76000700|FG003|COMPLETED|First Intervention (3 Hours)||8||
59876753|NCT02853760|76000701|FG004|COMPLETED|First Intervention (3 Hours)||8||
59876754|NCT02853760|76000702|FG005|COMPLETED|First Intervention (3 Hours)||7||
59876755|NCT02853760|76000697|FG000|NOT COMPLETED|First Intervention (3 Hours)||0||
59876756|NCT02853760|76000698|FG001|NOT COMPLETED|First Intervention (3 Hours)||0||
59876757|NCT02853760|76000699|FG002|NOT COMPLETED|First Intervention (3 Hours)||0||
59876758|NCT02853760|76000700|FG003|NOT COMPLETED|First Intervention (3 Hours)||0||
59876759|NCT02853760|76000701|FG004|NOT COMPLETED|First Intervention (3 Hours)||0||
59876760|NCT02853760|76000702|FG005|NOT COMPLETED|First Intervention (3 Hours)||0||
59876761|NCT02853760|76000697|FG000|STARTED|Washout (1 Week)||7||
59876762|NCT02853760|76000698|FG001|STARTED|Washout (1 Week)||10||
60002516|NCT02063854|76118387|FG004|NOT COMPLETED|Overall Study||11||
60002517|NCT02063854|76118388|FG005|NOT COMPLETED|Overall Study||31||
60002518|NCT02063854|76118389|FG006|NOT COMPLETED|Overall Study||6||
59749741|NCT00882999|75868831|FG006|Completed Study Treatment|Overall Study||31||
59749742|NCT00882999|75868825|FG000|COMPLETED|Overall Study||27||
59749743|NCT00882999|75868826|FG001|COMPLETED|Overall Study||26||
59749744|NCT00882999|75868827|FG002|COMPLETED|Overall Study||30||
59749745|NCT00882999|75868828|FG003|COMPLETED|Overall Study||31||
59876763|NCT02853760|76000699|FG002|STARTED|Washout (1 Week)||7||
59876764|NCT02853760|76000700|FG003|STARTED|Washout (1 Week)||8||
59876765|NCT02853760|76000701|FG004|STARTED|Washout (1 Week)||8||
59876766|NCT02853760|76000702|FG005|STARTED|Washout (1 Week)||7||
59876767|NCT02853760|76000697|FG000|COMPLETED|Washout (1 Week)||7||
59876768|NCT02853760|76000698|FG001|COMPLETED|Washout (1 Week)||10||
59876769|NCT02853760|76000699|FG002|COMPLETED|Washout (1 Week)||6||
59876770|NCT02853760|76000700|FG003|COMPLETED|Washout (1 Week)||6||
59876771|NCT02853760|76000701|FG004|COMPLETED|Washout (1 Week)||8||
59876772|NCT02853760|76000702|FG005|COMPLETED|Washout (1 Week)||5||
59876773|NCT02853760|76000697|FG000|NOT COMPLETED|Washout (1 Week)||0||
59876774|NCT02853760|76000698|FG001|NOT COMPLETED|Washout (1 Week)||0||
59876775|NCT02853760|76000699|FG002|NOT COMPLETED|Washout (1 Week)||1||
59876776|NCT02853760|76000700|FG003|NOT COMPLETED|Washout (1 Week)||2||
59876777|NCT02853760|76000701|FG004|NOT COMPLETED|Washout (1 Week)||0||
59876778|NCT02853760|76000702|FG005|NOT COMPLETED|Washout (1 Week)||2||
59876779|NCT02853760|76000697|FG000|STARTED|Second Intervention (3 Hours)||7||
59876780|NCT02853760|76000698|FG001|STARTED|Second Intervention (3 Hours)||10||
59876781|NCT02853760|76000699|FG002|STARTED|Second Intervention (3 Hours)||6||
59876782|NCT02853760|76000700|FG003|STARTED|Second Intervention (3 Hours)||6||
59876783|NCT02853760|76000701|FG004|STARTED|Second Intervention (3 Hours)||8||
59876784|NCT02853760|76000702|FG005|STARTED|Second Intervention (3 Hours)||5||
59876785|NCT02853760|76000697|FG000|COMPLETED|Second Intervention (3 Hours)||7||
59876786|NCT02853760|76000698|FG001|COMPLETED|Second Intervention (3 Hours)||10||
59876787|NCT02853760|76000699|FG002|COMPLETED|Second Intervention (3 Hours)||6||
59876788|NCT02853760|76000700|FG003|COMPLETED|Second Intervention (3 Hours)||6||
59876789|NCT02853760|76000701|FG004|COMPLETED|Second Intervention (3 Hours)||8||
59876790|NCT02853760|76000702|FG005|COMPLETED|Second Intervention (3 Hours)||5||
59876791|NCT02853760|76000697|FG000|NOT COMPLETED|Second Intervention (3 Hours)||0||
59876792|NCT02853760|76000698|FG001|NOT COMPLETED|Second Intervention (3 Hours)||0||
59876793|NCT02853760|76000699|FG002|NOT COMPLETED|Second Intervention (3 Hours)||0||
59876794|NCT02853760|76000700|FG003|NOT COMPLETED|Second Intervention (3 Hours)||0||
59876795|NCT02853760|76000701|FG004|NOT COMPLETED|Second Intervention (3 Hours)||0||
59876796|NCT02853760|76000702|FG005|NOT COMPLETED|Second Intervention (3 Hours)||0||
59876797|NCT02853760|76000697|FG000|STARTED|Washout (1 Week)||7||
59876798|NCT02853760|76000698|FG001|STARTED|Washout (1 Week)||10||
59876799|NCT02853760|76000699|FG002|STARTED|Washout (1 Week)||6||
59876800|NCT02853760|76000700|FG003|STARTED|Washout (1 Week)||6||
59876801|NCT02853760|76000701|FG004|STARTED|Washout (1 Week)||8||
59876802|NCT02853760|76000702|FG005|STARTED|Washout (1 Week)||5||
59876803|NCT02853760|76000697|FG000|COMPLETED|Washout (1 Week)||7||
59876804|NCT02853760|76000698|FG001|COMPLETED|Washout (1 Week)||10||
59876805|NCT02853760|76000699|FG002|COMPLETED|Washout (1 Week)||6||
59876806|NCT02853760|76000700|FG003|COMPLETED|Washout (1 Week)||6||
59876807|NCT02853760|76000701|FG004|COMPLETED|Washout (1 Week)||8||
59876808|NCT02853760|76000702|FG005|COMPLETED|Washout (1 Week)||5||
59876809|NCT02853760|76000697|FG000|NOT COMPLETED|Washout (1 Week)||0||
59876810|NCT02853760|76000698|FG001|NOT COMPLETED|Washout (1 Week)||0||
59876811|NCT02853760|76000699|FG002|NOT COMPLETED|Washout (1 Week)||0||
59876812|NCT02853760|76000700|FG003|NOT COMPLETED|Washout (1 Week)||0||
59876813|NCT02853760|76000701|FG004|NOT COMPLETED|Washout (1 Week)||0||
59876814|NCT02853760|76000702|FG005|NOT COMPLETED|Washout (1 Week)||0||
59876815|NCT02853760|76000697|FG000|STARTED|Third Intervention (3 Hours)||7||
59876816|NCT02853760|76000698|FG001|STARTED|Third Intervention (3 Hours)||10||
59876817|NCT02853760|76000699|FG002|STARTED|Third Intervention (3 Hours)||6||
59876818|NCT02853760|76000700|FG003|STARTED|Third Intervention (3 Hours)||6||
59876819|NCT02853760|76000701|FG004|STARTED|Third Intervention (3 Hours)||8||
59876820|NCT02853760|76000702|FG005|STARTED|Third Intervention (3 Hours)||5||
59876821|NCT02853760|76000697|FG000|COMPLETED|Third Intervention (3 Hours)||7||
59876822|NCT02853760|76000698|FG001|COMPLETED|Third Intervention (3 Hours)||10||
59876823|NCT02853760|76000699|FG002|COMPLETED|Third Intervention (3 Hours)||6||
59876824|NCT02853760|76000700|FG003|COMPLETED|Third Intervention (3 Hours)||6||
59876825|NCT02853760|76000701|FG004|COMPLETED|Third Intervention (3 Hours)||8||
59876826|NCT02853760|76000702|FG005|COMPLETED|Third Intervention (3 Hours)||5||
59876827|NCT02853760|76000697|FG000|NOT COMPLETED|Third Intervention (3 Hours)||0||
59876828|NCT02853760|76000698|FG001|NOT COMPLETED|Third Intervention (3 Hours)||0||
59876829|NCT02853760|76000699|FG002|NOT COMPLETED|Third Intervention (3 Hours)||0||
59876830|NCT02853760|76000700|FG003|NOT COMPLETED|Third Intervention (3 Hours)||0||
59876831|NCT02853760|76000701|FG004|NOT COMPLETED|Third Intervention (3 Hours)||0||
59876832|NCT02853760|76000702|FG005|NOT COMPLETED|Third Intervention (3 Hours)||0||
59876833|NCT02852434|76000712|FG000|STARTED|Overall Study||36||
59876834|NCT02852434|76000713|FG001|STARTED|Overall Study||36||
59876835|NCT02852434|76000712|FG000|COMPLETED|Overall Study||34||
59876836|NCT02852434|76000713|FG001|COMPLETED|Overall Study||35||
59876837|NCT02852434|76000712|FG000|NOT COMPLETED|Overall Study||2||
59876838|NCT02852434|76000713|FG001|NOT COMPLETED|Overall Study||1||
59876839|NCT02850016|76000721|FG000|STARTED|Overall Study||11||
59876840|NCT02850016|76000722|FG001|STARTED|Overall Study||9||
59876841|NCT02850016|76000721|FG000|COMPLETED|Overall Study||10||
59876842|NCT02850016|76000722|FG001|COMPLETED|Overall Study||7||
59876843|NCT02850016|76000721|FG000|NOT COMPLETED|Overall Study||1||
59876844|NCT02850016|76000722|FG001|NOT COMPLETED|Overall Study||2||
59876845|NCT02849704|76000730|FG000|STARTED|Washout Period - CP Subj on PERT - 3days||11|Subjects with a diagnosis of CP and who were taking PERT participated in this Period|
59876846|NCT02849704|76000731|FG001|STARTED|Washout Period - CP Subj on PERT - 3days||0|Subjects with a diagnosis of CP and who were taking PERT participated in this Period|
59876847|NCT02849704|76000730|FG000|COMPLETED|Washout Period - CP Subj on PERT - 3days||11||
59876848|NCT02849704|76000731|FG001|COMPLETED|Washout Period - CP Subj on PERT - 3days||0||
59876849|NCT02849704|76000730|FG000|NOT COMPLETED|Washout Period - CP Subj on PERT - 3days||0||
59876850|NCT02849704|76000731|FG001|NOT COMPLETED|Washout Period - CP Subj on PERT - 3days||0||
59876851|NCT02849704|76000730|FG000|STARTED|Baseline Assessments - All Subj - 7 Days||24||
59876852|NCT02849704|76000731|FG001|STARTED|Baseline Assessments - All Subj - 7 Days||24||
59876853|NCT02849704|76000730|FG000|COMPLETED|Baseline Assessments - All Subj - 7 Days||24||
59876854|NCT02849704|76000731|FG001|COMPLETED|Baseline Assessments - All Subj - 7 Days||24||
59876855|NCT02849704|76000730|FG000|NOT COMPLETED|Baseline Assessments - All Subj - 7 Days||0||
59876856|NCT02849704|76000731|FG001|NOT COMPLETED|Baseline Assessments - All Subj - 7 Days||0||
59876857|NCT02849704|76000730|FG000|STARTED|Assessment on PERT - CP Subj - 16 Days||24||
59876858|NCT02849704|76000731|FG001|STARTED|Assessment on PERT - CP Subj - 16 Days||0||
59876859|NCT02849704|76000730|FG000|COMPLETED|Assessment on PERT - CP Subj - 16 Days||21||
59876860|NCT02849704|76000731|FG001|COMPLETED|Assessment on PERT - CP Subj - 16 Days||0||
59876861|NCT02849704|76000730|FG000|NOT COMPLETED|Assessment on PERT - CP Subj - 16 Days||3||
59876862|NCT02849704|76000731|FG001|NOT COMPLETED|Assessment on PERT - CP Subj - 16 Days||0||
59876863|NCT02721082|76000743|FG000|STARTED|Overall Study||655||
59876864|NCT02721082|76000744|FG001|STARTED|Overall Study||345||
59876865|NCT02721082|76000743|FG000|COMPLETED|Overall Study||469||
59876866|NCT02721082|76000744|FG001|COMPLETED|Overall Study||270||
59876867|NCT02721082|76000743|FG000|NOT COMPLETED|Overall Study||186||
59876868|NCT02721082|76000744|FG001|NOT COMPLETED|Overall Study||75||
59876869|NCT03347396|76000752|FG000|STARTED|Part A (26 Weeks)||17||
59876870|NCT03347396|76000753|FG001|STARTED|Part A (26 Weeks)||7||
59876871|NCT03347396|76000752|FG000|COMPLETED|Part A (26 Weeks)||16||
59876872|NCT03347396|76000753|FG001|COMPLETED|Part A (26 Weeks)||6||
59876873|NCT03347396|76000752|FG000|NOT COMPLETED|Part A (26 Weeks)||1||
59876874|NCT03347396|76000753|FG001|NOT COMPLETED|Part A (26 Weeks)||1||
59876875|NCT03347396|76000752|FG000|STARTED|Part B (149 Weeks)||16||
59876876|NCT03347396|76000753|FG001|STARTED|Part B (149 Weeks)||6||
59876877|NCT03347396|76000752|FG000|COMPLETED|Part B (149 Weeks)||14||
59876878|NCT03347396|76000753|FG001|COMPLETED|Part B (149 Weeks)||5||
59876879|NCT03347396|76000752|FG000|NOT COMPLETED|Part B (149 Weeks)||2||
59876880|NCT03347396|76000753|FG001|NOT COMPLETED|Part B (149 Weeks)||1||
59876881|NCT03335150|76000764|FG000|STARTED|Overall Study||55||
59876882|NCT03335150|76000765|FG001|STARTED|Overall Study||55||
59876883|NCT03335150|76000764|FG000|Enrolled + Assigned Group|Overall Study||54||
59876884|NCT03335150|76000765|FG001|Enrolled + Assigned Group|Overall Study||55||
59876885|NCT03335150|76000764|FG000|PRE Testing Session|Overall Study||53||
59876886|NCT03335150|76000765|FG001|PRE Testing Session|Overall Study||55||
59876887|NCT03335150|76000764|FG000|Commenced Group|Overall Study||47||
59876888|NCT03335150|76000765|FG001|Commenced Group|Overall Study||52||
59876889|NCT03335150|76000764|FG000|POST Testing Session|Overall Study||45||
59876890|NCT03335150|76000765|FG001|POST Testing Session|Overall Study||50||
59876891|NCT03335150|76000764|FG000|COMPLETED|Overall Study||45||
59876892|NCT03335150|76000765|FG001|COMPLETED|Overall Study||50||
59876893|NCT03335150|76000764|FG000|NOT COMPLETED|Overall Study||10||
59876894|NCT03335150|76000765|FG001|NOT COMPLETED|Overall Study||5||
59876895|NCT03334448|76000771|FG000|STARTED|Period 1||12||
59876896|NCT03334448|76000772|FG001|STARTED|Period 1||12||
59876897|NCT03334448|76000773|FG002|STARTED|Period 1||13||
59876898|NCT03334448|76000774|FG003|STARTED|Period 1||12||
59876899|NCT03334448|76000771|FG000|Received at Least 1 Dose of Study Drug|Period 1||12||
59876900|NCT03334448|76000772|FG001|Received at Least 1 Dose of Study Drug|Period 1||12||
59876901|NCT03334448|76000773|FG002|Received at Least 1 Dose of Study Drug|Period 1||13||
59876902|NCT03334448|76000774|FG003|Received at Least 1 Dose of Study Drug|Period 1||12||
59876903|NCT03334448|76000771|FG000|COMPLETED|Period 1||12||
59876904|NCT03334448|76000772|FG001|COMPLETED|Period 1||12||
59876905|NCT03334448|76000773|FG002|COMPLETED|Period 1||13||
59876906|NCT03334448|76000774|FG003|COMPLETED|Period 1||12||
59876907|NCT03334448|76000771|FG000|NOT COMPLETED|Period 1||0||
59876908|NCT03334448|76000772|FG001|NOT COMPLETED|Period 1||0||
59876909|NCT03334448|76000773|FG002|NOT COMPLETED|Period 1||0||
59876910|NCT03334448|76000774|FG003|NOT COMPLETED|Period 1||0||
59876911|NCT03334448|76000771|FG000|STARTED|Washout||12||
59876912|NCT03334448|76000772|FG001|STARTED|Washout||12||
59876913|NCT03334448|76000773|FG002|STARTED|Washout||13||
59876914|NCT03334448|76000774|FG003|STARTED|Washout||12||
59876915|NCT03334448|76000771|FG000|COMPLETED|Washout||12||
59876916|NCT03334448|76000772|FG001|COMPLETED|Washout||12||
59876917|NCT03334448|76000773|FG002|COMPLETED|Washout||13||
59876918|NCT03334448|76000774|FG003|COMPLETED|Washout||12||
59876919|NCT03334448|76000771|FG000|NOT COMPLETED|Washout||0||
59876920|NCT03334448|76000772|FG001|NOT COMPLETED|Washout||0||
59876921|NCT03334448|76000773|FG002|NOT COMPLETED|Washout||0||
59876922|NCT03334448|76000774|FG003|NOT COMPLETED|Washout||0||
59876923|NCT03334448|76000771|FG000|STARTED|Period 2||12||
60002519|NCT02063698|76118409|FG000|STARTED|Overall Study||15||
60002520|NCT02063698|76118410|FG001|STARTED|Overall Study||15||
60135765|NCT01685008|76258448|FG000|Began Cycle 3 Treatment|Cycle 3 and Maintenance Treatment||25||
60135766|NCT01685008|76258449|FG001|Began Cycle 3 Treatment|Cycle 3 and Maintenance Treatment||13||
60135767|NCT01685008|76258450|FG002|Began Cycle 3 Treatment|Cycle 3 and Maintenance Treatment||5||
60135768|NCT01685008|76258451|FG003|Began Cycle 3 Treatment|Cycle 3 and Maintenance Treatment||7||
60002521|NCT02063698|76118409|FG000|COMPLETED|Overall Study||14||
60002522|NCT02063698|76118410|FG001|COMPLETED|Overall Study||13||
60002523|NCT02063698|76118409|FG000|NOT COMPLETED|Overall Study||1||
60002524|NCT02063698|76118410|FG001|NOT COMPLETED|Overall Study||2||
60002525|NCT04701333|76118418|FG000|STARTED|Overall Study||36||
60002526|NCT04701333|76118419|FG001|STARTED|Overall Study||37||
60002527|NCT04701333|76118418|FG000|COMPLETED|Overall Study||33||
60002528|NCT04701333|76118419|FG001|COMPLETED|Overall Study||29||
60002529|NCT04701333|76118418|FG000|NOT COMPLETED|Overall Study||3||
60002530|NCT04701333|76118419|FG001|NOT COMPLETED|Overall Study||8||
60002531|NCT02062450|76118427|FG000|STARTED|Overall Study|379 patients were successfully reached by phone and convoked for the 2-year follow-up visit.|379||
59876924|NCT03334448|76000772|FG001|STARTED|Period 2||12||
59876925|NCT03334448|76000773|FG002|STARTED|Period 2||13||
59876926|NCT03334448|76000774|FG003|STARTED|Period 2||12||
59876927|NCT03334448|76000771|FG000|Received at Least 1 Dose of Study Drug|Period 2||12||
59876928|NCT03334448|76000772|FG001|Received at Least 1 Dose of Study Drug|Period 2||12||
59876929|NCT03334448|76000773|FG002|Received at Least 1 Dose of Study Drug|Period 2||13||
59876930|NCT03334448|76000774|FG003|Received at Least 1 Dose of Study Drug|Period 2||12||
59876931|NCT03334448|76000771|FG000|COMPLETED|Period 2||12||
59876932|NCT03334448|76000772|FG001|COMPLETED|Period 2||12||
59876933|NCT03334448|76000773|FG002|COMPLETED|Period 2||13||
59876934|NCT03334448|76000774|FG003|COMPLETED|Period 2||12||
59876935|NCT03334448|76000771|FG000|NOT COMPLETED|Period 2||0||
59876936|NCT03334448|76000772|FG001|NOT COMPLETED|Period 2||0||
60002532|NCT02062450|76118427|FG000|Per Protocol Cohort|Overall Study|255 patients attended their 2-year follow-up visit.|255||
60002533|NCT02062450|76118427|FG000|COMPLETED|Overall Study||255||
59749746|NCT00882999|75868829|FG004|COMPLETED|Overall Study||28||
59749747|NCT00882999|75868830|FG005|COMPLETED|Overall Study||28||
59749748|NCT00882999|75868831|FG006|COMPLETED|Overall Study||27||
59749749|NCT00882999|75868825|FG000|NOT COMPLETED|Overall Study||8||
59876937|NCT03334448|76000773|FG002|NOT COMPLETED|Period 2||0||
59876938|NCT03334448|76000774|FG003|NOT COMPLETED|Period 2||0||
59876939|NCT03334448|76000771|FG000|STARTED|Washout||12||
59876940|NCT03334448|76000772|FG001|STARTED|Washout||12||
59876941|NCT03334448|76000773|FG002|STARTED|Washout||13||
59876942|NCT03334448|76000774|FG003|STARTED|Washout||12||
59876943|NCT03334448|76000771|FG000|COMPLETED|Washout||12||
59876944|NCT03334448|76000772|FG001|COMPLETED|Washout||11||
59876945|NCT03334448|76000773|FG002|COMPLETED|Washout||13||
59876946|NCT03334448|76000774|FG003|COMPLETED|Washout||12||
59876947|NCT03334448|76000771|FG000|NOT COMPLETED|Washout||0||
59876948|NCT03334448|76000772|FG001|NOT COMPLETED|Washout||1||
59876949|NCT03334448|76000773|FG002|NOT COMPLETED|Washout||0||
59876950|NCT03334448|76000774|FG003|NOT COMPLETED|Washout||0||
59876951|NCT03334448|76000771|FG000|STARTED|Period 3||12||
59876952|NCT03334448|76000772|FG001|STARTED|Period 3||11||
59876953|NCT03334448|76000773|FG002|STARTED|Period 3||13||
59876954|NCT03334448|76000774|FG003|STARTED|Period 3||12||
59876955|NCT03334448|76000771|FG000|Received at Least 1 Dose of Study Drug|Period 3||12||
59876956|NCT03334448|76000772|FG001|Received at Least 1 Dose of Study Drug|Period 3||11||
59876957|NCT03334448|76000773|FG002|Received at Least 1 Dose of Study Drug|Period 3||13||
59876958|NCT03334448|76000774|FG003|Received at Least 1 Dose of Study Drug|Period 3||12||
59876959|NCT03334448|76000771|FG000|COMPLETED|Period 3||12||
59876960|NCT03334448|76000772|FG001|COMPLETED|Period 3||11||
59876961|NCT03334448|76000773|FG002|COMPLETED|Period 3||13||
59876962|NCT03334448|76000774|FG003|COMPLETED|Period 3||12||
59876963|NCT03334448|76000771|FG000|NOT COMPLETED|Period 3||0||
59876964|NCT03334448|76000772|FG001|NOT COMPLETED|Period 3||0||
59876965|NCT03334448|76000773|FG002|NOT COMPLETED|Period 3||0||
59876966|NCT03334448|76000774|FG003|NOT COMPLETED|Period 3||0||
59876967|NCT03334448|76000771|FG000|STARTED|Washout||12||
59876968|NCT03334448|76000772|FG001|STARTED|Washout||11||
59876969|NCT03334448|76000773|FG002|STARTED|Washout||13||
59876970|NCT03334448|76000774|FG003|STARTED|Washout||12||
59876971|NCT03334448|76000771|FG000|COMPLETED|Washout||12||
59749750|NCT00882999|75868826|FG001|NOT COMPLETED|Overall Study||8||
59749751|NCT00882999|75868827|FG002|NOT COMPLETED|Overall Study||4||
59876972|NCT03334448|76000772|FG001|COMPLETED|Washout||11||
60002534|NCT02062450|76118427|FG000|NOT COMPLETED|Overall Study||124||
60002535|NCT02561247|76118435|FG000|STARTED|Overall Study||23||
59749752|NCT00882999|75868828|FG003|NOT COMPLETED|Overall Study||5||
59749753|NCT00882999|75868829|FG004|NOT COMPLETED|Overall Study||8||
59749754|NCT00882999|75868830|FG005|NOT COMPLETED|Overall Study||7||
59876973|NCT03334448|76000773|FG002|COMPLETED|Washout||13||
59876974|NCT03334448|76000774|FG003|COMPLETED|Washout||11||
59876975|NCT03334448|76000771|FG000|NOT COMPLETED|Washout||0||
59876976|NCT03334448|76000772|FG001|NOT COMPLETED|Washout||0||
59749755|NCT00882999|75868831|FG006|NOT COMPLETED|Overall Study||8||
59749756|NCT00671437|75868854|FG000|STARTED|Overall Study||42||
59749757|NCT00671437|75868854|FG000|COMPLETED|Overall Study||27||
59749758|NCT00671437|75868854|FG000|NOT COMPLETED|Overall Study||15||
59749759|NCT00882921|75868866|FG000|STARTED|Overall Study||26||
59749760|NCT00882921|75868866|FG000|COMPLETED|Overall Study||15||
59749761|NCT00882921|75868866|FG000|NOT COMPLETED|Overall Study||11||
59749762|NCT00582712|75868871|FG000|STARTED|Overall Study||5||
59749763|NCT00582712|75868871|FG000|COMPLETED|Overall Study||1||
59749764|NCT00582712|75868871|FG000|NOT COMPLETED|Overall Study||4||
59749765|NCT00582790|75868875|FG000|STARTED|Overall Study|only 11 of the 12 patients received study treatment.|12||
59749766|NCT00582790|75868875|FG000|COMPLETED|Overall Study||11||
59749767|NCT00582790|75868875|FG000|NOT COMPLETED|Overall Study||1||
59749768|NCT00881751|75868882|FG000|STARTED|Overall Study||47||
59749769|NCT00881751|75868883|FG001|STARTED|Overall Study||48||
59749770|NCT00881751|75868882|FG000|COMPLETED|Overall Study||47||
59749771|NCT00881751|75868883|FG001|COMPLETED|Overall Study||43||
59749772|NCT00881751|75868882|FG000|NOT COMPLETED|Overall Study||0||
59749773|NCT00881751|75868883|FG001|NOT COMPLETED|Overall Study||5||
59749774|NCT00934856|75868895|FG000|STARTED|Feasibility Part||6||
59749775|NCT00934856|75868896|FG001|STARTED|Feasibility Part||6||
59749776|NCT00934856|75868897|FG002|STARTED|Feasibility Part||3||
59749777|NCT00934856|75868898|FG003|STARTED|Feasibility Part||6||
59749778|NCT00934856|75868899|FG004|STARTED|Feasibility Part||12||
59749779|NCT00934856|75868900|FG005|STARTED|Feasibility Part||9||
59749780|NCT00934856|75868895|FG000|COMPLETED|Feasibility Part||1||
59749781|NCT00934856|75868896|FG001|COMPLETED|Feasibility Part||1||
59749782|NCT00934856|75868897|FG002|COMPLETED|Feasibility Part||0||
59749783|NCT00934856|75868898|FG003|COMPLETED|Feasibility Part||1||
59749784|NCT00934856|75868899|FG004|COMPLETED|Feasibility Part||12||
59749785|NCT00934856|75868900|FG005|COMPLETED|Feasibility Part||6||
59749786|NCT00934856|75868895|FG000|NOT COMPLETED|Feasibility Part||5||
59749787|NCT00934856|75868896|FG001|NOT COMPLETED|Feasibility Part||5||
59749788|NCT00934856|75868897|FG002|NOT COMPLETED|Feasibility Part||3||
59749789|NCT00934856|75868898|FG003|NOT COMPLETED|Feasibility Part||5||
59749790|NCT00934856|75868899|FG004|NOT COMPLETED|Feasibility Part||0||
59749791|NCT00934856|75868900|FG005|NOT COMPLETED|Feasibility Part||3||
59749792|NCT00934856|75868895|FG000|STARTED|Extension Part||0||
59749793|NCT00934856|75868896|FG001|STARTED|Extension Part||0||
59749794|NCT00934856|75868897|FG002|STARTED|Extension Part||0||
59749795|NCT00934856|75868898|FG003|STARTED|Extension Part|New participants were enrolled in the extension part.|4||
59749796|NCT00934856|75868899|FG004|STARTED|Extension Part|New participants were enrolled in the extension part.|28||
59749797|NCT00934856|75868900|FG005|STARTED|Extension Part|New participants were enrolled in the extension part.|24||
59749798|NCT00934856|75868895|FG000|COMPLETED|Extension Part||0||
59749799|NCT00934856|75868896|FG001|COMPLETED|Extension Part||0||
59749800|NCT00934856|75868897|FG002|COMPLETED|Extension Part||0||
59749801|NCT00934856|75868898|FG003|COMPLETED|Extension Part||2||
59749802|NCT00934856|75868899|FG004|COMPLETED|Extension Part||24||
59749803|NCT00934856|75868900|FG005|COMPLETED|Extension Part||19||
59749804|NCT00934856|75868895|FG000|NOT COMPLETED|Extension Part||0||
59749805|NCT00934856|75868896|FG001|NOT COMPLETED|Extension Part||0||
59749806|NCT00934856|75868897|FG002|NOT COMPLETED|Extension Part||0||
59749807|NCT00934856|75868898|FG003|NOT COMPLETED|Extension Part||2||
59749808|NCT00934856|75868899|FG004|NOT COMPLETED|Extension Part||4||
59749809|NCT00934856|75868900|FG005|NOT COMPLETED|Extension Part||5||
59749810|NCT00934700|75868934|FG000|STARTED|Overall Study||46||
59749811|NCT00934700|75868935|FG001|STARTED|Overall Study||46||
59749812|NCT00934700|75868934|FG000|COMPLETED|Overall Study||33||
59749813|NCT00934700|75868935|FG001|COMPLETED|Overall Study||34||
59749814|NCT00934700|75868934|FG000|NOT COMPLETED|Overall Study||13||
59749815|NCT00934700|75868935|FG001|NOT COMPLETED|Overall Study||12||
59749816|NCT00930176|75868942|FG000|STARTED|Overall Study||16||
59749817|NCT00930176|75868942|FG000|COMPLETED|Overall Study||15||
59749818|NCT00930176|75868942|FG000|NOT COMPLETED|Overall Study||1||
59749819|NCT00669409|75868952|FG000|STARTED|Part 1||6||
59749820|NCT00669409|75868953|FG001|STARTED|Part 1||6||
59749821|NCT00669409|75868954|FG002|STARTED|Part 1||6||
59749822|NCT00669409|75868955|FG003|STARTED|Part 1||6||
59749823|NCT00669409|75868956|FG004|STARTED|Part 1||6||
59749824|NCT00669409|75868957|FG005|STARTED|Part 1||12||
59749825|NCT00669409|75868958|FG006|STARTED|Part 1||0||
59749826|NCT00669409|75868959|FG007|STARTED|Part 1||0||
59749827|NCT00669409|75868960|FG008|STARTED|Part 1||0||
59749828|NCT00669409|75868961|FG009|STARTED|Part 1||0||
59749829|NCT00669409|75868962|FG010|STARTED|Part 1||0||
59749830|NCT00669409|75868952|FG000|COMPLETED|Part 1||6||
59749831|NCT00669409|75868953|FG001|COMPLETED|Part 1||6||
59749832|NCT00669409|75868954|FG002|COMPLETED|Part 1||6||
59749833|NCT00669409|75868955|FG003|COMPLETED|Part 1||6||
59749834|NCT00669409|75868956|FG004|COMPLETED|Part 1||6||
59749835|NCT00669409|75868957|FG005|COMPLETED|Part 1||12||
59749836|NCT00669409|75868958|FG006|COMPLETED|Part 1||0||
59749837|NCT00669409|75868959|FG007|COMPLETED|Part 1||0||
59749838|NCT00669409|75868960|FG008|COMPLETED|Part 1||0||
59749839|NCT00669409|75868961|FG009|COMPLETED|Part 1||0||
59749840|NCT00669409|75868962|FG010|COMPLETED|Part 1||0||
59749841|NCT00669409|75868952|FG000|NOT COMPLETED|Part 1||0||
59749842|NCT00669409|75868953|FG001|NOT COMPLETED|Part 1||0||
59749843|NCT00669409|75868954|FG002|NOT COMPLETED|Part 1||0||
59749844|NCT00669409|75868955|FG003|NOT COMPLETED|Part 1||0||
59749845|NCT00669409|75868956|FG004|NOT COMPLETED|Part 1||0||
59749846|NCT00669409|75868957|FG005|NOT COMPLETED|Part 1||0||
59749847|NCT00669409|75868958|FG006|NOT COMPLETED|Part 1||0||
59749848|NCT00669409|75868959|FG007|NOT COMPLETED|Part 1||0||
59749849|NCT00669409|75868960|FG008|NOT COMPLETED|Part 1||0||
59749850|NCT00669409|75868961|FG009|NOT COMPLETED|Part 1||0||
59749851|NCT00669409|75868962|FG010|NOT COMPLETED|Part 1||0||
59749852|NCT00669409|75868952|FG000|STARTED|Part 2||0||
59749853|NCT00669409|75868953|FG001|STARTED|Part 2||0||
59749854|NCT00669409|75868954|FG002|STARTED|Part 2||0||
59749855|NCT00669409|75868955|FG003|STARTED|Part 2||0||
59749856|NCT00669409|75868956|FG004|STARTED|Part 2||0||
59749857|NCT00669409|75868957|FG005|STARTED|Part 2||0||
59749858|NCT00669409|75868958|FG006|STARTED|Part 2||9||
59749859|NCT00669409|75868959|FG007|STARTED|Part 2||9||
59749860|NCT00669409|75868960|FG008|STARTED|Part 2||9||
59749861|NCT00669409|75868961|FG009|STARTED|Part 2||10||
59749862|NCT00669409|75868962|FG010|STARTED|Part 2||4||
59749863|NCT00669409|75868952|FG000|COMPLETED|Part 2||0||
59749864|NCT00669409|75868953|FG001|COMPLETED|Part 2||0||
59749865|NCT00669409|75868954|FG002|COMPLETED|Part 2||0||
59749866|NCT00669409|75868955|FG003|COMPLETED|Part 2||0||
59749867|NCT00669409|75868956|FG004|COMPLETED|Part 2||0||
59749868|NCT00669409|75868957|FG005|COMPLETED|Part 2||0||
59749869|NCT00669409|75868958|FG006|COMPLETED|Part 2||9||
59749870|NCT00669409|75868959|FG007|COMPLETED|Part 2||9||
59749871|NCT00669409|75868960|FG008|COMPLETED|Part 2||9||
59749872|NCT00669409|75868961|FG009|COMPLETED|Part 2||9||
59749873|NCT00669409|75868962|FG010|COMPLETED|Part 2||4||
59749874|NCT00669409|75868952|FG000|NOT COMPLETED|Part 2||0||
59749875|NCT00669409|75868953|FG001|NOT COMPLETED|Part 2||0||
59749876|NCT00669409|75868954|FG002|NOT COMPLETED|Part 2||0||
59749877|NCT00669409|75868955|FG003|NOT COMPLETED|Part 2||0||
59749878|NCT00669409|75868956|FG004|NOT COMPLETED|Part 2||0||
59749879|NCT00669409|75868957|FG005|NOT COMPLETED|Part 2||0||
59749880|NCT00669409|75868958|FG006|NOT COMPLETED|Part 2||0||
59749881|NCT00669409|75868959|FG007|NOT COMPLETED|Part 2||0||
59749882|NCT00669409|75868960|FG008|NOT COMPLETED|Part 2||0||
59749883|NCT00669409|75868961|FG009|NOT COMPLETED|Part 2||1||
59749884|NCT00669409|75868962|FG010|NOT COMPLETED|Part 2||0||
59749885|NCT00669331|75868991|FG000|STARTED|Randomisation to First Dose||244||
59749886|NCT00669331|75868992|FG001|STARTED|Randomisation to First Dose||241||
59749887|NCT00669331|75868991|FG000|COMPLETED|Randomisation to First Dose||233||
59749888|NCT00669331|75868992|FG001|COMPLETED|Randomisation to First Dose||228||
59749889|NCT00669331|75868991|FG000|NOT COMPLETED|Randomisation to First Dose||11||
59749890|NCT00669331|75868992|FG001|NOT COMPLETED|Randomisation to First Dose||13||
59749891|NCT00669331|75868991|FG000|STARTED|Blinded Treatment Period||233||
59749892|NCT00669331|75868992|FG001|STARTED|Blinded Treatment Period||228||
59749893|NCT00669331|75868991|FG000|COMPLETED|Blinded Treatment Period||191||
59749894|NCT00669331|75868992|FG001|COMPLETED|Blinded Treatment Period||189||
59749895|NCT00669331|75868991|FG000|NOT COMPLETED|Blinded Treatment Period||42||
59749896|NCT00669331|75868992|FG001|NOT COMPLETED|Blinded Treatment Period||39||
59749897|NCT00932126|75869000|FG000|STARTED|Overall Study||3||
59749898|NCT00932126|75869001|FG001|STARTED|Overall Study||3||
59749899|NCT00932126|75869002|FG002|STARTED|Overall Study||3||
59876977|NCT03334448|76000773|FG002|NOT COMPLETED|Washout||0||
59876978|NCT03334448|76000774|FG003|NOT COMPLETED|Washout||1||
59749900|NCT00932126|75869003|FG003|STARTED|Overall Study||3||
59749901|NCT00932126|75869004|FG004|STARTED|Overall Study||5||
59749902|NCT00932126|75869005|FG005|STARTED|Overall Study||3||
59749903|NCT00932126|75869006|FG006|STARTED|Overall Study||5||
59749904|NCT00932126|75869007|FG007|STARTED|Overall Study||10||
59876979|NCT03334448|76000771|FG000|STARTED|Period 4||12||
59876980|NCT03334448|76000772|FG001|STARTED|Period 4||11||
59749905|NCT00932126|75869000|FG000|COMPLETED|Overall Study||0||
59749906|NCT00932126|75869001|FG001|COMPLETED|Overall Study||0||
59749907|NCT00932126|75869002|FG002|COMPLETED|Overall Study||0||
59749908|NCT00932126|75869003|FG003|COMPLETED|Overall Study||0||
59749909|NCT00932126|75869004|FG004|COMPLETED|Overall Study||0||
59749910|NCT00932126|75869005|FG005|COMPLETED|Overall Study||0||
59749911|NCT00932126|75869006|FG006|COMPLETED|Overall Study||0||
59876981|NCT03334448|76000773|FG002|STARTED|Period 4||13||
59749912|NCT00932126|75869007|FG007|COMPLETED|Overall Study||0||
59749913|NCT00932126|75869000|FG000|NOT COMPLETED|Overall Study||3||
59749914|NCT00932126|75869001|FG001|NOT COMPLETED|Overall Study||3||
59749915|NCT00932126|75869002|FG002|NOT COMPLETED|Overall Study||3||
59749916|NCT00932126|75869003|FG003|NOT COMPLETED|Overall Study||3||
59749917|NCT00932126|75869004|FG004|NOT COMPLETED|Overall Study||5||
59749918|NCT00932126|75869005|FG005|NOT COMPLETED|Overall Study||3||
59749919|NCT00932126|75869006|FG006|NOT COMPLETED|Overall Study||5||
59749920|NCT00932126|75869007|FG007|NOT COMPLETED|Overall Study||10||
59749921|NCT00667225|75869029|FG000|STARTED|Overall Study||16||
59876982|NCT03334448|76000774|FG003|STARTED|Period 4||11||
59749922|NCT00667225|75869030|FG001|STARTED|Overall Study||13||
59749923|NCT00667225|75869029|FG000|COMPLETED|Overall Study||15||
59749924|NCT00667225|75869030|FG001|COMPLETED|Overall Study||12||
59749925|NCT00667225|75869029|FG000|NOT COMPLETED|Overall Study||1||
59749926|NCT00667225|75869030|FG001|NOT COMPLETED|Overall Study||1||
59749927|NCT00929864|75869038|FG000|STARTED|Overall Study||318||
59749928|NCT00929864|75869039|FG001|STARTED|Overall Study||328||
59749929|NCT00929864|75869038|FG000|COMPLETED|Overall Study||252||
59749930|NCT00929864|75869039|FG001|COMPLETED|Overall Study||245||
59749931|NCT00929864|75869038|FG000|NOT COMPLETED|Overall Study||66||
59749932|NCT00929864|75869039|FG001|NOT COMPLETED|Overall Study||83||
59749933|NCT00597753|75869047|FG000|STARTED|Overall Study|Randomization was 2:1 peginesatide to epoetin alfa|532||
59749934|NCT00597753|75869048|FG001|STARTED|Overall Study||271||
59749935|NCT00597753|75869047|FG000|COMPLETED|Overall Study||366||
59749936|NCT00597753|75869048|FG001|COMPLETED|Overall Study||202||
59749937|NCT00597753|75869047|FG000|NOT COMPLETED|Overall Study||166||
59749938|NCT00597753|75869048|FG001|NOT COMPLETED|Overall Study||69||
59749939|NCT00665431|75869057|FG000|STARTED|Overall Study|Safety population|243||
59749940|NCT00665431|75869058|FG001|STARTED|Overall Study|Safety population|245||
59749941|NCT00665431|75869059|FG002|STARTED|Overall Study|Safety population|122||
59749942|NCT00665431|75869057|FG000|COMPLETED|Overall Study||203||
59749943|NCT00665431|75869058|FG001|COMPLETED|Overall Study||188||
59749944|NCT00665431|75869059|FG002|COMPLETED|Overall Study||98||
59749945|NCT00665431|75869057|FG000|NOT COMPLETED|Overall Study||40||
59749946|NCT00665431|75869058|FG001|NOT COMPLETED|Overall Study||57||
59749947|NCT00665431|75869059|FG002|NOT COMPLETED|Overall Study||24||
59749948|NCT00934622|75869067|FG000|STARTED|Overall Study||76||
59749949|NCT00934622|75869067|FG000|COMPLETED|Overall Study||68||
59749950|NCT00934622|75869067|FG000|NOT COMPLETED|Overall Study||8||
59749951|NCT00881361|75869073|FG000|STARTED|Overall Study||707||
59749952|NCT00881361|75869074|FG001|STARTED|Overall Study||47||
59749953|NCT00881361|75869075|FG002|STARTED|Overall Study||2||
59749954|NCT00881361|75869073|FG000|COMPLETED|Overall Study||663||
59749955|NCT00881361|75869074|FG001|COMPLETED|Overall Study||38||
59749956|NCT00881361|75869075|FG002|COMPLETED|Overall Study||0||
59749957|NCT00881361|75869073|FG000|NOT COMPLETED|Overall Study||44||
59749958|NCT00881361|75869074|FG001|NOT COMPLETED|Overall Study||9||
59749959|NCT00881361|75869075|FG002|NOT COMPLETED|Overall Study||2||
59749960|NCT01000727|75869086|FG000|STARTED|Overall Study||6522||
59749961|NCT01000727|75869087|FG001|STARTED|Overall Study||6504||
59749962|NCT01000727|75869086|FG000|COMPLETED|Overall Study||6347||
59749963|NCT01000727|75869087|FG001|COMPLETED|Overall Study||6328||
59749964|NCT01000727|75869086|FG000|NOT COMPLETED|Overall Study||175||
59749965|NCT01000727|75869087|FG001|NOT COMPLETED|Overall Study||176||
59749966|NCT00881205|75869097|FG000|STARTED|Overall Study||45||
59749967|NCT00881205|75869098|FG001|STARTED|Overall Study||41||
59749968|NCT00881205|75869097|FG000|COMPLETED|Overall Study||34||
59749969|NCT00881205|75869098|FG001|COMPLETED|Overall Study||34||
59749970|NCT00881205|75869097|FG000|NOT COMPLETED|Overall Study||11||
59749971|NCT00881205|75869098|FG001|NOT COMPLETED|Overall Study||7||
59749972|NCT00879879|75869105|FG000|STARTED|Overall Study||20||
59749973|NCT00879879|75869105|FG000|COMPLETED|Overall Study||17||
59749974|NCT00879879|75869105|FG000|NOT COMPLETED|Overall Study||3||
59749975|NCT00661999|75869114|FG000|STARTED|Overall Study||164||
59749976|NCT00661999|75869115|FG001|STARTED|Overall Study||163||
59749977|NCT00661999|75869116|FG002|STARTED|Overall Study||163||
59749978|NCT00661999|75869114|FG000|COMPLETED|Overall Study||105||
59749979|NCT00661999|75869115|FG001|COMPLETED|Overall Study||113||
59749980|NCT00661999|75869116|FG002|COMPLETED|Overall Study||106||
59749981|NCT00661999|75869114|FG000|NOT COMPLETED|Overall Study||59||
59749982|NCT00661999|75869115|FG001|NOT COMPLETED|Overall Study||50||
59749983|NCT00661999|75869116|FG002|NOT COMPLETED|Overall Study||57||
59749984|NCT00665353|75869124|FG000|STARTED|Study Step 1||19||
59749985|NCT00665353|75869124|FG000|COMPLETED|Study Step 1||16||
59749986|NCT00665353|75869124|FG000|NOT COMPLETED|Study Step 1||3||
59749987|NCT00665353|75869124|FG000|STARTED|Study Step 2||16||
59749988|NCT00665353|75869124|FG000|COMPLETED|Study Step 2||2||
59749989|NCT00665353|75869124|FG000|NOT COMPLETED|Study Step 2||14||
59749990|NCT00597207|75869130|FG000|STARTED|Overall Study||2099||
59749991|NCT00597207|75869131|FG001|STARTED|Overall Study||2132||
59749992|NCT00597207|75869130|FG000|COMPLETED|Overall Study||2094||
59749993|NCT00597207|75869131|FG001|COMPLETED|Overall Study||2125||
59749994|NCT00597207|75869130|FG000|NOT COMPLETED|Overall Study||5||
59749995|NCT00597207|75869131|FG001|NOT COMPLETED|Overall Study||7||
59749996|NCT00879645|75869141|FG000|STARTED|Overall Study||9||
59749997|NCT00879645|75869142|FG001|STARTED|Overall Study||6||
59749998|NCT00879645|75869143|FG002|STARTED|Overall Study||6||
59749999|NCT00879645|75869144|FG003|STARTED|Overall Study||7||
59750000|NCT00879645|75869141|FG000|COMPLETED|Overall Study||8||
59750001|NCT00879645|75869142|FG001|COMPLETED|Overall Study||6||
59750002|NCT00879645|75869143|FG002|COMPLETED|Overall Study||6||
59750003|NCT00879645|75869144|FG003|COMPLETED|Overall Study||7||
59750004|NCT00879645|75869141|FG000|NOT COMPLETED|Overall Study||1||
59750005|NCT00879645|75869142|FG001|NOT COMPLETED|Overall Study||0||
59750006|NCT00879645|75869143|FG002|NOT COMPLETED|Overall Study||0||
59750007|NCT00879645|75869144|FG003|NOT COMPLETED|Overall Study||0||
59750008|NCT00664105|75869154|FG000|STARTED|Overall Study||63||
59750009|NCT00664105|75869154|FG000|COMPLETED|Overall Study||39||
59750010|NCT00664105|75869154|FG000|NOT COMPLETED|Overall Study||24||
59750011|NCT00661687|75869159|FG000|STARTED|Overall Study|Contralateral study design, numbers indicate number of subjects.|204||
59750012|NCT00661687|75869159|FG000|COMPLETED|Overall Study|Number indicates number of subjects successfully completing study.|189||
59750013|NCT00661687|75869159|FG000|NOT COMPLETED|Overall Study||15||
59750014|NCT00596817|75869168|FG000|STARTED|Open-label Period||0||
59750015|NCT00596817|75869169|FG001|STARTED|Open-label Period||639||
59750016|NCT00596817|75869168|FG000|COMPLETED|Open-label Period||0||
59750017|NCT00596817|75869169|FG001|COMPLETED|Open-label Period||492||
59750018|NCT00596817|75869168|FG000|NOT COMPLETED|Open-label Period||0||
59750019|NCT00596817|75869169|FG001|NOT COMPLETED|Open-label Period||147||
59750020|NCT00596817|75869168|FG000|STARTED|Open-label Period to Double-blind Period||0||
59750021|NCT00596817|75869169|FG001|STARTED|Open-label Period to Double-blind Period||492||
59750022|NCT00596817|75869168|FG000|COMPLETED|Open-label Period to Double-blind Period||0||
59750023|NCT00596817|75869169|FG001|COMPLETED|Open-label Period to Double-blind Period||400||
59750024|NCT00596817|75869168|FG000|NOT COMPLETED|Open-label Period to Double-blind Period||0||
59750025|NCT00596817|75869169|FG001|NOT COMPLETED|Open-label Period to Double-blind Period||92||
59750026|NCT00596817|75869168|FG000|STARTED|Double-blind Period|194 patients were randomised. 2 did not receive study medication. 192 is full-analysis set (FAS).|192||
59750027|NCT00596817|75869169|FG001|STARTED|Double-blind Period|206 patients were randomised. 2 did not receive study medication. 204 is FAS.|204||
59750028|NCT00596817|75869168|FG000|COMPLETED|Double-blind Period||104||
59750029|NCT00596817|75869169|FG001|COMPLETED|Double-blind Period||125||
59750030|NCT00596817|75869168|FG000|NOT COMPLETED|Double-blind Period||88||
59750031|NCT00596817|75869169|FG001|NOT COMPLETED|Double-blind Period||79||
59750032|NCT01000649|75869180|FG000|STARTED|Overall Study|This represents Full Analysis Set population, which comprised of all dosed patients.|10||
59750033|NCT01000649|75869181|FG001|STARTED|Overall Study|This represents Full Analysis Set population, which comprised of all dosed patients.|19||
59750034|NCT01000649|75869182|FG002|STARTED|Overall Study|This represents Full Analysis Set population, which comprised of all dosed patients.|2||
59750035|NCT01000649|75869183|FG003|STARTED|Overall Study|This represents Full Analysis Set population, which comprised of all dosed patients.|21||
59750036|NCT01000649|75869180|FG000|Intention-to-Treat (ITT) Analysis Set|Overall Study|ITT population comprised of all randomized patients.|10||
59750037|NCT01000649|75869181|FG001|Intention-to-Treat (ITT) Analysis Set|Overall Study|ITT population comprised of all randomized patients.|20||
59750038|NCT01000649|75869182|FG002|Intention-to-Treat (ITT) Analysis Set|Overall Study|ITT population comprised of all randomized patients.|2||
59750039|NCT01000649|75869183|FG003|Intention-to-Treat (ITT) Analysis Set|Overall Study|ITT population comprised of all randomized patients.|21||
59750040|NCT01000649|75869180|FG000|COMPLETED|Overall Study||5||
59750041|NCT01000649|75869181|FG001|COMPLETED|Overall Study||16||
59750042|NCT01000649|75869182|FG002|COMPLETED|Overall Study||0||
59750043|NCT01000649|75869183|FG003|COMPLETED|Overall Study||15||
59750044|NCT01000649|75869180|FG000|NOT COMPLETED|Overall Study||5||
59750045|NCT01000649|75869181|FG001|NOT COMPLETED|Overall Study||3||
59750046|NCT01000649|75869182|FG002|NOT COMPLETED|Overall Study||2||
59750047|NCT01000649|75869183|FG003|NOT COMPLETED|Overall Study||6||
59750048|NCT00879411|75869192|FG000|STARTED|Overall Study||701||
59750049|NCT00879411|75869192|FG000|COMPLETED|Overall Study||539||
59750050|NCT00879411|75869192|FG000|NOT COMPLETED|Overall Study||162||
59750051|NCT01000493|75869198|FG000|STARTED|Overall Study||60||
59750052|NCT01000493|75869199|FG001|STARTED|Overall Study||69||
59750053|NCT01000493|75869198|FG000|COMPLETED|Overall Study||21||
59750054|NCT01000493|75869199|FG001|COMPLETED|Overall Study||14||
59750055|NCT01000493|75869198|FG000|NOT COMPLETED|Overall Study||39||
59750056|NCT01000493|75869199|FG001|NOT COMPLETED|Overall Study||55||
59750057|NCT00666757|75869207|FG000|STARTED|Overall Study||372||
59750058|NCT00666757|75869208|FG001|STARTED|Overall Study||378||
59750059|NCT00666757|75869207|FG000|COMPLETED|Overall Study||272||
59750060|NCT00666757|75869208|FG001|COMPLETED|Overall Study||281||
59750061|NCT00666757|75869207|FG000|NOT COMPLETED|Overall Study||100||
59750062|NCT00666757|75869208|FG001|NOT COMPLETED|Overall Study||97||
59750063|NCT01000337|75869219|FG000|STARTED|Overall Study||34||
59750064|NCT01000337|75869220|FG001|STARTED|Overall Study||33||
59750065|NCT01000337|75869219|FG000|COMPLETED|Overall Study||30||
59750066|NCT01000337|75869220|FG001|COMPLETED|Overall Study||30||
59750067|NCT01000337|75869219|FG000|NOT COMPLETED|Overall Study||4||
59750068|NCT01000337|75869220|FG001|NOT COMPLETED|Overall Study||3||
59750069|NCT00666679|75869228|FG000|STARTED|First Intervention||66||
59750070|NCT00666679|75869229|FG001|STARTED|First Intervention||68||
59750071|NCT00666679|75869228|FG000|COMPLETED|First Intervention||62||
59750072|NCT00666679|75869229|FG001|COMPLETED|First Intervention||67||
59750073|NCT00666679|75869228|FG000|NOT COMPLETED|First Intervention||4||
59750074|NCT00666679|75869229|FG001|NOT COMPLETED|First Intervention||1||
59750075|NCT00666679|75869228|FG000|STARTED|Washout Period of 1 Week||62||
59750076|NCT00666679|75869229|FG001|STARTED|Washout Period of 1 Week||67||
59750077|NCT00666679|75869228|FG000|COMPLETED|Washout Period of 1 Week||62||
59750078|NCT00666679|75869229|FG001|COMPLETED|Washout Period of 1 Week||65||
59762505|NCT00866619|75882227|FG001|NOT COMPLETED|Overall Study||1270||
59750079|NCT00666679|75869228|FG000|NOT COMPLETED|Washout Period of 1 Week||0||
59750080|NCT00666679|75869229|FG001|NOT COMPLETED|Washout Period of 1 Week||2||
59750081|NCT00666679|75869228|FG000|STARTED|Second Intervention||62||
60135769|NCT01685008|76258448|FG000|Entered Maintenance Phase Treatment|Cycle 3 and Maintenance Treatment||8||
60135770|NCT01685008|76258449|FG001|Entered Maintenance Phase Treatment|Cycle 3 and Maintenance Treatment||6||
60135771|NCT01685008|76258450|FG002|Entered Maintenance Phase Treatment|Cycle 3 and Maintenance Treatment||0||
60135772|NCT01685008|76258451|FG003|Entered Maintenance Phase Treatment|Cycle 3 and Maintenance Treatment||2||
60135773|NCT01685008|76258448|FG000|COMPLETED|Cycle 3 and Maintenance Treatment||0||
60135774|NCT01685008|76258449|FG001|COMPLETED|Cycle 3 and Maintenance Treatment||1||
59750082|NCT00666679|75869229|FG001|STARTED|Second Intervention||65||
59750083|NCT00666679|75869228|FG000|COMPLETED|Second Intervention||61||
59750084|NCT00666679|75869229|FG001|COMPLETED|Second Intervention||64||
59750085|NCT00666679|75869228|FG000|NOT COMPLETED|Second Intervention||1||
59750086|NCT00666679|75869229|FG001|NOT COMPLETED|Second Intervention||1||
59750087|NCT00595413|75869239|FG000|STARTED|Overall Study||76||
59750088|NCT00595413|75869240|FG001|STARTED|Overall Study||78||
59750089|NCT00595413|75869241|FG002|STARTED|Overall Study||78||
59750090|NCT00595413|75869242|FG003|STARTED|Overall Study||79||
59750091|NCT00595413|75869239|FG000|COMPLETED|Overall Study||69||
59750092|NCT00595413|75869240|FG001|COMPLETED|Overall Study||73||
59750093|NCT00595413|75869241|FG002|COMPLETED|Overall Study||70||
59750094|NCT00595413|75869242|FG003|COMPLETED|Overall Study||75||
59750095|NCT00595413|75869239|FG000|NOT COMPLETED|Overall Study||7||
59750096|NCT00595413|75869240|FG001|NOT COMPLETED|Overall Study||5||
59876983|NCT03334448|76000771|FG000|Received at Least 1 Dose of Study Drug|Period 4||12||
59876984|NCT03334448|76000772|FG001|Received at Least 1 Dose of Study Drug|Period 4||11||
59876985|NCT03334448|76000773|FG002|Received at Least 1 Dose of Study Drug|Period 4||13||
60135775|NCT01685008|76258450|FG002|COMPLETED|Cycle 3 and Maintenance Treatment||0||
60135776|NCT01685008|76258451|FG003|COMPLETED|Cycle 3 and Maintenance Treatment||0||
60135777|NCT01685008|76258448|FG000|NOT COMPLETED|Cycle 3 and Maintenance Treatment||30||
60135778|NCT01685008|76258449|FG001|NOT COMPLETED|Cycle 3 and Maintenance Treatment||24||
59876986|NCT03334448|76000774|FG003|Received at Least 1 Dose of Study Drug|Period 4||11||
60135779|NCT01685008|76258450|FG002|NOT COMPLETED|Cycle 3 and Maintenance Treatment||10||
60135780|NCT01685008|76258451|FG003|NOT COMPLETED|Cycle 3 and Maintenance Treatment||10||
60135781|NCT01623167|76258468|FG000|STARTED|Overall Study||30||
60135782|NCT01623167|76258469|FG001|STARTED|Overall Study||31||
60135783|NCT01623167|76258470|FG002|STARTED|Overall Study||31||
60135784|NCT01623167|76258468|FG000|COMPLETED|Overall Study||13||
60135785|NCT01623167|76258469|FG001|COMPLETED|Overall Study||17||
59750097|NCT00595413|75869241|FG002|NOT COMPLETED|Overall Study||8||
59750098|NCT00595413|75869242|FG003|NOT COMPLETED|Overall Study||4||
59750099|NCT01000025|75869254|FG000|STARTED|Overall Study||480||
59750100|NCT01000025|75869255|FG001|STARTED|Overall Study||240||
59750101|NCT01000025|75869254|FG000|COMPLETED|Overall Study||12||
59876987|NCT03334448|76000771|FG000|COMPLETED|Period 4||12||
59876988|NCT03334448|76000772|FG001|COMPLETED|Period 4||11||
59876989|NCT03334448|76000773|FG002|COMPLETED|Period 4||13||
59876990|NCT03334448|76000774|FG003|COMPLETED|Period 4||11||
59876991|NCT03334448|76000771|FG000|NOT COMPLETED|Period 4||0||
59876992|NCT03334448|76000772|FG001|NOT COMPLETED|Period 4||0||
59876993|NCT03334448|76000773|FG002|NOT COMPLETED|Period 4||0||
59876994|NCT03334448|76000774|FG003|NOT COMPLETED|Period 4||0||
59876995|NCT02849080|76000782|FG000|STARTED|Main Phase: 0 - 52 Weeks||253||
59876996|NCT02849080|76000783|FG001|STARTED|Main Phase: 0 - 52 Weeks||251||
59876997|NCT02849080|76000784|FG002|STARTED|Main Phase: 0 - 52 Weeks||0||
59876998|NCT02849080|76000785|FG003|STARTED|Main Phase: 0 - 52 Weeks||0||
59876999|NCT02849080|76000782|FG000|Exposed|Main Phase: 0 - 52 Weeks||253||
59877000|NCT02849080|76000783|FG001|Exposed|Main Phase: 0 - 52 Weeks||250||
59877001|NCT02849080|76000784|FG002|Exposed|Main Phase: 0 - 52 Weeks||0||
59877002|NCT02849080|76000785|FG003|Exposed|Main Phase: 0 - 52 Weeks||0||
59877003|NCT02849080|76000782|FG000|Full Analysis Set (FAS)|Main Phase: 0 - 52 Weeks||253||
59877004|NCT02849080|76000783|FG001|Full Analysis Set (FAS)|Main Phase: 0 - 52 Weeks||251||
59877005|NCT02849080|76000784|FG002|Full Analysis Set (FAS)|Main Phase: 0 - 52 Weeks||0||
59877006|NCT02849080|76000785|FG003|Full Analysis Set (FAS)|Main Phase: 0 - 52 Weeks||0||
59877007|NCT02849080|76000782|FG000|Safety Analysis Set (SAS)|Main Phase: 0 - 52 Weeks||253||
59877008|NCT02849080|76000783|FG001|Safety Analysis Set (SAS)|Main Phase: 0 - 52 Weeks||250||
59877009|NCT02849080|76000784|FG002|Safety Analysis Set (SAS)|Main Phase: 0 - 52 Weeks||0||
59877010|NCT02849080|76000785|FG003|Safety Analysis Set (SAS)|Main Phase: 0 - 52 Weeks||0||
59877011|NCT02849080|76000782|FG000|COMPLETED|Main Phase: 0 - 52 Weeks||241||
59877012|NCT02849080|76000783|FG001|COMPLETED|Main Phase: 0 - 52 Weeks||244||
59877013|NCT02849080|76000784|FG002|COMPLETED|Main Phase: 0 - 52 Weeks||0||
59877014|NCT02849080|76000785|FG003|COMPLETED|Main Phase: 0 - 52 Weeks||0||
59877015|NCT02849080|76000782|FG000|NOT COMPLETED|Main Phase: 0 - 52 Weeks||12||
59877016|NCT02849080|76000783|FG001|NOT COMPLETED|Main Phase: 0 - 52 Weeks||7||
59877017|NCT02849080|76000784|FG002|NOT COMPLETED|Main Phase: 0 - 52 Weeks||0||
59877018|NCT02849080|76000785|FG003|NOT COMPLETED|Main Phase: 0 - 52 Weeks||0||
59877019|NCT02849080|76000782|FG000|STARTED|Extension Phase: 53 - 104 Weeks|Participants who had provided consent to continue in the extension phase started in this period.|185||
59877020|NCT02849080|76000783|FG001|STARTED|Extension Phase: 53 - 104 Weeks||0||
59877021|NCT02849080|76000784|FG002|STARTED|Extension Phase: 53 - 104 Weeks|Participants who had provided consent to continue in the extension phase started in this period.|100||
59877022|NCT02849080|76000785|FG003|STARTED|Extension Phase: 53 - 104 Weeks|Participants who had provided consent to continue in the extension phase started in this period.|98||
59877023|NCT02849080|76000782|FG000|Exposed|Extension Phase: 53 - 104 Weeks||184||
59877024|NCT02849080|76000783|FG001|Exposed|Extension Phase: 53 - 104 Weeks||0||
59877025|NCT02849080|76000784|FG002|Exposed|Extension Phase: 53 - 104 Weeks||100||
59877026|NCT02849080|76000785|FG003|Exposed|Extension Phase: 53 - 104 Weeks||97||
59877027|NCT02849080|76000782|FG000|COMPLETED|Extension Phase: 53 - 104 Weeks||182||
59877028|NCT02849080|76000783|FG001|COMPLETED|Extension Phase: 53 - 104 Weeks||0||
59877029|NCT02849080|76000784|FG002|COMPLETED|Extension Phase: 53 - 104 Weeks||99||
59877030|NCT02849080|76000785|FG003|COMPLETED|Extension Phase: 53 - 104 Weeks||98||
59877031|NCT02849080|76000782|FG000|NOT COMPLETED|Extension Phase: 53 - 104 Weeks||3||
59877032|NCT02849080|76000783|FG001|NOT COMPLETED|Extension Phase: 53 - 104 Weeks||0||
59877033|NCT02849080|76000784|FG002|NOT COMPLETED|Extension Phase: 53 - 104 Weeks||1||
59877034|NCT02849080|76000785|FG003|NOT COMPLETED|Extension Phase: 53 - 104 Weeks||0||
59877035|NCT03346070|76000802|FG000|STARTED|Overall Study||41||
59877036|NCT03346070|76000803|FG001|STARTED|Overall Study||41||
59877037|NCT03346070|76000804|FG002|STARTED|Overall Study||41||
59877038|NCT03346070|76000805|FG003|STARTED|Overall Study||42||
59877039|NCT03346070|76000806|FG004|STARTED|Overall Study||42||
59877040|NCT03346070|76000802|FG000|Treated|Overall Study||38||
59877041|NCT03346070|76000803|FG001|Treated|Overall Study||38||
59877042|NCT03346070|76000804|FG002|Treated|Overall Study||38||
59877043|NCT03346070|76000805|FG003|Treated|Overall Study||36||
59877044|NCT03346070|76000806|FG004|Treated|Overall Study||38||
59877045|NCT03346070|76000802|FG000|COMPLETED|Overall Study||38||
59877046|NCT03346070|76000803|FG001|COMPLETED|Overall Study||37||
59877047|NCT03346070|76000804|FG002|COMPLETED|Overall Study||37||
59877048|NCT03346070|76000805|FG003|COMPLETED|Overall Study||36||
59877049|NCT03346070|76000806|FG004|COMPLETED|Overall Study||37||
59877050|NCT03346070|76000802|FG000|NOT COMPLETED|Overall Study||3||
59877051|NCT03346070|76000803|FG001|NOT COMPLETED|Overall Study||4||
59877052|NCT03346070|76000804|FG002|NOT COMPLETED|Overall Study||4||
59877053|NCT03346070|76000805|FG003|NOT COMPLETED|Overall Study||6||
59877054|NCT03346070|76000806|FG004|NOT COMPLETED|Overall Study||5||
59877055|NCT02951780|76000829|FG000|STARTED|Period 1||3||
59877056|NCT02951780|76000830|FG001|STARTED|Period 1||2||
59877057|NCT02951780|76000831|FG002|STARTED|Period 1||3||
59877058|NCT02951780|76000832|FG003|STARTED|Period 1||3||
59877059|NCT02951780|76000833|FG004|STARTED|Period 1||2||
59877060|NCT02951780|76000834|FG005|STARTED|Period 1||3||
59877061|NCT02951780|76000835|FG006|STARTED|Period 1||2||
59877062|NCT02951780|76000836|FG007|STARTED|Period 1||3||
59877063|NCT02951780|76000837|FG008|STARTED|Period 1||2||
59877064|NCT02951780|76000829|FG000|COMPLETED|Period 1||3||
59877065|NCT02951780|76000830|FG001|COMPLETED|Period 1||2||
59877066|NCT02951780|76000831|FG002|COMPLETED|Period 1||3||
59877067|NCT02951780|76000832|FG003|COMPLETED|Period 1||2||
59877068|NCT02951780|76000833|FG004|COMPLETED|Period 1||2||
59877069|NCT02951780|76000834|FG005|COMPLETED|Period 1||3||
59877070|NCT02951780|76000835|FG006|COMPLETED|Period 1||2||
59877071|NCT02951780|76000836|FG007|COMPLETED|Period 1||2||
59877072|NCT02951780|76000837|FG008|COMPLETED|Period 1||2||
59877073|NCT02951780|76000829|FG000|NOT COMPLETED|Period 1||0||
59877074|NCT02951780|76000830|FG001|NOT COMPLETED|Period 1||0||
59877075|NCT02951780|76000831|FG002|NOT COMPLETED|Period 1||0||
59877076|NCT02951780|76000832|FG003|NOT COMPLETED|Period 1||1||
59877077|NCT02951780|76000833|FG004|NOT COMPLETED|Period 1||0||
59877078|NCT02951780|76000834|FG005|NOT COMPLETED|Period 1||0||
59877079|NCT02951780|76000835|FG006|NOT COMPLETED|Period 1||0||
59877080|NCT02951780|76000836|FG007|NOT COMPLETED|Period 1||1||
59877081|NCT02951780|76000837|FG008|NOT COMPLETED|Period 1||0||
59877082|NCT02951780|76000829|FG000|STARTED|Period 2||3||
59877083|NCT02951780|76000830|FG001|STARTED|Period 2||2||
59877084|NCT02951780|76000831|FG002|STARTED|Period 2||3||
59877085|NCT02951780|76000832|FG003|STARTED|Period 2||2||
59877086|NCT02951780|76000833|FG004|STARTED|Period 2||2||
59877087|NCT02951780|76000834|FG005|STARTED|Period 2||3||
59877088|NCT02951780|76000835|FG006|STARTED|Period 2||2||
59877089|NCT02951780|76000836|FG007|STARTED|Period 2||2||
59877090|NCT02951780|76000837|FG008|STARTED|Period 2||2||
59877091|NCT02951780|76000829|FG000|COMPLETED|Period 2||3||
59877092|NCT02951780|76000830|FG001|COMPLETED|Period 2||2||
59877093|NCT02951780|76000831|FG002|COMPLETED|Period 2||3||
59877094|NCT02951780|76000832|FG003|COMPLETED|Period 2||2||
59877095|NCT02951780|76000833|FG004|COMPLETED|Period 2||2||
59877096|NCT02951780|76000834|FG005|COMPLETED|Period 2||3||
59877097|NCT02951780|76000835|FG006|COMPLETED|Period 2||2||
59877098|NCT02951780|76000836|FG007|COMPLETED|Period 2||1||
59877099|NCT02951780|76000837|FG008|COMPLETED|Period 2||2||
59877100|NCT02951780|76000829|FG000|NOT COMPLETED|Period 2||0||
59877101|NCT02951780|76000830|FG001|NOT COMPLETED|Period 2||0||
59877102|NCT02951780|76000831|FG002|NOT COMPLETED|Period 2||0||
59877103|NCT02951780|76000832|FG003|NOT COMPLETED|Period 2||0||
59877104|NCT02951780|76000833|FG004|NOT COMPLETED|Period 2||0||
59877105|NCT02951780|76000834|FG005|NOT COMPLETED|Period 2||0||
59877106|NCT02951780|76000835|FG006|NOT COMPLETED|Period 2||0||
59877107|NCT02951780|76000836|FG007|NOT COMPLETED|Period 2||1||
59877108|NCT02951780|76000837|FG008|NOT COMPLETED|Period 2||0||
59877109|NCT02951780|76000829|FG000|STARTED|Period 3||3||
59877110|NCT02951780|76000830|FG001|STARTED|Period 3||2||
59877111|NCT02951780|76000831|FG002|STARTED|Period 3||3||
59877112|NCT02951780|76000832|FG003|STARTED|Period 3||2||
59877113|NCT02951780|76000833|FG004|STARTED|Period 3||2||
59877114|NCT02951780|76000834|FG005|STARTED|Period 3||3||
59877115|NCT02951780|76000835|FG006|STARTED|Period 3||2||
59877116|NCT02951780|76000836|FG007|STARTED|Period 3||1||
59877117|NCT02951780|76000837|FG008|STARTED|Period 3||2||
59877118|NCT02951780|76000829|FG000|COMPLETED|Period 3||3||
59877119|NCT02951780|76000830|FG001|COMPLETED|Period 3||2||
59877120|NCT02951780|76000831|FG002|COMPLETED|Period 3||3||
59877121|NCT02951780|76000832|FG003|COMPLETED|Period 3||2||
59877122|NCT02951780|76000833|FG004|COMPLETED|Period 3||2||
59877123|NCT02951780|76000834|FG005|COMPLETED|Period 3||3||
59877124|NCT02951780|76000835|FG006|COMPLETED|Period 3||2||
59877125|NCT02951780|76000836|FG007|COMPLETED|Period 3||1||
59877126|NCT02951780|76000837|FG008|COMPLETED|Period 3||2||
59877127|NCT02951780|76000829|FG000|NOT COMPLETED|Period 3||0||
59877128|NCT02951780|76000830|FG001|NOT COMPLETED|Period 3||0||
59877129|NCT02951780|76000831|FG002|NOT COMPLETED|Period 3||0||
59877130|NCT02951780|76000832|FG003|NOT COMPLETED|Period 3||0||
59877131|NCT02951780|76000833|FG004|NOT COMPLETED|Period 3||0||
59877132|NCT02951780|76000834|FG005|NOT COMPLETED|Period 3||0||
59877133|NCT02951780|76000835|FG006|NOT COMPLETED|Period 3||0||
59877134|NCT02951780|76000836|FG007|NOT COMPLETED|Period 3||0||
59877135|NCT02951780|76000837|FG008|NOT COMPLETED|Period 3||0||
59877136|NCT03334214|76000859|FG000|STARTED|Overall Study||15||
59877137|NCT03334214|76000860|FG001|STARTED|Overall Study||29||
59877138|NCT03334214|76000859|FG000|COMPLETED|Overall Study||14||
59877139|NCT03334214|76000860|FG001|COMPLETED|Overall Study||27||
59877140|NCT03334214|76000859|FG000|NOT COMPLETED|Overall Study||1||
59877141|NCT03334214|76000860|FG001|NOT COMPLETED|Overall Study||2||
59877142|NCT02250664|76000870|FG000|STARTED|Overall Study||254||
59877143|NCT02250664|76000871|FG001|STARTED|Overall Study||235||
59877144|NCT02250664|76000872|FG002|STARTED|Overall Study||286||
59877145|NCT02250664|76000870|FG000|COMPLETED|Overall Study||218||
59877146|NCT02250664|76000871|FG001|COMPLETED|Overall Study||190||
59877147|NCT02250664|76000872|FG002|COMPLETED|Overall Study||224||
59877148|NCT02250664|76000870|FG000|NOT COMPLETED|Overall Study||36||
59877149|NCT02250664|76000871|FG001|NOT COMPLETED|Overall Study||45||
59877150|NCT02250664|76000872|FG002|NOT COMPLETED|Overall Study||62||
59877151|NCT02646982|76000882|FG000|STARTED|Overall Study||38||
59877152|NCT02646982|76000883|FG001|STARTED|Overall Study||39||
59877153|NCT02646982|76000882|FG000|COMPLETED|Overall Study||35||
59877154|NCT02646982|76000883|FG001|COMPLETED|Overall Study||37||
59877155|NCT02646982|76000882|FG000|NOT COMPLETED|Overall Study||3||
59877156|NCT02646982|76000883|FG001|NOT COMPLETED|Overall Study||2||
59877157|NCT02845336|76000891|FG000|STARTED|Overall Study||6||
59877158|NCT02845336|76000892|FG001|STARTED|Overall Study||1||
59877159|NCT02845336|76000891|FG000|COMPLETED|Overall Study||1||
59877160|NCT02845336|76000892|FG001|COMPLETED|Overall Study||0||
59877161|NCT02845336|76000891|FG000|NOT COMPLETED|Overall Study||5||
59877162|NCT02845336|76000892|FG001|NOT COMPLETED|Overall Study||1||
59877163|NCT02844946|76000900|FG000|STARTED|Overall Study||27||
59877164|NCT02844946|76000901|FG001|STARTED|Overall Study||12||
59877165|NCT02844946|76000900|FG000|COMPLETED|Overall Study||20||
59877166|NCT02844946|76000901|FG001|COMPLETED|Overall Study||12||
59877167|NCT02844946|76000900|FG000|NOT COMPLETED|Overall Study||7||
59877168|NCT02844946|76000901|FG001|NOT COMPLETED|Overall Study||0||
59877169|NCT02951156|76000910|FG000|STARTED|Overall Study||9||
59877170|NCT02951156|76000911|FG001|STARTED|Overall Study||9||
59877171|NCT02951156|76000912|FG002|STARTED|Overall Study||11||
59877172|NCT02951156|76000910|FG000|COMPLETED|Overall Study||0||
59877173|NCT02951156|76000911|FG001|COMPLETED|Overall Study||0||
59877174|NCT02951156|76000912|FG002|COMPLETED|Overall Study||1||
59877175|NCT02951156|76000910|FG000|NOT COMPLETED|Overall Study||9||
59877176|NCT02951156|76000911|FG001|NOT COMPLETED|Overall Study||9||
59877177|NCT02951156|76000912|FG002|NOT COMPLETED|Overall Study||10||
59877178|NCT03345914|76000924|FG000|STARTED|Overall Study||123||
59877179|NCT03345914|76000925|FG001|STARTED|Overall Study||122||
59877180|NCT03345914|76000926|FG002|STARTED|Overall Study||122||
59877181|NCT03345914|76000924|FG000|Completed Week 16 Study Treatment|Overall Study||114||
59877182|NCT03345914|76000925|FG001|Completed Week 16 Study Treatment|Overall Study||118||
59877183|NCT03345914|76000926|FG002|Completed Week 16 Study Treatment|Overall Study||119||
59877184|NCT03345914|76000924|FG000|Completed Week 28 End of Study|Overall Study||0||
59877185|NCT03345914|76000925|FG001|Completed Week 28 End of Study|Overall Study||0||
59877186|NCT03345914|76000926|FG002|Completed Week 28 End of Study|Overall Study||0||
59877187|NCT03345914|76000924|FG000|COMPLETED|Overall Study||0||
59877188|NCT03345914|76000925|FG001|COMPLETED|Overall Study||0||
59877189|NCT03345914|76000926|FG002|COMPLETED|Overall Study||0||
59877190|NCT03345914|76000924|FG000|NOT COMPLETED|Overall Study||123||
59877191|NCT03345914|76000925|FG001|NOT COMPLETED|Overall Study||122||
59877192|NCT03345914|76000926|FG002|NOT COMPLETED|Overall Study||122||
59877193|NCT03369704|76000936|FG000|STARTED|Treatment Epoch||162||
59877194|NCT03369704|76000937|FG001|STARTED|Treatment Epoch||175||
59877195|NCT03369704|76000936|FG000|COMPLETED|Treatment Epoch||158||
59877196|NCT03369704|76000937|FG001|COMPLETED|Treatment Epoch||172||
59877197|NCT03369704|76000936|FG000|NOT COMPLETED|Treatment Epoch||4||
59877198|NCT03369704|76000937|FG001|NOT COMPLETED|Treatment Epoch||3||
59877199|NCT03369704|76000936|FG000|STARTED|Follow-up Epoch||161||
59877200|NCT03369704|76000937|FG001|STARTED|Follow-up Epoch||174||
59877201|NCT03369704|76000936|FG000|COMPLETED|Follow-up Epoch||160||
59877202|NCT03369704|76000937|FG001|COMPLETED|Follow-up Epoch||174||
59877203|NCT03369704|76000936|FG000|NOT COMPLETED|Follow-up Epoch||1||
59877204|NCT03369704|76000937|FG001|NOT COMPLETED|Follow-up Epoch||0||
59877205|NCT03366428|76000943|FG000|STARTED|Overall Study||51||
59877206|NCT03366428|76000943|FG000|COMPLETED|Overall Study||0||
59877207|NCT03366428|76000943|FG000|NOT COMPLETED|Overall Study||51||
59877208|NCT02839876|76000951|FG000|STARTED|Overall Study||41||
59877209|NCT02839876|76000952|FG001|STARTED|Overall Study||40||
59877210|NCT02839876|76000951|FG000|COMPLETED|Overall Study||31||
59877211|NCT02839876|76000952|FG001|COMPLETED|Overall Study||29||
59877212|NCT02839876|76000951|FG000|NOT COMPLETED|Overall Study||10||
59877213|NCT02839876|76000952|FG001|NOT COMPLETED|Overall Study||11||
59877214|NCT03366194|76000958|FG000|STARTED|Overall Study||36||
59877215|NCT03366194|76000958|FG000|COMPLETED|Overall Study||34||
59877216|NCT03366194|76000958|FG000|NOT COMPLETED|Overall Study||2||
59877217|NCT02839798|76000963|FG000|STARTED|Overall Study||6||
59877218|NCT02839798|76000963|FG000|COMPLETED|Overall Study||4||
59877219|NCT02839798|76000963|FG000|NOT COMPLETED|Overall Study||2||
59877220|NCT03345836|76000970|FG000|STARTED|Period 1: DB and OL Induction (12 Weeks)||171||
59877221|NCT03345836|76000971|FG001|STARTED|Period 1: DB and OL Induction (12 Weeks)||324||
59877222|NCT03345836|76000972|FG002|STARTED|Period 1: DB and OL Induction (12 Weeks)||129||
59877223|NCT03345836|76000973|FG003|STARTED|Period 1: DB and OL Induction (12 Weeks)||0||
59877224|NCT03345836|76000974|FG004|STARTED|Period 1: DB and OL Induction (12 Weeks)||0||
59877225|NCT03345836|76000975|FG005|STARTED|Period 1: DB and OL Induction (12 Weeks)||0||
59877226|NCT03345836|76000970|FG000|COMPLETED|Period 1: DB and OL Induction (12 Weeks)||149|Completed=completed the study|
59877227|NCT03345836|76000971|FG001|COMPLETED|Period 1: DB and OL Induction (12 Weeks)||291|Completed=completed the study|
59877228|NCT03345836|76000972|FG002|COMPLETED|Period 1: DB and OL Induction (12 Weeks)||123|Completed=completed the study|
59877229|NCT03345836|76000973|FG003|COMPLETED|Period 1: DB and OL Induction (12 Weeks)||0|Completed=completed the study|
59877230|NCT03345836|76000974|FG004|COMPLETED|Period 1: DB and OL Induction (12 Weeks)||0|Completed=completed the study|
59877231|NCT03345836|76000975|FG005|COMPLETED|Period 1: DB and OL Induction (12 Weeks)||0|Completed=completed the study|
59877232|NCT03345836|76000970|FG000|NOT COMPLETED|Period 1: DB and OL Induction (12 Weeks)||22||
59877233|NCT03345836|76000971|FG001|NOT COMPLETED|Period 1: DB and OL Induction (12 Weeks)||33||
59877234|NCT03345836|76000972|FG002|NOT COMPLETED|Period 1: DB and OL Induction (12 Weeks)||6||
59877235|NCT03345836|76000973|FG003|NOT COMPLETED|Period 1: DB and OL Induction (12 Weeks)||0||
59877236|NCT03345836|76000974|FG004|NOT COMPLETED|Period 1: DB and OL Induction (12 Weeks)||0||
59877237|NCT03345836|76000975|FG005|NOT COMPLETED|Period 1: DB and OL Induction (12 Weeks)||0||
59877238|NCT03345836|76000970|FG000|STARTED|Period 2: 12-Week Extended Treatment||0||
59877239|NCT03345836|76000971|FG001|STARTED|Period 2: 12-Week Extended Treatment||0||
59877240|NCT03345836|76000972|FG002|STARTED|Period 2: 12-Week Extended Treatment||0||
59877241|NCT03345836|76000973|FG003|STARTED|Period 2: 12-Week Extended Treatment||78||
59877242|NCT03345836|76000974|FG004|STARTED|Period 2: 12-Week Extended Treatment||69||
59877243|NCT03345836|76000975|FG005|STARTED|Period 2: 12-Week Extended Treatment||14||
59877244|NCT03345836|76000970|FG000|COMPLETED|Period 2: 12-Week Extended Treatment||0|Completed=completed the study|
59877245|NCT03345836|76000971|FG001|COMPLETED|Period 2: 12-Week Extended Treatment||0|Completed=completed the study|
59877246|NCT03345836|76000972|FG002|COMPLETED|Period 2: 12-Week Extended Treatment||0|Completed=completed the study|
59877247|NCT03345836|76000973|FG003|COMPLETED|Period 2: 12-Week Extended Treatment||67|Completed=completed the study|
59877248|NCT03345836|76000974|FG004|COMPLETED|Period 2: 12-Week Extended Treatment||51|Completed=completed the study|
59877249|NCT03345836|76000975|FG005|COMPLETED|Period 2: 12-Week Extended Treatment||8|Completed=completed the study|
59877250|NCT03345836|76000970|FG000|NOT COMPLETED|Period 2: 12-Week Extended Treatment||0||
59877251|NCT03345836|76000971|FG001|NOT COMPLETED|Period 2: 12-Week Extended Treatment||0||
59877252|NCT03345836|76000972|FG002|NOT COMPLETED|Period 2: 12-Week Extended Treatment||0||
59877253|NCT03345836|76000973|FG003|NOT COMPLETED|Period 2: 12-Week Extended Treatment||11||
59877254|NCT03345836|76000974|FG004|NOT COMPLETED|Period 2: 12-Week Extended Treatment||18||
59877255|NCT03345836|76000975|FG005|NOT COMPLETED|Period 2: 12-Week Extended Treatment||6||
59877256|NCT02839330|76000995|FG000|STARTED|Overall Study||804|as randomized population|
59877257|NCT02839330|76000996|FG001|STARTED|Overall Study||799|as randomized population|
59877258|NCT02839330|76000997|FG002|STARTED|Overall Study||795|as randomized population|
59877259|NCT02839330|76000998|FG003|STARTED|Overall Study||798|as randomized population|
59877260|NCT02839330|76000995|FG000|Exposed|Overall Study||804||
59877261|NCT02839330|76000996|FG001|Exposed|Overall Study||797||
59877262|NCT02839330|76000997|FG002|Exposed|Overall Study||793||
59877263|NCT02839330|76000998|FG003|Exposed|Overall Study||797||
59877264|NCT02839330|76000995|FG000|COMPLETED|Overall Study||746||
59877265|NCT02839330|76000996|FG001|COMPLETED|Overall Study||741||
59877266|NCT02839330|76000997|FG002|COMPLETED|Overall Study||747||
59877267|NCT02839330|76000998|FG003|COMPLETED|Overall Study||747||
59877268|NCT02839330|76000995|FG000|NOT COMPLETED|Overall Study||58||
59877269|NCT02839330|76000996|FG001|NOT COMPLETED|Overall Study||58||
59877270|NCT02839330|76000997|FG002|NOT COMPLETED|Overall Study||48||
59877271|NCT02839330|76000998|FG003|NOT COMPLETED|Overall Study||51||
59877272|NCT03363776|76001012|FG000|STARTED|Overall Study||4|Started = Entering the treatment period|
59877273|NCT03363776|76001013|FG001|STARTED|Overall Study||3|Started = Entering the treatment period|
59877274|NCT03363776|76001014|FG002|STARTED|Overall Study||3|Started = Entering the treatment period|
59877275|NCT03363776|76001012|FG000|COMPLETED|Overall Study||1|Completed = Completing the treatment period|
59877276|NCT03363776|76001013|FG001|COMPLETED|Overall Study||0|Completed = Completing the treatment period|
59877277|NCT03363776|76001014|FG002|COMPLETED|Overall Study||1|Completed = Completing the treatment period|
59877278|NCT03363776|76001012|FG000|NOT COMPLETED|Overall Study||3||
59877279|NCT03363776|76001013|FG001|NOT COMPLETED|Overall Study||3||
59877280|NCT03363776|76001014|FG002|NOT COMPLETED|Overall Study||2||
59877281|NCT03360344|76001025|FG000|STARTED|Overall Study||15|Analysis was completed on 68 wrists (units of study)|25
59877282|NCT03360344|76001026|FG001|STARTED|Overall Study||16|Analysis was completed on 68 wrists (units of study)|20
59877283|NCT03360344|76001027|FG002|STARTED|Overall Study||13|Analysis was completed on 68 wrists (units of study)|23
59877284|NCT03360344|76001025|FG000|COMPLETED|Overall Study||15|Analysis was completed on 68 wrists (units of study)|25
59877285|NCT03360344|76001026|FG001|COMPLETED|Overall Study||15|Analysis was completed on 68 wrists (units of study)|19
59877286|NCT03360344|76001027|FG002|COMPLETED|Overall Study||12|Analysis was completed on 68 wrists (units of study)|22
59877287|NCT03360344|76001025|FG000|NOT COMPLETED|Overall Study||0||0
59877288|NCT03360344|76001026|FG001|NOT COMPLETED|Overall Study||1||1
59877289|NCT03360344|76001027|FG002|NOT COMPLETED|Overall Study||1||1
59877290|NCT02838628|76001037|FG000|STARTED|Treatment and Follow-up Period||84||
59877291|NCT02838628|76001038|FG001|STARTED|Treatment and Follow-up Period||84||
59877292|NCT02838628|76001037|FG000|COMPLETED|Treatment and Follow-up Period||84||
59877293|NCT02838628|76001038|FG001|COMPLETED|Treatment and Follow-up Period||84||
59877294|NCT02838628|76001037|FG000|NOT COMPLETED|Treatment and Follow-up Period||0||
59877295|NCT02838628|76001038|FG001|NOT COMPLETED|Treatment and Follow-up Period||0||
59877296|NCT02838628|76001037|FG000|STARTED|Recurrence Follow-up Period||36|Participants who achieved 100% AK clearance at Day 57 visit entered the recurrence follow-up period.|
59877297|NCT02838628|76001038|FG001|STARTED|Recurrence Follow-up Period||27|Participants who achieved 100% AK clearance at Day 57 visit entered the recurrence follow-up period.|
59877298|NCT02838628|76001037|FG000|COMPLETED|Recurrence Follow-up Period||16||
59877299|NCT02838628|76001038|FG001|COMPLETED|Recurrence Follow-up Period||10||
59877300|NCT02838628|76001037|FG000|NOT COMPLETED|Recurrence Follow-up Period||20||
59877301|NCT02838628|76001038|FG001|NOT COMPLETED|Recurrence Follow-up Period||17||
59877302|NCT02835820|76001047|FG000|STARTED|Overall Study||7||
59877303|NCT02835820|76001048|FG001|STARTED|Overall Study||10||
59877304|NCT02835820|76001047|FG000|Baseline Screen (OGTT)|Overall Study||7||
59877305|NCT02835820|76001048|FG001|Baseline Screen (OGTT)|Overall Study||7||
59877306|NCT02835820|76001047|FG000|COMPLETED|Overall Study||7||
59877307|NCT02835820|76001048|FG001|COMPLETED|Overall Study||7||
59877308|NCT02835820|76001047|FG000|NOT COMPLETED|Overall Study||0||
59877309|NCT02835820|76001048|FG001|NOT COMPLETED|Overall Study||3||
59877310|NCT03359174|76001054|FG000|STARTED|Overall Study||2||
59877311|NCT03359174|76001054|FG000|COMPLETED|Overall Study||1||
59877312|NCT03359174|76001054|FG000|NOT COMPLETED|Overall Study||1||
59877313|NCT02832622|76001058|FG000|STARTED|Overall Study||2169||
59877314|NCT02832622|76001058|FG000|COMPLETED|Overall Study||433|Sixteen (16) cardiovascular deaths were included in the 433 subjects who completed the trial as they met one of the endpoint of the trial.|
59877315|NCT02832622|76001058|FG000|NOT COMPLETED|Overall Study||1736||
59877316|NCT00093015|76001065|FG000|STARTED|Overall Study||2026||
59877317|NCT00093015|76001066|FG001|STARTED|Overall Study||2012||
59877318|NCT00093015|76001065|FG000|Received Study Medication|Overall Study||2019||
59877319|NCT00093015|76001066|FG001|Received Study Medication|Overall Study||2004||
59877320|NCT00093015|76001065|FG000|COMPLETED|Overall Study||1361||
59877321|NCT00093015|76001066|FG001|COMPLETED|Overall Study||1348||
59877322|NCT00093015|76001065|FG000|NOT COMPLETED|Overall Study||665||
59877323|NCT00093015|76001066|FG001|NOT COMPLETED|Overall Study||664||
59877324|NCT03358238|76001074|FG000|STARTED|Overall Study||23||
59877325|NCT03358238|76001075|FG001|STARTED|Overall Study||25||
59877326|NCT03358238|76001074|FG000|COMPLETED|Overall Study||23||
59877327|NCT03358238|76001075|FG001|COMPLETED|Overall Study||24||
59877328|NCT03358238|76001074|FG000|NOT COMPLETED|Overall Study||0||
59877329|NCT03358238|76001075|FG001|NOT COMPLETED|Overall Study||1||
59877330|NCT03342638|76001087|FG000|STARTED|Overall Study||34||
59877331|NCT03342638|76001088|FG001|STARTED|Overall Study||32||
59877332|NCT03342638|76001087|FG000|COMPLETED|Overall Study||33||
59877333|NCT03342638|76001088|FG001|COMPLETED|Overall Study||31||
59877334|NCT03342638|76001087|FG000|NOT COMPLETED|Overall Study||1||
59877335|NCT03342638|76001088|FG001|NOT COMPLETED|Overall Study||1||
59877336|NCT03342560|76001094|FG000|STARTED|Overall Study||30||
59877337|NCT03342560|76001094|FG000|COMPLETED|Overall Study||28||
59877338|NCT03342560|76001094|FG000|NOT COMPLETED|Overall Study||2||
59877339|NCT03065517|76001104|FG000|STARTED|Overall Study||110||
59877340|NCT03065517|76001105|FG001|STARTED|Overall Study||106||
59877341|NCT03065517|76001104|FG000|COMPLETED|Overall Study||84||
59877342|NCT03065517|76001105|FG001|COMPLETED|Overall Study||90||
59877343|NCT03065517|76001104|FG000|NOT COMPLETED|Overall Study||26||
59877344|NCT03065517|76001105|FG001|NOT COMPLETED|Overall Study||16||
59877345|NCT03355742|76001111|FG000|STARTED|Overall Study||963||
59877346|NCT03355742|76001111|FG000|COMPLETED|Overall Study||864||
59877347|NCT03355742|76001111|FG000|NOT COMPLETED|Overall Study||99||
59877348|NCT03341312|76001115|FG000|STARTED|Period 1||9||
59877349|NCT03341312|76001116|FG001|STARTED|Period 1||10||
59877350|NCT03341312|76001117|FG002|STARTED|Period 1||9||
59877351|NCT03341312|76001118|FG003|STARTED|Period 1||8||
59877352|NCT03341312|76001115|FG000|Received at Least One Dose of Study Drug|Period 1||9||
59877353|NCT03341312|76001116|FG001|Received at Least One Dose of Study Drug|Period 1||10||
59877354|NCT03341312|76001117|FG002|Received at Least One Dose of Study Drug|Period 1||9||
59877355|NCT03341312|76001118|FG003|Received at Least One Dose of Study Drug|Period 1||8||
59877356|NCT03341312|76001115|FG000|COMPLETED|Period 1||9||
59877357|NCT03341312|76001116|FG001|COMPLETED|Period 1||9||
59877358|NCT03341312|76001117|FG002|COMPLETED|Period 1||9||
59877359|NCT03341312|76001118|FG003|COMPLETED|Period 1||8||
59877360|NCT03341312|76001115|FG000|NOT COMPLETED|Period 1||0||
59877361|NCT03341312|76001116|FG001|NOT COMPLETED|Period 1||1||
59877362|NCT03341312|76001117|FG002|NOT COMPLETED|Period 1||0||
59877363|NCT03341312|76001118|FG003|NOT COMPLETED|Period 1||0||
59877364|NCT03341312|76001115|FG000|STARTED|Period 2||9||
59877365|NCT03341312|76001116|FG001|STARTED|Period 2||9||
59877366|NCT03341312|76001117|FG002|STARTED|Period 2||9||
59877367|NCT03341312|76001118|FG003|STARTED|Period 2||8||
59877368|NCT03341312|76001115|FG000|COMPLETED|Period 2||9||
59877369|NCT03341312|76001116|FG001|COMPLETED|Period 2||9||
59877370|NCT03341312|76001117|FG002|COMPLETED|Period 2||9||
59877371|NCT03341312|76001118|FG003|COMPLETED|Period 2||8||
59877372|NCT03341312|76001115|FG000|NOT COMPLETED|Period 2||0||
59877373|NCT03341312|76001116|FG001|NOT COMPLETED|Period 2||0||
59877374|NCT03341312|76001117|FG002|NOT COMPLETED|Period 2||0||
59877375|NCT03341312|76001118|FG003|NOT COMPLETED|Period 2||0||
59877376|NCT03341312|76001115|FG000|STARTED|Period 3||9||
59877377|NCT03341312|76001116|FG001|STARTED|Period 3||9||
59877378|NCT03341312|76001117|FG002|STARTED|Period 3||9||
59877379|NCT03341312|76001118|FG003|STARTED|Period 3||8||
59877380|NCT03341312|76001115|FG000|COMPLETED|Period 3||9||
59877381|NCT03341312|76001116|FG001|COMPLETED|Period 3||9||
59877382|NCT03341312|76001117|FG002|COMPLETED|Period 3||9||
59877383|NCT03341312|76001118|FG003|COMPLETED|Period 3||8||
59877384|NCT03341312|76001115|FG000|NOT COMPLETED|Period 3||0||
59877385|NCT03341312|76001116|FG001|NOT COMPLETED|Period 3||0||
59877386|NCT03341312|76001117|FG002|NOT COMPLETED|Period 3||0||
59877387|NCT03341312|76001118|FG003|NOT COMPLETED|Period 3||0||
59877388|NCT03341312|76001115|FG000|STARTED|Period 4||9||
59877389|NCT03341312|76001116|FG001|STARTED|Period 4||9||
59877390|NCT03341312|76001117|FG002|STARTED|Period 4||9||
59877391|NCT03341312|76001118|FG003|STARTED|Period 4||8||
59877392|NCT03341312|76001115|FG000|COMPLETED|Period 4||9||
59877393|NCT03341312|76001116|FG001|COMPLETED|Period 4||9||
59750102|NCT01000025|75869255|FG001|COMPLETED|Overall Study||2||
59750103|NCT01000025|75869254|FG000|NOT COMPLETED|Overall Study||468||
59750104|NCT01000025|75869255|FG001|NOT COMPLETED|Overall Study||238||
59750105|NCT00595335|75869263|FG000|STARTED|Baseline to Six Months||13||
59750106|NCT00595335|75869264|FG001|STARTED|Baseline to Six Months||12||
59750107|NCT00595335|75869263|FG000|COMPLETED|Baseline to Six Months||11||
59750108|NCT00595335|75869264|FG001|COMPLETED|Baseline to Six Months||10||
59750109|NCT00595335|75869263|FG000|NOT COMPLETED|Baseline to Six Months||2||
59750110|NCT00595335|75869264|FG001|NOT COMPLETED|Baseline to Six Months||2||
59750111|NCT00595335|75869263|FG000|STARTED|Six Months to Twelve Months||11||
59750112|NCT00595335|75869264|FG001|STARTED|Six Months to Twelve Months||10||
59750113|NCT00595335|75869263|FG000|COMPLETED|Six Months to Twelve Months||10||
59877394|NCT03341312|76001117|FG002|COMPLETED|Period 4||9||
59877395|NCT03341312|76001118|FG003|COMPLETED|Period 4||8||
59877396|NCT03341312|76001115|FG000|NOT COMPLETED|Period 4||0||
59877397|NCT03341312|76001116|FG001|NOT COMPLETED|Period 4||0||
59877398|NCT03341312|76001117|FG002|NOT COMPLETED|Period 4||0||
59750114|NCT00595335|75869264|FG001|COMPLETED|Six Months to Twelve Months||9||
59750115|NCT00595335|75869263|FG000|NOT COMPLETED|Six Months to Twelve Months||1||
59750116|NCT00595335|75869264|FG001|NOT COMPLETED|Six Months to Twelve Months||1||
59877399|NCT03341312|76001118|FG003|NOT COMPLETED|Period 4||0||
59877400|NCT02949908|76001130|FG000|STARTED|Overall Study||2||
59877401|NCT02949908|76001130|FG000|COMPLETED|Overall Study||0||
59877402|NCT02949908|76001130|FG000|NOT COMPLETED|Overall Study||2||
59877403|NCT01358734|76001137|FG000|STARTED|Overall Study||15||
59877404|NCT01358734|76001138|FG001|STARTED|Overall Study||39||
59877405|NCT01358734|76001139|FG002|STARTED|Overall Study||34||
59877406|NCT01358734|76001137|FG000|Safety Population|Overall Study|The safety population includes all participants who received at least one dose of study drug.|14||
59950753|NCT03225287|76069596|FG000|COMPLETED|Overall Study||0||
59877407|NCT01358734|76001138|FG001|Safety Population|Overall Study|The safety population includes all participants who received at least one dose of study drug.|38||
59877408|NCT01358734|76001139|FG002|Safety Population|Overall Study|The safety population includes all participants who received at least one dose of study drug.|32||
59877409|NCT01358734|76001137|FG000|COMPLETED|Overall Study||0||
59877410|NCT01358734|76001138|FG001|COMPLETED|Overall Study||0||
59877411|NCT01358734|76001139|FG002|COMPLETED|Overall Study||0||
59877412|NCT01358734|76001137|FG000|NOT COMPLETED|Overall Study||15||
59877413|NCT01358734|76001138|FG001|NOT COMPLETED|Overall Study||39||
59877414|NCT01358734|76001139|FG002|NOT COMPLETED|Overall Study||34||
59877415|NCT01341652|76001149|FG000|STARTED|Overall Study||49||
59877416|NCT01341652|76001150|FG001|STARTED|Overall Study||50||
59877417|NCT01341652|76001149|FG000|COMPLETED|Overall Study||49||
59877418|NCT01341652|76001150|FG001|COMPLETED|Overall Study||48||
59877419|NCT01341652|76001149|FG000|NOT COMPLETED|Overall Study||0||
59877420|NCT01341652|76001150|FG001|NOT COMPLETED|Overall Study||2||
59877421|NCT02828644|76001158|FG000|STARTED|Overall Study||88||
59877422|NCT02828644|76001159|FG001|STARTED|Overall Study||87||
59877423|NCT02828644|76001158|FG000|COMPLETED|Overall Study||65||
59877424|NCT02828644|76001159|FG001|COMPLETED|Overall Study||65||
59877425|NCT02828644|76001158|FG000|NOT COMPLETED|Overall Study||23||
59877426|NCT02828644|76001159|FG001|NOT COMPLETED|Overall Study||22||
59877427|NCT02949362|76001168|FG000|STARTED|Retrospective Period||24||
59877428|NCT02949362|76001169|FG001|STARTED|Retrospective Period||5||
59877429|NCT02949362|76001170|FG002|STARTED|Retrospective Period||0||
59877430|NCT02949362|76001171|FG003|STARTED|Retrospective Period||0||
59877431|NCT02949362|76001168|FG000|COMPLETED|Retrospective Period||20||
59877432|NCT02949362|76001169|FG001|COMPLETED|Retrospective Period||4||
59877433|NCT02949362|76001170|FG002|COMPLETED|Retrospective Period||0||
59877434|NCT02949362|76001171|FG003|COMPLETED|Retrospective Period||0||
59877435|NCT02949362|76001168|FG000|NOT COMPLETED|Retrospective Period||4||
59877436|NCT02949362|76001169|FG001|NOT COMPLETED|Retrospective Period||1||
59877437|NCT02949362|76001170|FG002|NOT COMPLETED|Retrospective Period||0||
59877438|NCT02949362|76001171|FG003|NOT COMPLETED|Retrospective Period||0||
59877439|NCT02949362|76001168|FG000|STARTED|Prospective Period||0||
59877440|NCT02949362|76001169|FG001|STARTED|Prospective Period||0||
59877441|NCT02949362|76001170|FG002|STARTED|Prospective Period|Participants were enrolled from retrospective period.|5||
59877442|NCT02949362|76001171|FG003|STARTED|Prospective Period|Participants were enrolled from retrospective period.|19||
59877443|NCT02949362|76001168|FG000|COMPLETED|Prospective Period||0||
59877444|NCT02949362|76001169|FG001|COMPLETED|Prospective Period||0||
59877445|NCT02949362|76001170|FG002|COMPLETED|Prospective Period||4||
59877446|NCT02949362|76001171|FG003|COMPLETED|Prospective Period||15||
59877447|NCT02949362|76001168|FG000|NOT COMPLETED|Prospective Period||0||
59605396|NCT01994382|75715572|FG012|Received at Least 1 Dose of Study Drug|Overall Study||26|Safety Population|
59605397|NCT01994382|75715573|FG013|Received at Least 1 Dose of Study Drug|Overall Study||6|Safety Population|
59877448|NCT02949362|76001169|FG001|NOT COMPLETED|Prospective Period||0||
59877449|NCT02949362|76001170|FG002|NOT COMPLETED|Prospective Period||1||
59877450|NCT02949362|76001171|FG003|NOT COMPLETED|Prospective Period||4||
59877451|NCT02947022|76001183|FG000|STARTED|Overall Study||1||
59877452|NCT02947022|76001183|FG000|COMPLETED|Overall Study||0||
59877453|NCT02947022|76001183|FG000|NOT COMPLETED|Overall Study||1||
59877454|NCT03338972|76001194|FG000|STARTED|Overall Study||7||
59877455|NCT03338972|76001195|FG001|STARTED|Overall Study||8||
59877456|NCT03338972|76001196|FG002|STARTED|Overall Study||7||
59877457|NCT03338972|76001197|FG003|STARTED|Overall Study||3||
59877458|NCT03338972|76001194|FG000|COMPLETED|Overall Study||5||
59877459|NCT03338972|76001195|FG001|COMPLETED|Overall Study||7||
59877460|NCT03338972|76001196|FG002|COMPLETED|Overall Study||7||
59877461|NCT03338972|76001197|FG003|COMPLETED|Overall Study||3||
59877462|NCT03338972|76001194|FG000|NOT COMPLETED|Overall Study||2||
59877463|NCT03338972|76001195|FG001|NOT COMPLETED|Overall Study||1||
59877464|NCT03338972|76001196|FG002|NOT COMPLETED|Overall Study||0||
59877465|NCT03338972|76001197|FG003|NOT COMPLETED|Overall Study||0||
59877466|NCT03338816|76001213|FG000|STARTED|6-Month Double-blind Period||46||
59877467|NCT03338816|76001214|FG001|STARTED|6-Month Double-blind Period||48||
59877468|NCT03338816|76001215|FG002|STARTED|6-Month Double-blind Period||0||
59877469|NCT03338816|76001216|FG003|STARTED|6-Month Double-blind Period||0||
59877470|NCT03338816|76001213|FG000|COMPLETED|6-Month Double-blind Period||46||
59877471|NCT03338816|76001214|FG001|COMPLETED|6-Month Double-blind Period|1 participant discontinued treatment during the 6-month DB period due to an adverse event but completed the 6-month DB Visit|48||
59877472|NCT03338816|76001215|FG002|COMPLETED|6-Month Double-blind Period||0||
59877473|NCT03338816|76001216|FG003|COMPLETED|6-Month Double-blind Period||0||
59877474|NCT03338816|76001213|FG000|NOT COMPLETED|6-Month Double-blind Period||0||
59877475|NCT03338816|76001214|FG001|NOT COMPLETED|6-Month Double-blind Period||0||
59877476|NCT03338816|76001215|FG002|NOT COMPLETED|6-Month Double-blind Period||0||
59877477|NCT03338816|76001216|FG003|NOT COMPLETED|6-Month Double-blind Period||0||
59877478|NCT03338816|76001213|FG000|STARTED|6-Month DB + Open-Label Extension Period||0||
59877479|NCT03338816|76001214|FG001|STARTED|6-Month DB + Open-Label Extension Period||0||
59877480|NCT03338816|76001215|FG002|STARTED|6-Month DB + Open-Label Extension Period||46||
59877481|NCT03338816|76001216|FG003|STARTED|6-Month DB + Open-Label Extension Period||47||
59877482|NCT03338816|76001213|FG000|COMPLETED|6-Month DB + Open-Label Extension Period||0||
59877483|NCT03338816|76001214|FG001|COMPLETED|6-Month DB + Open-Label Extension Period||0||
59877484|NCT03338816|76001215|FG002|COMPLETED|6-Month DB + Open-Label Extension Period||38||
59877485|NCT03338816|76001216|FG003|COMPLETED|6-Month DB + Open-Label Extension Period||41||
59877486|NCT03338816|76001213|FG000|NOT COMPLETED|6-Month DB + Open-Label Extension Period||0||
59877487|NCT03338816|76001214|FG001|NOT COMPLETED|6-Month DB + Open-Label Extension Period||0||
59877488|NCT03338816|76001215|FG002|NOT COMPLETED|6-Month DB + Open-Label Extension Period||8||
59877489|NCT03338816|76001216|FG003|NOT COMPLETED|6-Month DB + Open-Label Extension Period||6||
59877490|NCT03337490|76001228|FG000|STARTED|Overall Study||128||
59877491|NCT03337490|76001229|FG001|STARTED|Overall Study||126||
59877492|NCT03337490|76001230|FG002|STARTED|Overall Study||42||
59877493|NCT03337490|76001228|FG000|COMPLETED|Overall Study||117||
59877494|NCT03337490|76001229|FG001|COMPLETED|Overall Study||112||
59877495|NCT03337490|76001230|FG002|COMPLETED|Overall Study||7||
59877496|NCT03337490|76001228|FG000|NOT COMPLETED|Overall Study||11||
59877497|NCT03337490|76001229|FG001|NOT COMPLETED|Overall Study||14||
59877498|NCT03337490|76001230|FG002|NOT COMPLETED|Overall Study||35||
59605398|NCT01994382|75715574|FG014|Received at Least 1 Dose of Study Drug|Overall Study||28|Safety Population|
59605399|NCT01994382|75715575|FG015|Received at Least 1 Dose of Study Drug|Overall Study||65|Safety Population|
59605400|NCT01994382|75715576|FG016|Received at Least 1 Dose of Study Drug|Overall Study||41|Safety Population|
59877499|NCT02944448|76001240|FG000|STARTED|Overall Study||316||
59877500|NCT02944448|76001241|FG001|STARTED|Overall Study||160||
59877501|NCT02944448|76001240|FG000|COMPLETED|Overall Study||227||
59877502|NCT02944448|76001241|FG001|COMPLETED|Overall Study||136||
59877503|NCT02944448|76001240|FG000|NOT COMPLETED|Overall Study||89||
59877504|NCT02944448|76001241|FG001|NOT COMPLETED|Overall Study||24||
59877505|NCT02943668|76001248|FG000|STARTED|Overall Study||2||
59877506|NCT02943668|76001248|FG000|COMPLETED|Overall Study||1||
59877507|NCT02943668|76001248|FG000|NOT COMPLETED|Overall Study||1||
59877508|NCT03491397|76001255|FG000|STARTED|Overall Study||40||
59877509|NCT03491397|76001255|FG000|COMPLETED|Overall Study||40||
59877510|NCT03491397|76001255|FG000|NOT COMPLETED|Overall Study||0||
59877511|NCT05166824|76001263|FG000|STARTED|Overall Study||1||
59877512|NCT05166824|76001264|FG001|STARTED|Overall Study||10||
59877513|NCT05166824|76001265|FG002|STARTED|Overall Study||68||
59877514|NCT05166824|76001266|FG003|STARTED|Overall Study||10||
59877515|NCT05166824|76001263|FG000|COMPLETED|Overall Study||1||
59877516|NCT05166824|76001264|FG001|COMPLETED|Overall Study||10||
59877517|NCT05166824|76001265|FG002|COMPLETED|Overall Study||59||
59877518|NCT05166824|76001266|FG003|COMPLETED|Overall Study||10||
59877519|NCT05166824|76001263|FG000|NOT COMPLETED|Overall Study||0||
59877520|NCT05166824|76001264|FG001|NOT COMPLETED|Overall Study||0||
59877521|NCT05166824|76001265|FG002|NOT COMPLETED|Overall Study||9||
59877522|NCT05166824|76001266|FG003|NOT COMPLETED|Overall Study||0||
59877523|NCT02891408|76001283|FG000|STARTED|Overall Study||10||
59877524|NCT02891408|76001284|FG001|STARTED|Overall Study||10||
59877525|NCT02891408|76001285|FG002|STARTED|Overall Study||14||
59877526|NCT02891408|76001286|FG003|STARTED|Overall Study||10||
59877527|NCT02891408|76001287|FG004|STARTED|Overall Study||10||
59877528|NCT02891408|76001288|FG005|STARTED|Overall Study||10||
59877529|NCT02891408|76001289|FG006|STARTED|Overall Study||10||
59877530|NCT02891408|76001283|FG000|COMPLETED|Overall Study||10||
59877531|NCT02891408|76001284|FG001|COMPLETED|Overall Study||10||
59605401|NCT01994382|75715560|FG000|COMPLETED|Overall Study||0||
59877532|NCT02891408|76001285|FG002|COMPLETED|Overall Study||13||
59877533|NCT02891408|76001286|FG003|COMPLETED|Overall Study||10||
59877534|NCT02891408|76001287|FG004|COMPLETED|Overall Study||10||
59877535|NCT02891408|76001288|FG005|COMPLETED|Overall Study||10||
59877536|NCT02891408|76001289|FG006|COMPLETED|Overall Study||10||
59877537|NCT02891408|76001283|FG000|NOT COMPLETED|Overall Study||0||
59877538|NCT02891408|76001284|FG001|NOT COMPLETED|Overall Study||0||
59877539|NCT02891408|76001285|FG002|NOT COMPLETED|Overall Study||1||
59877540|NCT02891408|76001286|FG003|NOT COMPLETED|Overall Study||0||
59877541|NCT02891408|76001287|FG004|NOT COMPLETED|Overall Study||0||
59877542|NCT02891408|76001288|FG005|NOT COMPLETED|Overall Study||0||
59877543|NCT02891408|76001289|FG006|NOT COMPLETED|Overall Study||0||
59877544|NCT03283670|76001315|FG000|STARTED|Placebo Gas||24||
59877545|NCT03283670|76001315|FG000|COMPLETED|Placebo Gas||22||
59877546|NCT03283670|76001315|FG000|NOT COMPLETED|Placebo Gas||2||
59877547|NCT03283670|76001315|FG000|STARTED|25% Nitrous Oxide||24||
59877548|NCT03283670|76001315|FG000|COMPLETED|25% Nitrous Oxide||20||
59877549|NCT03283670|76001315|FG000|NOT COMPLETED|25% Nitrous Oxide||4||
59877550|NCT03283670|76001315|FG000|STARTED|50% Nitrous Oxide||24||
59877551|NCT03283670|76001315|FG000|COMPLETED|50% Nitrous Oxide||23||
59877552|NCT03283670|76001315|FG000|NOT COMPLETED|50% Nitrous Oxide||1||
59877553|NCT03205358|76001325|FG000|STARTED|Overall Study||94||
59877554|NCT03205358|76001326|FG001|STARTED|Overall Study||94||
59877555|NCT03205358|76001325|FG000|COMPLETED|Overall Study||94||
59877556|NCT03205358|76001326|FG001|COMPLETED|Overall Study||94||
59877557|NCT03205358|76001325|FG000|NOT COMPLETED|Overall Study||0||
59877558|NCT03205358|76001326|FG001|NOT COMPLETED|Overall Study||0||
59877559|NCT01358578|76001336|FG000|STARTED|Induction Period||327||
59877560|NCT01358578|76001337|FG001|STARTED|Induction Period||327||
59877561|NCT01358578|76001338|FG002|STARTED|Induction Period||326||
59877562|NCT01358578|76001339|FG003|STARTED|Induction Period||326||
59877563|NCT01358578|76001340|FG004|STARTED|Induction Period|These groups are populated after the induction period|0||
59877564|NCT01358578|76001341|FG005|STARTED|Induction Period|These groups are populated after the induction period|0||
59877565|NCT01358578|76001336|FG000|COMPLETED|Induction Period||315||
59877566|NCT01358578|76001337|FG001|COMPLETED|Induction Period||312||
59877567|NCT01358578|76001338|FG002|COMPLETED|Induction Period||301||
59877568|NCT01358578|76001339|FG003|COMPLETED|Induction Period||305||
59877569|NCT01358578|76001340|FG004|COMPLETED|Induction Period|These groups are populated after the induction period|0||
59877570|NCT01358578|76001341|FG005|COMPLETED|Induction Period|These groups are populated after the induction period|0||
59877571|NCT01358578|76001336|FG000|NOT COMPLETED|Induction Period||12||
59877572|NCT01358578|76001337|FG001|NOT COMPLETED|Induction Period||15||
59877573|NCT01358578|76001338|FG002|NOT COMPLETED|Induction Period||25||
59877574|NCT01358578|76001339|FG003|NOT COMPLETED|Induction Period||21||
59877575|NCT01358578|76001340|FG004|NOT COMPLETED|Induction Period||0||
59877576|NCT01358578|76001341|FG005|NOT COMPLETED|Induction Period||0||
59877577|NCT01358578|76001336|FG000|STARTED|Maintenance Period||315||
59877578|NCT01358578|76001337|FG001|STARTED|Maintenance Period||312||
59877579|NCT01358578|76001338|FG002|STARTED|Maintenance Period||17||
59877580|NCT01358578|76001339|FG003|STARTED|Maintenance Period||305||
59877581|NCT01358578|76001340|FG004|STARTED|Maintenance Period||142||
59877582|NCT01358578|76001341|FG005|STARTED|Maintenance Period||142||
59877583|NCT01358578|76001336|FG000|COMPLETED|Maintenance Period||276||
59877584|NCT01358578|76001337|FG001|COMPLETED|Maintenance Period||290||
59877585|NCT01358578|76001338|FG002|COMPLETED|Maintenance Period||15||
59877586|NCT01358578|76001339|FG003|COMPLETED|Maintenance Period||263||
59877587|NCT01358578|76001340|FG004|COMPLETED|Maintenance Period||125||
59877588|NCT01358578|76001341|FG005|COMPLETED|Maintenance Period||131||
59877589|NCT01358578|76001336|FG000|NOT COMPLETED|Maintenance Period||39||
59877590|NCT01358578|76001337|FG001|NOT COMPLETED|Maintenance Period||22||
59877591|NCT01358578|76001338|FG002|NOT COMPLETED|Maintenance Period||2||
59877592|NCT01358578|76001339|FG003|NOT COMPLETED|Maintenance Period||42||
59605402|NCT01994382|75715561|FG001|COMPLETED|Overall Study||0||
59605403|NCT01994382|75715562|FG002|COMPLETED|Overall Study||0||
59877593|NCT01358578|76001340|FG004|NOT COMPLETED|Maintenance Period||17||
59877594|NCT01358578|76001341|FG005|NOT COMPLETED|Maintenance Period||11||
59877595|NCT01358578|76001336|FG000|STARTED|Follow-up Period|Patients prior to follow up who did not enter the extension study but received the 150 mg dose|148||
59950754|NCT03225287|76069597|FG001|COMPLETED|Overall Study||0||
59605404|NCT01994382|75715563|FG003|COMPLETED|Overall Study||0||
59877596|NCT01358578|76001337|FG001|STARTED|Follow-up Period|Patients prior to follow up who did not enter the extension study but received the 300 mg dose|125||
59877597|NCT01358578|76001338|FG002|STARTED|Follow-up Period|contains patients who participated in follow up period from induction and maintenance|26||
59877598|NCT01358578|76001339|FG003|STARTED|Follow-up Period|contains patients who participated in follow up period from induction and maintenance|279||
59877599|NCT01358578|76001340|FG004|STARTED|Follow-up Period|all placebo patients from induction were 1: 1 into either AIN457A 150 mg or 300 mg doses|0||
59877600|NCT01358578|76001341|FG005|STARTED|Follow-up Period|all placebo patients from induction were 1: 1 into either AIN457A 150 mg or 300 mg doses|0||
59877601|NCT01358578|76001336|FG000|COMPLETED|Follow-up Period||138||
59877602|NCT01358578|76001337|FG001|COMPLETED|Follow-up Period||119||
59877603|NCT01358578|76001338|FG002|COMPLETED|Follow-up Period|contains patients who completed follow up period from induction and maintenance|21||
59877604|NCT01358578|76001339|FG003|COMPLETED|Follow-up Period|contains patients who completed follow up period from induction and maintenance|260||
59877605|NCT01358578|76001340|FG004|COMPLETED|Follow-up Period|all placebo patients from induction were 1: 1 into either AIN457A 150 mg or 300 mg doses|0||
59877606|NCT01358578|76001341|FG005|COMPLETED|Follow-up Period|all placebo patients from induction were 1: 1 into either AIN457A 150 mg or 300 mg doses|0||
59877607|NCT01358578|76001336|FG000|NOT COMPLETED|Follow-up Period||10||
59877608|NCT01358578|76001337|FG001|NOT COMPLETED|Follow-up Period||6||
59877609|NCT01358578|76001338|FG002|NOT COMPLETED|Follow-up Period||5||
59877610|NCT01358578|76001339|FG003|NOT COMPLETED|Follow-up Period||19||
59877611|NCT01358578|76001340|FG004|NOT COMPLETED|Follow-up Period||0||
59877612|NCT01358578|76001341|FG005|NOT COMPLETED|Follow-up Period||0||
59877613|NCT02833948|76001371|FG000|STARTED|Overall Study||116||
59877614|NCT02833948|76001372|FG001|STARTED|Overall Study||115||
59877615|NCT02833948|76001371|FG000|COMPLETED|Overall Study||101||
59877616|NCT02833948|76001372|FG001|COMPLETED|Overall Study||97||
59877617|NCT02833948|76001371|FG000|NOT COMPLETED|Overall Study||15||
59877618|NCT02833948|76001372|FG001|NOT COMPLETED|Overall Study||18||
59877619|NCT02828020|76001385|FG000|STARTED|Treatment Period||559||
59877620|NCT02828020|76001386|FG001|STARTED|Treatment Period||556||
59877621|NCT02828020|76001387|FG002|STARTED|Treatment Period||557||
59877622|NCT02828020|76001385|FG000|Safety Population: Received Study Drug|Treatment Period||485||
59877623|NCT02828020|76001386|FG001|Safety Population: Received Study Drug|Treatment Period||466||
59877624|NCT02828020|76001387|FG002|Safety Population: Received Study Drug|Treatment Period||485||
59877625|NCT02828020|76001385|FG000|COMPLETED|Treatment Period||479||
59877626|NCT02828020|76001386|FG001|COMPLETED|Treatment Period||457||
59877627|NCT02828020|76001387|FG002|COMPLETED|Treatment Period||479||
59877628|NCT02828020|76001385|FG000|NOT COMPLETED|Treatment Period||80||
59877629|NCT02828020|76001386|FG001|NOT COMPLETED|Treatment Period||99||
59877630|NCT02828020|76001387|FG002|NOT COMPLETED|Treatment Period||78||
59877631|NCT02828020|76001385|FG000|STARTED|Safety Follow-up Period|1 participant who did not complete the Treatment Period, was counted in the Safety Follow-up Period.|480||
59877632|NCT02828020|76001386|FG001|STARTED|Safety Follow-up Period|1 participant who did not complete the Treatment Period, was counted in the Safety Follow-up Period.|458||
59877633|NCT02828020|76001387|FG002|STARTED|Safety Follow-up Period|1 participant who did not complete the Treatment Period, was counted in the Safety Follow-up Period.|480||
59877634|NCT02828020|76001385|FG000|COMPLETED|Safety Follow-up Period||460||
59877635|NCT02828020|76001386|FG001|COMPLETED|Safety Follow-up Period||440||
59877636|NCT02828020|76001387|FG002|COMPLETED|Safety Follow-up Period||461||
59877637|NCT02828020|76001385|FG000|NOT COMPLETED|Safety Follow-up Period||20||
59877638|NCT02828020|76001386|FG001|NOT COMPLETED|Safety Follow-up Period||18||
59877639|NCT02828020|76001387|FG002|NOT COMPLETED|Safety Follow-up Period||19||
59877640|NCT02605616|76001397|FG000|STARTED|Overall Study||46||
59877641|NCT02605616|76001398|FG001|STARTED|Overall Study||47||
59877642|NCT02605616|76001397|FG000|COMPLETED|Overall Study||42||
59877643|NCT02605616|76001398|FG001|COMPLETED|Overall Study||43||
59877644|NCT02605616|76001397|FG000|NOT COMPLETED|Overall Study||4||
59877645|NCT02605616|76001398|FG001|NOT COMPLETED|Overall Study||4||
59877646|NCT02827708|76001406|FG000|STARTED|Overall Study||163||
59877647|NCT02827708|76001407|FG001|STARTED|Overall Study||161||
59877648|NCT02827708|76001406|FG000|Full Analysis Set (FAS)|Overall Study||163||
59877649|NCT02827708|76001407|FG001|Full Analysis Set (FAS)|Overall Study||161||
59877650|NCT02827708|76001406|FG000|Safety Analysis Set (SAS)|Overall Study||163||
59877651|NCT02827708|76001407|FG001|Safety Analysis Set (SAS)|Overall Study||161||
59877652|NCT02827708|76001406|FG000|COMPLETED|Overall Study||158||
59877653|NCT02827708|76001407|FG001|COMPLETED|Overall Study||156||
59877654|NCT02827708|76001406|FG000|NOT COMPLETED|Overall Study||5||
59877655|NCT02827708|76001407|FG001|NOT COMPLETED|Overall Study||5||
59877656|NCT03760185|76001413|FG000|STARTED|Overall Study||13||13
59877657|NCT03760185|76001414|FG001|STARTED|Overall Study||13||13
59877658|NCT03760185|76001413|FG000|COMPLETED|Overall Study||12||12
59877659|NCT03760185|76001414|FG001|COMPLETED|Overall Study||12||12
59877660|NCT03760185|76001413|FG000|NOT COMPLETED|Overall Study||1||1
59877661|NCT03760185|76001414|FG001|NOT COMPLETED|Overall Study||1||1
59877662|NCT02891174|76001424|FG000|STARTED|First Intervention (24 Hours)||20||
59877663|NCT02891174|76001425|FG001|STARTED|First Intervention (24 Hours)||23||
59877664|NCT02891174|76001424|FG000|Received First Intervention|First Intervention (24 Hours)||19||
59877665|NCT02891174|76001425|FG001|Received First Intervention|First Intervention (24 Hours)||18||
59877666|NCT02891174|76001424|FG000|COMPLETED|First Intervention (24 Hours)||17||
59877667|NCT02891174|76001425|FG001|COMPLETED|First Intervention (24 Hours)||10||
59877668|NCT02891174|76001424|FG000|NOT COMPLETED|First Intervention (24 Hours)||3||
59877669|NCT02891174|76001425|FG001|NOT COMPLETED|First Intervention (24 Hours)||13||
59877670|NCT02891174|76001424|FG000|STARTED|Second Intervention (24 Hours)||17||
59877671|NCT02891174|76001425|FG001|STARTED|Second Intervention (24 Hours)||10||
59877672|NCT02891174|76001424|FG000|COMPLETED|Second Intervention (24 Hours)||11||
59877673|NCT02891174|76001425|FG001|COMPLETED|Second Intervention (24 Hours)||3||
59877674|NCT02891174|76001424|FG000|NOT COMPLETED|Second Intervention (24 Hours)||6||
59877675|NCT02891174|76001425|FG001|NOT COMPLETED|Second Intervention (24 Hours)||7||
59877676|NCT02046512|76001437|FG000|STARTED|Overall Study||45||
59877677|NCT02046512|76001438|FG001|STARTED|Overall Study||44||
59877678|NCT02046512|76001437|FG000|COMPLETED|Overall Study||44||
59877679|NCT02046512|76001438|FG001|COMPLETED|Overall Study||44||
59877680|NCT02046512|76001437|FG000|NOT COMPLETED|Overall Study||1||
59877681|NCT02046512|76001438|FG001|NOT COMPLETED|Overall Study||0||
59877682|NCT01751984|76001446|FG000|STARTED|Overall Study||37||
59877683|NCT01751984|76001447|FG001|STARTED|Overall Study||19||
59877684|NCT01751984|76001446|FG000|COMPLETED|Overall Study||31||
59877685|NCT01751984|76001447|FG001|COMPLETED|Overall Study||15||
59877686|NCT01751984|76001446|FG000|NOT COMPLETED|Overall Study||6||
59877687|NCT01751984|76001447|FG001|NOT COMPLETED|Overall Study||4||
59877688|NCT03330236|76001455|FG000|STARTED|Overall Study||779||
59877689|NCT03330236|76001456|FG001|STARTED|Overall Study||781||
59877690|NCT03330236|76001455|FG000|Received Surgery|Overall Study||779||
59877691|NCT03330236|76001456|FG001|Received Surgery|Overall Study||781||
59877692|NCT03330236|76001455|FG000|Modified ITT|Overall Study||773|Participants analyzed as the Modified ITT analysis population.|
59877693|NCT03330236|76001456|FG001|Modified ITT|Overall Study||774|Participants analyzed as the Modified ITT analysis population.|
59877694|NCT03330236|76001455|FG000|COMPLETED|Overall Study||679||
59877695|NCT03330236|76001456|FG001|COMPLETED|Overall Study||697||
59877696|NCT03330236|76001455|FG000|NOT COMPLETED|Overall Study||100||
59877697|NCT03330236|76001456|FG001|NOT COMPLETED|Overall Study||84||
59877698|NCT03330002|76001462|FG000|STARTED|Overall Study|Subjects that received the MANTA VCD|500||
59877699|NCT03330002|76001462|FG000|COMPLETED|Overall Study|Subjects that received the MANTA VCD and completed 30 day follow-up visit|478||
59877700|NCT03330002|76001462|FG000|NOT COMPLETED|Overall Study||22||
59877701|NCT02948582|76001466|FG000|STARTED|Treatment Period 1||7||
59877702|NCT02948582|76001467|FG001|STARTED|Treatment Period 1||7||
59877703|NCT02948582|76001468|FG002|STARTED|Treatment Period 1||7||
59877704|NCT02948582|76001469|FG003|STARTED|Treatment Period 1||7||
59877705|NCT02948582|76001470|FG004|STARTED|Treatment Period 1||7||
59877706|NCT02948582|76001471|FG005|STARTED|Treatment Period 1||7||
59877707|NCT02948582|76001466|FG000|COMPLETED|Treatment Period 1||7||
59877708|NCT02948582|76001467|FG001|COMPLETED|Treatment Period 1||7||
59877709|NCT02948582|76001468|FG002|COMPLETED|Treatment Period 1||7||
59877710|NCT02948582|76001469|FG003|COMPLETED|Treatment Period 1||7||
59877711|NCT02948582|76001470|FG004|COMPLETED|Treatment Period 1||7||
59877712|NCT02948582|76001471|FG005|COMPLETED|Treatment Period 1||7||
59877713|NCT02948582|76001466|FG000|NOT COMPLETED|Treatment Period 1||0||
59877714|NCT02948582|76001467|FG001|NOT COMPLETED|Treatment Period 1||0||
59605405|NCT01994382|75715564|FG004|COMPLETED|Overall Study||0||
59877715|NCT02948582|76001468|FG002|NOT COMPLETED|Treatment Period 1||0||
59877716|NCT02948582|76001469|FG003|NOT COMPLETED|Treatment Period 1||0||
59877717|NCT02948582|76001470|FG004|NOT COMPLETED|Treatment Period 1||0||
59877718|NCT02948582|76001471|FG005|NOT COMPLETED|Treatment Period 1||0||
59877719|NCT02948582|76001466|FG000|STARTED|Washout Period 1||7||
59877720|NCT02948582|76001467|FG001|STARTED|Washout Period 1||7||
59877721|NCT02948582|76001468|FG002|STARTED|Washout Period 1||7||
59877722|NCT02948582|76001469|FG003|STARTED|Washout Period 1||7||
59877723|NCT02948582|76001470|FG004|STARTED|Washout Period 1||7||
59877724|NCT02948582|76001471|FG005|STARTED|Washout Period 1||7||
59877725|NCT02948582|76001466|FG000|COMPLETED|Washout Period 1||7||
59877726|NCT02948582|76001467|FG001|COMPLETED|Washout Period 1||5||
59877727|NCT02948582|76001468|FG002|COMPLETED|Washout Period 1||7||
59877728|NCT02948582|76001469|FG003|COMPLETED|Washout Period 1||7||
59877729|NCT02948582|76001470|FG004|COMPLETED|Washout Period 1||7||
59877730|NCT02948582|76001471|FG005|COMPLETED|Washout Period 1||6||
59877731|NCT02948582|76001466|FG000|NOT COMPLETED|Washout Period 1||0||
59877732|NCT02948582|76001467|FG001|NOT COMPLETED|Washout Period 1||2||
59877733|NCT02948582|76001468|FG002|NOT COMPLETED|Washout Period 1||0||
59877734|NCT02948582|76001469|FG003|NOT COMPLETED|Washout Period 1||0||
59877735|NCT02948582|76001470|FG004|NOT COMPLETED|Washout Period 1||0||
59877736|NCT02948582|76001471|FG005|NOT COMPLETED|Washout Period 1||1||
59877737|NCT02948582|76001466|FG000|STARTED|Treatment Period 2||7||
59877738|NCT02948582|76001467|FG001|STARTED|Treatment Period 2||5||
59877739|NCT02948582|76001468|FG002|STARTED|Treatment Period 2||7||
59877740|NCT02948582|76001469|FG003|STARTED|Treatment Period 2||7||
59877741|NCT02948582|76001470|FG004|STARTED|Treatment Period 2||7||
59877742|NCT02948582|76001471|FG005|STARTED|Treatment Period 2||6||
59877743|NCT02948582|76001466|FG000|COMPLETED|Treatment Period 2||7||
59750117|NCT00661609|75869274|FG000|STARTED|Overall Study|All dosed patients|41||
59750118|NCT00661609|75869274|FG000|COMPLETED|Overall Study|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0||
59750119|NCT00661609|75869274|FG000|NOT COMPLETED|Overall Study||41||
59750120|NCT00661531|75869278|FG000|STARTED|Overall Study||11||
59750121|NCT00661531|75869278|FG000|COMPLETED|Overall Study||8||
59750122|NCT00661531|75869278|FG000|NOT COMPLETED|Overall Study||3||
59877744|NCT02948582|76001467|FG001|COMPLETED|Treatment Period 2||5||
59877745|NCT02948582|76001468|FG002|COMPLETED|Treatment Period 2||7||
59877746|NCT02948582|76001469|FG003|COMPLETED|Treatment Period 2||7||
59877747|NCT02948582|76001470|FG004|COMPLETED|Treatment Period 2||7||
59877748|NCT02948582|76001471|FG005|COMPLETED|Treatment Period 2||6||
59877749|NCT02948582|76001466|FG000|NOT COMPLETED|Treatment Period 2||0||
59877750|NCT02948582|76001467|FG001|NOT COMPLETED|Treatment Period 2||0||
59877751|NCT02948582|76001468|FG002|NOT COMPLETED|Treatment Period 2||0||
59877752|NCT02948582|76001469|FG003|NOT COMPLETED|Treatment Period 2||0||
59877753|NCT02948582|76001470|FG004|NOT COMPLETED|Treatment Period 2||0||
59877754|NCT02948582|76001471|FG005|NOT COMPLETED|Treatment Period 2||0||
59877755|NCT02948582|76001466|FG000|STARTED|Washout Period 2||7||
59877756|NCT02948582|76001467|FG001|STARTED|Washout Period 2||5||
59877757|NCT02948582|76001468|FG002|STARTED|Washout Period 2||7||
59877758|NCT02948582|76001469|FG003|STARTED|Washout Period 2||7||
59877759|NCT02948582|76001470|FG004|STARTED|Washout Period 2||7||
59877760|NCT02948582|76001471|FG005|STARTED|Washout Period 2||6||
59877761|NCT02948582|76001466|FG000|COMPLETED|Washout Period 2||7||
59877762|NCT02948582|76001467|FG001|COMPLETED|Washout Period 2||4||
59877763|NCT02948582|76001468|FG002|COMPLETED|Washout Period 2||7||
59877764|NCT02948582|76001469|FG003|COMPLETED|Washout Period 2||6||
59877765|NCT02948582|76001470|FG004|COMPLETED|Washout Period 2||7||
59877766|NCT02948582|76001471|FG005|COMPLETED|Washout Period 2||6||
59877767|NCT02948582|76001466|FG000|NOT COMPLETED|Washout Period 2||0||
59877768|NCT02948582|76001467|FG001|NOT COMPLETED|Washout Period 2||1||
59877769|NCT02948582|76001468|FG002|NOT COMPLETED|Washout Period 2||0||
59877770|NCT02948582|76001469|FG003|NOT COMPLETED|Washout Period 2||1||
59877771|NCT02948582|76001470|FG004|NOT COMPLETED|Washout Period 2||0||
59877772|NCT02948582|76001471|FG005|NOT COMPLETED|Washout Period 2||0||
59877773|NCT02948582|76001466|FG000|STARTED|Treatment Period 3||7||
59877774|NCT02948582|76001467|FG001|STARTED|Treatment Period 3||4||
59877775|NCT02948582|76001468|FG002|STARTED|Treatment Period 3||7||
59877776|NCT02948582|76001469|FG003|STARTED|Treatment Period 3||6||
59877777|NCT02948582|76001470|FG004|STARTED|Treatment Period 3||7||
59877778|NCT02948582|76001471|FG005|STARTED|Treatment Period 3||6||
59877779|NCT02948582|76001466|FG000|COMPLETED|Treatment Period 3||7||
59877780|NCT02948582|76001467|FG001|COMPLETED|Treatment Period 3||4||
59750123|NCT00998309|75869282|FG000|STARTED|Overall Study||502||
59750124|NCT00998309|75869282|FG000|COMPLETED|Overall Study||498||
59750125|NCT00998309|75869282|FG000|NOT COMPLETED|Overall Study||4||
59750126|NCT00999713|75869336|FG000|STARTED|Overall Study||26||
59750127|NCT00999713|75869337|FG001|STARTED|Overall Study||17||
59750128|NCT00999713|75869336|FG000|COMPLETED|Overall Study||24||
59750129|NCT00999713|75869337|FG001|COMPLETED|Overall Study||17||
59750130|NCT00999713|75869336|FG000|NOT COMPLETED|Overall Study||2||
59750131|NCT00999713|75869337|FG001|NOT COMPLETED|Overall Study||0||
59750132|NCT00997373|75869345|FG000|STARTED|Overall Study||28||
59750133|NCT00997373|75869346|FG001|STARTED|Overall Study||15||
59750134|NCT00997373|75869345|FG000|Received Letrozole|Overall Study||23||
59750135|NCT00997373|75869346|FG001|Received Letrozole|Overall Study||0||
59877781|NCT02948582|76001468|FG002|COMPLETED|Treatment Period 3||7||
59877782|NCT02948582|76001469|FG003|COMPLETED|Treatment Period 3||6||
59877783|NCT02948582|76001470|FG004|COMPLETED|Treatment Period 3||7||
59877784|NCT02948582|76001471|FG005|COMPLETED|Treatment Period 3||6||
59877785|NCT02948582|76001466|FG000|NOT COMPLETED|Treatment Period 3||0||
59877786|NCT02948582|76001467|FG001|NOT COMPLETED|Treatment Period 3||0||
59877787|NCT02948582|76001468|FG002|NOT COMPLETED|Treatment Period 3||0||
59877788|NCT02948582|76001469|FG003|NOT COMPLETED|Treatment Period 3||0||
59877789|NCT02948582|76001470|FG004|NOT COMPLETED|Treatment Period 3||0||
59877790|NCT02948582|76001471|FG005|NOT COMPLETED|Treatment Period 3||0||
59877791|NCT02948582|76001466|FG000|STARTED|Washout Period 3||7||
59877792|NCT02948582|76001467|FG001|STARTED|Washout Period 3||4||
59877793|NCT02948582|76001468|FG002|STARTED|Washout Period 3||7||
59877794|NCT02948582|76001469|FG003|STARTED|Washout Period 3||6||
59877795|NCT02948582|76001470|FG004|STARTED|Washout Period 3||7||
59877796|NCT02948582|76001471|FG005|STARTED|Washout Period 3||6||
59877797|NCT02948582|76001466|FG000|COMPLETED|Washout Period 3||7||
59877798|NCT02948582|76001467|FG001|COMPLETED|Washout Period 3||4||
59877799|NCT02948582|76001468|FG002|COMPLETED|Washout Period 3||7||
59877800|NCT02948582|76001469|FG003|COMPLETED|Washout Period 3||6||
59877801|NCT02948582|76001470|FG004|COMPLETED|Washout Period 3||7||
59877802|NCT02948582|76001471|FG005|COMPLETED|Washout Period 3||6||
59877803|NCT02948582|76001466|FG000|NOT COMPLETED|Washout Period 3||0||
59877804|NCT02948582|76001467|FG001|NOT COMPLETED|Washout Period 3||0||
59877805|NCT02948582|76001468|FG002|NOT COMPLETED|Washout Period 3||0||
59877806|NCT02948582|76001469|FG003|NOT COMPLETED|Washout Period 3||0||
59877807|NCT02948582|76001470|FG004|NOT COMPLETED|Washout Period 3||0||
59877808|NCT02948582|76001471|FG005|NOT COMPLETED|Washout Period 3||0||
59877809|NCT02948582|76001466|FG000|STARTED|Treatment Period 4||7||
59877810|NCT02948582|76001467|FG001|STARTED|Treatment Period 4||4||
59877811|NCT02948582|76001468|FG002|STARTED|Treatment Period 4||7||
59877812|NCT02948582|76001469|FG003|STARTED|Treatment Period 4||6||
59877813|NCT02948582|76001470|FG004|STARTED|Treatment Period 4||7||
59877814|NCT02948582|76001471|FG005|STARTED|Treatment Period 4||6||
59877815|NCT02948582|76001466|FG000|COMPLETED|Treatment Period 4||7||
59877816|NCT02948582|76001467|FG001|COMPLETED|Treatment Period 4||4||
59877817|NCT02948582|76001468|FG002|COMPLETED|Treatment Period 4||7||
59877818|NCT02948582|76001469|FG003|COMPLETED|Treatment Period 4||6||
59877819|NCT02948582|76001470|FG004|COMPLETED|Treatment Period 4||7||
59877820|NCT02948582|76001471|FG005|COMPLETED|Treatment Period 4||6||
59877821|NCT02948582|76001466|FG000|NOT COMPLETED|Treatment Period 4||0||
59877822|NCT02948582|76001467|FG001|NOT COMPLETED|Treatment Period 4||0||
59877823|NCT02948582|76001468|FG002|NOT COMPLETED|Treatment Period 4||0||
59877824|NCT02948582|76001469|FG003|NOT COMPLETED|Treatment Period 4||0||
59877825|NCT02948582|76001470|FG004|NOT COMPLETED|Treatment Period 4||0||
59877826|NCT02948582|76001471|FG005|NOT COMPLETED|Treatment Period 4||0||
59877827|NCT02948582|76001466|FG000|STARTED|Washout Period 4||7||
59877828|NCT02948582|76001467|FG001|STARTED|Washout Period 4||4||
59877829|NCT02948582|76001468|FG002|STARTED|Washout Period 4||7||
59877830|NCT02948582|76001469|FG003|STARTED|Washout Period 4||6||
59877831|NCT02948582|76001470|FG004|STARTED|Washout Period 4||7||
59877832|NCT02948582|76001471|FG005|STARTED|Washout Period 4||6||
59877833|NCT02948582|76001466|FG000|COMPLETED|Washout Period 4||6||
59877834|NCT02948582|76001467|FG001|COMPLETED|Washout Period 4||4||
59877835|NCT02948582|76001468|FG002|COMPLETED|Washout Period 4||6||
59877836|NCT02948582|76001469|FG003|COMPLETED|Washout Period 4||6||
59877837|NCT02948582|76001470|FG004|COMPLETED|Washout Period 4||7||
59877838|NCT02948582|76001471|FG005|COMPLETED|Washout Period 4||6||
59877839|NCT02948582|76001466|FG000|NOT COMPLETED|Washout Period 4||1||
59877840|NCT02948582|76001467|FG001|NOT COMPLETED|Washout Period 4||0||
59877841|NCT02948582|76001468|FG002|NOT COMPLETED|Washout Period 4||1||
59877842|NCT02948582|76001469|FG003|NOT COMPLETED|Washout Period 4||0||
59877843|NCT02948582|76001470|FG004|NOT COMPLETED|Washout Period 4||0||
59877844|NCT02948582|76001471|FG005|NOT COMPLETED|Washout Period 4||0||
59877845|NCT02948582|76001466|FG000|STARTED|Treatment Period 5||6||
59877846|NCT02948582|76001467|FG001|STARTED|Treatment Period 5||4||
59877847|NCT02948582|76001468|FG002|STARTED|Treatment Period 5||6||
59877848|NCT02948582|76001469|FG003|STARTED|Treatment Period 5||6||
59877849|NCT02948582|76001470|FG004|STARTED|Treatment Period 5||7||
59877850|NCT02948582|76001471|FG005|STARTED|Treatment Period 5||6||
59877851|NCT02948582|76001466|FG000|COMPLETED|Treatment Period 5||6||
59877852|NCT02948582|76001467|FG001|COMPLETED|Treatment Period 5||4||
59877853|NCT02948582|76001468|FG002|COMPLETED|Treatment Period 5||6||
59877854|NCT02948582|76001469|FG003|COMPLETED|Treatment Period 5||6||
59877855|NCT02948582|76001470|FG004|COMPLETED|Treatment Period 5||7||
59877856|NCT02948582|76001471|FG005|COMPLETED|Treatment Period 5||6||
59877857|NCT02948582|76001466|FG000|NOT COMPLETED|Treatment Period 5||0||
59877858|NCT02948582|76001467|FG001|NOT COMPLETED|Treatment Period 5||0||
59877859|NCT02948582|76001468|FG002|NOT COMPLETED|Treatment Period 5||0||
59877860|NCT02948582|76001469|FG003|NOT COMPLETED|Treatment Period 5||0||
59877861|NCT02948582|76001470|FG004|NOT COMPLETED|Treatment Period 5||0||
59877862|NCT02948582|76001471|FG005|NOT COMPLETED|Treatment Period 5||0||
59877863|NCT02948582|76001466|FG000|STARTED|Washout Period 5||6||
59750136|NCT00997373|75869345|FG000|Completed Hysterectomy|Overall Study||17||
59750137|NCT00997373|75869346|FG001|Completed Hysterectomy|Overall Study||15||
59750138|NCT00997373|75869345|FG000|COMPLETED|Overall Study||13||
59750139|NCT00997373|75869346|FG001|COMPLETED|Overall Study||15||
59750140|NCT00997373|75869345|FG000|NOT COMPLETED|Overall Study||15||
59750141|NCT00997373|75869346|FG001|NOT COMPLETED|Overall Study||0||
59877864|NCT02948582|76001467|FG001|STARTED|Washout Period 5||4||
59877865|NCT02948582|76001468|FG002|STARTED|Washout Period 5||6||
59877866|NCT02948582|76001469|FG003|STARTED|Washout Period 5||6||
59877867|NCT02948582|76001470|FG004|STARTED|Washout Period 5||7||
59877868|NCT02948582|76001471|FG005|STARTED|Washout Period 5||6||
59877869|NCT02948582|76001466|FG000|COMPLETED|Washout Period 5||6||
59877870|NCT02948582|76001467|FG001|COMPLETED|Washout Period 5||4||
59877871|NCT02948582|76001468|FG002|COMPLETED|Washout Period 5||6||
59877872|NCT02948582|76001469|FG003|COMPLETED|Washout Period 5||6||
59877873|NCT02948582|76001470|FG004|COMPLETED|Washout Period 5||7||
59877874|NCT02948582|76001471|FG005|COMPLETED|Washout Period 5||6||
59877875|NCT02948582|76001466|FG000|NOT COMPLETED|Washout Period 5||0||
59877876|NCT02948582|76001467|FG001|NOT COMPLETED|Washout Period 5||0||
59877877|NCT02948582|76001468|FG002|NOT COMPLETED|Washout Period 5||0||
59877878|NCT02948582|76001469|FG003|NOT COMPLETED|Washout Period 5||0||
59877879|NCT02948582|76001470|FG004|NOT COMPLETED|Washout Period 5||0||
59877880|NCT02948582|76001471|FG005|NOT COMPLETED|Washout Period 5||0||
59877881|NCT02948582|76001466|FG000|STARTED|Treatment Period 6||6||
59877882|NCT02948582|76001467|FG001|STARTED|Treatment Period 6||4||
59877883|NCT02948582|76001468|FG002|STARTED|Treatment Period 6||6||
59877884|NCT02948582|76001469|FG003|STARTED|Treatment Period 6||6||
59877885|NCT02948582|76001470|FG004|STARTED|Treatment Period 6||7||
59877886|NCT02948582|76001471|FG005|STARTED|Treatment Period 6||6||
59877887|NCT02948582|76001466|FG000|COMPLETED|Treatment Period 6||6||
59877888|NCT02948582|76001467|FG001|COMPLETED|Treatment Period 6||4||
59877889|NCT02948582|76001468|FG002|COMPLETED|Treatment Period 6||6||
59877890|NCT02948582|76001469|FG003|COMPLETED|Treatment Period 6||6||
59877891|NCT02948582|76001470|FG004|COMPLETED|Treatment Period 6||7||
59877892|NCT02948582|76001471|FG005|COMPLETED|Treatment Period 6||6||
59877893|NCT02948582|76001466|FG000|NOT COMPLETED|Treatment Period 6||0||
59877894|NCT02948582|76001467|FG001|NOT COMPLETED|Treatment Period 6||0||
59877895|NCT02948582|76001468|FG002|NOT COMPLETED|Treatment Period 6||0||
59877896|NCT02948582|76001469|FG003|NOT COMPLETED|Treatment Period 6||0||
59750142|NCT00663871|75869354|FG000|STARTED|Overall Study||134||
59750143|NCT00663871|75869355|FG001|STARTED|Overall Study||138||
59877897|NCT02948582|76001470|FG004|NOT COMPLETED|Treatment Period 6||0||
59877898|NCT02948582|76001471|FG005|NOT COMPLETED|Treatment Period 6||0||
59877899|NCT02948582|76001466|FG000|STARTED|Wshout Period 6||6||
59877900|NCT02948582|76001467|FG001|STARTED|Wshout Period 6||4||
59877901|NCT02948582|76001468|FG002|STARTED|Wshout Period 6||6||
59877902|NCT02948582|76001469|FG003|STARTED|Wshout Period 6||6||
59877903|NCT02948582|76001470|FG004|STARTED|Wshout Period 6||7||
59877904|NCT02948582|76001471|FG005|STARTED|Wshout Period 6||6||
59877905|NCT02948582|76001466|FG000|COMPLETED|Wshout Period 6||6||
59750144|NCT00663871|75869354|FG000|COMPLETED|Overall Study||124||
59750145|NCT00663871|75869355|FG001|COMPLETED|Overall Study||131||
59877906|NCT02948582|76001467|FG001|COMPLETED|Wshout Period 6||4||
59877907|NCT02948582|76001468|FG002|COMPLETED|Wshout Period 6||6||
59877908|NCT02948582|76001469|FG003|COMPLETED|Wshout Period 6||6||
59877909|NCT02948582|76001470|FG004|COMPLETED|Wshout Period 6||7||
59877910|NCT02948582|76001471|FG005|COMPLETED|Wshout Period 6||6||
59877911|NCT02948582|76001466|FG000|NOT COMPLETED|Wshout Period 6||0||
59877912|NCT02948582|76001467|FG001|NOT COMPLETED|Wshout Period 6||0||
59877913|NCT02948582|76001468|FG002|NOT COMPLETED|Wshout Period 6||0||
59877914|NCT02948582|76001469|FG003|NOT COMPLETED|Wshout Period 6||0||
59877915|NCT02948582|76001470|FG004|NOT COMPLETED|Wshout Period 6||0||
59877916|NCT02948582|76001471|FG005|NOT COMPLETED|Wshout Period 6||0||
59877917|NCT03756285|76001487|FG000|STARTED|Overall Study||27||
59877918|NCT03756285|76001488|FG001|STARTED|Overall Study||14||
59877919|NCT03756285|76001487|FG000|COMPLETED|Overall Study||24||
59877920|NCT03756285|76001488|FG001|COMPLETED|Overall Study||9||
59877921|NCT03756285|76001487|FG000|NOT COMPLETED|Overall Study||3||
59877922|NCT03756285|76001488|FG001|NOT COMPLETED|Overall Study||5||
59950755|NCT03225287|76069598|FG002|COMPLETED|Overall Study||0||
59750146|NCT00663871|75869354|FG000|NOT COMPLETED|Overall Study||10||
59750147|NCT00663871|75869355|FG001|NOT COMPLETED|Overall Study||7||
59877923|NCT02825992|76001495|FG000|STARTED|Overall Study|The procedure was terminated for clinical reasons in 2 patients, therefore only 127 were treated.|129||
59877924|NCT02825992|76001495|FG000|COMPLETED|Overall Study||121||
59877925|NCT02825992|76001495|FG000|NOT COMPLETED|Overall Study||8||
59877926|NCT01339000|76001507|FG000|STARTED|Overall Study|The patient received day 1, 29, 36, 43, 50, and 57 vaccines but did not receive interleukin-7 (IL-7)|1||
59877927|NCT01339000|76001508|FG001|STARTED|Overall Study||0||
59877928|NCT01339000|76001507|FG000|COMPLETED|Overall Study||0||
59877929|NCT01339000|76001508|FG001|COMPLETED|Overall Study||0||
59877930|NCT01339000|76001507|FG000|NOT COMPLETED|Overall Study||1||
59877931|NCT01339000|76001508|FG001|NOT COMPLETED|Overall Study||0||
59877932|NCT03755661|76001519|FG000|STARTED|Overall Study||12||
59877933|NCT03755661|76001520|FG001|STARTED|Overall Study||12||
59877934|NCT03755661|76001519|FG000|COMPLETED|Overall Study||11||
59877935|NCT03755661|76001520|FG001|COMPLETED|Overall Study||12||
59877936|NCT03755661|76001519|FG000|NOT COMPLETED|Overall Study||1||
59877937|NCT03755661|76001520|FG001|NOT COMPLETED|Overall Study||0||
59877938|NCT03752151|76001526|FG000|STARTED|Overall Study||77||
59877939|NCT03752151|76001526|FG000|COMPLETED|Overall Study||75||
59877940|NCT03752151|76001526|FG000|NOT COMPLETED|Overall Study||2||
59877941|NCT01336634|76001534|FG000|STARTED|Overall Study||84|All participants who received at least one dose of study treatment were included in the All Treated Population (ATP)|
59877942|NCT01336634|76001535|FG001|STARTED|Overall Study||57|All participants who received at least one dose of study treatment were included in the All Treated Population (ATP)|
59877943|NCT01336634|76001536|FG002|STARTED|Overall Study|includes 34 subjects from Cohort C and 2 subjects enrolled as protocol deviations from Cohort B.|36|All participants who received at least one dose of study treatment were included in the All Treated Population (ATP)|
59877944|NCT01336634|76001534|FG000|2nd Line Plus All Treated|Overall Study||78|All Treated Population who had relapsed or progressed after receiving at least one line of prior anti-cancer therapy for metastatic disease.|
59877945|NCT01336634|76001535|FG001|2nd Line Plus All Treated|Overall Study||57|All Treated Population who had relapsed or progressed after receiving at least one line of prior anti-cancer therapy for metastatic disease.|
59877946|NCT01336634|76001536|FG002|2nd Line Plus All Treated|Overall Study||0|All Treated Population who had relapsed or progressed after receiving at least one line of prior anti-cancer therapy for metastatic disease.|
59877947|NCT01336634|76001534|FG000|1st Line All Treated|Overall Study||6|All Treated Population who had not received any prior anti-cancer therapy for metastatic disease.|
59877948|NCT01336634|76001535|FG001|1st Line All Treated|Overall Study||2|All Treated Population who had not received any prior anti-cancer therapy for metastatic disease.|
59877949|NCT01336634|76001536|FG002|1st Line All Treated|Overall Study||34|All Treated Population who had not received any prior anti-cancer therapy for metastatic disease.|
59877950|NCT01336634|76001534|FG000|Crossover|Overall Study||20|All Treated Population who were assigned to monotherapy cohort and elected to crossover to combination treatment following disease progression on monotherapy.|
59877951|NCT01336634|76001535|FG001|Crossover|Overall Study||0|All Treated Population who were assigned to monotherapy cohort and elected to crossover to combination treatment following disease progression on monotherapy.|
59877952|NCT01336634|76001536|FG002|Crossover|Overall Study||0|All Treated Population who were assigned to monotherapy cohort and elected to crossover to combination treatment following disease progression on monotherapy.|
59877953|NCT01336634|76001534|FG000|COMPLETED|Overall Study||70|Study ended when progression of disease had occurred in all patients in Cohorts B and C, a minimum of 70% of subjects had died in each cohort, or five years had passed since the last subject's first dose, whichever came first.|
59877954|NCT01336634|76001535|FG001|COMPLETED|Overall Study||49|Study ended when progression of disease had occurred in all patients in Cohorts B and C, a minimum of 70% of subjects had died in each cohort, or five years had passed since the last subject's first dose, whichever came first.|
59877955|NCT01336634|76001536|FG002|COMPLETED|Overall Study||27|Study ended when progression of disease had occurred in all patients in Cohorts B and C, a minimum of 70% of subjects had died in each cohort, or five years had passed since the last subject's first dose, whichever came first.|
59877956|NCT01336634|76001534|FG000|NOT COMPLETED|Overall Study||14||
59877957|NCT01336634|76001535|FG001|NOT COMPLETED|Overall Study||8||
59877958|NCT01336634|76001536|FG002|NOT COMPLETED|Overall Study||9||
59877959|NCT00785798|76001547|FG000|STARTED|Overall Study||17||
59877960|NCT00785798|76001547|FG000|COMPLETED|Overall Study||16||
59877961|NCT00785798|76001547|FG000|NOT COMPLETED|Overall Study||1||
59877962|NCT02947100|76001551|FG000|STARTED|Overall Study||4||
59877963|NCT02947100|76001551|FG000|COMPLETED|Overall Study||0||
59877964|NCT02947100|76001551|FG000|NOT COMPLETED|Overall Study||4||
59877965|NCT03329846|76001557|FG000|STARTED|Overall Study||10||
59877966|NCT03329846|76001558|FG001|STARTED|Overall Study||10||
59877967|NCT03329846|76001557|FG000|COMPLETED|Overall Study||2||
59877968|NCT03329846|76001558|FG001|COMPLETED|Overall Study||1||
59877969|NCT03329846|76001557|FG000|NOT COMPLETED|Overall Study||8||
59877970|NCT03329846|76001558|FG001|NOT COMPLETED|Overall Study||9||
59877971|NCT03325010|76001566|FG000|STARTED|Overall Study||64||
59877972|NCT03325010|76001567|FG001|STARTED|Overall Study||63||
59877973|NCT03325010|76001566|FG000|Safety Analysis Set|Overall Study||62|The safety analysis set includes all participants who received at least one dose of study drug and have any post-baseline safety data collected.|
59877974|NCT03325010|76001567|FG001|Safety Analysis Set|Overall Study||59|The safety analysis set includes all participants who received at least one dose of study drug and have any post-baseline safety data collected.|
59950756|NCT03225287|76069596|FG000|NOT COMPLETED|Overall Study||10||
59950757|NCT03225287|76069597|FG001|NOT COMPLETED|Overall Study||6||
59877975|NCT03325010|76001566|FG000|Full Analysis Set|Overall Study||61|The full analysis set includes all randomized participants who have at least one evaluable change from baseline value for Total Tic Score reported at a visit (either scheduled or mapped early termination visit) during the treatment period.|
59877976|NCT03325010|76001567|FG001|Full Analysis Set|Overall Study||58|The full analysis set includes all randomized participants who have at least one evaluable change from baseline value for Total Tic Score reported at a visit (either scheduled or mapped early termination visit) during the treatment period.|
59877977|NCT03325010|76001566|FG000|COMPLETED|Overall Study||55||
59877978|NCT03325010|76001567|FG001|COMPLETED|Overall Study||43||
59877979|NCT03325010|76001566|FG000|NOT COMPLETED|Overall Study||9||
59877980|NCT03325010|76001567|FG001|NOT COMPLETED|Overall Study||20||
59877981|NCT02824432|76001575|FG000|STARTED|Overall Study||18||
59877982|NCT02824432|76001576|FG001|STARTED|Overall Study||19||
59877983|NCT02824432|76001575|FG000|COMPLETED|Overall Study||17||
59877984|NCT02824432|76001576|FG001|COMPLETED|Overall Study||19||
59877985|NCT02824432|76001575|FG000|NOT COMPLETED|Overall Study||1||
59877986|NCT02824432|76001576|FG001|NOT COMPLETED|Overall Study||0||
59877987|NCT02823964|76001582|FG000|STARTED|Overall Study||25||
59877988|NCT02823964|76001582|FG000|COMPLETED|Overall Study||20||
59877989|NCT02823964|76001582|FG000|NOT COMPLETED|Overall Study||5||
59877990|NCT01338610|76001589|FG000|STARTED|Overall Study||39||
59877991|NCT01338610|76001590|FG001|STARTED|Overall Study||56||
59877992|NCT01338610|76001591|FG002|STARTED|Overall Study||29||
59877993|NCT01338610|76001589|FG000|COMPLETED|Overall Study||34||
59877994|NCT01338610|76001590|FG001|COMPLETED|Overall Study||55||
59877995|NCT01338610|76001591|FG002|COMPLETED|Overall Study||28||
59877996|NCT01338610|76001589|FG000|NOT COMPLETED|Overall Study||5||
59877997|NCT01338610|76001590|FG001|NOT COMPLETED|Overall Study||1||
59877998|NCT01338610|76001591|FG002|NOT COMPLETED|Overall Study||1||
59877999|NCT01355302|76001598|FG000|STARTED|Phase 1b|Replaced 1 subject; who discontinued study drug in first cycle|7||
59878000|NCT01355302|76001599|FG001|STARTED|Phase 1b||0||
59878001|NCT01355302|76001600|FG002|STARTED|Phase 1b||0||
59878002|NCT01355302|76001598|FG000|COMPLETED|Phase 1b|The subject who completed 6 cycles was withdrawn by sponsor request.|1||
59878003|NCT01355302|76001599|FG001|COMPLETED|Phase 1b||0||
59878004|NCT01355302|76001600|FG002|COMPLETED|Phase 1b||0||
59878005|NCT01355302|76001598|FG000|NOT COMPLETED|Phase 1b||6||
59878006|NCT01355302|76001599|FG001|NOT COMPLETED|Phase 1b||0||
59878007|NCT01355302|76001600|FG002|NOT COMPLETED|Phase 1b||0||
59878008|NCT01355302|76001598|FG000|STARTED|Phase 2|Treatment arm not designated for phase 2.|0||
59878009|NCT01355302|76001599|FG001|STARTED|Phase 2|The study was terminated prior to enrollment|0||
59878010|NCT01355302|76001600|FG002|STARTED|Phase 2|The study was terminated prior to enrollment|0||
59878011|NCT01355302|76001598|FG000|COMPLETED|Phase 2||0||
59878012|NCT01355302|76001599|FG001|COMPLETED|Phase 2||0||
59878013|NCT01355302|76001600|FG002|COMPLETED|Phase 2||0||
59878014|NCT01355302|76001598|FG000|NOT COMPLETED|Phase 2||0||
59878015|NCT01355302|76001599|FG001|NOT COMPLETED|Phase 2||0||
59878016|NCT01355302|76001600|FG002|NOT COMPLETED|Phase 2||0||
59878017|NCT01355068|76001608|FG000|STARTED|First Intervention Period||13||
59878018|NCT01355068|76001609|FG001|STARTED|First Intervention Period||13||
59878019|NCT01355068|76001608|FG000|COMPLETED|First Intervention Period||13||
59878020|NCT01355068|76001609|FG001|COMPLETED|First Intervention Period||11||
59878021|NCT01355068|76001608|FG000|NOT COMPLETED|First Intervention Period||0||
59878022|NCT01355068|76001609|FG001|NOT COMPLETED|First Intervention Period||2||
59878023|NCT01355068|76001608|FG000|STARTED|Washout Period (at Least 7 Days)||13||
59878024|NCT01355068|76001609|FG001|STARTED|Washout Period (at Least 7 Days)||11||
59878025|NCT01355068|76001608|FG000|COMPLETED|Washout Period (at Least 7 Days)||13||
59878026|NCT01355068|76001609|FG001|COMPLETED|Washout Period (at Least 7 Days)||11||
59878027|NCT01355068|76001608|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||0||
59878028|NCT01355068|76001609|FG001|NOT COMPLETED|Washout Period (at Least 7 Days)||0||
59878029|NCT01355068|76001608|FG000|STARTED|Second Intervention Period||13||
59878030|NCT01355068|76001609|FG001|STARTED|Second Intervention Period||11||
59878031|NCT01355068|76001608|FG000|COMPLETED|Second Intervention Period||13||
59878032|NCT01355068|76001609|FG001|COMPLETED|Second Intervention Period||11||
59878033|NCT01355068|76001608|FG000|NOT COMPLETED|Second Intervention Period||0||
59878034|NCT01355068|76001609|FG001|NOT COMPLETED|Second Intervention Period||0||
59878035|NCT03756129|76001621|FG000|STARTED|Overall Study||11||
59878036|NCT03756129|76001622|FG001|STARTED|Overall Study||10||
59878037|NCT03756129|76001623|FG002|STARTED|Overall Study||10||
59878038|NCT03756129|76001624|FG003|STARTED|Overall Study|1 participant in this group was randomized but not treated, and is not included in this data set.|9||
60002536|NCT02561247|76118435|FG000|COMPLETED|Overall Study||17||
60002537|NCT02561247|76118435|FG000|NOT COMPLETED|Overall Study||6||
60002538|NCT02061592|76118441|FG000|STARTED|Period 1||66||
59878039|NCT03756129|76001625|FG004|STARTED|Overall Study|1 participant in this group was randomized but not treated, and is not included in this data set.|10||
59878040|NCT03756129|76001626|FG005|STARTED|Overall Study||20||
59878041|NCT03756129|76001621|FG000|COMPLETED|Overall Study||8||
59878042|NCT03756129|76001622|FG001|COMPLETED|Overall Study||8||
59878043|NCT03756129|76001623|FG002|COMPLETED|Overall Study||7||
59878044|NCT03756129|76001624|FG003|COMPLETED|Overall Study||6||
60002539|NCT02061592|76118442|FG001|STARTED|Period 1||62||
60002540|NCT02061592|76118441|FG000|COMPLETED|Period 1||64||
59878045|NCT03756129|76001625|FG004|COMPLETED|Overall Study||9||
59878046|NCT03756129|76001626|FG005|COMPLETED|Overall Study||15||
59878047|NCT03756129|76001621|FG000|NOT COMPLETED|Overall Study||3||
59878048|NCT03756129|76001622|FG001|NOT COMPLETED|Overall Study||2||
59878049|NCT03756129|76001623|FG002|NOT COMPLETED|Overall Study||3||
59878050|NCT03756129|76001624|FG003|NOT COMPLETED|Overall Study||3||
59878051|NCT03756129|76001625|FG004|NOT COMPLETED|Overall Study||1||
59878052|NCT03756129|76001626|FG005|NOT COMPLETED|Overall Study||5||
59878053|NCT02822794|76001652|FG000|STARTED|Overall Study||57||
59878054|NCT02822794|76001653|FG001|STARTED|Overall Study||60||
59878055|NCT02822794|76001652|FG000|COMPLETED|Overall Study||56||
59878056|NCT02822794|76001653|FG001|COMPLETED|Overall Study||60||
59878057|NCT02822794|76001652|FG000|NOT COMPLETED|Overall Study||1||
59878058|NCT02822794|76001653|FG001|NOT COMPLETED|Overall Study||0||
59878059|NCT01338298|76001668|FG000|STARTED|Overall Study||24||
59878060|NCT01338298|76001669|FG001|STARTED|Overall Study||18||
59878061|NCT01338298|76001668|FG000|COMPLETED|Overall Study||20||
59878062|NCT01338298|76001669|FG001|COMPLETED|Overall Study||15||
59878063|NCT01338298|76001668|FG000|NOT COMPLETED|Overall Study||4||
59878064|NCT01338298|76001669|FG001|NOT COMPLETED|Overall Study||3||
59878065|NCT01354132|76001677|FG000|STARTED|Randomization|1 never took study medication dropped by physician decision (White matter lesion on MRI)|32||
59878066|NCT01354132|76001678|FG001|STARTED|Randomization|1 never took study medication due to subject withdrawal|31||
59878067|NCT01354132|76001677|FG000|COMPLETED|Randomization||31||
59878068|NCT01354132|76001678|FG001|COMPLETED|Randomization||30||
59878069|NCT01354132|76001677|FG000|NOT COMPLETED|Randomization||1||
59878070|NCT01354132|76001678|FG001|NOT COMPLETED|Randomization||1||
59878071|NCT01354132|76001677|FG000|STARTED|Double Blind (Visits 1-7)|9 did not compete 7 study visits|31||
59878072|NCT01354132|76001678|FG001|STARTED|Double Blind (Visits 1-7)|11 did not compete 7 study visits|30||
59878073|NCT01354132|76001677|FG000|Completed More Than 1 Visit|Double Blind (Visits 1-7)||4||
59878074|NCT01354132|76001678|FG001|Completed More Than 1 Visit|Double Blind (Visits 1-7)||5||
59878075|NCT01354132|76001677|FG000|Stopped After First Visit|Double Blind (Visits 1-7)||3||
59878076|NCT01354132|76001678|FG001|Stopped After First Visit|Double Blind (Visits 1-7)||2||
59878077|NCT01354132|76001677|FG000|Didn't Complete at Least 1 Visit|Double Blind (Visits 1-7)||2||
59878078|NCT01354132|76001678|FG001|Didn't Complete at Least 1 Visit|Double Blind (Visits 1-7)||4||
59878079|NCT01354132|76001677|FG000|COMPLETED|Double Blind (Visits 1-7)||22||
59878080|NCT01354132|76001678|FG001|COMPLETED|Double Blind (Visits 1-7)||19||
59878081|NCT01354132|76001677|FG000|NOT COMPLETED|Double Blind (Visits 1-7)||9||
59878082|NCT01354132|76001678|FG001|NOT COMPLETED|Double Blind (Visits 1-7)||11||
59878083|NCT01354132|76001677|FG000|STARTED|1 Month Post Study Medication||22||
59878084|NCT01354132|76001678|FG001|STARTED|1 Month Post Study Medication||19||
59878085|NCT01354132|76001677|FG000|1 Follow-up Visit (Visit 8)|1 Month Post Study Medication||21||
59878086|NCT01354132|76001678|FG001|1 Follow-up Visit (Visit 8)|1 Month Post Study Medication||16||
59878087|NCT01354132|76001677|FG000|COMPLETED|1 Month Post Study Medication||21||
59878088|NCT01354132|76001678|FG001|COMPLETED|1 Month Post Study Medication||16||
59878089|NCT01354132|76001677|FG000|NOT COMPLETED|1 Month Post Study Medication||1||
59878090|NCT01354132|76001678|FG001|NOT COMPLETED|1 Month Post Study Medication||3||
59878091|NCT01353898|76001693|FG000|STARTED|Overall Study||2||
59878092|NCT01353898|76001694|FG001|STARTED|Overall Study||2||
59878093|NCT01353898|76001695|FG002|STARTED|Overall Study||2||
59878094|NCT01353898|76001696|FG003|STARTED|Overall Study||2||
59878095|NCT01353898|76001697|FG004|STARTED|Overall Study||2||
59878096|NCT01353898|76001698|FG005|STARTED|Overall Study||2||
59878097|NCT01353898|76001693|FG000|COMPLETED|Overall Study||2||
59878098|NCT01353898|76001694|FG001|COMPLETED|Overall Study||2||
59878099|NCT01353898|76001695|FG002|COMPLETED|Overall Study||2||
59878100|NCT01353898|76001696|FG003|COMPLETED|Overall Study||2||
59878101|NCT01353898|76001697|FG004|COMPLETED|Overall Study||2||
59878102|NCT01353898|76001698|FG005|COMPLETED|Overall Study||1||
59878103|NCT01353898|76001693|FG000|NOT COMPLETED|Overall Study||0||
59878104|NCT01353898|76001694|FG001|NOT COMPLETED|Overall Study||0||
59878105|NCT01353898|76001695|FG002|NOT COMPLETED|Overall Study||0||
59878106|NCT01353898|76001696|FG003|NOT COMPLETED|Overall Study||0||
59878107|NCT01353898|76001697|FG004|NOT COMPLETED|Overall Study||0||
59878108|NCT01353898|76001698|FG005|NOT COMPLETED|Overall Study||1||
59878109|NCT01372150|76001715|FG000|STARTED|Overall Study||112||
59878110|NCT01372150|76001716|FG001|STARTED|Overall Study||113||
59878111|NCT01372150|76001717|FG002|STARTED|Overall Study||115||
59878112|NCT01372150|76001715|FG000|Treated|Overall Study||112||
59878113|NCT01372150|76001716|FG001|Treated|Overall Study||112||
59878114|NCT01372150|76001717|FG002|Treated|Overall Study||115||
59878115|NCT01372150|76001715|FG000|COMPLETED|Overall Study||99||
59878116|NCT01372150|76001716|FG001|COMPLETED|Overall Study||99||
59878117|NCT01372150|76001717|FG002|COMPLETED|Overall Study||99||
59878118|NCT01372150|76001715|FG000|NOT COMPLETED|Overall Study||13||
59878119|NCT01372150|76001716|FG001|NOT COMPLETED|Overall Study||14||
59878120|NCT01372150|76001717|FG002|NOT COMPLETED|Overall Study||16||
59878121|NCT03329690|76001730|FG000|STARTED|Overall Study||126||
59878122|NCT03329690|76001731|FG001|STARTED|Overall Study||55||
59878123|NCT03329690|76001732|FG002|STARTED|Overall Study||7||
59878124|NCT03329690|76001733|FG003|STARTED|Overall Study||21||
59878125|NCT03329690|76001734|FG004|STARTED|Overall Study||24||
59878126|NCT03329690|76001730|FG000|Received Treatment|Overall Study||125||
59878127|NCT03329690|76001731|FG001|Received Treatment|Overall Study||55||
59878128|NCT03329690|76001732|FG002|Received Treatment|Overall Study||7||
59878129|NCT03329690|76001733|FG003|Received Treatment|Overall Study||20||
59878130|NCT03329690|76001734|FG004|Received Treatment|Overall Study||24||
59878131|NCT03329690|76001730|FG000|COMPLETED|Overall Study||0||
59878132|NCT03329690|76001731|FG001|COMPLETED|Overall Study||0||
59878133|NCT03329690|76001732|FG002|COMPLETED|Overall Study||0||
59878134|NCT03329690|76001733|FG003|COMPLETED|Overall Study||0||
59878135|NCT03329690|76001734|FG004|COMPLETED|Overall Study||0||
59878136|NCT03329690|76001730|FG000|NOT COMPLETED|Overall Study||126||
59878137|NCT03329690|76001731|FG001|NOT COMPLETED|Overall Study||55||
59878138|NCT03329690|76001732|FG002|NOT COMPLETED|Overall Study||7||
59878139|NCT03329690|76001733|FG003|NOT COMPLETED|Overall Study||21||
59878140|NCT03329690|76001734|FG004|NOT COMPLETED|Overall Study||24||
59878141|NCT03328832|76001754|FG000|STARTED|Overall Study||35||
59878142|NCT03328832|76001755|FG001|STARTED|Overall Study||35||
59878143|NCT03328832|76001754|FG000|COMPLETED|Overall Study||35||
59878144|NCT03328832|76001755|FG001|COMPLETED|Overall Study||34||
59878145|NCT03328832|76001754|FG000|NOT COMPLETED|Overall Study||0||
59878146|NCT03328832|76001755|FG001|NOT COMPLETED|Overall Study||1||
59878147|NCT02820844|76001763|FG000|STARTED|Double-blinded (Up to 48 Weeks)||124||
59878148|NCT02820844|76001764|FG001|STARTED|Double-blinded (Up to 48 Weeks)||124||
59878149|NCT02820844|76001765|FG002|STARTED|Double-blinded (Up to 48 Weeks)||0||
59878150|NCT02820844|76001766|FG003|STARTED|Double-blinded (Up to 48 Weeks)||0||
59878151|NCT02820844|76001767|FG004|STARTED|Double-blinded (Up to 48 Weeks)||0||
59878152|NCT02820844|76001768|FG005|STARTED|Double-blinded (Up to 48 Weeks)||0||
59878153|NCT02820844|76001763|FG000|COMPLETED|Double-blinded (Up to 48 Weeks)||119||
59878154|NCT02820844|76001764|FG001|COMPLETED|Double-blinded (Up to 48 Weeks)||115||
59878155|NCT02820844|76001765|FG002|COMPLETED|Double-blinded (Up to 48 Weeks)||0||
59878156|NCT02820844|76001766|FG003|COMPLETED|Double-blinded (Up to 48 Weeks)||0||
59878157|NCT02820844|76001767|FG004|COMPLETED|Double-blinded (Up to 48 Weeks)||0||
59878158|NCT02820844|76001768|FG005|COMPLETED|Double-blinded (Up to 48 Weeks)||0||
59878159|NCT02820844|76001763|FG000|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||5||
59878160|NCT02820844|76001764|FG001|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||9||
59878161|NCT02820844|76001765|FG002|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0||
59878162|NCT02820844|76001766|FG003|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0||
59878163|NCT02820844|76001767|FG004|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0||
59878164|NCT02820844|76001768|FG005|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0||
59878165|NCT02820844|76001763|FG000|STARTED|Open-label(2nd Treatment-Up to 48 Weeks)||0||
59878166|NCT02820844|76001764|FG001|STARTED|Open-label(2nd Treatment-Up to 48 Weeks)||0||
59878167|NCT02820844|76001765|FG002|STARTED|Open-label(2nd Treatment-Up to 48 Weeks)||108||
59878168|NCT02820844|76001766|FG003|STARTED|Open-label(2nd Treatment-Up to 48 Weeks)||88||
59878169|NCT02820844|76001767|FG004|STARTED|Open-label(2nd Treatment-Up to 48 Weeks)||0||
59878170|NCT02820844|76001768|FG005|STARTED|Open-label(2nd Treatment-Up to 48 Weeks)||0||
59878171|NCT02820844|76001763|FG000|COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0||
59878172|NCT02820844|76001764|FG001|COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0||
59878173|NCT02820844|76001765|FG002|COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||99||
59878174|NCT02820844|76001766|FG003|COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||84||
59878175|NCT02820844|76001767|FG004|COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0||
59878176|NCT02820844|76001768|FG005|COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0||
59878177|NCT02820844|76001763|FG000|NOT COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0||
59878178|NCT02820844|76001764|FG001|NOT COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0||
59750148|NCT04152447|75869365|FG000|STARTED|Overall Study||16||
59750149|NCT04152447|75869366|FG001|STARTED|Overall Study||19||
59750150|NCT04152447|75869365|FG000|COMPLETED|Overall Study||13||
59750151|NCT04152447|75869366|FG001|COMPLETED|Overall Study||14||
59750152|NCT04152447|75869365|FG000|NOT COMPLETED|Overall Study||3||
59750153|NCT04152447|75869366|FG001|NOT COMPLETED|Overall Study||5||
59750154|NCT00996593|75869372|FG000|STARTED|Dosimetric and Therapeutic Treatment||43||
59750155|NCT00996593|75869372|FG000|COMPLETED|Dosimetric and Therapeutic Treatment||0||
59750156|NCT00996593|75869372|FG000|NOT COMPLETED|Dosimetric and Therapeutic Treatment||43||
59750157|NCT00996593|75869372|FG000|STARTED|Long-Term Follow-Up|9 of the 40 participants withdrawing from Study BEX104507 enrolled in long-term follow-up study.|9||
59750158|NCT00996593|75869372|FG000|COMPLETED|Long-Term Follow-Up||6||
59750159|NCT00996593|75869372|FG000|NOT COMPLETED|Long-Term Follow-Up||3||
59750160|NCT00570661|75869376|FG000|STARTED|Overall Study||17||
59950758|NCT03225287|76069598|FG002|NOT COMPLETED|Overall Study||3||
59750161|NCT00570661|75869376|FG000|COMPLETED|Overall Study||10||
59878179|NCT02820844|76001765|FG002|NOT COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||9||
59878180|NCT02820844|76001766|FG003|NOT COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||4||
59878181|NCT02820844|76001767|FG004|NOT COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0||
59878182|NCT02820844|76001768|FG005|NOT COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0||
59878183|NCT02820844|76001763|FG000|STARTED|Open-label(3rd Treatment-Up to 48 Weeks)||0||
59878184|NCT02820844|76001764|FG001|STARTED|Open-label(3rd Treatment-Up to 48 Weeks)||0||
59878185|NCT02820844|76001765|FG002|STARTED|Open-label(3rd Treatment-Up to 48 Weeks)||0||
59878186|NCT02820844|76001766|FG003|STARTED|Open-label(3rd Treatment-Up to 48 Weeks)||0||
59878187|NCT02820844|76001767|FG004|STARTED|Open-label(3rd Treatment-Up to 48 Weeks)||56||
59878188|NCT02820844|76001768|FG005|STARTED|Open-label(3rd Treatment-Up to 48 Weeks)||43||
59878189|NCT02820844|76001763|FG000|COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0||
59878190|NCT02820844|76001764|FG001|COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0||
59878191|NCT02820844|76001765|FG002|COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0||
59878192|NCT02820844|76001766|FG003|COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0||
59878193|NCT02820844|76001767|FG004|COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||54||
59878194|NCT02820844|76001768|FG005|COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||42||
59878195|NCT02820844|76001763|FG000|NOT COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0||
59878196|NCT02820844|76001764|FG001|NOT COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0||
59878197|NCT02820844|76001765|FG002|NOT COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0||
59878198|NCT02820844|76001766|FG003|NOT COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0||
59878199|NCT02820844|76001767|FG004|NOT COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||2||
59878200|NCT02820844|76001768|FG005|NOT COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||1||
59878201|NCT02942576|76001787|FG000|STARTED|Overall Study||405||
59878202|NCT02942576|76001788|FG001|STARTED|Overall Study||197||
59878203|NCT02942576|76001787|FG000|COMPLETED|Overall Study||359||
59878204|NCT02942576|76001788|FG001|COMPLETED|Overall Study||174||
59878205|NCT02942576|76001787|FG000|NOT COMPLETED|Overall Study||46||
59878206|NCT02942576|76001788|FG001|NOT COMPLETED|Overall Study||23||
59878207|NCT02820298|76001796|FG000|STARTED|Overall Study||13||
59878208|NCT02820298|76001797|FG001|STARTED|Overall Study||12||
59878209|NCT02820298|76001796|FG000|COMPLETED|Overall Study||12||
59878210|NCT02820298|76001797|FG001|COMPLETED|Overall Study||10||
59878211|NCT02820298|76001796|FG000|NOT COMPLETED|Overall Study||1||
59878212|NCT02820298|76001797|FG001|NOT COMPLETED|Overall Study||2||
59878213|NCT02819440|76001811|FG000|STARTED|Overall Study||61||
59878214|NCT02819440|76001812|FG001|STARTED|Overall Study||64||
59878215|NCT02819440|76001811|FG000|COMPLETED|Overall Study||48||
59878216|NCT02819440|76001812|FG001|COMPLETED|Overall Study||52||
59878217|NCT02819440|76001811|FG000|NOT COMPLETED|Overall Study||13||
59878218|NCT02819440|76001812|FG001|NOT COMPLETED|Overall Study||12||
59878219|NCT03814720|76001823|FG000|STARTED|Overall Study||5||
59878220|NCT03814720|76001824|FG001|STARTED|Overall Study||12||
59878221|NCT03814720|76001825|FG002|STARTED|Overall Study||12||
59878222|NCT03814720|76001826|FG003|STARTED|Overall Study||12||
59878223|NCT03814720|76001827|FG004|STARTED|Overall Study||11||
59878224|NCT03814720|76001823|FG000|Received First Product Administration|Overall Study||5||
59878225|NCT03814720|76001824|FG001|Received First Product Administration|Overall Study||12||
59878226|NCT03814720|76001825|FG002|Received First Product Administration|Overall Study||12||
59878227|NCT03814720|76001826|FG003|Received First Product Administration|Overall Study||12||
59878228|NCT03814720|76001827|FG004|Received First Product Administration|Overall Study||11||
59878229|NCT03814720|76001823|FG000|Received All Product Administrations|Overall Study||5||
59878230|NCT03814720|76001824|FG001|Received All Product Administrations|Overall Study||12||
59878231|NCT03814720|76001825|FG002|Received All Product Administrations|Overall Study|One participant did not receive the second dose due to moving out of area and 4 participants did not receive the second dose due to the COVID-19 pandemic|7||
59878232|NCT03814720|76001826|FG003|Received All Product Administrations|Overall Study|Three (3) participants did not receive the second dose due to the COVID-19 pandemic|9||
59878233|NCT03814720|76001827|FG004|Received All Product Administrations|Overall Study|Four (4) participants did not receive the second dose due to the COVID-19 pandemic|7||
59878234|NCT03814720|76001823|FG000|COMPLETED|Overall Study||5||
59878235|NCT03814720|76001824|FG001|COMPLETED|Overall Study||11||
59878236|NCT03814720|76001825|FG002|COMPLETED|Overall Study||12||
59878237|NCT03814720|76001826|FG003|COMPLETED|Overall Study||12||
59878238|NCT03814720|76001827|FG004|COMPLETED|Overall Study||11||
59878239|NCT03814720|76001823|FG000|NOT COMPLETED|Overall Study||0||
59878240|NCT03814720|76001824|FG001|NOT COMPLETED|Overall Study||1||
59878241|NCT03814720|76001825|FG002|NOT COMPLETED|Overall Study||0||
59878242|NCT03814720|76001826|FG003|NOT COMPLETED|Overall Study||0||
59878243|NCT03814720|76001827|FG004|NOT COMPLETED|Overall Study||0||
59878244|NCT02818036|76001843|FG000|STARTED|Overall Study||42||
59878245|NCT02818036|76001844|FG001|STARTED|Overall Study||40||
59878246|NCT02818036|76001843|FG000|COMPLETED|Overall Study||40||
59878247|NCT02818036|76001844|FG001|COMPLETED|Overall Study||40||
59878248|NCT02818036|76001843|FG000|NOT COMPLETED|Overall Study||2||
59878249|NCT02818036|76001844|FG001|NOT COMPLETED|Overall Study||0||
59878250|NCT01287741|76001852|FG000|STARTED|Overall Study||712||
59878251|NCT01287741|76001853|FG001|STARTED|Overall Study||706||
59878252|NCT01287741|76001852|FG000|COMPLETED|Overall Study||86||
59878253|NCT01287741|76001853|FG001|COMPLETED|Overall Study||91||
59878254|NCT01287741|76001852|FG000|NOT COMPLETED|Overall Study||626||
59878255|NCT01287741|76001853|FG001|NOT COMPLETED|Overall Study||615||
59878256|NCT01180959|76001860|FG000|STARTED|Overall Study||44||
59878257|NCT01180959|76001860|FG000|COMPLETED|Overall Study||44||
59878258|NCT01180959|76001860|FG000|NOT COMPLETED|Overall Study||0||
59878259|NCT05372315|76001866|FG000|STARTED|Overall Study||40||
59878260|NCT05372315|76001867|FG001|STARTED|Overall Study||40||
59878261|NCT05372315|76001866|FG000|COMPLETED|Overall Study||39||
59878262|NCT05372315|76001867|FG001|COMPLETED|Overall Study||40||
59878263|NCT05372315|76001866|FG000|NOT COMPLETED|Overall Study||1||
59878264|NCT05372315|76001867|FG001|NOT COMPLETED|Overall Study||0||
59878265|NCT04929262|76001876|FG000|STARTED|Pre-Presentation Questionnaires||152||14
59878266|NCT04929262|76001877|FG001|STARTED|Pre-Presentation Questionnaires||131||13
59878267|NCT04929262|76001876|FG000|COMPLETED|Pre-Presentation Questionnaires||112||13
59878268|NCT04929262|76001877|FG001|COMPLETED|Pre-Presentation Questionnaires||97||12
59878269|NCT04929262|76001876|FG000|NOT COMPLETED|Pre-Presentation Questionnaires||40||1
59878270|NCT04929262|76001877|FG001|NOT COMPLETED|Pre-Presentation Questionnaires||34||1
59878271|NCT04929262|76001876|FG000|STARTED|Attended Presentation||112||13
59878272|NCT04929262|76001877|FG001|STARTED|Attended Presentation||97||12
59878273|NCT04929262|76001876|FG000|COMPLETED|Attended Presentation||57||13
59878274|NCT04929262|76001877|FG001|COMPLETED|Attended Presentation||52||12
59878275|NCT04929262|76001876|FG000|NOT COMPLETED|Attended Presentation||55||0
59878276|NCT04929262|76001877|FG001|NOT COMPLETED|Attended Presentation||45||0
59878277|NCT04929262|76001876|FG000|STARTED|Post-Presentation Questionnaires||57||13
59878278|NCT04929262|76001877|FG001|STARTED|Post-Presentation Questionnaires||52||12
59878279|NCT04929262|76001876|FG000|COMPLETED|Post-Presentation Questionnaires||49||13
59878280|NCT04929262|76001877|FG001|COMPLETED|Post-Presentation Questionnaires||47||12
59878281|NCT04929262|76001876|FG000|NOT COMPLETED|Post-Presentation Questionnaires||8||0
59878282|NCT04929262|76001877|FG001|NOT COMPLETED|Post-Presentation Questionnaires||5||0
59878283|NCT04929262|76001876|FG000|STARTED|3 Month Follow-Up Questionnaires||57||13
59878284|NCT04929262|76001877|FG001|STARTED|3 Month Follow-Up Questionnaires||52||12
59878285|NCT04929262|76001876|FG000|COMPLETED|3 Month Follow-Up Questionnaires||39||13
59878286|NCT04929262|76001877|FG001|COMPLETED|3 Month Follow-Up Questionnaires||36||12
59878287|NCT04929262|76001876|FG000|NOT COMPLETED|3 Month Follow-Up Questionnaires||18||0
59878288|NCT04929262|76001877|FG001|NOT COMPLETED|3 Month Follow-Up Questionnaires||16||0
59878289|NCT04913675|76001887|FG000|STARTED|Main Study (Up to Week 36)||393||
59878290|NCT04913675|76001888|FG001|STARTED|Main Study (Up to Week 36)||385||
59878291|NCT04913675|76001889|FG002|STARTED|Main Study (Up to Week 36)||195||
59878292|NCT04913675|76001890|FG003|STARTED|Main Study (Up to Week 36)||0||
59878293|NCT04913675|76001887|FG000|COMPLETED|Main Study (Up to Week 36)||356||
59878294|NCT04913675|76001888|FG001|COMPLETED|Main Study (Up to Week 36)||341||
59878295|NCT04913675|76001889|FG002|COMPLETED|Main Study (Up to Week 36)||176||
59878296|NCT04913675|76001890|FG003|COMPLETED|Main Study (Up to Week 36)||0||
59878297|NCT04913675|76001887|FG000|NOT COMPLETED|Main Study (Up to Week 36)||37||
59878298|NCT04913675|76001888|FG001|NOT COMPLETED|Main Study (Up to Week 36)||44||
59878299|NCT04913675|76001889|FG002|NOT COMPLETED|Main Study (Up to Week 36)||19||
59878300|NCT04913675|76001890|FG003|NOT COMPLETED|Main Study (Up to Week 36)||0||
59878301|NCT04913675|76001887|FG000|STARTED|Safety Sub-study (Up to Day 29)||0||
59878302|NCT04913675|76001888|FG001|STARTED|Safety Sub-study (Up to Day 29)||0||
59878303|NCT04913675|76001889|FG002|STARTED|Safety Sub-study (Up to Day 29)||0||
59878304|NCT04913675|76001890|FG003|STARTED|Safety Sub-study (Up to Day 29)||81||
59878305|NCT04913675|76001887|FG000|COMPLETED|Safety Sub-study (Up to Day 29)||0||
59878306|NCT04913675|76001888|FG001|COMPLETED|Safety Sub-study (Up to Day 29)||0||
59878307|NCT04913675|76001889|FG002|COMPLETED|Safety Sub-study (Up to Day 29)||0||
59878308|NCT04913675|76001890|FG003|COMPLETED|Safety Sub-study (Up to Day 29)||0||
59878309|NCT04913675|76001887|FG000|NOT COMPLETED|Safety Sub-study (Up to Day 29)||0||
59878310|NCT04913675|76001888|FG001|NOT COMPLETED|Safety Sub-study (Up to Day 29)||0||
59878311|NCT04913675|76001889|FG002|NOT COMPLETED|Safety Sub-study (Up to Day 29)||0||
59950759|NCT03140670|76069606|FG000|STARTED|Overall Study||46||
59878312|NCT04913675|76001890|FG003|NOT COMPLETED|Safety Sub-study (Up to Day 29)||81||
59878313|NCT04760314|76001907|FG000|STARTED|Induction Period||82||
59878314|NCT04760314|76001908|FG001|STARTED|Induction Period||81||
59878315|NCT04760314|76001909|FG002|STARTED|Induction Period||123||
59878316|NCT04760314|76001910|FG003|STARTED|Induction Period||0||
59878317|NCT04760314|76001911|FG004|STARTED|Induction Period||0||
59878318|NCT04760314|76001912|FG005|STARTED|Induction Period||0||
59878319|NCT04760314|76001913|FG006|STARTED|Induction Period||0||
59878320|NCT04760314|76001914|FG007|STARTED|Induction Period||0||
59878321|NCT04760314|76001915|FG008|STARTED|Induction Period||0||
59878322|NCT04760314|76001916|FG009|STARTED|Induction Period||0||
59878323|NCT04760314|76001917|FG010|STARTED|Induction Period||0||
59878324|NCT04760314|76001907|FG000|Received at Least One Dose of Study Drug|Induction Period||82||
59878325|NCT04760314|76001908|FG001|Received at Least One Dose of Study Drug|Induction Period||81||
59878326|NCT04760314|76001909|FG002|Received at Least One Dose of Study Drug|Induction Period||123||
59878327|NCT04760314|76001910|FG003|Received at Least One Dose of Study Drug|Induction Period||0||
59878328|NCT04760314|76001911|FG004|Received at Least One Dose of Study Drug|Induction Period||0||
59878329|NCT04760314|76001912|FG005|Received at Least One Dose of Study Drug|Induction Period||0||
59878330|NCT04760314|76001913|FG006|Received at Least One Dose of Study Drug|Induction Period||0||
59878331|NCT04760314|76001914|FG007|Received at Least One Dose of Study Drug|Induction Period||0||
59878332|NCT04760314|76001915|FG008|Received at Least One Dose of Study Drug|Induction Period||0||
59878333|NCT04760314|76001916|FG009|Received at Least One Dose of Study Drug|Induction Period||0||
59878334|NCT04760314|76001917|FG010|Received at Least One Dose of Study Drug|Induction Period||0||
59878335|NCT04760314|76001907|FG000|COMPLETED|Induction Period|Completed includes Responders n = 11; Non responders n = 71.|82||
59878336|NCT04760314|76001908|FG001|COMPLETED|Induction Period|Completed includes Responders n = 38; Non responders n = 42.|80||
59878337|NCT04760314|76001909|FG002|COMPLETED|Induction Period|Completed includes Responders n = 65; Non responders n = 55.|120||
59878338|NCT04760314|76001910|FG003|COMPLETED|Induction Period||0||
59878339|NCT04760314|76001911|FG004|COMPLETED|Induction Period||0||
59878340|NCT04760314|76001912|FG005|COMPLETED|Induction Period||0||
59878341|NCT04760314|76001913|FG006|COMPLETED|Induction Period||0||
59878342|NCT04760314|76001914|FG007|COMPLETED|Induction Period||0||
59878343|NCT04760314|76001915|FG008|COMPLETED|Induction Period||0||
59878344|NCT04760314|76001916|FG009|COMPLETED|Induction Period||0||
59878345|NCT04760314|76001917|FG010|COMPLETED|Induction Period||0||
59878346|NCT04760314|76001907|FG000|NOT COMPLETED|Induction Period||0||
59878347|NCT04760314|76001908|FG001|NOT COMPLETED|Induction Period||1||
59878348|NCT04760314|76001909|FG002|NOT COMPLETED|Induction Period||3||
59878349|NCT04760314|76001910|FG003|NOT COMPLETED|Induction Period||0||
59878350|NCT04760314|76001911|FG004|NOT COMPLETED|Induction Period||0||
59878351|NCT04760314|76001912|FG005|NOT COMPLETED|Induction Period||0||
59878352|NCT04760314|76001913|FG006|NOT COMPLETED|Induction Period||0||
59878353|NCT04760314|76001914|FG007|NOT COMPLETED|Induction Period||0||
59878354|NCT04760314|76001915|FG008|NOT COMPLETED|Induction Period||0||
59878355|NCT04760314|76001916|FG009|NOT COMPLETED|Induction Period||0||
59878356|NCT04760314|76001917|FG010|NOT COMPLETED|Induction Period||0||
59878357|NCT04760314|76001907|FG000|STARTED|Maintenance Blinded Period|Participants were assigned to this arm only during Induction Period.|0||
59878358|NCT04760314|76001908|FG001|STARTED|Maintenance Blinded Period|Participants were assigned to this arm only during Induction Period.|0||
59878359|NCT04760314|76001909|FG002|STARTED|Maintenance Blinded Period|Participants were assigned to this arm only during Induction Period.|0||
59878360|NCT04760314|76001910|FG003|STARTED|Maintenance Blinded Period|Only those participants who responded to Induction Placebo or Lebrikizumab at Week 16 entered the Maintenance Period.|11||
59878361|NCT04760314|76001911|FG004|STARTED|Maintenance Blinded Period|Only those participants who responded to Induction Placebo or Lebrikizumab at Week 16 entered the Maintenance Period.|38||
59878362|NCT04760314|76001912|FG005|STARTED|Maintenance Blinded Period|Only those participants who responded to Induction Placebo or Lebrikizumab at Week 16 entered the Maintenance Period.|33||
59878363|NCT04760314|76001913|FG006|STARTED|Maintenance Blinded Period|Only those participants who responded to Induction Placebo or Lebrikizumab at Week 16 entered the Maintenance Period.|32||
59878364|NCT04760314|76001914|FG007|STARTED|Maintenance Blinded Period||0||
59878365|NCT04760314|76001915|FG008|STARTED|Maintenance Blinded Period||0||
59878366|NCT04760314|76001916|FG009|STARTED|Maintenance Blinded Period||0||
59878367|NCT04760314|76001917|FG010|STARTED|Maintenance Blinded Period||0||
59878368|NCT04760314|76001907|FG000|Received at Least One Dose of Study Drug|Maintenance Blinded Period||0||
59878369|NCT04760314|76001908|FG001|Received at Least One Dose of Study Drug|Maintenance Blinded Period||0||
59878370|NCT04760314|76001909|FG002|Received at Least One Dose of Study Drug|Maintenance Blinded Period||0||
59878371|NCT04760314|76001910|FG003|Received at Least One Dose of Study Drug|Maintenance Blinded Period||11||
59878372|NCT04760314|76001911|FG004|Received at Least One Dose of Study Drug|Maintenance Blinded Period||38||
59878373|NCT04760314|76001912|FG005|Received at Least One Dose of Study Drug|Maintenance Blinded Period||33||
59878374|NCT04760314|76001913|FG006|Received at Least One Dose of Study Drug|Maintenance Blinded Period||32||
59878375|NCT04760314|76001914|FG007|Received at Least One Dose of Study Drug|Maintenance Blinded Period||0||
59878376|NCT04760314|76001915|FG008|Received at Least One Dose of Study Drug|Maintenance Blinded Period||0||
59878377|NCT04760314|76001916|FG009|Received at Least One Dose of Study Drug|Maintenance Blinded Period||0||
59878378|NCT04760314|76001917|FG010|Received at Least One Dose of Study Drug|Maintenance Blinded Period||0||
59878379|NCT04760314|76001907|FG000|COMPLETED|Maintenance Blinded Period||0||
59878380|NCT04760314|76001908|FG001|COMPLETED|Maintenance Blinded Period||0||
59878381|NCT04760314|76001909|FG002|COMPLETED|Maintenance Blinded Period||0||
59878382|NCT04760314|76001910|FG003|COMPLETED|Maintenance Blinded Period||9||
59878383|NCT04760314|76001911|FG004|COMPLETED|Maintenance Blinded Period||35||
59878384|NCT04760314|76001912|FG005|COMPLETED|Maintenance Blinded Period||27||
59878385|NCT04760314|76001913|FG006|COMPLETED|Maintenance Blinded Period||27||
59878386|NCT04760314|76001914|FG007|COMPLETED|Maintenance Blinded Period||0||
59878387|NCT04760314|76001915|FG008|COMPLETED|Maintenance Blinded Period||0||
59878388|NCT04760314|76001916|FG009|COMPLETED|Maintenance Blinded Period||0||
59878389|NCT04760314|76001917|FG010|COMPLETED|Maintenance Blinded Period||0||
59878390|NCT04760314|76001907|FG000|NOT COMPLETED|Maintenance Blinded Period||0||
59878391|NCT04760314|76001908|FG001|NOT COMPLETED|Maintenance Blinded Period||0||
59878392|NCT04760314|76001909|FG002|NOT COMPLETED|Maintenance Blinded Period||0||
59878393|NCT04760314|76001910|FG003|NOT COMPLETED|Maintenance Blinded Period||2||
59878394|NCT04760314|76001911|FG004|NOT COMPLETED|Maintenance Blinded Period||3||
59878395|NCT04760314|76001912|FG005|NOT COMPLETED|Maintenance Blinded Period||6||
59878396|NCT04760314|76001913|FG006|NOT COMPLETED|Maintenance Blinded Period||5||
59878397|NCT04760314|76001914|FG007|NOT COMPLETED|Maintenance Blinded Period||0||
59878398|NCT04760314|76001915|FG008|NOT COMPLETED|Maintenance Blinded Period||0||
59878399|NCT04760314|76001916|FG009|NOT COMPLETED|Maintenance Blinded Period||0||
59878400|NCT04760314|76001917|FG010|NOT COMPLETED|Maintenance Blinded Period||0||
59878401|NCT04760314|76001907|FG000|STARTED|Maintenance Open Label Escape Arm||0||
59878402|NCT04760314|76001908|FG001|STARTED|Maintenance Open Label Escape Arm||0||
59878403|NCT04760314|76001909|FG002|STARTED|Maintenance Open Label Escape Arm||0||
59878404|NCT04760314|76001910|FG003|STARTED|Maintenance Open Label Escape Arm||0||
59878405|NCT04760314|76001911|FG004|STARTED|Maintenance Open Label Escape Arm||0||
59878406|NCT04760314|76001912|FG005|STARTED|Maintenance Open Label Escape Arm||0||
59878407|NCT04760314|76001913|FG006|STARTED|Maintenance Open Label Escape Arm||0||
59878408|NCT04760314|76001914|FG007|STARTED|Maintenance Open Label Escape Arm|Only those participants who did not respond to Induction Placebo or Lebrikizumab entered Escape Arm at Week 16.|71||
59878409|NCT04760314|76001915|FG008|STARTED|Maintenance Open Label Escape Arm|Only those participants who did not respond to Induction Placebo or Lebrikizumab entered Escape Arm at Week 16.|42||
59878410|NCT04760314|76001916|FG009|STARTED|Maintenance Open Label Escape Arm|Only those participants who did not respond to Induction Placebo or Lebrikizumab entered Escape Arm at Week 16.|55||
59878411|NCT04760314|76001917|FG010|STARTED|Maintenance Open Label Escape Arm|Only those participants who did not respond to treatment during maintenance period (i.e.) not maintaining an EASI-50 response at Weeks 20, 24, 28, 32, 36, 40, 44, 48, 52, 56, 60, or 64 were entered here.|8||
59878412|NCT04760314|76001907|FG000|Received at Least One Dose of Study Drug|Maintenance Open Label Escape Arm||0||
59878413|NCT04760314|76001908|FG001|Received at Least One Dose of Study Drug|Maintenance Open Label Escape Arm||0||
59878414|NCT04760314|76001909|FG002|Received at Least One Dose of Study Drug|Maintenance Open Label Escape Arm||0||
59878415|NCT04760314|76001910|FG003|Received at Least One Dose of Study Drug|Maintenance Open Label Escape Arm||0||
59878416|NCT04760314|76001911|FG004|Received at Least One Dose of Study Drug|Maintenance Open Label Escape Arm||0||
59878417|NCT04760314|76001912|FG005|Received at Least One Dose of Study Drug|Maintenance Open Label Escape Arm||0||
59878418|NCT04760314|76001913|FG006|Received at Least One Dose of Study Drug|Maintenance Open Label Escape Arm||0||
59878419|NCT04760314|76001914|FG007|Received at Least One Dose of Study Drug|Maintenance Open Label Escape Arm||71||
59878420|NCT04760314|76001915|FG008|Received at Least One Dose of Study Drug|Maintenance Open Label Escape Arm||42||
59878421|NCT04760314|76001916|FG009|Received at Least One Dose of Study Drug|Maintenance Open Label Escape Arm||55||
59878422|NCT04760314|76001917|FG010|Received at Least One Dose of Study Drug|Maintenance Open Label Escape Arm||8||
59878423|NCT04760314|76001907|FG000|COMPLETED|Maintenance Open Label Escape Arm||0||
59878424|NCT04760314|76001908|FG001|COMPLETED|Maintenance Open Label Escape Arm||0||
59878425|NCT04760314|76001909|FG002|COMPLETED|Maintenance Open Label Escape Arm||0||
59878426|NCT04760314|76001910|FG003|COMPLETED|Maintenance Open Label Escape Arm||0||
59878427|NCT04760314|76001911|FG004|COMPLETED|Maintenance Open Label Escape Arm||0||
59878428|NCT04760314|76001912|FG005|COMPLETED|Maintenance Open Label Escape Arm||0||
59878429|NCT04760314|76001913|FG006|COMPLETED|Maintenance Open Label Escape Arm||0||
59878430|NCT04760314|76001914|FG007|COMPLETED|Maintenance Open Label Escape Arm||63||
59878431|NCT04760314|76001915|FG008|COMPLETED|Maintenance Open Label Escape Arm||40||
59878432|NCT04760314|76001916|FG009|COMPLETED|Maintenance Open Label Escape Arm||48||
59878433|NCT04760314|76001917|FG010|COMPLETED|Maintenance Open Label Escape Arm||7||
59878434|NCT04760314|76001907|FG000|NOT COMPLETED|Maintenance Open Label Escape Arm||0||
59878435|NCT04760314|76001908|FG001|NOT COMPLETED|Maintenance Open Label Escape Arm||0||
59878436|NCT04760314|76001909|FG002|NOT COMPLETED|Maintenance Open Label Escape Arm||0||
59878437|NCT04760314|76001910|FG003|NOT COMPLETED|Maintenance Open Label Escape Arm||0||
59878438|NCT04760314|76001911|FG004|NOT COMPLETED|Maintenance Open Label Escape Arm||0||
59878439|NCT04760314|76001912|FG005|NOT COMPLETED|Maintenance Open Label Escape Arm||0||
59878440|NCT04760314|76001913|FG006|NOT COMPLETED|Maintenance Open Label Escape Arm||0||
59878441|NCT04760314|76001914|FG007|NOT COMPLETED|Maintenance Open Label Escape Arm||8||
59878442|NCT04760314|76001915|FG008|NOT COMPLETED|Maintenance Open Label Escape Arm||2||
59878443|NCT04760314|76001916|FG009|NOT COMPLETED|Maintenance Open Label Escape Arm||7||
59878444|NCT04760314|76001917|FG010|NOT COMPLETED|Maintenance Open Label Escape Arm||1||
59878445|NCT04615923|76001936|FG000|STARTED|Overall Study||120||
59878446|NCT04615923|76001937|FG001|STARTED|Overall Study||42||
59878447|NCT04615923|76001936|FG000|COMPLETED|Overall Study||96||
59878448|NCT04615923|76001937|FG001|COMPLETED|Overall Study||38||
59878449|NCT04615923|76001936|FG000|NOT COMPLETED|Overall Study||24||
59878450|NCT04615923|76001937|FG001|NOT COMPLETED|Overall Study||4||
59878451|NCT04493684|76001960|FG000|STARTED|Part 1:Treatment Period 1-Up to 9 Weeks||3||
59878452|NCT04493684|76001961|FG001|STARTED|Part 1:Treatment Period 1-Up to 9 Weeks||3||
59878453|NCT04493684|76001962|FG002|STARTED|Part 1:Treatment Period 1-Up to 9 Weeks||3||
59878454|NCT04493684|76001963|FG003|STARTED|Part 1:Treatment Period 1-Up to 9 Weeks||6||
59878455|NCT04493684|76001964|FG004|STARTED|Part 1:Treatment Period 1-Up to 9 Weeks||3||
59878456|NCT04493684|76001965|FG005|STARTED|Part 1:Treatment Period 1-Up to 9 Weeks||3||
59878457|NCT04493684|76001966|FG006|STARTED|Part 1:Treatment Period 1-Up to 9 Weeks||3||
59878458|NCT04493684|76001967|FG007|STARTED|Part 1:Treatment Period 1-Up to 9 Weeks||3||
59878459|NCT04493684|76001968|FG008|STARTED|Part 1:Treatment Period 1-Up to 9 Weeks||0||
59878460|NCT04493684|76001969|FG009|STARTED|Part 1:Treatment Period 1-Up to 9 Weeks||0||
59878461|NCT04493684|76001970|FG010|STARTED|Part 1:Treatment Period 1-Up to 9 Weeks||0||
59878462|NCT04493684|76001971|FG011|STARTED|Part 1:Treatment Period 1-Up to 9 Weeks||0||
59878463|NCT04493684|76001972|FG012|STARTED|Part 1:Treatment Period 1-Up to 9 Weeks||0||
59878464|NCT04493684|76001973|FG013|STARTED|Part 1:Treatment Period 1-Up to 9 Weeks||0||
59878465|NCT04493684|76001974|FG014|STARTED|Part 1:Treatment Period 1-Up to 9 Weeks||0||
59878466|NCT04493684|76001975|FG015|STARTED|Part 1:Treatment Period 1-Up to 9 Weeks||0||
59878467|NCT04493684|76001976|FG016|STARTED|Part 1:Treatment Period 1-Up to 9 Weeks||0||
59878468|NCT04493684|76001960|FG000|COMPLETED|Part 1:Treatment Period 1-Up to 9 Weeks||2||
59878469|NCT04493684|76001961|FG001|COMPLETED|Part 1:Treatment Period 1-Up to 9 Weeks||3||
59878470|NCT04493684|76001962|FG002|COMPLETED|Part 1:Treatment Period 1-Up to 9 Weeks||2||
59878471|NCT04493684|76001963|FG003|COMPLETED|Part 1:Treatment Period 1-Up to 9 Weeks||6||
59878472|NCT04493684|76001964|FG004|COMPLETED|Part 1:Treatment Period 1-Up to 9 Weeks||3||
59878473|NCT04493684|76001965|FG005|COMPLETED|Part 1:Treatment Period 1-Up to 9 Weeks||2||
59878474|NCT04493684|76001966|FG006|COMPLETED|Part 1:Treatment Period 1-Up to 9 Weeks||3||
59878475|NCT04493684|76001967|FG007|COMPLETED|Part 1:Treatment Period 1-Up to 9 Weeks||3||
59878476|NCT04493684|76001968|FG008|COMPLETED|Part 1:Treatment Period 1-Up to 9 Weeks||0||
59878477|NCT04493684|76001969|FG009|COMPLETED|Part 1:Treatment Period 1-Up to 9 Weeks||0||
59878478|NCT04493684|76001970|FG010|COMPLETED|Part 1:Treatment Period 1-Up to 9 Weeks||0||
59878479|NCT04493684|76001971|FG011|COMPLETED|Part 1:Treatment Period 1-Up to 9 Weeks||0||
59878480|NCT04493684|76001972|FG012|COMPLETED|Part 1:Treatment Period 1-Up to 9 Weeks||0||
59878481|NCT04493684|76001973|FG013|COMPLETED|Part 1:Treatment Period 1-Up to 9 Weeks||0||
59878482|NCT04493684|76001974|FG014|COMPLETED|Part 1:Treatment Period 1-Up to 9 Weeks||0||
59878483|NCT04493684|76001975|FG015|COMPLETED|Part 1:Treatment Period 1-Up to 9 Weeks||0||
59878484|NCT04493684|76001976|FG016|COMPLETED|Part 1:Treatment Period 1-Up to 9 Weeks||0||
59878485|NCT04493684|76001960|FG000|NOT COMPLETED|Part 1:Treatment Period 1-Up to 9 Weeks||1||
59878486|NCT04493684|76001961|FG001|NOT COMPLETED|Part 1:Treatment Period 1-Up to 9 Weeks||0||
59605406|NCT01994382|75715565|FG005|COMPLETED|Overall Study||0||
59878487|NCT04493684|76001962|FG002|NOT COMPLETED|Part 1:Treatment Period 1-Up to 9 Weeks||1||
59878488|NCT04493684|76001963|FG003|NOT COMPLETED|Part 1:Treatment Period 1-Up to 9 Weeks||0||
59878489|NCT04493684|76001964|FG004|NOT COMPLETED|Part 1:Treatment Period 1-Up to 9 Weeks||0||
59878490|NCT04493684|76001965|FG005|NOT COMPLETED|Part 1:Treatment Period 1-Up to 9 Weeks||1||
59878491|NCT04493684|76001966|FG006|NOT COMPLETED|Part 1:Treatment Period 1-Up to 9 Weeks||0||
59878492|NCT04493684|76001967|FG007|NOT COMPLETED|Part 1:Treatment Period 1-Up to 9 Weeks||0||
59878493|NCT04493684|76001968|FG008|NOT COMPLETED|Part 1:Treatment Period 1-Up to 9 Weeks||0||
59878494|NCT04493684|76001969|FG009|NOT COMPLETED|Part 1:Treatment Period 1-Up to 9 Weeks||0||
59878495|NCT04493684|76001970|FG010|NOT COMPLETED|Part 1:Treatment Period 1-Up to 9 Weeks||0||
59878496|NCT04493684|76001971|FG011|NOT COMPLETED|Part 1:Treatment Period 1-Up to 9 Weeks||0||
59878497|NCT04493684|76001972|FG012|NOT COMPLETED|Part 1:Treatment Period 1-Up to 9 Weeks||0||
59878498|NCT04493684|76001973|FG013|NOT COMPLETED|Part 1:Treatment Period 1-Up to 9 Weeks||0||
59878499|NCT04493684|76001974|FG014|NOT COMPLETED|Part 1:Treatment Period 1-Up to 9 Weeks||0||
59750162|NCT00570661|75869376|FG000|NOT COMPLETED|Overall Study||7||
59750163|NCT00934544|75869383|FG000|STARTED|Primary Endpoint Analysis (Interim)||146||
59878500|NCT04493684|76001975|FG015|NOT COMPLETED|Part 1:Treatment Period 1-Up to 9 Weeks||0||
59878501|NCT04493684|76001976|FG016|NOT COMPLETED|Part 1:Treatment Period 1-Up to 9 Weeks||0||
59878502|NCT04493684|76001960|FG000|STARTED|Part 1:Treatment Period 2-Up to 9 Weeks|2 additional participants were enrolled and dosed.|4||
59878503|NCT04493684|76001961|FG001|STARTED|Part 1:Treatment Period 2-Up to 9 Weeks||3||
59878504|NCT04493684|76001962|FG002|STARTED|Part 1:Treatment Period 2-Up to 9 Weeks|1 additional participant was enrolled and dosed.|3||
59878505|NCT04493684|76001963|FG003|STARTED|Part 1:Treatment Period 2-Up to 9 Weeks||0||
59750164|NCT00934544|75869384|FG001|STARTED|Primary Endpoint Analysis (Interim)||73||
59878506|NCT04493684|76001964|FG004|STARTED|Part 1:Treatment Period 2-Up to 9 Weeks||0||
59878507|NCT04493684|76001965|FG005|STARTED|Part 1:Treatment Period 2-Up to 9 Weeks|1 additional participant was enrolled and dosed.|3||
59878508|NCT04493684|76001966|FG006|STARTED|Part 1:Treatment Period 2-Up to 9 Weeks||3||
59878509|NCT04493684|76001967|FG007|STARTED|Part 1:Treatment Period 2-Up to 9 Weeks||3||
59878510|NCT04493684|76001968|FG008|STARTED|Part 1:Treatment Period 2-Up to 9 Weeks||0||
59878511|NCT04493684|76001969|FG009|STARTED|Part 1:Treatment Period 2-Up to 9 Weeks||0||
59878512|NCT04493684|76001970|FG010|STARTED|Part 1:Treatment Period 2-Up to 9 Weeks||0||
59878513|NCT04493684|76001971|FG011|STARTED|Part 1:Treatment Period 2-Up to 9 Weeks||0||
59878514|NCT04493684|76001972|FG012|STARTED|Part 1:Treatment Period 2-Up to 9 Weeks||0||
59878515|NCT04493684|76001973|FG013|STARTED|Part 1:Treatment Period 2-Up to 9 Weeks||0||
59878516|NCT04493684|76001974|FG014|STARTED|Part 1:Treatment Period 2-Up to 9 Weeks||0||
59878517|NCT04493684|76001975|FG015|STARTED|Part 1:Treatment Period 2-Up to 9 Weeks||0||
59878518|NCT04493684|76001976|FG016|STARTED|Part 1:Treatment Period 2-Up to 9 Weeks||0||
59878519|NCT04493684|76001960|FG000|COMPLETED|Part 1:Treatment Period 2-Up to 9 Weeks||3||
59878520|NCT04493684|76001961|FG001|COMPLETED|Part 1:Treatment Period 2-Up to 9 Weeks||3||
59878521|NCT04493684|76001962|FG002|COMPLETED|Part 1:Treatment Period 2-Up to 9 Weeks||3||
59878522|NCT04493684|76001963|FG003|COMPLETED|Part 1:Treatment Period 2-Up to 9 Weeks||0||
59878523|NCT04493684|76001964|FG004|COMPLETED|Part 1:Treatment Period 2-Up to 9 Weeks||0||
59878524|NCT04493684|76001965|FG005|COMPLETED|Part 1:Treatment Period 2-Up to 9 Weeks||3||
59878525|NCT04493684|76001966|FG006|COMPLETED|Part 1:Treatment Period 2-Up to 9 Weeks||2||
59878526|NCT04493684|76001967|FG007|COMPLETED|Part 1:Treatment Period 2-Up to 9 Weeks||3||
59878527|NCT04493684|76001968|FG008|COMPLETED|Part 1:Treatment Period 2-Up to 9 Weeks||0||
59878528|NCT04493684|76001969|FG009|COMPLETED|Part 1:Treatment Period 2-Up to 9 Weeks||0||
59878529|NCT04493684|76001970|FG010|COMPLETED|Part 1:Treatment Period 2-Up to 9 Weeks||0||
59878530|NCT04493684|76001971|FG011|COMPLETED|Part 1:Treatment Period 2-Up to 9 Weeks||0||
59750165|NCT00934544|75869385|FG002|STARTED|Primary Endpoint Analysis (Interim)||0||
59750166|NCT00934544|75869383|FG000|COMPLETED|Primary Endpoint Analysis (Interim)||91||
59750167|NCT00934544|75869384|FG001|COMPLETED|Primary Endpoint Analysis (Interim)||31||
59750168|NCT00934544|75869385|FG002|COMPLETED|Primary Endpoint Analysis (Interim)||0||
59750169|NCT00934544|75869383|FG000|NOT COMPLETED|Primary Endpoint Analysis (Interim)||55||
59750170|NCT00934544|75869384|FG001|NOT COMPLETED|Primary Endpoint Analysis (Interim)||42||
59762506|NCT00866619|75882228|FG002|NOT COMPLETED|Overall Study||889||
59878531|NCT04493684|76001972|FG012|COMPLETED|Part 1:Treatment Period 2-Up to 9 Weeks||0||
59878532|NCT04493684|76001973|FG013|COMPLETED|Part 1:Treatment Period 2-Up to 9 Weeks||0||
59878533|NCT04493684|76001974|FG014|COMPLETED|Part 1:Treatment Period 2-Up to 9 Weeks||0||
59878534|NCT04493684|76001975|FG015|COMPLETED|Part 1:Treatment Period 2-Up to 9 Weeks||0||
59878535|NCT04493684|76001976|FG016|COMPLETED|Part 1:Treatment Period 2-Up to 9 Weeks||0||
59878536|NCT04493684|76001960|FG000|NOT COMPLETED|Part 1:Treatment Period 2-Up to 9 Weeks||1||
59878537|NCT04493684|76001961|FG001|NOT COMPLETED|Part 1:Treatment Period 2-Up to 9 Weeks||0||
59878538|NCT04493684|76001962|FG002|NOT COMPLETED|Part 1:Treatment Period 2-Up to 9 Weeks||0||
59878539|NCT04493684|76001963|FG003|NOT COMPLETED|Part 1:Treatment Period 2-Up to 9 Weeks||0||
59878540|NCT04493684|76001964|FG004|NOT COMPLETED|Part 1:Treatment Period 2-Up to 9 Weeks||0||
59878541|NCT04493684|76001965|FG005|NOT COMPLETED|Part 1:Treatment Period 2-Up to 9 Weeks||0||
59878542|NCT04493684|76001966|FG006|NOT COMPLETED|Part 1:Treatment Period 2-Up to 9 Weeks||1||
59878543|NCT04493684|76001967|FG007|NOT COMPLETED|Part 1:Treatment Period 2-Up to 9 Weeks||0||
59878544|NCT04493684|76001968|FG008|NOT COMPLETED|Part 1:Treatment Period 2-Up to 9 Weeks||0||
59878545|NCT04493684|76001969|FG009|NOT COMPLETED|Part 1:Treatment Period 2-Up to 9 Weeks||0||
59878546|NCT04493684|76001970|FG010|NOT COMPLETED|Part 1:Treatment Period 2-Up to 9 Weeks||0||
59878547|NCT04493684|76001971|FG011|NOT COMPLETED|Part 1:Treatment Period 2-Up to 9 Weeks||0||
59878548|NCT04493684|76001972|FG012|NOT COMPLETED|Part 1:Treatment Period 2-Up to 9 Weeks||0||
59878549|NCT04493684|76001973|FG013|NOT COMPLETED|Part 1:Treatment Period 2-Up to 9 Weeks||0||
59878550|NCT04493684|76001974|FG014|NOT COMPLETED|Part 1:Treatment Period 2-Up to 9 Weeks||0||
59878551|NCT04493684|76001975|FG015|NOT COMPLETED|Part 1:Treatment Period 2-Up to 9 Weeks||0||
59878552|NCT04493684|76001976|FG016|NOT COMPLETED|Part 1:Treatment Period 2-Up to 9 Weeks||0||
59878553|NCT04493684|76001960|FG000|STARTED|Part 1:Treatment Period 3-Up to 9 Weeks|1 additional participant was enrolled and dosed.|4||
59878554|NCT04493684|76001961|FG001|STARTED|Part 1:Treatment Period 3-Up to 9 Weeks||3||
59878555|NCT04493684|76001962|FG002|STARTED|Part 1:Treatment Period 3-Up to 9 Weeks||3||
59878556|NCT04493684|76001963|FG003|STARTED|Part 1:Treatment Period 3-Up to 9 Weeks||0||
59878557|NCT04493684|76001964|FG004|STARTED|Part 1:Treatment Period 3-Up to 9 Weeks||0||
59878558|NCT04493684|76001965|FG005|STARTED|Part 1:Treatment Period 3-Up to 9 Weeks|1 additional participant was enrolled and dosed.|4||
59878559|NCT04493684|76001966|FG006|STARTED|Part 1:Treatment Period 3-Up to 9 Weeks|1 additional participant was enrolled and dosed.|3||
59878560|NCT04493684|76001967|FG007|STARTED|Part 1:Treatment Period 3-Up to 9 Weeks||3||
59878561|NCT04493684|76001968|FG008|STARTED|Part 1:Treatment Period 3-Up to 9 Weeks||0||
59878562|NCT04493684|76001969|FG009|STARTED|Part 1:Treatment Period 3-Up to 9 Weeks||0||
59878563|NCT04493684|76001970|FG010|STARTED|Part 1:Treatment Period 3-Up to 9 Weeks||0||
59878564|NCT04493684|76001971|FG011|STARTED|Part 1:Treatment Period 3-Up to 9 Weeks||0||
59878565|NCT04493684|76001972|FG012|STARTED|Part 1:Treatment Period 3-Up to 9 Weeks||0||
59878566|NCT04493684|76001973|FG013|STARTED|Part 1:Treatment Period 3-Up to 9 Weeks||0||
59878567|NCT04493684|76001974|FG014|STARTED|Part 1:Treatment Period 3-Up to 9 Weeks||0||
59878568|NCT04493684|76001975|FG015|STARTED|Part 1:Treatment Period 3-Up to 9 Weeks||0||
59878569|NCT04493684|76001976|FG016|STARTED|Part 1:Treatment Period 3-Up to 9 Weeks||0||
59878570|NCT04493684|76001960|FG000|COMPLETED|Part 1:Treatment Period 3-Up to 9 Weeks||3||
59878571|NCT04493684|76001961|FG001|COMPLETED|Part 1:Treatment Period 3-Up to 9 Weeks||3||
59878572|NCT04493684|76001962|FG002|COMPLETED|Part 1:Treatment Period 3-Up to 9 Weeks||3||
59878573|NCT04493684|76001963|FG003|COMPLETED|Part 1:Treatment Period 3-Up to 9 Weeks||0||
59878574|NCT04493684|76001964|FG004|COMPLETED|Part 1:Treatment Period 3-Up to 9 Weeks||0||
59878575|NCT04493684|76001965|FG005|COMPLETED|Part 1:Treatment Period 3-Up to 9 Weeks||3||
59878576|NCT04493684|76001966|FG006|COMPLETED|Part 1:Treatment Period 3-Up to 9 Weeks||3||
59878577|NCT04493684|76001967|FG007|COMPLETED|Part 1:Treatment Period 3-Up to 9 Weeks||3||
59878578|NCT04493684|76001968|FG008|COMPLETED|Part 1:Treatment Period 3-Up to 9 Weeks||0||
59878579|NCT04493684|76001969|FG009|COMPLETED|Part 1:Treatment Period 3-Up to 9 Weeks||0||
59878580|NCT04493684|76001970|FG010|COMPLETED|Part 1:Treatment Period 3-Up to 9 Weeks||0||
59878581|NCT04493684|76001971|FG011|COMPLETED|Part 1:Treatment Period 3-Up to 9 Weeks||0||
59878582|NCT04493684|76001972|FG012|COMPLETED|Part 1:Treatment Period 3-Up to 9 Weeks||0||
59878583|NCT04493684|76001973|FG013|COMPLETED|Part 1:Treatment Period 3-Up to 9 Weeks||0||
59878584|NCT04493684|76001974|FG014|COMPLETED|Part 1:Treatment Period 3-Up to 9 Weeks||0||
59878585|NCT04493684|76001975|FG015|COMPLETED|Part 1:Treatment Period 3-Up to 9 Weeks||0||
59878586|NCT04493684|76001976|FG016|COMPLETED|Part 1:Treatment Period 3-Up to 9 Weeks||0||
59878587|NCT04493684|76001960|FG000|NOT COMPLETED|Part 1:Treatment Period 3-Up to 9 Weeks||1||
59878588|NCT04493684|76001961|FG001|NOT COMPLETED|Part 1:Treatment Period 3-Up to 9 Weeks||0||
59878589|NCT04493684|76001962|FG002|NOT COMPLETED|Part 1:Treatment Period 3-Up to 9 Weeks||0||
59878590|NCT04493684|76001963|FG003|NOT COMPLETED|Part 1:Treatment Period 3-Up to 9 Weeks||0||
59878591|NCT04493684|76001964|FG004|NOT COMPLETED|Part 1:Treatment Period 3-Up to 9 Weeks||0||
59878592|NCT04493684|76001965|FG005|NOT COMPLETED|Part 1:Treatment Period 3-Up to 9 Weeks||1||
59878593|NCT04493684|76001966|FG006|NOT COMPLETED|Part 1:Treatment Period 3-Up to 9 Weeks||0||
59878594|NCT04493684|76001967|FG007|NOT COMPLETED|Part 1:Treatment Period 3-Up to 9 Weeks||0||
59878595|NCT04493684|76001968|FG008|NOT COMPLETED|Part 1:Treatment Period 3-Up to 9 Weeks||0||
59878596|NCT04493684|76001969|FG009|NOT COMPLETED|Part 1:Treatment Period 3-Up to 9 Weeks||0||
59878597|NCT04493684|76001970|FG010|NOT COMPLETED|Part 1:Treatment Period 3-Up to 9 Weeks||0||
59878598|NCT04493684|76001971|FG011|NOT COMPLETED|Part 1:Treatment Period 3-Up to 9 Weeks||0||
59878599|NCT04493684|76001972|FG012|NOT COMPLETED|Part 1:Treatment Period 3-Up to 9 Weeks||0||
59878600|NCT04493684|76001973|FG013|NOT COMPLETED|Part 1:Treatment Period 3-Up to 9 Weeks||0||
59878601|NCT04493684|76001974|FG014|NOT COMPLETED|Part 1:Treatment Period 3-Up to 9 Weeks||0||
59878602|NCT04493684|76001975|FG015|NOT COMPLETED|Part 1:Treatment Period 3-Up to 9 Weeks||0||
59878603|NCT04493684|76001976|FG016|NOT COMPLETED|Part 1:Treatment Period 3-Up to 9 Weeks||0||
59878604|NCT04493684|76001960|FG000|STARTED|Part 2:Treatment Period 1-Up to 5 Weeks||0||
59878605|NCT04493684|76001961|FG001|STARTED|Part 2:Treatment Period 1-Up to 5 Weeks||0||
59878606|NCT04493684|76001962|FG002|STARTED|Part 2:Treatment Period 1-Up to 5 Weeks||0||
59878607|NCT04493684|76001963|FG003|STARTED|Part 2:Treatment Period 1-Up to 5 Weeks||0||
59878608|NCT04493684|76001964|FG004|STARTED|Part 2:Treatment Period 1-Up to 5 Weeks||0||
59878609|NCT04493684|76001965|FG005|STARTED|Part 2:Treatment Period 1-Up to 5 Weeks||0||
59878610|NCT04493684|76001966|FG006|STARTED|Part 2:Treatment Period 1-Up to 5 Weeks||0||
59878611|NCT04493684|76001967|FG007|STARTED|Part 2:Treatment Period 1-Up to 5 Weeks||0||
59878612|NCT04493684|76001968|FG008|STARTED|Part 2:Treatment Period 1-Up to 5 Weeks||9||
59878613|NCT04493684|76001969|FG009|STARTED|Part 2:Treatment Period 1-Up to 5 Weeks||7||
59878614|NCT04493684|76001970|FG010|STARTED|Part 2:Treatment Period 1-Up to 5 Weeks||7||
59878615|NCT04493684|76001971|FG011|STARTED|Part 2:Treatment Period 1-Up to 5 Weeks||7||
59878616|NCT04493684|76001972|FG012|STARTED|Part 2:Treatment Period 1-Up to 5 Weeks||3||
59878617|NCT04493684|76001973|FG013|STARTED|Part 2:Treatment Period 1-Up to 5 Weeks||7||
59878618|NCT04493684|76001974|FG014|STARTED|Part 2:Treatment Period 1-Up to 5 Weeks||0||
59878619|NCT04493684|76001975|FG015|STARTED|Part 2:Treatment Period 1-Up to 5 Weeks||0||
59878620|NCT04493684|76001976|FG016|STARTED|Part 2:Treatment Period 1-Up to 5 Weeks||0||
59878621|NCT04493684|76001960|FG000|COMPLETED|Part 2:Treatment Period 1-Up to 5 Weeks||0||
59878622|NCT04493684|76001961|FG001|COMPLETED|Part 2:Treatment Period 1-Up to 5 Weeks||0||
59878623|NCT04493684|76001962|FG002|COMPLETED|Part 2:Treatment Period 1-Up to 5 Weeks||0||
59878624|NCT04493684|76001963|FG003|COMPLETED|Part 2:Treatment Period 1-Up to 5 Weeks||0||
59878625|NCT04493684|76001964|FG004|COMPLETED|Part 2:Treatment Period 1-Up to 5 Weeks||0||
59878626|NCT04493684|76001965|FG005|COMPLETED|Part 2:Treatment Period 1-Up to 5 Weeks||0||
59878627|NCT04493684|76001966|FG006|COMPLETED|Part 2:Treatment Period 1-Up to 5 Weeks||0||
59878628|NCT04493684|76001967|FG007|COMPLETED|Part 2:Treatment Period 1-Up to 5 Weeks||0||
59878629|NCT04493684|76001968|FG008|COMPLETED|Part 2:Treatment Period 1-Up to 5 Weeks||9||
59878630|NCT04493684|76001969|FG009|COMPLETED|Part 2:Treatment Period 1-Up to 5 Weeks||7||
59878631|NCT04493684|76001970|FG010|COMPLETED|Part 2:Treatment Period 1-Up to 5 Weeks||7||
59878632|NCT04493684|76001971|FG011|COMPLETED|Part 2:Treatment Period 1-Up to 5 Weeks||6||
59878633|NCT04493684|76001972|FG012|COMPLETED|Part 2:Treatment Period 1-Up to 5 Weeks||3||
59878634|NCT04493684|76001973|FG013|COMPLETED|Part 2:Treatment Period 1-Up to 5 Weeks||7||
59878635|NCT04493684|76001974|FG014|COMPLETED|Part 2:Treatment Period 1-Up to 5 Weeks||0||
59878636|NCT04493684|76001975|FG015|COMPLETED|Part 2:Treatment Period 1-Up to 5 Weeks||0||
59878637|NCT04493684|76001976|FG016|COMPLETED|Part 2:Treatment Period 1-Up to 5 Weeks||0||
59878638|NCT04493684|76001960|FG000|NOT COMPLETED|Part 2:Treatment Period 1-Up to 5 Weeks||0||
59878639|NCT04493684|76001961|FG001|NOT COMPLETED|Part 2:Treatment Period 1-Up to 5 Weeks||0||
59878640|NCT04493684|76001962|FG002|NOT COMPLETED|Part 2:Treatment Period 1-Up to 5 Weeks||0||
59878641|NCT04493684|76001963|FG003|NOT COMPLETED|Part 2:Treatment Period 1-Up to 5 Weeks||0||
59878642|NCT04493684|76001964|FG004|NOT COMPLETED|Part 2:Treatment Period 1-Up to 5 Weeks||0||
59878643|NCT04493684|76001965|FG005|NOT COMPLETED|Part 2:Treatment Period 1-Up to 5 Weeks||0||
59878644|NCT04493684|76001966|FG006|NOT COMPLETED|Part 2:Treatment Period 1-Up to 5 Weeks||0||
59878645|NCT04493684|76001967|FG007|NOT COMPLETED|Part 2:Treatment Period 1-Up to 5 Weeks||0||
59878646|NCT04493684|76001968|FG008|NOT COMPLETED|Part 2:Treatment Period 1-Up to 5 Weeks||0||
59878647|NCT04493684|76001969|FG009|NOT COMPLETED|Part 2:Treatment Period 1-Up to 5 Weeks||0||
59878648|NCT04493684|76001970|FG010|NOT COMPLETED|Part 2:Treatment Period 1-Up to 5 Weeks||0||
59878649|NCT04493684|76001971|FG011|NOT COMPLETED|Part 2:Treatment Period 1-Up to 5 Weeks||1||
59878650|NCT04493684|76001972|FG012|NOT COMPLETED|Part 2:Treatment Period 1-Up to 5 Weeks||0||
59878651|NCT04493684|76001973|FG013|NOT COMPLETED|Part 2:Treatment Period 1-Up to 5 Weeks||0||
59878652|NCT04493684|76001974|FG014|NOT COMPLETED|Part 2:Treatment Period 1-Up to 5 Weeks||0||
59878653|NCT04493684|76001975|FG015|NOT COMPLETED|Part 2:Treatment Period 1-Up to 5 Weeks||0||
59878654|NCT04493684|76001976|FG016|NOT COMPLETED|Part 2:Treatment Period 1-Up to 5 Weeks||0||
59878655|NCT04493684|76001960|FG000|STARTED|Part 3:Treatment Period 1-Up to 4 Weeks||0||
59878656|NCT04493684|76001961|FG001|STARTED|Part 3:Treatment Period 1-Up to 4 Weeks||0||
59878657|NCT04493684|76001962|FG002|STARTED|Part 3:Treatment Period 1-Up to 4 Weeks||0||
59878658|NCT04493684|76001963|FG003|STARTED|Part 3:Treatment Period 1-Up to 4 Weeks||0||
59878659|NCT04493684|76001964|FG004|STARTED|Part 3:Treatment Period 1-Up to 4 Weeks||0||
59878660|NCT04493684|76001965|FG005|STARTED|Part 3:Treatment Period 1-Up to 4 Weeks||0||
59878661|NCT04493684|76001966|FG006|STARTED|Part 3:Treatment Period 1-Up to 4 Weeks||0||
59878662|NCT04493684|76001967|FG007|STARTED|Part 3:Treatment Period 1-Up to 4 Weeks||0||
59878663|NCT04493684|76001968|FG008|STARTED|Part 3:Treatment Period 1-Up to 4 Weeks||0||
59878664|NCT04493684|76001969|FG009|STARTED|Part 3:Treatment Period 1-Up to 4 Weeks||0||
59878665|NCT04493684|76001970|FG010|STARTED|Part 3:Treatment Period 1-Up to 4 Weeks||0||
59878666|NCT04493684|76001971|FG011|STARTED|Part 3:Treatment Period 1-Up to 4 Weeks||0||
59878667|NCT04493684|76001972|FG012|STARTED|Part 3:Treatment Period 1-Up to 4 Weeks||0||
59878668|NCT04493684|76001973|FG013|STARTED|Part 3:Treatment Period 1-Up to 4 Weeks||0||
59878669|NCT04493684|76001974|FG014|STARTED|Part 3:Treatment Period 1-Up to 4 Weeks||5||
59878670|NCT04493684|76001975|FG015|STARTED|Part 3:Treatment Period 1-Up to 4 Weeks||6||
59878671|NCT04493684|76001976|FG016|STARTED|Part 3:Treatment Period 1-Up to 4 Weeks||6||
59878672|NCT04493684|76001960|FG000|COMPLETED|Part 3:Treatment Period 1-Up to 4 Weeks||0||
59878673|NCT04493684|76001961|FG001|COMPLETED|Part 3:Treatment Period 1-Up to 4 Weeks||0||
59878674|NCT04493684|76001962|FG002|COMPLETED|Part 3:Treatment Period 1-Up to 4 Weeks||0||
59878675|NCT04493684|76001963|FG003|COMPLETED|Part 3:Treatment Period 1-Up to 4 Weeks||0||
59878676|NCT04493684|76001964|FG004|COMPLETED|Part 3:Treatment Period 1-Up to 4 Weeks||0||
59878677|NCT04493684|76001965|FG005|COMPLETED|Part 3:Treatment Period 1-Up to 4 Weeks||0||
59878678|NCT04493684|76001966|FG006|COMPLETED|Part 3:Treatment Period 1-Up to 4 Weeks||0||
59878679|NCT04493684|76001967|FG007|COMPLETED|Part 3:Treatment Period 1-Up to 4 Weeks||0||
59878680|NCT04493684|76001968|FG008|COMPLETED|Part 3:Treatment Period 1-Up to 4 Weeks||0||
59878681|NCT04493684|76001969|FG009|COMPLETED|Part 3:Treatment Period 1-Up to 4 Weeks||0||
59878682|NCT04493684|76001970|FG010|COMPLETED|Part 3:Treatment Period 1-Up to 4 Weeks||0||
59878683|NCT04493684|76001971|FG011|COMPLETED|Part 3:Treatment Period 1-Up to 4 Weeks||0||
59878684|NCT04493684|76001972|FG012|COMPLETED|Part 3:Treatment Period 1-Up to 4 Weeks||0||
59878685|NCT04493684|76001973|FG013|COMPLETED|Part 3:Treatment Period 1-Up to 4 Weeks||0||
59878686|NCT04493684|76001974|FG014|COMPLETED|Part 3:Treatment Period 1-Up to 4 Weeks||5||
59878687|NCT04493684|76001975|FG015|COMPLETED|Part 3:Treatment Period 1-Up to 4 Weeks||5||
59878688|NCT04493684|76001976|FG016|COMPLETED|Part 3:Treatment Period 1-Up to 4 Weeks||6||
59878689|NCT04493684|76001960|FG000|NOT COMPLETED|Part 3:Treatment Period 1-Up to 4 Weeks||0||
59878690|NCT04493684|76001961|FG001|NOT COMPLETED|Part 3:Treatment Period 1-Up to 4 Weeks||0||
59878691|NCT04493684|76001962|FG002|NOT COMPLETED|Part 3:Treatment Period 1-Up to 4 Weeks||0||
59878692|NCT04493684|76001963|FG003|NOT COMPLETED|Part 3:Treatment Period 1-Up to 4 Weeks||0||
59878693|NCT04493684|76001964|FG004|NOT COMPLETED|Part 3:Treatment Period 1-Up to 4 Weeks||0||
59878694|NCT04493684|76001965|FG005|NOT COMPLETED|Part 3:Treatment Period 1-Up to 4 Weeks||0||
59878695|NCT04493684|76001966|FG006|NOT COMPLETED|Part 3:Treatment Period 1-Up to 4 Weeks||0||
59878696|NCT04493684|76001967|FG007|NOT COMPLETED|Part 3:Treatment Period 1-Up to 4 Weeks||0||
59878697|NCT04493684|76001968|FG008|NOT COMPLETED|Part 3:Treatment Period 1-Up to 4 Weeks||0||
59878698|NCT04493684|76001969|FG009|NOT COMPLETED|Part 3:Treatment Period 1-Up to 4 Weeks||0||
59878699|NCT04493684|76001970|FG010|NOT COMPLETED|Part 3:Treatment Period 1-Up to 4 Weeks||0||
59878700|NCT04493684|76001971|FG011|NOT COMPLETED|Part 3:Treatment Period 1-Up to 4 Weeks||0||
59878701|NCT04493684|76001972|FG012|NOT COMPLETED|Part 3:Treatment Period 1-Up to 4 Weeks||0||
59878702|NCT04493684|76001973|FG013|NOT COMPLETED|Part 3:Treatment Period 1-Up to 4 Weeks||0||
59878703|NCT04493684|76001974|FG014|NOT COMPLETED|Part 3:Treatment Period 1-Up to 4 Weeks||0||
59878704|NCT04493684|76001975|FG015|NOT COMPLETED|Part 3:Treatment Period 1-Up to 4 Weeks||1||
59878705|NCT04493684|76001976|FG016|NOT COMPLETED|Part 3:Treatment Period 1-Up to 4 Weeks||0||
59878706|NCT04493684|76001960|FG000|STARTED|Part 3:Treatment Period 2-Up to 4 Weeks||0||
59878707|NCT04493684|76001961|FG001|STARTED|Part 3:Treatment Period 2-Up to 4 Weeks||0||
59878708|NCT04493684|76001962|FG002|STARTED|Part 3:Treatment Period 2-Up to 4 Weeks||0||
59878709|NCT04493684|76001963|FG003|STARTED|Part 3:Treatment Period 2-Up to 4 Weeks||0||
59878710|NCT04493684|76001964|FG004|STARTED|Part 3:Treatment Period 2-Up to 4 Weeks||0||
59878711|NCT04493684|76001965|FG005|STARTED|Part 3:Treatment Period 2-Up to 4 Weeks||0||
59878712|NCT04493684|76001966|FG006|STARTED|Part 3:Treatment Period 2-Up to 4 Weeks||0||
59878713|NCT04493684|76001967|FG007|STARTED|Part 3:Treatment Period 2-Up to 4 Weeks||0||
59878714|NCT04493684|76001968|FG008|STARTED|Part 3:Treatment Period 2-Up to 4 Weeks||0||
59878715|NCT04493684|76001969|FG009|STARTED|Part 3:Treatment Period 2-Up to 4 Weeks||0||
59878716|NCT04493684|76001970|FG010|STARTED|Part 3:Treatment Period 2-Up to 4 Weeks||0||
59878717|NCT04493684|76001971|FG011|STARTED|Part 3:Treatment Period 2-Up to 4 Weeks||0||
59878718|NCT04493684|76001972|FG012|STARTED|Part 3:Treatment Period 2-Up to 4 Weeks||0||
59878719|NCT04493684|76001973|FG013|STARTED|Part 3:Treatment Period 2-Up to 4 Weeks||0||
59878720|NCT04493684|76001974|FG014|STARTED|Part 3:Treatment Period 2-Up to 4 Weeks||5||
59878721|NCT04493684|76001975|FG015|STARTED|Part 3:Treatment Period 2-Up to 4 Weeks||5||
59878722|NCT04493684|76001976|FG016|STARTED|Part 3:Treatment Period 2-Up to 4 Weeks||6||
59878723|NCT04493684|76001960|FG000|COMPLETED|Part 3:Treatment Period 2-Up to 4 Weeks||0||
59878724|NCT04493684|76001961|FG001|COMPLETED|Part 3:Treatment Period 2-Up to 4 Weeks||0||
59878725|NCT04493684|76001962|FG002|COMPLETED|Part 3:Treatment Period 2-Up to 4 Weeks||0||
59878726|NCT04493684|76001963|FG003|COMPLETED|Part 3:Treatment Period 2-Up to 4 Weeks||0||
59878727|NCT04493684|76001964|FG004|COMPLETED|Part 3:Treatment Period 2-Up to 4 Weeks||0||
60002541|NCT02061592|76118442|FG001|COMPLETED|Period 1||62||
59878728|NCT04493684|76001965|FG005|COMPLETED|Part 3:Treatment Period 2-Up to 4 Weeks||0||
59878729|NCT04493684|76001966|FG006|COMPLETED|Part 3:Treatment Period 2-Up to 4 Weeks||0||
59878730|NCT04493684|76001967|FG007|COMPLETED|Part 3:Treatment Period 2-Up to 4 Weeks||0||
59878731|NCT04493684|76001968|FG008|COMPLETED|Part 3:Treatment Period 2-Up to 4 Weeks||0||
59878732|NCT04493684|76001969|FG009|COMPLETED|Part 3:Treatment Period 2-Up to 4 Weeks||0||
59878733|NCT04493684|76001970|FG010|COMPLETED|Part 3:Treatment Period 2-Up to 4 Weeks||0||
59878734|NCT04493684|76001971|FG011|COMPLETED|Part 3:Treatment Period 2-Up to 4 Weeks||0||
59878735|NCT04493684|76001972|FG012|COMPLETED|Part 3:Treatment Period 2-Up to 4 Weeks||0||
59878736|NCT04493684|76001973|FG013|COMPLETED|Part 3:Treatment Period 2-Up to 4 Weeks||0||
59878737|NCT04493684|76001974|FG014|COMPLETED|Part 3:Treatment Period 2-Up to 4 Weeks||5||
59878738|NCT04493684|76001975|FG015|COMPLETED|Part 3:Treatment Period 2-Up to 4 Weeks||4||
59878739|NCT04493684|76001976|FG016|COMPLETED|Part 3:Treatment Period 2-Up to 4 Weeks||6||
59878740|NCT04493684|76001960|FG000|NOT COMPLETED|Part 3:Treatment Period 2-Up to 4 Weeks||0||
59878741|NCT04493684|76001961|FG001|NOT COMPLETED|Part 3:Treatment Period 2-Up to 4 Weeks||0||
59878742|NCT04493684|76001962|FG002|NOT COMPLETED|Part 3:Treatment Period 2-Up to 4 Weeks||0||
59878743|NCT04493684|76001963|FG003|NOT COMPLETED|Part 3:Treatment Period 2-Up to 4 Weeks||0||
59878744|NCT04493684|76001964|FG004|NOT COMPLETED|Part 3:Treatment Period 2-Up to 4 Weeks||0||
59878745|NCT04493684|76001965|FG005|NOT COMPLETED|Part 3:Treatment Period 2-Up to 4 Weeks||0||
59878746|NCT04493684|76001966|FG006|NOT COMPLETED|Part 3:Treatment Period 2-Up to 4 Weeks||0||
59878747|NCT04493684|76001967|FG007|NOT COMPLETED|Part 3:Treatment Period 2-Up to 4 Weeks||0||
59878748|NCT04493684|76001968|FG008|NOT COMPLETED|Part 3:Treatment Period 2-Up to 4 Weeks||0||
59878749|NCT04493684|76001969|FG009|NOT COMPLETED|Part 3:Treatment Period 2-Up to 4 Weeks||0||
59878750|NCT04493684|76001970|FG010|NOT COMPLETED|Part 3:Treatment Period 2-Up to 4 Weeks||0||
59878751|NCT04493684|76001971|FG011|NOT COMPLETED|Part 3:Treatment Period 2-Up to 4 Weeks||0||
59878752|NCT04493684|76001972|FG012|NOT COMPLETED|Part 3:Treatment Period 2-Up to 4 Weeks||0||
59878753|NCT04493684|76001973|FG013|NOT COMPLETED|Part 3:Treatment Period 2-Up to 4 Weeks||0||
59878754|NCT04493684|76001974|FG014|NOT COMPLETED|Part 3:Treatment Period 2-Up to 4 Weeks||0||
59878755|NCT04493684|76001975|FG015|NOT COMPLETED|Part 3:Treatment Period 2-Up to 4 Weeks||1||
59878756|NCT04493684|76001976|FG016|NOT COMPLETED|Part 3:Treatment Period 2-Up to 4 Weeks||0||
59878757|NCT04493684|76001960|FG000|STARTED|Part 3:Treatment Period 3-Up to 4 Weeks||0||
59878758|NCT04493684|76001961|FG001|STARTED|Part 3:Treatment Period 3-Up to 4 Weeks||0||
59878759|NCT04493684|76001962|FG002|STARTED|Part 3:Treatment Period 3-Up to 4 Weeks||0||
59878760|NCT04493684|76001963|FG003|STARTED|Part 3:Treatment Period 3-Up to 4 Weeks||0||
59878761|NCT04493684|76001964|FG004|STARTED|Part 3:Treatment Period 3-Up to 4 Weeks||0||
59878762|NCT04493684|76001965|FG005|STARTED|Part 3:Treatment Period 3-Up to 4 Weeks||0||
59878763|NCT04493684|76001966|FG006|STARTED|Part 3:Treatment Period 3-Up to 4 Weeks||0||
59878764|NCT04493684|76001967|FG007|STARTED|Part 3:Treatment Period 3-Up to 4 Weeks||0||
59878765|NCT04493684|76001968|FG008|STARTED|Part 3:Treatment Period 3-Up to 4 Weeks||0||
59878766|NCT04493684|76001969|FG009|STARTED|Part 3:Treatment Period 3-Up to 4 Weeks||0||
59878767|NCT04493684|76001970|FG010|STARTED|Part 3:Treatment Period 3-Up to 4 Weeks||0||
59878768|NCT04493684|76001971|FG011|STARTED|Part 3:Treatment Period 3-Up to 4 Weeks||0||
59878769|NCT04493684|76001972|FG012|STARTED|Part 3:Treatment Period 3-Up to 4 Weeks||0||
59878770|NCT04493684|76001973|FG013|STARTED|Part 3:Treatment Period 3-Up to 4 Weeks||0||
59878771|NCT04493684|76001974|FG014|STARTED|Part 3:Treatment Period 3-Up to 4 Weeks||5||
59878772|NCT04493684|76001975|FG015|STARTED|Part 3:Treatment Period 3-Up to 4 Weeks||4||
59878773|NCT04493684|76001976|FG016|STARTED|Part 3:Treatment Period 3-Up to 4 Weeks||6||
59878774|NCT04493684|76001960|FG000|COMPLETED|Part 3:Treatment Period 3-Up to 4 Weeks||0||
59878775|NCT04493684|76001961|FG001|COMPLETED|Part 3:Treatment Period 3-Up to 4 Weeks||0||
59878776|NCT04493684|76001962|FG002|COMPLETED|Part 3:Treatment Period 3-Up to 4 Weeks||0||
59605407|NCT01994382|75715566|FG006|COMPLETED|Overall Study||0||
59605408|NCT01994382|75715567|FG007|COMPLETED|Overall Study||0||
59605409|NCT01994382|75715568|FG008|COMPLETED|Overall Study||0||
59605410|NCT01994382|75715569|FG009|COMPLETED|Overall Study||0||
59605411|NCT01994382|75715570|FG010|COMPLETED|Overall Study||0||
59605412|NCT01994382|75715571|FG011|COMPLETED|Overall Study||0||
59605413|NCT01994382|75715572|FG012|COMPLETED|Overall Study||0||
59878777|NCT04493684|76001963|FG003|COMPLETED|Part 3:Treatment Period 3-Up to 4 Weeks||0||
59878778|NCT04493684|76001964|FG004|COMPLETED|Part 3:Treatment Period 3-Up to 4 Weeks||0||
59878779|NCT04493684|76001965|FG005|COMPLETED|Part 3:Treatment Period 3-Up to 4 Weeks||0||
59878780|NCT04493684|76001966|FG006|COMPLETED|Part 3:Treatment Period 3-Up to 4 Weeks||0||
59878781|NCT04493684|76001967|FG007|COMPLETED|Part 3:Treatment Period 3-Up to 4 Weeks||0||
59878782|NCT04493684|76001968|FG008|COMPLETED|Part 3:Treatment Period 3-Up to 4 Weeks||0||
59605414|NCT01994382|75715573|FG013|COMPLETED|Overall Study||0||
59605415|NCT01994382|75715574|FG014|COMPLETED|Overall Study||0||
59605416|NCT01994382|75715575|FG015|COMPLETED|Overall Study||0||
59605417|NCT01994382|75715576|FG016|COMPLETED|Overall Study||0||
59605418|NCT01994382|75715560|FG000|NOT COMPLETED|Overall Study||3||
59605419|NCT01994382|75715561|FG001|NOT COMPLETED|Overall Study||6||
59605420|NCT01994382|75715562|FG002|NOT COMPLETED|Overall Study||7||
59605421|NCT01994382|75715563|FG003|NOT COMPLETED|Overall Study||3||
59605422|NCT01994382|75715564|FG004|NOT COMPLETED|Overall Study||3||
59605423|NCT01994382|75715565|FG005|NOT COMPLETED|Overall Study||3||
59605424|NCT01994382|75715566|FG006|NOT COMPLETED|Overall Study||4||
59605425|NCT01994382|75715567|FG007|NOT COMPLETED|Overall Study||6||
59605426|NCT01994382|75715568|FG008|NOT COMPLETED|Overall Study||3||
59605427|NCT01994382|75715569|FG009|NOT COMPLETED|Overall Study||5||
59605428|NCT01994382|75715570|FG010|NOT COMPLETED|Overall Study||42||
59605429|NCT01994382|75715571|FG011|NOT COMPLETED|Overall Study||12||
59605430|NCT01994382|75715572|FG012|NOT COMPLETED|Overall Study||26||
59878783|NCT04493684|76001969|FG009|COMPLETED|Part 3:Treatment Period 3-Up to 4 Weeks||0||
59878784|NCT04493684|76001970|FG010|COMPLETED|Part 3:Treatment Period 3-Up to 4 Weeks||0||
59878785|NCT04493684|76001971|FG011|COMPLETED|Part 3:Treatment Period 3-Up to 4 Weeks||0||
59878786|NCT04493684|76001972|FG012|COMPLETED|Part 3:Treatment Period 3-Up to 4 Weeks||0||
59878787|NCT04493684|76001973|FG013|COMPLETED|Part 3:Treatment Period 3-Up to 4 Weeks||0||
59878788|NCT04493684|76001974|FG014|COMPLETED|Part 3:Treatment Period 3-Up to 4 Weeks||5||
59878789|NCT04493684|76001975|FG015|COMPLETED|Part 3:Treatment Period 3-Up to 4 Weeks||4||
59878790|NCT04493684|76001976|FG016|COMPLETED|Part 3:Treatment Period 3-Up to 4 Weeks||6||
59878791|NCT04493684|76001960|FG000|NOT COMPLETED|Part 3:Treatment Period 3-Up to 4 Weeks||0||
59878792|NCT04493684|76001961|FG001|NOT COMPLETED|Part 3:Treatment Period 3-Up to 4 Weeks||0||
59878793|NCT04493684|76001962|FG002|NOT COMPLETED|Part 3:Treatment Period 3-Up to 4 Weeks||0||
59878794|NCT04493684|76001963|FG003|NOT COMPLETED|Part 3:Treatment Period 3-Up to 4 Weeks||0||
59878795|NCT04493684|76001964|FG004|NOT COMPLETED|Part 3:Treatment Period 3-Up to 4 Weeks||0||
59878796|NCT04493684|76001965|FG005|NOT COMPLETED|Part 3:Treatment Period 3-Up to 4 Weeks||0||
59878797|NCT04493684|76001966|FG006|NOT COMPLETED|Part 3:Treatment Period 3-Up to 4 Weeks||0||
59878798|NCT04493684|76001967|FG007|NOT COMPLETED|Part 3:Treatment Period 3-Up to 4 Weeks||0||
59878799|NCT04493684|76001968|FG008|NOT COMPLETED|Part 3:Treatment Period 3-Up to 4 Weeks||0||
59878800|NCT04493684|76001969|FG009|NOT COMPLETED|Part 3:Treatment Period 3-Up to 4 Weeks||0||
59878801|NCT04493684|76001970|FG010|NOT COMPLETED|Part 3:Treatment Period 3-Up to 4 Weeks||0||
59878802|NCT04493684|76001971|FG011|NOT COMPLETED|Part 3:Treatment Period 3-Up to 4 Weeks||0||
59878803|NCT04493684|76001972|FG012|NOT COMPLETED|Part 3:Treatment Period 3-Up to 4 Weeks||0||
59878804|NCT04493684|76001973|FG013|NOT COMPLETED|Part 3:Treatment Period 3-Up to 4 Weeks||0||
59878805|NCT04493684|76001974|FG014|NOT COMPLETED|Part 3:Treatment Period 3-Up to 4 Weeks||0||
59878806|NCT04493684|76001975|FG015|NOT COMPLETED|Part 3:Treatment Period 3-Up to 4 Weeks||0||
59878807|NCT04493684|76001976|FG016|NOT COMPLETED|Part 3:Treatment Period 3-Up to 4 Weeks||0||
59878808|NCT04299438|76002032|FG000|STARTED|Overall Study||84||
59878809|NCT04299438|76002033|FG001|STARTED|Overall Study||80||
59878810|NCT04299438|76002032|FG000|COMPLETED|Overall Study||84||
59878811|NCT04299438|76002033|FG001|COMPLETED|Overall Study||80||
59878812|NCT04299438|76002032|FG000|NOT COMPLETED|Overall Study||0||
59878813|NCT04299438|76002033|FG001|NOT COMPLETED|Overall Study||0||
59878814|NCT04289298|76002041|FG000|STARTED|Overall Study||22||
59878815|NCT04289298|76002042|FG001|STARTED|Overall Study||4||
59878816|NCT04289298|76002041|FG000|COMPLETED|Overall Study||15||
59878817|NCT04289298|76002042|FG001|COMPLETED|Overall Study||4||
59878818|NCT04289298|76002041|FG000|NOT COMPLETED|Overall Study||7||
59878819|NCT04289298|76002042|FG001|NOT COMPLETED|Overall Study||0||
59878820|NCT04116710|76002053|FG000|STARTED|Overall Study||4||
59878821|NCT04116710|76002054|FG001|STARTED|Overall Study||6||
59878822|NCT04116710|76002055|FG002|STARTED|Overall Study||3||
59878823|NCT04116710|76002056|FG003|STARTED|Overall Study||2||
59878824|NCT04116710|76002053|FG000|Disease Progression|Overall Study||4||
59878825|NCT04116710|76002054|FG001|Disease Progression|Overall Study||6||
59878826|NCT04116710|76002055|FG002|Disease Progression|Overall Study||2||
59878827|NCT04116710|76002056|FG003|Disease Progression|Overall Study||2||
59878828|NCT04116710|76002053|FG000|COMPLETED|Overall Study||0||
59878829|NCT04116710|76002054|FG001|COMPLETED|Overall Study||0||
59878830|NCT04116710|76002055|FG002|COMPLETED|Overall Study||0||
59878831|NCT04116710|76002056|FG003|COMPLETED|Overall Study||0||
59878832|NCT04116710|76002053|FG000|NOT COMPLETED|Overall Study||4||
59878833|NCT04116710|76002054|FG001|NOT COMPLETED|Overall Study||6||
59878834|NCT04116710|76002055|FG002|NOT COMPLETED|Overall Study||3||
59878835|NCT04116710|76002056|FG003|NOT COMPLETED|Overall Study||2||
59878836|NCT03736629|76002069|FG000|STARTED|Overall Study||3||
59878837|NCT03736629|76002070|FG001|STARTED|Overall Study||2||
59878838|NCT03736629|76002071|FG002|STARTED|Overall Study||12||
59878839|NCT03736629|76002069|FG000|COMPLETED|Overall Study||3||
59878840|NCT03736629|76002070|FG001|COMPLETED|Overall Study||2||
59878841|NCT03736629|76002071|FG002|COMPLETED|Overall Study||12||
59878842|NCT03736629|76002069|FG000|NOT COMPLETED|Overall Study||0||
59878843|NCT03736629|76002070|FG001|NOT COMPLETED|Overall Study||0||
59878844|NCT03736629|76002071|FG002|NOT COMPLETED|Overall Study||0||
59878845|NCT03656380|76002080|FG000|STARTED|Overall Study||32||
59878846|NCT03656380|76002081|FG001|STARTED|Overall Study||34||
59878847|NCT03656380|76002080|FG000|Received Intervention|Overall Study||32||
59878848|NCT03656380|76002081|FG001|Received Intervention|Overall Study||33||
59878849|NCT03656380|76002080|FG000|Completed Month 3|Overall Study||31||
59878850|NCT03656380|76002081|FG001|Completed Month 3|Overall Study||33||
59878851|NCT03656380|76002080|FG000|Subsequent 3 Months of Treatment (Part 2)|Overall Study||28||
59878852|NCT03656380|76002081|FG001|Subsequent 3 Months of Treatment (Part 2)|Overall Study||28||
59878853|NCT03656380|76002080|FG000|Completed Month 6|Overall Study||28||
59878854|NCT03656380|76002081|FG001|Completed Month 6|Overall Study||28||
59878855|NCT03656380|76002080|FG000|COMPLETED|Overall Study||27||
59878856|NCT03656380|76002081|FG001|COMPLETED|Overall Study||26||
59878857|NCT03656380|76002080|FG000|NOT COMPLETED|Overall Study||5||
59878858|NCT03656380|76002081|FG001|NOT COMPLETED|Overall Study||8||
59878859|NCT03424304|76002089|FG000|STARTED|Overall Study||20||
59750171|NCT00934544|75869385|FG002|NOT COMPLETED|Primary Endpoint Analysis (Interim)||0||
59750172|NCT00934544|75869383|FG000|STARTED|Overall Disposition at 5 Year Follow-up||146||
59750173|NCT00934544|75869384|FG001|STARTED|Overall Disposition at 5 Year Follow-up||28||
59750174|NCT00934544|75869385|FG002|STARTED|Overall Disposition at 5 Year Follow-up||45||
59750175|NCT00934544|75869383|FG000|Crossed Over After Qualifying Event|Overall Disposition at 5 Year Follow-up||0||
59750176|NCT00934544|75869384|FG001|Crossed Over After Qualifying Event|Overall Disposition at 5 Year Follow-up||0||
59750177|NCT00934544|75869385|FG002|Crossed Over After Qualifying Event|Overall Disposition at 5 Year Follow-up||27||
59750178|NCT00934544|75869383|FG000|Crossed Over After AMEND 5|Overall Disposition at 5 Year Follow-up||0||
59750179|NCT00934544|75869384|FG001|Crossed Over After AMEND 5|Overall Disposition at 5 Year Follow-up||0||
59750180|NCT00934544|75869385|FG002|Crossed Over After AMEND 5|Overall Disposition at 5 Year Follow-up||12||
59750181|NCT00934544|75869383|FG000|Crossed Over: Other|Overall Disposition at 5 Year Follow-up||0||
59750182|NCT00934544|75869384|FG001|Crossed Over: Other|Overall Disposition at 5 Year Follow-up||0||
59750183|NCT00934544|75869385|FG002|Crossed Over: Other|Overall Disposition at 5 Year Follow-up||6||
59750184|NCT00934544|75869383|FG000|COMPLETED|Overall Disposition at 5 Year Follow-up||39||
59750185|NCT00934544|75869384|FG001|COMPLETED|Overall Disposition at 5 Year Follow-up||0||
59750186|NCT00934544|75869385|FG002|COMPLETED|Overall Disposition at 5 Year Follow-up||11||
59750187|NCT00934544|75869383|FG000|NOT COMPLETED|Overall Disposition at 5 Year Follow-up||107||
59750188|NCT00934544|75869384|FG001|NOT COMPLETED|Overall Disposition at 5 Year Follow-up||28||
59750189|NCT00934544|75869385|FG002|NOT COMPLETED|Overall Disposition at 5 Year Follow-up||34||
59750190|NCT00999167|75869404|FG000|STARTED|Part A: Open Label Safety run-in||15||
59750191|NCT00999167|75869405|FG001|STARTED|Part A: Open Label Safety run-in||0||
59750192|NCT00999167|75869406|FG002|STARTED|Part A: Open Label Safety run-in||0||
59750193|NCT00999167|75869404|FG000|Received 9 mL BID|Part A: Open Label Safety run-in||15||
59750194|NCT00999167|75869405|FG001|Received 9 mL BID|Part A: Open Label Safety run-in||0||
59750195|NCT00999167|75869406|FG002|Received 9 mL BID|Part A: Open Label Safety run-in||0||
59750196|NCT00999167|75869404|FG000|COMPLETED|Part A: Open Label Safety run-in||8||
59750197|NCT00999167|75869405|FG001|COMPLETED|Part A: Open Label Safety run-in||0||
59750198|NCT00999167|75869406|FG002|COMPLETED|Part A: Open Label Safety run-in||0||
59750199|NCT00999167|75869404|FG000|NOT COMPLETED|Part A: Open Label Safety run-in||7||
59750200|NCT00999167|75869405|FG001|NOT COMPLETED|Part A: Open Label Safety run-in||0||
59750201|NCT00999167|75869406|FG002|NOT COMPLETED|Part A: Open Label Safety run-in||0||
59750202|NCT00999167|75869404|FG000|STARTED|Part B: Randomized, Placebo Controlled||0||
59750203|NCT00999167|75869405|FG001|STARTED|Part B: Randomized, Placebo Controlled|4 subjects who participated in Part A enrolled in Part B and remainder were newly enrolled|90||
59750204|NCT00999167|75869406|FG002|STARTED|Part B: Randomized, Placebo Controlled||88||
59750205|NCT00999167|75869404|FG000|COMPLETED|Part B: Randomized, Placebo Controlled||0||
59750206|NCT00999167|75869405|FG001|COMPLETED|Part B: Randomized, Placebo Controlled||55||
59750207|NCT00999167|75869406|FG002|COMPLETED|Part B: Randomized, Placebo Controlled||67||
59750208|NCT00999167|75869404|FG000|NOT COMPLETED|Part B: Randomized, Placebo Controlled||0||
59750209|NCT00999167|75869405|FG001|NOT COMPLETED|Part B: Randomized, Placebo Controlled||35||
59750210|NCT00999167|75869406|FG002|NOT COMPLETED|Part B: Randomized, Placebo Controlled||21||
59750211|NCT00570505|75869416|FG000|STARTED|Overall Study||149||
59750212|NCT00570505|75869416|FG000|COMPLETED|Overall Study|The number of subjects completing the 60-month study|108||
59750213|NCT00570505|75869416|FG000|NOT COMPLETED|Overall Study||41||
59750214|NCT00931892|75869422|FG000|STARTED|Completed Gluten Challenge||10||
59750215|NCT00931892|75869423|FG001|STARTED|Completed Gluten Challenge||10||
59750216|NCT00931892|75869422|FG000|COMPLETED|Completed Gluten Challenge||10||
59750217|NCT00931892|75869423|FG001|COMPLETED|Completed Gluten Challenge||10||
59750218|NCT00931892|75869422|FG000|NOT COMPLETED|Completed Gluten Challenge||0||
59750219|NCT00931892|75869423|FG001|NOT COMPLETED|Completed Gluten Challenge||0||
59750220|NCT00931892|75869422|FG000|STARTED|Completed Endoscopies||10||
59750221|NCT00931892|75869423|FG001|STARTED|Completed Endoscopies||10||
59750222|NCT00931892|75869422|FG000|First Endoscopy|Completed Endoscopies||10||
59750223|NCT00931892|75869423|FG001|First Endoscopy|Completed Endoscopies||10||
59750224|NCT00931892|75869422|FG000|Second Endoscopy|Completed Endoscopies||10||
59750225|NCT00931892|75869423|FG001|Second Endoscopy|Completed Endoscopies||10||
59750226|NCT00931892|75869422|FG000|Third Endoscopy|Completed Endoscopies||10||
59750227|NCT00931892|75869423|FG001|Third Endoscopy|Completed Endoscopies||9||
59750228|NCT00931892|75869422|FG000|COMPLETED|Completed Endoscopies||10||
59750229|NCT00931892|75869423|FG001|COMPLETED|Completed Endoscopies||9||
59750230|NCT00931892|75869422|FG000|NOT COMPLETED|Completed Endoscopies||0||
59750231|NCT00931892|75869423|FG001|NOT COMPLETED|Completed Endoscopies||1||
59750232|NCT00666211|75869471|FG000|STARTED|Overall Study||42||
59750233|NCT00666211|75869472|FG001|STARTED|Overall Study||56||
59750234|NCT00666211|75869471|FG000|COMPLETED|Overall Study||22||
59750235|NCT00666211|75869472|FG001|COMPLETED|Overall Study||18||
59750236|NCT00666211|75869471|FG000|NOT COMPLETED|Overall Study||20||
59750237|NCT00666211|75869472|FG001|NOT COMPLETED|Overall Study||38||
59750238|NCT00878709|75869480|FG000|STARTED|Overall Study||1420||
59750239|NCT00878709|75869481|FG001|STARTED|Overall Study||1420||
59750240|NCT00878709|75869480|FG000|COMPLETED|Overall Study||1095||
59878860|NCT03424304|76002089|FG000|COMPLETED|Overall Study||19||
59878861|NCT03424304|76002089|FG000|NOT COMPLETED|Overall Study||1||
59878862|NCT02946515|76002095|FG000|STARTED|Overall Study||22||
59878863|NCT02946515|76002096|FG001|STARTED|Overall Study||22||
59878864|NCT02946515|76002095|FG000|COMPLETED|Overall Study||20||
59878865|NCT02946515|76002096|FG001|COMPLETED|Overall Study||21||
59878866|NCT02946515|76002095|FG000|NOT COMPLETED|Overall Study||2||
59878867|NCT02946515|76002096|FG001|NOT COMPLETED|Overall Study||1||
59878868|NCT02830594|76002102|FG000|STARTED|Overall Study||14||
59878869|NCT02830594|76002102|FG000|COMPLETED|Overall Study||14||
59878870|NCT02830594|76002102|FG000|NOT COMPLETED|Overall Study||0||
59878871|NCT02586623|76002109|FG000|STARTED|Open-Label (Up to 16 Weeks)||453||
59878872|NCT02586623|76002110|FG001|STARTED|Open-Label (Up to 16 Weeks)||0||
59878873|NCT02586623|76002111|FG002|STARTED|Open-Label (Up to 16 Weeks)||0||
59878874|NCT02586623|76002109|FG000|Received at Least 1 Dose of Study Drug|Open-Label (Up to 16 Weeks)||451||
59878875|NCT02586623|76002110|FG001|Received at Least 1 Dose of Study Drug|Open-Label (Up to 16 Weeks)||0||
59878876|NCT02586623|76002111|FG002|Received at Least 1 Dose of Study Drug|Open-Label (Up to 16 Weeks)||0||
59878877|NCT02586623|76002109|FG000|Safety Set|Open-Label (Up to 16 Weeks)||451||
59878878|NCT02586623|76002110|FG001|Safety Set|Open-Label (Up to 16 Weeks)||0||
59878879|NCT02586623|76002111|FG002|Safety Set|Open-Label (Up to 16 Weeks)||0||
59878880|NCT02586623|76002109|FG000|COMPLETED|Open-Label (Up to 16 Weeks)||253||
59878881|NCT02586623|76002110|FG001|COMPLETED|Open-Label (Up to 16 Weeks)||0||
59878882|NCT02586623|76002111|FG002|COMPLETED|Open-Label (Up to 16 Weeks)||0||
59878883|NCT02586623|76002109|FG000|NOT COMPLETED|Open-Label (Up to 16 Weeks)||200||
59878884|NCT02586623|76002110|FG001|NOT COMPLETED|Open-Label (Up to 16 Weeks)||0||
59878885|NCT02586623|76002111|FG002|NOT COMPLETED|Open-Label (Up to 16 Weeks)||0||
59878886|NCT02586623|76002109|FG000|STARTED|Double-Blind (Up to 12 Weeks)||0||
59878887|NCT02586623|76002110|FG001|STARTED|Double-Blind (Up to 12 Weeks)||127||
59878888|NCT02586623|76002111|FG002|STARTED|Double-Blind (Up to 12 Weeks)||126||
59878889|NCT02586623|76002109|FG000|Received at Least 1 Dose of Study Drug|Double-Blind (Up to 12 Weeks)||0||
59878890|NCT02586623|76002110|FG001|Received at Least 1 Dose of Study Drug|Double-Blind (Up to 12 Weeks)||126||
59878891|NCT02586623|76002111|FG002|Received at Least 1 Dose of Study Drug|Double-Blind (Up to 12 Weeks)||126||
59878892|NCT02586623|76002109|FG000|Full Analysis Set (FAS)|Double-Blind (Up to 12 Weeks)||0||
59878893|NCT02586623|76002110|FG001|Full Analysis Set (FAS)|Double-Blind (Up to 12 Weeks)||126||
59878894|NCT02586623|76002111|FG002|Full Analysis Set (FAS)|Double-Blind (Up to 12 Weeks)||126||
59878895|NCT02586623|76002109|FG000|COMPLETED|Double-Blind (Up to 12 Weeks)||0||
59878896|NCT02586623|76002110|FG001|COMPLETED|Double-Blind (Up to 12 Weeks)||78||
59878897|NCT02586623|76002111|FG002|COMPLETED|Double-Blind (Up to 12 Weeks)||86||
59878898|NCT02586623|76002109|FG000|NOT COMPLETED|Double-Blind (Up to 12 Weeks)||0||
59878899|NCT02586623|76002110|FG001|NOT COMPLETED|Double-Blind (Up to 12 Weeks)||49||
59878900|NCT02586623|76002111|FG002|NOT COMPLETED|Double-Blind (Up to 12 Weeks)||40||
59878901|NCT01819831|76002118|FG000|STARTED|Overall Study||7||
59878902|NCT01819831|76002118|FG000|COMPLETED|Overall Study||6||
59878903|NCT01819831|76002118|FG000|NOT COMPLETED|Overall Study||1||
59878904|NCT01622543|76002124|FG000|STARTED|Overall Study||51||
59878905|NCT01622543|76002125|FG001|STARTED|Overall Study||52||
59878906|NCT01622543|76002124|FG000|COMPLETED|Overall Study||51||
59878907|NCT01622543|76002125|FG001|COMPLETED|Overall Study||52||
59878908|NCT01622543|76002124|FG000|NOT COMPLETED|Overall Study||0||
59878909|NCT01622543|76002125|FG001|NOT COMPLETED|Overall Study||0||
59878910|NCT00078949|76002135|FG000|STARTED|Overall Study||310||
59878911|NCT00078949|76002136|FG001|STARTED|Overall Study||309||
59878912|NCT00078949|76002137|FG002|STARTED|Overall Study||115||
59878913|NCT00078949|76002138|FG003|STARTED|Overall Study||115||
59878914|NCT00078949|76002135|FG000|COMPLETED|Overall Study||306||
59878915|NCT00078949|76002136|FG001|COMPLETED|Overall Study||304||
59878916|NCT00078949|76002137|FG002|COMPLETED|Overall Study||112||
59878917|NCT00078949|76002138|FG003|COMPLETED|Overall Study||112||
59878918|NCT00078949|76002135|FG000|NOT COMPLETED|Overall Study||4||
59878919|NCT00078949|76002136|FG001|NOT COMPLETED|Overall Study||5||
59878920|NCT00078949|76002137|FG002|NOT COMPLETED|Overall Study||3||
59878921|NCT00078949|76002138|FG003|NOT COMPLETED|Overall Study||3||
59878922|NCT03739203|76002153|FG000|STARTED|Double-blind Treatment Period (6 Weeks)||250||
59878923|NCT03739203|76002154|FG001|STARTED|Double-blind Treatment Period (6 Weeks)||250||
59878924|NCT03739203|76002155|FG002|STARTED|Double-blind Treatment Period (6 Weeks)||251||
59878925|NCT03739203|76002153|FG000|Modified Intent-to Treat (mITT) Population|Double-blind Treatment Period (6 Weeks)||249|mITT population included all randomized participants who had ≥1 postbaseline assessment of the Montgomery-Asberg Depression Rating Scale (MADRS) total score.|
59878926|NCT03739203|76002154|FG001|Modified Intent-to Treat (mITT) Population|Double-blind Treatment Period (6 Weeks)||250|mITT population included all randomized participants who had ≥1 postbaseline assessment of the Montgomery-Asberg Depression Rating Scale (MADRS) total score.|
59878927|NCT03739203|76002155|FG002|Modified Intent-to Treat (mITT) Population|Double-blind Treatment Period (6 Weeks)||251|mITT population included all randomized participants who had ≥1 postbaseline assessment of the Montgomery-Asberg Depression Rating Scale (MADRS) total score.|
59878928|NCT03739203|76002153|FG000|COMPLETED|Double-blind Treatment Period (6 Weeks)||235||
59878929|NCT03739203|76002154|FG001|COMPLETED|Double-blind Treatment Period (6 Weeks)||233||
59950760|NCT03140670|76069606|FG000|COMPLETED|Overall Study||42||
59878930|NCT03739203|76002155|FG002|COMPLETED|Double-blind Treatment Period (6 Weeks)||226||
59878931|NCT03739203|76002153|FG000|NOT COMPLETED|Double-blind Treatment Period (6 Weeks)||15||
59878932|NCT03739203|76002154|FG001|NOT COMPLETED|Double-blind Treatment Period (6 Weeks)||17||
59878933|NCT03739203|76002155|FG002|NOT COMPLETED|Double-blind Treatment Period (6 Weeks)||25||
59878934|NCT03739203|76002153|FG000|STARTED|Safety Follow-Up Period (4 Weeks)||242|As per protocol-defined criteria, some of the participants discontinued from the Double-blind Period but entered the Safety Follow-up Period.|
59878935|NCT03739203|76002154|FG001|STARTED|Safety Follow-Up Period (4 Weeks)||242|As per protocol-defined criteria, some of the participants discontinued from the Double-blind Period but entered the Safety Follow-up Period.|
59878936|NCT03739203|76002155|FG002|STARTED|Safety Follow-Up Period (4 Weeks)||242|As per protocol-defined criteria, some of the participants discontinued from the Double-blind Period but entered the Safety Follow-up Period.|
59878937|NCT03739203|76002153|FG000|COMPLETED|Safety Follow-Up Period (4 Weeks)||240||
59878938|NCT03739203|76002154|FG001|COMPLETED|Safety Follow-Up Period (4 Weeks)||240||
59878939|NCT03739203|76002155|FG002|COMPLETED|Safety Follow-Up Period (4 Weeks)||238||
59878940|NCT03739203|76002153|FG000|NOT COMPLETED|Safety Follow-Up Period (4 Weeks)||2||
59878941|NCT03739203|76002154|FG001|NOT COMPLETED|Safety Follow-Up Period (4 Weeks)||2||
59878942|NCT03739203|76002155|FG002|NOT COMPLETED|Safety Follow-Up Period (4 Weeks)||4||
59878943|NCT02942264|76002172|FG000|STARTED|Phase 1 MTD Finding Stage||6||
59878944|NCT02942264|76002173|FG001|STARTED|Phase 1 MTD Finding Stage||13||
59878945|NCT02942264|76002174|FG002|STARTED|Phase 1 MTD Finding Stage||3||
59878946|NCT02942264|76002175|FG003|STARTED|Phase 1 MTD Finding Stage||6||
59878947|NCT02942264|76002176|FG004|STARTED|Phase 1 MTD Finding Stage||3||
59878948|NCT02942264|76002177|FG005|STARTED|Phase 1 MTD Finding Stage||2||
59878949|NCT02942264|76002178|FG006|STARTED|Phase 1 MTD Finding Stage||7||
59878950|NCT02942264|76002179|FG007|STARTED|Phase 1 MTD Finding Stage||0||
59878951|NCT02942264|76002180|FG008|STARTED|Phase 1 MTD Finding Stage||0||
59878952|NCT02942264|76002172|FG000|COMPLETED|Phase 1 MTD Finding Stage||6||
59878953|NCT02942264|76002173|FG001|COMPLETED|Phase 1 MTD Finding Stage||12||
59878954|NCT02942264|76002174|FG002|COMPLETED|Phase 1 MTD Finding Stage||3||
59878955|NCT02942264|76002175|FG003|COMPLETED|Phase 1 MTD Finding Stage||6||
59878956|NCT02942264|76002176|FG004|COMPLETED|Phase 1 MTD Finding Stage||3||
59878957|NCT02942264|76002177|FG005|COMPLETED|Phase 1 MTD Finding Stage||2||
59878958|NCT02942264|76002178|FG006|COMPLETED|Phase 1 MTD Finding Stage||6||
59878959|NCT02942264|76002179|FG007|COMPLETED|Phase 1 MTD Finding Stage||0||
59878960|NCT02942264|76002180|FG008|COMPLETED|Phase 1 MTD Finding Stage||0||
59878961|NCT02942264|76002172|FG000|NOT COMPLETED|Phase 1 MTD Finding Stage||0||
59878962|NCT02942264|76002173|FG001|NOT COMPLETED|Phase 1 MTD Finding Stage||1||
59878963|NCT02942264|76002174|FG002|NOT COMPLETED|Phase 1 MTD Finding Stage||0||
59878964|NCT02942264|76002175|FG003|NOT COMPLETED|Phase 1 MTD Finding Stage||0||
59878965|NCT02942264|76002176|FG004|NOT COMPLETED|Phase 1 MTD Finding Stage||0||
59878966|NCT02942264|76002177|FG005|NOT COMPLETED|Phase 1 MTD Finding Stage||0||
59878967|NCT02942264|76002178|FG006|NOT COMPLETED|Phase 1 MTD Finding Stage||1||
59878968|NCT02942264|76002179|FG007|NOT COMPLETED|Phase 1 MTD Finding Stage||0||
59878969|NCT02942264|76002180|FG008|NOT COMPLETED|Phase 1 MTD Finding Stage||0||
59878970|NCT02942264|76002172|FG000|STARTED|Phase 1 Cohort Expansion Stage||0||
59878971|NCT02942264|76002173|FG001|STARTED|Phase 1 Cohort Expansion Stage||0||
59878972|NCT02942264|76002174|FG002|STARTED|Phase 1 Cohort Expansion Stage||0||
59878973|NCT02942264|76002175|FG003|STARTED|Phase 1 Cohort Expansion Stage||0||
59878974|NCT02942264|76002176|FG004|STARTED|Phase 1 Cohort Expansion Stage||0||
59878975|NCT02942264|76002177|FG005|STARTED|Phase 1 Cohort Expansion Stage||0||
59878976|NCT02942264|76002178|FG006|STARTED|Phase 1 Cohort Expansion Stage||0||
59878977|NCT02942264|76002179|FG007|STARTED|Phase 1 Cohort Expansion Stage||6||
59878978|NCT02942264|76002180|FG008|STARTED|Phase 1 Cohort Expansion Stage||7||
59878979|NCT02942264|76002172|FG000|COMPLETED|Phase 1 Cohort Expansion Stage||0||
59878980|NCT02942264|76002173|FG001|COMPLETED|Phase 1 Cohort Expansion Stage||0||
59878981|NCT02942264|76002174|FG002|COMPLETED|Phase 1 Cohort Expansion Stage||0||
59878982|NCT02942264|76002175|FG003|COMPLETED|Phase 1 Cohort Expansion Stage||0||
59878983|NCT02942264|76002176|FG004|COMPLETED|Phase 1 Cohort Expansion Stage||0||
59878984|NCT02942264|76002177|FG005|COMPLETED|Phase 1 Cohort Expansion Stage||0||
59878985|NCT02942264|76002178|FG006|COMPLETED|Phase 1 Cohort Expansion Stage||0||
59878986|NCT02942264|76002179|FG007|COMPLETED|Phase 1 Cohort Expansion Stage||6||
59878987|NCT02942264|76002180|FG008|COMPLETED|Phase 1 Cohort Expansion Stage||6||
59878988|NCT02942264|76002172|FG000|NOT COMPLETED|Phase 1 Cohort Expansion Stage||0||
59878989|NCT02942264|76002173|FG001|NOT COMPLETED|Phase 1 Cohort Expansion Stage||0||
59878990|NCT02942264|76002174|FG002|NOT COMPLETED|Phase 1 Cohort Expansion Stage||0||
59878991|NCT02942264|76002175|FG003|NOT COMPLETED|Phase 1 Cohort Expansion Stage||0||
59878992|NCT02942264|76002176|FG004|NOT COMPLETED|Phase 1 Cohort Expansion Stage||0||
59878993|NCT02942264|76002177|FG005|NOT COMPLETED|Phase 1 Cohort Expansion Stage||0||
59878994|NCT02942264|76002178|FG006|NOT COMPLETED|Phase 1 Cohort Expansion Stage||0||
59878995|NCT02942264|76002179|FG007|NOT COMPLETED|Phase 1 Cohort Expansion Stage||0||
59878996|NCT02942264|76002180|FG008|NOT COMPLETED|Phase 1 Cohort Expansion Stage||1||
59878997|NCT03322514|76002207|FG000|STARTED|Overall Study||6||
59878998|NCT03322514|76002208|FG001|STARTED|Overall Study||6||
59878999|NCT03322514|76002207|FG000|COMPLETED|Overall Study||5||
59879000|NCT03322514|76002208|FG001|COMPLETED|Overall Study||5||
59879001|NCT03322514|76002207|FG000|NOT COMPLETED|Overall Study||1||
59879002|NCT03322514|76002208|FG001|NOT COMPLETED|Overall Study||1||
59879003|NCT03325712|76002222|FG000|STARTED|Overall Study||10||
59879004|NCT03325712|76002223|FG001|STARTED|Overall Study||2||
59879005|NCT03325712|76002224|FG002|STARTED|Overall Study||8||
59879006|NCT03325712|76002225|FG003|STARTED|Overall Study||8||
59879007|NCT03325712|76002226|FG004|STARTED|Overall Study||8||
59879008|NCT03325712|76002227|FG005|STARTED|Overall Study||8||
59879009|NCT03325712|76002228|FG006|STARTED|Overall Study||8||
59879010|NCT03325712|76002229|FG007|STARTED|Overall Study||8||
59879011|NCT03325712|76002222|FG000|COMPLETED|Overall Study||10||
59879012|NCT03325712|76002223|FG001|COMPLETED|Overall Study||2||
59879013|NCT03325712|76002224|FG002|COMPLETED|Overall Study||8||
59879014|NCT03325712|76002225|FG003|COMPLETED|Overall Study||8||
59879015|NCT03325712|76002226|FG004|COMPLETED|Overall Study||6||
59879016|NCT03325712|76002227|FG005|COMPLETED|Overall Study||8||
59879017|NCT03325712|76002228|FG006|COMPLETED|Overall Study||8||
59879018|NCT03325712|76002229|FG007|COMPLETED|Overall Study||8||
59879019|NCT03325712|76002222|FG000|NOT COMPLETED|Overall Study||0||
59879020|NCT03325712|76002223|FG001|NOT COMPLETED|Overall Study||0||
59879021|NCT03325712|76002224|FG002|NOT COMPLETED|Overall Study||0||
59879022|NCT03325712|76002225|FG003|NOT COMPLETED|Overall Study||0||
59879023|NCT03325712|76002226|FG004|NOT COMPLETED|Overall Study||2||
59879024|NCT03325712|76002227|FG005|NOT COMPLETED|Overall Study||0||
59879025|NCT03325712|76002228|FG006|NOT COMPLETED|Overall Study||0||
59879026|NCT03325712|76002229|FG007|NOT COMPLETED|Overall Study||0||
59879027|NCT03734679|76002257|FG000|STARTED|Overall Study||12||
59879028|NCT03734679|76002257|FG000|COMPLETED|Overall Study||11||
59879029|NCT03734679|76002257|FG000|NOT COMPLETED|Overall Study||1||
59879030|NCT03325556|76002261|FG000|STARTED|Open-label Period||392||
59879031|NCT03325556|76002262|FG001|STARTED|Open-label Period||0||
59879032|NCT03325556|76002263|FG002|STARTED|Open-label Period||0||
59879033|NCT03325556|76002261|FG000|COMPLETED|Open-label Period||217||
59879034|NCT03325556|76002262|FG001|COMPLETED|Open-label Period||0||
59879035|NCT03325556|76002263|FG002|COMPLETED|Open-label Period||0||
59879036|NCT03325556|76002261|FG000|NOT COMPLETED|Open-label Period||175||
59879037|NCT03325556|76002262|FG001|NOT COMPLETED|Open-label Period||0||
59879038|NCT03325556|76002263|FG002|NOT COMPLETED|Open-label Period||0||
59879039|NCT03325556|76002261|FG000|STARTED|Double-blind Period||0||
59879040|NCT03325556|76002262|FG001|STARTED|Double-blind Period||105||
59879041|NCT03325556|76002263|FG002|STARTED|Double-blind Period||112||
59879042|NCT03325556|76002261|FG000|COMPLETED|Double-blind Period||0||
59879043|NCT03325556|76002262|FG001|COMPLETED|Double-blind Period||44||
59879044|NCT03325556|76002263|FG002|COMPLETED|Double-blind Period||35||
59879045|NCT03325556|76002261|FG000|NOT COMPLETED|Double-blind Period||0||
59879046|NCT03325556|76002262|FG001|NOT COMPLETED|Double-blind Period||61||
59879047|NCT03325556|76002263|FG002|NOT COMPLETED|Double-blind Period||77||
59879048|NCT03320564|76002270|FG000|STARTED|Overall Study||2||
59879049|NCT03320564|76002270|FG000|COMPLETED|Overall Study||1||
59879050|NCT03320564|76002270|FG000|NOT COMPLETED|Overall Study||1||
59879051|NCT03325166|76002274|FG000|STARTED|Overall Study||2||
59879052|NCT03325166|76002274|FG000|COMPLETED|Overall Study||1||
59879053|NCT03325166|76002274|FG000|NOT COMPLETED|Overall Study||1||
59879054|NCT02888756|76002281|FG000|STARTED|Vaccination Period||16||
59879055|NCT02888756|76002282|FG001|STARTED|Vaccination Period||9||
59879056|NCT02888756|76002283|FG002|STARTED|Vaccination Period||8||
59879057|NCT02888756|76002281|FG000|COMPLETED|Vaccination Period||16||
59879058|NCT02888756|76002282|FG001|COMPLETED|Vaccination Period||9||
59879059|NCT02888756|76002283|FG002|COMPLETED|Vaccination Period||8||
59879060|NCT02888756|76002281|FG000|NOT COMPLETED|Vaccination Period||0||
59879061|NCT02888756|76002282|FG001|NOT COMPLETED|Vaccination Period||0||
59879062|NCT02888756|76002283|FG002|NOT COMPLETED|Vaccination Period||0||
59879063|NCT02888756|76002281|FG000|STARTED|Analytical Treatment Interruption||15|One participant did not start treatment interruption|
59879064|NCT02888756|76002282|FG001|STARTED|Analytical Treatment Interruption||9|One participant did not start treatment interruption|
59879065|NCT02888756|76002283|FG002|STARTED|Analytical Treatment Interruption||8|One participant did not start treatment interruption|
59879066|NCT02888756|76002281|FG000|COMPLETED|Analytical Treatment Interruption||5||
60002542|NCT02061592|76118441|FG000|NOT COMPLETED|Period 1||2||
59879067|NCT02888756|76002282|FG001|COMPLETED|Analytical Treatment Interruption||3||
59879068|NCT02888756|76002283|FG002|COMPLETED|Analytical Treatment Interruption||3||
59879069|NCT02888756|76002281|FG000|NOT COMPLETED|Analytical Treatment Interruption||10||
59879070|NCT02888756|76002282|FG001|NOT COMPLETED|Analytical Treatment Interruption||6||
59879071|NCT02888756|76002283|FG002|NOT COMPLETED|Analytical Treatment Interruption||5||
59879072|NCT03305666|76002293|FG000|STARTED|Overall Study||18||
59879073|NCT03305666|76002294|FG001|STARTED|Overall Study||18||
59879074|NCT03305666|76002293|FG000|COMPLETED|Overall Study||16||
59879075|NCT03305666|76002294|FG001|COMPLETED|Overall Study||18||
59879076|NCT03305666|76002293|FG000|NOT COMPLETED|Overall Study||2||
59879077|NCT03305666|76002294|FG001|NOT COMPLETED|Overall Study||0||
59879078|NCT03304184|76002302|FG000|STARTED|Overall Study||15||
59879079|NCT03304184|76002303|FG001|STARTED|Overall Study||9||
59879080|NCT03304184|76002302|FG000|COMPLETED|Overall Study||14|Participants that completed all of the survey questions over a 3 month period.|
59879081|NCT03304184|76002303|FG001|COMPLETED|Overall Study||7|Participants that completed all of the survey questions over a 3 month period.|
59879082|NCT03304184|76002302|FG000|NOT COMPLETED|Overall Study||1||
59879083|NCT03304184|76002303|FG001|NOT COMPLETED|Overall Study||2||
59879084|NCT03736785|76002313|FG000|STARTED|Overall Study||135||
59879085|NCT03736785|76002314|FG001|STARTED|Overall Study||132||
59879086|NCT03736785|76002315|FG002|STARTED|Overall Study||132||
59879087|NCT03736785|76002313|FG000|COMPLETED|Overall Study||118||
59879088|NCT03736785|76002314|FG001|COMPLETED|Overall Study||115||
59879089|NCT03736785|76002315|FG002|COMPLETED|Overall Study||118||
59879090|NCT03736785|76002313|FG000|NOT COMPLETED|Overall Study||17||
59879091|NCT03736785|76002314|FG001|NOT COMPLETED|Overall Study||17||
59879092|NCT03736785|76002315|FG002|NOT COMPLETED|Overall Study||14||
59879093|NCT03734991|76002326|FG000|STARTED|Overall Study||249||
59879094|NCT03734991|76002327|FG001|STARTED|Overall Study||127||
59879095|NCT03734991|76002326|FG000|Withdrawn Before Treatment|Overall Study||2||
59879096|NCT03734991|76002327|FG001|Withdrawn Before Treatment|Overall Study||3||
59879097|NCT03734991|76002326|FG000|Withdrawn Before TOC|Overall Study||59||
59879098|NCT03734991|76002327|FG001|Withdrawn Before TOC|Overall Study||41||
59879099|NCT03734991|76002326|FG000|Completed the TOC Visit|Overall Study||188||
59879100|NCT03734991|76002327|FG001|Completed the TOC Visit|Overall Study||83||
59879101|NCT03734991|76002326|FG000|Withdrawn At or After the TOC Visit|Overall Study||5||
59879102|NCT03734991|76002327|FG001|Withdrawn At or After the TOC Visit|Overall Study||3||
59879103|NCT03734991|76002326|FG000|COMPLETED|Overall Study||183||
59879104|NCT03734991|76002327|FG001|COMPLETED|Overall Study||80||
59879105|NCT03734991|76002326|FG000|NOT COMPLETED|Overall Study||66||
59879106|NCT03734991|76002327|FG001|NOT COMPLETED|Overall Study||47||
59879107|NCT03303092|76002336|FG000|STARTED|Overall Study||121||
59879108|NCT03303092|76002337|FG001|STARTED|Overall Study||119||
59879109|NCT03303092|76002338|FG002|STARTED|Overall Study||117||
59750241|NCT00878709|75869481|FG001|COMPLETED|Overall Study||1183||
59750242|NCT00878709|75869480|FG000|NOT COMPLETED|Overall Study||325||
59750243|NCT00878709|75869481|FG001|NOT COMPLETED|Overall Study||237||
59750244|NCT00927758|75869488|FG000|STARTED|Treatment Cycle 1 (Day 1 - Day 7)|"Started  indicates randomized as well as safety set."|4||
59750245|NCT00927758|75869489|FG001|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||4||
59750246|NCT00927758|75869490|FG002|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||4||
59750247|NCT00927758|75869491|FG003|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||3||
59750248|NCT00927758|75869492|FG004|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||3||
59750249|NCT00927758|75869493|FG005|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||4||
59879110|NCT03303092|76002336|FG000|COMPLETED|Overall Study||118||
59879111|NCT03303092|76002337|FG001|COMPLETED|Overall Study||113||
59879112|NCT03303092|76002338|FG002|COMPLETED|Overall Study||112||
59879113|NCT03303092|76002336|FG000|NOT COMPLETED|Overall Study||3||
59879114|NCT03303092|76002337|FG001|NOT COMPLETED|Overall Study||6||
59879115|NCT03303092|76002338|FG002|NOT COMPLETED|Overall Study||5||
59879116|NCT03302936|76002348|FG000|STARTED|Overall Study||49||
59879117|NCT03302936|76002349|FG001|STARTED|Overall Study||49||
59879118|NCT03302936|76002348|FG000|COMPLETED|Overall Study||46||
59879119|NCT03302936|76002349|FG001|COMPLETED|Overall Study||45||
59879120|NCT03302936|76002348|FG000|NOT COMPLETED|Overall Study||3||
59879121|NCT03302936|76002349|FG001|NOT COMPLETED|Overall Study||4||
59879122|NCT03733899|76002359|FG000|STARTED|Period 1||3||
59879123|NCT03733899|76002360|FG001|STARTED|Period 1||3||
59879124|NCT03733899|76002361|FG002|STARTED|Period 1||3||
59879125|NCT03733899|76002362|FG003|STARTED|Period 1||4||
59750250|NCT00927758|75869488|FG000|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||4||
59750251|NCT00927758|75869489|FG001|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||4||
59750252|NCT00927758|75869490|FG002|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||4||
59879126|NCT03733899|76002363|FG004|STARTED|Period 1||4||
59879127|NCT03733899|76002364|FG005|STARTED|Period 1||3||
59750253|NCT00927758|75869491|FG003|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||2||
59879128|NCT03733899|76002359|FG000|COMPLETED|Period 1||3||
59879129|NCT03733899|76002360|FG001|COMPLETED|Period 1||3||
59879130|NCT03733899|76002361|FG002|COMPLETED|Period 1||3||
59879131|NCT03733899|76002362|FG003|COMPLETED|Period 1||4||
59879132|NCT03733899|76002363|FG004|COMPLETED|Period 1||4||
59879133|NCT03733899|76002364|FG005|COMPLETED|Period 1||2||
59879134|NCT03733899|76002359|FG000|NOT COMPLETED|Period 1||0||
59879135|NCT03733899|76002360|FG001|NOT COMPLETED|Period 1||0||
59879136|NCT03733899|76002361|FG002|NOT COMPLETED|Period 1||0||
59879137|NCT03733899|76002362|FG003|NOT COMPLETED|Period 1||0||
60135786|NCT01623167|76258470|FG002|COMPLETED|Overall Study||18||
60135787|NCT01623167|76258468|FG000|NOT COMPLETED|Overall Study||17||
59879138|NCT03733899|76002363|FG004|NOT COMPLETED|Period 1||0||
59879139|NCT03733899|76002364|FG005|NOT COMPLETED|Period 1||1||
59879140|NCT03733899|76002359|FG000|STARTED|Period 2||3||
59879141|NCT03733899|76002360|FG001|STARTED|Period 2||3||
59879142|NCT03733899|76002361|FG002|STARTED|Period 2||3||
59879143|NCT03733899|76002362|FG003|STARTED|Period 2||4||
59879144|NCT03733899|76002363|FG004|STARTED|Period 2||4||
59879145|NCT03733899|76002364|FG005|STARTED|Period 2||2||
59879146|NCT03733899|76002359|FG000|COMPLETED|Period 2||3||
59879147|NCT03733899|76002360|FG001|COMPLETED|Period 2||2||
59879148|NCT03733899|76002361|FG002|COMPLETED|Period 2||3||
59879149|NCT03733899|76002362|FG003|COMPLETED|Period 2||4||
59879150|NCT03733899|76002363|FG004|COMPLETED|Period 2||4||
59879151|NCT03733899|76002364|FG005|COMPLETED|Period 2||2||
59879152|NCT03733899|76002359|FG000|NOT COMPLETED|Period 2||0||
59879153|NCT03733899|76002360|FG001|NOT COMPLETED|Period 2||1||
59879154|NCT03733899|76002361|FG002|NOT COMPLETED|Period 2||0||
59879155|NCT03733899|76002362|FG003|NOT COMPLETED|Period 2||0||
59879156|NCT03733899|76002363|FG004|NOT COMPLETED|Period 2||0||
59879157|NCT03733899|76002364|FG005|NOT COMPLETED|Period 2||0||
59879158|NCT03733899|76002359|FG000|STARTED|Period 3||3||
59879159|NCT03733899|76002360|FG001|STARTED|Period 3||2||
59879160|NCT03733899|76002361|FG002|STARTED|Period 3||3||
59879161|NCT03733899|76002362|FG003|STARTED|Period 3||4||
59879162|NCT03733899|76002363|FG004|STARTED|Period 3||4||
59879163|NCT03733899|76002364|FG005|STARTED|Period 3||2||
59879164|NCT03733899|76002359|FG000|COMPLETED|Period 3||2||
59879165|NCT03733899|76002360|FG001|COMPLETED|Period 3||2||
59879166|NCT03733899|76002361|FG002|COMPLETED|Period 3||3||
59879167|NCT03733899|76002362|FG003|COMPLETED|Period 3||4||
59879168|NCT03733899|76002363|FG004|COMPLETED|Period 3||4||
59879169|NCT03733899|76002364|FG005|COMPLETED|Period 3||2||
59879170|NCT03733899|76002359|FG000|NOT COMPLETED|Period 3||1||
59879171|NCT03733899|76002360|FG001|NOT COMPLETED|Period 3||0||
59879172|NCT03733899|76002361|FG002|NOT COMPLETED|Period 3||0||
59879173|NCT03733899|76002362|FG003|NOT COMPLETED|Period 3||0||
59879174|NCT03733899|76002363|FG004|NOT COMPLETED|Period 3||0||
59879175|NCT03733899|76002364|FG005|NOT COMPLETED|Period 3||0||
59879176|NCT03727347|76002377|FG000|STARTED|Overall Study||50||
59879177|NCT03727347|76002377|FG000|2-week Evaluation|Overall Study||50||
59879178|NCT03727347|76002377|FG000|4-week Evaluation|Overall Study||50||
59879179|NCT03727347|76002377|FG000|12-week Primary Endpoint Evaluation|Overall Study||50||
59879180|NCT03727347|76002377|FG000|26-week Evaluation|Overall Study||48||
59879181|NCT03727347|76002377|FG000|52-week Evaluation|Overall Study||47||
59879182|NCT03727347|76002377|FG000|COMPLETED|Overall Study||47||
59879183|NCT03727347|76002377|FG000|NOT COMPLETED|Overall Study||3||
59879184|NCT03915626|76002390|FG000|STARTED|Overall Study||7|Study was intended to enroll and complete n=12 volunteers; however, funding was terminated due to pandemic.|
59879185|NCT03915626|76002390|FG000|COMPLETED|Overall Study||6||
59879186|NCT03915626|76002390|FG000|NOT COMPLETED|Overall Study||1||
59879187|NCT03301844|76002402|FG000|STARTED|Overall Study|Each patient apply the Blephapad Combo wipes to one eye and standard treatment to the other eye.|19||19
59879188|NCT03301844|76002403|FG001|STARTED|Overall Study|Each patient apply the Blephapad Combo wipes to one eye and standard treatment to the other eye.|19||19
59879189|NCT03301844|76002402|FG000|COMPLETED|Overall Study||18||18
59879190|NCT03301844|76002403|FG001|COMPLETED|Overall Study||18||18
59879191|NCT03301844|76002402|FG000|NOT COMPLETED|Overall Study||1||1
59879192|NCT03301844|76002403|FG001|NOT COMPLETED|Overall Study||1||1
59879193|NCT03313310|76002411|FG000|STARTED|Phase 2||51||
59879194|NCT03313310|76002412|FG001|STARTED|Phase 2|Phase 2 participants did not participate in Phase 3.|0||
59879195|NCT03313310|76002411|FG000|COMPLETED|Phase 2||47||
59879196|NCT03313310|76002412|FG001|COMPLETED|Phase 2|Phase 2 participants did not participate in Phase 3.|0||
59879197|NCT03313310|76002411|FG000|NOT COMPLETED|Phase 2||4||
59879198|NCT03313310|76002412|FG001|NOT COMPLETED|Phase 2||0||
59879199|NCT03313310|76002411|FG000|STARTED|Phase 3|Phase 3 participants did not participate in Phase 2.|0||
59879200|NCT03313310|76002412|FG001|STARTED|Phase 3||41||
59879201|NCT03313310|76002411|FG000|COMPLETED|Phase 3|Phase 3 participants did not participate in Phase 2.|0||
59879202|NCT03313310|76002412|FG001|COMPLETED|Phase 3||40||
59879203|NCT03313310|76002411|FG000|NOT COMPLETED|Phase 3||0||
59879204|NCT03313310|76002412|FG001|NOT COMPLETED|Phase 3||1||
60135788|NCT01623167|76258469|FG001|NOT COMPLETED|Overall Study||14||
60135789|NCT01623167|76258470|FG002|NOT COMPLETED|Overall Study||13||
59879205|NCT03313076|76002422|FG000|STARTED|Overall Study||7||
59879206|NCT03313076|76002423|FG001|STARTED|Overall Study||6||
59879207|NCT03313076|76002424|FG002|STARTED|Overall Study||6||
59879208|NCT03313076|76002425|FG003|STARTED|Overall Study||5||
59879209|NCT03313076|76002422|FG000|COMPLETED|Overall Study||5||
59879210|NCT03313076|76002423|FG001|COMPLETED|Overall Study||4||
59879211|NCT03313076|76002424|FG002|COMPLETED|Overall Study||4||
59879212|NCT03313076|76002425|FG003|COMPLETED|Overall Study||3||
59879213|NCT03313076|76002422|FG000|NOT COMPLETED|Overall Study||2||
59750254|NCT00927758|75869492|FG004|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||3||
59750255|NCT00927758|75869493|FG005|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||3||
59750256|NCT00927758|75869488|FG000|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||4||
59750257|NCT00927758|75869489|FG001|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||4||
59750258|NCT00927758|75869490|FG002|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||4||
59750259|NCT00927758|75869491|FG003|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||2||
59750260|NCT00927758|75869492|FG004|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||3||
59750261|NCT00927758|75869493|FG005|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||3||
59750262|NCT00927758|75869488|FG000|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||0||
59750263|NCT00927758|75869489|FG001|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||0||
59750264|NCT00927758|75869490|FG002|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||0||
59750265|NCT00927758|75869491|FG003|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||1||
59750266|NCT00927758|75869492|FG004|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||0||
59879214|NCT03313076|76002423|FG001|NOT COMPLETED|Overall Study||2||
59879215|NCT03313076|76002424|FG002|NOT COMPLETED|Overall Study||2||
59879216|NCT03313076|76002425|FG003|NOT COMPLETED|Overall Study||2||
59879217|NCT02940626|76002443|FG000|STARTED|Overall Study||77|Population = Intent to treat (ITT)|
59879218|NCT02940626|76002444|FG001|STARTED|Overall Study||78|Population = Intent to treat (ITT)|
59879219|NCT02940626|76002443|FG000|Randomized Into Primary Prevention Study|Overall Study||77||
59879220|NCT02940626|76002444|FG001|Randomized Into Primary Prevention Study|Overall Study||77||
59879221|NCT02940626|76002443|FG000|Randomized Into Treatment Sub-study|Overall Study||0|Single subject randomized/treated (placebo) in pneumonia treatment sub-study before trial terminated|
59879222|NCT02940626|76002444|FG001|Randomized Into Treatment Sub-study|Overall Study||1|Single subject randomized/treated (placebo) in pneumonia treatment sub-study before trial terminated|
59879223|NCT02940626|76002443|FG000|Received Study Treatment|Overall Study||77|Of the 77 subjects in the placebo arm, 76 were in primary prevention study, 1 in treatment sub-study|
59879224|NCT02940626|76002444|FG001|Received Study Treatment|Overall Study||77|Of the 77 subjects in the placebo arm, 76 were in primary prevention study, 1 in treatment sub-study|
59879225|NCT02940626|76002443|FG000|Completed Through Study Day 22|Overall Study||42||
59879226|NCT02940626|76002444|FG001|Completed Through Study Day 22|Overall Study||49||
59879227|NCT02940626|76002443|FG000|COMPLETED|Overall Study||30||
59879228|NCT02940626|76002444|FG001|COMPLETED|Overall Study||43||
59879229|NCT02940626|76002443|FG000|NOT COMPLETED|Overall Study||47||
59879230|NCT02940626|76002444|FG001|NOT COMPLETED|Overall Study||35||
59879231|NCT03300050|76002457|FG000|STARTED|Overall Study||20||
59879232|NCT03300050|76002458|FG001|STARTED|Overall Study||15||
59879233|NCT03300050|76002459|FG002|STARTED|Overall Study||5||
59750267|NCT00927758|75869493|FG005|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||1||
59750268|NCT00927758|75869488|FG000|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||4||
59750269|NCT00927758|75869489|FG001|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||4||
59750270|NCT00927758|75869490|FG002|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||4||
59750271|NCT00927758|75869491|FG003|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||2||
59750272|NCT00927758|75869492|FG004|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||3||
59750273|NCT00927758|75869493|FG005|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||3||
59750274|NCT00927758|75869488|FG000|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||4||
59750275|NCT00927758|75869489|FG001|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||4||
59750276|NCT00927758|75869490|FG002|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||3||
59879234|NCT03300050|76002460|FG003|STARTED|Overall Study||16||
59879235|NCT03300050|76002461|FG004|STARTED|Overall Study||10||
59879236|NCT03300050|76002457|FG000|Received Treatment|Overall Study||19||
59879237|NCT03300050|76002458|FG001|Received Treatment|Overall Study||14||
59879238|NCT03300050|76002459|FG002|Received Treatment|Overall Study||3||
59879239|NCT03300050|76002460|FG003|Received Treatment|Overall Study||15||
59879240|NCT03300050|76002461|FG004|Received Treatment|Overall Study||10||
59879241|NCT03300050|76002457|FG000|Received All Scheduled Treatments|Overall Study||16||
59605431|NCT01994382|75715573|FG013|NOT COMPLETED|Overall Study||6||
59750277|NCT00927758|75869491|FG003|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||1||
59879242|NCT03300050|76002458|FG001|Received All Scheduled Treatments|Overall Study||13||
59879243|NCT03300050|76002459|FG002|Received All Scheduled Treatments|Overall Study||2||
59879244|NCT03300050|76002460|FG003|Received All Scheduled Treatments|Overall Study||15||
59879245|NCT03300050|76002461|FG004|Received All Scheduled Treatments|Overall Study||10||
59879246|NCT03300050|76002457|FG000|COMPLETED|Overall Study||17||
59879247|NCT03300050|76002458|FG001|COMPLETED|Overall Study||13||
59879248|NCT03300050|76002459|FG002|COMPLETED|Overall Study||2||
59879249|NCT03300050|76002460|FG003|COMPLETED|Overall Study||15||
59879250|NCT03300050|76002461|FG004|COMPLETED|Overall Study||9||
59879251|NCT03300050|76002457|FG000|NOT COMPLETED|Overall Study||3||
59879252|NCT03300050|76002458|FG001|NOT COMPLETED|Overall Study||2||
59879253|NCT03300050|76002459|FG002|NOT COMPLETED|Overall Study||3||
59879254|NCT03300050|76002460|FG003|NOT COMPLETED|Overall Study||1||
59879255|NCT03300050|76002461|FG004|NOT COMPLETED|Overall Study||1||
59879256|NCT03725085|76002473|FG000|STARTED|Overall Study||552||
59879257|NCT03725085|76002473|FG000|COMPLETED|Overall Study||550||
60002543|NCT02061592|76118442|FG001|NOT COMPLETED|Period 1||0||
60002544|NCT02061592|76118441|FG000|STARTED|Period 2||64||
60002545|NCT02061592|76118442|FG001|STARTED|Period 2||62||
59879258|NCT03725085|76002473|FG000|NOT COMPLETED|Overall Study||2||
59879259|NCT02940392|76002478|FG000|STARTED|Overall Study||15||
59879260|NCT02940392|76002478|FG000|COMPLETED|Overall Study||7||
59879261|NCT02940392|76002478|FG000|NOT COMPLETED|Overall Study||8||
59879262|NCT03559010|76002482|FG000|STARTED|Overall Study|The number of participants to start a period is not equal to the number who completed previous period|189||
59879263|NCT03559010|76002482|FG000|Purchaser Population|Overall Study||113||
59879264|NCT03559010|76002482|FG000|Use Phase Norgestrel 0.075 mg|Overall Study||109||
60002546|NCT02061592|76118441|FG000|COMPLETED|Period 2||64||
60002547|NCT02061592|76118442|FG001|COMPLETED|Period 2||61||
60002548|NCT02061592|76118441|FG000|NOT COMPLETED|Period 2||0||
60002549|NCT02061592|76118442|FG001|NOT COMPLETED|Period 2||1||
59879265|NCT03559010|76002482|FG000|COMPLETED|Overall Study||189||
59879266|NCT03559010|76002482|FG000|NOT COMPLETED|Overall Study||0||
59879267|NCT03298412|76002491|FG000|STARTED|Run-in Period||10||
59879268|NCT03298412|76002491|FG000|COMPLETED|Run-in Period||1||
59879269|NCT03298412|76002491|FG000|NOT COMPLETED|Run-in Period||9||
59879270|NCT03298412|76002491|FG000|STARTED|Treatment Period||1||
59879271|NCT03298412|76002491|FG000|COMPLETED|Treatment Period||1||
59879272|NCT03298412|76002491|FG000|NOT COMPLETED|Treatment Period||0||
59879273|NCT03297398|76002498|FG000|STARTED|Overall Study||36||
59879274|NCT03297398|76002499|FG001|STARTED|Overall Study||40||
59879275|NCT03297398|76002500|FG002|STARTED|Overall Study||38||
59879276|NCT03297398|76002498|FG000|COMPLETED|Overall Study||28||
59879277|NCT03297398|76002499|FG001|COMPLETED|Overall Study||23||
59879278|NCT03297398|76002500|FG002|COMPLETED|Overall Study||23||
59879279|NCT03297398|76002498|FG000|NOT COMPLETED|Overall Study||8||
59879280|NCT03297398|76002499|FG001|NOT COMPLETED|Overall Study||17||
60135790|NCT01556490|76258480|FG000|STARTED|Randomized Patients Summary||263|The Overall Survival (OS) efficacy endpoints analyzed on the modified Intent-To-Treat (mITT) population, comprising 481/526 randomized patients who met eligibility criteria.|
60135791|NCT01556490|76258481|FG001|STARTED|Randomized Patients Summary||263|The Overall Survival (OS) efficacy endpoints analyzed on the modified Intent-To-Treat (mITT) population, comprising 481/526 randomized patients who met eligibility criteria.|
60135792|NCT01556490|76258480|FG000|COMPLETED|Randomized Patients Summary||241||
60135793|NCT01556490|76258481|FG001|COMPLETED|Randomized Patients Summary||240||
60135794|NCT01556490|76258480|FG000|NOT COMPLETED|Randomized Patients Summary||22||
60135795|NCT01556490|76258481|FG001|NOT COMPLETED|Randomized Patients Summary||23||
60135796|NCT01556490|76258480|FG000|STARTED|Overall Survival (OS)||241|Modified Intent-to-treat (mITT) Population: all randomized patients who met the trial eligibility criteria at randomization formed the mITT population. Patients were analyzed according to the group to which they were randomized. This population was used for all efficacy endpoints.|
60135797|NCT01556490|76258481|FG001|STARTED|Overall Survival (OS)||240|Modified Intent-to-treat (mITT) Population: all randomized patients who met the trial eligibility criteria at randomization formed the mITT population. Patients were analyzed according to the group to which they were randomized. This population was used for all efficacy endpoints.|
60135798|NCT01556490|76258480|FG000|COMPLETED|Overall Survival (OS)|Treated Patients who Discontinued/Completed from Study|229|mITT: Patients who died and patients who remained in follow-up at the data cut-off date (30Apr2022), are considered to have completed the study.|
60135799|NCT01556490|76258481|FG001|COMPLETED|Overall Survival (OS)|Treated Patients who Discontinued/Completed from Study|222|mITT: Patients who died and patients who remained in follow-up at the data cut-off date (30Apr2022), are considered to have completed the study.|
60135800|NCT01556490|76258480|FG000|NOT COMPLETED|Overall Survival (OS)||12||
60135801|NCT01556490|76258481|FG001|NOT COMPLETED|Overall Survival (OS)||18||
60135802|NCT01181947|76258489|FG000|STARTED|Overall Study||100||
60135803|NCT01181947|76258489|FG000|COMPLETED|Overall Study||100||
60135804|NCT01181947|76258489|FG000|NOT COMPLETED|Overall Study||0||
60135805|NCT01133990|76258500|FG000|STARTED|Phase 1b (Dose Escalation Phase)||5||
60135806|NCT01133990|76258501|FG001|STARTED|Phase 1b (Dose Escalation Phase)||0||
60135807|NCT01133990|76258502|FG002|STARTED|Phase 1b (Dose Escalation Phase)||0||
60135808|NCT01133990|76258503|FG003|STARTED|Phase 1b (Dose Escalation Phase)||0||
60135809|NCT01133990|76258504|FG004|STARTED|Phase 1b (Dose Escalation Phase)||0||
60135810|NCT01133990|76258505|FG005|STARTED|Phase 1b (Dose Escalation Phase)||0||
60135811|NCT01133990|76258500|FG000|COMPLETED|Phase 1b (Dose Escalation Phase)||1||
60135812|NCT01133990|76258501|FG001|COMPLETED|Phase 1b (Dose Escalation Phase)||0||
60135813|NCT01133990|76258502|FG002|COMPLETED|Phase 1b (Dose Escalation Phase)||0||
60135814|NCT01133990|76258503|FG003|COMPLETED|Phase 1b (Dose Escalation Phase)||0||
60135815|NCT01133990|76258504|FG004|COMPLETED|Phase 1b (Dose Escalation Phase)||0||
60135816|NCT01133990|76258505|FG005|COMPLETED|Phase 1b (Dose Escalation Phase)||0||
60135817|NCT01133990|76258500|FG000|NOT COMPLETED|Phase 1b (Dose Escalation Phase)||4||
60135818|NCT01133990|76258501|FG001|NOT COMPLETED|Phase 1b (Dose Escalation Phase)||0||
60135819|NCT01133990|76258502|FG002|NOT COMPLETED|Phase 1b (Dose Escalation Phase)||0||
60135820|NCT01133990|76258503|FG003|NOT COMPLETED|Phase 1b (Dose Escalation Phase)||0||
59879281|NCT03297398|76002500|FG002|NOT COMPLETED|Overall Study||15||
59879282|NCT03293654|76002511|FG000|STARTED|Overall Study||38||
59879283|NCT03293654|76002512|FG001|STARTED|Overall Study||38||
59879284|NCT03293654|76002513|FG002|STARTED|Overall Study||38||
59879285|NCT03293654|76002511|FG000|COMPLETED|Overall Study||38||
59879286|NCT03293654|76002512|FG001|COMPLETED|Overall Study||37||
59879287|NCT03293654|76002513|FG002|COMPLETED|Overall Study||38||
59879288|NCT03293654|76002511|FG000|NOT COMPLETED|Overall Study||0||
59879289|NCT03293654|76002512|FG001|NOT COMPLETED|Overall Study||1||
59879290|NCT03293654|76002513|FG002|NOT COMPLETED|Overall Study||0||
60135821|NCT01133990|76258504|FG004|NOT COMPLETED|Phase 1b (Dose Escalation Phase)||0||
60135822|NCT01133990|76258505|FG005|NOT COMPLETED|Phase 1b (Dose Escalation Phase)||0||
59879291|NCT03312218|76002523|FG000|STARTED|Overall Study||335||
59879292|NCT03312218|76002524|FG001|STARTED|Overall Study||299||
59879293|NCT03312218|76002523|FG000|COMPLETED|Overall Study||281||
59879294|NCT03312218|76002524|FG001|COMPLETED|Overall Study||241||
59879295|NCT03312218|76002523|FG000|NOT COMPLETED|Overall Study||54||
59879296|NCT03312218|76002524|FG001|NOT COMPLETED|Overall Study||58||
59879297|NCT03930615|76002532|FG000|STARTED|Overall Study||145|Randomized|
59879298|NCT03930615|76002533|FG001|STARTED|Overall Study||75|Randomized|
59879299|NCT03930615|76002532|FG000|Treated|Overall Study||144||
59879300|NCT03930615|76002533|FG001|Treated|Overall Study||74||
59879301|NCT03930615|76002532|FG000|COMPLETED|Overall Study||118||
59879302|NCT03930615|76002533|FG001|COMPLETED|Overall Study||63||
59879303|NCT03930615|76002532|FG000|NOT COMPLETED|Overall Study||27||
59879304|NCT03930615|76002533|FG001|NOT COMPLETED|Overall Study||12||
59879305|NCT03292640|76002541|FG000|STARTED|Overall Study||275||
59879306|NCT03292640|76002542|FG001|STARTED|Overall Study||272||
59879307|NCT03292640|76002541|FG000|COMPLETED|Overall Study||214||
59879308|NCT03292640|76002542|FG001|COMPLETED|Overall Study||230||
59879309|NCT03292640|76002541|FG000|NOT COMPLETED|Overall Study||61||
59879310|NCT03292640|76002542|FG001|NOT COMPLETED|Overall Study||42||
59879311|NCT03292406|76002555|FG000|STARTED|Overall Study||30|Participants Randomized|
59879312|NCT03292406|76002556|FG001|STARTED|Overall Study||28|Participants Randomized|
59879313|NCT03292406|76002557|FG002|STARTED|Overall Study||28|Participants Randomized|
59879314|NCT03292406|76002555|FG000|Participants Treated|Overall Study||30||
59879315|NCT03292406|76002556|FG001|Participants Treated|Overall Study||28||
59879316|NCT03292406|76002557|FG002|Participants Treated|Overall Study||27||
59879317|NCT03292406|76002555|FG000|COMPLETED|Overall Study||17||
59879318|NCT03292406|76002556|FG001|COMPLETED|Overall Study||15||
59879319|NCT03292406|76002557|FG002|COMPLETED|Overall Study||15||
59879320|NCT03292406|76002555|FG000|NOT COMPLETED|Overall Study||13||
59879321|NCT03292406|76002556|FG001|NOT COMPLETED|Overall Study||13||
59879322|NCT03292406|76002557|FG002|NOT COMPLETED|Overall Study||13||
59879323|NCT02633241|76002568|FG000|STARTED|Overall Study||15||
59879324|NCT02633241|76002569|FG001|STARTED|Overall Study||15||
59879325|NCT02633241|76002570|FG002|STARTED|Overall Study||41||
59879326|NCT02633241|76002568|FG000|COMPLETED|Overall Study||13||
59879327|NCT02633241|76002569|FG001|COMPLETED|Overall Study||14||
59879328|NCT02633241|76002570|FG002|COMPLETED|Overall Study||28||
59879329|NCT02633241|76002568|FG000|NOT COMPLETED|Overall Study||2||
59879330|NCT02633241|76002569|FG001|NOT COMPLETED|Overall Study||1||
59879331|NCT02633241|76002570|FG002|NOT COMPLETED|Overall Study||13||
59879332|NCT03292016|76002594|FG000|STARTED|First Intervention||1||
59879333|NCT03292016|76002595|FG001|STARTED|First Intervention||1||
59879334|NCT03292016|76002596|FG002|STARTED|First Intervention||2||
59879335|NCT03292016|76002597|FG003|STARTED|First Intervention||1||
59879336|NCT03292016|76002598|FG004|STARTED|First Intervention||1||
59879337|NCT03292016|76002599|FG005|STARTED|First Intervention||2||
59879338|NCT03292016|76002594|FG000|COMPLETED|First Intervention||1||
59879339|NCT03292016|76002595|FG001|COMPLETED|First Intervention||1||
59879340|NCT03292016|76002596|FG002|COMPLETED|First Intervention||2||
59879341|NCT03292016|76002597|FG003|COMPLETED|First Intervention||1||
59879342|NCT03292016|76002598|FG004|COMPLETED|First Intervention||1||
59879343|NCT03292016|76002599|FG005|COMPLETED|First Intervention||2||
59879344|NCT03292016|76002594|FG000|NOT COMPLETED|First Intervention||0||
59879345|NCT03292016|76002595|FG001|NOT COMPLETED|First Intervention||0||
59879346|NCT03292016|76002596|FG002|NOT COMPLETED|First Intervention||0||
59879347|NCT03292016|76002597|FG003|NOT COMPLETED|First Intervention||0||
59879348|NCT03292016|76002598|FG004|NOT COMPLETED|First Intervention||0||
59879349|NCT03292016|76002599|FG005|NOT COMPLETED|First Intervention||0||
59879350|NCT03292016|76002594|FG000|STARTED|First Washout||1||
59879351|NCT03292016|76002595|FG001|STARTED|First Washout||1||
59879352|NCT03292016|76002596|FG002|STARTED|First Washout||2||
59879353|NCT03292016|76002597|FG003|STARTED|First Washout||1||
59879354|NCT03292016|76002598|FG004|STARTED|First Washout||1||
59879355|NCT03292016|76002599|FG005|STARTED|First Washout||2||
59879356|NCT03292016|76002594|FG000|COMPLETED|First Washout||1||
59879357|NCT03292016|76002595|FG001|COMPLETED|First Washout||1||
59879358|NCT03292016|76002596|FG002|COMPLETED|First Washout||2||
59879359|NCT03292016|76002597|FG003|COMPLETED|First Washout||1||
59879360|NCT03292016|76002598|FG004|COMPLETED|First Washout||1||
60002550|NCT01663623|76118452|FG000|STARTED|Overall Study||52||
59605432|NCT01994382|75715574|FG014|NOT COMPLETED|Overall Study||28||
59605433|NCT01994382|75715575|FG015|NOT COMPLETED|Overall Study||65||
59605434|NCT01994382|75715576|FG016|NOT COMPLETED|Overall Study||41||
59750278|NCT00927758|75869492|FG004|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||3||
59750279|NCT00927758|75869493|FG005|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||2||
59750280|NCT00927758|75869488|FG000|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||4||
59750281|NCT00927758|75869489|FG001|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||4||
59750282|NCT00927758|75869490|FG002|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||3||
59750283|NCT00927758|75869491|FG003|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||1||
59750284|NCT00927758|75869492|FG004|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||3||
59750285|NCT00927758|75869493|FG005|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||2||
59750286|NCT00927758|75869488|FG000|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||0||
59750287|NCT00927758|75869489|FG001|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||0||
59750288|NCT00927758|75869490|FG002|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||1||
59750289|NCT00927758|75869491|FG003|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||1||
59750290|NCT00927758|75869492|FG004|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||0||
59750291|NCT00927758|75869493|FG005|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||1||
59750292|NCT00927758|75869488|FG000|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||4||
59750293|NCT00927758|75869489|FG001|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||4||
59750294|NCT00927758|75869490|FG002|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||3||
59750295|NCT00927758|75869491|FG003|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||1||
59750296|NCT00927758|75869492|FG004|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||3||
59750297|NCT00927758|75869493|FG005|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||2||
59750298|NCT00927758|75869488|FG000|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||4||
59750299|NCT00927758|75869489|FG001|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||4||
59750300|NCT00927758|75869490|FG002|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||3||
59750301|NCT00927758|75869491|FG003|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||1||
59750302|NCT00927758|75869492|FG004|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||3||
59750303|NCT00927758|75869493|FG005|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||2||
59750304|NCT00927758|75869488|FG000|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0||
59750305|NCT00927758|75869489|FG001|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0||
59750306|NCT00927758|75869490|FG002|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0||
59750307|NCT00927758|75869491|FG003|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0||
59750308|NCT00927758|75869492|FG004|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0||
59750309|NCT00927758|75869493|FG005|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0||
59750310|NCT00927368|75869504|FG000|STARTED|Overall Study||153||
59750311|NCT00927368|75869505|FG001|STARTED|Overall Study||157||
59750312|NCT00927368|75869506|FG002|STARTED|Overall Study||143||
59750313|NCT00927368|75869504|FG000|COMPLETED|Overall Study||147||
59750314|NCT00927368|75869505|FG001|COMPLETED|Overall Study||152||
59750315|NCT00927368|75869506|FG002|COMPLETED|Overall Study||138||
59750316|NCT00927368|75869504|FG000|NOT COMPLETED|Overall Study||6||
59750317|NCT00927368|75869505|FG001|NOT COMPLETED|Overall Study||5||
59750318|NCT00927368|75869506|FG002|NOT COMPLETED|Overall Study||5||
59750319|NCT00662857|75869514|FG000|STARTED|TI Dosing Period 1 (1 Day)||13||
59750320|NCT00662857|75869515|FG001|STARTED|TI Dosing Period 1 (1 Day)||16||
59750321|NCT00662857|75869514|FG000|COMPLETED|TI Dosing Period 1 (1 Day)||13||
59750322|NCT00662857|75869515|FG001|COMPLETED|TI Dosing Period 1 (1 Day)||16||
59750323|NCT00662857|75869514|FG000|NOT COMPLETED|TI Dosing Period 1 (1 Day)||0||
59750324|NCT00662857|75869515|FG001|NOT COMPLETED|TI Dosing Period 1 (1 Day)||0||
59750325|NCT00662857|75869514|FG000|STARTED|Washout 1 (3 - 14 Days)||13||
59750326|NCT00662857|75869515|FG001|STARTED|Washout 1 (3 - 14 Days)||16||
59750327|NCT00662857|75869514|FG000|COMPLETED|Washout 1 (3 - 14 Days)||13||
59750328|NCT00662857|75869515|FG001|COMPLETED|Washout 1 (3 - 14 Days)||14||
59750329|NCT00662857|75869514|FG000|NOT COMPLETED|Washout 1 (3 - 14 Days)||0||
59750330|NCT00662857|75869515|FG001|NOT COMPLETED|Washout 1 (3 - 14 Days)||2||
59750331|NCT00662857|75869514|FG000|STARTED|TI Dosing Period 2 (1 Day)||13||
59750332|NCT00662857|75869515|FG001|STARTED|TI Dosing Period 2 (1 Day)||14||
59750333|NCT00662857|75869514|FG000|COMPLETED|TI Dosing Period 2 (1 Day)||13||
59750334|NCT00662857|75869515|FG001|COMPLETED|TI Dosing Period 2 (1 Day)||14||
59750335|NCT00662857|75869514|FG000|NOT COMPLETED|TI Dosing Period 2 (1 Day)||0||
59750336|NCT00662857|75869515|FG001|NOT COMPLETED|TI Dosing Period 2 (1 Day)||0||
59750337|NCT00662857|75869514|FG000|STARTED|Washout 2 (3 - 14 Days)||13||
59750338|NCT00662857|75869515|FG001|STARTED|Washout 2 (3 - 14 Days)||14||
59750339|NCT00662857|75869514|FG000|COMPLETED|Washout 2 (3 - 14 Days)||12||
59750340|NCT00662857|75869515|FG001|COMPLETED|Washout 2 (3 - 14 Days)||14||
59750341|NCT00662857|75869514|FG000|NOT COMPLETED|Washout 2 (3 - 14 Days)||1||
59750342|NCT00662857|75869515|FG001|NOT COMPLETED|Washout 2 (3 - 14 Days)||0||
59750343|NCT00662857|75869514|FG000|STARTED|Lispro Dosing Period (1 Day)||12||
59750344|NCT00662857|75869515|FG001|STARTED|Lispro Dosing Period (1 Day)||14||
59750345|NCT00662857|75869514|FG000|COMPLETED|Lispro Dosing Period (1 Day)||12||
59750346|NCT00662857|75869515|FG001|COMPLETED|Lispro Dosing Period (1 Day)||14||
59605435|NCT02003898|75715619|FG000|STARTED|Overall Study||372||
59750347|NCT00662857|75869514|FG000|NOT COMPLETED|Lispro Dosing Period (1 Day)||0||
59750348|NCT00662857|75869515|FG001|NOT COMPLETED|Lispro Dosing Period (1 Day)||0||
59879361|NCT03292016|76002599|FG005|COMPLETED|First Washout||2||
59879362|NCT03292016|76002594|FG000|NOT COMPLETED|First Washout||0||
59879363|NCT03292016|76002595|FG001|NOT COMPLETED|First Washout||0||
59879364|NCT03292016|76002596|FG002|NOT COMPLETED|First Washout||0||
59879365|NCT03292016|76002597|FG003|NOT COMPLETED|First Washout||0||
59879366|NCT03292016|76002598|FG004|NOT COMPLETED|First Washout||0||
59879367|NCT03292016|76002599|FG005|NOT COMPLETED|First Washout||0||
59879368|NCT03292016|76002594|FG000|STARTED|Second Intervention||1||
59879369|NCT03292016|76002595|FG001|STARTED|Second Intervention||1||
59879370|NCT03292016|76002596|FG002|STARTED|Second Intervention||2||
59879371|NCT03292016|76002597|FG003|STARTED|Second Intervention||1||
59879372|NCT03292016|76002598|FG004|STARTED|Second Intervention||1||
59879373|NCT03292016|76002599|FG005|STARTED|Second Intervention||2||
59879374|NCT03292016|76002594|FG000|COMPLETED|Second Intervention||1||
59879375|NCT03292016|76002595|FG001|COMPLETED|Second Intervention||1||
59879376|NCT03292016|76002596|FG002|COMPLETED|Second Intervention||2||
59879377|NCT03292016|76002597|FG003|COMPLETED|Second Intervention||1||
59879378|NCT03292016|76002598|FG004|COMPLETED|Second Intervention||1||
59879379|NCT03292016|76002599|FG005|COMPLETED|Second Intervention||2||
59879380|NCT03292016|76002594|FG000|NOT COMPLETED|Second Intervention||0||
59879381|NCT03292016|76002595|FG001|NOT COMPLETED|Second Intervention||0||
59879382|NCT03292016|76002596|FG002|NOT COMPLETED|Second Intervention||0||
59879383|NCT03292016|76002597|FG003|NOT COMPLETED|Second Intervention||0||
59879384|NCT03292016|76002598|FG004|NOT COMPLETED|Second Intervention||0||
59879385|NCT03292016|76002599|FG005|NOT COMPLETED|Second Intervention||0||
59879386|NCT03292016|76002594|FG000|STARTED|Second Washout||1||
59879387|NCT03292016|76002595|FG001|STARTED|Second Washout||1||
59879388|NCT03292016|76002596|FG002|STARTED|Second Washout||2||
59879389|NCT03292016|76002597|FG003|STARTED|Second Washout||1||
59879390|NCT03292016|76002598|FG004|STARTED|Second Washout||1||
59879391|NCT03292016|76002599|FG005|STARTED|Second Washout||2||
59879392|NCT03292016|76002594|FG000|COMPLETED|Second Washout||1||
59879393|NCT03292016|76002595|FG001|COMPLETED|Second Washout||0||
59879394|NCT03292016|76002596|FG002|COMPLETED|Second Washout||2||
59879395|NCT03292016|76002597|FG003|COMPLETED|Second Washout||1||
59879396|NCT03292016|76002598|FG004|COMPLETED|Second Washout||1||
59879397|NCT03292016|76002599|FG005|COMPLETED|Second Washout||2||
59879398|NCT03292016|76002594|FG000|NOT COMPLETED|Second Washout||0||
59879399|NCT03292016|76002595|FG001|NOT COMPLETED|Second Washout||1||
59879400|NCT03292016|76002596|FG002|NOT COMPLETED|Second Washout||0||
59879401|NCT03292016|76002597|FG003|NOT COMPLETED|Second Washout||0||
59879402|NCT03292016|76002598|FG004|NOT COMPLETED|Second Washout||0||
59879403|NCT03292016|76002599|FG005|NOT COMPLETED|Second Washout||0||
59879404|NCT03292016|76002594|FG000|STARTED|Third Intervention||1||
59879405|NCT03292016|76002595|FG001|STARTED|Third Intervention||0||
59879406|NCT03292016|76002596|FG002|STARTED|Third Intervention||2||
59879407|NCT03292016|76002597|FG003|STARTED|Third Intervention||1||
59879408|NCT03292016|76002598|FG004|STARTED|Third Intervention||1||
59879409|NCT03292016|76002599|FG005|STARTED|Third Intervention||2||
59879410|NCT03292016|76002594|FG000|COMPLETED|Third Intervention||1||
59879411|NCT03292016|76002595|FG001|COMPLETED|Third Intervention||0||
59879412|NCT03292016|76002596|FG002|COMPLETED|Third Intervention||2||
59879413|NCT03292016|76002597|FG003|COMPLETED|Third Intervention||1||
59879414|NCT03292016|76002598|FG004|COMPLETED|Third Intervention||1||
59879415|NCT03292016|76002599|FG005|COMPLETED|Third Intervention||2||
59879416|NCT03292016|76002594|FG000|NOT COMPLETED|Third Intervention||0||
59879417|NCT03292016|76002595|FG001|NOT COMPLETED|Third Intervention||0||
59879418|NCT03292016|76002596|FG002|NOT COMPLETED|Third Intervention||0||
59879419|NCT03292016|76002597|FG003|NOT COMPLETED|Third Intervention||0||
59879420|NCT03292016|76002598|FG004|NOT COMPLETED|Third Intervention||0||
59879421|NCT03292016|76002599|FG005|NOT COMPLETED|Third Intervention||0||
59879422|NCT03290300|76002607|FG000|STARTED|Overall Study||39||
59879423|NCT03290300|76002607|FG000|COMPLETED|Overall Study||36||
59879424|NCT03290300|76002607|FG000|NOT COMPLETED|Overall Study||3||
59879425|NCT03289676|76002620|FG000|STARTED|Overall Study||27||
59879426|NCT03289676|76002621|FG001|STARTED|Overall Study||26||
59879427|NCT03289676|76002620|FG000|COMPLETED|Overall Study||23|Received 80% of the allotted intervention|
59879428|NCT03289676|76002621|FG001|COMPLETED|Overall Study|Received 80% of the allotted intervention|25|Received 80% of the allotted intervention|
59879429|NCT03289676|76002620|FG000|NOT COMPLETED|Overall Study||4||
59879430|NCT03289676|76002621|FG001|NOT COMPLETED|Overall Study||1||
59879431|NCT04251884|76002629|FG000|STARTED|Overall Study||23||
59879432|NCT04251884|76002630|FG001|STARTED|Overall Study||26||
59879433|NCT04251884|76002629|FG000|COMPLETED|Overall Study||23||
59879434|NCT04251884|76002630|FG001|COMPLETED|Overall Study||26||
59879435|NCT04251884|76002629|FG000|NOT COMPLETED|Overall Study||0||
59879436|NCT04251884|76002630|FG001|NOT COMPLETED|Overall Study||0||
59879437|NCT03287804|76002637|FG000|STARTED|Overall Study||12||
59879438|NCT03287804|76002637|FG000|Leukaperesed|Overall Study||12||
59879439|NCT03287804|76002637|FG000|Started Pre-conditioning Therapy|Overall Study||11||
59879440|NCT03287804|76002637|FG000|Received Study Treatment|Overall Study||11||
59879441|NCT03287804|76002637|FG000|COMPLETED|Overall Study||1||
59879442|NCT03287804|76002637|FG000|NOT COMPLETED|Overall Study||11||
59879443|NCT03286400|76002642|FG000|STARTED|Overall Study||127||
59879444|NCT03286400|76002642|FG000|COMPLETED|Overall Study||102||
59879445|NCT03286400|76002642|FG000|NOT COMPLETED|Overall Study||25||
59879446|NCT03310970|76002646|FG000|STARTED|Overall Study||11||
59879447|NCT03310970|76002647|FG001|STARTED|Overall Study||12||
59879448|NCT03310970|76002646|FG000|COMPLETED|Overall Study||11||
59879449|NCT03310970|76002647|FG001|COMPLETED|Overall Study||11||
59879450|NCT03310970|76002646|FG000|NOT COMPLETED|Overall Study||0||
59879451|NCT03310970|76002647|FG001|NOT COMPLETED|Overall Study||1||
59879452|NCT03285308|76002656|FG000|STARTED|Overall Study||167||
59879453|NCT03285308|76002657|FG001|STARTED|Overall Study||169||
59879454|NCT03285308|76002656|FG000|Safety Population|Overall Study||163|Safety Population included participants who received ≥1 administration of Double-blind study treatment.|
59879455|NCT03285308|76002657|FG001|Safety Population|Overall Study||163|Safety Population included participants who received ≥1 administration of Double-blind study treatment.|
59879456|NCT03285308|76002656|FG000|COMPLETED|Overall Study||147||
59879457|NCT03285308|76002657|FG001|COMPLETED|Overall Study||146||
59879458|NCT03285308|76002656|FG000|NOT COMPLETED|Overall Study||20||
59879459|NCT03285308|76002657|FG001|NOT COMPLETED|Overall Study||23||
59879460|NCT02722941|76002666|FG000|STARTED|Overall Study||15||
59879461|NCT02722941|76002667|FG001|STARTED|Overall Study||15||
59879462|NCT02722941|76002666|FG000|COMPLETED|Overall Study||15||
59879463|NCT02722941|76002667|FG001|COMPLETED|Overall Study||15||
59879464|NCT02722941|76002666|FG000|NOT COMPLETED|Overall Study||0||
59879465|NCT02722941|76002667|FG001|NOT COMPLETED|Overall Study||0||
59879466|NCT03723915|76002673|FG000|STARTED|Screening||17||
59879467|NCT03723915|76002673|FG000|COMPLETED|Screening||15||
59879468|NCT03723915|76002673|FG000|NOT COMPLETED|Screening||2||
59879469|NCT03723915|76002673|FG000|STARTED|On Treatment||15||
59879470|NCT03723915|76002673|FG000|Registered on Study|On Treatment||15||
59879471|NCT03723915|76002673|FG000|Received First Dose of Study Drugs|On Treatment||13||
59879472|NCT03723915|76002673|FG000|COMPLETED|On Treatment||13||
59879473|NCT03723915|76002673|FG000|NOT COMPLETED|On Treatment||2||
59879474|NCT03723915|76002673|FG000|STARTED|Survival Follow-up||13|Followed until progression (PD) or withdrawal of consent. At PD followed for survival until death.|
59879475|NCT03723915|76002673|FG000|COMPLETED|Survival Follow-up||13||
59879476|NCT03723915|76002673|FG000|NOT COMPLETED|Survival Follow-up||0||
59879477|NCT03281876|76002679|FG000|STARTED|Overall Study||304||
59879478|NCT03281876|76002680|FG001|STARTED|Overall Study||302||
59879479|NCT03281876|76002679|FG000|COMPLETED|Overall Study||281||
59879480|NCT03281876|76002680|FG001|COMPLETED|Overall Study||263||
59879481|NCT03281876|76002679|FG000|NOT COMPLETED|Overall Study||23||
59879482|NCT03281876|76002680|FG001|NOT COMPLETED|Overall Study||39||
59879483|NCT03310580|76002689|FG000|STARTED|Overall Study||15||
59879484|NCT03310580|76002690|FG001|STARTED|Overall Study||15||
59879485|NCT03310580|76002691|FG002|STARTED|Overall Study||12||
59879486|NCT03310580|76002689|FG000|COMPLETED|Overall Study||15||
59879487|NCT03310580|76002690|FG001|COMPLETED|Overall Study||14||
59879488|NCT03310580|76002691|FG002|COMPLETED|Overall Study||12||
59879489|NCT03310580|76002689|FG000|NOT COMPLETED|Overall Study||0||
59879490|NCT03310580|76002690|FG001|NOT COMPLETED|Overall Study||1||
59879491|NCT03310580|76002691|FG002|NOT COMPLETED|Overall Study||0||
59879492|NCT04514991|76002702|FG000|STARTED|Overall Study||41||41
59879493|NCT04514991|76002703|FG001|STARTED|Overall Study||45||45
59879494|NCT04514991|76002702|FG000|COMPLETED|Overall Study||30||30
59879495|NCT04514991|76002703|FG001|COMPLETED|Overall Study||36||36
59879496|NCT04514991|76002702|FG000|NOT COMPLETED|Overall Study||11||11
59879497|NCT04514991|76002703|FG001|NOT COMPLETED|Overall Study||9||9
59879498|NCT03415022|76002714|FG000|STARTED|Overall Study||21||
59879499|NCT03415022|76002715|FG001|STARTED|Overall Study||20||
59879500|NCT03415022|76002714|FG000|COMPLETED|Overall Study||16||
59879501|NCT03415022|76002715|FG001|COMPLETED|Overall Study||15||
59879502|NCT03415022|76002714|FG000|NOT COMPLETED|Overall Study||5||
59879503|NCT03415022|76002715|FG001|NOT COMPLETED|Overall Study||5||
59879504|NCT02816398|76002721|FG000|STARTED|Overall Study||26||
59879505|NCT02816398|76002721|FG000|COMPLETED|Overall Study||12||
59879506|NCT02816398|76002721|FG000|NOT COMPLETED|Overall Study||14||
59879507|NCT02812186|76002727|FG000|STARTED|Period 1||40||
59879508|NCT02812186|76002728|FG001|STARTED|Period 1||39||
59879509|NCT02812186|76002727|FG000|COMPLETED|Period 1||29||
59879510|NCT02812186|76002728|FG001|COMPLETED|Period 1||24||
59879511|NCT02812186|76002727|FG000|NOT COMPLETED|Period 1||11||
59879512|NCT02812186|76002728|FG001|NOT COMPLETED|Period 1||15||
59879513|NCT02812186|76002727|FG000|STARTED|Period 2||29||
59879514|NCT02812186|76002728|FG001|STARTED|Period 2||24||
59879515|NCT02812186|76002727|FG000|COMPLETED|Period 2||29||
59879516|NCT02812186|76002728|FG001|COMPLETED|Period 2||24||
59879517|NCT02812186|76002727|FG000|NOT COMPLETED|Period 2||0||
59879518|NCT02812186|76002728|FG001|NOT COMPLETED|Period 2||0||
59879519|NCT02811640|76002737|FG000|STARTED|Overall Study||12||
59879520|NCT02811640|76002737|FG000|COMPLETED|Overall Study||10||
59879521|NCT02811640|76002737|FG000|NOT COMPLETED|Overall Study||2||
59605436|NCT02003898|75715619|FG000|COMPLETED|Overall Study||305||
59879522|NCT03310268|76002744|FG000|STARTED|Overall Study||62||
59879523|NCT03310268|76002745|FG001|STARTED|Overall Study||62||
59605437|NCT02003898|75715619|FG000|NOT COMPLETED|Overall Study||67||
59879524|NCT03310268|76002746|FG002|STARTED|Overall Study||61||
59879525|NCT03310268|76002744|FG000|COMPLETED|Overall Study||61||
59879526|NCT03310268|76002745|FG001|COMPLETED|Overall Study||57||
59879527|NCT03310268|76002746|FG002|COMPLETED|Overall Study||61||
59879528|NCT03310268|76002744|FG000|NOT COMPLETED|Overall Study||1||
59879529|NCT03310268|76002745|FG001|NOT COMPLETED|Overall Study||5||
59879530|NCT03310268|76002746|FG002|NOT COMPLETED|Overall Study||0||
59879531|NCT02810392|76002756|FG000|STARTED|Overall Study||9||
59879532|NCT02810392|76002757|FG001|STARTED|Overall Study||10||
59879533|NCT02810392|76002756|FG000|COMPLETED|Overall Study||8||
59879534|NCT02810392|76002757|FG001|COMPLETED|Overall Study||9||
59879535|NCT02810392|76002756|FG000|NOT COMPLETED|Overall Study||1||
59879536|NCT02810392|76002757|FG001|NOT COMPLETED|Overall Study||1||
59605438|NCT01994226|75715625|FG000|STARTED|Overall Study||199||
59605439|NCT01994226|75715626|FG001|STARTED|Overall Study||200||
59605440|NCT01994226|75715625|FG000|COMPLETED|Overall Study||180||
59605441|NCT01994226|75715626|FG001|COMPLETED|Overall Study||179||
59605442|NCT01994226|75715625|FG000|NOT COMPLETED|Overall Study||19||
59605443|NCT01994226|75715626|FG001|NOT COMPLETED|Overall Study||21||
59605444|NCT02002884|75715635|FG000|STARTED|Main Period (MP)||87||
59750349|NCT00878553|75869528|FG000|STARTED|Sleep Study|This Intention to Treat population includes all randomized patients; one dropped prior to treatment.|67||
59750350|NCT00878553|75869529|FG001|STARTED|Sleep Study||0||
59750351|NCT00878553|75869530|FG002|STARTED|Sleep Study||0||
59750352|NCT00878553|75869531|FG003|STARTED|Sleep Study||0||
59750353|NCT00878553|75869532|FG004|STARTED|Sleep Study||0||
59605445|NCT02002884|75715636|FG001|STARTED|Main Period (MP)||88||
59605446|NCT02002884|75715637|FG002|STARTED|Main Period (MP)||176||
59605447|NCT02002884|75715638|FG003|STARTED|Main Period (MP)||0||
59605448|NCT02002884|75715635|FG000|Treated|Main Period (MP)||87||
59879537|NCT02815540|76002763|FG000|STARTED|Overall Study||2||
59879538|NCT02815540|76002763|FG000|COMPLETED|Overall Study||0||
59879539|NCT02815540|76002763|FG000|NOT COMPLETED|Overall Study||2||
59879540|NCT03280550|76002769|FG000|STARTED|Overall Study||66||
59879541|NCT03280550|76002770|FG001|STARTED|Overall Study||72||
59879542|NCT03280550|76002769|FG000|COMPLETED|Overall Study||64||
59879543|NCT03280550|76002770|FG001|COMPLETED|Overall Study||69||
59879544|NCT03280550|76002769|FG000|NOT COMPLETED|Overall Study||2||
59879545|NCT03280550|76002770|FG001|NOT COMPLETED|Overall Study||3||
59879546|NCT03276026|76002778|FG000|STARTED|Overall Study||35||
59879547|NCT03276026|76002779|FG001|STARTED|Overall Study||33||
59879548|NCT03276026|76002778|FG000|COMPLETED|Overall Study||34||
59879549|NCT03276026|76002779|FG001|COMPLETED|Overall Study||33||
59879550|NCT03276026|76002778|FG000|NOT COMPLETED|Overall Study||1||
59879551|NCT03276026|76002779|FG001|NOT COMPLETED|Overall Study||0||
59879552|NCT01589523|76002785|FG000|STARTED|Overall Study||5||
59879553|NCT01589523|76002785|FG000|COMPLETED|Overall Study||4||
59879554|NCT01589523|76002785|FG000|NOT COMPLETED|Overall Study||1||
59879555|NCT03277352|76002791|FG000|STARTED|Overall Study||10||
59879556|NCT03277352|76002791|FG000|COMPLETED|Overall Study||0||
59879557|NCT03277352|76002791|FG000|NOT COMPLETED|Overall Study||10||
59879558|NCT03276728|76002804|FG000|STARTED|Overall Study||22||
59879559|NCT03276728|76002805|FG001|STARTED|Overall Study||66||
59879560|NCT03276728|76002806|FG002|STARTED|Overall Study||16||
59879561|NCT03276728|76002807|FG003|STARTED|Overall Study||50||
59879562|NCT03276728|76002808|FG004|STARTED|Overall Study||7||
59879563|NCT03276728|76002809|FG005|STARTED|Overall Study||1||
59879564|NCT03276728|76002810|FG006|STARTED|Overall Study||17||
59879565|NCT03276728|76002811|FG007|STARTED|Overall Study||3||
59879566|NCT03276728|76002804|FG000|Treated Participants|Overall Study||22||
59879567|NCT03276728|76002805|FG001|Treated Participants|Overall Study||66||
59879568|NCT03276728|76002806|FG002|Treated Participants|Overall Study||16||
59879569|NCT03276728|76002807|FG003|Treated Participants|Overall Study||50||
59879570|NCT03276728|76002808|FG004|Treated Participants|Overall Study||7||
59879571|NCT03276728|76002809|FG005|Treated Participants|Overall Study||1||
59879572|NCT03276728|76002810|FG006|Treated Participants|Overall Study||16||
59879573|NCT03276728|76002811|FG007|Treated Participants|Overall Study||3||
59879574|NCT03276728|76002804|FG000|COMPLETED|Overall Study||22||
59879575|NCT03276728|76002805|FG001|COMPLETED|Overall Study||66||
60002551|NCT01663623|76118453|FG001|STARTED|Overall Study||53||
59605449|NCT02002884|75715636|FG001|Treated|Main Period (MP)||87||
59605450|NCT02002884|75715637|FG002|Treated|Main Period (MP)||176||
59605451|NCT02002884|75715638|FG003|Treated|Main Period (MP)||0||
59605452|NCT02002884|75715635|FG000|COMPLETED|Main Period (MP)||81||
59605453|NCT02002884|75715636|FG001|COMPLETED|Main Period (MP)||82||
59605454|NCT02002884|75715637|FG002|COMPLETED|Main Period (MP)||168||
59750354|NCT00878553|75869528|FG000|Number of Patients Receiving Placebo|Sleep Study||66||
59750355|NCT00878553|75869529|FG001|Number of Patients Receiving Placebo|Sleep Study||0||
59750356|NCT00878553|75869530|FG002|Number of Patients Receiving Placebo|Sleep Study||0||
59750357|NCT00878553|75869531|FG003|Number of Patients Receiving Placebo|Sleep Study||0||
59750358|NCT00878553|75869532|FG004|Number of Patients Receiving Placebo|Sleep Study||0||
59750359|NCT00878553|75869528|FG000|Number of Patients Receiving 10mg|Sleep Study||65||
59750360|NCT00878553|75869529|FG001|Number of Patients Receiving 10mg|Sleep Study||0||
59750361|NCT00878553|75869530|FG002|Number of Patients Receiving 10mg|Sleep Study||0||
59762507|NCT00866619|75882229|FG003|NOT COMPLETED|Overall Study||630||
59879576|NCT03276728|76002806|FG002|COMPLETED|Overall Study||14||
59879577|NCT03276728|76002807|FG003|COMPLETED|Overall Study||45||
59879578|NCT03276728|76002808|FG004|COMPLETED|Overall Study||6||
59879579|NCT03276728|76002809|FG005|COMPLETED|Overall Study||1||
59879580|NCT03276728|76002810|FG006|COMPLETED|Overall Study||15||
59879581|NCT03276728|76002811|FG007|COMPLETED|Overall Study||2||
59879582|NCT03276728|76002804|FG000|NOT COMPLETED|Overall Study||0||
59605455|NCT02002884|75715638|FG003|COMPLETED|Main Period (MP)||0||
59605456|NCT02002884|75715635|FG000|NOT COMPLETED|Main Period (MP)||6||
59605457|NCT02002884|75715636|FG001|NOT COMPLETED|Main Period (MP)||6||
59605458|NCT02002884|75715637|FG002|NOT COMPLETED|Main Period (MP)||8||
59879583|NCT03276728|76002805|FG001|NOT COMPLETED|Overall Study||0||
59879584|NCT03276728|76002806|FG002|NOT COMPLETED|Overall Study||2||
59879585|NCT03276728|76002807|FG003|NOT COMPLETED|Overall Study||5||
59879586|NCT03276728|76002808|FG004|NOT COMPLETED|Overall Study||1||
59879587|NCT03276728|76002809|FG005|NOT COMPLETED|Overall Study||0||
59879588|NCT03276728|76002810|FG006|NOT COMPLETED|Overall Study||2||
59879589|NCT03276728|76002811|FG007|NOT COMPLETED|Overall Study||1||
59879590|NCT03275246|76002831|FG000|STARTED|Overall Study||8||
59879591|NCT03275246|76002831|FG000|COMPLETED|Overall Study||2||
59879592|NCT03275246|76002831|FG000|NOT COMPLETED|Overall Study||6||
59879593|NCT02940860|76002837|FG000|STARTED|Overall Study||1027||
59879594|NCT02940860|76002838|FG001|STARTED|Overall Study||511||
59879595|NCT02940860|76002837|FG000|COMPLETED|Overall Study||971||
59879596|NCT02940860|76002838|FG001|COMPLETED|Overall Study||476||
59879597|NCT02940860|76002837|FG000|NOT COMPLETED|Overall Study||56||
59879598|NCT02940860|76002838|FG001|NOT COMPLETED|Overall Study||35||
59879599|NCT03309020|76002848|FG000|STARTED|Overall Study||12||
59879600|NCT03309020|76002849|FG001|STARTED|Overall Study||25||
59879601|NCT03309020|76002848|FG000|Underwent Cataract Surgery|Overall Study||10||
59879602|NCT03309020|76002849|FG001|Underwent Cataract Surgery|Overall Study||24||
59879603|NCT03309020|76002848|FG000|COMPLETED|Overall Study||9||
59879604|NCT03309020|76002849|FG001|COMPLETED|Overall Study||24||
59879605|NCT03309020|76002848|FG000|NOT COMPLETED|Overall Study||3||
59879606|NCT03309020|76002849|FG001|NOT COMPLETED|Overall Study||1||
59879607|NCT02806960|76002857|FG000|STARTED|Period 1||3||
59879608|NCT02806960|76002858|FG001|STARTED|Period 1||3||
59879609|NCT02806960|76002859|FG002|STARTED|Period 1||3||
59879610|NCT02806960|76002860|FG003|STARTED|Period 1||3||
59879611|NCT02806960|76002857|FG000|COMPLETED|Period 1||0||
59879612|NCT02806960|76002858|FG001|COMPLETED|Period 1||0||
59879613|NCT02806960|76002859|FG002|COMPLETED|Period 1||0||
59879614|NCT02806960|76002860|FG003|COMPLETED|Period 1||0||
59879615|NCT02806960|76002857|FG000|NOT COMPLETED|Period 1||3||
59879616|NCT02806960|76002858|FG001|NOT COMPLETED|Period 1||3||
59879617|NCT02806960|76002859|FG002|NOT COMPLETED|Period 1||3||
59879618|NCT02806960|76002860|FG003|NOT COMPLETED|Period 1||3||
59879619|NCT02806960|76002857|FG000|STARTED|Period 2||0||
59879620|NCT02806960|76002858|FG001|STARTED|Period 2||0||
59879621|NCT02806960|76002859|FG002|STARTED|Period 2||0||
59879622|NCT02806960|76002860|FG003|STARTED|Period 2||0||
59879623|NCT02806960|76002857|FG000|COMPLETED|Period 2||0||
59879624|NCT02806960|76002858|FG001|COMPLETED|Period 2||0||
59879625|NCT02806960|76002859|FG002|COMPLETED|Period 2||0||
59879626|NCT02806960|76002860|FG003|COMPLETED|Period 2||0||
59879627|NCT02806960|76002857|FG000|NOT COMPLETED|Period 2||0||
59879628|NCT02806960|76002858|FG001|NOT COMPLETED|Period 2||0||
59879629|NCT02806960|76002859|FG002|NOT COMPLETED|Period 2||0||
59879630|NCT02806960|76002860|FG003|NOT COMPLETED|Period 2||0||
59605459|NCT02002884|75715638|FG003|NOT COMPLETED|Main Period (MP)||0||
59879631|NCT02806960|76002857|FG000|STARTED|Period 3||0||
59879632|NCT02806960|76002858|FG001|STARTED|Period 3||0||
59879633|NCT02806960|76002859|FG002|STARTED|Period 3||0||
59879634|NCT02806960|76002860|FG003|STARTED|Period 3||0||
59879635|NCT02806960|76002857|FG000|COMPLETED|Period 3||0||
59879636|NCT02806960|76002858|FG001|COMPLETED|Period 3||0||
59879637|NCT02806960|76002859|FG002|COMPLETED|Period 3||0||
59879638|NCT02806960|76002860|FG003|COMPLETED|Period 3||0||
59879639|NCT02806960|76002857|FG000|NOT COMPLETED|Period 3||0||
59879640|NCT02806960|76002858|FG001|NOT COMPLETED|Period 3||0||
59879641|NCT02806960|76002859|FG002|NOT COMPLETED|Period 3||0||
59879642|NCT02806960|76002860|FG003|NOT COMPLETED|Period 3||0||
59879643|NCT02806960|76002857|FG000|STARTED|Period 4||0||
59879644|NCT02806960|76002858|FG001|STARTED|Period 4||0||
59879645|NCT02806960|76002859|FG002|STARTED|Period 4||0||
59879646|NCT02806960|76002860|FG003|STARTED|Period 4||0||
59879647|NCT02806960|76002857|FG000|COMPLETED|Period 4||0||
59879648|NCT02806960|76002858|FG001|COMPLETED|Period 4||0||
59879649|NCT02806960|76002859|FG002|COMPLETED|Period 4||0||
59879650|NCT02806960|76002860|FG003|COMPLETED|Period 4||0||
59879651|NCT02806960|76002857|FG000|NOT COMPLETED|Period 4||0||
59879652|NCT02806960|76002858|FG001|NOT COMPLETED|Period 4||0||
59879653|NCT02806960|76002859|FG002|NOT COMPLETED|Period 4||0||
59879654|NCT02806960|76002860|FG003|NOT COMPLETED|Period 4||0||
59879655|NCT03718143|76002870|FG000|STARTED|Overall Study||3||
59879656|NCT03718143|76002871|FG001|STARTED|Overall Study||2||
59879657|NCT03718143|76002872|FG002|STARTED|Overall Study||1||
59879658|NCT03718143|76002870|FG000|COMPLETED|Overall Study||0||
59879659|NCT03718143|76002871|FG001|COMPLETED|Overall Study||0||
59879660|NCT03718143|76002872|FG002|COMPLETED|Overall Study||0||
59879661|NCT03718143|76002870|FG000|NOT COMPLETED|Overall Study||3||
59879662|NCT03718143|76002871|FG001|NOT COMPLETED|Overall Study||2||
59879663|NCT03718143|76002872|FG002|NOT COMPLETED|Overall Study||1||
59879664|NCT03274466|76002882|FG000|STARTED|Overall Study||147||
59879665|NCT03274466|76002883|FG001|STARTED|Overall Study||147||
59879666|NCT03274466|76002882|FG000|COMPLETED|Overall Study||124||
59879667|NCT03274466|76002883|FG001|COMPLETED|Overall Study||118||
59879668|NCT03274466|76002882|FG000|NOT COMPLETED|Overall Study||23||
59879669|NCT03274466|76002883|FG001|NOT COMPLETED|Overall Study||29||
59879670|NCT02806726|76002889|FG000|STARTED|Overall Study|Subjects were treated contralaterally|7||14
59879671|NCT02806726|76002889|FG000|COMPLETED|Overall Study|Subjects were treated contralaterally|6||12
59879672|NCT02806726|76002889|FG000|NOT COMPLETED|Overall Study||1||2
59879673|NCT02806414|76002894|FG000|STARTED|Overall Study||25||
59879674|NCT02806414|76002894|FG000|COMPLETED|Overall Study||23||
59879675|NCT02806414|76002894|FG000|NOT COMPLETED|Overall Study||2||
59879676|NCT02806024|76002900|FG000|STARTED|Overall Study||7||
59879677|NCT02806024|76002901|FG001|STARTED|Overall Study||7||
59879678|NCT02806024|76002900|FG000|COMPLETED|Overall Study||6||
59879679|NCT02806024|76002901|FG001|COMPLETED|Overall Study||5||
59879680|NCT02806024|76002900|FG000|NOT COMPLETED|Overall Study||1||
59879681|NCT02806024|76002901|FG001|NOT COMPLETED|Overall Study||2||
59879682|NCT02805790|76002909|FG000|STARTED|First Intervention (4 Weeks)||14||
59879683|NCT02805790|76002910|FG001|STARTED|First Intervention (4 Weeks)||16||
59879684|NCT02805790|76002909|FG000|COMPLETED|First Intervention (4 Weeks)||14||
59879685|NCT02805790|76002910|FG001|COMPLETED|First Intervention (4 Weeks)||16||
59879686|NCT02805790|76002909|FG000|NOT COMPLETED|First Intervention (4 Weeks)||0||
59879687|NCT02805790|76002910|FG001|NOT COMPLETED|First Intervention (4 Weeks)||0||
59879688|NCT02805790|76002909|FG000|STARTED|Washout (4 Weeks)||14||
59879689|NCT02805790|76002910|FG001|STARTED|Washout (4 Weeks)||16||
59879690|NCT02805790|76002909|FG000|COMPLETED|Washout (4 Weeks)||14||
59879691|NCT02805790|76002910|FG001|COMPLETED|Washout (4 Weeks)||16||
59879692|NCT02805790|76002909|FG000|NOT COMPLETED|Washout (4 Weeks)||0||
59879693|NCT02805790|76002910|FG001|NOT COMPLETED|Washout (4 Weeks)||0||
59879694|NCT02805790|76002909|FG000|STARTED|Second Intervention (4 Weeks)||14||
59879695|NCT02805790|76002910|FG001|STARTED|Second Intervention (4 Weeks)||16||
59879696|NCT02805790|76002909|FG000|COMPLETED|Second Intervention (4 Weeks)||14||
59879697|NCT02805790|76002910|FG001|COMPLETED|Second Intervention (4 Weeks)||15||
59879698|NCT02805790|76002909|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0||
59879699|NCT02805790|76002910|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||1||
59879700|NCT02802592|76002916|FG000|STARTED|Overall Study||4||
59879701|NCT02802592|76002916|FG000|COMPLETED|Overall Study||0||
59879702|NCT02802592|76002916|FG000|NOT COMPLETED|Overall Study||4||
59879703|NCT02803138|76002921|FG000|STARTED|Overall Study||236|Treatment was not started in 20 participants.|
59879704|NCT02803138|76002921|FG000|COMPLETED|Overall Study||166||
59879705|NCT02803138|76002921|FG000|NOT COMPLETED|Overall Study||70||
59879706|NCT02801578|76002927|FG000|STARTED|Overall Study||11||
59879707|NCT02801578|76002927|FG000|COMPLETED|Overall Study||9||
59879708|NCT02801578|76002927|FG000|NOT COMPLETED|Overall Study||2||
59879709|NCT02799472|76002933|FG000|STARTED|Overall Study||11||
59879710|NCT02799472|76002934|FG001|STARTED|Overall Study||28||
59879711|NCT02799472|76002933|FG000|COMPLETED|Overall Study||7||
59879712|NCT02799472|76002934|FG001|COMPLETED|Overall Study||23||
59879713|NCT02799472|76002933|FG000|NOT COMPLETED|Overall Study||4||
59879714|NCT02799472|76002934|FG001|NOT COMPLETED|Overall Study||5||
59879715|NCT03245450|76002947|FG000|STARTED|Overall Study||3||
59879716|NCT03245450|76002948|FG001|STARTED|Overall Study||4||
59879717|NCT03245450|76002949|FG002|STARTED|Overall Study||3||
59879718|NCT03245450|76002950|FG003|STARTED|Overall Study||3||
59879719|NCT03245450|76002951|FG004|STARTED|Overall Study||9||
59879720|NCT03245450|76002952|FG005|STARTED|Overall Study||9||
59879721|NCT03245450|76002953|FG006|STARTED|Overall Study||9||
59879722|NCT03245450|76002947|FG000|COMPLETED|Overall Study||0||
59879723|NCT03245450|76002948|FG001|COMPLETED|Overall Study||0||
59879724|NCT03245450|76002949|FG002|COMPLETED|Overall Study||0||
59879725|NCT03245450|76002950|FG003|COMPLETED|Overall Study||0||
59879726|NCT03245450|76002951|FG004|COMPLETED|Overall Study||0||
59879727|NCT03245450|76002952|FG005|COMPLETED|Overall Study||0||
59879728|NCT03245450|76002953|FG006|COMPLETED|Overall Study||0||
59879729|NCT03245450|76002947|FG000|NOT COMPLETED|Overall Study||3||
59879730|NCT03245450|76002948|FG001|NOT COMPLETED|Overall Study||4||
59879731|NCT03245450|76002949|FG002|NOT COMPLETED|Overall Study||3||
59879732|NCT03245450|76002950|FG003|NOT COMPLETED|Overall Study||3||
59879733|NCT03245450|76002951|FG004|NOT COMPLETED|Overall Study||9||
59879734|NCT03245450|76002952|FG005|NOT COMPLETED|Overall Study||9||
59879735|NCT03245450|76002953|FG006|NOT COMPLETED|Overall Study||9||
59879736|NCT03712917|76002978|FG000|STARTED|Overall Study||40||
59879737|NCT03712917|76002979|FG001|STARTED|Overall Study||40||
59879738|NCT03712917|76002980|FG002|STARTED|Overall Study||40||
59879739|NCT03712917|76002978|FG000|COMPLETED|Overall Study||31||
59879740|NCT03712917|76002979|FG001|COMPLETED|Overall Study||32||
59879741|NCT03712917|76002980|FG002|COMPLETED|Overall Study||31||
59879742|NCT03712917|76002978|FG000|NOT COMPLETED|Overall Study||9||
59879743|NCT03712917|76002979|FG001|NOT COMPLETED|Overall Study||8||
59879744|NCT03712917|76002980|FG002|NOT COMPLETED|Overall Study||9||
59879745|NCT02748694|76003003|FG000|STARTED|Overall Study||10||
59879746|NCT02748694|76003004|FG001|STARTED|Overall Study||6||
59879747|NCT02748694|76003005|FG002|STARTED|Overall Study||6||
59879748|NCT02748694|76003006|FG003|STARTED|Overall Study||6||
59879749|NCT02748694|76003007|FG004|STARTED|Overall Study||6||
59879750|NCT02748694|76003008|FG005|STARTED|Overall Study||6||
59879751|NCT02748694|76003009|FG006|STARTED|Overall Study||8||
59879752|NCT02748694|76003010|FG007|STARTED|Overall Study||6||
59879753|NCT02748694|76003011|FG008|STARTED|Overall Study||6||
59879754|NCT02748694|76003012|FG009|STARTED|Overall Study||6||
59879755|NCT02748694|76003013|FG010|STARTED|Overall Study||6||
59879756|NCT02748694|76003014|FG011|STARTED|Overall Study||9||
59879757|NCT02748694|76003015|FG012|STARTED|Overall Study||9||
59879758|NCT02748694|76003016|FG013|STARTED|Overall Study||8||
59879759|NCT02748694|76003017|FG014|STARTED|Overall Study||16||
59879760|NCT02748694|76003003|FG000|COMPLETED|Overall Study||10||
59879761|NCT02748694|76003004|FG001|COMPLETED|Overall Study||6||
59879762|NCT02748694|76003005|FG002|COMPLETED|Overall Study||6||
59879763|NCT02748694|76003006|FG003|COMPLETED|Overall Study||6||
59879764|NCT02748694|76003007|FG004|COMPLETED|Overall Study||6||
59879765|NCT02748694|76003008|FG005|COMPLETED|Overall Study||6||
59879766|NCT02748694|76003009|FG006|COMPLETED|Overall Study||8||
59879767|NCT02748694|76003010|FG007|COMPLETED|Overall Study||6||
59879768|NCT02748694|76003011|FG008|COMPLETED|Overall Study||6||
59879769|NCT02748694|76003012|FG009|COMPLETED|Overall Study||6||
59879770|NCT02748694|76003013|FG010|COMPLETED|Overall Study||6||
59879771|NCT02748694|76003014|FG011|COMPLETED|Overall Study||9||
59879772|NCT02748694|76003015|FG012|COMPLETED|Overall Study||9||
59879773|NCT02748694|76003016|FG013|COMPLETED|Overall Study||8||
59879774|NCT02748694|76003017|FG014|COMPLETED|Overall Study||14||
59879775|NCT02748694|76003003|FG000|NOT COMPLETED|Overall Study||0||
59879776|NCT02748694|76003004|FG001|NOT COMPLETED|Overall Study||0||
59879777|NCT02748694|76003005|FG002|NOT COMPLETED|Overall Study||0||
59879778|NCT02748694|76003006|FG003|NOT COMPLETED|Overall Study||0||
59879779|NCT02748694|76003007|FG004|NOT COMPLETED|Overall Study||0||
59879780|NCT02748694|76003008|FG005|NOT COMPLETED|Overall Study||0||
59879781|NCT02748694|76003009|FG006|NOT COMPLETED|Overall Study||0||
59879782|NCT02748694|76003010|FG007|NOT COMPLETED|Overall Study||0||
59879783|NCT02748694|76003011|FG008|NOT COMPLETED|Overall Study||0||
59879784|NCT02748694|76003012|FG009|NOT COMPLETED|Overall Study||0||
59879785|NCT02748694|76003013|FG010|NOT COMPLETED|Overall Study||0||
59879786|NCT02748694|76003014|FG011|NOT COMPLETED|Overall Study||0||
59879787|NCT02748694|76003015|FG012|NOT COMPLETED|Overall Study||0||
59879788|NCT02748694|76003016|FG013|NOT COMPLETED|Overall Study||0||
59879789|NCT02748694|76003017|FG014|NOT COMPLETED|Overall Study||2||
59879790|NCT02800642|76003073|FG000|STARTED|Overall Study||162||
59879791|NCT02800642|76003073|FG000|COMPLETED|Overall Study||137||
59879792|NCT02800642|76003073|FG000|NOT COMPLETED|Overall Study||25||
59879793|NCT02799784|76003077|FG000|STARTED|Treatment Period 1 (TP1- 8 Weeks)||117||
59879794|NCT02799784|76003078|FG001|STARTED|Treatment Period 1 (TP1- 8 Weeks)||119||
59879795|NCT02799784|76003077|FG000|COMPLETED|Treatment Period 1 (TP1- 8 Weeks)||111||
59879796|NCT02799784|76003078|FG001|COMPLETED|Treatment Period 1 (TP1- 8 Weeks)||118||
59879797|NCT02799784|76003077|FG000|NOT COMPLETED|Treatment Period 1 (TP1- 8 Weeks)||6||
59879798|NCT02799784|76003078|FG001|NOT COMPLETED|Treatment Period 1 (TP1- 8 Weeks)||1||
59879799|NCT02799784|76003077|FG000|STARTED|Washout Period (3 Weeks)||111||
59879800|NCT02799784|76003078|FG001|STARTED|Washout Period (3 Weeks)||118||
59879801|NCT02799784|76003077|FG000|COMPLETED|Washout Period (3 Weeks)||111||
59879802|NCT02799784|76003078|FG001|COMPLETED|Washout Period (3 Weeks)||118||
59879803|NCT02799784|76003077|FG000|NOT COMPLETED|Washout Period (3 Weeks)||0||
59879804|NCT02799784|76003078|FG001|NOT COMPLETED|Washout Period (3 Weeks)||0||
59879805|NCT02799784|76003077|FG000|STARTED|Treatment Period 2 (TP2 - 8 Weeks)||111||
59879806|NCT02799784|76003078|FG001|STARTED|Treatment Period 2 (TP2 - 8 Weeks)||118||
59879807|NCT02799784|76003077|FG000|COMPLETED|Treatment Period 2 (TP2 - 8 Weeks)||110||
59879808|NCT02799784|76003078|FG001|COMPLETED|Treatment Period 2 (TP2 - 8 Weeks)||115||
59879809|NCT02799784|76003077|FG000|NOT COMPLETED|Treatment Period 2 (TP2 - 8 Weeks)||1||
59879810|NCT02799784|76003078|FG001|NOT COMPLETED|Treatment Period 2 (TP2 - 8 Weeks)||3||
59879811|NCT02054806|76003084|FG000|STARTED|Overall Study||477||
59879812|NCT02054806|76003084|FG000|Treated During First Course|Overall Study||475||
59879813|NCT02054806|76003084|FG000|Treated During Second Course|Overall Study||11||
59879814|NCT02054806|76003084|FG000|COMPLETED|Overall Study||0||
59879815|NCT02054806|76003084|FG000|NOT COMPLETED|Overall Study||477||
59879816|NCT01333072|76003117|FG000|STARTED|Overall Study||30||
59879817|NCT01333072|76003118|FG001|STARTED|Overall Study||31||
59879818|NCT01333072|76003117|FG000|COMPLETED|Overall Study||24||
59879819|NCT01333072|76003118|FG001|COMPLETED|Overall Study||27||
59879820|NCT01333072|76003117|FG000|NOT COMPLETED|Overall Study||6||
59879821|NCT01333072|76003118|FG001|NOT COMPLETED|Overall Study||4||
59879822|NCT01315353|76003127|FG000|STARTED|Overall Study||145||
59879823|NCT01315353|76003128|FG001|STARTED|Overall Study||143||
59879824|NCT01315353|76003129|FG002|STARTED|Overall Study||179||
59879825|NCT01315353|76003127|FG000|COMPLETED|Overall Study||116||
59879826|NCT01315353|76003128|FG001|COMPLETED|Overall Study||120||
59879827|NCT01315353|76003129|FG002|COMPLETED|Overall Study||166||
59879828|NCT01315353|76003127|FG000|NOT COMPLETED|Overall Study||29||
59879829|NCT01315353|76003128|FG001|NOT COMPLETED|Overall Study||23||
59879830|NCT01315353|76003129|FG002|NOT COMPLETED|Overall Study||13||
59879831|NCT03517540|76003141|FG000|STARTED|Overall Study||50||
59879832|NCT03517540|76003142|FG001|STARTED|Overall Study||48||
59879833|NCT03517540|76003143|FG002|STARTED|Overall Study||47||
59879834|NCT03517540|76003144|FG003|STARTED|Overall Study||48||
59879835|NCT03517540|76003141|FG000|COMPLETED|Overall Study||36||
59879836|NCT03517540|76003142|FG001|COMPLETED|Overall Study||41||
59879837|NCT03517540|76003143|FG002|COMPLETED|Overall Study||38||
59879838|NCT03517540|76003144|FG003|COMPLETED|Overall Study||43||
59879839|NCT03517540|76003141|FG000|NOT COMPLETED|Overall Study||14||
59879840|NCT03517540|76003142|FG001|NOT COMPLETED|Overall Study||7||
59879841|NCT03517540|76003143|FG002|NOT COMPLETED|Overall Study||9||
59879842|NCT03517540|76003144|FG003|NOT COMPLETED|Overall Study||5||
59879843|NCT02799082|76003156|FG000|STARTED|Overall Study||41||
59879844|NCT02799082|76003157|FG001|STARTED|Overall Study||81||
59879845|NCT02799082|76003156|FG000|COMPLETED|Overall Study||37||
59879846|NCT02799082|76003157|FG001|COMPLETED|Overall Study||77||
59879847|NCT02799082|76003156|FG000|NOT COMPLETED|Overall Study||4||
59879848|NCT02799082|76003157|FG001|NOT COMPLETED|Overall Study||4||
59879849|NCT03710889|76003163|FG000|STARTED|Overall Study||23||
59879850|NCT03710889|76003163|FG000|Received at Least 1 Dose of Study Drug|Overall Study||23|Safety Population|
59879851|NCT03710889|76003163|FG000|Bone-Biopsy Population|Overall Study||19|All enrolled participants who received an evaluable biopsy (defined as a biopsy sample that can be analyzed in the laboratory).|
59879852|NCT03710889|76003163|FG000|COMPLETED|Overall Study||20||
59879853|NCT03710889|76003163|FG000|NOT COMPLETED|Overall Study||3||
59879854|NCT02797678|76003167|FG000|STARTED|Screening Phase||62||
59879855|NCT02797678|76003168|FG001|STARTED|Screening Phase||0||
59879856|NCT02797678|76003169|FG002|STARTED|Screening Phase||0||
59879857|NCT02797678|76003170|FG003|STARTED|Screening Phase||0||
59879858|NCT02797678|76003167|FG000|COMPLETED|Screening Phase||37||
59879859|NCT02797678|76003168|FG001|COMPLETED|Screening Phase||0||
59879860|NCT02797678|76003169|FG002|COMPLETED|Screening Phase||0||
59879861|NCT02797678|76003170|FG003|COMPLETED|Screening Phase||0||
59879862|NCT02797678|76003167|FG000|NOT COMPLETED|Screening Phase||25||
59879863|NCT02797678|76003168|FG001|NOT COMPLETED|Screening Phase||0||
59879864|NCT02797678|76003169|FG002|NOT COMPLETED|Screening Phase||0||
59879865|NCT02797678|76003170|FG003|NOT COMPLETED|Screening Phase||0||
59879866|NCT02797678|76003167|FG000|STARTED|First Intervention (5 Nights)||0||
59879867|NCT02797678|76003168|FG001|STARTED|First Intervention (5 Nights)||20||
59879868|NCT02797678|76003169|FG002|STARTED|First Intervention (5 Nights)||17||
59879869|NCT02797678|76003170|FG003|STARTED|First Intervention (5 Nights)||0||
59879870|NCT02797678|76003167|FG000|COMPLETED|First Intervention (5 Nights)||0||
59879871|NCT02797678|76003168|FG001|COMPLETED|First Intervention (5 Nights)||19||
59879872|NCT02797678|76003169|FG002|COMPLETED|First Intervention (5 Nights)||17||
59879873|NCT02797678|76003170|FG003|COMPLETED|First Intervention (5 Nights)||0||
59879874|NCT02797678|76003167|FG000|NOT COMPLETED|First Intervention (5 Nights)||0||
59879875|NCT02797678|76003168|FG001|NOT COMPLETED|First Intervention (5 Nights)||1||
59879876|NCT02797678|76003169|FG002|NOT COMPLETED|First Intervention (5 Nights)||0||
59879877|NCT02797678|76003170|FG003|NOT COMPLETED|First Intervention (5 Nights)||0||
59879878|NCT02797678|76003167|FG000|STARTED|Washout||0||
59879879|NCT02797678|76003168|FG001|STARTED|Washout||19||
59879880|NCT02797678|76003169|FG002|STARTED|Washout||17||
59879881|NCT02797678|76003170|FG003|STARTED|Washout||0||
59879882|NCT02797678|76003167|FG000|COMPLETED|Washout||0||
60135823|NCT01133990|76258500|FG000|STARTED|Phase 2 (Dose-confirmation Phase)||0|The study was terminated after phase 1b (E7820 40 mg/day). Hence, no participants were enrolled in Phase 2.|
60135824|NCT01133990|76258501|FG001|STARTED|Phase 2 (Dose-confirmation Phase)||0|The study was terminated after phase 1b (E7820 40 mg/day). Hence, no participants were enrolled in Phase 2.|
60135825|NCT01133990|76258502|FG002|STARTED|Phase 2 (Dose-confirmation Phase)||0|The study was terminated after phase 1b (E7820 40 mg/day). Hence, no participants were enrolled in Phase 2.|
60135826|NCT01133990|76258503|FG003|STARTED|Phase 2 (Dose-confirmation Phase)||0|The study was terminated after phase 1b (E7820 40 mg/day). Hence, no participants were enrolled in Phase 2.|
60135827|NCT01133990|76258504|FG004|STARTED|Phase 2 (Dose-confirmation Phase)||0|The study was terminated after phase 1b (E7820 40 mg/day). Hence, no participants were enrolled in Phase 2.|
60135828|NCT01133990|76258505|FG005|STARTED|Phase 2 (Dose-confirmation Phase)||0|The study was terminated after phase 1b (E7820 40 mg/day). Hence, no participants were enrolled in Phase 2.|
60135829|NCT01133990|76258500|FG000|COMPLETED|Phase 2 (Dose-confirmation Phase)||0||
60135830|NCT01133990|76258501|FG001|COMPLETED|Phase 2 (Dose-confirmation Phase)||0||
60135831|NCT01133990|76258502|FG002|COMPLETED|Phase 2 (Dose-confirmation Phase)||0||
60135832|NCT01133990|76258503|FG003|COMPLETED|Phase 2 (Dose-confirmation Phase)||0||
60135833|NCT01133990|76258504|FG004|COMPLETED|Phase 2 (Dose-confirmation Phase)||0||
60135834|NCT01133990|76258505|FG005|COMPLETED|Phase 2 (Dose-confirmation Phase)||0||
60135835|NCT01133990|76258500|FG000|NOT COMPLETED|Phase 2 (Dose-confirmation Phase)||0||
60135836|NCT01133990|76258501|FG001|NOT COMPLETED|Phase 2 (Dose-confirmation Phase)||0||
60135837|NCT01133990|76258502|FG002|NOT COMPLETED|Phase 2 (Dose-confirmation Phase)||0||
60135838|NCT01133990|76258503|FG003|NOT COMPLETED|Phase 2 (Dose-confirmation Phase)||0||
60135839|NCT01133990|76258504|FG004|NOT COMPLETED|Phase 2 (Dose-confirmation Phase)||0||
60135840|NCT01133990|76258505|FG005|NOT COMPLETED|Phase 2 (Dose-confirmation Phase)||0||
60135841|NCT00910429|76258514|FG000|STARTED|Overall Study||155||
59879883|NCT02797678|76003168|FG001|COMPLETED|Washout||19||
59879884|NCT02797678|76003169|FG002|COMPLETED|Washout||17||
59879885|NCT02797678|76003170|FG003|COMPLETED|Washout||0||
59879886|NCT02797678|76003167|FG000|NOT COMPLETED|Washout||0||
59879887|NCT02797678|76003168|FG001|NOT COMPLETED|Washout||0||
59879888|NCT02797678|76003169|FG002|NOT COMPLETED|Washout||0||
59879889|NCT02797678|76003170|FG003|NOT COMPLETED|Washout||0||
59879890|NCT02797678|76003167|FG000|STARTED|Second Intervention (5 Nights)||0||
59879891|NCT02797678|76003168|FG001|STARTED|Second Intervention (5 Nights)||19||
59879892|NCT02797678|76003169|FG002|STARTED|Second Intervention (5 Nights)||17||
59879893|NCT02797678|76003170|FG003|STARTED|Second Intervention (5 Nights)||0||
59879894|NCT02797678|76003167|FG000|COMPLETED|Second Intervention (5 Nights)||0||
59879895|NCT02797678|76003168|FG001|COMPLETED|Second Intervention (5 Nights)||19||
59879896|NCT02797678|76003169|FG002|COMPLETED|Second Intervention (5 Nights)||16||
59879897|NCT02797678|76003170|FG003|COMPLETED|Second Intervention (5 Nights)||0||
59879898|NCT02797678|76003167|FG000|NOT COMPLETED|Second Intervention (5 Nights)||0||
59879899|NCT02797678|76003168|FG001|NOT COMPLETED|Second Intervention (5 Nights)||0||
59879900|NCT02797678|76003169|FG002|NOT COMPLETED|Second Intervention (5 Nights)||1||
59879901|NCT02797678|76003170|FG003|NOT COMPLETED|Second Intervention (5 Nights)||0||
59879902|NCT02797678|76003167|FG000|STARTED|Sub-Study||0||
59879903|NCT02797678|76003168|FG001|STARTED|Sub-Study||0||
59879904|NCT02797678|76003169|FG002|STARTED|Sub-Study||0||
59879905|NCT02797678|76003170|FG003|STARTED|Sub-Study||9||
59879906|NCT02797678|76003167|FG000|COMPLETED|Sub-Study||0||
59879907|NCT02797678|76003168|FG001|COMPLETED|Sub-Study||0||
59879908|NCT02797678|76003169|FG002|COMPLETED|Sub-Study||0||
59879909|NCT02797678|76003170|FG003|COMPLETED|Sub-Study||9||
59879910|NCT02797678|76003167|FG000|NOT COMPLETED|Sub-Study||0||
59879911|NCT02797678|76003168|FG001|NOT COMPLETED|Sub-Study||0||
59879912|NCT02797678|76003169|FG002|NOT COMPLETED|Sub-Study||0||
59879913|NCT02797678|76003170|FG003|NOT COMPLETED|Sub-Study||0||
59879914|NCT03308786|76003183|FG000|STARTED|Overall Study||9||
59879915|NCT03308786|76003183|FG000|COMPLETED|Overall Study||0||
59879916|NCT03308786|76003183|FG000|NOT COMPLETED|Overall Study||9||
59879917|NCT03274076|76003190|FG000|STARTED|24 Weeks Double Blind||10||
59879918|NCT03274076|76003191|FG001|STARTED|24 Weeks Double Blind||5||
59879919|NCT03274076|76003192|FG002|STARTED|24 Weeks Double Blind||0||
59879920|NCT03274076|76003193|FG003|STARTED|24 Weeks Double Blind||0||
59879921|NCT03274076|76003190|FG000|COMPLETED|24 Weeks Double Blind||10||
59879922|NCT03274076|76003191|FG001|COMPLETED|24 Weeks Double Blind||4||
59879923|NCT03274076|76003192|FG002|COMPLETED|24 Weeks Double Blind||0||
59879924|NCT03274076|76003193|FG003|COMPLETED|24 Weeks Double Blind||0||
59879925|NCT03274076|76003190|FG000|NOT COMPLETED|24 Weeks Double Blind||0||
59879926|NCT03274076|76003191|FG001|NOT COMPLETED|24 Weeks Double Blind||1||
59879927|NCT03274076|76003192|FG002|NOT COMPLETED|24 Weeks Double Blind||0||
59879928|NCT03274076|76003193|FG003|NOT COMPLETED|24 Weeks Double Blind||0||
60135842|NCT00910429|76258515|FG001|STARTED|Overall Study||82||
60135843|NCT00910429|76258514|FG000|COMPLETED|Overall Study|Completed treatment|116||
60135844|NCT00910429|76258515|FG001|COMPLETED|Overall Study|Completed treatment|61||
60135845|NCT00910429|76258514|FG000|NOT COMPLETED|Overall Study||39||
60135846|NCT00910429|76258515|FG001|NOT COMPLETED|Overall Study||21||
60135847|NCT00863681|76258524|FG000|STARTED|Overall Study||231||
60135848|NCT00863681|76258525|FG001|STARTED|Overall Study||109||
60135849|NCT00863681|76258526|FG002|STARTED|Overall Study||56||
60135850|NCT00863681|76258524|FG000|COMPLETED|Overall Study|Completed treatment|140||
60135851|NCT00863681|76258525|FG001|COMPLETED|Overall Study|Completed treatment|66||
60135852|NCT00863681|76258526|FG002|COMPLETED|Overall Study|Completed treatment|38||
60135853|NCT00863681|76258524|FG000|NOT COMPLETED|Overall Study||91||
60135854|NCT00863681|76258525|FG001|NOT COMPLETED|Overall Study||43||
60135855|NCT00863681|76258526|FG002|NOT COMPLETED|Overall Study||18||
60135856|NCT00846742|76258534|FG000|STARTED|Overall Study||85||
60135857|NCT00846742|76258534|FG000|With Radiation Therapy (RT)|Overall Study||17|Seventeen (17) participants out of the 85 analyzed received radiation therapy (RT)|
60135858|NCT00846742|76258534|FG000|Without Radiation Therapy (RT)|Overall Study||68|Sixty-eight (68) participants out of the 85 analyzed did not receive RT|
60135859|NCT00846742|76258534|FG000|COMPLETED|Overall Study||84||
60135860|NCT00846742|76258534|FG000|NOT COMPLETED|Overall Study||1||
60135861|NCT00734149|76258539|FG000|STARTED|Overall Study||45||
60135862|NCT00734149|76258539|FG000|COMPLETED|Overall Study||44||
60135863|NCT00734149|76258539|FG000|NOT COMPLETED|Overall Study||1||
60135864|NCT00587431|76258547|FG000|STARTED|Overall Study||63||
60135865|NCT00587431|76258548|FG001|STARTED|Overall Study||39||
60135866|NCT00587431|76258547|FG000|COMPLETED|Overall Study||62||
60135867|NCT00587431|76258548|FG001|COMPLETED|Overall Study||38||
60135868|NCT00587431|76258547|FG000|NOT COMPLETED|Overall Study||1||
60135869|NCT00587431|76258548|FG001|NOT COMPLETED|Overall Study||1||
60135870|NCT00514618|76258559|FG000|STARTED|Overall Study||5|The PI has left the institution. Efforts were exhausted in attempting to contact the PI/study team members. No study data are available. No UCI protocol.|
60135871|NCT00514618|76258560|FG001|STARTED|Overall Study||0|The PI has left the institution. Efforts were exhausted in attempting to contact the PI/study team members. No study data are available. No UCI protocol.|
60135872|NCT00514618|76258559|FG000|COMPLETED|Overall Study||5|The PI has left the institution. Efforts were exhausted in attempting to contact the PI/study team members. No study data are available. No UCI protocol.|
60135873|NCT00514618|76258560|FG001|COMPLETED|Overall Study||0|The PI has left the institution. Efforts were exhausted in attempting to contact the PI/study team members. No study data are available. No UCI protocol.|
60135874|NCT00514618|76258559|FG000|NOT COMPLETED|Overall Study||0||
60135875|NCT00514618|76258560|FG001|NOT COMPLETED|Overall Study||0||
60135876|NCT00097786|76258570|FG000|STARTED|Overall Study|"Started indicates Full Analysis Set (FAS) population. Initially enrolled 9518, 212 excluded."|2316||
60135877|NCT00097786|76258571|FG001|STARTED|Overall Study||2315||
59879929|NCT03274076|76003190|FG000|STARTED|24 Weeks Open Label||0||
59879930|NCT03274076|76003191|FG001|STARTED|24 Weeks Open Label||0||
59879931|NCT03274076|76003192|FG002|STARTED|24 Weeks Open Label||10||
59879932|NCT03274076|76003193|FG003|STARTED|24 Weeks Open Label||4||
59879933|NCT03274076|76003190|FG000|COMPLETED|24 Weeks Open Label||0||
59879934|NCT03274076|76003191|FG001|COMPLETED|24 Weeks Open Label||0||
59879935|NCT03274076|76003192|FG002|COMPLETED|24 Weeks Open Label||8||
59879936|NCT03274076|76003193|FG003|COMPLETED|24 Weeks Open Label||3||
59879937|NCT03274076|76003190|FG000|NOT COMPLETED|24 Weeks Open Label||0||
59879938|NCT03274076|76003191|FG001|NOT COMPLETED|24 Weeks Open Label||0||
59879939|NCT03274076|76003192|FG002|NOT COMPLETED|24 Weeks Open Label||2||
59879940|NCT03274076|76003193|FG003|NOT COMPLETED|24 Weeks Open Label||1||
59879941|NCT02797522|76003223|FG000|STARTED|Overall Study||4||
59879942|NCT02797522|76003224|FG001|STARTED|Overall Study||4||
59879943|NCT02797522|76003225|FG002|STARTED|Overall Study||4||
59879944|NCT02797522|76003226|FG003|STARTED|Overall Study||4||
59879945|NCT02797522|76003227|FG004|STARTED|Overall Study||4||
59879946|NCT02797522|76003228|FG005|STARTED|Overall Study||4||
59879947|NCT02797522|76003229|FG006|STARTED|Overall Study||12||
59879948|NCT02797522|76003230|FG007|STARTED|Overall Study||4||
59879949|NCT02797522|76003231|FG008|STARTED|Overall Study||2||
59879950|NCT02797522|76003232|FG009|STARTED|Overall Study||4||
59879951|NCT02797522|76003233|FG010|STARTED|Overall Study||1||
59879952|NCT02797522|76003223|FG000|COMPLETED|Overall Study||4||
59879953|NCT02797522|76003224|FG001|COMPLETED|Overall Study||4||
59879954|NCT02797522|76003225|FG002|COMPLETED|Overall Study||4||
59879955|NCT02797522|76003226|FG003|COMPLETED|Overall Study||4||
59879956|NCT02797522|76003227|FG004|COMPLETED|Overall Study||4||
59879957|NCT02797522|76003228|FG005|COMPLETED|Overall Study||4||
59879958|NCT02797522|76003229|FG006|COMPLETED|Overall Study||12||
59879959|NCT02797522|76003230|FG007|COMPLETED|Overall Study||0||
59879960|NCT02797522|76003231|FG008|COMPLETED|Overall Study||0||
59879961|NCT02797522|76003232|FG009|COMPLETED|Overall Study||0||
59879962|NCT02797522|76003233|FG010|COMPLETED|Overall Study||0||
59879963|NCT02797522|76003223|FG000|NOT COMPLETED|Overall Study||0||
59879964|NCT02797522|76003224|FG001|NOT COMPLETED|Overall Study||0||
59879965|NCT02797522|76003225|FG002|NOT COMPLETED|Overall Study||0||
59879966|NCT02797522|76003226|FG003|NOT COMPLETED|Overall Study||0||
59879967|NCT02797522|76003227|FG004|NOT COMPLETED|Overall Study||0||
59879968|NCT02797522|76003228|FG005|NOT COMPLETED|Overall Study||0||
59879969|NCT02797522|76003229|FG006|NOT COMPLETED|Overall Study||0||
59879970|NCT02797522|76003230|FG007|NOT COMPLETED|Overall Study||4||
59879971|NCT02797522|76003231|FG008|NOT COMPLETED|Overall Study||2||
59879972|NCT02797522|76003232|FG009|NOT COMPLETED|Overall Study||4||
59879973|NCT02797522|76003233|FG010|NOT COMPLETED|Overall Study||1||
59879974|NCT04873401|76003263|FG000|STARTED|Overall Study||271||
59879975|NCT04873401|76003264|FG001|STARTED|Overall Study||227||
59879976|NCT04873401|76003263|FG000|COMPLETED|Overall Study||263||
59879977|NCT04873401|76003264|FG001|COMPLETED|Overall Study||223||
59879978|NCT04873401|76003263|FG000|NOT COMPLETED|Overall Study||8||
59879979|NCT04873401|76003264|FG001|NOT COMPLETED|Overall Study||4||
59879980|NCT02659514|76003272|FG000|STARTED|Overall Study||33||
59879981|NCT02659514|76003273|FG001|STARTED|Overall Study||34||
59879982|NCT02659514|76003272|FG000|Safety Population|Overall Study||33|Safety Population included all participants who received at least one dose of poziotinib.|
59879983|NCT02659514|76003273|FG001|Safety Population|Overall Study||34|Safety Population included all participants who received at least one dose of poziotinib.|
59879984|NCT02659514|76003272|FG000|Evaluable Population|Overall Study||30|Evaluable Population included all participants who had received at least one cycle of poziotinib and had at least one evaluable post-baseline tumor response evaluation using response Evaluation Criteria in Solid Tumors, version 1.1 (RECIST, v1.1).|
59879985|NCT02659514|76003273|FG001|Evaluable Population|Overall Study||27|Evaluable Population included all participants who had received at least one cycle of poziotinib and had at least one evaluable post-baseline tumor response evaluation using response Evaluation Criteria in Solid Tumors, version 1.1 (RECIST, v1.1).|
59879986|NCT02659514|76003272|FG000|COMPLETED|Overall Study||1||
59879987|NCT02659514|76003273|FG001|COMPLETED|Overall Study||0||
59879988|NCT02659514|76003272|FG000|NOT COMPLETED|Overall Study||32||
59879989|NCT02659514|76003273|FG001|NOT COMPLETED|Overall Study||34||
59879990|NCT04570670|76003281|FG000|STARTED|Overall Study||25||
59879991|NCT04570670|76003282|FG001|STARTED|Overall Study||25||
59879992|NCT04570670|76003281|FG000|COMPLETED|Overall Study||24||
59879993|NCT04570670|76003282|FG001|COMPLETED|Overall Study||25||
59879994|NCT04570670|76003281|FG000|NOT COMPLETED|Overall Study||1||
59879995|NCT04570670|76003282|FG001|NOT COMPLETED|Overall Study||0||
59879996|NCT02797132|76003288|FG000|STARTED|Part A (15 Days)||12||
59879997|NCT02797132|76003288|FG000|Part A (<14 kg Weight)|Part A (15 Days)||4||
59879998|NCT02797132|76003288|FG000|Part A (>=14 kg Weight)|Part A (15 Days)||8||
59879999|NCT02797132|76003288|FG000|COMPLETED|Part A (15 Days)||11||
59880000|NCT02797132|76003288|FG000|NOT COMPLETED|Part A (15 Days)||1||
59880001|NCT02797132|76003288|FG000|STARTED|Part B (24 Weeks)|Participants from Part A may have participated in Part B.|60||
59880002|NCT02797132|76003288|FG000|Part B (<14 kg Weight)|Part B (24 Weeks)||19||
59880003|NCT02797132|76003288|FG000|Part B (>=14 kg Weight)|Part B (24 Weeks)||41||
59880004|NCT02797132|76003288|FG000|COMPLETED|Part B (24 Weeks)||57||
59880005|NCT02797132|76003288|FG000|NOT COMPLETED|Part B (24 Weeks)||3||
59880006|NCT03270644|76003301|FG000|STARTED|Day 1 Lasmiditan Reference||44||
59880007|NCT03270644|76003301|FG000|Received at Least One Dose of Study Drug|Day 1 Lasmiditan Reference||44||
59880008|NCT03270644|76003301|FG000|COMPLETED|Day 1 Lasmiditan Reference||43||
59880009|NCT03270644|76003301|FG000|NOT COMPLETED|Day 1 Lasmiditan Reference||1||
59880010|NCT03270644|76003301|FG000|STARTED|Day 4 - 10 Propranolol Reference||43||
59880011|NCT03270644|76003301|FG000|Received at Least One Dose of Study Drug|Day 4 - 10 Propranolol Reference||43||
59880012|NCT03270644|76003301|FG000|Day 9 Lasmiditan + Propranolol Test|Day 4 - 10 Propranolol Reference||42||
59880013|NCT03270644|76003301|FG000|COMPLETED|Day 4 - 10 Propranolol Reference||42||
59880014|NCT03270644|76003301|FG000|NOT COMPLETED|Day 4 - 10 Propranolol Reference||1||
59880015|NCT03269552|76003312|FG000|STARTED|Overall Study||4||
59880016|NCT03269552|76003312|FG000|COMPLETED|Overall Study||2||
59880017|NCT03269552|76003312|FG000|NOT COMPLETED|Overall Study||2||
59880018|NCT02796664|76003319|FG000|STARTED|Overall Study||29||
59880019|NCT02796664|76003320|FG001|STARTED|Overall Study||29||
59880020|NCT02796664|76003319|FG000|COMPLETED|Overall Study||28||
59880021|NCT02796664|76003320|FG001|COMPLETED|Overall Study||24||
59880022|NCT02796664|76003319|FG000|NOT COMPLETED|Overall Study||1||
59880023|NCT02796664|76003320|FG001|NOT COMPLETED|Overall Study||5||
59880024|NCT04233879|76003330|FG000|STARTED|Overall Study||298||
59880025|NCT04233879|76003331|FG001|STARTED|Overall Study||301||
59880026|NCT04233879|76003330|FG000|Treated|Overall Study||298||
59880027|NCT04233879|76003331|FG001|Treated|Overall Study||299||
59880028|NCT04233879|76003330|FG000|COMPLETED|Overall Study||1||
59880029|NCT04233879|76003331|FG001|COMPLETED|Overall Study||0||
59880030|NCT04233879|76003330|FG000|NOT COMPLETED|Overall Study||297||
59880031|NCT04233879|76003331|FG001|NOT COMPLETED|Overall Study||301||
59880032|NCT01370356|76003339|FG000|STARTED|Overall Study||751||
59880033|NCT01370356|76003340|FG001|STARTED|Overall Study||742||
59880034|NCT01370356|76003339|FG000|COMPLETED|Overall Study||559||
59880035|NCT01370356|76003340|FG001|COMPLETED|Overall Study||515||
59880036|NCT01370356|76003339|FG000|NOT COMPLETED|Overall Study||192||
59880037|NCT01370356|76003340|FG001|NOT COMPLETED|Overall Study||227||
59880038|NCT02794870|76003348|FG000|STARTED|Overall Study||22||
59880039|NCT02794870|76003349|FG001|STARTED|Overall Study||11||
59880040|NCT02794870|76003348|FG000|Received Inoculation|Overall Study||21||
59880041|NCT02794870|76003349|FG001|Received Inoculation|Overall Study||11||
59880042|NCT02794870|76003348|FG000|COMPLETED|Overall Study||20||
59880043|NCT02794870|76003349|FG001|COMPLETED|Overall Study||11||
59880044|NCT02794870|76003348|FG000|NOT COMPLETED|Overall Study||2||
60002552|NCT01663623|76118452|FG000|COMPLETED|Overall Study||40||
60002553|NCT01663623|76118453|FG001|COMPLETED|Overall Study||33||
60002554|NCT01663623|76118452|FG000|NOT COMPLETED|Overall Study||12||
60002555|NCT01663623|76118453|FG001|NOT COMPLETED|Overall Study||20||
60135878|NCT00097786|76258572|FG002|STARTED|Overall Study||2329||
60135879|NCT00097786|76258573|FG003|STARTED|Overall Study||2346||
60135880|NCT00097786|76258570|FG000|Complete FU for Progression to Diabetes|Overall Study||1709||
60135881|NCT00097786|76258571|FG001|Complete FU for Progression to Diabetes|Overall Study||1712||
60135882|NCT00097786|76258572|FG002|Complete FU for Progression to Diabetes|Overall Study||1734||
59880045|NCT02794870|76003349|FG001|NOT COMPLETED|Overall Study||0||
59880046|NCT01370590|76003357|FG000|STARTED|Period 1||203||
59880047|NCT01370590|76003358|FG001|STARTED|Period 1||203||
59880048|NCT01370590|76003357|FG000|COMPLETED|Period 1||187||
59880049|NCT01370590|76003358|FG001|COMPLETED|Period 1||192||
59880050|NCT01370590|76003357|FG000|NOT COMPLETED|Period 1||16||
59880051|NCT01370590|76003358|FG001|NOT COMPLETED|Period 1||11||
59880052|NCT01370590|76003357|FG000|STARTED|Crossover Washout Period||187||
60002556|NCT02042950|76118459|FG000|STARTED|Overall Study||4||
60002557|NCT02042950|76118459|FG000|COMPLETED|Overall Study||0||
59880053|NCT01370590|76003358|FG001|STARTED|Crossover Washout Period||192||
59880054|NCT01370590|76003357|FG000|COMPLETED|Crossover Washout Period||181||
59880055|NCT01370590|76003358|FG001|COMPLETED|Crossover Washout Period||186||
59880056|NCT01370590|76003357|FG000|NOT COMPLETED|Crossover Washout Period||6||
59880057|NCT01370590|76003358|FG001|NOT COMPLETED|Crossover Washout Period||6||
59880058|NCT01370590|76003357|FG000|STARTED|Period 2||181||
59880059|NCT01370590|76003358|FG001|STARTED|Period 2||186||
59880060|NCT01370590|76003357|FG000|COMPLETED|Period 2||180||
59880061|NCT01370590|76003358|FG001|COMPLETED|Period 2||184||
59880062|NCT01370590|76003357|FG000|NOT COMPLETED|Period 2||1||
59880063|NCT01370590|76003358|FG001|NOT COMPLETED|Period 2||2||
59880064|NCT03790306|76003364|FG000|STARTED|Overall Study||207||
59880065|NCT03790306|76003364|FG000|COMPLETED|Overall Study||207||
59880066|NCT03790306|76003364|FG000|NOT COMPLETED|Overall Study||0||
59880067|NCT05200455|76003369|FG000|STARTED|Overall Study||34||
59880068|NCT05200455|76003369|FG000|COMPLETED|Overall Study||30||
59880069|NCT05200455|76003369|FG000|NOT COMPLETED|Overall Study||4||
59880070|NCT04646109|76003376|FG000|STARTED|Overall Study||30||
59880071|NCT04646109|76003377|FG001|STARTED|Overall Study||36||
59880072|NCT04646109|76003376|FG000|COMPLETED|Overall Study||30||
59880073|NCT04646109|76003377|FG001|COMPLETED|Overall Study||30||
59880074|NCT04646109|76003376|FG000|NOT COMPLETED|Overall Study||0||
59880075|NCT04646109|76003377|FG001|NOT COMPLETED|Overall Study||6||
59880076|NCT04502979|76003386|FG000|STARTED|Overall Study||37||
59880077|NCT04502979|76003387|FG001|STARTED|Overall Study||34||
59880078|NCT04502979|76003386|FG000|COMPLETED|Overall Study||34||
59880079|NCT04502979|76003387|FG001|COMPLETED|Overall Study||30||
59880080|NCT04502979|76003386|FG000|NOT COMPLETED|Overall Study||3||
60002558|NCT02042950|76118459|FG000|NOT COMPLETED|Overall Study||4||
59605460|NCT02002884|75715635|FG000|STARTED|Open-Label Extension Period (OLEX)||0||
59605461|NCT02002884|75715636|FG001|STARTED|Open-Label Extension Period (OLEX)||0||
59880081|NCT04502979|76003387|FG001|NOT COMPLETED|Overall Study||4||
59880082|NCT04590027|76003395|FG000|STARTED|Overall Study||47||
59880083|NCT04590027|76003396|FG001|STARTED|Overall Study||39||
59880084|NCT04590027|76003395|FG000|COMPLETED|Overall Study||30||
59880085|NCT04590027|76003396|FG001|COMPLETED|Overall Study||22||
59880086|NCT04590027|76003395|FG000|NOT COMPLETED|Overall Study||17||
59880087|NCT04590027|76003396|FG001|NOT COMPLETED|Overall Study||17||
59880088|NCT04587453|76003408|FG000|STARTED|Treatment Period (Week 0 to Week 16)||53||
59880089|NCT04587453|76003409|FG001|STARTED|Treatment Period (Week 0 to Week 16)||53||
59880090|NCT04587453|76003408|FG000|Full Analysis Set|Treatment Period (Week 0 to Week 16)||53|All participants randomised and exposed to IMP.|
59605462|NCT02002884|75715637|FG002|STARTED|Open-Label Extension Period (OLEX)||0||
59750362|NCT00878553|75869531|FG003|Number of Patients Receiving 10mg|Sleep Study||0||
59750363|NCT00878553|75869532|FG004|Number of Patients Receiving 10mg|Sleep Study||0||
59750364|NCT00878553|75869528|FG000|Number of Patients Receiving 15mg|Sleep Study||65||
59750365|NCT00878553|75869529|FG001|Number of Patients Receiving 15mg|Sleep Study||0||
59750366|NCT00878553|75869530|FG002|Number of Patients Receiving 15mg|Sleep Study||0||
59750367|NCT00878553|75869531|FG003|Number of Patients Receiving 15mg|Sleep Study||0||
59750368|NCT00878553|75869532|FG004|Number of Patients Receiving 15mg|Sleep Study||0||
59750369|NCT00878553|75869528|FG000|Number of Patients Receiving 20mg|Sleep Study||65||
60135883|NCT00097786|76258573|FG003|Complete FU for Progression to Diabetes|Overall Study||1762||
60135884|NCT00097786|76258570|FG000|Complete Follow-up for Extended CV EPs|Overall Study||1969||
60135885|NCT00097786|76258571|FG001|Complete Follow-up for Extended CV EPs|Overall Study||1985||
60135886|NCT00097786|76258572|FG002|Complete Follow-up for Extended CV EPs|Overall Study||1987||
60135887|NCT00097786|76258573|FG003|Complete Follow-up for Extended CV EPs|Overall Study||2015||
60135888|NCT00097786|76258570|FG000|Complete Follow-up for Core CV EPs|Overall Study||1948||
60135889|NCT00097786|76258571|FG001|Complete Follow-up for Core CV EPs|Overall Study||1963||
60135890|NCT00097786|76258572|FG002|Complete Follow-up for Core CV EPs|Overall Study||1966||
60135891|NCT00097786|76258573|FG003|Complete Follow-up for Core CV EPs|Overall Study||1988||
60135892|NCT00097786|76258570|FG000|COMPLETED|Overall Study|"Completed means completed follow up for all cause death."|2020||
60135893|NCT00097786|76258571|FG001|COMPLETED|Overall Study||2023||
59605463|NCT02002884|75715638|FG003|STARTED|Open-Label Extension Period (OLEX)||331||
59605464|NCT02002884|75715635|FG000|COMPLETED|Open-Label Extension Period (OLEX)||0||
59605465|NCT02002884|75715636|FG001|COMPLETED|Open-Label Extension Period (OLEX)||0||
59605466|NCT02002884|75715637|FG002|COMPLETED|Open-Label Extension Period (OLEX)||0||
59605467|NCT02002884|75715638|FG003|COMPLETED|Open-Label Extension Period (OLEX)||281||
59605468|NCT02002884|75715635|FG000|NOT COMPLETED|Open-Label Extension Period (OLEX)||0||
59605469|NCT02002884|75715636|FG001|NOT COMPLETED|Open-Label Extension Period (OLEX)||0||
59750370|NCT00878553|75869529|FG001|Number of Patients Receiving 20mg|Sleep Study||0||
59750371|NCT00878553|75869530|FG002|Number of Patients Receiving 20mg|Sleep Study||0||
59750372|NCT00878553|75869531|FG003|Number of Patients Receiving 20mg|Sleep Study||0||
59750373|NCT00878553|75869532|FG004|Number of Patients Receiving 20mg|Sleep Study||0||
59750374|NCT00878553|75869528|FG000|COMPLETED|Sleep Study|5 patient withdraws result in greater than 5 lost patient data across groups due to CROSSOVER design|62||
59750375|NCT00878553|75869529|FG001|COMPLETED|Sleep Study||0||
59750376|NCT00878553|75869530|FG002|COMPLETED|Sleep Study||0||
59750377|NCT00878553|75869531|FG003|COMPLETED|Sleep Study||0||
59750378|NCT00878553|75869532|FG004|COMPLETED|Sleep Study||0||
59750379|NCT00878553|75869528|FG000|NOT COMPLETED|Sleep Study||5||
59750380|NCT00878553|75869529|FG001|NOT COMPLETED|Sleep Study||0||
59750381|NCT00878553|75869530|FG002|NOT COMPLETED|Sleep Study||0||
59750382|NCT00878553|75869531|FG003|NOT COMPLETED|Sleep Study||0||
59750383|NCT00878553|75869532|FG004|NOT COMPLETED|Sleep Study||0||
59750384|NCT00878553|75869528|FG000|STARTED|PK Study|A total of 62 randomized patients started this parallel group, single dose PK substudy.|0||
59750385|NCT00878553|75869529|FG001|STARTED|PK Study|During the PK period, 16 randomized participants received one bedtime dose of SKP-1041 placebo.|16||
59750386|NCT00878553|75869530|FG002|STARTED|PK Study|During the PK period, 17 randomized participants received one bedtime dose of 10mg SKP-1041.|17||
59750387|NCT00878553|75869531|FG003|STARTED|PK Study|During the PK period, 14 participants were randomized to receive one bedtime dose of 15mg SKP-1041.|14||
59750388|NCT00878553|75869532|FG004|STARTED|PK Study|During the PK period, 15 randomized participants received one bedtime dose of 20mg SKP-1041.|15||
59750389|NCT00878553|75869528|FG000|COMPLETED|PK Study|A total of 61 randomized patients completed this parallel group, single dose PK substudy.|0||
59750390|NCT00878553|75869529|FG001|COMPLETED|PK Study||16||
59750391|NCT00878553|75869530|FG002|COMPLETED|PK Study||17||
59750392|NCT00878553|75869531|FG003|COMPLETED|PK Study|One patient withdrew consent after completing the Sleep Substudy and prior to starting PK substudy.|13||
59750393|NCT00878553|75869532|FG004|COMPLETED|PK Study||15||
59750394|NCT00878553|75869528|FG000|NOT COMPLETED|PK Study||0||
59750395|NCT00878553|75869529|FG001|NOT COMPLETED|PK Study||0||
59750396|NCT00878553|75869530|FG002|NOT COMPLETED|PK Study||0||
59750397|NCT00878553|75869531|FG003|NOT COMPLETED|PK Study||1||
59750398|NCT00878553|75869532|FG004|NOT COMPLETED|PK Study||0||
59750399|NCT00996437|75869551|FG000|STARTED|Overall Study||125||
59750400|NCT00996437|75869552|FG001|STARTED|Overall Study||136||
59605470|NCT02002884|75715637|FG002|NOT COMPLETED|Open-Label Extension Period (OLEX)||0||
59750401|NCT00996437|75869551|FG000|COMPLETED|Overall Study||120||
59750402|NCT00996437|75869552|FG001|COMPLETED|Overall Study||129||
59750403|NCT00996437|75869551|FG000|NOT COMPLETED|Overall Study||5||
59750404|NCT00996437|75869552|FG001|NOT COMPLETED|Overall Study||7||
59750405|NCT00662311|75869561|FG000|STARTED|Overall Study||5||
59750406|NCT00662311|75869562|FG001|STARTED|Overall Study||0||
59750407|NCT00662311|75869563|FG002|STARTED|Overall Study||0||
59750408|NCT00662311|75869561|FG000|COMPLETED|Overall Study||4||
60135894|NCT00097786|76258572|FG002|COMPLETED|Overall Study||2016||
60135895|NCT00097786|76258573|FG003|COMPLETED|Overall Study||2036||
60135896|NCT00097786|76258570|FG000|NOT COMPLETED|Overall Study||296||
60135897|NCT00097786|76258571|FG001|NOT COMPLETED|Overall Study||292||
59880091|NCT04587453|76003409|FG001|Full Analysis Set|Treatment Period (Week 0 to Week 16)||53|All participants randomised and exposed to IMP.|
59950761|NCT03140670|76069606|FG000|NOT COMPLETED|Overall Study||4||
59750409|NCT00662311|75869562|FG001|COMPLETED|Overall Study||0||
59750410|NCT00662311|75869563|FG002|COMPLETED|Overall Study||0||
59750411|NCT00662311|75869561|FG000|NOT COMPLETED|Overall Study||1||
59750412|NCT00662311|75869562|FG001|NOT COMPLETED|Overall Study||0||
59750413|NCT00662311|75869563|FG002|NOT COMPLETED|Overall Study||0||
59750414|NCT00929708|75869576|FG000|STARTED|Overall Study||65||
59750415|NCT00929708|75869577|FG001|STARTED|Overall Study||69||
59750416|NCT00929708|75869578|FG002|STARTED|Overall Study||65||
59750417|NCT00929708|75869579|FG003|STARTED|Overall Study||67||
59750418|NCT00929708|75869580|FG004|STARTED|Overall Study||63||
59750419|NCT00929708|75869576|FG000|COMPLETED|Overall Study||61||
59750420|NCT00929708|75869577|FG001|COMPLETED|Overall Study||66||
59750421|NCT00929708|75869578|FG002|COMPLETED|Overall Study||62||
59750422|NCT00929708|75869579|FG003|COMPLETED|Overall Study||61||
59750423|NCT00929708|75869580|FG004|COMPLETED|Overall Study||57||
59750424|NCT00929708|75869576|FG000|NOT COMPLETED|Overall Study||4||
59750425|NCT00929708|75869577|FG001|NOT COMPLETED|Overall Study||3||
59750426|NCT00929708|75869578|FG002|NOT COMPLETED|Overall Study||3||
59750427|NCT00929708|75869579|FG003|NOT COMPLETED|Overall Study||6||
59750428|NCT00929708|75869580|FG004|NOT COMPLETED|Overall Study||6||
59750429|NCT00996281|75869594|FG000|STARTED|Overall Study||418||
59750430|NCT00996281|75869595|FG001|STARTED|Overall Study||419||
59750431|NCT00996281|75869594|FG000|COMPLETED|Overall Study||287||
59750432|NCT00996281|75869595|FG001|COMPLETED|Overall Study||330||
59750433|NCT00996281|75869594|FG000|NOT COMPLETED|Overall Study||131||
59750434|NCT00996281|75869595|FG001|NOT COMPLETED|Overall Study||89||
59750435|NCT00996203|75869601|FG000|STARTED|Overall Study||201||
59750436|NCT00996203|75869601|FG000|COMPLETED|Overall Study||194||
59750437|NCT00996203|75869601|FG000|NOT COMPLETED|Overall Study||7||
59750438|NCT00877929|75869608|FG000|STARTED|Overall Study||352||
59750439|NCT00877929|75869609|FG001|STARTED|Overall Study||354||
59750440|NCT00877929|75869608|FG000|COMPLETED|Overall Study||332||
59750441|NCT00877929|75869609|FG001|COMPLETED|Overall Study||319||
59750442|NCT00877929|75869608|FG000|NOT COMPLETED|Overall Study||20||
59750443|NCT00877929|75869609|FG001|NOT COMPLETED|Overall Study||35||
59750444|NCT00931268|75869619|FG000|STARTED|Overall Study||10||
59750445|NCT00931268|75869619|FG000|COMPLETED|Overall Study||4||
59750446|NCT00931268|75869619|FG000|NOT COMPLETED|Overall Study||6||
59750447|NCT00996125|75869625|FG000|STARTED|Overall Study||374||
59750448|NCT00996125|75869626|FG001|STARTED|Overall Study||376||
59750449|NCT00996125|75869625|FG000|COMPLETED|Overall Study||369||
59750450|NCT00996125|75869626|FG001|COMPLETED|Overall Study||365||
59750451|NCT00996125|75869625|FG000|NOT COMPLETED|Overall Study||5||
59750452|NCT00996125|75869626|FG001|NOT COMPLETED|Overall Study||11||
59750453|NCT04211363|75869634|FG000|STARTED|Overall Study||286||
59750454|NCT04211363|75869635|FG001|STARTED|Overall Study||153||
59750455|NCT04211363|75869634|FG000|COMPLETED|Overall Study||255||
59750456|NCT04211363|75869635|FG001|COMPLETED|Overall Study||133||
59750457|NCT04211363|75869634|FG000|NOT COMPLETED|Overall Study||31||
59750458|NCT04211363|75869635|FG001|NOT COMPLETED|Overall Study||20||
59750459|NCT00995345|75869646|FG000|STARTED|Overall Study||81||
59750460|NCT00995345|75869647|FG001|STARTED|Overall Study||81||
59750461|NCT00995345|75869648|FG002|STARTED|Overall Study||80||
59750462|NCT00995345|75869649|FG003|STARTED|Overall Study||81||
59750463|NCT00995345|75869650|FG004|STARTED|Overall Study||80||
59750464|NCT00995345|75869646|FG000|COMPLETED|Overall Study||70||
59750465|NCT00995345|75869647|FG001|COMPLETED|Overall Study||74||
59750466|NCT00995345|75869648|FG002|COMPLETED|Overall Study||73||
59880092|NCT04587453|76003408|FG000|Safety Analysis Set|Treatment Period (Week 0 to Week 16)||53|All participants exposed to IMP.|
59880093|NCT04587453|76003409|FG001|Safety Analysis Set|Treatment Period (Week 0 to Week 16)||53|All participants exposed to IMP.|
59880094|NCT04587453|76003408|FG000|COMPLETED|Treatment Period (Week 0 to Week 16)||53|Participants attended the Week 16 visit (end of treatment visit).|
59880095|NCT04587453|76003409|FG001|COMPLETED|Treatment Period (Week 0 to Week 16)||52|Participants attended the Week 16 visit (end of treatment visit).|
59880096|NCT04587453|76003408|FG000|NOT COMPLETED|Treatment Period (Week 0 to Week 16)||0||
59880097|NCT04587453|76003409|FG001|NOT COMPLETED|Treatment Period (Week 0 to Week 16)||1||
59880098|NCT04587453|76003408|FG000|STARTED|Safety Follow-up (Week 16 to Week 20)||8|Date of last contact was after the date of exposure end.|
59880099|NCT04587453|76003409|FG001|STARTED|Safety Follow-up (Week 16 to Week 20)||3|Date of last contact was after the date of exposure end.|
59880100|NCT04587453|76003408|FG000|Not Started|Safety Follow-up (Week 16 to Week 20)||45|Transferred to the long-term extension trial ECZTEND (LP0162-1337) instead of entering the safety follow-up period.|
59880101|NCT04587453|76003409|FG001|Not Started|Safety Follow-up (Week 16 to Week 20)||49|Transferred to the long-term extension trial ECZTEND (LP0162-1337) instead of entering the safety follow-up period.|
59880102|NCT04587453|76003408|FG000|Safety Follow-up Analysis Set|Safety Follow-up (Week 16 to Week 20)||8|Date of last contact was after the date of exposure end.|
59880103|NCT04587453|76003409|FG001|Safety Follow-up Analysis Set|Safety Follow-up (Week 16 to Week 20)|1 subject prematurely discontinued treatment before Week 16, but did have contact after last exposure date and was therefore included in the safety follow-up analysis set.|4|Date of last contact was after the date of exposure end.|
59880104|NCT04587453|76003408|FG000|COMPLETED|Safety Follow-up (Week 16 to Week 20)|1 participant transferred to ECZTEND (LP0162-1337) at the safety follow-up visit.|8|Completed the safety follow-up period with a safety follow-up visit.|
59880105|NCT04587453|76003409|FG001|COMPLETED|Safety Follow-up (Week 16 to Week 20)||3|Completed the safety follow-up period with a safety follow-up visit.|
59880106|NCT04587453|76003408|FG000|NOT COMPLETED|Safety Follow-up (Week 16 to Week 20)||0||
59880107|NCT04587453|76003409|FG001|NOT COMPLETED|Safety Follow-up (Week 16 to Week 20)||0||
59880108|NCT02793232|76003426|FG000|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||2||
59880109|NCT02793232|76003427|FG001|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||2||
59880110|NCT02793232|76003428|FG002|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||2||
59880111|NCT02793232|76003429|FG003|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||2||
59880112|NCT02793232|76003430|FG004|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||7||
59880113|NCT02793232|76003431|FG005|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||12||
59880114|NCT02793232|76003432|FG006|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||9||
59880115|NCT02793232|76003433|FG007|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||2||
59880116|NCT02793232|76003434|FG008|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||8||
59880117|NCT02793232|76003426|FG000|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||2||
59880118|NCT02793232|76003427|FG001|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||2||
59880119|NCT02793232|76003428|FG002|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||2||
59880120|NCT02793232|76003429|FG003|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||2||
59880121|NCT02793232|76003430|FG004|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||6||
59880122|NCT02793232|76003431|FG005|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||12||
59880123|NCT02793232|76003432|FG006|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||8||
59880124|NCT02793232|76003433|FG007|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||2||
59880125|NCT02793232|76003434|FG008|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||8||
59880126|NCT02793232|76003426|FG000|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0||
59880127|NCT02793232|76003427|FG001|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0||
59880128|NCT02793232|76003428|FG002|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0||
59880129|NCT02793232|76003429|FG003|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0||
59880130|NCT02793232|76003430|FG004|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||1||
59880131|NCT02793232|76003431|FG005|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0||
59880132|NCT02793232|76003432|FG006|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||1||
59880133|NCT02793232|76003433|FG007|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0||
59880134|NCT02793232|76003434|FG008|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0||
59880135|NCT02793232|76003426|FG000|STARTED|Washout Period 1(Part A:at Least 10days)||2||
59880136|NCT02793232|76003427|FG001|STARTED|Washout Period 1(Part A:at Least 10days)||2||
59880137|NCT02793232|76003428|FG002|STARTED|Washout Period 1(Part A:at Least 10days)||2||
59880138|NCT02793232|76003429|FG003|STARTED|Washout Period 1(Part A:at Least 10days)||2||
59880139|NCT02793232|76003430|FG004|STARTED|Washout Period 1(Part A:at Least 10days)||0||
59880140|NCT02793232|76003431|FG005|STARTED|Washout Period 1(Part A:at Least 10days)||0||
59880141|NCT02793232|76003432|FG006|STARTED|Washout Period 1(Part A:at Least 10days)||0||
59880142|NCT02793232|76003433|FG007|STARTED|Washout Period 1(Part A:at Least 10days)||0||
59880143|NCT02793232|76003434|FG008|STARTED|Washout Period 1(Part A:at Least 10days)||0||
59880144|NCT02793232|76003426|FG000|COMPLETED|Washout Period 1(Part A:at Least 10days)||2||
59880145|NCT02793232|76003427|FG001|COMPLETED|Washout Period 1(Part A:at Least 10days)||2||
59880146|NCT02793232|76003428|FG002|COMPLETED|Washout Period 1(Part A:at Least 10days)||2||
59880147|NCT02793232|76003429|FG003|COMPLETED|Washout Period 1(Part A:at Least 10days)||2||
59880148|NCT02793232|76003430|FG004|COMPLETED|Washout Period 1(Part A:at Least 10days)||0||
59880149|NCT02793232|76003431|FG005|COMPLETED|Washout Period 1(Part A:at Least 10days)||0||
60002559|NCT02042404|76118463|FG000|STARTED|Overall Study|Enrollment was stopped after 43 were enrolled, had approval to enroll 45 primary cohort subjects|43||
60002560|NCT02042404|76118464|FG001|STARTED|Overall Study||5||
60002561|NCT02042404|76118463|FG000|COMPLETED|Overall Study|39 subjects completed 30 days evaluation. 38 subjects completed 120 days evaluation.|38||
60002562|NCT02042404|76118464|FG001|COMPLETED|Overall Study||5||
60002563|NCT02042404|76118463|FG000|NOT COMPLETED|Overall Study||5||
60002564|NCT02042404|76118464|FG001|NOT COMPLETED|Overall Study||0||
60002565|NCT02042014|76118471|FG000|STARTED|Overall Study||8||
60002566|NCT02042014|76118471|FG000|COMPLETED|Overall Study||0||
60002567|NCT02042014|76118471|FG000|NOT COMPLETED|Overall Study||8||
60002568|NCT02041702|76118477|FG000|STARTED|Overall Study||140|Enrollment & Baseline|
60002569|NCT02041702|76118478|FG001|STARTED|Overall Study||143|Enrollment & Baseline|
60002570|NCT02041702|76118477|FG000|Pre MRI Scan/ Pre Waitng|Overall Study||129|Control Group: No non diagnostic cardiac MRI scan, subjects waited for 45 minutes +/- 15 minutes|
60002571|NCT02041702|76118478|FG001|Pre MRI Scan/ Pre Waitng|Overall Study||140|Control Group: No non diagnostic cardiac MRI scan, subjects waited for 45 minutes +/- 15 minutes|
60002572|NCT02041702|76118477|FG000|Post MRI Scan/ Post Waiting|Overall Study||129|Control Group: No non diagnostic cardiac MRI scan, subjects waited for 45 minutes +/- 15 minutes|
60002573|NCT02041702|76118478|FG001|Post MRI Scan/ Post Waiting|Overall Study||140|Control Group: No non diagnostic cardiac MRI scan, subjects waited for 45 minutes +/- 15 minutes|
60002574|NCT02041702|76118477|FG000|COMPLETED|Overall Study||129|One month post MRI Scan|
60002575|NCT02041702|76118478|FG001|COMPLETED|Overall Study||134|One month post MRI Scan|
60002576|NCT02041702|76118477|FG000|NOT COMPLETED|Overall Study||11||
60002577|NCT02041702|76118478|FG001|NOT COMPLETED|Overall Study||9||
60002578|NCT02565147|76118486|FG000|STARTED|Overall Study||38||
60002579|NCT02565147|76118487|FG001|STARTED|Overall Study||40||
60002580|NCT02565147|76118486|FG000|Received Study Drug|Overall Study||38|Safety Population included all enrolled participants who received either bivalirudin or UFH.|
60002581|NCT02565147|76118487|FG001|Received Study Drug|Overall Study||40|Safety Population included all enrolled participants who received either bivalirudin or UFH.|
60002582|NCT02565147|76118486|FG000|Per-Protocol Population|Overall Study||28|Enrolled participants who underwent successful PPCI and Day-5 CMR without major protocol deviations.|
60002583|NCT02565147|76118487|FG001|Per-Protocol Population|Overall Study||36|Enrolled participants who underwent successful PPCI and Day-5 CMR without major protocol deviations.|
60002584|NCT02565147|76118486|FG000|COMPLETED|Overall Study||32||
60002585|NCT02565147|76118487|FG001|COMPLETED|Overall Study||37||
60002586|NCT02565147|76118486|FG000|NOT COMPLETED|Overall Study||6||
60002587|NCT02565147|76118487|FG001|NOT COMPLETED|Overall Study||3||
60002588|NCT02061280|76118495|FG000|STARTED|Overall Study||71|Individuals who signed informed consent form.|
60002589|NCT02061280|76118496|FG001|STARTED|Overall Study||37|Individuals who signed informed consent form.|
60002590|NCT02061280|76118495|FG000|Randomized to Treatment|Overall Study||54|Individuals randomized to drug treatment at Visit 3.|
60002591|NCT02061280|76118496|FG001|Randomized to Treatment|Overall Study||25|Individuals randomized to drug treatment at Visit 3.|
60002592|NCT02061280|76118495|FG000|COMPLETED|Overall Study||53||
60002593|NCT02061280|76118496|FG001|COMPLETED|Overall Study||25||
60002594|NCT02061280|76118495|FG000|NOT COMPLETED|Overall Study||18||
60002595|NCT02061280|76118496|FG001|NOT COMPLETED|Overall Study||12||
60002596|NCT02061202|76118507|FG000|STARTED|Overall Study||36||
60002597|NCT02061202|76118508|FG001|STARTED|Overall Study||18||
60002598|NCT02061202|76118507|FG000|COMPLETED|Overall Study||35||
60002599|NCT02061202|76118508|FG001|COMPLETED|Overall Study||17||
60002600|NCT02061202|76118507|FG000|NOT COMPLETED|Overall Study||1||
60002601|NCT02061202|76118508|FG001|NOT COMPLETED|Overall Study||1||
60002602|NCT02059408|76118517|FG000|STARTED|Overall Study||604||
60002603|NCT02059408|76118518|FG001|STARTED|Overall Study||599||
60002604|NCT02059408|76118519|FG002|STARTED|Overall Study||616||
60002605|NCT02059408|76118517|FG000|COMPLETED|Overall Study||604||
60002606|NCT02059408|76118518|FG001|COMPLETED|Overall Study||269||
60002607|NCT02059408|76118519|FG002|COMPLETED|Overall Study||258||
59750467|NCT00995345|75869649|FG003|COMPLETED|Overall Study||76||
59750468|NCT00995345|75869650|FG004|COMPLETED|Overall Study||75||
59750469|NCT00995345|75869646|FG000|NOT COMPLETED|Overall Study||11||
59750470|NCT00995345|75869647|FG001|NOT COMPLETED|Overall Study||7||
60002608|NCT02059408|76118517|FG000|NOT COMPLETED|Overall Study||0||
60002609|NCT02059408|76118518|FG001|NOT COMPLETED|Overall Study||330||
60002610|NCT02059408|76118519|FG002|NOT COMPLETED|Overall Study||358||
60002611|NCT01625338|76118532|FG000|STARTED|Overall Study||114||
60002612|NCT01625338|76118533|FG001|STARTED|Overall Study||200||
60002613|NCT01625338|76118534|FG002|STARTED|Overall Study||220||
60002614|NCT01625338|76118532|FG000|COMPLETED|Overall Study||82||
60002615|NCT01625338|76118533|FG001|COMPLETED|Overall Study||156||
60002616|NCT01625338|76118534|FG002|COMPLETED|Overall Study||181||
60002617|NCT01625338|76118532|FG000|NOT COMPLETED|Overall Study||32||
60002618|NCT01625338|76118533|FG001|NOT COMPLETED|Overall Study||44||
60002619|NCT01625338|76118534|FG002|NOT COMPLETED|Overall Study||39||
60002620|NCT02560623|76118546|FG000|STARTED|Overall Study||19||
60002621|NCT02560623|76118547|FG001|STARTED|Overall Study||22||
60002622|NCT02560623|76118548|FG002|STARTED|Overall Study||112||
60002623|NCT02560623|76118549|FG003|STARTED|Overall Study||89||
60002624|NCT02560623|76118546|FG000|COMPLETED|Overall Study||19||
59605471|NCT02002884|75715638|FG003|NOT COMPLETED|Open-Label Extension Period (OLEX)||50||
59605472|NCT02002182|75715650|FG000|STARTED|Overall Study||9||
59605473|NCT02002182|75715651|FG001|STARTED|Overall Study||6||
59605474|NCT02002182|75715650|FG000|COMPLETED|Overall Study||4||
59750471|NCT00995345|75869648|FG002|NOT COMPLETED|Overall Study||7||
59750472|NCT00995345|75869649|FG003|NOT COMPLETED|Overall Study||5||
59750473|NCT00995345|75869650|FG004|NOT COMPLETED|Overall Study||5||
59750474|NCT00660907|75869664|FG000|STARTED|Overall Study|Of the 406 randomized participants only 400 were included in the full analysis set.|406||
59750475|NCT00660907|75869665|FG001|STARTED|Overall Study|Of the 408 randomized participants only 401 were included in the full analysis set.|408||
60002625|NCT02560623|76118547|FG001|COMPLETED|Overall Study||20||
60002626|NCT02560623|76118548|FG002|COMPLETED|Overall Study||112||
60002627|NCT02560623|76118549|FG003|COMPLETED|Overall Study||89||
60002628|NCT02560623|76118546|FG000|NOT COMPLETED|Overall Study||0||
60002629|NCT02560623|76118547|FG001|NOT COMPLETED|Overall Study||2||
60002630|NCT02560623|76118548|FG002|NOT COMPLETED|Overall Study||0||
60002631|NCT02560623|76118549|FG003|NOT COMPLETED|Overall Study||0||
60002632|NCT02560389|76118562|FG000|STARTED|Overall Study||34||
60135898|NCT00097786|76258572|FG002|NOT COMPLETED|Overall Study||313||
60002633|NCT02560389|76118563|FG001|STARTED|Overall Study||28||
60002634|NCT02560389|76118564|FG002|STARTED|Overall Study||29||
60002635|NCT02560389|76118562|FG000|COMPLETED|Overall Study||33||
60002636|NCT02560389|76118563|FG001|COMPLETED|Overall Study||25||
60002637|NCT02560389|76118564|FG002|COMPLETED|Overall Study||27||
60002638|NCT02560389|76118562|FG000|NOT COMPLETED|Overall Study||1||
60002639|NCT02560389|76118563|FG001|NOT COMPLETED|Overall Study||3||
60002640|NCT02560389|76118564|FG002|NOT COMPLETED|Overall Study||2||
60002641|NCT02564211|76118572|FG000|STARTED|Overall Study||77||
60002642|NCT02564211|76118572|FG000|COMPLETED|Overall Study||73||
60002643|NCT02564211|76118572|FG000|NOT COMPLETED|Overall Study||4||
60002644|NCT02093026|76118576|FG000|STARTED|Overall Study||465||
60002645|NCT02093026|76118576|FG000|COMPLETED|Overall Study|At predefined end-of-treatment date, 272 ongoing participants were designated as completed study.|272||
60002646|NCT02093026|76118576|FG000|NOT COMPLETED|Overall Study||193||
60002647|NCT02040844|76118584|FG000|STARTED|Overall Study||138||
60002648|NCT02040844|76118585|FG001|STARTED|Overall Study||148||
60002649|NCT02040844|76118586|FG002|STARTED|Overall Study||144||
60002650|NCT02040844|76118584|FG000|COMPLETED|Overall Study||88||
60002651|NCT02040844|76118585|FG001|COMPLETED|Overall Study||109||
60002652|NCT02040844|76118586|FG002|COMPLETED|Overall Study||97||
60002653|NCT02040844|76118584|FG000|NOT COMPLETED|Overall Study||50||
60002654|NCT02040844|76118585|FG001|NOT COMPLETED|Overall Study||39||
60002655|NCT02040844|76118586|FG002|NOT COMPLETED|Overall Study||47||
60002656|NCT02059174|76118594|FG000|STARTED|Period 1||37||
60002657|NCT02059174|76118595|FG001|STARTED|Period 1||39||
60002658|NCT02059174|76118594|FG000|COMPLETED|Period 1||37||
60002659|NCT02059174|76118595|FG001|COMPLETED|Period 1||37||
60002660|NCT02059174|76118594|FG000|NOT COMPLETED|Period 1||0||
60002661|NCT02059174|76118595|FG001|NOT COMPLETED|Period 1||2||
60002662|NCT02059174|76118594|FG000|STARTED|Period 2||37||
60002663|NCT02059174|76118595|FG001|STARTED|Period 2||37||
60002664|NCT02059174|76118594|FG000|COMPLETED|Period 2||36||
60002665|NCT02059174|76118595|FG001|COMPLETED|Period 2||35||
60002666|NCT02059174|76118594|FG000|NOT COMPLETED|Period 2||1||
60002667|NCT02059174|76118595|FG001|NOT COMPLETED|Period 2||2||
60002668|NCT02059174|76118594|FG000|STARTED|Period 3||36||
60002669|NCT02059174|76118595|FG001|STARTED|Period 3||35||
60002670|NCT02059174|76118594|FG000|COMPLETED|Period 3||35||
60002671|NCT02059174|76118595|FG001|COMPLETED|Period 3||35||
60002672|NCT02059174|76118594|FG000|NOT COMPLETED|Period 3||1||
60002673|NCT02059174|76118595|FG001|NOT COMPLETED|Period 3||0||
60002674|NCT02059174|76118594|FG000|STARTED|Period 4||35||
60002675|NCT02059174|76118595|FG001|STARTED|Period 4||35||
60002676|NCT02059174|76118594|FG000|COMPLETED|Period 4||35||
60002677|NCT02059174|76118595|FG001|COMPLETED|Period 4||35||
60002678|NCT02059174|76118594|FG000|NOT COMPLETED|Period 4||0||
60002679|NCT02059174|76118595|FG001|NOT COMPLETED|Period 4||0||
60002680|NCT02092324|76118603|FG000|STARTED|Overall Study||51||
60002681|NCT02092324|76118603|FG000|End of Cycle 6|Overall Study|This study has an accrual goal of 25 evaluable subjects who reach cycle 7, week 1.|25|We expanded accrual to enroll additional evaluable subjects for analysis of the secondary endpoints.|
60002682|NCT02092324|76118603|FG000|Wildtype CSF3R|Overall Study||23|Participants were stratified by CSF3R mutation status|
60002683|NCT02092324|76118603|FG000|Mutant CSF3R|Overall Study||26|Participants were stratified by CSF3R mutation status|
60002684|NCT02092324|76118603|FG000|COMPLETED|Overall Study||32||
60002685|NCT02092324|76118603|FG000|NOT COMPLETED|Overall Study||19||
60002686|NCT02040766|76118615|FG000|STARTED|Overall Study||127||
60002687|NCT02040766|76118616|FG001|STARTED|Overall Study||126||
60002688|NCT02040766|76118617|FG002|STARTED|Overall Study||125||
60002689|NCT02040766|76118618|FG003|STARTED|Overall Study||125||
60002690|NCT02040766|76118619|FG004|STARTED|Overall Study||125||
60002691|NCT02040766|76118615|FG000|COMPLETED|Overall Study||109||
60002692|NCT02040766|76118616|FG001|COMPLETED|Overall Study||116||
60002693|NCT02040766|76118617|FG002|COMPLETED|Overall Study||113||
60002694|NCT02040766|76118618|FG003|COMPLETED|Overall Study||112||
60002695|NCT02040766|76118619|FG004|COMPLETED|Overall Study||112||
60002696|NCT02040766|76118615|FG000|NOT COMPLETED|Overall Study||18||
60002697|NCT02040766|76118616|FG001|NOT COMPLETED|Overall Study||10||
60002698|NCT02040766|76118617|FG002|NOT COMPLETED|Overall Study||12||
60002699|NCT02040766|76118618|FG003|NOT COMPLETED|Overall Study||13||
60002700|NCT02040766|76118619|FG004|NOT COMPLETED|Overall Study||13||
60002701|NCT02040532|76118632|FG000|STARTED|Overall Study||32||
60002702|NCT02040532|76118632|FG000|Received at Least One Dose of Medication|Overall Study||26||
60002703|NCT02040532|76118632|FG000|COMPLETED|Overall Study||20||
60002704|NCT02040532|76118632|FG000|NOT COMPLETED|Overall Study||12||
60002705|NCT02039908|76118636|FG000|STARTED|Phase 1-Summer||129||
60002706|NCT02039908|76118637|FG001|STARTED|Phase 1-Summer||138||
60002707|NCT02039908|76118638|FG002|STARTED|Phase 1-Summer||0||
60002708|NCT02039908|76118639|FG003|STARTED|Phase 1-Summer||0||
60002709|NCT02039908|76118636|FG000|COMPLETED|Phase 1-Summer||116||
60002710|NCT02039908|76118637|FG001|COMPLETED|Phase 1-Summer||132||
60002711|NCT02039908|76118638|FG002|COMPLETED|Phase 1-Summer||0||
60002712|NCT02039908|76118639|FG003|COMPLETED|Phase 1-Summer||0||
60002713|NCT02039908|76118636|FG000|NOT COMPLETED|Phase 1-Summer||13||
60002714|NCT02039908|76118637|FG001|NOT COMPLETED|Phase 1-Summer||6||
60002715|NCT02039908|76118638|FG002|NOT COMPLETED|Phase 1-Summer||0||
60002716|NCT02039908|76118639|FG003|NOT COMPLETED|Phase 1-Summer||0||
60002717|NCT02039908|76118636|FG000|STARTED|Phase 2-School Year||0|Three participants elected not to continue in the study for the school -year phase.|
60002718|NCT02039908|76118637|FG001|STARTED|Phase 2-School Year||0|Three participants elected not to continue in the study for the school -year phase.|
60002719|NCT02039908|76118638|FG002|STARTED|Phase 2-School Year||121|Three participants elected not to continue in the study for the school -year phase.|
60002720|NCT02039908|76118639|FG003|STARTED|Phase 2-School Year||124|Three participants elected not to continue in the study for the school -year phase.|
60002721|NCT02039908|76118636|FG000|COMPLETED|Phase 2-School Year||0||
60002722|NCT02039908|76118637|FG001|COMPLETED|Phase 2-School Year||0||
60002723|NCT02039908|76118638|FG002|COMPLETED|Phase 2-School Year||109||
60002724|NCT02039908|76118639|FG003|COMPLETED|Phase 2-School Year||116||
60002725|NCT02039908|76118636|FG000|NOT COMPLETED|Phase 2-School Year||0||
60002726|NCT02039908|76118637|FG001|NOT COMPLETED|Phase 2-School Year||0||
60002727|NCT02039908|76118638|FG002|NOT COMPLETED|Phase 2-School Year||12||
60002728|NCT02039908|76118639|FG003|NOT COMPLETED|Phase 2-School Year||8||
60002729|NCT02058940|76118647|FG000|STARTED|Overall Study||8||
60002730|NCT02058940|76118647|FG000|COMPLETED|Overall Study||7||
60002731|NCT02058940|76118647|FG000|NOT COMPLETED|Overall Study||1||
60002732|NCT02058628|76118653|FG000|STARTED|Overall Study||111||
60002733|NCT02058628|76118654|FG001|STARTED|Overall Study||110||
60002734|NCT02058628|76118653|FG000|COMPLETED|Overall Study||104||
60002735|NCT02058628|76118654|FG001|COMPLETED|Overall Study||102||
60002736|NCT02058628|76118653|FG000|NOT COMPLETED|Overall Study||7||
60002737|NCT02058628|76118654|FG001|NOT COMPLETED|Overall Study||8||
60002738|NCT02058160|76118665|FG000|STARTED|Overall Study||367||
60002739|NCT02058160|76118666|FG001|STARTED|Overall Study||369||
60002740|NCT02058160|76118665|FG000|Treated|Overall Study||365||
60002741|NCT02058160|76118666|FG001|Treated|Overall Study||365||
60002742|NCT02058160|76118665|FG000|COMPLETED|Overall Study||336||
60002743|NCT02058160|76118666|FG001|COMPLETED|Overall Study||355||
60002744|NCT02058160|76118665|FG000|NOT COMPLETED|Overall Study||31||
60002745|NCT02058160|76118666|FG001|NOT COMPLETED|Overall Study||14||
60002746|NCT02090764|76118674|FG000|STARTED|Overall Study||206||
60002747|NCT02090764|76118675|FG001|STARTED|Overall Study||206||
60002748|NCT02090764|76118674|FG000|COMPLETED|Overall Study||200||
60002749|NCT02090764|76118675|FG001|COMPLETED|Overall Study||186||
60002750|NCT02090764|76118674|FG000|NOT COMPLETED|Overall Study||6||
60002751|NCT02090764|76118675|FG001|NOT COMPLETED|Overall Study||20||
60002752|NCT02057692|76118685|FG000|STARTED|Overall Study||8||
60002753|NCT02057692|76118686|FG001|STARTED|Overall Study||11||
60002754|NCT02057692|76118687|FG002|STARTED|Overall Study||6||
60002755|NCT02057692|76118688|FG003|STARTED|Overall Study||12||
60002756|NCT02057692|76118685|FG000|COMPLETED|Overall Study||7||
60002757|NCT02057692|76118686|FG001|COMPLETED|Overall Study||11||
60002758|NCT02057692|76118687|FG002|COMPLETED|Overall Study||6||
60002759|NCT02057692|76118688|FG003|COMPLETED|Overall Study||11||
60002760|NCT02057692|76118685|FG000|NOT COMPLETED|Overall Study||1||
60002761|NCT02057692|76118686|FG001|NOT COMPLETED|Overall Study||0||
60002762|NCT02057692|76118687|FG002|NOT COMPLETED|Overall Study||0||
60002763|NCT02057692|76118688|FG003|NOT COMPLETED|Overall Study||1||
60002764|NCT02038036|76118706|FG000|STARTED|Core Study||74||
60002765|NCT02038036|76118707|FG001|STARTED|Core Study||75||
60002766|NCT02038036|76118706|FG000|Full Analysis Set|Core Study||74|comprised of all patients to whom study treatment was assigned by randomization.|
60002767|NCT02038036|76118707|FG001|Full Analysis Set|Core Study||75|comprised of all patients to whom study treatment was assigned by randomization.|
60002768|NCT02038036|76118706|FG000|Crossover Set|Core Study||0|consisted of all patients randomized to the BAT arm, who crossed over and received at least one dose of ruxolitinib.|
60002769|NCT02038036|76118707|FG001|Crossover Set|Core Study||58|consisted of all patients randomized to the BAT arm, who crossed over and received at least one dose of ruxolitinib.|
60002770|NCT02038036|76118706|FG000|COMPLETED|Core Study||59||
60002771|NCT02038036|76118707|FG001|COMPLETED|Core Study||61||
60002772|NCT02038036|76118706|FG000|NOT COMPLETED|Core Study||15||
60002773|NCT02038036|76118707|FG001|NOT COMPLETED|Core Study||14||
60002774|NCT02038036|76118706|FG000|STARTED|Crossover Period||0||
60002775|NCT02038036|76118707|FG001|STARTED|Crossover Period|58 participants were eligible to crossover to the ruxolitinib arm|58||
60002776|NCT02038036|76118706|FG000|COMPLETED|Crossover Period||0||
60002777|NCT02038036|76118707|FG001|COMPLETED|Crossover Period||38||
60002778|NCT02038036|76118706|FG000|NOT COMPLETED|Crossover Period||0||
60002779|NCT02038036|76118707|FG001|NOT COMPLETED|Crossover Period||20||
60002780|NCT02037568|76118718|FG000|STARTED|Overall Study||83||
60002781|NCT02037568|76118719|FG001|STARTED|Overall Study||76||
60002782|NCT02037568|76118718|FG000|Month 1.5 (Post Transplantation)|Overall Study||79||
60002783|NCT02037568|76118719|FG001|Month 1.5 (Post Transplantation)|Overall Study||76||
60002784|NCT02037568|76118718|FG000|Month 3 (Post Transplantation)|Overall Study||66||
60002785|NCT02037568|76118719|FG001|Month 3 (Post Transplantation)|Overall Study||62||
60002786|NCT02037568|76118718|FG000|Month 6 (Post Transplantation)|Overall Study||63||
60002787|NCT02037568|76118719|FG001|Month 6 (Post Transplantation)|Overall Study||52||
60002788|NCT02037568|76118718|FG000|COMPLETED|Overall Study||47||
60002789|NCT02037568|76118719|FG001|COMPLETED|Overall Study||37||
60002790|NCT02037568|76118718|FG000|NOT COMPLETED|Overall Study||36||
60002791|NCT02037568|76118719|FG001|NOT COMPLETED|Overall Study||39||
60002792|NCT02088034|76118728|FG000|STARTED|Overall Study||33||
60002793|NCT02088034|76118729|FG001|STARTED|Overall Study||30||
60002794|NCT02088034|76118730|FG002|STARTED|Overall Study||29||
60002795|NCT02088034|76118728|FG000|COMPLETED|Overall Study||30||
60002796|NCT02088034|76118729|FG001|COMPLETED|Overall Study||28||
60002797|NCT02088034|76118730|FG002|COMPLETED|Overall Study||27||
60002798|NCT02088034|76118728|FG000|NOT COMPLETED|Overall Study||3||
60002799|NCT02088034|76118729|FG001|NOT COMPLETED|Overall Study||2||
60002800|NCT02088034|76118730|FG002|NOT COMPLETED|Overall Study||2||
60002801|NCT02037256|76118740|FG000|STARTED|Overall Study||3||
60002802|NCT02037256|76118741|FG001|STARTED|Overall Study||20||
60002803|NCT02037256|76118740|FG000|COMPLETED|Overall Study||3|"1 withdrew consent prior to Velcade infusion~1 removed from protocol prior to Velcade infusioin~1 failed to comply with protocol requirement to come to transplant in 2 months"|
60002804|NCT02037256|76118741|FG001|COMPLETED|Overall Study||17|"1 withdrew consent prior to Velcade infusion~1 removed from protocol prior to Velcade infusioin~1 failed to comply with protocol requirement to come to transplant in 2 months"|
59750476|NCT00660907|75869664|FG000|COMPLETED|Overall Study||322||
59750477|NCT00660907|75869665|FG001|COMPLETED|Overall Study||314||
59750478|NCT00660907|75869664|FG000|NOT COMPLETED|Overall Study||84||
60002805|NCT02037256|76118740|FG000|NOT COMPLETED|Overall Study||0||
60002806|NCT02037256|76118741|FG001|NOT COMPLETED|Overall Study||3||
60002807|NCT02035696|76118753|FG000|STARTED|Overall Study||174||
60002808|NCT02035696|76118754|FG001|STARTED|Overall Study||166||
60002809|NCT02035696|76118755|FG002|STARTED|Overall Study||167||
60002810|NCT02035696|76118756|FG003|STARTED|Overall Study||164||
60002811|NCT02035696|76118753|FG000|COMPLETED|Overall Study||171||
60002812|NCT02035696|76118754|FG001|COMPLETED|Overall Study||163||
60002813|NCT02035696|76118755|FG002|COMPLETED|Overall Study||164||
60002814|NCT02035696|76118756|FG003|COMPLETED|Overall Study||161||
60002815|NCT02035696|76118753|FG000|NOT COMPLETED|Overall Study||3||
60002816|NCT02035696|76118754|FG001|NOT COMPLETED|Overall Study||3||
60002817|NCT02035696|76118755|FG002|NOT COMPLETED|Overall Study||3||
60002818|NCT02035696|76118756|FG003|NOT COMPLETED|Overall Study||3||
60002819|NCT02057458|76118770|FG000|STARTED|Recruited for Participation||8||
59750479|NCT00660907|75869665|FG001|NOT COMPLETED|Overall Study||94||
59750480|NCT00877773|75869671|FG000|STARTED|Overall Study||44||
59750481|NCT00877773|75869671|FG000|COMPLETED|Overall Study|No participant reached to first restaging.|0||
59750482|NCT00877773|75869671|FG000|NOT COMPLETED|Overall Study||44||
59750483|NCT00659815|75869677|FG000|STARTED|Overall Study||157||
59750484|NCT00659815|75869678|FG001|STARTED|Overall Study||151||
59750485|NCT00659815|75869677|FG000|COMPLETED|Overall Study||153||
59750486|NCT00659815|75869678|FG001|COMPLETED|Overall Study||147||
59750487|NCT00659815|75869677|FG000|NOT COMPLETED|Overall Study||4||
59750488|NCT00659815|75869678|FG001|NOT COMPLETED|Overall Study||4||
60002820|NCT02057458|76118771|FG001|STARTED|Recruited for Participation||8||
59605475|NCT02002182|75715651|FG001|COMPLETED|Overall Study||5||
59605476|NCT02002182|75715650|FG000|NOT COMPLETED|Overall Study||5||
59750489|NCT00994643|75869684|FG000|STARTED|Overall Study||11||
59750490|NCT00994643|75869684|FG000|COMPLETED|Overall Study||10||
59750491|NCT00994643|75869684|FG000|NOT COMPLETED|Overall Study||1||
60002821|NCT02057458|76118772|FG002|STARTED|Recruited for Participation||3||
60002822|NCT02057458|76118770|FG000|COMPLETED|Recruited for Participation||8||
60002823|NCT02057458|76118771|FG001|COMPLETED|Recruited for Participation||8||
60002824|NCT02057458|76118772|FG002|COMPLETED|Recruited for Participation||3||
60002825|NCT02057458|76118770|FG000|NOT COMPLETED|Recruited for Participation||0||
60002826|NCT02057458|76118771|FG001|NOT COMPLETED|Recruited for Participation||0||
60002827|NCT02057458|76118772|FG002|NOT COMPLETED|Recruited for Participation||0||
60002828|NCT02057458|76118770|FG000|STARTED|Met Inclusion Criteria||8||
60002829|NCT02057458|76118771|FG001|STARTED|Met Inclusion Criteria||8||
60002830|NCT02057458|76118772|FG002|STARTED|Met Inclusion Criteria||3||
60002831|NCT02057458|76118770|FG000|COMPLETED|Met Inclusion Criteria||8||
59880150|NCT02793232|76003432|FG006|COMPLETED|Washout Period 1(Part A:at Least 10days)||0||
59605477|NCT02002182|75715651|FG001|NOT COMPLETED|Overall Study||1||
59880151|NCT02793232|76003433|FG007|COMPLETED|Washout Period 1(Part A:at Least 10days)||0||
59880152|NCT02793232|76003434|FG008|COMPLETED|Washout Period 1(Part A:at Least 10days)||0||
59880153|NCT02793232|76003426|FG000|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0||
59880154|NCT02793232|76003427|FG001|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0||
59880155|NCT02793232|76003428|FG002|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0||
59880156|NCT02793232|76003429|FG003|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0||
59880157|NCT02793232|76003430|FG004|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0||
59880158|NCT02793232|76003431|FG005|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0||
59880159|NCT02793232|76003432|FG006|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0||
59880160|NCT02793232|76003433|FG007|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0||
59880161|NCT02793232|76003434|FG008|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0||
59880162|NCT02793232|76003426|FG000|STARTED|Period 2 (Part A: 5 Days)||2||
59880163|NCT02793232|76003427|FG001|STARTED|Period 2 (Part A: 5 Days)||2||
59880164|NCT02793232|76003428|FG002|STARTED|Period 2 (Part A: 5 Days)||2||
59880165|NCT02793232|76003429|FG003|STARTED|Period 2 (Part A: 5 Days)||2||
59880166|NCT02793232|76003430|FG004|STARTED|Period 2 (Part A: 5 Days)||0||
59880167|NCT02793232|76003431|FG005|STARTED|Period 2 (Part A: 5 Days)||0||
59880168|NCT02793232|76003432|FG006|STARTED|Period 2 (Part A: 5 Days)||0||
59880169|NCT02793232|76003433|FG007|STARTED|Period 2 (Part A: 5 Days)||0||
59880170|NCT02793232|76003434|FG008|STARTED|Period 2 (Part A: 5 Days)||0||
59880171|NCT02793232|76003426|FG000|COMPLETED|Period 2 (Part A: 5 Days)||2||
59880172|NCT02793232|76003427|FG001|COMPLETED|Period 2 (Part A: 5 Days)||2||
59880173|NCT02793232|76003428|FG002|COMPLETED|Period 2 (Part A: 5 Days)||2||
59880174|NCT02793232|76003429|FG003|COMPLETED|Period 2 (Part A: 5 Days)||2||
59880175|NCT02793232|76003430|FG004|COMPLETED|Period 2 (Part A: 5 Days)||0||
59880176|NCT02793232|76003431|FG005|COMPLETED|Period 2 (Part A: 5 Days)||0||
59880177|NCT02793232|76003432|FG006|COMPLETED|Period 2 (Part A: 5 Days)||0||
59880178|NCT02793232|76003433|FG007|COMPLETED|Period 2 (Part A: 5 Days)||0||
59880179|NCT02793232|76003434|FG008|COMPLETED|Period 2 (Part A: 5 Days)||0||
59880180|NCT02793232|76003426|FG000|NOT COMPLETED|Period 2 (Part A: 5 Days)||0||
59880181|NCT02793232|76003427|FG001|NOT COMPLETED|Period 2 (Part A: 5 Days)||0||
59880182|NCT02793232|76003428|FG002|NOT COMPLETED|Period 2 (Part A: 5 Days)||0||
59880183|NCT02793232|76003429|FG003|NOT COMPLETED|Period 2 (Part A: 5 Days)||0||
59880184|NCT02793232|76003430|FG004|NOT COMPLETED|Period 2 (Part A: 5 Days)||0||
59880185|NCT02793232|76003431|FG005|NOT COMPLETED|Period 2 (Part A: 5 Days)||0||
59880186|NCT02793232|76003432|FG006|NOT COMPLETED|Period 2 (Part A: 5 Days)||0||
59880187|NCT02793232|76003433|FG007|NOT COMPLETED|Period 2 (Part A: 5 Days)||0||
59880188|NCT02793232|76003434|FG008|NOT COMPLETED|Period 2 (Part A: 5 Days)||0||
59880189|NCT02793232|76003426|FG000|STARTED|Washout Period 2(Part A:at Least 10days)||2||
59880190|NCT02793232|76003427|FG001|STARTED|Washout Period 2(Part A:at Least 10days)||2||
59880191|NCT02793232|76003428|FG002|STARTED|Washout Period 2(Part A:at Least 10days)||2||
59880192|NCT02793232|76003429|FG003|STARTED|Washout Period 2(Part A:at Least 10days)||2||
59880193|NCT02793232|76003430|FG004|STARTED|Washout Period 2(Part A:at Least 10days)||0||
59880194|NCT02793232|76003431|FG005|STARTED|Washout Period 2(Part A:at Least 10days)||0||
59880195|NCT02793232|76003432|FG006|STARTED|Washout Period 2(Part A:at Least 10days)||0||
59880196|NCT02793232|76003433|FG007|STARTED|Washout Period 2(Part A:at Least 10days)||0||
59880197|NCT02793232|76003434|FG008|STARTED|Washout Period 2(Part A:at Least 10days)||0||
59880198|NCT02793232|76003426|FG000|COMPLETED|Washout Period 2(Part A:at Least 10days)||2||
59880199|NCT02793232|76003427|FG001|COMPLETED|Washout Period 2(Part A:at Least 10days)||2||
59880200|NCT02793232|76003428|FG002|COMPLETED|Washout Period 2(Part A:at Least 10days)||2||
59880201|NCT02793232|76003429|FG003|COMPLETED|Washout Period 2(Part A:at Least 10days)||2||
59880202|NCT02793232|76003430|FG004|COMPLETED|Washout Period 2(Part A:at Least 10days)||0||
59880203|NCT02793232|76003431|FG005|COMPLETED|Washout Period 2(Part A:at Least 10days)||0||
59880204|NCT02793232|76003432|FG006|COMPLETED|Washout Period 2(Part A:at Least 10days)||0||
59880205|NCT02793232|76003433|FG007|COMPLETED|Washout Period 2(Part A:at Least 10days)||0||
60002832|NCT02057458|76118771|FG001|COMPLETED|Met Inclusion Criteria||7||
60002833|NCT02057458|76118772|FG002|COMPLETED|Met Inclusion Criteria||3||
60002834|NCT02057458|76118770|FG000|NOT COMPLETED|Met Inclusion Criteria||0||
60002835|NCT02057458|76118771|FG001|NOT COMPLETED|Met Inclusion Criteria||1||
60002836|NCT02057458|76118772|FG002|NOT COMPLETED|Met Inclusion Criteria||0||
60002837|NCT02057458|76118770|FG000|STARTED|Acute Study (1 Hour): First Intervention||8||
60002838|NCT02057458|76118771|FG001|STARTED|Acute Study (1 Hour): First Intervention||7||
60002839|NCT02057458|76118772|FG002|STARTED|Acute Study (1 Hour): First Intervention||0||
60002840|NCT02057458|76118770|FG000|COMPLETED|Acute Study (1 Hour): First Intervention||6||
60002841|NCT02057458|76118771|FG001|COMPLETED|Acute Study (1 Hour): First Intervention||7||
60002842|NCT02057458|76118772|FG002|COMPLETED|Acute Study (1 Hour): First Intervention||0||
60002843|NCT02057458|76118770|FG000|NOT COMPLETED|Acute Study (1 Hour): First Intervention||2||
60002844|NCT02057458|76118771|FG001|NOT COMPLETED|Acute Study (1 Hour): First Intervention||0||
60002845|NCT02057458|76118772|FG002|NOT COMPLETED|Acute Study (1 Hour): First Intervention||0||
60002846|NCT02057458|76118770|FG000|STARTED|Acute Study (1 Hour): Second Int.||6||
60002847|NCT02057458|76118771|FG001|STARTED|Acute Study (1 Hour): Second Int.||7||
60002848|NCT02057458|76118772|FG002|STARTED|Acute Study (1 Hour): Second Int.||0||
60002849|NCT02057458|76118770|FG000|COMPLETED|Acute Study (1 Hour): Second Int.||6||
60002850|NCT02057458|76118771|FG001|COMPLETED|Acute Study (1 Hour): Second Int.||7||
60002851|NCT02057458|76118772|FG002|COMPLETED|Acute Study (1 Hour): Second Int.||0||
60002852|NCT02057458|76118770|FG000|NOT COMPLETED|Acute Study (1 Hour): Second Int.||0||
60002853|NCT02057458|76118771|FG001|NOT COMPLETED|Acute Study (1 Hour): Second Int.||0||
60002854|NCT02057458|76118772|FG002|NOT COMPLETED|Acute Study (1 Hour): Second Int.||0||
60002855|NCT02057458|76118770|FG000|STARTED|Sub-Chronic Study (4 Weeks)||6||
60002856|NCT02057458|76118771|FG001|STARTED|Sub-Chronic Study (4 Weeks)||7||
60002857|NCT02057458|76118772|FG002|STARTED|Sub-Chronic Study (4 Weeks)||3||
60002858|NCT02057458|76118770|FG000|COMPLETED|Sub-Chronic Study (4 Weeks)||5||
60002859|NCT02057458|76118771|FG001|COMPLETED|Sub-Chronic Study (4 Weeks)||7||
60002860|NCT02057458|76118772|FG002|COMPLETED|Sub-Chronic Study (4 Weeks)||3||
60002861|NCT02057458|76118770|FG000|NOT COMPLETED|Sub-Chronic Study (4 Weeks)||1||
60002862|NCT02057458|76118771|FG001|NOT COMPLETED|Sub-Chronic Study (4 Weeks)||0||
60002863|NCT02057458|76118772|FG002|NOT COMPLETED|Sub-Chronic Study (4 Weeks)||0||
60002864|NCT02057068|76118804|FG000|STARTED|Overall Study||60|12 beta test dyads included in the intervention group, thus they were not randomized.|
60002865|NCT02057068|76118805|FG001|STARTED|Overall Study||36|12 beta test dyads included in the intervention group, thus they were not randomized.|
60002866|NCT02057068|76118804|FG000|COMPLETED|Overall Study||52||
60002867|NCT02057068|76118805|FG001|COMPLETED|Overall Study||28||
60002868|NCT02057068|76118804|FG000|NOT COMPLETED|Overall Study||8||
60002869|NCT02057068|76118805|FG001|NOT COMPLETED|Overall Study||8||
60002870|NCT02056834|76118813|FG000|STARTED|Overall Study||36||
60002871|NCT02056834|76118813|FG000|6 Weeks|Overall Study||34||
60002872|NCT02056834|76118813|FG000|6 Months|Overall Study||31||
60002873|NCT02056834|76118813|FG000|COMPLETED|Overall Study||29||
60002874|NCT02056834|76118813|FG000|NOT COMPLETED|Overall Study||7||
60002875|NCT02087176|76118818|FG000|STARTED|Overall Study||32||
60002876|NCT02087176|76118818|FG000|COMPLETED|Overall Study|The sponsor terminated the study early.|0||
60002877|NCT02087176|76118818|FG000|NOT COMPLETED|Overall Study||32||
60002878|NCT02056288|76118824|FG000|STARTED|In-Hospital Data||40|Randomized|
60002879|NCT02056288|76118825|FG001|STARTED|In-Hospital Data||38|Randomized|
60002880|NCT02056288|76118824|FG000|COMPLETED|In-Hospital Data||35||
60002881|NCT02056288|76118825|FG001|COMPLETED|In-Hospital Data||38||
60002882|NCT02056288|76118824|FG000|NOT COMPLETED|In-Hospital Data||5||
60002883|NCT02056288|76118825|FG001|NOT COMPLETED|In-Hospital Data||0||
60002884|NCT02056288|76118824|FG000|STARTED|48-Hour Post-Discharge Data||35||
60002885|NCT02056288|76118825|FG001|STARTED|48-Hour Post-Discharge Data||38||
60002886|NCT02056288|76118824|FG000|COMPLETED|48-Hour Post-Discharge Data||21||
60002887|NCT02056288|76118825|FG001|COMPLETED|48-Hour Post-Discharge Data||18||
60002888|NCT02056288|76118824|FG000|NOT COMPLETED|48-Hour Post-Discharge Data||14||
60002889|NCT02056288|76118825|FG001|NOT COMPLETED|48-Hour Post-Discharge Data||20||
60002890|NCT02086162|76118833|FG000|STARTED|Overall Study||78||
60002891|NCT02086162|76118834|FG001|STARTED|Overall Study||84||
60002892|NCT02086162|76118833|FG000|COMPLETED|Overall Study||68||
60002893|NCT02086162|76118834|FG001|COMPLETED|Overall Study||77||
60002894|NCT02086162|76118833|FG000|NOT COMPLETED|Overall Study||10||
60002895|NCT02086162|76118834|FG001|NOT COMPLETED|Overall Study||7||
60002896|NCT02700815|76118848|FG000|STARTED|Overall Study||75||
60002897|NCT02700815|76118849|FG001|STARTED|Overall Study||223||
60002898|NCT02700815|76118850|FG002|STARTED|Overall Study||223||
60002899|NCT02700815|76118851|FG003|STARTED|Overall Study||225||
60002900|NCT02700815|76118848|FG000|COMPLETED|Overall Study||74||
60002901|NCT02700815|76118849|FG001|COMPLETED|Overall Study||216||
60002902|NCT02700815|76118850|FG002|COMPLETED|Overall Study||219||
60002903|NCT02700815|76118851|FG003|COMPLETED|Overall Study||218||
60002904|NCT02700815|76118848|FG000|NOT COMPLETED|Overall Study||1||
60002905|NCT02700815|76118849|FG001|NOT COMPLETED|Overall Study||7||
60002906|NCT02700815|76118850|FG002|NOT COMPLETED|Overall Study||4||
60002907|NCT02700815|76118851|FG003|NOT COMPLETED|Overall Study||7||
60002908|NCT00708305|76118861|FG000|STARTED|Period 1||16||
60002909|NCT00708305|76118862|FG001|STARTED|Period 1||16||
60002910|NCT00708305|76118863|FG002|STARTED|Period 1||17||
60002911|NCT00708305|76118864|FG003|STARTED|Period 1||16||
60002912|NCT00708305|76118861|FG000|COMPLETED|Period 1||15||
60002913|NCT00708305|76118862|FG001|COMPLETED|Period 1||16||
60002914|NCT00708305|76118863|FG002|COMPLETED|Period 1||16||
60002915|NCT00708305|76118864|FG003|COMPLETED|Period 1||14||
60002916|NCT00708305|76118861|FG000|NOT COMPLETED|Period 1||1||
59750492|NCT00660829|75869690|FG000|STARTED|Overall Study|2 subjects were randomized in error|268||
59750493|NCT00660829|75869691|FG001|STARTED|Overall Study|2 subjects were randomized in error|268||
59750494|NCT00660829|75869690|FG000|COMPLETED|Overall Study||250||
59750495|NCT00660829|75869691|FG001|COMPLETED|Overall Study||249||
60002917|NCT00708305|76118862|FG001|NOT COMPLETED|Period 1||0||
60002918|NCT00708305|76118863|FG002|NOT COMPLETED|Period 1||1||
60002919|NCT00708305|76118864|FG003|NOT COMPLETED|Period 1||2||
60002920|NCT00708305|76118861|FG000|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|15||
60002921|NCT00708305|76118862|FG001|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|15||
60002922|NCT00708305|76118863|FG002|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|16||
60002923|NCT00708305|76118864|FG003|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|15||
59750496|NCT00660829|75869690|FG000|NOT COMPLETED|Overall Study||18||
60002924|NCT00708305|76118861|FG000|COMPLETED|Period 2||14||
60002925|NCT00708305|76118862|FG001|COMPLETED|Period 2||13||
60002926|NCT00708305|76118863|FG002|COMPLETED|Period 2||16||
60002927|NCT00708305|76118864|FG003|COMPLETED|Period 2||14||
60002928|NCT00708305|76118861|FG000|NOT COMPLETED|Period 2||1||
60002929|NCT00708305|76118862|FG001|NOT COMPLETED|Period 2||2||
60002930|NCT00708305|76118863|FG002|NOT COMPLETED|Period 2||0||
59750497|NCT00660829|75869691|FG001|NOT COMPLETED|Overall Study||19||
59750498|NCT00877383|75869699|FG000|STARTED|Overall Study||572||
59750499|NCT00877383|75869700|FG001|STARTED|Overall Study||570||
59750500|NCT00877383|75869699|FG000|COMPLETED|Overall Study||543||
59750501|NCT00877383|75869700|FG001|COMPLETED|Overall Study||533||
59750502|NCT00877383|75869699|FG000|NOT COMPLETED|Overall Study||29||
59750503|NCT00877383|75869700|FG001|NOT COMPLETED|Overall Study||37||
59750504|NCT00993473|75869708|FG000|STARTED|Overall Study|61 patients randomized to Lantus but 62 patients treated with Lantus due to a dispensation's error|61||
59750505|NCT00993473|75869709|FG001|STARTED|Overall Study|64 patients randomized to NPH but only 63 patients treated with NPH due to a dispensation's error|64||
59750506|NCT00993473|75869708|FG000|COMPLETED|Overall Study||57||
59880206|NCT02793232|76003434|FG008|COMPLETED|Washout Period 2(Part A:at Least 10days)||0||
59880207|NCT02793232|76003426|FG000|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0||
59880208|NCT02793232|76003427|FG001|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0||
59880209|NCT02793232|76003428|FG002|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0||
59880210|NCT02793232|76003429|FG003|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0||
59880211|NCT02793232|76003430|FG004|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0||
59750507|NCT00993473|75869709|FG001|COMPLETED|Overall Study||54||
59750508|NCT00993473|75869708|FG000|NOT COMPLETED|Overall Study||4||
59750509|NCT00993473|75869709|FG001|NOT COMPLETED|Overall Study||10||
59750510|NCT00660595|75869717|FG000|STARTED|Overall Study||19||
59750511|NCT00660595|75869718|FG001|STARTED|Overall Study||10||
59750512|NCT00660595|75869717|FG000|COMPLETED|Overall Study||1||
59750513|NCT00660595|75869718|FG001|COMPLETED|Overall Study|One of the two was lost to follow-up|1||
59750514|NCT00660595|75869717|FG000|NOT COMPLETED|Overall Study||18||
59750515|NCT00660595|75869718|FG001|NOT COMPLETED|Overall Study||9||
59750516|NCT00929240|75869724|FG000|STARTED|Initial Treatment Phase|Includes only the participants that received Initial Phase Treatment.|284||
59750517|NCT00929240|75869725|FG001|STARTED|Initial Treatment Phase|Participants were randomized to 1 of 2 treatment groups at the end of the initial treatment phase.|0||
59750518|NCT00929240|75869726|FG002|STARTED|Initial Treatment Phase||0||
59750519|NCT00929240|75869724|FG000|COMPLETED|Initial Treatment Phase|Participants were randomized to 1 of 2 treatment groups at the end of the initial treatment phase.|185||
59750520|NCT00929240|75869725|FG001|COMPLETED|Initial Treatment Phase||0||
59750521|NCT00929240|75869726|FG002|COMPLETED|Initial Treatment Phase||0||
59750522|NCT00929240|75869724|FG000|NOT COMPLETED|Initial Treatment Phase||99||
59750523|NCT00929240|75869725|FG001|NOT COMPLETED|Initial Treatment Phase||0||
59750524|NCT00929240|75869726|FG002|NOT COMPLETED|Initial Treatment Phase||0||
59762508|NCT02913131|75882266|FG000|STARTED|Overall Study||18||
59762627|NCT00871728|75882461|FG000|Treated|Overall Study||130||
59950762|NCT02779855|76069613|FG000|STARTED|Overall Study||4||
59950763|NCT02779855|76069614|FG001|STARTED|Overall Study||6||
59950764|NCT02779855|76069615|FG002|STARTED|Overall Study||40||
59950765|NCT02779855|76069613|FG000|COMPLETED|Overall Study||3||
59950766|NCT02779855|76069614|FG001|COMPLETED|Overall Study||6||
59950767|NCT02779855|76069615|FG002|COMPLETED|Overall Study||40||
59950768|NCT02779855|76069613|FG000|NOT COMPLETED|Overall Study||1||
59950769|NCT02779855|76069614|FG001|NOT COMPLETED|Overall Study||0||
59950770|NCT02779855|76069615|FG002|NOT COMPLETED|Overall Study||0||
59950771|NCT02682927|76069630|FG000|STARTED|Overall Study||40||
59950772|NCT02682927|76069631|FG001|STARTED|Overall Study||39||
59950773|NCT02682927|76069632|FG002|STARTED|Overall Study||40||
59950774|NCT02682927|76069633|FG003|STARTED|Overall Study||48||
59950775|NCT02682927|76069634|FG004|STARTED|Overall Study||46||
59950776|NCT02682927|76069635|FG005|STARTED|Overall Study||49||
59950777|NCT02682927|76069630|FG000|COMPLETED|Overall Study||37||
59950778|NCT02682927|76069631|FG001|COMPLETED|Overall Study||39||
59950779|NCT02682927|76069632|FG002|COMPLETED|Overall Study||34||
59950780|NCT02682927|76069633|FG003|COMPLETED|Overall Study||43||
59950781|NCT02682927|76069634|FG004|COMPLETED|Overall Study||45||
59950782|NCT02682927|76069635|FG005|COMPLETED|Overall Study||46||
59950783|NCT02682927|76069630|FG000|NOT COMPLETED|Overall Study||3||
59950784|NCT02682927|76069631|FG001|NOT COMPLETED|Overall Study||0||
59950785|NCT02682927|76069632|FG002|NOT COMPLETED|Overall Study||6||
59950786|NCT02682927|76069633|FG003|NOT COMPLETED|Overall Study||5||
59950787|NCT02682927|76069634|FG004|NOT COMPLETED|Overall Study||1||
60002931|NCT00708305|76118864|FG003|NOT COMPLETED|Period 2||1||
60002932|NCT00708305|76118861|FG000|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|15||
60002933|NCT00708305|76118862|FG001|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|14||
60002934|NCT00708305|76118863|FG002|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|14||
60002935|NCT00708305|76118864|FG003|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|14||
60002936|NCT00708305|76118861|FG000|COMPLETED|Period 3||14||
60002937|NCT00708305|76118862|FG001|COMPLETED|Period 3||12||
60002938|NCT00708305|76118863|FG002|COMPLETED|Period 3||14||
60002939|NCT00708305|76118864|FG003|COMPLETED|Period 3||14||
60002940|NCT00708305|76118861|FG000|NOT COMPLETED|Period 3||1||
60002941|NCT00708305|76118862|FG001|NOT COMPLETED|Period 3||2||
60002942|NCT00708305|76118863|FG002|NOT COMPLETED|Period 3||0||
60002943|NCT00708305|76118864|FG003|NOT COMPLETED|Period 3||0||
60002944|NCT00708305|76118861|FG000|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|12||
60002945|NCT00708305|76118862|FG001|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|14||
60002946|NCT00708305|76118863|FG002|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|14||
60002947|NCT00708305|76118864|FG003|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|14||
60002948|NCT00708305|76118861|FG000|COMPLETED|Period 4||12||
60002949|NCT00708305|76118862|FG001|COMPLETED|Period 4||14||
60002950|NCT00708305|76118863|FG002|COMPLETED|Period 4||14||
60002951|NCT00708305|76118864|FG003|COMPLETED|Period 4||14||
60002952|NCT00708305|76118861|FG000|NOT COMPLETED|Period 4||0||
60002953|NCT00708305|76118862|FG001|NOT COMPLETED|Period 4||0||
60002954|NCT00708305|76118863|FG002|NOT COMPLETED|Period 4||0||
60002955|NCT00708305|76118864|FG003|NOT COMPLETED|Period 4||0||
60002956|NCT02055976|76118886|FG000|STARTED|Overall Study||25||
60002957|NCT02055976|76118887|FG001|STARTED|Overall Study||24||
60002958|NCT02055976|76118888|FG002|STARTED|Overall Study||24||
60002959|NCT02055976|76118889|FG003|STARTED|Overall Study||26||
60002960|NCT02055976|76118890|FG004|STARTED|Overall Study||22||
60002961|NCT02055976|76118891|FG005|STARTED|Overall Study||25||
60002962|NCT02055976|76118892|FG006|STARTED|Overall Study||25||
59762628|NCT00871728|75882461|FG000|COMPLETED|Overall Study||112||
60002963|NCT02055976|76118893|FG007|STARTED|Overall Study||24||
60002964|NCT02055976|76118894|FG008|STARTED|Overall Study||23||
60002965|NCT02055976|76118886|FG000|COMPLETED|Overall Study||25||
60002966|NCT02055976|76118887|FG001|COMPLETED|Overall Study||24||
60002967|NCT02055976|76118888|FG002|COMPLETED|Overall Study||23||
60002968|NCT02055976|76118889|FG003|COMPLETED|Overall Study||25||
60002969|NCT02055976|76118890|FG004|COMPLETED|Overall Study||22||
60002970|NCT02055976|76118891|FG005|COMPLETED|Overall Study||24||
60002971|NCT02055976|76118892|FG006|COMPLETED|Overall Study||23||
60002972|NCT02055976|76118893|FG007|COMPLETED|Overall Study||24||
60002973|NCT02055976|76118894|FG008|COMPLETED|Overall Study||23||
60002974|NCT02055976|76118886|FG000|NOT COMPLETED|Overall Study||0||
60002975|NCT02055976|76118887|FG001|NOT COMPLETED|Overall Study||0||
60002976|NCT02055976|76118888|FG002|NOT COMPLETED|Overall Study||1||
60002977|NCT02055976|76118889|FG003|NOT COMPLETED|Overall Study||1||
60002978|NCT02055976|76118890|FG004|NOT COMPLETED|Overall Study||0||
60002979|NCT02055976|76118891|FG005|NOT COMPLETED|Overall Study||1||
60002980|NCT02055976|76118892|FG006|NOT COMPLETED|Overall Study||2||
60002981|NCT02055976|76118893|FG007|NOT COMPLETED|Overall Study||0||
60002982|NCT02055976|76118894|FG008|NOT COMPLETED|Overall Study||0||
59519066|NCT01118221|75612937|FG000|STARTED|Overall Study||14||
60002983|NCT02055898|76118923|FG000|STARTED|First Intervention (5 Days)||7||
60002984|NCT02055898|76118924|FG001|STARTED|First Intervention (5 Days)||6||
60002985|NCT02055898|76118923|FG000|COMPLETED|First Intervention (5 Days)||5||
60002986|NCT02055898|76118924|FG001|COMPLETED|First Intervention (5 Days)||5||
60002987|NCT02055898|76118923|FG000|NOT COMPLETED|First Intervention (5 Days)||2||
60002988|NCT02055898|76118924|FG001|NOT COMPLETED|First Intervention (5 Days)||1||
60002989|NCT02055898|76118923|FG000|STARTED|Washout (at Least 14 Days)||5||
60002990|NCT02055898|76118924|FG001|STARTED|Washout (at Least 14 Days)||5||
60002991|NCT02055898|76118923|FG000|COMPLETED|Washout (at Least 14 Days)||5||
60002992|NCT02055898|76118924|FG001|COMPLETED|Washout (at Least 14 Days)||5||
60002993|NCT02055898|76118923|FG000|NOT COMPLETED|Washout (at Least 14 Days)||0||
60002994|NCT02055898|76118924|FG001|NOT COMPLETED|Washout (at Least 14 Days)||0||
60002995|NCT02055898|76118923|FG000|STARTED|Second Intervention (5 Days)||5||
60002996|NCT02055898|76118924|FG001|STARTED|Second Intervention (5 Days)||5||
60002997|NCT02055898|76118923|FG000|COMPLETED|Second Intervention (5 Days)||5||
60002998|NCT02055898|76118924|FG001|COMPLETED|Second Intervention (5 Days)||5||
60002999|NCT02055898|76118923|FG000|NOT COMPLETED|Second Intervention (5 Days)||0||
60003000|NCT02055898|76118924|FG001|NOT COMPLETED|Second Intervention (5 Days)||0||
59750525|NCT00929240|75869724|FG000|STARTED|Maintenance Phase|Participants were randomized to 1 of 2 treatment groups at the end of the initial treatment phase.|0||
59750526|NCT00929240|75869725|FG001|STARTED|Maintenance Phase||94||
59750527|NCT00929240|75869726|FG002|STARTED|Maintenance Phase||91||
59750528|NCT00929240|75869724|FG000|COMPLETED|Maintenance Phase||0||
59750529|NCT00929240|75869725|FG001|COMPLETED|Maintenance Phase||0||
59750530|NCT00929240|75869726|FG002|COMPLETED|Maintenance Phase||0||
59750531|NCT00929240|75869724|FG000|NOT COMPLETED|Maintenance Phase||0||
60003001|NCT02564055|76118936|FG000|STARTED|Overall Study||40||
60003002|NCT02564055|76118937|FG001|STARTED|Overall Study||41||
60003003|NCT02564055|76118938|FG002|STARTED|Overall Study||43||
60003004|NCT02564055|76118939|FG003|STARTED|Overall Study||41||
60003005|NCT02564055|76118940|FG004|STARTED|Overall Study||42||
60003006|NCT02564055|76118941|FG005|STARTED|Overall Study||40||
60003007|NCT02564055|76118936|FG000|COMPLETED|Overall Study||34||
60003008|NCT02564055|76118937|FG001|COMPLETED|Overall Study||36||
60003009|NCT02564055|76118938|FG002|COMPLETED|Overall Study||31||
60003010|NCT02564055|76118939|FG003|COMPLETED|Overall Study||35||
60003011|NCT02564055|76118940|FG004|COMPLETED|Overall Study||27||
60003012|NCT02564055|76118941|FG005|COMPLETED|Overall Study||28||
60003013|NCT02564055|76118936|FG000|NOT COMPLETED|Overall Study||6||
60003014|NCT02564055|76118937|FG001|NOT COMPLETED|Overall Study||5||
60003015|NCT02564055|76118938|FG002|NOT COMPLETED|Overall Study||12||
60003016|NCT02564055|76118939|FG003|NOT COMPLETED|Overall Study||6||
60003017|NCT02564055|76118940|FG004|NOT COMPLETED|Overall Study||15||
60003018|NCT02564055|76118941|FG005|NOT COMPLETED|Overall Study||12||
60003019|NCT02563899|76118959|FG000|STARTED|Overall Study||18||
60003020|NCT02563899|76118960|FG001|STARTED|Overall Study||5||
59750532|NCT00929240|75869725|FG001|NOT COMPLETED|Maintenance Phase||94||
59750533|NCT00929240|75869726|FG002|NOT COMPLETED|Maintenance Phase||91||
59750534|NCT00993317|75869737|FG000|STARTED|Overall Study||42||
60003021|NCT02563899|76118961|FG002|STARTED|Overall Study||10||
60003022|NCT02563899|76118962|FG003|STARTED|Overall Study||6||
60003023|NCT02563899|76118959|FG000|COMPLETED|Overall Study||17||
60003024|NCT02563899|76118960|FG001|COMPLETED|Overall Study||5||
60003025|NCT02563899|76118961|FG002|COMPLETED|Overall Study||9||
60003026|NCT02563899|76118962|FG003|COMPLETED|Overall Study||6||
60003027|NCT02563899|76118959|FG000|NOT COMPLETED|Overall Study||1||
60003028|NCT02563899|76118960|FG001|NOT COMPLETED|Overall Study||0||
60003029|NCT02563899|76118961|FG002|NOT COMPLETED|Overall Study||1||
60003030|NCT02563899|76118962|FG003|NOT COMPLETED|Overall Study||0||
60003031|NCT02699099|76118976|FG000|STARTED|Overall Study||231||
60003032|NCT02699099|76118977|FG001|STARTED|Overall Study||236||
60003033|NCT02699099|76118978|FG002|STARTED|Overall Study||232||
60003034|NCT02699099|76118976|FG000|COMPLETED|Overall Study||223||
60003035|NCT02699099|76118977|FG001|COMPLETED|Overall Study||233||
60003036|NCT02699099|76118978|FG002|COMPLETED|Overall Study||226||
60003037|NCT02699099|76118976|FG000|NOT COMPLETED|Overall Study||8||
60003038|NCT02699099|76118977|FG001|NOT COMPLETED|Overall Study||3||
60003039|NCT02699099|76118978|FG002|NOT COMPLETED|Overall Study||6||
60135899|NCT00097786|76258573|FG003|NOT COMPLETED|Overall Study||310||
60003040|NCT02698865|76118990|FG000|STARTED|Overall Study||140||
60003041|NCT02698865|76118991|FG001|STARTED|Overall Study||80||
60003042|NCT02698865|76118990|FG000|Treated|Overall Study||140||
60003043|NCT02698865|76118991|FG001|Treated|Overall Study||80||
60003044|NCT02698865|76118990|FG000|COMPLETED|Overall Study||105||
60003045|NCT02698865|76118991|FG001|COMPLETED|Overall Study||47||
60003046|NCT02698865|76118990|FG000|NOT COMPLETED|Overall Study||35||
60003047|NCT02698865|76118991|FG001|NOT COMPLETED|Overall Study||33||
60003048|NCT02698787|76118999|FG000|STARTED|First Intervention (3 Months)||6||
60003049|NCT02698787|76119000|FG001|STARTED|First Intervention (3 Months)||5||
60003050|NCT02698787|76118999|FG000|COMPLETED|First Intervention (3 Months)||6||
60003051|NCT02698787|76119000|FG001|COMPLETED|First Intervention (3 Months)||5||
60003052|NCT02698787|76118999|FG000|NOT COMPLETED|First Intervention (3 Months)||0||
60003053|NCT02698787|76119000|FG001|NOT COMPLETED|First Intervention (3 Months)||0||
60003054|NCT02698787|76118999|FG000|STARTED|Second Intervention (3 Months)||6||
60003055|NCT02698787|76119000|FG001|STARTED|Second Intervention (3 Months)||5||
60003056|NCT02698787|76118999|FG000|COMPLETED|Second Intervention (3 Months)||6||
60003057|NCT02698787|76119000|FG001|COMPLETED|Second Intervention (3 Months)||4||
60003058|NCT02698787|76118999|FG000|NOT COMPLETED|Second Intervention (3 Months)||0||
60003059|NCT02698787|76119000|FG001|NOT COMPLETED|Second Intervention (3 Months)||1||
60003060|NCT02698475|76119007|FG000|STARTED|Main Study Period||44||
60003061|NCT02698475|76119007|FG000|COMPLETED|Main Study Period||41||
60003062|NCT02698475|76119007|FG000|NOT COMPLETED|Main Study Period||3||
60003063|NCT02698475|76119007|FG000|STARTED|Long-Term Extension Period|13 participants did not enter the long-term extension period.|28||
60003064|NCT02698475|76119007|FG000|COMPLETED|Long-Term Extension Period||0||
60003065|NCT02698475|76119007|FG000|NOT COMPLETED|Long-Term Extension Period||28||
60003066|NCT02559687|76119014|FG000|STARTED|Overall Study||121||
60003067|NCT02559687|76119014|FG000|Received First Course of Pembrolizumab|Overall Study||121||
60003068|NCT02559687|76119014|FG000|Received Second Course of Pembrolizumab|Overall Study||1||
60003069|NCT02559687|76119014|FG000|COMPLETED|Overall Study||0||
60003070|NCT02559687|76119014|FG000|NOT COMPLETED|Overall Study||121||
60003071|NCT03629925|76119021|FG000|STARTED|Overall Study||179||
60003072|NCT03629925|76119022|FG001|STARTED|Overall Study||178||
60003073|NCT03629925|76119021|FG000|COMPLETED|Overall Study||0||
60003074|NCT03629925|76119022|FG001|COMPLETED|Overall Study||0||
60003075|NCT03629925|76119021|FG000|NOT COMPLETED|Overall Study||179||
60003076|NCT03629925|76119022|FG001|NOT COMPLETED|Overall Study||178||
60003077|NCT04294719|76119028|FG000|STARTED|Overall Study||19||
60003078|NCT04294719|76119028|FG000|COMPLETED|Overall Study||18||
60003079|NCT04294719|76119028|FG000|NOT COMPLETED|Overall Study||1||
60003080|NCT02703311|76119036|FG000|STARTED|Overall Study||11||
59605478|NCT01990950|75715657|FG000|STARTED|Overall Study||21||
60003081|NCT02703311|76119036|FG000|Implanted|Overall Study||11||
60003082|NCT02703311|76119036|FG000|30 Day Follow-Up Completed|Overall Study||9||
60003083|NCT02703311|76119036|FG000|COMPLETED|Overall Study||3|Completed Study (2 years)|
60003084|NCT02703311|76119036|FG000|NOT COMPLETED|Overall Study||8||
60003085|NCT02697617|76119040|FG000|STARTED|Overall Study||9||
60003086|NCT02697617|76119041|FG001|STARTED|Overall Study||9||
60003087|NCT02697617|76119040|FG000|COMPLETED|Overall Study|15 completed both arms|8||
60003088|NCT02697617|76119041|FG001|COMPLETED|Overall Study||7||
60003089|NCT02697617|76119040|FG000|NOT COMPLETED|Overall Study||1||
60003090|NCT02697617|76119041|FG001|NOT COMPLETED|Overall Study||2||
60003091|NCT02698241|76119051|FG000|STARTED|Overall Study|Number of subjects enrolled the study|79||
60003092|NCT02698241|76119051|FG000|Baseline & Programming|Overall Study|Number of subjects that passed screening and completed baseline and programming visit|66|Subject characteristics collected and device diagnostic enabled at baseline and programming visit.|
60003093|NCT02698241|76119051|FG000|COMPLETED|Overall Study|Number of subjects completed the study (no early exit or death)|45||
60003094|NCT02698241|76119051|FG000|NOT COMPLETED|Overall Study||34||
60003095|NCT01663233|76119057|FG000|STARTED|Overall Study||130||
60003096|NCT01663233|76119058|FG001|STARTED|Overall Study||136||
60003097|NCT01663233|76119057|FG000|COMPLETED|Overall Study||126||
60003098|NCT01663233|76119058|FG001|COMPLETED|Overall Study||129||
60003099|NCT01663233|76119057|FG000|NOT COMPLETED|Overall Study||4||
59750535|NCT00993317|75869738|FG001|STARTED|Overall Study||85||
59750536|NCT00993317|75869737|FG000|COMPLETED|Overall Study||21||
59750537|NCT00993317|75869738|FG001|COMPLETED|Overall Study||60||
59750538|NCT00993317|75869737|FG000|NOT COMPLETED|Overall Study||21||
59750539|NCT00993317|75869738|FG001|NOT COMPLETED|Overall Study||25||
59750540|NCT01030133|75869746|FG000|STARTED|Overall Study||14||
59750541|NCT01030133|75869747|FG001|STARTED|Overall Study||14||
59750542|NCT01030133|75869746|FG000|COMPLETED|Overall Study||12||
59750543|NCT01030133|75869747|FG001|COMPLETED|Overall Study||12||
59750544|NCT01030133|75869746|FG000|NOT COMPLETED|Overall Study||2||
59750545|NCT01030133|75869747|FG001|NOT COMPLETED|Overall Study||2||
59750546|NCT00877071|75869757|FG000|STARTED|Overall Study||2||
59750547|NCT00877071|75869757|FG000|COMPLETED|Overall Study||0||
59750548|NCT00877071|75869757|FG000|NOT COMPLETED|Overall Study||2||
59750549|NCT00987389|75869763|FG000|STARTED|Overall Study||176||
59750550|NCT00987389|75869764|FG001|STARTED|Overall Study||176||
59750551|NCT00987389|75869765|FG002|STARTED|Overall Study||175||
59750552|NCT00987389|75869766|FG003|STARTED|Overall Study||177||
60003100|NCT01663233|76119058|FG001|NOT COMPLETED|Overall Study||7||
60003101|NCT04046055|76119064|FG000|STARTED|Overall Study||7||
60003102|NCT04046055|76119064|FG000|Sham|Overall Study||7||
60003103|NCT04046055|76119064|FG000|Unilateral, 2 mA|Overall Study||7||
60003104|NCT04046055|76119064|FG000|Bilateral, 2 mA|Overall Study||7||
60003105|NCT04046055|76119064|FG000|Unilateral, 4 mA|Overall Study||7||
60003106|NCT04046055|76119064|FG000|Bilateral, 4 mA|Overall Study||7||
59750553|NCT00987389|75869763|FG000|COMPLETED|Overall Study||167||
59750554|NCT00987389|75869764|FG001|COMPLETED|Overall Study||168||
59750555|NCT00987389|75869765|FG002|COMPLETED|Overall Study||167||
59750556|NCT00987389|75869766|FG003|COMPLETED|Overall Study||174||
59750557|NCT00987389|75869763|FG000|NOT COMPLETED|Overall Study||9||
59750558|NCT00987389|75869764|FG001|NOT COMPLETED|Overall Study||8||
59750559|NCT00987389|75869765|FG002|NOT COMPLETED|Overall Study||8||
59750560|NCT00987389|75869766|FG003|NOT COMPLETED|Overall Study||3||
59750561|NCT00929162|75869776|FG000|STARTED|Overall Study||59||
59750562|NCT00929162|75869777|FG001|STARTED|Overall Study||61||
59750563|NCT00929162|75869776|FG000|Patients Who Received Treatment|Overall Study||58||
59750564|NCT00929162|75869777|FG001|Patients Who Received Treatment|Overall Study||58||
60003107|NCT04046055|76119064|FG000|COMPLETED|Overall Study||7||
60003108|NCT04046055|76119064|FG000|NOT COMPLETED|Overall Study||0||
60003109|NCT02556255|76119077|FG000|STARTED|Overall Study||50||
59750565|NCT00929162|75869776|FG000|COMPLETED|Overall Study||11||
59750566|NCT00929162|75869777|FG001|COMPLETED|Overall Study||19||
59750567|NCT00929162|75869776|FG000|NOT COMPLETED|Overall Study||48||
59750568|NCT00929162|75869777|FG001|NOT COMPLETED|Overall Study||42||
59750569|NCT00992459|75869785|FG000|STARTED|Overall Study|All patients received HPN 100 placebo in Arm A (+ concomitant active NaPBA)|22||
59750570|NCT00992459|75869786|FG001|STARTED|Overall Study|All patients received NaPBA placebo in Arm B (+ concomitant active HPN 100)|24||
59750571|NCT00992459|75869785|FG000|COMPLETED|Overall Study|Totals enrolled and completed in Arm A NaPBA treatment + HPN 100 Placebo are not mutually exclusive.|21||
59750572|NCT00992459|75869786|FG001|COMPLETED|Overall Study|Totals enrolled and completed in Arm B HPN 100 treatment + NaPBA Placebo are not mutually exclusive.|23||
59750573|NCT00992459|75869785|FG000|NOT COMPLETED|Overall Study||1||
59750574|NCT00992459|75869786|FG001|NOT COMPLETED|Overall Study||1||
59750575|NCT00930722|75869792|FG000|STARTED|Overall Study||329||
60003110|NCT02556255|76119077|FG000|COMPLETED|Overall Study||46||
60003111|NCT02556255|76119077|FG000|NOT COMPLETED|Overall Study||4||
60003112|NCT02556801|76119085|FG000|STARTED|Overall Study||42||
60003113|NCT02556801|76119086|FG001|STARTED|Overall Study||42||
60003114|NCT02556801|76119087|FG002|STARTED|Overall Study||42||
60003115|NCT02556801|76119088|FG003|STARTED|Overall Study||42||
60003116|NCT02556801|76119085|FG000|COMPLETED|Overall Study||40||
60003117|NCT02556801|76119086|FG001|COMPLETED|Overall Study||35||
60003118|NCT02556801|76119087|FG002|COMPLETED|Overall Study||38||
60003119|NCT02556801|76119088|FG003|COMPLETED|Overall Study||37||
60003120|NCT02556801|76119085|FG000|NOT COMPLETED|Overall Study||2||
60003121|NCT02556801|76119086|FG001|NOT COMPLETED|Overall Study||7||
60003122|NCT02556801|76119087|FG002|NOT COMPLETED|Overall Study||4||
60003123|NCT02556801|76119088|FG003|NOT COMPLETED|Overall Study||5||
60003124|NCT02556177|76119100|FG000|STARTED|Overall Study||325||
60003125|NCT02556177|76119101|FG001|STARTED|Overall Study||152||
60003126|NCT02556177|76119100|FG000|COMPLETED|Overall Study||42||
60003127|NCT02556177|76119101|FG001|COMPLETED|Overall Study||91||
60003128|NCT02556177|76119100|FG000|NOT COMPLETED|Overall Study||283||
60003129|NCT02556177|76119101|FG001|NOT COMPLETED|Overall Study||61||
60003130|NCT02554929|76119109|FG000|STARTED|Overall Study||46||
60003131|NCT02554929|76119110|FG001|STARTED|Overall Study||44||
60003132|NCT02554929|76119109|FG000|Per Protocol Received Intervention|Overall Study||44||
60003133|NCT02554929|76119110|FG001|Per Protocol Received Intervention|Overall Study||36||
60003134|NCT02554929|76119109|FG000|Per Protocol Post-Intervention|Overall Study||42||
60003135|NCT02554929|76119110|FG001|Per Protocol Post-Intervention|Overall Study||36||
60003136|NCT02554929|76119109|FG000|Per Protocol 6 Month Follow-up|Overall Study||40||
60003137|NCT02554929|76119110|FG001|Per Protocol 6 Month Follow-up|Overall Study||32||
60003138|NCT02554929|76119109|FG000|COMPLETED|Overall Study||40||
60003139|NCT02554929|76119110|FG001|COMPLETED|Overall Study||32||
60003140|NCT02554929|76119109|FG000|NOT COMPLETED|Overall Study||6||
60003141|NCT02554929|76119110|FG001|NOT COMPLETED|Overall Study||12||
60003142|NCT03972501|76119118|FG000|STARTED|Overall Study|7 patients subsequently completed the Screening period.|9||
60003143|NCT03972501|76119119|FG001|STARTED|Overall Study|13 patients subsequently completed the Screening period.|17||
60003144|NCT03972501|76119118|FG000|COMPLETED|Overall Study||7||
60003145|NCT03972501|76119119|FG001|COMPLETED|Overall Study||7||
60003146|NCT03972501|76119118|FG000|NOT COMPLETED|Overall Study||2||
60003147|NCT03972501|76119119|FG001|NOT COMPLETED|Overall Study||10||
60003148|NCT02697773|76119128|FG000|STARTED|Overall Study||233||
60003149|NCT02697773|76119129|FG001|STARTED|Overall Study||232||
60003150|NCT02697773|76119130|FG002|STARTED|Overall Study||233||
60003151|NCT02697773|76119128|FG000|Treated|Overall Study||232||
60003152|NCT02697773|76119129|FG001|Treated|Overall Study||231||
60003153|NCT02697773|76119130|FG002|Treated|Overall Study||233||
60003154|NCT02697773|76119128|FG000|COMPLETED|Overall Study||195||
60003155|NCT02697773|76119129|FG001|COMPLETED|Overall Study||194||
60003156|NCT02697773|76119130|FG002|COMPLETED|Overall Study||193||
60003157|NCT02697773|76119128|FG000|NOT COMPLETED|Overall Study||38||
60003158|NCT02697773|76119129|FG001|NOT COMPLETED|Overall Study||38||
60003159|NCT02697773|76119130|FG002|NOT COMPLETED|Overall Study||40||
60003160|NCT02693171|76119138|FG000|STARTED|Overall Study|At study termination, 13 subjects had enrolled, 12 subjects received at least 1 dose of study drug.|12||
60003161|NCT02693171|76119138|FG000|COMPLETED|Overall Study||3||
60003162|NCT02693171|76119138|FG000|NOT COMPLETED|Overall Study||9||
60003163|NCT02692703|76119142|FG000|STARTED|Overall Study||100||
60003164|NCT02692703|76119142|FG000|COMPLETED|Overall Study||98||
60003165|NCT02692703|76119142|FG000|NOT COMPLETED|Overall Study||2||
60003166|NCT02692235|76119148|FG000|STARTED|Overall Study||14||
60003167|NCT02692235|76119149|FG001|STARTED|Overall Study||14||
60003168|NCT02692235|76119148|FG000|COMPLETED|Overall Study||11||
60003169|NCT02692235|76119149|FG001|COMPLETED|Overall Study||11||
60003170|NCT02692235|76119148|FG000|NOT COMPLETED|Overall Study||3||
60003171|NCT02692235|76119149|FG001|NOT COMPLETED|Overall Study||3||
60003172|NCT02552121|76119163|FG000|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||3||
60003173|NCT02552121|76119164|FG001|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0||
60003174|NCT02552121|76119165|FG002|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0||
60003175|NCT02552121|76119166|FG003|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0||
60003176|NCT02552121|76119167|FG004|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0||
60003177|NCT02552121|76119168|FG005|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0||
60003178|NCT02552121|76119169|FG006|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0||
60003179|NCT02552121|76119170|FG007|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0||
60003180|NCT02552121|76119163|FG000|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0||
60003181|NCT02552121|76119164|FG001|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0||
60135900|NCT01524692|76258583|FG000|STARTED|Overall Study||35||
60135901|NCT01524692|76258583|FG000|COMPLETED|Overall Study||32||
60135902|NCT01524692|76258583|FG000|NOT COMPLETED|Overall Study||3||
60135903|NCT00721539|76258588|FG000|STARTED|Overall Study||9||
60135904|NCT00721539|76258588|FG000|COMPLETED|Overall Study||9||
60135905|NCT00721539|76258588|FG000|NOT COMPLETED|Overall Study||0||
60135906|NCT00721617|76258592|FG000|STARTED|0 Hour (Baseline) of Saline Infusion||12||
60135907|NCT00721617|76258592|FG000|COMPLETED|0 Hour (Baseline) of Saline Infusion||12||
60135908|NCT00721617|76258592|FG000|NOT COMPLETED|0 Hour (Baseline) of Saline Infusion||0||
60135909|NCT00721617|76258592|FG000|STARTED|4 Hours Into Saline Infusion||12||
60135910|NCT00721617|76258592|FG000|COMPLETED|4 Hours Into Saline Infusion||12||
60135911|NCT00721617|76258592|FG000|NOT COMPLETED|4 Hours Into Saline Infusion||0||
60135912|NCT00721617|76258592|FG000|STARTED|8 Hours Into Saline Infusion||12||
60003182|NCT02552121|76119165|FG002|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0||
60003183|NCT02552121|76119166|FG003|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0||
60003184|NCT02552121|76119167|FG004|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0||
60003185|NCT02552121|76119168|FG005|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0||
60003186|NCT02552121|76119169|FG006|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0||
60003187|NCT02552121|76119170|FG007|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0||
60003188|NCT02552121|76119163|FG000|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||3||
60003189|NCT02552121|76119164|FG001|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0||
60003190|NCT02552121|76119165|FG002|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0||
60003191|NCT02552121|76119166|FG003|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0||
60003192|NCT02552121|76119167|FG004|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0||
60003193|NCT02552121|76119168|FG005|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0||
60003194|NCT02552121|76119169|FG006|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0||
60003195|NCT02552121|76119170|FG007|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0||
60003196|NCT02552121|76119163|FG000|STARTED|Part 1: Dose Level 2 (Week 17-48)||0||
60003197|NCT02552121|76119164|FG001|STARTED|Part 1: Dose Level 2 (Week 17-48)||6||
60135913|NCT00721617|76258592|FG000|COMPLETED|8 Hours Into Saline Infusion||12||
60135914|NCT00721617|76258592|FG000|NOT COMPLETED|8 Hours Into Saline Infusion||0||
60135915|NCT00721617|76258592|FG000|STARTED|0 Hour (Baseline) of Intralipid Infusion||12||
60135916|NCT00721617|76258592|FG000|COMPLETED|0 Hour (Baseline) of Intralipid Infusion||12||
60135917|NCT00721617|76258592|FG000|NOT COMPLETED|0 Hour (Baseline) of Intralipid Infusion||0||
60135918|NCT00721617|76258592|FG000|STARTED|4 Hours Into Intralipid Infusion||12||
60135919|NCT00721617|76258592|FG000|COMPLETED|4 Hours Into Intralipid Infusion||12||
60135920|NCT00721617|76258592|FG000|NOT COMPLETED|4 Hours Into Intralipid Infusion||0||
60135921|NCT00721617|76258592|FG000|STARTED|8 Hours Into Intralipid Infusion||12||
60135922|NCT00721617|76258592|FG000|COMPLETED|8 Hours Into Intralipid Infusion||12||
59750576|NCT00930722|75869792|FG000|COMPLETED|Overall Study||302||
59750577|NCT00930722|75869792|FG000|NOT COMPLETED|Overall Study||27||
59750578|NCT00992225|75869796|FG000|STARTED|Overall Study||43||
59750579|NCT00992225|75869796|FG000|Received at Least One Dose of Study Drug|Overall Study||33||
59750580|NCT00992225|75869796|FG000|COMPLETED|Overall Study||33||
59750581|NCT00992225|75869796|FG000|NOT COMPLETED|Overall Study||10||
59880212|NCT02793232|76003431|FG005|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0||
59880213|NCT02793232|76003432|FG006|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0||
59880214|NCT02793232|76003433|FG007|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0||
59880215|NCT02793232|76003434|FG008|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0||
59880216|NCT02793232|76003426|FG000|STARTED|Period 3 (Part A: 5 Days)||2||
59880217|NCT02793232|76003427|FG001|STARTED|Period 3 (Part A: 5 Days)||2||
59880218|NCT02793232|76003428|FG002|STARTED|Period 3 (Part A: 5 Days)||2||
59880219|NCT02793232|76003429|FG003|STARTED|Period 3 (Part A: 5 Days)||2||
59880220|NCT02793232|76003430|FG004|STARTED|Period 3 (Part A: 5 Days)||0||
59880221|NCT02793232|76003431|FG005|STARTED|Period 3 (Part A: 5 Days)||0||
59880222|NCT02793232|76003432|FG006|STARTED|Period 3 (Part A: 5 Days)||0||
59880223|NCT02793232|76003433|FG007|STARTED|Period 3 (Part A: 5 Days)||0||
59880224|NCT02793232|76003434|FG008|STARTED|Period 3 (Part A: 5 Days)||0||
59880225|NCT02793232|76003426|FG000|COMPLETED|Period 3 (Part A: 5 Days)||2||
59880226|NCT02793232|76003427|FG001|COMPLETED|Period 3 (Part A: 5 Days)||2||
59880227|NCT02793232|76003428|FG002|COMPLETED|Period 3 (Part A: 5 Days)||2||
59880228|NCT02793232|76003429|FG003|COMPLETED|Period 3 (Part A: 5 Days)||2||
59880229|NCT02793232|76003430|FG004|COMPLETED|Period 3 (Part A: 5 Days)||0||
59880230|NCT02793232|76003431|FG005|COMPLETED|Period 3 (Part A: 5 Days)||0||
59880231|NCT02793232|76003432|FG006|COMPLETED|Period 3 (Part A: 5 Days)||0||
59880232|NCT02793232|76003433|FG007|COMPLETED|Period 3 (Part A: 5 Days)||0||
59880233|NCT02793232|76003434|FG008|COMPLETED|Period 3 (Part A: 5 Days)||0||
59880234|NCT02793232|76003426|FG000|NOT COMPLETED|Period 3 (Part A: 5 Days)||0||
59880235|NCT02793232|76003427|FG001|NOT COMPLETED|Period 3 (Part A: 5 Days)||0||
59880236|NCT02793232|76003428|FG002|NOT COMPLETED|Period 3 (Part A: 5 Days)||0||
59880237|NCT02793232|76003429|FG003|NOT COMPLETED|Period 3 (Part A: 5 Days)||0||
59880238|NCT02793232|76003430|FG004|NOT COMPLETED|Period 3 (Part A: 5 Days)||0||
59880239|NCT02793232|76003431|FG005|NOT COMPLETED|Period 3 (Part A: 5 Days)||0||
59880240|NCT02793232|76003432|FG006|NOT COMPLETED|Period 3 (Part A: 5 Days)||0||
59880241|NCT02793232|76003433|FG007|NOT COMPLETED|Period 3 (Part A: 5 Days)||0||
59880242|NCT02793232|76003434|FG008|NOT COMPLETED|Period 3 (Part A: 5 Days)||0||
59880243|NCT02793232|76003426|FG000|STARTED|Washout Period 3(Part A:at Least 10days)||2||
59880244|NCT02793232|76003427|FG001|STARTED|Washout Period 3(Part A:at Least 10days)||2||
59880245|NCT02793232|76003428|FG002|STARTED|Washout Period 3(Part A:at Least 10days)||2||
59880246|NCT02793232|76003429|FG003|STARTED|Washout Period 3(Part A:at Least 10days)||2||
59880247|NCT02793232|76003430|FG004|STARTED|Washout Period 3(Part A:at Least 10days)||0||
59880248|NCT02793232|76003431|FG005|STARTED|Washout Period 3(Part A:at Least 10days)||0||
59880249|NCT02793232|76003432|FG006|STARTED|Washout Period 3(Part A:at Least 10days)||0||
59880250|NCT02793232|76003433|FG007|STARTED|Washout Period 3(Part A:at Least 10days)||0||
59880251|NCT02793232|76003434|FG008|STARTED|Washout Period 3(Part A:at Least 10days)||0||
59880252|NCT02793232|76003426|FG000|COMPLETED|Washout Period 3(Part A:at Least 10days)||2||
59880253|NCT02793232|76003427|FG001|COMPLETED|Washout Period 3(Part A:at Least 10days)||2||
59880254|NCT02793232|76003428|FG002|COMPLETED|Washout Period 3(Part A:at Least 10days)||2||
59880255|NCT02793232|76003429|FG003|COMPLETED|Washout Period 3(Part A:at Least 10days)||2||
59880256|NCT02793232|76003430|FG004|COMPLETED|Washout Period 3(Part A:at Least 10days)||0||
59880257|NCT02793232|76003431|FG005|COMPLETED|Washout Period 3(Part A:at Least 10days)||0||
59750582|NCT00659581|75869800|FG000|STARTED|Overall Study||20994||
59750583|NCT00659581|75869800|FG000|COMPLETED|Overall Study||12412||
59750584|NCT00659581|75869800|FG000|NOT COMPLETED|Overall Study||8582||
59750585|NCT00991289|75869804|FG000|STARTED|Overall Study|68 participants enrolled, one was found to have been ineligible and was excluded.|67||
59750586|NCT00991289|75869804|FG000|COMPLETED Week 16|Overall Study|Completed 16 weeks of the study (the primary endpoint time point). The study continued to Week 76.|61||
59750587|NCT00991289|75869804|FG000|COMPLETED|Overall Study|Completed study.|55||
59750588|NCT00991289|75869804|FG000|NOT COMPLETED|Overall Study||12||
59750589|NCT00930644|75869808|FG000|STARTED|Overall Study||88||
59750590|NCT00930644|75869808|FG000|COMPLETED|Overall Study||65||
59880258|NCT02793232|76003432|FG006|COMPLETED|Washout Period 3(Part A:at Least 10days)||0||
59880259|NCT02793232|76003433|FG007|COMPLETED|Washout Period 3(Part A:at Least 10days)||0||
59880260|NCT02793232|76003434|FG008|COMPLETED|Washout Period 3(Part A:at Least 10days)||0||
59880261|NCT02793232|76003426|FG000|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0||
60003198|NCT02552121|76119165|FG002|STARTED|Part 1: Dose Level 2 (Week 17-48)||0||
60003199|NCT02552121|76119166|FG003|STARTED|Part 1: Dose Level 2 (Week 17-48)||0||
60003200|NCT02552121|76119167|FG004|STARTED|Part 1: Dose Level 2 (Week 17-48)||0||
60003201|NCT02552121|76119168|FG005|STARTED|Part 1: Dose Level 2 (Week 17-48)||0||
60003202|NCT02552121|76119169|FG006|STARTED|Part 1: Dose Level 2 (Week 17-48)||0||
60003203|NCT02552121|76119170|FG007|STARTED|Part 1: Dose Level 2 (Week 17-48)||0||
60003204|NCT02552121|76119163|FG000|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0||
60003205|NCT02552121|76119164|FG001|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0||
60003206|NCT02552121|76119165|FG002|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0||
60003207|NCT02552121|76119166|FG003|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0||
60003208|NCT02552121|76119167|FG004|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0||
60003209|NCT02552121|76119168|FG005|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0||
60003210|NCT02552121|76119169|FG006|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0||
60003211|NCT02552121|76119170|FG007|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0||
60003212|NCT02552121|76119163|FG000|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0||
60003213|NCT02552121|76119164|FG001|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||6||
60003214|NCT02552121|76119165|FG002|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0||
59750591|NCT00930644|75869808|FG000|NOT COMPLETED|Overall Study||23||
59750592|NCT00990821|75869829|FG000|STARTED|Overall Study||14||
59750593|NCT00990821|75869830|FG001|STARTED|Overall Study||16||
59750594|NCT00990821|75869831|FG002|STARTED|Overall Study||14||
59750595|NCT00990821|75869832|FG003|STARTED|Overall Study||8||
59750596|NCT00990821|75869833|FG004|STARTED|Overall Study||17||
60003215|NCT02552121|76119166|FG003|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0||
60003216|NCT02552121|76119167|FG004|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0||
60003217|NCT02552121|76119168|FG005|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0||
59750597|NCT00990821|75869834|FG005|STARTED|Overall Study||17||
59750598|NCT00990821|75869835|FG006|STARTED|Overall Study||12||
59750599|NCT00990821|75869836|FG007|STARTED|Overall Study||14||
60003218|NCT02552121|76119169|FG006|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0||
60003219|NCT02552121|76119170|FG007|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0||
60003220|NCT02552121|76119163|FG000|STARTED|Part 2: Cohort Expansion||0||
60003221|NCT02552121|76119164|FG001|STARTED|Part 2: Cohort Expansion||0||
60003222|NCT02552121|76119165|FG002|STARTED|Part 2: Cohort Expansion||11||
60003223|NCT02552121|76119166|FG003|STARTED|Part 2: Cohort Expansion||3||
59750600|NCT00990821|75869837|FG008|STARTED|Overall Study||12||
59750601|NCT00990821|75869838|FG009|STARTED|Overall Study||14||
59750602|NCT00990821|75869839|FG010|STARTED|Overall Study||12||
59750603|NCT00990821|75869840|FG011|STARTED|Overall Study||14||
60003224|NCT02552121|76119167|FG004|STARTED|Part 2: Cohort Expansion||1||
60003225|NCT02552121|76119168|FG005|STARTED|Part 2: Cohort Expansion||5||
60003226|NCT02552121|76119169|FG006|STARTED|Part 2: Cohort Expansion||1||
60003227|NCT02552121|76119170|FG007|STARTED|Part 2: Cohort Expansion||3||
60003228|NCT02552121|76119163|FG000|COMPLETED|Part 2: Cohort Expansion||0||
60003229|NCT02552121|76119164|FG001|COMPLETED|Part 2: Cohort Expansion||0||
60003230|NCT02552121|76119165|FG002|COMPLETED|Part 2: Cohort Expansion||0||
60003231|NCT02552121|76119166|FG003|COMPLETED|Part 2: Cohort Expansion||0||
60003232|NCT02552121|76119167|FG004|COMPLETED|Part 2: Cohort Expansion||0||
60003233|NCT02552121|76119168|FG005|COMPLETED|Part 2: Cohort Expansion||1||
60003234|NCT02552121|76119169|FG006|COMPLETED|Part 2: Cohort Expansion||0||
60003235|NCT02552121|76119170|FG007|COMPLETED|Part 2: Cohort Expansion||0||
60003236|NCT02552121|76119163|FG000|NOT COMPLETED|Part 2: Cohort Expansion||0||
60003237|NCT02552121|76119164|FG001|NOT COMPLETED|Part 2: Cohort Expansion||0||
60003238|NCT02552121|76119165|FG002|NOT COMPLETED|Part 2: Cohort Expansion||11||
60003239|NCT02552121|76119166|FG003|NOT COMPLETED|Part 2: Cohort Expansion||3||
60003240|NCT02552121|76119167|FG004|NOT COMPLETED|Part 2: Cohort Expansion||1||
60003241|NCT02552121|76119168|FG005|NOT COMPLETED|Part 2: Cohort Expansion||4||
60003242|NCT02552121|76119169|FG006|NOT COMPLETED|Part 2: Cohort Expansion||1||
59750604|NCT00990821|75869841|FG012|STARTED|Overall Study||12||
59750605|NCT00990821|75869842|FG013|STARTED|Overall Study||12||
59750606|NCT00990821|75869829|FG000|COMPLETED|Overall Study||14||
59750607|NCT00990821|75869830|FG001|COMPLETED|Overall Study||14||
59750608|NCT00990821|75869831|FG002|COMPLETED|Overall Study||14||
59750609|NCT00990821|75869832|FG003|COMPLETED|Overall Study||8||
59750610|NCT00990821|75869833|FG004|COMPLETED|Overall Study||14||
59750611|NCT00990821|75869834|FG005|COMPLETED|Overall Study||14||
59750612|NCT00990821|75869835|FG006|COMPLETED|Overall Study||11||
59750613|NCT00990821|75869836|FG007|COMPLETED|Overall Study||14||
59750614|NCT00990821|75869837|FG008|COMPLETED|Overall Study||12||
59750615|NCT00990821|75869838|FG009|COMPLETED|Overall Study||13||
59750616|NCT00990821|75869839|FG010|COMPLETED|Overall Study||9||
59750617|NCT00990821|75869840|FG011|COMPLETED|Overall Study||9||
59750618|NCT00990821|75869841|FG012|COMPLETED|Overall Study||10||
59750619|NCT00990821|75869842|FG013|COMPLETED|Overall Study||11||
60003243|NCT02552121|76119170|FG007|NOT COMPLETED|Part 2: Cohort Expansion||3||
60003244|NCT03488355|76119204|FG000|STARTED|Overall Study||54||
60003245|NCT03488355|76119205|FG001|STARTED|Overall Study||46||
60003246|NCT03488355|76119204|FG000|COMPLETED|Overall Study||54||
59750620|NCT00990821|75869829|FG000|NOT COMPLETED|Overall Study||0||
60003247|NCT03488355|76119205|FG001|COMPLETED|Overall Study||46||
60003248|NCT03488355|76119204|FG000|NOT COMPLETED|Overall Study||0||
60003249|NCT03488355|76119205|FG001|NOT COMPLETED|Overall Study||0||
60003250|NCT02552355|76119215|FG000|STARTED|Overall Study||14||
60003251|NCT02552355|76119216|FG001|STARTED|Overall Study||13||
60003252|NCT02552355|76119217|FG002|STARTED|Overall Study||14||
59750621|NCT00990821|75869830|FG001|NOT COMPLETED|Overall Study||2||
59750622|NCT00990821|75869831|FG002|NOT COMPLETED|Overall Study||0||
59750623|NCT00990821|75869832|FG003|NOT COMPLETED|Overall Study||0||
59750624|NCT00990821|75869833|FG004|NOT COMPLETED|Overall Study||3||
59750625|NCT00990821|75869834|FG005|NOT COMPLETED|Overall Study||3||
59750626|NCT00990821|75869835|FG006|NOT COMPLETED|Overall Study||1||
59750627|NCT00990821|75869836|FG007|NOT COMPLETED|Overall Study||0||
59750628|NCT00990821|75869837|FG008|NOT COMPLETED|Overall Study||0||
59750629|NCT00990821|75869838|FG009|NOT COMPLETED|Overall Study||1||
59750630|NCT00990821|75869839|FG010|NOT COMPLETED|Overall Study||3||
60003253|NCT02552355|76119218|FG003|STARTED|Overall Study||15||
60003254|NCT02552355|76119215|FG000|COMPLETED|Overall Study||14||
60003255|NCT02552355|76119216|FG001|COMPLETED|Overall Study||11||
60003256|NCT02552355|76119217|FG002|COMPLETED|Overall Study||12||
60003257|NCT02552355|76119218|FG003|COMPLETED|Overall Study||14||
60003258|NCT02552355|76119215|FG000|NOT COMPLETED|Overall Study||0||
59750631|NCT00990821|75869840|FG011|NOT COMPLETED|Overall Study||5||
59750632|NCT00990821|75869841|FG012|NOT COMPLETED|Overall Study||2||
59750633|NCT00990821|75869842|FG013|NOT COMPLETED|Overall Study||1||
59750634|NCT00990665|75869859|FG000|STARTED|Overall Study||178||
59750635|NCT00990665|75869859|FG000|COMPLETED|Overall Study||130||
59750636|NCT00990665|75869859|FG000|NOT COMPLETED|Overall Study||48||
59750637|NCT00658567|75869868|FG000|STARTED|Overall Study||40||
59750638|NCT00658567|75869869|FG001|STARTED|Overall Study||42||
59750639|NCT00658567|75869870|FG002|STARTED|Overall Study||41||
59750640|NCT00658567|75869868|FG000|COMPLETED|Overall Study||32||
59750641|NCT00658567|75869869|FG001|COMPLETED|Overall Study||38||
59750642|NCT00658567|75869870|FG002|COMPLETED|Overall Study||35||
59750643|NCT00658567|75869868|FG000|NOT COMPLETED|Overall Study||8||
59750644|NCT00658567|75869869|FG001|NOT COMPLETED|Overall Study||4||
59750645|NCT00658567|75869870|FG002|NOT COMPLETED|Overall Study||6||
59880262|NCT02793232|76003427|FG001|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0||
59880263|NCT02793232|76003428|FG002|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0||
59880264|NCT02793232|76003429|FG003|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0||
59880265|NCT02793232|76003430|FG004|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0||
59880266|NCT02793232|76003431|FG005|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0||
59880267|NCT02793232|76003432|FG006|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0||
59880268|NCT02793232|76003433|FG007|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0||
59880269|NCT02793232|76003434|FG008|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0||
59880270|NCT02793232|76003426|FG000|STARTED|Period 4 (Part A: 5 Days)||2||
59880271|NCT02793232|76003427|FG001|STARTED|Period 4 (Part A: 5 Days)||2||
59880272|NCT02793232|76003428|FG002|STARTED|Period 4 (Part A: 5 Days)||2||
59880273|NCT02793232|76003429|FG003|STARTED|Period 4 (Part A: 5 Days)||2||
59880274|NCT02793232|76003430|FG004|STARTED|Period 4 (Part A: 5 Days)||0||
59880275|NCT02793232|76003431|FG005|STARTED|Period 4 (Part A: 5 Days)||0||
59880276|NCT02793232|76003432|FG006|STARTED|Period 4 (Part A: 5 Days)||0||
59880277|NCT02793232|76003433|FG007|STARTED|Period 4 (Part A: 5 Days)||0||
59880278|NCT02793232|76003434|FG008|STARTED|Period 4 (Part A: 5 Days)||0||
59880279|NCT02793232|76003426|FG000|COMPLETED|Period 4 (Part A: 5 Days)||2||
60003259|NCT02552355|76119216|FG001|NOT COMPLETED|Overall Study||2||
60003260|NCT02552355|76119217|FG002|NOT COMPLETED|Overall Study||2||
60003261|NCT02552355|76119218|FG003|NOT COMPLETED|Overall Study||1||
59750646|NCT00875433|75869878|FG000|STARTED|Overall Study|Treated|60||
59750647|NCT00875433|75869878|FG000|COMPLETED|Overall Study||0||
59750648|NCT00875433|75869878|FG000|NOT COMPLETED|Overall Study||60||
59750649|NCT00985985|75869886|FG000|STARTED|Overall Study||241||
59750650|NCT00985985|75869887|FG001|STARTED|Overall Study||242||
59750651|NCT00985985|75869888|FG002|STARTED|Overall Study||120||
59750652|NCT00985985|75869889|FG003|STARTED|Overall Study||120||
59880280|NCT02793232|76003427|FG001|COMPLETED|Period 4 (Part A: 5 Days)||2||
59880281|NCT02793232|76003428|FG002|COMPLETED|Period 4 (Part A: 5 Days)||2||
59880282|NCT02793232|76003429|FG003|COMPLETED|Period 4 (Part A: 5 Days)||2||
59880283|NCT02793232|76003430|FG004|COMPLETED|Period 4 (Part A: 5 Days)||0||
59880284|NCT02793232|76003431|FG005|COMPLETED|Period 4 (Part A: 5 Days)||0||
59880285|NCT02793232|76003432|FG006|COMPLETED|Period 4 (Part A: 5 Days)||0||
59880286|NCT02793232|76003433|FG007|COMPLETED|Period 4 (Part A: 5 Days)||0||
59880287|NCT02793232|76003434|FG008|COMPLETED|Period 4 (Part A: 5 Days)||0||
59880288|NCT02793232|76003426|FG000|NOT COMPLETED|Period 4 (Part A: 5 Days)||0||
59880289|NCT02793232|76003427|FG001|NOT COMPLETED|Period 4 (Part A: 5 Days)||0||
59880290|NCT02793232|76003428|FG002|NOT COMPLETED|Period 4 (Part A: 5 Days)||0||
59880291|NCT02793232|76003429|FG003|NOT COMPLETED|Period 4 (Part A: 5 Days)||0||
59880292|NCT02793232|76003430|FG004|NOT COMPLETED|Period 4 (Part A: 5 Days)||0||
59880293|NCT02793232|76003431|FG005|NOT COMPLETED|Period 4 (Part A: 5 Days)||0||
59880294|NCT02793232|76003432|FG006|NOT COMPLETED|Period 4 (Part A: 5 Days)||0||
60003262|NCT02551731|76119228|FG000|STARTED|Overall Study||9||
60003263|NCT02551731|76119228|FG000|COMPLETED|Overall Study||7||
60003264|NCT02551731|76119228|FG000|NOT COMPLETED|Overall Study||2||
60003265|NCT02542605|76119232|FG000|STARTED|Part A: PACAP-38 Dose Selection Phase||12||
60003266|NCT02542605|76119233|FG001|STARTED|Part A: PACAP-38 Dose Selection Phase||0||
60003267|NCT02542605|76119234|FG002|STARTED|Part A: PACAP-38 Dose Selection Phase||0||
60003268|NCT02542605|76119232|FG000|Received PACAP-38|Part A: PACAP-38 Dose Selection Phase||12||
60003269|NCT02542605|76119233|FG001|Received PACAP-38|Part A: PACAP-38 Dose Selection Phase||0||
60003270|NCT02542605|76119234|FG002|Received PACAP-38|Part A: PACAP-38 Dose Selection Phase||0||
60003271|NCT02542605|76119232|FG000|Proceeded to Part B Randomization Phase|Part A: PACAP-38 Dose Selection Phase||2||
60003272|NCT02542605|76119233|FG001|Proceeded to Part B Randomization Phase|Part A: PACAP-38 Dose Selection Phase||0||
60003273|NCT02542605|76119234|FG002|Proceeded to Part B Randomization Phase|Part A: PACAP-38 Dose Selection Phase||0||
60003274|NCT02542605|76119232|FG000|COMPLETED|Part A: PACAP-38 Dose Selection Phase||12||
59750653|NCT00985985|75869886|FG000|Safety Population|Overall Study||241||
59750654|NCT00985985|75869887|FG001|Safety Population|Overall Study||242||
59750655|NCT00985985|75869888|FG002|Safety Population|Overall Study||119||
59750656|NCT00985985|75869889|FG003|Safety Population|Overall Study||118||
59750657|NCT00985985|75869886|FG000|Full Analysis Set (FAS) Population|Overall Study||241||
59750658|NCT00985985|75869887|FG001|Full Analysis Set (FAS) Population|Overall Study||242||
59750659|NCT00985985|75869888|FG002|Full Analysis Set (FAS) Population|Overall Study||120||
59880295|NCT02793232|76003433|FG007|NOT COMPLETED|Period 4 (Part A: 5 Days)||0||
59880296|NCT02793232|76003434|FG008|NOT COMPLETED|Period 4 (Part A: 5 Days)||0||
59880297|NCT04584645|76003470|FG000|STARTED|Overall Study||24570||
59880298|NCT04584645|76003471|FG001|STARTED|Overall Study||24568||
59750660|NCT00985985|75869889|FG003|Full Analysis Set (FAS) Population|Overall Study|One participant withdrew consent and was not included as the FAS population.|119||
59750661|NCT00985985|75869886|FG000|COMPLETED|Overall Study||217||
59750662|NCT00985985|75869887|FG001|COMPLETED|Overall Study||218||
59750663|NCT00985985|75869888|FG002|COMPLETED|Overall Study||109||
59750664|NCT00985985|75869889|FG003|COMPLETED|Overall Study||107||
59750665|NCT00985985|75869886|FG000|NOT COMPLETED|Overall Study||24||
59750666|NCT00985985|75869887|FG001|NOT COMPLETED|Overall Study||24||
59750667|NCT00985985|75869888|FG002|NOT COMPLETED|Overall Study||11||
59750668|NCT00985985|75869889|FG003|NOT COMPLETED|Overall Study||13||
59750669|NCT00923936|75869906|FG000|STARTED|Overall Study||10||
59750670|NCT00923936|75869907|FG001|STARTED|Overall Study||6||
59750671|NCT00923936|75869906|FG000|COMPLETED|Overall Study||2||
59750672|NCT00923936|75869907|FG001|COMPLETED|Overall Study||3||
59750673|NCT00923936|75869906|FG000|NOT COMPLETED|Overall Study||8||
59750674|NCT00923936|75869907|FG001|NOT COMPLETED|Overall Study||3||
59750675|NCT00924950|75869915|FG000|STARTED|Overall Study||30||
59750676|NCT00924950|75869915|FG000|COMPLETED|Overall Study||28||
59750677|NCT00924950|75869915|FG000|NOT COMPLETED|Overall Study||2||
59750678|NCT00988637|75869924|FG000|STARTED|Overall Study||70||
59750679|NCT00988637|75869925|FG001|STARTED|Overall Study||68||
59750680|NCT00988637|75869924|FG000|COMPLETED|Overall Study||67||
59750681|NCT00988637|75869925|FG001|COMPLETED|Overall Study||65||
59750682|NCT00988637|75869924|FG000|NOT COMPLETED|Overall Study||3||
59750683|NCT00988637|75869925|FG001|NOT COMPLETED|Overall Study||3||
59750684|NCT00923156|75869934|FG000|STARTED|Overall Study|"Started indicates randomized, safety and pharmacodynamic population"|40||
59750685|NCT00923156|75869935|FG001|STARTED|Overall Study||42||
59750686|NCT00923156|75869936|FG002|STARTED|Overall Study||41||
59750687|NCT00923156|75869934|FG000|COMPLETED|Overall Study||40||
59750688|NCT00923156|75869935|FG001|COMPLETED|Overall Study||38||
59750689|NCT00923156|75869936|FG002|COMPLETED|Overall Study||38||
59750690|NCT00923156|75869934|FG000|NOT COMPLETED|Overall Study||0||
59750691|NCT00923156|75869935|FG001|NOT COMPLETED|Overall Study||4||
59750692|NCT00923156|75869936|FG002|NOT COMPLETED|Overall Study||3||
59750693|NCT00874731|75869944|FG000|STARTED|Part 1, Day 1: Placebo||23||
59750694|NCT00874731|75869945|FG001|STARTED|Part 1, Day 1: Placebo||0||
59750695|NCT00874731|75869946|FG002|STARTED|Part 1, Day 1: Placebo||0||
59750696|NCT00874731|75869944|FG000|COMPLETED|Part 1, Day 1: Placebo||22||
59750697|NCT00874731|75869945|FG001|COMPLETED|Part 1, Day 1: Placebo||0||
59750698|NCT00874731|75869946|FG002|COMPLETED|Part 1, Day 1: Placebo||0||
59750699|NCT00874731|75869944|FG000|NOT COMPLETED|Part 1, Day 1: Placebo||1||
59750700|NCT00874731|75869945|FG001|NOT COMPLETED|Part 1, Day 1: Placebo||0||
59750701|NCT00874731|75869946|FG002|NOT COMPLETED|Part 1, Day 1: Placebo||0||
59750702|NCT00874731|75869944|FG000|STARTED|Part 1, Day 2: Ridaforolimus 100 mg|"Participants completing Pt 1, Day 1, enter into the Pt 1, Day 2. Ridaforolimus 100 mg arm."|0||
59750703|NCT00874731|75869945|FG001|STARTED|Part 1, Day 2: Ridaforolimus 100 mg|"Participants completing Pt 1, Day 1, started this period in Pt 1, Day 2. Ridaforolimus 100 mg arm."|22||
59750704|NCT00874731|75869946|FG002|STARTED|Part 1, Day 2: Ridaforolimus 100 mg||0||
59880299|NCT04584645|76003470|FG000|COMPLETED|Overall Study||5575||
59880300|NCT04584645|76003471|FG001|COMPLETED|Overall Study||5662||
59880301|NCT04584645|76003470|FG000|NOT COMPLETED|Overall Study||18995||
59880302|NCT04584645|76003471|FG001|NOT COMPLETED|Overall Study||18906||
60003275|NCT02542605|76119233|FG001|COMPLETED|Part A: PACAP-38 Dose Selection Phase||0||
60003276|NCT02542605|76119234|FG002|COMPLETED|Part A: PACAP-38 Dose Selection Phase||0||
60003277|NCT02542605|76119232|FG000|NOT COMPLETED|Part A: PACAP-38 Dose Selection Phase||0||
60003278|NCT02542605|76119233|FG001|NOT COMPLETED|Part A: PACAP-38 Dose Selection Phase||0||
60003279|NCT02542605|76119234|FG002|NOT COMPLETED|Part A: PACAP-38 Dose Selection Phase||0||
59750705|NCT00874731|75869944|FG000|COMPLETED|Part 1, Day 2: Ridaforolimus 100 mg||0||
59750706|NCT00874731|75869945|FG001|COMPLETED|Part 1, Day 2: Ridaforolimus 100 mg||22||
59750707|NCT00874731|75869946|FG002|COMPLETED|Part 1, Day 2: Ridaforolimus 100 mg||0||
60003280|NCT02542605|76119232|FG000|STARTED|Part B: Challenge Phase||23|Participants starting Part B are all PACAP-38 naïve and did not participate in Part A.|
60003281|NCT02542605|76119233|FG001|STARTED|Part B: Challenge Phase||0|Participants starting Part B are all PACAP-38 naïve and did not participate in Part A.|
60003282|NCT02542605|76119234|FG002|STARTED|Part B: Challenge Phase||0|Participants starting Part B are all PACAP-38 naïve and did not participate in Part A.|
60003283|NCT02542605|76119232|FG000|Received PACAP-38|Part B: Challenge Phase||23||
60003284|NCT02542605|76119233|FG001|Received PACAP-38|Part B: Challenge Phase||0||
60003285|NCT02542605|76119234|FG002|Received PACAP-38|Part B: Challenge Phase||0||
60003286|NCT02542605|76119232|FG000|Proceeded to Randomization Phase|Part B: Challenge Phase||15||
60003287|NCT02542605|76119233|FG001|Proceeded to Randomization Phase|Part B: Challenge Phase||0||
60003288|NCT02542605|76119234|FG002|Proceeded to Randomization Phase|Part B: Challenge Phase||0||
60003289|NCT02542605|76119232|FG000|COMPLETED|Part B: Challenge Phase||22||
60003290|NCT02542605|76119233|FG001|COMPLETED|Part B: Challenge Phase||0||
60003291|NCT02542605|76119234|FG002|COMPLETED|Part B: Challenge Phase||0||
60003292|NCT02542605|76119232|FG000|NOT COMPLETED|Part B: Challenge Phase||1||
60003293|NCT02542605|76119233|FG001|NOT COMPLETED|Part B: Challenge Phase||0||
60003294|NCT02542605|76119234|FG002|NOT COMPLETED|Part B: Challenge Phase||0||
60003295|NCT02542605|76119232|FG000|STARTED|Part B: Randomization Phase||0||
60003296|NCT02542605|76119233|FG001|STARTED|Part B: Randomization Phase||9||
60003297|NCT02542605|76119234|FG002|STARTED|Part B: Randomization Phase||8||
60003298|NCT02542605|76119232|FG000|Not PACAP-38 naïve Participants|Part B: Randomization Phase||0|Participants received PACAP-38 during Part A dose selection.|
60003299|NCT02542605|76119233|FG001|Not PACAP-38 naïve Participants|Part B: Randomization Phase||2|Participants received PACAP-38 during Part A dose selection.|
60003300|NCT02542605|76119234|FG002|Not PACAP-38 naïve Participants|Part B: Randomization Phase||0|Participants received PACAP-38 during Part A dose selection.|
60003301|NCT02542605|76119232|FG000|PACAP-38 naïve Participants|Part B: Randomization Phase||0|Participants joined the study at Part B and did not receive PACAP-38 in Part A.|
60003302|NCT02542605|76119233|FG001|PACAP-38 naïve Participants|Part B: Randomization Phase||7|Participants joined the study at Part B and did not receive PACAP-38 in Part A.|
60003303|NCT02542605|76119234|FG002|PACAP-38 naïve Participants|Part B: Randomization Phase||8|Participants joined the study at Part B and did not receive PACAP-38 in Part A.|
60003304|NCT02542605|76119232|FG000|Received Placebo/Erenumab|Part B: Randomization Phase||0||
60003305|NCT02542605|76119233|FG001|Received Placebo/Erenumab|Part B: Randomization Phase||9||
59750708|NCT00874731|75869944|FG000|NOT COMPLETED|Part 1, Day 2: Ridaforolimus 100 mg||0||
59750709|NCT00874731|75869945|FG001|NOT COMPLETED|Part 1, Day 2: Ridaforolimus 100 mg||0||
59750710|NCT00874731|75869946|FG002|NOT COMPLETED|Part 1, Day 2: Ridaforolimus 100 mg||0||
59750711|NCT00874731|75869944|FG000|STARTED|Washout Period||0||
60003306|NCT02542605|76119234|FG002|Received Placebo/Erenumab|Part B: Randomization Phase||7||
60003307|NCT02542605|76119232|FG000|COMPLETED|Part B: Randomization Phase||0||
60003308|NCT02542605|76119233|FG001|COMPLETED|Part B: Randomization Phase||9||
60003309|NCT02542605|76119234|FG002|COMPLETED|Part B: Randomization Phase||7||
60003310|NCT02542605|76119232|FG000|NOT COMPLETED|Part B: Randomization Phase||0||
60003311|NCT02542605|76119233|FG001|NOT COMPLETED|Part B: Randomization Phase||0||
60003312|NCT02542605|76119234|FG002|NOT COMPLETED|Part B: Randomization Phase||1||
60003313|NCT02550873|76119245|FG000|STARTED|Randomized Double Blind||78|Number of patients randomized|
60003314|NCT02550873|76119246|FG001|STARTED|Randomized Double Blind||39|Number of patients randomized|
60003315|NCT02550873|76119247|FG002|STARTED|Randomized Double Blind||0|Number of patients randomized|
60003316|NCT02550873|76119245|FG000|Received Treatment|Randomized Double Blind||77||
60003317|NCT02550873|76119246|FG001|Received Treatment|Randomized Double Blind||39||
60003318|NCT02550873|76119247|FG002|Received Treatment|Randomized Double Blind||0||
60003319|NCT02550873|76119245|FG000|Continue to Open Label Extension|Randomized Double Blind||74||
60003320|NCT02550873|76119246|FG001|Continue to Open Label Extension|Randomized Double Blind||37||
60003321|NCT02550873|76119247|FG002|Continue to Open Label Extension|Randomized Double Blind||0||
60003322|NCT02550873|76119245|FG000|COMPLETED|Randomized Double Blind||74||
60003323|NCT02550873|76119246|FG001|COMPLETED|Randomized Double Blind||37||
60003324|NCT02550873|76119247|FG002|COMPLETED|Randomized Double Blind||0||
60003325|NCT02550873|76119245|FG000|NOT COMPLETED|Randomized Double Blind||4||
60003326|NCT02550873|76119246|FG001|NOT COMPLETED|Randomized Double Blind||2||
60003327|NCT02550873|76119247|FG002|NOT COMPLETED|Randomized Double Blind||0||
60003328|NCT02550873|76119245|FG000|STARTED|Open Label Extension||0||
60003329|NCT02550873|76119246|FG001|STARTED|Open Label Extension||0||
60003330|NCT02550873|76119247|FG002|STARTED|Open Label Extension||111||
60003331|NCT02550873|76119245|FG000|COMPLETED|Open Label Extension||0||
60003332|NCT02550873|76119246|FG001|COMPLETED|Open Label Extension||0||
60003333|NCT02550873|76119247|FG002|COMPLETED|Open Label Extension|Open Label extension is ongoing|0||
60003334|NCT02550873|76119245|FG000|NOT COMPLETED|Open Label Extension||0||
60003335|NCT02550873|76119246|FG001|NOT COMPLETED|Open Label Extension||0||
60003336|NCT02550873|76119247|FG002|NOT COMPLETED|Open Label Extension||111||
60003337|NCT02535741|76119269|FG000|STARTED|Overall Study||168||
60003338|NCT02535741|76119269|FG000|COMPLETED|Overall Study|Completed cases at 2 years follow-up|136||
60003339|NCT02535741|76119269|FG000|NOT COMPLETED|Overall Study||32||
60003340|NCT02702115|76119277|FG000|STARTED|Overall Study||1||
60003341|NCT02702115|76119278|FG001|STARTED|Overall Study||2||
60003342|NCT02702115|76119279|FG002|STARTED|Overall Study||0||
60003343|NCT02702115|76119277|FG000|COMPLETED|Overall Study||1||
60003344|NCT02702115|76119278|FG001|COMPLETED|Overall Study||2||
60003345|NCT02702115|76119279|FG002|COMPLETED|Overall Study||0||
60003346|NCT02702115|76119277|FG000|NOT COMPLETED|Overall Study||0||
60003347|NCT02702115|76119278|FG001|NOT COMPLETED|Overall Study||0||
60003348|NCT02702115|76119279|FG002|NOT COMPLETED|Overall Study||0||
60003349|NCT02550795|76119290|FG000|STARTED|Overall Study||50||
60003350|NCT02550795|76119291|FG001|STARTED|Overall Study||50||
60003351|NCT02550795|76119292|FG002|STARTED|Overall Study||50||
60003352|NCT02550795|76119290|FG000|COMPLETED|Overall Study||50||
60003353|NCT02550795|76119291|FG001|COMPLETED|Overall Study||49||
60003354|NCT02550795|76119292|FG002|COMPLETED|Overall Study||50||
60003355|NCT02550795|76119290|FG000|NOT COMPLETED|Overall Study||0||
60003356|NCT02550795|76119291|FG001|NOT COMPLETED|Overall Study||1||
60003357|NCT02550795|76119292|FG002|NOT COMPLETED|Overall Study||0||
60003358|NCT02541903|76119300|FG000|STARTED|Overall Study||8||
60003359|NCT02541903|76119300|FG000|COMPLETED|Overall Study||7||
60003360|NCT02541903|76119300|FG000|NOT COMPLETED|Overall Study||1||
60003361|NCT02541669|76119309|FG000|STARTED|Open Label Treatment Period||8||
60003362|NCT02541669|76119310|FG001|STARTED|Open Label Treatment Period||8||
60003363|NCT02541669|76119311|FG002|STARTED|Open Label Treatment Period||0||
60003364|NCT02541669|76119312|FG003|STARTED|Open Label Treatment Period||0||
60003365|NCT02541669|76119313|FG004|STARTED|Open Label Treatment Period||0||
60003366|NCT02541669|76119309|FG000|COMPLETED|Open Label Treatment Period||8||
60003367|NCT02541669|76119310|FG001|COMPLETED|Open Label Treatment Period||8||
60003368|NCT02541669|76119311|FG002|COMPLETED|Open Label Treatment Period||0||
60003369|NCT02541669|76119312|FG003|COMPLETED|Open Label Treatment Period||0||
60003370|NCT02541669|76119313|FG004|COMPLETED|Open Label Treatment Period||0||
60003371|NCT02541669|76119309|FG000|NOT COMPLETED|Open Label Treatment Period||0||
60003372|NCT02541669|76119310|FG001|NOT COMPLETED|Open Label Treatment Period||0||
60003373|NCT02541669|76119311|FG002|NOT COMPLETED|Open Label Treatment Period||0||
60003374|NCT02541669|76119312|FG003|NOT COMPLETED|Open Label Treatment Period||0||
60003375|NCT02541669|76119313|FG004|NOT COMPLETED|Open Label Treatment Period||0||
60003376|NCT02541669|76119309|FG000|STARTED|Double-Blinded Treatment Period||0||
60003377|NCT02541669|76119310|FG001|STARTED|Double-Blinded Treatment Period||0||
60003378|NCT02541669|76119311|FG002|STARTED|Double-Blinded Treatment Period||16||
60003379|NCT02541669|76119312|FG003|STARTED|Double-Blinded Treatment Period||16||
60003380|NCT02541669|76119313|FG004|STARTED|Double-Blinded Treatment Period||16||
60003381|NCT02541669|76119309|FG000|COMPLETED|Double-Blinded Treatment Period||0||
60003382|NCT02541669|76119310|FG001|COMPLETED|Double-Blinded Treatment Period||0||
60003383|NCT02541669|76119311|FG002|COMPLETED|Double-Blinded Treatment Period||15||
60003384|NCT02541669|76119312|FG003|COMPLETED|Double-Blinded Treatment Period||16||
60003385|NCT02541669|76119313|FG004|COMPLETED|Double-Blinded Treatment Period||15||
60003386|NCT02541669|76119309|FG000|NOT COMPLETED|Double-Blinded Treatment Period||0||
60003387|NCT02541669|76119310|FG001|NOT COMPLETED|Double-Blinded Treatment Period||0||
60003388|NCT02541669|76119311|FG002|NOT COMPLETED|Double-Blinded Treatment Period||1||
60003389|NCT02541669|76119312|FG003|NOT COMPLETED|Double-Blinded Treatment Period||0||
60003390|NCT02541669|76119313|FG004|NOT COMPLETED|Double-Blinded Treatment Period||1||
60003391|NCT02549859|76119324|FG000|STARTED|Visit 1||11||
60003392|NCT02549859|76119324|FG000|COMPLETED|Visit 1||11||
60003393|NCT02549859|76119324|FG000|NOT COMPLETED|Visit 1||0||
60003394|NCT02549859|76119324|FG000|STARTED|Long-term 60 Hz DBS||11||
60135923|NCT00721617|76258592|FG000|NOT COMPLETED|8 Hours Into Intralipid Infusion||0||
60003395|NCT02549859|76119324|FG000|COMPLETED|Long-term 60 Hz DBS||10||
60003396|NCT02549859|76119324|FG000|NOT COMPLETED|Long-term 60 Hz DBS||1||
60003397|NCT02549859|76119324|FG000|STARTED|Visit 2||10||
60003398|NCT02549859|76119324|FG000|COMPLETED|Visit 2||10||
60003399|NCT02549859|76119324|FG000|NOT COMPLETED|Visit 2||0||
60003400|NCT02688647|76119334|FG000|STARTED|Initial Treatment Period (24 Weeks)||52||
60003401|NCT02688647|76119335|FG001|STARTED|Initial Treatment Period (24 Weeks)||24||
60003402|NCT02688647|76119334|FG000|Treated|Initial Treatment Period (24 Weeks)|1 subject was randomized but did not receive treatment.|51||
60003403|NCT02688647|76119335|FG001|Treated|Initial Treatment Period (24 Weeks)||24||
60003404|NCT02688647|76119334|FG000|COMPLETED|Initial Treatment Period (24 Weeks)||51||
60003405|NCT02688647|76119335|FG001|COMPLETED|Initial Treatment Period (24 Weeks)||18||
60003406|NCT02688647|76119334|FG000|NOT COMPLETED|Initial Treatment Period (24 Weeks)||1||
60003407|NCT02688647|76119335|FG001|NOT COMPLETED|Initial Treatment Period (24 Weeks)||6||
60003408|NCT02688647|76119334|FG000|STARTED|Post Switch Treatment Period (72 Weeks)|51 subjects originally randomized to treatment with belumosudil 400 mg PO QD continued receiving belumosudil 400 mg PO QD.|51||
60003409|NCT02688647|76119335|FG001|STARTED|Post Switch Treatment Period (72 Weeks)|17 subjects randomized to treatment with BSC-R cross-overed to treatment with belumosudil 400 mg PO QD.|17||
60003410|NCT02688647|76119334|FG000|COMPLETED|Post Switch Treatment Period (72 Weeks)||23||
60003411|NCT02688647|76119335|FG001|COMPLETED|Post Switch Treatment Period (72 Weeks)||3||
60003412|NCT02688647|76119334|FG000|NOT COMPLETED|Post Switch Treatment Period (72 Weeks)||28||
60003413|NCT02688647|76119335|FG001|NOT COMPLETED|Post Switch Treatment Period (72 Weeks)||14||
60003414|NCT02687711|76119353|FG000|STARTED|Overall Study||544||
60003415|NCT02687711|76119353|FG000|COMPLETED|Overall Study||332||
60003416|NCT02687711|76119353|FG000|NOT COMPLETED|Overall Study||212||
60003417|NCT01662063|76119359|FG000|STARTED|Overall Study||44||
60003418|NCT01662063|76119360|FG001|STARTED|Overall Study||173||
60003419|NCT01662063|76119361|FG002|STARTED|Overall Study||1||
60003420|NCT01662063|76119359|FG000|COMPLETED|Overall Study||39||
60003421|NCT01662063|76119360|FG001|COMPLETED|Overall Study||144||
60003422|NCT01662063|76119361|FG002|COMPLETED|Overall Study||0||
60003423|NCT01662063|76119359|FG000|NOT COMPLETED|Overall Study||5||
60003424|NCT01662063|76119360|FG001|NOT COMPLETED|Overall Study||29||
60003425|NCT01662063|76119361|FG002|NOT COMPLETED|Overall Study||1||
60003426|NCT02548455|76119369|FG000|STARTED|Overall Study|A total of 499 subjects were enrolled at 31 investigational sites.|499|484 were successful and 15 were unsuccessful.|
60003427|NCT02548455|76119369|FG000|Completed Pre-Discharge|Overall Study||484||
60003428|NCT02548455|76119369|FG000|Completed 6-Month Follow-up|Overall Study||259||
60003429|NCT02548455|76119369|FG000|Completed 12-Month Follow-up|Overall Study|Study completed prior to all subjects reaching the 6- and 12-month visits.|61||
60003430|NCT02548455|76119369|FG000|COMPLETED|Overall Study|Completed 6-Month Follow-up|259||
60003431|NCT02548455|76119369|FG000|NOT COMPLETED|Overall Study||240||
60003432|NCT02691455|76119375|FG000|STARTED|Overall Study||23||23
60003433|NCT02691455|76119376|FG001|STARTED|Overall Study||22||22
60003434|NCT02691455|76119375|FG000|Randomized|Overall Study||23||23
60003435|NCT02691455|76119376|FG001|Randomized|Overall Study||22||22
60003436|NCT02691455|76119375|FG000|Received Assigned Intervention|Overall Study||22||22
60003437|NCT02691455|76119376|FG001|Received Assigned Intervention|Overall Study||20||20
60003438|NCT02691455|76119375|FG000|Week 1 Follow up|Overall Study||22||22
60003439|NCT02691455|76119376|FG001|Week 1 Follow up|Overall Study||19||19
60003440|NCT02691455|76119375|FG000|Month 1 Follow up|Overall Study||22||22
60003441|NCT02691455|76119376|FG001|Month 1 Follow up|Overall Study||18||18
60003442|NCT02691455|76119375|FG000|Month 3 Follow up|Overall Study||21||21
60003443|NCT02691455|76119376|FG001|Month 3 Follow up|Overall Study||18||18
60003444|NCT02691455|76119375|FG000|Month 6 Follow up|Overall Study||19||19
60003445|NCT02691455|76119376|FG001|Month 6 Follow up|Overall Study||19||19
60003446|NCT02691455|76119375|FG000|Month 12 Follow up|Overall Study||16||16
60003447|NCT02691455|76119376|FG001|Month 12 Follow up|Overall Study||16||16
60003448|NCT02691455|76119375|FG000|Year 2 Follow up|Overall Study||6||6
60003449|NCT02691455|76119376|FG001|Year 2 Follow up|Overall Study||9||9
60003450|NCT02691455|76119375|FG000|Year 3 Follow up|Overall Study||7||7
60003451|NCT02691455|76119376|FG001|Year 3 Follow up|Overall Study||5||5
60003452|NCT02691455|76119375|FG000|COMPLETED|Overall Study||7||7
60003453|NCT02691455|76119376|FG001|COMPLETED|Overall Study||5||5
60003454|NCT02691455|76119375|FG000|NOT COMPLETED|Overall Study||16||16
60003455|NCT02691455|76119376|FG001|NOT COMPLETED|Overall Study||17||17
60003456|NCT02534883|76119384|FG000|STARTED|Overall Study||8||
60003457|NCT02534883|76119385|FG001|STARTED|Overall Study||3||
60003458|NCT02534883|76119384|FG000|COMPLETED|Overall Study||0||
60003459|NCT02534883|76119385|FG001|COMPLETED|Overall Study||0||
60003460|NCT02534883|76119384|FG000|NOT COMPLETED|Overall Study||8||
60003461|NCT02534883|76119385|FG001|NOT COMPLETED|Overall Study||3||
60003462|NCT02685995|76119393|FG000|STARTED|Overall Study||50||
60003463|NCT02685995|76119394|FG001|STARTED|Overall Study||50||
60003464|NCT02685995|76119393|FG000|COMPLETED|Overall Study||49||
60003465|NCT02685995|76119394|FG001|COMPLETED|Overall Study||49||
60003466|NCT02685995|76119393|FG000|NOT COMPLETED|Overall Study||1||
60003467|NCT02685995|76119394|FG001|NOT COMPLETED|Overall Study||1||
60003468|NCT02548143|76119402|FG000|STARTED|Overall Study||6||
60003469|NCT02548143|76119403|FG001|STARTED|Overall Study||6||
60003470|NCT02548143|76119402|FG000|COMPLETED|Overall Study||5||
60003471|NCT02548143|76119403|FG001|COMPLETED|Overall Study||5||
60003472|NCT02548143|76119402|FG000|NOT COMPLETED|Overall Study||1||
60003473|NCT02548143|76119403|FG001|NOT COMPLETED|Overall Study||1||
60003474|NCT02547441|76119411|FG000|STARTED|Double-Blind Study Period||235||
60003475|NCT02547441|76119412|FG001|STARTED|Double-Blind Study Period||228||
60003476|NCT02547441|76119411|FG000|COMPLETED|Double-Blind Study Period||211||
60003477|NCT02547441|76119412|FG001|COMPLETED|Double-Blind Study Period||196||
60003478|NCT02547441|76119411|FG000|NOT COMPLETED|Double-Blind Study Period||24||
60003479|NCT02547441|76119412|FG001|NOT COMPLETED|Double-Blind Study Period||32||
60003480|NCT02547441|76119411|FG000|STARTED|Open-Label Study Period||188||
60003481|NCT02547441|76119412|FG001|STARTED|Open-Label Study Period||175||
60003482|NCT02547441|76119411|FG000|COMPLETED|Open-Label Study Period||66||
60003483|NCT02547441|76119412|FG001|COMPLETED|Open-Label Study Period||48||
60003484|NCT02547441|76119411|FG000|NOT COMPLETED|Open-Label Study Period||122||
60003485|NCT02547441|76119412|FG001|NOT COMPLETED|Open-Label Study Period||127||
60003486|NCT02540265|76119422|FG000|STARTED|Overall Study||20||
60003487|NCT02540265|76119423|FG001|STARTED|Overall Study||20||
60003488|NCT02540265|76119424|FG002|STARTED|Overall Study||19||
60003489|NCT02540265|76119422|FG000|Treatment Completion|Overall Study||20|Subjects receiving at least 2 study doses were considered as treatment complete|
60003490|NCT02540265|76119423|FG001|Treatment Completion|Overall Study||19|Subjects receiving at least 2 study doses were considered as treatment complete|
60003491|NCT02540265|76119424|FG002|Treatment Completion|Overall Study||18|Subjects receiving at least 2 study doses were considered as treatment complete|
60003492|NCT02540265|76119422|FG000|COMPLETED|Overall Study||20|Subjects who completed the final study followup were considered study completers|
60003493|NCT02540265|76119423|FG001|COMPLETED|Overall Study||20|Subjects who completed the final study followup were considered study completers|
60003494|NCT02540265|76119424|FG002|COMPLETED|Overall Study||18|Subjects who completed the final study followup were considered study completers|
60003495|NCT02540265|76119422|FG000|NOT COMPLETED|Overall Study||0||
60003496|NCT02540265|76119423|FG001|NOT COMPLETED|Overall Study||0||
60003497|NCT02540265|76119424|FG002|NOT COMPLETED|Overall Study||1||
60003498|NCT02547363|76119434|FG000|STARTED|3-day Treatment and 8-week Follow-up||211||
60003499|NCT02547363|76119435|FG001|STARTED|3-day Treatment and 8-week Follow-up||105||
60003500|NCT02547363|76119434|FG000|Treated|3-day Treatment and 8-week Follow-up||209||
60003501|NCT02547363|76119435|FG001|Treated|3-day Treatment and 8-week Follow-up||104||
60003502|NCT02547363|76119434|FG000|COMPLETED|3-day Treatment and 8-week Follow-up||207||
60003503|NCT02547363|76119435|FG001|COMPLETED|3-day Treatment and 8-week Follow-up||94||
60003504|NCT02547363|76119434|FG000|NOT COMPLETED|3-day Treatment and 8-week Follow-up||4||
60003505|NCT02547363|76119435|FG001|NOT COMPLETED|3-day Treatment and 8-week Follow-up||11||
60003506|NCT02547363|76119434|FG000|STARTED|12-month Follow-up||204||
60003507|NCT02547363|76119435|FG001|STARTED|12-month Follow-up||86||
60003508|NCT02547363|76119434|FG000|COMPLETED|12-month Follow-up||194||
60003509|NCT02547363|76119435|FG001|COMPLETED|12-month Follow-up||81||
60003510|NCT02547363|76119434|FG000|NOT COMPLETED|12-month Follow-up||10||
60003511|NCT02547363|76119435|FG001|NOT COMPLETED|12-month Follow-up||5||
60003512|NCT02539797|76119443|FG000|STARTED|Overall Study||12||
60003513|NCT02539797|76119444|FG001|STARTED|Overall Study||13||
60003514|NCT02539797|76119445|FG002|STARTED|Overall Study||13||
60003515|NCT02539797|76119443|FG000|COMPLETED|Overall Study||12||
60003516|NCT02539797|76119444|FG001|COMPLETED|Overall Study||12||
60003517|NCT02539797|76119445|FG002|COMPLETED|Overall Study||13||
60003518|NCT02539797|76119443|FG000|NOT COMPLETED|Overall Study||0||
60003519|NCT02539797|76119444|FG001|NOT COMPLETED|Overall Study||1||
60003520|NCT02539797|76119445|FG002|NOT COMPLETED|Overall Study||0||
60003521|NCT02684357|76119456|FG000|STARTED|Part A||98||
60003522|NCT02684357|76119457|FG001|STARTED|Part A||99||
60003523|NCT02684357|76119458|FG002|STARTED|Part A||294||
60003524|NCT02684357|76119459|FG003|STARTED|Part A||0||
60003525|NCT02684357|76119460|FG004|STARTED|Part A||0||
60003526|NCT02684357|76119461|FG005|STARTED|Part A||0||
60003527|NCT02684357|76119456|FG000|COMPLETED|Part A||94||
60003528|NCT02684357|76119457|FG001|COMPLETED|Part A||96||
60003529|NCT02684357|76119458|FG002|COMPLETED|Part A||292||
60003530|NCT02684357|76119459|FG003|COMPLETED|Part A||0||
60003531|NCT02684357|76119460|FG004|COMPLETED|Part A||0||
60003532|NCT02684357|76119461|FG005|COMPLETED|Part A||0||
60003533|NCT02684357|76119456|FG000|NOT COMPLETED|Part A||4||
60003534|NCT02684357|76119457|FG001|NOT COMPLETED|Part A||3||
60003535|NCT02684357|76119458|FG002|NOT COMPLETED|Part A||2||
60003536|NCT02684357|76119459|FG003|NOT COMPLETED|Part A||0||
60003537|NCT02684357|76119460|FG004|NOT COMPLETED|Part A||0||
60003538|NCT02684357|76119461|FG005|NOT COMPLETED|Part A||0||
60003539|NCT02684357|76119456|FG000|STARTED|Part B||0||
60003540|NCT02684357|76119457|FG001|STARTED|Part B||0||
60003541|NCT02684357|76119458|FG002|STARTED|Part B||0||
60003542|NCT02684357|76119459|FG003|STARTED|Part B|Participants who received placebo in Part A received risankizumab in Part B|94||
60003543|NCT02684357|76119460|FG004|STARTED|Part B|2 participants who received ustekinumab in Part A did not receive a dose of study drug in Part B.|94||
60003544|NCT02684357|76119461|FG005|STARTED|Part B|1 participant who received risankizumab in Part A did not receive a dose of study drug in Part B|291||
60003545|NCT02684357|76119456|FG000|COMPLETED|Part B||0||
60003546|NCT02684357|76119457|FG001|COMPLETED|Part B||0||
60003547|NCT02684357|76119458|FG002|COMPLETED|Part B||0||
60003548|NCT02684357|76119459|FG003|COMPLETED|Part B||91||
60003549|NCT02684357|76119460|FG004|COMPLETED|Part B||90||
60003550|NCT02684357|76119461|FG005|COMPLETED|Part B||278||
60003551|NCT02684357|76119456|FG000|NOT COMPLETED|Part B||0||
60003552|NCT02684357|76119457|FG001|NOT COMPLETED|Part B||0||
60003553|NCT02684357|76119458|FG002|NOT COMPLETED|Part B||0||
60003554|NCT02684357|76119459|FG003|NOT COMPLETED|Part B||3||
60003555|NCT02684357|76119460|FG004|NOT COMPLETED|Part B||4||
60003556|NCT02684357|76119461|FG005|NOT COMPLETED|Part B||13||
60003557|NCT02684279|76119474|FG000|STARTED|Overall Study||528||
60003558|NCT02684279|76119474|FG000|COMPLETED|Overall Study||249||
60003559|NCT02684279|76119474|FG000|NOT COMPLETED|Overall Study||279||
60003560|NCT02534493|76119478|FG000|STARTED|Overall Study||13||19
60003561|NCT02534493|76119478|FG000|COMPLETED|Overall Study||11||15
60003562|NCT02534493|76119478|FG000|NOT COMPLETED|Overall Study||2||4
60003563|NCT02547129|76119486|FG000|STARTED|Overall Study||2||
60003564|NCT02547129|76119487|FG001|STARTED|Overall Study||2||
60003565|NCT02547129|76119486|FG000|COMPLETED|Overall Study||1||
60003566|NCT02547129|76119487|FG001|COMPLETED|Overall Study||2||
60003567|NCT02547129|76119486|FG000|NOT COMPLETED|Overall Study||1||
60003568|NCT02547129|76119487|FG001|NOT COMPLETED|Overall Study||0||
60003569|NCT02546193|76119495|FG000|STARTED|Overall Study||10||
60003570|NCT02546193|76119496|FG001|STARTED|Overall Study||10||
60003571|NCT02546193|76119497|FG002|STARTED|Overall Study|Enrolled independently (Prospective study). Not counted in Outpatient Foley Catheter Arm.|2||
60003572|NCT02546193|76119498|FG003|STARTED|Overall Study||0||
60003573|NCT02546193|76119495|FG000|COMPLETED|Overall Study||4||
60003574|NCT02546193|76119496|FG001|COMPLETED|Overall Study||4||
60003575|NCT02546193|76119497|FG002|COMPLETED|Overall Study||0||
60003576|NCT02546193|76119498|FG003|COMPLETED|Overall Study||0||
60003577|NCT02546193|76119495|FG000|NOT COMPLETED|Overall Study||6||
60003578|NCT02546193|76119496|FG001|NOT COMPLETED|Overall Study||6||
60003579|NCT02546193|76119497|FG002|NOT COMPLETED|Overall Study||2||
60003580|NCT02546193|76119498|FG003|NOT COMPLETED|Overall Study||0||
60003581|NCT02538471|76119504|FG000|STARTED|Overall Study||3||
60003582|NCT02538471|76119504|FG000|COMPLETED|Overall Study||1||
60003583|NCT02538471|76119504|FG000|NOT COMPLETED|Overall Study||2||
60003584|NCT01661595|76119512|FG000|STARTED|Phase 1: Week 0-4||5||
60003585|NCT01661595|76119513|FG001|STARTED|Phase 1: Week 0-4||4||
60003586|NCT01661595|76119514|FG002|STARTED|Phase 1: Week 0-4||5||
60003587|NCT01661595|76119515|FG003|STARTED|Phase 1: Week 0-4||4||
60003588|NCT01661595|76119512|FG000|COMPLETED|Phase 1: Week 0-4||4||
60003589|NCT01661595|76119513|FG001|COMPLETED|Phase 1: Week 0-4||4||
60003590|NCT01661595|76119514|FG002|COMPLETED|Phase 1: Week 0-4||5||
60003591|NCT01661595|76119515|FG003|COMPLETED|Phase 1: Week 0-4||4||
60003592|NCT01661595|76119512|FG000|NOT COMPLETED|Phase 1: Week 0-4||1||
60003593|NCT01661595|76119513|FG001|NOT COMPLETED|Phase 1: Week 0-4||0||
60003594|NCT01661595|76119514|FG002|NOT COMPLETED|Phase 1: Week 0-4||0||
60003595|NCT01661595|76119515|FG003|NOT COMPLETED|Phase 1: Week 0-4||0||
60003596|NCT01661595|76119512|FG000|STARTED|Phase 2: Week 5-8.||4||
60003597|NCT01661595|76119513|FG001|STARTED|Phase 2: Week 5-8.||4||
60003598|NCT01661595|76119514|FG002|STARTED|Phase 2: Week 5-8.||5||
60003599|NCT01661595|76119515|FG003|STARTED|Phase 2: Week 5-8.||4||
60003600|NCT01661595|76119512|FG000|COMPLETED|Phase 2: Week 5-8.||4||
60003601|NCT01661595|76119513|FG001|COMPLETED|Phase 2: Week 5-8.||4||
60003602|NCT01661595|76119514|FG002|COMPLETED|Phase 2: Week 5-8.||4||
60003603|NCT01661595|76119515|FG003|COMPLETED|Phase 2: Week 5-8.||4||
60003604|NCT01661595|76119512|FG000|NOT COMPLETED|Phase 2: Week 5-8.||0||
59519067|NCT01118221|75612938|FG001|STARTED|Overall Study||11||
60003605|NCT01661595|76119513|FG001|NOT COMPLETED|Phase 2: Week 5-8.||0||
60003606|NCT01661595|76119514|FG002|NOT COMPLETED|Phase 2: Week 5-8.||1||
60003607|NCT01661595|76119515|FG003|NOT COMPLETED|Phase 2: Week 5-8.||0||
60003608|NCT02213133|76119535|FG000|STARTED|Overall Study||37|Enrolled|
59750712|NCT00874731|75869945|FG001|STARTED|Washout Period||22||
59750713|NCT00874731|75869946|FG002|STARTED|Washout Period||0||
59750714|NCT00874731|75869944|FG000|COMPLETED|Washout Period||0||
59750715|NCT00874731|75869945|FG001|COMPLETED|Washout Period||22||
59750716|NCT00874731|75869946|FG002|COMPLETED|Washout Period||0||
59750717|NCT00874731|75869944|FG000|NOT COMPLETED|Washout Period||0||
59750718|NCT00874731|75869945|FG001|NOT COMPLETED|Washout Period||0||
59750719|NCT00874731|75869946|FG002|NOT COMPLETED|Washout Period||0||
59750720|NCT00874731|75869944|FG000|STARTED|Part 2: Ridaforolimus 40 mg||0||
59750721|NCT00874731|75869945|FG001|STARTED|Part 2: Ridaforolimus 40 mg|"Participants completing Pt 1 and washout, enter into the Pt 2. Ridaforolimus 40 mg arm."|0||
59750722|NCT00874731|75869946|FG002|STARTED|Part 2: Ridaforolimus 40 mg|"Participants completing Pt 1 and washout, started this period in Pt 2. Ridaforolimus 40 mg arm."|22||
59750723|NCT00874731|75869944|FG000|COMPLETED|Part 2: Ridaforolimus 40 mg||0||
59750724|NCT00874731|75869945|FG001|COMPLETED|Part 2: Ridaforolimus 40 mg||0||
59750725|NCT00874731|75869946|FG002|COMPLETED|Part 2: Ridaforolimus 40 mg||0||
59750726|NCT00874731|75869944|FG000|NOT COMPLETED|Part 2: Ridaforolimus 40 mg||0||
59750727|NCT00874731|75869945|FG001|NOT COMPLETED|Part 2: Ridaforolimus 40 mg||0||
59750728|NCT00874731|75869946|FG002|NOT COMPLETED|Part 2: Ridaforolimus 40 mg||22||
59750729|NCT00924638|75869956|FG000|STARTED|Overall Study|Randomized to Continuous Monitoring Arm|221||
59750730|NCT00924638|75869957|FG001|STARTED|Overall Study|Randomized to Control Arm|220||
59750731|NCT00924638|75869956|FG000|COMPLETED|Overall Study|Completed 6 months of follow-up|209||
59750732|NCT00924638|75869957|FG001|COMPLETED|Overall Study|Completed 6 months of follow-up|207||
59750733|NCT00924638|75869956|FG000|NOT COMPLETED|Overall Study||12||
59750734|NCT00924638|75869957|FG001|NOT COMPLETED|Overall Study||13||
59750735|NCT00874497|75869965|FG000|STARTED|Overall Study|This is the number of participants who were treated and were considered as safety population.|51||
59750736|NCT00874497|75869966|FG001|STARTED|Overall Study|This is the number of participants who were treated and were considered as safety population.|33||
59750737|NCT00874497|75869965|FG000|COMPLETED|Overall Study||23||
59750738|NCT00874497|75869966|FG001|COMPLETED|Overall Study||15||
59750739|NCT00874497|75869965|FG000|NOT COMPLETED|Overall Study||28||
59750740|NCT00874497|75869966|FG001|NOT COMPLETED|Overall Study||18||
59750741|NCT00924560|75869975|FG000|STARTED|Overall Study||458||
59750742|NCT00924560|75869976|FG001|STARTED|Overall Study||448||
59750743|NCT00924560|75869977|FG002|STARTED|Overall Study||455||
59750744|NCT00924560|75869975|FG000|Received Treatment|Overall Study|Excludes 7 participants at 1 site that was closed. One participant received 28-day OC in error.|422||
59750745|NCT00924560|75869976|FG001|Received Treatment|Overall Study|Excludes 9 participants from one site that was closed due to audit findings.|411||
59750746|NCT00924560|75869977|FG002|Received Treatment|Overall Study||0||
59750747|NCT00924560|75869975|FG000|COMPLETED|Overall Study||247||
59750748|NCT00924560|75869976|FG001|COMPLETED|Overall Study||240||
59750749|NCT00924560|75869977|FG002|COMPLETED|Overall Study||372||
59750750|NCT00924560|75869975|FG000|NOT COMPLETED|Overall Study||211||
59750751|NCT00924560|75869976|FG001|NOT COMPLETED|Overall Study||208||
59750752|NCT00924560|75869977|FG002|NOT COMPLETED|Overall Study||83||
59750753|NCT00923078|75869990|FG000|STARTED|First Intervention (Weeks 1-4)||20||
59750754|NCT00923078|75869991|FG001|STARTED|First Intervention (Weeks 1-4)||20||
59750755|NCT00923078|75869992|FG002|STARTED|First Intervention (Weeks 1-4)||20||
59750756|NCT00923078|75869990|FG000|COMPLETED|First Intervention (Weeks 1-4)||19||
59750757|NCT00923078|75869991|FG001|COMPLETED|First Intervention (Weeks 1-4)||19||
59750758|NCT00923078|75869992|FG002|COMPLETED|First Intervention (Weeks 1-4)||0||
59750759|NCT00923078|75869990|FG000|NOT COMPLETED|First Intervention (Weeks 1-4)||1||
59750760|NCT00923078|75869991|FG001|NOT COMPLETED|First Intervention (Weeks 1-4)||1||
59750761|NCT00923078|75869992|FG002|NOT COMPLETED|First Intervention (Weeks 1-4)||20||
59750762|NCT00923078|75869990|FG000|STARTED|Second Intervention (Weeks 5-8)||19||
59750763|NCT00923078|75869991|FG001|STARTED|Second Intervention (Weeks 5-8)||19||
59750764|NCT00923078|75869992|FG002|STARTED|Second Intervention (Weeks 5-8)|Healthy Comparison sample subjects completed only a single test session (baseline)|0||
59750765|NCT00923078|75869990|FG000|COMPLETED|Second Intervention (Weeks 5-8)||19||
59750766|NCT00923078|75869991|FG001|COMPLETED|Second Intervention (Weeks 5-8)||19||
59750767|NCT00923078|75869992|FG002|COMPLETED|Second Intervention (Weeks 5-8)||0||
59750768|NCT00923078|75869990|FG000|NOT COMPLETED|Second Intervention (Weeks 5-8)||0||
59750769|NCT00923078|75869991|FG001|NOT COMPLETED|Second Intervention (Weeks 5-8)||0||
59750770|NCT00923078|75869992|FG002|NOT COMPLETED|Second Intervention (Weeks 5-8)||0||
59750771|NCT00978731|75870003|FG000|STARTED|Overall Study||22||
59750772|NCT00978731|75870004|FG001|STARTED|Overall Study||15||
59750773|NCT00978731|75870005|FG002|STARTED|Overall Study||5||
59750774|NCT00978731|75870006|FG003|STARTED|Overall Study||4||
59750775|NCT00978731|75870003|FG000|COMPLETED|Overall Study||0||
59750776|NCT00978731|75870004|FG001|COMPLETED|Overall Study||0||
59750777|NCT00978731|75870005|FG002|COMPLETED|Overall Study||0||
59750778|NCT00978731|75870006|FG003|COMPLETED|Overall Study||0||
59750779|NCT00978731|75870003|FG000|NOT COMPLETED|Overall Study||22||
59750780|NCT00978731|75870004|FG001|NOT COMPLETED|Overall Study||15||
59750781|NCT00978731|75870005|FG002|NOT COMPLETED|Overall Study||5||
59750782|NCT00978731|75870006|FG003|NOT COMPLETED|Overall Study||4||
59750783|NCT05056870|75870020|FG000|STARTED|Period 1||80||
59750784|NCT05056870|75870021|FG001|STARTED|Period 1||81||
60003609|NCT02213133|76119536|FG001|STARTED|Overall Study||5|Enrolled|
60003610|NCT02213133|76119537|FG002|STARTED|Overall Study||3|Enrolled|
60003611|NCT02213133|76119535|FG000|Treated|Overall Study||33||
60003612|NCT02213133|76119536|FG001|Treated|Overall Study||4||
60003613|NCT02213133|76119537|FG002|Treated|Overall Study||1||
60003614|NCT02213133|76119535|FG000|COMPLETED|Overall Study||0||
60003615|NCT02213133|76119536|FG001|COMPLETED|Overall Study||0||
60003616|NCT02213133|76119537|FG002|COMPLETED|Overall Study||0||
60003617|NCT02213133|76119535|FG000|NOT COMPLETED|Overall Study||37||
60003618|NCT02213133|76119536|FG001|NOT COMPLETED|Overall Study||5||
60003619|NCT02213133|76119537|FG002|NOT COMPLETED|Overall Study||3||
60003620|NCT02684981|76119549|FG000|STARTED|Overall Study||4100|Number of patients started are treated with known treatment.|
60003621|NCT02684981|76119550|FG001|STARTED|Overall Study||3179|Number of patients started are treated with known treatment.|
60003622|NCT02684981|76119551|FG002|STARTED|Overall Study||2186|Number of patients started are treated with known treatment.|
60003623|NCT02684981|76119549|FG000|COMPLETED|Overall Study||3860||
60003624|NCT02684981|76119550|FG001|COMPLETED|Overall Study||2969||
60003625|NCT02684981|76119551|FG002|COMPLETED|Overall Study||2059||
60003626|NCT02684981|76119549|FG000|NOT COMPLETED|Overall Study||240||
60003627|NCT02684981|76119550|FG001|NOT COMPLETED|Overall Study||210||
60003628|NCT02684981|76119551|FG002|NOT COMPLETED|Overall Study||127||
60003629|NCT02146833|76119565|FG000|STARTED|Overall Study||20||
60003630|NCT02146833|76119565|FG000|COMPLETED|Overall Study||9||
60003631|NCT02146833|76119565|FG000|NOT COMPLETED|Overall Study||11||
60003632|NCT02690207|76119569|FG000|STARTED|Overall Study||8687||
60003633|NCT02690207|76119569|FG000|COMPLETED|Overall Study||8434||
60003634|NCT02690207|76119569|FG000|NOT COMPLETED|Overall Study||253||
60003635|NCT02689349|76119575|FG000|STARTED|Overall Study||59||
60003636|NCT02689349|76119576|FG001|STARTED|Overall Study||58||
60003637|NCT02689349|76119575|FG000|COMPLETED|Overall Study||46||
60003638|NCT02689349|76119576|FG001|COMPLETED|Overall Study||58||
60003639|NCT02689349|76119575|FG000|NOT COMPLETED|Overall Study||13||
60003640|NCT02689349|76119576|FG001|NOT COMPLETED|Overall Study||0||
60003641|NCT02679287|76119587|FG000|STARTED|Period 1: Randomization-Study Session 1||47|Randomization|
60003642|NCT02679287|76119588|FG001|STARTED|Period 1: Randomization-Study Session 1||46|Randomization|
60003643|NCT02679287|76119587|FG000|COMPLETED|Period 1: Randomization-Study Session 1||43|Completion of Study Session 1 Group A=SAP Group B=Evening/Overnight CLC|
60003644|NCT02679287|76119588|FG001|COMPLETED|Period 1: Randomization-Study Session 1||40|Completion of Study Session 1 Group A=SAP Group B=Evening/Overnight CLC|
60003645|NCT02679287|76119587|FG000|NOT COMPLETED|Period 1: Randomization-Study Session 1||4||
60003646|NCT02679287|76119588|FG001|NOT COMPLETED|Period 1: Randomization-Study Session 1||6||
60003647|NCT02679287|76119587|FG000|STARTED|Period 2||43||
60003648|NCT02679287|76119588|FG001|STARTED|Period 2||40||
60003649|NCT02679287|76119587|FG000|COMPLETED|Period 2||40|"Completed Study Session 2:~Group A: Evening/Overnight CLC Group B: 24/7 CLC"|
60003650|NCT02679287|76119588|FG001|COMPLETED|Period 2||40|"Completed Study Session 2:~Group A: Evening/Overnight CLC Group B: 24/7 CLC"|
60003651|NCT02679287|76119587|FG000|NOT COMPLETED|Period 2||3||
60003652|NCT02679287|76119588|FG001|NOT COMPLETED|Period 2||0||
60003653|NCT02679287|76119587|FG000|STARTED|Period 3||40||
60003654|NCT02679287|76119588|FG001|STARTED|Period 3||40||
60003655|NCT02679287|76119587|FG000|COMPLETED|Period 3||40|"Completed Study Session 3:~Group A: 24/7 CLC Group B: Evening/Overnight CLC"|
60003656|NCT02679287|76119588|FG001|COMPLETED|Period 3||39|"Completed Study Session 3:~Group A: 24/7 CLC Group B: Evening/Overnight CLC"|
60003657|NCT02679287|76119587|FG000|NOT COMPLETED|Period 3||0||
60003658|NCT02679287|76119588|FG001|NOT COMPLETED|Period 3||1||
60003659|NCT02679287|76119587|FG000|STARTED|Phase 4||40|"Completed Study Session 4:~Group A: Evening/Overnight CLC Group B: SAP"|
60003660|NCT02679287|76119588|FG001|STARTED|Phase 4||39|"Completed Study Session 4:~Group A: Evening/Overnight CLC Group B: SAP"|
60003661|NCT02679287|76119587|FG000|COMPLETED|Phase 4||40||
60003662|NCT02679287|76119588|FG001|COMPLETED|Phase 4||39||
60003663|NCT02679287|76119587|FG000|NOT COMPLETED|Phase 4||0||
60003664|NCT02679287|76119588|FG001|NOT COMPLETED|Phase 4||0||
60003665|NCT02544633|76119604|FG000|STARTED|Treatment Period||28||
60003666|NCT02544633|76119605|FG001|STARTED|Treatment Period||20||
60003667|NCT02544633|76119606|FG002|STARTED|Treatment Period||8||
60003668|NCT02544633|76119607|FG003|STARTED|Treatment Period||12||
60003669|NCT02544633|76119604|FG000|COMPLETED|Treatment Period||0||
60003670|NCT02544633|76119605|FG001|COMPLETED|Treatment Period||0||
60003671|NCT02544633|76119606|FG002|COMPLETED|Treatment Period||0||
60003672|NCT02544633|76119607|FG003|COMPLETED|Treatment Period||0||
60003673|NCT02544633|76119604|FG000|NOT COMPLETED|Treatment Period||28||
60003674|NCT02544633|76119605|FG001|NOT COMPLETED|Treatment Period||20||
60003675|NCT02544633|76119606|FG002|NOT COMPLETED|Treatment Period||8||
60003676|NCT02544633|76119607|FG003|NOT COMPLETED|Treatment Period||12||
60003677|NCT02544633|76119604|FG000|STARTED|Survival Follow-up Period||28|2 patients on treatment at the time of primary report date|
60003678|NCT02544633|76119605|FG001|STARTED|Survival Follow-up Period||19|2 patients on treatment at the time of primary report date|
60003679|NCT02544633|76119606|FG002|STARTED|Survival Follow-up Period||7|2 patients on treatment at the time of primary report date|
60003680|NCT02544633|76119607|FG003|STARTED|Survival Follow-up Period||12|2 patients on treatment at the time of primary report date|
60003681|NCT02544633|76119604|FG000|COMPLETED|Survival Follow-up Period||0||
60003682|NCT02544633|76119605|FG001|COMPLETED|Survival Follow-up Period||0||
60003683|NCT02544633|76119606|FG002|COMPLETED|Survival Follow-up Period||0||
60003684|NCT02544633|76119607|FG003|COMPLETED|Survival Follow-up Period||0||
60003685|NCT02544633|76119604|FG000|NOT COMPLETED|Survival Follow-up Period||28||
60003686|NCT02544633|76119605|FG001|NOT COMPLETED|Survival Follow-up Period||19||
60003687|NCT02544633|76119606|FG002|NOT COMPLETED|Survival Follow-up Period||7||
60003688|NCT02544633|76119607|FG003|NOT COMPLETED|Survival Follow-up Period||12||
60003689|NCT02678351|76119629|FG000|STARTED|Overall Study||74||
60003690|NCT02678351|76119629|FG000|COMPLETED|Overall Study||73||
60003691|NCT02678351|76119629|FG000|NOT COMPLETED|Overall Study||1||
60003692|NCT02683187|76119633|FG000|STARTED|Overall Study||40||
60003693|NCT02683187|76119633|FG000|COMPLETED|Overall Study||32||
60003694|NCT02683187|76119633|FG000|NOT COMPLETED|Overall Study||8||
60003695|NCT02683109|76119643|FG000|STARTED|Overall Study||110||
60003696|NCT02683109|76119644|FG001|STARTED|Overall Study||111||
60003697|NCT02683109|76119643|FG000|COMPLETED|Overall Study||109||
60003698|NCT02683109|76119644|FG001|COMPLETED|Overall Study||111||
60003699|NCT02683109|76119643|FG000|NOT COMPLETED|Overall Study||1||
60003700|NCT02683109|76119644|FG001|NOT COMPLETED|Overall Study||0||
60003701|NCT02544321|76119653|FG000|STARTED|Overall Study||43||
60003702|NCT02544321|76119654|FG001|STARTED|Overall Study||43||
60003703|NCT02544321|76119653|FG000|Completed First Treatment|Overall Study||43||
60003704|NCT02544321|76119654|FG001|Completed First Treatment|Overall Study||41||
60003705|NCT02544321|76119653|FG000|Completed Washout|Overall Study||43||
60003706|NCT02544321|76119654|FG001|Completed Washout|Overall Study||41||
60003707|NCT02544321|76119653|FG000|Started Second Treatment|Overall Study||42||
60003708|NCT02544321|76119654|FG001|Started Second Treatment|Overall Study||40||
60003709|NCT02544321|76119653|FG000|COMPLETED|Overall Study||41||
60003710|NCT02544321|76119654|FG001|COMPLETED|Overall Study||39||
60003711|NCT02544321|76119653|FG000|NOT COMPLETED|Overall Study||2||
60003712|NCT02544321|76119654|FG001|NOT COMPLETED|Overall Study||4||
60003713|NCT02533401|76119669|FG000|STARTED|Overall Study||34||
60003714|NCT02533401|76119669|FG000|COMPLETED|Overall Study||23||
60003715|NCT02533401|76119669|FG000|NOT COMPLETED|Overall Study||11||
60003716|NCT02536833|76119677|FG000|STARTED|Overall Study||112||
60003717|NCT02536833|76119678|FG001|STARTED|Overall Study||117||
60003718|NCT02536833|76119679|FG002|STARTED|Overall Study||110||
60003719|NCT02536833|76119680|FG003|STARTED|Overall Study||116||
60003720|NCT02536833|76119677|FG000|COMPLETED|Overall Study||103||
60003721|NCT02536833|76119678|FG001|COMPLETED|Overall Study||107||
60003722|NCT02536833|76119679|FG002|COMPLETED|Overall Study||95||
60003723|NCT02536833|76119680|FG003|COMPLETED|Overall Study||97||
60003724|NCT02536833|76119677|FG000|NOT COMPLETED|Overall Study||9||
60003725|NCT02536833|76119678|FG001|NOT COMPLETED|Overall Study||10||
60003726|NCT02536833|76119679|FG002|NOT COMPLETED|Overall Study||15||
60003727|NCT02536833|76119680|FG003|NOT COMPLETED|Overall Study||19||
60003728|NCT02680847|76119694|FG000|STARTED|Overall Study||16||
59519068|NCT01118221|75612937|FG000|COMPLETED|Overall Study||11||
60003729|NCT02680847|76119695|FG001|STARTED|Overall Study||9||
60003730|NCT02680847|76119696|FG002|STARTED|Overall Study||7||
60003731|NCT02680847|76119694|FG000|COMPLETED|Overall Study||11||
60003732|NCT02680847|76119695|FG001|COMPLETED|Overall Study||6||
60003733|NCT02680847|76119696|FG002|COMPLETED|Overall Study||4||
60003734|NCT02680847|76119694|FG000|NOT COMPLETED|Overall Study||5||
60003735|NCT02680847|76119695|FG001|NOT COMPLETED|Overall Study||3||
60003736|NCT02680847|76119696|FG002|NOT COMPLETED|Overall Study||3||
60003737|NCT02532855|76119706|FG000|STARTED|Overall Study||307||
60003738|NCT02532855|76119707|FG001|STARTED|Overall Study||307||
60003739|NCT02532855|76119706|FG000|Treated|Overall Study||307||
60003740|NCT02532855|76119707|FG001|Treated|Overall Study|One participant had a protocol violation, was randomized but did not take study medication.|306||
60003741|NCT02532855|76119706|FG000|COMPLETED|Overall Study||299||
60003742|NCT02532855|76119707|FG001|COMPLETED|Overall Study||296||
60003743|NCT02532855|76119706|FG000|NOT COMPLETED|Overall Study||8||
60003744|NCT02532855|76119707|FG001|NOT COMPLETED|Overall Study||11||
60003745|NCT02530125|76119713|FG000|STARTED|Completed Treatment||4||
60003746|NCT02530125|76119713|FG000|COMPLETED|Completed Treatment||3||
60003747|NCT02530125|76119713|FG000|NOT COMPLETED|Completed Treatment||1||
60003748|NCT02530125|76119713|FG000|STARTED|Followed for Survival for 2 Years||3||
60003749|NCT02530125|76119713|FG000|COMPLETED|Followed for Survival for 2 Years||0||
60003750|NCT02530125|76119713|FG000|NOT COMPLETED|Followed for Survival for 2 Years||3||
60003751|NCT01661205|76119717|FG000|STARTED|Overall Study||26||
60003752|NCT01661205|76119717|FG000|COMPLETED|Overall Study||24||
60003753|NCT01661205|76119717|FG000|NOT COMPLETED|Overall Study||2||
60003754|NCT02055820|76119731|FG000|STARTED|Phase I: Dose-Finding||7||
60003755|NCT02055820|76119732|FG001|STARTED|Phase I: Dose-Finding||3||
60003756|NCT02055820|76119733|FG002|STARTED|Phase I: Dose-Finding||8||
60003757|NCT02055820|76119734|FG003|STARTED|Phase I: Dose-Finding||6||
60003758|NCT02055820|76119735|FG004|STARTED|Phase I: Dose-Finding||0||
60003759|NCT02055820|76119736|FG005|STARTED|Phase I: Dose-Finding||7||
60003760|NCT02055820|76119737|FG006|STARTED|Phase I: Dose-Finding||7||
60003761|NCT02055820|76119738|FG007|STARTED|Phase I: Dose-Finding||6||
60003762|NCT02055820|76119739|FG008|STARTED|Phase I: Dose-Finding||6||
60003763|NCT02055820|76119740|FG009|STARTED|Phase I: Dose-Finding||6||
60003764|NCT02055820|76119731|FG000|COMPLETED|Phase I: Dose-Finding||6||
60003765|NCT02055820|76119732|FG001|COMPLETED|Phase I: Dose-Finding||3||
60003766|NCT02055820|76119733|FG002|COMPLETED|Phase I: Dose-Finding||7||
60003767|NCT02055820|76119734|FG003|COMPLETED|Phase I: Dose-Finding||3||
60003768|NCT02055820|76119735|FG004|COMPLETED|Phase I: Dose-Finding||0||
60003769|NCT02055820|76119736|FG005|COMPLETED|Phase I: Dose-Finding||5||
60003770|NCT02055820|76119737|FG006|COMPLETED|Phase I: Dose-Finding||5||
60003771|NCT02055820|76119738|FG007|COMPLETED|Phase I: Dose-Finding||6||
60003772|NCT02055820|76119739|FG008|COMPLETED|Phase I: Dose-Finding||6||
60003773|NCT02055820|76119740|FG009|COMPLETED|Phase I: Dose-Finding||6||
60003774|NCT02055820|76119731|FG000|NOT COMPLETED|Phase I: Dose-Finding||1||
60003775|NCT02055820|76119732|FG001|NOT COMPLETED|Phase I: Dose-Finding||0||
60003776|NCT02055820|76119733|FG002|NOT COMPLETED|Phase I: Dose-Finding||1||
60003777|NCT02055820|76119734|FG003|NOT COMPLETED|Phase I: Dose-Finding||3||
60003778|NCT02055820|76119735|FG004|NOT COMPLETED|Phase I: Dose-Finding||0||
60003779|NCT02055820|76119736|FG005|NOT COMPLETED|Phase I: Dose-Finding||2||
60003780|NCT02055820|76119737|FG006|NOT COMPLETED|Phase I: Dose-Finding||2||
60003781|NCT02055820|76119738|FG007|NOT COMPLETED|Phase I: Dose-Finding||0||
60003782|NCT02055820|76119739|FG008|NOT COMPLETED|Phase I: Dose-Finding||0||
60003783|NCT02055820|76119740|FG009|NOT COMPLETED|Phase I: Dose-Finding||0||
60003784|NCT02055820|76119731|FG000|STARTED|Phase II: Expansion||0||
60003785|NCT02055820|76119732|FG001|STARTED|Phase II: Expansion||0||
60003786|NCT02055820|76119733|FG002|STARTED|Phase II: Expansion||0||
60003787|NCT02055820|76119734|FG003|STARTED|Phase II: Expansion||0||
60135924|NCT00721617|76258592|FG000|STARTED|0 Hour (Baseline) of Dextrose Infusion||12||
60003788|NCT02055820|76119735|FG004|STARTED|Phase II: Expansion||208||
60003789|NCT02055820|76119736|FG005|STARTED|Phase II: Expansion||0||
60003790|NCT02055820|76119737|FG006|STARTED|Phase II: Expansion||0||
60135925|NCT00721617|76258592|FG000|COMPLETED|0 Hour (Baseline) of Dextrose Infusion||12||
60135926|NCT00721617|76258592|FG000|NOT COMPLETED|0 Hour (Baseline) of Dextrose Infusion||0||
60135927|NCT00721617|76258592|FG000|STARTED|4 Hours Into Dextrose Infusion||12||
60135928|NCT00721617|76258592|FG000|COMPLETED|4 Hours Into Dextrose Infusion||12||
60135929|NCT00721617|76258592|FG000|NOT COMPLETED|4 Hours Into Dextrose Infusion||0||
60135930|NCT00721617|76258592|FG000|STARTED|8 Hours Into Dextrose Infusion||12||
60135931|NCT00721617|76258592|FG000|COMPLETED|8 Hours Into Dextrose Infusion||12||
60135932|NCT00721617|76258592|FG000|NOT COMPLETED|8 Hours Into Dextrose Infusion||0||
60135933|NCT00721617|76258592|FG000|STARTED|0 Hour (Baseline) of Intralipid/Dextrose||12||
60003791|NCT02055820|76119738|FG007|STARTED|Phase II: Expansion||0||
60003792|NCT02055820|76119739|FG008|STARTED|Phase II: Expansion||0||
60003793|NCT02055820|76119740|FG009|STARTED|Phase II: Expansion||0||
60135934|NCT00721617|76258592|FG000|COMPLETED|0 Hour (Baseline) of Intralipid/Dextrose||12||
60135935|NCT00721617|76258592|FG000|NOT COMPLETED|0 Hour (Baseline) of Intralipid/Dextrose||0||
60003794|NCT02055820|76119731|FG000|COMPLETED|Phase II: Expansion||0||
60003795|NCT02055820|76119732|FG001|COMPLETED|Phase II: Expansion||0||
60003796|NCT02055820|76119733|FG002|COMPLETED|Phase II: Expansion||0||
59605479|NCT01990950|75715657|FG000|COMPLETED|Overall Study||10||
59605480|NCT01990950|75715657|FG000|NOT COMPLETED|Overall Study||11||
59605481|NCT02001558|75715663|FG000|STARTED|Overall Study||32||
60003797|NCT02055820|76119734|FG003|COMPLETED|Phase II: Expansion||0||
60003798|NCT02055820|76119735|FG004|COMPLETED|Phase II: Expansion||159||
60003799|NCT02055820|76119736|FG005|COMPLETED|Phase II: Expansion||0||
60003800|NCT02055820|76119737|FG006|COMPLETED|Phase II: Expansion||0||
60003801|NCT02055820|76119738|FG007|COMPLETED|Phase II: Expansion||0||
60003802|NCT02055820|76119739|FG008|COMPLETED|Phase II: Expansion||0||
60003803|NCT02055820|76119740|FG009|COMPLETED|Phase II: Expansion||0||
60003804|NCT02055820|76119731|FG000|NOT COMPLETED|Phase II: Expansion||0||
60003805|NCT02055820|76119732|FG001|NOT COMPLETED|Phase II: Expansion||0||
60003806|NCT02055820|76119733|FG002|NOT COMPLETED|Phase II: Expansion||0||
60003807|NCT02055820|76119734|FG003|NOT COMPLETED|Phase II: Expansion||0||
60003808|NCT02055820|76119735|FG004|NOT COMPLETED|Phase II: Expansion||49||
60003809|NCT02055820|76119736|FG005|NOT COMPLETED|Phase II: Expansion||0||
60003810|NCT02055820|76119737|FG006|NOT COMPLETED|Phase II: Expansion||0||
60003811|NCT02055820|76119738|FG007|NOT COMPLETED|Phase II: Expansion||0||
60003812|NCT02055820|76119739|FG008|NOT COMPLETED|Phase II: Expansion||0||
60003813|NCT02055820|76119740|FG009|NOT COMPLETED|Phase II: Expansion||0||
60003814|NCT02055352|76119784|FG000|STARTED|Overall Study||109||
60003815|NCT02055352|76119785|FG001|STARTED|Overall Study||113||
60003816|NCT02055352|76119784|FG000|Per-Protocol Set (PPS)|Overall Study||108||
60003817|NCT02055352|76119785|FG001|Per-Protocol Set (PPS)|Overall Study||111||
60003818|NCT02055352|76119784|FG000|COMPLETED|Overall Study||103||
60003819|NCT02055352|76119785|FG001|COMPLETED|Overall Study||96||
60003820|NCT02055352|76119784|FG000|NOT COMPLETED|Overall Study||6||
60003821|NCT02055352|76119785|FG001|NOT COMPLETED|Overall Study||17||
60003822|NCT02034916|76119793|FG000|STARTED|Overall Study||49||
60003823|NCT02034916|76119794|FG001|STARTED|Overall Study||35||
60003824|NCT02034916|76119793|FG000|Treated|Overall Study||48||
60003825|NCT02034916|76119794|FG001|Treated|Overall Study||35||
60003826|NCT02034916|76119793|FG000|COMPLETED|Overall Study||0||
60003827|NCT02034916|76119794|FG001|COMPLETED|Overall Study||0||
60003828|NCT02034916|76119793|FG000|NOT COMPLETED|Overall Study||49||
60003829|NCT02034916|76119794|FG001|NOT COMPLETED|Overall Study||35||
60003830|NCT01374425|76119803|FG000|STARTED|Overall Study||188||
60003831|NCT01374425|76119804|FG001|STARTED|Overall Study||188||
60003832|NCT01374425|76119803|FG000|COMPLETED|Overall Study||0||
60003833|NCT01374425|76119804|FG001|COMPLETED|Overall Study||0||
59605482|NCT02001558|75715664|FG001|STARTED|Overall Study||33||
59605483|NCT02001558|75715663|FG000|COMPLETED|Overall Study||24||
59605484|NCT02001558|75715664|FG001|COMPLETED|Overall Study||19||
59605485|NCT02001558|75715663|FG000|NOT COMPLETED|Overall Study||8||
59605486|NCT02001558|75715664|FG001|NOT COMPLETED|Overall Study||14||
59605487|NCT02023866|75715670|FG000|STARTED|Overall Study||36||
60003834|NCT01374425|76119803|FG000|NOT COMPLETED|Overall Study||188||
60003835|NCT01374425|76119804|FG001|NOT COMPLETED|Overall Study||188||
60003836|NCT02085460|76119834|FG000|STARTED|Overall Study||31||
60003837|NCT02085460|76119835|FG001|STARTED|Overall Study||32||
60003838|NCT02085460|76119836|FG002|STARTED|Overall Study||31||
60003839|NCT02085460|76119834|FG000|COMPLETED|Overall Study||17||
60003840|NCT02085460|76119835|FG001|COMPLETED|Overall Study||24||
60003841|NCT02085460|76119836|FG002|COMPLETED|Overall Study||21||
60003842|NCT02085460|76119834|FG000|NOT COMPLETED|Overall Study||14||
60003843|NCT02085460|76119835|FG001|NOT COMPLETED|Overall Study||8||
60003844|NCT02085460|76119836|FG002|NOT COMPLETED|Overall Study||10||
60003845|NCT02084134|76119846|FG000|STARTED|Overall Study||23||
60003846|NCT02084134|76119847|FG001|STARTED|Overall Study||20||
60003847|NCT02084134|76119846|FG000|COMPLETED|Overall Study||19||
60003848|NCT02084134|76119847|FG001|COMPLETED|Overall Study||17||
60003849|NCT02084134|76119846|FG000|NOT COMPLETED|Overall Study||4||
60003850|NCT02084134|76119847|FG001|NOT COMPLETED|Overall Study||3||
60003851|NCT02034058|76119853|FG000|STARTED|Overall Study|Study stopped early per pre-defined criteria for interim analysis.|152||
60003852|NCT02034058|76119853|FG000|COMPLETED|Overall Study||149||
60003853|NCT02034058|76119853|FG000|NOT COMPLETED|Overall Study||3||
60003854|NCT01374269|76119859|FG000|STARTED|Overall Study||46||
60003855|NCT01374269|76119860|FG001|STARTED|Overall Study||44||
60003856|NCT01374269|76119859|FG000|COMPLETED|Overall Study||40||
60003857|NCT01374269|76119860|FG001|COMPLETED|Overall Study||39||
60003858|NCT01374269|76119859|FG000|NOT COMPLETED|Overall Study||6||
60003859|NCT01374269|76119860|FG001|NOT COMPLETED|Overall Study||5||
60003860|NCT02679755|76119868|FG000|STARTED|Overall Study||100||
60003861|NCT02679755|76119869|FG001|STARTED|Overall Study||152||
60003862|NCT02679755|76119868|FG000|COMPLETED|Overall Study||66||
60003863|NCT02679755|76119869|FG001|COMPLETED|Overall Study||47||
60003864|NCT02679755|76119868|FG000|NOT COMPLETED|Overall Study||34||
60003865|NCT02679755|76119869|FG001|NOT COMPLETED|Overall Study||105||
60003866|NCT02675075|76119880|FG000|STARTED|Overall Study||15||
60003867|NCT02675075|76119881|FG001|STARTED|Overall Study||19||
60003868|NCT02675075|76119880|FG000|COMPLETED|Overall Study||12||
60003869|NCT02675075|76119881|FG001|COMPLETED|Overall Study||19||
60003870|NCT02675075|76119880|FG000|NOT COMPLETED|Overall Study||3||
60003871|NCT02675075|76119881|FG001|NOT COMPLETED|Overall Study||0||
60003872|NCT02673515|76119891|FG000|STARTED|Overall Study||30||
60003873|NCT02673515|76119892|FG001|STARTED|Overall Study||30||
60003874|NCT02673515|76119891|FG000|COMPLETED|Overall Study||28||
60003875|NCT02673515|76119892|FG001|COMPLETED|Overall Study||29||
60003876|NCT02673515|76119891|FG000|NOT COMPLETED|Overall Study||2||
60003877|NCT02673515|76119892|FG001|NOT COMPLETED|Overall Study||1||
60003878|NCT02667275|76119900|FG000|STARTED|Overall Study||244||
60003879|NCT02667275|76119901|FG001|STARTED|Overall Study||243||
60003880|NCT02667275|76119900|FG000|COMPLETED|Overall Study||233||
60003881|NCT02667275|76119901|FG001|COMPLETED|Overall Study||228||
60003882|NCT02667275|76119900|FG000|NOT COMPLETED|Overall Study||11||
60003883|NCT02667275|76119901|FG001|NOT COMPLETED|Overall Study||15||
60003884|NCT02672423|76119910|FG000|STARTED|Period 1||7||
60003885|NCT02672423|76119911|FG001|STARTED|Period 1||7||
60003886|NCT02672423|76119912|FG002|STARTED|Period 1||14||
60003887|NCT02672423|76119913|FG003|STARTED|Period 1||15||
60003888|NCT02672423|76119914|FG004|STARTED|Period 1||15||
60003889|NCT02672423|76119915|FG005|STARTED|Period 1||15||
60003890|NCT02672423|76119916|FG006|STARTED|Period 1||15||
60003891|NCT02672423|76119917|FG007|STARTED|Period 1||15||
60003892|NCT02672423|76119918|FG008|STARTED|Period 1||12||
60003893|NCT02672423|76119919|FG009|STARTED|Period 1||12||
60003894|NCT02672423|76119910|FG000|Received at Least One Dose of Study Drug|Period 1||7||
60003895|NCT02672423|76119911|FG001|Received at Least One Dose of Study Drug|Period 1||7||
59605488|NCT02023866|75715670|FG000|COMPLETED|Overall Study||30||
60003896|NCT02672423|76119912|FG002|Received at Least One Dose of Study Drug|Period 1||14||
60003897|NCT02672423|76119913|FG003|Received at Least One Dose of Study Drug|Period 1||15||
60003898|NCT02672423|76119914|FG004|Received at Least One Dose of Study Drug|Period 1||15||
60003899|NCT02672423|76119915|FG005|Received at Least One Dose of Study Drug|Period 1||15||
60003900|NCT02672423|76119916|FG006|Received at Least One Dose of Study Drug|Period 1||15||
60003901|NCT02672423|76119917|FG007|Received at Least One Dose of Study Drug|Period 1||15||
60003902|NCT02672423|76119918|FG008|Received at Least One Dose of Study Drug|Period 1||12||
60003903|NCT02672423|76119919|FG009|Received at Least One Dose of Study Drug|Period 1||12||
60003904|NCT02672423|76119910|FG000|COMPLETED|Period 1||7||
60003905|NCT02672423|76119911|FG001|COMPLETED|Period 1||7||
60003906|NCT02672423|76119912|FG002|COMPLETED|Period 1||14||
60003907|NCT02672423|76119913|FG003|COMPLETED|Period 1||15||
60003908|NCT02672423|76119914|FG004|COMPLETED|Period 1||14||
60003909|NCT02672423|76119915|FG005|COMPLETED|Period 1||15||
60003910|NCT02672423|76119916|FG006|COMPLETED|Period 1||15||
60003911|NCT02672423|76119917|FG007|COMPLETED|Period 1||15||
60003912|NCT02672423|76119918|FG008|COMPLETED|Period 1||12||
60003913|NCT02672423|76119919|FG009|COMPLETED|Period 1||12||
60003914|NCT02672423|76119910|FG000|NOT COMPLETED|Period 1||0||
60003915|NCT02672423|76119911|FG001|NOT COMPLETED|Period 1||0||
60003916|NCT02672423|76119912|FG002|NOT COMPLETED|Period 1||0||
60003917|NCT02672423|76119913|FG003|NOT COMPLETED|Period 1||0||
60003918|NCT02672423|76119914|FG004|NOT COMPLETED|Period 1||1||
60003919|NCT02672423|76119915|FG005|NOT COMPLETED|Period 1||0||
60003920|NCT02672423|76119916|FG006|NOT COMPLETED|Period 1||0||
60003921|NCT02672423|76119917|FG007|NOT COMPLETED|Period 1||0||
60003922|NCT02672423|76119918|FG008|NOT COMPLETED|Period 1||0||
60003923|NCT02672423|76119919|FG009|NOT COMPLETED|Period 1||0||
60003924|NCT02672423|76119910|FG000|STARTED|Washout 1||7||
60003925|NCT02672423|76119911|FG001|STARTED|Washout 1||7||
60003926|NCT02672423|76119912|FG002|STARTED|Washout 1||14||
60003927|NCT02672423|76119913|FG003|STARTED|Washout 1||15||
60003928|NCT02672423|76119914|FG004|STARTED|Washout 1||14||
60003929|NCT02672423|76119915|FG005|STARTED|Washout 1||15||
60003930|NCT02672423|76119916|FG006|STARTED|Washout 1||15||
60003931|NCT02672423|76119917|FG007|STARTED|Washout 1||15||
60003932|NCT02672423|76119918|FG008|STARTED|Washout 1||12||
60003933|NCT02672423|76119919|FG009|STARTED|Washout 1||12||
60003934|NCT02672423|76119910|FG000|COMPLETED|Washout 1||7||
60003935|NCT02672423|76119911|FG001|COMPLETED|Washout 1||7||
60003936|NCT02672423|76119912|FG002|COMPLETED|Washout 1||14||
60003937|NCT02672423|76119913|FG003|COMPLETED|Washout 1||15||
60003938|NCT02672423|76119914|FG004|COMPLETED|Washout 1||14||
60003939|NCT02672423|76119915|FG005|COMPLETED|Washout 1||15||
60003940|NCT02672423|76119916|FG006|COMPLETED|Washout 1||15||
60003941|NCT02672423|76119917|FG007|COMPLETED|Washout 1||15||
60003942|NCT02672423|76119918|FG008|COMPLETED|Washout 1||12||
60003943|NCT02672423|76119919|FG009|COMPLETED|Washout 1||12||
60003944|NCT02672423|76119910|FG000|NOT COMPLETED|Washout 1||0||
60003945|NCT02672423|76119911|FG001|NOT COMPLETED|Washout 1||0||
60003946|NCT02672423|76119912|FG002|NOT COMPLETED|Washout 1||0||
60003947|NCT02672423|76119913|FG003|NOT COMPLETED|Washout 1||0||
60003948|NCT02672423|76119914|FG004|NOT COMPLETED|Washout 1||0||
60003949|NCT02672423|76119915|FG005|NOT COMPLETED|Washout 1||0||
60003950|NCT02672423|76119916|FG006|NOT COMPLETED|Washout 1||0||
60003951|NCT02672423|76119917|FG007|NOT COMPLETED|Washout 1||0||
60003952|NCT02672423|76119918|FG008|NOT COMPLETED|Washout 1||0||
60003953|NCT02672423|76119919|FG009|NOT COMPLETED|Washout 1||0||
60003954|NCT02672423|76119910|FG000|STARTED|Period 2||7||
60003955|NCT02672423|76119911|FG001|STARTED|Period 2||7||
60003956|NCT02672423|76119912|FG002|STARTED|Period 2||14||
60003957|NCT02672423|76119913|FG003|STARTED|Period 2||15||
60003958|NCT02672423|76119914|FG004|STARTED|Period 2||14||
60003959|NCT02672423|76119915|FG005|STARTED|Period 2||15||
60003960|NCT02672423|76119916|FG006|STARTED|Period 2||15||
60003961|NCT02672423|76119917|FG007|STARTED|Period 2||15||
60003962|NCT02672423|76119918|FG008|STARTED|Period 2||12||
60003963|NCT02672423|76119919|FG009|STARTED|Period 2||12||
60003964|NCT02672423|76119910|FG000|COMPLETED|Period 2||7||
60003965|NCT02672423|76119911|FG001|COMPLETED|Period 2||7||
60003966|NCT02672423|76119912|FG002|COMPLETED|Period 2||13||
60003967|NCT02672423|76119913|FG003|COMPLETED|Period 2||15||
60003968|NCT02672423|76119914|FG004|COMPLETED|Period 2||14||
60003969|NCT02672423|76119915|FG005|COMPLETED|Period 2||15||
60003970|NCT02672423|76119916|FG006|COMPLETED|Period 2||15||
60003971|NCT02672423|76119917|FG007|COMPLETED|Period 2||15||
60003972|NCT02672423|76119918|FG008|COMPLETED|Period 2||12||
60003973|NCT02672423|76119919|FG009|COMPLETED|Period 2||12||
60003974|NCT02672423|76119910|FG000|NOT COMPLETED|Period 2||0||
60003975|NCT02672423|76119911|FG001|NOT COMPLETED|Period 2||0||
60003976|NCT02672423|76119912|FG002|NOT COMPLETED|Period 2||1||
60003977|NCT02672423|76119913|FG003|NOT COMPLETED|Period 2||0||
60003978|NCT02672423|76119914|FG004|NOT COMPLETED|Period 2||0||
60003979|NCT02672423|76119915|FG005|NOT COMPLETED|Period 2||0||
60003980|NCT02672423|76119916|FG006|NOT COMPLETED|Period 2||0||
60003981|NCT02672423|76119917|FG007|NOT COMPLETED|Period 2||0||
60003982|NCT02672423|76119918|FG008|NOT COMPLETED|Period 2||0||
60003983|NCT02672423|76119919|FG009|NOT COMPLETED|Period 2||0||
60003984|NCT02672423|76119910|FG000|STARTED|Washout 2||7||
60003985|NCT02672423|76119911|FG001|STARTED|Washout 2||7||
60003986|NCT02672423|76119912|FG002|STARTED|Washout 2||13||
60003987|NCT02672423|76119913|FG003|STARTED|Washout 2||15||
60003988|NCT02672423|76119914|FG004|STARTED|Washout 2||14||
60003989|NCT02672423|76119915|FG005|STARTED|Washout 2||15||
60003990|NCT02672423|76119916|FG006|STARTED|Washout 2||15||
60003991|NCT02672423|76119917|FG007|STARTED|Washout 2||15||
60003992|NCT02672423|76119918|FG008|STARTED|Washout 2||12||
60003993|NCT02672423|76119919|FG009|STARTED|Washout 2||12||
60003994|NCT02672423|76119910|FG000|COMPLETED|Washout 2||7||
60003995|NCT02672423|76119911|FG001|COMPLETED|Washout 2||7||
60003996|NCT02672423|76119912|FG002|COMPLETED|Washout 2||13||
60003997|NCT02672423|76119913|FG003|COMPLETED|Washout 2||15||
60003998|NCT02672423|76119914|FG004|COMPLETED|Washout 2||14||
60003999|NCT02672423|76119915|FG005|COMPLETED|Washout 2||15||
60004000|NCT02672423|76119916|FG006|COMPLETED|Washout 2||15||
60004001|NCT02672423|76119917|FG007|COMPLETED|Washout 2||15||
60004002|NCT02672423|76119918|FG008|COMPLETED|Washout 2||12||
60004003|NCT02672423|76119919|FG009|COMPLETED|Washout 2||12||
60004004|NCT02672423|76119910|FG000|NOT COMPLETED|Washout 2||0||
60004005|NCT02672423|76119911|FG001|NOT COMPLETED|Washout 2||0||
60004006|NCT02672423|76119912|FG002|NOT COMPLETED|Washout 2||0||
60004007|NCT02672423|76119913|FG003|NOT COMPLETED|Washout 2||0||
60004008|NCT02672423|76119914|FG004|NOT COMPLETED|Washout 2||0||
60004009|NCT02672423|76119915|FG005|NOT COMPLETED|Washout 2||0||
60004010|NCT02672423|76119916|FG006|NOT COMPLETED|Washout 2||0||
60004011|NCT02672423|76119917|FG007|NOT COMPLETED|Washout 2||0||
60004012|NCT02672423|76119918|FG008|NOT COMPLETED|Washout 2||0||
60004013|NCT02672423|76119919|FG009|NOT COMPLETED|Washout 2||0||
60004014|NCT02672423|76119910|FG000|STARTED|Period 3|Part A was a 2-period study design.|0||
60004015|NCT02672423|76119911|FG001|STARTED|Period 3|Part A was a 2-period study design.|0||
60004016|NCT02672423|76119912|FG002|STARTED|Period 3||13||
60004017|NCT02672423|76119913|FG003|STARTED|Period 3||15||
60004018|NCT02672423|76119914|FG004|STARTED|Period 3||14||
60004019|NCT02672423|76119915|FG005|STARTED|Period 3||15||
60004020|NCT02672423|76119916|FG006|STARTED|Period 3||15||
60004021|NCT02672423|76119917|FG007|STARTED|Period 3||15||
60004022|NCT02672423|76119918|FG008|STARTED|Period 3|Part C was a 2-period study design.|0||
60004023|NCT02672423|76119919|FG009|STARTED|Period 3|Part C was a 2-period study design.|0||
60004024|NCT02672423|76119910|FG000|COMPLETED|Period 3||0||
60004025|NCT02672423|76119911|FG001|COMPLETED|Period 3||0||
60004026|NCT02672423|76119912|FG002|COMPLETED|Period 3||13||
60004027|NCT02672423|76119913|FG003|COMPLETED|Period 3||15||
60004028|NCT02672423|76119914|FG004|COMPLETED|Period 3||14||
60004029|NCT02672423|76119915|FG005|COMPLETED|Period 3||14||
60004030|NCT02672423|76119916|FG006|COMPLETED|Period 3||15||
60004031|NCT02672423|76119917|FG007|COMPLETED|Period 3||14||
60004032|NCT02672423|76119918|FG008|COMPLETED|Period 3||0||
60004033|NCT02672423|76119919|FG009|COMPLETED|Period 3||0||
60004034|NCT02672423|76119910|FG000|NOT COMPLETED|Period 3||0||
60004035|NCT02672423|76119911|FG001|NOT COMPLETED|Period 3||0||
60004036|NCT02672423|76119912|FG002|NOT COMPLETED|Period 3||0||
60004037|NCT02672423|76119913|FG003|NOT COMPLETED|Period 3||0||
60004038|NCT02672423|76119914|FG004|NOT COMPLETED|Period 3||0||
60004039|NCT02672423|76119915|FG005|NOT COMPLETED|Period 3||1||
60004040|NCT02672423|76119916|FG006|NOT COMPLETED|Period 3||0||
60004041|NCT02672423|76119917|FG007|NOT COMPLETED|Period 3||1||
60004042|NCT02672423|76119918|FG008|NOT COMPLETED|Period 3||0||
60004043|NCT02672423|76119919|FG009|NOT COMPLETED|Period 3||0||
60004044|NCT02670551|76119943|FG000|STARTED|Overall Study||163||
60004045|NCT02670551|76119944|FG001|STARTED|Overall Study||160||
60004046|NCT02670551|76119945|FG002|STARTED|Overall Study||165||
60004047|NCT02670551|76119943|FG000|Received Treatment (Safety Population)|Overall Study||158||
60004048|NCT02670551|76119944|FG001|Received Treatment (Safety Population)|Overall Study||157||
60004049|NCT02670551|76119945|FG002|Received Treatment (Safety Population)|Overall Study||165||
60004050|NCT02670551|76119943|FG000|COMPLETED|Overall Study||135||
60004051|NCT02670551|76119944|FG001|COMPLETED|Overall Study||134||
60004052|NCT02670551|76119945|FG002|COMPLETED|Overall Study||134||
60004053|NCT02670551|76119943|FG000|NOT COMPLETED|Overall Study||28||
60004054|NCT02670551|76119944|FG001|NOT COMPLETED|Overall Study||26||
60004055|NCT02670551|76119945|FG002|NOT COMPLETED|Overall Study||31||
60004056|NCT02670473|76119953|FG000|STARTED|Overall Study||35||
60004057|NCT02670473|76119953|FG000|COMPLETED|Overall Study||34||
60004058|NCT02670473|76119953|FG000|NOT COMPLETED|Overall Study||1||
60004059|NCT02667119|76119968|FG000|STARTED|Overall Study||14||
60004060|NCT02667119|76119969|FG001|STARTED|Overall Study||13||
60004061|NCT02667119|76119968|FG000|COMPLETED|Overall Study||11||
60004062|NCT02667119|76119969|FG001|COMPLETED|Overall Study||13||
60004063|NCT02667119|76119968|FG000|NOT COMPLETED|Overall Study||3||
60004064|NCT02667119|76119969|FG001|NOT COMPLETED|Overall Study||0||
60004065|NCT02670083|76119977|FG000|STARTED|Overall Study||409||
60004066|NCT02670083|76119978|FG001|STARTED|Overall Study||404||
60004067|NCT02670083|76119977|FG000|COMPLETED|Overall Study||88||
60004068|NCT02670083|76119978|FG001|COMPLETED|Overall Study||85||
60004069|NCT02670083|76119977|FG000|NOT COMPLETED|Overall Study||321||
60004070|NCT02670083|76119978|FG001|NOT COMPLETED|Overall Study||319||
60004071|NCT02669849|76119988|FG000|STARTED|Overall Study||29||
60004072|NCT02669849|76119989|FG001|STARTED|Overall Study||6||
60004073|NCT02669849|76119990|FG002|STARTED|Overall Study||32||
60004074|NCT02669849|76119988|FG000|COMPLETED|Overall Study||11||
60004075|NCT02669849|76119989|FG001|COMPLETED|Overall Study||4||
60004076|NCT02669849|76119990|FG002|COMPLETED|Overall Study||8||
60004077|NCT02669849|76119988|FG000|NOT COMPLETED|Overall Study||18||
60004078|NCT02669849|76119989|FG001|NOT COMPLETED|Overall Study||2||
60004079|NCT02669849|76119990|FG002|NOT COMPLETED|Overall Study||24||
60004080|NCT03625895|76119998|FG000|STARTED|Overall Study||1826||
60004081|NCT03625895|76119998|FG000|COMPLETED|Overall Study||1241||
60004082|NCT03625895|76119998|FG000|NOT COMPLETED|Overall Study||585||
60004083|NCT02663687|76120007|FG000|STARTED|Overall Study||12||
60004084|NCT02663687|76120008|FG001|STARTED|Overall Study||9||
60004085|NCT02663687|76120009|FG002|STARTED|Overall Study||9||
60004086|NCT02663687|76120010|FG003|STARTED|Overall Study||9||
60004087|NCT02663687|76120011|FG004|STARTED|Overall Study||9||
60004088|NCT02663687|76120007|FG000|Treatment Period 1 (IV)|Overall Study||12||
60004089|NCT02663687|76120008|FG001|Treatment Period 1 (IV)|Overall Study||9||
60004090|NCT02663687|76120009|FG002|Treatment Period 1 (IV)|Overall Study||9||
60004091|NCT02663687|76120010|FG003|Treatment Period 1 (IV)|Overall Study||9||
60004092|NCT02663687|76120011|FG004|Treatment Period 1 (IV)|Overall Study||9||
60004093|NCT02663687|76120007|FG000|Treatment Period 2 (SC)|Overall Study||10||
60004094|NCT02663687|76120008|FG001|Treatment Period 2 (SC)|Overall Study||9||
60004095|NCT02663687|76120009|FG002|Treatment Period 2 (SC)|Overall Study||8||
60004096|NCT02663687|76120010|FG003|Treatment Period 2 (SC)|Overall Study||9||
60004097|NCT02663687|76120011|FG004|Treatment Period 2 (SC)|Overall Study||9||
60004098|NCT02663687|76120007|FG000|COMPLETED|Overall Study||10||
60004099|NCT02663687|76120008|FG001|COMPLETED|Overall Study||9||
60004100|NCT02663687|76120009|FG002|COMPLETED|Overall Study||8||
60004101|NCT02663687|76120010|FG003|COMPLETED|Overall Study||9||
60004102|NCT02663687|76120011|FG004|COMPLETED|Overall Study||9||
60004103|NCT02663687|76120007|FG000|NOT COMPLETED|Overall Study||2||
60004104|NCT02663687|76120008|FG001|NOT COMPLETED|Overall Study||0||
60004105|NCT02663687|76120009|FG002|NOT COMPLETED|Overall Study||1||
60004106|NCT02663687|76120010|FG003|NOT COMPLETED|Overall Study||0||
60004107|NCT02663687|76120011|FG004|NOT COMPLETED|Overall Study||0||
60004108|NCT03106025|76120036|FG000|STARTED|Overall Study||5||
60004109|NCT03106025|76120036|FG000|COMPLETED|Overall Study||5||
60004110|NCT03106025|76120036|FG000|NOT COMPLETED|Overall Study||0||
60004111|NCT02663453|76120042|FG000|STARTED|Overall Study||22||
60004112|NCT02663453|76120043|FG001|STARTED|Overall Study||22||
60004113|NCT02663453|76120042|FG000|COMPLETED|Overall Study||17||
60004114|NCT02663453|76120043|FG001|COMPLETED|Overall Study||18||
60004115|NCT02663453|76120042|FG000|NOT COMPLETED|Overall Study||5||
60004116|NCT02663453|76120043|FG001|NOT COMPLETED|Overall Study||4||
60004117|NCT02055118|76120052|FG000|STARTED|Overall Study||15||
60004118|NCT02055118|76120053|FG001|STARTED|Overall Study||34||
60004119|NCT02055118|76120054|FG002|STARTED|Overall Study||9||
60004120|NCT02055118|76120052|FG000|COMPLETED|Overall Study||15||
60004121|NCT02055118|76120053|FG001|COMPLETED|Overall Study||32||
60004122|NCT02055118|76120054|FG002|COMPLETED|Overall Study||9||
60004123|NCT02055118|76120052|FG000|NOT COMPLETED|Overall Study||0||
60004124|NCT02055118|76120053|FG001|NOT COMPLETED|Overall Study||2||
60004125|NCT02055118|76120054|FG002|NOT COMPLETED|Overall Study||0||
60004126|NCT02084056|76120065|FG000|STARTED|Treatment Period 1 (4 Days)||28||
60004127|NCT02084056|76120066|FG001|STARTED|Treatment Period 1 (4 Days)||30||
60004128|NCT02084056|76120067|FG002|STARTED|Treatment Period 1 (4 Days)||8||
60004129|NCT02084056|76120068|FG003|STARTED|Treatment Period 1 (4 Days)||8||
60004130|NCT02084056|76120065|FG000|COMPLETED|Treatment Period 1 (4 Days)||27||
60004131|NCT02084056|76120066|FG001|COMPLETED|Treatment Period 1 (4 Days)||30||
60004132|NCT02084056|76120067|FG002|COMPLETED|Treatment Period 1 (4 Days)||8||
60004133|NCT02084056|76120068|FG003|COMPLETED|Treatment Period 1 (4 Days)||8||
60004134|NCT02084056|76120065|FG000|NOT COMPLETED|Treatment Period 1 (4 Days)||1||
60004135|NCT02084056|76120066|FG001|NOT COMPLETED|Treatment Period 1 (4 Days)||0||
60004136|NCT02084056|76120067|FG002|NOT COMPLETED|Treatment Period 1 (4 Days)||0||
60004137|NCT02084056|76120068|FG003|NOT COMPLETED|Treatment Period 1 (4 Days)||0||
60004138|NCT02084056|76120065|FG000|STARTED|Washout Period 1 (35 Days)||27||
60004139|NCT02084056|76120066|FG001|STARTED|Washout Period 1 (35 Days)||30||
60004140|NCT02084056|76120067|FG002|STARTED|Washout Period 1 (35 Days)||8||
60004141|NCT02084056|76120068|FG003|STARTED|Washout Period 1 (35 Days)||8||
60004142|NCT02084056|76120065|FG000|COMPLETED|Washout Period 1 (35 Days)||26||
60004143|NCT02084056|76120066|FG001|COMPLETED|Washout Period 1 (35 Days)||30||
60004144|NCT02084056|76120067|FG002|COMPLETED|Washout Period 1 (35 Days)||8||
60004145|NCT02084056|76120068|FG003|COMPLETED|Washout Period 1 (35 Days)||8||
60004146|NCT02084056|76120065|FG000|NOT COMPLETED|Washout Period 1 (35 Days)||1||
60004147|NCT02084056|76120066|FG001|NOT COMPLETED|Washout Period 1 (35 Days)||0||
60004148|NCT02084056|76120067|FG002|NOT COMPLETED|Washout Period 1 (35 Days)||0||
60004149|NCT02084056|76120068|FG003|NOT COMPLETED|Washout Period 1 (35 Days)||0||
60004150|NCT02084056|76120065|FG000|STARTED|Treatment Period 2 (4 Days)||26||
60004151|NCT02084056|76120066|FG001|STARTED|Treatment Period 2 (4 Days)||30||
60004152|NCT02084056|76120067|FG002|STARTED|Treatment Period 2 (4 Days)||8||
60004153|NCT02084056|76120068|FG003|STARTED|Treatment Period 2 (4 Days)||8||
60004154|NCT02084056|76120065|FG000|COMPLETED|Treatment Period 2 (4 Days)||26||
60004155|NCT02084056|76120066|FG001|COMPLETED|Treatment Period 2 (4 Days)||30||
60004156|NCT02084056|76120067|FG002|COMPLETED|Treatment Period 2 (4 Days)||8||
60004157|NCT02084056|76120068|FG003|COMPLETED|Treatment Period 2 (4 Days)||8||
60004158|NCT02084056|76120065|FG000|NOT COMPLETED|Treatment Period 2 (4 Days)||0||
60004159|NCT02084056|76120066|FG001|NOT COMPLETED|Treatment Period 2 (4 Days)||0||
60004160|NCT02084056|76120067|FG002|NOT COMPLETED|Treatment Period 2 (4 Days)||0||
60004161|NCT02084056|76120068|FG003|NOT COMPLETED|Treatment Period 2 (4 Days)||0||
60004162|NCT01625182|76120080|FG000|STARTED|Overall Study||54||
60004163|NCT01625182|76120081|FG001|STARTED|Overall Study||52||
60004164|NCT01625182|76120080|FG000|COMPLETED|Overall Study||34||
60004165|NCT01625182|76120081|FG001|COMPLETED|Overall Study||41||
60004166|NCT01625182|76120080|FG000|NOT COMPLETED|Overall Study||20||
60004167|NCT01625182|76120081|FG001|NOT COMPLETED|Overall Study||11||
60004168|NCT02661815|76120092|FG000|STARTED|Overall Study||6||
60004169|NCT02661815|76120093|FG001|STARTED|Overall Study||0||
60004170|NCT02661815|76120094|FG002|STARTED|Overall Study||0||
60004171|NCT02661815|76120095|FG003|STARTED|Overall Study||0||
60004172|NCT02661815|76120092|FG000|COMPLETED|Overall Study||5||
60004173|NCT02661815|76120093|FG001|COMPLETED|Overall Study||0||
60004174|NCT02661815|76120094|FG002|COMPLETED|Overall Study||0||
60004175|NCT02661815|76120095|FG003|COMPLETED|Overall Study||0||
60004176|NCT02661815|76120092|FG000|NOT COMPLETED|Overall Study||1||
60004177|NCT02661815|76120093|FG001|NOT COMPLETED|Overall Study||0||
60004178|NCT02661815|76120094|FG002|NOT COMPLETED|Overall Study||0||
60004179|NCT02661815|76120095|FG003|NOT COMPLETED|Overall Study||0||
60004180|NCT02053792|76120111|FG000|STARTED|Overall Study||83||
60004181|NCT02053792|76120112|FG001|STARTED|Overall Study||14||
60004182|NCT02053792|76120111|FG000|COMPLETED|Overall Study||77||
60004183|NCT02053792|76120112|FG001|COMPLETED|Overall Study||10||
60004184|NCT02053792|76120111|FG000|NOT COMPLETED|Overall Study||6||
60004185|NCT02053792|76120112|FG001|NOT COMPLETED|Overall Study||4||
60004186|NCT02082340|76120120|FG000|STARTED|Overall Study||194||
60004187|NCT02082340|76120121|FG001|STARTED|Overall Study||198||
60004188|NCT02082340|76120120|FG000|COMPLETED|Overall Study||193||
60004189|NCT02082340|76120121|FG001|COMPLETED|Overall Study||197||
60004190|NCT02082340|76120120|FG000|NOT COMPLETED|Overall Study||1||
60004191|NCT02082340|76120121|FG001|NOT COMPLETED|Overall Study||1||
60004192|NCT02053246|76120127|FG000|STARTED|Overall Study||11||
60004193|NCT02053246|76120127|FG000|COMPLETED|Overall Study||7||
60004194|NCT02053246|76120127|FG000|NOT COMPLETED|Overall Study||4||
60004195|NCT02053168|76120131|FG000|STARTED|Overall Study||25||
60004196|NCT02053168|76120131|FG000|COMPLETED|Overall Study||22||
60004197|NCT02053168|76120131|FG000|NOT COMPLETED|Overall Study||3||
60004198|NCT02052466|76120135|FG000|STARTED|Overall Study||32||
60004199|NCT02052466|76120135|FG000|COMPLETED|Overall Study||30||
60004200|NCT02052466|76120135|FG000|NOT COMPLETED|Overall Study||2||
60004201|NCT02032888|76120142|FG000|STARTED|Treatment Period||101||
60004202|NCT02032888|76120143|FG001|STARTED|Treatment Period||50||
60004203|NCT02032888|76120144|FG002|STARTED|Treatment Period||52||
60004204|NCT02032888|76120142|FG000|COMPLETED|Treatment Period||99||
60004205|NCT02032888|76120143|FG001|COMPLETED|Treatment Period||48||
60004206|NCT02032888|76120144|FG002|COMPLETED|Treatment Period||52||
60004207|NCT02032888|76120142|FG000|NOT COMPLETED|Treatment Period||2||
60004208|NCT02032888|76120143|FG001|NOT COMPLETED|Treatment Period||2||
60004209|NCT02032888|76120144|FG002|NOT COMPLETED|Treatment Period||0||
60004210|NCT02032888|76120142|FG000|STARTED|Follow-up Period|All patients who received study drug and not a nonstudy HCV therapy before treatment Week 4|100||
60004211|NCT02032888|76120143|FG001|STARTED|Follow-up Period|All patients who received study drug and not a nonstudy HCV therapy before treatment Week 4|49||
60004212|NCT02032888|76120144|FG002|STARTED|Follow-up Period||52||
60004213|NCT02032888|76120142|FG000|COMPLETED|Follow-up Period||97||
60004214|NCT02032888|76120143|FG001|COMPLETED|Follow-up Period||47||
60004215|NCT02032888|76120144|FG002|COMPLETED|Follow-up Period||52||
60004216|NCT02032888|76120142|FG000|NOT COMPLETED|Follow-up Period||3||
60004217|NCT02032888|76120143|FG001|NOT COMPLETED|Follow-up Period||2||
60004218|NCT02032888|76120144|FG002|NOT COMPLETED|Follow-up Period||0||
60004219|NCT02082262|76120161|FG000|STARTED|Overall Study||140||
60004220|NCT02082262|76120161|FG000|COMPLETED|Overall Study||89||
60004221|NCT02082262|76120161|FG000|NOT COMPLETED|Overall Study||51||
60004222|NCT04697069|76120167|FG000|STARTED|Overall Study||2||
60004223|NCT04697069|76120168|FG001|STARTED|Overall Study||2||
60004224|NCT04697069|76120167|FG000|COMPLETED|Overall Study||0||
60004225|NCT04697069|76120168|FG001|COMPLETED|Overall Study||0||
60004226|NCT04697069|76120167|FG000|NOT COMPLETED|Overall Study||2||
60004227|NCT04697069|76120168|FG001|NOT COMPLETED|Overall Study||2||
60004228|NCT02082184|76120176|FG000|STARTED|Overall Study||149||
60004229|NCT02082184|76120177|FG001|STARTED|Overall Study||75||
60004230|NCT02082184|76120176|FG000|COMPLETED|Overall Study||139||
60004231|NCT02082184|76120177|FG001|COMPLETED|Overall Study||62||
60004232|NCT02082184|76120176|FG000|NOT COMPLETED|Overall Study||10||
60004233|NCT02082184|76120177|FG001|NOT COMPLETED|Overall Study||13||
60004234|NCT01624870|76120183|FG000|STARTED|Overall Study|provided informed consent|200||
60004235|NCT01624870|76120183|FG000|COMPLETED|Overall Study|Completed 6 month follow up|173||
60004236|NCT01624870|76120183|FG000|NOT COMPLETED|Overall Study||27||
60004237|NCT02031640|76120194|FG000|STARTED|Screening Period|Consented|1113||
60004238|NCT02031640|76120195|FG001|STARTED|Screening Period||0||
60004239|NCT02031640|76120196|FG002|STARTED|Screening Period||0||
60004240|NCT02031640|76120197|FG003|STARTED|Screening Period||0||
60004241|NCT02031640|76120198|FG004|STARTED|Screening Period||0||
60004242|NCT02031640|76120199|FG005|STARTED|Screening Period||0||
60004243|NCT02031640|76120194|FG000|COMPLETED|Screening Period||701||
60004244|NCT02031640|76120195|FG001|COMPLETED|Screening Period||0||
60004245|NCT02031640|76120196|FG002|COMPLETED|Screening Period||0||
60004246|NCT02031640|76120197|FG003|COMPLETED|Screening Period||0||
60004247|NCT02031640|76120198|FG004|COMPLETED|Screening Period||0||
60004248|NCT02031640|76120199|FG005|COMPLETED|Screening Period||0||
60004249|NCT02031640|76120194|FG000|NOT COMPLETED|Screening Period||412||
60004250|NCT02031640|76120195|FG001|NOT COMPLETED|Screening Period||0||
60004251|NCT02031640|76120196|FG002|NOT COMPLETED|Screening Period||0||
60004252|NCT02031640|76120197|FG003|NOT COMPLETED|Screening Period||0||
60004253|NCT02031640|76120198|FG004|NOT COMPLETED|Screening Period||0||
60004254|NCT02031640|76120199|FG005|NOT COMPLETED|Screening Period||0||
60004255|NCT02031640|76120194|FG000|STARTED|Run-In Period||701||
60004256|NCT02031640|76120195|FG001|STARTED|Run-In Period||0||
60004257|NCT02031640|76120196|FG002|STARTED|Run-In Period||0||
60004258|NCT02031640|76120197|FG003|STARTED|Run-In Period||0||
60004259|NCT02031640|76120198|FG004|STARTED|Run-In Period||0||
60004260|NCT02031640|76120199|FG005|STARTED|Run-In Period||0||
60004261|NCT02031640|76120194|FG000|COMPLETED|Run-In Period||532||
60004262|NCT02031640|76120195|FG001|COMPLETED|Run-In Period||0||
60004263|NCT02031640|76120196|FG002|COMPLETED|Run-In Period||0||
60004264|NCT02031640|76120197|FG003|COMPLETED|Run-In Period||0||
60004265|NCT02031640|76120198|FG004|COMPLETED|Run-In Period||0||
60004266|NCT02031640|76120199|FG005|COMPLETED|Run-In Period||0||
60004267|NCT02031640|76120194|FG000|NOT COMPLETED|Run-In Period||169||
60004268|NCT02031640|76120195|FG001|NOT COMPLETED|Run-In Period||0||
60004269|NCT02031640|76120196|FG002|NOT COMPLETED|Run-In Period||0||
60004270|NCT02031640|76120197|FG003|NOT COMPLETED|Run-In Period||0||
60004271|NCT02031640|76120198|FG004|NOT COMPLETED|Run-In Period||0||
60004272|NCT02031640|76120199|FG005|NOT COMPLETED|Run-In Period||0||
60004273|NCT02031640|76120194|FG000|STARTED|Double-blind Treatment Period||0||
60004274|NCT02031640|76120195|FG001|STARTED|Double-blind Treatment Period||106||
60004275|NCT02031640|76120196|FG002|STARTED|Double-blind Treatment Period||106||
60004276|NCT02031640|76120197|FG003|STARTED|Double-blind Treatment Period||106||
60004277|NCT02031640|76120198|FG004|STARTED|Double-blind Treatment Period||107||
60004278|NCT02031640|76120199|FG005|STARTED|Double-blind Treatment Period||107||
60004279|NCT02031640|76120194|FG000|Full Analysis Set|Double-blind Treatment Period||0|Randomized patients with at least 1 dose of drug and 1 postbaseline trough am FEV1|
60067700|NCT01788423|76182878|FG001|COMPLETED|Overall Study|Four participants were unable to self-select hearing aids.|51||
59605489|NCT02023866|75715670|FG000|NOT COMPLETED|Overall Study||6||
59605490|NCT02023242|75715676|FG000|STARTED|Overall Study||75||
59605491|NCT02023242|75715677|FG001|STARTED|Overall Study||77||
59605492|NCT02023242|75715676|FG000|COMPLETED|Overall Study||72||
59605493|NCT02023242|75715677|FG001|COMPLETED|Overall Study||75||
59605494|NCT02023242|75715676|FG000|NOT COMPLETED|Overall Study||3||
59605495|NCT02023242|75715677|FG001|NOT COMPLETED|Overall Study||2||
59605496|NCT01967940|75715686|FG000|STARTED|Part 1||12||
60004280|NCT02031640|76120195|FG001|Full Analysis Set|Double-blind Treatment Period||106|Randomized patients with at least 1 dose of drug and 1 postbaseline trough am FEV1|
60004281|NCT02031640|76120196|FG002|Full Analysis Set|Double-blind Treatment Period||104|Randomized patients with at least 1 dose of drug and 1 postbaseline trough am FEV1|
60004282|NCT02031640|76120197|FG003|Full Analysis Set|Double-blind Treatment Period||106|Randomized patients with at least 1 dose of drug and 1 postbaseline trough am FEV1|
60004283|NCT02031640|76120198|FG004|Full Analysis Set|Double-blind Treatment Period||106|Randomized patients with at least 1 dose of drug and 1 postbaseline trough am FEV1|
60004284|NCT02031640|76120199|FG005|Full Analysis Set|Double-blind Treatment Period||107|Randomized patients with at least 1 dose of drug and 1 postbaseline trough am FEV1|
60004285|NCT02031640|76120194|FG000|COMPLETED|Double-blind Treatment Period||0||
60004286|NCT02031640|76120195|FG001|COMPLETED|Double-blind Treatment Period||84||
60004287|NCT02031640|76120196|FG002|COMPLETED|Double-blind Treatment Period||100||
60004288|NCT02031640|76120197|FG003|COMPLETED|Double-blind Treatment Period||99||
60004289|NCT02031640|76120198|FG004|COMPLETED|Double-blind Treatment Period||96||
60004290|NCT02031640|76120199|FG005|COMPLETED|Double-blind Treatment Period||104||
59605497|NCT01967940|75715687|FG001|STARTED|Part 1||28||
59605498|NCT01967940|75715688|FG002|STARTED|Part 1||15||
60004291|NCT02031640|76120194|FG000|NOT COMPLETED|Double-blind Treatment Period||0||
60004292|NCT02031640|76120195|FG001|NOT COMPLETED|Double-blind Treatment Period||22||
60004293|NCT02031640|76120196|FG002|NOT COMPLETED|Double-blind Treatment Period||6||
60004294|NCT02031640|76120197|FG003|NOT COMPLETED|Double-blind Treatment Period||7||
60004295|NCT02031640|76120198|FG004|NOT COMPLETED|Double-blind Treatment Period||11||
60004296|NCT02031640|76120199|FG005|NOT COMPLETED|Double-blind Treatment Period||3||
60004297|NCT02370173|76120220|FG000|STARTED|Overall Study||43||
60004298|NCT02370173|76120221|FG001|STARTED|Overall Study||47||
60004299|NCT02370173|76120220|FG000|COMPLETED|Overall Study||40||
60004300|NCT02370173|76120221|FG001|COMPLETED|Overall Study||44||
60004301|NCT02370173|76120220|FG000|NOT COMPLETED|Overall Study||3||
60004302|NCT02370173|76120221|FG001|NOT COMPLETED|Overall Study||3||
60004303|NCT02660489|76120231|FG000|STARTED|Overall Study||22||
60004304|NCT02660489|76120232|FG001|STARTED|Overall Study||22||
60004305|NCT02660489|76120231|FG000|COMPLETED|Overall Study|Completed with confirmed rhinovirus infection|16||
60004306|NCT02660489|76120232|FG001|COMPLETED|Overall Study|Completed with confirmed rhinovirus infection|14||
60004307|NCT02660489|76120231|FG000|NOT COMPLETED|Overall Study||6||
60004308|NCT02660489|76120232|FG001|NOT COMPLETED|Overall Study||8||
60004309|NCT02052310|76120240|FG000|STARTED|Overall Study||522||
60004310|NCT02052310|76120241|FG001|STARTED|Overall Study||521||
60004311|NCT02052310|76120240|FG000|Received at Least 1 Dose of Study Drug|Overall Study||522||
60004312|NCT02052310|76120241|FG001|Received at Least 1 Dose of Study Drug|Overall Study||517||
60004313|NCT02052310|76120240|FG000|COMPLETED|Overall Study||307||
60004314|NCT02052310|76120241|FG001|COMPLETED|Overall Study||309||
59605499|NCT01967940|75715689|FG003|STARTED|Part 1||0||
59605500|NCT01967940|75715686|FG000|COMPLETED|Part 1||12||
60004315|NCT02052310|76120240|FG000|NOT COMPLETED|Overall Study||215||
60004316|NCT02052310|76120241|FG001|NOT COMPLETED|Overall Study||212||
60004317|NCT02051764|76120249|FG000|STARTED|Overall Study||16||
60004318|NCT02051764|76120250|FG001|STARTED|Overall Study||28||
60004319|NCT02051764|76120249|FG000|COMPLETED|Overall Study||16||
60004320|NCT02051764|76120250|FG001|COMPLETED|Overall Study||21||
60004321|NCT02051764|76120249|FG000|NOT COMPLETED|Overall Study||0||
60004322|NCT02051764|76120250|FG001|NOT COMPLETED|Overall Study||7||
60004323|NCT02051296|76120258|FG000|STARTED|Overall Study||66||
60004324|NCT02051296|76120259|FG001|STARTED|Overall Study||65||
60004325|NCT02051296|76120258|FG000|Received Allocated Intervention|Overall Study||59||
60004326|NCT02051296|76120259|FG001|Received Allocated Intervention|Overall Study||58||
60004327|NCT02051296|76120258|FG000|COMPLETED|Overall Study||58||
60004328|NCT02051296|76120259|FG001|COMPLETED|Overall Study||56||
60004329|NCT02051296|76120258|FG000|NOT COMPLETED|Overall Study||8||
60004330|NCT02051296|76120259|FG001|NOT COMPLETED|Overall Study||9||
60004331|NCT02050048|76120267|FG000|STARTED|Overall Study||14||
60004332|NCT02050048|76120268|FG001|STARTED|Overall Study||12||
60004333|NCT02050048|76120267|FG000|COMPLETED|Overall Study||9||
60004334|NCT02050048|76120268|FG001|COMPLETED|Overall Study||10||
60004335|NCT02050048|76120267|FG000|NOT COMPLETED|Overall Study||5||
60004336|NCT02050048|76120268|FG001|NOT COMPLETED|Overall Study||2||
60004337|NCT02049814|76120276|FG000|STARTED|Overall Study||248||
60004338|NCT02049814|76120277|FG001|STARTED|Overall Study||246||
60004339|NCT02049814|76120276|FG000|Safety Set|Overall Study||248||
60004340|NCT02049814|76120277|FG001|Safety Set|Overall Study||245||
60004341|NCT02049814|76120276|FG000|COMPLETED|Overall Study||219||
60004342|NCT02049814|76120277|FG001|COMPLETED|Overall Study||219||
60004343|NCT02049814|76120276|FG000|NOT COMPLETED|Overall Study||29||
60004344|NCT02049814|76120277|FG001|NOT COMPLETED|Overall Study||27||
60004345|NCT02363387|76120285|FG000|STARTED|Overall Study||52||
60004346|NCT02363387|76120286|FG001|STARTED|Overall Study||50||
60004347|NCT02363387|76120285|FG000|COMPLETED|Overall Study||52||
60004348|NCT02363387|76120286|FG001|COMPLETED|Overall Study||50||
60004349|NCT02363387|76120285|FG000|NOT COMPLETED|Overall Study||0||
60004350|NCT02363387|76120286|FG001|NOT COMPLETED|Overall Study||0||
60004351|NCT02079844|76120295|FG000|STARTED|Treatment Period 1||6||
60004352|NCT02079844|76120296|FG001|STARTED|Treatment Period 1||7||
60004353|NCT02079844|76120297|FG002|STARTED|Treatment Period 1||7||
60004354|NCT02079844|76120295|FG000|COMPLETED|Treatment Period 1||6||
60004355|NCT02079844|76120296|FG001|COMPLETED|Treatment Period 1||7||
60004356|NCT02079844|76120297|FG002|COMPLETED|Treatment Period 1||5||
59750785|NCT05056870|75870020|FG000|COMPLETED|Period 1||76||
60004357|NCT02079844|76120295|FG000|NOT COMPLETED|Treatment Period 1||0||
60004358|NCT02079844|76120296|FG001|NOT COMPLETED|Treatment Period 1||0||
60004359|NCT02079844|76120297|FG002|NOT COMPLETED|Treatment Period 1||2||
60004360|NCT02079844|76120295|FG000|STARTED|Treatment Period 2|1 Participant was withdrawn due to an Adverse Event after completing Period 1.|5||
60004361|NCT02079844|76120296|FG001|STARTED|Treatment Period 2||7||
60004362|NCT02079844|76120297|FG002|STARTED|Treatment Period 2||5||
60004363|NCT02079844|76120295|FG000|COMPLETED|Treatment Period 2||5||
60004364|NCT02079844|76120296|FG001|COMPLETED|Treatment Period 2||6||
60004365|NCT02079844|76120297|FG002|COMPLETED|Treatment Period 2||5||
60004366|NCT02079844|76120295|FG000|NOT COMPLETED|Treatment Period 2||0||
60004367|NCT02079844|76120296|FG001|NOT COMPLETED|Treatment Period 2||1||
60004368|NCT02079844|76120297|FG002|NOT COMPLETED|Treatment Period 2||0||
60004369|NCT02079844|76120295|FG000|STARTED|Treatment Period 3||5||
60004370|NCT02079844|76120296|FG001|STARTED|Treatment Period 3|1 Participant Voluntarily Withdrew after completing Period 2.|5||
60004371|NCT02079844|76120297|FG002|STARTED|Treatment Period 3||5||
60004372|NCT02079844|76120295|FG000|COMPLETED|Treatment Period 3||5||
60004373|NCT02079844|76120296|FG001|COMPLETED|Treatment Period 3||5||
60135936|NCT00721617|76258592|FG000|STARTED|4 Hours Into Intralipid/Dextrose||12||
60004374|NCT02079844|76120297|FG002|COMPLETED|Treatment Period 3||5||
60004375|NCT02079844|76120295|FG000|NOT COMPLETED|Treatment Period 3||0||
60135937|NCT00721617|76258592|FG000|COMPLETED|4 Hours Into Intralipid/Dextrose||12||
60135938|NCT00721617|76258592|FG000|NOT COMPLETED|4 Hours Into Intralipid/Dextrose||0||
60004376|NCT02079844|76120296|FG001|NOT COMPLETED|Treatment Period 3||0||
60004377|NCT02079844|76120297|FG002|NOT COMPLETED|Treatment Period 3||0||
60004378|NCT03097757|76120310|FG000|STARTED|Overall Study||2||
60004379|NCT03097757|76120311|FG001|STARTED|Overall Study||2||
60004380|NCT03097757|76120310|FG000|COMPLETED|Overall Study||2||
59605501|NCT01967940|75715687|FG001|COMPLETED|Part 1||28||
59605502|NCT01967940|75715688|FG002|COMPLETED|Part 1||15||
59605503|NCT01967940|75715689|FG003|COMPLETED|Part 1||0||
59605504|NCT01967940|75715686|FG000|NOT COMPLETED|Part 1||0||
59605505|NCT01967940|75715687|FG001|NOT COMPLETED|Part 1||0||
59605506|NCT01967940|75715688|FG002|NOT COMPLETED|Part 1||0||
59880303|NCT03695367|76003497|FG000|STARTED|Overall Study||33||
59880304|NCT03695367|76003498|FG001|STARTED|Overall Study||30||
59880305|NCT03695367|76003497|FG000|COMPLETED|Overall Study||32||
59880306|NCT03695367|76003498|FG001|COMPLETED|Overall Study||26||
59880307|NCT03695367|76003497|FG000|NOT COMPLETED|Overall Study||1||
59880308|NCT03695367|76003498|FG001|NOT COMPLETED|Overall Study||4||
59880309|NCT02794480|76003506|FG000|STARTED|Period 1: Treatment Period 1 (28 Days)||80||
59880310|NCT02794480|76003507|FG001|STARTED|Period 1: Treatment Period 1 (28 Days)||82||
59880311|NCT02794480|76003508|FG002|STARTED|Period 1: Treatment Period 1 (28 Days)||81||
59880312|NCT02794480|76003509|FG003|STARTED|Period 1: Treatment Period 1 (28 Days)||81||
59880313|NCT02794480|76003506|FG000|COMPLETED|Period 1: Treatment Period 1 (28 Days)||80||
59880314|NCT02794480|76003507|FG001|COMPLETED|Period 1: Treatment Period 1 (28 Days)||80||
60135939|NCT00721617|76258592|FG000|STARTED|8 Hours Into Intralipid/Dextrose||12||
60135940|NCT00721617|76258592|FG000|COMPLETED|8 Hours Into Intralipid/Dextrose||12||
60135941|NCT00721617|76258592|FG000|NOT COMPLETED|8 Hours Into Intralipid/Dextrose||0||
59605507|NCT01967940|75715689|FG003|NOT COMPLETED|Part 1||0||
60135942|NCT01431287|76258602|FG000|STARTED|Overall Study|started are actually the randomized|510||
60135943|NCT01431287|76258603|FG001|STARTED|Overall Study||507||
60135944|NCT01431287|76258604|FG002|STARTED|Overall Study||507||
60135945|NCT01431287|76258605|FG003|STARTED|Overall Study||508||
60135946|NCT01431287|76258606|FG004|STARTED|Overall Study||507||
60135947|NCT01431287|76258602|FG000|COMPLETED|Overall Study||412||
59605508|NCT01967940|75715686|FG000|STARTED|Part 2|4 participants completed Part 1 and did not enter Part 2; 8 participants moved to the Part 2 group|0||
59750786|NCT05056870|75870021|FG001|COMPLETED|Period 1||77||
59750787|NCT05056870|75870020|FG000|NOT COMPLETED|Period 1||4||
59750788|NCT05056870|75870021|FG001|NOT COMPLETED|Period 1||4||
59750789|NCT05056870|75870020|FG000|STARTED|Period 2||76||
60135948|NCT01431287|76258603|FG001|COMPLETED|Overall Study||409||
60135949|NCT01431287|76258604|FG002|COMPLETED|Overall Study||410||
60135950|NCT01431287|76258605|FG003|COMPLETED|Overall Study||445||
60135951|NCT01431287|76258606|FG004|COMPLETED|Overall Study||430||
60135952|NCT01431287|76258602|FG000|NOT COMPLETED|Overall Study||98||
60135953|NCT01431287|76258603|FG001|NOT COMPLETED|Overall Study||98||
60135954|NCT01431287|76258604|FG002|NOT COMPLETED|Overall Study||97||
59750790|NCT05056870|75870021|FG001|STARTED|Period 2||77||
59750791|NCT05056870|75870020|FG000|COMPLETED|Period 2||74||
59750792|NCT05056870|75870021|FG001|COMPLETED|Period 2||77||
59750793|NCT05056870|75870020|FG000|NOT COMPLETED|Period 2||2||
59750794|NCT05056870|75870021|FG001|NOT COMPLETED|Period 2||0||
59750795|NCT04614363|75870031|FG000|STARTED|Overall Study||30||
59750796|NCT04614363|75870032|FG001|STARTED|Overall Study||50||
59750797|NCT04614363|75870031|FG000|COMPLETED|Overall Study||27||
59750798|NCT04614363|75870032|FG001|COMPLETED|Overall Study||49||
59750799|NCT04614363|75870031|FG000|NOT COMPLETED|Overall Study||3||
59750800|NCT04614363|75870032|FG001|NOT COMPLETED|Overall Study||1||
59750801|NCT04501445|75870039|FG000|STARTED|Overall Study||90||
59750802|NCT04501445|75870039|FG000|COMPLETED|Overall Study||90||
60004381|NCT03097757|76120311|FG001|COMPLETED|Overall Study||2||
60004382|NCT03097757|76120310|FG000|NOT COMPLETED|Overall Study||0||
60004383|NCT03097757|76120311|FG001|NOT COMPLETED|Overall Study||0||
60004384|NCT02048722|76120317|FG000|STARTED|2 Cycles of Treatment||31||
60004385|NCT02048722|76120317|FG000|Attempted 1st Cycle|2 Cycles of Treatment||31||
60004386|NCT02048722|76120317|FG000|Attempted 2nd Cycle|2 Cycles of Treatment||23||
60004387|NCT02048722|76120317|FG000|COMPLETED|2 Cycles of Treatment||23||
60004388|NCT02048722|76120317|FG000|NOT COMPLETED|2 Cycles of Treatment||8||
60004389|NCT02048722|76120317|FG000|STARTED|Reached 1st Response/Continued Treatment||23||
60004390|NCT02048722|76120317|FG000|Assessed for First Response|Reached 1st Response/Continued Treatment||23||
60004391|NCT02048722|76120317|FG000|Went on to Cycle 3 and Beyond|Reached 1st Response/Continued Treatment||13||
60004392|NCT02048722|76120317|FG000|COMPLETED|Reached 1st Response/Continued Treatment||13||
60004393|NCT02048722|76120317|FG000|NOT COMPLETED|Reached 1st Response/Continued Treatment||10||
60004394|NCT02048722|76120317|FG000|STARTED|Follow up 5 Years or Cut of Timepoint||31|All patients that have one does of study drug go into follow up after discontinuing treatment. Patients followed for 5 years or until October 12, 2021, whichever comes first.|
60004395|NCT02048722|76120317|FG000|COMPLETED|Follow up 5 Years or Cut of Timepoint||4||
60004396|NCT02048722|76120317|FG000|NOT COMPLETED|Follow up 5 Years or Cut of Timepoint||27||
60004397|NCT02030002|76120321|FG000|STARTED|Enrollment||49||
60004398|NCT02030002|76120321|FG000|COMPLETED|Enrollment||44||
60004399|NCT02030002|76120321|FG000|NOT COMPLETED|Enrollment||5||
60004400|NCT02030002|76120321|FG000|STARTED|APC Flash-Free Adhesive Coated Appliance||44||
60004401|NCT02030002|76120321|FG000|COMPLETED|APC Flash-Free Adhesive Coated Appliance||44||
60004402|NCT02030002|76120321|FG000|NOT COMPLETED|APC Flash-Free Adhesive Coated Appliance||0||
60004403|NCT02030002|76120321|FG000|STARTED|APC II Adhesive Coated Appliance System||44||
60004404|NCT02030002|76120321|FG000|COMPLETED|APC II Adhesive Coated Appliance System||44||
60004405|NCT02030002|76120321|FG000|NOT COMPLETED|APC II Adhesive Coated Appliance System||0||
60004406|NCT02030002|76120321|FG000|STARTED|Follow-up||44||
60004407|NCT02030002|76120321|FG000|COMPLETED|Follow-up||42||
60004408|NCT02030002|76120321|FG000|NOT COMPLETED|Follow-up||2||
60004409|NCT02079610|76120329|FG000|STARTED|Overall Study||19||
60004410|NCT02079610|76120330|FG001|STARTED|Overall Study||17||
60004411|NCT02079610|76120329|FG000|COMPLETED|Overall Study||18||
60004412|NCT02079610|76120330|FG001|COMPLETED|Overall Study||16||
60004413|NCT02079610|76120329|FG000|NOT COMPLETED|Overall Study||1||
60004414|NCT02079610|76120330|FG001|NOT COMPLETED|Overall Study||1||
60004415|NCT02079532|76120336|FG000|STARTED|Overall Study||302||
60004416|NCT02079532|76120336|FG000|COMPLETED|Overall Study||273||
60004417|NCT02079532|76120336|FG000|NOT COMPLETED|Overall Study||29||
60004418|NCT02958917|76120342|FG000|STARTED|Overall Study||27||
60004419|NCT02958917|76120343|FG001|STARTED|Overall Study||13||
60067885|NCT01756053|76183072|FG001|NOT COMPLETED|Washout Period (~21 Days)||0||
59519069|NCT01118221|75612938|FG001|COMPLETED|Overall Study||10||
59605509|NCT01967940|75715687|FG001|STARTED|Part 2|12 participants completed Part 1 and did not enter Part 2; 16 participants moved to the Part 2 group|0||
59605510|NCT01967940|75715688|FG002|STARTED|Part 2|1 participant completed Part 1 and did not enter Part 2; 14 participants moved to the Part 2 group|0||
59605511|NCT01967940|75715689|FG003|STARTED|Part 2|38 participants from the Part 1 groups moved to this Part 2 E/C/F/TAF + ATV group|38||
59605512|NCT01967940|75715686|FG000|COMPLETED|Part 2||0||
59880315|NCT02794480|76003508|FG002|COMPLETED|Period 1: Treatment Period 1 (28 Days)||79||
59880316|NCT02794480|76003509|FG003|COMPLETED|Period 1: Treatment Period 1 (28 Days)||78||
59880317|NCT02794480|76003506|FG000|NOT COMPLETED|Period 1: Treatment Period 1 (28 Days)||0||
59880318|NCT02794480|76003507|FG001|NOT COMPLETED|Period 1: Treatment Period 1 (28 Days)||2||
59880319|NCT02794480|76003508|FG002|NOT COMPLETED|Period 1: Treatment Period 1 (28 Days)||2||
59880320|NCT02794480|76003509|FG003|NOT COMPLETED|Period 1: Treatment Period 1 (28 Days)||3||
60135955|NCT01431287|76258605|FG003|NOT COMPLETED|Overall Study||63||
60135956|NCT01431287|76258606|FG004|NOT COMPLETED|Overall Study||77||
60135957|NCT00722007|76258618|FG000|STARTED|Overall Study||147||160
60135958|NCT00722007|76258618|FG000|COMPLETED|Overall Study||117||128
60135959|NCT00722007|76258618|FG000|NOT COMPLETED|Overall Study||30||32
60135960|NCT00729807|76258623|FG000|STARTED|Overall Study||6||
60135961|NCT00729807|76258623|FG000|COMPLETED|Overall Study||6||
60135962|NCT00729807|76258623|FG000|NOT COMPLETED|Overall Study||0||
60135963|NCT02079025|76258629|FG000|STARTED|Overall Study||839||
60135964|NCT02079025|76258630|FG001|STARTED|Overall Study||837||
60135965|NCT02079025|76258629|FG000|COMPLETED|Overall Study||839||
60135966|NCT02079025|76258630|FG001|COMPLETED|Overall Study||837||
60135967|NCT02079025|76258629|FG000|NOT COMPLETED|Overall Study||0||
60135968|NCT02079025|76258630|FG001|NOT COMPLETED|Overall Study||0||
60135969|NCT00730353|76258637|FG000|STARTED|Overall Study||28||
60135970|NCT00730353|76258637|FG000|COMPLETED|Overall Study||28||
60135971|NCT00730353|76258637|FG000|NOT COMPLETED|Overall Study||0||
60135972|NCT00749931|76258643|FG000|STARTED|Overall Study||298||
60135973|NCT00749931|76258644|FG001|STARTED|Overall Study||298||
60135974|NCT00749931|76258645|FG002|STARTED|Overall Study||68||
60135975|NCT00749931|76258643|FG000|COMPLETED|Overall Study||298||
59605513|NCT01967940|75715687|FG001|COMPLETED|Part 2||0||
59880321|NCT02794480|76003506|FG000|STARTED|Period 2: Treatment Period 2 (28 Days)||80||
59880322|NCT02794480|76003507|FG001|STARTED|Period 2: Treatment Period 2 (28 Days)||80||
59880323|NCT02794480|76003508|FG002|STARTED|Period 2: Treatment Period 2 (28 Days)||79||
59880324|NCT02794480|76003509|FG003|STARTED|Period 2: Treatment Period 2 (28 Days)||78||
59880325|NCT02794480|76003506|FG000|COMPLETED|Period 2: Treatment Period 2 (28 Days)||79||
59880326|NCT02794480|76003507|FG001|COMPLETED|Period 2: Treatment Period 2 (28 Days)||80||
59880327|NCT02794480|76003508|FG002|COMPLETED|Period 2: Treatment Period 2 (28 Days)||79||
59880328|NCT02794480|76003509|FG003|COMPLETED|Period 2: Treatment Period 2 (28 Days)||77||
59880329|NCT02794480|76003506|FG000|NOT COMPLETED|Period 2: Treatment Period 2 (28 Days)||1||
59880330|NCT02794480|76003507|FG001|NOT COMPLETED|Period 2: Treatment Period 2 (28 Days)||0||
59880331|NCT02794480|76003508|FG002|NOT COMPLETED|Period 2: Treatment Period 2 (28 Days)||0||
59880332|NCT02794480|76003509|FG003|NOT COMPLETED|Period 2: Treatment Period 2 (28 Days)||1||
59880333|NCT04558125|76003517|FG000|STARTED|Overall Study||2||
59880334|NCT04558125|76003517|FG000|COMPLETED|Overall Study||1||
60135976|NCT00749931|76258644|FG001|COMPLETED|Overall Study||298||
60135977|NCT00749931|76258645|FG002|COMPLETED|Overall Study||68||
60135978|NCT00749931|76258643|FG000|NOT COMPLETED|Overall Study||0||
60135979|NCT00749931|76258644|FG001|NOT COMPLETED|Overall Study||0||
59605514|NCT01967940|75715688|FG002|COMPLETED|Part 2||0||
59605515|NCT01967940|75715689|FG003|COMPLETED|Part 2||35||
59605516|NCT01967940|75715686|FG000|NOT COMPLETED|Part 2||0||
59605517|NCT01967940|75715687|FG001|NOT COMPLETED|Part 2||0||
59605518|NCT01967940|75715688|FG002|NOT COMPLETED|Part 2||0||
59880335|NCT04558125|76003517|FG000|NOT COMPLETED|Overall Study||1||
59880336|NCT02793622|76003523|FG000|STARTED|Overall Study||391||
59880337|NCT02793622|76003524|FG001|STARTED|Overall Study||391||
59880338|NCT02793622|76003523|FG000|COMPLETED|Overall Study||338||
59880339|NCT02793622|76003524|FG001|COMPLETED|Overall Study||349||
59880340|NCT02793622|76003523|FG000|NOT COMPLETED|Overall Study||53||
59880341|NCT02793622|76003524|FG001|NOT COMPLETED|Overall Study||42||
59880342|NCT04493931|76003537|FG000|STARTED|Cohort1:Treatment Period 1(Up to 3 Days)||14||
59880343|NCT04493931|76003538|FG001|STARTED|Cohort1:Treatment Period 1(Up to 3 Days)||0||
59880344|NCT04493931|76003539|FG002|STARTED|Cohort1:Treatment Period 1(Up to 3 Days)||0||
59880345|NCT04493931|76003540|FG003|STARTED|Cohort1:Treatment Period 1(Up to 3 Days)||0||
59880346|NCT04493931|76003541|FG004|STARTED|Cohort1:Treatment Period 1(Up to 3 Days)||0||
59880347|NCT04493931|76003542|FG005|STARTED|Cohort1:Treatment Period 1(Up to 3 Days)||0||
59880348|NCT04493931|76003543|FG006|STARTED|Cohort1:Treatment Period 1(Up to 3 Days)||0||
59880349|NCT04493931|76003537|FG000|COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||13||
59880350|NCT04493931|76003538|FG001|COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||0||
59880351|NCT04493931|76003539|FG002|COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||0||
59880352|NCT04493931|76003540|FG003|COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||0||
59880353|NCT04493931|76003541|FG004|COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||0||
59880354|NCT04493931|76003542|FG005|COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||0||
59605519|NCT01967940|75715689|FG003|NOT COMPLETED|Part 2||3||
59605520|NCT01990560|75715699|FG000|STARTED|Overall Study||8||
59605521|NCT01990560|75715699|FG000|COMPLETED|Overall Study||7||
59605522|NCT01990560|75715699|FG000|NOT COMPLETED|Overall Study||1||
59605523|NCT01998984|75715707|FG000|STARTED|Overall Study||55||
59605524|NCT01998984|75715708|FG001|STARTED|Overall Study||59||
59605525|NCT01998984|75715709|FG002|STARTED|Overall Study||49||
59605526|NCT01998984|75715710|FG003|STARTED|Overall Study||61||
59605527|NCT01998984|75715707|FG000|COMPLETED|Overall Study||55||
59605528|NCT01998984|75715708|FG001|COMPLETED|Overall Study||58||
59605529|NCT01998984|75715709|FG002|COMPLETED|Overall Study||48||
59605530|NCT01998984|75715710|FG003|COMPLETED|Overall Study||58||
59605531|NCT01998984|75715707|FG000|NOT COMPLETED|Overall Study||0||
59605532|NCT01998984|75715708|FG001|NOT COMPLETED|Overall Study||1||
59605533|NCT01998984|75715709|FG002|NOT COMPLETED|Overall Study||1||
59605534|NCT01998984|75715710|FG003|NOT COMPLETED|Overall Study||3||
59605535|NCT01967706|75715722|FG000|STARTED|Washout Period of 1 Day (Day 0)||22||
59605536|NCT01967706|75715723|FG001|STARTED|Washout Period of 1 Day (Day 0)||22||
59605537|NCT01967706|75715724|FG002|STARTED|Washout Period of 1 Day (Day 0)||9||
59605538|NCT01967706|75715725|FG003|STARTED|Washout Period of 1 Day (Day 0)||9||
59605539|NCT01967706|75715722|FG000|COMPLETED|Washout Period of 1 Day (Day 0)||22||
59605540|NCT01967706|75715723|FG001|COMPLETED|Washout Period of 1 Day (Day 0)||22||
59605541|NCT01967706|75715724|FG002|COMPLETED|Washout Period of 1 Day (Day 0)||9||
59605542|NCT01967706|75715725|FG003|COMPLETED|Washout Period of 1 Day (Day 0)||9||
59605543|NCT01967706|75715722|FG000|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0||
59605544|NCT01967706|75715723|FG001|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0||
59605545|NCT01967706|75715724|FG002|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0||
59605546|NCT01967706|75715725|FG003|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0||
59605547|NCT01967706|75715722|FG000|STARTED|First Intervention (Day 1)||22||
59605548|NCT01967706|75715723|FG001|STARTED|First Intervention (Day 1)||22||
59750803|NCT04501445|75870039|FG000|NOT COMPLETED|Overall Study||0||
59750804|NCT04488822|75870045|FG000|STARTED|Overall Study||40||
59750805|NCT04488822|75870045|FG000|COMPLETED|Overall Study||31|Completed = Participants ongoing treatment as of 27 Oct 2021, Not Completed =Participants who discontinued treatment|
59605549|NCT01967706|75715724|FG002|STARTED|First Intervention (Day 1)||9||
59605550|NCT01967706|75715725|FG003|STARTED|First Intervention (Day 1)||9||
59605551|NCT01967706|75715722|FG000|COMPLETED|First Intervention (Day 1)||21||
59605552|NCT01967706|75715723|FG001|COMPLETED|First Intervention (Day 1)||22||
59605553|NCT01967706|75715724|FG002|COMPLETED|First Intervention (Day 1)||9||
59605554|NCT01967706|75715725|FG003|COMPLETED|First Intervention (Day 1)||9||
59750806|NCT04488822|75870045|FG000|NOT COMPLETED|Overall Study||9||
59750807|NCT04472611|75870051|FG000|STARTED|Overall Study||125||
59750808|NCT04472611|75870052|FG001|STARTED|Overall Study||125||
59750809|NCT04472611|75870051|FG000|COMPLETED|Overall Study||122||
59750810|NCT04472611|75870052|FG001|COMPLETED|Overall Study||125||
59750811|NCT04472611|75870051|FG000|NOT COMPLETED|Overall Study||3||
59750812|NCT04472611|75870052|FG001|NOT COMPLETED|Overall Study||0||
59750813|NCT04396626|75870058|FG000|STARTED|Overall Study||975||
59750814|NCT04396626|75870058|FG000|COMPLETED|Overall Study||0||
59605555|NCT01967706|75715722|FG000|NOT COMPLETED|First Intervention (Day 1)||1||
59605556|NCT01967706|75715723|FG001|NOT COMPLETED|First Intervention (Day 1)||0||
59605557|NCT01967706|75715724|FG002|NOT COMPLETED|First Intervention (Day 1)||0||
59750815|NCT04396626|75870058|FG000|NOT COMPLETED|Overall Study||975||
59750816|NCT04242186|75870062|FG000|STARTED|Overall Study||140||
59750817|NCT04242186|75870062|FG000|Qualitative Interview Participants|Overall Study||28||
60135980|NCT00749931|76258645|FG002|NOT COMPLETED|Overall Study||0||
59605558|NCT01967706|75715725|FG003|NOT COMPLETED|First Intervention (Day 1)||0||
59605559|NCT01967706|75715722|FG000|STARTED|Washout Period of 1 Day (Day 2)||21||
59605560|NCT01967706|75715723|FG001|STARTED|Washout Period of 1 Day (Day 2)||22||
59605561|NCT01967706|75715724|FG002|STARTED|Washout Period of 1 Day (Day 2)||9||
59605562|NCT01967706|75715725|FG003|STARTED|Washout Period of 1 Day (Day 2)||9||
59605563|NCT01967706|75715722|FG000|COMPLETED|Washout Period of 1 Day (Day 2)||21||
59605564|NCT01967706|75715723|FG001|COMPLETED|Washout Period of 1 Day (Day 2)||22||
59605565|NCT01967706|75715724|FG002|COMPLETED|Washout Period of 1 Day (Day 2)||9||
59605566|NCT01967706|75715725|FG003|COMPLETED|Washout Period of 1 Day (Day 2)||9||
59605567|NCT01967706|75715722|FG000|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0||
59750818|NCT04242186|75870062|FG000|Nursing Home Residents|Overall Study||46||
59750819|NCT04242186|75870062|FG000|Facility Staff Members|Overall Study||66||
59750820|NCT04242186|75870062|FG000|COMPLETED|Overall Study||135||
59750821|NCT04242186|75870062|FG000|NOT COMPLETED|Overall Study||5||
59605568|NCT01967706|75715723|FG001|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0||
59605569|NCT01967706|75715724|FG002|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0||
59605570|NCT01967706|75715725|FG003|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0||
59605571|NCT01967706|75715722|FG000|STARTED|Second Intervention (Day 3)||21||
59605572|NCT01967706|75715723|FG001|STARTED|Second Intervention (Day 3)||22||
59605573|NCT01967706|75715724|FG002|STARTED|Second Intervention (Day 3)||9||
59750822|NCT03934216|75870069|FG000|STARTED|Randomization||88||
59605574|NCT01967706|75715725|FG003|STARTED|Second Intervention (Day 3)||9||
59750823|NCT03934216|75870070|FG001|STARTED|Randomization||43||
59750824|NCT03934216|75870069|FG000|COMPLETED|Randomization||87|= Will enter Treatment Period|
59750825|NCT03934216|75870070|FG001|COMPLETED|Randomization||42|= Will enter Treatment Period|
59750826|NCT03934216|75870069|FG000|NOT COMPLETED|Randomization||1||
59750827|NCT03934216|75870070|FG001|NOT COMPLETED|Randomization||1||
59750828|NCT03934216|75870069|FG000|STARTED|Treatment Period||87||
59750829|NCT03934216|75870070|FG001|STARTED|Treatment Period||42||
59750830|NCT03934216|75870069|FG000|COMPLETED|Treatment Period||69|= Completed Treatment Period|
59750831|NCT03934216|75870070|FG001|COMPLETED|Treatment Period||35|= Completed Treatment Period|
59750832|NCT03934216|75870069|FG000|NOT COMPLETED|Treatment Period||18||
59750833|NCT03934216|75870070|FG001|NOT COMPLETED|Treatment Period||7||
59750834|NCT03875885|75870078|FG000|STARTED|Overall Study||18||
59750835|NCT03875885|75870079|FG001|STARTED|Overall Study||22||
60004420|NCT02958917|76120342|FG000|COMPLETED|Overall Study||27|The study was terminated prematurely in December 2020 following the randomization of 40 patients due to the ongoing impacts of the COVID-19 pandemic.|
60004421|NCT02958917|76120343|FG001|COMPLETED|Overall Study||13|The study was terminated prematurely in December 2020 following the randomization of 40 patients due to the ongoing impacts of the COVID-19 pandemic.|
60004422|NCT02958917|76120342|FG000|NOT COMPLETED|Overall Study||0||
60004423|NCT02958917|76120343|FG001|NOT COMPLETED|Overall Study||0||
60004424|NCT02357849|76120353|FG000|STARTED|Overall Study||4||
60004425|NCT02357849|76120354|FG001|STARTED|Overall Study||5||
60004426|NCT02357849|76120353|FG000|COMPLETED|Overall Study||2||
60004427|NCT02357849|76120354|FG001|COMPLETED|Overall Study||2||
60004428|NCT02357849|76120353|FG000|NOT COMPLETED|Overall Study||2||
60004429|NCT02357849|76120354|FG001|NOT COMPLETED|Overall Study||3||
60004430|NCT02938013|76120363|FG000|STARTED|Overall Study||5||
60004431|NCT02938013|76120364|FG001|STARTED|Overall Study||5||
60004432|NCT02938013|76120365|FG002|STARTED|Overall Study||5||
60004433|NCT02938013|76120363|FG000|COMPLETED|Overall Study||5||
60004434|NCT02938013|76120364|FG001|COMPLETED|Overall Study||5||
60004435|NCT02938013|76120365|FG002|COMPLETED|Overall Study||5||
59750836|NCT03875885|75870078|FG000|COMPLETED|Overall Study||18||
59750837|NCT03875885|75870079|FG001|COMPLETED|Overall Study||22||
59750838|NCT03875885|75870078|FG000|NOT COMPLETED|Overall Study||0||
59750839|NCT03875885|75870079|FG001|NOT COMPLETED|Overall Study||0||
60004436|NCT02938013|76120363|FG000|NOT COMPLETED|Overall Study||0||
60004437|NCT02938013|76120364|FG001|NOT COMPLETED|Overall Study||0||
59750840|NCT03550066|75870089|FG000|STARTED|Overall Study||49||
59750841|NCT03550066|75870090|FG001|STARTED|Overall Study||41||
60004438|NCT02938013|76120365|FG002|NOT COMPLETED|Overall Study||0||
60004439|NCT02642315|76120373|FG000|STARTED|Overall Study||10||
60004440|NCT02642315|76120373|FG000|COMPLETED|Overall Study||8||
60004441|NCT02642315|76120373|FG000|NOT COMPLETED|Overall Study||2||
60004442|NCT02518139|76120380|FG000|STARTED|Overall Study||364||
60004443|NCT02518139|76120381|FG001|STARTED|Overall Study||335||
60004444|NCT02518139|76120382|FG002|STARTED|Overall Study||356||
60004445|NCT02518139|76120380|FG000|COMPLETED|Overall Study||219||
60004446|NCT02518139|76120381|FG001|COMPLETED|Overall Study||191||
60004447|NCT02518139|76120382|FG002|COMPLETED|Overall Study||262||
60004448|NCT02518139|76120380|FG000|NOT COMPLETED|Overall Study||145||
60004449|NCT02518139|76120381|FG001|NOT COMPLETED|Overall Study||144||
59750842|NCT03550066|75870089|FG000|COMPLETED|Overall Study||49||
59750843|NCT03550066|75870090|FG001|COMPLETED|Overall Study||41||
59750844|NCT03550066|75870089|FG000|NOT COMPLETED|Overall Study||0||
59750845|NCT03550066|75870090|FG001|NOT COMPLETED|Overall Study||0||
59750846|NCT03341052|75870098|FG000|STARTED|Overall Study||8||
59750847|NCT03341052|75870099|FG001|STARTED|Overall Study||8||
60004450|NCT02518139|76120382|FG002|NOT COMPLETED|Overall Study||94||
60004451|NCT02709889|76120398|FG000|STARTED|Overall Study||43||
60004452|NCT02709889|76120399|FG001|STARTED|Overall Study||57||
60004453|NCT02709889|76120400|FG002|STARTED|Overall Study||12||
60004454|NCT02709889|76120401|FG003|STARTED|Overall Study||88||
60004455|NCT02709889|76120398|FG000|Large Cell Neuroendocrine Carcinoma(NEC)|Overall Study||3||
60004456|NCT02709889|76120399|FG001|Large Cell Neuroendocrine Carcinoma(NEC)|Overall Study||4||
60004457|NCT02709889|76120400|FG002|Large Cell Neuroendocrine Carcinoma(NEC)|Overall Study||2||
59750848|NCT03341052|75870098|FG000|COMPLETED|Overall Study||8||
59750849|NCT03341052|75870099|FG001|COMPLETED|Overall Study||8||
59750850|NCT03341052|75870098|FG000|NOT COMPLETED|Overall Study||0||
59750851|NCT03341052|75870099|FG001|NOT COMPLETED|Overall Study||0||
59750852|NCT03183128|75870107|FG000|STARTED|Overall Study||89|"Started represents the number of participants assigned to each arm. Note: The number of participants who actually received SER-109 was 90, and those who actually received Placebo was 92."|
59750853|NCT03183128|75870108|FG001|STARTED|Overall Study||93|"Started represents the number of participants assigned to each arm. Note: The number of participants who actually received SER-109 was 90, and those who actually received Placebo was 92."|
59750854|NCT03183128|75870107|FG000|Completed 8-Week Follow-up|Overall Study||84||
59750855|NCT03183128|75870108|FG001|Completed 8-Week Follow-up|Overall Study||65||
59750856|NCT03183128|75870107|FG000|COMPLETED|Overall Study||77|Completed 24-Week Follow-up|
60004458|NCT02709889|76120401|FG003|Large Cell Neuroendocrine Carcinoma(NEC)|Overall Study||4||
60004459|NCT02709889|76120398|FG000|Neuroendocrine Prostate Cancer|Overall Study||4||
60004460|NCT02709889|76120399|FG001|Neuroendocrine Prostate Cancer|Overall Study||7||
60004461|NCT02709889|76120400|FG002|Neuroendocrine Prostate Cancer|Overall Study||3||
60004462|NCT02709889|76120401|FG003|Neuroendocrine Prostate Cancer|Overall Study||7||
60004463|NCT02709889|76120398|FG000|Gastroenteropancreatic NEC|Overall Study||6||
59880355|NCT04493931|76003543|FG006|COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||0||
60004464|NCT02709889|76120399|FG001|Gastroenteropancreatic NEC|Overall Study||5||
60004465|NCT02709889|76120400|FG002|Gastroenteropancreatic NEC|Overall Study||2||
60004466|NCT02709889|76120401|FG003|Gastroenteropancreatic NEC|Overall Study||23||
60004467|NCT02709889|76120398|FG000|Other NEC|Overall Study||11||
60004468|NCT02709889|76120399|FG001|Other NEC|Overall Study||12||
60004469|NCT02709889|76120400|FG002|Other NEC|Overall Study||1||
60004470|NCT02709889|76120401|FG003|Other NEC|Overall Study||7||
60004471|NCT02709889|76120398|FG000|Malignant Melanoma|Overall Study||3||
60004472|NCT02709889|76120399|FG001|Malignant Melanoma|Overall Study||6||
60004473|NCT02709889|76120400|FG002|Malignant Melanoma|Overall Study||0||
60004474|NCT02709889|76120401|FG003|Malignant Melanoma|Overall Study||11||
60004475|NCT02709889|76120398|FG000|Medullary Thyroid Cancer|Overall Study||3||
60004476|NCT02709889|76120399|FG001|Medullary Thyroid Cancer|Overall Study||3||
60004477|NCT02709889|76120400|FG002|Medullary Thyroid Cancer|Overall Study||0||
60004478|NCT02709889|76120401|FG003|Medullary Thyroid Cancer|Overall Study||7||
60004479|NCT02709889|76120398|FG000|Glioblastoma|Overall Study||4||
60004480|NCT02709889|76120399|FG001|Glioblastoma|Overall Study||4||
60004481|NCT02709889|76120400|FG002|Glioblastoma|Overall Study||1||
60004482|NCT02709889|76120401|FG003|Glioblastoma|Overall Study||14||
60004483|NCT02709889|76120398|FG000|Other Solid Tumors|Overall Study||9||
60004484|NCT02709889|76120399|FG001|Other Solid Tumors|Overall Study||16||
60004485|NCT02709889|76120400|FG002|Other Solid Tumors|Overall Study||3||
59750857|NCT03183128|75870108|FG001|COMPLETED|Overall Study||56|Completed 24-Week Follow-up|
59880356|NCT04493931|76003537|FG000|NOT COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||1||
59880357|NCT04493931|76003538|FG001|NOT COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||0||
59880358|NCT04493931|76003539|FG002|NOT COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||0||
59880359|NCT04493931|76003540|FG003|NOT COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||0||
59880360|NCT04493931|76003541|FG004|NOT COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||0||
59880361|NCT04493931|76003542|FG005|NOT COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||0||
60004486|NCT02709889|76120401|FG003|Other Solid Tumors|Overall Study||15||
60004487|NCT02709889|76120398|FG000|COMPLETED|Overall Study||0||
60004488|NCT02709889|76120399|FG001|COMPLETED|Overall Study||0||
59880362|NCT04493931|76003543|FG006|NOT COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||0||
59880363|NCT04493931|76003537|FG000|STARTED|Cohort 1:Washout Period 1 (Up to 3 Days)||13||
59880364|NCT04493931|76003538|FG001|STARTED|Cohort 1:Washout Period 1 (Up to 3 Days)||0||
59880365|NCT04493931|76003539|FG002|STARTED|Cohort 1:Washout Period 1 (Up to 3 Days)||0||
59880366|NCT04493931|76003540|FG003|STARTED|Cohort 1:Washout Period 1 (Up to 3 Days)||0||
60004489|NCT02709889|76120400|FG002|COMPLETED|Overall Study||0||
60004490|NCT02709889|76120401|FG003|COMPLETED|Overall Study||0||
60004491|NCT02709889|76120398|FG000|NOT COMPLETED|Overall Study||43||
60004492|NCT02709889|76120399|FG001|NOT COMPLETED|Overall Study||57||
60004493|NCT02709889|76120400|FG002|NOT COMPLETED|Overall Study||12||
60004494|NCT02709889|76120401|FG003|NOT COMPLETED|Overall Study||88||
60004495|NCT02711995|76120446|FG000|STARTED|First Intervention (30 Days)||8||
60004496|NCT02711995|76120446|FG000|COMPLETED|First Intervention (30 Days)||8||
60004497|NCT02711995|76120446|FG000|NOT COMPLETED|First Intervention (30 Days)||0||
60004498|NCT02711995|76120446|FG000|STARTED|Washout (90 Days)||8||
60004499|NCT02711995|76120446|FG000|COMPLETED|Washout (90 Days)||7||
60004500|NCT02711995|76120446|FG000|NOT COMPLETED|Washout (90 Days)||1||
60004501|NCT02711995|76120446|FG000|STARTED|Second Intervention (30 Days)||7||
60004502|NCT02711995|76120446|FG000|COMPLETED|Second Intervention (30 Days)||7||
59750858|NCT03183128|75870107|FG000|NOT COMPLETED|Overall Study||12||
59750859|NCT03183128|75870108|FG001|NOT COMPLETED|Overall Study||37||
59750860|NCT03006328|75870116|FG000|STARTED|Overall Study||220||9
59750861|NCT03006328|75870117|FG001|STARTED|Overall Study||269||10
59750862|NCT03006328|75870116|FG000|COMPLETED|Overall Study||220||9
59750863|NCT03006328|75870117|FG001|COMPLETED|Overall Study||269||10
59750864|NCT03006328|75870116|FG000|NOT COMPLETED|Overall Study||0||0
59750865|NCT03006328|75870117|FG001|NOT COMPLETED|Overall Study||0||0
59750866|NCT02901067|75870125|FG000|STARTED|Overall Study||19||
59750867|NCT02901067|75870126|FG001|STARTED|Overall Study||18||
59750868|NCT02901067|75870125|FG000|COMPLETED|Overall Study||19||
59750869|NCT02901067|75870126|FG001|COMPLETED|Overall Study||18||
59750870|NCT02901067|75870125|FG000|NOT COMPLETED|Overall Study||0||
59750871|NCT02901067|75870126|FG001|NOT COMPLETED|Overall Study||0||
59880367|NCT04493931|76003541|FG004|STARTED|Cohort 1:Washout Period 1 (Up to 3 Days)||0||
59880368|NCT04493931|76003542|FG005|STARTED|Cohort 1:Washout Period 1 (Up to 3 Days)||0||
59880369|NCT04493931|76003543|FG006|STARTED|Cohort 1:Washout Period 1 (Up to 3 Days)||0||
59880370|NCT04493931|76003537|FG000|COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||13||
59880371|NCT04493931|76003538|FG001|COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||0||
59880372|NCT04493931|76003539|FG002|COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||0||
59880373|NCT04493931|76003540|FG003|COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||0||
59880374|NCT04493931|76003541|FG004|COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||0||
59880375|NCT04493931|76003542|FG005|COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||0||
59880376|NCT04493931|76003543|FG006|COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||0||
59880377|NCT04493931|76003537|FG000|NOT COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||0||
59880378|NCT04493931|76003538|FG001|NOT COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||0||
59880379|NCT04493931|76003539|FG002|NOT COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||0||
59880380|NCT04493931|76003540|FG003|NOT COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||0||
59880381|NCT04493931|76003541|FG004|NOT COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||0||
59880382|NCT04493931|76003542|FG005|NOT COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||0||
59880383|NCT04493931|76003543|FG006|NOT COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||0||
59880384|NCT04493931|76003537|FG000|STARTED|Cohort1:Treatment Period 2(Up to 4 Days)||13||
59880385|NCT04493931|76003538|FG001|STARTED|Cohort1:Treatment Period 2(Up to 4 Days)||0||
59880386|NCT04493931|76003539|FG002|STARTED|Cohort1:Treatment Period 2(Up to 4 Days)||0||
59880387|NCT04493931|76003540|FG003|STARTED|Cohort1:Treatment Period 2(Up to 4 Days)||0||
59880388|NCT04493931|76003541|FG004|STARTED|Cohort1:Treatment Period 2(Up to 4 Days)||0||
59880389|NCT04493931|76003542|FG005|STARTED|Cohort1:Treatment Period 2(Up to 4 Days)||0||
59880390|NCT04493931|76003543|FG006|STARTED|Cohort1:Treatment Period 2(Up to 4 Days)||0||
59880391|NCT04493931|76003537|FG000|COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||13||
59880392|NCT04493931|76003538|FG001|COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||0||
59880393|NCT04493931|76003539|FG002|COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||0||
59880394|NCT04493931|76003540|FG003|COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||0||
59880395|NCT04493931|76003541|FG004|COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||0||
59880396|NCT04493931|76003542|FG005|COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||0||
59880397|NCT04493931|76003543|FG006|COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||0||
59880398|NCT04493931|76003537|FG000|NOT COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||0||
59880399|NCT04493931|76003538|FG001|NOT COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||0||
59880400|NCT04493931|76003539|FG002|NOT COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||0||
59880401|NCT04493931|76003540|FG003|NOT COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||0||
59880402|NCT04493931|76003541|FG004|NOT COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||0||
59750872|NCT02466074|75870134|FG000|STARTED|Overall Study||5||
59750873|NCT02466074|75870135|FG001|STARTED|Overall Study||0||
59750874|NCT02466074|75870134|FG000|COMPLETED|Overall Study||5||
59750875|NCT02466074|75870135|FG001|COMPLETED|Overall Study||0||
59750876|NCT02466074|75870134|FG000|NOT COMPLETED|Overall Study||0||
59750877|NCT02466074|75870135|FG001|NOT COMPLETED|Overall Study||0||
59750878|NCT02308488|75870141|FG000|STARTED|Overall Study||97||
59750879|NCT02308488|75870141|FG000|COMPLETED|Overall Study||95||
59750880|NCT02308488|75870141|FG000|NOT COMPLETED|Overall Study||2||
59750881|NCT02159950|75870147|FG000|STARTED|Overall Study||0||
59750882|NCT02159950|75870148|FG001|STARTED|Overall Study||2||
59750883|NCT02159950|75870147|FG000|COMPLETED|Overall Study||0||
59880403|NCT04493931|76003542|FG005|NOT COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||0||
59880404|NCT04493931|76003543|FG006|NOT COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||0||
59880405|NCT04493931|76003537|FG000|STARTED|Cohort 1: Follow-up (Up to 7 Days)||13||
59880406|NCT04493931|76003538|FG001|STARTED|Cohort 1: Follow-up (Up to 7 Days)||0||
59880407|NCT04493931|76003539|FG002|STARTED|Cohort 1: Follow-up (Up to 7 Days)||0||
59880408|NCT04493931|76003540|FG003|STARTED|Cohort 1: Follow-up (Up to 7 Days)||0||
59880409|NCT04493931|76003541|FG004|STARTED|Cohort 1: Follow-up (Up to 7 Days)||0||
59880410|NCT04493931|76003542|FG005|STARTED|Cohort 1: Follow-up (Up to 7 Days)||0||
59880411|NCT04493931|76003543|FG006|STARTED|Cohort 1: Follow-up (Up to 7 Days)||0||
59950788|NCT02682927|76069635|FG005|NOT COMPLETED|Overall Study||3||
59750884|NCT02159950|75870148|FG001|COMPLETED|Overall Study||0||
59880412|NCT04493931|76003537|FG000|COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||13||
59880413|NCT04493931|76003538|FG001|COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||0||
59880414|NCT04493931|76003539|FG002|COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||0||
59880415|NCT04493931|76003540|FG003|COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||0||
59880416|NCT04493931|76003541|FG004|COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||0||
59880417|NCT04493931|76003542|FG005|COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||0||
59880418|NCT04493931|76003543|FG006|COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||0||
59880419|NCT04493931|76003537|FG000|NOT COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||0||
59880420|NCT04493931|76003538|FG001|NOT COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||0||
59880421|NCT04493931|76003539|FG002|NOT COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||0||
59880422|NCT04493931|76003540|FG003|NOT COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||0||
59880423|NCT04493931|76003541|FG004|NOT COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||0||
59880424|NCT04493931|76003542|FG005|NOT COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||0||
59880425|NCT04493931|76003543|FG006|NOT COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||0||
59880426|NCT04493931|76003537|FG000|STARTED|Cohort2:Treatment Period 1(Up to 3 Days)||0||
59880427|NCT04493931|76003538|FG001|STARTED|Cohort2:Treatment Period 1(Up to 3 Days)||17||
59880428|NCT04493931|76003539|FG002|STARTED|Cohort2:Treatment Period 1(Up to 3 Days)||0||
59880429|NCT04493931|76003540|FG003|STARTED|Cohort2:Treatment Period 1(Up to 3 Days)||0||
59880430|NCT04493931|76003541|FG004|STARTED|Cohort2:Treatment Period 1(Up to 3 Days)||0||
59880431|NCT04493931|76003542|FG005|STARTED|Cohort2:Treatment Period 1(Up to 3 Days)||0||
59880432|NCT04493931|76003543|FG006|STARTED|Cohort2:Treatment Period 1(Up to 3 Days)||0||
59750885|NCT02159950|75870147|FG000|NOT COMPLETED|Overall Study||0||
59750886|NCT02159950|75870148|FG001|NOT COMPLETED|Overall Study||2||
59750887|NCT02152137|75870154|FG000|STARTED|Overall Study||19|Enrolled|
59750888|NCT02152137|75870154|FG000|Originally Assigned to Arm A|Overall Study||16||
59750889|NCT02152137|75870154|FG000|Originally Assigned to Arm B|Overall Study|With update #2, Arm B is closed and all patients should receive paclitaxel and efatutazone.|3||
59750890|NCT02152137|75870154|FG000|COMPLETED|Overall Study||15|received efatutazone and paclitaxel combination and were included in safety and efficacy analyses|
59750891|NCT02152137|75870154|FG000|NOT COMPLETED|Overall Study||4||
59750892|NCT02007512|75870162|FG000|STARTED|Double Blind Treatment Period||63||
59750893|NCT02007512|75870163|FG001|STARTED|Double Blind Treatment Period||64||
59750894|NCT02007512|75870164|FG002|STARTED|Double Blind Treatment Period||60||
59750895|NCT02007512|75870165|FG003|STARTED|Double Blind Treatment Period||60||
59750896|NCT02007512|75870162|FG000|Treated|Double Blind Treatment Period||62||
59880433|NCT04493931|76003537|FG000|COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||0||
59880434|NCT04493931|76003538|FG001|COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||17||
59880435|NCT04493931|76003539|FG002|COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||0||
59880436|NCT04493931|76003540|FG003|COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||0||
59880437|NCT04493931|76003541|FG004|COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||0||
59880438|NCT04493931|76003542|FG005|COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||0||
59880439|NCT04493931|76003543|FG006|COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||0||
59880440|NCT04493931|76003537|FG000|NOT COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||0||
59880441|NCT04493931|76003538|FG001|NOT COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||0||
59880442|NCT04493931|76003539|FG002|NOT COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||0||
59880443|NCT04493931|76003540|FG003|NOT COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||0||
59880444|NCT04493931|76003541|FG004|NOT COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||0||
59880445|NCT04493931|76003542|FG005|NOT COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||0||
59880446|NCT04493931|76003543|FG006|NOT COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||0||
59880447|NCT04493931|76003537|FG000|STARTED|Cohort 2:Washout Period 1(Up to 3 Days)||0||
59880448|NCT04493931|76003538|FG001|STARTED|Cohort 2:Washout Period 1(Up to 3 Days)||17||
59880449|NCT04493931|76003539|FG002|STARTED|Cohort 2:Washout Period 1(Up to 3 Days)||0||
59880450|NCT04493931|76003540|FG003|STARTED|Cohort 2:Washout Period 1(Up to 3 Days)||0||
59880451|NCT04493931|76003541|FG004|STARTED|Cohort 2:Washout Period 1(Up to 3 Days)||0||
59880452|NCT04493931|76003542|FG005|STARTED|Cohort 2:Washout Period 1(Up to 3 Days)||0||
59880453|NCT04493931|76003543|FG006|STARTED|Cohort 2:Washout Period 1(Up to 3 Days)||0||
59880454|NCT04493931|76003537|FG000|COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||0||
59880455|NCT04493931|76003538|FG001|COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||17||
59880456|NCT04493931|76003539|FG002|COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||0||
59880457|NCT04493931|76003540|FG003|COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||0||
59880458|NCT04493931|76003541|FG004|COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||0||
59880459|NCT04493931|76003542|FG005|COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||0||
59880460|NCT04493931|76003543|FG006|COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||0||
59880461|NCT04493931|76003537|FG000|NOT COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||0||
59880462|NCT04493931|76003538|FG001|NOT COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||0||
59880463|NCT04493931|76003539|FG002|NOT COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||0||
59880464|NCT04493931|76003540|FG003|NOT COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||0||
59880465|NCT04493931|76003541|FG004|NOT COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||0||
59880466|NCT04493931|76003542|FG005|NOT COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||0||
59880467|NCT04493931|76003543|FG006|NOT COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||0||
59880468|NCT04493931|76003537|FG000|STARTED|Cohort2:Treatment Period2(Up to 10 Days)||0||
59880469|NCT04493931|76003538|FG001|STARTED|Cohort2:Treatment Period2(Up to 10 Days)||17||
59880470|NCT04493931|76003539|FG002|STARTED|Cohort2:Treatment Period2(Up to 10 Days)||0||
59880471|NCT04493931|76003540|FG003|STARTED|Cohort2:Treatment Period2(Up to 10 Days)||0||
59880472|NCT04493931|76003541|FG004|STARTED|Cohort2:Treatment Period2(Up to 10 Days)||0||
59880473|NCT04493931|76003542|FG005|STARTED|Cohort2:Treatment Period2(Up to 10 Days)||0||
59750897|NCT02007512|75870163|FG001|Treated|Double Blind Treatment Period||63||
59750898|NCT02007512|75870164|FG002|Treated|Double Blind Treatment Period||60||
59750899|NCT02007512|75870165|FG003|Treated|Double Blind Treatment Period||60||
59750900|NCT02007512|75870162|FG000|COMPLETED|Double Blind Treatment Period||0||
59750901|NCT02007512|75870163|FG001|COMPLETED|Double Blind Treatment Period||0||
59750902|NCT02007512|75870164|FG002|COMPLETED|Double Blind Treatment Period||0||
59750903|NCT02007512|75870165|FG003|COMPLETED|Double Blind Treatment Period||0||
59750904|NCT02007512|75870162|FG000|NOT COMPLETED|Double Blind Treatment Period||63||
59750905|NCT02007512|75870163|FG001|NOT COMPLETED|Double Blind Treatment Period||64||
59750906|NCT02007512|75870164|FG002|NOT COMPLETED|Double Blind Treatment Period||60||
59750907|NCT02007512|75870165|FG003|NOT COMPLETED|Double Blind Treatment Period||60||
59750908|NCT02007512|75870162|FG000|STARTED|Open Label Treatment Period||0||
59750909|NCT02007512|75870163|FG001|STARTED|Open Label Treatment Period|Of the participants with disease progression in double blind period, 21 entered open label period.|21||
59880474|NCT04493931|76003543|FG006|STARTED|Cohort2:Treatment Period2(Up to 10 Days)||0||
59880475|NCT04493931|76003537|FG000|COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||0||
59880476|NCT04493931|76003538|FG001|COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||14||
59880477|NCT04493931|76003539|FG002|COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||0||
59880478|NCT04493931|76003540|FG003|COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||0||
59880479|NCT04493931|76003541|FG004|COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||0||
59880480|NCT04493931|76003542|FG005|COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||0||
59880481|NCT04493931|76003543|FG006|COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||0||
59880482|NCT04493931|76003537|FG000|NOT COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||0||
59880483|NCT04493931|76003538|FG001|NOT COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||3||
59880484|NCT04493931|76003539|FG002|NOT COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||0||
59880485|NCT04493931|76003540|FG003|NOT COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||0||
59880486|NCT04493931|76003541|FG004|NOT COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||0||
59880487|NCT04493931|76003542|FG005|NOT COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||0||
59880488|NCT04493931|76003543|FG006|NOT COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||0||
59880489|NCT04493931|76003537|FG000|STARTED|Cohort 2: Follow-up (Up to 10 Days)||0||
59880490|NCT04493931|76003538|FG001|STARTED|Cohort 2: Follow-up (Up to 10 Days)||14||
59880491|NCT04493931|76003539|FG002|STARTED|Cohort 2: Follow-up (Up to 10 Days)||0||
59880492|NCT04493931|76003540|FG003|STARTED|Cohort 2: Follow-up (Up to 10 Days)||0||
59880493|NCT04493931|76003541|FG004|STARTED|Cohort 2: Follow-up (Up to 10 Days)||0||
59880494|NCT04493931|76003542|FG005|STARTED|Cohort 2: Follow-up (Up to 10 Days)||0||
59880495|NCT04493931|76003543|FG006|STARTED|Cohort 2: Follow-up (Up to 10 Days)||0||
59880496|NCT04493931|76003537|FG000|COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||0||
59880497|NCT04493931|76003538|FG001|COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||14||
59880498|NCT04493931|76003539|FG002|COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||0||
59880499|NCT04493931|76003540|FG003|COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||0||
59880500|NCT04493931|76003541|FG004|COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||0||
59880501|NCT04493931|76003542|FG005|COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||0||
59880502|NCT04493931|76003543|FG006|COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||0||
59880503|NCT04493931|76003537|FG000|NOT COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||0||
59750910|NCT02007512|75870164|FG002|STARTED|Open Label Treatment Period||0||
59880504|NCT04493931|76003538|FG001|NOT COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||0||
59880505|NCT04493931|76003539|FG002|NOT COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||0||
59880506|NCT04493931|76003540|FG003|NOT COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||0||
59880507|NCT04493931|76003541|FG004|NOT COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||0||
59750911|NCT02007512|75870165|FG003|STARTED|Open Label Treatment Period|Of the participants with disease progression in double blind period, 12 entered open label period.|12||
59750912|NCT02007512|75870162|FG000|COMPLETED|Open Label Treatment Period||0||
59750913|NCT02007512|75870163|FG001|COMPLETED|Open Label Treatment Period||0||
59750914|NCT02007512|75870164|FG002|COMPLETED|Open Label Treatment Period||0||
59880508|NCT04493931|76003542|FG005|NOT COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||0||
59880509|NCT04493931|76003543|FG006|NOT COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||0||
59880510|NCT04493931|76003537|FG000|STARTED|Cohort3:Treatment Period 1(Up to 5 Days)||0||
59880511|NCT04493931|76003538|FG001|STARTED|Cohort3:Treatment Period 1(Up to 5 Days)||0||
59880512|NCT04493931|76003539|FG002|STARTED|Cohort3:Treatment Period 1(Up to 5 Days)||10||
59880513|NCT04493931|76003540|FG003|STARTED|Cohort3:Treatment Period 1(Up to 5 Days)||9||
59880514|NCT04493931|76003541|FG004|STARTED|Cohort3:Treatment Period 1(Up to 5 Days)||0||
59880515|NCT04493931|76003542|FG005|STARTED|Cohort3:Treatment Period 1(Up to 5 Days)||0||
59880516|NCT04493931|76003543|FG006|STARTED|Cohort3:Treatment Period 1(Up to 5 Days)||0||
59880517|NCT04493931|76003537|FG000|COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||0||
59750915|NCT02007512|75870165|FG003|COMPLETED|Open Label Treatment Period||0||
59750916|NCT02007512|75870162|FG000|NOT COMPLETED|Open Label Treatment Period||0||
59750917|NCT02007512|75870163|FG001|NOT COMPLETED|Open Label Treatment Period||21||
59750918|NCT02007512|75870164|FG002|NOT COMPLETED|Open Label Treatment Period||0||
59750919|NCT02007512|75870165|FG003|NOT COMPLETED|Open Label Treatment Period||12||
59750920|NCT01942135|75870180|FG000|STARTED|Overall Study||347||
59750921|NCT01942135|75870181|FG001|STARTED|Overall Study||174||
59750922|NCT01942135|75870180|FG000|COMPLETED|Overall Study||0||
59750923|NCT01942135|75870181|FG001|COMPLETED|Overall Study||0||
59880518|NCT04493931|76003538|FG001|COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||0||
59880519|NCT04493931|76003539|FG002|COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||9||
59880520|NCT04493931|76003540|FG003|COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||9||
59880521|NCT04493931|76003541|FG004|COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||0||
59880522|NCT04493931|76003542|FG005|COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||0||
59750924|NCT01942135|75870180|FG000|NOT COMPLETED|Overall Study||347||
59750925|NCT01942135|75870181|FG001|NOT COMPLETED|Overall Study||174||
59750926|NCT01889238|75870187|FG000|STARTED|Overall Study||118||
59750927|NCT01889238|75870187|FG000|COMPLETED|Overall Study|DP, AE, death, treatment withdrawal were considered completed (defined in protocol).|109||
59880523|NCT04493931|76003543|FG006|COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||0||
59880524|NCT04493931|76003537|FG000|NOT COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||0||
59880525|NCT04493931|76003538|FG001|NOT COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||0||
59880526|NCT04493931|76003539|FG002|NOT COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||1||
59880527|NCT04493931|76003540|FG003|NOT COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||0||
59880528|NCT04493931|76003541|FG004|NOT COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||0||
59880529|NCT04493931|76003542|FG005|NOT COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||0||
59880530|NCT04493931|76003543|FG006|NOT COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||0||
59880531|NCT04493931|76003537|FG000|STARTED|Cohort3:Washout Period 1(Up to 10 Days)||0||
59880532|NCT04493931|76003538|FG001|STARTED|Cohort3:Washout Period 1(Up to 10 Days)||0||
59880533|NCT04493931|76003539|FG002|STARTED|Cohort3:Washout Period 1(Up to 10 Days)||9||
59880534|NCT04493931|76003540|FG003|STARTED|Cohort3:Washout Period 1(Up to 10 Days)||9||
59880535|NCT04493931|76003541|FG004|STARTED|Cohort3:Washout Period 1(Up to 10 Days)||0||
59880536|NCT04493931|76003542|FG005|STARTED|Cohort3:Washout Period 1(Up to 10 Days)||0||
59880537|NCT04493931|76003543|FG006|STARTED|Cohort3:Washout Period 1(Up to 10 Days)||0||
59880538|NCT04493931|76003537|FG000|COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||0||
59880539|NCT04493931|76003538|FG001|COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||0||
59880540|NCT04493931|76003539|FG002|COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||9||
59880541|NCT04493931|76003540|FG003|COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||9||
59880542|NCT04493931|76003541|FG004|COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||0||
59880543|NCT04493931|76003542|FG005|COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||0||
59880544|NCT04493931|76003543|FG006|COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||0||
59880545|NCT04493931|76003537|FG000|NOT COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||0||
59880546|NCT04493931|76003538|FG001|NOT COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||0||
59880547|NCT04493931|76003539|FG002|NOT COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||0||
59880548|NCT04493931|76003540|FG003|NOT COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||0||
59880549|NCT04493931|76003541|FG004|NOT COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||0||
59880550|NCT04493931|76003542|FG005|NOT COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||0||
59750928|NCT01889238|75870187|FG000|NOT COMPLETED|Overall Study||9||
59750929|NCT01743131|75870195|FG000|STARTED|Overall Study||73|Enrolled|
59605575|NCT01967706|75715722|FG000|COMPLETED|Second Intervention (Day 3)||21||
59605576|NCT01967706|75715723|FG001|COMPLETED|Second Intervention (Day 3)||22||
59605577|NCT01967706|75715724|FG002|COMPLETED|Second Intervention (Day 3)||9||
59750930|NCT01743131|75870196|FG001|STARTED|Overall Study||69|Enrolled|
59750931|NCT01743131|75870197|FG002|STARTED|Overall Study||43|Enrolled|
59750932|NCT01743131|75870198|FG003|STARTED|Overall Study||1|Enrolled|
59750933|NCT01743131|75870199|FG004|STARTED|Overall Study||127|Enrolled|
59750934|NCT01743131|75870195|FG000|Not Included in Analysis|Overall Study||0||
59750935|NCT01743131|75870196|FG001|Not Included in Analysis|Overall Study||0||
59750936|NCT01743131|75870197|FG002|Not Included in Analysis|Overall Study||0||
59750937|NCT01743131|75870198|FG003|Not Included in Analysis|Overall Study||1||
59750938|NCT01743131|75870199|FG004|Not Included in Analysis|Overall Study||0||
59750939|NCT01743131|75870195|FG000|COMPLETED|Overall Study||73|Received study intervention.|
59750940|NCT01743131|75870196|FG001|COMPLETED|Overall Study||69|Received study intervention.|
59750941|NCT01743131|75870197|FG002|COMPLETED|Overall Study||43|Received study intervention.|
59750942|NCT01743131|75870198|FG003|COMPLETED|Overall Study||1|Received study intervention.|
59750943|NCT01743131|75870199|FG004|COMPLETED|Overall Study||127|Received study intervention.|
59750944|NCT01743131|75870195|FG000|NOT COMPLETED|Overall Study||0||
59750945|NCT01743131|75870196|FG001|NOT COMPLETED|Overall Study||0||
59750946|NCT01743131|75870197|FG002|NOT COMPLETED|Overall Study||0||
59750947|NCT01743131|75870198|FG003|NOT COMPLETED|Overall Study||0||
59750948|NCT01743131|75870199|FG004|NOT COMPLETED|Overall Study||0||
59750949|NCT01147016|75870208|FG000|STARTED|Overall Study||8||
59750950|NCT01147016|75870208|FG000|COMPLETED|Overall Study||8||
59750951|NCT01147016|75870208|FG000|NOT COMPLETED|Overall Study||0||
59750952|NCT00978341|75870213|FG000|STARTED|First Intervention||8||
59750953|NCT00978341|75870214|FG001|STARTED|First Intervention||7||
59750954|NCT00978341|75870213|FG000|COMPLETED|First Intervention||8||
59750955|NCT00978341|75870214|FG001|COMPLETED|First Intervention||7||
59750956|NCT00978341|75870213|FG000|NOT COMPLETED|First Intervention||0||
59750957|NCT00978341|75870214|FG001|NOT COMPLETED|First Intervention||0||
59750958|NCT00978341|75870213|FG000|STARTED|Washout Period of 2 Weeks||8||
59750959|NCT00978341|75870214|FG001|STARTED|Washout Period of 2 Weeks||7||
59750960|NCT00978341|75870213|FG000|COMPLETED|Washout Period of 2 Weeks||7||
59750961|NCT00978341|75870214|FG001|COMPLETED|Washout Period of 2 Weeks||7||
59750962|NCT00978341|75870213|FG000|NOT COMPLETED|Washout Period of 2 Weeks||1||
59750963|NCT00978341|75870214|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0||
59750964|NCT00978341|75870213|FG000|STARTED|Second Intervention||7||
59750965|NCT00978341|75870214|FG001|STARTED|Second Intervention||7||
59750966|NCT00978341|75870213|FG000|COMPLETED|Second Intervention||7||
59750967|NCT00978341|75870214|FG001|COMPLETED|Second Intervention||7||
59750968|NCT00978341|75870213|FG000|NOT COMPLETED|Second Intervention||0||
59750969|NCT00978341|75870214|FG001|NOT COMPLETED|Second Intervention||0||
59750970|NCT00978029|75870224|FG000|STARTED|Overall Study||65||
59750971|NCT00978029|75870225|FG001|STARTED|Overall Study||66||
59750972|NCT00978029|75870226|FG002|STARTED|Overall Study||65||
59750973|NCT00978029|75870224|FG000|COMPLETED|Overall Study||64||
59750974|NCT00978029|75870225|FG001|COMPLETED|Overall Study||63||
59750975|NCT00978029|75870226|FG002|COMPLETED|Overall Study||59||
59750976|NCT00978029|75870224|FG000|NOT COMPLETED|Overall Study||1||
59750977|NCT00978029|75870225|FG001|NOT COMPLETED|Overall Study||3||
59750978|NCT00978029|75870226|FG002|NOT COMPLETED|Overall Study||6||
59750979|NCT00871377|75870234|FG000|STARTED|First Intervention (10 Weeks)||3||
59750980|NCT00871377|75870235|FG001|STARTED|First Intervention (10 Weeks)||4||
59750981|NCT00871377|75870236|FG002|STARTED|First Intervention (10 Weeks)||4||
59750982|NCT00871377|75870237|FG003|STARTED|First Intervention (10 Weeks)||4||
59750983|NCT00871377|75870238|FG004|STARTED|First Intervention (10 Weeks)||4||
59750984|NCT00871377|75870239|FG005|STARTED|First Intervention (10 Weeks)||5||
59750985|NCT00871377|75870234|FG000|COMPLETED|First Intervention (10 Weeks)||3||
59750986|NCT00871377|75870235|FG001|COMPLETED|First Intervention (10 Weeks)||4||
59750987|NCT00871377|75870236|FG002|COMPLETED|First Intervention (10 Weeks)||3||
59750988|NCT00871377|75870237|FG003|COMPLETED|First Intervention (10 Weeks)||4||
59750989|NCT00871377|75870238|FG004|COMPLETED|First Intervention (10 Weeks)||4||
59750990|NCT00871377|75870239|FG005|COMPLETED|First Intervention (10 Weeks)||4||
59750991|NCT00871377|75870234|FG000|NOT COMPLETED|First Intervention (10 Weeks)||0||
59750992|NCT00871377|75870235|FG001|NOT COMPLETED|First Intervention (10 Weeks)||0||
59750993|NCT00871377|75870236|FG002|NOT COMPLETED|First Intervention (10 Weeks)||1||
59750994|NCT00871377|75870237|FG003|NOT COMPLETED|First Intervention (10 Weeks)||0||
59750995|NCT00871377|75870238|FG004|NOT COMPLETED|First Intervention (10 Weeks)||0||
59750996|NCT00871377|75870239|FG005|NOT COMPLETED|First Intervention (10 Weeks)||1||
59750997|NCT00871377|75870234|FG000|STARTED|Washout (6 Weeks)||3||
59750998|NCT00871377|75870235|FG001|STARTED|Washout (6 Weeks)||4||
59750999|NCT00871377|75870236|FG002|STARTED|Washout (6 Weeks)||3||
59880551|NCT04493931|76003543|FG006|NOT COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||0||
59605578|NCT01967706|75715725|FG003|COMPLETED|Second Intervention (Day 3)||9||
59605579|NCT01967706|75715722|FG000|NOT COMPLETED|Second Intervention (Day 3)||0||
59751000|NCT00871377|75870237|FG003|STARTED|Washout (6 Weeks)||4||
59751001|NCT00871377|75870238|FG004|STARTED|Washout (6 Weeks)||4||
59880552|NCT04493931|76003537|FG000|STARTED|Cohort3:Treatment Period 2(Up to 5 Days)||0||
59880553|NCT04493931|76003538|FG001|STARTED|Cohort3:Treatment Period 2(Up to 5 Days)||0||
59880554|NCT04493931|76003539|FG002|STARTED|Cohort3:Treatment Period 2(Up to 5 Days)||9||
59880555|NCT04493931|76003540|FG003|STARTED|Cohort3:Treatment Period 2(Up to 5 Days)||9||
59880556|NCT04493931|76003541|FG004|STARTED|Cohort3:Treatment Period 2(Up to 5 Days)||0||
59880557|NCT04493931|76003542|FG005|STARTED|Cohort3:Treatment Period 2(Up to 5 Days)||0||
59880558|NCT04493931|76003543|FG006|STARTED|Cohort3:Treatment Period 2(Up to 5 Days)||0||
59751002|NCT00871377|75870239|FG005|STARTED|Washout (6 Weeks)||4||
59751003|NCT00871377|75870234|FG000|COMPLETED|Washout (6 Weeks)||2||
59751004|NCT00871377|75870235|FG001|COMPLETED|Washout (6 Weeks)||4||
59751005|NCT00871377|75870236|FG002|COMPLETED|Washout (6 Weeks)||3||
59751006|NCT00871377|75870237|FG003|COMPLETED|Washout (6 Weeks)||4||
59880559|NCT04493931|76003537|FG000|COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||0||
59880560|NCT04493931|76003538|FG001|COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||0||
59880561|NCT04493931|76003539|FG002|COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||9||
59880562|NCT04493931|76003540|FG003|COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||9||
59880563|NCT04493931|76003541|FG004|COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||0||
59880564|NCT04493931|76003542|FG005|COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||0||
59751007|NCT00871377|75870238|FG004|COMPLETED|Washout (6 Weeks)||4||
59751008|NCT00871377|75870239|FG005|COMPLETED|Washout (6 Weeks)||4||
59751009|NCT00871377|75870234|FG000|NOT COMPLETED|Washout (6 Weeks)||1||
59751010|NCT00871377|75870235|FG001|NOT COMPLETED|Washout (6 Weeks)||0||
59751011|NCT00871377|75870236|FG002|NOT COMPLETED|Washout (6 Weeks)||0||
59751012|NCT00871377|75870237|FG003|NOT COMPLETED|Washout (6 Weeks)||0||
59751013|NCT00871377|75870238|FG004|NOT COMPLETED|Washout (6 Weeks)||0||
59880565|NCT04493931|76003543|FG006|COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||0||
59880566|NCT04493931|76003537|FG000|NOT COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||0||
59880567|NCT04493931|76003538|FG001|NOT COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||0||
59880568|NCT04493931|76003539|FG002|NOT COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||0||
59880569|NCT04493931|76003540|FG003|NOT COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||0||
59880570|NCT04493931|76003541|FG004|NOT COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||0||
59880571|NCT04493931|76003542|FG005|NOT COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||0||
59880572|NCT04493931|76003543|FG006|NOT COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||0||
59880573|NCT04493931|76003537|FG000|STARTED|Cohort 3: Follow-up (Up to 10 Days)||0||
59880574|NCT04493931|76003538|FG001|STARTED|Cohort 3: Follow-up (Up to 10 Days)||0||
59880575|NCT04493931|76003539|FG002|STARTED|Cohort 3: Follow-up (Up to 10 Days)||9||
59880576|NCT04493931|76003540|FG003|STARTED|Cohort 3: Follow-up (Up to 10 Days)||9||
59880577|NCT04493931|76003541|FG004|STARTED|Cohort 3: Follow-up (Up to 10 Days)||0||
59880578|NCT04493931|76003542|FG005|STARTED|Cohort 3: Follow-up (Up to 10 Days)||0||
59880579|NCT04493931|76003543|FG006|STARTED|Cohort 3: Follow-up (Up to 10 Days)||0||
59880580|NCT04493931|76003537|FG000|COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||0||
59880581|NCT04493931|76003538|FG001|COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||0||
59880582|NCT04493931|76003539|FG002|COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||9||
59880583|NCT04493931|76003540|FG003|COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||9||
59880584|NCT04493931|76003541|FG004|COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||0||
59880585|NCT04493931|76003542|FG005|COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||0||
59880586|NCT04493931|76003543|FG006|COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||0||
59880587|NCT04493931|76003537|FG000|NOT COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||0||
59880588|NCT04493931|76003538|FG001|NOT COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||0||
59880589|NCT04493931|76003539|FG002|NOT COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||0||
59880590|NCT04493931|76003540|FG003|NOT COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||0||
59880591|NCT04493931|76003541|FG004|NOT COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||0||
59880592|NCT04493931|76003542|FG005|NOT COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||0||
59880593|NCT04493931|76003543|FG006|NOT COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||0||
59880594|NCT04493931|76003537|FG000|STARTED|Cohort4:Treatment Period 1(Up to 3 Days)||0||
59880595|NCT04493931|76003538|FG001|STARTED|Cohort4:Treatment Period 1(Up to 3 Days)||0||
59751014|NCT00871377|75870239|FG005|NOT COMPLETED|Washout (6 Weeks)||0||
59751015|NCT00871377|75870234|FG000|STARTED|Second Intervention (10 Weeks)||2||
59751016|NCT00871377|75870235|FG001|STARTED|Second Intervention (10 Weeks)||4||
59751017|NCT00871377|75870236|FG002|STARTED|Second Intervention (10 Weeks)||3||
59751018|NCT00871377|75870237|FG003|STARTED|Second Intervention (10 Weeks)||4||
59751019|NCT00871377|75870238|FG004|STARTED|Second Intervention (10 Weeks)||4||
59751020|NCT00871377|75870239|FG005|STARTED|Second Intervention (10 Weeks)||4||
59751021|NCT00871377|75870234|FG000|COMPLETED|Second Intervention (10 Weeks)||2||
59751022|NCT00871377|75870235|FG001|COMPLETED|Second Intervention (10 Weeks)||4||
59751023|NCT00871377|75870236|FG002|COMPLETED|Second Intervention (10 Weeks)||3||
59751024|NCT00871377|75870237|FG003|COMPLETED|Second Intervention (10 Weeks)||4||
59751025|NCT00871377|75870238|FG004|COMPLETED|Second Intervention (10 Weeks)||4||
59751026|NCT00871377|75870239|FG005|COMPLETED|Second Intervention (10 Weeks)||4||
59751027|NCT00871377|75870234|FG000|NOT COMPLETED|Second Intervention (10 Weeks)||0||
59751028|NCT00871377|75870235|FG001|NOT COMPLETED|Second Intervention (10 Weeks)||0||
59751029|NCT00871377|75870236|FG002|NOT COMPLETED|Second Intervention (10 Weeks)||0||
59751030|NCT00871377|75870237|FG003|NOT COMPLETED|Second Intervention (10 Weeks)||0||
59751031|NCT00871377|75870238|FG004|NOT COMPLETED|Second Intervention (10 Weeks)||0||
59751032|NCT00871377|75870239|FG005|NOT COMPLETED|Second Intervention (10 Weeks)||0||
59751033|NCT00871377|75870234|FG000|STARTED|Washout (6 Weeks)||2||
59751034|NCT00871377|75870235|FG001|STARTED|Washout (6 Weeks)||4||
59751035|NCT00871377|75870236|FG002|STARTED|Washout (6 Weeks)||3||
59751036|NCT00871377|75870237|FG003|STARTED|Washout (6 Weeks)||4||
59751037|NCT00871377|75870238|FG004|STARTED|Washout (6 Weeks)||4||
59751038|NCT00871377|75870239|FG005|STARTED|Washout (6 Weeks)||4||
59751039|NCT00871377|75870234|FG000|COMPLETED|Washout (6 Weeks)||2||
59751040|NCT00871377|75870235|FG001|COMPLETED|Washout (6 Weeks)||4||
59751041|NCT00871377|75870236|FG002|COMPLETED|Washout (6 Weeks)||3||
59751042|NCT00871377|75870237|FG003|COMPLETED|Washout (6 Weeks)||4||
59751043|NCT00871377|75870238|FG004|COMPLETED|Washout (6 Weeks)||4||
59751044|NCT00871377|75870239|FG005|COMPLETED|Washout (6 Weeks)||3||
59751045|NCT00871377|75870234|FG000|NOT COMPLETED|Washout (6 Weeks)||0||
59751046|NCT00871377|75870235|FG001|NOT COMPLETED|Washout (6 Weeks)||0||
59751047|NCT00871377|75870236|FG002|NOT COMPLETED|Washout (6 Weeks)||0||
59751048|NCT00871377|75870237|FG003|NOT COMPLETED|Washout (6 Weeks)||0||
59751049|NCT00871377|75870238|FG004|NOT COMPLETED|Washout (6 Weeks)||0||
59751050|NCT00871377|75870239|FG005|NOT COMPLETED|Washout (6 Weeks)||1||
59751051|NCT00871377|75870234|FG000|STARTED|Third Intervention (10 Weeks)||2||
60135981|NCT01274715|76258652|FG000|STARTED|Overall Study||12||
60135982|NCT01274715|76258652|FG000|Screened Out at Baseline|Overall Study||3||
60135983|NCT01274715|76258652|FG000|COMPLETED|Overall Study||8||
60135984|NCT01274715|76258652|FG000|NOT COMPLETED|Overall Study||4||
60135985|NCT01410227|76258656|FG000|STARTED|Overall Study||8||
59751052|NCT00871377|75870235|FG001|STARTED|Third Intervention (10 Weeks)||4||
59751053|NCT00871377|75870236|FG002|STARTED|Third Intervention (10 Weeks)||3||
59751054|NCT00871377|75870237|FG003|STARTED|Third Intervention (10 Weeks)||4||
59751055|NCT00871377|75870238|FG004|STARTED|Third Intervention (10 Weeks)||4||
59751056|NCT00871377|75870239|FG005|STARTED|Third Intervention (10 Weeks)||3||
59751057|NCT00871377|75870234|FG000|COMPLETED|Third Intervention (10 Weeks)||2||
59751058|NCT00871377|75870235|FG001|COMPLETED|Third Intervention (10 Weeks)||4||
59751059|NCT00871377|75870236|FG002|COMPLETED|Third Intervention (10 Weeks)||3||
59751060|NCT00871377|75870237|FG003|COMPLETED|Third Intervention (10 Weeks)||3||
59751061|NCT00871377|75870238|FG004|COMPLETED|Third Intervention (10 Weeks)||4||
59751062|NCT00871377|75870239|FG005|COMPLETED|Third Intervention (10 Weeks)||3||
59751063|NCT00871377|75870234|FG000|NOT COMPLETED|Third Intervention (10 Weeks)||0||
59751064|NCT00871377|75870235|FG001|NOT COMPLETED|Third Intervention (10 Weeks)||0||
59751065|NCT00871377|75870236|FG002|NOT COMPLETED|Third Intervention (10 Weeks)||0||
59751066|NCT00871377|75870237|FG003|NOT COMPLETED|Third Intervention (10 Weeks)||1||
59751067|NCT00871377|75870238|FG004|NOT COMPLETED|Third Intervention (10 Weeks)||0||
59751068|NCT00871377|75870239|FG005|NOT COMPLETED|Third Intervention (10 Weeks)||0||
59751069|NCT00977561|75870249|FG000|STARTED|Overall Study||5||
60135986|NCT01410227|76258657|FG001|STARTED|Overall Study||8||
60135987|NCT01410227|76258658|FG002|STARTED|Overall Study||15||
60135988|NCT01410227|76258659|FG003|STARTED|Overall Study||6||
60135989|NCT01410227|76258656|FG000|COMPLETED|Overall Study||4||
60135990|NCT01410227|76258657|FG001|COMPLETED|Overall Study||8||
60135991|NCT01410227|76258658|FG002|COMPLETED|Overall Study||13||
60135992|NCT01410227|76258659|FG003|COMPLETED|Overall Study||5||
59751070|NCT00977561|75870250|FG001|STARTED|Overall Study||4||
59751071|NCT00977561|75870249|FG000|COMPLETED|Overall Study||0||
59751072|NCT00977561|75870250|FG001|COMPLETED|Overall Study||0||
59751073|NCT00977561|75870249|FG000|NOT COMPLETED|Overall Study||5||
59751074|NCT00977561|75870250|FG001|NOT COMPLETED|Overall Study||4||
59751075|NCT00594165|75870258|FG000|STARTED|Overall Study||217||
59751076|NCT00594165|75870258|FG000|COMPLETED|Overall Study|Study fully recruited. Completed upon market authorization and commercial availability of Neupro.|0||
59751077|NCT00594165|75870258|FG000|NOT COMPLETED|Overall Study||217||
59751078|NCT00975923|75870264|FG000|STARTED|Overall Study||30||
59751079|NCT00975923|75870265|FG001|STARTED|Overall Study||30||
60135993|NCT01410227|76258656|FG000|NOT COMPLETED|Overall Study||4||
60135994|NCT01410227|76258657|FG001|NOT COMPLETED|Overall Study||0||
60135995|NCT01410227|76258658|FG002|NOT COMPLETED|Overall Study||2||
59751080|NCT00975923|75870264|FG000|COMPLETED|Overall Study||30||
59762629|NCT00871728|75882461|FG000|NOT COMPLETED|Overall Study||20||
60135996|NCT01410227|76258659|FG003|NOT COMPLETED|Overall Study||1||
60135997|NCT01274559|76258671|FG000|STARTED|Overall Study||587||
60135998|NCT01274559|76258672|FG001|STARTED|Overall Study||586||
59751081|NCT00975923|75870265|FG001|COMPLETED|Overall Study|1 hospital was sold, yielding 29 hospitals in the Tool Kit Group|29||
59751082|NCT00975923|75870264|FG000|NOT COMPLETED|Overall Study||0||
59751083|NCT00975923|75870265|FG001|NOT COMPLETED|Overall Study||1||
59751084|NCT00928070|75870274|FG000|STARTED|Overall Study||283||
59751085|NCT00928070|75870275|FG001|STARTED|Overall Study||283||
59751086|NCT00928070|75870274|FG000|Treated|Overall Study||281||
59751087|NCT00928070|75870275|FG001|Treated|Overall Study||281||
59751088|NCT00928070|75870274|FG000|COMPLETED|Overall Study||220||
59751089|NCT00928070|75870275|FG001|COMPLETED|Overall Study||226||
59751090|NCT00928070|75870274|FG000|NOT COMPLETED|Overall Study||63||
59751091|NCT00928070|75870275|FG001|NOT COMPLETED|Overall Study||57||
59751092|NCT00924404|75870283|FG000|STARTED|Overall Study||27||
59751093|NCT00924404|75870284|FG001|STARTED|Overall Study||26||
59751094|NCT00924404|75870283|FG000|COMPLETED|Overall Study||21||
59751095|NCT00924404|75870284|FG001|COMPLETED|Overall Study||22||
59751096|NCT00924404|75870283|FG000|NOT COMPLETED|Overall Study||6||
59751097|NCT00924404|75870284|FG001|NOT COMPLETED|Overall Study||4||
59751098|NCT00976937|75870292|FG000|STARTED|Overall Study|Randomized|158||
59751099|NCT00976937|75870293|FG001|STARTED|Overall Study||161||
59751100|NCT00976937|75870292|FG000|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|158||
59751101|NCT00976937|75870293|FG001|Treated/Safety Population|Overall Study||161||
59751102|NCT00976937|75870292|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study|All randomized patients who received at least 1 dose of study drug.|158||
59751103|NCT00976937|75870293|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||161||
59751104|NCT00976937|75870292|FG000|COMPLETED|Overall Study||142||
59751105|NCT00976937|75870293|FG001|COMPLETED|Overall Study||150||
59751106|NCT00976937|75870292|FG000|NOT COMPLETED|Overall Study||16||
59751107|NCT00976937|75870293|FG001|NOT COMPLETED|Overall Study||11||
59751108|NCT00976703|75870301|FG000|STARTED|Overall Study||99||
59751109|NCT00976703|75870302|FG001|STARTED|Overall Study||98||
59751110|NCT00976703|75870301|FG000|COMPLETED|Overall Study||96||
59751111|NCT00976703|75870302|FG001|COMPLETED|Overall Study||95||
59751112|NCT00976703|75870301|FG000|NOT COMPLETED|Overall Study||3||
59751113|NCT00976703|75870302|FG001|NOT COMPLETED|Overall Study||3||
59751114|NCT00975689|75870310|FG000|STARTED|Overall Study||17||
59751115|NCT00975689|75870311|FG001|STARTED|Overall Study||18||
59751116|NCT00975689|75870310|FG000|COMPLETED|Overall Study||15||
59751117|NCT00975689|75870311|FG001|COMPLETED|Overall Study||15||
59751118|NCT00975689|75870310|FG000|NOT COMPLETED|Overall Study||2||
59751119|NCT00975689|75870311|FG001|NOT COMPLETED|Overall Study||3||
59751120|NCT00922766|75870317|FG000|STARTED|Overall Study||617||
59751121|NCT00922766|75870317|FG000|COMPLETED|Overall Study||610||
59751122|NCT00922766|75870317|FG000|NOT COMPLETED|Overall Study||7||
59751123|NCT00917852|75870321|FG000|STARTED|Overall Study||51||
59751124|NCT00917852|75870321|FG000|COMPLETED|Overall Study||45||
59751125|NCT00917852|75870321|FG000|NOT COMPLETED|Overall Study||6||
59751126|NCT00976391|75870328|FG000|STARTED|Treatment Period (52 Weeks)||285||
59751127|NCT00976391|75870329|FG001|STARTED|Treatment Period (52 Weeks)||281||
59751128|NCT00976391|75870328|FG000|COMPLETED|Treatment Period (52 Weeks)||243||
60135999|NCT01274559|76258671|FG000|Treated|Overall Study||572||
60136000|NCT01274559|76258672|FG001|Treated|Overall Study||572||
60136001|NCT01274559|76258671|FG000|COMPLETED|Overall Study||390||
60136002|NCT01274559|76258672|FG001|COMPLETED|Overall Study||441||
60136003|NCT01274559|76258671|FG000|NOT COMPLETED|Overall Study||197||
60136004|NCT01274559|76258672|FG001|NOT COMPLETED|Overall Study||145||
60136005|NCT01409993|76258680|FG000|STARTED|Overall Study||25||
59605580|NCT01967706|75715723|FG001|NOT COMPLETED|Second Intervention (Day 3)||0||
59751129|NCT00976391|75870329|FG001|COMPLETED|Treatment Period (52 Weeks)||242||
59751130|NCT00976391|75870328|FG000|NOT COMPLETED|Treatment Period (52 Weeks)||42||
59751131|NCT00976391|75870329|FG001|NOT COMPLETED|Treatment Period (52 Weeks)||39||
59751132|NCT00976391|75870328|FG000|STARTED|Follow-up Period (8 Weeks)||285||
59751133|NCT00976391|75870329|FG001|STARTED|Follow-up Period (8 Weeks)||281||
59751134|NCT00976391|75870328|FG000|COMPLETED|Follow-up Period (8 Weeks)||256||
59880596|NCT04493931|76003539|FG002|STARTED|Cohort4:Treatment Period 1(Up to 3 Days)||0||
59880597|NCT04493931|76003540|FG003|STARTED|Cohort4:Treatment Period 1(Up to 3 Days)||0||
59880598|NCT04493931|76003541|FG004|STARTED|Cohort4:Treatment Period 1(Up to 3 Days)||6||
59751135|NCT00976391|75870329|FG001|COMPLETED|Follow-up Period (8 Weeks)||247||
59751136|NCT00976391|75870328|FG000|NOT COMPLETED|Follow-up Period (8 Weeks)||29||
59751137|NCT00976391|75870329|FG001|NOT COMPLETED|Follow-up Period (8 Weeks)||34||
59950789|NCT02677493|76069658|FG000|STARTED|Overall Study||1197||
60136006|NCT01409993|76258681|FG001|STARTED|Overall Study||26||
60136007|NCT01409993|76258682|FG002|STARTED|Overall Study||14||
60136008|NCT01409993|76258683|FG003|STARTED|Overall Study||13||
60136009|NCT01409993|76258680|FG000|COMPLETED|Overall Study||21||
60136010|NCT01409993|76258681|FG001|COMPLETED|Overall Study||21||
60136011|NCT01409993|76258682|FG002|COMPLETED|Overall Study||11||
60136012|NCT01409993|76258683|FG003|COMPLETED|Overall Study||8||
60136013|NCT01409993|76258680|FG000|NOT COMPLETED|Overall Study||4||
59880599|NCT04493931|76003542|FG005|STARTED|Cohort4:Treatment Period 1(Up to 3 Days)||5||
59880600|NCT04493931|76003543|FG006|STARTED|Cohort4:Treatment Period 1(Up to 3 Days)||3||
59880601|NCT04493931|76003537|FG000|COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||0||
59880602|NCT04493931|76003538|FG001|COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||0||
59880603|NCT04493931|76003539|FG002|COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||0||
59880604|NCT04493931|76003540|FG003|COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||0||
59880605|NCT04493931|76003541|FG004|COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||6||
59880606|NCT04493931|76003542|FG005|COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||5||
59880607|NCT04493931|76003543|FG006|COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||3||
59880608|NCT04493931|76003537|FG000|NOT COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||0||
59880609|NCT04493931|76003538|FG001|NOT COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||0||
59880610|NCT04493931|76003539|FG002|NOT COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||0||
59880611|NCT04493931|76003540|FG003|NOT COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||0||
59880612|NCT04493931|76003541|FG004|NOT COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||0||
59880613|NCT04493931|76003542|FG005|NOT COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||0||
59880614|NCT04493931|76003543|FG006|NOT COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||0||
59880615|NCT04493931|76003537|FG000|STARTED|Cohort4:Washout Period 1(Up to 3 Days)||0||
59880616|NCT04493931|76003538|FG001|STARTED|Cohort4:Washout Period 1(Up to 3 Days)||0||
59880617|NCT04493931|76003539|FG002|STARTED|Cohort4:Washout Period 1(Up to 3 Days)||0||
59880618|NCT04493931|76003540|FG003|STARTED|Cohort4:Washout Period 1(Up to 3 Days)||0||
59880619|NCT04493931|76003541|FG004|STARTED|Cohort4:Washout Period 1(Up to 3 Days)||6||
59880620|NCT04493931|76003542|FG005|STARTED|Cohort4:Washout Period 1(Up to 3 Days)||5||
59880621|NCT04493931|76003543|FG006|STARTED|Cohort4:Washout Period 1(Up to 3 Days)||3||
59880622|NCT04493931|76003537|FG000|COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||0||
59880623|NCT04493931|76003538|FG001|COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||0||
59880624|NCT04493931|76003539|FG002|COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||0||
59880625|NCT04493931|76003540|FG003|COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||0||
59880626|NCT04493931|76003541|FG004|COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||6||
59880627|NCT04493931|76003542|FG005|COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||5||
59880628|NCT04493931|76003543|FG006|COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||3||
59880629|NCT04493931|76003537|FG000|NOT COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||0||
59880630|NCT04493931|76003538|FG001|NOT COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||0||
59880631|NCT04493931|76003539|FG002|NOT COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||0||
59880632|NCT04493931|76003540|FG003|NOT COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||0||
59880633|NCT04493931|76003541|FG004|NOT COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||0||
59880634|NCT04493931|76003542|FG005|NOT COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||0||
59880635|NCT04493931|76003543|FG006|NOT COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||0||
59880636|NCT04493931|76003537|FG000|STARTED|Cohort4:Treatment Period 2(Up to 3 Days)||0||
59880637|NCT04493931|76003538|FG001|STARTED|Cohort4:Treatment Period 2(Up to 3 Days)||0||
59880638|NCT04493931|76003539|FG002|STARTED|Cohort4:Treatment Period 2(Up to 3 Days)||0||
59880639|NCT04493931|76003540|FG003|STARTED|Cohort4:Treatment Period 2(Up to 3 Days)||0||
59880640|NCT04493931|76003541|FG004|STARTED|Cohort4:Treatment Period 2(Up to 3 Days)||6||
59880641|NCT04493931|76003542|FG005|STARTED|Cohort4:Treatment Period 2(Up to 3 Days)||5||
59880642|NCT04493931|76003543|FG006|STARTED|Cohort4:Treatment Period 2(Up to 3 Days)||3||
59880643|NCT04493931|76003537|FG000|COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||0||
59880644|NCT04493931|76003538|FG001|COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||0||
59880645|NCT04493931|76003539|FG002|COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||0||
59880646|NCT04493931|76003540|FG003|COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||0||
59880647|NCT04493931|76003541|FG004|COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||6||
59880648|NCT04493931|76003542|FG005|COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||5||
59880649|NCT04493931|76003543|FG006|COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||3||
59880650|NCT04493931|76003537|FG000|NOT COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||0||
60004503|NCT02711995|76120446|FG000|NOT COMPLETED|Second Intervention (30 Days)||0||
60004504|NCT03503617|76120454|FG000|STARTED|Overall Study||14||
60004505|NCT03503617|76120455|FG001|STARTED|Overall Study||13||
60004506|NCT03503617|76120454|FG000|COMPLETED|Overall Study||14||
60004507|NCT03503617|76120455|FG001|COMPLETED|Overall Study||10||
60004508|NCT03503617|76120454|FG000|NOT COMPLETED|Overall Study||0||
60004509|NCT03503617|76120455|FG001|NOT COMPLETED|Overall Study||3||
60004510|NCT01654315|76120464|FG000|STARTED|Overall Study||15||
60004511|NCT01654315|76120465|FG001|STARTED|Overall Study||10||
60004512|NCT01654315|76120466|FG002|STARTED|Overall Study||9||
60004513|NCT01654315|76120464|FG000|COMPLETED|Overall Study||15||
60004514|NCT01654315|76120465|FG001|COMPLETED|Overall Study||10||
60004515|NCT01654315|76120466|FG002|COMPLETED|Overall Study||9||
60004516|NCT01654315|76120464|FG000|NOT COMPLETED|Overall Study||0||
60004517|NCT01654315|76120465|FG001|NOT COMPLETED|Overall Study||0||
60004518|NCT01654315|76120466|FG002|NOT COMPLETED|Overall Study||0||
60004519|NCT02514239|76120484|FG000|STARTED|Overall Study||5||
60004520|NCT02514239|76120485|FG001|STARTED|Overall Study||4||
60004521|NCT02514239|76120486|FG002|STARTED|Overall Study||3||
60004522|NCT02514239|76120487|FG003|STARTED|Overall Study||3||
60004523|NCT02514239|76120488|FG004|STARTED|Overall Study||3||
60004524|NCT02514239|76120489|FG005|STARTED|Overall Study||5||
60004525|NCT02514239|76120490|FG006|STARTED|Overall Study||4||
60004526|NCT02514239|76120491|FG007|STARTED|Overall Study||3||
60004527|NCT02514239|76120492|FG008|STARTED|Overall Study||10||
60004528|NCT02514239|76120493|FG009|STARTED|Overall Study||3||
60004529|NCT02514239|76120484|FG000|Treated|Overall Study||5||
60004530|NCT02514239|76120485|FG001|Treated|Overall Study||3||
60004531|NCT02514239|76120486|FG002|Treated|Overall Study||3||
60004532|NCT02514239|76120487|FG003|Treated|Overall Study||3||
60004533|NCT02514239|76120488|FG004|Treated|Overall Study||3||
60004534|NCT02514239|76120489|FG005|Treated|Overall Study||5||
60004535|NCT02514239|76120490|FG006|Treated|Overall Study||4||
60004536|NCT02514239|76120491|FG007|Treated|Overall Study||3||
60004537|NCT02514239|76120492|FG008|Treated|Overall Study||10||
60004538|NCT02514239|76120493|FG009|Treated|Overall Study||3||
60004539|NCT02514239|76120484|FG000|COMPLETED|Overall Study||0|10 cycles completed|
60004540|NCT02514239|76120485|FG001|COMPLETED|Overall Study||0|10 cycles completed|
60004541|NCT02514239|76120486|FG002|COMPLETED|Overall Study||1|10 cycles completed|
60004542|NCT02514239|76120487|FG003|COMPLETED|Overall Study||0|10 cycles completed|
60004543|NCT02514239|76120488|FG004|COMPLETED|Overall Study||0|10 cycles completed|
60004544|NCT02514239|76120489|FG005|COMPLETED|Overall Study||1|10 cycles completed|
60004545|NCT02514239|76120490|FG006|COMPLETED|Overall Study||0|10 cycles completed|
60004546|NCT02514239|76120491|FG007|COMPLETED|Overall Study||0|10 cycles completed|
60004547|NCT02514239|76120492|FG008|COMPLETED|Overall Study||2|10 cycles completed|
60004548|NCT02514239|76120493|FG009|COMPLETED|Overall Study||0|10 cycles completed|
60004549|NCT02514239|76120484|FG000|NOT COMPLETED|Overall Study||5||
60004550|NCT02514239|76120485|FG001|NOT COMPLETED|Overall Study||4||
60004551|NCT02514239|76120486|FG002|NOT COMPLETED|Overall Study||2||
60004552|NCT02514239|76120487|FG003|NOT COMPLETED|Overall Study||3||
60004553|NCT02514239|76120488|FG004|NOT COMPLETED|Overall Study||3||
60004554|NCT02514239|76120489|FG005|NOT COMPLETED|Overall Study||4||
60004555|NCT02514239|76120490|FG006|NOT COMPLETED|Overall Study||4||
60004556|NCT02514239|76120491|FG007|NOT COMPLETED|Overall Study||3||
60004557|NCT02514239|76120492|FG008|NOT COMPLETED|Overall Study||8||
60004558|NCT02514239|76120493|FG009|NOT COMPLETED|Overall Study||3||
60004559|NCT02709109|76120537|FG000|STARTED|Treatment Period 1 (28 Days)||49||
60004560|NCT02709109|76120538|FG001|STARTED|Treatment Period 1 (28 Days)||47||
60004561|NCT02709109|76120539|FG002|STARTED|Treatment Period 1 (28 Days)||22||
60136014|NCT01409993|76258681|FG001|NOT COMPLETED|Overall Study||5||
60004562|NCT02709109|76120540|FG003|STARTED|Treatment Period 1 (28 Days)||24||
60004563|NCT02709109|76120537|FG000|COMPLETED|Treatment Period 1 (28 Days)||45||
60004564|NCT02709109|76120538|FG001|COMPLETED|Treatment Period 1 (28 Days)||42||
60004565|NCT02709109|76120539|FG002|COMPLETED|Treatment Period 1 (28 Days)||21||
60004566|NCT02709109|76120540|FG003|COMPLETED|Treatment Period 1 (28 Days)||24||
60004567|NCT02709109|76120537|FG000|NOT COMPLETED|Treatment Period 1 (28 Days)||4||
60004568|NCT02709109|76120538|FG001|NOT COMPLETED|Treatment Period 1 (28 Days)||5||
60004569|NCT02709109|76120539|FG002|NOT COMPLETED|Treatment Period 1 (28 Days)||1||
60004570|NCT02709109|76120540|FG003|NOT COMPLETED|Treatment Period 1 (28 Days)||0||
60004571|NCT02709109|76120537|FG000|STARTED|Washout Period (28 Days)||45||
60004572|NCT02709109|76120538|FG001|STARTED|Washout Period (28 Days)||42||
60004573|NCT02709109|76120539|FG002|STARTED|Washout Period (28 Days)||21||
60004574|NCT02709109|76120540|FG003|STARTED|Washout Period (28 Days)||24||
60004575|NCT02709109|76120537|FG000|COMPLETED|Washout Period (28 Days)||43||
60004576|NCT02709109|76120538|FG001|COMPLETED|Washout Period (28 Days)||40||
60004577|NCT02709109|76120539|FG002|COMPLETED|Washout Period (28 Days)||18||
60004578|NCT02709109|76120540|FG003|COMPLETED|Washout Period (28 Days)||24||
60004579|NCT02709109|76120537|FG000|NOT COMPLETED|Washout Period (28 Days)||2||
60004580|NCT02709109|76120538|FG001|NOT COMPLETED|Washout Period (28 Days)||2||
60136015|NCT01409993|76258682|FG002|NOT COMPLETED|Overall Study||3||
60004581|NCT02709109|76120539|FG002|NOT COMPLETED|Washout Period (28 Days)||3||
60004582|NCT02709109|76120540|FG003|NOT COMPLETED|Washout Period (28 Days)||0||
60004583|NCT02709109|76120537|FG000|STARTED|Treatment Period 2 (28 Days)||43||
60004584|NCT02709109|76120538|FG001|STARTED|Treatment Period 2 (28 Days)||40||
60004585|NCT02709109|76120539|FG002|STARTED|Treatment Period 2 (28 Days)||18||
60004586|NCT02709109|76120540|FG003|STARTED|Treatment Period 2 (28 Days)||24||
60004587|NCT02709109|76120537|FG000|COMPLETED|Treatment Period 2 (28 Days)||41||
60004588|NCT02709109|76120538|FG001|COMPLETED|Treatment Period 2 (28 Days)||36||
60004589|NCT02709109|76120539|FG002|COMPLETED|Treatment Period 2 (28 Days)||15||
60004590|NCT02709109|76120540|FG003|COMPLETED|Treatment Period 2 (28 Days)||24||
60004591|NCT02709109|76120537|FG000|NOT COMPLETED|Treatment Period 2 (28 Days)||2||
60004592|NCT02709109|76120538|FG001|NOT COMPLETED|Treatment Period 2 (28 Days)||4||
60004593|NCT02709109|76120539|FG002|NOT COMPLETED|Treatment Period 2 (28 Days)||3||
60004594|NCT02709109|76120540|FG003|NOT COMPLETED|Treatment Period 2 (28 Days)||0||
60004595|NCT01979003|76120551|FG000|STARTED|Overall Study||100||
60004596|NCT01979003|76120551|FG000|COMPLETED|Overall Study||72||
60004597|NCT01979003|76120551|FG000|NOT COMPLETED|Overall Study||28||
60004598|NCT04289051|76120555|FG000|STARTED|Overall Study||13||
60004599|NCT04289051|76120556|FG001|STARTED|Overall Study||13||
60004600|NCT04289051|76120557|FG002|STARTED|Overall Study||13||
60004601|NCT04289051|76120555|FG000|First Intervention (2 Weeks)|Overall Study||13||
60004602|NCT04289051|76120556|FG001|First Intervention (2 Weeks)|Overall Study||13||
60004603|NCT04289051|76120557|FG002|First Intervention (2 Weeks)|Overall Study||11||
60004604|NCT04289051|76120555|FG000|Washout (1 Week)|Overall Study||13||
60004605|NCT04289051|76120556|FG001|Washout (1 Week)|Overall Study||13||
60004606|NCT04289051|76120557|FG002|Washout (1 Week)|Overall Study||11||
60004607|NCT04289051|76120555|FG000|Second Intervention (2 Weeks)|Overall Study||13||
60004608|NCT04289051|76120556|FG001|Second Intervention (2 Weeks)|Overall Study||13||
60004609|NCT04289051|76120557|FG002|Second Intervention (2 Weeks)|Overall Study||11||
60004610|NCT04289051|76120555|FG000|Washout (1 Week)|Overall Study||13||
60004611|NCT04289051|76120556|FG001|Washout (1 Week)|Overall Study||13||
60004612|NCT04289051|76120557|FG002|Washout (1 Week)|Overall Study||11||
60004613|NCT04289051|76120555|FG000|Third Intervention (2 Weeks)|Overall Study||13||
60004614|NCT04289051|76120556|FG001|Third Intervention (2 Weeks)|Overall Study||13||
60004615|NCT04289051|76120557|FG002|Third Intervention (2 Weeks)|Overall Study||11||
60004616|NCT04289051|76120555|FG000|COMPLETED|Overall Study||13||
60004617|NCT04289051|76120556|FG001|COMPLETED|Overall Study||13||
60004618|NCT04289051|76120557|FG002|COMPLETED|Overall Study||11||
60004619|NCT04289051|76120555|FG000|NOT COMPLETED|Overall Study||0||
60004620|NCT04289051|76120556|FG001|NOT COMPLETED|Overall Study||0||
60004621|NCT04289051|76120557|FG002|NOT COMPLETED|Overall Study||2||
60004622|NCT02709655|76120565|FG000|STARTED|Single-Blind Phase (4 Weeks)||683||
60004623|NCT02709655|76120566|FG001|STARTED|Single-Blind Phase (4 Weeks)||0||
60004624|NCT02709655|76120567|FG002|STARTED|Single-Blind Phase (4 Weeks)||0||
60004625|NCT02709655|76120568|FG003|STARTED|Single-Blind Phase (4 Weeks)||0||
60004626|NCT02709655|76120569|FG004|STARTED|Single-Blind Phase (4 Weeks)||0||
60004627|NCT02709655|76120565|FG000|Received at Least 1 Dose of Study Drug|Single-Blind Phase (4 Weeks)||677||
60004628|NCT02709655|76120566|FG001|Received at Least 1 Dose of Study Drug|Single-Blind Phase (4 Weeks)||0||
60004629|NCT02709655|76120567|FG002|Received at Least 1 Dose of Study Drug|Single-Blind Phase (4 Weeks)||0||
60004630|NCT02709655|76120568|FG003|Received at Least 1 Dose of Study Drug|Single-Blind Phase (4 Weeks)||0||
60004631|NCT02709655|76120569|FG004|Received at Least 1 Dose of Study Drug|Single-Blind Phase (4 Weeks)||0||
60004632|NCT02709655|76120565|FG000|COMPLETED|Single-Blind Phase (4 Weeks)||540||
60004633|NCT02709655|76120566|FG001|COMPLETED|Single-Blind Phase (4 Weeks)||0||
60004634|NCT02709655|76120567|FG002|COMPLETED|Single-Blind Phase (4 Weeks)||0||
60004635|NCT02709655|76120568|FG003|COMPLETED|Single-Blind Phase (4 Weeks)||0||
60004636|NCT02709655|76120569|FG004|COMPLETED|Single-Blind Phase (4 Weeks)||0||
60004637|NCT02709655|76120565|FG000|NOT COMPLETED|Single-Blind Phase (4 Weeks)||143||
60004638|NCT02709655|76120566|FG001|NOT COMPLETED|Single-Blind Phase (4 Weeks)||0||
60004639|NCT02709655|76120567|FG002|NOT COMPLETED|Single-Blind Phase (4 Weeks)||0||
60004640|NCT02709655|76120568|FG003|NOT COMPLETED|Single-Blind Phase (4 Weeks)||0||
60004641|NCT02709655|76120569|FG004|NOT COMPLETED|Single-Blind Phase (4 Weeks)||0||
60136016|NCT01409993|76258683|FG003|NOT COMPLETED|Overall Study||5||
60004642|NCT02709655|76120565|FG000|STARTED|Double-Blind Phase (8 Weeks)||0||
60004643|NCT02709655|76120566|FG001|STARTED|Double-Blind Phase (8 Weeks)||153||
60004644|NCT02709655|76120567|FG002|STARTED|Double-Blind Phase (8 Weeks)||151||
60004645|NCT02709655|76120568|FG003|STARTED|Double-Blind Phase (8 Weeks)||153||
60004646|NCT02709655|76120569|FG004|STARTED|Double-Blind Phase (8 Weeks)||83||
60004647|NCT02709655|76120565|FG000|Received at Least 1 Dose of Study Drug|Double-Blind Phase (8 Weeks)||0||
60004648|NCT02709655|76120566|FG001|Received at Least 1 Dose of Study Drug|Double-Blind Phase (8 Weeks)||153||
60004649|NCT02709655|76120567|FG002|Received at Least 1 Dose of Study Drug|Double-Blind Phase (8 Weeks)||151||
60004650|NCT02709655|76120568|FG003|Received at Least 1 Dose of Study Drug|Double-Blind Phase (8 Weeks)||153||
60004651|NCT02709655|76120569|FG004|Received at Least 1 Dose of Study Drug|Double-Blind Phase (8 Weeks)||83||
60067886|NCT01756053|76183071|FG000|STARTED|Period 2 (10 Days)||7||
60004652|NCT02709655|76120565|FG000|Full Analysis Set (FAS)|Double-Blind Phase (8 Weeks)||0|All participants randomized to the double-blind, 8-week treatment period (Phase B) who took at least 1 dose of double-blind study drug and who had a valid baseline (Week 4 of Phase A) assessment and at least 1 valid post-baseline assessment of the Children Depression Rating Scale - Revised (CDRS-R) total score|
60004653|NCT02709655|76120566|FG001|Full Analysis Set (FAS)|Double-Blind Phase (8 Weeks)||153|All participants randomized to the double-blind, 8-week treatment period (Phase B) who took at least 1 dose of double-blind study drug and who had a valid baseline (Week 4 of Phase A) assessment and at least 1 valid post-baseline assessment of the Children Depression Rating Scale - Revised (CDRS-R) total score|
60004654|NCT02709655|76120567|FG002|Full Analysis Set (FAS)|Double-Blind Phase (8 Weeks)||148|All participants randomized to the double-blind, 8-week treatment period (Phase B) who took at least 1 dose of double-blind study drug and who had a valid baseline (Week 4 of Phase A) assessment and at least 1 valid post-baseline assessment of the Children Depression Rating Scale - Revised (CDRS-R) total score|
60004655|NCT02709655|76120568|FG003|Full Analysis Set (FAS)|Double-Blind Phase (8 Weeks)||148|All participants randomized to the double-blind, 8-week treatment period (Phase B) who took at least 1 dose of double-blind study drug and who had a valid baseline (Week 4 of Phase A) assessment and at least 1 valid post-baseline assessment of the Children Depression Rating Scale - Revised (CDRS-R) total score|
60004656|NCT02709655|76120569|FG004|Full Analysis Set (FAS)|Double-Blind Phase (8 Weeks)||81|All participants randomized to the double-blind, 8-week treatment period (Phase B) who took at least 1 dose of double-blind study drug and who had a valid baseline (Week 4 of Phase A) assessment and at least 1 valid post-baseline assessment of the Children Depression Rating Scale - Revised (CDRS-R) total score|
60004657|NCT02709655|76120565|FG000|COMPLETED|Double-Blind Phase (8 Weeks)||0||
60004658|NCT02709655|76120566|FG001|COMPLETED|Double-Blind Phase (8 Weeks)||138||
60004659|NCT02709655|76120567|FG002|COMPLETED|Double-Blind Phase (8 Weeks)||135||
60004660|NCT02709655|76120568|FG003|COMPLETED|Double-Blind Phase (8 Weeks)||133||
60004661|NCT02709655|76120569|FG004|COMPLETED|Double-Blind Phase (8 Weeks)||78||
60004662|NCT02709655|76120565|FG000|NOT COMPLETED|Double-Blind Phase (8 Weeks)||0||
60004663|NCT02709655|76120566|FG001|NOT COMPLETED|Double-Blind Phase (8 Weeks)||15||
60004664|NCT02709655|76120567|FG002|NOT COMPLETED|Double-Blind Phase (8 Weeks)||16||
60004665|NCT02709655|76120568|FG003|NOT COMPLETED|Double-Blind Phase (8 Weeks)||20||
60004666|NCT02709655|76120569|FG004|NOT COMPLETED|Double-Blind Phase (8 Weeks)||5||
59880651|NCT04493931|76003538|FG001|NOT COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||0||
59880652|NCT04493931|76003539|FG002|NOT COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||0||
59880653|NCT04493931|76003540|FG003|NOT COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||0||
59880654|NCT04493931|76003541|FG004|NOT COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||0||
59880655|NCT04493931|76003542|FG005|NOT COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||0||
59880656|NCT04493931|76003543|FG006|NOT COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||0||
59880657|NCT04493931|76003537|FG000|STARTED|Cohort4:Washout Period 2(Up to 3 Days)||0||
59880658|NCT04493931|76003538|FG001|STARTED|Cohort4:Washout Period 2(Up to 3 Days)||0||
59880659|NCT04493931|76003539|FG002|STARTED|Cohort4:Washout Period 2(Up to 3 Days)||0||
59880660|NCT04493931|76003540|FG003|STARTED|Cohort4:Washout Period 2(Up to 3 Days)||0||
59880661|NCT04493931|76003541|FG004|STARTED|Cohort4:Washout Period 2(Up to 3 Days)||6||
59880662|NCT04493931|76003542|FG005|STARTED|Cohort4:Washout Period 2(Up to 3 Days)||5||
60004667|NCT02708485|76120583|FG000|STARTED|Overall Study||3||
60004668|NCT02708485|76120584|FG001|STARTED|Overall Study||12||
60004669|NCT02708485|76120583|FG000|COMPLETED|Overall Study||0||
60004670|NCT02708485|76120584|FG001|COMPLETED|Overall Study||10||
60004671|NCT02708485|76120583|FG000|NOT COMPLETED|Overall Study||3||
60004672|NCT02708485|76120584|FG001|NOT COMPLETED|Overall Study||2||
60004673|NCT01307813|76120590|FG000|STARTED|Overall Study||4||
60004674|NCT01307813|76120590|FG000|COMPLETED|Overall Study||4||
60004675|NCT01307813|76120590|FG000|NOT COMPLETED|Overall Study||0||
60004676|NCT02709577|76120596|FG000|STARTED|Overall Study||12||
60004677|NCT02709577|76120597|FG001|STARTED|Overall Study||13||
60004678|NCT02709577|76120598|FG002|STARTED|Overall Study||6||
60004679|NCT02709577|76120599|FG003|STARTED|Overall Study||5||
60004680|NCT02709577|76120596|FG000|COMPLETED|Overall Study||10||
60004681|NCT02709577|76120597|FG001|COMPLETED|Overall Study||8||
60004682|NCT02709577|76120598|FG002|COMPLETED|Overall Study||4||
59880663|NCT04493931|76003543|FG006|STARTED|Cohort4:Washout Period 2(Up to 3 Days)||3||
60004683|NCT02709577|76120599|FG003|COMPLETED|Overall Study||5||
60004684|NCT02709577|76120596|FG000|NOT COMPLETED|Overall Study||2||
60004685|NCT02709577|76120597|FG001|NOT COMPLETED|Overall Study||5||
60004686|NCT02709577|76120598|FG002|NOT COMPLETED|Overall Study||2||
60004687|NCT02709577|76120599|FG003|NOT COMPLETED|Overall Study||0||
60004688|NCT02078752|76120620|FG000|STARTED|Overall Study||3||
60004689|NCT02078752|76120621|FG001|STARTED|Overall Study||13||
60004690|NCT02078752|76120622|FG002|STARTED|Overall Study||2||
60004691|NCT02078752|76120623|FG003|STARTED|Overall Study||7||
60004692|NCT02078752|76120624|FG004|STARTED|Overall Study||3||
60004693|NCT02078752|76120625|FG005|STARTED|Overall Study||9||
60004694|NCT02078752|76120626|FG006|STARTED|Overall Study||3||
60004695|NCT02078752|76120627|FG007|STARTED|Overall Study||6||
60004696|NCT02078752|76120628|FG008|STARTED|Overall Study||2||
60004697|NCT02078752|76120629|FG009|STARTED|Overall Study||12||
60004698|NCT02078752|76120620|FG000|COMPLETED|Overall Study||1||
60004699|NCT02078752|76120621|FG001|COMPLETED|Overall Study||6||
60004700|NCT02078752|76120622|FG002|COMPLETED|Overall Study||1||
60004701|NCT02078752|76120623|FG003|COMPLETED|Overall Study||5||
60004702|NCT02078752|76120624|FG004|COMPLETED|Overall Study||2||
60004703|NCT02078752|76120625|FG005|COMPLETED|Overall Study||5||
60004704|NCT02078752|76120626|FG006|COMPLETED|Overall Study||1||
60004705|NCT02078752|76120627|FG007|COMPLETED|Overall Study||3||
60004706|NCT02078752|76120628|FG008|COMPLETED|Overall Study||2||
60004707|NCT02078752|76120629|FG009|COMPLETED|Overall Study||2||
60004708|NCT02078752|76120620|FG000|NOT COMPLETED|Overall Study||2||
60004709|NCT02078752|76120621|FG001|NOT COMPLETED|Overall Study||7||
60004710|NCT02078752|76120622|FG002|NOT COMPLETED|Overall Study||1||
60004711|NCT02078752|76120623|FG003|NOT COMPLETED|Overall Study||2||
60004712|NCT02078752|76120624|FG004|NOT COMPLETED|Overall Study||1||
60004713|NCT02078752|76120625|FG005|NOT COMPLETED|Overall Study||4||
60004714|NCT02078752|76120626|FG006|NOT COMPLETED|Overall Study||2||
60004715|NCT02078752|76120627|FG007|NOT COMPLETED|Overall Study||3||
60004716|NCT02078752|76120628|FG008|NOT COMPLETED|Overall Study||0||
60004717|NCT02078752|76120629|FG009|NOT COMPLETED|Overall Study||10||
60004718|NCT02022748|76120662|FG000|STARTED|Overall Study||8||
60004719|NCT02022748|76120663|FG001|STARTED|Overall Study||6||
60004720|NCT02022748|76120664|FG002|STARTED|Overall Study||13||
60004721|NCT02022748|76120662|FG000|Subject Who Started Treatment|Overall Study||8||
60004722|NCT02022748|76120663|FG001|Subject Who Started Treatment|Overall Study||6||
60004723|NCT02022748|76120664|FG002|Subject Who Started Treatment|Overall Study||13||
60004724|NCT02022748|76120662|FG000|Subjects Who Completed Treatment|Overall Study||7||
60004725|NCT02022748|76120663|FG001|Subjects Who Completed Treatment|Overall Study||4||
60004726|NCT02022748|76120664|FG002|Subjects Who Completed Treatment|Overall Study||13||
60004727|NCT02022748|76120662|FG000|COMPLETED|Overall Study||7||
60004728|NCT02022748|76120663|FG001|COMPLETED|Overall Study||4||
60004729|NCT02022748|76120664|FG002|COMPLETED|Overall Study||13||
60004730|NCT02022748|76120662|FG000|NOT COMPLETED|Overall Study||1||
60004731|NCT02022748|76120663|FG001|NOT COMPLETED|Overall Study||2||
60004732|NCT02022748|76120664|FG002|NOT COMPLETED|Overall Study||0||
60004733|NCT02022670|76120675|FG000|STARTED|Overall Study||11||
60004734|NCT02022670|76120676|FG001|STARTED|Overall Study||10||
60004735|NCT02022670|76120677|FG002|STARTED|Overall Study||12||
60004736|NCT02022670|76120675|FG000|COMPLETED|Overall Study||10||
60004737|NCT02022670|76120676|FG001|COMPLETED|Overall Study||10||
60004738|NCT02022670|76120677|FG002|COMPLETED|Overall Study||11||
60004739|NCT02022670|76120675|FG000|NOT COMPLETED|Overall Study||1||
60004740|NCT02022670|76120676|FG001|NOT COMPLETED|Overall Study||0||
60004741|NCT02022670|76120677|FG002|NOT COMPLETED|Overall Study||1||
60004742|NCT02076334|76120690|FG000|STARTED|Overall Study||21||
60004743|NCT02076334|76120691|FG001|STARTED|Overall Study||21||
60004744|NCT02076334|76120692|FG002|STARTED|Overall Study||21||
60004745|NCT02076334|76120693|FG003|STARTED|Overall Study||21||
60004746|NCT02076334|76120690|FG000|COMPLETED|Overall Study||20||
60004747|NCT02076334|76120691|FG001|COMPLETED|Overall Study||20||
60004748|NCT02076334|76120692|FG002|COMPLETED|Overall Study||20||
59880664|NCT04493931|76003537|FG000|COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||0||
59880665|NCT04493931|76003538|FG001|COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||0||
59880666|NCT04493931|76003539|FG002|COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||0||
59880667|NCT04493931|76003540|FG003|COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||0||
59880668|NCT04493931|76003541|FG004|COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||6||
59880669|NCT04493931|76003542|FG005|COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||5||
59880670|NCT04493931|76003543|FG006|COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||3||
59880671|NCT04493931|76003537|FG000|NOT COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||0||
59880672|NCT04493931|76003538|FG001|NOT COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||0||
59880673|NCT04493931|76003539|FG002|NOT COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||0||
59880674|NCT04493931|76003540|FG003|NOT COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||0||
59880675|NCT04493931|76003541|FG004|NOT COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||0||
59880676|NCT04493931|76003542|FG005|NOT COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||0||
59880677|NCT04493931|76003543|FG006|NOT COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||0||
59880678|NCT04493931|76003537|FG000|STARTED|Cohort4:Treatment Period 3(Up to 3 Days)||0||
59880679|NCT04493931|76003538|FG001|STARTED|Cohort4:Treatment Period 3(Up to 3 Days)||0||
59880680|NCT04493931|76003539|FG002|STARTED|Cohort4:Treatment Period 3(Up to 3 Days)||0||
59880681|NCT04493931|76003540|FG003|STARTED|Cohort4:Treatment Period 3(Up to 3 Days)||0||
59880682|NCT04493931|76003541|FG004|STARTED|Cohort4:Treatment Period 3(Up to 3 Days)||6||
59880683|NCT04493931|76003542|FG005|STARTED|Cohort4:Treatment Period 3(Up to 3 Days)||5||
59880684|NCT04493931|76003543|FG006|STARTED|Cohort4:Treatment Period 3(Up to 3 Days)||3||
59880685|NCT04493931|76003537|FG000|COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||0||
59880686|NCT04493931|76003538|FG001|COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||0||
59880687|NCT04493931|76003539|FG002|COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||0||
59880688|NCT04493931|76003540|FG003|COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||0||
59880689|NCT04493931|76003541|FG004|COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||6||
59880690|NCT04493931|76003542|FG005|COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||5||
59880691|NCT04493931|76003543|FG006|COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||3||
59880692|NCT04493931|76003537|FG000|NOT COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||0||
59880693|NCT04493931|76003538|FG001|NOT COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||0||
59880694|NCT04493931|76003539|FG002|NOT COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||0||
59880695|NCT04493931|76003540|FG003|NOT COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||0||
59880696|NCT04493931|76003541|FG004|NOT COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||0||
59880697|NCT04493931|76003542|FG005|NOT COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||0||
59880698|NCT04493931|76003543|FG006|NOT COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||0||
59880699|NCT04493931|76003537|FG000|STARTED|Cohort 4: Follow-up (Up to 7 Days)||0||
59880700|NCT04493931|76003538|FG001|STARTED|Cohort 4: Follow-up (Up to 7 Days)||0||
59880701|NCT04493931|76003539|FG002|STARTED|Cohort 4: Follow-up (Up to 7 Days)||0||
59880702|NCT04493931|76003540|FG003|STARTED|Cohort 4: Follow-up (Up to 7 Days)||0||
59880703|NCT04493931|76003541|FG004|STARTED|Cohort 4: Follow-up (Up to 7 Days)||6||
59880704|NCT04493931|76003542|FG005|STARTED|Cohort 4: Follow-up (Up to 7 Days)||5||
59880705|NCT04493931|76003543|FG006|STARTED|Cohort 4: Follow-up (Up to 7 Days)||3||
59880706|NCT04493931|76003537|FG000|COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||0||
59880707|NCT04493931|76003538|FG001|COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||0||
59880708|NCT04493931|76003539|FG002|COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||0||
59880709|NCT04493931|76003540|FG003|COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||0||
59880710|NCT04493931|76003541|FG004|COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||6||
59880711|NCT04493931|76003542|FG005|COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||5||
59880712|NCT04493931|76003543|FG006|COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||3||
59880713|NCT04493931|76003537|FG000|NOT COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||0||
59880714|NCT04493931|76003538|FG001|NOT COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||0||
60004749|NCT02076334|76120693|FG003|COMPLETED|Overall Study||20||
59880715|NCT04493931|76003539|FG002|NOT COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||0||
59880716|NCT04493931|76003540|FG003|NOT COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||0||
59880717|NCT04493931|76003541|FG004|NOT COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||0||
59880718|NCT04493931|76003542|FG005|NOT COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||0||
59880719|NCT04493931|76003543|FG006|NOT COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||0||
59880720|NCT03437278|76003576|FG000|STARTED|Overall Study||24||
60004750|NCT02076334|76120690|FG000|NOT COMPLETED|Overall Study||1||
60004751|NCT02076334|76120691|FG001|NOT COMPLETED|Overall Study||1||
60004752|NCT02076334|76120692|FG002|NOT COMPLETED|Overall Study||1||
60004753|NCT02076334|76120693|FG003|NOT COMPLETED|Overall Study||1||
60004754|NCT02021812|76120703|FG000|STARTED|Overall Study||31||
60004755|NCT02021812|76120703|FG000|COMPLETED|Overall Study||16||
60004756|NCT02021812|76120703|FG000|NOT COMPLETED|Overall Study||15||
60004757|NCT02021656|76120707|FG000|STARTED|Overall Study||384||
60004758|NCT02021656|76120707|FG000|COMPLETED|Overall Study||378||
60004759|NCT02021656|76120707|FG000|NOT COMPLETED|Overall Study||6||
60004760|NCT02076022|76120717|FG000|STARTED|Overall Study||7||
60004761|NCT02076022|76120718|FG001|STARTED|Overall Study||3||
60004762|NCT02076022|76120717|FG000|COMPLETED|Overall Study||5||
60004763|NCT02076022|76120718|FG001|COMPLETED|Overall Study||3||
60004764|NCT02076022|76120717|FG000|NOT COMPLETED|Overall Study||2||
60004765|NCT02076022|76120718|FG001|NOT COMPLETED|Overall Study||0||
60004766|NCT02075632|76120726|FG000|STARTED|Overall Study||162||
60004767|NCT02075632|76120727|FG001|STARTED|Overall Study||148||
60004768|NCT02075632|76120726|FG000|COMPLETED|Overall Study||161||
60004769|NCT02075632|76120727|FG001|COMPLETED|Overall Study||143||
60004770|NCT02075632|76120726|FG000|NOT COMPLETED|Overall Study||1||
60004771|NCT02075632|76120727|FG001|NOT COMPLETED|Overall Study||5||
60004772|NCT02075554|76120733|FG000|STARTED|Overall Study||58||
60004773|NCT02075554|76120733|FG000|COMPLETED|Overall Study||43||
60004774|NCT02075554|76120733|FG000|NOT COMPLETED|Overall Study||15||
60004775|NCT02075476|76120739|FG000|STARTED|Overall Study||20||
60004776|NCT02075476|76120740|FG001|STARTED|Overall Study||20||
60004777|NCT02075476|76120739|FG000|COMPLETED|Overall Study||17||
60004778|NCT02075476|76120740|FG001|COMPLETED|Overall Study||15||
60004779|NCT02075476|76120739|FG000|NOT COMPLETED|Overall Study||3||
60004780|NCT02075476|76120740|FG001|NOT COMPLETED|Overall Study||5||
60004781|NCT02075320|76120746|FG000|STARTED|Overall Study||50||
60004782|NCT02075320|76120746|FG000|COMPLETED|Overall Study||48||
60004783|NCT02075320|76120746|FG000|NOT COMPLETED|Overall Study||2||
60004784|NCT02708095|76120753|FG000|STARTED|Overall Study||105||
60004785|NCT02708095|76120754|FG001|STARTED|Overall Study||105||
60004786|NCT02708095|76120755|FG002|STARTED|Overall Study||104||
60004787|NCT02708095|76120753|FG000|Received at Least 1 Dose of Study Drug|Overall Study||105||
60004788|NCT02708095|76120754|FG001|Received at Least 1 Dose of Study Drug|Overall Study||105||
60004789|NCT02708095|76120755|FG002|Received at Least 1 Dose of Study Drug|Overall Study||104||
60004790|NCT02708095|76120753|FG000|COMPLETED|Overall Study||83||
60004791|NCT02708095|76120754|FG001|COMPLETED|Overall Study||86||
60004792|NCT02708095|76120755|FG002|COMPLETED|Overall Study||86||
60004793|NCT02708095|76120753|FG000|NOT COMPLETED|Overall Study||22||
60004794|NCT02708095|76120754|FG001|NOT COMPLETED|Overall Study||19||
60004795|NCT02708095|76120755|FG002|NOT COMPLETED|Overall Study||18||
60004796|NCT02707861|76120767|FG000|STARTED|Overall Study||41||
60004797|NCT02707861|76120768|FG001|STARTED|Overall Study||38||
60004798|NCT02707861|76120767|FG000|COMPLETED|Overall Study||0||
60004799|NCT02707861|76120768|FG001|COMPLETED|Overall Study||0||
60004800|NCT02707861|76120767|FG000|NOT COMPLETED|Overall Study||41||
60004801|NCT02707861|76120768|FG001|NOT COMPLETED|Overall Study||38||
60004802|NCT02027428|76120776|FG000|STARTED|Induction||427||
60004803|NCT02027428|76120777|FG001|STARTED|Induction||0||
60004804|NCT02027428|76120778|FG002|STARTED|Induction||0||
60004805|NCT02027428|76120776|FG000|Received Study Drug|Induction||420||
60004806|NCT02027428|76120777|FG001|Received Study Drug|Induction||0||
60004807|NCT02027428|76120778|FG002|Received Study Drug|Induction||0||
60004808|NCT02027428|76120776|FG000|COMPLETED|Induction|If radiologically CR, PR or SD after 4 cycles of treatment, participants continue on to Maintenance.|202|Completed = participants who continued to maintenance period.|
60004809|NCT02027428|76120777|FG001|COMPLETED|Induction||0|Completed = participants who continued to maintenance period.|
60004810|NCT02027428|76120778|FG002|COMPLETED|Induction||0|Completed = participants who continued to maintenance period.|
60004811|NCT02027428|76120776|FG000|NOT COMPLETED|Induction||225||
60004812|NCT02027428|76120777|FG001|NOT COMPLETED|Induction||0||
60004813|NCT02027428|76120778|FG002|NOT COMPLETED|Induction||0||
60004814|NCT02027428|76120776|FG000|STARTED|Maintenance||0||
60004815|NCT02027428|76120777|FG001|STARTED|Maintenance||136||
60004816|NCT02027428|76120778|FG002|STARTED|Maintenance||66||
60004817|NCT02027428|76120776|FG000|COMPLETED|Maintenance||0|Completed = Participants who continued on treatment|
60004818|NCT02027428|76120777|FG001|COMPLETED|Maintenance||12|Completed = Participants who continued on treatment|
60004819|NCT02027428|76120778|FG002|COMPLETED|Maintenance||6|Completed = Participants who continued on treatment|
60004820|NCT02027428|76120776|FG000|NOT COMPLETED|Maintenance||0||
60004821|NCT02027428|76120777|FG001|NOT COMPLETED|Maintenance||124||
60004822|NCT02027428|76120778|FG002|NOT COMPLETED|Maintenance||60||
60004823|NCT02027428|76120776|FG000|STARTED|Survival Follow-up||0||
60004824|NCT02027428|76120777|FG001|STARTED|Survival Follow-up|Participants are not taking study intervention but are on appropriate standard of care.|117||
60004825|NCT02027428|76120778|FG002|STARTED|Survival Follow-up|Participants are not taking study intervention but are on appropriate standard of care.|55||
60004826|NCT02027428|76120776|FG000|COMPLETED|Survival Follow-up||0|Completed = Participants alive to end of study|
60004827|NCT02027428|76120777|FG001|COMPLETED|Survival Follow-up||38|Completed = Participants alive to end of study|
60004828|NCT02027428|76120778|FG002|COMPLETED|Survival Follow-up||9|Completed = Participants alive to end of study|
60004829|NCT02027428|76120776|FG000|NOT COMPLETED|Survival Follow-up||0||
60004830|NCT02027428|76120777|FG001|NOT COMPLETED|Survival Follow-up||79||
60004831|NCT02027428|76120778|FG002|NOT COMPLETED|Survival Follow-up||46||
60004832|NCT01995136|76120801|FG000|STARTED|Overall Study||32||
60004833|NCT01995136|76120801|FG000|COMPLETED|Overall Study||31||
60004834|NCT01995136|76120801|FG000|NOT COMPLETED|Overall Study||1||
60004835|NCT01994902|76120805|FG000|STARTED|Test Period 1||63||
60004836|NCT01994902|76120806|FG001|STARTED|Test Period 1|Randomisation mistake:a subject randomised to SenSura Convex Light but tested Coloplast test product|64||
60004837|NCT01994902|76120805|FG000|COMPLETED|Test Period 1||57||
60004838|NCT01994902|76120806|FG001|COMPLETED|Test Period 1|The subject testing Coloplast test product discontinued due to device deficiency with adverse event|61||
60004839|NCT01994902|76120805|FG000|NOT COMPLETED|Test Period 1||6||
60004840|NCT01994902|76120806|FG001|NOT COMPLETED|Test Period 1||3||
60004841|NCT01994902|76120805|FG000|STARTED|Test Period 2||57||
60004842|NCT01994902|76120806|FG001|STARTED|Test Period 2||61||
60004843|NCT01994902|76120805|FG000|COMPLETED|Test Period 2||57||
60004844|NCT01994902|76120806|FG001|COMPLETED|Test Period 2||55||
60004845|NCT01994902|76120805|FG000|NOT COMPLETED|Test Period 2||0||
60004846|NCT01994902|76120806|FG001|NOT COMPLETED|Test Period 2||6||
60004847|NCT02026258|76120814|FG000|STARTED|Randomized||20||
60004848|NCT02026258|76120815|FG001|STARTED|Randomized||21||
60004849|NCT02026258|76120814|FG000|COMPLETED|Randomized||16||
60004850|NCT02026258|76120815|FG001|COMPLETED|Randomized||19||
60004851|NCT02026258|76120814|FG000|NOT COMPLETED|Randomized||4||
60004852|NCT02026258|76120815|FG001|NOT COMPLETED|Randomized||2||
60004853|NCT02026258|76120814|FG000|STARTED|Recieved Allocated Intervention||16||
60004854|NCT02026258|76120815|FG001|STARTED|Recieved Allocated Intervention||19||
60004855|NCT02026258|76120814|FG000|COMPLETED|Recieved Allocated Intervention||15||
60004856|NCT02026258|76120815|FG001|COMPLETED|Recieved Allocated Intervention||17||
60004857|NCT02026258|76120814|FG000|NOT COMPLETED|Recieved Allocated Intervention||1||
60004858|NCT02026258|76120815|FG001|NOT COMPLETED|Recieved Allocated Intervention||2||
60004859|NCT01994590|76120822|FG000|STARTED|Overall Study||4||
60004860|NCT01994590|76120822|FG000|COMPLETED|Overall Study||2||
60004861|NCT01994590|76120822|FG000|NOT COMPLETED|Overall Study||2||
60004862|NCT02019550|76120828|FG000|STARTED|Treatment Period 1 (4 Weeks)||46||
60004863|NCT02019550|76120829|FG001|STARTED|Treatment Period 1 (4 Weeks)||51||
60004864|NCT02019550|76120828|FG000|COMPLETED|Treatment Period 1 (4 Weeks)||46||
60004865|NCT02019550|76120829|FG001|COMPLETED|Treatment Period 1 (4 Weeks)||50||
60004866|NCT02019550|76120828|FG000|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0||
60004867|NCT02019550|76120829|FG001|NOT COMPLETED|Treatment Period 1 (4 Weeks)||1||
60004868|NCT02019550|76120828|FG000|STARTED|Treatment Period 2 (4 Weeks)||46||
60004869|NCT02019550|76120829|FG001|STARTED|Treatment Period 2 (4 Weeks)||50||
60004870|NCT02019550|76120828|FG000|COMPLETED|Treatment Period 2 (4 Weeks)||46||
60004871|NCT02019550|76120829|FG001|COMPLETED|Treatment Period 2 (4 Weeks)||50||
60004872|NCT02019550|76120828|FG000|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0||
60004873|NCT02019550|76120829|FG001|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0||
59605581|NCT01967706|75715724|FG002|NOT COMPLETED|Second Intervention (Day 3)||0||
60004874|NCT02019472|76120840|FG000|STARTED|Overall Study||186||
60004875|NCT02019472|76120841|FG001|STARTED|Overall Study||186||
60004876|NCT02019472|76120842|FG002|STARTED|Overall Study||187||
60004877|NCT02019472|76120840|FG000|COMPLETED|Overall Study||149||
60004878|NCT02019472|76120841|FG001|COMPLETED|Overall Study||134||
60004879|NCT02019472|76120842|FG002|COMPLETED|Overall Study||145||
60004880|NCT02019472|76120840|FG000|NOT COMPLETED|Overall Study||37||
60004881|NCT02019472|76120841|FG001|NOT COMPLETED|Overall Study||52||
60004882|NCT02019472|76120842|FG002|NOT COMPLETED|Overall Study||42||
60004883|NCT02705755|76120854|FG000|STARTED|Part A (6 Days)||34|Each participant was titrated to their individual maximum tolerated dose.|
60004884|NCT02705755|76120855|FG001|STARTED|Part A (6 Days)||0|Each participant was titrated to their individual maximum tolerated dose.|
60004885|NCT02705755|76120856|FG002|STARTED|Part A (6 Days)||0|Each participant was titrated to their individual maximum tolerated dose.|
60004886|NCT02705755|76120857|FG003|STARTED|Part A (6 Days)||0|Each participant was titrated to their individual maximum tolerated dose.|
60004887|NCT02705755|76120854|FG000|Participants Who Received Placebo|Part A (6 Days)||34||
60004888|NCT02705755|76120855|FG001|Participants Who Received Placebo|Part A (6 Days)||0||
60004889|NCT02705755|76120856|FG002|Participants Who Received Placebo|Part A (6 Days)||0||
60004890|NCT02705755|76120857|FG003|Participants Who Received Placebo|Part A (6 Days)||0||
60004891|NCT02705755|76120854|FG000|Participants Who Received 1 mg Study Drug|Part A (6 Days)||17|Participants who were enrolled prior to protocol amendment 2 received a starting dose of 1 mg TD-9855 as an oral solution on Day 2 of Part A and escalated to 10 mg. Beginning with protocol amendment 2, the starting dose was changed to 2.5 mg with dose escalation to 20 mg.|
60004892|NCT02705755|76120855|FG001|Participants Who Received 1 mg Study Drug|Part A (6 Days)||0|Participants who were enrolled prior to protocol amendment 2 received a starting dose of 1 mg TD-9855 as an oral solution on Day 2 of Part A and escalated to 10 mg. Beginning with protocol amendment 2, the starting dose was changed to 2.5 mg with dose escalation to 20 mg.|
60004893|NCT02705755|76120856|FG002|Participants Who Received 1 mg Study Drug|Part A (6 Days)||0|Participants who were enrolled prior to protocol amendment 2 received a starting dose of 1 mg TD-9855 as an oral solution on Day 2 of Part A and escalated to 10 mg. Beginning with protocol amendment 2, the starting dose was changed to 2.5 mg with dose escalation to 20 mg.|
60004894|NCT02705755|76120857|FG003|Participants Who Received 1 mg Study Drug|Part A (6 Days)||0|Participants who were enrolled prior to protocol amendment 2 received a starting dose of 1 mg TD-9855 as an oral solution on Day 2 of Part A and escalated to 10 mg. Beginning with protocol amendment 2, the starting dose was changed to 2.5 mg with dose escalation to 20 mg.|
60004895|NCT02705755|76120854|FG000|Participants Who Received 2.5 mg Study Drug|Part A (6 Days)||31||
60004896|NCT02705755|76120855|FG001|Participants Who Received 2.5 mg Study Drug|Part A (6 Days)||0||
60004897|NCT02705755|76120856|FG002|Participants Who Received 2.5 mg Study Drug|Part A (6 Days)||0||
60004898|NCT02705755|76120857|FG003|Participants Who Received 2.5 mg Study Drug|Part A (6 Days)||0||
60004899|NCT02705755|76120854|FG000|Participants Who Received 5 mg Study Drug|Part A (6 Days)||29||
60004900|NCT02705755|76120855|FG001|Participants Who Received 5 mg Study Drug|Part A (6 Days)||0||
60004901|NCT02705755|76120856|FG002|Participants Who Received 5 mg Study Drug|Part A (6 Days)||0||
60004902|NCT02705755|76120857|FG003|Participants Who Received 5 mg Study Drug|Part A (6 Days)||0||
60004903|NCT02705755|76120854|FG000|Participants Who Received 10 mg Study Drug|Part A (6 Days)||28||
60004904|NCT02705755|76120855|FG001|Participants Who Received 10 mg Study Drug|Part A (6 Days)||0||
60004905|NCT02705755|76120856|FG002|Participants Who Received 10 mg Study Drug|Part A (6 Days)||0||
60004906|NCT02705755|76120857|FG003|Participants Who Received 10 mg Study Drug|Part A (6 Days)||0||
60004907|NCT02705755|76120854|FG000|Participants Who Received 20 mg Study Drug|Part A (6 Days)||13||
60004908|NCT02705755|76120855|FG001|Participants Who Received 20 mg Study Drug|Part A (6 Days)||0||
60004909|NCT02705755|76120856|FG002|Participants Who Received 20 mg Study Drug|Part A (6 Days)||0||
60004910|NCT02705755|76120857|FG003|Participants Who Received 20 mg Study Drug|Part A (6 Days)||0||
60004911|NCT02705755|76120854|FG000|Participants Who Rolled to Part B|Part A (6 Days)||10||
60004912|NCT02705755|76120855|FG001|Participants Who Rolled to Part B|Part A (6 Days)||0||
60004913|NCT02705755|76120856|FG002|Participants Who Rolled to Part B|Part A (6 Days)||0||
60004914|NCT02705755|76120857|FG003|Participants Who Rolled to Part B|Part A (6 Days)||0||
60004915|NCT02705755|76120854|FG000|Participants Who Rolled to Part C|Part A (6 Days)||21||
60004916|NCT02705755|76120855|FG001|Participants Who Rolled to Part C|Part A (6 Days)||0||
60004917|NCT02705755|76120856|FG002|Participants Who Rolled to Part C|Part A (6 Days)||0||
60004918|NCT02705755|76120857|FG003|Participants Who Rolled to Part C|Part A (6 Days)||0||
60004919|NCT02705755|76120854|FG000|COMPLETED|Part A (6 Days)||29||
60004920|NCT02705755|76120855|FG001|COMPLETED|Part A (6 Days)||0||
60004921|NCT02705755|76120856|FG002|COMPLETED|Part A (6 Days)||0||
59605582|NCT01967706|75715725|FG003|NOT COMPLETED|Second Intervention (Day 3)||0||
60004922|NCT02705755|76120857|FG003|COMPLETED|Part A (6 Days)||0||
60004923|NCT02705755|76120854|FG000|NOT COMPLETED|Part A (6 Days)||5||
60004924|NCT02705755|76120855|FG001|NOT COMPLETED|Part A (6 Days)||0||
60004925|NCT02705755|76120856|FG002|NOT COMPLETED|Part A (6 Days)||0||
60004926|NCT02705755|76120857|FG003|NOT COMPLETED|Part A (6 Days)||0||
60004927|NCT02705755|76120854|FG000|STARTED|Part B (1 Day)||0||
60004928|NCT02705755|76120855|FG001|STARTED|Part B (1 Day)||5||
60004929|NCT02705755|76120856|FG002|STARTED|Part B (1 Day)|Each participant received their individual maximum tolerated dose from Part A.|5||
60004930|NCT02705755|76120857|FG003|STARTED|Part B (1 Day)||0||
60004931|NCT02705755|76120854|FG000|Received Study Drug|Part B (1 Day)||0||
60004932|NCT02705755|76120855|FG001|Received Study Drug|Part B (1 Day)||5||
60004933|NCT02705755|76120856|FG002|Received Study Drug|Part B (1 Day)||5||
60004934|NCT02705755|76120857|FG003|Received Study Drug|Part B (1 Day)||0||
60004935|NCT02705755|76120854|FG000|COMPLETED|Part B (1 Day)||0||
60004936|NCT02705755|76120855|FG001|COMPLETED|Part B (1 Day)||5||
60004937|NCT02705755|76120856|FG002|COMPLETED|Part B (1 Day)||5||
60004938|NCT02705755|76120857|FG003|COMPLETED|Part B (1 Day)||0||
60004939|NCT02705755|76120854|FG000|NOT COMPLETED|Part B (1 Day)||0||
60004940|NCT02705755|76120855|FG001|NOT COMPLETED|Part B (1 Day)||0||
60004941|NCT02705755|76120856|FG002|NOT COMPLETED|Part B (1 Day)||0||
60004942|NCT02705755|76120857|FG003|NOT COMPLETED|Part B (1 Day)||0||
60004943|NCT02705755|76120854|FG000|STARTED|Part C (20 Weeks)||0||
60004944|NCT02705755|76120855|FG001|STARTED|Part C (20 Weeks)||0||
60004945|NCT02705755|76120856|FG002|STARTED|Part C (20 Weeks)||0||
60004946|NCT02705755|76120857|FG003|STARTED|Part C (20 Weeks)||21||
60004947|NCT02705755|76120854|FG000|Received Study Drug|Part C (20 Weeks)||0||
60004948|NCT02705755|76120855|FG001|Received Study Drug|Part C (20 Weeks)||0||
60004949|NCT02705755|76120856|FG002|Received Study Drug|Part C (20 Weeks)||0||
60004950|NCT02705755|76120857|FG003|Received Study Drug|Part C (20 Weeks)||21||
60004951|NCT02705755|76120854|FG000|COMPLETED|Part C (20 Weeks)||0||
60004952|NCT02705755|76120855|FG001|COMPLETED|Part C (20 Weeks)||0||
60004953|NCT02705755|76120856|FG002|COMPLETED|Part C (20 Weeks)||0||
60004954|NCT02705755|76120857|FG003|COMPLETED|Part C (20 Weeks)||11||
60004955|NCT02705755|76120854|FG000|NOT COMPLETED|Part C (20 Weeks)||0||
60004956|NCT02705755|76120855|FG001|NOT COMPLETED|Part C (20 Weeks)||0||
60004957|NCT02705755|76120856|FG002|NOT COMPLETED|Part C (20 Weeks)||0||
60004958|NCT02705755|76120857|FG003|NOT COMPLETED|Part C (20 Weeks)||10||
60004959|NCT02024932|76120890|FG000|STARTED|Overall Study||2||
60004960|NCT02024932|76120891|FG001|STARTED|Overall Study||4||
60004961|NCT02024932|76120892|FG002|STARTED|Overall Study||2||
59605583|NCT01967628|75715736|FG000|STARTED|Overall Study||48||
60004962|NCT02024932|76120893|FG003|STARTED|Overall Study||2||
60004963|NCT02024932|76120894|FG004|STARTED|Overall Study||18||
60004964|NCT02024932|76120895|FG005|STARTED|Overall Study||9||
60004965|NCT02024932|76120890|FG000|Safety Analysis Set|Overall Study||2||
60004966|NCT02024932|76120891|FG001|Safety Analysis Set|Overall Study||4||
60004967|NCT02024932|76120892|FG002|Safety Analysis Set|Overall Study||2||
60004968|NCT02024932|76120893|FG003|Safety Analysis Set|Overall Study||2||
60004969|NCT02024932|76120894|FG004|Safety Analysis Set|Overall Study||18||
60004970|NCT02024932|76120895|FG005|Safety Analysis Set|Overall Study||9||
60004971|NCT02024932|76120890|FG000|Pharmacokinetic (PK) Analysis Set|Overall Study||2||
60004972|NCT02024932|76120891|FG001|Pharmacokinetic (PK) Analysis Set|Overall Study||4||
60004973|NCT02024932|76120892|FG002|Pharmacokinetic (PK) Analysis Set|Overall Study||0||
60004974|NCT02024932|76120893|FG003|Pharmacokinetic (PK) Analysis Set|Overall Study||2||
60004975|NCT02024932|76120894|FG004|Pharmacokinetic (PK) Analysis Set|Overall Study||18||
60004976|NCT02024932|76120895|FG005|Pharmacokinetic (PK) Analysis Set|Overall Study||0||
60004977|NCT02024932|76120890|FG000|Pharmacodynamic (PD) Analysis Set|Overall Study||2||
60004978|NCT02024932|76120891|FG001|Pharmacodynamic (PD) Analysis Set|Overall Study||4||
60004979|NCT02024932|76120892|FG002|Pharmacodynamic (PD) Analysis Set|Overall Study||2||
60004980|NCT02024932|76120893|FG003|Pharmacodynamic (PD) Analysis Set|Overall Study||2||
60004981|NCT02024932|76120894|FG004|Pharmacodynamic (PD) Analysis Set|Overall Study||18||
60004982|NCT02024932|76120895|FG005|Pharmacodynamic (PD) Analysis Set|Overall Study||9||
60004983|NCT02024932|76120890|FG000|COMPLETED|Overall Study||0||
60004984|NCT02024932|76120891|FG001|COMPLETED|Overall Study||1||
60004985|NCT02024932|76120892|FG002|COMPLETED|Overall Study||2||
60004986|NCT02024932|76120893|FG003|COMPLETED|Overall Study||0||
60004987|NCT02024932|76120894|FG004|COMPLETED|Overall Study||16||
60004988|NCT02024932|76120895|FG005|COMPLETED|Overall Study||9||
60004989|NCT02024932|76120890|FG000|NOT COMPLETED|Overall Study||2||
60004990|NCT02024932|76120891|FG001|NOT COMPLETED|Overall Study||3||
60004991|NCT02024932|76120892|FG002|NOT COMPLETED|Overall Study||0||
60004992|NCT02024932|76120893|FG003|NOT COMPLETED|Overall Study||2||
60004993|NCT02024932|76120894|FG004|NOT COMPLETED|Overall Study||2||
60004994|NCT02024932|76120895|FG005|NOT COMPLETED|Overall Study||0||
60004995|NCT03178903|76120917|FG000|STARTED|Overall Study||25||
60004996|NCT03178903|76120918|FG001|STARTED|Overall Study||26||
60004997|NCT03178903|76120917|FG000|COMPLETED|Overall Study||25||
60004998|NCT03178903|76120918|FG001|COMPLETED|Overall Study||26||
60004999|NCT03178903|76120917|FG000|NOT COMPLETED|Overall Study||0||
60005000|NCT03178903|76120918|FG001|NOT COMPLETED|Overall Study||0||
60005001|NCT01993888|76120926|FG000|STARTED|Overall Study||50||
60005002|NCT01993888|76120927|FG001|STARTED|Overall Study||52||
60005003|NCT01993888|76120926|FG000|COMPLETED|Overall Study||48||
60005004|NCT01993888|76120927|FG001|COMPLETED|Overall Study||49||
60005005|NCT01993888|76120926|FG000|NOT COMPLETED|Overall Study||2||
60005006|NCT01993888|76120927|FG001|NOT COMPLETED|Overall Study||3||
60005007|NCT02024698|76120933|FG000|STARTED|First Intervention (7 Days)||16||
60005008|NCT02024698|76120934|FG001|STARTED|First Intervention (7 Days)||27||
60005009|NCT02024698|76120933|FG000|COMPLETED|First Intervention (7 Days)||16||
60005010|NCT02024698|76120934|FG001|COMPLETED|First Intervention (7 Days)||26||
60005011|NCT02024698|76120933|FG000|NOT COMPLETED|First Intervention (7 Days)||0||
60005012|NCT02024698|76120934|FG001|NOT COMPLETED|First Intervention (7 Days)||1||
60005013|NCT02024698|76120933|FG000|STARTED|Second Intervention (7 Days)||16||
60005014|NCT02024698|76120934|FG001|STARTED|Second Intervention (7 Days)||26||
60005015|NCT02024698|76120933|FG000|Received Etafilcon A Twice|Second Intervention (7 Days)||1||
60005016|NCT02024698|76120934|FG001|Received Etafilcon A Twice|Second Intervention (7 Days)||0||
60005017|NCT02024698|76120933|FG000|COMPLETED|Second Intervention (7 Days)||16||
60005018|NCT02024698|76120934|FG001|COMPLETED|Second Intervention (7 Days)||26||
60005019|NCT02024698|76120933|FG000|NOT COMPLETED|Second Intervention (7 Days)||0||
60005020|NCT02024698|76120934|FG001|NOT COMPLETED|Second Intervention (7 Days)||0||
60005021|NCT02018458|76120940|FG000|STARTED|Overall Study||10||
60005022|NCT02018458|76120940|FG000|COMPLETED|Overall Study||6||
60005023|NCT02018458|76120940|FG000|NOT COMPLETED|Overall Study||4||
60005024|NCT02017522|76120944|FG000|STARTED|Overall Study||3||
60005025|NCT02017522|76120944|FG000|Scan|Overall Study||2||
60005026|NCT02017522|76120944|FG000|COMPLETED|Overall Study||2||
60005027|NCT02017522|76120944|FG000|NOT COMPLETED|Overall Study||1||
60005028|NCT02017444|76120951|FG000|STARTED|Overall Study||14||
60005029|NCT02017444|76120952|FG001|STARTED|Overall Study||17||
60005030|NCT02017444|76120951|FG000|COMPLETED|Overall Study||12||
60005031|NCT02017444|76120952|FG001|COMPLETED|Overall Study|NB: One participant did not complete primary outcome.|17||
60005032|NCT02017444|76120951|FG000|NOT COMPLETED|Overall Study||2||
60005033|NCT02017444|76120952|FG001|NOT COMPLETED|Overall Study||0||
60005034|NCT01993186|76120960|FG000|STARTED|Double-Blind Placebo-Controlled Period||25||
60005035|NCT01993186|76120961|FG001|STARTED|Double-Blind Placebo-Controlled Period||11||
60005036|NCT01993186|76120960|FG000|COMPLETED|Double-Blind Placebo-Controlled Period||23||
60005037|NCT01993186|76120961|FG001|COMPLETED|Double-Blind Placebo-Controlled Period||11||
60005038|NCT01993186|76120960|FG000|NOT COMPLETED|Double-Blind Placebo-Controlled Period||2||
60005039|NCT01993186|76120961|FG001|NOT COMPLETED|Double-Blind Placebo-Controlled Period||0||
60005040|NCT01993186|76120960|FG000|STARTED|Open-Label Extension Period||23||
60005041|NCT01993186|76120961|FG001|STARTED|Open-Label Extension Period||11||
60005042|NCT01993186|76120960|FG000|COMPLETED|Open-Label Extension Period||16||
60136017|NCT01273623|76258697|FG000|STARTED|Overall Study|met angiographic criteria|55||
60136018|NCT01273623|76258697|FG000|COMPLETED|Overall Study|met IVUS criteria|26||
60005043|NCT01993186|76120961|FG001|COMPLETED|Open-Label Extension Period||5||
60005044|NCT01993186|76120960|FG000|NOT COMPLETED|Open-Label Extension Period||7||
60005045|NCT01993186|76120961|FG001|NOT COMPLETED|Open-Label Extension Period||6||
60005046|NCT02016898|76120970|FG000|STARTED|Overall Study||50||
60136019|NCT01273623|76258697|FG000|NOT COMPLETED|Overall Study||29||
60136020|NCT01409915|76258705|FG000|STARTED|Overall Study||21||
60005047|NCT02016898|76120971|FG001|STARTED|Overall Study||45||
60005048|NCT02016898|76120970|FG000|COMPLETED|Overall Study||45||
60005049|NCT02016898|76120971|FG001|COMPLETED|Overall Study||40||
60005050|NCT02016898|76120970|FG000|NOT COMPLETED|Overall Study||5||
60005051|NCT02016898|76120971|FG001|NOT COMPLETED|Overall Study||5||
60005052|NCT01993030|76120979|FG000|STARTED|Overall Study||36||
60005053|NCT01993030|76120980|FG001|STARTED|Overall Study||35||
60005054|NCT01993030|76120979|FG000|COMPLETED|Overall Study||36||
60005055|NCT01993030|76120980|FG001|COMPLETED|Overall Study||31||
60005056|NCT01993030|76120979|FG000|NOT COMPLETED|Overall Study||0||
60136021|NCT01409915|76258706|FG001|STARTED|Overall Study||23||
60005057|NCT01993030|76120980|FG001|NOT COMPLETED|Overall Study||4||
60005058|NCT01992094|76120989|FG000|STARTED|Overall Study||1335||
60005059|NCT01992094|76120990|FG001|STARTED|Overall Study||676||
60136022|NCT01409915|76258705|FG000|COMPLETED|Overall Study||20||
60005060|NCT01992094|76120991|FG002|STARTED|Overall Study||669||
60005061|NCT01992094|76120989|FG000|COMPLETED|Overall Study||1285||
60136023|NCT01409915|76258706|FG001|COMPLETED|Overall Study||20||
60136024|NCT01409915|76258705|FG000|NOT COMPLETED|Overall Study||1||
60136025|NCT01409915|76258706|FG001|NOT COMPLETED|Overall Study||3||
60136026|NCT01272921|76258714|FG000|STARTED|Overall Study||71||
60005062|NCT01992094|76120990|FG001|COMPLETED|Overall Study||652||
60005063|NCT01992094|76120991|FG002|COMPLETED|Overall Study||648||
60005064|NCT01992094|76120989|FG000|NOT COMPLETED|Overall Study||50||
60005065|NCT01992094|76120990|FG001|NOT COMPLETED|Overall Study||24||
60005066|NCT01992094|76120991|FG002|NOT COMPLETED|Overall Study||21||
60005067|NCT02706691|76121015|FG000|STARTED|Overall Study||1||
60005068|NCT02706691|76121015|FG000|COMPLETED|Overall Study||0||
60005069|NCT02706691|76121015|FG000|NOT COMPLETED|Overall Study||1||
60005070|NCT01991470|76121020|FG000|STARTED|Enlite 1 Period||161||
60005071|NCT01991470|76121020|FG000|COMPLETED|Enlite 1 Period||141||
60005072|NCT01991470|76121020|FG000|NOT COMPLETED|Enlite 1 Period||20||
60005073|NCT01991470|76121020|FG000|STARTED|Enlite 3 Period|Additional 25 subjects who participated only Enlite 3 phase|158||
60005074|NCT01991470|76121020|FG000|COMPLETED|Enlite 3 Period||146||
60005075|NCT01991470|76121020|FG000|NOT COMPLETED|Enlite 3 Period||12||
60005076|NCT01991314|76121034|FG000|STARTED|Overall Study||45||
60005077|NCT01991314|76121035|FG001|STARTED|Overall Study||43||
60005078|NCT01991314|76121034|FG000|COMPLETED|Overall Study||34||
60005079|NCT01991314|76121035|FG001|COMPLETED|Overall Study||32||
60005080|NCT01991314|76121034|FG000|NOT COMPLETED|Overall Study||11||
60005081|NCT01991314|76121035|FG001|NOT COMPLETED|Overall Study||11||
60005082|NCT01990768|76121044|FG000|STARTED|Intervention Started||345||
60005083|NCT01990768|76121045|FG001|STARTED|Intervention Started||345||
60005084|NCT01990768|76121046|FG002|STARTED|Intervention Started||373||
60005085|NCT01990768|76121044|FG000|COMPLETED|Intervention Started||309||
60005086|NCT01990768|76121045|FG001|COMPLETED|Intervention Started||312||
60005087|NCT01990768|76121046|FG002|COMPLETED|Intervention Started||346||
60005088|NCT01990768|76121044|FG000|NOT COMPLETED|Intervention Started||36||
60005089|NCT01990768|76121045|FG001|NOT COMPLETED|Intervention Started||33||
60005090|NCT01990768|76121046|FG002|NOT COMPLETED|Intervention Started||27||
60005091|NCT01990768|76121044|FG000|STARTED|Prehospital Study Drug Infusion||309||
60005092|NCT01990768|76121045|FG001|STARTED|Prehospital Study Drug Infusion||312||
60005093|NCT01990768|76121046|FG002|STARTED|Prehospital Study Drug Infusion||346||
60005094|NCT01990768|76121044|FG000|COMPLETED|Prehospital Study Drug Infusion||290||
60005095|NCT01990768|76121045|FG001|COMPLETED|Prehospital Study Drug Infusion||285||
60005096|NCT01990768|76121046|FG002|COMPLETED|Prehospital Study Drug Infusion||327||
60005097|NCT01990768|76121044|FG000|NOT COMPLETED|Prehospital Study Drug Infusion||19||
60005098|NCT01990768|76121045|FG001|NOT COMPLETED|Prehospital Study Drug Infusion||27||
60005099|NCT01990768|76121046|FG002|NOT COMPLETED|Prehospital Study Drug Infusion||19||
60005100|NCT01990768|76121044|FG000|STARTED|In-Hospital Study Drug Infusion||309||
60005101|NCT01990768|76121045|FG001|STARTED|In-Hospital Study Drug Infusion||312||
60005102|NCT01990768|76121046|FG002|STARTED|In-Hospital Study Drug Infusion||346||
60005103|NCT01990768|76121044|FG000|COMPLETED|In-Hospital Study Drug Infusion||214||
60005104|NCT01990768|76121045|FG001|COMPLETED|In-Hospital Study Drug Infusion||229||
60005105|NCT01990768|76121046|FG002|COMPLETED|In-Hospital Study Drug Infusion||266||
60005106|NCT01990768|76121044|FG000|NOT COMPLETED|In-Hospital Study Drug Infusion||95||
60005107|NCT01990768|76121045|FG001|NOT COMPLETED|In-Hospital Study Drug Infusion||83||
60005108|NCT01990768|76121046|FG002|NOT COMPLETED|In-Hospital Study Drug Infusion||80||
60005109|NCT01990768|76121044|FG000|STARTED|6-Month Follow-up||309||
60005110|NCT01990768|76121045|FG001|STARTED|6-Month Follow-up||312||
60005111|NCT01990768|76121046|FG002|STARTED|6-Month Follow-up||346||
60005112|NCT01990768|76121044|FG000|COMPLETED|6-Month Follow-up||270||
60005113|NCT01990768|76121045|FG001|COMPLETED|6-Month Follow-up||261||
60005114|NCT01990768|76121046|FG002|COMPLETED|6-Month Follow-up||288||
60005115|NCT01990768|76121044|FG000|NOT COMPLETED|6-Month Follow-up||39||
60005116|NCT01990768|76121045|FG001|NOT COMPLETED|6-Month Follow-up||51||
60005117|NCT01990768|76121046|FG002|NOT COMPLETED|6-Month Follow-up||58||
60005118|NCT01990612|76121057|FG000|STARTED|Overall Study||3044||
60005119|NCT01990612|76121058|FG001|STARTED|Overall Study||3062||
60005120|NCT01990612|76121057|FG000|COMPLETED|Overall Study||3037||
60005121|NCT01990612|76121058|FG001|COMPLETED|Overall Study||3059||
60005122|NCT01990612|76121057|FG000|NOT COMPLETED|Overall Study||7||
60005123|NCT01990612|76121058|FG001|NOT COMPLETED|Overall Study||3||
60005124|NCT01990534|76121064|FG000|STARTED|Overall Study||60||
60005125|NCT01990534|76121064|FG000|COMPLETED|Overall Study||25||
60005126|NCT01990534|76121064|FG000|NOT COMPLETED|Overall Study||35||
60005127|NCT01967134|76121071|FG000|STARTED|Overall Study||8||
60005128|NCT01967134|76121072|FG001|STARTED|Overall Study||8||
60005129|NCT01967134|76121073|FG002|STARTED|Overall Study||9||
60005130|NCT01967134|76121071|FG000|COMPLETED|Overall Study||8||
60005131|NCT01967134|76121072|FG001|COMPLETED|Overall Study||7||
60005132|NCT01967134|76121073|FG002|COMPLETED|Overall Study||9||
60005133|NCT01967134|76121071|FG000|NOT COMPLETED|Overall Study||0||
60005134|NCT01967134|76121072|FG001|NOT COMPLETED|Overall Study||1||
60005135|NCT01967134|76121073|FG002|NOT COMPLETED|Overall Study||0||
60005136|NCT01966432|76121084|FG000|STARTED|Overall Study||10||
60005137|NCT01966432|76121085|FG001|STARTED|Overall Study||34||
60005138|NCT01966432|76121086|FG002|STARTED|Overall Study||54||
60005139|NCT01966432|76121084|FG000|COMPLETED|Overall Study||5||
60005140|NCT01966432|76121085|FG001|COMPLETED|Overall Study||21||
60005141|NCT01966432|76121086|FG002|COMPLETED|Overall Study||28||
60005142|NCT01966432|76121084|FG000|NOT COMPLETED|Overall Study||5||
60005143|NCT01966432|76121085|FG001|NOT COMPLETED|Overall Study||13||
60005144|NCT01966432|76121086|FG002|NOT COMPLETED|Overall Study||26||
60005145|NCT02702401|76121098|FG000|STARTED|Overall Study||278||
60005146|NCT02702401|76121099|FG001|STARTED|Overall Study||135||
60005147|NCT02702401|76121098|FG000|Treated|Overall Study||278||
60005148|NCT02702401|76121099|FG001|Treated|Overall Study||135||
60005149|NCT02702401|76121098|FG000|Received Second Course|Overall Study||7||
60005150|NCT02702401|76121099|FG001|Received Second Course|Overall Study||0||
60005151|NCT02702401|76121098|FG000|COMPLETED|Overall Study||0||
60005152|NCT02702401|76121099|FG001|COMPLETED|Overall Study||0||
60005153|NCT02702401|76121098|FG000|NOT COMPLETED|Overall Study||278||
60005154|NCT02702401|76121099|FG001|NOT COMPLETED|Overall Study||135||
60005155|NCT02703337|76121106|FG000|STARTED|Period One (Part A)||5||
60005156|NCT02703337|76121107|FG001|STARTED|Period One (Part A)||5||
60005157|NCT02703337|76121108|FG002|STARTED|Period One (Part A)||5||
60005158|NCT02703337|76121109|FG003|STARTED|Period One (Part A)||5||
60005159|NCT02703337|76121110|FG004|STARTED|Period One (Part A)||5||
60005160|NCT02703337|76121111|FG005|STARTED|Period One (Part A)||5||
60005161|NCT02703337|76121112|FG006|STARTED|Period One (Part A)||0||
60005162|NCT02703337|76121113|FG007|STARTED|Period One (Part A)||0||
60005163|NCT02703337|76121106|FG000|Received Study Drug|Period One (Part A)||5||
60005164|NCT02703337|76121107|FG001|Received Study Drug|Period One (Part A)||5||
60005165|NCT02703337|76121108|FG002|Received Study Drug|Period One (Part A)||5||
60005166|NCT02703337|76121109|FG003|Received Study Drug|Period One (Part A)||5||
60005167|NCT02703337|76121110|FG004|Received Study Drug|Period One (Part A)||5||
60005168|NCT02703337|76121111|FG005|Received Study Drug|Period One (Part A)||5||
60005169|NCT02703337|76121112|FG006|Received Study Drug|Period One (Part A)||0||
60005170|NCT02703337|76121113|FG007|Received Study Drug|Period One (Part A)||0||
60005171|NCT02703337|76121106|FG000|COMPLETED|Period One (Part A)||5||
60005172|NCT02703337|76121107|FG001|COMPLETED|Period One (Part A)||5||
60005173|NCT02703337|76121108|FG002|COMPLETED|Period One (Part A)||5||
60005174|NCT02703337|76121109|FG003|COMPLETED|Period One (Part A)||5||
60005175|NCT02703337|76121110|FG004|COMPLETED|Period One (Part A)||4||
60005176|NCT02703337|76121111|FG005|COMPLETED|Period One (Part A)||5||
60005177|NCT02703337|76121112|FG006|COMPLETED|Period One (Part A)||0||
60005178|NCT02703337|76121113|FG007|COMPLETED|Period One (Part A)||0||
60005179|NCT02703337|76121106|FG000|NOT COMPLETED|Period One (Part A)||0||
60005180|NCT02703337|76121107|FG001|NOT COMPLETED|Period One (Part A)||0||
60005181|NCT02703337|76121108|FG002|NOT COMPLETED|Period One (Part A)||0||
60005182|NCT02703337|76121109|FG003|NOT COMPLETED|Period One (Part A)||0||
60005183|NCT02703337|76121110|FG004|NOT COMPLETED|Period One (Part A)||1||
60005184|NCT02703337|76121111|FG005|NOT COMPLETED|Period One (Part A)||0||
60005185|NCT02703337|76121112|FG006|NOT COMPLETED|Period One (Part A)||0||
60005186|NCT02703337|76121113|FG007|NOT COMPLETED|Period One (Part A)||0||
60005187|NCT02703337|76121106|FG000|STARTED|Period Two (Part A)||5||
59605584|NCT01967628|75715737|FG001|STARTED|Overall Study||50||
59605585|NCT01967628|75715736|FG000|COMPLETED|Overall Study||21||
59605586|NCT01967628|75715737|FG001|COMPLETED|Overall Study||19||
59605587|NCT01967628|75715736|FG000|NOT COMPLETED|Overall Study||27||
59605588|NCT01967628|75715737|FG001|NOT COMPLETED|Overall Study||31||
59605589|NCT01998906|75715746|FG000|STARTED|Overall Study||115||
59605590|NCT01998906|75715747|FG001|STARTED|Overall Study||116||
59605591|NCT01998906|75715748|FG002|STARTED|Overall Study||99||
59605592|NCT01998906|75715746|FG000|COMPLETED|Overall Study||1||
59605593|NCT01998906|75715747|FG001|COMPLETED|Overall Study||2||
59605594|NCT01998906|75715748|FG002|COMPLETED|Overall Study||1||
59605595|NCT01998906|75715746|FG000|NOT COMPLETED|Overall Study||114||
59605596|NCT01998906|75715747|FG001|NOT COMPLETED|Overall Study||114||
59605597|NCT01998906|75715748|FG002|NOT COMPLETED|Overall Study||98||
59605598|NCT01967550|75715761|FG000|STARTED|Overall Study||153||
59605599|NCT01967550|75715762|FG001|STARTED|Overall Study||151||
59605600|NCT01967550|75715761|FG000|COMPLETED|Overall Study||148||
60005188|NCT02703337|76121107|FG001|STARTED|Period Two (Part A)||5||
60005189|NCT02703337|76121108|FG002|STARTED|Period Two (Part A)||5||
60005190|NCT02703337|76121109|FG003|STARTED|Period Two (Part A)||5||
60005191|NCT02703337|76121110|FG004|STARTED|Period Two (Part A)||4||
60005192|NCT02703337|76121111|FG005|STARTED|Period Two (Part A)||5||
60005193|NCT02703337|76121112|FG006|STARTED|Period Two (Part A)||0||
60005194|NCT02703337|76121113|FG007|STARTED|Period Two (Part A)||0||
60005195|NCT02703337|76121106|FG000|Received Study Drug|Period Two (Part A)||5||
60005196|NCT02703337|76121107|FG001|Received Study Drug|Period Two (Part A)||5||
60005197|NCT02703337|76121108|FG002|Received Study Drug|Period Two (Part A)||5||
60005198|NCT02703337|76121109|FG003|Received Study Drug|Period Two (Part A)||5||
60005199|NCT02703337|76121110|FG004|Received Study Drug|Period Two (Part A)||4||
60005200|NCT02703337|76121111|FG005|Received Study Drug|Period Two (Part A)||5||
60005201|NCT02703337|76121112|FG006|Received Study Drug|Period Two (Part A)||0||
60005202|NCT02703337|76121113|FG007|Received Study Drug|Period Two (Part A)||0||
59605601|NCT01967550|75715762|FG001|COMPLETED|Overall Study||149||
59605602|NCT01967550|75715761|FG000|NOT COMPLETED|Overall Study||5||
59605603|NCT01967550|75715762|FG001|NOT COMPLETED|Overall Study||2||
59605604|NCT01989546|75715768|FG000|STARTED|Overall Study||9||
60005203|NCT02703337|76121106|FG000|COMPLETED|Period Two (Part A)||5||
60005204|NCT02703337|76121107|FG001|COMPLETED|Period Two (Part A)||5||
60005205|NCT02703337|76121108|FG002|COMPLETED|Period Two (Part A)||5||
60005206|NCT02703337|76121109|FG003|COMPLETED|Period Two (Part A)||5||
60005207|NCT02703337|76121110|FG004|COMPLETED|Period Two (Part A)||4||
60005208|NCT02703337|76121111|FG005|COMPLETED|Period Two (Part A)||5||
60005209|NCT02703337|76121112|FG006|COMPLETED|Period Two (Part A)||0||
60005210|NCT02703337|76121113|FG007|COMPLETED|Period Two (Part A)||0||
60005211|NCT02703337|76121106|FG000|NOT COMPLETED|Period Two (Part A)||0||
60005212|NCT02703337|76121107|FG001|NOT COMPLETED|Period Two (Part A)||0||
60005213|NCT02703337|76121108|FG002|NOT COMPLETED|Period Two (Part A)||0||
60005214|NCT02703337|76121109|FG003|NOT COMPLETED|Period Two (Part A)||0||
60005215|NCT02703337|76121110|FG004|NOT COMPLETED|Period Two (Part A)||0||
60005216|NCT02703337|76121111|FG005|NOT COMPLETED|Period Two (Part A)||0||
60005217|NCT02703337|76121112|FG006|NOT COMPLETED|Period Two (Part A)||0||
60005218|NCT02703337|76121113|FG007|NOT COMPLETED|Period Two (Part A)||0||
60005219|NCT02703337|76121106|FG000|STARTED|Period Three (Part A)||5||
60005220|NCT02703337|76121107|FG001|STARTED|Period Three (Part A)||5||
60005221|NCT02703337|76121108|FG002|STARTED|Period Three (Part A)||5||
60005222|NCT02703337|76121109|FG003|STARTED|Period Three (Part A)||5||
60005223|NCT02703337|76121110|FG004|STARTED|Period Three (Part A)||4||
60005224|NCT02703337|76121111|FG005|STARTED|Period Three (Part A)||5||
60005225|NCT02703337|76121112|FG006|STARTED|Period Three (Part A)||0||
60005226|NCT02703337|76121113|FG007|STARTED|Period Three (Part A)||0||
60005227|NCT02703337|76121106|FG000|Received Study Drug|Period Three (Part A)||5||
60005228|NCT02703337|76121107|FG001|Received Study Drug|Period Three (Part A)||5||
60005229|NCT02703337|76121108|FG002|Received Study Drug|Period Three (Part A)||5||
60005230|NCT02703337|76121109|FG003|Received Study Drug|Period Three (Part A)||5||
60005231|NCT02703337|76121110|FG004|Received Study Drug|Period Three (Part A)||4||
60005232|NCT02703337|76121111|FG005|Received Study Drug|Period Three (Part A)||5||
60005233|NCT02703337|76121112|FG006|Received Study Drug|Period Three (Part A)||0||
60005234|NCT02703337|76121113|FG007|Received Study Drug|Period Three (Part A)||0||
60005235|NCT02703337|76121106|FG000|COMPLETED|Period Three (Part A)||5||
60005236|NCT02703337|76121107|FG001|COMPLETED|Period Three (Part A)||5||
60005237|NCT02703337|76121108|FG002|COMPLETED|Period Three (Part A)||5||
60005238|NCT02703337|76121109|FG003|COMPLETED|Period Three (Part A)||5||
60005239|NCT02703337|76121110|FG004|COMPLETED|Period Three (Part A)||4||
60005240|NCT02703337|76121111|FG005|COMPLETED|Period Three (Part A)||5||
60005241|NCT02703337|76121112|FG006|COMPLETED|Period Three (Part A)||0||
60005242|NCT02703337|76121113|FG007|COMPLETED|Period Three (Part A)||0||
60005243|NCT02703337|76121106|FG000|NOT COMPLETED|Period Three (Part A)||0||
60005244|NCT02703337|76121107|FG001|NOT COMPLETED|Period Three (Part A)||0||
60005245|NCT02703337|76121108|FG002|NOT COMPLETED|Period Three (Part A)||0||
60005246|NCT02703337|76121109|FG003|NOT COMPLETED|Period Three (Part A)||0||
60005247|NCT02703337|76121110|FG004|NOT COMPLETED|Period Three (Part A)||0||
60005248|NCT02703337|76121111|FG005|NOT COMPLETED|Period Three (Part A)||0||
60005249|NCT02703337|76121112|FG006|NOT COMPLETED|Period Three (Part A)||0||
60005250|NCT02703337|76121113|FG007|NOT COMPLETED|Period Three (Part A)||0||
60005251|NCT02703337|76121106|FG000|STARTED|Period Four (Part A)||5||
60005252|NCT02703337|76121107|FG001|STARTED|Period Four (Part A)||5||
60005253|NCT02703337|76121108|FG002|STARTED|Period Four (Part A)||5||
60005254|NCT02703337|76121109|FG003|STARTED|Period Four (Part A)||5||
60005255|NCT02703337|76121110|FG004|STARTED|Period Four (Part A)||4||
60005256|NCT02703337|76121111|FG005|STARTED|Period Four (Part A)||5||
60005257|NCT02703337|76121112|FG006|STARTED|Period Four (Part A)||0||
60005258|NCT02703337|76121113|FG007|STARTED|Period Four (Part A)||0||
60005259|NCT02703337|76121106|FG000|Received Study Drug|Period Four (Part A)||5||
60005260|NCT02703337|76121107|FG001|Received Study Drug|Period Four (Part A)||5||
60005261|NCT02703337|76121108|FG002|Received Study Drug|Period Four (Part A)||5||
60005262|NCT02703337|76121109|FG003|Received Study Drug|Period Four (Part A)||5||
60005263|NCT02703337|76121110|FG004|Received Study Drug|Period Four (Part A)||4||
60005264|NCT02703337|76121111|FG005|Received Study Drug|Period Four (Part A)||5||
60005265|NCT02703337|76121112|FG006|Received Study Drug|Period Four (Part A)||0||
60005266|NCT02703337|76121113|FG007|Received Study Drug|Period Four (Part A)||0||
60005267|NCT02703337|76121106|FG000|COMPLETED|Period Four (Part A)||5||
60005268|NCT02703337|76121107|FG001|COMPLETED|Period Four (Part A)||5||
60005269|NCT02703337|76121108|FG002|COMPLETED|Period Four (Part A)||5||
60005270|NCT02703337|76121109|FG003|COMPLETED|Period Four (Part A)||5||
60005271|NCT02703337|76121110|FG004|COMPLETED|Period Four (Part A)||4||
60005272|NCT02703337|76121111|FG005|COMPLETED|Period Four (Part A)||5||
60005273|NCT02703337|76121112|FG006|COMPLETED|Period Four (Part A)||0||
60005274|NCT02703337|76121113|FG007|COMPLETED|Period Four (Part A)||0||
60005275|NCT02703337|76121106|FG000|NOT COMPLETED|Period Four (Part A)||0||
60005276|NCT02703337|76121107|FG001|NOT COMPLETED|Period Four (Part A)||0||
60067887|NCT01756053|76183072|FG001|STARTED|Period 2 (10 Days)||8||
60005277|NCT02703337|76121108|FG002|NOT COMPLETED|Period Four (Part A)||0||
60005278|NCT02703337|76121109|FG003|NOT COMPLETED|Period Four (Part A)||0||
60005279|NCT02703337|76121110|FG004|NOT COMPLETED|Period Four (Part A)||0||
60005280|NCT02703337|76121111|FG005|NOT COMPLETED|Period Four (Part A)||0||
60005281|NCT02703337|76121112|FG006|NOT COMPLETED|Period Four (Part A)||0||
60005282|NCT02703337|76121113|FG007|NOT COMPLETED|Period Four (Part A)||0||
60005283|NCT02703337|76121106|FG000|STARTED|Period Five (Part A)||5||
60005284|NCT02703337|76121107|FG001|STARTED|Period Five (Part A)||5||
60005285|NCT02703337|76121108|FG002|STARTED|Period Five (Part A)||5||
60005286|NCT02703337|76121109|FG003|STARTED|Period Five (Part A)||5||
60005287|NCT02703337|76121110|FG004|STARTED|Period Five (Part A)||4||
60005288|NCT02703337|76121111|FG005|STARTED|Period Five (Part A)||5||
60005289|NCT02703337|76121112|FG006|STARTED|Period Five (Part A)||0||
60005290|NCT02703337|76121113|FG007|STARTED|Period Five (Part A)||0||
60005291|NCT02703337|76121106|FG000|Received Study Drug|Period Five (Part A)||5||
60005292|NCT02703337|76121107|FG001|Received Study Drug|Period Five (Part A)||5||
60005293|NCT02703337|76121108|FG002|Received Study Drug|Period Five (Part A)||5||
60005294|NCT02703337|76121109|FG003|Received Study Drug|Period Five (Part A)||5||
60005295|NCT02703337|76121110|FG004|Received Study Drug|Period Five (Part A)||4||
60005296|NCT02703337|76121111|FG005|Received Study Drug|Period Five (Part A)||5||
60005297|NCT02703337|76121112|FG006|Received Study Drug|Period Five (Part A)||0||
60005298|NCT02703337|76121113|FG007|Received Study Drug|Period Five (Part A)||0||
60005299|NCT02703337|76121106|FG000|COMPLETED|Period Five (Part A)||5||
60005300|NCT02703337|76121107|FG001|COMPLETED|Period Five (Part A)||5||
60005301|NCT02703337|76121108|FG002|COMPLETED|Period Five (Part A)||5||
60005302|NCT02703337|76121109|FG003|COMPLETED|Period Five (Part A)||5||
60005303|NCT02703337|76121110|FG004|COMPLETED|Period Five (Part A)||4||
60005304|NCT02703337|76121111|FG005|COMPLETED|Period Five (Part A)||5||
60005305|NCT02703337|76121112|FG006|COMPLETED|Period Five (Part A)||0||
60005306|NCT02703337|76121113|FG007|COMPLETED|Period Five (Part A)||0||
60005307|NCT02703337|76121106|FG000|NOT COMPLETED|Period Five (Part A)||0||
60005308|NCT02703337|76121107|FG001|NOT COMPLETED|Period Five (Part A)||0||
60005309|NCT02703337|76121108|FG002|NOT COMPLETED|Period Five (Part A)||0||
60005310|NCT02703337|76121109|FG003|NOT COMPLETED|Period Five (Part A)||0||
60005311|NCT02703337|76121110|FG004|NOT COMPLETED|Period Five (Part A)||0||
60005312|NCT02703337|76121111|FG005|NOT COMPLETED|Period Five (Part A)||0||
60005313|NCT02703337|76121112|FG006|NOT COMPLETED|Period Five (Part A)||0||
60005314|NCT02703337|76121113|FG007|NOT COMPLETED|Period Five (Part A)||0||
60005315|NCT02703337|76121106|FG000|STARTED|Period Six (Part A)||5||
60005316|NCT02703337|76121107|FG001|STARTED|Period Six (Part A)||5||
60005317|NCT02703337|76121108|FG002|STARTED|Period Six (Part A)||5||
60005318|NCT02703337|76121109|FG003|STARTED|Period Six (Part A)||5||
60005319|NCT02703337|76121110|FG004|STARTED|Period Six (Part A)||4||
60005320|NCT02703337|76121111|FG005|STARTED|Period Six (Part A)||5||
60005321|NCT02703337|76121112|FG006|STARTED|Period Six (Part A)||0||
60005322|NCT02703337|76121113|FG007|STARTED|Period Six (Part A)||0||
60005323|NCT02703337|76121106|FG000|Received Study Drug|Period Six (Part A)||5||
60005324|NCT02703337|76121107|FG001|Received Study Drug|Period Six (Part A)||5||
60005325|NCT02703337|76121108|FG002|Received Study Drug|Period Six (Part A)||5||
60005326|NCT02703337|76121109|FG003|Received Study Drug|Period Six (Part A)||5||
60005327|NCT02703337|76121110|FG004|Received Study Drug|Period Six (Part A)||4||
60005328|NCT02703337|76121111|FG005|Received Study Drug|Period Six (Part A)||5||
60005329|NCT02703337|76121112|FG006|Received Study Drug|Period Six (Part A)||0||
60005330|NCT02703337|76121113|FG007|Received Study Drug|Period Six (Part A)||0||
60005331|NCT02703337|76121106|FG000|COMPLETED|Period Six (Part A)||5||
60005332|NCT02703337|76121107|FG001|COMPLETED|Period Six (Part A)||5||
60005333|NCT02703337|76121108|FG002|COMPLETED|Period Six (Part A)||5||
60005334|NCT02703337|76121109|FG003|COMPLETED|Period Six (Part A)||5||
60005335|NCT02703337|76121110|FG004|COMPLETED|Period Six (Part A)||4||
60005336|NCT02703337|76121111|FG005|COMPLETED|Period Six (Part A)||5||
60005337|NCT02703337|76121112|FG006|COMPLETED|Period Six (Part A)||0||
60005338|NCT02703337|76121113|FG007|COMPLETED|Period Six (Part A)||0||
60005339|NCT02703337|76121106|FG000|NOT COMPLETED|Period Six (Part A)||0||
60005340|NCT02703337|76121107|FG001|NOT COMPLETED|Period Six (Part A)||0||
60005341|NCT02703337|76121108|FG002|NOT COMPLETED|Period Six (Part A)||0||
60005342|NCT02703337|76121109|FG003|NOT COMPLETED|Period Six (Part A)||0||
60005343|NCT02703337|76121110|FG004|NOT COMPLETED|Period Six (Part A)||0||
60005344|NCT02703337|76121111|FG005|NOT COMPLETED|Period Six (Part A)||0||
60005345|NCT02703337|76121112|FG006|NOT COMPLETED|Period Six (Part A)||0||
60005346|NCT02703337|76121113|FG007|NOT COMPLETED|Period Six (Part A)||0||
60005347|NCT02703337|76121106|FG000|STARTED|Part B||0|Participants who completed all six periods in Part A were eligible for Part B.|
60005348|NCT02703337|76121107|FG001|STARTED|Part B||0|Participants who completed all six periods in Part A were eligible for Part B.|
60005349|NCT02703337|76121108|FG002|STARTED|Part B||0|Participants who completed all six periods in Part A were eligible for Part B.|
60005350|NCT02703337|76121109|FG003|STARTED|Part B||0|Participants who completed all six periods in Part A were eligible for Part B.|
60005351|NCT02703337|76121110|FG004|STARTED|Part B||0|Participants who completed all six periods in Part A were eligible for Part B.|
60067888|NCT01756053|76183071|FG000|COMPLETED|Period 2 (10 Days)||7||
60005352|NCT02703337|76121111|FG005|STARTED|Part B||0|Participants who completed all six periods in Part A were eligible for Part B.|
60005353|NCT02703337|76121112|FG006|STARTED|Part B||15|Participants who completed all six periods in Part A were eligible for Part B.|
60005354|NCT02703337|76121113|FG007|STARTED|Part B||14|Participants who completed all six periods in Part A were eligible for Part B.|
60005355|NCT02703337|76121106|FG000|Received Study Drug|Part B||0||
60005356|NCT02703337|76121107|FG001|Received Study Drug|Part B||0||
60005357|NCT02703337|76121108|FG002|Received Study Drug|Part B||0||
60005358|NCT02703337|76121109|FG003|Received Study Drug|Part B||0||
60005359|NCT02703337|76121110|FG004|Received Study Drug|Part B||0||
60005360|NCT02703337|76121111|FG005|Received Study Drug|Part B||0||
60005361|NCT02703337|76121112|FG006|Received Study Drug|Part B||15||
60005362|NCT02703337|76121113|FG007|Received Study Drug|Part B||14||
60005363|NCT02703337|76121106|FG000|COMPLETED|Part B||0||
60005364|NCT02703337|76121107|FG001|COMPLETED|Part B||0||
60005365|NCT02703337|76121108|FG002|COMPLETED|Part B||0||
60005366|NCT02703337|76121109|FG003|COMPLETED|Part B||0||
60005367|NCT02703337|76121110|FG004|COMPLETED|Part B||0||
60005368|NCT02703337|76121111|FG005|COMPLETED|Part B||0||
60005369|NCT02703337|76121112|FG006|COMPLETED|Part B||15||
60005370|NCT02703337|76121113|FG007|COMPLETED|Part B||14||
60005371|NCT02703337|76121106|FG000|NOT COMPLETED|Part B||0||
60005372|NCT02703337|76121107|FG001|NOT COMPLETED|Part B||0||
60005373|NCT02703337|76121108|FG002|NOT COMPLETED|Part B||0||
60005374|NCT02703337|76121109|FG003|NOT COMPLETED|Part B||0||
60005375|NCT02703337|76121110|FG004|NOT COMPLETED|Part B||0||
60005376|NCT02703337|76121111|FG005|NOT COMPLETED|Part B||0||
60005377|NCT02703337|76121112|FG006|NOT COMPLETED|Part B||0||
60005378|NCT02703337|76121113|FG007|NOT COMPLETED|Part B||0||
60005379|NCT01680497|76121131|FG000|STARTED|Overall Study||70||
60005380|NCT01680497|76121131|FG000|COMPLETED|Overall Study||68||
60005381|NCT01680497|76121131|FG000|NOT COMPLETED|Overall Study||2||
60005382|NCT01680341|76121137|FG000|STARTED|Overall Study||136||
60005383|NCT01680341|76121138|FG001|STARTED|Overall Study||136||
60005384|NCT01680341|76121137|FG000|Exposed|Overall Study|One (1) subject withdrew consent prior to exposure to trial product.|135||
60005385|NCT01680341|76121138|FG001|Exposed|Overall Study|Two (2) subjects withdrew consent prior to exposure to trial product.|134||
60005386|NCT01680341|76121137|FG000|COMPLETED|Overall Study||115||
60005387|NCT01680341|76121138|FG001|COMPLETED|Overall Study||119||
60005388|NCT01680341|76121137|FG000|NOT COMPLETED|Overall Study||21||
60005389|NCT01680341|76121138|FG001|NOT COMPLETED|Overall Study||17||
60005390|NCT01679405|76121146|FG000|STARTED|Overall Study||3||
60005391|NCT01679405|76121147|FG001|STARTED|Overall Study||6||
60005392|NCT01679405|76121146|FG000|COMPLETED|Overall Study||1||
60005393|NCT01679405|76121147|FG001|COMPLETED|Overall Study||1||
60005394|NCT01679405|76121146|FG000|NOT COMPLETED|Overall Study||2||
60005395|NCT01679405|76121147|FG001|NOT COMPLETED|Overall Study||5||
60005396|NCT01603355|76121153|FG000|STARTED|Overall Study||3||
60005397|NCT01603355|76121153|FG000|COMPLETED|Overall Study||1||
60005398|NCT01603355|76121153|FG000|NOT COMPLETED|Overall Study||2||
60005399|NCT02703259|76121159|FG000|STARTED|24 Hours Postoperative Assessment||70||
60005400|NCT02703259|76121160|FG001|STARTED|24 Hours Postoperative Assessment||67||
60005401|NCT02703259|76121159|FG000|COMPLETED|24 Hours Postoperative Assessment||68||
60005402|NCT02703259|76121160|FG001|COMPLETED|24 Hours Postoperative Assessment||61||
60005403|NCT02703259|76121159|FG000|NOT COMPLETED|24 Hours Postoperative Assessment||2||
60005404|NCT02703259|76121160|FG001|NOT COMPLETED|24 Hours Postoperative Assessment||6||
60005405|NCT02703259|76121159|FG000|STARTED|2 Weeks Postoperative Assessment||68||
60005406|NCT02703259|76121160|FG001|STARTED|2 Weeks Postoperative Assessment||61||
60005407|NCT02703259|76121159|FG000|COMPLETED|2 Weeks Postoperative Assessment||58||
60005408|NCT02703259|76121160|FG001|COMPLETED|2 Weeks Postoperative Assessment||51||
60005409|NCT02703259|76121159|FG000|NOT COMPLETED|2 Weeks Postoperative Assessment||10||
60005410|NCT02703259|76121160|FG001|NOT COMPLETED|2 Weeks Postoperative Assessment||10||
60005411|NCT00701701|76121168|FG000|STARTED|Overall Study||1||
60005412|NCT00701701|76121169|FG001|STARTED|Overall Study||3||
60005413|NCT00701701|76121168|FG000|COMPLETED|Overall Study||1||
60005414|NCT00701701|76121169|FG001|COMPLETED|Overall Study||1||
60005415|NCT00701701|76121168|FG000|NOT COMPLETED|Overall Study||0||
60005416|NCT00701701|76121169|FG001|NOT COMPLETED|Overall Study||2||
60005417|NCT01989754|76121178|FG000|STARTED|Overall Study||2905||
60005418|NCT01989754|76121179|FG001|STARTED|Overall Study||2907||
60005419|NCT01989754|76121178|FG000|Treated|Overall Study||2903||
60005420|NCT01989754|76121179|FG001|Treated|Overall Study||2904||
60005421|NCT01989754|76121178|FG000|COMPLETED|Overall Study|Participants who died are included in this category.|2866||
60005422|NCT01989754|76121179|FG001|COMPLETED|Overall Study|Participants who died are included in this category.|2872||
60005423|NCT01989754|76121178|FG000|NOT COMPLETED|Overall Study||39||
60005424|NCT01989754|76121179|FG001|NOT COMPLETED|Overall Study||35||
60005425|NCT01619878|76121185|FG000|STARTED|6 Week Follow-up Phase||20||
60005426|NCT01619878|76121185|FG000|COMPLETED|6 Week Follow-up Phase||19||
60005427|NCT01619878|76121185|FG000|NOT COMPLETED|6 Week Follow-up Phase||1||
60005428|NCT01619878|76121185|FG000|STARTED|Follow-up at 12 Months of Age||20||
60005429|NCT01619878|76121185|FG000|COMPLETED|Follow-up at 12 Months of Age||17||
60005430|NCT01619878|76121185|FG000|NOT COMPLETED|Follow-up at 12 Months of Age||3||
60005431|NCT02015104|76121191|FG000|STARTED|Overall Study||16||
60005432|NCT02015104|76121192|FG001|STARTED|Overall Study||16||
60005433|NCT02015104|76121191|FG000|COMPLETED|Overall Study||15||
60005434|NCT02015104|76121192|FG001|COMPLETED|Overall Study||15||
60005435|NCT02015104|76121191|FG000|NOT COMPLETED|Overall Study||1||
60005436|NCT02015104|76121192|FG001|NOT COMPLETED|Overall Study||1||
60005437|NCT01619800|76121203|FG000|STARTED|Overall Study||2||
60005438|NCT01619800|76121204|FG001|STARTED|Overall Study||0||
59751138|NCT00917462|75870335|FG000|STARTED|Overall Study||35||
59751139|NCT00917462|75870335|FG000|COMPLETED|Overall Study||34||
59751140|NCT00917462|75870335|FG000|NOT COMPLETED|Overall Study||1||
59605605|NCT01989546|75715768|FG000|COMPLETED|Overall Study||0||
59605606|NCT01989546|75715768|FG000|NOT COMPLETED|Overall Study||9||
59605607|NCT01997892|75715772|FG000|STARTED|Overall Study||1027||
59605608|NCT01997892|75715772|FG000|Received Darbepoetin Alfa|Overall Study||987||
59605609|NCT01997892|75715772|FG000|COMPLETED|Overall Study||959||
59605610|NCT01997892|75715772|FG000|NOT COMPLETED|Overall Study||68||
59605611|NCT01989468|75715784|FG000|STARTED|Overall Study||138|All randomized patients were included in the Full Analysis Set (FAS) and Safety Set (SAF).|
59605612|NCT01989468|75715785|FG001|STARTED|Overall Study||139|All randomized patients were included in the Full Analysis Set (FAS) and Safety Set (SAF).|
59605613|NCT01989468|75715786|FG002|STARTED|Overall Study||64|All randomized patients were included in the Full Analysis Set (FAS) and Safety Set (SAF).|
59605614|NCT01989468|75715787|FG003|STARTED|Overall Study||65|All randomized patients were included in the Full Analysis Set (FAS) and Safety Set (SAF).|
59605615|NCT01989468|75715788|FG004|STARTED|Overall Study||8|All randomized patients were included in the Full Analysis Set (FAS) and Safety Set (SAF).|
59605616|NCT01989468|75715784|FG000|COMPLETED|Overall Study||91|Completed Week 156|
59751141|NCT00979901|75870343|FG000|STARTED|Overall Study||352||
59751142|NCT00979901|75870344|FG001|STARTED|Overall Study||348||
59751143|NCT00979901|75870345|FG002|STARTED|Overall Study||602||
59751144|NCT00979901|75870346|FG003|STARTED|Overall Study||275||
59751145|NCT00979901|75870343|FG000|COMPLETED|Overall Study||334||
60005439|NCT01619800|76121203|FG000|COMPLETED|Overall Study||0||
60005440|NCT01619800|76121204|FG001|COMPLETED|Overall Study||0||
60005441|NCT01619800|76121203|FG000|NOT COMPLETED|Overall Study||2||
60005442|NCT01619800|76121204|FG001|NOT COMPLETED|Overall Study||0||
60005443|NCT01989208|76121212|FG000|STARTED|200 mg (7 Days)||4||
60005444|NCT01989208|76121213|FG001|STARTED|200 mg (7 Days)||12||
60005445|NCT01989208|76121212|FG000|COMPLETED|200 mg (7 Days)||4||
60005446|NCT01989208|76121213|FG001|COMPLETED|200 mg (7 Days)||11||
60005447|NCT01989208|76121212|FG000|NOT COMPLETED|200 mg (7 Days)||0||
60005448|NCT01989208|76121213|FG001|NOT COMPLETED|200 mg (7 Days)||1||
60005449|NCT01989208|76121212|FG000|STARTED|400 mg (7 Days)||4||
60005450|NCT01989208|76121213|FG001|STARTED|400 mg (7 Days)||11||
60005451|NCT01989208|76121212|FG000|COMPLETED|400 mg (7 Days)||4||
60005452|NCT01989208|76121213|FG001|COMPLETED|400 mg (7 Days)||11||
60005453|NCT01989208|76121212|FG000|NOT COMPLETED|400 mg (7 Days)||0||
60005454|NCT01989208|76121213|FG001|NOT COMPLETED|400 mg (7 Days)||0||
60005455|NCT01989208|76121212|FG000|STARTED|800 mg (7 Days)||4||
60005456|NCT01989208|76121213|FG001|STARTED|800 mg (7 Days)||11||
60005457|NCT01989208|76121212|FG000|COMPLETED|800 mg (7 Days)||4||
60005458|NCT01989208|76121213|FG001|COMPLETED|800 mg (7 Days)||11||
60005459|NCT01989208|76121212|FG000|NOT COMPLETED|800 mg (7 Days)||0||
60005460|NCT01989208|76121213|FG001|NOT COMPLETED|800 mg (7 Days)||0||
60005461|NCT01619410|76121233|FG000|STARTED|Overall Study||14||
60005462|NCT01619410|76121234|FG001|STARTED|Overall Study||11||
60005463|NCT01619410|76121233|FG000|COMPLETED|Overall Study||7||
59751146|NCT00979901|75870344|FG001|COMPLETED|Overall Study||336||
59751147|NCT00979901|75870345|FG002|COMPLETED|Overall Study||573||
59751148|NCT00979901|75870346|FG003|COMPLETED|Overall Study||159||
60005464|NCT01619410|76121234|FG001|COMPLETED|Overall Study||7||
60005465|NCT01619410|76121233|FG000|NOT COMPLETED|Overall Study||7||
60005466|NCT01619410|76121234|FG001|NOT COMPLETED|Overall Study||4||
60005467|NCT01966042|76121240|FG000|STARTED|Overall Study||13||
60005468|NCT01966042|76121240|FG000|COMPLETED|Overall Study||11||
60005469|NCT01966042|76121240|FG000|NOT COMPLETED|Overall Study||2||
60005470|NCT02014480|76121244|FG000|STARTED|Treatment Period 1 (14 Days)||35||
60005471|NCT02014480|76121245|FG001|STARTED|Treatment Period 1 (14 Days)||35||
60005472|NCT02014480|76121246|FG002|STARTED|Treatment Period 1 (14 Days)||34||
60005473|NCT02014480|76121247|FG003|STARTED|Treatment Period 1 (14 Days)||34||
60005474|NCT02014480|76121248|FG004|STARTED|Treatment Period 1 (14 Days)||35||
60067889|NCT01756053|76183072|FG001|COMPLETED|Period 2 (10 Days)||6||
60005475|NCT02014480|76121249|FG005|STARTED|Treatment Period 1 (14 Days)|One participant randomized to Sequence 6 actually received UMEC in Treatment Periods 2 and 3.|34||
60005476|NCT02014480|76121244|FG000|COMPLETED|Treatment Period 1 (14 Days)||35||
60005477|NCT02014480|76121245|FG001|COMPLETED|Treatment Period 1 (14 Days)||34||
60005478|NCT02014480|76121246|FG002|COMPLETED|Treatment Period 1 (14 Days)||33||
60005479|NCT02014480|76121247|FG003|COMPLETED|Treatment Period 1 (14 Days)||32||
60005480|NCT02014480|76121248|FG004|COMPLETED|Treatment Period 1 (14 Days)||34||
60005481|NCT02014480|76121249|FG005|COMPLETED|Treatment Period 1 (14 Days)||34||
60005482|NCT02014480|76121244|FG000|NOT COMPLETED|Treatment Period 1 (14 Days)||0||
60005483|NCT02014480|76121245|FG001|NOT COMPLETED|Treatment Period 1 (14 Days)||1||
60005484|NCT02014480|76121246|FG002|NOT COMPLETED|Treatment Period 1 (14 Days)||1||
60005485|NCT02014480|76121247|FG003|NOT COMPLETED|Treatment Period 1 (14 Days)||2||
60005486|NCT02014480|76121248|FG004|NOT COMPLETED|Treatment Period 1 (14 Days)||1||
60005487|NCT02014480|76121249|FG005|NOT COMPLETED|Treatment Period 1 (14 Days)||0||
60005488|NCT02014480|76121244|FG000|STARTED|Washout Period 1 (10 to 14 Days)||35||
60005489|NCT02014480|76121245|FG001|STARTED|Washout Period 1 (10 to 14 Days)||34||
60005490|NCT02014480|76121246|FG002|STARTED|Washout Period 1 (10 to 14 Days)||33||
60005491|NCT02014480|76121247|FG003|STARTED|Washout Period 1 (10 to 14 Days)||32||
60005492|NCT02014480|76121248|FG004|STARTED|Washout Period 1 (10 to 14 Days)||34||
60005493|NCT02014480|76121249|FG005|STARTED|Washout Period 1 (10 to 14 Days)||34||
60005494|NCT02014480|76121244|FG000|COMPLETED|Washout Period 1 (10 to 14 Days)||35||
60005495|NCT02014480|76121245|FG001|COMPLETED|Washout Period 1 (10 to 14 Days)||34||
60005496|NCT02014480|76121246|FG002|COMPLETED|Washout Period 1 (10 to 14 Days)||32||
60005497|NCT02014480|76121247|FG003|COMPLETED|Washout Period 1 (10 to 14 Days)||32||
60005498|NCT02014480|76121248|FG004|COMPLETED|Washout Period 1 (10 to 14 Days)||34||
60005499|NCT02014480|76121249|FG005|COMPLETED|Washout Period 1 (10 to 14 Days)||34||
60005500|NCT02014480|76121244|FG000|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0||
60005501|NCT02014480|76121245|FG001|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0||
60005502|NCT02014480|76121246|FG002|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||1||
60005503|NCT02014480|76121247|FG003|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0||
60005504|NCT02014480|76121248|FG004|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0||
60005505|NCT02014480|76121249|FG005|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0||
60005506|NCT02014480|76121244|FG000|STARTED|Treatment Period 2 (14 Days)||35||
60005507|NCT02014480|76121245|FG001|STARTED|Treatment Period 2 (14 Days)||34||
60005508|NCT02014480|76121246|FG002|STARTED|Treatment Period 2 (14 Days)||32||
59605617|NCT01989468|75715785|FG001|COMPLETED|Overall Study||102|Completed Week 156|
59605618|NCT01989468|75715786|FG002|COMPLETED|Overall Study||45|Completed Week 156|
59605619|NCT01989468|75715787|FG003|COMPLETED|Overall Study||49|Completed Week 156|
59605620|NCT01989468|75715788|FG004|COMPLETED|Overall Study||0|Completed Week 156|
59605621|NCT01989468|75715784|FG000|NOT COMPLETED|Overall Study||47||
59605622|NCT01989468|75715785|FG001|NOT COMPLETED|Overall Study||37||
59605623|NCT01989468|75715786|FG002|NOT COMPLETED|Overall Study||19||
59605624|NCT01989468|75715787|FG003|NOT COMPLETED|Overall Study||16||
59605625|NCT01989468|75715788|FG004|NOT COMPLETED|Overall Study||8||
59605626|NCT01989156|75715804|FG000|STARTED|Confinement Period (Population at Day 5)||80||
59605627|NCT01989156|75715805|FG001|STARTED|Confinement Period (Population at Day 5)||41||
59605628|NCT01989156|75715806|FG002|STARTED|Confinement Period (Population at Day 5)||39||
60005509|NCT02014480|76121247|FG003|STARTED|Treatment Period 2 (14 Days)||32||
60005510|NCT02014480|76121248|FG004|STARTED|Treatment Period 2 (14 Days)||34||
60005511|NCT02014480|76121249|FG005|STARTED|Treatment Period 2 (14 Days)||34||
60005512|NCT02014480|76121244|FG000|COMPLETED|Treatment Period 2 (14 Days)||34||
60005513|NCT02014480|76121245|FG001|COMPLETED|Treatment Period 2 (14 Days)||33||
60005514|NCT02014480|76121246|FG002|COMPLETED|Treatment Period 2 (14 Days)||30||
60005515|NCT02014480|76121247|FG003|COMPLETED|Treatment Period 2 (14 Days)||31||
60005516|NCT02014480|76121248|FG004|COMPLETED|Treatment Period 2 (14 Days)||34||
60005517|NCT02014480|76121249|FG005|COMPLETED|Treatment Period 2 (14 Days)||34||
60005518|NCT02014480|76121244|FG000|NOT COMPLETED|Treatment Period 2 (14 Days)||1||
60005519|NCT02014480|76121245|FG001|NOT COMPLETED|Treatment Period 2 (14 Days)||1||
60005520|NCT02014480|76121246|FG002|NOT COMPLETED|Treatment Period 2 (14 Days)||2||
60005521|NCT02014480|76121247|FG003|NOT COMPLETED|Treatment Period 2 (14 Days)||1||
60005522|NCT02014480|76121248|FG004|NOT COMPLETED|Treatment Period 2 (14 Days)||0||
60005523|NCT02014480|76121249|FG005|NOT COMPLETED|Treatment Period 2 (14 Days)||0||
60005524|NCT02014480|76121244|FG000|STARTED|Washout Period 2 (10 to 14 Days)||34||
60005525|NCT02014480|76121245|FG001|STARTED|Washout Period 2 (10 to 14 Days)||33||
60005526|NCT02014480|76121246|FG002|STARTED|Washout Period 2 (10 to 14 Days)||30||
60005527|NCT02014480|76121247|FG003|STARTED|Washout Period 2 (10 to 14 Days)||31||
60005528|NCT02014480|76121248|FG004|STARTED|Washout Period 2 (10 to 14 Days)||34||
60005529|NCT02014480|76121249|FG005|STARTED|Washout Period 2 (10 to 14 Days)||34||
60005530|NCT02014480|76121244|FG000|COMPLETED|Washout Period 2 (10 to 14 Days)||34||
59605629|NCT01989156|75715804|FG000|COMPLETED|Confinement Period (Population at Day 5)||80||
59605630|NCT01989156|75715805|FG001|COMPLETED|Confinement Period (Population at Day 5)||40||
59605631|NCT01989156|75715806|FG002|COMPLETED|Confinement Period (Population at Day 5)||34||
60005531|NCT02014480|76121245|FG001|COMPLETED|Washout Period 2 (10 to 14 Days)||33||
60005532|NCT02014480|76121246|FG002|COMPLETED|Washout Period 2 (10 to 14 Days)||30||
60005533|NCT02014480|76121247|FG003|COMPLETED|Washout Period 2 (10 to 14 Days)||31||
60005534|NCT02014480|76121248|FG004|COMPLETED|Washout Period 2 (10 to 14 Days)||34||
60005535|NCT02014480|76121249|FG005|COMPLETED|Washout Period 2 (10 to 14 Days)||34||
60005536|NCT02014480|76121244|FG000|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0||
60005537|NCT02014480|76121245|FG001|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0||
60005538|NCT02014480|76121246|FG002|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0||
60005539|NCT02014480|76121247|FG003|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0||
60005540|NCT02014480|76121248|FG004|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0||
60005541|NCT02014480|76121249|FG005|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0||
60005542|NCT02014480|76121244|FG000|STARTED|Treatment Period 3 (14 Days)||34||
60005543|NCT02014480|76121245|FG001|STARTED|Treatment Period 3 (14 Days)||33||
60005544|NCT02014480|76121246|FG002|STARTED|Treatment Period 3 (14 Days)||30||
60005545|NCT02014480|76121247|FG003|STARTED|Treatment Period 3 (14 Days)||31||
60005546|NCT02014480|76121248|FG004|STARTED|Treatment Period 3 (14 Days)||34||
60005547|NCT02014480|76121249|FG005|STARTED|Treatment Period 3 (14 Days)||34||
60005548|NCT02014480|76121244|FG000|COMPLETED|Treatment Period 3 (14 Days)||34||
60005549|NCT02014480|76121245|FG001|COMPLETED|Treatment Period 3 (14 Days)||32||
60005550|NCT02014480|76121246|FG002|COMPLETED|Treatment Period 3 (14 Days)||29||
60005551|NCT02014480|76121247|FG003|COMPLETED|Treatment Period 3 (14 Days)||31||
60005552|NCT02014480|76121248|FG004|COMPLETED|Treatment Period 3 (14 Days)||34||
60005553|NCT02014480|76121249|FG005|COMPLETED|Treatment Period 3 (14 Days)||32||
60005554|NCT02014480|76121244|FG000|NOT COMPLETED|Treatment Period 3 (14 Days)||0||
60005555|NCT02014480|76121245|FG001|NOT COMPLETED|Treatment Period 3 (14 Days)||1||
60005556|NCT02014480|76121246|FG002|NOT COMPLETED|Treatment Period 3 (14 Days)||1||
60005557|NCT02014480|76121247|FG003|NOT COMPLETED|Treatment Period 3 (14 Days)||0||
60005558|NCT02014480|76121248|FG004|NOT COMPLETED|Treatment Period 3 (14 Days)||0||
60005559|NCT02014480|76121249|FG005|NOT COMPLETED|Treatment Period 3 (14 Days)||2||
60005560|NCT01261247|76121257|FG000|STARTED|Overall Study||41||
60005561|NCT01261247|76121257|FG000|COMPLETED|Overall Study||39||
60005562|NCT01261247|76121257|FG000|NOT COMPLETED|Overall Study||2||
60005563|NCT01677767|76121261|FG000|STARTED|Overall Study||124||
60005564|NCT01677767|76121261|FG000|COMPLETED|Overall Study||102||
60005565|NCT01677767|76121261|FG000|NOT COMPLETED|Overall Study||22||
60005566|NCT03189563|76121270|FG000|STARTED|Overall Study||20||
60005567|NCT03189563|76121271|FG001|STARTED|Overall Study||21||
60005568|NCT03189563|76121272|FG002|STARTED|Overall Study||20||
60005569|NCT03189563|76121270|FG000|ITT Population|Overall Study||20||
60005570|NCT03189563|76121271|FG001|ITT Population|Overall Study||21||
60005571|NCT03189563|76121272|FG002|ITT Population|Overall Study||19||
60005572|NCT03189563|76121270|FG000|Safety Population|Overall Study||20||
60005573|NCT03189563|76121271|FG001|Safety Population|Overall Study||21||
60005574|NCT03189563|76121272|FG002|Safety Population|Overall Study||19||
60005575|NCT03189563|76121270|FG000|COMPLETED|Overall Study||19||
60005576|NCT03189563|76121271|FG001|COMPLETED|Overall Study||20||
60005577|NCT03189563|76121272|FG002|COMPLETED|Overall Study||18||
60005578|NCT03189563|76121270|FG000|NOT COMPLETED|Overall Study||1||
60005579|NCT03189563|76121271|FG001|NOT COMPLETED|Overall Study||1||
60005580|NCT03189563|76121272|FG002|NOT COMPLETED|Overall Study||2||
60005581|NCT01603277|76121282|FG000|STARTED|Overall Study||78||
60005582|NCT01603277|76121283|FG001|STARTED|Overall Study||82||
60005583|NCT01603277|76121282|FG000|COMPLETED|Overall Study||64||
60005584|NCT01603277|76121283|FG001|COMPLETED|Overall Study||64||
60005585|NCT01603277|76121282|FG000|NOT COMPLETED|Overall Study||14||
60005586|NCT01603277|76121283|FG001|NOT COMPLETED|Overall Study||18||
60005587|NCT01678313|76121291|FG000|STARTED|Completed the 3-month Therapy||70||
60005588|NCT01678313|76121292|FG001|STARTED|Completed the 3-month Therapy||70||
60005589|NCT01678313|76121291|FG000|COMPLETED|Completed the 3-month Therapy||64||
60005590|NCT01678313|76121292|FG001|COMPLETED|Completed the 3-month Therapy||58||
60005591|NCT01678313|76121291|FG000|NOT COMPLETED|Completed the 3-month Therapy||6||
60005592|NCT01678313|76121292|FG001|NOT COMPLETED|Completed the 3-month Therapy||12||
60005593|NCT01678313|76121291|FG000|STARTED|PSA >4 ng/dL at 3 Months||64||
60005594|NCT01678313|76121292|FG001|STARTED|PSA >4 ng/dL at 3 Months||58||
60005595|NCT01678313|76121291|FG000|COMPLETED|PSA >4 ng/dL at 3 Months||56||
60005596|NCT01678313|76121292|FG001|COMPLETED|PSA >4 ng/dL at 3 Months||49||
60005597|NCT01678313|76121291|FG000|NOT COMPLETED|PSA >4 ng/dL at 3 Months||8||
60005598|NCT01678313|76121292|FG001|NOT COMPLETED|PSA >4 ng/dL at 3 Months||9||
60005599|NCT01678313|76121291|FG000|STARTED|Prostate Biopsy at 3 Months||56||
60005600|NCT01678313|76121292|FG001|STARTED|Prostate Biopsy at 3 Months||49||
60005601|NCT01678313|76121291|FG000|COMPLETED|Prostate Biopsy at 3 Months||45||
60005602|NCT01678313|76121292|FG001|COMPLETED|Prostate Biopsy at 3 Months||37||
60005603|NCT01678313|76121291|FG000|NOT COMPLETED|Prostate Biopsy at 3 Months||11||
60005604|NCT01678313|76121292|FG001|NOT COMPLETED|Prostate Biopsy at 3 Months||12||
60005605|NCT01603121|76121298|FG000|STARTED|First Intervention, 10 Hours||1||
60005606|NCT01603121|76121299|FG001|STARTED|First Intervention, 10 Hours||0||
60005607|NCT01603121|76121298|FG000|COMPLETED|First Intervention, 10 Hours||1||
60005608|NCT01603121|76121299|FG001|COMPLETED|First Intervention, 10 Hours||0||
60005609|NCT01603121|76121298|FG000|NOT COMPLETED|First Intervention, 10 Hours||0||
60005610|NCT01603121|76121299|FG001|NOT COMPLETED|First Intervention, 10 Hours||0||
60005611|NCT01603121|76121298|FG000|STARTED|Second Intervention, 10 Hours||1||
60005612|NCT01603121|76121299|FG001|STARTED|Second Intervention, 10 Hours||0||
60005613|NCT01603121|76121298|FG000|COMPLETED|Second Intervention, 10 Hours||0||
60005614|NCT01603121|76121299|FG001|COMPLETED|Second Intervention, 10 Hours||0||
60005615|NCT01603121|76121298|FG000|NOT COMPLETED|Second Intervention, 10 Hours||1||
60005616|NCT01603121|76121299|FG001|NOT COMPLETED|Second Intervention, 10 Hours||0||
60005617|NCT01603043|76121307|FG000|STARTED|Overall Study||7||
60005618|NCT01603043|76121308|FG001|STARTED|Overall Study||3||
60005619|NCT01603043|76121307|FG000|COMPLETED|Overall Study||0||
60005620|NCT01603043|76121308|FG001|COMPLETED|Overall Study||0||
60136027|NCT01272921|76258715|FG001|STARTED|Overall Study||71||
60005621|NCT01603043|76121307|FG000|NOT COMPLETED|Overall Study||7||
60005622|NCT01603043|76121308|FG001|NOT COMPLETED|Overall Study||3||
60005623|NCT02014402|76121318|FG000|STARTED|Overall Study||31||
60005624|NCT02014402|76121319|FG001|STARTED|Overall Study||30||
60005625|NCT02014402|76121320|FG002|STARTED|Overall Study||35||
60005626|NCT02014402|76121321|FG003|STARTED|Overall Study||85||
60005627|NCT02014402|76121318|FG000|Human Thrombin|Overall Study||20||
60005628|NCT02014402|76121319|FG001|Human Thrombin|Overall Study||20||
60005629|NCT02014402|76121320|FG002|Human Thrombin|Overall Study||23||
60005630|NCT02014402|76121321|FG003|Human Thrombin|Overall Study||57||
60005631|NCT02014402|76121318|FG000|Bovine Thrombin|Overall Study||11||
60005632|NCT02014402|76121319|FG001|Bovine Thrombin|Overall Study||10||
60005633|NCT02014402|76121320|FG002|Bovine Thrombin|Overall Study||12||
60005634|NCT02014402|76121321|FG003|Bovine Thrombin|Overall Study||28||
60005635|NCT02014402|76121318|FG000|COMPLETED|Overall Study||29||
60005636|NCT02014402|76121319|FG001|COMPLETED|Overall Study||27||
60005637|NCT02014402|76121320|FG002|COMPLETED|Overall Study||32||
60005638|NCT02014402|76121321|FG003|COMPLETED|Overall Study||82||
60005639|NCT02014402|76121318|FG000|NOT COMPLETED|Overall Study||2||
60005640|NCT02014402|76121319|FG001|NOT COMPLETED|Overall Study||3||
60005641|NCT02014402|76121320|FG002|NOT COMPLETED|Overall Study||3||
60005642|NCT02014402|76121321|FG003|NOT COMPLETED|Overall Study||3||
60005643|NCT01988662|76121340|FG000|STARTED|Overall Study||104||
60005644|NCT01988662|76121341|FG001|STARTED|Overall Study||101||
60005645|NCT01988662|76121340|FG000|COMPLETED|Overall Study||100||
60005646|NCT01988662|76121341|FG001|COMPLETED|Overall Study||99||
60005647|NCT01988662|76121340|FG000|NOT COMPLETED|Overall Study||4||
60005648|NCT01988662|76121341|FG001|NOT COMPLETED|Overall Study||2||
60005649|NCT02839343|76121350|FG000|STARTED|Overall Study||70||
60005650|NCT02839343|76121351|FG001|STARTED|Overall Study||56||
60005651|NCT02839343|76121350|FG000|COMPLETED|Overall Study||65||
60005652|NCT02839343|76121351|FG001|COMPLETED|Overall Study||55||
60005653|NCT02839343|76121350|FG000|NOT COMPLETED|Overall Study||5||
60005654|NCT02839343|76121351|FG001|NOT COMPLETED|Overall Study||1||
60005655|NCT00127673|76121361|FG000|STARTED|Overall Study||48||
60005656|NCT00127673|76121362|FG001|STARTED|Overall Study||61||
60005657|NCT00127673|76121363|FG002|STARTED|Overall Study||55||
60005658|NCT00127673|76121364|FG003|STARTED|Overall Study||36||
60005659|NCT00127673|76121361|FG000|COMPLETED|Overall Study||23||
60005660|NCT00127673|76121362|FG001|COMPLETED|Overall Study||44||
60005661|NCT00127673|76121363|FG002|COMPLETED|Overall Study||35||
60005662|NCT00127673|76121364|FG003|COMPLETED|Overall Study||25||
60005663|NCT00127673|76121361|FG000|NOT COMPLETED|Overall Study||25||
60005664|NCT00127673|76121362|FG001|NOT COMPLETED|Overall Study||17||
60005665|NCT00127673|76121363|FG002|NOT COMPLETED|Overall Study||20||
60005666|NCT00127673|76121364|FG003|NOT COMPLETED|Overall Study||11||
60005667|NCT01965652|76121380|FG000|STARTED|Overall Study|Includes two participants who each enrolled at two different sites|623||
60005668|NCT01965652|76121381|FG001|STARTED|Overall Study|Includes three participants who each enrolled at two different sites|623||
60005669|NCT01965652|76121380|FG000|Received Treatment|Overall Study||622||
60005670|NCT01965652|76121381|FG001|Received Treatment|Overall Study||623||
60005671|NCT01965652|76121380|FG000|COMPLETED|Overall Study||413||
60005672|NCT01965652|76121381|FG001|COMPLETED|Overall Study||413||
60005673|NCT01965652|76121380|FG000|NOT COMPLETED|Overall Study||210||
60005674|NCT01965652|76121381|FG001|NOT COMPLETED|Overall Study||210||
60005675|NCT01602965|76121389|FG000|STARTED|Overall Study||20||
60005676|NCT01602965|76121390|FG001|STARTED|Overall Study||20||
60005677|NCT01602965|76121389|FG000|COMPLETED|Overall Study||16||
60005678|NCT01602965|76121390|FG001|COMPLETED|Overall Study||18||
60005679|NCT01602965|76121389|FG000|NOT COMPLETED|Overall Study||4||
60005680|NCT01602965|76121390|FG001|NOT COMPLETED|Overall Study||2||
60005681|NCT01987960|76121398|FG000|STARTED|Period 1||417||
60005682|NCT01987960|76121399|FG001|STARTED|Period 1||0||
60005683|NCT01987960|76121400|FG002|STARTED|Period 1||0||
60005684|NCT01987960|76121401|FG003|STARTED|Period 1||0||
60005685|NCT01987960|76121398|FG000|COMPLETED|Period 1||231||
60005686|NCT01987960|76121399|FG001|COMPLETED|Period 1||0||
60005687|NCT01987960|76121400|FG002|COMPLETED|Period 1||0||
60005688|NCT01987960|76121401|FG003|COMPLETED|Period 1||0||
60005689|NCT01987960|76121398|FG000|NOT COMPLETED|Period 1||186||
60005690|NCT01987960|76121399|FG001|NOT COMPLETED|Period 1||0||
60005691|NCT01987960|76121400|FG002|NOT COMPLETED|Period 1||0||
60005692|NCT01987960|76121401|FG003|NOT COMPLETED|Period 1||0||
60005693|NCT01987960|76121398|FG000|STARTED|Period 2||0||
59519070|NCT01118221|75612937|FG000|NOT COMPLETED|Overall Study||3||
60005694|NCT01987960|76121399|FG001|STARTED|Period 2||17||
60005695|NCT01987960|76121400|FG002|STARTED|Period 2||23||
60005696|NCT01987960|76121401|FG003|STARTED|Period 2||0||
60005697|NCT01987960|76121398|FG000|COMPLETED|Period 2||0||
60005698|NCT01987960|76121399|FG001|COMPLETED|Period 2||12||
59880721|NCT03437278|76003577|FG001|STARTED|Overall Study||13||
59880722|NCT03437278|76003578|FG002|STARTED|Overall Study||12||
59880723|NCT03437278|76003576|FG000|COMPLETED|Overall Study||22||
59880724|NCT03437278|76003577|FG001|COMPLETED|Overall Study||13||
59880725|NCT03437278|76003578|FG002|COMPLETED|Overall Study||10||
59880726|NCT03437278|76003576|FG000|NOT COMPLETED|Overall Study||2||
59880727|NCT03437278|76003577|FG001|NOT COMPLETED|Overall Study||0||
59880728|NCT03437278|76003578|FG002|NOT COMPLETED|Overall Study||2||
59880729|NCT04553913|76003588|FG000|STARTED|Overall Study||15||
59880730|NCT04553913|76003588|FG000|COMPLETED|Overall Study||9||
59880731|NCT04553913|76003588|FG000|NOT COMPLETED|Overall Study||6||
59880732|NCT04490499|76003593|FG000|STARTED|Overall Study||207||
59880733|NCT04490499|76003593|FG000|Vaccinated|Overall Study||205||
59880734|NCT04490499|76003593|FG000|COMPLETED|Overall Study||205||
59880735|NCT04490499|76003593|FG000|NOT COMPLETED|Overall Study||2||
59880736|NCT01332994|76003597|FG000|STARTED|Overall Study||519||
59880737|NCT01332994|76003597|FG000|Completed Week 16|Overall Study||463||
59880738|NCT01332994|76003597|FG000|Completed Week 32 (TCZ/TCZ)|Overall Study||200||
59880739|NCT01332994|76003597|FG000|Completed Week 32 (TCZ/RTX)|Overall Study||26||
59880740|NCT01332994|76003597|FG000|Completed Week 66 (TCZ/RTX)|Overall Study||25||
59880741|NCT01332994|76003597|FG000|COMPLETED|Overall Study||448||
59880742|NCT01332994|76003597|FG000|NOT COMPLETED|Overall Study||71||
59880743|NCT03698331|76003603|FG000|STARTED|Overall Study||44||
59880744|NCT03698331|76003604|FG001|STARTED|Overall Study||45||
59880745|NCT03698331|76003603|FG000|Entered Withdrawal Period|Overall Study||42||
59880746|NCT03698331|76003604|FG001|Entered Withdrawal Period|Overall Study||39||
59880747|NCT03698331|76003603|FG000|COMPLETED|Overall Study||40||
59880748|NCT03698331|76003604|FG001|COMPLETED|Overall Study||39||
59880749|NCT03698331|76003603|FG000|NOT COMPLETED|Overall Study||4||
59880750|NCT03698331|76003604|FG001|NOT COMPLETED|Overall Study||6||
59880751|NCT04889625|76003610|FG000|STARTED|Period 1||40||
59880752|NCT04889625|76003611|FG001|STARTED|Period 1||38||
59880753|NCT04889625|76003610|FG000|COMPLETED|Period 1||37||
59880754|NCT04889625|76003611|FG001|COMPLETED|Period 1||34||
59880755|NCT04889625|76003610|FG000|NOT COMPLETED|Period 1||3||
59880756|NCT04889625|76003611|FG001|NOT COMPLETED|Period 1||4||
59880757|NCT04889625|76003610|FG000|STARTED|Period 2||37||
59880758|NCT04889625|76003611|FG001|STARTED|Period 2||34||
59880759|NCT04889625|76003610|FG000|COMPLETED|Period 2||35||
59880760|NCT04889625|76003611|FG001|COMPLETED|Period 2||33||
59880761|NCT04889625|76003610|FG000|NOT COMPLETED|Period 2||2||
59880762|NCT04889625|76003611|FG001|NOT COMPLETED|Period 2||1||
59880763|NCT04889625|76003610|FG000|STARTED|Period 3||35||
59880764|NCT04889625|76003611|FG001|STARTED|Period 3||33||
59880765|NCT04889625|76003610|FG000|COMPLETED|Period 3||35||
59880766|NCT04889625|76003611|FG001|COMPLETED|Period 3||33||
59880767|NCT04889625|76003610|FG000|NOT COMPLETED|Period 3||0||
59880768|NCT04889625|76003611|FG001|NOT COMPLETED|Period 3||0||
59880769|NCT04883541|76003619|FG000|STARTED|Overall Study||46||
59880770|NCT04883541|76003620|FG001|STARTED|Overall Study||69||
59880771|NCT04883541|76003619|FG000|COMPLETED|Overall Study||30||
59880772|NCT04883541|76003620|FG001|COMPLETED|Overall Study||60||
59880773|NCT04883541|76003619|FG000|NOT COMPLETED|Overall Study||16||
59880774|NCT04883541|76003620|FG001|NOT COMPLETED|Overall Study||9||
59880775|NCT04882995|76003628|FG000|STARTED|Overall Study||41||
59880776|NCT04882995|76003629|FG001|STARTED|Overall Study||43||
59880777|NCT04882995|76003628|FG000|COMPLETED|Overall Study||35||
59880778|NCT04882995|76003629|FG001|COMPLETED|Overall Study||36||
59880779|NCT04882995|76003628|FG000|NOT COMPLETED|Overall Study||6||
59880780|NCT04882995|76003629|FG001|NOT COMPLETED|Overall Study||7||
59880781|NCT04483011|76003637|FG000|STARTED|Intervention Period 1 (8 Days)||9||
59880782|NCT04483011|76003638|FG001|STARTED|Intervention Period 1 (8 Days)||9||
59880783|NCT04483011|76003637|FG000|COMPLETED|Intervention Period 1 (8 Days)||9||
59880784|NCT04483011|76003638|FG001|COMPLETED|Intervention Period 1 (8 Days)||9||
59880785|NCT04483011|76003637|FG000|NOT COMPLETED|Intervention Period 1 (8 Days)||0||
59880786|NCT04483011|76003638|FG001|NOT COMPLETED|Intervention Period 1 (8 Days)||0||
59880787|NCT04483011|76003637|FG000|STARTED|Washout (7 Days)||9||
59880788|NCT04483011|76003638|FG001|STARTED|Washout (7 Days)||9||
59880789|NCT04483011|76003637|FG000|COMPLETED|Washout (7 Days)||9||
59880790|NCT04483011|76003638|FG001|COMPLETED|Washout (7 Days)||8||
59880791|NCT04483011|76003637|FG000|NOT COMPLETED|Washout (7 Days)||0||
59880792|NCT04483011|76003638|FG001|NOT COMPLETED|Washout (7 Days)||1||
59880793|NCT04483011|76003637|FG000|STARTED|Intervention Period 2 (8 Days)||9||
59880794|NCT04483011|76003638|FG001|STARTED|Intervention Period 2 (8 Days)||8||
59880795|NCT04483011|76003637|FG000|COMPLETED|Intervention Period 2 (8 Days)||9||
59880796|NCT04483011|76003638|FG001|COMPLETED|Intervention Period 2 (8 Days)||8||
60005699|NCT01987960|76121400|FG002|COMPLETED|Period 2||14||
60005700|NCT01987960|76121401|FG003|COMPLETED|Period 2||0||
60005701|NCT01987960|76121398|FG000|NOT COMPLETED|Period 2||0||
60005702|NCT01987960|76121399|FG001|NOT COMPLETED|Period 2||5||
60005703|NCT01987960|76121400|FG002|NOT COMPLETED|Period 2||9||
60005704|NCT01987960|76121401|FG003|NOT COMPLETED|Period 2||0||
60005705|NCT01987960|76121398|FG000|STARTED|Period 3||0||
60005706|NCT01987960|76121399|FG001|STARTED|Period 3||0||
60005707|NCT01987960|76121400|FG002|STARTED|Period 3||0||
60005708|NCT01987960|76121401|FG003|STARTED|Period 3||190||
60005709|NCT01987960|76121398|FG000|COMPLETED|Period 3||0||
60005710|NCT01987960|76121399|FG001|COMPLETED|Period 3||0||
60005711|NCT01987960|76121400|FG002|COMPLETED|Period 3||0||
60005712|NCT01987960|76121401|FG003|COMPLETED|Period 3||119||
60005713|NCT01987960|76121398|FG000|NOT COMPLETED|Period 3||0||
60005714|NCT01987960|76121399|FG001|NOT COMPLETED|Period 3||0||
60005715|NCT01987960|76121400|FG002|NOT COMPLETED|Period 3||0||
60005716|NCT01987960|76121401|FG003|NOT COMPLETED|Period 3||71||
60005717|NCT02013778|76121411|FG000|STARTED|Overall Study||8||
60005718|NCT02013778|76121411|FG000|COMPLETED|Overall Study||1||
60005719|NCT02013778|76121411|FG000|NOT COMPLETED|Overall Study||7||
60005720|NCT02013622|76121415|FG000|STARTED|Overall Study||49||
60005721|NCT02013622|76121415|FG000|COMPLETED|Overall Study||25||
60005722|NCT02013622|76121415|FG000|NOT COMPLETED|Overall Study||24||
60005723|NCT01987102|76121421|FG000|STARTED|2 Courses of HDMTX With SOC Rescue||8||
60005724|NCT01987102|76121422|FG001|STARTED|2 Courses of HDMTX With SOC Rescue||10||
60005725|NCT01987102|76121421|FG000|COMPLETED|2 Courses of HDMTX With SOC Rescue||4||
60005726|NCT01987102|76121422|FG001|COMPLETED|2 Courses of HDMTX With SOC Rescue||4||
60005727|NCT01987102|76121421|FG000|NOT COMPLETED|2 Courses of HDMTX With SOC Rescue||4||
60005728|NCT01987102|76121422|FG001|NOT COMPLETED|2 Courses of HDMTX With SOC Rescue||6||
60005729|NCT01987102|76121421|FG000|STARTED|2 Courses of HDMTX With MOD Rescue||4||
60005730|NCT01987102|76121422|FG001|STARTED|2 Courses of HDMTX With MOD Rescue||4||
60005731|NCT01987102|76121421|FG000|COMPLETED|2 Courses of HDMTX With MOD Rescue||4||
60005732|NCT01987102|76121422|FG001|COMPLETED|2 Courses of HDMTX With MOD Rescue||3||
60005733|NCT01987102|76121421|FG000|NOT COMPLETED|2 Courses of HDMTX With MOD Rescue||0||
60005734|NCT01987102|76121422|FG001|NOT COMPLETED|2 Courses of HDMTX With MOD Rescue||1||
60005735|NCT02013544|76121431|FG000|STARTED|Overall Study||182||
60005736|NCT02013544|76121432|FG001|STARTED|Overall Study||376||
60005737|NCT02013544|76121431|FG000|Safety Population|Overall Study||180||
60005738|NCT02013544|76121432|FG001|Safety Population|Overall Study||374||
60005739|NCT02013544|76121431|FG000|ITT Population|Overall Study||157||
60005740|NCT02013544|76121432|FG001|ITT Population|Overall Study||325||
60005741|NCT02013544|76121431|FG000|COMPLETED|Overall Study||171||
60005742|NCT02013544|76121432|FG001|COMPLETED|Overall Study||356||
60005743|NCT02013544|76121431|FG000|NOT COMPLETED|Overall Study||11||
60005744|NCT02013544|76121432|FG001|NOT COMPLETED|Overall Study||20||
60005745|NCT02013388|76121446|FG000|STARTED|Overall Study||9||
60005746|NCT02013388|76121447|FG001|STARTED|Overall Study||6||
60005747|NCT02013388|76121448|FG002|STARTED|Overall Study||6||
60005748|NCT02013388|76121449|FG003|STARTED|Overall Study||6||
60005749|NCT02013388|76121450|FG004|STARTED|Overall Study||6||
60005750|NCT02013388|76121451|FG005|STARTED|Overall Study||6||
60005751|NCT02013388|76121452|FG006|STARTED|Overall Study||6||
60005752|NCT02013388|76121453|FG007|STARTED|Overall Study||4||
60005753|NCT02013388|76121446|FG000|COMPLETED|Overall Study||8||
60005754|NCT02013388|76121447|FG001|COMPLETED|Overall Study||6||
60005755|NCT02013388|76121448|FG002|COMPLETED|Overall Study||6||
60005756|NCT02013388|76121449|FG003|COMPLETED|Overall Study||6||
60005757|NCT02013388|76121450|FG004|COMPLETED|Overall Study||5||
60005758|NCT02013388|76121451|FG005|COMPLETED|Overall Study||6||
60005759|NCT02013388|76121452|FG006|COMPLETED|Overall Study||6||
60005760|NCT02013388|76121453|FG007|COMPLETED|Overall Study||4||
60005761|NCT02013388|76121446|FG000|NOT COMPLETED|Overall Study||1||
60005762|NCT02013388|76121447|FG001|NOT COMPLETED|Overall Study||0||
60005763|NCT02013388|76121448|FG002|NOT COMPLETED|Overall Study||0||
60005764|NCT02013388|76121449|FG003|NOT COMPLETED|Overall Study||0||
60005765|NCT02013388|76121450|FG004|NOT COMPLETED|Overall Study||1||
60005766|NCT02013388|76121451|FG005|NOT COMPLETED|Overall Study||0||
60005767|NCT02013388|76121452|FG006|NOT COMPLETED|Overall Study||0||
60005768|NCT02013388|76121453|FG007|NOT COMPLETED|Overall Study||0||
60005769|NCT02012686|76121477|FG000|STARTED|Overall Study||50||
60005770|NCT02012686|76121478|FG001|STARTED|Overall Study||50||
60005771|NCT02012686|76121477|FG000|COMPLETED|Overall Study||50||
60005772|NCT02012686|76121478|FG001|COMPLETED|Overall Study||48||
60005773|NCT02012686|76121477|FG000|NOT COMPLETED|Overall Study||0||
60005774|NCT02012686|76121478|FG001|NOT COMPLETED|Overall Study||2||
60005775|NCT02012452|76121486|FG000|STARTED|Overall Study||7||
60005776|NCT02012452|76121487|FG001|STARTED|Overall Study||2||
60005777|NCT02012452|76121486|FG000|COMPLETED|Overall Study||1||
60005778|NCT02012452|76121487|FG001|COMPLETED|Overall Study||1||
60005779|NCT02012452|76121486|FG000|NOT COMPLETED|Overall Study||6||
60005780|NCT02012452|76121487|FG001|NOT COMPLETED|Overall Study||1||
60005781|NCT01676909|76121495|FG000|STARTED|Overall Study||124||
60005782|NCT01676909|76121496|FG001|STARTED|Overall Study||118||
60005783|NCT01676909|76121495|FG000|Post-Treatment Assessment|Overall Study|19 not completed (3 withdrawn, 15 timed out, 1 declined)|105||
60005784|NCT01676909|76121496|FG001|Post-Treatment Assessment|Overall Study|11 not completed (5 withdrawn, 6 timed out)|107||
60005785|NCT01676909|76121495|FG000|COMPLETED|Overall Study|18 not completed (3 withdrawn, 15 timed out)|106||
60005786|NCT01676909|76121496|FG001|COMPLETED|Overall Study|14 not completed (5 withdrawn, 9 timed out|104||
60005787|NCT01676909|76121495|FG000|NOT COMPLETED|Overall Study||18||
60005788|NCT01676909|76121496|FG001|NOT COMPLETED|Overall Study||14||
60005789|NCT02012296|76121507|FG000|STARTED|Overall Study||33||
60005790|NCT02012296|76121508|FG001|STARTED|Overall Study||33||
60005791|NCT02012296|76121509|FG002|STARTED|Overall Study||22||
60005792|NCT02012296|76121507|FG000|COMPLETED|Overall Study||33||
60005793|NCT02012296|76121508|FG001|COMPLETED|Overall Study||32||
60005794|NCT02012296|76121509|FG002|COMPLETED|Overall Study||0||
60005795|NCT02012296|76121507|FG000|NOT COMPLETED|Overall Study||0||
60005796|NCT02012296|76121508|FG001|NOT COMPLETED|Overall Study||1||
60005797|NCT02012296|76121509|FG002|NOT COMPLETED|Overall Study||22||
60005798|NCT02012218|76121526|FG000|STARTED|Overall Study||12||
60005799|NCT02012218|76121527|FG001|STARTED|Overall Study||11||
60005800|NCT02012218|76121528|FG002|STARTED|Overall Study||13||
60005801|NCT02012218|76121529|FG003|STARTED|Overall Study||19||
60005802|NCT02012218|76121530|FG004|STARTED|Overall Study||6||
60005803|NCT02012218|76121526|FG000|COMPLETED|Overall Study||8||
60005804|NCT02012218|76121527|FG001|COMPLETED|Overall Study||10||
60005805|NCT02012218|76121528|FG002|COMPLETED|Overall Study||11||
60005806|NCT02012218|76121529|FG003|COMPLETED|Overall Study||17||
60005807|NCT02012218|76121530|FG004|COMPLETED|Overall Study||5||
60005808|NCT02012218|76121526|FG000|NOT COMPLETED|Overall Study||4||
60005809|NCT02012218|76121527|FG001|NOT COMPLETED|Overall Study||1||
60005810|NCT02012218|76121528|FG002|NOT COMPLETED|Overall Study||2||
60005811|NCT02012218|76121529|FG003|NOT COMPLETED|Overall Study||2||
60005812|NCT02012218|76121530|FG004|NOT COMPLETED|Overall Study||1||
60005813|NCT01965262|76121542|FG000|STARTED|First Intervention (7 Days)||15||
60005814|NCT01965262|76121543|FG001|STARTED|First Intervention (7 Days)||15||
60005815|NCT01965262|76121542|FG000|COMPLETED|First Intervention (7 Days)||15||
60005816|NCT01965262|76121543|FG001|COMPLETED|First Intervention (7 Days)||15||
60005817|NCT01965262|76121542|FG000|NOT COMPLETED|First Intervention (7 Days)||0||
60005818|NCT01965262|76121543|FG001|NOT COMPLETED|First Intervention (7 Days)||0||
60005819|NCT01965262|76121542|FG000|STARTED|Second Intervention (7 Days)||15||
59751149|NCT00979901|75870343|FG000|NOT COMPLETED|Overall Study||18||
59751150|NCT00979901|75870344|FG001|NOT COMPLETED|Overall Study||12||
59751151|NCT00979901|75870345|FG002|NOT COMPLETED|Overall Study||29||
59751152|NCT00979901|75870346|FG003|NOT COMPLETED|Overall Study||116||
59751153|NCT00975611|75870355|FG000|STARTED|Overall Study||22||
60005820|NCT01965262|76121543|FG001|STARTED|Second Intervention (7 Days)||15||
59519071|NCT01118221|75612938|FG001|NOT COMPLETED|Overall Study||1||
59751154|NCT00975611|75870355|FG000|COMPLETED|Overall Study||5||
59751155|NCT00975611|75870355|FG000|NOT COMPLETED|Overall Study||17||
59751156|NCT00970307|75870362|FG000|STARTED|Overall Study||141||
59751157|NCT00970307|75870363|FG001|STARTED|Overall Study||139||
59751158|NCT00970307|75870364|FG002|STARTED|Overall Study||141||
60005821|NCT01965262|76121542|FG000|COMPLETED|Second Intervention (7 Days)||14||
60005822|NCT01965262|76121543|FG001|COMPLETED|Second Intervention (7 Days)||5||
60005823|NCT01965262|76121542|FG000|NOT COMPLETED|Second Intervention (7 Days)||1||
60005824|NCT01965262|76121543|FG001|NOT COMPLETED|Second Intervention (7 Days)||10||
60005825|NCT01677377|76121552|FG000|STARTED|Overall Study||15||
60005826|NCT01677377|76121553|FG001|STARTED|Overall Study||15||
60005827|NCT01677377|76121554|FG002|STARTED|Overall Study||15||
60005828|NCT01677377|76121552|FG000|COMPLETED|Overall Study||14||
60005829|NCT01677377|76121553|FG001|COMPLETED|Overall Study||14||
60005830|NCT01677377|76121554|FG002|COMPLETED|Overall Study||9||
60005831|NCT01677377|76121552|FG000|NOT COMPLETED|Overall Study||1||
60005832|NCT01677377|76121553|FG001|NOT COMPLETED|Overall Study||1||
60005833|NCT01677377|76121554|FG002|NOT COMPLETED|Overall Study||6||
60005834|NCT01964950|76121564|FG000|STARTED|Overall Study|Data reports overall population,since data not collected separately per arm as specified in protocol|1101||
59751159|NCT00970307|75870362|FG000|COMPLETED|Overall Study||138||
59751160|NCT00970307|75870363|FG001|COMPLETED|Overall Study||136||
59751161|NCT00970307|75870364|FG002|COMPLETED|Overall Study||139||
59751162|NCT00970307|75870362|FG000|NOT COMPLETED|Overall Study||3||
59751163|NCT00970307|75870363|FG001|NOT COMPLETED|Overall Study||3||
59751164|NCT00970307|75870364|FG002|NOT COMPLETED|Overall Study||2||
60005835|NCT01964950|76121564|FG000|COMPLETED|Overall Study||1076||
60005836|NCT01964950|76121564|FG000|NOT COMPLETED|Overall Study||25||
59751165|NCT00917384|75870374|FG000|STARTED|Overall Study||238||
59751166|NCT00917384|75870375|FG001|STARTED|Overall Study||117||
59751167|NCT00917384|75870374|FG000|Received at Least 1 Dose of Study Drug|Overall Study||236||
59751168|NCT00917384|75870375|FG001|Received at Least 1 Dose of Study Drug|Overall Study||115||
59751169|NCT00917384|75870374|FG000|COMPLETED|Overall Study||224||
59751170|NCT00917384|75870375|FG001|COMPLETED|Overall Study||113||
59880797|NCT04483011|76003637|FG000|NOT COMPLETED|Intervention Period 2 (8 Days)||0||
59880798|NCT04483011|76003638|FG001|NOT COMPLETED|Intervention Period 2 (8 Days)||0||
59880799|NCT04545567|76003648|FG000|STARTED|Overall Study||10||
59880800|NCT04545567|76003649|FG001|STARTED|Overall Study||11||
59880801|NCT04545567|76003648|FG000|COMPLETED|Overall Study||9||
59880802|NCT04545567|76003649|FG001|COMPLETED|Overall Study||9||
59880803|NCT04545567|76003648|FG000|NOT COMPLETED|Overall Study||1||
59880804|NCT04545567|76003649|FG001|NOT COMPLETED|Overall Study||2||
59880805|NCT04534491|76003655|FG000|STARTED|Overall Study||855||
59880806|NCT04534491|76003655|FG000|Treated|Overall Study||727||
59880807|NCT04534491|76003655|FG000|COMPLETED|Overall Study||703||
59880808|NCT04534491|76003655|FG000|NOT COMPLETED|Overall Study||152||
59880809|NCT03694821|76003662|FG000|STARTED|Overall Study||4||
59880810|NCT03694821|76003663|FG001|STARTED|Overall Study||8||
59880811|NCT03694821|76003664|FG002|STARTED|Overall Study||6||
59880812|NCT03694821|76003662|FG000|COMPLETED|Overall Study||0||
59880813|NCT03694821|76003663|FG001|COMPLETED|Overall Study||0||
59880814|NCT03694821|76003664|FG002|COMPLETED|Overall Study||2||
59880815|NCT03694821|76003662|FG000|NOT COMPLETED|Overall Study||4||
59880816|NCT03694821|76003663|FG001|NOT COMPLETED|Overall Study||8||
59880817|NCT03694821|76003664|FG002|NOT COMPLETED|Overall Study||4||
59880818|NCT04531527|76003672|FG000|STARTED|Overall Study||32||
59880819|NCT04531527|76003672|FG000|Treated|Overall Study||29||
59880820|NCT04531527|76003672|FG000|COMPLETED|Overall Study||29||
59880821|NCT04531527|76003672|FG000|NOT COMPLETED|Overall Study||3||
59880822|NCT04474197|76003680|FG000|STARTED|Overall Study||7||
59880823|NCT04474197|76003681|FG001|STARTED|Overall Study||10||
59880824|NCT04474197|76003682|FG002|STARTED|Overall Study||9||
59880825|NCT04474197|76003683|FG003|STARTED|Overall Study||18||
59880826|NCT04474197|76003680|FG000|COMPLETED|Overall Study||7||
59880827|NCT04474197|76003681|FG001|COMPLETED|Overall Study||9||
59880828|NCT04474197|76003682|FG002|COMPLETED|Overall Study||9||
59880829|NCT04474197|76003683|FG003|COMPLETED|Overall Study||18||
59880830|NCT04474197|76003680|FG000|NOT COMPLETED|Overall Study||0||
59880831|NCT04474197|76003681|FG001|NOT COMPLETED|Overall Study||1||
59880832|NCT04474197|76003682|FG002|NOT COMPLETED|Overall Study||0||
59880833|NCT04474197|76003683|FG003|NOT COMPLETED|Overall Study||0||
59880834|NCT02079766|76003700|FG000|STARTED|Overall Study||30||
59880835|NCT02079766|76003701|FG001|STARTED|Overall Study||11||
59880836|NCT02079766|76003700|FG000|COMPLETED|Overall Study||28||
59880837|NCT02079766|76003701|FG001|COMPLETED|Overall Study||11||
59880838|NCT02079766|76003700|FG000|NOT COMPLETED|Overall Study||2||
59880839|NCT02079766|76003701|FG001|NOT COMPLETED|Overall Study||0||
59880840|NCT04841577|76003709|FG000|STARTED|Overall Study||442||
59880841|NCT04841577|76003710|FG001|STARTED|Overall Study||443||
59880842|NCT04841577|76003709|FG000|COMPLETED|Overall Study||429||
59880843|NCT04841577|76003710|FG001|COMPLETED|Overall Study||417||
59880844|NCT04841577|76003709|FG000|NOT COMPLETED|Overall Study||13||
59880845|NCT04841577|76003710|FG001|NOT COMPLETED|Overall Study||26||
59880846|NCT04529109|76003716|FG000|STARTED|Period 1||27||
59880847|NCT04529109|76003717|FG001|STARTED|Period 1||29||
59880848|NCT04529109|76003716|FG000|COMPLETED|Period 1||27||
59880849|NCT04529109|76003717|FG001|COMPLETED|Period 1||28||
59880850|NCT04529109|76003716|FG000|NOT COMPLETED|Period 1||0||
59880851|NCT04529109|76003717|FG001|NOT COMPLETED|Period 1||1||
59880852|NCT04529109|76003716|FG000|STARTED|Period 2||27||
59880853|NCT04529109|76003717|FG001|STARTED|Period 2||28||
59880854|NCT04529109|76003716|FG000|COMPLETED|Period 2||27||
59880855|NCT04529109|76003717|FG001|COMPLETED|Period 2||28||
59880856|NCT04529109|76003716|FG000|NOT COMPLETED|Period 2||0||
59880857|NCT04529109|76003717|FG001|NOT COMPLETED|Period 2||0||
59880858|NCT04528641|76003729|FG000|STARTED|Overall Study||15||
59880859|NCT04528641|76003730|FG001|STARTED|Overall Study||15||
59880860|NCT04528641|76003731|FG002|STARTED|Overall Study||15||
60005837|NCT01964716|76121573|FG000|STARTED|Overall Study||250||
59751171|NCT00917384|75870374|FG000|NOT COMPLETED|Overall Study||14||
59751172|NCT00917384|75870375|FG001|NOT COMPLETED|Overall Study||4||
59880861|NCT04528641|76003732|FG003|STARTED|Overall Study||16||
59880862|NCT04528641|76003733|FG004|STARTED|Overall Study||15||
59880863|NCT04528641|76003734|FG005|STARTED|Overall Study||15||
59880864|NCT04528641|76003729|FG000|COMPLETED|Overall Study||15||
59880865|NCT04528641|76003730|FG001|COMPLETED|Overall Study||15||
60005838|NCT01964716|76121574|FG001|STARTED|Overall Study||250||
60005839|NCT01964716|76121573|FG000|Vaccinated Dose 1|Overall Study||250||
60005840|NCT01964716|76121574|FG001|Vaccinated Dose 1|Overall Study||250||
60005841|NCT01964716|76121573|FG000|Vaccinated Dose 2|Overall Study||249||
60005842|NCT01964716|76121574|FG001|Vaccinated Dose 2|Overall Study||248||
60005843|NCT01964716|76121573|FG000|Vaccinated Dose 3|Overall Study||247||
60005844|NCT01964716|76121574|FG001|Vaccinated Dose 3|Overall Study||244||
60005845|NCT01964716|76121573|FG000|COMPLETED|Overall Study||245||
60005846|NCT01964716|76121574|FG001|COMPLETED|Overall Study||244||
60005847|NCT01964716|76121573|FG000|NOT COMPLETED|Overall Study||5||
60005848|NCT01964716|76121574|FG001|NOT COMPLETED|Overall Study||6||
60005849|NCT01964560|76121588|FG000|STARTED|Overall Study||540||
60005850|NCT01964560|76121588|FG000|COMPLETED|Overall Study||395||
60005851|NCT01964560|76121588|FG000|NOT COMPLETED|Overall Study||145||
60005852|NCT02659943|76121599|FG000|STARTED|Overall Study||3||
60005853|NCT02659943|76121600|FG001|STARTED|Overall Study||2||
60005854|NCT02659943|76121601|FG002|STARTED|Overall Study||1||
60005855|NCT02659943|76121602|FG003|STARTED|Overall Study||4||
60005856|NCT02659943|76121603|FG004|STARTED|Overall Study||2||
60005857|NCT02659943|76121604|FG005|STARTED|Overall Study||9||
60005858|NCT02659943|76121605|FG006|STARTED|Overall Study||6||
60005859|NCT02659943|76121599|FG000|COMPLETED|Overall Study||2||
60005860|NCT02659943|76121600|FG001|COMPLETED|Overall Study||0||
60005861|NCT02659943|76121601|FG002|COMPLETED|Overall Study||0||
60005862|NCT02659943|76121602|FG003|COMPLETED|Overall Study||1||
60005863|NCT02659943|76121603|FG004|COMPLETED|Overall Study||0||
60005864|NCT02659943|76121604|FG005|COMPLETED|Overall Study||4||
60005865|NCT02659943|76121605|FG006|COMPLETED|Overall Study||0||
60005866|NCT02659943|76121599|FG000|NOT COMPLETED|Overall Study||1||
60005867|NCT02659943|76121600|FG001|NOT COMPLETED|Overall Study||2||
60005868|NCT02659943|76121601|FG002|NOT COMPLETED|Overall Study||1||
60005869|NCT02659943|76121602|FG003|NOT COMPLETED|Overall Study||3||
60005870|NCT02659943|76121603|FG004|NOT COMPLETED|Overall Study||2||
60005871|NCT02659943|76121604|FG005|NOT COMPLETED|Overall Study||5||
60005872|NCT02659943|76121605|FG006|NOT COMPLETED|Overall Study||6||
60005873|NCT01677299|76121630|FG000|STARTED|Overall Study||6||
60005874|NCT01677299|76121631|FG001|STARTED|Overall Study||6||
60005875|NCT01677299|76121632|FG002|STARTED|Overall Study||6||
60005876|NCT01677299|76121633|FG003|STARTED|Overall Study||6||
60005877|NCT01677299|76121630|FG000|COMPLETED|Overall Study||6||
60005878|NCT01677299|76121631|FG001|COMPLETED|Overall Study||3||
60005879|NCT01677299|76121632|FG002|COMPLETED|Overall Study||5||
60005880|NCT01677299|76121633|FG003|COMPLETED|Overall Study||5||
60005881|NCT01677299|76121630|FG000|NOT COMPLETED|Overall Study||0||
60005882|NCT01677299|76121631|FG001|NOT COMPLETED|Overall Study||3||
60005883|NCT01677299|76121632|FG002|NOT COMPLETED|Overall Study||1||
60005884|NCT01677299|76121633|FG003|NOT COMPLETED|Overall Study||1||
60005885|NCT01964326|76121647|FG000|STARTED|Overall Study||1311||
60005886|NCT01964326|76121647|FG000|COMPLETED|Overall Study||1014||
60005887|NCT01964326|76121647|FG000|NOT COMPLETED|Overall Study||297||
60005888|NCT02699749|76121665|FG000|STARTED|Overall Study||3||
60005889|NCT02699749|76121666|FG001|STARTED|Overall Study||3||
60005890|NCT02699749|76121667|FG002|STARTED|Overall Study||16||
60005891|NCT02699749|76121668|FG003|STARTED|Overall Study||3||
60005892|NCT02699749|76121669|FG004|STARTED|Overall Study||3||
60005893|NCT02699749|76121670|FG005|STARTED|Overall Study||9||
60005894|NCT02699749|76121671|FG006|STARTED|Overall Study||6||
60005895|NCT02699749|76121672|FG007|STARTED|Overall Study||6||
60005896|NCT02699749|76121673|FG008|STARTED|Overall Study||6||
60005897|NCT02699749|76121674|FG009|STARTED|Overall Study||6||
60005898|NCT02699749|76121675|FG010|STARTED|Overall Study||6||
60005899|NCT02699749|76121676|FG011|STARTED|Overall Study||4||
60005900|NCT02699749|76121677|FG012|STARTED|Overall Study||3||
60005901|NCT02699749|76121678|FG013|STARTED|Overall Study||6||
60005902|NCT02699749|76121665|FG000|COMPLETED|Overall Study||0||
60005903|NCT02699749|76121666|FG001|COMPLETED|Overall Study||0||
60005904|NCT02699749|76121667|FG002|COMPLETED|Overall Study||0||
60005905|NCT02699749|76121668|FG003|COMPLETED|Overall Study||0||
60005906|NCT02699749|76121669|FG004|COMPLETED|Overall Study||0||
60005907|NCT02699749|76121670|FG005|COMPLETED|Overall Study||0||
60005908|NCT02699749|76121671|FG006|COMPLETED|Overall Study||0||
60005909|NCT02699749|76121672|FG007|COMPLETED|Overall Study||0||
60005910|NCT02699749|76121673|FG008|COMPLETED|Overall Study||0||
60005911|NCT02699749|76121674|FG009|COMPLETED|Overall Study||0||
60005912|NCT02699749|76121675|FG010|COMPLETED|Overall Study||0||
60005913|NCT02699749|76121676|FG011|COMPLETED|Overall Study||0||
60005914|NCT02699749|76121677|FG012|COMPLETED|Overall Study||0||
60005915|NCT02699749|76121678|FG013|COMPLETED|Overall Study||0||
60005916|NCT02699749|76121665|FG000|NOT COMPLETED|Overall Study||3||
60005917|NCT02699749|76121666|FG001|NOT COMPLETED|Overall Study||3||
60005918|NCT02699749|76121667|FG002|NOT COMPLETED|Overall Study||16||
60005919|NCT02699749|76121668|FG003|NOT COMPLETED|Overall Study||3||
60005920|NCT02699749|76121669|FG004|NOT COMPLETED|Overall Study||3||
60005921|NCT02699749|76121670|FG005|NOT COMPLETED|Overall Study||9||
60005922|NCT02699749|76121671|FG006|NOT COMPLETED|Overall Study||6||
60005923|NCT02699749|76121672|FG007|NOT COMPLETED|Overall Study||6||
60005924|NCT02699749|76121673|FG008|NOT COMPLETED|Overall Study||6||
60005925|NCT02699749|76121674|FG009|NOT COMPLETED|Overall Study||6||
60005926|NCT02699749|76121675|FG010|NOT COMPLETED|Overall Study||6||
60005927|NCT02699749|76121676|FG011|NOT COMPLETED|Overall Study||4||
60005928|NCT02699749|76121677|FG012|NOT COMPLETED|Overall Study||3||
60005929|NCT02699749|76121678|FG013|NOT COMPLETED|Overall Study||6||
60005930|NCT02699593|76121708|FG000|STARTED|Period 1||72||
60005931|NCT02699593|76121709|FG001|STARTED|Period 1||69||
60005932|NCT02699593|76121708|FG000|COMPLETED|Period 1||67||
60005933|NCT02699593|76121709|FG001|COMPLETED|Period 1||62||
60005934|NCT02699593|76121708|FG000|NOT COMPLETED|Period 1||5||
60005935|NCT02699593|76121709|FG001|NOT COMPLETED|Period 1||7||
60005936|NCT02699593|76121708|FG000|STARTED|Period 2||67||
60005937|NCT02699593|76121709|FG001|STARTED|Period 2||62||
60005938|NCT02699593|76121708|FG000|COMPLETED|Period 2||65||
60005939|NCT02699593|76121709|FG001|COMPLETED|Period 2||60||
60005940|NCT02699593|76121708|FG000|NOT COMPLETED|Period 2||2||
60005941|NCT02699593|76121709|FG001|NOT COMPLETED|Period 2||2||
60005942|NCT00708097|76121715|FG000|STARTED|Period 1||11||
60005943|NCT00708097|76121716|FG001|STARTED|Period 1||12||
60005944|NCT00708097|76121717|FG002|STARTED|Period 1||12||
60005945|NCT00708097|76121718|FG003|STARTED|Period 1||11||
60005946|NCT00708097|76121719|FG004|STARTED|Period 1||11||
60005947|NCT00708097|76121715|FG000|COMPLETED|Period 1||11||
60005948|NCT00708097|76121716|FG001|COMPLETED|Period 1||11||
60005949|NCT00708097|76121717|FG002|COMPLETED|Period 1||12||
60005950|NCT00708097|76121718|FG003|COMPLETED|Period 1||9||
60005951|NCT00708097|76121719|FG004|COMPLETED|Period 1||10||
60005952|NCT00708097|76121715|FG000|NOT COMPLETED|Period 1||0||
60005953|NCT00708097|76121716|FG001|NOT COMPLETED|Period 1||1||
60005954|NCT00708097|76121717|FG002|NOT COMPLETED|Period 1||0||
60005955|NCT00708097|76121718|FG003|NOT COMPLETED|Period 1||2||
60005956|NCT00708097|76121719|FG004|NOT COMPLETED|Period 1||1||
60005957|NCT00708097|76121715|FG000|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|10||
60005958|NCT00708097|76121716|FG001|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|12||
60005959|NCT00708097|76121717|FG002|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|10||
60005960|NCT00708097|76121718|FG003|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|11||
60005961|NCT00708097|76121719|FG004|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|10||
60005962|NCT00708097|76121715|FG000|COMPLETED|Period 2||10||
60005963|NCT00708097|76121716|FG001|COMPLETED|Period 2||11||
60005964|NCT00708097|76121717|FG002|COMPLETED|Period 2||9||
60005965|NCT00708097|76121718|FG003|COMPLETED|Period 2||10||
60005966|NCT00708097|76121719|FG004|COMPLETED|Period 2||10||
60005967|NCT00708097|76121715|FG000|NOT COMPLETED|Period 2||0||
60005968|NCT00708097|76121716|FG001|NOT COMPLETED|Period 2||1||
60005969|NCT00708097|76121717|FG002|NOT COMPLETED|Period 2||1||
60005970|NCT00708097|76121718|FG003|NOT COMPLETED|Period 2||1||
60005971|NCT00708097|76121719|FG004|NOT COMPLETED|Period 2||0||
60005972|NCT00708097|76121715|FG000|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|9||
60005973|NCT00708097|76121716|FG001|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|11||
60136028|NCT01272921|76258714|FG000|COMPLETED|Overall Study||69||
59751173|NCT00864513|75870381|FG000|STARTED|Overall Study||15||
59751174|NCT00864513|75870381|FG000|COMPLETED|Overall Study||12||
59751175|NCT00864513|75870381|FG000|NOT COMPLETED|Overall Study||3||
59751176|NCT00917150|75870389|FG000|STARTED|Overall Study||192||
59751177|NCT00917150|75870390|FG001|STARTED|Overall Study||198||
59751178|NCT00917150|75870391|FG002|STARTED|Overall Study||191||
59751179|NCT00917150|75870392|FG003|STARTED|Overall Study||190||
59751180|NCT00917150|75870389|FG000|COMPLETED|Overall Study||155||
59751181|NCT00917150|75870390|FG001|COMPLETED|Overall Study||161||
59751182|NCT00917150|75870391|FG002|COMPLETED|Overall Study||149||
59751183|NCT00917150|75870392|FG003|COMPLETED|Overall Study||156||
59751184|NCT00917150|75870389|FG000|NOT COMPLETED|Overall Study||37||
59751185|NCT00917150|75870390|FG001|NOT COMPLETED|Overall Study||37||
59751186|NCT00917150|75870391|FG002|NOT COMPLETED|Overall Study||42||
59751187|NCT00917150|75870392|FG003|NOT COMPLETED|Overall Study||34||
59751188|NCT00659425|75870412|FG000|STARTED|Overall Study||1||
59751189|NCT00659425|75870413|FG001|STARTED|Overall Study||1||
59880866|NCT04528641|76003731|FG002|COMPLETED|Overall Study||15||
59880867|NCT04528641|76003732|FG003|COMPLETED|Overall Study||15||
59880868|NCT04528641|76003733|FG004|COMPLETED|Overall Study||15||
59880869|NCT04528641|76003734|FG005|COMPLETED|Overall Study||14||
59880870|NCT04528641|76003729|FG000|NOT COMPLETED|Overall Study||0||
59880871|NCT04528641|76003730|FG001|NOT COMPLETED|Overall Study||0||
59751190|NCT00659425|75870414|FG002|STARTED|Overall Study||1||
59751191|NCT00659425|75870415|FG003|STARTED|Overall Study||4||
59751192|NCT00659425|75870416|FG004|STARTED|Overall Study||4||
59751193|NCT00659425|75870417|FG005|STARTED|Overall Study||5||
59880872|NCT04528641|76003731|FG002|NOT COMPLETED|Overall Study||0||
59880873|NCT04528641|76003732|FG003|NOT COMPLETED|Overall Study||1||
59880874|NCT04528641|76003733|FG004|NOT COMPLETED|Overall Study||0||
59880875|NCT04528641|76003734|FG005|NOT COMPLETED|Overall Study||1||
59880876|NCT04527471|76003753|FG000|STARTED|Overall Study||30||
59880877|NCT04527471|76003754|FG001|STARTED|Overall Study||15||
59880878|NCT04527471|76003753|FG000|Hospitalized up to 7 Days|Overall Study||24||
59880879|NCT04527471|76003754|FG001|Hospitalized up to 7 Days|Overall Study||12||
59880880|NCT04527471|76003753|FG000|Hospitalized for > 7 Days|Overall Study||6||
59880881|NCT04527471|76003754|FG001|Hospitalized for > 7 Days|Overall Study||3||
59880882|NCT04527471|76003753|FG000|COMPLETED|Overall Study||28|Through Day 60 Follow-up|
59880883|NCT04527471|76003754|FG001|COMPLETED|Overall Study||15|Through Day 60 Follow-up|
59880884|NCT04527471|76003753|FG000|NOT COMPLETED|Overall Study||2||
59880885|NCT04527471|76003754|FG001|NOT COMPLETED|Overall Study||0||
59880886|NCT04471935|76003760|FG000|STARTED|Overall Study||10||
59880887|NCT04471935|76003760|FG000|COMPLETED|Overall Study||8||
59880888|NCT04471935|76003760|FG000|NOT COMPLETED|Overall Study||2||
59880889|NCT04468347|76003768|FG000|STARTED|Overall Study||6||
59880890|NCT04468347|76003769|FG001|STARTED|Overall Study||11||
59751194|NCT00659425|75870418|FG006|STARTED|Overall Study||8||
59751195|NCT00659425|75870419|FG007|STARTED|Overall Study||11||
59751196|NCT00659425|75870420|FG008|STARTED|Overall Study||6||
59751197|NCT00659425|75870421|FG009|STARTED|Overall Study||14||
59751198|NCT00659425|75870412|FG000|COMPLETED|Overall Study||0||
59880891|NCT04468347|76003770|FG002|STARTED|Overall Study||47||
59880892|NCT04468347|76003771|FG003|STARTED|Overall Study||25||
59880893|NCT04468347|76003768|FG000|Baseline Flortacuipir PET Scan|Overall Study||5||
59751199|NCT00659425|75870413|FG001|COMPLETED|Overall Study||0||
59751200|NCT00659425|75870414|FG002|COMPLETED|Overall Study||0||
59751201|NCT00659425|75870415|FG003|COMPLETED|Overall Study||0||
59751202|NCT00659425|75870416|FG004|COMPLETED|Overall Study||0||
59880894|NCT04468347|76003769|FG001|Baseline Flortacuipir PET Scan|Overall Study||11||
59880895|NCT04468347|76003770|FG002|Baseline Flortacuipir PET Scan|Overall Study||45||
59880896|NCT04468347|76003771|FG003|Baseline Flortacuipir PET Scan|Overall Study||25||
59880897|NCT04468347|76003768|FG000|COMPLETED|Overall Study||4||
59880898|NCT04468347|76003769|FG001|COMPLETED|Overall Study||10||
60005974|NCT00708097|76121717|FG002|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|10||
60005975|NCT00708097|76121718|FG003|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|10||
60005976|NCT00708097|76121719|FG004|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|10||
60005977|NCT00708097|76121715|FG000|COMPLETED|Period 3||9||
60005978|NCT00708097|76121716|FG001|COMPLETED|Period 3||11||
60005979|NCT00708097|76121717|FG002|COMPLETED|Period 3||10||
60005980|NCT00708097|76121718|FG003|COMPLETED|Period 3||10||
60136029|NCT01272921|76258715|FG001|COMPLETED|Overall Study||70||
60136030|NCT01272921|76258714|FG000|NOT COMPLETED|Overall Study||2||
59751203|NCT00659425|75870417|FG005|COMPLETED|Overall Study||1||
60136031|NCT01272921|76258715|FG001|NOT COMPLETED|Overall Study||1||
59751204|NCT00659425|75870418|FG006|COMPLETED|Overall Study||0||
59751205|NCT00659425|75870419|FG007|COMPLETED|Overall Study||0||
59880899|NCT04468347|76003770|FG002|COMPLETED|Overall Study||41||
59880900|NCT04468347|76003771|FG003|COMPLETED|Overall Study||21||
59880901|NCT04468347|76003768|FG000|NOT COMPLETED|Overall Study||2||
59880902|NCT04468347|76003769|FG001|NOT COMPLETED|Overall Study||1||
60005981|NCT00708097|76121719|FG004|COMPLETED|Period 3||10||
60005982|NCT00708097|76121715|FG000|NOT COMPLETED|Period 3||0||
60005983|NCT00708097|76121716|FG001|NOT COMPLETED|Period 3||0||
60005984|NCT00708097|76121717|FG002|NOT COMPLETED|Period 3||0||
60005985|NCT00708097|76121718|FG003|NOT COMPLETED|Period 3||0||
60005986|NCT00708097|76121719|FG004|NOT COMPLETED|Period 3||0||
60005987|NCT00708097|76121715|FG000|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|12||
60005988|NCT00708097|76121716|FG001|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|9||
60005989|NCT00708097|76121717|FG002|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|10||
60005990|NCT00708097|76121718|FG003|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|11||
60005991|NCT00708097|76121719|FG004|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|8||
60005992|NCT00708097|76121715|FG000|COMPLETED|Period 4||12||
60005993|NCT00708097|76121716|FG001|COMPLETED|Period 4||9||
60005994|NCT00708097|76121717|FG002|COMPLETED|Period 4||10||
60005995|NCT00708097|76121718|FG003|COMPLETED|Period 4||11||
60005996|NCT00708097|76121719|FG004|COMPLETED|Period 4||8||
60005997|NCT00708097|76121715|FG000|NOT COMPLETED|Period 4||0||
60005998|NCT00708097|76121716|FG001|NOT COMPLETED|Period 4||0||
60005999|NCT00708097|76121717|FG002|NOT COMPLETED|Period 4||0||
60006000|NCT00708097|76121718|FG003|NOT COMPLETED|Period 4||0||
60006001|NCT00708097|76121719|FG004|NOT COMPLETED|Period 4||0||
60006002|NCT00708097|76121715|FG000|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|8||
60006003|NCT00708097|76121716|FG001|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|9||
60006004|NCT00708097|76121717|FG002|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|11||
60006005|NCT00708097|76121718|FG003|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|10||
60006006|NCT00708097|76121719|FG004|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|12||
60006007|NCT00708097|76121715|FG000|COMPLETED|Period 5||8||
60006008|NCT00708097|76121716|FG001|COMPLETED|Period 5||9||
60006009|NCT00708097|76121717|FG002|COMPLETED|Period 5||11||
60006010|NCT00708097|76121718|FG003|COMPLETED|Period 5||10||
60006011|NCT00708097|76121719|FG004|COMPLETED|Period 5||12||
60006012|NCT00708097|76121715|FG000|NOT COMPLETED|Period 5||0||
60006013|NCT00708097|76121716|FG001|NOT COMPLETED|Period 5||0||
60006014|NCT00708097|76121717|FG002|NOT COMPLETED|Period 5||0||
60006015|NCT00708097|76121718|FG003|NOT COMPLETED|Period 5||0||
60006016|NCT00708097|76121719|FG004|NOT COMPLETED|Period 5||0||
60006017|NCT02659631|76121746|FG000|STARTED|Overall Study||1|This study was terminated early and Part 2 was not initiated. The form only includes arms in Part 1.|
60006018|NCT02659631|76121747|FG001|STARTED|Overall Study||2|This study was terminated early and Part 2 was not initiated. The form only includes arms in Part 1.|
60006019|NCT02659631|76121748|FG002|STARTED|Overall Study||3|This study was terminated early and Part 2 was not initiated. The form only includes arms in Part 1.|
60006020|NCT02659631|76121749|FG003|STARTED|Overall Study||2|This study was terminated early and Part 2 was not initiated. The form only includes arms in Part 1.|
60006021|NCT02659631|76121750|FG004|STARTED|Overall Study||5|This study was terminated early and Part 2 was not initiated. The form only includes arms in Part 1.|
60006022|NCT02659631|76121751|FG005|STARTED|Overall Study||5|This study was terminated early and Part 2 was not initiated. The form only includes arms in Part 1.|
60006023|NCT02659631|76121752|FG006|STARTED|Overall Study||4|This study was terminated early and Part 2 was not initiated. The form only includes arms in Part 1.|
60006024|NCT02659631|76121753|FG007|STARTED|Overall Study||3|This study was terminated early and Part 2 was not initiated. The form only includes arms in Part 1.|
60006025|NCT02659631|76121754|FG008|STARTED|Overall Study||2|This study was terminated early and Part 2 was not initiated. The form only includes arms in Part 1.|
60006026|NCT02659631|76121755|FG009|STARTED|Overall Study||1|This study was terminated early and Part 2 was not initiated. The form only includes arms in Part 1.|
60006027|NCT02659631|76121746|FG000|COMPLETED|Overall Study||0||
60006028|NCT02659631|76121747|FG001|COMPLETED|Overall Study||0||
60006029|NCT02659631|76121748|FG002|COMPLETED|Overall Study||0||
60006030|NCT02659631|76121749|FG003|COMPLETED|Overall Study||0||
60006031|NCT02659631|76121750|FG004|COMPLETED|Overall Study||0||
60006032|NCT02659631|76121751|FG005|COMPLETED|Overall Study||2||
60006033|NCT02659631|76121752|FG006|COMPLETED|Overall Study||3||
60006034|NCT02659631|76121753|FG007|COMPLETED|Overall Study||0||
60006035|NCT02659631|76121754|FG008|COMPLETED|Overall Study||0||
60006036|NCT02659631|76121755|FG009|COMPLETED|Overall Study||1||
60006037|NCT02659631|76121746|FG000|NOT COMPLETED|Overall Study||1||
60006038|NCT02659631|76121747|FG001|NOT COMPLETED|Overall Study||2||
60006039|NCT02659631|76121748|FG002|NOT COMPLETED|Overall Study||3||
60006040|NCT02659631|76121749|FG003|NOT COMPLETED|Overall Study||2||
60006041|NCT02659631|76121750|FG004|NOT COMPLETED|Overall Study||5||
60006042|NCT02659631|76121751|FG005|NOT COMPLETED|Overall Study||3||
60006043|NCT02659631|76121752|FG006|NOT COMPLETED|Overall Study||1||
60006044|NCT02659631|76121753|FG007|NOT COMPLETED|Overall Study||3||
60006045|NCT02659631|76121754|FG008|NOT COMPLETED|Overall Study||2||
60006046|NCT02659631|76121755|FG009|NOT COMPLETED|Overall Study||0||
60006047|NCT02699125|76121779|FG000|STARTED|Placebo||21||
60006048|NCT02699125|76121780|FG001|STARTED|Placebo||20||
60006049|NCT02699125|76121779|FG000|COMPLETED|Placebo||18||
60006050|NCT02699125|76121780|FG001|COMPLETED|Placebo||16||
60006051|NCT02699125|76121779|FG000|NOT COMPLETED|Placebo||3||
60006052|NCT02699125|76121780|FG001|NOT COMPLETED|Placebo||4||
60006053|NCT02699125|76121779|FG000|STARTED|First Intervention (6 Weeks).||18||
60006054|NCT02699125|76121780|FG001|STARTED|First Intervention (6 Weeks).||16||
60006055|NCT02699125|76121779|FG000|COMPLETED|First Intervention (6 Weeks).||18||
60006056|NCT02699125|76121780|FG001|COMPLETED|First Intervention (6 Weeks).||16||
60006057|NCT02699125|76121779|FG000|NOT COMPLETED|First Intervention (6 Weeks).||0||
60006058|NCT02699125|76121780|FG001|NOT COMPLETED|First Intervention (6 Weeks).||0||
60006059|NCT02699125|76121779|FG000|STARTED|Second Intervention (6 Weeks).||18||
60006060|NCT02699125|76121780|FG001|STARTED|Second Intervention (6 Weeks).||16||
60006061|NCT02699125|76121779|FG000|COMPLETED|Second Intervention (6 Weeks).||11||
60006062|NCT02699125|76121780|FG001|COMPLETED|Second Intervention (6 Weeks).||14||
60006063|NCT02699125|76121779|FG000|NOT COMPLETED|Second Intervention (6 Weeks).||7||
60006064|NCT02699125|76121780|FG001|NOT COMPLETED|Second Intervention (6 Weeks).||2||
60006065|NCT02698891|76121790|FG000|STARTED|Overall Study||127||
60006066|NCT02698891|76121790|FG000|Treated|Overall Study||125||
60006067|NCT02698891|76121790|FG000|COMPLETED|Overall Study||115||
60006068|NCT02698891|76121790|FG000|NOT COMPLETED|Overall Study||12||
60006069|NCT02698423|76121796|FG000|STARTED|Overall Study||336||
60006070|NCT02698423|76121797|FG001|STARTED|Overall Study||331||
60006071|NCT02698423|76121796|FG000|COMPLETED|Overall Study||317||
60006072|NCT02698423|76121797|FG001|COMPLETED|Overall Study||307||
60006073|NCT02698423|76121796|FG000|NOT COMPLETED|Overall Study||19||
60006074|NCT02698423|76121797|FG001|NOT COMPLETED|Overall Study||24||
60006075|NCT02700997|76121805|FG000|STARTED|Overall Study||17||
60006076|NCT02700997|76121805|FG000|COMPLETED|Overall Study||15||
60006077|NCT02700997|76121805|FG000|NOT COMPLETED|Overall Study||2||
60006078|NCT02658149|76121811|FG000|STARTED|Overall Study||50||
60006079|NCT02658149|76121812|FG001|STARTED|Overall Study||50||
60006080|NCT02658149|76121811|FG000|COMPLETED|Overall Study||49||
60006081|NCT02658149|76121812|FG001|COMPLETED|Overall Study||50||
60006082|NCT02658149|76121811|FG000|NOT COMPLETED|Overall Study||1||
60006083|NCT02658149|76121812|FG001|NOT COMPLETED|Overall Study||0||
60006084|NCT02698189|76121820|FG000|STARTED|Overall Study||3||
60006085|NCT02698189|76121821|FG001|STARTED|Overall Study||6||
60006086|NCT02698189|76121820|FG000|COMPLETED|Overall Study||0||
60006087|NCT02698189|76121821|FG001|COMPLETED|Overall Study||0||
60006088|NCT02698189|76121820|FG000|NOT COMPLETED|Overall Study||3||
60006089|NCT02698189|76121821|FG001|NOT COMPLETED|Overall Study||6||
60006090|NCT02702011|76121833|FG000|STARTED|Overall Study|Started are the treated patients.|11||
60006091|NCT02702011|76121834|FG001|STARTED|Overall Study|Started are the treated patients.|13||
60006092|NCT02702011|76121835|FG002|STARTED|Overall Study|Started are the treated patients.|12||
60006093|NCT02702011|76121836|FG003|STARTED|Overall Study|Started are the treated patients.|12||
60006094|NCT02702011|76121833|FG000|COMPLETED|Overall Study||11||
60006095|NCT02702011|76121834|FG001|COMPLETED|Overall Study||12||
60006096|NCT02702011|76121835|FG002|COMPLETED|Overall Study||12||
60006097|NCT02702011|76121836|FG003|COMPLETED|Overall Study||12||
60006098|NCT02702011|76121833|FG000|NOT COMPLETED|Overall Study||0||
60006099|NCT02702011|76121834|FG001|NOT COMPLETED|Overall Study||1||
60006100|NCT02702011|76121835|FG002|NOT COMPLETED|Overall Study||0||
60006101|NCT02702011|76121836|FG003|NOT COMPLETED|Overall Study||0||
60006102|NCT02657369|76121846|FG000|STARTED|Overall Study||34||
60006103|NCT02657369|76121846|FG000|COMPLETED|Overall Study||0||
60006104|NCT02657369|76121846|FG000|NOT COMPLETED|Overall Study||34||
60006105|NCT02701777|76121854|FG000|STARTED|Overall Study||17||
60006106|NCT02701777|76121855|FG001|STARTED|Overall Study||16||
60006107|NCT02701777|76121856|FG002|STARTED|Overall Study||16||
60006108|NCT02701777|76121857|FG003|STARTED|Overall Study||13||
60006109|NCT02701777|76121854|FG000|COMPLETED|Overall Study||13||
60006110|NCT02701777|76121855|FG001|COMPLETED|Overall Study||13||
60006111|NCT02701777|76121856|FG002|COMPLETED|Overall Study||12||
60006112|NCT02701777|76121857|FG003|COMPLETED|Overall Study||11||
60006113|NCT02701777|76121854|FG000|NOT COMPLETED|Overall Study||4||
60006114|NCT02701777|76121855|FG001|NOT COMPLETED|Overall Study||3||
60006115|NCT02701777|76121856|FG002|NOT COMPLETED|Overall Study||4||
60006116|NCT02701777|76121857|FG003|NOT COMPLETED|Overall Study||2||
60006117|NCT04604015|76121871|FG000|STARTED|Overall Study||154||
60006118|NCT04604015|76121871|FG000|COMPLETED|Overall Study||121||
60006119|NCT04604015|76121871|FG000|NOT COMPLETED|Overall Study||33||
60006120|NCT03871595|76121878|FG000|STARTED|Treatment Period 1 (P1) + Wash-out||7||
60006121|NCT03871595|76121879|FG001|STARTED|Treatment Period 1 (P1) + Wash-out||7||
60006122|NCT03871595|76121878|FG000|COMPLETED|Treatment Period 1 (P1) + Wash-out||7||
60006123|NCT03871595|76121879|FG001|COMPLETED|Treatment Period 1 (P1) + Wash-out||7||
60006124|NCT03871595|76121878|FG000|NOT COMPLETED|Treatment Period 1 (P1) + Wash-out||0||
60006125|NCT03871595|76121879|FG001|NOT COMPLETED|Treatment Period 1 (P1) + Wash-out||0||
60006126|NCT03871595|76121878|FG000|STARTED|Treatment Period 2 (P2)||7||
60006127|NCT03871595|76121879|FG001|STARTED|Treatment Period 2 (P2)||7||
60006128|NCT03871595|76121878|FG000|COMPLETED|Treatment Period 2 (P2)||7||
60006129|NCT03871595|76121879|FG001|COMPLETED|Treatment Period 2 (P2)||7||
60006130|NCT03871595|76121878|FG000|NOT COMPLETED|Treatment Period 2 (P2)||0||
60006131|NCT03871595|76121879|FG001|NOT COMPLETED|Treatment Period 2 (P2)||0||
60006132|NCT01675661|76121887|FG000|STARTED|Overall Study||153||
60006133|NCT01675661|76121888|FG001|STARTED|Overall Study||149||
60006134|NCT01675661|76121887|FG000|COMPLETED|Overall Study||113||
60006135|NCT01675661|76121888|FG001|COMPLETED|Overall Study||103||
60006136|NCT01675661|76121887|FG000|NOT COMPLETED|Overall Study||40||
60006137|NCT01675661|76121888|FG001|NOT COMPLETED|Overall Study||46||
60006138|NCT01602341|76121896|FG000|STARTED|Overall Study||44||
60006139|NCT01602341|76121897|FG001|STARTED|Overall Study||42||
60006140|NCT01602341|76121896|FG000|COMPLETED|Overall Study||44||
60006141|NCT01602341|76121897|FG001|COMPLETED|Overall Study||41||
60006142|NCT01602341|76121896|FG000|NOT COMPLETED|Overall Study||0||
60006143|NCT01602341|76121897|FG001|NOT COMPLETED|Overall Study||1||
60006144|NCT02700919|76121910|FG000|STARTED|Overall Study||94||
60006145|NCT02700919|76121911|FG001|STARTED|Overall Study||97||
60006146|NCT02700919|76121912|FG002|STARTED|Overall Study||91||
60006147|NCT02700919|76121910|FG000|COMPLETED|Overall Study||82||
60006148|NCT02700919|76121911|FG001|COMPLETED|Overall Study||85||
60006149|NCT02700919|76121912|FG002|COMPLETED|Overall Study||87||
60006150|NCT02700919|76121910|FG000|NOT COMPLETED|Overall Study||12||
60006151|NCT02700919|76121911|FG001|NOT COMPLETED|Overall Study||12||
60006152|NCT02700919|76121912|FG002|NOT COMPLETED|Overall Study||4||
60006153|NCT01986010|76121937|FG000|STARTED|Overall Study||13||
60006154|NCT01986010|76121938|FG001|STARTED|Overall Study||14||
60006155|NCT01986010|76121939|FG002|STARTED|Overall Study||14||
60006156|NCT01986010|76121940|FG003|STARTED|Overall Study||10||
60006157|NCT01986010|76121941|FG004|STARTED|Overall Study||11||
60006158|NCT01986010|76121942|FG005|STARTED|Overall Study||19||
60006159|NCT01986010|76121943|FG006|STARTED|Overall Study||10||
60006160|NCT01986010|76121944|FG007|STARTED|Overall Study||4||
60006161|NCT01986010|76121945|FG008|STARTED|Overall Study||12||
60006162|NCT01986010|76121946|FG009|STARTED|Overall Study||10||
60006163|NCT01986010|76121947|FG010|STARTED|Overall Study||10||
60006164|NCT01986010|76121948|FG011|STARTED|Overall Study||11||
60006165|NCT01986010|76121949|FG012|STARTED|Overall Study||10||
60006166|NCT01986010|76121950|FG013|STARTED|Overall Study||11||
60006167|NCT01986010|76121951|FG014|STARTED|Overall Study||16||
60006168|NCT01986010|76121952|FG015|STARTED|Overall Study||11||
60006169|NCT01986010|76121953|FG016|STARTED|Overall Study||4||
60006170|NCT01986010|76121937|FG000|Vaccination 1|Overall Study||13||
60006171|NCT01986010|76121938|FG001|Vaccination 1|Overall Study||14||
60006172|NCT01986010|76121939|FG002|Vaccination 1|Overall Study||14||
60006173|NCT01986010|76121940|FG003|Vaccination 1|Overall Study||10||
60006174|NCT01986010|76121941|FG004|Vaccination 1|Overall Study||11||
60006175|NCT01986010|76121942|FG005|Vaccination 1|Overall Study||19||
60006176|NCT01986010|76121943|FG006|Vaccination 1|Overall Study||10||
60006177|NCT01986010|76121944|FG007|Vaccination 1|Overall Study||4||
60006178|NCT01986010|76121945|FG008|Vaccination 1|Overall Study||12||
60006179|NCT01986010|76121946|FG009|Vaccination 1|Overall Study||10||
60006180|NCT01986010|76121947|FG010|Vaccination 1|Overall Study||10||
60006181|NCT01986010|76121948|FG011|Vaccination 1|Overall Study||11||
60006182|NCT01986010|76121949|FG012|Vaccination 1|Overall Study||10||
60006183|NCT01986010|76121950|FG013|Vaccination 1|Overall Study||11||
60006184|NCT01986010|76121951|FG014|Vaccination 1|Overall Study||16||
60006185|NCT01986010|76121952|FG015|Vaccination 1|Overall Study||11||
60006186|NCT01986010|76121953|FG016|Vaccination 1|Overall Study||4||
60006187|NCT01986010|76121937|FG000|Vaccination 2|Overall Study||12||
60006188|NCT01986010|76121938|FG001|Vaccination 2|Overall Study||13||
60006189|NCT01986010|76121939|FG002|Vaccination 2|Overall Study||12||
60006190|NCT01986010|76121940|FG003|Vaccination 2|Overall Study||10||
60006191|NCT01986010|76121941|FG004|Vaccination 2|Overall Study||9||
60006192|NCT01986010|76121942|FG005|Vaccination 2|Overall Study||19||
60006193|NCT01986010|76121943|FG006|Vaccination 2|Overall Study||10||
60006194|NCT01986010|76121944|FG007|Vaccination 2|Overall Study||4||
60006195|NCT01986010|76121945|FG008|Vaccination 2|Overall Study||11||
60006196|NCT01986010|76121946|FG009|Vaccination 2|Overall Study||10||
60006197|NCT01986010|76121947|FG010|Vaccination 2|Overall Study||10||
60006198|NCT01986010|76121948|FG011|Vaccination 2|Overall Study||10||
60006199|NCT01986010|76121949|FG012|Vaccination 2|Overall Study||10||
60006200|NCT01986010|76121950|FG013|Vaccination 2|Overall Study||9||
60006201|NCT01986010|76121951|FG014|Vaccination 2|Overall Study||16||
60006202|NCT01986010|76121952|FG015|Vaccination 2|Overall Study||10||
60006203|NCT01986010|76121953|FG016|Vaccination 2|Overall Study||4||
60006204|NCT01986010|76121937|FG000|Vaccination 3|Overall Study||10||
60006205|NCT01986010|76121938|FG001|Vaccination 3|Overall Study||10||
60006206|NCT01986010|76121939|FG002|Vaccination 3|Overall Study||9||
60006207|NCT01986010|76121940|FG003|Vaccination 3|Overall Study||10||
60006208|NCT01986010|76121941|FG004|Vaccination 3|Overall Study||9||
60006209|NCT01986010|76121942|FG005|Vaccination 3|Overall Study||15||
60006210|NCT01986010|76121943|FG006|Vaccination 3|Overall Study||10||
60006211|NCT01986010|76121944|FG007|Vaccination 3|Overall Study||4||
60006212|NCT01986010|76121945|FG008|Vaccination 3|Overall Study||10||
60006213|NCT01986010|76121946|FG009|Vaccination 3|Overall Study||10||
60006214|NCT01986010|76121947|FG010|Vaccination 3|Overall Study||10||
60006215|NCT01986010|76121948|FG011|Vaccination 3|Overall Study||8||
60006216|NCT01986010|76121949|FG012|Vaccination 3|Overall Study||10||
60006217|NCT01986010|76121950|FG013|Vaccination 3|Overall Study||9||
60006218|NCT01986010|76121951|FG014|Vaccination 3|Overall Study||13||
60006219|NCT01986010|76121952|FG015|Vaccination 3|Overall Study||10||
60006220|NCT01986010|76121953|FG016|Vaccination 3|Overall Study||4||
60006221|NCT01986010|76121937|FG000|COMPLETED|Overall Study||7||
60006222|NCT01986010|76121938|FG001|COMPLETED|Overall Study||6||
60006223|NCT01986010|76121939|FG002|COMPLETED|Overall Study||7||
60006224|NCT01986010|76121940|FG003|COMPLETED|Overall Study||8||
60006225|NCT01986010|76121941|FG004|COMPLETED|Overall Study||6||
60006226|NCT01986010|76121942|FG005|COMPLETED|Overall Study||11||
60006227|NCT01986010|76121943|FG006|COMPLETED|Overall Study||10||
60006228|NCT01986010|76121944|FG007|COMPLETED|Overall Study||4||
60006229|NCT01986010|76121945|FG008|COMPLETED|Overall Study||6||
60006230|NCT01986010|76121946|FG009|COMPLETED|Overall Study||7||
60006231|NCT01986010|76121947|FG010|COMPLETED|Overall Study||3||
60006232|NCT01986010|76121948|FG011|COMPLETED|Overall Study||1||
60006233|NCT01986010|76121949|FG012|COMPLETED|Overall Study||0||
60006234|NCT01986010|76121950|FG013|COMPLETED|Overall Study||0||
60006235|NCT01986010|76121951|FG014|COMPLETED|Overall Study||6||
60006236|NCT01986010|76121952|FG015|COMPLETED|Overall Study||0||
60006237|NCT01986010|76121953|FG016|COMPLETED|Overall Study||0||
60006238|NCT01986010|76121937|FG000|NOT COMPLETED|Overall Study||6||
60006239|NCT01986010|76121938|FG001|NOT COMPLETED|Overall Study||8||
60006240|NCT01986010|76121939|FG002|NOT COMPLETED|Overall Study||7||
60006241|NCT01986010|76121940|FG003|NOT COMPLETED|Overall Study||2||
60006242|NCT01986010|76121941|FG004|NOT COMPLETED|Overall Study||5||
60006243|NCT01986010|76121942|FG005|NOT COMPLETED|Overall Study||8||
60006244|NCT01986010|76121943|FG006|NOT COMPLETED|Overall Study||0||
60006245|NCT01986010|76121944|FG007|NOT COMPLETED|Overall Study||0||
60006246|NCT01986010|76121945|FG008|NOT COMPLETED|Overall Study||6||
60006247|NCT01986010|76121946|FG009|NOT COMPLETED|Overall Study||3||
60006248|NCT01986010|76121947|FG010|NOT COMPLETED|Overall Study||7||
60006249|NCT01986010|76121948|FG011|NOT COMPLETED|Overall Study||10||
60006250|NCT01986010|76121949|FG012|NOT COMPLETED|Overall Study||10||
60006251|NCT01986010|76121950|FG013|NOT COMPLETED|Overall Study||11||
60006252|NCT01986010|76121951|FG014|NOT COMPLETED|Overall Study||10||
60006253|NCT01986010|76121952|FG015|NOT COMPLETED|Overall Study||11||
60006254|NCT01986010|76121953|FG016|NOT COMPLETED|Overall Study||4||
60006255|NCT01963780|76121999|FG000|STARTED|Overall Study|Patients received lung transplant|79||
60006256|NCT01963780|76121999|FG000|COMPLETED|Overall Study||72|Subjects completed 12-month follow-up|
60006257|NCT01963780|76121999|FG000|NOT COMPLETED|Overall Study||7||
60006258|NCT02009878|76122006|FG000|STARTED|Overall Study||10||
60006259|NCT02009878|76122007|FG001|STARTED|Overall Study||11||
60006260|NCT02009878|76122008|FG002|STARTED|Overall Study||9||
60006261|NCT02009878|76122006|FG000|COMPLETED|Overall Study||10||
60006262|NCT02009878|76122007|FG001|COMPLETED|Overall Study||10||
60006263|NCT02009878|76122008|FG002|COMPLETED|Overall Study||9||
60006264|NCT02009878|76122006|FG000|NOT COMPLETED|Overall Study||0||
60006265|NCT02009878|76122007|FG001|NOT COMPLETED|Overall Study||1||
60006266|NCT02009878|76122008|FG002|NOT COMPLETED|Overall Study||0||
60006267|NCT02009722|76122018|FG000|STARTED|Overall Study||41||
60006268|NCT02009722|76122019|FG001|STARTED|Overall Study||43||
60006269|NCT02009722|76122018|FG000|Received Intervention|Overall Study||41||
60006270|NCT02009722|76122019|FG001|Received Intervention|Overall Study||42||
60006271|NCT02009722|76122018|FG000|COMPLETED|Overall Study||40||
60006272|NCT02009722|76122019|FG001|COMPLETED|Overall Study||40||
60006273|NCT02009722|76122018|FG000|NOT COMPLETED|Overall Study||1||
60006274|NCT02009722|76122019|FG001|NOT COMPLETED|Overall Study||3||
60006275|NCT02655419|76122027|FG000|STARTED|Overall Study||17||
60006276|NCT02655419|76122028|FG001|STARTED|Overall Study||23||
60006277|NCT02655419|76122027|FG000|Treated|Overall Study||16||
60006278|NCT02655419|76122028|FG001|Treated|Overall Study||18||
60006279|NCT02655419|76122027|FG000|COMPLETED|Overall Study||12||
60006280|NCT02655419|76122028|FG001|COMPLETED|Overall Study||16||
60006281|NCT02655419|76122027|FG000|NOT COMPLETED|Overall Study||5||
60006282|NCT02655419|76122028|FG001|NOT COMPLETED|Overall Study||7||
60006283|NCT01962922|76122040|FG000|STARTED|PK Portion Day 7||27||
60006284|NCT01962922|76122041|FG001|STARTED|PK Portion Day 7||23||
60006285|NCT01962922|76122040|FG000|COMPLETED|PK Portion Day 7||23||
60006286|NCT01962922|76122041|FG001|COMPLETED|PK Portion Day 7||23||
60006287|NCT01962922|76122040|FG000|NOT COMPLETED|PK Portion Day 7||4||
60006288|NCT01962922|76122041|FG001|NOT COMPLETED|PK Portion Day 7||0||
60006289|NCT01962922|76122040|FG000|STARTED|PK Portion Day 14||23||
60006290|NCT01962922|76122041|FG001|STARTED|PK Portion Day 14||23||
60006291|NCT01962922|76122040|FG000|COMPLETED|PK Portion Day 14||23||
60006292|NCT01962922|76122041|FG001|COMPLETED|PK Portion Day 14||23||
60006293|NCT01962922|76122040|FG000|NOT COMPLETED|PK Portion Day 14||0||
60006294|NCT01962922|76122041|FG001|NOT COMPLETED|PK Portion Day 14||0||
60006295|NCT01962922|76122040|FG000|STARTED|PK Portion Day 21||23||
60006296|NCT01962922|76122041|FG001|STARTED|PK Portion Day 21||23||
60006297|NCT01962922|76122040|FG000|COMPLETED|PK Portion Day 21||23||
60006298|NCT01962922|76122041|FG001|COMPLETED|PK Portion Day 21||23||
60006299|NCT01962922|76122040|FG000|NOT COMPLETED|PK Portion Day 21||0||
60006300|NCT01962922|76122041|FG001|NOT COMPLETED|PK Portion Day 21||0||
60006301|NCT01962922|76122040|FG000|STARTED|Extendion Portion (up to Month 6)||23||
60006302|NCT01962922|76122041|FG001|STARTED|Extendion Portion (up to Month 6)||23||
60006303|NCT01962922|76122040|FG000|COMPLETED|Extendion Portion (up to Month 6)||18||
60006304|NCT01962922|76122041|FG001|COMPLETED|Extendion Portion (up to Month 6)||20||
60006305|NCT01962922|76122040|FG000|NOT COMPLETED|Extendion Portion (up to Month 6)||5||
60006306|NCT01962922|76122041|FG001|NOT COMPLETED|Extendion Portion (up to Month 6)||3||
60006307|NCT01984684|76122049|FG000|STARTED|Overall Study||423||
60006308|NCT01984684|76122050|FG001|STARTED|Overall Study||427||
60006309|NCT01984684|76122049|FG000|COMPLETED|Overall Study||366||
60006310|NCT01984684|76122050|FG001|COMPLETED|Overall Study||368||
60006311|NCT01984684|76122049|FG000|NOT COMPLETED|Overall Study||57||
60006312|NCT01984684|76122050|FG001|NOT COMPLETED|Overall Study||59||
60006313|NCT02694523|76122058|FG000|STARTED|Part A||304||
60006314|NCT02694523|76122059|FG001|STARTED|Part A||301||
60006315|NCT02694523|76122060|FG002|STARTED|Part A||0||
60006316|NCT02694523|76122061|FG003|STARTED|Part A||0||
60006317|NCT02694523|76122062|FG004|STARTED|Part A||0||
60006318|NCT02694523|76122063|FG005|STARTED|Part A||0||
60006319|NCT02694523|76122064|FG006|STARTED|Part A||0||
60006320|NCT02694523|76122058|FG000|COMPLETED|Part A||291||
60006321|NCT02694523|76122059|FG001|COMPLETED|Part A||294||
60006322|NCT02694523|76122060|FG002|COMPLETED|Part A||0||
60006323|NCT02694523|76122061|FG003|COMPLETED|Part A||0||
60006324|NCT02694523|76122062|FG004|COMPLETED|Part A||0||
60006325|NCT02694523|76122063|FG005|COMPLETED|Part A||0||
60006326|NCT02694523|76122064|FG006|COMPLETED|Part A||0||
60006327|NCT02694523|76122058|FG000|NOT COMPLETED|Part A||13||
60006328|NCT02694523|76122059|FG001|NOT COMPLETED|Part A||7||
60006329|NCT02694523|76122060|FG002|NOT COMPLETED|Part A||0||
60006330|NCT02694523|76122061|FG003|NOT COMPLETED|Part A||0||
60006331|NCT02694523|76122062|FG004|NOT COMPLETED|Part A||0||
60006332|NCT02694523|76122063|FG005|NOT COMPLETED|Part A||0||
60006333|NCT02694523|76122064|FG006|NOT COMPLETED|Part A||0||
60006334|NCT02694523|76122058|FG000|STARTED|Part B||0||
60006335|NCT02694523|76122059|FG001|STARTED|Part B||0||
60006336|NCT02694523|76122060|FG002|STARTED|Part B|Participants who received risankizumab in Part A continued to received risankizumab in Part B|294||
60006337|NCT02694523|76122061|FG003|STARTED|Part B|Adalimumab responders in Part A continued to received adalimumab in Part B|144||
60006338|NCT02694523|76122062|FG004|STARTED|Part B|Adalimumab nonresponders in Part A switched to risankizumab in Part B|38||
60006339|NCT02694523|76122063|FG005|STARTED|Part B|Adalimumab inadequate responders in Part A, rerandomized to adalimumab in Part B|56||
60006340|NCT02694523|76122064|FG006|STARTED|Part B|Adalimumab inadequate responders in Part A, rerandomized to risankizumab in Part B|53||
60006341|NCT02694523|76122058|FG000|COMPLETED|Part B||0||
60006342|NCT02694523|76122059|FG001|COMPLETED|Part B||0||
60006343|NCT02694523|76122060|FG002|COMPLETED|Part B||274||
60006344|NCT02694523|76122061|FG003|COMPLETED|Part B||140||
60006345|NCT02694523|76122062|FG004|COMPLETED|Part B||34||
60006346|NCT02694523|76122063|FG005|COMPLETED|Part B||51||
60006347|NCT02694523|76122064|FG006|COMPLETED|Part B||51||
60006348|NCT02694523|76122058|FG000|NOT COMPLETED|Part B||0||
60006349|NCT02694523|76122059|FG001|NOT COMPLETED|Part B||0||
60006350|NCT02694523|76122060|FG002|NOT COMPLETED|Part B||20||
60006351|NCT02694523|76122061|FG003|NOT COMPLETED|Part B||4||
60006352|NCT02694523|76122062|FG004|NOT COMPLETED|Part B||4||
60006353|NCT02694523|76122063|FG005|NOT COMPLETED|Part B||5||
60006354|NCT02694523|76122064|FG006|NOT COMPLETED|Part B||2||
60006355|NCT01353703|76122078|FG000|STARTED|Overall Study||112||
60006356|NCT01353703|76122079|FG001|STARTED|Overall Study||112||
60006357|NCT01353703|76122078|FG000|COMPLETED|Overall Study||111||
60006358|NCT01353703|76122079|FG001|COMPLETED|Overall Study||112||
60006359|NCT01353703|76122078|FG000|NOT COMPLETED|Overall Study||1||
60006360|NCT01353703|76122079|FG001|NOT COMPLETED|Overall Study||0||
60006361|NCT02009332|76122093|FG000|STARTED|Phase 1: Dose Level 1 (Weeks 1-10)||3||
60006362|NCT02009332|76122094|FG001|STARTED|Phase 1: Dose Level 1 (Weeks 1-10)||0||
60006363|NCT02009332|76122095|FG002|STARTED|Phase 1: Dose Level 1 (Weeks 1-10)||0||
60006364|NCT02009332|76122096|FG003|STARTED|Phase 1: Dose Level 1 (Weeks 1-10)||0||
60006365|NCT02009332|76122097|FG004|STARTED|Phase 1: Dose Level 1 (Weeks 1-10)||0||
60006366|NCT02009332|76122098|FG005|STARTED|Phase 1: Dose Level 1 (Weeks 1-10)||0||
60006367|NCT02009332|76122093|FG000|COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)|Cohort 1 completed 6-week treatment.|3||
60006368|NCT02009332|76122094|FG001|COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0||
60006369|NCT02009332|76122095|FG002|COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0||
60006370|NCT02009332|76122096|FG003|COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0||
60006371|NCT02009332|76122097|FG004|COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0||
60006372|NCT02009332|76122098|FG005|COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0||
60006373|NCT02009332|76122093|FG000|NOT COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0||
60006374|NCT02009332|76122094|FG001|NOT COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0||
60006375|NCT02009332|76122095|FG002|NOT COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0||
60006376|NCT02009332|76122096|FG003|NOT COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0||
60006377|NCT02009332|76122097|FG004|NOT COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0||
60006378|NCT02009332|76122098|FG005|NOT COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0||
60006379|NCT02009332|76122093|FG000|STARTED|Phase 1: Dose Level 2/2b (Wks 11-29)||0||
60006380|NCT02009332|76122094|FG001|STARTED|Phase 1: Dose Level 2/2b (Wks 11-29)||4||
60006381|NCT02009332|76122095|FG002|STARTED|Phase 1: Dose Level 2/2b (Wks 11-29)||1||
60006382|NCT02009332|76122096|FG003|STARTED|Phase 1: Dose Level 2/2b (Wks 11-29)||0||
60006383|NCT02009332|76122097|FG004|STARTED|Phase 1: Dose Level 2/2b (Wks 11-29)||0||
60006384|NCT02009332|76122098|FG005|STARTED|Phase 1: Dose Level 2/2b (Wks 11-29)||0||
60006385|NCT02009332|76122093|FG000|COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||0||
60006386|NCT02009332|76122094|FG001|COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)|Cohort 2 completed 6-week treatment.|3||
60006387|NCT02009332|76122095|FG002|COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)|Cohort 2b stopped due to lack of enrollment.|1||
60006388|NCT02009332|76122096|FG003|COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||0||
60006389|NCT02009332|76122097|FG004|COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||0||
60006390|NCT02009332|76122098|FG005|COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||0||
60006391|NCT02009332|76122093|FG000|NOT COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||0||
60006392|NCT02009332|76122094|FG001|NOT COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||1||
60006393|NCT02009332|76122095|FG002|NOT COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||0||
60006394|NCT02009332|76122096|FG003|NOT COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||0||
60006395|NCT02009332|76122097|FG004|NOT COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||0||
60006396|NCT02009332|76122098|FG005|NOT COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||0||
60006397|NCT02009332|76122093|FG000|STARTED|Phase 1: Dose Level 3 (Weeks 30-47)||0||
60006398|NCT02009332|76122094|FG001|STARTED|Phase 1: Dose Level 3 (Weeks 30-47)||0||
60006399|NCT02009332|76122095|FG002|STARTED|Phase 1: Dose Level 3 (Weeks 30-47)||0||
60006400|NCT02009332|76122096|FG003|STARTED|Phase 1: Dose Level 3 (Weeks 30-47)||3||
60006401|NCT02009332|76122097|FG004|STARTED|Phase 1: Dose Level 3 (Weeks 30-47)||0||
60006402|NCT02009332|76122098|FG005|STARTED|Phase 1: Dose Level 3 (Weeks 30-47)||0||
60006403|NCT02009332|76122093|FG000|COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0||
60006404|NCT02009332|76122094|FG001|COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0||
60067890|NCT01756053|76183071|FG000|NOT COMPLETED|Period 2 (10 Days)||0||
60006405|NCT02009332|76122095|FG002|COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0||
60006406|NCT02009332|76122096|FG003|COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)|Cohort 3 completed 6-week treatment.|3||
60006407|NCT02009332|76122097|FG004|COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0||
60006408|NCT02009332|76122098|FG005|COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0||
60006409|NCT02009332|76122093|FG000|NOT COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0||
60006410|NCT02009332|76122094|FG001|NOT COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0||
60006411|NCT02009332|76122095|FG002|NOT COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0||
60006412|NCT02009332|76122096|FG003|NOT COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0||
60006413|NCT02009332|76122097|FG004|NOT COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0||
60006414|NCT02009332|76122098|FG005|NOT COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0||
60006415|NCT02009332|76122093|FG000|STARTED|Phase 1: Dose Level 4 (Weeks 48-77)||0||
60006416|NCT02009332|76122094|FG001|STARTED|Phase 1: Dose Level 4 (Weeks 48-77)||0||
60006417|NCT02009332|76122095|FG002|STARTED|Phase 1: Dose Level 4 (Weeks 48-77)||0||
60006418|NCT02009332|76122096|FG003|STARTED|Phase 1: Dose Level 4 (Weeks 48-77)||0||
60006419|NCT02009332|76122097|FG004|STARTED|Phase 1: Dose Level 4 (Weeks 48-77)||4||
60006420|NCT02009332|76122098|FG005|STARTED|Phase 1: Dose Level 4 (Weeks 48-77)||0||
60006421|NCT02009332|76122093|FG000|COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0||
60006422|NCT02009332|76122094|FG001|COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0||
60006423|NCT02009332|76122095|FG002|COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0||
59751206|NCT00659425|75870420|FG008|COMPLETED|Overall Study||0||
59751207|NCT00659425|75870421|FG009|COMPLETED|Overall Study||1||
59751208|NCT00659425|75870412|FG000|NOT COMPLETED|Overall Study||1||
60006424|NCT02009332|76122096|FG003|COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0||
60006425|NCT02009332|76122097|FG004|COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)|Cohort 4 completed 6-week treatment.|3||
60006426|NCT02009332|76122098|FG005|COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0||
60006427|NCT02009332|76122093|FG000|NOT COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0||
60006428|NCT02009332|76122094|FG001|NOT COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0||
60006429|NCT02009332|76122095|FG002|NOT COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0||
60006430|NCT02009332|76122096|FG003|NOT COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0||
60006431|NCT02009332|76122097|FG004|NOT COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||1||
60006432|NCT02009332|76122098|FG005|NOT COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0||
60006433|NCT02009332|76122093|FG000|STARTED|Phase 2 (Weeks 206-252)||0||
60006434|NCT02009332|76122094|FG001|STARTED|Phase 2 (Weeks 206-252)||0||
60006435|NCT02009332|76122095|FG002|STARTED|Phase 2 (Weeks 206-252)||0||
60006436|NCT02009332|76122096|FG003|STARTED|Phase 2 (Weeks 206-252)||0||
60006437|NCT02009332|76122097|FG004|STARTED|Phase 2 (Weeks 206-252)||0||
60006438|NCT02009332|76122098|FG005|STARTED|Phase 2 (Weeks 206-252)||6||
60006439|NCT02009332|76122093|FG000|COMPLETED|Phase 2 (Weeks 206-252)||0||
60006440|NCT02009332|76122094|FG001|COMPLETED|Phase 2 (Weeks 206-252)||0||
60006441|NCT02009332|76122095|FG002|COMPLETED|Phase 2 (Weeks 206-252)||0||
60006442|NCT02009332|76122096|FG003|COMPLETED|Phase 2 (Weeks 206-252)||0||
60006443|NCT02009332|76122097|FG004|COMPLETED|Phase 2 (Weeks 206-252)||0||
60006444|NCT02009332|76122098|FG005|COMPLETED|Phase 2 (Weeks 206-252)|Phase 2 stopped due to lack of efficacy.|5||
60006445|NCT02009332|76122093|FG000|NOT COMPLETED|Phase 2 (Weeks 206-252)||0||
60006446|NCT02009332|76122094|FG001|NOT COMPLETED|Phase 2 (Weeks 206-252)||0||
60006447|NCT02009332|76122095|FG002|NOT COMPLETED|Phase 2 (Weeks 206-252)||0||
60006448|NCT02009332|76122096|FG003|NOT COMPLETED|Phase 2 (Weeks 206-252)||0||
60006449|NCT02009332|76122097|FG004|NOT COMPLETED|Phase 2 (Weeks 206-252)||0||
60006450|NCT02009332|76122098|FG005|NOT COMPLETED|Phase 2 (Weeks 206-252)||1||
60006451|NCT01984294|76122115|FG000|STARTED|Overall Study||35||
60006452|NCT01984294|76122116|FG001|STARTED|Overall Study||32||
60006453|NCT01984294|76122117|FG002|STARTED|Overall Study||34||
60006454|NCT01984294|76122115|FG000|COMPLETED|Overall Study||31||
60006455|NCT01984294|76122116|FG001|COMPLETED|Overall Study||29||
60006456|NCT01984294|76122117|FG002|COMPLETED|Overall Study||27||
60006457|NCT01984294|76122115|FG000|NOT COMPLETED|Overall Study||4||
60006458|NCT01984294|76122116|FG001|NOT COMPLETED|Overall Study||3||
59751209|NCT00659425|75870413|FG001|NOT COMPLETED|Overall Study||1||
59751210|NCT00659425|75870414|FG002|NOT COMPLETED|Overall Study||1||
59751211|NCT00659425|75870415|FG003|NOT COMPLETED|Overall Study||4||
60006459|NCT01984294|76122117|FG002|NOT COMPLETED|Overall Study||7||
60006460|NCT01962298|76122130|FG000|STARTED|Overall Study||15||
60006461|NCT01962298|76122131|FG001|STARTED|Overall Study||15||
60006462|NCT01962298|76122132|FG002|STARTED|Overall Study||15||
60006463|NCT01962298|76122133|FG003|STARTED|Overall Study||15||
60006464|NCT01962298|76122134|FG004|STARTED|Overall Study||15||
60006465|NCT01962298|76122130|FG000|Received Intervention|Overall Study|1 subject did not receive the planned intervention and received a different one for clinical reasons|14||
60006466|NCT01962298|76122131|FG001|Received Intervention|Overall Study||15||
60006467|NCT01962298|76122132|FG002|Received Intervention|Overall Study||15||
60006468|NCT01962298|76122133|FG003|Received Intervention|Overall Study||15||
60006469|NCT01962298|76122134|FG004|Received Intervention|Overall Study||15||
60006470|NCT01962298|76122130|FG000|COMPLETED|Overall Study||12||
59880903|NCT04468347|76003770|FG002|NOT COMPLETED|Overall Study||6||
59880904|NCT04468347|76003771|FG003|NOT COMPLETED|Overall Study||4||
59880905|NCT04822701|76003787|FG000|STARTED|Overall Study||4||
59880906|NCT04822701|76003788|FG001|STARTED|Overall Study||1||
59880907|NCT04822701|76003787|FG000|Treated|Overall Study||2||
59880908|NCT04822701|76003788|FG001|Treated|Overall Study||1||
59880909|NCT04822701|76003787|FG000|COMPLETED|Overall Study||0|Completed planned observation time|
59880910|NCT04822701|76003788|FG001|COMPLETED|Overall Study||1|Completed planned observation time|
59880911|NCT04822701|76003787|FG000|NOT COMPLETED|Overall Study||4||
59880912|NCT04822701|76003788|FG001|NOT COMPLETED|Overall Study||0||
59880913|NCT04461795|76003794|FG000|STARTED|Overall Study||40||
59880914|NCT04461795|76003794|FG000|COMPLETED|Overall Study||35||
59880915|NCT04461795|76003794|FG000|NOT COMPLETED|Overall Study||5||
59880916|NCT04461015|76003801|FG000|STARTED|Overall Study||5||
59880917|NCT04461015|76003802|FG001|STARTED|Overall Study||7||
59880918|NCT04461015|76003801|FG000|COMPLETED|Overall Study||5||
59880919|NCT04461015|76003802|FG001|COMPLETED|Overall Study||5||
59880920|NCT04461015|76003801|FG000|NOT COMPLETED|Overall Study||0||
59880921|NCT04461015|76003802|FG001|NOT COMPLETED|Overall Study||2||
59880922|NCT04810221|76003808|FG000|STARTED|Overall Study||16||
59880923|NCT04810221|76003808|FG000|COMPLETED|Overall Study|"Included in the 13 subjects which completed the study, it is necessary to consider the case 0, a pilot test for the verification of study procedures. Data from this subject were not used in the statistical evaluation, which therefore included data from 12 eligible subjects that completed the study."|13||
59880924|NCT04810221|76003808|FG000|NOT COMPLETED|Overall Study||3||
59880925|NCT03694353|76003812|FG000|STARTED|Overall Study||37||
59880926|NCT03694353|76003812|FG000|COMPLETED|Overall Study||35||
59880927|NCT03694353|76003812|FG000|NOT COMPLETED|Overall Study||2||
59880928|NCT04521777|76003816|FG000|STARTED|Overall Study||24||
59880929|NCT04521777|76003816|FG000|COMPLETED|Overall Study||20||
59880930|NCT04521777|76003816|FG000|NOT COMPLETED|Overall Study||4||
59880931|NCT03700671|76003822|FG000|STARTED|Overall Study||21||
59880932|NCT03700671|76003823|FG001|STARTED|Overall Study||21||
59880933|NCT03700671|76003822|FG000|COMPLETED|Overall Study||20||
59880934|NCT03700671|76003823|FG001|COMPLETED|Overall Study||19||
59880935|NCT03700671|76003822|FG000|NOT COMPLETED|Overall Study||1||
59880936|NCT03700671|76003823|FG001|NOT COMPLETED|Overall Study||2||
59880937|NCT04764669|76003835|FG000|STARTED|Overall Study||10||
59880938|NCT04764669|76003836|FG001|STARTED|Overall Study||11||
59880939|NCT04764669|76003837|FG002|STARTED|Overall Study||10||
59880940|NCT04764669|76003838|FG003|STARTED|Overall Study||3||
59880941|NCT04764669|76003835|FG000|COMPLETED|Overall Study||7||
59880942|NCT04764669|76003836|FG001|COMPLETED|Overall Study||11||
59880943|NCT04764669|76003837|FG002|COMPLETED|Overall Study||8||
59880944|NCT04764669|76003838|FG003|COMPLETED|Overall Study||3||
59880945|NCT04764669|76003835|FG000|NOT COMPLETED|Overall Study||3||
59880946|NCT04764669|76003836|FG001|NOT COMPLETED|Overall Study||0||
59880947|NCT04764669|76003837|FG002|NOT COMPLETED|Overall Study||2||
59880948|NCT04764669|76003838|FG003|NOT COMPLETED|Overall Study||0||
59880949|NCT04439253|76003848|FG000|STARTED|Overall Study||4|All 4 patients enrolled were eligible and treated in the arm.|
59880950|NCT04439253|76003848|FG000|COMPLETED|Overall Study||0|Treatment continued until disease progression or intolerability.|
59880951|NCT04439253|76003848|FG000|NOT COMPLETED|Overall Study||4||
59880952|NCT04438785|76003854|FG000|STARTED|Overall Study||20||
59880953|NCT04438785|76003855|FG001|STARTED|Overall Study||20||
59880954|NCT04438785|76003854|FG000|COMPLETED|Overall Study||18||
59880955|NCT04438785|76003855|FG001|COMPLETED|Overall Study||10||
59605632|NCT01989156|75715804|FG000|NOT COMPLETED|Confinement Period (Population at Day 5)||0||
59605633|NCT01989156|75715805|FG001|NOT COMPLETED|Confinement Period (Population at Day 5)||1||
59605634|NCT01989156|75715806|FG002|NOT COMPLETED|Confinement Period (Population at Day 5)||5||
60006471|NCT01962298|76122131|FG001|COMPLETED|Overall Study||11||
60006472|NCT01962298|76122132|FG002|COMPLETED|Overall Study||10||
60006473|NCT01962298|76122133|FG003|COMPLETED|Overall Study||13||
60006474|NCT01962298|76122134|FG004|COMPLETED|Overall Study||9||
60006475|NCT01962298|76122130|FG000|NOT COMPLETED|Overall Study||3||
60006476|NCT01962298|76122131|FG001|NOT COMPLETED|Overall Study||4||
60006477|NCT01962298|76122132|FG002|NOT COMPLETED|Overall Study||5||
60006478|NCT01962298|76122133|FG003|NOT COMPLETED|Overall Study||2||
60006479|NCT01962298|76122134|FG004|NOT COMPLETED|Overall Study||6||
60006480|NCT02693743|76122148|FG000|STARTED|Overall Study||1||
60006481|NCT02693743|76122149|FG001|STARTED|Overall Study||0||
60006482|NCT02693743|76122148|FG000|COMPLETED|Overall Study||0||
60006483|NCT02693743|76122149|FG001|COMPLETED|Overall Study||0||
60006484|NCT02693743|76122148|FG000|NOT COMPLETED|Overall Study||1||
60006485|NCT02693743|76122149|FG001|NOT COMPLETED|Overall Study||0||
60006486|NCT02655887|76122155|FG000|STARTED|Overall Study|Intent to Treat (ITT) population.|170||
60006487|NCT02655887|76122155|FG000|COMPLETED|Overall Study|Completed 12-month follow-up.|156||
60006488|NCT02655887|76122155|FG000|NOT COMPLETED|Overall Study||14||
60006489|NCT02008318|76122161|FG000|STARTED|Overall Study||41||
60006490|NCT02008318|76122162|FG001|STARTED|Overall Study||2||
60006491|NCT02008318|76122161|FG000|Received At Least 1 Dose of Study Drug|Overall Study||41||
60006492|NCT02008318|76122162|FG001|Received At Least 1 Dose of Study Drug|Overall Study||2||
60006493|NCT02008318|76122161|FG000|COMPLETED|Overall Study||29|Completed at least 6 cycles|
60006494|NCT02008318|76122162|FG001|COMPLETED|Overall Study||1|Completed at least 6 cycles|
60006495|NCT02008318|76122161|FG000|NOT COMPLETED|Overall Study||12||
60006496|NCT02008318|76122162|FG001|NOT COMPLETED|Overall Study||1||
60006497|NCT01982812|76122173|FG000|STARTED|Overall Study||23||
60006498|NCT01982812|76122174|FG001|STARTED|Overall Study||21||
60006499|NCT01982812|76122173|FG000|COMPLETED|Overall Study||22||
60006500|NCT01982812|76122174|FG001|COMPLETED|Overall Study||11||
60006501|NCT01982812|76122173|FG000|NOT COMPLETED|Overall Study||1||
60006502|NCT01982812|76122174|FG001|NOT COMPLETED|Overall Study||10||
60006503|NCT02007070|76122180|FG000|STARTED|Overall Study||38||
60006504|NCT02007070|76122180|FG000|COMPLETED|Overall Study|Completed 2 years of treatment.|5||
60006505|NCT02007070|76122180|FG000|NOT COMPLETED|Overall Study||33||
60006506|NCT02006758|76122184|FG000|STARTED|Overall Study|Total number of enrolled participants|68||
60006507|NCT02006758|76122184|FG000|Underwent Renal Denervation|Overall Study|Underwent renal denervation|67||
60006508|NCT02006758|76122184|FG000|1-month Follow up|Overall Study|1-month follow up completed|66||
60006509|NCT02006758|76122184|FG000|6-month Follow up|Overall Study|6-month follow up completed|60||
60006510|NCT02006758|76122184|FG000|12-month Follow up|Overall Study|12-month follow up completed|55||
60006511|NCT02006758|76122184|FG000|COMPLETED|Overall Study||55||
60006512|NCT02006758|76122184|FG000|NOT COMPLETED|Overall Study||13||
60006513|NCT01960816|76122189|FG000|STARTED|Overall Study||33||
60006514|NCT01960816|76122189|FG000|COMPLETED|Overall Study||32||
60006515|NCT01960816|76122189|FG000|NOT COMPLETED|Overall Study||1||
60006516|NCT01602419|76122193|FG000|STARTED|Overall Study||120||
60136032|NCT01409837|76258725|FG000|STARTED|Overall Study||17||
60136033|NCT01409837|76258726|FG001|STARTED|Overall Study||16||
60136034|NCT01409837|76258725|FG000|6th Week|Overall Study||17||
60136035|NCT01409837|76258726|FG001|6th Week|Overall Study||16||
60136036|NCT01409837|76258725|FG000|12th Week|Overall Study|Moved away to another location|16||
60136037|NCT01409837|76258726|FG001|12th Week|Overall Study||16||
60136038|NCT01409837|76258725|FG000|24th Week|Overall Study||16||
60136039|NCT01409837|76258726|FG001|24th Week|Overall Study|Diagnosed with Lymphocytic Lymphoma and withdrawn|15||
60136040|NCT01409837|76258725|FG000|48th Week|Overall Study|Lost to follow-up|15||
60136041|NCT01409837|76258726|FG001|48th Week|Overall Study||15||
60136042|NCT01409837|76258725|FG000|96th Week|Overall Study||15||
60136043|NCT01409837|76258726|FG001|96th Week|Overall Study||15||
60136044|NCT01409837|76258725|FG000|102nd Week|Overall Study||15||
60136045|NCT01409837|76258726|FG001|102nd Week|Overall Study|Married another wife|14||
60136046|NCT01409837|76258725|FG000|114th Week|Overall Study||15||
60136047|NCT01409837|76258726|FG001|114th Week|Overall Study||14||
60136048|NCT01409837|76258725|FG000|138th Week|Overall Study||15||
60136049|NCT01409837|76258726|FG001|138th Week|Overall Study||14||
60136050|NCT01409837|76258725|FG000|186th Week|Overall Study|Moved away to another location|14||
60006517|NCT01602419|76122193|FG000|SAF Population|Overall Study||111||
60006518|NCT01602419|76122193|FG000|ITT Population|Overall Study||102||
60006519|NCT01602419|76122193|FG000|EFF Population|Overall Study||91||
60006520|NCT01602419|76122193|FG000|COMPLETED|Overall Study||91||
60006521|NCT01602419|76122193|FG000|NOT COMPLETED|Overall Study||29||
60006522|NCT01981954|76122238|FG000|STARTED|Titration Period||23||
60006523|NCT01981954|76122238|FG000|Treated|Titration Period||23||
60006524|NCT01981954|76122238|FG000|COMPLETED|Titration Period||22||
60006525|NCT01981954|76122238|FG000|NOT COMPLETED|Titration Period||1||
60006526|NCT01981954|76122238|FG000|STARTED|Fixed-Dose Assessment Period||22||
60136051|NCT01409837|76258726|FG001|186th Week|Overall Study||14||
60006527|NCT01981954|76122238|FG000|Treated|Fixed-Dose Assessment Period||22||
60006528|NCT01981954|76122238|FG000|COMPLETED|Fixed-Dose Assessment Period||21||
60006529|NCT01981954|76122238|FG000|NOT COMPLETED|Fixed-Dose Assessment Period||1||
60006530|NCT02693119|76122244|FG000|STARTED|Double-Blind Period||8||
60006531|NCT02693119|76122245|FG001|STARTED|Double-Blind Period||4||
60006532|NCT02693119|76122244|FG000|COMPLETED|Double-Blind Period||8||
60006533|NCT02693119|76122245|FG001|COMPLETED|Double-Blind Period||4||
60006534|NCT02693119|76122244|FG000|NOT COMPLETED|Double-Blind Period||0||
60006535|NCT02693119|76122245|FG001|NOT COMPLETED|Double-Blind Period||0||
60006536|NCT02693119|76122244|FG000|STARTED|Open-Label Period||8||
60006537|NCT02693119|76122245|FG001|STARTED|Open-Label Period||4||
60006538|NCT02693119|76122244|FG000|COMPLETED|Open-Label Period||8||
60006539|NCT02693119|76122245|FG001|COMPLETED|Open-Label Period||3||
60006540|NCT02693119|76122244|FG000|NOT COMPLETED|Open-Label Period||0||
60006541|NCT02693119|76122245|FG001|NOT COMPLETED|Open-Label Period||1||
60006542|NCT05641311|76122283|FG000|STARTED|Dosing Period 1||12||
60006543|NCT05641311|76122284|FG001|STARTED|Dosing Period 1||12||
60006544|NCT05641311|76122283|FG000|Received At Least 1 Dose Of Study Drug|Dosing Period 1||12||
60006545|NCT05641311|76122284|FG001|Received At Least 1 Dose Of Study Drug|Dosing Period 1||12||
60006546|NCT05641311|76122283|FG000|COMPLETED|Dosing Period 1||11||
60006547|NCT05641311|76122284|FG001|COMPLETED|Dosing Period 1||12||
60006548|NCT05641311|76122283|FG000|NOT COMPLETED|Dosing Period 1||1||
60006549|NCT05641311|76122284|FG001|NOT COMPLETED|Dosing Period 1||0||
60006550|NCT05641311|76122283|FG000|STARTED|Dosing Period 2||11||
60006551|NCT05641311|76122284|FG001|STARTED|Dosing Period 2||12||
60006552|NCT05641311|76122283|FG000|Received At Least 1 Dose Of Study Drug|Dosing Period 2||11||
60006553|NCT05641311|76122284|FG001|Received At Least 1 Dose Of Study Drug|Dosing Period 2||12||
60006554|NCT05641311|76122283|FG000|COMPLETED|Dosing Period 2||11||
60006555|NCT05641311|76122284|FG001|COMPLETED|Dosing Period 2||12||
60006556|NCT05641311|76122283|FG000|NOT COMPLETED|Dosing Period 2||0||
60006557|NCT05641311|76122284|FG001|NOT COMPLETED|Dosing Period 2||0||
60006558|NCT05633082|76122290|FG000|STARTED|Period 1: Lens 1, 15 Minutes||40||
60006559|NCT05633082|76122291|FG001|STARTED|Period 1: Lens 1, 15 Minutes|All participants received Lens 1 in Period 1.|0||
60006560|NCT05633082|76122290|FG000|COMPLETED|Period 1: Lens 1, 15 Minutes||40||
60006561|NCT05633082|76122291|FG001|COMPLETED|Period 1: Lens 1, 15 Minutes||0||
60006562|NCT05633082|76122290|FG000|NOT COMPLETED|Period 1: Lens 1, 15 Minutes||0||
60006563|NCT05633082|76122291|FG001|NOT COMPLETED|Period 1: Lens 1, 15 Minutes||0||
60006564|NCT05633082|76122290|FG000|STARTED|Period 2: Lens 2, 15 Minutes|All participants received Lens 2 in Period 2.|0||
60006565|NCT05633082|76122291|FG001|STARTED|Period 2: Lens 2, 15 Minutes||40||
60006566|NCT05633082|76122290|FG000|COMPLETED|Period 2: Lens 2, 15 Minutes||0||
60006567|NCT05633082|76122291|FG001|COMPLETED|Period 2: Lens 2, 15 Minutes||40||
60006568|NCT05633082|76122290|FG000|NOT COMPLETED|Period 2: Lens 2, 15 Minutes||0||
60006569|NCT05633082|76122291|FG001|NOT COMPLETED|Period 2: Lens 2, 15 Minutes||0||
60006570|NCT05502289|76122297|FG000|STARTED|Period 1||35||
60006571|NCT05502289|76122298|FG001|STARTED|Period 1||31||
60006572|NCT05502289|76122297|FG000|COMPLETED|Period 1||34||
60006573|NCT05502289|76122298|FG001|COMPLETED|Period 1||31||
60006574|NCT05502289|76122297|FG000|NOT COMPLETED|Period 1||1||
60006575|NCT05502289|76122298|FG001|NOT COMPLETED|Period 1||0||
60136052|NCT01409837|76258725|FG000|282nd Week|Overall Study||14||
59518892|NCT03537664|75612775|FG000|Metabolic Activity of Bacteria|Overall Study|5 patients were excluded from metabolic activity analysis (lost of RNA)|15||
59518893|NCT03537664|75612776|FG001|Metabolic Activity of Bacteria|Overall Study||25||
60006576|NCT05502289|76122297|FG000|STARTED|Period 2||34||
60006577|NCT05502289|76122298|FG001|STARTED|Period 2||31||
60006578|NCT05502289|76122297|FG000|COMPLETED|Period 2||34||
60006579|NCT05502289|76122298|FG001|COMPLETED|Period 2||31||
60006580|NCT05502289|76122297|FG000|NOT COMPLETED|Period 2||0||
60006581|NCT05502289|76122298|FG001|NOT COMPLETED|Period 2||0||
60006582|NCT05445921|76122304|FG000|STARTED|Overall Study||20||
59518894|NCT03537664|75612775|FG000|Bacterial Levels|Overall Study||20||
59518895|NCT03537664|75612776|FG001|Bacterial Levels|Overall Study||25||
60006583|NCT05445921|76122304|FG000|COMPLETED|Overall Study||20||
60006584|NCT05445921|76122304|FG000|NOT COMPLETED|Overall Study||0||
60006585|NCT04934722|76122310|FG000|STARTED|Overall Study||92||
60006586|NCT04934722|76122311|FG001|STARTED|Overall Study||94||
60006587|NCT04934722|76122310|FG000|COMPLETED|Overall Study||0||
60006588|NCT04934722|76122311|FG001|COMPLETED|Overall Study||0||
60006589|NCT04934722|76122310|FG000|NOT COMPLETED|Overall Study||92||
60006590|NCT04934722|76122311|FG001|NOT COMPLETED|Overall Study||94||
60006591|NCT04778592|76122319|FG000|STARTED|Overall Study||75||
60006592|NCT04778592|76122320|FG001|STARTED|Overall Study||74||
60006593|NCT04778592|76122319|FG000|COMPLETED|Overall Study||73||
60006594|NCT04778592|76122320|FG001|COMPLETED|Overall Study||70||
59605635|NCT01989156|75715804|FG000|STARTED|End of Study (Population at Day 90)||80||
59605636|NCT01989156|75715805|FG001|STARTED|End of Study (Population at Day 90)||40||
59605637|NCT01989156|75715806|FG002|STARTED|End of Study (Population at Day 90)||34||
60006595|NCT04778592|76122319|FG000|NOT COMPLETED|Overall Study||2||
60006596|NCT04778592|76122320|FG001|NOT COMPLETED|Overall Study||4||
60006597|NCT04688671|76122328|FG000|STARTED|Overall Study||83||
60006598|NCT04688671|76122329|FG001|STARTED|Overall Study||84||
60006599|NCT04688671|76122328|FG000|COMPLETED|Overall Study||75||
60006600|NCT04688671|76122329|FG001|COMPLETED|Overall Study||80||
60006601|NCT04688671|76122328|FG000|NOT COMPLETED|Overall Study||8||
60006602|NCT04688671|76122329|FG001|NOT COMPLETED|Overall Study||4||
60006603|NCT04668209|76122337|FG000|STARTED|Overall Study||15||
60006604|NCT04668209|76122338|FG001|STARTED|Overall Study||14||
60006605|NCT04668209|76122337|FG000|COMPLETED|Overall Study||8||
60006606|NCT04668209|76122338|FG001|COMPLETED|Overall Study||6||
60006607|NCT04668209|76122337|FG000|NOT COMPLETED|Overall Study||7||
60006608|NCT04668209|76122338|FG001|NOT COMPLETED|Overall Study||8||
60006609|NCT04456998|76122348|FG000|STARTED|Overall Study||42||
60006610|NCT04456998|76122349|FG001|STARTED|Overall Study||44||
60006611|NCT04456998|76122348|FG000|COMPLETED|Overall Study||42||
60006612|NCT04456998|76122349|FG001|COMPLETED|Overall Study||38||
60006613|NCT04456998|76122348|FG000|NOT COMPLETED|Overall Study||0||
60006614|NCT04456998|76122349|FG001|NOT COMPLETED|Overall Study||6||
60006615|NCT04405089|76122357|FG000|STARTED|Overall Study||15||
60006616|NCT04405089|76122358|FG001|STARTED|Overall Study||16||
60006617|NCT04405089|76122357|FG000|COMPLETED|Overall Study||8||
60006618|NCT04405089|76122358|FG001|COMPLETED|Overall Study||9||
60006619|NCT04405089|76122357|FG000|NOT COMPLETED|Overall Study||7||
60006620|NCT04405089|76122358|FG001|NOT COMPLETED|Overall Study||7||
59605638|NCT01989156|75715804|FG000|COMPLETED|End of Study (Population at Day 90)||73||
59605639|NCT01989156|75715805|FG001|COMPLETED|End of Study (Population at Day 90)||35||
60006621|NCT04400760|76122372|FG000|STARTED|Overall Study||40||
60006622|NCT04400760|76122372|FG000|COMPLETED|Overall Study||27||
60006623|NCT04400760|76122372|FG000|NOT COMPLETED|Overall Study||13||
60006624|NCT04251221|76122378|FG000|STARTED|Overall Study||11||
60006625|NCT04251221|76122379|FG001|STARTED|Overall Study||3||
60006626|NCT04251221|76122378|FG000|COMPLETED|Overall Study||9||
60006627|NCT04251221|76122379|FG001|COMPLETED|Overall Study||3||
60006628|NCT04251221|76122378|FG000|NOT COMPLETED|Overall Study||2||
60006629|NCT04251221|76122379|FG001|NOT COMPLETED|Overall Study||0||
60006630|NCT04203238|76122387|FG000|STARTED|Overall Study||18||
60006631|NCT04203238|76122388|FG001|STARTED|Overall Study||18||
60006632|NCT04203238|76122387|FG000|COMPLETED|Overall Study||14||
60006633|NCT04203238|76122388|FG001|COMPLETED|Overall Study||17||
60006634|NCT04203238|76122387|FG000|NOT COMPLETED|Overall Study||4||
60006635|NCT04203238|76122388|FG001|NOT COMPLETED|Overall Study||1||
60006636|NCT04200313|76122399|FG000|STARTED|RCT||219||
60006637|NCT04200313|76122400|FG001|STARTED|RCT||114||
60006638|NCT04200313|76122401|FG002|STARTED|RCT||107||
60006639|NCT04200313|76122402|FG003|STARTED|RCT||0||
60006640|NCT04200313|76122403|FG004|STARTED|RCT||0||
60006641|NCT04200313|76122404|FG005|STARTED|RCT||0||
60006642|NCT04200313|76122405|FG006|STARTED|RCT||0||
60006643|NCT04200313|76122399|FG000|COMPLETED|RCT||216||
60006644|NCT04200313|76122400|FG001|COMPLETED|RCT||113||
60006645|NCT04200313|76122401|FG002|COMPLETED|RCT||107||
60006646|NCT04200313|76122402|FG003|COMPLETED|RCT||0||
60006647|NCT04200313|76122403|FG004|COMPLETED|RCT||0||
60006648|NCT04200313|76122404|FG005|COMPLETED|RCT||0||
60006649|NCT04200313|76122405|FG006|COMPLETED|RCT||0||
60006650|NCT04200313|76122399|FG000|NOT COMPLETED|RCT||3||
60006651|NCT04200313|76122400|FG001|NOT COMPLETED|RCT||1||
60006652|NCT04200313|76122401|FG002|NOT COMPLETED|RCT||0||
60006653|NCT04200313|76122402|FG003|NOT COMPLETED|RCT||0||
60006654|NCT04200313|76122403|FG004|NOT COMPLETED|RCT||0||
60006655|NCT04200313|76122404|FG005|NOT COMPLETED|RCT||0||
60006656|NCT04200313|76122405|FG006|NOT COMPLETED|RCT||0||
60006657|NCT04200313|76122399|FG000|STARTED|BG Run Ancillary Study||0||
60006658|NCT04200313|76122400|FG001|STARTED|BG Run Ancillary Study||0||
60006659|NCT04200313|76122401|FG002|STARTED|BG Run Ancillary Study||0||
60006660|NCT04200313|76122402|FG003|STARTED|BG Run Ancillary Study||58||
60006661|NCT04200313|76122403|FG004|STARTED|BG Run Ancillary Study||0||
60006662|NCT04200313|76122404|FG005|STARTED|BG Run Ancillary Study||0||
60006663|NCT04200313|76122405|FG006|STARTED|BG Run Ancillary Study||0||
60006664|NCT04200313|76122399|FG000|COMPLETED|BG Run Ancillary Study||0||
60006665|NCT04200313|76122400|FG001|COMPLETED|BG Run Ancillary Study||0||
60006666|NCT04200313|76122401|FG002|COMPLETED|BG Run Ancillary Study||0||
60006667|NCT04200313|76122402|FG003|COMPLETED|BG Run Ancillary Study||54||
60006668|NCT04200313|76122403|FG004|COMPLETED|BG Run Ancillary Study||0||
60006669|NCT04200313|76122404|FG005|COMPLETED|BG Run Ancillary Study||0||
60006670|NCT04200313|76122405|FG006|COMPLETED|BG Run Ancillary Study||0||
60006671|NCT04200313|76122399|FG000|NOT COMPLETED|BG Run Ancillary Study||0||
60006672|NCT04200313|76122400|FG001|NOT COMPLETED|BG Run Ancillary Study||0||
60006673|NCT04200313|76122401|FG002|NOT COMPLETED|BG Run Ancillary Study||0||
60006674|NCT04200313|76122402|FG003|NOT COMPLETED|BG Run Ancillary Study||4||
60006675|NCT04200313|76122403|FG004|NOT COMPLETED|BG Run Ancillary Study||0||
60006676|NCT04200313|76122404|FG005|NOT COMPLETED|BG Run Ancillary Study||0||
60006677|NCT04200313|76122405|FG006|NOT COMPLETED|BG Run Ancillary Study||0||
60006678|NCT04200313|76122399|FG000|STARTED|Transition Phase||0||
60006679|NCT04200313|76122400|FG001|STARTED|Transition Phase||0||
60006680|NCT04200313|76122401|FG002|STARTED|Transition Phase||0||
60006681|NCT04200313|76122402|FG003|STARTED|Transition Phase||0||
60006682|NCT04200313|76122403|FG004|STARTED|Transition Phase||148||
60006683|NCT04200313|76122404|FG005|STARTED|Transition Phase||149||
60006684|NCT04200313|76122405|FG006|STARTED|Transition Phase||0||
60006685|NCT04200313|76122399|FG000|COMPLETED|Transition Phase||0||
60006686|NCT04200313|76122400|FG001|COMPLETED|Transition Phase||0||
60006687|NCT04200313|76122401|FG002|COMPLETED|Transition Phase||0||
60006688|NCT04200313|76122402|FG003|COMPLETED|Transition Phase||0||
60006689|NCT04200313|76122403|FG004|COMPLETED|Transition Phase||148||
60006690|NCT04200313|76122404|FG005|COMPLETED|Transition Phase||147||
60006691|NCT04200313|76122405|FG006|COMPLETED|Transition Phase||0||
60006692|NCT04200313|76122399|FG000|NOT COMPLETED|Transition Phase||0||
60006693|NCT04200313|76122400|FG001|NOT COMPLETED|Transition Phase||0||
60006694|NCT04200313|76122401|FG002|NOT COMPLETED|Transition Phase||0||
60006695|NCT04200313|76122402|FG003|NOT COMPLETED|Transition Phase||0||
60006696|NCT04200313|76122403|FG004|NOT COMPLETED|Transition Phase||0||
60006697|NCT04200313|76122404|FG005|NOT COMPLETED|Transition Phase||2||
60006698|NCT04200313|76122405|FG006|NOT COMPLETED|Transition Phase||0||
60006699|NCT04200313|76122399|FG000|STARTED|Extension Phase||0||
60006700|NCT04200313|76122400|FG001|STARTED|Extension Phase||0||
60006701|NCT04200313|76122401|FG002|STARTED|Extension Phase||0||
60006702|NCT04200313|76122402|FG003|STARTED|Extension Phase||0||
60006703|NCT04200313|76122403|FG004|STARTED|Extension Phase||0||
60006704|NCT04200313|76122404|FG005|STARTED|Extension Phase||0||
60006705|NCT04200313|76122405|FG006|STARTED|Extension Phase||90||
60006706|NCT04200313|76122399|FG000|COMPLETED|Extension Phase||0||
60006707|NCT04200313|76122400|FG001|COMPLETED|Extension Phase||0||
60006708|NCT04200313|76122401|FG002|COMPLETED|Extension Phase||0||
60006709|NCT04200313|76122402|FG003|COMPLETED|Extension Phase||0||
60006710|NCT04200313|76122403|FG004|COMPLETED|Extension Phase||0||
60006711|NCT04200313|76122404|FG005|COMPLETED|Extension Phase||0||
60006712|NCT04200313|76122405|FG006|COMPLETED|Extension Phase||84||
60006713|NCT04200313|76122399|FG000|NOT COMPLETED|Extension Phase||0||
60006714|NCT04200313|76122400|FG001|NOT COMPLETED|Extension Phase||0||
60006715|NCT04200313|76122401|FG002|NOT COMPLETED|Extension Phase||0||
60006716|NCT04200313|76122402|FG003|NOT COMPLETED|Extension Phase||0||
60006717|NCT04200313|76122403|FG004|NOT COMPLETED|Extension Phase||0||
60006718|NCT04200313|76122404|FG005|NOT COMPLETED|Extension Phase||0||
60006719|NCT04200313|76122405|FG006|NOT COMPLETED|Extension Phase||6||
60006720|NCT04099524|76122419|FG000|STARTED|Overall Study||20||
60006721|NCT04099524|76122420|FG001|STARTED|Overall Study||20||
60006722|NCT04099524|76122419|FG000|COMPLETED|Overall Study||20||
60006723|NCT04099524|76122420|FG001|COMPLETED|Overall Study||19||
60006724|NCT04099524|76122419|FG000|NOT COMPLETED|Overall Study||0||
60006725|NCT04099524|76122420|FG001|NOT COMPLETED|Overall Study||1||
60006726|NCT04055844|76122426|FG000|STARTED|Overall Study||14||
60006727|NCT04055844|76122426|FG000|COMPLETED|Overall Study||0||
60006728|NCT04055844|76122426|FG000|NOT COMPLETED|Overall Study||14||
60006729|NCT03939533|76122433|FG000|STARTED|Overall Study||15||
60006730|NCT03939533|76122434|FG001|STARTED|Overall Study||15||
60006731|NCT03939533|76122435|FG002|STARTED|Overall Study||34||
60006732|NCT03939533|76122433|FG000|COMPLETED|Overall Study||12||
60006733|NCT03939533|76122434|FG001|COMPLETED|Overall Study||13||
60006734|NCT03939533|76122435|FG002|COMPLETED|Overall Study||30||
60006735|NCT03939533|76122433|FG000|NOT COMPLETED|Overall Study||3||
60006736|NCT03939533|76122434|FG001|NOT COMPLETED|Overall Study||2||
60006737|NCT03939533|76122435|FG002|NOT COMPLETED|Overall Study||4||
60006738|NCT03905655|76122448|FG000|STARTED|Overall Study||13||
60006739|NCT03905655|76122449|FG001|STARTED|Overall Study||13||
60006740|NCT03905655|76122450|FG002|STARTED|Overall Study||11||
60006741|NCT03905655|76122451|FG003|STARTED|Overall Study||14||
60006742|NCT03905655|76122448|FG000|COMPLETED|Overall Study||12||
60006743|NCT03905655|76122449|FG001|COMPLETED|Overall Study||13||
60006744|NCT03905655|76122450|FG002|COMPLETED|Overall Study||10||
60006745|NCT03905655|76122451|FG003|COMPLETED|Overall Study||13||
60006746|NCT03905655|76122448|FG000|NOT COMPLETED|Overall Study||1||
60006747|NCT03905655|76122449|FG001|NOT COMPLETED|Overall Study||0||
60006748|NCT03905655|76122450|FG002|NOT COMPLETED|Overall Study||1||
60006749|NCT03905655|76122451|FG003|NOT COMPLETED|Overall Study||1||
60006750|NCT03761849|76122467|FG000|STARTED|Overall Study||36||
60006751|NCT03761849|76122468|FG001|STARTED|Overall Study||36||
60006752|NCT03761849|76122469|FG002|STARTED|Overall Study||36||
60006753|NCT03761849|76122470|FG003|STARTED|Overall Study|NDC Arms were enrolled after the completion of ODC|263||
60006754|NCT03761849|76122471|FG004|STARTED|Overall Study|NDC Arms were enrolled after the completion of ODC|264||
60006755|NCT03761849|76122472|FG005|STARTED|Overall Study|NDC Arms were enrolled after the completion of ODC|264||
60006756|NCT03761849|76122467|FG000|COMPLETED|Overall Study||0|Participants were transferred to Open Label Extension|
60006757|NCT03761849|76122468|FG001|COMPLETED|Overall Study||0|Participants were transferred to Open Label Extension|
60006758|NCT03761849|76122469|FG002|COMPLETED|Overall Study||0|Participants were transferred to Open Label Extension|
60006759|NCT03761849|76122470|FG003|COMPLETED|Overall Study||216|Participants were transferred to Open Label Extension|
60006760|NCT03761849|76122471|FG004|COMPLETED|Overall Study||207|Participants were transferred to Open Label Extension|
60006761|NCT03761849|76122472|FG005|COMPLETED|Overall Study||211|Participants were transferred to Open Label Extension|
60006762|NCT03761849|76122467|FG000|NOT COMPLETED|Overall Study||36||
60006763|NCT03761849|76122468|FG001|NOT COMPLETED|Overall Study||36||
60006764|NCT03761849|76122469|FG002|NOT COMPLETED|Overall Study||36||
60006765|NCT03761849|76122470|FG003|NOT COMPLETED|Overall Study||47||
60006766|NCT03761849|76122471|FG004|NOT COMPLETED|Overall Study||57||
60006767|NCT03761849|76122472|FG005|NOT COMPLETED|Overall Study||53||
60006768|NCT03698994|76122486|FG000|STARTED|Overall Study||20||
60006769|NCT03698994|76122486|FG000|COMPLETED|Overall Study||1||
60006770|NCT03698994|76122486|FG000|NOT COMPLETED|Overall Study||19||
60006771|NCT03613727|76122490|FG000|STARTED|Overall Study||55||
60006772|NCT03613727|76122490|FG000|COMPLETED|Overall Study||55||
60006773|NCT03613727|76122490|FG000|NOT COMPLETED|Overall Study||0||
60006774|NCT03604432|76122496|FG000|STARTED|Overall Study||31||
60006775|NCT03604432|76122497|FG001|STARTED|Overall Study||29||
60006776|NCT03604432|76122496|FG000|COMPLETED|Overall Study||31||
60006777|NCT03604432|76122497|FG001|COMPLETED|Overall Study||29||
60006778|NCT03604432|76122496|FG000|NOT COMPLETED|Overall Study||0||
60006779|NCT03604432|76122497|FG001|NOT COMPLETED|Overall Study||0||
60006780|NCT03555149|76122511|FG000|STARTED|Overall Study||24||
60006781|NCT03555149|76122512|FG001|STARTED|Overall Study||15||
60006782|NCT03555149|76122513|FG002|STARTED|Overall Study||15||
60006783|NCT03555149|76122514|FG003|STARTED|Overall Study||6||
60006784|NCT03555149|76122515|FG004|STARTED|Overall Study||4||
60006785|NCT03555149|76122516|FG005|STARTED|Overall Study||15||
60006786|NCT03555149|76122517|FG006|STARTED|Overall Study||15||
60006787|NCT03555149|76122518|FG007|STARTED|Overall Study||2||
60006788|NCT03555149|76122511|FG000|Received at Least One Dose of Study Treatment|Overall Study||19|Safety Population|
60006789|NCT03555149|76122512|FG001|Received at Least One Dose of Study Treatment|Overall Study||15|Safety Population|
60006790|NCT03555149|76122513|FG002|Received at Least One Dose of Study Treatment|Overall Study||15|Safety Population|
60006791|NCT03555149|76122514|FG003|Received at Least One Dose of Study Treatment|Overall Study||6|Safety Population|
60006792|NCT03555149|76122515|FG004|Received at Least One Dose of Study Treatment|Overall Study||4|Safety Population|
60006793|NCT03555149|76122516|FG005|Received at Least One Dose of Study Treatment|Overall Study||15|Safety Population|
60006794|NCT03555149|76122517|FG006|Received at Least One Dose of Study Treatment|Overall Study||15|Safety Population|
60006795|NCT03555149|76122518|FG007|Received at Least One Dose of Study Treatment|Overall Study||2|Safety Population|
60006796|NCT03555149|76122511|FG000|COMPLETED|Overall Study||0||
60006797|NCT03555149|76122512|FG001|COMPLETED|Overall Study||0||
60006798|NCT03555149|76122513|FG002|COMPLETED|Overall Study||0||
60006799|NCT03555149|76122514|FG003|COMPLETED|Overall Study||0||
60006800|NCT03555149|76122515|FG004|COMPLETED|Overall Study||0||
60006801|NCT03555149|76122516|FG005|COMPLETED|Overall Study||0||
60006802|NCT03555149|76122517|FG006|COMPLETED|Overall Study||0||
60006803|NCT03555149|76122518|FG007|COMPLETED|Overall Study||0||
60006804|NCT03555149|76122511|FG000|NOT COMPLETED|Overall Study||24||
60006805|NCT03555149|76122512|FG001|NOT COMPLETED|Overall Study||15||
60006806|NCT03555149|76122513|FG002|NOT COMPLETED|Overall Study||15||
60006807|NCT03555149|76122514|FG003|NOT COMPLETED|Overall Study||6||
60006808|NCT03555149|76122515|FG004|NOT COMPLETED|Overall Study||4||
59880956|NCT04438785|76003854|FG000|NOT COMPLETED|Overall Study||2||
59880957|NCT04438785|76003855|FG001|NOT COMPLETED|Overall Study||10||
59880958|NCT04741503|76003863|FG000|STARTED|Initial Enrollment||160||
59880959|NCT04741503|76003864|FG001|STARTED|Initial Enrollment||164||
59880960|NCT04741503|76003865|FG002|STARTED|Initial Enrollment||953||
59880961|NCT04741503|76003863|FG000|COMPLETED|Initial Enrollment||160||
59880962|NCT04741503|76003864|FG001|COMPLETED|Initial Enrollment||164||
59880963|NCT04741503|76003865|FG002|COMPLETED|Initial Enrollment||0||
59880964|NCT04741503|76003863|FG000|NOT COMPLETED|Initial Enrollment||0||
59880965|NCT04741503|76003864|FG001|NOT COMPLETED|Initial Enrollment||0||
59880966|NCT04741503|76003865|FG002|NOT COMPLETED|Initial Enrollment||953||
59880967|NCT04741503|76003863|FG000|STARTED|Met Protocol Criteria for Data Inclusion||160||
59880968|NCT04741503|76003864|FG001|STARTED|Met Protocol Criteria for Data Inclusion||164||
59880969|NCT04741503|76003865|FG002|STARTED|Met Protocol Criteria for Data Inclusion||0||
59880970|NCT04741503|76003863|FG000|COMPLETED|Met Protocol Criteria for Data Inclusion||137||
59880971|NCT04741503|76003864|FG001|COMPLETED|Met Protocol Criteria for Data Inclusion||147||
59880972|NCT04741503|76003865|FG002|COMPLETED|Met Protocol Criteria for Data Inclusion||0||
59880973|NCT04741503|76003863|FG000|NOT COMPLETED|Met Protocol Criteria for Data Inclusion||23||
59880974|NCT04741503|76003864|FG001|NOT COMPLETED|Met Protocol Criteria for Data Inclusion||17||
59880975|NCT04741503|76003865|FG002|NOT COMPLETED|Met Protocol Criteria for Data Inclusion||0||
59880976|NCT04734873|76003874|FG000|STARTED|Overall Study||16||
59880977|NCT04734873|76003875|FG001|STARTED|Overall Study||14||
59880978|NCT04734873|76003876|FG002|STARTED|Overall Study||12||
59880979|NCT04734873|76003874|FG000|COMPLETED|Overall Study||14||
59880980|NCT04734873|76003875|FG001|COMPLETED|Overall Study||11||
59880981|NCT04734873|76003876|FG002|COMPLETED|Overall Study||9||
59880982|NCT04734873|76003874|FG000|NOT COMPLETED|Overall Study||2||
59880983|NCT04734873|76003875|FG001|NOT COMPLETED|Overall Study||3||
59880984|NCT04734873|76003876|FG002|NOT COMPLETED|Overall Study||3||
59880985|NCT04435665|76003888|FG000|STARTED|Overall Study||12||
59880986|NCT04435665|76003889|FG001|STARTED|Overall Study||11||
59880987|NCT04435665|76003890|FG002|STARTED|Overall Study||12||
59880988|NCT04435665|76003891|FG003|STARTED|Overall Study||13||
59880989|NCT04435665|76003888|FG000|COMPLETED|Overall Study||12||
59880990|NCT04435665|76003889|FG001|COMPLETED|Overall Study||11||
59880991|NCT04435665|76003890|FG002|COMPLETED|Overall Study||12||
59880992|NCT04435665|76003891|FG003|COMPLETED|Overall Study||12||
59880993|NCT04435665|76003888|FG000|NOT COMPLETED|Overall Study||0||
59880994|NCT04435665|76003889|FG001|NOT COMPLETED|Overall Study||0||
59880995|NCT04435665|76003890|FG002|NOT COMPLETED|Overall Study||0||
59880996|NCT04435665|76003891|FG003|NOT COMPLETED|Overall Study||1||
59880997|NCT04428411|76003901|FG000|STARTED|Overall Study||486||
59880998|NCT04428411|76003901|FG000|Participants With Difficult to Treat Sites|Overall Study||397||
59880999|NCT04428411|76003901|FG000|Participants Without Difficulty to Treat Sites|Overall Study||89||
59881000|NCT04428411|76003901|FG000|Participants Adherent to Treatment|Overall Study||417||
59881001|NCT04428411|76003901|FG000|Participants Not Adherent to Treatment|Overall Study||69||
59881002|NCT04428411|76003901|FG000|COMPLETED|Overall Study||372||
59881003|NCT04428411|76003901|FG000|NOT COMPLETED|Overall Study||114||
59881004|NCT04422561|76003910|FG000|STARTED|Overall Study||228||
59881005|NCT04422561|76003911|FG001|STARTED|Overall Study||112||
60006809|NCT03555149|76122516|FG005|NOT COMPLETED|Overall Study||15||
60006810|NCT03555149|76122517|FG006|NOT COMPLETED|Overall Study||15||
60006811|NCT03555149|76122518|FG007|NOT COMPLETED|Overall Study||2||
60006812|NCT03515811|76122538|FG000|STARTED|Overall Study||51||
60006813|NCT03515811|76122539|FG001|STARTED|Overall Study||85||
60006814|NCT03515811|76122538|FG000|COMPLETED|Overall Study||46||
60006815|NCT03515811|76122539|FG001|COMPLETED|Overall Study||77||
59881006|NCT04422561|76003910|FG000|COMPLETED|Overall Study||203||
59881007|NCT04422561|76003911|FG001|COMPLETED|Overall Study||101||
59881008|NCT04422561|76003910|FG000|NOT COMPLETED|Overall Study||25||
59881009|NCT04422561|76003911|FG001|NOT COMPLETED|Overall Study||11||
59881010|NCT01369498|76003921|FG000|STARTED|Overall Study||12||
60006816|NCT03515811|76122538|FG000|NOT COMPLETED|Overall Study||5||
59881011|NCT01369498|76003922|FG001|STARTED|Overall Study||12||
59881012|NCT01369498|76003923|FG002|STARTED|Overall Study||15||
59881013|NCT01369498|76003924|FG003|STARTED|Overall Study||15||
59881014|NCT01369498|76003921|FG000|COMPLETED|Overall Study||0||
59881015|NCT01369498|76003922|FG001|COMPLETED|Overall Study||0||
59881016|NCT01369498|76003923|FG002|COMPLETED|Overall Study||0||
59881017|NCT01369498|76003924|FG003|COMPLETED|Overall Study||0||
59881018|NCT01369498|76003921|FG000|NOT COMPLETED|Overall Study||12||
59881019|NCT01369498|76003922|FG001|NOT COMPLETED|Overall Study||12||
59881020|NCT01369498|76003923|FG002|NOT COMPLETED|Overall Study||15||
59881021|NCT01369498|76003924|FG003|NOT COMPLETED|Overall Study||15||
59881022|NCT04709835|76003938|FG000|STARTED|Overall Study||40||
59881023|NCT04709835|76003939|FG001|STARTED|Overall Study||30||
59881024|NCT04709835|76003940|FG002|STARTED|Overall Study||30||
59881025|NCT04709835|76003938|FG000|COMPLETED|Overall Study||40||
59881026|NCT04709835|76003939|FG001|COMPLETED|Overall Study||29||
59881027|NCT04709835|76003940|FG002|COMPLETED|Overall Study||30||
59881028|NCT04709835|76003938|FG000|NOT COMPLETED|Overall Study||0||
60006817|NCT03515811|76122539|FG001|NOT COMPLETED|Overall Study||8||
60006818|NCT03463265|76122554|FG000|STARTED|Overall Study||7||
60006819|NCT03463265|76122555|FG001|STARTED|Overall Study||6||
60006820|NCT03463265|76122556|FG002|STARTED|Overall Study||9||
60006821|NCT03463265|76122557|FG003|STARTED|Overall Study||4||
60006822|NCT03463265|76122558|FG004|STARTED|Overall Study||10||
60006823|NCT03463265|76122559|FG005|STARTED|Overall Study||26||
60006824|NCT03463265|76122554|FG000|COMPLETED|Overall Study||7||
60006825|NCT03463265|76122555|FG001|COMPLETED|Overall Study||6||
60006826|NCT03463265|76122556|FG002|COMPLETED|Overall Study||9||
60006827|NCT03463265|76122557|FG003|COMPLETED|Overall Study||4||
60006828|NCT03463265|76122558|FG004|COMPLETED|Overall Study||10||
60136053|NCT01409837|76258726|FG001|282nd Week|Overall Study||14||
60136054|NCT01409837|76258725|FG000|COMPLETED|Overall Study||14||
59881029|NCT04709835|76003939|FG001|NOT COMPLETED|Overall Study||1||
59881030|NCT04709835|76003940|FG002|NOT COMPLETED|Overall Study||0||
59881031|NCT04407507|76003954|FG000|STARTED|Overall Study||33||
59881032|NCT04407507|76003955|FG001|STARTED|Overall Study||33||
59881033|NCT04407507|76003954|FG000|COMPLETED|Overall Study||33||
59881034|NCT04407507|76003955|FG001|COMPLETED|Overall Study||32||
59881035|NCT04407507|76003954|FG000|NOT COMPLETED|Overall Study||0||
59881036|NCT04407507|76003955|FG001|NOT COMPLETED|Overall Study||1||
59881037|NCT04698993|76003963|FG000|STARTED|Overall Study||275||
59881038|NCT04698993|76003964|FG001|STARTED|Overall Study||113||
59881039|NCT04698993|76003963|FG000|COMPLETED|Overall Study||272||
59881040|NCT04698993|76003964|FG001|COMPLETED|Overall Study||106||
59881041|NCT04698993|76003963|FG000|NOT COMPLETED|Overall Study||3||
59881042|NCT04698993|76003964|FG001|NOT COMPLETED|Overall Study||7||
59881043|NCT04359771|76003972|FG000|STARTED|Overall Study|Right eye of every participant was assigned to the diode MPL group|15|1 eye from each patient was assigned to one arm and the other eye of the same patient to the 2nd arm|15
59881044|NCT04359771|76003973|FG001|STARTED|Overall Study|Left eye of every participant was assigned to the diode MPL group|15|1 eye from each patient was assigned to one arm and the other eye of the same patient to the 2nd arm|15
59881045|NCT04359771|76003972|FG000|COMPLETED|Overall Study|The right eye of each participant was assigned to the diode MPL group|13|1 eye from each patient was assigned to one arm and the other eye of the same patient to the 2nd arm|13
59881046|NCT04359771|76003973|FG001|COMPLETED|Overall Study|The left eye of every participant was assigned to the diode MPL group|13|1 eye from each patient was assigned to one arm and the other eye of the same patient to the 2nd arm|13
59881047|NCT04359771|76003972|FG000|NOT COMPLETED|Overall Study||2||2
59881048|NCT04359771|76003973|FG001|NOT COMPLETED|Overall Study||2||2
59881049|NCT04356573|76003981|FG000|STARTED|Overall Study||7||
59881050|NCT04356573|76003982|FG001|STARTED|Overall Study||6||
59881051|NCT04356573|76003981|FG000|COMPLETED|Overall Study||6||
59881052|NCT04356573|76003982|FG001|COMPLETED|Overall Study||6||
59881053|NCT04356573|76003981|FG000|NOT COMPLETED|Overall Study||1||
59881054|NCT04356573|76003982|FG001|NOT COMPLETED|Overall Study||0||
59881055|NCT03542877|76003988|FG000|STARTED|Overall Study||44||
59881056|NCT03542877|76003988|FG000|COMPLETED|Overall Study||23||
59881057|NCT03542877|76003988|FG000|NOT COMPLETED|Overall Study||21||
59881058|NCT04352127|76003998|FG000|STARTED|Overall Study||29||
59881059|NCT04352127|76003999|FG001|STARTED|Overall Study||26||
59881060|NCT04352127|76003998|FG000|COMPLETED|Overall Study||25||
59881061|NCT04352127|76003999|FG001|COMPLETED|Overall Study||25||
59881062|NCT04352127|76003998|FG000|NOT COMPLETED|Overall Study||4||
59881063|NCT04352127|76003999|FG001|NOT COMPLETED|Overall Study||1||
59881064|NCT04351269|76004008|FG000|STARTED|Overall Study||237||
59881065|NCT04351269|76004009|FG001|STARTED|Overall Study||260||
59881066|NCT04351269|76004010|FG002|STARTED|Overall Study||100||
59881067|NCT04351269|76004008|FG000|COMPLETED|Overall Study||165||
59881068|NCT04351269|76004009|FG001|COMPLETED|Overall Study||219||
60006829|NCT03463265|76122559|FG005|COMPLETED|Overall Study||26||
60006830|NCT03463265|76122554|FG000|NOT COMPLETED|Overall Study||0||
60006831|NCT03463265|76122555|FG001|NOT COMPLETED|Overall Study||0||
60006832|NCT03463265|76122556|FG002|NOT COMPLETED|Overall Study||0||
60006833|NCT03463265|76122557|FG003|NOT COMPLETED|Overall Study||0||
60136055|NCT01409837|76258726|FG001|COMPLETED|Overall Study||14||
60136056|NCT01409837|76258725|FG000|NOT COMPLETED|Overall Study||3||
59881069|NCT04351269|76004010|FG002|COMPLETED|Overall Study||71||
60136057|NCT01409837|76258726|FG001|NOT COMPLETED|Overall Study||2||
59881070|NCT04351269|76004008|FG000|NOT COMPLETED|Overall Study||72||
59881071|NCT04351269|76004009|FG001|NOT COMPLETED|Overall Study||41||
59881072|NCT04351269|76004010|FG002|NOT COMPLETED|Overall Study||29||
59881073|NCT04348851|76004025|FG000|STARTED|Post-Test 1||13||
60136058|NCT00750165|76258734|FG000|STARTED|Overall Study||32||
60136059|NCT00750165|76258734|FG000|COMPLETED|Overall Study||21||
60136060|NCT00750165|76258734|FG000|NOT COMPLETED|Overall Study||11||
60136061|NCT00731055|76258738|FG000|STARTED|Overall Study|This is a within-subjects study design.|16||
59881074|NCT04348851|76004026|FG001|STARTED|Post-Test 1||13||
59881075|NCT04348851|76004027|FG002|STARTED|Post-Test 1||13||
60006834|NCT03463265|76122558|FG004|NOT COMPLETED|Overall Study||0||
60006835|NCT03463265|76122559|FG005|NOT COMPLETED|Overall Study||0||
60006836|NCT03329300|76122576|FG000|STARTED|Overall Study||17||
60006837|NCT03329300|76122577|FG001|STARTED|Overall Study||17||
59881076|NCT04348851|76004028|FG003|STARTED|Post-Test 1||14||
60006838|NCT03329300|76122576|FG000|COMPLETED|Overall Study||17||
60006839|NCT03329300|76122577|FG001|COMPLETED|Overall Study||17||
60006840|NCT03329300|76122576|FG000|NOT COMPLETED|Overall Study||0||
60006841|NCT03329300|76122577|FG001|NOT COMPLETED|Overall Study||0||
60006842|NCT03304210|76122589|FG000|STARTED|Overall Study||2||
60006843|NCT03304210|76122590|FG001|STARTED|Overall Study||2||
60006844|NCT03304210|76122591|FG002|STARTED|Overall Study||3||
60006845|NCT03304210|76122592|FG003|STARTED|Overall Study||3||
60006846|NCT03304210|76122593|FG004|STARTED|Overall Study||10||
60006847|NCT03304210|76122589|FG000|COMPLETED|Overall Study||2||
60006848|NCT03304210|76122590|FG001|COMPLETED|Overall Study||2||
60006849|NCT03304210|76122591|FG002|COMPLETED|Overall Study||3||
60006850|NCT03304210|76122592|FG003|COMPLETED|Overall Study||3||
60006851|NCT03304210|76122593|FG004|COMPLETED|Overall Study||10||
60006852|NCT03304210|76122589|FG000|NOT COMPLETED|Overall Study||0||
60006853|NCT03304210|76122590|FG001|NOT COMPLETED|Overall Study||0||
60006854|NCT03304210|76122591|FG002|NOT COMPLETED|Overall Study||0||
60006855|NCT03304210|76122592|FG003|NOT COMPLETED|Overall Study||0||
60006856|NCT03304210|76122593|FG004|NOT COMPLETED|Overall Study||0||
60006857|NCT03246529|76122608|FG000|STARTED|Core Study (Until 100 d Post-transplant)||12||
60006858|NCT03246529|76122609|FG001|STARTED|Core Study (Until 100 d Post-transplant)||80||
60006859|NCT03246529|76122610|FG002|STARTED|Core Study (Until 100 d Post-transplant)||42||
60006860|NCT03246529|76122608|FG000|Post Transplantation Analysis Set|Core Study (Until 100 d Post-transplant)||12||
60006861|NCT03246529|76122609|FG001|Post Transplantation Analysis Set|Core Study (Until 100 d Post-transplant)||77||
60006862|NCT03246529|76122610|FG002|Post Transplantation Analysis Set|Core Study (Until 100 d Post-transplant)||37||
60006863|NCT03246529|76122608|FG000|COMPLETED|Core Study (Until 100 d Post-transplant)||12||
60006864|NCT03246529|76122609|FG001|COMPLETED|Core Study (Until 100 d Post-transplant)||74||
60006865|NCT03246529|76122610|FG002|COMPLETED|Core Study (Until 100 d Post-transplant)||34||
60006866|NCT03246529|76122608|FG000|NOT COMPLETED|Core Study (Until 100 d Post-transplant)||0||
60006867|NCT03246529|76122609|FG001|NOT COMPLETED|Core Study (Until 100 d Post-transplant)||6||
60006868|NCT03246529|76122610|FG002|NOT COMPLETED|Core Study (Until 100 d Post-transplant)||8||
60006869|NCT03246529|76122608|FG000|STARTED|Follow-up Period at 1 Year FU Completion||12||
60006870|NCT03246529|76122609|FG001|STARTED|Follow-up Period at 1 Year FU Completion|One (1) subject early terminated the study following the core study period and before the follow up (FU)|73||
60006871|NCT03246529|76122610|FG002|STARTED|Follow-up Period at 1 Year FU Completion||34||
60006872|NCT03246529|76122608|FG000|COMPLETED|Follow-up Period at 1 Year FU Completion||9|Long Term FU is ongoing. Numbers are of the subject ongoing in the study.|
60006873|NCT03246529|76122609|FG001|COMPLETED|Follow-up Period at 1 Year FU Completion||66|Long Term FU is ongoing. Numbers are of the subject ongoing in the study.|
60006874|NCT03246529|76122610|FG002|COMPLETED|Follow-up Period at 1 Year FU Completion||32|Long Term FU is ongoing. Numbers are of the subject ongoing in the study.|
60006875|NCT03246529|76122608|FG000|NOT COMPLETED|Follow-up Period at 1 Year FU Completion||3||
60006876|NCT03246529|76122609|FG001|NOT COMPLETED|Follow-up Period at 1 Year FU Completion||7||
60006877|NCT03246529|76122610|FG002|NOT COMPLETED|Follow-up Period at 1 Year FU Completion||2||
60006878|NCT02975934|76122626|FG000|STARTED|Treatment Phase||270||
60006879|NCT02975934|76122627|FG001|STARTED|Treatment Phase||135||
60006880|NCT02975934|76122626|FG000|COMPLETED|Treatment Phase||237||
60006881|NCT02975934|76122627|FG001|COMPLETED|Treatment Phase||125||
60006882|NCT02975934|76122626|FG000|NOT COMPLETED|Treatment Phase||33||
60006883|NCT02975934|76122627|FG001|NOT COMPLETED|Treatment Phase||10||
60006884|NCT02975934|76122626|FG000|STARTED|Cross-Over Phase|Participants randomized to rucaparib will not have the option to cross-over to abiraterone acetate, enzalutamide, or docetaxel treatment after progressing by IRR.|0||
60006885|NCT02975934|76122627|FG001|STARTED|Cross-Over Phase|"Only participants randomized to the Abiraterone acetate/Enzalutamide/Docetaxel arm and radiographically progress by IRR have an opportunity to cross-over to rucaparib treatment.~Enrollment into cross-over was ongoing at date of data analysis; also participants may complete docetaxel treatment from previous period and await progression: therefore overall counts of participants completing prior period will not be the same. Data for cross-over participants is not analyzed at time of data-cut."|63||
60006886|NCT02975934|76122626|FG000|COMPLETED|Cross-Over Phase||0||
60006887|NCT02975934|76122627|FG001|COMPLETED|Cross-Over Phase||56||
60006888|NCT02975934|76122626|FG000|NOT COMPLETED|Cross-Over Phase||0||
60006889|NCT02975934|76122627|FG001|NOT COMPLETED|Cross-Over Phase||7||
60006890|NCT02847598|76122641|FG000|STARTED|Overall Study||56||
60006891|NCT02847598|76122642|FG001|STARTED|Overall Study||6||
60006892|NCT02847598|76122643|FG002|STARTED|Overall Study||6||
60006893|NCT02847598|76122644|FG003|STARTED|Overall Study||64||
60006894|NCT02847598|76122645|FG004|STARTED|Overall Study||33||
60006895|NCT02847598|76122646|FG005|STARTED|Overall Study||26||
60006896|NCT02847598|76122647|FG006|STARTED|Overall Study||25||
60006897|NCT02847598|76122648|FG007|STARTED|Overall Study||48||
60006898|NCT02847598|76122641|FG000|COMPLETED|Overall Study||51||
60006899|NCT02847598|76122642|FG001|COMPLETED|Overall Study||6||
60006900|NCT02847598|76122643|FG002|COMPLETED|Overall Study||6||
60006901|NCT02847598|76122644|FG003|COMPLETED|Overall Study||60||
60006902|NCT02847598|76122645|FG004|COMPLETED|Overall Study||30||
60006903|NCT02847598|76122646|FG005|COMPLETED|Overall Study||23||
60006904|NCT02847598|76122647|FG006|COMPLETED|Overall Study||23||
60006905|NCT02847598|76122648|FG007|COMPLETED|Overall Study||44||
60006906|NCT02847598|76122641|FG000|NOT COMPLETED|Overall Study||5||
60006907|NCT02847598|76122642|FG001|NOT COMPLETED|Overall Study||0||
60006908|NCT02847598|76122643|FG002|NOT COMPLETED|Overall Study||0||
60006909|NCT02847598|76122644|FG003|NOT COMPLETED|Overall Study||4||
60006910|NCT02847598|76122645|FG004|NOT COMPLETED|Overall Study||3||
60006911|NCT02847598|76122646|FG005|NOT COMPLETED|Overall Study||3||
60006912|NCT02847598|76122647|FG006|NOT COMPLETED|Overall Study||2||
60006913|NCT02847598|76122648|FG007|NOT COMPLETED|Overall Study||4||
60006914|NCT02834975|76122672|FG000|STARTED|Overall Study||26||
60006915|NCT02834975|76122672|FG000|COMPLETED|Overall Study||21||
60006916|NCT02834975|76122672|FG000|NOT COMPLETED|Overall Study||5||
60006917|NCT02822508|76122680|FG000|STARTED|Overall Study||114||
60006918|NCT02822508|76122681|FG001|STARTED|Overall Study||105||
60006919|NCT02822508|76122682|FG002|STARTED|Overall Study||115||
60006920|NCT02822508|76122683|FG003|STARTED|Overall Study||100||
60006921|NCT02822508|76122680|FG000|COMPLETED|Overall Study||101||
60006922|NCT02822508|76122681|FG001|COMPLETED|Overall Study||90||
60006923|NCT02822508|76122682|FG002|COMPLETED|Overall Study||100||
60006924|NCT02822508|76122683|FG003|COMPLETED|Overall Study||90||
60006925|NCT02822508|76122680|FG000|NOT COMPLETED|Overall Study||13||
60006926|NCT02822508|76122681|FG001|NOT COMPLETED|Overall Study||15||
60006927|NCT02822508|76122682|FG002|NOT COMPLETED|Overall Study||15||
60006928|NCT02822508|76122683|FG003|NOT COMPLETED|Overall Study||10||
60006929|NCT02684123|76122695|FG000|STARTED|Phase 1||20||
60006930|NCT02684123|76122696|FG001|STARTED|Phase 1||10||
60006931|NCT02684123|76122695|FG000|COMPLETED|Phase 1||12||
60006932|NCT02684123|76122696|FG001|COMPLETED|Phase 1||9||
60006933|NCT02684123|76122695|FG000|NOT COMPLETED|Phase 1||8||
60006934|NCT02684123|76122696|FG001|NOT COMPLETED|Phase 1||1||
60006935|NCT02684123|76122695|FG000|STARTED|Eligibility Determination for Phase 2||12||
60006936|NCT02684123|76122696|FG001|STARTED|Eligibility Determination for Phase 2||9||
60006937|NCT02684123|76122695|FG000|COMPLETED|Eligibility Determination for Phase 2||1||
60006938|NCT02684123|76122696|FG001|COMPLETED|Eligibility Determination for Phase 2||9||
60006939|NCT02684123|76122695|FG000|NOT COMPLETED|Eligibility Determination for Phase 2||11||
60006940|NCT02684123|76122696|FG001|NOT COMPLETED|Eligibility Determination for Phase 2||0||
60006941|NCT02684123|76122695|FG000|STARTED|Phase 2||1||
60006942|NCT02684123|76122696|FG001|STARTED|Phase 2||9||
60006943|NCT02684123|76122695|FG000|COMPLETED|Phase 2||0||
60006944|NCT02684123|76122696|FG001|COMPLETED|Phase 2||1||
60006945|NCT02684123|76122695|FG000|NOT COMPLETED|Phase 2||1||
60006946|NCT02684123|76122696|FG001|NOT COMPLETED|Phase 2||8||
60006947|NCT02584309|76122705|FG000|STARTED|Overall Study||62||
60006948|NCT02584309|76122706|FG001|STARTED|Overall Study||10||
60006949|NCT02584309|76122707|FG002|STARTED|Overall Study||1||
60006950|NCT02584309|76122705|FG000|COMPLETED|Overall Study||62||
60006951|NCT02584309|76122706|FG001|COMPLETED|Overall Study||10||
60006952|NCT02584309|76122707|FG002|COMPLETED|Overall Study||0||
60006953|NCT02584309|76122705|FG000|NOT COMPLETED|Overall Study||0||
60006954|NCT02584309|76122706|FG001|NOT COMPLETED|Overall Study||0||
60006955|NCT02584309|76122707|FG002|NOT COMPLETED|Overall Study||1||
60006956|NCT02576574|76122717|FG000|STARTED|Overall Study||366||
60006957|NCT02576574|76122718|FG001|STARTED|Overall Study||322||
60006958|NCT02576574|76122719|FG002|STARTED|Overall Study||526||
60006959|NCT02576574|76122717|FG000|Treated|Overall Study||361||
59881077|NCT04348851|76004025|FG000|COMPLETED|Post-Test 1||13||
59881078|NCT04348851|76004026|FG001|COMPLETED|Post-Test 1||11||
59881079|NCT04348851|76004027|FG002|COMPLETED|Post-Test 1||13||
59881080|NCT04348851|76004028|FG003|COMPLETED|Post-Test 1||14||
59881081|NCT04348851|76004025|FG000|NOT COMPLETED|Post-Test 1||0||
59881082|NCT04348851|76004026|FG001|NOT COMPLETED|Post-Test 1||2||
59881083|NCT04348851|76004027|FG002|NOT COMPLETED|Post-Test 1||0||
59881084|NCT04348851|76004028|FG003|NOT COMPLETED|Post-Test 1||0||
59881085|NCT04348851|76004025|FG000|STARTED|Post-Test 2||13||
59881086|NCT04348851|76004026|FG001|STARTED|Post-Test 2||11||
59881087|NCT04348851|76004027|FG002|STARTED|Post-Test 2||13||
59881088|NCT04348851|76004028|FG003|STARTED|Post-Test 2||14||
59881089|NCT04348851|76004025|FG000|COMPLETED|Post-Test 2||13||
59881090|NCT04348851|76004026|FG001|COMPLETED|Post-Test 2||10||
59881091|NCT04348851|76004027|FG002|COMPLETED|Post-Test 2||13||
59881092|NCT04348851|76004028|FG003|COMPLETED|Post-Test 2||13||
59881093|NCT04348851|76004025|FG000|NOT COMPLETED|Post-Test 2||0||
59881094|NCT04348851|76004026|FG001|NOT COMPLETED|Post-Test 2||1||
59881095|NCT04348851|76004027|FG002|NOT COMPLETED|Post-Test 2||0||
59881096|NCT04348851|76004028|FG003|NOT COMPLETED|Post-Test 2||1||
59881097|NCT04346199|76004040|FG000|STARTED|Overall Study||89||
59881098|NCT04346199|76004041|FG001|STARTED|Overall Study||88||
59881099|NCT04346199|76004040|FG000|COMPLETED|Overall Study||74||
59881100|NCT04346199|76004041|FG001|COMPLETED|Overall Study||77||
59881101|NCT04346199|76004040|FG000|NOT COMPLETED|Overall Study||15||
59881102|NCT04346199|76004041|FG001|NOT COMPLETED|Overall Study||11||
59881103|NCT04345653|76004047|FG000|STARTED|Overall Study||48||
59881104|NCT04345653|76004047|FG000|COMPLETED|Overall Study||46||
59881105|NCT04345653|76004047|FG000|NOT COMPLETED|Overall Study||2||
59881106|NCT04342689|76004054|FG000|STARTED|Overall Study||113||
59881107|NCT04342689|76004055|FG001|STARTED|Overall Study||113||
59881108|NCT04342689|76004054|FG000|COMPLETED|Overall Study||71||
59881109|NCT04342689|76004055|FG001|COMPLETED|Overall Study||68||
59881110|NCT04342689|76004054|FG000|NOT COMPLETED|Overall Study||42||
59881111|NCT04342689|76004055|FG001|NOT COMPLETED|Overall Study||45||
59881112|NCT04169061|76004063|FG000|STARTED|Overall Study||36||
59881113|NCT04169061|76004063|FG000|Safety Population|Overall Study||36||
59881114|NCT04169061|76004063|FG000|Modified Intent to Treat (mITT) Population|Overall Study||34||
59881115|NCT04169061|76004063|FG000|COMPLETED|Overall Study||31||
59881116|NCT04169061|76004063|FG000|NOT COMPLETED|Overall Study||5||
59881117|NCT02792218|76004069|FG000|STARTED|Overall Study||465||
59881118|NCT02792218|76004070|FG001|STARTED|Overall Study||462||
59881119|NCT02792218|76004069|FG000|COMPLETED|Overall Study||416||
59881120|NCT02792218|76004070|FG001|COMPLETED|Overall Study||381||
59881121|NCT02792218|76004069|FG000|NOT COMPLETED|Overall Study||49||
59881122|NCT02792218|76004070|FG001|NOT COMPLETED|Overall Study||81||
59881123|NCT00153101|76004081|FG000|STARTED|Overall Study||8502||
59881124|NCT00153101|76004082|FG001|STARTED|Overall Study||8542||
59881125|NCT00153101|76004083|FG002|STARTED|Overall Study||8576||
59881126|NCT00153101|76004084|FG003|STARTED|Overall Study||2954||
59881127|NCT00153101|76004085|FG004|STARTED|Overall Study||2972||
59881128|NCT00153101|76004081|FG000|COMPLETED|Overall Study||8485||
59881129|NCT00153101|76004082|FG001|COMPLETED|Overall Study||8524||
59881130|NCT00153101|76004083|FG002|COMPLETED|Overall Study||8561||
59881131|NCT00153101|76004084|FG003|COMPLETED|Overall Study||2946||
59881132|NCT00153101|76004085|FG004|COMPLETED|Overall Study||2962||
59881133|NCT00153101|76004081|FG000|NOT COMPLETED|Overall Study||17||
59881134|NCT00153101|76004082|FG001|NOT COMPLETED|Overall Study||18||
59881135|NCT00153101|76004083|FG002|NOT COMPLETED|Overall Study||15||
59881136|NCT00153101|76004084|FG003|NOT COMPLETED|Overall Study||8||
59881137|NCT00153101|76004085|FG004|NOT COMPLETED|Overall Study||10||
59881138|NCT04401579|76004101|FG000|STARTED|Overall Study||515||
59881139|NCT04401579|76004102|FG001|STARTED|Overall Study||518||
59881140|NCT04401579|76004101|FG000|Treated|Overall Study||507||
59881141|NCT04401579|76004102|FG001|Treated|Overall Study||509||
59881142|NCT04401579|76004101|FG000|COMPLETED|Overall Study||431||
59881143|NCT04401579|76004102|FG001|COMPLETED|Overall Study||408||
59881144|NCT04401579|76004101|FG000|NOT COMPLETED|Overall Study||84||
59881145|NCT04401579|76004102|FG001|NOT COMPLETED|Overall Study||110||
59881146|NCT04161807|76004108|FG000|STARTED|Overall Study||42||
59881147|NCT04161807|76004108|FG000|COMPLETED|Overall Study||38||
59881148|NCT04161807|76004108|FG000|NOT COMPLETED|Overall Study||4||
59881149|NCT04401423|76004114|FG000|STARTED|Overall Study||11||
59881150|NCT04401423|76004115|FG001|STARTED|Overall Study||11||
59881151|NCT04401423|76004114|FG000|COMPLETED|Overall Study||6||
59881152|NCT04401423|76004115|FG001|COMPLETED|Overall Study||9||
59881153|NCT04401423|76004114|FG000|NOT COMPLETED|Overall Study||5||
59881154|NCT04401423|76004115|FG001|NOT COMPLETED|Overall Study||2||
59881155|NCT04399161|76004126|FG000|STARTED|Overall Study||20||
59881156|NCT04399161|76004127|FG001|STARTED|Overall Study||20||
59881157|NCT04399161|76004128|FG002|STARTED|Overall Study||20||
59881158|NCT04399161|76004126|FG000|COMPLETED|Overall Study||18||
59881159|NCT04399161|76004127|FG001|COMPLETED|Overall Study||18||
59881160|NCT04399161|76004128|FG002|COMPLETED|Overall Study||18||
59881161|NCT04399161|76004126|FG000|NOT COMPLETED|Overall Study||2||
59881162|NCT04399161|76004127|FG001|NOT COMPLETED|Overall Study||2||
59881163|NCT04399161|76004128|FG002|NOT COMPLETED|Overall Study||2||
59881164|NCT02076178|76004138|FG000|STARTED|Oral Phase||21||
59881165|NCT02076178|76004139|FG001|STARTED|Oral Phase||106||
59881166|NCT02076178|76004138|FG000|COMPLETED|Oral Phase||21||
59881167|NCT02076178|76004139|FG001|COMPLETED|Oral Phase||94||
59881168|NCT02076178|76004138|FG000|NOT COMPLETED|Oral Phase||0||
59881169|NCT02076178|76004139|FG001|NOT COMPLETED|Oral Phase||12||
59881170|NCT02076178|76004138|FG000|STARTED|Injection Phase||21||
59881171|NCT02076178|76004139|FG001|STARTED|Injection Phase||94||
59881172|NCT02076178|76004138|FG000|COMPLETED|Injection Phase||20||
59881173|NCT02076178|76004139|FG001|COMPLETED|Injection Phase||87||
59881174|NCT02076178|76004138|FG000|NOT COMPLETED|Injection Phase||1||
59881175|NCT02076178|76004139|FG001|NOT COMPLETED|Injection Phase||7||
59881176|NCT00149825|76004149|FG000|STARTED|Overall Study||15||
59881177|NCT00149825|76004150|FG001|STARTED|Overall Study||15||
59881178|NCT00149825|76004149|FG000|COMPLETED|Overall Study||10||
59881179|NCT00149825|76004150|FG001|COMPLETED|Overall Study||12||
59881180|NCT00149825|76004149|FG000|NOT COMPLETED|Overall Study||5||
59881181|NCT00149825|76004150|FG001|NOT COMPLETED|Overall Study||3||
59881182|NCT04397757|76004158|FG000|STARTED|Overall Study||41||
59881183|NCT04397757|76004159|FG001|STARTED|Overall Study||39||
59881184|NCT04397757|76004158|FG000|Treated|Overall Study||39||
59881185|NCT04397757|76004159|FG001|Treated|Overall Study||39||
59881186|NCT04397757|76004158|FG000|COMPLETED|Overall Study||32||
59881187|NCT04397757|76004159|FG001|COMPLETED|Overall Study||25||
59881188|NCT04397757|76004158|FG000|NOT COMPLETED|Overall Study||9||
59881189|NCT04397757|76004159|FG001|NOT COMPLETED|Overall Study||14||
59881190|NCT02792062|76004176|FG000|STARTED|Intervention Period 1 (6 Days)||2||
59881191|NCT02792062|76004177|FG001|STARTED|Intervention Period 1 (6 Days)||2||
59881192|NCT02792062|76004178|FG002|STARTED|Intervention Period 1 (6 Days)||2||
59881193|NCT02792062|76004179|FG003|STARTED|Intervention Period 1 (6 Days)||2||
59881194|NCT02792062|76004180|FG004|STARTED|Intervention Period 1 (6 Days)||2||
59881195|NCT02792062|76004181|FG005|STARTED|Intervention Period 1 (6 Days)||2||
59881196|NCT02792062|76004176|FG000|COMPLETED|Intervention Period 1 (6 Days)||2||
59881197|NCT02792062|76004177|FG001|COMPLETED|Intervention Period 1 (6 Days)||2||
59881198|NCT02792062|76004178|FG002|COMPLETED|Intervention Period 1 (6 Days)||2||
59881199|NCT02792062|76004179|FG003|COMPLETED|Intervention Period 1 (6 Days)||2||
59881200|NCT02792062|76004180|FG004|COMPLETED|Intervention Period 1 (6 Days)||2||
59881201|NCT02792062|76004181|FG005|COMPLETED|Intervention Period 1 (6 Days)||2||
59881202|NCT02792062|76004176|FG000|NOT COMPLETED|Intervention Period 1 (6 Days)||0||
59881203|NCT02792062|76004177|FG001|NOT COMPLETED|Intervention Period 1 (6 Days)||0||
59881204|NCT02792062|76004178|FG002|NOT COMPLETED|Intervention Period 1 (6 Days)||0||
59881205|NCT02792062|76004179|FG003|NOT COMPLETED|Intervention Period 1 (6 Days)||0||
59881206|NCT02792062|76004180|FG004|NOT COMPLETED|Intervention Period 1 (6 Days)||0||
59881207|NCT02792062|76004181|FG005|NOT COMPLETED|Intervention Period 1 (6 Days)||0||
59881208|NCT02792062|76004176|FG000|STARTED|Washout Period (at Least 14 Days)||2||
59881209|NCT02792062|76004177|FG001|STARTED|Washout Period (at Least 14 Days)||2||
59881210|NCT02792062|76004178|FG002|STARTED|Washout Period (at Least 14 Days)||2||
59881211|NCT02792062|76004179|FG003|STARTED|Washout Period (at Least 14 Days)||2||
59881212|NCT02792062|76004180|FG004|STARTED|Washout Period (at Least 14 Days)||2||
59881213|NCT02792062|76004181|FG005|STARTED|Washout Period (at Least 14 Days)||2||
59881214|NCT02792062|76004176|FG000|COMPLETED|Washout Period (at Least 14 Days)||2||
59881215|NCT02792062|76004177|FG001|COMPLETED|Washout Period (at Least 14 Days)||2||
59881216|NCT02792062|76004178|FG002|COMPLETED|Washout Period (at Least 14 Days)||2||
59881217|NCT02792062|76004179|FG003|COMPLETED|Washout Period (at Least 14 Days)||2||
59881218|NCT02792062|76004180|FG004|COMPLETED|Washout Period (at Least 14 Days)||2||
59881219|NCT02792062|76004181|FG005|COMPLETED|Washout Period (at Least 14 Days)||2||
59881220|NCT02792062|76004176|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0||
59950790|NCT02677493|76069659|FG001|STARTED|Overall Study||298||
60006960|NCT02576574|76122718|FG001|Treated|Overall Study||318||
60006961|NCT02576574|76122719|FG002|Treated|Overall Study||500||
60006962|NCT02576574|76122717|FG000|COMPLETED|Overall Study||296||
60006963|NCT02576574|76122718|FG001|COMPLETED|Overall Study||252||
60006964|NCT02576574|76122719|FG002|COMPLETED|Overall Study||427||
60006965|NCT02576574|76122717|FG000|NOT COMPLETED|Overall Study||70||
60006966|NCT02576574|76122718|FG001|NOT COMPLETED|Overall Study||70||
60006967|NCT02576574|76122719|FG002|NOT COMPLETED|Overall Study||99||
60006968|NCT02439775|76122731|FG000|STARTED|Overall Study||206||
60006969|NCT02439775|76122732|FG001|STARTED|Overall Study||131||
60006970|NCT02439775|76122731|FG000|COMPLETED|Overall Study||115||
60006971|NCT02439775|76122732|FG001|COMPLETED|Overall Study||73||
60006972|NCT02439775|76122731|FG000|NOT COMPLETED|Overall Study||91||
60006973|NCT02439775|76122732|FG001|NOT COMPLETED|Overall Study||58||
60006974|NCT02257177|76122749|FG000|STARTED|Overall Study||4||
60006975|NCT02257177|76122750|FG001|STARTED|Overall Study||4||
60006976|NCT02257177|76122751|FG002|STARTED|Overall Study||4||
60006977|NCT02257177|76122752|FG003|STARTED|Overall Study||4||
60006978|NCT02257177|76122753|FG004|STARTED|Overall Study||4||
60006979|NCT02257177|76122754|FG005|STARTED|Overall Study||4||
60006980|NCT02257177|76122755|FG006|STARTED|Overall Study||12||
60006981|NCT02257177|76122756|FG007|STARTED|Overall Study||5||
60006982|NCT02257177|76122757|FG008|STARTED|Overall Study||5||
60006983|NCT02257177|76122758|FG009|STARTED|Overall Study||5||
60006984|NCT02257177|76122759|FG010|STARTED|Overall Study||9||
60006985|NCT02257177|76122749|FG000|COMPLETED|Overall Study||4||
60006986|NCT02257177|76122750|FG001|COMPLETED|Overall Study||4||
60006987|NCT02257177|76122751|FG002|COMPLETED|Overall Study||4||
60006988|NCT02257177|76122752|FG003|COMPLETED|Overall Study||4||
60006989|NCT02257177|76122753|FG004|COMPLETED|Overall Study||4||
60006990|NCT02257177|76122754|FG005|COMPLETED|Overall Study||4||
60006991|NCT02257177|76122755|FG006|COMPLETED|Overall Study||12||
60006992|NCT02257177|76122756|FG007|COMPLETED|Overall Study||5||
60006993|NCT02257177|76122757|FG008|COMPLETED|Overall Study||5||
60006994|NCT02257177|76122758|FG009|COMPLETED|Overall Study||4||
60006995|NCT02257177|76122759|FG010|COMPLETED|Overall Study||9||
60006996|NCT02257177|76122749|FG000|NOT COMPLETED|Overall Study||0||
60006997|NCT02257177|76122750|FG001|NOT COMPLETED|Overall Study||0||
60006998|NCT02257177|76122751|FG002|NOT COMPLETED|Overall Study||0||
60006999|NCT02257177|76122752|FG003|NOT COMPLETED|Overall Study||0||
60007000|NCT02257177|76122753|FG004|NOT COMPLETED|Overall Study||0||
60136062|NCT00731055|76258738|FG000|Received Placebo|Overall Study||16||
60136063|NCT00731055|76258738|FG000|Received Varenicline 0.5 mg|Overall Study||16||
60007001|NCT02257177|76122754|FG005|NOT COMPLETED|Overall Study||0||
60007002|NCT02257177|76122755|FG006|NOT COMPLETED|Overall Study||0||
60007003|NCT02257177|76122756|FG007|NOT COMPLETED|Overall Study||0||
60007004|NCT02257177|76122757|FG008|NOT COMPLETED|Overall Study||0||
60007005|NCT02257177|76122758|FG009|NOT COMPLETED|Overall Study||1||
60007006|NCT02257177|76122759|FG010|NOT COMPLETED|Overall Study||0||
60007007|NCT02203331|76122789|FG000|STARTED|Overall Study||52||
60007008|NCT02203331|76122790|FG001|STARTED|Overall Study||53||
60007009|NCT02203331|76122791|FG002|STARTED|Overall Study||55||
60007010|NCT02203331|76122792|FG003|STARTED|Overall Study||53||
60007011|NCT02203331|76122793|FG004|STARTED|Overall Study||53||
60007012|NCT02203331|76122794|FG005|STARTED|Overall Study||53||
60007013|NCT02203331|76122789|FG000|Treated|Overall Study||49||
60007014|NCT02203331|76122790|FG001|Treated|Overall Study||50||
60007015|NCT02203331|76122791|FG002|Treated|Overall Study||54||
60007016|NCT02203331|76122792|FG003|Treated|Overall Study||49||
60007017|NCT02203331|76122793|FG004|Treated|Overall Study||50||
60007018|NCT02203331|76122794|FG005|Treated|Overall Study||53||
60007019|NCT02203331|76122789|FG000|COMPLETED|Overall Study||45||
60007020|NCT02203331|76122790|FG001|COMPLETED|Overall Study||39||
60007021|NCT02203331|76122791|FG002|COMPLETED|Overall Study||50||
60007022|NCT02203331|76122792|FG003|COMPLETED|Overall Study||46||
60007023|NCT02203331|76122793|FG004|COMPLETED|Overall Study||46||
60007024|NCT02203331|76122794|FG005|COMPLETED|Overall Study||46||
60007025|NCT02203331|76122789|FG000|NOT COMPLETED|Overall Study||7||
60007026|NCT02203331|76122790|FG001|NOT COMPLETED|Overall Study||14||
60007027|NCT02203331|76122791|FG002|NOT COMPLETED|Overall Study||5||
60007028|NCT02203331|76122792|FG003|NOT COMPLETED|Overall Study||7||
60007029|NCT02203331|76122793|FG004|NOT COMPLETED|Overall Study||7||
60007030|NCT02203331|76122794|FG005|NOT COMPLETED|Overall Study||7||
60007031|NCT02178436|76122811|FG000|STARTED|Overall Study||9||
60007032|NCT02178436|76122812|FG001|STARTED|Overall Study||0||
60007033|NCT02178436|76122813|FG002|STARTED|Overall Study||4||
60007034|NCT02178436|76122811|FG000|COMPLETED|Overall Study||9||
60007035|NCT02178436|76122812|FG001|COMPLETED|Overall Study||0||
60007036|NCT02178436|76122813|FG002|COMPLETED|Overall Study||4||
60007037|NCT02178436|76122811|FG000|NOT COMPLETED|Overall Study||0||
60007038|NCT02178436|76122812|FG001|NOT COMPLETED|Overall Study||0||
60007039|NCT02178436|76122813|FG002|NOT COMPLETED|Overall Study||0||
60007040|NCT02170025|76122823|FG000|STARTED|Overall Study||14||
60007041|NCT02170025|76122824|FG001|STARTED|Overall Study||7||
60007042|NCT02170025|76122823|FG000|COMPLETED|Overall Study||12||
60007043|NCT02170025|76122824|FG001|COMPLETED|Overall Study||7||
60007044|NCT02170025|76122823|FG000|NOT COMPLETED|Overall Study||2||
60007045|NCT02170025|76122824|FG001|NOT COMPLETED|Overall Study||0||
60007046|NCT02164578|76122832|FG000|STARTED|Treatment Period||89||
60007047|NCT02164578|76122833|FG001|STARTED|Treatment Period||90||
60007048|NCT02164578|76122832|FG000|COMPLETED|Treatment Period||72||
60007049|NCT02164578|76122833|FG001|COMPLETED|Treatment Period||79||
60007050|NCT02164578|76122832|FG000|NOT COMPLETED|Treatment Period||17||
60007051|NCT02164578|76122833|FG001|NOT COMPLETED|Treatment Period||11||
60007052|NCT02164578|76122832|FG000|STARTED|Extension Period|37 of 40 planned patients continued treatment period and were included in the extension period|37|According to protocol only 80 patients were planned to participate in the extion period. In total, 73 subjects were included in the extension period.|
60007053|NCT02164578|76122833|FG001|STARTED|Extension Period|36 of 40 planned patients continued treatment period and were included in the extension period|36|According to protocol only 80 patients were planned to participate in the extion period. In total, 73 subjects were included in the extension period.|
60007054|NCT02164578|76122832|FG000|COMPLETED|Extension Period||30||
60007055|NCT02164578|76122833|FG001|COMPLETED|Extension Period||35||
60007056|NCT02164578|76122832|FG000|NOT COMPLETED|Extension Period||7||
60007057|NCT02164578|76122833|FG001|NOT COMPLETED|Extension Period||1||
60007058|NCT02107703|76122841|FG000|STARTED|Overall Study||446||
60007059|NCT02107703|76122842|FG001|STARTED|Overall Study||223||
60007060|NCT02107703|76122841|FG000|Received at Least 1 Dose of Study Drug|Overall Study||441||
60007061|NCT02107703|76122842|FG001|Received at Least 1 Dose of Study Drug|Overall Study||223||
60007062|NCT02107703|76122841|FG000|COMPLETED|Overall Study||332||
60007063|NCT02107703|76122842|FG001|COMPLETED|Overall Study||188||
60007064|NCT02107703|76122841|FG000|NOT COMPLETED|Overall Study||114||
60007065|NCT02107703|76122842|FG001|NOT COMPLETED|Overall Study||35||
60007066|NCT02054247|76122851|FG000|STARTED|Overall Study||15||
60007067|NCT02054247|76122852|FG001|STARTED|Overall Study||16||
60007068|NCT02054247|76122853|FG002|STARTED|Overall Study||15||
60007069|NCT02054247|76122851|FG000|COMPLETED|Overall Study||15||
60007070|NCT02054247|76122852|FG001|COMPLETED|Overall Study||16||
60007071|NCT02054247|76122853|FG002|COMPLETED|Overall Study||15||
60007072|NCT02054247|76122851|FG000|NOT COMPLETED|Overall Study||0||
60007073|NCT02054247|76122852|FG001|NOT COMPLETED|Overall Study||0||
60007074|NCT02054247|76122853|FG002|NOT COMPLETED|Overall Study||0||
60007075|NCT02029443|76122866|FG000|STARTED|Overall Study||134||
60007076|NCT02029443|76122867|FG001|STARTED|Overall Study||99||
60007077|NCT02029443|76122868|FG002|STARTED|Overall Study||33||
60007078|NCT02029443|76122869|FG003|STARTED|Overall Study||29||
60007079|NCT02029443|76122870|FG004|STARTED|Overall Study||6||
60007080|NCT02029443|76122866|FG000|COMPLETED|Overall Study||41||
60007081|NCT02029443|76122867|FG001|COMPLETED|Overall Study||70||
60007082|NCT02029443|76122868|FG002|COMPLETED|Overall Study||6||
60007083|NCT02029443|76122869|FG003|COMPLETED|Overall Study||3||
60007084|NCT02029443|76122870|FG004|COMPLETED|Overall Study||0||
60007085|NCT02029443|76122866|FG000|NOT COMPLETED|Overall Study||93||
60007086|NCT02029443|76122867|FG001|NOT COMPLETED|Overall Study||29||
60007087|NCT02029443|76122868|FG002|NOT COMPLETED|Overall Study||27||
60007088|NCT02029443|76122869|FG003|NOT COMPLETED|Overall Study||26||
60007089|NCT02029443|76122870|FG004|NOT COMPLETED|Overall Study||6||
60007090|NCT01823198|76122911|FG000|STARTED|Overall Study||6||
60007091|NCT01823198|76122912|FG001|STARTED|Overall Study||6||
60007092|NCT01823198|76122913|FG002|STARTED|Overall Study||4||
60007093|NCT01823198|76122914|FG003|STARTED|Overall Study||4||
60007094|NCT01823198|76122915|FG004|STARTED|Overall Study||1||
60007095|NCT01823198|76122916|FG005|STARTED|Overall Study||21||
60007096|NCT01823198|76122917|FG006|STARTED|Overall Study||21||
60007097|NCT01823198|76122911|FG000|COMPLETED|Overall Study||6||
60007098|NCT01823198|76122912|FG001|COMPLETED|Overall Study||5||
60007099|NCT01823198|76122913|FG002|COMPLETED|Overall Study||4||
60007100|NCT01823198|76122914|FG003|COMPLETED|Overall Study||4||
60007101|NCT01823198|76122915|FG004|COMPLETED|Overall Study||1||
60007102|NCT01823198|76122916|FG005|COMPLETED|Overall Study||18||
60007103|NCT01823198|76122917|FG006|COMPLETED|Overall Study||18||
60007104|NCT01823198|76122911|FG000|NOT COMPLETED|Overall Study||0||
60007105|NCT01823198|76122912|FG001|NOT COMPLETED|Overall Study||1||
60007106|NCT01823198|76122913|FG002|NOT COMPLETED|Overall Study||0||
60007107|NCT01823198|76122914|FG003|NOT COMPLETED|Overall Study||0||
60007108|NCT01823198|76122915|FG004|NOT COMPLETED|Overall Study||0||
60007109|NCT01823198|76122916|FG005|NOT COMPLETED|Overall Study||3||
60007110|NCT01823198|76122917|FG006|NOT COMPLETED|Overall Study||3||
60007111|NCT01761292|76122935|FG000|STARTED|Part 1||20||
60007112|NCT01761292|76122935|FG000|Patients Receiving Drug in Part 1|Part 1|One patient was enrolled in Part 1 and started treatment in Part 2.|19||
60007113|NCT01761292|76122935|FG000|COMPLETED|Part 1||18||
60007114|NCT01761292|76122935|FG000|NOT COMPLETED|Part 1||2||
60007115|NCT01761292|76122935|FG000|STARTED|Part 2|1 pt was enrolled in Part 1 but started the treatment in Part 2. So 19 pts started Part 2.|19||
60007116|NCT01761292|76122935|FG000|COMPLETED|Part 2||19||
60136064|NCT00731055|76258738|FG000|Received Varenicline 1.0 mg|Overall Study||16||
60136065|NCT00731055|76258738|FG000|Received Varenicline 2.0 mg|Overall Study||16||
60136066|NCT00731055|76258738|FG000|COMPLETED|Overall Study||16||
60136067|NCT00731055|76258738|FG000|NOT COMPLETED|Overall Study||0||
60136068|NCT01430585|76258745|FG000|STARTED|Overall Study||14||
60136069|NCT01430585|76258745|FG000|COMPLETED|Overall Study||0||
60136070|NCT01430585|76258745|FG000|NOT COMPLETED|Overall Study||14||
60136071|NCT04005859|76258757|FG000|STARTED|Overall Study||32||
60136072|NCT04005859|76258758|FG001|STARTED|Overall Study||29||
60136073|NCT04005859|76258757|FG000|COMPLETED|Overall Study||28||
59605640|NCT01989156|75715806|FG002|COMPLETED|End of Study (Population at Day 90)||31||
59605641|NCT01989156|75715804|FG000|NOT COMPLETED|End of Study (Population at Day 90)||7||
60007117|NCT01761292|76122935|FG000|NOT COMPLETED|Part 2||0||
60007118|NCT01761292|76122935|FG000|STARTED|Extension 1||19||
60007119|NCT01761292|76122935|FG000|COMPLETED|Extension 1||18||
60007120|NCT01761292|76122935|FG000|NOT COMPLETED|Extension 1||1||
60007121|NCT01761292|76122935|FG000|STARTED|Extension 2||18||
60007122|NCT01761292|76122935|FG000|COMPLETED|Extension 2||18||
60007123|NCT01761292|76122935|FG000|NOT COMPLETED|Extension 2||0||
60007124|NCT01761292|76122935|FG000|STARTED|Extension 3||18||
60007125|NCT01761292|76122935|FG000|COMPLETED|Extension 3||18||
60007126|NCT01761292|76122935|FG000|NOT COMPLETED|Extension 3||0||
60007127|NCT01725113|76122946|FG000|STARTED|Overall Study||6||
60007128|NCT01725113|76122947|FG001|STARTED|Overall Study||6||
60007129|NCT01725113|76122946|FG000|COMPLETED|Overall Study||5||
60007130|NCT01725113|76122947|FG001|COMPLETED|Overall Study||4||
60007131|NCT01725113|76122946|FG000|NOT COMPLETED|Overall Study||1||
60007132|NCT01725113|76122947|FG001|NOT COMPLETED|Overall Study||2||
60007133|NCT01580293|76122960|FG000|STARTED|Part A_Main Trial||20|Received Treatment|
60007134|NCT01580293|76122961|FG001|STARTED|Part A_Main Trial||114|Received Treatment|
60007135|NCT01580293|76122962|FG002|STARTED|Part A_Main Trial|Participants in Part B were not counted for Part A|0|Received Treatment|
60007136|NCT01580293|76122960|FG000|COMPLETED|Part A_Main Trial||18||
60007137|NCT01580293|76122961|FG001|COMPLETED|Part A_Main Trial||108||
60136074|NCT04005859|76258758|FG001|COMPLETED|Overall Study||25||
60007138|NCT01580293|76122962|FG002|COMPLETED|Part A_Main Trial||0||
60007139|NCT01580293|76122960|FG000|NOT COMPLETED|Part A_Main Trial||2||
60007140|NCT01580293|76122961|FG001|NOT COMPLETED|Part A_Main Trial||6||
60007141|NCT01580293|76122962|FG002|NOT COMPLETED|Part A_Main Trial||0||
60007142|NCT01580293|76122960|FG000|STARTED|Part A_Extension|Not all participants from main trial entered extension or remained in the same arm.|14||
60007143|NCT01580293|76122961|FG001|STARTED|Part A_Extension|Not all participants from main trial entered extension or remained in the same arm.|107||
60007144|NCT01580293|76122962|FG002|STARTED|Part A_Extension|Participants in Part B were not counted for part A|0||
60007145|NCT01580293|76122960|FG000|COMPLETED|Part A_Extension||14||
60007146|NCT01580293|76122961|FG001|COMPLETED|Part A_Extension||95||
60007147|NCT01580293|76122962|FG002|COMPLETED|Part A_Extension||0||
60007148|NCT01580293|76122960|FG000|NOT COMPLETED|Part A_Extension||0||
60007149|NCT01580293|76122961|FG001|NOT COMPLETED|Part A_Extension||12||
60007150|NCT01580293|76122962|FG002|NOT COMPLETED|Part A_Extension||0||
60007151|NCT01580293|76122960|FG000|STARTED|Part B|Time in Part A for 8 participants coming from Part A was not counted in part B.|0|Treated in Part B|
60007152|NCT01580293|76122961|FG001|STARTED|Part B|Time in Part A for 8 participants coming from Part A was not counted in part B.|0|Treated in Part B|
60007153|NCT01580293|76122962|FG002|STARTED|Part B|11 participants were enrolled in Part B only, 8 participants switched from Part A to Part B.|19|Treated in Part B|
60007154|NCT01580293|76122960|FG000|COMPLETED|Part B||0||
60007155|NCT01580293|76122961|FG001|COMPLETED|Part B||0||
60007156|NCT01580293|76122962|FG002|COMPLETED|Part B||17||
60007157|NCT01580293|76122960|FG000|NOT COMPLETED|Part B||0||
60007158|NCT01580293|76122961|FG001|NOT COMPLETED|Part B||0||
60007159|NCT01580293|76122962|FG002|NOT COMPLETED|Part B||2||
60136075|NCT04005859|76258757|FG000|NOT COMPLETED|Overall Study||4||
60136076|NCT04005859|76258758|FG001|NOT COMPLETED|Overall Study||4||
60136077|NCT01408901|76258768|FG000|STARTED|6-Week Follow-Up||53||
60136078|NCT01408901|76258769|FG001|STARTED|6-Week Follow-Up||53||
60136079|NCT01408901|76258770|FG002|STARTED|6-Week Follow-Up||53||
60136080|NCT01408901|76258771|FG003|STARTED|6-Week Follow-Up||51||
60136081|NCT01408901|76258768|FG000|COMPLETED|6-Week Follow-Up||50||
60136082|NCT01408901|76258769|FG001|COMPLETED|6-Week Follow-Up||51||
60136083|NCT01408901|76258770|FG002|COMPLETED|6-Week Follow-Up||50||
60136084|NCT01408901|76258771|FG003|COMPLETED|6-Week Follow-Up||47||
60136085|NCT01408901|76258768|FG000|NOT COMPLETED|6-Week Follow-Up||3||
60136086|NCT01408901|76258769|FG001|NOT COMPLETED|6-Week Follow-Up||2||
60136087|NCT01408901|76258770|FG002|NOT COMPLETED|6-Week Follow-Up||3||
60136088|NCT01408901|76258771|FG003|NOT COMPLETED|6-Week Follow-Up||4||
60136089|NCT01408901|76258768|FG000|STARTED|12-Week Follow-Up (Primary Endpoint)||50||
60136090|NCT01408901|76258769|FG001|STARTED|12-Week Follow-Up (Primary Endpoint)||52||
60136091|NCT01408901|76258770|FG002|STARTED|12-Week Follow-Up (Primary Endpoint)||50||
60136092|NCT01408901|76258771|FG003|STARTED|12-Week Follow-Up (Primary Endpoint)||49||
60136093|NCT01408901|76258768|FG000|COMPLETED|12-Week Follow-Up (Primary Endpoint)||49||
60136094|NCT01408901|76258769|FG001|COMPLETED|12-Week Follow-Up (Primary Endpoint)||50||
60136095|NCT01408901|76258770|FG002|COMPLETED|12-Week Follow-Up (Primary Endpoint)||50||
60136096|NCT01408901|76258771|FG003|COMPLETED|12-Week Follow-Up (Primary Endpoint)||46||
60136097|NCT01408901|76258768|FG000|NOT COMPLETED|12-Week Follow-Up (Primary Endpoint)||1||
60136098|NCT01408901|76258769|FG001|NOT COMPLETED|12-Week Follow-Up (Primary Endpoint)||2||
60136099|NCT01408901|76258770|FG002|NOT COMPLETED|12-Week Follow-Up (Primary Endpoint)||0||
60007160|NCT01089933|76122991|FG000|STARTED|Overall Study||65||
60007161|NCT01089933|76122992|FG001|STARTED|Overall Study||64||
60007162|NCT01089933|76122991|FG000|COMPLETED|Overall Study||65||
60007163|NCT01089933|76122992|FG001|COMPLETED|Overall Study||64||
60007164|NCT01089933|76122991|FG000|NOT COMPLETED|Overall Study||0||
60007165|NCT01089933|76122992|FG001|NOT COMPLETED|Overall Study||0||
60007166|NCT00208507|76123000|FG000|STARTED|Overall Study||177||
60007167|NCT00208507|76123001|FG001|STARTED|Overall Study||87||
60007168|NCT00208507|76123000|FG000|COMPLETED|Overall Study||163||
60007169|NCT00208507|76123001|FG001|COMPLETED|Overall Study||79||
60007170|NCT00208507|76123000|FG000|NOT COMPLETED|Overall Study||14||
60007171|NCT00208507|76123001|FG001|NOT COMPLETED|Overall Study||8||
60007172|NCT00167219|76123009|FG000|STARTED|Overall Study||15||
60007173|NCT00167219|76123009|FG000|COMPLETED|Overall Study||15||
60007174|NCT00167219|76123009|FG000|NOT COMPLETED|Overall Study||0||
60007175|NCT01960348|76123015|FG000|STARTED|Overall Study||148||
60007176|NCT01960348|76123016|FG001|STARTED|Overall Study||77||
60007177|NCT01960348|76123015|FG000|COMPLETED|Overall Study||138|Participants who completed this study could enter the extension study NCT02510261 (ALN-TTR02-006)|
60007178|NCT01960348|76123016|FG001|COMPLETED|Overall Study||55|Participants who completed this study could enter the extension study NCT02510261 (ALN-TTR02-006)|
60007179|NCT01960348|76123015|FG000|NOT COMPLETED|Overall Study||10||
60007180|NCT01960348|76123016|FG001|NOT COMPLETED|Overall Study||22||
60007181|NCT02653625|76123022|FG000|STARTED|Overall Study||24||
60136100|NCT01408901|76258771|FG003|NOT COMPLETED|12-Week Follow-Up (Primary Endpoint)||3||
60136101|NCT01408901|76258768|FG000|STARTED|26-Week Follow-Up||49||
60136102|NCT01408901|76258769|FG001|STARTED|26-Week Follow-Up||52||
59605642|NCT01989156|75715805|FG001|NOT COMPLETED|End of Study (Population at Day 90)||5||
60136103|NCT01408901|76258770|FG002|STARTED|26-Week Follow-Up||50||
60007182|NCT02653625|76123022|FG000|COMPLETED|Overall Study||20||
60007183|NCT02653625|76123022|FG000|NOT COMPLETED|Overall Study||4||
60007184|NCT01981096|76123028|FG000|STARTED|Overall Study||20||
60007185|NCT01981096|76123029|FG001|STARTED|Overall Study||20||
60007186|NCT01981096|76123028|FG000|Post-treatment|Overall Study||17||
60007187|NCT01981096|76123029|FG001|Post-treatment|Overall Study||19||
60007188|NCT01981096|76123028|FG000|COMPLETED|Overall Study||17||
60007189|NCT01981096|76123029|FG001|COMPLETED|Overall Study||19||
60007190|NCT01981096|76123028|FG000|NOT COMPLETED|Overall Study||3||
60007191|NCT01981096|76123029|FG001|NOT COMPLETED|Overall Study||1||
60007192|NCT02652767|76123035|FG000|STARTED|Overall Study||39||
60007193|NCT02652767|76123035|FG000|Completed Week 48|Overall Study||38||
60007194|NCT02652767|76123035|FG000|COMPLETED|Overall Study||35||
60007195|NCT02652767|76123035|FG000|NOT COMPLETED|Overall Study||4||
60007196|NCT01980940|76123049|FG000|STARTED|Overall Study||5||
60007197|NCT01980940|76123050|FG001|STARTED|Overall Study||5||
60007198|NCT01980940|76123051|FG002|STARTED|Overall Study||5||
60007199|NCT01980940|76123052|FG003|STARTED|Overall Study||3||
60007200|NCT01980940|76123053|FG004|STARTED|Overall Study||2||
60007201|NCT01980940|76123054|FG005|STARTED|Overall Study||2||
60007202|NCT01980940|76123055|FG006|STARTED|Overall Study||24||
60007203|NCT01980940|76123056|FG007|STARTED|Overall Study||24||
60007204|NCT01980940|76123049|FG000|Treated|Overall Study||5||
60007205|NCT01980940|76123050|FG001|Treated|Overall Study||5||
60007206|NCT01980940|76123051|FG002|Treated|Overall Study||5||
60007207|NCT01980940|76123052|FG003|Treated|Overall Study||3||
60007208|NCT01980940|76123053|FG004|Treated|Overall Study||2||
60007209|NCT01980940|76123054|FG005|Treated|Overall Study||2||
60007210|NCT01980940|76123055|FG006|Treated|Overall Study||24||
60007211|NCT01980940|76123056|FG007|Treated|Overall Study||24||
60007212|NCT01980940|76123049|FG000|COMPLETED|Overall Study||5||
60007213|NCT01980940|76123050|FG001|COMPLETED|Overall Study||5||
60007214|NCT01980940|76123051|FG002|COMPLETED|Overall Study||5||
60007215|NCT01980940|76123052|FG003|COMPLETED|Overall Study||3||
60007216|NCT01980940|76123053|FG004|COMPLETED|Overall Study||2||
60007217|NCT01980940|76123054|FG005|COMPLETED|Overall Study||0||
60007218|NCT01980940|76123055|FG006|COMPLETED|Overall Study||24||
60007219|NCT01980940|76123056|FG007|COMPLETED|Overall Study||24||
60007220|NCT01980940|76123049|FG000|NOT COMPLETED|Overall Study||0||
60007221|NCT01980940|76123050|FG001|NOT COMPLETED|Overall Study||0||
60007222|NCT01980940|76123051|FG002|NOT COMPLETED|Overall Study||0||
60007223|NCT01980940|76123052|FG003|NOT COMPLETED|Overall Study||0||
60007224|NCT01980940|76123053|FG004|NOT COMPLETED|Overall Study||0||
60007225|NCT01980940|76123054|FG005|NOT COMPLETED|Overall Study||2||
60007226|NCT01980940|76123055|FG006|NOT COMPLETED|Overall Study||0||
60007227|NCT01980940|76123056|FG007|NOT COMPLETED|Overall Study||0||
60007228|NCT02699983|76123082|FG000|STARTED|Overall Study||18||
60007229|NCT02699983|76123083|FG001|STARTED|Overall Study||17||
60007230|NCT02699983|76123082|FG000|COMPLETED|Overall Study||17||
60007231|NCT02699983|76123083|FG001|COMPLETED|Overall Study||17||
60007232|NCT02699983|76123082|FG000|NOT COMPLETED|Overall Study||1||
60007233|NCT02699983|76123083|FG001|NOT COMPLETED|Overall Study||0||
60007234|NCT01960114|76123095|FG000|STARTED|Overall Study||134||
60007235|NCT01960114|76123096|FG001|STARTED|Overall Study||269||
60007236|NCT01960114|76123095|FG000|COMPLETED|Overall Study||133||
60007237|NCT01960114|76123096|FG001|COMPLETED|Overall Study||268||
60007238|NCT01960114|76123095|FG000|NOT COMPLETED|Overall Study||1||
60007239|NCT01960114|76123096|FG001|NOT COMPLETED|Overall Study||1||
60007240|NCT02005276|76123106|FG000|STARTED|Overall Study||65||
60007241|NCT02005276|76123107|FG001|STARTED|Overall Study||41||
60007242|NCT02005276|76123108|FG002|STARTED|Overall Study||59||
60007243|NCT02005276|76123109|FG003|STARTED|Overall Study||44||
60007244|NCT02005276|76123106|FG000|Completed Intervention|Overall Study||61||
60007245|NCT02005276|76123107|FG001|Completed Intervention|Overall Study||39||
60007246|NCT02005276|76123108|FG002|Completed Intervention|Overall Study||56||
60007247|NCT02005276|76123109|FG003|Completed Intervention|Overall Study||42||
60007248|NCT02005276|76123106|FG000|COMPLETED|Overall Study||60|Completed follow-up|
60007249|NCT02005276|76123107|FG001|COMPLETED|Overall Study||39|Completed follow-up|
60007250|NCT02005276|76123108|FG002|COMPLETED|Overall Study||56|Completed follow-up|
60007251|NCT02005276|76123109|FG003|COMPLETED|Overall Study||41|Completed follow-up|
60007252|NCT02005276|76123106|FG000|NOT COMPLETED|Overall Study||5||
60007253|NCT02005276|76123107|FG001|NOT COMPLETED|Overall Study||2||
60007254|NCT02005276|76123108|FG002|NOT COMPLETED|Overall Study||3||
60007255|NCT02005276|76123109|FG003|NOT COMPLETED|Overall Study||3||
60007256|NCT01980706|76123124|FG000|STARTED|Overall Study||40||
60007257|NCT01980706|76123125|FG001|STARTED|Overall Study||43||
60007258|NCT01980706|76123126|FG002|STARTED|Overall Study||37||
60007259|NCT01980706|76123124|FG000|COMPLETED|Overall Study||23||
60007260|NCT01980706|76123125|FG001|COMPLETED|Overall Study||26||
60007261|NCT01980706|76123126|FG002|COMPLETED|Overall Study||24||
60007262|NCT01980706|76123124|FG000|NOT COMPLETED|Overall Study||17||
60007263|NCT01980706|76123125|FG001|NOT COMPLETED|Overall Study||17||
60007264|NCT01980706|76123126|FG002|NOT COMPLETED|Overall Study||13||
60007265|NCT02692417|76123136|FG000|STARTED|Overall Study||9||
60007266|NCT02692417|76123137|FG001|STARTED|Overall Study||7||
60007267|NCT02692417|76123136|FG000|COMPLETED|Overall Study||3||
60007268|NCT02692417|76123137|FG001|COMPLETED|Overall Study||6||
60007269|NCT02692417|76123136|FG000|NOT COMPLETED|Overall Study||6||
60007270|NCT02692417|76123137|FG001|NOT COMPLETED|Overall Study||1||
60007271|NCT02004886|76123147|FG000|STARTED|Overall Study||19||
60007272|NCT02004886|76123148|FG001|STARTED|Overall Study||18||
60007273|NCT02004886|76123149|FG002|STARTED|Overall Study||18||
60007274|NCT02004886|76123150|FG003|STARTED|Overall Study||19||
60007275|NCT02004886|76123147|FG000|COMPLETED|Overall Study||18||
60007276|NCT02004886|76123148|FG001|COMPLETED|Overall Study||17||
59605643|NCT01989156|75715806|FG002|NOT COMPLETED|End of Study (Population at Day 90)||3||
60007277|NCT02004886|76123149|FG002|COMPLETED|Overall Study||18||
60007278|NCT02004886|76123150|FG003|COMPLETED|Overall Study||19||
60007279|NCT02004886|76123147|FG000|NOT COMPLETED|Overall Study||1||
60007280|NCT02004886|76123148|FG001|NOT COMPLETED|Overall Study||1||
60007281|NCT02004886|76123149|FG002|NOT COMPLETED|Overall Study||0||
60007282|NCT02004886|76123150|FG003|NOT COMPLETED|Overall Study||0||
60007283|NCT01959880|76123164|FG000|STARTED|Overall Study||1132||
60007284|NCT01959880|76123165|FG001|STARTED|Overall Study||369||
60007285|NCT01959880|76123166|FG002|STARTED|Overall Study||209||
60007286|NCT01959880|76123167|FG003|STARTED|Overall Study||181||
60007287|NCT01959880|76123164|FG000|COMPLETED|Overall Study|FDA granted approval for devices leading to early study completion. One subject reached 10 years.|0||
60007288|NCT01959880|76123165|FG001|COMPLETED|Overall Study|FDA granted approval for devices leading to early study completion. One subject reached 10 years.|0||
60007289|NCT01959880|76123166|FG002|COMPLETED|Overall Study|FDA granted approval for devices leading to early study completion. One subject reached 10 years.|1||
60007290|NCT01959880|76123167|FG003|COMPLETED|Overall Study|FDA granted approval for devices leading to early study completion. One subject reached 10 years.|0||
60136104|NCT01408901|76258771|FG003|STARTED|26-Week Follow-Up||47||
60136105|NCT01408901|76258768|FG000|COMPLETED|26-Week Follow-Up||48||
60007291|NCT01959880|76123164|FG000|NOT COMPLETED|Overall Study||1132||
60007292|NCT01959880|76123165|FG001|NOT COMPLETED|Overall Study||369||
60007293|NCT01959880|76123166|FG002|NOT COMPLETED|Overall Study||208||
60007294|NCT01959880|76123167|FG003|NOT COMPLETED|Overall Study||181||
60007295|NCT01980628|76123177|FG000|STARTED|Overall Study|Total number of patients enrolled to the study and received study treatment|63||
60007296|NCT01980628|76123177|FG000|COMPLETED|Overall Study|Participants who remain on treatment at Final Analysis.|0||
60007297|NCT01980628|76123177|FG000|NOT COMPLETED|Overall Study||63||
60007298|NCT01979614|76123184|FG000|STARTED|Overall Study||30||
60007299|NCT01979614|76123185|FG001|STARTED|Overall Study||28||
60007300|NCT01979614|76123184|FG000|Safety Analysis Set|Overall Study||30||
60007301|NCT01979614|76123185|FG001|Safety Analysis Set|Overall Study||28||
60007302|NCT01979614|76123184|FG000|PK Analysis Set|Overall Study||30||
60007303|NCT01979614|76123185|FG001|PK Analysis Set|Overall Study||0||
60007304|NCT01979614|76123184|FG000|PD Analysis Set|Overall Study||25||
60007305|NCT01979614|76123185|FG001|PD Analysis Set|Overall Study||26||
60007306|NCT01979614|76123184|FG000|COMPLETED|Overall Study||29||
60007307|NCT01979614|76123185|FG001|COMPLETED|Overall Study||27||
60007308|NCT01979614|76123184|FG000|NOT COMPLETED|Overall Study||1||
60007309|NCT01979614|76123185|FG001|NOT COMPLETED|Overall Study||1||
60136106|NCT01408901|76258769|FG001|COMPLETED|26-Week Follow-Up||50||
60136107|NCT01408901|76258770|FG002|COMPLETED|26-Week Follow-Up||50||
59605644|NCT01620762|75715817|FG000|STARTED|Overall Study||468||
59605645|NCT01620762|75715818|FG001|STARTED|Overall Study||470||
59605646|NCT01620762|75715819|FG002|STARTED|Overall Study||470||
59605647|NCT01620762|75715817|FG000|COMPLETED|Overall Study||420||
59605648|NCT01620762|75715818|FG001|COMPLETED|Overall Study||412||
59605649|NCT01620762|75715819|FG002|COMPLETED|Overall Study||417||
60007310|NCT02654717|76123193|FG000|STARTED|Overall Study||56||
60007311|NCT02654717|76123194|FG001|STARTED|Overall Study||55||
60007312|NCT02654717|76123193|FG000|COMPLETED|Overall Study||50||
60007313|NCT02654717|76123194|FG001|COMPLETED|Overall Study||50||
60007314|NCT02654717|76123193|FG000|NOT COMPLETED|Overall Study||6||
60007315|NCT02654717|76123194|FG001|NOT COMPLETED|Overall Study||5||
60007316|NCT03343301|76123202|FG000|STARTED|Overall Study||3||
60007317|NCT03343301|76123203|FG001|STARTED|Overall Study||9||
60007318|NCT03343301|76123202|FG000|Received Any Study Treatment|Overall Study||3||
60007319|NCT03343301|76123203|FG001|Received Any Study Treatment|Overall Study||9||
60007320|NCT03343301|76123202|FG000|COMPLETED|Overall Study||0||
60007321|NCT03343301|76123203|FG001|COMPLETED|Overall Study||0||
60007322|NCT03343301|76123202|FG000|NOT COMPLETED|Overall Study||3||
60007323|NCT03343301|76123203|FG001|NOT COMPLETED|Overall Study||9||
60007324|NCT02696785|76123213|FG000|STARTED|Blinded Treatment Period||87||
60007325|NCT02696785|76123214|FG001|STARTED|Blinded Treatment Period||90||
60007326|NCT02696785|76123215|FG002|STARTED|Blinded Treatment Period||83||
60007327|NCT02696785|76123216|FG003|STARTED|Blinded Treatment Period||81||
60007328|NCT02696785|76123213|FG000|Received at Least One Dose of Study Drug|Blinded Treatment Period||86||
60007329|NCT02696785|76123214|FG001|Received at Least One Dose of Study Drug|Blinded Treatment Period||90||
60007330|NCT02696785|76123215|FG002|Received at Least One Dose of Study Drug|Blinded Treatment Period||83||
60007331|NCT02696785|76123216|FG003|Received at Least One Dose of Study Drug|Blinded Treatment Period||81||
60007332|NCT02696785|76123213|FG000|COMPLETED|Blinded Treatment Period||86||
60007333|NCT02696785|76123214|FG001|COMPLETED|Blinded Treatment Period||88||
60007334|NCT02696785|76123215|FG002|COMPLETED|Blinded Treatment Period||79||
60007335|NCT02696785|76123216|FG003|COMPLETED|Blinded Treatment Period||78||
60007336|NCT02696785|76123213|FG000|NOT COMPLETED|Blinded Treatment Period||1||
60007337|NCT02696785|76123214|FG001|NOT COMPLETED|Blinded Treatment Period||2||
60007338|NCT02696785|76123215|FG002|NOT COMPLETED|Blinded Treatment Period||4||
60007339|NCT02696785|76123216|FG003|NOT COMPLETED|Blinded Treatment Period||3||
60007340|NCT02696785|76123213|FG000|STARTED|Washout Period|Washout period occurred only for Adalimumab group.|0||
60007341|NCT02696785|76123214|FG001|STARTED|Washout Period||88||
60007342|NCT02696785|76123215|FG002|STARTED|Washout Period|Washout period occurred only for Adalimumab group.|0||
60007343|NCT02696785|76123216|FG003|STARTED|Washout Period|Washout period occurred only for Adalimumab group.|0||
60007344|NCT02696785|76123213|FG000|COMPLETED|Washout Period||0||
60007345|NCT02696785|76123214|FG001|COMPLETED|Washout Period||86||
60007346|NCT02696785|76123215|FG002|COMPLETED|Washout Period||0||
60007347|NCT02696785|76123216|FG003|COMPLETED|Washout Period||0||
60007348|NCT02696785|76123213|FG000|NOT COMPLETED|Washout Period||0||
60007349|NCT02696785|76123214|FG001|NOT COMPLETED|Washout Period||2||
60007350|NCT02696785|76123215|FG002|NOT COMPLETED|Washout Period||0||
60007351|NCT02696785|76123216|FG003|NOT COMPLETED|Washout Period||0||
59605650|NCT01620762|75715817|FG000|NOT COMPLETED|Overall Study||48||
59605651|NCT01620762|75715818|FG001|NOT COMPLETED|Overall Study||58||
60007352|NCT02696785|76123213|FG000|STARTED|Extended Treatment Period||86||
60007353|NCT02696785|76123214|FG001|STARTED|Extended Treatment Period||86||
60007354|NCT02696785|76123215|FG002|STARTED|Extended Treatment Period||79||
60007355|NCT02696785|76123216|FG003|STARTED|Extended Treatment Period||78||
60007356|NCT02696785|76123213|FG000|COMPLETED|Extended Treatment Period||83||
60007357|NCT02696785|76123214|FG001|COMPLETED|Extended Treatment Period||80||
60007358|NCT02696785|76123215|FG002|COMPLETED|Extended Treatment Period||74||
60007359|NCT02696785|76123216|FG003|COMPLETED|Extended Treatment Period||72||
60007360|NCT02696785|76123213|FG000|NOT COMPLETED|Extended Treatment Period||3||
59605652|NCT01620762|75715819|FG002|NOT COMPLETED|Overall Study||53||
60007361|NCT02696785|76123214|FG001|NOT COMPLETED|Extended Treatment Period||6||
60007362|NCT02696785|76123215|FG002|NOT COMPLETED|Extended Treatment Period||5||
60007363|NCT02696785|76123216|FG003|NOT COMPLETED|Extended Treatment Period||6||
60007364|NCT02696785|76123213|FG000|STARTED|Follow-up Period|Participants who completed study were eligible to enroll RHBY & who didn't enroll entered Follow-Up.|1||
60007365|NCT02696785|76123214|FG001|STARTED|Follow-up Period|Participants who completed study were eligible to enroll RHBY & who didn't enroll entered Follow-Up.|0||
60007366|NCT02696785|76123215|FG002|STARTED|Follow-up Period|Participants who completed study were eligible to enroll RHBY & who didn't enroll entered Follow-Up.|24||
60007367|NCT02696785|76123216|FG003|STARTED|Follow-up Period|Participants who completed study were eligible to enroll RHBY & who didn't enroll entered Follow-Up.|16||
60007368|NCT02696785|76123213|FG000|COMPLETED|Follow-up Period||0||
60007369|NCT02696785|76123214|FG001|COMPLETED|Follow-up Period||0||
60007370|NCT02696785|76123215|FG002|COMPLETED|Follow-up Period||11||
60007371|NCT02696785|76123216|FG003|COMPLETED|Follow-up Period||8||
60007372|NCT02696785|76123213|FG000|NOT COMPLETED|Follow-up Period||1||
60007373|NCT02696785|76123214|FG001|NOT COMPLETED|Follow-up Period||0||
60007374|NCT02696785|76123215|FG002|NOT COMPLETED|Follow-up Period||13||
60007375|NCT02696785|76123216|FG003|NOT COMPLETED|Follow-up Period||8||
60007376|NCT02004262|76123250|FG000|STARTED|Overall Study||73||
60007377|NCT02004262|76123251|FG001|STARTED|Overall Study||68||
60007378|NCT02004262|76123252|FG002|STARTED|Overall Study||72||
60007379|NCT02004262|76123253|FG003|STARTED|Overall Study||29||
60007380|NCT02004262|76123254|FG004|STARTED|Overall Study||31||
60007381|NCT02004262|76123255|FG005|STARTED|Overall Study||30||
60007382|NCT02004262|76123250|FG000|Treated|Overall Study||68||
60007383|NCT02004262|76123251|FG001|Treated|Overall Study||58||
60007384|NCT02004262|76123252|FG002|Treated|Overall Study||43||
60007385|NCT02004262|76123253|FG003|Treated|Overall Study||26||
60007386|NCT02004262|76123254|FG004|Treated|Overall Study||29||
60007387|NCT02004262|76123255|FG005|Treated|Overall Study||11||
60007388|NCT02004262|76123250|FG000|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0|No predetermined study completion date or study completion event specified in protocol.|
60007389|NCT02004262|76123251|FG001|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0|No predetermined study completion date or study completion event specified in protocol.|
60007390|NCT02004262|76123252|FG002|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0|No predetermined study completion date or study completion event specified in protocol.|
60007391|NCT02004262|76123253|FG003|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0|No predetermined study completion date or study completion event specified in protocol.|
60007392|NCT02004262|76123254|FG004|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0|No predetermined study completion date or study completion event specified in protocol.|
60007393|NCT02004262|76123255|FG005|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0|No predetermined study completion date or study completion event specified in protocol.|
60007394|NCT02004262|76123250|FG000|NOT COMPLETED|Overall Study||73||
60007395|NCT02004262|76123251|FG001|NOT COMPLETED|Overall Study||68||
60007396|NCT02004262|76123252|FG002|NOT COMPLETED|Overall Study||72||
60007397|NCT02004262|76123253|FG003|NOT COMPLETED|Overall Study||29||
60007398|NCT02004262|76123254|FG004|NOT COMPLETED|Overall Study||31||
60007399|NCT02004262|76123255|FG005|NOT COMPLETED|Overall Study||30||
60007400|NCT01675427|76123269|FG000|STARTED|Overall Study||4766||
60007401|NCT01675427|76123269|FG000|COMPLETED|Overall Study||4732||
60007402|NCT01675427|76123269|FG000|NOT COMPLETED|Overall Study||34||
60007403|NCT01978912|76123307|FG000|STARTED|Overall Study||6||
60007404|NCT01978912|76123308|FG001|STARTED|Overall Study||6||
60007405|NCT01978912|76123309|FG002|STARTED|Overall Study||6||
60007406|NCT01978912|76123310|FG003|STARTED|Overall Study||6||
60007407|NCT01978912|76123307|FG000|COMPLETED|Overall Study||3||
60007408|NCT01978912|76123308|FG001|COMPLETED|Overall Study||3||
60007409|NCT01978912|76123309|FG002|COMPLETED|Overall Study||3||
60007410|NCT01978912|76123310|FG003|COMPLETED|Overall Study||3||
60007411|NCT01978912|76123307|FG000|NOT COMPLETED|Overall Study||3||
60007412|NCT01978912|76123308|FG001|NOT COMPLETED|Overall Study||3||
60007413|NCT01978912|76123309|FG002|NOT COMPLETED|Overall Study||3||
60007414|NCT01978912|76123310|FG003|NOT COMPLETED|Overall Study||3||
60007415|NCT01977898|76123322|FG000|STARTED|Overall Study||28||
60007416|NCT01977898|76123323|FG001|STARTED|Overall Study||35||
60007417|NCT01977898|76123322|FG000|COMPLETED|Overall Study||27||
60007418|NCT01977898|76123323|FG001|COMPLETED|Overall Study||34||
60007419|NCT01977898|76123322|FG000|NOT COMPLETED|Overall Study||1||
60007420|NCT01977898|76123323|FG001|NOT COMPLETED|Overall Study||1||
60007421|NCT02003638|76123331|FG000|STARTED|Overall Study||6||
60007422|NCT02003638|76123332|FG001|STARTED|Overall Study||3||
60007423|NCT02003638|76123331|FG000|COMPLETED|Overall Study|1 withdrew after developing bacterial pharyngitis. Not considered treatment-emergent.|5||
60007424|NCT02003638|76123332|FG001|COMPLETED|Overall Study||3||
60007425|NCT02003638|76123331|FG000|NOT COMPLETED|Overall Study||1||
60007426|NCT02003638|76123332|FG001|NOT COMPLETED|Overall Study||0||
60007427|NCT02696317|76123338|FG000|STARTED|Habitual, 10 Days of Wear||42||
60007428|NCT02696317|76123339|FG001|STARTED|Habitual, 10 Days of Wear||40||
60007429|NCT02696317|76123338|FG000|COMPLETED|Habitual, 10 Days of Wear||40||
60007430|NCT02696317|76123339|FG001|COMPLETED|Habitual, 10 Days of Wear||36||
60007431|NCT02696317|76123338|FG000|NOT COMPLETED|Habitual, 10 Days of Wear||2||
60007432|NCT02696317|76123339|FG001|NOT COMPLETED|Habitual, 10 Days of Wear||4||
60007433|NCT02696317|76123338|FG000|STARTED|Period 1, 10 Days of Wear||40||
60007434|NCT02696317|76123339|FG001|STARTED|Period 1, 10 Days of Wear||36||
60007435|NCT02696317|76123338|FG000|COMPLETED|Period 1, 10 Days of Wear||40||
60007436|NCT02696317|76123339|FG001|COMPLETED|Period 1, 10 Days of Wear||36||
60007437|NCT02696317|76123338|FG000|NOT COMPLETED|Period 1, 10 Days of Wear||0||
60007438|NCT02696317|76123339|FG001|NOT COMPLETED|Period 1, 10 Days of Wear||0||
60007439|NCT02696317|76123338|FG000|STARTED|Period 2, 10 Days of Wear||40||
60007440|NCT02696317|76123339|FG001|STARTED|Period 2, 10 Days of Wear||36||
60007441|NCT02696317|76123338|FG000|COMPLETED|Period 2, 10 Days of Wear||39||
60007442|NCT02696317|76123339|FG001|COMPLETED|Period 2, 10 Days of Wear||36||
60007443|NCT02696317|76123338|FG000|NOT COMPLETED|Period 2, 10 Days of Wear||1||
60007444|NCT02696317|76123339|FG001|NOT COMPLETED|Period 2, 10 Days of Wear||0||
60007445|NCT01959412|76123347|FG000|STARTED|Overall Study||15||
60007446|NCT01959412|76123348|FG001|STARTED|Overall Study||15||
60007447|NCT01959412|76123349|FG002|STARTED|Overall Study||15||
60007448|NCT01959412|76123350|FG003|STARTED|Overall Study||15||
60007449|NCT01959412|76123351|FG004|STARTED|Overall Study||16||
60007450|NCT01959412|76123352|FG005|STARTED|Overall Study||15||
60007451|NCT01959412|76123347|FG000|COMPLETED|Overall Study||14||
60007452|NCT01959412|76123348|FG001|COMPLETED|Overall Study||14||
60007453|NCT01959412|76123349|FG002|COMPLETED|Overall Study||15||
60007454|NCT01959412|76123350|FG003|COMPLETED|Overall Study||13||
60007455|NCT01959412|76123351|FG004|COMPLETED|Overall Study||13||
60007456|NCT01959412|76123352|FG005|COMPLETED|Overall Study||15||
60007457|NCT01959412|76123347|FG000|NOT COMPLETED|Overall Study||1||
60007458|NCT01959412|76123348|FG001|NOT COMPLETED|Overall Study||1||
60007459|NCT01959412|76123349|FG002|NOT COMPLETED|Overall Study||0||
60007460|NCT01959412|76123350|FG003|NOT COMPLETED|Overall Study||2||
60007461|NCT01959412|76123351|FG004|NOT COMPLETED|Overall Study||3||
60007462|NCT01959412|76123352|FG005|NOT COMPLETED|Overall Study||0||
60007463|NCT01977820|76123368|FG000|STARTED|Overall Study||1||
60007464|NCT01977820|76123369|FG001|STARTED|Overall Study||1||
60007465|NCT01977820|76123368|FG000|COMPLETED|Overall Study||0||
60007466|NCT01977820|76123369|FG001|COMPLETED|Overall Study||0||
60007467|NCT01977820|76123368|FG000|NOT COMPLETED|Overall Study||1||
60007468|NCT01977820|76123369|FG001|NOT COMPLETED|Overall Study||1||
60007469|NCT02003014|76123375|FG000|STARTED|Overall Study||899||
60007470|NCT02003014|76123375|FG000|COMPLETED|Overall Study||880||
60007471|NCT02003014|76123375|FG000|NOT COMPLETED|Overall Study||19||
60007472|NCT01977352|76123381|FG000|STARTED|Overall Study||21||
60007473|NCT01977352|76123382|FG001|STARTED|Overall Study||21||
60007474|NCT01977352|76123381|FG000|COMPLETED|Overall Study||20||
60007475|NCT01977352|76123382|FG001|COMPLETED|Overall Study||19||
60007476|NCT01977352|76123381|FG000|NOT COMPLETED|Overall Study||1||
60007477|NCT01977352|76123382|FG001|NOT COMPLETED|Overall Study||2||
60007478|NCT02001688|76123391|FG000|STARTED|Overall Study||12||
60007479|NCT02001688|76123392|FG001|STARTED|Overall Study||12||
60007480|NCT02001688|76123393|FG002|STARTED|Overall Study||12||
60007481|NCT02001688|76123391|FG000|COMPLETED|Overall Study||12||
60007482|NCT02001688|76123392|FG001|COMPLETED|Overall Study||11||
60007483|NCT02001688|76123393|FG002|COMPLETED|Overall Study||11||
60007484|NCT02001688|76123391|FG000|NOT COMPLETED|Overall Study||0||
60007485|NCT02001688|76123392|FG001|NOT COMPLETED|Overall Study||1||
60007486|NCT02001688|76123393|FG002|NOT COMPLETED|Overall Study||1||
60007487|NCT02001064|76123404|FG000|STARTED|Overall Study||30||
60007488|NCT02001064|76123405|FG001|STARTED|Overall Study||30||
60007489|NCT02001064|76123404|FG000|COMPLETED|Overall Study||28||
60007490|NCT02001064|76123405|FG001|COMPLETED|Overall Study||29||
60007491|NCT02001064|76123404|FG000|NOT COMPLETED|Overall Study||2||
60007492|NCT02001064|76123405|FG001|NOT COMPLETED|Overall Study||1||
60007493|NCT02000752|76123413|FG000|STARTED|Overall Study||60||
60007494|NCT02000752|76123414|FG001|STARTED|Overall Study||60||
60007495|NCT02000752|76123413|FG000|COMPLETED|Overall Study||29||
60007496|NCT02000752|76123414|FG001|COMPLETED|Overall Study||47||
60007497|NCT02000752|76123413|FG000|NOT COMPLETED|Overall Study||31||
60007498|NCT02000752|76123414|FG001|NOT COMPLETED|Overall Study||13||
60007499|NCT02000440|76123420|FG000|STARTED|Overall Study||17||
60007500|NCT02000440|76123420|FG000|COMPLETED|Overall Study||13||
60007501|NCT02000440|76123420|FG000|NOT COMPLETED|Overall Study||4||
60007502|NCT02687815|76123426|FG000|STARTED|Overall Study||96||
60007503|NCT02687815|76123427|FG001|STARTED|Overall Study||96||
60007504|NCT02687815|76123426|FG000|COMPLETED|Overall Study||92||
60007505|NCT02687815|76123427|FG001|COMPLETED|Overall Study||88||
60007506|NCT02687815|76123426|FG000|NOT COMPLETED|Overall Study||4||
60007507|NCT02687815|76123427|FG001|NOT COMPLETED|Overall Study||8||
59519072|NCT01093417|75612950|FG000|STARTED|Overall Study||15||
60007508|NCT01959334|76123435|FG000|STARTED|First Dose||26||
60007509|NCT01959334|76123436|FG001|STARTED|First Dose||49||
60007510|NCT01959334|76123435|FG000|COMPLETED|First Dose|Each Dosing Period separated by at least 7 calendar days.|26||
60007511|NCT01959334|76123436|FG001|COMPLETED|First Dose|Each Dosing Period is separated by at least 7 calendar days.|49||
60007512|NCT01959334|76123435|FG000|NOT COMPLETED|First Dose||0||
60007513|NCT01959334|76123436|FG001|NOT COMPLETED|First Dose||0||
60007514|NCT01959334|76123435|FG000|STARTED|Second Dose||26||
60007515|NCT01959334|76123436|FG001|STARTED|Second Dose||49||
60007516|NCT01959334|76123435|FG000|COMPLETED|Second Dose||25||
60007517|NCT01959334|76123436|FG001|COMPLETED|Second Dose||49||
60007518|NCT01959334|76123435|FG000|NOT COMPLETED|Second Dose||1||
60007519|NCT01959334|76123436|FG001|NOT COMPLETED|Second Dose||0||
60007520|NCT01959334|76123435|FG000|STARTED|Third Dose||25||
60007521|NCT01959334|76123436|FG001|STARTED|Third Dose||49||
60007522|NCT01959334|76123435|FG000|COMPLETED|Third Dose||25||
60007523|NCT01959334|76123436|FG001|COMPLETED|Third Dose||48||
60007524|NCT01959334|76123435|FG000|NOT COMPLETED|Third Dose||0||
60007525|NCT01959334|76123436|FG001|NOT COMPLETED|Third Dose||1||
60007526|NCT02687581|76123446|FG000|STARTED|Overall Study||6||
60007527|NCT02687581|76123447|FG001|STARTED|Overall Study||6||
60007528|NCT02687581|76123448|FG002|STARTED|Overall Study||2||
60007529|NCT02687581|76123449|FG003|STARTED|Overall Study||4||
60007530|NCT02687581|76123446|FG000|COMPLETED|Overall Study||2||
60007531|NCT02687581|76123447|FG001|COMPLETED|Overall Study||4||
60007532|NCT02687581|76123448|FG002|COMPLETED|Overall Study||2||
60007533|NCT02687581|76123449|FG003|COMPLETED|Overall Study||3||
60007534|NCT02687581|76123446|FG000|NOT COMPLETED|Overall Study||4||
60007535|NCT02687581|76123447|FG001|NOT COMPLETED|Overall Study||2||
60007536|NCT02687581|76123448|FG002|NOT COMPLETED|Overall Study||0||
60007537|NCT02687581|76123449|FG003|NOT COMPLETED|Overall Study||1||
60007538|NCT01977040|76123459|FG000|STARTED|Overall Study||68||
60007539|NCT01977040|76123459|FG000|COMPLETED|Overall Study||66||
60007540|NCT01977040|76123459|FG000|NOT COMPLETED|Overall Study||2||
60007541|NCT01958476|76123469|FG000|STARTED|Overall Study||59||
60007542|NCT01958476|76123470|FG001|STARTED|Overall Study||58||
60007543|NCT01958476|76123469|FG000|COMPLETED|Overall Study||58||
60007544|NCT01958476|76123470|FG001|COMPLETED|Overall Study||58||
60007545|NCT01958476|76123469|FG000|NOT COMPLETED|Overall Study||1||
60007546|NCT01958476|76123470|FG001|NOT COMPLETED|Overall Study||0||
60007547|NCT01057121|76123478|FG000|STARTED|Phase I: 10 mg/Day Lenalidomide||3||
60007548|NCT01057121|76123479|FG001|STARTED|Phase I: 10 mg/Day Lenalidomide||0||
60007549|NCT01057121|76123480|FG002|STARTED|Phase I: 10 mg/Day Lenalidomide||0||
60007550|NCT01057121|76123481|FG003|STARTED|Phase I: 10 mg/Day Lenalidomide||0||
60007551|NCT01057121|76123482|FG004|STARTED|Phase I: 10 mg/Day Lenalidomide||0||
60007552|NCT01057121|76123478|FG000|COMPLETED|Phase I: 10 mg/Day Lenalidomide||3||
60007553|NCT01057121|76123479|FG001|COMPLETED|Phase I: 10 mg/Day Lenalidomide||0||
60007554|NCT01057121|76123480|FG002|COMPLETED|Phase I: 10 mg/Day Lenalidomide||0||
60007555|NCT01057121|76123481|FG003|COMPLETED|Phase I: 10 mg/Day Lenalidomide||0||
60007556|NCT01057121|76123482|FG004|COMPLETED|Phase I: 10 mg/Day Lenalidomide||0||
60007557|NCT01057121|76123478|FG000|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0||
60007558|NCT01057121|76123479|FG001|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0||
60007559|NCT01057121|76123480|FG002|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0||
60007560|NCT01057121|76123481|FG003|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0||
59881221|NCT02792062|76004177|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0||
59881222|NCT02792062|76004178|FG002|NOT COMPLETED|Washout Period (at Least 14 Days)||0||
59881223|NCT02792062|76004179|FG003|NOT COMPLETED|Washout Period (at Least 14 Days)||0||
59881224|NCT02792062|76004180|FG004|NOT COMPLETED|Washout Period (at Least 14 Days)||0||
59881225|NCT02792062|76004181|FG005|NOT COMPLETED|Washout Period (at Least 14 Days)||0||
59881226|NCT02792062|76004176|FG000|STARTED|Intervention Period 2 (6 Days)||2||
59881227|NCT02792062|76004177|FG001|STARTED|Intervention Period 2 (6 Days)||2||
59881228|NCT02792062|76004178|FG002|STARTED|Intervention Period 2 (6 Days)||2||
59881229|NCT02792062|76004179|FG003|STARTED|Intervention Period 2 (6 Days)||2||
59751212|NCT00659425|75870416|FG004|NOT COMPLETED|Overall Study||4||
59751213|NCT00659425|75870417|FG005|NOT COMPLETED|Overall Study||4||
59751214|NCT00659425|75870418|FG006|NOT COMPLETED|Overall Study||8||
59881230|NCT02792062|76004180|FG004|STARTED|Intervention Period 2 (6 Days)||2||
59881231|NCT02792062|76004181|FG005|STARTED|Intervention Period 2 (6 Days)||2||
59881232|NCT02792062|76004176|FG000|COMPLETED|Intervention Period 2 (6 Days)||2||
59881233|NCT02792062|76004177|FG001|COMPLETED|Intervention Period 2 (6 Days)||2||
60007561|NCT01057121|76123482|FG004|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0||
60007562|NCT01057121|76123478|FG000|STARTED|Phase I: 15 mg/Day Lenolidomide||0||
60007563|NCT01057121|76123479|FG001|STARTED|Phase I: 15 mg/Day Lenolidomide||3||
60007564|NCT01057121|76123480|FG002|STARTED|Phase I: 15 mg/Day Lenolidomide||0||
60007565|NCT01057121|76123481|FG003|STARTED|Phase I: 15 mg/Day Lenolidomide||0||
60007566|NCT01057121|76123482|FG004|STARTED|Phase I: 15 mg/Day Lenolidomide||0||
60007567|NCT01057121|76123478|FG000|COMPLETED|Phase I: 15 mg/Day Lenolidomide||0||
60007568|NCT01057121|76123479|FG001|COMPLETED|Phase I: 15 mg/Day Lenolidomide||3||
60007569|NCT01057121|76123480|FG002|COMPLETED|Phase I: 15 mg/Day Lenolidomide||0||
59751215|NCT00659425|75870419|FG007|NOT COMPLETED|Overall Study||11||
59751216|NCT00659425|75870420|FG008|NOT COMPLETED|Overall Study||6||
59751217|NCT00659425|75870421|FG009|NOT COMPLETED|Overall Study||13||
59751218|NCT00656851|75870458|FG000|STARTED|Overall Study||12||
59751219|NCT00656851|75870459|FG001|STARTED|Overall Study||12||
59751220|NCT00656851|75870458|FG000|COMPLETED|Overall Study||12||
59751221|NCT00656851|75870459|FG001|COMPLETED|Overall Study||8||
59751222|NCT00656851|75870458|FG000|NOT COMPLETED|Overall Study||0||
59751223|NCT00656851|75870459|FG001|NOT COMPLETED|Overall Study||4||
59751224|NCT00656617|75870465|FG000|STARTED|Overall Study||106||
59751225|NCT00656617|75870465|FG000|Run-in Induction Phase|Overall Study|Initial run-in: Vorinostat induction dose 500 mg orally three times daily for 3 days.|3||
60007570|NCT01057121|76123481|FG003|COMPLETED|Phase I: 15 mg/Day Lenolidomide||0||
60007571|NCT01057121|76123482|FG004|COMPLETED|Phase I: 15 mg/Day Lenolidomide||0||
60007572|NCT01057121|76123478|FG000|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0||
60007573|NCT01057121|76123479|FG001|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0||
60007574|NCT01057121|76123480|FG002|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0||
60007575|NCT01057121|76123481|FG003|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0||
60007576|NCT01057121|76123482|FG004|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0||
60007577|NCT01057121|76123478|FG000|STARTED|Phase I: 20 mg/Day Lenalidomide||0||
60007578|NCT01057121|76123479|FG001|STARTED|Phase I: 20 mg/Day Lenalidomide||0||
60007579|NCT01057121|76123480|FG002|STARTED|Phase I: 20 mg/Day Lenalidomide||3||
60007580|NCT01057121|76123481|FG003|STARTED|Phase I: 20 mg/Day Lenalidomide||0||
60007581|NCT01057121|76123482|FG004|STARTED|Phase I: 20 mg/Day Lenalidomide||0||
60007582|NCT01057121|76123478|FG000|COMPLETED|Phase I: 20 mg/Day Lenalidomide||0||
60007583|NCT01057121|76123479|FG001|COMPLETED|Phase I: 20 mg/Day Lenalidomide||0||
60007584|NCT01057121|76123480|FG002|COMPLETED|Phase I: 20 mg/Day Lenalidomide||3||
60007585|NCT01057121|76123481|FG003|COMPLETED|Phase I: 20 mg/Day Lenalidomide||0||
60007586|NCT01057121|76123482|FG004|COMPLETED|Phase I: 20 mg/Day Lenalidomide||0||
60007587|NCT01057121|76123478|FG000|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0||
60007588|NCT01057121|76123479|FG001|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0||
60007589|NCT01057121|76123480|FG002|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0||
60007590|NCT01057121|76123481|FG003|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0||
60007591|NCT01057121|76123482|FG004|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0||
60007592|NCT01057121|76123478|FG000|STARTED|Phase I: 25 mg/Day Lenalidomide||0||
60007593|NCT01057121|76123479|FG001|STARTED|Phase I: 25 mg/Day Lenalidomide||0||
60007594|NCT01057121|76123480|FG002|STARTED|Phase I: 25 mg/Day Lenalidomide||0||
60007595|NCT01057121|76123481|FG003|STARTED|Phase I: 25 mg/Day Lenalidomide||6||
60007596|NCT01057121|76123482|FG004|STARTED|Phase I: 25 mg/Day Lenalidomide||0||
60007597|NCT01057121|76123478|FG000|COMPLETED|Phase I: 25 mg/Day Lenalidomide||0||
60007598|NCT01057121|76123479|FG001|COMPLETED|Phase I: 25 mg/Day Lenalidomide||0||
60007599|NCT01057121|76123480|FG002|COMPLETED|Phase I: 25 mg/Day Lenalidomide||0||
60007600|NCT01057121|76123481|FG003|COMPLETED|Phase I: 25 mg/Day Lenalidomide||6||
60007601|NCT01057121|76123482|FG004|COMPLETED|Phase I: 25 mg/Day Lenalidomide||0||
60007602|NCT01057121|76123478|FG000|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0||
60007603|NCT01057121|76123479|FG001|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0||
60007604|NCT01057121|76123480|FG002|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0||
60007605|NCT01057121|76123481|FG003|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0||
60007606|NCT01057121|76123482|FG004|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0||
60007607|NCT01057121|76123478|FG000|STARTED|Phase II: 25 mg/Day Lenalidomide||0||
60007608|NCT01057121|76123479|FG001|STARTED|Phase II: 25 mg/Day Lenalidomide||0||
60007609|NCT01057121|76123480|FG002|STARTED|Phase II: 25 mg/Day Lenalidomide||0||
60007610|NCT01057121|76123481|FG003|STARTED|Phase II: 25 mg/Day Lenalidomide||0||
60007611|NCT01057121|76123482|FG004|STARTED|Phase II: 25 mg/Day Lenalidomide||23||
60007612|NCT01057121|76123478|FG000|COMPLETED|Phase II: 25 mg/Day Lenalidomide||0||
60007613|NCT01057121|76123479|FG001|COMPLETED|Phase II: 25 mg/Day Lenalidomide||0||
60007614|NCT01057121|76123480|FG002|COMPLETED|Phase II: 25 mg/Day Lenalidomide||0||
60007615|NCT01057121|76123481|FG003|COMPLETED|Phase II: 25 mg/Day Lenalidomide||0||
60007616|NCT01057121|76123482|FG004|COMPLETED|Phase II: 25 mg/Day Lenalidomide||23||
60007617|NCT01057121|76123478|FG000|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0||
60007618|NCT01057121|76123479|FG001|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0||
60007619|NCT01057121|76123480|FG002|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0||
60007620|NCT01057121|76123481|FG003|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0||
60007621|NCT01057121|76123482|FG004|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0||
60007622|NCT02695537|76123506|FG000|STARTED|Overall Study||89||
60007623|NCT02695537|76123506|FG000|COMPLETED|Overall Study||51||
60007624|NCT02695537|76123506|FG000|NOT COMPLETED|Overall Study||38||
60007625|NCT02691247|76123513|FG000|STARTED|Overall Study||40||
60007626|NCT02691247|76123514|FG001|STARTED|Overall Study||24||
60007627|NCT02691247|76123515|FG002|STARTED|Overall Study||46||
60007628|NCT02691247|76123513|FG000|COMPLETED|Overall Study||37||
60007629|NCT02691247|76123514|FG001|COMPLETED|Overall Study||22||
60007630|NCT02691247|76123515|FG002|COMPLETED|Overall Study||43||
60007631|NCT02691247|76123513|FG000|NOT COMPLETED|Overall Study||3||
60007632|NCT02691247|76123514|FG001|NOT COMPLETED|Overall Study||2||
60007633|NCT02691247|76123515|FG002|NOT COMPLETED|Overall Study||3||
60007634|NCT01362491|76123526|FG000|STARTED|Overall Study||91||
60007635|NCT01362491|76123527|FG001|STARTED|Overall Study||89||
60007636|NCT01362491|76123528|FG002|STARTED|Overall Study||46||
60007637|NCT01362491|76123526|FG000|COMPLETED|Overall Study||90||
60007638|NCT01362491|76123527|FG001|COMPLETED|Overall Study||89||
60007639|NCT01362491|76123528|FG002|COMPLETED|Overall Study||46||
60007640|NCT01362491|76123526|FG000|NOT COMPLETED|Overall Study||1||
60007641|NCT01362491|76123527|FG001|NOT COMPLETED|Overall Study||0||
60007642|NCT01362491|76123528|FG002|NOT COMPLETED|Overall Study||0||
60007643|NCT02687191|76123543|FG000|STARTED|Overall Study||3||
60007644|NCT02687191|76123544|FG001|STARTED|Overall Study||3||
60007645|NCT02687191|76123545|FG002|STARTED|Overall Study||3||
60007646|NCT02687191|76123546|FG003|STARTED|Overall Study||6||
60007647|NCT02687191|76123547|FG004|STARTED|Overall Study||3||
60007648|NCT02687191|76123548|FG005|STARTED|Overall Study||3||
60007649|NCT02687191|76123543|FG000|COMPLETED|Overall Study||3||
60007650|NCT02687191|76123544|FG001|COMPLETED|Overall Study||2||
60007651|NCT02687191|76123545|FG002|COMPLETED|Overall Study||2||
60007652|NCT02687191|76123546|FG003|COMPLETED|Overall Study||5||
60007653|NCT02687191|76123547|FG004|COMPLETED|Overall Study||2||
60007654|NCT02687191|76123548|FG005|COMPLETED|Overall Study||2||
60007655|NCT02687191|76123543|FG000|NOT COMPLETED|Overall Study||0||
60007656|NCT02687191|76123544|FG001|NOT COMPLETED|Overall Study||1||
60007657|NCT02687191|76123545|FG002|NOT COMPLETED|Overall Study||1||
60007658|NCT02687191|76123546|FG003|NOT COMPLETED|Overall Study||1||
60007659|NCT02687191|76123547|FG004|NOT COMPLETED|Overall Study||1||
60007660|NCT02687191|76123548|FG005|NOT COMPLETED|Overall Study||1||
60007661|NCT02687035|76123562|FG000|STARTED|Overall Study||1822||
60007662|NCT02687035|76123562|FG000|COMPLETED|Overall Study||1638||
60007663|NCT02687035|76123562|FG000|NOT COMPLETED|Overall Study||184||
60007664|NCT02691013|76123568|FG000|STARTED|Overall Study||61||
60007665|NCT02691013|76123569|FG001|STARTED|Overall Study||59||
60007666|NCT02691013|76123568|FG000|COMPLETED|Overall Study||58||
60007667|NCT02691013|76123569|FG001|COMPLETED|Overall Study||59||
60007668|NCT02691013|76123568|FG000|NOT COMPLETED|Overall Study||3||
60007669|NCT02691013|76123569|FG001|NOT COMPLETED|Overall Study||0||
60007670|NCT02690701|76123579|FG000|STARTED|Treatment Period 1||46|46|
60007671|NCT02690701|76123580|FG001|STARTED|Treatment Period 1||45|46|
60007672|NCT02690701|76123579|FG000|COMPLETED|Treatment Period 1||44|44|
60007673|NCT02690701|76123580|FG001|COMPLETED|Treatment Period 1||42|44|
60007674|NCT02690701|76123579|FG000|NOT COMPLETED|Treatment Period 1||2||
60007675|NCT02690701|76123580|FG001|NOT COMPLETED|Treatment Period 1||3||
60007676|NCT02690701|76123579|FG000|STARTED|Treatment Period 2|Completed Treatment Period 1 and continued to Treatment Period 2|44|44|
60007677|NCT02690701|76123580|FG001|STARTED|Treatment Period 2||42|44|
60007678|NCT02690701|76123579|FG000|COMPLETED|Treatment Period 2|Completed Treatment Period 2|41|41|
60136108|NCT01408901|76258771|FG003|COMPLETED|26-Week Follow-Up||46||
60007679|NCT02690701|76123580|FG001|COMPLETED|Treatment Period 2||37|41|
60007680|NCT02690701|76123579|FG000|NOT COMPLETED|Treatment Period 2||3||
60007681|NCT02690701|76123580|FG001|NOT COMPLETED|Treatment Period 2||5||
60007682|NCT02694757|76123587|FG000|STARTED|Overall Study||3||
60007683|NCT02694757|76123587|FG000|COMPLETED|Overall Study||0||
60007684|NCT02694757|76123587|FG000|NOT COMPLETED|Overall Study||3||
60007685|NCT03805841|76123594|FG000|STARTED|Overall Study||11||
60007686|NCT03805841|76123595|FG001|STARTED|Overall Study||22||
60007687|NCT03805841|76123596|FG002|STARTED|Overall Study||8||
60007688|NCT03805841|76123594|FG000|COMPLETED|Overall Study||6||
60007689|NCT03805841|76123595|FG001|COMPLETED|Overall Study||12||
60007690|NCT03805841|76123596|FG002|COMPLETED|Overall Study||5||
60007691|NCT03805841|76123594|FG000|NOT COMPLETED|Overall Study||5||
60007692|NCT03805841|76123595|FG001|NOT COMPLETED|Overall Study||10||
60007693|NCT03805841|76123596|FG002|NOT COMPLETED|Overall Study||3||
60007694|NCT02684617|76123607|FG000|STARTED|Overall Study||18||
60007695|NCT02684617|76123608|FG001|STARTED|Overall Study||17||
60007696|NCT02684617|76123609|FG002|STARTED|Overall Study||40||
60007697|NCT02684617|76123607|FG000|Treated|Overall Study||17||
60007698|NCT02684617|76123608|FG001|Treated|Overall Study||17||
60007699|NCT02684617|76123609|FG002|Treated|Overall Study||38||
60007700|NCT02684617|76123607|FG000|COMPLETED|Overall Study||0||
60007701|NCT02684617|76123608|FG001|COMPLETED|Overall Study||0||
60007702|NCT02684617|76123609|FG002|COMPLETED|Overall Study||0||
60007703|NCT02684617|76123607|FG000|NOT COMPLETED|Overall Study||18||
60007704|NCT02684617|76123608|FG001|NOT COMPLETED|Overall Study||17||
60007705|NCT02684617|76123609|FG002|NOT COMPLETED|Overall Study||40||
60007706|NCT01999972|76123623|FG000|STARTED|Dose Escalation Part||5||
60007707|NCT01999972|76123624|FG001|STARTED|Dose Escalation Part||3||
60007708|NCT01999972|76123625|FG002|STARTED|Dose Escalation Part||5||
60007709|NCT01999972|76123626|FG003|STARTED|Dose Escalation Part||11||
60007710|NCT01999972|76123627|FG004|STARTED|Dose Escalation Part||0||
60007711|NCT01999972|76123628|FG005|STARTED|Dose Escalation Part||0||
60007712|NCT01999972|76123623|FG000|Treated|Dose Escalation Part||5||
60007713|NCT01999972|76123624|FG001|Treated|Dose Escalation Part||3||
60007714|NCT01999972|76123625|FG002|Treated|Dose Escalation Part||4||
60007715|NCT01999972|76123626|FG003|Treated|Dose Escalation Part||10||
60007716|NCT01999972|76123627|FG004|Treated|Dose Escalation Part||0||
60007717|NCT01999972|76123628|FG005|Treated|Dose Escalation Part||0||
60007718|NCT01999972|76123623|FG000|COMPLETED|Dose Escalation Part||0||
59762630|NCT00868998|75882465|FG000|STARTED|Overall Study||5||
60007719|NCT01999972|76123624|FG001|COMPLETED|Dose Escalation Part||0||
60007720|NCT01999972|76123625|FG002|COMPLETED|Dose Escalation Part||0||
60007721|NCT01999972|76123626|FG003|COMPLETED|Dose Escalation Part||0||
60007722|NCT01999972|76123627|FG004|COMPLETED|Dose Escalation Part||0||
60007723|NCT01999972|76123628|FG005|COMPLETED|Dose Escalation Part||0||
60007724|NCT01999972|76123623|FG000|NOT COMPLETED|Dose Escalation Part||5||
60007725|NCT01999972|76123624|FG001|NOT COMPLETED|Dose Escalation Part||3||
60007726|NCT01999972|76123625|FG002|NOT COMPLETED|Dose Escalation Part||5||
60007727|NCT01999972|76123626|FG003|NOT COMPLETED|Dose Escalation Part||11||
60007728|NCT01999972|76123627|FG004|NOT COMPLETED|Dose Escalation Part||0||
60007729|NCT01999972|76123628|FG005|NOT COMPLETED|Dose Escalation Part||0||
60007730|NCT01999972|76123623|FG000|STARTED|Dose Expansion Part||0||
60007731|NCT01999972|76123624|FG001|STARTED|Dose Expansion Part||0||
60007732|NCT01999972|76123625|FG002|STARTED|Dose Expansion Part||0||
60007733|NCT01999972|76123626|FG003|STARTED|Dose Expansion Part||0||
60007734|NCT01999972|76123627|FG004|STARTED|Dose Expansion Part||21||
60007735|NCT01999972|76123628|FG005|STARTED|Dose Expansion Part||7||
60007736|NCT01999972|76123623|FG000|Treated|Dose Expansion Part||0||
60007737|NCT01999972|76123624|FG001|Treated|Dose Expansion Part||0||
60007738|NCT01999972|76123625|FG002|Treated|Dose Expansion Part||0||
60007739|NCT01999972|76123626|FG003|Treated|Dose Expansion Part||0||
60007740|NCT01999972|76123627|FG004|Treated|Dose Expansion Part||21||
60007741|NCT01999972|76123628|FG005|Treated|Dose Expansion Part||7||
60007742|NCT01999972|76123623|FG000|COMPLETED|Dose Expansion Part||0||
60007743|NCT01999972|76123624|FG001|COMPLETED|Dose Expansion Part||0||
60007744|NCT01999972|76123625|FG002|COMPLETED|Dose Expansion Part||0||
60007745|NCT01999972|76123626|FG003|COMPLETED|Dose Expansion Part||0||
60007746|NCT01999972|76123627|FG004|COMPLETED|Dose Expansion Part||0||
60007747|NCT01999972|76123628|FG005|COMPLETED|Dose Expansion Part||0||
60007748|NCT01999972|76123623|FG000|NOT COMPLETED|Dose Expansion Part||0||
60007749|NCT01999972|76123624|FG001|NOT COMPLETED|Dose Expansion Part||0||
60007750|NCT01999972|76123625|FG002|NOT COMPLETED|Dose Expansion Part||0||
60007751|NCT01999972|76123626|FG003|NOT COMPLETED|Dose Expansion Part||0||
60007752|NCT01999972|76123627|FG004|NOT COMPLETED|Dose Expansion Part||21||
60007753|NCT01999972|76123628|FG005|NOT COMPLETED|Dose Expansion Part||7||
60007754|NCT01999894|76123644|FG000|STARTED|Overall Study||102||
60007755|NCT01999894|76123644|FG000|COMPLETED|Overall Study||66||
60007756|NCT01999894|76123644|FG000|NOT COMPLETED|Overall Study||36||
60007757|NCT02679235|76123649|FG000|STARTED|Overall Study||15||
60007758|NCT02679235|76123649|FG000|COMPLETED|Overall Study||11||
60007759|NCT02679235|76123649|FG000|NOT COMPLETED|Overall Study||4||
59605653|NCT01966068|75715829|FG000|STARTED|Overall Study||294||
60007760|NCT01976806|76123655|FG000|STARTED|Overall Study||27||
60007761|NCT01976806|76123656|FG001|STARTED|Overall Study||28||
60007762|NCT01976806|76123655|FG000|COMPLETED|Overall Study||24||
60007763|NCT01976806|76123656|FG001|COMPLETED|Overall Study||22||
60007764|NCT01976806|76123655|FG000|NOT COMPLETED|Overall Study||3||
60007765|NCT01976806|76123656|FG001|NOT COMPLETED|Overall Study||6||
60007766|NCT02679079|76123665|FG000|STARTED|Overall Study||33||
60007767|NCT02679079|76123666|FG001|STARTED|Overall Study||32||
60007768|NCT02679079|76123667|FG002|STARTED|Overall Study||33||
60007769|NCT02679079|76123665|FG000|ITT Analysis Set|Overall Study||31|Intent-to-treat (ITT) analysis set included all randomized participants who received at least one dose of study drug, had postbaseline safety data, and had a baseline (Day -1) and at least one postrandomization Total Tic Score (TTS) value reported at a scheduled or mapped early termination (ET) visit during the 6 week treatment period.|
60007770|NCT02679079|76123666|FG001|ITT Analysis Set|Overall Study||32|Intent-to-treat (ITT) analysis set included all randomized participants who received at least one dose of study drug, had postbaseline safety data, and had a baseline (Day -1) and at least one postrandomization Total Tic Score (TTS) value reported at a scheduled or mapped early termination (ET) visit during the 6 week treatment period.|
60007771|NCT02679079|76123667|FG002|ITT Analysis Set|Overall Study||32|Intent-to-treat (ITT) analysis set included all randomized participants who received at least one dose of study drug, had postbaseline safety data, and had a baseline (Day -1) and at least one postrandomization Total Tic Score (TTS) value reported at a scheduled or mapped early termination (ET) visit during the 6 week treatment period.|
60007772|NCT02679079|76123665|FG000|COMPLETED|Overall Study||29||
60007773|NCT02679079|76123666|FG001|COMPLETED|Overall Study||30||
60007774|NCT02679079|76123667|FG002|COMPLETED|Overall Study||31||
60007775|NCT02679079|76123665|FG000|NOT COMPLETED|Overall Study||4||
60007776|NCT02679079|76123666|FG001|NOT COMPLETED|Overall Study||2||
60007777|NCT02679079|76123667|FG002|NOT COMPLETED|Overall Study||2||
60007778|NCT02678923|76123677|FG000|STARTED|Overall Study||59||
60007779|NCT02678923|76123678|FG001|STARTED|Overall Study||67||
60007780|NCT02678923|76123677|FG000|Received at Least 1 Dose of Study Drug|Overall Study||58|Randomized participants included in the Safety population.|
60007781|NCT02678923|76123678|FG001|Received at Least 1 Dose of Study Drug|Overall Study||64|Randomized participants included in the Safety population.|
60007782|NCT02678923|76123677|FG000|mITT Population|Overall Study||52||
60007783|NCT02678923|76123678|FG001|mITT Population|Overall Study||61||
60007784|NCT02678923|76123677|FG000|COMPLETED|Overall Study||53||
60007785|NCT02678923|76123678|FG001|COMPLETED|Overall Study||62||
60007786|NCT02678923|76123677|FG000|NOT COMPLETED|Overall Study||6||
60007787|NCT02678923|76123678|FG001|NOT COMPLETED|Overall Study||5||
60007788|NCT01976728|76123688|FG000|STARTED|Overall Study||10||
60007789|NCT01976728|76123689|FG001|STARTED|Overall Study||9||
60007790|NCT01976728|76123690|FG002|STARTED|Overall Study||10||
60007791|NCT01976728|76123691|FG003|STARTED|Overall Study||10||
60007792|NCT01976728|76123688|FG000|Dosed|Overall Study||10||
60007793|NCT01976728|76123689|FG001|Dosed|Overall Study||9||
60007794|NCT01976728|76123690|FG002|Dosed|Overall Study||10||
60007795|NCT01976728|76123691|FG003|Dosed|Overall Study||10||
60007796|NCT01976728|76123688|FG000|COMPLETED|Overall Study||9||
60007797|NCT01976728|76123689|FG001|COMPLETED|Overall Study||9||
60007798|NCT01976728|76123690|FG002|COMPLETED|Overall Study||10||
60007799|NCT01976728|76123691|FG003|COMPLETED|Overall Study||10||
60007800|NCT01976728|76123688|FG000|NOT COMPLETED|Overall Study||1||
60007801|NCT01976728|76123689|FG001|NOT COMPLETED|Overall Study||0||
60007802|NCT01976728|76123690|FG002|NOT COMPLETED|Overall Study||0||
60007803|NCT01976728|76123691|FG003|NOT COMPLETED|Overall Study||0||
60007804|NCT02689219|76123719|FG000|STARTED|Overall Study||11||
60007805|NCT02689219|76123720|FG001|STARTED|Overall Study||7||
59762631|NCT00868998|75882465|FG000|COMPLETED|Overall Study||0||
60007806|NCT02689219|76123719|FG000|COMPLETED|Overall Study||0||
60007807|NCT02689219|76123720|FG001|COMPLETED|Overall Study||0||
60007808|NCT02689219|76123719|FG000|NOT COMPLETED|Overall Study||11||
60007809|NCT02689219|76123720|FG001|NOT COMPLETED|Overall Study||7||
60007810|NCT02683525|76123726|FG000|STARTED|Overall Study||37||
60007811|NCT02683525|76123726|FG000|COMPLETED|Overall Study||29||
60007812|NCT02683525|76123726|FG000|NOT COMPLETED|Overall Study||8||
60007813|NCT01976338|76123732|FG000|STARTED|Overall Study||190||
60007814|NCT01976338|76123733|FG001|STARTED|Overall Study||93||
60007815|NCT01976338|76123732|FG000|Completed 6 Months|Overall Study||185||
60007816|NCT01976338|76123733|FG001|Completed 6 Months|Overall Study||91||
60007817|NCT01976338|76123732|FG000|Discontinued Study Prior to 6 Months|Overall Study||5||
60007818|NCT01976338|76123733|FG001|Discontinued Study Prior to 6 Months|Overall Study||2||
60007819|NCT01976338|76123732|FG000|COMPLETED|Overall Study|12 months|177||
60007820|NCT01976338|76123733|FG001|COMPLETED|Overall Study|12 months|89||
60007821|NCT01976338|76123732|FG000|NOT COMPLETED|Overall Study||13||
60007822|NCT01976338|76123733|FG001|NOT COMPLETED|Overall Study||4||
60007823|NCT02674633|76123742|FG000|STARTED|Overall Study||180||
60007824|NCT02674633|76123743|FG001|STARTED|Overall Study||168||
60007825|NCT02674633|76123742|FG000|COMPLETED|Overall Study||175||
60007826|NCT02674633|76123743|FG001|COMPLETED|Overall Study||164||
60007827|NCT02674633|76123742|FG000|NOT COMPLETED|Overall Study||5||
60007828|NCT02674633|76123743|FG001|NOT COMPLETED|Overall Study||4||
60007829|NCT02651987|76123751|FG000|STARTED|Overall Study||48||
60007830|NCT02651987|76123752|FG001|STARTED|Overall Study||51||
60007831|NCT02651987|76123751|FG000|COMPLETED|Overall Study||43||
60007832|NCT02651987|76123752|FG001|COMPLETED|Overall Study||46||
60007833|NCT02651987|76123751|FG000|NOT COMPLETED|Overall Study||5||
60007834|NCT02651987|76123752|FG001|NOT COMPLETED|Overall Study||5||
60007835|NCT02677987|76123763|FG000|STARTED|Overall Study||23||
60007836|NCT02677987|76123764|FG001|STARTED|Overall Study||24||
60007837|NCT02677987|76123763|FG000|COMPLETED|Overall Study||19||
60007838|NCT02677987|76123764|FG001|COMPLETED|Overall Study||24||
60007839|NCT02677987|76123763|FG000|NOT COMPLETED|Overall Study||4||
60007840|NCT02677987|76123764|FG001|NOT COMPLETED|Overall Study||0||
60007841|NCT02463773|76123774|FG000|STARTED|Overall Study||14||
60007842|NCT02463773|76123774|FG000|COMPLETED|Overall Study||14||
60007843|NCT02463773|76123774|FG000|NOT COMPLETED|Overall Study||0||
60007844|NCT01999114|76123783|FG000|STARTED|Overall Study||66||
60007845|NCT01999114|76123784|FG001|STARTED|Overall Study||66||
60007846|NCT01999114|76123785|FG002|STARTED|Overall Study||66||
60007847|NCT01999114|76123786|FG003|STARTED|Overall Study||65||
60007848|NCT01999114|76123787|FG004|STARTED|Overall Study||65||
60007849|NCT01999114|76123783|FG000|COMPLETED|Overall Study||58||
60007850|NCT01999114|76123784|FG001|COMPLETED|Overall Study||59||
60007851|NCT01999114|76123785|FG002|COMPLETED|Overall Study||61||
60007852|NCT01999114|76123786|FG003|COMPLETED|Overall Study||62||
60007853|NCT01999114|76123787|FG004|COMPLETED|Overall Study||61||
60007854|NCT01999114|76123783|FG000|NOT COMPLETED|Overall Study||8||
60007855|NCT01999114|76123784|FG001|NOT COMPLETED|Overall Study||7||
60007856|NCT01999114|76123785|FG002|NOT COMPLETED|Overall Study||5||
60007857|NCT01999114|76123786|FG003|NOT COMPLETED|Overall Study||3||
60007858|NCT01999114|76123787|FG004|NOT COMPLETED|Overall Study||4||
60007859|NCT02682823|76123818|FG000|STARTED|Overall Study||17||
60007860|NCT02682823|76123819|FG001|STARTED|Overall Study||19||
60007861|NCT02682823|76123820|FG002|STARTED|Overall Study||19||
60007862|NCT02682823|76123821|FG003|STARTED|Overall Study||17||
60007863|NCT02682823|76123822|FG004|STARTED|Overall Study||19||
60007864|NCT02682823|76123818|FG000|Safety Population|Overall Study|All CGs who administered at least one dose of study drug.|17||
60007865|NCT02682823|76123819|FG001|Safety Population|Overall Study|All HCPs who administered at least one dose of study drug.|19||
60007866|NCT02682823|76123820|FG002|Safety Population|Overall Study|All participants who received at least one dose of study drug.|18||
60007867|NCT02682823|76123821|FG003|Safety Population|Overall Study|All participants who received at least one dose of study drug.|17||
60007868|NCT02682823|76123822|FG004|Safety Population|Overall Study|All participants who received at least one dose of study drug.|19||
60007869|NCT02682823|76123818|FG000|COMPLETED|Overall Study||17||
60007870|NCT02682823|76123819|FG001|COMPLETED|Overall Study||18||
60007871|NCT02682823|76123820|FG002|COMPLETED|Overall Study||18||
60007872|NCT02682823|76123821|FG003|COMPLETED|Overall Study||16||
60007873|NCT02682823|76123822|FG004|COMPLETED|Overall Study||18||
60007874|NCT02682823|76123818|FG000|NOT COMPLETED|Overall Study||0||
60007875|NCT02682823|76123819|FG001|NOT COMPLETED|Overall Study||1||
60007876|NCT02682823|76123820|FG002|NOT COMPLETED|Overall Study||1||
60007877|NCT02682823|76123821|FG003|NOT COMPLETED|Overall Study||1||
60007878|NCT02682823|76123822|FG004|NOT COMPLETED|Overall Study||1||
60007879|NCT01374451|76123836|FG000|STARTED|Overall Study||79||
60007880|NCT01374451|76123837|FG001|STARTED|Overall Study||81||
60007881|NCT01374451|76123836|FG000|COMPLETED|Overall Study||78||
60007882|NCT01374451|76123837|FG001|COMPLETED|Overall Study||81||
60007883|NCT01374451|76123836|FG000|NOT COMPLETED|Overall Study||1||
60007884|NCT01374451|76123837|FG001|NOT COMPLETED|Overall Study||0||
60007885|NCT02674477|76123845|FG000|STARTED|Overall Study||48||
60007886|NCT02674477|76123846|FG001|STARTED|Overall Study||47||
60007887|NCT02674477|76123845|FG000|COMPLETED|Overall Study||40||
60007888|NCT02674477|76123846|FG001|COMPLETED|Overall Study||45||
60007889|NCT02674477|76123845|FG000|NOT COMPLETED|Overall Study||8||
60007890|NCT02674477|76123846|FG001|NOT COMPLETED|Overall Study||2||
60007891|NCT01352845|76123854|FG000|STARTED|Overall Study||2471||
60007892|NCT01352845|76123855|FG001|STARTED|Overall Study||822||
60007893|NCT01352845|76123854|FG000|COMPLETED|Overall Study||1800||
60007894|NCT01352845|76123855|FG001|COMPLETED|Overall Study||619||
60007895|NCT01352845|76123854|FG000|NOT COMPLETED|Overall Study||671||
60007896|NCT01352845|76123855|FG001|NOT COMPLETED|Overall Study||203||
60007897|NCT02674399|76123863|FG000|STARTED|Overall Study||19||
60007898|NCT02674399|76123864|FG001|STARTED|Overall Study||9||
60007899|NCT02674399|76123863|FG000|COMPLETED|Overall Study||17||
59751226|NCT00656617|75870465|FG000|Induction Phase|Overall Study|Induction phase following determination of safe combination Vorinostat with Idarubicin.|103||
59751227|NCT00656617|75870465|FG000|COMPLETED|Overall Study||99||
59751228|NCT00656617|75870465|FG000|NOT COMPLETED|Overall Study||7||
59751229|NCT00659269|75870472|FG000|STARTED|Overall Study||157||
59751230|NCT00659269|75870473|FG001|STARTED|Overall Study||162||
59751231|NCT00659269|75870472|FG000|Group 1 (Heavy Metals)|Overall Study||52||
60007900|NCT02674399|76123864|FG001|COMPLETED|Overall Study||9||
60007901|NCT02674399|76123863|FG000|NOT COMPLETED|Overall Study||2||
60007902|NCT02674399|76123864|FG001|NOT COMPLETED|Overall Study||0||
60007903|NCT02676895|76123873|FG000|STARTED|Overall Study||22||
60007904|NCT02676895|76123874|FG001|STARTED|Overall Study||26||
60007905|NCT02676895|76123875|FG002|STARTED|Overall Study||24||
60007906|NCT02676895|76123873|FG000|COMPLETED|Overall Study||20||
60007907|NCT02676895|76123874|FG001|COMPLETED|Overall Study||23||
60007908|NCT02676895|76123875|FG002|COMPLETED|Overall Study||21||
60007909|NCT02676895|76123873|FG000|NOT COMPLETED|Overall Study||2||
60007910|NCT02676895|76123874|FG001|NOT COMPLETED|Overall Study||3||
60007911|NCT02676895|76123875|FG002|NOT COMPLETED|Overall Study||3||
60007912|NCT02673697|76123886|FG000|STARTED|Overall Study||453|Randomized|
60007913|NCT02673697|76123887|FG001|STARTED|Overall Study||457|Randomized|
60007914|NCT02673697|76123886|FG000|Implanted|Overall Study||450||
60007915|NCT02673697|76123887|FG001|Implanted|Overall Study||446||
60007916|NCT02673697|76123886|FG000|Per-Protocol Population|Overall Study||407||
60007917|NCT02673697|76123887|FG001|Per-Protocol Population|Overall Study||412||
60007918|NCT02673697|76123886|FG000|COMPLETED|Overall Study||0||
60007919|NCT02673697|76123887|FG001|COMPLETED|Overall Study||0||
60007920|NCT02673697|76123886|FG000|NOT COMPLETED|Overall Study||453||
60007921|NCT02673697|76123887|FG001|NOT COMPLETED|Overall Study||457||
60007922|NCT05168579|76123895|FG000|STARTED|Overall Study||36||
60007923|NCT05168579|76123896|FG001|STARTED|Overall Study||36||
60007924|NCT05168579|76123895|FG000|COMPLETED|Overall Study||30||
60007925|NCT05168579|76123896|FG001|COMPLETED|Overall Study||21||
60007926|NCT05168579|76123895|FG000|NOT COMPLETED|Overall Study||6||
60007927|NCT05168579|76123896|FG001|NOT COMPLETED|Overall Study||15||
60007928|NCT02673619|76123909|FG000|STARTED|Overall Study||20||
60007929|NCT02673619|76123910|FG001|STARTED|Overall Study||5||
59751232|NCT00659269|75870473|FG001|Group 1 (Heavy Metals)|Overall Study||52||
60007930|NCT02673619|76123911|FG002|STARTED|Overall Study||26||
60007931|NCT02673619|76123912|FG003|STARTED|Overall Study||7||
60007932|NCT02673619|76123909|FG000|COMPLETED|Overall Study||18||
60007933|NCT02673619|76123910|FG001|COMPLETED|Overall Study||4||
60007934|NCT02673619|76123911|FG002|COMPLETED|Overall Study||23||
60007935|NCT02673619|76123912|FG003|COMPLETED|Overall Study||7||
60007936|NCT02673619|76123909|FG000|NOT COMPLETED|Overall Study||2||
60007937|NCT02673619|76123910|FG001|NOT COMPLETED|Overall Study||1||
60007938|NCT02673619|76123911|FG002|NOT COMPLETED|Overall Study||3||
60007939|NCT02673619|76123912|FG003|NOT COMPLETED|Overall Study||0||
60007940|NCT04253587|76123925|FG000|STARTED|Overall Study||25||
60007941|NCT04253587|76123926|FG001|STARTED|Overall Study||25||
60007942|NCT04253587|76123925|FG000|Baseline T1|Overall Study||24||
60007943|NCT04253587|76123926|FG001|Baseline T1|Overall Study||21||
60007944|NCT04253587|76123925|FG000|Post Training T2|Overall Study||21||
60007945|NCT04253587|76123926|FG001|Post Training T2|Overall Study||21||
60007946|NCT04253587|76123925|FG000|COMPLETED|Overall Study||21||
60007947|NCT04253587|76123926|FG001|COMPLETED|Overall Study||21||
60007948|NCT04253587|76123925|FG000|NOT COMPLETED|Overall Study||4||
60007949|NCT04253587|76123926|FG001|NOT COMPLETED|Overall Study||4||
60007950|NCT02680639|76123934|FG000|STARTED|Screening Period||10||
60007951|NCT02680639|76123935|FG001|STARTED|Screening Period||0||
60007952|NCT02680639|76123936|FG002|STARTED|Screening Period||0||
60007953|NCT02680639|76123934|FG000|COMPLETED|Screening Period||3||
60007954|NCT02680639|76123935|FG001|COMPLETED|Screening Period||0||
60007955|NCT02680639|76123936|FG002|COMPLETED|Screening Period||0||
59881234|NCT02792062|76004178|FG002|COMPLETED|Intervention Period 2 (6 Days)||2||
59881235|NCT02792062|76004179|FG003|COMPLETED|Intervention Period 2 (6 Days)||2||
59881236|NCT02792062|76004180|FG004|COMPLETED|Intervention Period 2 (6 Days)||2||
59881237|NCT02792062|76004181|FG005|COMPLETED|Intervention Period 2 (6 Days)||2||
59881238|NCT02792062|76004176|FG000|NOT COMPLETED|Intervention Period 2 (6 Days)||0||
59881239|NCT02792062|76004177|FG001|NOT COMPLETED|Intervention Period 2 (6 Days)||0||
59881240|NCT02792062|76004178|FG002|NOT COMPLETED|Intervention Period 2 (6 Days)||0||
59881241|NCT02792062|76004179|FG003|NOT COMPLETED|Intervention Period 2 (6 Days)||0||
59881242|NCT02792062|76004180|FG004|NOT COMPLETED|Intervention Period 2 (6 Days)||0||
59881243|NCT02792062|76004181|FG005|NOT COMPLETED|Intervention Period 2 (6 Days)||0||
59881244|NCT02792062|76004176|FG000|STARTED|Washout Period (at Least 14 Days)||2||
59881245|NCT02792062|76004177|FG001|STARTED|Washout Period (at Least 14 Days)||2||
59881246|NCT02792062|76004178|FG002|STARTED|Washout Period (at Least 14 Days)||2||
59881247|NCT02792062|76004179|FG003|STARTED|Washout Period (at Least 14 Days)||2||
59881248|NCT02792062|76004180|FG004|STARTED|Washout Period (at Least 14 Days)||2||
59881249|NCT02792062|76004181|FG005|STARTED|Washout Period (at Least 14 Days)||2||
59881250|NCT02792062|76004176|FG000|COMPLETED|Washout Period (at Least 14 Days)||1||
59881251|NCT02792062|76004177|FG001|COMPLETED|Washout Period (at Least 14 Days)||2||
59881252|NCT02792062|76004178|FG002|COMPLETED|Washout Period (at Least 14 Days)||2||
59881253|NCT02792062|76004179|FG003|COMPLETED|Washout Period (at Least 14 Days)||2||
59881254|NCT02792062|76004180|FG004|COMPLETED|Washout Period (at Least 14 Days)||2||
59881255|NCT02792062|76004181|FG005|COMPLETED|Washout Period (at Least 14 Days)||2||
59881256|NCT02792062|76004176|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||1||
59881257|NCT02792062|76004177|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0||
59881258|NCT02792062|76004178|FG002|NOT COMPLETED|Washout Period (at Least 14 Days)||0||
59881259|NCT02792062|76004179|FG003|NOT COMPLETED|Washout Period (at Least 14 Days)||0||
59881260|NCT02792062|76004180|FG004|NOT COMPLETED|Washout Period (at Least 14 Days)||0||
59881261|NCT02792062|76004181|FG005|NOT COMPLETED|Washout Period (at Least 14 Days)||0||
59881262|NCT02792062|76004176|FG000|STARTED|Intervention Period 3 (6 Days)||1||
59881263|NCT02792062|76004177|FG001|STARTED|Intervention Period 3 (6 Days)||2||
59881264|NCT02792062|76004178|FG002|STARTED|Intervention Period 3 (6 Days)||2||
59881265|NCT02792062|76004179|FG003|STARTED|Intervention Period 3 (6 Days)||2||
59881266|NCT02792062|76004180|FG004|STARTED|Intervention Period 3 (6 Days)||2||
59881267|NCT02792062|76004181|FG005|STARTED|Intervention Period 3 (6 Days)||2||
59881268|NCT02792062|76004176|FG000|COMPLETED|Intervention Period 3 (6 Days)||1||
59881269|NCT02792062|76004177|FG001|COMPLETED|Intervention Period 3 (6 Days)||2||
59881270|NCT02792062|76004178|FG002|COMPLETED|Intervention Period 3 (6 Days)||2||
59881271|NCT02792062|76004179|FG003|COMPLETED|Intervention Period 3 (6 Days)||2||
59881272|NCT02792062|76004180|FG004|COMPLETED|Intervention Period 3 (6 Days)||2||
59881273|NCT02792062|76004181|FG005|COMPLETED|Intervention Period 3 (6 Days)||2||
59881274|NCT02792062|76004176|FG000|NOT COMPLETED|Intervention Period 3 (6 Days)||0||
59881275|NCT02792062|76004177|FG001|NOT COMPLETED|Intervention Period 3 (6 Days)||0||
59881276|NCT02792062|76004178|FG002|NOT COMPLETED|Intervention Period 3 (6 Days)||0||
59881277|NCT02792062|76004179|FG003|NOT COMPLETED|Intervention Period 3 (6 Days)||0||
59881278|NCT02792062|76004180|FG004|NOT COMPLETED|Intervention Period 3 (6 Days)||0||
59881279|NCT02792062|76004181|FG005|NOT COMPLETED|Intervention Period 3 (6 Days)||0||
59881280|NCT00196937|76004192|FG000|STARTED|Overall Study||229||
59881281|NCT00196937|76004193|FG001|STARTED|Overall Study||226||
59881282|NCT00196937|76004194|FG002|STARTED|Overall Study||211||
59881283|NCT00196937|76004192|FG000|COMPLETED|Overall Study||220||
59881284|NCT00196937|76004193|FG001|COMPLETED|Overall Study||221||
59881285|NCT00196937|76004194|FG002|COMPLETED|Overall Study||204||
59881286|NCT00196937|76004192|FG000|NOT COMPLETED|Overall Study||9||
59881287|NCT00196937|76004193|FG001|NOT COMPLETED|Overall Study||5||
59881288|NCT00196937|76004194|FG002|NOT COMPLETED|Overall Study||7||
59881289|NCT04397445|76004203|FG000|STARTED|Overall Study||5||
59881290|NCT04397445|76004204|FG001|STARTED|Overall Study||5||
59881291|NCT04397445|76004205|FG002|STARTED|Overall Study||4||
59881292|NCT04397445|76004206|FG003|STARTED|Overall Study||4||
59881293|NCT04397445|76004203|FG000|COMPLETED|Overall Study||4||
59881294|NCT04397445|76004204|FG001|COMPLETED|Overall Study||5||
59605654|NCT01966068|75715829|FG000|Used the MyAsthma Portal at Least Once|Overall Study||237||
60007956|NCT02680639|76123934|FG000|NOT COMPLETED|Screening Period||7||
60007957|NCT02680639|76123935|FG001|NOT COMPLETED|Screening Period||0||
60007958|NCT02680639|76123936|FG002|NOT COMPLETED|Screening Period||0||
60007959|NCT02680639|76123934|FG000|STARTED|High Frequency Oscillation (HFO) Therapy||0||
60007960|NCT02680639|76123935|FG001|STARTED|High Frequency Oscillation (HFO) Therapy||2||
60007961|NCT02680639|76123936|FG002|STARTED|High Frequency Oscillation (HFO) Therapy||1||
60007962|NCT02680639|76123934|FG000|COMPLETED|High Frequency Oscillation (HFO) Therapy||0||
60007963|NCT02680639|76123935|FG001|COMPLETED|High Frequency Oscillation (HFO) Therapy||2||
60007964|NCT02680639|76123936|FG002|COMPLETED|High Frequency Oscillation (HFO) Therapy||1||
60007965|NCT02680639|76123934|FG000|NOT COMPLETED|High Frequency Oscillation (HFO) Therapy||0||
60007966|NCT02680639|76123935|FG001|NOT COMPLETED|High Frequency Oscillation (HFO) Therapy||0||
60007967|NCT02680639|76123936|FG002|NOT COMPLETED|High Frequency Oscillation (HFO) Therapy||0||
60007968|NCT01674725|76123948|FG000|STARTED|Overall Study||92||
60007969|NCT01674725|76123949|FG001|STARTED|Overall Study||95||
60007970|NCT01674725|76123948|FG000|COMPLETED|Overall Study||89||
60007971|NCT01674725|76123949|FG001|COMPLETED|Overall Study||94||
60007972|NCT01674725|76123948|FG000|NOT COMPLETED|Overall Study||3||
60007973|NCT01674725|76123949|FG001|NOT COMPLETED|Overall Study||1||
60007974|NCT01674569|76123955|FG000|STARTED|Overall Study||3||
60007975|NCT01674569|76123956|FG001|STARTED|Overall Study||8||
60007976|NCT01674569|76123957|FG002|STARTED|Overall Study||4||
60007977|NCT01674569|76123958|FG003|STARTED|Overall Study||10||
60007978|NCT01674569|76123959|FG004|STARTED|Overall Study||7||
60007979|NCT01674569|76123960|FG005|STARTED|Overall Study||3||
60007980|NCT01674569|76123955|FG000|COMPLETED|Overall Study||3||
60007981|NCT01674569|76123956|FG001|COMPLETED|Overall Study||5||
60007982|NCT01674569|76123957|FG002|COMPLETED|Overall Study||2||
60007983|NCT01674569|76123958|FG003|COMPLETED|Overall Study||9||
60007984|NCT01674569|76123959|FG004|COMPLETED|Overall Study||5||
60007985|NCT01674569|76123960|FG005|COMPLETED|Overall Study||1||
60007986|NCT01674569|76123955|FG000|NOT COMPLETED|Overall Study||0||
60007987|NCT01674569|76123956|FG001|NOT COMPLETED|Overall Study||3||
60007988|NCT01674569|76123957|FG002|NOT COMPLETED|Overall Study||2||
60007989|NCT01674569|76123958|FG003|NOT COMPLETED|Overall Study||1||
60007990|NCT01674569|76123959|FG004|NOT COMPLETED|Overall Study||2||
60007991|NCT01674569|76123960|FG005|NOT COMPLETED|Overall Study||2||
60007992|NCT01374217|76123964|FG000|STARTED|Overall Study||13||
60007993|NCT01374217|76123964|FG000|COMPLETED|Overall Study||0||
60007994|NCT01374217|76123964|FG000|NOT COMPLETED|Overall Study||13||
60136109|NCT01408901|76258768|FG000|NOT COMPLETED|26-Week Follow-Up||1||
60136110|NCT01408901|76258769|FG001|NOT COMPLETED|26-Week Follow-Up||2||
60136111|NCT01408901|76258770|FG002|NOT COMPLETED|26-Week Follow-Up||0||
60136112|NCT01408901|76258771|FG003|NOT COMPLETED|26-Week Follow-Up||1||
60136113|NCT02080195|76258783|FG000|STARTED|Overall Study||1||
60136114|NCT02080195|76258783|FG000|COMPLETED|Overall Study||1||
60136115|NCT02080195|76258783|FG000|NOT COMPLETED|Overall Study||0||
60136116|NCT01428713|76258787|FG000|STARTED|Overall Study||9||
60136117|NCT01428713|76258788|FG001|STARTED|Overall Study||8||
60136118|NCT01428713|76258787|FG000|COMPLETED|Overall Study||6||
60136119|NCT01428713|76258788|FG001|COMPLETED|Overall Study||3||
60136120|NCT01428713|76258787|FG000|NOT COMPLETED|Overall Study||3||
60136121|NCT01428713|76258788|FG001|NOT COMPLETED|Overall Study||5||
60136122|NCT01408277|76258796|FG000|STARTED|Overall Study||28||
60136123|NCT01408277|76258797|FG001|STARTED|Overall Study||27||
60136124|NCT01408277|76258796|FG000|COMPLETED|Overall Study||20||
59605655|NCT01966068|75715829|FG000|Use the MyAsthma Portal More Than Once|Overall Study||156||
60007995|NCT01674647|76123970|FG000|STARTED|Treatment Period||1002||
60136125|NCT01408277|76258797|FG001|COMPLETED|Overall Study||23||
60136126|NCT01408277|76258796|FG000|NOT COMPLETED|Overall Study||8||
60007996|NCT01674647|76123971|FG001|STARTED|Treatment Period||502||
60007997|NCT01674647|76123970|FG000|Subjects Received Treatment|Treatment Period||988||
60007998|NCT01674647|76123971|FG001|Subjects Received Treatment|Treatment Period||499||
60007999|NCT01674647|76123970|FG000|COMPLETED|Treatment Period||846||
60008000|NCT01674647|76123971|FG001|COMPLETED|Treatment Period||400||
60136127|NCT01408277|76258797|FG001|NOT COMPLETED|Overall Study||4||
60136128|NCT01408043|76258803|FG000|STARTED|Overall Study||25||
60136129|NCT01408043|76258803|FG000|COMPLETED|Overall Study||24||
60008001|NCT01674647|76123970|FG000|NOT COMPLETED|Treatment Period||156||
60008002|NCT01674647|76123971|FG001|NOT COMPLETED|Treatment Period||102||
60008003|NCT01674647|76123970|FG000|STARTED|30-day Safety Follow-up Period||982||
60008004|NCT01674647|76123971|FG001|STARTED|30-day Safety Follow-up Period||487||
60008005|NCT01674647|76123970|FG000|COMPLETED|30-day Safety Follow-up Period||924||
60008006|NCT01674647|76123971|FG001|COMPLETED|30-day Safety Follow-up Period||446||
60008007|NCT01674647|76123970|FG000|NOT COMPLETED|30-day Safety Follow-up Period||58||
60008008|NCT01674647|76123971|FG001|NOT COMPLETED|30-day Safety Follow-up Period||41||
60008009|NCT02669407|76123977|FG000|STARTED|Overall Study||14||
60008010|NCT02669407|76123977|FG000|COMPLETED|Overall Study||11||
60008011|NCT02669407|76123977|FG000|NOT COMPLETED|Overall Study||3||
60008012|NCT02667457|76123983|FG000|STARTED|Overall Study||27|All screened/enrolled participants|
60008013|NCT02667457|76123984|FG001|STARTED|Overall Study||12|All screened/enrolled participants|
60008014|NCT02667457|76123983|FG000|Dosed Participants|Overall Study||26|All infused enrolled participants were included in Safety Population Set|
60008015|NCT02667457|76123984|FG001|Dosed Participants|Overall Study||10|All infused enrolled participants were included in Safety Population Set|
60008016|NCT02667457|76123983|FG000|Full Analysis Set Population (FAS)|Overall Study||25|Dosed participants who completed 99mTc-rhAnnexin V-128 imaging procedure.|
60008017|NCT02667457|76123984|FG001|Full Analysis Set Population (FAS)|Overall Study||10|Dosed participants who completed 99mTc-rhAnnexin V-128 imaging procedure.|
60008018|NCT02667457|76123983|FG000|COMPLETED|Overall Study||26||
60008019|NCT02667457|76123984|FG001|COMPLETED|Overall Study||10||
60008020|NCT02667457|76123983|FG000|NOT COMPLETED|Overall Study||1||
60008021|NCT02667457|76123984|FG001|NOT COMPLETED|Overall Study||2||
60008022|NCT02669095|76123993|FG000|STARTED|Overall Study||75||
60008023|NCT02669095|76123994|FG001|STARTED|Overall Study||75||
60008024|NCT02669095|76123993|FG000|COMPLETED|Overall Study||74||
60008025|NCT02669095|76123994|FG001|COMPLETED|Overall Study||72||
60008026|NCT02669095|76123993|FG000|NOT COMPLETED|Overall Study||1||
60008027|NCT02669095|76123994|FG001|NOT COMPLETED|Overall Study||3||
60008028|NCT02667301|76124000|FG000|STARTED|Overall Study||16||
60008029|NCT02667301|76124000|FG000|COMPLETED|Overall Study||14||
60008030|NCT02667301|76124000|FG000|NOT COMPLETED|Overall Study||2||
60008031|NCT05274165|76124008|FG000|STARTED|Overall Study||12||
60008032|NCT05274165|76124009|FG001|STARTED|Overall Study||13||
60008033|NCT05274165|76124008|FG000|COMPLETED|Overall Study||9||
60008034|NCT05274165|76124009|FG001|COMPLETED|Overall Study||10||
60008035|NCT05274165|76124008|FG000|NOT COMPLETED|Overall Study||3||
60008036|NCT05274165|76124009|FG001|NOT COMPLETED|Overall Study||3||
60008037|NCT04612049|76124017|FG000|STARTED|Overall Study||12||
60008038|NCT04612049|76124018|FG001|STARTED|Overall Study||0||
60008039|NCT04612049|76124017|FG000|COMPLETED|Overall Study||12||
60008040|NCT04612049|76124018|FG001|COMPLETED|Overall Study||0||
60008041|NCT04612049|76124017|FG000|NOT COMPLETED|Overall Study||0||
60008042|NCT04612049|76124018|FG001|NOT COMPLETED|Overall Study||0||
60008043|NCT04588688|76124026|FG000|STARTED|Overall Study||3||
60008044|NCT04588688|76124026|FG000|COMPLETED|Overall Study||3||
60008045|NCT04588688|76124026|FG000|NOT COMPLETED|Overall Study||0||
60008046|NCT04558281|76124036|FG000|STARTED|Overall Study||2||
60008047|NCT04558281|76124037|FG001|STARTED|Overall Study||2||
60008048|NCT04558281|76124036|FG000|COMPLETED|Overall Study||2||
60008049|NCT04558281|76124037|FG001|COMPLETED|Overall Study||2||
60008050|NCT04558281|76124036|FG000|NOT COMPLETED|Overall Study||0||
60008051|NCT04558281|76124037|FG001|NOT COMPLETED|Overall Study||0||
60008052|NCT04510090|76124051|FG000|STARTED|SAD-HS||10||
60008053|NCT04510090|76124052|FG001|STARTED|SAD-HS||0||
60008054|NCT04510090|76124053|FG002|STARTED|SAD-HS||6||
60008055|NCT04510090|76124054|FG003|STARTED|SAD-HS||0||
60008056|NCT04510090|76124055|FG004|STARTED|SAD-HS||6||
60008057|NCT04510090|76124056|FG005|STARTED|SAD-HS||6||
60008058|NCT04510090|76124057|FG006|STARTED|SAD-HS||6||
60008059|NCT04510090|76124058|FG007|STARTED|SAD-HS||6||
60008060|NCT04510090|76124051|FG000|COMPLETED|SAD-HS||10||
60008061|NCT04510090|76124052|FG001|COMPLETED|SAD-HS||0||
60008062|NCT04510090|76124053|FG002|COMPLETED|SAD-HS||6||
60008063|NCT04510090|76124054|FG003|COMPLETED|SAD-HS||0||
60008064|NCT04510090|76124055|FG004|COMPLETED|SAD-HS||6||
60008065|NCT04510090|76124056|FG005|COMPLETED|SAD-HS||6||
60008066|NCT04510090|76124057|FG006|COMPLETED|SAD-HS||6||
60008067|NCT04510090|76124058|FG007|COMPLETED|SAD-HS||6||
60008068|NCT04510090|76124051|FG000|NOT COMPLETED|SAD-HS||0||
60008069|NCT04510090|76124052|FG001|NOT COMPLETED|SAD-HS||0||
60008070|NCT04510090|76124053|FG002|NOT COMPLETED|SAD-HS||0||
60008071|NCT04510090|76124054|FG003|NOT COMPLETED|SAD-HS||0||
60008072|NCT04510090|76124055|FG004|NOT COMPLETED|SAD-HS||0||
60008073|NCT04510090|76124056|FG005|NOT COMPLETED|SAD-HS||0||
60008074|NCT04510090|76124057|FG006|NOT COMPLETED|SAD-HS||0||
60008075|NCT04510090|76124058|FG007|NOT COMPLETED|SAD-HS||0||
60008076|NCT04510090|76124051|FG000|STARTED|MAD-HS||6||
60008077|NCT04510090|76124052|FG001|STARTED|MAD-HS||0||
60008078|NCT04510090|76124053|FG002|STARTED|MAD-HS||6||
60008079|NCT04510090|76124054|FG003|STARTED|MAD-HS||0||
60008080|NCT04510090|76124055|FG004|STARTED|MAD-HS||6||
60008081|NCT04510090|76124056|FG005|STARTED|MAD-HS||6||
60008082|NCT04510090|76124057|FG006|STARTED|MAD-HS||0||
60008083|NCT04510090|76124058|FG007|STARTED|MAD-HS||0||
60008084|NCT04510090|76124051|FG000|COMPLETED|MAD-HS||6||
60008085|NCT04510090|76124052|FG001|COMPLETED|MAD-HS||0||
60008086|NCT04510090|76124053|FG002|COMPLETED|MAD-HS||6||
60008087|NCT04510090|76124054|FG003|COMPLETED|MAD-HS||0||
60008088|NCT04510090|76124055|FG004|COMPLETED|MAD-HS||6||
60008089|NCT04510090|76124056|FG005|COMPLETED|MAD-HS||6||
60008090|NCT04510090|76124057|FG006|COMPLETED|MAD-HS||0||
60008091|NCT04510090|76124058|FG007|COMPLETED|MAD-HS||0||
60008092|NCT04510090|76124051|FG000|NOT COMPLETED|MAD-HS||0||
60008093|NCT04510090|76124052|FG001|NOT COMPLETED|MAD-HS||0||
60008094|NCT04510090|76124053|FG002|NOT COMPLETED|MAD-HS||0||
60008095|NCT04510090|76124054|FG003|NOT COMPLETED|MAD-HS||0||
60008096|NCT04510090|76124055|FG004|NOT COMPLETED|MAD-HS||0||
60008097|NCT04510090|76124056|FG005|NOT COMPLETED|MAD-HS||0||
60008098|NCT04510090|76124057|FG006|NOT COMPLETED|MAD-HS||0||
60008099|NCT04510090|76124058|FG007|NOT COMPLETED|MAD-HS||0||
60008100|NCT04510090|76124051|FG000|STARTED|FE-HS||0||
60008101|NCT04510090|76124052|FG001|STARTED|FE-HS||0||
60008102|NCT04510090|76124053|FG002|STARTED|FE-HS||0||
60008103|NCT04510090|76124054|FG003|STARTED|FE-HS||0||
60008104|NCT04510090|76124055|FG004|STARTED|FE-HS||5||
60008105|NCT04510090|76124056|FG005|STARTED|FE-HS||0||
60008106|NCT04510090|76124057|FG006|STARTED|FE-HS||0||
60008107|NCT04510090|76124058|FG007|STARTED|FE-HS||0||
60008108|NCT04510090|76124051|FG000|COMPLETED|FE-HS||0||
60008109|NCT04510090|76124052|FG001|COMPLETED|FE-HS||0||
60008110|NCT04510090|76124053|FG002|COMPLETED|FE-HS||0||
60008111|NCT04510090|76124054|FG003|COMPLETED|FE-HS||0||
60008112|NCT04510090|76124055|FG004|COMPLETED|FE-HS||4||
60008113|NCT04510090|76124056|FG005|COMPLETED|FE-HS||0||
60008114|NCT04510090|76124057|FG006|COMPLETED|FE-HS||0||
60008115|NCT04510090|76124058|FG007|COMPLETED|FE-HS||0||
60008116|NCT04510090|76124051|FG000|NOT COMPLETED|FE-HS||0||
60008117|NCT04510090|76124052|FG001|NOT COMPLETED|FE-HS||0||
60008118|NCT04510090|76124053|FG002|NOT COMPLETED|FE-HS||0||
60008119|NCT04510090|76124054|FG003|NOT COMPLETED|FE-HS||0||
60008120|NCT04510090|76124055|FG004|NOT COMPLETED|FE-HS||1||
60008121|NCT04510090|76124056|FG005|NOT COMPLETED|FE-HS||0||
60008122|NCT04510090|76124057|FG006|NOT COMPLETED|FE-HS||0||
60008123|NCT04510090|76124058|FG007|NOT COMPLETED|FE-HS||0||
60008124|NCT04510090|76124051|FG000|STARTED|SD-CP||0||
60008125|NCT04510090|76124052|FG001|STARTED|SD-CP||0||
60008126|NCT04510090|76124053|FG002|STARTED|SD-CP||0||
60008127|NCT04510090|76124054|FG003|STARTED|SD-CP||0||
60008128|NCT04510090|76124055|FG004|STARTED|SD-CP||5||
60008129|NCT04510090|76124056|FG005|STARTED|SD-CP||0||
60008130|NCT04510090|76124057|FG006|STARTED|SD-CP||0||
60008131|NCT04510090|76124058|FG007|STARTED|SD-CP||0||
60008132|NCT04510090|76124051|FG000|COMPLETED|SD-CP||0||
60008133|NCT04510090|76124052|FG001|COMPLETED|SD-CP||0||
60008134|NCT04510090|76124053|FG002|COMPLETED|SD-CP||0||
60008135|NCT04510090|76124054|FG003|COMPLETED|SD-CP||0||
60008136|NCT04510090|76124055|FG004|COMPLETED|SD-CP||5||
60008137|NCT04510090|76124056|FG005|COMPLETED|SD-CP||0||
60008138|NCT04510090|76124057|FG006|COMPLETED|SD-CP||0||
60008139|NCT04510090|76124058|FG007|COMPLETED|SD-CP||0||
60008140|NCT04510090|76124051|FG000|NOT COMPLETED|SD-CP||0||
60008141|NCT04510090|76124052|FG001|NOT COMPLETED|SD-CP||0||
60008142|NCT04510090|76124053|FG002|NOT COMPLETED|SD-CP||0||
60008143|NCT04510090|76124054|FG003|NOT COMPLETED|SD-CP||0||
60008144|NCT04510090|76124055|FG004|NOT COMPLETED|SD-CP||0||
60008145|NCT04510090|76124056|FG005|NOT COMPLETED|SD-CP||0||
60008146|NCT04510090|76124057|FG006|NOT COMPLETED|SD-CP||0||
60008147|NCT04510090|76124058|FG007|NOT COMPLETED|SD-CP||0||
60008148|NCT04510090|76124051|FG000|STARTED|SD-UP||0||
60008149|NCT04510090|76124052|FG001|STARTED|SD-UP||0||
60008150|NCT04510090|76124053|FG002|STARTED|SD-UP||0||
60008151|NCT04510090|76124054|FG003|STARTED|SD-UP||0||
60008152|NCT04510090|76124055|FG004|STARTED|SD-UP||6||
60008153|NCT04510090|76124056|FG005|STARTED|SD-UP||0||
60008154|NCT04510090|76124057|FG006|STARTED|SD-UP||0||
60008155|NCT04510090|76124058|FG007|STARTED|SD-UP||0||
60008156|NCT04510090|76124051|FG000|COMPLETED|SD-UP||0||
60008157|NCT04510090|76124052|FG001|COMPLETED|SD-UP||0||
60008158|NCT04510090|76124053|FG002|COMPLETED|SD-UP||0||
60008159|NCT04510090|76124054|FG003|COMPLETED|SD-UP||0||
60008160|NCT04510090|76124055|FG004|COMPLETED|SD-UP||6||
60008161|NCT04510090|76124056|FG005|COMPLETED|SD-UP||0||
60008162|NCT04510090|76124057|FG006|COMPLETED|SD-UP||0||
60008163|NCT04510090|76124058|FG007|COMPLETED|SD-UP||0||
60008164|NCT04510090|76124051|FG000|NOT COMPLETED|SD-UP||0||
60008165|NCT04510090|76124052|FG001|NOT COMPLETED|SD-UP||0||
60008166|NCT04510090|76124053|FG002|NOT COMPLETED|SD-UP||0||
60008167|NCT04510090|76124054|FG003|NOT COMPLETED|SD-UP||0||
60008168|NCT04510090|76124055|FG004|NOT COMPLETED|SD-UP||0||
60008169|NCT04510090|76124056|FG005|NOT COMPLETED|SD-UP||0||
60008170|NCT04510090|76124057|FG006|NOT COMPLETED|SD-UP||0||
60008171|NCT04510090|76124058|FG007|NOT COMPLETED|SD-UP||0||
60008172|NCT04510090|76124051|FG000|STARTED|MD-CP||1||
60008173|NCT04510090|76124052|FG001|STARTED|MD-CP||0||
60008174|NCT04510090|76124053|FG002|STARTED|MD-CP||0||
60008175|NCT04510090|76124054|FG003|STARTED|MD-CP||2||
60008176|NCT04510090|76124055|FG004|STARTED|MD-CP||0||
60008177|NCT04510090|76124056|FG005|STARTED|MD-CP||0||
60008178|NCT04510090|76124057|FG006|STARTED|MD-CP||0||
60008179|NCT04510090|76124058|FG007|STARTED|MD-CP||0||
60008180|NCT04510090|76124051|FG000|COMPLETED|MD-CP||1||
60008181|NCT04510090|76124052|FG001|COMPLETED|MD-CP||0||
60008182|NCT04510090|76124053|FG002|COMPLETED|MD-CP||0||
60008183|NCT04510090|76124054|FG003|COMPLETED|MD-CP||2||
60008184|NCT04510090|76124055|FG004|COMPLETED|MD-CP||0||
60008185|NCT04510090|76124056|FG005|COMPLETED|MD-CP||0||
60008186|NCT04510090|76124057|FG006|COMPLETED|MD-CP||0||
60008187|NCT04510090|76124058|FG007|COMPLETED|MD-CP||0||
60008188|NCT04510090|76124051|FG000|NOT COMPLETED|MD-CP||0||
60008189|NCT04510090|76124052|FG001|NOT COMPLETED|MD-CP||0||
60008190|NCT04510090|76124053|FG002|NOT COMPLETED|MD-CP||0||
60008191|NCT04510090|76124054|FG003|NOT COMPLETED|MD-CP||0||
60008192|NCT04510090|76124055|FG004|NOT COMPLETED|MD-CP||0||
60008193|NCT04510090|76124056|FG005|NOT COMPLETED|MD-CP||0||
60008194|NCT04510090|76124057|FG006|NOT COMPLETED|MD-CP||0||
60008195|NCT04510090|76124058|FG007|NOT COMPLETED|MD-CP||0||
60008196|NCT04510090|76124051|FG000|STARTED|MD-UP||2||
60008197|NCT04510090|76124052|FG001|STARTED|MD-UP||4||
60008198|NCT04510090|76124053|FG002|STARTED|MD-UP||0||
60008199|NCT04510090|76124054|FG003|STARTED|MD-UP||0||
60008200|NCT04510090|76124055|FG004|STARTED|MD-UP||0||
60008201|NCT04510090|76124056|FG005|STARTED|MD-UP||0||
60008202|NCT04510090|76124057|FG006|STARTED|MD-UP||0||
60008203|NCT04510090|76124058|FG007|STARTED|MD-UP||0||
60008204|NCT04510090|76124051|FG000|COMPLETED|MD-UP||2||
60008205|NCT04510090|76124052|FG001|COMPLETED|MD-UP||4||
60008206|NCT04510090|76124053|FG002|COMPLETED|MD-UP||0||
60008207|NCT04510090|76124054|FG003|COMPLETED|MD-UP||0||
60008208|NCT04510090|76124055|FG004|COMPLETED|MD-UP||0||
60008209|NCT04510090|76124056|FG005|COMPLETED|MD-UP||0||
60008210|NCT04510090|76124057|FG006|COMPLETED|MD-UP||0||
60008211|NCT04510090|76124058|FG007|COMPLETED|MD-UP||0||
60008212|NCT04510090|76124051|FG000|NOT COMPLETED|MD-UP||0||
60008213|NCT04510090|76124052|FG001|NOT COMPLETED|MD-UP||0||
60008214|NCT04510090|76124053|FG002|NOT COMPLETED|MD-UP||0||
60008215|NCT04510090|76124054|FG003|NOT COMPLETED|MD-UP||0||
60008216|NCT04510090|76124055|FG004|NOT COMPLETED|MD-UP||0||
60008217|NCT04510090|76124056|FG005|NOT COMPLETED|MD-UP||0||
60008218|NCT04510090|76124057|FG006|NOT COMPLETED|MD-UP||0||
60008219|NCT04510090|76124058|FG007|NOT COMPLETED|MD-UP||0||
60008220|NCT04491006|76124088|FG000|STARTED|Overall Study||24||
60008221|NCT04491006|76124089|FG001|STARTED|Overall Study||27||
60008222|NCT04491006|76124090|FG002|STARTED|Overall Study||26||
60008223|NCT04491006|76124088|FG000|COMPLETED|Overall Study||23||
60008224|NCT04491006|76124089|FG001|COMPLETED|Overall Study||24||
60008225|NCT04491006|76124090|FG002|COMPLETED|Overall Study||19||
60008226|NCT04491006|76124088|FG000|NOT COMPLETED|Overall Study||1||
60008227|NCT04491006|76124089|FG001|NOT COMPLETED|Overall Study||3||
60008228|NCT04491006|76124090|FG002|NOT COMPLETED|Overall Study||7||
59751233|NCT00659269|75870472|FG000|Group 2 (Vinca Alkaloids)|Overall Study||12||
60008229|NCT04436510|76124100|FG000|STARTED|Overall Study||126||
60008230|NCT04436510|76124101|FG001|STARTED|Overall Study||41||
60008231|NCT04436510|76124100|FG000|COMPLETED|Overall Study||95||
60008232|NCT04436510|76124101|FG001|COMPLETED|Overall Study||35||
60008233|NCT04436510|76124100|FG000|NOT COMPLETED|Overall Study||31||
60008234|NCT04436510|76124101|FG001|NOT COMPLETED|Overall Study||6||
60008235|NCT04365400|76124110|FG000|STARTED|Overall Study||79||
60008236|NCT04365400|76124111|FG001|STARTED|Overall Study||77||
60008237|NCT04365400|76124112|FG002|STARTED|Overall Study||77||
60008238|NCT04365400|76124110|FG000|COMPLETED|Overall Study||49||
60008239|NCT04365400|76124111|FG001|COMPLETED|Overall Study||50||
60008240|NCT04365400|76124112|FG002|COMPLETED|Overall Study||50||
60008241|NCT04365400|76124110|FG000|NOT COMPLETED|Overall Study||30||
60008242|NCT04365400|76124111|FG001|NOT COMPLETED|Overall Study||27||
60008243|NCT04365400|76124112|FG002|NOT COMPLETED|Overall Study||27||
60008244|NCT04343222|76124123|FG000|STARTED|Overall Study||16||
60008245|NCT04343222|76124124|FG001|STARTED|Overall Study||15||
60008246|NCT04343222|76124125|FG002|STARTED|Overall Study||15||
60008247|NCT04343222|76124123|FG000|COMPLETED|Overall Study||16||
60008248|NCT04343222|76124124|FG001|COMPLETED|Overall Study||15||
60008249|NCT04343222|76124125|FG002|COMPLETED|Overall Study||15||
60008250|NCT04343222|76124123|FG000|NOT COMPLETED|Overall Study||0||
60008251|NCT04343222|76124124|FG001|NOT COMPLETED|Overall Study||0||
60008252|NCT04343222|76124125|FG002|NOT COMPLETED|Overall Study||0||
60008253|NCT04162470|76124133|FG000|STARTED|Overall Study||24||
60008254|NCT04162470|76124133|FG000|COMPLETED|Overall Study||0||
60008255|NCT04162470|76124133|FG000|NOT COMPLETED|Overall Study||24||
60008256|NCT04122625|76124143|FG000|STARTED|Part A (up to 2.92 Years)||3||
60008257|NCT04122625|76124144|FG001|STARTED|Part A (up to 2.92 Years)||8||
60008258|NCT04122625|76124145|FG002|STARTED|Part A (up to 2.92 Years)||0||
60008259|NCT04122625|76124146|FG003|STARTED|Part A (up to 2.92 Years)||0||
60008260|NCT04122625|76124147|FG004|STARTED|Part A (up to 2.92 Years)||0||
60008261|NCT04122625|76124148|FG005|STARTED|Part A (up to 2.92 Years)||0||
60008262|NCT04122625|76124143|FG000|COMPLETED|Part A (up to 2.92 Years)||1|Completed also includes 1 participant in arm group, Part A: Debio 1143 200 mg + Nivolumab who entered and completed the extension phase of Part A.|
60008263|NCT04122625|76124144|FG001|COMPLETED|Part A (up to 2.92 Years)||4|Completed also includes 1 participant in arm group, Part A: Debio 1143 200 mg + Nivolumab who entered and completed the extension phase of Part A.|
60008264|NCT04122625|76124145|FG002|COMPLETED|Part A (up to 2.92 Years)||0|Completed also includes 1 participant in arm group, Part A: Debio 1143 200 mg + Nivolumab who entered and completed the extension phase of Part A.|
60008265|NCT04122625|76124146|FG003|COMPLETED|Part A (up to 2.92 Years)||0|Completed also includes 1 participant in arm group, Part A: Debio 1143 200 mg + Nivolumab who entered and completed the extension phase of Part A.|
60008266|NCT04122625|76124147|FG004|COMPLETED|Part A (up to 2.92 Years)||0|Completed also includes 1 participant in arm group, Part A: Debio 1143 200 mg + Nivolumab who entered and completed the extension phase of Part A.|
60008267|NCT04122625|76124148|FG005|COMPLETED|Part A (up to 2.92 Years)||0|Completed also includes 1 participant in arm group, Part A: Debio 1143 200 mg + Nivolumab who entered and completed the extension phase of Part A.|
60008268|NCT04122625|76124143|FG000|NOT COMPLETED|Part A (up to 2.92 Years)||2||
60008269|NCT04122625|76124144|FG001|NOT COMPLETED|Part A (up to 2.92 Years)||4||
60008270|NCT04122625|76124145|FG002|NOT COMPLETED|Part A (up to 2.92 Years)||0||
60008271|NCT04122625|76124146|FG003|NOT COMPLETED|Part A (up to 2.92 Years)||0||
60008272|NCT04122625|76124147|FG004|NOT COMPLETED|Part A (up to 2.92 Years)||0||
60008273|NCT04122625|76124148|FG005|NOT COMPLETED|Part A (up to 2.92 Years)||0||
59751234|NCT00659269|75870473|FG001|Group 2 (Vinca Alkaloids)|Overall Study||12||
59751235|NCT00659269|75870472|FG000|Group 3 (Taxanes)|Overall Study||92||
60008274|NCT04122625|76124143|FG000|STARTED|Part B (up to 2.33 Years)||0||
60008275|NCT04122625|76124144|FG001|STARTED|Part B (up to 2.33 Years)||0||
60008276|NCT04122625|76124145|FG002|STARTED|Part B (up to 2.33 Years)||8||
60008277|NCT04122625|76124146|FG003|STARTED|Part B (up to 2.33 Years)||8||
60008278|NCT04122625|76124147|FG004|STARTED|Part B (up to 2.33 Years)||8||
60008279|NCT04122625|76124148|FG005|STARTED|Part B (up to 2.33 Years)||11||
60008280|NCT04122625|76124143|FG000|COMPLETED|Part B (up to 2.33 Years)||0||
60008281|NCT04122625|76124144|FG001|COMPLETED|Part B (up to 2.33 Years)||0||
60008282|NCT04122625|76124145|FG002|COMPLETED|Part B (up to 2.33 Years)||2||
60008283|NCT04122625|76124146|FG003|COMPLETED|Part B (up to 2.33 Years)||0||
60008284|NCT04122625|76124147|FG004|COMPLETED|Part B (up to 2.33 Years)||0||
59751236|NCT00659269|75870473|FG001|Group 3 (Taxanes)|Overall Study||97||
59751237|NCT00659269|75870472|FG000|COMPLETED|Overall Study||156||
59751238|NCT00659269|75870473|FG001|COMPLETED|Overall Study||161||
59751239|NCT00659269|75870472|FG000|NOT COMPLETED|Overall Study||1||
59751240|NCT00659269|75870473|FG001|NOT COMPLETED|Overall Study||1||
59881295|NCT04397445|76004205|FG002|COMPLETED|Overall Study||4||
59881296|NCT04397445|76004206|FG003|COMPLETED|Overall Study||4||
59881297|NCT04397445|76004203|FG000|NOT COMPLETED|Overall Study||1||
59881298|NCT04397445|76004204|FG001|NOT COMPLETED|Overall Study||0||
59881299|NCT04397445|76004205|FG002|NOT COMPLETED|Overall Study||0||
59881300|NCT04397445|76004206|FG003|NOT COMPLETED|Overall Study||0||
59881301|NCT00191945|76004223|FG000|STARTED|Double-Blind Acute Treatment||100||
59881302|NCT00191945|76004224|FG001|STARTED|Double-Blind Acute Treatment||51||
59881303|NCT00191945|76004223|FG000|COMPLETED|Double-Blind Acute Treatment||94||
60008285|NCT04122625|76124148|FG005|COMPLETED|Part B (up to 2.33 Years)||4||
60008286|NCT04122625|76124143|FG000|NOT COMPLETED|Part B (up to 2.33 Years)||0||
60008287|NCT04122625|76124144|FG001|NOT COMPLETED|Part B (up to 2.33 Years)||0||
60008288|NCT04122625|76124145|FG002|NOT COMPLETED|Part B (up to 2.33 Years)||6||
60008289|NCT04122625|76124146|FG003|NOT COMPLETED|Part B (up to 2.33 Years)||8||
60008290|NCT04122625|76124147|FG004|NOT COMPLETED|Part B (up to 2.33 Years)||8||
60008291|NCT04122625|76124148|FG005|NOT COMPLETED|Part B (up to 2.33 Years)||7||
60008292|NCT03824704|76124166|FG000|STARTED|Overall Study||1||
60008293|NCT03824704|76124166|FG000|COMPLETED|Overall Study||0||
60008294|NCT03824704|76124166|FG000|NOT COMPLETED|Overall Study||1||
60008295|NCT03800537|76124170|FG000|STARTED|Overall Study||14||
60008296|NCT03800537|76124170|FG000|COMPLETED|Overall Study||10||
60008297|NCT03800537|76124170|FG000|NOT COMPLETED|Overall Study||4||
60008298|NCT03766581|76124182|FG000|STARTED|Randomization||691||
60008299|NCT03766581|76124183|FG001|STARTED|Randomization||328||
60008300|NCT03766581|76124184|FG002|STARTED|Randomization||318||
60136130|NCT01408043|76258803|FG000|NOT COMPLETED|Overall Study||1||
59751241|NCT00658333|75870490|FG000|STARTED|Overall Study||15||
59751242|NCT00658333|75870491|FG001|STARTED|Overall Study||15||
59751243|NCT00658333|75870490|FG000|COMPLETED|Overall Study||13||
60008301|NCT03766581|76124185|FG003|STARTED|Randomization||328||
60008302|NCT03766581|76124186|FG004|STARTED|Randomization||310||
60008303|NCT03766581|76124187|FG005|STARTED|Randomization||351||
60008304|NCT03766581|76124188|FG006|STARTED|Randomization||22||
60008305|NCT03766581|76124189|FG007|STARTED|Randomization||18||
60008306|NCT03766581|76124182|FG000|COMPLETED|Randomization||682||
60008307|NCT03766581|76124183|FG001|COMPLETED|Randomization||324||
60008308|NCT03766581|76124184|FG002|COMPLETED|Randomization||313||
60008309|NCT03766581|76124185|FG003|COMPLETED|Randomization||325||
60008310|NCT03766581|76124186|FG004|COMPLETED|Randomization||306||
60008311|NCT03766581|76124187|FG005|COMPLETED|Randomization||345||
60008312|NCT03766581|76124188|FG006|COMPLETED|Randomization||22||
60008313|NCT03766581|76124189|FG007|COMPLETED|Randomization||17||
60008314|NCT03766581|76124182|FG000|NOT COMPLETED|Randomization||9||
60008315|NCT03766581|76124183|FG001|NOT COMPLETED|Randomization||4||
60008316|NCT03766581|76124184|FG002|NOT COMPLETED|Randomization||5||
60008317|NCT03766581|76124185|FG003|NOT COMPLETED|Randomization||3||
60008318|NCT03766581|76124186|FG004|NOT COMPLETED|Randomization||4||
60008319|NCT03766581|76124187|FG005|NOT COMPLETED|Randomization||6||
60008320|NCT03766581|76124188|FG006|NOT COMPLETED|Randomization||0||
60008321|NCT03766581|76124189|FG007|NOT COMPLETED|Randomization||1||
60008322|NCT03766581|76124182|FG000|STARTED|Treatment||682||
60008323|NCT03766581|76124183|FG001|STARTED|Treatment|1 participant was randomized to Milvexian 200 mg BID, but received Milvexian 25 mg QD.|325||
60008324|NCT03766581|76124184|FG002|STARTED|Treatment||313||
60008325|NCT03766581|76124185|FG003|STARTED|Treatment||325||
60008326|NCT03766581|76124186|FG004|STARTED|Treatment||306||
60008327|NCT03766581|76124187|FG005|STARTED|Treatment|1 participant was randomized to Milvexian 200 mg BID, but received Milvexian 25 mg QD.|344||
60008328|NCT03766581|76124188|FG006|STARTED|Treatment||22||
60008329|NCT03766581|76124189|FG007|STARTED|Treatment||17||
60008330|NCT03766581|76124182|FG000|COMPLETED|Treatment||529||
60008331|NCT03766581|76124183|FG001|COMPLETED|Treatment||260||
60008332|NCT03766581|76124184|FG002|COMPLETED|Treatment||242||
60008333|NCT03766581|76124185|FG003|COMPLETED|Treatment||251||
60008334|NCT03766581|76124186|FG004|COMPLETED|Treatment||230||
60008335|NCT03766581|76124187|FG005|COMPLETED|Treatment||240||
60008336|NCT03766581|76124188|FG006|COMPLETED|Treatment||15||
60008337|NCT03766581|76124189|FG007|COMPLETED|Treatment||14||
60008338|NCT03766581|76124182|FG000|NOT COMPLETED|Treatment||153||
60008339|NCT03766581|76124183|FG001|NOT COMPLETED|Treatment||65||
60008340|NCT03766581|76124184|FG002|NOT COMPLETED|Treatment||71||
60008341|NCT03766581|76124185|FG003|NOT COMPLETED|Treatment||74||
60008342|NCT03766581|76124186|FG004|NOT COMPLETED|Treatment||76||
60008343|NCT03766581|76124187|FG005|NOT COMPLETED|Treatment||104||
60008344|NCT03766581|76124188|FG006|NOT COMPLETED|Treatment||7||
60008345|NCT03766581|76124189|FG007|NOT COMPLETED|Treatment||3||
60008346|NCT03675321|76124214|FG000|STARTED|Overall Study||54||
60008347|NCT03675321|76124215|FG001|STARTED|Overall Study||54||
60008348|NCT03675321|76124214|FG000|COMPLETED|Overall Study||51||
60008349|NCT03675321|76124215|FG001|COMPLETED|Overall Study||49||
60008350|NCT03675321|76124214|FG000|NOT COMPLETED|Overall Study||3||
60008351|NCT03675321|76124215|FG001|NOT COMPLETED|Overall Study||5||
60008352|NCT03613363|76124223|FG000|STARTED|Overall Study||20||
60008353|NCT03613363|76124223|FG000|COMPLETED|Overall Study||20||
60008354|NCT03613363|76124223|FG000|NOT COMPLETED|Overall Study||0||
60008355|NCT03538262|76124231|FG000|STARTED|Overall Study||226||
60008356|NCT03538262|76124231|FG000|COMPLETED|Overall Study||203||
60008357|NCT03538262|76124231|FG000|NOT COMPLETED|Overall Study||23||
60008358|NCT03527745|76124261|FG000|STARTED|Overall Study||27||
60008359|NCT03527745|76124262|FG001|STARTED|Overall Study||27||
60008360|NCT03527745|76124263|FG002|STARTED|Overall Study||30||
60008361|NCT03527745|76124264|FG003|STARTED|Overall Study||27||
60008362|NCT03527745|76124265|FG004|STARTED|Overall Study||46||
60008363|NCT03527745|76124266|FG005|STARTED|Overall Study||45||
60008364|NCT03527745|76124267|FG006|STARTED|Overall Study||46||
60008365|NCT03527745|76124268|FG007|STARTED|Overall Study||43||
60008366|NCT03527745|76124269|FG008|STARTED|Overall Study||10||
60008367|NCT03527745|76124270|FG009|STARTED|Overall Study||11||
60008368|NCT03527745|76124271|FG010|STARTED|Overall Study||9||
60008369|NCT03527745|76124272|FG011|STARTED|Overall Study||12||
60008370|NCT03527745|76124273|FG012|STARTED|Overall Study|During screening, the principal investigator decided to remove the this arm due to recruitment.|0||
60008371|NCT03527745|76124274|FG013|STARTED|Overall Study||13||
60008372|NCT03527745|76124275|FG014|STARTED|Overall Study||13||
60008373|NCT03527745|76124276|FG015|STARTED|Overall Study||12||
60008374|NCT03527745|76124277|FG016|STARTED|Overall Study||24||
60008375|NCT03527745|76124278|FG017|STARTED|Overall Study||27||
60008376|NCT03527745|76124279|FG018|STARTED|Overall Study||27||
60008377|NCT03527745|76124280|FG019|STARTED|Overall Study||29||
60008378|NCT03527745|76124281|FG020|STARTED|Overall Study||26||
60008379|NCT03527745|76124282|FG021|STARTED|Overall Study||40||
60008380|NCT03527745|76124283|FG022|STARTED|Overall Study||41||
60008381|NCT03527745|76124284|FG023|STARTED|Overall Study||38||
60008382|NCT03527745|76124285|FG024|STARTED|Overall Study||40||
60008383|NCT03527745|76124286|FG025|STARTED|Overall Study||37||
60008384|NCT03527745|76124261|FG000|COMPLETED|Overall Study||24||
60008385|NCT03527745|76124262|FG001|COMPLETED|Overall Study||21||
60008386|NCT03527745|76124263|FG002|COMPLETED|Overall Study||23||
60008387|NCT03527745|76124264|FG003|COMPLETED|Overall Study||18||
60008388|NCT03527745|76124265|FG004|COMPLETED|Overall Study||46||
60008389|NCT03527745|76124266|FG005|COMPLETED|Overall Study||43||
60008390|NCT03527745|76124267|FG006|COMPLETED|Overall Study||43||
60008391|NCT03527745|76124268|FG007|COMPLETED|Overall Study||41||
60008392|NCT03527745|76124269|FG008|COMPLETED|Overall Study||7||
60008393|NCT03527745|76124270|FG009|COMPLETED|Overall Study||9||
59605656|NCT01966068|75715829|FG000|COMPLETED|Overall Study||156||
59605657|NCT01966068|75715829|FG000|NOT COMPLETED|Overall Study||138||
59605658|NCT01620528|75715837|FG000|STARTED|Treatment Period||374||
59605659|NCT01620528|75715838|FG001|STARTED|Treatment Period||249||
59605660|NCT01620528|75715839|FG002|STARTED|Treatment Period|1 subject did not receive study drug|249||
59605661|NCT01620528|75715837|FG000|COMPLETED|Treatment Period||274||
59605662|NCT01620528|75715838|FG001|COMPLETED|Treatment Period||196||
59605663|NCT01620528|75715839|FG002|COMPLETED|Treatment Period||183||
59751244|NCT00658333|75870491|FG001|COMPLETED|Overall Study||14||
60008394|NCT03527745|76124271|FG010|COMPLETED|Overall Study||8||
60008395|NCT03527745|76124272|FG011|COMPLETED|Overall Study||11||
60008396|NCT03527745|76124273|FG012|COMPLETED|Overall Study||0||
60008397|NCT03527745|76124274|FG013|COMPLETED|Overall Study||13||
60008398|NCT03527745|76124275|FG014|COMPLETED|Overall Study||13||
60008399|NCT03527745|76124276|FG015|COMPLETED|Overall Study||12||
60008400|NCT03527745|76124277|FG016|COMPLETED|Overall Study||23||
60008401|NCT03527745|76124278|FG017|COMPLETED|Overall Study||27||
60008402|NCT03527745|76124279|FG018|COMPLETED|Overall Study||27||
60008403|NCT03527745|76124280|FG019|COMPLETED|Overall Study||28||
60008404|NCT03527745|76124281|FG020|COMPLETED|Overall Study||25||
60008405|NCT03527745|76124282|FG021|COMPLETED|Overall Study||35||
60008406|NCT03527745|76124283|FG022|COMPLETED|Overall Study||35||
60008407|NCT03527745|76124284|FG023|COMPLETED|Overall Study||30||
60008408|NCT03527745|76124285|FG024|COMPLETED|Overall Study||39||
60008409|NCT03527745|76124286|FG025|COMPLETED|Overall Study||34||
60008410|NCT03527745|76124261|FG000|NOT COMPLETED|Overall Study||3||
60008411|NCT03527745|76124262|FG001|NOT COMPLETED|Overall Study||6||
60008412|NCT03527745|76124263|FG002|NOT COMPLETED|Overall Study||7||
60008413|NCT03527745|76124264|FG003|NOT COMPLETED|Overall Study||9||
60008414|NCT03527745|76124265|FG004|NOT COMPLETED|Overall Study||0||
60008415|NCT03527745|76124266|FG005|NOT COMPLETED|Overall Study||2||
60008416|NCT03527745|76124267|FG006|NOT COMPLETED|Overall Study||3||
60008417|NCT03527745|76124268|FG007|NOT COMPLETED|Overall Study||2||
60008418|NCT03527745|76124269|FG008|NOT COMPLETED|Overall Study||3||
60008419|NCT03527745|76124270|FG009|NOT COMPLETED|Overall Study||2||
60008420|NCT03527745|76124271|FG010|NOT COMPLETED|Overall Study||1||
60008421|NCT03527745|76124272|FG011|NOT COMPLETED|Overall Study||1||
60008422|NCT03527745|76124273|FG012|NOT COMPLETED|Overall Study||0||
60008423|NCT03527745|76124274|FG013|NOT COMPLETED|Overall Study||0||
60008424|NCT03527745|76124275|FG014|NOT COMPLETED|Overall Study||0||
60008425|NCT03527745|76124276|FG015|NOT COMPLETED|Overall Study||0||
60008426|NCT03527745|76124277|FG016|NOT COMPLETED|Overall Study||1||
60008427|NCT03527745|76124278|FG017|NOT COMPLETED|Overall Study||0||
60008428|NCT03527745|76124279|FG018|NOT COMPLETED|Overall Study||0||
60008429|NCT03527745|76124280|FG019|NOT COMPLETED|Overall Study||1||
60008430|NCT03527745|76124281|FG020|NOT COMPLETED|Overall Study||1||
60008431|NCT03527745|76124282|FG021|NOT COMPLETED|Overall Study||5||
60008432|NCT03527745|76124283|FG022|NOT COMPLETED|Overall Study||6||
60008433|NCT03527745|76124284|FG023|NOT COMPLETED|Overall Study||8||
60008434|NCT03527745|76124285|FG024|NOT COMPLETED|Overall Study||1||
60008435|NCT03527745|76124286|FG025|NOT COMPLETED|Overall Study||3||
60008436|NCT03522584|76124362|FG000|STARTED|Overall Study||6||
60008437|NCT03522584|76124362|FG000|COMPLETED|Overall Study||6||
60008438|NCT03522584|76124362|FG000|NOT COMPLETED|Overall Study||0||
60008439|NCT03174782|76124368|FG000|STARTED|Overall Study||19||
60008440|NCT03174782|76124369|FG001|STARTED|Overall Study||23||
60008441|NCT03174782|76124368|FG000|COMPLETED|Overall Study||18||
60008442|NCT03174782|76124369|FG001|COMPLETED|Overall Study||22||
60008443|NCT03174782|76124368|FG000|NOT COMPLETED|Overall Study||1||
60008444|NCT03174782|76124369|FG001|NOT COMPLETED|Overall Study||1||
60008445|NCT02919969|76124375|FG000|STARTED|Overall Study||32||
60008446|NCT02919969|76124375|FG000|COMPLETED|Overall Study||1||
60008447|NCT02919969|76124375|FG000|NOT COMPLETED|Overall Study||31||
60008448|NCT02416622|76124383|FG000|STARTED|Overall Study||6||
60008449|NCT02416622|76124384|FG001|STARTED|Overall Study||8||
60008450|NCT02416622|76124385|FG002|STARTED|Overall Study||13||
60008451|NCT02416622|76124383|FG000|Completed Month 12|Overall Study||6||
60008452|NCT02416622|76124384|FG001|Completed Month 12|Overall Study||8||
60008453|NCT02416622|76124385|FG002|Completed Month 12|Overall Study||13||
60008454|NCT02416622|76124383|FG000|Started Long-Term Follow-Up|Overall Study||6||
60008455|NCT02416622|76124384|FG001|Started Long-Term Follow-Up|Overall Study||8||
60008456|NCT02416622|76124385|FG002|Started Long-Term Follow-Up|Overall Study||13||
60008457|NCT02416622|76124383|FG000|COMPLETED|Overall Study||0||
60008458|NCT02416622|76124384|FG001|COMPLETED|Overall Study||0||
60008459|NCT02416622|76124385|FG002|COMPLETED|Overall Study||0||
60008460|NCT02416622|76124383|FG000|NOT COMPLETED|Overall Study||6||
60008461|NCT02416622|76124384|FG001|NOT COMPLETED|Overall Study||8||
60008462|NCT02416622|76124385|FG002|NOT COMPLETED|Overall Study||13||
60008463|NCT01891344|76124397|FG000|STARTED|Overall Study||40||
60008464|NCT01891344|76124398|FG001|STARTED|Overall Study||82||
60008465|NCT01891344|76124399|FG002|STARTED|Overall Study||70||
60008466|NCT01891344|76124400|FG003|STARTED|Overall Study||12||
60008467|NCT01891344|76124401|FG004|STARTED|Overall Study||84||
60008468|NCT01891344|76124402|FG005|STARTED|Overall Study||73||
60008469|NCT01891344|76124403|FG006|STARTED|Overall Study||107||
60008470|NCT01891344|76124404|FG007|STARTED|Overall Study||23||
60008471|NCT01891344|76124397|FG000|COMPLETED|Overall Study||34||
60008472|NCT01891344|76124398|FG001|COMPLETED|Overall Study||80||
60008473|NCT01891344|76124399|FG002|COMPLETED|Overall Study||70||
60008474|NCT01891344|76124400|FG003|COMPLETED|Overall Study||11||
60008475|NCT01891344|76124401|FG004|COMPLETED|Overall Study||80||
60008476|NCT01891344|76124402|FG005|COMPLETED|Overall Study||72||
60008477|NCT01891344|76124403|FG006|COMPLETED|Overall Study||107||
60008478|NCT01891344|76124404|FG007|COMPLETED|Overall Study||23||
60008479|NCT01891344|76124397|FG000|NOT COMPLETED|Overall Study||6||
60008480|NCT01891344|76124398|FG001|NOT COMPLETED|Overall Study||2||
60008481|NCT01891344|76124399|FG002|NOT COMPLETED|Overall Study||0||
60008482|NCT01891344|76124400|FG003|NOT COMPLETED|Overall Study||1||
60008483|NCT01891344|76124401|FG004|NOT COMPLETED|Overall Study||4||
60008484|NCT01891344|76124402|FG005|NOT COMPLETED|Overall Study||1||
60008485|NCT01891344|76124403|FG006|NOT COMPLETED|Overall Study||0||
60008486|NCT01891344|76124404|FG007|NOT COMPLETED|Overall Study||0||
60008487|NCT01188096|76124422|FG000|STARTED|Overall Study||23||
60008488|NCT01188096|76124422|FG000|COMPLETED|Overall Study||17||
60008489|NCT01188096|76124422|FG000|NOT COMPLETED|Overall Study||6||
60008490|NCT00632853|76124430|FG000|STARTED|Overall Study||313||
60008491|NCT00632853|76124431|FG001|STARTED|Overall Study||325||
60008492|NCT00632853|76124432|FG002|STARTED|Overall Study||93||
60008493|NCT00632853|76124430|FG000|COMPLETED|Overall Study||313||
60008494|NCT00632853|76124431|FG001|COMPLETED|Overall Study||325||
60008495|NCT00632853|76124432|FG002|COMPLETED|Overall Study||93||
60008496|NCT00632853|76124430|FG000|NOT COMPLETED|Overall Study||0||
60008497|NCT00632853|76124431|FG001|NOT COMPLETED|Overall Study||0||
60008498|NCT00632853|76124432|FG002|NOT COMPLETED|Overall Study||0||
60008499|NCT00579826|76124442|FG000|STARTED|Overall Study||29||
60008500|NCT00579826|76124443|FG001|STARTED|Overall Study||26||
60008501|NCT00579826|76124442|FG000|6 Months|Overall Study|RPFNA for assessment for primary endpoint.|28||
60008502|NCT00579826|76124443|FG001|6 Months|Overall Study|RPFNA for assessment for primary endpoint.|25||
60008503|NCT00579826|76124442|FG000|COMPLETED|Overall Study|Optional open label letrozole months 6-12; followed by RPFNA,|24||
60008504|NCT00579826|76124443|FG001|COMPLETED|Overall Study|Optional open label letrozole months 6-12; followed by RPFNA,|23||
60008505|NCT00579826|76124442|FG000|NOT COMPLETED|Overall Study||5||
60008506|NCT00579826|76124443|FG001|NOT COMPLETED|Overall Study||3||
60008507|NCT00106691|76124451|FG000|STARTED|Overall Study||802||
60008508|NCT00106691|76124452|FG001|STARTED|Overall Study||787||
60008509|NCT00106691|76124451|FG000|COMPLETED|Overall Study||598||
60008510|NCT00106691|76124452|FG001|COMPLETED|Overall Study||588||
60008511|NCT00106691|76124451|FG000|NOT COMPLETED|Overall Study||204||
60008512|NCT00106691|76124452|FG001|NOT COMPLETED|Overall Study||199||
60008513|NCT03982043|76124462|FG000|STARTED|Overall Study||43||
60008514|NCT03982043|76124463|FG001|STARTED|Overall Study||4||
60008515|NCT03982043|76124462|FG000|COMPLETED|Overall Study||43||
60008516|NCT03982043|76124463|FG001|COMPLETED|Overall Study||4||
60008517|NCT03982043|76124462|FG000|NOT COMPLETED|Overall Study||0||
60008518|NCT03982043|76124463|FG001|NOT COMPLETED|Overall Study||0||
60008519|NCT00887783|76124472|FG000|STARTED|Overall Study||58||
60008520|NCT00887783|76124473|FG001|STARTED|Overall Study||59||
60008521|NCT00887783|76124472|FG000|COMPLETED|Overall Study||58||
60008522|NCT00887783|76124473|FG001|COMPLETED|Overall Study||59||
60008523|NCT00887783|76124472|FG000|NOT COMPLETED|Overall Study||0||
60008524|NCT00887783|76124473|FG001|NOT COMPLETED|Overall Study||0||
60008525|NCT03287843|76124481|FG000|STARTED|Overall Study||175||
60008526|NCT03287843|76124482|FG001|STARTED|Overall Study||175||
60008527|NCT03287843|76124481|FG000|Excluded|Overall Study|No surgery n=5 R2 resection n=5 Stage IV n=2|12||
60008528|NCT03287843|76124482|FG001|Excluded|Overall Study|No surgery n=4 R2 resection n=2 Stage IV n=2|8||
60008529|NCT03287843|76124481|FG000|Lost to Follow up|Overall Study||3||
60008530|NCT03287843|76124482|FG001|Lost to Follow up|Overall Study||0||
60008531|NCT03287843|76124481|FG000|COMPLETED|Overall Study||160||
60008532|NCT03287843|76124482|FG001|COMPLETED|Overall Study||167||
60008533|NCT03287843|76124481|FG000|NOT COMPLETED|Overall Study||15||
60008534|NCT03287843|76124482|FG001|NOT COMPLETED|Overall Study||8||
60008535|NCT01125371|76124491|FG000|STARTED|Overall Study||146||
60008536|NCT01125371|76124492|FG001|STARTED|Overall Study||145||
60008537|NCT01125371|76124493|FG002|STARTED|Overall Study||148||
60008538|NCT01125371|76124491|FG000|3 Months Follow up|Overall Study||127||
60008539|NCT01125371|76124492|FG001|3 Months Follow up|Overall Study||131||
60008540|NCT01125371|76124493|FG002|3 Months Follow up|Overall Study||135||
60008541|NCT01125371|76124491|FG000|6 Months Follow up|Overall Study||125||
60008542|NCT01125371|76124492|FG001|6 Months Follow up|Overall Study||133||
60008543|NCT01125371|76124493|FG002|6 Months Follow up|Overall Study||131||
60008544|NCT01125371|76124491|FG000|12 Months Follow up|Overall Study||120||
60008545|NCT01125371|76124492|FG001|12 Months Follow up|Overall Study||130||
60008546|NCT01125371|76124493|FG002|12 Months Follow up|Overall Study||129||
60008547|NCT01125371|76124491|FG000|COMPLETED|Overall Study||120||
60008548|NCT01125371|76124492|FG001|COMPLETED|Overall Study||130||
60008549|NCT01125371|76124493|FG002|COMPLETED|Overall Study||129||
60008550|NCT01125371|76124491|FG000|NOT COMPLETED|Overall Study||26||
60008551|NCT01125371|76124492|FG001|NOT COMPLETED|Overall Study||15||
60008552|NCT01125371|76124493|FG002|NOT COMPLETED|Overall Study||19||
60008553|NCT00416351|76124506|FG000|STARTED|Overall Study||1||
60008554|NCT00416351|76124507|FG001|STARTED|Overall Study||3||
60008555|NCT00416351|76124508|FG002|STARTED|Overall Study||4||
60008556|NCT00416351|76124509|FG003|STARTED|Overall Study||17||
60008557|NCT00416351|76124510|FG004|STARTED|Overall Study||4||
60008558|NCT00416351|76124506|FG000|COMPLETED|Overall Study||1||
60008559|NCT00416351|76124507|FG001|COMPLETED|Overall Study||3||
60008560|NCT00416351|76124508|FG002|COMPLETED|Overall Study||4||
60008561|NCT00416351|76124509|FG003|COMPLETED|Overall Study||17||
60008562|NCT00416351|76124510|FG004|COMPLETED|Overall Study||4||
60008563|NCT00416351|76124506|FG000|NOT COMPLETED|Overall Study||0||
60008564|NCT00416351|76124507|FG001|NOT COMPLETED|Overall Study||0||
60008565|NCT00416351|76124508|FG002|NOT COMPLETED|Overall Study||0||
60008566|NCT00416351|76124509|FG003|NOT COMPLETED|Overall Study||0||
60008567|NCT00416351|76124510|FG004|NOT COMPLETED|Overall Study||0||
60008568|NCT03947333|76124529|FG000|STARTED|Overall Study||135||
60008569|NCT03947333|76124530|FG001|STARTED|Overall Study||135||
60008570|NCT03947333|76124529|FG000|COMPLETED|Overall Study||135||
60008571|NCT03947333|76124530|FG001|COMPLETED|Overall Study||135||
60008572|NCT03947333|76124529|FG000|NOT COMPLETED|Overall Study||0||
60008573|NCT03947333|76124530|FG001|NOT COMPLETED|Overall Study||0||
60008574|NCT00418301|76124537|FG000|STARTED|Overall Study||15||
60008575|NCT00418301|76124537|FG000|COMPLETED|Overall Study||12||
60008576|NCT00418301|76124537|FG000|NOT COMPLETED|Overall Study||3||
60008577|NCT02644967|76124541|FG000|STARTED|Overall Study|All participants who received at least 1 dose of study treatment (8 mg Tilso/Ipi) including nine rollover participants from the Phase 1 study.|53||
60008578|NCT02644967|76124541|FG000|COMPLETED|Overall Study||18||
60008579|NCT02644967|76124541|FG000|NOT COMPLETED|Overall Study||35||
60008580|NCT02644343|76124545|FG000|STARTED|Overall Study||40||
60008581|NCT02644343|76124545|FG000|COMPLETED|Overall Study||39||
60008582|NCT02644343|76124545|FG000|NOT COMPLETED|Overall Study||1||
60008583|NCT02644109|76124551|FG000|STARTED|Overall Study||24||
60008584|NCT02644109|76124552|FG001|STARTED|Overall Study||28||
60008585|NCT02644109|76124551|FG000|COMPLETED|Overall Study||24||
60008586|NCT02644109|76124552|FG001|COMPLETED|Overall Study||24||
60008587|NCT02644109|76124551|FG000|NOT COMPLETED|Overall Study||0||
60008588|NCT02644109|76124552|FG001|NOT COMPLETED|Overall Study||4||
60008589|NCT02642159|76124560|FG000|STARTED|Overall Study|Randomized|276||
60008590|NCT02642159|76124561|FG001|STARTED|Overall Study|Randomized|137||
60008591|NCT02642159|76124560|FG000|Treated (Safety Population)|Overall Study||275||
60008592|NCT02642159|76124561|FG001|Treated (Safety Population)|Overall Study||137||
60008593|NCT02642159|76124560|FG000|ITT Population|Overall Study||273||
60008594|NCT02642159|76124561|FG001|ITT Population|Overall Study||136||
60008595|NCT02642159|76124560|FG000|ITT: Intent to Prescribe Fenofibrate|Overall Study|Fenofibrate was only 'intended to prescribe' in the Alirocumab arm but not actually administered.|47||
60008596|NCT02642159|76124561|FG001|ITT: Intent to Prescribe Fenofibrate|Overall Study||24||
60008597|NCT02642159|76124560|FG000|COMPLETED|Overall Study||245|Completed = treatment completion|
60008598|NCT02642159|76124561|FG001|COMPLETED|Overall Study||129|Completed = treatment completion|
60008599|NCT02642159|76124560|FG000|NOT COMPLETED|Overall Study||31||
60008600|NCT02642159|76124561|FG001|NOT COMPLETED|Overall Study||8||
60008601|NCT02669017|76124577|FG000|STARTED|Overall Study||4||
60008602|NCT02669017|76124578|FG001|STARTED|Overall Study||4||
60008603|NCT02669017|76124579|FG002|STARTED|Overall Study||4||
60008604|NCT02669017|76124580|FG003|STARTED|Overall Study||5||
60008605|NCT02669017|76124581|FG004|STARTED|Overall Study||16||
60008606|NCT02669017|76124582|FG005|STARTED|Overall Study||26||
60008607|NCT02669017|76124583|FG006|STARTED|Overall Study||19||
60008608|NCT02669017|76124584|FG007|STARTED|Overall Study||69||
60008609|NCT02669017|76124585|FG008|STARTED|Overall Study||36||
60008610|NCT02669017|76124577|FG000|COMPLETED|Overall Study||3||
60008611|NCT02669017|76124578|FG001|COMPLETED|Overall Study||2||
60008612|NCT02669017|76124579|FG002|COMPLETED|Overall Study||2||
60008613|NCT02669017|76124580|FG003|COMPLETED|Overall Study||1||
60008614|NCT02669017|76124581|FG004|COMPLETED|Overall Study||4||
60008615|NCT02669017|76124582|FG005|COMPLETED|Overall Study||7||
60008616|NCT02669017|76124583|FG006|COMPLETED|Overall Study||8||
60008617|NCT02669017|76124584|FG007|COMPLETED|Overall Study||7||
60008618|NCT02669017|76124585|FG008|COMPLETED|Overall Study||11||
60008619|NCT02669017|76124577|FG000|NOT COMPLETED|Overall Study||1||
60008620|NCT02669017|76124578|FG001|NOT COMPLETED|Overall Study||2||
60008621|NCT02669017|76124579|FG002|NOT COMPLETED|Overall Study||2||
60008622|NCT02669017|76124580|FG003|NOT COMPLETED|Overall Study||4||
60008623|NCT02669017|76124581|FG004|NOT COMPLETED|Overall Study||12||
60008624|NCT02669017|76124582|FG005|NOT COMPLETED|Overall Study||19||
60008625|NCT02669017|76124583|FG006|NOT COMPLETED|Overall Study||11||
60008626|NCT02669017|76124584|FG007|NOT COMPLETED|Overall Study||62||
60008627|NCT02669017|76124585|FG008|NOT COMPLETED|Overall Study||25||
60008628|NCT02668393|76124615|FG000|STARTED|Overall Study||7||
60008629|NCT02668393|76124616|FG001|STARTED|Overall Study||7||
60008630|NCT02668393|76124615|FG000|COMPLETED|Overall Study||0||
60008631|NCT02668393|76124616|FG001|COMPLETED|Overall Study||1||
60008632|NCT02668393|76124615|FG000|NOT COMPLETED|Overall Study||7||
60008633|NCT02668393|76124616|FG001|NOT COMPLETED|Overall Study||6||
60008634|NCT01998958|76124630|FG000|STARTED|Period 1 (Panel A and B)||33||
60008635|NCT01998958|76124631|FG001|STARTED|Period 1 (Panel A and B)||11||
60008636|NCT01998958|76124632|FG002|STARTED|Period 1 (Panel A and B)||11||
60008637|NCT01998958|76124633|FG003|STARTED|Period 1 (Panel A and B)||12||
60008638|NCT01998958|76124634|FG004|STARTED|Period 1 (Panel A and B)||21||
60008639|NCT01998958|76124635|FG005|STARTED|Period 1 (Panel A and B)||11||
60008640|NCT01998958|76124636|FG006|STARTED|Period 1 (Panel A and B)||9||
60008641|NCT01998958|76124637|FG007|STARTED|Period 1 (Panel A and B)||0||
60008642|NCT01998958|76124638|FG008|STARTED|Period 1 (Panel A and B)||0||
60008643|NCT01998958|76124639|FG009|STARTED|Period 1 (Panel A and B)||0||
60008644|NCT01998958|76124640|FG010|STARTED|Period 1 (Panel A and B)||0||
60008645|NCT01998958|76124641|FG011|STARTED|Period 1 (Panel A and B)||0||
59605664|NCT01620528|75715837|FG000|NOT COMPLETED|Treatment Period||100||
59605665|NCT01620528|75715838|FG001|NOT COMPLETED|Treatment Period||53||
59605666|NCT01620528|75715839|FG002|NOT COMPLETED|Treatment Period||66||
59881304|NCT00191945|76004224|FG001|COMPLETED|Double-Blind Acute Treatment||48||
59881305|NCT00191945|76004223|FG000|NOT COMPLETED|Double-Blind Acute Treatment||6||
59881306|NCT00191945|76004224|FG001|NOT COMPLETED|Double-Blind Acute Treatment||3||
59881307|NCT00191945|76004223|FG000|STARTED|Open-Label Treatment Extension||94||
59881308|NCT00191945|76004224|FG001|STARTED|Open-Label Treatment Extension||48||
59881309|NCT00191945|76004223|FG000|COMPLETED|Open-Label Treatment Extension||94||
59881310|NCT00191945|76004224|FG001|COMPLETED|Open-Label Treatment Extension||48||
59881311|NCT00191945|76004223|FG000|NOT COMPLETED|Open-Label Treatment Extension||0||
59881312|NCT00191945|76004224|FG001|NOT COMPLETED|Open-Label Treatment Extension||0||
59881313|NCT01369342|76004234|FG000|STARTED|Overall Study||214||
59881314|NCT01369342|76004235|FG001|STARTED|Overall Study||213||
59881315|NCT01369342|76004236|FG002|STARTED|Overall Study||213||
59881316|NCT01369342|76004234|FG000|COMPLETED|Overall Study||201||
59881317|NCT01369342|76004235|FG001|COMPLETED|Overall Study||204||
59881318|NCT01369342|76004236|FG002|COMPLETED|Overall Study||210||
59881319|NCT01369342|76004234|FG000|NOT COMPLETED|Overall Study||13||
59881320|NCT01369342|76004235|FG001|NOT COMPLETED|Overall Study||9||
59881321|NCT01369342|76004236|FG002|NOT COMPLETED|Overall Study||3||
59881322|NCT00191477|76004246|FG000|STARTED|Overall Study||179||
59881323|NCT00191477|76004247|FG001|STARTED|Overall Study||176||
59881324|NCT00191477|76004246|FG000|Received Study Drug|Overall Study||166||
59881325|NCT00191477|76004247|FG001|Received Study Drug|Overall Study||162||
59881326|NCT00191477|76004246|FG000|COMPLETED|Overall Study||41||
59881327|NCT00191477|76004247|FG001|COMPLETED|Overall Study||47||
59881328|NCT00191477|76004246|FG000|NOT COMPLETED|Overall Study||138||
59881329|NCT00191477|76004247|FG001|NOT COMPLETED|Overall Study||129||
59881330|NCT04320615|76004255|FG000|STARTED|Overall Study||144||
59881331|NCT04320615|76004256|FG001|STARTED|Overall Study||294||
59881332|NCT04320615|76004255|FG000|COMPLETED|Overall Study||96||
59881333|NCT04320615|76004256|FG001|COMPLETED|Overall Study||190||
59881334|NCT04320615|76004255|FG000|NOT COMPLETED|Overall Study||48||
59881335|NCT04320615|76004256|FG001|NOT COMPLETED|Overall Study||104||
59881336|NCT00149747|76004268|FG000|STARTED|Overall Study||36||
59881337|NCT00149747|76004269|FG001|STARTED|Overall Study||30||
59881338|NCT00149747|76004268|FG000|COMPLETED|Overall Study||32||
59881339|NCT00149747|76004269|FG001|COMPLETED|Overall Study||27||
59881340|NCT00149747|76004268|FG000|NOT COMPLETED|Overall Study||4||
59881341|NCT00149747|76004269|FG001|NOT COMPLETED|Overall Study||3||
59881342|NCT00187889|76004277|FG000|STARTED|Overall Study||25||
59881343|NCT00187889|76004278|FG001|STARTED|Overall Study||26||
59881344|NCT00187889|76004277|FG000|COMPLETED|Overall Study||19||
59881345|NCT00187889|76004278|FG001|COMPLETED|Overall Study||22||
59881346|NCT00187889|76004277|FG000|NOT COMPLETED|Overall Study||6||
59881347|NCT00187889|76004278|FG001|NOT COMPLETED|Overall Study||4||
59881348|NCT00148343|76004287|FG000|STARTED|Overall Study||54||
59881349|NCT00148343|76004288|FG001|STARTED|Overall Study||56||
59881350|NCT00148343|76004287|FG000|COMPLETED|Overall Study||39||
59881351|NCT00148343|76004288|FG001|COMPLETED|Overall Study||45||
59881352|NCT00148343|76004287|FG000|NOT COMPLETED|Overall Study||15||
59881353|NCT00148343|76004288|FG001|NOT COMPLETED|Overall Study||11||
59881354|NCT04150341|76004294|FG000|STARTED|Overall Study||4||
59881355|NCT04150341|76004295|FG001|STARTED|Overall Study||4||
59881356|NCT04150341|76004296|FG002|STARTED|Overall Study||4||
59881357|NCT04150341|76004297|FG003|STARTED|Overall Study||4||
59605667|NCT01620528|75715837|FG000|STARTED|Post-Treatment Follow-Up Period|elected to enter the PTFU Period|68||
59605668|NCT01620528|75715838|FG001|STARTED|Post-Treatment Follow-Up Period|elected to enter the PTFU Period|48||
59605669|NCT01620528|75715839|FG002|STARTED|Post-Treatment Follow-Up Period|elected to enter the PTFU Period|51||
59605670|NCT01620528|75715837|FG000|Completed PTFU Month 6|Post-Treatment Follow-Up Period||46|Met criteria (reported post-treatment menses, met the DXA criteria, and had a PTFU Month 6 visit).|
59613481|NCT01684878|75724610|FG000|Participants Randomized But Not Treated|Part 2: Randomized Phase||0||
59881358|NCT04150341|76004298|FG004|STARTED|Overall Study||4||
59881359|NCT04150341|76004299|FG005|STARTED|Overall Study||4||
59881360|NCT04150341|76004294|FG000|COMPLETED|Overall Study||4||
59881361|NCT04150341|76004295|FG001|COMPLETED|Overall Study||4||
59881362|NCT04150341|76004296|FG002|COMPLETED|Overall Study||3||
59881363|NCT04150341|76004297|FG003|COMPLETED|Overall Study||4||
59751245|NCT00658333|75870490|FG000|NOT COMPLETED|Overall Study||2||
59751246|NCT00658333|75870491|FG001|NOT COMPLETED|Overall Study||1||
59751247|NCT00570037|75870499|FG000|STARTED|Overall Study||238||
59751248|NCT00570037|75870500|FG001|STARTED|Overall Study||306||
59751249|NCT00570037|75870499|FG000|COMPLETED|Overall Study||194||
59751250|NCT00570037|75870500|FG001|COMPLETED|Overall Study||237||
59751251|NCT00570037|75870499|FG000|NOT COMPLETED|Overall Study||44||
59751252|NCT00570037|75870500|FG001|NOT COMPLETED|Overall Study||69||
59751253|NCT00863655|75870508|FG000|STARTED|Overall Study||485||
59751254|NCT00863655|75870509|FG001|STARTED|Overall Study||239||
59751255|NCT00863655|75870508|FG000|COMPLETED|Overall Study|Completed means discontinued the treatment period.|0||
59751256|NCT00863655|75870509|FG001|COMPLETED|Overall Study|Completed means discontinued the treatment period.|0||
60008646|NCT01998958|76124642|FG012|STARTED|Period 1 (Panel A and B)||0||
60008647|NCT01998958|76124643|FG013|STARTED|Period 1 (Panel A and B)||0||
60008648|NCT01998958|76124644|FG014|STARTED|Period 1 (Panel A and B)||0||
60008649|NCT01998958|76124645|FG015|STARTED|Period 1 (Panel A and B)||0||
60008650|NCT01998958|76124646|FG016|STARTED|Period 1 (Panel A and B)||0||
60008651|NCT01998958|76124647|FG017|STARTED|Period 1 (Panel A and B)||0||
60008652|NCT01998958|76124648|FG018|STARTED|Period 1 (Panel A and B)||0||
60008653|NCT01998958|76124649|FG019|STARTED|Period 1 (Panel A and B)||0||
60008654|NCT01998958|76124650|FG020|STARTED|Period 1 (Panel A and B)||0||
60008655|NCT01998958|76124651|FG021|STARTED|Period 1 (Panel A and B)||0||
60008656|NCT01998958|76124652|FG022|STARTED|Period 1 (Panel A and B)||0||
60008657|NCT01998958|76124653|FG023|STARTED|Period 1 (Panel A and B)||0||
60008658|NCT01998958|76124654|FG024|STARTED|Period 1 (Panel A and B)||0||
60008659|NCT01998958|76124655|FG025|STARTED|Period 1 (Panel A and B)||0||
60008660|NCT01998958|76124656|FG026|STARTED|Period 1 (Panel A and B)||0||
60008661|NCT01998958|76124657|FG027|STARTED|Period 1 (Panel A and B)||0||
60008662|NCT01998958|76124658|FG028|STARTED|Period 1 (Panel A and B)||0||
60008663|NCT01998958|76124659|FG029|STARTED|Period 1 (Panel A and B)||0||
60008664|NCT01998958|76124660|FG030|STARTED|Period 1 (Panel A and B)||0||
60008665|NCT01998958|76124661|FG031|STARTED|Period 1 (Panel A and B)||0||
60008666|NCT01998958|76124630|FG000|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||9||
60008667|NCT01998958|76124631|FG001|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0||
60008668|NCT01998958|76124632|FG002|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0||
60008669|NCT01998958|76124633|FG003|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0||
60008670|NCT01998958|76124634|FG004|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0||
60008671|NCT01998958|76124635|FG005|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0||
60008672|NCT01998958|76124636|FG006|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0||
60008673|NCT01998958|76124637|FG007|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0||
60008674|NCT01998958|76124638|FG008|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0||
60008675|NCT01998958|76124639|FG009|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0||
60008676|NCT01998958|76124640|FG010|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0||
60008677|NCT01998958|76124641|FG011|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0||
60008678|NCT01998958|76124642|FG012|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0||
60008679|NCT01998958|76124643|FG013|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0||
60008680|NCT01998958|76124644|FG014|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0||
60008681|NCT01998958|76124645|FG015|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0||
60008682|NCT01998958|76124646|FG016|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0||
60008683|NCT01998958|76124647|FG017|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0||
60008684|NCT01998958|76124648|FG018|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0||
60008685|NCT01998958|76124649|FG019|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0||
60008686|NCT01998958|76124650|FG020|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0||
60008687|NCT01998958|76124651|FG021|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0||
60008688|NCT01998958|76124652|FG022|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0||
60008689|NCT01998958|76124653|FG023|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0||
60008690|NCT01998958|76124654|FG024|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0||
60008691|NCT01998958|76124655|FG025|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0||
60008692|NCT01998958|76124656|FG026|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0||
60008693|NCT01998958|76124657|FG027|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0||
60008694|NCT01998958|76124658|FG028|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0||
60008695|NCT01998958|76124659|FG029|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0||
60008696|NCT01998958|76124660|FG030|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0||
60008697|NCT01998958|76124661|FG031|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0||
60008698|NCT01998958|76124630|FG000|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||8||
60008699|NCT01998958|76124631|FG001|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0||
60008700|NCT01998958|76124632|FG002|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0||
60008701|NCT01998958|76124633|FG003|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0||
60008702|NCT01998958|76124634|FG004|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0||
60008703|NCT01998958|76124635|FG005|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0||
60008704|NCT01998958|76124636|FG006|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0||
60008705|NCT01998958|76124637|FG007|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0||
60008706|NCT01998958|76124638|FG008|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0||
60008707|NCT01998958|76124639|FG009|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0||
60008708|NCT01998958|76124640|FG010|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0||
60008709|NCT01998958|76124641|FG011|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0||
60008710|NCT01998958|76124642|FG012|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0||
60008711|NCT01998958|76124643|FG013|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0||
60008712|NCT01998958|76124644|FG014|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0||
60008713|NCT01998958|76124645|FG015|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0||
60008714|NCT01998958|76124646|FG016|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0||
60008715|NCT01998958|76124647|FG017|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0||
60008716|NCT01998958|76124648|FG018|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0||
60008717|NCT01998958|76124649|FG019|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0||
60008718|NCT01998958|76124650|FG020|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0||
60008719|NCT01998958|76124651|FG021|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0||
60008720|NCT01998958|76124652|FG022|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0||
60008721|NCT01998958|76124653|FG023|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0||
60008722|NCT01998958|76124654|FG024|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0||
60008723|NCT01998958|76124655|FG025|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0||
60008724|NCT01998958|76124656|FG026|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0||
60008725|NCT01998958|76124657|FG027|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0||
60008726|NCT01998958|76124658|FG028|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0||
60008727|NCT01998958|76124659|FG029|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0||
60008728|NCT01998958|76124660|FG030|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0||
60008729|NCT01998958|76124661|FG031|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0||
60008730|NCT01998958|76124630|FG000|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||5||
60008731|NCT01998958|76124631|FG001|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0||
60008732|NCT01998958|76124632|FG002|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0||
60008733|NCT01998958|76124633|FG003|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0||
60008734|NCT01998958|76124634|FG004|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0||
60008735|NCT01998958|76124635|FG005|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0||
60008736|NCT01998958|76124636|FG006|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0||
60008737|NCT01998958|76124637|FG007|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0||
60008738|NCT01998958|76124638|FG008|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0||
60008739|NCT01998958|76124639|FG009|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0||
60008740|NCT01998958|76124640|FG010|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0||
60008741|NCT01998958|76124641|FG011|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0||
60008742|NCT01998958|76124642|FG012|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0||
60008743|NCT01998958|76124643|FG013|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0||
60008744|NCT01998958|76124644|FG014|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0||
60008745|NCT01998958|76124645|FG015|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0||
60008746|NCT01998958|76124646|FG016|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0||
60008747|NCT01998958|76124647|FG017|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0||
60008748|NCT01998958|76124648|FG018|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0||
60008749|NCT01998958|76124649|FG019|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0||
60008750|NCT01998958|76124650|FG020|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0||
59881364|NCT04150341|76004298|FG004|COMPLETED|Overall Study||3||
59881365|NCT04150341|76004299|FG005|COMPLETED|Overall Study||4||
59881366|NCT04150341|76004294|FG000|NOT COMPLETED|Overall Study||0||
59881367|NCT04150341|76004295|FG001|NOT COMPLETED|Overall Study||0||
59881368|NCT04150341|76004296|FG002|NOT COMPLETED|Overall Study||1||
59881369|NCT04150341|76004297|FG003|NOT COMPLETED|Overall Study||0||
60008751|NCT01998958|76124651|FG021|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0||
60008752|NCT01998958|76124652|FG022|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0||
59881370|NCT04150341|76004298|FG004|NOT COMPLETED|Overall Study||1||
59881371|NCT04150341|76004299|FG005|NOT COMPLETED|Overall Study||0||
59881372|NCT00148109|76004311|FG000|STARTED|Overall Study||15||
59881373|NCT00148109|76004312|FG001|STARTED|Overall Study||21||
59881374|NCT00148109|76004311|FG000|COMPLETED|Overall Study||3||
59881375|NCT00148109|76004312|FG001|COMPLETED|Overall Study||1||
59881376|NCT00148109|76004311|FG000|NOT COMPLETED|Overall Study||12||
59881377|NCT00148109|76004312|FG001|NOT COMPLETED|Overall Study||20||
59881378|NCT00186485|76004318|FG000|STARTED|Overall Study||28||
59881379|NCT00186485|76004318|FG000|COMPLETED|Overall Study||25||
60067891|NCT01756053|76183072|FG001|NOT COMPLETED|Period 2 (10 Days)||2||
60008753|NCT01998958|76124653|FG023|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0||
60008754|NCT01998958|76124654|FG024|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0||
60008755|NCT01998958|76124655|FG025|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0||
60008756|NCT01998958|76124656|FG026|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0||
60008757|NCT01998958|76124657|FG027|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0||
60008758|NCT01998958|76124658|FG028|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0||
60008759|NCT01998958|76124659|FG029|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0||
60008760|NCT01998958|76124660|FG030|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0||
60008761|NCT01998958|76124661|FG031|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0||
60008762|NCT01998958|76124630|FG000|COMPLETED|Period 1 (Panel A and B)||32||
60008763|NCT01998958|76124631|FG001|COMPLETED|Period 1 (Panel A and B)||8||
60008764|NCT01998958|76124632|FG002|COMPLETED|Period 1 (Panel A and B)||11||
60008765|NCT01998958|76124633|FG003|COMPLETED|Period 1 (Panel A and B)||12||
60008766|NCT01998958|76124634|FG004|COMPLETED|Period 1 (Panel A and B)||21||
60008767|NCT01998958|76124635|FG005|COMPLETED|Period 1 (Panel A and B)||11||
60008768|NCT01998958|76124636|FG006|COMPLETED|Period 1 (Panel A and B)||9||
60008769|NCT01998958|76124637|FG007|COMPLETED|Period 1 (Panel A and B)||0||
59519073|NCT01093417|75612951|FG001|STARTED|Overall Study||30||
59519074|NCT01093417|75612950|FG000|COMPLETED|Overall Study||15||
59519075|NCT01093417|75612951|FG001|COMPLETED|Overall Study||29||
59519076|NCT01093417|75612950|FG000|NOT COMPLETED|Overall Study||0||
60008770|NCT01998958|76124638|FG008|COMPLETED|Period 1 (Panel A and B)||0||
60008771|NCT01998958|76124639|FG009|COMPLETED|Period 1 (Panel A and B)||0||
60008772|NCT01998958|76124640|FG010|COMPLETED|Period 1 (Panel A and B)||0||
60008773|NCT01998958|76124641|FG011|COMPLETED|Period 1 (Panel A and B)||0||
60008774|NCT01998958|76124642|FG012|COMPLETED|Period 1 (Panel A and B)||0||
60008775|NCT01998958|76124643|FG013|COMPLETED|Period 1 (Panel A and B)||0||
60008776|NCT01998958|76124644|FG014|COMPLETED|Period 1 (Panel A and B)||0||
60008777|NCT01998958|76124645|FG015|COMPLETED|Period 1 (Panel A and B)||0||
60008778|NCT01998958|76124646|FG016|COMPLETED|Period 1 (Panel A and B)||0||
60008779|NCT01998958|76124647|FG017|COMPLETED|Period 1 (Panel A and B)||0||
60008780|NCT01998958|76124648|FG018|COMPLETED|Period 1 (Panel A and B)||0||
60008781|NCT01998958|76124649|FG019|COMPLETED|Period 1 (Panel A and B)||0||
60008782|NCT01998958|76124650|FG020|COMPLETED|Period 1 (Panel A and B)||0||
60008783|NCT01998958|76124651|FG021|COMPLETED|Period 1 (Panel A and B)||0||
60008784|NCT01998958|76124652|FG022|COMPLETED|Period 1 (Panel A and B)||0||
60008785|NCT01998958|76124653|FG023|COMPLETED|Period 1 (Panel A and B)||0||
60008786|NCT01998958|76124654|FG024|COMPLETED|Period 1 (Panel A and B)||0||
60008787|NCT01998958|76124655|FG025|COMPLETED|Period 1 (Panel A and B)||0||
60008788|NCT01998958|76124656|FG026|COMPLETED|Period 1 (Panel A and B)||0||
60008789|NCT01998958|76124657|FG027|COMPLETED|Period 1 (Panel A and B)||0||
60008790|NCT01998958|76124658|FG028|COMPLETED|Period 1 (Panel A and B)||0||
60008791|NCT01998958|76124659|FG029|COMPLETED|Period 1 (Panel A and B)||0||
60008792|NCT01998958|76124660|FG030|COMPLETED|Period 1 (Panel A and B)||0||
60008793|NCT01998958|76124661|FG031|COMPLETED|Period 1 (Panel A and B)||0||
60008794|NCT01998958|76124630|FG000|NOT COMPLETED|Period 1 (Panel A and B)||1||
60008795|NCT01998958|76124631|FG001|NOT COMPLETED|Period 1 (Panel A and B)||3||
60008796|NCT01998958|76124632|FG002|NOT COMPLETED|Period 1 (Panel A and B)||0||
60008797|NCT01998958|76124633|FG003|NOT COMPLETED|Period 1 (Panel A and B)||0||
60008798|NCT01998958|76124634|FG004|NOT COMPLETED|Period 1 (Panel A and B)||0||
60008799|NCT01998958|76124635|FG005|NOT COMPLETED|Period 1 (Panel A and B)||0||
60008800|NCT01998958|76124636|FG006|NOT COMPLETED|Period 1 (Panel A and B)||0||
60008801|NCT01998958|76124637|FG007|NOT COMPLETED|Period 1 (Panel A and B)||0||
60008802|NCT01998958|76124638|FG008|NOT COMPLETED|Period 1 (Panel A and B)||0||
60008803|NCT01998958|76124639|FG009|NOT COMPLETED|Period 1 (Panel A and B)||0||
60008804|NCT01998958|76124640|FG010|NOT COMPLETED|Period 1 (Panel A and B)||0||
60008805|NCT01998958|76124641|FG011|NOT COMPLETED|Period 1 (Panel A and B)||0||
60008806|NCT01998958|76124642|FG012|NOT COMPLETED|Period 1 (Panel A and B)||0||
60008807|NCT01998958|76124643|FG013|NOT COMPLETED|Period 1 (Panel A and B)||0||
60008808|NCT01998958|76124644|FG014|NOT COMPLETED|Period 1 (Panel A and B)||0||
60008809|NCT01998958|76124645|FG015|NOT COMPLETED|Period 1 (Panel A and B)||0||
60008810|NCT01998958|76124646|FG016|NOT COMPLETED|Period 1 (Panel A and B)||0||
60008811|NCT01998958|76124647|FG017|NOT COMPLETED|Period 1 (Panel A and B)||0||
60008812|NCT01998958|76124648|FG018|NOT COMPLETED|Period 1 (Panel A and B)||0||
60008813|NCT01998958|76124649|FG019|NOT COMPLETED|Period 1 (Panel A and B)||0||
60008814|NCT01998958|76124650|FG020|NOT COMPLETED|Period 1 (Panel A and B)||0||
60008815|NCT01998958|76124651|FG021|NOT COMPLETED|Period 1 (Panel A and B)||0||
60008816|NCT01998958|76124652|FG022|NOT COMPLETED|Period 1 (Panel A and B)||0||
60008817|NCT01998958|76124653|FG023|NOT COMPLETED|Period 1 (Panel A and B)||0||
60008818|NCT01998958|76124654|FG024|NOT COMPLETED|Period 1 (Panel A and B)||0||
60008819|NCT01998958|76124655|FG025|NOT COMPLETED|Period 1 (Panel A and B)||0||
60008820|NCT01998958|76124656|FG026|NOT COMPLETED|Period 1 (Panel A and B)||0||
60008821|NCT01998958|76124657|FG027|NOT COMPLETED|Period 1 (Panel A and B)||0||
60008822|NCT01998958|76124658|FG028|NOT COMPLETED|Period 1 (Panel A and B)||0||
60008823|NCT01998958|76124659|FG029|NOT COMPLETED|Period 1 (Panel A and B)||0||
60008824|NCT01998958|76124660|FG030|NOT COMPLETED|Period 1 (Panel A and B)||0||
59751257|NCT00863655|75870508|FG000|NOT COMPLETED|Overall Study||485||
60008825|NCT01998958|76124661|FG031|NOT COMPLETED|Period 1 (Panel A and B)||0||
60008826|NCT01998958|76124630|FG000|STARTED|Period 2 (Panel A and B)||0||
60008827|NCT01998958|76124631|FG001|STARTED|Period 2 (Panel A and B)||0||
60008828|NCT01998958|76124632|FG002|STARTED|Period 2 (Panel A and B)||0||
60008829|NCT01998958|76124633|FG003|STARTED|Period 2 (Panel A and B)||0||
60008830|NCT01998958|76124634|FG004|STARTED|Period 2 (Panel A and B)||0||
60008831|NCT01998958|76124635|FG005|STARTED|Period 2 (Panel A and B)||0||
60008832|NCT01998958|76124636|FG006|STARTED|Period 2 (Panel A and B)||0||
60008833|NCT01998958|76124637|FG007|STARTED|Period 2 (Panel A and B)||6||
60008834|NCT01998958|76124638|FG008|STARTED|Period 2 (Panel A and B)||4||
60008835|NCT01998958|76124639|FG009|STARTED|Period 2 (Panel A and B)||8||
60008836|NCT01998958|76124640|FG010|STARTED|Period 2 (Panel A and B)||9||
60008837|NCT01998958|76124641|FG011|STARTED|Period 2 (Panel A and B)||5||
60008838|NCT01998958|76124642|FG012|STARTED|Period 2 (Panel A and B)||8||
60008839|NCT01998958|76124643|FG013|STARTED|Period 2 (Panel A and B)||11||
59751258|NCT00863655|75870509|FG001|NOT COMPLETED|Overall Study||239||
59751259|NCT00658723|75870517|FG000|STARTED|Overall Study||60||
59751260|NCT00658723|75870518|FG001|STARTED|Overall Study||30||
59751261|NCT00658723|75870519|FG002|STARTED|Overall Study||51||
59751262|NCT00658723|75870517|FG000|COMPLETED|Overall Study||56||
60008840|NCT01998958|76124644|FG014|STARTED|Period 2 (Panel A and B)||12||
60008841|NCT01998958|76124645|FG015|STARTED|Period 2 (Panel A and B)||5||
60008842|NCT01998958|76124646|FG016|STARTED|Period 2 (Panel A and B)||8||
60008843|NCT01998958|76124647|FG017|STARTED|Period 2 (Panel A and B)||5||
60008844|NCT01998958|76124648|FG018|STARTED|Period 2 (Panel A and B)||3||
60008845|NCT01998958|76124649|FG019|STARTED|Period 2 (Panel A and B)||11||
60008846|NCT01998958|76124650|FG020|STARTED|Period 2 (Panel A and B)||9||
60008847|NCT01998958|76124651|FG021|STARTED|Period 2 (Panel A and B)||0||
60008848|NCT01998958|76124652|FG022|STARTED|Period 2 (Panel A and B)||0||
60008849|NCT01998958|76124653|FG023|STARTED|Period 2 (Panel A and B)||0||
60008850|NCT01998958|76124654|FG024|STARTED|Period 2 (Panel A and B)||0||
60008851|NCT01998958|76124655|FG025|STARTED|Period 2 (Panel A and B)||0||
60008852|NCT01998958|76124656|FG026|STARTED|Period 2 (Panel A and B)||0||
60008853|NCT01998958|76124657|FG027|STARTED|Period 2 (Panel A and B)||0||
60008854|NCT01998958|76124658|FG028|STARTED|Period 2 (Panel A and B)||0||
60008855|NCT01998958|76124659|FG029|STARTED|Period 2 (Panel A and B)||0||
60008856|NCT01998958|76124660|FG030|STARTED|Period 2 (Panel A and B)||0||
60008857|NCT01998958|76124661|FG031|STARTED|Period 2 (Panel A and B)||0||
59751263|NCT00658723|75870518|FG001|COMPLETED|Overall Study||26||
59751264|NCT00658723|75870519|FG002|COMPLETED|Overall Study||44||
59751265|NCT00658723|75870517|FG000|NOT COMPLETED|Overall Study||4||
59751266|NCT00658723|75870518|FG001|NOT COMPLETED|Overall Study||4||
60008858|NCT01998958|76124630|FG000|COMPLETED|Period 2 (Panel A and B)||0||
60008859|NCT01998958|76124631|FG001|COMPLETED|Period 2 (Panel A and B)||0||
60008860|NCT01998958|76124632|FG002|COMPLETED|Period 2 (Panel A and B)||0||
60008861|NCT01998958|76124633|FG003|COMPLETED|Period 2 (Panel A and B)||0||
60008862|NCT01998958|76124634|FG004|COMPLETED|Period 2 (Panel A and B)||0||
60008863|NCT01998958|76124635|FG005|COMPLETED|Period 2 (Panel A and B)||0||
60008864|NCT01998958|76124636|FG006|COMPLETED|Period 2 (Panel A and B)||0||
60008865|NCT01998958|76124637|FG007|COMPLETED|Period 2 (Panel A and B)||6||
60008866|NCT01998958|76124638|FG008|COMPLETED|Period 2 (Panel A and B)||4||
60008867|NCT01998958|76124639|FG009|COMPLETED|Period 2 (Panel A and B)||8||
60008868|NCT01998958|76124640|FG010|COMPLETED|Period 2 (Panel A and B)||8||
60008869|NCT01998958|76124641|FG011|COMPLETED|Period 2 (Panel A and B)||5||
60008870|NCT01998958|76124642|FG012|COMPLETED|Period 2 (Panel A and B)||8||
60008871|NCT01998958|76124643|FG013|COMPLETED|Period 2 (Panel A and B)||11||
60008872|NCT01998958|76124644|FG014|COMPLETED|Period 2 (Panel A and B)||10||
60008873|NCT01998958|76124645|FG015|COMPLETED|Period 2 (Panel A and B)||5||
60008874|NCT01998958|76124646|FG016|COMPLETED|Period 2 (Panel A and B)||8||
60008875|NCT01998958|76124647|FG017|COMPLETED|Period 2 (Panel A and B)||5||
60008876|NCT01998958|76124648|FG018|COMPLETED|Period 2 (Panel A and B)||2||
60008877|NCT01998958|76124649|FG019|COMPLETED|Period 2 (Panel A and B)||11||
60008878|NCT01998958|76124650|FG020|COMPLETED|Period 2 (Panel A and B)||9||
59751267|NCT00658723|75870519|FG002|NOT COMPLETED|Overall Study||7||
60008879|NCT01998958|76124651|FG021|COMPLETED|Period 2 (Panel A and B)||0||
60008880|NCT01998958|76124652|FG022|COMPLETED|Period 2 (Panel A and B)||0||
60136131|NCT01524224|76258815|FG000|STARTED|Overall Study||4||
59881380|NCT00186485|76004318|FG000|NOT COMPLETED|Overall Study||3||
59881381|NCT00147251|76004324|FG000|STARTED|Recruitment and Enrollment||271||
59881382|NCT00147251|76004325|FG001|STARTED|Recruitment and Enrollment||277||
59881383|NCT00147251|76004324|FG000|COMPLETED|Recruitment and Enrollment||247||
59881384|NCT00147251|76004325|FG001|COMPLETED|Recruitment and Enrollment||252||
59881385|NCT00147251|76004324|FG000|NOT COMPLETED|Recruitment and Enrollment||24||
59881386|NCT00147251|76004325|FG001|NOT COMPLETED|Recruitment and Enrollment||25||
59881387|NCT00147251|76004324|FG000|STARTED|Follow up||247||
59881388|NCT00147251|76004325|FG001|STARTED|Follow up||252||
59881389|NCT00147251|76004324|FG000|COMPLETED|Follow up||247||
59881390|NCT00147251|76004325|FG001|COMPLETED|Follow up||252||
59881391|NCT00147251|76004324|FG000|NOT COMPLETED|Follow up||0||
59881392|NCT00147251|76004325|FG001|NOT COMPLETED|Follow up||0||
59881393|NCT04390191|76004335|FG000|STARTED|Overall Study||1||
59881394|NCT04390191|76004336|FG001|STARTED|Overall Study||3||
59881395|NCT04390191|76004335|FG000|COMPLETED|Overall Study||0||
59881396|NCT04390191|76004336|FG001|COMPLETED|Overall Study||3||
59881397|NCT04390191|76004335|FG000|NOT COMPLETED|Overall Study||1||
59881398|NCT04390191|76004336|FG001|NOT COMPLETED|Overall Study||0||
59881399|NCT04405076|76004348|FG000|STARTED|Part A (Blinded Phase)||200||
59881400|NCT04405076|76004349|FG001|STARTED|Part A (Blinded Phase)||200||
59881401|NCT04405076|76004350|FG002|STARTED|Part A (Blinded Phase)||200||
59881402|NCT04405076|76004351|FG003|STARTED|Part A (Blinded Phase)||0||
59881403|NCT04405076|76004352|FG004|STARTED|Part A (Blinded Phase)||0||
59881404|NCT04405076|76004353|FG005|STARTED|Part A (Blinded Phase)||0||
59881405|NCT04405076|76004354|FG006|STARTED|Part A (Blinded Phase)||0||
59881406|NCT04405076|76004355|FG007|STARTED|Part A (Blinded Phase)||0||
59881407|NCT04405076|76004356|FG008|STARTED|Part A (Blinded Phase)||0||
59881408|NCT04405076|76004348|FG000|Received at Least 1 Dose of Study Drug During Part A|Part A (Blinded Phase)||200||
59881409|NCT04405076|76004349|FG001|Received at Least 1 Dose of Study Drug During Part A|Part A (Blinded Phase)||200||
59881410|NCT04405076|76004350|FG002|Received at Least 1 Dose of Study Drug During Part A|Part A (Blinded Phase)||200||
59881411|NCT04405076|76004351|FG003|Received at Least 1 Dose of Study Drug During Part A|Part A (Blinded Phase)||0||
60136132|NCT01524224|76258816|FG001|STARTED|Overall Study||3||
60136133|NCT01524224|76258817|FG002|STARTED|Overall Study||3||
60136134|NCT01524224|76258818|FG003|STARTED|Overall Study||3||
60136135|NCT01524224|76258819|FG004|STARTED|Overall Study||4||
60136136|NCT01524224|76258820|FG005|STARTED|Overall Study||3||
60136137|NCT01524224|76258821|FG006|STARTED|Overall Study||3||
60136138|NCT01524224|76258822|FG007|STARTED|Overall Study||6||
60136139|NCT01524224|76258815|FG000|Received at Least One Dose of Study Drug|Overall Study||4||
59881412|NCT04405076|76004352|FG004|Received at Least 1 Dose of Study Drug During Part A|Part A (Blinded Phase)||0||
59881413|NCT04405076|76004353|FG005|Received at Least 1 Dose of Study Drug During Part A|Part A (Blinded Phase)||0||
59881414|NCT04405076|76004354|FG006|Received at Least 1 Dose of Study Drug During Part A|Part A (Blinded Phase)||0||
59881415|NCT04405076|76004355|FG007|Received at Least 1 Dose of Study Drug During Part A|Part A (Blinded Phase)||0||
59881416|NCT04405076|76004356|FG008|Received at Least 1 Dose of Study Drug During Part A|Part A (Blinded Phase)||0||
59881417|NCT04405076|76004348|FG000|COMPLETED|Part A (Blinded Phase)||188||
59881418|NCT04405076|76004349|FG001|COMPLETED|Part A (Blinded Phase)||185||
59881419|NCT04405076|76004350|FG002|COMPLETED|Part A (Blinded Phase)||182||
59881420|NCT04405076|76004351|FG003|COMPLETED|Part A (Blinded Phase)||0||
59881421|NCT04405076|76004352|FG004|COMPLETED|Part A (Blinded Phase)||0||
59881422|NCT04405076|76004353|FG005|COMPLETED|Part A (Blinded Phase)||0||
59881423|NCT04405076|76004354|FG006|COMPLETED|Part A (Blinded Phase)||0||
59881424|NCT04405076|76004355|FG007|COMPLETED|Part A (Blinded Phase)||0||
59881425|NCT04405076|76004356|FG008|COMPLETED|Part A (Blinded Phase)||0||
59881426|NCT04405076|76004348|FG000|NOT COMPLETED|Part A (Blinded Phase)||12||
59881427|NCT04405076|76004349|FG001|NOT COMPLETED|Part A (Blinded Phase)||15||
59881428|NCT04405076|76004350|FG002|NOT COMPLETED|Part A (Blinded Phase)||18||
59881429|NCT04405076|76004351|FG003|NOT COMPLETED|Part A (Blinded Phase)||0||
59881430|NCT04405076|76004352|FG004|NOT COMPLETED|Part A (Blinded Phase)||0||
59881431|NCT04405076|76004353|FG005|NOT COMPLETED|Part A (Blinded Phase)||0||
59881432|NCT04405076|76004354|FG006|NOT COMPLETED|Part A (Blinded Phase)||0||
59881433|NCT04405076|76004355|FG007|NOT COMPLETED|Part A (Blinded Phase)||0||
59881434|NCT04405076|76004356|FG008|NOT COMPLETED|Part A (Blinded Phase)||0||
59881435|NCT04405076|76004348|FG000|STARTED|Part B (Open-Label Interventional Phase)||0||
59881436|NCT04405076|76004349|FG001|STARTED|Part B (Open-Label Interventional Phase)||0||
59881437|NCT04405076|76004350|FG002|STARTED|Part B (Open-Label Interventional Phase)||0||
59881438|NCT04405076|76004351|FG003|STARTED|Part B (Open-Label Interventional Phase)||173||
59881439|NCT04405076|76004352|FG004|STARTED|Part B (Open-Label Interventional Phase)||171||
59881440|NCT04405076|76004353|FG005|STARTED|Part B (Open-Label Interventional Phase)||158||
60136140|NCT01524224|76258816|FG001|Received at Least One Dose of Study Drug|Overall Study||3||
60136141|NCT01524224|76258817|FG002|Received at Least One Dose of Study Drug|Overall Study||3||
60136142|NCT01524224|76258818|FG003|Received at Least One Dose of Study Drug|Overall Study||3||
60008881|NCT01998958|76124653|FG023|COMPLETED|Period 2 (Panel A and B)||0||
60008882|NCT01998958|76124654|FG024|COMPLETED|Period 2 (Panel A and B)||0||
60008883|NCT01998958|76124655|FG025|COMPLETED|Period 2 (Panel A and B)||0||
60008884|NCT01998958|76124656|FG026|COMPLETED|Period 2 (Panel A and B)||0||
60008885|NCT01998958|76124657|FG027|COMPLETED|Period 2 (Panel A and B)||0||
60008886|NCT01998958|76124658|FG028|COMPLETED|Period 2 (Panel A and B)||0||
60008887|NCT01998958|76124659|FG029|COMPLETED|Period 2 (Panel A and B)||0||
60008888|NCT01998958|76124660|FG030|COMPLETED|Period 2 (Panel A and B)||0||
60008889|NCT01998958|76124661|FG031|COMPLETED|Period 2 (Panel A and B)||0||
60008890|NCT01998958|76124630|FG000|NOT COMPLETED|Period 2 (Panel A and B)||0||
60008891|NCT01998958|76124631|FG001|NOT COMPLETED|Period 2 (Panel A and B)||0||
60008892|NCT01998958|76124632|FG002|NOT COMPLETED|Period 2 (Panel A and B)||0||
60008893|NCT01998958|76124633|FG003|NOT COMPLETED|Period 2 (Panel A and B)||0||
60008894|NCT01998958|76124634|FG004|NOT COMPLETED|Period 2 (Panel A and B)||0||
60008895|NCT01998958|76124635|FG005|NOT COMPLETED|Period 2 (Panel A and B)||0||
60008896|NCT01998958|76124636|FG006|NOT COMPLETED|Period 2 (Panel A and B)||0||
60008897|NCT01998958|76124637|FG007|NOT COMPLETED|Period 2 (Panel A and B)||0||
60008898|NCT01998958|76124638|FG008|NOT COMPLETED|Period 2 (Panel A and B)||0||
60008899|NCT01998958|76124639|FG009|NOT COMPLETED|Period 2 (Panel A and B)||0||
60008900|NCT01998958|76124640|FG010|NOT COMPLETED|Period 2 (Panel A and B)||1||
60008901|NCT01998958|76124641|FG011|NOT COMPLETED|Period 2 (Panel A and B)||0||
60008902|NCT01998958|76124642|FG012|NOT COMPLETED|Period 2 (Panel A and B)||0||
60008903|NCT01998958|76124643|FG013|NOT COMPLETED|Period 2 (Panel A and B)||0||
60008904|NCT01998958|76124644|FG014|NOT COMPLETED|Period 2 (Panel A and B)||2||
60008905|NCT01998958|76124645|FG015|NOT COMPLETED|Period 2 (Panel A and B)||0||
60008906|NCT01998958|76124646|FG016|NOT COMPLETED|Period 2 (Panel A and B)||0||
60008907|NCT01998958|76124647|FG017|NOT COMPLETED|Period 2 (Panel A and B)||0||
60008908|NCT01998958|76124648|FG018|NOT COMPLETED|Period 2 (Panel A and B)||1||
60008909|NCT01998958|76124649|FG019|NOT COMPLETED|Period 2 (Panel A and B)||0||
60008910|NCT01998958|76124650|FG020|NOT COMPLETED|Period 2 (Panel A and B)||0||
60008911|NCT01998958|76124651|FG021|NOT COMPLETED|Period 2 (Panel A and B)||0||
60008912|NCT01998958|76124652|FG022|NOT COMPLETED|Period 2 (Panel A and B)||0||
60008913|NCT01998958|76124653|FG023|NOT COMPLETED|Period 2 (Panel A and B)||0||
60008914|NCT01998958|76124654|FG024|NOT COMPLETED|Period 2 (Panel A and B)||0||
60008915|NCT01998958|76124655|FG025|NOT COMPLETED|Period 2 (Panel A and B)||0||
60008916|NCT01998958|76124656|FG026|NOT COMPLETED|Period 2 (Panel A and B)||0||
60008917|NCT01998958|76124657|FG027|NOT COMPLETED|Period 2 (Panel A and B)||0||
60008918|NCT01998958|76124658|FG028|NOT COMPLETED|Period 2 (Panel A and B)||0||
60008919|NCT01998958|76124659|FG029|NOT COMPLETED|Period 2 (Panel A and B)||0||
60008920|NCT01998958|76124660|FG030|NOT COMPLETED|Period 2 (Panel A and B)||0||
60008921|NCT01998958|76124661|FG031|NOT COMPLETED|Period 2 (Panel A and B)||0||
60008922|NCT01998958|76124630|FG000|STARTED|Open Label Phase (Optional)||0||
60008923|NCT01998958|76124631|FG001|STARTED|Open Label Phase (Optional)||0||
60008924|NCT01998958|76124632|FG002|STARTED|Open Label Phase (Optional)||0||
60008925|NCT01998958|76124633|FG003|STARTED|Open Label Phase (Optional)||0||
60008926|NCT01998958|76124634|FG004|STARTED|Open Label Phase (Optional)||0||
60008927|NCT01998958|76124635|FG005|STARTED|Open Label Phase (Optional)||0||
60008928|NCT01998958|76124636|FG006|STARTED|Open Label Phase (Optional)||0||
60008929|NCT01998958|76124637|FG007|STARTED|Open Label Phase (Optional)||0||
60008930|NCT01998958|76124638|FG008|STARTED|Open Label Phase (Optional)||0||
60008931|NCT01998958|76124639|FG009|STARTED|Open Label Phase (Optional)||0||
60008932|NCT01998958|76124640|FG010|STARTED|Open Label Phase (Optional)||0||
60008933|NCT01998958|76124641|FG011|STARTED|Open Label Phase (Optional)||0||
60008934|NCT01998958|76124642|FG012|STARTED|Open Label Phase (Optional)||0||
60008935|NCT01998958|76124643|FG013|STARTED|Open Label Phase (Optional)||0||
60008936|NCT01998958|76124644|FG014|STARTED|Open Label Phase (Optional)||0||
60008937|NCT01998958|76124645|FG015|STARTED|Open Label Phase (Optional)||0||
60008938|NCT01998958|76124646|FG016|STARTED|Open Label Phase (Optional)||0||
60008939|NCT01998958|76124647|FG017|STARTED|Open Label Phase (Optional)||0||
60008940|NCT01998958|76124648|FG018|STARTED|Open Label Phase (Optional)||0||
60008941|NCT01998958|76124649|FG019|STARTED|Open Label Phase (Optional)||0||
60008942|NCT01998958|76124650|FG020|STARTED|Open Label Phase (Optional)||0||
60008943|NCT01998958|76124651|FG021|STARTED|Open Label Phase (Optional)||10||
60008944|NCT01998958|76124652|FG022|STARTED|Open Label Phase (Optional)||20||
60008945|NCT01998958|76124653|FG023|STARTED|Open Label Phase (Optional)||27||
60008946|NCT01998958|76124654|FG024|STARTED|Open Label Phase (Optional)||13||
60008947|NCT01998958|76124655|FG025|STARTED|Open Label Phase (Optional)||7||
60008948|NCT01998958|76124656|FG026|STARTED|Open Label Phase (Optional)||19||
60008949|NCT01998958|76124657|FG027|STARTED|Open Label Phase (Optional)||0||
60008950|NCT01998958|76124658|FG028|STARTED|Open Label Phase (Optional)||0||
60008951|NCT01998958|76124659|FG029|STARTED|Open Label Phase (Optional)||0||
60008952|NCT01998958|76124660|FG030|STARTED|Open Label Phase (Optional)||0||
60008953|NCT01998958|76124661|FG031|STARTED|Open Label Phase (Optional)||0||
60008954|NCT01998958|76124630|FG000|COMPLETED|Open Label Phase (Optional)||0||
60008955|NCT01998958|76124631|FG001|COMPLETED|Open Label Phase (Optional)||0||
60008956|NCT01998958|76124632|FG002|COMPLETED|Open Label Phase (Optional)||0||
60008957|NCT01998958|76124633|FG003|COMPLETED|Open Label Phase (Optional)||0||
60008958|NCT01998958|76124634|FG004|COMPLETED|Open Label Phase (Optional)||0||
60008959|NCT01998958|76124635|FG005|COMPLETED|Open Label Phase (Optional)||0||
60008960|NCT01998958|76124636|FG006|COMPLETED|Open Label Phase (Optional)||0||
60008961|NCT01998958|76124637|FG007|COMPLETED|Open Label Phase (Optional)||0||
60008962|NCT01998958|76124638|FG008|COMPLETED|Open Label Phase (Optional)||0||
60008963|NCT01998958|76124639|FG009|COMPLETED|Open Label Phase (Optional)||0||
60008964|NCT01998958|76124640|FG010|COMPLETED|Open Label Phase (Optional)||0||
60008965|NCT01998958|76124641|FG011|COMPLETED|Open Label Phase (Optional)||0||
60008966|NCT01998958|76124642|FG012|COMPLETED|Open Label Phase (Optional)||0||
60008967|NCT01998958|76124643|FG013|COMPLETED|Open Label Phase (Optional)||0||
60008968|NCT01998958|76124644|FG014|COMPLETED|Open Label Phase (Optional)||0||
60008969|NCT01998958|76124645|FG015|COMPLETED|Open Label Phase (Optional)||0||
60008970|NCT01998958|76124646|FG016|COMPLETED|Open Label Phase (Optional)||0||
60008971|NCT01998958|76124647|FG017|COMPLETED|Open Label Phase (Optional)||0||
60008972|NCT01998958|76124648|FG018|COMPLETED|Open Label Phase (Optional)||0||
60008973|NCT01998958|76124649|FG019|COMPLETED|Open Label Phase (Optional)||0||
60008974|NCT01998958|76124650|FG020|COMPLETED|Open Label Phase (Optional)||0||
60008975|NCT01998958|76124651|FG021|COMPLETED|Open Label Phase (Optional)||7||
60008976|NCT01998958|76124652|FG022|COMPLETED|Open Label Phase (Optional)||11||
60008977|NCT01998958|76124653|FG023|COMPLETED|Open Label Phase (Optional)||23||
60008978|NCT01998958|76124654|FG024|COMPLETED|Open Label Phase (Optional)||13||
60008979|NCT01998958|76124655|FG025|COMPLETED|Open Label Phase (Optional)||7||
60008980|NCT01998958|76124656|FG026|COMPLETED|Open Label Phase (Optional)||19||
60008981|NCT01998958|76124657|FG027|COMPLETED|Open Label Phase (Optional)||0||
60008982|NCT01998958|76124658|FG028|COMPLETED|Open Label Phase (Optional)||0||
60008983|NCT01998958|76124659|FG029|COMPLETED|Open Label Phase (Optional)||0||
60008984|NCT01998958|76124660|FG030|COMPLETED|Open Label Phase (Optional)||0||
60008985|NCT01998958|76124661|FG031|COMPLETED|Open Label Phase (Optional)||0||
60008986|NCT01998958|76124630|FG000|NOT COMPLETED|Open Label Phase (Optional)||0||
60008987|NCT01998958|76124631|FG001|NOT COMPLETED|Open Label Phase (Optional)||0||
60008988|NCT01998958|76124632|FG002|NOT COMPLETED|Open Label Phase (Optional)||0||
60008989|NCT01998958|76124633|FG003|NOT COMPLETED|Open Label Phase (Optional)||0||
60008990|NCT01998958|76124634|FG004|NOT COMPLETED|Open Label Phase (Optional)||0||
60008991|NCT01998958|76124635|FG005|NOT COMPLETED|Open Label Phase (Optional)||0||
60008992|NCT01998958|76124636|FG006|NOT COMPLETED|Open Label Phase (Optional)||0||
60008993|NCT01998958|76124637|FG007|NOT COMPLETED|Open Label Phase (Optional)||0||
60008994|NCT01998958|76124638|FG008|NOT COMPLETED|Open Label Phase (Optional)||0||
60008995|NCT01998958|76124639|FG009|NOT COMPLETED|Open Label Phase (Optional)||0||
60008996|NCT01998958|76124640|FG010|NOT COMPLETED|Open Label Phase (Optional)||0||
60008997|NCT01998958|76124641|FG011|NOT COMPLETED|Open Label Phase (Optional)||0||
60008998|NCT01998958|76124642|FG012|NOT COMPLETED|Open Label Phase (Optional)||0||
60008999|NCT01998958|76124643|FG013|NOT COMPLETED|Open Label Phase (Optional)||0||
60009000|NCT01998958|76124644|FG014|NOT COMPLETED|Open Label Phase (Optional)||0||
60009001|NCT01998958|76124645|FG015|NOT COMPLETED|Open Label Phase (Optional)||0||
60009002|NCT01998958|76124646|FG016|NOT COMPLETED|Open Label Phase (Optional)||0||
60009003|NCT01998958|76124647|FG017|NOT COMPLETED|Open Label Phase (Optional)||0||
60009004|NCT01998958|76124648|FG018|NOT COMPLETED|Open Label Phase (Optional)||0||
60009005|NCT01998958|76124649|FG019|NOT COMPLETED|Open Label Phase (Optional)||0||
60009006|NCT01998958|76124650|FG020|NOT COMPLETED|Open Label Phase (Optional)||0||
60009007|NCT01998958|76124651|FG021|NOT COMPLETED|Open Label Phase (Optional)||3||
60009008|NCT01998958|76124652|FG022|NOT COMPLETED|Open Label Phase (Optional)||9||
60009009|NCT01998958|76124653|FG023|NOT COMPLETED|Open Label Phase (Optional)||4||
60009010|NCT01998958|76124654|FG024|NOT COMPLETED|Open Label Phase (Optional)||0||
60009011|NCT01998958|76124655|FG025|NOT COMPLETED|Open Label Phase (Optional)||0||
60009012|NCT01998958|76124656|FG026|NOT COMPLETED|Open Label Phase (Optional)||0||
60009013|NCT01998958|76124657|FG027|NOT COMPLETED|Open Label Phase (Optional)||0||
60009014|NCT01998958|76124658|FG028|NOT COMPLETED|Open Label Phase (Optional)||0||
60009015|NCT01998958|76124659|FG029|NOT COMPLETED|Open Label Phase (Optional)||0||
60009016|NCT01998958|76124660|FG030|NOT COMPLETED|Open Label Phase (Optional)||0||
60009017|NCT01998958|76124661|FG031|NOT COMPLETED|Open Label Phase (Optional)||0||
60009018|NCT01998958|76124630|FG000|STARTED|Follow-up Phase||0||
60009019|NCT01998958|76124631|FG001|STARTED|Follow-up Phase||0||
60009020|NCT01998958|76124632|FG002|STARTED|Follow-up Phase||0||
59881441|NCT04405076|76004354|FG006|STARTED|Part B (Open-Label Interventional Phase)||0||
59881442|NCT04405076|76004355|FG007|STARTED|Part B (Open-Label Interventional Phase)||0||
59881443|NCT04405076|76004356|FG008|STARTED|Part B (Open-Label Interventional Phase)||0||
59881444|NCT04405076|76004348|FG000|Received at Least 1 Dose of Study Drug During Part B|Part B (Open-Label Interventional Phase)||0||
59881445|NCT04405076|76004349|FG001|Received at Least 1 Dose of Study Drug During Part B|Part B (Open-Label Interventional Phase)||0||
59881446|NCT04405076|76004350|FG002|Received at Least 1 Dose of Study Drug During Part B|Part B (Open-Label Interventional Phase)||0||
59881447|NCT04405076|76004351|FG003|Received at Least 1 Dose of Study Drug During Part B|Part B (Open-Label Interventional Phase)||173||
59881448|NCT04405076|76004352|FG004|Received at Least 1 Dose of Study Drug During Part B|Part B (Open-Label Interventional Phase)||171||
59881449|NCT04405076|76004353|FG005|Received at Least 1 Dose of Study Drug During Part B|Part B (Open-Label Interventional Phase)||158||
59881450|NCT04405076|76004354|FG006|Received at Least 1 Dose of Study Drug During Part B|Part B (Open-Label Interventional Phase)||0||
59881451|NCT04405076|76004355|FG007|Received at Least 1 Dose of Study Drug During Part B|Part B (Open-Label Interventional Phase)||0||
59881452|NCT04405076|76004356|FG008|Received at Least 1 Dose of Study Drug During Part B|Part B (Open-Label Interventional Phase)||0||
59881453|NCT04405076|76004348|FG000|COMPLETED|Part B (Open-Label Interventional Phase)||0||
59881454|NCT04405076|76004349|FG001|COMPLETED|Part B (Open-Label Interventional Phase)||0||
59881455|NCT04405076|76004350|FG002|COMPLETED|Part B (Open-Label Interventional Phase)||0||
59881456|NCT04405076|76004351|FG003|COMPLETED|Part B (Open-Label Interventional Phase)||161||
59881457|NCT04405076|76004352|FG004|COMPLETED|Part B (Open-Label Interventional Phase)||166||
59881458|NCT04405076|76004353|FG005|COMPLETED|Part B (Open-Label Interventional Phase)||152||
59881459|NCT04405076|76004354|FG006|COMPLETED|Part B (Open-Label Interventional Phase)||0||
59881460|NCT04405076|76004355|FG007|COMPLETED|Part B (Open-Label Interventional Phase)||0||
59881461|NCT04405076|76004356|FG008|COMPLETED|Part B (Open-Label Interventional Phase)||0||
59881462|NCT04405076|76004348|FG000|NOT COMPLETED|Part B (Open-Label Interventional Phase)||0||
59881463|NCT04405076|76004349|FG001|NOT COMPLETED|Part B (Open-Label Interventional Phase)||0||
59881464|NCT04405076|76004350|FG002|NOT COMPLETED|Part B (Open-Label Interventional Phase)||0||
59881465|NCT04405076|76004351|FG003|NOT COMPLETED|Part B (Open-Label Interventional Phase)||12||
59881466|NCT04405076|76004352|FG004|NOT COMPLETED|Part B (Open-Label Interventional Phase)||5||
59881467|NCT04405076|76004353|FG005|NOT COMPLETED|Part B (Open-Label Interventional Phase)||6||
59881468|NCT04405076|76004354|FG006|NOT COMPLETED|Part B (Open-Label Interventional Phase)||0||
59881469|NCT04405076|76004355|FG007|NOT COMPLETED|Part B (Open-Label Interventional Phase)||0||
59881470|NCT04405076|76004356|FG008|NOT COMPLETED|Part B (Open-Label Interventional Phase)||0||
59881471|NCT04405076|76004348|FG000|STARTED|Part C (Rollover Proof of Concept)||0||
59881472|NCT04405076|76004349|FG001|STARTED|Part C (Rollover Proof of Concept)||0||
59881473|NCT04405076|76004350|FG002|STARTED|Part C (Rollover Proof of Concept)||0||
59881474|NCT04405076|76004351|FG003|STARTED|Part C (Rollover Proof of Concept)||0||
59881475|NCT04405076|76004352|FG004|STARTED|Part C (Rollover Proof of Concept)||0||
59881476|NCT04405076|76004353|FG005|STARTED|Part C (Rollover Proof of Concept)||0||
59881477|NCT04405076|76004354|FG006|STARTED|Part C (Rollover Proof of Concept)||20||
59881478|NCT04405076|76004355|FG007|STARTED|Part C (Rollover Proof of Concept)||20||
59881479|NCT04405076|76004356|FG008|STARTED|Part C (Rollover Proof of Concept)||20||
59881480|NCT04405076|76004348|FG000|COMPLETED|Part C (Rollover Proof of Concept)||0||
59881481|NCT04405076|76004349|FG001|COMPLETED|Part C (Rollover Proof of Concept)||0||
59881482|NCT04405076|76004350|FG002|COMPLETED|Part C (Rollover Proof of Concept)||0||
59881483|NCT04405076|76004351|FG003|COMPLETED|Part C (Rollover Proof of Concept)||0||
59881484|NCT04405076|76004352|FG004|COMPLETED|Part C (Rollover Proof of Concept)||0||
59881485|NCT04405076|76004353|FG005|COMPLETED|Part C (Rollover Proof of Concept)||0||
60009021|NCT01998958|76124633|FG003|STARTED|Follow-up Phase||0||
60009022|NCT01998958|76124634|FG004|STARTED|Follow-up Phase||0||
60009023|NCT01998958|76124635|FG005|STARTED|Follow-up Phase||0||
60009024|NCT01998958|76124636|FG006|STARTED|Follow-up Phase||0||
60009025|NCT01998958|76124637|FG007|STARTED|Follow-up Phase||0||
60009026|NCT01998958|76124638|FG008|STARTED|Follow-up Phase||0||
60009027|NCT01998958|76124639|FG009|STARTED|Follow-up Phase||0||
60009028|NCT01998958|76124640|FG010|STARTED|Follow-up Phase||0||
60009029|NCT01998958|76124641|FG011|STARTED|Follow-up Phase||0||
60009030|NCT01998958|76124642|FG012|STARTED|Follow-up Phase||0||
60009031|NCT01998958|76124643|FG013|STARTED|Follow-up Phase||0||
60009032|NCT01998958|76124644|FG014|STARTED|Follow-up Phase||0||
60009033|NCT01998958|76124645|FG015|STARTED|Follow-up Phase||0||
60009034|NCT01998958|76124646|FG016|STARTED|Follow-up Phase||0||
60009035|NCT01998958|76124647|FG017|STARTED|Follow-up Phase||0||
60009036|NCT01998958|76124648|FG018|STARTED|Follow-up Phase||0||
60009037|NCT01998958|76124649|FG019|STARTED|Follow-up Phase||0||
60009038|NCT01998958|76124650|FG020|STARTED|Follow-up Phase||0||
60009039|NCT01998958|76124651|FG021|STARTED|Follow-up Phase||0||
60009040|NCT01998958|76124652|FG022|STARTED|Follow-up Phase||0||
60009041|NCT01998958|76124653|FG023|STARTED|Follow-up Phase||0||
60009042|NCT01998958|76124654|FG024|STARTED|Follow-up Phase||0||
60009043|NCT01998958|76124655|FG025|STARTED|Follow-up Phase||0||
60009044|NCT01998958|76124656|FG026|STARTED|Follow-up Phase||0||
60009045|NCT01998958|76124657|FG027|STARTED|Follow-up Phase||1||
60009046|NCT01998958|76124658|FG028|STARTED|Follow-up Phase||4||
60009047|NCT01998958|76124659|FG029|STARTED|Follow-up Phase||12||
60009048|NCT01998958|76124660|FG030|STARTED|Follow-up Phase||39||
60009049|NCT01998958|76124661|FG031|STARTED|Follow-up Phase||42||
60009050|NCT01998958|76124630|FG000|COMPLETED|Follow-up Phase||0||
60009051|NCT01998958|76124631|FG001|COMPLETED|Follow-up Phase||0||
60009052|NCT01998958|76124632|FG002|COMPLETED|Follow-up Phase||0||
60009053|NCT01998958|76124633|FG003|COMPLETED|Follow-up Phase||0||
60009054|NCT01998958|76124634|FG004|COMPLETED|Follow-up Phase||0||
60009055|NCT01998958|76124635|FG005|COMPLETED|Follow-up Phase||0||
60009056|NCT01998958|76124636|FG006|COMPLETED|Follow-up Phase||0||
60009057|NCT01998958|76124637|FG007|COMPLETED|Follow-up Phase||0||
60009058|NCT01998958|76124638|FG008|COMPLETED|Follow-up Phase||0||
60009059|NCT01998958|76124639|FG009|COMPLETED|Follow-up Phase||0||
60009060|NCT01998958|76124640|FG010|COMPLETED|Follow-up Phase||0||
60009061|NCT01998958|76124641|FG011|COMPLETED|Follow-up Phase||0||
60009062|NCT01998958|76124642|FG012|COMPLETED|Follow-up Phase||0||
60009063|NCT01998958|76124643|FG013|COMPLETED|Follow-up Phase||0||
60009064|NCT01998958|76124644|FG014|COMPLETED|Follow-up Phase||0||
60009065|NCT01998958|76124645|FG015|COMPLETED|Follow-up Phase||0||
60009066|NCT01998958|76124646|FG016|COMPLETED|Follow-up Phase||0||
60009067|NCT01998958|76124647|FG017|COMPLETED|Follow-up Phase||0||
60009068|NCT01998958|76124648|FG018|COMPLETED|Follow-up Phase||0||
60009069|NCT01998958|76124649|FG019|COMPLETED|Follow-up Phase||0||
60009070|NCT01998958|76124650|FG020|COMPLETED|Follow-up Phase||0||
60009071|NCT01998958|76124651|FG021|COMPLETED|Follow-up Phase||0||
60009072|NCT01998958|76124652|FG022|COMPLETED|Follow-up Phase||0||
60009073|NCT01998958|76124653|FG023|COMPLETED|Follow-up Phase||0||
60009074|NCT01998958|76124654|FG024|COMPLETED|Follow-up Phase||0||
60009075|NCT01998958|76124655|FG025|COMPLETED|Follow-up Phase||0||
60009076|NCT01998958|76124656|FG026|COMPLETED|Follow-up Phase||0||
60009077|NCT01998958|76124657|FG027|COMPLETED|Follow-up Phase||1||
60009078|NCT01998958|76124658|FG028|COMPLETED|Follow-up Phase||4||
60009079|NCT01998958|76124659|FG029|COMPLETED|Follow-up Phase||12||
60009080|NCT01998958|76124660|FG030|COMPLETED|Follow-up Phase||39||
60009081|NCT01998958|76124661|FG031|COMPLETED|Follow-up Phase||42||
60009082|NCT01998958|76124630|FG000|NOT COMPLETED|Follow-up Phase||0||
60009083|NCT01998958|76124631|FG001|NOT COMPLETED|Follow-up Phase||0||
60009084|NCT01998958|76124632|FG002|NOT COMPLETED|Follow-up Phase||0||
60009085|NCT01998958|76124633|FG003|NOT COMPLETED|Follow-up Phase||0||
60009086|NCT01998958|76124634|FG004|NOT COMPLETED|Follow-up Phase||0||
60009087|NCT01998958|76124635|FG005|NOT COMPLETED|Follow-up Phase||0||
60009088|NCT01998958|76124636|FG006|NOT COMPLETED|Follow-up Phase||0||
60009089|NCT01998958|76124637|FG007|NOT COMPLETED|Follow-up Phase||0||
60009090|NCT01998958|76124638|FG008|NOT COMPLETED|Follow-up Phase||0||
60009091|NCT01998958|76124639|FG009|NOT COMPLETED|Follow-up Phase||0||
60009092|NCT01998958|76124640|FG010|NOT COMPLETED|Follow-up Phase||0||
60009093|NCT01998958|76124641|FG011|NOT COMPLETED|Follow-up Phase||0||
60009094|NCT01998958|76124642|FG012|NOT COMPLETED|Follow-up Phase||0||
60009095|NCT01998958|76124643|FG013|NOT COMPLETED|Follow-up Phase||0||
60009096|NCT01998958|76124644|FG014|NOT COMPLETED|Follow-up Phase||0||
60009097|NCT01998958|76124645|FG015|NOT COMPLETED|Follow-up Phase||0||
60009098|NCT01998958|76124646|FG016|NOT COMPLETED|Follow-up Phase||0||
60009099|NCT01998958|76124647|FG017|NOT COMPLETED|Follow-up Phase||0||
60009100|NCT01998958|76124648|FG018|NOT COMPLETED|Follow-up Phase||0||
60009101|NCT01998958|76124649|FG019|NOT COMPLETED|Follow-up Phase||0||
60009102|NCT01998958|76124650|FG020|NOT COMPLETED|Follow-up Phase||0||
60009103|NCT01998958|76124651|FG021|NOT COMPLETED|Follow-up Phase||0||
60009104|NCT01998958|76124652|FG022|NOT COMPLETED|Follow-up Phase||0||
60009105|NCT01998958|76124653|FG023|NOT COMPLETED|Follow-up Phase||0||
60009106|NCT01998958|76124654|FG024|NOT COMPLETED|Follow-up Phase||0||
60009107|NCT01998958|76124655|FG025|NOT COMPLETED|Follow-up Phase||0||
60009108|NCT01998958|76124656|FG026|NOT COMPLETED|Follow-up Phase||0||
60009109|NCT01998958|76124657|FG027|NOT COMPLETED|Follow-up Phase||0||
60009110|NCT01998958|76124658|FG028|NOT COMPLETED|Follow-up Phase||0||
60009111|NCT01998958|76124659|FG029|NOT COMPLETED|Follow-up Phase||0||
60009112|NCT01998958|76124660|FG030|NOT COMPLETED|Follow-up Phase||0||
60009113|NCT01998958|76124661|FG031|NOT COMPLETED|Follow-up Phase||0||
60009114|NCT01958164|76124713|FG000|STARTED|Overall Study|Randomised and treated|6||
60009115|NCT01958164|76124714|FG001|STARTED|Overall Study|Randomised and treated|10||
60009116|NCT01958164|76124713|FG000|COMPLETED|Overall Study||4||
60009117|NCT01958164|76124714|FG001|COMPLETED|Overall Study||5||
60009118|NCT01958164|76124713|FG000|NOT COMPLETED|Overall Study||2||
60009119|NCT01958164|76124714|FG001|NOT COMPLETED|Overall Study||5||
60009120|NCT01976104|76124724|FG000|STARTED|Overall Study||43||
60009121|NCT01976104|76124725|FG001|STARTED|Overall Study||70||
60009122|NCT01976104|76124726|FG002|STARTED|Overall Study||33||
60009123|NCT01976104|76124727|FG003|STARTED|Overall Study||58||
60009124|NCT01976104|76124724|FG000|COMPLETED|Overall Study||37||
60009125|NCT01976104|76124725|FG001|COMPLETED|Overall Study||68||
60009126|NCT01976104|76124726|FG002|COMPLETED|Overall Study||31||
60009127|NCT01976104|76124727|FG003|COMPLETED|Overall Study||55||
60009128|NCT01976104|76124724|FG000|NOT COMPLETED|Overall Study||6||
60009129|NCT01976104|76124725|FG001|NOT COMPLETED|Overall Study||2||
60009130|NCT01976104|76124726|FG002|NOT COMPLETED|Overall Study||2||
60009131|NCT01976104|76124727|FG003|NOT COMPLETED|Overall Study||3||
60009132|NCT01372501|76124738|FG000|STARTED|Overall Study||19||
60009133|NCT01372501|76124738|FG000|COMPLETED|Overall Study||14||
60009134|NCT01372501|76124738|FG000|NOT COMPLETED|Overall Study||5||
60009135|NCT01958008|76124747|FG000|STARTED|Overall Study||21||
60009136|NCT01958008|76124748|FG001|STARTED|Overall Study||21||
60009137|NCT01958008|76124749|FG002|STARTED|Overall Study||21||
60009138|NCT01958008|76124750|FG003|STARTED|Overall Study||21||
60009139|NCT01958008|76124747|FG000|COMPLETED|Overall Study||20||
60009140|NCT01958008|76124748|FG001|COMPLETED|Overall Study||21||
60009141|NCT01958008|76124749|FG002|COMPLETED|Overall Study||20||
60009142|NCT01958008|76124750|FG003|COMPLETED|Overall Study||21||
60009143|NCT01958008|76124747|FG000|NOT COMPLETED|Overall Study||1||
60009144|NCT01958008|76124748|FG001|NOT COMPLETED|Overall Study||0||
60009145|NCT01958008|76124749|FG002|NOT COMPLETED|Overall Study||1||
60009146|NCT01958008|76124750|FG003|NOT COMPLETED|Overall Study||0||
60009147|NCT04645264|76124766|FG000|STARTED|Overall Study||3||
60009148|NCT04645264|76124767|FG001|STARTED|Overall Study||2||
60009149|NCT04645264|76124768|FG002|STARTED|Overall Study||2||
60009150|NCT04645264|76124766|FG000|COMPLETED|Overall Study||3||
60009151|NCT04645264|76124767|FG001|COMPLETED|Overall Study||2||
60009152|NCT04645264|76124768|FG002|COMPLETED|Overall Study||2||
60009153|NCT04645264|76124766|FG000|NOT COMPLETED|Overall Study||0||
60009154|NCT04645264|76124767|FG001|NOT COMPLETED|Overall Study||0||
60009155|NCT04645264|76124768|FG002|NOT COMPLETED|Overall Study||0||
60009156|NCT01998880|76124778|FG000|STARTED|Overall Study||233||
60009157|NCT01998880|76124779|FG001|STARTED|Overall Study||118||
60009158|NCT01998880|76124778|FG000|Received Study Drug|Overall Study||230||
60009159|NCT01998880|76124779|FG001|Received Study Drug|Overall Study||116||
60009160|NCT01998880|76124778|FG000|COMPLETED|Overall Study|Completed=Completed treatment.|205||
60009161|NCT01998880|76124779|FG001|COMPLETED|Overall Study||78||
60009162|NCT01998880|76124778|FG000|NOT COMPLETED|Overall Study||28||
60009163|NCT01998880|76124779|FG001|NOT COMPLETED|Overall Study||40||
60009164|NCT01975948|76124789|FG000|STARTED|Overall Study||56||
60009165|NCT01975948|76124790|FG001|STARTED|Overall Study||55||
60009166|NCT01975948|76124791|FG002|STARTED|Overall Study||72||
60009167|NCT01975948|76124792|FG003|STARTED|Overall Study||57||
60009168|NCT01975948|76124789|FG000|COMPLETED|Overall Study||39||
60009169|NCT01975948|76124790|FG001|COMPLETED|Overall Study||34||
60009170|NCT01975948|76124791|FG002|COMPLETED|Overall Study||65||
60009171|NCT01975948|76124792|FG003|COMPLETED|Overall Study||51||
60009172|NCT01975948|76124789|FG000|NOT COMPLETED|Overall Study||17||
60009173|NCT01975948|76124790|FG001|NOT COMPLETED|Overall Study||21||
60009174|NCT01975948|76124791|FG002|NOT COMPLETED|Overall Study||7||
60009175|NCT01975948|76124792|FG003|NOT COMPLETED|Overall Study||6||
60009176|NCT01975246|76124804|FG000|STARTED|Overall Study||149||
60009177|NCT01975246|76124805|FG001|STARTED|Overall Study||160||
60009178|NCT01975246|76124804|FG000|COMPLETED|Overall Study||145||
60009179|NCT01975246|76124805|FG001|COMPLETED|Overall Study||158||
60009180|NCT01975246|76124804|FG000|NOT COMPLETED|Overall Study||4||
60009181|NCT01975246|76124805|FG001|NOT COMPLETED|Overall Study||2||
60009182|NCT01621126|76124811|FG000|STARTED|Overall Study||40||
60009183|NCT01621126|76124811|FG000|COMPLETED|Overall Study||34||
60009184|NCT01621126|76124811|FG000|NOT COMPLETED|Overall Study||6||
60009185|NCT01973998|76124817|FG000|STARTED|Overall Study||33||
60009186|NCT01973998|76124818|FG001|STARTED|Overall Study||35||
60009187|NCT01973998|76124817|FG000|COMPLETED|Overall Study||31||
60009188|NCT01973998|76124818|FG001|COMPLETED|Overall Study||33||
60009189|NCT01973998|76124817|FG000|NOT COMPLETED|Overall Study||2||
60009190|NCT01973998|76124818|FG001|NOT COMPLETED|Overall Study||2||
60009191|NCT02664415|76124826|FG000|STARTED|Overall Study||14||
60009192|NCT02664415|76124827|FG001|STARTED|Overall Study||5||
60009193|NCT02664415|76124826|FG000|COMPLETED|Overall Study||13||
60009194|NCT02664415|76124827|FG001|COMPLETED|Overall Study||5||
60009195|NCT02664415|76124826|FG000|NOT COMPLETED|Overall Study||1||
60009196|NCT02664415|76124827|FG001|NOT COMPLETED|Overall Study||0||
60009197|NCT02661061|76124835|FG000|STARTED|Overall Study||5||
60009198|NCT02661061|76124836|FG001|STARTED|Overall Study||4||
60009199|NCT02661061|76124835|FG000|COMPLETED|Overall Study||3||
60009200|NCT02661061|76124836|FG001|COMPLETED|Overall Study||2||
60009201|NCT02661061|76124835|FG000|NOT COMPLETED|Overall Study||2||
60009202|NCT02661061|76124836|FG001|NOT COMPLETED|Overall Study||2||
60009203|NCT01995838|76124849|FG000|STARTED|Overall Study||56||
60009204|NCT01995838|76124850|FG001|STARTED|Overall Study||32||
60009205|NCT01995838|76124851|FG002|STARTED|Overall Study||27||
60009206|NCT01995838|76124852|FG003|STARTED|Overall Study||38||
60009207|NCT01995838|76124853|FG004|STARTED|Overall Study||32||
60009208|NCT01995838|76124854|FG005|STARTED|Overall Study||56||
60009209|NCT01995838|76124855|FG006|STARTED|Overall Study||50||
60009210|NCT01995838|76124849|FG000|COMPLETED|Overall Study||51||
60009211|NCT01995838|76124850|FG001|COMPLETED|Overall Study||30||
60009212|NCT01995838|76124851|FG002|COMPLETED|Overall Study||27||
60009213|NCT01995838|76124852|FG003|COMPLETED|Overall Study||36||
60009214|NCT01995838|76124853|FG004|COMPLETED|Overall Study||30||
60009215|NCT01995838|76124854|FG005|COMPLETED|Overall Study||54||
60009216|NCT01995838|76124855|FG006|COMPLETED|Overall Study||45||
60009217|NCT01995838|76124849|FG000|NOT COMPLETED|Overall Study||5||
60009218|NCT01995838|76124850|FG001|NOT COMPLETED|Overall Study||2||
60009219|NCT01995838|76124851|FG002|NOT COMPLETED|Overall Study||0||
60009220|NCT01995838|76124852|FG003|NOT COMPLETED|Overall Study||2||
60009221|NCT01995838|76124853|FG004|NOT COMPLETED|Overall Study||2||
60009222|NCT01995838|76124854|FG005|NOT COMPLETED|Overall Study||2||
60009223|NCT01995838|76124855|FG006|NOT COMPLETED|Overall Study||5||
60009224|NCT04019275|76124872|FG000|STARTED|Overall Study||30||
60009225|NCT04019275|76124872|FG000|COMPLETED|Overall Study||24||
60009226|NCT04019275|76124872|FG000|NOT COMPLETED|Overall Study||6||
60009227|NCT01957462|76124876|FG000|STARTED|Test Period 1||16||
60009228|NCT01957462|76124877|FG001|STARTED|Test Period 1||15||
60009229|NCT01957462|76124876|FG000|COMPLETED|Test Period 1||14||
60009230|NCT01957462|76124877|FG001|COMPLETED|Test Period 1||15||
60009231|NCT01957462|76124876|FG000|NOT COMPLETED|Test Period 1||2||
60009232|NCT01957462|76124877|FG001|NOT COMPLETED|Test Period 1||0||
60009233|NCT01957462|76124876|FG000|STARTED|Test Period 2||14||
60009234|NCT01957462|76124877|FG001|STARTED|Test Period 2||15||
60009235|NCT01957462|76124876|FG000|COMPLETED|Test Period 2||14||
60009236|NCT01957462|76124877|FG001|COMPLETED|Test Period 2||15||
60009237|NCT01957462|76124876|FG000|NOT COMPLETED|Test Period 2||0||
60009238|NCT01957462|76124877|FG001|NOT COMPLETED|Test Period 2||0||
60009239|NCT01957150|76124885|FG000|STARTED|Overall Study||142||
60009240|NCT01957150|76124886|FG001|STARTED|Overall Study||141||
60009241|NCT01957150|76124885|FG000|COMPLETED|Overall Study||87||
60009242|NCT01957150|76124886|FG001|COMPLETED|Overall Study||83||
60009243|NCT01957150|76124885|FG000|NOT COMPLETED|Overall Study||55||
60009244|NCT01957150|76124886|FG001|NOT COMPLETED|Overall Study||58||
60009245|NCT01955122|76124894|FG000|STARTED|Overall Study|"Excluded (n = 5)~Included in analysis (n = 59)"|64||
60009246|NCT01955122|76124895|FG001|STARTED|Overall Study|"Excluded (n = 5)~Included in analysis (n = 57)"|62||
60009247|NCT01955122|76124894|FG000|No.Patients Enrolled|Overall Study||64||
60009248|NCT01955122|76124895|FG001|No.Patients Enrolled|Overall Study||62||
60009249|NCT01955122|76124894|FG000|No. Patients Completed Double Procedure|Overall Study||59||
60009250|NCT01955122|76124895|FG001|No. Patients Completed Double Procedure|Overall Study||57||
60009251|NCT01955122|76124894|FG000|COMPLETED|Overall Study||59||
60009252|NCT01955122|76124895|FG001|COMPLETED|Overall Study||57||
60009253|NCT01955122|76124894|FG000|NOT COMPLETED|Overall Study||5||
60009254|NCT01955122|76124895|FG001|NOT COMPLETED|Overall Study||5||
60009255|NCT01995526|76124907|FG000|STARTED|Overall Study||11||
60009256|NCT01995526|76124907|FG000|Received One Dose of Study Drug|Overall Study||11||
60009257|NCT01995526|76124907|FG000|COMPLETED|Overall Study||10||
60009258|NCT01995526|76124907|FG000|NOT COMPLETED|Overall Study||1||
60009259|NCT01955044|76124914|FG000|STARTED|Overall Study||10||
60009260|NCT01955044|76124915|FG001|STARTED|Overall Study||10||
60009261|NCT01955044|76124916|FG002|STARTED|Overall Study||10||
60009262|NCT01955044|76124914|FG000|COMPLETED|Overall Study||9||
60009263|NCT01955044|76124915|FG001|COMPLETED|Overall Study||9||
60009264|NCT01955044|76124916|FG002|COMPLETED|Overall Study||10||
60009265|NCT01955044|76124914|FG000|NOT COMPLETED|Overall Study||1||
60009266|NCT01955044|76124915|FG001|NOT COMPLETED|Overall Study||1||
60009267|NCT01955044|76124916|FG002|NOT COMPLETED|Overall Study||0||
60009268|NCT01973218|76124926|FG000|STARTED|Overall Study||176||
60009269|NCT01973218|76124927|FG001|STARTED|Overall Study||88||
60009270|NCT01973218|76124926|FG000|COMPLETED|Overall Study||174||
60009271|NCT01973218|76124927|FG001|COMPLETED|Overall Study||88||
60009272|NCT01973218|76124926|FG000|NOT COMPLETED|Overall Study||2||
60009273|NCT01973218|76124927|FG001|NOT COMPLETED|Overall Study||0||
60009274|NCT01954342|76124939|FG000|STARTED|Overall Study||36||
60009275|NCT01954342|76124940|FG001|STARTED|Overall Study||8||
60009276|NCT01954342|76124941|FG002|STARTED|Overall Study||10||
60009277|NCT01954342|76124942|FG003|STARTED|Overall Study||18||
60009278|NCT01954342|76124939|FG000|COMPLETED|Overall Study||36||
60009279|NCT01954342|76124940|FG001|COMPLETED|Overall Study||8||
60009280|NCT01954342|76124941|FG002|COMPLETED|Overall Study||10||
60009281|NCT01954342|76124942|FG003|COMPLETED|Overall Study||0||
60009282|NCT01954342|76124939|FG000|NOT COMPLETED|Overall Study||0||
60009283|NCT01954342|76124940|FG001|NOT COMPLETED|Overall Study||0||
60009284|NCT01954342|76124941|FG002|NOT COMPLETED|Overall Study||0||
60009285|NCT01954342|76124942|FG003|NOT COMPLETED|Overall Study||18||
60009286|NCT01972438|76124954|FG000|STARTED|Baseline-Month 3 Crossover Period|Two participants never started IP: one died and one did not meet the inclusion criteria|9||
60009287|NCT01972438|76124955|FG001|STARTED|Baseline-Month 3 Crossover Period|One participant never started IP, as unable to donate blood for preparation of ASEDs|9||
60009288|NCT01972438|76124954|FG000|COMPLETED|Baseline-Month 3 Crossover Period||6||
60009289|NCT01972438|76124955|FG001|COMPLETED|Baseline-Month 3 Crossover Period||6||
60009290|NCT01972438|76124954|FG000|NOT COMPLETED|Baseline-Month 3 Crossover Period||3||
60009291|NCT01972438|76124955|FG001|NOT COMPLETED|Baseline-Month 3 Crossover Period||3||
60009292|NCT01972438|76124954|FG000|STARTED|Months 3-6 Crossover Period||6||
60009293|NCT01972438|76124955|FG001|STARTED|Months 3-6 Crossover Period|Two participants who missed Month 3 visit completed this pd but one who completed Month 3 didn't|7||
60009294|NCT01972438|76124954|FG000|COMPLETED|Months 3-6 Crossover Period||6||
60009295|NCT01972438|76124955|FG001|COMPLETED|Months 3-6 Crossover Period||6||
60009296|NCT01972438|76124954|FG000|NOT COMPLETED|Months 3-6 Crossover Period||0||
60009297|NCT01972438|76124955|FG001|NOT COMPLETED|Months 3-6 Crossover Period||1||
60009298|NCT01972438|76124954|FG000|STARTED|Months 6-12 Study Period||6||
60009299|NCT01972438|76124955|FG001|STARTED|Months 6-12 Study Period||6||
60009300|NCT01972438|76124954|FG000|COMPLETED|Months 6-12 Study Period||3||
60009301|NCT01972438|76124955|FG001|COMPLETED|Months 6-12 Study Period||4||
60009302|NCT01972438|76124954|FG000|NOT COMPLETED|Months 6-12 Study Period||3||
60009303|NCT01972438|76124955|FG001|NOT COMPLETED|Months 6-12 Study Period||2||
60009304|NCT01972438|76124954|FG000|STARTED|Post Month 12 Study Period||3||
60009305|NCT01972438|76124955|FG001|STARTED|Post Month 12 Study Period||4||
60009306|NCT01972438|76124954|FG000|COMPLETED|Post Month 12 Study Period||0||
60009307|NCT01972438|76124955|FG001|COMPLETED|Post Month 12 Study Period||0||
60009308|NCT01972438|76124954|FG000|NOT COMPLETED|Post Month 12 Study Period||3||
60009309|NCT01972438|76124955|FG001|NOT COMPLETED|Post Month 12 Study Period||4||
60009310|NCT01946152|76124967|FG000|STARTED|Overall Study||3||
60009311|NCT01946152|76124968|FG001|STARTED|Overall Study||3||
60009312|NCT01946152|76124969|FG002|STARTED|Overall Study||6||
60009313|NCT01946152|76124970|FG003|STARTED|Overall Study||8||
60009314|NCT01946152|76124967|FG000|COMPLETED|Overall Study||2||
60009315|NCT01946152|76124968|FG001|COMPLETED|Overall Study||0||
60009316|NCT01946152|76124969|FG002|COMPLETED|Overall Study||0||
60009317|NCT01946152|76124970|FG003|COMPLETED|Overall Study||0||
60009318|NCT01946152|76124967|FG000|NOT COMPLETED|Overall Study||1||
60009319|NCT01946152|76124968|FG001|NOT COMPLETED|Overall Study||3||
60009320|NCT01946152|76124969|FG002|NOT COMPLETED|Overall Study||6||
60009321|NCT01946152|76124970|FG003|NOT COMPLETED|Overall Study||8||
60009322|NCT01945996|76124984|FG000|STARTED|Overall Study||22||
60009323|NCT01945996|76124985|FG001|STARTED|Overall Study||22||
60009324|NCT01945996|76124984|FG000|COMPLETED|Overall Study||19||
60009325|NCT01945996|76124985|FG001|COMPLETED|Overall Study||17||
60009326|NCT01945996|76124984|FG000|NOT COMPLETED|Overall Study||3||
60009327|NCT01945996|76124985|FG001|NOT COMPLETED|Overall Study||5||
60009328|NCT01971346|76124993|FG000|STARTED|Overall Study|Four subjects signed the informed consent and terminated the study before beginning.|50||
60009329|NCT01971346|76124993|FG000|COMPLETED|Overall Study||42||
60009330|NCT01971346|76124993|FG000|NOT COMPLETED|Overall Study||8||
60009331|NCT01945216|76125008|FG000|STARTED|Overall Study||3317||
60009332|NCT01945216|76125008|FG000|COMPLETED|Overall Study||3218||
60009333|NCT01945216|76125008|FG000|NOT COMPLETED|Overall Study||99||
60009334|NCT02641379|76125027|FG000|STARTED|Overall Study||142||
60009335|NCT02641379|76125028|FG001|STARTED|Overall Study||152||
60009336|NCT02641379|76125029|FG002|STARTED|Overall Study||78||
60009337|NCT02641379|76125030|FG003|STARTED|Overall Study||156||
60009338|NCT02641379|76125031|FG004|STARTED|Overall Study||17||
60009339|NCT02641379|76125032|FG005|STARTED|Overall Study||36||
60009340|NCT02641379|76125033|FG006|STARTED|Overall Study||25||
60009341|NCT02641379|76125034|FG007|STARTED|Overall Study||20||
60009342|NCT02641379|76125035|FG008|STARTED|Overall Study||42||
60009343|NCT02641379|76125036|FG009|STARTED|Overall Study||45||
60009344|NCT02641379|76125037|FG010|STARTED|Overall Study||8||
60009345|NCT02641379|76125027|FG000|COMPLETED|Overall Study||107||
60009346|NCT02641379|76125028|FG001|COMPLETED|Overall Study||101||
60009347|NCT02641379|76125029|FG002|COMPLETED|Overall Study||7||
60009348|NCT02641379|76125030|FG003|COMPLETED|Overall Study||139||
60009349|NCT02641379|76125031|FG004|COMPLETED|Overall Study||0||
60009350|NCT02641379|76125032|FG005|COMPLETED|Overall Study||20||
60009351|NCT02641379|76125033|FG006|COMPLETED|Overall Study||12||
60009352|NCT02641379|76125034|FG007|COMPLETED|Overall Study||1||
60009353|NCT02641379|76125035|FG008|COMPLETED|Overall Study||36||
60009354|NCT02641379|76125036|FG009|COMPLETED|Overall Study||36||
60009355|NCT02641379|76125037|FG010|COMPLETED|Overall Study||0||
60009356|NCT02641379|76125027|FG000|NOT COMPLETED|Overall Study||35||
60009357|NCT02641379|76125028|FG001|NOT COMPLETED|Overall Study||51||
60009358|NCT02641379|76125029|FG002|NOT COMPLETED|Overall Study||71||
60009359|NCT02641379|76125030|FG003|NOT COMPLETED|Overall Study||17||
60009360|NCT02641379|76125031|FG004|NOT COMPLETED|Overall Study||17||
60009361|NCT02641379|76125032|FG005|NOT COMPLETED|Overall Study||16||
60009362|NCT02641379|76125033|FG006|NOT COMPLETED|Overall Study||13||
60009363|NCT02641379|76125034|FG007|NOT COMPLETED|Overall Study||19||
60009364|NCT02641379|76125035|FG008|NOT COMPLETED|Overall Study||6||
60009365|NCT02641379|76125036|FG009|NOT COMPLETED|Overall Study||9||
60009366|NCT02641379|76125037|FG010|NOT COMPLETED|Overall Study||8||
60009367|NCT02660983|76125068|FG000|STARTED|Double-blind (DB) Phase (24 Weeks)||154||
60009368|NCT02660983|76125069|FG001|STARTED|Double-blind (DB) Phase (24 Weeks)||148||
60009369|NCT02660983|76125068|FG000|Treated/Safety Set|Double-blind (DB) Phase (24 Weeks)||153||
60009370|NCT02660983|76125069|FG001|Treated/Safety Set|Double-blind (DB) Phase (24 Weeks)||147||
60009371|NCT02660983|76125068|FG000|COMPLETED|Double-blind (DB) Phase (24 Weeks)||130||
60009372|NCT02660983|76125069|FG001|COMPLETED|Double-blind (DB) Phase (24 Weeks)||122||
60009373|NCT02660983|76125068|FG000|NOT COMPLETED|Double-blind (DB) Phase (24 Weeks)||24||
60009374|NCT02660983|76125069|FG001|NOT COMPLETED|Double-blind (DB) Phase (24 Weeks)||26||
60009375|NCT02660983|76125068|FG000|STARTED|Open Label Extension Phase (24 Weeks)|Eligible participants who consented to continue from DB phase to OLE phase.|86||
60009376|NCT02660983|76125069|FG001|STARTED|Open Label Extension Phase (24 Weeks)|Eligible participants who consented to continue from DB phase to OLE phase.|75||
60009377|NCT02660983|76125068|FG000|Safety Set|Open Label Extension Phase (24 Weeks)||86||
60009378|NCT02660983|76125069|FG001|Safety Set|Open Label Extension Phase (24 Weeks)||75||
60009379|NCT02660983|76125068|FG000|COMPLETED|Open Label Extension Phase (24 Weeks)||83||
60009380|NCT02660983|76125069|FG001|COMPLETED|Open Label Extension Phase (24 Weeks)||66||
60009381|NCT02660983|76125068|FG000|NOT COMPLETED|Open Label Extension Phase (24 Weeks)||3||
60009382|NCT02660983|76125069|FG001|NOT COMPLETED|Open Label Extension Phase (24 Weeks)||9||
60009383|NCT01953328|76125084|FG000|STARTED|Overall Study||49||
60009384|NCT01953328|76125085|FG001|STARTED|Overall Study||50||
60009385|NCT01953328|76125086|FG002|STARTED|Overall Study||50||
60009386|NCT01953328|76125087|FG003|STARTED|Overall Study||50||
60009387|NCT01953328|76125088|FG004|STARTED|Overall Study||52||
60009388|NCT01953328|76125089|FG005|STARTED|Overall Study||51||
60009389|NCT01953328|76125090|FG006|STARTED|Overall Study||51||
60009390|NCT01953328|76125091|FG007|STARTED|Overall Study||51||
60009391|NCT01953328|76125084|FG000|Received Treatment|Overall Study||49||
60009392|NCT01953328|76125085|FG001|Received Treatment|Overall Study||50||
60009393|NCT01953328|76125086|FG002|Received Treatment|Overall Study||50||
60009394|NCT01953328|76125087|FG003|Received Treatment|Overall Study||50||
60009395|NCT01953328|76125088|FG004|Received Treatment|Overall Study||52||
60009396|NCT01953328|76125089|FG005|Received Treatment|Overall Study||51||
60009397|NCT01953328|76125090|FG006|Received Treatment|Overall Study||51||
60009398|NCT01953328|76125091|FG007|Received Treatment|Overall Study||51||
60009399|NCT01953328|76125084|FG000|COMPLETED|Overall Study||49||
60009400|NCT01953328|76125085|FG001|COMPLETED|Overall Study||50||
60009401|NCT01953328|76125086|FG002|COMPLETED|Overall Study||50||
60009402|NCT01953328|76125087|FG003|COMPLETED|Overall Study||50||
60009403|NCT01953328|76125088|FG004|COMPLETED|Overall Study||50||
60009404|NCT01953328|76125089|FG005|COMPLETED|Overall Study||51||
60009405|NCT01953328|76125090|FG006|COMPLETED|Overall Study||51||
60009406|NCT01953328|76125091|FG007|COMPLETED|Overall Study||51||
60009407|NCT01953328|76125084|FG000|NOT COMPLETED|Overall Study||0||
60009408|NCT01953328|76125085|FG001|NOT COMPLETED|Overall Study||0||
60009409|NCT01953328|76125086|FG002|NOT COMPLETED|Overall Study||0||
60009410|NCT01953328|76125087|FG003|NOT COMPLETED|Overall Study||0||
60009411|NCT01953328|76125088|FG004|NOT COMPLETED|Overall Study||2||
60009412|NCT01953328|76125089|FG005|NOT COMPLETED|Overall Study||0||
60009413|NCT01953328|76125090|FG006|NOT COMPLETED|Overall Study||0||
60009414|NCT01953328|76125091|FG007|NOT COMPLETED|Overall Study||0||
60009415|NCT02640755|76125111|FG000|STARTED|Single Dose Period (Day 1 - 8)||3||
60009416|NCT02640755|76125112|FG001|STARTED|Single Dose Period (Day 1 - 8)||1||
60009417|NCT02640755|76125111|FG000|COMPLETED|Single Dose Period (Day 1 - 8)||3||
60009418|NCT02640755|76125112|FG001|COMPLETED|Single Dose Period (Day 1 - 8)||1||
60009419|NCT02640755|76125111|FG000|NOT COMPLETED|Single Dose Period (Day 1 - 8)||0||
60136143|NCT01524224|76258819|FG004|Received at Least One Dose of Study Drug|Overall Study||4||
60136144|NCT01524224|76258820|FG005|Received at Least One Dose of Study Drug|Overall Study||3||
60136145|NCT01524224|76258821|FG006|Received at Least One Dose of Study Drug|Overall Study||3||
60136146|NCT01524224|76258822|FG007|Received at Least One Dose of Study Drug|Overall Study||6||
60136147|NCT01524224|76258815|FG000|COMPLETED|Overall Study||1||
60136148|NCT01524224|76258816|FG001|COMPLETED|Overall Study||2||
60136149|NCT01524224|76258817|FG002|COMPLETED|Overall Study||1||
60136150|NCT01524224|76258818|FG003|COMPLETED|Overall Study||1||
60136151|NCT01524224|76258819|FG004|COMPLETED|Overall Study||0||
60136152|NCT01524224|76258820|FG005|COMPLETED|Overall Study||1||
60136153|NCT01524224|76258821|FG006|COMPLETED|Overall Study||0||
60136154|NCT01524224|76258822|FG007|COMPLETED|Overall Study||0||
60136155|NCT01524224|76258815|FG000|NOT COMPLETED|Overall Study||3||
60136156|NCT01524224|76258816|FG001|NOT COMPLETED|Overall Study||1||
60009420|NCT02640755|76125112|FG001|NOT COMPLETED|Single Dose Period (Day 1 - 8)||0||
60009421|NCT02640755|76125111|FG000|STARTED|Multiple Dose Period (Day 8 - EoS)||3||
60136157|NCT01524224|76258817|FG002|NOT COMPLETED|Overall Study||2||
60136158|NCT01524224|76258818|FG003|NOT COMPLETED|Overall Study||2||
60136159|NCT01524224|76258819|FG004|NOT COMPLETED|Overall Study||4||
60136160|NCT01524224|76258820|FG005|NOT COMPLETED|Overall Study||2||
60136161|NCT01524224|76258821|FG006|NOT COMPLETED|Overall Study||3||
60136162|NCT01524224|76258822|FG007|NOT COMPLETED|Overall Study||6||
60136163|NCT00219349|76258840|FG000|STARTED|Cognitive Behavioral Therapy Phase||25||
60136164|NCT00219349|76258840|FG000|COMPLETED|Cognitive Behavioral Therapy Phase||15||
60136165|NCT00219349|76258840|FG000|NOT COMPLETED|Cognitive Behavioral Therapy Phase||10||
60136166|NCT00219349|76258840|FG000|STARTED|Escitalopram Phase|7 responders to CBT were ineligible to start and 1 declined, leaving 7 who started escitalopram|7||
60136167|NCT00219349|76258840|FG000|COMPLETED|Escitalopram Phase||4||
60136168|NCT00219349|76258840|FG000|NOT COMPLETED|Escitalopram Phase||3||
60136169|NCT01523756|76258844|FG000|STARTED|Baseline Period||11||
60136170|NCT01523756|76258845|FG001|STARTED|Baseline Period||9||
60136171|NCT01523756|76258844|FG000|COMPLETED|Baseline Period||11||
60136172|NCT01523756|76258845|FG001|COMPLETED|Baseline Period||8||
60136173|NCT01523756|76258844|FG000|NOT COMPLETED|Baseline Period||0||
60009422|NCT02640755|76125112|FG001|STARTED|Multiple Dose Period (Day 8 - EoS)||1||
60009423|NCT02640755|76125111|FG000|COMPLETED|Multiple Dose Period (Day 8 - EoS)||1||
60067892|NCT01785069|76183082|FG000|STARTED|Overall Study||107||
60009424|NCT02640755|76125112|FG001|COMPLETED|Multiple Dose Period (Day 8 - EoS)||0||
60009425|NCT02640755|76125111|FG000|NOT COMPLETED|Multiple Dose Period (Day 8 - EoS)||2||
60009426|NCT02640755|76125112|FG001|NOT COMPLETED|Multiple Dose Period (Day 8 - EoS)||1||
60009427|NCT02640677|76125119|FG000|STARTED|Overall Study||2||
60009428|NCT02640677|76125119|FG000|COMPLETED|Overall Study||0||
60009429|NCT02640677|76125119|FG000|NOT COMPLETED|Overall Study||2||
60009430|NCT02643251|76125125|FG000|STARTED|Overall Study||69||
60009431|NCT02643251|76125126|FG001|STARTED|Overall Study||69||
60009432|NCT02643251|76125125|FG000|COMPLETED|Overall Study||58||
60009433|NCT02643251|76125126|FG001|COMPLETED|Overall Study||67||
60009434|NCT02643251|76125125|FG000|NOT COMPLETED|Overall Study||11||
60009435|NCT02643251|76125126|FG001|NOT COMPLETED|Overall Study||2||
60009436|NCT01970878|76125136|FG000|STARTED|Overall Study||290||
60009437|NCT01970878|76125137|FG001|STARTED|Overall Study|218 subjects were reported in the CSR, 1 had no completion status|218||
60009438|NCT01970878|76125138|FG002|STARTED|Overall Study||213||
60009439|NCT01970878|76125139|FG003|STARTED|Overall Study||171||
60009440|NCT01970878|76125136|FG000|COMPLETED|Overall Study||253||
60009441|NCT01970878|76125137|FG001|COMPLETED|Overall Study||191||
60009442|NCT01970878|76125138|FG002|COMPLETED|Overall Study||187||
60009443|NCT01970878|76125139|FG003|COMPLETED|Overall Study||147||
60009444|NCT01970878|76125136|FG000|NOT COMPLETED|Overall Study||37||
60009445|NCT01970878|76125137|FG001|NOT COMPLETED|Overall Study||27||
60009446|NCT01970878|76125138|FG002|NOT COMPLETED|Overall Study||26||
60009447|NCT01970878|76125139|FG003|NOT COMPLETED|Overall Study||24||
60009448|NCT01970488|76125151|FG000|STARTED|Part 1: Through Week 16||175||
60009449|NCT01970488|76125152|FG001|STARTED|Part 1: Through Week 16||175||
60009450|NCT01970488|76125153|FG002|STARTED|Part 1: Through Week 16||0||
60009451|NCT01970488|76125154|FG003|STARTED|Part 1: Through Week 16||0||
60009452|NCT01970488|76125155|FG004|STARTED|Part 1: Through Week 16||0||
60009453|NCT01970488|76125151|FG000|Received Treatment|Part 1: Through Week 16||174||
60009454|NCT01970488|76125152|FG001|Received Treatment|Part 1: Through Week 16||173||
60009455|NCT01970488|76125153|FG002|Received Treatment|Part 1: Through Week 16||0||
60009456|NCT01970488|76125154|FG003|Received Treatment|Part 1: Through Week 16||0||
60009457|NCT01970488|76125155|FG004|Received Treatment|Part 1: Through Week 16||0||
60009458|NCT01970488|76125151|FG000|COMPLETED|Part 1: Through Week 16||164||
60009459|NCT01970488|76125152|FG001|COMPLETED|Part 1: Through Week 16||162||
60009460|NCT01970488|76125153|FG002|COMPLETED|Part 1: Through Week 16||0||
60009461|NCT01970488|76125154|FG003|COMPLETED|Part 1: Through Week 16||0||
60009462|NCT01970488|76125155|FG004|COMPLETED|Part 1: Through Week 16||0||
60009463|NCT01970488|76125151|FG000|NOT COMPLETED|Part 1: Through Week 16||11||
60009464|NCT01970488|76125152|FG001|NOT COMPLETED|Part 1: Through Week 16||13||
60009465|NCT01970488|76125153|FG002|NOT COMPLETED|Part 1: Through Week 16||0||
60009466|NCT01970488|76125154|FG003|NOT COMPLETED|Part 1: Through Week 16||0||
60009467|NCT01970488|76125155|FG004|NOT COMPLETED|Part 1: Through Week 16||0||
60009468|NCT01970488|76125151|FG000|STARTED|Part 2: Post Week 16||0||
60009469|NCT01970488|76125152|FG001|STARTED|Part 2: Post Week 16||0||
60009470|NCT01970488|76125153|FG002|STARTED|Part 2: Post Week 16|Only participants who completed week 16 and with a PASI 50 response continued in Part 2|152||
60009471|NCT01970488|76125154|FG003|STARTED|Part 2: Post Week 16|Only participants who completed week 16 and with a PASI 50 response continued in Part 2|79||
60009472|NCT01970488|76125155|FG004|STARTED|Part 2: Post Week 16|Only participants who completed week 16 and with a PASI 50 response continued in Part 2|77||
60009473|NCT01970488|76125151|FG000|COMPLETED|Part 2: Post Week 16||0||
60009474|NCT01970488|76125152|FG001|COMPLETED|Part 2: Post Week 16||0||
60009475|NCT01970488|76125153|FG002|COMPLETED|Part 2: Post Week 16||135||
60009476|NCT01970488|76125154|FG003|COMPLETED|Part 2: Post Week 16||71||
60009477|NCT01970488|76125155|FG004|COMPLETED|Part 2: Post Week 16||69||
60009478|NCT01970488|76125151|FG000|NOT COMPLETED|Part 2: Post Week 16||0||
60009479|NCT01970488|76125152|FG001|NOT COMPLETED|Part 2: Post Week 16||0||
60009480|NCT01970488|76125153|FG002|NOT COMPLETED|Part 2: Post Week 16||17||
60009481|NCT01970488|76125154|FG003|NOT COMPLETED|Part 2: Post Week 16||8||
60009482|NCT01970488|76125155|FG004|NOT COMPLETED|Part 2: Post Week 16||8||
60009483|NCT02661217|76125172|FG000|STARTED|Overall Study||500|Randomized|
60009484|NCT02661217|76125173|FG001|STARTED|Overall Study||502|Randomized|
60009485|NCT02661217|76125172|FG000|Started 10 Weeks Treatment Epoch|Overall Study||497||
60009486|NCT02661217|76125173|FG001|Started 10 Weeks Treatment Epoch|Overall Study||501||
60009487|NCT02661217|76125172|FG000|Completed 10 Weeks Treatment Epoch|Overall Study||460||
60009488|NCT02661217|76125173|FG001|Completed 10 Weeks Treatment Epoch|Overall Study||455||
60009489|NCT02661217|76125172|FG000|COMPLETED|Overall Study||425|Completed 16 weeks follow-up epoch|
60009490|NCT02661217|76125173|FG001|COMPLETED|Overall Study||419|Completed 16 weeks follow-up epoch|
60009491|NCT02661217|76125172|FG000|NOT COMPLETED|Overall Study||75||
60009492|NCT02661217|76125173|FG001|NOT COMPLETED|Overall Study||83||
60009493|NCT01952080|76125184|FG000|STARTED|Overall Study||5||
60009494|NCT01952080|76125185|FG001|STARTED|Overall Study||8||
60009495|NCT01952080|76125186|FG002|STARTED|Overall Study||14||
60009496|NCT01952080|76125187|FG003|STARTED|Overall Study||15||
60009497|NCT01952080|76125184|FG000|Treated|Overall Study||5||
60009498|NCT01952080|76125185|FG001|Treated|Overall Study||8||
60009499|NCT01952080|76125186|FG002|Treated|Overall Study||14||
60009500|NCT01952080|76125187|FG003|Treated|Overall Study||15||
60009501|NCT01952080|76125184|FG000|COMPLETED|Overall Study||5||
60009502|NCT01952080|76125185|FG001|COMPLETED|Overall Study||7||
60009503|NCT01952080|76125186|FG002|COMPLETED|Overall Study||14||
60009504|NCT01952080|76125187|FG003|COMPLETED|Overall Study||14||
60009505|NCT01952080|76125184|FG000|NOT COMPLETED|Overall Study||0||
60009506|NCT01952080|76125185|FG001|NOT COMPLETED|Overall Study||1||
59881486|NCT04405076|76004354|FG006|COMPLETED|Part C (Rollover Proof of Concept)||18||
59881487|NCT04405076|76004355|FG007|COMPLETED|Part C (Rollover Proof of Concept)||18||
60009507|NCT01952080|76125186|FG002|NOT COMPLETED|Overall Study||0||
60009508|NCT01952080|76125187|FG003|NOT COMPLETED|Overall Study||1||
60009509|NCT01951378|76125199|FG000|STARTED|Overall Study||23||
60009510|NCT01951378|76125200|FG001|STARTED|Overall Study||17||
60009511|NCT01951378|76125199|FG000|COMPLETED|Overall Study||0||
60009512|NCT01951378|76125200|FG001|COMPLETED|Overall Study||0||
60009513|NCT01951378|76125199|FG000|NOT COMPLETED|Overall Study||23||
60009514|NCT01951378|76125200|FG001|NOT COMPLETED|Overall Study||17||
60009515|NCT01944670|76125206|FG000|STARTED|Overall Study||26||
60009516|NCT01944670|76125206|FG000|COMPLETED|Overall Study||24||
60009517|NCT01944670|76125206|FG000|NOT COMPLETED|Overall Study||2||
60009518|NCT01361009|76125210|FG000|STARTED|Overall Study||2017||
60009519|NCT01361009|76125210|FG000|COMPLETED|Overall Study||1901||
60009520|NCT01361009|76125210|FG000|NOT COMPLETED|Overall Study||116||
60009521|NCT01944046|76125216|FG000|STARTED|Randomized to DB||146||
60009522|NCT01944046|76125217|FG001|STARTED|Randomized to DB||144||
60009523|NCT01944046|76125216|FG000|COMPLETED|Randomized to DB||125||
60009524|NCT01944046|76125217|FG001|COMPLETED|Randomized to DB||125||
60009525|NCT01944046|76125216|FG000|NOT COMPLETED|Randomized to DB||21||
60009526|NCT01944046|76125217|FG001|NOT COMPLETED|Randomized to DB||19||
60009527|NCT01944046|76125216|FG000|STARTED|Open Label Eligible and Consented||124|1 from each treatment group declined to consent for openlabel|
60009528|NCT01944046|76125217|FG001|STARTED|Open Label Eligible and Consented||124|1 from each treatment group declined to consent for openlabel|
60009529|NCT01944046|76125216|FG000|COMPLETED|Open Label Eligible and Consented||110||
60009530|NCT01944046|76125217|FG001|COMPLETED|Open Label Eligible and Consented||116||
60009531|NCT01944046|76125216|FG000|NOT COMPLETED|Open Label Eligible and Consented||14||
60009532|NCT01944046|76125217|FG001|NOT COMPLETED|Open Label Eligible and Consented||8||
60009533|NCT01969084|76125229|FG000|STARTED|Overall Study||19||
60009534|NCT01969084|76125230|FG001|STARTED|Overall Study||22||
60009535|NCT01969084|76125229|FG000|COMPLETED|Overall Study||19||
60009536|NCT01969084|76125230|FG001|COMPLETED|Overall Study|One subject withdrew due to unrelated serious adverse event|21||
60009537|NCT01969084|76125229|FG000|NOT COMPLETED|Overall Study||0||
60009538|NCT01969084|76125230|FG001|NOT COMPLETED|Overall Study||1||
60009539|NCT01942486|76125240|FG000|STARTED|Overall Study||35||
60009540|NCT01942486|76125240|FG000|COMPLETED|Overall Study||8||
60009541|NCT01942486|76125240|FG000|NOT COMPLETED|Overall Study||27||
60009542|NCT01941940|76125244|FG000|STARTED|Overall Study||227||
60009543|NCT01941940|76125244|FG000|COMPLETED|Overall Study||194||
60009544|NCT01941940|76125244|FG000|NOT COMPLETED|Overall Study||33||
60009545|NCT01968694|76125250|FG000|STARTED|Visit 1 (1 Day)||10||
60009546|NCT01968694|76125251|FG001|STARTED|Visit 1 (1 Day)||9||
59881488|NCT04405076|76004356|FG008|COMPLETED|Part C (Rollover Proof of Concept)||19||
59881489|NCT04405076|76004348|FG000|NOT COMPLETED|Part C (Rollover Proof of Concept)||0||
59881490|NCT04405076|76004349|FG001|NOT COMPLETED|Part C (Rollover Proof of Concept)||0||
60009547|NCT01968694|76125250|FG000|COMPLETED|Visit 1 (1 Day)||10||
60009548|NCT01968694|76125251|FG001|COMPLETED|Visit 1 (1 Day)||9||
60009549|NCT01968694|76125250|FG000|NOT COMPLETED|Visit 1 (1 Day)||0||
60009550|NCT01968694|76125251|FG001|NOT COMPLETED|Visit 1 (1 Day)||0||
60009551|NCT01968694|76125250|FG000|STARTED|Washout (1 Month)||10||
59881491|NCT04405076|76004350|FG002|NOT COMPLETED|Part C (Rollover Proof of Concept)||0||
59881492|NCT04405076|76004351|FG003|NOT COMPLETED|Part C (Rollover Proof of Concept)||0||
59881493|NCT04405076|76004352|FG004|NOT COMPLETED|Part C (Rollover Proof of Concept)||0||
60009552|NCT01968694|76125251|FG001|STARTED|Washout (1 Month)||9||
60009553|NCT01968694|76125250|FG000|COMPLETED|Washout (1 Month)||10||
60009554|NCT01968694|76125251|FG001|COMPLETED|Washout (1 Month)||8||
60009555|NCT01968694|76125250|FG000|NOT COMPLETED|Washout (1 Month)||0||
60009556|NCT01968694|76125251|FG001|NOT COMPLETED|Washout (1 Month)||1||
60009557|NCT01968694|76125250|FG000|STARTED|Visit 2 (1 Day)||10||
60009558|NCT01968694|76125251|FG001|STARTED|Visit 2 (1 Day)||8||
60009559|NCT01968694|76125250|FG000|COMPLETED|Visit 2 (1 Day)||10||
60009560|NCT01968694|76125251|FG001|COMPLETED|Visit 2 (1 Day)||8||
60009561|NCT01968694|76125250|FG000|NOT COMPLETED|Visit 2 (1 Day)||0||
60009562|NCT01968694|76125251|FG001|NOT COMPLETED|Visit 2 (1 Day)||0||
60009563|NCT01968226|76125259|FG000|STARTED|Overall Study||3||
60009564|NCT01968226|76125259|FG000|COMPLETED|Overall Study||1||
60009565|NCT01968226|76125259|FG000|NOT COMPLETED|Overall Study||2||
60009566|NCT02640053|76125265|FG000|STARTED|Overall Study||21|Treatment|
60009567|NCT02640053|76125266|FG001|STARTED|Overall Study||21|Treatment|
59751268|NCT00593385|75870530|FG000|STARTED|Overall Study||165||
59751269|NCT00593385|75870530|FG000|Intention to Treat (ITT) Population|Overall Study|Excludes 13 subjects who did not meet inclusion/exclusion criteria.|152|Subjects who signed written informed consent, enrolled in the study and met study entry criteria.|
59751270|NCT00593385|75870530|FG000|COMPLETED|Overall Study|125 of 165 enrolled patients completed the study.|125||
59751271|NCT00593385|75870530|FG000|NOT COMPLETED|Overall Study||40||
59751272|NCT00658021|75870539|FG000|STARTED|28-Week Treatment Period||42|Randomized to treatment.|
59751273|NCT00658021|75870540|FG001|STARTED|28-Week Treatment Period||38|Randomized to treatment.|
59751274|NCT00658021|75870541|FG002|STARTED|28-Week Treatment Period||42|Randomized to treatment.|
59751275|NCT00658021|75870539|FG000|Received Treatment|28-Week Treatment Period||40||
59751276|NCT00658021|75870540|FG001|Received Treatment|28-Week Treatment Period||38||
59751277|NCT00658021|75870541|FG002|Received Treatment|28-Week Treatment Period||42||
59881494|NCT04405076|76004353|FG005|NOT COMPLETED|Part C (Rollover Proof of Concept)||0||
59881495|NCT04405076|76004354|FG006|NOT COMPLETED|Part C (Rollover Proof of Concept)||2||
59881496|NCT04405076|76004355|FG007|NOT COMPLETED|Part C (Rollover Proof of Concept)||2||
59881497|NCT04405076|76004356|FG008|NOT COMPLETED|Part C (Rollover Proof of Concept)||1||
59881498|NCT04311177|76004384|FG000|STARTED|Overall Study||58||
59881499|NCT04311177|76004385|FG001|STARTED|Overall Study||59||
59881500|NCT04311177|76004384|FG000|COMPLETED|Overall Study||50||
59881501|NCT04311177|76004385|FG001|COMPLETED|Overall Study||55||
59881502|NCT04311177|76004384|FG000|NOT COMPLETED|Overall Study||8||
59881503|NCT04311177|76004385|FG001|NOT COMPLETED|Overall Study||4||
59881504|NCT03267212|76004391|FG000|STARTED|First Intervention|Non-invasive ventilation|6||
59881505|NCT03267212|76004392|FG001|STARTED|First Intervention|"First Intervention (1 day), Washout (2 days), and Second Intervention (1 day)"|9||
59881506|NCT03267212|76004391|FG000|High SCI|First Intervention||2||
59881507|NCT03267212|76004392|FG001|High SCI|First Intervention||5||
59881508|NCT03267212|76004391|FG000|Low SCI|First Intervention||4||
59881509|NCT03267212|76004392|FG001|Low SCI|First Intervention||4||
59881510|NCT03267212|76004391|FG000|COMPLETED|First Intervention||5||
59881511|NCT03267212|76004392|FG001|COMPLETED|First Intervention||6||
59881512|NCT03267212|76004391|FG000|NOT COMPLETED|First Intervention||1||
59881513|NCT03267212|76004392|FG001|NOT COMPLETED|First Intervention||3||
59881514|NCT03267212|76004391|FG000|STARTED|Washout (Min 2 Days / Max 7 Days)||5||
59881515|NCT03267212|76004392|FG001|STARTED|Washout (Min 2 Days / Max 7 Days)||6||
59881516|NCT03267212|76004391|FG000|COMPLETED|Washout (Min 2 Days / Max 7 Days)||4||
59881517|NCT03267212|76004392|FG001|COMPLETED|Washout (Min 2 Days / Max 7 Days)||6||
59881518|NCT03267212|76004391|FG000|NOT COMPLETED|Washout (Min 2 Days / Max 7 Days)||1||
59881519|NCT03267212|76004392|FG001|NOT COMPLETED|Washout (Min 2 Days / Max 7 Days)||0||
59881520|NCT03267212|76004391|FG000|STARTED|Second Intervention||4||
59881521|NCT03267212|76004392|FG001|STARTED|Second Intervention||6||
59881522|NCT03267212|76004391|FG000|COMPLETED|Second Intervention||4||
59881523|NCT03267212|76004392|FG001|COMPLETED|Second Intervention||6||
59881524|NCT03267212|76004391|FG000|NOT COMPLETED|Second Intervention||0||
59881525|NCT03267212|76004392|FG001|NOT COMPLETED|Second Intervention||0||
59881526|NCT04292535|76004412|FG000|STARTED|Overall Study||8||
59881527|NCT04292535|76004413|FG001|STARTED|Overall Study||8||
59881528|NCT04292535|76004414|FG002|STARTED|Overall Study||9||
59881529|NCT04292535|76004415|FG003|STARTED|Overall Study||8||
59881530|NCT04292535|76004416|FG004|STARTED|Overall Study||8||
59881531|NCT04292535|76004417|FG005|STARTED|Overall Study||9||
59881532|NCT04292535|76004418|FG006|STARTED|Overall Study||8||
59881533|NCT04292535|76004419|FG007|STARTED|Overall Study||10||
59881534|NCT04292535|76004420|FG008|STARTED|Overall Study||8||
59881535|NCT04292535|76004421|FG009|STARTED|Overall Study||8||
59881536|NCT04292535|76004422|FG010|STARTED|Overall Study||7||
59881537|NCT04292535|76004423|FG011|STARTED|Overall Study||7||
59881538|NCT04292535|76004424|FG012|STARTED|Overall Study||9||
59881539|NCT04292535|76004425|FG013|STARTED|Overall Study||9||
59881540|NCT04292535|76004412|FG000|COMPLETED|Overall Study||8||
59881541|NCT04292535|76004413|FG001|COMPLETED|Overall Study||8||
59881542|NCT04292535|76004414|FG002|COMPLETED|Overall Study||9||
59881543|NCT04292535|76004415|FG003|COMPLETED|Overall Study||8||
59881544|NCT04292535|76004416|FG004|COMPLETED|Overall Study||8||
59881545|NCT04292535|76004417|FG005|COMPLETED|Overall Study||9||
59881546|NCT04292535|76004418|FG006|COMPLETED|Overall Study||8||
59881547|NCT04292535|76004419|FG007|COMPLETED|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL (n = 1)|8||
59881548|NCT04292535|76004420|FG008|COMPLETED|Overall Study||8||
60009568|NCT02640053|76125265|FG000|COMPLETED|Overall Study||17||
60009569|NCT02640053|76125266|FG001|COMPLETED|Overall Study||17||
59881549|NCT04292535|76004421|FG009|COMPLETED|Overall Study||8||
59881550|NCT04292535|76004422|FG010|COMPLETED|Overall Study||7||
60009570|NCT02640053|76125265|FG000|NOT COMPLETED|Overall Study||4||
60009571|NCT02640053|76125266|FG001|NOT COMPLETED|Overall Study||4||
60009572|NCT01950364|76125274|FG000|STARTED|Overall Study||10||
60009573|NCT01950364|76125275|FG001|STARTED|Overall Study||10||
60009574|NCT01950364|76125274|FG000|COMPLETED|Overall Study||0||
60009575|NCT01950364|76125275|FG001|COMPLETED|Overall Study||0||
60009576|NCT01950364|76125274|FG000|NOT COMPLETED|Overall Study||10||
60009577|NCT01950364|76125275|FG001|NOT COMPLETED|Overall Study||10||
60009578|NCT01968070|76125299|FG000|STARTED|Period 1||4||
60009579|NCT01968070|76125300|FG001|STARTED|Period 1||4||
60009580|NCT01968070|76125301|FG002|STARTED|Period 1||4||
60009581|NCT01968070|76125302|FG003|STARTED|Period 1||4||
60009582|NCT01968070|76125303|FG004|STARTED|Period 1||4||
60009583|NCT01968070|76125304|FG005|STARTED|Period 1||4||
60009584|NCT01968070|76125305|FG006|STARTED|Period 1||10||
60009585|NCT01968070|76125306|FG007|STARTED|Period 1||2||
60009586|NCT01968070|76125307|FG008|STARTED|Period 1||2||
60009587|NCT01968070|76125308|FG009|STARTED|Period 1||9||
60009588|NCT01968070|76125309|FG010|STARTED|Period 1||2||
60009589|NCT01968070|76125310|FG011|STARTED|Period 1||2||
60009590|NCT01968070|76125311|FG012|STARTED|Period 1||9||
60009591|NCT01968070|76125312|FG013|STARTED|Period 1||2||
60009592|NCT01968070|76125313|FG014|STARTED|Period 1||2||
60009593|NCT01968070|76125314|FG015|STARTED|Period 1||9||
60009594|NCT01968070|76125315|FG016|STARTED|Period 1||2||
60009595|NCT01968070|76125316|FG017|STARTED|Period 1||2||
60009596|NCT01968070|76125299|FG000|COMPLETED|Period 1||4||
60009597|NCT01968070|76125300|FG001|COMPLETED|Period 1||3||
60009598|NCT01968070|76125301|FG002|COMPLETED|Period 1||4||
60009599|NCT01968070|76125302|FG003|COMPLETED|Period 1||2||
60009600|NCT01968070|76125303|FG004|COMPLETED|Period 1||3||
60009601|NCT01968070|76125304|FG005|COMPLETED|Period 1||4||
60009602|NCT01968070|76125305|FG006|COMPLETED|Period 1||8||
60009603|NCT01968070|76125306|FG007|COMPLETED|Period 1||2||
60009604|NCT01968070|76125307|FG008|COMPLETED|Period 1||2||
60009605|NCT01968070|76125308|FG009|COMPLETED|Period 1||9||
60009606|NCT01968070|76125309|FG010|COMPLETED|Period 1||2||
60009607|NCT01968070|76125310|FG011|COMPLETED|Period 1||1||
60009608|NCT01968070|76125311|FG012|COMPLETED|Period 1||9||
60009609|NCT01968070|76125312|FG013|COMPLETED|Period 1||2||
60009610|NCT01968070|76125313|FG014|COMPLETED|Period 1||2||
60009611|NCT01968070|76125314|FG015|COMPLETED|Period 1||8||
60009612|NCT01968070|76125315|FG016|COMPLETED|Period 1||2||
60009613|NCT01968070|76125316|FG017|COMPLETED|Period 1||2||
60009614|NCT01968070|76125299|FG000|NOT COMPLETED|Period 1||0||
60009615|NCT01968070|76125300|FG001|NOT COMPLETED|Period 1||1||
60009616|NCT01968070|76125301|FG002|NOT COMPLETED|Period 1||0||
60009617|NCT01968070|76125302|FG003|NOT COMPLETED|Period 1||2||
60009618|NCT01968070|76125303|FG004|NOT COMPLETED|Period 1||1||
60009619|NCT01968070|76125304|FG005|NOT COMPLETED|Period 1||0||
60009620|NCT01968070|76125305|FG006|NOT COMPLETED|Period 1||2||
60009621|NCT01968070|76125306|FG007|NOT COMPLETED|Period 1||0||
60009622|NCT01968070|76125307|FG008|NOT COMPLETED|Period 1||0||
60009623|NCT01968070|76125308|FG009|NOT COMPLETED|Period 1||0||
60009624|NCT01968070|76125309|FG010|NOT COMPLETED|Period 1||0||
60009625|NCT01968070|76125310|FG011|NOT COMPLETED|Period 1||1||
60009626|NCT01968070|76125311|FG012|NOT COMPLETED|Period 1||0||
60009627|NCT01968070|76125312|FG013|NOT COMPLETED|Period 1||0||
60009628|NCT01968070|76125313|FG014|NOT COMPLETED|Period 1||0||
60009629|NCT01968070|76125314|FG015|NOT COMPLETED|Period 1||1||
60009630|NCT01968070|76125315|FG016|NOT COMPLETED|Period 1||0||
60009631|NCT01968070|76125316|FG017|NOT COMPLETED|Period 1||0||
60009632|NCT01968070|76125299|FG000|STARTED|Period 2||4||
60009633|NCT01968070|76125300|FG001|STARTED|Period 2|1 participant was added to replace the participant who discontinued the period 1.|4||
60009634|NCT01968070|76125301|FG002|STARTED|Period 2||4||
60009635|NCT01968070|76125302|FG003|STARTED|Period 2|2 participants were added to replace the 2 participants who discontinued the period 1.|4||
60009636|NCT01968070|76125303|FG004|STARTED|Period 2||3||
60009637|NCT01968070|76125304|FG005|STARTED|Period 2||4||
60009638|NCT01968070|76125305|FG006|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0||
60009639|NCT01968070|76125306|FG007|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0||
60009640|NCT01968070|76125307|FG008|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0||
60009641|NCT01968070|76125308|FG009|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0||
60009642|NCT01968070|76125309|FG010|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0||
60009643|NCT01968070|76125310|FG011|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0||
60009644|NCT01968070|76125311|FG012|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0||
60009645|NCT01968070|76125312|FG013|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0||
60009646|NCT01968070|76125313|FG014|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0||
60009647|NCT01968070|76125314|FG015|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0||
60009648|NCT01968070|76125315|FG016|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0||
59751278|NCT00658021|75870539|FG000|COMPLETED|28-Week Treatment Period||31|Completed the Week 28 treatment period.|
59751279|NCT00658021|75870540|FG001|COMPLETED|28-Week Treatment Period||25|Completed the Week 28 treatment period.|
59751280|NCT00658021|75870541|FG002|COMPLETED|28-Week Treatment Period||25|Completed the Week 28 treatment period.|
59751281|NCT00658021|75870539|FG000|NOT COMPLETED|28-Week Treatment Period||11||
60009649|NCT01968070|76125316|FG017|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0||
60009650|NCT01968070|76125299|FG000|COMPLETED|Period 2||4||
60009651|NCT01968070|76125300|FG001|COMPLETED|Period 2||4||
60009652|NCT01968070|76125301|FG002|COMPLETED|Period 2||4||
60009653|NCT01968070|76125302|FG003|COMPLETED|Period 2||4||
60009654|NCT01968070|76125303|FG004|COMPLETED|Period 2||2||
60009655|NCT01968070|76125304|FG005|COMPLETED|Period 2||4||
60009656|NCT01968070|76125305|FG006|COMPLETED|Period 2||0||
60009657|NCT01968070|76125306|FG007|COMPLETED|Period 2||0||
60009658|NCT01968070|76125307|FG008|COMPLETED|Period 2||0||
60009659|NCT01968070|76125308|FG009|COMPLETED|Period 2||0||
60009660|NCT01968070|76125309|FG010|COMPLETED|Period 2||0||
60009661|NCT01968070|76125310|FG011|COMPLETED|Period 2||0||
60009662|NCT01968070|76125311|FG012|COMPLETED|Period 2||0||
60009663|NCT01968070|76125312|FG013|COMPLETED|Period 2||0||
60009664|NCT01968070|76125313|FG014|COMPLETED|Period 2||0||
60009665|NCT01968070|76125314|FG015|COMPLETED|Period 2||0||
60009666|NCT01968070|76125315|FG016|COMPLETED|Period 2||0||
60009667|NCT01968070|76125316|FG017|COMPLETED|Period 2||0||
60009668|NCT01968070|76125299|FG000|NOT COMPLETED|Period 2||0||
60009669|NCT01968070|76125300|FG001|NOT COMPLETED|Period 2||0||
60009670|NCT01968070|76125301|FG002|NOT COMPLETED|Period 2||0||
60009671|NCT01968070|76125302|FG003|NOT COMPLETED|Period 2||0||
60009672|NCT01968070|76125303|FG004|NOT COMPLETED|Period 2||1||
60009673|NCT01968070|76125304|FG005|NOT COMPLETED|Period 2||0||
60009674|NCT01968070|76125305|FG006|NOT COMPLETED|Period 2||0||
60009675|NCT01968070|76125306|FG007|NOT COMPLETED|Period 2||0||
60009676|NCT01968070|76125307|FG008|NOT COMPLETED|Period 2||0||
60009677|NCT01968070|76125308|FG009|NOT COMPLETED|Period 2||0||
60009678|NCT01968070|76125309|FG010|NOT COMPLETED|Period 2||0||
60009679|NCT01968070|76125310|FG011|NOT COMPLETED|Period 2||0||
60009680|NCT01968070|76125311|FG012|NOT COMPLETED|Period 2||0||
60009681|NCT01968070|76125312|FG013|NOT COMPLETED|Period 2||0||
60009682|NCT01968070|76125313|FG014|NOT COMPLETED|Period 2||0||
60009683|NCT01968070|76125314|FG015|NOT COMPLETED|Period 2||0||
60009684|NCT01968070|76125315|FG016|NOT COMPLETED|Period 2||0||
60009685|NCT01968070|76125316|FG017|NOT COMPLETED|Period 2||0||
60009686|NCT01968070|76125299|FG000|STARTED|Period 3||4||
60009687|NCT01968070|76125300|FG001|STARTED|Period 3||4||
60009688|NCT01968070|76125301|FG002|STARTED|Period 3||4||
60009689|NCT01968070|76125302|FG003|STARTED|Period 3||4||
60009690|NCT01968070|76125303|FG004|STARTED|Period 3||3||
60009691|NCT01968070|76125304|FG005|STARTED|Period 3||4||
60009692|NCT01968070|76125305|FG006|STARTED|Period 3||0||
60009693|NCT01968070|76125306|FG007|STARTED|Period 3||0||
60009694|NCT01968070|76125307|FG008|STARTED|Period 3||0||
60009695|NCT01968070|76125308|FG009|STARTED|Period 3||0||
60009696|NCT01968070|76125309|FG010|STARTED|Period 3||0||
60009697|NCT01968070|76125310|FG011|STARTED|Period 3||0||
60009698|NCT01968070|76125311|FG012|STARTED|Period 3||0||
60009699|NCT01968070|76125312|FG013|STARTED|Period 3||0||
60009700|NCT01968070|76125313|FG014|STARTED|Period 3||0||
60009701|NCT01968070|76125314|FG015|STARTED|Period 3||0||
60009702|NCT01968070|76125315|FG016|STARTED|Period 3||0||
60009703|NCT01968070|76125316|FG017|STARTED|Period 3||0||
60009704|NCT01968070|76125299|FG000|COMPLETED|Period 3||4||
60009705|NCT01968070|76125300|FG001|COMPLETED|Period 3||4||
60009706|NCT01968070|76125301|FG002|COMPLETED|Period 3||4||
60009707|NCT01968070|76125302|FG003|COMPLETED|Period 3||4||
60009708|NCT01968070|76125303|FG004|COMPLETED|Period 3||3||
60009709|NCT01968070|76125304|FG005|COMPLETED|Period 3||4||
60009710|NCT01968070|76125305|FG006|COMPLETED|Period 3||0||
60009711|NCT01968070|76125306|FG007|COMPLETED|Period 3||0||
60009712|NCT01968070|76125307|FG008|COMPLETED|Period 3||0||
60009713|NCT01968070|76125308|FG009|COMPLETED|Period 3||0||
60009714|NCT01968070|76125309|FG010|COMPLETED|Period 3||0||
60009715|NCT01968070|76125310|FG011|COMPLETED|Period 3||0||
60009716|NCT01968070|76125311|FG012|COMPLETED|Period 3||0||
60009717|NCT01968070|76125312|FG013|COMPLETED|Period 3||0||
60009718|NCT01968070|76125313|FG014|COMPLETED|Period 3||0||
60009719|NCT01968070|76125314|FG015|COMPLETED|Period 3||0||
60009720|NCT01968070|76125315|FG016|COMPLETED|Period 3||0||
60009721|NCT01968070|76125316|FG017|COMPLETED|Period 3||0||
60009722|NCT01968070|76125299|FG000|NOT COMPLETED|Period 3||0||
60009723|NCT01968070|76125300|FG001|NOT COMPLETED|Period 3||0||
60136174|NCT01523756|76258845|FG001|NOT COMPLETED|Baseline Period||1||
60136175|NCT01523756|76258844|FG000|STARTED|Test Period 1||11||
60136176|NCT01523756|76258845|FG001|STARTED|Test Period 1||8||
60136177|NCT01523756|76258844|FG000|COMPLETED|Test Period 1||10||
60136178|NCT01523756|76258845|FG001|COMPLETED|Test Period 1||8||
60136179|NCT01523756|76258844|FG000|NOT COMPLETED|Test Period 1||1||
60136180|NCT01523756|76258845|FG001|NOT COMPLETED|Test Period 1||0||
60136181|NCT01523756|76258844|FG000|STARTED|Test Period 2||10||
60136182|NCT01523756|76258845|FG001|STARTED|Test Period 2||8||
60136183|NCT01523756|76258844|FG000|COMPLETED|Test Period 2||10||
60136184|NCT01523756|76258845|FG001|COMPLETED|Test Period 2||7||
60136185|NCT01523756|76258844|FG000|NOT COMPLETED|Test Period 2||0||
60136186|NCT01523756|76258845|FG001|NOT COMPLETED|Test Period 2||1||
60136187|NCT00218257|76258853|FG000|STARTED|Intervention 1||23||
60136188|NCT00218257|76258854|FG001|STARTED|Intervention 1||22||
60136189|NCT00218257|76258853|FG000|COMPLETED|Intervention 1||23||
60136190|NCT00218257|76258854|FG001|COMPLETED|Intervention 1||22||
60136191|NCT00218257|76258853|FG000|NOT COMPLETED|Intervention 1||0||
60136192|NCT00218257|76258854|FG001|NOT COMPLETED|Intervention 1||0||
60136193|NCT00218257|76258853|FG000|STARTED|Period Between Visit 1 and 2||23||
60136194|NCT00218257|76258854|FG001|STARTED|Period Between Visit 1 and 2||22||
60136195|NCT00218257|76258853|FG000|COMPLETED|Period Between Visit 1 and 2||19||
60136196|NCT00218257|76258854|FG001|COMPLETED|Period Between Visit 1 and 2||19||
60136197|NCT00218257|76258853|FG000|NOT COMPLETED|Period Between Visit 1 and 2||4||
60136198|NCT00218257|76258854|FG001|NOT COMPLETED|Period Between Visit 1 and 2||3||
60136199|NCT00218257|76258853|FG000|STARTED|Intervention 2||19||
60136200|NCT00218257|76258854|FG001|STARTED|Intervention 2||19||
60136201|NCT00218257|76258853|FG000|COMPLETED|Intervention 2||19||
60136202|NCT00218257|76258854|FG001|COMPLETED|Intervention 2||19||
60136203|NCT00218257|76258853|FG000|NOT COMPLETED|Intervention 2||0||
60136204|NCT00218257|76258854|FG001|NOT COMPLETED|Intervention 2||0||
60136205|NCT01523366|76258865|FG000|STARTED|Treatment Period 1||20||
60136206|NCT01523366|76258866|FG001|STARTED|Treatment Period 1||20||
60136207|NCT01523366|76258865|FG000|COMPLETED|Treatment Period 1||19||
60136208|NCT01523366|76258866|FG001|COMPLETED|Treatment Period 1||20||
60136209|NCT01523366|76258865|FG000|NOT COMPLETED|Treatment Period 1||1||
60136210|NCT01523366|76258866|FG001|NOT COMPLETED|Treatment Period 1||0||
60136211|NCT01523366|76258865|FG000|STARTED|Washout Period - 10-14 Days||19||
60136212|NCT01523366|76258866|FG001|STARTED|Washout Period - 10-14 Days||20||
60136213|NCT01523366|76258865|FG000|COMPLETED|Washout Period - 10-14 Days||19||
60136214|NCT01523366|76258866|FG001|COMPLETED|Washout Period - 10-14 Days||20||
60136215|NCT01523366|76258865|FG000|NOT COMPLETED|Washout Period - 10-14 Days||0||
60136216|NCT01523366|76258866|FG001|NOT COMPLETED|Washout Period - 10-14 Days||0||
60136217|NCT01523366|76258865|FG000|STARTED|Treatment Period 2||19||
60136218|NCT01523366|76258866|FG001|STARTED|Treatment Period 2||20||
60136219|NCT01523366|76258865|FG000|COMPLETED|Treatment Period 2||18||
60136220|NCT01523366|76258866|FG001|COMPLETED|Treatment Period 2||20||
60136221|NCT01523366|76258865|FG000|NOT COMPLETED|Treatment Period 2||1||
60136222|NCT01523366|76258866|FG001|NOT COMPLETED|Treatment Period 2||0||
60136223|NCT01427933|76258876|FG000|STARTED|Overall Study||71||
60136224|NCT01427933|76258877|FG001|STARTED|Overall Study||70||
60136225|NCT01427933|76258876|FG000|Received at Least 1 Dose of Study Drug|Overall Study||69||
60136226|NCT01427933|76258877|FG001|Received at Least 1 Dose of Study Drug|Overall Study||65||
60136227|NCT01427933|76258876|FG000|COMPLETED|Overall Study||63||
60136228|NCT01427933|76258877|FG001|COMPLETED|Overall Study||57||
60136229|NCT01427933|76258876|FG000|NOT COMPLETED|Overall Study||8||
60136230|NCT01427933|76258877|FG001|NOT COMPLETED|Overall Study||13||
60136231|NCT00217087|76258886|FG000|STARTED|Overall Study||36||
60136232|NCT00217087|76258887|FG001|STARTED|Overall Study||37||
60136233|NCT00217087|76258886|FG000|COMPLETED|Overall Study||25||
60136234|NCT00217087|76258887|FG001|COMPLETED|Overall Study||17||
60136235|NCT00217087|76258886|FG000|NOT COMPLETED|Overall Study||11||
60136236|NCT00217087|76258887|FG001|NOT COMPLETED|Overall Study||20||
60136237|NCT01406873|76258901|FG000|STARTED|Overall Study||21||
60136238|NCT01406873|76258902|FG001|STARTED|Overall Study||21||
60136239|NCT01406873|76258901|FG000|COMPLETED|Overall Study||20||
60136240|NCT01406873|76258902|FG001|COMPLETED|Overall Study||20||
60136241|NCT01406873|76258901|FG000|NOT COMPLETED|Overall Study||1||
60136242|NCT01406873|76258902|FG001|NOT COMPLETED|Overall Study||1||
60136243|NCT01406795|76258918|FG000|STARTED|Overall Study||1||
60136244|NCT01406795|76258918|FG000|COMPLETED|Overall Study||0||
60136245|NCT01406795|76258918|FG000|NOT COMPLETED|Overall Study||1||
60136246|NCT01406717|76258924|FG000|STARTED|Overall Study||180||
60136247|NCT01406717|76258925|FG001|STARTED|Overall Study||180||
60136248|NCT01406717|76258924|FG000|COMPLETED|Overall Study||137||
60136249|NCT01406717|76258925|FG001|COMPLETED|Overall Study||149||
60136250|NCT01406717|76258924|FG000|NOT COMPLETED|Overall Study||43||
60136251|NCT01406717|76258925|FG001|NOT COMPLETED|Overall Study||31||
60136252|NCT01406015|76258943|FG000|STARTED|Overall Study||19||
60136253|NCT01406015|76258944|FG001|STARTED|Overall Study||19||
60136254|NCT01406015|76258943|FG000|COMPLETED|Overall Study||16||
60136255|NCT01406015|76258944|FG001|COMPLETED|Overall Study||16||
60136256|NCT01406015|76258943|FG000|NOT COMPLETED|Overall Study||3||
60009724|NCT01968070|76125301|FG002|NOT COMPLETED|Period 3||0||
60009725|NCT01968070|76125302|FG003|NOT COMPLETED|Period 3||0||
60009726|NCT01968070|76125303|FG004|NOT COMPLETED|Period 3||0||
60009727|NCT01968070|76125304|FG005|NOT COMPLETED|Period 3||0||
60009728|NCT01968070|76125305|FG006|NOT COMPLETED|Period 3||0||
60009729|NCT01968070|76125306|FG007|NOT COMPLETED|Period 3||0||
60009730|NCT01968070|76125307|FG008|NOT COMPLETED|Period 3||0||
60009731|NCT01968070|76125308|FG009|NOT COMPLETED|Period 3||0||
60009732|NCT01968070|76125309|FG010|NOT COMPLETED|Period 3||0||
60009733|NCT01968070|76125310|FG011|NOT COMPLETED|Period 3||0||
60009734|NCT01968070|76125311|FG012|NOT COMPLETED|Period 3||0||
60009735|NCT01968070|76125312|FG013|NOT COMPLETED|Period 3||0||
60009736|NCT01968070|76125313|FG014|NOT COMPLETED|Period 3||0||
60009737|NCT01968070|76125314|FG015|NOT COMPLETED|Period 3||0||
60009738|NCT01968070|76125315|FG016|NOT COMPLETED|Period 3||0||
60009739|NCT01968070|76125316|FG017|NOT COMPLETED|Period 3||0||
60009740|NCT01918774|76125354|FG000|STARTED|Overall Study||57||
60009741|NCT01918774|76125354|FG000|COMPLETED|Overall Study||52||
60009742|NCT01918774|76125354|FG000|NOT COMPLETED|Overall Study||5||
60009743|NCT01949116|76125360|FG000|STARTED|Overall Study||86||
60009744|NCT01949116|76125361|FG001|STARTED|Overall Study||90||
60009745|NCT01949116|76125360|FG000|COMPLETED|Overall Study||78||
60009746|NCT01949116|76125361|FG001|COMPLETED|Overall Study||84||
60009747|NCT01949116|76125360|FG000|NOT COMPLETED|Overall Study||8||
60009748|NCT01949116|76125361|FG001|NOT COMPLETED|Overall Study||6||
60009749|NCT01673009|76125371|FG000|STARTED|Overall Study||36||
60009750|NCT01673009|76125371|FG000|COMPLETED|Overall Study||23||
60009751|NCT01673009|76125371|FG000|NOT COMPLETED|Overall Study||13||
60009752|NCT01939366|76125380|FG000|STARTED|Overall Study||66||
60009753|NCT01939366|76125381|FG001|STARTED|Overall Study||64||
60009754|NCT01939366|76125382|FG002|STARTED|Overall Study||65||
60009755|NCT01939366|76125383|FG003|STARTED|Overall Study||68||
60009756|NCT01939366|76125384|FG004|STARTED|Overall Study||66||
60009757|NCT01939366|76125380|FG000|Allocated Set Excl. Non-compliant Sites|Overall Study||64||
60009758|NCT01939366|76125381|FG001|Allocated Set Excl. Non-compliant Sites|Overall Study||61||
60009759|NCT01939366|76125382|FG002|Allocated Set Excl. Non-compliant Sites|Overall Study||63||
60009760|NCT01939366|76125383|FG003|Allocated Set Excl. Non-compliant Sites|Overall Study||65||
60009761|NCT01939366|76125384|FG004|Allocated Set Excl. Non-compliant Sites|Overall Study||63||
60009762|NCT01939366|76125380|FG000|Safety Set|Overall Study||64||
60009763|NCT01939366|76125381|FG001|Safety Set|Overall Study||61||
60009764|NCT01939366|76125382|FG002|Safety Set|Overall Study||62||
60009765|NCT01939366|76125383|FG003|Safety Set|Overall Study||65||
60009766|NCT01939366|76125384|FG004|Safety Set|Overall Study||62||
60009767|NCT01939366|76125380|FG000|Full Analysis Set|Overall Study||64||
60009768|NCT01939366|76125381|FG001|Full Analysis Set|Overall Study||60||
60009769|NCT01939366|76125382|FG002|Full Analysis Set|Overall Study||61||
60009770|NCT01939366|76125383|FG003|Full Analysis Set|Overall Study||65||
60009771|NCT01939366|76125384|FG004|Full Analysis Set|Overall Study||62||
60009772|NCT01939366|76125380|FG000|Per Protocol Set|Overall Study||58||
60009773|NCT01939366|76125381|FG001|Per Protocol Set|Overall Study||55||
60009774|NCT01939366|76125382|FG002|Per Protocol Set|Overall Study||50||
60009775|NCT01939366|76125383|FG003|Per Protocol Set|Overall Study||51||
60136257|NCT01406015|76258944|FG001|NOT COMPLETED|Overall Study||3||
60136258|NCT00215683|76258953|FG000|STARTED|Overall Study|Safety analysis set|45||
60136259|NCT00215683|76258954|FG001|STARTED|Overall Study||48||
60136260|NCT00215683|76258955|FG002|STARTED|Overall Study||44||
60136261|NCT00215683|76258953|FG000|Switched to 160 mg|Overall Study|A protocol amendment changed the dosage to 160 mg (40 mg/mL) for all participants|32||
60136262|NCT00215683|76258954|FG001|Switched to 160 mg|Overall Study||41||
60136263|NCT00215683|76258955|FG002|Switched to 160 mg|Overall Study||36||
60136264|NCT00215683|76258953|FG000|COMPLETED|Overall Study|Participants ongoing at the time of study closure were considered to have completed the study|16||
60136265|NCT00215683|76258954|FG001|COMPLETED|Overall Study||22||
60136266|NCT00215683|76258955|FG002|COMPLETED|Overall Study||12||
60136267|NCT00215683|76258953|FG000|NOT COMPLETED|Overall Study||29||
60136268|NCT00215683|76258954|FG001|NOT COMPLETED|Overall Study||26||
60136269|NCT00215683|76258955|FG002|NOT COMPLETED|Overall Study||32||
60136270|NCT00215137|76258963|FG000|STARTED|Open Label Escitalopram||14||
60136271|NCT00215137|76258964|FG001|STARTED|Open Label Escitalopram||0||
60136272|NCT00215137|76258965|FG002|STARTED|Open Label Escitalopram||0||
60136273|NCT00215137|76258963|FG000|COMPLETED|Open Label Escitalopram||13||
60136274|NCT00215137|76258964|FG001|COMPLETED|Open Label Escitalopram||0||
60136275|NCT00215137|76258965|FG002|COMPLETED|Open Label Escitalopram||0||
60136276|NCT00215137|76258963|FG000|NOT COMPLETED|Open Label Escitalopram||1||
60136277|NCT00215137|76258964|FG001|NOT COMPLETED|Open Label Escitalopram||0||
60136278|NCT00215137|76258965|FG002|NOT COMPLETED|Open Label Escitalopram||0||
60136279|NCT00215137|76258963|FG000|STARTED|Randomization Period||0||
60136280|NCT00215137|76258964|FG001|STARTED|Randomization Period||7||
60136281|NCT00215137|76258965|FG002|STARTED|Randomization Period||5||
60136282|NCT00215137|76258963|FG000|COMPLETED|Randomization Period||0||
60136283|NCT00215137|76258964|FG001|COMPLETED|Randomization Period||5||
60136284|NCT00215137|76258965|FG002|COMPLETED|Randomization Period||5||
60136285|NCT00215137|76258963|FG000|NOT COMPLETED|Randomization Period||0||
60136286|NCT00215137|76258964|FG001|NOT COMPLETED|Randomization Period||2||
60136287|NCT00215137|76258965|FG002|NOT COMPLETED|Randomization Period||0||
60136288|NCT00214201|76258975|FG000|STARTED|Overall Study||20||
60136289|NCT00214201|76258976|FG001|STARTED|Overall Study||20||
60136290|NCT00214201|76258975|FG000|COMPLETED|Overall Study||18||
60136291|NCT00214201|76258976|FG001|COMPLETED|Overall Study||18||
60136292|NCT00214201|76258975|FG000|NOT COMPLETED|Overall Study||2||
60136293|NCT00214201|76258976|FG001|NOT COMPLETED|Overall Study||2||
60136294|NCT01486784|76258989|FG000|STARTED|Overall Study||3||
60136295|NCT01486784|76258990|FG001|STARTED|Overall Study||7||
60136296|NCT01486784|76258991|FG002|STARTED|Overall Study||6||
60136297|NCT01486784|76258992|FG003|STARTED|Overall Study||1||
59519077|NCT01093417|75612951|FG001|NOT COMPLETED|Overall Study||1||
60136298|NCT01486784|76258993|FG004|STARTED|Overall Study||5||
60136299|NCT01486784|76258994|FG005|STARTED|Overall Study||5||
60136300|NCT01486784|76258989|FG000|Completed Cycle 1|Overall Study||2||
60136301|NCT01486784|76258990|FG001|Completed Cycle 1|Overall Study||6||
60136302|NCT01486784|76258991|FG002|Completed Cycle 1|Overall Study||3||
60136303|NCT01486784|76258992|FG003|Completed Cycle 1|Overall Study||1||
60136304|NCT01486784|76258993|FG004|Completed Cycle 1|Overall Study||3||
60136305|NCT01486784|76258994|FG005|Completed Cycle 1|Overall Study||2||
60136306|NCT01486784|76258989|FG000|Received Treatment|Overall Study||3|Number of subjects in each arm, who enrolled in study and received study treatment.|
60136307|NCT01486784|76258990|FG001|Received Treatment|Overall Study||7|Number of subjects in each arm, who enrolled in study and received study treatment.|
60136308|NCT01486784|76258991|FG002|Received Treatment|Overall Study||5|Number of subjects in each arm, who enrolled in study and received study treatment.|
60136309|NCT01486784|76258992|FG003|Received Treatment|Overall Study||1|Number of subjects in each arm, who enrolled in study and received study treatment.|
60136310|NCT01486784|76258993|FG004|Received Treatment|Overall Study||3|Number of subjects in each arm, who enrolled in study and received study treatment.|
60136311|NCT01486784|76258994|FG005|Received Treatment|Overall Study||2|Number of subjects in each arm, who enrolled in study and received study treatment.|
60136312|NCT01486784|76258989|FG000|COMPLETED|Overall Study||3||
60136313|NCT01486784|76258990|FG001|COMPLETED|Overall Study||7||
60136314|NCT01486784|76258991|FG002|COMPLETED|Overall Study||5||
60136315|NCT01486784|76258992|FG003|COMPLETED|Overall Study||1||
60136316|NCT01486784|76258993|FG004|COMPLETED|Overall Study||3||
60136317|NCT01486784|76258994|FG005|COMPLETED|Overall Study||2||
60136318|NCT01486784|76258989|FG000|NOT COMPLETED|Overall Study||0||
60136319|NCT01486784|76258990|FG001|NOT COMPLETED|Overall Study||0||
60136320|NCT01486784|76258991|FG002|NOT COMPLETED|Overall Study||1||
60136321|NCT01486784|76258992|FG003|NOT COMPLETED|Overall Study||0||
60136322|NCT01486784|76258993|FG004|NOT COMPLETED|Overall Study||2||
60136323|NCT01486784|76258994|FG005|NOT COMPLETED|Overall Study||3||
60136324|NCT01521884|76259008|FG000|STARTED|Overall Study||62||
60136325|NCT01521884|76259008|FG000|COMPLETED|Overall Study||35||
60136326|NCT01521884|76259008|FG000|NOT COMPLETED|Overall Study||27||
60136327|NCT01677858|76259017|FG000|STARTED|Overall Study||3||
60136328|NCT01677858|76259018|FG001|STARTED|Overall Study||3||
60136329|NCT01677858|76259019|FG002|STARTED|Overall Study||15||
60136330|NCT01677858|76259020|FG003|STARTED|Overall Study||6||
60136331|NCT01677858|76259021|FG004|STARTED|Overall Study||89||
60136332|NCT01677858|76259017|FG000|COMPLETED|Overall Study|Completed indicates participants ongoing in study|0||
60136333|NCT01677858|76259018|FG001|COMPLETED|Overall Study|Completed indicates participants ongoing in study|1||
60136334|NCT01677858|76259019|FG002|COMPLETED|Overall Study|Completed indicates participants ongoing in study|1||
60136335|NCT01677858|76259020|FG003|COMPLETED|Overall Study|Completed indicates participants ongoing in study|0||
60136336|NCT01677858|76259021|FG004|COMPLETED|Overall Study|Completed indicates participants ongoing in study|4||
60136337|NCT01677858|76259017|FG000|NOT COMPLETED|Overall Study||3||
60136338|NCT01677858|76259018|FG001|NOT COMPLETED|Overall Study||2||
60136339|NCT01677858|76259019|FG002|NOT COMPLETED|Overall Study||14||
60136340|NCT01677858|76259020|FG003|NOT COMPLETED|Overall Study||6||
60136341|NCT01677858|76259021|FG004|NOT COMPLETED|Overall Study||85||
60136342|NCT01486316|76259041|FG000|STARTED|Overall Study|prior to study closure, 24 subjects were enrolled 7 subjects randomized to Control Arm|7||
60136343|NCT01486316|76259042|FG001|STARTED|Overall Study|prior to study closure, 24 subjects were enrolled with 10 being randomized to HFRS Guided Arm|10||
60136344|NCT01486316|76259043|FG002|STARTED|Overall Study|Exited prior to implant|5||
60136345|NCT01486316|76259044|FG003|STARTED|Overall Study|Exited prior to 6 month visit|2||
60136346|NCT01486316|76259041|FG000|COMPLETED|Overall Study||3|18 Month/Exit Visit|
60136347|NCT01486316|76259042|FG001|COMPLETED|Overall Study||7|18 Month/Exit Visit|
60136348|NCT01486316|76259043|FG002|COMPLETED|Overall Study||0|18 Month/Exit Visit|
60136349|NCT01486316|76259044|FG003|COMPLETED|Overall Study||0|18 Month/Exit Visit|
60136350|NCT01486316|76259041|FG000|NOT COMPLETED|Overall Study||4||
60136351|NCT01486316|76259042|FG001|NOT COMPLETED|Overall Study||3||
60136352|NCT01486316|76259043|FG002|NOT COMPLETED|Overall Study||5||
60136353|NCT01486316|76259044|FG003|NOT COMPLETED|Overall Study||2||
60136354|NCT01486238|76259055|FG000|STARTED|Overall Study||23||
60136355|NCT01486238|76259056|FG001|STARTED|Overall Study||49||
60136356|NCT01486238|76259055|FG000|COMPLETED|Overall Study||21||
60136357|NCT01486238|76259056|FG001|COMPLETED|Overall Study||43||
60136358|NCT01486238|76259055|FG000|NOT COMPLETED|Overall Study||2||
60136359|NCT01486238|76259056|FG001|NOT COMPLETED|Overall Study||6||
60136360|NCT01602744|76259064|FG000|STARTED|Overall Study||176||
60136361|NCT01602744|76259065|FG001|STARTED|Overall Study||183||
60136362|NCT01602744|76259064|FG000|COMPLETED|Overall Study||146||
60136363|NCT01602744|76259065|FG001|COMPLETED|Overall Study||160||
60136364|NCT01602744|76259064|FG000|NOT COMPLETED|Overall Study||30||
60136365|NCT01602744|76259065|FG001|NOT COMPLETED|Overall Study||23||
60136366|NCT03598777|76259076|FG000|STARTED|Overall Study||13||
60136367|NCT03598777|76259077|FG001|STARTED|Overall Study||8||
60136368|NCT03598777|76259078|FG002|STARTED|Overall Study||8||
60136369|NCT03598777|76259079|FG003|STARTED|Overall Study||14||
60136370|NCT03598777|76259080|FG004|STARTED|Overall Study||17||
60136371|NCT03598777|76259076|FG000|Received Treatment in Cycle 1 DB Treatment Period|Overall Study||13||
60136372|NCT03598777|76259077|FG001|Received Treatment in Cycle 1 DB Treatment Period|Overall Study||8||
60136373|NCT03598777|76259078|FG002|Received Treatment in Cycle 1 DB Treatment Period|Overall Study||8||
60136374|NCT03598777|76259079|FG003|Received Treatment in Cycle 1 DB Treatment Period|Overall Study||14||
60136375|NCT03598777|76259080|FG004|Received Treatment in Cycle 1 DB Treatment Period|Overall Study||17||
60136376|NCT03598777|76259076|FG000|Retreated in Cycle 2 OL Treatment Period|Overall Study||13||
60136377|NCT03598777|76259077|FG001|Retreated in Cycle 2 OL Treatment Period|Overall Study||7||
60136378|NCT03598777|76259078|FG002|Retreated in Cycle 2 OL Treatment Period|Overall Study||8||
60136379|NCT03598777|76259079|FG003|Retreated in Cycle 2 OL Treatment Period|Overall Study||13||
60136380|NCT03598777|76259080|FG004|Retreated in Cycle 2 OL Treatment Period|Overall Study||11||
60136381|NCT03598777|76259076|FG000|Retreated in Cycle 3 OL Treatment Period|Overall Study||8||
60136382|NCT03598777|76259077|FG001|Retreated in Cycle 3 OL Treatment Period|Overall Study||6||
60136383|NCT03598777|76259078|FG002|Retreated in Cycle 3 OL Treatment Period|Overall Study||6||
60136384|NCT03598777|76259079|FG003|Retreated in Cycle 3 OL Treatment Period|Overall Study||12||
60136385|NCT03598777|76259080|FG004|Retreated in Cycle 3 OL Treatment Period|Overall Study||2||
60136386|NCT03598777|76259076|FG000|Retreated in Cycle 4 OL Treatment Period|Overall Study||1||
60136387|NCT03598777|76259077|FG001|Retreated in Cycle 4 OL Treatment Period|Overall Study||0||
60136388|NCT03598777|76259078|FG002|Retreated in Cycle 4 OL Treatment Period|Overall Study||1||
60136389|NCT03598777|76259079|FG003|Retreated in Cycle 4 OL Treatment Period|Overall Study||3||
60136390|NCT03598777|76259080|FG004|Retreated in Cycle 4 OL Treatment Period|Overall Study||0||
60136391|NCT03598777|76259076|FG000|COMPLETED|Overall Study||7||
60136392|NCT03598777|76259077|FG001|COMPLETED|Overall Study||7||
60136393|NCT03598777|76259078|FG002|COMPLETED|Overall Study||8||
60136394|NCT03598777|76259079|FG003|COMPLETED|Overall Study||14||
60136395|NCT03598777|76259080|FG004|COMPLETED|Overall Study||2||
60136396|NCT03598777|76259076|FG000|NOT COMPLETED|Overall Study||6||
60136397|NCT03598777|76259077|FG001|NOT COMPLETED|Overall Study||1||
60136398|NCT03598777|76259078|FG002|NOT COMPLETED|Overall Study||0||
60136399|NCT03598777|76259079|FG003|NOT COMPLETED|Overall Study||0||
60136400|NCT03598777|76259080|FG004|NOT COMPLETED|Overall Study||15||
60136401|NCT05276830|76259098|FG000|STARTED|Overall Study||2||
60136402|NCT05276830|76259099|FG001|STARTED|Overall Study||1||
60136403|NCT05276830|76259100|FG002|STARTED|Overall Study||2||
60136404|NCT05276830|76259098|FG000|COMPLETED|Overall Study||2||
60136405|NCT05276830|76259099|FG001|COMPLETED|Overall Study||1||
60136406|NCT05276830|76259100|FG002|COMPLETED|Overall Study||2||
60136407|NCT05276830|76259098|FG000|NOT COMPLETED|Overall Study||0||
60136408|NCT05276830|76259099|FG001|NOT COMPLETED|Overall Study||0||
60136409|NCT05276830|76259100|FG002|NOT COMPLETED|Overall Study||0||
60136410|NCT05203068|76259108|FG000|STARTED|RTA Result Assessment, 72 Hours||150||
60136411|NCT05203068|76259108|FG000|COMPLETED|RTA Result Assessment, 72 Hours||150||
60136412|NCT05203068|76259108|FG000|NOT COMPLETED|RTA Result Assessment, 72 Hours||0||
60136413|NCT05203068|76259108|FG000|STARTED|RTA Safety Assessment, 28 Days||150||
60136414|NCT05203068|76259108|FG000|COMPLETED|RTA Safety Assessment, 28 Days||150||
60136415|NCT05203068|76259108|FG000|NOT COMPLETED|RTA Safety Assessment, 28 Days||0||
60136416|NCT05182554|76259116|FG000|STARTED|Overall Study|Vaccine Ambassadors were not enrolled in the control group.||"The number of participants in each group is the number of people who signed up as a vaccine ambassador in each treatment arm. The Facebook ads were not run in control group counties."|417
60136417|NCT05182554|76259117|FG001|STARTED|Overall Study|"5933089 unique Facebook users saw the study's Treatment 1 (Direct) social media campaign.~Vaccine Ambassadors were not enrolled in the Treatment 1: Direct arm."||"The number of participants in each group is the number of people who signed up as a vaccine ambassador in each treatment arm. The Facebook ads were not run in control group counties."|275
60136418|NCT05182554|76259118|FG002|STARTED|Overall Study|5952765 unique Facebook users saw the study's Treatment 2 (Friends) social media campaign.|4|"The number of participants in each group is the number of people who signed up as a vaccine ambassador in each treatment arm. The Facebook ads were not run in control group counties."|274
60136419|NCT05182554|76259119|FG003|STARTED|Overall Study|5942915 unique Facebook users saw the study's Treatment 3 (Gossips) social media campaign.|2|"The number of participants in each group is the number of people who signed up as a vaccine ambassador in each treatment arm. The Facebook ads were not run in control group counties."|276
60136420|NCT05182554|76259116|FG000|COMPLETED|Overall Study|"417 counties were randomized to the control group, where no social media campaign was served. No intervention was carried out in the control group, and the only data used were publicly available county-level data.~Vaccine Ambassadors were not enrolled in the Treatment 1: Direct arm."||"The study intervention was a social media campaign that displayed ads on Facebook which encouraged people to get a Covid-19 vaccine. As there was no way to complete the study, the number of participants who started and the number of participants who completed the study is the same."|417
60136421|NCT05182554|76259117|FG001|COMPLETED|Overall Study|Vaccine Ambassadors were not enrolled in the Treatment 1: Direct arm.||"The study intervention was a social media campaign that displayed ads on Facebook which encouraged people to get a Covid-19 vaccine. As there was no way to complete the study, the number of participants who started and the number of participants who completed the study is the same."|275
60136422|NCT05182554|76259118|FG002|COMPLETED|Overall Study||4|"The study intervention was a social media campaign that displayed ads on Facebook which encouraged people to get a Covid-19 vaccine. As there was no way to complete the study, the number of participants who started and the number of participants who completed the study is the same."|274
60136423|NCT05182554|76259119|FG003|COMPLETED|Overall Study||2|"The study intervention was a social media campaign that displayed ads on Facebook which encouraged people to get a Covid-19 vaccine. As there was no way to complete the study, the number of participants who started and the number of participants who completed the study is the same."|276
60136424|NCT05182554|76259116|FG000|NOT COMPLETED|Overall Study||||0
60136425|NCT05182554|76259117|FG001|NOT COMPLETED|Overall Study||||0
60136426|NCT05182554|76259118|FG002|NOT COMPLETED|Overall Study||0||0
60136427|NCT05182554|76259119|FG003|NOT COMPLETED|Overall Study||0||0
60136428|NCT04732780|76259129|FG000|STARTED|Overall Study||253||
60136429|NCT04732780|76259129|FG000|COMPLETED|Overall Study||253||
60136430|NCT04732780|76259129|FG000|NOT COMPLETED|Overall Study||0||
60136431|NCT04348591|76259135|FG000|STARTED|Imaging Session (120 Min)||29||
60136432|NCT04348591|76259136|FG001|STARTED|Imaging Session (120 Min)||30||
60136433|NCT04348591|76259135|FG000|COMPLETED|Imaging Session (120 Min)||27||
60136434|NCT04348591|76259136|FG001|COMPLETED|Imaging Session (120 Min)||27||
60136435|NCT04348591|76259135|FG000|NOT COMPLETED|Imaging Session (120 Min)||2||
60136436|NCT04348591|76259136|FG001|NOT COMPLETED|Imaging Session (120 Min)||3||
60136437|NCT04348591|76259135|FG000|STARTED|CR Training (45 Min)||27||
60136438|NCT04348591|76259136|FG001|STARTED|CR Training (45 Min)||27||
60136439|NCT04348591|76259135|FG000|COMPLETED|CR Training (45 Min)||27||
60136440|NCT04348591|76259136|FG001|COMPLETED|CR Training (45 Min)||27||
60136441|NCT04348591|76259135|FG000|NOT COMPLETED|CR Training (45 Min)||0||
60136442|NCT04348591|76259136|FG001|NOT COMPLETED|CR Training (45 Min)||0||
60136443|NCT04348591|76259135|FG000|STARTED|Experimental Task (45 Min)||27||
60136444|NCT04348591|76259136|FG001|STARTED|Experimental Task (45 Min)||27||
60136445|NCT04348591|76259135|FG000|Completed Sham rTMS Experimental Condition|Experimental Task (45 Min)||26|Each participant listened to neutral, aversive, and misophonic trigger sounds that were personalized while receiving sham neurostimulation|
60136446|NCT04348591|76259136|FG001|Completed Sham rTMS Experimental Condition|Experimental Task (45 Min)||27|Each participant listened to neutral, aversive, and misophonic trigger sounds that were personalized while receiving sham neurostimulation|
60136447|NCT04348591|76259135|FG000|Completed HF rTMS Over the Right dlPFC Experimental Condition|Experimental Task (45 Min)||26|Each participant listened to neutral, aversive, and misophonic trigger sounds that were personalized while receiving high frequency neurostimulation over the right dlPFC|
60136448|NCT04348591|76259136|FG001|Completed HF rTMS Over the Right dlPFC Experimental Condition|Experimental Task (45 Min)||27|Each participant listened to neutral, aversive, and misophonic trigger sounds that were personalized while receiving high frequency neurostimulation over the right dlPFC|
60136449|NCT04348591|76259135|FG000|Completed LF rTMS Over the Right mPFC Experimental Condition|Experimental Task (45 Min)||27|Each participant listened to neutral, aversive, and misophonic trigger sounds that were personalized while receiving low frequency neurostimulation over the right mPFC|
60136450|NCT04348591|76259136|FG001|Completed LF rTMS Over the Right mPFC Experimental Condition|Experimental Task (45 Min)||27|Each participant listened to neutral, aversive, and misophonic trigger sounds that were personalized while receiving low frequency neurostimulation over the right mPFC|
60136451|NCT04348591|76259135|FG000|COMPLETED|Experimental Task (45 Min)||27||
60136452|NCT04348591|76259136|FG001|COMPLETED|Experimental Task (45 Min)||27||
60136453|NCT04348591|76259135|FG000|NOT COMPLETED|Experimental Task (45 Min)||0||
60136454|NCT04348591|76259136|FG001|NOT COMPLETED|Experimental Task (45 Min)||0||
60136455|NCT04051320|76259144|FG000|STARTED|Overall Study||13||
60136456|NCT04051320|76259145|FG001|STARTED|Overall Study||10||
60136457|NCT04051320|76259144|FG000|COMPLETED|Overall Study||13||
60136458|NCT04051320|76259145|FG001|COMPLETED|Overall Study||10||
59605671|NCT01620528|75715838|FG001|Completed PTFU Month 6|Post-Treatment Follow-Up Period|Met criteria (reported a post-treatment menses, met the DXA criteria, and had a PTFU Month 6 visit).|26|Met criteria (reported post-treatment menses, met the DXA criteria, and had a PTFU Month 6 visit).|
59605672|NCT01620528|75715839|FG002|Completed PTFU Month 6|Post-Treatment Follow-Up Period|Met criteria (reported a post-treatment menses, met the DXA criteria, and had a PTFU Month 6 visit).|18|Met criteria (reported post-treatment menses, met the DXA criteria, and had a PTFU Month 6 visit).|
59605673|NCT01620528|75715837|FG000|Completed PTFU Month 12|Post-Treatment Follow-Up Period||2||
60136459|NCT04051320|76259144|FG000|NOT COMPLETED|Overall Study||0||
60136460|NCT04051320|76259145|FG001|NOT COMPLETED|Overall Study||0||
60136461|NCT04046250|76259155|FG000|STARTED|Overall Study||11||
60136462|NCT04046250|76259156|FG001|STARTED|Overall Study||11||
60136463|NCT04046250|76259155|FG000|COMPLETED|Overall Study|Four Methotrexate + TK-112690 Treatments|8||
60136464|NCT04046250|76259156|FG001|COMPLETED|Overall Study|Four Methotrexate + TK-12260 Placebo Treatments|7||
60136465|NCT04046250|76259155|FG000|NOT COMPLETED|Overall Study||3||
60136466|NCT04046250|76259156|FG001|NOT COMPLETED|Overall Study||4||
60136467|NCT03841526|76259164|FG000|STARTED|CRC Phase: First Treatment||8||
60136468|NCT03841526|76259165|FG001|STARTED|CRC Phase: First Treatment||10||
60136469|NCT03841526|76259166|FG002|STARTED|CRC Phase: First Treatment||6||
60136470|NCT03841526|76259167|FG003|STARTED|CRC Phase: First Treatment||11||
60136471|NCT03841526|76259168|FG004|STARTED|CRC Phase: First Treatment||5||
60136472|NCT03841526|76259169|FG005|STARTED|CRC Phase: First Treatment||8||
60136473|NCT03841526|76259164|FG000|Received 1st CRC Dose|CRC Phase: First Treatment||8||
60136474|NCT03841526|76259165|FG001|Received 1st CRC Dose|CRC Phase: First Treatment||10||
60136475|NCT03841526|76259166|FG002|Received 1st CRC Dose|CRC Phase: First Treatment||6||
60136476|NCT03841526|76259167|FG003|Received 1st CRC Dose|CRC Phase: First Treatment||11||
60136477|NCT03841526|76259168|FG004|Received 1st CRC Dose|CRC Phase: First Treatment||5||
60136478|NCT03841526|76259169|FG005|Received 1st CRC Dose|CRC Phase: First Treatment||8||
60136479|NCT03841526|76259164|FG000|COMPLETED|CRC Phase: First Treatment||8||
60136480|NCT03841526|76259165|FG001|COMPLETED|CRC Phase: First Treatment||10||
60136481|NCT03841526|76259166|FG002|COMPLETED|CRC Phase: First Treatment||6||
60136482|NCT03841526|76259167|FG003|COMPLETED|CRC Phase: First Treatment||11||
60136483|NCT03841526|76259168|FG004|COMPLETED|CRC Phase: First Treatment||5||
60136484|NCT03841526|76259169|FG005|COMPLETED|CRC Phase: First Treatment||8||
60136485|NCT03841526|76259164|FG000|NOT COMPLETED|CRC Phase: First Treatment||0||
60136486|NCT03841526|76259165|FG001|NOT COMPLETED|CRC Phase: First Treatment||0||
60136487|NCT03841526|76259166|FG002|NOT COMPLETED|CRC Phase: First Treatment||0||
60136488|NCT03841526|76259167|FG003|NOT COMPLETED|CRC Phase: First Treatment||0||
60136489|NCT03841526|76259168|FG004|NOT COMPLETED|CRC Phase: First Treatment||0||
60136490|NCT03841526|76259169|FG005|NOT COMPLETED|CRC Phase: First Treatment||0||
60136491|NCT03841526|76259164|FG000|STARTED|CRC Phase: Second Treatment||8||
60136492|NCT03841526|76259165|FG001|STARTED|CRC Phase: Second Treatment||10||
60136493|NCT03841526|76259166|FG002|STARTED|CRC Phase: Second Treatment||6||
60136494|NCT03841526|76259167|FG003|STARTED|CRC Phase: Second Treatment||11||
60136495|NCT03841526|76259168|FG004|STARTED|CRC Phase: Second Treatment||5||
60136496|NCT03841526|76259169|FG005|STARTED|CRC Phase: Second Treatment||8||
60136497|NCT03841526|76259164|FG000|Received 2nd CRC Dose|CRC Phase: Second Treatment||7||
60136498|NCT03841526|76259165|FG001|Received 2nd CRC Dose|CRC Phase: Second Treatment||10||
60136499|NCT03841526|76259166|FG002|Received 2nd CRC Dose|CRC Phase: Second Treatment||6||
60136500|NCT03841526|76259167|FG003|Received 2nd CRC Dose|CRC Phase: Second Treatment||9||
60136501|NCT03841526|76259168|FG004|Received 2nd CRC Dose|CRC Phase: Second Treatment||5||
60136502|NCT03841526|76259169|FG005|Received 2nd CRC Dose|CRC Phase: Second Treatment||8||
60136503|NCT03841526|76259164|FG000|COMPLETED|CRC Phase: Second Treatment||7||
60136504|NCT03841526|76259165|FG001|COMPLETED|CRC Phase: Second Treatment||10||
60136505|NCT03841526|76259166|FG002|COMPLETED|CRC Phase: Second Treatment||6||
60136506|NCT03841526|76259167|FG003|COMPLETED|CRC Phase: Second Treatment||9||
60136507|NCT03841526|76259168|FG004|COMPLETED|CRC Phase: Second Treatment||5||
59751282|NCT00658021|75870540|FG001|NOT COMPLETED|28-Week Treatment Period||13||
59751283|NCT00658021|75870541|FG002|NOT COMPLETED|28-Week Treatment Period||17||
59751284|NCT00658021|75870539|FG000|STARTED|Long-term Safety Follow-up Period|Entered safety follow-up period.|7|Entered safety follow-up period.|
60136508|NCT03841526|76259169|FG005|COMPLETED|CRC Phase: Second Treatment||8||
60136509|NCT03841526|76259164|FG000|NOT COMPLETED|CRC Phase: Second Treatment||1||
60136510|NCT03841526|76259165|FG001|NOT COMPLETED|CRC Phase: Second Treatment||0||
60136511|NCT03841526|76259166|FG002|NOT COMPLETED|CRC Phase: Second Treatment||0||
60136512|NCT03841526|76259167|FG003|NOT COMPLETED|CRC Phase: Second Treatment||2||
60136513|NCT03841526|76259168|FG004|NOT COMPLETED|CRC Phase: Second Treatment||0||
60136514|NCT03841526|76259169|FG005|NOT COMPLETED|CRC Phase: Second Treatment||0||
60136515|NCT03841526|76259164|FG000|STARTED|Outpatient Phase Treatment||7||
60136516|NCT03841526|76259165|FG001|STARTED|Outpatient Phase Treatment||10||
60136517|NCT03841526|76259166|FG002|STARTED|Outpatient Phase Treatment||6||
60136518|NCT03841526|76259167|FG003|STARTED|Outpatient Phase Treatment||9||
60136519|NCT03841526|76259168|FG004|STARTED|Outpatient Phase Treatment||5||
60136520|NCT03841526|76259169|FG005|STARTED|Outpatient Phase Treatment||8||
60136521|NCT03841526|76259164|FG000|Received at Least 1 Outpatient Dose|Outpatient Phase Treatment||7||
60136522|NCT03841526|76259165|FG001|Received at Least 1 Outpatient Dose|Outpatient Phase Treatment||9||
60136523|NCT03841526|76259166|FG002|Received at Least 1 Outpatient Dose|Outpatient Phase Treatment||6||
60136524|NCT03841526|76259167|FG003|Received at Least 1 Outpatient Dose|Outpatient Phase Treatment||9||
60136525|NCT03841526|76259168|FG004|Received at Least 1 Outpatient Dose|Outpatient Phase Treatment||5||
60136526|NCT03841526|76259169|FG005|Received at Least 1 Outpatient Dose|Outpatient Phase Treatment||8||
60136527|NCT03841526|76259164|FG000|COMPLETED|Outpatient Phase Treatment||7||
60136528|NCT03841526|76259165|FG001|COMPLETED|Outpatient Phase Treatment||9||
60136529|NCT03841526|76259166|FG002|COMPLETED|Outpatient Phase Treatment||5||
60136530|NCT03841526|76259167|FG003|COMPLETED|Outpatient Phase Treatment||9||
60136531|NCT03841526|76259168|FG004|COMPLETED|Outpatient Phase Treatment||5||
60136532|NCT03841526|76259169|FG005|COMPLETED|Outpatient Phase Treatment||7||
60136533|NCT03841526|76259164|FG000|NOT COMPLETED|Outpatient Phase Treatment||0||
60136534|NCT03841526|76259165|FG001|NOT COMPLETED|Outpatient Phase Treatment||1||
60136535|NCT03841526|76259166|FG002|NOT COMPLETED|Outpatient Phase Treatment||1||
60136536|NCT03841526|76259167|FG003|NOT COMPLETED|Outpatient Phase Treatment||0||
60136537|NCT03841526|76259168|FG004|NOT COMPLETED|Outpatient Phase Treatment||0||
60136538|NCT03841526|76259169|FG005|NOT COMPLETED|Outpatient Phase Treatment||1||
60136539|NCT03834506|76259192|FG000|STARTED|Overall Study||515||
60136540|NCT03834506|76259193|FG001|STARTED|Overall Study||515||
60136541|NCT03834506|76259192|FG000|Treated|Overall Study||514||
60136542|NCT03834506|76259193|FG001|Treated|Overall Study||514||
60136543|NCT03834506|76259192|FG000|COMPLETED|Overall Study||0||
60136544|NCT03834506|76259193|FG001|COMPLETED|Overall Study||0||
60136545|NCT03834506|76259192|FG000|NOT COMPLETED|Overall Study||515||
60136546|NCT03834506|76259193|FG001|NOT COMPLETED|Overall Study||515||
60136547|NCT03535740|76259199|FG000|STARTED|Overall Study||103||
60136548|NCT03535740|76259199|FG000|Participants Who Received Escalated Dose of Brigatinib 240 mg|Overall Study||13||
60136549|NCT03535740|76259199|FG000|COMPLETED|Overall Study||0||
60136550|NCT03535740|76259199|FG000|NOT COMPLETED|Overall Study||103||
60136551|NCT03359889|76259204|FG000|STARTED|Overall Study||5||
60136552|NCT03359889|76259204|FG000|COMPLETED|Overall Study||5||
60136553|NCT03359889|76259204|FG000|NOT COMPLETED|Overall Study||0||
60136554|NCT03351049|76259210|FG000|STARTED|Overall Study||323||
60136555|NCT03351049|76259211|FG001|STARTED|Overall Study||128||
60136556|NCT03351049|76259210|FG000|COMPLETED|Overall Study||297||
60136557|NCT03351049|76259211|FG001|COMPLETED|Overall Study||106||
60136558|NCT03351049|76259210|FG000|NOT COMPLETED|Overall Study||26||
60136559|NCT03351049|76259211|FG001|NOT COMPLETED|Overall Study||22||
60136560|NCT03304262|76259220|FG000|STARTED|Overall Study||4||
60136561|NCT03304262|76259221|FG001|STARTED|Overall Study||5||
60136562|NCT03304262|76259222|FG002|STARTED|Overall Study||4||
60136563|NCT03304262|76259220|FG000|COMPLETED|Overall Study||4||
60136564|NCT03304262|76259221|FG001|COMPLETED|Overall Study||5||
60136565|NCT03304262|76259222|FG002|COMPLETED|Overall Study||4||
60136566|NCT03304262|76259220|FG000|NOT COMPLETED|Overall Study||0||
60136567|NCT03304262|76259221|FG001|NOT COMPLETED|Overall Study||0||
60136568|NCT03304262|76259222|FG002|NOT COMPLETED|Overall Study||0||
60136569|NCT03288506|76259232|FG000|STARTED|Overall Study||60||
60136570|NCT03288506|76259232|FG000|COMPLETED|Overall Study||8|Due to low numbers the control arm was dropped from the design and ethical amendment was sought from university committee|
60136571|NCT03288506|76259232|FG000|NOT COMPLETED|Overall Study||52||
60136572|NCT03180684|76259240|FG000|STARTED|Overall Study||25||
60136573|NCT03180684|76259241|FG001|STARTED|Overall Study||8||
60136574|NCT03180684|76259240|FG000|Modified Intent-to-Treat (mITT) Population|Overall Study||25|mITT population included all participants who received at least 1 dose of VGX-3100 + EP (with or without imiquimod) and had an analysis endpoint of interest.|
60136575|NCT03180684|76259241|FG001|Modified Intent-to-Treat (mITT) Population|Overall Study||8|mITT population included all participants who received at least 1 dose of VGX-3100 + EP (with or without imiquimod) and had an analysis endpoint of interest.|
60136576|NCT03180684|76259240|FG000|Safety Population|Overall Study||25|Safety population included all participants who received at least 1 dose of VGX-3100 (with or without EP).|
60136577|NCT03180684|76259241|FG001|Safety Population|Overall Study||8|Safety population included all participants who received at least 1 dose of VGX-3100 (with or without EP).|
60136578|NCT03180684|76259240|FG000|COMPLETED|Overall Study||17||
60136579|NCT03180684|76259241|FG001|COMPLETED|Overall Study||8||
60136580|NCT03180684|76259240|FG000|NOT COMPLETED|Overall Study||8||
60136581|NCT03180684|76259241|FG001|NOT COMPLETED|Overall Study||0||
60136582|NCT03083561|76259254|FG000|STARTED|Overall Study||6||
60136583|NCT03083561|76259255|FG001|STARTED|Overall Study||6||
60136584|NCT03083561|76259256|FG002|STARTED|Overall Study||6||
60136585|NCT03083561|76259257|FG003|STARTED|Overall Study||6||
60136586|NCT03083561|76259258|FG004|STARTED|Overall Study||3||
60136587|NCT03083561|76259259|FG005|STARTED|Overall Study||9||
60136588|NCT03083561|76259254|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6||
60136589|NCT03083561|76259255|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6||
60136590|NCT03083561|76259256|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6||
60136591|NCT03083561|76259257|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6||
60136592|NCT03083561|76259258|FG004|Received at Least 1 Dose of Study Drug|Overall Study||3||
60136593|NCT03083561|76259259|FG005|Received at Least 1 Dose of Study Drug|Overall Study||9||
60136594|NCT03083561|76259254|FG000|COMPLETED|Overall Study||6||
60136595|NCT03083561|76259255|FG001|COMPLETED|Overall Study||6||
60136596|NCT03083561|76259256|FG002|COMPLETED|Overall Study||6||
60136597|NCT03083561|76259257|FG003|COMPLETED|Overall Study||6||
60136598|NCT03083561|76259258|FG004|COMPLETED|Overall Study||3||
60136599|NCT03083561|76259259|FG005|COMPLETED|Overall Study||9||
60136600|NCT03083561|76259254|FG000|NOT COMPLETED|Overall Study||0||
60136601|NCT03083561|76259255|FG001|NOT COMPLETED|Overall Study||0||
60136602|NCT03083561|76259256|FG002|NOT COMPLETED|Overall Study||0||
60136603|NCT03083561|76259257|FG003|NOT COMPLETED|Overall Study||0||
60136604|NCT03083561|76259258|FG004|NOT COMPLETED|Overall Study||0||
60136605|NCT03083561|76259259|FG005|NOT COMPLETED|Overall Study||0||
60136606|NCT02914379|76259279|FG000|STARTED|Overall Study||6||
60136607|NCT02914379|76259279|FG000|COMPLETED|Overall Study||6||
60136608|NCT02914379|76259279|FG000|NOT COMPLETED|Overall Study||0||
60136609|NCT02747927|76259285|FG000|STARTED|Overall Study||6698||
60136610|NCT02747927|76259286|FG001|STARTED|Overall Study||13401||
60136611|NCT02747927|76259285|FG000|Treated: Safety Set|Overall Study||6687|Safety Set included all randomized participants who received at least 1 dose of the trial vaccines (TDV or placebo).|
60136612|NCT02747927|76259286|FG001|Treated: Safety Set|Overall Study||13380|Safety Set included all randomized participants who received at least 1 dose of the trial vaccines (TDV or placebo).|
60136613|NCT02747927|76259285|FG000|COMPLETED|Overall Study||6477|Completed = Number of participants who had not discontinued from the trial at the time of the Part 1 analysis.|
60136614|NCT02747927|76259286|FG001|COMPLETED|Overall Study||12943|Completed = Number of participants who had not discontinued from the trial at the time of the Part 1 analysis.|
60136615|NCT02747927|76259285|FG000|NOT COMPLETED|Overall Study||221||
60136616|NCT02747927|76259286|FG001|NOT COMPLETED|Overall Study||458||
60136617|NCT02740920|76259292|FG000|STARTED|Overall Study||9||
60136618|NCT02740920|76259292|FG000|COMPLETED|Overall Study||9||
60136619|NCT02740920|76259292|FG000|NOT COMPLETED|Overall Study||0||
60136620|NCT02515227|76259298|FG000|STARTED|Overall Study||6||
60136621|NCT02515227|76259299|FG001|STARTED|Overall Study||16||
60136622|NCT02515227|76259298|FG000|Received at Least 1 Vaccine|Overall Study||6||
60136623|NCT02515227|76259299|FG001|Received at Least 1 Vaccine|Overall Study||16||
60136624|NCT02515227|76259298|FG000|COMPLETED|Overall Study||4|This milestone reflects receipt of all 6 vaccines and remaining on study to week 13 at least.|
60136625|NCT02515227|76259299|FG001|COMPLETED|Overall Study||5|This milestone reflects receipt of all 6 vaccines and remaining on study to week 13 at least.|
60136626|NCT02515227|76259298|FG000|NOT COMPLETED|Overall Study||2||
60136627|NCT02515227|76259299|FG001|NOT COMPLETED|Overall Study||11||
60136628|NCT02369458|76259309|FG000|STARTED|Overall Study||35||
60136629|NCT02369458|76259310|FG001|STARTED|Overall Study||13||
60136630|NCT02369458|76259309|FG000|COMPLETED|Overall Study||34||
60136631|NCT02369458|76259310|FG001|COMPLETED|Overall Study||13||
60136632|NCT02369458|76259309|FG000|NOT COMPLETED|Overall Study||1||
60136633|NCT02369458|76259310|FG001|NOT COMPLETED|Overall Study||0||
60136634|NCT01776190|76259316|FG000|STARTED|Overall Study||6||
60136635|NCT01776190|76259316|FG000|COMPLETED|Overall Study||5||
60136636|NCT01776190|76259316|FG000|NOT COMPLETED|Overall Study||1||
60136637|NCT01266642|76259322|FG000|STARTED|Overall Study||149||
60136638|NCT01266642|76259323|FG001|STARTED|Overall Study||138||
60136639|NCT01266642|76259322|FG000|COMPLETED|Overall Study||149||
60136640|NCT01266642|76259323|FG001|COMPLETED|Overall Study||137||
60136641|NCT01266642|76259322|FG000|NOT COMPLETED|Overall Study||0||
60136642|NCT01266642|76259323|FG001|NOT COMPLETED|Overall Study||1||
60136643|NCT00754845|76259331|FG000|STARTED|Overall Study||959||
60136644|NCT00754845|76259332|FG001|STARTED|Overall Study||959||
60136645|NCT00754845|76259331|FG000|COMPLETED|Overall Study||959||
60136646|NCT00754845|76259332|FG001|COMPLETED|Overall Study||959||
60136647|NCT00754845|76259331|FG000|NOT COMPLETED|Overall Study||0||
60136648|NCT00754845|76259332|FG001|NOT COMPLETED|Overall Study||0||
60136649|NCT00095784|76259340|FG000|STARTED|Overall Study||21||
60136650|NCT00095784|76259340|FG000|COMPLETED|Overall Study||21||
60136651|NCT00095784|76259340|FG000|NOT COMPLETED|Overall Study||0||
60136652|NCT00083174|76259347|FG000|STARTED|Randomization Period||2285||
60136653|NCT00083174|76259348|FG001|STARTED|Randomization Period||2275||
60136654|NCT00083174|76259349|FG002|STARTED|Randomization Period||0||
60136655|NCT00083174|76259347|FG000|COMPLETED|Randomization Period|All women randomized were included in the analysis based on intent-to-treat principle.|2285||
60136656|NCT00083174|76259348|FG001|COMPLETED|Randomization Period|All women randomized were included in the analysis based on intent-to-treat principle.|2275||
60136657|NCT00083174|76259349|FG002|COMPLETED|Randomization Period||0||
60136658|NCT00083174|76259347|FG000|NOT COMPLETED|Randomization Period||0||
60136659|NCT00083174|76259348|FG001|NOT COMPLETED|Randomization Period||0||
60136660|NCT00083174|76259349|FG002|NOT COMPLETED|Randomization Period||0||
60136661|NCT00083174|76259347|FG000|STARTED|Open-label Extension||0||
60136662|NCT00083174|76259348|FG001|STARTED|Open-label Extension||0||
60136663|NCT00083174|76259349|FG002|STARTED|Open-label Extension||2831||
60136664|NCT00083174|76259347|FG000|COMPLETED|Open-label Extension||0||
60136665|NCT00083174|76259348|FG001|COMPLETED|Open-label Extension||0||
60136666|NCT00083174|76259349|FG002|COMPLETED|Open-label Extension||2831||
60136667|NCT00083174|76259347|FG000|NOT COMPLETED|Open-label Extension||0||
60136668|NCT00083174|76259348|FG001|NOT COMPLETED|Open-label Extension||0||
60136669|NCT00083174|76259349|FG002|NOT COMPLETED|Open-label Extension||0||
60136670|NCT00070499|76259363|FG000|STARTED|Overall Study||75||
60136671|NCT00070499|76259364|FG001|STARTED|Overall Study||78||
60136672|NCT00070499|76259365|FG002|STARTED|Overall Study||126||
60136673|NCT00070499|76259366|FG003|STARTED|Overall Study||127||
60136674|NCT00070499|76259363|FG000|Eligible|Overall Study||73||
60136675|NCT00070499|76259364|FG001|Eligible|Overall Study||73||
60136676|NCT00070499|76259365|FG002|Eligible|Overall Study||123||
60136677|NCT00070499|76259366|FG003|Eligible|Overall Study||125||
60136678|NCT00070499|76259363|FG000|Eligible and Treated|Overall Study||72||
60136679|NCT00070499|76259364|FG001|Eligible and Treated|Overall Study||73||
60136680|NCT00070499|76259365|FG002|Eligible and Treated|Overall Study||123||
60136681|NCT00070499|76259366|FG003|Eligible and Treated|Overall Study||123||
60136682|NCT00070499|76259363|FG000|COMPLETED|Overall Study||37||
60136683|NCT00070499|76259364|FG001|COMPLETED|Overall Study||52||
60136684|NCT00070499|76259365|FG002|COMPLETED|Overall Study||6||
60136685|NCT00070499|76259366|FG003|COMPLETED|Overall Study||17||
60136686|NCT00070499|76259363|FG000|NOT COMPLETED|Overall Study||38||
60136687|NCT00070499|76259364|FG001|NOT COMPLETED|Overall Study||26||
60136688|NCT00070499|76259365|FG002|NOT COMPLETED|Overall Study||120||
60136689|NCT00070499|76259366|FG003|NOT COMPLETED|Overall Study||110||
60136690|NCT00066573|76259386|FG000|STARTED|Overall Study||3789||
60136691|NCT00066573|76259387|FG001|STARTED|Overall Study||3787||
60136692|NCT00066573|76259386|FG000|COMPLETED|Overall Study||3761||
60136693|NCT00066573|76259387|FG001|COMPLETED|Overall Study||3759||
60136694|NCT00066573|76259386|FG000|NOT COMPLETED|Overall Study||28||
60136695|NCT00066573|76259387|FG001|NOT COMPLETED|Overall Study||28||
60136696|NCT03594955|76259393|FG000|STARTED|Overall Study||7||
60136697|NCT03594955|76259393|FG000|COMPLETED|Overall Study||0||
60136698|NCT03594955|76259393|FG000|NOT COMPLETED|Overall Study||7||
60136699|NCT03369444|76259401|FG000|STARTED|Overall Study||2||
60136700|NCT03369444|76259402|FG001|STARTED|Overall Study||2||
60136701|NCT03369444|76259403|FG002|STARTED|Overall Study||2||
60136702|NCT03369444|76259404|FG003|STARTED|Overall Study||4||
60136703|NCT03369444|76259401|FG000|COMPLETED|Overall Study||2||
60136704|NCT03369444|76259402|FG001|COMPLETED|Overall Study||2||
60136705|NCT03369444|76259403|FG002|COMPLETED|Overall Study||2||
60136706|NCT03369444|76259404|FG003|COMPLETED|Overall Study||4||
60136707|NCT03369444|76259401|FG000|NOT COMPLETED|Overall Study||0||
60136708|NCT03369444|76259402|FG001|NOT COMPLETED|Overall Study||0||
60136709|NCT03369444|76259403|FG002|NOT COMPLETED|Overall Study||0||
60136710|NCT03369444|76259404|FG003|NOT COMPLETED|Overall Study||0||
60136711|NCT01677624|76259421|FG000|STARTED|Overall Study||28||
60136712|NCT01677624|76259421|FG000|COMPLETED|Overall Study||27||
60136713|NCT01677624|76259421|FG000|NOT COMPLETED|Overall Study||1||
60136714|NCT02080273|76259428|FG000|STARTED|Overall Study||45||
60136715|NCT02080273|76259429|FG001|STARTED|Overall Study||45||
60136716|NCT02080273|76259430|FG002|STARTED|Overall Study||45||
60136717|NCT02080273|76259428|FG000|COMPLETED|Overall Study||45||
60136718|NCT02080273|76259429|FG001|COMPLETED|Overall Study||45||
60136719|NCT02080273|76259430|FG002|COMPLETED|Overall Study||45||
60136720|NCT02080273|76259428|FG000|NOT COMPLETED|Overall Study||0||
60136721|NCT02080273|76259429|FG001|NOT COMPLETED|Overall Study||0||
60136722|NCT02080273|76259430|FG002|NOT COMPLETED|Overall Study||0||
60136723|NCT01272219|76259442|FG000|STARTED|Main Period: Week 0 to Week 56||959||
60136724|NCT01272219|76259443|FG001|STARTED|Main Period: Week 0 to Week 56|This arm is not considered for main period as these subjects belong to re-randomised period|0||
60136725|NCT01272219|76259444|FG002|STARTED|Main Period: Week 0 to Week 56|This arm is not considered for main period as these subjects belong to re-randomised period|0||
60136726|NCT01272219|76259445|FG003|STARTED|Main Period: Week 0 to Week 56||487||
60136727|NCT01272219|76259446|FG004|STARTED|Main Period: Week 0 to Week 56||1528||
60136728|NCT01272219|76259447|FG005|STARTED|Main Period: Week 0 to Week 56||757||
60136729|NCT01272219|76259442|FG000|Exposed|Main Period: Week 0 to Week 56||957||
60136730|NCT01272219|76259443|FG001|Exposed|Main Period: Week 0 to Week 56||0||
60136731|NCT01272219|76259444|FG002|Exposed|Main Period: Week 0 to Week 56||0||
60136732|NCT01272219|76259445|FG003|Exposed|Main Period: Week 0 to Week 56||487||
60136733|NCT01272219|76259446|FG004|Exposed|Main Period: Week 0 to Week 56||1524||
60136734|NCT01272219|76259447|FG005|Exposed|Main Period: Week 0 to Week 56||755||
60136735|NCT01272219|76259442|FG000|COMPLETED|Main Period: Week 0 to Week 56||679||
60136736|NCT01272219|76259443|FG001|COMPLETED|Main Period: Week 0 to Week 56||0||
60136737|NCT01272219|76259444|FG002|COMPLETED|Main Period: Week 0 to Week 56||0||
60136738|NCT01272219|76259445|FG003|COMPLETED|Main Period: Week 0 to Week 56||296||
60136739|NCT01272219|76259446|FG004|COMPLETED|Main Period: Week 0 to Week 56||1110||
60136740|NCT01272219|76259447|FG005|COMPLETED|Main Period: Week 0 to Week 56||505||
60136741|NCT01272219|76259442|FG000|NOT COMPLETED|Main Period: Week 0 to Week 56||280||
60136742|NCT01272219|76259443|FG001|NOT COMPLETED|Main Period: Week 0 to Week 56||0||
60136743|NCT01272219|76259444|FG002|NOT COMPLETED|Main Period: Week 0 to Week 56||0||
60136744|NCT01272219|76259445|FG003|NOT COMPLETED|Main Period: Week 0 to Week 56||191||
60136745|NCT01272219|76259446|FG004|NOT COMPLETED|Main Period: Week 0 to Week 56||418||
60136746|NCT01272219|76259447|FG005|NOT COMPLETED|Main Period: Week 0 to Week 56||252||
60136747|NCT01272219|76259442|FG000|STARTED|Re-randomised Period: Week 56 to Week 68|This arm is not considered for re-randomised period as these subjects belong to main period|0||
60136748|NCT01272219|76259443|FG001|STARTED|Re-randomised Period: Week 56 to Week 68|Incorrect stratification: In this period, overall 37 pre-diabetic subjects were included by error.|351||
60136749|NCT01272219|76259444|FG002|STARTED|Re-randomised Period: Week 56 to Week 68|Incorrect stratification: In this period, overall 37 pre-diabetic subjects were included by error.|350||
60136750|NCT01272219|76259445|FG003|STARTED|Re-randomised Period: Week 56 to Week 68|Incorrect stratification: In this period, overall 37 pre-diabetic subjects were included by error.|304||
60136751|NCT01272219|76259446|FG004|STARTED|Re-randomised Period: Week 56 to Week 68|This arm is not considered for re-randomised period as these subjects belong to main period|0||
60136752|NCT01272219|76259447|FG005|STARTED|Re-randomised Period: Week 56 to Week 68|This arm is not considered for re-randomised period as these subjects belong to main period|0||
60136753|NCT01272219|76259442|FG000|COMPLETED|Re-randomised Period: Week 56 to Week 68||0||
60136754|NCT01272219|76259443|FG001|COMPLETED|Re-randomised Period: Week 56 to Week 68||342||
60136755|NCT01272219|76259444|FG002|COMPLETED|Re-randomised Period: Week 56 to Week 68||343||
60136756|NCT01272219|76259445|FG003|COMPLETED|Re-randomised Period: Week 56 to Week 68||289||
60136757|NCT01272219|76259446|FG004|COMPLETED|Re-randomised Period: Week 56 to Week 68||0||
60136758|NCT01272219|76259447|FG005|COMPLETED|Re-randomised Period: Week 56 to Week 68||0||
60136759|NCT01272219|76259442|FG000|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||0||
60136760|NCT01272219|76259443|FG001|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||9||
60136761|NCT01272219|76259444|FG002|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||7||
60136762|NCT01272219|76259445|FG003|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||15||
60136763|NCT01272219|76259446|FG004|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||0||
60136764|NCT01272219|76259447|FG005|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||0||
60136765|NCT01272219|76259442|FG000|STARTED|Main + Extension Period: Week 0-172|This arm is not considered for this period as these subjects belong to main period|0||
60136766|NCT01272219|76259443|FG001|STARTED|Main + Extension Period: Week 0-172|This arm is not considered for this period as these subjects belong to re-randomised period|0||
60136767|NCT01272219|76259444|FG002|STARTED|Main + Extension Period: Week 0-172|This arm is not considered for this period as these subjects belong to re-randomised period|0||
60136768|NCT01272219|76259445|FG003|STARTED|Main + Extension Period: Week 0-172|This arm is not considered for this period as these subjects belong to main and re-randomised period|0||
60136769|NCT01272219|76259446|FG004|STARTED|Main + Extension Period: Week 0-172|Incorrect stratification: In this period, overall 6 subjects with no pre-diabetes included by error.|1505||
60136770|NCT01272219|76259447|FG005|STARTED|Main + Extension Period: Week 0-172|Incorrect stratification: In this period, overall 6 subjects with no pre-diabetes included by error.|749||
60136771|NCT01272219|76259442|FG000|Exposed|Main + Extension Period: Week 0-172||0||
60136772|NCT01272219|76259443|FG001|Exposed|Main + Extension Period: Week 0-172||0||
60136773|NCT01272219|76259444|FG002|Exposed|Main + Extension Period: Week 0-172||0||
60136774|NCT01272219|76259445|FG003|Exposed|Main + Extension Period: Week 0-172||0||
60136775|NCT01272219|76259446|FG004|Exposed|Main + Extension Period: Week 0-172||1501||
60136776|NCT01272219|76259447|FG005|Exposed|Main + Extension Period: Week 0-172||747||
60136777|NCT01272219|76259442|FG000|COMPLETED|Main + Extension Period: Week 0-172||0||
60136778|NCT01272219|76259443|FG001|COMPLETED|Main + Extension Period: Week 0-172||0||
60136779|NCT01272219|76259444|FG002|COMPLETED|Main + Extension Period: Week 0-172||0||
60136780|NCT01272219|76259445|FG003|COMPLETED|Main + Extension Period: Week 0-172||0||
60136781|NCT01272219|76259446|FG004|COMPLETED|Main + Extension Period: Week 0-172||783||
60136782|NCT01272219|76259447|FG005|COMPLETED|Main + Extension Period: Week 0-172||327||
60136783|NCT01272219|76259442|FG000|NOT COMPLETED|Main + Extension Period: Week 0-172||0||
60136784|NCT01272219|76259443|FG001|NOT COMPLETED|Main + Extension Period: Week 0-172||0||
60136785|NCT01272219|76259444|FG002|NOT COMPLETED|Main + Extension Period: Week 0-172||0||
60136786|NCT01272219|76259445|FG003|NOT COMPLETED|Main + Extension Period: Week 0-172||0||
60136787|NCT01272219|76259446|FG004|NOT COMPLETED|Main + Extension Period: Week 0-172||722||
60136788|NCT01272219|76259447|FG005|NOT COMPLETED|Main + Extension Period: Week 0-172||422||
60136789|NCT01510028|76259464|FG000|STARTED|Overall Study||6||
60136790|NCT01510028|76259465|FG001|STARTED|Overall Study||6||
60136791|NCT01510028|76259466|FG002|STARTED|Overall Study||6||
60136792|NCT01510028|76259467|FG003|STARTED|Overall Study||6||
60136793|NCT01510028|76259464|FG000|COMPLETED|Overall Study||5||
60136794|NCT01510028|76259465|FG001|COMPLETED|Overall Study||6||
60136795|NCT01510028|76259466|FG002|COMPLETED|Overall Study||6||
60136796|NCT01510028|76259467|FG003|COMPLETED|Overall Study||6||
60136797|NCT01510028|76259464|FG000|NOT COMPLETED|Overall Study||1||
60136798|NCT01510028|76259465|FG001|NOT COMPLETED|Overall Study||0||
60136799|NCT01510028|76259466|FG002|NOT COMPLETED|Overall Study||0||
60136800|NCT01510028|76259467|FG003|NOT COMPLETED|Overall Study||0||
60136801|NCT00731211|76259479|FG000|STARTED|Overall Study|2 patients ineligible (papillary histologic type-1 pt. Previous treatment with everolimus alone-1 pt|55||
60136802|NCT00731211|76259479|FG000|COMPLETED|Overall Study||55||
60136803|NCT00731211|76259479|FG000|NOT COMPLETED|Overall Study||0||
60136804|NCT01521494|76259488|FG000|STARTED|Overall Study||39||
60136805|NCT01521494|76259489|FG001|STARTED|Overall Study||36||
60136806|NCT01521494|76259490|FG002|STARTED|Overall Study||35||
60136807|NCT01521494|76259491|FG003|STARTED|Overall Study||36||
60136808|NCT01521494|76259492|FG004|STARTED|Overall Study||37||
60136809|NCT01521494|76259488|FG000|COMPLETED|Overall Study||37||
60136810|NCT01521494|76259489|FG001|COMPLETED|Overall Study||31||
60136811|NCT01521494|76259490|FG002|COMPLETED|Overall Study||23||
60136812|NCT01521494|76259491|FG003|COMPLETED|Overall Study||15||
60136813|NCT01521494|76259492|FG004|COMPLETED|Overall Study||30||
60136814|NCT01521494|76259488|FG000|NOT COMPLETED|Overall Study||2||
60136815|NCT01521494|76259489|FG001|NOT COMPLETED|Overall Study||5||
60136816|NCT01521494|76259490|FG002|NOT COMPLETED|Overall Study||12||
60136817|NCT01521494|76259491|FG003|NOT COMPLETED|Overall Study||21||
60136818|NCT01521494|76259492|FG004|NOT COMPLETED|Overall Study||7||
60136819|NCT01270971|76259506|FG000|STARTED|Overall Study||400||
60136820|NCT01270971|76259507|FG001|STARTED|Overall Study||194||
60136821|NCT01270971|76259506|FG000|COMPLETED|Overall Study||348||
60136822|NCT01270971|76259507|FG001|COMPLETED|Overall Study||171||
60136823|NCT01270971|76259506|FG000|NOT COMPLETED|Overall Study||52||
60136824|NCT01270971|76259507|FG001|NOT COMPLETED|Overall Study||23||
60136825|NCT00732225|76259518|FG000|STARTED|Overall Study|76 eyes of 71 patients|71||
60136826|NCT00732225|76259519|FG001|STARTED|Overall Study|41 eyes of 40 patients|40||
60136827|NCT00732225|76259520|FG002|STARTED|Overall Study|26 eyes of 26 patients|26||
60136828|NCT00732225|76259521|FG003|STARTED|Overall Study|33 eyes of 33 patients|33||
60136829|NCT00732225|76259522|FG004|STARTED|Overall Study|55 eyes of 54 patients|54||
60136830|NCT00732225|76259518|FG000|COMPLETED|Overall Study|64 eyes of 60 patients|60||
60136831|NCT00732225|76259519|FG001|COMPLETED|Overall Study|33 eyes of 32 patients|32||
60136832|NCT00732225|76259520|FG002|COMPLETED|Overall Study|23 eyes of 23 patients|23||
60136833|NCT00732225|76259521|FG003|COMPLETED|Overall Study|29 eyes of 29 patients|29||
60136834|NCT00732225|76259522|FG004|COMPLETED|Overall Study|48 eyes of 48 patients|48||
60136835|NCT00732225|76259518|FG000|NOT COMPLETED|Overall Study||11||
60136836|NCT00732225|76259519|FG001|NOT COMPLETED|Overall Study||8||
60136837|NCT00732225|76259520|FG002|NOT COMPLETED|Overall Study||3||
60136838|NCT00732225|76259521|FG003|NOT COMPLETED|Overall Study||4||
60136839|NCT00732225|76259522|FG004|NOT COMPLETED|Overall Study||6||
60136840|NCT01270503|76259534|FG000|STARTED|Overall Study||538||
60136841|NCT01270503|76259534|FG000|COMPLETED|Overall Study||537||
60136842|NCT01270503|76259534|FG000|NOT COMPLETED|Overall Study||1||
60136843|NCT00751179|76259541|FG000|STARTED|Overall Study|10 of 76 randomized were not treated with sugammadex; 4 of these 10 received rocuronium only|76||
60136844|NCT00751179|76259542|FG001|STARTED|Overall Study|5 of 85 randomized were not treated with succinylcholine|85||
60136845|NCT00751179|76259541|FG000|COMPLETED|Overall Study||62||
60136846|NCT00751179|76259542|FG001|COMPLETED|Overall Study||70||
60136847|NCT00751179|76259541|FG000|NOT COMPLETED|Overall Study||14||
60136848|NCT00751179|76259542|FG001|NOT COMPLETED|Overall Study||15||
60136849|NCT01277211|76259551|FG000|STARTED|Overall Study||738||
60136850|NCT01277211|76259552|FG001|STARTED|Overall Study||245||
60136851|NCT01277211|76259551|FG000|Treated|Overall Study||714||
60136852|NCT01277211|76259552|FG001|Treated|Overall Study||232||
60136853|NCT01277211|76259551|FG000|COMPLETED|Overall Study||588||
60136854|NCT01277211|76259552|FG001|COMPLETED|Overall Study||182||
60136855|NCT01277211|76259551|FG000|NOT COMPLETED|Overall Study||150||
60136856|NCT01277211|76259552|FG001|NOT COMPLETED|Overall Study||63||
60136857|NCT01676220|76259560|FG000|STARTED|Overall Study||439||
60136858|NCT01676220|76259561|FG001|STARTED|Overall Study||439||
60136859|NCT01676220|76259560|FG000|Treated|Overall Study||435||
60136860|NCT01676220|76259561|FG001|Treated|Overall Study||438||
60136861|NCT01676220|76259560|FG000|Modified Intent-To-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|432||
60136862|NCT01676220|76259561|FG001|Modified Intent-To-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|430||
60136863|NCT01676220|76259560|FG000|COMPLETED|Overall Study||337||
60136864|NCT01676220|76259561|FG001|COMPLETED|Overall Study||314||
60136865|NCT01676220|76259560|FG000|NOT COMPLETED|Overall Study||102||
60136866|NCT01676220|76259561|FG001|NOT COMPLETED|Overall Study||125||
60136867|NCT00734409|76259571|FG000|STARTED|Overall Study||155||
60136868|NCT00734409|76259572|FG001|STARTED|Overall Study||145||
60136869|NCT00734409|76259571|FG000|COMPLETED|Overall Study||155||
60136870|NCT00734409|76259572|FG001|COMPLETED|Overall Study||145||
60136871|NCT00734409|76259571|FG000|NOT COMPLETED|Overall Study||0||
60136872|NCT00734409|76259572|FG001|NOT COMPLETED|Overall Study||0||
60136873|NCT00734799|76259580|FG000|STARTED|Overall Study||9||
60136874|NCT00734799|76259581|FG001|STARTED|Overall Study||13||
60136875|NCT00734799|76259580|FG000|COMPLETED|Overall Study||9||
60136876|NCT00734799|76259581|FG001|COMPLETED|Overall Study||9||
60136877|NCT00734799|76259580|FG000|NOT COMPLETED|Overall Study||0||
60136878|NCT00734799|76259581|FG001|NOT COMPLETED|Overall Study||4||
60136879|NCT04007094|76259587|FG000|STARTED|Overall Study||21||58
60136880|NCT04007094|76259588|FG001|STARTED|Overall Study||21||58
60136881|NCT04007094|76259587|FG000|COMPLETED|Overall Study||20||55
60136882|NCT04007094|76259588|FG001|COMPLETED|Overall Study||20||55
60136883|NCT04007094|76259587|FG000|NOT COMPLETED|Overall Study||1||3
60136884|NCT04007094|76259588|FG001|NOT COMPLETED|Overall Study||1||3
60136885|NCT04023175|76259596|FG000|STARTED|Overall Study||59||
60136886|NCT04023175|76259597|FG001|STARTED|Overall Study||59||
60136887|NCT04023175|76259596|FG000|COMPLETED|Overall Study||53||
60136888|NCT04023175|76259597|FG001|COMPLETED|Overall Study||48||
60136889|NCT04023175|76259596|FG000|NOT COMPLETED|Overall Study||6||
60136890|NCT04023175|76259597|FG001|NOT COMPLETED|Overall Study||11||
60136891|NCT01485614|76259609|FG000|STARTED|Randomization||96||
60136892|NCT01485614|76259610|FG001|STARTED|Randomization||90||
60136893|NCT01485614|76259611|FG002|STARTED|Randomization||9||
60136894|NCT01485614|76259612|FG003|STARTED|Randomization||5||
60136895|NCT01485614|76259609|FG000|COMPLETED|Randomization||95||
60136896|NCT01485614|76259610|FG001|COMPLETED|Randomization||90||
60136897|NCT01485614|76259611|FG002|COMPLETED|Randomization||9||
60136898|NCT01485614|76259612|FG003|COMPLETED|Randomization||5||
60136899|NCT01485614|76259609|FG000|NOT COMPLETED|Randomization||1||
60136900|NCT01485614|76259610|FG001|NOT COMPLETED|Randomization||0||
60136901|NCT01485614|76259611|FG002|NOT COMPLETED|Randomization||0||
60136902|NCT01485614|76259612|FG003|NOT COMPLETED|Randomization||0||
60136903|NCT01485614|76259609|FG000|STARTED|Weeks 0-20||95||
60136904|NCT01485614|76259610|FG001|STARTED|Weeks 0-20||90||
60136905|NCT01485614|76259611|FG002|STARTED|Weeks 0-20||9||
60136906|NCT01485614|76259612|FG003|STARTED|Weeks 0-20||5||
60136907|NCT01485614|76259609|FG000|Treated|Weeks 0-20||95||
60136908|NCT01485614|76259610|FG001|Treated|Weeks 0-20||90||
60136909|NCT01485614|76259611|FG002|Treated|Weeks 0-20||9||
60136910|NCT01485614|76259612|FG003|Treated|Weeks 0-20||5||
60136911|NCT01485614|76259609|FG000|COMPLETED|Weeks 0-20||85||
60136912|NCT01485614|76259610|FG001|COMPLETED|Weeks 0-20||86||
60136913|NCT01485614|76259611|FG002|COMPLETED|Weeks 0-20||8||
60136914|NCT01485614|76259612|FG003|COMPLETED|Weeks 0-20||5||
60136915|NCT01485614|76259609|FG000|NOT COMPLETED|Weeks 0-20||10||
60136916|NCT01485614|76259610|FG001|NOT COMPLETED|Weeks 0-20||4||
60136917|NCT01485614|76259611|FG002|NOT COMPLETED|Weeks 0-20||1||
60136918|NCT01485614|76259612|FG003|NOT COMPLETED|Weeks 0-20||0||
60136919|NCT01485614|76259609|FG000|STARTED|Weeks 20-54||85||
60136920|NCT01485614|76259610|FG001|STARTED|Weeks 20-54||86||
60136921|NCT01485614|76259611|FG002|STARTED|Weeks 20-54||8||
60136922|NCT01485614|76259612|FG003|STARTED|Weeks 20-54||5||
60136923|NCT01485614|76259609|FG000|COMPLETED|Weeks 20-54||74||
60136924|NCT01485614|76259610|FG001|COMPLETED|Weeks 20-54||78||
60136925|NCT01485614|76259611|FG002|COMPLETED|Weeks 20-54||6||
60136926|NCT01485614|76259612|FG003|COMPLETED|Weeks 20-54||5||
60136927|NCT01485614|76259609|FG000|NOT COMPLETED|Weeks 20-54||11||
60136928|NCT01485614|76259610|FG001|NOT COMPLETED|Weeks 20-54||8||
60136929|NCT01485614|76259611|FG002|NOT COMPLETED|Weeks 20-54||2||
60136930|NCT01485614|76259612|FG003|NOT COMPLETED|Weeks 20-54||0||
60136931|NCT00722553|76259628|FG000|STARTED|Overall Study||30||
60136932|NCT00722553|76259628|FG000|COMPLETED|Overall Study||30||
60136933|NCT00722553|76259628|FG000|NOT COMPLETED|Overall Study||0||
60136934|NCT00735969|76259634|FG000|STARTED|Overall Study||21||
60136935|NCT00735969|76259634|FG000|COMPLETED|Overall Study||21||
60136936|NCT00735969|76259634|FG000|NOT COMPLETED|Overall Study||0||
60136937|NCT00752973|76259638|FG000|STARTED|Overall Study||12||
60136938|NCT00752973|76259638|FG000|COMPLETED|Overall Study||12||
60136939|NCT00752973|76259638|FG000|NOT COMPLETED|Overall Study||0||
60136940|NCT00736125|76259646|FG000|STARTED|Overall Study||10||
60136941|NCT00736125|76259647|FG001|STARTED|Overall Study||10||
60136942|NCT00736125|76259646|FG000|COMPLETED|Overall Study||9||
60136943|NCT00736125|76259647|FG001|COMPLETED|Overall Study||8||
60136944|NCT00736125|76259646|FG000|NOT COMPLETED|Overall Study||1||
60136945|NCT00736125|76259647|FG001|NOT COMPLETED|Overall Study||2||
60136946|NCT00753363|76259655|FG000|STARTED|Overall Study||59||
60136947|NCT00753363|76259656|FG001|STARTED|Overall Study||60||
60136948|NCT00753363|76259655|FG000|COMPLETED|Overall Study||19||
60136949|NCT00753363|76259656|FG001|COMPLETED|Overall Study||21||
60136950|NCT00753363|76259655|FG000|NOT COMPLETED|Overall Study||40||
60136951|NCT00753363|76259656|FG001|NOT COMPLETED|Overall Study||39||
60136952|NCT01485536|76259662|FG000|STARTED|Overall Study||21||
60136953|NCT01485536|76259662|FG000|COMPLETED|Overall Study||17||
60136954|NCT01485536|76259662|FG000|NOT COMPLETED|Overall Study||4||
60136955|NCT02658630|76259666|FG000|STARTED|Overall Study||46||
60136956|NCT02658630|76259666|FG000|COMPLETED|Overall Study||42||
60136957|NCT02658630|76259666|FG000|NOT COMPLETED|Overall Study||4||
60136958|NCT01484912|76259672|FG000|STARTED|Overall Study||39||
60136959|NCT01484912|76259673|FG001|STARTED|Overall Study||40||
60136960|NCT01484912|76259672|FG000|COMPLETED|Overall Study||38||
60136961|NCT01484912|76259673|FG001|COMPLETED|Overall Study||39||
60136962|NCT01484912|76259672|FG000|NOT COMPLETED|Overall Study||1||
60136963|NCT01484912|76259673|FG001|NOT COMPLETED|Overall Study||1||
60136964|NCT01520870|76259679|FG000|STARTED|Overall Study||49||
60136965|NCT01520870|76259679|FG000|COMPLETED|Overall Study||47||
60136966|NCT01520870|76259679|FG000|NOT COMPLETED|Overall Study||2||
60136967|NCT01520714|76259685|FG000|STARTED|Overall Study||0||
60136968|NCT01520714|76259686|FG001|STARTED|Overall Study||11||
60136969|NCT01520714|76259685|FG000|COMPLETED|Overall Study||0||
60136970|NCT01520714|76259686|FG001|COMPLETED|Overall Study||5||
60136971|NCT01520714|76259685|FG000|NOT COMPLETED|Overall Study||0||
60136972|NCT01520714|76259686|FG001|NOT COMPLETED|Overall Study||6||
60136973|NCT00722865|76259692|FG000|STARTED|Overall Study||25||
60136974|NCT00722865|76259692|FG000|COMPLETED|Overall Study||23||
60136975|NCT00722865|76259692|FG000|NOT COMPLETED|Overall Study||2||
60136976|NCT02700529|76259698|FG000|STARTED|Overall Study||27||
60136977|NCT02700529|76259699|FG001|STARTED|Overall Study||27||
60136978|NCT02700529|76259698|FG000|COMPLETED|Overall Study||26||
60136979|NCT02700529|76259699|FG001|COMPLETED|Overall Study||27||
60136980|NCT02700529|76259698|FG000|NOT COMPLETED|Overall Study||1||
60136981|NCT02700529|76259699|FG001|NOT COMPLETED|Overall Study||0||
60136982|NCT02659098|76259705|FG000|STARTED|Overall Study||21||
60136983|NCT02659098|76259705|FG000|COMPLETED|Overall Study||14||
60136984|NCT02659098|76259705|FG000|NOT COMPLETED|Overall Study||7||
60136985|NCT00723099|76259709|FG000|STARTED|Overall Study||73||
60136986|NCT00723099|76259709|FG000|COMPLETED|Overall Study||72||
60136987|NCT00723099|76259709|FG000|NOT COMPLETED|Overall Study||1||
60136988|NCT01508936|76259716|FG000|STARTED|Overall Study||102||
60136989|NCT01508936|76259717|FG001|STARTED|Overall Study||409||
60136990|NCT01508936|76259716|FG000|Randomized, Not Analyzed|Overall Study|Participants from two centers were omitted from all analyses.|4||
60136991|NCT01508936|76259717|FG001|Randomized, Not Analyzed|Overall Study|Participants from two centers were omitted from all analyses.|11||
60136992|NCT01508936|76259716|FG000|Randomized|Overall Study||98||
60136993|NCT01508936|76259717|FG001|Randomized|Overall Study||398||
60136994|NCT01508936|76259716|FG000|Randomized, Not Treated|Overall Study||1||
60136995|NCT01508936|76259717|FG001|Randomized, Not Treated|Overall Study||3||
60136996|NCT01508936|76259716|FG000|Safety Analysis Set|Overall Study||97||
60136997|NCT01508936|76259717|FG001|Safety Analysis Set|Overall Study||395||
60136998|NCT01508936|76259716|FG000|Full Analysis Set|Overall Study||97||
60136999|NCT01508936|76259717|FG001|Full Analysis Set|Overall Study||395||
60137000|NCT01508936|76259716|FG000|FEV1 Subpopulation Analysis Set|Overall Study||91||
60137001|NCT01508936|76259717|FG001|FEV1 Subpopulation Analysis Set|Overall Study||346||
60137002|NCT01508936|76259716|FG000|COMPLETED|Overall Study||79||
60137003|NCT01508936|76259717|FG001|COMPLETED|Overall Study||330||
60137004|NCT01508936|76259716|FG000|NOT COMPLETED|Overall Study||23||
60137005|NCT01508936|76259717|FG001|NOT COMPLETED|Overall Study||79||
60137006|NCT00723177|76259726|FG000|STARTED|Overall Study||15||
60137007|NCT00723177|76259727|FG001|STARTED|Overall Study||14||
60137008|NCT00723177|76259728|FG002|STARTED|Overall Study||15||
60137009|NCT00723177|76259726|FG000|COMPLETED|Overall Study||10||
60137010|NCT00723177|76259727|FG001|COMPLETED|Overall Study||10||
60137011|NCT00723177|76259728|FG002|COMPLETED|Overall Study||10||
60137012|NCT00723177|76259726|FG000|NOT COMPLETED|Overall Study||5||
60137013|NCT00723177|76259727|FG001|NOT COMPLETED|Overall Study||4||
60137014|NCT00723177|76259728|FG002|NOT COMPLETED|Overall Study||5||
60137015|NCT01508702|76259738|FG000|STARTED|Overall Study||107||
60137016|NCT01508702|76259739|FG001|STARTED|Overall Study||107||
60137017|NCT01508702|76259738|FG000|COMPLETED|Overall Study||84||
60137018|NCT01508702|76259739|FG001|COMPLETED|Overall Study||94||
60137019|NCT01508702|76259738|FG000|NOT COMPLETED|Overall Study||23||
60137020|NCT01508702|76259739|FG001|NOT COMPLETED|Overall Study||13||
60137021|NCT00723645|76259745|FG000|STARTED|Visit 1 (≤4 Weeks Post-treatment)||258||
60137022|NCT00723645|76259745|FG000|COMPLETED|Visit 1 (≤4 Weeks Post-treatment)||258||
60137023|NCT00723645|76259745|FG000|NOT COMPLETED|Visit 1 (≤4 Weeks Post-treatment)||0||
60137024|NCT00723645|76259745|FG000|STARTED|Visit 2 (Week 24 Post-treatment)|10 discontinued before Visit 2; 7 lost to follow-up and 3 were HCV RNA+ before Wk 24|248||
60137025|NCT00723645|76259745|FG000|COMPLETED|Visit 2 (Week 24 Post-treatment)||248||
60137026|NCT00723645|76259745|FG000|NOT COMPLETED|Visit 2 (Week 24 Post-treatment)||0||
60137027|NCT00723645|76259745|FG000|STARTED|Visit 3 (Week 72 Post-treatment)|61 discontinued before V3; 26 lost to followup, 34 HCV RNA+ at Wk 24,1 death,1 HCV RNA not available|187||
60137028|NCT00723645|76259745|FG000|COMPLETED|Visit 3 (Week 72 Post-treatment)||187||
60137029|NCT00723645|76259745|FG000|NOT COMPLETED|Visit 3 (Week 72 Post-treatment)||0||
60137030|NCT01484834|76259753|FG000|STARTED|Overall Study||65||
60137031|NCT01484834|76259754|FG001|STARTED|Overall Study||62||
60137032|NCT01484834|76259755|FG002|STARTED|Overall Study||39||
60137033|NCT01484834|76259756|FG003|STARTED|Overall Study||24||
60137034|NCT01484834|76259753|FG000|COMPLETED|Overall Study||60||
60137035|NCT01484834|76259754|FG001|COMPLETED|Overall Study||54||
60137036|NCT01484834|76259755|FG002|COMPLETED|Overall Study||38||
60137037|NCT01484834|76259756|FG003|COMPLETED|Overall Study||20||
60137038|NCT01484834|76259753|FG000|NOT COMPLETED|Overall Study||5||
60137039|NCT01484834|76259754|FG001|NOT COMPLETED|Overall Study||8||
60137040|NCT01484834|76259755|FG002|NOT COMPLETED|Overall Study||1||
60137041|NCT01484834|76259756|FG003|NOT COMPLETED|Overall Study||4||
60137042|NCT01484132|76259766|FG000|STARTED|Overall Study||113||
60137043|NCT01484132|76259766|FG000|Pre-treatment Urine Sample|Overall Study|Urine samples were collected twice pre-treatment. 101 subjects completed at least one urine sample.|101||
60137044|NCT01484132|76259766|FG000|COMPLETED|Overall Study|91 subjects had at least one pre-treatment and at least one post-treatment urine sample.|91||
60137045|NCT01484132|76259766|FG000|NOT COMPLETED|Overall Study||22||
60137046|NCT01276041|76259770|FG000|STARTED|Overall Study||70||
60137047|NCT01276041|76259770|FG000|COMPLETED|Overall Study||67||
60137048|NCT01276041|76259770|FG000|NOT COMPLETED|Overall Study||3||
60137049|NCT01275339|76259778|FG000|STARTED|Overall Study||2||
60137050|NCT01275339|76259779|FG001|STARTED|Overall Study||0||
60137051|NCT01275339|76259780|FG002|STARTED|Overall Study||4||
60137052|NCT01275339|76259781|FG003|STARTED|Overall Study||4||
60137053|NCT01275339|76259778|FG000|COMPLETED|Overall Study||1||
60137054|NCT01275339|76259779|FG001|COMPLETED|Overall Study||0||
60137055|NCT01275339|76259780|FG002|COMPLETED|Overall Study||3||
60137056|NCT01275339|76259781|FG003|COMPLETED|Overall Study||4||
60137057|NCT01275339|76259778|FG000|NOT COMPLETED|Overall Study||1||
60137058|NCT01275339|76259779|FG001|NOT COMPLETED|Overall Study||0||
60137059|NCT01275339|76259780|FG002|NOT COMPLETED|Overall Study||1||
60137060|NCT01275339|76259781|FG003|NOT COMPLETED|Overall Study||0||
60137061|NCT01520402|76259791|FG000|STARTED|Overall Study||35||
60137062|NCT01520402|76259791|FG000|COMPLETED|Overall Study||30||
60137063|NCT01520402|76259791|FG000|NOT COMPLETED|Overall Study||5||
60137064|NCT00738543|76259802|FG000|STARTED|Povidone Iodine||48||
60137065|NCT00738543|76259802|FG000|COMPLETED|Povidone Iodine||48||
60137066|NCT00738543|76259802|FG000|NOT COMPLETED|Povidone Iodine||0||
60137067|NCT00738543|76259802|FG000|STARTED|Sodium Hypochlorite||48||
60137068|NCT00738543|76259802|FG000|COMPLETED|Sodium Hypochlorite||48||
60137069|NCT00738543|76259802|FG000|NOT COMPLETED|Sodium Hypochlorite||0||
60137070|NCT00738543|76259802|FG000|STARTED|Control||48||
60137071|NCT00738543|76259802|FG000|COMPLETED|Control||48||
60137072|NCT00738543|76259802|FG000|NOT COMPLETED|Control||0||
60137073|NCT01520324|76259806|FG000|STARTED|Overall Study||53||
60137074|NCT01520324|76259806|FG000|COMPLETED|Overall Study||52||
60137075|NCT01520324|76259806|FG000|NOT COMPLETED|Overall Study||1||
60137076|NCT01519934|76259810|FG000|STARTED|Overall Study||48||
60137077|NCT01519934|76259810|FG000|COMPLETED|Overall Study||45||
60137078|NCT01519934|76259810|FG000|NOT COMPLETED|Overall Study||3||
60137079|NCT01484054|76259814|FG000|STARTED|Period 1||50||
60137080|NCT01484054|76259815|FG001|STARTED|Period 1||50||
60137081|NCT01484054|76259814|FG000|COMPLETED|Period 1||50||
60137082|NCT01484054|76259815|FG001|COMPLETED|Period 1||49||
60137083|NCT01484054|76259814|FG000|NOT COMPLETED|Period 1||0||
60137084|NCT01484054|76259815|FG001|NOT COMPLETED|Period 1||1||
60137085|NCT01484054|76259814|FG000|STARTED|Period 2||50||
60137086|NCT01484054|76259815|FG001|STARTED|Period 2||49||
60137087|NCT01484054|76259814|FG000|COMPLETED|Period 2||50||
60137088|NCT01484054|76259815|FG001|COMPLETED|Period 2||49||
60137089|NCT01484054|76259814|FG000|NOT COMPLETED|Period 2||0||
60137090|NCT01484054|76259815|FG001|NOT COMPLETED|Period 2||0||
60137091|NCT02080507|76259824|FG000|STARTED|Overall Study||5||
60137092|NCT02080507|76259825|FG001|STARTED|Overall Study||7||
60137093|NCT02080507|76259824|FG000|COMPLETED|Overall Study||5||
60137094|NCT02080507|76259825|FG001|COMPLETED|Overall Study||7||
60137095|NCT02080507|76259824|FG000|NOT COMPLETED|Overall Study||0||
60137096|NCT02080507|76259825|FG001|NOT COMPLETED|Overall Study||0||
60137097|NCT01507298|76259833|FG000|STARTED|Overall Study||1||
60137098|NCT01507298|76259834|FG001|STARTED|Overall Study||20||
60137099|NCT01507298|76259833|FG000|COMPLETED|Overall Study||1||
60137100|NCT01507298|76259834|FG001|COMPLETED|Overall Study||14||
60137101|NCT01507298|76259833|FG000|NOT COMPLETED|Overall Study||0||
60137102|NCT01507298|76259834|FG001|NOT COMPLETED|Overall Study||6||
60137103|NCT01483118|76259843|FG000|STARTED|Overall Study||23||
60137104|NCT01483118|76259844|FG001|STARTED|Overall Study||22||
60137105|NCT01483118|76259843|FG000|Completed 3 Months|Overall Study||15||
60137106|NCT01483118|76259844|FG001|Completed 3 Months|Overall Study||11||
60137107|NCT01483118|76259843|FG000|COMPLETED|Overall Study||11|(entire 6 months)|
60137108|NCT01483118|76259844|FG001|COMPLETED|Overall Study||6|(entire 6 months)|
60137109|NCT01483118|76259843|FG000|NOT COMPLETED|Overall Study||12||
60137110|NCT01483118|76259844|FG001|NOT COMPLETED|Overall Study||16||
60137111|NCT01506908|76259854|FG000|STARTED|Overall Study||162||
60137112|NCT01506908|76259855|FG001|STARTED|Overall Study||161||
60137113|NCT01506908|76259854|FG000|COMPLETED|Overall Study||161||
60137114|NCT01506908|76259855|FG001|COMPLETED|Overall Study||161||
60137115|NCT01506908|76259854|FG000|NOT COMPLETED|Overall Study||1||
60137116|NCT01506908|76259855|FG001|NOT COMPLETED|Overall Study||0||
60137117|NCT01519778|76259863|FG000|STARTED|Overall Study||200||
60137118|NCT01519778|76259863|FG000|COMPLETED|Overall Study||186||
60137119|NCT01519778|76259863|FG000|NOT COMPLETED|Overall Study||14||
60137120|NCT01519700|76259871|FG000|STARTED|Overall Study||54||
60137121|NCT01519700|76259872|FG001|STARTED|Overall Study||55||
60137122|NCT01519700|76259873|FG002|STARTED|Overall Study||55||
60137123|NCT01519700|76259874|FG003|STARTED|Overall Study||54||
60137124|NCT01519700|76259871|FG000|Treated Cycle 1 EP2006|Overall Study||53||
60137125|NCT01519700|76259872|FG001|Treated Cycle 1 EP2006|Overall Study||54||
60137126|NCT01519700|76259873|FG002|Treated Cycle 1 EP2006|Overall Study||0||
60137127|NCT01519700|76259874|FG003|Treated Cycle 1 EP2006|Overall Study||0||
60137128|NCT01519700|76259871|FG000|Treated Cycle 1 Neupogen|Overall Study||0||
60137129|NCT01519700|76259872|FG001|Treated Cycle 1 Neupogen|Overall Study||0||
60137130|NCT01519700|76259873|FG002|Treated Cycle 1 Neupogen|Overall Study||55||
60137131|NCT01519700|76259874|FG003|Treated Cycle 1 Neupogen|Overall Study||52||
60137132|NCT01519700|76259871|FG000|Treated Cycle 2 EP2006|Overall Study||52||
60137133|NCT01519700|76259872|FG001|Treated Cycle 2 EP2006|Overall Study||0||
60137134|NCT01519700|76259873|FG002|Treated Cycle 2 EP2006|Overall Study||55||
60137135|NCT01519700|76259874|FG003|Treated Cycle 2 EP2006|Overall Study||0||
60137136|NCT01519700|76259871|FG000|Treated Cycle 2 Neupogen|Overall Study||0||
60137137|NCT01519700|76259872|FG001|Treated Cycle 2 Neupogen|Overall Study||52||
60137138|NCT01519700|76259873|FG002|Treated Cycle 2 Neupogen|Overall Study||0||
60137139|NCT01519700|76259874|FG003|Treated Cycle 2 Neupogen|Overall Study||51||
60137140|NCT01519700|76259871|FG000|Treated Cycle 3 EP2006|Overall Study||51||
60137141|NCT01519700|76259872|FG001|Treated Cycle 3 EP2006|Overall Study||51||
60137142|NCT01519700|76259873|FG002|Treated Cycle 3 EP2006|Overall Study||0||
60137143|NCT01519700|76259874|FG003|Treated Cycle 3 EP2006|Overall Study||0||
60137144|NCT01519700|76259871|FG000|Treated Cycle 3 Neupogen|Overall Study||0||
60137145|NCT01519700|76259872|FG001|Treated Cycle 3 Neupogen|Overall Study||0||
60137146|NCT01519700|76259873|FG002|Treated Cycle 3 Neupogen|Overall Study||54||
60137147|NCT01519700|76259874|FG003|Treated Cycle 3 Neupogen|Overall Study||51||
60137148|NCT01519700|76259871|FG000|Treated Cycle 4 EP2006|Overall Study||51||
60137149|NCT01519700|76259872|FG001|Treated Cycle 4 EP2006|Overall Study||0||
60137150|NCT01519700|76259873|FG002|Treated Cycle 4 EP2006|Overall Study||50||
60137151|NCT01519700|76259874|FG003|Treated Cycle 4 EP2006|Overall Study||0||
60137152|NCT01519700|76259871|FG000|Treated Cycle 4 Neupogen|Overall Study||0||
60137153|NCT01519700|76259872|FG001|Treated Cycle 4 Neupogen|Overall Study||51||
60137154|NCT01519700|76259873|FG002|Treated Cycle 4 Neupogen|Overall Study||0||
60137155|NCT01519700|76259874|FG003|Treated Cycle 4 Neupogen|Overall Study||50||
60137156|NCT01519700|76259871|FG000|Treated Cycle 5 EP2006|Overall Study||46||
60137157|NCT01519700|76259872|FG001|Treated Cycle 5 EP2006|Overall Study||49||
60137158|NCT01519700|76259873|FG002|Treated Cycle 5 EP2006|Overall Study||0||
60137159|NCT01519700|76259874|FG003|Treated Cycle 5 EP2006|Overall Study||0||
60137160|NCT01519700|76259871|FG000|Treated Cycle 5 Neupogen|Overall Study||0||
60137161|NCT01519700|76259872|FG001|Treated Cycle 5 Neupogen|Overall Study||0||
60137162|NCT01519700|76259873|FG002|Treated Cycle 5 Neupogen|Overall Study||48||
60137163|NCT01519700|76259874|FG003|Treated Cycle 5 Neupogen|Overall Study||50||
60137164|NCT01519700|76259871|FG000|Treated Cycle 6 EP2006|Overall Study||45||
60137165|NCT01519700|76259872|FG001|Treated Cycle 6 EP2006|Overall Study||0||
60137166|NCT01519700|76259873|FG002|Treated Cycle 6 EP2006|Overall Study||48||
60137167|NCT01519700|76259874|FG003|Treated Cycle 6 EP2006|Overall Study||0||
60137168|NCT01519700|76259871|FG000|Treated Cycle 6 Neupogen|Overall Study||0||
60137169|NCT01519700|76259872|FG001|Treated Cycle 6 Neupogen|Overall Study||49||
60137170|NCT01519700|76259873|FG002|Treated Cycle 6 Neupogen|Overall Study||0||
60137171|NCT01519700|76259874|FG003|Treated Cycle 6 Neupogen|Overall Study||49||
60137172|NCT01519700|76259871|FG000|COMPLETED|Overall Study||45||
60137173|NCT01519700|76259872|FG001|COMPLETED|Overall Study||49||
60137174|NCT01519700|76259873|FG002|COMPLETED|Overall Study||48||
60137175|NCT01519700|76259874|FG003|COMPLETED|Overall Study||47||
60137176|NCT01519700|76259871|FG000|NOT COMPLETED|Overall Study||9||
60137177|NCT01519700|76259872|FG001|NOT COMPLETED|Overall Study||6||
60137178|NCT01519700|76259873|FG002|NOT COMPLETED|Overall Study||7||
60137179|NCT01519700|76259874|FG003|NOT COMPLETED|Overall Study||7||
60137180|NCT02656680|76259892|FG000|STARTED|Overall Study||40||
60137181|NCT02656680|76259893|FG001|STARTED|Overall Study||40||
60137182|NCT02656680|76259892|FG000|COMPLETED|Overall Study||40||
60137183|NCT02656680|76259893|FG001|COMPLETED|Overall Study||39||
60137184|NCT02656680|76259892|FG000|NOT COMPLETED|Overall Study||0||
60137185|NCT02656680|76259893|FG001|NOT COMPLETED|Overall Study||1||
60137186|NCT02080819|76259904|FG000|STARTED|Overall Study||63||
60137187|NCT02080819|76259905|FG001|STARTED|Overall Study||35||
60137188|NCT02080819|76259906|FG002|STARTED|Overall Study||33||
60137189|NCT02080819|76259904|FG000|COMPLETED|Overall Study||38||
60137190|NCT02080819|76259905|FG001|COMPLETED|Overall Study||9||
60137191|NCT02080819|76259906|FG002|COMPLETED|Overall Study||11||
60137192|NCT02080819|76259904|FG000|NOT COMPLETED|Overall Study||25||
60137193|NCT02080819|76259905|FG001|NOT COMPLETED|Overall Study||26||
60137194|NCT02080819|76259906|FG002|NOT COMPLETED|Overall Study||22||
60137195|NCT03476317|76259917|FG000|STARTED|Overall Study|Group 1 study was not completed|0||
60137196|NCT03476317|76259918|FG001|STARTED|Overall Study|Group 1 study was not completed|0||
60137197|NCT03476317|76259919|FG002|STARTED|Overall Study||10||
60137198|NCT03476317|76259917|FG000|COMPLETED|Overall Study|Group 1 study was not completed|0||
60137199|NCT03476317|76259918|FG001|COMPLETED|Overall Study|Group 1 study was not completed|0||
60137200|NCT03476317|76259919|FG002|COMPLETED|Overall Study||10||
60137201|NCT03476317|76259917|FG000|NOT COMPLETED|Overall Study||0||
60137202|NCT03476317|76259918|FG001|NOT COMPLETED|Overall Study||0||
60137203|NCT03476317|76259919|FG002|NOT COMPLETED|Overall Study||0||
60137204|NCT02658084|76259929|FG000|STARTED|Overall Study||2||
60137205|NCT02658084|76259930|FG001|STARTED|Overall Study||0||
60137206|NCT02658084|76259929|FG000|COMPLETED|Overall Study||0||
60137207|NCT02658084|76259930|FG001|COMPLETED|Overall Study||0||
60137208|NCT02658084|76259929|FG000|NOT COMPLETED|Overall Study||2||
60137209|NCT02658084|76259930|FG001|NOT COMPLETED|Overall Study||0||
59881551|NCT04292535|76004423|FG011|COMPLETED|Overall Study||6||
59881552|NCT04292535|76004424|FG012|COMPLETED|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL (n = 1)|8||
59881553|NCT04292535|76004425|FG013|COMPLETED|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL (n = 1) Condition stopped due to Report of Dizziness (n = 1)|7||
59881554|NCT04292535|76004412|FG000|NOT COMPLETED|Overall Study||0||
60137210|NCT03912805|76259937|FG000|STARTED|Overall Study||19||
60137211|NCT03912805|76259938|FG001|STARTED|Overall Study||19||
60137212|NCT03912805|76259937|FG000|COMPLETED|Overall Study||19||
60137213|NCT03912805|76259938|FG001|COMPLETED|Overall Study||19||
60137214|NCT03912805|76259937|FG000|NOT COMPLETED|Overall Study||0||
60137215|NCT03912805|76259938|FG001|NOT COMPLETED|Overall Study||0||
60137216|NCT01482962|76259946|FG000|STARTED|Overall Study||138||
60137217|NCT01482962|76259947|FG001|STARTED|Overall Study||133||
60137218|NCT01482962|76259946|FG000|Safety Population: Received Study Drug|Overall Study||137||
60137219|NCT01482962|76259947|FG001|Safety Population: Received Study Drug|Overall Study||127||
60137220|NCT01482962|76259946|FG000|COMPLETED|Overall Study||0||
60137221|NCT01482962|76259947|FG001|COMPLETED|Overall Study||0||
60137222|NCT01482962|76259946|FG000|NOT COMPLETED|Overall Study||138||
60137223|NCT01482962|76259947|FG001|NOT COMPLETED|Overall Study||133||
60137224|NCT02655666|76259955|FG000|STARTED|Overall Study||16||
60137225|NCT02655666|76259955|FG000|COMPLETED|Overall Study||4||
60137226|NCT02655666|76259955|FG000|NOT COMPLETED|Overall Study||12||
59519078|NCT01093651|75612959|FG000|STARTED|Overall Study||10||
59881555|NCT04292535|76004413|FG001|NOT COMPLETED|Overall Study||0||
60137227|NCT01506596|76259959|FG000|STARTED|Overall Study||42||
60137228|NCT01506596|76259959|FG000|COMPLETED|Overall Study|One enrolled patient had ineligible pathology after starting treatment; was removed from treatment.|41||
60137229|NCT01506596|76259959|FG000|NOT COMPLETED|Overall Study||1||
60137230|NCT03895801|76259966|FG000|STARTED|Overall Study||18||
60137231|NCT03895801|76259967|FG001|STARTED|Overall Study||24||
60137232|NCT03895801|76259968|FG002|STARTED|Overall Study||15||
60137233|NCT03895801|76259966|FG000|COMPLETED|Overall Study||16||
60137234|NCT03895801|76259967|FG001|COMPLETED|Overall Study||22||
60137235|NCT03895801|76259968|FG002|COMPLETED|Overall Study||13||
60137236|NCT03895801|76259966|FG000|NOT COMPLETED|Overall Study||2||
60137237|NCT03895801|76259967|FG001|NOT COMPLETED|Overall Study||2||
60137238|NCT03895801|76259968|FG002|NOT COMPLETED|Overall Study||2||
60137239|NCT01482884|76259978|FG000|STARTED|Overall Study|One participant did not receive study treatment|56||
60137240|NCT01482884|76259979|FG001|STARTED|Overall Study||55||
60137241|NCT01482884|76259978|FG000|COMPLETED|Overall Study||43||
60137242|NCT01482884|76259979|FG001|COMPLETED|Overall Study||37||
60137243|NCT01482884|76259978|FG000|NOT COMPLETED|Overall Study||13||
60137244|NCT01482884|76259979|FG001|NOT COMPLETED|Overall Study||18||
60137245|NCT01518374|76259985|FG000|STARTED|Overall Study||1768||
60137246|NCT01518374|76259985|FG000|COMPLETED|Overall Study||1761||
60137247|NCT01518374|76259985|FG000|NOT COMPLETED|Overall Study||7||
60137248|NCT01481324|76259992|FG000|STARTED|Overall Study||21||
60137249|NCT01481324|76259993|FG001|STARTED|Overall Study||24||
60137250|NCT01481324|76259994|FG002|STARTED|Overall Study||22||
60137251|NCT01481324|76259992|FG000|Month 1-Wear Rate Data|Overall Study||15||
60137252|NCT01481324|76259993|FG001|Month 1-Wear Rate Data|Overall Study||16||
60137253|NCT01481324|76259994|FG002|Month 1-Wear Rate Data|Overall Study||8||
60137254|NCT01481324|76259992|FG000|Month 2-Wear Rate Data|Overall Study||9||
60137255|NCT01481324|76259993|FG001|Month 2-Wear Rate Data|Overall Study||13||
60137256|NCT01481324|76259994|FG002|Month 2-Wear Rate Data|Overall Study||7||
60137257|NCT01481324|76259992|FG000|Month 3-Wear Rate Data|Overall Study||7||
60137258|NCT01481324|76259993|FG001|Month 3-Wear Rate Data|Overall Study||11||
60137259|NCT01481324|76259994|FG002|Month 3-Wear Rate Data|Overall Study||6||
60137260|NCT01481324|76259992|FG000|COMPLETED|Overall Study||21||
60137261|NCT01481324|76259993|FG001|COMPLETED|Overall Study||22||
60137262|NCT01481324|76259994|FG002|COMPLETED|Overall Study||20||
60137263|NCT01481324|76259992|FG000|NOT COMPLETED|Overall Study||0||
60137264|NCT01481324|76259993|FG001|NOT COMPLETED|Overall Study||2||
60137265|NCT01481324|76259994|FG002|NOT COMPLETED|Overall Study||2||
60137266|NCT04591626|76260004|FG000|STARTED|Overall Study||144||
60137267|NCT04591626|76260005|FG001|STARTED|Overall Study||147||
60137268|NCT04591626|76260004|FG000|Received At Least One Dose of Study Drug|Overall Study||144||
60137269|NCT04591626|76260005|FG001|Received At Least One Dose of Study Drug|Overall Study||147||
60137270|NCT04591626|76260004|FG000|COMPLETED|Overall Study||134||
60137271|NCT04591626|76260005|FG001|COMPLETED|Overall Study||142||
60137272|NCT04591626|76260004|FG000|NOT COMPLETED|Overall Study||10||
60137273|NCT04591626|76260005|FG001|NOT COMPLETED|Overall Study||5||
60137274|NCT03583333|76260013|FG000|STARTED|Overall Study||138||
60137275|NCT03583333|76260014|FG001|STARTED|Overall Study||136||
60137276|NCT03583333|76260013|FG000|Treated|Overall Study||134||
60137277|NCT03583333|76260014|FG001|Treated|Overall Study||136||
60137278|NCT03583333|76260013|FG000|COMPLETED|Overall Study||90||
60137279|NCT03583333|76260014|FG001|COMPLETED|Overall Study||106||
60137280|NCT03583333|76260013|FG000|NOT COMPLETED|Overall Study||48||
60137281|NCT03583333|76260014|FG001|NOT COMPLETED|Overall Study||30||
60137282|NCT01602510|76260020|FG000|STARTED|Open Label Phase||420||
60137283|NCT01602510|76260021|FG001|STARTED|Open Label Phase||0||
60137284|NCT01602510|76260022|FG002|STARTED|Open Label Phase||0||
60137285|NCT01602510|76260020|FG000|COMPLETED|Open Label Phase||117||
60137286|NCT01602510|76260021|FG001|COMPLETED|Open Label Phase||0||
60137287|NCT01602510|76260022|FG002|COMPLETED|Open Label Phase||0||
60137288|NCT01602510|76260020|FG000|NOT COMPLETED|Open Label Phase||303||
60137289|NCT01602510|76260021|FG001|NOT COMPLETED|Open Label Phase||0||
60137290|NCT01602510|76260022|FG002|NOT COMPLETED|Open Label Phase||0||
60137291|NCT01602510|76260020|FG000|STARTED|Randomized Phase||0||
60137292|NCT01602510|76260021|FG001|STARTED|Randomized Phase||133||
60137293|NCT01602510|76260022|FG002|STARTED|Randomized Phase||131||
60137294|NCT01602510|76260020|FG000|COMPLETED|Randomized Phase||0||
60137295|NCT01602510|76260021|FG001|COMPLETED|Randomized Phase||59||
60137296|NCT01602510|76260022|FG002|COMPLETED|Randomized Phase||58||
60137297|NCT01602510|76260020|FG000|NOT COMPLETED|Randomized Phase||0||
60137298|NCT01602510|76260021|FG001|NOT COMPLETED|Randomized Phase||74||
60137299|NCT01602510|76260022|FG002|NOT COMPLETED|Randomized Phase||73||
60137300|NCT03887533|76260030|FG000|STARTED|Overall Study||1||
60137301|NCT03887533|76260031|FG001|STARTED|Overall Study||1||
60137302|NCT03887533|76260030|FG000|COMPLETED|Overall Study||1||
60137303|NCT03887533|76260031|FG001|COMPLETED|Overall Study||1||
60137304|NCT03887533|76260030|FG000|NOT COMPLETED|Overall Study||0||
60137305|NCT03887533|76260031|FG001|NOT COMPLETED|Overall Study||0||
60137306|NCT01675596|76260037|FG000|STARTED|Overall Study|One patient did not receive the study device.|199||
60137307|NCT01675596|76260037|FG000|COMPLETED|Overall Study||191|30 day follow-up|
60137308|NCT01675596|76260037|FG000|NOT COMPLETED|Overall Study||8||
60137309|NCT03029611|76260041|FG000|STARTED|Overall Study|We had 11 patients sign consent with 2 patients deciding not to continue to receive treatment.|9||
60137310|NCT03029611|76260041|FG000|COMPLETED|Overall Study|Please note that we did not fully enroll this study due to lack of funding. The complete date here relates to the last treatment administration.|9||
60137311|NCT03029611|76260041|FG000|NOT COMPLETED|Overall Study||0||
60137312|NCT02653326|76260047|FG000|STARTED|Overall Study||32||
60137313|NCT02653326|76260048|FG001|STARTED|Overall Study||34||
60137314|NCT02653326|76260047|FG000|COMPLETED|Overall Study||22||
60137315|NCT02653326|76260048|FG001|COMPLETED|Overall Study||27||
60137316|NCT02653326|76260047|FG000|NOT COMPLETED|Overall Study||10||
60137317|NCT02653326|76260048|FG001|NOT COMPLETED|Overall Study||7||
60137318|NCT02653170|76260057|FG000|STARTED|Overall Study||87|Numbers are reported for patient participants only.|
60137319|NCT02653170|76260058|FG001|STARTED|Overall Study||88|Numbers are reported for patient participants only.|
60137320|NCT02653170|76260059|FG002|STARTED|Overall Study||90|Numbers are reported for patient participants only.|
60137321|NCT02653170|76260057|FG000|COMPLETED|Overall Study||70||
60137322|NCT02653170|76260058|FG001|COMPLETED|Overall Study||72||
60137323|NCT02653170|76260059|FG002|COMPLETED|Overall Study||72||
60137324|NCT02653170|76260057|FG000|NOT COMPLETED|Overall Study||17||
60137325|NCT02653170|76260058|FG001|NOT COMPLETED|Overall Study||16||
60137326|NCT02653170|76260059|FG002|NOT COMPLETED|Overall Study||18||
60137327|NCT03076164|76260067|FG000|STARTED|Overall Study||24||
60137328|NCT03076164|76260067|FG000|COMPLETED|Overall Study||24||
60137329|NCT03076164|76260067|FG000|NOT COMPLETED|Overall Study||0||
60137330|NCT01463696|76260079|FG000|STARTED|Overall Study||1||
60137331|NCT01463696|76260080|FG001|STARTED|Overall Study||6||
60137332|NCT01463696|76260081|FG002|STARTED|Overall Study||3||
60137333|NCT01463696|76260082|FG003|STARTED|Overall Study||7||
60137334|NCT01463696|76260083|FG004|STARTED|Overall Study||3||
60137335|NCT01463696|76260084|FG005|STARTED|Overall Study||6||
60137336|NCT01463696|76260085|FG006|STARTED|Overall Study||16||
60137337|NCT01463696|76260086|FG007|STARTED|Overall Study||6||
60137338|NCT01463696|76260079|FG000|Treated|Overall Study||1||
60137339|NCT01463696|76260080|FG001|Treated|Overall Study||6||
60137340|NCT01463696|76260081|FG002|Treated|Overall Study||3||
60137341|NCT01463696|76260082|FG003|Treated|Overall Study||7||
60137342|NCT01463696|76260083|FG004|Treated|Overall Study||3||
60137343|NCT01463696|76260084|FG005|Treated|Overall Study||6||
60137344|NCT01463696|76260085|FG006|Treated|Overall Study||15||
60137345|NCT01463696|76260086|FG007|Treated|Overall Study||6||
60137346|NCT01463696|76260079|FG000|COMPLETED|Overall Study||1||
60137347|NCT01463696|76260080|FG001|COMPLETED|Overall Study||4||
60137348|NCT01463696|76260081|FG002|COMPLETED|Overall Study||2||
60137349|NCT01463696|76260082|FG003|COMPLETED|Overall Study||3||
60137350|NCT01463696|76260083|FG004|COMPLETED|Overall Study||2||
60137351|NCT01463696|76260084|FG005|COMPLETED|Overall Study||3||
60137352|NCT01463696|76260085|FG006|COMPLETED|Overall Study||6||
60137353|NCT01463696|76260086|FG007|COMPLETED|Overall Study||2||
60137354|NCT01463696|76260079|FG000|NOT COMPLETED|Overall Study||0||
60137355|NCT01463696|76260080|FG001|NOT COMPLETED|Overall Study||2||
60137356|NCT01463696|76260081|FG002|NOT COMPLETED|Overall Study||1||
60137357|NCT01463696|76260082|FG003|NOT COMPLETED|Overall Study||4||
60137358|NCT01463696|76260083|FG004|NOT COMPLETED|Overall Study||1||
60137359|NCT01463696|76260084|FG005|NOT COMPLETED|Overall Study||3||
60137360|NCT01463696|76260085|FG006|NOT COMPLETED|Overall Study||10||
60137361|NCT01463696|76260086|FG007|NOT COMPLETED|Overall Study||4||
60137362|NCT04080908|76260104|FG000|STARTED|Overall Study||1||
60137363|NCT04080908|76260104|FG000|COMPLETED|Overall Study||1||
60137364|NCT04080908|76260104|FG000|NOT COMPLETED|Overall Study||0||
60137365|NCT02653482|76260110|FG000|STARTED|Overall Study||131||
60137366|NCT02653482|76260111|FG001|STARTED|Overall Study||132||
60137367|NCT02653482|76260110|FG000|COMPLETED|Overall Study||130||
60137368|NCT02653482|76260111|FG001|COMPLETED|Overall Study||131||
60137369|NCT02653482|76260110|FG000|NOT COMPLETED|Overall Study||1||
60137370|NCT02653482|76260111|FG001|NOT COMPLETED|Overall Study||1||
60137371|NCT01362348|76260117|FG000|STARTED|Overall Study||19||
60137372|NCT01362348|76260117|FG000|COMPLETED|Overall Study||5||
60137373|NCT01362348|76260117|FG000|NOT COMPLETED|Overall Study||14||
60137374|NCT00698022|76260124|FG000|STARTED|Overall Study||30||
60137375|NCT00698022|76260125|FG001|STARTED|Overall Study||30||
60137376|NCT00698022|76260126|FG002|STARTED|Overall Study||16||
60137377|NCT00698022|76260124|FG000|COMPLETED|Overall Study||14||
60137378|NCT00698022|76260125|FG001|COMPLETED|Overall Study||20||
60137379|NCT00698022|76260126|FG002|COMPLETED|Overall Study||14||
60137380|NCT00698022|76260124|FG000|NOT COMPLETED|Overall Study||16||
60137381|NCT00698022|76260125|FG001|NOT COMPLETED|Overall Study||10||
60137382|NCT00698022|76260126|FG002|NOT COMPLETED|Overall Study||2||
60137383|NCT02570503|76260136|FG000|STARTED|Overall Study||34||
60137384|NCT02570503|76260137|FG001|STARTED|Overall Study||30||
60137385|NCT02570503|76260136|FG000|COMPLETED|Overall Study||34||
60137386|NCT02570503|76260137|FG001|COMPLETED|Overall Study||30||
60137387|NCT02570503|76260136|FG000|NOT COMPLETED|Overall Study||0||
60137388|NCT02570503|76260137|FG001|NOT COMPLETED|Overall Study||0||
60137389|NCT00617994|76260148|FG000|STARTED|Overall Study||5||
60137390|NCT00617994|76260149|FG001|STARTED|Overall Study||5||
60137391|NCT00617994|76260150|FG002|STARTED|Overall Study||5||
60137392|NCT00617994|76260151|FG003|STARTED|Overall Study||5||
60137393|NCT00617994|76260152|FG004|STARTED|Overall Study||5||
60137394|NCT00617994|76260148|FG000|COMPLETED|Overall Study||5||
60137395|NCT00617994|76260149|FG001|COMPLETED|Overall Study||5||
60137396|NCT00617994|76260150|FG002|COMPLETED|Overall Study||5||
60137397|NCT00617994|76260151|FG003|COMPLETED|Overall Study||5||
60137398|NCT00617994|76260152|FG004|COMPLETED|Overall Study||5||
60137399|NCT00617994|76260148|FG000|NOT COMPLETED|Overall Study||0||
60137400|NCT00617994|76260149|FG001|NOT COMPLETED|Overall Study||0||
60137401|NCT00617994|76260150|FG002|NOT COMPLETED|Overall Study||0||
60137402|NCT00617994|76260151|FG003|NOT COMPLETED|Overall Study||0||
60137403|NCT00617994|76260152|FG004|NOT COMPLETED|Overall Study||0||
60137404|NCT03463525|76260180|FG000|STARTED|Overall Study||4||
60137405|NCT03463525|76260180|FG000|COMPLETED|Overall Study||4||
60137406|NCT03463525|76260180|FG000|NOT COMPLETED|Overall Study||0||
60137407|NCT01675128|76260187|FG000|STARTED|Overall Study||4||
60137408|NCT01675128|76260188|FG001|STARTED|Overall Study||10||
60137409|NCT01675128|76260189|FG002|STARTED|Overall Study||10||
60137410|NCT01675128|76260187|FG000|COMPLETED|Overall Study||2||
60137411|NCT01675128|76260188|FG001|COMPLETED|Overall Study||8||
60137412|NCT01675128|76260189|FG002|COMPLETED|Overall Study||9||
60137413|NCT01675128|76260187|FG000|NOT COMPLETED|Overall Study||2||
60137414|NCT01675128|76260188|FG001|NOT COMPLETED|Overall Study||2||
60137415|NCT01675128|76260189|FG002|NOT COMPLETED|Overall Study||1||
60137416|NCT04511208|76260204|FG000|STARTED|First Surgery||8||
60137417|NCT04511208|76260205|FG001|STARTED|First Surgery||7||
60137418|NCT04511208|76260206|FG002|STARTED|First Surgery||8||
60137419|NCT04511208|76260207|FG003|STARTED|First Surgery||7||
60137420|NCT04511208|76260204|FG000|COMPLETED|First Surgery||8||
60137421|NCT04511208|76260205|FG001|COMPLETED|First Surgery||7||
60137422|NCT04511208|76260206|FG002|COMPLETED|First Surgery||8||
60137423|NCT04511208|76260207|FG003|COMPLETED|First Surgery||7||
60137424|NCT04511208|76260204|FG000|NOT COMPLETED|First Surgery||0||
60137425|NCT04511208|76260205|FG001|NOT COMPLETED|First Surgery||0||
60137426|NCT04511208|76260206|FG002|NOT COMPLETED|First Surgery||0||
60137427|NCT04511208|76260207|FG003|NOT COMPLETED|First Surgery||0||
60137428|NCT04511208|76260204|FG000|STARTED|Second Surgery||8||
60137429|NCT04511208|76260205|FG001|STARTED|Second Surgery||7||
60137430|NCT04511208|76260206|FG002|STARTED|Second Surgery||8||
60137431|NCT04511208|76260207|FG003|STARTED|Second Surgery||7||
60137432|NCT04511208|76260204|FG000|COMPLETED|Second Surgery||8||
60137433|NCT04511208|76260205|FG001|COMPLETED|Second Surgery||7||
60137434|NCT04511208|76260206|FG002|COMPLETED|Second Surgery||8||
60137435|NCT04511208|76260207|FG003|COMPLETED|Second Surgery||7||
60137436|NCT04511208|76260204|FG000|NOT COMPLETED|Second Surgery||0||
60137437|NCT04511208|76260205|FG001|NOT COMPLETED|Second Surgery||0||
60137438|NCT04511208|76260206|FG002|NOT COMPLETED|Second Surgery||0||
60137439|NCT04511208|76260207|FG003|NOT COMPLETED|Second Surgery||0||
60137440|NCT04511208|76260204|FG000|STARTED|Third Surgery||8||
60137441|NCT04511208|76260205|FG001|STARTED|Third Surgery||7||
60137442|NCT04511208|76260206|FG002|STARTED|Third Surgery||8||
60137443|NCT04511208|76260207|FG003|STARTED|Third Surgery||7||
60137444|NCT04511208|76260204|FG000|COMPLETED|Third Surgery||8||
60137445|NCT04511208|76260205|FG001|COMPLETED|Third Surgery||7||
60137446|NCT04511208|76260206|FG002|COMPLETED|Third Surgery||8||
60137447|NCT04511208|76260207|FG003|COMPLETED|Third Surgery||7||
60137448|NCT04511208|76260204|FG000|NOT COMPLETED|Third Surgery||0||
60137449|NCT04511208|76260205|FG001|NOT COMPLETED|Third Surgery||0||
60137450|NCT04511208|76260206|FG002|NOT COMPLETED|Third Surgery||0||
60137451|NCT04511208|76260207|FG003|NOT COMPLETED|Third Surgery||0||
60137452|NCT04511208|76260204|FG000|STARTED|Forth Surgery||8||
60137453|NCT04511208|76260205|FG001|STARTED|Forth Surgery||7||
60137454|NCT04511208|76260206|FG002|STARTED|Forth Surgery||8||
60137455|NCT04511208|76260207|FG003|STARTED|Forth Surgery||7||
60137456|NCT04511208|76260204|FG000|COMPLETED|Forth Surgery||8||
60137457|NCT04511208|76260205|FG001|COMPLETED|Forth Surgery||7||
60137458|NCT04511208|76260206|FG002|COMPLETED|Forth Surgery||8||
60137459|NCT04511208|76260207|FG003|COMPLETED|Forth Surgery||7||
60137460|NCT04511208|76260204|FG000|NOT COMPLETED|Forth Surgery||0||
60137461|NCT04511208|76260205|FG001|NOT COMPLETED|Forth Surgery||0||
60137462|NCT04511208|76260206|FG002|NOT COMPLETED|Forth Surgery||0||
60137463|NCT04511208|76260207|FG003|NOT COMPLETED|Forth Surgery||0||
60137464|NCT02081365|76260215|FG000|STARTED|Overall Study||74||
60137465|NCT02081365|76260216|FG001|STARTED|Overall Study||77||
60137466|NCT02081365|76260215|FG000|Received Allocated Intervention|Overall Study||46||
60137467|NCT02081365|76260216|FG001|Received Allocated Intervention|Overall Study||59||
60137468|NCT02081365|76260215|FG000|COMPLETED|Overall Study||44||
60137469|NCT02081365|76260216|FG001|COMPLETED|Overall Study||54||
60137470|NCT02081365|76260215|FG000|NOT COMPLETED|Overall Study||30||
60137471|NCT02081365|76260216|FG001|NOT COMPLETED|Overall Study||23||
60137472|NCT02081443|76260224|FG000|STARTED|Overall Study||30||
60137473|NCT02081443|76260225|FG001|STARTED|Overall Study||30||
60137474|NCT02081443|76260224|FG000|COMPLETED|Overall Study||30||
60137475|NCT02081443|76260225|FG001|COMPLETED|Overall Study||30||
60137476|NCT02081443|76260224|FG000|NOT COMPLETED|Overall Study||0||
60137477|NCT02081443|76260225|FG001|NOT COMPLETED|Overall Study||0||
60137478|NCT01427309|76260235|FG000|STARTED|Overall Study||7253||
60137479|NCT01427309|76260236|FG001|STARTED|Overall Study||7244||
60137480|NCT01427309|76260237|FG002|STARTED|Overall Study||8737||
60137481|NCT01427309|76260238|FG003|STARTED|Overall Study||8749||
60137482|NCT01427309|76260235|FG000|COMPLETED|Overall Study||6881||
60137483|NCT01427309|76260236|FG001|COMPLETED|Overall Study||6837||
60137484|NCT01427309|76260237|FG002|COMPLETED|Overall Study||8376||
60137485|NCT01427309|76260238|FG003|COMPLETED|Overall Study||8373||
60137486|NCT01427309|76260235|FG000|NOT COMPLETED|Overall Study||372||
60137487|NCT01427309|76260236|FG001|NOT COMPLETED|Overall Study||407||
60137488|NCT01427309|76260237|FG002|NOT COMPLETED|Overall Study||361||
60137489|NCT01427309|76260238|FG003|NOT COMPLETED|Overall Study||376||
60137490|NCT01426373|76260248|FG000|STARTED|Overall Study||165||
60137491|NCT01426373|76260248|FG000|COMPLETED|Overall Study|Completed the last follow-up visit 12 months after last treatment|131||
60137492|NCT01426373|76260248|FG000|NOT COMPLETED|Overall Study||34||
60137493|NCT01426217|76260256|FG000|STARTED|Overall Study||314||
60137494|NCT01426217|76260257|FG001|STARTED|Overall Study||280||
60137495|NCT01426217|76260256|FG000|COMPLETED|Overall Study||306||
60137496|NCT01426217|76260257|FG001|COMPLETED|Overall Study||266||
60137497|NCT01426217|76260256|FG000|NOT COMPLETED|Overall Study||8||
60137498|NCT01426217|76260257|FG001|NOT COMPLETED|Overall Study||14||
60137499|NCT01425749|76260265|FG000|STARTED|Overall Study||13||
60137500|NCT01425749|76260266|FG001|STARTED|Overall Study||12||
60137501|NCT01425749|76260265|FG000|COMPLETED|Overall Study||13||
60137502|NCT01425749|76260266|FG001|COMPLETED|Overall Study||11||
60137503|NCT01425749|76260265|FG000|NOT COMPLETED|Overall Study||0||
60137504|NCT01425749|76260266|FG001|NOT COMPLETED|Overall Study||1||
60137505|NCT03852901|76260275|FG000|STARTED|Overall Study||21||
60137506|NCT03852901|76260275|FG000|COMPLETED|Overall Study||20||
60137507|NCT03852901|76260275|FG000|NOT COMPLETED|Overall Study||1||
60137508|NCT01403987|76260282|FG000|STARTED|Overall Study||34||
60137509|NCT01403987|76260283|FG001|STARTED|Overall Study||34||
60137510|NCT01403987|76260284|FG002|STARTED|Overall Study||68||
60137511|NCT01403987|76260282|FG000|COMPLETED|Overall Study||16||
60137512|NCT01403987|76260283|FG001|COMPLETED|Overall Study||17||
60137513|NCT01403987|76260284|FG002|COMPLETED|Overall Study||50||
60137514|NCT01403987|76260282|FG000|NOT COMPLETED|Overall Study||18||
60137515|NCT01403987|76260283|FG001|NOT COMPLETED|Overall Study||17||
60137516|NCT01403987|76260284|FG002|NOT COMPLETED|Overall Study||18||
60137517|NCT01425359|76260294|FG000|STARTED|Overall Study||476||
60137518|NCT01425359|76260295|FG001|STARTED|Overall Study||473||
60137519|NCT01425359|76260294|FG000|COMPLETED|Overall Study||457||
60137520|NCT01425359|76260295|FG001|COMPLETED|Overall Study||451||
60137521|NCT01425359|76260294|FG000|NOT COMPLETED|Overall Study||19||
60137522|NCT01425359|76260295|FG001|NOT COMPLETED|Overall Study||22||
60137523|NCT02082145|76260304|FG000|STARTED|Overall Study||5||
60137524|NCT02082145|76260305|FG001|STARTED|Overall Study||9||
60137525|NCT02082145|76260304|FG000|COMPLETED|Overall Study||5||
60137526|NCT02082145|76260305|FG001|COMPLETED|Overall Study||9||
60137527|NCT02082145|76260304|FG000|NOT COMPLETED|Overall Study||0||
60137528|NCT02082145|76260305|FG001|NOT COMPLETED|Overall Study||0||
60137529|NCT01403051|76260315|FG000|STARTED|Overall Study||81||
60137530|NCT01403051|76260316|FG001|STARTED|Overall Study||86||
60137531|NCT01403051|76260315|FG000|Initiated Study Treatment|Overall Study||81||
60137532|NCT01403051|76260316|FG001|Initiated Study Treatment|Overall Study||86||
60137533|NCT01403051|76260315|FG000|COMPLETED|Overall Study||71||
60137534|NCT01403051|76260316|FG001|COMPLETED|Overall Study||80||
60137535|NCT01403051|76260315|FG000|NOT COMPLETED|Overall Study||10||
60137536|NCT01403051|76260316|FG001|NOT COMPLETED|Overall Study||6||
60137537|NCT03873337|76260323|FG000|STARTED|Overall Study||34||
60137538|NCT03873337|76260323|FG000|COMPLETED|Overall Study||22||
60137539|NCT03873337|76260323|FG000|NOT COMPLETED|Overall Study||12||
60137540|NCT04115748|76260331|FG000|STARTED|Main Study (Up to 16 Weeks)||19||
60137541|NCT04115748|76260332|FG001|STARTED|Main Study (Up to 16 Weeks)||19||
60137542|NCT04115748|76260333|FG002|STARTED|Main Study (Up to 16 Weeks)||9||
60137543|NCT04115748|76260334|FG003|STARTED|Main Study (Up to 16 Weeks)||20||
60137544|NCT04115748|76260335|FG004|STARTED|Main Study (Up to 16 Weeks)||0||
60137545|NCT04115748|76260336|FG005|STARTED|Main Study (Up to 16 Weeks)||0||
60137546|NCT04115748|76260337|FG006|STARTED|Main Study (Up to 16 Weeks)||0||
60137547|NCT04115748|76260338|FG007|STARTED|Main Study (Up to 16 Weeks)||0||
60137548|NCT04115748|76260339|FG008|STARTED|Main Study (Up to 16 Weeks)||0||
60137549|NCT04115748|76260340|FG009|STARTED|Main Study (Up to 16 Weeks)||0||
60137550|NCT04115748|76260331|FG000|COMPLETED|Main Study (Up to 16 Weeks)||4||
60137551|NCT04115748|76260332|FG001|COMPLETED|Main Study (Up to 16 Weeks)||3||
60137552|NCT04115748|76260333|FG002|COMPLETED|Main Study (Up to 16 Weeks)||2||
60137553|NCT04115748|76260334|FG003|COMPLETED|Main Study (Up to 16 Weeks)||4||
60137554|NCT04115748|76260335|FG004|COMPLETED|Main Study (Up to 16 Weeks)||0||
60137555|NCT04115748|76260336|FG005|COMPLETED|Main Study (Up to 16 Weeks)||0||
60137556|NCT04115748|76260337|FG006|COMPLETED|Main Study (Up to 16 Weeks)||0||
60137557|NCT04115748|76260338|FG007|COMPLETED|Main Study (Up to 16 Weeks)||0||
60137558|NCT04115748|76260339|FG008|COMPLETED|Main Study (Up to 16 Weeks)||0||
60137559|NCT04115748|76260340|FG009|COMPLETED|Main Study (Up to 16 Weeks)||0||
60137560|NCT04115748|76260331|FG000|NOT COMPLETED|Main Study (Up to 16 Weeks)||15||
60137561|NCT04115748|76260332|FG001|NOT COMPLETED|Main Study (Up to 16 Weeks)||16||
60137562|NCT04115748|76260333|FG002|NOT COMPLETED|Main Study (Up to 16 Weeks)||7||
60137563|NCT04115748|76260334|FG003|NOT COMPLETED|Main Study (Up to 16 Weeks)||16||
60137564|NCT04115748|76260335|FG004|NOT COMPLETED|Main Study (Up to 16 Weeks)||0||
60137565|NCT04115748|76260336|FG005|NOT COMPLETED|Main Study (Up to 16 Weeks)||0||
60137566|NCT04115748|76260337|FG006|NOT COMPLETED|Main Study (Up to 16 Weeks)||0||
60137567|NCT04115748|76260338|FG007|NOT COMPLETED|Main Study (Up to 16 Weeks)||0||
60137568|NCT04115748|76260339|FG008|NOT COMPLETED|Main Study (Up to 16 Weeks)||0||
60137569|NCT04115748|76260340|FG009|NOT COMPLETED|Main Study (Up to 16 Weeks)||0||
60137570|NCT04115748|76260331|FG000|STARTED|LTE (After 16 Weeks to Week 50)|Participants who completed main study received filgotinib 200 mg.|0||
60137571|NCT04115748|76260332|FG001|STARTED|LTE (After 16 Weeks to Week 50)|Participants who completed main study received filgotinib 100 mg.|0||
60137572|NCT04115748|76260333|FG002|STARTED|LTE (After 16 Weeks to Week 50)|Participants who completed main study were randomized in LTE phase to receive filgotinib 200 mg or 100 mg.|0||
60137573|NCT04115748|76260334|FG003|STARTED|LTE (After 16 Weeks to Week 50)|Participants who completed main study were randomized in LTE phase to receive filgotinib 200 mg or 100 mg.|0||
60137574|NCT04115748|76260335|FG004|STARTED|LTE (After 16 Weeks to Week 50)|Participants who completed main study received filgotinib 200 mg.|4||
60137575|NCT04115748|76260336|FG005|STARTED|LTE (After 16 Weeks to Week 50)|Participants who completed main study received filgotinib 100 mg.|3||
60137576|NCT04115748|76260337|FG006|STARTED|LTE (After 16 Weeks to Week 50)|1 participant who received adalimumab injection and completed main study were randomised in LTE phase to receive filgotinib 200 mg.|1||
60137577|NCT04115748|76260338|FG007|STARTED|LTE (After 16 Weeks to Week 50)|1 participant who received adalimumab injection and completed main study were randomised in LTE phase to receive filgotinib 100 mg.|1||
60137578|NCT04115748|76260339|FG008|STARTED|LTE (After 16 Weeks to Week 50)|2 participants who received placebo and completed main study were randomised in LTE phase to receive filgotinib 200 mg.|2||
60137579|NCT04115748|76260340|FG009|STARTED|LTE (After 16 Weeks to Week 50)|2 participants who received placebo and completed main study were randomised in LTE phase to receive filgotinib 100 mg.|2||
60137580|NCT04115748|76260331|FG000|COMPLETED|LTE (After 16 Weeks to Week 50)||0||
60137581|NCT04115748|76260332|FG001|COMPLETED|LTE (After 16 Weeks to Week 50)||0||
60137582|NCT04115748|76260333|FG002|COMPLETED|LTE (After 16 Weeks to Week 50)||0||
60137583|NCT04115748|76260334|FG003|COMPLETED|LTE (After 16 Weeks to Week 50)||0||
60137584|NCT04115748|76260335|FG004|COMPLETED|LTE (After 16 Weeks to Week 50)||0||
60137585|NCT04115748|76260336|FG005|COMPLETED|LTE (After 16 Weeks to Week 50)||0||
60137586|NCT04115748|76260337|FG006|COMPLETED|LTE (After 16 Weeks to Week 50)||0||
60137587|NCT04115748|76260338|FG007|COMPLETED|LTE (After 16 Weeks to Week 50)||0||
60137588|NCT04115748|76260339|FG008|COMPLETED|LTE (After 16 Weeks to Week 50)||0||
60137589|NCT04115748|76260340|FG009|COMPLETED|LTE (After 16 Weeks to Week 50)||0||
60137590|NCT04115748|76260331|FG000|NOT COMPLETED|LTE (After 16 Weeks to Week 50)||0||
60137591|NCT04115748|76260332|FG001|NOT COMPLETED|LTE (After 16 Weeks to Week 50)||0||
60137592|NCT04115748|76260333|FG002|NOT COMPLETED|LTE (After 16 Weeks to Week 50)||0||
60137593|NCT04115748|76260334|FG003|NOT COMPLETED|LTE (After 16 Weeks to Week 50)||0||
60137594|NCT04115748|76260335|FG004|NOT COMPLETED|LTE (After 16 Weeks to Week 50)||4||
60137595|NCT04115748|76260336|FG005|NOT COMPLETED|LTE (After 16 Weeks to Week 50)||3||
60137596|NCT04115748|76260337|FG006|NOT COMPLETED|LTE (After 16 Weeks to Week 50)||1||
60137597|NCT04115748|76260338|FG007|NOT COMPLETED|LTE (After 16 Weeks to Week 50)||1||
60137598|NCT04115748|76260339|FG008|NOT COMPLETED|LTE (After 16 Weeks to Week 50)||2||
60137599|NCT04115748|76260340|FG009|NOT COMPLETED|LTE (After 16 Weeks to Week 50)||2||
60137600|NCT02082769|76260365|FG000|STARTED|Overall Study||168||
60137601|NCT02082769|76260366|FG001|STARTED|Overall Study||168||
60137602|NCT02082769|76260367|FG002|STARTED|Overall Study||168||
60137603|NCT02082769|76260365|FG000|COMPLETED|Overall Study||144||
60137604|NCT02082769|76260366|FG001|COMPLETED|Overall Study||141||
60137605|NCT02082769|76260367|FG002|COMPLETED|Overall Study||132||
60137606|NCT02082769|76260365|FG000|NOT COMPLETED|Overall Study||24||
60137607|NCT02082769|76260366|FG001|NOT COMPLETED|Overall Study||27||
60137608|NCT02082769|76260367|FG002|NOT COMPLETED|Overall Study||36||
60137609|NCT03867396|76260375|FG000|STARTED|Intervention 1||8||
60137610|NCT03867396|76260376|FG001|STARTED|Intervention 1||8||
60137611|NCT03867396|76260377|FG002|STARTED|Intervention 1||7||
60137612|NCT03867396|76260378|FG003|STARTED|Intervention 1||5||
60137613|NCT03867396|76260379|FG004|STARTED|Intervention 1||7||
60137614|NCT03867396|76260380|FG005|STARTED|Intervention 1||5||
60137615|NCT03867396|76260375|FG000|Data Collection|Intervention 1||8||
60137616|NCT03867396|76260376|FG001|Data Collection|Intervention 1||5||
60137617|NCT03867396|76260377|FG002|Data Collection|Intervention 1||7||
60137618|NCT03867396|76260378|FG003|Data Collection|Intervention 1||5||
60137619|NCT03867396|76260379|FG004|Data Collection|Intervention 1||0||
60137620|NCT03867396|76260380|FG005|Data Collection|Intervention 1||0||
60137621|NCT03867396|76260375|FG000|COMPLETED|Intervention 1||8||
60137622|NCT03867396|76260376|FG001|COMPLETED|Intervention 1||5||
60137623|NCT03867396|76260377|FG002|COMPLETED|Intervention 1||7||
60137624|NCT03867396|76260378|FG003|COMPLETED|Intervention 1||5||
60137625|NCT03867396|76260379|FG004|COMPLETED|Intervention 1||0||
60137626|NCT03867396|76260380|FG005|COMPLETED|Intervention 1||0||
60137627|NCT03867396|76260375|FG000|NOT COMPLETED|Intervention 1||0||
60137628|NCT03867396|76260376|FG001|NOT COMPLETED|Intervention 1||3||
60137629|NCT03867396|76260377|FG002|NOT COMPLETED|Intervention 1||0||
60137630|NCT03867396|76260378|FG003|NOT COMPLETED|Intervention 1||0||
60137631|NCT03867396|76260379|FG004|NOT COMPLETED|Intervention 1||7||
60137632|NCT03867396|76260380|FG005|NOT COMPLETED|Intervention 1||5||
60137633|NCT03867396|76260375|FG000|STARTED|Intervention 2||8||
60137634|NCT03867396|76260376|FG001|STARTED|Intervention 2||5||
60137635|NCT03867396|76260377|FG002|STARTED|Intervention 2||7||
60137636|NCT03867396|76260378|FG003|STARTED|Intervention 2||5||
60137637|NCT03867396|76260379|FG004|STARTED|Intervention 2||0||
60137638|NCT03867396|76260380|FG005|STARTED|Intervention 2||0||
60137639|NCT03867396|76260375|FG000|COMPLETED|Intervention 2||8||
60137640|NCT03867396|76260376|FG001|COMPLETED|Intervention 2||5||
60137641|NCT03867396|76260377|FG002|COMPLETED|Intervention 2||7||
60137642|NCT03867396|76260378|FG003|COMPLETED|Intervention 2||5||
60137643|NCT03867396|76260379|FG004|COMPLETED|Intervention 2||0||
60137644|NCT03867396|76260380|FG005|COMPLETED|Intervention 2||0||
60137645|NCT03867396|76260375|FG000|NOT COMPLETED|Intervention 2||0||
60137646|NCT03867396|76260376|FG001|NOT COMPLETED|Intervention 2||0||
60137647|NCT03867396|76260377|FG002|NOT COMPLETED|Intervention 2||0||
60137648|NCT03867396|76260378|FG003|NOT COMPLETED|Intervention 2||0||
60137649|NCT03867396|76260379|FG004|NOT COMPLETED|Intervention 2||0||
60137650|NCT03867396|76260380|FG005|NOT COMPLETED|Intervention 2||0||
60137651|NCT03867396|76260375|FG000|STARTED|Intervention 3||8||
60137652|NCT03867396|76260376|FG001|STARTED|Intervention 3||5||
60137653|NCT03867396|76260377|FG002|STARTED|Intervention 3||7||
60137654|NCT03867396|76260378|FG003|STARTED|Intervention 3||5||
60137655|NCT03867396|76260379|FG004|STARTED|Intervention 3||0||
60137656|NCT03867396|76260380|FG005|STARTED|Intervention 3||0||
60137657|NCT03867396|76260375|FG000|COMPLETED|Intervention 3||8||
60137658|NCT03867396|76260376|FG001|COMPLETED|Intervention 3||5||
60137659|NCT03867396|76260377|FG002|COMPLETED|Intervention 3||7||
60137660|NCT03867396|76260378|FG003|COMPLETED|Intervention 3||5||
60137661|NCT03867396|76260379|FG004|COMPLETED|Intervention 3||0||
60137662|NCT03867396|76260380|FG005|COMPLETED|Intervention 3||0||
60137663|NCT03867396|76260375|FG000|NOT COMPLETED|Intervention 3||0||
60137664|NCT03867396|76260376|FG001|NOT COMPLETED|Intervention 3||0||
60137665|NCT03867396|76260377|FG002|NOT COMPLETED|Intervention 3||0||
60137666|NCT03867396|76260378|FG003|NOT COMPLETED|Intervention 3||0||
60137667|NCT03867396|76260379|FG004|NOT COMPLETED|Intervention 3||0||
60137668|NCT03867396|76260380|FG005|NOT COMPLETED|Intervention 3||0||
60137669|NCT00003469|76260391|FG000|STARTED|Overall Study||4||
60137670|NCT00003469|76260391|FG000|COMPLETED|Overall Study||4||
60137671|NCT00003469|76260391|FG000|NOT COMPLETED|Overall Study||0||
60137672|NCT02652624|76260397|FG000|STARTED|Randomized Phase||234||
60137673|NCT02652624|76260398|FG001|STARTED|Randomized Phase||236||
60137674|NCT02652624|76260397|FG000|COMPLETED|Randomized Phase||231||
60137675|NCT02652624|76260398|FG001|COMPLETED|Randomized Phase||231||
60137676|NCT02652624|76260397|FG000|NOT COMPLETED|Randomized Phase||3||
60137677|NCT02652624|76260398|FG001|NOT COMPLETED|Randomized Phase||5||
60137678|NCT02652624|76260397|FG000|STARTED|Extension Phase||231||
60137679|NCT02652624|76260398|FG001|STARTED|Extension Phase|3 participants completed the Randomized Phase, but did not enter the Extension Phase.|228||
60137680|NCT02652624|76260397|FG000|COMPLETED|Extension Phase||227||
60137681|NCT02652624|76260398|FG001|COMPLETED|Extension Phase||224||
60137682|NCT02652624|76260397|FG000|NOT COMPLETED|Extension Phase||4||
60137683|NCT02652624|76260398|FG001|NOT COMPLETED|Extension Phase||4||
60137684|NCT00249795|76260408|FG000|STARTED|Overall Study|randomized patients: patients remained in the study whether treated or not until planned study end|4518||
60137685|NCT00249795|76260409|FG001|STARTED|Overall Study|randomized patients: patients remained in the study whether treated or not until planned study end|4498||
60137686|NCT00249795|76260408|FG000|COMPLETED|Overall Study|started and completed study drug|3124||
60137687|NCT00249795|76260409|FG001|COMPLETED|Overall Study|started and completed study drug|3108||
60137688|NCT00249795|76260408|FG000|NOT COMPLETED|Overall Study||1394||
60137689|NCT00249795|76260409|FG001|NOT COMPLETED|Overall Study||1390||
60137690|NCT02651220|76260418|FG000|STARTED|Overall Study||337||
60137691|NCT02651220|76260419|FG001|STARTED|Overall Study||335||
60137692|NCT02651220|76260420|FG002|STARTED|Overall Study||329||
60137693|NCT02651220|76260418|FG000|COMPLETED|Overall Study||314||
60137694|NCT02651220|76260419|FG001|COMPLETED|Overall Study||308||
60137695|NCT02651220|76260420|FG002|COMPLETED|Overall Study||300||
60137696|NCT02651220|76260418|FG000|NOT COMPLETED|Overall Study||23||
60137697|NCT02651220|76260419|FG001|NOT COMPLETED|Overall Study||27||
60137698|NCT02651220|76260420|FG002|NOT COMPLETED|Overall Study||29||
60137699|NCT00724347|76260428|FG000|STARTED|Overall Study|Training was the final step in the program, once the outcome tests had been developed.|18||
60137700|NCT00724347|76260428|FG000|Baseline Testing|Overall Study||18||
60137701|NCT00724347|76260428|FG000|COMPLETED|Overall Study||16||
60137702|NCT00724347|76260428|FG000|NOT COMPLETED|Overall Study||2||
60137703|NCT03719287|76260435|FG000|STARTED|Overall Study||100||
60137704|NCT03719287|76260436|FG001|STARTED|Overall Study||99||
60137705|NCT03719287|76260437|FG002|STARTED|Overall Study||96||
60137706|NCT03719287|76260435|FG000|COMPLETED|Overall Study||100||
60137707|NCT03719287|76260436|FG001|COMPLETED|Overall Study||99||
60137708|NCT03719287|76260437|FG002|COMPLETED|Overall Study||96||
60137709|NCT03719287|76260435|FG000|NOT COMPLETED|Overall Study||0||
60137710|NCT03719287|76260436|FG001|NOT COMPLETED|Overall Study||0||
60137711|NCT03719287|76260437|FG002|NOT COMPLETED|Overall Study||0||
60137712|NCT00780403|76260445|FG000|STARTED|First Intervention||109||
60137713|NCT00780403|76260446|FG001|STARTED|First Intervention||111||
60137714|NCT00780403|76260445|FG000|COMPLETED|First Intervention||109||
60137715|NCT00780403|76260446|FG001|COMPLETED|First Intervention||111||
60137716|NCT00780403|76260445|FG000|NOT COMPLETED|First Intervention||0||
60137717|NCT00780403|76260446|FG001|NOT COMPLETED|First Intervention||0||
60137718|NCT00780403|76260445|FG000|STARTED|Interval Between Doses (8-10 Minutes)||109||
60137719|NCT00780403|76260446|FG001|STARTED|Interval Between Doses (8-10 Minutes)||111||
60137720|NCT00780403|76260445|FG000|COMPLETED|Interval Between Doses (8-10 Minutes)||109||
60137721|NCT00780403|76260446|FG001|COMPLETED|Interval Between Doses (8-10 Minutes)||111||
60137722|NCT00780403|76260445|FG000|NOT COMPLETED|Interval Between Doses (8-10 Minutes)||0||
60137723|NCT00780403|76260446|FG001|NOT COMPLETED|Interval Between Doses (8-10 Minutes)||0||
60137724|NCT00780403|76260445|FG000|STARTED|Second Intervention||109||
60137725|NCT00780403|76260446|FG001|STARTED|Second Intervention||111||
60137726|NCT00780403|76260445|FG000|COMPLETED|Second Intervention||109||
60137727|NCT00780403|76260446|FG001|COMPLETED|Second Intervention||111||
60137728|NCT00780403|76260445|FG000|NOT COMPLETED|Second Intervention||0||
60137729|NCT00780403|76260446|FG001|NOT COMPLETED|Second Intervention||0||
60137730|NCT00741273|76260455|FG000|STARTED|Overall Study||8||
60137731|NCT00741273|76260456|FG001|STARTED|Overall Study||8||
60137732|NCT00741273|76260455|FG000|COMPLETED|Overall Study||8||
60137733|NCT00741273|76260456|FG001|COMPLETED|Overall Study||8||
60137734|NCT00741273|76260455|FG000|NOT COMPLETED|Overall Study||0||
60137735|NCT00741273|76260456|FG001|NOT COMPLETED|Overall Study||0||
60137736|NCT00247611|76260468|FG000|STARTED|Baselined|Participants randomized|304||
60137737|NCT00247611|76260469|FG001|STARTED|Baselined|Participants randomized|290||
60137738|NCT00247611|76260468|FG000|COMPLETED|Baselined|Randomized participants who completed at least 2 adherence assessments/sessions|287||
60137739|NCT00247611|76260469|FG001|COMPLETED|Baselined|Randomized participants who completed at least 2 adherence assessments/sessions|277||
60137740|NCT00247611|76260468|FG000|NOT COMPLETED|Baselined||17||
60137741|NCT00247611|76260469|FG001|NOT COMPLETED|Baselined||13||
60137742|NCT00247611|76260468|FG000|STARTED|Intention to Treat Sample|Participants randomized|304||
60137743|NCT00247611|76260469|FG001|STARTED|Intention to Treat Sample|Participants randomized|290||
60137744|NCT00247611|76260468|FG000|COMPLETED|Intention to Treat Sample|Randomized participants who completed at least 2 adherence assessments/sessions|287||
60137745|NCT00247611|76260469|FG001|COMPLETED|Intention to Treat Sample|Randomized participants who completed at least 2 adherence assessments/sessions|277||
60137746|NCT00247611|76260468|FG000|NOT COMPLETED|Intention to Treat Sample||17||
60137747|NCT00247611|76260469|FG001|NOT COMPLETED|Intention to Treat Sample||13||
60137748|NCT00247611|76260468|FG000|STARTED|On Protocol Sample|ITT sample participants|287||
60137749|NCT00247611|76260469|FG001|STARTED|On Protocol Sample|ITT sample participants|277||
60137750|NCT00247611|76260468|FG000|COMPLETED|On Protocol Sample|Participants with no interruptions in ART receipt and completing 6 or more LifeWindows assessments|176||
60137751|NCT00247611|76260469|FG001|COMPLETED|On Protocol Sample|Participants with no interruptions in ART receipt and completing 6 or more LifeWindows assessments|152||
60137752|NCT00247611|76260468|FG000|NOT COMPLETED|On Protocol Sample||111||
60137753|NCT00247611|76260469|FG001|NOT COMPLETED|On Protocol Sample||125||
60137754|NCT00742053|76260481|FG000|STARTED|Overall Study||7||
60137755|NCT00742053|76260481|FG000|COMPLETED|Overall Study||7||
60137756|NCT00742053|76260481|FG000|NOT COMPLETED|Overall Study||0||
60137757|NCT03628339|76260485|FG000|STARTED|Treatment Period 1||12||
60137758|NCT03628339|76260486|FG001|STARTED|Treatment Period 1||0||
60137759|NCT03628339|76260485|FG000|COMPLETED|Treatment Period 1||12||
60137760|NCT03628339|76260486|FG001|COMPLETED|Treatment Period 1||0||
60137761|NCT03628339|76260485|FG000|NOT COMPLETED|Treatment Period 1||0||
60137762|NCT03628339|76260486|FG001|NOT COMPLETED|Treatment Period 1||0||
60137763|NCT03628339|76260485|FG000|STARTED|Treatment Period 2||0||
60137764|NCT03628339|76260486|FG001|STARTED|Treatment Period 2||12||
60137765|NCT03628339|76260485|FG000|COMPLETED|Treatment Period 2||0||
60137766|NCT03628339|76260486|FG001|COMPLETED|Treatment Period 2||12||
60137767|NCT03628339|76260485|FG000|NOT COMPLETED|Treatment Period 2||0||
60137768|NCT03628339|76260486|FG001|NOT COMPLETED|Treatment Period 2||0||
60137769|NCT00246753|76260492|FG000|STARTED|Overall Study||29||
60137770|NCT00246753|76260492|FG000|COMPLETED|Overall Study||21||
60137771|NCT00246753|76260492|FG000|NOT COMPLETED|Overall Study||8||
60137772|NCT02083861|76260498|FG000|STARTED|Overall Study||57||
60137773|NCT02083861|76260499|FG001|STARTED|Overall Study||36||
60137774|NCT02083861|76260498|FG000|Treated|Overall Study||55||
60137775|NCT02083861|76260499|FG001|Treated|Overall Study||35||
60137776|NCT02083861|76260498|FG000|COMPLETED|Overall Study||51||
60137777|NCT02083861|76260499|FG001|COMPLETED|Overall Study||33||
60137778|NCT02083861|76260498|FG000|NOT COMPLETED|Overall Study||6||
60137779|NCT02083861|76260499|FG001|NOT COMPLETED|Overall Study||3||
60137780|NCT00246129|76260509|FG000|STARTED|Overall Study||82||
60137781|NCT00246129|76260510|FG001|STARTED|Overall Study||41||
60137782|NCT00246129|76260509|FG000|COMPLETED|Overall Study||75||
60137783|NCT00246129|76260510|FG001|COMPLETED|Overall Study||39||
60137784|NCT00246129|76260509|FG000|NOT COMPLETED|Overall Study||7||
60137785|NCT00246129|76260510|FG001|NOT COMPLETED|Overall Study||2||
60137786|NCT00746187|76260521|FG000|STARTED|Overall Study||18||
60137787|NCT00746187|76260522|FG001|STARTED|Overall Study||18||
60137788|NCT00746187|76260521|FG000|COMPLETED|Overall Study||15||
60137789|NCT00746187|76260522|FG001|COMPLETED|Overall Study||16||
60137790|NCT00746187|76260521|FG000|NOT COMPLETED|Overall Study||3||
60137791|NCT00746187|76260522|FG001|NOT COMPLETED|Overall Study||2||
60137792|NCT03182868|76260533|FG000|STARTED|Overall Study||12||
60137793|NCT03182868|76260534|FG001|STARTED|Overall Study||20||
60137794|NCT03182868|76260535|FG002|STARTED|Overall Study||21||
60137795|NCT03182868|76260536|FG003|STARTED|Overall Study||1||
60137796|NCT03182868|76260537|FG004|STARTED|Overall Study||24||
60137797|NCT03182868|76260533|FG000|COMPLETED|Overall Study||9||
60137798|NCT03182868|76260534|FG001|COMPLETED|Overall Study||20||
60137799|NCT03182868|76260535|FG002|COMPLETED|Overall Study||17||
60137800|NCT03182868|76260536|FG003|COMPLETED|Overall Study||0||
60137801|NCT03182868|76260537|FG004|COMPLETED|Overall Study||16||
60137802|NCT03182868|76260533|FG000|NOT COMPLETED|Overall Study||3||
60137803|NCT03182868|76260534|FG001|NOT COMPLETED|Overall Study||0||
60137804|NCT03182868|76260535|FG002|NOT COMPLETED|Overall Study||4||
60137805|NCT03182868|76260536|FG003|NOT COMPLETED|Overall Study||1||
60137806|NCT03182868|76260537|FG004|NOT COMPLETED|Overall Study||8||
60137807|NCT00754377|76260550|FG000|STARTED|Overall Study||50||
60137808|NCT00754377|76260551|FG001|STARTED|Overall Study||42||
60137809|NCT00754377|76260550|FG000|COMPLETED|Overall Study||50||
60137810|NCT00754377|76260551|FG001|COMPLETED|Overall Study||42||
60137811|NCT00754377|76260550|FG000|NOT COMPLETED|Overall Study||0||
60137812|NCT00754377|76260551|FG001|NOT COMPLETED|Overall Study||0||
60137813|NCT00245583|76260561|FG000|STARTED|Overall Study||20||
60137814|NCT00245583|76260562|FG001|STARTED|Overall Study||22||
60137815|NCT00245583|76260561|FG000|COMPLETED|Overall Study||14||
60137816|NCT00245583|76260562|FG001|COMPLETED|Overall Study||13||
60137817|NCT00245583|76260561|FG000|NOT COMPLETED|Overall Study||6||
60137818|NCT00245583|76260562|FG001|NOT COMPLETED|Overall Study||9||
60137819|NCT02652156|76260571|FG000|STARTED|Overall Study||4||
60137820|NCT02652156|76260572|FG001|STARTED|Overall Study||6||
60137821|NCT02652156|76260573|FG002|STARTED|Overall Study||4||
60137822|NCT02652156|76260571|FG000|COMPLETED|Overall Study||3||
60137823|NCT02652156|76260572|FG001|COMPLETED|Overall Study||6||
60137824|NCT02652156|76260573|FG002|COMPLETED|Overall Study||4||
60137825|NCT02652156|76260571|FG000|NOT COMPLETED|Overall Study||1||
60137826|NCT02652156|76260572|FG001|NOT COMPLETED|Overall Study||0||
60137827|NCT02652156|76260573|FG002|NOT COMPLETED|Overall Study||0||
60137828|NCT00754923|76260581|FG000|STARTED|Overall Study||11||
60137829|NCT00754923|76260581|FG000|COMPLETED|Overall Study||11||
60137830|NCT00754923|76260581|FG000|NOT COMPLETED|Overall Study||0||
60137831|NCT00746421|76260587|FG000|STARTED|Overall Study||12||
60137832|NCT00746421|76260588|FG001|STARTED|Overall Study||11||
60137833|NCT00746421|76260587|FG000|COMPLETED|Overall Study||5||
60137834|NCT00746421|76260588|FG001|COMPLETED|Overall Study||9||
60137835|NCT00746421|76260587|FG000|NOT COMPLETED|Overall Study||7||
60137836|NCT00746421|76260588|FG001|NOT COMPLETED|Overall Study||2||
60137837|NCT00755235|76260596|FG000|STARTED|Overall Study||106||
60137838|NCT00755235|76260597|FG001|STARTED|Overall Study||102||
60137839|NCT00755235|76260596|FG000|COMPLETED|Overall Study||104||
60137840|NCT00755235|76260597|FG001|COMPLETED|Overall Study||93||
60137841|NCT00755235|76260596|FG000|NOT COMPLETED|Overall Study||2||
60137842|NCT00755235|76260597|FG001|NOT COMPLETED|Overall Study||9||
60009776|NCT01939366|76125384|FG004|Per Protocol Set|Overall Study||49||
60009777|NCT01939366|76125380|FG000|COMPLETED|Overall Study||52||
60009778|NCT01939366|76125381|FG001|COMPLETED|Overall Study||41||
60009779|NCT01939366|76125382|FG002|COMPLETED|Overall Study||27||
60009780|NCT01939366|76125383|FG003|COMPLETED|Overall Study||51||
60009781|NCT01939366|76125384|FG004|COMPLETED|Overall Study||48||
60009782|NCT01939366|76125380|FG000|NOT COMPLETED|Overall Study||14||
60009783|NCT01939366|76125381|FG001|NOT COMPLETED|Overall Study||23||
60009784|NCT01939366|76125382|FG002|NOT COMPLETED|Overall Study||38||
60009785|NCT01939366|76125383|FG003|NOT COMPLETED|Overall Study||17||
60009786|NCT01939366|76125384|FG004|NOT COMPLETED|Overall Study||18||
60009787|NCT01918306|76125398|FG000|STARTED|Overall Study||6|11 total patients. 2 pts received Cisplatin alone. 9 pts started Cisplatin and GDC-0941.|
60009788|NCT01918306|76125399|FG001|STARTED|Overall Study|No patients enrolled|0|11 total patients. 2 pts received Cisplatin alone. 9 pts started Cisplatin and GDC-0941.|
60009789|NCT01918306|76125400|FG002|STARTED|Overall Study|1 participant Crossed-over to ARM 2|2|11 total patients. 2 pts received Cisplatin alone. 9 pts started Cisplatin and GDC-0941.|
60009790|NCT01918306|76125401|FG003|STARTED|Overall Study||3|11 total patients. 2 pts received Cisplatin alone. 9 pts started Cisplatin and GDC-0941.|
60009791|NCT01918306|76125398|FG000|COMPLETED|Overall Study||0||
60009792|NCT01918306|76125399|FG001|COMPLETED|Overall Study||0||
60009793|NCT01918306|76125400|FG002|COMPLETED|Overall Study||0||
60009794|NCT01918306|76125401|FG003|COMPLETED|Overall Study||0||
60009795|NCT01918306|76125398|FG000|NOT COMPLETED|Overall Study||6||
60009796|NCT01918306|76125399|FG001|NOT COMPLETED|Overall Study||0||
60009797|NCT01918306|76125400|FG002|NOT COMPLETED|Overall Study||2||
60009798|NCT01918306|76125401|FG003|NOT COMPLETED|Overall Study||3||
60009799|NCT01917526|76125423|FG000|STARTED|Overall Study||250||
60009800|NCT01917526|76125424|FG001|STARTED|Overall Study||250||
60009801|NCT01917526|76125423|FG000|COMPLETED|Overall Study|One patient in oxygen mask received oxygen cannula|249||
60009802|NCT01917526|76125424|FG001|COMPLETED|Overall Study|1 patient in oxygen cannula group receive oxygen mask|249||
60009803|NCT01917526|76125423|FG000|NOT COMPLETED|Overall Study||1||
60009804|NCT01917526|76125424|FG001|NOT COMPLETED|Overall Study||1||
60009805|NCT01948258|76125430|FG000|STARTED|Overall Study||395||
60009806|NCT01948258|76125430|FG000|COMPLETED|Overall Study||233||
60009807|NCT01948258|76125430|FG000|NOT COMPLETED|Overall Study||162||
60009808|NCT01916980|76125436|FG000|STARTED|Overall Study||65||
60009809|NCT01916980|76125437|FG001|STARTED|Overall Study||29||
60009810|NCT01916980|76125436|FG000|COMPLETED|Overall Study||58||
60009811|NCT01916980|76125437|FG001|COMPLETED|Overall Study||25||
60009812|NCT01916980|76125436|FG000|NOT COMPLETED|Overall Study||7||
60009813|NCT01916980|76125437|FG001|NOT COMPLETED|Overall Study||4||
60009814|NCT05940077|76125443|FG000|STARTED|Overall Study||20||
60009815|NCT05940077|76125443|FG000|COMPLETED|Overall Study||19||
60009816|NCT05940077|76125443|FG000|NOT COMPLETED|Overall Study||1||
60009817|NCT05045638|76125448|FG000|STARTED|Overall Study||13||
60009818|NCT05045638|76125448|FG000|Received Rosuvastatin Alone|Overall Study||13||
60009819|NCT05045638|76125448|FG000|Received Rosuvastatin Coadministered With Sotorasib|Overall Study||13||
60009820|NCT05045638|76125448|FG000|COMPLETED|Overall Study||13||
60009821|NCT05045638|76125448|FG000|NOT COMPLETED|Overall Study||0||
60009822|NCT05011513|76125457|FG000|STARTED|Overall Study||658||
60009823|NCT05011513|76125458|FG001|STARTED|Overall Study||638||
60009824|NCT05011513|76125457|FG000|Treated|Overall Study||654||
60009825|NCT05011513|76125458|FG001|Treated|Overall Study||634||
60009826|NCT05011513|76125457|FG000|COMPLETED|Overall Study||632||
60009827|NCT05011513|76125458|FG001|COMPLETED|Overall Study||618||
60009828|NCT05011513|76125457|FG000|NOT COMPLETED|Overall Study||26||
60009829|NCT05011513|76125458|FG001|NOT COMPLETED|Overall Study||20||
60009830|NCT04750239|76125464|FG000|STARTED|Overall Study||3||
60009831|NCT04750239|76125464|FG000|COMPLETED|Overall Study||0||
60009832|NCT04750239|76125464|FG000|NOT COMPLETED|Overall Study||3||
60009833|NCT04590248|76125469|FG000|STARTED|Overall Study||109||
60009834|NCT04590248|76125469|FG000|COMPLETED|Overall Study||90||
60009835|NCT04590248|76125469|FG000|NOT COMPLETED|Overall Study||19||
60009836|NCT04560816|76125473|FG000|STARTED|Overall Study||11||
60009837|NCT04560816|76125474|FG001|STARTED|Overall Study||10||
60009838|NCT04560816|76125475|FG002|STARTED|Overall Study||8||
60009839|NCT04560816|76125476|FG003|STARTED|Overall Study||9||
60009840|NCT04560816|76125477|FG004|STARTED|Overall Study||11||
60009841|NCT04560816|76125478|FG005|STARTED|Overall Study||8||
60009842|NCT04560816|76125473|FG000|COMPLETED|Overall Study||8||
60009843|NCT04560816|76125474|FG001|COMPLETED|Overall Study||9||
60009844|NCT04560816|76125475|FG002|COMPLETED|Overall Study||7||
60009845|NCT04560816|76125476|FG003|COMPLETED|Overall Study||9||
60009846|NCT04560816|76125477|FG004|COMPLETED|Overall Study||8||
60009847|NCT04560816|76125478|FG005|COMPLETED|Overall Study||8||
60009848|NCT04560816|76125473|FG000|NOT COMPLETED|Overall Study||3||
60009849|NCT04560816|76125474|FG001|NOT COMPLETED|Overall Study||1||
60009850|NCT04560816|76125475|FG002|NOT COMPLETED|Overall Study||1||
60009851|NCT04560816|76125476|FG003|NOT COMPLETED|Overall Study||0||
60009852|NCT04560816|76125477|FG004|NOT COMPLETED|Overall Study||3||
60009853|NCT04560816|76125478|FG005|NOT COMPLETED|Overall Study||0||
60009854|NCT04092582|76125492|FG000|STARTED|Overall Study||69||
60009855|NCT04092582|76125493|FG001|STARTED|Overall Study||66||
60137843|NCT00724477|76260603|FG000|STARTED|Overall Study|This safety population (SAF)analysed consisted of all patients who took at least one tablet of INEGY|1663||
60137844|NCT00724477|76260603|FG000|COMPLETED|Overall Study||1663||
60137845|NCT00724477|76260603|FG000|NOT COMPLETED|Overall Study||0||
60137846|NCT00746889|76260609|FG000|STARTED|Overall Study||40||
60137847|NCT00746889|76260610|FG001|STARTED|Overall Study||39||
60137848|NCT00746889|76260609|FG000|COMPLETED|Overall Study||36||
60137849|NCT00746889|76260610|FG001|COMPLETED|Overall Study||35||
60137850|NCT00746889|76260609|FG000|NOT COMPLETED|Overall Study||4||
60137851|NCT00746889|76260610|FG001|NOT COMPLETED|Overall Study||4||
60137852|NCT01675050|76260620|FG000|STARTED|Period One Treatment||2||
60137853|NCT01675050|76260621|FG001|STARTED|Period One Treatment||2||
60137854|NCT01675050|76260620|FG000|COMPLETED|Period One Treatment||1||
60137855|NCT01675050|76260621|FG001|COMPLETED|Period One Treatment||2||
60137856|NCT01675050|76260620|FG000|NOT COMPLETED|Period One Treatment||1||
60137857|NCT01675050|76260621|FG001|NOT COMPLETED|Period One Treatment||0||
60137858|NCT01675050|76260620|FG000|STARTED|Wash Out Period||1||
60137859|NCT01675050|76260621|FG001|STARTED|Wash Out Period||2||
60137860|NCT01675050|76260620|FG000|COMPLETED|Wash Out Period||1||
60137861|NCT01675050|76260621|FG001|COMPLETED|Wash Out Period||2||
60137862|NCT01675050|76260620|FG000|NOT COMPLETED|Wash Out Period||0||
60137863|NCT01675050|76260621|FG001|NOT COMPLETED|Wash Out Period||0||
60137864|NCT01675050|76260620|FG000|STARTED|Second Period Treatment||1||
60137865|NCT01675050|76260621|FG001|STARTED|Second Period Treatment||2||
60137866|NCT01675050|76260620|FG000|COMPLETED|Second Period Treatment||1||
60137867|NCT01675050|76260621|FG001|COMPLETED|Second Period Treatment||2||
60137868|NCT01675050|76260620|FG000|NOT COMPLETED|Second Period Treatment||0||
60137869|NCT01675050|76260621|FG001|NOT COMPLETED|Second Period Treatment||0||
60137870|NCT00756093|76260627|FG000|STARTED|First Intervention||5||
60137871|NCT00756093|76260628|FG001|STARTED|First Intervention||5||
60137872|NCT00756093|76260629|FG002|STARTED|First Intervention||5||
60137873|NCT00756093|76260630|FG003|STARTED|First Intervention||5||
60137874|NCT00756093|76260627|FG000|COMPLETED|First Intervention||5||
60137875|NCT00756093|76260628|FG001|COMPLETED|First Intervention||5||
60137876|NCT00756093|76260629|FG002|COMPLETED|First Intervention||5||
60137877|NCT00756093|76260630|FG003|COMPLETED|First Intervention||5||
60137878|NCT00756093|76260627|FG000|NOT COMPLETED|First Intervention||0||
60137879|NCT00756093|76260628|FG001|NOT COMPLETED|First Intervention||0||
60137880|NCT00756093|76260629|FG002|NOT COMPLETED|First Intervention||0||
60137881|NCT00756093|76260630|FG003|NOT COMPLETED|First Intervention||0||
60137882|NCT00756093|76260627|FG000|STARTED|Second Intervention||5||
60137883|NCT00756093|76260628|FG001|STARTED|Second Intervention||5||
60137884|NCT00756093|76260629|FG002|STARTED|Second Intervention||5||
60137885|NCT00756093|76260630|FG003|STARTED|Second Intervention||5||
60137886|NCT00756093|76260627|FG000|COMPLETED|Second Intervention||5||
60137887|NCT00756093|76260628|FG001|COMPLETED|Second Intervention||5||
60137888|NCT00756093|76260629|FG002|COMPLETED|Second Intervention||5||
60137889|NCT00756093|76260630|FG003|COMPLETED|Second Intervention||5||
60137890|NCT00756093|76260627|FG000|NOT COMPLETED|Second Intervention||0||
60137891|NCT00756093|76260628|FG001|NOT COMPLETED|Second Intervention||0||
60137892|NCT00756093|76260629|FG002|NOT COMPLETED|Second Intervention||0||
60137893|NCT00756093|76260630|FG003|NOT COMPLETED|Second Intervention||0||
60137894|NCT00756093|76260627|FG000|STARTED|Third Intervention||5||
60137895|NCT00756093|76260628|FG001|STARTED|Third Intervention||5||
60137896|NCT00756093|76260629|FG002|STARTED|Third Intervention||5||
60137897|NCT00756093|76260630|FG003|STARTED|Third Intervention||5||
60137898|NCT00756093|76260627|FG000|COMPLETED|Third Intervention||5||
60137899|NCT00756093|76260628|FG001|COMPLETED|Third Intervention||5||
60137900|NCT00756093|76260629|FG002|COMPLETED|Third Intervention||5||
60137901|NCT00756093|76260630|FG003|COMPLETED|Third Intervention||5||
60137902|NCT00756093|76260627|FG000|NOT COMPLETED|Third Intervention||0||
60137903|NCT00756093|76260628|FG001|NOT COMPLETED|Third Intervention||0||
60137904|NCT00756093|76260629|FG002|NOT COMPLETED|Third Intervention||0||
60137905|NCT00756093|76260630|FG003|NOT COMPLETED|Third Intervention||0||
60137906|NCT00756093|76260627|FG000|STARTED|Fourth Intervention||5||
60137907|NCT00756093|76260628|FG001|STARTED|Fourth Intervention||5||
60137908|NCT00756093|76260629|FG002|STARTED|Fourth Intervention||5||
60137909|NCT00756093|76260630|FG003|STARTED|Fourth Intervention||5||
60137910|NCT00756093|76260627|FG000|COMPLETED|Fourth Intervention||5||
60137911|NCT00756093|76260628|FG001|COMPLETED|Fourth Intervention||5||
60137912|NCT00756093|76260629|FG002|COMPLETED|Fourth Intervention||5||
60137913|NCT00756093|76260630|FG003|COMPLETED|Fourth Intervention||5||
60137914|NCT00756093|76260627|FG000|NOT COMPLETED|Fourth Intervention||0||
60137915|NCT00756093|76260628|FG001|NOT COMPLETED|Fourth Intervention||0||
60137916|NCT00756093|76260629|FG002|NOT COMPLETED|Fourth Intervention||0||
60137917|NCT00756093|76260630|FG003|NOT COMPLETED|Fourth Intervention||0||
60137918|NCT00244881|76260640|FG000|STARTED|Overall Study||26||
60137919|NCT00244881|76260640|FG000|COMPLETED|Overall Study||23||
60137920|NCT00244881|76260640|FG000|NOT COMPLETED|Overall Study||3||
60137921|NCT00005803|76260644|FG000|STARTED|Overall Study||76||
60137922|NCT00005803|76260644|FG000|COMPLETED|Overall Study||54||
60137923|NCT00005803|76260644|FG000|NOT COMPLETED|Overall Study||22||
60009856|NCT04092582|76125492|FG000|Safety Population|Overall Study||69|The safety analysis population included all randomized participants who received at least one dose of study drug during the 48-week double-blind treatment period.|
60009857|NCT04092582|76125493|FG001|Safety Population|Overall Study||65|The safety analysis population included all randomized participants who received at least one dose of study drug during the 48-week double-blind treatment period.|
60009858|NCT04092582|76125492|FG000|COMPLETED|Overall Study||64||
60009859|NCT04092582|76125493|FG001|COMPLETED|Overall Study||63||
60009860|NCT04092582|76125492|FG000|NOT COMPLETED|Overall Study||5||
60009861|NCT04092582|76125493|FG001|NOT COMPLETED|Overall Study||3||
60009862|NCT04060719|76125500|FG000|STARTED|Period 1||16||
60009863|NCT04060719|76125500|FG000|COMPLETED|Period 1||16||
60009864|NCT04060719|76125500|FG000|NOT COMPLETED|Period 1||0||
60009865|NCT04060719|76125500|FG000|STARTED|Washout Period||16||
60009866|NCT04060719|76125500|FG000|COMPLETED|Washout Period||16||
60009867|NCT04060719|76125500|FG000|NOT COMPLETED|Washout Period||0||
60009868|NCT04060719|76125500|FG000|STARTED|Period 2||16||
60009869|NCT04060719|76125500|FG000|COMPLETED|Period 2||16||
60009870|NCT04060719|76125500|FG000|NOT COMPLETED|Period 2||0||
60009871|NCT03910413|76125509|FG000|STARTED|Overall Study||11||
60009872|NCT03910413|76125509|FG000|COMPLETED|Overall Study||6||
60009873|NCT03910413|76125509|FG000|NOT COMPLETED|Overall Study||5||
60009874|NCT03722173|76125513|FG000|STARTED|Period 1 (2 Days)||14|Started are treated|
60009875|NCT03722173|76125513|FG000|COMPLETED|Period 1 (2 Days)||14||
60009876|NCT03722173|76125513|FG000|NOT COMPLETED|Period 1 (2 Days)||0||
60009877|NCT03722173|76125513|FG000|STARTED|Washout Period||14||
60009878|NCT03722173|76125513|FG000|COMPLETED|Washout Period||14||
60009879|NCT03722173|76125513|FG000|NOT COMPLETED|Washout Period||0||
60009880|NCT03722173|76125513|FG000|STARTED|Period 2 (4 Days)||14||
60009881|NCT03722173|76125513|FG000|COMPLETED|Period 2 (4 Days)||14||
60009882|NCT03722173|76125513|FG000|NOT COMPLETED|Period 2 (4 Days)||0||
60009883|NCT03636256|76125529|FG000|STARTED|Overall Study||4||
60009884|NCT03636256|76125530|FG001|STARTED|Overall Study||3||
60009885|NCT03636256|76125531|FG002|STARTED|Overall Study||3||
60009886|NCT03636256|76125532|FG003|STARTED|Overall Study||9||
60009887|NCT03636256|76125533|FG004|STARTED|Overall Study||1||
60009888|NCT03636256|76125534|FG005|STARTED|Overall Study||5||
60009889|NCT03636256|76125535|FG006|STARTED|Overall Study||2||
60009890|NCT03636256|76125536|FG007|STARTED|Overall Study||2||
60009891|NCT03636256|76125537|FG008|STARTED|Overall Study||7||
60009892|NCT03636256|76125529|FG000|COMPLETED|Overall Study||1||
60009893|NCT03636256|76125530|FG001|COMPLETED|Overall Study||3||
60009894|NCT03636256|76125531|FG002|COMPLETED|Overall Study||1||
60009895|NCT03636256|76125532|FG003|COMPLETED|Overall Study||8||
60009896|NCT03636256|76125533|FG004|COMPLETED|Overall Study||1||
60009897|NCT03636256|76125534|FG005|COMPLETED|Overall Study||1||
60009898|NCT03636256|76125535|FG006|COMPLETED|Overall Study||0||
60009899|NCT03636256|76125536|FG007|COMPLETED|Overall Study||2||
60009900|NCT03636256|76125537|FG008|COMPLETED|Overall Study||2||
60009901|NCT03636256|76125529|FG000|NOT COMPLETED|Overall Study||3||
60009902|NCT03636256|76125530|FG001|NOT COMPLETED|Overall Study||0||
60009903|NCT03636256|76125531|FG002|NOT COMPLETED|Overall Study||2||
60009904|NCT03636256|76125532|FG003|NOT COMPLETED|Overall Study||1||
60009905|NCT03636256|76125533|FG004|NOT COMPLETED|Overall Study||0||
60009906|NCT03636256|76125534|FG005|NOT COMPLETED|Overall Study||4||
60009907|NCT03636256|76125535|FG006|NOT COMPLETED|Overall Study||2||
60009908|NCT03636256|76125536|FG007|NOT COMPLETED|Overall Study||0||
60009909|NCT03636256|76125537|FG008|NOT COMPLETED|Overall Study||5||
60009910|NCT03614676|76125568|FG000|STARTED|Overall Study||2311||
60009911|NCT03614676|76125569|FG001|STARTED|Overall Study||2181||
60009912|NCT03614676|76125568|FG000|COMPLETED|Overall Study||2195||
60009913|NCT03614676|76125569|FG001|COMPLETED|Overall Study||2017||
60009914|NCT03614676|76125568|FG000|NOT COMPLETED|Overall Study||116||
60009915|NCT03614676|76125569|FG001|NOT COMPLETED|Overall Study||164||
60009916|NCT03230890|76125575|FG000|STARTED|Overall Study||32||
60009917|NCT03230890|76125575|FG000|COMPLETED|Overall Study||32||
60009918|NCT03230890|76125575|FG000|NOT COMPLETED|Overall Study||0||
60009919|NCT02727478|76125581|FG000|STARTED|Overall Study||61||
60009920|NCT02727478|76125582|FG001|STARTED|Overall Study||56||
60009921|NCT02727478|76125581|FG000|COMPLETED|Overall Study||53||
60009922|NCT02727478|76125582|FG001|COMPLETED|Overall Study||46||
60009923|NCT02727478|76125581|FG000|NOT COMPLETED|Overall Study||8||
60009924|NCT02727478|76125582|FG001|NOT COMPLETED|Overall Study||10||
60009925|NCT02614794|76125590|FG000|STARTED|Overall Study||410||
60009926|NCT02614794|76125591|FG001|STARTED|Overall Study||202||
60009927|NCT02614794|76125590|FG000|COMPLETED|Overall Study||0||
60009928|NCT02614794|76125591|FG001|COMPLETED|Overall Study||0||
60009929|NCT02614794|76125590|FG000|NOT COMPLETED|Overall Study||410||
60009930|NCT02614794|76125591|FG001|NOT COMPLETED|Overall Study||202||
60009931|NCT02361944|76125599|FG000|STARTED|Overall Study||100||
60009932|NCT02361944|76125600|FG001|STARTED|Overall Study||101||
60009933|NCT02361944|76125599|FG000|COMPLETED|Overall Study||100||
60009934|NCT02361944|76125600|FG001|COMPLETED|Overall Study||100||
60009935|NCT02361944|76125599|FG000|NOT COMPLETED|Overall Study||0||
60009936|NCT02361944|76125600|FG001|NOT COMPLETED|Overall Study||1||
60009937|NCT01782443|76125606|FG000|STARTED|Overall Study||19||
60137924|NCT03593629|76260655|FG000|STARTED|Overall Study||166||
60137925|NCT03593629|76260656|FG001|STARTED|Overall Study||166||
60137926|NCT03593629|76260657|FG002|STARTED|Overall Study||295||
60137927|NCT03593629|76260658|FG003|STARTED|Overall Study||163||
60137928|NCT03593629|76260655|FG000|COMPLETED|Overall Study||166||
60137929|NCT03593629|76260656|FG001|COMPLETED|Overall Study||166||
60137930|NCT03593629|76260657|FG002|COMPLETED|Overall Study||295||
60137931|NCT03593629|76260658|FG003|COMPLETED|Overall Study||163||
60137932|NCT03593629|76260655|FG000|NOT COMPLETED|Overall Study||0||
60137933|NCT03593629|76260656|FG001|NOT COMPLETED|Overall Study||0||
60137934|NCT03593629|76260657|FG002|NOT COMPLETED|Overall Study||0||
60137935|NCT03593629|76260658|FG003|NOT COMPLETED|Overall Study||0||
60137936|NCT00244725|76260671|FG000|STARTED|Overall Study||237||
60137937|NCT00244725|76260672|FG001|STARTED|Overall Study||245||
60137938|NCT00244725|76260673|FG002|STARTED|Overall Study||239||
60137939|NCT00244725|76260674|FG003|STARTED|Overall Study||237||
60137940|NCT00244725|76260671|FG000|COMPLETED|Overall Study||214||
60137941|NCT00244725|76260672|FG001|COMPLETED|Overall Study||226||
60137942|NCT00244725|76260673|FG002|COMPLETED|Overall Study||215||
60137943|NCT00244725|76260674|FG003|COMPLETED|Overall Study||216||
60137944|NCT00244725|76260671|FG000|NOT COMPLETED|Overall Study||23||
60137945|NCT00244725|76260672|FG001|NOT COMPLETED|Overall Study||19||
60137946|NCT00244725|76260673|FG002|NOT COMPLETED|Overall Study||24||
60137947|NCT00244725|76260674|FG003|NOT COMPLETED|Overall Study||21||
60137948|NCT02649894|76260686|FG000|STARTED|Overall Study||81||
60137949|NCT02649894|76260687|FG001|STARTED|Overall Study||38||
60137950|NCT02649894|76260686|FG000|Device Inserted|Overall Study||77||
60137951|NCT02649894|76260687|FG001|Device Inserted|Overall Study||37||
60137952|NCT02649894|76260686|FG000|Completed Day 30|Overall Study||56||
60137953|NCT02649894|76260687|FG001|Completed Day 30|Overall Study||35||
60137954|NCT02649894|76260686|FG000|COMPLETED|Overall Study||37|Day 90|
60137955|NCT02649894|76260687|FG001|COMPLETED|Overall Study||27|Day 90|
60137956|NCT02649894|76260686|FG000|NOT COMPLETED|Overall Study||44||
60137957|NCT02649894|76260687|FG001|NOT COMPLETED|Overall Study||11||
60137958|NCT01278615|76260693|FG000|STARTED|Overall Study||16||
60137959|NCT01278615|76260693|FG000|COMPLETED|Overall Study||14||
60137960|NCT01278615|76260693|FG000|NOT COMPLETED|Overall Study||2||
60137961|NCT00350701|76260700|FG000|STARTED|Overall Study||17||
60137962|NCT00350701|76260701|FG001|STARTED|Overall Study||17||
60137963|NCT00350701|76260702|FG002|STARTED|Overall Study||15||
60137964|NCT00350701|76260700|FG000|COMPLETED|Overall Study||17||
60137965|NCT00350701|76260701|FG001|COMPLETED|Overall Study||17||
60137966|NCT00350701|76260702|FG002|COMPLETED|Overall Study||15||
60137967|NCT00350701|76260700|FG000|NOT COMPLETED|Overall Study||0||
60137968|NCT00350701|76260701|FG001|NOT COMPLETED|Overall Study||0||
60137969|NCT00350701|76260702|FG002|NOT COMPLETED|Overall Study||0||
60137970|NCT00756561|76260710|FG000|STARTED|Overall Study||10||
60137971|NCT00756561|76260710|FG000|COMPLETED|Overall Study||10||
60137972|NCT00756561|76260710|FG000|NOT COMPLETED|Overall Study||0||
60137973|NCT01505114|76260719|FG000|STARTED|Overall Study||148||
60137974|NCT01505114|76260720|FG001|STARTED|Overall Study||148||
60137975|NCT01505114|76260721|FG002|STARTED|Overall Study||147||
60137976|NCT01505114|76260722|FG003|STARTED|Overall Study||151||
60137977|NCT01505114|76260719|FG000|COMPLETED|Overall Study||123||
60137978|NCT01505114|76260720|FG001|COMPLETED|Overall Study||135||
60137979|NCT01505114|76260721|FG002|COMPLETED|Overall Study||129||
60137980|NCT01505114|76260722|FG003|COMPLETED|Overall Study||128||
60137981|NCT01505114|76260719|FG000|NOT COMPLETED|Overall Study||25||
60137982|NCT01505114|76260720|FG001|NOT COMPLETED|Overall Study||13||
60137983|NCT01505114|76260721|FG002|NOT COMPLETED|Overall Study||18||
60137984|NCT01505114|76260722|FG003|NOT COMPLETED|Overall Study||23||
60137985|NCT00006151|76260734|FG000|STARTED|Overall Study||30||
60137986|NCT00006151|76260735|FG001|STARTED|Overall Study||30||
60137987|NCT00006151|76260734|FG000|COMPLETED|Overall Study||17||
60137988|NCT00006151|76260735|FG001|COMPLETED|Overall Study||16||
60137989|NCT00006151|76260734|FG000|NOT COMPLETED|Overall Study||13||
60137990|NCT00006151|76260735|FG001|NOT COMPLETED|Overall Study||14||
60137991|NCT00747747|76260744|FG000|STARTED|Overall Study||14||
60137992|NCT00747747|76260745|FG001|STARTED|Overall Study||14||
60137993|NCT00747747|76260746|FG002|STARTED|Overall Study||21||
60137994|NCT00747747|76260744|FG000|COMPLETED|Overall Study|13 with acute episode + 1 with recurrent episode|14||
60137995|NCT00747747|76260745|FG001|COMPLETED|Overall Study|11 with acute episode + 3 with recurrent episode|14||
60137996|NCT00747747|76260746|FG002|COMPLETED|Overall Study|17 with acute episode + 4 with recurrent episode|21||
60137997|NCT00747747|76260744|FG000|NOT COMPLETED|Overall Study||0||
60137998|NCT00747747|76260745|FG001|NOT COMPLETED|Overall Study||0||
60137999|NCT00747747|76260746|FG002|NOT COMPLETED|Overall Study||0||
60138000|NCT02651922|76260754|FG000|STARTED|Overall Study||156||
60138001|NCT02651922|76260754|FG000|COMPLETED|Overall Study||154||
60138002|NCT02651922|76260754|FG000|NOT COMPLETED|Overall Study||2||
60138003|NCT01277757|76260758|FG000|STARTED|Overall Study||30||
60138004|NCT01277757|76260758|FG000|COMPLETED|Overall Study||28||
60138005|NCT01277757|76260758|FG000|NOT COMPLETED|Overall Study||2||
60138006|NCT01276821|76260764|FG000|STARTED|Overall Study||50||
60138007|NCT01276821|76260765|FG001|STARTED|Overall Study||50||
59751285|NCT00658021|75870540|FG001|STARTED|Long-term Safety Follow-up Period|Entered safety follow-up period.|5|Entered safety follow-up period.|
59751286|NCT00658021|75870541|FG002|STARTED|Long-term Safety Follow-up Period|Entered safety follow-up period.|7|Entered safety follow-up period.|
59751287|NCT00658021|75870539|FG000|COMPLETED|Long-term Safety Follow-up Period||7|Completed safety follow-up period.|
59751288|NCT00658021|75870540|FG001|COMPLETED|Long-term Safety Follow-up Period||2|Completed safety follow-up period.|
59751289|NCT00658021|75870541|FG002|COMPLETED|Long-term Safety Follow-up Period||7|Completed safety follow-up period.|
59751290|NCT00658021|75870539|FG000|NOT COMPLETED|Long-term Safety Follow-up Period||0||
59751291|NCT00658021|75870540|FG001|NOT COMPLETED|Long-term Safety Follow-up Period||3||
59751292|NCT00658021|75870541|FG002|NOT COMPLETED|Long-term Safety Follow-up Period||0||
59751293|NCT00920816|75870555|FG000|STARTED|Overall Study||192||
59751294|NCT00920816|75870556|FG001|STARTED|Overall Study||96||
59751295|NCT00920816|75870557|FG002|STARTED|Overall Study||135||
59881556|NCT04292535|76004414|FG002|NOT COMPLETED|Overall Study||0||
59881557|NCT04292535|76004415|FG003|NOT COMPLETED|Overall Study||0||
59881558|NCT04292535|76004416|FG004|NOT COMPLETED|Overall Study||0||
59881559|NCT04292535|76004417|FG005|NOT COMPLETED|Overall Study||0||
59881560|NCT04292535|76004418|FG006|NOT COMPLETED|Overall Study||0||
59881561|NCT04292535|76004419|FG007|NOT COMPLETED|Overall Study||2||
59881562|NCT04292535|76004420|FG008|NOT COMPLETED|Overall Study||0||
60138008|NCT01276821|76260764|FG000|COMPLETED|Overall Study||50||
60138009|NCT01276821|76260765|FG001|COMPLETED|Overall Study||49||
60138010|NCT01276821|76260764|FG000|NOT COMPLETED|Overall Study||0||
60138011|NCT01276821|76260765|FG001|NOT COMPLETED|Overall Study||1||
60138012|NCT00245037|76260771|FG000|STARTED|Overall Study||147||
60138013|NCT00245037|76260771|FG000|COMPLETED|Overall Study|17 participants died from infectious complications.|130||
60138014|NCT00245037|76260771|FG000|NOT COMPLETED|Overall Study||17||
60138015|NCT00241839|76260777|FG000|STARTED|Overall Study||71||
59881563|NCT04292535|76004421|FG009|NOT COMPLETED|Overall Study||0||
59881564|NCT04292535|76004422|FG010|NOT COMPLETED|Overall Study||0||
59881565|NCT04292535|76004423|FG011|NOT COMPLETED|Overall Study||1||
59881566|NCT04292535|76004424|FG012|NOT COMPLETED|Overall Study||1||
59881567|NCT04292535|76004425|FG013|NOT COMPLETED|Overall Study||2||
59881568|NCT04385199|76004457|FG000|STARTED|Overall Study||20||
59881569|NCT04385199|76004458|FG001|STARTED|Overall Study||10||
59881570|NCT04385199|76004457|FG000|COMPLETED|Overall Study||19||
59881571|NCT04385199|76004458|FG001|COMPLETED|Overall Study||10||
59881572|NCT04385199|76004457|FG000|NOT COMPLETED|Overall Study||1||
59881573|NCT04385199|76004458|FG001|NOT COMPLETED|Overall Study||0||
59881574|NCT04284813|76004464|FG000|STARTED|Overall Study|One family member participant was assigned to the intervention but did not start the intervention due to withdrawal by subject.|21||
59881575|NCT04284813|76004464|FG000|COMPLETED|Overall Study||20||
59881576|NCT04284813|76004464|FG000|NOT COMPLETED|Overall Study||1||
59881577|NCT03263780|76004468|FG000|STARTED|Overall Study||21||
59881578|NCT03263780|76004468|FG000|COMPLETED|Overall Study|13 evaluable for primary outcome, but 11 total completed study.|11||
59881579|NCT03263780|76004468|FG000|NOT COMPLETED|Overall Study||10||
59881580|NCT02791438|76004474|FG000|STARTED|Run-In Period||22||
59881581|NCT02791438|76004475|FG001|STARTED|Run-In Period||5||
59881582|NCT02791438|76004474|FG000|COMPLETED|Run-In Period||22||
60138016|NCT00241839|76260778|FG001|STARTED|Overall Study||71||
59881583|NCT02791438|76004475|FG001|COMPLETED|Run-In Period||5||
59881584|NCT02791438|76004474|FG000|NOT COMPLETED|Run-In Period||0||
60138017|NCT00241839|76260777|FG000|COMPLETED|Overall Study|N=52 represents number with both baseline and 8-10 week data. N<52 implies missing data.|52||
60138018|NCT00241839|76260778|FG001|COMPLETED|Overall Study|N=53 represents number with both baseline and 8-10 week data. N<53 implies missing data.|53||
60138019|NCT00241839|76260777|FG000|NOT COMPLETED|Overall Study||19||
60138020|NCT00241839|76260778|FG001|NOT COMPLETED|Overall Study||18||
60138021|NCT02651688|76260787|FG000|STARTED|Overall Study||18||
60138022|NCT02651688|76260788|FG001|STARTED|Overall Study||17||
60138023|NCT02651688|76260789|FG002|STARTED|Overall Study||15||
60138024|NCT02651688|76260787|FG000|COMPLETED|Overall Study||16||
60138025|NCT02651688|76260788|FG001|COMPLETED|Overall Study||12||
60138026|NCT02651688|76260789|FG002|COMPLETED|Overall Study||12||
60138027|NCT02651688|76260787|FG000|NOT COMPLETED|Overall Study||2||
60138028|NCT02651688|76260788|FG001|NOT COMPLETED|Overall Study||5||
60138029|NCT02651688|76260789|FG002|NOT COMPLETED|Overall Study||3||
60138030|NCT01276353|76260799|FG000|STARTED|Double-blind||22||
59881585|NCT02791438|76004475|FG001|NOT COMPLETED|Run-In Period||0||
59881586|NCT02791438|76004474|FG000|STARTED|Treatment Period||22||
59881587|NCT02791438|76004475|FG001|STARTED|Treatment Period||5||
59881588|NCT02791438|76004474|FG000|COMPLETED|Treatment Period||19||
59881589|NCT02791438|76004475|FG001|COMPLETED|Treatment Period||4||
59881590|NCT02791438|76004474|FG000|NOT COMPLETED|Treatment Period||3||
59881591|NCT02791438|76004475|FG001|NOT COMPLETED|Treatment Period||1||
59881592|NCT03712124|76004483|FG000|STARTED|Overall Study||10||
60138031|NCT01276353|76260800|FG001|STARTED|Double-blind||23||
60138032|NCT01276353|76260799|FG000|COMPLETED|Double-blind||19||
60138033|NCT01276353|76260800|FG001|COMPLETED|Double-blind||23||
60138034|NCT01276353|76260799|FG000|NOT COMPLETED|Double-blind||3||
60138035|NCT01276353|76260800|FG001|NOT COMPLETED|Double-blind||0||
60138036|NCT01276353|76260799|FG000|STARTED|Extension||19||
60138037|NCT01276353|76260800|FG001|STARTED|Extension||23||
60138038|NCT01276353|76260799|FG000|COMPLETED|Extension||12||
60138039|NCT01276353|76260800|FG001|COMPLETED|Extension||14||
60138040|NCT01276353|76260799|FG000|NOT COMPLETED|Extension||7||
60138041|NCT01276353|76260800|FG001|NOT COMPLETED|Extension||9||
60138042|NCT00762021|76260812|FG000|STARTED|Overall Study||52||
60138043|NCT00762021|76260813|FG001|STARTED|Overall Study||52||
60138044|NCT00762021|76260812|FG000|COMPLETED|Overall Study||44||
60138045|NCT00762021|76260813|FG001|COMPLETED|Overall Study||44||
60138046|NCT00762021|76260812|FG000|NOT COMPLETED|Overall Study||8||
60138047|NCT00762021|76260813|FG001|NOT COMPLETED|Overall Study||8||
60138048|NCT00762177|76260822|FG000|STARTED|1st Treatment Period||8||
60138049|NCT00762177|76260823|FG001|STARTED|1st Treatment Period||8||
59751296|NCT00920816|75870558|FG003|STARTED|Overall Study||69||
60009938|NCT01782443|76125606|FG000|COMPLETED|Overall Study||19||
60009939|NCT01782443|76125606|FG000|NOT COMPLETED|Overall Study||0||
60009940|NCT01649232|76125613|FG000|STARTED|Overall Study||30||
60009941|NCT01649232|76125614|FG001|STARTED|Overall Study||30||
60009942|NCT01649232|76125613|FG000|COMPLETED|Overall Study|technical problems or excessive artifacts, two data sets were excluded from further analysis.|28||
60009943|NCT01649232|76125614|FG001|COMPLETED|Overall Study||30||
60009944|NCT01649232|76125613|FG000|NOT COMPLETED|Overall Study||2||
60009945|NCT01649232|76125614|FG001|NOT COMPLETED|Overall Study||0||
60009946|NCT00955968|76125628|FG000|STARTED|Overall Study||828||
60009947|NCT00955968|76125629|FG001|STARTED|Overall Study||825||
60009948|NCT00955968|76125628|FG000|COMPLETED|Overall Study||691||
60009949|NCT00955968|76125629|FG001|COMPLETED|Overall Study||699||
60009950|NCT00955968|76125628|FG000|NOT COMPLETED|Overall Study||137||
60138050|NCT00762177|76260824|FG002|STARTED|1st Treatment Period||8||
60138051|NCT00762177|76260822|FG000|COMPLETED|1st Treatment Period||8||
60138052|NCT00762177|76260823|FG001|COMPLETED|1st Treatment Period||8||
60138053|NCT00762177|76260824|FG002|COMPLETED|1st Treatment Period||8||
60138054|NCT00762177|76260822|FG000|NOT COMPLETED|1st Treatment Period||0||
60009951|NCT00955968|76125629|FG001|NOT COMPLETED|Overall Study||126||
60009952|NCT00896012|76125640|FG000|STARTED|Overall Study||29||
60009953|NCT00896012|76125641|FG001|STARTED|Overall Study||23||
60009954|NCT00896012|76125640|FG000|COMPLETED|Overall Study||18||
60009955|NCT00896012|76125641|FG001|COMPLETED|Overall Study||12||
60009956|NCT00896012|76125640|FG000|NOT COMPLETED|Overall Study||11||
60138055|NCT00762177|76260823|FG001|NOT COMPLETED|1st Treatment Period||0||
60138056|NCT00762177|76260824|FG002|NOT COMPLETED|1st Treatment Period||0||
60138057|NCT00762177|76260822|FG000|STARTED|Washout After 1st Treatment||8||
60138058|NCT00762177|76260823|FG001|STARTED|Washout After 1st Treatment||8||
60138059|NCT00762177|76260824|FG002|STARTED|Washout After 1st Treatment||8||
60138060|NCT00762177|76260822|FG000|COMPLETED|Washout After 1st Treatment||8||
59751297|NCT00920816|75870555|FG000|Treated|Overall Study||189||
60009957|NCT00896012|76125641|FG001|NOT COMPLETED|Overall Study||11||
60009958|NCT05310877|76125647|FG000|STARTED|Overall Study||7||
60009959|NCT05310877|76125647|FG000|COMPLETED|Overall Study||6||
60009960|NCT05310877|76125647|FG000|NOT COMPLETED|Overall Study||1||
60138061|NCT00762177|76260823|FG001|COMPLETED|Washout After 1st Treatment||8||
60138062|NCT00762177|76260824|FG002|COMPLETED|Washout After 1st Treatment||8||
60138063|NCT00762177|76260822|FG000|NOT COMPLETED|Washout After 1st Treatment||0||
60138064|NCT00762177|76260823|FG001|NOT COMPLETED|Washout After 1st Treatment||0||
60138065|NCT00762177|76260824|FG002|NOT COMPLETED|Washout After 1st Treatment||0||
60138066|NCT00762177|76260822|FG000|STARTED|2nd Treatment Period||8||
60138067|NCT00762177|76260823|FG001|STARTED|2nd Treatment Period||8||
60138068|NCT00762177|76260824|FG002|STARTED|2nd Treatment Period||8||
60138069|NCT00762177|76260822|FG000|COMPLETED|2nd Treatment Period||8||
60138070|NCT00762177|76260823|FG001|COMPLETED|2nd Treatment Period||8||
60138071|NCT00762177|76260824|FG002|COMPLETED|2nd Treatment Period||8||
60138072|NCT00762177|76260822|FG000|NOT COMPLETED|2nd Treatment Period||0||
60138073|NCT00762177|76260823|FG001|NOT COMPLETED|2nd Treatment Period||0||
60138074|NCT00762177|76260824|FG002|NOT COMPLETED|2nd Treatment Period||0||
60138075|NCT00762177|76260822|FG000|STARTED|Washout After 2nd Treatment||8||
60138076|NCT00762177|76260823|FG001|STARTED|Washout After 2nd Treatment||8||
60138077|NCT00762177|76260824|FG002|STARTED|Washout After 2nd Treatment||8||
60138078|NCT00762177|76260822|FG000|COMPLETED|Washout After 2nd Treatment||8||
60138079|NCT00762177|76260823|FG001|COMPLETED|Washout After 2nd Treatment||8||
60138080|NCT00762177|76260824|FG002|COMPLETED|Washout After 2nd Treatment||8||
60138081|NCT00762177|76260822|FG000|NOT COMPLETED|Washout After 2nd Treatment||0||
60138082|NCT00762177|76260823|FG001|NOT COMPLETED|Washout After 2nd Treatment||0||
60138083|NCT00762177|76260824|FG002|NOT COMPLETED|Washout After 2nd Treatment||0||
60138084|NCT00762177|76260822|FG000|STARTED|3rd Treatment Period||8||
60138085|NCT00762177|76260823|FG001|STARTED|3rd Treatment Period||8||
60138086|NCT00762177|76260824|FG002|STARTED|3rd Treatment Period||8||
60138087|NCT00762177|76260822|FG000|COMPLETED|3rd Treatment Period||8||
60138088|NCT00762177|76260823|FG001|COMPLETED|3rd Treatment Period||8||
60138089|NCT00762177|76260824|FG002|COMPLETED|3rd Treatment Period||8||
60138090|NCT00762177|76260822|FG000|NOT COMPLETED|3rd Treatment Period||0||
60138091|NCT00762177|76260823|FG001|NOT COMPLETED|3rd Treatment Period||0||
60138092|NCT00762177|76260824|FG002|NOT COMPLETED|3rd Treatment Period||0||
60138093|NCT02536794|76260835|FG000|STARTED|Reached 1st Response Assessment||30||
60138094|NCT02536794|76260835|FG000|Started Treatment|Reached 1st Response Assessment||30||
60138095|NCT02536794|76260835|FG000|Attempted First Cycle|Reached 1st Response Assessment||30||
60138096|NCT02536794|76260835|FG000|Attempted Second Cycle|Reached 1st Response Assessment||24||
60138097|NCT02536794|76260835|FG000|Reached First Response|Reached 1st Response Assessment||24||
60138098|NCT02536794|76260835|FG000|COMPLETED|Reached 1st Response Assessment||24||
60138099|NCT02536794|76260835|FG000|NOT COMPLETED|Reached 1st Response Assessment||6||
60138100|NCT02536794|76260835|FG000|STARTED|Continued Treatment After 1st Response||24||
60138101|NCT02536794|76260835|FG000|Went on to Start Cycle 3|Continued Treatment After 1st Response||16||
60138102|NCT02536794|76260835|FG000|COMPLETED|Continued Treatment After 1st Response||16||
60138103|NCT02536794|76260835|FG000|NOT COMPLETED|Continued Treatment After 1st Response||8||
60138104|NCT02536794|76260835|FG000|STARTED|Follow up for 3 Years or Death|one patient did not go into follow up as treatment was discontinued due to a protocol violation|29|All patients who are treated on study go into the follow up phase|
60138105|NCT02536794|76260835|FG000|COMPLETED|Follow up for 3 Years or Death||29||
60138106|NCT02536794|76260835|FG000|NOT COMPLETED|Follow up for 3 Years or Death||0||
59751298|NCT00920816|75870556|FG001|Treated|Overall Study||96||
59751299|NCT00920816|75870557|FG002|Treated|Overall Study||135||
59751300|NCT00920816|75870558|FG003|Treated|Overall Study||69||
60138107|NCT00749073|76260839|FG000|STARTED|Overall Study||10||
60138108|NCT00749073|76260839|FG000|COMPLETED|Overall Study||10||
60138109|NCT00749073|76260839|FG000|NOT COMPLETED|Overall Study||0||
60138110|NCT00777855|76260844|FG000|STARTED|First Intervention||5||
60138111|NCT00777855|76260845|FG001|STARTED|First Intervention||5||
60138112|NCT00777855|76260844|FG000|COMPLETED|First Intervention||5||
60138113|NCT00777855|76260845|FG001|COMPLETED|First Intervention||5||
60138114|NCT00777855|76260844|FG000|NOT COMPLETED|First Intervention||0||
60138115|NCT00777855|76260845|FG001|NOT COMPLETED|First Intervention||0||
60138116|NCT00777855|76260844|FG000|STARTED|Washout Period (>= 14 Days)||5||
60138117|NCT00777855|76260845|FG001|STARTED|Washout Period (>= 14 Days)||5||
60138118|NCT00777855|76260844|FG000|COMPLETED|Washout Period (>= 14 Days)||5||
60138119|NCT00777855|76260845|FG001|COMPLETED|Washout Period (>= 14 Days)||5||
60138120|NCT00777855|76260844|FG000|NOT COMPLETED|Washout Period (>= 14 Days)||0||
60138121|NCT00777855|76260845|FG001|NOT COMPLETED|Washout Period (>= 14 Days)||0||
60138122|NCT00777855|76260844|FG000|STARTED|Second Intervention||5||
60138123|NCT00777855|76260845|FG001|STARTED|Second Intervention||5||
60138124|NCT00777855|76260844|FG000|COMPLETED|Second Intervention||5||
60138125|NCT00777855|76260845|FG001|COMPLETED|Second Intervention||5||
60138126|NCT00777855|76260844|FG000|NOT COMPLETED|Second Intervention||0||
60138127|NCT00777855|76260845|FG001|NOT COMPLETED|Second Intervention||0||
59751301|NCT00920816|75870555|FG000|Participants From China (Excluded From Safety Analysis)|Overall Study||16||
60138128|NCT00758667|76260852|FG000|STARTED|Overall Study||9||
60138129|NCT00758667|76260853|FG001|STARTED|Overall Study||11||
59751302|NCT00920816|75870556|FG001|Participants From China (Excluded From Safety Analysis)|Overall Study||8||
60138130|NCT00758667|76260852|FG000|COMPLETED|Overall Study||9||
60138131|NCT00758667|76260853|FG001|COMPLETED|Overall Study||11||
60138132|NCT00758667|76260852|FG000|NOT COMPLETED|Overall Study||0||
60138133|NCT00758667|76260853|FG001|NOT COMPLETED|Overall Study||0||
60138134|NCT03509857|76260862|FG000|STARTED|Overall Study||50||
60138135|NCT03509857|76260863|FG001|STARTED|Overall Study||50||
60138136|NCT03509857|76260862|FG000|COMPLETED|Overall Study||50||
60138137|NCT03509857|76260863|FG001|COMPLETED|Overall Study||50||
60138138|NCT03509857|76260862|FG000|NOT COMPLETED|Overall Study||0||
60138139|NCT03509857|76260863|FG001|NOT COMPLETED|Overall Study||0||
60138140|NCT00758745|76260871|FG000|STARTED|Overall Study||81||
60138141|NCT00758745|76260872|FG001|STARTED|Overall Study||81||
60138142|NCT00758745|76260871|FG000|COMPLETED|Overall Study||60||
60138143|NCT00758745|76260872|FG001|COMPLETED|Overall Study||60||
60138144|NCT00758745|76260871|FG000|NOT COMPLETED|Overall Study||21||
60138145|NCT00758745|76260872|FG001|NOT COMPLETED|Overall Study||21||
60138146|NCT00778167|76260881|FG000|STARTED|Overall Study||6||
60138147|NCT00778167|76260882|FG001|STARTED|Overall Study||8||
60138148|NCT00778167|76260883|FG002|STARTED|Overall Study||4||
60138149|NCT00778167|76260881|FG000|COMPLETED|Overall Study||6||
60138150|NCT00778167|76260882|FG001|COMPLETED|Overall Study||8||
60138151|NCT00778167|76260883|FG002|COMPLETED|Overall Study||4||
60138152|NCT00778167|76260881|FG000|NOT COMPLETED|Overall Study||0||
60138153|NCT00778167|76260882|FG001|NOT COMPLETED|Overall Study||0||
60138154|NCT00778167|76260883|FG002|NOT COMPLETED|Overall Study||0||
60138155|NCT00778869|76260891|FG000|STARTED|Overall Study||10||
60138156|NCT00778869|76260891|FG000|COMPLETED|Overall Study||10||
60138157|NCT00778869|76260891|FG000|NOT COMPLETED|Overall Study||0||
60138158|NCT00779103|76260895|FG000|STARTED|Overall Study|Initial Phase (First Implant) - 36 Completed|36||
60138159|NCT00779103|76260895|FG000|Second & Third Implant|Overall Study|Initial Extension Phase/Extended Access Phase (Second and Third Implant) - 22 Completed|31||
60138160|NCT00779103|76260895|FG000|Fourth Implant|Overall Study|Second Extension Phase (4th Implant with Yearly Implantations till no longer required): 11 Completed|13||
60138161|NCT00779103|76260895|FG000|No Treatment|Overall Study|Optional Long Term Follow-up Phase (No Treatment)|9||
60138162|NCT00779103|76260895|FG000|COMPLETED|Overall Study|Initial Phase (First Implant)|36||
60138163|NCT00779103|76260895|FG000|NOT COMPLETED|Overall Study||0||
60138164|NCT01480076|76260905|FG000|STARTED|Overall Study|enrolled and started run-in treatment|901||
60138165|NCT01480076|76260905|FG000|Intent to Treat Population|Overall Study|Received ≥1 dose of study drug & provided ≥1 efficacy assessment at Baseline & the 3-month visit.|835||
60138166|NCT01480076|76260905|FG000|COMPLETED|Overall Study||611||
60138167|NCT01480076|76260905|FG000|NOT COMPLETED|Overall Study||290||
60138168|NCT00759525|76260921|FG000|STARTED|First Intervention (14 Days)||7||
60138169|NCT00759525|76260922|FG001|STARTED|First Intervention (14 Days)||8||
60138170|NCT00759525|76260921|FG000|COMPLETED|First Intervention (14 Days)||7||
60138171|NCT00759525|76260922|FG001|COMPLETED|First Intervention (14 Days)||8||
60138172|NCT00759525|76260921|FG000|NOT COMPLETED|First Intervention (14 Days)||0||
60138173|NCT00759525|76260922|FG001|NOT COMPLETED|First Intervention (14 Days)||0||
60138174|NCT00759525|76260921|FG000|STARTED|Washout (14 Days)||7||
60138175|NCT00759525|76260922|FG001|STARTED|Washout (14 Days)||8||
60138176|NCT00759525|76260921|FG000|COMPLETED|Washout (14 Days)||7||
60138177|NCT00759525|76260922|FG001|COMPLETED|Washout (14 Days)||8||
60138178|NCT00759525|76260921|FG000|NOT COMPLETED|Washout (14 Days)||0||
60138179|NCT00759525|76260922|FG001|NOT COMPLETED|Washout (14 Days)||0||
60138180|NCT00759525|76260921|FG000|STARTED|Second Intervention (14 Days)||7||
60138181|NCT00759525|76260922|FG001|STARTED|Second Intervention (14 Days)||8||
60138182|NCT00759525|76260921|FG000|COMPLETED|Second Intervention (14 Days)||7||
60138183|NCT00759525|76260922|FG001|COMPLETED|Second Intervention (14 Days)||8||
60138184|NCT00759525|76260921|FG000|NOT COMPLETED|Second Intervention (14 Days)||0||
60138185|NCT00759525|76260922|FG001|NOT COMPLETED|Second Intervention (14 Days)||0||
60138186|NCT00759603|76260928|FG000|STARTED|Overall Study||59||
60138187|NCT00759603|76260928|FG000|COMPLETED|Overall Study||59||
60138188|NCT00759603|76260928|FG000|NOT COMPLETED|Overall Study||0||
60138189|NCT03505099|76260934|FG000|STARTED|Overall Study||14||
60138190|NCT03505099|76260935|FG001|STARTED|Overall Study||15||
60138191|NCT03505099|76260934|FG000|Received AVXS-101|Overall Study||14||
60138192|NCT03505099|76260935|FG001|Received AVXS-101|Overall Study||15||
60138193|NCT03505099|76260934|FG000|COMPLETED|Overall Study||14||
60138194|NCT03505099|76260935|FG001|COMPLETED|Overall Study||15||
60138195|NCT03505099|76260934|FG000|NOT COMPLETED|Overall Study||0||
60138196|NCT03505099|76260935|FG001|NOT COMPLETED|Overall Study||0||
60138197|NCT04273737|76260941|FG000|STARTED|Overall Study||11||
60138198|NCT04273737|76260941|FG000|COMPLETED|Overall Study||11||
60138199|NCT04273737|76260941|FG000|NOT COMPLETED|Overall Study||0||
60138200|NCT00780741|76260947|FG000|STARTED|Overall Study|randomized|82||
60138201|NCT00780741|76260948|FG001|STARTED|Overall Study|randomized|81||
60138202|NCT00780741|76260947|FG000|6-Month Visit|Overall Study|6 months (±2 weeks) timed from randomization|73||
60138203|NCT00780741|76260948|FG001|6-Month Visit|Overall Study|6 months (±2 weeks) timed from randomization|67||
60138204|NCT00780741|76260947|FG000|COMPLETED|Overall Study|18 months of age (±4 weeks)|75||
60138205|NCT00780741|76260948|FG001|COMPLETED|Overall Study|18 months of age (±4 weeks)|71||
60138206|NCT00780741|76260947|FG000|NOT COMPLETED|Overall Study||7||
60138207|NCT00780741|76260948|FG001|NOT COMPLETED|Overall Study||10||
60138208|NCT00782379|76260955|FG000|STARTED|Overall Study||20||
60138209|NCT00782379|76260955|FG000|COMPLETED|Overall Study||20||
60138210|NCT00782379|76260955|FG000|NOT COMPLETED|Overall Study||0||
60138211|NCT00761007|76260963|FG000|STARTED|Overall Study||142||
60138212|NCT00761007|76260964|FG001|STARTED|Overall Study||135||
60138213|NCT00761007|76260965|FG002|STARTED|Overall Study||139||
60138214|NCT00761007|76260966|FG003|STARTED|Overall Study||138||
60138215|NCT00761007|76260963|FG000|Safety (>=1 Dose of Study Medication)|Overall Study||140||
60138216|NCT00761007|76260964|FG001|Safety (>=1 Dose of Study Medication)|Overall Study||135||
60138217|NCT00761007|76260965|FG002|Safety (>=1 Dose of Study Medication)|Overall Study||139||
60138218|NCT00761007|76260966|FG003|Safety (>=1 Dose of Study Medication)|Overall Study||137||
60138219|NCT00761007|76260963|FG000|ITT (>= 1 Assessment Post-Randomisation)|Overall Study||140||
60138220|NCT00761007|76260964|FG001|ITT (>= 1 Assessment Post-Randomisation)|Overall Study||133||
60138221|NCT00761007|76260965|FG002|ITT (>= 1 Assessment Post-Randomisation)|Overall Study||135||
60138222|NCT00761007|76260966|FG003|ITT (>= 1 Assessment Post-Randomisation)|Overall Study||136||
60138223|NCT00761007|76260963|FG000|COMPLETED|Overall Study||129||
60138224|NCT00761007|76260964|FG001|COMPLETED|Overall Study||124||
60138225|NCT00761007|76260965|FG002|COMPLETED|Overall Study||121||
60138226|NCT00761007|76260966|FG003|COMPLETED|Overall Study||131||
60138227|NCT00761007|76260963|FG000|NOT COMPLETED|Overall Study||13||
60138228|NCT00761007|76260964|FG001|NOT COMPLETED|Overall Study||11||
60138229|NCT00761007|76260965|FG002|NOT COMPLETED|Overall Study||18||
60138230|NCT00761007|76260966|FG003|NOT COMPLETED|Overall Study||7||
60138231|NCT00761085|76260980|FG000|STARTED|Overall Study||12||
60138232|NCT00761085|76260981|FG001|STARTED|Overall Study||12||
60138233|NCT00761085|76260982|FG002|STARTED|Overall Study||11||
60138234|NCT00761085|76260983|FG003|STARTED|Overall Study||12||
60138235|NCT00761085|76260980|FG000|COMPLETED|Overall Study||12||
60138236|NCT00761085|76260981|FG001|COMPLETED|Overall Study||6||
60138237|NCT00761085|76260982|FG002|COMPLETED|Overall Study||11||
60138238|NCT00761085|76260983|FG003|COMPLETED|Overall Study||8||
60138239|NCT00761085|76260980|FG000|NOT COMPLETED|Overall Study||0||
60138240|NCT00761085|76260981|FG001|NOT COMPLETED|Overall Study||6||
60138241|NCT00761085|76260982|FG002|NOT COMPLETED|Overall Study||0||
60138242|NCT00761085|76260983|FG003|NOT COMPLETED|Overall Study||4||
60138243|NCT02650128|76260993|FG000|STARTED|Overall Study||60||
60138244|NCT02650128|76260993|FG000|30 Day Primary and Safety Endpoint|Overall Study||60||
60138245|NCT02650128|76260993|FG000|COMPLETED|Overall Study||58|180 day major adverse cardiac event (Post-Market Clinical Follow-up)|
60138246|NCT02650128|76260993|FG000|NOT COMPLETED|Overall Study||2||
60138247|NCT02145039|76260998|FG000|STARTED|Overall Study||2||
60138248|NCT02145039|76260998|FG000|COMPLETED|Overall Study||2||
60138249|NCT02145039|76260998|FG000|NOT COMPLETED|Overall Study||0||
60138250|NCT02147301|76261002|FG000|STARTED|Overall Study||17||
60138251|NCT02147301|76261002|FG000|COMPLETED|Overall Study||17||
60138252|NCT02147301|76261002|FG000|NOT COMPLETED|Overall Study||0||
60138253|NCT01362270|76261008|FG000|STARTED|Overall Study||7||
60138254|NCT01362270|76261009|FG001|STARTED|Overall Study||8||
60138255|NCT01362270|76261008|FG000|COMPLETED|Overall Study||5||
60138256|NCT01362270|76261009|FG001|COMPLETED|Overall Study||6||
60138257|NCT01362270|76261008|FG000|NOT COMPLETED|Overall Study||2||
60138258|NCT01362270|76261009|FG001|NOT COMPLETED|Overall Study||2||
60138259|NCT02147613|76261017|FG000|STARTED|Overall Study||10||
60138260|NCT02147613|76261018|FG001|STARTED|Overall Study||9||
60138261|NCT02147613|76261017|FG000|COMPLETED|Overall Study||9||
60138262|NCT02147613|76261018|FG001|COMPLETED|Overall Study||6||
60138263|NCT02147613|76261017|FG000|NOT COMPLETED|Overall Study||1||
60138264|NCT02147613|76261018|FG001|NOT COMPLETED|Overall Study||3||
60138265|NCT02147769|76261024|FG000|STARTED|Overall Study||111||
60138266|NCT02147769|76261024|FG000|COMPLETED|Overall Study||111||
60138267|NCT02147769|76261024|FG000|NOT COMPLETED|Overall Study||0||
60138268|NCT00089479|76261030|FG000|STARTED|Overall Study||1304||
60138269|NCT00089479|76261031|FG001|STARTED|Overall Study||1307||
60138270|NCT00089479|76261030|FG000|Received Treatment|Overall Study|Safety Population (includes 19 patients randomized to ACXT, who received ACT)|1305||
60138271|NCT00089479|76261031|FG001|Received Treatment|Overall Study|Safety Population (includes 5 patients randomized to ACT, who received ACXT)|1283||
60138272|NCT00089479|76261030|FG000|COMPLETED|Overall Study|total includes Completed and Alive in follow-up|973||
60138273|NCT00089479|76261031|FG001|COMPLETED|Overall Study|total includes Completed and Alive in follow-up|1018||
60138274|NCT00089479|76261030|FG000|NOT COMPLETED|Overall Study||331||
60138275|NCT00089479|76261031|FG001|NOT COMPLETED|Overall Study||289||
60138276|NCT01463306|76261040|FG000|STARTED|Overall Study||384||
60138277|NCT01463306|76261041|FG001|STARTED|Overall Study||210||
60138278|NCT01463306|76261042|FG002|STARTED|Overall Study||11||
60138279|NCT01463306|76261040|FG000|COMPLETED|Overall Study||298||
60138280|NCT01463306|76261041|FG001|COMPLETED|Overall Study||158||
60138281|NCT01463306|76261042|FG002|COMPLETED|Overall Study||6||
60138282|NCT01463306|76261040|FG000|NOT COMPLETED|Overall Study||86||
60138283|NCT01463306|76261041|FG001|NOT COMPLETED|Overall Study||52||
60138284|NCT01463306|76261042|FG002|NOT COMPLETED|Overall Study||5||
60138285|NCT00765375|76261050|FG000|STARTED|Overall Study||5||
60138286|NCT00765375|76261050|FG000|COMPLETED|Overall Study||5||
60138287|NCT00765375|76261050|FG000|NOT COMPLETED|Overall Study||0||
60138288|NCT02149173|76261056|FG000|STARTED|Overall Study||29||
60138289|NCT02149173|76261056|FG000|COMPLETED|Overall Study||29||
60138290|NCT02149173|76261056|FG000|NOT COMPLETED|Overall Study||0||
60138291|NCT01504412|76261071|FG000|STARTED|Overall Study||89||
60138292|NCT01504412|76261072|FG001|STARTED|Overall Study||87||
60138293|NCT01504412|76261073|FG002|STARTED|Overall Study||90||
60138294|NCT01504412|76261074|FG003|STARTED|Overall Study||94||
60138295|NCT01504412|76261075|FG004|STARTED|Overall Study||90||
60138296|NCT01504412|76261071|FG000|COMPLETED|Overall Study||84||
60138297|NCT01504412|76261072|FG001|COMPLETED|Overall Study||75||
60138298|NCT01504412|76261073|FG002|COMPLETED|Overall Study||86||
60138299|NCT01504412|76261074|FG003|COMPLETED|Overall Study||75||
60138300|NCT01504412|76261075|FG004|COMPLETED|Overall Study||77||
60138301|NCT01504412|76261071|FG000|NOT COMPLETED|Overall Study||5||
60138302|NCT01504412|76261072|FG001|NOT COMPLETED|Overall Study||12||
60138303|NCT01504412|76261073|FG002|NOT COMPLETED|Overall Study||4||
60138304|NCT01504412|76261074|FG003|NOT COMPLETED|Overall Study||19||
60138305|NCT01504412|76261075|FG004|NOT COMPLETED|Overall Study||13||
60138306|NCT00784095|76261090|FG000|STARTED|Overall Study||12||
60138307|NCT00784095|76261091|FG001|STARTED|Overall Study||12||
60138308|NCT00784095|76261092|FG002|STARTED|Overall Study||12||
60138309|NCT00784095|76261090|FG000|COMPLETED|Overall Study||12||
60138310|NCT00784095|76261091|FG001|COMPLETED|Overall Study||11||
60138311|NCT00784095|76261092|FG002|COMPLETED|Overall Study||11||
60138312|NCT00784095|76261090|FG000|NOT COMPLETED|Overall Study||0||
60138313|NCT00784095|76261091|FG001|NOT COMPLETED|Overall Study||1||
60138314|NCT00784095|76261092|FG002|NOT COMPLETED|Overall Study||1||
60138315|NCT01503164|76261105|FG000|STARTED|Overall Study||55||
60138316|NCT01503164|76261106|FG001|STARTED|Overall Study||56||
60138317|NCT01503164|76261105|FG000|COMPLETED|Overall Study||53||
60138318|NCT01503164|76261106|FG001|COMPLETED|Overall Study||55||
60138319|NCT01503164|76261105|FG000|NOT COMPLETED|Overall Study||2||
60138320|NCT01503164|76261106|FG001|NOT COMPLETED|Overall Study||1||
60138321|NCT00088465|76261112|FG000|STARTED|Overall Study||931||
60138322|NCT00088465|76261112|FG000|COMPLETED|Overall Study||370||
60138323|NCT00088465|76261112|FG000|NOT COMPLETED|Overall Study||561||
60138324|NCT00784641|76261119|FG000|STARTED|Overall Study||189||
60138325|NCT00784641|76261120|FG001|STARTED|Overall Study||189||
60138326|NCT00784641|76261121|FG002|STARTED|Overall Study||189||
60138327|NCT00784641|76261119|FG000|COMPLETED|Overall Study||183||
60138328|NCT00784641|76261120|FG001|COMPLETED|Overall Study||186||
60138329|NCT00784641|76261121|FG002|COMPLETED|Overall Study||187||
60138330|NCT00784641|76261119|FG000|NOT COMPLETED|Overall Study||6||
60138331|NCT00784641|76261120|FG001|NOT COMPLETED|Overall Study||3||
60138332|NCT00784641|76261121|FG002|NOT COMPLETED|Overall Study||2||
60138333|NCT00793611|76261131|FG000|STARTED|Overall Study||10||
60138334|NCT00793611|76261132|FG001|STARTED|Overall Study||10||
60138335|NCT00793611|76261131|FG000|COMPLETED|Overall Study||10||
60138336|NCT00793611|76261132|FG001|COMPLETED|Overall Study||10||
60138337|NCT00793611|76261131|FG000|NOT COMPLETED|Overall Study||0||
60138338|NCT00793611|76261132|FG001|NOT COMPLETED|Overall Study||0||
60138339|NCT00088153|76261140|FG000|STARTED|Overall Study||55||
60138340|NCT00088153|76261141|FG001|STARTED|Overall Study||55||
60138341|NCT00088153|76261140|FG000|COMPLETED|Overall Study||31||
60138342|NCT00088153|76261141|FG001|COMPLETED|Overall Study||30||
60138343|NCT00088153|76261140|FG000|NOT COMPLETED|Overall Study||24||
60138344|NCT00088153|76261141|FG001|NOT COMPLETED|Overall Study||25||
60138345|NCT02074358|76261147|FG000|STARTED|Overall Study||3||
60138346|NCT02074358|76261148|FG001|STARTED|Overall Study||3||
60138347|NCT02074358|76261149|FG002|STARTED|Overall Study||2||
60138348|NCT02074358|76261150|FG003|STARTED|Overall Study||2||
60138349|NCT02074358|76261151|FG004|STARTED|Overall Study||3||
60138350|NCT02074358|76261152|FG005|STARTED|Overall Study||2||
60138351|NCT02074358|76261147|FG000|COMPLETED|Overall Study||3||
60138352|NCT02074358|76261148|FG001|COMPLETED|Overall Study||3||
60138353|NCT02074358|76261149|FG002|COMPLETED|Overall Study||2||
60138354|NCT02074358|76261150|FG003|COMPLETED|Overall Study||2||
60138355|NCT02074358|76261151|FG004|COMPLETED|Overall Study||3||
60138356|NCT02074358|76261152|FG005|COMPLETED|Overall Study||2||
60138357|NCT02074358|76261147|FG000|NOT COMPLETED|Overall Study||0||
60138358|NCT02074358|76261148|FG001|NOT COMPLETED|Overall Study||0||
60138359|NCT02074358|76261149|FG002|NOT COMPLETED|Overall Study||0||
60138360|NCT02074358|76261150|FG003|NOT COMPLETED|Overall Study||0||
60138361|NCT02074358|76261151|FG004|NOT COMPLETED|Overall Study||0||
60138362|NCT02074358|76261152|FG005|NOT COMPLETED|Overall Study||0||
60138363|NCT01502228|76261160|FG000|STARTED|Overall Study||14||
60138364|NCT01502228|76261160|FG000|COMPLETED|Overall Study||13||
60138365|NCT01502228|76261160|FG000|NOT COMPLETED|Overall Study||1||
60138366|NCT01502072|76261167|FG000|STARTED|Overall Study||14||
60138367|NCT01502072|76261168|FG001|STARTED|Overall Study||10||
60138368|NCT01502072|76261169|FG002|STARTED|Overall Study||20||
60138369|NCT01502072|76261167|FG000|COMPLETED|Overall Study||13||
60138370|NCT01502072|76261168|FG001|COMPLETED|Overall Study||9||
60138371|NCT01502072|76261169|FG002|COMPLETED|Overall Study||20||
60138372|NCT01502072|76261167|FG000|NOT COMPLETED|Overall Study||1||
60138373|NCT01502072|76261168|FG001|NOT COMPLETED|Overall Study||1||
60138374|NCT01502072|76261169|FG002|NOT COMPLETED|Overall Study||0||
60138375|NCT01462370|76261177|FG000|STARTED|Overall Study||69||
60138376|NCT01462370|76261178|FG001|STARTED|Overall Study||70||
60138377|NCT01462370|76261177|FG000|COMPLETED|Overall Study||68||
60138378|NCT01462370|76261178|FG001|COMPLETED|Overall Study||65||
60138379|NCT01462370|76261177|FG000|NOT COMPLETED|Overall Study||1||
60138380|NCT01462370|76261178|FG001|NOT COMPLETED|Overall Study||5||
60138381|NCT01479764|76261186|FG000|STARTED|Randomized||76||
60138382|NCT01479764|76261187|FG001|STARTED|Randomized||78||
60138383|NCT01479764|76261186|FG000|COMPLETED|Randomized|2 randomized participants did not receive study drug|74||
60138384|NCT01479764|76261187|FG001|COMPLETED|Randomized|1 randomized participant did not receive study drug|77||
60138385|NCT01479764|76261186|FG000|NOT COMPLETED|Randomized||2||
60138386|NCT01479764|76261187|FG001|NOT COMPLETED|Randomized||1||
60138387|NCT01479764|76261186|FG000|STARTED|Treated||74||
60138388|NCT01479764|76261187|FG001|STARTED|Treated||77||
60138389|NCT01479764|76261186|FG000|COMPLETED|Treated||74||
60138390|NCT01479764|76261187|FG001|COMPLETED|Treated||75||
60138391|NCT01479764|76261186|FG000|NOT COMPLETED|Treated||0||
60138392|NCT01479764|76261187|FG001|NOT COMPLETED|Treated||2||
60138393|NCT01479530|76261195|FG000|STARTED|Overall Study||158||
60138394|NCT01479530|76261196|FG001|STARTED|Overall Study||163||
60138395|NCT01479530|76261195|FG000|COMPLETED|Overall Study||148||
60138396|NCT01479530|76261196|FG001|COMPLETED|Overall Study||151||
60138397|NCT01479530|76261195|FG000|NOT COMPLETED|Overall Study||10||
60138398|NCT01479530|76261196|FG001|NOT COMPLETED|Overall Study||12||
60138399|NCT01479374|76261205|FG000|STARTED|Overall Study||66||
60138400|NCT01479374|76261206|FG001|STARTED|Overall Study||68||
60138401|NCT01479374|76261207|FG002|STARTED|Overall Study||68||
60138402|NCT01479374|76261205|FG000|COMPLETED|Overall Study||63||
60138403|NCT01479374|76261206|FG001|COMPLETED|Overall Study||60||
60138404|NCT01479374|76261207|FG002|COMPLETED|Overall Study||63||
60138405|NCT01479374|76261205|FG000|NOT COMPLETED|Overall Study||3||
60138406|NCT01479374|76261206|FG001|NOT COMPLETED|Overall Study||8||
60138407|NCT01479374|76261207|FG002|NOT COMPLETED|Overall Study||5||
60138408|NCT00087529|76261217|FG000|STARTED|Overall Study||147||
60138409|NCT00087529|76261218|FG001|STARTED|Overall Study||292||
60138410|NCT00087529|76261217|FG000|COMPLETED|Overall Study||116||
60138411|NCT00087529|76261218|FG001|COMPLETED|Overall Study||224||
60138412|NCT00087529|76261217|FG000|NOT COMPLETED|Overall Study||31||
60138413|NCT00087529|76261218|FG001|NOT COMPLETED|Overall Study||68||
60138414|NCT00794313|76261224|FG000|STARTED|Overall Study||1||
60138415|NCT00794313|76261225|FG001|STARTED|Overall Study||1||
60138416|NCT00794313|76261226|FG002|STARTED|Overall Study||1||
60138417|NCT00794313|76261224|FG000|COMPLETED|Overall Study||1||
60138418|NCT00794313|76261225|FG001|COMPLETED|Overall Study||1||
60138419|NCT00794313|76261226|FG002|COMPLETED|Overall Study||1||
60138420|NCT00794313|76261224|FG000|NOT COMPLETED|Overall Study||0||
60138421|NCT00794313|76261225|FG001|NOT COMPLETED|Overall Study||0||
60138422|NCT00794313|76261226|FG002|NOT COMPLETED|Overall Study||0||
60138423|NCT00794469|76261237|FG000|STARTED|Overall Study||21||
60138424|NCT00794469|76261237|FG000|COMPLETED|Overall Study||21||
60138425|NCT00794469|76261237|FG000|NOT COMPLETED|Overall Study||0||
60138426|NCT01500434|76261241|FG000|STARTED|Overall Study||102||
60138427|NCT01500434|76261241|FG000|COMPLETED|Overall Study||95||
60138428|NCT01500434|76261241|FG000|NOT COMPLETED|Overall Study||7||
60138429|NCT00087139|76261248|FG000|STARTED|Overall Study||39||
60138430|NCT00087139|76261249|FG001|STARTED|Overall Study||49||
60138431|NCT00087139|76261250|FG002|STARTED|Overall Study||36||
60138432|NCT00087139|76261248|FG000|Treated|Overall Study||39||
60138433|NCT00087139|76261249|FG001|Treated|Overall Study||48||
60138434|NCT00087139|76261250|FG002|Treated|Overall Study||36||
60138435|NCT00087139|76261248|FG000|Eligible and Treated|Overall Study||35||
60138436|NCT00087139|76261249|FG001|Eligible and Treated|Overall Study||42||
60138437|NCT00087139|76261250|FG002|Eligible and Treated|Overall Study||32||
60138438|NCT00087139|76261248|FG000|Patients for the Analysis of PSA Respons|Overall Study||30||
60138439|NCT00087139|76261249|FG001|Patients for the Analysis of PSA Respons|Overall Study||34||
60138440|NCT00087139|76261250|FG002|Patients for the Analysis of PSA Respons|Overall Study||22||
60138441|NCT00087139|76261248|FG000|Patients With Measurable Disease|Overall Study||22||
60138442|NCT00087139|76261249|FG001|Patients With Measurable Disease|Overall Study||25||
60138443|NCT00087139|76261250|FG002|Patients With Measurable Disease|Overall Study||24||
60138444|NCT00087139|76261248|FG000|Patients With PSA Response|Overall Study||10||
60138445|NCT00087139|76261249|FG001|Patients With PSA Response|Overall Study||8||
60138446|NCT00087139|76261250|FG002|Patients With PSA Response|Overall Study||4||
60138447|NCT00087139|76261248|FG000|Patients w/ Measurable Disease Response|Overall Study||5||
60138448|NCT00087139|76261249|FG001|Patients w/ Measurable Disease Response|Overall Study||2||
60138449|NCT00087139|76261250|FG002|Patients w/ Measurable Disease Response|Overall Study||0||
60138450|NCT00087139|76261248|FG000|COMPLETED|Overall Study||0||
59751303|NCT00920816|75870557|FG002|Participants From China (Excluded From Safety Analysis)|Overall Study||124||
59751304|NCT00920816|75870558|FG003|Participants From China (Excluded From Safety Analysis)|Overall Study||64||
59751305|NCT00920816|75870555|FG000|COMPLETED|Overall Study||0||
59751306|NCT00920816|75870556|FG001|COMPLETED|Overall Study||0||
59751307|NCT00920816|75870557|FG002|COMPLETED|Overall Study||0||
59751308|NCT00920816|75870558|FG003|COMPLETED|Overall Study||0||
59751309|NCT00920816|75870555|FG000|NOT COMPLETED|Overall Study||192||
59751310|NCT00920816|75870556|FG001|NOT COMPLETED|Overall Study||96||
59751311|NCT00920816|75870557|FG002|NOT COMPLETED|Overall Study||135||
59751312|NCT00920816|75870558|FG003|NOT COMPLETED|Overall Study||69||
59751313|NCT00657709|75870573|FG000|STARTED|Overall Study||833||
59881593|NCT03712124|76004484|FG001|STARTED|Overall Study||11||
59881594|NCT03712124|76004483|FG000|Received at Least 1 Dose of Study Drug|Overall Study||10||
59881595|NCT03712124|76004484|FG001|Received at Least 1 Dose of Study Drug|Overall Study||11||
59881596|NCT03712124|76004483|FG000|COMPLETED|Overall Study||9||
60138451|NCT00087139|76261249|FG001|COMPLETED|Overall Study||0||
60138452|NCT00087139|76261250|FG002|COMPLETED|Overall Study||0||
60138453|NCT00087139|76261248|FG000|NOT COMPLETED|Overall Study||39||
60138454|NCT00087139|76261249|FG001|NOT COMPLETED|Overall Study||49||
60138455|NCT00087139|76261250|FG002|NOT COMPLETED|Overall Study||36||
60138456|NCT00794547|76261256|FG000|STARTED|Overall Study||18||
60138457|NCT00794547|76261257|FG001|STARTED|Overall Study||16||
60138458|NCT00794547|76261256|FG000|COMPLETED|Overall Study||18||
60138459|NCT00794547|76261257|FG001|COMPLETED|Overall Study||16||
60138460|NCT00794547|76261256|FG000|NOT COMPLETED|Overall Study||0||
60138461|NCT00794547|76261257|FG001|NOT COMPLETED|Overall Study||0||
60138462|NCT00786825|76261263|FG000|STARTED|Overall Study||5||
60138463|NCT00786825|76261264|FG001|STARTED|Overall Study||5||
60138464|NCT00786825|76261263|FG000|COMPLETED|Overall Study||5||
60138465|NCT00786825|76261264|FG001|COMPLETED|Overall Study||5||
60138466|NCT00786825|76261263|FG000|NOT COMPLETED|Overall Study||0||
60138467|NCT00786825|76261264|FG001|NOT COMPLETED|Overall Study||0||
60138468|NCT00768261|76261274|FG000|STARTED|Overall Study||14||
60138469|NCT00768261|76261275|FG001|STARTED|Overall Study||18||
59881597|NCT03712124|76004484|FG001|COMPLETED|Overall Study||11||
59881598|NCT03712124|76004483|FG000|NOT COMPLETED|Overall Study||1||
59881599|NCT03712124|76004484|FG001|NOT COMPLETED|Overall Study||0||
59881600|NCT03689582|76004490|FG000|STARTED|Overall Study||11||
59881601|NCT03689582|76004490|FG000|COMPLETED|Overall Study||11||
59881602|NCT03689582|76004490|FG000|NOT COMPLETED|Overall Study||0||
59881603|NCT02791516|76004498|FG000|STARTED|Overall Study||33||
59881604|NCT02791516|76004499|FG001|STARTED|Overall Study||34||
59881605|NCT02791516|76004498|FG000|Completed 6-month Treatment Period|Overall Study||33||
59881606|NCT02791516|76004499|FG001|Completed 6-month Treatment Period|Overall Study||33||
59881607|NCT02791516|76004498|FG000|COMPLETED|Overall Study||32|Completed 9-month study period|
59881608|NCT02791516|76004499|FG001|COMPLETED|Overall Study||33|Completed 9-month study period|
59881609|NCT02791516|76004498|FG000|NOT COMPLETED|Overall Study||1||
59881610|NCT02791516|76004499|FG001|NOT COMPLETED|Overall Study||1||
59881611|NCT03263702|76004507|FG000|STARTED|Overall Study||38||
59881612|NCT03263702|76004508|FG001|STARTED|Overall Study||26||
59881613|NCT03263702|76004507|FG000|COMPLETED|Overall Study||35||
59881614|NCT03263702|76004508|FG001|COMPLETED|Overall Study||22||
60009961|NCT05062759|76125653|FG000|STARTED|Overall Study||35||
60009962|NCT05062759|76125654|FG001|STARTED|Overall Study||35||
60009963|NCT05062759|76125653|FG000|COMPLETED|Overall Study||34||
60009964|NCT05062759|76125654|FG001|COMPLETED|Overall Study||34||
60009965|NCT05062759|76125653|FG000|NOT COMPLETED|Overall Study||1||
60009966|NCT05062759|76125654|FG001|NOT COMPLETED|Overall Study||1||
60009967|NCT05047640|76125662|FG000|STARTED|Overall Study||30||
60009968|NCT05047640|76125663|FG001|STARTED|Overall Study||28||
60009969|NCT05047640|76125662|FG000|COMPLETED|Overall Study||30||
60138470|NCT00768261|76261276|FG002|STARTED|Overall Study||39||
60138471|NCT00768261|76261277|FG003|STARTED|Overall Study||56||
60138472|NCT00768261|76261274|FG000|COMPLETED|Overall Study||14||
59751314|NCT00657709|75870574|FG001|STARTED|Overall Study||828||
59881615|NCT03263702|76004507|FG000|NOT COMPLETED|Overall Study||3||
59881616|NCT03263702|76004508|FG001|NOT COMPLETED|Overall Study||4||
59881617|NCT04130919|76004517|FG000|STARTED|Blinded Treatment Phase||7||
59881618|NCT04130919|76004518|FG001|STARTED|Blinded Treatment Phase||6||
59881619|NCT04130919|76004519|FG002|STARTED|Blinded Treatment Phase||6||
59881620|NCT04130919|76004520|FG003|STARTED|Blinded Treatment Phase||0||
60138473|NCT00768261|76261275|FG001|COMPLETED|Overall Study||18||
60138474|NCT00768261|76261276|FG002|COMPLETED|Overall Study||14||
60138475|NCT00768261|76261277|FG003|COMPLETED|Overall Study||56||
60138476|NCT00768261|76261274|FG000|NOT COMPLETED|Overall Study||0||
59751315|NCT00657709|75870575|FG002|STARTED|Overall Study||820||
59881621|NCT04130919|76004521|FG004|STARTED|Blinded Treatment Phase||0||
60009970|NCT05047640|76125663|FG001|COMPLETED|Overall Study||28||
60009971|NCT05047640|76125662|FG000|NOT COMPLETED|Overall Study||0||
60009972|NCT05047640|76125663|FG001|NOT COMPLETED|Overall Study||0||
60067893|NCT01785069|76183083|FG001|STARTED|Overall Study||76||
60138477|NCT00768261|76261275|FG001|NOT COMPLETED|Overall Study||0||
60138478|NCT00768261|76261276|FG002|NOT COMPLETED|Overall Study||25||
60138479|NCT00768261|76261277|FG003|NOT COMPLETED|Overall Study||0||
60138480|NCT00797277|76261292|FG000|STARTED|Overall Study||37||
60138481|NCT00797277|76261293|FG001|STARTED|Overall Study||30||
60138482|NCT00797277|76261292|FG000|COMPLETED|Overall Study||37||
60138483|NCT00797277|76261293|FG001|COMPLETED|Overall Study||30||
60138484|NCT00797277|76261292|FG000|NOT COMPLETED|Overall Study||0||
60138485|NCT00797277|76261293|FG001|NOT COMPLETED|Overall Study||0||
60138486|NCT01500278|76261302|FG000|STARTED|Week 0 - Week 12||457||
60138487|NCT01500278|76261303|FG001|STARTED|Week 0 - Week 12||458||
60138488|NCT01500278|76261302|FG000|COMPLETED|Week 0 - Week 12||426||
60138489|NCT01500278|76261303|FG001|COMPLETED|Week 0 - Week 12||428||
60138490|NCT01500278|76261302|FG000|NOT COMPLETED|Week 0 - Week 12||31||
60138491|NCT01500278|76261303|FG001|NOT COMPLETED|Week 0 - Week 12||30||
60138492|NCT01500278|76261302|FG000|STARTED|Week 13 - Week 104||426||
60138493|NCT01500278|76261303|FG001|STARTED|Week 13 - Week 104||428||
60138494|NCT01500278|76261302|FG000|COMPLETED|Week 13 - Week 104||287||
60138495|NCT01500278|76261303|FG001|COMPLETED|Week 13 - Week 104||302||
60138496|NCT01500278|76261302|FG000|NOT COMPLETED|Week 13 - Week 104||139||
60138497|NCT01500278|76261303|FG001|NOT COMPLETED|Week 13 - Week 104||126||
60138498|NCT00086281|76261326|FG000|STARTED|Phase 1||11||
60138499|NCT00086281|76261327|FG001|STARTED|Phase 1||12||
60138500|NCT00086281|76261328|FG002|STARTED|Phase 1||8||
60138501|NCT00086281|76261329|FG003|STARTED|Phase 1||11||
60138502|NCT00086281|76261330|FG004|STARTED|Phase 1||1||
60138503|NCT00086281|76261331|FG005|STARTED|Phase 1||3||
60138504|NCT00086281|76261332|FG006|STARTED|Phase 1||1||
60138505|NCT00086281|76261333|FG007|STARTED|Phase 1||1||
60138506|NCT00086281|76261334|FG008|STARTED|Phase 1||2||
60138507|NCT00086281|76261335|FG009|STARTED|Phase 1||1||
60138508|NCT00086281|76261336|FG010|STARTED|Phase 1||3||
60138509|NCT00086281|76261337|FG011|STARTED|Phase 1||1||
60138510|NCT00086281|76261338|FG012|STARTED|Phase 1||1||
60138511|NCT00086281|76261339|FG013|STARTED|Phase 1||1||
60138512|NCT00086281|76261340|FG014|STARTED|Phase 1||3||
60138513|NCT00086281|76261326|FG000|COMPLETED|Phase 1||11||
60138514|NCT00086281|76261327|FG001|COMPLETED|Phase 1||12||
60138515|NCT00086281|76261328|FG002|COMPLETED|Phase 1||8||
60138516|NCT00086281|76261329|FG003|COMPLETED|Phase 1||11||
60138517|NCT00086281|76261330|FG004|COMPLETED|Phase 1||1||
60138518|NCT00086281|76261331|FG005|COMPLETED|Phase 1||3||
60138519|NCT00086281|76261332|FG006|COMPLETED|Phase 1||1||
60138520|NCT00086281|76261333|FG007|COMPLETED|Phase 1||1||
60138521|NCT00086281|76261334|FG008|COMPLETED|Phase 1||2||
60138522|NCT00086281|76261335|FG009|COMPLETED|Phase 1||0||
60138523|NCT00086281|76261336|FG010|COMPLETED|Phase 1||0||
60138524|NCT00086281|76261337|FG011|COMPLETED|Phase 1||0||
60138525|NCT00086281|76261338|FG012|COMPLETED|Phase 1||0||
60138526|NCT00086281|76261339|FG013|COMPLETED|Phase 1||0||
60138527|NCT00086281|76261340|FG014|COMPLETED|Phase 1||0||
60138528|NCT00086281|76261326|FG000|NOT COMPLETED|Phase 1||0||
60138529|NCT00086281|76261327|FG001|NOT COMPLETED|Phase 1||0||
60138530|NCT00086281|76261328|FG002|NOT COMPLETED|Phase 1||0||
60138531|NCT00086281|76261329|FG003|NOT COMPLETED|Phase 1||0||
60138532|NCT00086281|76261330|FG004|NOT COMPLETED|Phase 1||0||
60138533|NCT00086281|76261331|FG005|NOT COMPLETED|Phase 1||0||
60138534|NCT00086281|76261332|FG006|NOT COMPLETED|Phase 1||0||
60138535|NCT00086281|76261333|FG007|NOT COMPLETED|Phase 1||0||
60138536|NCT00086281|76261334|FG008|NOT COMPLETED|Phase 1||0||
60138537|NCT00086281|76261335|FG009|NOT COMPLETED|Phase 1||1||
60138538|NCT00086281|76261336|FG010|NOT COMPLETED|Phase 1||3||
60138539|NCT00086281|76261337|FG011|NOT COMPLETED|Phase 1||1||
60138540|NCT00086281|76261338|FG012|NOT COMPLETED|Phase 1||1||
60138541|NCT00086281|76261339|FG013|NOT COMPLETED|Phase 1||1||
60138542|NCT00086281|76261340|FG014|NOT COMPLETED|Phase 1||3||
60138543|NCT00086281|76261326|FG000|STARTED|Phase 2||0||
60138544|NCT00086281|76261327|FG001|STARTED|Phase 2||0||
60138545|NCT00086281|76261328|FG002|STARTED|Phase 2||0||
60138546|NCT00086281|76261329|FG003|STARTED|Phase 2||0||
60138547|NCT00086281|76261330|FG004|STARTED|Phase 2||0||
60138548|NCT00086281|76261331|FG005|STARTED|Phase 2||0||
60138549|NCT00086281|76261332|FG006|STARTED|Phase 2||0||
60138550|NCT00086281|76261333|FG007|STARTED|Phase 2||0||
60138551|NCT00086281|76261334|FG008|STARTED|Phase 2||0||
60138552|NCT00086281|76261335|FG009|STARTED|Phase 2||0||
60138553|NCT00086281|76261336|FG010|STARTED|Phase 2||0||
60138554|NCT00086281|76261337|FG011|STARTED|Phase 2||0||
60138555|NCT00086281|76261338|FG012|STARTED|Phase 2||23||
60138556|NCT00086281|76261339|FG013|STARTED|Phase 2||27||
60138557|NCT00086281|76261340|FG014|STARTED|Phase 2||0||
60138558|NCT00086281|76261326|FG000|COMPLETED|Phase 2||0||
60138559|NCT00086281|76261327|FG001|COMPLETED|Phase 2||0||
60138560|NCT00086281|76261328|FG002|COMPLETED|Phase 2||0||
60138561|NCT00086281|76261329|FG003|COMPLETED|Phase 2||0||
60138562|NCT00086281|76261330|FG004|COMPLETED|Phase 2||0||
60138563|NCT00086281|76261331|FG005|COMPLETED|Phase 2||0||
60138564|NCT00086281|76261332|FG006|COMPLETED|Phase 2||0||
60138565|NCT00086281|76261333|FG007|COMPLETED|Phase 2||0||
60138566|NCT00086281|76261334|FG008|COMPLETED|Phase 2||0||
60138567|NCT00086281|76261335|FG009|COMPLETED|Phase 2||0||
60138568|NCT00086281|76261336|FG010|COMPLETED|Phase 2||0||
60138569|NCT00086281|76261337|FG011|COMPLETED|Phase 2||0||
60138570|NCT00086281|76261338|FG012|COMPLETED|Phase 2||22||
59881622|NCT04130919|76004522|FG005|STARTED|Blinded Treatment Phase||0||
59881623|NCT04130919|76004517|FG000|COMPLETED|Blinded Treatment Phase||5||
59881624|NCT04130919|76004518|FG001|COMPLETED|Blinded Treatment Phase||4||
59881625|NCT04130919|76004519|FG002|COMPLETED|Blinded Treatment Phase||3||
60009973|NCT05033262|76125673|FG000|STARTED|Overall Study||3|After initial verbal screening and randomization, 4 dyads did not participant in the study. These dyads stopped answering calls after initial verbal consent.|
60009974|NCT05033262|76125674|FG001|STARTED|Overall Study||3|After initial verbal screening and randomization, 4 dyads did not participant in the study. These dyads stopped answering calls after initial verbal consent.|
60009975|NCT05033262|76125675|FG002|STARTED|Overall Study||4|After initial verbal screening and randomization, 4 dyads did not participant in the study. These dyads stopped answering calls after initial verbal consent.|
60009976|NCT05033262|76125676|FG003|STARTED|Overall Study||4|After initial verbal screening and randomization, 4 dyads did not participant in the study. These dyads stopped answering calls after initial verbal consent.|
60009977|NCT05033262|76125673|FG000|COMPLETED|Overall Study||2||
60009978|NCT05033262|76125674|FG001|COMPLETED|Overall Study||3||
60009979|NCT05033262|76125675|FG002|COMPLETED|Overall Study||4||
60009980|NCT05033262|76125676|FG003|COMPLETED|Overall Study||3||
60009981|NCT05033262|76125673|FG000|NOT COMPLETED|Overall Study||1||
60009982|NCT05033262|76125674|FG001|NOT COMPLETED|Overall Study||0||
60009983|NCT05033262|76125675|FG002|NOT COMPLETED|Overall Study||0||
60009984|NCT05033262|76125676|FG003|NOT COMPLETED|Overall Study||1||
60009985|NCT04963062|76125690|FG000|STARTED|Overall Study||56||
60009986|NCT04963062|76125691|FG001|STARTED|Overall Study||58||
60009987|NCT04963062|76125690|FG000|COMPLETED|Overall Study||52||
60009988|NCT04963062|76125691|FG001|COMPLETED|Overall Study||56||
59881626|NCT04130919|76004520|FG003|COMPLETED|Blinded Treatment Phase||0||
59881627|NCT04130919|76004521|FG004|COMPLETED|Blinded Treatment Phase||0||
59881628|NCT04130919|76004522|FG005|COMPLETED|Blinded Treatment Phase||0||
59881629|NCT04130919|76004517|FG000|NOT COMPLETED|Blinded Treatment Phase||2||
59881630|NCT04130919|76004518|FG001|NOT COMPLETED|Blinded Treatment Phase||2||
60009989|NCT04963062|76125690|FG000|NOT COMPLETED|Overall Study||4||
60009990|NCT04963062|76125691|FG001|NOT COMPLETED|Overall Study||2||
60009991|NCT04900220|76125703|FG000|STARTED|Overall Study||33||
60009992|NCT04900220|76125704|FG001|STARTED|Overall Study||33||
60009993|NCT04900220|76125703|FG000|COMPLETED|Overall Study||32||
60009994|NCT04900220|76125704|FG001|COMPLETED|Overall Study||32||
60009995|NCT04900220|76125703|FG000|NOT COMPLETED|Overall Study||1||
60138571|NCT00086281|76261339|FG013|COMPLETED|Phase 2||26||
60138572|NCT00086281|76261340|FG014|COMPLETED|Phase 2||0||
60138573|NCT00086281|76261326|FG000|NOT COMPLETED|Phase 2||0||
60138574|NCT00086281|76261327|FG001|NOT COMPLETED|Phase 2||0||
60138575|NCT00086281|76261328|FG002|NOT COMPLETED|Phase 2||0||
60138576|NCT00086281|76261329|FG003|NOT COMPLETED|Phase 2||0||
60138577|NCT00086281|76261330|FG004|NOT COMPLETED|Phase 2||0||
60138578|NCT00086281|76261331|FG005|NOT COMPLETED|Phase 2||0||
60138579|NCT00086281|76261332|FG006|NOT COMPLETED|Phase 2||0||
60138580|NCT00086281|76261333|FG007|NOT COMPLETED|Phase 2||0||
60138581|NCT00086281|76261334|FG008|NOT COMPLETED|Phase 2||0||
60138582|NCT00086281|76261335|FG009|NOT COMPLETED|Phase 2||0||
60138583|NCT00086281|76261336|FG010|NOT COMPLETED|Phase 2||0||
60138584|NCT00086281|76261337|FG011|NOT COMPLETED|Phase 2||0||
60138585|NCT00086281|76261338|FG012|NOT COMPLETED|Phase 2||1||
60138586|NCT00086281|76261339|FG013|NOT COMPLETED|Phase 2||1||
60138587|NCT00086281|76261340|FG014|NOT COMPLETED|Phase 2||0||
60138588|NCT00086047|76261352|FG000|STARTED|Overall Study||57||
60138589|NCT00086047|76261353|FG001|STARTED|Overall Study||57||
60138590|NCT00086047|76261352|FG000|COMPLETED|Overall Study||50||
60138591|NCT00086047|76261353|FG001|COMPLETED|Overall Study||50||
60138592|NCT00086047|76261352|FG000|NOT COMPLETED|Overall Study||7||
60138593|NCT00086047|76261353|FG001|NOT COMPLETED|Overall Study||7||
60138594|NCT00787761|76261359|FG000|STARTED|Overall Study||24||
60138595|NCT00787761|76261359|FG000|COMPLETED|Overall Study||24||
60138596|NCT00787761|76261359|FG000|NOT COMPLETED|Overall Study||0||
60138597|NCT01478828|76261365|FG000|STARTED|Overall Study||2||
60138598|NCT01478828|76261365|FG000|COMPLETED|Overall Study||1||
60138599|NCT01478828|76261365|FG000|NOT COMPLETED|Overall Study||1||
60138600|NCT00085423|76261370|FG000|STARTED|Overall Study||20||
60138601|NCT00085423|76261370|FG000|COMPLETED|Overall Study||18||
60138602|NCT00085423|76261370|FG000|NOT COMPLETED|Overall Study||2||
60138603|NCT00084487|76261374|FG000|STARTED|Overall Study||21||
60138604|NCT00084487|76261374|FG000|COMPLETED|Overall Study||20||
60138605|NCT00084487|76261374|FG000|NOT COMPLETED|Overall Study||1||
60138606|NCT00799227|76261378|FG000|STARTED|Overall Study||56||
60138607|NCT00799227|76261378|FG000|COMPLETED|Overall Study||53||
60138608|NCT00799227|76261378|FG000|NOT COMPLETED|Overall Study||3||
60138609|NCT00770133|76261386|FG000|STARTED|Overall Study||35||
60138610|NCT00770133|76261387|FG001|STARTED|Overall Study||36||
60138611|NCT00770133|76261388|FG002|STARTED|Overall Study||35||
60138612|NCT00770133|76261389|FG003|STARTED|Overall Study||35||
60138613|NCT00770133|76261386|FG000|COMPLETED|Overall Study||32||
60138614|NCT00770133|76261387|FG001|COMPLETED|Overall Study||35||
60138615|NCT00770133|76261388|FG002|COMPLETED|Overall Study||32||
60138616|NCT00770133|76261389|FG003|COMPLETED|Overall Study||32||
60138617|NCT00770133|76261386|FG000|NOT COMPLETED|Overall Study||3||
60138618|NCT00770133|76261387|FG001|NOT COMPLETED|Overall Study||1||
60138619|NCT00770133|76261388|FG002|NOT COMPLETED|Overall Study||3||
60138620|NCT00770133|76261389|FG003|NOT COMPLETED|Overall Study||3||
60138621|NCT00800865|76261401|FG000|STARTED|Overall Study||15||
60138622|NCT00800865|76261402|FG001|STARTED|Overall Study||16||
60138623|NCT00800865|76261401|FG000|COMPLETED|Overall Study||15||
60138624|NCT00800865|76261402|FG001|COMPLETED|Overall Study||16||
60138625|NCT00800865|76261401|FG000|NOT COMPLETED|Overall Study||0||
60138626|NCT00800865|76261402|FG001|NOT COMPLETED|Overall Study||0||
60138627|NCT00770757|76261408|FG000|STARTED|Overall Study||13||
60138628|NCT00770757|76261408|FG000|COMPLETED|Overall Study||13||
60138629|NCT00770757|76261408|FG000|NOT COMPLETED|Overall Study||0||
60138630|NCT01425281|76261414|FG000|STARTED|At 30-day Clinical Follow-up|Intent-to-Treat (ITT) Population|335||
60138631|NCT01425281|76261415|FG001|STARTED|At 30-day Clinical Follow-up|Intent-to-Treat (ITT) Population|166||
60138632|NCT01425281|76261414|FG000|COMPLETED|At 30-day Clinical Follow-up||334||
60138633|NCT01425281|76261415|FG001|COMPLETED|At 30-day Clinical Follow-up||166||
60138634|NCT01425281|76261414|FG000|NOT COMPLETED|At 30-day Clinical Follow-up||1||
60138635|NCT01425281|76261415|FG001|NOT COMPLETED|At 30-day Clinical Follow-up||0||
60138636|NCT01425281|76261414|FG000|STARTED|At 180-day Clinical Follow-up||334||
60138637|NCT01425281|76261415|FG001|STARTED|At 180-day Clinical Follow-up||166||
60138638|NCT01425281|76261414|FG000|COMPLETED|At 180-day Clinical Follow-up||331||
60138639|NCT01425281|76261415|FG001|COMPLETED|At 180-day Clinical Follow-up||165||
60138640|NCT01425281|76261414|FG000|NOT COMPLETED|At 180-day Clinical Follow-up||3||
60138641|NCT01425281|76261415|FG001|NOT COMPLETED|At 180-day Clinical Follow-up||1||
60138642|NCT01425281|76261414|FG000|STARTED|At 1-year Clinical Follow-up||331||
60138643|NCT01425281|76261415|FG001|STARTED|At 1-year Clinical Follow-up||165||
60138644|NCT01425281|76261414|FG000|COMPLETED|At 1-year Clinical Follow-up||329||
60138645|NCT01425281|76261415|FG001|COMPLETED|At 1-year Clinical Follow-up||164||
60138646|NCT01425281|76261414|FG000|NOT COMPLETED|At 1-year Clinical Follow-up||2||
60138647|NCT01425281|76261415|FG001|NOT COMPLETED|At 1-year Clinical Follow-up||1||
60138648|NCT01425281|76261414|FG000|STARTED|At 2-year Clinical Follow-up||329||
60138649|NCT01425281|76261415|FG001|STARTED|At 2-year Clinical Follow-up||164||
60138650|NCT01425281|76261414|FG000|COMPLETED|At 2-year Clinical Follow-up||323||
60138651|NCT01425281|76261415|FG001|COMPLETED|At 2-year Clinical Follow-up||163||
60138652|NCT01425281|76261414|FG000|NOT COMPLETED|At 2-year Clinical Follow-up||6||
60138653|NCT01425281|76261415|FG001|NOT COMPLETED|At 2-year Clinical Follow-up||1||
60138654|NCT01425281|76261414|FG000|STARTED|At 3-year Clinical Follow-up||323||
60138655|NCT01425281|76261415|FG001|STARTED|At 3-year Clinical Follow-up||163||
60138656|NCT01425281|76261414|FG000|COMPLETED|At 3-year Clinical Follow-up||318||
60138657|NCT01425281|76261415|FG001|COMPLETED|At 3-year Clinical Follow-up||157||
59605674|NCT01620528|75715838|FG001|Completed PTFU Month 12|Post-Treatment Follow-Up Period||5||
60138658|NCT01425281|76261414|FG000|NOT COMPLETED|At 3-year Clinical Follow-up||5||
60138659|NCT01425281|76261415|FG001|NOT COMPLETED|At 3-year Clinical Follow-up||6||
60138660|NCT01425281|76261414|FG000|STARTED|At 4-year Clinical Follow-up||318||
60138661|NCT01425281|76261415|FG001|STARTED|At 4-year Clinical Follow-up||157||
60138662|NCT01425281|76261414|FG000|COMPLETED|At 4-year Clinical Follow-up||288||
60138663|NCT01425281|76261415|FG001|COMPLETED|At 4-year Clinical Follow-up||136||
60138664|NCT01425281|76261414|FG000|NOT COMPLETED|At 4-year Clinical Follow-up||30||
60138665|NCT01425281|76261415|FG001|NOT COMPLETED|At 4-year Clinical Follow-up||21||
60138666|NCT01425281|76261414|FG000|STARTED|At 5-year Clinical Follow-up||288||
60138667|NCT01425281|76261415|FG001|STARTED|At 5-year Clinical Follow-up||136||
60138668|NCT01425281|76261414|FG000|COMPLETED|At 5-year Clinical Follow-up||256||
60138669|NCT01425281|76261415|FG001|COMPLETED|At 5-year Clinical Follow-up||125||
60138670|NCT01425281|76261414|FG000|NOT COMPLETED|At 5-year Clinical Follow-up||32||
60138671|NCT01425281|76261415|FG001|NOT COMPLETED|At 5-year Clinical Follow-up||11||
60138672|NCT00789867|76261425|FG000|STARTED|Overall Study||17||
60138673|NCT00789867|76261426|FG001|STARTED|Overall Study||10||
60138674|NCT00789867|76261427|FG002|STARTED|Overall Study||8||
60138675|NCT00789867|76261425|FG000|COMPLETED|Overall Study||17||
60138676|NCT00789867|76261426|FG001|COMPLETED|Overall Study||10||
60138677|NCT00789867|76261427|FG002|COMPLETED|Overall Study||8||
60138678|NCT00789867|76261425|FG000|NOT COMPLETED|Overall Study||0||
60138679|NCT00789867|76261426|FG001|NOT COMPLETED|Overall Study||0||
60138680|NCT00789867|76261427|FG002|NOT COMPLETED|Overall Study||0||
60138681|NCT02648724|76261443|FG000|STARTED|Overall Study||3||
60138682|NCT02648724|76261444|FG001|STARTED|Overall Study||3||
60138683|NCT02648724|76261445|FG002|STARTED|Overall Study||3||
60138684|NCT02648724|76261446|FG003|STARTED|Overall Study||3||
60138685|NCT02648724|76261447|FG004|STARTED|Overall Study||25||
60138686|NCT02648724|76261448|FG005|STARTED|Overall Study||8||
60138687|NCT02648724|76261449|FG006|STARTED|Overall Study||12||
60138688|NCT02648724|76261443|FG000|COMPLETED|Overall Study||0||
60138689|NCT02648724|76261444|FG001|COMPLETED|Overall Study||0||
60138690|NCT02648724|76261445|FG002|COMPLETED|Overall Study||0||
60138691|NCT02648724|76261446|FG003|COMPLETED|Overall Study||0||
60138692|NCT02648724|76261447|FG004|COMPLETED|Overall Study||0||
60138693|NCT02648724|76261448|FG005|COMPLETED|Overall Study||0||
60138694|NCT02648724|76261449|FG006|COMPLETED|Overall Study||0||
60138695|NCT02648724|76261443|FG000|NOT COMPLETED|Overall Study||3||
60138696|NCT02648724|76261444|FG001|NOT COMPLETED|Overall Study||3||
60138697|NCT02648724|76261445|FG002|NOT COMPLETED|Overall Study||3||
60138698|NCT02648724|76261446|FG003|NOT COMPLETED|Overall Study||3||
60138699|NCT02648724|76261447|FG004|NOT COMPLETED|Overall Study||25||
60138700|NCT02648724|76261448|FG005|NOT COMPLETED|Overall Study||8||
60138701|NCT02648724|76261449|FG006|NOT COMPLETED|Overall Study||12||
60138702|NCT01402817|76261481|FG000|STARTED|Overall Study||19||
60138703|NCT01402817|76261481|FG000|COMPLETED|Overall Study||8||
60138704|NCT01402817|76261481|FG000|NOT COMPLETED|Overall Study||11||
60138705|NCT01425203|76261488|FG000|STARTED|Treatment Phase||159||
60138706|NCT01425203|76261489|FG001|STARTED|Treatment Phase||79||
60138707|NCT01425203|76261490|FG002|STARTED|Treatment Phase||0||
60138708|NCT01425203|76261488|FG000|Treated (FAS)|Treatment Phase||159||
60138709|NCT01425203|76261489|FG001|Treated (FAS)|Treatment Phase||78||
60138710|NCT01425203|76261490|FG002|Treated (FAS)|Treatment Phase||0||
60138711|NCT01425203|76261488|FG000|COMPLETED|Treatment Phase||132||
60138712|NCT01425203|76261489|FG001|COMPLETED|Treatment Phase||42||
60138713|NCT01425203|76261490|FG002|COMPLETED|Treatment Phase||0||
60138714|NCT01425203|76261488|FG000|NOT COMPLETED|Treatment Phase||27||
60138715|NCT01425203|76261489|FG001|NOT COMPLETED|Treatment Phase||37||
59605675|NCT01620528|75715839|FG002|Completed PTFU Month 12|Post-Treatment Follow-Up Period||19||
59605676|NCT01620528|75715837|FG000|COMPLETED|Post-Treatment Follow-Up Period||48||
59605677|NCT01620528|75715838|FG001|COMPLETED|Post-Treatment Follow-Up Period||31||
59605678|NCT01620528|75715839|FG002|COMPLETED|Post-Treatment Follow-Up Period||37||
59605679|NCT01620528|75715837|FG000|NOT COMPLETED|Post-Treatment Follow-Up Period||20||
59605680|NCT01620528|75715838|FG001|NOT COMPLETED|Post-Treatment Follow-Up Period||17||
59605681|NCT01620528|75715839|FG002|NOT COMPLETED|Post-Treatment Follow-Up Period||14||
59605682|NCT01965834|75715847|FG000|STARTED|Overall Study||6||
59605683|NCT01965834|75715847|FG000|COMPLETED|Overall Study||2||
59605684|NCT01965834|75715847|FG000|NOT COMPLETED|Overall Study||4||
59605685|NCT01965600|75715851|FG000|STARTED|First Intervention||6||
60138716|NCT01425203|76261490|FG002|NOT COMPLETED|Treatment Phase||0||
60138717|NCT01425203|76261488|FG000|STARTED|Crossover Phase|Phase only for participants in PBO + PR Control arm who failed futility rule at TW12 or 24|0||
60138718|NCT01425203|76261489|FG001|STARTED|Crossover Phase|Phase only for participants in PBO + PR Control arm who failed futility rule at TW12 or 24|0||
60138719|NCT01425203|76261490|FG002|STARTED|Crossover Phase|Phase only for participants in PBO + PR Control arm who failed futility rule at TW12 or 24|27||
60138720|NCT01425203|76261488|FG000|COMPLETED|Crossover Phase||0||
60138721|NCT01425203|76261489|FG001|COMPLETED|Crossover Phase||0||
60138722|NCT01425203|76261490|FG002|COMPLETED|Crossover Phase||21||
60138723|NCT01425203|76261488|FG000|NOT COMPLETED|Crossover Phase||0||
60138724|NCT01425203|76261489|FG001|NOT COMPLETED|Crossover Phase||0||
60138725|NCT01425203|76261490|FG002|NOT COMPLETED|Crossover Phase||6||
60138726|NCT01425203|76261488|FG000|STARTED|Follow-up Phase|6 participants who started treatment in RGT BOC + PR arm did not enter follow-up.|153||
60138727|NCT01425203|76261489|FG001|STARTED|Follow-up Phase|27 starting treatment in PBO+PR Control arm switched to Crossover arm and 2 did not enter follow-up|49||
60138728|NCT01425203|76261490|FG002|STARTED|Follow-up Phase|All participants treated in crossover arm entered follow-up.|27||
60138729|NCT01425203|76261488|FG000|COMPLETED|Follow-up Phase||153||
60138730|NCT01425203|76261489|FG001|COMPLETED|Follow-up Phase||49||
60138731|NCT01425203|76261490|FG002|COMPLETED|Follow-up Phase||27||
60138732|NCT01425203|76261488|FG000|NOT COMPLETED|Follow-up Phase||0||
60138733|NCT01425203|76261489|FG001|NOT COMPLETED|Follow-up Phase||0||
60138734|NCT01425203|76261490|FG002|NOT COMPLETED|Follow-up Phase||0||
60138735|NCT00081289|76261500|FG000|STARTED|Overall Study||73||
60138736|NCT00081289|76261501|FG001|STARTED|Overall Study||73||
60138737|NCT00081289|76261500|FG000|Primary Endpoint Population|Overall Study||48|First 48 eligible patients accrued per arm after the protocol amendment|
60138738|NCT00081289|76261501|FG001|Primary Endpoint Population|Overall Study||48|First 48 eligible patients accrued per arm after the protocol amendment|
60138739|NCT00081289|76261500|FG000|General Analysis Population|Overall Study||52|Eligible participants enrolled after the protocol ammendment|
60138740|NCT00081289|76261501|FG001|General Analysis Population|Overall Study||52|Eligible participants enrolled after the protocol ammendment|
60138741|NCT00081289|76261500|FG000|Full AE Population|Overall Study||70|All eligible patients including those enrolled prior to protocol amendment|
60138742|NCT00081289|76261501|FG001|Full AE Population|Overall Study||68|All eligible patients including those enrolled prior to protocol amendment|
60138743|NCT00081289|76261500|FG000|Surgery|Overall Study||47|Eligible patients enrolled after the protocol amendment who had surgery|
60138744|NCT00081289|76261501|FG001|Surgery|Overall Study||51|Eligible patients enrolled after the protocol amendment who had surgery|
60138745|NCT00081289|76261500|FG000|Global Health Status Score at End of CR|Overall Study|European Organization for Research & Treatment of Cancer Quality of Life Questionnaire [EORTC QLQ]|34|EORTC QLQ-C30 Global Health Status (GHS) Score at baseline and end of chemoradiation (CR)|
60138746|NCT00081289|76261501|FG001|Global Health Status Score at End of CR|Overall Study||32|EORTC QLQ-C30 Global Health Status (GHS) Score at baseline and end of chemoradiation (CR)|
60138747|NCT00081289|76261500|FG000|GHS at End of Post-op CT|Overall Study||20|EORTC QLQ-C30 GHS Score at baseline and end of post-operative chemotherapy (CT)|
60138748|NCT00081289|76261501|FG001|GHS at End of Post-op CT|Overall Study||28|EORTC QLQ-C30 GHS Score at baseline and end of post-operative chemotherapy (CT)|
60138749|NCT00081289|76261500|FG000|GHS at Two Years|Overall Study||21|EORTC QLQ-C30 GHS Score at baseline and two years|
60138750|NCT00081289|76261501|FG001|GHS at Two Years|Overall Study||20|EORTC QLQ-C30 GHS Score at baseline and two years|
60138751|NCT00081289|76261500|FG000|GI Symptom Score at End of CR|Overall Study||34|EORTC QLQ-CR38 Gastro-Intestinal (GI) Symptom Score at baseline and end of chemoradiation|
60138752|NCT00081289|76261501|FG001|GI Symptom Score at End of CR|Overall Study||33|EORTC QLQ-CR38 Gastro-Intestinal (GI) Symptom Score at baseline and end of chemoradiation|
60138753|NCT00081289|76261500|FG000|GI Symptom Score at End of Post-op CT|Overall Study||22|EORTC QLQ-CR38 GI Symptom Score at baseline and end of post-operative chemotherapy|
60138754|NCT00081289|76261501|FG001|GI Symptom Score at End of Post-op CT|Overall Study||27|EORTC QLQ-CR38 GI Symptom Score at baseline and end of post-operative chemotherapy|
60138755|NCT00081289|76261500|FG000|GI Symptom Score at Two Years|Overall Study||21|EORTC QLQ-CR38 GI Symptom Score at baseline and two years|
60138756|NCT00081289|76261501|FG001|GI Symptom Score at Two Years|Overall Study||20|EORTC QLQ-CR38 GI Symptom Score at baseline and two years|
60138757|NCT00081289|76261500|FG000|Defecation Symptom Score at End of CR|Overall Study||32|EORTC QLQ-CR38 Defecation Symptom Score at baseline and end of chemoradiation|
60138758|NCT00081289|76261501|FG001|Defecation Symptom Score at End of CR|Overall Study||32|EORTC QLQ-CR38 Defecation Symptom Score at baseline and end of chemoradiation|
60138759|NCT00081289|76261500|FG000|DS Score at End of Post-op CT|Overall Study||12|EORTC QLQ-CR38 Defecation Symptom (DS) Score at baseline and end of post-operative chemotherapy|
60138760|NCT00081289|76261501|FG001|DS Score at End of Post-op CT|Overall Study||14|EORTC QLQ-CR38 Defecation Symptom (DS) Score at baseline and end of post-operative chemotherapy|
60138761|NCT00081289|76261500|FG000|Defecation Symptom Score at Two Years|Overall Study||13|EORTC QLQ-CR38 Defecation Symptom Score at baseline and two years|
60138762|NCT00081289|76261501|FG001|Defecation Symptom Score at Two Years|Overall Study||15|EORTC QLQ-CR38 Defecation Symptom Score at baseline and two years|
60138763|NCT00081289|76261500|FG000|COMPLETED|Overall Study||52|Subjects contributing any data to analysis are considered to have completed the study|
60138764|NCT00081289|76261501|FG001|COMPLETED|Overall Study||52|Subjects contributing any data to analysis are considered to have completed the study|
60138765|NCT00081289|76261500|FG000|NOT COMPLETED|Overall Study||21||
60138766|NCT00081289|76261501|FG001|NOT COMPLETED|Overall Study||21||
60138767|NCT01478594|76261510|FG000|STARTED|Overall Study||177||
60138768|NCT01478594|76261511|FG001|STARTED|Overall Study||88||
60138769|NCT01478594|76261510|FG000|Treated|Overall Study||177||
60138770|NCT01478594|76261511|FG001|Treated|Overall Study||87||
60138771|NCT01478594|76261510|FG000|COMPLETED|Overall Study|Participants still on study as of 28 February 2014|112||
60138772|NCT01478594|76261511|FG001|COMPLETED|Overall Study|Participants still on study as of 28 February 2014|60||
60138773|NCT01478594|76261510|FG000|NOT COMPLETED|Overall Study||65||
60138774|NCT01478594|76261511|FG001|NOT COMPLETED|Overall Study||28||
60138775|NCT01424813|76261572|FG000|STARTED|Overall Study||79||
60138776|NCT01424813|76261573|FG001|STARTED|Overall Study||79||
60138777|NCT01424813|76261572|FG000|Treated|Overall Study|Safety set and full analysis set|79||
60138778|NCT01424813|76261573|FG001|Treated|Overall Study|Safety set and full analysis set|78||
60138779|NCT01424813|76261572|FG000|COMPLETED|Overall Study||74||
60138780|NCT01424813|76261573|FG001|COMPLETED|Overall Study||77||
60138781|NCT01424813|76261572|FG000|NOT COMPLETED|Overall Study||5||
60138782|NCT01424813|76261573|FG001|NOT COMPLETED|Overall Study||2||
60138783|NCT00080899|76261579|FG000|STARTED|Overall Study||23||
60138784|NCT00080899|76261579|FG000|COMPLETED|Overall Study||22||
60138785|NCT00080899|76261579|FG000|NOT COMPLETED|Overall Study||1||
60138786|NCT00089635|76261583|FG000|STARTED|Overall Study||203||
60009996|NCT04900220|76125704|FG001|NOT COMPLETED|Overall Study||1||
60009997|NCT04726514|76125710|FG000|STARTED|Overall Study||10||
60009998|NCT04726514|76125710|FG000|COMPLETED|Overall Study||8||
60009999|NCT04726514|76125710|FG000|NOT COMPLETED|Overall Study||2||
60010000|NCT04599062|76125716|FG000|STARTED|Overall Study||6||
60010001|NCT04599062|76125717|FG001|STARTED|Overall Study||2||
60010002|NCT04599062|76125716|FG000|COMPLETED|Overall Study||5||
60010003|NCT04599062|76125717|FG001|COMPLETED|Overall Study||2||
60010004|NCT04599062|76125716|FG000|NOT COMPLETED|Overall Study||1||
60138787|NCT00089635|76261583|FG000|COMPLETED|Overall Study||160||
60138788|NCT00089635|76261583|FG000|NOT COMPLETED|Overall Study||43||
60138789|NCT03435835|76261587|FG000|STARTED|First Intervention||8||
60138790|NCT03435835|76261588|FG001|STARTED|First Intervention||8||
60138791|NCT03435835|76261587|FG000|COMPLETED|First Intervention||8||
60138792|NCT03435835|76261588|FG001|COMPLETED|First Intervention||8||
60138793|NCT03435835|76261587|FG000|NOT COMPLETED|First Intervention||0||
60138794|NCT03435835|76261588|FG001|NOT COMPLETED|First Intervention||0||
60138795|NCT03435835|76261587|FG000|STARTED|Washout||8||
60138796|NCT03435835|76261588|FG001|STARTED|Washout||8||
60138797|NCT03435835|76261587|FG000|COMPLETED|Washout||8||
60138798|NCT03435835|76261588|FG001|COMPLETED|Washout||8||
60138799|NCT03435835|76261587|FG000|NOT COMPLETED|Washout||0||
60138800|NCT03435835|76261588|FG001|NOT COMPLETED|Washout||0||
60138801|NCT03435835|76261587|FG000|STARTED|Second Intervention||8||
60138802|NCT03435835|76261588|FG001|STARTED|Second Intervention||8||
60138803|NCT03435835|76261587|FG000|COMPLETED|Second Intervention||8||
60138804|NCT03435835|76261588|FG001|COMPLETED|Second Intervention||8||
60138805|NCT03435835|76261587|FG000|NOT COMPLETED|Second Intervention||0||
60138806|NCT03435835|76261588|FG001|NOT COMPLETED|Second Intervention||0||
60138807|NCT01500200|76261597|FG000|STARTED|Stage 1||98||
60138808|NCT01500200|76261598|FG001|STARTED|Stage 1||24||
60138809|NCT01500200|76261599|FG002|STARTED|Stage 1||19||
60138810|NCT01500200|76261600|FG003|STARTED|Stage 1||0||
60138811|NCT01500200|76261601|FG004|STARTED|Stage 1||0||
60138812|NCT01500200|76261602|FG005|STARTED|Stage 1||0||
60138813|NCT01500200|76261597|FG000|COMPLETED|Stage 1||90||
60138814|NCT01500200|76261598|FG001|COMPLETED|Stage 1||18||
60138815|NCT01500200|76261599|FG002|COMPLETED|Stage 1||13||
60138816|NCT01500200|76261600|FG003|COMPLETED|Stage 1||0||
60138817|NCT01500200|76261601|FG004|COMPLETED|Stage 1||0||
60138818|NCT01500200|76261602|FG005|COMPLETED|Stage 1||0||
60138819|NCT01500200|76261597|FG000|NOT COMPLETED|Stage 1||8||
60138820|NCT01500200|76261598|FG001|NOT COMPLETED|Stage 1||6||
60138821|NCT01500200|76261599|FG002|NOT COMPLETED|Stage 1||6||
60138822|NCT01500200|76261600|FG003|NOT COMPLETED|Stage 1||0||
60138823|NCT01500200|76261601|FG004|NOT COMPLETED|Stage 1||0||
60138824|NCT01500200|76261602|FG005|NOT COMPLETED|Stage 1||0||
60138825|NCT01500200|76261597|FG000|STARTED|Stage 2||0|Subjects in Stage 2 are a subset of those randomized to placebo in Stage 1.|
60138826|NCT01500200|76261598|FG001|STARTED|Stage 2||0|Subjects in Stage 2 are a subset of those randomized to placebo in Stage 1.|
60138827|NCT01500200|76261599|FG002|STARTED|Stage 2||0|Subjects in Stage 2 are a subset of those randomized to placebo in Stage 1.|
60138828|NCT01500200|76261600|FG003|STARTED|Stage 2||20|Subjects in Stage 2 are a subset of those randomized to placebo in Stage 1.|
60138829|NCT01500200|76261601|FG004|STARTED|Stage 2||23|Subjects in Stage 2 are a subset of those randomized to placebo in Stage 1.|
60138830|NCT01500200|76261602|FG005|STARTED|Stage 2||22|Subjects in Stage 2 are a subset of those randomized to placebo in Stage 1.|
60138831|NCT01500200|76261597|FG000|COMPLETED|Stage 2||0||
60138832|NCT01500200|76261598|FG001|COMPLETED|Stage 2||0||
60138833|NCT01500200|76261599|FG002|COMPLETED|Stage 2||0||
60138834|NCT01500200|76261600|FG003|COMPLETED|Stage 2||20||
60138835|NCT01500200|76261601|FG004|COMPLETED|Stage 2||18||
60138836|NCT01500200|76261602|FG005|COMPLETED|Stage 2||18||
60138837|NCT01500200|76261597|FG000|NOT COMPLETED|Stage 2||0||
60138838|NCT01500200|76261598|FG001|NOT COMPLETED|Stage 2||0||
60138839|NCT01500200|76261599|FG002|NOT COMPLETED|Stage 2||0||
60138840|NCT01500200|76261600|FG003|NOT COMPLETED|Stage 2||0||
60138841|NCT01500200|76261601|FG004|NOT COMPLETED|Stage 2||5||
60138842|NCT01500200|76261602|FG005|NOT COMPLETED|Stage 2||4||
60138843|NCT01478360|76261618|FG000|STARTED|Overall Study||31||
60138844|NCT01478360|76261619|FG001|STARTED|Overall Study||15||
60138845|NCT01478360|76261618|FG000|PD (Pharmacodynamic) Analysis Set|Overall Study||31||
60138846|NCT01478360|76261619|FG001|PD (Pharmacodynamic) Analysis Set|Overall Study||15||
60138847|NCT01478360|76261618|FG000|PK (Pharmacokinetics) Analysis Set|Overall Study|Serum samples were collected during the study and analyzed only for the AIN457 group|31||
60138848|NCT01478360|76261619|FG001|PK (Pharmacokinetics) Analysis Set|Overall Study||0||
60138849|NCT01478360|76261618|FG000|COMPLETED|Overall Study||29||
60138850|NCT01478360|76261619|FG001|COMPLETED|Overall Study||12||
60138851|NCT01478360|76261618|FG000|NOT COMPLETED|Overall Study||2||
59751316|NCT00657709|75870576|FG003|STARTED|Overall Study||659||
59751317|NCT00657709|75870577|FG004|STARTED|Overall Study||490||
59751318|NCT00657709|75870573|FG000|COMPLETED|Overall Study||810||
59751319|NCT00657709|75870574|FG001|COMPLETED|Overall Study||795||
60138852|NCT01478360|76261619|FG001|NOT COMPLETED|Overall Study||3||
60138853|NCT00790335|76261627|FG000|STARTED|Overall Study||337||
60138854|NCT00790335|76261628|FG001|STARTED|Overall Study||355||
60138855|NCT00790335|76261627|FG000|COMPLETED|Overall Study||257||
60138856|NCT00790335|76261628|FG001|COMPLETED|Overall Study||243||
60138857|NCT00790335|76261627|FG000|NOT COMPLETED|Overall Study||80||
60138858|NCT00790335|76261628|FG001|NOT COMPLETED|Overall Study||112||
60138859|NCT01461980|76261637|FG000|STARTED|Overall Study||888||
60138860|NCT01461980|76261638|FG001|STARTED|Overall Study||878||
60138861|NCT01461980|76261639|FG002|STARTED|Overall Study||882||
60138862|NCT01461980|76261637|FG000|Vaccination 1|Overall Study||884||
60138863|NCT01461980|76261638|FG001|Vaccination 1|Overall Study||870||
60138864|NCT01461980|76261639|FG002|Vaccination 1|Overall Study||875||
60138865|NCT01461980|76261637|FG000|Vaccination 2|Overall Study||802||
60138866|NCT01461980|76261638|FG001|Vaccination 2|Overall Study||819||
60138867|NCT01461980|76261639|FG002|Vaccination 2|Overall Study||799||
60138868|NCT01461980|76261637|FG000|Vaccination 3|Overall Study||757||
60138869|NCT01461980|76261638|FG001|Vaccination 3|Overall Study||777||
60138870|NCT01461980|76261639|FG002|Vaccination 3|Overall Study||748||
60138871|NCT01461980|76261637|FG000|COMPLETED|Overall Study||722||
60138872|NCT01461980|76261638|FG001|COMPLETED|Overall Study||733||
60138873|NCT01461980|76261639|FG002|COMPLETED|Overall Study||717||
60138874|NCT01461980|76261637|FG000|NOT COMPLETED|Overall Study||166||
60138875|NCT01461980|76261638|FG001|NOT COMPLETED|Overall Study||145||
60138876|NCT01461980|76261639|FG002|NOT COMPLETED|Overall Study||165||
60138877|NCT01424501|76261654|FG000|STARTED|Overall Study||7||
60138878|NCT01424501|76261655|FG001|STARTED|Overall Study||6||
60138879|NCT01424501|76261656|FG002|STARTED|Overall Study||24||
60138880|NCT01424501|76261657|FG003|STARTED|Overall Study||25||
60138881|NCT01424501|76261658|FG004|STARTED|Overall Study||40||
60138882|NCT01424501|76261659|FG005|STARTED|Overall Study||40||
60138883|NCT01424501|76261654|FG000|COMPLETED|Overall Study||6||
59751320|NCT00657709|75870575|FG002|COMPLETED|Overall Study||792||
60138884|NCT01424501|76261655|FG001|COMPLETED|Overall Study||5||
59751321|NCT00657709|75870576|FG003|COMPLETED|Overall Study||645||
59751322|NCT00657709|75870577|FG004|COMPLETED|Overall Study||457||
59751323|NCT00657709|75870573|FG000|NOT COMPLETED|Overall Study||23||
59751324|NCT00657709|75870574|FG001|NOT COMPLETED|Overall Study||33||
60138885|NCT01424501|76261656|FG002|COMPLETED|Overall Study||22||
60138886|NCT01424501|76261657|FG003|COMPLETED|Overall Study||25||
60138887|NCT01424501|76261658|FG004|COMPLETED|Overall Study||40||
60138888|NCT01424501|76261659|FG005|COMPLETED|Overall Study||40||
60138889|NCT01424501|76261654|FG000|NOT COMPLETED|Overall Study||1||
60138890|NCT01424501|76261655|FG001|NOT COMPLETED|Overall Study||1||
60138891|NCT01424501|76261656|FG002|NOT COMPLETED|Overall Study||2||
60138892|NCT01424501|76261657|FG003|NOT COMPLETED|Overall Study||0||
60138893|NCT01424501|76261658|FG004|NOT COMPLETED|Overall Study||0||
60138894|NCT01424501|76261659|FG005|NOT COMPLETED|Overall Study||0||
60138895|NCT00771537|76261690|FG000|STARTED|Overall Study||135||
60138896|NCT00771537|76261691|FG001|STARTED|Overall Study||124||
60138897|NCT00771537|76261692|FG002|STARTED|Overall Study||151||
60138898|NCT00771537|76261693|FG003|STARTED|Overall Study||114||
60138899|NCT00771537|76261694|FG004|STARTED|Overall Study||127||
60138900|NCT00771537|76261695|FG005|STARTED|Overall Study||118||
60138901|NCT00771537|76261696|FG006|STARTED|Overall Study||128||
60138902|NCT00771537|76261697|FG007|STARTED|Overall Study||132||
60138903|NCT00771537|76261698|FG008|STARTED|Overall Study||115||
60138904|NCT00771537|76261699|FG009|STARTED|Overall Study||119||
60138905|NCT00771537|76261700|FG010|STARTED|Overall Study||133||
60138906|NCT00771537|76261701|FG011|STARTED|Overall Study||137||
60138907|NCT00771537|76261702|FG012|STARTED|Overall Study||128||
60138908|NCT00771537|76261703|FG013|STARTED|Overall Study||124||
60138909|NCT00771537|76261704|FG014|STARTED|Overall Study||124||
60138910|NCT00771537|76261705|FG015|STARTED|Overall Study||122||
60138911|NCT00771537|76261690|FG000|COMPLETED|Overall Study||135||
60138912|NCT00771537|76261691|FG001|COMPLETED|Overall Study||124||
60138913|NCT00771537|76261692|FG002|COMPLETED|Overall Study||151||
60138914|NCT00771537|76261693|FG003|COMPLETED|Overall Study||114||
60138915|NCT00771537|76261694|FG004|COMPLETED|Overall Study||127||
60138916|NCT00771537|76261695|FG005|COMPLETED|Overall Study||118||
60138917|NCT00771537|76261696|FG006|COMPLETED|Overall Study||128||
60138918|NCT00771537|76261697|FG007|COMPLETED|Overall Study||132||
60138919|NCT00771537|76261698|FG008|COMPLETED|Overall Study||115||
60138920|NCT00771537|76261699|FG009|COMPLETED|Overall Study||119||
60138921|NCT00771537|76261700|FG010|COMPLETED|Overall Study||133||
60138922|NCT00771537|76261701|FG011|COMPLETED|Overall Study||137||
60138923|NCT00771537|76261702|FG012|COMPLETED|Overall Study||128||
60138924|NCT00771537|76261703|FG013|COMPLETED|Overall Study||124||
60138925|NCT00771537|76261704|FG014|COMPLETED|Overall Study||124||
60138926|NCT00771537|76261705|FG015|COMPLETED|Overall Study||122||
60138927|NCT00771537|76261690|FG000|NOT COMPLETED|Overall Study||0||
60138928|NCT00771537|76261691|FG001|NOT COMPLETED|Overall Study||0||
60138929|NCT00771537|76261692|FG002|NOT COMPLETED|Overall Study||0||
60138930|NCT00771537|76261693|FG003|NOT COMPLETED|Overall Study||0||
60138931|NCT00771537|76261694|FG004|NOT COMPLETED|Overall Study||0||
60138932|NCT00771537|76261695|FG005|NOT COMPLETED|Overall Study||0||
60138933|NCT00771537|76261696|FG006|NOT COMPLETED|Overall Study||0||
60138934|NCT00771537|76261697|FG007|NOT COMPLETED|Overall Study||0||
60138935|NCT00771537|76261698|FG008|NOT COMPLETED|Overall Study||0||
60138936|NCT00771537|76261699|FG009|NOT COMPLETED|Overall Study||0||
60138937|NCT00771537|76261700|FG010|NOT COMPLETED|Overall Study||0||
60138938|NCT00771537|76261701|FG011|NOT COMPLETED|Overall Study||0||
60138939|NCT00771537|76261702|FG012|NOT COMPLETED|Overall Study||0||
60138940|NCT00771537|76261703|FG013|NOT COMPLETED|Overall Study||0||
60138941|NCT00771537|76261704|FG014|NOT COMPLETED|Overall Study||0||
60138942|NCT00771537|76261705|FG015|NOT COMPLETED|Overall Study||0||
60138943|NCT00791037|76261731|FG000|STARTED|Overall Study||23||
60138944|NCT00791037|76261731|FG000|Primary Outcome|Overall Study||19||
60138945|NCT00791037|76261731|FG000|Skeletal or Bone-only Disease by FDG-PET|Overall Study||1||
60138946|NCT00791037|76261731|FG000|COMPLETED|Overall Study||23||
60138947|NCT00791037|76261731|FG000|NOT COMPLETED|Overall Study||0||
60138948|NCT01401959|76261740|FG000|STARTED|Enrolled||54||
60138949|NCT01401959|76261741|FG001|STARTED|Enrolled||42||
60138950|NCT01401959|76261742|FG002|STARTED|Enrolled||31||
60138951|NCT01401959|76261740|FG000|COMPLETED|Enrolled||53||
60138952|NCT01401959|76261741|FG001|COMPLETED|Enrolled||42||
60138953|NCT01401959|76261742|FG002|COMPLETED|Enrolled||31||
60138954|NCT01401959|76261740|FG000|NOT COMPLETED|Enrolled||1||
60138955|NCT01401959|76261741|FG001|NOT COMPLETED|Enrolled||0||
60138956|NCT01401959|76261742|FG002|NOT COMPLETED|Enrolled||0||
60138957|NCT01401959|76261740|FG000|STARTED|Treated||53||
60138958|NCT01401959|76261741|FG001|STARTED|Treated||42||
60138959|NCT01401959|76261742|FG002|STARTED|Treated||31||
60138960|NCT01401959|76261740|FG000|COMPLETED|Treated||46||
60138961|NCT01401959|76261741|FG001|COMPLETED|Treated||34||
60138962|NCT01401959|76261742|FG002|COMPLETED|Treated||26||
60138963|NCT01401959|76261740|FG000|NOT COMPLETED|Treated||7||
60138964|NCT01401959|76261741|FG001|NOT COMPLETED|Treated||8||
60138965|NCT01401959|76261742|FG002|NOT COMPLETED|Treated||5||
60138966|NCT00791817|76261754|FG000|STARTED|1: Single Dose Followed by Week Washout||5||
60138967|NCT00791817|76261755|FG001|STARTED|1: Single Dose Followed by Week Washout||5||
60138968|NCT00791817|76261754|FG000|COMPLETED|1: Single Dose Followed by Week Washout||5||
60138969|NCT00791817|76261755|FG001|COMPLETED|1: Single Dose Followed by Week Washout||5||
60138970|NCT00791817|76261754|FG000|NOT COMPLETED|1: Single Dose Followed by Week Washout||0||
60138971|NCT00791817|76261755|FG001|NOT COMPLETED|1: Single Dose Followed by Week Washout||0||
60138972|NCT00791817|76261754|FG000|STARTED|2: Single Dose||5||
60138973|NCT00791817|76261755|FG001|STARTED|2: Single Dose||5||
60138974|NCT00791817|76261754|FG000|COMPLETED|2: Single Dose||5||
60138975|NCT00791817|76261755|FG001|COMPLETED|2: Single Dose||5||
60138976|NCT00791817|76261754|FG000|NOT COMPLETED|2: Single Dose||0||
59751325|NCT00657709|75870575|FG002|NOT COMPLETED|Overall Study||28||
59751326|NCT00657709|75870576|FG003|NOT COMPLETED|Overall Study||14||
59751327|NCT00657709|75870577|FG004|NOT COMPLETED|Overall Study||33||
59751328|NCT00915356|75870604|FG000|STARTED|Overall Study||26||
59751329|NCT00915356|75870605|FG001|STARTED|Overall Study||45||
59751330|NCT00915356|75870606|FG002|STARTED|Overall Study||45||
60138977|NCT00791817|76261755|FG001|NOT COMPLETED|2: Single Dose||0||
60138978|NCT00801723|76261763|FG000|STARTED|Overall Study||61||
60138979|NCT00801723|76261764|FG001|STARTED|Overall Study||62||
60138980|NCT00801723|76261763|FG000|COMPLETED|Overall Study||25||
60138981|NCT00801723|76261764|FG001|COMPLETED|Overall Study||27||
60138982|NCT00801723|76261763|FG000|NOT COMPLETED|Overall Study||36||
60138983|NCT00801723|76261764|FG001|NOT COMPLETED|Overall Study||35||
60138984|NCT01478048|76261772|FG000|STARTED|Overall Study||77||
60138985|NCT01478048|76261773|FG001|STARTED|Overall Study||75||
60138986|NCT01478048|76261772|FG000|Received Treatment|Overall Study|1 randomized to E-Bd but received Bd. Included in E-Bd group for efficacy and Bd group for safety|76||
60138987|NCT01478048|76261773|FG001|Received Treatment|Overall Study|1 randomized to E-Bd but received Bd. Included in E-Bd group for efficacy and Bd group for safety|74||
60138988|NCT01478048|76261772|FG000|COMPLETED|Overall Study||0|Completed = Still on treatment|
60138989|NCT01478048|76261773|FG001|COMPLETED|Overall Study||0|Completed = Still on treatment|
60138990|NCT01478048|76261772|FG000|NOT COMPLETED|Overall Study||77||
60138991|NCT01478048|76261773|FG001|NOT COMPLETED|Overall Study||75||
60138992|NCT01424189|76261781|FG000|STARTED|Overall Study||386||
60138993|NCT01424189|76261782|FG001|STARTED|Overall Study||188||
60138994|NCT01424189|76261781|FG000|COMPLETED|Overall Study||373||
60138995|NCT01424189|76261782|FG001|COMPLETED|Overall Study||182||
60138996|NCT01424189|76261781|FG000|NOT COMPLETED|Overall Study||13||
60138997|NCT01424189|76261782|FG001|NOT COMPLETED|Overall Study||6||
60138998|NCT04585776|76261788|FG000|STARTED|Overall Study||31||
60138999|NCT04585776|76261788|FG000|Received Atleast 1 Dose of Study Drug|Overall Study||31||
60139000|NCT04585776|76261788|FG000|COMPLETED|Overall Study||31||
60139001|NCT04585776|76261788|FG000|NOT COMPLETED|Overall Study||0||
60139002|NCT01401647|76261795|FG000|STARTED|Overall Study||972||
60139003|NCT01401647|76261796|FG001|STARTED|Overall Study||993||
60139004|NCT01401647|76261797|FG002|STARTED|Overall Study||1059||
60139005|NCT01401647|76261795|FG000|COMPLETED|Overall Study||968||
60139006|NCT01401647|76261796|FG001|COMPLETED|Overall Study||985||
60139007|NCT01401647|76261797|FG002|COMPLETED|Overall Study||1056||
60139008|NCT01401647|76261795|FG000|NOT COMPLETED|Overall Study||4||
60139009|NCT01401647|76261796|FG001|NOT COMPLETED|Overall Study||8||
60139010|NCT01401647|76261797|FG002|NOT COMPLETED|Overall Study||3||
60139011|NCT01499810|76261805|FG000|STARTED|Overall Study||53||
60139012|NCT01499810|76261805|FG000|COMPLETED|Overall Study||41||
60139013|NCT01499810|76261805|FG000|NOT COMPLETED|Overall Study||12||
60139014|NCT01423253|76261810|FG000|STARTED|Overall Study||48||
60139015|NCT01423253|76261810|FG000|COMPLETED|Overall Study||39||
60139016|NCT01423253|76261810|FG000|NOT COMPLETED|Overall Study||9||
60139017|NCT01477892|76261816|FG000|STARTED|Overall Study||7||
60139018|NCT01477892|76261817|FG001|STARTED|Overall Study||7||
60139019|NCT01477892|76261816|FG000|COMPLETED|Overall Study||7||
60139020|NCT01477892|76261817|FG001|COMPLETED|Overall Study||5||
60139021|NCT01477892|76261816|FG000|NOT COMPLETED|Overall Study||0||
59751331|NCT00915356|75870607|FG003|STARTED|Overall Study||12||
59751332|NCT00915356|75870608|FG004|STARTED|Overall Study||43||
59751333|NCT00915356|75870604|FG000|COMPLETED|Overall Study||25||
59751334|NCT00915356|75870605|FG001|COMPLETED|Overall Study||45||
60139022|NCT01477892|76261817|FG001|NOT COMPLETED|Overall Study||2||
60139023|NCT00801801|76261823|FG000|STARTED|Overall Study||5||
60139024|NCT00801801|76261823|FG000|COMPLETED|Overall Study||5||
60139025|NCT00801801|76261823|FG000|NOT COMPLETED|Overall Study||0||
59751335|NCT00915356|75870606|FG002|COMPLETED|Overall Study||45||
59751336|NCT00915356|75870607|FG003|COMPLETED|Overall Study||12||
59751337|NCT00915356|75870608|FG004|COMPLETED|Overall Study||43||
59751338|NCT00915356|75870604|FG000|NOT COMPLETED|Overall Study||1||
59881631|NCT04130919|76004519|FG002|NOT COMPLETED|Blinded Treatment Phase||3||
60139026|NCT01422239|76261830|FG000|STARTED|Overall Study||14||
60139027|NCT01422239|76261831|FG001|STARTED|Overall Study||6||
60139028|NCT01422239|76261830|FG000|COMPLETED|Overall Study||10||
60139029|NCT01422239|76261831|FG001|COMPLETED|Overall Study||3||
60139030|NCT01422239|76261830|FG000|NOT COMPLETED|Overall Study||4||
60139031|NCT01422239|76261831|FG001|NOT COMPLETED|Overall Study||3||
60139032|NCT01499576|76261837|FG000|STARTED|Overall Study||126||
60139033|NCT01499576|76261837|FG000|COMPLETED|Overall Study||105||
60139034|NCT01499576|76261837|FG000|NOT COMPLETED|Overall Study||21||
60139035|NCT00802113|76261844|FG000|STARTED|Overall Study||6||
60139036|NCT00802113|76261845|FG001|STARTED|Overall Study||17||
60139037|NCT00802113|76261844|FG000|COMPLETED|Overall Study||6||
59519079|NCT01093651|75612960|FG001|STARTED|Overall Study||10||
59751339|NCT00915356|75870605|FG001|NOT COMPLETED|Overall Study||0||
59751340|NCT00915356|75870606|FG002|NOT COMPLETED|Overall Study||0||
59751341|NCT00915356|75870607|FG003|NOT COMPLETED|Overall Study||0||
60139038|NCT00802113|76261845|FG001|COMPLETED|Overall Study||17||
60139039|NCT00802113|76261844|FG000|NOT COMPLETED|Overall Study||0||
60139040|NCT00802113|76261845|FG001|NOT COMPLETED|Overall Study||0||
60139041|NCT01476722|76261851|FG000|STARTED|Overall Study||125||
60139042|NCT01476722|76261851|FG000|COMPLETED|Overall Study||124||
60139043|NCT01476722|76261851|FG000|NOT COMPLETED|Overall Study||1||
60139044|NCT00791973|76261857|FG000|STARTED|First Intervention (1 Week)||8||
60139045|NCT00791973|76261858|FG001|STARTED|First Intervention (1 Week)||7||
60139046|NCT00791973|76261857|FG000|COMPLETED|First Intervention (1 Week)||8||
60139047|NCT00791973|76261858|FG001|COMPLETED|First Intervention (1 Week)||7||
60139048|NCT00791973|76261857|FG000|NOT COMPLETED|First Intervention (1 Week)||0||
60139049|NCT00791973|76261858|FG001|NOT COMPLETED|First Intervention (1 Week)||0||
60139050|NCT00791973|76261857|FG000|STARTED|Washout (1 Week)||8||
60139051|NCT00791973|76261858|FG001|STARTED|Washout (1 Week)||7||
60139052|NCT00791973|76261857|FG000|COMPLETED|Washout (1 Week)||8||
60139053|NCT00791973|76261858|FG001|COMPLETED|Washout (1 Week)||7||
60139054|NCT00791973|76261857|FG000|NOT COMPLETED|Washout (1 Week)||0||
60139055|NCT00791973|76261858|FG001|NOT COMPLETED|Washout (1 Week)||0||
60139056|NCT00791973|76261857|FG000|STARTED|Second Intervention (1 Week)||8||
60139057|NCT00791973|76261858|FG001|STARTED|Second Intervention (1 Week)||7||
60139058|NCT00791973|76261857|FG000|COMPLETED|Second Intervention (1 Week)||8||
60139059|NCT00791973|76261858|FG001|COMPLETED|Second Intervention (1 Week)||7||
60139060|NCT00791973|76261857|FG000|NOT COMPLETED|Second Intervention (1 Week)||0||
60139061|NCT00791973|76261858|FG001|NOT COMPLETED|Second Intervention (1 Week)||0||
60139062|NCT01476644|76261864|FG000|STARTED|Overall Study||161||
60139063|NCT01476644|76261864|FG000|COMPLETED|Overall Study||122||
60139064|NCT01476644|76261864|FG000|NOT COMPLETED|Overall Study||39||
60139065|NCT00802503|76261871|FG000|STARTED|Overall Study||152||
60139066|NCT00802503|76261872|FG001|STARTED|Overall Study||153||
60139067|NCT00802503|76261871|FG000|COMPLETED|Overall Study||142||
60139068|NCT00802503|76261872|FG001|COMPLETED|Overall Study||133||
60139069|NCT00802503|76261871|FG000|NOT COMPLETED|Overall Study||10||
60139070|NCT00802503|76261872|FG001|NOT COMPLETED|Overall Study||20||
60139071|NCT00773955|76261882|FG000|STARTED|Overall Study||15||
60139072|NCT00773955|76261882|FG000|COMPLETED|Overall Study||15||
60139073|NCT00773955|76261882|FG000|NOT COMPLETED|Overall Study||0||
60139074|NCT01421459|76261888|FG000|STARTED|Overall Study||379||
60139075|NCT01421459|76261889|FG001|STARTED|Overall Study||380||
60139076|NCT01421459|76261888|FG000|Received at Least 1 Dose of Study Drug|Overall Study||376||
60139077|NCT01421459|76261889|FG001|Received at Least 1 Dose of Study Drug|Overall Study||380||
60139078|NCT01421459|76261888|FG000|COMPLETED|Overall Study||334||
60139079|NCT01421459|76261889|FG001|COMPLETED|Overall Study||328||
60139080|NCT01421459|76261888|FG000|NOT COMPLETED|Overall Study||45||
60139081|NCT01421459|76261889|FG001|NOT COMPLETED|Overall Study||52||
60139082|NCT01498952|76261897|FG000|STARTED|Overall Study||3||
60139083|NCT01498952|76261898|FG001|STARTED|Overall Study||3||
60139084|NCT01498952|76261899|FG002|STARTED|Overall Study||0||
60139085|NCT01498952|76261900|FG003|STARTED|Overall Study||0||
60139086|NCT01498952|76261901|FG004|STARTED|Overall Study||0||
60139087|NCT01498952|76261897|FG000|COMPLETED|Overall Study||1||
60139088|NCT01498952|76261898|FG001|COMPLETED|Overall Study||1||
60139089|NCT01498952|76261899|FG002|COMPLETED|Overall Study||0||
60139090|NCT01498952|76261900|FG003|COMPLETED|Overall Study||0||
60139091|NCT01498952|76261901|FG004|COMPLETED|Overall Study||0||
59605686|NCT01965600|75715852|FG001|STARTED|First Intervention||8||
60139092|NCT01498952|76261897|FG000|NOT COMPLETED|Overall Study||2||
60139093|NCT01498952|76261898|FG001|NOT COMPLETED|Overall Study||2||
60139094|NCT01498952|76261899|FG002|NOT COMPLETED|Overall Study||0||
60139095|NCT01498952|76261900|FG003|NOT COMPLETED|Overall Study||0||
60139096|NCT01498952|76261901|FG004|NOT COMPLETED|Overall Study||0||
60139097|NCT00774267|76261918|FG000|STARTED|Overall Study||132||
60139098|NCT00774267|76261919|FG001|STARTED|Overall Study||111||
60139099|NCT00774267|76261920|FG002|STARTED|Overall Study||129||
60139100|NCT00774267|76261921|FG003|STARTED|Overall Study||135||
60139101|NCT00774267|76261918|FG000|COMPLETED|Overall Study||132||
60139102|NCT00774267|76261919|FG001|COMPLETED|Overall Study||111||
60139103|NCT00774267|76261920|FG002|COMPLETED|Overall Study||129||
60139104|NCT00774267|76261921|FG003|COMPLETED|Overall Study||135||
60139105|NCT00774267|76261918|FG000|NOT COMPLETED|Overall Study||0||
60139106|NCT00774267|76261919|FG001|NOT COMPLETED|Overall Study||0||
60139107|NCT00774267|76261920|FG002|NOT COMPLETED|Overall Study||0||
60139108|NCT00774267|76261921|FG003|NOT COMPLETED|Overall Study||0||
60139109|NCT01461044|76261933|FG000|STARTED|Overall Study||150||
60139110|NCT01461044|76261934|FG001|STARTED|Overall Study||77||
60139111|NCT01461044|76261933|FG000|Participants Alive at Inclusion|Overall Study||127||
60139112|NCT01461044|76261934|FG001|Participants Alive at Inclusion|Overall Study||58||
60139113|NCT01461044|76261933|FG000|COMPLETED|Overall Study||80||
60139114|NCT01461044|76261934|FG001|COMPLETED|Overall Study||37||
60139115|NCT01461044|76261933|FG000|NOT COMPLETED|Overall Study||70||
60139116|NCT01461044|76261934|FG001|NOT COMPLETED|Overall Study||40||
60139117|NCT00774579|76261945|FG000|STARTED|Overall Study||9||
60139118|NCT00774579|76261946|FG001|STARTED|Overall Study||9||
60139119|NCT00774579|76261945|FG000|COMPLETED|Overall Study||9||
60139120|NCT00774579|76261946|FG001|COMPLETED|Overall Study||9||
60139121|NCT00774579|76261945|FG000|NOT COMPLETED|Overall Study||0||
59881632|NCT04130919|76004520|FG003|NOT COMPLETED|Blinded Treatment Phase||0||
59881633|NCT04130919|76004521|FG004|NOT COMPLETED|Blinded Treatment Phase||0||
59881634|NCT04130919|76004522|FG005|NOT COMPLETED|Blinded Treatment Phase||0||
59751342|NCT00915356|75870608|FG004|NOT COMPLETED|Overall Study||0||
59751343|NCT00657553|75870622|FG000|STARTED|Overall Study||5||
59751344|NCT00657553|75870623|FG001|STARTED|Overall Study||5||
59751345|NCT00657553|75870622|FG000|COMPLETED|Overall Study||0||
59751346|NCT00657553|75870623|FG001|COMPLETED|Overall Study||0||
59751347|NCT00657553|75870622|FG000|NOT COMPLETED|Overall Study||5||
59751348|NCT00657553|75870623|FG001|NOT COMPLETED|Overall Study||5||
59751349|NCT00862719|75870633|FG000|STARTED|Overall Study||17||
59751350|NCT00862719|75870634|FG001|STARTED|Overall Study||7||
59751351|NCT00862719|75870635|FG002|STARTED|Overall Study||4||
59751352|NCT00862719|75870636|FG003|STARTED|Overall Study||1||
59751353|NCT00862719|75870633|FG000|COMPLETED|Overall Study||7||
59881635|NCT04130919|76004517|FG000|STARTED|Open-label Treatment Phase|Participants who completed the Blinded Treatment phase and did not achieve the clinical response per modified MCS at Week 10 entered in Open-label Treatment phase to receive tilpisertib 300 mg.|0||
59881636|NCT04130919|76004518|FG001|STARTED|Open-label Treatment Phase|Participants who completed the Blinded Treatment phase and did not achieve the clinical response per modified MCS at Week 10 entered in Open-label Treatment phase to receive tilpisertib 300 mg.|0||
59950791|NCT02677493|76069660|FG002|STARTED|Overall Study||299||
59950792|NCT02677493|76069658|FG000|COMPLETED|Overall Study||1186||
59950793|NCT02677493|76069659|FG001|COMPLETED|Overall Study||296||
59950794|NCT02677493|76069660|FG002|COMPLETED|Overall Study||296||
59950795|NCT02677493|76069658|FG000|NOT COMPLETED|Overall Study||11||
59751354|NCT00862719|75870634|FG001|COMPLETED|Overall Study||1||
59751355|NCT00862719|75870635|FG002|COMPLETED|Overall Study||0||
59751356|NCT00862719|75870636|FG003|COMPLETED|Overall Study||0||
59950796|NCT02677493|76069659|FG001|NOT COMPLETED|Overall Study||2||
59950797|NCT02677493|76069660|FG002|NOT COMPLETED|Overall Study||3||
59950798|NCT02633059|76069675|FG000|STARTED|Overall Study||4||
59950799|NCT02633059|76069676|FG001|STARTED|Overall Study||7||
59950800|NCT02633059|76069677|FG002|STARTED|Overall Study||4||
59950801|NCT02633059|76069678|FG003|STARTED|Overall Study||18||
59950802|NCT02633059|76069675|FG000|COMPLETED|Overall Study||4||
59950803|NCT02633059|76069676|FG001|COMPLETED|Overall Study||6||
59950804|NCT02633059|76069677|FG002|COMPLETED|Overall Study||4||
59950805|NCT02633059|76069678|FG003|COMPLETED|Overall Study||16||
59950806|NCT02633059|76069675|FG000|NOT COMPLETED|Overall Study||0||
59950807|NCT02633059|76069676|FG001|NOT COMPLETED|Overall Study||1||
59950808|NCT02633059|76069677|FG002|NOT COMPLETED|Overall Study||0||
59950809|NCT02633059|76069678|FG003|NOT COMPLETED|Overall Study||2||
59950810|NCT02566850|76069690|FG000|STARTED|Overall Study||4||
59950811|NCT02566850|76069690|FG000|COMPLETED|Overall Study||3||
59950812|NCT02566850|76069690|FG000|NOT COMPLETED|Overall Study||1||
59950813|NCT02460692|76069697|FG000|STARTED|Overall Study||44||
59950814|NCT02460692|76069698|FG001|STARTED|Overall Study||43||
59950815|NCT02460692|76069699|FG002|STARTED|Overall Study||44||
59950816|NCT02460692|76069697|FG000|COMPLETED|Overall Study||29||
59950817|NCT02460692|76069698|FG001|COMPLETED|Overall Study||26||
59950818|NCT02460692|76069699|FG002|COMPLETED|Overall Study||36||
59950819|NCT02460692|76069697|FG000|NOT COMPLETED|Overall Study||15||
59950820|NCT02460692|76069698|FG001|NOT COMPLETED|Overall Study||17||
59950821|NCT02460692|76069699|FG002|NOT COMPLETED|Overall Study||8||
59950822|NCT02408120|76069709|FG000|STARTED|Overall Study||112||
59751357|NCT00862719|75870633|FG000|NOT COMPLETED|Overall Study||10||
59751358|NCT00862719|75870634|FG001|NOT COMPLETED|Overall Study||6||
59751359|NCT00862719|75870635|FG002|NOT COMPLETED|Overall Study||4||
59751360|NCT00862719|75870636|FG003|NOT COMPLETED|Overall Study||1||
59751361|NCT00862641|75870650|FG000|STARTED|Overall Study||177||
59751362|NCT00862641|75870651|FG001|STARTED|Overall Study||360||
59751363|NCT00862641|75870652|FG002|STARTED|Overall Study||152||
59751364|NCT00862641|75870653|FG003|STARTED|Overall Study||320||
59751365|NCT00862641|75870650|FG000|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|176||
59751366|NCT00862641|75870651|FG001|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|356||
59751367|NCT00862641|75870652|FG002|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|151||
59751368|NCT00862641|75870653|FG003|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|316||
60010005|NCT04599062|76125717|FG001|NOT COMPLETED|Overall Study||0||
60010006|NCT04537208|76125734|FG000|STARTED|Overall Study||34||
60010007|NCT04537208|76125735|FG001|STARTED|Overall Study||34||
60010008|NCT04537208|76125736|FG002|STARTED|Overall Study||34||
60010009|NCT04537208|76125737|FG003|STARTED|Overall Study||34||
60010010|NCT04537208|76125738|FG004|STARTED|Overall Study||34||
60010011|NCT04537208|76125739|FG005|STARTED|Overall Study||28||
60010012|NCT04537208|76125740|FG006|STARTED|Overall Study||84||
60010013|NCT04537208|76125741|FG007|STARTED|Overall Study||27||
60010014|NCT04537208|76125742|FG008|STARTED|Overall Study||85||
60010015|NCT04537208|76125743|FG009|STARTED|Overall Study||18||
60010016|NCT04537208|76125744|FG010|STARTED|Overall Study||29||
60010017|NCT04537208|76125734|FG000|Vaccinated on Day 1|Overall Study||34||
60010018|NCT04537208|76125735|FG001|Vaccinated on Day 1|Overall Study||34||
60010019|NCT04537208|76125736|FG002|Vaccinated on Day 1|Overall Study||34||
60010020|NCT04537208|76125737|FG003|Vaccinated on Day 1|Overall Study||34||
60010021|NCT04537208|76125738|FG004|Vaccinated on Day 1|Overall Study||34||
60010022|NCT04537208|76125739|FG005|Vaccinated on Day 1|Overall Study||28||
60010023|NCT04537208|76125740|FG006|Vaccinated on Day 1|Overall Study||82||
60010024|NCT04537208|76125741|FG007|Vaccinated on Day 1|Overall Study||27||
60010025|NCT04537208|76125742|FG008|Vaccinated on Day 1|Overall Study||85||
60010026|NCT04537208|76125743|FG009|Vaccinated on Day 1|Overall Study||18||
60010027|NCT04537208|76125744|FG010|Vaccinated on Day 1|Overall Study||29||
60010028|NCT04537208|76125734|FG000|Vaccinated on Day 22|Overall Study||0|Only Cohort 2 participants received second dose of vaccine at Day 22.|
60010029|NCT04537208|76125735|FG001|Vaccinated on Day 22|Overall Study||0|Only Cohort 2 participants received second dose of vaccine at Day 22.|
60010030|NCT04537208|76125736|FG002|Vaccinated on Day 22|Overall Study||0|Only Cohort 2 participants received second dose of vaccine at Day 22.|
60010031|NCT04537208|76125737|FG003|Vaccinated on Day 22|Overall Study||0|Only Cohort 2 participants received second dose of vaccine at Day 22.|
60010032|NCT04537208|76125738|FG004|Vaccinated on Day 22|Overall Study||0|Only Cohort 2 participants received second dose of vaccine at Day 22.|
60010033|NCT04537208|76125739|FG005|Vaccinated on Day 22|Overall Study||26|Only Cohort 2 participants received second dose of vaccine at Day 22.|
60010034|NCT04537208|76125740|FG006|Vaccinated on Day 22|Overall Study||80|Only Cohort 2 participants received second dose of vaccine at Day 22.|
60010035|NCT04537208|76125741|FG007|Vaccinated on Day 22|Overall Study||26|Only Cohort 2 participants received second dose of vaccine at Day 22.|
60010036|NCT04537208|76125742|FG008|Vaccinated on Day 22|Overall Study||85|Only Cohort 2 participants received second dose of vaccine at Day 22.|
60010037|NCT04537208|76125743|FG009|Vaccinated on Day 22|Overall Study||17|Only Cohort 2 participants received second dose of vaccine at Day 22.|
60010038|NCT04537208|76125744|FG010|Vaccinated on Day 22|Overall Study||29|Only Cohort 2 participants received second dose of vaccine at Day 22.|
60010039|NCT04537208|76125734|FG000|Safety Analysis Set (SafAS)|Overall Study|2 participants randomized to 'Cohort 2: Group 6: SARS-CoV-2 Vaccine LD + AF03' received only one injection in Cohort 2 and thus included in arm 'Cohort 1: Group 1: SARS-CoV-2 Vaccine LD + AF03' for safety analysis.|36|Participants who had received at least one injection of study intervention and were analyzed according to the study intervention they actually received.|
60010040|NCT04537208|76125735|FG001|Safety Analysis Set (SafAS)|Overall Study|2 participants randomized to 'Cohort 2: Group 7: SARS-CoV-2 Vaccine LD + AS03' received only one injection in Cohort 2 and thus included in arm 'Cohort 1: Group 2: SARS-CoV-2 Vaccine LD + AS03' for safety analysis.|36|Participants who had received at least one injection of study intervention and were analyzed according to the study intervention they actually received.|
60010041|NCT04537208|76125736|FG002|Safety Analysis Set (SafAS)|Overall Study|1 participant randomized to 'Cohort 2: Group 8: SARS-CoV-2 Vaccine HD + AF03' received only one injection in Cohort 2 and thus included in arm 'Cohort 1: Group 3: SARS-CoV-2 Vaccine HD + AF03' for safety analysis.|35|Participants who had received at least one injection of study intervention and were analyzed according to the study intervention they actually received.|
60010042|NCT04537208|76125737|FG003|Safety Analysis Set (SafAS)|Overall Study||34|Participants who had received at least one injection of study intervention and were analyzed according to the study intervention they actually received.|
60010043|NCT04537208|76125738|FG004|Safety Analysis Set (SafAS)|Overall Study||34|Participants who had received at least one injection of study intervention and were analyzed according to the study intervention they actually received.|
60067701|NCT01788423|76182879|FG002|COMPLETED|Overall Study|Three people developed unrelated health problems and two were unable to fit/use hearing aids.|50||
60067702|NCT01788423|76182877|FG000|NOT COMPLETED|Overall Study||0||
60067703|NCT01788423|76182878|FG001|NOT COMPLETED|Overall Study||4||
59519080|NCT01093651|75612959|FG000|COMPLETED|Overall Study||10||
60139122|NCT00774579|76261946|FG001|NOT COMPLETED|Overall Study||0||
60139123|NCT04041869|76261952|FG000|STARTED|Overall Study||68||
60139124|NCT04041869|76261952|FG000|COMPLETED|Overall Study||54||
60139125|NCT04041869|76261952|FG000|NOT COMPLETED|Overall Study||14||
60139126|NCT00793455|76261959|FG000|STARTED|Overall Study||314||
60139127|NCT00793455|76261960|FG001|STARTED|Overall Study||314||
60139128|NCT00793455|76261959|FG000|COMPLETED|Overall Study||314||
60139129|NCT00793455|76261960|FG001|COMPLETED|Overall Study||314||
60139130|NCT00793455|76261959|FG000|NOT COMPLETED|Overall Study||0||
60139131|NCT00793455|76261960|FG001|NOT COMPLETED|Overall Study||0||
60139132|NCT01421303|76261967|FG000|STARTED|Overall Study||80||
60139133|NCT01421303|76261967|FG000|COMPLETED|Overall Study||58||
60139134|NCT01421303|76261967|FG000|NOT COMPLETED|Overall Study||22||
60139135|NCT01475474|76261971|FG000|STARTED|Baseline Period - 4 Weeks||97||
60139136|NCT01475474|76261971|FG000|COMPLETED|Baseline Period - 4 Weeks||91||
60139137|NCT01475474|76261971|FG000|NOT COMPLETED|Baseline Period - 4 Weeks||6||
60139138|NCT01475474|76261971|FG000|STARTED|Treatment Period - 12 Weeks||91||
60139139|NCT01475474|76261971|FG000|COMPLETED|Treatment Period - 12 Weeks||73||
60139140|NCT01475474|76261971|FG000|NOT COMPLETED|Treatment Period - 12 Weeks||18||
60139141|NCT01475474|76261971|FG000|STARTED|Return to Baseline Period - 4 Weeks||73||
60139142|NCT01475474|76261971|FG000|COMPLETED|Return to Baseline Period - 4 Weeks||71||
60139143|NCT01475474|76261971|FG000|NOT COMPLETED|Return to Baseline Period - 4 Weeks||2||
60139144|NCT01400243|76261978|FG000|STARTED|Overall Study||64||
60139145|NCT01400243|76261979|FG001|STARTED|Overall Study||63||
60139146|NCT01400243|76261978|FG000|COMPLETED|Overall Study||56||
60139147|NCT01400243|76261979|FG001|COMPLETED|Overall Study||52||
60139148|NCT01400243|76261978|FG000|NOT COMPLETED|Overall Study||8||
60139149|NCT01400243|76261979|FG001|NOT COMPLETED|Overall Study||11||
60139150|NCT00809055|76261989|FG000|STARTED|Overall Study||37||
60139151|NCT00809055|76261990|FG001|STARTED|Overall Study||37||
60139152|NCT00809055|76261989|FG000|COMPLETED|Overall Study||28||
60139153|NCT00809055|76261990|FG001|COMPLETED|Overall Study||30||
60139154|NCT00809055|76261989|FG000|NOT COMPLETED|Overall Study||9||
60139155|NCT00809055|76261990|FG001|NOT COMPLETED|Overall Study||7||
60139156|NCT01475162|76261996|FG000|STARTED|Overall Study||14||
60139157|NCT01475162|76261996|FG000|COMPLETED|Overall Study||0||
60139158|NCT01475162|76261996|FG000|NOT COMPLETED|Overall Study||14||
60139159|NCT01421225|76262003|FG000|STARTED|Overall Study||4||
60139160|NCT01421225|76262004|FG001|STARTED|Overall Study||6||
60139161|NCT01421225|76262003|FG000|COMPLETED|Overall Study||4||
60139162|NCT01421225|76262004|FG001|COMPLETED|Overall Study||5||
60139163|NCT01421225|76262003|FG000|NOT COMPLETED|Overall Study||0||
60139164|NCT01421225|76262004|FG001|NOT COMPLETED|Overall Study||1||
60139165|NCT00803751|76262013|FG000|STARTED|Overall Study||26||
60139166|NCT00803751|76262014|FG001|STARTED|Overall Study||23||
60139167|NCT00803751|76262013|FG000|COMPLETED|Overall Study||26||
60139168|NCT00803751|76262014|FG001|COMPLETED|Overall Study||23||
60139169|NCT00803751|76262013|FG000|NOT COMPLETED|Overall Study||0||
60139170|NCT00803751|76262014|FG001|NOT COMPLETED|Overall Study||0||
60139171|NCT01498640|76262020|FG000|STARTED|Overall Study||52||
60139172|NCT01498640|76262020|FG000|COMPLETED|Overall Study||47||
60139173|NCT01498640|76262020|FG000|NOT COMPLETED|Overall Study||5||
60139174|NCT01498484|76262032|FG000|STARTED|Overall Study||25||
60139175|NCT01498484|76262033|FG001|STARTED|Overall Study||10||
60139176|NCT01498484|76262034|FG002|STARTED|Overall Study||3||
60139177|NCT01498484|76262035|FG003|STARTED|Overall Study||3||
60139178|NCT01498484|76262036|FG004|STARTED|Overall Study||2||
60139179|NCT01498484|76262037|FG005|STARTED|Overall Study||3||
60139180|NCT01498484|76262038|FG006|STARTED|Overall Study||25||
60139181|NCT01498484|76262039|FG007|STARTED|Overall Study||14||
60139182|NCT01498484|76262040|FG008|STARTED|Overall Study||2||
60139183|NCT01498484|76262032|FG000|COMPLETED|Overall Study||11||
60139184|NCT01498484|76262033|FG001|COMPLETED|Overall Study||3||
60139185|NCT01498484|76262034|FG002|COMPLETED|Overall Study||1||
60139186|NCT01498484|76262035|FG003|COMPLETED|Overall Study||0||
60139187|NCT01498484|76262036|FG004|COMPLETED|Overall Study||1||
60139188|NCT01498484|76262037|FG005|COMPLETED|Overall Study||2||
60139189|NCT01498484|76262038|FG006|COMPLETED|Overall Study||3||
60139190|NCT01498484|76262039|FG007|COMPLETED|Overall Study||0||
60139191|NCT01498484|76262040|FG008|COMPLETED|Overall Study||0||
60139192|NCT01498484|76262032|FG000|NOT COMPLETED|Overall Study||14||
60139193|NCT01498484|76262033|FG001|NOT COMPLETED|Overall Study||7||
60139194|NCT01498484|76262034|FG002|NOT COMPLETED|Overall Study||2||
60139195|NCT01498484|76262035|FG003|NOT COMPLETED|Overall Study||3||
60139196|NCT01498484|76262036|FG004|NOT COMPLETED|Overall Study||1||
60139197|NCT01498484|76262037|FG005|NOT COMPLETED|Overall Study||1||
60139198|NCT01498484|76262038|FG006|NOT COMPLETED|Overall Study||22||
60139199|NCT01498484|76262039|FG007|NOT COMPLETED|Overall Study||14||
60139200|NCT01498484|76262040|FG008|NOT COMPLETED|Overall Study||2||
60139201|NCT01474772|76262049|FG000|STARTED|Period 1|STARTED=treated. In Period 1 a participant discontinued due to an AE and later died due to the AE.|101||
60139202|NCT01474772|76262050|FG001|STARTED|Period 1|STARTED=treated|102||
60010044|NCT04537208|76125739|FG005|Safety Analysis Set (SafAS)|Overall Study|2 participants randomized to 'Cohort 2: Group 6: SARS-CoV-2 Vaccine LD + AF03' received only one injection in Cohort 2 and thus included in arm 'Cohort 1: Group 1: SARS-CoV-2 Vaccine LD + AF03' for safety analysis.|26|Participants who had received at least one injection of study intervention and were analyzed according to the study intervention they actually received.|
60010045|NCT04537208|76125740|FG006|Safety Analysis Set (SafAS)|Overall Study|2 participants randomized to 'Cohort 2: Group 7: SARS-CoV-2 Vaccine LD + AS03' received only one injection in Cohort 2 and thus included in arm 'Cohort 1: Group 2: SARS-CoV-2 Vaccine LD + AS03' for safety analysis.|80|Participants who had received at least one injection of study intervention and were analyzed according to the study intervention they actually received.|
60010046|NCT04537208|76125741|FG007|Safety Analysis Set (SafAS)|Overall Study|1 participant randomized to 'Cohort 2: Group 8: SARS-CoV-2 Vaccine HD + AF03' received only one injection in Cohort 2 and thus included in arm 'Cohort 1: Group 3: SARS-CoV-2 Vaccine HD + AF03' for safety analysis.|26|Participants who had received at least one injection of study intervention and were analyzed according to the study intervention they actually received.|
60139203|NCT01474772|76262049|FG000|COMPLETED|Period 1||89||
60139204|NCT01474772|76262050|FG001|COMPLETED|Period 1||99||
60139205|NCT01474772|76262049|FG000|NOT COMPLETED|Period 1||12||
60139206|NCT01474772|76262050|FG001|NOT COMPLETED|Period 1||3||
60139207|NCT01474772|76262049|FG000|STARTED|Washout||89||
60139208|NCT01474772|76262050|FG001|STARTED|Washout||99||
60139209|NCT01474772|76262049|FG000|COMPLETED|Washout||86||
60139210|NCT01474772|76262050|FG001|COMPLETED|Washout||97||
60139211|NCT01474772|76262049|FG000|NOT COMPLETED|Washout||3||
60139212|NCT01474772|76262050|FG001|NOT COMPLETED|Washout||2||
60139213|NCT01474772|76262049|FG000|STARTED|Period 2||86||
60139214|NCT01474772|76262050|FG001|STARTED|Period 2||97||
60139215|NCT01474772|76262049|FG000|COMPLETED|Period 2||77||
60139216|NCT01474772|76262050|FG001|COMPLETED|Period 2||87||
60139217|NCT01474772|76262049|FG000|NOT COMPLETED|Period 2||9||
60139218|NCT01474772|76262050|FG001|NOT COMPLETED|Period 2||10||
60139219|NCT01474772|76262049|FG000|STARTED|Follow-up||77||
60139220|NCT01474772|76262050|FG001|STARTED|Follow-up||87||
60139221|NCT01474772|76262049|FG000|COMPLETED|Follow-up||77||
60139222|NCT01474772|76262050|FG001|COMPLETED|Follow-up||86||
60139223|NCT01474772|76262049|FG000|NOT COMPLETED|Follow-up||0||
60139224|NCT01474772|76262050|FG001|NOT COMPLETED|Follow-up||1||
60139225|NCT01421147|76262058|FG000|STARTED|Treatment Period||269||
60139226|NCT01421147|76262059|FG001|STARTED|Treatment Period||267||
60139227|NCT01421147|76262058|FG000|Received at Least 1 Dose of Study Drug|Treatment Period||268||
60139228|NCT01421147|76262059|FG001|Received at Least 1 Dose of Study Drug|Treatment Period||267||
60139229|NCT01421147|76262058|FG000|COMPLETED|Treatment Period||253||
60139230|NCT01421147|76262059|FG001|COMPLETED|Treatment Period||256||
60139231|NCT01421147|76262058|FG000|NOT COMPLETED|Treatment Period||16||
60139232|NCT01421147|76262059|FG001|NOT COMPLETED|Treatment Period||11||
60139233|NCT01421147|76262058|FG000|STARTED|Extension Period||253||
60139234|NCT01421147|76262059|FG001|STARTED|Extension Period||256||
60139235|NCT01421147|76262058|FG000|COMPLETED|Extension Period||245||
60139236|NCT01421147|76262059|FG001|COMPLETED|Extension Period||245||
60139237|NCT01421147|76262058|FG000|NOT COMPLETED|Extension Period||8||
60139238|NCT01421147|76262059|FG001|NOT COMPLETED|Extension Period||11||
60139239|NCT00809523|76262067|FG000|STARTED|Overall Study||54||
60139240|NCT00809523|76262068|FG001|STARTED|Overall Study||52||
60139241|NCT00809523|76262067|FG000|COMPLETED|Overall Study||47||
60139242|NCT00809523|76262068|FG001|COMPLETED|Overall Study||48||
60139243|NCT00809523|76262067|FG000|NOT COMPLETED|Overall Study||7||
60139244|NCT00809523|76262068|FG001|NOT COMPLETED|Overall Study||4||
60139245|NCT01497938|76262076|FG000|STARTED|Overall Study||121||
60139246|NCT01497938|76262077|FG001|STARTED|Overall Study||126||
60139247|NCT01497938|76262076|FG000|COMPLETED|Overall Study||116||
60139248|NCT01497938|76262077|FG001|COMPLETED|Overall Study||124||
60139249|NCT01497938|76262076|FG000|NOT COMPLETED|Overall Study||5||
60139250|NCT01497938|76262077|FG001|NOT COMPLETED|Overall Study||2||
60139251|NCT00804609|76262085|FG000|STARTED|Overall Study||15||
60139252|NCT00804609|76262086|FG001|STARTED|Overall Study||15||
60139253|NCT00804609|76262085|FG000|COMPLETED|Overall Study||15||
60139254|NCT00804609|76262086|FG001|COMPLETED|Overall Study||14||
60139255|NCT00804609|76262085|FG000|NOT COMPLETED|Overall Study||0||
60139256|NCT00804609|76262086|FG001|NOT COMPLETED|Overall Study||1||
60139257|NCT00804999|76262096|FG000|STARTED|Overall Study||15||
60139258|NCT00804999|76262097|FG001|STARTED|Overall Study||12||
60139259|NCT00804999|76262098|FG002|STARTED|Overall Study||14||
60139260|NCT00804999|76262099|FG003|STARTED|Overall Study||10||
60139261|NCT00804999|76262096|FG000|COMPLETED|Overall Study||15||
60139262|NCT00804999|76262097|FG001|COMPLETED|Overall Study||12||
60139263|NCT00804999|76262098|FG002|COMPLETED|Overall Study||14||
60139264|NCT00804999|76262099|FG003|COMPLETED|Overall Study||10||
60139265|NCT00804999|76262096|FG000|NOT COMPLETED|Overall Study||0||
60139266|NCT00804999|76262097|FG001|NOT COMPLETED|Overall Study||0||
59881637|NCT04130919|76004519|FG002|STARTED|Open-label Treatment Phase|Participants who completed the Blinded Treatment phase and did not achieve the clinical response per modified MCS at Week 10 entered in Open-label Treatment phase to receive tilpisertib 300 mg.|0||
59881638|NCT04130919|76004520|FG003|STARTED|Open-label Treatment Phase|Participants who completed the Blinded Treatment phase and did not achieve the clinical response per modified MCS at Week 10 entered in Open-label Treatment phase to receive tilpisertib 300 mg.|4||
59881639|NCT04130919|76004521|FG004|STARTED|Open-label Treatment Phase|Participants who completed the Blinded Treatment phase and did not achieve the clinical response per modified MCS at Week 10 entered in Open-label Treatment phase to receive tilpisertib 300 mg.|3||
59881640|NCT04130919|76004522|FG005|STARTED|Open-label Treatment Phase|Participants who completed the Blinded Treatment phase and did not achieve the clinical response per modified MCS at Week 10 entered in Open-label Treatment phase to receive tilpisertib 300 mg.|3||
59881641|NCT04130919|76004517|FG000|COMPLETED|Open-label Treatment Phase||0||
59751369|NCT00862641|75870650|FG000|NOT COMPLETED|Overall Study||1||
59751370|NCT00862641|75870651|FG001|NOT COMPLETED|Overall Study||4||
59751371|NCT00862641|75870652|FG002|NOT COMPLETED|Overall Study||1||
59751372|NCT00862641|75870653|FG003|NOT COMPLETED|Overall Study||4||
59751373|NCT00861471|75870663|FG000|STARTED|Overall Study||12||
59751374|NCT00861471|75870663|FG000|COMPLETED|Overall Study||3||
59751375|NCT00861471|75870663|FG000|NOT COMPLETED|Overall Study||9||
59881642|NCT04130919|76004518|FG001|COMPLETED|Open-label Treatment Phase||0||
59881643|NCT04130919|76004519|FG002|COMPLETED|Open-label Treatment Phase||0||
60139267|NCT00804999|76262098|FG002|NOT COMPLETED|Overall Study||0||
60139268|NCT00804999|76262099|FG003|NOT COMPLETED|Overall Study||0||
60139269|NCT00810303|76262109|FG000|STARTED|Efavirenz Alone - Day 1-5||12||
60139270|NCT00810303|76262109|FG000|COMPLETED|Efavirenz Alone - Day 1-5||12||
60139271|NCT00810303|76262109|FG000|NOT COMPLETED|Efavirenz Alone - Day 1-5||0||
60139272|NCT00810303|76262109|FG000|STARTED|Ezetimibe Alone - Day 6-15||12||
60139273|NCT00810303|76262109|FG000|COMPLETED|Ezetimibe Alone - Day 6-15||12||
60139274|NCT00810303|76262109|FG000|NOT COMPLETED|Ezetimibe Alone - Day 6-15||0||
60139275|NCT00810303|76262109|FG000|STARTED|Ezetimibe and Efavirenz - Day 16-20||12||
60139276|NCT00810303|76262109|FG000|COMPLETED|Ezetimibe and Efavirenz - Day 16-20||12||
60139277|NCT00810303|76262109|FG000|NOT COMPLETED|Ezetimibe and Efavirenz - Day 16-20||0||
60139278|NCT00810303|76262109|FG000|STARTED|Ezetimibe and Efavirenz - Day 21-30||12||
60139279|NCT00810303|76262109|FG000|COMPLETED|Ezetimibe and Efavirenz - Day 21-30||12||
60139280|NCT00810303|76262109|FG000|NOT COMPLETED|Ezetimibe and Efavirenz - Day 21-30||0||
60139281|NCT00810459|76262117|FG000|STARTED|Overall Study||4||
60139282|NCT00810459|76262118|FG001|STARTED|Overall Study||2||
60139283|NCT00810459|76262117|FG000|COMPLETED|Overall Study||4||
60139284|NCT00810459|76262118|FG001|COMPLETED|Overall Study||2||
60139285|NCT00810459|76262117|FG000|NOT COMPLETED|Overall Study||0||
60139286|NCT00810459|76262118|FG001|NOT COMPLETED|Overall Study||0||
60139287|NCT01460342|76262127|FG000|STARTED|Overall Study||304||
60139288|NCT01460342|76262128|FG001|STARTED|Overall Study||306||
60139289|NCT01460342|76262127|FG000|Received at Least 1 Dose of Study Drug|Overall Study||304||
59751376|NCT00860067|75870670|FG000|STARTED|Overall Study||1200||
59751377|NCT00860067|75870671|FG001|STARTED|Overall Study||299||
60139290|NCT01460342|76262128|FG001|Received at Least 1 Dose of Study Drug|Overall Study||306||
59881644|NCT04130919|76004520|FG003|COMPLETED|Open-label Treatment Phase||1||
60139291|NCT01460342|76262127|FG000|COMPLETED|Overall Study||293||
60139292|NCT01460342|76262128|FG001|COMPLETED|Overall Study||292||
60139293|NCT01460342|76262127|FG000|NOT COMPLETED|Overall Study||11||
60139294|NCT01460342|76262128|FG001|NOT COMPLETED|Overall Study||14||
60139295|NCT00810771|76262137|FG000|STARTED|Overall Study||232||
60139296|NCT00810771|76262138|FG001|STARTED|Overall Study||234||
60139297|NCT00810771|76262139|FG002|STARTED|Overall Study||84||
60139298|NCT00810771|76262137|FG000|COMPLETED|Overall Study||232||
60139299|NCT00810771|76262138|FG001|COMPLETED|Overall Study||234||
60139300|NCT00810771|76262139|FG002|COMPLETED|Overall Study||84||
59751378|NCT00860067|75870672|FG002|STARTED|Overall Study||301||
59751379|NCT00860067|75870670|FG000|COMPLETED|Overall Study||1149||
59751380|NCT00860067|75870671|FG001|COMPLETED|Overall Study||290||
60139301|NCT00810771|76262137|FG000|NOT COMPLETED|Overall Study||0||
60139302|NCT00810771|76262138|FG001|NOT COMPLETED|Overall Study||0||
60139303|NCT00810771|76262139|FG002|NOT COMPLETED|Overall Study||0||
60139304|NCT00775671|76262151|FG000|STARTED|Overall Study||23||
60139305|NCT00775671|76262152|FG001|STARTED|Overall Study||23||
60139306|NCT00775671|76262151|FG000|COMPLETED|Overall Study||23||
60139307|NCT00775671|76262152|FG001|COMPLETED|Overall Study||23||
59751381|NCT00860067|75870672|FG002|COMPLETED|Overall Study||292||
59881645|NCT04130919|76004521|FG004|COMPLETED|Open-label Treatment Phase||1||
59881646|NCT04130919|76004522|FG005|COMPLETED|Open-label Treatment Phase||0||
59881647|NCT04130919|76004517|FG000|NOT COMPLETED|Open-label Treatment Phase||0||
59881648|NCT04130919|76004518|FG001|NOT COMPLETED|Open-label Treatment Phase||0||
59881649|NCT04130919|76004519|FG002|NOT COMPLETED|Open-label Treatment Phase||0||
59881650|NCT04130919|76004520|FG003|NOT COMPLETED|Open-label Treatment Phase||3||
59881651|NCT04130919|76004521|FG004|NOT COMPLETED|Open-label Treatment Phase||2||
59881652|NCT04130919|76004522|FG005|NOT COMPLETED|Open-label Treatment Phase||3||
59881653|NCT04128267|76004536|FG000|STARTED|Overall Study||32||
59881654|NCT04128267|76004536|FG000|COMPLETED|Overall Study||17||
59881655|NCT04128267|76004536|FG000|NOT COMPLETED|Overall Study||15||
59881656|NCT03691779|76004540|FG000|STARTED|Part A (15 Days)||16||
59881657|NCT03691779|76004541|FG001|STARTED|Part A (15 Days)||0||
59881658|NCT03691779|76004540|FG000|COMPLETED|Part A (15 Days)||16||
59881659|NCT03691779|76004541|FG001|COMPLETED|Part A (15 Days)||0||
59881660|NCT03691779|76004540|FG000|NOT COMPLETED|Part A (15 Days)||0||
59881661|NCT03691779|76004541|FG001|NOT COMPLETED|Part A (15 Days)||0||
59881662|NCT03691779|76004540|FG000|STARTED|Part B (24 Weeks)||0||
59881663|NCT03691779|76004541|FG001|STARTED|Part B (24 Weeks)|Out of the 16 participants from Part A, 11 participants also participated in Part B of the study.|66||
59881664|NCT03691779|76004540|FG000|COMPLETED|Part B (24 Weeks)||0||
59881665|NCT03691779|76004541|FG001|COMPLETED|Part B (24 Weeks)||64||
59881666|NCT03691779|76004540|FG000|NOT COMPLETED|Part B (24 Weeks)||0||
60139308|NCT00775671|76262151|FG000|NOT COMPLETED|Overall Study||0||
60139309|NCT00775671|76262152|FG001|NOT COMPLETED|Overall Study||0||
60139310|NCT01459796|76262160|FG000|STARTED|Overall Study||94||
60139311|NCT01459796|76262161|FG001|STARTED|Overall Study||126||
60139312|NCT01459796|76262160|FG000|COMPLETED|Overall Study||0||
59605687|NCT01965600|75715853|FG002|STARTED|First Intervention||5||
59605688|NCT01965600|75715854|FG003|STARTED|First Intervention||4||
59605689|NCT01965600|75715851|FG000|Received at Least One Dose of Drug|First Intervention||6||
59605690|NCT01965600|75715852|FG001|Received at Least One Dose of Drug|First Intervention||8||
59605691|NCT01965600|75715853|FG002|Received at Least One Dose of Drug|First Intervention||5||
59881667|NCT03691779|76004541|FG001|NOT COMPLETED|Part B (24 Weeks)||2||
60139313|NCT01459796|76262161|FG001|COMPLETED|Overall Study||0||
60139314|NCT01459796|76262160|FG000|NOT COMPLETED|Overall Study||94||
60139315|NCT01459796|76262161|FG001|NOT COMPLETED|Overall Study||126||
60139316|NCT00776295|76262167|FG000|STARTED|Overall Study||2||
60139317|NCT00776295|76262167|FG000|COMPLETED|Overall Study||2||
60139318|NCT00776295|76262167|FG000|NOT COMPLETED|Overall Study||0||
60139319|NCT01459718|76262171|FG000|STARTED|Overall Study||13||
60139320|NCT01459718|76262171|FG000|Safety Analysis Set|Overall Study||13||
60139321|NCT01459718|76262171|FG000|COMPLETED|Overall Study||10||
60139322|NCT01459718|76262171|FG000|NOT COMPLETED|Overall Study||3||
60139323|NCT04008069|76262175|FG000|STARTED|Open-Label Period||15||
60139324|NCT04008069|76262176|FG001|STARTED|Open-Label Period||0||
60139325|NCT04008069|76262177|FG002|STARTED|Open-Label Period||0||
60139326|NCT04008069|76262175|FG000|Completed Treatment up to Week 16|Open-Label Period||10||
60139327|NCT04008069|76262176|FG001|Completed Treatment up to Week 16|Open-Label Period||0||
60139328|NCT04008069|76262177|FG002|Completed Treatment up to Week 16|Open-Label Period||0||
60139329|NCT04008069|76262175|FG000|COMPLETED|Open-Label Period||10||
60139330|NCT04008069|76262176|FG001|COMPLETED|Open-Label Period||0||
60139331|NCT04008069|76262177|FG002|COMPLETED|Open-Label Period||0||
60139332|NCT04008069|76262175|FG000|NOT COMPLETED|Open-Label Period||5||
60139333|NCT04008069|76262176|FG001|NOT COMPLETED|Open-Label Period||0||
60139334|NCT04008069|76262177|FG002|NOT COMPLETED|Open-Label Period||0||
60139335|NCT04008069|76262175|FG000|STARTED|Randomized-Withdrawal Period||0||
60139336|NCT04008069|76262176|FG001|STARTED|Randomized-Withdrawal Period||2||
60139337|NCT04008069|76262177|FG002|STARTED|Randomized-Withdrawal Period||8||
60139338|NCT04008069|76262175|FG000|Completed Treatment With Study Drug|Randomized-Withdrawal Period||0||
60139339|NCT04008069|76262176|FG001|Completed Treatment With Study Drug|Randomized-Withdrawal Period||1||
60139340|NCT04008069|76262177|FG002|Completed Treatment With Study Drug|Randomized-Withdrawal Period||5||
60139341|NCT04008069|76262175|FG000|COMPLETED|Randomized-Withdrawal Period||0||
60139342|NCT04008069|76262176|FG001|COMPLETED|Randomized-Withdrawal Period||1||
60139343|NCT04008069|76262177|FG002|COMPLETED|Randomized-Withdrawal Period||5||
60139344|NCT04008069|76262175|FG000|NOT COMPLETED|Randomized-Withdrawal Period||0||
60139345|NCT04008069|76262176|FG001|NOT COMPLETED|Randomized-Withdrawal Period||1||
60139346|NCT04008069|76262177|FG002|NOT COMPLETED|Randomized-Withdrawal Period||3||
60139347|NCT00811317|76262187|FG000|STARTED|Overall Study||11||
60139348|NCT00811317|76262187|FG000|COMPLETED|Overall Study||11||
59881668|NCT04258995|76004550|FG000|STARTED|Overall Study||76||
59881669|NCT04258995|76004551|FG001|STARTED|Overall Study||75||
59881670|NCT04258995|76004550|FG000|Vaccinated|Overall Study||76||
59881671|NCT04258995|76004551|FG001|Vaccinated|Overall Study||75||
59881672|NCT04258995|76004550|FG000|COMPLETED|Overall Study||75||
60139349|NCT00811317|76262187|FG000|NOT COMPLETED|Overall Study||0||
60139350|NCT01474538|76262193|FG000|STARTED|Treatment Period 1||60||
60139351|NCT01474538|76262194|FG001|STARTED|Treatment Period 1||62||
60139352|NCT01474538|76262193|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 1||60||
60139353|NCT01474538|76262194|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 1||62||
60139354|NCT01474538|76262193|FG000|COMPLETED|Treatment Period 1||57||
60139355|NCT01474538|76262194|FG001|COMPLETED|Treatment Period 1||58||
60139356|NCT01474538|76262193|FG000|NOT COMPLETED|Treatment Period 1||3||
60139357|NCT01474538|76262194|FG001|NOT COMPLETED|Treatment Period 1||4||
60139358|NCT01474538|76262193|FG000|STARTED|Treatment Period 2||57||
60139359|NCT01474538|76262194|FG001|STARTED|Treatment Period 2||58||
60139360|NCT01474538|76262193|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 2||57||
60139361|NCT01474538|76262194|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 2||58||
60139362|NCT01474538|76262193|FG000|COMPLETED|Treatment Period 2||51||
60139363|NCT01474538|76262194|FG001|COMPLETED|Treatment Period 2||56||
60139364|NCT01474538|76262193|FG000|NOT COMPLETED|Treatment Period 2||6||
60139365|NCT01474538|76262194|FG001|NOT COMPLETED|Treatment Period 2||2||
60139366|NCT02647788|76262202|FG000|STARTED|Overall Study||70||
60139367|NCT02647788|76262203|FG001|STARTED|Overall Study||70||
60139368|NCT02647788|76262202|FG000|COMPLETED|Overall Study||54||
60139369|NCT02647788|76262203|FG001|COMPLETED|Overall Study||57||
60139370|NCT02647788|76262202|FG000|NOT COMPLETED|Overall Study||16||
60139371|NCT02647788|76262203|FG001|NOT COMPLETED|Overall Study||13||
60139372|NCT01459016|76262209|FG000|STARTED|Overall Study||56||
60139373|NCT01459016|76262209|FG000|COMPLETED|Overall Study||41||
60139374|NCT01459016|76262209|FG000|NOT COMPLETED|Overall Study||15||
60139375|NCT00843531|76262213|FG000|STARTED|Overall Study||17||
60139376|NCT00843531|76262213|FG000|COMPLETED|Overall Study||17||
60139377|NCT00843531|76262213|FG000|NOT COMPLETED|Overall Study||0||
60139378|NCT00812877|76262223|FG000|STARTED|Overall Study||195||
60139379|NCT00812877|76262224|FG001|STARTED|Overall Study||181||
60139380|NCT00812877|76262223|FG000|COMPLETED|Overall Study||158||
60139381|NCT00812877|76262224|FG001|COMPLETED|Overall Study||130||
60139382|NCT00812877|76262223|FG000|NOT COMPLETED|Overall Study||37||
60139383|NCT00812877|76262224|FG001|NOT COMPLETED|Overall Study||51||
60139384|NCT00813111|76262232|FG000|STARTED|Overall Study||66||
60139385|NCT00813111|76262233|FG001|STARTED|Overall Study||70||
60139386|NCT00813111|76262232|FG000|COMPLETED|Overall Study||64||
60139387|NCT00813111|76262233|FG001|COMPLETED|Overall Study||70||
60139388|NCT00813111|76262232|FG000|NOT COMPLETED|Overall Study||2||
60139389|NCT00813111|76262233|FG001|NOT COMPLETED|Overall Study||0||
60139390|NCT00845481|76262239|FG000|STARTED|Overall Study||24||
60139391|NCT00845481|76262239|FG000|COMPLETED|Overall Study||24||
60139392|NCT00845481|76262239|FG000|NOT COMPLETED|Overall Study||0||
60139393|NCT01458392|76262251|FG000|STARTED|Overall Study||2||
60139394|NCT01458392|76262252|FG001|STARTED|Overall Study||13||
60139395|NCT01458392|76262253|FG002|STARTED|Overall Study||31||
60139396|NCT01458392|76262251|FG000|COMPLETED|Overall Study||0||
60139397|NCT01458392|76262252|FG001|COMPLETED|Overall Study||0||
60139398|NCT01458392|76262253|FG002|COMPLETED|Overall Study||0||
60139399|NCT01458392|76262251|FG000|NOT COMPLETED|Overall Study||2||
60139400|NCT01458392|76262252|FG001|NOT COMPLETED|Overall Study||13||
60139401|NCT01458392|76262253|FG002|NOT COMPLETED|Overall Study||31||
60139402|NCT01421069|76262265|FG000|STARTED|Parent Study||127||
60139403|NCT01421069|76262265|FG000|COMPLETED|Parent Study||119||
60139404|NCT01421069|76262265|FG000|NOT COMPLETED|Parent Study||8||
60139405|NCT01421069|76262265|FG000|STARTED|Overall Period for Extension Study||109||
60139406|NCT01421069|76262265|FG000|Enrolled Into Active Treatment Period|Overall Period for Extension Study||99||
60139407|NCT01421069|76262265|FG000|Enrolled Into Observational Period|Overall Period for Extension Study||10||
60139408|NCT01421069|76262265|FG000|COMPLETED|Overall Period for Extension Study|27 participants completed study in Active Treatment period, 45 completed study in Observational Period, 5 completed study in Re-treatment Period, and 7 completed study in Withdrawal Period.|84||
60139409|NCT01421069|76262265|FG000|NOT COMPLETED|Overall Period for Extension Study||25||
60139410|NCT01421069|76262265|FG000|STARTED|Active Treatment Period||99||
60139411|NCT01421069|76262265|FG000|ERA|Active Treatment Period||31||
60139412|NCT01421069|76262265|FG000|PsA|Active Treatment Period||23||
60139413|NCT01421069|76262265|FG000|COMPLETED|Active Treatment Period||27||
60139414|NCT01421069|76262265|FG000|NOT COMPLETED|Active Treatment Period||72||
60139415|NCT01421069|76262265|FG000|STARTED|2a. Withdrawal Period|Participants from active treatment, who either met Wallace definition for clinically inactive disease for at least 6 months or had good clinical response and would benefit from treatment withdrawal entered withdrawal period.|30||
60139416|NCT01421069|76262265|FG000|ERA|2a. Withdrawal Period||9||
60139417|NCT01421069|76262265|FG000|PsA|2a. Withdrawal Period||5||
60139418|NCT01421069|76262265|FG000|COMPLETED|2a. Withdrawal Period||7||
60139419|NCT01421069|76262265|FG000|NOT COMPLETED|2a. Withdrawal Period||23||
60139420|NCT01421069|76262265|FG000|STARTED|2b. Retreatment Period|Participants requiring re-treatment per investigator's judgment entered re-treatment period.|13||
60139421|NCT01421069|76262265|FG000|ERA|2b. Retreatment Period||2||
60139422|NCT01421069|76262265|FG000|PsA|2b. Retreatment Period||3||
60139423|NCT01421069|76262265|FG000|COMPLETED|2b. Retreatment Period||5||
60139424|NCT01421069|76262265|FG000|NOT COMPLETED|2b. Retreatment Period||8||
60139425|NCT01421069|76262265|FG000|STARTED|Observational Period|10 participants entered directly from Parent study B1801014 (NCT00962741)|53||
60139426|NCT01421069|76262265|FG000|COMPLETED|Observational Period||45||
60139427|NCT01421069|76262265|FG000|NOT COMPLETED|Observational Period||8||
60139428|NCT00848367|76262271|FG000|STARTED|Overall Study||52||
60139429|NCT00848367|76262272|FG001|STARTED|Overall Study||50||
60139430|NCT00848367|76262271|FG000|COMPLETED|Overall Study||43||
60139431|NCT00848367|76262272|FG001|COMPLETED|Overall Study||41||
60139432|NCT00848367|76262271|FG000|NOT COMPLETED|Overall Study||9||
60139433|NCT00848367|76262272|FG001|NOT COMPLETED|Overall Study||9||
60139434|NCT00814671|76262283|FG000|STARTED|Overall Study||54||
60139435|NCT00814671|76262284|FG001|STARTED|Overall Study||48||
60139436|NCT00814671|76262285|FG002|STARTED|Overall Study||51||
60139437|NCT00814671|76262283|FG000|COMPLETED|Overall Study||47||
60139438|NCT00814671|76262284|FG001|COMPLETED|Overall Study||44||
60139439|NCT00814671|76262285|FG002|COMPLETED|Overall Study||49||
60139440|NCT00814671|76262283|FG000|NOT COMPLETED|Overall Study||7||
60139441|NCT00814671|76262284|FG001|NOT COMPLETED|Overall Study||4||
60139442|NCT00814671|76262285|FG002|NOT COMPLETED|Overall Study||2||
60139443|NCT01473836|76262297|FG000|STARTED|Overall Study||38||
60139444|NCT01473836|76262297|FG000|COMPLETED|Overall Study||32||
60139445|NCT01473836|76262297|FG000|NOT COMPLETED|Overall Study||6||
60139446|NCT00815685|76262301|FG000|STARTED|Overall Study||36||
60139447|NCT00815685|76262301|FG000|COMPLETED|Overall Study|Complete pre and post-treatment serum samples were available for 14 participants.|14||
60139448|NCT00815685|76262301|FG000|NOT COMPLETED|Overall Study||22||
60139449|NCT00850473|76262305|FG000|STARTED|Overall Study||3||
60139450|NCT00850473|76262305|FG000|COMPLETED|Overall Study||3||
60139451|NCT00850473|76262305|FG000|NOT COMPLETED|Overall Study||0||
60139452|NCT00815997|76262311|FG000|STARTED|Overall Study||80||
60139453|NCT00815997|76262312|FG001|STARTED|Overall Study||80||
60139454|NCT00815997|76262311|FG000|COMPLETED|Overall Study||80||
60139455|NCT00815997|76262312|FG001|COMPLETED|Overall Study||80||
60139456|NCT00815997|76262311|FG000|NOT COMPLETED|Overall Study||0||
60139457|NCT00815997|76262312|FG001|NOT COMPLETED|Overall Study||0||
60139458|NCT01473758|76262322|FG000|STARTED|Cycle 1||38||
60139459|NCT01473758|76262323|FG001|STARTED|Cycle 1||43||
60139460|NCT01473758|76262324|FG002|STARTED|Cycle 1||0||
60139461|NCT01473758|76262325|FG003|STARTED|Cycle 1||0||
60139462|NCT01473758|76262322|FG000|COMPLETED|Cycle 1||27||
60139463|NCT01473758|76262323|FG001|COMPLETED|Cycle 1||40||
60139464|NCT01473758|76262324|FG002|COMPLETED|Cycle 1||0||
60139465|NCT01473758|76262325|FG003|COMPLETED|Cycle 1||0||
60139466|NCT01473758|76262322|FG000|NOT COMPLETED|Cycle 1||11||
60139467|NCT01473758|76262323|FG001|NOT COMPLETED|Cycle 1||3||
60139468|NCT01473758|76262324|FG002|NOT COMPLETED|Cycle 1||0||
60139469|NCT01473758|76262325|FG003|NOT COMPLETED|Cycle 1||0||
60139470|NCT01473758|76262322|FG000|STARTED|Cycle 2||0||
60139471|NCT01473758|76262323|FG001|STARTED|Cycle 2||0||
60139472|NCT01473758|76262324|FG002|STARTED|Cycle 2||10||
60139473|NCT01473758|76262325|FG003|STARTED|Cycle 2||4||
60139474|NCT01473758|76262322|FG000|COMPLETED|Cycle 2||0||
60139475|NCT01473758|76262323|FG001|COMPLETED|Cycle 2||0||
60139476|NCT01473758|76262324|FG002|COMPLETED|Cycle 2||5||
60139477|NCT01473758|76262325|FG003|COMPLETED|Cycle 2||4||
60139478|NCT01473758|76262322|FG000|NOT COMPLETED|Cycle 2||0||
60139479|NCT01473758|76262323|FG001|NOT COMPLETED|Cycle 2||0||
60139480|NCT01473758|76262324|FG002|NOT COMPLETED|Cycle 2||5||
60139481|NCT01473758|76262325|FG003|NOT COMPLETED|Cycle 2||0||
60139482|NCT01420679|76262335|FG000|STARTED|Overall Study||14||
60139483|NCT01420679|76262336|FG001|STARTED|Overall Study||7||
60139484|NCT01420679|76262335|FG000|COMPLETED|Overall Study||0||
60139485|NCT01420679|76262336|FG001|COMPLETED|Overall Study||0||
60139486|NCT01420679|76262335|FG000|NOT COMPLETED|Overall Study||14||
60139487|NCT01420679|76262336|FG001|NOT COMPLETED|Overall Study||7||
60139488|NCT00851409|76262342|FG000|STARTED|Overall Study||25||
60139489|NCT00851409|76262342|FG000|COMPLETED|Overall Study||25||
60139490|NCT00851409|76262342|FG000|NOT COMPLETED|Overall Study||0||
59605692|NCT01965600|75715854|FG003|Received at Least One Dose of Drug|First Intervention||4||
60139491|NCT01496846|76262353|FG000|STARTED|IANB Articaine (All Participants)||28||
60139492|NCT01496846|76262354|FG001|STARTED|IANB Articaine (All Participants)||24||
60139493|NCT01496846|76262355|FG002|STARTED|IANB Articaine (All Participants)||36||
60139494|NCT01496846|76262356|FG003|STARTED|IANB Articaine (All Participants)||40||
60139495|NCT01496846|76262357|FG004|STARTED|IANB Articaine (All Participants)||35||
60139496|NCT01496846|76262358|FG005|STARTED|IANB Articaine (All Participants)||38||
60139497|NCT01496846|76262353|FG000|COMPLETED|IANB Articaine (All Participants)||27||
60139498|NCT01496846|76262354|FG001|COMPLETED|IANB Articaine (All Participants)||23||
60139499|NCT01496846|76262355|FG002|COMPLETED|IANB Articaine (All Participants)||36||
60139500|NCT01496846|76262356|FG003|COMPLETED|IANB Articaine (All Participants)||40||
60139501|NCT01496846|76262357|FG004|COMPLETED|IANB Articaine (All Participants)||35||
60139502|NCT01496846|76262358|FG005|COMPLETED|IANB Articaine (All Participants)||38||
60139503|NCT01496846|76262353|FG000|NOT COMPLETED|IANB Articaine (All Participants)||1||
60139504|NCT01496846|76262354|FG001|NOT COMPLETED|IANB Articaine (All Participants)||1||
60139505|NCT01496846|76262355|FG002|NOT COMPLETED|IANB Articaine (All Participants)||0||
60139506|NCT01496846|76262356|FG003|NOT COMPLETED|IANB Articaine (All Participants)||0||
60139507|NCT01496846|76262357|FG004|NOT COMPLETED|IANB Articaine (All Participants)||0||
60139508|NCT01496846|76262358|FG005|NOT COMPLETED|IANB Articaine (All Participants)||0||
60139509|NCT01496846|76262353|FG000|STARTED|Supplemental Buccal Infiltration|No participants with successful IANB initially were brought forward to supplemental anesthetic|0|Supplemental buccal anesthesia (SUP) was provided in cases of unsuccessful IANB.|
60139510|NCT01496846|76262354|FG001|STARTED|Supplemental Buccal Infiltration|No participants with successful IANB initially were brought forward to supplemental anesthetic|0|Supplemental buccal anesthesia (SUP) was provided in cases of unsuccessful IANB.|
60139511|NCT01496846|76262355|FG002|STARTED|Supplemental Buccal Infiltration|Only after unsuccessful IANB.|36|Supplemental buccal anesthesia (SUP) was provided in cases of unsuccessful IANB.|
60139512|NCT01496846|76262356|FG003|STARTED|Supplemental Buccal Infiltration|Only after unsuccessful IANB.|40|Supplemental buccal anesthesia (SUP) was provided in cases of unsuccessful IANB.|
60139513|NCT01496846|76262357|FG004|STARTED|Supplemental Buccal Infiltration|Only after unsuccessful IANB.|35|Supplemental buccal anesthesia (SUP) was provided in cases of unsuccessful IANB.|
60139514|NCT01496846|76262358|FG005|STARTED|Supplemental Buccal Infiltration|Only after unsuccessful IANB.|38|Supplemental buccal anesthesia (SUP) was provided in cases of unsuccessful IANB.|
60139515|NCT01496846|76262353|FG000|COMPLETED|Supplemental Buccal Infiltration||0||
60139516|NCT01496846|76262354|FG001|COMPLETED|Supplemental Buccal Infiltration||0||
60139517|NCT01496846|76262355|FG002|COMPLETED|Supplemental Buccal Infiltration||36||
60139518|NCT01496846|76262356|FG003|COMPLETED|Supplemental Buccal Infiltration||40||
60139519|NCT01496846|76262357|FG004|COMPLETED|Supplemental Buccal Infiltration||35||
60139520|NCT01496846|76262358|FG005|COMPLETED|Supplemental Buccal Infiltration||38||
60139521|NCT01496846|76262353|FG000|NOT COMPLETED|Supplemental Buccal Infiltration||0||
60139522|NCT01496846|76262354|FG001|NOT COMPLETED|Supplemental Buccal Infiltration||0||
60139523|NCT01496846|76262355|FG002|NOT COMPLETED|Supplemental Buccal Infiltration||0||
60139524|NCT01496846|76262356|FG003|NOT COMPLETED|Supplemental Buccal Infiltration||0||
60139525|NCT01496846|76262357|FG004|NOT COMPLETED|Supplemental Buccal Infiltration||0||
60139526|NCT01496846|76262358|FG005|NOT COMPLETED|Supplemental Buccal Infiltration||0||
60139527|NCT00964002|76262369|FG000|STARTED|Overall Study||61||
60139528|NCT00964002|76262369|FG000|Assessable for Safety|Overall Study|59 patients were assessable for safety, they received treatment at least once.|59||
60139529|NCT00964002|76262369|FG000|COMPLETED|Overall Study||53||
60139530|NCT00964002|76262369|FG000|NOT COMPLETED|Overall Study||8||
60139531|NCT00818337|76262373|FG000|STARTED|Overall Study||36||
60139532|NCT00818337|76262373|FG000|COMPLETED|Overall Study||36||
60139533|NCT00818337|76262373|FG000|NOT COMPLETED|Overall Study||0||
60139534|NCT01399697|76262381|FG000|STARTED|Overall Study||96||
60139535|NCT01399697|76262382|FG001|STARTED|Overall Study||83||
60139536|NCT01399697|76262383|FG002|STARTED|Overall Study||82||
60139537|NCT01399697|76262381|FG000|COMPLETED|Overall Study||55||
60139538|NCT01399697|76262382|FG001|COMPLETED|Overall Study||80||
60139539|NCT01399697|76262383|FG002|COMPLETED|Overall Study||78||
60139540|NCT01399697|76262381|FG000|NOT COMPLETED|Overall Study||41||
60139541|NCT01399697|76262382|FG001|NOT COMPLETED|Overall Study||3||
60139542|NCT01399697|76262383|FG002|NOT COMPLETED|Overall Study||4||
60139543|NCT00853671|76262394|FG000|STARTED|Overall Study||50||
60139544|NCT00853671|76262394|FG000|COMPLETED|Overall Study||50||
60139545|NCT00853671|76262394|FG000|NOT COMPLETED|Overall Study||0||
60139546|NCT00818805|76262398|FG000|STARTED|First Intervention||25||
60139547|NCT00818805|76262399|FG001|STARTED|First Intervention||25||
60139548|NCT00818805|76262398|FG000|COMPLETED|First Intervention||25||
60139549|NCT00818805|76262399|FG001|COMPLETED|First Intervention||25||
60139550|NCT00818805|76262398|FG000|NOT COMPLETED|First Intervention||0||
60139551|NCT00818805|76262399|FG001|NOT COMPLETED|First Intervention||0||
60139552|NCT00818805|76262398|FG000|STARTED|Second Intervention||25||
60139553|NCT00818805|76262399|FG001|STARTED|Second Intervention||25||
60139554|NCT00818805|76262398|FG000|COMPLETED|Second Intervention||25||
60139555|NCT00818805|76262399|FG001|COMPLETED|Second Intervention||25||
60139556|NCT00818805|76262398|FG000|NOT COMPLETED|Second Intervention||0||
60139557|NCT00818805|76262399|FG001|NOT COMPLETED|Second Intervention||0||
60139558|NCT00854061|76262409|FG000|STARTED|Overall Study||172||
60139559|NCT00854061|76262409|FG000|Completed 1st Surgery (T-PRED in One Eye and Pred Forte in the Other Eye)|Overall Study||162||
60139560|NCT00854061|76262409|FG000|Completed 2nd Surgery (T-PRED and Pred Forte in Opposite Eyes Compared to 1st Surgery)|Overall Study||149||
60139561|NCT00854061|76262409|FG000|COMPLETED|Overall Study||149||
60139562|NCT00854061|76262409|FG000|NOT COMPLETED|Overall Study||23||
60139563|NCT01473602|76262417|FG000|STARTED|Overall Study||18||
59881673|NCT04258995|76004551|FG001|COMPLETED|Overall Study||74||
59881674|NCT04258995|76004550|FG000|NOT COMPLETED|Overall Study||1||
59881675|NCT04258995|76004551|FG001|NOT COMPLETED|Overall Study||1||
59881676|NCT04247061|76004557|FG000|STARTED|Overall Study|13 Subjects completed the required pre-dental appointment study activities and were scheduled to attend the dental clinic|13||
59881677|NCT04247061|76004557|FG000|COMPLETED|Overall Study||4||
59881678|NCT04247061|76004557|FG000|NOT COMPLETED|Overall Study||9||
59881679|NCT04241133|76004563|FG000|STARTED|Overall Study||44||
59881680|NCT04241133|76004564|FG001|STARTED|Overall Study||34||
59881681|NCT04241133|76004563|FG000|COMPLETED|Overall Study||30||
59881682|NCT04241133|76004564|FG001|COMPLETED|Overall Study||0||
60139564|NCT01473602|76262418|FG001|STARTED|Overall Study||21||
60139565|NCT01473602|76262417|FG000|Received at Least 1 Dose of Study Drug|Overall Study||18||
60139566|NCT01473602|76262418|FG001|Received at Least 1 Dose of Study Drug|Overall Study||20||
60139567|NCT01473602|76262417|FG000|Completed 6 Months|Overall Study||12||
60139568|NCT01473602|76262418|FG001|Completed 6 Months|Overall Study||15||
60139569|NCT01473602|76262417|FG000|Completed 12 Months|Overall Study||10||
60139570|NCT01473602|76262418|FG001|Completed 12 Months|Overall Study||13||
60139571|NCT01473602|76262417|FG000|COMPLETED|Overall Study||10||
60139572|NCT01473602|76262418|FG001|COMPLETED|Overall Study||13||
60139573|NCT01473602|76262417|FG000|NOT COMPLETED|Overall Study||8||
60139574|NCT01473602|76262418|FG001|NOT COMPLETED|Overall Study||8||
60139575|NCT01496612|76262426|FG000|STARTED|1st Intervention||3||
60139576|NCT01496612|76262427|FG001|STARTED|1st Intervention||4||
59881683|NCT04241133|76004563|FG000|NOT COMPLETED|Overall Study||14||
59881684|NCT04241133|76004564|FG001|NOT COMPLETED|Overall Study||34||
60139577|NCT01496612|76262426|FG000|COMPLETED|1st Intervention||1||
60139578|NCT01496612|76262427|FG001|COMPLETED|1st Intervention||4||
60139579|NCT01496612|76262426|FG000|NOT COMPLETED|1st Intervention||2||
60139580|NCT01496612|76262427|FG001|NOT COMPLETED|1st Intervention||0||
60139581|NCT01496612|76262426|FG000|STARTED|2nd Intervention||1||
59881685|NCT04123665|76004572|FG000|STARTED|Overall Study||50||
59881686|NCT04123665|76004573|FG001|STARTED|Overall Study||48||
59881687|NCT04123665|76004572|FG000|COMPLETED|Overall Study||42||
59881688|NCT04123665|76004573|FG001|COMPLETED|Overall Study||48||
59881689|NCT04123665|76004572|FG000|NOT COMPLETED|Overall Study||8||
59881690|NCT04123665|76004573|FG001|NOT COMPLETED|Overall Study||0||
59881691|NCT04232943|76004582|FG000|STARTED|Overall Study||32||
59881692|NCT04232943|76004583|FG001|STARTED|Overall Study||33||
59881693|NCT04232943|76004584|FG002|STARTED|Overall Study||22||
59881694|NCT04232943|76004582|FG000|Received Study Vaccination|Overall Study||30||
59881695|NCT04232943|76004583|FG001|Received Study Vaccination|Overall Study||30||
59881696|NCT04232943|76004584|FG002|Received Study Vaccination|Overall Study||20||
59881697|NCT04232943|76004582|FG000|Received bOPV Challenge on Day 29|Overall Study||29||
59881698|NCT04232943|76004583|FG001|Received bOPV Challenge on Day 29|Overall Study||30||
59881699|NCT04232943|76004584|FG002|Received bOPV Challenge on Day 29|Overall Study||20||
60139582|NCT01496612|76262427|FG001|STARTED|2nd Intervention||4||
60139583|NCT01496612|76262426|FG000|COMPLETED|2nd Intervention||1||
60139584|NCT01496612|76262427|FG001|COMPLETED|2nd Intervention||4||
60139585|NCT01496612|76262426|FG000|NOT COMPLETED|2nd Intervention||0||
60139586|NCT01496612|76262427|FG001|NOT COMPLETED|2nd Intervention||0||
60139587|NCT03303391|76262437|FG000|STARTED|Overall Study||9||
60139588|NCT03303391|76262438|FG001|STARTED|Overall Study||3||
60139589|NCT03303391|76262437|FG000|COMPLETED|Overall Study||9||
60139590|NCT03303391|76262438|FG001|COMPLETED|Overall Study||3||
60139591|NCT03303391|76262437|FG000|NOT COMPLETED|Overall Study||0||
59881700|NCT04232943|76004582|FG000|COMPLETED|Overall Study||29||
59881701|NCT04232943|76004583|FG001|COMPLETED|Overall Study||29||
59881702|NCT04232943|76004584|FG002|COMPLETED|Overall Study||20||
59881703|NCT04232943|76004582|FG000|NOT COMPLETED|Overall Study||3||
60139592|NCT03303391|76262438|FG001|NOT COMPLETED|Overall Study||0||
60139593|NCT00790218|76262444|FG000|STARTED|Overall Study||6||
60139594|NCT00790218|76262445|FG001|STARTED|Overall Study||6||
60139595|NCT00790218|76262446|FG002|STARTED|Overall Study||7||
60139596|NCT00790218|76262444|FG000|COMPLETED|Overall Study||5||
60139597|NCT00790218|76262445|FG001|COMPLETED|Overall Study||6||
60139598|NCT00790218|76262446|FG002|COMPLETED|Overall Study||7||
60139599|NCT00790218|76262444|FG000|NOT COMPLETED|Overall Study||1||
60139600|NCT00790218|76262445|FG001|NOT COMPLETED|Overall Study||0||
60139601|NCT00790218|76262446|FG002|NOT COMPLETED|Overall Study||0||
60139602|NCT00818961|76262454|FG000|STARTED|Overall Study||36||
60139603|NCT00818961|76262454|FG000|COMPLETED|Overall Study||36||
60139604|NCT00818961|76262454|FG000|NOT COMPLETED|Overall Study||0||
60139605|NCT00819507|76262458|FG000|STARTED|Overall Study||25||
60139606|NCT00819507|76262458|FG000|COMPLETED|Overall Study||25||
60139607|NCT00819507|76262458|FG000|NOT COMPLETED|Overall Study||0||
60139608|NCT00820443|76262462|FG000|STARTED|Pre-Op||253||
60139609|NCT00820443|76262462|FG000|COMPLETED|Pre-Op||253||
60139610|NCT00820443|76262462|FG000|NOT COMPLETED|Pre-Op||0||
60139611|NCT00820443|76262462|FG000|STARTED|Op||253||
60139612|NCT00820443|76262462|FG000|COMPLETED|Op||253||
60139613|NCT00820443|76262462|FG000|NOT COMPLETED|Op||0||
60139614|NCT00820443|76262462|FG000|STARTED|Immediately||253||
60139615|NCT00820443|76262462|FG000|COMPLETED|Immediately||248||
60139616|NCT00820443|76262462|FG000|NOT COMPLETED|Immediately||5||
60139617|NCT00820443|76262462|FG000|STARTED|3 Month||253||
60139618|NCT00820443|76262462|FG000|COMPLETED|3 Month||244||
60139619|NCT00820443|76262462|FG000|NOT COMPLETED|3 Month||9||
60139620|NCT00820443|76262462|FG000|STARTED|6 Month||253||
60139621|NCT00820443|76262462|FG000|COMPLETED|6 Month||233||
60139622|NCT00820443|76262462|FG000|NOT COMPLETED|6 Month||20||
60139623|NCT00820443|76262462|FG000|STARTED|12 Month||250||
60139624|NCT00820443|76262462|FG000|COMPLETED|12 Month||226||
60139625|NCT00820443|76262462|FG000|NOT COMPLETED|12 Month||24||
60139626|NCT00820443|76262462|FG000|STARTED|24 Month||245||
60139627|NCT00820443|76262462|FG000|COMPLETED|24 Month||202||
59605693|NCT01965600|75715851|FG000|COMPLETED|First Intervention||6||
59605694|NCT01965600|75715852|FG001|COMPLETED|First Intervention||8||
59605695|NCT01965600|75715853|FG002|COMPLETED|First Intervention||5||
59605696|NCT01965600|75715854|FG003|COMPLETED|First Intervention||4||
60139628|NCT00820443|76262462|FG000|NOT COMPLETED|24 Month||43||
60139629|NCT01457924|76262472|FG000|STARTED|Treatment Phase (Weeks 0-24)||67||
60139630|NCT01457924|76262473|FG001|STARTED|Treatment Phase (Weeks 0-24)||34||
60139631|NCT01457924|76262474|FG002|STARTED|Treatment Phase (Weeks 0-24)||32||
60139632|NCT01457924|76262475|FG003|STARTED|Treatment Phase (Weeks 0-24)||34||
60139633|NCT01457924|76262476|FG004|STARTED|Treatment Phase (Weeks 0-24)||64||
60139634|NCT01457924|76262472|FG000|Completed to Week 12|Treatment Phase (Weeks 0-24)||65||
60139635|NCT01457924|76262473|FG001|Completed to Week 12|Treatment Phase (Weeks 0-24)||31||
60139636|NCT01457924|76262474|FG002|Completed to Week 12|Treatment Phase (Weeks 0-24)||30||
59605697|NCT01965600|75715851|FG000|NOT COMPLETED|First Intervention||0||
59605698|NCT01965600|75715852|FG001|NOT COMPLETED|First Intervention||0||
60139637|NCT01457924|76262475|FG003|Completed to Week 12|Treatment Phase (Weeks 0-24)||33||
60139638|NCT01457924|76262476|FG004|Completed to Week 12|Treatment Phase (Weeks 0-24)||60||
60139639|NCT01457924|76262472|FG000|COMPLETED|Treatment Phase (Weeks 0-24)||64||
60139640|NCT01457924|76262473|FG001|COMPLETED|Treatment Phase (Weeks 0-24)||29||
60139641|NCT01457924|76262474|FG002|COMPLETED|Treatment Phase (Weeks 0-24)||30||
59605699|NCT01965600|75715853|FG002|NOT COMPLETED|First Intervention||0||
59605700|NCT01965600|75715854|FG003|NOT COMPLETED|First Intervention||0||
59605701|NCT01965600|75715851|FG000|STARTED|Washout Period of Approximately 15 Days||6||
60139642|NCT01457924|76262475|FG003|COMPLETED|Treatment Phase (Weeks 0-24)||33||
60139643|NCT01457924|76262476|FG004|COMPLETED|Treatment Phase (Weeks 0-24)||58||
60139644|NCT01457924|76262472|FG000|NOT COMPLETED|Treatment Phase (Weeks 0-24)||3||
60139645|NCT01457924|76262473|FG001|NOT COMPLETED|Treatment Phase (Weeks 0-24)||5||
60139646|NCT01457924|76262474|FG002|NOT COMPLETED|Treatment Phase (Weeks 0-24)||2||
60139647|NCT01457924|76262475|FG003|NOT COMPLETED|Treatment Phase (Weeks 0-24)||1||
60139648|NCT01457924|76262476|FG004|NOT COMPLETED|Treatment Phase (Weeks 0-24)||6||
60139649|NCT01457924|76262472|FG000|STARTED|FUP (Weeks 24-48)||66|A total of 221 par. entered the FUP, including 7 of the 17 par. who were withdrawn before Week 24.|
60139650|NCT01457924|76262473|FG001|STARTED|FUP (Weeks 24-48)||31|A total of 221 par. entered the FUP, including 7 of the 17 par. who were withdrawn before Week 24.|
60139651|NCT01457924|76262474|FG002|STARTED|FUP (Weeks 24-48)||32|A total of 221 par. entered the FUP, including 7 of the 17 par. who were withdrawn before Week 24.|
60139652|NCT01457924|76262475|FG003|STARTED|FUP (Weeks 24-48)||33|A total of 221 par. entered the FUP, including 7 of the 17 par. who were withdrawn before Week 24.|
60139653|NCT01457924|76262476|FG004|STARTED|FUP (Weeks 24-48)||59|A total of 221 par. entered the FUP, including 7 of the 17 par. who were withdrawn before Week 24.|
60139654|NCT01457924|76262472|FG000|COMPLETED|FUP (Weeks 24-48)||63||
60139655|NCT01457924|76262473|FG001|COMPLETED|FUP (Weeks 24-48)||30||
60139656|NCT01457924|76262474|FG002|COMPLETED|FUP (Weeks 24-48)||30||
60139657|NCT01457924|76262475|FG003|COMPLETED|FUP (Weeks 24-48)||32||
60139658|NCT01457924|76262476|FG004|COMPLETED|FUP (Weeks 24-48)||57||
60139659|NCT01457924|76262472|FG000|NOT COMPLETED|FUP (Weeks 24-48)||3||
60139660|NCT01457924|76262473|FG001|NOT COMPLETED|FUP (Weeks 24-48)||1||
60139661|NCT01457924|76262474|FG002|NOT COMPLETED|FUP (Weeks 24-48)||2||
60139662|NCT01457924|76262475|FG003|NOT COMPLETED|FUP (Weeks 24-48)||1||
60139663|NCT01457924|76262476|FG004|NOT COMPLETED|FUP (Weeks 24-48)||2||
60139664|NCT01457924|76262472|FG000|STARTED|Individualized FUP (Weeks 48+)||16|Par. whose CD19+ B lymphocyte counts had not recovered to lower limit of normal entered IFU phase.|
60139665|NCT01457924|76262473|FG001|STARTED|Individualized FUP (Weeks 48+)||18|Par. whose CD19+ B lymphocyte counts had not recovered to lower limit of normal entered IFU phase.|
60139666|NCT01457924|76262474|FG002|STARTED|Individualized FUP (Weeks 48+)||16|Par. whose CD19+ B lymphocyte counts had not recovered to lower limit of normal entered IFU phase.|
60139667|NCT01457924|76262475|FG003|STARTED|Individualized FUP (Weeks 48+)||20|Par. whose CD19+ B lymphocyte counts had not recovered to lower limit of normal entered IFU phase.|
60139668|NCT01457924|76262476|FG004|STARTED|Individualized FUP (Weeks 48+)||42|Par. whose CD19+ B lymphocyte counts had not recovered to lower limit of normal entered IFU phase.|
60139669|NCT01457924|76262472|FG000|COMPLETED|Individualized FUP (Weeks 48+)||11||
60139670|NCT01457924|76262473|FG001|COMPLETED|Individualized FUP (Weeks 48+)||14||
60139671|NCT01457924|76262474|FG002|COMPLETED|Individualized FUP (Weeks 48+)||12||
60139672|NCT01457924|76262475|FG003|COMPLETED|Individualized FUP (Weeks 48+)||15||
60139673|NCT01457924|76262476|FG004|COMPLETED|Individualized FUP (Weeks 48+)||36||
60139674|NCT01457924|76262472|FG000|NOT COMPLETED|Individualized FUP (Weeks 48+)||5||
60139675|NCT01457924|76262473|FG001|NOT COMPLETED|Individualized FUP (Weeks 48+)||4||
60139676|NCT01457924|76262474|FG002|NOT COMPLETED|Individualized FUP (Weeks 48+)||4||
60139677|NCT01457924|76262475|FG003|NOT COMPLETED|Individualized FUP (Weeks 48+)||5||
60139678|NCT01457924|76262476|FG004|NOT COMPLETED|Individualized FUP (Weeks 48+)||6||
60139679|NCT01307631|76262488|FG000|STARTED|Overall Study||9||
60139680|NCT01307631|76262489|FG001|STARTED|Overall Study||28||
60139681|NCT01307631|76262488|FG000|COMPLETED|Overall Study||9||
60139682|NCT01307631|76262489|FG001|COMPLETED|Overall Study||28||
60139683|NCT01307631|76262488|FG000|NOT COMPLETED|Overall Study||0||
60139684|NCT01307631|76262489|FG001|NOT COMPLETED|Overall Study||0||
60139685|NCT01399619|76262497|FG000|STARTED|Overall Study||123||
60139686|NCT01399619|76262498|FG001|STARTED|Overall Study||84||
60139687|NCT01399619|76262499|FG002|STARTED|Overall Study||86||
60139688|NCT01399619|76262500|FG003|STARTED|Overall Study||17||
60139689|NCT01399619|76262497|FG000|COMPLETED|Overall Study||98||
60139690|NCT01399619|76262498|FG001|COMPLETED|Overall Study||84||
60139691|NCT01399619|76262499|FG002|COMPLETED|Overall Study||74||
60139692|NCT01399619|76262500|FG003|COMPLETED|Overall Study||0||
60139693|NCT01399619|76262497|FG000|NOT COMPLETED|Overall Study||25||
60139694|NCT01399619|76262498|FG001|NOT COMPLETED|Overall Study||0||
60139695|NCT01399619|76262499|FG002|NOT COMPLETED|Overall Study||12||
60139696|NCT01399619|76262500|FG003|NOT COMPLETED|Overall Study||17||
60139697|NCT01496456|76262515|FG000|STARTED|Overall Study||17||
60139698|NCT01496456|76262515|FG000|Baseline|Overall Study|Baseline group started with 16 patients.|16||
60139699|NCT01496456|76262515|FG000|1-yr Recall|Overall Study||12||
60139700|NCT01496456|76262515|FG000|2-yr Recall|Overall Study||10||
60139701|NCT01496456|76262515|FG000|3-yr Final Recall|Overall Study||9||
60139702|NCT01496456|76262515|FG000|COMPLETED|Overall Study||9||
60139703|NCT01496456|76262515|FG000|NOT COMPLETED|Overall Study||8||
60139704|NCT03327649|76262524|FG000|STARTED|Overall Study||26||
60139705|NCT03327649|76262525|FG001|STARTED|Overall Study||26||
60139706|NCT03327649|76262524|FG000|COMPLETED|Overall Study||24||
60139707|NCT03327649|76262525|FG001|COMPLETED|Overall Study||24||
60139708|NCT03327649|76262524|FG000|NOT COMPLETED|Overall Study||2||
60139709|NCT03327649|76262525|FG001|NOT COMPLETED|Overall Study||2||
60139710|NCT04040621|76262531|FG000|STARTED|Overall Study||4||
60139711|NCT04040621|76262531|FG000|COMPLETED|Overall Study||4||
60139712|NCT04040621|76262531|FG000|NOT COMPLETED|Overall Study||0||
60139713|NCT00856791|76262535|FG000|STARTED|Overall Study||1||
60139714|NCT00856791|76262535|FG000|COMPLETED|Overall Study||1||
60139715|NCT00856791|76262535|FG000|NOT COMPLETED|Overall Study||0||
60139716|NCT00857493|76262541|FG000|STARTED|Overall Study||62||
60139717|NCT00857493|76262542|FG001|STARTED|Overall Study||58||
60139718|NCT00857493|76262541|FG000|COMPLETED|Overall Study||59|active study phase|
60139719|NCT00857493|76262542|FG001|COMPLETED|Overall Study||58|active study phase|
60139720|NCT00857493|76262541|FG000|NOT COMPLETED|Overall Study||3||
60139721|NCT00857493|76262542|FG001|NOT COMPLETED|Overall Study||0||
60139722|NCT00857727|76262550|FG000|STARTED|Overall Study||14||
60139723|NCT00857727|76262551|FG001|STARTED|Overall Study||14||
60139724|NCT00857727|76262550|FG000|COMPLETED|Overall Study||14||
60139725|NCT00857727|76262551|FG001|COMPLETED|Overall Study||14||
60139726|NCT00857727|76262550|FG000|NOT COMPLETED|Overall Study||0||
60139727|NCT00857727|76262551|FG001|NOT COMPLETED|Overall Study||0||
60139728|NCT00857961|76262557|FG000|STARTED|Overall Study||21||
60139729|NCT00857961|76262557|FG000|COMPLETED|Overall Study||21||
60139730|NCT00857961|76262557|FG000|NOT COMPLETED|Overall Study||0||
60139731|NCT00823797|76262569|FG000|STARTED|Overall Study||29||
60139732|NCT00823797|76262570|FG001|STARTED|Overall Study||16||
60139733|NCT00823797|76262569|FG000|COMPLETED|Overall Study||29||
60139734|NCT00823797|76262570|FG001|COMPLETED|Overall Study||16||
60139735|NCT00823797|76262569|FG000|NOT COMPLETED|Overall Study||0||
60139736|NCT00823797|76262570|FG001|NOT COMPLETED|Overall Study||0||
60139737|NCT00858507|76262577|FG000|STARTED|Overall Study||105||
60139738|NCT00858507|76262578|FG001|STARTED|Overall Study||116||
60139739|NCT00858507|76262577|FG000|COMPLETED|Overall Study||83||
60139740|NCT00858507|76262578|FG001|COMPLETED|Overall Study||101||
60139741|NCT00858507|76262577|FG000|NOT COMPLETED|Overall Study||22||
60139742|NCT00858507|76262578|FG001|NOT COMPLETED|Overall Study||15||
60139743|NCT02150109|76262584|FG000|STARTED|Overall Study||372||
60139744|NCT02150109|76262584|FG000|COMPLETED|Overall Study||372||
60139745|NCT02150109|76262584|FG000|NOT COMPLETED|Overall Study||0||
60139746|NCT00824733|76262594|FG000|STARTED|Overall Study||6||
60139747|NCT00824733|76262594|FG000|COMPLETED|Overall Study||6||
60139748|NCT00824733|76262594|FG000|NOT COMPLETED|Overall Study||0||
60139749|NCT02150499|76262600|FG000|STARTED|Overall Study||9||
60139750|NCT02150499|76262601|FG001|STARTED|Overall Study||9||
60139751|NCT02150499|76262600|FG000|COMPLETED|Overall Study||9||
60139752|NCT02150499|76262601|FG001|COMPLETED|Overall Study||9||
60139753|NCT02150499|76262600|FG000|NOT COMPLETED|Overall Study||0||
60139754|NCT02150499|76262601|FG001|NOT COMPLETED|Overall Study||0||
60139755|NCT03287947|76262607|FG000|STARTED|Overall Study|Five subjects were enrolled to the study.|5||
60139756|NCT03287947|76262607|FG000|COMPLETED|Overall Study|All subjects enrolled discontinued treatment and are now off study.|5||
60139757|NCT03287947|76262607|FG000|NOT COMPLETED|Overall Study||0||
60139758|NCT00859053|76262615|FG000|STARTED|Overall Study||6||
60139759|NCT00859053|76262616|FG001|STARTED|Overall Study||6||
60139760|NCT00859053|76262617|FG002|STARTED|Overall Study||6||
60139761|NCT00859053|76262618|FG003|STARTED|Overall Study||12||
60139762|NCT00859053|76262615|FG000|COMPLETED|Overall Study||6||
60139763|NCT00859053|76262616|FG001|COMPLETED|Overall Study||6||
60139764|NCT00859053|76262617|FG002|COMPLETED|Overall Study||6||
60139765|NCT00859053|76262618|FG003|COMPLETED|Overall Study||12||
60139766|NCT00859053|76262615|FG000|NOT COMPLETED|Overall Study||0||
60139767|NCT00859053|76262616|FG001|NOT COMPLETED|Overall Study||0||
60139768|NCT00859053|76262617|FG002|NOT COMPLETED|Overall Study||0||
60139769|NCT00859053|76262618|FG003|NOT COMPLETED|Overall Study||0||
60139770|NCT00859131|76262630|FG000|STARTED|Overall Study||102||
60139771|NCT00859131|76262631|FG001|STARTED|Overall Study||98||
60139772|NCT00859131|76262630|FG000|COMPLETED|Overall Study||102||
60139773|NCT00859131|76262631|FG001|COMPLETED|Overall Study||98||
60139774|NCT00859131|76262630|FG000|NOT COMPLETED|Overall Study||0||
60139775|NCT00859131|76262631|FG001|NOT COMPLETED|Overall Study||0||
60139776|NCT00859833|76262637|FG000|STARTED|Overall Study||30||
60139777|NCT00859833|76262637|FG000|COMPLETED|Overall Study||30||
60139778|NCT00859833|76262637|FG000|NOT COMPLETED|Overall Study||0||
60139779|NCT02154477|76262644|FG000|STARTED|Overall Study||6||
60139780|NCT02154477|76262645|FG001|STARTED|Overall Study||8||
60139781|NCT02154477|76262644|FG000|COMPLETED|Overall Study||6||
60139782|NCT02154477|76262645|FG001|COMPLETED|Overall Study||8||
60139783|NCT02154477|76262644|FG000|NOT COMPLETED|Overall Study||0||
60139784|NCT02154477|76262645|FG001|NOT COMPLETED|Overall Study||0||
60139785|NCT00860379|76262654|FG000|STARTED|Overall Study||4||
60139786|NCT00860379|76262655|FG001|STARTED|Overall Study||6||
60139787|NCT00860379|76262656|FG002|STARTED|Overall Study||4||
60139788|NCT00860379|76262654|FG000|COMPLETED|Overall Study||4||
60139789|NCT00860379|76262655|FG001|COMPLETED|Overall Study||6||
60139790|NCT00860379|76262656|FG002|COMPLETED|Overall Study||4||
60139791|NCT00860379|76262654|FG000|NOT COMPLETED|Overall Study||0||
60139792|NCT00860379|76262655|FG001|NOT COMPLETED|Overall Study||0||
60139793|NCT00860379|76262656|FG002|NOT COMPLETED|Overall Study||0||
60139794|NCT00860457|76262664|FG000|STARTED|Overall Study||22||
60139795|NCT00860457|76262664|FG000|COMPLETED|Overall Study||11||
60139796|NCT00860457|76262664|FG000|NOT COMPLETED|Overall Study||11||
60139797|NCT00860535|76262668|FG000|STARTED|Overall Study||9||
60139798|NCT00860535|76262668|FG000|DISCONTINUED|Overall Study|Participant did not meet inclusion criteria and did not complete the study.|1||
60139799|NCT00860535|76262668|FG000|COMPLETED|Overall Study||8||
60139800|NCT00860535|76262668|FG000|NOT COMPLETED|Overall Study||1||
60139801|NCT00827073|76262674|FG000|STARTED|Overall Study||20||
60139802|NCT00827073|76262675|FG001|STARTED|Overall Study||20||
60139803|NCT00827073|76262674|FG000|COMPLETED|Overall Study||20||
60139804|NCT00827073|76262675|FG001|COMPLETED|Overall Study||20||
60139805|NCT00827073|76262674|FG000|NOT COMPLETED|Overall Study||0||
60139806|NCT00827073|76262675|FG001|NOT COMPLETED|Overall Study||0||
60139807|NCT00860847|76262683|FG000|STARTED|Overall Study||32||
60139808|NCT00860847|76262684|FG001|STARTED|Overall Study||33||
60139809|NCT00860847|76262683|FG000|COMPLETED|Overall Study||28||
60139810|NCT00860847|76262684|FG001|COMPLETED|Overall Study||28||
60139811|NCT00860847|76262683|FG000|NOT COMPLETED|Overall Study||4||
60139812|NCT00860847|76262684|FG001|NOT COMPLETED|Overall Study||5||
60139813|NCT02155101|76262692|FG000|STARTED|Overall Study||39||
60139814|NCT02155101|76262693|FG001|STARTED|Overall Study||81||
60139815|NCT02155101|76262692|FG000|COMPLETED|Overall Study||39||
60139816|NCT02155101|76262693|FG001|COMPLETED|Overall Study||80||
60139817|NCT02155101|76262692|FG000|NOT COMPLETED|Overall Study||0||
60139818|NCT02155101|76262693|FG001|NOT COMPLETED|Overall Study||1||
60139819|NCT02155257|76262702|FG000|STARTED|Overall Study||10||
60139820|NCT02155257|76262703|FG001|STARTED|Overall Study||10||
60139821|NCT02155257|76262704|FG002|STARTED|Overall Study||10||
60139822|NCT02155257|76262702|FG000|COMPLETED|Overall Study||10||
60139823|NCT02155257|76262703|FG001|COMPLETED|Overall Study||10||
60139824|NCT02155257|76262704|FG002|COMPLETED|Overall Study||10||
60139825|NCT02155257|76262702|FG000|NOT COMPLETED|Overall Study||0||
60139826|NCT02155257|76262703|FG001|NOT COMPLETED|Overall Study||0||
60139827|NCT02155257|76262704|FG002|NOT COMPLETED|Overall Study||0||
60139828|NCT01673646|76262715|FG000|STARTED|Overall Study||11||
60139829|NCT01673646|76262716|FG001|STARTED|Overall Study||11||
60139830|NCT01673646|76262717|FG002|STARTED|Overall Study||11||
60139831|NCT01673646|76262715|FG000|Entered/Treated in Core Phase|Overall Study||11||
60139832|NCT01673646|76262716|FG001|Entered/Treated in Core Phase|Overall Study||11||
60139833|NCT01673646|76262717|FG002|Entered/Treated in Core Phase|Overall Study||11||
60139834|NCT01673646|76262715|FG000|Completed Core Phase|Overall Study||9||
60139835|NCT01673646|76262716|FG001|Completed Core Phase|Overall Study||10||
60139836|NCT01673646|76262717|FG002|Completed Core Phase|Overall Study||10||
60139837|NCT01673646|76262715|FG000|Entered Ext. Phase|Overall Study||7||
60139838|NCT01673646|76262716|FG001|Entered Ext. Phase|Overall Study||9||
60139839|NCT01673646|76262717|FG002|Entered Ext. Phase|Overall Study||9||
60139840|NCT01673646|76262715|FG000|Did Not Enter Ext. Phase|Overall Study||2||
60139841|NCT01673646|76262716|FG001|Did Not Enter Ext. Phase|Overall Study||1||
60139842|NCT01673646|76262717|FG002|Did Not Enter Ext. Phase|Overall Study||1||
60139843|NCT01673646|76262715|FG000|Treated Beyond 24 Months|Overall Study||7||
60139844|NCT01673646|76262716|FG001|Treated Beyond 24 Months|Overall Study||8||
60139845|NCT01673646|76262717|FG002|Treated Beyond 24 Months|Overall Study||8||
60139846|NCT01673646|76262715|FG000|Discontinued Beyond 24 Months|Overall Study||0||
60139847|NCT01673646|76262716|FG001|Discontinued Beyond 24 Months|Overall Study||4||
60139848|NCT01673646|76262717|FG002|Discontinued Beyond 24 Months|Overall Study||1||
60139849|NCT01673646|76262715|FG000|COMPLETED|Overall Study||7||
60139850|NCT01673646|76262716|FG001|COMPLETED|Overall Study||4||
60139851|NCT01673646|76262717|FG002|COMPLETED|Overall Study||7||
60139852|NCT01673646|76262715|FG000|NOT COMPLETED|Overall Study||4||
60139853|NCT01673646|76262716|FG001|NOT COMPLETED|Overall Study||7||
60139854|NCT01673646|76262717|FG002|NOT COMPLETED|Overall Study||4||
60139855|NCT00862563|76262733|FG000|STARTED|Overall Study||19||
60139856|NCT00862563|76262734|FG001|STARTED|Overall Study||21||
60139857|NCT00862563|76262735|FG002|STARTED|Overall Study||21||
60139858|NCT00862563|76262736|FG003|STARTED|Overall Study||24||
60139859|NCT00862563|76262733|FG000|COMPLETED|Overall Study||15||
60139860|NCT00862563|76262734|FG001|COMPLETED|Overall Study||17||
60139861|NCT00862563|76262735|FG002|COMPLETED|Overall Study||15||
59881704|NCT04232943|76004583|FG001|NOT COMPLETED|Overall Study||4||
59881705|NCT04232943|76004584|FG002|NOT COMPLETED|Overall Study||2||
60139862|NCT00862563|76262736|FG003|COMPLETED|Overall Study||19||
60139863|NCT00862563|76262733|FG000|NOT COMPLETED|Overall Study||4||
60139864|NCT00862563|76262734|FG001|NOT COMPLETED|Overall Study||4||
60139865|NCT00862563|76262735|FG002|NOT COMPLETED|Overall Study||6||
60139866|NCT00862563|76262736|FG003|NOT COMPLETED|Overall Study||5||
60139867|NCT02647944|76262757|FG000|STARTED|Overall Study||19||
60139868|NCT02647944|76262758|FG001|STARTED|Overall Study||21||
60139869|NCT02647944|76262757|FG000|COMPLETED|Overall Study||17||
60139870|NCT02647944|76262758|FG001|COMPLETED|Overall Study||18||
60139871|NCT02647944|76262757|FG000|NOT COMPLETED|Overall Study||2||
60139872|NCT02647944|76262758|FG001|NOT COMPLETED|Overall Study||3||
60139873|NCT00863109|76262764|FG000|STARTED|Treatment Period||130||
60139874|NCT00863109|76262764|FG000|COMPLETED|Treatment Period||53||
60139875|NCT00863109|76262764|FG000|NOT COMPLETED|Treatment Period||77||
60139876|NCT00863109|76262764|FG000|STARTED|Follow-up Period|Follow-up performed on 53 who completed Treatment Period plus 6 who discontinued treatment|59||
60139877|NCT00863109|76262764|FG000|COMPLETED|Follow-up Period||48||
60139878|NCT00863109|76262764|FG000|NOT COMPLETED|Follow-up Period||11||
60139879|NCT00863265|76262770|FG000|STARTED|Overall Study||4||
60139880|NCT00863265|76262771|FG001|STARTED|Overall Study||3||
60139881|NCT00863265|76262772|FG002|STARTED|Overall Study||4||
60139882|NCT00863265|76262773|FG003|STARTED|Overall Study||4||
60139883|NCT00863265|76262774|FG004|STARTED|Overall Study||4||
60139884|NCT00863265|76262775|FG005|STARTED|Overall Study||3||
60139885|NCT00863265|76262770|FG000|COMPLETED|Overall Study||4||
60139886|NCT00863265|76262771|FG001|COMPLETED|Overall Study||3||
60139887|NCT00863265|76262772|FG002|COMPLETED|Overall Study||4||
60139888|NCT00863265|76262773|FG003|COMPLETED|Overall Study||4||
60139889|NCT00863265|76262774|FG004|COMPLETED|Overall Study||3||
60139890|NCT00863265|76262775|FG005|COMPLETED|Overall Study||3||
60139891|NCT00863265|76262770|FG000|NOT COMPLETED|Overall Study||0||
60139892|NCT00863265|76262771|FG001|NOT COMPLETED|Overall Study||0||
60139893|NCT00863265|76262772|FG002|NOT COMPLETED|Overall Study||0||
60139894|NCT00863265|76262773|FG003|NOT COMPLETED|Overall Study||0||
60139895|NCT00863265|76262774|FG004|NOT COMPLETED|Overall Study||1||
59881706|NCT03694275|76004595|FG000|STARTED|Overall Study||8||
59881707|NCT03694275|76004596|FG001|STARTED|Overall Study||12||
59881708|NCT03694275|76004595|FG000|COMPLETED|Overall Study||8||
59881709|NCT03694275|76004596|FG001|COMPLETED|Overall Study||10||
59881710|NCT03694275|76004595|FG000|NOT COMPLETED|Overall Study||0||
60139896|NCT00863265|76262775|FG005|NOT COMPLETED|Overall Study||0||
60139897|NCT00863343|76262791|FG000|STARTED|Overall Study||17||
60139898|NCT00863343|76262792|FG001|STARTED|Overall Study||374||
60139899|NCT00863343|76262791|FG000|COMPLETED|Overall Study||17||
60139900|NCT00863343|76262792|FG001|COMPLETED|Overall Study||374||
60139901|NCT00863343|76262791|FG000|NOT COMPLETED|Overall Study||0||
60139902|NCT00863343|76262792|FG001|NOT COMPLETED|Overall Study||0||
60139903|NCT00831675|76262802|FG000|STARTED|Overall Study||12||
60139904|NCT00831675|76262803|FG001|STARTED|Overall Study||18||
60139905|NCT00831675|76262802|FG000|COMPLETED|Overall Study||12||
60139906|NCT00831675|76262803|FG001|COMPLETED|Overall Study||18||
60139907|NCT00831675|76262802|FG000|NOT COMPLETED|Overall Study||0||
60139908|NCT00831675|76262803|FG001|NOT COMPLETED|Overall Study||0||
60139909|NCT01397825|76262813|FG000|STARTED|Overall Study||13||
60139910|NCT01397825|76262814|FG001|STARTED|Overall Study||4||
60139911|NCT01397825|76262815|FG002|STARTED|Overall Study||25||
59881711|NCT03694275|76004596|FG001|NOT COMPLETED|Overall Study||2||
59881712|NCT04230213|76004603|FG000|STARTED|TP1: Week 0 (Day 1) to Week 10||445||
59881713|NCT04230213|76004604|FG001|STARTED|TP1: Week 0 (Day 1) to Week 10||0||
59881714|NCT04230213|76004605|FG002|STARTED|TP1: Week 0 (Day 1) to Week 10||0||
60139912|NCT01397825|76262816|FG003|STARTED|Overall Study||3||
60139913|NCT01397825|76262817|FG004|STARTED|Overall Study||0||
60139914|NCT01397825|76262813|FG000|COMPLETED|Overall Study||0||
60139915|NCT01397825|76262814|FG001|COMPLETED|Overall Study||0||
60139916|NCT01397825|76262815|FG002|COMPLETED|Overall Study||0||
60139917|NCT01397825|76262816|FG003|COMPLETED|Overall Study||0||
60139918|NCT01397825|76262817|FG004|COMPLETED|Overall Study||0||
60139919|NCT01397825|76262813|FG000|NOT COMPLETED|Overall Study||13||
60139920|NCT01397825|76262814|FG001|NOT COMPLETED|Overall Study||4||
60139921|NCT01397825|76262815|FG002|NOT COMPLETED|Overall Study||25||
60139922|NCT01397825|76262816|FG003|NOT COMPLETED|Overall Study||3||
60139923|NCT01397825|76262817|FG004|NOT COMPLETED|Overall Study||0||
60139924|NCT00831753|76262833|FG000|STARTED|Overall Study||132||
60139925|NCT00831753|76262834|FG001|STARTED|Overall Study||131||
60139926|NCT00831753|76262833|FG000|COMPLETED|Overall Study||132||
60139927|NCT00831753|76262834|FG001|COMPLETED|Overall Study||131||
60139928|NCT00831753|76262833|FG000|NOT COMPLETED|Overall Study||0||
60139929|NCT00831753|76262834|FG001|NOT COMPLETED|Overall Study||0||
60139930|NCT01397747|76262840|FG000|STARTED|Overall Study||11016||
60139931|NCT01397747|76262840|FG000|COMPLETED|Overall Study||9989||
60139932|NCT01397747|76262840|FG000|NOT COMPLETED|Overall Study||1027||
60139933|NCT00831987|76262847|FG000|STARTED|Overall Study||60||
60139934|NCT00831987|76262848|FG001|STARTED|Overall Study||60||
60139935|NCT00831987|76262847|FG000|COMPLETED|Overall Study||60||
60139936|NCT00831987|76262848|FG001|COMPLETED|Overall Study||60||
60139937|NCT00831987|76262847|FG000|NOT COMPLETED|Overall Study||0||
60139938|NCT00831987|76262848|FG001|NOT COMPLETED|Overall Study||0||
60139939|NCT00832767|76262856|FG000|STARTED|Overall Study||121||
60139940|NCT00832767|76262857|FG001|STARTED|Overall Study||81||
60139941|NCT00832767|76262856|FG000|COMPLETED|Overall Study||99||
60139942|NCT00832767|76262857|FG001|COMPLETED|Overall Study||63||
60139943|NCT00832767|76262856|FG000|NOT COMPLETED|Overall Study||22||
60139944|NCT00832767|76262857|FG001|NOT COMPLETED|Overall Study||18||
60139945|NCT00833781|76262867|FG000|STARTED|Overall Study||10||
60139946|NCT00833781|76262868|FG001|STARTED|Overall Study||5||
60139947|NCT00833781|76262867|FG000|COMPLETED|Overall Study||10||
60139948|NCT00833781|76262868|FG001|COMPLETED|Overall Study||5||
60139949|NCT00833781|76262867|FG000|NOT COMPLETED|Overall Study||0||
60139950|NCT00833781|76262868|FG001|NOT COMPLETED|Overall Study||0||
60139951|NCT01397201|76262878|FG000|STARTED|Overall Study||6||
60139952|NCT01397201|76262879|FG001|STARTED|Overall Study||6||
60139953|NCT01397201|76262880|FG002|STARTED|Overall Study||6||
60139954|NCT01397201|76262881|FG003|STARTED|Overall Study||7||
60139955|NCT01397201|76262882|FG004|STARTED|Overall Study||5||
60139956|NCT01397201|76262878|FG000|Treated|Overall Study||6||
60139957|NCT01397201|76262879|FG001|Treated|Overall Study||6||
60139958|NCT01397201|76262880|FG002|Treated|Overall Study||5||
60139959|NCT01397201|76262881|FG003|Treated|Overall Study||7||
60139960|NCT01397201|76262882|FG004|Treated|Overall Study||5||
60139961|NCT01397201|76262878|FG000|COMPLETED|Overall Study||1||
60139962|NCT01397201|76262879|FG001|COMPLETED|Overall Study||0||
60139963|NCT01397201|76262880|FG002|COMPLETED|Overall Study||0||
60139964|NCT01397201|76262881|FG003|COMPLETED|Overall Study||2||
60139965|NCT01397201|76262882|FG004|COMPLETED|Overall Study||1||
60139966|NCT01397201|76262878|FG000|NOT COMPLETED|Overall Study||5||
60139967|NCT01397201|76262879|FG001|NOT COMPLETED|Overall Study||6||
60139968|NCT01397201|76262880|FG002|NOT COMPLETED|Overall Study||6||
60139969|NCT01397201|76262881|FG003|NOT COMPLETED|Overall Study||5||
60139970|NCT01397201|76262882|FG004|NOT COMPLETED|Overall Study||4||
60139971|NCT00834171|76262896|FG000|STARTED|Overall Study||43||
60139972|NCT00834171|76262897|FG001|STARTED|Overall Study||7||
60139973|NCT00834171|76262896|FG000|COMPLETED|Overall Study||43||
60139974|NCT00834171|76262897|FG001|COMPLETED|Overall Study||7||
60139975|NCT00834171|76262896|FG000|NOT COMPLETED|Overall Study||0||
60139976|NCT00834171|76262897|FG001|NOT COMPLETED|Overall Study||0||
60139977|NCT00834483|76262905|FG000|STARTED|Overall Study||31||
60139978|NCT00834483|76262906|FG001|STARTED|Overall Study||29||
60139979|NCT00834483|76262905|FG000|COMPLETED|Overall Study||31||
60139980|NCT00834483|76262906|FG001|COMPLETED|Overall Study||29||
60139981|NCT00834483|76262905|FG000|NOT COMPLETED|Overall Study||0||
60139982|NCT00834483|76262906|FG001|NOT COMPLETED|Overall Study||0||
60139983|NCT01393613|76262916|FG000|STARTED|Overall Study||120||
60139984|NCT01393613|76262917|FG001|STARTED|Overall Study||186||
60139985|NCT01393613|76262918|FG002|STARTED|Overall Study||184||
60139986|NCT01393613|76262919|FG003|STARTED|Overall Study||184||
60139987|NCT01393613|76262916|FG000|COMPLETED|Overall Study||81||
60139988|NCT01393613|76262917|FG001|COMPLETED|Overall Study||129||
60139989|NCT01393613|76262918|FG002|COMPLETED|Overall Study||130||
60139990|NCT01393613|76262919|FG003|COMPLETED|Overall Study||118||
60139991|NCT01393613|76262916|FG000|NOT COMPLETED|Overall Study||39||
60139992|NCT01393613|76262917|FG001|NOT COMPLETED|Overall Study||57||
60139993|NCT01393613|76262918|FG002|NOT COMPLETED|Overall Study||54||
60139994|NCT01393613|76262919|FG003|NOT COMPLETED|Overall Study||66||
60139995|NCT00835185|76262931|FG000|STARTED|Overall Study||44||
60139996|NCT00835185|76262931|FG000|Received at Least 1 Dose of Study Drug|Overall Study||44||
60139997|NCT00835185|76262931|FG000|COMPLETED|Overall Study||44||
60139998|NCT00835185|76262931|FG000|NOT COMPLETED|Overall Study||0||
60139999|NCT00864123|76262938|FG000|STARTED|Overall Study||15||
60140000|NCT00864123|76262939|FG001|STARTED|Overall Study||15||
60140001|NCT00864123|76262938|FG000|COMPLETED|Overall Study||15||
60140002|NCT00864123|76262939|FG001|COMPLETED|Overall Study||15||
60140003|NCT00864123|76262938|FG000|NOT COMPLETED|Overall Study||0||
60140004|NCT00864123|76262939|FG001|NOT COMPLETED|Overall Study||0||
60140005|NCT00836433|76262947|FG000|STARTED|Overall Study||361||
60140006|NCT00836433|76262948|FG001|STARTED|Overall Study||328||
60140007|NCT00836433|76262947|FG000|COMPLETED|Overall Study||349||
60140008|NCT00836433|76262948|FG001|COMPLETED|Overall Study||321||
60140009|NCT00836433|76262947|FG000|NOT COMPLETED|Overall Study||12||
60140010|NCT00836433|76262948|FG001|NOT COMPLETED|Overall Study||7||
60140011|NCT00867789|76262958|FG000|STARTED|Overall Study||70||
60140012|NCT00867789|76262959|FG001|STARTED|Overall Study||70||
60140013|NCT00867789|76262958|FG000|COMPLETED|Overall Study||68||
60140014|NCT00867789|76262959|FG001|COMPLETED|Overall Study||70||
60140015|NCT00867789|76262958|FG000|NOT COMPLETED|Overall Study||2||
60140016|NCT00867789|76262959|FG001|NOT COMPLETED|Overall Study||0||
60140017|NCT01396421|76262969|FG000|STARTED|Overall Study||180||
60140018|NCT01396421|76262970|FG001|STARTED|Overall Study||182||
60140019|NCT01396421|76262971|FG002|STARTED|Overall Study||90||
60140020|NCT01396421|76262972|FG003|STARTED|Overall Study||184||
60140021|NCT01396421|76262969|FG000|COMPLETED|Overall Study||121||
60140022|NCT01396421|76262970|FG001|COMPLETED|Overall Study||124||
60140023|NCT01396421|76262971|FG002|COMPLETED|Overall Study||56||
60140024|NCT01396421|76262972|FG003|COMPLETED|Overall Study||109||
60140025|NCT01396421|76262969|FG000|NOT COMPLETED|Overall Study||59||
60140026|NCT01396421|76262970|FG001|NOT COMPLETED|Overall Study||58||
60140027|NCT01396421|76262971|FG002|NOT COMPLETED|Overall Study||34||
60140028|NCT01396421|76262972|FG003|NOT COMPLETED|Overall Study||75||
60140029|NCT00868101|76262998|FG000|STARTED|Overall Study||12||
60140030|NCT00868101|76262999|FG001|STARTED|Overall Study||10||
60140031|NCT00868101|76262998|FG000|COMPLETED|Overall Study||12||
60140032|NCT00868101|76262999|FG001|COMPLETED|Overall Study||10||
60140033|NCT00868101|76262998|FG000|NOT COMPLETED|Overall Study||0||
60140034|NCT00868101|76262999|FG001|NOT COMPLETED|Overall Study||0||
60140035|NCT00837447|76263007|FG000|STARTED|Overall Study|Each of the 54 pts received a Nexgen CR on one side and a Nexgen CR-Flex on the contralateral side.|54||
60140036|NCT00837447|76263007|FG000|COMPLETED|Overall Study|Each of the 54 pts received a Nexgen CR on one side and a Nexgen CR-Flex on the contralateral side.|54||
60140037|NCT00837447|76263007|FG000|NOT COMPLETED|Overall Study||0||
60140038|NCT00838695|76263014|FG000|STARTED|Overall Study||42||
60140039|NCT00838695|76263015|FG001|STARTED|Overall Study||64||
60140040|NCT00838695|76263014|FG000|COMPLETED|Overall Study||42||
60140041|NCT00838695|76263015|FG001|COMPLETED|Overall Study||64||
60140042|NCT00838695|76263014|FG000|NOT COMPLETED|Overall Study||0||
60140043|NCT00838695|76263015|FG001|NOT COMPLETED|Overall Study||0||
60140044|NCT00839241|76263023|FG000|STARTED|Overall Study||20||
60140045|NCT00839241|76263024|FG001|STARTED|Overall Study||25||
60140046|NCT00839241|76263023|FG000|COMPLETED|Overall Study||15||
60140047|NCT00839241|76263024|FG001|COMPLETED|Overall Study||8||
60140048|NCT00839241|76263023|FG000|NOT COMPLETED|Overall Study||5||
60140049|NCT00839241|76263024|FG001|NOT COMPLETED|Overall Study||17||
60140050|NCT01396265|76263030|FG000|STARTED|Afatinib||22||
60140051|NCT01396265|76263030|FG000|COMPLETED|Afatinib||22||
60140052|NCT01396265|76263030|FG000|NOT COMPLETED|Afatinib||0||
60140053|NCT01396265|76263030|FG000|STARTED|Washout||22||
60140054|NCT01396265|76263030|FG000|COMPLETED|Washout||22||
60140055|NCT01396265|76263030|FG000|NOT COMPLETED|Washout||0||
60140056|NCT01396265|76263030|FG000|STARTED|Rifa+Afatinib||22||
60140057|NCT01396265|76263030|FG000|COMPLETED|Rifa+Afatinib||21||
60140058|NCT01396265|76263030|FG000|NOT COMPLETED|Rifa+Afatinib||1||
60140059|NCT00839319|76263041|FG000|STARTED|Overall Study||8||
60140060|NCT00839319|76263042|FG001|STARTED|Overall Study||8||
60140061|NCT00839319|76263043|FG002|STARTED|Overall Study||8||
60140062|NCT00839319|76263044|FG003|STARTED|Overall Study||8||
60140063|NCT00839319|76263045|FG004|STARTED|Overall Study||8||
60140064|NCT00839319|76263041|FG000|COMPLETED|Overall Study|1 withdrew consent prior to procedures; 1 excluded from analysis (low serum LH)|6||
60140065|NCT00839319|76263042|FG001|COMPLETED|Overall Study|1 excluded from analysis (low serum LH)|7||
60140066|NCT00839319|76263043|FG002|COMPLETED|Overall Study|1 dropped out after Day 1 visit, 2 excluded from analysis (low serum LH)|5||
60140067|NCT00839319|76263044|FG003|COMPLETED|Overall Study|1 withdrawn by investigator for syncopal reaction , 2 excluded from analysis (low serum LH)|5||
60140068|NCT00839319|76263045|FG004|COMPLETED|Overall Study||8||
60140069|NCT00839319|76263041|FG000|NOT COMPLETED|Overall Study||2||
60140070|NCT00839319|76263042|FG001|NOT COMPLETED|Overall Study||1||
60140071|NCT00839319|76263043|FG002|NOT COMPLETED|Overall Study||3||
60140072|NCT00839319|76263044|FG003|NOT COMPLETED|Overall Study||3||
60140073|NCT00839319|76263045|FG004|NOT COMPLETED|Overall Study||0||
60140074|NCT00890721|76263059|FG000|STARTED|Overall Study||95||
60140075|NCT00890721|76263060|FG001|STARTED|Overall Study||94||
60140076|NCT00890721|76263059|FG000|COMPLETED|Overall Study||94||
60140077|NCT00890721|76263060|FG001|COMPLETED|Overall Study||93||
60140078|NCT00890721|76263059|FG000|NOT COMPLETED|Overall Study||1||
60140079|NCT00890721|76263060|FG001|NOT COMPLETED|Overall Study||1||
60140080|NCT00868959|76263066|FG000|STARTED|Overall Study|817 represents total number of subjects who provided informed consent.|817||
60140081|NCT00868959|76263066|FG000|COMPLETED|Overall Study||559||
60140082|NCT00868959|76263066|FG000|NOT COMPLETED|Overall Study||258||
60140083|NCT02647866|76263075|FG000|STARTED|Overall Study||9||
60140084|NCT02647866|76263076|FG001|STARTED|Overall Study||10||
60140085|NCT02647866|76263077|FG002|STARTED|Overall Study||9||
60140086|NCT02647866|76263078|FG003|STARTED|Overall Study||21||
60140087|NCT02647866|76263079|FG004|STARTED|Overall Study||17||
60140088|NCT02647866|76263075|FG000|Completed Induction Therapy|Overall Study|Subjects received KHK4083 1.0 mg/kg for 12 weeks|8||
60140089|NCT02647866|76263076|FG001|Completed Induction Therapy|Overall Study|Subjects received KHK4083 3.0 mg/kg for 12 weeks|9||
60140090|NCT02647866|76263077|FG002|Completed Induction Therapy|Overall Study|Subjects received KHK4083 10.0 mg/kg for 12 weeks|8||
60140091|NCT02647866|76263078|FG003|Completed Induction Therapy|Overall Study|Subjects received the maximum tolerated dose of KHK4083 10.0 mg/kg for 12 weeks|19||
60140092|NCT02647866|76263079|FG004|Completed Induction Therapy|Overall Study|Subjects received Placebo for 12 weeks|17||
60140093|NCT02647866|76263075|FG000|Completed Induction Therapy Follow-Up|Overall Study||5||
60140094|NCT02647866|76263076|FG001|Completed Induction Therapy Follow-Up|Overall Study||1||
60140095|NCT02647866|76263077|FG002|Completed Induction Therapy Follow-Up|Overall Study||2||
60140096|NCT02647866|76263078|FG003|Completed Induction Therapy Follow-Up|Overall Study||0||
60140097|NCT02647866|76263079|FG004|Completed Induction Therapy Follow-Up|Overall Study||2||
60140098|NCT02647866|76263075|FG000|Completed Long-Term Extension Therapy|Overall Study|10 add'l treatments of KHK4083 (same dose as Induction Therapy) as maintenance therapy.|3||
60140099|NCT02647866|76263076|FG001|Completed Long-Term Extension Therapy|Overall Study||0||
60140100|NCT02647866|76263077|FG002|Completed Long-Term Extension Therapy|Overall Study||0||
60140101|NCT02647866|76263078|FG003|Completed Long-Term Extension Therapy|Overall Study||0||
60140102|NCT02647866|76263079|FG004|Completed Long-Term Extension Therapy|Overall Study||0||
60140103|NCT02647866|76263075|FG000|Completed LTE Follow-up|Overall Study||2||
60140104|NCT02647866|76263076|FG001|Completed LTE Follow-up|Overall Study||0||
60140105|NCT02647866|76263077|FG002|Completed LTE Follow-up|Overall Study||0||
60140106|NCT02647866|76263078|FG003|Completed LTE Follow-up|Overall Study||0||
60140107|NCT02647866|76263079|FG004|Completed LTE Follow-up|Overall Study||0||
60140108|NCT02647866|76263075|FG000|Completed Open-Label Extension Therapy|Overall Study||0||
60140109|NCT02647866|76263076|FG001|Completed Open-Label Extension Therapy|Overall Study|10 add'l treatments of Open-Label KHK4083 (same dose as Induction Therapy) as maintenance therapy.|7||
60140110|NCT02647866|76263077|FG002|Completed Open-Label Extension Therapy|Overall Study|10 add'l treatments of Open-Label KHK4083 (same dose as Induction Therapy) as maintenance therapy|4||
60140111|NCT02647866|76263078|FG003|Completed Open-Label Extension Therapy|Overall Study|10 add'l treatments of Open-Label KHK4083 (same dose as Induction Therapy) as maintenance therapy|17||
60140112|NCT02647866|76263079|FG004|Completed Open-Label Extension Therapy|Overall Study|10 add'l treatments of Open-Label KHK4083 (same dose as Induction Therapy) as maintenance therapy|13||
60140113|NCT02647866|76263075|FG000|Completed OLE Follow-up|Overall Study||0||
60140114|NCT02647866|76263076|FG001|Completed OLE Follow-up|Overall Study||6||
60140115|NCT02647866|76263077|FG002|Completed OLE Follow-up|Overall Study||4||
60140116|NCT02647866|76263078|FG003|Completed OLE Follow-up|Overall Study||14||
60140117|NCT02647866|76263079|FG004|Completed OLE Follow-up|Overall Study||10||
60140118|NCT02647866|76263075|FG000|Moved From LTE to OLE Therapy|Overall Study||0||
59751382|NCT00860067|75870670|FG000|NOT COMPLETED|Overall Study||51||
59751383|NCT00860067|75870671|FG001|NOT COMPLETED|Overall Study||9||
59751384|NCT00860067|75870672|FG002|NOT COMPLETED|Overall Study||9||
60140119|NCT02647866|76263076|FG001|Moved From LTE to OLE Therapy|Overall Study||5||
60140120|NCT02647866|76263077|FG002|Moved From LTE to OLE Therapy|Overall Study||0||
60140121|NCT02647866|76263078|FG003|Moved From LTE to OLE Therapy|Overall Study||0||
60140122|NCT02647866|76263079|FG004|Moved From LTE to OLE Therapy|Overall Study||2||
60140123|NCT02647866|76263075|FG000|Discontinued the Treatment|Overall Study||4||
60140124|NCT02647866|76263076|FG001|Discontinued the Treatment|Overall Study||5||
60140125|NCT02647866|76263077|FG002|Discontinued the Treatment|Overall Study||5||
60140126|NCT02647866|76263078|FG003|Discontinued the Treatment|Overall Study||5||
60140127|NCT02647866|76263079|FG004|Discontinued the Treatment|Overall Study||8||
60140128|NCT02647866|76263075|FG000|Discontinued the Study|Overall Study||5||
60140129|NCT02647866|76263076|FG001|Discontinued the Study|Overall Study||4||
60140130|NCT02647866|76263077|FG002|Discontinued the Study|Overall Study||5||
60140131|NCT02647866|76263078|FG003|Discontinued the Study|Overall Study||6||
60140132|NCT02647866|76263079|FG004|Discontinued the Study|Overall Study||8||
59751385|NCT00858117|75870683|FG000|STARTED|Treatment on Study||30||
59751386|NCT00858117|75870683|FG000|Completed 18 Weeks of Treatment|Treatment on Study||28||
60140133|NCT02647866|76263075|FG000|COMPLETED|Overall Study||4||
60140134|NCT02647866|76263076|FG001|COMPLETED|Overall Study||6||
60140135|NCT02647866|76263077|FG002|COMPLETED|Overall Study||4||
60140136|NCT02647866|76263078|FG003|COMPLETED|Overall Study||15||
60140137|NCT02647866|76263079|FG004|COMPLETED|Overall Study||9||
60140138|NCT02647866|76263075|FG000|NOT COMPLETED|Overall Study||5||
60140139|NCT02647866|76263076|FG001|NOT COMPLETED|Overall Study||4||
60140140|NCT02647866|76263077|FG002|NOT COMPLETED|Overall Study||5||
60140141|NCT02647866|76263078|FG003|NOT COMPLETED|Overall Study||6||
60140142|NCT02647866|76263079|FG004|NOT COMPLETED|Overall Study||8||
60140143|NCT00869349|76263101|FG000|STARTED|Overall Study||39||
60140144|NCT00869349|76263102|FG001|STARTED|Overall Study||40||
60140145|NCT00869349|76263101|FG000|COMPLETED|Overall Study||32||
60140146|NCT00869349|76263102|FG001|COMPLETED|Overall Study||36||
60140147|NCT00869349|76263101|FG000|NOT COMPLETED|Overall Study||7||
60140148|NCT00869349|76263102|FG001|NOT COMPLETED|Overall Study||4||
60140149|NCT00870363|76263112|FG000|STARTED|Overall Study||10||
60140150|NCT00870363|76263113|FG001|STARTED|Overall Study||11||
60140151|NCT00870363|76263114|FG002|STARTED|Overall Study||11||
60140152|NCT00870363|76263115|FG003|STARTED|Overall Study||12||
60140153|NCT00870363|76263112|FG000|COMPLETED|Overall Study||10||
60140154|NCT00870363|76263113|FG001|COMPLETED|Overall Study||8||
60140155|NCT00870363|76263114|FG002|COMPLETED|Overall Study||8||
60140156|NCT00870363|76263115|FG003|COMPLETED|Overall Study||12||
60140157|NCT00870363|76263112|FG000|NOT COMPLETED|Overall Study||0||
60140158|NCT00870363|76263113|FG001|NOT COMPLETED|Overall Study||3||
60140159|NCT00870363|76263114|FG002|NOT COMPLETED|Overall Study||3||
60140160|NCT00870363|76263115|FG003|NOT COMPLETED|Overall Study||0||
60140161|NCT00871143|76263127|FG000|STARTED|Overall Study||21||
60140162|NCT00871143|76263128|FG001|STARTED|Overall Study||25||
60140163|NCT00871143|76263127|FG000|COMPLETED|Overall Study||21||
60140164|NCT00871143|76263128|FG001|COMPLETED|Overall Study||25||
60140165|NCT00871143|76263127|FG000|NOT COMPLETED|Overall Study||0||
60140166|NCT00871143|76263128|FG001|NOT COMPLETED|Overall Study||0||
60140167|NCT01396187|76263139|FG000|STARTED|Overall Study||8||
60140168|NCT01396187|76263140|FG001|STARTED|Overall Study||12||
60140169|NCT01396187|76263141|FG002|STARTED|Overall Study||10||
60140170|NCT01396187|76263142|FG003|STARTED|Overall Study||10||
60140171|NCT01396187|76263143|FG004|STARTED|Overall Study||10||
60140172|NCT01396187|76263139|FG000|COMPLETED|Overall Study||7||
60140173|NCT01396187|76263140|FG001|COMPLETED|Overall Study||9||
60140174|NCT01396187|76263141|FG002|COMPLETED|Overall Study||9||
60140175|NCT01396187|76263142|FG003|COMPLETED|Overall Study||10||
60140176|NCT01396187|76263143|FG004|COMPLETED|Overall Study||9||
60140177|NCT01396187|76263139|FG000|NOT COMPLETED|Overall Study||1||
60140178|NCT01396187|76263140|FG001|NOT COMPLETED|Overall Study||3||
60140179|NCT01396187|76263141|FG002|NOT COMPLETED|Overall Study||1||
60140180|NCT01396187|76263142|FG003|NOT COMPLETED|Overall Study||0||
60140181|NCT01396187|76263143|FG004|NOT COMPLETED|Overall Study||1||
60140182|NCT00871689|76263159|FG000|STARTED|Overall Study||2||
60140183|NCT00871689|76263159|FG000|COMPLETED|Overall Study||2||
60140184|NCT00871689|76263159|FG000|NOT COMPLETED|Overall Study||0||
60140185|NCT02084797|76263163|FG000|STARTED|Overall Study||10||
60140186|NCT02084797|76263163|FG000|COMPLETED|Overall Study||10||
60140187|NCT02084797|76263163|FG000|NOT COMPLETED|Overall Study||0||
60140188|NCT00871845|76263169|FG000|STARTED|Overall Study||11||
60140189|NCT00871845|76263170|FG001|STARTED|Overall Study||25||
60140190|NCT00871845|76263169|FG000|COMPLETED|Overall Study||11||
60140191|NCT00871845|76263170|FG001|COMPLETED|Overall Study||25||
60140192|NCT00871845|76263169|FG000|NOT COMPLETED|Overall Study||0||
60140193|NCT00871845|76263170|FG001|NOT COMPLETED|Overall Study||0||
60140194|NCT00872079|76263180|FG000|STARTED|Overall Study||175||
60140195|NCT00872079|76263180|FG000|COMPLETED|Overall Study||175||
60140196|NCT00872079|76263180|FG000|NOT COMPLETED|Overall Study||0||
60140197|NCT00873327|76263184|FG000|STARTED|Overall Study||32||
60140198|NCT00873327|76263184|FG000|COMPLETED|Overall Study||32||
60140199|NCT00873327|76263184|FG000|NOT COMPLETED|Overall Study||0||
60140200|NCT01392677|76263190|FG000|STARTED|Overall Study||109||
60140201|NCT01392677|76263191|FG001|STARTED|Overall Study||109||
60140202|NCT01392677|76263190|FG000|COMPLETED|Overall Study||101||
60140203|NCT01392677|76263191|FG001|COMPLETED|Overall Study||101||
60140204|NCT01392677|76263190|FG000|NOT COMPLETED|Overall Study||8||
60140205|NCT01392677|76263191|FG001|NOT COMPLETED|Overall Study||8||
60140206|NCT00841269|76263199|FG000|STARTED|Overall Study||20||
60140207|NCT00841269|76263200|FG001|STARTED|Overall Study||22||
60140208|NCT00841269|76263199|FG000|COMPLETED|Overall Study||12||
60140209|NCT00841269|76263200|FG001|COMPLETED|Overall Study||13||
60140210|NCT00841269|76263199|FG000|NOT COMPLETED|Overall Study||8||
60140211|NCT00841269|76263200|FG001|NOT COMPLETED|Overall Study||9||
60140212|NCT00841971|76263207|FG000|STARTED|Overall Study||100||
60140213|NCT00841971|76263208|FG001|STARTED|Overall Study||100||
60140214|NCT00841971|76263207|FG000|COMPLETED|Overall Study||98||
60140215|NCT00841971|76263208|FG001|COMPLETED|Overall Study||99||
60140216|NCT00841971|76263207|FG000|NOT COMPLETED|Overall Study||2||
60140217|NCT00841971|76263208|FG001|NOT COMPLETED|Overall Study||1||
60140218|NCT00842751|76263214|FG000|STARTED|Overall Study||11||
60140219|NCT00842751|76263214|FG000|COMPLETED|Overall Study||11||
60140220|NCT00842751|76263214|FG000|NOT COMPLETED|Overall Study||0||
60140221|NCT02154243|76263230|FG000|STARTED|Overall Study||5||
60140222|NCT02154243|76263231|FG001|STARTED|Overall Study||4||
60140223|NCT02154243|76263232|FG002|STARTED|Overall Study||4||
60140224|NCT02154243|76263230|FG000|COMPLETED|Overall Study||5||
60140225|NCT02154243|76263231|FG001|COMPLETED|Overall Study||4||
60140226|NCT02154243|76263232|FG002|COMPLETED|Overall Study||4||
60140227|NCT02154243|76263230|FG000|NOT COMPLETED|Overall Study||0||
60140228|NCT02154243|76263231|FG001|NOT COMPLETED|Overall Study||0||
60140229|NCT02154243|76263232|FG002|NOT COMPLETED|Overall Study||0||
60140230|NCT01392443|76263240|FG000|STARTED|Overall Study||120||
60140231|NCT01392443|76263240|FG000|COMPLETED|Overall Study||52|Completed = End of Treatment|
60140232|NCT01392443|76263240|FG000|NOT COMPLETED|Overall Study||68||
60140233|NCT01391819|76263244|FG000|STARTED|Overall Study||2116||
60140234|NCT01391819|76263244|FG000|COMPLETED|Overall Study||1714||
60140235|NCT01391819|76263244|FG000|NOT COMPLETED|Overall Study||402||
60140236|NCT03845023|76263255|FG000|STARTED|Placebo Run-In Period (2 Nights)||36||
60140237|NCT03845023|76263256|FG001|STARTED|Placebo Run-In Period (2 Nights)||36||
60140238|NCT03845023|76263257|FG002|STARTED|Placebo Run-In Period (2 Nights)||34||
60140239|NCT03845023|76263258|FG003|STARTED|Placebo Run-In Period (2 Nights)||34||
60140240|NCT03845023|76263255|FG000|COMPLETED|Placebo Run-In Period (2 Nights)||36||
60140241|NCT03845023|76263256|FG001|COMPLETED|Placebo Run-In Period (2 Nights)||36||
60140242|NCT03845023|76263257|FG002|COMPLETED|Placebo Run-In Period (2 Nights)||34||
60140243|NCT03845023|76263258|FG003|COMPLETED|Placebo Run-In Period (2 Nights)||34||
60140244|NCT03845023|76263255|FG000|NOT COMPLETED|Placebo Run-In Period (2 Nights)||0||
60140245|NCT03845023|76263256|FG001|NOT COMPLETED|Placebo Run-In Period (2 Nights)||0||
60140246|NCT03845023|76263257|FG002|NOT COMPLETED|Placebo Run-In Period (2 Nights)||0||
60140247|NCT03845023|76263258|FG003|NOT COMPLETED|Placebo Run-In Period (2 Nights)||0||
60140248|NCT03845023|76263255|FG000|STARTED|Low Dose Run-In (3 Nights)||36||
60140249|NCT03845023|76263256|FG001|STARTED|Low Dose Run-In (3 Nights)||36||
60140250|NCT03845023|76263257|FG002|STARTED|Low Dose Run-In (3 Nights)||34||
60140251|NCT03845023|76263258|FG003|STARTED|Low Dose Run-In (3 Nights)||34||
60140252|NCT03845023|76263255|FG000|COMPLETED|Low Dose Run-In (3 Nights)||36||
60140253|NCT03845023|76263256|FG001|COMPLETED|Low Dose Run-In (3 Nights)||36||
60140254|NCT03845023|76263257|FG002|COMPLETED|Low Dose Run-In (3 Nights)||34||
60140255|NCT03845023|76263258|FG003|COMPLETED|Low Dose Run-In (3 Nights)||34||
60140256|NCT03845023|76263255|FG000|NOT COMPLETED|Low Dose Run-In (3 Nights)||0||
60140257|NCT03845023|76263256|FG001|NOT COMPLETED|Low Dose Run-In (3 Nights)||0||
60140258|NCT03845023|76263257|FG002|NOT COMPLETED|Low Dose Run-In (3 Nights)||0||
60140259|NCT03845023|76263258|FG003|NOT COMPLETED|Low Dose Run-In (3 Nights)||0||
60140260|NCT03845023|76263255|FG000|STARTED|Treatment Period (7 Nights)||36||
60140261|NCT03845023|76263256|FG001|STARTED|Treatment Period (7 Nights)||36||
60140262|NCT03845023|76263257|FG002|STARTED|Treatment Period (7 Nights)||34||
60140263|NCT03845023|76263258|FG003|STARTED|Treatment Period (7 Nights)||34||
60140264|NCT03845023|76263255|FG000|COMPLETED|Treatment Period (7 Nights)||36||
60140265|NCT03845023|76263256|FG001|COMPLETED|Treatment Period (7 Nights)||36||
60140266|NCT03845023|76263257|FG002|COMPLETED|Treatment Period (7 Nights)||34||
60140267|NCT03845023|76263258|FG003|COMPLETED|Treatment Period (7 Nights)||34||
60140268|NCT03845023|76263255|FG000|NOT COMPLETED|Treatment Period (7 Nights)||0||
60140269|NCT03845023|76263256|FG001|NOT COMPLETED|Treatment Period (7 Nights)||0||
60140270|NCT03845023|76263257|FG002|NOT COMPLETED|Treatment Period (7 Nights)||0||
60140271|NCT03845023|76263258|FG003|NOT COMPLETED|Treatment Period (7 Nights)||0||
60140272|NCT03845023|76263255|FG000|STARTED|Follow-Up (14 Days)||36||
60140273|NCT03845023|76263256|FG001|STARTED|Follow-Up (14 Days)||36||
60140274|NCT03845023|76263257|FG002|STARTED|Follow-Up (14 Days)||34||
60140275|NCT03845023|76263258|FG003|STARTED|Follow-Up (14 Days)||34||
60140276|NCT03845023|76263255|FG000|COMPLETED|Follow-Up (14 Days)||35||
60140277|NCT03845023|76263256|FG001|COMPLETED|Follow-Up (14 Days)||36||
60140278|NCT03845023|76263257|FG002|COMPLETED|Follow-Up (14 Days)||33||
60140279|NCT03845023|76263258|FG003|COMPLETED|Follow-Up (14 Days)||33||
60140280|NCT03845023|76263255|FG000|NOT COMPLETED|Follow-Up (14 Days)||1||
60140281|NCT03845023|76263256|FG001|NOT COMPLETED|Follow-Up (14 Days)||0||
60140282|NCT03845023|76263257|FG002|NOT COMPLETED|Follow-Up (14 Days)||1||
60140283|NCT03845023|76263258|FG003|NOT COMPLETED|Follow-Up (14 Days)||1||
60140284|NCT03249103|76263268|FG000|STARTED|Overall Study||22||
60140285|NCT03249103|76263268|FG000|COMPLETED|Overall Study||20||
60140286|NCT03249103|76263268|FG000|NOT COMPLETED|Overall Study||2||
60140287|NCT00873873|76263276|FG000|STARTED|Overall Study||20||
60140288|NCT00873873|76263277|FG001|STARTED|Overall Study||8||
60140289|NCT00873873|76263278|FG002|STARTED|Overall Study||9||
60140290|NCT00873873|76263279|FG003|STARTED|Overall Study||18||
60140291|NCT00873873|76263276|FG000|COMPLETED|Overall Study||20||
60140292|NCT00873873|76263277|FG001|COMPLETED|Overall Study||8||
60140293|NCT00873873|76263278|FG002|COMPLETED|Overall Study||9||
60140294|NCT00873873|76263279|FG003|COMPLETED|Overall Study||18||
60140295|NCT00873873|76263276|FG000|NOT COMPLETED|Overall Study||0||
60140296|NCT00873873|76263277|FG001|NOT COMPLETED|Overall Study||0||
60140297|NCT00873873|76263278|FG002|NOT COMPLETED|Overall Study||0||
60140298|NCT00873873|76263279|FG003|NOT COMPLETED|Overall Study||0||
60140299|NCT00874887|76263291|FG000|STARTED|Overall Study||32||
60140300|NCT00874887|76263292|FG001|STARTED|Overall Study||34||
60140301|NCT00874887|76263291|FG000|COMPLETED|Overall Study||32||
60140302|NCT00874887|76263292|FG001|COMPLETED|Overall Study||34||
60140303|NCT00874887|76263291|FG000|NOT COMPLETED|Overall Study||0||
60140304|NCT00874887|76263292|FG001|NOT COMPLETED|Overall Study||0||
60140305|NCT00875277|76263298|FG000|STARTED|Overall Study||24||
60140306|NCT00875277|76263298|FG000|COMPLETED|Overall Study||24||
60140307|NCT00875277|76263298|FG000|NOT COMPLETED|Overall Study||0||
60140308|NCT00875589|76263311|FG000|STARTED|Overall Study||15||
60140309|NCT00875589|76263312|FG001|STARTED|Overall Study||11||
60140310|NCT00875589|76263311|FG000|COMPLETED|Overall Study||15||
60140311|NCT00875589|76263312|FG001|COMPLETED|Overall Study||11||
60140312|NCT00875589|76263311|FG000|NOT COMPLETED|Overall Study||0||
60140313|NCT00875589|76263312|FG001|NOT COMPLETED|Overall Study||0||
60140314|NCT01395017|76263320|FG000|STARTED|Overall Study||100||
60140315|NCT01395017|76263321|FG001|STARTED|Overall Study||102||
60140316|NCT01395017|76263320|FG000|Treated|Overall Study||98||
60140317|NCT01395017|76263321|FG001|Treated|Overall Study||101||
60140318|NCT01395017|76263320|FG000|COMPLETED|Overall Study||0||
60140319|NCT01395017|76263321|FG001|COMPLETED|Overall Study||0||
60140320|NCT01395017|76263320|FG000|NOT COMPLETED|Overall Study||100||
60140321|NCT01395017|76263321|FG001|NOT COMPLETED|Overall Study||102||
60140322|NCT00876915|76263331|FG000|STARTED|Overall Study||50||
60140323|NCT00876915|76263332|FG001|STARTED|Overall Study||48||
60140324|NCT00876915|76263333|FG002|STARTED|Overall Study||101||
60140325|NCT00876915|76263331|FG000|Week 4|Overall Study||38||
60140326|NCT00876915|76263332|FG001|Week 4|Overall Study||45||
60140327|NCT00876915|76263333|FG002|Week 4|Overall Study||0||
60140328|NCT00876915|76263331|FG000|Week 8|Overall Study||33||
60140329|NCT00876915|76263332|FG001|Week 8|Overall Study||36||
60140330|NCT00876915|76263333|FG002|Week 8|Overall Study||0||
60140331|NCT00876915|76263331|FG000|COMPLETED|Overall Study||31||
60140332|NCT00876915|76263332|FG001|COMPLETED|Overall Study||34||
60140333|NCT00876915|76263333|FG002|COMPLETED|Overall Study||101||
60140334|NCT00876915|76263331|FG000|NOT COMPLETED|Overall Study||19||
60140335|NCT00876915|76263332|FG001|NOT COMPLETED|Overall Study||14||
60140336|NCT00876915|76263333|FG002|NOT COMPLETED|Overall Study||0||
60140337|NCT00896181|76263341|FG000|STARTED|Overall Study||26||
60140338|NCT00896181|76263341|FG000|COMPLETED|Overall Study||26||
60140339|NCT00896181|76263341|FG000|NOT COMPLETED|Overall Study||0||
60140340|NCT02647320|76263350|FG000|STARTED|Overall Study||46||
60140341|NCT02647320|76263351|FG001|STARTED|Overall Study||46||
60140342|NCT02647320|76263352|FG002|STARTED|Overall Study||69||
60140343|NCT02647320|76263353|FG003|STARTED|Overall Study||68||
60140344|NCT02647320|76263354|FG004|STARTED|Overall Study||69||
60140345|NCT02647320|76263350|FG000|Inadvertently Randomized|Overall Study||0||
60140346|NCT02647320|76263351|FG001|Inadvertently Randomized|Overall Study||0||
60140347|NCT02647320|76263352|FG002|Inadvertently Randomized|Overall Study||0||
60140348|NCT02647320|76263353|FG003|Inadvertently Randomized|Overall Study||1||
60140349|NCT02647320|76263354|FG004|Inadvertently Randomized|Overall Study||0||
60140350|NCT02647320|76263350|FG000|Safety Set|Overall Study||43||
60140351|NCT02647320|76263351|FG001|Safety Set|Overall Study||44||
60140352|NCT02647320|76263352|FG002|Safety Set|Overall Study||68||
60140353|NCT02647320|76263353|FG003|Safety Set|Overall Study||68||
60140354|NCT02647320|76263354|FG004|Safety Set|Overall Study||69||
60140355|NCT02647320|76263350|FG000|Modified Intent-to-Treat Set (mITT)|Overall Study||40||
60140356|NCT02647320|76263351|FG001|Modified Intent-to-Treat Set (mITT)|Overall Study||38||
60140357|NCT02647320|76263352|FG002|Modified Intent-to-Treat Set (mITT)|Overall Study||61||
60140358|NCT02647320|76263353|FG003|Modified Intent-to-Treat Set (mITT)|Overall Study||62||
60140359|NCT02647320|76263354|FG004|Modified Intent-to-Treat Set (mITT)|Overall Study||62||
60140360|NCT02647320|76263350|FG000|COMPLETED|Overall Study||34||
60140361|NCT02647320|76263351|FG001|COMPLETED|Overall Study||35||
60140362|NCT02647320|76263352|FG002|COMPLETED|Overall Study||54||
60140363|NCT02647320|76263353|FG003|COMPLETED|Overall Study||58||
60140364|NCT02647320|76263354|FG004|COMPLETED|Overall Study||52||
60140365|NCT02647320|76263350|FG000|NOT COMPLETED|Overall Study||12||
60140366|NCT02647320|76263351|FG001|NOT COMPLETED|Overall Study||11||
60140367|NCT02647320|76263352|FG002|NOT COMPLETED|Overall Study||15||
60140368|NCT02647320|76263353|FG003|NOT COMPLETED|Overall Study||10||
60140369|NCT02647320|76263354|FG004|NOT COMPLETED|Overall Study||17||
60140370|NCT00879255|76263370|FG000|STARTED|Overall Study||61||
60140371|NCT00879255|76263371|FG001|STARTED|Overall Study||64||
60140372|NCT00879255|76263370|FG000|Received Allocated Intervention:|Overall Study||51||
60140373|NCT00879255|76263371|FG001|Received Allocated Intervention:|Overall Study||56||
60140374|NCT00879255|76263370|FG000|Completed Posttreatment Follow-up|Overall Study||50||
60140375|NCT00879255|76263371|FG001|Completed Posttreatment Follow-up|Overall Study||55||
60140376|NCT00879255|76263370|FG000|Completed 3-mo Follow-up|Overall Study||48||
60140377|NCT00879255|76263371|FG001|Completed 3-mo Follow-up|Overall Study||49||
60140378|NCT00879255|76263370|FG000|COMPLETED|Overall Study|Completed 6-mo follow-up|45||
60140379|NCT00879255|76263371|FG001|COMPLETED|Overall Study|Completed 6-mo follow-up|45||
60140380|NCT00879255|76263370|FG000|NOT COMPLETED|Overall Study||16||
60140381|NCT00879255|76263371|FG001|NOT COMPLETED|Overall Study||19||
60140382|NCT03458325|76263377|FG000|STARTED|Overall Study||25||
60140383|NCT03458325|76263377|FG000|COMPLETED|Overall Study||24||
60140384|NCT03458325|76263377|FG000|NOT COMPLETED|Overall Study||1||
60140385|NCT00880425|76263384|FG000|STARTED|Overall Study||18||
60140386|NCT00880425|76263385|FG001|STARTED|Overall Study||27||
60140387|NCT00880425|76263384|FG000|COMPLETED|Overall Study||18||
60140388|NCT00880425|76263385|FG001|COMPLETED|Overall Study||27||
60140389|NCT00880425|76263384|FG000|NOT COMPLETED|Overall Study||0||
60140390|NCT00880425|76263385|FG001|NOT COMPLETED|Overall Study||0||
60140391|NCT00897897|76263391|FG000|STARTED|Overall Study||33||
60140392|NCT00897897|76263391|FG000|COMPLETED|Overall Study||33||
60140393|NCT00897897|76263391|FG000|NOT COMPLETED|Overall Study||0||
60140394|NCT00882687|76263399|FG000|STARTED|Overall Study||15||
60140395|NCT00882687|76263400|FG001|STARTED|Overall Study||15||
60140396|NCT00882687|76263401|FG002|STARTED|Overall Study||15||
60140397|NCT00882687|76263402|FG003|STARTED|Overall Study||15||
60140398|NCT00882687|76263399|FG000|COMPLETED|Overall Study||13||
60140399|NCT00882687|76263400|FG001|COMPLETED|Overall Study||13||
60140400|NCT00882687|76263401|FG002|COMPLETED|Overall Study||12||
60140401|NCT00882687|76263402|FG003|COMPLETED|Overall Study||13||
60140402|NCT00882687|76263399|FG000|NOT COMPLETED|Overall Study||2||
60140403|NCT00882687|76263400|FG001|NOT COMPLETED|Overall Study||2||
60140404|NCT00882687|76263401|FG002|NOT COMPLETED|Overall Study||3||
60140405|NCT00882687|76263402|FG003|NOT COMPLETED|Overall Study||2||
60140406|NCT02644122|76263412|FG000|STARTED|Overall Study||1||
60140407|NCT02644122|76263412|FG000|COMPLETED|Overall Study||0||
60140408|NCT02644122|76263412|FG000|NOT COMPLETED|Overall Study||1||
60140409|NCT00883233|76263421|FG000|STARTED|Overall Study||32||
60140410|NCT00883233|76263422|FG001|STARTED|Overall Study||32||
60140411|NCT00883233|76263423|FG002|STARTED|Overall Study||29||
60140412|NCT00883233|76263424|FG003|STARTED|Overall Study||30||
60140413|NCT00883233|76263421|FG000|COMPLETED|Overall Study||27||
60140414|NCT00883233|76263422|FG001|COMPLETED|Overall Study||28||
60140415|NCT00883233|76263423|FG002|COMPLETED|Overall Study||25||
60140416|NCT00883233|76263424|FG003|COMPLETED|Overall Study||25||
60140417|NCT00883233|76263421|FG000|NOT COMPLETED|Overall Study||5||
60140418|NCT00883233|76263422|FG001|NOT COMPLETED|Overall Study||4||
60140419|NCT00883233|76263423|FG002|NOT COMPLETED|Overall Study||4||
60140420|NCT00883233|76263424|FG003|NOT COMPLETED|Overall Study||5||
60140421|NCT01394939|76263438|FG000|STARTED|Overall Study||4||
60140422|NCT01394939|76263439|FG001|STARTED|Overall Study||25||
60140423|NCT01394939|76263440|FG002|STARTED|Overall Study||4||
60140424|NCT01394939|76263441|FG003|STARTED|Overall Study||17||
60140425|NCT01394939|76263438|FG000|COMPLETED|Overall Study||3||
60140426|NCT01394939|76263439|FG001|COMPLETED|Overall Study||15||
60140427|NCT01394939|76263440|FG002|COMPLETED|Overall Study||4||
60140428|NCT01394939|76263441|FG003|COMPLETED|Overall Study||10||
60140429|NCT01394939|76263438|FG000|NOT COMPLETED|Overall Study||1||
60140430|NCT01394939|76263439|FG001|NOT COMPLETED|Overall Study||10||
60140431|NCT01394939|76263440|FG002|NOT COMPLETED|Overall Study||0||
60140432|NCT01394939|76263441|FG003|NOT COMPLETED|Overall Study||7||
60140433|NCT00883389|76263451|FG000|STARTED|Overall Study||26||
60140434|NCT00883389|76263451|FG000|COMPLETED|Overall Study||26||
60140435|NCT00883389|76263451|FG000|NOT COMPLETED|Overall Study||0||
60140436|NCT00880581|76263455|FG000|STARTED|Cycle 1||30||
60140437|NCT00880581|76263455|FG000|COMPLETED|Cycle 1||30||
59605702|NCT01965600|75715852|FG001|STARTED|Washout Period of Approximately 15 Days||8||
59605703|NCT01965600|75715853|FG002|STARTED|Washout Period of Approximately 15 Days||5||
60140438|NCT00880581|76263455|FG000|NOT COMPLETED|Cycle 1||0||
60140439|NCT00880581|76263455|FG000|STARTED|Cycle 2 Re-treatment|6 subjects with progessive disease were not treated and evaluated in Cycle 2|24||
60140440|NCT00880581|76263455|FG000|COMPLETED|Cycle 2 Re-treatment||24||
60140441|NCT00880581|76263455|FG000|NOT COMPLETED|Cycle 2 Re-treatment||0||
60140442|NCT01394627|76263459|FG000|STARTED|First Intervention (1 Day)||8||
60140443|NCT01394627|76263460|FG001|STARTED|First Intervention (1 Day)||13||
60140444|NCT01394627|76263459|FG000|COMPLETED|First Intervention (1 Day)||8||
60140445|NCT01394627|76263460|FG001|COMPLETED|First Intervention (1 Day)||12||
60140446|NCT01394627|76263459|FG000|NOT COMPLETED|First Intervention (1 Day)||0||
60140447|NCT01394627|76263460|FG001|NOT COMPLETED|First Intervention (1 Day)||1||
60140448|NCT01394627|76263459|FG000|STARTED|Washout (1-3 Months)||8||
60140449|NCT01394627|76263460|FG001|STARTED|Washout (1-3 Months)||12||
60140450|NCT01394627|76263459|FG000|COMPLETED|Washout (1-3 Months)||7||
60140451|NCT01394627|76263460|FG001|COMPLETED|Washout (1-3 Months)||12||
60140452|NCT01394627|76263459|FG000|NOT COMPLETED|Washout (1-3 Months)||1||
60140453|NCT01394627|76263460|FG001|NOT COMPLETED|Washout (1-3 Months)||0||
60140454|NCT01394627|76263459|FG000|STARTED|Second Intervention (1 Day)||7||
60140455|NCT01394627|76263460|FG001|STARTED|Second Intervention (1 Day)||12||
60140456|NCT01394627|76263459|FG000|COMPLETED|Second Intervention (1 Day)||7||
60140457|NCT01394627|76263460|FG001|COMPLETED|Second Intervention (1 Day)||12||
60140458|NCT01394627|76263459|FG000|NOT COMPLETED|Second Intervention (1 Day)||0||
60140459|NCT01394627|76263460|FG001|NOT COMPLETED|Second Intervention (1 Day)||0||
60140460|NCT02288377|76263468|FG000|STARTED|Overall Study||26||
60140461|NCT02288377|76263469|FG001|STARTED|Overall Study||27||
60140462|NCT02288377|76263468|FG000|COMPLETED|Overall Study||25||
60140463|NCT02288377|76263469|FG001|COMPLETED|Overall Study||27||
60140464|NCT02288377|76263468|FG000|NOT COMPLETED|Overall Study||1||
60140465|NCT02288377|76263469|FG001|NOT COMPLETED|Overall Study||0||
60140466|NCT01391663|76263479|FG000|STARTED|Overall Study||12||
60140467|NCT01391663|76263480|FG001|STARTED|Overall Study||12||
60140468|NCT01391663|76263481|FG002|STARTED|Overall Study||12||
60140469|NCT01391663|76263482|FG003|STARTED|Overall Study||12||
60140470|NCT01391663|76263479|FG000|COMPLETED|Overall Study||12||
60140471|NCT01391663|76263480|FG001|COMPLETED|Overall Study||12||
60140472|NCT01391663|76263481|FG002|COMPLETED|Overall Study||11||
60140473|NCT01391663|76263482|FG003|COMPLETED|Overall Study||12||
60140474|NCT01391663|76263479|FG000|NOT COMPLETED|Overall Study||0||
60140475|NCT01391663|76263480|FG001|NOT COMPLETED|Overall Study||0||
60140476|NCT01391663|76263481|FG002|NOT COMPLETED|Overall Study||1||
60140477|NCT01391663|76263482|FG003|NOT COMPLETED|Overall Study||0||
60140478|NCT00886899|76263492|FG000|STARTED|Overall Study||147||
60140479|NCT00886899|76263492|FG000|COMPLETED|Overall Study||147||
60140480|NCT00886899|76263492|FG000|NOT COMPLETED|Overall Study||0||
60140481|NCT02281500|76263496|FG000|STARTED|Overall Study||22||
60140482|NCT02281500|76263496|FG000|COMPLETED|Overall Study||22||
60140483|NCT02281500|76263496|FG000|NOT COMPLETED|Overall Study||0||
60140484|NCT02641392|76263503|FG000|STARTED|Overall Study||4||
60140485|NCT02641392|76263504|FG001|STARTED|Overall Study||13||
60140486|NCT02641392|76263505|FG002|STARTED|Overall Study||293||
60140487|NCT02641392|76263503|FG000|COMPLETED|Overall Study||0||
60140488|NCT02641392|76263504|FG001|COMPLETED|Overall Study||0||
60140489|NCT02641392|76263505|FG002|COMPLETED|Overall Study||0||
60140490|NCT02641392|76263503|FG000|NOT COMPLETED|Overall Study||4||
60140491|NCT02641392|76263504|FG001|NOT COMPLETED|Overall Study||13||
60140492|NCT02641392|76263505|FG002|NOT COMPLETED|Overall Study||293||
60140493|NCT04440007|76263515|FG000|STARTED|Overall Study||48||
60140494|NCT04440007|76263516|FG001|STARTED|Overall Study||48||
60140495|NCT04440007|76263515|FG000|COMPLETED|Overall Study||36||
60140496|NCT04440007|76263516|FG001|COMPLETED|Overall Study||36||
60140497|NCT04440007|76263515|FG000|NOT COMPLETED|Overall Study||12||
60140498|NCT04440007|76263516|FG001|NOT COMPLETED|Overall Study||12||
60140499|NCT01391507|76263526|FG000|STARTED|Overall Study||10||
60140500|NCT01391507|76263527|FG001|STARTED|Overall Study||8||
60140501|NCT01391507|76263528|FG002|STARTED|Overall Study||6||
60140502|NCT01391507|76263529|FG003|STARTED|Overall Study||12||
60140503|NCT01391507|76263526|FG000|COMPLETED|Overall Study||6||
60140504|NCT01391507|76263527|FG001|COMPLETED|Overall Study||4||
60140505|NCT01391507|76263528|FG002|COMPLETED|Overall Study||2||
60140506|NCT01391507|76263529|FG003|COMPLETED|Overall Study||5||
60140507|NCT01391507|76263526|FG000|NOT COMPLETED|Overall Study||4||
59751387|NCT00858117|75870683|FG000|COMPLETED|Treatment on Study||28||
60140508|NCT01391507|76263527|FG001|NOT COMPLETED|Overall Study||4||
60140509|NCT01391507|76263528|FG002|NOT COMPLETED|Overall Study||4||
60140510|NCT01391507|76263529|FG003|NOT COMPLETED|Overall Study||7||
60140511|NCT03940326|76263541|FG000|STARTED|Overall Study||45||
60140512|NCT03940326|76263542|FG001|STARTED|Overall Study||58||
60140513|NCT03940326|76263541|FG000|COMPLETED|Overall Study||45||
60140514|NCT03940326|76263542|FG001|COMPLETED|Overall Study||58||
60140515|NCT03940326|76263541|FG000|NOT COMPLETED|Overall Study||0||
60140516|NCT03940326|76263542|FG001|NOT COMPLETED|Overall Study||0||
60140517|NCT01473524|76263551|FG000|STARTED|DB Phase||71||
60140518|NCT01473524|76263552|FG001|STARTED|DB Phase||73||
60140519|NCT01473524|76263553|FG002|STARTED|DB Phase||73||
60140520|NCT01473524|76263554|FG003|STARTED|DB Phase||0||
60140521|NCT01473524|76263555|FG004|STARTED|DB Phase||0||
60140522|NCT01473524|76263556|FG005|STARTED|DB Phase||0||
60140523|NCT01473524|76263551|FG000|Received at Least 1 Dose of Study Drug|DB Phase||70||
60140524|NCT01473524|76263552|FG001|Received at Least 1 Dose of Study Drug|DB Phase||73||
60140525|NCT01473524|76263553|FG002|Received at Least 1 Dose of Study Drug|DB Phase||73||
60140526|NCT01473524|76263554|FG003|Received at Least 1 Dose of Study Drug|DB Phase||0||
60140527|NCT01473524|76263555|FG004|Received at Least 1 Dose of Study Drug|DB Phase||0||
60140528|NCT01473524|76263556|FG005|Received at Least 1 Dose of Study Drug|DB Phase||0||
60140529|NCT01473524|76263551|FG000|COMPLETED|DB Phase||64||
60140530|NCT01473524|76263552|FG001|COMPLETED|DB Phase||64||
60140531|NCT01473524|76263553|FG002|COMPLETED|DB Phase||70||
60140532|NCT01473524|76263554|FG003|COMPLETED|DB Phase||0||
60140533|NCT01473524|76263555|FG004|COMPLETED|DB Phase||0||
60140534|NCT01473524|76263556|FG005|COMPLETED|DB Phase||0||
60140535|NCT01473524|76263551|FG000|NOT COMPLETED|DB Phase||7||
60140536|NCT01473524|76263552|FG001|NOT COMPLETED|DB Phase||9||
60140537|NCT01473524|76263553|FG002|NOT COMPLETED|DB Phase||3||
60140538|NCT01473524|76263554|FG003|NOT COMPLETED|DB Phase||0||
60140539|NCT01473524|76263555|FG004|NOT COMPLETED|DB Phase||0||
60140540|NCT01473524|76263556|FG005|NOT COMPLETED|DB Phase||0||
60140541|NCT01473524|76263551|FG000|STARTED|LTSE Phase||0||
60140542|NCT01473524|76263552|FG001|STARTED|LTSE Phase||0||
60140543|NCT01473524|76263553|FG002|STARTED|LTSE Phase||0||
60140544|NCT01473524|76263554|FG003|STARTED|LTSE Phase|One participant in the double-blind OCA 5-10 mg group did not enroll in the LTSE phase.|63||
60140545|NCT01473524|76263555|FG004|STARTED|LTSE Phase||64||
60140546|NCT01473524|76263556|FG005|STARTED|LTSE Phase|Four participants in the double-blind placebo group did not enroll in the LTSE phase.|66||
60140547|NCT01473524|76263551|FG000|Received at Least 1 Dose of OCA in LTSE|LTSE Phase||0||
60140548|NCT01473524|76263552|FG001|Received at Least 1 Dose of OCA in LTSE|LTSE Phase||0||
60140549|NCT01473524|76263553|FG002|Received at Least 1 Dose of OCA in LTSE|LTSE Phase||0||
60140550|NCT01473524|76263554|FG003|Received at Least 1 Dose of OCA in LTSE|LTSE Phase||63||
60140551|NCT01473524|76263555|FG004|Received at Least 1 Dose of OCA in LTSE|LTSE Phase||64||
60140552|NCT01473524|76263556|FG005|Received at Least 1 Dose of OCA in LTSE|LTSE Phase||66||
60140553|NCT01473524|76263551|FG000|COMPLETED|LTSE Phase||0||
60140554|NCT01473524|76263552|FG001|COMPLETED|LTSE Phase||0||
60140555|NCT01473524|76263553|FG002|COMPLETED|LTSE Phase||0||
60140556|NCT01473524|76263554|FG003|COMPLETED|LTSE Phase||54||
60140557|NCT01473524|76263555|FG004|COMPLETED|LTSE Phase||47||
60140558|NCT01473524|76263556|FG005|COMPLETED|LTSE Phase||45||
60140559|NCT01473524|76263551|FG000|NOT COMPLETED|LTSE Phase||0||
60140560|NCT01473524|76263552|FG001|NOT COMPLETED|LTSE Phase||0||
60140561|NCT01473524|76263553|FG002|NOT COMPLETED|LTSE Phase||0||
60140562|NCT01473524|76263554|FG003|NOT COMPLETED|LTSE Phase||9||
60140563|NCT01473524|76263555|FG004|NOT COMPLETED|LTSE Phase||17||
60140564|NCT01473524|76263556|FG005|NOT COMPLETED|LTSE Phase||21||
60140565|NCT01905384|76263580|FG000|STARTED|Overall Study||3||
60140566|NCT01905384|76263581|FG001|STARTED|Overall Study||3||
60140567|NCT01905384|76263580|FG000|COMPLETED|Overall Study||3||
60140568|NCT01905384|76263581|FG001|COMPLETED|Overall Study||3||
60140569|NCT01905384|76263580|FG000|NOT COMPLETED|Overall Study||0||
60140570|NCT01905384|76263581|FG001|NOT COMPLETED|Overall Study||0||
60140571|NCT01390649|76263587|FG000|STARTED|Overall Study|Subjects treated with Privigen|57||
60140572|NCT01390649|76263587|FG000|COMPLETED|Overall Study||56||
60140573|NCT01390649|76263587|FG000|NOT COMPLETED|Overall Study||1||
60140574|NCT01390181|76263591|FG000|STARTED|Overall Study||4||
60140575|NCT01390181|76263591|FG000|COMPLETED|Overall Study||0||
60140576|NCT01390181|76263591|FG000|NOT COMPLETED|Overall Study||4||
60140577|NCT02641080|76263597|FG000|STARTED|Overall Study||40||
60140578|NCT02641080|76263598|FG001|STARTED|Overall Study||40||
60140579|NCT02641080|76263597|FG000|COMPLETED|Overall Study||38||
60140580|NCT02641080|76263598|FG001|COMPLETED|Overall Study||33||
60140581|NCT02641080|76263597|FG000|NOT COMPLETED|Overall Study||2||
60140582|NCT02641080|76263598|FG001|NOT COMPLETED|Overall Study||7||
60140583|NCT01457846|76263606|FG000|STARTED|Overall Study||41||
60140584|NCT01457846|76263607|FG001|STARTED|Overall Study||30||
60140585|NCT01457846|76263606|FG000|Received Treatment|Overall Study||40||
60140586|NCT01457846|76263607|FG001|Received Treatment|Overall Study||27||
60140587|NCT01457846|76263606|FG000|Did Not Receive Treatment|Overall Study||1||
60140588|NCT01457846|76263607|FG001|Did Not Receive Treatment|Overall Study||3||
60140589|NCT01457846|76263606|FG000|Ongoing Treatment at Data Cut-off|Overall Study||1||
60140590|NCT01457846|76263607|FG001|Ongoing Treatment at Data Cut-off|Overall Study||1||
60140591|NCT01457846|76263606|FG000|COMPLETED|Overall Study||0||
60140592|NCT01457846|76263607|FG001|COMPLETED|Overall Study||0||
60140593|NCT01457846|76263606|FG000|NOT COMPLETED|Overall Study||41||
60140594|NCT01457846|76263607|FG001|NOT COMPLETED|Overall Study||30||
60140595|NCT01275846|76263613|FG000|STARTED|Overall Study||26||
60140596|NCT01275846|76263613|FG000|COMPLETED|Overall Study||25||
60140597|NCT01275846|76263613|FG000|NOT COMPLETED|Overall Study||1||
60140598|NCT01496066|76263619|FG000|STARTED|Overall Study||403||
60140599|NCT01496066|76263620|FG001|STARTED|Overall Study||197||
60140600|NCT01496066|76263619|FG000|COMPLETED|Overall Study||391||
60140601|NCT01496066|76263620|FG001|COMPLETED|Overall Study||188||
60140602|NCT01496066|76263619|FG000|NOT COMPLETED|Overall Study||12||
60140603|NCT01496066|76263620|FG001|NOT COMPLETED|Overall Study||9||
60140604|NCT01389323|76263633|FG000|STARTED|Treatment Period (up to 48 Weeks)||246||
60140605|NCT01389323|76263633|FG000|COMPLETED|Treatment Period (up to 48 Weeks)||151||
60140606|NCT01389323|76263633|FG000|NOT COMPLETED|Treatment Period (up to 48 Weeks)||95||
60140607|NCT01389323|76263633|FG000|STARTED|Follow-up Period (up to 48 Weeks)|Out of 246 participants who entered the treatment period, 221 continued in the follow-up period.|221||
60140608|NCT01389323|76263633|FG000|COMPLETED|Follow-up Period (up to 48 Weeks)||184||
60140609|NCT01389323|76263633|FG000|NOT COMPLETED|Follow-up Period (up to 48 Weeks)||37||
60140610|NCT01389245|76263644|FG000|STARTED|Overall Study||42||110
60140611|NCT01389245|76263644|FG000|COMPLETED|Overall Study||27||66
60140612|NCT01389245|76263644|FG000|NOT COMPLETED|Overall Study||15||44
60140613|NCT01494818|76263650|FG000|STARTED|Overall Study||39||
60140614|NCT01494818|76263651|FG001|STARTED|Overall Study||39||
60140615|NCT01494818|76263650|FG000|COMPLETED|Overall Study||37||
60140616|NCT01494818|76263651|FG001|COMPLETED|Overall Study||37||
60140617|NCT01494818|76263650|FG000|NOT COMPLETED|Overall Study||2||
60140618|NCT01494818|76263651|FG001|NOT COMPLETED|Overall Study||2||
60140619|NCT01494584|76263657|FG000|STARTED|Overall Study||5||
59881715|NCT04230213|76004603|FG000|COMPLETED|TP1: Week 0 (Day 1) to Week 10||427||
60140620|NCT01494584|76263657|FG000|COMPLETED|Overall Study||4||
60140621|NCT01494584|76263657|FG000|NOT COMPLETED|Overall Study||1||
60140622|NCT01388543|76263682|FG000|STARTED|Day 7, Primary End Point||15||
59881716|NCT04230213|76004604|FG001|COMPLETED|TP1: Week 0 (Day 1) to Week 10||0||
59881717|NCT04230213|76004605|FG002|COMPLETED|TP1: Week 0 (Day 1) to Week 10||0||
59881718|NCT04230213|76004603|FG000|NOT COMPLETED|TP1: Week 0 (Day 1) to Week 10||18||
59881719|NCT04230213|76004604|FG001|NOT COMPLETED|TP1: Week 0 (Day 1) to Week 10||0||
59881720|NCT04230213|76004605|FG002|NOT COMPLETED|TP1: Week 0 (Day 1) to Week 10||0||
59881721|NCT04230213|76004603|FG000|STARTED|TP2: Week 10 to Week 16|TP1 ended when participants were randomized to Switching and Non-switching Arms|0||
60140623|NCT01388543|76263683|FG001|STARTED|Day 7, Primary End Point||16||
59881722|NCT04230213|76004604|FG001|STARTED|TP2: Week 10 to Week 16|Participants who completed TP1 were randomized to Switching arm.|213||
59881723|NCT04230213|76004605|FG002|STARTED|TP2: Week 10 to Week 16|Participants who completed TP1 were randomized to Non-switching arm.|214||
60140624|NCT01388543|76263682|FG000|COMPLETED|Day 7, Primary End Point||15||
59881724|NCT04230213|76004603|FG000|COMPLETED|TP2: Week 10 to Week 16||0||
60140625|NCT01388543|76263683|FG001|COMPLETED|Day 7, Primary End Point||16||
60140626|NCT01388543|76263682|FG000|NOT COMPLETED|Day 7, Primary End Point||0||
60140627|NCT01388543|76263683|FG001|NOT COMPLETED|Day 7, Primary End Point||0||
60140628|NCT01388543|76263682|FG000|STARTED|Day 14||15||
60140629|NCT01388543|76263683|FG001|STARTED|Day 14||16||
59881725|NCT04230213|76004604|FG001|COMPLETED|TP2: Week 10 to Week 16||211||
60140630|NCT01388543|76263682|FG000|COMPLETED|Day 14||14||
60140631|NCT01388543|76263683|FG001|COMPLETED|Day 14||12||
60140632|NCT01388543|76263682|FG000|NOT COMPLETED|Day 14||1||
60140633|NCT01388543|76263683|FG001|NOT COMPLETED|Day 14||4||
60140634|NCT00900237|76263691|FG000|STARTED|Overall Study||7||
60140635|NCT00900237|76263692|FG001|STARTED|Overall Study||7||
60140636|NCT00900237|76263691|FG000|COMPLETED|Overall Study||7||
60140637|NCT00900237|76263692|FG001|COMPLETED|Overall Study||7||
60140638|NCT00900237|76263691|FG000|NOT COMPLETED|Overall Study||0||
60140639|NCT00900237|76263692|FG001|NOT COMPLETED|Overall Study||0||
60140640|NCT00893997|76263698|FG000|STARTED|Overall Study||10||
60140641|NCT00893997|76263698|FG000|COMPLETED|Overall Study||10||
60140642|NCT00893997|76263698|FG000|NOT COMPLETED|Overall Study||0||
60140643|NCT00512317|76263702|FG000|STARTED|Overall Study||123||
60140644|NCT00512317|76263702|FG000|COMPLETED|Overall Study||6||
60140645|NCT00512317|76263702|FG000|NOT COMPLETED|Overall Study||117||
60140646|NCT00901017|76263708|FG000|STARTED|Overall Study||14||
60140647|NCT00901017|76263708|FG000|COMPLETED|Overall Study||14||
60140648|NCT00901017|76263708|FG000|NOT COMPLETED|Overall Study||0||
60140649|NCT01494506|76263718|FG000|STARTED|Overall Study|Started = Intent to Treat Population and includes all randomized participants|151||
60140650|NCT01494506|76263719|FG001|STARTED|Overall Study||149||
60140651|NCT01494506|76263720|FG002|STARTED|Overall Study||117||
60140652|NCT01494506|76263718|FG000|Treated Population|Overall Study|Treated population: Patients who received at least 1 dose of study drug.|147||
60140653|NCT01494506|76263719|FG001|Treated Population|Overall Study||134||
60140654|NCT01494506|76263720|FG002|Treated Population|Overall Study|2 randomized Arm C patients did not receive study drug. 1 patient each in A and B received Arm C.|117||
60140655|NCT01494506|76263718|FG000|COMPLETED|Overall Study|Completed = Subjects remaining on treatment at the time of the primary analysis data cut off.|3||
60140656|NCT01494506|76263719|FG001|COMPLETED|Overall Study||6||
60140657|NCT01494506|76263720|FG002|COMPLETED|Overall Study||14||
60140658|NCT01494506|76263718|FG000|NOT COMPLETED|Overall Study||148||
60140659|NCT01494506|76263719|FG001|NOT COMPLETED|Overall Study||143||
60140660|NCT01494506|76263720|FG002|NOT COMPLETED|Overall Study||103||
60140661|NCT02643420|76263732|FG000|STARTED|Overall Study||196||
60140662|NCT02643420|76263733|FG001|STARTED|Overall Study||210||
60140663|NCT02643420|76263732|FG000|Safety Population|Overall Study|One participant was randomized to the Arm 2: Pegfilgrastim and TC but was inadvertently administered SPI-2012 on Cycle 1, Day 2 and was included in the Arm 1: SPI-2012 and TC for the Safety Population.|197|Safety Population included all participants who had received at least one dose of any protocol specified drug (TC, SPI-2012, or pegfilgrastim).|
60140664|NCT02643420|76263733|FG001|Safety Population|Overall Study||208|Safety Population included all participants who had received at least one dose of any protocol specified drug (TC, SPI-2012, or pegfilgrastim).|
60140665|NCT02643420|76263732|FG000|COMPLETED|Overall Study||142||
60140666|NCT02643420|76263733|FG001|COMPLETED|Overall Study||145||
60140667|NCT02643420|76263732|FG000|NOT COMPLETED|Overall Study||54||
60140668|NCT02643420|76263733|FG001|NOT COMPLETED|Overall Study||65||
60140669|NCT00894465|76263747|FG000|STARTED|Overall Study||22||
60140670|NCT00894465|76263748|FG001|STARTED|Overall Study||22||
60140671|NCT00894465|76263747|FG000|COMPLETED|Overall Study||22||
60140672|NCT00894465|76263748|FG001|COMPLETED|Overall Study||22||
60140673|NCT00894465|76263747|FG000|NOT COMPLETED|Overall Study||0||
60140674|NCT00894465|76263748|FG001|NOT COMPLETED|Overall Study||0||
60140675|NCT01456130|76263756|FG000|STARTED|Overall Study||67||
60140676|NCT01456130|76263756|FG000|COMPLETED|Overall Study||57||
60140677|NCT01456130|76263756|FG000|NOT COMPLETED|Overall Study||10||
60140678|NCT01456052|76263763|FG000|STARTED|Overall Study||10||
60140679|NCT01456052|76263764|FG001|STARTED|Overall Study|One subject did not receive any study drug. That subject is not included in the safety population.|25||
60140680|NCT01456052|76263765|FG002|STARTED|Overall Study||24||
60140681|NCT01456052|76263763|FG000|COMPLETED|Overall Study||8||
60140682|NCT01456052|76263764|FG001|COMPLETED|Overall Study||20||
60140683|NCT01456052|76263765|FG002|COMPLETED|Overall Study||19||
60140684|NCT01456052|76263763|FG000|NOT COMPLETED|Overall Study||2||
60140685|NCT01456052|76263764|FG001|NOT COMPLETED|Overall Study||5||
60140686|NCT01456052|76263765|FG002|NOT COMPLETED|Overall Study||5||
60140687|NCT01387607|76263776|FG000|STARTED|Overall Study||173||
60140688|NCT01387607|76263777|FG001|STARTED|Overall Study||170||
60140689|NCT01387607|76263776|FG000|Received Treatment|Overall Study||170||
60140690|NCT01387607|76263777|FG001|Received Treatment|Overall Study||164||
60140691|NCT01387607|76263776|FG000|COMPLETED|Overall Study||122||
60140692|NCT01387607|76263777|FG001|COMPLETED|Overall Study||125||
60140693|NCT01387607|76263776|FG000|NOT COMPLETED|Overall Study||51||
60140694|NCT01387607|76263777|FG001|NOT COMPLETED|Overall Study||45||
60140695|NCT03451045|76263786|FG000|STARTED|Overall Study||175||
60140696|NCT03451045|76263787|FG001|STARTED|Overall Study||91||
60140697|NCT03451045|76263788|FG002|STARTED|Overall Study||181||
60140698|NCT03451045|76263786|FG000|COMPLETED|Overall Study||148||
60140699|NCT03451045|76263787|FG001|COMPLETED|Overall Study||85||
60140700|NCT03451045|76263788|FG002|COMPLETED|Overall Study||154||
60140701|NCT03451045|76263786|FG000|NOT COMPLETED|Overall Study||27||
60140702|NCT03451045|76263787|FG001|NOT COMPLETED|Overall Study||6||
60140703|NCT03451045|76263788|FG002|NOT COMPLETED|Overall Study||27||
60140704|NCT03219567|76263799|FG000|STARTED|Overall Study||18||
60140705|NCT03219567|76263800|FG001|STARTED|Overall Study||64||
60140706|NCT03219567|76263799|FG000|COMPLETED|Overall Study||18||
60140707|NCT03219567|76263800|FG001|COMPLETED|Overall Study||63||
60140708|NCT03219567|76263799|FG000|NOT COMPLETED|Overall Study||0||
60140709|NCT03219567|76263800|FG001|NOT COMPLETED|Overall Study||1||
60140710|NCT01386125|76263809|FG000|STARTED|Overall Study||375||
60140711|NCT01386125|76263810|FG001|STARTED|Overall Study||373||
60140712|NCT01386125|76263809|FG000|COMPLETED|Overall Study||350||
60140713|NCT01386125|76263810|FG001|COMPLETED|Overall Study||336||
60140714|NCT01386125|76263809|FG000|NOT COMPLETED|Overall Study||25||
60140715|NCT01386125|76263810|FG001|NOT COMPLETED|Overall Study||37||
60140716|NCT01384877|76263818|FG000|STARTED|Treatment 1||17||
60140717|NCT01384877|76263819|FG001|STARTED|Treatment 1||15||
60140718|NCT01384877|76263818|FG000|COMPLETED|Treatment 1||17||
60140719|NCT01384877|76263819|FG001|COMPLETED|Treatment 1||15||
60140720|NCT01384877|76263818|FG000|NOT COMPLETED|Treatment 1||0||
60140721|NCT01384877|76263819|FG001|NOT COMPLETED|Treatment 1||0||
60140722|NCT01384877|76263818|FG000|STARTED|Treatment 2|1 Patient died between treatment periods|16||
60140723|NCT01384877|76263819|FG001|STARTED|Treatment 2|2 Patients died between treatment periods|13||
60140724|NCT01384877|76263818|FG000|COMPLETED|Treatment 2||14||
60140725|NCT01384877|76263819|FG001|COMPLETED|Treatment 2||11||
60140726|NCT01384877|76263818|FG000|NOT COMPLETED|Treatment 2||2||
60140727|NCT01384877|76263819|FG001|NOT COMPLETED|Treatment 2||2||
60140728|NCT00114517|76263829|FG000|STARTED|Overall Study||137||
60140729|NCT00114517|76263830|FG001|STARTED|Overall Study||134||
60140730|NCT00114517|76263831|FG002|STARTED|Overall Study||186||
60140731|NCT00114517|76263832|FG003|STARTED|Overall Study||186||
60140732|NCT00114517|76263829|FG000|COMPLETED|Overall Study||125||
60140733|NCT00114517|76263830|FG001|COMPLETED|Overall Study||123||
60140734|NCT00114517|76263831|FG002|COMPLETED|Overall Study||172||
60140735|NCT00114517|76263832|FG003|COMPLETED|Overall Study||176||
60140736|NCT00114517|76263829|FG000|NOT COMPLETED|Overall Study||12||
60140737|NCT00114517|76263830|FG001|NOT COMPLETED|Overall Study||11||
60140738|NCT00114517|76263831|FG002|NOT COMPLETED|Overall Study||14||
60140739|NCT00114517|76263832|FG003|NOT COMPLETED|Overall Study||10||
60140740|NCT04027439|76263844|FG000|STARTED|Part A (R, PC, PG) Single Dose||6|Started Part A|
60140741|NCT04027439|76263845|FG001|STARTED|Part A (R, PC, PG) Single Dose||6|Started Part A|
60140742|NCT04027439|76263846|FG002|STARTED|Part A (R, PC, PG) Single Dose||7|Started Part A|
60140743|NCT04027439|76263847|FG003|STARTED|Part A (R, PC, PG) Single Dose||6|Started Part A|
60140744|NCT04027439|76263848|FG004|STARTED|Part A (R, PC, PG) Single Dose||6|Started Part A|
60140745|NCT04027439|76263849|FG005|STARTED|Part A (R, PC, PG) Single Dose||6|Started Part A|
60140746|NCT04027439|76263850|FG006|STARTED|Part A (R, PC, PG) Single Dose||0|Started Part A|
60140747|NCT04027439|76263851|FG007|STARTED|Part A (R, PC, PG) Single Dose||0|Started Part A|
60140748|NCT04027439|76263852|FG008|STARTED|Part A (R, PC, PG) Single Dose||0|Started Part A|
60140749|NCT04027439|76263853|FG009|STARTED|Part A (R, PC, PG) Single Dose||0|Started Part A|
60140750|NCT04027439|76263854|FG010|STARTED|Part A (R, PC, PG) Single Dose||0|Started Part A|
60140751|NCT04027439|76263855|FG011|STARTED|Part A (R, PC, PG) Single Dose||0|Started Part A|
60140752|NCT04027439|76263856|FG012|STARTED|Part A (R, PC, PG) Single Dose||0|Started Part A|
60140753|NCT04027439|76263857|FG013|STARTED|Part A (R, PC, PG) Single Dose||0|Started Part A|
60140754|NCT04027439|76263858|FG014|STARTED|Part A (R, PC, PG) Single Dose||0|Started Part A|
60140755|NCT04027439|76263859|FG015|STARTED|Part A (R, PC, PG) Single Dose||0|Started Part A|
60140756|NCT04027439|76263844|FG000|COMPLETED|Part A (R, PC, PG) Single Dose||6|Completed Part A|
60140757|NCT04027439|76263845|FG001|COMPLETED|Part A (R, PC, PG) Single Dose||6|Completed Part A|
60140758|NCT04027439|76263846|FG002|COMPLETED|Part A (R, PC, PG) Single Dose||7|Completed Part A|
60140759|NCT04027439|76263847|FG003|COMPLETED|Part A (R, PC, PG) Single Dose||6|Completed Part A|
60140760|NCT04027439|76263848|FG004|COMPLETED|Part A (R, PC, PG) Single Dose||6|Completed Part A|
60140761|NCT04027439|76263849|FG005|COMPLETED|Part A (R, PC, PG) Single Dose||6|Completed Part A|
60140762|NCT04027439|76263850|FG006|COMPLETED|Part A (R, PC, PG) Single Dose||0|Completed Part A|
60140763|NCT04027439|76263851|FG007|COMPLETED|Part A (R, PC, PG) Single Dose||0|Completed Part A|
60140764|NCT04027439|76263852|FG008|COMPLETED|Part A (R, PC, PG) Single Dose||0|Completed Part A|
60140765|NCT04027439|76263853|FG009|COMPLETED|Part A (R, PC, PG) Single Dose||0|Completed Part A|
60140766|NCT04027439|76263854|FG010|COMPLETED|Part A (R, PC, PG) Single Dose||0|Completed Part A|
60140767|NCT04027439|76263855|FG011|COMPLETED|Part A (R, PC, PG) Single Dose||0|Completed Part A|
60140768|NCT04027439|76263856|FG012|COMPLETED|Part A (R, PC, PG) Single Dose||0|Completed Part A|
60140769|NCT04027439|76263857|FG013|COMPLETED|Part A (R, PC, PG) Single Dose||0|Completed Part A|
60140770|NCT04027439|76263858|FG014|COMPLETED|Part A (R, PC, PG) Single Dose||0|Completed Part A|
60140771|NCT04027439|76263859|FG015|COMPLETED|Part A (R, PC, PG) Single Dose||0|Completed Part A|
60140772|NCT04027439|76263844|FG000|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0||
60140773|NCT04027439|76263845|FG001|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0||
60140774|NCT04027439|76263846|FG002|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0||
59518896|NCT03537664|75612775|FG000|Bacterial Community Diversity|Overall Study||10||
59519081|NCT01093651|75612960|FG001|COMPLETED|Overall Study||10||
60140775|NCT04027439|76263847|FG003|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0||
60140776|NCT04027439|76263848|FG004|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0||
60140777|NCT04027439|76263849|FG005|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0||
60140778|NCT04027439|76263850|FG006|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0||
60140779|NCT04027439|76263851|FG007|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0||
60140780|NCT04027439|76263852|FG008|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0||
60140781|NCT04027439|76263853|FG009|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0||
60140782|NCT04027439|76263854|FG010|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0||
60140783|NCT04027439|76263855|FG011|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0||
60140784|NCT04027439|76263856|FG012|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0||
60140785|NCT04027439|76263857|FG013|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0||
60140786|NCT04027439|76263858|FG014|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0||
60140787|NCT04027439|76263859|FG015|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0||
60140788|NCT04027439|76263844|FG000|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||0||
60140789|NCT04027439|76263845|FG001|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||0||
60140790|NCT04027439|76263846|FG002|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||0||
60140791|NCT04027439|76263847|FG003|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||0||
60140792|NCT04027439|76263848|FG004|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||0||
60140793|NCT04027439|76263849|FG005|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||0||
60140794|NCT04027439|76263850|FG006|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||4||
60140795|NCT04027439|76263851|FG007|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||3||
60140796|NCT04027439|76263852|FG008|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||4||
60140797|NCT04027439|76263853|FG009|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||3||
60140798|NCT04027439|76263854|FG010|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||4||
60140799|NCT04027439|76263855|FG011|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||3||
60140800|NCT04027439|76263856|FG012|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||3||
60140801|NCT04027439|76263857|FG013|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||4||
60140802|NCT04027439|76263858|FG014|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||4||
60140803|NCT04027439|76263859|FG015|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||3||
60140804|NCT04027439|76263844|FG000|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0||
60140805|NCT04027439|76263845|FG001|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0||
60140806|NCT04027439|76263846|FG002|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0||
60140807|NCT04027439|76263847|FG003|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0||
60140808|NCT04027439|76263848|FG004|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0||
60140809|NCT04027439|76263849|FG005|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0||
60140810|NCT04027439|76263850|FG006|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||4||
60140811|NCT04027439|76263851|FG007|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day|1 patient discontinued in part b/period 2 and another in part b/period 3.|1||
60140812|NCT04027439|76263852|FG008|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||4||
60140813|NCT04027439|76263853|FG009|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||3||
60140814|NCT04027439|76263854|FG010|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||4||
60140815|NCT04027439|76263855|FG011|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||3||
60140816|NCT04027439|76263856|FG012|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||3||
60140817|NCT04027439|76263857|FG013|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||4||
60140818|NCT04027439|76263858|FG014|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||4||
60140819|NCT04027439|76263859|FG015|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||3||
60140820|NCT04027439|76263844|FG000|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0||
60140821|NCT04027439|76263845|FG001|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0||
60140822|NCT04027439|76263846|FG002|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0||
60140823|NCT04027439|76263847|FG003|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0||
60140824|NCT04027439|76263848|FG004|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0||
60140825|NCT04027439|76263849|FG005|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0||
60140826|NCT04027439|76263850|FG006|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0||
60140827|NCT04027439|76263851|FG007|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||2||
60140828|NCT04027439|76263852|FG008|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0||
60140829|NCT04027439|76263853|FG009|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0||
60140830|NCT04027439|76263854|FG010|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0||
60140831|NCT04027439|76263855|FG011|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0||
60140832|NCT04027439|76263856|FG012|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0||
60140833|NCT04027439|76263857|FG013|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0||
60140834|NCT04027439|76263858|FG014|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0||
60140835|NCT04027439|76263859|FG015|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0||
60140836|NCT01384019|76263885|FG000|STARTED|Overall Study||65||
60140837|NCT01384019|76263886|FG001|STARTED|Overall Study||61||
60140838|NCT01384019|76263885|FG000|COMPLETED|Overall Study||55||
60140839|NCT01384019|76263886|FG001|COMPLETED|Overall Study||55||
60140840|NCT01384019|76263885|FG000|NOT COMPLETED|Overall Study||10||
60140841|NCT01384019|76263886|FG001|NOT COMPLETED|Overall Study||6||
60140842|NCT00033631|76263894|FG000|STARTED|Overall Study||769||
60140843|NCT00033631|76263895|FG001|STARTED|Overall Study||763||
60140844|NCT00033631|76263894|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|751||
60140845|NCT00033631|76263895|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|748||
60140846|NCT00033631|76263894|FG000|NOT COMPLETED|Overall Study||18||
60140847|NCT00033631|76263895|FG001|NOT COMPLETED|Overall Study||15||
60140848|NCT01471574|76263906|FG000|STARTED|Treatment Period||132||
60140849|NCT01471574|76263907|FG001|STARTED|Treatment Period||39||
60140850|NCT01471574|76263908|FG002|STARTED|Treatment Period||106||
60140851|NCT01471574|76263909|FG003|STARTED|Treatment Period||24||
60010047|NCT04537208|76125742|FG008|Safety Analysis Set (SafAS)|Overall Study||85|Participants who had received at least one injection of study intervention and were analyzed according to the study intervention they actually received.|
60010048|NCT04537208|76125743|FG009|Safety Analysis Set (SafAS)|Overall Study||18|Participants who had received at least one injection of study intervention and were analyzed according to the study intervention they actually received.|
60010049|NCT04537208|76125744|FG010|Safety Analysis Set (SafAS)|Overall Study||29|Participants who had received at least one injection of study intervention and were analyzed according to the study intervention they actually received.|
60010050|NCT04537208|76125734|FG000|COMPLETED|Overall Study||26||
60010051|NCT04537208|76125735|FG001|COMPLETED|Overall Study||31||
60010052|NCT04537208|76125736|FG002|COMPLETED|Overall Study||28||
60010053|NCT04537208|76125737|FG003|COMPLETED|Overall Study||27||
60010054|NCT04537208|76125738|FG004|COMPLETED|Overall Study||26||
60010055|NCT04537208|76125739|FG005|COMPLETED|Overall Study||23||
60010056|NCT04537208|76125740|FG006|COMPLETED|Overall Study||71||
60140852|NCT01471574|76263906|FG000|COMPLETED|Treatment Period||101||
60140853|NCT01471574|76263907|FG001|COMPLETED|Treatment Period||29||
60140854|NCT01471574|76263908|FG002|COMPLETED|Treatment Period||82||
60140855|NCT01471574|76263909|FG003|COMPLETED|Treatment Period||21||
60140856|NCT01471574|76263906|FG000|NOT COMPLETED|Treatment Period||31||
60140857|NCT01471574|76263907|FG001|NOT COMPLETED|Treatment Period||10||
60140858|NCT01471574|76263908|FG002|NOT COMPLETED|Treatment Period||24||
60140859|NCT01471574|76263909|FG003|NOT COMPLETED|Treatment Period||3||
60140860|NCT01471574|76263906|FG000|STARTED|Follow-up Period||121||
60140861|NCT01471574|76263907|FG001|STARTED|Follow-up Period||34||
60140862|NCT01471574|76263908|FG002|STARTED|Follow-up Period||102||
60140863|NCT01471574|76263909|FG003|STARTED|Follow-up Period||24||
60140864|NCT01471574|76263906|FG000|COMPLETED|Follow-up Period||114||
60140865|NCT01471574|76263907|FG001|COMPLETED|Follow-up Period||32||
60140866|NCT01471574|76263908|FG002|COMPLETED|Follow-up Period||95||
60140867|NCT01471574|76263909|FG003|COMPLETED|Follow-up Period||21||
60140868|NCT01471574|76263906|FG000|NOT COMPLETED|Follow-up Period||7||
60140869|NCT01471574|76263907|FG001|NOT COMPLETED|Follow-up Period||2||
60140870|NCT01471574|76263908|FG002|NOT COMPLETED|Follow-up Period||7||
60140871|NCT01471574|76263909|FG003|NOT COMPLETED|Follow-up Period||3||
60140872|NCT01383707|76263925|FG000|STARTED|Overall Study||77||
60140873|NCT01383707|76263925|FG000|COMPLETED|Overall Study||5||
60140874|NCT01383707|76263925|FG000|NOT COMPLETED|Overall Study||72||
60140875|NCT01383317|76263931|FG000|STARTED|Overall Study||29||
60140876|NCT01383317|76263932|FG001|STARTED|Overall Study||35||
60140877|NCT01383317|76263931|FG000|COMPLETED|Overall Study||26||
60140878|NCT01383317|76263932|FG001|COMPLETED|Overall Study||33||
60140879|NCT01383317|76263931|FG000|NOT COMPLETED|Overall Study||3||
60140880|NCT01383317|76263932|FG001|NOT COMPLETED|Overall Study||2||
60140881|NCT01455428|76263940|FG000|STARTED|Overall Study||112||
60140882|NCT01455428|76263941|FG001|STARTED|Overall Study||110||
60140883|NCT01455428|76263940|FG000|Treated|Overall Study||111||
60010057|NCT04537208|76125741|FG007|COMPLETED|Overall Study||24||
60010058|NCT04537208|76125742|FG008|COMPLETED|Overall Study||69||
60010059|NCT04537208|76125743|FG009|COMPLETED|Overall Study||14||
60010060|NCT04537208|76125744|FG010|COMPLETED|Overall Study||21||
60010061|NCT04537208|76125734|FG000|NOT COMPLETED|Overall Study||8||
60010062|NCT04537208|76125735|FG001|NOT COMPLETED|Overall Study||3||
60010063|NCT04537208|76125736|FG002|NOT COMPLETED|Overall Study||6||
60010064|NCT04537208|76125737|FG003|NOT COMPLETED|Overall Study||7||
60010065|NCT04537208|76125738|FG004|NOT COMPLETED|Overall Study||8||
60010066|NCT04537208|76125739|FG005|NOT COMPLETED|Overall Study||5||
60010067|NCT04537208|76125740|FG006|NOT COMPLETED|Overall Study||13||
60010068|NCT04537208|76125741|FG007|NOT COMPLETED|Overall Study||3||
60010069|NCT04537208|76125742|FG008|NOT COMPLETED|Overall Study||16||
60010070|NCT04537208|76125743|FG009|NOT COMPLETED|Overall Study||4||
60010071|NCT04537208|76125744|FG010|NOT COMPLETED|Overall Study||8||
60010072|NCT04502433|76125773|FG000|STARTED|Overall Study||8||
59518897|NCT03537664|75612776|FG001|Bacterial Community Diversity|Overall Study||0||
60010073|NCT04502433|76125774|FG001|STARTED|Overall Study||14||
60010074|NCT04502433|76125773|FG000|COMPLETED|Overall Study||5||
60140884|NCT01455428|76263941|FG001|Treated|Overall Study||109||
60140885|NCT01455428|76263940|FG000|COMPLETED|Overall Study||98||
60140886|NCT01455428|76263941|FG001|COMPLETED|Overall Study||92||
60140887|NCT01455428|76263940|FG000|NOT COMPLETED|Overall Study||14||
60140888|NCT01455428|76263941|FG001|NOT COMPLETED|Overall Study||18||
60140889|NCT01383161|76263949|FG000|STARTED|Overall Study||25||
60140890|NCT01383161|76263950|FG001|STARTED|Overall Study||21||
60140891|NCT01383161|76263949|FG000|COMPLETED|Overall Study||20||
60140892|NCT01383161|76263950|FG001|COMPLETED|Overall Study||17||
60140893|NCT01383161|76263949|FG000|NOT COMPLETED|Overall Study||5||
60140894|NCT01383161|76263950|FG001|NOT COMPLETED|Overall Study||4||
60140895|NCT00894699|76263958|FG000|STARTED|Overall Study||21||
60140896|NCT00894699|76263959|FG001|STARTED|Overall Study||19||
60140897|NCT00894699|76263958|FG000|COMPLETED|Overall Study||21||
60140898|NCT00894699|76263959|FG001|COMPLETED|Overall Study||19||
60140899|NCT00894699|76263958|FG000|NOT COMPLETED|Overall Study||0||
60140900|NCT00894699|76263959|FG001|NOT COMPLETED|Overall Study||0||
60140901|NCT03087019|76263967|FG000|STARTED|Overall Study||11||
60140902|NCT03087019|76263968|FG001|STARTED|Overall Study||10||
60140903|NCT03087019|76263967|FG000|COMPLETED|Overall Study||10||
60140904|NCT03087019|76263968|FG001|COMPLETED|Overall Study||10||
60140905|NCT03087019|76263967|FG000|NOT COMPLETED|Overall Study||1||
60140906|NCT03087019|76263968|FG001|NOT COMPLETED|Overall Study||0||
60140907|NCT01382225|76263976|FG000|STARTED|Overall Study||725||
60140908|NCT01382225|76263977|FG001|STARTED|Overall Study||729||
60140909|NCT01382225|76263976|FG000|COMPLETED|Overall Study||711||
60140910|NCT01382225|76263977|FG001|COMPLETED|Overall Study||722||
60140911|NCT01382225|76263976|FG000|NOT COMPLETED|Overall Study||14||
60140912|NCT01382225|76263977|FG001|NOT COMPLETED|Overall Study||7||
60140913|NCT01381679|76263983|FG000|STARTED|Overall Study||1682||
60140914|NCT01381679|76263983|FG000|COMPLETED|Overall Study||794||
60140915|NCT01381679|76263983|FG000|NOT COMPLETED|Overall Study||888||
60140916|NCT01455194|76263990|FG000|STARTED|Overall Study||153||
60140917|NCT01455194|76263991|FG001|STARTED|Overall Study||120||
60140918|NCT01455194|76263992|FG002|STARTED|Overall Study||122||
60140919|NCT01455194|76263993|FG003|STARTED|Overall Study||125||
60140920|NCT01455194|76263990|FG000|COMPLETED|Overall Study||0||
60140921|NCT01455194|76263991|FG001|COMPLETED|Overall Study||89||
59518898|NCT03537664|75612775|FG000|Endodontic Success|Overall Study||20||
60140922|NCT01455194|76263992|FG002|COMPLETED|Overall Study||92||
60140923|NCT01455194|76263993|FG003|COMPLETED|Overall Study||97||
60140924|NCT01455194|76263990|FG000|NOT COMPLETED|Overall Study||153||
60140925|NCT01455194|76263991|FG001|NOT COMPLETED|Overall Study||31||
60140926|NCT01455194|76263992|FG002|NOT COMPLETED|Overall Study||30||
60140927|NCT01455194|76263993|FG003|NOT COMPLETED|Overall Study||28||
60140928|NCT03089281|76264008|FG000|STARTED|Overall Study||225||
60140929|NCT03089281|76264009|FG001|STARTED|Overall Study||215||
59751388|NCT00858117|75870683|FG000|NOT COMPLETED|Treatment on Study||2||
59751389|NCT00858117|75870683|FG000|STARTED|Follow up for 5 Years|All patients who receive at least one dose of drug under the protocol go into follow up for survival|30||
59751390|NCT00858117|75870683|FG000|COMPLETED|Follow up for 5 Years||17||
59751391|NCT00858117|75870683|FG000|NOT COMPLETED|Follow up for 5 Years||13||
60140930|NCT03089281|76264008|FG000|COMPLETED|Overall Study||197||
60140931|NCT03089281|76264009|FG001|COMPLETED|Overall Study||198||
60140932|NCT03089281|76264008|FG000|NOT COMPLETED|Overall Study||28||
60140933|NCT03089281|76264009|FG001|NOT COMPLETED|Overall Study||17||
60140934|NCT01454726|76264017|FG000|STARTED|Overall Study||16||
60140935|NCT01454726|76264018|FG001|STARTED|Overall Study||11||
60140936|NCT01454726|76264017|FG000|COMPLETED|Overall Study||16||
60140937|NCT01454726|76264018|FG001|COMPLETED|Overall Study||10||
60140938|NCT01454726|76264017|FG000|NOT COMPLETED|Overall Study||0||
60140939|NCT01454726|76264018|FG001|NOT COMPLETED|Overall Study||1||
60140940|NCT01361568|76264030|FG000|STARTED|Overall Study||71||
60140941|NCT01361568|76264031|FG001|STARTED|Overall Study||71||
60140942|NCT01361568|76264032|FG002|STARTED|Overall Study||20||
60140943|NCT01361568|76264033|FG003|STARTED|Overall Study||21||
60140944|NCT01361568|76264034|FG004|STARTED|Overall Study||7||
60140945|NCT01361568|76264035|FG005|STARTED|Overall Study||13||
60140946|NCT01361568|76264030|FG000|COMPLETED|Overall Study||69||
60140947|NCT01361568|76264031|FG001|COMPLETED|Overall Study||70||
60140948|NCT01361568|76264032|FG002|COMPLETED|Overall Study||20||
60140949|NCT01361568|76264033|FG003|COMPLETED|Overall Study||21||
60140950|NCT01361568|76264034|FG004|COMPLETED|Overall Study||6||
60140951|NCT01361568|76264035|FG005|COMPLETED|Overall Study||11||
60140952|NCT01361568|76264030|FG000|NOT COMPLETED|Overall Study||2||
60140953|NCT01361568|76264031|FG001|NOT COMPLETED|Overall Study||1||
59518899|NCT03537664|75612776|FG001|Endodontic Success|Overall Study||10||
60140954|NCT01361568|76264032|FG002|NOT COMPLETED|Overall Study||0||
60140955|NCT01361568|76264033|FG003|NOT COMPLETED|Overall Study||0||
59751392|NCT00652951|75870690|FG000|STARTED|Primary Phase||260||
59751393|NCT00652951|75870691|FG001|STARTED|Primary Phase||260||
60140956|NCT01361568|76264034|FG004|NOT COMPLETED|Overall Study||1||
60140957|NCT01361568|76264035|FG005|NOT COMPLETED|Overall Study||2||
60140958|NCT03084367|76264050|FG000|STARTED|Overall Study||500||
60140959|NCT03084367|76264050|FG000|Analyzable iFR Pullback Assessment Post Angiographically Successful PCI|Overall Study||467||
60140960|NCT03084367|76264050|FG000|COMPLETED|Overall Study||463|completed means study follow-up at 1 year completed|
60140961|NCT03084367|76264050|FG000|NOT COMPLETED|Overall Study||37||
60140962|NCT04076696|76264059|FG000|STARTED|Overall Study||38||
60140963|NCT04076696|76264059|FG000|COMPLETED|Overall Study||38||
59751394|NCT00652951|75870692|FG002|STARTED|Primary Phase||260||
59751395|NCT00652951|75870690|FG000|COMPLETED|Primary Phase||260||
59751396|NCT00652951|75870691|FG001|COMPLETED|Primary Phase||260||
59751397|NCT00652951|75870692|FG002|COMPLETED|Primary Phase||260||
59751398|NCT00652951|75870690|FG000|NOT COMPLETED|Primary Phase||0||
59751399|NCT00652951|75870691|FG001|NOT COMPLETED|Primary Phase||0||
59751400|NCT00652951|75870692|FG002|NOT COMPLETED|Primary Phase||0||
59751401|NCT00652951|75870690|FG000|STARTED|Booster Phase||257||
59751402|NCT00652951|75870691|FG001|STARTED|Booster Phase||259||
59751403|NCT00652951|75870692|FG002|STARTED|Booster Phase||258||
59751404|NCT00652951|75870690|FG000|COMPLETED|Booster Phase||256||
59751405|NCT00652951|75870691|FG001|COMPLETED|Booster Phase||258||
59751406|NCT00652951|75870692|FG002|COMPLETED|Booster Phase||258||
59751407|NCT00652951|75870690|FG000|NOT COMPLETED|Booster Phase||1||
59881726|NCT04230213|76004605|FG002|COMPLETED|TP2: Week 10 to Week 16||211||
59881727|NCT04230213|76004603|FG000|NOT COMPLETED|TP2: Week 10 to Week 16||0||
59881728|NCT04230213|76004604|FG001|NOT COMPLETED|TP2: Week 10 to Week 16||2||
59881729|NCT04230213|76004605|FG002|NOT COMPLETED|TP2: Week 10 to Week 16||3||
59881730|NCT04230213|76004603|FG000|STARTED|TP3: Week 16 to Week 22||0||
59881731|NCT04230213|76004604|FG001|STARTED|TP3: Week 16 to Week 22||211||
59881732|NCT04230213|76004605|FG002|STARTED|TP3: Week 16 to Week 22||211||
59881733|NCT04230213|76004603|FG000|COMPLETED|TP3: Week 16 to Week 22||0||
59881734|NCT04230213|76004604|FG001|COMPLETED|TP3: Week 16 to Week 22||210||
59881735|NCT04230213|76004605|FG002|COMPLETED|TP3: Week 16 to Week 22||204||
59881736|NCT04230213|76004603|FG000|NOT COMPLETED|TP3: Week 16 to Week 22||0||
60010075|NCT04502433|76125774|FG001|COMPLETED|Overall Study||9||
60010076|NCT04502433|76125773|FG000|NOT COMPLETED|Overall Study||3||
60010077|NCT04502433|76125774|FG001|NOT COMPLETED|Overall Study||5||
60010078|NCT04411914|76125782|FG000|STARTED|CLAV 500mg/Day for Days 1-3||10||
60010079|NCT04411914|76125783|FG001|STARTED|CLAV 500mg/Day for Days 1-3||3||
60010080|NCT04411914|76125782|FG000|COMPLETED|CLAV 500mg/Day for Days 1-3||9||
60010081|NCT04411914|76125783|FG001|COMPLETED|CLAV 500mg/Day for Days 1-3||3||
60010082|NCT04411914|76125782|FG000|NOT COMPLETED|CLAV 500mg/Day for Days 1-3||1||
60010083|NCT04411914|76125783|FG001|NOT COMPLETED|CLAV 500mg/Day for Days 1-3||0||
60010084|NCT04411914|76125782|FG000|STARTED|CLAV 750mg/Day for Days 4-6|9 participants who completed Period 1 (3 days of CLAV 500mg for 3 days) had dose escalation to 750mg/d for 3 days in Period 2.|9||
60010085|NCT04411914|76125783|FG001|STARTED|CLAV 750mg/Day for Days 4-6||3||
60010086|NCT04411914|76125782|FG000|COMPLETED|CLAV 750mg/Day for Days 4-6||9||
60010087|NCT04411914|76125783|FG001|COMPLETED|CLAV 750mg/Day for Days 4-6||3||
60010088|NCT04411914|76125782|FG000|NOT COMPLETED|CLAV 750mg/Day for Days 4-6||0||
60010089|NCT04411914|76125783|FG001|NOT COMPLETED|CLAV 750mg/Day for Days 4-6||0||
60010090|NCT04411914|76125782|FG000|STARTED|CLAV 1000m/d for Days 7-10|The same 9 participants who started the study and received 3days of CLAV 500mg/day and 3 days of CLAV 750mg/day were then dose escalated to CLAV 1000mg/day for 4 days.|9||
60010091|NCT04411914|76125783|FG001|STARTED|CLAV 1000m/d for Days 7-10||3||
60010092|NCT04411914|76125782|FG000|COMPLETED|CLAV 1000m/d for Days 7-10||9||
60010093|NCT04411914|76125783|FG001|COMPLETED|CLAV 1000m/d for Days 7-10||3||
60010094|NCT04411914|76125782|FG000|NOT COMPLETED|CLAV 1000m/d for Days 7-10||0||
60010095|NCT04411914|76125783|FG001|NOT COMPLETED|CLAV 1000m/d for Days 7-10||0||
60010096|NCT04389671|76125802|FG000|STARTED|Overall Study||20||
60010097|NCT04389671|76125802|FG000|COMPLETED|Overall Study||13||
60010098|NCT04389671|76125802|FG000|NOT COMPLETED|Overall Study||7||
60010099|NCT04381494|76125806|FG000|STARTED|Overall Study||40||
60010100|NCT04381494|76125806|FG000|COMPLETED|Overall Study||5||
60010101|NCT04381494|76125806|FG000|NOT COMPLETED|Overall Study||35||
60010102|NCT04290039|76125813|FG000|STARTED|Period 1 (Visit 1; Day 1)||5||
60010103|NCT04290039|76125814|FG001|STARTED|Period 1 (Visit 1; Day 1)||5||
60010104|NCT04290039|76125815|FG002|STARTED|Period 1 (Visit 1; Day 1)||5||
60010105|NCT04290039|76125813|FG000|COMPLETED|Period 1 (Visit 1; Day 1)||5||
60010106|NCT04290039|76125814|FG001|COMPLETED|Period 1 (Visit 1; Day 1)||5||
60010107|NCT04290039|76125815|FG002|COMPLETED|Period 1 (Visit 1; Day 1)||5||
60010108|NCT04290039|76125813|FG000|NOT COMPLETED|Period 1 (Visit 1; Day 1)||0||
60010109|NCT04290039|76125814|FG001|NOT COMPLETED|Period 1 (Visit 1; Day 1)||0||
60010110|NCT04290039|76125815|FG002|NOT COMPLETED|Period 1 (Visit 1; Day 1)||0||
60010111|NCT04290039|76125813|FG000|STARTED|Period 2 (Visit 2; Day 8)||5||
60010112|NCT04290039|76125814|FG001|STARTED|Period 2 (Visit 2; Day 8)||5||
60010113|NCT04290039|76125815|FG002|STARTED|Period 2 (Visit 2; Day 8)||5||
60010114|NCT04290039|76125813|FG000|COMPLETED|Period 2 (Visit 2; Day 8)||5||
60010115|NCT04290039|76125814|FG001|COMPLETED|Period 2 (Visit 2; Day 8)||5||
60010116|NCT04290039|76125815|FG002|COMPLETED|Period 2 (Visit 2; Day 8)||5||
60010117|NCT04290039|76125813|FG000|NOT COMPLETED|Period 2 (Visit 2; Day 8)||0||
60010118|NCT04290039|76125814|FG001|NOT COMPLETED|Period 2 (Visit 2; Day 8)||0||
60010119|NCT04290039|76125815|FG002|NOT COMPLETED|Period 2 (Visit 2; Day 8)||0||
60010120|NCT04290039|76125813|FG000|STARTED|Period 3 (Visit 3; Day 15)||5||
60010121|NCT04290039|76125814|FG001|STARTED|Period 3 (Visit 3; Day 15)||4||
60010122|NCT04290039|76125815|FG002|STARTED|Period 3 (Visit 3; Day 15)||5||
60010123|NCT04290039|76125813|FG000|COMPLETED|Period 3 (Visit 3; Day 15)||5||
60010124|NCT04290039|76125814|FG001|COMPLETED|Period 3 (Visit 3; Day 15)||4||
60010125|NCT04290039|76125815|FG002|COMPLETED|Period 3 (Visit 3; Day 15)||5||
60140964|NCT04076696|76264059|FG000|NOT COMPLETED|Overall Study||0||
60140965|NCT01454570|76264063|FG000|STARTED|Overall Study||19||
60140966|NCT01454570|76264063|FG000|COMPLETED|Overall Study||10||
60140967|NCT01454570|76264063|FG000|NOT COMPLETED|Overall Study||9||
60140968|NCT02079311|76264069|FG000|STARTED|Overall Study||28||
60140969|NCT02079311|76264070|FG001|STARTED|Overall Study||27||
60140970|NCT02079311|76264069|FG000|COMPLETED|Overall Study||28||
60140971|NCT02079311|76264070|FG001|COMPLETED|Overall Study||26||
60140972|NCT02079311|76264069|FG000|NOT COMPLETED|Overall Study||0||
60140973|NCT02079311|76264070|FG001|NOT COMPLETED|Overall Study||1||
60140974|NCT01494350|76264076|FG000|STARTED|Overall Study||50||
60140975|NCT01494350|76264076|FG000|COMPLETED|Overall Study||49||
60140976|NCT01494350|76264076|FG000|NOT COMPLETED|Overall Study||1||
60140977|NCT02135484|76264080|FG000|STARTED|Overall Study||25||
60140978|NCT02135484|76264080|FG000|COMPLETED|Overall Study||25||
60140979|NCT02135484|76264080|FG000|NOT COMPLETED|Overall Study||0||
60140980|NCT03281629|76264086|FG000|STARTED|Overall Study||18||
60140981|NCT03281629|76264087|FG001|STARTED|Overall Study||12||
60140982|NCT03281629|76264086|FG000|COMPLETED|Overall Study||16||
60140983|NCT03281629|76264087|FG001|COMPLETED|Overall Study||10||
60140984|NCT03281629|76264086|FG000|NOT COMPLETED|Overall Study||2||
60140985|NCT03281629|76264087|FG001|NOT COMPLETED|Overall Study||2||
60140986|NCT00218543|76264093|FG000|STARTED|Overall Study||20||
60140987|NCT00218543|76264093|FG000|COMPLETED|Overall Study|13 reached the maintenance dose phase of treatment; 9 completed at least six weeks of treatment.|5||
60140988|NCT00218543|76264093|FG000|NOT COMPLETED|Overall Study||15||
60140989|NCT00910845|76264099|FG000|STARTED|Treatment Cycle 1||280||
60140990|NCT00910845|76264100|FG001|STARTED|Treatment Cycle 1||277||
60140991|NCT00910845|76264099|FG000|COMPLETED|Treatment Cycle 1||249||
60140992|NCT00910845|76264100|FG001|COMPLETED|Treatment Cycle 1||243||
60140993|NCT00910845|76264099|FG000|NOT COMPLETED|Treatment Cycle 1||31||
60140994|NCT00910845|76264100|FG001|NOT COMPLETED|Treatment Cycle 1||34||
60140995|NCT00910845|76264099|FG000|STARTED|Treatment Cycle 2|Not all participants who completed Treatment Cycle 1 went onto Treatment Cycle 2|141||
60140996|NCT00910845|76264100|FG001|STARTED|Treatment Cycle 2|Not all participants who completed Treatment Cycle 1 went onto Treatment Cycle 2|212||
60140997|NCT00910845|76264099|FG000|COMPLETED|Treatment Cycle 2||136||
60140998|NCT00910845|76264100|FG001|COMPLETED|Treatment Cycle 2||203||
60140999|NCT00910845|76264099|FG000|NOT COMPLETED|Treatment Cycle 2||5||
60141000|NCT00910845|76264100|FG001|NOT COMPLETED|Treatment Cycle 2||9||
60141001|NCT00216671|76264108|FG000|STARTED|Overall Study||110||
60141002|NCT00216671|76264109|FG001|STARTED|Overall Study||110||
60141003|NCT00216671|76264108|FG000|COMPLETED|Overall Study||75||
60141004|NCT00216671|76264109|FG001|COMPLETED|Overall Study||60||
60141005|NCT00216671|76264108|FG000|NOT COMPLETED|Overall Study||35||
60141006|NCT00216671|76264109|FG001|NOT COMPLETED|Overall Study||50||
60141007|NCT00216203|76264115|FG000|STARTED|Overall Study||36||
60141008|NCT00216203|76264115|FG000|COMPLETED|Overall Study||34||
60141009|NCT00216203|76264115|FG000|NOT COMPLETED|Overall Study||2||
60141010|NCT04474704|76264122|FG000|STARTED|Overall Study||21||
60141011|NCT04474704|76264123|FG001|STARTED|Overall Study||26||
60141012|NCT04474704|76264122|FG000|COMPLETED|Overall Study||21||
60141013|NCT04474704|76264123|FG001|COMPLETED|Overall Study||26||
60141014|NCT04474704|76264122|FG000|NOT COMPLETED|Overall Study||0||
60141015|NCT04474704|76264123|FG001|NOT COMPLETED|Overall Study||0||
60141016|NCT00904995|76264131|FG000|STARTED|Overall Study||10||
60141017|NCT00904995|76264132|FG001|STARTED|Overall Study||11||
60141018|NCT00904995|76264131|FG000|COMPLETED|Overall Study||10||
60141019|NCT00904995|76264132|FG001|COMPLETED|Overall Study||11||
60141020|NCT00904995|76264131|FG000|NOT COMPLETED|Overall Study||0||
60141021|NCT00904995|76264132|FG001|NOT COMPLETED|Overall Study||0||
60141022|NCT02488135|76264140|FG000|STARTED|Overall Study||13||
60141023|NCT02488135|76264141|FG001|STARTED|Overall Study||13||
60141024|NCT02488135|76264140|FG000|COMPLETED|Overall Study||13||
60141025|NCT02488135|76264141|FG001|COMPLETED|Overall Study||13||
60141026|NCT02488135|76264140|FG000|NOT COMPLETED|Overall Study||0||
60141027|NCT02488135|76264141|FG001|NOT COMPLETED|Overall Study||0||
60141028|NCT02644668|76264150|FG000|STARTED|Overall Study||26||
60141029|NCT02644668|76264151|FG001|STARTED|Overall Study||24||
60141030|NCT02644668|76264152|FG002|STARTED|Overall Study||20||
60141031|NCT02644668|76264150|FG000|COMPLETED|Overall Study||24||
60141032|NCT02644668|76264151|FG001|COMPLETED|Overall Study||24||
60141033|NCT02644668|76264152|FG002|COMPLETED|Overall Study||17||
60141034|NCT02644668|76264150|FG000|NOT COMPLETED|Overall Study||2||
60141035|NCT02644668|76264151|FG001|NOT COMPLETED|Overall Study||0||
60141036|NCT02644668|76264152|FG002|NOT COMPLETED|Overall Study||3||
60141037|NCT00912795|76264164|FG000|STARTED|Overall Study||76||
60141038|NCT00912795|76264165|FG001|STARTED|Overall Study||75||
60141039|NCT00912795|76264164|FG000|COMPLETED|Overall Study||29||
60141040|NCT00912795|76264165|FG001|COMPLETED|Overall Study||17||
60141041|NCT00912795|76264164|FG000|NOT COMPLETED|Overall Study||47||
60141042|NCT00912795|76264165|FG001|NOT COMPLETED|Overall Study||58||
60141043|NCT02644356|76264171|FG000|STARTED|Overall Study||51||
60141044|NCT02644356|76264171|FG000|COMPLETED|Overall Study|49 of the 51 consented subjects completed pre-post knowledge testing (96%)|49||
60141045|NCT02644356|76264171|FG000|NOT COMPLETED|Overall Study||2||
60141046|NCT03179995|76264177|FG000|STARTED|Overall Study||20||
60141047|NCT03179995|76264178|FG001|STARTED|Overall Study||4||
60141048|NCT03179995|76264177|FG000|COMPLETED|Overall Study||4||
60141049|NCT03179995|76264178|FG001|COMPLETED|Overall Study||1||
60141050|NCT03179995|76264177|FG000|NOT COMPLETED|Overall Study||16||
60141051|NCT03179995|76264178|FG001|NOT COMPLETED|Overall Study||3||
60141052|NCT00905151|76264184|FG000|STARTED|Overall Study||206||
60141053|NCT00905151|76264184|FG000|COMPLETED|Overall Study||200||
60141054|NCT00905151|76264184|FG000|NOT COMPLETED|Overall Study||6||
60141055|NCT00906165|76264190|FG000|STARTED|Overall Study||14||
60141056|NCT00906165|76264191|FG001|STARTED|Overall Study||14||
60141057|NCT00906165|76264190|FG000|COMPLETED|Overall Study||10||
60141058|NCT00906165|76264191|FG001|COMPLETED|Overall Study||14||
60141059|NCT00906165|76264190|FG000|NOT COMPLETED|Overall Study||4||
60141060|NCT00906165|76264191|FG001|NOT COMPLETED|Overall Study||0||
60141061|NCT00912873|76264199|FG000|STARTED|Overall Study||26||
60141062|NCT00912873|76264200|FG001|STARTED|Overall Study||24||
60141063|NCT00912873|76264199|FG000|COMPLETED|Overall Study||26||
60141064|NCT00912873|76264200|FG001|COMPLETED|Overall Study||24||
60141065|NCT00912873|76264199|FG000|NOT COMPLETED|Overall Study||0||
60141066|NCT00912873|76264200|FG001|NOT COMPLETED|Overall Study||0||
60141067|NCT01494038|76264212|FG000|STARTED|Overall Study||477||
60141068|NCT01494038|76264213|FG001|STARTED|Overall Study||479||
60141069|NCT01494038|76264212|FG000|COMPLETED|Overall Study||389||
60141070|NCT01494038|76264213|FG001|COMPLETED|Overall Study||396||
60141071|NCT01494038|76264212|FG000|NOT COMPLETED|Overall Study||88||
60141072|NCT01494038|76264213|FG001|NOT COMPLETED|Overall Study||83||
60141073|NCT00915603|76264236|FG000|STARTED|Overall Study|One patient enrolled/randomized but did not start treatment|56||
60141074|NCT00915603|76264237|FG001|STARTED|Overall Study|One patient enrolled/randomized but did not start treatment|55||
60141075|NCT00915603|76264236|FG000|COMPLETED|Overall Study||0||
60141076|NCT00915603|76264237|FG001|COMPLETED|Overall Study||0||
59751408|NCT00652951|75870691|FG001|NOT COMPLETED|Booster Phase||1||
59751409|NCT00652951|75870692|FG002|NOT COMPLETED|Booster Phase||0||
59751410|NCT00848211|75870704|FG000|STARTED|Overall Study||6||
59751411|NCT00848211|75870705|FG001|STARTED|Overall Study||7||
59751412|NCT00848211|75870706|FG002|STARTED|Overall Study||6||
59751413|NCT00848211|75870707|FG003|STARTED|Overall Study||5||
59751414|NCT00848211|75870704|FG000|COMPLETED|Overall Study||6||
59751415|NCT00848211|75870705|FG001|COMPLETED|Overall Study||6||
59751416|NCT00848211|75870706|FG002|COMPLETED|Overall Study||5||
60141077|NCT00915603|76264236|FG000|NOT COMPLETED|Overall Study||56||
60141078|NCT00915603|76264237|FG001|NOT COMPLETED|Overall Study||55||
59751417|NCT00848211|75870707|FG003|COMPLETED|Overall Study||5||
59751418|NCT00848211|75870704|FG000|NOT COMPLETED|Overall Study||0||
59751419|NCT00848211|75870705|FG001|NOT COMPLETED|Overall Study||1||
59751420|NCT00848211|75870706|FG002|NOT COMPLETED|Overall Study||1||
60141079|NCT00906243|76264243|FG000|STARTED|Overall Study||6||
60141080|NCT00906243|76264243|FG000|COMPLETED|Overall Study||6||
60141081|NCT00906243|76264243|FG000|NOT COMPLETED|Overall Study||0||
60141082|NCT02640612|76264250|FG000|STARTED|Overall Study||225||
60141083|NCT02640612|76264251|FG001|STARTED|Overall Study||103||
60141084|NCT02640612|76264252|FG002|STARTED|Overall Study||102||
60141085|NCT02640612|76264250|FG000|COMPLETED|Overall Study||203||
60141086|NCT02640612|76264251|FG001|COMPLETED|Overall Study||89||
60141087|NCT02640612|76264252|FG002|COMPLETED|Overall Study||96||
60141088|NCT02640612|76264250|FG000|NOT COMPLETED|Overall Study||22||
60141089|NCT02640612|76264251|FG001|NOT COMPLETED|Overall Study||14||
60141090|NCT02640612|76264252|FG002|NOT COMPLETED|Overall Study||6||
60141091|NCT00639769|76264260|FG000|STARTED|Overall Study||40||
60141092|NCT00639769|76264260|FG000|COMPLETED|Overall Study||0||
60141093|NCT00639769|76264260|FG000|NOT COMPLETED|Overall Study||40||
60141094|NCT00639457|76264266|FG000|STARTED|Overall Study||22||
60141095|NCT00639457|76264267|FG001|STARTED|Overall Study||22||
60141096|NCT00639457|76264266|FG000|COMPLETED|Overall Study||20||
60141097|NCT00639457|76264267|FG001|COMPLETED|Overall Study||19||
60141098|NCT00639457|76264266|FG000|NOT COMPLETED|Overall Study||2||
60141099|NCT00639457|76264267|FG001|NOT COMPLETED|Overall Study||3||
60141100|NCT00639379|76264273|FG000|STARTED|Period 1 - 2 Weeks||44||
59751421|NCT00848211|75870707|FG003|NOT COMPLETED|Overall Study||0||
59751422|NCT00592683|75870719|FG000|STARTED|Overall Study||10||
60141101|NCT00639379|76264274|FG001|STARTED|Period 1 - 2 Weeks||45||
60141102|NCT00639379|76264273|FG000|COMPLETED|Period 1 - 2 Weeks||39||
60141103|NCT00639379|76264274|FG001|COMPLETED|Period 1 - 2 Weeks||45||
60141104|NCT00639379|76264273|FG000|NOT COMPLETED|Period 1 - 2 Weeks||5||
60141105|NCT00639379|76264274|FG001|NOT COMPLETED|Period 1 - 2 Weeks||0||
60141106|NCT00639379|76264273|FG000|STARTED|Period 2 - 2 Weeks||39||
60141107|NCT00639379|76264274|FG001|STARTED|Period 2 - 2 Weeks||45||
60010126|NCT04290039|76125813|FG000|NOT COMPLETED|Period 3 (Visit 3; Day 15)||0||
60010127|NCT04290039|76125814|FG001|NOT COMPLETED|Period 3 (Visit 3; Day 15)||0||
60010128|NCT04290039|76125815|FG002|NOT COMPLETED|Period 3 (Visit 3; Day 15)||0||
60010129|NCT04201574|76125827|FG000|STARTED|Overall Study||46||
60010130|NCT04201574|76125828|FG001|STARTED|Overall Study||46||
60010131|NCT04201574|76125829|FG002|STARTED|Overall Study||46||
60141108|NCT00639379|76264273|FG000|COMPLETED|Period 2 - 2 Weeks||39||
60141109|NCT00639379|76264274|FG001|COMPLETED|Period 2 - 2 Weeks||45||
60141110|NCT00639379|76264273|FG000|NOT COMPLETED|Period 2 - 2 Weeks||0||
60141111|NCT00639379|76264274|FG001|NOT COMPLETED|Period 2 - 2 Weeks||0||
60141112|NCT00639223|76264282|FG000|STARTED|Overall Study||22||
60141113|NCT00639223|76264283|FG001|STARTED|Overall Study||21||
60141114|NCT00639223|76264282|FG000|COMPLETED|Overall Study||22||
60141115|NCT00639223|76264283|FG001|COMPLETED|Overall Study||19||
60141116|NCT00639223|76264282|FG000|NOT COMPLETED|Overall Study||0||
60141117|NCT00639223|76264283|FG001|NOT COMPLETED|Overall Study||2||
60141118|NCT00638989|76264292|FG000|STARTED|Overall Study||10||
60141119|NCT00638989|76264293|FG001|STARTED|Overall Study||10||
60141120|NCT00638989|76264294|FG002|STARTED|Overall Study||10||
60141121|NCT00638989|76264292|FG000|COMPLETED|Overall Study||10||
60141122|NCT00638989|76264293|FG001|COMPLETED|Overall Study||10||
60141123|NCT00638989|76264294|FG002|COMPLETED|Overall Study||9||
60141124|NCT00638989|76264292|FG000|NOT COMPLETED|Overall Study||0||
60141125|NCT00638989|76264293|FG001|NOT COMPLETED|Overall Study||0||
60141126|NCT00638989|76264294|FG002|NOT COMPLETED|Overall Study||1||
60141127|NCT00913263|76264304|FG000|STARTED|Overall Study||24||
60141128|NCT00913263|76264304|FG000|COMPLETED|Overall Study||24||
60141129|NCT00913263|76264304|FG000|NOT COMPLETED|Overall Study||0||
60141130|NCT00637273|76264315|FG000|STARTED|Overall Study||170||
60141131|NCT00637273|76264316|FG001|STARTED|Overall Study||172||
60141132|NCT00637273|76264317|FG002|STARTED|Overall Study||172||
60141133|NCT00637273|76264315|FG000|Intent to Treat (ITT)|Overall Study||160||
60141134|NCT00637273|76264316|FG001|Intent to Treat (ITT)|Overall Study||166||
60141135|NCT00637273|76264317|FG002|Intent to Treat (ITT)|Overall Study||165||
60141136|NCT00637273|76264315|FG000|COMPLETED|Overall Study||127||
60141137|NCT00637273|76264316|FG001|COMPLETED|Overall Study||144||
60141138|NCT00637273|76264317|FG002|COMPLETED|Overall Study||131||
60141139|NCT00637273|76264315|FG000|NOT COMPLETED|Overall Study||43||
60141140|NCT00637273|76264316|FG001|NOT COMPLETED|Overall Study||28||
60141141|NCT00637273|76264317|FG002|NOT COMPLETED|Overall Study||41||
60141142|NCT00988351|76264327|FG000|STARTED|Overall Study||78||
60141143|NCT00988351|76264328|FG001|STARTED|Overall Study||78||
60141144|NCT00988351|76264327|FG000|CPAP Titration|Overall Study|8 declined CPAP treatment|78||
60141145|NCT00988351|76264328|FG001|CPAP Titration|Overall Study|no titration needed|78||
60141146|NCT00988351|76264327|FG000|PAP Setup|Overall Study|CPAP treatment started|70||
60141147|NCT00988351|76264328|FG001|PAP Setup|Overall Study|APAP treatment started|78||
60141148|NCT00988351|76264327|FG000|Clinic Visit|Overall Study|6 lost to follow-up or no show for clinic|64||
59605704|NCT01965600|75715854|FG003|STARTED|Washout Period of Approximately 15 Days||4||
59751423|NCT00592683|75870720|FG001|STARTED|Overall Study||10||
59751424|NCT00592683|75870719|FG000|COMPLETED|Overall Study||6||
59751425|NCT00592683|75870720|FG001|COMPLETED|Overall Study||6||
60010132|NCT04201574|76125827|FG000|COMPLETED|Overall Study||46||
60010133|NCT04201574|76125828|FG001|COMPLETED|Overall Study||46||
59751426|NCT00592683|75870719|FG000|NOT COMPLETED|Overall Study||4||
59751427|NCT00592683|75870720|FG001|NOT COMPLETED|Overall Study||4||
59751428|NCT00847665|75870728|FG000|STARTED|Overall Study||165||
60141149|NCT00988351|76264328|FG001|Clinic Visit|Overall Study|9 lost to follow-up or no show for clinic|69||
59751429|NCT00847665|75870729|FG001|STARTED|Overall Study||165||
59751430|NCT00847665|75870728|FG000|COMPLETED|Overall Study||164||
59751431|NCT00847665|75870729|FG001|COMPLETED|Overall Study||165||
59751432|NCT00847665|75870728|FG000|NOT COMPLETED|Overall Study||1||
59751433|NCT00847665|75870729|FG001|NOT COMPLETED|Overall Study||0||
59751434|NCT00916370|75870737|FG000|STARTED|Overall Study||401||
59751435|NCT00916370|75870738|FG001|STARTED|Overall Study||104||
59751436|NCT00916370|75870737|FG000|COMPLETED|Overall Study||396||
59751437|NCT00916370|75870738|FG001|COMPLETED|Overall Study||102||
59751438|NCT00916370|75870737|FG000|NOT COMPLETED|Overall Study||5||
60010134|NCT04201574|76125829|FG002|COMPLETED|Overall Study||46||
60010135|NCT04201574|76125827|FG000|NOT COMPLETED|Overall Study||0||
60010136|NCT04201574|76125828|FG001|NOT COMPLETED|Overall Study||0||
60141150|NCT00988351|76264327|FG000|Using CPAP or APAP|Overall Study|5 not using CPAP (use < 1/2 hour per night)|59||
60141151|NCT00988351|76264328|FG001|Using CPAP or APAP|Overall Study|3 not using APAP (less than 1/2 hour per night)|66||
59751439|NCT00916370|75870738|FG001|NOT COMPLETED|Overall Study||2||
59751440|NCT00847197|75870747|FG000|STARTED|Overall Study||116||
59751441|NCT00847197|75870748|FG001|STARTED|Overall Study||75||
59751442|NCT00847197|75870747|FG000|COMPLETED|Overall Study||92||
60141152|NCT00988351|76264327|FG000|COMPLETED|Overall Study||59||
60141153|NCT00988351|76264328|FG001|COMPLETED|Overall Study||66||
60141154|NCT00988351|76264327|FG000|NOT COMPLETED|Overall Study||19||
60141155|NCT00988351|76264328|FG001|NOT COMPLETED|Overall Study||12||
60141156|NCT00988117|76264334|FG000|STARTED|4.6 mg/24 Hours From Baseline to Week 4||15||
60141157|NCT00988117|76264334|FG000|COMPLETED|4.6 mg/24 Hours From Baseline to Week 4||14||
60141158|NCT00988117|76264334|FG000|NOT COMPLETED|4.6 mg/24 Hours From Baseline to Week 4||1||
60141159|NCT00988117|76264334|FG000|STARTED|9.5 mg/24 Hours From Week 4 to 12||14||
60141160|NCT00988117|76264334|FG000|COMPLETED|9.5 mg/24 Hours From Week 4 to 12||12||
60141161|NCT00988117|76264334|FG000|NOT COMPLETED|9.5 mg/24 Hours From Week 4 to 12||2||
60141162|NCT00637195|76264341|FG000|STARTED|Overall Study||76||
60141163|NCT00637195|76264342|FG001|STARTED|Overall Study||76||
60141164|NCT00637195|76264341|FG000|COMPLETED|Overall Study||73||
60141165|NCT00637195|76264342|FG001|COMPLETED|Overall Study||75||
60141166|NCT00637195|76264341|FG000|NOT COMPLETED|Overall Study||3||
60141167|NCT00637195|76264342|FG001|NOT COMPLETED|Overall Study||1||
60141168|NCT00915759|76264348|FG000|STARTED|Overall Study|number of participants|40||
60141169|NCT00915759|76264348|FG000|COMPLETED|Overall Study|number of participants|40||
60141170|NCT00915759|76264348|FG000|NOT COMPLETED|Overall Study||0||
60141171|NCT00636961|76264360|FG000|STARTED|Period 1||14||
60141172|NCT00636961|76264361|FG001|STARTED|Period 1||13||
60141173|NCT00636961|76264360|FG000|COMPLETED|Period 1||13||
60141174|NCT00636961|76264361|FG001|COMPLETED|Period 1||12||
60141175|NCT00636961|76264360|FG000|NOT COMPLETED|Period 1||1||
60141176|NCT00636961|76264361|FG001|NOT COMPLETED|Period 1||1||
60141177|NCT00636961|76264360|FG000|STARTED|Period 2||13||
60141178|NCT00636961|76264361|FG001|STARTED|Period 2||12||
60141179|NCT00636961|76264360|FG000|COMPLETED|Period 2||12||
60141180|NCT00636961|76264361|FG001|COMPLETED|Period 2||12||
60141181|NCT00636961|76264360|FG000|NOT COMPLETED|Period 2||1||
60141182|NCT00636961|76264361|FG001|NOT COMPLETED|Period 2||0||
60141183|NCT04314648|76264369|FG000|STARTED|Overall Study||38||
60141184|NCT04314648|76264370|FG001|STARTED|Overall Study||50||
60141185|NCT04314648|76264369|FG000|COMPLETED|Overall Study||38||
60141186|NCT04314648|76264370|FG001|COMPLETED|Overall Study||50||
60141187|NCT04314648|76264369|FG000|NOT COMPLETED|Overall Study||0||
60141188|NCT04314648|76264370|FG001|NOT COMPLETED|Overall Study||0||
59751443|NCT00847197|75870748|FG001|COMPLETED|Overall Study||70||
60141189|NCT00635089|76264376|FG000|STARTED|Overall Study||190||
60141190|NCT00635089|76264376|FG000|Completed >/= 16 Weeks of Study|Overall Study||181||
60141191|NCT00635089|76264376|FG000|COMPLETED|Overall Study|Participants who had not withdrawn at the time of study termination.|112||
60141192|NCT00635089|76264376|FG000|NOT COMPLETED|Overall Study||78||
60141193|NCT01493414|76264393|FG000|STARTED|Overall Study||2233||
60141194|NCT01493414|76264393|FG000|COMPLETED|Overall Study||1283||
60141195|NCT01493414|76264393|FG000|NOT COMPLETED|Overall Study||950||
60141196|NCT00634543|76264403|FG000|STARTED|Overall Study||78||
60141197|NCT00634543|76264404|FG001|STARTED|Overall Study||84||
60141198|NCT00634543|76264403|FG000|Treated|Overall Study||76||
60141199|NCT00634543|76264404|FG001|Treated|Overall Study||80||
60141200|NCT00634543|76264403|FG000|COMPLETED|Overall Study||59||
60141201|NCT00634543|76264404|FG001|COMPLETED|Overall Study||63||
60141202|NCT00634543|76264403|FG000|NOT COMPLETED|Overall Study||19||
60141203|NCT00634543|76264404|FG001|NOT COMPLETED|Overall Study||21||
60141204|NCT00985465|76264412|FG000|STARTED|Overall Study||141||
60141205|NCT00985465|76264413|FG001|STARTED|Overall Study||69||
59751444|NCT00847197|75870747|FG000|NOT COMPLETED|Overall Study||24||
59751445|NCT00847197|75870748|FG001|NOT COMPLETED|Overall Study||5||
60141206|NCT00985465|76264412|FG000|COMPLETED|Overall Study||140||
60141207|NCT00985465|76264413|FG001|COMPLETED|Overall Study||66||
60141208|NCT00985465|76264412|FG000|NOT COMPLETED|Overall Study||1||
60141209|NCT00985465|76264413|FG001|NOT COMPLETED|Overall Study||3||
60141210|NCT01049919|76264422|FG000|STARTED|Overall Study||117||119
60141211|NCT01049919|76264423|FG001|STARTED|Overall Study|One participant is counted in both treatment groups due to one leg being randomized to each group.|36||36
60141212|NCT01049919|76264422|FG000|COMPLETED|Overall Study||65||67
60141213|NCT01049919|76264423|FG001|COMPLETED|Overall Study|Incl. 11 participants that received crossover treatment after completing 52 week primary follow up.|19||19
60141214|NCT01049919|76264422|FG000|NOT COMPLETED|Overall Study||52||52
60141215|NCT01049919|76264423|FG001|NOT COMPLETED|Overall Study||17||17
60141216|NCT01049373|76264431|FG000|STARTED|Overall Study||112||
60141217|NCT01049373|76264432|FG001|STARTED|Overall Study||109||
60141218|NCT01049373|76264431|FG000|COMPLETED|Overall Study||73||
59751446|NCT00654901|75870758|FG000|STARTED|Overall Study||254||
59751447|NCT00654901|75870759|FG001|STARTED|Overall Study||262||
59751448|NCT00654901|75870760|FG002|STARTED|Overall Study||252||
59751449|NCT00654901|75870761|FG003|STARTED|Overall Study||113||
60141219|NCT01049373|76264432|FG001|COMPLETED|Overall Study||65||
60141220|NCT01049373|76264431|FG000|NOT COMPLETED|Overall Study||39||
60141221|NCT01049373|76264432|FG001|NOT COMPLETED|Overall Study||44||
60141222|NCT00985231|76264442|FG000|STARTED|Overall Study||133||
60141223|NCT00985231|76264443|FG001|STARTED|Overall Study||132||
60141224|NCT00985231|76264442|FG000|COMPLETED|Overall Study||130||
60141225|NCT00985231|76264443|FG001|COMPLETED|Overall Study||129||
60141226|NCT00985231|76264442|FG000|NOT COMPLETED|Overall Study||3||
60141227|NCT00985231|76264443|FG001|NOT COMPLETED|Overall Study||3||
60141228|NCT00917865|76264449|FG000|STARTED|Overall Study||11||
60141229|NCT00917865|76264449|FG000|COMPLETED|Overall Study||11||
60141230|NCT00917865|76264449|FG000|NOT COMPLETED|Overall Study||0||
60141231|NCT01048671|76264463|FG000|STARTED|Overall Study||66||
60141232|NCT01048671|76264464|FG001|STARTED|Overall Study||264||
60141233|NCT01048671|76264465|FG002|STARTED|Overall Study||152||
60141234|NCT01048671|76264463|FG000|COMPLETED|Overall Study||66||
60141235|NCT01048671|76264464|FG001|COMPLETED|Overall Study||263||
60141236|NCT01048671|76264465|FG002|COMPLETED|Overall Study||151||
60141237|NCT01048671|76264463|FG000|NOT COMPLETED|Overall Study||0||
60141238|NCT01048671|76264464|FG001|NOT COMPLETED|Overall Study||1||
60141239|NCT01048671|76264465|FG002|NOT COMPLETED|Overall Study||1||
60141240|NCT01360866|76264477|FG000|STARTED|Overall Study||516||
60141241|NCT01360866|76264478|FG001|STARTED|Overall Study||707||
60141242|NCT01360866|76264479|FG002|STARTED|Overall Study||1645||
60141243|NCT01360866|76264480|FG003|STARTED|Overall Study||76||
60141244|NCT01360866|76264477|FG000|COMPLETED|Overall Study||295||
60141245|NCT01360866|76264478|FG001|COMPLETED|Overall Study||420||
60141246|NCT01360866|76264479|FG002|COMPLETED|Overall Study||1126||
60141247|NCT01360866|76264480|FG003|COMPLETED|Overall Study||54||
60141248|NCT01360866|76264477|FG000|NOT COMPLETED|Overall Study||221||
60141249|NCT01360866|76264478|FG001|NOT COMPLETED|Overall Study||287||
60141250|NCT01360866|76264479|FG002|NOT COMPLETED|Overall Study||519||
60141251|NCT01360866|76264480|FG003|NOT COMPLETED|Overall Study||22||
60141252|NCT00985153|76264494|FG000|STARTED|Overall Study||985||
60141253|NCT00985153|76264495|FG001|STARTED|Overall Study||968||
60141254|NCT00985153|76264496|FG002|STARTED|Overall Study||962||
60141255|NCT00985153|76264497|FG003|STARTED|Overall Study||1012||
60141256|NCT00985153|76264494|FG000|Vaccinated at Visit 1|Overall Study||985||
60141257|NCT00985153|76264495|FG001|Vaccinated at Visit 1|Overall Study||968||
60141258|NCT00985153|76264496|FG002|Vaccinated at Visit 1|Overall Study||962||
60141259|NCT00985153|76264497|FG003|Vaccinated at Visit 1|Overall Study||1012||
60141260|NCT00985153|76264494|FG000|COMPLETED|Overall Study||950||
60141261|NCT00985153|76264495|FG001|COMPLETED|Overall Study||924||
60141262|NCT00985153|76264496|FG002|COMPLETED|Overall Study||918||
60141263|NCT00985153|76264497|FG003|COMPLETED|Overall Study||965||
60141264|NCT00985153|76264494|FG000|NOT COMPLETED|Overall Study||35||
60141265|NCT00985153|76264495|FG001|NOT COMPLETED|Overall Study||44||
60141266|NCT00985153|76264496|FG002|NOT COMPLETED|Overall Study||44||
60141267|NCT00985153|76264497|FG003|NOT COMPLETED|Overall Study||47||
60141268|NCT01047345|76264509|FG000|STARTED|Base Study||618||
60141269|NCT01047345|76264510|FG001|STARTED|Base Study||306||
60141270|NCT01047345|76264511|FG002|STARTED|Base Study||0||
60141271|NCT01047345|76264509|FG000|Vaccination 1|Base Study||615||
60141272|NCT01047345|76264510|FG001|Vaccination 1|Base Study||306||
60141273|NCT01047345|76264511|FG002|Vaccination 1|Base Study||0||
60141274|NCT01047345|76264509|FG000|Vaccination 2|Base Study||604||
60141275|NCT01047345|76264510|FG001|Vaccination 2|Base Study||304||
60141276|NCT01047345|76264511|FG002|Vaccination 2|Base Study||0||
60141277|NCT01047345|76264509|FG000|Vaccination 3|Base Study||597||
60141278|NCT01047345|76264510|FG001|Vaccination 3|Base Study||300||
60141279|NCT01047345|76264511|FG002|Vaccination 3|Base Study||0||
60141280|NCT01047345|76264509|FG000|COMPLETED|Base Study|Includes 1 participant for whom completion status is unknown|596||
60141281|NCT01047345|76264510|FG001|COMPLETED|Base Study||300||
60141282|NCT01047345|76264511|FG002|COMPLETED|Base Study||0||
60141283|NCT01047345|76264509|FG000|NOT COMPLETED|Base Study||22||
60141284|NCT01047345|76264510|FG001|NOT COMPLETED|Base Study||6||
60141285|NCT01047345|76264511|FG002|NOT COMPLETED|Base Study||0||
60141286|NCT01047345|76264509|FG000|STARTED|Extension||0||
60141287|NCT01047345|76264510|FG001|STARTED|Extension||0||
60141288|NCT01047345|76264511|FG002|STARTED|Extension|Not all eligible participants elected to participate in extension|102||
60141289|NCT01047345|76264509|FG000|Vaccination 4|Extension||0||
60141290|NCT01047345|76264510|FG001|Vaccination 4|Extension||0||
60141291|NCT01047345|76264511|FG002|Vaccination 4|Extension||102||
60141292|NCT01047345|76264509|FG000|Vaccination 5|Extension||0||
60141293|NCT01047345|76264510|FG001|Vaccination 5|Extension||0||
60141294|NCT01047345|76264511|FG002|Vaccination 5|Extension||99||
60141295|NCT01047345|76264509|FG000|Vaccination 6|Extension||0||
60141296|NCT01047345|76264510|FG001|Vaccination 6|Extension||0||
60141297|NCT01047345|76264511|FG002|Vaccination 6|Extension|1 participant received 6th vaccination outside the context of study but completed the study.|95||
60141298|NCT01047345|76264509|FG000|COMPLETED|Extension||0||
60141299|NCT01047345|76264510|FG001|COMPLETED|Extension||0||
60141300|NCT01047345|76264511|FG002|COMPLETED|Extension||96||
60141301|NCT01047345|76264509|FG000|NOT COMPLETED|Extension||0||
60141302|NCT01047345|76264510|FG001|NOT COMPLETED|Extension||0||
60141303|NCT01047345|76264511|FG002|NOT COMPLETED|Extension||6||
60141304|NCT01046877|76264519|FG000|STARTED|Overall Study||25||
60141305|NCT01046877|76264519|FG000|Completed on Schedule|Overall Study|Final visit = the earlier of 24 months post-procedure or 12 months after extrusion.|6||
60141306|NCT01046877|76264519|FG000|Completed Study Late|Overall Study|One completed (evidencing extrusions) at 23.5 mos. Missed 9 mo visit. Exam not possible at 12 mo.|1||
60141307|NCT01046877|76264519|FG000|COMPLETED|Overall Study||7||
60141308|NCT01046877|76264519|FG000|NOT COMPLETED|Overall Study||18||
60141309|NCT00984061|76264523|FG000|STARTED|Colchicine Alone||24||
60141310|NCT00984061|76264523|FG000|COMPLETED|Colchicine Alone||24||
60141311|NCT00984061|76264523|FG000|NOT COMPLETED|Colchicine Alone||0||
60141312|NCT00984061|76264523|FG000|STARTED|21 Day Washout Period||24||
60141313|NCT00984061|76264523|FG000|COMPLETED|21 Day Washout Period||24||
60141314|NCT00984061|76264523|FG000|NOT COMPLETED|21 Day Washout Period||0||
60141315|NCT00984061|76264523|FG000|STARTED|Clarithromycin Alone||24||
60141316|NCT00984061|76264523|FG000|COMPLETED|Clarithromycin Alone|One subject was dropped due to noncompliance with outpatient clarithromycin regimen.|23||
60141317|NCT00984061|76264523|FG000|NOT COMPLETED|Clarithromycin Alone||1||
60141318|NCT00984061|76264523|FG000|STARTED|Colchicine With Clarithromycin||23||
60141319|NCT00984061|76264523|FG000|COMPLETED|Colchicine With Clarithromycin||23||
60141320|NCT00984061|76264523|FG000|NOT COMPLETED|Colchicine With Clarithromycin||0||
60141321|NCT01046643|76264532|FG000|STARTED|First Period Treatment or Placebo||9||
60141322|NCT01046643|76264533|FG001|STARTED|First Period Treatment or Placebo||7||
60141323|NCT01046643|76264534|FG002|STARTED|First Period Treatment or Placebo||7||
60141324|NCT01046643|76264535|FG003|STARTED|First Period Treatment or Placebo||7||
60141325|NCT01046643|76264532|FG000|COMPLETED|First Period Treatment or Placebo||9||
60141326|NCT01046643|76264533|FG001|COMPLETED|First Period Treatment or Placebo||6||
60141327|NCT01046643|76264534|FG002|COMPLETED|First Period Treatment or Placebo||7||
60141328|NCT01046643|76264535|FG003|COMPLETED|First Period Treatment or Placebo||7||
60141329|NCT01046643|76264532|FG000|NOT COMPLETED|First Period Treatment or Placebo||0||
60141330|NCT01046643|76264533|FG001|NOT COMPLETED|First Period Treatment or Placebo||1||
60141331|NCT01046643|76264534|FG002|NOT COMPLETED|First Period Treatment or Placebo||0||
60141332|NCT01046643|76264535|FG003|NOT COMPLETED|First Period Treatment or Placebo||0||
60141333|NCT01046643|76264532|FG000|STARTED|Washout Period||9||
60141334|NCT01046643|76264533|FG001|STARTED|Washout Period||6||
60141335|NCT01046643|76264534|FG002|STARTED|Washout Period||7||
60141336|NCT01046643|76264535|FG003|STARTED|Washout Period||7||
60141337|NCT01046643|76264532|FG000|COMPLETED|Washout Period||9||
60141338|NCT01046643|76264533|FG001|COMPLETED|Washout Period||6||
60141339|NCT01046643|76264534|FG002|COMPLETED|Washout Period||7||
60141340|NCT01046643|76264535|FG003|COMPLETED|Washout Period||7||
60141341|NCT01046643|76264532|FG000|NOT COMPLETED|Washout Period||0||
60141342|NCT01046643|76264533|FG001|NOT COMPLETED|Washout Period||0||
60141343|NCT01046643|76264534|FG002|NOT COMPLETED|Washout Period||0||
60141344|NCT01046643|76264535|FG003|NOT COMPLETED|Washout Period||0||
60141345|NCT01046643|76264532|FG000|STARTED|Second Period Treatment or Placebo||9||
60141346|NCT01046643|76264533|FG001|STARTED|Second Period Treatment or Placebo||6||
60141347|NCT01046643|76264534|FG002|STARTED|Second Period Treatment or Placebo||7||
60141348|NCT01046643|76264535|FG003|STARTED|Second Period Treatment or Placebo||7||
60141349|NCT01046643|76264532|FG000|COMPLETED|Second Period Treatment or Placebo||9||
60141350|NCT01046643|76264533|FG001|COMPLETED|Second Period Treatment or Placebo||6||
60141351|NCT01046643|76264534|FG002|COMPLETED|Second Period Treatment or Placebo||7||
60141352|NCT01046643|76264535|FG003|COMPLETED|Second Period Treatment or Placebo||7||
60141353|NCT01046643|76264532|FG000|NOT COMPLETED|Second Period Treatment or Placebo||0||
60141354|NCT01046643|76264533|FG001|NOT COMPLETED|Second Period Treatment or Placebo||0||
60141355|NCT01046643|76264534|FG002|NOT COMPLETED|Second Period Treatment or Placebo||0||
60141356|NCT01046643|76264535|FG003|NOT COMPLETED|Second Period Treatment or Placebo||0||
60141357|NCT00983905|76264545|FG000|STARTED|Theophylline Alone||30||
60141358|NCT00983905|76264545|FG000|COMPLETED|Theophylline Alone|withdrawn by sponsor due to vomiting(1)|29||
60141359|NCT00983905|76264545|FG000|NOT COMPLETED|Theophylline Alone||1||
60141360|NCT00983905|76264545|FG000|STARTED|4 Day Washout Period||29||
60141361|NCT00983905|76264545|FG000|COMPLETED|4 Day Washout Period||29||
60141362|NCT00983905|76264545|FG000|NOT COMPLETED|4 Day Washout Period||0||
60141363|NCT00983905|76264545|FG000|STARTED|Colchicine Alone||29||
59518900|NCT03537664|75612775|FG000|COMPLETED|Overall Study||20||
59518901|NCT03537664|75612776|FG001|COMPLETED|Overall Study||25||
60141364|NCT00983905|76264545|FG000|COMPLETED|Colchicine Alone|withdrawn by sponsor due to: diarrhea(1); vomiting and diarrhea(1)|27||
60141365|NCT00983905|76264545|FG000|NOT COMPLETED|Colchicine Alone||2||
60141366|NCT00983905|76264545|FG000|STARTED|Theophylline With Colchicine||27||
60141367|NCT00983905|76264545|FG000|COMPLETED|Theophylline With Colchicine||27||
60141368|NCT00983905|76264545|FG000|NOT COMPLETED|Theophylline With Colchicine||0||
60141369|NCT01046565|76264552|FG000|STARTED|Overall Study||75||
60141370|NCT01046565|76264552|FG000|COMPLETED|Overall Study||66||
60141371|NCT01046565|76264552|FG000|NOT COMPLETED|Overall Study||9||
60141372|NCT00983827|76264561|FG000|STARTED|Overall Study||8||
60141373|NCT00983827|76264561|FG000|COMPLETED|Overall Study||7||
60141374|NCT00983827|76264561|FG000|NOT COMPLETED|Overall Study||1||
60141375|NCT00983749|76264567|FG000|STARTED|Acute Phase (Enrollment to Hospital DC)||13||
60141376|NCT00983749|76264568|FG001|STARTED|Acute Phase (Enrollment to Hospital DC)||10||
60141377|NCT00983749|76264567|FG000|COMPLETED|Acute Phase (Enrollment to Hospital DC)||13||
60141378|NCT00983749|76264568|FG001|COMPLETED|Acute Phase (Enrollment to Hospital DC)||10||
60141379|NCT00983749|76264567|FG000|NOT COMPLETED|Acute Phase (Enrollment to Hospital DC)||0||
60141380|NCT00983749|76264568|FG001|NOT COMPLETED|Acute Phase (Enrollment to Hospital DC)||0||
60141381|NCT00983749|76264567|FG000|STARTED|Follow-up Phase (Hospital DC to 30 Days)||13||
59751450|NCT00654901|75870758|FG000|COMPLETED|Overall Study||250||
60141382|NCT00983749|76264568|FG001|STARTED|Follow-up Phase (Hospital DC to 30 Days)||10||
60141383|NCT00983749|76264567|FG000|COMPLETED|Follow-up Phase (Hospital DC to 30 Days)||12||
60141384|NCT00983749|76264568|FG001|COMPLETED|Follow-up Phase (Hospital DC to 30 Days)||7||
60141385|NCT00983749|76264567|FG000|NOT COMPLETED|Follow-up Phase (Hospital DC to 30 Days)||1||
60141386|NCT00983749|76264568|FG001|NOT COMPLETED|Follow-up Phase (Hospital DC to 30 Days)||3||
60141387|NCT01046253|76264576|FG000|STARTED|First Intervention||25||
60141388|NCT01046253|76264577|FG001|STARTED|First Intervention||25||
60141389|NCT01046253|76264576|FG000|COMPLETED|First Intervention||25||
60141390|NCT01046253|76264577|FG001|COMPLETED|First Intervention||25||
60141391|NCT01046253|76264576|FG000|NOT COMPLETED|First Intervention||0||
60141392|NCT01046253|76264577|FG001|NOT COMPLETED|First Intervention||0||
60141393|NCT01046253|76264576|FG000|STARTED|First Washout of 7 Days||25||
60141394|NCT01046253|76264577|FG001|STARTED|First Washout of 7 Days||25||
60141395|NCT01046253|76264576|FG000|COMPLETED|First Washout of 7 Days||25||
60141396|NCT01046253|76264577|FG001|COMPLETED|First Washout of 7 Days||25||
60141397|NCT01046253|76264576|FG000|NOT COMPLETED|First Washout of 7 Days||0||
60141398|NCT01046253|76264577|FG001|NOT COMPLETED|First Washout of 7 Days||0||
60141399|NCT01046253|76264576|FG000|STARTED|Second Intervention||25||
60141400|NCT01046253|76264577|FG001|STARTED|Second Intervention||25||
60141401|NCT01046253|76264576|FG000|COMPLETED|Second Intervention||25||
60141402|NCT01046253|76264577|FG001|COMPLETED|Second Intervention||23||
60141403|NCT01046253|76264576|FG000|NOT COMPLETED|Second Intervention||0||
60141404|NCT01046253|76264577|FG001|NOT COMPLETED|Second Intervention||2||
60141405|NCT01046253|76264576|FG000|STARTED|Second Washout of 7 Days||25||
60141406|NCT01046253|76264577|FG001|STARTED|Second Washout of 7 Days||23||
60141407|NCT01046253|76264576|FG000|COMPLETED|Second Washout of 7 Days||25||
60141408|NCT01046253|76264577|FG001|COMPLETED|Second Washout of 7 Days||23||
60141409|NCT01046253|76264576|FG000|NOT COMPLETED|Second Washout of 7 Days||0||
60141410|NCT01046253|76264577|FG001|NOT COMPLETED|Second Washout of 7 Days||0||
60141411|NCT01046253|76264576|FG000|STARTED|Third Intervention||25||
60141412|NCT01046253|76264577|FG001|STARTED|Third Intervention||23||
60141413|NCT01046253|76264576|FG000|COMPLETED|Third Intervention||25||
60141414|NCT01046253|76264577|FG001|COMPLETED|Third Intervention||23||
60141415|NCT01046253|76264576|FG000|NOT COMPLETED|Third Intervention||0||
60141416|NCT01046253|76264577|FG001|NOT COMPLETED|Third Intervention||0||
59751451|NCT00654901|75870759|FG001|COMPLETED|Overall Study||262||
60141417|NCT01046253|76264576|FG000|STARTED|Third Washout of 7 Days||25||
60141418|NCT01046253|76264577|FG001|STARTED|Third Washout of 7 Days||23||
60141419|NCT01046253|76264576|FG000|COMPLETED|Third Washout of 7 Days||25||
60141420|NCT01046253|76264577|FG001|COMPLETED|Third Washout of 7 Days||23||
60141421|NCT01046253|76264576|FG000|NOT COMPLETED|Third Washout of 7 Days||0||
60141422|NCT01046253|76264577|FG001|NOT COMPLETED|Third Washout of 7 Days||0||
60141423|NCT01046253|76264576|FG000|STARTED|Fourth Intervention||25||
60141424|NCT01046253|76264577|FG001|STARTED|Fourth Intervention||23||
60141425|NCT01046253|76264576|FG000|COMPLETED|Fourth Intervention||25||
60141426|NCT01046253|76264577|FG001|COMPLETED|Fourth Intervention||23||
60141427|NCT01046253|76264576|FG000|NOT COMPLETED|Fourth Intervention||0||
60141428|NCT01046253|76264577|FG001|NOT COMPLETED|Fourth Intervention||0||
60141429|NCT00983515|76264583|FG000|STARTED|Colchicine Alone||24||
59751452|NCT00654901|75870760|FG002|COMPLETED|Overall Study||250||
59751453|NCT00654901|75870761|FG003|COMPLETED|Overall Study||113||
59751454|NCT00654901|75870758|FG000|NOT COMPLETED|Overall Study||4||
60141430|NCT00983515|76264583|FG000|COMPLETED|Colchicine Alone||24||
60141431|NCT00983515|76264583|FG000|NOT COMPLETED|Colchicine Alone||0||
60141432|NCT00983515|76264583|FG000|STARTED|14 Day Washout Period||24||
60141433|NCT00983515|76264583|FG000|COMPLETED|14 Day Washout Period||24||
60141434|NCT00983515|76264583|FG000|NOT COMPLETED|14 Day Washout Period||0||
60141435|NCT00983515|76264583|FG000|STARTED|Ritonavir Alone||24||
60141436|NCT00983515|76264583|FG000|COMPLETED|Ritonavir Alone||18||
60141437|NCT00983515|76264583|FG000|NOT COMPLETED|Ritonavir Alone||6||
60141438|NCT00983515|76264583|FG000|STARTED|Colchicine With Ritonavir||18||
60141439|NCT00983515|76264583|FG000|COMPLETED|Colchicine With Ritonavir|pharmacokinetic data included since parameters could be estimated for both dosing conditions|17||
60141440|NCT00983515|76264583|FG000|NOT COMPLETED|Colchicine With Ritonavir||1||
60141441|NCT00982735|76264590|FG000|STARTED|Overall Study||987||
60141442|NCT00982735|76264590|FG000|COMPLETED|Overall Study||757||
60141443|NCT00982735|76264590|FG000|NOT COMPLETED|Overall Study||230||
60141444|NCT01361178|76264596|FG000|STARTED|Overall Study||122||
60141445|NCT01361178|76264597|FG001|STARTED|Overall Study||11||
60141446|NCT01361178|76264596|FG000|COMPLETED|Overall Study||109||
60141447|NCT01361178|76264597|FG001|COMPLETED|Overall Study||11||
60141448|NCT01361178|76264596|FG000|NOT COMPLETED|Overall Study||13||
60141449|NCT01361178|76264597|FG001|NOT COMPLETED|Overall Study||0||
60141450|NCT00981799|76264607|FG000|STARTED|Overall Study||6||
60141451|NCT00981799|76264608|FG001|STARTED|Overall Study||7||
60141452|NCT00981799|76264609|FG002|STARTED|Overall Study||10||
60141453|NCT00981799|76264610|FG003|STARTED|Overall Study||0||
60141454|NCT00981799|76264607|FG000|COMPLETED|Overall Study||5||
60141455|NCT00981799|76264608|FG001|COMPLETED|Overall Study||6||
60141456|NCT00981799|76264609|FG002|COMPLETED|Overall Study||10||
60141457|NCT00981799|76264610|FG003|COMPLETED|Overall Study||0||
60141458|NCT00981799|76264607|FG000|NOT COMPLETED|Overall Study||1||
60141459|NCT00981799|76264608|FG001|NOT COMPLETED|Overall Study||1||
60141460|NCT00981799|76264609|FG002|NOT COMPLETED|Overall Study||0||
60141461|NCT00981799|76264610|FG003|NOT COMPLETED|Overall Study||0||
60141462|NCT00981175|76264624|FG000|STARTED|Primary Dose Vaccination||101||
60141463|NCT00981175|76264625|FG001|STARTED|Primary Dose Vaccination||101||
60141464|NCT00981175|76264624|FG000|COMPLETED|Primary Dose Vaccination||98||
60141465|NCT00981175|76264625|FG001|COMPLETED|Primary Dose Vaccination||99||
60141466|NCT00981175|76264624|FG000|NOT COMPLETED|Primary Dose Vaccination||3||
60141467|NCT00981175|76264625|FG001|NOT COMPLETED|Primary Dose Vaccination||2||
60141468|NCT00981175|76264624|FG000|STARTED|Booster Dose Vaccination|A sub-set of participants in the group received the booster ChimeriVax™-JE vaccine.|55||
60141469|NCT00981175|76264625|FG001|STARTED|Booster Dose Vaccination|A sub-set of participants in the group received the booster ChimeriVax™-JE vaccine.|43||
60141470|NCT00981175|76264624|FG000|COMPLETED|Booster Dose Vaccination||53||
60141471|NCT00981175|76264625|FG001|COMPLETED|Booster Dose Vaccination||40||
60141472|NCT00981175|76264624|FG000|NOT COMPLETED|Booster Dose Vaccination||2||
60141473|NCT00981175|76264625|FG001|NOT COMPLETED|Booster Dose Vaccination||3||
60141474|NCT00981019|76264638|FG000|STARTED|Overall Study||778||
60141475|NCT00981019|76264638|FG000|COMPLETED|Overall Study||301||
60141476|NCT00981019|76264638|FG000|NOT COMPLETED|Overall Study||477||
60141477|NCT01045161|76264645|FG000|STARTED|Part A - 12 Weeks Double Blind Treatment||182||
60141478|NCT01045161|76264646|FG001|STARTED|Part A - 12 Weeks Double Blind Treatment||184||
60141479|NCT01045161|76264647|FG002|STARTED|Part A - 12 Weeks Double Blind Treatment||178||
60141480|NCT01045161|76264645|FG000|COMPLETED|Part A - 12 Weeks Double Blind Treatment||151||
60141481|NCT01045161|76264646|FG001|COMPLETED|Part A - 12 Weeks Double Blind Treatment||155||
60141482|NCT01045161|76264647|FG002|COMPLETED|Part A - 12 Weeks Double Blind Treatment||148||
60141483|NCT01045161|76264645|FG000|NOT COMPLETED|Part A - 12 Weeks Double Blind Treatment||31||
60141484|NCT01045161|76264646|FG001|NOT COMPLETED|Part A - 12 Weeks Double Blind Treatment||29||
60141485|NCT01045161|76264647|FG002|NOT COMPLETED|Part A - 12 Weeks Double Blind Treatment||30||
60141486|NCT01045161|76264645|FG000|STARTED|Part B - 40 Additional Weeks Open Label||147||
60141487|NCT01045161|76264646|FG001|STARTED|Part B - 40 Additional Weeks Open Label||154||
60141488|NCT01045161|76264647|FG002|STARTED|Part B - 40 Additional Weeks Open Label||147||
60141489|NCT01045161|76264645|FG000|COMPLETED|Part B - 40 Additional Weeks Open Label||111||
60141490|NCT01045161|76264646|FG001|COMPLETED|Part B - 40 Additional Weeks Open Label||118||
60141491|NCT01045161|76264647|FG002|COMPLETED|Part B - 40 Additional Weeks Open Label||115||
60141492|NCT01045161|76264645|FG000|NOT COMPLETED|Part B - 40 Additional Weeks Open Label||36||
60141493|NCT01045161|76264646|FG001|NOT COMPLETED|Part B - 40 Additional Weeks Open Label||36||
60141494|NCT01045161|76264647|FG002|NOT COMPLETED|Part B - 40 Additional Weeks Open Label||32||
60141495|NCT00633217|76264666|FG000|STARTED|Overall Study||121||
59751455|NCT00654901|75870759|FG001|NOT COMPLETED|Overall Study||0||
59605705|NCT01965600|75715851|FG000|COMPLETED|Washout Period of Approximately 15 Days||4||
60010137|NCT04201574|76125829|FG002|NOT COMPLETED|Overall Study||0||
60010138|NCT04176133|76125844|FG000|STARTED|Overall Study||20||
60010139|NCT04176133|76125845|FG001|STARTED|Overall Study||19||
60010140|NCT04176133|76125846|FG002|STARTED|Overall Study||6||
60010141|NCT04176133|76125847|FG003|STARTED|Overall Study||16||
60010142|NCT04176133|76125844|FG000|COMPLETED|Overall Study||20||
60010143|NCT04176133|76125845|FG001|COMPLETED|Overall Study||19||
60010144|NCT04176133|76125846|FG002|COMPLETED|Overall Study||6||
60010145|NCT04176133|76125847|FG003|COMPLETED|Overall Study||16||
60010146|NCT04176133|76125844|FG000|NOT COMPLETED|Overall Study||0||
60010147|NCT04176133|76125845|FG001|NOT COMPLETED|Overall Study||0||
60010148|NCT04176133|76125846|FG002|NOT COMPLETED|Overall Study||0||
60010149|NCT04176133|76125847|FG003|NOT COMPLETED|Overall Study||0||
60010150|NCT04109196|76125857|FG000|STARTED|Overall Study||24||
60010151|NCT04109196|76125857|FG000|COMPLETED|Overall Study||24||
60010152|NCT04109196|76125857|FG000|NOT COMPLETED|Overall Study||0||
60010153|NCT04094584|76125861|FG000|STARTED|Overall Study||179||
60010154|NCT04094584|76125861|FG000|Screened for Eligibility|Overall Study||55|Screened for eligibility based on pre-screening result of being interested and willing to undergo screened|
60010155|NCT04094584|76125861|FG000|Enrolled and Received First Injection|Overall Study||32||
60010156|NCT04094584|76125861|FG000|COMPLETED|Overall Study||23||
60010157|NCT04094584|76125861|FG000|NOT COMPLETED|Overall Study||156||
60010158|NCT04082338|76125867|FG000|STARTED|Overall Study Baseline||191||
60010159|NCT04082338|76125868|FG001|STARTED|Overall Study Baseline||191||
60010160|NCT04082338|76125867|FG000|COMPLETED|Overall Study Baseline||191||
60010161|NCT04082338|76125868|FG001|COMPLETED|Overall Study Baseline||191||
60010162|NCT04082338|76125867|FG000|NOT COMPLETED|Overall Study Baseline||0||
60010163|NCT04082338|76125868|FG001|NOT COMPLETED|Overall Study Baseline||0||
60010164|NCT04082338|76125867|FG000|STARTED|12-month Follow-up||191||
60010165|NCT04082338|76125868|FG001|STARTED|12-month Follow-up||191||
60010166|NCT04082338|76125867|FG000|COMPLETED|12-month Follow-up||186||
60010167|NCT04082338|76125868|FG001|COMPLETED|12-month Follow-up||186||
60010168|NCT04082338|76125867|FG000|NOT COMPLETED|12-month Follow-up||5||
60010169|NCT04082338|76125868|FG001|NOT COMPLETED|12-month Follow-up||5||
60010170|NCT04082338|76125867|FG000|STARTED|18-month Follow-up||186||
60010171|NCT04082338|76125868|FG001|STARTED|18-month Follow-up||186||
60010172|NCT04082338|76125867|FG000|COMPLETED|18-month Follow-up||181||
60010173|NCT04082338|76125868|FG001|COMPLETED|18-month Follow-up||184||
60010174|NCT04082338|76125867|FG000|NOT COMPLETED|18-month Follow-up||5||
60010175|NCT04082338|76125868|FG001|NOT COMPLETED|18-month Follow-up||2||
60010176|NCT04020341|76125876|FG000|STARTED|Overall Study||767|Participants randomly assigned to the study treatment were included in Intent-to-Treat (ITT) population|
60010177|NCT04020341|76125877|FG001|STARTED|Overall Study||764|Participants randomly assigned to the study treatment were included in Intent-to-Treat (ITT) population|
60010178|NCT04020341|76125876|FG000|Safety Population|Overall Study||766|Safety population included all randomized participants who receive at least 1 dose of study treatment.|
60010179|NCT04020341|76125877|FG001|Safety Population|Overall Study||760|Safety population included all randomized participants who receive at least 1 dose of study treatment.|
60010180|NCT04020341|76125876|FG000|Microbiological ITT (Micro ITT) Population|Overall Study||401|Microbiological ITT (micro-ITT) population included all participants randomly assigned to study treatment who receive at least 1 dose of study treatment and have a qualifying baseline uropathogen [10^5 CFU/mL] from a quantitative bacteriological culture of a pretreatment clean catch midstream urine specimen.|
60010181|NCT04020341|76125877|FG001|Microbiological ITT (Micro ITT) Population|Overall Study||365|Microbiological ITT (micro-ITT) population included all participants randomly assigned to study treatment who receive at least 1 dose of study treatment and have a qualifying baseline uropathogen [10^5 CFU/mL] from a quantitative bacteriological culture of a pretreatment clean catch midstream urine specimen.|
60010182|NCT04020341|76125876|FG000|Micro-ITT NTF-S Population|Overall Study||336|Micro-ITT NTF-S population is defined as all participants in the micro-ITT population whose baseline qualifying uropathogens [10^5 CFU/mL] are all susceptible to nitrofurantoin (NTF-S).|
60067704|NCT01788423|76182879|FG002|NOT COMPLETED|Overall Study||5||
60067705|NCT01617187|76182891|FG000|STARTED|Randomization Through Start Treatment|Randomized|98||
59605706|NCT01965600|75715852|FG001|COMPLETED|Washout Period of Approximately 15 Days||4||
59605707|NCT01965600|75715853|FG002|COMPLETED|Washout Period of Approximately 15 Days||3||
59881737|NCT04230213|76004604|FG001|NOT COMPLETED|TP3: Week 16 to Week 22||1||
59881738|NCT04230213|76004605|FG002|NOT COMPLETED|TP3: Week 16 to Week 22||7||
59881739|NCT04230213|76004603|FG000|STARTED|TP4: Week 22 to Week 32||0||
59881740|NCT04230213|76004604|FG001|STARTED|TP4: Week 22 to Week 32||210||
59881741|NCT04230213|76004605|FG002|STARTED|TP4: Week 22 to Week 32||204||
59881742|NCT04230213|76004603|FG000|COMPLETED|TP4: Week 22 to Week 32||0||
59881743|NCT04230213|76004604|FG001|COMPLETED|TP4: Week 22 to Week 32||202||
59881744|NCT04230213|76004605|FG002|COMPLETED|TP4: Week 22 to Week 32||196||
59881745|NCT04230213|76004603|FG000|NOT COMPLETED|TP4: Week 22 to Week 32||0||
59881746|NCT04230213|76004604|FG001|NOT COMPLETED|TP4: Week 22 to Week 32||8||
59881747|NCT04230213|76004605|FG002|NOT COMPLETED|TP4: Week 22 to Week 32||8||
59881748|NCT04230213|76004603|FG000|STARTED|Follow up: Week 32 to Week 36||0||
59881749|NCT04230213|76004604|FG001|STARTED|Follow up: Week 32 to Week 36||202||
59881750|NCT04230213|76004605|FG002|STARTED|Follow up: Week 32 to Week 36||196||
59881751|NCT04230213|76004603|FG000|COMPLETED|Follow up: Week 32 to Week 36||0||
60141496|NCT00633217|76264667|FG001|STARTED|Overall Study||126||
60141497|NCT00633217|76264666|FG000|COMPLETED|Overall Study||106||
60141498|NCT00633217|76264667|FG001|COMPLETED|Overall Study||103||
60141499|NCT00633217|76264666|FG000|NOT COMPLETED|Overall Study||15||
60141500|NCT00633217|76264667|FG001|NOT COMPLETED|Overall Study||23||
60141501|NCT01673490|76264673|FG000|STARTED|Overall Study||59||
60141502|NCT01673490|76264673|FG000|COMPLETED|Overall Study||52||
60141503|NCT01673490|76264673|FG000|NOT COMPLETED|Overall Study||7||
60141504|NCT00215657|76264685|FG000|STARTED|Overall Study||26||
60141505|NCT00215657|76264686|FG001|STARTED|Overall Study||12||
60141506|NCT00215657|76264687|FG002|STARTED|Overall Study||13||
60141507|NCT00215657|76264688|FG003|STARTED|Overall Study||24||
60141508|NCT00215657|76264689|FG004|STARTED|Overall Study||27||
60141509|NCT00215657|76264690|FG005|STARTED|Overall Study||24||
60141510|NCT00215657|76264691|FG006|STARTED|Overall Study||27||
60141511|NCT00215657|76264692|FG007|STARTED|Overall Study||27||
60141512|NCT00215657|76264685|FG000|Intention-to-treat Population|Overall Study||25||
60141513|NCT00215657|76264686|FG001|Intention-to-treat Population|Overall Study||12||
60141514|NCT00215657|76264687|FG002|Intention-to-treat Population|Overall Study||12||
60141515|NCT00215657|76264688|FG003|Intention-to-treat Population|Overall Study||24||
60141516|NCT00215657|76264689|FG004|Intention-to-treat Population|Overall Study||24||
60141517|NCT00215657|76264690|FG005|Intention-to-treat Population|Overall Study||24||
60141518|NCT00215657|76264691|FG006|Intention-to-treat Population|Overall Study||24||
60010183|NCT04020341|76125877|FG001|Micro-ITT NTF-S Population|Overall Study||298|Micro-ITT NTF-S population is defined as all participants in the micro-ITT population whose baseline qualifying uropathogens [10^5 CFU/mL] are all susceptible to nitrofurantoin (NTF-S).|
60010184|NCT04020341|76125876|FG000|Micro-ITT NTF-S (IA Set) Population|Overall Study||320|Microbiological intent-to-treat susceptible to nitrofurantoin (micro-ITT NTF-S) (IA Set) population included participants in the micro ITT NTF-S who per the interim analysis data had the opportunity to reach their Test of Cure (TOC) visit, or had not yet reached their TOC visit, but were already known to be failures.|
60067706|NCT01617187|76182892|FG001|STARTED|Randomization Through Start Treatment|Randomized|113||
60067707|NCT01617187|76182893|FG002|STARTED|Randomization Through Start Treatment|Randomized|46||
60067708|NCT01617187|76182894|FG003|STARTED|Randomization Through Start Treatment|Randomized|103||
60141519|NCT00215657|76264692|FG007|Intention-to-treat Population|Overall Study||27||
60141520|NCT00215657|76264685|FG000|Started FE200486 CS07A|Overall Study||20||
60141521|NCT00215657|76264686|FG001|Started FE200486 CS07A|Overall Study||6||
60141522|NCT00215657|76264687|FG002|Started FE200486 CS07A|Overall Study||7||
60141523|NCT00215657|76264688|FG003|Started FE200486 CS07A|Overall Study||24||
60141524|NCT00215657|76264689|FG004|Started FE200486 CS07A|Overall Study||17||
60141525|NCT00215657|76264690|FG005|Started FE200486 CS07A|Overall Study||20||
60141526|NCT00215657|76264691|FG006|Started FE200486 CS07A|Overall Study||14||
60141527|NCT00215657|76264692|FG007|Started FE200486 CS07A|Overall Study||23||
60141528|NCT00215657|76264685|FG000|COMPLETED|Overall Study|Participants ongoing at the time of study closure were considered to have completed the study.|4||
60141529|NCT00215657|76264686|FG001|COMPLETED|Overall Study||1||
60141530|NCT00215657|76264687|FG002|COMPLETED|Overall Study||2||
60141531|NCT00215657|76264688|FG003|COMPLETED|Overall Study||6||
60141532|NCT00215657|76264689|FG004|COMPLETED|Overall Study||4||
60141533|NCT00215657|76264690|FG005|COMPLETED|Overall Study||4||
60141534|NCT00215657|76264691|FG006|COMPLETED|Overall Study||4||
60141535|NCT00215657|76264692|FG007|COMPLETED|Overall Study||11||
60141536|NCT00215657|76264685|FG000|NOT COMPLETED|Overall Study||22||
60141537|NCT00215657|76264686|FG001|NOT COMPLETED|Overall Study||11||
60141538|NCT00215657|76264687|FG002|NOT COMPLETED|Overall Study||11||
60141539|NCT00215657|76264688|FG003|NOT COMPLETED|Overall Study||18||
60141540|NCT00215657|76264689|FG004|NOT COMPLETED|Overall Study||23||
60141541|NCT00215657|76264690|FG005|NOT COMPLETED|Overall Study||20||
60141542|NCT00215657|76264691|FG006|NOT COMPLETED|Overall Study||23||
60141543|NCT00215657|76264692|FG007|NOT COMPLETED|Overall Study||16||
60141544|NCT00633061|76264712|FG000|STARTED|Overall Study|Study was on hold for 2 months for continuing review|136||
60141545|NCT00633061|76264713|FG001|STARTED|Overall Study||0||
60141546|NCT00633061|76264712|FG000|Met Criteria for Imaging|Overall Study||25||
60141547|NCT00633061|76264713|FG001|Met Criteria for Imaging|Overall Study||0||
60141548|NCT00633061|76264712|FG000|Had Prior Thrombosis Identified|Overall Study||25||
60141549|NCT00633061|76264713|FG001|Had Prior Thrombosis Identified|Overall Study||0||
60141550|NCT00633061|76264712|FG000|COMPLETED|Overall Study||50||
60141551|NCT00633061|76264713|FG001|COMPLETED|Overall Study||0||
60141552|NCT00633061|76264712|FG000|NOT COMPLETED|Overall Study||86||
60141553|NCT00633061|76264713|FG001|NOT COMPLETED|Overall Study||0||
60141554|NCT00632827|76264721|FG000|STARTED|Overall Study||21||
60141555|NCT00632827|76264721|FG000|Received GVD|Overall Study||21||
60141556|NCT00632827|76264721|FG000|Received M-CHOP|Overall Study||18||
60141557|NCT00632827|76264721|FG000|Evaluated Post Stem Cell Transplant|Overall Study||16||
60141558|NCT00632827|76264721|FG000|COMPLETED|Overall Study||11||
60141559|NCT00632827|76264721|FG000|NOT COMPLETED|Overall Study||10||
60141560|NCT00214019|76264726|FG000|STARTED|Overall Study||36||
60141561|NCT00214019|76264726|FG000|Placebo/Placebo Arm|Overall Study||6||
60141562|NCT00214019|76264726|FG000|Placebo/Salmeterol Arm|Overall Study||6||
60141563|NCT00214019|76264726|FG000|Fluticasone/Placebo Arm|Overall Study||6||
60141564|NCT00214019|76264726|FG000|Fluticason/Salmeterol Arm|Overall Study||6||
60141565|NCT00214019|76264726|FG000|COMPLETED|Overall Study||6||
60141566|NCT00214019|76264726|FG000|NOT COMPLETED|Overall Study||30||
60141567|NCT00210119|76264733|FG000|STARTED|Overall Study||19||
60141568|NCT00210119|76264733|FG000|COMPLETED|Overall Study||17||
60141569|NCT00210119|76264733|FG000|NOT COMPLETED|Overall Study||2||
60141570|NCT01044459|76264739|FG000|STARTED|Overall Study||312||
60141571|NCT01044459|76264740|FG001|STARTED|Overall Study||293||
60141572|NCT01044459|76264739|FG000|COMPLETED|Overall Study||179||
60141573|NCT01044459|76264740|FG001|COMPLETED|Overall Study||162||
60141574|NCT01044459|76264739|FG000|NOT COMPLETED|Overall Study||133||
60141575|NCT01044459|76264740|FG001|NOT COMPLETED|Overall Study||131||
60141576|NCT00980005|76264748|FG000|STARTED|Overall Study||1055||
60141577|NCT00980005|76264749|FG001|STARTED|Overall Study||1061||
60141578|NCT00980005|76264748|FG000|COMPLETED|Overall Study||1008||
60141579|NCT00980005|76264749|FG001|COMPLETED|Overall Study||998||
60141580|NCT00980005|76264748|FG000|NOT COMPLETED|Overall Study||47||
60141581|NCT00980005|76264749|FG001|NOT COMPLETED|Overall Study||63||
60141582|NCT01044303|76264759|FG000|STARTED|Overall Study||32||
60141583|NCT01044303|76264759|FG000|COMPLETED|Overall Study||30||
60141584|NCT01044303|76264759|FG000|NOT COMPLETED|Overall Study||2||
60141585|NCT00983437|76264766|FG000|STARTED|Overall Study||47||
60141586|NCT00983437|76264766|FG000|Safety Analysis Set (SAS)|Overall Study|Participants who received at least 1 dose of study drug were evaluable for safety.|47||
60141587|NCT00983437|76264766|FG000|Full Analysis Set (FAS)|Overall Study|Participants had to have at least 1 postbaseline efficacy assessment to be evaluable for efficacy.|45||
60141588|NCT00983437|76264766|FG000|COMPLETED|Overall Study|Completed 12 months of treatment with armodafinil.|0||
60141589|NCT00983437|76264766|FG000|NOT COMPLETED|Overall Study||47||
60141590|NCT01042977|76264772|FG000|STARTED|Overall Study|Of 482 part. 480 were included in full analysis set. Thereof, 1 part. treated but not randomized.|482||
60141591|NCT01042977|76264773|FG001|STARTED|Overall Study|Of the 483 participants only 482 were included in the full analysis set.|483||
60141592|NCT01042977|76264772|FG000|COMPLETED|Overall Study||441||
60141593|NCT01042977|76264773|FG001|COMPLETED|Overall Study||428||
60141594|NCT01042977|76264772|FG000|NOT COMPLETED|Overall Study||41||
60141595|NCT01042977|76264773|FG001|NOT COMPLETED|Overall Study||55||
60141596|NCT01041573|76264783|FG000|STARTED|Overall Study||540||
60141597|NCT01041573|76264784|FG001|STARTED|Overall Study||871||
60141598|NCT01041573|76264785|FG002|STARTED|Overall Study||394||
60141599|NCT01041573|76264786|FG003|STARTED|Overall Study||64||
60141600|NCT01041573|76264783|FG000|COMPLETED|Overall Study||535||
60141601|NCT01041573|76264784|FG001|COMPLETED|Overall Study||858||
60141602|NCT01041573|76264785|FG002|COMPLETED|Overall Study||387||
60141603|NCT01041573|76264786|FG003|COMPLETED|Overall Study||62||
60141604|NCT01041573|76264783|FG000|NOT COMPLETED|Overall Study||5||
60141605|NCT01041573|76264784|FG001|NOT COMPLETED|Overall Study||13||
60141606|NCT01041573|76264785|FG002|NOT COMPLETED|Overall Study||7||
60141607|NCT01041573|76264786|FG003|NOT COMPLETED|Overall Study||2||
60141608|NCT00906789|76264805|FG000|STARTED|Overall Study|Radiologists served as own control. Total enrollment is 15 radiologists.|15||
60141609|NCT00906789|76264805|FG000|COMPLETED|Overall Study||15||
60141610|NCT00906789|76264805|FG000|NOT COMPLETED|Overall Study||0||
60141611|NCT01041495|76264813|FG000|STARTED|Overall Study||16||
60141612|NCT01041495|76264814|FG001|STARTED|Overall Study||12||
60141613|NCT01041495|76264813|FG000|COMPLETED|Overall Study||12||
60141614|NCT01041495|76264814|FG001|COMPLETED|Overall Study||5||
60141615|NCT01041495|76264813|FG000|NOT COMPLETED|Overall Study||4||
60141616|NCT01041495|76264814|FG001|NOT COMPLETED|Overall Study||7||
60141617|NCT01041417|76264822|FG000|STARTED|Overall Study||80||
60141618|NCT01041417|76264823|FG001|STARTED|Overall Study||79||
60141619|NCT01041417|76264822|FG000|COMPLETED|Overall Study||73||
60141620|NCT01041417|76264823|FG001|COMPLETED|Overall Study||76||
60141621|NCT01041417|76264822|FG000|NOT COMPLETED|Overall Study||7||
60141622|NCT01041417|76264823|FG001|NOT COMPLETED|Overall Study||3||
60141623|NCT01040871|76264833|FG000|STARTED|Overall Study|Intent to Treat, Randomized|84||
60141624|NCT01040871|76264834|FG001|STARTED|Overall Study|Intent to Treat, Randomized|80||
60141625|NCT01040871|76264833|FG000|COMPLETED|Overall Study||71||
60141626|NCT01040871|76264834|FG001|COMPLETED|Overall Study||73||
60141627|NCT01040871|76264833|FG000|NOT COMPLETED|Overall Study||13||
60141628|NCT01040871|76264834|FG001|NOT COMPLETED|Overall Study||7||
60141629|NCT01040169|76264842|FG000|STARTED|Overall Study||35||
60141630|NCT01040169|76264843|FG001|STARTED|Overall Study||44||
60141631|NCT01040169|76264842|FG000|COMPLETED|Overall Study||32||
60141632|NCT01040169|76264843|FG001|COMPLETED|Overall Study||36||
60141633|NCT01040169|76264842|FG000|NOT COMPLETED|Overall Study||3||
60141634|NCT01040169|76264843|FG001|NOT COMPLETED|Overall Study||8||
60141635|NCT00916539|76264851|FG000|STARTED|Overall Study||31||
60141636|NCT00916539|76264852|FG001|STARTED|Overall Study||31||
60141637|NCT00916539|76264851|FG000|COMPLETED|Overall Study||31||
60141638|NCT00916539|76264852|FG001|COMPLETED|Overall Study||31||
60141639|NCT00916539|76264851|FG000|NOT COMPLETED|Overall Study||0||
60141640|NCT00916539|76264852|FG001|NOT COMPLETED|Overall Study||0||
60141641|NCT01673178|76264863|FG000|STARTED|Overall Study||22||
60141642|NCT01673178|76264864|FG001|STARTED|Overall Study||21||
60141643|NCT01673178|76264865|FG002|STARTED|Overall Study||21||
60141644|NCT01673178|76264866|FG003|STARTED|Overall Study||22||
60141645|NCT01673178|76264867|FG004|STARTED|Overall Study||21||
60141646|NCT01673178|76264863|FG000|COMPLETED|Overall Study||19||
60141647|NCT01673178|76264864|FG001|COMPLETED|Overall Study||19||
60141648|NCT01673178|76264865|FG002|COMPLETED|Overall Study||18||
60141649|NCT01673178|76264866|FG003|COMPLETED|Overall Study||14||
60141650|NCT01673178|76264867|FG004|COMPLETED|Overall Study||19||
60141651|NCT01673178|76264863|FG000|NOT COMPLETED|Overall Study||3||
60141652|NCT01673178|76264864|FG001|NOT COMPLETED|Overall Study||2||
60141653|NCT01673178|76264865|FG002|NOT COMPLETED|Overall Study||3||
60141654|NCT01673178|76264866|FG003|NOT COMPLETED|Overall Study||8||
60141655|NCT01673178|76264867|FG004|NOT COMPLETED|Overall Study||2||
60141656|NCT02155335|76264883|FG000|STARTED|Period 1||50||
60141657|NCT02155335|76264884|FG001|STARTED|Period 1||50||
60141658|NCT02155335|76264883|FG000|Treated|Period 1||50||
60141659|NCT02155335|76264884|FG001|Treated|Period 1||49||
60141660|NCT02155335|76264883|FG000|COMPLETED|Period 1||50||
60141661|NCT02155335|76264884|FG001|COMPLETED|Period 1||49||
60141662|NCT02155335|76264883|FG000|NOT COMPLETED|Period 1||0||
60141663|NCT02155335|76264884|FG001|NOT COMPLETED|Period 1||1||
60141664|NCT02155335|76264883|FG000|STARTED|Period 2||50||
60141665|NCT02155335|76264884|FG001|STARTED|Period 2||49||
60141666|NCT02155335|76264883|FG000|COMPLETED|Period 2||50||
60141667|NCT02155335|76264884|FG001|COMPLETED|Period 2||49||
60141668|NCT02155335|76264883|FG000|NOT COMPLETED|Period 2||0||
60141669|NCT02155335|76264884|FG001|NOT COMPLETED|Period 2||0||
60141670|NCT03597035|76264888|FG000|STARTED|Overall Study||8||
60141671|NCT03597035|76264888|FG000|COMPLETED|Overall Study||4||
60141672|NCT03597035|76264888|FG000|NOT COMPLETED|Overall Study||4||
60141673|NCT03593213|76264896|FG000|STARTED|Open-label Treatment Period (18 Weeks)|Out of 162 participants who completed Open-label Treatment Period, 159 participants were randomized to Double-blind treatment Period.|587||
60141674|NCT03593213|76264897|FG001|STARTED|Open-label Treatment Period (18 Weeks)||0||
60141675|NCT03593213|76264898|FG002|STARTED|Open-label Treatment Period (18 Weeks)||0||
60141676|NCT03593213|76264899|FG003|STARTED|Open-label Treatment Period (18 Weeks)||0||
60141677|NCT03593213|76264896|FG000|COMPLETED|Open-label Treatment Period (18 Weeks)||162||
60141678|NCT03593213|76264897|FG001|COMPLETED|Open-label Treatment Period (18 Weeks)||0||
60141679|NCT03593213|76264898|FG002|COMPLETED|Open-label Treatment Period (18 Weeks)||0||
60141680|NCT03593213|76264899|FG003|COMPLETED|Open-label Treatment Period (18 Weeks)||0||
60141681|NCT03593213|76264896|FG000|NOT COMPLETED|Open-label Treatment Period (18 Weeks)||425||
60141682|NCT03593213|76264897|FG001|NOT COMPLETED|Open-label Treatment Period (18 Weeks)||0||
60141683|NCT03593213|76264898|FG002|NOT COMPLETED|Open-label Treatment Period (18 Weeks)||0||
60141684|NCT03593213|76264899|FG003|NOT COMPLETED|Open-label Treatment Period (18 Weeks)||0||
60141685|NCT03593213|76264896|FG000|STARTED|Double-blind Treatment Period (26 Weeks)||0||
60141686|NCT03593213|76264897|FG001|STARTED|Double-blind Treatment Period (26 Weeks)||54||
60141687|NCT03593213|76264898|FG002|STARTED|Double-blind Treatment Period (26 Weeks)||49||
60141688|NCT03593213|76264899|FG003|STARTED|Double-blind Treatment Period (26 Weeks)||56||
60141689|NCT03593213|76264896|FG000|Safety Population|Double-blind Treatment Period (26 Weeks)||0|Double-blind Safety Population included all participants who took at least 1 dose of cariprazine during and double-blind treatment period.|
60141690|NCT03593213|76264897|FG001|Safety Population|Double-blind Treatment Period (26 Weeks)||53|Double-blind Safety Population included all participants who took at least 1 dose of cariprazine during and double-blind treatment period.|
60141691|NCT03593213|76264898|FG002|Safety Population|Double-blind Treatment Period (26 Weeks)||49|Double-blind Safety Population included all participants who took at least 1 dose of cariprazine during and double-blind treatment period.|
60141692|NCT03593213|76264899|FG003|Safety Population|Double-blind Treatment Period (26 Weeks)||54|Double-blind Safety Population included all participants who took at least 1 dose of cariprazine during and double-blind treatment period.|
60141693|NCT03593213|76264896|FG000|COMPLETED|Double-blind Treatment Period (26 Weeks)||0||
60141694|NCT03593213|76264897|FG001|COMPLETED|Double-blind Treatment Period (26 Weeks)||14||
60141695|NCT03593213|76264898|FG002|COMPLETED|Double-blind Treatment Period (26 Weeks)||16||
60141696|NCT03593213|76264899|FG003|COMPLETED|Double-blind Treatment Period (26 Weeks)||21||
60141697|NCT03593213|76264896|FG000|NOT COMPLETED|Double-blind Treatment Period (26 Weeks)||0||
60141698|NCT03593213|76264897|FG001|NOT COMPLETED|Double-blind Treatment Period (26 Weeks)||40||
60141699|NCT03593213|76264898|FG002|NOT COMPLETED|Double-blind Treatment Period (26 Weeks)||33||
60141700|NCT03593213|76264899|FG003|NOT COMPLETED|Double-blind Treatment Period (26 Weeks)||35||
60141701|NCT00918723|76264912|FG000|STARTED|Overall Study||40||
60141702|NCT00918723|76264912|FG000|COMPLETED|Overall Study||40||
60141703|NCT00918723|76264912|FG000|NOT COMPLETED|Overall Study||0||
60141704|NCT04953390|76264918|FG000|STARTED|Overall Study||19||
60141705|NCT04953390|76264918|FG000|COMPLETED|Overall Study||19||
60141706|NCT04953390|76264918|FG000|NOT COMPLETED|Overall Study||0||
60141707|NCT00919035|76264922|FG000|STARTED|Overall Study||21||
60141708|NCT00919035|76264922|FG000|COMPLETED|Overall Study||21||
60141709|NCT00919035|76264922|FG000|NOT COMPLETED|Overall Study||0||
60141710|NCT04133064|76264926|FG000|STARTED|Overall Study||234||
60141711|NCT04133064|76264926|FG000|COMPLETED|Overall Study||215||
60141712|NCT04133064|76264926|FG000|NOT COMPLETED|Overall Study||19||
60141713|NCT00919113|76264934|FG000|STARTED|Overall Study||50||
60141714|NCT00919113|76264935|FG001|STARTED|Overall Study||48||
60141715|NCT00919113|76264934|FG000|Received Uracyst|Overall Study|One subject was misrandomized. Actual treatment was used for Demographic and Safety analysis.|49||
60141716|NCT00919113|76264935|FG001|Received Uracyst|Overall Study||0||
60141717|NCT00919113|76264934|FG000|Received Placebo|Overall Study||0||
60141718|NCT00919113|76264935|FG001|Received Placebo|Overall Study|One subject was misrandomized. Actual treatment was used for Demographic and Safety analysis.|49||
60141719|NCT00919113|76264934|FG000|COMPLETED|Overall Study||41||
60141720|NCT00919113|76264935|FG001|COMPLETED|Overall Study||40||
60141721|NCT00919113|76264934|FG000|NOT COMPLETED|Overall Study||9||
60141722|NCT00919113|76264935|FG001|NOT COMPLETED|Overall Study||8||
60141723|NCT00013611|76264943|FG000|STARTED|Overall Study|138 were excluded from sites that did not re-consent 2/3 of patients to the amended protocol in 2003|849||
60141724|NCT00013611|76264944|FG001|STARTED|Overall Study|138 were excluded from sites that did not re-consent 2/3 of patients to the amended protocol in 2003|846||
60141725|NCT00013611|76264943|FG000|COMPLETED|Overall Study||758||
60141726|NCT00013611|76264944|FG001|COMPLETED|Overall Study||746||
60141727|NCT00013611|76264943|FG000|NOT COMPLETED|Overall Study||91||
60141728|NCT00013611|76264944|FG001|NOT COMPLETED|Overall Study||100||
60141729|NCT00010257|76264952|FG000|STARTED|Overall Study||25||
60141730|NCT00010257|76264953|FG001|STARTED|Overall Study||21||
60141731|NCT00010257|76264952|FG000|COMPLETED|Overall Study||24||
60141732|NCT00010257|76264953|FG001|COMPLETED|Overall Study||21||
60141733|NCT00010257|76264952|FG000|NOT COMPLETED|Overall Study||1||
60141734|NCT00010257|76264953|FG001|NOT COMPLETED|Overall Study||0||
60141735|NCT00919191|76264959|FG000|STARTED|Overall Study||26||
60141736|NCT00919191|76264959|FG000|COMPLETED|Overall Study||26||
60141737|NCT00919191|76264959|FG000|NOT COMPLETED|Overall Study||0||
60141738|NCT02155725|76264967|FG000|STARTED|Treatment Period||224||
60141739|NCT02155725|76264968|FG001|STARTED|Treatment Period||213||
60141740|NCT02155725|76264967|FG000|COMPLETED|Treatment Period||224||
60141741|NCT02155725|76264968|FG001|COMPLETED|Treatment Period||213||
60141742|NCT02155725|76264967|FG000|NOT COMPLETED|Treatment Period||0||
60141743|NCT02155725|76264968|FG001|NOT COMPLETED|Treatment Period||0||
60141744|NCT02155725|76264967|FG000|STARTED|Follow-up Period||224||
60141745|NCT02155725|76264968|FG001|STARTED|Follow-up Period||213||
60141746|NCT02155725|76264967|FG000|COMPLETED|Follow-up Period||207||
60141747|NCT02155725|76264968|FG001|COMPLETED|Follow-up Period||202||
60141748|NCT02155725|76264967|FG000|NOT COMPLETED|Follow-up Period||17||
60141749|NCT02155725|76264968|FG001|NOT COMPLETED|Follow-up Period||11||
60141750|NCT00919503|76264982|FG000|STARTED|Overall Study||84||
60141751|NCT00919503|76264983|FG001|STARTED|Overall Study||14||
60141752|NCT00919503|76264982|FG000|COMPLETED|Overall Study||84||
60141753|NCT00919503|76264983|FG001|COMPLETED|Overall Study||14||
60141754|NCT00919503|76264982|FG000|NOT COMPLETED|Overall Study||0||
60141755|NCT00919503|76264983|FG001|NOT COMPLETED|Overall Study||0||
60141756|NCT00211757|76264991|FG000|STARTED|Overall Study||11||
60141757|NCT00211757|76264992|FG001|STARTED|Overall Study||16||
60141758|NCT00211757|76264991|FG000|COMPLETED|Overall Study||10||
60141759|NCT00211757|76264992|FG001|COMPLETED|Overall Study||14||
60141760|NCT00211757|76264991|FG000|NOT COMPLETED|Overall Study||1||
60141761|NCT00211757|76264992|FG001|NOT COMPLETED|Overall Study||2||
60141762|NCT00921687|76265002|FG000|STARTED|Overall Study|eligible patients seen in clinic between 1/1/09 and 1/1/10|418||
60141763|NCT00921687|76265003|FG001|STARTED|Overall Study||363||
60141764|NCT00921687|76265002|FG000|COMPLETED|Overall Study||418||
60141765|NCT00921687|76265003|FG001|COMPLETED|Overall Study||363||
60141766|NCT00921687|76265002|FG000|NOT COMPLETED|Overall Study||0||
60141767|NCT00921687|76265003|FG001|NOT COMPLETED|Overall Study||0||
60141768|NCT02639052|76265009|FG000|STARTED|Overall Study||35||
60141769|NCT02639052|76265009|FG000|Visit 1 (Baseline)|Overall Study||35||
60141770|NCT02639052|76265009|FG000|Visit 2 (1-week Follow-up)|Overall Study||35||
60141771|NCT02639052|76265009|FG000|Visit 3 (1-month Follow-up)|Overall Study||35||
60141772|NCT02639052|76265009|FG000|Visit 4 (3-month Follow-up)|Overall Study||34||
60141773|NCT02639052|76265009|FG000|COMPLETED|Overall Study||34||
60141774|NCT02639052|76265009|FG000|NOT COMPLETED|Overall Study||1||
60141775|NCT00921843|76265019|FG000|STARTED|Overall Study||10||
60141776|NCT00921843|76265020|FG001|STARTED|Overall Study||10||
60141777|NCT00921843|76265021|FG002|STARTED|Overall Study||11||
60141778|NCT00921843|76265022|FG003|STARTED|Overall Study||30||
60141779|NCT00921843|76265019|FG000|COMPLETED|Overall Study||10||
60141780|NCT00921843|76265020|FG001|COMPLETED|Overall Study||10||
60141781|NCT00921843|76265021|FG002|COMPLETED|Overall Study||11||
60141782|NCT00921843|76265022|FG003|COMPLETED|Overall Study||30||
60141783|NCT00921843|76265019|FG000|NOT COMPLETED|Overall Study||0||
60141784|NCT00921843|76265020|FG001|NOT COMPLETED|Overall Study||0||
60141785|NCT00921843|76265021|FG002|NOT COMPLETED|Overall Study||0||
60141786|NCT00921843|76265022|FG003|NOT COMPLETED|Overall Study||0||
60141787|NCT02080637|76265034|FG000|STARTED|Overall Study||13||
60141788|NCT02080637|76265035|FG001|STARTED|Overall Study||3||
60141789|NCT02080637|76265034|FG000|COMPLETED|Overall Study||13||
60141790|NCT02080637|76265035|FG001|COMPLETED|Overall Study||3||
60141791|NCT02080637|76265034|FG000|NOT COMPLETED|Overall Study||0||
60141792|NCT02080637|76265035|FG001|NOT COMPLETED|Overall Study||0||
60141793|NCT00924885|76265043|FG000|STARTED|Overall Study||129||
60141794|NCT00924885|76265044|FG001|STARTED|Overall Study||128||
60141795|NCT00924885|76265043|FG000|COMPLETED|Overall Study||126||
60141796|NCT00924885|76265044|FG001|COMPLETED|Overall Study||124||
60141797|NCT00924885|76265043|FG000|NOT COMPLETED|Overall Study||3||
60141798|NCT00924885|76265044|FG001|NOT COMPLETED|Overall Study||4||
60141799|NCT00925119|76265052|FG000|STARTED|Overall Study||31||
60141800|NCT00925119|76265052|FG000|COMPLETED|Overall Study||19||
60141801|NCT00925119|76265052|FG000|NOT COMPLETED|Overall Study||12||
60141802|NCT00920439|76265056|FG000|STARTED|Overall Study||25||
60141803|NCT00920439|76265056|FG000|COMPLETED|Overall Study||25||
60141804|NCT00920439|76265056|FG000|NOT COMPLETED|Overall Study||0||
60141805|NCT00929331|76265062|FG000|STARTED|Overall Study||55||
60141806|NCT00929331|76265063|FG001|STARTED|Overall Study||55||
60141807|NCT00929331|76265062|FG000|COMPLETED|Overall Study||55||
60141808|NCT00929331|76265063|FG001|COMPLETED|Overall Study||55||
60141809|NCT00929331|76265062|FG000|NOT COMPLETED|Overall Study||0||
60141810|NCT00929331|76265063|FG001|NOT COMPLETED|Overall Study||0||
60141811|NCT04458090|76265071|FG000|STARTED|Overall Study||72||
60141812|NCT04458090|76265072|FG001|STARTED|Overall Study||72||
60141813|NCT04458090|76265071|FG000|COMPLETED|Overall Study||72||
60141814|NCT04458090|76265072|FG001|COMPLETED|Overall Study||72||
60141815|NCT04458090|76265071|FG000|NOT COMPLETED|Overall Study||0||
60141816|NCT04458090|76265072|FG001|NOT COMPLETED|Overall Study||0||
60141817|NCT00922233|76265078|FG000|STARTED|Overall Study||72||
60141818|NCT00922233|76265078|FG000|COMPLETED|Overall Study||68||
60141819|NCT00922233|76265078|FG000|NOT COMPLETED|Overall Study||4||
60141820|NCT00922701|76265083|FG000|STARTED|Overall Study||4||
60141821|NCT00922701|76265083|FG000|COMPLETED|Overall Study||4||
60141822|NCT00922701|76265083|FG000|NOT COMPLETED|Overall Study||0||
60141823|NCT00923481|76265087|FG000|STARTED|Overall Study||37||
60141824|NCT00923481|76265087|FG000|COMPLETED|Overall Study||37||
60141825|NCT00923481|76265087|FG000|NOT COMPLETED|Overall Study||0||
60141826|NCT00931359|76265093|FG000|STARTED|Overall Study||39||
60141827|NCT00931359|76265094|FG001|STARTED|Overall Study||81||
60141828|NCT00931359|76265093|FG000|COMPLETED|Overall Study||33||
60141829|NCT00931359|76265094|FG001|COMPLETED|Overall Study||68||
60141830|NCT00931359|76265093|FG000|NOT COMPLETED|Overall Study||6||
60141831|NCT00931359|76265094|FG001|NOT COMPLETED|Overall Study||13||
60141832|NCT02157909|76265102|FG000|STARTED|Overall Study||66||
60141833|NCT02157909|76265103|FG001|STARTED|Overall Study||66||
60141834|NCT02157909|76265102|FG000|COMPLETED|Overall Study||66||
60141835|NCT02157909|76265103|FG001|COMPLETED|Overall Study||66||
60141836|NCT02157909|76265102|FG000|NOT COMPLETED|Overall Study||0||
60141837|NCT02157909|76265103|FG001|NOT COMPLETED|Overall Study||0||
60141838|NCT00923949|76265110|FG000|STARTED|Overall Study||1||
60141839|NCT00923949|76265110|FG000|COMPLETED|Overall Study||1||
60141840|NCT00923949|76265110|FG000|NOT COMPLETED|Overall Study||0||
60141841|NCT02635776|76265116|FG000|STARTED|Overall Study||416||
60141842|NCT02635776|76265117|FG001|STARTED|Overall Study||139||
60141843|NCT02635776|76265116|FG000|COMPLETED|Overall Study||314||
60141844|NCT02635776|76265117|FG001|COMPLETED|Overall Study||128||
60141845|NCT02635776|76265116|FG000|NOT COMPLETED|Overall Study||102||
60141846|NCT02635776|76265117|FG001|NOT COMPLETED|Overall Study||11||
60141847|NCT04369833|76265125|FG000|STARTED|Overall Study||130||
60141848|NCT04369833|76265125|FG000|COMPLETED|Overall Study||129||
60141849|NCT04369833|76265125|FG000|NOT COMPLETED|Overall Study||1||
60141850|NCT02704403|76265131|FG000|STARTED|Overall Study||1437||
60141851|NCT02704403|76265132|FG001|STARTED|Overall Study||720||
60141852|NCT02704403|76265131|FG000|Full Intent-to-Treat Population|Overall Study||1437||
60141853|NCT02704403|76265132|FG001|Full Intent-to-Treat Population|Overall Study||720||
60141854|NCT02704403|76265131|FG000|Full Safety Population|Overall Study||1433||
60141855|NCT02704403|76265132|FG001|Full Safety Population|Overall Study||717||
60141856|NCT02704403|76265131|FG000|COMPLETED|Overall Study||0||
60141857|NCT02704403|76265132|FG001|COMPLETED|Overall Study||0||
60141858|NCT02704403|76265131|FG000|NOT COMPLETED|Overall Study||1437||
60141859|NCT02704403|76265132|FG001|NOT COMPLETED|Overall Study||720||
60141860|NCT02709317|76265140|FG000|STARTED|Overall Study||50||
60141861|NCT02709317|76265141|FG001|STARTED|Overall Study||58||
60141862|NCT02709317|76265140|FG000|COMPLETED|Overall Study||18||
60141863|NCT02709317|76265141|FG001|COMPLETED|Overall Study||31||
60141864|NCT02709317|76265140|FG000|NOT COMPLETED|Overall Study||32||
60141865|NCT02709317|76265141|FG001|NOT COMPLETED|Overall Study||27||
60141866|NCT00927849|76265150|FG000|STARTED|Overall Study||21||
60141867|NCT00927849|76265151|FG001|STARTED|Overall Study||21||
60141868|NCT00927849|76265152|FG002|STARTED|Overall Study||21||
60141869|NCT00927849|76265150|FG000|COMPLETED|Overall Study||21||
60141870|NCT00927849|76265151|FG001|COMPLETED|Overall Study||21||
60141871|NCT00927849|76265152|FG002|COMPLETED|Overall Study||21||
60141872|NCT00927849|76265150|FG000|NOT COMPLETED|Overall Study||0||
60141873|NCT00927849|76265151|FG001|NOT COMPLETED|Overall Study||0||
60141874|NCT00927849|76265152|FG002|NOT COMPLETED|Overall Study||0||
60141875|NCT00936741|76265160|FG000|STARTED|Overall Study||30||
60141876|NCT00936741|76265160|FG000|COMPLETED|Overall Study||21||
60141877|NCT00936741|76265160|FG000|NOT COMPLETED|Overall Study||9||
60141878|NCT02636868|76265167|FG000|STARTED|Overall Study||73||
60141879|NCT02636868|76265168|FG001|STARTED|Overall Study||76||
60141880|NCT02636868|76265169|FG002|STARTED|Overall Study||72||
60141881|NCT02636868|76265167|FG000|COMPLETED|Overall Study||73||
60141882|NCT02636868|76265168|FG001|COMPLETED|Overall Study||75||
60141883|NCT02636868|76265169|FG002|COMPLETED|Overall Study||70||
60141884|NCT02636868|76265167|FG000|NOT COMPLETED|Overall Study||0||
60141885|NCT02636868|76265168|FG001|NOT COMPLETED|Overall Study||1||
60141886|NCT02636868|76265169|FG002|NOT COMPLETED|Overall Study||2||
60141887|NCT00928083|76265180|FG000|STARTED|Overall Study||10||
60141888|NCT00928083|76265181|FG001|STARTED|Overall Study||8||
60141889|NCT00928083|76265182|FG002|STARTED|Overall Study||8||
60141890|NCT00928083|76265183|FG003|STARTED|Overall Study||6||
60141891|NCT00928083|76265184|FG004|STARTED|Overall Study||7||
60141892|NCT00928083|76265185|FG005|STARTED|Overall Study||6||
60141893|NCT00928083|76265186|FG006|STARTED|Overall Study||6||
60141894|NCT00928083|76265187|FG007|STARTED|Overall Study||6||
60141895|NCT00928083|76265188|FG008|STARTED|Overall Study||6||
60141896|NCT00928083|76265180|FG000|COMPLETED|Overall Study||6||
60141897|NCT00928083|76265181|FG001|COMPLETED|Overall Study||8||
60141898|NCT00928083|76265182|FG002|COMPLETED|Overall Study||8||
60141899|NCT00928083|76265183|FG003|COMPLETED|Overall Study||5||
60141900|NCT00928083|76265184|FG004|COMPLETED|Overall Study||6||
60141901|NCT00928083|76265185|FG005|COMPLETED|Overall Study||6||
60141902|NCT00928083|76265186|FG006|COMPLETED|Overall Study||6||
60141903|NCT00928083|76265187|FG007|COMPLETED|Overall Study||6||
60141904|NCT00928083|76265188|FG008|COMPLETED|Overall Study||6||
60141905|NCT00928083|76265180|FG000|NOT COMPLETED|Overall Study||4||
60141906|NCT00928083|76265181|FG001|NOT COMPLETED|Overall Study||0||
60141907|NCT00928083|76265182|FG002|NOT COMPLETED|Overall Study||0||
60141908|NCT00928083|76265183|FG003|NOT COMPLETED|Overall Study||1||
60141909|NCT00928083|76265184|FG004|NOT COMPLETED|Overall Study||1||
60141910|NCT00928083|76265185|FG005|NOT COMPLETED|Overall Study||0||
60141911|NCT00928083|76265186|FG006|NOT COMPLETED|Overall Study||0||
60141912|NCT00928083|76265187|FG007|NOT COMPLETED|Overall Study||0||
60141913|NCT00928083|76265188|FG008|NOT COMPLETED|Overall Study||0||
60141914|NCT00928395|76265237|FG000|STARTED|Overall Study||50||
60141915|NCT00928395|76265237|FG000|COMPLETED|Overall Study||29||
60141916|NCT00928395|76265237|FG000|NOT COMPLETED|Overall Study||21||
60141917|NCT00938457|76265241|FG000|STARTED|Overall Study||3||
60141918|NCT00938457|76265241|FG000|COMPLETED|Overall Study||3||
60141919|NCT00938457|76265241|FG000|NOT COMPLETED|Overall Study||0||
60141920|NCT02635386|76265250|FG000|STARTED|Overall Study||23||
60141921|NCT02635386|76265251|FG001|STARTED|Overall Study||23||
60141922|NCT02635386|76265252|FG002|STARTED|Overall Study||22||
60141923|NCT02635386|76265253|FG003|STARTED|Overall Study||26||
60141924|NCT02635386|76265254|FG004|STARTED|Overall Study||25||
60141925|NCT02635386|76265250|FG000|COMPLETED|Overall Study||20||
60141926|NCT02635386|76265251|FG001|COMPLETED|Overall Study||17||
60141927|NCT02635386|76265252|FG002|COMPLETED|Overall Study||20||
60141928|NCT02635386|76265253|FG003|COMPLETED|Overall Study||19||
60141929|NCT02635386|76265254|FG004|COMPLETED|Overall Study||16||
60141930|NCT02635386|76265250|FG000|NOT COMPLETED|Overall Study||3||
60141931|NCT02635386|76265251|FG001|NOT COMPLETED|Overall Study||6||
60141932|NCT02635386|76265252|FG002|NOT COMPLETED|Overall Study||2||
60141933|NCT02635386|76265253|FG003|NOT COMPLETED|Overall Study||7||
60141934|NCT02635386|76265254|FG004|NOT COMPLETED|Overall Study||9||
60141935|NCT00934635|76265280|FG000|STARTED|Overall Study||0||
60141936|NCT00934635|76265281|FG001|STARTED|Overall Study||1||
60141937|NCT00934635|76265282|FG002|STARTED|Overall Study||0||
60141938|NCT00934635|76265283|FG003|STARTED|Overall Study||0||
60141939|NCT00934635|76265284|FG004|STARTED|Overall Study||0||
60141940|NCT00934635|76265285|FG005|STARTED|Overall Study||0||
60141941|NCT00934635|76265286|FG006|STARTED|Overall Study||0||
60141942|NCT00934635|76265287|FG007|STARTED|Overall Study||0||
60141943|NCT00934635|76265288|FG008|STARTED|Overall Study||1||
60141944|NCT00934635|76265280|FG000|COMPLETED|Overall Study||0||
60141945|NCT00934635|76265281|FG001|COMPLETED|Overall Study||1||
60141946|NCT00934635|76265282|FG002|COMPLETED|Overall Study||0||
60141947|NCT00934635|76265283|FG003|COMPLETED|Overall Study||0||
60141948|NCT00934635|76265284|FG004|COMPLETED|Overall Study||0||
60141949|NCT00934635|76265285|FG005|COMPLETED|Overall Study||0||
60141950|NCT00934635|76265286|FG006|COMPLETED|Overall Study||0||
60141951|NCT00934635|76265287|FG007|COMPLETED|Overall Study||0||
60141952|NCT00934635|76265288|FG008|COMPLETED|Overall Study||1||
60141953|NCT00934635|76265280|FG000|NOT COMPLETED|Overall Study||0||
60141954|NCT00934635|76265281|FG001|NOT COMPLETED|Overall Study||0||
60141955|NCT00934635|76265282|FG002|NOT COMPLETED|Overall Study||0||
60141956|NCT00934635|76265283|FG003|NOT COMPLETED|Overall Study||0||
60141957|NCT00934635|76265284|FG004|NOT COMPLETED|Overall Study||0||
60141958|NCT00934635|76265285|FG005|NOT COMPLETED|Overall Study||0||
60141959|NCT00934635|76265286|FG006|NOT COMPLETED|Overall Study||0||
60141960|NCT00934635|76265287|FG007|NOT COMPLETED|Overall Study||0||
60141961|NCT00934635|76265288|FG008|NOT COMPLETED|Overall Study||0||
60141962|NCT00936351|76265310|FG000|STARTED|Overall Study||18||
60141963|NCT00936351|76265311|FG001|STARTED|Overall Study||16||
60141964|NCT00936351|76265310|FG000|COMPLETED|Overall Study||15||
60141965|NCT00936351|76265311|FG001|COMPLETED|Overall Study||14||
60141966|NCT00936351|76265310|FG000|NOT COMPLETED|Overall Study||3||
60141967|NCT00936351|76265311|FG001|NOT COMPLETED|Overall Study||2||
60141968|NCT00939159|76265317|FG000|STARTED|Overall Study||13||
60141969|NCT00939159|76265317|FG000|COMPLETED|Overall Study||13||
60141970|NCT00939159|76265317|FG000|NOT COMPLETED|Overall Study||0||
60141971|NCT00939471|76265321|FG000|STARTED|Overall Study||44||
60141972|NCT00939471|76265321|FG000|COMPLETED|Overall Study||33||
60141973|NCT00939471|76265321|FG000|NOT COMPLETED|Overall Study||11||
60141974|NCT00942825|76265327|FG000|STARTED|Overall Study||97||
60141975|NCT00942825|76265328|FG001|STARTED|Overall Study||98||
60141976|NCT00942825|76265327|FG000|COMPLETED|Overall Study||97||
60141977|NCT00942825|76265328|FG001|COMPLETED|Overall Study||98||
60141978|NCT00942825|76265327|FG000|NOT COMPLETED|Overall Study||0||
60141979|NCT00942825|76265328|FG001|NOT COMPLETED|Overall Study||0||
60141980|NCT00947505|76265336|FG000|STARTED|Overall Study||33||
60141981|NCT00947505|76265337|FG001|STARTED|Overall Study||16||
60141982|NCT00947505|76265336|FG000|COMPLETED|Overall Study||24||
60141983|NCT00947505|76265337|FG001|COMPLETED|Overall Study||14||
60141984|NCT00947505|76265336|FG000|NOT COMPLETED|Overall Study||9||
59881752|NCT04230213|76004604|FG001|COMPLETED|Follow up: Week 32 to Week 36||201||
59881753|NCT04230213|76004605|FG002|COMPLETED|Follow up: Week 32 to Week 36||194||
59881754|NCT04230213|76004603|FG000|NOT COMPLETED|Follow up: Week 32 to Week 36||0||
59881755|NCT04230213|76004604|FG001|NOT COMPLETED|Follow up: Week 32 to Week 36||1||
59881756|NCT04230213|76004605|FG002|NOT COMPLETED|Follow up: Week 32 to Week 36||2||
59881757|NCT04222725|76004617|FG000|STARTED|Overall Study||8||
59881758|NCT04222725|76004618|FG001|STARTED|Overall Study||10||
59881759|NCT04222725|76004619|FG002|STARTED|Overall Study||9||
59881760|NCT04222725|76004620|FG003|STARTED|Overall Study||10||
59881761|NCT04222725|76004617|FG000|COMPLETED|Overall Study||8||
60141985|NCT00947505|76265337|FG001|NOT COMPLETED|Overall Study||2||
60141986|NCT00947661|76265345|FG000|STARTED|Overall Study||289||
60141987|NCT00947661|76265346|FG001|STARTED|Overall Study||289||
60141988|NCT00947661|76265345|FG000|COMPLETED|Overall Study||276||
60141989|NCT00947661|76265346|FG001|COMPLETED|Overall Study||274||
60141990|NCT00947661|76265345|FG000|NOT COMPLETED|Overall Study||13||
60141991|NCT00947661|76265346|FG001|NOT COMPLETED|Overall Study||15||
60141992|NCT02634606|76265352|FG000|STARTED|Overall Study||13|13 eligible participants enrolled; none were assigned to an intervention prior to termination.|
60141993|NCT02634606|76265352|FG000|COMPLETED|Overall Study||0||
60141994|NCT02634606|76265352|FG000|NOT COMPLETED|Overall Study||13||
60141995|NCT00942903|76265360|FG000|STARTED|Overall Study||20||
60141996|NCT00942903|76265360|FG000|COMPLETED|Overall Study||20||
60141997|NCT00942903|76265360|FG000|NOT COMPLETED|Overall Study||0||
60141998|NCT02335229|76265364|FG000|STARTED|Overall Study||30||
60141999|NCT02335229|76265364|FG000|Received Trial System|Overall Study||10||
60142000|NCT02335229|76265364|FG000|Received Permanent System|Overall Study||26||
60142001|NCT02335229|76265364|FG000|COMPLETED|Overall Study||23||
60142002|NCT02335229|76265364|FG000|NOT COMPLETED|Overall Study||7||
60142003|NCT00939705|76265370|FG000|STARTED|Period 1 - First Intervention - 5 Days||9||
60142004|NCT00939705|76265371|FG001|STARTED|Period 1 - First Intervention - 5 Days||9||
60142005|NCT00939705|76265370|FG000|COMPLETED|Period 1 - First Intervention - 5 Days||9||
60142006|NCT00939705|76265371|FG001|COMPLETED|Period 1 - First Intervention - 5 Days||9||
60142007|NCT00939705|76265370|FG000|NOT COMPLETED|Period 1 - First Intervention - 5 Days||0||
60142008|NCT00939705|76265371|FG001|NOT COMPLETED|Period 1 - First Intervention - 5 Days||0||
60142009|NCT00939705|76265370|FG000|STARTED|Period 2 - Washout Period - 21 Days||9||
60142010|NCT00939705|76265371|FG001|STARTED|Period 2 - Washout Period - 21 Days||9||
60142011|NCT00939705|76265370|FG000|COMPLETED|Period 2 - Washout Period - 21 Days||9||
60142012|NCT00939705|76265371|FG001|COMPLETED|Period 2 - Washout Period - 21 Days||9||
60142013|NCT00939705|76265370|FG000|NOT COMPLETED|Period 2 - Washout Period - 21 Days||0||
60142014|NCT00939705|76265371|FG001|NOT COMPLETED|Period 2 - Washout Period - 21 Days||0||
60142015|NCT00939705|76265370|FG000|STARTED|Period 3 - Second Intervent - 5 Days||9||
60142016|NCT00939705|76265371|FG001|STARTED|Period 3 - Second Intervent - 5 Days||9||
60142017|NCT00939705|76265370|FG000|COMPLETED|Period 3 - Second Intervent - 5 Days||9||
60142018|NCT00939705|76265371|FG001|COMPLETED|Period 3 - Second Intervent - 5 Days||9||
60142019|NCT00939705|76265370|FG000|NOT COMPLETED|Period 3 - Second Intervent - 5 Days||0||
60142020|NCT00939705|76265371|FG001|NOT COMPLETED|Period 3 - Second Intervent - 5 Days||0||
60142021|NCT02159079|76265379|FG000|STARTED|Overall Study||15||
60142022|NCT02159079|76265380|FG001|STARTED|Overall Study||15||
60142023|NCT02159079|76265379|FG000|COMPLETED|Overall Study||15||
60142024|NCT02159079|76265380|FG001|COMPLETED|Overall Study||15||
60142025|NCT02159079|76265379|FG000|NOT COMPLETED|Overall Study||0||
60142026|NCT02159079|76265380|FG001|NOT COMPLETED|Overall Study||0||
60142027|NCT00944073|76265388|FG000|STARTED|Overall Study||292||
60142028|NCT00944073|76265389|FG001|STARTED|Overall Study||291||
60142029|NCT00944073|76265388|FG000|COMPLETED|Overall Study||287||
60142030|NCT00944073|76265389|FG001|COMPLETED|Overall Study||287||
60142031|NCT00944073|76265388|FG000|NOT COMPLETED|Overall Study||5||
60142032|NCT00944073|76265389|FG001|NOT COMPLETED|Overall Study||4||
60142033|NCT01672866|76265398|FG000|STARTED|Blinded Phase (up to 240 Weeks)||74||
60142034|NCT01672866|76265399|FG001|STARTED|Blinded Phase (up to 240 Weeks)||74||
60142035|NCT01672866|76265400|FG002|STARTED|Blinded Phase (up to 240 Weeks)||74||
60142036|NCT01672866|76265398|FG000|COMPLETED|Blinded Phase (up to 240 Weeks)||0||
60142037|NCT01672866|76265399|FG001|COMPLETED|Blinded Phase (up to 240 Weeks)||0||
60142038|NCT01672866|76265400|FG002|COMPLETED|Blinded Phase (up to 240 Weeks)||0||
60142039|NCT01672866|76265398|FG000|NOT COMPLETED|Blinded Phase (up to 240 Weeks)||74||
60142040|NCT01672866|76265399|FG001|NOT COMPLETED|Blinded Phase (up to 240 Weeks)||74||
60142041|NCT01672866|76265400|FG002|NOT COMPLETED|Blinded Phase (up to 240 Weeks)||74||
60142042|NCT01672866|76265398|FG000|STARTED|Open-Label Phase (up to 240 Weeks)|Met protocol-specified reason(s) for study discontinuation during Blinded Phase & entered Open-Label|11||
60142043|NCT01672866|76265399|FG001|STARTED|Open-Label Phase (up to 240 Weeks)|Met protocol-specified reason(s) for study discontinuation during Blinded Phase & entered Open-Label|15||
60142044|NCT01672866|76265400|FG002|STARTED|Open-Label Phase (up to 240 Weeks)|Met protocol-specified reason(s) for study discontinuation during Blinded Phase & entered Open-Label|16||
60142045|NCT01672866|76265398|FG000|COMPLETED|Open-Label Phase (up to 240 Weeks)||0||
59881762|NCT04222725|76004618|FG001|COMPLETED|Overall Study||9||
59881763|NCT04222725|76004619|FG002|COMPLETED|Overall Study||9||
59881764|NCT04222725|76004620|FG003|COMPLETED|Overall Study||10||
60142046|NCT01672866|76265399|FG001|COMPLETED|Open-Label Phase (up to 240 Weeks)||0||
60142047|NCT01672866|76265400|FG002|COMPLETED|Open-Label Phase (up to 240 Weeks)||0||
60142048|NCT01672866|76265398|FG000|NOT COMPLETED|Open-Label Phase (up to 240 Weeks)||11||
60142049|NCT01672866|76265399|FG001|NOT COMPLETED|Open-Label Phase (up to 240 Weeks)||15||
60142050|NCT01672866|76265400|FG002|NOT COMPLETED|Open-Label Phase (up to 240 Weeks)||16||
60142051|NCT00950235|76265412|FG000|STARTED|Overall Study||60||
60142052|NCT00950235|76265413|FG001|STARTED|Overall Study||58||
60142053|NCT00950235|76265412|FG000|COMPLETED|Overall Study||58||
60142054|NCT00950235|76265413|FG001|COMPLETED|Overall Study||54||
60142055|NCT00950235|76265412|FG000|NOT COMPLETED|Overall Study||2||
60142056|NCT00950235|76265413|FG001|NOT COMPLETED|Overall Study||4||
60142057|NCT03583931|76265421|FG000|STARTED|Overall Study||5||
60142058|NCT03583931|76265422|FG001|STARTED|Overall Study||5||
60142059|NCT03583931|76265421|FG000|COMPLETED|Overall Study||5||
60142060|NCT03583931|76265422|FG001|COMPLETED|Overall Study||5||
60142061|NCT03583931|76265421|FG000|NOT COMPLETED|Overall Study||0||
60142062|NCT03583931|76265422|FG001|NOT COMPLETED|Overall Study||0||
60142063|NCT00951093|76265428|FG000|STARTED|Before GBP||53||
60142064|NCT00951093|76265428|FG000|COMPLETED|Before GBP||53||
60142065|NCT00951093|76265428|FG000|NOT COMPLETED|Before GBP||0||
60142066|NCT00951093|76265428|FG000|STARTED|6 Months After GBP||53||
60142067|NCT00951093|76265428|FG000|COMPLETED|6 Months After GBP||53||
60142068|NCT00951093|76265428|FG000|NOT COMPLETED|6 Months After GBP||0||
60142069|NCT00951561|76265434|FG000|STARTED|Overall Study|Randomized Vipon or Ibuprofen period 1, crossover period 2, randomized period 3, crossover period 4|25||
60142070|NCT00951561|76265435|FG001|STARTED|Overall Study||29||
60142071|NCT00951561|76265436|FG002|STARTED|Overall Study|1 subject used Vipon periods 1 & 2 instead of Ibuprofen period 2.|21||
60142072|NCT00951561|76265437|FG003|STARTED|Overall Study||27||
60142073|NCT00951561|76265434|FG000|COMPLETED|Overall Study||25||
60142074|NCT00951561|76265435|FG001|COMPLETED|Overall Study||29||
60142075|NCT00951561|76265436|FG002|COMPLETED|Overall Study|3 subjects dropped after period 2|18||
60142076|NCT00951561|76265437|FG003|COMPLETED|Overall Study|1 subject dropped after period 2|26||
60142077|NCT00951561|76265434|FG000|NOT COMPLETED|Overall Study||0||
60142078|NCT00951561|76265435|FG001|NOT COMPLETED|Overall Study||0||
60142079|NCT00951561|76265436|FG002|NOT COMPLETED|Overall Study||3||
60142080|NCT00951561|76265437|FG003|NOT COMPLETED|Overall Study||1||
60142081|NCT03581279|76265444|FG000|STARTED|Overall Study||18||
60142082|NCT03581279|76265445|FG001|STARTED|Overall Study||0||
60142083|NCT03581279|76265444|FG000|COMPLETED|Overall Study||16||
60142084|NCT03581279|76265445|FG001|COMPLETED|Overall Study||0||
60142085|NCT03581279|76265444|FG000|NOT COMPLETED|Overall Study||2||
60142086|NCT03581279|76265445|FG001|NOT COMPLETED|Overall Study||0||
60142087|NCT03020225|76265454|FG000|STARTED|Overall Study||12||
60142088|NCT03020225|76265455|FG001|STARTED|Overall Study||11||
60142089|NCT03020225|76265456|FG002|STARTED|Overall Study||13||
60142090|NCT03020225|76265454|FG000|COMPLETED|Overall Study||12||
60142091|NCT03020225|76265455|FG001|COMPLETED|Overall Study||11||
60142092|NCT03020225|76265456|FG002|COMPLETED|Overall Study||13||
60142093|NCT03020225|76265454|FG000|NOT COMPLETED|Overall Study||0||
60142094|NCT03020225|76265455|FG001|NOT COMPLETED|Overall Study||0||
60142095|NCT03020225|76265456|FG002|NOT COMPLETED|Overall Study||0||
60142096|NCT00941889|76265490|FG000|STARTED|Overall Study||17||
60142097|NCT00941889|76265491|FG001|STARTED|Overall Study||15||
60142098|NCT00941889|76265490|FG000|COMPLETED|Overall Study||5||
60142099|NCT00941889|76265491|FG001|COMPLETED|Overall Study||3||
60142100|NCT00941889|76265490|FG000|NOT COMPLETED|Overall Study||12||
60142101|NCT00941889|76265491|FG001|NOT COMPLETED|Overall Study||12||
60142102|NCT00946023|76265497|FG000|STARTED|Overall Study||83||
60142103|NCT00946023|76265497|FG000|COMPLETED|Overall Study||83||
60142104|NCT00946023|76265497|FG000|NOT COMPLETED|Overall Study||0||
60142105|NCT00952653|76265501|FG000|STARTED|Period 1: MDZ Alone||28||
60142106|NCT00952653|76265501|FG000|COMPLETED|Period 1: MDZ Alone||28||
60142107|NCT00952653|76265501|FG000|NOT COMPLETED|Period 1: MDZ Alone||0||
60142108|NCT00952653|76265501|FG000|STARTED|Period 2: Coadministration DVS SR, MDZ||28||
60142109|NCT00952653|76265501|FG000|COMPLETED|Period 2: Coadministration DVS SR, MDZ||28||
60142110|NCT00952653|76265501|FG000|NOT COMPLETED|Period 2: Coadministration DVS SR, MDZ||0||
60142111|NCT00953121|76265511|FG000|STARTED|Overall Study||40||
60142112|NCT00953121|76265512|FG001|STARTED|Overall Study||39||
60142113|NCT00953121|76265513|FG002|STARTED|Overall Study||25||
60142114|NCT00953121|76265511|FG000|COMPLETED|Overall Study||40||
60142115|NCT00953121|76265512|FG001|COMPLETED|Overall Study||39||
60142116|NCT00953121|76265513|FG002|COMPLETED|Overall Study||25||
60142117|NCT00953121|76265511|FG000|NOT COMPLETED|Overall Study||0||
60142118|NCT00953121|76265512|FG001|NOT COMPLETED|Overall Study||0||
60142119|NCT00953121|76265513|FG002|NOT COMPLETED|Overall Study||0||
60142120|NCT00953199|76265523|FG000|STARTED|Overall Study||254||
60142121|NCT00953199|76265524|FG001|STARTED|Overall Study||252||
60142122|NCT00953199|76265523|FG000|COMPLETED|Overall Study||254||
60142123|NCT00953199|76265524|FG001|COMPLETED|Overall Study||252||
60142124|NCT00953199|76265523|FG000|NOT COMPLETED|Overall Study||0||
60142125|NCT00953199|76265524|FG001|NOT COMPLETED|Overall Study||0||
60142126|NCT00947271|76265536|FG000|STARTED|3 Months Post Intervention||254||
60142127|NCT00947271|76265537|FG001|STARTED|3 Months Post Intervention||252||
60142128|NCT00947271|76265538|FG002|STARTED|3 Months Post Intervention||254||
60142129|NCT00947271|76265539|FG003|STARTED|3 Months Post Intervention||250||
60142130|NCT00947271|76265536|FG000|COMPLETED|3 Months Post Intervention||202||
60142131|NCT00947271|76265537|FG001|COMPLETED|3 Months Post Intervention||204||
60142132|NCT00947271|76265538|FG002|COMPLETED|3 Months Post Intervention||218||
60142133|NCT00947271|76265539|FG003|COMPLETED|3 Months Post Intervention||206||
60142134|NCT00947271|76265536|FG000|NOT COMPLETED|3 Months Post Intervention||52||
60142135|NCT00947271|76265537|FG001|NOT COMPLETED|3 Months Post Intervention||48||
60142136|NCT00947271|76265538|FG002|NOT COMPLETED|3 Months Post Intervention||36||
60142137|NCT00947271|76265539|FG003|NOT COMPLETED|3 Months Post Intervention||44||
60142138|NCT00947271|76265536|FG000|STARTED|6 Months Post Intervention||254||
60142139|NCT00947271|76265537|FG001|STARTED|6 Months Post Intervention||252||
60142140|NCT00947271|76265538|FG002|STARTED|6 Months Post Intervention||254||
60142141|NCT00947271|76265539|FG003|STARTED|6 Months Post Intervention||250||
60142142|NCT00947271|76265536|FG000|COMPLETED|6 Months Post Intervention||199||
60142143|NCT00947271|76265537|FG001|COMPLETED|6 Months Post Intervention||199||
60142144|NCT00947271|76265538|FG002|COMPLETED|6 Months Post Intervention||196||
60142145|NCT00947271|76265539|FG003|COMPLETED|6 Months Post Intervention||196||
60142146|NCT00947271|76265536|FG000|NOT COMPLETED|6 Months Post Intervention||55||
60142147|NCT00947271|76265537|FG001|NOT COMPLETED|6 Months Post Intervention||53||
60142148|NCT00947271|76265538|FG002|NOT COMPLETED|6 Months Post Intervention||58||
60142149|NCT00947271|76265539|FG003|NOT COMPLETED|6 Months Post Intervention||54||
60142150|NCT00947271|76265536|FG000|STARTED|9 Months Post Intervention||254||
60142151|NCT00947271|76265537|FG001|STARTED|9 Months Post Intervention||252||
60142152|NCT00947271|76265538|FG002|STARTED|9 Months Post Intervention||254||
60142153|NCT00947271|76265539|FG003|STARTED|9 Months Post Intervention||250||
60142154|NCT00947271|76265536|FG000|COMPLETED|9 Months Post Intervention||184||
60142155|NCT00947271|76265537|FG001|COMPLETED|9 Months Post Intervention||192||
60142156|NCT00947271|76265538|FG002|COMPLETED|9 Months Post Intervention||193||
60142157|NCT00947271|76265539|FG003|COMPLETED|9 Months Post Intervention||191||
60142158|NCT00947271|76265536|FG000|NOT COMPLETED|9 Months Post Intervention||70||
60142159|NCT00947271|76265537|FG001|NOT COMPLETED|9 Months Post Intervention||60||
60142160|NCT00947271|76265538|FG002|NOT COMPLETED|9 Months Post Intervention||61||
60142161|NCT00947271|76265539|FG003|NOT COMPLETED|9 Months Post Intervention||59||
60142162|NCT00947271|76265536|FG000|STARTED|12 Months Post Intervention||254||
60142163|NCT00947271|76265537|FG001|STARTED|12 Months Post Intervention||252||
60142164|NCT00947271|76265538|FG002|STARTED|12 Months Post Intervention||254||
60142165|NCT00947271|76265539|FG003|STARTED|12 Months Post Intervention||250||
60142166|NCT00947271|76265536|FG000|COMPLETED|12 Months Post Intervention||183||
60142167|NCT00947271|76265537|FG001|COMPLETED|12 Months Post Intervention||192||
60142168|NCT00947271|76265538|FG002|COMPLETED|12 Months Post Intervention||195||
60142169|NCT00947271|76265539|FG003|COMPLETED|12 Months Post Intervention||188||
60142170|NCT00947271|76265536|FG000|NOT COMPLETED|12 Months Post Intervention||71||
60142171|NCT00947271|76265537|FG001|NOT COMPLETED|12 Months Post Intervention||60||
60142172|NCT00947271|76265538|FG002|NOT COMPLETED|12 Months Post Intervention||59||
60142173|NCT00947271|76265539|FG003|NOT COMPLETED|12 Months Post Intervention||62||
60142174|NCT00956085|76265549|FG000|STARTED|Overall Study||12||
60142175|NCT00956085|76265549|FG000|COMPLETED|Overall Study||12||
60142176|NCT00956085|76265549|FG000|NOT COMPLETED|Overall Study||0||
60142177|NCT01005459|76265555|FG000|STARTED|Overall Study||23||
60142178|NCT01005459|76265556|FG001|STARTED|Overall Study||23||
60142179|NCT01005459|76265555|FG000|COMPLETED|Overall Study||23||
60142180|NCT01005459|76265556|FG001|COMPLETED|Overall Study||23||
60142181|NCT01005459|76265555|FG000|NOT COMPLETED|Overall Study||0||
60142182|NCT01005459|76265556|FG001|NOT COMPLETED|Overall Study||0||
60142183|NCT01007643|76265564|FG000|STARTED|Overall Study||8||
60142184|NCT01007643|76265565|FG001|STARTED|Overall Study||14||
60142185|NCT01007643|76265564|FG000|COMPLETED|Overall Study||8||
60142186|NCT01007643|76265565|FG001|COMPLETED|Overall Study||14||
60142187|NCT01007643|76265564|FG000|NOT COMPLETED|Overall Study||0||
60142188|NCT01007643|76265565|FG001|NOT COMPLETED|Overall Study||0||
60142189|NCT00956631|76265571|FG000|STARTED|Overall Study||78||
60142190|NCT00956631|76265571|FG000|COMPLETED|Overall Study||62||
60142191|NCT00956631|76265571|FG000|NOT COMPLETED|Overall Study||16||
60142192|NCT01008969|76265577|FG000|STARTED|Overall Study||10||
60142193|NCT01008969|76265577|FG000|COMPLETED|Overall Study||10||
60142194|NCT01008969|76265577|FG000|NOT COMPLETED|Overall Study||0||
60142195|NCT00956709|76265583|FG000|STARTED|Overall Study||16||
60142196|NCT00956709|76265584|FG001|STARTED|Overall Study||19||
60142197|NCT00956709|76265583|FG000|COMPLETED|Overall Study||16||
60142198|NCT00956709|76265584|FG001|COMPLETED|Overall Study||19||
60142199|NCT00956709|76265583|FG000|NOT COMPLETED|Overall Study||0||
60142200|NCT00956709|76265584|FG001|NOT COMPLETED|Overall Study||0||
60142201|NCT00957333|76265590|FG000|STARTED|Overall Study||44||
60142202|NCT00957333|76265590|FG000|COMPLETED|Overall Study||44||
60142203|NCT00957333|76265590|FG000|NOT COMPLETED|Overall Study||0||
60142204|NCT01010763|76265596|FG000|STARTED|Overall Study||96||
60142205|NCT01010763|76265597|FG001|STARTED|Overall Study||84||
60142206|NCT01010763|76265596|FG000|COMPLETED|Overall Study||61||
60142207|NCT01010763|76265597|FG001|COMPLETED|Overall Study||54||
60142208|NCT01010763|76265596|FG000|NOT COMPLETED|Overall Study||35||
60142209|NCT01010763|76265597|FG001|NOT COMPLETED|Overall Study||30||
60142210|NCT02159547|76265605|FG000|STARTED|Overall Study||112||
60142211|NCT02159547|76265606|FG001|STARTED|Overall Study||112||
60142212|NCT02159547|76265605|FG000|COMPLETED|Overall Study||112||
60142213|NCT02159547|76265606|FG001|COMPLETED|Overall Study||112||
60142214|NCT02159547|76265605|FG000|NOT COMPLETED|Overall Study||0||
60142215|NCT02159547|76265606|FG001|NOT COMPLETED|Overall Study||0||
60142216|NCT00958035|76265615|FG000|STARTED|Overall Study||46||
60142217|NCT00958035|76265616|FG001|STARTED|Overall Study||43||
60142218|NCT00958035|76265615|FG000|COMPLETED|Overall Study||43||
60142219|NCT00958035|76265616|FG001|COMPLETED|Overall Study||39||
60142220|NCT00958035|76265615|FG000|NOT COMPLETED|Overall Study||3||
60142221|NCT00958035|76265616|FG001|NOT COMPLETED|Overall Study||4||
60142222|NCT04465877|76265626|FG000|STARTED|Overall Study||9||
60142223|NCT04465877|76265627|FG001|STARTED|Overall Study||9||
60010185|NCT04020341|76125877|FG001|Micro-ITT NTF-S (IA Set) Population|Overall Study||287|Microbiological intent-to-treat susceptible to nitrofurantoin (micro-ITT NTF-S) (IA Set) population included participants in the micro ITT NTF-S who per the interim analysis data had the opportunity to reach their Test of Cure (TOC) visit, or had not yet reached their TOC visit, but were already known to be failures.|
60010186|NCT04020341|76125876|FG000|COMPLETED|Overall Study||734||
60010187|NCT04020341|76125877|FG001|COMPLETED|Overall Study||736||
60010188|NCT04020341|76125876|FG000|NOT COMPLETED|Overall Study||33||
60010189|NCT04020341|76125877|FG001|NOT COMPLETED|Overall Study||28||
60010190|NCT04011280|76125885|FG000|STARTED|Overall Study||14||
60010191|NCT04011280|76125886|FG001|STARTED|Overall Study||14||
60010192|NCT04011280|76125885|FG000|COMPLETED|Overall Study||9||
60010193|NCT04011280|76125886|FG001|COMPLETED|Overall Study||12||
60142224|NCT04465877|76265628|FG002|STARTED|Overall Study||10||
60142225|NCT04465877|76265629|FG003|STARTED|Overall Study||9||
60142226|NCT04465877|76265626|FG000|Randomized Population|Overall Study||9|Randomized Population consists of all subjects randomized to receive JTT-662 or placebo on Day 1.|
60142227|NCT04465877|76265627|FG001|Randomized Population|Overall Study||9|Randomized Population consists of all subjects randomized to receive JTT-662 or placebo on Day 1.|
60142228|NCT04465877|76265628|FG002|Randomized Population|Overall Study||10|Randomized Population consists of all subjects randomized to receive JTT-662 or placebo on Day 1.|
60010194|NCT04011280|76125885|FG000|NOT COMPLETED|Overall Study||5||
60142229|NCT04465877|76265629|FG003|Randomized Population|Overall Study||9|Randomized Population consists of all subjects randomized to receive JTT-662 or placebo on Day 1.|
60142230|NCT04465877|76265626|FG000|Safety Population|Overall Study||9|Safety Population consists of subjects who were randomly assigned to treatment and who received at least one dose of study drug.|
60010195|NCT04011280|76125886|FG001|NOT COMPLETED|Overall Study||2||
60010196|NCT03962348|76125893|FG000|STARTED|Overall Study||8||
60142231|NCT04465877|76265627|FG001|Safety Population|Overall Study||9|Safety Population consists of subjects who were randomly assigned to treatment and who received at least one dose of study drug.|
60142232|NCT04465877|76265628|FG002|Safety Population|Overall Study||10|Safety Population consists of subjects who were randomly assigned to treatment and who received at least one dose of study drug.|
60010197|NCT03962348|76125893|FG000|COMPLETED|Overall Study||8||
60010198|NCT03962348|76125893|FG000|NOT COMPLETED|Overall Study||0||
60010199|NCT03868891|76125899|FG000|STARTED|Overall Study||8||
60010200|NCT03868891|76125900|FG001|STARTED|Overall Study||3||
60010201|NCT03868891|76125899|FG000|Visit 2|Overall Study||7||
60010202|NCT03868891|76125900|FG001|Visit 2|Overall Study||1||
60010203|NCT03868891|76125899|FG000|Visit 3|Overall Study||4||
60010204|NCT03868891|76125900|FG001|Visit 3|Overall Study||0||
60010205|NCT03868891|76125899|FG000|COMPLETED|Overall Study||4||
60010206|NCT03868891|76125900|FG001|COMPLETED|Overall Study||0||
60010207|NCT03868891|76125899|FG000|NOT COMPLETED|Overall Study||4||
60010208|NCT03868891|76125900|FG001|NOT COMPLETED|Overall Study||3||
60010209|NCT03827655|76125911|FG000|STARTED|Overall Study||52||
60010210|NCT03827655|76125912|FG001|STARTED|Overall Study||27||
60010211|NCT03827655|76125913|FG002|STARTED|Overall Study||51||
60010212|NCT03827655|76125914|FG003|STARTED|Overall Study||27||
60010213|NCT03827655|76125915|FG004|STARTED|Overall Study||52||
60010214|NCT03827655|76125911|FG000|Safety Set|Overall Study||49|Safety Set included all participants who were randomized and received at least 1 dose of double-blind study medication.|
60010215|NCT03827655|76125912|FG001|Safety Set|Overall Study||26|Safety Set included all participants who were randomized and received at least 1 dose of double-blind study medication.|
60010216|NCT03827655|76125913|FG002|Safety Set|Overall Study||48|Safety Set included all participants who were randomized and received at least 1 dose of double-blind study medication.|
60010217|NCT03827655|76125914|FG003|Safety Set|Overall Study||25|Safety Set included all participants who were randomized and received at least 1 dose of double-blind study medication.|
60010218|NCT03827655|76125915|FG004|Safety Set|Overall Study||50|Safety Set included all participants who were randomized and received at least 1 dose of double-blind study medication.|
60010219|NCT03827655|76125911|FG000|Full Analysis Set (FAS)|Overall Study||45|FAS included all participants who were randomized, received at least 1 dose of study drug, and had at least 1 valid postbaseline on-treatment primary efficacy evaluation (bowel movement or tolerating solid food).|
60010220|NCT03827655|76125912|FG001|Full Analysis Set (FAS)|Overall Study||23|FAS included all participants who were randomized, received at least 1 dose of study drug, and had at least 1 valid postbaseline on-treatment primary efficacy evaluation (bowel movement or tolerating solid food).|
60010221|NCT03827655|76125913|FG002|Full Analysis Set (FAS)|Overall Study||42|FAS included all participants who were randomized, received at least 1 dose of study drug, and had at least 1 valid postbaseline on-treatment primary efficacy evaluation (bowel movement or tolerating solid food).|
60010222|NCT03827655|76125914|FG003|Full Analysis Set (FAS)|Overall Study||21|FAS included all participants who were randomized, received at least 1 dose of study drug, and had at least 1 valid postbaseline on-treatment primary efficacy evaluation (bowel movement or tolerating solid food).|
60010223|NCT03827655|76125915|FG004|Full Analysis Set (FAS)|Overall Study||44|FAS included all participants who were randomized, received at least 1 dose of study drug, and had at least 1 valid postbaseline on-treatment primary efficacy evaluation (bowel movement or tolerating solid food).|
60010224|NCT03827655|76125911|FG000|Pharmacokinetic (PK) Analysis Set|Overall Study||0|PK Analysis Set included all participants who were randomized, received at least 1 dose and had at least 1 measurable post-dose plasma for TAK-954.|
60010225|NCT03827655|76125912|FG001|Pharmacokinetic (PK) Analysis Set|Overall Study||26|PK Analysis Set included all participants who were randomized, received at least 1 dose and had at least 1 measurable post-dose plasma for TAK-954.|
60010226|NCT03827655|76125913|FG002|Pharmacokinetic (PK) Analysis Set|Overall Study||47|PK Analysis Set included all participants who were randomized, received at least 1 dose and had at least 1 measurable post-dose plasma for TAK-954.|
60067709|NCT01617187|76182891|FG000|COMPLETED|Randomization Through Start Treatment||97||
60142233|NCT04465877|76265629|FG003|Safety Population|Overall Study||9|Safety Population consists of subjects who were randomly assigned to treatment and who received at least one dose of study drug.|
60142234|NCT04465877|76265626|FG000|PK (Pharmacokinetic) Population|Overall Study||9|PK (Pharmacokinetic) Population consists of subjects randomized to JTT-662 treatment groups who received at least one dose of JTT-662 and had available PK data.|
60142235|NCT04465877|76265627|FG001|PK (Pharmacokinetic) Population|Overall Study||9|PK (Pharmacokinetic) Population consists of subjects randomized to JTT-662 treatment groups who received at least one dose of JTT-662 and had available PK data.|
60142236|NCT04465877|76265628|FG002|PK (Pharmacokinetic) Population|Overall Study||10|PK (Pharmacokinetic) Population consists of subjects randomized to JTT-662 treatment groups who received at least one dose of JTT-662 and had available PK data.|
60142237|NCT04465877|76265629|FG003|PK (Pharmacokinetic) Population|Overall Study||0|PK (Pharmacokinetic) Population consists of subjects randomized to JTT-662 treatment groups who received at least one dose of JTT-662 and had available PK data.|
60142238|NCT04465877|76265626|FG000|PD (Pharmacodynamic) Population|Overall Study||9|PD (Pharmacodynamic) Population consists of subjects who were randomly assigned to treatment, received at least one dose of JTT-662 or placebo starting on Day 1 and had evaluable PD data.|
60142239|NCT04465877|76265627|FG001|PD (Pharmacodynamic) Population|Overall Study||9|PD (Pharmacodynamic) Population consists of subjects who were randomly assigned to treatment, received at least one dose of JTT-662 or placebo starting on Day 1 and had evaluable PD data.|
60142240|NCT04465877|76265628|FG002|PD (Pharmacodynamic) Population|Overall Study||10|PD (Pharmacodynamic) Population consists of subjects who were randomly assigned to treatment, received at least one dose of JTT-662 or placebo starting on Day 1 and had evaluable PD data.|
60142241|NCT04465877|76265629|FG003|PD (Pharmacodynamic) Population|Overall Study||9|PD (Pharmacodynamic) Population consists of subjects who were randomly assigned to treatment, received at least one dose of JTT-662 or placebo starting on Day 1 and had evaluable PD data.|
60142242|NCT04465877|76265626|FG000|COMPLETED|Overall Study||9||
60142243|NCT04465877|76265627|FG001|COMPLETED|Overall Study||9||
60142244|NCT04465877|76265628|FG002|COMPLETED|Overall Study||9||
60142245|NCT04465877|76265629|FG003|COMPLETED|Overall Study||9||
60142246|NCT04465877|76265626|FG000|NOT COMPLETED|Overall Study||0||
60142247|NCT04465877|76265627|FG001|NOT COMPLETED|Overall Study||0||
60142248|NCT04465877|76265628|FG002|NOT COMPLETED|Overall Study||1||
60142249|NCT04465877|76265629|FG003|NOT COMPLETED|Overall Study||0||
60142250|NCT01011075|76265641|FG000|STARTED|Overall Study||34||
60142251|NCT01011075|76265641|FG000|COMPLETED|Overall Study||34||
60142252|NCT01011075|76265641|FG000|NOT COMPLETED|Overall Study||0||
60142253|NCT00958581|76265648|FG000|STARTED|Overall Study||61||
60142254|NCT00958581|76265649|FG001|STARTED|Overall Study||61||
60142255|NCT00958581|76265650|FG002|STARTED|Overall Study||55||
60142256|NCT00958581|76265648|FG000|COMPLETED|Overall Study||61||
60142257|NCT00958581|76265649|FG001|COMPLETED|Overall Study||61||
60142258|NCT00958581|76265650|FG002|COMPLETED|Overall Study||55||
60142259|NCT00958581|76265648|FG000|NOT COMPLETED|Overall Study||0||
60142260|NCT00958581|76265649|FG001|NOT COMPLETED|Overall Study||0||
60142261|NCT00958581|76265650|FG002|NOT COMPLETED|Overall Study||0||
60142262|NCT01012089|76265663|FG000|STARTED|Overall Study||6||
60142263|NCT01012089|76265663|FG000|COMPLETED|Overall Study||6||
60142264|NCT01012089|76265663|FG000|NOT COMPLETED|Overall Study||0||
60142265|NCT00959985|76265673|FG000|STARTED|Overall Study||8||
60142266|NCT00959985|76265674|FG001|STARTED|Overall Study||7||
60142267|NCT00959985|76265675|FG002|STARTED|Overall Study||4||
60142268|NCT00959985|76265676|FG003|STARTED|Overall Study||4||
60142269|NCT00959985|76265673|FG000|COMPLETED|Overall Study||8||
60142270|NCT00959985|76265674|FG001|COMPLETED|Overall Study||7||
60142271|NCT00959985|76265675|FG002|COMPLETED|Overall Study||4||
60142272|NCT00959985|76265676|FG003|COMPLETED|Overall Study||4||
60142273|NCT00959985|76265673|FG000|NOT COMPLETED|Overall Study||0||
60142274|NCT00959985|76265674|FG001|NOT COMPLETED|Overall Study||0||
60142275|NCT00959985|76265675|FG002|NOT COMPLETED|Overall Study||0||
60142276|NCT00959985|76265676|FG003|NOT COMPLETED|Overall Study||0||
60142277|NCT04267133|76265686|FG000|STARTED|Overall Study||256||
60142278|NCT04267133|76265686|FG000|COMPLETED|Overall Study||251||
60142279|NCT04267133|76265686|FG000|NOT COMPLETED|Overall Study||5||
60142280|NCT02081573|76265690|FG000|STARTED|Overall Study||10||
60142281|NCT02081573|76265690|FG000|COMPLETED|Overall Study||10||
60142282|NCT02081573|76265690|FG000|NOT COMPLETED|Overall Study||0||
60142283|NCT01012245|76265698|FG000|STARTED|Overall Study||28812||
60142284|NCT01012245|76265698|FG000|COMPLETED|Overall Study|More than 1 discontinuation (DC) reason possible per subject. See outcome measure Reasons for DC.|26385||
60142285|NCT01012245|76265698|FG000|NOT COMPLETED|Overall Study||2427||
60142286|NCT00961233|76265711|FG000|STARTED|Overall Study||13||
60142287|NCT00961233|76265712|FG001|STARTED|Overall Study||12||
60142288|NCT00961233|76265711|FG000|COMPLETED|Overall Study||11||
60142289|NCT00961233|76265712|FG001|COMPLETED|Overall Study||11||
60142290|NCT00961233|76265711|FG000|NOT COMPLETED|Overall Study||2||
60142291|NCT00961233|76265712|FG001|NOT COMPLETED|Overall Study||1||
60142292|NCT00961311|76265720|FG000|STARTED|Overall Study||51||
60142293|NCT00961311|76265720|FG000|COMPLETED|Overall Study||51||
60142294|NCT00961311|76265720|FG000|NOT COMPLETED|Overall Study||0||
60142295|NCT00962871|76265728|FG000|STARTED|Overall Study||6||
60142296|NCT00962871|76265729|FG001|STARTED|Overall Study||6||
60142297|NCT00962871|76265730|FG002|STARTED|Overall Study||12||
60142298|NCT00962871|76265731|FG003|STARTED|Overall Study||6||
60142299|NCT00962871|76265728|FG000|COMPLETED|Overall Study||6||
60142300|NCT00962871|76265729|FG001|COMPLETED|Overall Study||6||
60142301|NCT00962871|76265730|FG002|COMPLETED|Overall Study||12||
60142302|NCT00962871|76265731|FG003|COMPLETED|Overall Study||6||
60142303|NCT00962871|76265728|FG000|NOT COMPLETED|Overall Study||0||
60142304|NCT00962871|76265729|FG001|NOT COMPLETED|Overall Study||0||
60142305|NCT00962871|76265730|FG002|NOT COMPLETED|Overall Study||0||
60142306|NCT00962871|76265731|FG003|NOT COMPLETED|Overall Study||0||
60142307|NCT01014351|76265741|FG000|STARTED|Overall Study||70||
60142308|NCT01014351|76265741|FG000|COMPLETED|Overall Study||33||
60142309|NCT01014351|76265741|FG000|NOT COMPLETED|Overall Study||37||
60142310|NCT01014741|76265747|FG000|STARTED|Overall Study||105||
60142311|NCT01014741|76265748|FG001|STARTED|Overall Study||95||
60142312|NCT01014741|76265747|FG000|COMPLETED|Overall Study||94||
60142313|NCT01014741|76265748|FG001|COMPLETED|Overall Study||90||
60142314|NCT01014741|76265747|FG000|NOT COMPLETED|Overall Study||11||
60142315|NCT01014741|76265748|FG001|NOT COMPLETED|Overall Study||5||
60142316|NCT01015443|76265756|FG000|STARTED|Overall Study||191||
60142317|NCT01015443|76265757|FG001|STARTED|Overall Study||94||
60142318|NCT01015443|76265756|FG000|Treated|Overall Study||191||
60142319|NCT01015443|76265757|FG001|Treated|Overall Study||93||
60142320|NCT01015443|76265756|FG000|COMPLETED|Overall Study||191||
60142321|NCT01015443|76265757|FG001|COMPLETED|Overall Study||94||
60142322|NCT01015443|76265756|FG000|NOT COMPLETED|Overall Study||0||
60142323|NCT01015443|76265757|FG001|NOT COMPLETED|Overall Study||0||
60142324|NCT00962949|76265765|FG000|STARTED|Overall Study||13||
60142325|NCT00962949|76265766|FG001|STARTED|Overall Study||15||
60142326|NCT00962949|76265765|FG000|COMPLETED|Overall Study||13||
60142327|NCT00962949|76265766|FG001|COMPLETED|Overall Study||15||
60142328|NCT00962949|76265765|FG000|NOT COMPLETED|Overall Study||0||
60142329|NCT00962949|76265766|FG001|NOT COMPLETED|Overall Study||0||
60142330|NCT02081807|76265780|FG000|STARTED|Overall Study||7668||
60142331|NCT02081807|76265781|FG001|STARTED|Overall Study||26149||
60142332|NCT02081807|76265782|FG002|STARTED|Overall Study||14852||
60142333|NCT02081807|76265783|FG003|STARTED|Overall Study||9112||
60142334|NCT02081807|76265784|FG004|STARTED|Overall Study||27456||
60142335|NCT02081807|76265785|FG005|STARTED|Overall Study||76055||
60142336|NCT02081807|76265786|FG006|STARTED|Overall Study||40207||
60142337|NCT02081807|76265787|FG007|STARTED|Overall Study||19729||
60142338|NCT02081807|76265780|FG000|COMPLETED|Overall Study||7668||
60142339|NCT02081807|76265781|FG001|COMPLETED|Overall Study||26149||
60142340|NCT02081807|76265782|FG002|COMPLETED|Overall Study||14852||
60142341|NCT02081807|76265783|FG003|COMPLETED|Overall Study||9112||
60142342|NCT02081807|76265784|FG004|COMPLETED|Overall Study||27456||
60142343|NCT02081807|76265785|FG005|COMPLETED|Overall Study||76055||
60142344|NCT02081807|76265786|FG006|COMPLETED|Overall Study||40207||
60142345|NCT02081807|76265787|FG007|COMPLETED|Overall Study||19729||
60142346|NCT02081807|76265780|FG000|NOT COMPLETED|Overall Study||0||
60142347|NCT02081807|76265781|FG001|NOT COMPLETED|Overall Study||0||
60142348|NCT02081807|76265782|FG002|NOT COMPLETED|Overall Study||0||
60142349|NCT02081807|76265783|FG003|NOT COMPLETED|Overall Study||0||
60142350|NCT02081807|76265784|FG004|NOT COMPLETED|Overall Study||0||
60142351|NCT02081807|76265785|FG005|NOT COMPLETED|Overall Study||0||
60142352|NCT02081807|76265786|FG006|NOT COMPLETED|Overall Study||0||
60142353|NCT02081807|76265787|FG007|NOT COMPLETED|Overall Study||0||
60142354|NCT02631876|76265817|FG000|STARTED|Overall Study||248|ITT population: all participants randomized in the study.|
60142355|NCT02631876|76265818|FG001|STARTED|Overall Study||118|ITT population: all participants randomized in the study.|
60142356|NCT02631876|76265817|FG000|Safety Population|Overall Study||243|Enrolled participants who received at least 1 dose of mirvetuximab soravtansine or IC chemotherapy.|
60142357|NCT02631876|76265818|FG001|Safety Population|Overall Study||109|Enrolled participants who received at least 1 dose of mirvetuximab soravtansine or IC chemotherapy.|
60142358|NCT02631876|76265817|FG000|COMPLETED|Overall Study||129||
60142359|NCT02631876|76265818|FG001|COMPLETED|Overall Study||55||
60142360|NCT02631876|76265817|FG000|NOT COMPLETED|Overall Study||119||
60142361|NCT02631876|76265818|FG001|NOT COMPLETED|Overall Study||63||
60142362|NCT04436796|76265827|FG000|STARTED|Overall Study||19||
60142363|NCT04436796|76265828|FG001|STARTED|Overall Study||16||
60142364|NCT04436796|76265827|FG000|COMPLETED|Overall Study||19||
60142365|NCT04436796|76265828|FG001|COMPLETED|Overall Study||16||
60142366|NCT04436796|76265827|FG000|NOT COMPLETED|Overall Study||0||
60142367|NCT04436796|76265828|FG001|NOT COMPLETED|Overall Study||0||
60142368|NCT02081963|76265836|FG000|STARTED|Overall Study||79||
60142369|NCT02081963|76265837|FG001|STARTED|Overall Study||73||
60142370|NCT02081963|76265836|FG000|COMPLETED|Overall Study||74||
60142371|NCT02081963|76265837|FG001|COMPLETED|Overall Study||69||
60142372|NCT02081963|76265836|FG000|NOT COMPLETED|Overall Study||5||
60142373|NCT02081963|76265837|FG001|NOT COMPLETED|Overall Study||4||
60142374|NCT02082119|76265843|FG000|STARTED|Overall Study||82||
60142375|NCT02082119|76265843|FG000|COMPLETED|Overall Study||82||
60142376|NCT02082119|76265843|FG000|NOT COMPLETED|Overall Study||0||
60142377|NCT02633046|76265847|FG000|STARTED|Overall Study||63||
60142378|NCT02633046|76265847|FG000|Safety Population|Overall Study||63||
60142379|NCT02633046|76265847|FG000|COMPLETED|Overall Study||36||
60142380|NCT02633046|76265847|FG000|NOT COMPLETED|Overall Study||27||
60142381|NCT04364802|76265857|FG000|STARTED|Overall Study||11||
60142382|NCT04364802|76265858|FG001|STARTED|Overall Study||38||
60142383|NCT04364802|76265859|FG002|STARTED|Overall Study||17||
60142384|NCT04364802|76265860|FG003|STARTED|Overall Study||14||
60142385|NCT04364802|76265861|FG004|STARTED|Overall Study||2||
60142386|NCT04364802|76265862|FG005|STARTED|Overall Study||16||
60142387|NCT04364802|76265857|FG000|COMPLETED|Overall Study||11||
60142388|NCT04364802|76265858|FG001|COMPLETED|Overall Study||38||
60142389|NCT04364802|76265859|FG002|COMPLETED|Overall Study||17||
60142390|NCT04364802|76265860|FG003|COMPLETED|Overall Study||14||
60142391|NCT04364802|76265861|FG004|COMPLETED|Overall Study||2||
60142392|NCT04364802|76265862|FG005|COMPLETED|Overall Study||16||
60142393|NCT04364802|76265857|FG000|NOT COMPLETED|Overall Study||0||
60142394|NCT04364802|76265858|FG001|NOT COMPLETED|Overall Study||0||
60142395|NCT04364802|76265859|FG002|NOT COMPLETED|Overall Study||0||
60142396|NCT04364802|76265860|FG003|NOT COMPLETED|Overall Study||0||
60142397|NCT04364802|76265861|FG004|NOT COMPLETED|Overall Study||0||
60142398|NCT04364802|76265862|FG005|NOT COMPLETED|Overall Study||0||
60142399|NCT00963105|76265879|FG000|STARTED|Overall Study||34||
60142400|NCT00963105|76265880|FG001|STARTED|Overall Study||35||
60142401|NCT00963105|76265881|FG002|STARTED|Overall Study||35||
60142402|NCT00963105|76265879|FG000|Received Treatment|Overall Study||34||
60142403|NCT00963105|76265880|FG001|Received Treatment|Overall Study||34||
60142404|NCT00963105|76265881|FG002|Received Treatment|Overall Study||35||
60142405|NCT00963105|76265879|FG000|COMPLETED|Overall Study||34|completed represents participants who discontinued the study.|
60142406|NCT00963105|76265880|FG001|COMPLETED|Overall Study||35|completed represents participants who discontinued the study.|
60142407|NCT00963105|76265881|FG002|COMPLETED|Overall Study||35|completed represents participants who discontinued the study.|
60142408|NCT00963105|76265879|FG000|NOT COMPLETED|Overall Study||0||
60142409|NCT00963105|76265880|FG001|NOT COMPLETED|Overall Study||0||
60142410|NCT00963105|76265881|FG002|NOT COMPLETED|Overall Study||0||
60142411|NCT00964119|76265889|FG000|STARTED|Overall Study||15||
60142412|NCT00964119|76265889|FG000|COMPLETED|Overall Study||15||
60142413|NCT00964119|76265889|FG000|NOT COMPLETED|Overall Study||0||
60142414|NCT01016691|76265896|FG000|STARTED|Overall Study||17||
60142415|NCT01016691|76265897|FG001|STARTED|Overall Study||12||
60142416|NCT01016691|76265898|FG002|STARTED|Overall Study||18||
60142417|NCT01016691|76265896|FG000|COMPLETED|Overall Study||17||
60142418|NCT01016691|76265897|FG001|COMPLETED|Overall Study||12||
60142419|NCT01016691|76265898|FG002|COMPLETED|Overall Study||18||
60142420|NCT01016691|76265896|FG000|NOT COMPLETED|Overall Study||0||
60142421|NCT01016691|76265897|FG001|NOT COMPLETED|Overall Study||0||
60142422|NCT01016691|76265898|FG002|NOT COMPLETED|Overall Study||0||
60142423|NCT01672788|76265906|FG000|STARTED|Treatment Period 1 (3 Days)||9||
60142424|NCT01672788|76265907|FG001|STARTED|Treatment Period 1 (3 Days)||9||
60142425|NCT01672788|76265908|FG002|STARTED|Treatment Period 1 (3 Days)||9||
60142426|NCT01672788|76265909|FG003|STARTED|Treatment Period 1 (3 Days)||9||
60142427|NCT01672788|76265906|FG000|COMPLETED|Treatment Period 1 (3 Days)||9||
60142428|NCT01672788|76265907|FG001|COMPLETED|Treatment Period 1 (3 Days)||9||
60142429|NCT01672788|76265908|FG002|COMPLETED|Treatment Period 1 (3 Days)||9||
60142430|NCT01672788|76265909|FG003|COMPLETED|Treatment Period 1 (3 Days)||9||
60142431|NCT01672788|76265906|FG000|NOT COMPLETED|Treatment Period 1 (3 Days)||0||
60142432|NCT01672788|76265907|FG001|NOT COMPLETED|Treatment Period 1 (3 Days)||0||
60142433|NCT01672788|76265908|FG002|NOT COMPLETED|Treatment Period 1 (3 Days)||0||
60142434|NCT01672788|76265909|FG003|NOT COMPLETED|Treatment Period 1 (3 Days)||0||
60142435|NCT01672788|76265906|FG000|STARTED|Washout Period 1 (7 Days)||9||
60142436|NCT01672788|76265907|FG001|STARTED|Washout Period 1 (7 Days)||9||
60142437|NCT01672788|76265908|FG002|STARTED|Washout Period 1 (7 Days)||9||
60142438|NCT01672788|76265909|FG003|STARTED|Washout Period 1 (7 Days)||9||
60142439|NCT01672788|76265906|FG000|COMPLETED|Washout Period 1 (7 Days)||9||
60142440|NCT01672788|76265907|FG001|COMPLETED|Washout Period 1 (7 Days)||9||
60142441|NCT01672788|76265908|FG002|COMPLETED|Washout Period 1 (7 Days)||9||
60142442|NCT01672788|76265909|FG003|COMPLETED|Washout Period 1 (7 Days)||9||
60142443|NCT01672788|76265906|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0||
60142444|NCT01672788|76265907|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0||
60142445|NCT01672788|76265908|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0||
60142446|NCT01672788|76265909|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0||
60142447|NCT01672788|76265906|FG000|STARTED|Treatment Period 2 (3 Days)||9||
60142448|NCT01672788|76265907|FG001|STARTED|Treatment Period 2 (3 Days)||9||
60142449|NCT01672788|76265908|FG002|STARTED|Treatment Period 2 (3 Days)||9||
60142450|NCT01672788|76265909|FG003|STARTED|Treatment Period 2 (3 Days)||9||
60142451|NCT01672788|76265906|FG000|COMPLETED|Treatment Period 2 (3 Days)||9||
60142452|NCT01672788|76265907|FG001|COMPLETED|Treatment Period 2 (3 Days)||9||
60142453|NCT01672788|76265908|FG002|COMPLETED|Treatment Period 2 (3 Days)||9||
60142454|NCT01672788|76265909|FG003|COMPLETED|Treatment Period 2 (3 Days)||9||
60142455|NCT01672788|76265906|FG000|NOT COMPLETED|Treatment Period 2 (3 Days)||0||
60142456|NCT01672788|76265907|FG001|NOT COMPLETED|Treatment Period 2 (3 Days)||0||
60142457|NCT01672788|76265908|FG002|NOT COMPLETED|Treatment Period 2 (3 Days)||0||
60142458|NCT01672788|76265909|FG003|NOT COMPLETED|Treatment Period 2 (3 Days)||0||
60142459|NCT01672788|76265906|FG000|STARTED|Washout Period 2 (7 Days)||9||
60142460|NCT01672788|76265907|FG001|STARTED|Washout Period 2 (7 Days)||9||
60142461|NCT01672788|76265908|FG002|STARTED|Washout Period 2 (7 Days)||9||
60142462|NCT01672788|76265909|FG003|STARTED|Washout Period 2 (7 Days)||9||
60142463|NCT01672788|76265906|FG000|COMPLETED|Washout Period 2 (7 Days)||9||
60142464|NCT01672788|76265907|FG001|COMPLETED|Washout Period 2 (7 Days)||9||
60142465|NCT01672788|76265908|FG002|COMPLETED|Washout Period 2 (7 Days)||9||
60142466|NCT01672788|76265909|FG003|COMPLETED|Washout Period 2 (7 Days)||8||
60142467|NCT01672788|76265906|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0||
60142468|NCT01672788|76265907|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0||
60142469|NCT01672788|76265908|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0||
60142470|NCT01672788|76265909|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||1||
60142471|NCT01672788|76265906|FG000|STARTED|Treatment Period 3 (3 Days)||9||
60142472|NCT01672788|76265907|FG001|STARTED|Treatment Period 3 (3 Days)||9||
60142473|NCT01672788|76265908|FG002|STARTED|Treatment Period 3 (3 Days)||9||
60142474|NCT01672788|76265909|FG003|STARTED|Treatment Period 3 (3 Days)||8||
60142475|NCT01672788|76265906|FG000|COMPLETED|Treatment Period 3 (3 Days)||9||
60142476|NCT01672788|76265907|FG001|COMPLETED|Treatment Period 3 (3 Days)||9||
60142477|NCT01672788|76265908|FG002|COMPLETED|Treatment Period 3 (3 Days)||9||
60142478|NCT01672788|76265909|FG003|COMPLETED|Treatment Period 3 (3 Days)||8||
60142479|NCT01672788|76265906|FG000|NOT COMPLETED|Treatment Period 3 (3 Days)||0||
60142480|NCT01672788|76265907|FG001|NOT COMPLETED|Treatment Period 3 (3 Days)||0||
60142481|NCT01672788|76265908|FG002|NOT COMPLETED|Treatment Period 3 (3 Days)||0||
60142482|NCT01672788|76265909|FG003|NOT COMPLETED|Treatment Period 3 (3 Days)||0||
60142483|NCT01672788|76265906|FG000|STARTED|Washout Period 3 (7 Days)||9||
60142484|NCT01672788|76265907|FG001|STARTED|Washout Period 3 (7 Days)||9||
60142485|NCT01672788|76265908|FG002|STARTED|Washout Period 3 (7 Days)||9||
60142486|NCT01672788|76265909|FG003|STARTED|Washout Period 3 (7 Days)||8||
60142487|NCT01672788|76265906|FG000|COMPLETED|Washout Period 3 (7 Days)||9||
60142488|NCT01672788|76265907|FG001|COMPLETED|Washout Period 3 (7 Days)||9||
60142489|NCT01672788|76265908|FG002|COMPLETED|Washout Period 3 (7 Days)||9||
60142490|NCT01672788|76265909|FG003|COMPLETED|Washout Period 3 (7 Days)||8||
60142491|NCT01672788|76265906|FG000|NOT COMPLETED|Washout Period 3 (7 Days)||0||
60142492|NCT01672788|76265907|FG001|NOT COMPLETED|Washout Period 3 (7 Days)||0||
60142493|NCT01672788|76265908|FG002|NOT COMPLETED|Washout Period 3 (7 Days)||0||
60142494|NCT01672788|76265909|FG003|NOT COMPLETED|Washout Period 3 (7 Days)||0||
60142495|NCT01672788|76265906|FG000|STARTED|Treatment Period 4 (3 Days)||9||
60142496|NCT01672788|76265907|FG001|STARTED|Treatment Period 4 (3 Days)||9||
60142497|NCT01672788|76265908|FG002|STARTED|Treatment Period 4 (3 Days)||9||
60142498|NCT01672788|76265909|FG003|STARTED|Treatment Period 4 (3 Days)||8||
60142499|NCT01672788|76265906|FG000|COMPLETED|Treatment Period 4 (3 Days)||9||
60142500|NCT01672788|76265907|FG001|COMPLETED|Treatment Period 4 (3 Days)||9||
60142501|NCT01672788|76265908|FG002|COMPLETED|Treatment Period 4 (3 Days)||9||
60142502|NCT01672788|76265909|FG003|COMPLETED|Treatment Period 4 (3 Days)||8||
60142503|NCT01672788|76265906|FG000|NOT COMPLETED|Treatment Period 4 (3 Days)||0||
60142504|NCT01672788|76265907|FG001|NOT COMPLETED|Treatment Period 4 (3 Days)||0||
60142505|NCT01672788|76265908|FG002|NOT COMPLETED|Treatment Period 4 (3 Days)||0||
60142506|NCT01672788|76265909|FG003|NOT COMPLETED|Treatment Period 4 (3 Days)||0||
60142507|NCT02632110|76265924|FG000|STARTED|Overall Study||25||25
60142508|NCT02632110|76265925|FG001|STARTED|Overall Study||25||25
60142509|NCT02632110|76265926|FG002|STARTED|Overall Study||27||27
60142510|NCT02632110|76265927|FG003|STARTED|Overall Study||27||27
60142511|NCT02632110|76265928|FG004|STARTED|Overall Study||29||29
60142512|NCT02632110|76265929|FG005|STARTED|Overall Study||29||29
60142513|NCT02632110|76265930|FG006|STARTED|Overall Study||26||26
60142514|NCT02632110|76265931|FG007|STARTED|Overall Study||26||26
60142515|NCT02632110|76265932|FG008|STARTED|Overall Study||30||30
60142516|NCT02632110|76265933|FG009|STARTED|Overall Study||30||30
60142517|NCT02632110|76265924|FG000|COMPLETED|Overall Study||24||24
60142518|NCT02632110|76265925|FG001|COMPLETED|Overall Study||24||24
60142519|NCT02632110|76265926|FG002|COMPLETED|Overall Study||27||27
60142520|NCT02632110|76265927|FG003|COMPLETED|Overall Study||27||27
60142521|NCT02632110|76265928|FG004|COMPLETED|Overall Study||28||28
60142522|NCT02632110|76265929|FG005|COMPLETED|Overall Study||28||28
60142523|NCT02632110|76265930|FG006|COMPLETED|Overall Study||23||23
60142524|NCT02632110|76265931|FG007|COMPLETED|Overall Study||23||23
60142525|NCT02632110|76265932|FG008|COMPLETED|Overall Study||29||29
60142526|NCT02632110|76265933|FG009|COMPLETED|Overall Study||29||29
60142527|NCT02632110|76265924|FG000|NOT COMPLETED|Overall Study||1||1
60142528|NCT02632110|76265925|FG001|NOT COMPLETED|Overall Study||1||1
60142529|NCT02632110|76265926|FG002|NOT COMPLETED|Overall Study||0||0
60142530|NCT02632110|76265927|FG003|NOT COMPLETED|Overall Study||0||0
60142531|NCT02632110|76265928|FG004|NOT COMPLETED|Overall Study||1||1
60142532|NCT02632110|76265929|FG005|NOT COMPLETED|Overall Study||1||1
60142533|NCT02632110|76265930|FG006|NOT COMPLETED|Overall Study||3||3
60142534|NCT02632110|76265931|FG007|NOT COMPLETED|Overall Study||3||3
60142535|NCT02632110|76265932|FG008|NOT COMPLETED|Overall Study||1||1
60142536|NCT02632110|76265933|FG009|NOT COMPLETED|Overall Study||1||1
60142537|NCT01016769|76265954|FG000|STARTED|Overall Study||4||
60142538|NCT01016769|76265955|FG001|STARTED|Overall Study||7||
60142539|NCT01016769|76265956|FG002|STARTED|Overall Study||7||
60142540|NCT01016769|76265957|FG003|STARTED|Overall Study||30||
60142541|NCT01016769|76265954|FG000|COMPLETED|Overall Study||3||
60142542|NCT01016769|76265955|FG001|COMPLETED|Overall Study||6||
60142543|NCT01016769|76265956|FG002|COMPLETED|Overall Study||6||
60142544|NCT01016769|76265957|FG003|COMPLETED|Overall Study||30||
60142545|NCT01016769|76265954|FG000|NOT COMPLETED|Overall Study||1||
60142546|NCT01016769|76265955|FG001|NOT COMPLETED|Overall Study||1||
60142547|NCT01016769|76265956|FG002|NOT COMPLETED|Overall Study||1||
60142548|NCT01016769|76265957|FG003|NOT COMPLETED|Overall Study||0||
60142549|NCT00964353|76265968|FG000|STARTED|Overall Study||181||
60142550|NCT00964353|76265969|FG001|STARTED|Overall Study||178||
60142551|NCT00964353|76265968|FG000|COMPLETED|Overall Study||181||
60142552|NCT00964353|76265969|FG001|COMPLETED|Overall Study||178||
60142553|NCT00964353|76265968|FG000|NOT COMPLETED|Overall Study||0||
60142554|NCT00964353|76265969|FG001|NOT COMPLETED|Overall Study||0||
60142555|NCT00964431|76265979|FG000|STARTED|Overall Study||50||
60142556|NCT00964431|76265980|FG001|STARTED|Overall Study||51||
60142557|NCT00964431|76265981|FG002|STARTED|Overall Study||51||
60142558|NCT00964431|76265982|FG003|STARTED|Overall Study||51||
60142559|NCT00964431|76265979|FG000|COMPLETED|Overall Study||50||
60142560|NCT00964431|76265980|FG001|COMPLETED|Overall Study||51||
60142561|NCT00964431|76265981|FG002|COMPLETED|Overall Study||51||
60142562|NCT00964431|76265982|FG003|COMPLETED|Overall Study||51||
60142563|NCT00964431|76265979|FG000|NOT COMPLETED|Overall Study||0||
60142564|NCT00964431|76265980|FG001|NOT COMPLETED|Overall Study||0||
60142565|NCT00964431|76265981|FG002|NOT COMPLETED|Overall Study||0||
60142566|NCT00964431|76265982|FG003|NOT COMPLETED|Overall Study||0||
60142567|NCT00966849|76265995|FG000|STARTED|Overall Study||3660||1319
60142568|NCT00966849|76265996|FG001|STARTED|Overall Study||3976||1525
60142569|NCT00966849|76265997|FG002|STARTED|Overall Study||3169||1199
60142570|NCT00966849|76265995|FG000|COMPLETED|Overall Study||2119||1248
60142571|NCT00966849|76265996|FG001|COMPLETED|Overall Study||2498||1452
60142572|NCT00966849|76265997|FG002|COMPLETED|Overall Study||1876||1118
60142573|NCT00966849|76265995|FG000|NOT COMPLETED|Overall Study||1541||71
60142574|NCT00966849|76265996|FG001|NOT COMPLETED|Overall Study||1478||73
60142575|NCT00966849|76265997|FG002|NOT COMPLETED|Overall Study||1293||81
60142576|NCT01017003|76266005|FG000|STARTED|Single Dose Colchicine 0.6 mg, Day 1||13||
60142577|NCT01017003|76266005|FG000|COMPLETED|Single Dose Colchicine 0.6 mg, Day 1||13||
60142578|NCT01017003|76266005|FG000|NOT COMPLETED|Single Dose Colchicine 0.6 mg, Day 1||0||
60142579|NCT01017003|76266005|FG000|STARTED|14 Day Washout Period||13||
60142580|NCT01017003|76266005|FG000|COMPLETED|14 Day Washout Period||13||
60142581|NCT01017003|76266005|FG000|NOT COMPLETED|14 Day Washout Period||0||
60142582|NCT01017003|76266005|FG000|STARTED|Colchicine 0.6 mg Twice Daily x 10 Days||13||
60142583|NCT01017003|76266005|FG000|COMPLETED|Colchicine 0.6 mg Twice Daily x 10 Days||13||
60142584|NCT01017003|76266005|FG000|NOT COMPLETED|Colchicine 0.6 mg Twice Daily x 10 Days||0||
60142585|NCT01017003|76266005|FG000|STARTED|Colchicine 0.6 mg Final Dose||13||
60142586|NCT01017003|76266005|FG000|COMPLETED|Colchicine 0.6 mg Final Dose||13||
60142587|NCT01017003|76266005|FG000|NOT COMPLETED|Colchicine 0.6 mg Final Dose||0||
60142588|NCT01017237|76266013|FG000|STARTED|Overall Study||10||
60142589|NCT01017237|76266014|FG001|STARTED|Overall Study||8||
60142590|NCT01017237|76266013|FG000|COMPLETED|Overall Study||5||
60142591|NCT01017237|76266014|FG001|COMPLETED|Overall Study||6||
60142592|NCT01017237|76266013|FG000|NOT COMPLETED|Overall Study||5||
60142593|NCT01017237|76266014|FG001|NOT COMPLETED|Overall Study||2||
60142594|NCT01390415|76266025|FG000|STARTED|Overall Study||99||
60142595|NCT01390415|76266026|FG001|STARTED|Overall Study||37||
60142596|NCT01390415|76266025|FG000|COMPLETED|Overall Study||99||
60142597|NCT01390415|76266026|FG001|COMPLETED|Overall Study||37||
60142598|NCT01390415|76266025|FG000|NOT COMPLETED|Overall Study||0||
60142599|NCT01390415|76266026|FG001|NOT COMPLETED|Overall Study||0||
60142600|NCT01018095|76266034|FG000|STARTED|Overall Study||135||
60142601|NCT01018095|76266035|FG001|STARTED|Overall Study||135||
60142602|NCT01018095|76266034|FG000|COMPLETED|Overall Study||79||
60142603|NCT01018095|76266035|FG001|COMPLETED|Overall Study||73||
60142604|NCT01018095|76266034|FG000|NOT COMPLETED|Overall Study||56||
60142605|NCT01018095|76266035|FG001|NOT COMPLETED|Overall Study||62||
60142606|NCT00967473|76266041|FG000|STARTED|Overall Study||15||
60142607|NCT00967473|76266041|FG000|COMPLETED|Overall Study||15||
60142608|NCT00967473|76266041|FG000|NOT COMPLETED|Overall Study||0||
60142609|NCT03783533|76266045|FG000|STARTED|Overall Study||11||
60142610|NCT03783533|76266045|FG000|COMPLETED|Overall Study||7||
60142611|NCT03783533|76266045|FG000|NOT COMPLETED|Overall Study||4||
60142612|NCT00967551|76266051|FG000|STARTED|Overall Study||68||
60142613|NCT00967551|76266052|FG001|STARTED|Overall Study||75||
60142614|NCT00967551|76266051|FG000|COMPLETED|Overall Study||68||
60142615|NCT00967551|76266052|FG001|COMPLETED|Overall Study||75||
60142616|NCT00967551|76266051|FG000|NOT COMPLETED|Overall Study||0||
60142617|NCT00967551|76266052|FG001|NOT COMPLETED|Overall Study||0||
60142618|NCT01020591|76266060|FG000|STARTED|Overall Study||15||
60142619|NCT01020591|76266061|FG001|STARTED|Overall Study||15||
60142620|NCT01020591|76266060|FG000|COMPLETED|Overall Study||15||
60142621|NCT01020591|76266061|FG001|COMPLETED|Overall Study||15||
60142622|NCT01020591|76266060|FG000|NOT COMPLETED|Overall Study||0||
60142623|NCT01020591|76266061|FG001|NOT COMPLETED|Overall Study||0||
60142624|NCT00967941|76266072|FG000|STARTED|Overall Study||67||
60142625|NCT00967941|76266073|FG001|STARTED|Overall Study||54||
60142626|NCT00967941|76266074|FG002|STARTED|Overall Study||60||
60142627|NCT00967941|76266072|FG000|COMPLETED|Overall Study||62||
60142628|NCT00967941|76266073|FG001|COMPLETED|Overall Study||51||
60142629|NCT00967941|76266074|FG002|COMPLETED|Overall Study||56||
60142630|NCT00967941|76266072|FG000|NOT COMPLETED|Overall Study||5||
60142631|NCT00967941|76266073|FG001|NOT COMPLETED|Overall Study||3||
60142632|NCT00967941|76266074|FG002|NOT COMPLETED|Overall Study||4||
60142633|NCT00968019|76266082|FG000|STARTED|Overall Study||318||
60142634|NCT00968019|76266082|FG000|COMPLETED|Overall Study||303||
60142635|NCT00968019|76266082|FG000|NOT COMPLETED|Overall Study||15||
60142636|NCT01368185|76266086|FG000|STARTED|Overall Study||1705||
60142637|NCT01368185|76266086|FG000|COMPLETED|Overall Study||1705||
60142638|NCT01368185|76266086|FG000|NOT COMPLETED|Overall Study||0||
60142639|NCT00969501|76266090|FG000|STARTED|Overall Study||32||
60142640|NCT00969501|76266090|FG000|COMPLETED|Overall Study||27||
60142641|NCT00969501|76266090|FG000|NOT COMPLETED|Overall Study||5||
60142642|NCT03774407|76266094|FG000|STARTED|Overall Study||21||
60142643|NCT03774407|76266094|FG000|COMPLETED|Overall Study||12||
60142644|NCT03774407|76266094|FG000|NOT COMPLETED|Overall Study||9||
60142645|NCT00970203|76266102|FG000|STARTED|Overall Study||7||
60142646|NCT00970203|76266103|FG001|STARTED|Overall Study||6||
60142647|NCT00970203|76266102|FG000|COMPLETED|Overall Study||7||
60142648|NCT00970203|76266103|FG001|COMPLETED|Overall Study||6||
60142649|NCT00970203|76266102|FG000|NOT COMPLETED|Overall Study||0||
60142650|NCT00970203|76266103|FG001|NOT COMPLETED|Overall Study||0||
60142651|NCT00971295|76266109|FG000|STARTED|Overall Study||10||
60142652|NCT00971295|76266110|FG001|STARTED|Overall Study||10||
60142653|NCT00971295|76266109|FG000|COMPLETED|Overall Study||10||
60142654|NCT00971295|76266110|FG001|COMPLETED|Overall Study||9||
60142655|NCT00971295|76266109|FG000|NOT COMPLETED|Overall Study||0||
60142656|NCT00971295|76266110|FG001|NOT COMPLETED|Overall Study||1||
60142657|NCT00954681|76266116|FG000|STARTED|Overall Study||15||
60142658|NCT00954681|76266116|FG000|COMPLETED|Overall Study||10||
60142659|NCT00954681|76266116|FG000|NOT COMPLETED|Overall Study||5||
60142660|NCT00971841|76266120|FG000|STARTED|Overall Study||1||
60142661|NCT00971841|76266120|FG000|COMPLETED|Overall Study||1||
60142662|NCT00971841|76266120|FG000|NOT COMPLETED|Overall Study||0||
60142663|NCT00972621|76266126|FG000|STARTED|Overall Study||200||
60142664|NCT00972621|76266127|FG001|STARTED|Overall Study||200||
60142665|NCT00972621|76266126|FG000|COMPLETED|Overall Study||200||
60142666|NCT00972621|76266127|FG001|COMPLETED|Overall Study|One subject discontinued due to lens exchange.|199||
60142667|NCT00972621|76266126|FG000|NOT COMPLETED|Overall Study||0||
60142668|NCT00972621|76266127|FG001|NOT COMPLETED|Overall Study||1||
60142669|NCT00954993|76266133|FG000|STARTED|Period 1||3||
60142670|NCT00954993|76266133|FG000|COMPLETED|Period 1||3||
60142671|NCT00954993|76266133|FG000|NOT COMPLETED|Period 1||0||
60142672|NCT00954993|76266133|FG000|STARTED|Washout||3||
60142673|NCT00954993|76266133|FG000|COMPLETED|Washout||3||
60142674|NCT00954993|76266133|FG000|NOT COMPLETED|Washout||0||
60142675|NCT00954993|76266133|FG000|STARTED|Period 2||3||
60142676|NCT00954993|76266133|FG000|COMPLETED|Period 2||3||
60142677|NCT00954993|76266133|FG000|NOT COMPLETED|Period 2||0||
60142678|NCT02159703|76266139|FG000|STARTED|Overall Study||60||
60142679|NCT02159703|76266139|FG000|COMPLETED|Overall Study||60||
60142680|NCT02159703|76266139|FG000|NOT COMPLETED|Overall Study||0||
60142681|NCT02159859|76266143|FG000|STARTED|Overall Study||7||
60142682|NCT02159859|76266143|FG000|COMPLETED|Overall Study||7||
60142683|NCT02159859|76266143|FG000|NOT COMPLETED|Overall Study||0||
60142684|NCT00974493|76266149|FG000|STARTED|Overall Study||527||
60142685|NCT00974493|76266150|FG001|STARTED|Overall Study||527||
60142686|NCT00974493|76266149|FG000|COMPLETED|Overall Study||509||
60142687|NCT00974493|76266150|FG001|COMPLETED|Overall Study||506||
60142688|NCT00974493|76266149|FG000|NOT COMPLETED|Overall Study||18||
60142689|NCT00974493|76266150|FG001|NOT COMPLETED|Overall Study||21||
60142690|NCT02083679|76266160|FG000|STARTED|Overall Study||3||
60142691|NCT02083679|76266161|FG001|STARTED|Overall Study||6||
60142692|NCT02083679|76266162|FG002|STARTED|Overall Study||3||
60142693|NCT02083679|76266163|FG003|STARTED|Overall Study||3||
60142694|NCT02083679|76266160|FG000|COMPLETED|Overall Study||3||
60142695|NCT02083679|76266161|FG001|COMPLETED|Overall Study||6||
60142696|NCT02083679|76266162|FG002|COMPLETED|Overall Study||3||
60142697|NCT02083679|76266163|FG003|COMPLETED|Overall Study||3||
60142698|NCT02083679|76266160|FG000|NOT COMPLETED|Overall Study||0||
60142699|NCT02083679|76266161|FG001|NOT COMPLETED|Overall Study||0||
60142700|NCT02083679|76266162|FG002|NOT COMPLETED|Overall Study||0||
60142701|NCT02083679|76266163|FG003|NOT COMPLETED|Overall Study||0||
60142702|NCT01672710|76266175|FG000|STARTED|Controlled Comparison 5 Week Follow-up||22||
60142703|NCT01672710|76266176|FG001|STARTED|Controlled Comparison 5 Week Follow-up||10||
60142704|NCT01672710|76266175|FG000|COMPLETED|Controlled Comparison 5 Week Follow-up|sauna intervention group repeat all assessments 7 days after complete the regimen|22||
60142705|NCT01672710|76266176|FG001|COMPLETED|Controlled Comparison 5 Week Follow-up|waitlist group repeat baseline assessments after 4 week time period then begin sauna|10||
60142706|NCT01672710|76266175|FG000|NOT COMPLETED|Controlled Comparison 5 Week Follow-up||0||
60142707|NCT01672710|76266176|FG001|NOT COMPLETED|Controlled Comparison 5 Week Follow-up||0||
60142708|NCT01672710|76266175|FG000|STARTED|Waitlist Assessed After Sauna Regimen|immediate start group no further assessments until 3 month follow up|22||
60142709|NCT01672710|76266176|FG001|STARTED|Waitlist Assessed After Sauna Regimen|waitlisted group receive the 4 week intervention and complete 7 day assessments|10||
60142710|NCT01672710|76266175|FG000|COMPLETED|Waitlist Assessed After Sauna Regimen|non applicable, cannot compare the immediate start and waitlist in this period|22||
60142711|NCT01672710|76266176|FG001|COMPLETED|Waitlist Assessed After Sauna Regimen||9||
60142712|NCT01672710|76266175|FG000|NOT COMPLETED|Waitlist Assessed After Sauna Regimen||0||
60142713|NCT01672710|76266176|FG001|NOT COMPLETED|Waitlist Assessed After Sauna Regimen||1||
60142714|NCT01672710|76266175|FG000|STARTED|3 Month Follow up||22||
60142715|NCT01672710|76266176|FG001|STARTED|3 Month Follow up||9||
60142716|NCT01672710|76266175|FG000|COMPLETED|3 Month Follow up||16||
60142717|NCT01672710|76266176|FG001|COMPLETED|3 Month Follow up||5||
60142718|NCT01672710|76266175|FG000|NOT COMPLETED|3 Month Follow up||6||
60142719|NCT01672710|76266176|FG001|NOT COMPLETED|3 Month Follow up||4||
60142720|NCT00976521|76266186|FG000|STARTED|Overall Study||118||
60142721|NCT00976521|76266187|FG001|STARTED|Overall Study||111||
60142722|NCT00976521|76266188|FG002|STARTED|Overall Study||111||
60142723|NCT00976521|76266189|FG003|STARTED|Overall Study||112||
60142724|NCT00976521|76266186|FG000|COMPLETED|Overall Study||109||
60142725|NCT00976521|76266187|FG001|COMPLETED|Overall Study||99||
60142726|NCT00976521|76266188|FG002|COMPLETED|Overall Study||102||
60142727|NCT00976521|76266189|FG003|COMPLETED|Overall Study||93||
60142728|NCT00976521|76266186|FG000|NOT COMPLETED|Overall Study||9||
60142729|NCT00976521|76266187|FG001|NOT COMPLETED|Overall Study||12||
60142730|NCT00976521|76266188|FG002|NOT COMPLETED|Overall Study||9||
60142731|NCT00976521|76266189|FG003|NOT COMPLETED|Overall Study||19||
60142732|NCT00976599|76266202|FG000|STARTED|Overall Study||15||
60142733|NCT00976599|76266203|FG001|STARTED|Overall Study||14||
60142734|NCT00976599|76266202|FG000|COMPLETED|Overall Study||15||
60142735|NCT00976599|76266203|FG001|COMPLETED|Overall Study||14||
60142736|NCT00976599|76266202|FG000|NOT COMPLETED|Overall Study||0||
60142737|NCT00976599|76266203|FG001|NOT COMPLETED|Overall Study||0||
60142738|NCT02630472|76266211|FG000|STARTED|Overall Study||10||
60142739|NCT02630472|76266212|FG001|STARTED|Overall Study||0||
60142740|NCT02630472|76266211|FG000|COMPLETED|Overall Study||0|Trial was discontinued due to physician priorities; no subjects completed the trial.|
60142741|NCT02630472|76266212|FG001|COMPLETED|Overall Study||0|Trial was discontinued due to physician priorities; no subjects completed the trial.|
60142742|NCT02630472|76266211|FG000|NOT COMPLETED|Overall Study||10||
60142743|NCT02630472|76266212|FG001|NOT COMPLETED|Overall Study||0||
60142744|NCT00977769|76266222|FG000|STARTED|Overall Study||25||
60142745|NCT00977769|76266223|FG001|STARTED|Overall Study||26||
60142746|NCT00977769|76266224|FG002|STARTED|Overall Study||25||
60142747|NCT00977769|76266222|FG000|COMPLETED|Overall Study||25||
60142748|NCT00977769|76266223|FG001|COMPLETED|Overall Study||26||
60142749|NCT00977769|76266224|FG002|COMPLETED|Overall Study||25||
60142750|NCT00977769|76266222|FG000|NOT COMPLETED|Overall Study||0||
60142751|NCT00977769|76266223|FG001|NOT COMPLETED|Overall Study||0||
60142752|NCT00977769|76266224|FG002|NOT COMPLETED|Overall Study||0||
60142753|NCT03724487|76266234|FG000|STARTED|Overall Study||30||
60142754|NCT03724487|76266235|FG001|STARTED|Overall Study||30||
60142755|NCT03724487|76266234|FG000|COMPLETED|Overall Study||30||
60142756|NCT03724487|76266235|FG001|COMPLETED|Overall Study||30||
60142757|NCT03724487|76266234|FG000|NOT COMPLETED|Overall Study||0||
60142758|NCT03724487|76266235|FG001|NOT COMPLETED|Overall Study||0||
60142759|NCT00979017|76266242|FG000|STARTED|Overall Study||41||
60142760|NCT00979017|76266242|FG000|COMPLETED|Overall Study||41||
60142761|NCT00979017|76266242|FG000|NOT COMPLETED|Overall Study||0||
60142762|NCT01670526|76266248|FG000|STARTED|Overall Study||49||
60142763|NCT01670526|76266249|FG001|STARTED|Overall Study||45||
60142764|NCT01670526|76266248|FG000|COMPLETED|Overall Study||37||
60142765|NCT01670526|76266249|FG001|COMPLETED|Overall Study||39||
60142766|NCT01670526|76266248|FG000|NOT COMPLETED|Overall Study||12||
60142767|NCT01670526|76266249|FG001|NOT COMPLETED|Overall Study||6||
60142768|NCT00945035|76266255|FG000|STARTED|Period 1||18||
60142769|NCT00945035|76266256|FG001|STARTED|Period 1||18||
60142770|NCT00945035|76266255|FG000|COMPLETED|Period 1||18||
60142771|NCT00945035|76266256|FG001|COMPLETED|Period 1||18||
60142772|NCT00945035|76266255|FG000|NOT COMPLETED|Period 1||0||
60142773|NCT00945035|76266256|FG001|NOT COMPLETED|Period 1||0||
60142774|NCT00945035|76266255|FG000|STARTED|Period 2||18||
60142775|NCT00945035|76266256|FG001|STARTED|Period 2||18||
60142776|NCT00945035|76266255|FG000|COMPLETED|Period 2||18||
60142777|NCT00945035|76266256|FG001|COMPLETED|Period 2||18||
60142778|NCT00945035|76266255|FG000|NOT COMPLETED|Period 2||0||
60142779|NCT00945035|76266256|FG001|NOT COMPLETED|Period 2||0||
60142780|NCT00979875|76266262|FG000|STARTED|Intervention 1||2||
60142781|NCT00979875|76266263|FG001|STARTED|Intervention 1||2||
60142782|NCT00979875|76266264|FG002|STARTED|Intervention 1||3||
60142783|NCT00979875|76266265|FG003|STARTED|Intervention 1||2||
60142784|NCT00979875|76266266|FG004|STARTED|Intervention 1||3||
60142785|NCT00979875|76266267|FG005|STARTED|Intervention 1||2||
60142786|NCT00979875|76266262|FG000|Received at Least 1 Dose of Study Drug|Intervention 1||2||
60142787|NCT00979875|76266263|FG001|Received at Least 1 Dose of Study Drug|Intervention 1||2||
60142788|NCT00979875|76266264|FG002|Received at Least 1 Dose of Study Drug|Intervention 1||3||
60142789|NCT00979875|76266265|FG003|Received at Least 1 Dose of Study Drug|Intervention 1||2||
60142790|NCT00979875|76266266|FG004|Received at Least 1 Dose of Study Drug|Intervention 1||3||
60142791|NCT00979875|76266267|FG005|Received at Least 1 Dose of Study Drug|Intervention 1||2||
60142792|NCT00979875|76266262|FG000|COMPLETED|Intervention 1||2||
60142793|NCT00979875|76266263|FG001|COMPLETED|Intervention 1||2||
60142794|NCT00979875|76266264|FG002|COMPLETED|Intervention 1||3||
60142795|NCT00979875|76266265|FG003|COMPLETED|Intervention 1||2||
60142796|NCT00979875|76266266|FG004|COMPLETED|Intervention 1||3||
60142797|NCT00979875|76266267|FG005|COMPLETED|Intervention 1||2||
60142798|NCT00979875|76266262|FG000|NOT COMPLETED|Intervention 1||0||
60142799|NCT00979875|76266263|FG001|NOT COMPLETED|Intervention 1||0||
60142800|NCT00979875|76266264|FG002|NOT COMPLETED|Intervention 1||0||
60142801|NCT00979875|76266265|FG003|NOT COMPLETED|Intervention 1||0||
60142802|NCT00979875|76266266|FG004|NOT COMPLETED|Intervention 1||0||
60142803|NCT00979875|76266267|FG005|NOT COMPLETED|Intervention 1||0||
60142804|NCT00979875|76266262|FG000|STARTED|Washout 1 (3 to 14 Days)||2||
60142805|NCT00979875|76266263|FG001|STARTED|Washout 1 (3 to 14 Days)||2||
60142806|NCT00979875|76266264|FG002|STARTED|Washout 1 (3 to 14 Days)||3||
60142807|NCT00979875|76266265|FG003|STARTED|Washout 1 (3 to 14 Days)||2||
60142808|NCT00979875|76266266|FG004|STARTED|Washout 1 (3 to 14 Days)||3||
60142809|NCT00979875|76266267|FG005|STARTED|Washout 1 (3 to 14 Days)||2||
60142810|NCT00979875|76266262|FG000|COMPLETED|Washout 1 (3 to 14 Days)||2||
60142811|NCT00979875|76266263|FG001|COMPLETED|Washout 1 (3 to 14 Days)||2||
60142812|NCT00979875|76266264|FG002|COMPLETED|Washout 1 (3 to 14 Days)||3||
60142813|NCT00979875|76266265|FG003|COMPLETED|Washout 1 (3 to 14 Days)||2||
60142814|NCT00979875|76266266|FG004|COMPLETED|Washout 1 (3 to 14 Days)||3||
60142815|NCT00979875|76266267|FG005|COMPLETED|Washout 1 (3 to 14 Days)||2||
60142816|NCT00979875|76266262|FG000|NOT COMPLETED|Washout 1 (3 to 14 Days)||0||
60142817|NCT00979875|76266263|FG001|NOT COMPLETED|Washout 1 (3 to 14 Days)||0||
60142818|NCT00979875|76266264|FG002|NOT COMPLETED|Washout 1 (3 to 14 Days)||0||
60142819|NCT00979875|76266265|FG003|NOT COMPLETED|Washout 1 (3 to 14 Days)||0||
60142820|NCT00979875|76266266|FG004|NOT COMPLETED|Washout 1 (3 to 14 Days)||0||
60142821|NCT00979875|76266267|FG005|NOT COMPLETED|Washout 1 (3 to 14 Days)||0||
60142822|NCT00979875|76266262|FG000|STARTED|Intervention 2||2||
60142823|NCT00979875|76266263|FG001|STARTED|Intervention 2||2||
60142824|NCT00979875|76266264|FG002|STARTED|Intervention 2||3||
60142825|NCT00979875|76266265|FG003|STARTED|Intervention 2||2||
60142826|NCT00979875|76266266|FG004|STARTED|Intervention 2||3||
60142827|NCT00979875|76266267|FG005|STARTED|Intervention 2||2||
60142828|NCT00979875|76266262|FG000|COMPLETED|Intervention 2||2||
60142829|NCT00979875|76266263|FG001|COMPLETED|Intervention 2||2||
60142830|NCT00979875|76266264|FG002|COMPLETED|Intervention 2||3||
60142831|NCT00979875|76266265|FG003|COMPLETED|Intervention 2||2||
60142832|NCT00979875|76266266|FG004|COMPLETED|Intervention 2||3||
60142833|NCT00979875|76266267|FG005|COMPLETED|Intervention 2||2||
60142834|NCT00979875|76266262|FG000|NOT COMPLETED|Intervention 2||0||
60142835|NCT00979875|76266263|FG001|NOT COMPLETED|Intervention 2||0||
60142836|NCT00979875|76266264|FG002|NOT COMPLETED|Intervention 2||0||
60142837|NCT00979875|76266265|FG003|NOT COMPLETED|Intervention 2||0||
60142838|NCT00979875|76266266|FG004|NOT COMPLETED|Intervention 2||0||
60142839|NCT00979875|76266267|FG005|NOT COMPLETED|Intervention 2||0||
60142840|NCT00979875|76266262|FG000|STARTED|Washout 2 (3 to 14 Days)||2||
60142841|NCT00979875|76266263|FG001|STARTED|Washout 2 (3 to 14 Days)||2||
60142842|NCT00979875|76266264|FG002|STARTED|Washout 2 (3 to 14 Days)||3||
60142843|NCT00979875|76266265|FG003|STARTED|Washout 2 (3 to 14 Days)||2||
60142844|NCT00979875|76266266|FG004|STARTED|Washout 2 (3 to 14 Days)||3||
60142845|NCT00979875|76266267|FG005|STARTED|Washout 2 (3 to 14 Days)||2||
60142846|NCT00979875|76266262|FG000|COMPLETED|Washout 2 (3 to 14 Days)||2||
60142847|NCT00979875|76266263|FG001|COMPLETED|Washout 2 (3 to 14 Days)||2||
60142848|NCT00979875|76266264|FG002|COMPLETED|Washout 2 (3 to 14 Days)||3||
60142849|NCT00979875|76266265|FG003|COMPLETED|Washout 2 (3 to 14 Days)||2||
60142850|NCT00979875|76266266|FG004|COMPLETED|Washout 2 (3 to 14 Days)||3||
60142851|NCT00979875|76266267|FG005|COMPLETED|Washout 2 (3 to 14 Days)||2||
60142852|NCT00979875|76266262|FG000|NOT COMPLETED|Washout 2 (3 to 14 Days)||0||
60142853|NCT00979875|76266263|FG001|NOT COMPLETED|Washout 2 (3 to 14 Days)||0||
60142854|NCT00979875|76266264|FG002|NOT COMPLETED|Washout 2 (3 to 14 Days)||0||
60142855|NCT00979875|76266265|FG003|NOT COMPLETED|Washout 2 (3 to 14 Days)||0||
60142856|NCT00979875|76266266|FG004|NOT COMPLETED|Washout 2 (3 to 14 Days)||0||
60142857|NCT00979875|76266267|FG005|NOT COMPLETED|Washout 2 (3 to 14 Days)||0||
60142858|NCT00979875|76266262|FG000|STARTED|Intervention 3||2||
60142859|NCT00979875|76266263|FG001|STARTED|Intervention 3||2||
60142860|NCT00979875|76266264|FG002|STARTED|Intervention 3||3||
60142861|NCT00979875|76266265|FG003|STARTED|Intervention 3||2||
60142862|NCT00979875|76266266|FG004|STARTED|Intervention 3||3||
60142863|NCT00979875|76266267|FG005|STARTED|Intervention 3||2||
60142864|NCT00979875|76266262|FG000|COMPLETED|Intervention 3||2||
60142865|NCT00979875|76266263|FG001|COMPLETED|Intervention 3||2||
60142866|NCT00979875|76266264|FG002|COMPLETED|Intervention 3||3||
60142867|NCT00979875|76266265|FG003|COMPLETED|Intervention 3||2||
60142868|NCT00979875|76266266|FG004|COMPLETED|Intervention 3||3||
60142869|NCT00979875|76266267|FG005|COMPLETED|Intervention 3||2||
60142870|NCT00979875|76266262|FG000|NOT COMPLETED|Intervention 3||0||
60142871|NCT00979875|76266263|FG001|NOT COMPLETED|Intervention 3||0||
60142872|NCT00979875|76266264|FG002|NOT COMPLETED|Intervention 3||0||
60142873|NCT00979875|76266265|FG003|NOT COMPLETED|Intervention 3||0||
60142874|NCT00979875|76266266|FG004|NOT COMPLETED|Intervention 3||0||
60142875|NCT00979875|76266267|FG005|NOT COMPLETED|Intervention 3||0||
60142876|NCT03714425|76266283|FG000|STARTED|Overall Study||62||
60142877|NCT03714425|76266284|FG001|STARTED|Overall Study||57||
60142878|NCT03714425|76266283|FG000|COMPLETED|Overall Study||55||
60142879|NCT03714425|76266284|FG001|COMPLETED|Overall Study||46||
60142880|NCT03714425|76266283|FG000|NOT COMPLETED|Overall Study||7||
60142881|NCT03714425|76266284|FG001|NOT COMPLETED|Overall Study||11||
60142882|NCT02630706|76266293|FG000|STARTED|Overall Study||170||
59751456|NCT00654901|75870760|FG002|NOT COMPLETED|Overall Study||2||
60142883|NCT02630706|76266294|FG001|STARTED|Overall Study||169||
60142884|NCT02630706|76266295|FG002|STARTED|Overall Study||167||
60142885|NCT02630706|76266293|FG000|Treated|Overall Study||170||
60142886|NCT02630706|76266294|FG001|Treated|Overall Study||169||
60142887|NCT02630706|76266295|FG002|Treated|Overall Study||167||
60142888|NCT02630706|76266293|FG000|COMPLETED|Overall Study||163||
60142889|NCT02630706|76266294|FG001|COMPLETED|Overall Study||160||
60142890|NCT02630706|76266295|FG002|COMPLETED|Overall Study||157||
60142891|NCT02630706|76266293|FG000|NOT COMPLETED|Overall Study||7||
60142892|NCT02630706|76266294|FG001|NOT COMPLETED|Overall Study||9||
60142893|NCT02630706|76266295|FG002|NOT COMPLETED|Overall Study||10||
60142894|NCT02084069|76266305|FG000|STARTED|Overall Study||29||
60142895|NCT02084069|76266306|FG001|STARTED|Overall Study||29||
60142896|NCT02084069|76266305|FG000|COMPLETED|Overall Study||29||
60142897|NCT02084069|76266306|FG001|COMPLETED|Overall Study||29||
60142898|NCT02084069|76266305|FG000|NOT COMPLETED|Overall Study||0||
60142899|NCT02084069|76266306|FG001|NOT COMPLETED|Overall Study||0||
60142900|NCT03682601|76266315|FG000|STARTED|Overall Study||12||
60142901|NCT03682601|76266316|FG001|STARTED|Overall Study||7||
60142902|NCT03682601|76266317|FG002|STARTED|Overall Study||13||
60142903|NCT03682601|76266315|FG000|COMPLETED|Overall Study||12||
60142904|NCT03682601|76266316|FG001|COMPLETED|Overall Study||7||
60142905|NCT03682601|76266317|FG002|COMPLETED|Overall Study||13||
60142906|NCT03682601|76266315|FG000|NOT COMPLETED|Overall Study||0||
60142907|NCT03682601|76266316|FG001|NOT COMPLETED|Overall Study||0||
60142908|NCT03682601|76266317|FG002|NOT COMPLETED|Overall Study||0||
60142909|NCT00981045|76266330|FG000|STARTED|Overall Study||1290||
60142910|NCT00981045|76266331|FG001|STARTED|Overall Study||1294||
60142911|NCT00981045|76266330|FG000|COMPLETED|Overall Study||1276||
60142912|NCT00981045|76266331|FG001|COMPLETED|Overall Study||1285||
60142913|NCT00981045|76266330|FG000|NOT COMPLETED|Overall Study||14||
60142914|NCT00981045|76266331|FG001|NOT COMPLETED|Overall Study||9||
60142915|NCT00981435|76266340|FG000|STARTED|Overall Study||31||
60142916|NCT00981435|76266341|FG001|STARTED|Overall Study||29||
60142917|NCT00981435|76266342|FG002|STARTED|Overall Study||37||
60142918|NCT00981435|76266340|FG000|COMPLETED|Overall Study||31||
60142919|NCT00981435|76266341|FG001|COMPLETED|Overall Study||29||
60142920|NCT00981435|76266342|FG002|COMPLETED|Overall Study||37||
60142921|NCT00981435|76266340|FG000|NOT COMPLETED|Overall Study||0||
60142922|NCT00981435|76266341|FG001|NOT COMPLETED|Overall Study||0||
60142923|NCT00981435|76266342|FG002|NOT COMPLETED|Overall Study||0||
60142924|NCT00981669|76266352|FG000|STARTED|Overall Study||40||
60142925|NCT00981669|76266353|FG001|STARTED|Overall Study||40||
60142926|NCT00981669|76266352|FG000|COMPLETED|Overall Study||39||
60142927|NCT00981669|76266353|FG001|COMPLETED|Overall Study||40||
60142928|NCT00981669|76266352|FG000|NOT COMPLETED|Overall Study||1||
60142929|NCT00981669|76266353|FG001|NOT COMPLETED|Overall Study||0||
60142930|NCT00981825|76266361|FG000|STARTED|First Intervention||11||
60142931|NCT00981825|76266362|FG001|STARTED|First Intervention||11||
60142932|NCT00981825|76266361|FG000|COMPLETED|First Intervention||11||
60142933|NCT00981825|76266362|FG001|COMPLETED|First Intervention||11||
60142934|NCT00981825|76266361|FG000|NOT COMPLETED|First Intervention||0||
60142935|NCT00981825|76266362|FG001|NOT COMPLETED|First Intervention||0||
60142936|NCT00981825|76266361|FG000|STARTED|Washout After 1st Intervention||11||
60142937|NCT00981825|76266362|FG001|STARTED|Washout After 1st Intervention||11||
60142938|NCT00981825|76266361|FG000|COMPLETED|Washout After 1st Intervention||11||
60142939|NCT00981825|76266362|FG001|COMPLETED|Washout After 1st Intervention||11||
60142940|NCT00981825|76266361|FG000|NOT COMPLETED|Washout After 1st Intervention||0||
60142941|NCT00981825|76266362|FG001|NOT COMPLETED|Washout After 1st Intervention||0||
60142942|NCT00981825|76266361|FG000|STARTED|Second Intervention||11||
60142943|NCT00981825|76266362|FG001|STARTED|Second Intervention||11||
60142944|NCT00981825|76266361|FG000|COMPLETED|Second Intervention||11||
60142945|NCT00981825|76266362|FG001|COMPLETED|Second Intervention||11||
60142946|NCT00981825|76266361|FG000|NOT COMPLETED|Second Intervention||0||
60142947|NCT00981825|76266362|FG001|NOT COMPLETED|Second Intervention||0||
60142948|NCT00983307|76266368|FG000|STARTED|Overall Study||17||
60142949|NCT00983307|76266368|FG000|COMPLETED|Overall Study||17||
60142950|NCT00983307|76266368|FG000|NOT COMPLETED|Overall Study||0||
60142951|NCT03673865|76266374|FG000|STARTED|Overall Study||13||
60142952|NCT03673865|76266375|FG001|STARTED|Overall Study||12||
59751457|NCT00654901|75870761|FG003|NOT COMPLETED|Overall Study||0||
60142953|NCT03673865|76266374|FG000|COMPLETED|Overall Study||13||
60142954|NCT03673865|76266375|FG001|COMPLETED|Overall Study||12||
60142955|NCT03673865|76266374|FG000|NOT COMPLETED|Overall Study||0||
60142956|NCT03673865|76266375|FG001|NOT COMPLETED|Overall Study||0||
60142957|NCT00983541|76266381|FG000|STARTED|Overall Study||1||
60142958|NCT00983541|76266381|FG000|COMPLETED|Overall Study||1||
60142959|NCT00983541|76266381|FG000|NOT COMPLETED|Overall Study||0||
60142960|NCT00985257|76266385|FG000|STARTED|Overall Study||123||
60142961|NCT00985257|76266385|FG000|COMPLETED|Overall Study||123||
60142962|NCT00985257|76266385|FG000|NOT COMPLETED|Overall Study||0||
60142963|NCT00986583|76266391|FG000|STARTED|Overall Study||38||
60142964|NCT00986583|76266392|FG001|STARTED|Overall Study||32||
60142965|NCT00986583|76266391|FG000|COMPLETED|Overall Study||38||
60142966|NCT00986583|76266392|FG001|COMPLETED|Overall Study||32||
60142967|NCT00986583|76266391|FG000|NOT COMPLETED|Overall Study||0||
60142968|NCT00986583|76266392|FG001|NOT COMPLETED|Overall Study||0||
60142969|NCT00988143|76266402|FG000|STARTED|Overall Study||220||
60142970|NCT00988143|76266403|FG001|STARTED|Overall Study||190||
60142971|NCT00988143|76266404|FG002|STARTED|Overall Study||190||
60142972|NCT00988143|76266402|FG000|COMPLETED|Overall Study||220||
60142973|NCT00988143|76266403|FG001|COMPLETED|Overall Study||190||
60142974|NCT00988143|76266404|FG002|COMPLETED|Overall Study||190||
60142975|NCT00988143|76266402|FG000|NOT COMPLETED|Overall Study||0||
60142976|NCT00988143|76266403|FG001|NOT COMPLETED|Overall Study||0||
60142977|NCT00988143|76266404|FG002|NOT COMPLETED|Overall Study||0||
60142978|NCT02160873|76266414|FG000|STARTED|Overall Study||6||
60142979|NCT02160873|76266415|FG001|STARTED|Overall Study||6||
60142980|NCT02160873|76266414|FG000|COMPLETED|Overall Study||6||
60142981|NCT02160873|76266415|FG001|COMPLETED|Overall Study||6||
60142982|NCT02160873|76266414|FG000|NOT COMPLETED|Overall Study||0||
60142983|NCT02160873|76266415|FG001|NOT COMPLETED|Overall Study||0||
60142984|NCT00989157|76266429|FG000|STARTED|Overall Study||10||
60142985|NCT00989157|76266430|FG001|STARTED|Overall Study||10||
60142986|NCT00989157|76266429|FG000|COMPLETED|Overall Study||10||
60142987|NCT00989157|76266430|FG001|COMPLETED|Overall Study||10||
60142988|NCT00989157|76266429|FG000|NOT COMPLETED|Overall Study||0||
60142989|NCT00989157|76266430|FG001|NOT COMPLETED|Overall Study||0||
60142990|NCT00990561|76266440|FG000|STARTED|Period 1||20||
60142991|NCT00990561|76266441|FG001|STARTED|Period 1||20||
60142992|NCT00990561|76266442|FG002|STARTED|Period 1||0||
60142993|NCT00990561|76266443|FG003|STARTED|Period 1||0||
60142994|NCT00990561|76266440|FG000|COMPLETED|Period 1||20||
60142995|NCT00990561|76266441|FG001|COMPLETED|Period 1||19||
60142996|NCT00990561|76266442|FG002|COMPLETED|Period 1||0||
60142997|NCT00990561|76266443|FG003|COMPLETED|Period 1||0||
60142998|NCT00990561|76266440|FG000|NOT COMPLETED|Period 1||0||
60142999|NCT00990561|76266441|FG001|NOT COMPLETED|Period 1||1||
60143000|NCT00990561|76266442|FG002|NOT COMPLETED|Period 1||0||
60143001|NCT00990561|76266443|FG003|NOT COMPLETED|Period 1||0||
60143002|NCT00990561|76266440|FG000|STARTED|Period 2||0||
60143003|NCT00990561|76266441|FG001|STARTED|Period 2||0||
60143004|NCT00990561|76266442|FG002|STARTED|Period 2||20||
60143005|NCT00990561|76266443|FG003|STARTED|Period 2||19||
60143006|NCT00990561|76266440|FG000|COMPLETED|Period 2||0||
60143007|NCT00990561|76266441|FG001|COMPLETED|Period 2||0||
60143008|NCT00990561|76266442|FG002|COMPLETED|Period 2||20||
60143009|NCT00990561|76266443|FG003|COMPLETED|Period 2||17||
60143010|NCT00990561|76266440|FG000|NOT COMPLETED|Period 2||0||
60143011|NCT00990561|76266441|FG001|NOT COMPLETED|Period 2||0||
60143012|NCT00990561|76266442|FG002|NOT COMPLETED|Period 2||0||
60143013|NCT00990561|76266443|FG003|NOT COMPLETED|Period 2||2||
60143014|NCT00004547|76266452|FG000|STARTED|Overall Study||83||
60143015|NCT00004547|76266453|FG001|STARTED|Overall Study||48||
60143016|NCT00004547|76266454|FG002|STARTED|Overall Study||57||
60143017|NCT00004547|76266452|FG000|Not Evaluable|Overall Study||21||
60143018|NCT00004547|76266453|FG001|Not Evaluable|Overall Study||9||
60143019|NCT00004547|76266454|FG002|Not Evaluable|Overall Study||23||
60143020|NCT00004547|76266452|FG000|COMPLETED|Overall Study||61||
60143021|NCT00004547|76266453|FG001|COMPLETED|Overall Study||39||
60143022|NCT00004547|76266454|FG002|COMPLETED|Overall Study||35||
60143023|NCT00004547|76266452|FG000|NOT COMPLETED|Overall Study||22||
60143024|NCT00004547|76266453|FG001|NOT COMPLETED|Overall Study||9||
60143025|NCT00004547|76266454|FG002|NOT COMPLETED|Overall Study||22||
60143026|NCT00005669|76266465|FG000|STARTED|Overall Study||53||
60143027|NCT00005669|76266466|FG001|STARTED|Overall Study||47||
60143028|NCT00005669|76266465|FG000|COMPLETED|Overall Study||45||
60143029|NCT00005669|76266466|FG001|COMPLETED|Overall Study||40||
60143030|NCT00005669|76266465|FG000|NOT COMPLETED|Overall Study||8||
60143031|NCT00005669|76266466|FG001|NOT COMPLETED|Overall Study||7||
60143032|NCT02089997|76266472|FG000|STARTED|Overall Study||3304||
60143033|NCT02089997|76266472|FG000|COMPLETED|Overall Study||3058||
60143034|NCT02089997|76266472|FG000|NOT COMPLETED|Overall Study||246||
60143035|NCT01363661|76266478|FG000|STARTED|Overall Study||32||
60143036|NCT01363661|76266479|FG001|STARTED|Overall Study||32||
60143037|NCT01363661|76266478|FG000|COMPLETED|Overall Study||18||
60143038|NCT01363661|76266479|FG001|COMPLETED|Overall Study||28||
60143039|NCT01363661|76266478|FG000|NOT COMPLETED|Overall Study||14||
60143040|NCT01363661|76266479|FG001|NOT COMPLETED|Overall Study||4||
60143041|NCT02628600|76266487|FG000|STARTED|Overall Study||73||
60143042|NCT02628600|76266488|FG001|STARTED|Overall Study||90||
60143043|NCT02628600|76266487|FG000|Participant Discontinued the Study|Overall Study||24||
60143044|NCT02628600|76266488|FG001|Participant Discontinued the Study|Overall Study||32||
60143045|NCT02628600|76266487|FG000|COMPLETED|Overall Study||49||
60143046|NCT02628600|76266488|FG001|COMPLETED|Overall Study||58||
60143047|NCT02628600|76266487|FG000|NOT COMPLETED|Overall Study||24||
60143048|NCT02628600|76266488|FG001|NOT COMPLETED|Overall Study||32||
60143049|NCT00006101|76266496|FG000|STARTED|Overall Study||38||
60143050|NCT00006101|76266497|FG001|STARTED|Overall Study||38||
60143051|NCT00006101|76266496|FG000|COMPLETED|Overall Study||33||
60143052|NCT00006101|76266497|FG001|COMPLETED|Overall Study||33||
60143053|NCT00006101|76266496|FG000|NOT COMPLETED|Overall Study||5||
60143054|NCT00006101|76266497|FG001|NOT COMPLETED|Overall Study||5||
60143055|NCT00591318|76266505|FG000|STARTED|Overall Study||5||
60143056|NCT00591318|76266506|FG001|STARTED|Overall Study||5||
60143057|NCT00591318|76266505|FG000|COMPLETED|Overall Study|For our protocol, participants in both treatment arms were considered completers if they completed at least 6 weeks. At the 6 week point, if response on PANS was not sufficient (15% or greater), they were considered unlikely to respond and therefore were not given the option of the 2 additional weeks of ceftriaxone or placebo. For the analysis, we used the last observed rating between baseline to week 8 for each participant, regardless of whether the participant completed the study treatments.|1||
60143058|NCT00591318|76266506|FG001|COMPLETED|Overall Study|For our protocol, participants in both treatment arms were considered completers if they completed at least 6 weeks. At the 6 week point, if response on PANS was not sufficient (15% or greater), they were considered unlikely to respond and therefore were not given the option of the 2 additional weeks of ceftriaxone or placebo. For the analysis, we used the last observed rating between baseline to week 8 for each participant regardless of whether the participant completed the study treatments..|5||
60143059|NCT00591318|76266505|FG000|NOT COMPLETED|Overall Study||4||
60143060|NCT00591318|76266506|FG001|NOT COMPLETED|Overall Study||0||
60143061|NCT01360632|76266519|FG000|STARTED|Phase A (8 Weeks)|A total of 1539 participants were enrolled, 7 discontinued before taking any sponsor-provided ADT|1532||
60143062|NCT01360632|76266520|FG001|STARTED|Phase A (8 Weeks)|These participants were from the randomized sample.|0||
60143063|NCT01360632|76266521|FG002|STARTED|Phase A (8 Weeks)|These participants were from the randomized sample.|0||
60143064|NCT01360632|76266522|FG003|STARTED|Phase A (8 Weeks)|These participants were from the randomized sample.|0||
60143065|NCT01360632|76266523|FG004|STARTED|Phase A (8 Weeks)||0||
60143066|NCT01360632|76266519|FG000|COMPLETED|Phase A (8 Weeks)||1277||
60143067|NCT01360632|76266520|FG001|COMPLETED|Phase A (8 Weeks)||0||
60143068|NCT01360632|76266521|FG002|COMPLETED|Phase A (8 Weeks)||0||
60143069|NCT01360632|76266522|FG003|COMPLETED|Phase A (8 Weeks)||0||
60143070|NCT01360632|76266523|FG004|COMPLETED|Phase A (8 Weeks)||0||
60143071|NCT01360632|76266519|FG000|NOT COMPLETED|Phase A (8 Weeks)||255||
60143072|NCT01360632|76266520|FG001|NOT COMPLETED|Phase A (8 Weeks)||0||
60143073|NCT01360632|76266521|FG002|NOT COMPLETED|Phase A (8 Weeks)||0||
60143074|NCT01360632|76266522|FG003|NOT COMPLETED|Phase A (8 Weeks)||0||
60143075|NCT01360632|76266523|FG004|NOT COMPLETED|Phase A (8 Weeks)||0||
60143076|NCT01360632|76266519|FG000|STARTED|Phase B (6 Weeks)||0||
60143077|NCT01360632|76266520|FG001|STARTED|Phase B (6 Weeks)|These participants were from the randomized sample.|226||
60143078|NCT01360632|76266521|FG002|STARTED|Phase B (6 Weeks)|These participants were from the randomized sample.|230||
60143079|NCT01360632|76266522|FG003|STARTED|Phase B (6 Weeks)|These participants were from the randomized sample.|221||
60143080|NCT01360632|76266523|FG004|STARTED|Phase B (6 Weeks)||0||
60143081|NCT01360632|76266519|FG000|COMPLETED|Phase B (6 Weeks)||0||
60143082|NCT01360632|76266520|FG001|COMPLETED|Phase B (6 Weeks)||216||
60143083|NCT01360632|76266521|FG002|COMPLETED|Phase B (6 Weeks)||210||
60143084|NCT01360632|76266522|FG003|COMPLETED|Phase B (6 Weeks)||208||
60143085|NCT01360632|76266523|FG004|COMPLETED|Phase B (6 Weeks)||0||
60143086|NCT01360632|76266519|FG000|NOT COMPLETED|Phase B (6 Weeks)||0||
60143087|NCT01360632|76266520|FG001|NOT COMPLETED|Phase B (6 Weeks)||10||
60143088|NCT01360632|76266521|FG002|NOT COMPLETED|Phase B (6 Weeks)||20||
60143089|NCT01360632|76266522|FG003|NOT COMPLETED|Phase B (6 Weeks)||13||
60143090|NCT01360632|76266523|FG004|NOT COMPLETED|Phase B (6 Weeks)||0||
60143091|NCT01360632|76266519|FG000|STARTED|Phase A+||0||
60143092|NCT01360632|76266520|FG001|STARTED|Phase A+||0||
60143093|NCT01360632|76266521|FG002|STARTED|Phase A+||0||
60143094|NCT01360632|76266522|FG003|STARTED|Phase A+||0||
60143095|NCT01360632|76266523|FG004|STARTED|Phase A+||600||
60143096|NCT01360632|76266519|FG000|COMPLETED|Phase A+||0||
60143097|NCT01360632|76266520|FG001|COMPLETED|Phase A+||0||
60143098|NCT01360632|76266521|FG002|COMPLETED|Phase A+||0||
60143099|NCT01360632|76266522|FG003|COMPLETED|Phase A+||0||
60143100|NCT01360632|76266523|FG004|COMPLETED|Phase A+||575||
60143101|NCT01360632|76266519|FG000|NOT COMPLETED|Phase A+||0||
60143102|NCT01360632|76266520|FG001|NOT COMPLETED|Phase A+||0||
60143103|NCT01360632|76266521|FG002|NOT COMPLETED|Phase A+||0||
60143104|NCT01360632|76266522|FG003|NOT COMPLETED|Phase A+||0||
60143105|NCT01360632|76266523|FG004|NOT COMPLETED|Phase A+||25||
60143106|NCT00991029|76266533|FG000|STARTED|Overall Study||2432||
60143107|NCT00991029|76266534|FG001|STARTED|Overall Study||2449||
60143108|NCT00991029|76266533|FG000|COMPLETED|Overall Study||2276||
60143109|NCT00991029|76266534|FG001|COMPLETED|Overall Study||2281||
60143110|NCT00991029|76266533|FG000|NOT COMPLETED|Overall Study||156||
60143111|NCT00991029|76266534|FG001|NOT COMPLETED|Overall Study||168||
60143112|NCT00991185|76266540|FG000|STARTED|Overall Study||8||
60143113|NCT00991185|76266540|FG000|COMPLETED|Overall Study||8||
60143114|NCT00991185|76266540|FG000|NOT COMPLETED|Overall Study||0||
60143115|NCT00991809|76266546|FG000|STARTED|Overall Study||12||
60143116|NCT00991809|76266547|FG001|STARTED|Overall Study||10||
60143117|NCT00991809|76266546|FG000|COMPLETED|Overall Study||8||
60143118|NCT00991809|76266547|FG001|COMPLETED|Overall Study||4||
60143119|NCT00991809|76266546|FG000|NOT COMPLETED|Overall Study||4||
60143120|NCT00991809|76266547|FG001|NOT COMPLETED|Overall Study||6||
60143121|NCT00992433|76266557|FG000|STARTED|Overall Study||95||
60143122|NCT00992433|76266558|FG001|STARTED|Overall Study||97||
60143123|NCT00992433|76266557|FG000|COMPLETED|Overall Study||91||
60143124|NCT00992433|76266558|FG001|COMPLETED|Overall Study||90||
60143125|NCT00992433|76266557|FG000|NOT COMPLETED|Overall Study||4||
60143126|NCT00992433|76266558|FG001|NOT COMPLETED|Overall Study||7||
60143127|NCT00994929|76266564|FG000|STARTED|Overall Study||9||
60143128|NCT00994929|76266564|FG000|COMPLETED|Overall Study||9||
60143129|NCT00994929|76266564|FG000|NOT COMPLETED|Overall Study||0||
60143130|NCT04157400|76266569|FG000|STARTED|Overall Study||5||
60143131|NCT04157400|76266569|FG000|COMPLETED|Overall Study||1||
60143132|NCT04157400|76266569|FG000|NOT COMPLETED|Overall Study||4||
60143133|NCT00929253|76266576|FG000|STARTED|Overall Study||91||
60143134|NCT00929253|76266577|FG001|STARTED|Overall Study||79||
60143135|NCT00929253|76266576|FG000|COMPLETED|Overall Study||91||
60143136|NCT00929253|76266577|FG001|COMPLETED|Overall Study||79||
60143137|NCT00929253|76266576|FG000|NOT COMPLETED|Overall Study||0||
60143138|NCT00929253|76266577|FG001|NOT COMPLETED|Overall Study||0||
60143139|NCT00997113|76266585|FG000|STARTED|Overall Study||10||
60143140|NCT00997113|76266586|FG001|STARTED|Overall Study||10||
60143141|NCT00997113|76266585|FG000|COMPLETED|Overall Study||10||
60143142|NCT00997113|76266586|FG001|COMPLETED|Overall Study||10||
60143143|NCT00997113|76266585|FG000|NOT COMPLETED|Overall Study||0||
60143144|NCT00997113|76266586|FG001|NOT COMPLETED|Overall Study||0||
60143145|NCT02163837|76266592|FG000|STARTED|Before Rifaximin||15||
60143146|NCT02163837|76266592|FG000|COMPLETED|Before Rifaximin||15||
60143147|NCT02163837|76266592|FG000|NOT COMPLETED|Before Rifaximin||0||
60143148|NCT02163837|76266592|FG000|STARTED|Day 28 of Rifaximin Treatment||15||
60143149|NCT02163837|76266592|FG000|COMPLETED|Day 28 of Rifaximin Treatment||15||
60143150|NCT02163837|76266592|FG000|NOT COMPLETED|Day 28 of Rifaximin Treatment||0||
60143151|NCT01021761|76266599|FG000|STARTED|Overall Study||42||
60143152|NCT01021761|76266600|FG001|STARTED|Overall Study||42||
60143153|NCT01021761|76266601|FG002|STARTED|Overall Study||42||
60143154|NCT01021761|76266599|FG000|COMPLETED|Overall Study||41||
60143155|NCT01021761|76266600|FG001|COMPLETED|Overall Study||38||
60143156|NCT01021761|76266601|FG002|COMPLETED|Overall Study||42||
60143157|NCT01021761|76266599|FG000|NOT COMPLETED|Overall Study||1||
60143158|NCT01021761|76266600|FG001|NOT COMPLETED|Overall Study||4||
60143159|NCT01021761|76266601|FG002|NOT COMPLETED|Overall Study||0||
60143160|NCT01022073|76266611|FG000|STARTED|Overall Study||86||
60143161|NCT01022073|76266612|FG001|STARTED|Overall Study||70||
60143162|NCT01022073|76266611|FG000|COMPLETED|Overall Study||67||
60143163|NCT01022073|76266612|FG001|COMPLETED|Overall Study||52||
60143164|NCT01022073|76266611|FG000|NOT COMPLETED|Overall Study||19||
60143165|NCT01022073|76266612|FG001|NOT COMPLETED|Overall Study||18||
60143166|NCT00997425|76266618|FG000|STARTED|Overall Study||19||
60143167|NCT00997425|76266618|FG000|COMPLETED|Overall Study||19||
60143168|NCT00997425|76266618|FG000|NOT COMPLETED|Overall Study||0||
60143169|NCT00998049|76266623|FG000|STARTED|Overall Study||39||
60143170|NCT00998049|76266623|FG000|COMPLETED|Overall Study||39||
60143171|NCT00998049|76266623|FG000|NOT COMPLETED|Overall Study||0||
60143172|NCT00998205|76266627|FG000|STARTED|Overall Study||16||
60143173|NCT00998205|76266627|FG000|COMPLETED|Overall Study||16||
60143174|NCT00998205|76266627|FG000|NOT COMPLETED|Overall Study||0||
60143175|NCT01022307|76266634|FG000|STARTED|Overall Study||184||
60143176|NCT01022307|76266635|FG001|STARTED|Overall Study||28||
60143177|NCT01022307|76266634|FG000|COMPLETED|Overall Study||184||
60143178|NCT01022307|76266635|FG001|COMPLETED|Overall Study|Some TBI patients could not undergo MR scanning due to contraindications.|24||
60143179|NCT01022307|76266634|FG000|NOT COMPLETED|Overall Study||0||
60143180|NCT01022307|76266635|FG001|NOT COMPLETED|Overall Study||4||
60143181|NCT02626182|76266643|FG000|STARTED|Overall Study||11||
60143182|NCT02626182|76266644|FG001|STARTED|Overall Study||3||
60143183|NCT02626182|76266643|FG000|COMPLETED|Overall Study||9||
60143184|NCT02626182|76266644|FG001|COMPLETED|Overall Study||3||
60143185|NCT02626182|76266643|FG000|NOT COMPLETED|Overall Study||2||
60143186|NCT02626182|76266644|FG001|NOT COMPLETED|Overall Study||0||
60143187|NCT00998517|76266653|FG000|STARTED|Overall Study||888||
60143188|NCT00998517|76266654|FG001|STARTED|Overall Study||906||
60143189|NCT00998517|76266655|FG002|STARTED|Overall Study||918||
60143190|NCT00998517|76266653|FG000|COMPLETED|Overall Study||888||
60143191|NCT00998517|76266654|FG001|COMPLETED|Overall Study||906||
60143192|NCT00998517|76266655|FG002|COMPLETED|Overall Study||918||
60143193|NCT00998517|76266653|FG000|NOT COMPLETED|Overall Study||0||
60143194|NCT00998517|76266654|FG001|NOT COMPLETED|Overall Study||0||
60143195|NCT00998517|76266655|FG002|NOT COMPLETED|Overall Study||0||
60143196|NCT01023477|76266665|FG000|STARTED|Overall Study||7||
60143197|NCT01023477|76266666|FG001|STARTED|Overall Study||5||
60143198|NCT01023477|76266665|FG000|COMPLETED|Overall Study||7||
60143199|NCT01023477|76266666|FG001|COMPLETED|Overall Study||5||
60143200|NCT01023477|76266665|FG000|NOT COMPLETED|Overall Study||0||
60143201|NCT01023477|76266666|FG001|NOT COMPLETED|Overall Study||0||
60143202|NCT00999141|76266672|FG000|STARTED|Overall Study|Randomized and treated|75||
60143203|NCT00999141|76266672|FG000|COMPLETED|Overall Study||75||
60143204|NCT00999141|76266672|FG000|NOT COMPLETED|Overall Study||0||
60143205|NCT01023711|76266728|FG000|STARTED|Overall Study||107||
60143206|NCT01023711|76266728|FG000|COMPLETED|Overall Study||107||
60143207|NCT01023711|76266728|FG000|NOT COMPLETED|Overall Study||0||
60143208|NCT01001403|76266735|FG000|STARTED|Overall Study||31||
60143209|NCT01001403|76266736|FG001|STARTED|Overall Study||31||
59751458|NCT00846807|75870771|FG000|STARTED|Overall Study|Entered and treated.|5292||
59751459|NCT00846807|75870771|FG000|COMPLETED|Overall Study|Completed treatment.|4660||
60143210|NCT01001403|76266735|FG000|COMPLETED|Overall Study||31||
60143211|NCT01001403|76266736|FG001|COMPLETED|Overall Study||31||
60143212|NCT01001403|76266735|FG000|NOT COMPLETED|Overall Study||0||
60143213|NCT01001403|76266736|FG001|NOT COMPLETED|Overall Study||0||
60143214|NCT01024335|76266744|FG000|STARTED|Overall Study||20||
60143215|NCT01024335|76266745|FG001|STARTED|Overall Study||40||
59751460|NCT00846807|75870771|FG000|NOT COMPLETED|Overall Study||632||
59751461|NCT00846495|75870777|FG000|STARTED|Overall Study||28||
60143216|NCT01024335|76266744|FG000|COMPLETED|Overall Study||7||
60143217|NCT01024335|76266745|FG001|COMPLETED|Overall Study||14||
60143218|NCT01024335|76266744|FG000|NOT COMPLETED|Overall Study||13||
60143219|NCT01024335|76266745|FG001|NOT COMPLETED|Overall Study||26||
60143220|NCT01669902|76266751|FG000|STARTED|Overall Study||107||
60143221|NCT01669902|76266751|FG000|COMPLETED|Overall Study||78||
60143222|NCT01669902|76266751|FG000|NOT COMPLETED|Overall Study||29||
60143223|NCT01024569|76266757|FG000|STARTED|Overall Study||276||
60143224|NCT01024569|76266758|FG001|STARTED|Overall Study||279||
60143225|NCT01024569|76266757|FG000|COMPLETED|Overall Study||251||
60143226|NCT01024569|76266758|FG001|COMPLETED|Overall Study||268||
60143227|NCT01024569|76266757|FG000|NOT COMPLETED|Overall Study||25||
60143228|NCT01024569|76266758|FG001|NOT COMPLETED|Overall Study||11||
60143229|NCT01001559|76266768|FG000|STARTED|Overall Study||95||
60143230|NCT01001559|76266769|FG001|STARTED|Overall Study||147||
60143231|NCT01001559|76266768|FG000|COMPLETED|Overall Study||95||
60143232|NCT01001559|76266769|FG001|COMPLETED|Overall Study||147||
60143233|NCT01001559|76266768|FG000|NOT COMPLETED|Overall Study||0||
60143234|NCT01001559|76266769|FG001|NOT COMPLETED|Overall Study||0||
60143235|NCT01003275|76266777|FG000|STARTED|Overall Study||11||
60143236|NCT01003275|76266778|FG001|STARTED|Overall Study||11||
60143237|NCT01003275|76266777|FG000|COMPLETED|Overall Study||10||
60143238|NCT01003275|76266778|FG001|COMPLETED|Overall Study||11||
60143239|NCT01003275|76266777|FG000|NOT COMPLETED|Overall Study||1||
60143240|NCT01003275|76266778|FG001|NOT COMPLETED|Overall Study||0||
60143241|NCT01670292|76266784|FG000|STARTED|Overall Study||82||
60143242|NCT01670292|76266784|FG000|COMPLETED|Overall Study||68||
60143243|NCT01670292|76266784|FG000|NOT COMPLETED|Overall Study||14||
60143244|NCT01025427|76266796|FG000|STARTED|Overall Study||16||
60143245|NCT01025427|76266796|FG000|COMPLETED|Overall Study||16||
60143246|NCT01025427|76266796|FG000|NOT COMPLETED|Overall Study||0||
60143247|NCT02162433|76266804|FG000|STARTED|Overall Study||23||
60143248|NCT02162433|76266805|FG001|STARTED|Overall Study||23||
60143249|NCT02162433|76266806|FG002|STARTED|Overall Study||23||
60143250|NCT02162433|76266807|FG003|STARTED|Overall Study||23||
60143251|NCT02162433|76266804|FG000|COMPLETED|Overall Study||22||
60143252|NCT02162433|76266805|FG001|COMPLETED|Overall Study||21||
60143253|NCT02162433|76266806|FG002|COMPLETED|Overall Study||21||
60143254|NCT02162433|76266807|FG003|COMPLETED|Overall Study||22||
60143255|NCT02162433|76266804|FG000|NOT COMPLETED|Overall Study||1||
60143256|NCT02162433|76266805|FG001|NOT COMPLETED|Overall Study||2||
60143257|NCT02162433|76266806|FG002|NOT COMPLETED|Overall Study||2||
60143258|NCT02162433|76266807|FG003|NOT COMPLETED|Overall Study||1||
60143259|NCT01004991|76266817|FG000|STARTED|Overall Study||12||
60143260|NCT01004991|76266817|FG000|COMPLETED|Overall Study||12||
60143261|NCT01004991|76266817|FG000|NOT COMPLETED|Overall Study||0||
60143262|NCT01026909|76266823|FG000|STARTED|Overall Study||1||
60143263|NCT01026909|76266824|FG001|STARTED|Overall Study||2||
60143264|NCT01026909|76266823|FG000|COMPLETED|Overall Study||1||
60143265|NCT01026909|76266824|FG001|COMPLETED|Overall Study||2||
60143266|NCT01026909|76266823|FG000|NOT COMPLETED|Overall Study||0||
60143267|NCT01026909|76266824|FG001|NOT COMPLETED|Overall Study||0||
60143268|NCT01028937|76266830|FG000|STARTED|Overall Study||6||
60143269|NCT01028937|76266830|FG000|COMPLETED|Overall Study||6||
60143270|NCT01028937|76266830|FG000|NOT COMPLETED|Overall Study||0||
60143271|NCT01030653|76266836|FG000|STARTED|Loading Dose & First Maintenance Regimen||4||
60143272|NCT01030653|76266837|FG001|STARTED|Loading Dose & First Maintenance Regimen||4||
60143273|NCT01030653|76266836|FG000|COMPLETED|Loading Dose & First Maintenance Regimen||4||
60143274|NCT01030653|76266837|FG001|COMPLETED|Loading Dose & First Maintenance Regimen||4||
60143275|NCT01030653|76266836|FG000|NOT COMPLETED|Loading Dose & First Maintenance Regimen||0||
60143276|NCT01030653|76266837|FG001|NOT COMPLETED|Loading Dose & First Maintenance Regimen||0||
60143277|NCT01030653|76266836|FG000|STARTED|7-Day Washout Period||4||
60143278|NCT01030653|76266837|FG001|STARTED|7-Day Washout Period||4||
60143279|NCT01030653|76266836|FG000|COMPLETED|7-Day Washout Period||4||
60143280|NCT01030653|76266837|FG001|COMPLETED|7-Day Washout Period||4||
60143281|NCT01030653|76266836|FG000|NOT COMPLETED|7-Day Washout Period||0||
60143282|NCT01030653|76266837|FG001|NOT COMPLETED|7-Day Washout Period||0||
60143283|NCT01030653|76266836|FG000|STARTED|Loading Dose & 2nd Maintenance Regimen||4||
60143284|NCT01030653|76266837|FG001|STARTED|Loading Dose & 2nd Maintenance Regimen||4||
60143285|NCT01030653|76266836|FG000|COMPLETED|Loading Dose & 2nd Maintenance Regimen||4||
60143286|NCT01030653|76266837|FG001|COMPLETED|Loading Dose & 2nd Maintenance Regimen||4||
60143287|NCT01030653|76266836|FG000|NOT COMPLETED|Loading Dose & 2nd Maintenance Regimen||0||
60143288|NCT01030653|76266837|FG001|NOT COMPLETED|Loading Dose & 2nd Maintenance Regimen||0||
60143289|NCT01031043|76266844|FG000|STARTED|Overall Study||5||
60143290|NCT01031043|76266844|FG000|COMPLETED|Overall Study||4||
60143291|NCT01031043|76266844|FG000|NOT COMPLETED|Overall Study||1||
60143292|NCT01050153|76266850|FG000|STARTED|Overall Study||25||
60143293|NCT01050153|76266851|FG001|STARTED|Overall Study||25||
60143294|NCT01050153|76266850|FG000|COMPLETED|Overall Study||25||
60143295|NCT01050153|76266851|FG001|COMPLETED|Overall Study||25||
60143296|NCT01050153|76266850|FG000|NOT COMPLETED|Overall Study||0||
60143297|NCT01050153|76266851|FG001|NOT COMPLETED|Overall Study||0||
60143298|NCT01050231|76266859|FG000|STARTED|Overall Study||10||
60143299|NCT01050231|76266860|FG001|STARTED|Overall Study||10||
60143300|NCT01050231|76266859|FG000|COMPLETED|Overall Study||10||
60143301|NCT01050231|76266860|FG001|COMPLETED|Overall Study||10||
60143302|NCT01050231|76266859|FG000|NOT COMPLETED|Overall Study||0||
60143303|NCT01050231|76266860|FG001|NOT COMPLETED|Overall Study||0||
60143304|NCT01032135|76266871|FG000|STARTED|2 Week Randomization||311||
60143305|NCT01032135|76266872|FG001|STARTED|2 Week Randomization||93||
60143306|NCT01032135|76266873|FG002|STARTED|2 Week Randomization||96||
60143307|NCT01032135|76266874|FG003|STARTED|2 Week Randomization||0||
60143308|NCT01032135|76266875|FG004|STARTED|2 Week Randomization||0||
60143309|NCT01032135|76266876|FG005|STARTED|2 Week Randomization||0||
60143310|NCT01032135|76266877|FG006|STARTED|2 Week Randomization||0||
60143311|NCT01032135|76266871|FG000|COMPLETED|2 Week Randomization||311||
60143312|NCT01032135|76266872|FG001|COMPLETED|2 Week Randomization||93||
60143313|NCT01032135|76266873|FG002|COMPLETED|2 Week Randomization||96||
60143314|NCT01032135|76266874|FG003|COMPLETED|2 Week Randomization||0||
60143315|NCT01032135|76266875|FG004|COMPLETED|2 Week Randomization||0||
60143316|NCT01032135|76266876|FG005|COMPLETED|2 Week Randomization||0||
60143317|NCT01032135|76266877|FG006|COMPLETED|2 Week Randomization||0||
60143318|NCT01032135|76266871|FG000|NOT COMPLETED|2 Week Randomization||0||
60143319|NCT01032135|76266872|FG001|NOT COMPLETED|2 Week Randomization||0||
60143320|NCT01032135|76266873|FG002|NOT COMPLETED|2 Week Randomization||0||
60143321|NCT01032135|76266874|FG003|NOT COMPLETED|2 Week Randomization||0||
60143322|NCT01032135|76266875|FG004|NOT COMPLETED|2 Week Randomization||0||
60143323|NCT01032135|76266876|FG005|NOT COMPLETED|2 Week Randomization||0||
60143324|NCT01032135|76266877|FG006|NOT COMPLETED|2 Week Randomization||0||
60143325|NCT01032135|76266871|FG000|STARTED|8 Week Randomization||227||
60143326|NCT01032135|76266872|FG001|STARTED|8 Week Randomization||0||
60143327|NCT01032135|76266873|FG002|STARTED|8 Week Randomization||0||
60143328|NCT01032135|76266874|FG003|STARTED|8 Week Randomization||41||
60143329|NCT01032135|76266875|FG004|STARTED|8 Week Randomization||43||
60143330|NCT01032135|76266876|FG005|STARTED|8 Week Randomization||48||
60143331|NCT01032135|76266877|FG006|STARTED|8 Week Randomization||54||
60143332|NCT01032135|76266871|FG000|12 Week Follow up|8 Week Randomization|These participants were'nt included in analyses as they didn't meet criteria for study intervention.|217||
60143333|NCT01032135|76266872|FG001|12 Week Follow up|8 Week Randomization||0||
60143334|NCT01032135|76266873|FG002|12 Week Follow up|8 Week Randomization||0||
60143335|NCT01032135|76266874|FG003|12 Week Follow up|8 Week Randomization||34||
60143336|NCT01032135|76266875|FG004|12 Week Follow up|8 Week Randomization||38||
60143337|NCT01032135|76266876|FG005|12 Week Follow up|8 Week Randomization||36||
60143338|NCT01032135|76266877|FG006|12 Week Follow up|8 Week Randomization||41||
60143339|NCT01032135|76266871|FG000|COMPLETED|8 Week Randomization|These participants were'nt included in analyses as they didn't meet criteria for study intervention.|201||
60143340|NCT01032135|76266872|FG001|COMPLETED|8 Week Randomization||0||
60143341|NCT01032135|76266873|FG002|COMPLETED|8 Week Randomization||0||
60143342|NCT01032135|76266874|FG003|COMPLETED|8 Week Randomization||30||
60143343|NCT01032135|76266875|FG004|COMPLETED|8 Week Randomization||34||
60143344|NCT01032135|76266876|FG005|COMPLETED|8 Week Randomization||31||
60143345|NCT01032135|76266877|FG006|COMPLETED|8 Week Randomization||36||
60143346|NCT01032135|76266871|FG000|NOT COMPLETED|8 Week Randomization||26||
60143347|NCT01032135|76266872|FG001|NOT COMPLETED|8 Week Randomization||0||
60143348|NCT01032135|76266873|FG002|NOT COMPLETED|8 Week Randomization||0||
60143349|NCT01032135|76266874|FG003|NOT COMPLETED|8 Week Randomization||11||
60143350|NCT01032135|76266875|FG004|NOT COMPLETED|8 Week Randomization||9||
60143351|NCT01032135|76266876|FG005|NOT COMPLETED|8 Week Randomization||17||
60143352|NCT01032135|76266877|FG006|NOT COMPLETED|8 Week Randomization||18||
60143353|NCT01032759|76266893|FG000|STARTED|Overall Study||32||
60143354|NCT01032759|76266894|FG001|STARTED|Overall Study||31||
60143355|NCT01032759|76266893|FG000|Completed 24 Hour Assessment|Overall Study||32||
60143356|NCT01032759|76266894|FG001|Completed 24 Hour Assessment|Overall Study||30||
60143357|NCT01032759|76266893|FG000|Completed 48 Hour Assessment|Overall Study||31||
60143358|NCT01032759|76266894|FG001|Completed 48 Hour Assessment|Overall Study||28||
60143359|NCT01032759|76266893|FG000|COMPLETED|Overall Study||31||
60143360|NCT01032759|76266894|FG001|COMPLETED|Overall Study||28||
60143361|NCT01032759|76266893|FG000|NOT COMPLETED|Overall Study||1||
60143362|NCT01032759|76266894|FG001|NOT COMPLETED|Overall Study||3||
60143363|NCT01032993|76266902|FG000|STARTED|Overall Study||19||
60143364|NCT01032993|76266903|FG001|STARTED|Overall Study||20||
60143365|NCT01032993|76266902|FG000|COMPLETED|Overall Study||19||
60143366|NCT01032993|76266903|FG001|COMPLETED|Overall Study||20||
60143367|NCT01032993|76266902|FG000|NOT COMPLETED|Overall Study||0||
60143368|NCT01032993|76266903|FG001|NOT COMPLETED|Overall Study||0||
60143369|NCT01033227|76266911|FG000|STARTED|Overall Study||3||
60143370|NCT01033227|76266912|FG001|STARTED|Overall Study||2||
60143371|NCT01033227|76266911|FG000|COMPLETED|Overall Study||3||
60143372|NCT01033227|76266912|FG001|COMPLETED|Overall Study||2||
60143373|NCT01033227|76266911|FG000|NOT COMPLETED|Overall Study||0||
60143374|NCT01033227|76266912|FG001|NOT COMPLETED|Overall Study||0||
60143375|NCT01033383|76266924|FG000|STARTED|Overall Study||20||
60143376|NCT01033383|76266925|FG001|STARTED|Overall Study||20||
60143377|NCT01033383|76266926|FG002|STARTED|Overall Study||20||
60143378|NCT01033383|76266927|FG003|STARTED|Overall Study||20||
60143379|NCT01033383|76266924|FG000|COMPLETED|Overall Study||20||
60143380|NCT01033383|76266925|FG001|COMPLETED|Overall Study||20||
60143381|NCT01033383|76266926|FG002|COMPLETED|Overall Study||20||
60143382|NCT01033383|76266927|FG003|COMPLETED|Overall Study||20||
60143383|NCT01033383|76266924|FG000|NOT COMPLETED|Overall Study||0||
60143384|NCT01033383|76266925|FG001|NOT COMPLETED|Overall Study||0||
60143385|NCT01033383|76266926|FG002|NOT COMPLETED|Overall Study||0||
60143386|NCT01033383|76266927|FG003|NOT COMPLETED|Overall Study||0||
60143387|NCT01033773|76266937|FG000|STARTED|Overall Study||86||
60143388|NCT01033773|76266937|FG000|COMPLETED|Overall Study||51||
60143389|NCT01033773|76266937|FG000|NOT COMPLETED|Overall Study||35||
60143390|NCT02167815|76266943|FG000|STARTED|Overall Study||9||
60143391|NCT02167815|76266944|FG001|STARTED|Overall Study||21||
60143392|NCT02167815|76266943|FG000|COMPLETED|Overall Study||9||
60143393|NCT02167815|76266944|FG001|COMPLETED|Overall Study||21||
60143394|NCT02167815|76266943|FG000|NOT COMPLETED|Overall Study||0||
60143395|NCT02167815|76266944|FG001|NOT COMPLETED|Overall Study||0||
60143396|NCT01053507|76266954|FG000|STARTED|Overall Study||11||
60143397|NCT01053507|76266955|FG001|STARTED|Overall Study||12||
60143398|NCT01053507|76266954|FG000|COMPLETED|Overall Study||8||
60143399|NCT01053507|76266955|FG001|COMPLETED|Overall Study||11||
60143400|NCT01053507|76266954|FG000|NOT COMPLETED|Overall Study||3||
60143401|NCT01053507|76266955|FG001|NOT COMPLETED|Overall Study||1||
60143402|NCT01053819|76266961|FG000|STARTED|Overall Study||6||
60143403|NCT01053819|76266961|FG000|COMPLETED|Overall Study||6||
60143404|NCT01053819|76266961|FG000|NOT COMPLETED|Overall Study||0||
60143405|NCT01053897|76266966|FG000|STARTED|Overall Study||5||
60143406|NCT01053897|76266966|FG000|COMPLETED|Overall Study||5||
60143407|NCT01053897|76266966|FG000|NOT COMPLETED|Overall Study||0||
60143408|NCT01054209|76266978|FG000|STARTED|Overall Study||58||
60143409|NCT01054209|76266979|FG001|STARTED|Overall Study||58||
60143410|NCT01054209|76266978|FG000|COMPLETED|Overall Study||58||
60143411|NCT01054209|76266979|FG001|COMPLETED|Overall Study||58||
60143412|NCT01054209|76266978|FG000|NOT COMPLETED|Overall Study||0||
60143413|NCT01054209|76266979|FG001|NOT COMPLETED|Overall Study||0||
60143414|NCT01054911|76266985|FG000|STARTED|Overall Study||5||
60143415|NCT01054911|76266985|FG000|COMPLETED|Overall Study||5||
60143416|NCT01054911|76266985|FG000|NOT COMPLETED|Overall Study||0||
60143417|NCT01055067|76266991|FG000|STARTED|Overall Study||27||
60143418|NCT01055067|76266991|FG000|COMPLETED|Overall Study||27|Defined as participants who had progressive disease|
60143419|NCT01055067|76266991|FG000|NOT COMPLETED|Overall Study||0||
60143420|NCT01055223|76266997|FG000|STARTED|Overall Study||98483||
60143421|NCT01055223|76266997|FG000|COMPLETED|Overall Study||98483||
60143422|NCT01055223|76266997|FG000|NOT COMPLETED|Overall Study||0||
60143423|NCT02168361|76267012|FG000|STARTED|Overall Study||62||
60143424|NCT02168361|76267013|FG001|STARTED|Overall Study||31||
60143425|NCT02168361|76267012|FG000|COMPLETED|Overall Study||57||
60143426|NCT02168361|76267013|FG001|COMPLETED|Overall Study||21||
59751462|NCT00846495|75870778|FG001|STARTED|Overall Study||27||
59881765|NCT04222725|76004617|FG000|NOT COMPLETED|Overall Study||0||
59881766|NCT04222725|76004618|FG001|NOT COMPLETED|Overall Study||1||
59881767|NCT04222725|76004619|FG002|NOT COMPLETED|Overall Study||0||
59881768|NCT04222725|76004620|FG003|NOT COMPLETED|Overall Study||0||
59881769|NCT04213989|76004632|FG000|STARTED|Overall Study||18||
59881770|NCT04213989|76004633|FG001|STARTED|Overall Study||18||
59881771|NCT04213989|76004632|FG000|COMPLETED|Overall Study||14||
59881772|NCT04213989|76004633|FG001|COMPLETED|Overall Study||12||
59881773|NCT04213989|76004632|FG000|NOT COMPLETED|Overall Study||4||
59881774|NCT04213989|76004633|FG001|NOT COMPLETED|Overall Study||6||
59881775|NCT03242252|76004642|FG000|STARTED|Overall Study||260||
59881776|NCT03242252|76004643|FG001|STARTED|Overall Study||263||
59881777|NCT03242252|76004644|FG002|STARTED|Overall Study||264||
59881778|NCT03242252|76004642|FG000|COMPLETED|Overall Study||224||
59881779|NCT03242252|76004643|FG001|COMPLETED|Overall Study||240||
59881780|NCT03242252|76004644|FG002|COMPLETED|Overall Study||232||
59881781|NCT03242252|76004642|FG000|NOT COMPLETED|Overall Study||36||
59881782|NCT03242252|76004643|FG001|NOT COMPLETED|Overall Study||23||
59881783|NCT03242252|76004644|FG002|NOT COMPLETED|Overall Study||32||
60143427|NCT02168361|76267012|FG000|NOT COMPLETED|Overall Study||5||
59881784|NCT04109391|76004661|FG000|STARTED|Overall Study||175||
59881785|NCT04109391|76004662|FG001|STARTED|Overall Study||82||
59881786|NCT04109391|76004663|FG002|STARTED|Overall Study||81||
59881787|NCT04109391|76004661|FG000|COMPLETED|Overall Study||165||
59881788|NCT04109391|76004662|FG001|COMPLETED|Overall Study||77||
59881789|NCT04109391|76004663|FG002|COMPLETED|Overall Study||77||
59881790|NCT04109391|76004661|FG000|NOT COMPLETED|Overall Study||10||
59881791|NCT04109391|76004662|FG001|NOT COMPLETED|Overall Study||5||
59881792|NCT04109391|76004663|FG002|NOT COMPLETED|Overall Study||4||
59881793|NCT04106817|76004674|FG000|STARTED|Overall Study||12||
59881794|NCT04106817|76004675|FG001|STARTED|Overall Study||11||
59881795|NCT04106817|76004676|FG002|STARTED|Overall Study||12||
59881796|NCT04106817|76004674|FG000|COMPLETED|Overall Study||11|All participants completed the influenza challenge, and 1 participant was lost in AE follow-up|
59881797|NCT04106817|76004675|FG001|COMPLETED|Overall Study||11|All participants completed the influenza challenge, and 1 participant was lost in AE follow-up|
59881798|NCT04106817|76004676|FG002|COMPLETED|Overall Study||12|All participants completed the influenza challenge, and 1 participant was lost in AE follow-up|
59881799|NCT04106817|76004674|FG000|NOT COMPLETED|Overall Study||1||
59881800|NCT04106817|76004675|FG001|NOT COMPLETED|Overall Study||0||
59881801|NCT04106817|76004676|FG002|NOT COMPLETED|Overall Study||0||
59881802|NCT04097925|76004684|FG000|STARTED|Overall Study||30||
59881803|NCT04097925|76004684|FG000|COMPLETED|Overall Study||29||
59881804|NCT04097925|76004684|FG000|NOT COMPLETED|Overall Study||1||
59881805|NCT04195893|76004688|FG000|STARTED|First Intervention||27||
59881806|NCT04195893|76004689|FG001|STARTED|First Intervention||29||
59881807|NCT04195893|76004688|FG000|COMPLETED|First Intervention||27||
60143428|NCT02168361|76267013|FG001|NOT COMPLETED|Overall Study||10||
60143429|NCT01360554|76267021|FG000|STARTED|Overall Study|Three participants were randomized but not treated.|439||
60143430|NCT01360554|76267022|FG001|STARTED|Overall Study|Three participants were randomized but not treated.|439||
60143431|NCT01360554|76267021|FG000|Treated|Overall Study||436||
60143432|NCT01360554|76267022|FG001|Treated|Overall Study||436||
59751463|NCT00846495|75870777|FG000|COMPLETED|Overall Study||20||
59751464|NCT00846495|75870778|FG001|COMPLETED|Overall Study||24||
59751465|NCT00846495|75870777|FG000|NOT COMPLETED|Overall Study||8||
59751466|NCT00846495|75870778|FG001|NOT COMPLETED|Overall Study||3||
59751467|NCT00654745|75870784|FG000|STARTED|Overall Study|This is single group study in which subjects were titrated to the next of 7 arms if BP goal not met.|207||
59751468|NCT00654745|75870784|FG000|COMPLETED|Overall Study||164||
59751469|NCT00654745|75870784|FG000|NOT COMPLETED|Overall Study||43||
59881808|NCT04195893|76004689|FG001|COMPLETED|First Intervention||29||
59881809|NCT04195893|76004688|FG000|NOT COMPLETED|First Intervention||0||
59881810|NCT04195893|76004689|FG001|NOT COMPLETED|First Intervention||0||
59881811|NCT04195893|76004688|FG000|STARTED|Second Intervention||27||
60010227|NCT03827655|76125914|FG003|Pharmacokinetic (PK) Analysis Set|Overall Study||24|PK Analysis Set included all participants who were randomized, received at least 1 dose and had at least 1 measurable post-dose plasma for TAK-954.|
59881812|NCT04195893|76004689|FG001|STARTED|Second Intervention||29||
59881813|NCT04195893|76004688|FG000|COMPLETED|Second Intervention||26||
59881814|NCT04195893|76004689|FG001|COMPLETED|Second Intervention||29||
59881815|NCT04195893|76004688|FG000|NOT COMPLETED|Second Intervention||1||
59881816|NCT04195893|76004689|FG001|NOT COMPLETED|Second Intervention||0||
59881817|NCT04195581|76004695|FG000|STARTED|Comfilcon A With All in One Light||28||
59881818|NCT04195581|76004695|FG000|COMPLETED|Comfilcon A With All in One Light||24||
59881819|NCT04195581|76004695|FG000|NOT COMPLETED|Comfilcon A With All in One Light||4||
59881820|NCT04195581|76004695|FG000|STARTED|Comfilcon A With Hy-Care||30||
59881821|NCT04195581|76004695|FG000|COMPLETED|Comfilcon A With Hy-Care||25||
59881822|NCT04195581|76004695|FG000|NOT COMPLETED|Comfilcon A With Hy-Care||5||
59881823|NCT04195581|76004695|FG000|STARTED|Comfilcon A With Refine One Step||25||
59881824|NCT04195581|76004695|FG000|COMPLETED|Comfilcon A With Refine One Step||24||
59881825|NCT04195581|76004695|FG000|NOT COMPLETED|Comfilcon A With Refine One Step||1||
59881826|NCT04195581|76004695|FG000|STARTED|Fanfilcon A With All in One Light||28||
59881827|NCT04195581|76004695|FG000|COMPLETED|Fanfilcon A With All in One Light||27||
59881828|NCT04195581|76004695|FG000|NOT COMPLETED|Fanfilcon A With All in One Light||1||
59881829|NCT04195581|76004695|FG000|STARTED|Fanfilcon A With Hy-Care||28||
59881830|NCT04195581|76004695|FG000|COMPLETED|Fanfilcon A With Hy-Care||25||
59881831|NCT04195581|76004695|FG000|NOT COMPLETED|Fanfilcon A With Hy-Care||3||
59881832|NCT04195581|76004695|FG000|STARTED|Fanfilcon A With Refine One Step||29||
59881833|NCT04195581|76004695|FG000|COMPLETED|Fanfilcon A With Refine One Step||27||
59881834|NCT04195581|76004695|FG000|NOT COMPLETED|Fanfilcon A With Refine One Step||2||
59881835|NCT04096365|76004713|FG000|STARTED|Overall Study||12||
59881836|NCT04096365|76004713|FG000|COMPLETED|Overall Study||11||
59881837|NCT04096365|76004713|FG000|NOT COMPLETED|Overall Study||1||
59881838|NCT04094883|76004717|FG000|STARTED|Overall Study||11||
59881839|NCT04094883|76004717|FG000|COMPLETED|Overall Study||10||
59881840|NCT04094883|76004717|FG000|NOT COMPLETED|Overall Study||1||
59881841|NCT01368562|76004721|FG000|STARTED|Overall Study||26||
59881842|NCT01368562|76004721|FG000|Received at Least 1 Dose of Study Drug|Overall Study||25||
59881843|NCT01368562|76004721|FG000|COMPLETED|Overall Study||7||
59881844|NCT01368562|76004721|FG000|NOT COMPLETED|Overall Study||19||
59881845|NCT03242018|76004728|FG000|STARTED|Overall Study||93||
59881846|NCT03242018|76004729|FG001|STARTED|Overall Study||92||
59881847|NCT03242018|76004730|FG002|STARTED|Overall Study||92||
59881848|NCT03242018|76004728|FG000|COMPLETED|Overall Study||75||
59881849|NCT03242018|76004729|FG001|COMPLETED|Overall Study||78||
59881850|NCT03242018|76004730|FG002|COMPLETED|Overall Study||78||
59881851|NCT03242018|76004728|FG000|NOT COMPLETED|Overall Study||18||
59881852|NCT03242018|76004729|FG001|NOT COMPLETED|Overall Study||14||
59881853|NCT03242018|76004730|FG002|NOT COMPLETED|Overall Study||14||
59881854|NCT02789176|76004743|FG000|STARTED|Overall Study||99||
59881855|NCT02789176|76004744|FG001|STARTED|Overall Study||55||
59881856|NCT02789176|76004745|FG002|STARTED|Overall Study||95||
59881857|NCT02789176|76004746|FG003|STARTED|Overall Study||54||
59881858|NCT02789176|76004743|FG000|COMPLETED|Overall Study||91||
59881859|NCT02789176|76004744|FG001|COMPLETED|Overall Study||53||
59881860|NCT02789176|76004745|FG002|COMPLETED|Overall Study||85||
59881861|NCT02789176|76004746|FG003|COMPLETED|Overall Study||53||
59881862|NCT02789176|76004743|FG000|NOT COMPLETED|Overall Study||8||
59881863|NCT02789176|76004744|FG001|NOT COMPLETED|Overall Study||2||
59881864|NCT02789176|76004745|FG002|NOT COMPLETED|Overall Study||10||
59881865|NCT02789176|76004746|FG003|NOT COMPLETED|Overall Study||1||
59881866|NCT03259490|76004758|FG000|STARTED|Period 1||15||
60067710|NCT01617187|76182892|FG001|COMPLETED|Randomization Through Start Treatment||113||
59881867|NCT03259490|76004759|FG001|STARTED|Period 1||15||
59881868|NCT03259490|76004758|FG000|COMPLETED|Period 1||15||
59881869|NCT03259490|76004759|FG001|COMPLETED|Period 1||14||
59881870|NCT03259490|76004758|FG000|NOT COMPLETED|Period 1||0||
59881871|NCT03259490|76004759|FG001|NOT COMPLETED|Period 1||1||
59881872|NCT03259490|76004758|FG000|STARTED|Period 2||15||
59881873|NCT03259490|76004759|FG001|STARTED|Period 2||14||
59881874|NCT03259490|76004758|FG000|COMPLETED|Period 2||14||
59881875|NCT03259490|76004759|FG001|COMPLETED|Period 2||14||
59881876|NCT03259490|76004758|FG000|NOT COMPLETED|Period 2||1||
59881877|NCT03259490|76004759|FG001|NOT COMPLETED|Period 2||0||
59881878|NCT03259334|76004768|FG000|STARTED|Overall Study||76||
59881879|NCT03259334|76004769|FG001|STARTED|Overall Study||153||
59881880|NCT03259334|76004770|FG002|STARTED|Overall Study||151||
59881881|NCT03259334|76004768|FG000|Treated|Overall Study||76||
59881882|NCT03259334|76004769|FG001|Treated|Overall Study||151||
59881883|NCT03259334|76004770|FG002|Treated|Overall Study||151||
59881884|NCT03259334|76004768|FG000|COMPLETED|Overall Study||66||
59881885|NCT03259334|76004769|FG001|COMPLETED|Overall Study||136||
59881886|NCT03259334|76004770|FG002|COMPLETED|Overall Study||138||
60143433|NCT01360554|76267021|FG000|COMPLETED|Overall Study||0||
60143434|NCT01360554|76267022|FG001|COMPLETED|Overall Study||0||
60143435|NCT01360554|76267021|FG000|NOT COMPLETED|Overall Study||439||
60143436|NCT01360554|76267022|FG001|NOT COMPLETED|Overall Study||439||
60143437|NCT01055769|76267028|FG000|STARTED|First Intervention||10||
60143438|NCT01055769|76267029|FG001|STARTED|First Intervention||10||
60143439|NCT01055769|76267028|FG000|COMPLETED|First Intervention||10||
60010228|NCT03827655|76125915|FG004|Pharmacokinetic (PK) Analysis Set|Overall Study||50|PK Analysis Set included all participants who were randomized, received at least 1 dose and had at least 1 measurable post-dose plasma for TAK-954.|
60010229|NCT03827655|76125911|FG000|COMPLETED|Overall Study||45||
60010230|NCT03827655|76125912|FG001|COMPLETED|Overall Study||24||
60010231|NCT03827655|76125913|FG002|COMPLETED|Overall Study||47||
60010232|NCT03827655|76125914|FG003|COMPLETED|Overall Study||25||
60143440|NCT01055769|76267029|FG001|COMPLETED|First Intervention||10||
60143441|NCT01055769|76267028|FG000|NOT COMPLETED|First Intervention||0||
60143442|NCT01055769|76267029|FG001|NOT COMPLETED|First Intervention||0||
60143443|NCT01055769|76267028|FG000|STARTED|Washout Period of Atleast 4 Days||10||
60143444|NCT01055769|76267029|FG001|STARTED|Washout Period of Atleast 4 Days||10||
60143445|NCT01055769|76267028|FG000|COMPLETED|Washout Period of Atleast 4 Days||10||
60143446|NCT01055769|76267029|FG001|COMPLETED|Washout Period of Atleast 4 Days||10||
60143447|NCT01055769|76267028|FG000|NOT COMPLETED|Washout Period of Atleast 4 Days||0||
60143448|NCT01055769|76267029|FG001|NOT COMPLETED|Washout Period of Atleast 4 Days||0||
60143449|NCT01055769|76267028|FG000|STARTED|Second Intervention||10||
60143450|NCT01055769|76267029|FG001|STARTED|Second Intervention||10||
60143451|NCT01055769|76267028|FG000|COMPLETED|Second Intervention||10||
60143452|NCT01055769|76267029|FG001|COMPLETED|Second Intervention||10||
60143453|NCT01055769|76267028|FG000|NOT COMPLETED|Second Intervention||0||
60143454|NCT01055769|76267029|FG001|NOT COMPLETED|Second Intervention||0||
60143455|NCT01057017|76267036|FG000|STARTED|Overall Study||5||
60143456|NCT01057017|76267036|FG000|COMPLETED|Overall Study||5||
60143457|NCT01057017|76267036|FG000|NOT COMPLETED|Overall Study||0||
60143458|NCT01059357|76267040|FG000|STARTED|Overall Study||58||
60143459|NCT01059357|76267040|FG000|COMPLETED|Overall Study||54||
60143460|NCT01059357|76267040|FG000|NOT COMPLETED|Overall Study||4||
60143461|NCT01360398|76267044|FG000|STARTED|Overall Study||127||
60143462|NCT01360398|76267044|FG000|COMPLETED|Overall Study||105||
60143463|NCT01360398|76267044|FG000|NOT COMPLETED|Overall Study||22||
60143464|NCT02626026|76267054|FG000|STARTED|Overall Study||8||
60143465|NCT02626026|76267055|FG001|STARTED|Overall Study||2||
60143466|NCT02626026|76267056|FG002|STARTED|Overall Study||8||
60143467|NCT02626026|76267057|FG003|STARTED|Overall Study||2||
60143468|NCT02626026|76267058|FG004|STARTED|Overall Study||17||
60143469|NCT02626026|76267059|FG005|STARTED|Overall Study||5||
60143470|NCT02626026|76267054|FG000|COMPLETED|Overall Study||8||
60143471|NCT02626026|76267055|FG001|COMPLETED|Overall Study||2||
60143472|NCT02626026|76267056|FG002|COMPLETED|Overall Study||8||
60143473|NCT02626026|76267057|FG003|COMPLETED|Overall Study||2||
60143474|NCT02626026|76267058|FG004|COMPLETED|Overall Study||16||
60143475|NCT02626026|76267059|FG005|COMPLETED|Overall Study||5||
60143476|NCT02626026|76267054|FG000|NOT COMPLETED|Overall Study||0||
60143477|NCT02626026|76267055|FG001|NOT COMPLETED|Overall Study||0||
60143478|NCT02626026|76267056|FG002|NOT COMPLETED|Overall Study||0||
60143479|NCT02626026|76267057|FG003|NOT COMPLETED|Overall Study||0||
60010233|NCT03827655|76125915|FG004|COMPLETED|Overall Study||49||
60010234|NCT03827655|76125911|FG000|NOT COMPLETED|Overall Study||7||
60010235|NCT03827655|76125912|FG001|NOT COMPLETED|Overall Study||3||
60010236|NCT03827655|76125913|FG002|NOT COMPLETED|Overall Study||4||
60010237|NCT03827655|76125914|FG003|NOT COMPLETED|Overall Study||2||
60010238|NCT03827655|76125915|FG004|NOT COMPLETED|Overall Study||3||
60010239|NCT03801382|76125937|FG000|STARTED|First Assessment||99||
60010240|NCT03801382|76125938|FG001|STARTED|First Assessment||101||
60010241|NCT03801382|76125939|FG002|STARTED|First Assessment||53||
60010242|NCT03801382|76125940|FG003|STARTED|First Assessment||49||
60010243|NCT03801382|76125941|FG004|STARTED|First Assessment||148||
60010244|NCT03801382|76125937|FG000|COMPLETED|First Assessment||99||
60010245|NCT03801382|76125938|FG001|COMPLETED|First Assessment||101||
60010246|NCT03801382|76125939|FG002|COMPLETED|First Assessment||53||
60010247|NCT03801382|76125940|FG003|COMPLETED|First Assessment||49||
60010248|NCT03801382|76125941|FG004|COMPLETED|First Assessment||148||
60143480|NCT02626026|76267058|FG004|NOT COMPLETED|Overall Study||1||
60143481|NCT02626026|76267059|FG005|NOT COMPLETED|Overall Study||0||
60143482|NCT01059435|76267085|FG000|STARTED|Overall Study||14||
60143483|NCT01059435|76267086|FG001|STARTED|Overall Study||6||
60143484|NCT01059435|76267087|FG002|STARTED|Overall Study||8||
60143485|NCT01059435|76267088|FG003|STARTED|Overall Study||9||
60143486|NCT01059435|76267089|FG004|STARTED|Overall Study||6||
60143487|NCT01059435|76267090|FG005|STARTED|Overall Study||9||
60143488|NCT01059435|76267091|FG006|STARTED|Overall Study||6||
60143489|NCT01059435|76267092|FG007|STARTED|Overall Study||4||
60143490|NCT01059435|76267093|FG008|STARTED|Overall Study||6||
60143491|NCT01059435|76267094|FG009|STARTED|Overall Study||6||
60143492|NCT01059435|76267085|FG000|Received Study Drug|Overall Study||14||
60143493|NCT01059435|76267086|FG001|Received Study Drug|Overall Study||6||
60143494|NCT01059435|76267087|FG002|Received Study Drug|Overall Study||6||
60143495|NCT01059435|76267088|FG003|Received Study Drug|Overall Study||9||
60143496|NCT01059435|76267089|FG004|Received Study Drug|Overall Study||6||
60143497|NCT01059435|76267090|FG005|Received Study Drug|Overall Study||9||
60143498|NCT01059435|76267091|FG006|Received Study Drug|Overall Study||6||
60143499|NCT01059435|76267092|FG007|Received Study Drug|Overall Study||4||
60143500|NCT01059435|76267093|FG008|Received Study Drug|Overall Study||6||
60143501|NCT01059435|76267094|FG009|Received Study Drug|Overall Study||6||
60143502|NCT01059435|76267085|FG000|COMPLETED|Overall Study||14||
60143503|NCT01059435|76267086|FG001|COMPLETED|Overall Study||6||
60143504|NCT01059435|76267087|FG002|COMPLETED|Overall Study||6||
60143505|NCT01059435|76267088|FG003|COMPLETED|Overall Study||9||
60143506|NCT01059435|76267089|FG004|COMPLETED|Overall Study||6||
60143507|NCT01059435|76267090|FG005|COMPLETED|Overall Study||9||
60143508|NCT01059435|76267091|FG006|COMPLETED|Overall Study||6||
60143509|NCT01059435|76267092|FG007|COMPLETED|Overall Study||4||
60143510|NCT01059435|76267093|FG008|COMPLETED|Overall Study||6||
60143511|NCT01059435|76267094|FG009|COMPLETED|Overall Study||6||
60143512|NCT01059435|76267085|FG000|NOT COMPLETED|Overall Study||0||
60143513|NCT01059435|76267086|FG001|NOT COMPLETED|Overall Study||0||
60143514|NCT01059435|76267087|FG002|NOT COMPLETED|Overall Study||2||
60143515|NCT01059435|76267088|FG003|NOT COMPLETED|Overall Study||0||
60143516|NCT01059435|76267089|FG004|NOT COMPLETED|Overall Study||0||
60143517|NCT01059435|76267090|FG005|NOT COMPLETED|Overall Study||0||
60143518|NCT01059435|76267091|FG006|NOT COMPLETED|Overall Study||0||
60143519|NCT01059435|76267092|FG007|NOT COMPLETED|Overall Study||0||
60143520|NCT01059435|76267093|FG008|NOT COMPLETED|Overall Study||0||
60143521|NCT01059435|76267094|FG009|NOT COMPLETED|Overall Study||0||
60143522|NCT01062009|76267130|FG000|STARTED|Overall Study||7||
60143523|NCT01062009|76267131|FG001|STARTED|Overall Study||6||
60143524|NCT01062009|76267132|FG002|STARTED|Overall Study||6||
60143525|NCT01062009|76267133|FG003|STARTED|Overall Study||6||
60143526|NCT01062009|76267130|FG000|COMPLETED|Overall Study||6||
60143527|NCT01062009|76267131|FG001|COMPLETED|Overall Study||6||
60143528|NCT01062009|76267132|FG002|COMPLETED|Overall Study||6||
60143529|NCT01062009|76267133|FG003|COMPLETED|Overall Study||6||
60143530|NCT01062009|76267130|FG000|NOT COMPLETED|Overall Study||1||
60143531|NCT01062009|76267131|FG001|NOT COMPLETED|Overall Study||0||
60143532|NCT01062009|76267132|FG002|NOT COMPLETED|Overall Study||0||
60143533|NCT01062009|76267133|FG003|NOT COMPLETED|Overall Study||0||
60143534|NCT01062165|76267143|FG000|STARTED|Overall Study||18||
60143535|NCT01062165|76267143|FG000|COMPLETED|Overall Study||18||
60143536|NCT01062165|76267143|FG000|NOT COMPLETED|Overall Study||0||
60143537|NCT01067781|76267151|FG000|STARTED|Up to Day 180||203||
60143538|NCT01067781|76267152|FG001|STARTED|Up to Day 180||199||
60143539|NCT01067781|76267153|FG002|STARTED|Up to Day 180||97||
60143540|NCT01067781|76267154|FG003|STARTED|Up to Day 180||101||
60143541|NCT01067781|76267151|FG000|COMPLETED|Up to Day 180||173||
60143542|NCT01067781|76267152|FG001|COMPLETED|Up to Day 180||168||
60143543|NCT01067781|76267153|FG002|COMPLETED|Up to Day 180||89||
60143544|NCT01067781|76267154|FG003|COMPLETED|Up to Day 180||89||
60143545|NCT01067781|76267151|FG000|NOT COMPLETED|Up to Day 180||30||
60143546|NCT01067781|76267152|FG001|NOT COMPLETED|Up to Day 180||31||
60143547|NCT01067781|76267153|FG002|NOT COMPLETED|Up to Day 180||8||
60143548|NCT01067781|76267154|FG003|NOT COMPLETED|Up to Day 180||12||
60143549|NCT01067781|76267151|FG000|STARTED|180 to Day 720||173||
60143550|NCT01067781|76267152|FG001|STARTED|180 to Day 720||168||
60143551|NCT01067781|76267153|FG002|STARTED|180 to Day 720||89||
60143552|NCT01067781|76267154|FG003|STARTED|180 to Day 720||89||
60143553|NCT01067781|76267151|FG000|COMPLETED|180 to Day 720|all subjects followed till Day180;if ongoing local AE, FU every 6 mths till AE resolved (max.Day720)|3||
60143554|NCT01067781|76267152|FG001|COMPLETED|180 to Day 720|all subjects followed till Day180;if ongoing local AE, FU every 6 mths till AE resolved (max.Day720)|4||
60143555|NCT01067781|76267153|FG002|COMPLETED|180 to Day 720|all subjects followed till Day180;if ongoing local AE, FU every 6 mths till AE resolved (max.Day720)|0||
60143556|NCT01067781|76267154|FG003|COMPLETED|180 to Day 720|all subjects followed till Day180;if ongoing local AE, FU every 6 mths till AE resolved (max.Day720)|0||
60143557|NCT01067781|76267151|FG000|NOT COMPLETED|180 to Day 720||170||
60143558|NCT01067781|76267152|FG001|NOT COMPLETED|180 to Day 720||164||
60143559|NCT01067781|76267153|FG002|NOT COMPLETED|180 to Day 720||89||
60143560|NCT01067781|76267154|FG003|NOT COMPLETED|180 to Day 720||89||
60143561|NCT01068873|76267166|FG000|STARTED|Overall Study||1||
60143562|NCT01068873|76267166|FG000|COMPLETED|Overall Study||1||
60143563|NCT01068873|76267166|FG000|NOT COMPLETED|Overall Study||0||
60143564|NCT01069185|76267172|FG000|STARTED|Overall Study||47||
60143565|NCT01069185|76267173|FG001|STARTED|Overall Study||45||
60143566|NCT01069185|76267172|FG000|COMPLETED|Overall Study||47||
60143567|NCT01069185|76267173|FG001|COMPLETED|Overall Study||45||
60143568|NCT01069185|76267172|FG000|NOT COMPLETED|Overall Study||0||
60143569|NCT01069185|76267173|FG001|NOT COMPLETED|Overall Study||0||
60143570|NCT01072617|76267179|FG000|STARTED|Overall Study||8||
60143571|NCT01072617|76267179|FG000|COMPLETED|Overall Study||8||
60143572|NCT01072617|76267179|FG000|NOT COMPLETED|Overall Study||0||
60143573|NCT01072773|76267184|FG000|STARTED|Overall Study||2||
60143574|NCT01072773|76267184|FG000|COMPLETED|Overall Study||2||
60143575|NCT01072773|76267184|FG000|NOT COMPLETED|Overall Study||0||
60143576|NCT01074099|76267190|FG000|STARTED|Overall Study||2||
60143577|NCT01074099|76267191|FG001|STARTED|Overall Study||3||
60143578|NCT01074099|76267190|FG000|COMPLETED|Overall Study||2||
60143579|NCT01074099|76267191|FG001|COMPLETED|Overall Study||3||
60143580|NCT01074099|76267190|FG000|NOT COMPLETED|Overall Study||0||
60143581|NCT01074099|76267191|FG001|NOT COMPLETED|Overall Study||0||
60143582|NCT01074177|76267197|FG000|STARTED|Overall Study||24||
60143583|NCT01074177|76267197|FG000|COMPLETED|Overall Study||24||
60143584|NCT01074177|76267197|FG000|NOT COMPLETED|Overall Study||0||
60143585|NCT01075347|76267203|FG000|STARTED|Overall Study||82||
60143586|NCT01075347|76267204|FG001|STARTED|Overall Study||83||
60143587|NCT01075347|76267203|FG000|COMPLETED|Overall Study||82||
60143588|NCT01075347|76267204|FG001|COMPLETED|Overall Study||83||
60143589|NCT01075347|76267203|FG000|NOT COMPLETED|Overall Study||0||
60143590|NCT01075347|76267204|FG001|NOT COMPLETED|Overall Study||0||
60143591|NCT01076049|76267213|FG000|STARTED|Overall Study||52||
60143592|NCT01076049|76267214|FG001|STARTED|Overall Study||55||
60143593|NCT01076049|76267215|FG002|STARTED|Overall Study||1||
60143594|NCT01076049|76267213|FG000|COMPLETED|Overall Study||45||
60143595|NCT01076049|76267214|FG001|COMPLETED|Overall Study||52||
60143596|NCT01076049|76267215|FG002|COMPLETED|Overall Study||1||
60143597|NCT01076049|76267213|FG000|NOT COMPLETED|Overall Study||7||
60143598|NCT01076049|76267214|FG001|NOT COMPLETED|Overall Study||3||
60143599|NCT01076049|76267215|FG002|NOT COMPLETED|Overall Study||0||
60143600|NCT01076283|76267227|FG000|STARTED|Overall Study||7||
60143601|NCT01076283|76267228|FG001|STARTED|Overall Study||7||
60143602|NCT01076283|76267227|FG000|COMPLETED|Overall Study||6||
60143603|NCT01076283|76267228|FG001|COMPLETED|Overall Study||7||
60143604|NCT01076283|76267227|FG000|NOT COMPLETED|Overall Study||1||
60143605|NCT01076283|76267228|FG001|NOT COMPLETED|Overall Study||0||
60143606|NCT01076985|76267234|FG000|STARTED|Overall Study||24||
60143607|NCT01076985|76267234|FG000|COMPLETED|Overall Study||24||
60143608|NCT01076985|76267234|FG000|NOT COMPLETED|Overall Study||0||
60143609|NCT02176005|76267244|FG000|STARTED|Overall Study||14||
60143610|NCT02176005|76267245|FG001|STARTED|Overall Study||14||
60143611|NCT02176005|76267246|FG002|STARTED|Overall Study||8||
60143612|NCT02176005|76267247|FG003|STARTED|Overall Study||8||
60143613|NCT02176005|76267244|FG000|COMPLETED|Overall Study||14||
60143614|NCT02176005|76267245|FG001|COMPLETED|Overall Study||14||
60143615|NCT02176005|76267246|FG002|COMPLETED|Overall Study||8||
60143616|NCT02176005|76267247|FG003|COMPLETED|Overall Study||8||
60143617|NCT02176005|76267244|FG000|NOT COMPLETED|Overall Study||0||
60143618|NCT02176005|76267245|FG001|NOT COMPLETED|Overall Study||0||
60143619|NCT02176005|76267246|FG002|NOT COMPLETED|Overall Study||0||
60143620|NCT02176005|76267247|FG003|NOT COMPLETED|Overall Study||0||
60143621|NCT02176083|76267259|FG000|STARTED|Overall Study||11||
60143622|NCT02176083|76267260|FG001|STARTED|Overall Study||27||
60143623|NCT02176083|76267259|FG000|COMPLETED|Overall Study||11||
60143624|NCT02176083|76267260|FG001|COMPLETED|Overall Study||27||
60143625|NCT02176083|76267259|FG000|NOT COMPLETED|Overall Study||0||
60143626|NCT02176083|76267260|FG001|NOT COMPLETED|Overall Study||0||
60143627|NCT01077921|76267268|FG000|STARTED|First Intervention||14||
60143628|NCT01077921|76267269|FG001|STARTED|First Intervention||13||
60143629|NCT01077921|76267268|FG000|COMPLETED|First Intervention||13||
60143630|NCT01077921|76267269|FG001|COMPLETED|First Intervention||12||
60143631|NCT01077921|76267268|FG000|NOT COMPLETED|First Intervention||1||
60143632|NCT01077921|76267269|FG001|NOT COMPLETED|First Intervention||1||
60143633|NCT01077921|76267268|FG000|STARTED|Washout||13||
60143634|NCT01077921|76267269|FG001|STARTED|Washout||12||
60143635|NCT01077921|76267268|FG000|COMPLETED|Washout||13||
60143636|NCT01077921|76267269|FG001|COMPLETED|Washout||10||
60143637|NCT01077921|76267268|FG000|NOT COMPLETED|Washout||0||
60143638|NCT01077921|76267269|FG001|NOT COMPLETED|Washout||2||
60143639|NCT01077921|76267268|FG000|STARTED|Second Intervention||13||
60143640|NCT01077921|76267269|FG001|STARTED|Second Intervention||10||
60143641|NCT01077921|76267268|FG000|COMPLETED|Second Intervention||13||
60143642|NCT01077921|76267269|FG001|COMPLETED|Second Intervention||9||
60143643|NCT01077921|76267268|FG000|NOT COMPLETED|Second Intervention||0||
60143644|NCT01077921|76267269|FG001|NOT COMPLETED|Second Intervention||1||
60143645|NCT01078233|76267282|FG000|STARTED|Overall Study||656||
60143646|NCT01078233|76267283|FG001|STARTED|Overall Study||296||
60143647|NCT01078233|76267284|FG002|STARTED|Overall Study||1681||
60143648|NCT01078233|76267285|FG003|STARTED|Overall Study||631||
60143649|NCT01078233|76267286|FG004|STARTED|Overall Study||3199||
60143650|NCT01078233|76267287|FG005|STARTED|Overall Study||154||
60143651|NCT01078233|76267282|FG000|COMPLETED|Overall Study||656||
60143652|NCT01078233|76267283|FG001|COMPLETED|Overall Study||296||
60143653|NCT01078233|76267284|FG002|COMPLETED|Overall Study||1681||
60143654|NCT01078233|76267285|FG003|COMPLETED|Overall Study||631||
60143655|NCT01078233|76267286|FG004|COMPLETED|Overall Study||3199||
60143656|NCT01078233|76267287|FG005|COMPLETED|Overall Study||154||
60143657|NCT01078233|76267282|FG000|NOT COMPLETED|Overall Study||0||
60143658|NCT01078233|76267283|FG001|NOT COMPLETED|Overall Study||0||
60143659|NCT01078233|76267284|FG002|NOT COMPLETED|Overall Study||0||
60143660|NCT01078233|76267285|FG003|NOT COMPLETED|Overall Study||0||
60143661|NCT01078233|76267286|FG004|NOT COMPLETED|Overall Study||0||
60143662|NCT01078233|76267287|FG005|NOT COMPLETED|Overall Study||0||
60143663|NCT01080261|76267295|FG000|STARTED|Overall Study||60||
60143664|NCT01080261|76267295|FG000|COMPLETED|Overall Study||60||
60143665|NCT01080261|76267295|FG000|NOT COMPLETED|Overall Study||0||
60143666|NCT02169453|76267303|FG000|STARTED|Overall Study||3||
60143667|NCT02169453|76267304|FG001|STARTED|Overall Study||3||
60143668|NCT02169453|76267305|FG002|STARTED|Overall Study||3||
60143669|NCT02169453|76267306|FG003|STARTED|Overall Study||3||
60143670|NCT02169453|76267303|FG000|25 mg BIA 9-1067|Overall Study||3||
60143671|NCT02169453|76267304|FG001|25 mg BIA 9-1067|Overall Study||3||
60143672|NCT02169453|76267305|FG002|25 mg BIA 9-1067|Overall Study||3||
60143673|NCT02169453|76267306|FG003|25 mg BIA 9-1067|Overall Study||3||
60143674|NCT02169453|76267303|FG000|50 mg BIA 9-1067|Overall Study||3||
60143675|NCT02169453|76267304|FG001|50 mg BIA 9-1067|Overall Study||3||
60143676|NCT02169453|76267305|FG002|50 mg BIA 9-1067|Overall Study||2||
60143677|NCT02169453|76267306|FG003|50 mg BIA 9-1067|Overall Study||3||
60143678|NCT02169453|76267303|FG000|100 mg BIA 9-1067|Overall Study||3||
60143679|NCT02169453|76267304|FG001|100 mg BIA 9-1067|Overall Study||3||
60143680|NCT02169453|76267305|FG002|100 mg BIA 9-1067|Overall Study||3||
60143681|NCT02169453|76267306|FG003|100 mg BIA 9-1067|Overall Study||3||
60143682|NCT02169453|76267303|FG000|Placebo|Overall Study||3||
60143683|NCT02169453|76267304|FG001|Placebo|Overall Study||3||
60143684|NCT02169453|76267305|FG002|Placebo|Overall Study||3||
60143685|NCT02169453|76267306|FG003|Placebo|Overall Study||3||
60143686|NCT02169453|76267303|FG000|COMPLETED|Overall Study||3||
60143687|NCT02169453|76267304|FG001|COMPLETED|Overall Study||3||
60143688|NCT02169453|76267305|FG002|COMPLETED|Overall Study||2||
60143689|NCT02169453|76267306|FG003|COMPLETED|Overall Study||3||
60143690|NCT02169453|76267303|FG000|NOT COMPLETED|Overall Study||0||
60143691|NCT02169453|76267304|FG001|NOT COMPLETED|Overall Study||0||
60143692|NCT02169453|76267305|FG002|NOT COMPLETED|Overall Study||1||
60143693|NCT02169453|76267306|FG003|NOT COMPLETED|Overall Study||0||
60143694|NCT01765296|76267319|FG000|STARTED|Overall Study||71||
60143695|NCT01765296|76267320|FG001|STARTED|Overall Study||146||
60143696|NCT01765296|76267321|FG002|STARTED|Overall Study||145||
60143697|NCT01765296|76267319|FG000|COMPLETED|Overall Study||66||
60143698|NCT01765296|76267320|FG001|COMPLETED|Overall Study||126||
60143699|NCT01765296|76267321|FG002|COMPLETED|Overall Study||132||
60143700|NCT01765296|76267319|FG000|NOT COMPLETED|Overall Study||5||
60143701|NCT01765296|76267320|FG001|NOT COMPLETED|Overall Study||20||
60143702|NCT01765296|76267321|FG002|NOT COMPLETED|Overall Study||13||
60143703|NCT01081041|76267332|FG000|STARTED|Overall Study||33||
60143704|NCT01081041|76267333|FG001|STARTED|Overall Study||81||
60143705|NCT01081041|76267334|FG002|STARTED|Overall Study||73||
60143706|NCT01081041|76267332|FG000|Received at Least 1 Dose of Study Drug|Overall Study||33||
60143707|NCT01081041|76267333|FG001|Received at Least 1 Dose of Study Drug|Overall Study||77||
60143708|NCT01081041|76267334|FG002|Received at Least 1 Dose of Study Drug|Overall Study||71||
60143709|NCT01081041|76267332|FG000|COMPLETED|Overall Study||33||
59605708|NCT01965600|75715854|FG003|COMPLETED|Washout Period of Approximately 15 Days||2||
60143710|NCT01081041|76267333|FG001|COMPLETED|Overall Study||77||
60143711|NCT01081041|76267334|FG002|COMPLETED|Overall Study||71||
60143712|NCT01081041|76267332|FG000|NOT COMPLETED|Overall Study||0||
60143713|NCT01081041|76267333|FG001|NOT COMPLETED|Overall Study||4||
60143714|NCT01081041|76267334|FG002|NOT COMPLETED|Overall Study||2||
60143715|NCT01083849|76267349|FG000|STARTED|Overall Study||121||
60143716|NCT01083849|76267350|FG001|STARTED|Overall Study||638||
60143717|NCT01083849|76267349|FG000|COMPLETED|Overall Study||61||
60143718|NCT01083849|76267350|FG001|COMPLETED|Overall Study||527||
60143719|NCT01083849|76267349|FG000|NOT COMPLETED|Overall Study||60||
60143720|NCT01083849|76267350|FG001|NOT COMPLETED|Overall Study||111||
60143721|NCT05451225|76267359|FG000|STARTED|Baseline||200||
60143722|NCT05451225|76267359|FG000|COMPLETED|Baseline||200||
60143723|NCT05451225|76267359|FG000|NOT COMPLETED|Baseline||0||
60143724|NCT05451225|76267359|FG000|STARTED|6 Months|The enrollment reported at 6 months is not sequential to baseline. Different COs were enrolled during this time period.|123||
59605709|NCT01965600|75715851|FG000|NOT COMPLETED|Washout Period of Approximately 15 Days||2||
59605710|NCT01965600|75715852|FG001|NOT COMPLETED|Washout Period of Approximately 15 Days||4||
60143725|NCT05451225|76267359|FG000|COMPLETED|6 Months||123||
60143726|NCT05451225|76267359|FG000|NOT COMPLETED|6 Months||0||
60143727|NCT05451225|76267359|FG000|STARTED|12 Months|The enrollment reported at 12 months is not sequential to baseline and 6 months. Different COs were enrolled during this time period.|128||
60143728|NCT05451225|76267359|FG000|COMPLETED|12 Months||128||
60143729|NCT05451225|76267359|FG000|NOT COMPLETED|12 Months||0||
60143730|NCT03022617|76267363|FG000|STARTED|Overall Study||12||
60143731|NCT03022617|76267363|FG000|COMPLETED|Overall Study||6||
60143732|NCT03022617|76267363|FG000|NOT COMPLETED|Overall Study||6||
60010249|NCT03801382|76125937|FG000|NOT COMPLETED|First Assessment||0||
60010250|NCT03801382|76125938|FG001|NOT COMPLETED|First Assessment||0||
60010251|NCT03801382|76125939|FG002|NOT COMPLETED|First Assessment||0||
60010252|NCT03801382|76125940|FG003|NOT COMPLETED|First Assessment||0||
60010253|NCT03801382|76125941|FG004|NOT COMPLETED|First Assessment||0||
60010254|NCT03801382|76125937|FG000|STARTED|Second Assessment||99||
60010255|NCT03801382|76125938|FG001|STARTED|Second Assessment||101||
60010256|NCT03801382|76125939|FG002|STARTED|Second Assessment||53||
60010257|NCT03801382|76125940|FG003|STARTED|Second Assessment||49||
60010258|NCT03801382|76125941|FG004|STARTED|Second Assessment||0||
60010259|NCT03801382|76125937|FG000|COMPLETED|Second Assessment||99||
60010260|NCT03801382|76125938|FG001|COMPLETED|Second Assessment||101||
60010261|NCT03801382|76125939|FG002|COMPLETED|Second Assessment||53||
60010262|NCT03801382|76125940|FG003|COMPLETED|Second Assessment||49||
60010263|NCT03801382|76125941|FG004|COMPLETED|Second Assessment||0||
60010264|NCT03801382|76125937|FG000|NOT COMPLETED|Second Assessment||0||
60010265|NCT03801382|76125938|FG001|NOT COMPLETED|Second Assessment||0||
60010266|NCT03801382|76125939|FG002|NOT COMPLETED|Second Assessment||0||
60010267|NCT03801382|76125940|FG003|NOT COMPLETED|Second Assessment||0||
60010268|NCT03801382|76125941|FG004|NOT COMPLETED|Second Assessment||0||
60010269|NCT03782064|76125950|FG000|STARTED|Overall Study||5|Enrolled and had Tumor and Dendritic Cells Collected|
60010270|NCT03782064|76125950|FG000|Initiated Treatment|Overall Study||2||
60010271|NCT03782064|76125950|FG000|COMPLETED|Overall Study||0||
60010272|NCT03782064|76125950|FG000|NOT COMPLETED|Overall Study||5||
60010273|NCT03772522|76125956|FG000|STARTED|Pre-intervention||12||
60010274|NCT03772522|76125957|FG001|STARTED|Pre-intervention||15||
60010275|NCT03772522|76125956|FG000|COMPLETED|Pre-intervention||9||
60010276|NCT03772522|76125957|FG001|COMPLETED|Pre-intervention||11||
60010277|NCT03772522|76125956|FG000|NOT COMPLETED|Pre-intervention||3||
60010278|NCT03772522|76125957|FG001|NOT COMPLETED|Pre-intervention||4||
60010279|NCT03772522|76125956|FG000|STARTED|Intervention||9||
60010280|NCT03772522|76125957|FG001|STARTED|Intervention||11||
60010281|NCT03772522|76125956|FG000|COMPLETED|Intervention||8||
60010282|NCT03772522|76125957|FG001|COMPLETED|Intervention||11||
60010283|NCT03772522|76125956|FG000|NOT COMPLETED|Intervention||1||
60010284|NCT03772522|76125957|FG001|NOT COMPLETED|Intervention||0||
60010285|NCT03772522|76125956|FG000|STARTED|Post-intervention Follow-up||8||
60010286|NCT03772522|76125957|FG001|STARTED|Post-intervention Follow-up||11||
60010287|NCT03772522|76125956|FG000|COMPLETED|Post-intervention Follow-up||7||
60010288|NCT03772522|76125957|FG001|COMPLETED|Post-intervention Follow-up||11||
60010289|NCT03772522|76125956|FG000|NOT COMPLETED|Post-intervention Follow-up||1||
60010290|NCT03772522|76125957|FG001|NOT COMPLETED|Post-intervention Follow-up||0||
60010291|NCT03755518|76125967|FG000|STARTED|Overall Study||38||
60010292|NCT03755518|76125967|FG000|COMPLETED|Overall Study||13|Completed = Continuing Treatment|
60010293|NCT03755518|76125967|FG000|NOT COMPLETED|Overall Study||25||
60010294|NCT03739112|76125973|FG000|STARTED|Overall Study||6396||
60010295|NCT03739112|76125974|FG001|STARTED|Overall Study||6398||
60010296|NCT03739112|76125973|FG000|Vaccinated|Overall Study||6365||
60010297|NCT03739112|76125974|FG001|Vaccinated|Overall Study||6373||
60010298|NCT03739112|76125973|FG000|COMPLETED|Overall Study||6196||
60010299|NCT03739112|76125974|FG001|COMPLETED|Overall Study||6222||
60010300|NCT03739112|76125973|FG000|NOT COMPLETED|Overall Study||200||
60010301|NCT03739112|76125974|FG001|NOT COMPLETED|Overall Study||176||
60143733|NCT01085331|76267369|FG000|STARTED|Overall Study||10||
60143734|NCT01085331|76267370|FG001|STARTED|Overall Study||6||
60010302|NCT03622593|76125983|FG000|STARTED|Overall Study||317|Intent-to-Treat (ITT) Population|
60010303|NCT03622593|76125984|FG001|STARTED|Overall Study||319|Intent-to-Treat (ITT) Population|
60010304|NCT03622593|76125985|FG002|STARTED|Overall Study||315|Intent-to-Treat (ITT) Population|
60010305|NCT03622593|76125983|FG000|Received at Least One Dose of Study Drug|Overall Study||317|Safety-Evaluable Population|
60010306|NCT03622593|76125984|FG001|Received at Least One Dose of Study Drug|Overall Study||319|Safety-Evaluable Population|
60010307|NCT03622593|76125985|FG002|Received at Least One Dose of Study Drug|Overall Study||314|Safety-Evaluable Population|
60010308|NCT03622593|76125983|FG000|Completed up to Week 56|Overall Study||298|Primary Completion Date Cutoff|
60010309|NCT03622593|76125984|FG001|Completed up to Week 56|Overall Study||312|Primary Completion Date Cutoff|
60010310|NCT03622593|76125985|FG002|Completed up to Week 56|Overall Study||299|Primary Completion Date Cutoff|
60010311|NCT03622593|76125983|FG000|COMPLETED|Overall Study||275||
60010312|NCT03622593|76125984|FG001|COMPLETED|Overall Study||288||
60010313|NCT03622593|76125985|FG002|COMPLETED|Overall Study||267||
60010314|NCT03622593|76125983|FG000|NOT COMPLETED|Overall Study||42||
60010315|NCT03622593|76125984|FG001|NOT COMPLETED|Overall Study||31||
60010316|NCT03622593|76125985|FG002|NOT COMPLETED|Overall Study||48||
60010317|NCT03593655|76125996|FG000|STARTED|First Product Use Period||124||
60010318|NCT03593655|76125997|FG001|STARTED|First Product Use Period||123||
60010319|NCT03593655|76125996|FG000|COMPLETED|First Product Use Period||122||
60143735|NCT01085331|76267369|FG000|COMPLETED|Overall Study||10||
60143736|NCT01085331|76267370|FG001|COMPLETED|Overall Study||6||
60010320|NCT03593655|76125997|FG001|COMPLETED|First Product Use Period||119||
60010321|NCT03593655|76125996|FG000|NOT COMPLETED|First Product Use Period||2||
60010322|NCT03593655|76125997|FG001|NOT COMPLETED|First Product Use Period||4||
60010323|NCT03593655|76125996|FG000|STARTED|Second Product Use Period||122||
60010324|NCT03593655|76125997|FG001|STARTED|Second Product Use Period||119||
60010325|NCT03593655|76125996|FG000|COMPLETED|Second Product Use Period||120||
60010326|NCT03593655|76125997|FG001|COMPLETED|Second Product Use Period||118||
60010327|NCT03593655|76125996|FG000|NOT COMPLETED|Second Product Use Period||2||
60010328|NCT03593655|76125997|FG001|NOT COMPLETED|Second Product Use Period||1||
60010329|NCT03593655|76125996|FG000|STARTED|Third Product Use Period||120||
60010330|NCT03593655|76125997|FG001|STARTED|Third Product Use Period||118||
60010331|NCT03593655|76125996|FG000|Always Chose Dapivirine Vaginal Ring|Third Product Use Period||66||
60010332|NCT03593655|76125997|FG001|Always Chose Dapivirine Vaginal Ring|Third Product Use Period||71||
60010333|NCT03593655|76125996|FG000|Always Chose FTC/TDF|Third Product Use Period||35||
60010334|NCT03593655|76125997|FG001|Always Chose FTC/TDF|Third Product Use Period||27||
60010335|NCT03593655|76125996|FG000|At Least One Switch|Third Product Use Period||17|This category includes participants who switched between the ring and FTC/TDF, as well as participants who switched between using one/both of the products and using neither product.|
60010336|NCT03593655|76125997|FG001|At Least One Switch|Third Product Use Period||13|This category includes participants who switched between the ring and FTC/TDF, as well as participants who switched between using one/both of the products and using neither product.|
60010337|NCT03593655|76125996|FG000|Never Chose Either Product|Third Product Use Period||2||
60010338|NCT03593655|76125997|FG001|Never Chose Either Product|Third Product Use Period||7||
60010339|NCT03593655|76125996|FG000|COMPLETED|Third Product Use Period||119||
60010340|NCT03593655|76125997|FG001|COMPLETED|Third Product Use Period||114||
60010341|NCT03593655|76125996|FG000|NOT COMPLETED|Third Product Use Period||1||
60010342|NCT03593655|76125997|FG001|NOT COMPLETED|Third Product Use Period||4||
60010343|NCT03577106|76126006|FG000|STARTED|Overall Study||24||
60010344|NCT03577106|76126006|FG000|COMPLETED|Overall Study||21||
60010345|NCT03577106|76126006|FG000|NOT COMPLETED|Overall Study||3||
60010346|NCT03458416|76126010|FG000|STARTED|Overall Study||0||
60010347|NCT03458416|76126010|FG000|COMPLETED|Overall Study||0||
60010348|NCT03458416|76126010|FG000|NOT COMPLETED|Overall Study||0||
60010349|NCT03364231|76126016|FG000|STARTED|Overall Study||8||
60010350|NCT03364231|76126017|FG001|STARTED|Overall Study||13||
60010351|NCT03364231|76126016|FG000|Safety Population|Overall Study||8|Safety population included all enrolled participants who received at least one dose of study treatment.|
60010352|NCT03364231|76126017|FG001|Safety Population|Overall Study||13|Safety population included all enrolled participants who received at least one dose of study treatment.|
60010353|NCT03364231|76126016|FG000|Modified Intent-To-Treat (mITT)|Overall Study||8|mITT population included all participants who received at least one dose of study treatment and provided at least some post baseline efficacy assessment.|
60010354|NCT03364231|76126017|FG001|Modified Intent-To-Treat (mITT)|Overall Study||10|mITT population included all participants who received at least one dose of study treatment and provided at least some post baseline efficacy assessment.|
60010355|NCT03364231|76126016|FG000|COMPLETED|Overall Study||0||
60010356|NCT03364231|76126017|FG001|COMPLETED|Overall Study||0||
60010357|NCT03364231|76126016|FG000|NOT COMPLETED|Overall Study||8||
60010358|NCT03364231|76126017|FG001|NOT COMPLETED|Overall Study||13||
60010359|NCT03303625|76126028|FG000|STARTED|Overall Study||8||
60010360|NCT03303625|76126029|FG001|STARTED|Overall Study||4||
60010361|NCT03303625|76126030|FG002|STARTED|Overall Study||24||
60010362|NCT03303625|76126031|FG003|STARTED|Overall Study||12||
60010363|NCT03303625|76126028|FG000|COMPLETED|Overall Study||6||
60010364|NCT03303625|76126029|FG001|COMPLETED|Overall Study||4||
60010365|NCT03303625|76126030|FG002|COMPLETED|Overall Study||24||
60010366|NCT03303625|76126031|FG003|COMPLETED|Overall Study||12||
60010367|NCT03303625|76126028|FG000|NOT COMPLETED|Overall Study||2||
60010368|NCT03303625|76126029|FG001|NOT COMPLETED|Overall Study||0||
60010369|NCT03303625|76126030|FG002|NOT COMPLETED|Overall Study||0||
60010370|NCT03303625|76126031|FG003|NOT COMPLETED|Overall Study||0||
60010371|NCT03299816|76126043|FG000|STARTED|Phase 1: 4-month Intervention Period||70||
60010372|NCT03299816|76126044|FG001|STARTED|Phase 1: 4-month Intervention Period||72||
60010373|NCT03299816|76126043|FG000|COMPLETED|Phase 1: 4-month Intervention Period||69||
60010374|NCT03299816|76126044|FG001|COMPLETED|Phase 1: 4-month Intervention Period||72||
60010375|NCT03299816|76126043|FG000|NOT COMPLETED|Phase 1: 4-month Intervention Period||1||
60010376|NCT03299816|76126044|FG001|NOT COMPLETED|Phase 1: 4-month Intervention Period||0||
60010377|NCT03299816|76126043|FG000|STARTED|Phase 2: 12-month Follow-up Period|The number of eligible C-DASH participants included 53 who were randomized prior to 2021, minus 1 who dropped out during Phase 1. Seventeen C-DASH participants who were randomized in 2021 were invited to participate in Phase 1 only and were not included in Phase 2 of this study.|52||
60010378|NCT03299816|76126044|FG001|STARTED|Phase 2: 12-month Follow-up Period|The number of eligible S-DASH participants included 56 who were randomized prior to 2021. Sixteen S-DASH participants who were randomized in 2021 were invited to participate in Phase 1 only and were not included in Phase 2 of this study.|56||
60010379|NCT03299816|76126043|FG000|COMPLETED|Phase 2: 12-month Follow-up Period||49||
60010380|NCT03299816|76126044|FG001|COMPLETED|Phase 2: 12-month Follow-up Period||53||
60010381|NCT03299816|76126043|FG000|NOT COMPLETED|Phase 2: 12-month Follow-up Period||3||
60010382|NCT03299816|76126044|FG001|NOT COMPLETED|Phase 2: 12-month Follow-up Period||3||
60010383|NCT03288493|76126057|FG000|STARTED|Overall Study||69||
60010384|NCT03288493|76126058|FG001|STARTED|Overall Study||3||
60010385|NCT03288493|76126059|FG002|STARTED|Overall Study||1||
60010386|NCT03288493|76126060|FG003|STARTED|Overall Study||8||
60010387|NCT03288493|76126061|FG004|STARTED|Overall Study||5||
60010388|NCT03288493|76126062|FG005|STARTED|Overall Study||16||
60010389|NCT03288493|76126063|FG006|STARTED|Overall Study||3||
60143737|NCT01085331|76267369|FG000|NOT COMPLETED|Overall Study||0||
60143738|NCT01085331|76267370|FG001|NOT COMPLETED|Overall Study||0||
60143739|NCT02171247|76267382|FG000|STARTED|Overall Study||16||
60143740|NCT02171247|76267383|FG001|STARTED|Overall Study||17||
60143741|NCT02171247|76267382|FG000|COMPLETED|Overall Study||16||
60143742|NCT02171247|76267383|FG001|COMPLETED|Overall Study||17||
60143743|NCT02171247|76267382|FG000|NOT COMPLETED|Overall Study||0||
60143744|NCT02171247|76267383|FG001|NOT COMPLETED|Overall Study||0||
60143745|NCT02089685|76267395|FG000|STARTED|Overall Study||23||
60143746|NCT02089685|76267396|FG001|STARTED|Overall Study||14||
60143747|NCT02089685|76267397|FG002|STARTED|Overall Study||3||
60143748|NCT02089685|76267398|FG003|STARTED|Overall Study||153||
60143749|NCT02089685|76267399|FG004|STARTED|Overall Study||51||
60143750|NCT02089685|76267400|FG005|STARTED|Overall Study||51||
60010390|NCT03288493|76126057|FG000|COMPLETED|Overall Study||3|Completed Study is defined as a subject completing Post-Treatment Follow-up Visits to Month 24.|
60010391|NCT03288493|76126058|FG001|COMPLETED|Overall Study||0|Completed Study is defined as a subject completing Post-Treatment Follow-up Visits to Month 24.|
60010392|NCT03288493|76126059|FG002|COMPLETED|Overall Study||0|Completed Study is defined as a subject completing Post-Treatment Follow-up Visits to Month 24.|
60010393|NCT03288493|76126060|FG003|COMPLETED|Overall Study||0|Completed Study is defined as a subject completing Post-Treatment Follow-up Visits to Month 24.|
60010394|NCT03288493|76126061|FG004|COMPLETED|Overall Study||0|Completed Study is defined as a subject completing Post-Treatment Follow-up Visits to Month 24.|
60010395|NCT03288493|76126062|FG005|COMPLETED|Overall Study||0|Completed Study is defined as a subject completing Post-Treatment Follow-up Visits to Month 24.|
60010396|NCT03288493|76126063|FG006|COMPLETED|Overall Study||0|Completed Study is defined as a subject completing Post-Treatment Follow-up Visits to Month 24.|
60010397|NCT03288493|76126057|FG000|NOT COMPLETED|Overall Study||66||
60010398|NCT03288493|76126058|FG001|NOT COMPLETED|Overall Study||3||
60010399|NCT03288493|76126059|FG002|NOT COMPLETED|Overall Study||1||
60010400|NCT03288493|76126060|FG003|NOT COMPLETED|Overall Study||8||
60010401|NCT03288493|76126061|FG004|NOT COMPLETED|Overall Study||5||
60010402|NCT03288493|76126062|FG005|NOT COMPLETED|Overall Study||16||
60010403|NCT03288493|76126063|FG006|NOT COMPLETED|Overall Study||3||
60010404|NCT03238300|76126083|FG000|STARTED|Baseline (Before Intervention)||18||
60010405|NCT03238300|76126084|FG001|STARTED|Baseline (Before Intervention)||17||
60010406|NCT03238300|76126083|FG000|COMPLETED|Baseline (Before Intervention)||18||
60010407|NCT03238300|76126084|FG001|COMPLETED|Baseline (Before Intervention)||16||
60010408|NCT03238300|76126083|FG000|NOT COMPLETED|Baseline (Before Intervention)||0||
60010409|NCT03238300|76126084|FG001|NOT COMPLETED|Baseline (Before Intervention)||1||
60010410|NCT03238300|76126083|FG000|STARTED|First Intervention (10-Days)||18||
60010411|NCT03238300|76126084|FG001|STARTED|First Intervention (10-Days)||16||
60010412|NCT03238300|76126083|FG000|COMPLETED|First Intervention (10-Days)||18||
60143751|NCT02089685|76267395|FG000|Treated|Overall Study||22||
60143752|NCT02089685|76267396|FG001|Treated|Overall Study||14||
60143753|NCT02089685|76267397|FG002|Treated|Overall Study||3||
60143754|NCT02089685|76267398|FG003|Treated|Overall Study||153||
60143755|NCT02089685|76267399|FG004|Treated|Overall Study||51||
60143756|NCT02089685|76267400|FG005|Treated|Overall Study||51||
60143757|NCT02089685|76267395|FG000|COMPLETED|Overall Study||0||
60010413|NCT03238300|76126084|FG001|COMPLETED|First Intervention (10-Days)||16||
60010414|NCT03238300|76126083|FG000|NOT COMPLETED|First Intervention (10-Days)||0||
60010415|NCT03238300|76126084|FG001|NOT COMPLETED|First Intervention (10-Days)||0||
60010416|NCT03238300|76126083|FG000|STARTED|Washout Period (11-Days)||18||
60010417|NCT03238300|76126084|FG001|STARTED|Washout Period (11-Days)||16||
60010418|NCT03238300|76126083|FG000|COMPLETED|Washout Period (11-Days)||17||
60010419|NCT03238300|76126084|FG001|COMPLETED|Washout Period (11-Days)||16||
60010420|NCT03238300|76126083|FG000|NOT COMPLETED|Washout Period (11-Days)||1||
60010421|NCT03238300|76126084|FG001|NOT COMPLETED|Washout Period (11-Days)||0||
60010422|NCT03238300|76126083|FG000|STARTED|Second Intervention (10-Days)||17||
60010423|NCT03238300|76126084|FG001|STARTED|Second Intervention (10-Days)||16||
60010424|NCT03238300|76126083|FG000|COMPLETED|Second Intervention (10-Days)||15||
60010425|NCT03238300|76126084|FG001|COMPLETED|Second Intervention (10-Days)||16||
60010426|NCT03238300|76126083|FG000|NOT COMPLETED|Second Intervention (10-Days)||2||
60010427|NCT03238300|76126084|FG001|NOT COMPLETED|Second Intervention (10-Days)||0||
60010428|NCT03178045|76126096|FG000|STARTED|Overall Study||1396||
60143758|NCT02089685|76267396|FG001|COMPLETED|Overall Study||0||
60143759|NCT02089685|76267397|FG002|COMPLETED|Overall Study||0||
60143760|NCT02089685|76267398|FG003|COMPLETED|Overall Study||0||
60143761|NCT02089685|76267399|FG004|COMPLETED|Overall Study||0||
60143762|NCT02089685|76267400|FG005|COMPLETED|Overall Study||0||
60143763|NCT02089685|76267395|FG000|NOT COMPLETED|Overall Study||23||
60143764|NCT02089685|76267396|FG001|NOT COMPLETED|Overall Study||14||
60143765|NCT02089685|76267397|FG002|NOT COMPLETED|Overall Study||3||
60143766|NCT02089685|76267398|FG003|NOT COMPLETED|Overall Study||153||
60143767|NCT02089685|76267399|FG004|NOT COMPLETED|Overall Study||51||
60143768|NCT02089685|76267400|FG005|NOT COMPLETED|Overall Study||51||
60143769|NCT01088295|76267424|FG000|STARTED|Overall Study||36||
60143770|NCT01088295|76267424|FG000|COMPLETED|Overall Study||35||
60143771|NCT01088295|76267424|FG000|NOT COMPLETED|Overall Study||1||
60143772|NCT01089231|76267432|FG000|STARTED|Overall Study||10||
60143773|NCT01089231|76267433|FG001|STARTED|Overall Study||10||
60143774|NCT01089231|76267434|FG002|STARTED|Overall Study||10||
60143775|NCT01089231|76267435|FG003|STARTED|Overall Study||10||
60143776|NCT01089231|76267432|FG000|COMPLETED|Overall Study|4 subjects excluded (2 alcohol use / TG level changes; 1 use of not allowed drugs; 1 low RNA yield)|6||
60143777|NCT01089231|76267433|FG001|COMPLETED|Overall Study|2 subjects excluded (1 highly elevated TG and TC data; 1 elevated inflammation (CRP level))|8||
60143778|NCT01089231|76267434|FG002|COMPLETED|Overall Study|2 subject excluded (1 use of not allowed drugs; 1 low RNA yield)|8||
60143779|NCT01089231|76267435|FG003|COMPLETED|Overall Study|1 subject excluded (low RNA yield)|9||
60143780|NCT01089231|76267432|FG000|NOT COMPLETED|Overall Study||4||
60143781|NCT01089231|76267433|FG001|NOT COMPLETED|Overall Study||2||
60143782|NCT01089231|76267434|FG002|NOT COMPLETED|Overall Study||2||
60143783|NCT01089231|76267435|FG003|NOT COMPLETED|Overall Study||1||
60143784|NCT01092195|76267448|FG000|STARTED|Overall Study||23||
60143785|NCT01092195|76267449|FG001|STARTED|Overall Study||21||
60143786|NCT01092195|76267450|FG002|STARTED|Overall Study||20||
60143787|NCT01092195|76267448|FG000|COMPLETED|Overall Study||23||
60143788|NCT01092195|76267449|FG001|COMPLETED|Overall Study||21||
60143789|NCT01092195|76267450|FG002|COMPLETED|Overall Study||20||
60143790|NCT01092195|76267448|FG000|NOT COMPLETED|Overall Study||0||
60143791|NCT01092195|76267449|FG001|NOT COMPLETED|Overall Study||0||
60143792|NCT01092195|76267450|FG002|NOT COMPLETED|Overall Study||0||
60143793|NCT05282004|76267458|FG000|STARTED|Overall Study||36||
60143794|NCT05282004|76267458|FG000|COMPLETED|Overall Study||34||
60143795|NCT05282004|76267458|FG000|NOT COMPLETED|Overall Study||2||
60143796|NCT05004649|76267462|FG000|STARTED|Overall Study||19||
60143797|NCT05004649|76267462|FG000|COMPLETED|Overall Study||11||
60143798|NCT05004649|76267462|FG000|NOT COMPLETED|Overall Study||8||
60143799|NCT04666298|76267472|FG000|STARTED|Overall Study||57||
60143800|NCT04666298|76267473|FG001|STARTED|Overall Study||55||
60143801|NCT04666298|76267474|FG002|STARTED|Overall Study||101||
60143802|NCT04666298|76267475|FG003|STARTED|Overall Study||99||
60143803|NCT04666298|76267472|FG000|COMPLETED|Overall Study||55||
60143804|NCT04666298|76267473|FG001|COMPLETED|Overall Study||55||
60143805|NCT04666298|76267474|FG002|COMPLETED|Overall Study||100||
60143806|NCT04666298|76267475|FG003|COMPLETED|Overall Study||95||
60143807|NCT04666298|76267472|FG000|NOT COMPLETED|Overall Study||2||
60143808|NCT04666298|76267473|FG001|NOT COMPLETED|Overall Study||0||
60143809|NCT04666298|76267474|FG002|NOT COMPLETED|Overall Study||1||
60143810|NCT04666298|76267475|FG003|NOT COMPLETED|Overall Study||4||
60143811|NCT04550234|76267490|FG000|STARTED|Overall Study||5||
60143812|NCT04550234|76267491|FG001|STARTED|Overall Study||5||
60143813|NCT04550234|76267492|FG002|STARTED|Overall Study||5||
60143814|NCT04550234|76267493|FG003|STARTED|Overall Study||5||
60143815|NCT04550234|76267494|FG004|STARTED|Overall Study||5||
60143816|NCT04550234|76267490|FG000|COMPLETED|Overall Study||5||
60143817|NCT04550234|76267491|FG001|COMPLETED|Overall Study||5||
60143818|NCT04550234|76267492|FG002|COMPLETED|Overall Study||5||
60143819|NCT04550234|76267493|FG003|COMPLETED|Overall Study||5||
60143820|NCT04550234|76267494|FG004|COMPLETED|Overall Study||5||
60143821|NCT04550234|76267490|FG000|NOT COMPLETED|Overall Study||0||
60143822|NCT04550234|76267491|FG001|NOT COMPLETED|Overall Study||0||
60143823|NCT04550234|76267492|FG002|NOT COMPLETED|Overall Study||0||
60143824|NCT04550234|76267493|FG003|NOT COMPLETED|Overall Study||0||
60143825|NCT04550234|76267494|FG004|NOT COMPLETED|Overall Study||0||
60143826|NCT04471805|76267507|FG000|STARTED|Overall Study||10||
60143827|NCT04471805|76267507|FG000|tDCS, Early Follicular Phase|Overall Study||10||
60143828|NCT04471805|76267507|FG000|Sham, Early Follicular Phase|Overall Study||10||
60143829|NCT04471805|76267507|FG000|tDCS, Late Follicular Phase|Overall Study||10||
60143830|NCT04471805|76267507|FG000|Sham, Late Follicular Phase|Overall Study||10||
60143831|NCT04471805|76267507|FG000|tDCS, Mid-Luteal Phase|Overall Study||10||
60143832|NCT04471805|76267507|FG000|Sham, Mid-Luteal Phase|Overall Study||10||
60143833|NCT04471805|76267507|FG000|COMPLETED|Overall Study||10||
60143834|NCT04471805|76267507|FG000|NOT COMPLETED|Overall Study||0||
60143835|NCT04188301|76267514|FG000|STARTED|Baseline||52||
60143836|NCT04188301|76267515|FG001|STARTED|Baseline||51||
60143837|NCT04188301|76267516|FG002|STARTED|Baseline||51||
60143838|NCT04188301|76267514|FG000|COMPLETED|Baseline||52||
60143839|NCT04188301|76267515|FG001|COMPLETED|Baseline||51||
60143840|NCT04188301|76267516|FG002|COMPLETED|Baseline||51||
60143841|NCT04188301|76267514|FG000|NOT COMPLETED|Baseline||0||
60143842|NCT04188301|76267515|FG001|NOT COMPLETED|Baseline||0||
60143843|NCT04188301|76267516|FG002|NOT COMPLETED|Baseline||0||
60143844|NCT04188301|76267514|FG000|STARTED|Month 3||52||
60143845|NCT04188301|76267515|FG001|STARTED|Month 3||51||
60143846|NCT04188301|76267516|FG002|STARTED|Month 3||51||
60143847|NCT04188301|76267514|FG000|COMPLETED|Month 3||52||
60143848|NCT04188301|76267515|FG001|COMPLETED|Month 3|1 participant was not able to be followed up with at Month 3, but was seen at Month 12 and 18|51||
60143849|NCT04188301|76267516|FG002|COMPLETED|Month 3||50||
60143850|NCT04188301|76267514|FG000|NOT COMPLETED|Month 3||0||
60143851|NCT04188301|76267515|FG001|NOT COMPLETED|Month 3||0||
60143852|NCT04188301|76267516|FG002|NOT COMPLETED|Month 3||1||
60143853|NCT04188301|76267514|FG000|STARTED|Month 12||52||
60143854|NCT04188301|76267515|FG001|STARTED|Month 12||51||
60143855|NCT04188301|76267516|FG002|STARTED|Month 12||50||
60143856|NCT04188301|76267514|FG000|COMPLETED|Month 12||51||
60143857|NCT04188301|76267515|FG001|COMPLETED|Month 12||50||
60143858|NCT04188301|76267516|FG002|COMPLETED|Month 12||48||
60143859|NCT04188301|76267514|FG000|NOT COMPLETED|Month 12||1||
60143860|NCT04188301|76267515|FG001|NOT COMPLETED|Month 12||1||
60143861|NCT04188301|76267516|FG002|NOT COMPLETED|Month 12||2||
60143862|NCT04188301|76267514|FG000|STARTED|Month 18||51||
60143863|NCT04188301|76267515|FG001|STARTED|Month 18||50||
60143864|NCT04188301|76267516|FG002|STARTED|Month 18||48||
60143865|NCT04188301|76267514|FG000|COMPLETED|Month 18||45||
60143866|NCT04188301|76267515|FG001|COMPLETED|Month 18|Previous participant who was loss to follow up was able to complete the 18 month time point|50||
60143867|NCT04188301|76267516|FG002|COMPLETED|Month 18||48||
60143868|NCT04188301|76267514|FG000|NOT COMPLETED|Month 18||6||
60143869|NCT04188301|76267515|FG001|NOT COMPLETED|Month 18||0||
60143870|NCT04188301|76267516|FG002|NOT COMPLETED|Month 18||0||
60143871|NCT04006925|76267526|FG000|STARTED|Overall Study||12||
60143872|NCT04006925|76267527|FG001|STARTED|Overall Study||12||
60143873|NCT04006925|76267526|FG000|COMPLETED|Overall Study||10||
60143874|NCT04006925|76267527|FG001|COMPLETED|Overall Study||12||
60143875|NCT04006925|76267526|FG000|NOT COMPLETED|Overall Study||2||
60143876|NCT04006925|76267527|FG001|NOT COMPLETED|Overall Study||0||
60143877|NCT03660618|76267533|FG000|STARTED|Overall Study||1||
60143878|NCT03660618|76267533|FG000|COMPLETED|Overall Study||1||
60143879|NCT03660618|76267533|FG000|NOT COMPLETED|Overall Study||0||
60143880|NCT03597061|76267539|FG000|STARTED|Overall Study||17||
60143881|NCT03597061|76267540|FG001|STARTED|Overall Study||17||
60143882|NCT03597061|76267539|FG000|COMPLETED|Overall Study||16||
60143883|NCT03597061|76267540|FG001|COMPLETED|Overall Study||16||
60143884|NCT03597061|76267539|FG000|NOT COMPLETED|Overall Study||1||
60143885|NCT03597061|76267540|FG001|NOT COMPLETED|Overall Study||1||
60143886|NCT03229538|76267548|FG000|STARTED|Overall Study||599||
60143887|NCT03229538|76267549|FG001|STARTED|Overall Study||601||
60143888|NCT03229538|76267548|FG000|COMPLETED|Overall Study||599||
60143889|NCT03229538|76267549|FG001|COMPLETED|Overall Study||601||
60143890|NCT03229538|76267548|FG000|NOT COMPLETED|Overall Study||0||
60143891|NCT03229538|76267549|FG001|NOT COMPLETED|Overall Study||0||
60143892|NCT03195127|76267557|FG000|STARTED|Overall Study||15||
60143893|NCT03195127|76267558|FG001|STARTED|Overall Study||18||
60143894|NCT03195127|76267557|FG000|COMPLETED|Overall Study||15||
60143895|NCT03195127|76267558|FG001|COMPLETED|Overall Study||17||
60143896|NCT03195127|76267557|FG000|NOT COMPLETED|Overall Study||0||
60143897|NCT03195127|76267558|FG001|NOT COMPLETED|Overall Study||1||
60143898|NCT03148795|76267568|FG000|STARTED|Overall Study||128||
60143899|NCT03148795|76267568|FG000|Treated|Overall Study||127||
60143900|NCT03148795|76267568|FG000|COMPLETED|Overall Study||0||
60143901|NCT03148795|76267568|FG000|NOT COMPLETED|Overall Study||128||
60143902|NCT03146845|76267574|FG000|STARTED|Overall Study||25||
60143903|NCT03146845|76267575|FG001|STARTED|Overall Study||15||
60143904|NCT03146845|76267574|FG000|COMPLETED|Overall Study||20||
60143905|NCT03146845|76267575|FG001|COMPLETED|Overall Study||11||
60143906|NCT03146845|76267574|FG000|NOT COMPLETED|Overall Study||5||
60143907|NCT03146845|76267575|FG001|NOT COMPLETED|Overall Study||4||
60143908|NCT02975700|76267581|FG000|STARTED|Overall Study||6||
60143909|NCT02975700|76267581|FG000|COMPLETED|Overall Study||0||
60143910|NCT02975700|76267581|FG000|NOT COMPLETED|Overall Study||6||
60143911|NCT02895360|76267591|FG000|STARTED|Phase 1 - 30 mg/m² Cohort||4||
60143912|NCT02895360|76267592|FG001|STARTED|Phase 1 - 30 mg/m² Cohort||0||
60143913|NCT02895360|76267593|FG002|STARTED|Phase 1 - 30 mg/m² Cohort||0||
60143914|NCT02895360|76267594|FG003|STARTED|Phase 1 - 30 mg/m² Cohort||0||
60143915|NCT02895360|76267595|FG004|STARTED|Phase 1 - 30 mg/m² Cohort||0||
60143916|NCT02895360|76267596|FG005|STARTED|Phase 1 - 30 mg/m² Cohort||0||
60143917|NCT02895360|76267591|FG000|COMPLETED|Phase 1 - 30 mg/m² Cohort||0||
60143918|NCT02895360|76267592|FG001|COMPLETED|Phase 1 - 30 mg/m² Cohort||0||
60143919|NCT02895360|76267593|FG002|COMPLETED|Phase 1 - 30 mg/m² Cohort||0||
60143920|NCT02895360|76267594|FG003|COMPLETED|Phase 1 - 30 mg/m² Cohort||0||
60143921|NCT02895360|76267595|FG004|COMPLETED|Phase 1 - 30 mg/m² Cohort||0||
60143922|NCT02895360|76267596|FG005|COMPLETED|Phase 1 - 30 mg/m² Cohort||0||
60143923|NCT02895360|76267591|FG000|NOT COMPLETED|Phase 1 - 30 mg/m² Cohort||4||
60143924|NCT02895360|76267592|FG001|NOT COMPLETED|Phase 1 - 30 mg/m² Cohort||0||
60143925|NCT02895360|76267593|FG002|NOT COMPLETED|Phase 1 - 30 mg/m² Cohort||0||
60143926|NCT02895360|76267594|FG003|NOT COMPLETED|Phase 1 - 30 mg/m² Cohort||0||
60143927|NCT02895360|76267595|FG004|NOT COMPLETED|Phase 1 - 30 mg/m² Cohort||0||
60143928|NCT02895360|76267596|FG005|NOT COMPLETED|Phase 1 - 30 mg/m² Cohort||0||
60143929|NCT02895360|76267591|FG000|STARTED|Phase 1 - 45 mg/m² Cohort||0||
60143930|NCT02895360|76267592|FG001|STARTED|Phase 1 - 45 mg/m² Cohort||3||
60143931|NCT02895360|76267593|FG002|STARTED|Phase 1 - 45 mg/m² Cohort||0||
60143932|NCT02895360|76267594|FG003|STARTED|Phase 1 - 45 mg/m² Cohort||0||
60143933|NCT02895360|76267595|FG004|STARTED|Phase 1 - 45 mg/m² Cohort||0||
60143934|NCT02895360|76267596|FG005|STARTED|Phase 1 - 45 mg/m² Cohort||0||
60143935|NCT02895360|76267591|FG000|COMPLETED|Phase 1 - 45 mg/m² Cohort||0||
60143936|NCT02895360|76267592|FG001|COMPLETED|Phase 1 - 45 mg/m² Cohort||0||
60143937|NCT02895360|76267593|FG002|COMPLETED|Phase 1 - 45 mg/m² Cohort||0||
60143938|NCT02895360|76267594|FG003|COMPLETED|Phase 1 - 45 mg/m² Cohort||0||
60143939|NCT02895360|76267595|FG004|COMPLETED|Phase 1 - 45 mg/m² Cohort||0||
60143940|NCT02895360|76267596|FG005|COMPLETED|Phase 1 - 45 mg/m² Cohort||0||
60143941|NCT02895360|76267591|FG000|NOT COMPLETED|Phase 1 - 45 mg/m² Cohort||0||
60143942|NCT02895360|76267592|FG001|NOT COMPLETED|Phase 1 - 45 mg/m² Cohort||3||
60143943|NCT02895360|76267593|FG002|NOT COMPLETED|Phase 1 - 45 mg/m² Cohort||0||
60143944|NCT02895360|76267594|FG003|NOT COMPLETED|Phase 1 - 45 mg/m² Cohort||0||
60143945|NCT02895360|76267595|FG004|NOT COMPLETED|Phase 1 - 45 mg/m² Cohort||0||
60143946|NCT02895360|76267596|FG005|NOT COMPLETED|Phase 1 - 45 mg/m² Cohort||0||
60143947|NCT02895360|76267591|FG000|STARTED|Phase 1 - 70 mg/m² Cohort||0||
60143948|NCT02895360|76267592|FG001|STARTED|Phase 1 - 70 mg/m² Cohort||0||
60143949|NCT02895360|76267593|FG002|STARTED|Phase 1 - 70 mg/m² Cohort||9||
60143950|NCT02895360|76267594|FG003|STARTED|Phase 1 - 70 mg/m² Cohort||0||
60143951|NCT02895360|76267595|FG004|STARTED|Phase 1 - 70 mg/m² Cohort||0||
60143952|NCT02895360|76267596|FG005|STARTED|Phase 1 - 70 mg/m² Cohort||0||
60143953|NCT02895360|76267591|FG000|COMPLETED|Phase 1 - 70 mg/m² Cohort||0||
60143954|NCT02895360|76267592|FG001|COMPLETED|Phase 1 - 70 mg/m² Cohort||0||
60143955|NCT02895360|76267593|FG002|COMPLETED|Phase 1 - 70 mg/m² Cohort||0||
60143956|NCT02895360|76267594|FG003|COMPLETED|Phase 1 - 70 mg/m² Cohort||0||
60143957|NCT02895360|76267595|FG004|COMPLETED|Phase 1 - 70 mg/m² Cohort||0||
60143958|NCT02895360|76267596|FG005|COMPLETED|Phase 1 - 70 mg/m² Cohort||0||
60143959|NCT02895360|76267591|FG000|NOT COMPLETED|Phase 1 - 70 mg/m² Cohort||0||
60143960|NCT02895360|76267592|FG001|NOT COMPLETED|Phase 1 - 70 mg/m² Cohort||0||
60143961|NCT02895360|76267593|FG002|NOT COMPLETED|Phase 1 - 70 mg/m² Cohort||9||
60143962|NCT02895360|76267594|FG003|NOT COMPLETED|Phase 1 - 70 mg/m² Cohort||0||
60143963|NCT02895360|76267595|FG004|NOT COMPLETED|Phase 1 - 70 mg/m² Cohort||0||
60143964|NCT02895360|76267596|FG005|NOT COMPLETED|Phase 1 - 70 mg/m² Cohort||0||
60143965|NCT02895360|76267591|FG000|STARTED|Phase 1 - 90 mg/m² Cohort||0||
60143966|NCT02895360|76267592|FG001|STARTED|Phase 1 - 90 mg/m² Cohort||0||
60143967|NCT02895360|76267593|FG002|STARTED|Phase 1 - 90 mg/m² Cohort||0||
60143968|NCT02895360|76267594|FG003|STARTED|Phase 1 - 90 mg/m² Cohort||4||
60143969|NCT02895360|76267595|FG004|STARTED|Phase 1 - 90 mg/m² Cohort||0||
60143970|NCT02895360|76267596|FG005|STARTED|Phase 1 - 90 mg/m² Cohort||0||
60143971|NCT02895360|76267591|FG000|COMPLETED|Phase 1 - 90 mg/m² Cohort||0||
60143972|NCT02895360|76267592|FG001|COMPLETED|Phase 1 - 90 mg/m² Cohort||0||
60143973|NCT02895360|76267593|FG002|COMPLETED|Phase 1 - 90 mg/m² Cohort||0||
60143974|NCT02895360|76267594|FG003|COMPLETED|Phase 1 - 90 mg/m² Cohort||0||
60143975|NCT02895360|76267595|FG004|COMPLETED|Phase 1 - 90 mg/m² Cohort||0||
60143976|NCT02895360|76267596|FG005|COMPLETED|Phase 1 - 90 mg/m² Cohort||0||
60143977|NCT02895360|76267591|FG000|NOT COMPLETED|Phase 1 - 90 mg/m² Cohort||0||
60143978|NCT02895360|76267592|FG001|NOT COMPLETED|Phase 1 - 90 mg/m² Cohort||0||
60143979|NCT02895360|76267593|FG002|NOT COMPLETED|Phase 1 - 90 mg/m² Cohort||0||
60143980|NCT02895360|76267594|FG003|NOT COMPLETED|Phase 1 - 90 mg/m² Cohort||4||
60143981|NCT02895360|76267595|FG004|NOT COMPLETED|Phase 1 - 90 mg/m² Cohort||0||
60143982|NCT02895360|76267596|FG005|NOT COMPLETED|Phase 1 - 90 mg/m² Cohort||0||
60143983|NCT02895360|76267591|FG000|STARTED|Phase 2a||0||
60143984|NCT02895360|76267592|FG001|STARTED|Phase 2a||0||
60143985|NCT02895360|76267593|FG002|STARTED|Phase 2a||0||
60143986|NCT02895360|76267594|FG003|STARTED|Phase 2a||0||
60143987|NCT02895360|76267595|FG004|STARTED|Phase 2a||11||
60143988|NCT02895360|76267596|FG005|STARTED|Phase 2a||12||
60143989|NCT02895360|76267591|FG000|COMPLETED|Phase 2a||0||
60143990|NCT02895360|76267592|FG001|COMPLETED|Phase 2a||0||
60143991|NCT02895360|76267593|FG002|COMPLETED|Phase 2a||0||
60143992|NCT02895360|76267594|FG003|COMPLETED|Phase 2a||0||
60143993|NCT02895360|76267595|FG004|COMPLETED|Phase 2a||0||
60143994|NCT02895360|76267596|FG005|COMPLETED|Phase 2a||0||
60143995|NCT02895360|76267591|FG000|NOT COMPLETED|Phase 2a||0||
60143996|NCT02895360|76267592|FG001|NOT COMPLETED|Phase 2a||0||
60143997|NCT02895360|76267593|FG002|NOT COMPLETED|Phase 2a||0||
60143998|NCT02895360|76267594|FG003|NOT COMPLETED|Phase 2a||0||
60143999|NCT02895360|76267595|FG004|NOT COMPLETED|Phase 2a||11||
60144000|NCT02895360|76267596|FG005|NOT COMPLETED|Phase 2a||12||
60144001|NCT02863809|76267630|FG000|STARTED|Overall Study||34|Subjects randomized in the study groups|
60144002|NCT02863809|76267631|FG001|STARTED|Overall Study||34|Subjects randomized in the study groups|
60144003|NCT02863809|76267630|FG000|Screen Fail (Post Randomization)|Overall Study||1|Subject that did not meet eligibility criteria after the study randomization had occured.|
60144004|NCT02863809|76267631|FG001|Screen Fail (Post Randomization)|Overall Study||0|Subject that did not meet eligibility criteria after the study randomization had occured.|
60144005|NCT02863809|76267630|FG000|COMPLETED|Overall Study||24||
60144006|NCT02863809|76267631|FG001|COMPLETED|Overall Study||24||
60144007|NCT02863809|76267630|FG000|NOT COMPLETED|Overall Study||10||
60144008|NCT02863809|76267631|FG001|NOT COMPLETED|Overall Study||10||
60144009|NCT02786394|76267637|FG000|STARTED|Overall Study||11||
60144010|NCT02786394|76267637|FG000|COMPLETED|Overall Study||10||
60144011|NCT02786394|76267637|FG000|NOT COMPLETED|Overall Study||1||
60144012|NCT02775760|76267644|FG000|STARTED|Overall Study||17||
60144013|NCT02775760|76267645|FG001|STARTED|Overall Study||12||
60144014|NCT02775760|76267644|FG000|COMPLETED|Overall Study||12||
60144015|NCT02775760|76267645|FG001|COMPLETED|Overall Study||7||
60144016|NCT02775760|76267644|FG000|NOT COMPLETED|Overall Study||5||
60144017|NCT02775760|76267645|FG001|NOT COMPLETED|Overall Study||5||
60144018|NCT02753530|76267655|FG000|STARTED|Overall Study|One patient was randomized in error to arimoclomol but was not treated and was excluded from the intention-to-treat (ITT) and safety populations|74||
60144019|NCT02753530|76267656|FG001|STARTED|Overall Study|One patient was randomized in error and was therefore excluded from the intention-to-treat (ITT) population but included in the safety population since exclusion occurred after dosing.|78||
60144020|NCT02753530|76267655|FG000|COMPLETED|Overall Study||62||
60144021|NCT02753530|76267656|FG001|COMPLETED|Overall Study||72||
60144022|NCT02753530|76267655|FG000|NOT COMPLETED|Overall Study||12||
60144023|NCT02753530|76267656|FG001|NOT COMPLETED|Overall Study||6||
59881887|NCT03259334|76004768|FG000|NOT COMPLETED|Overall Study||10||
59881888|NCT03259334|76004769|FG001|NOT COMPLETED|Overall Study||17||
59881889|NCT03259334|76004770|FG002|NOT COMPLETED|Overall Study||13||
59881890|NCT01331824|76004778|FG000|STARTED|Overall Study||22||
59881891|NCT01331824|76004778|FG000|COMPLETED|Overall Study||9||
59881892|NCT01331824|76004778|FG000|NOT COMPLETED|Overall Study||13||
59881893|NCT03258710|76004782|FG000|STARTED|Overall Study||75||
59881894|NCT03258710|76004782|FG000|COMPLETED|Overall Study||72||
59881895|NCT03258710|76004782|FG000|NOT COMPLETED|Overall Study||3||
59881896|NCT03240692|76004786|FG000|STARTED|Overall Study||23||
60144024|NCT02380716|76267662|FG000|STARTED|Overall Study||21||
60144025|NCT02380716|76267662|FG000|Primary Endpoint Analyzed|Overall Study||19||
60144026|NCT02380716|76267662|FG000|COMPLETED|Overall Study|Completed to date (Aug 2022)|1||
60144027|NCT02380716|76267662|FG000|NOT COMPLETED|Overall Study||20||
60144028|NCT02289079|76267668|FG000|STARTED|Overall Study||30||
60144029|NCT02289079|76267669|FG001|STARTED|Overall Study||30||
60144030|NCT02289079|76267668|FG000|COMPLETED|Overall Study||28||
60144031|NCT02289079|76267669|FG001|COMPLETED|Overall Study||29||
60144032|NCT02289079|76267668|FG000|NOT COMPLETED|Overall Study||2||
60144033|NCT02289079|76267669|FG001|NOT COMPLETED|Overall Study||1||
60144034|NCT02287480|76267679|FG000|STARTED|Overall Study||35||
60144035|NCT02287480|76267680|FG001|STARTED|Overall Study||16||
60144036|NCT02287480|76267681|FG002|STARTED|Overall Study||13||
60144037|NCT02287480|76267682|FG003|STARTED|Overall Study||51||
60144038|NCT02287480|76267679|FG000|COMPLETED|Overall Study||35||
60144039|NCT02287480|76267680|FG001|COMPLETED|Overall Study||16||
60144040|NCT02287480|76267681|FG002|COMPLETED|Overall Study||13||
60144041|NCT02287480|76267682|FG003|COMPLETED|Overall Study||51||
60144042|NCT02287480|76267679|FG000|NOT COMPLETED|Overall Study||0||
60144043|NCT02287480|76267680|FG001|NOT COMPLETED|Overall Study||0||
60144044|NCT02287480|76267681|FG002|NOT COMPLETED|Overall Study||0||
60144045|NCT02287480|76267682|FG003|NOT COMPLETED|Overall Study||0||
60144046|NCT02058706|76267701|FG000|STARTED|Overall Study||35||
60144047|NCT02058706|76267702|FG001|STARTED|Overall Study||36||
60144048|NCT02058706|76267701|FG000|COMPLETED|Overall Study||35||
60144049|NCT02058706|76267702|FG001|COMPLETED|Overall Study||36||
60144050|NCT02058706|76267701|FG000|NOT COMPLETED|Overall Study||0||
60144051|NCT02058706|76267702|FG001|NOT COMPLETED|Overall Study||0||
60144052|NCT01932801|76267714|FG000|STARTED|Overall Study||74||
60144053|NCT01932801|76267715|FG001|STARTED|Overall Study||78||
60144054|NCT01932801|76267716|FG002|STARTED|Overall Study||79||
60144055|NCT01932801|76267717|FG003|STARTED|Overall Study||77||
60144056|NCT01932801|76267714|FG000|Week 0 Session|Overall Study||67||
60144057|NCT01932801|76267715|FG001|Week 0 Session|Overall Study||66||
60144058|NCT01932801|76267716|FG002|Week 0 Session|Overall Study||71||
59881897|NCT03240692|76004786|FG000|COMPLETED|Overall Study||21||
59881898|NCT03240692|76004786|FG000|NOT COMPLETED|Overall Study||2||
59881899|NCT03233048|76004790|FG000|STARTED|Overall Study||5||
59881900|NCT03233048|76004790|FG000|COMPLETED|Overall Study||4||
59881901|NCT03233048|76004790|FG000|NOT COMPLETED|Overall Study||1||
59881902|NCT02937740|76004796|FG000|STARTED|BID for 90 Days, 22 mg/Day||24||
59881903|NCT02937740|76004797|FG001|STARTED|BID for 90 Days, 22 mg/Day||93||
59881904|NCT02937740|76004796|FG000|COMPLETED|BID for 90 Days, 22 mg/Day||19||
60144059|NCT01932801|76267717|FG003|Week 0 Session|Overall Study||65||
60144060|NCT01932801|76267714|FG000|Week 4 Session|Overall Study||54||
60144061|NCT01932801|76267715|FG001|Week 4 Session|Overall Study||54||
59881905|NCT02937740|76004797|FG001|COMPLETED|BID for 90 Days, 22 mg/Day||62||
59881906|NCT02937740|76004796|FG000|NOT COMPLETED|BID for 90 Days, 22 mg/Day||5||
59881907|NCT02937740|76004797|FG001|NOT COMPLETED|BID for 90 Days, 22 mg/Day||31||
59881908|NCT02937740|76004796|FG000|STARTED|Uptitrated to TID on Day 90 for 30 Days||13||
59881909|NCT02937740|76004797|FG001|STARTED|Uptitrated to TID on Day 90 for 30 Days||17||
59881910|NCT02937740|76004796|FG000|COMPLETED|Uptitrated to TID on Day 90 for 30 Days||12||
60144062|NCT01932801|76267716|FG002|Week 4 Session|Overall Study||60||
60144063|NCT01932801|76267717|FG003|Week 4 Session|Overall Study||41||
60144064|NCT01932801|76267714|FG000|Week 8 Session|Overall Study||51||
60144065|NCT01932801|76267715|FG001|Week 8 Session|Overall Study||48||
60144066|NCT01932801|76267716|FG002|Week 8 Session|Overall Study||56||
60144067|NCT01932801|76267717|FG003|Week 8 Session|Overall Study||42||
60144068|NCT01932801|76267714|FG000|Week 12 Session|Overall Study||56||
60144069|NCT01932801|76267715|FG001|Week 12 Session|Overall Study||50||
60144070|NCT01932801|76267716|FG002|Week 12 Session|Overall Study||55||
60144071|NCT01932801|76267717|FG003|Week 12 Session|Overall Study||40||
60144072|NCT01932801|76267714|FG000|Week 24 Session|Overall Study||49||
60144073|NCT01932801|76267715|FG001|Week 24 Session|Overall Study||46||
60144074|NCT01932801|76267716|FG002|Week 24 Session|Overall Study||53||
60144075|NCT01932801|76267717|FG003|Week 24 Session|Overall Study||40||
60144076|NCT01932801|76267714|FG000|Week 36 Session|Overall Study||48||
59881911|NCT02937740|76004797|FG001|COMPLETED|Uptitrated to TID on Day 90 for 30 Days||15||
59881912|NCT02937740|76004796|FG000|NOT COMPLETED|Uptitrated to TID on Day 90 for 30 Days||1||
59881913|NCT02937740|76004797|FG001|NOT COMPLETED|Uptitrated to TID on Day 90 for 30 Days||2||
59881914|NCT03927716|76004811|FG000|STARTED|Overall Study||236||
59881915|NCT03927716|76004812|FG001|STARTED|Overall Study||116||
59881916|NCT03927716|76004811|FG000|COMPLETED|Overall Study||192||
60144077|NCT01932801|76267715|FG001|Week 36 Session|Overall Study||48||
60144078|NCT01932801|76267716|FG002|Week 36 Session|Overall Study||54||
60144079|NCT01932801|76267717|FG003|Week 36 Session|Overall Study||40||
60144080|NCT01932801|76267714|FG000|COMPLETED|Overall Study||48||
60144081|NCT01932801|76267715|FG001|COMPLETED|Overall Study||48||
60144082|NCT01932801|76267716|FG002|COMPLETED|Overall Study||54||
60144083|NCT01932801|76267717|FG003|COMPLETED|Overall Study||40||
60144084|NCT01932801|76267714|FG000|NOT COMPLETED|Overall Study||26||
60144085|NCT01932801|76267715|FG001|NOT COMPLETED|Overall Study||30||
60144086|NCT01932801|76267716|FG002|NOT COMPLETED|Overall Study||25||
60144087|NCT01932801|76267717|FG003|NOT COMPLETED|Overall Study||37||
60144088|NCT00602667|76267736|FG000|STARTED|Overall Study||57||
60144089|NCT00602667|76267737|FG001|STARTED|Overall Study||156||
60144090|NCT00602667|76267738|FG002|STARTED|Overall Study||77||
60144091|NCT00602667|76267736|FG000|COMPLETED|Overall Study||38||
60144092|NCT00602667|76267737|FG001|COMPLETED|Overall Study||75||
60144093|NCT00602667|76267738|FG002|COMPLETED|Overall Study||14||
60144094|NCT00602667|76267736|FG000|NOT COMPLETED|Overall Study||19||
60144095|NCT00602667|76267737|FG001|NOT COMPLETED|Overall Study||81||
60144096|NCT00602667|76267738|FG002|NOT COMPLETED|Overall Study||63||
60144097|NCT00544466|76267775|FG000|STARTED|Overall Study||62||
60144098|NCT00544466|76267775|FG000|COMPLETED|Overall Study||62||
60144099|NCT00544466|76267775|FG000|NOT COMPLETED|Overall Study||0||
60144100|NCT02088905|76267781|FG000|STARTED|Overall Study||13||
60144101|NCT02088905|76267782|FG001|STARTED|Overall Study||10||
60144102|NCT02088905|76267781|FG000|Week 9|Overall Study||10|Last Observation Carried Forward for 10 treatment and 9 wait list who completed Week 9 Assessment|
60144103|NCT02088905|76267782|FG001|Week 9|Overall Study||9|Last Observation Carried Forward for 10 treatment and 9 wait list who completed Week 9 Assessment|
60144104|NCT02088905|76267781|FG000|COMPLETED|Overall Study||8|Last Observation Carried Forward for 10 treatment and 9 wait list who completed Week 9 Assessment|
60144105|NCT02088905|76267782|FG001|COMPLETED|Overall Study||9|Last Observation Carried Forward for 10 treatment and 9 wait list who completed Week 9 Assessment|
60144106|NCT02088905|76267781|FG000|NOT COMPLETED|Overall Study||5||
59881917|NCT03927716|76004812|FG001|COMPLETED|Overall Study||106||
59881918|NCT03927716|76004811|FG000|NOT COMPLETED|Overall Study||44||
59881919|NCT03927716|76004812|FG001|NOT COMPLETED|Overall Study||10||
59881920|NCT04173741|76004820|FG000|STARTED|Overall Study||23||
59881921|NCT04173741|76004821|FG001|STARTED|Overall Study||23||
60144107|NCT02088905|76267782|FG001|NOT COMPLETED|Overall Study||1||
60144108|NCT02088047|76267790|FG000|STARTED|Overall Study||3||
60144109|NCT02088047|76267791|FG001|STARTED|Overall Study||1||
60144110|NCT02088047|76267790|FG000|COMPLETED|Overall Study||2||
60144111|NCT02088047|76267791|FG001|COMPLETED|Overall Study||1||
60144112|NCT02088047|76267790|FG000|NOT COMPLETED|Overall Study||1||
60144113|NCT02088047|76267791|FG001|NOT COMPLETED|Overall Study||0||
60144114|NCT01096875|76267799|FG000|STARTED|Overall Study||30||
60144115|NCT01096875|76267800|FG001|STARTED|Overall Study||30||
60144116|NCT01096875|76267799|FG000|COMPLETED|Overall Study||30||
60144117|NCT01096875|76267800|FG001|COMPLETED|Overall Study||29||
60144118|NCT01096875|76267799|FG000|NOT COMPLETED|Overall Study||0||
60144119|NCT01096875|76267800|FG001|NOT COMPLETED|Overall Study||1||
60144120|NCT01097343|76267808|FG000|STARTED|First Intervention- 30 Days||25||
60144121|NCT01097343|76267809|FG001|STARTED|First Intervention- 30 Days||25||
60144122|NCT01097343|76267808|FG000|COMPLETED|First Intervention- 30 Days||25||
60144123|NCT01097343|76267809|FG001|COMPLETED|First Intervention- 30 Days||25||
60144124|NCT01097343|76267808|FG000|NOT COMPLETED|First Intervention- 30 Days||0||
60144125|NCT01097343|76267809|FG001|NOT COMPLETED|First Intervention- 30 Days||0||
60144126|NCT01097343|76267808|FG000|STARTED|Second Intervention- 30 Days||25||
60144127|NCT01097343|76267809|FG001|STARTED|Second Intervention- 30 Days||25||
60144128|NCT01097343|76267808|FG000|COMPLETED|Second Intervention- 30 Days||25||
60144129|NCT01097343|76267809|FG001|COMPLETED|Second Intervention- 30 Days||25||
60144130|NCT01097343|76267808|FG000|NOT COMPLETED|Second Intervention- 30 Days||0||
60144131|NCT01097343|76267809|FG001|NOT COMPLETED|Second Intervention- 30 Days||0||
60144132|NCT02086565|76267817|FG000|STARTED|Overall Study||151||
60144133|NCT02086565|76267818|FG001|STARTED|Overall Study||150||
60144134|NCT02086565|76267817|FG000|COMPLETED|Overall Study||135||
60144135|NCT02086565|76267818|FG001|COMPLETED|Overall Study||138||
60144136|NCT02086565|76267817|FG000|NOT COMPLETED|Overall Study||16||
60144137|NCT02086565|76267818|FG001|NOT COMPLETED|Overall Study||12||
60144138|NCT02085941|76267826|FG000|STARTED|Overall Study||25||
60144139|NCT02085941|76267827|FG001|STARTED|Overall Study||5||
60144140|NCT02085941|76267826|FG000|COMPLETED|Overall Study||17||
60144141|NCT02085941|76267827|FG001|COMPLETED|Overall Study||2||
60144142|NCT02085941|76267826|FG000|NOT COMPLETED|Overall Study||8||
60144143|NCT02085941|76267827|FG001|NOT COMPLETED|Overall Study||3||
60144144|NCT02085785|76267835|FG000|STARTED|Overall Study||7||
60144145|NCT02085785|76267836|FG001|STARTED|Overall Study||8||
60144146|NCT02085785|76267835|FG000|COMPLETED|Overall Study||5||
60144147|NCT02085785|76267836|FG001|COMPLETED|Overall Study||6||
60144148|NCT02085785|76267835|FG000|NOT COMPLETED|Overall Study||2||
60144149|NCT02085785|76267836|FG001|NOT COMPLETED|Overall Study||2||
60144150|NCT01098747|76267848|FG000|STARTED|Overall Study||48||
60144151|NCT01098747|76267849|FG001|STARTED|Overall Study||95||
60144152|NCT01098747|76267850|FG002|STARTED|Overall Study||86||
60144153|NCT01098747|76267851|FG003|STARTED|Overall Study||87||
60144154|NCT01098747|76267848|FG000|COMPLETED|Overall Study||48||
60144155|NCT01098747|76267849|FG001|COMPLETED|Overall Study||95||
60144156|NCT01098747|76267850|FG002|COMPLETED|Overall Study||86||
60144157|NCT01098747|76267851|FG003|COMPLETED|Overall Study||87||
60144158|NCT01098747|76267848|FG000|NOT COMPLETED|Overall Study||0||
60144159|NCT01098747|76267849|FG001|NOT COMPLETED|Overall Study||0||
60144160|NCT01098747|76267850|FG002|NOT COMPLETED|Overall Study||0||
60144161|NCT01098747|76267851|FG003|NOT COMPLETED|Overall Study||0||
60144162|NCT02085161|76267864|FG000|STARTED|Overall Study||76||
60144163|NCT02085161|76267865|FG001|STARTED|Overall Study||76||
60144164|NCT02085161|76267866|FG002|STARTED|Overall Study||76||
60144165|NCT02085161|76267867|FG003|STARTED|Overall Study||76||
60144166|NCT02085161|76267864|FG000|COMPLETED|Overall Study||64||
60144167|NCT02085161|76267865|FG001|COMPLETED|Overall Study||66||
60144168|NCT02085161|76267866|FG002|COMPLETED|Overall Study||71||
60144169|NCT02085161|76267867|FG003|COMPLETED|Overall Study||66||
60144170|NCT02085161|76267864|FG000|NOT COMPLETED|Overall Study||12||
60144171|NCT02085161|76267865|FG001|NOT COMPLETED|Overall Study||10||
60144172|NCT02085161|76267866|FG002|NOT COMPLETED|Overall Study||5||
60144173|NCT02085161|76267867|FG003|NOT COMPLETED|Overall Study||10||
60144174|NCT01034553|76267878|FG000|STARTED|Overall Study||3||
60144175|NCT01034553|76267879|FG001|STARTED|Overall Study||4||
60144176|NCT01034553|76267880|FG002|STARTED|Overall Study||3||
60144177|NCT01034553|76267881|FG003|STARTED|Overall Study||3||
60144178|NCT01034553|76267882|FG004|STARTED|Overall Study||6||
60144179|NCT01034553|76267883|FG005|STARTED|Overall Study||7||
60144180|NCT01034553|76267878|FG000|COMPLETED|Overall Study||3||
60144181|NCT01034553|76267879|FG001|COMPLETED|Overall Study||4||
60144182|NCT01034553|76267880|FG002|COMPLETED|Overall Study||3||
60144183|NCT01034553|76267881|FG003|COMPLETED|Overall Study||3||
60144184|NCT01034553|76267882|FG004|COMPLETED|Overall Study||6||
60144185|NCT01034553|76267883|FG005|COMPLETED|Overall Study||7||
60144186|NCT01034553|76267878|FG000|NOT COMPLETED|Overall Study||0||
60144187|NCT01034553|76267879|FG001|NOT COMPLETED|Overall Study||0||
60144188|NCT01034553|76267880|FG002|NOT COMPLETED|Overall Study||0||
60144189|NCT01034553|76267881|FG003|NOT COMPLETED|Overall Study||0||
60144190|NCT01034553|76267882|FG004|NOT COMPLETED|Overall Study||0||
60144191|NCT01034553|76267883|FG005|NOT COMPLETED|Overall Study||0||
60144192|NCT01035333|76267897|FG000|STARTED|Overall Study||19||
60144193|NCT01035333|76267897|FG000|COMPLETED|Overall Study||9||
60144194|NCT01035333|76267897|FG000|NOT COMPLETED|Overall Study||10||
60144195|NCT03568643|76267903|FG000|STARTED|Overall Study||161||
60144196|NCT03568643|76267904|FG001|STARTED|Overall Study||140||
60144197|NCT03568643|76267903|FG000|COMPLETED|Overall Study||161||
60144198|NCT03568643|76267904|FG001|COMPLETED|Overall Study||140||
60144199|NCT03568643|76267903|FG000|NOT COMPLETED|Overall Study||0||
60144200|NCT03568643|76267904|FG001|NOT COMPLETED|Overall Study||0||
60144201|NCT01100931|76267912|FG000|STARTED|Phase I||22||
60144202|NCT01100931|76267913|FG001|STARTED|Phase I||0||
60144203|NCT01100931|76267912|FG000|COMPLETED|Phase I||22||
60144204|NCT01100931|76267913|FG001|COMPLETED|Phase I||0||
60144205|NCT01100931|76267912|FG000|NOT COMPLETED|Phase I||0||
60144206|NCT01100931|76267913|FG001|NOT COMPLETED|Phase I||0||
60144207|NCT01100931|76267912|FG000|STARTED|Phase II||0||
60144208|NCT01100931|76267913|FG001|STARTED|Phase II||19||
60144209|NCT01100931|76267912|FG000|COMPLETED|Phase II||0||
60144210|NCT01100931|76267913|FG001|COMPLETED|Phase II||19||
60144211|NCT01100931|76267912|FG000|NOT COMPLETED|Phase II||0||
60144212|NCT01100931|76267913|FG001|NOT COMPLETED|Phase II||0||
60144213|NCT01101867|76267922|FG000|STARTED|Overall Study||63||
60144214|NCT01101867|76267923|FG001|STARTED|Overall Study||63||
60144215|NCT01101867|76267922|FG000|COMPLETED|Overall Study||62||
60144216|NCT01101867|76267923|FG001|COMPLETED|Overall Study||59||
60144217|NCT01101867|76267922|FG000|NOT COMPLETED|Overall Study||1||
60144218|NCT01101867|76267923|FG001|NOT COMPLETED|Overall Study||4||
60144219|NCT01039467|76267935|FG000|STARTED|Overall Study||196||
60144220|NCT01039467|76267936|FG001|STARTED|Overall Study||189||
60144221|NCT01039467|76267935|FG000|COMPLETED|Overall Study||156||
60144222|NCT01039467|76267936|FG001|COMPLETED|Overall Study||140||
60144223|NCT01039467|76267935|FG000|NOT COMPLETED|Overall Study||40||
60144224|NCT01039467|76267936|FG001|NOT COMPLETED|Overall Study||49||
60144225|NCT01102413|76267946|FG000|STARTED|Overall Study||233||
60144226|NCT01102413|76267947|FG001|STARTED|Overall Study||118||
60144227|NCT01102413|76267946|FG000|COMPLETED|Overall Study||208||
60144228|NCT01102413|76267947|FG001|COMPLETED|Overall Study||106||
60144229|NCT01102413|76267946|FG000|NOT COMPLETED|Overall Study||25||
59605711|NCT01965600|75715853|FG002|NOT COMPLETED|Washout Period of Approximately 15 Days||2||
59605712|NCT01965600|75715854|FG003|NOT COMPLETED|Washout Period of Approximately 15 Days||2||
59605713|NCT01965600|75715851|FG000|STARTED|Second Intervention||4||
59605714|NCT01965600|75715852|FG001|STARTED|Second Intervention||4||
59881922|NCT04173741|76004820|FG000|COMPLETED|Overall Study||22||
60144230|NCT01102413|76267947|FG001|NOT COMPLETED|Overall Study||12||
60144231|NCT01103271|76267955|FG000|STARTED|Overall Study||11||
60144232|NCT01103271|76267956|FG001|STARTED|Overall Study||9||
60144233|NCT01103271|76267955|FG000|COMPLETED|Overall Study||10||
60144234|NCT01103271|76267956|FG001|COMPLETED|Overall Study||5||
60144235|NCT01103271|76267955|FG000|NOT COMPLETED|Overall Study||1||
59605715|NCT01965600|75715853|FG002|STARTED|Second Intervention||3||
60144236|NCT01103271|76267956|FG001|NOT COMPLETED|Overall Study||4||
60144237|NCT01103505|76267965|FG000|STARTED|Overall Study||763||
60144238|NCT01103505|76267966|FG001|STARTED|Overall Study||757||
60144239|NCT01103505|76267965|FG000|COMPLETED|Overall Study||739||
60144240|NCT01103505|76267966|FG001|COMPLETED|Overall Study||737||
60144241|NCT01103505|76267965|FG000|NOT COMPLETED|Overall Study||24||
60144242|NCT01103505|76267966|FG001|NOT COMPLETED|Overall Study||20||
60144243|NCT01103973|76267982|FG000|STARTED|Overall Study||51||
60144244|NCT01103973|76267983|FG001|STARTED|Overall Study||46||
60144245|NCT01103973|76267982|FG000|COMPLETED|Overall Study||51||
60144246|NCT01103973|76267983|FG001|COMPLETED|Overall Study||46||
60144247|NCT01103973|76267982|FG000|NOT COMPLETED|Overall Study||0||
60144248|NCT01103973|76267983|FG001|NOT COMPLETED|Overall Study||0||
60144249|NCT01104207|76267991|FG000|STARTED|Overall Study||35||
60144250|NCT01104207|76267992|FG001|STARTED|Overall Study||35||
60144251|NCT01104207|76267991|FG000|COMPLETED|Overall Study||32||
60144252|NCT01104207|76267992|FG001|COMPLETED|Overall Study||32||
60144253|NCT01104207|76267991|FG000|NOT COMPLETED|Overall Study||3||
60144254|NCT01104207|76267992|FG001|NOT COMPLETED|Overall Study||3||
60144255|NCT01104285|76268000|FG000|STARTED|Overall Study||112||
60144256|NCT01104285|76268001|FG001|STARTED|Overall Study||86||
60144257|NCT01104285|76268000|FG000|COMPLETED|Overall Study||112||
60144258|NCT01104285|76268001|FG001|COMPLETED|Overall Study||86||
60144259|NCT01104285|76268000|FG000|NOT COMPLETED|Overall Study||0||
60144260|NCT01104285|76268001|FG001|NOT COMPLETED|Overall Study||0||
60144261|NCT01106859|76268007|FG000|STARTED|Overall Study|Intent to treat population and safety population are the same (40 participants)|40||
60144262|NCT01106859|76268007|FG000|COMPLETED|Overall Study||40||
60144263|NCT01106859|76268007|FG000|NOT COMPLETED|Overall Study||0||
60144264|NCT01042509|76268018|FG000|STARTED|Overall Study||15||
60144265|NCT01042509|76268018|FG000|COMPLETED|Overall Study||15||
60144266|NCT01042509|76268018|FG000|NOT COMPLETED|Overall Study||0||
60144267|NCT02179047|76268024|FG000|STARTED|Overall Study||194||
60144268|NCT02179047|76268025|FG001|STARTED|Overall Study||20||
60144269|NCT02179047|76268024|FG000|COMPLETED|Overall Study||187||
60144270|NCT02179047|76268025|FG001|COMPLETED|Overall Study||20||
60144271|NCT02179047|76268024|FG000|NOT COMPLETED|Overall Study||7||
60144272|NCT02179047|76268025|FG001|NOT COMPLETED|Overall Study||0||
60144273|NCT02179671|76268047|FG000|STARTED|Overall Study||1||
60144274|NCT02179671|76268048|FG001|STARTED|Overall Study||1||
60144275|NCT02179671|76268049|FG002|STARTED|Overall Study||2||
60144276|NCT02179671|76268050|FG003|STARTED|Overall Study||14||
60144277|NCT02179671|76268051|FG004|STARTED|Overall Study||14||
60144278|NCT02179671|76268047|FG000|COMPLETED|Overall Study||0||
60144279|NCT02179671|76268048|FG001|COMPLETED|Overall Study||0||
60144280|NCT02179671|76268049|FG002|COMPLETED|Overall Study||1||
60144281|NCT02179671|76268050|FG003|COMPLETED|Overall Study||1||
60144282|NCT02179671|76268051|FG004|COMPLETED|Overall Study||1||
60144283|NCT02179671|76268047|FG000|NOT COMPLETED|Overall Study||1||
60144284|NCT02179671|76268048|FG001|NOT COMPLETED|Overall Study||1||
60144285|NCT02179671|76268049|FG002|NOT COMPLETED|Overall Study||1||
60144286|NCT02179671|76268050|FG003|NOT COMPLETED|Overall Study||13||
60144287|NCT02179671|76268051|FG004|NOT COMPLETED|Overall Study||13||
60144288|NCT02322333|76268065|FG000|STARTED|Overall Study||80||
60144289|NCT02322333|76268066|FG001|STARTED|Overall Study||77||
60144290|NCT02322333|76268065|FG000|COMPLETED|Overall Study||63||
60144291|NCT02322333|76268066|FG001|COMPLETED|Overall Study||61||
60144292|NCT02322333|76268065|FG000|NOT COMPLETED|Overall Study||17||
60144293|NCT02322333|76268066|FG001|NOT COMPLETED|Overall Study||16||
60144294|NCT01110135|76268072|FG000|STARTED|Overall Study||43||
60144295|NCT01110135|76268072|FG000|COMPLETED|Overall Study||34||
60144296|NCT01110135|76268072|FG000|NOT COMPLETED|Overall Study||9||
60144297|NCT01043133|76268078|FG000|STARTED|Overall Study||75||
60144298|NCT01043133|76268079|FG001|STARTED|Overall Study||80||
60144299|NCT01043133|76268078|FG000|COMPLETED|Overall Study||74||
60144300|NCT01043133|76268079|FG001|COMPLETED|Overall Study||78||
60144301|NCT01043133|76268078|FG000|NOT COMPLETED|Overall Study||1||
60144302|NCT01043133|76268079|FG001|NOT COMPLETED|Overall Study||2||
60144303|NCT01043523|76268085|FG000|STARTED|Overall Study||52||
60144304|NCT01043523|76268085|FG000|Participants With Unenhanced Images|Overall Study||51||
60144305|NCT01043523|76268085|FG000|COMPLETED|Overall Study||52||
60144306|NCT01043523|76268085|FG000|NOT COMPLETED|Overall Study||0||
60144307|NCT01112241|76268093|FG000|STARTED|Overall Study||17||
60144308|NCT01112241|76268093|FG000|COMPLETED|Overall Study||17||
60144309|NCT01112241|76268093|FG000|NOT COMPLETED|Overall Study||0||
60144310|NCT02174913|76268099|FG000|STARTED|Overall Study||17||
60144311|NCT02174913|76268100|FG001|STARTED|Overall Study||17||
60144312|NCT02174913|76268099|FG000|COMPLETED|Overall Study||17||
60144313|NCT02174913|76268100|FG001|COMPLETED|Overall Study||17||
60144314|NCT02174913|76268099|FG000|NOT COMPLETED|Overall Study||0||
60144315|NCT02174913|76268100|FG001|NOT COMPLETED|Overall Study||0||
60144316|NCT01112865|76268106|FG000|STARTED|First Intervention||59||
60144317|NCT01112865|76268107|FG001|STARTED|First Intervention||61||
60144318|NCT01112865|76268106|FG000|COMPLETED|First Intervention||59||
60144319|NCT01112865|76268107|FG001|COMPLETED|First Intervention||61||
60144320|NCT01112865|76268106|FG000|NOT COMPLETED|First Intervention||0||
60144321|NCT01112865|76268107|FG001|NOT COMPLETED|First Intervention||0||
60144322|NCT01112865|76268106|FG000|STARTED|Second Intervention||59||
60144323|NCT01112865|76268107|FG001|STARTED|Second Intervention||61||
60144324|NCT01112865|76268106|FG000|COMPLETED|Second Intervention||59||
60144325|NCT01112865|76268107|FG001|COMPLETED|Second Intervention||61||
60144326|NCT01112865|76268106|FG000|NOT COMPLETED|Second Intervention||0||
60144327|NCT01112865|76268107|FG001|NOT COMPLETED|Second Intervention||0||
60144328|NCT01113723|76268115|FG000|STARTED|Overall Study||70||
60144329|NCT01113723|76268116|FG001|STARTED|Overall Study||70||
60144330|NCT01113723|76268115|FG000|COMPLETED|Overall Study||70||
60144331|NCT01113723|76268116|FG001|COMPLETED|Overall Study||70||
60144332|NCT01113723|76268115|FG000|NOT COMPLETED|Overall Study||0||
60144333|NCT01113723|76268116|FG001|NOT COMPLETED|Overall Study||0||
60144334|NCT01114503|76268124|FG000|STARTED|Overall Study||2||
60144335|NCT01114503|76268124|FG000|COMPLETED|Overall Study||2||
60144336|NCT01114503|76268124|FG000|NOT COMPLETED|Overall Study||0||
60144337|NCT01044537|76268135|FG000|STARTED|Overall Study||6||
60144338|NCT01044537|76268136|FG001|STARTED|Overall Study||6||
60144339|NCT01044537|76268137|FG002|STARTED|Overall Study||6||
60144340|NCT01044537|76268138|FG003|STARTED|Overall Study||6||
60144341|NCT01044537|76268139|FG004|STARTED|Overall Study||5||
60144342|NCT01044537|76268140|FG005|STARTED|Overall Study||5||
60144343|NCT01044537|76268141|FG006|STARTED|Overall Study||16||
60144344|NCT01044537|76268135|FG000|COMPLETED|Overall Study||6||
60144345|NCT01044537|76268136|FG001|COMPLETED|Overall Study||6||
60144346|NCT01044537|76268137|FG002|COMPLETED|Overall Study||6||
60144347|NCT01044537|76268138|FG003|COMPLETED|Overall Study||6||
60144348|NCT01044537|76268139|FG004|COMPLETED|Overall Study||5||
60144349|NCT01044537|76268140|FG005|COMPLETED|Overall Study||5||
60144350|NCT01044537|76268141|FG006|COMPLETED|Overall Study||16||
60144351|NCT01044537|76268135|FG000|NOT COMPLETED|Overall Study||0||
60144352|NCT01044537|76268136|FG001|NOT COMPLETED|Overall Study||0||
60144353|NCT01044537|76268137|FG002|NOT COMPLETED|Overall Study||0||
60144354|NCT01044537|76268138|FG003|NOT COMPLETED|Overall Study||0||
60144355|NCT01044537|76268139|FG004|NOT COMPLETED|Overall Study||0||
60144356|NCT01044537|76268140|FG005|NOT COMPLETED|Overall Study||0||
60144357|NCT01044537|76268141|FG006|NOT COMPLETED|Overall Study||0||
60144358|NCT01114581|76268159|FG000|STARTED|Overall Study||19||
60144359|NCT01114581|76268160|FG001|STARTED|Overall Study||19||
60144360|NCT01114581|76268159|FG000|COMPLETED|Overall Study||19||
60144361|NCT01114581|76268160|FG001|COMPLETED|Overall Study||19||
60144362|NCT01114581|76268159|FG000|NOT COMPLETED|Overall Study||0||
60144363|NCT01114581|76268160|FG001|NOT COMPLETED|Overall Study||0||
60144364|NCT01114893|76268171|FG000|STARTED|Overall Study||14||
60144365|NCT01114893|76268172|FG001|STARTED|Overall Study||14||
60144366|NCT01114893|76268173|FG002|STARTED|Overall Study||14||
60144367|NCT01114893|76268174|FG003|STARTED|Overall Study||13||
60144368|NCT01114893|76268175|FG004|STARTED|Overall Study||12||
60144369|NCT01114893|76268171|FG000|COMPLETED|Overall Study||14||
60144370|NCT01114893|76268172|FG001|COMPLETED|Overall Study||14||
60144371|NCT01114893|76268173|FG002|COMPLETED|Overall Study||14||
60144372|NCT01114893|76268174|FG003|COMPLETED|Overall Study||13||
60144373|NCT01114893|76268175|FG004|COMPLETED|Overall Study||12||
60144374|NCT01114893|76268171|FG000|NOT COMPLETED|Overall Study||0||
60144375|NCT01114893|76268172|FG001|NOT COMPLETED|Overall Study||0||
60144376|NCT01114893|76268173|FG002|NOT COMPLETED|Overall Study||0||
60144377|NCT01114893|76268174|FG003|NOT COMPLETED|Overall Study||0||
60144378|NCT01114893|76268175|FG004|NOT COMPLETED|Overall Study||0||
60144379|NCT01114971|76268190|FG000|STARTED|Overall Study||25||
60144380|NCT01114971|76268191|FG001|STARTED|Overall Study||25||
60144381|NCT01114971|76268192|FG002|STARTED|Overall Study||25||
60144382|NCT01114971|76268190|FG000|COMPLETED|Overall Study||25||
60144383|NCT01114971|76268191|FG001|COMPLETED|Overall Study||25||
60144384|NCT01114971|76268192|FG002|COMPLETED|Overall Study||25||
60144385|NCT01114971|76268190|FG000|NOT COMPLETED|Overall Study||0||
60144386|NCT01114971|76268191|FG001|NOT COMPLETED|Overall Study||0||
60144387|NCT01114971|76268192|FG002|NOT COMPLETED|Overall Study||0||
60144388|NCT01044693|76268200|FG000|STARTED|Overall Study||3||
60144389|NCT01044693|76268201|FG001|STARTED|Overall Study||1||
60144390|NCT01044693|76268202|FG002|STARTED|Overall Study||1||
60144391|NCT01044693|76268203|FG003|STARTED|Overall Study||1||
60144392|NCT01044693|76268204|FG004|STARTED|Overall Study||1||
60144393|NCT01044693|76268205|FG005|STARTED|Overall Study||2||
60144394|NCT01044693|76268206|FG006|STARTED|Overall Study||1||
60144395|NCT01044693|76268207|FG007|STARTED|Overall Study||1||
60144396|NCT01044693|76268208|FG008|STARTED|Overall Study||1||
60144397|NCT01044693|76268209|FG009|STARTED|Overall Study||1||
60144398|NCT01044693|76268210|FG010|STARTED|Overall Study||1||
60144399|NCT01044693|76268211|FG011|STARTED|Overall Study||1||
60144400|NCT01044693|76268212|FG012|STARTED|Overall Study||2||
60144401|NCT01044693|76268213|FG013|STARTED|Overall Study||1||
60144402|NCT01044693|76268214|FG014|STARTED|Overall Study||1||
60144403|NCT01044693|76268215|FG015|STARTED|Overall Study||1||
60144404|NCT01044693|76268200|FG000|COMPLETED|Overall Study||3||
60144405|NCT01044693|76268201|FG001|COMPLETED|Overall Study||1||
60010429|NCT03178045|76126097|FG001|STARTED|Overall Study||1397||
60010430|NCT03178045|76126096|FG000|COMPLETED|Overall Study||1310||
60010431|NCT03178045|76126097|FG001|COMPLETED|Overall Study||1314||
60010432|NCT03178045|76126096|FG000|NOT COMPLETED|Overall Study||86||
60010433|NCT03178045|76126097|FG001|NOT COMPLETED|Overall Study||83||
60010434|NCT03154307|76126108|FG000|STARTED|Overall Study||2||
60010435|NCT03154307|76126109|FG001|STARTED|Overall Study||0||
60010436|NCT03154307|76126110|FG002|STARTED|Overall Study||0||
60010437|NCT03154307|76126111|FG003|STARTED|Overall Study||0||
60010438|NCT03154307|76126108|FG000|COMPLETED|Overall Study||1||
60010439|NCT03154307|76126109|FG001|COMPLETED|Overall Study||0||
60010440|NCT03154307|76126110|FG002|COMPLETED|Overall Study||0||
60010441|NCT03154307|76126111|FG003|COMPLETED|Overall Study||0||
60010442|NCT03154307|76126108|FG000|NOT COMPLETED|Overall Study||1||
60144406|NCT01044693|76268202|FG002|COMPLETED|Overall Study||1||
60144407|NCT01044693|76268203|FG003|COMPLETED|Overall Study||1||
60144408|NCT01044693|76268204|FG004|COMPLETED|Overall Study||1||
60144409|NCT01044693|76268205|FG005|COMPLETED|Overall Study||2||
60144410|NCT01044693|76268206|FG006|COMPLETED|Overall Study||1||
60144411|NCT01044693|76268207|FG007|COMPLETED|Overall Study||1||
60144412|NCT01044693|76268208|FG008|COMPLETED|Overall Study||1||
60144413|NCT01044693|76268209|FG009|COMPLETED|Overall Study||1||
60144414|NCT01044693|76268210|FG010|COMPLETED|Overall Study||1||
60144415|NCT01044693|76268211|FG011|COMPLETED|Overall Study||1||
60144416|NCT01044693|76268212|FG012|COMPLETED|Overall Study||2||
60144417|NCT01044693|76268213|FG013|COMPLETED|Overall Study||1||
60144418|NCT01044693|76268214|FG014|COMPLETED|Overall Study||1||
60144419|NCT01044693|76268215|FG015|COMPLETED|Overall Study||1||
60144420|NCT01044693|76268200|FG000|NOT COMPLETED|Overall Study||0||
60144421|NCT01044693|76268201|FG001|NOT COMPLETED|Overall Study||0||
60144422|NCT01044693|76268202|FG002|NOT COMPLETED|Overall Study||0||
60144423|NCT01044693|76268203|FG003|NOT COMPLETED|Overall Study||0||
60144424|NCT01044693|76268204|FG004|NOT COMPLETED|Overall Study||0||
60144425|NCT01044693|76268205|FG005|NOT COMPLETED|Overall Study||0||
60144426|NCT01044693|76268206|FG006|NOT COMPLETED|Overall Study||0||
60144427|NCT01044693|76268207|FG007|NOT COMPLETED|Overall Study||0||
60144428|NCT01044693|76268208|FG008|NOT COMPLETED|Overall Study||0||
60010443|NCT03154307|76126109|FG001|NOT COMPLETED|Overall Study||0||
60010444|NCT03154307|76126110|FG002|NOT COMPLETED|Overall Study||0||
60010445|NCT03154307|76126111|FG003|NOT COMPLETED|Overall Study||0||
60010446|NCT03113500|76126121|FG000|STARTED|Overall Study||48||
60010447|NCT03113500|76126121|FG000|COMPLETED|Overall Study||47||
60010448|NCT03113500|76126121|FG000|NOT COMPLETED|Overall Study||1||
60010449|NCT03072602|76126127|FG000|STARTED|Overall Study||39|81 participants started the study; 39 Blacks and 42 Whites|
60010450|NCT03072602|76126128|FG001|STARTED|Overall Study||42|81 participants started the study; 39 Blacks and 42 Whites|
60010451|NCT03072602|76126127|FG000|Total Participant Screened for the Purpose of Eligibilty|Overall Study||47|94 participants were screened for eligibility|
60010452|NCT03072602|76126128|FG001|Total Participant Screened for the Purpose of Eligibilty|Overall Study||47|94 participants were screened for eligibility|
60010453|NCT03072602|76126127|FG000|Ineligible Participants|Overall Study||8|13 determined ineligible by screening labs|
60010454|NCT03072602|76126128|FG001|Ineligible Participants|Overall Study||5|13 determined ineligible by screening labs|
60010455|NCT03072602|76126127|FG000|Participant Received Standardized Meals|Overall Study||39|81 Participants received 3 days of standardized meals to control for salt intake|
60010456|NCT03072602|76126128|FG001|Participant Received Standardized Meals|Overall Study||42|81 Participants received 3 days of standardized meals to control for salt intake|
60010457|NCT03072602|76126127|FG000|Study Dropouts|Overall Study||4|7 study dropouts|
60010458|NCT03072602|76126128|FG001|Study Dropouts|Overall Study||3|7 study dropouts|
60067711|NCT01617187|76182893|FG002|COMPLETED|Randomization Through Start Treatment||46||
60144429|NCT01044693|76268209|FG009|NOT COMPLETED|Overall Study||0||
60144430|NCT01044693|76268210|FG010|NOT COMPLETED|Overall Study||0||
60144431|NCT01044693|76268211|FG011|NOT COMPLETED|Overall Study||0||
60144432|NCT01044693|76268212|FG012|NOT COMPLETED|Overall Study||0||
60144433|NCT01044693|76268213|FG013|NOT COMPLETED|Overall Study||0||
60144434|NCT01044693|76268214|FG014|NOT COMPLETED|Overall Study||0||
60144435|NCT01044693|76268215|FG015|NOT COMPLETED|Overall Study||0||
60144436|NCT01115517|76268227|FG000|STARTED|Overall Study||18||
60144437|NCT01115517|76268228|FG001|STARTED|Overall Study||21||
60144438|NCT01115517|76268227|FG000|COMPLETED|Overall Study||14||
60144439|NCT01115517|76268228|FG001|COMPLETED|Overall Study||16||
60144440|NCT01115517|76268227|FG000|NOT COMPLETED|Overall Study||4||
60144441|NCT01115517|76268228|FG001|NOT COMPLETED|Overall Study||5||
60144442|NCT01044771|76268234|FG000|STARTED|Overall Study||20||
60144443|NCT01044771|76268234|FG000|COMPLETED|Overall Study||20||
60144444|NCT01044771|76268234|FG000|NOT COMPLETED|Overall Study||0||
60144445|NCT01115673|76268242|FG000|STARTED|Overall Study||239||
60144446|NCT01115673|76268243|FG001|STARTED|Overall Study||241||
60144447|NCT01115673|76268244|FG002|STARTED|Overall Study||60||
60144448|NCT01115673|76268242|FG000|COMPLETED|Overall Study||239||
60144449|NCT01115673|76268243|FG001|COMPLETED|Overall Study||241||
60144450|NCT01115673|76268244|FG002|COMPLETED|Overall Study||60||
60144451|NCT01115673|76268242|FG000|NOT COMPLETED|Overall Study||0||
60144452|NCT01115673|76268243|FG001|NOT COMPLETED|Overall Study||0||
59881923|NCT04173741|76004821|FG001|COMPLETED|Overall Study||22||
59881924|NCT04173741|76004820|FG000|NOT COMPLETED|Overall Study||1||
59881925|NCT04173741|76004821|FG001|NOT COMPLETED|Overall Study||1||
59881926|NCT03231800|76004829|FG000|STARTED|Overall Study||48||
59881927|NCT03231800|76004830|FG001|STARTED|Overall Study||47||
59881928|NCT03231800|76004829|FG000|Safety Population|Overall Study||47||
59881929|NCT03231800|76004830|FG001|Safety Population|Overall Study||47||
59881930|NCT03231800|76004829|FG000|COMPLETED|Overall Study||45||
59881931|NCT03231800|76004830|FG001|COMPLETED|Overall Study||44||
59881932|NCT03231800|76004829|FG000|NOT COMPLETED|Overall Study||3||
59881933|NCT03231800|76004830|FG001|NOT COMPLETED|Overall Study||3||
59881934|NCT04085601|76004838|FG000|STARTED|Overall Study||35||
59881935|NCT04085601|76004839|FG001|STARTED|Overall Study||18||
59881936|NCT04085601|76004838|FG000|SoC to Pegcetacoplan (Escape Therapy)|Overall Study||0||
59881937|NCT04085601|76004839|FG001|SoC to Pegcetacoplan (Escape Therapy)|Overall Study||11||
59881938|NCT04085601|76004838|FG000|COMPLETED|Overall Study||33||
59881939|NCT04085601|76004839|FG001|COMPLETED|Overall Study||17||
59881940|NCT04085601|76004838|FG000|NOT COMPLETED|Overall Study||2||
59881941|NCT04085601|76004839|FG001|NOT COMPLETED|Overall Study||1||
59881942|NCT03230864|76004848|FG000|STARTED|Prospective Confirmation (PC) Period||68||
59881943|NCT03230864|76004849|FG001|STARTED|Prospective Confirmation (PC) Period||51||
59881944|NCT03230864|76004850|FG002|STARTED|Prospective Confirmation (PC) Period||0||
59881945|NCT03230864|76004851|FG003|STARTED|Prospective Confirmation (PC) Period||0||
59881946|NCT03230864|76004848|FG000|COMPLETED|Prospective Confirmation (PC) Period||36||
59881947|NCT03230864|76004849|FG001|COMPLETED|Prospective Confirmation (PC) Period||32||
59881948|NCT03230864|76004850|FG002|COMPLETED|Prospective Confirmation (PC) Period||0||
59881949|NCT03230864|76004851|FG003|COMPLETED|Prospective Confirmation (PC) Period||0||
59881950|NCT03230864|76004848|FG000|NOT COMPLETED|Prospective Confirmation (PC) Period||32||
59881951|NCT03230864|76004849|FG001|NOT COMPLETED|Prospective Confirmation (PC) Period||19||
59881952|NCT03230864|76004850|FG002|NOT COMPLETED|Prospective Confirmation (PC) Period||0||
59881953|NCT03230864|76004851|FG003|NOT COMPLETED|Prospective Confirmation (PC) Period||0||
59881954|NCT03230864|76004848|FG000|STARTED|Double Blind Treatment (DBT) Period||0||
59881955|NCT03230864|76004849|FG001|STARTED|Double Blind Treatment (DBT) Period||0||
59881956|NCT03230864|76004850|FG002|STARTED|Double Blind Treatment (DBT) Period||35||
59881957|NCT03230864|76004851|FG003|STARTED|Double Blind Treatment (DBT) Period||33||
59881958|NCT03230864|76004848|FG000|COMPLETED|Double Blind Treatment (DBT) Period||0||
59881959|NCT03230864|76004849|FG001|COMPLETED|Double Blind Treatment (DBT) Period||0||
59881960|NCT03230864|76004850|FG002|COMPLETED|Double Blind Treatment (DBT) Period||27||
59881961|NCT03230864|76004851|FG003|COMPLETED|Double Blind Treatment (DBT) Period||31||
59881962|NCT03230864|76004848|FG000|NOT COMPLETED|Double Blind Treatment (DBT) Period||0||
59881963|NCT03230864|76004849|FG001|NOT COMPLETED|Double Blind Treatment (DBT) Period||0||
59881964|NCT03230864|76004850|FG002|NOT COMPLETED|Double Blind Treatment (DBT) Period||8||
59881965|NCT03230864|76004851|FG003|NOT COMPLETED|Double Blind Treatment (DBT) Period||2||
59881966|NCT04085367|76004863|FG000|STARTED|Overall Study||364||
59881967|NCT04085367|76004864|FG001|STARTED|Overall Study||193||
59881968|NCT04085367|76004863|FG000|COMPLETED|Overall Study||344||
59881969|NCT04085367|76004864|FG001|COMPLETED|Overall Study||185||
59881970|NCT04085367|76004863|FG000|NOT COMPLETED|Overall Study||20||
59881971|NCT04085367|76004864|FG001|NOT COMPLETED|Overall Study||8||
59881972|NCT03228836|76004870|FG000|STARTED|Overall Study||28||
59881973|NCT03228836|76004870|FG000|Treated|Overall Study||28||
59881974|NCT03228836|76004870|FG000|COMPLETED|Overall Study||11||
59881975|NCT03228836|76004870|FG000|NOT COMPLETED|Overall Study||17||
59881976|NCT02937350|76004877|FG000|STARTED|Overall Study||43||
59881977|NCT02937350|76004878|FG001|STARTED|Overall Study||25||
59881978|NCT02937350|76004879|FG002|STARTED|Overall Study||20||
59881979|NCT02937350|76004877|FG000|COMPLETED|Overall Study||43||
59881980|NCT02937350|76004878|FG001|COMPLETED|Overall Study||24||
59881981|NCT02937350|76004879|FG002|COMPLETED|Overall Study||20||
59881982|NCT02937350|76004877|FG000|NOT COMPLETED|Overall Study||0||
59881983|NCT02937350|76004878|FG001|NOT COMPLETED|Overall Study||1||
59881984|NCT02937350|76004879|FG002|NOT COMPLETED|Overall Study||0||
59881985|NCT04085289|76004888|FG000|STARTED|Overall Study||6||
59881986|NCT04085289|76004889|FG001|STARTED|Overall Study||12||
59881987|NCT04085289|76004890|FG002|STARTED|Overall Study||12||
59881988|NCT04085289|76004888|FG000|Received at Least One Dose of Study Drug|Overall Study||6||
59881989|NCT04085289|76004889|FG001|Received at Least One Dose of Study Drug|Overall Study||12||
59881990|NCT04085289|76004890|FG002|Received at Least One Dose of Study Drug|Overall Study||12||
59881991|NCT04085289|76004888|FG000|COMPLETED|Overall Study||6||
59881992|NCT04085289|76004889|FG001|COMPLETED|Overall Study||12||
59881993|NCT04085289|76004890|FG002|COMPLETED|Overall Study||11||
59881994|NCT04085289|76004888|FG000|NOT COMPLETED|Overall Study||0||
59881995|NCT04085289|76004889|FG001|NOT COMPLETED|Overall Study||0||
59881996|NCT04085289|76004890|FG002|NOT COMPLETED|Overall Study||1||
59881997|NCT04080297|76004899|FG000|STARTED|Overall Study||10||
59881998|NCT04080297|76004900|FG001|STARTED|Overall Study||11||
59881999|NCT04080297|76004899|FG000|COMPLETED|Overall Study||8||
59882000|NCT04080297|76004900|FG001|COMPLETED|Overall Study||8||
60144453|NCT01115673|76268244|FG002|NOT COMPLETED|Overall Study||0||
59882001|NCT04080297|76004899|FG000|NOT COMPLETED|Overall Study||2||
60144454|NCT01116921|76268254|FG000|STARTED|Overall Study||53||
60144455|NCT01116921|76268255|FG001|STARTED|Overall Study||50||
60144456|NCT01116921|76268254|FG000|COMPLETED|Overall Study||53||
60144457|NCT01116921|76268255|FG001|COMPLETED|Overall Study||50||
60144458|NCT01116921|76268254|FG000|NOT COMPLETED|Overall Study||0||
60144459|NCT01116921|76268255|FG001|NOT COMPLETED|Overall Study||0||
60144460|NCT01117311|76268261|FG000|STARTED|Lead-in Mixed Meal 1||3||
60144461|NCT01117311|76268262|FG001|STARTED|Lead-in Mixed Meal 1||4||
60144462|NCT01117311|76268261|FG000|COMPLETED|Lead-in Mixed Meal 1||3||
60144463|NCT01117311|76268262|FG001|COMPLETED|Lead-in Mixed Meal 1||4||
60144464|NCT01117311|76268261|FG000|NOT COMPLETED|Lead-in Mixed Meal 1||0||
60144465|NCT01117311|76268262|FG001|NOT COMPLETED|Lead-in Mixed Meal 1||0||
60144466|NCT01117311|76268261|FG000|STARTED|First Intervention - Mixed Meal 2||3||
60144467|NCT01117311|76268262|FG001|STARTED|First Intervention - Mixed Meal 2||4||
60144468|NCT01117311|76268261|FG000|COMPLETED|First Intervention - Mixed Meal 2||3||
60144469|NCT01117311|76268262|FG001|COMPLETED|First Intervention - Mixed Meal 2||4||
60144470|NCT01117311|76268261|FG000|NOT COMPLETED|First Intervention - Mixed Meal 2||0||
60144471|NCT01117311|76268262|FG001|NOT COMPLETED|First Intervention - Mixed Meal 2||0||
60144472|NCT01117311|76268261|FG000|STARTED|Second Intervention - Mixed Meal 3||3||
60144473|NCT01117311|76268262|FG001|STARTED|Second Intervention - Mixed Meal 3||4||
60144474|NCT01117311|76268261|FG000|COMPLETED|Second Intervention - Mixed Meal 3||3||
60144475|NCT01117311|76268262|FG001|COMPLETED|Second Intervention - Mixed Meal 3||4||
60144476|NCT01117311|76268261|FG000|NOT COMPLETED|Second Intervention - Mixed Meal 3||0||
60144477|NCT01117311|76268262|FG001|NOT COMPLETED|Second Intervention - Mixed Meal 3||0||
60144478|NCT01118091|76268270|FG000|STARTED|Overall Study|2pts were randomized to Arm 2, were not able to grow cell product, were treated with Arm 1 regimen.|7||
60144479|NCT01118091|76268271|FG001|STARTED|Overall Study||5||
60144480|NCT01118091|76268270|FG000|COMPLETED|Overall Study|Continued from above: These 2 pts are only represented in Arm 1 (and not Arm 2).|7||
60144481|NCT01118091|76268271|FG001|COMPLETED|Overall Study||5||
60144482|NCT01118091|76268270|FG000|NOT COMPLETED|Overall Study||0||
60144483|NCT01118091|76268271|FG001|NOT COMPLETED|Overall Study||0||
60144484|NCT01045551|76268277|FG000|STARTED|Overall Study||10||
60144485|NCT01045551|76268277|FG000|COMPLETED|Overall Study||10||
60144486|NCT01045551|76268277|FG000|NOT COMPLETED|Overall Study||0||
60144487|NCT01047189|76268284|FG000|STARTED|Overall Study||13||
60144488|NCT01047189|76268285|FG001|STARTED|Overall Study||13||
60144489|NCT01047189|76268284|FG000|COMPLETED|Overall Study||9||
60144490|NCT01047189|76268285|FG001|COMPLETED|Overall Study||13||
60144491|NCT01047189|76268284|FG000|NOT COMPLETED|Overall Study||4||
60144492|NCT01047189|76268285|FG001|NOT COMPLETED|Overall Study||0||
60144493|NCT01048593|76268294|FG000|STARTED|Overall Study||3||
60144494|NCT01048593|76268295|FG001|STARTED|Overall Study||2||
60144495|NCT01048593|76268296|FG002|STARTED|Overall Study||1||
60144496|NCT01048593|76268294|FG000|COMPLETED|Overall Study||3||
60144497|NCT01048593|76268295|FG001|COMPLETED|Overall Study||2||
60144498|NCT01048593|76268296|FG002|COMPLETED|Overall Study||1||
60144499|NCT01048593|76268294|FG000|NOT COMPLETED|Overall Study||0||
60144500|NCT01048593|76268295|FG001|NOT COMPLETED|Overall Study||0||
60144501|NCT01048593|76268296|FG002|NOT COMPLETED|Overall Study||0||
60144502|NCT01118715|76268306|FG000|STARTED|Overall Study||68||
60144503|NCT01118715|76268307|FG001|STARTED|Overall Study||60||
60144504|NCT01118715|76268306|FG000|COMPLETED|Overall Study||68||
60144505|NCT01118715|76268307|FG001|COMPLETED|Overall Study||60||
60144506|NCT01118715|76268306|FG000|NOT COMPLETED|Overall Study||0||
60144507|NCT01118715|76268307|FG001|NOT COMPLETED|Overall Study||0||
60144508|NCT01120197|76268336|FG000|STARTED|Overall Study||47||
60144509|NCT01120197|76268337|FG001|STARTED|Overall Study||42||
60144510|NCT01120197|76268336|FG000|COMPLETED|Overall Study||38||
60144511|NCT01120197|76268337|FG001|COMPLETED|Overall Study||32||
60144512|NCT01120197|76268336|FG000|NOT COMPLETED|Overall Study||9||
60144513|NCT01120197|76268337|FG001|NOT COMPLETED|Overall Study||10||
60144514|NCT01048905|76268344|FG000|STARTED|Overall Study||13||
60144515|NCT01048905|76268344|FG000|COMPLETED|Overall Study||12||
60144516|NCT01048905|76268344|FG000|NOT COMPLETED|Overall Study||1||
60144517|NCT01121211|76268350|FG000|STARTED|Overall Study||43||
60144518|NCT01121211|76268351|FG001|STARTED|Overall Study||47||
60144519|NCT01121211|76268350|FG000|COMPLETED|Overall Study||32||
60144520|NCT01121211|76268351|FG001|COMPLETED|Overall Study||35||
60144521|NCT01121211|76268350|FG000|NOT COMPLETED|Overall Study||11||
60144522|NCT01121211|76268351|FG001|NOT COMPLETED|Overall Study||12||
60144523|NCT01162551|76268357|FG000|STARTED|Overall Study|2 subjects were enrolled but withdrew before receiving any study treatment|3||
60144524|NCT01162551|76268357|FG000|COMPLETED|Overall Study||3||
60144525|NCT01162551|76268357|FG000|NOT COMPLETED|Overall Study||0||
60144526|NCT01163097|76268364|FG000|STARTED|Overall Study|15 subjects were successfully titrated and entered the palifermin treatment|20||
60144527|NCT01163097|76268365|FG001|STARTED|Overall Study||16||
60144528|NCT01163097|76268366|FG002|STARTED|Overall Study||8||
60144529|NCT01163097|76268364|FG000|COMPLETED|Overall Study||14||
60144530|NCT01163097|76268365|FG001|COMPLETED|Overall Study||16||
59882002|NCT04080297|76004900|FG001|NOT COMPLETED|Overall Study||3||
59882003|NCT04013529|76004908|FG000|STARTED|Overall Study||20||
59882004|NCT04013529|76004909|FG001|STARTED|Overall Study||20||
59882005|NCT04013529|76004908|FG000|COMPLETED|Overall Study||19||
59882006|NCT04013529|76004909|FG001|COMPLETED|Overall Study||19||
59882007|NCT04013529|76004908|FG000|NOT COMPLETED|Overall Study||1||
59882008|NCT04013529|76004909|FG001|NOT COMPLETED|Overall Study||1||
59882009|NCT04011735|76004918|FG000|STARTED|Overall Study||133||
59882010|NCT04011735|76004919|FG001|STARTED|Overall Study||71||
59882011|NCT04011735|76004920|FG002|STARTED|Overall Study||56||
59882012|NCT04011735|76004918|FG000|COMPLETED|Overall Study||132||
60144531|NCT01163097|76268366|FG002|COMPLETED|Overall Study||8||
60144532|NCT01163097|76268364|FG000|NOT COMPLETED|Overall Study||6||
60144533|NCT01163097|76268365|FG001|NOT COMPLETED|Overall Study||0||
60144534|NCT01163097|76268366|FG002|NOT COMPLETED|Overall Study||0||
60144535|NCT01163643|76268382|FG000|STARTED|Overall Study||68||
60144536|NCT01163643|76268383|FG001|STARTED|Overall Study||37||
60144537|NCT01163643|76268384|FG002|STARTED|Overall Study||35||
60144538|NCT01163643|76268385|FG003|STARTED|Overall Study||74||
60144539|NCT01163643|76268386|FG004|STARTED|Overall Study||69||
60144540|NCT01163643|76268387|FG005|STARTED|Overall Study||73||
60144541|NCT01163643|76268382|FG000|COMPLETED|Overall Study||62||
60144542|NCT01163643|76268383|FG001|COMPLETED|Overall Study||35||
60144543|NCT01163643|76268384|FG002|COMPLETED|Overall Study||33||
60144544|NCT01163643|76268385|FG003|COMPLETED|Overall Study||69||
60144545|NCT01163643|76268386|FG004|COMPLETED|Overall Study||61||
60144546|NCT01163643|76268387|FG005|COMPLETED|Overall Study||66||
60144547|NCT01163643|76268382|FG000|NOT COMPLETED|Overall Study||6||
60144548|NCT01163643|76268383|FG001|NOT COMPLETED|Overall Study||2||
60144549|NCT01163643|76268384|FG002|NOT COMPLETED|Overall Study||2||
60144550|NCT01163643|76268385|FG003|NOT COMPLETED|Overall Study||5||
60144551|NCT01163643|76268386|FG004|NOT COMPLETED|Overall Study||8||
60144552|NCT01163643|76268387|FG005|NOT COMPLETED|Overall Study||7||
60144553|NCT01122849|76268404|FG000|STARTED|Overall Study||20||
60144554|NCT01122849|76268405|FG001|STARTED|Overall Study||21||
60144555|NCT01122849|76268406|FG002|STARTED|Overall Study||20||
60144556|NCT01122849|76268404|FG000|COMPLETED|Overall Study||20||
60144557|NCT01122849|76268405|FG001|COMPLETED|Overall Study||21||
60144558|NCT01122849|76268406|FG002|COMPLETED|Overall Study||20||
60144559|NCT01122849|76268404|FG000|NOT COMPLETED|Overall Study||0||
60144560|NCT01122849|76268405|FG001|NOT COMPLETED|Overall Study||0||
60144561|NCT01122849|76268406|FG002|NOT COMPLETED|Overall Study||0||
60144562|NCT03088137|76268426|FG000|STARTED|Overall Study||55||
60144563|NCT03088137|76268427|FG001|STARTED|Overall Study||55||
60144564|NCT03088137|76268426|FG000|COMPLETED|Overall Study||55||
60144565|NCT03088137|76268427|FG001|COMPLETED|Overall Study||55||
60144566|NCT03088137|76268426|FG000|NOT COMPLETED|Overall Study||0||
60144567|NCT03088137|76268427|FG001|NOT COMPLETED|Overall Study||0||
60144568|NCT01163955|76268435|FG000|STARTED|Overall Study||26||
60144569|NCT01163955|76268436|FG001|STARTED|Overall Study||30||
60144570|NCT01163955|76268435|FG000|COMPLETED|Overall Study||26||
60144571|NCT01163955|76268436|FG001|COMPLETED|Overall Study||26||
60144572|NCT01163955|76268435|FG000|NOT COMPLETED|Overall Study||0||
60144573|NCT01163955|76268436|FG001|NOT COMPLETED|Overall Study||4||
60144574|NCT02951481|76268444|FG000|STARTED|Overall Study||231||
60144575|NCT02951481|76268445|FG001|STARTED|Overall Study||172||
60144576|NCT02951481|76268444|FG000|COMPLETED|Overall Study||231||
60144577|NCT02951481|76268445|FG001|COMPLETED|Overall Study||172||
60144578|NCT02951481|76268444|FG000|NOT COMPLETED|Overall Study||0||
60144579|NCT02951481|76268445|FG001|NOT COMPLETED|Overall Study||0||
60144580|NCT01124955|76268453|FG000|STARTED|Overall Study||40||
60144581|NCT01124955|76268454|FG001|STARTED|Overall Study||40||
59882013|NCT04011735|76004919|FG001|COMPLETED|Overall Study||70||
59882014|NCT04011735|76004920|FG002|COMPLETED|Overall Study||55||
59882015|NCT04011735|76004918|FG000|NOT COMPLETED|Overall Study||1||
60144582|NCT01124955|76268453|FG000|COMPLETED|Overall Study||40||
60144583|NCT01124955|76268454|FG001|COMPLETED|Overall Study||40||
60144584|NCT01124955|76268453|FG000|NOT COMPLETED|Overall Study||0||
60144585|NCT01124955|76268454|FG001|NOT COMPLETED|Overall Study||0||
60144586|NCT01165047|76268460|FG000|STARTED|Overall Study||10||
60144587|NCT01165047|76268460|FG000|COMPLETED|Overall Study||10||
60144588|NCT01165047|76268460|FG000|NOT COMPLETED|Overall Study||0||
60144589|NCT01165983|76268466|FG000|STARTED|Overall Study||51||
60144590|NCT01165983|76268467|FG001|STARTED|Overall Study||49||
60144591|NCT01165983|76268466|FG000|COMPLETED|Overall Study||46||
60144592|NCT01165983|76268467|FG001|COMPLETED|Overall Study||42||
60144593|NCT01165983|76268466|FG000|NOT COMPLETED|Overall Study||5||
60144594|NCT01165983|76268467|FG001|NOT COMPLETED|Overall Study||7||
60144595|NCT01166139|76268475|FG000|STARTED|Overall Study||10||
60144596|NCT01166139|76268475|FG000|COMPLETED|Overall Study||7||
60144597|NCT01166139|76268475|FG000|NOT COMPLETED|Overall Study||3||
60144598|NCT01166997|76268481|FG000|STARTED|Overall Study||29||
60144599|NCT01166997|76268482|FG001|STARTED|Overall Study||30||
60144600|NCT01166997|76268481|FG000|COMPLETED|Overall Study||27||
60144601|NCT01166997|76268482|FG001|COMPLETED|Overall Study||30||
60144602|NCT01166997|76268481|FG000|NOT COMPLETED|Overall Study||2||
60144603|NCT01166997|76268482|FG001|NOT COMPLETED|Overall Study||0||
60144604|NCT01170117|76268492|FG000|STARTED|Overall Study||77||
60144605|NCT01170117|76268493|FG001|STARTED|Overall Study||75||
60144606|NCT01170117|76268492|FG000|COMPLETED|Overall Study||47||
60144607|NCT01170117|76268493|FG001|COMPLETED|Overall Study||55||
60144608|NCT01170117|76268492|FG000|NOT COMPLETED|Overall Study||30||
60144609|NCT01170117|76268493|FG001|NOT COMPLETED|Overall Study||20||
60144610|NCT01172067|76268501|FG000|STARTED|Overall Study||200||
60144611|NCT01172067|76268502|FG001|STARTED|Overall Study||200||
60144612|NCT01172067|76268501|FG000|COMPLETED|Overall Study||153||
60144613|NCT01172067|76268502|FG001|COMPLETED|Overall Study||163||
60144614|NCT01172067|76268501|FG000|NOT COMPLETED|Overall Study||47||
60144615|NCT01172067|76268502|FG001|NOT COMPLETED|Overall Study||37||
60144616|NCT01172145|76268510|FG000|STARTED|Overall Study||11||
60144617|NCT01172145|76268511|FG001|STARTED|Overall Study||11||
60144618|NCT01172145|76268510|FG000|COMPLETED|Overall Study||11||
60144619|NCT01172145|76268511|FG001|COMPLETED|Overall Study||11||
60144620|NCT01172145|76268510|FG000|NOT COMPLETED|Overall Study||0||
60144621|NCT01172145|76268511|FG001|NOT COMPLETED|Overall Study||0||
60144622|NCT01173159|76268517|FG000|STARTED|Overall Study||10||
60144623|NCT01173159|76268517|FG000|COMPLETED|Overall Study||10||
60144624|NCT01173159|76268517|FG000|NOT COMPLETED|Overall Study||0||
60144625|NCT01175031|76268521|FG000|STARTED|Overall Study||45||
60144626|NCT01175031|76268521|FG000|COMPLETED|Overall Study||45||
60144627|NCT01175031|76268521|FG000|NOT COMPLETED|Overall Study||0||
60144628|NCT01175343|76268529|FG000|STARTED|Overall Study||44||
60144629|NCT01175343|76268529|FG000|COMPLETED|Overall Study||44||
60144630|NCT01175343|76268529|FG000|NOT COMPLETED|Overall Study||0||
60144631|NCT01176435|76268536|FG000|STARTED|Overall Study||15||
60144632|NCT01176435|76268537|FG001|STARTED|Overall Study||15||
60144633|NCT01176435|76268538|FG002|STARTED|Overall Study||15||
60144634|NCT01176435|76268536|FG000|COMPLETED|Overall Study||15||
60144635|NCT01176435|76268537|FG001|COMPLETED|Overall Study||15||
60144636|NCT01176435|76268538|FG002|COMPLETED|Overall Study||15||
60144637|NCT01176435|76268536|FG000|NOT COMPLETED|Overall Study||0||
60144638|NCT01176435|76268537|FG001|NOT COMPLETED|Overall Study||0||
60144639|NCT01176435|76268538|FG002|NOT COMPLETED|Overall Study||0||
60144640|NCT01176591|76268548|FG000|STARTED|Session 1||10||
60144641|NCT01176591|76268549|FG001|STARTED|Session 1||3||
60144642|NCT01176591|76268548|FG000|COMPLETED|Session 1||10||
60144643|NCT01176591|76268549|FG001|COMPLETED|Session 1||3||
60144644|NCT01176591|76268548|FG000|NOT COMPLETED|Session 1||0||
60144645|NCT01176591|76268549|FG001|NOT COMPLETED|Session 1||0||
60144646|NCT01176591|76268548|FG000|STARTED|Session 2||10||
60144647|NCT01176591|76268549|FG001|STARTED|Session 2||3||
60144648|NCT01176591|76268548|FG000|COMPLETED|Session 2||10||
60144649|NCT01176591|76268549|FG001|COMPLETED|Session 2||3||
60144650|NCT01176591|76268548|FG000|NOT COMPLETED|Session 2||0||
60144651|NCT01176591|76268549|FG001|NOT COMPLETED|Session 2||0||
60144652|NCT01176981|76268557|FG000|STARTED|Overall Study||6||
60144653|NCT01176981|76268557|FG000|COMPLETED|Overall Study||6||
60144654|NCT01176981|76268557|FG000|NOT COMPLETED|Overall Study||0||
60144655|NCT01126593|76268564|FG000|STARTED|Overall Study||33||
60144656|NCT01126593|76268565|FG001|STARTED|Overall Study||29||
60144657|NCT01126593|76268566|FG002|STARTED|Overall Study||34||
60144658|NCT01126593|76268564|FG000|COMPLETED|Overall Study||29||
60144659|NCT01126593|76268565|FG001|COMPLETED|Overall Study||27||
60144660|NCT01126593|76268566|FG002|COMPLETED|Overall Study||32||
60144661|NCT01126593|76268564|FG000|NOT COMPLETED|Overall Study||4||
60144662|NCT01126593|76268565|FG001|NOT COMPLETED|Overall Study||2||
60144663|NCT01126593|76268566|FG002|NOT COMPLETED|Overall Study||2||
60144664|NCT01181349|76268574|FG000|STARTED|Overall Study||350||
60144665|NCT01181349|76268574|FG000|COMPLETED|Overall Study||350||
60144666|NCT01181349|76268574|FG000|NOT COMPLETED|Overall Study||0||
60144667|NCT01126671|76268582|FG000|STARTED|Overall Study||26||
60144668|NCT01126671|76268583|FG001|STARTED|Overall Study||30||
60144669|NCT01126671|76268582|FG000|COMPLETED|Overall Study||24||
60144670|NCT01126671|76268583|FG001|COMPLETED|Overall Study||29||
60144671|NCT01126671|76268582|FG000|NOT COMPLETED|Overall Study||2||
60144672|NCT01126671|76268583|FG001|NOT COMPLETED|Overall Study||1||
60144673|NCT01182675|76268593|FG000|STARTED|Overall Study||7||
60144674|NCT01182675|76268594|FG001|STARTED|Overall Study||0||
60144675|NCT01182675|76268593|FG000|COMPLETED|Overall Study||7||
60144676|NCT01182675|76268594|FG001|COMPLETED|Overall Study||0||
60144677|NCT01182675|76268593|FG000|NOT COMPLETED|Overall Study||0||
60144678|NCT01182675|76268594|FG001|NOT COMPLETED|Overall Study||0||
60144679|NCT01129245|76268604|FG000|STARTED|Control Cycle (no Celecoxib or Placebo)||10||
60144680|NCT01129245|76268605|FG001|STARTED|Control Cycle (no Celecoxib or Placebo)||10||
60144681|NCT01129245|76268604|FG000|COMPLETED|Control Cycle (no Celecoxib or Placebo)||10||
60144682|NCT01129245|76268605|FG001|COMPLETED|Control Cycle (no Celecoxib or Placebo)||10||
60144683|NCT01129245|76268604|FG000|NOT COMPLETED|Control Cycle (no Celecoxib or Placebo)||0||
60144684|NCT01129245|76268605|FG001|NOT COMPLETED|Control Cycle (no Celecoxib or Placebo)||0||
60144685|NCT01129245|76268604|FG000|STARTED|Treatment Cycle 1||10||
60144686|NCT01129245|76268605|FG001|STARTED|Treatment Cycle 1||10||
60144687|NCT01129245|76268604|FG000|COMPLETED|Treatment Cycle 1||10||
60144688|NCT01129245|76268605|FG001|COMPLETED|Treatment Cycle 1||10||
60144689|NCT01129245|76268604|FG000|NOT COMPLETED|Treatment Cycle 1||0||
60144690|NCT01129245|76268605|FG001|NOT COMPLETED|Treatment Cycle 1||0||
60144691|NCT01129245|76268604|FG000|STARTED|Washout Cycle||10||
60144692|NCT01129245|76268605|FG001|STARTED|Washout Cycle||10||
60144693|NCT01129245|76268604|FG000|COMPLETED|Washout Cycle||10||
60144694|NCT01129245|76268605|FG001|COMPLETED|Washout Cycle||10||
60144695|NCT01129245|76268604|FG000|NOT COMPLETED|Washout Cycle||0||
60144696|NCT01129245|76268605|FG001|NOT COMPLETED|Washout Cycle||0||
60144697|NCT01129245|76268604|FG000|STARTED|Treatment Cycle 2||10||
60144698|NCT01129245|76268605|FG001|STARTED|Treatment Cycle 2||10||
60144699|NCT01129245|76268604|FG000|COMPLETED|Treatment Cycle 2||10||
60144700|NCT01129245|76268605|FG001|COMPLETED|Treatment Cycle 2||10||
60144701|NCT01129245|76268604|FG000|NOT COMPLETED|Treatment Cycle 2||0||
60144702|NCT01129245|76268605|FG001|NOT COMPLETED|Treatment Cycle 2||0||
60144703|NCT01183533|76268614|FG000|STARTED|Overall Study|Between Oct 2010 and Oct 2013.|40||
60144704|NCT01183533|76268614|FG000|COMPLETED|Overall Study|- all pre-planned 40 patients received the study medication.|40||
60010459|NCT03072602|76126127|FG000|Participants Returned for Glucose Challenge Protocol|Overall Study||35|74 participants returned for the glucose challenge protocol|
60010460|NCT03072602|76126128|FG001|Participants Returned for Glucose Challenge Protocol|Overall Study||39|74 participants returned for the glucose challenge protocol|
60010461|NCT03072602|76126127|FG000|Unable to Complete the Protocol|Overall Study||1||
60010462|NCT03072602|76126128|FG001|Unable to Complete the Protocol|Overall Study||1||
60144705|NCT01183533|76268614|FG000|NOT COMPLETED|Overall Study||0||
60144706|NCT01183689|76268621|FG000|STARTED|Overall Study||202||
60144707|NCT01183689|76268622|FG001|STARTED|Overall Study||200||
60144708|NCT01183689|76268623|FG002|STARTED|Overall Study||197||
60144709|NCT01183689|76268621|FG000|Month 4 Visit|Overall Study||197||
60144710|NCT01183689|76268622|FG001|Month 4 Visit|Overall Study||192||
60144711|NCT01183689|76268623|FG002|Month 4 Visit|Overall Study||187||
60144712|NCT01183689|76268621|FG000|Year 1 Visit|Overall Study||187||
60144713|NCT01183689|76268622|FG001|Year 1 Visit|Overall Study||172||
60144714|NCT01183689|76268623|FG002|Year 1 Visit|Overall Study||183||
60144715|NCT01183689|76268621|FG000|Year 2 Visit|Overall Study||178||
60144716|NCT01183689|76268622|FG001|Year 2 Visit|Overall Study||172||
60144717|NCT01183689|76268623|FG002|Year 2 Visit|Overall Study||174||
60144718|NCT01183689|76268621|FG000|Year 3 Visit|Overall Study||139||
60144719|NCT01183689|76268622|FG001|Year 3 Visit|Overall Study||125||
60144720|NCT01183689|76268623|FG002|Year 3 Visit|Overall Study||126||
60144721|NCT01183689|76268621|FG000|Year 4 Visit|Overall Study||38||
60144722|NCT01183689|76268622|FG001|Year 4 Visit|Overall Study||33||
60144723|NCT01183689|76268623|FG002|Year 4 Visit|Overall Study||30||
60144724|NCT01183689|76268621|FG000|COMPLETED|Overall Study||202||
60144725|NCT01183689|76268622|FG001|COMPLETED|Overall Study||200||
60144726|NCT01183689|76268623|FG002|COMPLETED|Overall Study||197||
60144727|NCT01183689|76268621|FG000|NOT COMPLETED|Overall Study||0||
60144728|NCT01183689|76268622|FG001|NOT COMPLETED|Overall Study||0||
60144729|NCT01183689|76268623|FG002|NOT COMPLETED|Overall Study||0||
60144730|NCT01183923|76268633|FG000|STARTED|Intervention 1 (7 Days)||1||
60144731|NCT01183923|76268634|FG001|STARTED|Intervention 1 (7 Days)||0||
60144732|NCT01183923|76268633|FG000|COMPLETED|Intervention 1 (7 Days)||1||
60144733|NCT01183923|76268634|FG001|COMPLETED|Intervention 1 (7 Days)||0||
60144734|NCT01183923|76268633|FG000|NOT COMPLETED|Intervention 1 (7 Days)||0||
60144735|NCT01183923|76268634|FG001|NOT COMPLETED|Intervention 1 (7 Days)||0||
60144736|NCT01183923|76268633|FG000|STARTED|Washout (14 Days)||1||
60144737|NCT01183923|76268634|FG001|STARTED|Washout (14 Days)||0||
60144738|NCT01183923|76268633|FG000|COMPLETED|Washout (14 Days)||1||
60144739|NCT01183923|76268634|FG001|COMPLETED|Washout (14 Days)||0||
60144740|NCT01183923|76268633|FG000|NOT COMPLETED|Washout (14 Days)||0||
60144741|NCT01183923|76268634|FG001|NOT COMPLETED|Washout (14 Days)||0||
60144742|NCT01183923|76268633|FG000|STARTED|Intervention 2 (7 Days)||1||
60144743|NCT01183923|76268634|FG001|STARTED|Intervention 2 (7 Days)||0||
60144744|NCT01183923|76268633|FG000|COMPLETED|Intervention 2 (7 Days)||1||
60144745|NCT01183923|76268634|FG001|COMPLETED|Intervention 2 (7 Days)||0||
60144746|NCT01183923|76268633|FG000|NOT COMPLETED|Intervention 2 (7 Days)||0||
60144747|NCT01183923|76268634|FG001|NOT COMPLETED|Intervention 2 (7 Days)||0||
60144748|NCT01187355|76268641|FG000|STARTED|Overall Study||294||
60144749|NCT01187355|76268642|FG001|STARTED|Overall Study||297||
60144750|NCT01187355|76268641|FG000|COMPLETED|Overall Study||276||
60144751|NCT01187355|76268642|FG001|COMPLETED|Overall Study||277||
60144752|NCT01187355|76268641|FG000|NOT COMPLETED|Overall Study||18||
60144753|NCT01187355|76268642|FG001|NOT COMPLETED|Overall Study||20||
60144754|NCT01134081|76268648|FG000|STARTED|Overall Study||44||
60144755|NCT01134081|76268648|FG000|COMPLETED|Overall Study||44||
60144756|NCT01134081|76268648|FG000|NOT COMPLETED|Overall Study||0||
60144757|NCT01187511|76268658|FG000|STARTED|Overall Study||22||
60144758|NCT01187511|76268659|FG001|STARTED|Overall Study||22||
60144759|NCT01187511|76268658|FG000|COMPLETED|Overall Study||14||
60144760|NCT01187511|76268659|FG001|COMPLETED|Overall Study||21||
60144761|NCT01187511|76268658|FG000|NOT COMPLETED|Overall Study||8||
60144762|NCT01187511|76268659|FG001|NOT COMPLETED|Overall Study||1||
60144763|NCT01188369|76268667|FG000|STARTED|Overall Study||10||
60144764|NCT01188369|76268668|FG001|STARTED|Overall Study||10||
60144765|NCT01188369|76268667|FG000|COMPLETED|Overall Study||10||
60144766|NCT01188369|76268668|FG001|COMPLETED|Overall Study||10||
60144767|NCT01188369|76268667|FG000|NOT COMPLETED|Overall Study||0||
60144768|NCT01188369|76268668|FG001|NOT COMPLETED|Overall Study||0||
60144769|NCT01188447|76268674|FG000|STARTED|Overall Study||4034||
60144770|NCT01188447|76268674|FG000|COMPLETED|Overall Study||4034||
60144771|NCT01188447|76268674|FG000|NOT COMPLETED|Overall Study||0||
60144772|NCT01134549|76268684|FG000|STARTED|Overall Study||8||
60144773|NCT01134549|76268685|FG001|STARTED|Overall Study||6||
60144774|NCT01134549|76268686|FG002|STARTED|Overall Study||6||
60144775|NCT01134549|76268687|FG003|STARTED|Overall Study||6||
60144776|NCT01134549|76268688|FG004|STARTED|Overall Study||6||
60144777|NCT01134549|76268684|FG000|COMPLETED|Overall Study||8||
60144778|NCT01134549|76268685|FG001|COMPLETED|Overall Study||6||
60144779|NCT01134549|76268686|FG002|COMPLETED|Overall Study||6||
60144780|NCT01134549|76268687|FG003|COMPLETED|Overall Study||6||
60144781|NCT01134549|76268688|FG004|COMPLETED|Overall Study||6||
60144782|NCT01134549|76268684|FG000|NOT COMPLETED|Overall Study||0||
60144783|NCT01134549|76268685|FG001|NOT COMPLETED|Overall Study||0||
60144784|NCT01134549|76268686|FG002|NOT COMPLETED|Overall Study||0||
60144785|NCT01134549|76268687|FG003|NOT COMPLETED|Overall Study||0||
60144786|NCT01134549|76268688|FG004|NOT COMPLETED|Overall Study||0||
60144787|NCT01188603|76268705|FG000|STARTED|Overall Study||24||
60144788|NCT01188603|76268705|FG000|COMPLETED|Overall Study||24||
60144789|NCT01188603|76268705|FG000|NOT COMPLETED|Overall Study||0||
60144790|NCT01189617|76268711|FG000|STARTED|Overall Study||35||
60144791|NCT01189617|76268712|FG001|STARTED|Overall Study||35||
60144792|NCT01189617|76268711|FG000|COMPLETED|Overall Study||35||
60144793|NCT01189617|76268712|FG001|COMPLETED|Overall Study||35||
60144794|NCT01189617|76268711|FG000|NOT COMPLETED|Overall Study||0||
60144795|NCT01189617|76268712|FG001|NOT COMPLETED|Overall Study||0||
60144796|NCT01135095|76268718|FG000|STARTED|Overall Study||101||
60144797|NCT01135095|76268718|FG000|COMPLETED|Overall Study||101||
60144798|NCT01135095|76268718|FG000|NOT COMPLETED|Overall Study||0||
60144799|NCT01135329|76268722|FG000|STARTED|Overall Study||15||
60144800|NCT01135329|76268722|FG000|COMPLETED|Overall Study||15||
60144801|NCT01135329|76268722|FG000|NOT COMPLETED|Overall Study||0||
60144802|NCT01190085|76268730|FG000|STARTED|Overall Study||13||
60144803|NCT01190085|76268731|FG001|STARTED|Overall Study||14||
60144804|NCT01190085|76268732|FG002|STARTED|Overall Study||18||
60144805|NCT01190085|76268730|FG000|COMPLETED|Overall Study||13||
60144806|NCT01190085|76268731|FG001|COMPLETED|Overall Study||14||
60144807|NCT01190085|76268732|FG002|COMPLETED|Overall Study||18||
60144808|NCT01190085|76268730|FG000|NOT COMPLETED|Overall Study||0||
60144809|NCT01190085|76268731|FG001|NOT COMPLETED|Overall Study||0||
60144810|NCT01190085|76268732|FG002|NOT COMPLETED|Overall Study||0||
60144811|NCT02082977|76268750|FG000|STARTED|Part 1 (Up to 3.2 Years)||2||
60144812|NCT02082977|76268751|FG001|STARTED|Part 1 (Up to 3.2 Years)||1||
60144813|NCT02082977|76268752|FG002|STARTED|Part 1 (Up to 3.2 Years)||1||
60144814|NCT02082977|76268753|FG003|STARTED|Part 1 (Up to 3.2 Years)||1||
60144815|NCT02082977|76268754|FG004|STARTED|Part 1 (Up to 3.2 Years)||3||
60144816|NCT02082977|76268755|FG005|STARTED|Part 1 (Up to 3.2 Years)||4||
60144817|NCT02082977|76268756|FG006|STARTED|Part 1 (Up to 3.2 Years)||10||
60144818|NCT02082977|76268757|FG007|STARTED|Part 1 (Up to 3.2 Years)||12||
60144819|NCT02082977|76268758|FG008|STARTED|Part 1 (Up to 3.2 Years)||7||
60144820|NCT02082977|76268759|FG009|STARTED|Part 1 (Up to 3.2 Years)||0||
60144821|NCT02082977|76268750|FG000|COMPLETED|Part 1 (Up to 3.2 Years)||1||
60144822|NCT02082977|76268751|FG001|COMPLETED|Part 1 (Up to 3.2 Years)||1||
60144823|NCT02082977|76268752|FG002|COMPLETED|Part 1 (Up to 3.2 Years)||1||
60144824|NCT02082977|76268753|FG003|COMPLETED|Part 1 (Up to 3.2 Years)||1||
60144825|NCT02082977|76268754|FG004|COMPLETED|Part 1 (Up to 3.2 Years)||2||
60144826|NCT02082977|76268755|FG005|COMPLETED|Part 1 (Up to 3.2 Years)||1||
60144827|NCT02082977|76268756|FG006|COMPLETED|Part 1 (Up to 3.2 Years)||4||
60144828|NCT02082977|76268757|FG007|COMPLETED|Part 1 (Up to 3.2 Years)||7||
60144829|NCT02082977|76268758|FG008|COMPLETED|Part 1 (Up to 3.2 Years)||4||
60144830|NCT02082977|76268759|FG009|COMPLETED|Part 1 (Up to 3.2 Years)||0||
60144831|NCT02082977|76268750|FG000|NOT COMPLETED|Part 1 (Up to 3.2 Years)||1||
60144832|NCT02082977|76268751|FG001|NOT COMPLETED|Part 1 (Up to 3.2 Years)||0||
60144833|NCT02082977|76268752|FG002|NOT COMPLETED|Part 1 (Up to 3.2 Years)||0||
60144834|NCT02082977|76268753|FG003|NOT COMPLETED|Part 1 (Up to 3.2 Years)||0||
60144835|NCT02082977|76268754|FG004|NOT COMPLETED|Part 1 (Up to 3.2 Years)||1||
60144836|NCT02082977|76268755|FG005|NOT COMPLETED|Part 1 (Up to 3.2 Years)||3||
60144837|NCT02082977|76268756|FG006|NOT COMPLETED|Part 1 (Up to 3.2 Years)||6||
60144838|NCT02082977|76268757|FG007|NOT COMPLETED|Part 1 (Up to 3.2 Years)||5||
60144839|NCT02082977|76268758|FG008|NOT COMPLETED|Part 1 (Up to 3.2 Years)||3||
60144840|NCT02082977|76268759|FG009|NOT COMPLETED|Part 1 (Up to 3.2 Years)||0||
60144841|NCT02082977|76268750|FG000|STARTED|Part 2 (Up to 3.2 Years)||0||
60144842|NCT02082977|76268751|FG001|STARTED|Part 2 (Up to 3.2 Years)||0||
60144843|NCT02082977|76268752|FG002|STARTED|Part 2 (Up to 3.2 Years)||0||
60144844|NCT02082977|76268753|FG003|STARTED|Part 2 (Up to 3.2 Years)||0||
60144845|NCT02082977|76268754|FG004|STARTED|Part 2 (Up to 3.2 Years)||0||
60144846|NCT02082977|76268755|FG005|STARTED|Part 2 (Up to 3.2 Years)||0||
60144847|NCT02082977|76268756|FG006|STARTED|Part 2 (Up to 3.2 Years)||0||
60144848|NCT02082977|76268757|FG007|STARTED|Part 2 (Up to 3.2 Years)||0||
60144849|NCT02082977|76268758|FG008|STARTED|Part 2 (Up to 3.2 Years)||0||
60144850|NCT02082977|76268759|FG009|STARTED|Part 2 (Up to 3.2 Years)||0||
60144851|NCT02082977|76268750|FG000|COMPLETED|Part 2 (Up to 3.2 Years)||0||
60144852|NCT02082977|76268751|FG001|COMPLETED|Part 2 (Up to 3.2 Years)||0||
60144853|NCT02082977|76268752|FG002|COMPLETED|Part 2 (Up to 3.2 Years)||0||
60144854|NCT02082977|76268753|FG003|COMPLETED|Part 2 (Up to 3.2 Years)||0||
60144855|NCT02082977|76268754|FG004|COMPLETED|Part 2 (Up to 3.2 Years)||0||
60144856|NCT02082977|76268755|FG005|COMPLETED|Part 2 (Up to 3.2 Years)||0||
60144857|NCT02082977|76268756|FG006|COMPLETED|Part 2 (Up to 3.2 Years)||0||
60144858|NCT02082977|76268757|FG007|COMPLETED|Part 2 (Up to 3.2 Years)||0||
60144859|NCT02082977|76268758|FG008|COMPLETED|Part 2 (Up to 3.2 Years)||0||
60144860|NCT02082977|76268759|FG009|COMPLETED|Part 2 (Up to 3.2 Years)||0||
60144861|NCT02082977|76268750|FG000|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0||
60144862|NCT02082977|76268751|FG001|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0||
60144863|NCT02082977|76268752|FG002|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0||
60144864|NCT02082977|76268753|FG003|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0||
60144865|NCT02082977|76268754|FG004|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0||
60144866|NCT02082977|76268755|FG005|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0||
60144867|NCT02082977|76268756|FG006|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0||
60144868|NCT02082977|76268757|FG007|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0||
60144869|NCT02082977|76268758|FG008|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0||
60144870|NCT02082977|76268759|FG009|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0||
60144871|NCT01624259|76268793|FG000|STARTED|Overall Study||299||
59751470|NCT00846027|75870794|FG000|STARTED|Overall Study||90||
60144872|NCT01624259|76268794|FG001|STARTED|Overall Study||300||
60144873|NCT01624259|76268793|FG000|Received at Least One Dose of Study Drug|Overall Study||299||
60144874|NCT01624259|76268794|FG001|Received at Least One Dose of Study Drug|Overall Study||300||
60144875|NCT01624259|76268793|FG000|COMPLETED|Overall Study|Completed the study on study treatment|269||
60144876|NCT01624259|76268794|FG001|COMPLETED|Overall Study|Completed the study on study treatment|269||
60144877|NCT01624259|76268793|FG000|NOT COMPLETED|Overall Study||30||
60144878|NCT01624259|76268794|FG001|NOT COMPLETED|Overall Study||31||
60144879|NCT02081417|76268804|FG000|STARTED|Overall Study|Randomized to intervention|163|These individuals were determined eligible, randomized to study arms and attended 1 treatment group.|
60144880|NCT02081417|76268805|FG001|STARTED|Overall Study||166|These individuals were determined eligible, randomized to study arms and attended 1 treatment group.|
60144881|NCT02081417|76268804|FG000|1st Interview Completed|Overall Study||146|These individuals attended one treatment session, were consented and completed a first interview.|
60144882|NCT02081417|76268805|FG001|1st Interview Completed|Overall Study||145|These individuals attended one treatment session, were consented and completed a first interview.|
60144883|NCT02081417|76268804|FG000|3-Month Follow-Up|Overall Study||94||
60144884|NCT02081417|76268805|FG001|3-Month Follow-Up|Overall Study||95||
60144885|NCT02081417|76268804|FG000|6-Month Follow-Up|Overall Study||82||
60144886|NCT02081417|76268805|FG001|6-Month Follow-Up|Overall Study||92||
60144887|NCT02081417|76268804|FG000|COMPLETED|Overall Study||107|Defined as completing at least one follow-up interview (3 or 6 months)|
60144888|NCT02081417|76268805|FG001|COMPLETED|Overall Study||115|Defined as completing at least one follow-up interview (3 or 6 months)|
60144889|NCT02081417|76268804|FG000|NOT COMPLETED|Overall Study||56||
60144890|NCT02081417|76268805|FG001|NOT COMPLETED|Overall Study||51||
60144891|NCT02081183|76268813|FG000|STARTED|Overall Study||5||
60144892|NCT02081183|76268814|FG001|STARTED|Overall Study||6||
60144893|NCT02081183|76268813|FG000|COMPLETED|Overall Study||1||
60144894|NCT02081183|76268814|FG001|COMPLETED|Overall Study||2||
60144895|NCT02081183|76268813|FG000|NOT COMPLETED|Overall Study||4||
60144896|NCT02081183|76268814|FG001|NOT COMPLETED|Overall Study||4||
60144897|NCT02080871|76268820|FG000|STARTED|Overall Study||134||
60144898|NCT02080871|76268820|FG000|COMPLETED|Overall Study||132|Completion of the primary outcome measure (9 months). The study is in long term follow-up.|
60144899|NCT02080871|76268820|FG000|NOT COMPLETED|Overall Study||2||
60144900|NCT02080481|76268826|FG000|STARTED|Overall Study||68||
60144901|NCT02080481|76268827|FG001|STARTED|Overall Study||67||
60144902|NCT02080481|76268826|FG000|COMPLETED|Overall Study||67|The patients completed the study were included in the analysis|
60144903|NCT02080481|76268827|FG001|COMPLETED|Overall Study||67|The patients completed the study were included in the analysis|
60144904|NCT02080481|76268826|FG000|NOT COMPLETED|Overall Study||1||
60144905|NCT02080481|76268827|FG001|NOT COMPLETED|Overall Study||0||
60144906|NCT02080403|76268835|FG000|STARTED|Overall Study||146||
60144907|NCT02080403|76268836|FG001|STARTED|Overall Study||144||
60144908|NCT02080403|76268835|FG000|COMPLETED|Overall Study||131||
60144909|NCT02080403|76268836|FG001|COMPLETED|Overall Study||132||
60144910|NCT02080403|76268835|FG000|NOT COMPLETED|Overall Study||15||
60144911|NCT02080403|76268836|FG001|NOT COMPLETED|Overall Study||12||
60144912|NCT02080091|76268842|FG000|STARTED|Overall Study||25||
60144913|NCT02080091|76268842|FG000|COMPLETED|Overall Study||0||
60144914|NCT02080091|76268842|FG000|NOT COMPLETED|Overall Study||25||
60144915|NCT02079077|76268848|FG000|STARTED|Overall Study||43||
60144916|NCT02079077|76268849|FG001|STARTED|Overall Study||48||
60144917|NCT02079077|76268848|FG000|COMPLETED|Overall Study||37||
60144918|NCT02079077|76268849|FG001|COMPLETED|Overall Study||39||
60144919|NCT02079077|76268848|FG000|NOT COMPLETED|Overall Study||6||
60144920|NCT02079077|76268849|FG001|NOT COMPLETED|Overall Study||9||
60144921|NCT01191255|76268859|FG000|STARTED|Safety Assessment Period|3 subjects were assigned to receive KRX-0502 but didn't receive a single dose|149||
60144922|NCT01191255|76268860|FG001|STARTED|Safety Assessment Period||292||
60144923|NCT01191255|76268861|FG002|STARTED|Safety Assessment Period||0||
60144924|NCT01191255|76268862|FG003|STARTED|Safety Assessment Period||0||
60144925|NCT01191255|76268859|FG000|Safety Population|Safety Assessment Period||149||
60144926|NCT01191255|76268860|FG001|Safety Population|Safety Assessment Period||289||
60144927|NCT01191255|76268861|FG002|Safety Population|Safety Assessment Period||0||
60144928|NCT01191255|76268862|FG003|Safety Population|Safety Assessment Period||0||
60144929|NCT01191255|76268859|FG000|COMPLETED|Safety Assessment Period||111||
60144930|NCT01191255|76268860|FG001|COMPLETED|Safety Assessment Period||193||
60144931|NCT01191255|76268861|FG002|COMPLETED|Safety Assessment Period||0||
60144932|NCT01191255|76268862|FG003|COMPLETED|Safety Assessment Period||0||
60144933|NCT01191255|76268859|FG000|NOT COMPLETED|Safety Assessment Period||38||
60144934|NCT01191255|76268860|FG001|NOT COMPLETED|Safety Assessment Period||99||
60144935|NCT01191255|76268861|FG002|NOT COMPLETED|Safety Assessment Period||0||
60144936|NCT01191255|76268862|FG003|NOT COMPLETED|Safety Assessment Period||0||
60144937|NCT01191255|76268859|FG000|STARTED|Efficacy Assessment Period||0||
60144938|NCT01191255|76268860|FG001|STARTED|Efficacy Assessment Period||0||
60144939|NCT01191255|76268861|FG002|STARTED|Efficacy Assessment Period||96||
60144940|NCT01191255|76268862|FG003|STARTED|Efficacy Assessment Period||96||
60144941|NCT01191255|76268859|FG000|COMPLETED|Efficacy Assessment Period||0||
60144942|NCT01191255|76268860|FG001|COMPLETED|Efficacy Assessment Period||0||
59605716|NCT01965600|75715854|FG003|STARTED|Second Intervention||2||
60144943|NCT01191255|76268861|FG002|COMPLETED|Efficacy Assessment Period||70||
60144944|NCT01191255|76268862|FG003|COMPLETED|Efficacy Assessment Period||90||
60144945|NCT01191255|76268859|FG000|NOT COMPLETED|Efficacy Assessment Period||0||
60144946|NCT01191255|76268860|FG001|NOT COMPLETED|Efficacy Assessment Period||0||
60144947|NCT01191255|76268861|FG002|NOT COMPLETED|Efficacy Assessment Period||26||
60144948|NCT01191255|76268862|FG003|NOT COMPLETED|Efficacy Assessment Period||6||
60144949|NCT02078219|76268877|FG000|STARTED|Overall Study||41||
60144950|NCT02078219|76268878|FG001|STARTED|Overall Study||40||
60144951|NCT02078219|76268879|FG002|STARTED|Overall Study||41||
60144952|NCT02078219|76268880|FG003|STARTED|Overall Study||41||
60144953|NCT02078219|76268881|FG004|STARTED|Overall Study||41||
60144954|NCT02078219|76268877|FG000|COMPLETED|Overall Study||38||
60144955|NCT02078219|76268878|FG001|COMPLETED|Overall Study||36||
60144956|NCT02078219|76268879|FG002|COMPLETED|Overall Study||35||
60144957|NCT02078219|76268880|FG003|COMPLETED|Overall Study||37||
60144958|NCT02078219|76268881|FG004|COMPLETED|Overall Study||39||
60144959|NCT02078219|76268877|FG000|NOT COMPLETED|Overall Study||3||
60144960|NCT02078219|76268878|FG001|NOT COMPLETED|Overall Study||4||
60144961|NCT02078219|76268879|FG002|NOT COMPLETED|Overall Study||6||
60144962|NCT02078219|76268880|FG003|NOT COMPLETED|Overall Study||4||
60144963|NCT02078219|76268881|FG004|NOT COMPLETED|Overall Study||2||
60144964|NCT02075255|76268896|FG000|STARTED|Overall Study||72||
60144965|NCT02075255|76268897|FG001|STARTED|Overall Study||73||
60144966|NCT02075255|76268898|FG002|STARTED|Overall Study||75||
60144967|NCT02075255|76268896|FG000|COMPLETED|Overall Study||68||
60144968|NCT02075255|76268897|FG001|COMPLETED|Overall Study||69||
60144969|NCT02075255|76268898|FG002|COMPLETED|Overall Study||72||
60144970|NCT02075255|76268896|FG000|NOT COMPLETED|Overall Study||4||
60144971|NCT02075255|76268897|FG001|NOT COMPLETED|Overall Study||4||
60144972|NCT02075255|76268898|FG002|NOT COMPLETED|Overall Study||3||
60144973|NCT01191333|76268908|FG000|STARTED|Overall Study||81||
60144974|NCT01191333|76268909|FG001|STARTED|Overall Study||83||
60144975|NCT01191333|76268908|FG000|COMPLETED|Overall Study||60||
60144976|NCT01191333|76268909|FG001|COMPLETED|Overall Study||65||
60144977|NCT01191333|76268908|FG000|NOT COMPLETED|Overall Study||21||
60144978|NCT01191333|76268909|FG001|NOT COMPLETED|Overall Study||18||
60144979|NCT01191411|76268918|FG000|STARTED|Overall Study||1593||
60144980|NCT01191411|76268919|FG001|STARTED|Overall Study||479||
60144981|NCT01191411|76268920|FG002|STARTED|Overall Study||3898||
60144982|NCT01191411|76268918|FG000|COMPLETED|Overall Study||648||
60144983|NCT01191411|76268919|FG001|COMPLETED|Overall Study||118||
60144984|NCT01191411|76268920|FG002|COMPLETED|Overall Study||471||
60144985|NCT01191411|76268918|FG000|NOT COMPLETED|Overall Study||945||
60144986|NCT01191411|76268919|FG001|NOT COMPLETED|Overall Study||361||
60144987|NCT01191411|76268920|FG002|NOT COMPLETED|Overall Study||3427||
60144988|NCT01191723|76268928|FG000|STARTED|Overall Study||9||
60144989|NCT01191723|76268929|FG001|STARTED|Overall Study||9||
60144990|NCT01191723|76268930|FG002|STARTED|Overall Study||9||
60144991|NCT01191723|76268931|FG003|STARTED|Overall Study||9||
60144992|NCT01191723|76268932|FG004|STARTED|Overall Study||9||
60144993|NCT01191723|76268933|FG005|STARTED|Overall Study||9||
60144994|NCT01191723|76268928|FG000|COMPLETED|Overall Study||9||
60144995|NCT01191723|76268929|FG001|COMPLETED|Overall Study||9||
60144996|NCT01191723|76268930|FG002|COMPLETED|Overall Study||9||
60144997|NCT01191723|76268931|FG003|COMPLETED|Overall Study||9||
60144998|NCT01191723|76268932|FG004|COMPLETED|Overall Study||9||
60144999|NCT01191723|76268933|FG005|COMPLETED|Overall Study||9||
60145000|NCT01191723|76268928|FG000|NOT COMPLETED|Overall Study||0||
60145001|NCT01191723|76268929|FG001|NOT COMPLETED|Overall Study||0||
60145002|NCT01191723|76268930|FG002|NOT COMPLETED|Overall Study||0||
60145003|NCT01191723|76268931|FG003|NOT COMPLETED|Overall Study||0||
60145004|NCT01191723|76268932|FG004|NOT COMPLETED|Overall Study||0||
60145005|NCT01191723|76268933|FG005|NOT COMPLETED|Overall Study||0||
60145006|NCT01193049|76268942|FG000|STARTED|Period 1: Placebo Run-In||5||
60145007|NCT01193049|76268943|FG001|STARTED|Period 1: Placebo Run-In||6||
60145008|NCT01193049|76268942|FG000|COMPLETED|Period 1: Placebo Run-In||5||
60145009|NCT01193049|76268943|FG001|COMPLETED|Period 1: Placebo Run-In||6||
60145010|NCT01193049|76268942|FG000|NOT COMPLETED|Period 1: Placebo Run-In||0||
60145011|NCT01193049|76268943|FG001|NOT COMPLETED|Period 1: Placebo Run-In||0||
60145012|NCT01193049|76268942|FG000|STARTED|Washout 1 : 21 Day Washout||5||
60145013|NCT01193049|76268943|FG001|STARTED|Washout 1 : 21 Day Washout||6||
60145014|NCT01193049|76268942|FG000|COMPLETED|Washout 1 : 21 Day Washout||5||
60145015|NCT01193049|76268943|FG001|COMPLETED|Washout 1 : 21 Day Washout||6||
60145016|NCT01193049|76268942|FG000|NOT COMPLETED|Washout 1 : 21 Day Washout||0||
60145017|NCT01193049|76268943|FG001|NOT COMPLETED|Washout 1 : 21 Day Washout||0||
60145018|NCT01193049|76268942|FG000|STARTED|Period 2 : Double Blind Crossover||5||
60145019|NCT01193049|76268943|FG001|STARTED|Period 2 : Double Blind Crossover||6||
60145020|NCT01193049|76268942|FG000|COMPLETED|Period 2 : Double Blind Crossover||5||
60145021|NCT01193049|76268943|FG001|COMPLETED|Period 2 : Double Blind Crossover||6||
60145022|NCT01193049|76268942|FG000|NOT COMPLETED|Period 2 : Double Blind Crossover||0||
60145023|NCT01193049|76268943|FG001|NOT COMPLETED|Period 2 : Double Blind Crossover||0||
60145024|NCT01193049|76268942|FG000|STARTED|Washout 2 : 21 Day Washout||5||
60145025|NCT01193049|76268943|FG001|STARTED|Washout 2 : 21 Day Washout||6||
60145026|NCT01193049|76268942|FG000|COMPLETED|Washout 2 : 21 Day Washout||5||
60145027|NCT01193049|76268943|FG001|COMPLETED|Washout 2 : 21 Day Washout||6||
60145028|NCT01193049|76268942|FG000|NOT COMPLETED|Washout 2 : 21 Day Washout||0||
60145029|NCT01193049|76268943|FG001|NOT COMPLETED|Washout 2 : 21 Day Washout||0||
60145030|NCT01193049|76268942|FG000|STARTED|Period 3 : Double Blind Crossover||5||
60145031|NCT01193049|76268943|FG001|STARTED|Period 3 : Double Blind Crossover||6||
60145032|NCT01193049|76268942|FG000|COMPLETED|Period 3 : Double Blind Crossover||5||
60145033|NCT01193049|76268943|FG001|COMPLETED|Period 3 : Double Blind Crossover||6||
60145034|NCT01193049|76268942|FG000|NOT COMPLETED|Period 3 : Double Blind Crossover||0||
60145035|NCT01193049|76268943|FG001|NOT COMPLETED|Period 3 : Double Blind Crossover||0||
60145036|NCT01193907|76268953|FG000|STARTED|Overall Study||22||
60145037|NCT01193907|76268954|FG001|STARTED|Overall Study||22||
60145038|NCT01193907|76268955|FG002|STARTED|Overall Study||22||
60145039|NCT01193907|76268956|FG003|STARTED|Overall Study||22||
60145040|NCT01193907|76268953|FG000|COMPLETED|Overall Study||21||
60145041|NCT01193907|76268954|FG001|COMPLETED|Overall Study||22||
60145042|NCT01193907|76268955|FG002|COMPLETED|Overall Study||22||
60145043|NCT01193907|76268956|FG003|COMPLETED|Overall Study||21||
60145044|NCT01193907|76268953|FG000|NOT COMPLETED|Overall Study||1||
60145045|NCT01193907|76268954|FG001|NOT COMPLETED|Overall Study||0||
60145046|NCT01193907|76268955|FG002|NOT COMPLETED|Overall Study||0||
60145047|NCT01193907|76268956|FG003|NOT COMPLETED|Overall Study||1||
60145048|NCT01194297|76268968|FG000|STARTED|Overall Study||2||
60145049|NCT01194297|76268969|FG001|STARTED|Overall Study||1||
60145050|NCT01194297|76268968|FG000|COMPLETED|Overall Study||2||
60145051|NCT01194297|76268969|FG001|COMPLETED|Overall Study||1||
60145052|NCT01194297|76268968|FG000|NOT COMPLETED|Overall Study||0||
60145053|NCT01194297|76268969|FG001|NOT COMPLETED|Overall Study||0||
60145054|NCT01194453|76268977|FG000|STARTED|Overall Study||144||
60145055|NCT01194453|76268978|FG001|STARTED|Overall Study||144||
60145056|NCT01194453|76268977|FG000|COMPLETED|Overall Study||127||
60145057|NCT01194453|76268978|FG001|COMPLETED|Overall Study||127||
60145058|NCT01194453|76268977|FG000|NOT COMPLETED|Overall Study||17||
60145059|NCT01194453|76268978|FG001|NOT COMPLETED|Overall Study||17||
60145060|NCT01195467|76268984|FG000|STARTED|Overall Study||40||
60145061|NCT01195467|76268984|FG000|COMPLETED|Overall Study||30||
60145062|NCT01195467|76268984|FG000|NOT COMPLETED|Overall Study||10||
60145063|NCT01195701|76268990|FG000|STARTED|Overall Study||10||
60145064|NCT01195701|76268991|FG001|STARTED|Overall Study||25||
60145065|NCT01195701|76268990|FG000|COMPLETED|Overall Study||10||
60145066|NCT01195701|76268991|FG001|COMPLETED|Overall Study||20||
60145067|NCT01195701|76268990|FG000|NOT COMPLETED|Overall Study||0||
60145068|NCT01195701|76268991|FG001|NOT COMPLETED|Overall Study||5||
60145069|NCT01195779|76269011|FG000|STARTED|Overall Study||0||
60145070|NCT01195779|76269012|FG001|STARTED|Overall Study||0||
60145071|NCT01195779|76269013|FG002|STARTED|Overall Study||0||
60145072|NCT01195779|76269014|FG003|STARTED|Overall Study||0||
60145073|NCT01195779|76269015|FG004|STARTED|Overall Study||1||
60145074|NCT01195779|76269016|FG005|STARTED|Overall Study||0||
60145075|NCT01195779|76269017|FG006|STARTED|Overall Study||0||
60145076|NCT01195779|76269018|FG007|STARTED|Overall Study||1||
60145077|NCT01195779|76269019|FG008|STARTED|Overall Study||0||
60145078|NCT01195779|76269020|FG009|STARTED|Overall Study||0||
60145079|NCT01195779|76269021|FG010|STARTED|Overall Study||0||
60145080|NCT01195779|76269022|FG011|STARTED|Overall Study||1||
60145081|NCT01195779|76269023|FG012|STARTED|Overall Study||0||
59882016|NCT04011735|76004919|FG001|NOT COMPLETED|Overall Study||1||
59882017|NCT04011735|76004920|FG002|NOT COMPLETED|Overall Study||1||
59882018|NCT04009629|76004932|FG000|STARTED|Overall Study||23||
60145082|NCT01195779|76269024|FG013|STARTED|Overall Study||1||
60145083|NCT01195779|76269011|FG000|COMPLETED|Overall Study||0||
60145084|NCT01195779|76269012|FG001|COMPLETED|Overall Study||0||
60145085|NCT01195779|76269013|FG002|COMPLETED|Overall Study||0||
60145086|NCT01195779|76269014|FG003|COMPLETED|Overall Study||0||
60145087|NCT01195779|76269015|FG004|COMPLETED|Overall Study||1||
60145088|NCT01195779|76269016|FG005|COMPLETED|Overall Study||0||
60145089|NCT01195779|76269017|FG006|COMPLETED|Overall Study||0||
60145090|NCT01195779|76269018|FG007|COMPLETED|Overall Study||1||
60145091|NCT01195779|76269019|FG008|COMPLETED|Overall Study||0||
60145092|NCT01195779|76269020|FG009|COMPLETED|Overall Study||0||
60145093|NCT01195779|76269021|FG010|COMPLETED|Overall Study||0||
60145094|NCT01195779|76269022|FG011|COMPLETED|Overall Study||1||
60145095|NCT01195779|76269023|FG012|COMPLETED|Overall Study||0||
60145096|NCT01195779|76269024|FG013|COMPLETED|Overall Study||1||
60145097|NCT01195779|76269011|FG000|NOT COMPLETED|Overall Study||0||
60145098|NCT01195779|76269012|FG001|NOT COMPLETED|Overall Study||0||
60145099|NCT01195779|76269013|FG002|NOT COMPLETED|Overall Study||0||
60145100|NCT01195779|76269014|FG003|NOT COMPLETED|Overall Study||0||
60145101|NCT01195779|76269015|FG004|NOT COMPLETED|Overall Study||0||
60145102|NCT01195779|76269016|FG005|NOT COMPLETED|Overall Study||0||
60145103|NCT01195779|76269017|FG006|NOT COMPLETED|Overall Study||0||
60145104|NCT01195779|76269018|FG007|NOT COMPLETED|Overall Study||0||
59882019|NCT04009629|76004933|FG001|STARTED|Overall Study||38||
59882020|NCT04009629|76004932|FG000|COMPLETED|Overall Study||21||
59882021|NCT04009629|76004933|FG001|COMPLETED|Overall Study||38||
59882022|NCT04009629|76004932|FG000|NOT COMPLETED|Overall Study||2||
59882023|NCT04009629|76004933|FG001|NOT COMPLETED|Overall Study||0||
59882024|NCT03694197|76004942|FG000|STARTED|Overall Study||1385|Safety analysis set (SAF): all participants who received any study drug|
59882025|NCT03694197|76004942|FG000|COMPLETED|Overall Study||0|The study was terminated early by the Sponsor before any participants completed the originally planned treatment period of up to 192 weeks.|
59882026|NCT03694197|76004942|FG000|NOT COMPLETED|Overall Study||1385||
60010463|NCT03072602|76126127|FG000|COMPLETED|Overall Study||34|72 participants completed the study; 34 Blacks and 38 Whites|
60145105|NCT01195779|76269019|FG008|NOT COMPLETED|Overall Study||0||
60145106|NCT01195779|76269020|FG009|NOT COMPLETED|Overall Study||0||
59882027|NCT04365699|76004949|FG000|STARTED|Overall Study||10||
59882028|NCT04365699|76004950|FG001|STARTED|Overall Study||16||
59882029|NCT04365699|76004951|FG002|STARTED|Overall Study||55||
59882030|NCT04365699|76004949|FG000|COMPLETED|Overall Study||8||
59882031|NCT04365699|76004950|FG001|COMPLETED|Overall Study||11||
59882032|NCT04365699|76004951|FG002|COMPLETED|Overall Study||40||
59882033|NCT04365699|76004949|FG000|NOT COMPLETED|Overall Study||2||
59882034|NCT04365699|76004950|FG001|NOT COMPLETED|Overall Study||5||
59882035|NCT04365699|76004951|FG002|NOT COMPLETED|Overall Study||15||
60010464|NCT03072602|76126128|FG001|COMPLETED|Overall Study||38|72 participants completed the study; 34 Blacks and 38 Whites|
60010465|NCT03072602|76126127|FG000|NOT COMPLETED|Overall Study||5||
60145107|NCT01195779|76269021|FG010|NOT COMPLETED|Overall Study||0||
60145108|NCT01195779|76269022|FG011|NOT COMPLETED|Overall Study||0||
60145109|NCT01195779|76269023|FG012|NOT COMPLETED|Overall Study||0||
60145110|NCT01195779|76269024|FG013|NOT COMPLETED|Overall Study||0||
60145111|NCT01196793|76269054|FG000|STARTED|Overall Study||108||
60145112|NCT01196793|76269054|FG000|COMPLETED|Overall Study||108||
60145113|NCT01196793|76269054|FG000|NOT COMPLETED|Overall Study||0||
60145114|NCT01138917|76269058|FG000|STARTED|Overall Study||101||
60145115|NCT01138917|76269058|FG000|COMPLETED|Overall Study||77||
60145116|NCT01138917|76269058|FG000|NOT COMPLETED|Overall Study||24||
60145117|NCT02400671|76269069|FG000|STARTED|Overall Study||276||
60145118|NCT02400671|76269070|FG001|STARTED|Overall Study||271||
60145119|NCT02400671|76269071|FG002|STARTED|Overall Study||277||
60145120|NCT02400671|76269069|FG000|COMPLETED|Overall Study||249||
60145121|NCT02400671|76269070|FG001|COMPLETED|Overall Study||239||
60145122|NCT02400671|76269071|FG002|COMPLETED|Overall Study||249||
60145123|NCT02400671|76269069|FG000|NOT COMPLETED|Overall Study||27||
60145124|NCT02400671|76269070|FG001|NOT COMPLETED|Overall Study||32||
60145125|NCT02400671|76269071|FG002|NOT COMPLETED|Overall Study||28||
60145126|NCT00089999|76269081|FG000|STARTED|Overall Study||69||
60145127|NCT00089999|76269082|FG001|STARTED|Overall Study||69||
60145128|NCT00089999|76269081|FG000|COMPLETED|Overall Study||0||
59882036|NCT04005885|76004959|FG000|STARTED|First Intervention||26||
59882037|NCT04005885|76004960|FG001|STARTED|First Intervention||29||
60145129|NCT00089999|76269082|FG001|COMPLETED|Overall Study||0||
60145130|NCT00089999|76269081|FG000|NOT COMPLETED|Overall Study||69||
60145131|NCT00089999|76269082|FG001|NOT COMPLETED|Overall Study||69||
60145132|NCT00089843|76269093|FG000|STARTED|Overall Study||19||
60145133|NCT00089843|76269094|FG001|STARTED|Overall Study||20||
60145134|NCT00089843|76269095|FG002|STARTED|Overall Study||20||
60145135|NCT00089843|76269096|FG003|STARTED|Overall Study||18||
60145136|NCT00089843|76269093|FG000|COMPLETED|Overall Study||17||
60145137|NCT00089843|76269094|FG001|COMPLETED|Overall Study||16||
60145138|NCT00089843|76269095|FG002|COMPLETED|Overall Study||15||
60145139|NCT00089843|76269096|FG003|COMPLETED|Overall Study||11||
60145140|NCT00089843|76269093|FG000|NOT COMPLETED|Overall Study||2||
60145141|NCT00089843|76269094|FG001|NOT COMPLETED|Overall Study||4||
60145142|NCT00089843|76269095|FG002|NOT COMPLETED|Overall Study||5||
60145143|NCT00089843|76269096|FG003|NOT COMPLETED|Overall Study||7||
59605717|NCT01965600|75715851|FG000|COMPLETED|Second Intervention||4||
59605718|NCT01965600|75715852|FG001|COMPLETED|Second Intervention||4||
59605719|NCT01965600|75715853|FG002|COMPLETED|Second Intervention||1||
59605720|NCT01965600|75715854|FG003|COMPLETED|Second Intervention||0||
59605721|NCT01965600|75715851|FG000|NOT COMPLETED|Second Intervention||0||
59605722|NCT01965600|75715852|FG001|NOT COMPLETED|Second Intervention||0||
60145144|NCT00089297|76269106|FG000|STARTED|Overall Study||74||
60145145|NCT00089297|76269106|FG000|Treated|Overall Study||70||
60145146|NCT00089297|76269106|FG000|Eligible|Overall Study||63||
60145147|NCT00089297|76269106|FG000|COMPLETED|Overall Study||36||
60145148|NCT00089297|76269106|FG000|NOT COMPLETED|Overall Study||38||
60145149|NCT03483077|76269117|FG000|STARTED|Overall Study||12||
60145150|NCT03483077|76269118|FG001|STARTED|Overall Study||6||
60145151|NCT03483077|76269119|FG002|STARTED|Overall Study||6||
60145152|NCT03483077|76269120|FG003|STARTED|Overall Study||6||
60145153|NCT03483077|76269121|FG004|STARTED|Overall Study||6||
60145154|NCT03483077|76269122|FG005|STARTED|Overall Study||6||
60145155|NCT03483077|76269123|FG006|STARTED|Overall Study||6||
60145156|NCT03483077|76269117|FG000|COMPLETED|Overall Study||12||
60145157|NCT03483077|76269118|FG001|COMPLETED|Overall Study||6||
60145158|NCT03483077|76269119|FG002|COMPLETED|Overall Study||6||
60145159|NCT03483077|76269120|FG003|COMPLETED|Overall Study||6||
60145160|NCT03483077|76269121|FG004|COMPLETED|Overall Study||6||
60145161|NCT03483077|76269122|FG005|COMPLETED|Overall Study||6||
59751471|NCT00846027|75870794|FG000|Received Treatment|Overall Study||83||
59751472|NCT00846027|75870794|FG000|COMPLETED|Overall Study||0||
60145162|NCT03483077|76269123|FG006|COMPLETED|Overall Study||6||
60145163|NCT03483077|76269117|FG000|NOT COMPLETED|Overall Study||0||
60145164|NCT03483077|76269118|FG001|NOT COMPLETED|Overall Study||0||
60145165|NCT03483077|76269119|FG002|NOT COMPLETED|Overall Study||0||
60145166|NCT03483077|76269120|FG003|NOT COMPLETED|Overall Study||0||
60145167|NCT03483077|76269121|FG004|NOT COMPLETED|Overall Study||0||
60145168|NCT03483077|76269122|FG005|NOT COMPLETED|Overall Study||0||
60145169|NCT03483077|76269123|FG006|NOT COMPLETED|Overall Study||0||
60145170|NCT00088907|76269148|FG000|STARTED|Randomized Study (Step 1)||136||
60145171|NCT00088907|76269149|FG001|STARTED|Randomized Study (Step 1)||134||
60145172|NCT00088907|76269148|FG000|Treated|Randomized Study (Step 1)||129||
60145173|NCT00088907|76269149|FG001|Treated|Randomized Study (Step 1)||124||
60145174|NCT00088907|76269148|FG000|Eligible|Randomized Study (Step 1)||117||
60145175|NCT00088907|76269149|FG001|Eligible|Randomized Study (Step 1)||122||
60145176|NCT00088907|76269148|FG000|Eligible and Treated|Randomized Study (Step 1)||117||
60145177|NCT00088907|76269149|FG001|Eligible and Treated|Randomized Study (Step 1)||122||
60145178|NCT00088907|76269148|FG000|COMPLETED|Randomized Study (Step 1)|Treatment would continue until disease progression, no certain fixed number of cycles.|0||
60145179|NCT00088907|76269149|FG001|COMPLETED|Randomized Study (Step 1)|Treatment would continue until disease progression, no certain fixed number of cycles|0||
60145180|NCT00088907|76269148|FG000|NOT COMPLETED|Randomized Study (Step 1)||136||
60145181|NCT00088907|76269149|FG001|NOT COMPLETED|Randomized Study (Step 1)||134||
60145182|NCT00088907|76269148|FG000|STARTED|Single Gefitinib Treatment (Step 2)|Patients on Arm I could cross over to gefitinib after disease progression on step 1.|24||
60145183|NCT00088907|76269149|FG001|STARTED|Single Gefitinib Treatment (Step 2)|Cross over to single gefitinib therapy at progression was allowed for patients on Arm I only.|0||
60145184|NCT00088907|76269148|FG000|Treated|Single Gefitinib Treatment (Step 2)||19||
60145185|NCT00088907|76269149|FG001|Treated|Single Gefitinib Treatment (Step 2)||0||
60145186|NCT00088907|76269148|FG000|COMPLETED|Single Gefitinib Treatment (Step 2)||0||
60145187|NCT00088907|76269149|FG001|COMPLETED|Single Gefitinib Treatment (Step 2)||0||
60145188|NCT00088907|76269148|FG000|NOT COMPLETED|Single Gefitinib Treatment (Step 2)||24||
60145189|NCT00088907|76269149|FG001|NOT COMPLETED|Single Gefitinib Treatment (Step 2)||0||
60145190|NCT00088829|76269156|FG000|STARTED|Overall Study||22||
60145191|NCT00088829|76269156|FG000|COMPLETED|Overall Study||0||
59605723|NCT01965600|75715853|FG002|NOT COMPLETED|Second Intervention||2||
60145192|NCT00088829|76269156|FG000|NOT COMPLETED|Overall Study||22||
60145193|NCT00088595|76269160|FG000|STARTED|Overall Study||45||
60145194|NCT00088595|76269160|FG000|COMPLETED|Overall Study||17||
60145195|NCT00088595|76269160|FG000|NOT COMPLETED|Overall Study||28||
60145196|NCT00088205|76269174|FG000|STARTED|Overall Study||60||
60145197|NCT00088205|76269174|FG000|Received at Least 1 Dose of Study Drug|Overall Study||60||
60145198|NCT00088205|76269174|FG000|Efficacy Population|Overall Study|Participants with diagnosis of relapsed mantle cell lymphoma.|59||
60145199|NCT00088205|76269174|FG000|COMPLETED|Overall Study||0||
60145200|NCT00088205|76269174|FG000|NOT COMPLETED|Overall Study||60||
60145201|NCT01196871|76269184|FG000|STARTED|Stage 1: Period 1||5||
60145202|NCT01196871|76269185|FG001|STARTED|Stage 1: Period 1||3||
60145203|NCT01196871|76269186|FG002|STARTED|Stage 1: Period 1||4||
59605724|NCT01965600|75715854|FG003|NOT COMPLETED|Second Intervention||2||
60145204|NCT01196871|76269187|FG003|STARTED|Stage 1: Period 1|Zero participants noted since these participants started in Stage 2|0||
60145205|NCT01196871|76269188|FG004|STARTED|Stage 1: Period 1|Zero participants noted since these participants started in Stage 2|0||
60145206|NCT01196871|76269189|FG005|STARTED|Stage 1: Period 1|Zero participants noted since these participants started in Stage 2|0||
60145207|NCT01196871|76269184|FG000|PK Population|Stage 1: Period 1||5|Participants with evaluable PK data who successfully completed at least Period 1 and 2 in any stage|
60145208|NCT01196871|76269185|FG001|PK Population|Stage 1: Period 1||3|Participants with evaluable PK data who successfully completed at least Period 1 and 2 in any stage|
60145209|NCT01196871|76269186|FG002|PK Population|Stage 1: Period 1||4|Participants with evaluable PK data who successfully completed at least Period 1 and 2 in any stage|
60145210|NCT01196871|76269187|FG003|PK Population|Stage 1: Period 1||0|Participants with evaluable PK data who successfully completed at least Period 1 and 2 in any stage|
60145211|NCT01196871|76269188|FG004|PK Population|Stage 1: Period 1||0|Participants with evaluable PK data who successfully completed at least Period 1 and 2 in any stage|
60145212|NCT01196871|76269189|FG005|PK Population|Stage 1: Period 1||0|Participants with evaluable PK data who successfully completed at least Period 1 and 2 in any stage|
60145213|NCT01196871|76269184|FG000|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||5|Safety Population|
60145214|NCT01196871|76269185|FG001|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||3|Safety Population|
60145215|NCT01196871|76269186|FG002|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||4|Safety Population|
60145216|NCT01196871|76269187|FG003|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||0|Safety Population|
60145217|NCT01196871|76269188|FG004|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||0|Safety Population|
60145218|NCT01196871|76269189|FG005|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||0|Safety Population|
60145219|NCT01196871|76269184|FG000|COMPLETED|Stage 1: Period 1||5||
60145220|NCT01196871|76269185|FG001|COMPLETED|Stage 1: Period 1||3||
60145221|NCT01196871|76269186|FG002|COMPLETED|Stage 1: Period 1||4||
60145222|NCT01196871|76269187|FG003|COMPLETED|Stage 1: Period 1||0||
60145223|NCT01196871|76269188|FG004|COMPLETED|Stage 1: Period 1||0||
60145224|NCT01196871|76269189|FG005|COMPLETED|Stage 1: Period 1||0||
60145225|NCT01196871|76269184|FG000|NOT COMPLETED|Stage 1: Period 1||0||
60145226|NCT01196871|76269185|FG001|NOT COMPLETED|Stage 1: Period 1||0||
60145227|NCT01196871|76269186|FG002|NOT COMPLETED|Stage 1: Period 1||0||
60145228|NCT01196871|76269187|FG003|NOT COMPLETED|Stage 1: Period 1||0||
60145229|NCT01196871|76269188|FG004|NOT COMPLETED|Stage 1: Period 1||0||
60145230|NCT01196871|76269189|FG005|NOT COMPLETED|Stage 1: Period 1||0||
60145231|NCT01196871|76269184|FG000|STARTED|Stage 1: Period 2||5||
60145232|NCT01196871|76269185|FG001|STARTED|Stage 1: Period 2||3||
60145233|NCT01196871|76269186|FG002|STARTED|Stage 1: Period 2||4||
60145234|NCT01196871|76269187|FG003|STARTED|Stage 1: Period 2|Zero participants noted since these participants started in Stage 2|0||
60145235|NCT01196871|76269188|FG004|STARTED|Stage 1: Period 2|Zero participants noted since these participants started in Stage 2|0||
60145236|NCT01196871|76269189|FG005|STARTED|Stage 1: Period 2|Zero participants noted since these participants started in Stage 2|0||
60145237|NCT01196871|76269184|FG000|PK Population|Stage 1: Period 2||5|Participants with evaluable PK data who successfully completed at least Period 1 and 2 in any stage|
60145238|NCT01196871|76269185|FG001|PK Population|Stage 1: Period 2||3|Participants with evaluable PK data who successfully completed at least Period 1 and 2 in any stage|
60145239|NCT01196871|76269186|FG002|PK Population|Stage 1: Period 2||4|Participants with evaluable PK data who successfully completed at least Period 1 and 2 in any stage|
60145240|NCT01196871|76269187|FG003|PK Population|Stage 1: Period 2||0|Participants with evaluable PK data who successfully completed at least Period 1 and 2 in any stage|
60145241|NCT01196871|76269188|FG004|PK Population|Stage 1: Period 2||0|Participants with evaluable PK data who successfully completed at least Period 1 and 2 in any stage|
60145242|NCT01196871|76269189|FG005|PK Population|Stage 1: Period 2||0|Participants with evaluable PK data who successfully completed at least Period 1 and 2 in any stage|
60145243|NCT01196871|76269184|FG000|COMPLETED|Stage 1: Period 2||5||
60145244|NCT01196871|76269185|FG001|COMPLETED|Stage 1: Period 2||3||
60145245|NCT01196871|76269186|FG002|COMPLETED|Stage 1: Period 2||4||
60145246|NCT01196871|76269187|FG003|COMPLETED|Stage 1: Period 2||0||
60145247|NCT01196871|76269188|FG004|COMPLETED|Stage 1: Period 2||0||
60145248|NCT01196871|76269189|FG005|COMPLETED|Stage 1: Period 2||0||
60145249|NCT01196871|76269184|FG000|NOT COMPLETED|Stage 1: Period 2||0||
60145250|NCT01196871|76269185|FG001|NOT COMPLETED|Stage 1: Period 2||0||
60145251|NCT01196871|76269186|FG002|NOT COMPLETED|Stage 1: Period 2||0||
60145252|NCT01196871|76269187|FG003|NOT COMPLETED|Stage 1: Period 2||0||
60145253|NCT01196871|76269188|FG004|NOT COMPLETED|Stage 1: Period 2||0||
60145254|NCT01196871|76269189|FG005|NOT COMPLETED|Stage 1: Period 2||0||
60145255|NCT01196871|76269184|FG000|STARTED|Stage 1: Period 3||5||
60145256|NCT01196871|76269185|FG001|STARTED|Stage 1: Period 3||3||
60145257|NCT01196871|76269186|FG002|STARTED|Stage 1: Period 3||4||
60145258|NCT01196871|76269187|FG003|STARTED|Stage 1: Period 3|Zero participants noted since these participants started in Stage 2|0||
60145259|NCT01196871|76269188|FG004|STARTED|Stage 1: Period 3|Zero participants noted since these participants started in Stage 2|0||
60145260|NCT01196871|76269189|FG005|STARTED|Stage 1: Period 3|Zero participants noted since these participants started in Stage 2|0||
60145261|NCT01196871|76269184|FG000|COMPLETED|Stage 1: Period 3||5||
60145262|NCT01196871|76269185|FG001|COMPLETED|Stage 1: Period 3||3||
60145263|NCT01196871|76269186|FG002|COMPLETED|Stage 1: Period 3||4||
60145264|NCT01196871|76269187|FG003|COMPLETED|Stage 1: Period 3||0||
60145265|NCT01196871|76269188|FG004|COMPLETED|Stage 1: Period 3||0||
60145266|NCT01196871|76269189|FG005|COMPLETED|Stage 1: Period 3||0||
60145267|NCT01196871|76269184|FG000|NOT COMPLETED|Stage 1: Period 3||0||
60145268|NCT01196871|76269185|FG001|NOT COMPLETED|Stage 1: Period 3||0||
60145269|NCT01196871|76269186|FG002|NOT COMPLETED|Stage 1: Period 3||0||
60145270|NCT01196871|76269187|FG003|NOT COMPLETED|Stage 1: Period 3||0||
60145271|NCT01196871|76269188|FG004|NOT COMPLETED|Stage 1: Period 3||0||
60145272|NCT01196871|76269189|FG005|NOT COMPLETED|Stage 1: Period 3||0||
60145273|NCT01196871|76269184|FG000|STARTED|Stage 2: Period 1|Zero participants noted because participants had completed Stage 1|0||
60145274|NCT01196871|76269185|FG001|STARTED|Stage 2: Period 1|Zero participants noted because participants had completed Stage 1|0||
60145275|NCT01196871|76269186|FG002|STARTED|Stage 2: Period 1|Zero participants noted because participants had completed Stage 1|0||
60145276|NCT01196871|76269187|FG003|STARTED|Stage 2: Period 1|Both participants re-enrolled into Stage 2 after completing Stage 1|2||
60145277|NCT01196871|76269188|FG004|STARTED|Stage 2: Period 1|One participant re-enrolled into Stage 2 after completing Stage 1|5||
60145278|NCT01196871|76269189|FG005|STARTED|Stage 2: Period 1||4||
60145279|NCT01196871|76269184|FG000|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||0|Safety Population|
60145280|NCT01196871|76269185|FG001|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||0|Safety Population|
60145281|NCT01196871|76269186|FG002|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||0|Safety Population|
60145282|NCT01196871|76269187|FG003|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||2|Safety Population|
60145283|NCT01196871|76269188|FG004|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||5|Safety Population|
60145284|NCT01196871|76269189|FG005|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||4|Safety Population|
60145285|NCT01196871|76269184|FG000|PK Population|Stage 2: Period 1||0|Participants with evaluable PK data who successfully completed at least Period 1 and 2 in any stage|
60145286|NCT01196871|76269185|FG001|PK Population|Stage 2: Period 1||0|Participants with evaluable PK data who successfully completed at least Period 1 and 2 in any stage|
60145287|NCT01196871|76269186|FG002|PK Population|Stage 2: Period 1||0|Participants with evaluable PK data who successfully completed at least Period 1 and 2 in any stage|
60145288|NCT01196871|76269187|FG003|PK Population|Stage 2: Period 1||1|Participants with evaluable PK data who successfully completed at least Period 1 and 2 in any stage|
60145289|NCT01196871|76269188|FG004|PK Population|Stage 2: Period 1||5|Participants with evaluable PK data who successfully completed at least Period 1 and 2 in any stage|
60145290|NCT01196871|76269189|FG005|PK Population|Stage 2: Period 1||4|Participants with evaluable PK data who successfully completed at least Period 1 and 2 in any stage|
60145291|NCT01196871|76269184|FG000|COMPLETED|Stage 2: Period 1||0||
60145292|NCT01196871|76269185|FG001|COMPLETED|Stage 2: Period 1||0||
60145293|NCT01196871|76269186|FG002|COMPLETED|Stage 2: Period 1||0||
60145294|NCT01196871|76269187|FG003|COMPLETED|Stage 2: Period 1||2||
60145295|NCT01196871|76269188|FG004|COMPLETED|Stage 2: Period 1||5||
60145296|NCT01196871|76269189|FG005|COMPLETED|Stage 2: Period 1||4||
60145297|NCT01196871|76269184|FG000|NOT COMPLETED|Stage 2: Period 1||0||
60145298|NCT01196871|76269185|FG001|NOT COMPLETED|Stage 2: Period 1||0||
60145299|NCT01196871|76269186|FG002|NOT COMPLETED|Stage 2: Period 1||0||
60145300|NCT01196871|76269187|FG003|NOT COMPLETED|Stage 2: Period 1||0||
60145301|NCT01196871|76269188|FG004|NOT COMPLETED|Stage 2: Period 1||0||
60145302|NCT01196871|76269189|FG005|NOT COMPLETED|Stage 2: Period 1||0||
60145303|NCT01196871|76269184|FG000|STARTED|Stage 2: Period 2|Zero participants noted because participants had completed Stage 1|0||
60145304|NCT01196871|76269185|FG001|STARTED|Stage 2: Period 2|Zero participants noted because participants had completed Stage 1|0||
60145305|NCT01196871|76269186|FG002|STARTED|Stage 2: Period 2|Zero participants noted because participants had completed Stage 1|0||
60145306|NCT01196871|76269187|FG003|STARTED|Stage 2: Period 2|One participant switched agalsidase dose from 0.5 mg/kg in Period 1 to 1.0 mg/kg in Period 2|1||
60145307|NCT01196871|76269188|FG004|STARTED|Stage 2: Period 2|One participant switched agalsidase dose from 0.5 mg/kg in Period 1 to 1.0 mg/kg in Period 2|6||
60145308|NCT01196871|76269189|FG005|STARTED|Stage 2: Period 2||4||
60145309|NCT01196871|76269184|FG000|PK Population|Stage 2: Period 2||0|Participants with evaluable PK data who successfully completed at least Period 1 and 2 in any stage|
60145310|NCT01196871|76269185|FG001|PK Population|Stage 2: Period 2||0|Participants with evaluable PK data who successfully completed at least Period 1 and 2 in any stage|
60145311|NCT01196871|76269186|FG002|PK Population|Stage 2: Period 2||0|Participants with evaluable PK data who successfully completed at least Period 1 and 2 in any stage|
60145312|NCT01196871|76269187|FG003|PK Population|Stage 2: Period 2||1|Participants with evaluable PK data who successfully completed at least Period 1 and 2 in any stage|
60145313|NCT01196871|76269188|FG004|PK Population|Stage 2: Period 2||6|Participants with evaluable PK data who successfully completed at least Period 1 and 2 in any stage|
60145314|NCT01196871|76269189|FG005|PK Population|Stage 2: Period 2||4|Participants with evaluable PK data who successfully completed at least Period 1 and 2 in any stage|
60145315|NCT01196871|76269184|FG000|COMPLETED|Stage 2: Period 2||0||
60145316|NCT01196871|76269185|FG001|COMPLETED|Stage 2: Period 2||0||
60145317|NCT01196871|76269186|FG002|COMPLETED|Stage 2: Period 2||0||
60145318|NCT01196871|76269187|FG003|COMPLETED|Stage 2: Period 2||1||
60145319|NCT01196871|76269188|FG004|COMPLETED|Stage 2: Period 2||6||
60145320|NCT01196871|76269189|FG005|COMPLETED|Stage 2: Period 2||4||
60145321|NCT01196871|76269184|FG000|NOT COMPLETED|Stage 2: Period 2||0||
60145322|NCT01196871|76269185|FG001|NOT COMPLETED|Stage 2: Period 2||0||
60145323|NCT01196871|76269186|FG002|NOT COMPLETED|Stage 2: Period 2||0||
59882038|NCT04005885|76004959|FG000|COMPLETED|First Intervention||25||
60010466|NCT03072602|76126128|FG001|NOT COMPLETED|Overall Study||4||
60010467|NCT02935543|76126136|FG000|STARTED|Overall Study||1||
60010468|NCT02935543|76126136|FG000|COMPLETED|Overall Study||1||
60010469|NCT02935543|76126136|FG000|NOT COMPLETED|Overall Study||0||
60010470|NCT02924727|76126142|FG000|STARTED|Overall Study||2834|All randomized patients (RAN)|
60010471|NCT02924727|76126143|FG001|STARTED|Overall Study||2835|All randomized patients (RAN)|
60010472|NCT02924727|76126142|FG000|Full Analysis Set (FAS)|Overall Study||2830|All patients in the RAN population who were not mis-randomized patients (who were not qualified for randomization and who did not take study drug, but were inadvertently randomized into the study).|
60010473|NCT02924727|76126143|FG001|Full Analysis Set (FAS)|Overall Study||2831|All patients in the RAN population who were not mis-randomized patients (who were not qualified for randomization and who did not take study drug, but were inadvertently randomized into the study).|
60010474|NCT02924727|76126142|FG000|Safety Set (SAF)|Overall Study||2820|All randomized patients who received at least one dose of study drug.|
60010475|NCT02924727|76126143|FG001|Safety Set (SAF)|Overall Study||2816|All randomized patients who received at least one dose of study drug.|
60010476|NCT02924727|76126142|FG000|COMPLETED|Overall Study||2605||
60010477|NCT02924727|76126143|FG001|COMPLETED|Overall Study||2576||
60010478|NCT02924727|76126142|FG000|NOT COMPLETED|Overall Study||229||
60010479|NCT02924727|76126143|FG001|NOT COMPLETED|Overall Study||259||
60010480|NCT02901626|76126153|FG000|STARTED|Overall Study||280||
60010481|NCT02901626|76126154|FG001|STARTED|Overall Study||264||
60010482|NCT02901626|76126153|FG000|COMPLETED|Overall Study||279||
60010483|NCT02901626|76126154|FG001|COMPLETED|Overall Study||263||
60010484|NCT02901626|76126153|FG000|NOT COMPLETED|Overall Study||1||
60010485|NCT02901626|76126154|FG001|NOT COMPLETED|Overall Study||1||
60010486|NCT02808507|76126167|FG000|STARTED|Overall Study||1929||
60010487|NCT02808507|76126168|FG001|STARTED|Overall Study||1413||
60010488|NCT02808507|76126169|FG002|STARTED|Overall Study||1510||
60010489|NCT02808507|76126167|FG000|COMPLETED|Overall Study||1929||
60010490|NCT02808507|76126168|FG001|COMPLETED|Overall Study||1413||
60010491|NCT02808507|76126169|FG002|COMPLETED|Overall Study||1510||
60010492|NCT02808507|76126167|FG000|NOT COMPLETED|Overall Study||0||
60010493|NCT02808507|76126168|FG001|NOT COMPLETED|Overall Study||0||
60010494|NCT02808507|76126169|FG002|NOT COMPLETED|Overall Study||0||
60010495|NCT02798523|76126180|FG000|STARTED|2 Hour or 4 Hour Post Infusion||4||
60010496|NCT02798523|76126181|FG001|STARTED|2 Hour or 4 Hour Post Infusion||21||
60010497|NCT02798523|76126180|FG000|COMPLETED|2 Hour or 4 Hour Post Infusion||4||
60010498|NCT02798523|76126181|FG001|COMPLETED|2 Hour or 4 Hour Post Infusion||21||
60010499|NCT02798523|76126180|FG000|NOT COMPLETED|2 Hour or 4 Hour Post Infusion||0||
60010500|NCT02798523|76126181|FG001|NOT COMPLETED|2 Hour or 4 Hour Post Infusion||0||
60010501|NCT02798523|76126180|FG000|STARTED|4 Hours Then 2 Hours Post Infusion||0||
60010502|NCT02798523|76126181|FG001|STARTED|4 Hours Then 2 Hours Post Infusion|One subject from the 4-hour post infusion arm also participated in the 2-hour post infusion arm|1||
60010503|NCT02798523|76126180|FG000|COMPLETED|4 Hours Then 2 Hours Post Infusion||0||
59518902|NCT03537664|75612775|FG000|NOT COMPLETED|Overall Study||0||
59882039|NCT04005885|76004960|FG001|COMPLETED|First Intervention||28||
59882040|NCT04005885|76004959|FG000|NOT COMPLETED|First Intervention||1||
59882041|NCT04005885|76004960|FG001|NOT COMPLETED|First Intervention||1||
59882042|NCT04005885|76004959|FG000|STARTED|Second Intervention||25||
59882043|NCT04005885|76004960|FG001|STARTED|Second Intervention||28||
59882044|NCT04005885|76004959|FG000|COMPLETED|Second Intervention||25||
59882045|NCT04005885|76004960|FG001|COMPLETED|Second Intervention||26||
59882046|NCT04005885|76004959|FG000|NOT COMPLETED|Second Intervention||0||
60010504|NCT02798523|76126181|FG001|COMPLETED|4 Hours Then 2 Hours Post Infusion||1||
60010505|NCT02798523|76126180|FG000|NOT COMPLETED|4 Hours Then 2 Hours Post Infusion||0||
60010506|NCT02798523|76126181|FG001|NOT COMPLETED|4 Hours Then 2 Hours Post Infusion||0||
60010507|NCT02766582|76126187|FG000|STARTED|Overall Study||29||
60010508|NCT02766582|76126187|FG000|COMPLETED|Overall Study||29||
60010509|NCT02766582|76126187|FG000|NOT COMPLETED|Overall Study||0||
60010510|NCT02720692|76126193|FG000|STARTED|Overall Study||539||
60010511|NCT02720692|76126194|FG001|STARTED|Overall Study||183||
60010512|NCT02720692|76126193|FG000|Treated|Overall Study||538||
59518903|NCT03537664|75612776|FG001|NOT COMPLETED|Overall Study||0||
60145324|NCT01196871|76269187|FG003|NOT COMPLETED|Stage 2: Period 2||0||
60145325|NCT01196871|76269188|FG004|NOT COMPLETED|Stage 2: Period 2||0||
60145326|NCT01196871|76269189|FG005|NOT COMPLETED|Stage 2: Period 2||0||
60145327|NCT01138995|76269214|FG000|STARTED|Overall Study||98||
60145328|NCT01138995|76269215|FG001|STARTED|Overall Study||99||
60145329|NCT01138995|76269214|FG000|COMPLETED|Overall Study||88||
60145330|NCT01138995|76269215|FG001|COMPLETED|Overall Study||74||
60145331|NCT01138995|76269214|FG000|NOT COMPLETED|Overall Study||10||
60145332|NCT01138995|76269215|FG001|NOT COMPLETED|Overall Study||25||
60145333|NCT01197495|76269224|FG000|STARTED|Overall Study||157||
60145334|NCT01197495|76269225|FG001|STARTED|Overall Study||56||
60145335|NCT01197495|76269224|FG000|COMPLETED|Overall Study||144||
60145336|NCT01197495|76269225|FG001|COMPLETED|Overall Study||49||
60145337|NCT01197495|76269224|FG000|NOT COMPLETED|Overall Study||13||
60145338|NCT01197495|76269225|FG001|NOT COMPLETED|Overall Study||7||
60145339|NCT01197573|76269235|FG000|STARTED|Overall Study||33||
60145340|NCT01197573|76269236|FG001|STARTED|Overall Study||46||
60145341|NCT01197573|76269237|FG002|STARTED|Overall Study||12||
60145342|NCT01197573|76269238|FG003|STARTED|Overall Study||12||
60145343|NCT01197573|76269235|FG000|COMPLETED|Overall Study||33||
60145344|NCT01197573|76269236|FG001|COMPLETED|Overall Study||46||
60145345|NCT01197573|76269237|FG002|COMPLETED|Overall Study||12||
60145346|NCT01197573|76269238|FG003|COMPLETED|Overall Study||12||
60145347|NCT01197573|76269235|FG000|NOT COMPLETED|Overall Study||0||
60145348|NCT01197573|76269236|FG001|NOT COMPLETED|Overall Study||0||
60145349|NCT01197573|76269237|FG002|NOT COMPLETED|Overall Study||0||
60145350|NCT01197573|76269238|FG003|NOT COMPLETED|Overall Study||0||
60145351|NCT01201629|76269250|FG000|STARTED|Overall Study||8|Study started in 9/16/2010|
60145352|NCT01201629|76269251|FG001|STARTED|Overall Study||8|Study started in 9/16/2010|
60145353|NCT01201629|76269250|FG000|COMPLETED|Overall Study||8|Study terminated in 12/2015|
60145354|NCT01201629|76269251|FG001|COMPLETED|Overall Study||8|Study terminated in 12/2015|
60145355|NCT01201629|76269250|FG000|NOT COMPLETED|Overall Study||0||
60145356|NCT01201629|76269251|FG001|NOT COMPLETED|Overall Study||0||
60145357|NCT02185131|76269259|FG000|STARTED|Overall Study||7||
60145358|NCT02185131|76269260|FG001|STARTED|Overall Study||9||
60145359|NCT02185131|76269259|FG000|COMPLETED|Overall Study||6||
60145360|NCT02185131|76269260|FG001|COMPLETED|Overall Study||8||
60145361|NCT02185131|76269259|FG000|NOT COMPLETED|Overall Study||1||
60145362|NCT02185131|76269260|FG001|NOT COMPLETED|Overall Study||1||
60145363|NCT00085709|76269268|FG000|STARTED|Overall Study||317||
60145364|NCT00085709|76269269|FG001|STARTED|Overall Study||320||
60145365|NCT00085709|76269268|FG000|Eligible|Overall Study||298||
60145366|NCT00085709|76269269|FG001|Eligible|Overall Study||301||
60145367|NCT00085709|76269268|FG000|Eligible and Did Not Withdraw Consent|Overall Study||296||
60145368|NCT00085709|76269269|FG001|Eligible and Did Not Withdraw Consent|Overall Study||300||
60145369|NCT00085709|76269268|FG000|COMPLETED|Overall Study||264||
60145370|NCT00085709|76269269|FG001|COMPLETED|Overall Study||270||
60145371|NCT00085709|76269268|FG000|NOT COMPLETED|Overall Study||53||
60145372|NCT00085709|76269269|FG001|NOT COMPLETED|Overall Study||50||
60145373|NCT01201863|76269286|FG000|STARTED|Overall Study||12||
60145374|NCT01201863|76269287|FG001|STARTED|Overall Study||10||
60145375|NCT01201863|76269288|FG002|STARTED|Overall Study||24||
60145376|NCT01201863|76269286|FG000|COMPLETED|Overall Study||11||
60145377|NCT01201863|76269287|FG001|COMPLETED|Overall Study||6||
60145378|NCT01201863|76269288|FG002|COMPLETED|Overall Study||18||
60145379|NCT01201863|76269286|FG000|NOT COMPLETED|Overall Study||1||
60145380|NCT01201863|76269287|FG001|NOT COMPLETED|Overall Study||4||
60145381|NCT01201863|76269288|FG002|NOT COMPLETED|Overall Study||6||
60145382|NCT01202253|76269296|FG000|STARTED|Overall Study||50||
60145383|NCT01202253|76269296|FG000|COMPLETED|Overall Study||50||
60145384|NCT01202253|76269296|FG000|NOT COMPLETED|Overall Study||0||
60145385|NCT01202565|76269300|FG000|STARTED|Overall Study||506||
60145386|NCT01202565|76269300|FG000|Full Analysis Set|Overall Study|Participants with a signed informed consent and any available data regarding adalimumab treatment.|501||
60145387|NCT01202565|76269300|FG000|COMPLETED|Overall Study|Indicates participants who completed the Month 12 visit|439||
60145388|NCT01202565|76269300|FG000|NOT COMPLETED|Overall Study||67||
60145389|NCT00085631|76269304|FG000|STARTED|Overall Study||13||
60145390|NCT00085631|76269305|FG001|STARTED|Overall Study||49||
60145391|NCT00085631|76269306|FG002|STARTED|Overall Study||39||
60145392|NCT00085631|76269304|FG000|COMPLETED|Overall Study||9||
60145393|NCT00085631|76269305|FG001|COMPLETED|Overall Study||38||
60145394|NCT00085631|76269306|FG002|COMPLETED|Overall Study||32||
60145395|NCT00085631|76269304|FG000|NOT COMPLETED|Overall Study||4||
60145396|NCT00085631|76269305|FG001|NOT COMPLETED|Overall Study||11||
60145397|NCT00085631|76269306|FG002|NOT COMPLETED|Overall Study||7||
60145398|NCT01141491|76269315|FG000|STARTED|Overall Study||68||
60145399|NCT01141491|76269316|FG001|STARTED|Overall Study||68||
60145400|NCT01141491|76269315|FG000|COMPLETED|Overall Study||20||
60145401|NCT01141491|76269316|FG001|COMPLETED|Overall Study||21||
60145402|NCT01141491|76269315|FG000|NOT COMPLETED|Overall Study||48||
60145403|NCT01141491|76269316|FG001|NOT COMPLETED|Overall Study||47||
60145404|NCT00084929|76269322|FG000|STARTED|Overall Study||2600||
60145405|NCT00084929|76269322|FG000|COMPLETED|Overall Study||2531||
60145406|NCT00084929|76269322|FG000|NOT COMPLETED|Overall Study||69||
60145407|NCT01141569|76269330|FG000|STARTED|Overall Study||12||
60145408|NCT01141569|76269330|FG000|COMPLETED|Overall Study||12||
60145409|NCT01141569|76269330|FG000|NOT COMPLETED|Overall Study||0||
60145410|NCT01141647|76269334|FG000|STARTED|Overall Study||213||
60145411|NCT01141647|76269334|FG000|COMPLETED|Overall Study||167||
60145412|NCT01141647|76269334|FG000|NOT COMPLETED|Overall Study||46||
60145413|NCT01202643|76269345|FG000|STARTED|Period 1||6||
60145414|NCT01202643|76269346|FG001|STARTED|Period 1||6||
60145415|NCT01202643|76269345|FG000|COMPLETED|Period 1||6||
60145416|NCT01202643|76269346|FG001|COMPLETED|Period 1||6||
60145417|NCT01202643|76269345|FG000|NOT COMPLETED|Period 1||0||
60145418|NCT01202643|76269346|FG001|NOT COMPLETED|Period 1||0||
60145419|NCT01202643|76269345|FG000|STARTED|Crossover Cycle|One patient became pregnant following Period 1, Only one non-pregnant chose to cycle again|1|Patients were invited to the crossover but most chose not to continue in the study|
60145420|NCT01202643|76269346|FG001|STARTED|Crossover Cycle|Three patients became pregnant after Period 1, 1 patient chose not to cycle again|2|Patients were invited to the crossover but most chose not to continue in the study|
60145421|NCT01202643|76269345|FG000|COMPLETED|Crossover Cycle||1||
60145422|NCT01202643|76269346|FG001|COMPLETED|Crossover Cycle||2||
60145423|NCT01202643|76269345|FG000|NOT COMPLETED|Crossover Cycle||0||
60145424|NCT01202643|76269346|FG001|NOT COMPLETED|Crossover Cycle||0||
60145425|NCT01141725|76269352|FG000|STARTED|Overall Study||3||
60145426|NCT01141725|76269353|FG001|STARTED|Overall Study||33||
60145427|NCT01141725|76269354|FG002|STARTED|Overall Study||3||
60145428|NCT01141725|76269352|FG000|COMPLETED|Overall Study||3||
60145429|NCT01141725|76269353|FG001|COMPLETED|Overall Study||33||
60145430|NCT01141725|76269354|FG002|COMPLETED|Overall Study||3||
60145431|NCT01141725|76269352|FG000|NOT COMPLETED|Overall Study||0||
60145432|NCT01141725|76269353|FG001|NOT COMPLETED|Overall Study||0||
60145433|NCT01141725|76269354|FG002|NOT COMPLETED|Overall Study||0||
60145434|NCT01202721|76269365|FG000|STARTED|Overall Study||18||
60145435|NCT01202721|76269366|FG001|STARTED|Overall Study||26||
60145436|NCT01202721|76269367|FG002|STARTED|Overall Study||14||
60145437|NCT01202721|76269368|FG003|STARTED|Overall Study||27||
60145438|NCT01202721|76269365|FG000|COMPLETED|Overall Study||18||
60145439|NCT01202721|76269366|FG001|COMPLETED|Overall Study||26||
60145440|NCT01202721|76269367|FG002|COMPLETED|Overall Study||14||
60145441|NCT01202721|76269368|FG003|COMPLETED|Overall Study||27||
60145442|NCT01202721|76269365|FG000|NOT COMPLETED|Overall Study||0||
60145443|NCT01202721|76269366|FG001|NOT COMPLETED|Overall Study||0||
60145444|NCT01202721|76269367|FG002|NOT COMPLETED|Overall Study||0||
60145445|NCT01202721|76269368|FG003|NOT COMPLETED|Overall Study||0||
60145446|NCT00084617|76269380|FG000|STARTED|Overall Study||39||
60145447|NCT00084617|76269380|FG000|COMPLETED|Overall Study||30||
60145448|NCT00084617|76269380|FG000|NOT COMPLETED|Overall Study||9||
60145449|NCT01203189|76269387|FG000|STARTED|First 4 Weeks Treatment||10||
60145450|NCT01203189|76269388|FG001|STARTED|First 4 Weeks Treatment||10||
60145451|NCT01203189|76269389|FG002|STARTED|First 4 Weeks Treatment||3||
60145452|NCT01203189|76269387|FG000|COMPLETED|First 4 Weeks Treatment||8||
60145453|NCT01203189|76269388|FG001|COMPLETED|First 4 Weeks Treatment||8||
60145454|NCT01203189|76269389|FG002|COMPLETED|First 4 Weeks Treatment||3||
60145455|NCT01203189|76269387|FG000|NOT COMPLETED|First 4 Weeks Treatment||2||
60145456|NCT01203189|76269388|FG001|NOT COMPLETED|First 4 Weeks Treatment||2||
60145457|NCT01203189|76269389|FG002|NOT COMPLETED|First 4 Weeks Treatment||0||
60145458|NCT01203189|76269387|FG000|STARTED|Cross Over Period 4 Weeks Treatment||0||
60145459|NCT01203189|76269388|FG001|STARTED|Cross Over Period 4 Weeks Treatment||0||
60145460|NCT01203189|76269389|FG002|STARTED|Cross Over Period 4 Weeks Treatment||3||
60145461|NCT01203189|76269387|FG000|COMPLETED|Cross Over Period 4 Weeks Treatment||0||
60145462|NCT01203189|76269388|FG001|COMPLETED|Cross Over Period 4 Weeks Treatment||0||
60145463|NCT01203189|76269389|FG002|COMPLETED|Cross Over Period 4 Weeks Treatment||3||
60145464|NCT01203189|76269387|FG000|NOT COMPLETED|Cross Over Period 4 Weeks Treatment||0||
60145465|NCT01203189|76269388|FG001|NOT COMPLETED|Cross Over Period 4 Weeks Treatment||0||
60145466|NCT01203189|76269389|FG002|NOT COMPLETED|Cross Over Period 4 Weeks Treatment||0||
60145467|NCT01204203|76269397|FG000|STARTED|Overall Study||8||
60145468|NCT01204203|76269397|FG000|COMPLETED|Overall Study||8||
60145469|NCT01204203|76269397|FG000|NOT COMPLETED|Overall Study||0||
60145470|NCT01206387|76269403|FG000|STARTED|Overall Study||60||
60145471|NCT01206387|76269404|FG001|STARTED|Overall Study||60||
60145472|NCT01206387|76269403|FG000|COMPLETED|Overall Study||59||
60145473|NCT01206387|76269404|FG001|COMPLETED|Overall Study||60||
60145474|NCT01206387|76269403|FG000|NOT COMPLETED|Overall Study||1||
60145475|NCT01206387|76269404|FG001|NOT COMPLETED|Overall Study||0||
60145476|NCT01207401|76269412|FG000|STARTED|Overall Study||26||
60145477|NCT01207401|76269413|FG001|STARTED|Overall Study||24||
60145478|NCT01207401|76269412|FG000|COMPLETED|Overall Study||26||
60145479|NCT01207401|76269413|FG001|COMPLETED|Overall Study||24||
60145480|NCT01207401|76269412|FG000|NOT COMPLETED|Overall Study||0||
60145481|NCT01207401|76269413|FG001|NOT COMPLETED|Overall Study||0||
60145482|NCT01209195|76269421|FG000|STARTED|Overall Study||7||
60145483|NCT01209195|76269422|FG001|STARTED|Overall Study||3||
60145484|NCT01209195|76269423|FG002|STARTED|Overall Study||6||
60145485|NCT01209195|76269424|FG003|STARTED|Overall Study||6||
60145486|NCT01209195|76269425|FG004|STARTED|Overall Study||6||
60145487|NCT01209195|76269426|FG005|STARTED|Overall Study||13||
60145488|NCT01209195|76269421|FG000|COMPLETED|Overall Study||7||
60145489|NCT01209195|76269422|FG001|COMPLETED|Overall Study||3||
60145490|NCT01209195|76269423|FG002|COMPLETED|Overall Study||6||
60145491|NCT01209195|76269424|FG003|COMPLETED|Overall Study||6||
60145492|NCT01209195|76269425|FG004|COMPLETED|Overall Study||6||
60145493|NCT01209195|76269426|FG005|COMPLETED|Overall Study||13||
60145494|NCT01209195|76269421|FG000|NOT COMPLETED|Overall Study||0||
60145495|NCT01209195|76269422|FG001|NOT COMPLETED|Overall Study||0||
60145496|NCT01209195|76269423|FG002|NOT COMPLETED|Overall Study||0||
60145497|NCT01209195|76269424|FG003|NOT COMPLETED|Overall Study||0||
60145498|NCT01209195|76269425|FG004|NOT COMPLETED|Overall Study||0||
60145499|NCT01209195|76269426|FG005|NOT COMPLETED|Overall Study||0||
60145500|NCT01144143|76269445|FG000|STARTED|Overall Study||8||
60145501|NCT01144143|76269446|FG001|STARTED|Overall Study||4||
60145502|NCT01144143|76269447|FG002|STARTED|Overall Study||4||
60145503|NCT01144143|76269445|FG000|COMPLETED|Overall Study||8||
60145504|NCT01144143|76269446|FG001|COMPLETED|Overall Study||4||
60145505|NCT01144143|76269447|FG002|COMPLETED|Overall Study||4||
60145506|NCT01144143|76269445|FG000|NOT COMPLETED|Overall Study||0||
60145507|NCT01144143|76269446|FG001|NOT COMPLETED|Overall Study||0||
60145508|NCT01144143|76269447|FG002|NOT COMPLETED|Overall Study||0||
60145509|NCT01212471|76269462|FG000|STARTED|Overall Study||141||
60145510|NCT01212471|76269463|FG001|STARTED|Overall Study||140||
60145511|NCT01212471|76269464|FG002|STARTED|Overall Study||139||
60145512|NCT01212471|76269462|FG000|COMPLETED|Overall Study||139||
60145513|NCT01212471|76269463|FG001|COMPLETED|Overall Study||137||
60145514|NCT01212471|76269464|FG002|COMPLETED|Overall Study||132||
60145515|NCT01212471|76269462|FG000|NOT COMPLETED|Overall Study||2||
60145516|NCT01212471|76269463|FG001|NOT COMPLETED|Overall Study||3||
60145517|NCT01212471|76269464|FG002|NOT COMPLETED|Overall Study||7||
60145518|NCT00083915|76269474|FG000|STARTED|Overall Study||52||
60145519|NCT00083915|76269475|FG001|STARTED|Overall Study||45||
60145520|NCT00083915|76269474|FG000|COMPLETED|Overall Study||2||
60145521|NCT00083915|76269475|FG001|COMPLETED|Overall Study||8||
60145522|NCT00083915|76269474|FG000|NOT COMPLETED|Overall Study||50||
60145523|NCT00083915|76269475|FG001|NOT COMPLETED|Overall Study||37||
60145524|NCT01144455|76269484|FG000|STARTED|Overall Study||69||
60145525|NCT01144455|76269485|FG001|STARTED|Overall Study||71||
60145526|NCT01144455|76269486|FG002|STARTED|Overall Study||74||
60145527|NCT01144455|76269484|FG000|COMPLETED|Overall Study||19||
60145528|NCT01144455|76269485|FG001|COMPLETED|Overall Study||29||
60145529|NCT01144455|76269486|FG002|COMPLETED|Overall Study||38||
60145530|NCT01144455|76269484|FG000|NOT COMPLETED|Overall Study||50||
60145531|NCT01144455|76269485|FG001|NOT COMPLETED|Overall Study||42||
60145532|NCT01144455|76269486|FG002|NOT COMPLETED|Overall Study||36||
60145533|NCT01212627|76269494|FG000|STARTED|Overall Study||12||
60145534|NCT01212627|76269494|FG000|COMPLETED|Overall Study||12||
60145535|NCT01212627|76269494|FG000|NOT COMPLETED|Overall Study||0||
59605725|NCT01996332|75715862|FG000|STARTED|Overall Study||1805||
59605726|NCT01996332|75715862|FG000|COMPLETED|Overall Study||0||
59605727|NCT01996332|75715862|FG000|NOT COMPLETED|Overall Study||1805||
60145536|NCT03392753|76269500|FG000|STARTED|Overall Study||83||
60145537|NCT03392753|76269501|FG001|STARTED|Overall Study||84||
60145538|NCT03392753|76269500|FG000|COMPLETED|Overall Study||47||
60145539|NCT03392753|76269501|FG001|COMPLETED|Overall Study||50||
60145540|NCT03392753|76269500|FG000|NOT COMPLETED|Overall Study||36||
60145541|NCT03392753|76269501|FG001|NOT COMPLETED|Overall Study||34||
60145542|NCT01145001|76269511|FG000|STARTED|Overall Study||36||
60145543|NCT01145001|76269512|FG001|STARTED|Overall Study||37||
59605728|NCT01996254|75715868|FG000|STARTED|Overall Study||5||
60145544|NCT01145001|76269513|FG002|STARTED|Overall Study||44||
60145545|NCT01145001|76269514|FG003|STARTED|Overall Study||37||
60145546|NCT01145001|76269511|FG000|COMPLETED|Overall Study||28||
60145547|NCT01145001|76269512|FG001|COMPLETED|Overall Study||31||
60145548|NCT01145001|76269513|FG002|COMPLETED|Overall Study||39||
60145549|NCT01145001|76269514|FG003|COMPLETED|Overall Study||31||
59605729|NCT01996254|75715869|FG001|STARTED|Overall Study||14||
59605730|NCT01996254|75715870|FG002|STARTED|Overall Study||14||
59605731|NCT01996254|75715868|FG000|Safety Set|Overall Study||5|All subjects that underwent Lead placement|
59605732|NCT01996254|75715869|FG001|Safety Set|Overall Study||14|All subjects that underwent Lead placement|
59751473|NCT00846027|75870794|FG000|NOT COMPLETED|Overall Study||90||
60145550|NCT01145001|76269511|FG000|NOT COMPLETED|Overall Study||8||
60145551|NCT01145001|76269512|FG001|NOT COMPLETED|Overall Study||6||
60145552|NCT01145001|76269513|FG002|NOT COMPLETED|Overall Study||5||
60145553|NCT01145001|76269514|FG003|NOT COMPLETED|Overall Study||6||
60145554|NCT01214109|76269524|FG000|STARTED|Overall Study||24||
60145555|NCT01214109|76269525|FG001|STARTED|Overall Study||24||
60145556|NCT01214109|76269526|FG002|STARTED|Overall Study||24||
60145557|NCT01214109|76269527|FG003|STARTED|Overall Study||24||
60145558|NCT01214109|76269524|FG000|COMPLETED|Overall Study||24||
59751474|NCT00646399|75870800|FG000|STARTED|Overall Study||792||
60145559|NCT01214109|76269525|FG001|COMPLETED|Overall Study||24||
60145560|NCT01214109|76269526|FG002|COMPLETED|Overall Study||24||
60145561|NCT01214109|76269527|FG003|COMPLETED|Overall Study||24||
60145562|NCT01214109|76269524|FG000|NOT COMPLETED|Overall Study||0||
60145563|NCT01214109|76269525|FG001|NOT COMPLETED|Overall Study||0||
60145564|NCT01214109|76269526|FG002|NOT COMPLETED|Overall Study||0||
60145565|NCT01214109|76269527|FG003|NOT COMPLETED|Overall Study||0||
60145566|NCT01145391|76269542|FG000|STARTED|Overall Study||293||
60145567|NCT01145391|76269543|FG001|STARTED|Overall Study||298||
60145568|NCT01145391|76269542|FG000|9 Months Post-randomization|Overall Study||293||
60145569|NCT01145391|76269543|FG001|9 Months Post-randomization|Overall Study||298||
60145570|NCT01145391|76269542|FG000|COMPLETED|Overall Study||293||
60145571|NCT01145391|76269543|FG001|COMPLETED|Overall Study||298||
60145572|NCT01145391|76269542|FG000|NOT COMPLETED|Overall Study||0||
60145573|NCT01145391|76269543|FG001|NOT COMPLETED|Overall Study||0||
60145574|NCT03150407|76269553|FG000|STARTED|Period 1||36||
60145575|NCT03150407|76269554|FG001|STARTED|Period 1||36||
60145576|NCT03150407|76269553|FG000|COMPLETED|Period 1||32||
60145577|NCT03150407|76269554|FG001|COMPLETED|Period 1||34||
60145578|NCT03150407|76269553|FG000|NOT COMPLETED|Period 1||4||
60145579|NCT03150407|76269554|FG001|NOT COMPLETED|Period 1||2||
60145580|NCT03150407|76269553|FG000|STARTED|Washout||32||
60145581|NCT03150407|76269554|FG001|STARTED|Washout||34||
60145582|NCT03150407|76269553|FG000|COMPLETED|Washout||31||
60145583|NCT03150407|76269554|FG001|COMPLETED|Washout||33||
60145584|NCT03150407|76269553|FG000|NOT COMPLETED|Washout||1||
60145585|NCT03150407|76269554|FG001|NOT COMPLETED|Washout||1||
60145586|NCT03150407|76269553|FG000|STARTED|Period 2||31||
60145587|NCT03150407|76269554|FG001|STARTED|Period 2||33||
60145588|NCT03150407|76269553|FG000|COMPLETED|Period 2||30||
60145589|NCT03150407|76269554|FG001|COMPLETED|Period 2||33||
60145590|NCT03150407|76269553|FG000|NOT COMPLETED|Period 2||1||
60145591|NCT03150407|76269554|FG001|NOT COMPLETED|Period 2||0||
60145592|NCT03150407|76269553|FG000|STARTED|Long-Term Safety Extension||27||
60145593|NCT03150407|76269554|FG001|STARTED|Long-Term Safety Extension||30||
60145594|NCT03150407|76269553|FG000|COMPLETED|Long-Term Safety Extension||26||
60145595|NCT03150407|76269554|FG001|COMPLETED|Long-Term Safety Extension||27||
60145596|NCT03150407|76269553|FG000|NOT COMPLETED|Long-Term Safety Extension||1||
60145597|NCT03150407|76269554|FG001|NOT COMPLETED|Long-Term Safety Extension||3||
60145598|NCT01145547|76269572|FG000|STARTED|Overall Study||4||
60145599|NCT01145547|76269573|FG001|STARTED|Overall Study||3||
60145600|NCT01145547|76269572|FG000|COMPLETED|Overall Study||4||
60145601|NCT01145547|76269573|FG001|COMPLETED|Overall Study||3||
60145602|NCT01145547|76269572|FG000|NOT COMPLETED|Overall Study||0||
60145603|NCT01145547|76269573|FG001|NOT COMPLETED|Overall Study||0||
60145604|NCT01214811|76269579|FG000|STARTED|Overall Study||27||
60145605|NCT01214811|76269579|FG000|COMPLETED|Overall Study||24||
60145606|NCT01214811|76269579|FG000|NOT COMPLETED|Overall Study||3||
60145607|NCT01215123|76269583|FG000|STARTED|Overall Study||28||
60145608|NCT01215123|76269583|FG000|COMPLETED|Overall Study||28||
60145609|NCT01215123|76269583|FG000|NOT COMPLETED|Overall Study||0||
60145610|NCT01215279|76269589|FG000|STARTED|Overall Study||31||
60145611|NCT01215279|76269590|FG001|STARTED|Overall Study||32||
60145612|NCT01215279|76269589|FG000|COMPLETED|Overall Study||31||
60145613|NCT01215279|76269590|FG001|COMPLETED|Overall Study||32||
60145614|NCT01215279|76269589|FG000|NOT COMPLETED|Overall Study||0||
60145615|NCT01215279|76269590|FG001|NOT COMPLETED|Overall Study||0||
60145616|NCT02189889|76269598|FG000|STARTED|Overall Study||2||
60145617|NCT02189889|76269599|FG001|STARTED|Overall Study||3||
60145618|NCT02189889|76269598|FG000|COMPLETED|Overall Study||2||
60145619|NCT02189889|76269599|FG001|COMPLETED|Overall Study||3||
60145620|NCT02189889|76269598|FG000|NOT COMPLETED|Overall Study||0||
60145621|NCT02189889|76269599|FG001|NOT COMPLETED|Overall Study||0||
60145622|NCT01148745|76269605|FG000|STARTED|Overall Study||15||
60145623|NCT01148745|76269605|FG000|COMPLETED|Overall Study||15||
60145624|NCT01148745|76269605|FG000|NOT COMPLETED|Overall Study||0||
60145625|NCT02190045|76269613|FG000|STARTED|Overall Study||15||
60145626|NCT02190045|76269614|FG001|STARTED|Overall Study||15||
60145627|NCT02190045|76269613|FG000|COMPLETED|Overall Study||12||
60145628|NCT02190045|76269614|FG001|COMPLETED|Overall Study||15||
60145629|NCT02190045|76269613|FG000|NOT COMPLETED|Overall Study||3||
60145630|NCT02190045|76269614|FG001|NOT COMPLETED|Overall Study||0||
60145631|NCT03372161|76269622|FG000|STARTED|Overall Study||202||
60145632|NCT03372161|76269623|FG001|STARTED|Overall Study||199||
60145633|NCT03372161|76269622|FG000|COMPLETED|Overall Study||193||
60145634|NCT03372161|76269623|FG001|COMPLETED|Overall Study||192||
60145635|NCT03372161|76269622|FG000|NOT COMPLETED|Overall Study||9||
60145636|NCT03372161|76269623|FG001|NOT COMPLETED|Overall Study||7||
60145637|NCT02190747|76269632|FG000|STARTED|Overall Study||21||
60145638|NCT02190747|76269633|FG001|STARTED|Overall Study||9||
60145639|NCT02190747|76269634|FG002|STARTED|Overall Study||10||
60145640|NCT02190747|76269632|FG000|COMPLETED|Overall Study||21||
60145641|NCT02190747|76269633|FG001|COMPLETED|Overall Study||9||
60145642|NCT02190747|76269634|FG002|COMPLETED|Overall Study||10||
60145643|NCT02190747|76269632|FG000|NOT COMPLETED|Overall Study||0||
60145644|NCT02190747|76269633|FG001|NOT COMPLETED|Overall Study||0||
60145645|NCT02190747|76269634|FG002|NOT COMPLETED|Overall Study||0||
60145646|NCT02190903|76269644|FG000|STARTED|Overall Study||6||
60145647|NCT02190903|76269645|FG001|STARTED|Overall Study||6||
60145648|NCT02190903|76269644|FG000|COMPLETED|Overall Study||6||
60145649|NCT02190903|76269645|FG001|COMPLETED|Overall Study||6||
60145650|NCT02190903|76269644|FG000|NOT COMPLETED|Overall Study||0||
60145651|NCT02190903|76269645|FG001|NOT COMPLETED|Overall Study||0||
60145652|NCT01149759|76269651|FG000|STARTED|Overall Study||9||
60145653|NCT01149759|76269651|FG000|COMPLETED|Overall Study||9||
60145654|NCT01149759|76269651|FG000|NOT COMPLETED|Overall Study||0||
60145655|NCT01216761|76269655|FG000|STARTED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1421||
60145656|NCT01216761|76269656|FG001|STARTED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1410||
60145657|NCT01216761|76269657|FG002|STARTED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1379||
60145658|NCT01216761|76269655|FG000|COMPLETED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1421||
60145659|NCT01216761|76269656|FG001|COMPLETED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1410||
60145660|NCT01216761|76269657|FG002|COMPLETED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1379||
60145661|NCT01216761|76269655|FG000|NOT COMPLETED|Overall Study||0||
60145662|NCT01216761|76269656|FG001|NOT COMPLETED|Overall Study||0||
60145663|NCT01216761|76269657|FG002|NOT COMPLETED|Overall Study||0||
60145664|NCT01150461|76269667|FG000|STARTED|Overall Study||11||
60145665|NCT01150461|76269668|FG001|STARTED|Overall Study||9||
60145666|NCT01150461|76269667|FG000|COMPLETED|Overall Study||11||
60145667|NCT01150461|76269668|FG001|COMPLETED|Overall Study||9||
60145668|NCT01150461|76269667|FG000|NOT COMPLETED|Overall Study||0||
60145669|NCT01150461|76269668|FG001|NOT COMPLETED|Overall Study||0||
60145670|NCT01218399|76269676|FG000|STARTED|Overall Study||5||
60145671|NCT01218399|76269677|FG001|STARTED|Overall Study||5||
60145672|NCT01218399|76269676|FG000|COMPLETED|Overall Study||5||
60145673|NCT01218399|76269677|FG001|COMPLETED|Overall Study||5||
60145674|NCT01218399|76269676|FG000|NOT COMPLETED|Overall Study||0||
60145675|NCT01218399|76269677|FG001|NOT COMPLETED|Overall Study||0||
60145676|NCT01219881|76269685|FG000|STARTED|Overall Study||38||
60145677|NCT01219881|76269686|FG001|STARTED|Overall Study||37||
60145678|NCT01219881|76269685|FG000|COMPLETED|Overall Study||34||
60145679|NCT01219881|76269686|FG001|COMPLETED|Overall Study||32||
60145680|NCT01219881|76269685|FG000|NOT COMPLETED|Overall Study||4||
60145681|NCT01219881|76269686|FG001|NOT COMPLETED|Overall Study||5||
60145682|NCT01220739|76269694|FG000|STARTED|Overall Study||7||
60145683|NCT01220739|76269695|FG001|STARTED|Overall Study||5||
60145684|NCT01220739|76269694|FG000|COMPLETED|Overall Study||7||
60145685|NCT01220739|76269695|FG001|COMPLETED|Overall Study||5||
60145686|NCT01220739|76269694|FG000|NOT COMPLETED|Overall Study||0||
60145687|NCT01220739|76269695|FG001|NOT COMPLETED|Overall Study||0||
60145688|NCT01220973|76269701|FG000|STARTED|Overall Study||27||
60145689|NCT01220973|76269701|FG000|COMPLETED|Overall Study||23||
60145690|NCT01220973|76269701|FG000|NOT COMPLETED|Overall Study||4||
60145691|NCT01221207|76269708|FG000|STARTED|Overall Study||75||
60145692|NCT01221207|76269709|FG001|STARTED|Overall Study||75||
60145693|NCT01221207|76269710|FG002|STARTED|Overall Study||75||
60145694|NCT01221207|76269708|FG000|COMPLETED|Overall Study||43||
60145695|NCT01221207|76269709|FG001|COMPLETED|Overall Study||66||
60145696|NCT01221207|76269710|FG002|COMPLETED|Overall Study||54||
60145697|NCT01221207|76269708|FG000|NOT COMPLETED|Overall Study||32||
60145698|NCT01221207|76269709|FG001|NOT COMPLETED|Overall Study||9||
60145699|NCT01221207|76269710|FG002|NOT COMPLETED|Overall Study||21||
60145700|NCT01221441|76269720|FG000|STARTED|Overall Study||67||
60145701|NCT01221441|76269721|FG001|STARTED|Overall Study||35||
60145702|NCT01221441|76269720|FG000|COMPLETED|Overall Study||45||
60145703|NCT01221441|76269721|FG001|COMPLETED|Overall Study||23||
60145704|NCT01221441|76269720|FG000|NOT COMPLETED|Overall Study||22||
60145705|NCT01221441|76269721|FG001|NOT COMPLETED|Overall Study||12||
60145706|NCT01153503|76269730|FG000|STARTED|Overall Study||25||
60145707|NCT01153503|76269731|FG001|STARTED|Overall Study||25||
60145708|NCT01153503|76269732|FG002|STARTED|Overall Study||25||
60145709|NCT01153503|76269730|FG000|COMPLETED|Overall Study||25||
60145710|NCT01153503|76269731|FG001|COMPLETED|Overall Study||24||
59518904|NCT01116037|75612787|FG000|STARTED|Overall Study||26||
59518905|NCT01116037|75612787|FG000|COMPLETED|Overall Study||1||
59518906|NCT01116037|75612787|FG000|NOT COMPLETED|Overall Study||25||
60145711|NCT01153503|76269732|FG002|COMPLETED|Overall Study||25||
60145712|NCT01153503|76269730|FG000|NOT COMPLETED|Overall Study||0||
59518907|NCT03538678|75612793|FG000|STARTED|Overall Study||20||
60145713|NCT01153503|76269731|FG001|NOT COMPLETED|Overall Study||1||
60145714|NCT01153503|76269732|FG002|NOT COMPLETED|Overall Study||0||
60145715|NCT01222299|76269744|FG000|STARTED|Overall Study||21||
60145716|NCT01222299|76269745|FG001|STARTED|Overall Study||23||
60145717|NCT01222299|76269746|FG002|STARTED|Overall Study||22||
60145718|NCT01222299|76269747|FG003|STARTED|Overall Study||23||
60145719|NCT01222299|76269744|FG000|COMPLETED|Overall Study||21||
60145720|NCT01222299|76269745|FG001|COMPLETED|Overall Study||21||
60145721|NCT01222299|76269746|FG002|COMPLETED|Overall Study||20||
60145722|NCT01222299|76269747|FG003|COMPLETED|Overall Study||18||
60145723|NCT01222299|76269744|FG000|NOT COMPLETED|Overall Study||0||
60010513|NCT02720692|76126194|FG001|Treated|Overall Study||183||
60010514|NCT02720692|76126193|FG000|Completed Treatment|Overall Study||519||
60010515|NCT02720692|76126194|FG001|Completed Treatment|Overall Study||177||
60010516|NCT02720692|76126193|FG000|COMPLETED|Overall Study||526||
60010517|NCT02720692|76126194|FG001|COMPLETED|Overall Study||180||
60010518|NCT02720692|76126193|FG000|NOT COMPLETED|Overall Study||13||
60145724|NCT01222299|76269745|FG001|NOT COMPLETED|Overall Study||2||
60145725|NCT01222299|76269746|FG002|NOT COMPLETED|Overall Study||2||
60010519|NCT02720692|76126194|FG001|NOT COMPLETED|Overall Study||3||
60010520|NCT02656303|76126203|FG000|STARTED|Overall Study||67||
60010521|NCT02656303|76126204|FG001|STARTED|Overall Study||31||
60010522|NCT02656303|76126205|FG002|STARTED|Overall Study||18||
60010523|NCT02656303|76126203|FG000|COMPLETED|Overall Study||0||
60010524|NCT02656303|76126204|FG001|COMPLETED|Overall Study||0||
60010525|NCT02656303|76126205|FG002|COMPLETED|Overall Study||0||
60010526|NCT02656303|76126203|FG000|NOT COMPLETED|Overall Study||67||
60010527|NCT02656303|76126204|FG001|NOT COMPLETED|Overall Study||31||
60010528|NCT02656303|76126205|FG002|NOT COMPLETED|Overall Study||18||
60010529|NCT02628626|76126215|FG000|STARTED|Overall Study||32||
60010530|NCT02628626|76126216|FG001|STARTED|Overall Study||24||
60010531|NCT02628626|76126215|FG000|COMPLETED|Overall Study||30||
60010532|NCT02628626|76126216|FG001|COMPLETED|Overall Study||22||
60010533|NCT02628626|76126215|FG000|NOT COMPLETED|Overall Study||2||
60010534|NCT02628626|76126216|FG001|NOT COMPLETED|Overall Study||2||
60010535|NCT02559609|76126226|FG000|STARTED|Overall Study||50||
60010536|NCT02559609|76126227|FG001|STARTED|Overall Study||65||
60010537|NCT02559609|76126228|FG002|STARTED|Overall Study||58||
60010538|NCT02559609|76126229|FG003|STARTED|Overall Study||67||
60010539|NCT02559609|76126226|FG000|COMPLETED|Overall Study||50||
60010540|NCT02559609|76126227|FG001|COMPLETED|Overall Study||64||
60010541|NCT02559609|76126228|FG002|COMPLETED|Overall Study||58||
60010542|NCT02559609|76126229|FG003|COMPLETED|Overall Study||67||
60010543|NCT02559609|76126226|FG000|NOT COMPLETED|Overall Study||0||
60010544|NCT02559609|76126227|FG001|NOT COMPLETED|Overall Study||1||
60010545|NCT02559609|76126228|FG002|NOT COMPLETED|Overall Study||0||
60010546|NCT02559609|76126229|FG003|NOT COMPLETED|Overall Study||0||
60010547|NCT02527707|76126248|FG000|STARTED|Overall Study||15||
60010548|NCT02527707|76126248|FG000|COMPLETED|Overall Study||13||
60010549|NCT02527707|76126248|FG000|NOT COMPLETED|Overall Study||2||
60010550|NCT02470754|76126252|FG000|STARTED|Overall Study||19||
60010551|NCT02470754|76126253|FG001|STARTED|Overall Study||19||
60010552|NCT02470754|76126252|FG000|COMPLETED|Overall Study||17||
60010553|NCT02470754|76126253|FG001|COMPLETED|Overall Study||19||
60010554|NCT02470754|76126252|FG000|NOT COMPLETED|Overall Study||2||
60010555|NCT02470754|76126253|FG001|NOT COMPLETED|Overall Study||0||
60010556|NCT02453191|76126259|FG000|STARTED|Overall Study||30||
60010557|NCT02453191|76126259|FG000|COMPLETED|Overall Study||29||
60010558|NCT02453191|76126259|FG000|NOT COMPLETED|Overall Study||1||
60010559|NCT02352090|76126267|FG000|STARTED|Overall Study||20||
60010560|NCT02352090|76126268|FG001|STARTED|Overall Study||20||
60010561|NCT02352090|76126269|FG002|STARTED|Overall Study||19||
60010562|NCT02352090|76126267|FG000|COMPLETED|Overall Study||19||
60010563|NCT02352090|76126268|FG001|COMPLETED|Overall Study||20||
60010564|NCT02352090|76126269|FG002|COMPLETED|Overall Study||17||
60010565|NCT02352090|76126267|FG000|NOT COMPLETED|Overall Study||1||
60010566|NCT02352090|76126268|FG001|NOT COMPLETED|Overall Study||0||
60145726|NCT01222299|76269747|FG003|NOT COMPLETED|Overall Study||5||
60145727|NCT03286283|76269757|FG000|STARTED|Overall Study||55||
60145728|NCT03286283|76269757|FG000|COMPLETED|Overall Study||55||
60145729|NCT03286283|76269757|FG000|NOT COMPLETED|Overall Study||0||
60010567|NCT02352090|76126269|FG002|NOT COMPLETED|Overall Study||2||
60010568|NCT02135107|76126279|FG000|STARTED|Treatment Period||437||
60010569|NCT02135107|76126280|FG001|STARTED|Treatment Period||80||
60010570|NCT02135107|76126281|FG002|STARTED|Treatment Period||0||
60010571|NCT02135107|76126282|FG003|STARTED|Treatment Period||0||
60010572|NCT02135107|76126279|FG000|COMPLETED|Treatment Period||305||
60010573|NCT02135107|76126280|FG001|COMPLETED|Treatment Period||54||
60010574|NCT02135107|76126281|FG002|COMPLETED|Treatment Period||0||
60010575|NCT02135107|76126282|FG003|COMPLETED|Treatment Period||0||
60010576|NCT02135107|76126279|FG000|NOT COMPLETED|Treatment Period||132||
60010577|NCT02135107|76126280|FG001|NOT COMPLETED|Treatment Period||26||
60010578|NCT02135107|76126281|FG002|NOT COMPLETED|Treatment Period||0||
60010579|NCT02135107|76126282|FG003|NOT COMPLETED|Treatment Period||0||
60010580|NCT02135107|76126279|FG000|STARTED|Maintenance Therapy Period|Treatment Phase only|0||
60145730|NCT01222689|76269761|FG000|STARTED|Overall Study||46||
60145731|NCT01222689|76269761|FG000|COMPLETED|Overall Study||46||
60145732|NCT01222689|76269761|FG000|NOT COMPLETED|Overall Study||0||
60145733|NCT01153581|76269765|FG000|STARTED|Overall Study||109||
60145734|NCT01153581|76269765|FG000|COMPLETED|Overall Study||109||
60145735|NCT01153581|76269765|FG000|NOT COMPLETED|Overall Study||0||
60145736|NCT01223469|76269777|FG000|STARTED|Overall Study||34||
60145737|NCT01223469|76269778|FG001|STARTED|Overall Study||43||
60145738|NCT01223469|76269777|FG000|COMPLETED|Overall Study||34||
60145739|NCT01223469|76269778|FG001|COMPLETED|Overall Study||43||
60145740|NCT01223469|76269777|FG000|NOT COMPLETED|Overall Study||0||
60145741|NCT01223469|76269778|FG001|NOT COMPLETED|Overall Study||0||
60145742|NCT01223703|76269786|FG000|STARTED|Overall Study||67||
60145743|NCT01223703|76269787|FG001|STARTED|Overall Study||66||
60145744|NCT01223703|76269786|FG000|COMPLETED|Overall Study||67||
60145745|NCT01223703|76269787|FG001|COMPLETED|Overall Study||66||
60145746|NCT01223703|76269786|FG000|NOT COMPLETED|Overall Study||0||
60145747|NCT01223703|76269787|FG001|NOT COMPLETED|Overall Study||0||
60145748|NCT01224015|76269796|FG000|STARTED|Overall Study||361||
60145749|NCT01224015|76269797|FG001|STARTED|Overall Study||227||
60145750|NCT01224015|76269798|FG002|STARTED|Overall Study||96||
60145751|NCT01224015|76269796|FG000|COMPLETED|Overall Study||347||
60145752|NCT01224015|76269797|FG001|COMPLETED|Overall Study||211||
60145753|NCT01224015|76269798|FG002|COMPLETED|Overall Study||83||
60145754|NCT01224015|76269796|FG000|NOT COMPLETED|Overall Study||14||
60145755|NCT01224015|76269797|FG001|NOT COMPLETED|Overall Study||16||
60145756|NCT01224015|76269798|FG002|NOT COMPLETED|Overall Study||13||
60145757|NCT01225029|76269808|FG000|STARTED|Overall Study||32||
60145758|NCT01225029|76269809|FG001|STARTED|Overall Study||32||
60145759|NCT01225029|76269808|FG000|COMPLETED|Overall Study||32||
60145760|NCT01225029|76269809|FG001|COMPLETED|Overall Study||32||
60145761|NCT01225029|76269808|FG000|NOT COMPLETED|Overall Study||0||
60145762|NCT01225029|76269809|FG001|NOT COMPLETED|Overall Study||0||
60145763|NCT01225263|76269817|FG000|STARTED|Weeks 1 to 12||28||
60145764|NCT01225263|76269818|FG001|STARTED|Weeks 1 to 12||29||
60145765|NCT01225263|76269817|FG000|COMPLETED|Weeks 1 to 12||28||
60145766|NCT01225263|76269818|FG001|COMPLETED|Weeks 1 to 12||29||
60145767|NCT01225263|76269817|FG000|NOT COMPLETED|Weeks 1 to 12||0||
60145768|NCT01225263|76269818|FG001|NOT COMPLETED|Weeks 1 to 12||0||
60145769|NCT01225263|76269817|FG000|STARTED|Weeks 13 to 24||28||
60145770|NCT01225263|76269818|FG001|STARTED|Weeks 13 to 24||29||
60145771|NCT01225263|76269817|FG000|COMPLETED|Weeks 13 to 24||24||
60145772|NCT01225263|76269818|FG001|COMPLETED|Weeks 13 to 24||28||
60145773|NCT01225263|76269817|FG000|NOT COMPLETED|Weeks 13 to 24||4||
60145774|NCT01225263|76269818|FG001|NOT COMPLETED|Weeks 13 to 24||1||
60145775|NCT01154751|76269825|FG000|STARTED|6-month Follow-up||109||
60145776|NCT01154751|76269825|FG000|COMPLETED|6-month Follow-up||98||
60145777|NCT01154751|76269825|FG000|NOT COMPLETED|6-month Follow-up||11||
60145778|NCT01154751|76269825|FG000|STARTED|1-year Follow-up||98||
60145779|NCT01154751|76269825|FG000|COMPLETED|1-year Follow-up||93||
60145780|NCT01154751|76269825|FG000|NOT COMPLETED|1-year Follow-up||5||
60145781|NCT01154751|76269825|FG000|STARTED|2-year Follow-up||93||
60145782|NCT01154751|76269825|FG000|COMPLETED|2-year Follow-up||83||
60145783|NCT01154751|76269825|FG000|NOT COMPLETED|2-year Follow-up||10||
60145784|NCT01154751|76269825|FG000|STARTED|3-year Follow-up||83||
60145785|NCT01154751|76269825|FG000|COMPLETED|3-year Follow-up||34||
60145786|NCT01154751|76269825|FG000|NOT COMPLETED|3-year Follow-up||49||
60145787|NCT01226979|76269829|FG000|STARTED|Overall Study||16||
60145788|NCT01226979|76269829|FG000|COMPLETED|Overall Study||16||
60145789|NCT01226979|76269829|FG000|NOT COMPLETED|Overall Study||0||
60145790|NCT01154985|76269837|FG000|STARTED|Overall Study|Randomized|75||
60145791|NCT01154985|76269838|FG001|STARTED|Overall Study|Randomized|82||
60145792|NCT01154985|76269839|FG002|STARTED|Overall Study|Randomized|86||
60145793|NCT01154985|76269837|FG000|Full Analysis Set|Overall Study|Received at least one dose of study medication|75||
60145794|NCT01154985|76269838|FG001|Full Analysis Set|Overall Study|Received at least one dose of study medication|82||
60145795|NCT01154985|76269839|FG002|Full Analysis Set|Overall Study|Received at least one dose of study medication|86||
60145796|NCT01154985|76269837|FG000|Valid Biopsy -Baseline and Month 12.5|Overall Study||60||
60145797|NCT01154985|76269838|FG001|Valid Biopsy -Baseline and Month 12.5|Overall Study||62||
60145798|NCT01154985|76269839|FG002|Valid Biopsy -Baseline and Month 12.5|Overall Study||68||
60145799|NCT01154985|76269837|FG000|Efficacy Evaluable Analysis Set|Overall Study|12-months histological data, no major protocol violations; after minimum 6 months treatment|55||
60145800|NCT01154985|76269838|FG001|Efficacy Evaluable Analysis Set|Overall Study|12-months histological data, no major protocol violations; after minimum 6 months treatment|55||
60145801|NCT01154985|76269839|FG002|Efficacy Evaluable Analysis Set|Overall Study|12-months histological data, no major protocol violations; after minimum 6 months treatment|64||
60145802|NCT01154985|76269837|FG000|COMPLETED|Overall Study||58||
60145803|NCT01154985|76269838|FG001|COMPLETED|Overall Study||55||
60145804|NCT01154985|76269839|FG002|COMPLETED|Overall Study||68||
60145805|NCT01154985|76269837|FG000|NOT COMPLETED|Overall Study||17||
60145806|NCT01154985|76269838|FG001|NOT COMPLETED|Overall Study||27||
60145807|NCT01154985|76269839|FG002|NOT COMPLETED|Overall Study||18||
60145808|NCT01227057|76269849|FG000|STARTED|Overall Study||31||
60145809|NCT01227057|76269850|FG001|STARTED|Overall Study||27||
60145810|NCT01227057|76269849|FG000|COMPLETED|Overall Study||25||
60145811|NCT01227057|76269850|FG001|COMPLETED|Overall Study||19||
60145812|NCT01227057|76269849|FG000|NOT COMPLETED|Overall Study||6||
60145813|NCT01227057|76269850|FG001|NOT COMPLETED|Overall Study||8||
60145814|NCT01227681|76269860|FG000|STARTED|Overall Study||4||
60145815|NCT01227681|76269861|FG001|STARTED|Overall Study||0||
60145816|NCT01227681|76269862|FG002|STARTED|Overall Study||0||
60145817|NCT01227681|76269860|FG000|COMPLETED|Overall Study||4||
59751475|NCT00646399|75870801|FG001|STARTED|Overall Study||787||
59751476|NCT00646399|75870800|FG000|COMPLETED|Overall Study||709||
60145818|NCT01227681|76269861|FG001|COMPLETED|Overall Study||0||
60145819|NCT01227681|76269862|FG002|COMPLETED|Overall Study||0||
60145820|NCT01227681|76269860|FG000|NOT COMPLETED|Overall Study||0||
60145821|NCT01227681|76269861|FG001|NOT COMPLETED|Overall Study||0||
60145822|NCT01227681|76269862|FG002|NOT COMPLETED|Overall Study||0||
60145823|NCT01227993|76269866|FG000|STARTED|Overall Study||3||
60145824|NCT01227993|76269866|FG000|COMPLETED|Overall Study||3||
60145825|NCT01227993|76269866|FG000|NOT COMPLETED|Overall Study||0||
60145826|NCT01155999|76269872|FG000|STARTED|Overall Study||146||
60145827|NCT01155999|76269873|FG001|STARTED|Overall Study||140||
60145828|NCT01155999|76269872|FG000|COMPLETED|Overall Study||139||
60145829|NCT01155999|76269873|FG001|COMPLETED|Overall Study||136||
60145830|NCT01155999|76269872|FG000|NOT COMPLETED|Overall Study||7||
60145831|NCT01155999|76269873|FG001|NOT COMPLETED|Overall Study||4||
60145832|NCT01228149|76269881|FG000|STARTED|Overall Study||32||
60145833|NCT01228149|76269882|FG001|STARTED|Overall Study||30||
60145834|NCT01228149|76269881|FG000|COMPLETED|Overall Study||27||
60145835|NCT01228149|76269882|FG001|COMPLETED|Overall Study||26||
60145836|NCT01228149|76269881|FG000|NOT COMPLETED|Overall Study||5||
60145837|NCT01228149|76269882|FG001|NOT COMPLETED|Overall Study||4||
60145838|NCT01228929|76269894|FG000|STARTED|Nominal Condition||6||
60145839|NCT01228929|76269895|FG001|STARTED|Nominal Condition||6||
60145840|NCT01228929|76269896|FG002|STARTED|Nominal Condition||6||
60145841|NCT01228929|76269894|FG000|COMPLETED|Nominal Condition||6||
60145842|NCT01228929|76269895|FG001|COMPLETED|Nominal Condition||6||
60145843|NCT01228929|76269896|FG002|COMPLETED|Nominal Condition||6||
60145844|NCT01228929|76269894|FG000|NOT COMPLETED|Nominal Condition||0||
60145845|NCT01228929|76269895|FG001|NOT COMPLETED|Nominal Condition||0||
60145846|NCT01228929|76269896|FG002|NOT COMPLETED|Nominal Condition||0||
60145847|NCT01228929|76269894|FG000|STARTED|Low Humidity Condition||6||
60145848|NCT01228929|76269895|FG001|STARTED|Low Humidity Condition||6||
60145849|NCT01228929|76269896|FG002|STARTED|Low Humidity Condition||6||
60145850|NCT01228929|76269894|FG000|COMPLETED|Low Humidity Condition||6||
60145851|NCT01228929|76269895|FG001|COMPLETED|Low Humidity Condition||6||
60145852|NCT01228929|76269896|FG002|COMPLETED|Low Humidity Condition||6||
60145853|NCT01228929|76269894|FG000|NOT COMPLETED|Low Humidity Condition||0||
60145854|NCT01228929|76269895|FG001|NOT COMPLETED|Low Humidity Condition||0||
60145855|NCT01228929|76269896|FG002|NOT COMPLETED|Low Humidity Condition||0||
60145856|NCT01228929|76269894|FG000|STARTED|High Temperature Condition||6||
60145857|NCT01228929|76269895|FG001|STARTED|High Temperature Condition||6||
60145858|NCT01228929|76269896|FG002|STARTED|High Temperature Condition||6||
60145859|NCT01228929|76269894|FG000|COMPLETED|High Temperature Condition||6||
60145860|NCT01228929|76269895|FG001|COMPLETED|High Temperature Condition||6||
60145861|NCT01228929|76269896|FG002|COMPLETED|High Temperature Condition||6||
60145862|NCT01228929|76269894|FG000|NOT COMPLETED|High Temperature Condition||0||
60145863|NCT01228929|76269895|FG001|NOT COMPLETED|High Temperature Condition||0||
60145864|NCT01228929|76269896|FG002|NOT COMPLETED|High Temperature Condition||0||
60145865|NCT02192307|76269906|FG000|STARTED|Overall Study||30||
60145866|NCT02192307|76269907|FG001|STARTED|Overall Study||30||
60145867|NCT02192307|76269906|FG000|COMPLETED|Overall Study||30||
60145868|NCT02192307|76269907|FG001|COMPLETED|Overall Study||30||
60145869|NCT02192307|76269906|FG000|NOT COMPLETED|Overall Study||0||
60145870|NCT02192307|76269907|FG001|NOT COMPLETED|Overall Study||0||
60145871|NCT02192541|76269915|FG000|STARTED|Overall Study||2||
60145872|NCT02192541|76269916|FG001|STARTED|Overall Study||3||
60145873|NCT02192541|76269915|FG000|Treated|Overall Study||2||
60145874|NCT02192541|76269916|FG001|Treated|Overall Study||3||
60145875|NCT02192541|76269915|FG000|Evaluable for Response|Overall Study||1||
60145876|NCT02192541|76269916|FG001|Evaluable for Response|Overall Study||3||
60145877|NCT02192541|76269915|FG000|COMPLETED|Overall Study||2||
60145878|NCT02192541|76269916|FG001|COMPLETED|Overall Study||3||
60145879|NCT02192541|76269915|FG000|NOT COMPLETED|Overall Study||0||
60145880|NCT02192541|76269916|FG001|NOT COMPLETED|Overall Study||0||
60145881|NCT01156701|76269923|FG000|STARTED|Overall Study||257||
60145882|NCT01156701|76269924|FG001|STARTED|Overall Study||1007||
60145883|NCT01156701|76269925|FG002|STARTED|Overall Study||163716||
60145884|NCT01156701|76269926|FG003|STARTED|Overall Study||6725||
60145885|NCT01156701|76269923|FG000|COMPLETED|Overall Study||257||
60145886|NCT01156701|76269924|FG001|COMPLETED|Overall Study||1007||
60145887|NCT01156701|76269925|FG002|COMPLETED|Overall Study||163716||
60145888|NCT01156701|76269926|FG003|COMPLETED|Overall Study||6725||
60145889|NCT01156701|76269923|FG000|NOT COMPLETED|Overall Study||0||
60145890|NCT01156701|76269924|FG001|NOT COMPLETED|Overall Study||0||
60145891|NCT01156701|76269925|FG002|NOT COMPLETED|Overall Study||0||
60145892|NCT01156701|76269926|FG003|NOT COMPLETED|Overall Study||0||
60145893|NCT01230021|76269936|FG000|STARTED|Overall Study||6||
60145894|NCT01230021|76269936|FG000|COMPLETED|Overall Study||6||
60145895|NCT01230021|76269936|FG000|NOT COMPLETED|Overall Study||0||
60145896|NCT05005390|76269942|FG000|STARTED|Overall Study||76||
60145897|NCT05005390|76269943|FG001|STARTED|Overall Study||71||
60145898|NCT05005390|76269942|FG000|Successfully Completed First Ventilation (Step 1)|Overall Study||64||
60145899|NCT05005390|76269943|FG001|Successfully Completed First Ventilation (Step 1)|Overall Study||52||
60145900|NCT05005390|76269942|FG000|Successfully Completed Second Ventilation (Step 2)|Overall Study||63||
60145901|NCT05005390|76269943|FG001|Successfully Completed Second Ventilation (Step 2)|Overall Study||63||
60145902|NCT05005390|76269942|FG000|COMPLETED|Overall Study||57|Successfully Completed First and Second Ventilation|
60145903|NCT05005390|76269943|FG001|COMPLETED|Overall Study||50|Successfully Completed First and Second Ventilation|
60145904|NCT05005390|76269942|FG000|NOT COMPLETED|Overall Study||19||
60145905|NCT05005390|76269943|FG001|NOT COMPLETED|Overall Study||21||
60145906|NCT04755790|76269949|FG000|STARTED|No Prosthesis (Day 0)||13||
60145907|NCT04755790|76269949|FG000|COMPLETED|No Prosthesis (Day 0)||13||
60145908|NCT04755790|76269949|FG000|NOT COMPLETED|No Prosthesis (Day 0)||0||
60145909|NCT04755790|76269949|FG000|STARTED|Prosthesis (Day 0)||13||
60145910|NCT04755790|76269949|FG000|COMPLETED|Prosthesis (Day 0)||13||
60145911|NCT04755790|76269949|FG000|NOT COMPLETED|Prosthesis (Day 0)||0||
60145912|NCT04755790|76269949|FG000|STARTED|Prosthesis (Day 30)||13||
60145913|NCT04755790|76269949|FG000|COMPLETED|Prosthesis (Day 30)||11||
60145914|NCT04755790|76269949|FG000|NOT COMPLETED|Prosthesis (Day 30)||2||
60145915|NCT04755790|76269949|FG000|STARTED|Prosthesis (Day 60)||11||
60145916|NCT04755790|76269949|FG000|COMPLETED|Prosthesis (Day 60)||11||
60145917|NCT04755790|76269949|FG000|NOT COMPLETED|Prosthesis (Day 60)||0||
60145918|NCT04726969|76269956|FG000|STARTED|Overall Study||85||
60145919|NCT04726969|76269957|FG001|STARTED|Overall Study||84||
60145920|NCT04726969|76269958|FG002|STARTED|Overall Study||86||
60145921|NCT04726969|76269956|FG000|COMPLETED|Overall Study||72||
60145922|NCT04726969|76269957|FG001|COMPLETED|Overall Study||67||
60145923|NCT04726969|76269958|FG002|COMPLETED|Overall Study||71||
60145924|NCT04726969|76269956|FG000|NOT COMPLETED|Overall Study||13||
60145925|NCT04726969|76269957|FG001|NOT COMPLETED|Overall Study||17||
60145926|NCT04726969|76269958|FG002|NOT COMPLETED|Overall Study||15||
60145927|NCT04505722|76269971|FG000|STARTED|Overall Study||22174||
60145928|NCT04505722|76269972|FG001|STARTED|Overall Study||22150||
60145929|NCT04505722|76269971|FG000|Vaccinated|Overall Study||21898||
60145930|NCT04505722|76269972|FG001|Vaccinated|Overall Study||21890||
60145931|NCT04505722|76269971|FG000|Participants in Entire Double Blind Phase|Overall Study||21894||
60145932|NCT04505722|76269972|FG001|Participants in Entire Double Blind Phase|Overall Study||21882||
60145933|NCT04505722|76269971|FG000|COMPLETED|Overall Study||0||
60145934|NCT04505722|76269972|FG001|COMPLETED|Overall Study||0||
60145935|NCT04505722|76269971|FG000|NOT COMPLETED|Overall Study||22174||
60145936|NCT04505722|76269972|FG001|NOT COMPLETED|Overall Study||22150||
60145937|NCT04465760|76269978|FG000|STARTED|Overall Study||9||
60145938|NCT04465760|76269978|FG000|COMPLETED|Overall Study||9||
60145939|NCT04465760|76269978|FG000|NOT COMPLETED|Overall Study||0||
60145940|NCT04463251|76269985|FG000|STARTED|Overall Study||34||
60145941|NCT04463251|76269986|FG001|STARTED|Overall Study||34||
60145942|NCT04463251|76269987|FG002|STARTED|Overall Study||34||
60145943|NCT04463251|76269985|FG000|Safety Set|Overall Study||34||
60145944|NCT04463251|76269986|FG001|Safety Set|Overall Study||34||
60145945|NCT04463251|76269987|FG002|Safety Set|Overall Study||34||
60145946|NCT04463251|76269985|FG000|Full Analysis Set|Overall Study||34|One patient in the Placebo arm was excluded from FAS population due to absence of High-sensitivity C-reactive protein (hsCRP) baseline measurement (the central laboratory was notable to perform an assay due to hemolysis)|
60145947|NCT04463251|76269986|FG001|Full Analysis Set|Overall Study||34|One patient in the Placebo arm was excluded from FAS population due to absence of High-sensitivity C-reactive protein (hsCRP) baseline measurement (the central laboratory was notable to perform an assay due to hemolysis)|
60145948|NCT04463251|76269987|FG002|Full Analysis Set|Overall Study||33|One patient in the Placebo arm was excluded from FAS population due to absence of High-sensitivity C-reactive protein (hsCRP) baseline measurement (the central laboratory was notable to perform an assay due to hemolysis)|
60145949|NCT04463251|76269985|FG000|Per Protocol Set|Overall Study||30||
60145950|NCT04463251|76269986|FG001|Per Protocol Set|Overall Study||31||
60145951|NCT04463251|76269987|FG002|Per Protocol Set|Overall Study||31||
60145952|NCT04463251|76269985|FG000|Completed the Study Per Protocol|Overall Study||33||
60145953|NCT04463251|76269986|FG001|Completed the Study Per Protocol|Overall Study||30||
60145954|NCT04463251|76269987|FG002|Completed the Study Per Protocol|Overall Study||31||
60145955|NCT04463251|76269985|FG000|COMPLETED|Overall Study||33||
60145956|NCT04463251|76269986|FG001|COMPLETED|Overall Study||30||
60145957|NCT04463251|76269987|FG002|COMPLETED|Overall Study||31||
60145958|NCT04463251|76269985|FG000|NOT COMPLETED|Overall Study||1||
60145959|NCT04463251|76269986|FG001|NOT COMPLETED|Overall Study||4||
60145960|NCT04463251|76269987|FG002|NOT COMPLETED|Overall Study||3||
60145961|NCT04254913|76270000|FG000|STARTED|Overall Study||6||
60145962|NCT04254913|76270000|FG000|COMPLETED|Overall Study||5||
60145963|NCT04254913|76270000|FG000|NOT COMPLETED|Overall Study||1||
60145964|NCT04176224|76270004|FG000|STARTED|Overall Study||9||
60145965|NCT04176224|76270004|FG000|COMPLETED|Overall Study||9||
60145966|NCT04176224|76270004|FG000|NOT COMPLETED|Overall Study||0||
60145967|NCT04160091|76270012|FG000|STARTED|Overall Study||7||
60145968|NCT04160091|76270013|FG001|STARTED|Overall Study||3||
60145969|NCT04160091|76270014|FG002|STARTED|Overall Study||5||
60145970|NCT04160091|76270015|FG003|STARTED|Overall Study||4||
60145971|NCT04160091|76270012|FG000|COMPLETED|Overall Study||0||
60145972|NCT04160091|76270013|FG001|COMPLETED|Overall Study||0||
60145973|NCT04160091|76270014|FG002|COMPLETED|Overall Study||0||
60145974|NCT04160091|76270015|FG003|COMPLETED|Overall Study||0||
60145975|NCT04160091|76270012|FG000|NOT COMPLETED|Overall Study||7||
60145976|NCT04160091|76270013|FG001|NOT COMPLETED|Overall Study||3||
60145977|NCT04160091|76270014|FG002|NOT COMPLETED|Overall Study||5||
60145978|NCT04160091|76270015|FG003|NOT COMPLETED|Overall Study||4||
59882047|NCT04005885|76004960|FG001|NOT COMPLETED|Second Intervention||2||
59882048|NCT04005885|76004959|FG000|STARTED|Third Intervention||25||
59882049|NCT04005885|76004960|FG001|STARTED|Third Intervention||26||
59882050|NCT04005885|76004959|FG000|COMPLETED|Third Intervention||25||
59882051|NCT04005885|76004960|FG001|COMPLETED|Third Intervention||26||
59882052|NCT04005885|76004959|FG000|NOT COMPLETED|Third Intervention||0||
59882053|NCT04005885|76004960|FG001|NOT COMPLETED|Third Intervention||0||
59882054|NCT04003623|76004973|FG000|STARTED|Overall Study||1||
59882055|NCT04003623|76004974|FG001|STARTED|Overall Study||0||
59882056|NCT04003623|76004973|FG000|COMPLETED|Overall Study||0||
59882057|NCT04003623|76004974|FG001|COMPLETED|Overall Study||0||
59882058|NCT04003623|76004973|FG000|NOT COMPLETED|Overall Study||1||
60145979|NCT04145895|76270027|FG000|STARTED|Overall Study||42||
60145980|NCT04145895|76270028|FG001|STARTED|Overall Study||126||
60145981|NCT04145895|76270027|FG000|COMPLETED|Overall Study||40||
59882059|NCT04003623|76004974|FG001|NOT COMPLETED|Overall Study||0||
59882060|NCT04480424|76004982|FG000|STARTED|Overall Study||50||
60145982|NCT04145895|76270028|FG001|COMPLETED|Overall Study||124||
60145983|NCT04145895|76270027|FG000|NOT COMPLETED|Overall Study||2||
60145984|NCT04145895|76270028|FG001|NOT COMPLETED|Overall Study||2||
60145985|NCT04077437|76270036|FG000|STARTED|Overall Study||53||
60145986|NCT04077437|76270037|FG001|STARTED|Overall Study||51||
60145987|NCT04077437|76270036|FG000|COMPLETED|Overall Study||52|Primary Outcome (Visit 19)|
60145988|NCT04077437|76270037|FG001|COMPLETED|Overall Study||45|Primary Outcome (Visit 19)|
60145989|NCT04077437|76270036|FG000|NOT COMPLETED|Overall Study||1||
60145990|NCT04077437|76270037|FG001|NOT COMPLETED|Overall Study||6||
60145991|NCT04068948|76270046|FG000|STARTED|Overall Study||20||
60145992|NCT04068948|76270047|FG001|STARTED|Overall Study||17||
60145993|NCT04068948|76270046|FG000|COMPLETED|Overall Study||20||
59882061|NCT04480424|76004983|FG001|STARTED|Overall Study||50||
59882062|NCT04480424|76004982|FG000|COMPLETED|Overall Study||28||
59882063|NCT04480424|76004983|FG001|COMPLETED|Overall Study||24||
59882064|NCT04480424|76004982|FG000|NOT COMPLETED|Overall Study||22||
59882065|NCT04480424|76004983|FG001|NOT COMPLETED|Overall Study||26||
59882066|NCT03256526|76004992|FG000|STARTED|Overall Study||19||
59882067|NCT03256526|76004993|FG001|STARTED|Overall Study||17||
59882068|NCT03256526|76004994|FG002|STARTED|Overall Study||17||
59882069|NCT03256526|76004992|FG000|COMPLETED|Overall Study||17||
60010581|NCT02135107|76126280|FG001|STARTED|Maintenance Therapy Period|Treatment Phase only|0||
60010582|NCT02135107|76126281|FG002|STARTED|Maintenance Therapy Period|Only eligible participants entered into the Maintenance Therapy Period|178||
60010583|NCT02135107|76126282|FG003|STARTED|Maintenance Therapy Period|Only eligible participants entered into the Maintenance Therapy Period|181||
60010584|NCT02135107|76126279|FG000|COMPLETED|Maintenance Therapy Period||0||
60010585|NCT02135107|76126280|FG001|COMPLETED|Maintenance Therapy Period||0||
60010586|NCT02135107|76126281|FG002|COMPLETED|Maintenance Therapy Period||163||
60010587|NCT02135107|76126282|FG003|COMPLETED|Maintenance Therapy Period||161||
60010588|NCT02135107|76126279|FG000|NOT COMPLETED|Maintenance Therapy Period||0||
60010589|NCT02135107|76126280|FG001|NOT COMPLETED|Maintenance Therapy Period||0||
60010590|NCT02135107|76126281|FG002|NOT COMPLETED|Maintenance Therapy Period||15||
60010591|NCT02135107|76126282|FG003|NOT COMPLETED|Maintenance Therapy Period||20||
60010592|NCT02030847|76126294|FG000|STARTED|Overall Study||42||
60010593|NCT02030847|76126294|FG000|COMPLETED|Overall Study||5||
60010594|NCT02030847|76126294|FG000|NOT COMPLETED|Overall Study||37||
60010595|NCT02030834|76126302|FG000|STARTED|Overall Study||50||
60145994|NCT04068948|76270047|FG001|COMPLETED|Overall Study||17||
60145995|NCT04068948|76270046|FG000|NOT COMPLETED|Overall Study||0||
59882070|NCT03256526|76004993|FG001|COMPLETED|Overall Study||17||
59882071|NCT03256526|76004994|FG002|COMPLETED|Overall Study||14||
59882072|NCT03256526|76004992|FG000|NOT COMPLETED|Overall Study||2||
59882073|NCT03256526|76004993|FG001|NOT COMPLETED|Overall Study||0||
60010596|NCT02030834|76126303|FG001|STARTED|Overall Study||3||
60010597|NCT02030834|76126304|FG002|STARTED|Overall Study||10||
60010598|NCT02030834|76126302|FG000|COMPLETED|Overall Study||39||
60145996|NCT04068948|76270047|FG001|NOT COMPLETED|Overall Study||0||
60145997|NCT04065074|76270055|FG000|STARTED|Overall Study||16||
60145998|NCT04065074|76270055|FG000|COMPLETED|Overall Study||14||
60145999|NCT04065074|76270055|FG000|NOT COMPLETED|Overall Study||2||
60146000|NCT03814746|76270062|FG000|STARTED|Overall Study||84||
60146001|NCT03814746|76270063|FG001|STARTED|Overall Study||83||
60146002|NCT03814746|76270064|FG002|STARTED|Overall Study||85||
60146003|NCT03814746|76270062|FG000|COMPLETED|Overall Study||66|Completed = Ongoing|
60146004|NCT03814746|76270063|FG001|COMPLETED|Overall Study||68|Completed = Ongoing|
60146005|NCT03814746|76270064|FG002|COMPLETED|Overall Study||58|Completed = Ongoing|
60146006|NCT03814746|76270062|FG000|NOT COMPLETED|Overall Study||18||
60146007|NCT03814746|76270063|FG001|NOT COMPLETED|Overall Study||15||
60146008|NCT03814746|76270064|FG002|NOT COMPLETED|Overall Study||27||
60146009|NCT03793010|76270075|FG000|STARTED|Overall Study||35||
60146010|NCT03793010|76270076|FG001|STARTED|Overall Study||35||
60146011|NCT03793010|76270075|FG000|Randomized But Not Dosed|Overall Study||2||
60146012|NCT03793010|76270076|FG001|Randomized But Not Dosed|Overall Study||0||
60146013|NCT03793010|76270075|FG000|COMPLETED|Overall Study||7||
60146014|NCT03793010|76270076|FG001|COMPLETED|Overall Study||8||
60146015|NCT03793010|76270075|FG000|NOT COMPLETED|Overall Study||28||
60146016|NCT03793010|76270076|FG001|NOT COMPLETED|Overall Study||27||
60146017|NCT03617536|76270086|FG000|STARTED|Overall Study||69||
60146018|NCT03617536|76270087|FG001|STARTED|Overall Study||66||
60146019|NCT03617536|76270088|FG002|STARTED|Overall Study||67||
60146020|NCT03617536|76270089|FG003|STARTED|Overall Study||67||
60146021|NCT03617536|76270086|FG000|COMPLETED|Overall Study||60||
60146022|NCT03617536|76270087|FG001|COMPLETED|Overall Study||57||
60146023|NCT03617536|76270088|FG002|COMPLETED|Overall Study||54||
60146024|NCT03617536|76270089|FG003|COMPLETED|Overall Study||57||
60146025|NCT03617536|76270086|FG000|NOT COMPLETED|Overall Study||9||
60146026|NCT03617536|76270087|FG001|NOT COMPLETED|Overall Study||9||
60146027|NCT03617536|76270088|FG002|NOT COMPLETED|Overall Study||13||
60146028|NCT03617536|76270089|FG003|NOT COMPLETED|Overall Study||10||
60146029|NCT03615534|76270103|FG000|STARTED|Overall Study||14||
60146030|NCT03615534|76270104|FG001|STARTED|Overall Study||15||
60146031|NCT03615534|76270105|FG002|STARTED|Overall Study||14||
60146032|NCT03615534|76270106|FG003|STARTED|Overall Study||14||
60146033|NCT03615534|76270103|FG000|COMPLETED|Overall Study||12||
60146034|NCT03615534|76270104|FG001|COMPLETED|Overall Study||15||
60146035|NCT03615534|76270105|FG002|COMPLETED|Overall Study||14||
60146036|NCT03615534|76270106|FG003|COMPLETED|Overall Study||13||
60146037|NCT03615534|76270103|FG000|NOT COMPLETED|Overall Study||2||
60146038|NCT03615534|76270104|FG001|NOT COMPLETED|Overall Study||0||
60146039|NCT03615534|76270105|FG002|NOT COMPLETED|Overall Study||0||
60146040|NCT03615534|76270106|FG003|NOT COMPLETED|Overall Study||1||
60146041|NCT03537014|76270118|FG000|STARTED|Overall Study||46||
60146042|NCT03537014|76270119|FG001|STARTED|Overall Study||45||
60146043|NCT03537014|76270118|FG000|Withdrew Consent Before Dosing|Overall Study||0||
60146044|NCT03537014|76270119|FG001|Withdrew Consent Before Dosing|Overall Study||1||
60146045|NCT03537014|76270118|FG000|Completed First Experimental Session|Overall Study||46||
60146046|NCT03537014|76270119|FG001|Completed First Experimental Session|Overall Study||44||
60146047|NCT03537014|76270118|FG000|Completed Second Experimental Session|Overall Study||43||
60146048|NCT03537014|76270119|FG001|Completed Second Experimental Session|Overall Study||41||
60146049|NCT03537014|76270118|FG000|COMPLETED|Overall Study||42|Completed Primary Endpoint|
60146050|NCT03537014|76270119|FG001|COMPLETED|Overall Study||40|Completed Primary Endpoint|
60146051|NCT03537014|76270118|FG000|NOT COMPLETED|Overall Study||4||
60146052|NCT03537014|76270119|FG001|NOT COMPLETED|Overall Study||5||
60146053|NCT03529942|76270125|FG000|STARTED|Overall Study||129||
60146054|NCT03529942|76270125|FG000|Reached Week 6 With Paired MRI|Overall Study||108||
60146055|NCT03529942|76270125|FG000|COMPLETED|Overall Study||106||
60146056|NCT03529942|76270125|FG000|NOT COMPLETED|Overall Study||23||
60146057|NCT03485287|76270132|FG000|STARTED|Overall Study||4||
60146058|NCT03485287|76270132|FG000|COMPLETED|Overall Study||3||
60146059|NCT03485287|76270132|FG000|NOT COMPLETED|Overall Study||1||
60146060|NCT03484819|76270136|FG000|STARTED|Overall Study||12||
60146061|NCT03484819|76270136|FG000|COMPLETED|Overall Study||0||
60146062|NCT03484819|76270136|FG000|NOT COMPLETED|Overall Study||12||
60146063|NCT03382262|76270144|FG000|STARTED|Overall Study||12||
60146064|NCT03382262|76270145|FG001|STARTED|Overall Study||13||
60146065|NCT03382262|76270146|FG002|STARTED|Overall Study||15||
60146066|NCT03382262|76270147|FG003|STARTED|Overall Study||15||
60146067|NCT03382262|76270144|FG000|COMPLETED|Overall Study||12||
60146068|NCT03382262|76270145|FG001|COMPLETED|Overall Study||13||
60146069|NCT03382262|76270146|FG002|COMPLETED|Overall Study||14||
60146070|NCT03382262|76270147|FG003|COMPLETED|Overall Study||14||
60146071|NCT03382262|76270144|FG000|NOT COMPLETED|Overall Study||0||
60146072|NCT03382262|76270145|FG001|NOT COMPLETED|Overall Study||0||
60146073|NCT03382262|76270146|FG002|NOT COMPLETED|Overall Study||1||
60146074|NCT03382262|76270147|FG003|NOT COMPLETED|Overall Study||1||
59605733|NCT01996254|75715870|FG002|Safety Set|Overall Study||14|All subjects that underwent Lead placement|
60146075|NCT03381274|76270162|FG000|STARTED|Overall Study||5||
60146076|NCT03381274|76270163|FG001|STARTED|Overall Study||21||
60146077|NCT03381274|76270164|FG002|STARTED|Overall Study||6||
60146078|NCT03381274|76270165|FG003|STARTED|Overall Study||6||
60146079|NCT03381274|76270166|FG004|STARTED|Overall Study||5||
60146080|NCT03381274|76270162|FG000|COMPLETED|Overall Study||0||
60146081|NCT03381274|76270163|FG001|COMPLETED|Overall Study||0||
60146082|NCT03381274|76270164|FG002|COMPLETED|Overall Study||0||
60146083|NCT03381274|76270165|FG003|COMPLETED|Overall Study||0||
60146084|NCT03381274|76270166|FG004|COMPLETED|Overall Study||0||
60146085|NCT03381274|76270162|FG000|NOT COMPLETED|Overall Study||5||
60146086|NCT03381274|76270163|FG001|NOT COMPLETED|Overall Study||21||
60146087|NCT03381274|76270164|FG002|NOT COMPLETED|Overall Study||6||
60146088|NCT03381274|76270165|FG003|NOT COMPLETED|Overall Study||6||
60146089|NCT03381274|76270166|FG004|NOT COMPLETED|Overall Study||5||
60146090|NCT03378076|76270184|FG000|STARTED|Overall Study||12||
60146091|NCT03378076|76270185|FG001|STARTED|Overall Study||12||
60146092|NCT03378076|76270184|FG000|COMPLETED|Overall Study||12||
60146093|NCT03378076|76270185|FG001|COMPLETED|Overall Study||12||
60146094|NCT03378076|76270184|FG000|NOT COMPLETED|Overall Study||0||
60146095|NCT03378076|76270185|FG001|NOT COMPLETED|Overall Study||0||
60146096|NCT03365375|76270193|FG000|STARTED|Overall Study||14||
60146097|NCT03365375|76270194|FG001|STARTED|Overall Study||14||
60146098|NCT03365375|76270193|FG000|COMPLETED|Overall Study||14||
60146099|NCT03365375|76270194|FG001|COMPLETED|Overall Study||9||
60146100|NCT03365375|76270193|FG000|NOT COMPLETED|Overall Study||0||
60146101|NCT03365375|76270194|FG001|NOT COMPLETED|Overall Study||5||
60146102|NCT03282123|76270200|FG000|STARTED|Overall Study||38||
60146103|NCT03282123|76270200|FG000|COMPLETED|Overall Study||33||
60146104|NCT03282123|76270200|FG000|NOT COMPLETED|Overall Study||5||
60146105|NCT03046446|76270205|FG000|STARTED|Overall Study||208||
60146106|NCT03046446|76270205|FG000|Second Injection|Overall Study||179|1 patient received 2nd injection after week 24 and is not included in the efficacy data analysis.|
60146107|NCT03046446|76270205|FG000|Completed at Week 12|Overall Study||10||
60146108|NCT03046446|76270205|FG000|Completed at Week 24|Overall Study||6||
60146109|NCT03046446|76270205|FG000|Completed at Week 52|Overall Study||133||
60146110|NCT03046446|76270205|FG000|COMPLETED|Overall Study||149||
60146111|NCT03046446|76270205|FG000|NOT COMPLETED|Overall Study||59||
60146112|NCT02986230|76270212|FG000|STARTED|Overall Study||11402||11
60146113|NCT02986230|76270213|FG001|STARTED|Overall Study||10138||11
60146114|NCT02986230|76270214|FG002|STARTED|Overall Study||14413||12
60146115|NCT02986230|76270212|FG000|COMPLETED|Overall Study||10122||11
60146116|NCT02986230|76270213|FG001|COMPLETED|Overall Study||9034||11
60146117|NCT02986230|76270214|FG002|COMPLETED|Overall Study||12960||12
60146118|NCT02986230|76270212|FG000|NOT COMPLETED|Overall Study||1280||0
60146119|NCT02986230|76270213|FG001|NOT COMPLETED|Overall Study||1104||0
60146120|NCT02986230|76270214|FG002|NOT COMPLETED|Overall Study||1453||0
60146121|NCT02876172|76270224|FG000|STARTED|Overall Study||6||
60146122|NCT02876172|76270225|FG001|STARTED|Overall Study||6||
60146123|NCT02876172|76270224|FG000|COMPLETED|Overall Study||6||
60146124|NCT02876172|76270225|FG001|COMPLETED|Overall Study||6||
60146125|NCT02876172|76270224|FG000|NOT COMPLETED|Overall Study||0||
60146126|NCT02876172|76270225|FG001|NOT COMPLETED|Overall Study||0||
60146127|NCT02762370|76270234|FG000|STARTED|Overall Study||18||
60146128|NCT02762370|76270235|FG001|STARTED|Overall Study||15||
60146129|NCT02762370|76270234|FG000|COMPLETED|Overall Study||17||
60146130|NCT02762370|76270235|FG001|COMPLETED|Overall Study||15||
60146131|NCT02762370|76270234|FG000|NOT COMPLETED|Overall Study||1||
60146132|NCT02762370|76270235|FG001|NOT COMPLETED|Overall Study||0||
60146133|NCT02751580|76270243|FG000|STARTED|Overall Study||37||
59882074|NCT03256526|76004994|FG002|NOT COMPLETED|Overall Study||3||
59882075|NCT03255980|76005006|FG000|STARTED|Overall Study||20||
59882076|NCT03255980|76005007|FG001|STARTED|Overall Study||20||
59882077|NCT03255980|76005008|FG002|STARTED|Overall Study||20||
59882078|NCT03255980|76005009|FG003|STARTED|Overall Study||20||
59882079|NCT03255980|76005006|FG000|COMPLETED|Overall Study||17||
59882080|NCT03255980|76005007|FG001|COMPLETED|Overall Study||12||
59882081|NCT03255980|76005008|FG002|COMPLETED|Overall Study||14||
60010599|NCT02030834|76126303|FG001|COMPLETED|Overall Study||3||
60010600|NCT02030834|76126304|FG002|COMPLETED|Overall Study||7||
60010601|NCT02030834|76126302|FG000|NOT COMPLETED|Overall Study||11||
60010602|NCT02030834|76126303|FG001|NOT COMPLETED|Overall Study||0||
60146134|NCT02751580|76270243|FG000|COMPLETED|Overall Study||31||
60146135|NCT02751580|76270243|FG000|NOT COMPLETED|Overall Study||6||
60146136|NCT02717611|76270247|FG000|STARTED|Overall Study||60||
60146137|NCT02717611|76270247|FG000|COMPLETED|Overall Study||0||
59882082|NCT03255980|76005009|FG003|COMPLETED|Overall Study||8||
59882083|NCT03255980|76005006|FG000|NOT COMPLETED|Overall Study||3||
60010603|NCT02030834|76126304|FG002|NOT COMPLETED|Overall Study||3||
60010604|NCT01982448|76126314|FG000|STARTED|Preoperative Chemotherapy||75||
60010605|NCT01982448|76126315|FG001|STARTED|Preoperative Chemotherapy||72||
60010606|NCT01982448|76126314|FG000|Eligible & Treated|Preoperative Chemotherapy||72||
60010607|NCT01982448|76126315|FG001|Eligible & Treated|Preoperative Chemotherapy||70||
60010608|NCT01982448|76126314|FG000|Evaluable for Safety|Preoperative Chemotherapy||72|Participants who completed at least one cycle of neoadjuvant chemotherapy were evaluable for adverse events.|
60010609|NCT01982448|76126315|FG001|Evaluable for Safety|Preoperative Chemotherapy||68|Participants who completed at least one cycle of neoadjuvant chemotherapy were evaluable for adverse events.|
60010610|NCT01982448|76126314|FG000|COMPLETED|Preoperative Chemotherapy||72||
60146138|NCT02717611|76270247|FG000|NOT COMPLETED|Overall Study||60||
60146139|NCT02518945|76270253|FG000|STARTED|Overall Study||9||
60146140|NCT02518945|76270254|FG001|STARTED|Overall Study||17||
60146141|NCT02518945|76270253|FG000|COMPLETED|Overall Study||9||
60146142|NCT02518945|76270254|FG001|COMPLETED|Overall Study||17||
60146143|NCT02518945|76270253|FG000|NOT COMPLETED|Overall Study||0||
60146144|NCT02518945|76270254|FG001|NOT COMPLETED|Overall Study||0||
60146145|NCT02513394|76270262|FG000|STARTED|Overall Study||2896||
60146146|NCT02513394|76270263|FG001|STARTED|Overall Study||2900||
60146147|NCT02513394|76270262|FG000|COMPLETED|Overall Study||2884||
60146148|NCT02513394|76270263|FG001|COMPLETED|Overall Study||2877||
60146149|NCT02513394|76270262|FG000|NOT COMPLETED|Overall Study||12||
60146150|NCT02513394|76270263|FG001|NOT COMPLETED|Overall Study||23||
60146151|NCT02468583|76270271|FG000|STARTED|Overall Study||3||
60146152|NCT02468583|76270272|FG001|STARTED|Overall Study||3||
60146153|NCT02468583|76270271|FG000|COMPLETED|Overall Study||3||
60146154|NCT02468583|76270272|FG001|COMPLETED|Overall Study||3||
60146155|NCT02468583|76270271|FG000|NOT COMPLETED|Overall Study||0||
60146156|NCT02468583|76270272|FG001|NOT COMPLETED|Overall Study||0||
60146157|NCT02427568|76270280|FG000|STARTED|Overall Study||5||
60146158|NCT02427568|76270281|FG001|STARTED|Overall Study||13||
60146159|NCT02427568|76270280|FG000|COMPLETED|Overall Study||5||
60146160|NCT02427568|76270281|FG001|COMPLETED|Overall Study||13||
60146161|NCT02427568|76270280|FG000|NOT COMPLETED|Overall Study||0||
60146162|NCT02427568|76270281|FG001|NOT COMPLETED|Overall Study||0||
60146163|NCT02284113|76270293|FG000|STARTED|Overall Study||74||
60146164|NCT02284113|76270294|FG001|STARTED|Overall Study||76||
60146165|NCT02284113|76270293|FG000|COMPLETED|Overall Study||71||
60146166|NCT02284113|76270294|FG001|COMPLETED|Overall Study||73||
60146167|NCT02284113|76270293|FG000|NOT COMPLETED|Overall Study||3||
60146168|NCT02284113|76270294|FG001|NOT COMPLETED|Overall Study||3||
60146169|NCT02116972|76270303|FG000|STARTED|Overall Study||102||
60146170|NCT02116972|76270304|FG001|STARTED|Overall Study||104||
60146171|NCT02116972|76270305|FG002|STARTED|Overall Study||104||
60146172|NCT02116972|76270303|FG000|COMPLETED|Overall Study||83||
60146173|NCT02116972|76270304|FG001|COMPLETED|Overall Study||87||
60146174|NCT02116972|76270305|FG002|COMPLETED|Overall Study||85||
60146175|NCT02116972|76270303|FG000|NOT COMPLETED|Overall Study||19||
60146176|NCT02116972|76270304|FG001|NOT COMPLETED|Overall Study||17||
60146177|NCT02116972|76270305|FG002|NOT COMPLETED|Overall Study||19||
60146178|NCT02091960|76270315|FG000|STARTED|Overall Study||103||
60146179|NCT02091960|76270315|FG000|Received Treatment|Overall Study||103||
60146180|NCT02091960|76270315|FG000|COMPLETED|Overall Study|Completed indicates participants with disease progression|52||
60146181|NCT02091960|76270315|FG000|NOT COMPLETED|Overall Study||51||
60146182|NCT02008396|76270321|FG000|STARTED|Overall Study||4||
60146183|NCT02008396|76270322|FG001|STARTED|Overall Study||8||
60146184|NCT02008396|76270321|FG000|COMPLETED|Overall Study||4||
60146185|NCT02008396|76270322|FG001|COMPLETED|Overall Study||7||
60146186|NCT02008396|76270321|FG000|NOT COMPLETED|Overall Study||0||
60146187|NCT02008396|76270322|FG001|NOT COMPLETED|Overall Study||1||
60146188|NCT01904136|76270338|FG000|STARTED|Overall Study||1||
60146189|NCT01904136|76270339|FG001|STARTED|Overall Study||2||
60146190|NCT01904136|76270340|FG002|STARTED|Overall Study||3||
60146191|NCT01904136|76270341|FG003|STARTED|Overall Study||3||
60146192|NCT01904136|76270342|FG004|STARTED|Overall Study||2||
60146193|NCT01904136|76270343|FG005|STARTED|Overall Study||3||
60146194|NCT01904136|76270344|FG006|STARTED|Overall Study||3||
60146195|NCT01904136|76270345|FG007|STARTED|Overall Study||10||
60146196|NCT01904136|76270346|FG008|STARTED|Overall Study||27||
60146197|NCT01904136|76270338|FG000|COMPLETED|Overall Study||1||
60146198|NCT01904136|76270339|FG001|COMPLETED|Overall Study||2||
60146199|NCT01904136|76270340|FG002|COMPLETED|Overall Study||3||
60146200|NCT01904136|76270341|FG003|COMPLETED|Overall Study||3||
59605734|NCT01996254|75715868|FG000|Full Analysis Set|Overall Study||0|Subjects from the Revised Study Design that enrolled and met all eligibility prior to Lead placement|
60146201|NCT01904136|76270342|FG004|COMPLETED|Overall Study||2||
60146202|NCT01904136|76270343|FG005|COMPLETED|Overall Study||2||
60146203|NCT01904136|76270344|FG006|COMPLETED|Overall Study||3||
60146204|NCT01904136|76270345|FG007|COMPLETED|Overall Study||10||
60146205|NCT01904136|76270346|FG008|COMPLETED|Overall Study||27||
60146206|NCT01904136|76270338|FG000|NOT COMPLETED|Overall Study||0||
60146207|NCT01904136|76270339|FG001|NOT COMPLETED|Overall Study||0||
60146208|NCT01904136|76270340|FG002|NOT COMPLETED|Overall Study||0||
60146209|NCT01904136|76270341|FG003|NOT COMPLETED|Overall Study||0||
60146210|NCT01904136|76270342|FG004|NOT COMPLETED|Overall Study||0||
60146211|NCT01904136|76270343|FG005|NOT COMPLETED|Overall Study||1||
60146212|NCT01904136|76270344|FG006|NOT COMPLETED|Overall Study||0||
60146213|NCT01904136|76270345|FG007|NOT COMPLETED|Overall Study||0||
60146214|NCT01904136|76270346|FG008|NOT COMPLETED|Overall Study||0||
60146215|NCT01863901|76270366|FG000|STARTED|Overall Study||19||
60146216|NCT01863901|76270366|FG000|COMPLETED|Overall Study||19|Completion of Day 30 timepoint is considered a completed subject.|
60146217|NCT01863901|76270366|FG000|NOT COMPLETED|Overall Study||0||
60146218|NCT01828099|76270372|FG000|STARTED|Overall Study||189||
60146219|NCT01828099|76270373|FG001|STARTED|Overall Study||187||
60146220|NCT01828099|76270372|FG000|Untreated Patients|Overall Study||0||
60146221|NCT01828099|76270373|FG001|Untreated Patients|Overall Study||12||
60146222|NCT01828099|76270372|FG000|Treated|Overall Study|discontinued from treatment phase = Not completed|189||
60146223|NCT01828099|76270373|FG001|Treated|Overall Study||175||
60146224|NCT01828099|76270372|FG000|Discontinued From Treatment Phase|Overall Study||94||
60146225|NCT01828099|76270373|FG001|Discontinued From Treatment Phase|Overall Study||157||
60146226|NCT01828099|76270372|FG000|Entered Extension-treatment Phase|Overall Study||0||
60146227|NCT01828099|76270373|FG001|Entered Extension-treatment Phase|Overall Study||81||
60146228|NCT01828099|76270372|FG000|Entered Post-treatment Follow-up Phase|Overall Study||10||
60146229|NCT01828099|76270373|FG001|Entered Post-treatment Follow-up Phase|Overall Study||16||
60146230|NCT01828099|76270372|FG000|Entered Survival Follow-up Phase|Overall Study||64||
60146231|NCT01828099|76270373|FG001|Entered Survival Follow-up Phase|Overall Study||31||
60146232|NCT01828099|76270372|FG000|Discontinued From Study|Overall Study||20||
60146233|NCT01828099|76270373|FG001|Discontinued From Study|Overall Study||29||
60146234|NCT01828099|76270372|FG000|COMPLETED|Overall Study|Completed = Patients ongoing at the time of data cut-off of 24-Jun-2016|95||
60146235|NCT01828099|76270373|FG001|COMPLETED|Overall Study|Completed = Patients ongoing at the time of data cut-off of 24-Jun-2016|30||
60146236|NCT01828099|76270372|FG000|NOT COMPLETED|Overall Study||94||
60146237|NCT01828099|76270373|FG001|NOT COMPLETED|Overall Study||157||
60146238|NCT01793610|76270382|FG000|STARTED|Overall Study||6||
60146239|NCT01793610|76270383|FG001|STARTED|Overall Study||9||
60146240|NCT01793610|76270384|FG002|STARTED|Overall Study||13||
60146241|NCT01793610|76270382|FG000|COMPLETED|Overall Study||5||
60146242|NCT01793610|76270383|FG001|COMPLETED|Overall Study||9||
60146243|NCT01793610|76270384|FG002|COMPLETED|Overall Study||12||
60146244|NCT01793610|76270382|FG000|NOT COMPLETED|Overall Study||1||
60146245|NCT01793610|76270383|FG001|NOT COMPLETED|Overall Study||0||
60146246|NCT01793610|76270384|FG002|NOT COMPLETED|Overall Study||1||
60146247|NCT01769222|76270398|FG000|STARTED|Study Phase 1||3||
60146248|NCT01769222|76270399|FG001|STARTED|Study Phase 1||0||
60146249|NCT01769222|76270398|FG000|COMPLETED|Study Phase 1||3||
60146250|NCT01769222|76270399|FG001|COMPLETED|Study Phase 1||0||
60146251|NCT01769222|76270398|FG000|NOT COMPLETED|Study Phase 1||0||
60146252|NCT01769222|76270399|FG001|NOT COMPLETED|Study Phase 1||0||
60146253|NCT01769222|76270398|FG000|STARTED|Study Phase 2||0||
60146254|NCT01769222|76270399|FG001|STARTED|Study Phase 2||0||
60146255|NCT01769222|76270398|FG000|COMPLETED|Study Phase 2||0||
60146256|NCT01769222|76270399|FG001|COMPLETED|Study Phase 2||0||
60146257|NCT01769222|76270398|FG000|NOT COMPLETED|Study Phase 2||0||
60146258|NCT01769222|76270399|FG001|NOT COMPLETED|Study Phase 2||0||
60146259|NCT01753765|76270405|FG000|STARTED|Overall Study||26||
60146260|NCT01753765|76270405|FG000|COMPLETED|Overall Study||26||
60146261|NCT01753765|76270405|FG000|NOT COMPLETED|Overall Study||0||
60146262|NCT01689740|76270412|FG000|STARTED|Overall Study||2||
60146263|NCT01689740|76270413|FG001|STARTED|Overall Study||3||
60146264|NCT01689740|76270414|FG002|STARTED|Overall Study||5||
60146265|NCT01689740|76270412|FG000|COMPLETED|Overall Study||2||
60146266|NCT01689740|76270413|FG001|COMPLETED|Overall Study||3||
60146267|NCT01689740|76270414|FG002|COMPLETED|Overall Study||5||
60146268|NCT01689740|76270412|FG000|NOT COMPLETED|Overall Study||0||
60146269|NCT01689740|76270413|FG001|NOT COMPLETED|Overall Study||0||
60146270|NCT01689740|76270414|FG002|NOT COMPLETED|Overall Study||0||
60146271|NCT01681745|76270424|FG000|STARTED|Overall Study||0||
60146272|NCT01681745|76270424|FG000|COMPLETED|Overall Study||0||
60146273|NCT01681745|76270424|FG000|NOT COMPLETED|Overall Study||0||
60146274|NCT01458327|76270428|FG000|STARTED|Overall Study||3||
60146275|NCT01458327|76270428|FG000|COMPLETED|Overall Study||3||
60146276|NCT01458327|76270428|FG000|NOT COMPLETED|Overall Study||0||
60146277|NCT01320085|76270436|FG000|STARTED|Overall Study||41||
60146278|NCT01320085|76270437|FG001|STARTED|Overall Study||117||
60146279|NCT01320085|76270438|FG002|STARTED|Overall Study||25||
60146280|NCT01320085|76270436|FG000|COMPLETED|Overall Study||0||
60146281|NCT01320085|76270437|FG001|COMPLETED|Overall Study||0||
60146282|NCT01320085|76270438|FG002|COMPLETED|Overall Study||0||
60146283|NCT01320085|76270436|FG000|NOT COMPLETED|Overall Study||41||
60146284|NCT01320085|76270437|FG001|NOT COMPLETED|Overall Study||117||
60146285|NCT01320085|76270438|FG002|NOT COMPLETED|Overall Study||25||
60146286|NCT01211405|76270449|FG000|STARTED|Overall Study||7||
60146287|NCT01211405|76270450|FG001|STARTED|Overall Study||7||
60146288|NCT01211405|76270451|FG002|STARTED|Overall Study||12||
60146289|NCT01211405|76270449|FG000|Completed Primary Endpoint|Overall Study||7||
60146290|NCT01211405|76270450|FG001|Completed Primary Endpoint|Overall Study||7||
60146291|NCT01211405|76270451|FG002|Completed Primary Endpoint|Overall Study||12||
60146292|NCT01211405|76270449|FG000|Completed Stage 1|Overall Study||6||
60146293|NCT01211405|76270450|FG001|Completed Stage 1|Overall Study||6||
60146294|NCT01211405|76270451|FG002|Completed Stage 1|Overall Study||12||
60146295|NCT01211405|76270449|FG000|Completed Stage 2|Overall Study||6||
60146296|NCT01211405|76270450|FG001|Completed Stage 2|Overall Study||6||
60146297|NCT01211405|76270451|FG002|Completed Stage 2|Overall Study||0||
60146298|NCT01211405|76270449|FG000|COMPLETED|Overall Study||6|Completed 12-month follow-up|
60146299|NCT01211405|76270450|FG001|COMPLETED|Overall Study||7|Completed 12-month follow-up|
60146300|NCT01211405|76270451|FG002|COMPLETED|Overall Study||11|Completed 12-month follow-up|
60146301|NCT01211405|76270449|FG000|NOT COMPLETED|Overall Study||1||
60146302|NCT01211405|76270450|FG001|NOT COMPLETED|Overall Study||0||
60146303|NCT01211405|76270451|FG002|NOT COMPLETED|Overall Study||1||
60146304|NCT01207492|76270459|FG000|STARTED|Overall Study||17||
60146305|NCT01207492|76270459|FG000|COMPLETED|Overall Study||2||
60146306|NCT01207492|76270459|FG000|NOT COMPLETED|Overall Study||15||
60146307|NCT01167140|76270463|FG000|STARTED|Overall Study||42||
60146308|NCT01167140|76270463|FG000|COMPLETED|Overall Study||41||
60146309|NCT01167140|76270463|FG000|NOT COMPLETED|Overall Study||1||
60146310|NCT00402298|76270469|FG000|STARTED|Overall Study||3||
60146311|NCT00402298|76270470|FG001|STARTED|Overall Study||2||
60146312|NCT00402298|76270469|FG000|COMPLETED|Overall Study||2||
60146313|NCT00402298|76270470|FG001|COMPLETED|Overall Study||2||
60146314|NCT00402298|76270469|FG000|NOT COMPLETED|Overall Study||1||
60146315|NCT00402298|76270470|FG001|NOT COMPLETED|Overall Study||0||
60146316|NCT00090064|76270478|FG000|STARTED|Overall Study||15||
60146317|NCT00090064|76270479|FG001|STARTED|Overall Study||8||
60146318|NCT00090064|76270478|FG000|COMPLETED|Overall Study||13||
60146319|NCT00090064|76270479|FG001|COMPLETED|Overall Study||8||
60146320|NCT00090064|76270478|FG000|NOT COMPLETED|Overall Study||2||
60146321|NCT00090064|76270479|FG001|NOT COMPLETED|Overall Study||0||
60146322|NCT01158573|76270491|FG000|STARTED|Overall Study|Aimed to recruit 160 from July 2010 to May 2013. Each subject studied on one time point only|30||
60146323|NCT01158573|76270492|FG001|STARTED|Overall Study||30||
60146324|NCT01158573|76270493|FG002|STARTED|Overall Study||29||
60146325|NCT01158573|76270494|FG003|STARTED|Overall Study||28||
60146326|NCT01158573|76270491|FG000|COMPLETED|Overall Study|Study completed at 117 subjects.|30||
60146327|NCT01158573|76270492|FG001|COMPLETED|Overall Study||30||
60146328|NCT01158573|76270493|FG002|COMPLETED|Overall Study||29||
60146329|NCT01158573|76270494|FG003|COMPLETED|Overall Study||28||
60146330|NCT01158573|76270491|FG000|NOT COMPLETED|Overall Study||0||
60146331|NCT01158573|76270492|FG001|NOT COMPLETED|Overall Study||0||
60146332|NCT01158573|76270493|FG002|NOT COMPLETED|Overall Study||0||
60146333|NCT01158573|76270494|FG003|NOT COMPLETED|Overall Study||0||
60146334|NCT01230177|76270504|FG000|STARTED|Overall Study||3||
60146335|NCT01230177|76270504|FG000|COMPLETED|Overall Study||3||
60146336|NCT01230177|76270504|FG000|NOT COMPLETED|Overall Study||0||
60146337|NCT01158651|76270508|FG000|STARTED|Overall Study||23||
60146338|NCT01158651|76270508|FG000|COMPLETED|Overall Study||22||
60146339|NCT01158651|76270508|FG000|NOT COMPLETED|Overall Study||1||
60146340|NCT01230801|76270515|FG000|STARTED|Overall Study||3||
60146341|NCT01230801|76270516|FG001|STARTED|Overall Study||3||
60146342|NCT01230801|76270517|FG002|STARTED|Overall Study||16||
60146343|NCT01230801|76270515|FG000|COMPLETED|Overall Study||3||
60146344|NCT01230801|76270516|FG001|COMPLETED|Overall Study||3||
60146345|NCT01230801|76270517|FG002|COMPLETED|Overall Study||15||
60146346|NCT01230801|76270515|FG000|NOT COMPLETED|Overall Study||0||
60146347|NCT01230801|76270516|FG001|NOT COMPLETED|Overall Study||0||
60146348|NCT01230801|76270517|FG002|NOT COMPLETED|Overall Study||1||
60146349|NCT01232205|76270530|FG000|STARTED|Overall Study||52||
60146350|NCT01232205|76270531|FG001|STARTED|Overall Study||58||
60146351|NCT01232205|76270530|FG000|COMPLETED|Overall Study||49||
60146352|NCT01232205|76270531|FG001|COMPLETED|Overall Study||55||
60146353|NCT01232205|76270530|FG000|NOT COMPLETED|Overall Study||3||
60146354|NCT01232205|76270531|FG001|NOT COMPLETED|Overall Study||3||
60146355|NCT01158885|76270537|FG000|STARTED|Treatment Course 1||2||
60146356|NCT01158885|76270537|FG000|COMPLETED|Treatment Course 1||2||
60146357|NCT01158885|76270537|FG000|NOT COMPLETED|Treatment Course 1||0||
60146358|NCT01158885|76270537|FG000|STARTED|Treatment Course 2|Neither of the patients that were treated on Treatment Course 1 were eligible to proceed to Course 2|0|Neither of the patients that were treated on Treatment Course 1 were eligible to proceed to Course 2|
60146359|NCT01158885|76270537|FG000|COMPLETED|Treatment Course 2||0||
60146360|NCT01158885|76270537|FG000|NOT COMPLETED|Treatment Course 2||0||
60146361|NCT01232829|76270541|FG000|STARTED|Overall Study||18||
60146362|NCT01232829|76270541|FG000|COMPLETED|Overall Study||18||
59882084|NCT03255980|76005007|FG001|NOT COMPLETED|Overall Study||8||
60146363|NCT01232829|76270541|FG000|NOT COMPLETED|Overall Study||0||
60146364|NCT01233921|76270547|FG000|STARTED|Overall Study||3||
60146365|NCT01233921|76270548|FG001|STARTED|Overall Study||3||
60146366|NCT01233921|76270547|FG000|COMPLETED|Overall Study||3||
60146367|NCT01233921|76270548|FG001|COMPLETED|Overall Study||3||
60146368|NCT01233921|76270547|FG000|NOT COMPLETED|Overall Study||0||
60146369|NCT01233921|76270548|FG001|NOT COMPLETED|Overall Study||0||
59882085|NCT03255980|76005008|FG002|NOT COMPLETED|Overall Study||6||
60146370|NCT01236105|76270554|FG000|STARTED|Overall Study||21||
60146371|NCT01236105|76270554|FG000|COMPLETED|Overall Study||21||
60146372|NCT01236105|76270554|FG000|NOT COMPLETED|Overall Study||0||
60146373|NCT01159743|76270564|FG000|STARTED|Overall Study||237||
59882086|NCT03255980|76005009|FG003|NOT COMPLETED|Overall Study||12||
60146374|NCT01159743|76270565|FG001|STARTED|Overall Study||109||
60146375|NCT01159743|76270564|FG000|COMPLETED|Overall Study||237||
60146376|NCT01159743|76270565|FG001|COMPLETED|Overall Study||109||
60146377|NCT01159743|76270564|FG000|NOT COMPLETED|Overall Study||0||
60146378|NCT01159743|76270565|FG001|NOT COMPLETED|Overall Study||0||
60146379|NCT01160445|76270573|FG000|STARTED|Overall Study||7||
60146380|NCT01160445|76270574|FG001|STARTED|Overall Study||2||
59605735|NCT01996254|75715869|FG001|Full Analysis Set|Overall Study||12|Subjects from the Revised Study Design that enrolled and met all eligibility prior to Lead placement|
59605736|NCT01996254|75715870|FG002|Full Analysis Set|Overall Study||14|Subjects from the Revised Study Design that enrolled and met all eligibility prior to Lead placement|
59605737|NCT01996254|75715868|FG000|Long Term Analysis Set|Overall Study||0|Full Analysis Set with imputed data for missed visits and exclusion due to early termination.|
59613482|NCT01684878|75724611|FG001|Participants Randomized But Not Treated|Part 2: Randomized Phase||0||
60146381|NCT01160445|76270573|FG000|COMPLETED|Overall Study||7||
60146382|NCT01160445|76270574|FG001|COMPLETED|Overall Study||2||
60146383|NCT01160445|76270573|FG000|NOT COMPLETED|Overall Study||0||
60146384|NCT01160445|76270574|FG001|NOT COMPLETED|Overall Study||0||
60146385|NCT01237041|76270585|FG000|STARTED|Overall Study||2||
60146386|NCT01237041|76270586|FG001|STARTED|Overall Study||3||
60146387|NCT01237041|76270587|FG002|STARTED|Overall Study||2||
60146388|NCT01237041|76270588|FG003|STARTED|Overall Study||5||
60146389|NCT01237041|76270589|FG004|STARTED|Overall Study||5||
60146390|NCT01237041|76270585|FG000|COMPLETED|Overall Study||2||
60146391|NCT01237041|76270586|FG001|COMPLETED|Overall Study||3||
60146392|NCT01237041|76270587|FG002|COMPLETED|Overall Study||2||
60146393|NCT01237041|76270588|FG003|COMPLETED|Overall Study||5||
60146394|NCT01237041|76270589|FG004|COMPLETED|Overall Study||5||
60146395|NCT01237041|76270585|FG000|NOT COMPLETED|Overall Study||0||
60146396|NCT01237041|76270586|FG001|NOT COMPLETED|Overall Study||0||
60146397|NCT01237041|76270587|FG002|NOT COMPLETED|Overall Study||0||
60146398|NCT01237041|76270588|FG003|NOT COMPLETED|Overall Study||0||
60146399|NCT01237041|76270589|FG004|NOT COMPLETED|Overall Study||0||
60146400|NCT01237197|76270601|FG000|STARTED|Randomization Period||13||
60146401|NCT01237197|76270602|FG001|STARTED|Randomization Period||13||
60146402|NCT01237197|76270601|FG000|COMPLETED|Randomization Period||12||
60146403|NCT01237197|76270602|FG001|COMPLETED|Randomization Period||10||
60146404|NCT01237197|76270601|FG000|NOT COMPLETED|Randomization Period||1||
60146405|NCT01237197|76270602|FG001|NOT COMPLETED|Randomization Period||3||
60146406|NCT01237197|76270601|FG000|STARTED|Open Label Period||12||
60146407|NCT01237197|76270602|FG001|STARTED|Open Label Period||10||
60146408|NCT01237197|76270601|FG000|COMPLETED|Open Label Period||12||
60146409|NCT01237197|76270602|FG001|COMPLETED|Open Label Period||10||
60146410|NCT01237197|76270601|FG000|NOT COMPLETED|Open Label Period||0||
60146411|NCT01237197|76270602|FG001|NOT COMPLETED|Open Label Period||0||
60146412|NCT01237353|76270608|FG000|STARTED|Overall Study||6||
60146413|NCT01237353|76270608|FG000|COMPLETED|Overall Study||6||
60146414|NCT01237353|76270608|FG000|NOT COMPLETED|Overall Study||0||
60146415|NCT01237821|76270614|FG000|STARTED|Overall Study||32||
60146416|NCT01237821|76270615|FG001|STARTED|Overall Study||34||
60146417|NCT01237821|76270614|FG000|COMPLETED|Overall Study||26||
60146418|NCT01237821|76270615|FG001|COMPLETED|Overall Study||34||
60146419|NCT01237821|76270614|FG000|NOT COMPLETED|Overall Study||6||
60146420|NCT01237821|76270615|FG001|NOT COMPLETED|Overall Study||0||
60146421|NCT01241565|76270621|FG000|STARTED|Overall Study||50||
60146422|NCT01241565|76270621|FG000|COMPLETED|Overall Study||50||
60146423|NCT01241565|76270621|FG000|NOT COMPLETED|Overall Study||0||
60146424|NCT01161225|76270629|FG000|STARTED|Overall Study||59||
60146425|NCT01161225|76270630|FG001|STARTED|Overall Study||53||
60146426|NCT01161225|76270631|FG002|STARTED|Overall Study||14||
60146427|NCT01161225|76270629|FG000|COMPLETED|Overall Study||45||
60146428|NCT01161225|76270630|FG001|COMPLETED|Overall Study||44||
60146429|NCT01161225|76270631|FG002|COMPLETED|Overall Study||12||
60146430|NCT01161225|76270629|FG000|NOT COMPLETED|Overall Study||14||
60146431|NCT01161225|76270630|FG001|NOT COMPLETED|Overall Study||9||
60146432|NCT01161225|76270631|FG002|NOT COMPLETED|Overall Study||2||
60146433|NCT01243593|76270645|FG000|STARTED|Overall Study||16||
60146434|NCT01243593|76270646|FG001|STARTED|Overall Study||16||
60146435|NCT01243593|76270645|FG000|COMPLETED|Overall Study||16||
60146436|NCT01243593|76270646|FG001|COMPLETED|Overall Study||16||
60146437|NCT01243593|76270645|FG000|NOT COMPLETED|Overall Study||0||
60146438|NCT01243593|76270646|FG001|NOT COMPLETED|Overall Study||0||
60146439|NCT01161771|76270652|FG000|STARTED|Overall Study||32||
60146440|NCT01161771|76270652|FG000|COMPLETED|Overall Study||32||
60146441|NCT01161771|76270652|FG000|NOT COMPLETED|Overall Study||0||
60146442|NCT04362761|76270656|FG000|STARTED|Part A (48 Weeks)||172||
60146443|NCT04362761|76270656|FG000|COMPLETED|Part A (48 Weeks)||159||
60146444|NCT04362761|76270656|FG000|NOT COMPLETED|Part A (48 Weeks)||13||
60146445|NCT04362761|76270656|FG000|STARTED|Part B (86 Weeks)|Out of the 172 participants from Part A, only 50 participants participated in Part B of the study.|50||
60146446|NCT04362761|76270656|FG000|COMPLETED|Part B (86 Weeks)||0||
60146447|NCT04362761|76270656|FG000|NOT COMPLETED|Part B (86 Weeks)||50||
60146448|NCT01162005|76270664|FG000|STARTED|Overall Study||44||
60146449|NCT01162005|76270665|FG001|STARTED|Overall Study||33||
60146450|NCT01162005|76270664|FG000|COMPLETED|Overall Study||44||
60146451|NCT01162005|76270665|FG001|COMPLETED|Overall Study||33||
60146452|NCT01162005|76270664|FG000|NOT COMPLETED|Overall Study||0||
60146453|NCT01162005|76270665|FG001|NOT COMPLETED|Overall Study||0||
60146454|NCT01244451|76270673|FG000|STARTED|Overall Study||49||
60146455|NCT01244451|76270673|FG000|COMPLETED|Overall Study||36||
60146456|NCT01244451|76270673|FG000|NOT COMPLETED|Overall Study||13||
60146457|NCT01244529|76270678|FG000|STARTED|Overall Study||41||
60146458|NCT01244529|76270678|FG000|COMPLETED|Overall Study||41||
60146459|NCT01244529|76270678|FG000|NOT COMPLETED|Overall Study||0||
60146460|NCT01162317|76270696|FG000|STARTED|Overall Study||30||
60146461|NCT01162317|76270697|FG001|STARTED|Overall Study||30||
60146462|NCT01162317|76270696|FG000|COMPLETED|Overall Study||27||
60146463|NCT01162317|76270697|FG001|COMPLETED|Overall Study||28||
60146464|NCT01162317|76270696|FG000|NOT COMPLETED|Overall Study||3||
60146465|NCT01162317|76270697|FG001|NOT COMPLETED|Overall Study||2||
60146466|NCT01245699|76270705|FG000|STARTED|Overall Study||61||
60146467|NCT01245699|76270706|FG001|STARTED|Overall Study||54||
60146468|NCT01245699|76270705|FG000|COMPLETED|Overall Study||52||
60146469|NCT01245699|76270706|FG001|COMPLETED|Overall Study||49||
60146470|NCT01245699|76270705|FG000|NOT COMPLETED|Overall Study||9||
60146471|NCT01245699|76270706|FG001|NOT COMPLETED|Overall Study||5||
60146472|NCT01246401|76270715|FG000|STARTED|Overall Study||66||
60146473|NCT01246401|76270716|FG001|STARTED|Overall Study||27||
60146474|NCT01246401|76270715|FG000|COMPLETED|Overall Study||66||
60146475|NCT01246401|76270716|FG001|COMPLETED|Overall Study||27||
60146476|NCT01246401|76270715|FG000|NOT COMPLETED|Overall Study||0||
60146477|NCT01246401|76270716|FG001|NOT COMPLETED|Overall Study||0||
60146478|NCT01281501|76270726|FG000|STARTED|Overall Study||44||
60146479|NCT01281501|76270727|FG001|STARTED|Overall Study||43||
60146480|NCT01281501|76270726|FG000|COMPLETED|Overall Study||44||
60146481|NCT01281501|76270727|FG001|COMPLETED|Overall Study||43||
60146482|NCT01281501|76270726|FG000|NOT COMPLETED|Overall Study||0||
60146483|NCT01281501|76270727|FG001|NOT COMPLETED|Overall Study||0||
60146484|NCT01246479|76270733|FG000|STARTED|Overall Study||23||
60146485|NCT01246479|76270733|FG000|COMPLETED|Overall Study|primary endpoint at Month 12|18||
60146486|NCT01246479|76270733|FG000|NOT COMPLETED|Overall Study||5||
60146487|NCT01246713|76270737|FG000|STARTED|First Acetaminophen Dosing (1 Day)||6||
60146488|NCT01246713|76270738|FG001|STARTED|First Acetaminophen Dosing (1 Day)||9||
60146489|NCT01246713|76270737|FG000|COMPLETED|First Acetaminophen Dosing (1 Day)||6||
60146490|NCT01246713|76270738|FG001|COMPLETED|First Acetaminophen Dosing (1 Day)||9||
60146491|NCT01246713|76270737|FG000|NOT COMPLETED|First Acetaminophen Dosing (1 Day)||0||
60146492|NCT01246713|76270738|FG001|NOT COMPLETED|First Acetaminophen Dosing (1 Day)||0||
60146493|NCT01246713|76270737|FG000|STARTED|Washout (at Least 14 Days)||6||
60146494|NCT01246713|76270738|FG001|STARTED|Washout (at Least 14 Days)||9||
60146495|NCT01246713|76270737|FG000|COMPLETED|Washout (at Least 14 Days)||6||
60146496|NCT01246713|76270738|FG001|COMPLETED|Washout (at Least 14 Days)||9||
60146497|NCT01246713|76270737|FG000|NOT COMPLETED|Washout (at Least 14 Days)||0||
60146498|NCT01246713|76270738|FG001|NOT COMPLETED|Washout (at Least 14 Days)||0||
60146499|NCT01246713|76270737|FG000|STARTED|Second Acetaminophen Dosing (1 Day)||6||
60146500|NCT01246713|76270738|FG001|STARTED|Second Acetaminophen Dosing (1 Day)||9||
60146501|NCT01246713|76270737|FG000|COMPLETED|Second Acetaminophen Dosing (1 Day)||6||
60146502|NCT01246713|76270738|FG001|COMPLETED|Second Acetaminophen Dosing (1 Day)||9||
60146503|NCT01246713|76270737|FG000|NOT COMPLETED|Second Acetaminophen Dosing (1 Day)||0||
60146504|NCT01246713|76270738|FG001|NOT COMPLETED|Second Acetaminophen Dosing (1 Day)||0||
60146505|NCT01246791|76270744|FG000|STARTED|Overall Study||12||
60146506|NCT01246791|76270744|FG000|COMPLETED|Overall Study||12||
60146507|NCT01246791|76270744|FG000|NOT COMPLETED|Overall Study||0||
60146508|NCT01247571|76270748|FG000|STARTED|Overall Study||22||
60146509|NCT01247571|76270748|FG000|COMPLETED|Overall Study||19||
60146510|NCT01247571|76270748|FG000|NOT COMPLETED|Overall Study||3||
60146511|NCT01285635|76270755|FG000|STARTED|First Intervention (2 Weeks)||13||
60146512|NCT01285635|76270756|FG001|STARTED|First Intervention (2 Weeks)||11||
60146513|NCT01285635|76270757|FG002|STARTED|First Intervention (2 Weeks)||11||
60146514|NCT01285635|76270755|FG000|COMPLETED|First Intervention (2 Weeks)||13||
60146515|NCT01285635|76270756|FG001|COMPLETED|First Intervention (2 Weeks)||11||
60146516|NCT01285635|76270757|FG002|COMPLETED|First Intervention (2 Weeks)||11||
60146517|NCT01285635|76270755|FG000|NOT COMPLETED|First Intervention (2 Weeks)||0||
60146518|NCT01285635|76270756|FG001|NOT COMPLETED|First Intervention (2 Weeks)||0||
60146519|NCT01285635|76270757|FG002|NOT COMPLETED|First Intervention (2 Weeks)||0||
60146520|NCT01285635|76270755|FG000|STARTED|Second Intervention (10, 3 Week Cycles)||13||
60146521|NCT01285635|76270756|FG001|STARTED|Second Intervention (10, 3 Week Cycles)||11||
60146522|NCT01285635|76270757|FG002|STARTED|Second Intervention (10, 3 Week Cycles)||11||
60146523|NCT01285635|76270755|FG000|COMPLETED|Second Intervention (10, 3 Week Cycles)||13||
60146524|NCT01285635|76270756|FG001|COMPLETED|Second Intervention (10, 3 Week Cycles)||11||
60146525|NCT01285635|76270757|FG002|COMPLETED|Second Intervention (10, 3 Week Cycles)||11||
60146526|NCT01285635|76270755|FG000|NOT COMPLETED|Second Intervention (10, 3 Week Cycles)||0||
60146527|NCT01285635|76270756|FG001|NOT COMPLETED|Second Intervention (10, 3 Week Cycles)||0||
60146528|NCT01285635|76270757|FG002|NOT COMPLETED|Second Intervention (10, 3 Week Cycles)||0||
60146529|NCT01285713|76270770|FG000|STARTED|Overall Study||42||
60146530|NCT01285713|76270771|FG001|STARTED|Overall Study||41||
60146531|NCT01285713|76270770|FG000|COMPLETED|Overall Study||42||
60146532|NCT01285713|76270771|FG001|COMPLETED|Overall Study||41||
60146533|NCT01285713|76270770|FG000|NOT COMPLETED|Overall Study||0||
60146534|NCT01285713|76270771|FG001|NOT COMPLETED|Overall Study||0||
60146535|NCT01285791|76270780|FG000|STARTED|Overall Study||11||
60146536|NCT01285791|76270781|FG001|STARTED|Overall Study||15||
60146537|NCT01285791|76270782|FG002|STARTED|Overall Study||13||
60146538|NCT01285791|76270780|FG000|COMPLETED|Overall Study||11||
60146539|NCT01285791|76270781|FG001|COMPLETED|Overall Study||15||
60146540|NCT01285791|76270782|FG002|COMPLETED|Overall Study||13||
60146541|NCT01285791|76270780|FG000|NOT COMPLETED|Overall Study||0||
60146542|NCT01285791|76270781|FG001|NOT COMPLETED|Overall Study||0||
60146543|NCT01285791|76270782|FG002|NOT COMPLETED|Overall Study||0||
60146544|NCT01286259|76270790|FG000|STARTED|Overall Study||16||
60146545|NCT01286259|76270790|FG000|COMPLETED|Overall Study||16||
60146546|NCT01286259|76270790|FG000|NOT COMPLETED|Overall Study||0||
60146547|NCT01286493|76270794|FG000|STARTED|Overall Study||33||
60146548|NCT01286493|76270794|FG000|COMPLETED|Overall Study||30||
60146549|NCT01286493|76270794|FG000|NOT COMPLETED|Overall Study||3||
60146550|NCT01286805|76270800|FG000|STARTED|Overall Study||41||
60146551|NCT01286805|76270801|FG001|STARTED|Overall Study||42||
60146552|NCT01286805|76270800|FG000|COMPLETED|Overall Study||41||
60146553|NCT01286805|76270801|FG001|COMPLETED|Overall Study||41||
60146554|NCT01286805|76270800|FG000|NOT COMPLETED|Overall Study||0||
60146555|NCT01286805|76270801|FG001|NOT COMPLETED|Overall Study||1||
60146556|NCT04019561|76270810|FG000|STARTED|Overall Study||25||
60146557|NCT04019561|76270811|FG001|STARTED|Overall Study||25||
60146558|NCT04019561|76270812|FG002|STARTED|Overall Study||24||
60146559|NCT04019561|76270810|FG000|COMPLETED|Overall Study||21||
60146560|NCT04019561|76270811|FG001|COMPLETED|Overall Study||23||
60146561|NCT04019561|76270812|FG002|COMPLETED|Overall Study||19||
60146562|NCT04019561|76270810|FG000|NOT COMPLETED|Overall Study||4||
60146563|NCT04019561|76270811|FG001|NOT COMPLETED|Overall Study||2||
60146564|NCT04019561|76270812|FG002|NOT COMPLETED|Overall Study||5||
60146565|NCT01288521|76270822|FG000|STARTED|Overall Study||3||
60146566|NCT01288521|76270823|FG001|STARTED|Overall Study||5||
60146567|NCT01288521|76270822|FG000|COMPLETED|Overall Study||3||
60146568|NCT01288521|76270823|FG001|COMPLETED|Overall Study||5||
60146569|NCT01288521|76270822|FG000|NOT COMPLETED|Overall Study||0||
60146570|NCT01288521|76270823|FG001|NOT COMPLETED|Overall Study||0||
60146571|NCT01288833|76270831|FG000|STARTED|Overall Study||277||
60146572|NCT01288833|76270832|FG001|STARTED|Overall Study||281||
60146573|NCT01288833|76270831|FG000|COMPLETED|Overall Study||277||
60146574|NCT01288833|76270832|FG001|COMPLETED|Overall Study||281||
60146575|NCT01288833|76270831|FG000|NOT COMPLETED|Overall Study||0||
60146576|NCT01288833|76270832|FG001|NOT COMPLETED|Overall Study||0||
60146577|NCT00632749|76270852|FG000|STARTED|Overall Study||4||
60146578|NCT00632749|76270853|FG001|STARTED|Overall Study||5||
60146579|NCT00632749|76270854|FG002|STARTED|Overall Study||3||
60146580|NCT00632749|76270855|FG003|STARTED|Overall Study||4||
60146581|NCT00632749|76270856|FG004|STARTED|Overall Study||7||
60146582|NCT00632749|76270857|FG005|STARTED|Overall Study||8||
60146583|NCT00632749|76270858|FG006|STARTED|Overall Study||5||
60146584|NCT00632749|76270859|FG007|STARTED|Overall Study||4||
60146585|NCT00632749|76270860|FG008|STARTED|Overall Study||5||
60146586|NCT00632749|76270861|FG009|STARTED|Overall Study||3||
60146587|NCT00632749|76270862|FG010|STARTED|Overall Study||7||
60146588|NCT00632749|76270863|FG011|STARTED|Overall Study||4||
60146589|NCT00632749|76270864|FG012|STARTED|Overall Study||3||
60146590|NCT00632749|76270865|FG013|STARTED|Overall Study||6||
60146591|NCT00632749|76270852|FG000|Treated|Overall Study||4||
60146592|NCT00632749|76270853|FG001|Treated|Overall Study||3||
60146593|NCT00632749|76270854|FG002|Treated|Overall Study||3||
60146594|NCT00632749|76270855|FG003|Treated|Overall Study||4||
60146595|NCT00632749|76270856|FG004|Treated|Overall Study||7||
60146596|NCT00632749|76270857|FG005|Treated|Overall Study||7||
60146597|NCT00632749|76270858|FG006|Treated|Overall Study||4||
60146598|NCT00632749|76270859|FG007|Treated|Overall Study||4||
60146599|NCT00632749|76270860|FG008|Treated|Overall Study||5||
59751477|NCT00646399|75870801|FG001|COMPLETED|Overall Study||713||
59751478|NCT00646399|75870800|FG000|NOT COMPLETED|Overall Study||83||
60146600|NCT00632749|76270861|FG009|Treated|Overall Study||3||
60146601|NCT00632749|76270862|FG010|Treated|Overall Study||7||
60146602|NCT00632749|76270863|FG011|Treated|Overall Study||4||
60146603|NCT00632749|76270864|FG012|Treated|Overall Study||3||
60146604|NCT00632749|76270865|FG013|Treated|Overall Study||6||
60146605|NCT00632749|76270852|FG000|Not Treated|Overall Study||0||
59751479|NCT00646399|75870801|FG001|NOT COMPLETED|Overall Study||74||
59751480|NCT00652327|75870809|FG000|STARTED|Overall Study|Participants who recieved randomized treatment assignment to ezetimibe and ongoing statin|42||
59751481|NCT00652327|75870810|FG001|STARTED|Overall Study|Participants who recieved randomized treatment assignment to double the dose of ongoing statin|41||
60146606|NCT00632749|76270853|FG001|Not Treated|Overall Study||2||
60146607|NCT00632749|76270854|FG002|Not Treated|Overall Study||0||
60146608|NCT00632749|76270855|FG003|Not Treated|Overall Study||0||
60146609|NCT00632749|76270856|FG004|Not Treated|Overall Study||0||
60146610|NCT00632749|76270857|FG005|Not Treated|Overall Study||1||
60146611|NCT00632749|76270858|FG006|Not Treated|Overall Study||1||
60146612|NCT00632749|76270859|FG007|Not Treated|Overall Study||0||
60146613|NCT00632749|76270860|FG008|Not Treated|Overall Study||0||
60146614|NCT00632749|76270861|FG009|Not Treated|Overall Study||0||
60146615|NCT00632749|76270862|FG010|Not Treated|Overall Study||0||
60146616|NCT00632749|76270863|FG011|Not Treated|Overall Study||0||
60146617|NCT00632749|76270864|FG012|Not Treated|Overall Study||0||
60146618|NCT00632749|76270865|FG013|Not Treated|Overall Study||0||
60146619|NCT00632749|76270852|FG000|COMPLETED|Overall Study||0||
60146620|NCT00632749|76270853|FG001|COMPLETED|Overall Study||0||
59751482|NCT00652327|75870809|FG000|COMPLETED|Overall Study||42||
59751483|NCT00652327|75870810|FG001|COMPLETED|Overall Study||36||
59751484|NCT00652327|75870809|FG000|NOT COMPLETED|Overall Study||0||
59751485|NCT00652327|75870810|FG001|NOT COMPLETED|Overall Study||5||
59751486|NCT00645853|75870818|FG000|STARTED|Overall Study||288||
59751487|NCT00645853|75870819|FG001|STARTED|Overall Study||235||
60010611|NCT01982448|76126315|FG001|COMPLETED|Preoperative Chemotherapy||67||
60010612|NCT01982448|76126314|FG000|NOT COMPLETED|Preoperative Chemotherapy||3||
60146621|NCT00632749|76270854|FG002|COMPLETED|Overall Study||0||
60146622|NCT00632749|76270855|FG003|COMPLETED|Overall Study||0||
60146623|NCT00632749|76270856|FG004|COMPLETED|Overall Study||0||
60146624|NCT00632749|76270857|FG005|COMPLETED|Overall Study||0||
60146625|NCT00632749|76270858|FG006|COMPLETED|Overall Study||0||
60146626|NCT00632749|76270859|FG007|COMPLETED|Overall Study||0||
60146627|NCT00632749|76270860|FG008|COMPLETED|Overall Study||0||
60146628|NCT00632749|76270861|FG009|COMPLETED|Overall Study||0||
60146629|NCT00632749|76270862|FG010|COMPLETED|Overall Study||0||
60146630|NCT00632749|76270863|FG011|COMPLETED|Overall Study||0||
60146631|NCT00632749|76270864|FG012|COMPLETED|Overall Study||0||
60146632|NCT00632749|76270865|FG013|COMPLETED|Overall Study||0||
60146633|NCT00632749|76270852|FG000|NOT COMPLETED|Overall Study||4||
60146634|NCT00632749|76270853|FG001|NOT COMPLETED|Overall Study||5||
60146635|NCT00632749|76270854|FG002|NOT COMPLETED|Overall Study||3||
60146636|NCT00632749|76270855|FG003|NOT COMPLETED|Overall Study||4||
60146637|NCT00632749|76270856|FG004|NOT COMPLETED|Overall Study||7||
60146638|NCT00632749|76270857|FG005|NOT COMPLETED|Overall Study||8||
60146639|NCT00632749|76270858|FG006|NOT COMPLETED|Overall Study||5||
60146640|NCT00632749|76270859|FG007|NOT COMPLETED|Overall Study||4||
60146641|NCT00632749|76270860|FG008|NOT COMPLETED|Overall Study||5||
60146642|NCT00632749|76270861|FG009|NOT COMPLETED|Overall Study||3||
60146643|NCT00632749|76270862|FG010|NOT COMPLETED|Overall Study||7||
60146644|NCT00632749|76270863|FG011|NOT COMPLETED|Overall Study||4||
60146645|NCT00632749|76270864|FG012|NOT COMPLETED|Overall Study||3||
60146646|NCT00632749|76270865|FG013|NOT COMPLETED|Overall Study||6||
60146647|NCT01289067|76270901|FG000|STARTED|Overall Study||13||
60146648|NCT01289067|76270901|FG000|COMPLETED|Overall Study||13||
60146649|NCT01289067|76270901|FG000|NOT COMPLETED|Overall Study||0||
60146650|NCT03616223|76270909|FG000|STARTED|Overall Study||4||
60146651|NCT03616223|76270910|FG001|STARTED|Overall Study||4||
60146652|NCT03616223|76270911|FG002|STARTED|Overall Study||7||
60146653|NCT03616223|76270912|FG003|STARTED|Overall Study||8||
60146654|NCT03616223|76270909|FG000|COMPLETED|Overall Study||4||
60146655|NCT03616223|76270910|FG001|COMPLETED|Overall Study||4||
60010613|NCT01982448|76126315|FG001|NOT COMPLETED|Preoperative Chemotherapy||5||
60010614|NCT01982448|76126314|FG000|STARTED|Definitive Breast Surgery||72||
60010615|NCT01982448|76126315|FG001|STARTED|Definitive Breast Surgery||67||
60010616|NCT01982448|76126314|FG000|Evaluable for Response by Homologous Recombination Deficiency (HRD)|Definitive Breast Surgery||56|Participants with baseline diagnostic tissue for HRD analysis.|
60010617|NCT01982448|76126315|FG001|Evaluable for Response by Homologous Recombination Deficiency (HRD)|Definitive Breast Surgery||48|Participants with baseline diagnostic tissue for HRD analysis.|
60010618|NCT01982448|76126314|FG000|COMPLETED|Definitive Breast Surgery||72||
60010619|NCT01982448|76126315|FG001|COMPLETED|Definitive Breast Surgery||67||
60010620|NCT01982448|76126314|FG000|NOT COMPLETED|Definitive Breast Surgery||0||
60010621|NCT01982448|76126315|FG001|NOT COMPLETED|Definitive Breast Surgery||0||
60010622|NCT01773421|76126329|FG000|STARTED|Treatment Phase||7||
60010623|NCT01773421|76126330|FG001|STARTED|Treatment Phase||8||
60010624|NCT01773421|76126331|FG002|STARTED|Treatment Phase||19||
59518908|NCT03538678|75612794|FG001|STARTED|Overall Study||20||
59751488|NCT00645853|75870818|FG000|No of Patients After Dose Switch|Overall Study|All patients in the AZD0837 arm switched from their initial doses, to a general dose of 300 mg od|209||
59751489|NCT00645853|75870819|FG001|No of Patients After Dose Switch|Overall Study|No changes for VKA patients|188||
59751490|NCT00645853|75870818|FG000|Discontinued Patient No Due to Closure|Overall Study|No of patients discontinued due the study termination caused tablet formulation stability problems|196||
60010625|NCT01773421|76126332|FG003|STARTED|Treatment Phase||7||
60010626|NCT01773421|76126333|FG004|STARTED|Treatment Phase||0||
59762632|NCT00868998|75882465|FG000|NOT COMPLETED|Overall Study||5||
59762633|NCT04920929|75882471|FG000|STARTED|Overall Study||3||
60010627|NCT01773421|76126334|FG005|STARTED|Treatment Phase||0||
60010628|NCT01773421|76126335|FG006|STARTED|Treatment Phase||0||
60010629|NCT01773421|76126329|FG000|COMPLETED|Treatment Phase||7||
60146656|NCT03616223|76270911|FG002|COMPLETED|Overall Study||7||
60146657|NCT03616223|76270912|FG003|COMPLETED|Overall Study||8||
60146658|NCT03616223|76270909|FG000|NOT COMPLETED|Overall Study||0||
60146659|NCT03616223|76270910|FG001|NOT COMPLETED|Overall Study||0||
60146660|NCT03616223|76270911|FG002|NOT COMPLETED|Overall Study||0||
60146661|NCT03616223|76270912|FG003|NOT COMPLETED|Overall Study||0||
60146662|NCT00632359|76270926|FG000|STARTED|Overall Study||33||
60146663|NCT00632359|76270926|FG000|COMPLETED|Overall Study||31||
60146664|NCT00632359|76270926|FG000|NOT COMPLETED|Overall Study||2||
60146665|NCT00632203|76270933|FG000|STARTED|Overall Study||26||
60146666|NCT00632203|76270934|FG001|STARTED|Overall Study||27||
60146667|NCT00632203|76270933|FG000|COMPLETED|Overall Study||25||
60146668|NCT00632203|76270934|FG001|COMPLETED|Overall Study||27||
60146669|NCT00632203|76270933|FG000|NOT COMPLETED|Overall Study||1||
60146670|NCT00632203|76270934|FG001|NOT COMPLETED|Overall Study||0||
60146671|NCT01289457|76270943|FG000|STARTED|Overall Study||12||
60146672|NCT01289457|76270944|FG001|STARTED|Overall Study||157||
60146673|NCT01289457|76270945|FG002|STARTED|Overall Study||113||
60146674|NCT01289457|76270943|FG000|COMPLETED|Overall Study||12||
60146675|NCT01289457|76270944|FG001|COMPLETED|Overall Study||157||
60146676|NCT01289457|76270945|FG002|COMPLETED|Overall Study||113||
60146677|NCT01289457|76270943|FG000|NOT COMPLETED|Overall Study||0||
60146678|NCT01289457|76270944|FG001|NOT COMPLETED|Overall Study||0||
60146679|NCT01289457|76270945|FG002|NOT COMPLETED|Overall Study||0||
60146680|NCT03830333|76270955|FG000|STARTED|Overall Study||134||
60146681|NCT03830333|76270956|FG001|STARTED|Overall Study||134||
60146682|NCT03830333|76270955|FG000|Clinically Evaluable Population|Overall Study||105||
60146683|NCT03830333|76270956|FG001|Clinically Evaluable Population|Overall Study||116||
60146684|NCT03830333|76270955|FG000|COMPLETED|Overall Study||126||
60146685|NCT03830333|76270956|FG001|COMPLETED|Overall Study||130||
60146686|NCT03830333|76270955|FG000|NOT COMPLETED|Overall Study||8||
60146687|NCT03830333|76270956|FG001|NOT COMPLETED|Overall Study||4||
60146688|NCT01248741|76270962|FG000|STARTED|Overall Study||20||
60146689|NCT01248741|76270962|FG000|COMPLETED|Overall Study||20||
60146690|NCT01248741|76270962|FG000|NOT COMPLETED|Overall Study||0||
60146691|NCT01251315|76270972|FG000|STARTED|Overall Study||4||
60146692|NCT01251315|76270973|FG001|STARTED|Overall Study||4||
59605738|NCT01996254|75715869|FG001|Long Term Analysis Set|Overall Study||12|Full Analysis Set with imputed data for missed visits and exclusion due to early termination.|
59762634|NCT04920929|75882472|FG001|STARTED|Overall Study||4||
60146693|NCT01251315|76270974|FG002|STARTED|Overall Study||4||
60146694|NCT01251315|76270975|FG003|STARTED|Overall Study||4||
60146695|NCT01251315|76270976|FG004|STARTED|Overall Study||4||
60146696|NCT01251315|76270977|FG005|STARTED|Overall Study||4||
60146697|NCT01251315|76270972|FG000|COMPLETED|Overall Study||4||
60146698|NCT01251315|76270973|FG001|COMPLETED|Overall Study||4||
60146699|NCT01251315|76270974|FG002|COMPLETED|Overall Study||4||
60146700|NCT01251315|76270975|FG003|COMPLETED|Overall Study||4||
60146701|NCT01251315|76270976|FG004|COMPLETED|Overall Study||4||
60146702|NCT01251315|76270977|FG005|COMPLETED|Overall Study||4||
60146703|NCT01251315|76270972|FG000|NOT COMPLETED|Overall Study||0||
60146704|NCT01251315|76270973|FG001|NOT COMPLETED|Overall Study||0||
60146705|NCT01251315|76270974|FG002|NOT COMPLETED|Overall Study||0||
60146706|NCT01251315|76270975|FG003|NOT COMPLETED|Overall Study||0||
60146707|NCT01251315|76270976|FG004|NOT COMPLETED|Overall Study||0||
60146708|NCT01251315|76270977|FG005|NOT COMPLETED|Overall Study||0||
60146709|NCT01290237|76270997|FG000|STARTED|Overall Study||30||
60146710|NCT01290237|76270998|FG001|STARTED|Overall Study||29||
60146711|NCT01290237|76270997|FG000|COMPLETED|Overall Study||19||
60146712|NCT01290237|76270998|FG001|COMPLETED|Overall Study||27||
60146713|NCT01290237|76270997|FG000|NOT COMPLETED|Overall Study||11||
60146714|NCT01290237|76270998|FG001|NOT COMPLETED|Overall Study||2||
60146715|NCT01251393|76271008|FG000|STARTED|Overall Study||56||
60146716|NCT01251393|76271009|FG001|STARTED|Overall Study||55||
60146717|NCT01251393|76271008|FG000|COMPLETED|Overall Study||24||
60146718|NCT01251393|76271009|FG001|COMPLETED|Overall Study||11||
60146719|NCT01251393|76271008|FG000|NOT COMPLETED|Overall Study||32||
60146720|NCT01251393|76271009|FG001|NOT COMPLETED|Overall Study||44||
60146721|NCT01253343|76271017|FG000|STARTED|Overall Study||9||
60146722|NCT01253343|76271018|FG001|STARTED|Overall Study||8||
60146723|NCT01253343|76271017|FG000|COMPLETED|Overall Study||9||
60146724|NCT01253343|76271018|FG001|COMPLETED|Overall Study||8||
60146725|NCT01253343|76271017|FG000|NOT COMPLETED|Overall Study||0||
60146726|NCT01253343|76271018|FG001|NOT COMPLETED|Overall Study||0||
60146727|NCT00631969|76271042|FG000|STARTED|Overall Study||186||
60146728|NCT00631969|76271043|FG001|STARTED|Overall Study||176||
60146729|NCT00631969|76271042|FG000|Received Treatment|Overall Study|safety population|184||
60146730|NCT00631969|76271043|FG001|Received Treatment|Overall Study|safety population|174||
60146731|NCT00631969|76271042|FG000|COMPLETED|Overall Study||171||
60146732|NCT00631969|76271043|FG001|COMPLETED|Overall Study||155||
60146733|NCT00631969|76271042|FG000|NOT COMPLETED|Overall Study||15||
60146734|NCT00631969|76271043|FG001|NOT COMPLETED|Overall Study||21||
60146735|NCT03539861|76271051|FG000|STARTED|Overall Study||2||
60146736|NCT03539861|76271051|FG000|COMPLETED|Overall Study||2||
60146737|NCT03539861|76271051|FG000|NOT COMPLETED|Overall Study||0||
60146738|NCT01290627|76271058|FG000|STARTED|Overall Study||10||
60146739|NCT01290627|76271059|FG001|STARTED|Overall Study||10||
60146740|NCT01290627|76271060|FG002|STARTED|Overall Study||10||
60146741|NCT01290627|76271058|FG000|COMPLETED|Overall Study||10||
60146742|NCT01290627|76271059|FG001|COMPLETED|Overall Study||10||
60146743|NCT01290627|76271060|FG002|COMPLETED|Overall Study||10||
60146744|NCT01290627|76271058|FG000|NOT COMPLETED|Overall Study||0||
60146745|NCT01290627|76271059|FG001|NOT COMPLETED|Overall Study||0||
60146746|NCT01290627|76271060|FG002|NOT COMPLETED|Overall Study||0||
60146747|NCT01255137|76271068|FG000|STARTED|Overall Study||13||
60146748|NCT01255137|76271068|FG000|COMPLETED|Overall Study||13||
60146749|NCT01255137|76271068|FG000|NOT COMPLETED|Overall Study||0||
60146750|NCT01255449|76271072|FG000|STARTED|Overall Study||26||
60146751|NCT01255449|76271072|FG000|COMPLETED|Overall Study||26||
60146752|NCT01255449|76271072|FG000|NOT COMPLETED|Overall Study||0||
60146753|NCT00631657|76271079|FG000|STARTED|6-Month Treatment Period||344||
60146754|NCT00631657|76271080|FG001|STARTED|6-Month Treatment Period||0||
60146755|NCT00631657|76271081|FG002|STARTED|6-Month Treatment Period||116||
60146756|NCT00631657|76271079|FG000|Treated|6-Month Treatment Period|Two randomized participants were not treated during the 6-month Treatment Period.|342||
60146757|NCT00631657|76271080|FG001|Treated|6-Month Treatment Period||0||
60146758|NCT00631657|76271081|FG002|Treated|6-Month Treatment Period|One randomized participant was not treated during the 6-month Treatment Period.|115||
60146759|NCT00631657|76271079|FG000|COMPLETED|6-Month Treatment Period||203||
60146760|NCT00631657|76271080|FG001|COMPLETED|6-Month Treatment Period||0||
60146761|NCT00631657|76271081|FG002|COMPLETED|6-Month Treatment Period||66||
60146762|NCT00631657|76271079|FG000|NOT COMPLETED|6-Month Treatment Period||141||
60146763|NCT00631657|76271080|FG001|NOT COMPLETED|6-Month Treatment Period||0||
60146764|NCT00631657|76271081|FG002|NOT COMPLETED|6-Month Treatment Period||50||
60146765|NCT00631657|76271079|FG000|STARTED|7-Day Discontinuation Period|One participant was radomized in the Discont. Period, without completing the Treatment Period.|67||
60146766|NCT00631657|76271080|FG001|STARTED|7-Day Discontinuation Period||137||
60146767|NCT00631657|76271081|FG002|STARTED|7-Day Discontinuation Period||66||
60146768|NCT00631657|76271079|FG000|Treated|7-Day Discontinuation Period|One participant was not treated during the Discontinuation Period.|66||
60146769|NCT00631657|76271080|FG001|Treated|7-Day Discontinuation Period|One participant was not treated during the Discontinuation Period.|136||
60146770|NCT00631657|76271081|FG002|Treated|7-Day Discontinuation Period|One participant was not treated during the Discontinuation Period.|65||
60146771|NCT00631657|76271079|FG000|COMPLETED|7-Day Discontinuation Period||65||
60146772|NCT00631657|76271080|FG001|COMPLETED|7-Day Discontinuation Period||136||
60146773|NCT00631657|76271081|FG002|COMPLETED|7-Day Discontinuation Period||65||
60146774|NCT00631657|76271079|FG000|NOT COMPLETED|7-Day Discontinuation Period||2||
60146775|NCT00631657|76271080|FG001|NOT COMPLETED|7-Day Discontinuation Period||1||
60146776|NCT00631657|76271081|FG002|NOT COMPLETED|7-Day Discontinuation Period||1||
60146777|NCT01257087|76271094|FG000|STARTED|Overall Study||18||
60146778|NCT01257087|76271095|FG001|STARTED|Overall Study||17||
60146779|NCT01257087|76271094|FG000|COMPLETED|Overall Study||18||
60146780|NCT01257087|76271095|FG001|COMPLETED|Overall Study||17||
60146781|NCT01257087|76271094|FG000|NOT COMPLETED|Overall Study||0||
60146782|NCT01257087|76271095|FG001|NOT COMPLETED|Overall Study||0||
60146783|NCT01259427|76271103|FG000|STARTED|Overall Study||124||
60146784|NCT01259427|76271104|FG001|STARTED|Overall Study||124||
60146785|NCT01259427|76271103|FG000|COMPLETED|Overall Study||106||
60146786|NCT01259427|76271104|FG001|COMPLETED|Overall Study||110||
60146787|NCT01259427|76271103|FG000|NOT COMPLETED|Overall Study||18||
60146788|NCT01259427|76271104|FG001|NOT COMPLETED|Overall Study||14||
60146789|NCT02947997|76271111|FG000|STARTED|Overall Study||4||
60146790|NCT02947997|76271111|FG000|COMPLETED|Overall Study||4||
60146791|NCT02947997|76271111|FG000|NOT COMPLETED|Overall Study||0||
60146792|NCT00631189|76271119|FG000|STARTED|Initial Phase||668||
60146793|NCT00631189|76271120|FG001|STARTED|Initial Phase||0||
60146794|NCT00631189|76271121|FG002|STARTED|Initial Phase||0||
60146795|NCT00631189|76271122|FG003|STARTED|Initial Phase||0||
60146796|NCT00631189|76271119|FG000|COMPLETED|Initial Phase||317||
60146797|NCT00631189|76271120|FG001|COMPLETED|Initial Phase||0||
60146798|NCT00631189|76271121|FG002|COMPLETED|Initial Phase||0||
60146799|NCT00631189|76271122|FG003|COMPLETED|Initial Phase||0||
60146800|NCT00631189|76271119|FG000|NOT COMPLETED|Initial Phase||351||
60146801|NCT00631189|76271120|FG001|NOT COMPLETED|Initial Phase||0||
60146802|NCT00631189|76271121|FG002|NOT COMPLETED|Initial Phase||0||
60146803|NCT00631189|76271122|FG003|NOT COMPLETED|Initial Phase||0||
60146804|NCT00631189|76271119|FG000|STARTED|Treatment Phase||0||
60146805|NCT00631189|76271120|FG001|STARTED|Treatment Phase||104||
60146806|NCT00631189|76271121|FG002|STARTED|Treatment Phase||103||
60146807|NCT00631189|76271122|FG003|STARTED|Treatment Phase||110||
60146808|NCT00631189|76271119|FG000|COMPLETED|Treatment Phase||0||
60146809|NCT00631189|76271120|FG001|COMPLETED|Treatment Phase||97||
60146810|NCT00631189|76271121|FG002|COMPLETED|Treatment Phase||92||
60146811|NCT00631189|76271122|FG003|COMPLETED|Treatment Phase||103||
60146812|NCT00631189|76271119|FG000|NOT COMPLETED|Treatment Phase||0||
60146813|NCT00631189|76271120|FG001|NOT COMPLETED|Treatment Phase||7||
60146814|NCT00631189|76271121|FG002|NOT COMPLETED|Treatment Phase||11||
60146815|NCT00631189|76271122|FG003|NOT COMPLETED|Treatment Phase||7||
60146816|NCT00630877|76271135|FG000|STARTED|Overall Study|For all arms, started means treated.|91||
60146817|NCT00630877|76271136|FG001|STARTED|Overall Study||90||
60146818|NCT00630877|76271137|FG002|STARTED|Overall Study||90||
60146819|NCT00630877|76271135|FG000|COMPLETED|Overall Study||72||
60146820|NCT00630877|76271136|FG001|COMPLETED|Overall Study||75||
60146821|NCT00630877|76271137|FG002|COMPLETED|Overall Study||80||
60146822|NCT00630877|76271135|FG000|NOT COMPLETED|Overall Study||19||
60146823|NCT00630877|76271136|FG001|NOT COMPLETED|Overall Study||15||
60146824|NCT00630877|76271137|FG002|NOT COMPLETED|Overall Study||10||
60146825|NCT02915783|76271149|FG000|STARTED|Overall Study||31||
60146826|NCT02915783|76271149|FG000|COMPLETED|Overall Study||7||
60146827|NCT02915783|76271149|FG000|NOT COMPLETED|Overall Study||24||
60146828|NCT02736149|76271153|FG000|STARTED|Overall Study||51||
60146829|NCT02736149|76271153|FG000|COMPLETED|Overall Study||0||
60146830|NCT02736149|76271153|FG000|NOT COMPLETED|Overall Study||51||
60146831|NCT02198183|76271157|FG000|STARTED|Overall Study||34||
60146832|NCT02198183|76271157|FG000|COMPLETED|Overall Study||25||
60146833|NCT02198183|76271157|FG000|NOT COMPLETED|Overall Study||9||
60146834|NCT00630331|76271164|FG000|STARTED|Overall Study||3828||
60146835|NCT00630331|76271165|FG001|STARTED|Overall Study||3676||
60146836|NCT00630331|76271166|FG002|STARTED|Overall Study||3900||
60146837|NCT00630331|76271164|FG000|COMPLETED|Overall Study||3622||
60146838|NCT00630331|76271165|FG001|COMPLETED|Overall Study||3510||
60146839|NCT00630331|76271166|FG002|COMPLETED|Overall Study||3712||
60146840|NCT00630331|76271164|FG000|NOT COMPLETED|Overall Study||206||
60146841|NCT00630331|76271165|FG001|NOT COMPLETED|Overall Study||166||
60146842|NCT00630331|76271166|FG002|NOT COMPLETED|Overall Study||188||
60146843|NCT02337517|76271174|FG000|STARTED|Overall Study||6||
60146844|NCT02337517|76271174|FG000|COMPLETED|Overall Study||6||
60146845|NCT02337517|76271174|FG000|NOT COMPLETED|Overall Study||0||
60146846|NCT03167099|76271180|FG000|STARTED|Overall Study||26||
60146847|NCT03167099|76271181|FG001|STARTED|Overall Study||27||
60146848|NCT03167099|76271180|FG000|COMPLETED|Overall Study||19||
60146849|NCT03167099|76271181|FG001|COMPLETED|Overall Study||19||
60146850|NCT03167099|76271180|FG000|NOT COMPLETED|Overall Study||7||
60146851|NCT03167099|76271181|FG001|NOT COMPLETED|Overall Study||8||
60146852|NCT03082313|76271187|FG000|STARTED|Overall Study||12||
60146853|NCT03082313|76271187|FG000|COMPLETED|Overall Study||12||
60146854|NCT03082313|76271187|FG000|NOT COMPLETED|Overall Study||0||
60146855|NCT03569111|76271191|FG000|STARTED|Overall Study||30||
60146856|NCT03569111|76271191|FG000|Procedure|Overall Study||30||
60146857|NCT03569111|76271191|FG000|1-Month|Overall Study||30||
60146858|NCT03569111|76271191|FG000|COMPLETED|Overall Study||30||
60146859|NCT03569111|76271191|FG000|NOT COMPLETED|Overall Study||0||
60146860|NCT02392637|76271199|FG000|STARTED|Overall Study||32||
60146861|NCT02392637|76271200|FG001|STARTED|Overall Study||28||
60146862|NCT02392637|76271199|FG000|COMPLETED|Overall Study||32||
60146863|NCT02392637|76271200|FG001|COMPLETED|Overall Study||28||
60146864|NCT02392637|76271199|FG000|NOT COMPLETED|Overall Study||0||
60146865|NCT02392637|76271200|FG001|NOT COMPLETED|Overall Study||0||
60146866|NCT00639509|76271209|FG000|STARTED|Overall Study||24||
60146867|NCT00639509|76271209|FG000|COMPLETED|Overall Study||23||
60146868|NCT00639509|76271209|FG000|NOT COMPLETED|Overall Study||1||
60146869|NCT00638963|76271215|FG000|STARTED|Overall Study|Received randomized treatment assignment|3||
60146870|NCT00638963|76271216|FG001|STARTED|Overall Study|Received randomized treatment assignment|3||
60146871|NCT00638963|76271215|FG000|COMPLETED|Overall Study|including follow-up at Week 38 & Week 52|2||
60146872|NCT00638963|76271216|FG001|COMPLETED|Overall Study|including follow-up at Week 38 & Week 52|3||
60146873|NCT00638963|76271215|FG000|NOT COMPLETED|Overall Study||1||
60146874|NCT00638963|76271216|FG001|NOT COMPLETED|Overall Study||0||
60146875|NCT00638183|76271222|FG000|STARTED|Overall Study||385||
60146876|NCT00638183|76271222|FG000|COMPLETED|Overall Study||266||
60146877|NCT00638183|76271222|FG000|NOT COMPLETED|Overall Study||119||
60146878|NCT00638027|76271228|FG000|STARTED|Overall Study||11||
60146879|NCT00638027|76271229|FG001|STARTED|Overall Study||10||
60146880|NCT00638027|76271228|FG000|COMPLETED|Overall Study||11||
60146881|NCT00638027|76271229|FG001|COMPLETED|Overall Study|all 10 included in analyses|8||
60146882|NCT00638027|76271228|FG000|NOT COMPLETED|Overall Study||0||
60146883|NCT00638027|76271229|FG001|NOT COMPLETED|Overall Study||2||
60146884|NCT00636155|76271235|FG000|STARTED|Overall Study||20||
60146885|NCT00636155|76271235|FG000|COMPLETED|Overall Study|Completed maximum 6 cycles of treatment|2||
60146886|NCT00636155|76271235|FG000|NOT COMPLETED|Overall Study||18||
60146887|NCT00634907|76271241|FG000|STARTED|Overall Study||131||
60146888|NCT00634907|76271242|FG001|STARTED|Overall Study||132||
60146889|NCT00634907|76271241|FG000|COMPLETED|Overall Study||114||
60146890|NCT00634907|76271242|FG001|COMPLETED|Overall Study||115||
60146891|NCT00634907|76271241|FG000|NOT COMPLETED|Overall Study||17||
60146892|NCT00634907|76271242|FG001|NOT COMPLETED|Overall Study||17||
60146893|NCT02315755|76271248|FG000|STARTED|Overall Study||102||
60146894|NCT02315755|76271248|FG000|COMPLETED|Overall Study|Participants who died, were considered as 'completed'.|102||
60146895|NCT02315755|76271248|FG000|NOT COMPLETED|Overall Study||0||
60146896|NCT00634751|76271256|FG000|STARTED|Phase I: 200mg Sorafenib+2DOC||9||
60146897|NCT00634751|76271257|FG001|STARTED|Phase I: 200mg Sorafenib+2DOC||0||
60146898|NCT00634751|76271258|FG002|STARTED|Phase I: 200mg Sorafenib+2DOC||0||
60146899|NCT00634751|76271259|FG003|STARTED|Phase I: 200mg Sorafenib+2DOC||0||
60146900|NCT00634751|76271256|FG000|COMPLETED|Phase I: 200mg Sorafenib+2DOC||8||
60146901|NCT00634751|76271257|FG001|COMPLETED|Phase I: 200mg Sorafenib+2DOC||0||
60146902|NCT00634751|76271258|FG002|COMPLETED|Phase I: 200mg Sorafenib+2DOC||0||
60146903|NCT00634751|76271259|FG003|COMPLETED|Phase I: 200mg Sorafenib+2DOC||0||
60146904|NCT00634751|76271256|FG000|NOT COMPLETED|Phase I: 200mg Sorafenib+2DOC||1||
60146905|NCT00634751|76271257|FG001|NOT COMPLETED|Phase I: 200mg Sorafenib+2DOC||0||
60146906|NCT00634751|76271258|FG002|NOT COMPLETED|Phase I: 200mg Sorafenib+2DOC||0||
60146907|NCT00634751|76271259|FG003|NOT COMPLETED|Phase I: 200mg Sorafenib+2DOC||0||
60146908|NCT00634751|76271256|FG000|STARTED|Phase I: 400mg Sorafenib BID+2DOC||0||
60146909|NCT00634751|76271257|FG001|STARTED|Phase I: 400mg Sorafenib BID+2DOC||7||
60146910|NCT00634751|76271258|FG002|STARTED|Phase I: 400mg Sorafenib BID+2DOC||0||
60146911|NCT00634751|76271259|FG003|STARTED|Phase I: 400mg Sorafenib BID+2DOC||0||
60146912|NCT00634751|76271256|FG000|COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0||
60146913|NCT00634751|76271257|FG001|COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||6||
60146914|NCT00634751|76271258|FG002|COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0||
60146915|NCT00634751|76271259|FG003|COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0||
60146916|NCT00634751|76271256|FG000|NOT COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0||
60146917|NCT00634751|76271257|FG001|NOT COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||1||
60146918|NCT00634751|76271258|FG002|NOT COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0||
60146919|NCT00634751|76271259|FG003|NOT COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0||
60146920|NCT00634751|76271256|FG000|STARTED|Pancreatic and Bilial Tract Cancer||0||
60146921|NCT00634751|76271257|FG001|STARTED|Pancreatic and Bilial Tract Cancer||0||
60146922|NCT00634751|76271258|FG002|STARTED|Pancreatic and Bilial Tract Cancer||24||
60146923|NCT00634751|76271259|FG003|STARTED|Pancreatic and Bilial Tract Cancer||8||
60146924|NCT00634751|76271256|FG000|COMPLETED|Pancreatic and Bilial Tract Cancer||0||
60146925|NCT00634751|76271257|FG001|COMPLETED|Pancreatic and Bilial Tract Cancer||0||
60146926|NCT00634751|76271258|FG002|COMPLETED|Pancreatic and Bilial Tract Cancer||23||
60146927|NCT00634751|76271259|FG003|COMPLETED|Pancreatic and Bilial Tract Cancer||7||
60146928|NCT00634751|76271256|FG000|NOT COMPLETED|Pancreatic and Bilial Tract Cancer||0||
60146929|NCT00634751|76271257|FG001|NOT COMPLETED|Pancreatic and Bilial Tract Cancer||0||
60146930|NCT00634751|76271258|FG002|NOT COMPLETED|Pancreatic and Bilial Tract Cancer||1||
60146931|NCT00634751|76271259|FG003|NOT COMPLETED|Pancreatic and Bilial Tract Cancer||1||
60146932|NCT03020017|76271269|FG000|STARTED|NU-0129||8||
60146933|NCT03020017|76271269|FG000|COMPLETED|NU-0129||8||
60146934|NCT03020017|76271269|FG000|NOT COMPLETED|NU-0129||0||
60146935|NCT03020017|76271269|FG000|STARTED|Standard of Care Resection||8||
60146936|NCT03020017|76271269|FG000|COMPLETED|Standard of Care Resection||8||
60146937|NCT03020017|76271269|FG000|NOT COMPLETED|Standard of Care Resection||0||
60146938|NCT03015259|76271276|FG000|STARTED|Overall Study||613|Safety Population includes all participants who received at least one dose of a treatment.|
60146939|NCT03015259|76271277|FG001|STARTED|Overall Study||622|Safety Population includes all participants who received at least one dose of a treatment.|
60146940|NCT03015259|76271278|FG002|STARTED|Overall Study||204|Safety Population includes all participants who received at least one dose of a treatment.|
60146941|NCT03015259|76271276|FG000|COMPLETED|Overall Study||598|Per Protocol Population includes all participants who provided analyzable data for primary endpoints|
60146942|NCT03015259|76271277|FG001|COMPLETED|Overall Study||604|Per Protocol Population includes all participants who provided analyzable data for primary endpoints|
60146943|NCT03015259|76271278|FG002|COMPLETED|Overall Study||199|Per Protocol Population includes all participants who provided analyzable data for primary endpoints|
60146944|NCT03015259|76271276|FG000|NOT COMPLETED|Overall Study||15||
60146945|NCT03015259|76271277|FG001|NOT COMPLETED|Overall Study||18||
60146946|NCT03015259|76271278|FG002|NOT COMPLETED|Overall Study||5||
60146947|NCT02315989|76271286|FG000|STARTED|Overall Study||6||
60146948|NCT02315989|76271286|FG000|COMPLETED|Overall Study||6||
60146949|NCT02315989|76271286|FG000|NOT COMPLETED|Overall Study||0||
60146950|NCT00634049|76271294|FG000|STARTED|Overall Study||149||
60146951|NCT00634049|76271294|FG000|COMPLETED|Overall Study||146||
60146952|NCT00634049|76271294|FG000|NOT COMPLETED|Overall Study||3||
60146953|NCT03128957|76271327|FG000|STARTED|Overall Study||10||
60146954|NCT03128957|76271327|FG000|COMPLETED|Overall Study||10||
60146955|NCT03128957|76271327|FG000|NOT COMPLETED|Overall Study||0||
60146956|NCT00632099|76271333|FG000|STARTED|Overall Study||10||
60146957|NCT00632099|76271334|FG001|STARTED|Overall Study||11||
60146958|NCT00632099|76271333|FG000|COMPLETED|Overall Study||7||
60146959|NCT00632099|76271334|FG001|COMPLETED|Overall Study||8||
60146960|NCT00632099|76271333|FG000|NOT COMPLETED|Overall Study||3||
60146961|NCT00632099|76271334|FG001|NOT COMPLETED|Overall Study||3||
60146962|NCT00632021|76271342|FG000|STARTED|Overall Study||432||
60146963|NCT00632021|76271343|FG001|STARTED|Overall Study||430||
60146964|NCT00632021|76271342|FG000|COMPLETED|Overall Study||428||
60146965|NCT00632021|76271343|FG001|COMPLETED|Overall Study||423||
60146966|NCT00632021|76271342|FG000|NOT COMPLETED|Overall Study||4||
60146967|NCT00632021|76271343|FG001|NOT COMPLETED|Overall Study||7||
60146968|NCT00631475|76271350|FG000|STARTED|Overall Study||128||
60146969|NCT00631475|76271350|FG000|COMPLETED|Overall Study||83||
60146970|NCT00631475|76271350|FG000|NOT COMPLETED|Overall Study||45||
60146971|NCT03098485|76271358|FG000|STARTED|Overall Study||5||
60146972|NCT03098485|76271359|FG001|STARTED|Overall Study||5||
60146973|NCT03098485|76271360|FG002|STARTED|Overall Study||5||
60146974|NCT03098485|76271361|FG003|STARTED|Overall Study||5||
60146975|NCT03098485|76271358|FG000|COMPLETED|Overall Study||5||
60146976|NCT03098485|76271359|FG001|COMPLETED|Overall Study||5||
60146977|NCT03098485|76271360|FG002|COMPLETED|Overall Study||5||
60146978|NCT03098485|76271361|FG003|COMPLETED|Overall Study||5||
60146979|NCT03098485|76271358|FG000|NOT COMPLETED|Overall Study||0||
60146980|NCT03098485|76271359|FG001|NOT COMPLETED|Overall Study||0||
60146981|NCT03098485|76271360|FG002|NOT COMPLETED|Overall Study||0||
60146982|NCT03098485|76271361|FG003|NOT COMPLETED|Overall Study||0||
60146983|NCT00631163|76271371|FG000|STARTED|Number of Participants in Year 1||102||
60146984|NCT00631163|76271371|FG000|COMPLETED|Number of Participants in Year 1||68||
60146985|NCT00631163|76271371|FG000|NOT COMPLETED|Number of Participants in Year 1||34||
60146986|NCT00631163|76271371|FG000|STARTED|Number of Participants in Year 2||57||
60146987|NCT00631163|76271371|FG000|COMPLETED|Number of Participants in Year 2||52||
60146988|NCT00631163|76271371|FG000|NOT COMPLETED|Number of Participants in Year 2||5||
60146989|NCT00631007|76271388|FG000|STARTED|Overall Study||60||
60146990|NCT00631007|76271389|FG001|STARTED|Overall Study||61||
60146991|NCT00631007|76271390|FG002|STARTED|Overall Study||63||
60146992|NCT00631007|76271391|FG003|STARTED|Overall Study||62||
60146993|NCT00631007|76271392|FG004|STARTED|Overall Study||60||
60146994|NCT00631007|76271393|FG005|STARTED|Overall Study||61||
59751491|NCT00645853|75870819|FG001|Discontinued Patient No Due to Closure|Overall Study|No of patients discontinued due the study termination caused tablet formulation stability problems|178||
59751492|NCT00645853|75870818|FG000|AZ Study Closure in Hungary|Overall Study||60||
59751493|NCT00645853|75870819|FG001|AZ Study Closure in Hungary|Overall Study||40||
59751494|NCT00645853|75870818|FG000|COMPLETED|Overall Study||196||
60146995|NCT00631007|76271388|FG000|COMPLETED|Overall Study||49||
60146996|NCT00631007|76271389|FG001|COMPLETED|Overall Study||50||
60146997|NCT00631007|76271390|FG002|COMPLETED|Overall Study||53||
60146998|NCT00631007|76271391|FG003|COMPLETED|Overall Study||53||
60146999|NCT00631007|76271392|FG004|COMPLETED|Overall Study||48||
60147000|NCT00631007|76271393|FG005|COMPLETED|Overall Study||46||
60147001|NCT00631007|76271388|FG000|NOT COMPLETED|Overall Study||11||
60147002|NCT00631007|76271389|FG001|NOT COMPLETED|Overall Study||11||
60147003|NCT00631007|76271390|FG002|NOT COMPLETED|Overall Study||10||
60147004|NCT00631007|76271391|FG003|NOT COMPLETED|Overall Study||9||
60147005|NCT00631007|76271392|FG004|NOT COMPLETED|Overall Study||12||
60147006|NCT00631007|76271393|FG005|NOT COMPLETED|Overall Study||15||
60147007|NCT00630539|76271411|FG000|STARTED|Overall Study||34||
60147008|NCT00630539|76271412|FG001|STARTED|Overall Study||33||
60147009|NCT00630539|76271413|FG002|STARTED|Overall Study||29||
60147010|NCT00630539|76271414|FG003|STARTED|Overall Study||30||
60147011|NCT00630539|76271411|FG000|COMPLETED|Overall Study||33||
60147012|NCT00630539|76271412|FG001|COMPLETED|Overall Study||29||
60147013|NCT00630539|76271413|FG002|COMPLETED|Overall Study||28||
59751495|NCT00645853|75870819|FG001|COMPLETED|Overall Study||178||
59751496|NCT00645853|75870818|FG000|NOT COMPLETED|Overall Study||92||
59751497|NCT00645853|75870819|FG001|NOT COMPLETED|Overall Study||57||
60147014|NCT00630539|76271414|FG003|COMPLETED|Overall Study||27||
60147015|NCT00630539|76271411|FG000|NOT COMPLETED|Overall Study||1||
60147016|NCT00630539|76271412|FG001|NOT COMPLETED|Overall Study||4||
60147017|NCT00630539|76271413|FG002|NOT COMPLETED|Overall Study||1||
60147018|NCT00630539|76271414|FG003|NOT COMPLETED|Overall Study||3||
60147019|NCT02195349|76271442|FG000|STARTED|Overall Study||14||
60147020|NCT02195349|76271443|FG001|STARTED|Overall Study||1||
60147021|NCT02195349|76271444|FG002|STARTED|Overall Study||1||
60147022|NCT02195349|76271445|FG003|STARTED|Overall Study||6||
60147023|NCT02195349|76271446|FG004|STARTED|Overall Study||6||
60147024|NCT02195349|76271447|FG005|STARTED|Overall Study||6||
60147025|NCT02195349|76271448|FG006|STARTED|Overall Study||6||
60147026|NCT02195349|76271449|FG007|STARTED|Overall Study||9||
60147027|NCT02195349|76271450|FG008|STARTED|Overall Study||6||
60147028|NCT02195349|76271451|FG009|STARTED|Overall Study||6||
60147029|NCT02195349|76271452|FG010|STARTED|Overall Study||6||
60147030|NCT02195349|76271442|FG000|COMPLETED|Overall Study||14||
60147031|NCT02195349|76271443|FG001|COMPLETED|Overall Study||1||
60147032|NCT02195349|76271444|FG002|COMPLETED|Overall Study||1||
60147033|NCT02195349|76271445|FG003|COMPLETED|Overall Study||6||
60147034|NCT02195349|76271446|FG004|COMPLETED|Overall Study||6||
60147035|NCT02195349|76271447|FG005|COMPLETED|Overall Study||6||
60147036|NCT02195349|76271448|FG006|COMPLETED|Overall Study||6||
60147037|NCT02195349|76271449|FG007|COMPLETED|Overall Study||9||
60147038|NCT02195349|76271450|FG008|COMPLETED|Overall Study||6||
60147039|NCT02195349|76271451|FG009|COMPLETED|Overall Study||6||
60147040|NCT02195349|76271452|FG010|COMPLETED|Overall Study||6||
60147041|NCT02195349|76271442|FG000|NOT COMPLETED|Overall Study||0||
60147042|NCT02195349|76271443|FG001|NOT COMPLETED|Overall Study||0||
60147043|NCT02195349|76271444|FG002|NOT COMPLETED|Overall Study||0||
60147044|NCT02195349|76271445|FG003|NOT COMPLETED|Overall Study||0||
60147045|NCT02195349|76271446|FG004|NOT COMPLETED|Overall Study||0||
60147046|NCT02195349|76271447|FG005|NOT COMPLETED|Overall Study||0||
60147047|NCT02195349|76271448|FG006|NOT COMPLETED|Overall Study||0||
60147048|NCT02195349|76271449|FG007|NOT COMPLETED|Overall Study||0||
60147049|NCT02195349|76271450|FG008|NOT COMPLETED|Overall Study||0||
60147050|NCT02195349|76271451|FG009|NOT COMPLETED|Overall Study||0||
60147051|NCT02195349|76271452|FG010|NOT COMPLETED|Overall Study||0||
60147052|NCT00630305|76271492|FG000|STARTED|Overall Study||37||
60147053|NCT00630305|76271492|FG000|COMPLETED|Overall Study||35||
60147054|NCT00630305|76271492|FG000|NOT COMPLETED|Overall Study||2||
60147055|NCT01262547|76271505|FG000|STARTED|Overall Study||3||
60147056|NCT01262547|76271505|FG000|COMPLETED|Overall Study||3||
60147057|NCT01262547|76271505|FG000|NOT COMPLETED|Overall Study||0||
60147058|NCT01293825|76271514|FG000|STARTED|Overall Study||30||
60147059|NCT01293825|76271514|FG000|COMPLETED|Overall Study||20||
60147060|NCT01293825|76271514|FG000|NOT COMPLETED|Overall Study||10||
60147061|NCT01263717|76271520|FG000|STARTED|Overall Study||28||
60147062|NCT01263717|76271521|FG001|STARTED|Overall Study||26||
60147063|NCT01263717|76271520|FG000|Baseline Visit|Overall Study||28||
60147064|NCT01263717|76271521|FG001|Baseline Visit|Overall Study||22||
60147065|NCT01263717|76271520|FG000|COMPLETED|Overall Study||23||
60147066|NCT01263717|76271521|FG001|COMPLETED|Overall Study||20||
60147067|NCT01263717|76271520|FG000|NOT COMPLETED|Overall Study||5||
60147068|NCT01263717|76271521|FG001|NOT COMPLETED|Overall Study||6||
60147069|NCT01265667|76271529|FG000|STARTED|Overall Study||145||
60147070|NCT01265667|76271530|FG001|STARTED|Overall Study||148||
60147071|NCT01265667|76271529|FG000|COMPLETED|Overall Study||125||
60147072|NCT01265667|76271530|FG001|COMPLETED|Overall Study||135||
60147073|NCT01265667|76271529|FG000|NOT COMPLETED|Overall Study||20||
60147074|NCT01265667|76271530|FG001|NOT COMPLETED|Overall Study||13||
60147075|NCT01266447|76271536|FG000|STARTED|Overall Study||27||
60147076|NCT01266447|76271536|FG000|COMPLETED|Overall Study|Eligible and treated patients|27||
60147077|NCT01266447|76271536|FG000|NOT COMPLETED|Overall Study||0||
60147078|NCT01267227|76271544|FG000|STARTED|Overall Study||20||
60147079|NCT01267227|76271545|FG001|STARTED|Overall Study||20||
60147080|NCT01267227|76271546|FG002|STARTED|Overall Study||20||
60147081|NCT01267227|76271547|FG003|STARTED|Overall Study||20||
60147082|NCT01267227|76271544|FG000|COMPLETED|Overall Study||19||
60147083|NCT01267227|76271545|FG001|COMPLETED|Overall Study||19||
60147084|NCT01267227|76271546|FG002|COMPLETED|Overall Study||18||
60147085|NCT01267227|76271547|FG003|COMPLETED|Overall Study||17||
60147086|NCT01267227|76271544|FG000|NOT COMPLETED|Overall Study||1||
60147087|NCT01267227|76271545|FG001|NOT COMPLETED|Overall Study||1||
60147088|NCT01267227|76271546|FG002|NOT COMPLETED|Overall Study||2||
60147089|NCT01267227|76271547|FG003|NOT COMPLETED|Overall Study||3||
59751498|NCT00652093|75870831|FG000|STARTED|Overall Study||4||
60147090|NCT01267929|76271563|FG000|STARTED|Overall Study||15||
60147091|NCT01267929|76271564|FG001|STARTED|Overall Study||15||
60147092|NCT01267929|76271563|FG000|COMPLETED|Overall Study||15||
60147093|NCT01267929|76271564|FG001|COMPLETED|Overall Study||15||
60147094|NCT01267929|76271563|FG000|NOT COMPLETED|Overall Study||0||
60147095|NCT01267929|76271564|FG001|NOT COMPLETED|Overall Study||0||
60147096|NCT01268553|76271570|FG000|STARTED|Overall Study||6||
60147097|NCT01268553|76271570|FG000|COMPLETED|Overall Study||6||
60147098|NCT01268553|76271570|FG000|NOT COMPLETED|Overall Study||0||
60147099|NCT01268943|76271578|FG000|STARTED|Overall Study||6||
60147100|NCT01268943|76271579|FG001|STARTED|Overall Study||3||
60147101|NCT01268943|76271580|FG002|STARTED|Overall Study||3||
60147102|NCT01268943|76271581|FG003|STARTED|Overall Study||6||
60147103|NCT01268943|76271578|FG000|COMPLETED|Overall Study||6||
60147104|NCT01268943|76271579|FG001|COMPLETED|Overall Study||3||
60147105|NCT01268943|76271580|FG002|COMPLETED|Overall Study||3||
60147106|NCT01268943|76271581|FG003|COMPLETED|Overall Study||6||
60147107|NCT01268943|76271578|FG000|NOT COMPLETED|Overall Study||0||
60147108|NCT01268943|76271579|FG001|NOT COMPLETED|Overall Study||0||
60147109|NCT01268943|76271580|FG002|NOT COMPLETED|Overall Study||0||
60147110|NCT01268943|76271581|FG003|NOT COMPLETED|Overall Study||0||
60147111|NCT01269801|76271593|FG000|STARTED|Overall Study||74||
59882087|NCT03228212|76005019|FG000|STARTED|Period 1||65||
59882088|NCT03228212|76005020|FG001|STARTED|Period 1||65||
59882089|NCT03228212|76005019|FG000|COMPLETED|Period 1||64||
59882090|NCT03228212|76005020|FG001|COMPLETED|Period 1||64||
59882091|NCT03228212|76005019|FG000|NOT COMPLETED|Period 1||1||
60147112|NCT01269801|76271594|FG001|STARTED|Overall Study||80||
60147113|NCT01269801|76271593|FG000|COMPLETED|Overall Study||74||
60147114|NCT01269801|76271594|FG001|COMPLETED|Overall Study||77||
60147115|NCT01269801|76271593|FG000|NOT COMPLETED|Overall Study||0||
60147116|NCT01269801|76271594|FG001|NOT COMPLETED|Overall Study||3||
60147117|NCT01297257|76271600|FG000|STARTED|Overall Study||7740||
60147118|NCT01297257|76271600|FG000|COMPLETED|Overall Study||7740||
60147119|NCT01297257|76271600|FG000|NOT COMPLETED|Overall Study||0||
60147120|NCT01297335|76271605|FG000|STARTED|Overall Study||10||
60147121|NCT01297335|76271605|FG000|COMPLETED|Overall Study||10||
60147122|NCT01297335|76271605|FG000|NOT COMPLETED|Overall Study||0||
60147123|NCT01270659|76271615|FG000|STARTED|Overall Study||6||
60147124|NCT01270659|76271616|FG001|STARTED|Overall Study||25||
60147125|NCT01270659|76271617|FG002|STARTED|Overall Study||4||
60147126|NCT01270659|76271618|FG003|STARTED|Overall Study||25||
60147127|NCT01270659|76271615|FG000|COMPLETED|Overall Study||6||
59882092|NCT03228212|76005020|FG001|NOT COMPLETED|Period 1||1||
59882093|NCT03228212|76005019|FG000|STARTED|Period 2||64||
59882094|NCT03228212|76005020|FG001|STARTED|Period 2||64||
59882095|NCT03228212|76005019|FG000|COMPLETED|Period 2||63||
59882096|NCT03228212|76005020|FG001|COMPLETED|Period 2||64||
60147128|NCT01270659|76271616|FG001|COMPLETED|Overall Study||25||
60147129|NCT01270659|76271617|FG002|COMPLETED|Overall Study||4||
60147130|NCT01270659|76271618|FG003|COMPLETED|Overall Study||25||
60147131|NCT01270659|76271615|FG000|NOT COMPLETED|Overall Study||0||
60147132|NCT01270659|76271616|FG001|NOT COMPLETED|Overall Study||0||
60147133|NCT01270659|76271617|FG002|NOT COMPLETED|Overall Study||0||
60147134|NCT01270659|76271618|FG003|NOT COMPLETED|Overall Study||0||
60147135|NCT01271907|76271631|FG000|STARTED|Overall Study||3||
60147136|NCT01271907|76271632|FG001|STARTED|Overall Study||0||
59882097|NCT03228212|76005019|FG000|NOT COMPLETED|Period 2||1||
59882098|NCT03228212|76005020|FG001|NOT COMPLETED|Period 2||0||
59882099|NCT03228212|76005019|FG000|STARTED|Period 3||63||
59882100|NCT03228212|76005020|FG001|STARTED|Period 3||64||
59882101|NCT03228212|76005019|FG000|COMPLETED|Period 3||63||
59882102|NCT03228212|76005020|FG001|COMPLETED|Period 3||64||
60147137|NCT01271907|76271633|FG002|STARTED|Overall Study||0||
60147138|NCT01271907|76271631|FG000|COMPLETED|Overall Study||3||
60147139|NCT01271907|76271632|FG001|COMPLETED|Overall Study||0||
60147140|NCT01271907|76271633|FG002|COMPLETED|Overall Study||0||
60147141|NCT01271907|76271631|FG000|NOT COMPLETED|Overall Study||0||
59882103|NCT03228212|76005019|FG000|NOT COMPLETED|Period 3||0||
59882104|NCT03228212|76005020|FG001|NOT COMPLETED|Period 3||0||
60147142|NCT01271907|76271632|FG001|NOT COMPLETED|Overall Study||0||
60147143|NCT01271907|76271633|FG002|NOT COMPLETED|Overall Study||0||
60147144|NCT01299285|76271641|FG000|STARTED|Overall Study||6||
60147145|NCT01299285|76271641|FG000|COMPLETED|Overall Study||6||
60147146|NCT01299285|76271641|FG000|NOT COMPLETED|Overall Study||0||
60147147|NCT01300065|76271649|FG000|STARTED|Overall Study||221||
60147148|NCT01300065|76271650|FG001|STARTED|Overall Study||220||
60147149|NCT01300065|76271649|FG000|COMPLETED|Overall Study||215||
60147150|NCT01300065|76271650|FG001|COMPLETED|Overall Study||217||
60147151|NCT01300065|76271649|FG000|NOT COMPLETED|Overall Study||6||
60147152|NCT01300065|76271650|FG001|NOT COMPLETED|Overall Study||3||
60147153|NCT01273857|76271658|FG000|STARTED|Overall Study||7||
60147154|NCT01273857|76271659|FG001|STARTED|Overall Study||7||
60147155|NCT01273857|76271658|FG000|COMPLETED|Overall Study||7||
60147156|NCT01273857|76271659|FG001|COMPLETED|Overall Study||7||
60147157|NCT01273857|76271658|FG000|NOT COMPLETED|Overall Study||0||
59882105|NCT04000815|76005029|FG000|STARTED|Overall Study||29||
59882106|NCT04000815|76005030|FG001|STARTED|Overall Study||20||
59882107|NCT04000815|76005031|FG002|STARTED|Overall Study||22||
59882108|NCT04000815|76005029|FG000|COMPLETED|Overall Study||15||
59882109|NCT04000815|76005030|FG001|COMPLETED|Overall Study||15||
59882110|NCT04000815|76005031|FG002|COMPLETED|Overall Study||15||
59882111|NCT04000815|76005029|FG000|NOT COMPLETED|Overall Study||14||
60147158|NCT01273857|76271659|FG001|NOT COMPLETED|Overall Study||0||
60147159|NCT01276197|76271667|FG000|STARTED|Overall Study||308||
60147160|NCT01276197|76271668|FG001|STARTED|Overall Study||310||
60147161|NCT01276197|76271667|FG000|COMPLETED|Overall Study||200||
60147162|NCT01276197|76271668|FG001|COMPLETED|Overall Study||200||
60147163|NCT01276197|76271667|FG000|NOT COMPLETED|Overall Study||108||
60147164|NCT01276197|76271668|FG001|NOT COMPLETED|Overall Study||110||
60147165|NCT01302483|76271676|FG000|STARTED|Overall Study||30||
60147166|NCT01302483|76271677|FG001|STARTED|Overall Study||15||
59882112|NCT04000815|76005030|FG001|NOT COMPLETED|Overall Study||5||
59882113|NCT04000815|76005031|FG002|NOT COMPLETED|Overall Study||7||
59882114|NCT04000581|76005041|FG000|STARTED|Overall Study||5||
59882115|NCT04000581|76005042|FG001|STARTED|Overall Study||12||
60147167|NCT01302483|76271676|FG000|COMPLETED|Overall Study||30||
60147168|NCT01302483|76271677|FG001|COMPLETED|Overall Study||15||
60147169|NCT01302483|76271676|FG000|NOT COMPLETED|Overall Study||0||
60147170|NCT01302483|76271677|FG001|NOT COMPLETED|Overall Study||0||
60147171|NCT01304277|76271689|FG000|STARTED|Screening (Replagal RB, Week 0- Week 2)||17||
60147172|NCT01304277|76271689|FG000|COMPLETED|Screening (Replagal RB, Week 0- Week 2)||17||
60147173|NCT01304277|76271689|FG000|NOT COMPLETED|Screening (Replagal RB, Week 0- Week 2)||0||
60147174|NCT01304277|76271689|FG000|STARTED|Treatment (Replagal AF, Week 2- EOS)||17||
60147175|NCT01304277|76271689|FG000|COMPLETED|Treatment (Replagal AF, Week 2- EOS)||17||
60147176|NCT01304277|76271689|FG000|NOT COMPLETED|Treatment (Replagal AF, Week 2- EOS)||0||
60147177|NCT01279317|76271696|FG000|STARTED|Period 1||6||
60147178|NCT01279317|76271697|FG001|STARTED|Period 1||6||
60147179|NCT01279317|76271696|FG000|COMPLETED|Period 1||6||
60147180|NCT01279317|76271697|FG001|COMPLETED|Period 1||6||
60147181|NCT01279317|76271696|FG000|NOT COMPLETED|Period 1||0||
60147182|NCT01279317|76271697|FG001|NOT COMPLETED|Period 1||0||
60147183|NCT01279317|76271696|FG000|STARTED|Washout||6||
60147184|NCT01279317|76271697|FG001|STARTED|Washout||6||
60147185|NCT01279317|76271696|FG000|COMPLETED|Washout||6||
60147186|NCT01279317|76271697|FG001|COMPLETED|Washout||6||
60147187|NCT01279317|76271696|FG000|NOT COMPLETED|Washout||0||
60147188|NCT01279317|76271697|FG001|NOT COMPLETED|Washout||0||
60147189|NCT01279317|76271696|FG000|STARTED|Period 2||6||
60147190|NCT01279317|76271697|FG001|STARTED|Period 2||6||
60147191|NCT01279317|76271696|FG000|COMPLETED|Period 2||6||
60147192|NCT01279317|76271697|FG001|COMPLETED|Period 2||6||
60147193|NCT01279317|76271696|FG000|NOT COMPLETED|Period 2||0||
60147194|NCT01279317|76271697|FG001|NOT COMPLETED|Period 2||0||
60147195|NCT01304589|76271702|FG000|STARTED|Overall Study||31||
60147196|NCT01304589|76271702|FG000|COMPLETED|Overall Study||18||
60147197|NCT01304589|76271702|FG000|NOT COMPLETED|Overall Study||13||
60147198|NCT01280409|76271709|FG000|STARTED|Overall Study||59||
60147199|NCT01280409|76271710|FG001|STARTED|Overall Study||55||
60010630|NCT01773421|76126330|FG001|COMPLETED|Treatment Phase||8||
60010631|NCT01773421|76126331|FG002|COMPLETED|Treatment Phase||13||
60010632|NCT01773421|76126332|FG003|COMPLETED|Treatment Phase||5||
60010633|NCT01773421|76126333|FG004|COMPLETED|Treatment Phase||0||
60010634|NCT01773421|76126334|FG005|COMPLETED|Treatment Phase||0||
60010635|NCT01773421|76126335|FG006|COMPLETED|Treatment Phase||0||
60010636|NCT01773421|76126329|FG000|NOT COMPLETED|Treatment Phase||0||
60010637|NCT01773421|76126330|FG001|NOT COMPLETED|Treatment Phase||0||
60010638|NCT01773421|76126331|FG002|NOT COMPLETED|Treatment Phase||6||
60010639|NCT01773421|76126332|FG003|NOT COMPLETED|Treatment Phase||2||
60010640|NCT01773421|76126333|FG004|NOT COMPLETED|Treatment Phase||0||
60010641|NCT01773421|76126334|FG005|NOT COMPLETED|Treatment Phase||0||
60010642|NCT01773421|76126335|FG006|NOT COMPLETED|Treatment Phase||0||
60010643|NCT01773421|76126329|FG000|STARTED|Extension Phase||0||
60010644|NCT01773421|76126330|FG001|STARTED|Extension Phase||0||
60010645|NCT01773421|76126331|FG002|STARTED|Extension Phase||0||
60010646|NCT01773421|76126332|FG003|STARTED|Extension Phase||0||
60010647|NCT01773421|76126333|FG004|STARTED|Extension Phase||15||
60010648|NCT01773421|76126334|FG005|STARTED|Extension Phase||3||
60010649|NCT01773421|76126335|FG006|STARTED|Extension Phase||0||
60010650|NCT01773421|76126329|FG000|COMPLETED|Extension Phase||0||
60010651|NCT01773421|76126330|FG001|COMPLETED|Extension Phase||0||
60010652|NCT01773421|76126331|FG002|COMPLETED|Extension Phase||0||
60010653|NCT01773421|76126332|FG003|COMPLETED|Extension Phase||0||
60010654|NCT01773421|76126333|FG004|COMPLETED|Extension Phase||12||
60010655|NCT01773421|76126334|FG005|COMPLETED|Extension Phase||1||
60010656|NCT01773421|76126335|FG006|COMPLETED|Extension Phase||0||
60010657|NCT01773421|76126329|FG000|NOT COMPLETED|Extension Phase||0||
60010658|NCT01773421|76126330|FG001|NOT COMPLETED|Extension Phase||0||
60147200|NCT01280409|76271709|FG000|COMPLETED|Overall Study||43||
60010659|NCT01773421|76126331|FG002|NOT COMPLETED|Extension Phase||0||
60010660|NCT01773421|76126332|FG003|NOT COMPLETED|Extension Phase||0||
60010661|NCT01773421|76126333|FG004|NOT COMPLETED|Extension Phase||3||
60010662|NCT01773421|76126334|FG005|NOT COMPLETED|Extension Phase||2||
60010663|NCT01773421|76126335|FG006|NOT COMPLETED|Extension Phase||0||
60010664|NCT01747486|76126353|FG000|STARTED|Stage 1||15||
60010665|NCT01747486|76126354|FG001|STARTED|Stage 1||15||
60147201|NCT01280409|76271710|FG001|COMPLETED|Overall Study||36||
60147202|NCT01280409|76271709|FG000|NOT COMPLETED|Overall Study||16||
60147203|NCT01280409|76271710|FG001|NOT COMPLETED|Overall Study||19||
60147204|NCT01926197|76271718|FG000|STARTED|Overall Study||13||
60010666|NCT01747486|76126353|FG000|COMPLETED|Stage 1||3||
60010667|NCT01747486|76126354|FG001|COMPLETED|Stage 1||2||
60010668|NCT01747486|76126353|FG000|NOT COMPLETED|Stage 1||12||
60010669|NCT01747486|76126354|FG001|NOT COMPLETED|Stage 1||13||
60010670|NCT01747486|76126353|FG000|STARTED|Stage 2||12||
60010671|NCT01747486|76126354|FG001|STARTED|Stage 2||0||
60010672|NCT01747486|76126353|FG000|COMPLETED|Stage 2||3||
60010673|NCT01747486|76126354|FG001|COMPLETED|Stage 2||0||
60010674|NCT01747486|76126353|FG000|NOT COMPLETED|Stage 2||9||
60010675|NCT01747486|76126354|FG001|NOT COMPLETED|Stage 2||0||
60010676|NCT01733238|76126360|FG000|STARTED|Overall Study||13||
60147205|NCT01926197|76271719|FG001|STARTED|Overall Study||14||
60147206|NCT01926197|76271718|FG000|COMPLETED|Overall Study||12||
60147207|NCT01926197|76271719|FG001|COMPLETED|Overall Study||13||
60147208|NCT01926197|76271718|FG000|NOT COMPLETED|Overall Study||1||
60147209|NCT01926197|76271719|FG001|NOT COMPLETED|Overall Study||1||
60147210|NCT01925573|76271725|FG000|STARTED|Overall Study||7||
60147211|NCT01925573|76271725|FG000|COMPLETED|Overall Study||0||
60147212|NCT01925573|76271725|FG000|NOT COMPLETED|Overall Study||7||
59605739|NCT01996254|75715870|FG002|Long Term Analysis Set|Overall Study||14|Full Analysis Set with imputed data for missed visits and exclusion due to early termination.|
60147213|NCT01305213|76271731|FG000|STARTED|Overall Study||53||
60147214|NCT01305213|76271732|FG001|STARTED|Overall Study||54||
60147215|NCT01305213|76271731|FG000|COMPLETED|Overall Study||53||
60147216|NCT01305213|76271732|FG001|COMPLETED|Overall Study||54||
60147217|NCT01305213|76271731|FG000|NOT COMPLETED|Overall Study||0||
60147218|NCT01305213|76271732|FG001|NOT COMPLETED|Overall Study||0||
60147219|NCT00989963|76271744|FG000|STARTED|Overall Study||12|Full Analysis Population: All randomized participants (per intended treatment assignment).|
60147220|NCT00989963|76271745|FG001|STARTED|Overall Study||12|Full Analysis Population: All randomized participants (per intended treatment assignment).|
60147221|NCT00989963|76271746|FG002|STARTED|Overall Study||12|Full Analysis Population: All randomized participants (per intended treatment assignment).|
60147222|NCT00989963|76271744|FG000|Safety Population|Overall Study|1 participant randomized to MTD received FD 60 ug; was included in FD 60 ug arm for this population|13|Randomized participants (per actual treatment received) who received ≥1 dose of study drug.|
60147223|NCT00989963|76271745|FG001|Safety Population|Overall Study||12|Randomized participants (per actual treatment received) who received ≥1 dose of study drug.|
60147224|NCT00989963|76271746|FG002|Safety Population|Overall Study|1 participant randomized to MTD received FD 60 ug; was included in FD 60 ug arm for this population|11|Randomized participants (per actual treatment received) who received ≥1 dose of study drug.|
60147225|NCT00989963|76271744|FG000|Per-Protocol Population|Overall Study|1 participant randomized to MTD received FD 60 ug; was included in FD 60 ug arm for this population|12|Randomized participants (actual treatment received), completed study, no major protocol deviations.|
60147226|NCT00989963|76271745|FG001|Per-Protocol Population|Overall Study||11|Randomized participants (actual treatment received), completed study, no major protocol deviations.|
60147227|NCT00989963|76271746|FG002|Per-Protocol Population|Overall Study|1 participant randomized to MTD received FD 60 ug; was included in FD 60 ug arm for this population|10|Randomized participants (actual treatment received), completed study, no major protocol deviations.|
60147228|NCT00989963|76271744|FG000|COMPLETED|Overall Study||11||
60147229|NCT00989963|76271745|FG001|COMPLETED|Overall Study||11||
60147230|NCT00989963|76271746|FG002|COMPLETED|Overall Study||11||
60147231|NCT00989963|76271744|FG000|NOT COMPLETED|Overall Study||1||
60147232|NCT00989963|76271745|FG001|NOT COMPLETED|Overall Study||1||
60147233|NCT00989963|76271746|FG002|NOT COMPLETED|Overall Study||1||
60147234|NCT01337739|76271756|FG000|STARTED|Overall Study||6||
60147235|NCT01337739|76271757|FG001|STARTED|Overall Study||4||
60147236|NCT01337739|76271756|FG000|COMPLETED|Overall Study||6||
60147237|NCT01337739|76271757|FG001|COMPLETED|Overall Study||4||
60147238|NCT01337739|76271756|FG000|NOT COMPLETED|Overall Study||0||
60147239|NCT01337739|76271757|FG001|NOT COMPLETED|Overall Study||0||
60147240|NCT01339299|76271765|FG000|STARTED|Overall Study||50||
60147241|NCT01339299|76271766|FG001|STARTED|Overall Study||50||
60147242|NCT01339299|76271765|FG000|COMPLETED|Overall Study||50||
60147243|NCT01339299|76271766|FG001|COMPLETED|Overall Study||50||
60147244|NCT01339299|76271765|FG000|NOT COMPLETED|Overall Study||0||
60147245|NCT01339299|76271766|FG001|NOT COMPLETED|Overall Study||0||
60147246|NCT01307007|76271774|FG000|STARTED|Overall Study||25||
60147247|NCT01307007|76271775|FG001|STARTED|Overall Study||30||
60147248|NCT01307007|76271774|FG000|COMPLETED|Overall Study||25||
60147249|NCT01307007|76271775|FG001|COMPLETED|Overall Study||30||
60147250|NCT01307007|76271774|FG000|NOT COMPLETED|Overall Study||0||
60147251|NCT01307007|76271775|FG001|NOT COMPLETED|Overall Study||0||
60147252|NCT00989573|76271784|FG000|STARTED|Overall Study||65||
60147253|NCT00989573|76271785|FG001|STARTED|Overall Study||63||
60147254|NCT00989573|76271786|FG002|STARTED|Overall Study||63||
60147255|NCT00989573|76271784|FG000|COMPLETED|Overall Study||52||
60147256|NCT00989573|76271785|FG001|COMPLETED|Overall Study||41||
60147257|NCT00989573|76271786|FG002|COMPLETED|Overall Study||55||
60147258|NCT00989573|76271784|FG000|NOT COMPLETED|Overall Study||13||
60147259|NCT00989573|76271785|FG001|NOT COMPLETED|Overall Study||22||
60147260|NCT00989573|76271786|FG002|NOT COMPLETED|Overall Study||8||
60147261|NCT02197455|76271794|FG000|STARTED|Overall Study||30||
60147262|NCT02197455|76271794|FG000|COMPLETED|Overall Study||30||
60147263|NCT02197455|76271794|FG000|NOT COMPLETED|Overall Study||0||
60147264|NCT01307397|76271798|FG000|STARTED|Overall Study||3219||
60147265|NCT01307397|76271798|FG000|COMPLETED|Overall Study|A participant completed study in case of progressive disease, adverse events or consent withdrawn|3219||
59605740|NCT01996254|75715868|FG000|Per Protocol Set|Overall Study||0|Full Analysis Set with adequate diary completion, paresthesia coverage, and continued eligibility|
60147266|NCT01307397|76271798|FG000|NOT COMPLETED|Overall Study||0||
60147267|NCT04552535|76271804|FG000|STARTED|Overall Study||99||
60147268|NCT04552535|76271805|FG001|STARTED|Overall Study||101||
60147269|NCT04552535|76271804|FG000|COMPLETED|Overall Study||99||
60147270|NCT04552535|76271805|FG001|COMPLETED|Overall Study||101||
60147271|NCT04552535|76271804|FG000|NOT COMPLETED|Overall Study||0||
60147272|NCT04552535|76271805|FG001|NOT COMPLETED|Overall Study||0||
60147273|NCT02197767|76271814|FG000|STARTED|Overall Study||11||
59613483|NCT01684878|75724612|FG002|Participants Randomized But Not Treated|Part 2: Randomized Phase||1||
60147274|NCT02197767|76271814|FG000|COMPLETED|Overall Study||11||
60147275|NCT02197767|76271814|FG000|NOT COMPLETED|Overall Study||0||
60147276|NCT02199717|76271818|FG000|STARTED|Overall Study||66||
60147277|NCT02199717|76271818|FG000|COMPLETED|Overall Study||66||
60147278|NCT02199717|76271818|FG000|NOT COMPLETED|Overall Study||0||
60147279|NCT01342029|76271823|FG000|STARTED|Period 1||70||
60147280|NCT01342029|76271824|FG001|STARTED|Period 1||72||
60147281|NCT01342029|76271823|FG000|Dropout|Period 1||3||
60147282|NCT01342029|76271824|FG001|Dropout|Period 1||1||
60147283|NCT01342029|76271823|FG000|COMPLETED|Period 1||67||
60147284|NCT01342029|76271824|FG001|COMPLETED|Period 1||71||
60147285|NCT01342029|76271823|FG000|NOT COMPLETED|Period 1||3||
60147286|NCT01342029|76271824|FG001|NOT COMPLETED|Period 1||1||
60147287|NCT01342029|76271823|FG000|STARTED|Washout||67||
60147288|NCT01342029|76271824|FG001|STARTED|Washout||71||
60147289|NCT01342029|76271823|FG000|COMPLETED|Washout||67||
60147290|NCT01342029|76271824|FG001|COMPLETED|Washout||67||
60147291|NCT01342029|76271823|FG000|NOT COMPLETED|Washout||0||
60147292|NCT01342029|76271824|FG001|NOT COMPLETED|Washout||4||
60147293|NCT01342029|76271823|FG000|STARTED|Period 2||67||
60147294|NCT01342029|76271824|FG001|STARTED|Period 2||67||
60147295|NCT01342029|76271823|FG000|Dropout|Period 2||2||
60147296|NCT01342029|76271824|FG001|Dropout|Period 2||0||
60147297|NCT01342029|76271823|FG000|COMPLETED|Period 2||65||
60147298|NCT01342029|76271824|FG001|COMPLETED|Period 2||67||
60147299|NCT01342029|76271823|FG000|NOT COMPLETED|Period 2||2||
60147300|NCT01342029|76271824|FG001|NOT COMPLETED|Period 2||0||
60147301|NCT01342107|76271834|FG000|STARTED|Overall Study||34||
60147302|NCT01342107|76271835|FG001|STARTED|Overall Study||32||
59751499|NCT00652093|75870832|FG001|STARTED|Overall Study||4||
59751500|NCT00652093|75870833|FG002|STARTED|Overall Study||4||
59751501|NCT00652093|75870834|FG003|STARTED|Overall Study||4||
59882116|NCT04000581|76005041|FG000|COMPLETED|Overall Study||5||
59882117|NCT04000581|76005042|FG001|COMPLETED|Overall Study||11||
59605741|NCT01996254|75715869|FG001|Per Protocol Set|Overall Study||10|Full Analysis Set with adequate diary completion, paresthesia coverage, and continued eligibility|
60147303|NCT01342107|76271834|FG000|COMPLETED|Overall Study||34||
60147304|NCT01342107|76271835|FG001|COMPLETED|Overall Study||32||
60147305|NCT01342107|76271834|FG000|NOT COMPLETED|Overall Study||0||
60147306|NCT01342107|76271835|FG001|NOT COMPLETED|Overall Study||0||
60147307|NCT01343667|76271843|FG000|STARTED|Overall Study||425||
60147308|NCT01343667|76271844|FG001|STARTED|Overall Study||972||
60147309|NCT01343667|76271843|FG000|COMPLETED|Overall Study||413||
60147310|NCT01343667|76271844|FG001|COMPLETED|Overall Study||916||
60147311|NCT01343667|76271843|FG000|NOT COMPLETED|Overall Study||12||
60147312|NCT01343667|76271844|FG001|NOT COMPLETED|Overall Study||56||
60147313|NCT01346085|76271850|FG000|STARTED|Overall Study||10||
60147314|NCT01346085|76271850|FG000|COMPLETED|Overall Study||10||
59751502|NCT00652093|75870835|FG004|STARTED|Overall Study||4||
59751503|NCT00652093|75870836|FG005|STARTED|Overall Study||4||
59751504|NCT00652093|75870831|FG000|COMPLETED|Overall Study||4||
59751505|NCT00652093|75870832|FG001|COMPLETED|Overall Study||4||
59751506|NCT00652093|75870833|FG002|COMPLETED|Overall Study||3||
59751507|NCT00652093|75870834|FG003|COMPLETED|Overall Study||4||
59751508|NCT00652093|75870835|FG004|COMPLETED|Overall Study||2||
59751509|NCT00652093|75870836|FG005|COMPLETED|Overall Study||4||
59751510|NCT00652093|75870831|FG000|NOT COMPLETED|Overall Study||0||
59751511|NCT00652093|75870832|FG001|NOT COMPLETED|Overall Study||0||
59882118|NCT04000581|76005041|FG000|NOT COMPLETED|Overall Study||0||
59882119|NCT04000581|76005042|FG001|NOT COMPLETED|Overall Study||1||
59882120|NCT03848403|76005048|FG000|STARTED|Period 1 (Day 1)||24||
59751512|NCT00652093|75870833|FG002|NOT COMPLETED|Overall Study||1||
60147315|NCT01346085|76271850|FG000|NOT COMPLETED|Overall Study||0||
60147316|NCT04126213|76271860|FG000|STARTED|Overall Study||70||
60147317|NCT04126213|76271861|FG001|STARTED|Overall Study||75||
60147318|NCT04126213|76271862|FG002|STARTED|Overall Study||68||
60147319|NCT04126213|76271863|FG003|STARTED|Overall Study||67||
60147320|NCT04126213|76271864|FG004|STARTED|Overall Study||73||
60147321|NCT04126213|76271865|FG005|STARTED|Overall Study||66||
60147322|NCT04126213|76271860|FG000|COMPLETED|Overall Study||58||
60147323|NCT04126213|76271861|FG001|COMPLETED|Overall Study||70||
59751513|NCT00652093|75870834|FG003|NOT COMPLETED|Overall Study||0||
59882121|NCT03848403|76005049|FG001|STARTED|Period 1 (Day 1)||24||
60147324|NCT04126213|76271862|FG002|COMPLETED|Overall Study||59||
59882122|NCT03848403|76005050|FG002|STARTED|Period 1 (Day 1)||22||
60147325|NCT04126213|76271863|FG003|COMPLETED|Overall Study||54||
60147326|NCT04126213|76271864|FG004|COMPLETED|Overall Study||67||
60147327|NCT04126213|76271865|FG005|COMPLETED|Overall Study||55||
60147328|NCT04126213|76271860|FG000|NOT COMPLETED|Overall Study||12||
60147329|NCT04126213|76271861|FG001|NOT COMPLETED|Overall Study||5||
60147330|NCT04126213|76271862|FG002|NOT COMPLETED|Overall Study||9||
60147331|NCT04126213|76271863|FG003|NOT COMPLETED|Overall Study||13||
60147332|NCT04126213|76271864|FG004|NOT COMPLETED|Overall Study||6||
60147333|NCT04126213|76271865|FG005|NOT COMPLETED|Overall Study||11||
60147334|NCT04128319|76271882|FG000|STARTED|Overall Study||3||
60147335|NCT04128319|76271882|FG000|Initiated T-Guard Treatment|Overall Study||3||
60147336|NCT04128319|76271882|FG000|COMPLETED|Overall Study||0||
60147337|NCT04128319|76271882|FG000|NOT COMPLETED|Overall Study||3||
60147338|NCT04120363|76271888|FG000|STARTED|Phase 1||16||
60147339|NCT04120363|76271889|FG001|STARTED|Phase 1||18||
60147340|NCT04120363|76271888|FG000|COMPLETED|Phase 1||16||
60147341|NCT04120363|76271889|FG001|COMPLETED|Phase 1||18||
60147342|NCT04120363|76271888|FG000|NOT COMPLETED|Phase 1||0||
60147343|NCT04120363|76271889|FG001|NOT COMPLETED|Phase 1||0||
60147344|NCT04120363|76271888|FG000|STARTED|Phase 2||16||
60147345|NCT04120363|76271889|FG001|STARTED|Phase 2||18||
60147346|NCT04120363|76271888|FG000|COMPLETED|Phase 2||16||
60147347|NCT04120363|76271889|FG001|COMPLETED|Phase 2||16||
60147348|NCT04120363|76271888|FG000|NOT COMPLETED|Phase 2||0||
60147349|NCT04120363|76271889|FG001|NOT COMPLETED|Phase 2||2||
60147350|NCT04120363|76271888|FG000|STARTED|Phase 3||16||
60147351|NCT04120363|76271889|FG001|STARTED|Phase 3||16||
60147352|NCT04120363|76271888|FG000|COMPLETED|Phase 3||16||
60147353|NCT04120363|76271889|FG001|COMPLETED|Phase 3||16||
60147354|NCT04120363|76271888|FG000|NOT COMPLETED|Phase 3||0||
60147355|NCT04120363|76271889|FG001|NOT COMPLETED|Phase 3||0||
59613484|NCT01684878|75724613|FG003|Participants Randomized But Not Treated|Part 2: Randomized Phase||2||
59751514|NCT00652093|75870835|FG004|NOT COMPLETED|Overall Study||2||
60147356|NCT04125745|76271895|FG000|STARTED|Overall Study||1||
60147357|NCT04125745|76271895|FG000|COMPLETED|Overall Study||1||
60147358|NCT04125745|76271895|FG000|NOT COMPLETED|Overall Study||0||
60147359|NCT04126057|76271901|FG000|STARTED|Overall Study||50||50
60147360|NCT04126057|76271902|FG001|STARTED|Overall Study||50||50
60147361|NCT04126057|76271901|FG000|COMPLETED|Overall Study||47||47
60147362|NCT04126057|76271902|FG001|COMPLETED|Overall Study||46||46
60147363|NCT04126057|76271901|FG000|NOT COMPLETED|Overall Study||3||3
60147364|NCT04126057|76271902|FG001|NOT COMPLETED|Overall Study||4||4
60147365|NCT02337959|76271911|FG000|STARTED|Overall Study||10||
60147366|NCT02337959|76271912|FG001|STARTED|Overall Study||10||
60147367|NCT02337959|76271913|FG002|STARTED|Overall Study||7||
60147368|NCT02337959|76271911|FG000|COMPLETED|Overall Study||10||
60147369|NCT02337959|76271912|FG001|COMPLETED|Overall Study||7||
60147370|NCT02337959|76271913|FG002|COMPLETED|Overall Study||7||
60147371|NCT02337959|76271911|FG000|NOT COMPLETED|Overall Study||0||
60147372|NCT02337959|76271912|FG001|NOT COMPLETED|Overall Study||3||
60147373|NCT02337959|76271913|FG002|NOT COMPLETED|Overall Study||0||
60147374|NCT03295643|76271921|FG000|STARTED|Overall Study||319||
60147375|NCT03295643|76271921|FG000|Completed Explore Stage|Overall Study||283||
60147376|NCT03295643|76271921|FG000|Completed Build Stage|Overall Study||183||
60147377|NCT03295643|76271921|FG000|Completed Mobilize Stage|Overall Study||139||
60147378|NCT03295643|76271921|FG000|Completed Quit Stage|Overall Study||131||
60147379|NCT03295643|76271921|FG000|Completed Secure Stage|Overall Study||126||
60147380|NCT03295643|76271921|FG000|COMPLETED|Overall Study||272|Completed the end-of-Pivot questionnaire and thus completed the study|
60147381|NCT03295643|76271921|FG000|NOT COMPLETED|Overall Study||47||
60147382|NCT05038293|76271928|FG000|STARTED|Overall Study||24||
60147383|NCT05038293|76271929|FG001|STARTED|Overall Study||18||
60147384|NCT05038293|76271928|FG000|COMPLETED|Overall Study||22||
60147385|NCT05038293|76271929|FG001|COMPLETED|Overall Study||18||
60147386|NCT05038293|76271928|FG000|NOT COMPLETED|Overall Study||2||
60147387|NCT05038293|76271929|FG001|NOT COMPLETED|Overall Study||0||
60147388|NCT04897607|76271937|FG000|STARTED|Overall Study||17||
60147389|NCT04897607|76271938|FG001|STARTED|Overall Study||20||
60147390|NCT04897607|76271937|FG000|COMPLETED|Overall Study||11||
60147391|NCT04897607|76271938|FG001|COMPLETED|Overall Study||13||
60147392|NCT04897607|76271937|FG000|NOT COMPLETED|Overall Study||6||
60147393|NCT04897607|76271938|FG001|NOT COMPLETED|Overall Study||7||
60147394|NCT04753164|76271946|FG000|STARTED|Overall Study||68||
60147395|NCT04753164|76271947|FG001|STARTED|Overall Study||68||
60147396|NCT04753164|76271946|FG000|COMPLETED|Overall Study||41||
60147397|NCT04753164|76271947|FG001|COMPLETED|Overall Study||48||
60147398|NCT04753164|76271946|FG000|NOT COMPLETED|Overall Study||27||
60147399|NCT04753164|76271947|FG001|NOT COMPLETED|Overall Study||20||
60147400|NCT04729101|76271955|FG000|STARTED|Overall Study||23||
60147401|NCT04729101|76271956|FG001|STARTED|Overall Study||21||
60147402|NCT04729101|76271955|FG000|Received Treatment|Overall Study||23||
60147403|NCT04729101|76271956|FG001|Received Treatment|Overall Study||21||
60147404|NCT04729101|76271955|FG000|COMPLETED|Overall Study||20||
60147405|NCT04729101|76271956|FG001|COMPLETED|Overall Study||21||
60147406|NCT04729101|76271955|FG000|NOT COMPLETED|Overall Study||3||
60147407|NCT04729101|76271956|FG001|NOT COMPLETED|Overall Study||0||
60147408|NCT04719013|76271962|FG000|STARTED|Overall Study||85||
60147409|NCT04719013|76271962|FG000|COMPLETED|Overall Study||75||
60147410|NCT04719013|76271962|FG000|NOT COMPLETED|Overall Study||10||
60147411|NCT04351750|76271969|FG000|STARTED|Overall Study||14||
60147412|NCT04351750|76271970|FG001|STARTED|Overall Study||15||
60147413|NCT04351750|76271971|FG002|STARTED|Overall Study||18||
60147414|NCT04351750|76271969|FG000|COMPLETED|Overall Study||12||
60147415|NCT04351750|76271970|FG001|COMPLETED|Overall Study||13||
60147416|NCT04351750|76271971|FG002|COMPLETED|Overall Study||13||
60147417|NCT04351750|76271969|FG000|NOT COMPLETED|Overall Study||2||
60147418|NCT04351750|76271970|FG001|NOT COMPLETED|Overall Study||2||
60147419|NCT04351750|76271971|FG002|NOT COMPLETED|Overall Study||5||
60147420|NCT04569968|76271982|FG000|STARTED|Overall Study||86||
60147421|NCT04569968|76271983|FG001|STARTED|Overall Study||60||
60147422|NCT04569968|76271982|FG000|COMPLETED|Overall Study||15||
60147423|NCT04569968|76271983|FG001|COMPLETED|Overall Study||16||
60147424|NCT04569968|76271982|FG000|NOT COMPLETED|Overall Study||71||
60147425|NCT04569968|76271983|FG001|NOT COMPLETED|Overall Study||44||
60147426|NCT03385304|76271991|FG000|STARTED|Overall Study||828|Total Study Duration|7
60147427|NCT03385304|76271992|FG001|STARTED|Overall Study||810|Total Study Duration|7
60147428|NCT03385304|76271991|FG000|Months 1-2|Overall Study||114||7
60147429|NCT03385304|76271992|FG001|Months 1-2|Overall Study||108||7
60147430|NCT03385304|76271991|FG000|Months 3-4|Overall Study||102||7
60147431|NCT03385304|76271992|FG001|Months 3-4|Overall Study||104||7
60147432|NCT03385304|76271991|FG000|Months 5-6|Overall Study||98||7
60147433|NCT03385304|76271992|FG001|Months 5-6|Overall Study||53||5
60147434|NCT03385304|76271991|FG000|Months 7-8|Overall Study||50||5
60147435|NCT03385304|76271992|FG001|Months 7-8|Overall Study||68||7
60147436|NCT03385304|76271991|FG000|Months 9-10|Overall Study||91||6
60147437|NCT03385304|76271992|FG001|Months 9-10|Overall Study||63||5
60147438|NCT03385304|76271991|FG000|Months 11-12|Overall Study||72||5
60147439|NCT03385304|76271992|FG001|Months 11-12|Overall Study||75||5
60147440|NCT03385304|76271991|FG000|Months 13-14|Overall Study||62||5
60147441|NCT03385304|76271992|FG001|Months 13-14|Overall Study||50||4
60147442|NCT03385304|76271991|FG000|Months 15-16|Overall Study||38||4
60147443|NCT03385304|76271992|FG001|Months 15-16|Overall Study||55||5
60147444|NCT03385304|76271991|FG000|Months 17-18|Overall Study||38||5
60147445|NCT03385304|76271992|FG001|Months 17-18|Overall Study||44||5
60147446|NCT03385304|76271991|FG000|Months 19-20|Overall Study||32||5
60147447|NCT03385304|76271992|FG001|Months 19-20|Overall Study||46||3
60147448|NCT03385304|76271991|FG000|Months 21-22|Overall Study||50||4
60147449|NCT03385304|76271992|FG001|Months 21-22|Overall Study||40||5
60147450|NCT03385304|76271991|FG000|Months 23-24|Overall Study||30||4
60147451|NCT03385304|76271992|FG001|Months 23-24|Overall Study||64||5
60147452|NCT03385304|76271991|FG000|Months 25-26|Overall Study||22||1
60147453|NCT03385304|76271992|FG001|Months 25-26|Overall Study||14||1
60147454|NCT03385304|76271991|FG000|Months 27-28|Overall Study||21||1
59605742|NCT01996254|75715870|FG002|Per Protocol Set|Overall Study||13|Full Analysis Set with adequate diary completion, paresthesia coverage, and continued eligibility|
59605743|NCT01996254|75715868|FG000|COMPLETED|Overall Study||4||
59605744|NCT01996254|75715869|FG001|COMPLETED|Overall Study||9||
59605745|NCT01996254|75715870|FG002|COMPLETED|Overall Study||6||
59605746|NCT01996254|75715868|FG000|NOT COMPLETED|Overall Study||1||
59605747|NCT01996254|75715869|FG001|NOT COMPLETED|Overall Study||5||
59605748|NCT01996254|75715870|FG002|NOT COMPLETED|Overall Study||8||
59605749|NCT01987986|75715884|FG000|STARTED|Overall Study||43||
59605750|NCT01987986|75715885|FG001|STARTED|Overall Study||43||
60010677|NCT01733238|76126360|FG000|COMPLETED|Overall Study|8 subjects completed the Induction Phase and 7 subjects started Maintenance Phase|8|8 subjects completed the Induction Phase and 7 subjects started Maintenance Phase|
60010678|NCT01733238|76126360|FG000|NOT COMPLETED|Overall Study||5||
60010679|NCT01593254|76126366|FG000|STARTED|Overall Study||86|Started = Started Treatment Period|
60010680|NCT01593254|76126367|FG001|STARTED|Overall Study||174|Started = Started Treatment Period|
60010681|NCT01593254|76126366|FG000|Crossed Over to Dasatinib|Overall Study||46||
60010682|NCT01593254|76126367|FG001|Crossed Over to Dasatinib|Overall Study||0||
60010683|NCT01593254|76126366|FG000|COMPLETED|Overall Study||0|Completed = Continuing in Treatment Period|
60010684|NCT01593254|76126367|FG001|COMPLETED|Overall Study||0|Completed = Continuing in Treatment Period|
60010685|NCT01593254|76126366|FG000|NOT COMPLETED|Overall Study||86||
60010686|NCT01593254|76126367|FG001|NOT COMPLETED|Overall Study||174||
60010687|NCT01559818|76126374|FG000|STARTED|Overall Study||10||
60010688|NCT01559818|76126374|FG000|COMPLETED|Overall Study||3||
60147455|NCT03385304|76271992|FG001|Months 27-28|Overall Study||18||1
60147456|NCT03385304|76271991|FG000|Months 29-30|Overall Study||0||0
60147457|NCT03385304|76271992|FG001|Months 29-30|Overall Study||8||1
60147458|NCT03385304|76271991|FG000|Months 31-32|Overall Study||8||1
60147459|NCT03385304|76271992|FG001|Months 31-32|Overall Study||0||0
60147460|NCT03385304|76271991|FG000|COMPLETED|Overall Study||787|Total Study Duration|7
60147461|NCT03385304|76271992|FG001|COMPLETED|Overall Study||784|Total Study Duration|7
60147462|NCT03385304|76271991|FG000|NOT COMPLETED|Overall Study||41||0
60147463|NCT03385304|76271992|FG001|NOT COMPLETED|Overall Study||26||0
60147464|NCT03325608|76272002|FG000|STARTED|Overall Study||455||
60147465|NCT03325608|76272003|FG001|STARTED|Overall Study||455||
60147466|NCT03325608|76272004|FG002|STARTED|Overall Study||434||
60010689|NCT01559818|76126374|FG000|NOT COMPLETED|Overall Study||7||
60010690|NCT01454934|76126381|FG000|STARTED|Overall Study||270||
60147467|NCT03325608|76272005|FG003|STARTED|Overall Study||434||
60147468|NCT03325608|76272002|FG000|COMPLETED|Overall Study||320||
60147469|NCT03325608|76272003|FG001|COMPLETED|Overall Study||320||
60010691|NCT01454934|76126382|FG001|STARTED|Overall Study||270||
60147470|NCT03325608|76272004|FG002|COMPLETED|Overall Study||322||
60147471|NCT03325608|76272005|FG003|COMPLETED|Overall Study||322||
60147472|NCT03325608|76272002|FG000|NOT COMPLETED|Overall Study||135||
60147473|NCT03325608|76272003|FG001|NOT COMPLETED|Overall Study||135||
60147474|NCT03325608|76272004|FG002|NOT COMPLETED|Overall Study||112||
60147475|NCT03325608|76272005|FG003|NOT COMPLETED|Overall Study||112||
60147476|NCT03183141|76272015|FG000|STARTED|Overall Study||29||
60147477|NCT03183141|76272016|FG001|STARTED|Overall Study||234||
60147478|NCT03183141|76272015|FG000|Completed 8-week Follow-up|Overall Study||29||
60147479|NCT03183141|76272016|FG001|Completed 8-week Follow-up|Overall Study||228||
60147480|NCT03183141|76272015|FG000|COMPLETED|Overall Study||27|Completed 24-week Follow-up|
60147481|NCT03183141|76272016|FG001|COMPLETED|Overall Study||222|Completed 24-week Follow-up|
60147482|NCT03183141|76272015|FG000|NOT COMPLETED|Overall Study||2||
60147483|NCT03183141|76272016|FG001|NOT COMPLETED|Overall Study||12||
60147484|NCT02957539|76272025|FG000|STARTED|Baseline to Week 16||73||
60147485|NCT02957539|76272026|FG001|STARTED|Baseline to Week 16||91||
60147486|NCT02957539|76272027|FG002|STARTED|Baseline to Week 16||87||
60147487|NCT02957539|76272025|FG000|COMPLETED|Baseline to Week 16||51||
60147488|NCT02957539|76272026|FG001|COMPLETED|Baseline to Week 16||77||
60147489|NCT02957539|76272027|FG002|COMPLETED|Baseline to Week 16||66||
60147490|NCT02957539|76272025|FG000|NOT COMPLETED|Baseline to Week 16||22||
60147491|NCT02957539|76272026|FG001|NOT COMPLETED|Baseline to Week 16||14||
60147492|NCT02957539|76272027|FG002|NOT COMPLETED|Baseline to Week 16||21||
60147493|NCT02957539|76272025|FG000|STARTED|Week 16 to 32||51||
60147494|NCT02957539|76272026|FG001|STARTED|Week 16 to 32||77||
60147495|NCT02957539|76272027|FG002|STARTED|Week 16 to 32||66||
60147496|NCT02957539|76272025|FG000|COMPLETED|Week 16 to 32||40||
60147497|NCT02957539|76272026|FG001|COMPLETED|Week 16 to 32||67||
60147498|NCT02957539|76272027|FG002|COMPLETED|Week 16 to 32||60||
60147499|NCT02957539|76272025|FG000|NOT COMPLETED|Week 16 to 32||11||
60147500|NCT02957539|76272026|FG001|NOT COMPLETED|Week 16 to 32||10||
60147501|NCT02957539|76272027|FG002|NOT COMPLETED|Week 16 to 32||6||
60147502|NCT02957539|76272025|FG000|STARTED|Week 32 to Week 52||40||
60147503|NCT02957539|76272026|FG001|STARTED|Week 32 to Week 52||67||
60147504|NCT02957539|76272027|FG002|STARTED|Week 32 to Week 52||60||
60147505|NCT02957539|76272025|FG000|COMPLETED|Week 32 to Week 52||29||
60147506|NCT02957539|76272026|FG001|COMPLETED|Week 32 to Week 52||50||
60010692|NCT01454934|76126381|FG000|COMPLETED|Overall Study||0||
60010693|NCT01454934|76126382|FG001|COMPLETED|Overall Study||0||
60010694|NCT01454934|76126381|FG000|NOT COMPLETED|Overall Study||270||
60010695|NCT01454934|76126382|FG001|NOT COMPLETED|Overall Study||270||
60010696|NCT01439282|76126390|FG000|STARTED|Overall Study||67||
60010697|NCT01439282|76126391|FG001|STARTED|Overall Study||10||
60010698|NCT01439282|76126390|FG000|COMPLETED|Overall Study||59||
60010699|NCT01439282|76126391|FG001|COMPLETED|Overall Study||9||
60010700|NCT01439282|76126390|FG000|NOT COMPLETED|Overall Study||8||
60010701|NCT01439282|76126391|FG001|NOT COMPLETED|Overall Study||1||
60010702|NCT01326312|76126401|FG000|STARTED|Overall Study||53||
60010703|NCT01326312|76126402|FG001|STARTED|Overall Study||55||
60010704|NCT01326312|76126403|FG002|STARTED|Overall Study||51||
60147507|NCT02957539|76272027|FG002|COMPLETED|Week 32 to Week 52||33||
60147508|NCT02957539|76272025|FG000|NOT COMPLETED|Week 32 to Week 52||11||
60147509|NCT02957539|76272026|FG001|NOT COMPLETED|Week 32 to Week 52||17||
60147510|NCT02957539|76272027|FG002|NOT COMPLETED|Week 32 to Week 52||27||
60147511|NCT02690077|76272040|FG000|STARTED|Overall Study||73||
60147512|NCT02690077|76272041|FG001|STARTED|Overall Study||76||
60147513|NCT02690077|76272040|FG000|COMPLETED|Overall Study||68||
60010705|NCT01326312|76126401|FG000|COMPLETED|Overall Study||0||
60010706|NCT01326312|76126402|FG001|COMPLETED|Overall Study||0||
60147514|NCT02690077|76272041|FG001|COMPLETED|Overall Study||61||
60147515|NCT02690077|76272040|FG000|NOT COMPLETED|Overall Study||5||
60147516|NCT02690077|76272041|FG001|NOT COMPLETED|Overall Study||15||
60147517|NCT02275780|76272049|FG000|STARTED|Base Study: 96 Weeks||385||
60147518|NCT02275780|76272050|FG001|STARTED|Base Study: 96 Weeks||384||
60147519|NCT02275780|76272049|FG000|Treated|Base Study: 96 Weeks||383||
60147520|NCT02275780|76272050|FG001|Treated|Base Study: 96 Weeks||383||
60147521|NCT02275780|76272049|FG000|COMPLETED|Base Study: 96 Weeks||292||
60147522|NCT02275780|76272050|FG001|COMPLETED|Base Study: 96 Weeks||273||
60147523|NCT02275780|76272049|FG000|NOT COMPLETED|Base Study: 96 Weeks||93||
60147524|NCT02275780|76272050|FG001|NOT COMPLETED|Base Study: 96 Weeks||111||
60147525|NCT02275780|76272049|FG000|STARTED|Extension Study: up to 192 Weeks|The extension study is optional; not all eligible participants enrolled|260||
60147526|NCT02275780|76272050|FG001|STARTED|Extension Study: up to 192 Weeks|The extension study is optional; not all eligible participants enrolled|233||
60147527|NCT02275780|76272049|FG000|COMPLETED|Extension Study: up to 192 Weeks|The extension study is ongoing|0||
60147528|NCT02275780|76272050|FG001|COMPLETED|Extension Study: up to 192 Weeks|The extension study is ongoing|0||
60147529|NCT02275780|76272049|FG000|NOT COMPLETED|Extension Study: up to 192 Weeks||260||
60010707|NCT01326312|76126403|FG002|COMPLETED|Overall Study||0||
60010708|NCT01326312|76126401|FG000|NOT COMPLETED|Overall Study||53||
60010709|NCT01326312|76126402|FG001|NOT COMPLETED|Overall Study||55||
60010710|NCT01326312|76126403|FG002|NOT COMPLETED|Overall Study||51||
60147530|NCT02275780|76272050|FG001|NOT COMPLETED|Extension Study: up to 192 Weeks||233||
60147531|NCT00545077|76272058|FG000|STARTED|Overall Study||189||
60147532|NCT00545077|76272059|FG001|STARTED|Overall Study||191||
60147533|NCT00545077|76272058|FG000|COMPLETED|Overall Study||41||
60147534|NCT00545077|76272059|FG001|COMPLETED|Overall Study||36||
60147535|NCT00545077|76272058|FG000|NOT COMPLETED|Overall Study||148||
60147536|NCT00545077|76272059|FG001|NOT COMPLETED|Overall Study||155||
60147537|NCT00130533|76272067|FG000|STARTED|Overall Study||448||
60147538|NCT00130533|76272068|FG001|STARTED|Overall Study||428||
60147539|NCT00130533|76272067|FG000|COMPLETED|Overall Study||337||
60147540|NCT00130533|76272068|FG001|COMPLETED|Overall Study||398||
60147541|NCT00130533|76272067|FG000|NOT COMPLETED|Overall Study||111||
60147542|NCT00130533|76272068|FG001|NOT COMPLETED|Overall Study||30||
60147543|NCT00129935|76272076|FG000|STARTED|Overall Study||669||
60147544|NCT00129935|76272077|FG001|STARTED|Overall Study||715||
60147545|NCT00129935|76272076|FG000|COMPLETED|Overall Study|2 patients crossed from arm A to B by error, and 1 patient received other treatment by error.|633||
60147546|NCT00129935|76272077|FG001|COMPLETED|Overall Study|1 patient crossed from arm B to A by error.|623||
60147547|NCT00129935|76272076|FG000|NOT COMPLETED|Overall Study||36||
60147548|NCT00129935|76272077|FG001|NOT COMPLETED|Overall Study||92||
60147549|NCT01647828|76272092|FG000|STARTED|Overall Study||5||
60147550|NCT01647828|76272093|FG001|STARTED|Overall Study||4||
60147551|NCT01647828|76272094|FG002|STARTED|Overall Study||4||
60147552|NCT01647828|76272095|FG003|STARTED|Overall Study||6||
60147553|NCT01647828|76272096|FG004|STARTED|Overall Study||6||
60147554|NCT01647828|76272097|FG005|STARTED|Overall Study||3||
60147555|NCT01647828|76272098|FG006|STARTED|Overall Study||12||
60147556|NCT01647828|76272099|FG007|STARTED|Overall Study||88||
60147557|NCT01647828|76272100|FG008|STARTED|Overall Study||89||
60147558|NCT01647828|76272092|FG000|COMPLETED|Overall Study||0||
60147559|NCT01647828|76272093|FG001|COMPLETED|Overall Study||0||
60147560|NCT01647828|76272094|FG002|COMPLETED|Overall Study||0||
60147561|NCT01647828|76272095|FG003|COMPLETED|Overall Study||0||
60147562|NCT01647828|76272096|FG004|COMPLETED|Overall Study||0||
60147563|NCT01647828|76272097|FG005|COMPLETED|Overall Study||0||
60147564|NCT01647828|76272098|FG006|COMPLETED|Overall Study||0||
60147565|NCT01647828|76272099|FG007|COMPLETED|Overall Study||0||
60147566|NCT01647828|76272100|FG008|COMPLETED|Overall Study||0||
60147567|NCT01647828|76272092|FG000|NOT COMPLETED|Overall Study||5||
60147568|NCT01647828|76272093|FG001|NOT COMPLETED|Overall Study||4||
60147569|NCT01647828|76272094|FG002|NOT COMPLETED|Overall Study||4||
60147570|NCT01647828|76272095|FG003|NOT COMPLETED|Overall Study||6||
60147571|NCT01647828|76272096|FG004|NOT COMPLETED|Overall Study||6||
60147572|NCT01647828|76272097|FG005|NOT COMPLETED|Overall Study||3||
60147573|NCT01647828|76272098|FG006|NOT COMPLETED|Overall Study||12||
60147574|NCT01647828|76272099|FG007|NOT COMPLETED|Overall Study||88||
60147575|NCT01647828|76272100|FG008|NOT COMPLETED|Overall Study||89||
60147576|NCT00989261|76272122|FG000|STARTED|Overall Study||157||
60147577|NCT00989261|76272123|FG001|STARTED|Overall Study||176||
60147578|NCT00989261|76272122|FG000|COMPLETED|Overall Study||142||
60147579|NCT00989261|76272123|FG001|COMPLETED|Overall Study||154||
60147580|NCT00989261|76272122|FG000|NOT COMPLETED|Overall Study||15||
60147581|NCT00989261|76272123|FG001|NOT COMPLETED|Overall Study||22||
60147582|NCT04279925|76272131|FG000|STARTED|Overall Study||4||
60147583|NCT04279925|76272132|FG001|STARTED|Overall Study||5||
60147584|NCT04279925|76272131|FG000|COMPLETED|Overall Study||4||
60147585|NCT04279925|76272132|FG001|COMPLETED|Overall Study||5||
60147586|NCT04279925|76272131|FG000|NOT COMPLETED|Overall Study||0||
60147587|NCT04279925|76272132|FG001|NOT COMPLETED|Overall Study||0||
60147588|NCT00988559|76272142|FG000|STARTED|Overall Study||10||
60147589|NCT00988559|76272143|FG001|STARTED|Overall Study||11||
60147590|NCT00988559|76272144|FG002|STARTED|Overall Study||11||
60147591|NCT00988559|76272145|FG003|STARTED|Overall Study||7||
60147592|NCT00988559|76272142|FG000|COMPLETED|Overall Study||9||
60147593|NCT00988559|76272143|FG001|COMPLETED|Overall Study||9||
60147594|NCT00988559|76272144|FG002|COMPLETED|Overall Study||9||
60147595|NCT00988559|76272145|FG003|COMPLETED|Overall Study||6||
60147596|NCT00988559|76272142|FG000|NOT COMPLETED|Overall Study||1||
60147597|NCT00988559|76272143|FG001|NOT COMPLETED|Overall Study||2||
60147598|NCT00988559|76272144|FG002|NOT COMPLETED|Overall Study||2||
60147599|NCT00988559|76272145|FG003|NOT COMPLETED|Overall Study||1||
60147600|NCT00988169|76272155|FG000|STARTED|Overall Study||6||
60147601|NCT00988169|76272155|FG000|COMPLETED|Overall Study||5||
60147602|NCT00988169|76272155|FG000|NOT COMPLETED|Overall Study||1||
60147603|NCT02967133|76272161|FG000|STARTED|Overall Study||3||
60147604|NCT02967133|76272162|FG001|STARTED|Overall Study||4||
60147605|NCT02967133|76272161|FG000|COMPLETED|Overall Study||3||
60147606|NCT02967133|76272162|FG001|COMPLETED|Overall Study||4||
60147607|NCT02967133|76272161|FG000|NOT COMPLETED|Overall Study||0||
60147608|NCT02967133|76272162|FG001|NOT COMPLETED|Overall Study||0||
60147609|NCT01311687|76272170|FG000|STARTED|Treatment Phase||302||
60147610|NCT01311687|76272171|FG001|STARTED|Treatment Phase||153||
60147611|NCT01311687|76272170|FG000|Received Study Drug|Treatment Phase||300||
60147612|NCT01311687|76272171|FG001|Received Study Drug|Treatment Phase||150||
60147613|NCT01311687|76272170|FG000|Crossed-over to Pomalidomide|Treatment Phase|Not applicable to participants initially randomized to receive pomalidomide|0||
60147614|NCT01311687|76272171|FG001|Crossed-over to Pomalidomide|Treatment Phase|After Amendment 4 participants still on HD-Dex treatment were permitted to crossover to pomalidomide|11||
60147615|NCT01311687|76272170|FG000|COMPLETED|Treatment Phase||302|Completed represents participants who discontinued from study treatment|
60147616|NCT01311687|76272171|FG001|COMPLETED|Treatment Phase||153|Completed represents participants who discontinued from study treatment|
60147617|NCT01311687|76272170|FG000|NOT COMPLETED|Treatment Phase||0||
60147618|NCT01311687|76272171|FG001|NOT COMPLETED|Treatment Phase||0||
60147619|NCT01311687|76272170|FG000|STARTED|PFS Follow-up Phase||11||
60147620|NCT01311687|76272171|FG001|STARTED|PFS Follow-up Phase||8||
60147621|NCT01311687|76272170|FG000|Crossed-over to Pomalidomide|PFS Follow-up Phase||11|After Amendment 4 participants still on HD-Dex treatment were permitted to crossover to pomalidomide|
60147622|NCT01311687|76272171|FG001|Crossed-over to Pomalidomide|PFS Follow-up Phase||0|After Amendment 4 participants still on HD-Dex treatment were permitted to crossover to pomalidomide|
60147623|NCT01311687|76272170|FG000|COMPLETED|PFS Follow-up Phase||11|Completed represents participants who discontinued from PFS follow-up|
60147624|NCT01311687|76272171|FG001|COMPLETED|PFS Follow-up Phase||8|Completed represents participants who discontinued from PFS follow-up|
60147625|NCT01311687|76272170|FG000|NOT COMPLETED|PFS Follow-up Phase||0||
60147626|NCT01311687|76272171|FG001|NOT COMPLETED|PFS Follow-up Phase||0||
60147627|NCT00988091|76272182|FG000|STARTED|Double-blind Period||298||
60147628|NCT00988091|76272183|FG001|STARTED|Double-blind Period||298||
60147629|NCT00988091|76272182|FG000|Intent to Treat Population|Double-blind Period|ITT population excludes participants from one site which was closed for non-compliance.|294||
60147630|NCT00988091|76272183|FG001|Intent to Treat Population|Double-blind Period|ITT population excludes participants from one site which was closed for non-compliance.|295||
60147631|NCT00988091|76272182|FG000|COMPLETED|Double-blind Period||255||
60147632|NCT00988091|76272183|FG001|COMPLETED|Double-blind Period||251||
60147633|NCT00988091|76272182|FG000|NOT COMPLETED|Double-blind Period||43||
60147634|NCT00988091|76272183|FG001|NOT COMPLETED|Double-blind Period||47||
60147635|NCT00988091|76272182|FG000|STARTED|Open-label Period|Participation in the Open-label period was optional.|229||
60147636|NCT00988091|76272183|FG001|STARTED|Open-label Period|Participation in the Open-label period was optional.|225||
60147637|NCT00988091|76272182|FG000|COMPLETED|Open-label Period||208||
60147638|NCT00988091|76272183|FG001|COMPLETED|Open-label Period||192||
60147639|NCT00988091|76272182|FG000|NOT COMPLETED|Open-label Period||21||
60147640|NCT00988091|76272183|FG001|NOT COMPLETED|Open-label Period||33||
60147641|NCT02965729|76272193|FG000|STARTED|Overall Study||24||
60147642|NCT02965729|76272194|FG001|STARTED|Overall Study||25||
60147643|NCT02965729|76272195|FG002|STARTED|Overall Study||56||
60147644|NCT02965729|76272193|FG000|COMPLETED|Overall Study||17||
60147645|NCT02965729|76272194|FG001|COMPLETED|Overall Study||22||
60147646|NCT02965729|76272195|FG002|COMPLETED|Overall Study||45||
60147647|NCT02965729|76272193|FG000|NOT COMPLETED|Overall Study||7||
60147648|NCT02965729|76272194|FG001|NOT COMPLETED|Overall Study||3||
60147649|NCT02965729|76272195|FG002|NOT COMPLETED|Overall Study||11||
60147650|NCT01346397|76272205|FG000|STARTED|Overall Study||85||
60147651|NCT01346397|76272206|FG001|STARTED|Overall Study||85||
60147652|NCT01346397|76272205|FG000|COMPLETED|Overall Study||85||
60147653|NCT01346397|76272206|FG001|COMPLETED|Overall Study||85||
60147654|NCT01346397|76272205|FG000|NOT COMPLETED|Overall Study||0||
60147655|NCT01346397|76272206|FG001|NOT COMPLETED|Overall Study||0||
60147656|NCT01347255|76272212|FG000|STARTED|Overall Study||24||
60147657|NCT01347255|76272212|FG000|COMPLETED|Overall Study||24||
60147658|NCT01347255|76272212|FG000|NOT COMPLETED|Overall Study||0||
60147659|NCT01312233|76272222|FG000|STARTED|Overall Study||44||
60147660|NCT01312233|76272223|FG001|STARTED|Overall Study||44||
60147661|NCT01312233|76272224|FG002|STARTED|Overall Study||43||
60147662|NCT01312233|76272222|FG000|COMPLETED|Overall Study||42||
60147663|NCT01312233|76272223|FG001|COMPLETED|Overall Study||44||
60147664|NCT01312233|76272224|FG002|COMPLETED|Overall Study||36||
60147665|NCT01312233|76272222|FG000|NOT COMPLETED|Overall Study||2||
60147666|NCT01312233|76272223|FG001|NOT COMPLETED|Overall Study||0||
60147667|NCT01312233|76272224|FG002|NOT COMPLETED|Overall Study||7||
60147668|NCT01347333|76272234|FG000|STARTED|Overall Study||23||
60147669|NCT01347333|76272235|FG001|STARTED|Overall Study|No participants were enrolled in the Primary Liver Tumor arm.|0||
60147670|NCT01347333|76272234|FG000|COMPLETED|Overall Study||23||
60147671|NCT01347333|76272235|FG001|COMPLETED|Overall Study||0||
60147672|NCT01347333|76272234|FG000|NOT COMPLETED|Overall Study||0||
60147673|NCT01347333|76272235|FG001|NOT COMPLETED|Overall Study||0||
60147674|NCT01312389|76272244|FG000|STARTED|Phase 1||3||
60147675|NCT01312389|76272245|FG001|STARTED|Phase 1||0||
60147676|NCT01312389|76272246|FG002|STARTED|Phase 1||0||
60147677|NCT01312389|76272244|FG000|COMPLETED|Phase 1||3||
60147678|NCT01312389|76272245|FG001|COMPLETED|Phase 1||0||
60147679|NCT01312389|76272246|FG002|COMPLETED|Phase 1||0||
60147680|NCT01312389|76272244|FG000|NOT COMPLETED|Phase 1||0||
60147681|NCT01312389|76272245|FG001|NOT COMPLETED|Phase 1||0||
60147682|NCT01312389|76272246|FG002|NOT COMPLETED|Phase 1||0||
60147683|NCT01312389|76272244|FG000|STARTED|Phase 2||0||
60147684|NCT01312389|76272245|FG001|STARTED|Phase 2||0||
60147685|NCT01312389|76272246|FG002|STARTED|Phase 2||0||
60147686|NCT01312389|76272244|FG000|COMPLETED|Phase 2||0||
60147687|NCT01312389|76272245|FG001|COMPLETED|Phase 2||0||
60147688|NCT01312389|76272246|FG002|COMPLETED|Phase 2||0||
60147689|NCT01312389|76272244|FG000|NOT COMPLETED|Phase 2||0||
60147690|NCT01312389|76272245|FG001|NOT COMPLETED|Phase 2||0||
60147691|NCT01312389|76272246|FG002|NOT COMPLETED|Phase 2||0||
60147692|NCT01350453|76272256|FG000|STARTED|Overall Study||11||
60147693|NCT01350453|76272257|FG001|STARTED|Overall Study||8||
60147694|NCT01350453|76272256|FG000|COMPLETED|Overall Study||9||
60147695|NCT01350453|76272257|FG001|COMPLETED|Overall Study||7||
60147696|NCT01350453|76272256|FG000|NOT COMPLETED|Overall Study||2||
60147697|NCT01350453|76272257|FG001|NOT COMPLETED|Overall Study||1||
60147698|NCT01351077|76272267|FG000|STARTED|Overall Study||180||
60147699|NCT01351077|76272268|FG001|STARTED|Overall Study||180||
60147700|NCT01351077|76272267|FG000|COMPLETED|Overall Study||180||
60147701|NCT01351077|76272268|FG001|COMPLETED|Overall Study||180||
60147702|NCT01351077|76272267|FG000|NOT COMPLETED|Overall Study||0||
60147703|NCT01351077|76272268|FG001|NOT COMPLETED|Overall Study||0||
60147704|NCT01352637|76272278|FG000|STARTED|Exposure Therapy||97||
60147705|NCT01352637|76272279|FG001|STARTED|Exposure Therapy||95||
60147706|NCT01352637|76272280|FG002|STARTED|Exposure Therapy||0||
60147707|NCT01352637|76272281|FG003|STARTED|Exposure Therapy||0||
60147708|NCT01352637|76272278|FG000|COMPLETED|Exposure Therapy||70||
60147709|NCT01352637|76272279|FG001|COMPLETED|Exposure Therapy||62||
60147710|NCT01352637|76272280|FG002|COMPLETED|Exposure Therapy||0||
60147711|NCT01352637|76272281|FG003|COMPLETED|Exposure Therapy||0||
60147712|NCT01352637|76272278|FG000|NOT COMPLETED|Exposure Therapy||27||
60147713|NCT01352637|76272279|FG001|NOT COMPLETED|Exposure Therapy||33||
60147714|NCT01352637|76272280|FG002|NOT COMPLETED|Exposure Therapy||0||
60147715|NCT01352637|76272281|FG003|NOT COMPLETED|Exposure Therapy||0||
60147716|NCT01352637|76272278|FG000|STARTED|Drug||0||
60147717|NCT01352637|76272279|FG001|STARTED|Drug||0||
60147718|NCT01352637|76272280|FG002|STARTED|Drug||95||
60147719|NCT01352637|76272281|FG003|STARTED|Drug||97||
60147720|NCT01352637|76272278|FG000|COMPLETED|Drug||0||
60147721|NCT01352637|76272279|FG001|COMPLETED|Drug||0||
60147722|NCT01352637|76272280|FG002|COMPLETED|Drug||70||
60147723|NCT01352637|76272281|FG003|COMPLETED|Drug||62||
60147724|NCT01352637|76272278|FG000|NOT COMPLETED|Drug||0||
60147725|NCT01352637|76272279|FG001|NOT COMPLETED|Drug||0||
60147726|NCT01352637|76272280|FG002|NOT COMPLETED|Drug||25||
60147727|NCT01352637|76272281|FG003|NOT COMPLETED|Drug||35||
60147728|NCT01314417|76272291|FG000|STARTED|Overall Study||2||
60147729|NCT01314417|76272291|FG000|COMPLETED|Overall Study||2||
60147730|NCT01314417|76272291|FG000|NOT COMPLETED|Overall Study||0||
60147731|NCT01314963|76272295|FG000|STARTED|Overall Study||50||
60147732|NCT01314963|76272295|FG000|COMPLETED|Overall Study||50||
60147733|NCT01314963|76272295|FG000|NOT COMPLETED|Overall Study||0||
60147734|NCT01353495|76272303|FG000|STARTED|Overall Study||19||
60147735|NCT01353495|76272304|FG001|STARTED|Overall Study||20||
60147736|NCT01353495|76272303|FG000|COMPLETED|Overall Study||19||
60147737|NCT01353495|76272304|FG001|COMPLETED|Overall Study||20||
60147738|NCT01353495|76272303|FG000|NOT COMPLETED|Overall Study||0||
60147739|NCT01353495|76272304|FG001|NOT COMPLETED|Overall Study||0||
60147740|NCT02893423|76272313|FG000|STARTED|Overall Study||17||
60147741|NCT02893423|76272314|FG001|STARTED|Overall Study||16||
60147742|NCT02893423|76272315|FG002|STARTED|Overall Study||18||
60147743|NCT02893423|76272313|FG000|COMPLETED|Overall Study||17||
60147744|NCT02893423|76272314|FG001|COMPLETED|Overall Study||16||
60147745|NCT02893423|76272315|FG002|COMPLETED|Overall Study||18||
60147746|NCT02893423|76272313|FG000|NOT COMPLETED|Overall Study||0||
60147747|NCT02893423|76272314|FG001|NOT COMPLETED|Overall Study||0||
60147748|NCT02893423|76272315|FG002|NOT COMPLETED|Overall Study||0||
60147749|NCT01354197|76272325|FG000|STARTED|Overall Study||4652||
60147750|NCT01354197|76272325|FG000|COMPLETED|Overall Study||4652||
60147751|NCT01354197|76272325|FG000|NOT COMPLETED|Overall Study||0||
60147752|NCT01315665|76272332|FG000|STARTED|Overall Study||10||
60147753|NCT01315665|76272333|FG001|STARTED|Overall Study||5||
60147754|NCT01315665|76272332|FG000|COMPLETED|Overall Study||10||
60147755|NCT01315665|76272333|FG001|COMPLETED|Overall Study||5||
60147756|NCT01315665|76272332|FG000|NOT COMPLETED|Overall Study||0||
60147757|NCT01315665|76272333|FG001|NOT COMPLETED|Overall Study||0||
60147758|NCT01356147|76272343|FG000|STARTED|Overall Study||5||
60147759|NCT01356147|76272344|FG001|STARTED|Overall Study||6||
60147760|NCT01356147|76272343|FG000|COMPLETED|Overall Study||5||
60147761|NCT01356147|76272344|FG001|COMPLETED|Overall Study||6||
60147762|NCT01356147|76272343|FG000|NOT COMPLETED|Overall Study||0||
60147763|NCT01356147|76272344|FG001|NOT COMPLETED|Overall Study||0||
60147764|NCT02883673|76272350|FG000|STARTED|Overall Study||107||
60147765|NCT02883673|76272350|FG000|COMPLETED|Overall Study||107||
60147766|NCT02883673|76272350|FG000|NOT COMPLETED|Overall Study||0||
60147767|NCT02865811|76272355|FG000|STARTED|Overall Study||26||
60147768|NCT02865811|76272355|FG000|COMPLETED|Overall Study||26||
60147769|NCT02865811|76272355|FG000|NOT COMPLETED|Overall Study||0||
60147770|NCT02808871|76272362|FG000|STARTED|Overall Study||63||
60147771|NCT02808871|76272363|FG001|STARTED|Overall Study||60||
60147772|NCT02808871|76272362|FG000|COMPLETED|Overall Study||52||
60147773|NCT02808871|76272363|FG001|COMPLETED|Overall Study||51||
60147774|NCT02808871|76272362|FG000|NOT COMPLETED|Overall Study||11||
60147775|NCT02808871|76272363|FG001|NOT COMPLETED|Overall Study||9||
60147776|NCT02467621|76272373|FG000|STARTED|Overall Study||1645|"52 patients were randomised in error BEFORE receiving the first dose of IMP/placebo.~3350-52=3298"|
60147777|NCT02467621|76272374|FG001|STARTED|Overall Study||1653|"52 patients were randomised in error BEFORE receiving the first dose of IMP/placebo.~3350-52=3298"|
60147778|NCT02467621|76272373|FG000|COMPLETED|Overall Study||1644|1644/1647 in the secondary outcome analyses 1642/1640 in the primary outcome analysis|
60147779|NCT02467621|76272374|FG001|COMPLETED|Overall Study||1647|1644/1647 in the secondary outcome analyses 1642/1640 in the primary outcome analysis|
60147780|NCT02467621|76272373|FG000|NOT COMPLETED|Overall Study||1||
60147781|NCT02467621|76272374|FG001|NOT COMPLETED|Overall Study||6||
60147782|NCT01316211|76272382|FG000|STARTED|Overall Study||116||
60147783|NCT01316211|76272383|FG001|STARTED|Overall Study||123||
60147784|NCT01316211|76272382|FG000|COMPLETED|Overall Study||105||
60147785|NCT01316211|76272383|FG001|COMPLETED|Overall Study||111||
60147786|NCT01316211|76272382|FG000|NOT COMPLETED|Overall Study||11||
60147787|NCT01316211|76272383|FG001|NOT COMPLETED|Overall Study||12||
60147788|NCT01359111|76272389|FG000|STARTED|Overall Study||20||
60147789|NCT01359111|76272389|FG000|COMPLETED|Overall Study||20||
60147790|NCT01359111|76272389|FG000|NOT COMPLETED|Overall Study||0||
60147791|NCT02181075|76272397|FG000|STARTED|Overall Study||6||
60147792|NCT02181075|76272398|FG001|STARTED|Overall Study||4||
60147793|NCT02181075|76272397|FG000|COMPLETED|Overall Study||6||
60147794|NCT02181075|76272398|FG001|COMPLETED|Overall Study||4||
60147795|NCT02181075|76272397|FG000|NOT COMPLETED|Overall Study||0||
60147796|NCT02181075|76272398|FG001|NOT COMPLETED|Overall Study||0||
60147797|NCT01359735|76272410|FG000|STARTED|Overall Study||4||
60147798|NCT01359735|76272411|FG001|STARTED|Overall Study||4||
60147799|NCT01359735|76272410|FG000|COMPLETED|Overall Study||4||
60147800|NCT01359735|76272411|FG001|COMPLETED|Overall Study||4||
60147801|NCT01359735|76272410|FG000|NOT COMPLETED|Overall Study||0||
60147802|NCT01359735|76272411|FG001|NOT COMPLETED|Overall Study||0||
60147803|NCT01361217|76272417|FG000|STARTED|Overall Study||10||
60147804|NCT01361217|76272417|FG000|COMPLETED|Overall Study||10||
60147805|NCT01361217|76272417|FG000|NOT COMPLETED|Overall Study||0||
60147806|NCT01319799|76272423|FG000|STARTED|Overall Study||10||
60147807|NCT01319799|76272423|FG000|COMPLETED|Overall Study||10||
60147808|NCT01319799|76272423|FG000|NOT COMPLETED|Overall Study||0||
60147809|NCT02196831|76272429|FG000|STARTED|Overall Study||30||
60147810|NCT02196831|76272430|FG001|STARTED|Overall Study||30||
60147811|NCT02196831|76272429|FG000|Received Follow-up Imaging|Overall Study||26||
60147812|NCT02196831|76272430|FG001|Received Follow-up Imaging|Overall Study||28||
60147813|NCT02196831|76272429|FG000|COMPLETED|Overall Study||21||
60147814|NCT02196831|76272430|FG001|COMPLETED|Overall Study||26||
60147815|NCT02196831|76272429|FG000|NOT COMPLETED|Overall Study||9||
60147816|NCT02196831|76272430|FG001|NOT COMPLETED|Overall Study||4||
60147817|NCT01363479|76272439|FG000|STARTED|Overall Study|number of randomised patients|371||
60147818|NCT01363479|76272440|FG001|STARTED|Overall Study|number of randomised patients|372||
60147819|NCT01363479|76272439|FG000|COMPLETED|Overall Study||359||
60147820|NCT01363479|76272440|FG001|COMPLETED|Overall Study||351||
60147821|NCT01363479|76272439|FG000|NOT COMPLETED|Overall Study||12||
60147822|NCT01363479|76272440|FG001|NOT COMPLETED|Overall Study||21||
60147823|NCT02181231|76272448|FG000|STARTED|Overall Study||12||
60147824|NCT02181231|76272449|FG001|STARTED|Overall Study||6||
60147825|NCT02181231|76272448|FG000|COMPLETED|Overall Study||10||
60147826|NCT02181231|76272449|FG001|COMPLETED|Overall Study||6||
60147827|NCT02181231|76272448|FG000|NOT COMPLETED|Overall Study||2||
60147828|NCT02181231|76272449|FG001|NOT COMPLETED|Overall Study||0||
60147829|NCT01364259|76272457|FG000|STARTED|Overall Study||9||
60147830|NCT01364259|76272458|FG001|STARTED|Overall Study||8||
60147831|NCT01364259|76272457|FG000|COMPLETED|Overall Study||9||
60147832|NCT01364259|76272458|FG001|COMPLETED|Overall Study||8||
60147833|NCT01364259|76272457|FG000|NOT COMPLETED|Overall Study||0||
60147834|NCT01364259|76272458|FG001|NOT COMPLETED|Overall Study||0||
60147835|NCT01321437|76272464|FG000|STARTED|Overall Study||11||
60147836|NCT01321437|76272464|FG000|COMPLETED|Overall Study||11||
60147837|NCT01321437|76272464|FG000|NOT COMPLETED|Overall Study||0||
60147838|NCT02623218|76272473|FG000|STARTED|Overall Study||5||
60147839|NCT02623218|76272474|FG001|STARTED|Overall Study||4||
60147840|NCT02623218|76272475|FG002|STARTED|Overall Study||4||
60147841|NCT02623218|76272476|FG003|STARTED|Overall Study||4||
60147842|NCT02623218|76272477|FG004|STARTED|Overall Study||4||
60147843|NCT02623218|76272473|FG000|COMPLETED|Overall Study||5||
60147844|NCT02623218|76272474|FG001|COMPLETED|Overall Study||3||
60147845|NCT02623218|76272475|FG002|COMPLETED|Overall Study||4||
60147846|NCT02623218|76272476|FG003|COMPLETED|Overall Study||4||
60147847|NCT02623218|76272477|FG004|COMPLETED|Overall Study||4||
60147848|NCT02623218|76272473|FG000|NOT COMPLETED|Overall Study||0||
60147849|NCT02623218|76272474|FG001|NOT COMPLETED|Overall Study||1||
60147850|NCT02623218|76272475|FG002|NOT COMPLETED|Overall Study||0||
60147851|NCT02623218|76272476|FG003|NOT COMPLETED|Overall Study||0||
60147852|NCT02623218|76272477|FG004|NOT COMPLETED|Overall Study||0||
60147853|NCT01365585|76272489|FG000|STARTED|Overall Study||227||
60147854|NCT01365585|76272489|FG000|COMPLETED|Overall Study||227||
60147855|NCT01365585|76272489|FG000|NOT COMPLETED|Overall Study||0||
60147856|NCT02181387|76272495|FG000|STARTED|Overall Study||14||
60147857|NCT02181387|76272496|FG001|STARTED|Overall Study||19||
60147858|NCT02181387|76272495|FG000|COMPLETED|Overall Study||12||
60147859|NCT02181387|76272496|FG001|COMPLETED|Overall Study||15||
60147860|NCT02181387|76272495|FG000|NOT COMPLETED|Overall Study||2||
60147861|NCT02181387|76272496|FG001|NOT COMPLETED|Overall Study||4||
60147862|NCT02622828|76272502|FG000|STARTED|Overall Study||4||
60147863|NCT02622828|76272502|FG000|COMPLETED|Overall Study||1||
60147864|NCT02622828|76272502|FG000|NOT COMPLETED|Overall Study||3||
60147865|NCT01322607|76272508|FG000|STARTED|Overall Study||11||
60147866|NCT01322607|76272509|FG001|STARTED|Overall Study||9||
60147867|NCT01322607|76272508|FG000|COMPLETED|Overall Study||10||
60147868|NCT01322607|76272509|FG001|COMPLETED|Overall Study||9||
60147869|NCT01322607|76272508|FG000|NOT COMPLETED|Overall Study||1||
60147870|NCT01322607|76272509|FG001|NOT COMPLETED|Overall Study||0||
60147871|NCT01365819|76272517|FG000|STARTED|Overall Study||25||
60147872|NCT01365819|76272518|FG001|STARTED|Overall Study||27||
60147873|NCT01365819|76272517|FG000|COMPLETED|Overall Study||12||
60147874|NCT01365819|76272518|FG001|COMPLETED|Overall Study||14||
60147875|NCT01365819|76272517|FG000|NOT COMPLETED|Overall Study||13||
60147876|NCT01365819|76272518|FG001|NOT COMPLETED|Overall Study||13||
60147877|NCT01322841|76272526|FG000|STARTED|Overall Study||1116||
60147878|NCT01322841|76272527|FG001|STARTED|Overall Study||1123||
60147879|NCT01322841|76272526|FG000|COMPLETED|Overall Study||1116||
60147880|NCT01322841|76272527|FG001|COMPLETED|Overall Study||1123||
60147881|NCT01322841|76272526|FG000|NOT COMPLETED|Overall Study||0||
60147882|NCT01322841|76272527|FG001|NOT COMPLETED|Overall Study||0||
60147883|NCT01369875|76272535|FG000|STARTED|Overall Study||1||
60147884|NCT01369875|76272536|FG001|STARTED|Overall Study||1||
60147885|NCT01369875|76272535|FG000|COMPLETED|Overall Study||1||
60147886|NCT01369875|76272536|FG001|COMPLETED|Overall Study||1||
60147887|NCT01369875|76272535|FG000|NOT COMPLETED|Overall Study||0||
60147888|NCT01369875|76272536|FG001|NOT COMPLETED|Overall Study||0||
60147889|NCT01323153|76272544|FG000|STARTED|Overall Study||150||
60147890|NCT01323153|76272545|FG001|STARTED|Overall Study||150||
60147891|NCT01323153|76272544|FG000|COMPLETED|Overall Study||133||
60147892|NCT01323153|76272545|FG001|COMPLETED|Overall Study||142||
60147893|NCT01323153|76272544|FG000|NOT COMPLETED|Overall Study||17||
60147894|NCT01323153|76272545|FG001|NOT COMPLETED|Overall Study||8||
60147895|NCT01323777|76272551|FG000|STARTED|Overall Study||65||
60147896|NCT01323777|76272551|FG000|COMPLETED|Overall Study||65||
60147897|NCT01323777|76272551|FG000|NOT COMPLETED|Overall Study||0||
60147898|NCT01323855|76272567|FG000|STARTED|Overall Study||9||
60147899|NCT01323855|76272568|FG001|STARTED|Overall Study||9||
60147900|NCT01323855|76272569|FG002|STARTED|Overall Study||8||
60147901|NCT01323855|76272570|FG003|STARTED|Overall Study||9||
60147902|NCT01323855|76272571|FG004|STARTED|Overall Study||11||
60147903|NCT01323855|76272567|FG000|COMPLETED|Overall Study||9||
60147904|NCT01323855|76272568|FG001|COMPLETED|Overall Study||9||
60147905|NCT01323855|76272569|FG002|COMPLETED|Overall Study||8||
60147906|NCT01323855|76272570|FG003|COMPLETED|Overall Study||9||
60147907|NCT01323855|76272571|FG004|COMPLETED|Overall Study||11||
60147908|NCT01323855|76272567|FG000|NOT COMPLETED|Overall Study||0||
60147909|NCT01323855|76272568|FG001|NOT COMPLETED|Overall Study||0||
60147910|NCT01323855|76272569|FG002|NOT COMPLETED|Overall Study||0||
60147911|NCT01323855|76272570|FG003|NOT COMPLETED|Overall Study||0||
60147912|NCT01323855|76272571|FG004|NOT COMPLETED|Overall Study||0||
60147913|NCT02197065|76272585|FG000|STARTED|Overall Study||10||
60147914|NCT02197065|76272586|FG001|STARTED|Overall Study||10||
60147915|NCT02197065|76272585|FG000|COMPLETED|Overall Study||10||
60147916|NCT02197065|76272586|FG001|COMPLETED|Overall Study||10||
60147917|NCT02197065|76272585|FG000|NOT COMPLETED|Overall Study||0||
60147918|NCT02197065|76272586|FG001|NOT COMPLETED|Overall Study||0||
60147919|NCT01375491|76272598|FG000|STARTED|Overall Study||11||
60147920|NCT01375491|76272599|FG001|STARTED|Overall Study||13||
60147921|NCT01375491|76272600|FG002|STARTED|Overall Study||15||
60147922|NCT01375491|76272598|FG000|COMPLETED|Overall Study||9||
60147923|NCT01375491|76272599|FG001|COMPLETED|Overall Study||12||
60147924|NCT01375491|76272600|FG002|COMPLETED|Overall Study||15||
60147925|NCT01375491|76272598|FG000|NOT COMPLETED|Overall Study||2||
60147926|NCT01375491|76272599|FG001|NOT COMPLETED|Overall Study||1||
60147927|NCT01375491|76272600|FG002|NOT COMPLETED|Overall Study||0||
60147928|NCT01325181|76272609|FG000|STARTED|Overall Study||18||
60147929|NCT01325181|76272610|FG001|STARTED|Overall Study||16||
60147930|NCT01325181|76272609|FG000|COMPLETED|Overall Study||18||
60147931|NCT01325181|76272610|FG001|COMPLETED|Overall Study||14||
60147932|NCT01325181|76272609|FG000|NOT COMPLETED|Overall Study||0||
60147933|NCT01325181|76272610|FG001|NOT COMPLETED|Overall Study||2||
60147934|NCT01375569|76272616|FG000|STARTED|Overall Study||11||
60147935|NCT01375569|76272616|FG000|COMPLETED|Overall Study||11||
60147936|NCT01375569|76272616|FG000|NOT COMPLETED|Overall Study||0||
60147937|NCT01378065|76272620|FG000|STARTED|Overall Study|31 subjects were enrolled/consented. However, 1 subject was not implanted with a study device.|30||
60147938|NCT01378065|76272620|FG000|6 Week|Overall Study||30||
60147939|NCT01378065|76272620|FG000|3 Months|Overall Study||30||
60147940|NCT01378065|76272620|FG000|6 Months|Overall Study||30||
60147941|NCT01378065|76272620|FG000|12 Months|Overall Study||30||
60147942|NCT01378065|76272620|FG000|COMPLETED|Overall Study||30||
60147943|NCT01378065|76272620|FG000|NOT COMPLETED|Overall Study||0||
60147944|NCT01327677|76272626|FG000|STARTED|Overall Study||68||
60147945|NCT01327677|76272627|FG001|STARTED|Overall Study||69||
60147946|NCT01327677|76272626|FG000|COMPLETED|Overall Study||48||
60147947|NCT01327677|76272627|FG001|COMPLETED|Overall Study||56||
60147948|NCT01327677|76272626|FG000|NOT COMPLETED|Overall Study||20||
60147949|NCT01327677|76272627|FG001|NOT COMPLETED|Overall Study||13||
60147950|NCT02621034|76272638|FG000|STARTED|Overall Study||53||
60147951|NCT02621034|76272639|FG001|STARTED|Overall Study||52||
60147952|NCT02621034|76272640|FG002|STARTED|Overall Study||55||
60147953|NCT02621034|76272638|FG000|COMPLETED|Overall Study||50||
60147954|NCT02621034|76272639|FG001|COMPLETED|Overall Study||50||
60147955|NCT02621034|76272640|FG002|COMPLETED|Overall Study||50||
60147956|NCT02621034|76272638|FG000|NOT COMPLETED|Overall Study||3||
60147957|NCT02621034|76272639|FG001|NOT COMPLETED|Overall Study||2||
60147958|NCT02621034|76272640|FG002|NOT COMPLETED|Overall Study||5||
60147959|NCT02572453|76272653|FG000|STARTED|Overall Study||1||
60147960|NCT02572453|76272654|FG001|STARTED|Overall Study||4||
60147961|NCT02572453|76272655|FG002|STARTED|Overall Study||20||
60147962|NCT02572453|76272653|FG000|COMPLETED|Overall Study||1||
60147963|NCT02572453|76272654|FG001|COMPLETED|Overall Study||4||
60147964|NCT02572453|76272655|FG002|COMPLETED|Overall Study||20||
60147965|NCT02572453|76272653|FG000|NOT COMPLETED|Overall Study||0||
60147966|NCT02572453|76272654|FG001|NOT COMPLETED|Overall Study||0||
60147967|NCT02572453|76272655|FG002|NOT COMPLETED|Overall Study||0||
60147968|NCT01327989|76272663|FG000|STARTED|Overall Study||202||
60147969|NCT01327989|76272663|FG000|COMPLETED|Overall Study||188||
60147970|NCT01327989|76272663|FG000|NOT COMPLETED|Overall Study||14||
60147971|NCT01328379|76272670|FG000|STARTED|Overall Study||143||
60147972|NCT01328379|76272671|FG001|STARTED|Overall Study||144||
60147973|NCT01328379|76272672|FG002|STARTED|Overall Study||143||
60147974|NCT01328379|76272670|FG000|COMPLETED|Overall Study||142||
60147975|NCT01328379|76272671|FG001|COMPLETED|Overall Study||144||
60147976|NCT01328379|76272672|FG002|COMPLETED|Overall Study||143||
60147977|NCT01328379|76272670|FG000|NOT COMPLETED|Overall Study||1||
60147978|NCT01328379|76272671|FG001|NOT COMPLETED|Overall Study||0||
60147979|NCT01328379|76272672|FG002|NOT COMPLETED|Overall Study||0||
60147980|NCT01328769|76272682|FG000|STARTED|Overall Study||25||
60147981|NCT01328769|76272683|FG001|STARTED|Overall Study||24||
60147982|NCT01328769|76272682|FG000|COMPLETED|Overall Study||25||
60147983|NCT01328769|76272683|FG001|COMPLETED|Overall Study||23||
60147984|NCT01328769|76272682|FG000|NOT COMPLETED|Overall Study||0||
60147985|NCT01328769|76272683|FG001|NOT COMPLETED|Overall Study||1||
60147986|NCT01378221|76272691|FG000|STARTED|Overall Study||36||
60147987|NCT01378221|76272692|FG001|STARTED|Overall Study||39||
60147988|NCT01378221|76272691|FG000|COMPLETED|Overall Study||29||
60147989|NCT01378221|76272692|FG001|COMPLETED|Overall Study||30||
60147990|NCT01378221|76272691|FG000|NOT COMPLETED|Overall Study||7||
60147991|NCT01378221|76272692|FG001|NOT COMPLETED|Overall Study||9||
60147992|NCT02620020|76272702|FG000|STARTED|Overall Study||141|Full analysis set (FAS): All randomized participants per interactive voice response system (IVRS)|
60147993|NCT02620020|76272703|FG001|STARTED|Overall Study||141|Full analysis set (FAS): All randomized participants per interactive voice response system (IVRS)|
60147994|NCT02620020|76272704|FG002|STARTED|Overall Study||140|Full analysis set (FAS): All randomized participants per interactive voice response system (IVRS)|
60147995|NCT02620020|76272705|FG003|STARTED|Overall Study||141|Full analysis set (FAS): All randomized participants per interactive voice response system (IVRS)|
60147996|NCT02620020|76272702|FG000|Modified Intent to Treat Set (mITT)|Overall Study||140|mITT: Participants who received at least 1 dose of study drug & data up to 5 wks after last dose|
60147997|NCT02620020|76272703|FG001|Modified Intent to Treat Set (mITT)|Overall Study||139|mITT: Participants who received at least 1 dose of study drug & data up to 5 wks after last dose|
60147998|NCT02620020|76272704|FG002|Modified Intent to Treat Set (mITT)|Overall Study||139|mITT: Participants who received at least 1 dose of study drug & data up to 5 wks after last dose|
60147999|NCT02620020|76272705|FG003|Modified Intent to Treat Set (mITT)|Overall Study||140|mITT: Participants who received at least 1 dose of study drug & data up to 5 wks after last dose|
60148000|NCT02620020|76272702|FG000|COMPLETED|Overall Study||97||
60148001|NCT02620020|76272703|FG001|COMPLETED|Overall Study||106||
60148002|NCT02620020|76272704|FG002|COMPLETED|Overall Study||115||
60148003|NCT02620020|76272705|FG003|COMPLETED|Overall Study||115||
60148004|NCT02620020|76272702|FG000|NOT COMPLETED|Overall Study||44||
60148005|NCT02620020|76272703|FG001|NOT COMPLETED|Overall Study||35||
60148006|NCT02620020|76272704|FG002|NOT COMPLETED|Overall Study||25||
60148007|NCT02620020|76272705|FG003|NOT COMPLETED|Overall Study||26||
60148008|NCT02549989|76272715|FG000|STARTED|Overall Study||28||
60148009|NCT02549989|76272715|FG000|COMPLETED|Overall Study||1||
60148010|NCT02549989|76272715|FG000|NOT COMPLETED|Overall Study||27||
60148011|NCT01378299|76272719|FG000|STARTED|Overall Study||105||
60148012|NCT01378299|76272719|FG000|BMI group1|Overall Study||38|BMI of <30 kg/m^2|
60148013|NCT01378299|76272719|FG000|BMI Group 2|Overall Study||40|BMI between 30 to <35 kg/m^2|
60148014|NCT01378299|76272719|FG000|BMI Group 3|Overall Study||27|BMI = or >35 kg/m^2|
60148015|NCT01378299|76272719|FG000|COMPLETED|Overall Study||74||
60148016|NCT01378299|76272719|FG000|NOT COMPLETED|Overall Study||31||
60148017|NCT04929522|76272753|FG000|STARTED|Overall Study||40||
60148018|NCT04929522|76272754|FG001|STARTED|Overall Study||40||
60148019|NCT04929522|76272755|FG002|STARTED|Overall Study||40||
60148020|NCT04929522|76272756|FG003|STARTED|Overall Study||40||
60148021|NCT04929522|76272753|FG000|COMPLETED|Overall Study||40||
60148022|NCT04929522|76272754|FG001|COMPLETED|Overall Study||40||
60148023|NCT04929522|76272755|FG002|COMPLETED|Overall Study||40||
60148024|NCT04929522|76272756|FG003|COMPLETED|Overall Study||40||
60148025|NCT04929522|76272753|FG000|NOT COMPLETED|Overall Study||0||
60148026|NCT04929522|76272754|FG001|NOT COMPLETED|Overall Study||0||
59751515|NCT00652093|75870836|FG005|NOT COMPLETED|Overall Study||0||
60148027|NCT04929522|76272755|FG002|NOT COMPLETED|Overall Study||0||
60148028|NCT04929522|76272756|FG003|NOT COMPLETED|Overall Study||0||
60148029|NCT02522845|76272768|FG000|STARTED|Overall Study||100||
60148030|NCT02522845|76272769|FG001|STARTED|Overall Study||104||
60148031|NCT02522845|76272768|FG000|COMPLETED|Overall Study||63||
60148032|NCT02522845|76272769|FG001|COMPLETED|Overall Study||69||
60148033|NCT02522845|76272768|FG000|NOT COMPLETED|Overall Study||37||
60148034|NCT02522845|76272769|FG001|NOT COMPLETED|Overall Study||35||
60148035|NCT02390323|76272775|FG000|STARTED|Overall Study||13||
60148036|NCT02390323|76272775|FG000|COMPLETED|Overall Study||13||
60148037|NCT02390323|76272775|FG000|NOT COMPLETED|Overall Study||0||
60148038|NCT02487745|76272782|FG000|STARTED|Overall Study||47||
60148039|NCT02487745|76272783|FG001|STARTED|Overall Study||44||
60148040|NCT02487745|76272782|FG000|COMPLETED|Overall Study||47||
60148041|NCT02487745|76272783|FG001|COMPLETED|Overall Study||44||
60148042|NCT02487745|76272782|FG000|NOT COMPLETED|Overall Study||0||
60148043|NCT02487745|76272783|FG001|NOT COMPLETED|Overall Study||0||
60148044|NCT01378377|76272792|FG000|STARTED|Overall Study||4||
60148045|NCT01378377|76272793|FG001|STARTED|Overall Study||23||
60148046|NCT01378377|76272794|FG002|STARTED|Overall Study||6||
60148047|NCT01378377|76272792|FG000|COMPLETED|Overall Study||4||
60148048|NCT01378377|76272793|FG001|COMPLETED|Overall Study||23||
60148049|NCT01378377|76272794|FG002|COMPLETED|Overall Study||6||
60148050|NCT01378377|76272792|FG000|NOT COMPLETED|Overall Study||0||
60148051|NCT01378377|76272793|FG001|NOT COMPLETED|Overall Study||0||
60148052|NCT01378377|76272794|FG002|NOT COMPLETED|Overall Study||0||
60148053|NCT01379625|76272809|FG000|STARTED|Overall Study||16||
60148054|NCT01379625|76272810|FG001|STARTED|Overall Study||16||
60148055|NCT01379625|76272809|FG000|COMPLETED|Overall Study||16||
60148056|NCT01379625|76272810|FG001|COMPLETED|Overall Study||16||
60148057|NCT01379625|76272809|FG000|NOT COMPLETED|Overall Study||0||
60148058|NCT01379625|76272810|FG001|NOT COMPLETED|Overall Study||0||
60148059|NCT01380639|76272818|FG000|STARTED|Overall Study||42||
60148060|NCT01380639|76272819|FG001|STARTED|Overall Study||40||
60148061|NCT01380639|76272818|FG000|COMPLETED|Overall Study||36||
60148062|NCT01380639|76272819|FG001|COMPLETED|Overall Study||36||
60148063|NCT01380639|76272818|FG000|NOT COMPLETED|Overall Study||6||
60148064|NCT01380639|76272819|FG001|NOT COMPLETED|Overall Study||4||
60148065|NCT01382901|76272827|FG000|STARTED|Overall Study||24||
60148066|NCT01382901|76272828|FG001|STARTED|Overall Study||21||
60148067|NCT01382901|76272827|FG000|COMPLETED|Overall Study||7||
60148068|NCT01382901|76272828|FG001|COMPLETED|Overall Study||7||
60148069|NCT01382901|76272827|FG000|NOT COMPLETED|Overall Study||17||
60148070|NCT01382901|76272828|FG001|NOT COMPLETED|Overall Study||14||
60148071|NCT01330953|76272839|FG000|STARTED|Overall Study||8||
60148072|NCT01330953|76272840|FG001|STARTED|Overall Study||6||
60148073|NCT01330953|76272841|FG002|STARTED|Overall Study||6||
60148074|NCT01330953|76272842|FG003|STARTED|Overall Study||6||
60148075|NCT01330953|76272843|FG004|STARTED|Overall Study||6||
60148076|NCT01330953|76272839|FG000|COMPLETED|Overall Study||8||
60148077|NCT01330953|76272840|FG001|COMPLETED|Overall Study||6||
60148078|NCT01330953|76272841|FG002|COMPLETED|Overall Study||6||
60148079|NCT01330953|76272842|FG003|COMPLETED|Overall Study||6||
60148080|NCT01330953|76272843|FG004|COMPLETED|Overall Study||6||
60148081|NCT01330953|76272839|FG000|NOT COMPLETED|Overall Study||0||
60148082|NCT01330953|76272840|FG001|NOT COMPLETED|Overall Study||0||
60148083|NCT01330953|76272841|FG002|NOT COMPLETED|Overall Study||0||
60148084|NCT01330953|76272842|FG003|NOT COMPLETED|Overall Study||0||
60148085|NCT01330953|76272843|FG004|NOT COMPLETED|Overall Study||0||
60148086|NCT01332123|76272860|FG000|STARTED|Overall Study||10||
60148087|NCT01332123|76272860|FG000|COMPLETED|Overall Study||10||
60148088|NCT01332123|76272860|FG000|NOT COMPLETED|Overall Study||0||
60148089|NCT00987935|76272874|FG000|STARTED|Overall Study||4||
60148090|NCT00987935|76272875|FG001|STARTED|Overall Study||3||
60148091|NCT00987935|76272876|FG002|STARTED|Overall Study||3||
60148092|NCT00987935|76272877|FG003|STARTED|Overall Study||3||
60148093|NCT00987935|76272878|FG004|STARTED|Overall Study||7||
60148094|NCT00987935|76272879|FG005|STARTED|Overall Study||3||
60148095|NCT00987935|76272880|FG006|STARTED|Overall Study||16||
60148096|NCT00987935|76272881|FG007|STARTED|Overall Study||63||
60148097|NCT00987935|76272882|FG008|STARTED|Overall Study||32||
60148098|NCT00987935|76272874|FG000|COMPLETED|Overall Study||0||
60148099|NCT00987935|76272875|FG001|COMPLETED|Overall Study||0||
60148100|NCT00987935|76272876|FG002|COMPLETED|Overall Study||0||
60148101|NCT00987935|76272877|FG003|COMPLETED|Overall Study||0||
60148102|NCT00987935|76272878|FG004|COMPLETED|Overall Study||0||
60148103|NCT00987935|76272879|FG005|COMPLETED|Overall Study||0||
60148104|NCT00987935|76272880|FG006|COMPLETED|Overall Study|On-treatment at analysis cut-off date (16 July 2014).|1||
60148105|NCT00987935|76272881|FG007|COMPLETED|Overall Study|On-treatment at analysis cut-off date (16 July 2014).|1||
60148106|NCT00987935|76272882|FG008|COMPLETED|Overall Study||0||
60148107|NCT00987935|76272874|FG000|NOT COMPLETED|Overall Study||4||
60148108|NCT00987935|76272875|FG001|NOT COMPLETED|Overall Study||3||
60148109|NCT00987935|76272876|FG002|NOT COMPLETED|Overall Study||3||
60148110|NCT00987935|76272877|FG003|NOT COMPLETED|Overall Study||3||
60148111|NCT00987935|76272878|FG004|NOT COMPLETED|Overall Study||7||
60148112|NCT00987935|76272879|FG005|NOT COMPLETED|Overall Study||3||
60148113|NCT00987935|76272880|FG006|NOT COMPLETED|Overall Study||15||
60148114|NCT00987935|76272881|FG007|NOT COMPLETED|Overall Study||62||
60148115|NCT00987935|76272882|FG008|NOT COMPLETED|Overall Study||32||
60148116|NCT01597050|76272910|FG000|STARTED|Overall Study||36||
60148117|NCT01597050|76272911|FG001|STARTED|Overall Study||18||
60148118|NCT01597050|76272910|FG000|COMPLETED|Overall Study||35||
60148119|NCT01597050|76272911|FG001|COMPLETED|Overall Study||18||
60148120|NCT01597050|76272910|FG000|NOT COMPLETED|Overall Study||1||
60148121|NCT01597050|76272911|FG001|NOT COMPLETED|Overall Study||0||
60148122|NCT01383213|76272919|FG000|STARTED|Overall Study||40||
60148123|NCT01383213|76272920|FG001|STARTED|Overall Study||41||
60148124|NCT01383213|76272919|FG000|COMPLETED|Overall Study||40||
60148125|NCT01383213|76272920|FG001|COMPLETED|Overall Study||41||
60148126|NCT01383213|76272919|FG000|NOT COMPLETED|Overall Study||0||
60148127|NCT01383213|76272920|FG001|NOT COMPLETED|Overall Study||0||
60148128|NCT00987623|76272928|FG000|STARTED|Overall Study||145||
60148129|NCT00987623|76272929|FG001|STARTED|Overall Study||154||
60148130|NCT00987623|76272928|FG000|COMPLETED|Overall Study||140||
60148131|NCT00987623|76272929|FG001|COMPLETED|Overall Study||151||
60148132|NCT00987623|76272928|FG000|NOT COMPLETED|Overall Study||5||
60148133|NCT00987623|76272929|FG001|NOT COMPLETED|Overall Study||3||
60148134|NCT00987467|76272935|FG000|STARTED|Overall Study||12||
60148135|NCT00987467|76272935|FG000|COMPLETED|Overall Study||10||
60148136|NCT00987467|76272935|FG000|NOT COMPLETED|Overall Study||2||
60148137|NCT04990440|76272943|FG000|STARTED|Overall Study||1||
60148138|NCT04990440|76272944|FG001|STARTED|Overall Study||4||
60148139|NCT04990440|76272945|FG002|STARTED|Overall Study||1||
60148140|NCT04990440|76272943|FG000|COMPLETED|Overall Study||1||
60148141|NCT04990440|76272944|FG001|COMPLETED|Overall Study||4||
60148142|NCT04990440|76272945|FG002|COMPLETED|Overall Study||0||
60148143|NCT04990440|76272943|FG000|NOT COMPLETED|Overall Study||0||
60148144|NCT04990440|76272944|FG001|NOT COMPLETED|Overall Study||0||
59751516|NCT00651937|75870852|FG000|STARTED|Overall Study||39||
59751517|NCT00651937|75870853|FG001|STARTED|Overall Study||41||
59751518|NCT00651937|75870852|FG000|COMPLETED|Overall Study||35||
60148145|NCT04990440|76272945|FG002|NOT COMPLETED|Overall Study||1||
60148146|NCT04829747|76272953|FG000|STARTED|Overall Study||3||
60148147|NCT04829747|76272953|FG000|COMPLETED|Overall Study||2||
60148148|NCT04829747|76272953|FG000|NOT COMPLETED|Overall Study||1||
60148149|NCT04789499|76272959|FG000|STARTED|Overall Study||26||
60148150|NCT04789499|76272960|FG001|STARTED|Overall Study||25||
60148151|NCT04789499|76272959|FG000|COMPLETED|Overall Study||22||
60148152|NCT04789499|76272960|FG001|COMPLETED|Overall Study||23||
60148153|NCT04789499|76272959|FG000|NOT COMPLETED|Overall Study||4||
60148154|NCT04789499|76272960|FG001|NOT COMPLETED|Overall Study||2||
60148155|NCT04432727|76272968|FG000|STARTED|Overall Study||15||
60148156|NCT04432727|76272969|FG001|STARTED|Overall Study||14||
60148157|NCT04432727|76272968|FG000|COMPLETED|Overall Study||14||
60148158|NCT04432727|76272969|FG001|COMPLETED|Overall Study||11||
60148159|NCT04432727|76272968|FG000|NOT COMPLETED|Overall Study||1||
60148160|NCT04432727|76272969|FG001|NOT COMPLETED|Overall Study||3||
60148161|NCT04264156|76272981|FG000|STARTED|Overall Study||11||
60148162|NCT04264156|76272982|FG001|STARTED|Overall Study||1||
60148163|NCT04264156|76272981|FG000|COMPLETED|Overall Study||11||
59751519|NCT00651937|75870853|FG001|COMPLETED|Overall Study||40||
59751520|NCT00651937|75870852|FG000|NOT COMPLETED|Overall Study||4||
59751521|NCT00651937|75870853|FG001|NOT COMPLETED|Overall Study||1||
59751522|NCT00654355|75870861|FG000|STARTED|Overall Study||15||
59751523|NCT00654355|75870862|FG001|STARTED|Overall Study||15||
59751524|NCT00654355|75870861|FG000|COMPLETED|Overall Study||13||
60148164|NCT04264156|76272982|FG001|COMPLETED|Overall Study||1||
60148165|NCT04264156|76272981|FG000|NOT COMPLETED|Overall Study||0||
60148166|NCT04264156|76272982|FG001|NOT COMPLETED|Overall Study||0||
59751525|NCT00654355|75870862|FG001|COMPLETED|Overall Study||13||
60148167|NCT04258423|76272991|FG000|STARTED|Overall Study||2||
60148168|NCT04258423|76272992|FG001|STARTED|Overall Study||2||
60148169|NCT04258423|76272991|FG000|COMPLETED|Overall Study||0||
60148170|NCT04258423|76272992|FG001|COMPLETED|Overall Study||0||
60148171|NCT04258423|76272991|FG000|NOT COMPLETED|Overall Study||2||
60148172|NCT04258423|76272992|FG001|NOT COMPLETED|Overall Study||2||
59518909|NCT03538678|75612793|FG000|COMPLETED|Overall Study||5||
59751526|NCT00654355|75870861|FG000|NOT COMPLETED|Overall Study||2||
59751527|NCT00654355|75870862|FG001|NOT COMPLETED|Overall Study||2||
60148173|NCT04178967|76273000|FG000|STARTED|Induction Period||150||
60148174|NCT04178967|76273001|FG001|STARTED|Induction Period||295||
60148175|NCT04178967|76273002|FG002|STARTED|Induction Period||0||
60148176|NCT04178967|76273003|FG003|STARTED|Induction Period||0||
60148177|NCT04178967|76273004|FG004|STARTED|Induction Period||0||
60148178|NCT04178967|76273005|FG005|STARTED|Induction Period||0||
60148179|NCT04178967|76273006|FG006|STARTED|Induction Period||0||
60148180|NCT04178967|76273007|FG007|STARTED|Induction Period||0||
60148181|NCT04178967|76273008|FG008|STARTED|Induction Period||0||
60148182|NCT04178967|76273009|FG009|STARTED|Induction Period||0||
60148183|NCT04178967|76273010|FG010|STARTED|Induction Period||0||
60148184|NCT04178967|76273000|FG000|Received at Least One Dose of Study Drug|Induction Period||149||
60148185|NCT04178967|76273001|FG001|Received at Least One Dose of Study Drug|Induction Period||295||
60148186|NCT04178967|76273002|FG002|Received at Least One Dose of Study Drug|Induction Period||0||
60148187|NCT04178967|76273003|FG003|Received at Least One Dose of Study Drug|Induction Period||0||
60148188|NCT04178967|76273004|FG004|Received at Least One Dose of Study Drug|Induction Period||0||
60148189|NCT04178967|76273005|FG005|Received at Least One Dose of Study Drug|Induction Period||0||
60148190|NCT04178967|76273006|FG006|Received at Least One Dose of Study Drug|Induction Period||0||
60148191|NCT04178967|76273007|FG007|Received at Least One Dose of Study Drug|Induction Period||0||
60148192|NCT04178967|76273008|FG008|Received at Least One Dose of Study Drug|Induction Period||0||
60148193|NCT04178967|76273009|FG009|Received at Least One Dose of Study Drug|Induction Period||0||
60148194|NCT04178967|76273010|FG010|Received at Least One Dose of Study Drug|Induction Period||0||
60148195|NCT04178967|76273000|FG000|COMPLETED|Induction Period|Completed includes Responders n=25; Non responders n=108|133||
60148196|NCT04178967|76273001|FG001|COMPLETED|Induction Period|Completed includes Responders n=148; Non responders n=125|273||
60148197|NCT04178967|76273002|FG002|COMPLETED|Induction Period||0||
60148198|NCT04178967|76273003|FG003|COMPLETED|Induction Period||0||
60148199|NCT04178967|76273004|FG004|COMPLETED|Induction Period||0||
60148200|NCT04178967|76273005|FG005|COMPLETED|Induction Period||0||
60148201|NCT04178967|76273006|FG006|COMPLETED|Induction Period||0||
60148202|NCT04178967|76273007|FG007|COMPLETED|Induction Period||0||
60148203|NCT04178967|76273008|FG008|COMPLETED|Induction Period||0||
60148204|NCT04178967|76273009|FG009|COMPLETED|Induction Period||0||
59518910|NCT03538678|75612794|FG001|COMPLETED|Overall Study||9||
60148205|NCT04178967|76273010|FG010|COMPLETED|Induction Period||0||
60148206|NCT04178967|76273000|FG000|NOT COMPLETED|Induction Period||17||
60148207|NCT04178967|76273001|FG001|NOT COMPLETED|Induction Period||22||
60148208|NCT04178967|76273002|FG002|NOT COMPLETED|Induction Period||0||
60148209|NCT04178967|76273003|FG003|NOT COMPLETED|Induction Period||0||
60148210|NCT04178967|76273004|FG004|NOT COMPLETED|Induction Period||0||
60148211|NCT04178967|76273005|FG005|NOT COMPLETED|Induction Period||0||
60148212|NCT04178967|76273006|FG006|NOT COMPLETED|Induction Period||0||
60148213|NCT04178967|76273007|FG007|NOT COMPLETED|Induction Period||0||
60148214|NCT04178967|76273008|FG008|NOT COMPLETED|Induction Period||0||
60148215|NCT04178967|76273009|FG009|NOT COMPLETED|Induction Period||0||
60148216|NCT04178967|76273010|FG010|NOT COMPLETED|Induction Period||0||
60148217|NCT04178967|76273000|FG000|STARTED|Maintenance Blinded Treatment Period|Participants were assigned to this arm only during Induction Period.|0||
60148218|NCT04178967|76273001|FG001|STARTED|Maintenance Blinded Treatment Period|Participants were assigned to this arm only during Induction Period.|0||
60148219|NCT04178967|76273002|FG002|STARTED|Maintenance Blinded Treatment Period|Only those participants who responded to induction placebo or Lebrikizumab at week 16 entered the Maintenance Period.|5||
60148220|NCT04178967|76273003|FG003|STARTED|Maintenance Blinded Treatment Period|Only those participants who responded to induction placebo or Lebrikizumab at week 16 entered the Maintenance Period.|9||
60148221|NCT04178967|76273004|FG004|STARTED|Maintenance Blinded Treatment Period|Only those participants who responded to induction placebo or Lebrikizumab at week 16 entered the Maintenance Period.|11||
60148222|NCT04178967|76273005|FG005|STARTED|Maintenance Blinded Treatment Period|Only those participants who responded to induction placebo or Lebrikizumab at week 16 entered the Maintenance Period.|30||
60148223|NCT04178967|76273006|FG006|STARTED|Maintenance Blinded Treatment Period|Only those participants who responded to induction placebo or Lebrikizumab at week 16 entered the Maintenance Period.|59||
60148224|NCT04178967|76273007|FG007|STARTED|Maintenance Blinded Treatment Period|Only those participants who responded to induction placebo or Lebrikizumab at week 16 entered the Maintenance Period.|59||
60148225|NCT04178967|76273008|FG008|STARTED|Maintenance Blinded Treatment Period||0||
60148226|NCT04178967|76273009|FG009|STARTED|Maintenance Blinded Treatment Period||0||
60148227|NCT04178967|76273010|FG010|STARTED|Maintenance Blinded Treatment Period||0||
60148228|NCT04178967|76273000|FG000|Received at Least One Dose of Study Drug|Maintenance Blinded Treatment Period||0||
60148229|NCT04178967|76273001|FG001|Received at Least One Dose of Study Drug|Maintenance Blinded Treatment Period||0||
60148230|NCT04178967|76273002|FG002|Received at Least One Dose of Study Drug|Maintenance Blinded Treatment Period||5||
60148231|NCT04178967|76273003|FG003|Received at Least One Dose of Study Drug|Maintenance Blinded Treatment Period||9||
60148232|NCT04178967|76273004|FG004|Received at Least One Dose of Study Drug|Maintenance Blinded Treatment Period||11||
60148233|NCT04178967|76273005|FG005|Received at Least One Dose of Study Drug|Maintenance Blinded Treatment Period||30||
60148234|NCT04178967|76273006|FG006|Received at Least One Dose of Study Drug|Maintenance Blinded Treatment Period||59||
60148235|NCT04178967|76273007|FG007|Received at Least One Dose of Study Drug|Maintenance Blinded Treatment Period||59||
60148236|NCT04178967|76273008|FG008|Received at Least One Dose of Study Drug|Maintenance Blinded Treatment Period||0||
60148237|NCT04178967|76273009|FG009|Received at Least One Dose of Study Drug|Maintenance Blinded Treatment Period||0||
60148238|NCT04178967|76273010|FG010|Received at Least One Dose of Study Drug|Maintenance Blinded Treatment Period||0||
60148239|NCT04178967|76273000|FG000|COMPLETED|Maintenance Blinded Treatment Period||0||
60148240|NCT04178967|76273001|FG001|COMPLETED|Maintenance Blinded Treatment Period||0||
60148241|NCT04178967|76273002|FG002|COMPLETED|Maintenance Blinded Treatment Period||4||
60148242|NCT04178967|76273003|FG003|COMPLETED|Maintenance Blinded Treatment Period||6||
60148243|NCT04178967|76273004|FG004|COMPLETED|Maintenance Blinded Treatment Period||9||
60148244|NCT04178967|76273005|FG005|COMPLETED|Maintenance Blinded Treatment Period||22||
60148245|NCT04178967|76273006|FG006|COMPLETED|Maintenance Blinded Treatment Period||51||
60148246|NCT04178967|76273007|FG007|COMPLETED|Maintenance Blinded Treatment Period||42||
60148247|NCT04178967|76273008|FG008|COMPLETED|Maintenance Blinded Treatment Period||0||
60148248|NCT04178967|76273009|FG009|COMPLETED|Maintenance Blinded Treatment Period||0||
60148249|NCT04178967|76273010|FG010|COMPLETED|Maintenance Blinded Treatment Period||0||
60148250|NCT04178967|76273000|FG000|NOT COMPLETED|Maintenance Blinded Treatment Period||0||
60148251|NCT04178967|76273001|FG001|NOT COMPLETED|Maintenance Blinded Treatment Period||0||
60148252|NCT04178967|76273002|FG002|NOT COMPLETED|Maintenance Blinded Treatment Period||1||
60148253|NCT04178967|76273003|FG003|NOT COMPLETED|Maintenance Blinded Treatment Period||3||
60148254|NCT04178967|76273004|FG004|NOT COMPLETED|Maintenance Blinded Treatment Period||2||
60148255|NCT04178967|76273005|FG005|NOT COMPLETED|Maintenance Blinded Treatment Period||8||
60148256|NCT04178967|76273006|FG006|NOT COMPLETED|Maintenance Blinded Treatment Period||8||
60148257|NCT04178967|76273007|FG007|NOT COMPLETED|Maintenance Blinded Treatment Period||17||
60148258|NCT04178967|76273008|FG008|NOT COMPLETED|Maintenance Blinded Treatment Period||0||
60148259|NCT04178967|76273009|FG009|NOT COMPLETED|Maintenance Blinded Treatment Period||0||
60148260|NCT04178967|76273010|FG010|NOT COMPLETED|Maintenance Blinded Treatment Period||0||
60148261|NCT04178967|76273000|FG000|STARTED|Maintenance Open Label Escape Arm||0||
60148262|NCT04178967|76273001|FG001|STARTED|Maintenance Open Label Escape Arm||0||
60148263|NCT04178967|76273002|FG002|STARTED|Maintenance Open Label Escape Arm||0||
60148264|NCT04178967|76273003|FG003|STARTED|Maintenance Open Label Escape Arm||0||
60148265|NCT04178967|76273004|FG004|STARTED|Maintenance Open Label Escape Arm||0||
60148266|NCT04178967|76273005|FG005|STARTED|Maintenance Open Label Escape Arm||0||
60148267|NCT04178967|76273006|FG006|STARTED|Maintenance Open Label Escape Arm||0||
60148268|NCT04178967|76273007|FG007|STARTED|Maintenance Open Label Escape Arm||0||
60148269|NCT04178967|76273008|FG008|STARTED|Maintenance Open Label Escape Arm|Only those participants who did not respond to induction placebo or Lebrikizumab entered Escape Arm at week 16.|108||
60148270|NCT04178967|76273009|FG009|STARTED|Maintenance Open Label Escape Arm|Only those participants who did not respond to induction placebo or Lebrikizumab entered Escape Arm at week 16.|125||
60148271|NCT04178967|76273010|FG010|STARTED|Maintenance Open Label Escape Arm|Only those participants who did not respond to treatment during maintenance period (i.e.) not maintaining an EASI-50 response at Weeks 24, 32, 40, or 48 were entered.|11||
60148272|NCT04178967|76273000|FG000|Received at Least One Dose of Study Drug|Maintenance Open Label Escape Arm||0||
60148273|NCT04178967|76273001|FG001|Received at Least One Dose of Study Drug|Maintenance Open Label Escape Arm||0||
60148274|NCT04178967|76273002|FG002|Received at Least One Dose of Study Drug|Maintenance Open Label Escape Arm||0||
60148275|NCT04178967|76273003|FG003|Received at Least One Dose of Study Drug|Maintenance Open Label Escape Arm||0||
60148276|NCT04178967|76273004|FG004|Received at Least One Dose of Study Drug|Maintenance Open Label Escape Arm||0||
60148277|NCT04178967|76273005|FG005|Received at Least One Dose of Study Drug|Maintenance Open Label Escape Arm||0||
60148278|NCT04178967|76273006|FG006|Received at Least One Dose of Study Drug|Maintenance Open Label Escape Arm||0||
60148279|NCT04178967|76273007|FG007|Received at Least One Dose of Study Drug|Maintenance Open Label Escape Arm||0||
60148280|NCT04178967|76273008|FG008|Received at Least One Dose of Study Drug|Maintenance Open Label Escape Arm||108||
60148281|NCT04178967|76273009|FG009|Received at Least One Dose of Study Drug|Maintenance Open Label Escape Arm||125||
60148282|NCT04178967|76273010|FG010|Received at Least One Dose of Study Drug|Maintenance Open Label Escape Arm||11||
60148283|NCT04178967|76273000|FG000|COMPLETED|Maintenance Open Label Escape Arm||0||
60148284|NCT04178967|76273001|FG001|COMPLETED|Maintenance Open Label Escape Arm||0||
60148285|NCT04178967|76273002|FG002|COMPLETED|Maintenance Open Label Escape Arm||0||
60148286|NCT04178967|76273003|FG003|COMPLETED|Maintenance Open Label Escape Arm||0||
60148287|NCT04178967|76273004|FG004|COMPLETED|Maintenance Open Label Escape Arm||0||
60148288|NCT04178967|76273005|FG005|COMPLETED|Maintenance Open Label Escape Arm||0||
60148289|NCT04178967|76273006|FG006|COMPLETED|Maintenance Open Label Escape Arm||0||
60148290|NCT04178967|76273007|FG007|COMPLETED|Maintenance Open Label Escape Arm||0||
60148291|NCT04178967|76273008|FG008|COMPLETED|Maintenance Open Label Escape Arm||85||
60148292|NCT04178967|76273009|FG009|COMPLETED|Maintenance Open Label Escape Arm||83||
60148293|NCT04178967|76273010|FG010|COMPLETED|Maintenance Open Label Escape Arm||8||
60148294|NCT04178967|76273000|FG000|NOT COMPLETED|Maintenance Open Label Escape Arm||0||
60148295|NCT04178967|76273001|FG001|NOT COMPLETED|Maintenance Open Label Escape Arm||0||
60148296|NCT04178967|76273002|FG002|NOT COMPLETED|Maintenance Open Label Escape Arm||0||
60148297|NCT04178967|76273003|FG003|NOT COMPLETED|Maintenance Open Label Escape Arm||0||
60148298|NCT04178967|76273004|FG004|NOT COMPLETED|Maintenance Open Label Escape Arm||0||
60148299|NCT04178967|76273005|FG005|NOT COMPLETED|Maintenance Open Label Escape Arm||0||
60148300|NCT04178967|76273006|FG006|NOT COMPLETED|Maintenance Open Label Escape Arm||0||
60148301|NCT04178967|76273007|FG007|NOT COMPLETED|Maintenance Open Label Escape Arm||0||
60148302|NCT04178967|76273008|FG008|NOT COMPLETED|Maintenance Open Label Escape Arm||23||
60148303|NCT04178967|76273009|FG009|NOT COMPLETED|Maintenance Open Label Escape Arm||42||
60148304|NCT04178967|76273010|FG010|NOT COMPLETED|Maintenance Open Label Escape Arm||3||
60148305|NCT04163900|76273032|FG000|STARTED|Overall Study||388||
60148306|NCT04163900|76273033|FG001|STARTED|Overall Study||385||
60148307|NCT04163900|76273032|FG000|Received Study Treatment (Safety Population)|Overall Study||383||
60148308|NCT04163900|76273033|FG001|Received Study Treatment (Safety Population)|Overall Study||378||
60148309|NCT04163900|76273032|FG000|COMPLETED|Overall Study||0||
60148310|NCT04163900|76273033|FG001|COMPLETED|Overall Study||0||
60148311|NCT04163900|76273032|FG000|NOT COMPLETED|Overall Study||388||
60148312|NCT04163900|76273033|FG001|NOT COMPLETED|Overall Study||385||
60148313|NCT04161495|76273041|FG000|STARTED|Overall Study||133||
60148314|NCT04161495|76273042|FG001|STARTED|Overall Study||26||
60148315|NCT04161495|76273041|FG000|Historical Prophylaxis in OBS16221|Overall Study|Number of participants rolled over from study OBS16221 who were on prophylactic treatment with a marketed FVIII product for at least 6 months during OBS16221.|82||
60148316|NCT04161495|76273042|FG001|Historical Prophylaxis in OBS16221|Overall Study|Number of participants rolled over from study OBS16221 and were on treatment with a marketed FVIII product for at least 6 months during OBS16221.|10||
60148317|NCT04161495|76273041|FG000|Arm B: On-demand|Overall Study||0||
60148318|NCT04161495|76273042|FG001|Arm B: On-demand|Overall Study||26||
60148319|NCT04161495|76273041|FG000|Arm B: Prophylaxis|Overall Study||0||
60148320|NCT04161495|76273042|FG001|Arm B: Prophylaxis|Overall Study||26||
60148321|NCT04161495|76273041|FG000|COMPLETED|Overall Study||124||
60148322|NCT04161495|76273042|FG001|COMPLETED|Overall Study||25||
60148323|NCT04161495|76273041|FG000|NOT COMPLETED|Overall Study||9||
60148324|NCT04161495|76273042|FG001|NOT COMPLETED|Overall Study||1||
60148325|NCT04146038|76273063|FG000|STARTED|Overall Study||5||
59882123|NCT03848403|76005048|FG000|Received Intervention|Period 1 (Day 1)||24||
60148326|NCT04146038|76273063|FG000|COMPLETED|Overall Study||5||
60148327|NCT04146038|76273063|FG000|NOT COMPLETED|Overall Study||0||
60148328|NCT04108000|76273071|FG000|STARTED|Overall Study||9||
60148329|NCT04108000|76273072|FG001|STARTED|Overall Study||9||
60148330|NCT04108000|76273073|FG002|STARTED|Overall Study||10||
60148331|NCT04108000|76273074|FG003|STARTED|Overall Study||10||
60148332|NCT04108000|76273071|FG000|COMPLETED|Overall Study||6||
60148333|NCT04108000|76273072|FG001|COMPLETED|Overall Study||6||
60148334|NCT04108000|76273073|FG002|COMPLETED|Overall Study||9||
60148335|NCT04108000|76273074|FG003|COMPLETED|Overall Study||9||
60148336|NCT04108000|76273071|FG000|NOT COMPLETED|Overall Study||3||
60148337|NCT04108000|76273072|FG001|NOT COMPLETED|Overall Study||3||
60148338|NCT04108000|76273073|FG002|NOT COMPLETED|Overall Study||1||
60148339|NCT04108000|76273074|FG003|NOT COMPLETED|Overall Study||1||
60148340|NCT03945266|76273090|FG000|STARTED|Overall Study||15||
60148341|NCT03945266|76273091|FG001|STARTED|Overall Study||16||
60148342|NCT03945266|76273090|FG000|COMPLETED|Overall Study||13||
60148343|NCT03945266|76273091|FG001|COMPLETED|Overall Study||14||
60148344|NCT03945266|76273090|FG000|NOT COMPLETED|Overall Study||2||
60148345|NCT03945266|76273091|FG001|NOT COMPLETED|Overall Study||2||
60148346|NCT03916484|76273105|FG000|STARTED|Stage 1 Intervention (Months 1-3)||7||
60148347|NCT03916484|76273106|FG001|STARTED|Stage 1 Intervention (Months 1-3)||41||
60148348|NCT03916484|76273107|FG002|STARTED|Stage 1 Intervention (Months 1-3)||15||
60148349|NCT03916484|76273108|FG003|STARTED|Stage 1 Intervention (Months 1-3)||8||
60148350|NCT03916484|76273105|FG000|COMPLETED|Stage 1 Intervention (Months 1-3)||7||
60148351|NCT03916484|76273106|FG001|COMPLETED|Stage 1 Intervention (Months 1-3)||40||
60148352|NCT03916484|76273107|FG002|COMPLETED|Stage 1 Intervention (Months 1-3)||15||
60148353|NCT03916484|76273108|FG003|COMPLETED|Stage 1 Intervention (Months 1-3)||8||
60148354|NCT03916484|76273105|FG000|NOT COMPLETED|Stage 1 Intervention (Months 1-3)||0||
60148355|NCT03916484|76273106|FG001|NOT COMPLETED|Stage 1 Intervention (Months 1-3)||1||
60148356|NCT03916484|76273107|FG002|NOT COMPLETED|Stage 1 Intervention (Months 1-3)||0||
60148357|NCT03916484|76273108|FG003|NOT COMPLETED|Stage 1 Intervention (Months 1-3)||0||
60148358|NCT03916484|76273105|FG000|STARTED|Stage 2 Intervention (Months 4-6)||7||
60148359|NCT03916484|76273106|FG001|STARTED|Stage 2 Intervention (Months 4-6)||40||
60148360|NCT03916484|76273107|FG002|STARTED|Stage 2 Intervention (Months 4-6)||15||
60148361|NCT03916484|76273108|FG003|STARTED|Stage 2 Intervention (Months 4-6)||8||
60148362|NCT03916484|76273105|FG000|COMPLETED|Stage 2 Intervention (Months 4-6)||5||
60148363|NCT03916484|76273106|FG001|COMPLETED|Stage 2 Intervention (Months 4-6)||29||
60148364|NCT03916484|76273107|FG002|COMPLETED|Stage 2 Intervention (Months 4-6)||11||
60148365|NCT03916484|76273108|FG003|COMPLETED|Stage 2 Intervention (Months 4-6)||7||
60148366|NCT03916484|76273105|FG000|NOT COMPLETED|Stage 2 Intervention (Months 4-6)||2||
60148367|NCT03916484|76273106|FG001|NOT COMPLETED|Stage 2 Intervention (Months 4-6)||11||
60148368|NCT03916484|76273107|FG002|NOT COMPLETED|Stage 2 Intervention (Months 4-6)||4||
60148369|NCT03916484|76273108|FG003|NOT COMPLETED|Stage 2 Intervention (Months 4-6)||1||
60148370|NCT03769311|76273123|FG000|STARTED|Overall Study||15||
60148371|NCT03769311|76273123|FG000|COMPLETED|Overall Study||14||
60148372|NCT03769311|76273123|FG000|NOT COMPLETED|Overall Study||1||
60148373|NCT03738566|76273131|FG000|STARTED|Initial Study Phase||6||
60148374|NCT03738566|76273132|FG001|STARTED|Initial Study Phase||6||
60148375|NCT03738566|76273133|FG002|STARTED|Initial Study Phase||14||
60148376|NCT03738566|76273134|FG003|STARTED|Initial Study Phase||0||
60148377|NCT03738566|76273131|FG000|COMPLETED|Initial Study Phase||0||
60148378|NCT03738566|76273132|FG001|COMPLETED|Initial Study Phase||4||
60148379|NCT03738566|76273133|FG002|COMPLETED|Initial Study Phase||12||
60148380|NCT03738566|76273134|FG003|COMPLETED|Initial Study Phase||0||
60148381|NCT03738566|76273131|FG000|NOT COMPLETED|Initial Study Phase||6||
60148382|NCT03738566|76273132|FG001|NOT COMPLETED|Initial Study Phase||2||
60148383|NCT03738566|76273133|FG002|NOT COMPLETED|Initial Study Phase||2||
60148384|NCT03738566|76273134|FG003|NOT COMPLETED|Initial Study Phase||0||
60148385|NCT03738566|76273131|FG000|STARTED|Cross-over for Treatment Failure||0||
60148386|NCT03738566|76273132|FG001|STARTED|Cross-over for Treatment Failure||0||
60148387|NCT03738566|76273133|FG002|STARTED|Cross-over for Treatment Failure||0||
60148388|NCT03738566|76273134|FG003|STARTED|Cross-over for Treatment Failure||5||
60148389|NCT03738566|76273131|FG000|COMPLETED|Cross-over for Treatment Failure||0||
60148390|NCT03738566|76273132|FG001|COMPLETED|Cross-over for Treatment Failure||0||
60148391|NCT03738566|76273133|FG002|COMPLETED|Cross-over for Treatment Failure||0||
60148392|NCT03738566|76273134|FG003|COMPLETED|Cross-over for Treatment Failure||4||
60148393|NCT03738566|76273131|FG000|NOT COMPLETED|Cross-over for Treatment Failure||0||
60148394|NCT03738566|76273132|FG001|NOT COMPLETED|Cross-over for Treatment Failure||0||
60148395|NCT03738566|76273133|FG002|NOT COMPLETED|Cross-over for Treatment Failure||0||
60148396|NCT03738566|76273134|FG003|NOT COMPLETED|Cross-over for Treatment Failure||1||
60148397|NCT03702816|76273151|FG000|STARTED|Overall Study||10||
60148398|NCT03702816|76273152|FG001|STARTED|Overall Study||7||
60148399|NCT03702816|76273153|FG002|STARTED|Overall Study||3||
60148400|NCT03702816|76273154|FG003|STARTED|Overall Study||4||
60148401|NCT03702816|76273151|FG000|COMPLETED|Overall Study||10||
60148402|NCT03702816|76273152|FG001|COMPLETED|Overall Study||7||
60148403|NCT03702816|76273153|FG002|COMPLETED|Overall Study||3||
60148404|NCT03702816|76273154|FG003|COMPLETED|Overall Study||4||
60148405|NCT03702816|76273151|FG000|NOT COMPLETED|Overall Study||0||
60148406|NCT03702816|76273152|FG001|NOT COMPLETED|Overall Study||0||
60148407|NCT03702816|76273153|FG002|NOT COMPLETED|Overall Study||0||
60148408|NCT03702816|76273154|FG003|NOT COMPLETED|Overall Study||0||
60148409|NCT03533751|76273169|FG000|STARTED|Overall Study||60||
60148410|NCT03533751|76273170|FG001|STARTED|Overall Study||61||
60148411|NCT03533751|76273171|FG002|STARTED|Overall Study||61||
60148412|NCT03533751|76273172|FG003|STARTED|Overall Study||60||
60148413|NCT03533751|76273173|FG004|STARTED|Overall Study||60||
60148414|NCT03533751|76273169|FG000|Treated|Overall Study||60||
60148415|NCT03533751|76273170|FG001|Treated|Overall Study||61||
60148416|NCT03533751|76273171|FG002|Treated|Overall Study||59||
60148417|NCT03533751|76273172|FG003|Treated|Overall Study||60||
60148418|NCT03533751|76273173|FG004|Treated|Overall Study||60||
60148419|NCT03533751|76273169|FG000|COMPLETED|Overall Study||41||
60148420|NCT03533751|76273170|FG001|COMPLETED|Overall Study||36||
60148421|NCT03533751|76273171|FG002|COMPLETED|Overall Study||39||
60148422|NCT03533751|76273172|FG003|COMPLETED|Overall Study||40||
60148423|NCT03533751|76273173|FG004|COMPLETED|Overall Study||37||
60148424|NCT03533751|76273169|FG000|NOT COMPLETED|Overall Study||19||
60148425|NCT03533751|76273170|FG001|NOT COMPLETED|Overall Study||25||
60148426|NCT03533751|76273171|FG002|NOT COMPLETED|Overall Study||22||
60148427|NCT03533751|76273172|FG003|NOT COMPLETED|Overall Study||20||
60148428|NCT03533751|76273173|FG004|NOT COMPLETED|Overall Study||23||
60148429|NCT05072457|76273185|FG000|STARTED|Overall Study||10||
60148430|NCT05072457|76273185|FG000|COMPLETED|Overall Study||10||
60148431|NCT05072457|76273185|FG000|NOT COMPLETED|Overall Study||0||
60148432|NCT04856917|76273192|FG000|STARTED|Overall Study||42||
60148433|NCT04856917|76273193|FG001|STARTED|Overall Study||40||
60148434|NCT04856917|76273194|FG002|STARTED|Overall Study||41||
60148435|NCT04856917|76273192|FG000|Safety Analysis Set|Overall Study||41|The Safety Analysis Set included all randomized participants who received at least 1 dose of imsidolimab or placebo.|
60148436|NCT04856917|76273193|FG001|Safety Analysis Set|Overall Study||39|The Safety Analysis Set included all randomized participants who received at least 1 dose of imsidolimab or placebo.|
59751528|NCT00651313|75870870|FG000|STARTED|Overall Study||41||
59751529|NCT00651313|75870871|FG001|STARTED|Overall Study||43||
60148437|NCT04856917|76273194|FG002|Safety Analysis Set|Overall Study||41|The Safety Analysis Set included all randomized participants who received at least 1 dose of imsidolimab or placebo.|
60148438|NCT04856917|76273192|FG000|COMPLETED|Overall Study||34||
60148439|NCT04856917|76273193|FG001|COMPLETED|Overall Study||34||
60148440|NCT04856917|76273194|FG002|COMPLETED|Overall Study||37||
60148441|NCT04856917|76273192|FG000|NOT COMPLETED|Overall Study||8||
60148442|NCT04856917|76273193|FG001|NOT COMPLETED|Overall Study||6||
60148443|NCT04856917|76273194|FG002|NOT COMPLETED|Overall Study||4||
60148444|NCT04790786|76273207|FG000|STARTED|Overall Study||128||
60148445|NCT04790786|76273208|FG001|STARTED|Overall Study||2454||
60148446|NCT04790786|76273209|FG002|STARTED|Overall Study||885||
60148447|NCT04790786|76273210|FG003|STARTED|Overall Study||1104||
60148448|NCT04790786|76273207|FG000|COMPLETED|Overall Study||128||
60148449|NCT04790786|76273208|FG001|COMPLETED|Overall Study||2454||
60148450|NCT04790786|76273209|FG002|COMPLETED|Overall Study||885||
60148451|NCT04790786|76273210|FG003|COMPLETED|Overall Study||1104||
60148452|NCT04790786|76273207|FG000|NOT COMPLETED|Overall Study||0||
60148453|NCT04790786|76273208|FG001|NOT COMPLETED|Overall Study||0||
60148454|NCT04790786|76273209|FG002|NOT COMPLETED|Overall Study||0||
60148455|NCT04790786|76273210|FG003|NOT COMPLETED|Overall Study||0||
60148456|NCT04675242|76273223|FG000|STARTED|Overall Study||111||111
60148457|NCT04675242|76273224|FG001|STARTED|Overall Study||113||113
60148458|NCT04675242|76273223|FG000|COMPLETED|Overall Study||109||109
60148459|NCT04675242|76273224|FG001|COMPLETED|Overall Study||112||112
60148460|NCT04675242|76273223|FG000|NOT COMPLETED|Overall Study||2||2
60148461|NCT04675242|76273224|FG001|NOT COMPLETED|Overall Study||1||1
60148462|NCT04615247|76273232|FG000|STARTED|Overall Study||17||
60148463|NCT04615247|76273233|FG001|STARTED|Overall Study||19||
60148464|NCT04615247|76273232|FG000|COMPLETED|Overall Study||16||
60148465|NCT04615247|76273233|FG001|COMPLETED|Overall Study||16||
60148466|NCT04615247|76273232|FG000|NOT COMPLETED|Overall Study||1||
60148467|NCT04615247|76273233|FG001|NOT COMPLETED|Overall Study||3||
60148468|NCT04578015|76273241|FG000|STARTED|Overall Study||8||
60148469|NCT04578015|76273242|FG001|STARTED|Overall Study||8||
60148470|NCT04578015|76273241|FG000|COMPLETED|Overall Study||0||
60148471|NCT04578015|76273242|FG001|COMPLETED|Overall Study||0||
60148472|NCT04578015|76273241|FG000|NOT COMPLETED|Overall Study||8||
60148473|NCT04578015|76273242|FG001|NOT COMPLETED|Overall Study||8||
60148474|NCT04575428|76273248|FG000|STARTED|Overall Study||4||
59751530|NCT00651313|75870870|FG000|COMPLETED|Overall Study||35||
59751531|NCT00651313|75870871|FG001|COMPLETED|Overall Study||37||
59751532|NCT00651313|75870870|FG000|NOT COMPLETED|Overall Study||6||
59751533|NCT00651313|75870871|FG001|NOT COMPLETED|Overall Study||6||
59751534|NCT00969761|75870889|FG000|STARTED|Discont. Before Start of Treat. Cycle 2||3||
59751535|NCT00969761|75870890|FG001|STARTED|Discont. Before Start of Treat. Cycle 2||3||
60148475|NCT04575428|76273248|FG000|COMPLETED|Overall Study||4||
60148476|NCT04575428|76273248|FG000|NOT COMPLETED|Overall Study||0||
60148477|NCT04552132|76273254|FG000|STARTED|Overall Study||31||
60148478|NCT04552132|76273255|FG001|STARTED|Overall Study||32||
60148479|NCT04552132|76273254|FG000|COMPLETED|Overall Study||26||
60148480|NCT04552132|76273255|FG001|COMPLETED|Overall Study||29||
60148481|NCT04552132|76273254|FG000|NOT COMPLETED|Overall Study||5||
60148482|NCT04552132|76273255|FG001|NOT COMPLETED|Overall Study||3||
60148483|NCT04421456|76273264|FG000|STARTED|Randomized Placebo Run-in Period||0||
60148484|NCT04421456|76273265|FG001|STARTED|Randomized Placebo Run-in Period||0||
60148485|NCT04421456|76273266|FG002|STARTED|Randomized Placebo Run-in Period||95||
60148486|NCT04421456|76273264|FG000|COMPLETED|Randomized Placebo Run-in Period||0||
60148487|NCT04421456|76273265|FG001|COMPLETED|Randomized Placebo Run-in Period||0||
60148488|NCT04421456|76273266|FG002|COMPLETED|Randomized Placebo Run-in Period||77||
60148489|NCT04421456|76273264|FG000|NOT COMPLETED|Randomized Placebo Run-in Period||0||
60148490|NCT04421456|76273265|FG001|NOT COMPLETED|Randomized Placebo Run-in Period||0||
60148491|NCT04421456|76273266|FG002|NOT COMPLETED|Randomized Placebo Run-in Period||18||
60148492|NCT04421456|76273264|FG000|STARTED|Randomized Treatment Period|Of the 77 participants who completed the Placebo Run-in Period, 27 were randomized to GWP42003-P 300 mg.|27||
60148493|NCT04421456|76273265|FG001|STARTED|Randomized Treatment Period|Of the 77 participants who completed the Placebo Run-in Period, 24 were randomized to GWP42003-P 1000 mg.|24||
59751536|NCT00969761|75870891|FG002|STARTED|Discont. Before Start of Treat. Cycle 2||12||
60148494|NCT04421456|76273266|FG002|STARTED|Randomized Treatment Period|Of the 77 participants who completed the Placebo Run-in Period, 26 were randomized to pooled placebo.|26||
60148495|NCT04421456|76273264|FG000|COMPLETED|Randomized Treatment Period||23||
60148496|NCT04421456|76273265|FG001|COMPLETED|Randomized Treatment Period||19||
60148497|NCT04421456|76273266|FG002|COMPLETED|Randomized Treatment Period||19||
60148498|NCT04421456|76273264|FG000|NOT COMPLETED|Randomized Treatment Period||4||
60148499|NCT04421456|76273265|FG001|NOT COMPLETED|Randomized Treatment Period||5||
60148500|NCT04421456|76273266|FG002|NOT COMPLETED|Randomized Treatment Period||7||
60148501|NCT04341363|76273275|FG000|STARTED|Overall Study||8||
60148502|NCT04341363|76273275|FG000|COMPLETED|Overall Study||6||
60148503|NCT04341363|76273275|FG000|NOT COMPLETED|Overall Study||2||
60148504|NCT04277962|76273279|FG000|STARTED|Overall Study||0||
60148505|NCT04277962|76273279|FG000|COMPLETED|Overall Study||0||
60148506|NCT04277962|76273279|FG000|NOT COMPLETED|Overall Study||0||
60148507|NCT04268303|76273286|FG000|STARTED|Overall Study||129||
60148508|NCT04268303|76273287|FG001|STARTED|Overall Study|One participant enrolled in both the 120 microgram treatment group and subsequently the 180 microgram treatment group (at a second site) completed both courses of treatments, but is included only in the 120 microgram group for the randomized population.|125||
60148509|NCT04268303|76273288|FG002|STARTED|Overall Study||126||
60148510|NCT04268303|76273286|FG000|COMPLETED|Overall Study||126||
60148511|NCT04268303|76273287|FG001|COMPLETED|Overall Study||123||
60148512|NCT04268303|76273288|FG002|COMPLETED|Overall Study||123||
60148513|NCT04268303|76273286|FG000|NOT COMPLETED|Overall Study||3||
60148514|NCT04268303|76273287|FG001|NOT COMPLETED|Overall Study||2||
60148515|NCT04268303|76273288|FG002|NOT COMPLETED|Overall Study||3||
60148516|NCT04249687|76273298|FG000|STARTED|Overall Study||230||
60148517|NCT04249687|76273299|FG001|STARTED|Overall Study||73||
60148518|NCT04249687|76273298|FG000|COMPLETED|Overall Study||223||
60148519|NCT04249687|76273299|FG001|COMPLETED|Overall Study||67||
60148520|NCT04249687|76273298|FG000|NOT COMPLETED|Overall Study||7||
60148521|NCT04249687|76273299|FG001|NOT COMPLETED|Overall Study||6||
60148522|NCT04249583|76273307|FG000|STARTED|Overall Study||225||
60148523|NCT04249583|76273308|FG001|STARTED|Overall Study||75||
60148524|NCT04249583|76273307|FG000|COMPLETED|Overall Study||210||
60148525|NCT04249583|76273308|FG001|COMPLETED|Overall Study||66||
60148526|NCT04249583|76273307|FG000|NOT COMPLETED|Overall Study||15||
60148527|NCT04249583|76273308|FG001|NOT COMPLETED|Overall Study||9||
60148528|NCT04225260|76273314|FG000|STARTED|Overall Study||902||
60148529|NCT04225260|76273314|FG000|COMPLETED|Overall Study||790||
60148530|NCT04225260|76273314|FG000|NOT COMPLETED|Overall Study||112||
60148531|NCT04149821|76273321|FG000|STARTED|Overall Study||0||
60148532|NCT04149821|76273322|FG001|STARTED|Overall Study||1||
60148533|NCT04149821|76273321|FG000|COMPLETED|Overall Study||0||
60148534|NCT04149821|76273322|FG001|COMPLETED|Overall Study||1||
60148535|NCT04149821|76273321|FG000|NOT COMPLETED|Overall Study||0||
60148536|NCT04149821|76273322|FG001|NOT COMPLETED|Overall Study||0||
60148537|NCT04092452|76273332|FG000|STARTED|Overall Study||48||
60148538|NCT04092452|76273333|FG001|STARTED|Overall Study||47||
60148539|NCT04092452|76273334|FG002|STARTED|Overall Study||52||
60148540|NCT04092452|76273335|FG003|STARTED|Overall Study||47||
60148541|NCT04092452|76273332|FG000|COMPLETED|Overall Study||35|(treatment completed)|
60148542|NCT04092452|76273333|FG001|COMPLETED|Overall Study||30|(treatment completed)|
60148543|NCT04092452|76273334|FG002|COMPLETED|Overall Study||37|(treatment completed)|
60148544|NCT04092452|76273335|FG003|COMPLETED|Overall Study||31|(treatment completed)|
60148545|NCT04092452|76273332|FG000|NOT COMPLETED|Overall Study||13||
60148546|NCT04092452|76273333|FG001|NOT COMPLETED|Overall Study||17||
60148547|NCT04092452|76273334|FG002|NOT COMPLETED|Overall Study||15||
60148548|NCT04092452|76273335|FG003|NOT COMPLETED|Overall Study||16||
60148549|NCT04029116|76273350|FG000|STARTED|Overall Study||130||
60148550|NCT04029116|76273351|FG001|STARTED|Overall Study||130||
60148551|NCT04029116|76273350|FG000|Discontinued|Overall Study||12||
60148552|NCT04029116|76273351|FG001|Discontinued|Overall Study||16||
60148553|NCT04029116|76273350|FG000|COMPLETED|Overall Study||118||
60148554|NCT04029116|76273351|FG001|COMPLETED|Overall Study||114||
60148555|NCT04029116|76273350|FG000|NOT COMPLETED|Overall Study||12||
60148556|NCT04029116|76273351|FG001|NOT COMPLETED|Overall Study||16||
60148557|NCT03944057|76273357|FG000|STARTED|Overall Study||82||
60148558|NCT03944057|76273357|FG000|COMPLETED|Overall Study||82||
60148559|NCT03944057|76273357|FG000|NOT COMPLETED|Overall Study||0||
60148560|NCT03926026|76273365|FG000|STARTED|Overall Study||10||
60148561|NCT03926026|76273366|FG001|STARTED|Overall Study||5||
60148562|NCT03926026|76273367|FG002|STARTED|Overall Study||10||
60148563|NCT03926026|76273368|FG003|STARTED|Overall Study||11||
60148564|NCT03926026|76273365|FG000|COMPLETED|Overall Study||10||
60148565|NCT03926026|76273366|FG001|COMPLETED|Overall Study||5||
60148566|NCT03926026|76273367|FG002|COMPLETED|Overall Study||10||
60148567|NCT03926026|76273368|FG003|COMPLETED|Overall Study||11||
60148568|NCT03926026|76273365|FG000|NOT COMPLETED|Overall Study||0||
60148569|NCT03926026|76273366|FG001|NOT COMPLETED|Overall Study||0||
60148570|NCT03926026|76273367|FG002|NOT COMPLETED|Overall Study||0||
60148571|NCT03926026|76273368|FG003|NOT COMPLETED|Overall Study||0||
60148572|NCT03734029|76273382|FG000|STARTED|Overall Study||373||
60148573|NCT03734029|76273383|FG001|STARTED|Overall Study||184||
60148574|NCT03734029|76273382|FG000|Full Analysis Set (All Randomized Patients)|Overall Study||373||
60148575|NCT03734029|76273383|FG001|Full Analysis Set (All Randomized Patients)|Overall Study||184||
60148576|NCT03734029|76273382|FG000|Safety Analysis Set (All Randomized Patients Who Received at Least 1 Dose of Study Treatment)|Overall Study||371||
60148577|NCT03734029|76273383|FG001|Safety Analysis Set (All Randomized Patients Who Received at Least 1 Dose of Study Treatment)|Overall Study||172||
60148578|NCT03734029|76273382|FG000|COMPLETED|Overall Study||58|Ongoing as of 11 Jan 2022|
60148579|NCT03734029|76273383|FG001|COMPLETED|Overall Study||3|Ongoing as of 11 Jan 2022|
60148580|NCT03734029|76273382|FG000|NOT COMPLETED|Overall Study||315||
60148581|NCT03734029|76273383|FG001|NOT COMPLETED|Overall Study||181||
60148582|NCT03724032|76273392|FG000|STARTED|Overall Study||6||
60148583|NCT03724032|76273393|FG001|STARTED|Overall Study||6||
60148584|NCT03724032|76273394|FG002|STARTED|Overall Study|3 participants were enrolled in the study. Secondary data from an additional 12 participants was analyzed during the data analysis phase.|15||
60148585|NCT03724032|76273392|FG000|COMPLETED|Overall Study||3||
60148586|NCT03724032|76273393|FG001|COMPLETED|Overall Study||4||
60148587|NCT03724032|76273394|FG002|COMPLETED|Overall Study||14||
60148588|NCT03724032|76273392|FG000|NOT COMPLETED|Overall Study||3||
60148589|NCT03724032|76273393|FG001|NOT COMPLETED|Overall Study||2||
60148590|NCT03724032|76273394|FG002|NOT COMPLETED|Overall Study||1||
60148591|NCT03705962|76273404|FG000|STARTED|Overall Study||8||
60148592|NCT03705962|76273405|FG001|STARTED|Overall Study||3||
60148593|NCT03705962|76273404|FG000|COMPLETED|Overall Study||8||
60148594|NCT03705962|76273405|FG001|COMPLETED|Overall Study||3||
60148595|NCT03705962|76273404|FG000|NOT COMPLETED|Overall Study||0||
60148596|NCT03705962|76273405|FG001|NOT COMPLETED|Overall Study||0||
60148597|NCT03657797|76273415|FG000|STARTED|Overall Study|Met inclusion/exclusion criteria, including IOP entry criteria at 2 eligibility visits|111||111
60148598|NCT03657797|76273416|FG001|STARTED|Overall Study|Met inclusion/exclusion criteria, including IOP entry criteria at 2 eligibility visits|108||108
60148599|NCT03657797|76273417|FG002|STARTED|Overall Study|Met inclusion/exclusion criteria, including IOP entry criteria at 2 eligibility visits|107||107
60148600|NCT03657797|76273418|FG003|STARTED|Overall Study|Met inclusion/exclusion criteria, including IOP entry criteria at 2 eligibility visits|107||107
60148601|NCT03657797|76273415|FG000|COMPLETED|Overall Study||111||111
60148602|NCT03657797|76273416|FG001|COMPLETED|Overall Study||105||105
60148603|NCT03657797|76273417|FG002|COMPLETED|Overall Study||102||102
60148604|NCT03657797|76273418|FG003|COMPLETED|Overall Study||107||107
60148605|NCT03657797|76273415|FG000|NOT COMPLETED|Overall Study||0||0
60148606|NCT03657797|76273416|FG001|NOT COMPLETED|Overall Study||3||3
60148607|NCT03657797|76273417|FG002|NOT COMPLETED|Overall Study||5||5
60148608|NCT03657797|76273418|FG003|NOT COMPLETED|Overall Study||0||0
60148609|NCT03551938|76273434|FG000|STARTED|3-Month Follow Up||160||
60148610|NCT03551938|76273435|FG001|STARTED|3-Month Follow Up||158||
60148611|NCT03551938|76273434|FG000|COMPLETED|3-Month Follow Up||121||
60148612|NCT03551938|76273435|FG001|COMPLETED|3-Month Follow Up||120||
60148613|NCT03551938|76273434|FG000|NOT COMPLETED|3-Month Follow Up||39||
60148614|NCT03551938|76273435|FG001|NOT COMPLETED|3-Month Follow Up||38||
60148615|NCT03551938|76273434|FG000|STARTED|6-Month Follow Up||160||
60148616|NCT03551938|76273435|FG001|STARTED|6-Month Follow Up||158||
60148617|NCT03551938|76273434|FG000|COMPLETED|6-Month Follow Up||114||
60148618|NCT03551938|76273435|FG001|COMPLETED|6-Month Follow Up||116||
60148619|NCT03551938|76273434|FG000|NOT COMPLETED|6-Month Follow Up||46||
60148620|NCT03551938|76273435|FG001|NOT COMPLETED|6-Month Follow Up||42||
60148621|NCT03551938|76273434|FG000|STARTED|9-Month Follow Up||160||
60148622|NCT03551938|76273435|FG001|STARTED|9-Month Follow Up||158||
60148623|NCT03551938|76273434|FG000|COMPLETED|9-Month Follow Up||116||
60148624|NCT03551938|76273435|FG001|COMPLETED|9-Month Follow Up||115||
60148625|NCT03551938|76273434|FG000|NOT COMPLETED|9-Month Follow Up||44||
60148626|NCT03551938|76273435|FG001|NOT COMPLETED|9-Month Follow Up||43||
60148627|NCT03525600|76273444|FG000|STARTED|Overall Study||206||
60148628|NCT03525600|76273445|FG001|STARTED|Overall Study||208||
60148629|NCT03525600|76273446|FG002|STARTED|Overall Study||102||
60148630|NCT03525600|76273447|FG003|STARTED|Overall Study||105||
60148631|NCT03525600|76273444|FG000|COMPLETED|Overall Study||147||
60148632|NCT03525600|76273445|FG001|COMPLETED|Overall Study||161||
60148633|NCT03525600|76273446|FG002|COMPLETED|Overall Study||78||
60148634|NCT03525600|76273447|FG003|COMPLETED|Overall Study||83||
60148635|NCT03525600|76273444|FG000|NOT COMPLETED|Overall Study||59||
60148636|NCT03525600|76273445|FG001|NOT COMPLETED|Overall Study||47||
60148637|NCT03525600|76273446|FG002|NOT COMPLETED|Overall Study||24||
60148638|NCT03525600|76273447|FG003|NOT COMPLETED|Overall Study||22||
60148639|NCT03472040|76273464|FG000|STARTED|Overall Study||100||
60148640|NCT03472040|76273465|FG001|STARTED|Overall Study||287||
60148641|NCT03472040|76273464|FG000|COMPLETED|Overall Study||0||
60148642|NCT03472040|76273465|FG001|COMPLETED|Overall Study||1||
60148643|NCT03472040|76273464|FG000|NOT COMPLETED|Overall Study||100||
60148644|NCT03472040|76273465|FG001|NOT COMPLETED|Overall Study||286||
60148645|NCT03428126|76273471|FG000|STARTED|Overall Study||29||
60148646|NCT03428126|76273471|FG000|COMPLETED|Overall Study||29||
60148647|NCT03428126|76273471|FG000|NOT COMPLETED|Overall Study||0||
60148648|NCT03360656|76273477|FG000|STARTED|Overall Study||30||
60148649|NCT03360656|76273477|FG000|COMPLETED|Overall Study||30||
60148650|NCT03360656|76273477|FG000|NOT COMPLETED|Overall Study||0||
60148651|NCT03323385|76273483|FG000|STARTED|Overall Study||27||
60148652|NCT03323385|76273484|FG001|STARTED|Overall Study||30||
60148653|NCT03323385|76273483|FG000|Dosed|Overall Study||27||
60148654|NCT03323385|76273484|FG001|Dosed|Overall Study||28||
60148655|NCT03323385|76273483|FG000|COMPLETED|Overall Study||26||
60148656|NCT03323385|76273484|FG001|COMPLETED|Overall Study||27||
60148657|NCT03323385|76273483|FG000|NOT COMPLETED|Overall Study||1||
60148658|NCT03323385|76273484|FG001|NOT COMPLETED|Overall Study||3||
60148659|NCT03161483|76273494|FG000|STARTED|Placebo Controlled Phase||83||
60148660|NCT03161483|76273495|FG001|STARTED|Placebo Controlled Phase||82||
60148661|NCT03161483|76273496|FG002|STARTED|Placebo Controlled Phase||42||
60148662|NCT03161483|76273497|FG003|STARTED|Placebo Controlled Phase||82||
60148663|NCT03161483|76273494|FG000|COMPLETED|Placebo Controlled Phase||83||
60148664|NCT03161483|76273495|FG001|COMPLETED|Placebo Controlled Phase||81||
60148665|NCT03161483|76273496|FG002|COMPLETED|Placebo Controlled Phase||42||
60148666|NCT03161483|76273497|FG003|COMPLETED|Placebo Controlled Phase||82||
60148667|NCT03161483|76273494|FG000|NOT COMPLETED|Placebo Controlled Phase||0||
60148668|NCT03161483|76273495|FG001|NOT COMPLETED|Placebo Controlled Phase||1||
60148669|NCT03161483|76273496|FG002|NOT COMPLETED|Placebo Controlled Phase||0||
60148670|NCT03161483|76273497|FG003|NOT COMPLETED|Placebo Controlled Phase||0||
60148671|NCT03161483|76273494|FG000|STARTED|Treatment Period||83|Started = Entered placebo-controlled phase|
60148672|NCT03161483|76273495|FG001|STARTED|Treatment Period||81|Started = Entered placebo-controlled phase|
60148673|NCT03161483|76273496|FG002|STARTED|Treatment Period||42|Started = Entered placebo-controlled phase|
60148674|NCT03161483|76273497|FG003|STARTED|Treatment Period||82|Started = Entered placebo-controlled phase|
60148675|NCT03161483|76273494|FG000|Going to 0.30mg After Week 24|Treatment Period||36|After Week 24|
60148676|NCT03161483|76273495|FG001|Going to 0.30mg After Week 24|Treatment Period||0|After Week 24|
60148677|NCT03161483|76273496|FG002|Going to 0.30mg After Week 24|Treatment Period||0|After Week 24|
60148678|NCT03161483|76273497|FG003|Going to 0.30mg After Week 24|Treatment Period||0|After Week 24|
60148679|NCT03161483|76273494|FG000|Going to 0.45mg After Week 24|Treatment Period||36||
60148680|NCT03161483|76273495|FG001|Going to 0.45mg After Week 24|Treatment Period||0||
60148681|NCT03161483|76273496|FG002|Going to 0.45mg After Week 24|Treatment Period||0||
60148682|NCT03161483|76273497|FG003|Going to 0.45mg After Week 24|Treatment Period||0||
60148683|NCT03161483|76273494|FG000|Staying on Placebo After Week 24|Treatment Period||11||
60148684|NCT03161483|76273495|FG001|Staying on Placebo After Week 24|Treatment Period||0||
60148685|NCT03161483|76273496|FG002|Staying on Placebo After Week 24|Treatment Period||0||
60148686|NCT03161483|76273497|FG003|Staying on Placebo After Week 24|Treatment Period||0||
60148687|NCT03161483|76273494|FG000|COMPLETED|Treatment Period||73|Completed = Finished placebo-controlled phase|
60148688|NCT03161483|76273495|FG001|COMPLETED|Treatment Period||73|Completed = Finished placebo-controlled phase|
60148689|NCT03161483|76273496|FG002|COMPLETED|Treatment Period||39|Completed = Finished placebo-controlled phase|
60148690|NCT03161483|76273497|FG003|COMPLETED|Treatment Period||62|Completed = Finished placebo-controlled phase|
60148691|NCT03161483|76273494|FG000|NOT COMPLETED|Treatment Period||10||
60148692|NCT03161483|76273495|FG001|NOT COMPLETED|Treatment Period||8||
60148693|NCT03161483|76273496|FG002|NOT COMPLETED|Treatment Period||3||
60148694|NCT03161483|76273497|FG003|NOT COMPLETED|Treatment Period||20||
60148695|NCT03132636|76273511|FG000|STARTED|Overall Study||54||
60148696|NCT03132636|76273512|FG001|STARTED|Overall Study||84||
60148697|NCT03132636|76273511|FG000|COMPLETED|Overall Study||1||
60148698|NCT03132636|76273512|FG001|COMPLETED|Overall Study||9||
60148699|NCT03132636|76273511|FG000|NOT COMPLETED|Overall Study||53||
60148700|NCT03132636|76273512|FG001|NOT COMPLETED|Overall Study||75||
60148701|NCT02906202|76273518|FG000|STARTED|Overall Study||24||
60148702|NCT02906202|76273518|FG000|Transplant Population|Overall Study||23||
60148703|NCT02906202|76273518|FG000|COMPLETED|Overall Study||23||
60148704|NCT02906202|76273518|FG000|NOT COMPLETED|Overall Study||1||
60148705|NCT02869789|76273526|FG000|STARTED|Overall Study||391||
60148706|NCT02869789|76273527|FG001|STARTED|Overall Study||198||
60148707|NCT02869789|76273528|FG002|STARTED|Overall Study||395||
60148708|NCT02869789|76273529|FG003|STARTED|Overall Study||57||
60148709|NCT02869789|76273526|FG000|COMPLETED|Overall Study||56||
60148710|NCT02869789|76273527|FG001|COMPLETED|Overall Study||16||
59518911|NCT03538678|75612793|FG000|NOT COMPLETED|Overall Study||15||
60148711|NCT02869789|76273528|FG002|COMPLETED|Overall Study||30||
60148712|NCT02869789|76273529|FG003|COMPLETED|Overall Study||12||
60148713|NCT02869789|76273526|FG000|NOT COMPLETED|Overall Study||335||
60148714|NCT02869789|76273527|FG001|NOT COMPLETED|Overall Study||182||
60148715|NCT02869789|76273528|FG002|NOT COMPLETED|Overall Study||365||
60148716|NCT02869789|76273529|FG003|NOT COMPLETED|Overall Study||45||
60148717|NCT02863445|76273540|FG000|STARTED|Overall Study||35||
60148718|NCT02863445|76273541|FG001|STARTED|Overall Study||35||
60148719|NCT02863445|76273540|FG000|COMPLETED|Overall Study||35||
60148720|NCT02863445|76273541|FG001|COMPLETED|Overall Study||35||
60148721|NCT02863445|76273540|FG000|NOT COMPLETED|Overall Study||0||
60148722|NCT02863445|76273541|FG001|NOT COMPLETED|Overall Study||0||
60148723|NCT02760485|76273550|FG000|STARTED|Phase 1||7||
60148724|NCT02760485|76273551|FG001|STARTED|Phase 1||7||
60148725|NCT02760485|76273552|FG002|STARTED|Phase 1||0||
60148726|NCT02760485|76273550|FG000|COMPLETED|Phase 1||0||
60148727|NCT02760485|76273551|FG001|COMPLETED|Phase 1||0||
60148728|NCT02760485|76273552|FG002|COMPLETED|Phase 1||0||
60148729|NCT02760485|76273550|FG000|NOT COMPLETED|Phase 1||7||
60148730|NCT02760485|76273551|FG001|NOT COMPLETED|Phase 1||7||
60148731|NCT02760485|76273552|FG002|NOT COMPLETED|Phase 1||0||
60148732|NCT02760485|76273550|FG000|STARTED|Phase 2||0||
60148733|NCT02760485|76273551|FG001|STARTED|Phase 2||0||
60148734|NCT02760485|76273552|FG002|STARTED|Phase 2||19||
60148735|NCT02760485|76273550|FG000|COMPLETED|Phase 2||0||
60148736|NCT02760485|76273551|FG001|COMPLETED|Phase 2||0||
60148737|NCT02760485|76273552|FG002|COMPLETED|Phase 2||0||
60148738|NCT02760485|76273550|FG000|NOT COMPLETED|Phase 2||0||
60148739|NCT02760485|76273551|FG001|NOT COMPLETED|Phase 2||0||
60148740|NCT02760485|76273552|FG002|NOT COMPLETED|Phase 2||19||
60148741|NCT02661282|76273566|FG000|STARTED|Overall Study||3||
60148742|NCT02661282|76273567|FG001|STARTED|Overall Study||3||
60148743|NCT02661282|76273568|FG002|STARTED|Overall Study||3||
60148744|NCT02661282|76273569|FG003|STARTED|Overall Study||7||
60148745|NCT02661282|76273570|FG004|STARTED|Overall Study||3||
60148746|NCT02661282|76273571|FG005|STARTED|Overall Study||1||
60148747|NCT02661282|76273566|FG000|COMPLETED|Overall Study||3||
60148748|NCT02661282|76273567|FG001|COMPLETED|Overall Study||3||
60148749|NCT02661282|76273568|FG002|COMPLETED|Overall Study||3||
60148750|NCT02661282|76273569|FG003|COMPLETED|Overall Study||7||
60148751|NCT02661282|76273570|FG004|COMPLETED|Overall Study||3||
60148752|NCT02661282|76273571|FG005|COMPLETED|Overall Study||1||
60148753|NCT02661282|76273566|FG000|NOT COMPLETED|Overall Study||0||
59751537|NCT00969761|75870892|FG003|STARTED|Discont. Before Start of Treat. Cycle 2||6||
59751538|NCT00969761|75870893|FG004|STARTED|Discont. Before Start of Treat. Cycle 2||3||
59751539|NCT00969761|75870894|FG005|STARTED|Discont. Before Start of Treat. Cycle 2||3||
59751540|NCT00969761|75870895|FG006|STARTED|Discont. Before Start of Treat. Cycle 2||3||
59751541|NCT00969761|75870896|FG007|STARTED|Discont. Before Start of Treat. Cycle 2||6||
59751542|NCT00969761|75870897|FG008|STARTED|Discont. Before Start of Treat. Cycle 2||13||
60148754|NCT02661282|76273567|FG001|NOT COMPLETED|Overall Study||0||
60148755|NCT02661282|76273568|FG002|NOT COMPLETED|Overall Study||0||
60148756|NCT02661282|76273569|FG003|NOT COMPLETED|Overall Study||0||
60148757|NCT02661282|76273570|FG004|NOT COMPLETED|Overall Study||0||
60148758|NCT02661282|76273571|FG005|NOT COMPLETED|Overall Study||0||
60148759|NCT02634333|76273587|FG000|STARTED|Overall Study|Number of Eyes|200||200
60148760|NCT02634333|76273588|FG001|STARTED|Overall Study|Number of Eyes|199||199
60148761|NCT02634333|76273587|FG000|COMPLETED|Overall Study|Number of Eyes|160||160
60148762|NCT02634333|76273588|FG001|COMPLETED|Overall Study|Number of Eyes|167||167
60148763|NCT02634333|76273587|FG000|NOT COMPLETED|Overall Study||40||40
60148764|NCT02634333|76273588|FG001|NOT COMPLETED|Overall Study||32||32
60148765|NCT02515630|76273597|FG000|STARTED|Overall Study||41||
60148766|NCT02515630|76273597|FG000|COMPLETED|Overall Study||25||
60148767|NCT02515630|76273597|FG000|NOT COMPLETED|Overall Study||16||
60148768|NCT02450331|76273606|FG000|STARTED|Overall Study||403||
60148769|NCT02450331|76273607|FG001|STARTED|Overall Study||406||
60148770|NCT02450331|76273606|FG000|COMPLETED|Overall Study||171||
60148771|NCT02450331|76273607|FG001|COMPLETED|Overall Study||178||
60148772|NCT02450331|76273606|FG000|NOT COMPLETED|Overall Study||232||
60148773|NCT02450331|76273607|FG001|NOT COMPLETED|Overall Study||228||
60148774|NCT02335944|76273624|FG000|STARTED|Treatment Phase||4||
60148775|NCT02335944|76273625|FG001|STARTED|Treatment Phase||5||
60148776|NCT02335944|76273626|FG002|STARTED|Treatment Phase||3||
60148777|NCT02335944|76273627|FG003|STARTED|Treatment Phase||16||
60148778|NCT02335944|76273628|FG004|STARTED|Treatment Phase||5||
60148779|NCT02335944|76273629|FG005|STARTED|Treatment Phase||52||
60148780|NCT02335944|76273630|FG006|STARTED|Treatment Phase||3||
60148781|NCT02335944|76273631|FG007|STARTED|Treatment Phase||47||
60148782|NCT02335944|76273632|FG008|STARTED|Treatment Phase||42||
60148783|NCT02335944|76273633|FG009|STARTED|Treatment Phase|Study was early terminated prior to initiating enrollment of Phase II- Group 5|0||
60148784|NCT02335944|76273624|FG000|COMPLETED|Treatment Phase||0||
60148785|NCT02335944|76273625|FG001|COMPLETED|Treatment Phase||0||
60148786|NCT02335944|76273626|FG002|COMPLETED|Treatment Phase||0||
60148787|NCT02335944|76273627|FG003|COMPLETED|Treatment Phase||1||
60148788|NCT02335944|76273628|FG004|COMPLETED|Treatment Phase||0||
60148789|NCT02335944|76273629|FG005|COMPLETED|Treatment Phase||2||
60148790|NCT02335944|76273630|FG006|COMPLETED|Treatment Phase||0||
59751543|NCT00969761|75870898|FG009|STARTED|Discont. Before Start of Treat. Cycle 2||3||
59751544|NCT00969761|75870899|FG010|STARTED|Discont. Before Start of Treat. Cycle 2||3||
59751545|NCT00969761|75870900|FG011|STARTED|Discont. Before Start of Treat. Cycle 2||3||
59751546|NCT00969761|75870889|FG000|COMPLETED|Discont. Before Start of Treat. Cycle 2||2||
60148791|NCT02335944|76273631|FG007|COMPLETED|Treatment Phase||5||
60148792|NCT02335944|76273632|FG008|COMPLETED|Treatment Phase||6||
60148793|NCT02335944|76273633|FG009|COMPLETED|Treatment Phase||0||
60148794|NCT02335944|76273624|FG000|NOT COMPLETED|Treatment Phase||4||
60148795|NCT02335944|76273625|FG001|NOT COMPLETED|Treatment Phase||5||
60148796|NCT02335944|76273626|FG002|NOT COMPLETED|Treatment Phase||3||
60148797|NCT02335944|76273627|FG003|NOT COMPLETED|Treatment Phase||15||
60148798|NCT02335944|76273628|FG004|NOT COMPLETED|Treatment Phase||5||
60148799|NCT02335944|76273629|FG005|NOT COMPLETED|Treatment Phase||50||
60148800|NCT02335944|76273630|FG006|NOT COMPLETED|Treatment Phase||3||
60148801|NCT02335944|76273631|FG007|NOT COMPLETED|Treatment Phase||42||
60148802|NCT02335944|76273632|FG008|NOT COMPLETED|Treatment Phase||36||
60148803|NCT02335944|76273633|FG009|NOT COMPLETED|Treatment Phase||0||
60148804|NCT02335944|76273624|FG000|STARTED|Post-treatment Follow-up||1||
60148805|NCT02335944|76273625|FG001|STARTED|Post-treatment Follow-up||0||
60148806|NCT02335944|76273626|FG002|STARTED|Post-treatment Follow-up||0||
60148807|NCT02335944|76273627|FG003|STARTED|Post-treatment Follow-up||2||
60148808|NCT02335944|76273628|FG004|STARTED|Post-treatment Follow-up||0||
60148809|NCT02335944|76273629|FG005|STARTED|Post-treatment Follow-up||13||
60148810|NCT02335944|76273630|FG006|STARTED|Post-treatment Follow-up||0||
60148811|NCT02335944|76273631|FG007|STARTED|Post-treatment Follow-up||5||
60148812|NCT02335944|76273632|FG008|STARTED|Post-treatment Follow-up||3||
60148813|NCT02335944|76273633|FG009|STARTED|Post-treatment Follow-up||0||
60148814|NCT02335944|76273624|FG000|COMPLETED|Post-treatment Follow-up||0||
60148815|NCT02335944|76273625|FG001|COMPLETED|Post-treatment Follow-up||0||
60148816|NCT02335944|76273626|FG002|COMPLETED|Post-treatment Follow-up||0||
60148817|NCT02335944|76273627|FG003|COMPLETED|Post-treatment Follow-up||0||
60148818|NCT02335944|76273628|FG004|COMPLETED|Post-treatment Follow-up||0||
60148819|NCT02335944|76273629|FG005|COMPLETED|Post-treatment Follow-up||0||
60148820|NCT02335944|76273630|FG006|COMPLETED|Post-treatment Follow-up||0||
60148821|NCT02335944|76273631|FG007|COMPLETED|Post-treatment Follow-up||0||
60148822|NCT02335944|76273632|FG008|COMPLETED|Post-treatment Follow-up||0||
60148823|NCT02335944|76273633|FG009|COMPLETED|Post-treatment Follow-up||0||
60148824|NCT02335944|76273624|FG000|NOT COMPLETED|Post-treatment Follow-up||1||
60148825|NCT02335944|76273625|FG001|NOT COMPLETED|Post-treatment Follow-up||0||
60148826|NCT02335944|76273626|FG002|NOT COMPLETED|Post-treatment Follow-up||0||
60148827|NCT02335944|76273627|FG003|NOT COMPLETED|Post-treatment Follow-up||2||
60148828|NCT02335944|76273628|FG004|NOT COMPLETED|Post-treatment Follow-up||0||
60148829|NCT02335944|76273629|FG005|NOT COMPLETED|Post-treatment Follow-up||13||
60148830|NCT02335944|76273630|FG006|NOT COMPLETED|Post-treatment Follow-up||0||
60148831|NCT02335944|76273631|FG007|NOT COMPLETED|Post-treatment Follow-up||5||
60148832|NCT02335944|76273632|FG008|NOT COMPLETED|Post-treatment Follow-up||3||
60148833|NCT02335944|76273633|FG009|NOT COMPLETED|Post-treatment Follow-up||0||
60148834|NCT02326974|76273671|FG000|STARTED|Overall Study||164||
60148835|NCT02326974|76273671|FG000|Treated|Overall Study||163||
60148836|NCT02326974|76273671|FG000|COMPLETED|Overall Study||157||
60148837|NCT02326974|76273671|FG000|NOT COMPLETED|Overall Study||7||
60148838|NCT02214550|76273688|FG000|STARTED|Overall Study||6||
60148839|NCT02214550|76273689|FG001|STARTED|Overall Study||4||
60148840|NCT02214550|76273690|FG002|STARTED|Overall Study||8||
60148841|NCT02214550|76273691|FG003|STARTED|Overall Study||15||
60148842|NCT02214550|76273692|FG004|STARTED|Overall Study||45||
60148843|NCT02214550|76273693|FG005|STARTED|Overall Study||39||
60148844|NCT02214550|76273694|FG006|STARTED|Overall Study||187||
60148845|NCT02214550|76273695|FG007|STARTED|Overall Study||35||
60148846|NCT02214550|76273696|FG008|STARTED|Overall Study||14||
60148847|NCT02214550|76273688|FG000|Baseline|Overall Study||6||
60148848|NCT02214550|76273689|FG001|Baseline|Overall Study||4||
60148849|NCT02214550|76273690|FG002|Baseline|Overall Study||8||
60148850|NCT02214550|76273691|FG003|Baseline|Overall Study||14||
60148851|NCT02214550|76273692|FG004|Baseline|Overall Study||37||
60148852|NCT02214550|76273693|FG005|Baseline|Overall Study||31||
60148853|NCT02214550|76273694|FG006|Baseline|Overall Study||102||
60148854|NCT02214550|76273695|FG007|Baseline|Overall Study||34||
60148855|NCT02214550|76273696|FG008|Baseline|Overall Study||10||
60148856|NCT02214550|76273688|FG000|Month 6|Overall Study||6||
60148857|NCT02214550|76273689|FG001|Month 6|Overall Study||4||
60148858|NCT02214550|76273690|FG002|Month 6|Overall Study||5||
60148859|NCT02214550|76273691|FG003|Month 6|Overall Study||8||
60148860|NCT02214550|76273692|FG004|Month 6|Overall Study||0||
60148861|NCT02214550|76273693|FG005|Month 6|Overall Study||0||
60148862|NCT02214550|76273694|FG006|Month 6|Overall Study||0||
59518912|NCT03538678|75612794|FG001|NOT COMPLETED|Overall Study||11||
59751547|NCT00969761|75870890|FG001|COMPLETED|Discont. Before Start of Treat. Cycle 2||3||
59751548|NCT00969761|75870891|FG002|COMPLETED|Discont. Before Start of Treat. Cycle 2||10||
59751549|NCT00969761|75870892|FG003|COMPLETED|Discont. Before Start of Treat. Cycle 2||5||
59751550|NCT00969761|75870893|FG004|COMPLETED|Discont. Before Start of Treat. Cycle 2||3||
59882124|NCT03848403|76005049|FG001|Received Intervention|Period 1 (Day 1)||24||
60148863|NCT02214550|76273695|FG007|Month 6|Overall Study||0||
60148864|NCT02214550|76273696|FG008|Month 6|Overall Study||0||
60148865|NCT02214550|76273688|FG000|COMPLETED|Overall Study||6||
60148866|NCT02214550|76273689|FG001|COMPLETED|Overall Study||4||
60148867|NCT02214550|76273690|FG002|COMPLETED|Overall Study||5||
60148868|NCT02214550|76273691|FG003|COMPLETED|Overall Study||6||
60148869|NCT02214550|76273692|FG004|COMPLETED|Overall Study||37||
60148870|NCT02214550|76273693|FG005|COMPLETED|Overall Study||31||
60148871|NCT02214550|76273694|FG006|COMPLETED|Overall Study||102||
60148872|NCT02214550|76273695|FG007|COMPLETED|Overall Study||34||
60148873|NCT02214550|76273696|FG008|COMPLETED|Overall Study||10||
60148874|NCT02214550|76273688|FG000|NOT COMPLETED|Overall Study||0||
60148875|NCT02214550|76273689|FG001|NOT COMPLETED|Overall Study||0||
60148876|NCT02214550|76273690|FG002|NOT COMPLETED|Overall Study||3||
60148877|NCT02214550|76273691|FG003|NOT COMPLETED|Overall Study||9||
60148878|NCT02214550|76273692|FG004|NOT COMPLETED|Overall Study||8||
60148879|NCT02214550|76273693|FG005|NOT COMPLETED|Overall Study||8||
60148880|NCT02214550|76273694|FG006|NOT COMPLETED|Overall Study||85||
60148881|NCT02214550|76273695|FG007|NOT COMPLETED|Overall Study||1||
60148882|NCT02214550|76273696|FG008|NOT COMPLETED|Overall Study||4||
60148883|NCT02200445|76273719|FG000|STARTED|Overall Study||4||
60148884|NCT02200445|76273720|FG001|STARTED|Overall Study||17||
60148885|NCT02200445|76273721|FG002|STARTED|Overall Study||5||
60148886|NCT02200445|76273719|FG000|COMPLETED|Overall Study||3||
60148887|NCT02200445|76273720|FG001|COMPLETED|Overall Study||13||
60148888|NCT02200445|76273721|FG002|COMPLETED|Overall Study||3||
60148889|NCT02200445|76273719|FG000|NOT COMPLETED|Overall Study||1||
60148890|NCT02200445|76273720|FG001|NOT COMPLETED|Overall Study||4||
60148891|NCT02200445|76273721|FG002|NOT COMPLETED|Overall Study||2||
60148892|NCT02120352|76273729|FG000|STARTED|Induction Period (20 Weeks)||309||
60148893|NCT02120352|76273730|FG001|STARTED|Induction Period (20 Weeks)||0||
60148894|NCT02120352|76273731|FG002|STARTED|Induction Period (20 Weeks)||0||
60148895|NCT02120352|76273732|FG003|STARTED|Induction Period (20 Weeks)||0||
60148896|NCT02120352|76273729|FG000|COMPLETED|Induction Period (20 Weeks)||288||
60148897|NCT02120352|76273730|FG001|COMPLETED|Induction Period (20 Weeks)||0||
60148898|NCT02120352|76273731|FG002|COMPLETED|Induction Period (20 Weeks)||0||
60148899|NCT02120352|76273732|FG003|COMPLETED|Induction Period (20 Weeks)||0||
60148900|NCT02120352|76273729|FG000|NOT COMPLETED|Induction Period (20 Weeks)||21||
60148901|NCT02120352|76273730|FG001|NOT COMPLETED|Induction Period (20 Weeks)||0||
60148902|NCT02120352|76273731|FG002|NOT COMPLETED|Induction Period (20 Weeks)||0||
60148903|NCT02120352|76273732|FG003|NOT COMPLETED|Induction Period (20 Weeks)||0||
60148904|NCT02120352|76273729|FG000|STARTED|Maintenance Period (32 Weeks)||0|2 participants did not enter Maintenance phase as they had Day 1 viral loads >50 copies/milliliter.|
60148905|NCT02120352|76273730|FG001|STARTED|Maintenance Period (32 Weeks)||115|2 participants did not enter Maintenance phase as they had Day 1 viral loads >50 copies/milliliter.|
60148906|NCT02120352|76273731|FG002|STARTED|Maintenance Period (32 Weeks)||115|2 participants did not enter Maintenance phase as they had Day 1 viral loads >50 copies/milliliter.|
60148907|NCT02120352|76273732|FG003|STARTED|Maintenance Period (32 Weeks)||56|2 participants did not enter Maintenance phase as they had Day 1 viral loads >50 copies/milliliter.|
60148908|NCT02120352|76273729|FG000|COMPLETED|Maintenance Period (32 Weeks)||0||
60148909|NCT02120352|76273730|FG001|COMPLETED|Maintenance Period (32 Weeks)||0||
60148910|NCT02120352|76273731|FG002|COMPLETED|Maintenance Period (32 Weeks)||0||
60148911|NCT02120352|76273732|FG003|COMPLETED|Maintenance Period (32 Weeks)||0||
60148912|NCT02120352|76273729|FG000|NOT COMPLETED|Maintenance Period (32 Weeks)||0||
60148913|NCT02120352|76273730|FG001|NOT COMPLETED|Maintenance Period (32 Weeks)||115||
60148914|NCT02120352|76273731|FG002|NOT COMPLETED|Maintenance Period (32 Weeks)||115||
60148915|NCT02120352|76273732|FG003|NOT COMPLETED|Maintenance Period (32 Weeks)||56||
60148916|NCT02058693|76273748|FG000|STARTED|Phase 1||21||
60148917|NCT02058693|76273749|FG001|STARTED|Phase 1||20||
60148918|NCT02058693|76273748|FG000|COMPLETED|Phase 1||16||
60148919|NCT02058693|76273749|FG001|COMPLETED|Phase 1||16||
60148920|NCT02058693|76273748|FG000|NOT COMPLETED|Phase 1||5||
60148921|NCT02058693|76273749|FG001|NOT COMPLETED|Phase 1||4||
60148922|NCT02058693|76273748|FG000|STARTED|Phase 2||16||
60148923|NCT02058693|76273749|FG001|STARTED|Phase 2||16||
60148924|NCT02058693|76273748|FG000|COMPLETED|Phase 2||16||
60148925|NCT02058693|76273749|FG001|COMPLETED|Phase 2||14||
60148926|NCT02058693|76273748|FG000|NOT COMPLETED|Phase 2||0||
60148927|NCT02058693|76273749|FG001|NOT COMPLETED|Phase 2||2||
60148928|NCT02039856|76273759|FG000|STARTED|Overall Study||2720||8
60148929|NCT02039856|76273760|FG001|STARTED|Overall Study||1180||4
60148930|NCT02039856|76273759|FG000|Baseline Started - Patients|Overall Study||2183||8
60148931|NCT02039856|76273760|FG001|Baseline Started - Patients|Overall Study||919||4
60148932|NCT02039856|76273759|FG000|Baseline Completed - Patients|Overall Study||953||8
60148933|NCT02039856|76273760|FG001|Baseline Completed - Patients|Overall Study||442||4
60148934|NCT02039856|76273759|FG000|Baseline Started - Providers/Staff|Overall Study||537||8
60148935|NCT02039856|76273760|FG001|Baseline Started - Providers/Staff|Overall Study||261||4
60148936|NCT02039856|76273759|FG000|Baseline Completed -Providers/Staff|Overall Study||194||8
60148937|NCT02039856|76273760|FG001|Baseline Completed -Providers/Staff|Overall Study||94||4
60148938|NCT02039856|76273759|FG000|Total Baseline Completed|Overall Study||1147||8
60148939|NCT02039856|76273760|FG001|Total Baseline Completed|Overall Study||536||4
60148940|NCT02039856|76273759|FG000|12-month Started-patients|Overall Study||953||8
59518913|NCT03393208|75612804|FG000|STARTED|Treatment Period 1 (Day 1-Day 3)||13||
60148941|NCT02039856|76273760|FG001|12-month Started-patients|Overall Study||442||4
60148942|NCT02039856|76273759|FG000|12-month Completed- Patients|Overall Study||580||8
60148943|NCT02039856|76273760|FG001|12-month Completed- Patients|Overall Study||241||4
60148944|NCT02039856|76273759|FG000|12-month Providers/Staff|Overall Study||0||0
60148945|NCT02039856|76273760|FG001|12-month Providers/Staff|Overall Study||0||0
60148946|NCT02039856|76273759|FG000|24-month Started|Overall Study||1518||8
60148947|NCT02039856|76273760|FG001|24-month Started|Overall Study||746||4
60148948|NCT02039856|76273759|FG000|24-month Started - Patients|Overall Study||953||8
59751551|NCT00969761|75870894|FG005|COMPLETED|Discont. Before Start of Treat. Cycle 2||3||
59751552|NCT00969761|75870895|FG006|COMPLETED|Discont. Before Start of Treat. Cycle 2||3||
60010711|NCT01321554|76126414|FG000|STARTED|Randomization Phase||261||
60010712|NCT01321554|76126415|FG001|STARTED|Randomization Phase||131||
60010713|NCT01321554|76126416|FG002|STARTED|Randomization Phase||0||
60010714|NCT01321554|76126417|FG003|STARTED|Randomization Phase||0||
60010715|NCT01321554|76126414|FG000|COMPLETED|Randomization Phase||261||
60010716|NCT01321554|76126415|FG001|COMPLETED|Randomization Phase||131||
60010717|NCT01321554|76126416|FG002|COMPLETED|Randomization Phase||0||
60010718|NCT01321554|76126417|FG003|COMPLETED|Randomization Phase||0||
60010719|NCT01321554|76126414|FG000|NOT COMPLETED|Randomization Phase||0||
60010720|NCT01321554|76126415|FG001|NOT COMPLETED|Randomization Phase||0||
60010721|NCT01321554|76126416|FG002|NOT COMPLETED|Randomization Phase||0||
60010722|NCT01321554|76126417|FG003|NOT COMPLETED|Randomization Phase||0||
60010723|NCT01321554|76126414|FG000|STARTED|OOL Lenvatinib Treatment Period||0||
60010724|NCT01321554|76126415|FG001|STARTED|OOL Lenvatinib Treatment Period||0||
60010725|NCT01321554|76126416|FG002|STARTED|OOL Lenvatinib Treatment Period|Participants from randomization phase were re-randomized to OOL, treatment period.|85||
60010726|NCT01321554|76126417|FG003|STARTED|OOL Lenvatinib Treatment Period|Participants from randomization phase were re-randomized to OOL, treatment period.|30||
60010727|NCT01321554|76126414|FG000|COMPLETED|OOL Lenvatinib Treatment Period||0||
60010728|NCT01321554|76126415|FG001|COMPLETED|OOL Lenvatinib Treatment Period||0||
60010729|NCT01321554|76126416|FG002|COMPLETED|OOL Lenvatinib Treatment Period||85||
60010730|NCT01321554|76126417|FG003|COMPLETED|OOL Lenvatinib Treatment Period||30||
60010731|NCT01321554|76126414|FG000|NOT COMPLETED|OOL Lenvatinib Treatment Period||0||
60010732|NCT01321554|76126415|FG001|NOT COMPLETED|OOL Lenvatinib Treatment Period||0||
60010733|NCT01321554|76126416|FG002|NOT COMPLETED|OOL Lenvatinib Treatment Period||0||
60010734|NCT01321554|76126417|FG003|NOT COMPLETED|OOL Lenvatinib Treatment Period||0||
60010735|NCT01269346|76126425|FG000|STARTED|Treatment Phase||52||
60010736|NCT01269346|76126425|FG000|Completed 6 Cycles|Treatment Phase||45||
60010737|NCT01269346|76126425|FG000|COMPLETED|Treatment Phase||43||
60010738|NCT01269346|76126425|FG000|NOT COMPLETED|Treatment Phase||9||
60010739|NCT01269346|76126425|FG000|STARTED|Extension Phase|Out of 52 participants randomized, only 43 continued into the Extension Phase of the study.|43||
60010740|NCT01269346|76126425|FG000|COMPLETED|Extension Phase||0||
60010741|NCT01269346|76126425|FG000|NOT COMPLETED|Extension Phase||43||
60010742|NCT01268293|76126430|FG000|STARTED|Overall Study||9||
60010743|NCT01268293|76126430|FG000|Completed Cycle 1|Overall Study||9||
60010744|NCT01268293|76126430|FG000|COMPLETED|Overall Study||0||
60010745|NCT01268293|76126430|FG000|NOT COMPLETED|Overall Study||9||
60010746|NCT01268150|76126434|FG000|STARTED|Treatment Phase||56||
60010747|NCT01268150|76126434|FG000|COMPLETED|Treatment Phase||28||
60010748|NCT01268150|76126434|FG000|NOT COMPLETED|Treatment Phase||28||
60010749|NCT01268150|76126434|FG000|STARTED|Extension Phase|28 participants discontinued study drug in Treatment Phase so did not enter the Extension Phase|28||
60010750|NCT01268150|76126434|FG000|Treatment Ongoing at Data Cutoff Date|Extension Phase||1||
60010751|NCT01268150|76126434|FG000|COMPLETED|Extension Phase||1||
60010752|NCT01268150|76126434|FG000|NOT COMPLETED|Extension Phase||27||
60010753|NCT01267175|76126438|FG000|STARTED|Overall Study||31||
60010754|NCT01267175|76126438|FG000|COMPLETED|Overall Study||29||
60010755|NCT01267175|76126438|FG000|NOT COMPLETED|Overall Study||2||
60010756|NCT01231841|76126442|FG000|STARTED|Overall Study||20||
60010757|NCT01231841|76126442|FG000|COMPLETED|Overall Study||20||
60010758|NCT01231841|76126442|FG000|NOT COMPLETED|Overall Study||0||
60010759|NCT01133756|76126449|FG000|STARTED|Overall Study||2||
60010760|NCT01133756|76126450|FG001|STARTED|Overall Study||3||
60010761|NCT01133756|76126451|FG002|STARTED|Overall Study||2||
60010762|NCT01133756|76126449|FG000|Completed 6 Cycles|Overall Study|One participant completed 6 cycles and remained in the study until 18 Sep 2012.|1||
60010763|NCT01133756|76126450|FG001|Completed 6 Cycles|Overall Study||0||
60010764|NCT01133756|76126451|FG002|Completed 6 Cycles|Overall Study||0||
60010765|NCT01133756|76126449|FG000|COMPLETED|Overall Study||0||
60010766|NCT01133756|76126450|FG001|COMPLETED|Overall Study||0||
60010767|NCT01133756|76126451|FG002|COMPLETED|Overall Study||0||
60010768|NCT01133756|76126449|FG000|NOT COMPLETED|Overall Study||2||
60010769|NCT01133756|76126450|FG001|NOT COMPLETED|Overall Study||3||
60148949|NCT02039856|76273760|FG001|24-month Started - Patients|Overall Study||442||4
59751553|NCT00969761|75870896|FG007|COMPLETED|Discont. Before Start of Treat. Cycle 2||6||
59751554|NCT00969761|75870897|FG008|COMPLETED|Discont. Before Start of Treat. Cycle 2||11||
60010770|NCT01133756|76126451|FG002|NOT COMPLETED|Overall Study||2||
60010771|NCT01126736|76126464|FG000|STARTED|Overall Study||4||
60010772|NCT01126736|76126465|FG001|STARTED|Overall Study||6||
60148950|NCT02039856|76273759|FG000|24-month Completed - Patients|Overall Study||519||8
59751555|NCT00969761|75870898|FG009|COMPLETED|Discont. Before Start of Treat. Cycle 2||2||
59751556|NCT00969761|75870899|FG010|COMPLETED|Discont. Before Start of Treat. Cycle 2||3||
59751557|NCT00969761|75870900|FG011|COMPLETED|Discont. Before Start of Treat. Cycle 2||3||
60010773|NCT01126736|76126466|FG002|STARTED|Overall Study||5||
60010774|NCT01126736|76126467|FG003|STARTED|Overall Study||42||
60010775|NCT01126736|76126468|FG004|STARTED|Overall Study||41||
60010776|NCT01126736|76126464|FG000|Safety Population|Overall Study||4||
60010777|NCT01126736|76126465|FG001|Safety Population|Overall Study||6||
60148951|NCT02039856|76273760|FG001|24-month Completed - Patients|Overall Study||222||4
60148952|NCT02039856|76273759|FG000|24-month Started Providers/Staff|Overall Study||565||8
60148953|NCT02039856|76273760|FG001|24-month Started Providers/Staff|Overall Study||304||4
60148954|NCT02039856|76273759|FG000|24-month Completed Providers/Staff|Overall Study||174||8
60148955|NCT02039856|76273760|FG001|24-month Completed Providers/Staff|Overall Study||105||4
60148956|NCT02039856|76273759|FG000|Total 24-month Completed|Overall Study||693||8
60148957|NCT02039856|76273760|FG001|Total 24-month Completed|Overall Study||327||4
60148958|NCT02039856|76273759|FG000|COMPLETED|Overall Study||693||8
60148959|NCT02039856|76273760|FG001|COMPLETED|Overall Study||327||4
60148960|NCT02039856|76273759|FG000|NOT COMPLETED|Overall Study||2027||0
60148961|NCT02039856|76273760|FG001|NOT COMPLETED|Overall Study||853||0
60148962|NCT01796392|76273770|FG000|STARTED|Overall Study||128||
60148963|NCT01796392|76273771|FG001|STARTED|Overall Study||62||
60148964|NCT01796392|76273770|FG000|COMPLETED|Overall Study|119 active subjects at 12-months|119||
60148965|NCT01796392|76273771|FG001|COMPLETED|Overall Study|59 active subjects at 12-months|59||
60148966|NCT01796392|76273770|FG000|NOT COMPLETED|Overall Study||9||
60148967|NCT01796392|76273771|FG001|NOT COMPLETED|Overall Study||3||
60148968|NCT01571635|76273782|FG000|STARTED|Overall Study||8||
60148969|NCT01571635|76273783|FG001|STARTED|Overall Study||9||
60148970|NCT01571635|76273784|FG002|STARTED|Overall Study||8||
60148971|NCT01571635|76273785|FG003|STARTED|Overall Study||12||
60148972|NCT01571635|76273786|FG004|STARTED|Overall Study||9||
60148973|NCT01571635|76273782|FG000|COMPLETED|Overall Study||2||
60148974|NCT01571635|76273783|FG001|COMPLETED|Overall Study||1||
60148975|NCT01571635|76273784|FG002|COMPLETED|Overall Study||1||
60148976|NCT01571635|76273785|FG003|COMPLETED|Overall Study||0||
60148977|NCT01571635|76273786|FG004|COMPLETED|Overall Study||0||
60148978|NCT01571635|76273782|FG000|NOT COMPLETED|Overall Study||6||
60148979|NCT01571635|76273783|FG001|NOT COMPLETED|Overall Study||8||
60148980|NCT01571635|76273784|FG002|NOT COMPLETED|Overall Study||7||
60148981|NCT01571635|76273785|FG003|NOT COMPLETED|Overall Study||12||
60148982|NCT01571635|76273786|FG004|NOT COMPLETED|Overall Study||9||
60148983|NCT01248715|76273800|FG000|STARTED|Overall Study||556||
60148984|NCT01248715|76273801|FG001|STARTED|Overall Study||551||
60148985|NCT01248715|76273800|FG000|COMPLETED|Overall Study||55||
60148986|NCT01248715|76273801|FG001|COMPLETED|Overall Study||41||
60148987|NCT01248715|76273800|FG000|NOT COMPLETED|Overall Study||501||
60148988|NCT01248715|76273801|FG001|NOT COMPLETED|Overall Study||510||
60148989|NCT00963040|76273811|FG000|STARTED|TI-004 Protocol||22||
60148990|NCT00963040|76273812|FG001|STARTED|TI-004 Protocol||18||
60148991|NCT00963040|76273813|FG002|STARTED|TI-004 Protocol||0||
60148992|NCT00963040|76273814|FG003|STARTED|TI-004 Protocol||0||
60148993|NCT00963040|76273811|FG000|COMPLETED|TI-004 Protocol||22||
60148994|NCT00963040|76273812|FG001|COMPLETED|TI-004 Protocol||18||
60148995|NCT00963040|76273813|FG002|COMPLETED|TI-004 Protocol||0||
60148996|NCT00963040|76273814|FG003|COMPLETED|TI-004 Protocol||0||
60148997|NCT00963040|76273811|FG000|NOT COMPLETED|TI-004 Protocol||0||
60148998|NCT00963040|76273812|FG001|NOT COMPLETED|TI-004 Protocol||0||
60148999|NCT00963040|76273813|FG002|NOT COMPLETED|TI-004 Protocol||0||
60149000|NCT00963040|76273814|FG003|NOT COMPLETED|TI-004 Protocol||0||
60149001|NCT00963040|76273811|FG000|STARTED|TI-005 Protocol||0||
60149002|NCT00963040|76273812|FG001|STARTED|TI-005 Protocol||0||
60149003|NCT00963040|76273813|FG002|STARTED|TI-005 Protocol||12||
60149004|NCT00963040|76273814|FG003|STARTED|TI-005 Protocol||8||
60149005|NCT00963040|76273811|FG000|COMPLETED|TI-005 Protocol||0||
60149006|NCT00963040|76273812|FG001|COMPLETED|TI-005 Protocol||0||
60149007|NCT00963040|76273813|FG002|COMPLETED|TI-005 Protocol||12||
60149008|NCT00963040|76273814|FG003|COMPLETED|TI-005 Protocol||8||
60149009|NCT00963040|76273811|FG000|NOT COMPLETED|TI-005 Protocol||0||
60149010|NCT00963040|76273812|FG001|NOT COMPLETED|TI-005 Protocol||0||
60149011|NCT00963040|76273813|FG002|NOT COMPLETED|TI-005 Protocol||0||
60149012|NCT00963040|76273814|FG003|NOT COMPLETED|TI-005 Protocol||0||
60149013|NCT00908050|76273826|FG000|STARTED|Overall Study||10||
60149014|NCT00908050|76273827|FG001|STARTED|Overall Study||13||
60149015|NCT00908050|76273826|FG000|COMPLETED|Overall Study||10||
60149016|NCT00908050|76273827|FG001|COMPLETED|Overall Study||13||
60149017|NCT00908050|76273826|FG000|NOT COMPLETED|Overall Study||0||
60149018|NCT00908050|76273827|FG001|NOT COMPLETED|Overall Study||0||
60149019|NCT00812214|76273853|FG000|STARTED|Overall Study||38||
60149020|NCT00812214|76273854|FG001|STARTED|Overall Study||41||
60149021|NCT00812214|76273853|FG000|COMPLETED|Overall Study||35||
60149022|NCT00812214|76273854|FG001|COMPLETED|Overall Study||40||
60149023|NCT00812214|76273853|FG000|NOT COMPLETED|Overall Study||3||
60149024|NCT00812214|76273854|FG001|NOT COMPLETED|Overall Study||1||
60149025|NCT00217425|76273861|FG000|STARTED|Overall Study||46||
60149026|NCT00217425|76273861|FG000|Treated|Overall Study||44||
60149027|NCT00217425|76273861|FG000|Eligible and Treated|Overall Study||39||
60149028|NCT00217425|76273861|FG000|COMPLETED|Overall Study||9||
60149029|NCT00217425|76273861|FG000|NOT COMPLETED|Overall Study||37||
60149030|NCT03452917|76273868|FG000|STARTED|Overall Study||499||
60149031|NCT03452917|76273869|FG001|STARTED|Overall Study||500||
60149032|NCT03452917|76273870|FG002|STARTED|Overall Study||498||
60149033|NCT03452917|76273868|FG000|COMPLETED|Overall Study||499||
60149034|NCT03452917|76273869|FG001|COMPLETED|Overall Study||500||
60149035|NCT03452917|76273870|FG002|COMPLETED|Overall Study||498||
60149036|NCT03452917|76273868|FG000|NOT COMPLETED|Overall Study||0||
60149037|NCT03452917|76273869|FG001|NOT COMPLETED|Overall Study||0||
60149038|NCT03452917|76273870|FG002|NOT COMPLETED|Overall Study||0||
60149039|NCT03208231|76273880|FG000|STARTED|Overall Study||30||
60149040|NCT03208231|76273881|FG001|STARTED|Overall Study||31||
60149041|NCT03208231|76273880|FG000|Evaluable|Overall Study||30|One infant in No-VRC01 arm did not return to the clinic after Week 0. This infant was not included in analyses of outcome measures.|
60149042|NCT03208231|76273881|FG001|Evaluable|Overall Study||30|One infant in No-VRC01 arm did not return to the clinic after Week 0. This infant was not included in analyses of outcome measures.|
60149043|NCT03208231|76273880|FG000|COMPLETED|Overall Study||28||
60149044|NCT03208231|76273881|FG001|COMPLETED|Overall Study||28||
60149045|NCT03208231|76273880|FG000|NOT COMPLETED|Overall Study||2||
60149046|NCT03208231|76273881|FG001|NOT COMPLETED|Overall Study||3||
60149047|NCT03198000|76273890|FG000|STARTED|Overall Study||41||
60149048|NCT03198000|76273891|FG001|STARTED|Overall Study||38||
60149049|NCT03198000|76273892|FG002|STARTED|Overall Study||41||
60149050|NCT03198000|76273890|FG000|COMPLETED|Overall Study||41||
60149051|NCT03198000|76273891|FG001|COMPLETED|Overall Study||38||
60149052|NCT03198000|76273892|FG002|COMPLETED|Overall Study||41||
60149053|NCT03198000|76273890|FG000|NOT COMPLETED|Overall Study||0||
60149054|NCT03198000|76273891|FG001|NOT COMPLETED|Overall Study||0||
60149055|NCT03198000|76273892|FG002|NOT COMPLETED|Overall Study||0||
60149056|NCT03102242|76273900|FG000|STARTED|Overall Study||64||
60149057|NCT03102242|76273900|FG000|COMPLETED|Overall Study||62||
60149058|NCT03102242|76273900|FG000|NOT COMPLETED|Overall Study||2||
60149059|NCT03097328|76273904|FG000|STARTED|Overall Study||39||
60149060|NCT03097328|76273904|FG000|Treated|Overall Study||38||
60149061|NCT03097328|76273904|FG000|COMPLETED|Overall Study||0||
60149062|NCT03097328|76273904|FG000|NOT COMPLETED|Overall Study||39||
60149063|NCT03033602|76273910|FG000|STARTED|Overall Study||85||
60149064|NCT03033602|76273911|FG001|STARTED|Overall Study||84||
60149065|NCT03033602|76273910|FG000|COMPLETED|Overall Study||65|completed treatment|
60149066|NCT03033602|76273911|FG001|COMPLETED|Overall Study||47|completed treatment|
60149067|NCT03033602|76273910|FG000|NOT COMPLETED|Overall Study||20||
60149068|NCT03033602|76273911|FG001|NOT COMPLETED|Overall Study||37||
60149069|NCT03030625|76273917|FG000|STARTED|Overall Study||30||
60149070|NCT03030625|76273917|FG000|COMPLETED|Overall Study||30||
60149071|NCT03030625|76273917|FG000|NOT COMPLETED|Overall Study||0||
60149072|NCT02994784|76273922|FG000|STARTED|Enrolled||27||
60149073|NCT02994784|76273922|FG000|COMPLETED|Enrolled||27||
60149074|NCT02994784|76273922|FG000|NOT COMPLETED|Enrolled||0||
60149075|NCT02994784|76273922|FG000|STARTED|6 Months Follow-up||27||
60149076|NCT02994784|76273922|FG000|COMPLETED|6 Months Follow-up||24||
60149077|NCT02994784|76273922|FG000|NOT COMPLETED|6 Months Follow-up||3||
60149078|NCT02994784|76273922|FG000|STARTED|12 Month Follow-up||24||
60149079|NCT02994784|76273922|FG000|COMPLETED|12 Month Follow-up||24||
60149080|NCT02994784|76273922|FG000|NOT COMPLETED|12 Month Follow-up||0||
60149081|NCT02948829|76273926|FG000|STARTED|Overall Study||200||
60149082|NCT02948829|76273926|FG000|COMPLETED|Overall Study||184||
60149083|NCT02948829|76273926|FG000|NOT COMPLETED|Overall Study||16||
60149084|NCT02851303|76273947|FG000|STARTED|Overall Study|Parent-Infant Dyads|15||
60149085|NCT02851303|76273948|FG001|STARTED|Overall Study|Parent-Infant Dyads|13||
60149086|NCT02851303|76273947|FG000|COMPLETED|Overall Study|Parent-Infant Dyads|15||
60149087|NCT02851303|76273948|FG001|COMPLETED|Overall Study|Parent-Infant Dyads|13||
60149088|NCT02851303|76273947|FG000|NOT COMPLETED|Overall Study||0||
60149089|NCT02851303|76273948|FG001|NOT COMPLETED|Overall Study||0||
60149090|NCT02617446|76273957|FG000|STARTED|Overall Study||39||
60149091|NCT02617446|76273958|FG001|STARTED|Overall Study||41||
60149092|NCT02617446|76273959|FG002|STARTED|Overall Study||40||
60149093|NCT02617446|76273957|FG000|COMPLETED|Overall Study||35||
60149094|NCT02617446|76273958|FG001|COMPLETED|Overall Study||39||
60149095|NCT02617446|76273959|FG002|COMPLETED|Overall Study||33||
60149096|NCT02617446|76273957|FG000|NOT COMPLETED|Overall Study||4||
60149097|NCT02617446|76273958|FG001|NOT COMPLETED|Overall Study||2||
60149098|NCT02617446|76273959|FG002|NOT COMPLETED|Overall Study||7||
60149099|NCT02549170|76273973|FG000|STARTED|Epoch 1: Day 1 to Approximately 32 Weeks||70||
60149100|NCT02549170|76273974|FG001|STARTED|Epoch 1: Day 1 to Approximately 32 Weeks||62||
60149101|NCT02549170|76273975|FG002|STARTED|Epoch 1: Day 1 to Approximately 32 Weeks||0||
60149102|NCT02549170|76273976|FG003|STARTED|Epoch 1: Day 1 to Approximately 32 Weeks||0||
60149103|NCT02549170|76273977|FG004|STARTED|Epoch 1: Day 1 to Approximately 32 Weeks||0||
60149104|NCT02549170|76273973|FG000|COMPLETED|Epoch 1: Day 1 to Approximately 32 Weeks||46||
60149105|NCT02549170|76273974|FG001|COMPLETED|Epoch 1: Day 1 to Approximately 32 Weeks||48||
60149106|NCT02549170|76273975|FG002|COMPLETED|Epoch 1: Day 1 to Approximately 32 Weeks||0||
60149107|NCT02549170|76273976|FG003|COMPLETED|Epoch 1: Day 1 to Approximately 32 Weeks||0||
60149108|NCT02549170|76273977|FG004|COMPLETED|Epoch 1: Day 1 to Approximately 32 Weeks||0||
60149109|NCT02549170|76273973|FG000|NOT COMPLETED|Epoch 1: Day 1 to Approximately 32 Weeks||24||
60149110|NCT02549170|76273974|FG001|NOT COMPLETED|Epoch 1: Day 1 to Approximately 32 Weeks||14||
60149111|NCT02549170|76273975|FG002|NOT COMPLETED|Epoch 1: Day 1 to Approximately 32 Weeks||0||
60149112|NCT02549170|76273976|FG003|NOT COMPLETED|Epoch 1: Day 1 to Approximately 32 Weeks||0||
60149113|NCT02549170|76273977|FG004|NOT COMPLETED|Epoch 1: Day 1 to Approximately 32 Weeks||0||
60149114|NCT02549170|76273973|FG000|STARTED|Epoch 2: Up to Approximately Week 61||0||
60149115|NCT02549170|76273974|FG001|STARTED|Epoch 2: Up to Approximately Week 61||0||
60149116|NCT02549170|76273975|FG002|STARTED|Epoch 2: Up to Approximately Week 61||16||
60149117|NCT02549170|76273976|FG003|STARTED|Epoch 2: Up to Approximately Week 61||4||
60149118|NCT02549170|76273977|FG004|STARTED|Epoch 2: Up to Approximately Week 61||1||
60149119|NCT02549170|76273973|FG000|COMPLETED|Epoch 2: Up to Approximately Week 61||0||
60149120|NCT02549170|76273974|FG001|COMPLETED|Epoch 2: Up to Approximately Week 61||0||
60149121|NCT02549170|76273975|FG002|COMPLETED|Epoch 2: Up to Approximately Week 61||16||
60149122|NCT02549170|76273976|FG003|COMPLETED|Epoch 2: Up to Approximately Week 61||4||
60149123|NCT02549170|76273977|FG004|COMPLETED|Epoch 2: Up to Approximately Week 61||1||
60149124|NCT02549170|76273973|FG000|NOT COMPLETED|Epoch 2: Up to Approximately Week 61||0||
60149125|NCT02549170|76273974|FG001|NOT COMPLETED|Epoch 2: Up to Approximately Week 61||0||
60149126|NCT02549170|76273975|FG002|NOT COMPLETED|Epoch 2: Up to Approximately Week 61||0||
60149127|NCT02549170|76273976|FG003|NOT COMPLETED|Epoch 2: Up to Approximately Week 61||0||
60149128|NCT02549170|76273977|FG004|NOT COMPLETED|Epoch 2: Up to Approximately Week 61||0||
60149129|NCT02410902|76273994|FG000|STARTED|Overall Study||92||
60149130|NCT02410902|76273995|FG001|STARTED|Overall Study||98||
60149131|NCT02410902|76273994|FG000|Randomized|Overall Study||92||
60149132|NCT02410902|76273995|FG001|Randomized|Overall Study||98||
60149133|NCT02410902|76273994|FG000|ITT|Overall Study||92||
60149134|NCT02410902|76273995|FG001|ITT|Overall Study||98||
60149135|NCT02410902|76273994|FG000|COMPLETED|Overall Study||71||
60149136|NCT02410902|76273995|FG001|COMPLETED|Overall Study||80||
60149137|NCT02410902|76273994|FG000|NOT COMPLETED|Overall Study||21||
60149138|NCT02410902|76273995|FG001|NOT COMPLETED|Overall Study||18||
60149139|NCT02101736|76274005|FG000|STARTED|Overall Study||23||
60149140|NCT02101736|76274006|FG001|STARTED|Overall Study||22||
60149141|NCT02101736|76274005|FG000|COMPLETED|Overall Study||19||
60149142|NCT02101736|76274006|FG001|COMPLETED|Overall Study||21||
60149143|NCT02101736|76274005|FG000|NOT COMPLETED|Overall Study||4||
60149144|NCT02101736|76274006|FG001|NOT COMPLETED|Overall Study||1||
60149145|NCT01918397|76274018|FG000|STARTED|Overall Study||27||
60149146|NCT01918397|76274019|FG001|STARTED|Overall Study||29||
60149147|NCT01918397|76274020|FG002|STARTED|Overall Study||28||
60149148|NCT01918397|76274021|FG003|STARTED|Overall Study||27||
60149149|NCT01918397|76274018|FG000|COMPLETED|Overall Study||16||
60149150|NCT01918397|76274019|FG001|COMPLETED|Overall Study||21||
60149151|NCT01918397|76274020|FG002|COMPLETED|Overall Study||20||
60149152|NCT01918397|76274021|FG003|COMPLETED|Overall Study||20||
60149153|NCT01918397|76274018|FG000|NOT COMPLETED|Overall Study||11||
60149154|NCT01918397|76274019|FG001|NOT COMPLETED|Overall Study||8||
60149155|NCT01918397|76274020|FG002|NOT COMPLETED|Overall Study||8||
60149156|NCT01918397|76274021|FG003|NOT COMPLETED|Overall Study||7||
60149157|NCT00819637|76274034|FG000|STARTED|Overall Study||2||
60149158|NCT00819637|76274035|FG001|STARTED|Overall Study||0||
60149159|NCT00819637|76274036|FG002|STARTED|Overall Study||0||
60149160|NCT00819637|76274034|FG000|COMPLETED|Overall Study||2||
60149161|NCT00819637|76274035|FG001|COMPLETED|Overall Study||0||
60149162|NCT00819637|76274036|FG002|COMPLETED|Overall Study||0||
60149163|NCT00819637|76274034|FG000|NOT COMPLETED|Overall Study||0||
60149164|NCT00819637|76274035|FG001|NOT COMPLETED|Overall Study||0||
60149165|NCT00819637|76274036|FG002|NOT COMPLETED|Overall Study||0||
60149166|NCT01332357|76274049|FG000|STARTED|Overall Study||6139||
60149167|NCT01332357|76274049|FG000|COMPLETED|Overall Study||6139||
60149168|NCT01332357|76274049|FG000|NOT COMPLETED|Overall Study||0||
60149169|NCT00986921|76274055|FG000|STARTED|Overall Study||25||
60149170|NCT00986921|76274056|FG001|STARTED|Overall Study||25||
60149171|NCT00986921|76274055|FG000|COMPLETED|Overall Study||24||
60149172|NCT00986921|76274056|FG001|COMPLETED|Overall Study||25||
60149173|NCT00986921|76274055|FG000|NOT COMPLETED|Overall Study||1||
60149174|NCT00986921|76274056|FG001|NOT COMPLETED|Overall Study||0||
60149175|NCT01596972|76274067|FG000|STARTED|Overall Study||25||
60149176|NCT01596972|76274068|FG001|STARTED|Overall Study||26||
60149177|NCT01596972|76274067|FG000|COMPLETED|Overall Study||24||
60149178|NCT01596972|76274068|FG001|COMPLETED|Overall Study||12||
60149179|NCT01596972|76274067|FG000|NOT COMPLETED|Overall Study||1||
60149180|NCT01596972|76274068|FG001|NOT COMPLETED|Overall Study||14||
60149181|NCT01383759|76274076|FG000|STARTED|Overall Study||19||
60149182|NCT01383759|76274077|FG001|STARTED|Overall Study||1||
60149183|NCT01383759|76274076|FG000|COMPLETED|Overall Study||19||
60149184|NCT01383759|76274077|FG001|COMPLETED|Overall Study||1||
60149185|NCT01383759|76274076|FG000|NOT COMPLETED|Overall Study||0||
60149186|NCT01383759|76274077|FG001|NOT COMPLETED|Overall Study||0||
60149187|NCT01332435|76274087|FG000|STARTED|Overall Study||1572||
60149188|NCT01332435|76274088|FG001|STARTED|Overall Study||1064||
60149189|NCT01332435|76274089|FG002|STARTED|Overall Study||2604||
60149190|NCT01332435|76274090|FG003|STARTED|Overall Study||1656||
60149191|NCT01332435|76274087|FG000|COMPLETED|Overall Study||1572||
60149192|NCT01332435|76274088|FG001|COMPLETED|Overall Study||1064||
60149193|NCT01332435|76274089|FG002|COMPLETED|Overall Study||2604||
60149194|NCT01332435|76274090|FG003|COMPLETED|Overall Study||1656||
60149195|NCT01332435|76274087|FG000|NOT COMPLETED|Overall Study||0||
60149196|NCT01332435|76274088|FG001|NOT COMPLETED|Overall Study||0||
60149197|NCT01332435|76274089|FG002|NOT COMPLETED|Overall Study||0||
60149198|NCT01332435|76274090|FG003|NOT COMPLETED|Overall Study||0||
60149199|NCT01384539|76274103|FG000|STARTED|Overall Study||64||
60149200|NCT01384539|76274104|FG001|STARTED|Overall Study||64||
60149201|NCT01384539|76274103|FG000|COMPLETED|Overall Study||58||
60149202|NCT01384539|76274104|FG001|COMPLETED|Overall Study||57||
60149203|NCT01384539|76274103|FG000|NOT COMPLETED|Overall Study||6||
60149204|NCT01384539|76274104|FG001|NOT COMPLETED|Overall Study||7||
60149205|NCT01387581|76274113|FG000|STARTED|Overall Study||108||
60149206|NCT01387581|76274114|FG001|STARTED|Overall Study||107||
60149207|NCT01387581|76274115|FG002|STARTED|Overall Study||12||
60149208|NCT01387581|76274113|FG000|COMPLETED|Overall Study||101||
60149209|NCT01387581|76274114|FG001|COMPLETED|Overall Study||101||
60149210|NCT01387581|76274115|FG002|COMPLETED|Overall Study||9||
60149211|NCT01387581|76274113|FG000|NOT COMPLETED|Overall Study||7||
60149212|NCT01387581|76274114|FG001|NOT COMPLETED|Overall Study||6||
60149213|NCT01387581|76274115|FG002|NOT COMPLETED|Overall Study||3||
60149214|NCT03421197|76274127|FG000|STARTED|Overall Study||105||
60149215|NCT03421197|76274128|FG001|STARTED|Overall Study||107||
60149216|NCT03421197|76274129|FG002|STARTED|Overall Study||107||
60149217|NCT03421197|76274130|FG003|STARTED|Overall Study||107||
60149218|NCT03421197|76274127|FG000|COMPLETED|Overall Study||67||
60149219|NCT03421197|76274128|FG001|COMPLETED|Overall Study||68||
60149220|NCT03421197|76274129|FG002|COMPLETED|Overall Study||56||
60149221|NCT03421197|76274130|FG003|COMPLETED|Overall Study||62||
60149222|NCT03421197|76274127|FG000|NOT COMPLETED|Overall Study||38||
60149223|NCT03421197|76274128|FG001|NOT COMPLETED|Overall Study||39||
60149224|NCT03421197|76274129|FG002|NOT COMPLETED|Overall Study||51||
60149225|NCT03421197|76274130|FG003|NOT COMPLETED|Overall Study||45||
60149226|NCT01332981|76274140|FG000|STARTED|Overall Study||220||
60149227|NCT01332981|76274140|FG000|COMPLETED|Overall Study||220||
60149228|NCT01332981|76274140|FG000|NOT COMPLETED|Overall Study||0||
60149229|NCT01333527|76274149|FG000|STARTED|Overall Study||105||
60149230|NCT01333527|76274150|FG001|STARTED|Overall Study||106||
60149231|NCT01333527|76274149|FG000|COMPLETED|Overall Study||87||
60149232|NCT01333527|76274150|FG001|COMPLETED|Overall Study||89||
60149233|NCT01333527|76274149|FG000|NOT COMPLETED|Overall Study||18||
60149234|NCT01333527|76274150|FG001|NOT COMPLETED|Overall Study||17||
60149235|NCT04904640|76274156|FG000|STARTED|Overall Study||150||200
60149236|NCT04904640|76274156|FG000|COMPLETED|Overall Study||150||200
60149237|NCT04904640|76274156|FG000|NOT COMPLETED|Overall Study||0||0
60149238|NCT00985751|76274169|FG000|STARTED|Overall Study||51||
60149239|NCT00985751|76274170|FG001|STARTED|Overall Study||52||
60149240|NCT00985751|76274171|FG002|STARTED|Overall Study||52||
60149241|NCT00985751|76274172|FG003|STARTED|Overall Study||51||
60149242|NCT00985751|76274173|FG004|STARTED|Overall Study||51||
60149243|NCT00985751|76274169|FG000|COMPLETED|Overall Study||51||
60149244|NCT00985751|76274170|FG001|COMPLETED|Overall Study||52||
60149245|NCT00985751|76274171|FG002|COMPLETED|Overall Study||52||
60149246|NCT00985751|76274172|FG003|COMPLETED|Overall Study||51||
60149247|NCT00985751|76274173|FG004|COMPLETED|Overall Study||50||
60149248|NCT00985751|76274169|FG000|NOT COMPLETED|Overall Study||0||
60149249|NCT00985751|76274170|FG001|NOT COMPLETED|Overall Study||0||
60149250|NCT00985751|76274171|FG002|NOT COMPLETED|Overall Study||0||
60149251|NCT00985751|76274172|FG003|NOT COMPLETED|Overall Study||0||
60149252|NCT00985751|76274173|FG004|NOT COMPLETED|Overall Study||1||
60149253|NCT02435173|76274191|FG000|STARTED|Overall Study||6|All participants who were enrolled in Part I or randomized in Part II.|
60149254|NCT02435173|76274192|FG001|STARTED|Overall Study||21|All participants who were enrolled in Part I or randomized in Part II.|
60149255|NCT02435173|76274193|FG002|STARTED|Overall Study||10|All participants who were enrolled in Part I or randomized in Part II.|
60149256|NCT02435173|76274191|FG000|Pharmacokinetics (PK) Analysis Set|Overall Study||6|All enrolled participants with at least one available valid PK concentration measurement, who received CDZ173 study drug and experienced no protocol deviations with relevant impact on PK data.|
60149257|NCT02435173|76274192|FG001|Pharmacokinetics (PK) Analysis Set|Overall Study||19|All enrolled participants with at least one available valid PK concentration measurement, who received CDZ173 study drug and experienced no protocol deviations with relevant impact on PK data.|
60149258|NCT02435173|76274193|FG002|Pharmacokinetics (PK) Analysis Set|Overall Study||0|All enrolled participants with at least one available valid PK concentration measurement, who received CDZ173 study drug and experienced no protocol deviations with relevant impact on PK data.|
60149259|NCT02435173|76274191|FG000|Pharmacodynamic (PD) Analysis Set|Overall Study||6|All enrolled participants who received any study drug and with no protocol deviations with relevant impact on PD data.|
60149260|NCT02435173|76274192|FG001|Pharmacodynamic (PD) Analysis Set|Overall Study||19|All enrolled participants who received any study drug and with no protocol deviations with relevant impact on PD data.|
60149261|NCT02435173|76274193|FG002|Pharmacodynamic (PD) Analysis Set|Overall Study||8|All enrolled participants who received any study drug and with no protocol deviations with relevant impact on PD data.|
60149262|NCT02435173|76274191|FG000|COMPLETED|Overall Study||6||
60149263|NCT02435173|76274192|FG001|COMPLETED|Overall Study||21||
60149264|NCT02435173|76274193|FG002|COMPLETED|Overall Study||10||
60149265|NCT02435173|76274191|FG000|NOT COMPLETED|Overall Study||0||
60149266|NCT02435173|76274192|FG001|NOT COMPLETED|Overall Study||0||
60149267|NCT02435173|76274193|FG002|NOT COMPLETED|Overall Study||0||
60149268|NCT01387815|76274209|FG000|STARTED|Overall Study||302|Participant flow shows intent to treat (ITT) population (595) vs. enrolled (662).|
60149269|NCT01387815|76274210|FG001|STARTED|Overall Study||293|Participant flow shows intent to treat (ITT) population (595) vs. enrolled (662).|
60149270|NCT01387815|76274209|FG000|COMPLETED|Overall Study||162||
60149271|NCT01387815|76274210|FG001|COMPLETED|Overall Study||189||
60149272|NCT01387815|76274209|FG000|NOT COMPLETED|Overall Study||140||
60149273|NCT01387815|76274210|FG001|NOT COMPLETED|Overall Study||104||
60149274|NCT01596582|76274218|FG000|STARTED|Overall Study||172||
60149275|NCT01596582|76274219|FG001|STARTED|Overall Study||180||
60149276|NCT01596582|76274218|FG000|COMPLETED|Overall Study||168||
60149277|NCT01596582|76274219|FG001|COMPLETED|Overall Study||173||
60149278|NCT01596582|76274218|FG000|NOT COMPLETED|Overall Study||4||
60149279|NCT01596582|76274219|FG001|NOT COMPLETED|Overall Study||7||
60149280|NCT01596504|76274235|FG000|STARTED|Overall Study||48||
60149281|NCT01596504|76274236|FG001|STARTED|Overall Study||47||
60149282|NCT01596504|76274237|FG002|STARTED|Overall Study||47||
60149283|NCT01596504|76274235|FG000|COMPLETED|Overall Study||46||
60149284|NCT01596504|76274236|FG001|COMPLETED|Overall Study||44||
60149285|NCT01596504|76274237|FG002|COMPLETED|Overall Study||46||
60149286|NCT01596504|76274235|FG000|NOT COMPLETED|Overall Study||2||
60149287|NCT01596504|76274236|FG001|NOT COMPLETED|Overall Study||3||
60149288|NCT01596504|76274237|FG002|NOT COMPLETED|Overall Study||1||
60149289|NCT02396251|76274248|FG000|STARTED|Overall Study||36||
60149290|NCT02396251|76274249|FG001|STARTED|Overall Study||12||
60149291|NCT02396251|76274248|FG000|COMPLETED|Overall Study||23||
60149292|NCT02396251|76274249|FG001|COMPLETED|Overall Study||7||
60149293|NCT02396251|76274248|FG000|NOT COMPLETED|Overall Study||13||
60149294|NCT02396251|76274249|FG001|NOT COMPLETED|Overall Study||5||
60149295|NCT01389765|76274254|FG000|STARTED|First Intervention (Day 1)||12||
60149296|NCT01389765|76274255|FG001|STARTED|First Intervention (Day 1)||12||
60149297|NCT01389765|76274254|FG000|COMPLETED|First Intervention (Day 1)||12||
60149298|NCT01389765|76274255|FG001|COMPLETED|First Intervention (Day 1)||12||
60149299|NCT01389765|76274254|FG000|NOT COMPLETED|First Intervention (Day 1)||0||
60149300|NCT01389765|76274255|FG001|NOT COMPLETED|First Intervention (Day 1)||0||
60149301|NCT01389765|76274254|FG000|STARTED|Washout Period (7 Days)||12||
60149302|NCT01389765|76274255|FG001|STARTED|Washout Period (7 Days)||12||
60149303|NCT01389765|76274254|FG000|COMPLETED|Washout Period (7 Days)||12||
60149304|NCT01389765|76274255|FG001|COMPLETED|Washout Period (7 Days)||12||
60149305|NCT01389765|76274254|FG000|NOT COMPLETED|Washout Period (7 Days)||0||
60149306|NCT01389765|76274255|FG001|NOT COMPLETED|Washout Period (7 Days)||0||
60149307|NCT01389765|76274254|FG000|STARTED|Second Intervention (Day 1)||12||
60149308|NCT01389765|76274255|FG001|STARTED|Second Intervention (Day 1)||12||
60149309|NCT01389765|76274254|FG000|COMPLETED|Second Intervention (Day 1)||12||
60149310|NCT01389765|76274255|FG001|COMPLETED|Second Intervention (Day 1)||12||
60149311|NCT01389765|76274254|FG000|NOT COMPLETED|Second Intervention (Day 1)||0||
60149312|NCT01389765|76274255|FG001|NOT COMPLETED|Second Intervention (Day 1)||0||
60149313|NCT02394769|76274264|FG000|STARTED|Overall Study||60||
60149314|NCT02394769|76274265|FG001|STARTED|Overall Study||60||
60149315|NCT02394769|76274266|FG002|STARTED|Overall Study||60||
60149316|NCT02394769|76274264|FG000|COMPLETED|Overall Study||58||
60149317|NCT02394769|76274265|FG001|COMPLETED|Overall Study||57||
60149318|NCT02394769|76274266|FG002|COMPLETED|Overall Study||54||
60149319|NCT02394769|76274264|FG000|NOT COMPLETED|Overall Study||2||
60149320|NCT02394769|76274265|FG001|NOT COMPLETED|Overall Study||3||
60149321|NCT02394769|76274266|FG002|NOT COMPLETED|Overall Study||6||
60149322|NCT01334229|76274276|FG000|STARTED|Overall Study||11||
60149323|NCT01334229|76274277|FG001|STARTED|Overall Study||11||
60149324|NCT01334229|76274276|FG000|COMPLETED|Overall Study||11||
60149325|NCT01334229|76274277|FG001|COMPLETED|Overall Study||11||
60149326|NCT01334229|76274276|FG000|NOT COMPLETED|Overall Study||0||
60149327|NCT01334229|76274277|FG001|NOT COMPLETED|Overall Study||0||
60149328|NCT01390077|76274283|FG000|STARTED|Overall Study||8||
60149329|NCT01390077|76274283|FG000|Treatment|Overall Study||7||
60149330|NCT01390077|76274283|FG000|COMPLETED|Overall Study||7||
60149331|NCT01390077|76274283|FG000|NOT COMPLETED|Overall Study||1||
60149332|NCT02616900|76274292|FG000|STARTED|Overall Study||74||
60149333|NCT02616900|76274292|FG000|Completed 3mo Trial|Overall Study||57||
60149334|NCT02616900|76274292|FG000|COMPLETED|Overall Study|Six participants not included in study results because of incomplete data.|51||
60149335|NCT02616900|76274292|FG000|NOT COMPLETED|Overall Study||23||
60149336|NCT01404039|76274305|FG000|STARTED|Overall Study||5||
60149337|NCT01404039|76274306|FG001|STARTED|Overall Study||5||
60149338|NCT01404039|76274307|FG002|STARTED|Overall Study||5||
60149339|NCT01404039|76274308|FG003|STARTED|Overall Study||10||
60149340|NCT01404039|76274309|FG004|STARTED|Overall Study||10||
60149341|NCT01404039|76274310|FG005|STARTED|Overall Study||10||
60149342|NCT01404039|76274311|FG006|STARTED|Overall Study||10||
60149343|NCT01404039|76274312|FG007|STARTED|Overall Study||15||
60149344|NCT01404039|76274313|FG008|STARTED|Overall Study||15||
60149345|NCT01404039|76274314|FG009|STARTED|Overall Study||15||
60149346|NCT01404039|76274315|FG010|STARTED|Overall Study||15||
60149347|NCT01404039|76274316|FG011|STARTED|Overall Study||0||
60149348|NCT01404039|76274317|FG012|STARTED|Overall Study||0||
60149349|NCT01404039|76274305|FG000|COMPLETED|Overall Study||4||
60149350|NCT01404039|76274306|FG001|COMPLETED|Overall Study||5||
60149351|NCT01404039|76274307|FG002|COMPLETED|Overall Study||5||
60149352|NCT01404039|76274308|FG003|COMPLETED|Overall Study||10||
60149353|NCT01404039|76274309|FG004|COMPLETED|Overall Study||10||
60149354|NCT01404039|76274310|FG005|COMPLETED|Overall Study||10||
60149355|NCT01404039|76274311|FG006|COMPLETED|Overall Study||10||
60149356|NCT01404039|76274312|FG007|COMPLETED|Overall Study||15||
60149357|NCT01404039|76274313|FG008|COMPLETED|Overall Study||15||
60149358|NCT01404039|76274314|FG009|COMPLETED|Overall Study||14||
60149359|NCT01404039|76274315|FG010|COMPLETED|Overall Study||14||
60149360|NCT01404039|76274316|FG011|COMPLETED|Overall Study||0||
60149361|NCT01404039|76274317|FG012|COMPLETED|Overall Study||0||
60149362|NCT01404039|76274305|FG000|NOT COMPLETED|Overall Study||1||
60149363|NCT01404039|76274306|FG001|NOT COMPLETED|Overall Study||0||
60149364|NCT01404039|76274307|FG002|NOT COMPLETED|Overall Study||0||
60149365|NCT01404039|76274308|FG003|NOT COMPLETED|Overall Study||0||
60149366|NCT01404039|76274309|FG004|NOT COMPLETED|Overall Study||0||
60149367|NCT01404039|76274310|FG005|NOT COMPLETED|Overall Study||0||
60149368|NCT01404039|76274311|FG006|NOT COMPLETED|Overall Study||0||
60149369|NCT01404039|76274312|FG007|NOT COMPLETED|Overall Study||0||
60149370|NCT01404039|76274313|FG008|NOT COMPLETED|Overall Study||0||
60149371|NCT01404039|76274314|FG009|NOT COMPLETED|Overall Study||1||
60149372|NCT01404039|76274315|FG010|NOT COMPLETED|Overall Study||1||
60149373|NCT01404039|76274316|FG011|NOT COMPLETED|Overall Study||0||
60149374|NCT01404039|76274317|FG012|NOT COMPLETED|Overall Study||0||
60149375|NCT01404429|76274343|FG000|STARTED|Overall Study||47||
60149376|NCT01404429|76274344|FG001|STARTED|Overall Study||53||
60149377|NCT01404429|76274343|FG000|COMPLETED|Overall Study||38||
60149378|NCT01404429|76274344|FG001|COMPLETED|Overall Study||46||
60149379|NCT01404429|76274343|FG000|NOT COMPLETED|Overall Study||9||
60149380|NCT01404429|76274344|FG001|NOT COMPLETED|Overall Study||7||
60149381|NCT01390233|76274355|FG000|STARTED|Overall Study||35||
60149382|NCT01390233|76274356|FG001|STARTED|Overall Study||31||
60149383|NCT01390233|76274357|FG002|STARTED|Overall Study||36||
60149384|NCT01390233|76274355|FG000|COMPLETED|Overall Study||30||
60149385|NCT01390233|76274356|FG001|COMPLETED|Overall Study||29||
60149386|NCT01390233|76274357|FG002|COMPLETED|Overall Study||30||
60149387|NCT01390233|76274355|FG000|NOT COMPLETED|Overall Study||5||
60149388|NCT01390233|76274356|FG001|NOT COMPLETED|Overall Study||2||
60149389|NCT01390233|76274357|FG002|NOT COMPLETED|Overall Study||6||
60149390|NCT01391013|76274367|FG000|STARTED|Overall Study||15||
60149391|NCT01391013|76274368|FG001|STARTED|Overall Study||15||
60149392|NCT01391013|76274367|FG000|COMPLETED|Overall Study||15||
60149393|NCT01391013|76274368|FG001|COMPLETED|Overall Study||15||
60149394|NCT01391013|76274367|FG000|NOT COMPLETED|Overall Study||0||
60149395|NCT01391013|76274368|FG001|NOT COMPLETED|Overall Study||0||
60149396|NCT01391325|76274374|FG000|STARTED|Overall Study||1732||
60149397|NCT01391325|76274374|FG000|COMPLETED|Overall Study||1238||
60149398|NCT01391325|76274374|FG000|NOT COMPLETED|Overall Study||494||
60149399|NCT01391559|76274378|FG000|STARTED|First Intervention||10||
60149400|NCT01391559|76274379|FG001|STARTED|First Intervention||10||
60149401|NCT01391559|76274378|FG000|COMPLETED|First Intervention||10||
60149402|NCT01391559|76274379|FG001|COMPLETED|First Intervention||10||
60149403|NCT01391559|76274378|FG000|NOT COMPLETED|First Intervention||0||
60149404|NCT01391559|76274379|FG001|NOT COMPLETED|First Intervention||0||
60149405|NCT01391559|76274378|FG000|STARTED|Second Intervention||10||
60149406|NCT01391559|76274379|FG001|STARTED|Second Intervention||10||
60149407|NCT01391559|76274378|FG000|COMPLETED|Second Intervention||10||
60149408|NCT01391559|76274379|FG001|COMPLETED|Second Intervention||10||
60149409|NCT01391559|76274378|FG000|NOT COMPLETED|Second Intervention||0||
60149410|NCT01391559|76274379|FG001|NOT COMPLETED|Second Intervention||0||
60149411|NCT01335789|76274387|FG000|STARTED|Overall Study||8||
60149412|NCT01335789|76274388|FG001|STARTED|Overall Study||8||
60149413|NCT01335789|76274387|FG000|COMPLETED|Overall Study||8||
60149414|NCT01335789|76274388|FG001|COMPLETED|Overall Study||8||
60149415|NCT01335789|76274387|FG000|NOT COMPLETED|Overall Study||0||
60149416|NCT01335789|76274388|FG001|NOT COMPLETED|Overall Study||0||
60149417|NCT02202135|76274394|FG000|STARTED|Overall Study||4||
60149418|NCT02202135|76274394|FG000|COMPLETED|Overall Study||4||
60149419|NCT02202135|76274394|FG000|NOT COMPLETED|Overall Study||0||
60149420|NCT00985673|76274404|FG000|STARTED|Overall Study||102||
60149421|NCT00985673|76274405|FG001|STARTED|Overall Study||104||
60149422|NCT00985673|76274406|FG002|STARTED|Overall Study||102||
60149423|NCT00985673|76274407|FG003|STARTED|Overall Study||100||
60149424|NCT00985673|76274408|FG004|STARTED|Overall Study||101||
60149425|NCT00985673|76274409|FG005|STARTED|Overall Study||102||
60149426|NCT00985673|76274404|FG000|COMPLETED|Overall Study||95||
60149427|NCT00985673|76274405|FG001|COMPLETED|Overall Study||93||
60149428|NCT00985673|76274406|FG002|COMPLETED|Overall Study||90||
60149429|NCT00985673|76274407|FG003|COMPLETED|Overall Study||88||
60149430|NCT00985673|76274408|FG004|COMPLETED|Overall Study||93||
60149431|NCT00985673|76274409|FG005|COMPLETED|Overall Study||96||
60149432|NCT00985673|76274404|FG000|NOT COMPLETED|Overall Study||7||
60149433|NCT00985673|76274405|FG001|NOT COMPLETED|Overall Study||11||
60149434|NCT00985673|76274406|FG002|NOT COMPLETED|Overall Study||12||
60149435|NCT00985673|76274407|FG003|NOT COMPLETED|Overall Study||12||
60149436|NCT00985673|76274408|FG004|NOT COMPLETED|Overall Study||8||
60149437|NCT00985673|76274409|FG005|NOT COMPLETED|Overall Study||6||
60149438|NCT01335867|76274426|FG000|STARTED|Overall Study||16||
60149439|NCT01335867|76274427|FG001|STARTED|Overall Study||16||
60149440|NCT01335867|76274426|FG000|COMPLETED|Overall Study||9||
60149441|NCT01335867|76274427|FG001|COMPLETED|Overall Study||12||
60149442|NCT01335867|76274426|FG000|NOT COMPLETED|Overall Study||7||
60149443|NCT01335867|76274427|FG001|NOT COMPLETED|Overall Study||4||
60149444|NCT01336413|76274442|FG000|STARTED|Overall Study||27||
60149445|NCT01336413|76274443|FG001|STARTED|Overall Study||26||
60149446|NCT01336413|76274442|FG000|COMPLETED|Overall Study||26||
60149447|NCT01336413|76274443|FG001|COMPLETED|Overall Study||18||
60149448|NCT01336413|76274442|FG000|NOT COMPLETED|Overall Study||1||
60149449|NCT01336413|76274443|FG001|NOT COMPLETED|Overall Study||8||
60149450|NCT00985439|76274455|FG000|STARTED|Overall Study||49||
60149451|NCT00985439|76274456|FG001|STARTED|Overall Study||51||
60149452|NCT00985439|76274457|FG002|STARTED|Overall Study||51||
60149453|NCT00985439|76274458|FG003|STARTED|Overall Study||51||
60149454|NCT00985439|76274455|FG000|COMPLETED|Overall Study||49||
60149455|NCT00985439|76274456|FG001|COMPLETED|Overall Study||51||
60149456|NCT00985439|76274457|FG002|COMPLETED|Overall Study||50||
60149457|NCT00985439|76274458|FG003|COMPLETED|Overall Study||51||
60149458|NCT00985439|76274455|FG000|NOT COMPLETED|Overall Study||0||
60149459|NCT00985439|76274456|FG001|NOT COMPLETED|Overall Study||0||
60149460|NCT00985439|76274457|FG002|NOT COMPLETED|Overall Study||1||
60149461|NCT00985439|76274458|FG003|NOT COMPLETED|Overall Study||0||
59605751|NCT01987986|75715886|FG002|STARTED|Overall Study||40||
59605752|NCT01987986|75715887|FG003|STARTED|Overall Study||24||
59605753|NCT01987986|75715884|FG000|COMPLETED|Overall Study||41||
59605754|NCT01987986|75715885|FG001|COMPLETED|Overall Study||43||
59882125|NCT03848403|76005050|FG002|Received Intervention|Period 1 (Day 1)||22||
59882126|NCT03848403|76005048|FG000|COMPLETED|Period 1 (Day 1)||24||
59605755|NCT01987986|75715886|FG002|COMPLETED|Overall Study||38||
60149462|NCT02618928|76274468|FG000|STARTED|Overall Study||735||
60149463|NCT02618928|76274468|FG000|Received Treatment|Overall Study||728||
60149464|NCT02618928|76274468|FG000|COMPLETED|Overall Study||677|HCV ribonucleic acid (RNA) treatment assessment performed at least 10 weeks post-treatment|
60149465|NCT02618928|76274468|FG000|NOT COMPLETED|Overall Study||58||
60149466|NCT02249065|76274475|FG000|STARTED|Overall Study||205||
60149467|NCT02249065|76274475|FG000|Treated|Overall Study||181||
60149468|NCT02249065|76274475|FG000|COMPLETED|Overall Study||176||
60149469|NCT02249065|76274475|FG000|NOT COMPLETED|Overall Study||29||
60149470|NCT00983957|76274479|FG000|STARTED|Overall Study||20||
60149471|NCT00983957|76274479|FG000|Treatment A|Overall Study||20||
60149472|NCT00983957|76274479|FG000|Treatment B|Overall Study||20||
60149473|NCT00983957|76274479|FG000|Treatment C|Overall Study||18||
60149474|NCT00983957|76274479|FG000|COMPLETED|Overall Study||18||
60149475|NCT00983957|76274479|FG000|NOT COMPLETED|Overall Study||2||
60149476|NCT01336959|76274492|FG000|STARTED|Overall Study||8||
60149477|NCT01336959|76274493|FG001|STARTED|Overall Study||42||
60149478|NCT01336959|76274494|FG002|STARTED|Overall Study||41||
60149479|NCT01336959|76274492|FG000|COMPLETED|Overall Study||8||
60149480|NCT01336959|76274493|FG001|COMPLETED|Overall Study||37||
60149481|NCT01336959|76274494|FG002|COMPLETED|Overall Study||40||
60149482|NCT01336959|76274492|FG000|NOT COMPLETED|Overall Study||0||
60149483|NCT01336959|76274493|FG001|NOT COMPLETED|Overall Study||5||
60149484|NCT01336959|76274494|FG002|NOT COMPLETED|Overall Study||1||
60149485|NCT01406223|76274509|FG000|STARTED|Overall Study||18||
60149486|NCT01406223|76274510|FG001|STARTED|Overall Study||19||
60149487|NCT01406223|76274511|FG002|STARTED|Overall Study||20||
60149488|NCT01406223|76274512|FG003|STARTED|Overall Study||19||
60149489|NCT01406223|76274509|FG000|COMPLETED|Overall Study||6||
60149490|NCT01406223|76274510|FG001|COMPLETED|Overall Study||7||
60149491|NCT01406223|76274511|FG002|COMPLETED|Overall Study||2||
60149492|NCT01406223|76274512|FG003|COMPLETED|Overall Study||3||
60149493|NCT01406223|76274509|FG000|NOT COMPLETED|Overall Study||12||
60010778|NCT01126736|76126466|FG002|Safety Population|Overall Study||5||
60010779|NCT01126736|76126467|FG003|Safety Population|Overall Study||41||
60010780|NCT01126736|76126468|FG004|Safety Population|Overall Study||39||
60010781|NCT01126736|76126464|FG000|Modified Intent-to-treat (MITT)|Overall Study||4||
60010782|NCT01126736|76126465|FG001|Modified Intent-to-treat (MITT)|Overall Study||6||
60010783|NCT01126736|76126466|FG002|Modified Intent-to-treat (MITT)|Overall Study||5||
60010784|NCT01126736|76126467|FG003|Modified Intent-to-treat (MITT)|Overall Study||39||
60010785|NCT01126736|76126468|FG004|Modified Intent-to-treat (MITT)|Overall Study||39||
60010786|NCT01126736|76126464|FG000|COMPLETED|Overall Study||0||
60010787|NCT01126736|76126465|FG001|COMPLETED|Overall Study||0||
60010788|NCT01126736|76126466|FG002|COMPLETED|Overall Study||0||
60010789|NCT01126736|76126467|FG003|COMPLETED|Overall Study||0||
60010790|NCT01126736|76126468|FG004|COMPLETED|Overall Study||0||
60010791|NCT01126736|76126464|FG000|NOT COMPLETED|Overall Study||4||
60010792|NCT01126736|76126465|FG001|NOT COMPLETED|Overall Study||6||
60010793|NCT01126736|76126466|FG002|NOT COMPLETED|Overall Study||5||
60010794|NCT01126736|76126467|FG003|NOT COMPLETED|Overall Study||42||
60010795|NCT01126736|76126468|FG004|NOT COMPLETED|Overall Study||41||
60010796|NCT01111461|76126480|FG000|STARTED|Overall Study||133||
60149494|NCT01406223|76274510|FG001|NOT COMPLETED|Overall Study||12||
60149495|NCT01406223|76274511|FG002|NOT COMPLETED|Overall Study||18||
60149496|NCT01406223|76274512|FG003|NOT COMPLETED|Overall Study||16||
60149497|NCT01408329|76274524|FG000|STARTED|Overall Study||13||
60149498|NCT01408329|76274525|FG001|STARTED|Overall Study||15||
60149499|NCT01408329|76274524|FG000|COMPLETED|Overall Study||10||
60149500|NCT01408329|76274525|FG001|COMPLETED|Overall Study||11||
60149501|NCT01408329|76274524|FG000|NOT COMPLETED|Overall Study||3||
60149502|NCT01408329|76274525|FG001|NOT COMPLETED|Overall Study||4||
60149503|NCT00981149|76274533|FG000|STARTED|Overall Study||12||
60149504|NCT00981149|76274534|FG001|STARTED|Overall Study||12||
60149505|NCT00981149|76274533|FG000|COMPLETED|Overall Study||10||
60149506|NCT00981149|76274534|FG001|COMPLETED|Overall Study||9||
60149507|NCT00981149|76274533|FG000|NOT COMPLETED|Overall Study||2||
60149508|NCT00981149|76274534|FG001|NOT COMPLETED|Overall Study||3||
60149509|NCT01408719|76274560|FG000|STARTED|First Intervention (35 Days)||2||
60149510|NCT01408719|76274561|FG001|STARTED|First Intervention (35 Days)||3||
60149511|NCT01408719|76274562|FG002|STARTED|First Intervention (35 Days)||2||
60149512|NCT01408719|76274563|FG003|STARTED|First Intervention (35 Days)||2||
60149513|NCT01408719|76274564|FG004|STARTED|First Intervention (35 Days)||4||
60149514|NCT01408719|76274565|FG005|STARTED|First Intervention (35 Days)||3||
60149515|NCT01408719|76274566|FG006|STARTED|First Intervention (35 Days)||2||
60149516|NCT01408719|76274567|FG007|STARTED|First Intervention (35 Days)||3||
60149517|NCT01408719|76274568|FG008|STARTED|First Intervention (35 Days)||2||
60149518|NCT01408719|76274569|FG009|STARTED|First Intervention (35 Days)||1||
60149519|NCT01408719|76274570|FG010|STARTED|First Intervention (35 Days)||2||
60149520|NCT01408719|76274571|FG011|STARTED|First Intervention (35 Days)||2||
60149521|NCT01408719|76274572|FG012|STARTED|First Intervention (35 Days)||2||
60149522|NCT01408719|76274573|FG013|STARTED|First Intervention (35 Days)||5||
60149523|NCT01408719|76274574|FG014|STARTED|First Intervention (35 Days)||1||
60149524|NCT01408719|76274575|FG015|STARTED|First Intervention (35 Days)||2||
60149525|NCT01408719|76274576|FG016|STARTED|First Intervention (35 Days)||3||
60149526|NCT01408719|76274577|FG017|STARTED|First Intervention (35 Days)||2||
60149527|NCT01408719|76274578|FG018|STARTED|First Intervention (35 Days)||1||
60149528|NCT01408719|76274579|FG019|STARTED|First Intervention (35 Days)||1||
60149529|NCT01408719|76274560|FG000|COMPLETED|First Intervention (35 Days)||2||
60149530|NCT01408719|76274561|FG001|COMPLETED|First Intervention (35 Days)||3||
60149531|NCT01408719|76274562|FG002|COMPLETED|First Intervention (35 Days)||1||
60149532|NCT01408719|76274563|FG003|COMPLETED|First Intervention (35 Days)||2||
60149533|NCT01408719|76274564|FG004|COMPLETED|First Intervention (35 Days)||3||
60149534|NCT01408719|76274565|FG005|COMPLETED|First Intervention (35 Days)||3||
60149535|NCT01408719|76274566|FG006|COMPLETED|First Intervention (35 Days)||2||
60149536|NCT01408719|76274567|FG007|COMPLETED|First Intervention (35 Days)||3||
60149537|NCT01408719|76274568|FG008|COMPLETED|First Intervention (35 Days)||1||
60149538|NCT01408719|76274569|FG009|COMPLETED|First Intervention (35 Days)||1||
60149539|NCT01408719|76274570|FG010|COMPLETED|First Intervention (35 Days)||2||
60149540|NCT01408719|76274571|FG011|COMPLETED|First Intervention (35 Days)||2||
60149541|NCT01408719|76274572|FG012|COMPLETED|First Intervention (35 Days)||2||
60149542|NCT01408719|76274573|FG013|COMPLETED|First Intervention (35 Days)||4||
60149543|NCT01408719|76274574|FG014|COMPLETED|First Intervention (35 Days)||1||
60149544|NCT01408719|76274575|FG015|COMPLETED|First Intervention (35 Days)||2||
60149545|NCT01408719|76274576|FG016|COMPLETED|First Intervention (35 Days)||2||
60149546|NCT01408719|76274577|FG017|COMPLETED|First Intervention (35 Days)||2||
60149547|NCT01408719|76274578|FG018|COMPLETED|First Intervention (35 Days)||0||
60149548|NCT01408719|76274579|FG019|COMPLETED|First Intervention (35 Days)||1||
60149549|NCT01408719|76274560|FG000|NOT COMPLETED|First Intervention (35 Days)||0||
60149550|NCT01408719|76274561|FG001|NOT COMPLETED|First Intervention (35 Days)||0||
60149551|NCT01408719|76274562|FG002|NOT COMPLETED|First Intervention (35 Days)||1||
60149552|NCT01408719|76274563|FG003|NOT COMPLETED|First Intervention (35 Days)||0||
60149553|NCT01408719|76274564|FG004|NOT COMPLETED|First Intervention (35 Days)||1||
60149554|NCT01408719|76274565|FG005|NOT COMPLETED|First Intervention (35 Days)||0||
60149555|NCT01408719|76274566|FG006|NOT COMPLETED|First Intervention (35 Days)||0||
60149556|NCT01408719|76274567|FG007|NOT COMPLETED|First Intervention (35 Days)||0||
60149557|NCT01408719|76274568|FG008|NOT COMPLETED|First Intervention (35 Days)||1||
60149558|NCT01408719|76274569|FG009|NOT COMPLETED|First Intervention (35 Days)||0||
60149559|NCT01408719|76274570|FG010|NOT COMPLETED|First Intervention (35 Days)||0||
60149560|NCT01408719|76274571|FG011|NOT COMPLETED|First Intervention (35 Days)||0||
60149561|NCT01408719|76274572|FG012|NOT COMPLETED|First Intervention (35 Days)||0||
60149562|NCT01408719|76274573|FG013|NOT COMPLETED|First Intervention (35 Days)||1||
60149563|NCT01408719|76274574|FG014|NOT COMPLETED|First Intervention (35 Days)||0||
60149564|NCT01408719|76274575|FG015|NOT COMPLETED|First Intervention (35 Days)||0||
60149565|NCT01408719|76274576|FG016|NOT COMPLETED|First Intervention (35 Days)||1||
60149566|NCT01408719|76274577|FG017|NOT COMPLETED|First Intervention (35 Days)||0||
60149567|NCT01408719|76274578|FG018|NOT COMPLETED|First Intervention (35 Days)||1||
60149568|NCT01408719|76274579|FG019|NOT COMPLETED|First Intervention (35 Days)||0||
60149569|NCT01408719|76274560|FG000|STARTED|Washout Period (28 Days)||2||
60149570|NCT01408719|76274561|FG001|STARTED|Washout Period (28 Days)||3||
60149571|NCT01408719|76274562|FG002|STARTED|Washout Period (28 Days)||1||
60149572|NCT01408719|76274563|FG003|STARTED|Washout Period (28 Days)||2||
60149573|NCT01408719|76274564|FG004|STARTED|Washout Period (28 Days)||3||
60149574|NCT01408719|76274565|FG005|STARTED|Washout Period (28 Days)||3||
60149575|NCT01408719|76274566|FG006|STARTED|Washout Period (28 Days)||2||
60149576|NCT01408719|76274567|FG007|STARTED|Washout Period (28 Days)||3||
60149577|NCT01408719|76274568|FG008|STARTED|Washout Period (28 Days)||1||
60149578|NCT01408719|76274569|FG009|STARTED|Washout Period (28 Days)||1||
60149579|NCT01408719|76274570|FG010|STARTED|Washout Period (28 Days)||2||
60149580|NCT01408719|76274571|FG011|STARTED|Washout Period (28 Days)||2||
60149581|NCT01408719|76274572|FG012|STARTED|Washout Period (28 Days)||2||
60149582|NCT01408719|76274573|FG013|STARTED|Washout Period (28 Days)||4||
60149583|NCT01408719|76274574|FG014|STARTED|Washout Period (28 Days)||1||
60149584|NCT01408719|76274575|FG015|STARTED|Washout Period (28 Days)||2||
60149585|NCT01408719|76274576|FG016|STARTED|Washout Period (28 Days)||2||
60149586|NCT01408719|76274577|FG017|STARTED|Washout Period (28 Days)||2||
60149587|NCT01408719|76274578|FG018|STARTED|Washout Period (28 Days)||0||
60149588|NCT01408719|76274579|FG019|STARTED|Washout Period (28 Days)||1||
60149589|NCT01408719|76274560|FG000|COMPLETED|Washout Period (28 Days)||2||
60149590|NCT01408719|76274561|FG001|COMPLETED|Washout Period (28 Days)||3||
60149591|NCT01408719|76274562|FG002|COMPLETED|Washout Period (28 Days)||1||
60149592|NCT01408719|76274563|FG003|COMPLETED|Washout Period (28 Days)||2||
60149593|NCT01408719|76274564|FG004|COMPLETED|Washout Period (28 Days)||3||
60149594|NCT01408719|76274565|FG005|COMPLETED|Washout Period (28 Days)||3||
60149595|NCT01408719|76274566|FG006|COMPLETED|Washout Period (28 Days)||2||
60149596|NCT01408719|76274567|FG007|COMPLETED|Washout Period (28 Days)||3||
60149597|NCT01408719|76274568|FG008|COMPLETED|Washout Period (28 Days)||1||
60149598|NCT01408719|76274569|FG009|COMPLETED|Washout Period (28 Days)||1||
60149599|NCT01408719|76274570|FG010|COMPLETED|Washout Period (28 Days)||2||
60149600|NCT01408719|76274571|FG011|COMPLETED|Washout Period (28 Days)||2||
60149601|NCT01408719|76274572|FG012|COMPLETED|Washout Period (28 Days)||2||
60149602|NCT01408719|76274573|FG013|COMPLETED|Washout Period (28 Days)||4||
60149603|NCT01408719|76274574|FG014|COMPLETED|Washout Period (28 Days)||1||
60149604|NCT01408719|76274575|FG015|COMPLETED|Washout Period (28 Days)||2||
60149605|NCT01408719|76274576|FG016|COMPLETED|Washout Period (28 Days)||2||
60149606|NCT01408719|76274577|FG017|COMPLETED|Washout Period (28 Days)||2||
60149607|NCT01408719|76274578|FG018|COMPLETED|Washout Period (28 Days)||0||
60149608|NCT01408719|76274579|FG019|COMPLETED|Washout Period (28 Days)||1||
60149609|NCT01408719|76274560|FG000|NOT COMPLETED|Washout Period (28 Days)||0||
60149610|NCT01408719|76274561|FG001|NOT COMPLETED|Washout Period (28 Days)||0||
60149611|NCT01408719|76274562|FG002|NOT COMPLETED|Washout Period (28 Days)||0||
60149612|NCT01408719|76274563|FG003|NOT COMPLETED|Washout Period (28 Days)||0||
60149613|NCT01408719|76274564|FG004|NOT COMPLETED|Washout Period (28 Days)||0||
60149614|NCT01408719|76274565|FG005|NOT COMPLETED|Washout Period (28 Days)||0||
60149615|NCT01408719|76274566|FG006|NOT COMPLETED|Washout Period (28 Days)||0||
60149616|NCT01408719|76274567|FG007|NOT COMPLETED|Washout Period (28 Days)||0||
60149617|NCT01408719|76274568|FG008|NOT COMPLETED|Washout Period (28 Days)||0||
60149618|NCT01408719|76274569|FG009|NOT COMPLETED|Washout Period (28 Days)||0||
60149619|NCT01408719|76274570|FG010|NOT COMPLETED|Washout Period (28 Days)||0||
60149620|NCT01408719|76274571|FG011|NOT COMPLETED|Washout Period (28 Days)||0||
60149621|NCT01408719|76274572|FG012|NOT COMPLETED|Washout Period (28 Days)||0||
60149622|NCT01408719|76274573|FG013|NOT COMPLETED|Washout Period (28 Days)||0||
60149623|NCT01408719|76274574|FG014|NOT COMPLETED|Washout Period (28 Days)||0||
60149624|NCT01408719|76274575|FG015|NOT COMPLETED|Washout Period (28 Days)||0||
60149625|NCT01408719|76274576|FG016|NOT COMPLETED|Washout Period (28 Days)||0||
60149626|NCT01408719|76274577|FG017|NOT COMPLETED|Washout Period (28 Days)||0||
60149627|NCT01408719|76274578|FG018|NOT COMPLETED|Washout Period (28 Days)||0||
60149628|NCT01408719|76274579|FG019|NOT COMPLETED|Washout Period (28 Days)||0||
60149629|NCT01408719|76274560|FG000|STARTED|Second Intervention (35 Days)||2||
60149630|NCT01408719|76274561|FG001|STARTED|Second Intervention (35 Days)||3||
60149631|NCT01408719|76274562|FG002|STARTED|Second Intervention (35 Days)||1||
60149632|NCT01408719|76274563|FG003|STARTED|Second Intervention (35 Days)||2||
60149633|NCT01408719|76274564|FG004|STARTED|Second Intervention (35 Days)||3||
60149634|NCT01408719|76274565|FG005|STARTED|Second Intervention (35 Days)||3||
60149635|NCT01408719|76274566|FG006|STARTED|Second Intervention (35 Days)||2||
60149636|NCT01408719|76274567|FG007|STARTED|Second Intervention (35 Days)||3||
60149637|NCT01408719|76274568|FG008|STARTED|Second Intervention (35 Days)||1||
60149638|NCT01408719|76274569|FG009|STARTED|Second Intervention (35 Days)||1||
60149639|NCT01408719|76274570|FG010|STARTED|Second Intervention (35 Days)||2||
60149640|NCT01408719|76274571|FG011|STARTED|Second Intervention (35 Days)||2||
60149641|NCT01408719|76274572|FG012|STARTED|Second Intervention (35 Days)||2||
60149642|NCT01408719|76274573|FG013|STARTED|Second Intervention (35 Days)||4||
60149643|NCT01408719|76274574|FG014|STARTED|Second Intervention (35 Days)||1||
60149644|NCT01408719|76274575|FG015|STARTED|Second Intervention (35 Days)||2||
60149645|NCT01408719|76274576|FG016|STARTED|Second Intervention (35 Days)||2||
60149646|NCT01408719|76274577|FG017|STARTED|Second Intervention (35 Days)||2||
60149647|NCT01408719|76274578|FG018|STARTED|Second Intervention (35 Days)||0||
60149648|NCT01408719|76274579|FG019|STARTED|Second Intervention (35 Days)||1||
59751558|NCT00969761|75870889|FG000|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||1||
59751559|NCT00969761|75870890|FG001|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0||
59751560|NCT00969761|75870891|FG002|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||2||
60010797|NCT01111461|76126480|FG000|COMPLETED|Overall Study|On treatment at data cut-off or on treatment until disease progression|82||
60010798|NCT01111461|76126480|FG000|NOT COMPLETED|Overall Study||51||
60010799|NCT01104155|76126486|FG000|STARTED|Overall Study||63||
60010800|NCT01104155|76126487|FG001|STARTED|Overall Study||60||
60010801|NCT01104155|76126486|FG000|COMPLETED|Overall Study||38||
60010802|NCT01104155|76126487|FG001|COMPLETED|Overall Study||42||
60010803|NCT01104155|76126486|FG000|NOT COMPLETED|Overall Study||25||
60010804|NCT01104155|76126487|FG001|NOT COMPLETED|Overall Study||18||
60010805|NCT01065597|76126493|FG000|STARTED|Overall Study||13||
60010806|NCT01065597|76126493|FG000|COMPLETED|Overall Study||12||
60010807|NCT01065597|76126493|FG000|NOT COMPLETED|Overall Study||1||
60010808|NCT01051856|76126499|FG000|STARTED|Overall Study||33||
60010809|NCT01051856|76126500|FG001|STARTED|Overall Study||35||
60010810|NCT01051856|76126499|FG000|COMPLETED|Overall Study||32||
60010811|NCT01051856|76126500|FG001|COMPLETED|Overall Study||35||
60010812|NCT01051856|76126499|FG000|NOT COMPLETED|Overall Study||1||
60010813|NCT01051856|76126500|FG001|NOT COMPLETED|Overall Study||0||
60010814|NCT01029366|76126508|FG000|STARTED|Overall Study||18||
60010815|NCT01029366|76126509|FG001|STARTED|Overall Study||8||
60010816|NCT01029366|76126508|FG000|COMPLETED|Overall Study||14||
60010817|NCT01029366|76126509|FG001|COMPLETED|Overall Study||6||
60010818|NCT01029366|76126508|FG000|NOT COMPLETED|Overall Study||4||
60010819|NCT01029366|76126509|FG001|NOT COMPLETED|Overall Study||2||
60010820|NCT00879086|76126518|FG000|STARTED|Overall Study||52||
60010821|NCT00879086|76126519|FG001|STARTED|Overall Study||52||
60010822|NCT00879086|76126518|FG000|Safety Analysis Set (SAS)|Overall Study||51||
60010823|NCT00879086|76126519|FG001|Safety Analysis Set (SAS)|Overall Study||50||
60010824|NCT00879086|76126518|FG000|COMPLETED|Overall Study||0||
60010825|NCT00879086|76126519|FG001|COMPLETED|Overall Study||0||
60010826|NCT00879086|76126518|FG000|NOT COMPLETED|Overall Study||52||
60010827|NCT00879086|76126519|FG001|NOT COMPLETED|Overall Study||52||
60010828|NCT00677040|76126525|FG000|STARTED|Overall Study||20||
60010829|NCT00677040|76126525|FG000|COMPLETED|Overall Study||20||
60010830|NCT00677040|76126525|FG000|NOT COMPLETED|Overall Study||0||
60010831|NCT00675922|76126530|FG000|STARTED|Overall Study||98||
60010832|NCT00675922|76126530|FG000|COMPLETED|Overall Study||98||
60010833|NCT00675922|76126530|FG000|NOT COMPLETED|Overall Study||0||
60010834|NCT00244933|76126535|FG000|STARTED|Overall Study||19||
60010835|NCT00244933|76126535|FG000|COMPLETED|Overall Study||17||
60010836|NCT00244933|76126535|FG000|NOT COMPLETED|Overall Study||2||
60010837|NCT00121719|76126551|FG000|STARTED|Dose Escalation (4 Weeks)||4||
60010838|NCT00121719|76126552|FG001|STARTED|Dose Escalation (4 Weeks)||4||
60010839|NCT00121719|76126553|FG002|STARTED|Dose Escalation (4 Weeks)||4||
60010840|NCT00121719|76126554|FG003|STARTED|Dose Escalation (4 Weeks)||3||
60010841|NCT00121719|76126555|FG004|STARTED|Dose Escalation (4 Weeks)||3||
60010842|NCT00121719|76126556|FG005|STARTED|Dose Escalation (4 Weeks)||3||
60010843|NCT00121719|76126557|FG006|STARTED|Dose Escalation (4 Weeks)||12||
60010844|NCT00121719|76126558|FG007|STARTED|Dose Escalation (4 Weeks)||9||
60010845|NCT00121719|76126559|FG008|STARTED|Dose Escalation (4 Weeks)||6||
60010846|NCT00121719|76126560|FG009|STARTED|Dose Escalation (4 Weeks)||3||
60010847|NCT00121719|76126561|FG010|STARTED|Dose Escalation (4 Weeks)||0||
60010848|NCT00121719|76126562|FG011|STARTED|Dose Escalation (4 Weeks)||0||
60010849|NCT00121719|76126563|FG012|STARTED|Dose Escalation (4 Weeks)||24||
60010850|NCT00121719|76126564|FG013|STARTED|Dose Escalation (4 Weeks)||7||
60010851|NCT00121719|76126551|FG000|COMPLETED|Dose Escalation (4 Weeks)||4||
60010852|NCT00121719|76126552|FG001|COMPLETED|Dose Escalation (4 Weeks)||4||
60010853|NCT00121719|76126553|FG002|COMPLETED|Dose Escalation (4 Weeks)||4||
60010854|NCT00121719|76126554|FG003|COMPLETED|Dose Escalation (4 Weeks)||3||
60010855|NCT00121719|76126555|FG004|COMPLETED|Dose Escalation (4 Weeks)||3||
60010856|NCT00121719|76126556|FG005|COMPLETED|Dose Escalation (4 Weeks)||3||
60010857|NCT00121719|76126557|FG006|COMPLETED|Dose Escalation (4 Weeks)||12||
60010858|NCT00121719|76126558|FG007|COMPLETED|Dose Escalation (4 Weeks)||9||
60010859|NCT00121719|76126559|FG008|COMPLETED|Dose Escalation (4 Weeks)||6||
60010860|NCT00121719|76126560|FG009|COMPLETED|Dose Escalation (4 Weeks)||3||
60010861|NCT00121719|76126561|FG010|COMPLETED|Dose Escalation (4 Weeks)||0||
60010862|NCT00121719|76126562|FG011|COMPLETED|Dose Escalation (4 Weeks)||0||
60010863|NCT00121719|76126563|FG012|COMPLETED|Dose Escalation (4 Weeks)||24||
60010864|NCT00121719|76126564|FG013|COMPLETED|Dose Escalation (4 Weeks)||7||
60010865|NCT00121719|76126551|FG000|NOT COMPLETED|Dose Escalation (4 Weeks)||0||
60010866|NCT00121719|76126552|FG001|NOT COMPLETED|Dose Escalation (4 Weeks)||0||
60010867|NCT00121719|76126553|FG002|NOT COMPLETED|Dose Escalation (4 Weeks)||0||
60010868|NCT00121719|76126554|FG003|NOT COMPLETED|Dose Escalation (4 Weeks)||0||
60010869|NCT00121719|76126555|FG004|NOT COMPLETED|Dose Escalation (4 Weeks)||0||
60010870|NCT00121719|76126556|FG005|NOT COMPLETED|Dose Escalation (4 Weeks)||0||
60010871|NCT00121719|76126557|FG006|NOT COMPLETED|Dose Escalation (4 Weeks)||0||
60010872|NCT00121719|76126558|FG007|NOT COMPLETED|Dose Escalation (4 Weeks)||0||
60010873|NCT00121719|76126559|FG008|NOT COMPLETED|Dose Escalation (4 Weeks)||0||
60149649|NCT01408719|76274560|FG000|COMPLETED|Second Intervention (35 Days)||2||
60149650|NCT01408719|76274561|FG001|COMPLETED|Second Intervention (35 Days)||3||
60149651|NCT01408719|76274562|FG002|COMPLETED|Second Intervention (35 Days)||1||
60149652|NCT01408719|76274563|FG003|COMPLETED|Second Intervention (35 Days)||2||
60149653|NCT01408719|76274564|FG004|COMPLETED|Second Intervention (35 Days)||3||
60149654|NCT01408719|76274565|FG005|COMPLETED|Second Intervention (35 Days)||3||
60149655|NCT01408719|76274566|FG006|COMPLETED|Second Intervention (35 Days)||2||
60149656|NCT01408719|76274567|FG007|COMPLETED|Second Intervention (35 Days)||3||
60149657|NCT01408719|76274568|FG008|COMPLETED|Second Intervention (35 Days)||1||
60149658|NCT01408719|76274569|FG009|COMPLETED|Second Intervention (35 Days)||1||
60149659|NCT01408719|76274570|FG010|COMPLETED|Second Intervention (35 Days)||2||
60149660|NCT01408719|76274571|FG011|COMPLETED|Second Intervention (35 Days)||2||
60149661|NCT01408719|76274572|FG012|COMPLETED|Second Intervention (35 Days)||2||
60149662|NCT01408719|76274573|FG013|COMPLETED|Second Intervention (35 Days)||3||
60149663|NCT01408719|76274574|FG014|COMPLETED|Second Intervention (35 Days)||1||
60149664|NCT01408719|76274575|FG015|COMPLETED|Second Intervention (35 Days)||2||
60149665|NCT01408719|76274576|FG016|COMPLETED|Second Intervention (35 Days)||2||
60149666|NCT01408719|76274577|FG017|COMPLETED|Second Intervention (35 Days)||2||
60149667|NCT01408719|76274578|FG018|COMPLETED|Second Intervention (35 Days)||0||
60149668|NCT01408719|76274579|FG019|COMPLETED|Second Intervention (35 Days)||1||
60149669|NCT01408719|76274560|FG000|NOT COMPLETED|Second Intervention (35 Days)||0||
60149670|NCT01408719|76274561|FG001|NOT COMPLETED|Second Intervention (35 Days)||0||
59605756|NCT01987986|75715887|FG003|COMPLETED|Overall Study||24||
60149671|NCT01408719|76274562|FG002|NOT COMPLETED|Second Intervention (35 Days)||0||
60149672|NCT01408719|76274563|FG003|NOT COMPLETED|Second Intervention (35 Days)||0||
60149673|NCT01408719|76274564|FG004|NOT COMPLETED|Second Intervention (35 Days)||0||
60149674|NCT01408719|76274565|FG005|NOT COMPLETED|Second Intervention (35 Days)||0||
60149675|NCT01408719|76274566|FG006|NOT COMPLETED|Second Intervention (35 Days)||0||
60149676|NCT01408719|76274567|FG007|NOT COMPLETED|Second Intervention (35 Days)||0||
60149677|NCT01408719|76274568|FG008|NOT COMPLETED|Second Intervention (35 Days)||0||
60149678|NCT01408719|76274569|FG009|NOT COMPLETED|Second Intervention (35 Days)||0||
60149679|NCT01408719|76274570|FG010|NOT COMPLETED|Second Intervention (35 Days)||0||
60149680|NCT01408719|76274571|FG011|NOT COMPLETED|Second Intervention (35 Days)||0||
60149681|NCT01408719|76274572|FG012|NOT COMPLETED|Second Intervention (35 Days)||0||
60149682|NCT01408719|76274573|FG013|NOT COMPLETED|Second Intervention (35 Days)||1||
60149683|NCT01408719|76274574|FG014|NOT COMPLETED|Second Intervention (35 Days)||0||
60149684|NCT01408719|76274575|FG015|NOT COMPLETED|Second Intervention (35 Days)||0||
60149685|NCT01408719|76274576|FG016|NOT COMPLETED|Second Intervention (35 Days)||0||
60149686|NCT01408719|76274577|FG017|NOT COMPLETED|Second Intervention (35 Days)||0||
60149687|NCT01408719|76274578|FG018|NOT COMPLETED|Second Intervention (35 Days)||0||
60149688|NCT01408719|76274579|FG019|NOT COMPLETED|Second Intervention (35 Days)||0||
59605757|NCT01987986|75715884|FG000|NOT COMPLETED|Overall Study||2||
59605758|NCT01987986|75715885|FG001|NOT COMPLETED|Overall Study||0||
59605759|NCT01987986|75715886|FG002|NOT COMPLETED|Overall Study||2||
59605760|NCT01987986|75715887|FG003|NOT COMPLETED|Overall Study||0||
59605761|NCT01987908|75715897|FG000|STARTED|Placebo Lead-in Period||23||
59605762|NCT01987908|75715898|FG001|STARTED|Placebo Lead-in Period||0||
60149689|NCT01408719|76274560|FG000|STARTED|Washout Period (28 Days)||2||
60149690|NCT01408719|76274561|FG001|STARTED|Washout Period (28 Days)||3||
59605763|NCT01987908|75715899|FG002|STARTED|Placebo Lead-in Period||0||
60149691|NCT01408719|76274562|FG002|STARTED|Washout Period (28 Days)||1||
60149692|NCT01408719|76274563|FG003|STARTED|Washout Period (28 Days)||2||
60149693|NCT01408719|76274564|FG004|STARTED|Washout Period (28 Days)||3||
60149694|NCT01408719|76274565|FG005|STARTED|Washout Period (28 Days)||3||
60149695|NCT01408719|76274566|FG006|STARTED|Washout Period (28 Days)||2||
60149696|NCT01408719|76274567|FG007|STARTED|Washout Period (28 Days)||3||
60149697|NCT01408719|76274568|FG008|STARTED|Washout Period (28 Days)||1||
60149698|NCT01408719|76274569|FG009|STARTED|Washout Period (28 Days)||1||
60149699|NCT01408719|76274570|FG010|STARTED|Washout Period (28 Days)||2||
60149700|NCT01408719|76274571|FG011|STARTED|Washout Period (28 Days)||2||
60149701|NCT01408719|76274572|FG012|STARTED|Washout Period (28 Days)||2||
60149702|NCT01408719|76274573|FG013|STARTED|Washout Period (28 Days)||3||
60149703|NCT01408719|76274574|FG014|STARTED|Washout Period (28 Days)||1||
60149704|NCT01408719|76274575|FG015|STARTED|Washout Period (28 Days)||1||
60149705|NCT01408719|76274576|FG016|STARTED|Washout Period (28 Days)||2||
60149706|NCT01408719|76274577|FG017|STARTED|Washout Period (28 Days)||2||
60149707|NCT01408719|76274578|FG018|STARTED|Washout Period (28 Days)||0||
60149708|NCT01408719|76274579|FG019|STARTED|Washout Period (28 Days)||1||
60149709|NCT01408719|76274560|FG000|COMPLETED|Washout Period (28 Days)||2||
60149710|NCT01408719|76274561|FG001|COMPLETED|Washout Period (28 Days)||3||
60149711|NCT01408719|76274562|FG002|COMPLETED|Washout Period (28 Days)||1||
60149712|NCT01408719|76274563|FG003|COMPLETED|Washout Period (28 Days)||2||
60149713|NCT01408719|76274564|FG004|COMPLETED|Washout Period (28 Days)||3||
60149714|NCT01408719|76274565|FG005|COMPLETED|Washout Period (28 Days)||3||
60149715|NCT01408719|76274566|FG006|COMPLETED|Washout Period (28 Days)||2||
60149716|NCT01408719|76274567|FG007|COMPLETED|Washout Period (28 Days)||3||
60149717|NCT01408719|76274568|FG008|COMPLETED|Washout Period (28 Days)||1||
60149718|NCT01408719|76274569|FG009|COMPLETED|Washout Period (28 Days)||1||
60149719|NCT01408719|76274570|FG010|COMPLETED|Washout Period (28 Days)||2||
60149720|NCT01408719|76274571|FG011|COMPLETED|Washout Period (28 Days)||2||
60149721|NCT01408719|76274572|FG012|COMPLETED|Washout Period (28 Days)||2||
60149722|NCT01408719|76274573|FG013|COMPLETED|Washout Period (28 Days)||3||
60149723|NCT01408719|76274574|FG014|COMPLETED|Washout Period (28 Days)||1||
60149724|NCT01408719|76274575|FG015|COMPLETED|Washout Period (28 Days)||1||
60149725|NCT01408719|76274576|FG016|COMPLETED|Washout Period (28 Days)||2||
60149726|NCT01408719|76274577|FG017|COMPLETED|Washout Period (28 Days)||2||
60149727|NCT01408719|76274578|FG018|COMPLETED|Washout Period (28 Days)||0||
60149728|NCT01408719|76274579|FG019|COMPLETED|Washout Period (28 Days)||1||
60149729|NCT01408719|76274560|FG000|NOT COMPLETED|Washout Period (28 Days)||0||
60149730|NCT01408719|76274561|FG001|NOT COMPLETED|Washout Period (28 Days)||0||
60149731|NCT01408719|76274562|FG002|NOT COMPLETED|Washout Period (28 Days)||0||
60149732|NCT01408719|76274563|FG003|NOT COMPLETED|Washout Period (28 Days)||0||
60149733|NCT01408719|76274564|FG004|NOT COMPLETED|Washout Period (28 Days)||0||
60149734|NCT01408719|76274565|FG005|NOT COMPLETED|Washout Period (28 Days)||0||
60149735|NCT01408719|76274566|FG006|NOT COMPLETED|Washout Period (28 Days)||0||
60149736|NCT01408719|76274567|FG007|NOT COMPLETED|Washout Period (28 Days)||0||
60149737|NCT01408719|76274568|FG008|NOT COMPLETED|Washout Period (28 Days)||0||
60149738|NCT01408719|76274569|FG009|NOT COMPLETED|Washout Period (28 Days)||0||
60149739|NCT01408719|76274570|FG010|NOT COMPLETED|Washout Period (28 Days)||0||
60149740|NCT01408719|76274571|FG011|NOT COMPLETED|Washout Period (28 Days)||0||
60149741|NCT01408719|76274572|FG012|NOT COMPLETED|Washout Period (28 Days)||0||
60149742|NCT01408719|76274573|FG013|NOT COMPLETED|Washout Period (28 Days)||0||
60149743|NCT01408719|76274574|FG014|NOT COMPLETED|Washout Period (28 Days)||0||
60149744|NCT01408719|76274575|FG015|NOT COMPLETED|Washout Period (28 Days)||0||
60149745|NCT01408719|76274576|FG016|NOT COMPLETED|Washout Period (28 Days)||0||
60149746|NCT01408719|76274577|FG017|NOT COMPLETED|Washout Period (28 Days)||0||
60149747|NCT01408719|76274578|FG018|NOT COMPLETED|Washout Period (28 Days)||0||
60149748|NCT01408719|76274579|FG019|NOT COMPLETED|Washout Period (28 Days)||0||
60149749|NCT01408719|76274560|FG000|STARTED|Third Intervention (35 Days)||2||
60149750|NCT01408719|76274561|FG001|STARTED|Third Intervention (35 Days)||3||
60149751|NCT01408719|76274562|FG002|STARTED|Third Intervention (35 Days)||1||
60149752|NCT01408719|76274563|FG003|STARTED|Third Intervention (35 Days)||2||
60149753|NCT01408719|76274564|FG004|STARTED|Third Intervention (35 Days)||3||
60149754|NCT01408719|76274565|FG005|STARTED|Third Intervention (35 Days)||3||
60149755|NCT01408719|76274566|FG006|STARTED|Third Intervention (35 Days)||2||
60149756|NCT01408719|76274567|FG007|STARTED|Third Intervention (35 Days)||3||
60149757|NCT01408719|76274568|FG008|STARTED|Third Intervention (35 Days)||1||
60149758|NCT01408719|76274569|FG009|STARTED|Third Intervention (35 Days)||1||
60149759|NCT01408719|76274570|FG010|STARTED|Third Intervention (35 Days)||2||
60149760|NCT01408719|76274571|FG011|STARTED|Third Intervention (35 Days)||2||
60149761|NCT01408719|76274572|FG012|STARTED|Third Intervention (35 Days)||2||
60149762|NCT01408719|76274573|FG013|STARTED|Third Intervention (35 Days)||3||
60149763|NCT01408719|76274574|FG014|STARTED|Third Intervention (35 Days)||1||
60149764|NCT01408719|76274575|FG015|STARTED|Third Intervention (35 Days)||1||
60149765|NCT01408719|76274576|FG016|STARTED|Third Intervention (35 Days)||2||
60149766|NCT01408719|76274577|FG017|STARTED|Third Intervention (35 Days)||2||
60149767|NCT01408719|76274578|FG018|STARTED|Third Intervention (35 Days)||0||
60149768|NCT01408719|76274579|FG019|STARTED|Third Intervention (35 Days)||1||
60149769|NCT01408719|76274560|FG000|COMPLETED|Third Intervention (35 Days)||2||
60149770|NCT01408719|76274561|FG001|COMPLETED|Third Intervention (35 Days)||3||
60149771|NCT01408719|76274562|FG002|COMPLETED|Third Intervention (35 Days)||1||
60149772|NCT01408719|76274563|FG003|COMPLETED|Third Intervention (35 Days)||2||
60149773|NCT01408719|76274564|FG004|COMPLETED|Third Intervention (35 Days)||3||
60149774|NCT01408719|76274565|FG005|COMPLETED|Third Intervention (35 Days)||3||
60149775|NCT01408719|76274566|FG006|COMPLETED|Third Intervention (35 Days)||2||
60149776|NCT01408719|76274567|FG007|COMPLETED|Third Intervention (35 Days)||2||
60149777|NCT01408719|76274568|FG008|COMPLETED|Third Intervention (35 Days)||1||
60149778|NCT01408719|76274569|FG009|COMPLETED|Third Intervention (35 Days)||1||
60149779|NCT01408719|76274570|FG010|COMPLETED|Third Intervention (35 Days)||2||
60149780|NCT01408719|76274571|FG011|COMPLETED|Third Intervention (35 Days)||2||
60149781|NCT01408719|76274572|FG012|COMPLETED|Third Intervention (35 Days)||2||
60149782|NCT01408719|76274573|FG013|COMPLETED|Third Intervention (35 Days)||3||
60149783|NCT01408719|76274574|FG014|COMPLETED|Third Intervention (35 Days)||1||
60149784|NCT01408719|76274575|FG015|COMPLETED|Third Intervention (35 Days)||1||
60149785|NCT01408719|76274576|FG016|COMPLETED|Third Intervention (35 Days)||2||
60149786|NCT01408719|76274577|FG017|COMPLETED|Third Intervention (35 Days)||2||
60149787|NCT01408719|76274578|FG018|COMPLETED|Third Intervention (35 Days)||0||
60149788|NCT01408719|76274579|FG019|COMPLETED|Third Intervention (35 Days)||1||
60149789|NCT01408719|76274560|FG000|NOT COMPLETED|Third Intervention (35 Days)||0||
60149790|NCT01408719|76274561|FG001|NOT COMPLETED|Third Intervention (35 Days)||0||
60149791|NCT01408719|76274562|FG002|NOT COMPLETED|Third Intervention (35 Days)||0||
60149792|NCT01408719|76274563|FG003|NOT COMPLETED|Third Intervention (35 Days)||0||
60149793|NCT01408719|76274564|FG004|NOT COMPLETED|Third Intervention (35 Days)||0||
60149794|NCT01408719|76274565|FG005|NOT COMPLETED|Third Intervention (35 Days)||0||
60149795|NCT01408719|76274566|FG006|NOT COMPLETED|Third Intervention (35 Days)||0||
60149796|NCT01408719|76274567|FG007|NOT COMPLETED|Third Intervention (35 Days)||1||
60149797|NCT01408719|76274568|FG008|NOT COMPLETED|Third Intervention (35 Days)||0||
60149798|NCT01408719|76274569|FG009|NOT COMPLETED|Third Intervention (35 Days)||0||
60149799|NCT01408719|76274570|FG010|NOT COMPLETED|Third Intervention (35 Days)||0||
60149800|NCT01408719|76274571|FG011|NOT COMPLETED|Third Intervention (35 Days)||0||
60149801|NCT01408719|76274572|FG012|NOT COMPLETED|Third Intervention (35 Days)||0||
60149802|NCT01408719|76274573|FG013|NOT COMPLETED|Third Intervention (35 Days)||0||
59605764|NCT01987908|75715897|FG000|COMPLETED|Placebo Lead-in Period||14||
59605765|NCT01987908|75715898|FG001|COMPLETED|Placebo Lead-in Period||0||
59605766|NCT01987908|75715899|FG002|COMPLETED|Placebo Lead-in Period||0||
59605767|NCT01987908|75715897|FG000|NOT COMPLETED|Placebo Lead-in Period||9||
59605768|NCT01987908|75715898|FG001|NOT COMPLETED|Placebo Lead-in Period||0||
59605769|NCT01987908|75715899|FG002|NOT COMPLETED|Placebo Lead-in Period||0||
59605770|NCT01987908|75715897|FG000|STARTED|Treatment Period||0||
59605771|NCT01987908|75715898|FG001|STARTED|Treatment Period||11||
59605772|NCT01987908|75715899|FG002|STARTED|Treatment Period||3||
60149803|NCT01408719|76274574|FG014|NOT COMPLETED|Third Intervention (35 Days)||0||
60149804|NCT01408719|76274575|FG015|NOT COMPLETED|Third Intervention (35 Days)||0||
60149805|NCT01408719|76274576|FG016|NOT COMPLETED|Third Intervention (35 Days)||0||
60149806|NCT01408719|76274577|FG017|NOT COMPLETED|Third Intervention (35 Days)||0||
60149807|NCT01408719|76274578|FG018|NOT COMPLETED|Third Intervention (35 Days)||0||
60149808|NCT01408719|76274579|FG019|NOT COMPLETED|Third Intervention (35 Days)||0||
60149809|NCT01408719|76274560|FG000|STARTED|Washout Period (28 Days)||2||
60149810|NCT01408719|76274561|FG001|STARTED|Washout Period (28 Days)||3||
60149811|NCT01408719|76274562|FG002|STARTED|Washout Period (28 Days)||1||
60149812|NCT01408719|76274563|FG003|STARTED|Washout Period (28 Days)||2||
60149813|NCT01408719|76274564|FG004|STARTED|Washout Period (28 Days)||3||
60149814|NCT01408719|76274565|FG005|STARTED|Washout Period (28 Days)||3||
60149815|NCT01408719|76274566|FG006|STARTED|Washout Period (28 Days)||2||
60149816|NCT01408719|76274567|FG007|STARTED|Washout Period (28 Days)||2||
60149817|NCT01408719|76274568|FG008|STARTED|Washout Period (28 Days)||1||
60149818|NCT01408719|76274569|FG009|STARTED|Washout Period (28 Days)||1||
60149819|NCT01408719|76274570|FG010|STARTED|Washout Period (28 Days)||2||
60149820|NCT01408719|76274571|FG011|STARTED|Washout Period (28 Days)||2||
60149821|NCT01408719|76274572|FG012|STARTED|Washout Period (28 Days)||1||
59605773|NCT01987908|75715897|FG000|COMPLETED|Treatment Period||0||
59605774|NCT01987908|75715898|FG001|COMPLETED|Treatment Period||10||
59605775|NCT01987908|75715899|FG002|COMPLETED|Treatment Period||2||
59605776|NCT01987908|75715897|FG000|NOT COMPLETED|Treatment Period||0||
59605777|NCT01987908|75715898|FG001|NOT COMPLETED|Treatment Period||1||
59605778|NCT01987908|75715899|FG002|NOT COMPLETED|Treatment Period||1||
59605779|NCT01987908|75715897|FG000|STARTED|Post-Treatment Observation Period||0||
60149822|NCT01408719|76274573|FG013|STARTED|Washout Period (28 Days)||3||
60149823|NCT01408719|76274574|FG014|STARTED|Washout Period (28 Days)||1||
59605780|NCT01987908|75715898|FG001|STARTED|Post-Treatment Observation Period||10||
60149824|NCT01408719|76274575|FG015|STARTED|Washout Period (28 Days)||1||
60149825|NCT01408719|76274576|FG016|STARTED|Washout Period (28 Days)||2||
60149826|NCT01408719|76274577|FG017|STARTED|Washout Period (28 Days)||2||
60149827|NCT01408719|76274578|FG018|STARTED|Washout Period (28 Days)||0||
60149828|NCT01408719|76274579|FG019|STARTED|Washout Period (28 Days)||1||
60149829|NCT01408719|76274560|FG000|COMPLETED|Washout Period (28 Days)||2||
60149830|NCT01408719|76274561|FG001|COMPLETED|Washout Period (28 Days)||3||
60149831|NCT01408719|76274562|FG002|COMPLETED|Washout Period (28 Days)||1||
60149832|NCT01408719|76274563|FG003|COMPLETED|Washout Period (28 Days)||2||
60149833|NCT01408719|76274564|FG004|COMPLETED|Washout Period (28 Days)||3||
60149834|NCT01408719|76274565|FG005|COMPLETED|Washout Period (28 Days)||3||
60149835|NCT01408719|76274566|FG006|COMPLETED|Washout Period (28 Days)||2||
60149836|NCT01408719|76274567|FG007|COMPLETED|Washout Period (28 Days)||2||
60149837|NCT01408719|76274568|FG008|COMPLETED|Washout Period (28 Days)||1||
60149838|NCT01408719|76274569|FG009|COMPLETED|Washout Period (28 Days)||1||
60149839|NCT01408719|76274570|FG010|COMPLETED|Washout Period (28 Days)||2||
60149840|NCT01408719|76274571|FG011|COMPLETED|Washout Period (28 Days)||2||
60149841|NCT01408719|76274572|FG012|COMPLETED|Washout Period (28 Days)||1||
60149842|NCT01408719|76274573|FG013|COMPLETED|Washout Period (28 Days)||3||
60149843|NCT01408719|76274574|FG014|COMPLETED|Washout Period (28 Days)||1||
60149844|NCT01408719|76274575|FG015|COMPLETED|Washout Period (28 Days)||1||
60149845|NCT01408719|76274576|FG016|COMPLETED|Washout Period (28 Days)||2||
60149846|NCT01408719|76274577|FG017|COMPLETED|Washout Period (28 Days)||2||
60149847|NCT01408719|76274578|FG018|COMPLETED|Washout Period (28 Days)||0||
60149848|NCT01408719|76274579|FG019|COMPLETED|Washout Period (28 Days)||1||
60149849|NCT01408719|76274560|FG000|NOT COMPLETED|Washout Period (28 Days)||0||
60149850|NCT01408719|76274561|FG001|NOT COMPLETED|Washout Period (28 Days)||0||
60149851|NCT01408719|76274562|FG002|NOT COMPLETED|Washout Period (28 Days)||0||
60149852|NCT01408719|76274563|FG003|NOT COMPLETED|Washout Period (28 Days)||0||
60149853|NCT01408719|76274564|FG004|NOT COMPLETED|Washout Period (28 Days)||0||
60149854|NCT01408719|76274565|FG005|NOT COMPLETED|Washout Period (28 Days)||0||
60149855|NCT01408719|76274566|FG006|NOT COMPLETED|Washout Period (28 Days)||0||
60149856|NCT01408719|76274567|FG007|NOT COMPLETED|Washout Period (28 Days)||0||
60149857|NCT01408719|76274568|FG008|NOT COMPLETED|Washout Period (28 Days)||0||
60149858|NCT01408719|76274569|FG009|NOT COMPLETED|Washout Period (28 Days)||0||
60149859|NCT01408719|76274570|FG010|NOT COMPLETED|Washout Period (28 Days)||0||
60149860|NCT01408719|76274571|FG011|NOT COMPLETED|Washout Period (28 Days)||0||
60149861|NCT01408719|76274572|FG012|NOT COMPLETED|Washout Period (28 Days)||0||
60149862|NCT01408719|76274573|FG013|NOT COMPLETED|Washout Period (28 Days)||0||
60149863|NCT01408719|76274574|FG014|NOT COMPLETED|Washout Period (28 Days)||0||
60149864|NCT01408719|76274575|FG015|NOT COMPLETED|Washout Period (28 Days)||0||
60149865|NCT01408719|76274576|FG016|NOT COMPLETED|Washout Period (28 Days)||0||
60149866|NCT01408719|76274577|FG017|NOT COMPLETED|Washout Period (28 Days)||0||
60149867|NCT01408719|76274578|FG018|NOT COMPLETED|Washout Period (28 Days)||0||
60149868|NCT01408719|76274579|FG019|NOT COMPLETED|Washout Period (28 Days)||0||
60149869|NCT01408719|76274560|FG000|STARTED|Fourth Intervention (35 Days)||2||
60149870|NCT01408719|76274561|FG001|STARTED|Fourth Intervention (35 Days)||3||
60149871|NCT01408719|76274562|FG002|STARTED|Fourth Intervention (35 Days)||1||
60149872|NCT01408719|76274563|FG003|STARTED|Fourth Intervention (35 Days)||2||
60149873|NCT01408719|76274564|FG004|STARTED|Fourth Intervention (35 Days)||3||
60149874|NCT01408719|76274565|FG005|STARTED|Fourth Intervention (35 Days)||3||
60149875|NCT01408719|76274566|FG006|STARTED|Fourth Intervention (35 Days)||2||
60149876|NCT01408719|76274567|FG007|STARTED|Fourth Intervention (35 Days)||2||
60149877|NCT01408719|76274568|FG008|STARTED|Fourth Intervention (35 Days)||1||
60149878|NCT01408719|76274569|FG009|STARTED|Fourth Intervention (35 Days)||1||
60149879|NCT01408719|76274570|FG010|STARTED|Fourth Intervention (35 Days)||2||
60149880|NCT01408719|76274571|FG011|STARTED|Fourth Intervention (35 Days)||2||
60149881|NCT01408719|76274572|FG012|STARTED|Fourth Intervention (35 Days)||1||
60149882|NCT01408719|76274573|FG013|STARTED|Fourth Intervention (35 Days)||3||
60149883|NCT01408719|76274574|FG014|STARTED|Fourth Intervention (35 Days)||1||
60149884|NCT01408719|76274575|FG015|STARTED|Fourth Intervention (35 Days)||1||
60149885|NCT01408719|76274576|FG016|STARTED|Fourth Intervention (35 Days)||2||
60149886|NCT01408719|76274577|FG017|STARTED|Fourth Intervention (35 Days)||2||
60149887|NCT01408719|76274578|FG018|STARTED|Fourth Intervention (35 Days)||0||
60149888|NCT01408719|76274579|FG019|STARTED|Fourth Intervention (35 Days)||1||
60149889|NCT01408719|76274560|FG000|COMPLETED|Fourth Intervention (35 Days)||2||
60149890|NCT01408719|76274561|FG001|COMPLETED|Fourth Intervention (35 Days)||3||
60149891|NCT01408719|76274562|FG002|COMPLETED|Fourth Intervention (35 Days)||1||
60149892|NCT01408719|76274563|FG003|COMPLETED|Fourth Intervention (35 Days)||2||
60149893|NCT01408719|76274564|FG004|COMPLETED|Fourth Intervention (35 Days)||3||
60149894|NCT01408719|76274565|FG005|COMPLETED|Fourth Intervention (35 Days)||3||
60149895|NCT01408719|76274566|FG006|COMPLETED|Fourth Intervention (35 Days)||2||
60149896|NCT01408719|76274567|FG007|COMPLETED|Fourth Intervention (35 Days)||2||
60149897|NCT01408719|76274568|FG008|COMPLETED|Fourth Intervention (35 Days)||1||
60149898|NCT01408719|76274569|FG009|COMPLETED|Fourth Intervention (35 Days)||1||
60149899|NCT01408719|76274570|FG010|COMPLETED|Fourth Intervention (35 Days)||2||
60149900|NCT01408719|76274571|FG011|COMPLETED|Fourth Intervention (35 Days)||2||
60149901|NCT01408719|76274572|FG012|COMPLETED|Fourth Intervention (35 Days)||1||
60149902|NCT01408719|76274573|FG013|COMPLETED|Fourth Intervention (35 Days)||3||
60149903|NCT01408719|76274574|FG014|COMPLETED|Fourth Intervention (35 Days)||1||
60149904|NCT01408719|76274575|FG015|COMPLETED|Fourth Intervention (35 Days)||1||
60149905|NCT01408719|76274576|FG016|COMPLETED|Fourth Intervention (35 Days)||2||
60149906|NCT01408719|76274577|FG017|COMPLETED|Fourth Intervention (35 Days)||2||
60149907|NCT01408719|76274578|FG018|COMPLETED|Fourth Intervention (35 Days)||0||
60149908|NCT01408719|76274579|FG019|COMPLETED|Fourth Intervention (35 Days)||1||
60149909|NCT01408719|76274560|FG000|NOT COMPLETED|Fourth Intervention (35 Days)||0||
60149910|NCT01408719|76274561|FG001|NOT COMPLETED|Fourth Intervention (35 Days)||0||
60149911|NCT01408719|76274562|FG002|NOT COMPLETED|Fourth Intervention (35 Days)||0||
60149912|NCT01408719|76274563|FG003|NOT COMPLETED|Fourth Intervention (35 Days)||0||
60149913|NCT01408719|76274564|FG004|NOT COMPLETED|Fourth Intervention (35 Days)||0||
60149914|NCT01408719|76274565|FG005|NOT COMPLETED|Fourth Intervention (35 Days)||0||
60149915|NCT01408719|76274566|FG006|NOT COMPLETED|Fourth Intervention (35 Days)||0||
60149916|NCT01408719|76274567|FG007|NOT COMPLETED|Fourth Intervention (35 Days)||0||
60149917|NCT01408719|76274568|FG008|NOT COMPLETED|Fourth Intervention (35 Days)||0||
60149918|NCT01408719|76274569|FG009|NOT COMPLETED|Fourth Intervention (35 Days)||0||
60149919|NCT01408719|76274570|FG010|NOT COMPLETED|Fourth Intervention (35 Days)||0||
60149920|NCT01408719|76274571|FG011|NOT COMPLETED|Fourth Intervention (35 Days)||0||
60149921|NCT01408719|76274572|FG012|NOT COMPLETED|Fourth Intervention (35 Days)||0||
60149922|NCT01408719|76274573|FG013|NOT COMPLETED|Fourth Intervention (35 Days)||0||
60149923|NCT01408719|76274574|FG014|NOT COMPLETED|Fourth Intervention (35 Days)||0||
60149924|NCT01408719|76274575|FG015|NOT COMPLETED|Fourth Intervention (35 Days)||0||
60149925|NCT01408719|76274576|FG016|NOT COMPLETED|Fourth Intervention (35 Days)||0||
60149926|NCT01408719|76274577|FG017|NOT COMPLETED|Fourth Intervention (35 Days)||0||
60149927|NCT01408719|76274578|FG018|NOT COMPLETED|Fourth Intervention (35 Days)||0||
60149928|NCT01408719|76274579|FG019|NOT COMPLETED|Fourth Intervention (35 Days)||0||
60149929|NCT01595646|76274592|FG000|STARTED|Overall Study||13||
60149930|NCT01595646|76274593|FG001|STARTED|Overall Study||12||
60149931|NCT01595646|76274594|FG002|STARTED|Overall Study||12||
60149932|NCT01595646|76274592|FG000|COMPLETED|Overall Study||12||
60149933|NCT01595646|76274593|FG001|COMPLETED|Overall Study||12||
60149934|NCT01595646|76274594|FG002|COMPLETED|Overall Study||12||
60149935|NCT01595646|76274592|FG000|NOT COMPLETED|Overall Study||1||
60149936|NCT01595646|76274593|FG001|NOT COMPLETED|Overall Study||0||
60149937|NCT01595646|76274594|FG002|NOT COMPLETED|Overall Study||0||
60149938|NCT01907191|76274607|FG000|STARTED|Overall Study||13||
60149939|NCT01907191|76274608|FG001|STARTED|Overall Study||10||
60149940|NCT01907191|76274607|FG000|COMPLETED|Overall Study||13||
60149941|NCT01907191|76274608|FG001|COMPLETED|Overall Study||10||
60149942|NCT01907191|76274607|FG000|NOT COMPLETED|Overall Study||0||
60149943|NCT01907191|76274608|FG001|NOT COMPLETED|Overall Study||0||
60149944|NCT01395537|76274616|FG000|STARTED|Phase I||13||
60149945|NCT01395537|76274616|FG000|COMPLETED|Phase I||13||
60149946|NCT01395537|76274616|FG000|NOT COMPLETED|Phase I||0||
60149947|NCT01395537|76274616|FG000|STARTED|Phase II||1|Only one participant was eligible to move to the phase II part of the study.|
60149948|NCT01395537|76274616|FG000|COMPLETED|Phase II||1||
60149949|NCT01395537|76274616|FG000|NOT COMPLETED|Phase II||0||
60149950|NCT00981461|76274622|FG000|STARTED|Overall Study||48||
60149951|NCT00981461|76274623|FG001|STARTED|Overall Study||24||
60149952|NCT00981461|76274622|FG000|COMPLETED|Overall Study||43||
60149953|NCT00981461|76274623|FG001|COMPLETED|Overall Study||22||
60149954|NCT00981461|76274622|FG000|NOT COMPLETED|Overall Study||5||
60149955|NCT00981461|76274623|FG001|NOT COMPLETED|Overall Study||2||
60149956|NCT02317549|76274631|FG000|STARTED|Overall Study||5||
60149957|NCT02317549|76274632|FG001|STARTED|Overall Study||3||
60149958|NCT02317549|76274631|FG000|COMPLETED|Overall Study||5||
60149959|NCT02317549|76274632|FG001|COMPLETED|Overall Study||3||
60149960|NCT02317549|76274631|FG000|NOT COMPLETED|Overall Study||0||
60149961|NCT02317549|76274632|FG001|NOT COMPLETED|Overall Study||0||
60149962|NCT02618616|76274640|FG000|STARTED|Overall Study||87||
60149963|NCT02618616|76274641|FG001|STARTED|Overall Study||42||
60149964|NCT02618616|76274640|FG000|COMPLETED|Overall Study||66||
60149965|NCT02618616|76274641|FG001|COMPLETED|Overall Study||35||
60149966|NCT02618616|76274640|FG000|NOT COMPLETED|Overall Study||21||
60149967|NCT02618616|76274641|FG001|NOT COMPLETED|Overall Study||7||
60149968|NCT01396239|76274651|FG000|STARTED|Overall Study||4||
60149969|NCT01396239|76274652|FG001|STARTED|Overall Study||2||
60149970|NCT01396239|76274653|FG002|STARTED|Overall Study||4||
60149971|NCT01396239|76274654|FG003|STARTED|Overall Study||2||
60149972|NCT01396239|76274651|FG000|COMPLETED|Overall Study||4||
60149973|NCT01396239|76274652|FG001|COMPLETED|Overall Study||2||
60149974|NCT01396239|76274653|FG002|COMPLETED|Overall Study||4||
60149975|NCT01396239|76274654|FG003|COMPLETED|Overall Study||2||
59519082|NCT01093651|75612959|FG000|NOT COMPLETED|Overall Study||0||
60149976|NCT01396239|76274651|FG000|NOT COMPLETED|Overall Study||0||
60149977|NCT01396239|76274652|FG001|NOT COMPLETED|Overall Study||0||
60149978|NCT01396239|76274653|FG002|NOT COMPLETED|Overall Study||0||
60149979|NCT01396239|76274654|FG003|NOT COMPLETED|Overall Study||0||
60149980|NCT02225275|76274671|FG000|STARTED|Overall Study||9||
60149981|NCT02225275|76274671|FG000|COMPLETED|Overall Study||9||
60149982|NCT02225275|76274671|FG000|NOT COMPLETED|Overall Study||0||
60149983|NCT01411137|76274675|FG000|STARTED|Part 1: Dose Conversion||43||
60149984|NCT01411137|76274675|FG000|COMPLETED|Part 1: Dose Conversion||33||
60149985|NCT01411137|76274675|FG000|NOT COMPLETED|Part 1: Dose Conversion||10||
60149986|NCT01411137|76274675|FG000|STARTED|Part 2: Open-Label Extension|1 subject who completed Part 1 did not elect to continue into Part 2.|32||
60149987|NCT01411137|76274675|FG000|COMPLETED|Part 2: Open-Label Extension||25||
60149988|NCT01411137|76274675|FG000|NOT COMPLETED|Part 2: Open-Label Extension||7||
60149989|NCT01411137|76274675|FG000|STARTED|Part 3: Open-Label Extension|Two sites with 11 completers of Part 2 did not participate in Part 3. Two subjects lost contact.|12||
60149990|NCT01411137|76274675|FG000|COMPLETED|Part 3: Open-Label Extension||12||
60149991|NCT01411137|76274675|FG000|NOT COMPLETED|Part 3: Open-Label Extension||0||
60149992|NCT01411527|76274692|FG000|STARTED|Overall Study||1864||
60149993|NCT01411527|76274693|FG001|STARTED|Overall Study||93||
60149994|NCT01411527|76274692|FG000|COMPLETED|Overall Study||1864|116 participants were later transferred to the longitudinal cohort|
60149995|NCT01411527|76274693|FG001|COMPLETED|Overall Study||93|116 participants were later transferred to the longitudinal cohort|
60149996|NCT01411527|76274692|FG000|NOT COMPLETED|Overall Study||0||
60149997|NCT01411527|76274693|FG001|NOT COMPLETED|Overall Study||0||
60149998|NCT02216851|76274700|FG000|STARTED|Overall Study||98||
60149999|NCT02216851|76274701|FG001|STARTED|Overall Study||33||
60150000|NCT02216851|76274700|FG000|COMPLETED|Overall Study||96||
60150001|NCT02216851|76274701|FG001|COMPLETED|Overall Study||32||
60150002|NCT02216851|76274700|FG000|NOT COMPLETED|Overall Study||2||
60150003|NCT02216851|76274701|FG001|NOT COMPLETED|Overall Study||1||
60150004|NCT01396551|76274707|FG000|STARTED|Overall Study||69||
60150005|NCT01396551|76274707|FG000|COMPLETED|Overall Study||69||
60150006|NCT01396551|76274707|FG000|NOT COMPLETED|Overall Study||0||
60150007|NCT01399827|76274713|FG000|STARTED|Overall Study||1||
60150008|NCT01399827|76274714|FG001|STARTED|Overall Study||1||
60150009|NCT01399827|76274713|FG000|COMPLETED|Overall Study||1||
60150010|NCT01399827|76274714|FG001|COMPLETED|Overall Study||1||
60150011|NCT01399827|76274713|FG000|NOT COMPLETED|Overall Study||0||
60150012|NCT01399827|76274714|FG001|NOT COMPLETED|Overall Study||0||
60150013|NCT02618382|76274720|FG000|STARTED|Overall Study|Enrolled and consented for study treatment|32||
60150014|NCT02618382|76274720|FG000|COMPLETED|Overall Study|Completed Study treatment|29||
60150015|NCT02618382|76274720|FG000|NOT COMPLETED|Overall Study||3||
60150016|NCT01412541|76274726|FG000|STARTED|Overall Study||372||
60150017|NCT01412541|76274727|FG001|STARTED|Overall Study||160||
60150018|NCT01412541|76274726|FG000|COMPLETED|Overall Study||246||
60150019|NCT01412541|76274727|FG001|COMPLETED|Overall Study||117||
60150020|NCT01412541|76274726|FG000|NOT COMPLETED|Overall Study||126||
60150021|NCT01412541|76274727|FG001|NOT COMPLETED|Overall Study||43||
60150022|NCT01413087|76274738|FG000|STARTED|Overall Study||6||
60150023|NCT01413087|76274739|FG001|STARTED|Overall Study||6||
60150024|NCT01413087|76274738|FG000|COMPLETED|Overall Study||6||
60150025|NCT01413087|76274739|FG001|COMPLETED|Overall Study||6||
60150026|NCT01413087|76274738|FG000|NOT COMPLETED|Overall Study||0||
60150027|NCT01413087|76274739|FG001|NOT COMPLETED|Overall Study||0||
60150028|NCT01474863|76274748|FG000|STARTED|Overall Study||26||
60150029|NCT01474863|76274749|FG001|STARTED|Overall Study||22||
60150030|NCT01474863|76274750|FG002|STARTED|Overall Study||24||
60150031|NCT01474863|76274748|FG000|COMPLETED|Overall Study||26||
60150032|NCT01474863|76274749|FG001|COMPLETED|Overall Study||22||
60150033|NCT01474863|76274750|FG002|COMPLETED|Overall Study||24||
60150034|NCT01474863|76274748|FG000|NOT COMPLETED|Overall Study||0||
60150035|NCT01474863|76274749|FG001|NOT COMPLETED|Overall Study||0||
60150036|NCT01474863|76274750|FG002|NOT COMPLETED|Overall Study||0||
60150037|NCT01475175|76274758|FG000|STARTED|Overall Study||12||
60150038|NCT01475175|76274758|FG000|COMPLETED|Overall Study||12||
60150039|NCT01475175|76274758|FG000|NOT COMPLETED|Overall Study||0||
60150040|NCT00980057|76274764|FG000|STARTED|Overall Study||318||
60150041|NCT00980057|76274765|FG001|STARTED|Overall Study||160||
60150042|NCT00980057|76274764|FG000|COMPLETED|Overall Study||299||
60150043|NCT00980057|76274765|FG001|COMPLETED|Overall Study||155||
60150044|NCT00980057|76274764|FG000|NOT COMPLETED|Overall Study||19||
60150045|NCT00980057|76274765|FG001|NOT COMPLETED|Overall Study||5||
60150046|NCT03006185|76274772|FG000|STARTED|Overall Study|Since all participants had two test areas each, all participants received both interventions (18 test areas received CO2 and 18 test areas received microdermabrasion)|18||36
60150047|NCT03006185|76274772|FG000|Number of Test Areas Recieving AFL|Overall Study||18||36
60150048|NCT03006185|76274772|FG000|Number of Test Areas Receiving MD|Overall Study||18||36
60150049|NCT03006185|76274772|FG000|COMPLETED|Overall Study||18||36
60150050|NCT03006185|76274772|FG000|NOT COMPLETED|Overall Study||0||0
60150051|NCT01475643|76274780|FG000|STARTED|Overall Study|53 included in Intent-to-treat (ITT) population, due to no post-treatment assessment.|54||
60150052|NCT01475643|76274781|FG001|STARTED|Overall Study|52 included in Intent-to-treat (ITT) population, due to no post-treatment assessment.|53||
60150053|NCT01475643|76274780|FG000|COMPLETED|Overall Study||40||
60150054|NCT01475643|76274781|FG001|COMPLETED|Overall Study||43||
60150055|NCT01475643|76274780|FG000|NOT COMPLETED|Overall Study||14||
60150056|NCT01475643|76274781|FG001|NOT COMPLETED|Overall Study||10||
60150057|NCT01836445|76274789|FG000|STARTED|Intervention Modules||445||
60150058|NCT01836445|76274790|FG001|STARTED|Intervention Modules||456||
60150059|NCT01836445|76274789|FG000|COMPLETED|Intervention Modules||375||
60150060|NCT01836445|76274790|FG001|COMPLETED|Intervention Modules||434||
60150061|NCT01836445|76274789|FG000|NOT COMPLETED|Intervention Modules||70||
60150062|NCT01836445|76274790|FG001|NOT COMPLETED|Intervention Modules||22||
60150063|NCT01836445|76274789|FG000|STARTED|3 Month Follow-up Assessment|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|445||
60150064|NCT01836445|76274790|FG001|STARTED|3 Month Follow-up Assessment|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|456||
59751561|NCT00969761|75870892|FG003|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||1||
59751562|NCT00969761|75870893|FG004|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0||
59751563|NCT00969761|75870894|FG005|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0||
59751564|NCT00969761|75870895|FG006|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0||
59751565|NCT00969761|75870896|FG007|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0||
60150065|NCT01836445|76274789|FG000|COMPLETED|3 Month Follow-up Assessment||348||
60150066|NCT01836445|76274790|FG001|COMPLETED|3 Month Follow-up Assessment||409||
60150067|NCT01836445|76274789|FG000|NOT COMPLETED|3 Month Follow-up Assessment||97||
60150068|NCT01836445|76274790|FG001|NOT COMPLETED|3 Month Follow-up Assessment||47||
60150069|NCT01836445|76274789|FG000|STARTED|6 Month Follow-up Assessment|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|445||
60150070|NCT01836445|76274790|FG001|STARTED|6 Month Follow-up Assessment|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|455||
59751566|NCT00969761|75870897|FG008|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||2||
59751567|NCT00969761|75870898|FG009|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||1||
59751568|NCT00969761|75870899|FG010|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0||
59882127|NCT03848403|76005049|FG001|COMPLETED|Period 1 (Day 1)||24||
59882128|NCT03848403|76005050|FG002|COMPLETED|Period 1 (Day 1)||22||
59882129|NCT03848403|76005048|FG000|NOT COMPLETED|Period 1 (Day 1)||0||
60150071|NCT01836445|76274789|FG000|COMPLETED|6 Month Follow-up Assessment||342||
60150072|NCT01836445|76274790|FG001|COMPLETED|6 Month Follow-up Assessment||380||
60150073|NCT01836445|76274789|FG000|NOT COMPLETED|6 Month Follow-up Assessment||103||
60150074|NCT01836445|76274790|FG001|NOT COMPLETED|6 Month Follow-up Assessment||75||
60150075|NCT01836445|76274789|FG000|STARTED|12 Month Follow-up Assessment|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|445||
60150076|NCT01836445|76274790|FG001|STARTED|12 Month Follow-up Assessment|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|455||
60150077|NCT01836445|76274789|FG000|COMPLETED|12 Month Follow-up Assessment||370||
60150078|NCT01836445|76274790|FG001|COMPLETED|12 Month Follow-up Assessment||391||
60150079|NCT01836445|76274789|FG000|NOT COMPLETED|12 Month Follow-up Assessment||75||
60150080|NCT01836445|76274790|FG001|NOT COMPLETED|12 Month Follow-up Assessment||64||
60150081|NCT01836445|76274789|FG000|STARTED|12 Month STI Testing|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|445||
60150082|NCT01836445|76274790|FG001|STARTED|12 Month STI Testing|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|455||
60150083|NCT01836445|76274789|FG000|COMPLETED|12 Month STI Testing||365||
60150084|NCT01836445|76274790|FG001|COMPLETED|12 Month STI Testing||378||
60150085|NCT01836445|76274789|FG000|NOT COMPLETED|12 Month STI Testing||80||
60150086|NCT01836445|76274790|FG001|NOT COMPLETED|12 Month STI Testing||77||
60150087|NCT03237377|76274798|FG000|STARTED|Overall Study||9||
60150088|NCT03237377|76274799|FG001|STARTED|Overall Study||0||
60150089|NCT03237377|76274798|FG000|COMPLETED|Overall Study||9||
59751569|NCT00969761|75870900|FG011|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0||
60150090|NCT03237377|76274799|FG001|COMPLETED|Overall Study||0||
60150091|NCT03237377|76274798|FG000|NOT COMPLETED|Overall Study||0||
60150092|NCT03237377|76274799|FG001|NOT COMPLETED|Overall Study||0||
60150093|NCT01475955|76274810|FG000|STARTED|Overall Study||48||
60150094|NCT01475955|76274811|FG001|STARTED|Overall Study||48||
60150095|NCT01475955|76274812|FG002|STARTED|Overall Study||47||
60150096|NCT01475955|76274813|FG003|STARTED|Overall Study||46||
60150097|NCT01475955|76274814|FG004|STARTED|Overall Study||46||
60150098|NCT01475955|76274810|FG000|COMPLETED|Overall Study||47||
60150099|NCT01475955|76274811|FG001|COMPLETED|Overall Study||48||
60150100|NCT01475955|76274812|FG002|COMPLETED|Overall Study||44||
60150101|NCT01475955|76274813|FG003|COMPLETED|Overall Study||46||
60150102|NCT01475955|76274814|FG004|COMPLETED|Overall Study||46||
60150103|NCT01475955|76274810|FG000|NOT COMPLETED|Overall Study||1||
60150104|NCT01475955|76274811|FG001|NOT COMPLETED|Overall Study||0||
60150105|NCT01475955|76274812|FG002|NOT COMPLETED|Overall Study||3||
60150106|NCT01475955|76274813|FG003|NOT COMPLETED|Overall Study||0||
60150107|NCT01475955|76274814|FG004|NOT COMPLETED|Overall Study||0||
60150108|NCT01476267|76274845|FG000|STARTED|Overall Study||6||
60150109|NCT01476267|76274845|FG000|COMPLETED|Overall Study||6||
59605781|NCT01987908|75715899|FG002|STARTED|Post-Treatment Observation Period||2||
60150110|NCT01476267|76274845|FG000|NOT COMPLETED|Overall Study||0||
60150111|NCT01476345|76274849|FG000|STARTED|Period 1||40||
60150112|NCT01476345|76274850|FG001|STARTED|Period 1||40||
60150113|NCT01476345|76274849|FG000|Received at Least 1 Dose of Study Drug|Period 1||40||
60150114|NCT01476345|76274850|FG001|Received at Least 1 Dose of Study Drug|Period 1||40||
60150115|NCT01476345|76274849|FG000|COMPLETED|Period 1||40||
60150116|NCT01476345|76274850|FG001|COMPLETED|Period 1||40||
60150117|NCT01476345|76274849|FG000|NOT COMPLETED|Period 1||0||
60150118|NCT01476345|76274850|FG001|NOT COMPLETED|Period 1||0||
60150119|NCT01476345|76274849|FG000|STARTED|Period 2||40||
60150120|NCT01476345|76274850|FG001|STARTED|Period 2||40||
60150121|NCT01476345|76274849|FG000|COMPLETED|Period 2|1 did not enter Period 3 due to participant's decision.|40||
60150122|NCT01476345|76274850|FG001|COMPLETED|Period 2|1 did not enter Period 3 due to participant's decision.|40||
60150123|NCT01476345|76274849|FG000|NOT COMPLETED|Period 2||0||
60150124|NCT01476345|76274850|FG001|NOT COMPLETED|Period 2||0||
60150125|NCT01476345|76274849|FG000|STARTED|Period 3||39||
60150126|NCT01476345|76274850|FG001|STARTED|Period 3||39||
60150127|NCT01476345|76274849|FG000|COMPLETED|Period 3||39||
60150128|NCT01476345|76274850|FG001|COMPLETED|Period 3||39||
60150129|NCT01476345|76274849|FG000|NOT COMPLETED|Period 3||0||
60150130|NCT01476345|76274850|FG001|NOT COMPLETED|Period 3||0||
60150131|NCT01476345|76274849|FG000|STARTED|Period 4||39||
60150132|NCT01476345|76274850|FG001|STARTED|Period 4||39||
60150133|NCT01476345|76274849|FG000|COMPLETED|Period 4||39||
60150134|NCT01476345|76274850|FG001|COMPLETED|Period 4||39||
60150135|NCT01476345|76274849|FG000|NOT COMPLETED|Period 4||0||
60150136|NCT01476345|76274850|FG001|NOT COMPLETED|Period 4||0||
60150137|NCT01401543|76274856|FG000|STARTED|First Intervention||6||
60150138|NCT01401543|76274857|FG001|STARTED|First Intervention||6||
60150139|NCT01401543|76274858|FG002|STARTED|First Intervention||6||
60150140|NCT01401543|76274859|FG003|STARTED|First Intervention||6||
60150141|NCT01401543|76274856|FG000|COMPLETED|First Intervention||6||
60150142|NCT01401543|76274857|FG001|COMPLETED|First Intervention||6||
60150143|NCT01401543|76274858|FG002|COMPLETED|First Intervention||6||
60150144|NCT01401543|76274859|FG003|COMPLETED|First Intervention||6||
60150145|NCT01401543|76274856|FG000|NOT COMPLETED|First Intervention||0||
60150146|NCT01401543|76274857|FG001|NOT COMPLETED|First Intervention||0||
60150147|NCT01401543|76274858|FG002|NOT COMPLETED|First Intervention||0||
60150148|NCT01401543|76274859|FG003|NOT COMPLETED|First Intervention||0||
60150149|NCT01401543|76274856|FG000|STARTED|First Washout Period of 1 Week||6||
60150150|NCT01401543|76274857|FG001|STARTED|First Washout Period of 1 Week||6||
60150151|NCT01401543|76274858|FG002|STARTED|First Washout Period of 1 Week||6||
60150152|NCT01401543|76274859|FG003|STARTED|First Washout Period of 1 Week||6||
60150153|NCT01401543|76274856|FG000|COMPLETED|First Washout Period of 1 Week||6||
60150154|NCT01401543|76274857|FG001|COMPLETED|First Washout Period of 1 Week||6||
60150155|NCT01401543|76274858|FG002|COMPLETED|First Washout Period of 1 Week||6||
60150156|NCT01401543|76274859|FG003|COMPLETED|First Washout Period of 1 Week||6||
60150157|NCT01401543|76274856|FG000|NOT COMPLETED|First Washout Period of 1 Week||0||
59762635|NCT04920929|75882471|FG000|COMPLETED|Overall Study||3||
60150158|NCT01401543|76274857|FG001|NOT COMPLETED|First Washout Period of 1 Week||0||
60150159|NCT01401543|76274858|FG002|NOT COMPLETED|First Washout Period of 1 Week||0||
60150160|NCT01401543|76274859|FG003|NOT COMPLETED|First Washout Period of 1 Week||0||
60150161|NCT01401543|76274856|FG000|STARTED|Second Intervention||6||
60150162|NCT01401543|76274857|FG001|STARTED|Second Intervention||6||
60150163|NCT01401543|76274858|FG002|STARTED|Second Intervention||6||
60150164|NCT01401543|76274859|FG003|STARTED|Second Intervention||6||
60150165|NCT01401543|76274856|FG000|COMPLETED|Second Intervention||6||
60150166|NCT01401543|76274857|FG001|COMPLETED|Second Intervention||6||
60150167|NCT01401543|76274858|FG002|COMPLETED|Second Intervention||6||
60150168|NCT01401543|76274859|FG003|COMPLETED|Second Intervention||6||
60150169|NCT01401543|76274856|FG000|NOT COMPLETED|Second Intervention||0||
60150170|NCT01401543|76274857|FG001|NOT COMPLETED|Second Intervention||0||
60150171|NCT01401543|76274858|FG002|NOT COMPLETED|Second Intervention||0||
60150172|NCT01401543|76274859|FG003|NOT COMPLETED|Second Intervention||0||
60150173|NCT01401543|76274856|FG000|STARTED|Second Washout Period of 1 Week||6||
60150174|NCT01401543|76274857|FG001|STARTED|Second Washout Period of 1 Week||6||
60150175|NCT01401543|76274858|FG002|STARTED|Second Washout Period of 1 Week||6||
60150176|NCT01401543|76274859|FG003|STARTED|Second Washout Period of 1 Week||6||
60150177|NCT01401543|76274856|FG000|COMPLETED|Second Washout Period of 1 Week||6||
60150178|NCT01401543|76274857|FG001|COMPLETED|Second Washout Period of 1 Week||6||
60150179|NCT01401543|76274858|FG002|COMPLETED|Second Washout Period of 1 Week||6||
60150180|NCT01401543|76274859|FG003|COMPLETED|Second Washout Period of 1 Week||6||
60150181|NCT01401543|76274856|FG000|NOT COMPLETED|Second Washout Period of 1 Week||0||
60150182|NCT01401543|76274857|FG001|NOT COMPLETED|Second Washout Period of 1 Week||0||
60150183|NCT01401543|76274858|FG002|NOT COMPLETED|Second Washout Period of 1 Week||0||
60150184|NCT01401543|76274859|FG003|NOT COMPLETED|Second Washout Period of 1 Week||0||
60150185|NCT01401543|76274856|FG000|STARTED|Third Intervention||6||
60150186|NCT01401543|76274857|FG001|STARTED|Third Intervention||6||
60150187|NCT01401543|76274858|FG002|STARTED|Third Intervention||6||
60150188|NCT01401543|76274859|FG003|STARTED|Third Intervention||6||
60150189|NCT01401543|76274856|FG000|COMPLETED|Third Intervention||6||
60150190|NCT01401543|76274857|FG001|COMPLETED|Third Intervention||6||
60150191|NCT01401543|76274858|FG002|COMPLETED|Third Intervention||6||
60150192|NCT01401543|76274859|FG003|COMPLETED|Third Intervention||6||
60150193|NCT01401543|76274856|FG000|NOT COMPLETED|Third Intervention||0||
60150194|NCT01401543|76274857|FG001|NOT COMPLETED|Third Intervention||0||
60150195|NCT01401543|76274858|FG002|NOT COMPLETED|Third Intervention||0||
60150196|NCT01401543|76274859|FG003|NOT COMPLETED|Third Intervention||0||
60150197|NCT01401543|76274856|FG000|STARTED|Third Washout Period of 1 Week||6||
60150198|NCT01401543|76274857|FG001|STARTED|Third Washout Period of 1 Week||6||
60150199|NCT01401543|76274858|FG002|STARTED|Third Washout Period of 1 Week||6||
60150200|NCT01401543|76274859|FG003|STARTED|Third Washout Period of 1 Week||6||
60150201|NCT01401543|76274856|FG000|COMPLETED|Third Washout Period of 1 Week||6||
60150202|NCT01401543|76274857|FG001|COMPLETED|Third Washout Period of 1 Week||6||
60150203|NCT01401543|76274858|FG002|COMPLETED|Third Washout Period of 1 Week||6||
60150204|NCT01401543|76274859|FG003|COMPLETED|Third Washout Period of 1 Week||6||
60150205|NCT01401543|76274856|FG000|NOT COMPLETED|Third Washout Period of 1 Week||0||
60150206|NCT01401543|76274857|FG001|NOT COMPLETED|Third Washout Period of 1 Week||0||
60150207|NCT01401543|76274858|FG002|NOT COMPLETED|Third Washout Period of 1 Week||0||
60150208|NCT01401543|76274859|FG003|NOT COMPLETED|Third Washout Period of 1 Week||0||
60150209|NCT01401543|76274856|FG000|STARTED|Fourth Intervention||6||
60150210|NCT01401543|76274857|FG001|STARTED|Fourth Intervention||6||
60150211|NCT01401543|76274858|FG002|STARTED|Fourth Intervention||6||
60150212|NCT01401543|76274859|FG003|STARTED|Fourth Intervention||6||
60150213|NCT01401543|76274856|FG000|COMPLETED|Fourth Intervention||6||
60150214|NCT01401543|76274857|FG001|COMPLETED|Fourth Intervention||6||
60150215|NCT01401543|76274858|FG002|COMPLETED|Fourth Intervention||6||
60150216|NCT01401543|76274859|FG003|COMPLETED|Fourth Intervention||6||
60150217|NCT01401543|76274856|FG000|NOT COMPLETED|Fourth Intervention||0||
60150218|NCT01401543|76274857|FG001|NOT COMPLETED|Fourth Intervention||0||
60150219|NCT01401543|76274858|FG002|NOT COMPLETED|Fourth Intervention||0||
60150220|NCT01401543|76274859|FG003|NOT COMPLETED|Fourth Intervention||0||
60150221|NCT01414413|76274875|FG000|STARTED|Overall Study|Adult population denominator for cluster randomised trial|8194||
60150222|NCT01414413|76274876|FG001|STARTED|Overall Study|Adult population denominator for cluster randomised trial|8466||
60150223|NCT01414413|76274875|FG000|COMPLETED|Overall Study|Adult population denominator for cluster randomised trial|8194||
60150224|NCT01414413|76274876|FG001|COMPLETED|Overall Study|Adult population denominator for cluster randomised trial|8466||
60150225|NCT01414413|76274875|FG000|NOT COMPLETED|Overall Study||0||
60150226|NCT01414413|76274876|FG001|NOT COMPLETED|Overall Study||0||
60150227|NCT04486560|76274882|FG000|STARTED|Overall Study||51||
60150228|NCT04486560|76274882|FG000|COMPLETED|Overall Study||50||
60150229|NCT04486560|76274882|FG000|NOT COMPLETED|Overall Study||1||
60150230|NCT04126733|76274886|FG000|STARTED|Treatment Period||70||
60150231|NCT04126733|76274886|FG000|COMPLETED|Treatment Period||0||
60150232|NCT04126733|76274886|FG000|NOT COMPLETED|Treatment Period||70||
60150233|NCT04126733|76274886|FG000|STARTED|Active Follow-up Period|Participants had the option to decline participation in active follow-up.|39||
60150234|NCT04126733|76274886|FG000|COMPLETED|Active Follow-up Period||19||
60150235|NCT04126733|76274886|FG000|NOT COMPLETED|Active Follow-up Period||20||
60150236|NCT04126733|76274886|FG000|STARTED|Long-term Follow-up Period|All participants who accepted long-term follow-up.|29||
60150237|NCT04126733|76274886|FG000|COMPLETED|Long-term Follow-up Period||0||
60150238|NCT04126733|76274886|FG000|NOT COMPLETED|Long-term Follow-up Period||29||
60150239|NCT02115373|76274893|FG000|STARTED|Overall Study||4||
60150240|NCT02115373|76274894|FG001|STARTED|Overall Study||13||
60150241|NCT02115373|76274895|FG002|STARTED|Overall Study||49||
60150242|NCT02115373|76274893|FG000|COMPLETED|Overall Study||4||
60150243|NCT02115373|76274894|FG001|COMPLETED|Overall Study||13||
60150244|NCT02115373|76274895|FG002|COMPLETED|Overall Study||49||
60150245|NCT02115373|76274893|FG000|NOT COMPLETED|Overall Study||0||
60150246|NCT02115373|76274894|FG001|NOT COMPLETED|Overall Study||0||
60150247|NCT02115373|76274895|FG002|NOT COMPLETED|Overall Study||0||
60150248|NCT02053909|76274912|FG000|STARTED|Overall Study||123||
60150249|NCT02053909|76274913|FG001|STARTED|Overall Study||127||
60150250|NCT02053909|76274912|FG000|COMPLETED|Overall Study||123||
60150251|NCT02053909|76274913|FG001|COMPLETED|Overall Study||127||
60150252|NCT02053909|76274912|FG000|NOT COMPLETED|Overall Study||0||
60150253|NCT02053909|76274913|FG001|NOT COMPLETED|Overall Study||0||
60150254|NCT00988247|76274921|FG000|STARTED|Overall Study||418||
60150255|NCT00988247|76274922|FG001|STARTED|Overall Study||111||
60150256|NCT00988247|76274921|FG000|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|415||
60150257|NCT00988247|76274922|FG001|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|111||
60150258|NCT00988247|76274921|FG000|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment|414||
60150259|NCT00988247|76274922|FG001|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment|110||
60150260|NCT00988247|76274921|FG000|COMPLETED|Overall Study||335||
60150261|NCT00988247|76274922|FG001|COMPLETED|Overall Study||85||
60150262|NCT00988247|76274921|FG000|NOT COMPLETED|Overall Study||83||
60150263|NCT00988247|76274922|FG001|NOT COMPLETED|Overall Study||26||
60150264|NCT00984659|76274932|FG000|STARTED|2-week Run-in Period||418||
60150265|NCT00984659|76274933|FG001|STARTED|2-week Run-in Period||0||
60150266|NCT00984659|76274934|FG002|STARTED|2-week Run-in Period||0||
60150267|NCT00984659|76274935|FG003|STARTED|2-week Run-in Period||0||
60150268|NCT00984659|76274932|FG000|COMPLETED|2-week Run-in Period||366||
60150269|NCT00984659|76274933|FG001|COMPLETED|2-week Run-in Period||0||
60150270|NCT00984659|76274934|FG002|COMPLETED|2-week Run-in Period||0||
60150271|NCT00984659|76274935|FG003|COMPLETED|2-week Run-in Period||0||
60150272|NCT00984659|76274932|FG000|NOT COMPLETED|2-week Run-in Period||52||
60150273|NCT00984659|76274933|FG001|NOT COMPLETED|2-week Run-in Period||0||
59751570|NCT00969761|75870889|FG000|STARTED|Treated in and Beyond Treat. Cycle 2||2||
59751571|NCT00969761|75870890|FG001|STARTED|Treated in and Beyond Treat. Cycle 2||3||
59751572|NCT00969761|75870891|FG002|STARTED|Treated in and Beyond Treat. Cycle 2||10||
60150274|NCT00984659|76274934|FG002|NOT COMPLETED|2-week Run-in Period||0||
60150275|NCT00984659|76274935|FG003|NOT COMPLETED|2-week Run-in Period||0||
60150276|NCT00984659|76274932|FG000|STARTED|6-week Double-blind Treatment Period||0||
60150277|NCT00984659|76274933|FG001|STARTED|6-week Double-blind Treatment Period||75||
60150278|NCT00984659|76274934|FG002|STARTED|6-week Double-blind Treatment Period||152||
60150279|NCT00984659|76274935|FG003|STARTED|6-week Double-blind Treatment Period||139||
60150280|NCT00984659|76274932|FG000|COMPLETED|6-week Double-blind Treatment Period||0||
60150281|NCT00984659|76274933|FG001|COMPLETED|6-week Double-blind Treatment Period||69||
60150282|NCT00984659|76274934|FG002|COMPLETED|6-week Double-blind Treatment Period||141||
60150283|NCT00984659|76274935|FG003|COMPLETED|6-week Double-blind Treatment Period||126||
60150284|NCT00984659|76274932|FG000|NOT COMPLETED|6-week Double-blind Treatment Period||0||
60150285|NCT00984659|76274933|FG001|NOT COMPLETED|6-week Double-blind Treatment Period||6||
60150286|NCT00984659|76274934|FG002|NOT COMPLETED|6-week Double-blind Treatment Period||11||
60150287|NCT00984659|76274935|FG003|NOT COMPLETED|6-week Double-blind Treatment Period||13||
60150288|NCT00982319|76274944|FG000|STARTED|Overall Study||17||
60150289|NCT00982319|76274945|FG001|STARTED|Overall Study||17||
60150290|NCT00982319|76274944|FG000|COMPLETED|Overall Study||15||
60150291|NCT00982319|76274945|FG001|COMPLETED|Overall Study||15||
60150292|NCT00982319|76274944|FG000|NOT COMPLETED|Overall Study||2||
60150293|NCT00982319|76274945|FG001|NOT COMPLETED|Overall Study||2||
60150294|NCT02315261|76274951|FG000|STARTED|Overall Study||364||
60150295|NCT02315261|76274951|FG000|COMPLETED|Overall Study||364||
60150296|NCT02315261|76274951|FG000|NOT COMPLETED|Overall Study||0||
59751573|NCT00969761|75870892|FG003|STARTED|Treated in and Beyond Treat. Cycle 2||5||
59762636|NCT04920929|75882472|FG001|COMPLETED|Overall Study||4||
60150297|NCT02612064|76274957|FG000|STARTED|Overall Study||115||
60150298|NCT02612064|76274958|FG001|STARTED|Overall Study||115||
60150299|NCT02612064|76274957|FG000|COMPLETED|Overall Study||114||
60150300|NCT02612064|76274958|FG001|COMPLETED|Overall Study||112||
60150301|NCT02612064|76274957|FG000|NOT COMPLETED|Overall Study||1||
60150302|NCT02612064|76274958|FG001|NOT COMPLETED|Overall Study||3||
60150303|NCT01728805|76274966|FG000|STARTED|Randomization Period||186||
60150304|NCT01728805|76274967|FG001|STARTED|Randomization Period||186||
60150305|NCT01728805|76274968|FG002|STARTED|Randomization Period||0||
60150306|NCT01728805|76274966|FG000|COMPLETED|Randomization Period||186||
60150307|NCT01728805|76274967|FG001|COMPLETED|Randomization Period||186||
60150308|NCT01728805|76274968|FG002|COMPLETED|Randomization Period||0||
60150309|NCT01728805|76274966|FG000|NOT COMPLETED|Randomization Period||0||
60150310|NCT01728805|76274967|FG001|NOT COMPLETED|Randomization Period||0||
60150311|NCT01728805|76274968|FG002|NOT COMPLETED|Randomization Period||0||
60150312|NCT01728805|76274966|FG000|STARTED|Crossover Period||0||
60150313|NCT01728805|76274967|FG001|STARTED|Crossover Period||0||
60150314|NCT01728805|76274968|FG002|STARTED|Crossover Period||136||
60150315|NCT01728805|76274966|FG000|COMPLETED|Crossover Period||0||
60150316|NCT01728805|76274967|FG001|COMPLETED|Crossover Period||0||
60150317|NCT01728805|76274968|FG002|COMPLETED|Crossover Period||136||
60150318|NCT01728805|76274966|FG000|NOT COMPLETED|Crossover Period||0||
60150319|NCT01728805|76274967|FG001|NOT COMPLETED|Crossover Period||0||
60150320|NCT01728805|76274968|FG002|NOT COMPLETED|Crossover Period||0||
60150321|NCT02614560|76274977|FG000|STARTED|Overall Study||6||
60150322|NCT02614560|76274978|FG001|STARTED|Overall Study||8||
60150323|NCT02614560|76274977|FG000|COMPLETED|Overall Study||0||
60150324|NCT02614560|76274978|FG001|COMPLETED|Overall Study||6||
60150325|NCT02614560|76274977|FG000|NOT COMPLETED|Overall Study||6||
60150326|NCT02614560|76274978|FG001|NOT COMPLETED|Overall Study||2||
60150327|NCT03821675|76274986|FG000|STARTED|Overall Study||19||
60150328|NCT03821675|76274987|FG001|STARTED|Overall Study||19||
60150329|NCT03821675|76274986|FG000|COMPLETED|Overall Study||16||
60150330|NCT03821675|76274987|FG001|COMPLETED|Overall Study||17||
60150331|NCT03821675|76274986|FG000|NOT COMPLETED|Overall Study||3||
60150332|NCT03821675|76274987|FG001|NOT COMPLETED|Overall Study||2||
60150333|NCT01669122|76274995|FG000|STARTED|Period I|Participants who received Lozenge A=10, Lozenge B=10, Lozenge C=10, Reference Lozenge=10|40||
60150334|NCT01669122|76274995|FG000|Safety Population|Period I||39||
60150335|NCT01669122|76274995|FG000|COMPLETED|Period I||39||
60150336|NCT01669122|76274995|FG000|NOT COMPLETED|Period I||1||
60150337|NCT01669122|76274995|FG000|STARTED|Washout Period I||39||
60150338|NCT01669122|76274995|FG000|COMPLETED|Washout Period I||39||
60150339|NCT01669122|76274995|FG000|NOT COMPLETED|Washout Period I||0||
60150340|NCT01669122|76274995|FG000|STARTED|Period II|Participants who received Lozenge A=9, Lozenge B=10, Lozenge C=10, Reference Lozenge=10|39||
60150341|NCT01669122|76274995|FG000|COMPLETED|Period II||39||
60150342|NCT01669122|76274995|FG000|NOT COMPLETED|Period II||0||
60150343|NCT01669122|76274995|FG000|STARTED|Washout Period II||39||
60150344|NCT01669122|76274995|FG000|COMPLETED|Washout Period II||37||
60150345|NCT01669122|76274995|FG000|NOT COMPLETED|Washout Period II||2||
60150346|NCT01669122|76274995|FG000|STARTED|Washout Period III||37||
60150347|NCT01669122|76274995|FG000|COMPLETED|Washout Period III||37||
60150348|NCT01669122|76274995|FG000|NOT COMPLETED|Washout Period III||0||
60150349|NCT01669122|76274995|FG000|STARTED|Period III|Participants who received Lozenge A=10, Lozenge B=8, Lozenge C=10, Reference Lozenge=9|37||
60150350|NCT01669122|76274995|FG000|COMPLETED|Period III||37||
60150351|NCT01669122|76274995|FG000|NOT COMPLETED|Period III||0||
60150352|NCT01669122|76274995|FG000|STARTED|Period IV|Participants who received Lozenge A=9, Lozenge B=10, Lozenge C=9, Reference Lozenge=9|37||
60150353|NCT01669122|76274995|FG000|COMPLETED|Period IV||37||
60150354|NCT01669122|76274995|FG000|NOT COMPLETED|Period IV||0||
60150355|NCT01311115|76275008|FG000|STARTED|Overall Study||132||
60150356|NCT01311115|76275009|FG001|STARTED|Overall Study||69||
60150357|NCT01311115|76275008|FG000|COMPLETED|Overall Study||132||
60150358|NCT01311115|76275009|FG001|COMPLETED|Overall Study||69||
60150359|NCT01311115|76275008|FG000|NOT COMPLETED|Overall Study||0||
60150360|NCT01311115|76275009|FG001|NOT COMPLETED|Overall Study||0||
60150361|NCT01308619|76275017|FG000|STARTED|Overall Study||84||
60150362|NCT01308619|76275018|FG001|STARTED|Overall Study||86||
60150363|NCT01308619|76275017|FG000|COMPLETED|Overall Study||77||
60150364|NCT01308619|76275018|FG001|COMPLETED|Overall Study||83||
60150365|NCT01308619|76275017|FG000|NOT COMPLETED|Overall Study||7||
60150366|NCT01308619|76275018|FG001|NOT COMPLETED|Overall Study||3||
60150367|NCT02611752|76275028|FG000|STARTED|Overall Study||22||
60150368|NCT02611752|76275029|FG001|STARTED|Overall Study||25||
60150369|NCT02611752|76275028|FG000|Day 1-3 Hydromorphone Challenge Injs|Overall Study||22||
60150370|NCT02611752|76275029|FG001|Day 1-3 Hydromorphone Challenge Injs|Overall Study||25||
60150371|NCT02611752|76275028|FG000|Day 4-6 Hydromorphone Challenge Injs|Overall Study||22||
60150372|NCT02611752|76275029|FG001|Day 4-6 Hydromorphone Challenge Injs|Overall Study||24||
60150373|NCT02611752|76275028|FG000|Day 8-10 Hydromorphone Challenge Injs|Overall Study||22||
60150374|NCT02611752|76275029|FG001|Day 8-10 Hydromorphone Challenge Injs|Overall Study||24||
60150375|NCT02611752|76275028|FG000|Day11-13 Hydromorphone Challenge Injs|Overall Study||22||
60150376|NCT02611752|76275029|FG001|Day11-13 Hydromorphone Challenge Injs|Overall Study||24||
60150377|NCT02611752|76275028|FG000|COMPLETED|Overall Study||22||
60150378|NCT02611752|76275029|FG001|COMPLETED|Overall Study||24||
60150379|NCT02611752|76275028|FG000|NOT COMPLETED|Overall Study||0||
60150380|NCT02611752|76275029|FG001|NOT COMPLETED|Overall Study||1||
60150381|NCT02611362|76275050|FG000|STARTED|Overall Study||41||
60150382|NCT02611362|76275051|FG001|STARTED|Overall Study||41||
60150383|NCT02611362|76275050|FG000|Immediate Posttest (3 Months)|Overall Study||33||
60150384|NCT02611362|76275051|FG001|Immediate Posttest (3 Months)|Overall Study||34||
60150385|NCT02611362|76275050|FG000|6-month Follow-up|Overall Study||32||
60150386|NCT02611362|76275051|FG001|6-month Follow-up|Overall Study||35||
60150387|NCT02611362|76275050|FG000|COMPLETED|Overall Study||32||
60150388|NCT02611362|76275051|FG001|COMPLETED|Overall Study||35||
60150389|NCT02611362|76275050|FG000|NOT COMPLETED|Overall Study||9||
60150390|NCT02611362|76275051|FG001|NOT COMPLETED|Overall Study||6||
60150391|NCT00580489|76275060|FG000|STARTED|Overall Study||104||
60150392|NCT00580489|76275061|FG001|STARTED|Overall Study||100||
60150393|NCT00580489|76275060|FG000|COMPLETED|Overall Study||104||
60150394|NCT00580489|76275061|FG001|COMPLETED|Overall Study||100||
60150395|NCT00580489|76275060|FG000|NOT COMPLETED|Overall Study||0||
60150396|NCT00580489|76275061|FG001|NOT COMPLETED|Overall Study||0||
60150397|NCT01594476|76275071|FG000|STARTED|Overall Study||101||
60150398|NCT01594476|76275072|FG001|STARTED|Overall Study||100||
60150399|NCT01594476|76275071|FG000|Received Intervention|Overall Study||66||
60150400|NCT01594476|76275072|FG001|Received Intervention|Overall Study||73||
60150401|NCT01594476|76275071|FG000|Excluded After Allocation|Overall Study||1||
60150402|NCT01594476|76275072|FG001|Excluded After Allocation|Overall Study||3||
60150403|NCT01594476|76275071|FG000|IUD Removal|Overall Study||3|By 6 months|
60150404|NCT01594476|76275072|FG001|IUD Removal|Overall Study||5|By 6 months|
60150405|NCT01594476|76275071|FG000|IUD Expulsion|Overall Study||2|By 6 months|
60150406|NCT01594476|76275072|FG001|IUD Expulsion|Overall Study||0|By 6 months|
60150407|NCT01594476|76275071|FG000|Pregnant|Overall Study||2|By 6 months None had IUD in place at the time of pregnancy|
60150408|NCT01594476|76275072|FG001|Pregnant|Overall Study||5|By 6 months None had IUD in place at the time of pregnancy|
60150409|NCT01594476|76275071|FG000|COMPLETED|Overall Study||100|Analyzed for intent to treat|
60150410|NCT01594476|76275072|FG001|COMPLETED|Overall Study||97|Analyzed for intent to treat|
60150411|NCT01594476|76275071|FG000|NOT COMPLETED|Overall Study||1||
60150412|NCT01594476|76275072|FG001|NOT COMPLETED|Overall Study||3||
60150413|NCT00468715|76275082|FG000|STARTED|Overall Study||28||
60150414|NCT00468715|76275082|FG000|COMPLETED|Overall Study||28||
60150415|NCT00468715|76275082|FG000|NOT COMPLETED|Overall Study||0||
60150416|NCT01668966|76275086|FG000|STARTED|Overall Study||23||
60150417|NCT01668966|76275086|FG000|Treated|Overall Study||21||
60150418|NCT01668966|76275086|FG000|COMPLETED|Overall Study||19||
60150419|NCT01668966|76275086|FG000|NOT COMPLETED|Overall Study||4||
60150420|NCT02609724|76275093|FG000|STARTED|Overall Study||65||
60150421|NCT02609724|76275094|FG001|STARTED|Overall Study||64||
60150422|NCT02609724|76275095|FG002|STARTED|Overall Study||65||
60150423|NCT02609724|76275093|FG000|Post Intensive Treatment Phase (= Primary Endpoint)|Overall Study||63||
60150424|NCT02609724|76275094|FG001|Post Intensive Treatment Phase (= Primary Endpoint)|Overall Study||63||
60150425|NCT02609724|76275095|FG002|Post Intensive Treatment Phase (= Primary Endpoint)|Overall Study||64||
60150426|NCT02609724|76275093|FG000|COMPLETED|Overall Study|post follow-up phase|60||
60150427|NCT02609724|76275094|FG001|COMPLETED|Overall Study|post follow-up phase|61||
60150428|NCT02609724|76275095|FG002|COMPLETED|Overall Study|post follow-up phase|61||
60150429|NCT02609724|76275093|FG000|NOT COMPLETED|Overall Study||5||
60150430|NCT02609724|76275094|FG001|NOT COMPLETED|Overall Study||3||
60150431|NCT02609724|76275095|FG002|NOT COMPLETED|Overall Study||4||
60150432|NCT01415427|76275107|FG000|STARTED|Overall Study||29||
60150433|NCT01415427|76275108|FG001|STARTED|Overall Study||29||
60150434|NCT01415427|76275109|FG002|STARTED|Overall Study||59||
60150435|NCT01415427|76275110|FG003|STARTED|Overall Study||56||
60150436|NCT01415427|76275107|FG000|COMPLETED|Overall Study||0||
60150437|NCT01415427|76275108|FG001|COMPLETED|Overall Study||0||
60150438|NCT01415427|76275109|FG002|COMPLETED|Overall Study||1||
60150439|NCT01415427|76275110|FG003|COMPLETED|Overall Study||0||
60150440|NCT01415427|76275107|FG000|NOT COMPLETED|Overall Study||29||
60150441|NCT01415427|76275108|FG001|NOT COMPLETED|Overall Study||29||
60150442|NCT01415427|76275109|FG002|NOT COMPLETED|Overall Study||58||
60150443|NCT01415427|76275110|FG003|NOT COMPLETED|Overall Study||56||
60150444|NCT02610816|76275124|FG000|STARTED|Phase 1||38||
60150445|NCT02610816|76275125|FG001|STARTED|Phase 1||25||
60150446|NCT02610816|76275126|FG002|STARTED|Phase 1||0||
60150447|NCT02610816|76275127|FG003|STARTED|Phase 1||0||
60150448|NCT02610816|76275124|FG000|COMPLETED|Phase 1||34||
60150449|NCT02610816|76275125|FG001|COMPLETED|Phase 1||17||
60150450|NCT02610816|76275126|FG002|COMPLETED|Phase 1||0||
60150451|NCT02610816|76275127|FG003|COMPLETED|Phase 1||0||
60150452|NCT02610816|76275124|FG000|NOT COMPLETED|Phase 1||4||
60150453|NCT02610816|76275125|FG001|NOT COMPLETED|Phase 1||8||
60150454|NCT02610816|76275126|FG002|NOT COMPLETED|Phase 1||0||
60150455|NCT02610816|76275127|FG003|NOT COMPLETED|Phase 1||0||
60150456|NCT02610816|76275124|FG000|STARTED|Phase 2||0||
60150457|NCT02610816|76275125|FG001|STARTED|Phase 2||0||
60150458|NCT02610816|76275126|FG002|STARTED|Phase 2||19||
60150459|NCT02610816|76275127|FG003|STARTED|Phase 2||10||
60150460|NCT02610816|76275124|FG000|COMPLETED|Phase 2||0||
60150461|NCT02610816|76275125|FG001|COMPLETED|Phase 2||0||
60150462|NCT02610816|76275126|FG002|COMPLETED|Phase 2||8||
60150463|NCT02610816|76275127|FG003|COMPLETED|Phase 2||4||
60150464|NCT02610816|76275124|FG000|NOT COMPLETED|Phase 2||0||
60150465|NCT02610816|76275125|FG001|NOT COMPLETED|Phase 2||0||
60150466|NCT02610816|76275126|FG002|NOT COMPLETED|Phase 2||11||
60150467|NCT02610816|76275127|FG003|NOT COMPLETED|Phase 2||6||
60150468|NCT01896505|76275143|FG000|STARTED|Overall Study||10||
60150469|NCT01896505|76275144|FG001|STARTED|Overall Study||9||
60150470|NCT01896505|76275145|FG002|STARTED|Overall Study||17||
60150471|NCT01896505|76275146|FG003|STARTED|Overall Study||7||
60150472|NCT01896505|76275147|FG004|STARTED|Overall Study||5||
60150473|NCT01896505|76275148|FG005|STARTED|Overall Study||6||
60150474|NCT01896505|76275143|FG000|COMPLETED|Overall Study||0||
60150475|NCT01896505|76275144|FG001|COMPLETED|Overall Study||0||
60150476|NCT01896505|76275145|FG002|COMPLETED|Overall Study||0||
60150477|NCT01896505|76275146|FG003|COMPLETED|Overall Study||0||
60150478|NCT01896505|76275147|FG004|COMPLETED|Overall Study||0||
60150479|NCT01896505|76275148|FG005|COMPLETED|Overall Study||0||
60150480|NCT01896505|76275143|FG000|NOT COMPLETED|Overall Study||10||
60150481|NCT01896505|76275144|FG001|NOT COMPLETED|Overall Study||9||
60150482|NCT01896505|76275145|FG002|NOT COMPLETED|Overall Study||17||
60150483|NCT01896505|76275146|FG003|NOT COMPLETED|Overall Study||7||
60150484|NCT01896505|76275147|FG004|NOT COMPLETED|Overall Study||5||
60150485|NCT01896505|76275148|FG005|NOT COMPLETED|Overall Study||6||
60150486|NCT00332605|76275186|FG000|STARTED|Overall Study||14||
60150487|NCT00332605|76275187|FG001|STARTED|Overall Study||14||
60150488|NCT00332605|76275188|FG002|STARTED|Overall Study||17||
60150489|NCT00332605|76275186|FG000|COMPLETED|Overall Study||12||
60150490|NCT00332605|76275187|FG001|COMPLETED|Overall Study||12||
60150491|NCT00332605|76275188|FG002|COMPLETED|Overall Study||9||
60150492|NCT00332605|76275186|FG000|NOT COMPLETED|Overall Study||2||
60150493|NCT00332605|76275187|FG001|NOT COMPLETED|Overall Study||2||
60150494|NCT00332605|76275188|FG002|NOT COMPLETED|Overall Study||8||
60150495|NCT01540071|76275196|FG000|STARTED|Overall Study||38||
60150496|NCT01540071|76275196|FG000|COMPLETED|Overall Study||38||
60150497|NCT01540071|76275196|FG000|NOT COMPLETED|Overall Study||0||
60150498|NCT01415583|76275203|FG000|STARTED|Overall Study||157||
60150499|NCT01415583|76275204|FG001|STARTED|Overall Study||157||
60150500|NCT01415583|76275203|FG000|COMPLETED|Overall Study||157||
60150501|NCT01415583|76275204|FG001|COMPLETED|Overall Study||157||
60150502|NCT01415583|76275203|FG000|NOT COMPLETED|Overall Study||0||
60150503|NCT01415583|76275204|FG001|NOT COMPLETED|Overall Study||0||
60150504|NCT01416129|76275212|FG000|STARTED|Control Condition: Ischial Containment||5||
60150505|NCT01416129|76275213|FG001|STARTED|Control Condition: Ischial Containment||5||
60150506|NCT01416129|76275212|FG000|COMPLETED|Control Condition: Ischial Containment||5||
60150507|NCT01416129|76275213|FG001|COMPLETED|Control Condition: Ischial Containment||5||
60150508|NCT01416129|76275212|FG000|NOT COMPLETED|Control Condition: Ischial Containment||0||
60150509|NCT01416129|76275213|FG001|NOT COMPLETED|Control Condition: Ischial Containment||0||
60150510|NCT01416129|76275212|FG000|STARTED|Experimental Condition: Brimless||5||
60150511|NCT01416129|76275213|FG001|STARTED|Experimental Condition: Brimless||5||
60150512|NCT01416129|76275212|FG000|COMPLETED|Experimental Condition: Brimless||5||
60150513|NCT01416129|76275213|FG001|COMPLETED|Experimental Condition: Brimless||5||
60150514|NCT01416129|76275212|FG000|NOT COMPLETED|Experimental Condition: Brimless||0||
60150515|NCT01416129|76275213|FG001|NOT COMPLETED|Experimental Condition: Brimless||0||
60150516|NCT01416987|76275219|FG000|STARTED|Overall Study||600||
60150517|NCT01416987|76275219|FG000|COMPLETED|Overall Study||600||
60150518|NCT01416987|76275219|FG000|NOT COMPLETED|Overall Study||0||
60150519|NCT01417455|76275231|FG000|STARTED|Overall Study||16||
60150520|NCT01417455|76275232|FG001|STARTED|Overall Study||16||
60150521|NCT01417455|76275233|FG002|STARTED|Overall Study||17||
60150522|NCT01417455|76275234|FG003|STARTED|Overall Study||17||
60150523|NCT01417455|76275235|FG004|STARTED|Overall Study||30||
60150524|NCT01417455|76275236|FG005|STARTED|Overall Study||13||
60150525|NCT01417455|76275237|FG006|STARTED|Overall Study||13||
60150526|NCT01417455|76275238|FG007|STARTED|Overall Study||25||
60150527|NCT01417455|76275231|FG000|COMPLETED|Overall Study||16||
60150528|NCT01417455|76275232|FG001|COMPLETED|Overall Study||16||
60150529|NCT01417455|76275233|FG002|COMPLETED|Overall Study||17||
60150530|NCT01417455|76275234|FG003|COMPLETED|Overall Study||17||
60150531|NCT01417455|76275235|FG004|COMPLETED|Overall Study||30||
60150532|NCT01417455|76275236|FG005|COMPLETED|Overall Study||13||
60150533|NCT01417455|76275237|FG006|COMPLETED|Overall Study||13||
60150534|NCT01417455|76275238|FG007|COMPLETED|Overall Study||25||
60150535|NCT01417455|76275231|FG000|NOT COMPLETED|Overall Study||0||
60150536|NCT01417455|76275232|FG001|NOT COMPLETED|Overall Study||0||
60150537|NCT01417455|76275233|FG002|NOT COMPLETED|Overall Study||0||
60150538|NCT01417455|76275234|FG003|NOT COMPLETED|Overall Study||0||
60150539|NCT01417455|76275235|FG004|NOT COMPLETED|Overall Study||0||
60150540|NCT01417455|76275236|FG005|NOT COMPLETED|Overall Study||0||
60150541|NCT01417455|76275237|FG006|NOT COMPLETED|Overall Study||0||
60150542|NCT01417455|76275238|FG007|NOT COMPLETED|Overall Study||0||
60150543|NCT01540773|76275256|FG000|STARTED|First Intervention||8||
60150544|NCT01540773|76275257|FG001|STARTED|First Intervention||8||
60150545|NCT01540773|76275256|FG000|COMPLETED|First Intervention||8||
60150546|NCT01540773|76275257|FG001|COMPLETED|First Intervention||8||
60150547|NCT01540773|76275256|FG000|NOT COMPLETED|First Intervention||0||
60150548|NCT01540773|76275257|FG001|NOT COMPLETED|First Intervention||0||
60150549|NCT01540773|76275256|FG000|STARTED|Wash Out Period of 1 Week||8||
60150550|NCT01540773|76275257|FG001|STARTED|Wash Out Period of 1 Week||8||
60150551|NCT01540773|76275256|FG000|COMPLETED|Wash Out Period of 1 Week||8||
60150552|NCT01540773|76275257|FG001|COMPLETED|Wash Out Period of 1 Week||8||
60150553|NCT01540773|76275256|FG000|NOT COMPLETED|Wash Out Period of 1 Week||0||
60150554|NCT01540773|76275257|FG001|NOT COMPLETED|Wash Out Period of 1 Week||0||
60150555|NCT01540773|76275256|FG000|STARTED|Second Intervention||8||
60150556|NCT01540773|76275257|FG001|STARTED|Second Intervention||8||
60150557|NCT01540773|76275256|FG000|COMPLETED|Second Intervention||8||
60150558|NCT01540773|76275257|FG001|COMPLETED|Second Intervention||8||
60150559|NCT01540773|76275256|FG000|NOT COMPLETED|Second Intervention||0||
60150560|NCT01540773|76275257|FG001|NOT COMPLETED|Second Intervention||0||
60150561|NCT02612610|76275269|FG000|STARTED|Overall Study||63||
60150562|NCT02612610|76275270|FG001|STARTED|Overall Study||64||
60150563|NCT02612610|76275271|FG002|STARTED|Overall Study||63||
60150564|NCT02612610|76275272|FG003|STARTED|Overall Study||63||
60150565|NCT02612610|76275269|FG000|Treated|Overall Study||63||
60150566|NCT02612610|76275270|FG001|Treated|Overall Study||63||
60150567|NCT02612610|76275271|FG002|Treated|Overall Study||63||
60150568|NCT02612610|76275272|FG003|Treated|Overall Study||63||
60150569|NCT02612610|76275269|FG000|COMPLETED|Overall Study||58||
60150570|NCT02612610|76275270|FG001|COMPLETED|Overall Study||56||
60150571|NCT02612610|76275271|FG002|COMPLETED|Overall Study||58||
60150572|NCT02612610|76275272|FG003|COMPLETED|Overall Study||50||
60150573|NCT02612610|76275269|FG000|NOT COMPLETED|Overall Study||5||
60150574|NCT02612610|76275270|FG001|NOT COMPLETED|Overall Study||8||
60150575|NCT02612610|76275271|FG002|NOT COMPLETED|Overall Study||5||
60150576|NCT02612610|76275272|FG003|NOT COMPLETED|Overall Study||13||
60150577|NCT01541553|76275284|FG000|STARTED|Overall Study||167||
60150578|NCT01541553|76275285|FG001|STARTED|Overall Study||162||
60150579|NCT01541553|76275284|FG000|COMPLETED|Overall Study||155||
60150580|NCT01541553|76275285|FG001|COMPLETED|Overall Study||148||
60150581|NCT01541553|76275284|FG000|NOT COMPLETED|Overall Study||12||
60150582|NCT01541553|76275285|FG001|NOT COMPLETED|Overall Study||14||
60150583|NCT01418001|76275291|FG000|STARTED|Overall Study||5||
60150584|NCT01418001|76275291|FG000|COMPLETED|Overall Study||5||
60150585|NCT01418001|76275291|FG000|NOT COMPLETED|Overall Study||0||
60150586|NCT00394147|76275296|FG000|STARTED|Overall Study||17||
60150587|NCT00394147|76275296|FG000|COMPLETED|Overall Study||17||
60150588|NCT00394147|76275296|FG000|NOT COMPLETED|Overall Study||0||
60150589|NCT01542255|76275300|FG000|STARTED|Overall Study||7||
60150590|NCT01542255|76275300|FG000|Analyzed for Time to Progression|Overall Study||7||
60150591|NCT01542255|76275300|FG000|COMPLETED|Overall Study||7||
60150592|NCT01542255|76275300|FG000|NOT COMPLETED|Overall Study||0||
60150593|NCT01418703|76275307|FG000|STARTED|Overall Study||13||
60150594|NCT01418703|76275308|FG001|STARTED|Overall Study||13||
60150595|NCT01418703|76275309|FG002|STARTED|Overall Study||6||
60150596|NCT01418703|76275310|FG003|STARTED|Overall Study||6||
60150597|NCT01418703|76275307|FG000|COMPLETED|Overall Study||13||
60150598|NCT01418703|76275308|FG001|COMPLETED|Overall Study||13||
60150599|NCT01418703|76275309|FG002|COMPLETED|Overall Study||6||
60150600|NCT01418703|76275310|FG003|COMPLETED|Overall Study||6||
60150601|NCT01418703|76275307|FG000|NOT COMPLETED|Overall Study||0||
60150602|NCT01418703|76275308|FG001|NOT COMPLETED|Overall Study||0||
60150603|NCT01418703|76275309|FG002|NOT COMPLETED|Overall Study||0||
60150604|NCT01418703|76275310|FG003|NOT COMPLETED|Overall Study||0||
60150605|NCT01419171|76275317|FG000|STARTED|Overall Study||328||
60150606|NCT01419171|76275317|FG000|COMPLETED|Overall Study||328||
60150607|NCT01419171|76275317|FG000|NOT COMPLETED|Overall Study||0||
60150608|NCT01419249|76275323|FG000|STARTED|Overall Study||318||
60150609|NCT01419249|76275324|FG001|STARTED|Overall Study||140||
60150610|NCT01419249|76275323|FG000|COMPLETED|Overall Study||318||
60150611|NCT01419249|76275324|FG001|COMPLETED|Overall Study||140||
60150612|NCT01419249|76275323|FG000|NOT COMPLETED|Overall Study||0||
60150613|NCT01419249|76275324|FG001|NOT COMPLETED|Overall Study||0||
60150614|NCT01419639|76275331|FG000|STARTED|Overall Study||10||
60150615|NCT01419639|76275331|FG000|COMPLETED|Overall Study||9||
60150616|NCT01419639|76275331|FG000|NOT COMPLETED|Overall Study||1||
60150617|NCT01419795|76275337|FG000|STARTED|Overall Study||3||
60150618|NCT01419795|76275338|FG001|STARTED|Overall Study||0||
60150619|NCT01419795|76275337|FG000|COMPLETED|Overall Study||3||
60150620|NCT01419795|76275338|FG001|COMPLETED|Overall Study||0||
60150621|NCT01419795|76275337|FG000|NOT COMPLETED|Overall Study||0||
60150622|NCT01419795|76275338|FG001|NOT COMPLETED|Overall Study||0||
60150623|NCT02087995|76275344|FG000|STARTED|Overall Study||51||
60150624|NCT02087995|76275344|FG000|COMPLETED|Overall Study||51||
60150625|NCT02087995|76275344|FG000|NOT COMPLETED|Overall Study||0||
60150626|NCT02856581|76275350|FG000|STARTED|Overall Study||12||
60150627|NCT02856581|76275351|FG001|STARTED|Overall Study||11||
60150628|NCT02856581|76275350|FG000|COMPLETED|Overall Study||12||
60150629|NCT02856581|76275351|FG001|COMPLETED|Overall Study||11||
60150630|NCT02856581|76275350|FG000|NOT COMPLETED|Overall Study||0||
60150631|NCT02856581|76275351|FG001|NOT COMPLETED|Overall Study||0||
60150632|NCT01479543|76275364|FG000|STARTED|Overall Study||21||
60150633|NCT01479543|76275365|FG001|STARTED|Overall Study||20||
60150634|NCT01479543|76275366|FG002|STARTED|Overall Study||21||
60150635|NCT01479543|76275367|FG003|STARTED|Overall Study||20||
60150636|NCT01479543|76275368|FG004|STARTED|Overall Study||21||
60150637|NCT01479543|76275364|FG000|COMPLETED|Overall Study||20||
60150638|NCT01479543|76275365|FG001|COMPLETED|Overall Study||20||
60150639|NCT01479543|76275366|FG002|COMPLETED|Overall Study||20||
60150640|NCT01479543|76275367|FG003|COMPLETED|Overall Study||20||
60150641|NCT01479543|76275368|FG004|COMPLETED|Overall Study||20||
60150642|NCT01479543|76275364|FG000|NOT COMPLETED|Overall Study||1||
60150643|NCT01479543|76275365|FG001|NOT COMPLETED|Overall Study||0||
60150644|NCT01479543|76275366|FG002|NOT COMPLETED|Overall Study||1||
60150645|NCT01479543|76275367|FG003|NOT COMPLETED|Overall Study||0||
60150646|NCT01479543|76275368|FG004|NOT COMPLETED|Overall Study||1||
60150647|NCT01480089|76275382|FG000|STARTED|Overall Study||25||
60150648|NCT01480089|76275383|FG001|STARTED|Overall Study||30||
60150649|NCT01480089|76275382|FG000|COMPLETED|Overall Study||25||
60150650|NCT01480089|76275383|FG001|COMPLETED|Overall Study||30||
60150651|NCT01480089|76275382|FG000|NOT COMPLETED|Overall Study||0||
60150652|NCT01480089|76275383|FG001|NOT COMPLETED|Overall Study||0||
60150653|NCT01542645|76275391|FG000|STARTED|Overall Study||82||
60150654|NCT01542645|76275392|FG001|STARTED|Overall Study||82||
60150655|NCT01542645|76275391|FG000|COMPLETED|Overall Study||77||
60150656|NCT01542645|76275392|FG001|COMPLETED|Overall Study||79||
60150657|NCT01542645|76275391|FG000|NOT COMPLETED|Overall Study||5||
60150658|NCT01542645|76275392|FG001|NOT COMPLETED|Overall Study||3||
60150659|NCT01016353|76275404|FG000|STARTED|Overall Study||180||
60150660|NCT01016353|76275405|FG001|STARTED|Overall Study||103||
60150661|NCT01016353|76275404|FG000|COMPLETED|Overall Study||178||
60150662|NCT01016353|76275405|FG001|COMPLETED|Overall Study||102||
60150663|NCT01016353|76275404|FG000|NOT COMPLETED|Overall Study||2||
60150664|NCT01016353|76275405|FG001|NOT COMPLETED|Overall Study||1||
60150665|NCT01542957|76275413|FG000|STARTED|End of Therapy||65||
60150666|NCT01542957|76275414|FG001|STARTED|End of Therapy||63||
60150667|NCT01542957|76275413|FG000|COMPLETED|End of Therapy||53||
60150668|NCT01542957|76275414|FG001|COMPLETED|End of Therapy||53||
60150669|NCT01542957|76275413|FG000|NOT COMPLETED|End of Therapy||12||
60150670|NCT01542957|76275414|FG001|NOT COMPLETED|End of Therapy||10||
60150671|NCT01542957|76275413|FG000|STARTED|3-month Follow-up||53||
60150672|NCT01542957|76275414|FG001|STARTED|3-month Follow-up||53||
60150673|NCT01542957|76275413|FG000|COMPLETED|3-month Follow-up||50||
60150674|NCT01542957|76275414|FG001|COMPLETED|3-month Follow-up||45||
60150675|NCT01542957|76275413|FG000|NOT COMPLETED|3-month Follow-up||3||
60150676|NCT01542957|76275414|FG001|NOT COMPLETED|3-month Follow-up||8||
60150677|NCT01542957|76275413|FG000|STARTED|12-month Follow-up||53||
60150678|NCT01542957|76275414|FG001|STARTED|12-month Follow-up||53||
60150679|NCT01542957|76275413|FG000|COMPLETED|12-month Follow-up||37||
60150680|NCT01542957|76275414|FG001|COMPLETED|12-month Follow-up||40||
60150681|NCT01542957|76275413|FG000|NOT COMPLETED|12-month Follow-up||16||
60150682|NCT01542957|76275414|FG001|NOT COMPLETED|12-month Follow-up||13||
60150683|NCT01420653|76275424|FG000|STARTED|Overall Study||110||
60150684|NCT01420653|76275425|FG001|STARTED|Overall Study||111||
60150685|NCT01420653|76275426|FG002|STARTED|Overall Study||112||
60150686|NCT01420653|76275427|FG003|STARTED|Overall Study||75||
60150687|NCT01420653|76275424|FG000|COMPLETED|Overall Study||107||
60150688|NCT01420653|76275425|FG001|COMPLETED|Overall Study||108||
60150689|NCT01420653|76275426|FG002|COMPLETED|Overall Study||108||
60150690|NCT01420653|76275427|FG003|COMPLETED|Overall Study||68||
60150691|NCT01420653|76275424|FG000|NOT COMPLETED|Overall Study||3||
60150692|NCT01420653|76275425|FG001|NOT COMPLETED|Overall Study||3||
60150693|NCT01420653|76275426|FG002|NOT COMPLETED|Overall Study||4||
60150694|NCT01420653|76275427|FG003|NOT COMPLETED|Overall Study||7||
60150695|NCT01543581|76275437|FG000|STARTED|Overall Study||1||
60150696|NCT01543581|76275438|FG001|STARTED|Overall Study||0||
60150697|NCT01543581|76275437|FG000|COMPLETED|Overall Study||1||
60150698|NCT01543581|76275438|FG001|COMPLETED|Overall Study||0||
60150699|NCT01543581|76275437|FG000|NOT COMPLETED|Overall Study||0||
60150700|NCT01543581|76275438|FG001|NOT COMPLETED|Overall Study||0||
60150701|NCT01421355|76275444|FG000|STARTED|Overall Study||21||
60150702|NCT01421355|76275444|FG000|COMPLETED|Overall Study||15||
60150703|NCT01421355|76275444|FG000|NOT COMPLETED|Overall Study||6||
60150704|NCT01421589|76275448|FG000|STARTED|Overall Study||15||
60150705|NCT01421589|76275448|FG000|COMPLETED|Overall Study||15||
60150706|NCT01421589|76275448|FG000|NOT COMPLETED|Overall Study||0||
60150707|NCT01422135|76275453|FG000|STARTED|Overall Study||4||
60150708|NCT01422135|76275454|FG001|STARTED|Overall Study||4||
60150709|NCT01422135|76275455|FG002|STARTED|Overall Study||4||
60150710|NCT01422135|76275456|FG003|STARTED|Overall Study||4||
60150711|NCT01422135|76275457|FG004|STARTED|Overall Study||4||
60150712|NCT01422135|76275458|FG005|STARTED|Overall Study||4||
60150713|NCT01422135|76275453|FG000|COMPLETED|Overall Study||4||
60150714|NCT01422135|76275454|FG001|COMPLETED|Overall Study||4||
60150715|NCT01422135|76275455|FG002|COMPLETED|Overall Study||3||
60150716|NCT01422135|76275456|FG003|COMPLETED|Overall Study||4||
60150717|NCT01422135|76275457|FG004|COMPLETED|Overall Study||4||
60150718|NCT01422135|76275458|FG005|COMPLETED|Overall Study||3||
60150719|NCT01422135|76275453|FG000|NOT COMPLETED|Overall Study||0||
60150720|NCT01422135|76275454|FG001|NOT COMPLETED|Overall Study||0||
60150721|NCT01422135|76275455|FG002|NOT COMPLETED|Overall Study||1||
60150722|NCT01422135|76275456|FG003|NOT COMPLETED|Overall Study||0||
60150723|NCT01422135|76275457|FG004|NOT COMPLETED|Overall Study||0||
60150724|NCT01422135|76275458|FG005|NOT COMPLETED|Overall Study||1||
60150725|NCT01544361|76275469|FG000|STARTED|Overall Study||8||
60150726|NCT01544361|76275470|FG001|STARTED|Overall Study||6||
60150727|NCT01544361|76275471|FG002|STARTED|Overall Study||6||
60150728|NCT01544361|76275472|FG003|STARTED|Overall Study||6||
60150729|NCT01544361|76275473|FG004|STARTED|Overall Study||6||
60150730|NCT01544361|76275469|FG000|COMPLETED|Overall Study||8||
60150731|NCT01544361|76275470|FG001|COMPLETED|Overall Study||6||
60150732|NCT01544361|76275471|FG002|COMPLETED|Overall Study||6||
60150733|NCT01544361|76275472|FG003|COMPLETED|Overall Study||6||
60150734|NCT01544361|76275473|FG004|COMPLETED|Overall Study||6||
60150735|NCT01544361|76275469|FG000|NOT COMPLETED|Overall Study||0||
60150736|NCT01544361|76275470|FG001|NOT COMPLETED|Overall Study||0||
60150737|NCT01544361|76275471|FG002|NOT COMPLETED|Overall Study||0||
60150738|NCT01544361|76275472|FG003|NOT COMPLETED|Overall Study||0||
60150739|NCT01544361|76275473|FG004|NOT COMPLETED|Overall Study||0||
60150740|NCT02610192|76275485|FG000|STARTED|Overall Study|52 subjects had signed consent form, but 50 subjects have been treated. 2 subjects became SF.|50||
60150741|NCT02610192|76275485|FG000|COMPLETED|Overall Study||41||
60150742|NCT02610192|76275485|FG000|NOT COMPLETED|Overall Study||9||
60150743|NCT01482351|76275491|FG000|STARTED|Overall Study||68||
60150744|NCT01482351|76275491|FG000|6 Months|Overall Study|14 dropped out|54||
60150745|NCT01482351|76275491|FG000|12 Months|Overall Study||54||
60150746|NCT01482351|76275491|FG000|COMPLETED|Overall Study||54||
60150747|NCT01482351|76275491|FG000|NOT COMPLETED|Overall Study||14||
60150748|NCT01545765|76275499|FG000|STARTED|Overall Study||31||
60150749|NCT01545765|76275499|FG000|COMPLETED|Overall Study||31||
60150750|NCT01545765|76275499|FG000|NOT COMPLETED|Overall Study||0||
60150751|NCT02208297|76275508|FG000|STARTED|Overall Study||163||
60150752|NCT02208297|76275509|FG001|STARTED|Overall Study||163||
60150753|NCT02208297|76275508|FG000|COMPLETED|Overall Study||141||
60150754|NCT02208297|76275509|FG001|COMPLETED|Overall Study||107||
60150755|NCT02208297|76275508|FG000|NOT COMPLETED|Overall Study||22||
60150756|NCT02208297|76275509|FG001|NOT COMPLETED|Overall Study||56||
60150757|NCT01422369|76275515|FG000|STARTED|NK-104 4mg QD||28||
60150758|NCT01422369|76275515|FG000|COMPLETED|NK-104 4mg QD||28||
60150759|NCT01422369|76275515|FG000|NOT COMPLETED|NK-104 4mg QD||0||
60150760|NCT01422369|76275515|FG000|STARTED|Prezista 800mg/100mg QD||28||
60150761|NCT01422369|76275515|FG000|COMPLETED|Prezista 800mg/100mg QD||28||
60150762|NCT01422369|76275515|FG000|NOT COMPLETED|Prezista 800mg/100mg QD||0||
60150763|NCT01422369|76275515|FG000|STARTED|NK-104 4mg QD & Prezista 800mg/100mg QD||28||
60150764|NCT01422369|76275515|FG000|COMPLETED|NK-104 4mg QD & Prezista 800mg/100mg QD||27||
60150765|NCT01422369|76275515|FG000|NOT COMPLETED|NK-104 4mg QD & Prezista 800mg/100mg QD||1||
60150766|NCT01423773|76275520|FG000|STARTED|Period One, 2 Days||10||
60150767|NCT01423773|76275521|FG001|STARTED|Period One, 2 Days||10||
60150768|NCT01423773|76275520|FG000|COMPLETED|Period One, 2 Days||10||
60150769|NCT01423773|76275521|FG001|COMPLETED|Period One, 2 Days||10||
60150770|NCT01423773|76275520|FG000|NOT COMPLETED|Period One, 2 Days||0||
60150771|NCT01423773|76275521|FG001|NOT COMPLETED|Period One, 2 Days||0||
60150772|NCT01423773|76275520|FG000|STARTED|Period 2, 2 Days||10||
60150773|NCT01423773|76275521|FG001|STARTED|Period 2, 2 Days||10||
60150774|NCT01423773|76275520|FG000|COMPLETED|Period 2, 2 Days||10||
60150775|NCT01423773|76275521|FG001|COMPLETED|Period 2, 2 Days||10||
60150776|NCT01423773|76275520|FG000|NOT COMPLETED|Period 2, 2 Days||0||
60150777|NCT01423773|76275521|FG001|NOT COMPLETED|Period 2, 2 Days||0||
59751574|NCT00969761|75870893|FG004|STARTED|Treated in and Beyond Treat. Cycle 2||3||
59751575|NCT00969761|75870894|FG005|STARTED|Treated in and Beyond Treat. Cycle 2||3||
59751576|NCT00969761|75870895|FG006|STARTED|Treated in and Beyond Treat. Cycle 2||3||
59751577|NCT00969761|75870896|FG007|STARTED|Treated in and Beyond Treat. Cycle 2||6||
59751578|NCT00969761|75870897|FG008|STARTED|Treated in and Beyond Treat. Cycle 2||11||
59751579|NCT00969761|75870898|FG009|STARTED|Treated in and Beyond Treat. Cycle 2||2||
59751580|NCT00969761|75870899|FG010|STARTED|Treated in and Beyond Treat. Cycle 2||3||
60150778|NCT01424943|76275529|FG000|STARTED|Overall Study||25||
60150779|NCT01424943|76275530|FG001|STARTED|Overall Study||24||
60150780|NCT01424943|76275529|FG000|COMPLETED|Overall Study||12||
60150781|NCT01424943|76275530|FG001|COMPLETED|Overall Study||23||
60150782|NCT01424943|76275529|FG000|NOT COMPLETED|Overall Study||13||
60150783|NCT01424943|76275530|FG001|NOT COMPLETED|Overall Study||1||
60150784|NCT01547247|76275538|FG000|STARTED|Overall Study||104||
60150785|NCT01547247|76275539|FG001|STARTED|Overall Study||104||
60150786|NCT01547247|76275538|FG000|COMPLETED|Overall Study||98||
60150787|NCT01547247|76275539|FG001|COMPLETED|Overall Study||98||
60150788|NCT01547247|76275538|FG000|NOT COMPLETED|Overall Study||6||
60150789|NCT01547247|76275539|FG001|NOT COMPLETED|Overall Study||6||
60150790|NCT01547715|76275548|FG000|STARTED|Overall Study||60||
60150791|NCT01547715|76275549|FG001|STARTED|Overall Study||60||
60150792|NCT01547715|76275550|FG002|STARTED|Overall Study||60||
60150793|NCT01547715|76275548|FG000|COMPLETED|Overall Study||60||
60150794|NCT01547715|76275549|FG001|COMPLETED|Overall Study||60||
60150795|NCT01547715|76275550|FG002|COMPLETED|Overall Study||60||
60150796|NCT01547715|76275548|FG000|NOT COMPLETED|Overall Study||0||
60150797|NCT01547715|76275549|FG001|NOT COMPLETED|Overall Study||0||
60150798|NCT01547715|76275550|FG002|NOT COMPLETED|Overall Study||0||
60150799|NCT01548339|76275562|FG000|STARTED|Overall Study||44||
60150800|NCT01548339|76275563|FG001|STARTED|Overall Study||42||
60150801|NCT01548339|76275562|FG000|COMPLETED|Overall Study||38||
60150802|NCT01548339|76275563|FG001|COMPLETED|Overall Study||41||
60150803|NCT01548339|76275562|FG000|NOT COMPLETED|Overall Study||6||
60150804|NCT01548339|76275563|FG001|NOT COMPLETED|Overall Study||1||
60150805|NCT01425879|76275569|FG000|STARTED|Overall Study||8||
60150806|NCT01425879|76275569|FG000|COMPLETED|Overall Study||8||
60150807|NCT01425879|76275569|FG000|NOT COMPLETED|Overall Study||0||
60150808|NCT01426191|76275573|FG000|STARTED|Overall Study||2032||
60150809|NCT01426191|76275573|FG000|COMPLETED|Overall Study||2032||
60150810|NCT01426191|76275573|FG000|NOT COMPLETED|Overall Study||0||
60150811|NCT01548885|76275577|FG000|STARTED|Overall Study||146||
60150812|NCT01548885|76275577|FG000|COMPLETED|Overall Study||146||
60150813|NCT01548885|76275577|FG000|NOT COMPLETED|Overall Study||0||
60150814|NCT01426581|76275583|FG000|STARTED|Overall Study||62||
60150815|NCT01426581|76275584|FG001|STARTED|Overall Study||58||
60150816|NCT01426581|76275583|FG000|COMPLETED|Overall Study||62||
60150817|NCT01426581|76275584|FG001|COMPLETED|Overall Study||58||
60150818|NCT01426581|76275583|FG000|NOT COMPLETED|Overall Study||0||
60150819|NCT01426581|76275584|FG001|NOT COMPLETED|Overall Study||0||
60150820|NCT01427517|76275595|FG000|STARTED|Overall Study||3||
60150821|NCT01427517|76275596|FG001|STARTED|Overall Study||3||
60150822|NCT01427517|76275597|FG002|STARTED|Overall Study||3||
60150823|NCT01427517|76275595|FG000|COMPLETED|Overall Study||3||
60150824|NCT01427517|76275596|FG001|COMPLETED|Overall Study||3||
60150825|NCT01427517|76275597|FG002|COMPLETED|Overall Study||3||
60150826|NCT01427517|76275595|FG000|NOT COMPLETED|Overall Study||0||
60150827|NCT01427517|76275596|FG001|NOT COMPLETED|Overall Study||0||
59751581|NCT00969761|75870900|FG011|STARTED|Treated in and Beyond Treat. Cycle 2||3||
60150828|NCT01427517|76275597|FG002|NOT COMPLETED|Overall Study||0||
60150829|NCT01485393|76275605|FG000|STARTED|Overall Study||5||
60150830|NCT01485393|76275606|FG001|STARTED|Overall Study||5||
60150831|NCT01485393|76275605|FG000|COMPLETED|Overall Study||5||
60150832|NCT01485393|76275606|FG001|COMPLETED|Overall Study||5||
60150833|NCT01485393|76275605|FG000|NOT COMPLETED|Overall Study||0||
60150834|NCT01485393|76275606|FG001|NOT COMPLETED|Overall Study||0||
60150835|NCT02609178|76275613|FG000|STARTED|First Crown||0||
60150836|NCT02609178|76275614|FG001|STARTED|First Crown||1||
60150837|NCT02609178|76275615|FG002|STARTED|First Crown||6||
60150838|NCT02609178|76275616|FG003|STARTED|First Crown||3||
60150839|NCT02609178|76275617|FG004|STARTED|First Crown||0||
60150840|NCT02609178|76275618|FG005|STARTED|First Crown||2||
60150841|NCT02609178|76275613|FG000|COMPLETED|First Crown||0||
60150842|NCT02609178|76275614|FG001|COMPLETED|First Crown||1||
60150843|NCT02609178|76275615|FG002|COMPLETED|First Crown||5||
60150844|NCT02609178|76275616|FG003|COMPLETED|First Crown||2||
60150845|NCT02609178|76275617|FG004|COMPLETED|First Crown||0||
60150846|NCT02609178|76275618|FG005|COMPLETED|First Crown||2||
60150847|NCT02609178|76275613|FG000|NOT COMPLETED|First Crown||0||
60150848|NCT02609178|76275614|FG001|NOT COMPLETED|First Crown||0||
60150849|NCT02609178|76275615|FG002|NOT COMPLETED|First Crown||1||
60150850|NCT02609178|76275616|FG003|NOT COMPLETED|First Crown||1||
60150851|NCT02609178|76275617|FG004|NOT COMPLETED|First Crown||0||
60150852|NCT02609178|76275618|FG005|NOT COMPLETED|First Crown||0||
60150853|NCT02609178|76275613|FG000|STARTED|5-minute Washout Time||0||
60150854|NCT02609178|76275614|FG001|STARTED|5-minute Washout Time||1||
60150855|NCT02609178|76275615|FG002|STARTED|5-minute Washout Time||5||
60150856|NCT02609178|76275616|FG003|STARTED|5-minute Washout Time||2||
60150857|NCT02609178|76275617|FG004|STARTED|5-minute Washout Time||0||
60150858|NCT02609178|76275618|FG005|STARTED|5-minute Washout Time||2||
60150859|NCT02609178|76275613|FG000|COMPLETED|5-minute Washout Time||0||
60150860|NCT02609178|76275614|FG001|COMPLETED|5-minute Washout Time||1||
60150861|NCT02609178|76275615|FG002|COMPLETED|5-minute Washout Time||5||
60150862|NCT02609178|76275616|FG003|COMPLETED|5-minute Washout Time||2||
60150863|NCT02609178|76275617|FG004|COMPLETED|5-minute Washout Time||0||
60150864|NCT02609178|76275618|FG005|COMPLETED|5-minute Washout Time||2||
60150865|NCT02609178|76275613|FG000|NOT COMPLETED|5-minute Washout Time||0||
60150866|NCT02609178|76275614|FG001|NOT COMPLETED|5-minute Washout Time||0||
60150867|NCT02609178|76275615|FG002|NOT COMPLETED|5-minute Washout Time||0||
60150868|NCT02609178|76275616|FG003|NOT COMPLETED|5-minute Washout Time||0||
60150869|NCT02609178|76275617|FG004|NOT COMPLETED|5-minute Washout Time||0||
60150870|NCT02609178|76275618|FG005|NOT COMPLETED|5-minute Washout Time||0||
60150871|NCT02609178|76275613|FG000|STARTED|Second Crown||0||
60150872|NCT02609178|76275614|FG001|STARTED|Second Crown||1||
60150873|NCT02609178|76275615|FG002|STARTED|Second Crown||5||
60150874|NCT02609178|76275616|FG003|STARTED|Second Crown||2||
60150875|NCT02609178|76275617|FG004|STARTED|Second Crown||0||
60150876|NCT02609178|76275618|FG005|STARTED|Second Crown||2||
60150877|NCT02609178|76275613|FG000|COMPLETED|Second Crown||0||
60150878|NCT02609178|76275614|FG001|COMPLETED|Second Crown||1||
60150879|NCT02609178|76275615|FG002|COMPLETED|Second Crown||5||
60150880|NCT02609178|76275616|FG003|COMPLETED|Second Crown||2||
60150881|NCT02609178|76275617|FG004|COMPLETED|Second Crown||0||
60150882|NCT02609178|76275618|FG005|COMPLETED|Second Crown||2||
60150883|NCT02609178|76275613|FG000|NOT COMPLETED|Second Crown||0||
60150884|NCT02609178|76275614|FG001|NOT COMPLETED|Second Crown||0||
60150885|NCT02609178|76275615|FG002|NOT COMPLETED|Second Crown||0||
60150886|NCT02609178|76275616|FG003|NOT COMPLETED|Second Crown||0||
60150887|NCT02609178|76275617|FG004|NOT COMPLETED|Second Crown||0||
60150888|NCT02609178|76275618|FG005|NOT COMPLETED|Second Crown||0||
60150889|NCT02609178|76275613|FG000|STARTED|5-minute Washout Time||0||
60150890|NCT02609178|76275614|FG001|STARTED|5-minute Washout Time||1||
60150891|NCT02609178|76275615|FG002|STARTED|5-minute Washout Time||5||
60150892|NCT02609178|76275616|FG003|STARTED|5-minute Washout Time||2||
60150893|NCT02609178|76275617|FG004|STARTED|5-minute Washout Time||0||
60150894|NCT02609178|76275618|FG005|STARTED|5-minute Washout Time||2||
60150895|NCT02609178|76275613|FG000|COMPLETED|5-minute Washout Time||0||
60150896|NCT02609178|76275614|FG001|COMPLETED|5-minute Washout Time||1||
60150897|NCT02609178|76275615|FG002|COMPLETED|5-minute Washout Time||5||
60150898|NCT02609178|76275616|FG003|COMPLETED|5-minute Washout Time||2||
60150899|NCT02609178|76275617|FG004|COMPLETED|5-minute Washout Time||0||
60150900|NCT02609178|76275618|FG005|COMPLETED|5-minute Washout Time||2||
60150901|NCT02609178|76275613|FG000|NOT COMPLETED|5-minute Washout Time||0||
60150902|NCT02609178|76275614|FG001|NOT COMPLETED|5-minute Washout Time||0||
60150903|NCT02609178|76275615|FG002|NOT COMPLETED|5-minute Washout Time||0||
60150904|NCT02609178|76275616|FG003|NOT COMPLETED|5-minute Washout Time||0||
60150905|NCT02609178|76275617|FG004|NOT COMPLETED|5-minute Washout Time||0||
60150906|NCT02609178|76275618|FG005|NOT COMPLETED|5-minute Washout Time||0||
60150907|NCT02609178|76275613|FG000|STARTED|Third Crown||0||
60150908|NCT02609178|76275614|FG001|STARTED|Third Crown||1||
60150909|NCT02609178|76275615|FG002|STARTED|Third Crown||5||
60150910|NCT02609178|76275616|FG003|STARTED|Third Crown||2||
60150911|NCT02609178|76275617|FG004|STARTED|Third Crown||0||
60150912|NCT02609178|76275618|FG005|STARTED|Third Crown||2||
60150913|NCT02609178|76275613|FG000|COMPLETED|Third Crown||0||
60150914|NCT02609178|76275614|FG001|COMPLETED|Third Crown||1||
60150915|NCT02609178|76275615|FG002|COMPLETED|Third Crown||5||
60150916|NCT02609178|76275616|FG003|COMPLETED|Third Crown||2||
60150917|NCT02609178|76275617|FG004|COMPLETED|Third Crown||0||
60150918|NCT02609178|76275618|FG005|COMPLETED|Third Crown||2||
60150919|NCT02609178|76275613|FG000|NOT COMPLETED|Third Crown||0||
60150920|NCT02609178|76275614|FG001|NOT COMPLETED|Third Crown||0||
60150921|NCT02609178|76275615|FG002|NOT COMPLETED|Third Crown||0||
60150922|NCT02609178|76275616|FG003|NOT COMPLETED|Third Crown||0||
60150923|NCT02609178|76275617|FG004|NOT COMPLETED|Third Crown||0||
60150924|NCT02609178|76275618|FG005|NOT COMPLETED|Third Crown||0||
60150925|NCT03030235|76275626|FG000|STARTED|Overall Study||162||
60150926|NCT03030235|76275627|FG001|STARTED|Overall Study||162||
60150927|NCT03030235|76275626|FG000|COMPLETED|Overall Study||146||
60150928|NCT03030235|76275627|FG001|COMPLETED|Overall Study||145||
60150929|NCT03030235|76275626|FG000|NOT COMPLETED|Overall Study||16||
59605782|NCT01987908|75715897|FG000|COMPLETED|Post-Treatment Observation Period||0||
59605783|NCT01987908|75715898|FG001|COMPLETED|Post-Treatment Observation Period||7||
59605784|NCT01987908|75715899|FG002|COMPLETED|Post-Treatment Observation Period||2||
60150930|NCT03030235|76275627|FG001|NOT COMPLETED|Overall Study||17||
60150931|NCT02088385|76275635|FG000|STARTED|Overall Study||10||
60150932|NCT02088385|76275636|FG001|STARTED|Overall Study||10||
60150933|NCT02088385|76275635|FG000|COMPLETED|Overall Study||10||
60150934|NCT02088385|76275636|FG001|COMPLETED|Overall Study||10||
60150935|NCT02088385|76275635|FG000|NOT COMPLETED|Overall Study||0||
60150936|NCT02088385|76275636|FG001|NOT COMPLETED|Overall Study||0||
60150937|NCT02955511|76275645|FG000|STARTED|Overall Study||1||
60150938|NCT02955511|76275646|FG001|STARTED|Overall Study||3||
60150939|NCT02955511|76275647|FG002|STARTED|Overall Study||1||
60150940|NCT02955511|76275645|FG000|COMPLETED|Overall Study||1||
60150941|NCT02955511|76275646|FG001|COMPLETED|Overall Study||3||
60150942|NCT02955511|76275647|FG002|COMPLETED|Overall Study||1||
60150943|NCT02955511|76275645|FG000|NOT COMPLETED|Overall Study||0||
60150944|NCT02955511|76275646|FG001|NOT COMPLETED|Overall Study||0||
60150945|NCT02955511|76275647|FG002|NOT COMPLETED|Overall Study||0||
60150946|NCT02816255|76275657|FG000|STARTED|Overall Study||6||
60150947|NCT02816255|76275658|FG001|STARTED|Overall Study||5||
60150948|NCT02816255|76275657|FG000|COMPLETED|Overall Study||6||
60150949|NCT02816255|76275658|FG001|COMPLETED|Overall Study||5||
60150950|NCT02816255|76275657|FG000|NOT COMPLETED|Overall Study||0||
60150951|NCT02816255|76275658|FG001|NOT COMPLETED|Overall Study||0||
60150952|NCT01550367|76275666|FG000|STARTED|Overall Study||30||
60150953|NCT01550367|76275666|FG000|1200 mg/d HCQ|Overall Study||13||
60150954|NCT01550367|76275666|FG000|600 mg/d HCQ|Overall Study||17||
60150955|NCT01550367|76275666|FG000|COMPLETED|Overall Study||30||
60150956|NCT01550367|76275666|FG000|NOT COMPLETED|Overall Study||0||
60150957|NCT01427595|76275675|FG000|STARTED|Overall Study||25||
60150958|NCT01427595|76275675|FG000|COMPLETED|Overall Study||12||
60150959|NCT01427595|76275675|FG000|NOT COMPLETED|Overall Study||13||
60150960|NCT02212977|76275681|FG000|STARTED|Overall Study||55||
60150961|NCT02212977|76275682|FG001|STARTED|Overall Study||54||
60150962|NCT02212977|76275681|FG000|COMPLETED|Overall Study||50||
60150963|NCT02212977|76275682|FG001|COMPLETED|Overall Study||48||
60150964|NCT02212977|76275681|FG000|NOT COMPLETED|Overall Study||5||
60150965|NCT02212977|76275682|FG001|NOT COMPLETED|Overall Study||6||
60150966|NCT01428765|76275688|FG000|STARTED|Overall Study||1063||
60150967|NCT01428765|76275688|FG000|COMPLETED|Overall Study||1063||
60150968|NCT01428765|76275688|FG000|NOT COMPLETED|Overall Study||0||
60150969|NCT00716443|76275692|FG000|STARTED|Overall Study||51||
60150970|NCT00716443|76275692|FG000|COMPLETED|Overall Study||51||
60150971|NCT00716443|76275692|FG000|NOT COMPLETED|Overall Study||0||
60150972|NCT02802293|76275700|FG000|STARTED|Overall Study||1||
60150973|NCT02802293|76275701|FG001|STARTED|Overall Study||2||
60150974|NCT02802293|76275702|FG002|STARTED|Overall Study||3||
60150975|NCT02802293|76275700|FG000|COMPLETED|Overall Study||0||
60150976|NCT02802293|76275701|FG001|COMPLETED|Overall Study||1||
60150977|NCT02802293|76275702|FG002|COMPLETED|Overall Study||1||
60150978|NCT02802293|76275700|FG000|NOT COMPLETED|Overall Study||1||
60150979|NCT02802293|76275701|FG001|NOT COMPLETED|Overall Study||1||
60150980|NCT02802293|76275702|FG002|NOT COMPLETED|Overall Study||2||
60150981|NCT02308709|76275710|FG000|STARTED|Overall Study||34||
60150982|NCT02308709|76275710|FG000|COMPLETED|Overall Study||33||
60150983|NCT02308709|76275710|FG000|NOT COMPLETED|Overall Study||1||
60150984|NCT02213289|76275720|FG000|STARTED|Overall Study||68||
60150985|NCT02213289|76275721|FG001|STARTED|Overall Study||12||
59605785|NCT01987908|75715897|FG000|NOT COMPLETED|Post-Treatment Observation Period||0||
59605786|NCT01987908|75715898|FG001|NOT COMPLETED|Post-Treatment Observation Period||3||
59605787|NCT01987908|75715899|FG002|NOT COMPLETED|Post-Treatment Observation Period||0||
60150986|NCT02213289|76275720|FG000|Immuno-oncology|Overall Study||5||
60150987|NCT02213289|76275721|FG001|Immuno-oncology|Overall Study||0||
60150988|NCT02213289|76275720|FG000|HER2 Amplified|Overall Study||16||
59762637|NCT04920929|75882471|FG000|NOT COMPLETED|Overall Study||0||
60150989|NCT02213289|76275721|FG001|HER2 Amplified|Overall Study||0||
60150990|NCT02213289|76275720|FG000|EGFR Amplified|Overall Study||8||
60150991|NCT02213289|76275721|FG001|EGFR Amplified|Overall Study||0||
60150992|NCT02213289|76275720|FG000|FGFR2 Amplified|Overall Study||1||
60150993|NCT02213289|76275721|FG001|FGFR2 Amplified|Overall Study||0||
60150994|NCT02213289|76275720|FG000|MAPK/PIK3CA Aberrant|Overall Study||20||
60150995|NCT02213289|76275721|FG001|MAPK/PIK3CA Aberrant|Overall Study||0||
60150996|NCT02213289|76275720|FG000|EGFR Expressing|Overall Study||9||
60150997|NCT02213289|76275721|FG001|EGFR Expressing|Overall Study||0||
60150998|NCT02213289|76275720|FG000|All Negative|Overall Study||9||
60150999|NCT02213289|76275721|FG001|All Negative|Overall Study||0||
60151000|NCT02213289|76275720|FG000|Other (Non-ITT)|Overall Study||0||
60151001|NCT02213289|76275721|FG001|Other (Non-ITT)|Overall Study||12||
60151002|NCT02213289|76275720|FG000|COMPLETED|Overall Study||68||
60151003|NCT02213289|76275721|FG001|COMPLETED|Overall Study||12||
60151004|NCT02213289|76275720|FG000|NOT COMPLETED|Overall Study||0||
60151005|NCT02213289|76275721|FG001|NOT COMPLETED|Overall Study||0||
60151006|NCT00053989|76275731|FG000|STARTED|Overall Study||41||
60151007|NCT00053989|76275731|FG000|COMPLETED|Overall Study||41||
60151008|NCT00053989|76275731|FG000|NOT COMPLETED|Overall Study||0||
60151009|NCT02085473|76275739|FG000|STARTED|Overall Study||15||
60151010|NCT02085473|76275740|FG001|STARTED|Overall Study||15||
60151011|NCT02085473|76275741|FG002|STARTED|Overall Study||15||
60151012|NCT02085473|76275742|FG003|STARTED|Overall Study||15||
60151013|NCT02085473|76275739|FG000|COMPLETED|Overall Study||15||
60151014|NCT02085473|76275740|FG001|COMPLETED|Overall Study||15||
60151015|NCT02085473|76275741|FG002|COMPLETED|Overall Study||15||
60151016|NCT02085473|76275742|FG003|COMPLETED|Overall Study||15||
60151017|NCT02085473|76275739|FG000|NOT COMPLETED|Overall Study||0||
60151018|NCT02085473|76275740|FG001|NOT COMPLETED|Overall Study||0||
60151019|NCT02085473|76275741|FG002|NOT COMPLETED|Overall Study||0||
60151020|NCT02085473|76275742|FG003|NOT COMPLETED|Overall Study||0||
60151021|NCT02085551|76275752|FG000|STARTED|Overall Study||85||
60151022|NCT02085551|76275752|FG000|COMPLETED|Overall Study||85||
60151023|NCT02085551|76275752|FG000|NOT COMPLETED|Overall Study||0||
60151024|NCT02665481|76275760|FG000|STARTED|Overall Study||150||
59882130|NCT03848403|76005049|FG001|NOT COMPLETED|Period 1 (Day 1)||0||
59882131|NCT03848403|76005050|FG002|NOT COMPLETED|Period 1 (Day 1)||0||
60151025|NCT02665481|76275761|FG001|STARTED|Overall Study||138||
60151026|NCT02665481|76275762|FG002|STARTED|Overall Study||144||
60151027|NCT02665481|76275763|FG003|STARTED|Overall Study||153||
60151028|NCT02665481|76275760|FG000|COMPLETED|Overall Study||139||
60151029|NCT02665481|76275761|FG001|COMPLETED|Overall Study||119||
60151030|NCT02665481|76275762|FG002|COMPLETED|Overall Study||106||
60151031|NCT02665481|76275763|FG003|COMPLETED|Overall Study||111||
60151032|NCT02665481|76275760|FG000|NOT COMPLETED|Overall Study||11||
60151033|NCT02665481|76275761|FG001|NOT COMPLETED|Overall Study||19||
60151034|NCT02665481|76275762|FG002|NOT COMPLETED|Overall Study||38||
60151035|NCT02665481|76275763|FG003|NOT COMPLETED|Overall Study||42||
60151036|NCT02214147|76275776|FG000|STARTED|Overall Study||16||
59605788|NCT01995552|75715923|FG000|STARTED|Overall Study|There were 249 patients were included for Baseline cohort and 233 in analysis cohort|250|The study required to enroll 250 patients:|
59762638|NCT04920929|75882472|FG001|NOT COMPLETED|Overall Study||0||
59762639|NCT00533845|75882480|FG000|STARTED|Overall Study||15||
59762640|NCT00533845|75882481|FG001|STARTED|Overall Study||15||
59762641|NCT00533845|75882480|FG000|COMPLETED|Overall Study||14||
59762642|NCT00533845|75882481|FG001|COMPLETED|Overall Study||15||
59762643|NCT00533845|75882480|FG000|NOT COMPLETED|Overall Study||1||
59762644|NCT00533845|75882481|FG001|NOT COMPLETED|Overall Study||0||
59762645|NCT00857649|75882489|FG000|STARTED|Overall Study||182||
59762646|NCT00857649|75882490|FG001|STARTED|Overall Study||187||
59762647|NCT00857649|75882489|FG000|COMPLETED|Overall Study||151||
59762648|NCT00857649|75882490|FG001|COMPLETED|Overall Study||155||
59762649|NCT00857649|75882489|FG000|NOT COMPLETED|Overall Study||31||
59762650|NCT00857649|75882490|FG001|NOT COMPLETED|Overall Study||32||
59762651|NCT00857415|75882498|FG000|STARTED|Overall Study||152||
59762652|NCT00857415|75882499|FG001|STARTED|Overall Study||74||
59762653|NCT00857415|75882498|FG000|Deceased Within One Year of AV-45 Scan|Overall Study||37||
59762654|NCT00857415|75882499|FG001|Deceased Within One Year of AV-45 Scan|Overall Study|Subjects in the specificity cohort were not followed to autopsy|0||
59762655|NCT00857415|75882498|FG000|COMPLETED|Overall Study||35||
59762656|NCT00857415|75882499|FG001|COMPLETED|Overall Study||74||
59762657|NCT00857415|75882498|FG000|NOT COMPLETED|Overall Study||117||
59762658|NCT00857415|75882499|FG001|NOT COMPLETED|Overall Study||0||
59762659|NCT00532441|75882505|FG000|STARTED|Overall Study||14||
59762660|NCT00532441|75882506|FG001|STARTED|Overall Study||11||
59762661|NCT00532441|75882505|FG000|COMPLETED|Overall Study||13||
59762662|NCT00532441|75882506|FG001|COMPLETED|Overall Study||11||
59762663|NCT00532441|75882505|FG000|NOT COMPLETED|Overall Study||1||
59762664|NCT00532441|75882506|FG001|NOT COMPLETED|Overall Study||0||
59762665|NCT01886963|75882517|FG000|STARTED|Overall Study||57||
59882132|NCT03848403|76005048|FG000|STARTED|Period 2 (Day 8)||24||
59882133|NCT03848403|76005049|FG001|STARTED|Period 2 (Day 8)||24||
59882134|NCT03848403|76005050|FG002|STARTED|Period 2 (Day 8)||22||
59882135|NCT03848403|76005048|FG000|Received at Least One Dose of Study Drug|Period 2 (Day 8)||24||
59882136|NCT03848403|76005049|FG001|Received at Least One Dose of Study Drug|Period 2 (Day 8)||24||
60151037|NCT02214147|76275777|FG001|STARTED|Overall Study||12||
60151038|NCT02214147|76275778|FG002|STARTED|Overall Study||8||
60151039|NCT02214147|76275776|FG000|COMPLETED|Overall Study||16|Completed=Completed protocol-specified dosing and PK assessment.|
60151040|NCT02214147|76275777|FG001|COMPLETED|Overall Study||12|Completed=Completed protocol-specified dosing and PK assessment.|
60151041|NCT02214147|76275778|FG002|COMPLETED|Overall Study||8|Completed=Completed protocol-specified dosing and PK assessment.|
60151042|NCT02214147|76275776|FG000|NOT COMPLETED|Overall Study||0||
60151043|NCT02214147|76275777|FG001|NOT COMPLETED|Overall Study||0||
60151044|NCT02214147|76275778|FG002|NOT COMPLETED|Overall Study||0||
60151045|NCT02086331|76275786|FG000|STARTED|Overall Study||5||
60151046|NCT02086331|76275786|FG000|COMPLETED|Overall Study||5||
60151047|NCT02086331|76275786|FG000|NOT COMPLETED|Overall Study||0||
60151048|NCT02214615|76275801|FG000|STARTED|First Intervention||1||
60151049|NCT02214615|76275802|FG001|STARTED|First Intervention||1||
60151050|NCT02214615|76275801|FG000|COMPLETED|First Intervention||1||
60151051|NCT02214615|76275802|FG001|COMPLETED|First Intervention||1||
60151052|NCT02214615|76275801|FG000|NOT COMPLETED|First Intervention||0||
60151053|NCT02214615|76275802|FG001|NOT COMPLETED|First Intervention||0||
60151054|NCT02214615|76275801|FG000|STARTED|Washout||1||
60151055|NCT02214615|76275802|FG001|STARTED|Washout||1||
60151056|NCT02214615|76275801|FG000|COMPLETED|Washout||1||
60151057|NCT02214615|76275802|FG001|COMPLETED|Washout||1||
60151058|NCT02214615|76275801|FG000|NOT COMPLETED|Washout||0||
60151059|NCT02214615|76275802|FG001|NOT COMPLETED|Washout||0||
59882137|NCT03848403|76005050|FG002|Received at Least One Dose of Study Drug|Period 2 (Day 8)||22||
59882138|NCT03848403|76005048|FG000|COMPLETED|Period 2 (Day 8)||15||
59882139|NCT03848403|76005049|FG001|COMPLETED|Period 2 (Day 8)||15||
59882140|NCT03848403|76005050|FG002|COMPLETED|Period 2 (Day 8)||15||
59882141|NCT03848403|76005048|FG000|NOT COMPLETED|Period 2 (Day 8)||9||
59882142|NCT03848403|76005049|FG001|NOT COMPLETED|Period 2 (Day 8)||9||
60151060|NCT02214615|76275801|FG000|STARTED|Second Intervention||1||
60151061|NCT02214615|76275802|FG001|STARTED|Second Intervention||1||
60151062|NCT02214615|76275801|FG000|COMPLETED|Second Intervention||1||
60151063|NCT02214615|76275802|FG001|COMPLETED|Second Intervention||1||
60151064|NCT02214615|76275801|FG000|NOT COMPLETED|Second Intervention||0||
60151065|NCT02214615|76275802|FG001|NOT COMPLETED|Second Intervention||0||
60151066|NCT01554891|76275811|FG000|STARTED|Overall Study||105||
59882143|NCT03848403|76005050|FG002|NOT COMPLETED|Period 2 (Day 8)||7||
59882144|NCT03848403|76005048|FG000|STARTED|Period 3 (Day 15)||15||
59882145|NCT03848403|76005049|FG001|STARTED|Period 3 (Day 15)||15||
59882146|NCT03848403|76005050|FG002|STARTED|Period 3 (Day 15)||15||
59882147|NCT03848403|76005048|FG000|COMPLETED|Period 3 (Day 15)||15||
59882148|NCT03848403|76005049|FG001|COMPLETED|Period 3 (Day 15)||15||
60151067|NCT01554891|76275812|FG001|STARTED|Overall Study||120||
60151068|NCT01554891|76275813|FG002|STARTED|Overall Study||57||
60151069|NCT01554891|76275811|FG000|COMPLETED|Overall Study||98||
60151070|NCT01554891|76275812|FG001|COMPLETED|Overall Study||115||
60151071|NCT01554891|76275813|FG002|COMPLETED|Overall Study||55||
60151072|NCT01554891|76275811|FG000|NOT COMPLETED|Overall Study||7||
60151073|NCT01554891|76275812|FG001|NOT COMPLETED|Overall Study||5||
60151074|NCT01554891|76275813|FG002|NOT COMPLETED|Overall Study||2||
59882149|NCT03848403|76005050|FG002|COMPLETED|Period 3 (Day 15)||15||
59882150|NCT03848403|76005048|FG000|NOT COMPLETED|Period 3 (Day 15)||0||
59882151|NCT03848403|76005049|FG001|NOT COMPLETED|Period 3 (Day 15)||0||
59882152|NCT03848403|76005050|FG002|NOT COMPLETED|Period 3 (Day 15)||0||
59882153|NCT04054011|76005058|FG000|STARTED|Overall Study||15||
59882154|NCT04054011|76005058|FG000|COMPLETED|Overall Study||12||
59882155|NCT04054011|76005058|FG000|NOT COMPLETED|Overall Study||3||
60151075|NCT01430091|76275821|FG000|STARTED|Overall Study||18||
60151076|NCT01430091|76275821|FG000|COMPLETED|Overall Study||18||
60151077|NCT01430091|76275821|FG000|NOT COMPLETED|Overall Study||0||
60151078|NCT02607228|76275842|FG000|STARTED|Overall Study||5||
60151079|NCT02607228|76275843|FG001|STARTED|Overall Study||4||
60151080|NCT02607228|76275844|FG002|STARTED|Overall Study||3||
60151081|NCT02607228|76275845|FG003|STARTED|Overall Study||6||
60151082|NCT02607228|76275846|FG004|STARTED|Overall Study||5||
60151083|NCT02607228|76275847|FG005|STARTED|Overall Study||6||
60151084|NCT02607228|76275848|FG006|STARTED|Overall Study||2||
60151085|NCT02607228|76275842|FG000|COMPLETED|Overall Study||0||
60151086|NCT02607228|76275843|FG001|COMPLETED|Overall Study||0||
60151087|NCT02607228|76275844|FG002|COMPLETED|Overall Study||0||
60151088|NCT02607228|76275845|FG003|COMPLETED|Overall Study||0||
60151089|NCT02607228|76275846|FG004|COMPLETED|Overall Study||0||
60151090|NCT02607228|76275847|FG005|COMPLETED|Overall Study||0||
60151091|NCT02607228|76275848|FG006|COMPLETED|Overall Study||0||
60151092|NCT02607228|76275842|FG000|NOT COMPLETED|Overall Study||5||
60151093|NCT02607228|76275843|FG001|NOT COMPLETED|Overall Study||4||
60151094|NCT02607228|76275844|FG002|NOT COMPLETED|Overall Study||3||
60151095|NCT02607228|76275845|FG003|NOT COMPLETED|Overall Study||6||
60151096|NCT02607228|76275846|FG004|NOT COMPLETED|Overall Study||5||
60151097|NCT02607228|76275847|FG005|NOT COMPLETED|Overall Study||6||
60151098|NCT02607228|76275848|FG006|NOT COMPLETED|Overall Study||2||
60151099|NCT01430169|76275865|FG000|STARTED|Overall Study||20||
60151100|NCT01430169|76275865|FG000|COMPLETED|Overall Study||20||
60151101|NCT01430169|76275865|FG000|NOT COMPLETED|Overall Study||0||
60151102|NCT02638883|76275869|FG000|STARTED|Overall Study||6||
60151103|NCT02638883|76275869|FG000|COMPLETED|Overall Study||6||
60151104|NCT02638883|76275869|FG000|NOT COMPLETED|Overall Study||0||
60151105|NCT01430325|76275877|FG000|STARTED|Overall Study||10||
60151106|NCT01430325|76275878|FG001|STARTED|Overall Study||12||
60151107|NCT01430325|76275879|FG002|STARTED|Overall Study||8||
60151108|NCT01430325|76275880|FG003|STARTED|Overall Study||12||
60151109|NCT01430325|76275877|FG000|COMPLETED|Overall Study||10||
60151110|NCT01430325|76275878|FG001|COMPLETED|Overall Study||12||
60151111|NCT01430325|76275879|FG002|COMPLETED|Overall Study||8||
60151112|NCT01430325|76275880|FG003|COMPLETED|Overall Study||12||
60151113|NCT01430325|76275877|FG000|NOT COMPLETED|Overall Study||0||
60151114|NCT01430325|76275878|FG001|NOT COMPLETED|Overall Study||0||
60151115|NCT01430325|76275879|FG002|NOT COMPLETED|Overall Study||0||
60151116|NCT01430325|76275880|FG003|NOT COMPLETED|Overall Study||0||
60151117|NCT01668654|76275890|FG000|STARTED|Overall Study||4||
60151118|NCT01668654|76275890|FG000|COMPLETED|Overall Study||0||
60151119|NCT01668654|76275890|FG000|NOT COMPLETED|Overall Study||4||
60151120|NCT01431105|76275894|FG000|STARTED|Overall Study||34||
60151121|NCT01431105|76275894|FG000|COMPLETED|Overall Study||34||
60151122|NCT01431105|76275894|FG000|NOT COMPLETED|Overall Study||0||
60151123|NCT02633267|76275900|FG000|STARTED|Overall Study||120||
60151124|NCT02633267|76275901|FG001|STARTED|Overall Study||130||
60151125|NCT02633267|76275900|FG000|COMPLETED|Overall Study||89||
60151126|NCT02633267|76275901|FG001|COMPLETED|Overall Study||91||
60151127|NCT02633267|76275900|FG000|NOT COMPLETED|Overall Study||31||
60151128|NCT02633267|76275901|FG001|NOT COMPLETED|Overall Study||39||
60151129|NCT01431339|76275909|FG000|STARTED|Overall Study||371||
60151130|NCT01431339|76275910|FG001|STARTED|Overall Study||368||
60151131|NCT01431339|76275909|FG000|Safety Population|Overall Study||368||
60151132|NCT01431339|76275910|FG001|Safety Population|Overall Study||367||
60151133|NCT01431339|76275909|FG000|COMPLETED|Overall Study||332||
60151134|NCT01431339|76275910|FG001|COMPLETED|Overall Study||333||
60151135|NCT01431339|76275909|FG000|NOT COMPLETED|Overall Study||39||
60151136|NCT01431339|76275910|FG001|NOT COMPLETED|Overall Study||35||
60151137|NCT01431573|76275916|FG000|STARTED|Overall Study||8||
60151138|NCT01431573|76275916|FG000|COMPLETED|Overall Study||8||
60151139|NCT01431573|76275916|FG000|NOT COMPLETED|Overall Study||0||
60151140|NCT01488279|76275922|FG000|STARTED|Overall Study||5||
60151141|NCT01488279|76275923|FG001|STARTED|Overall Study||5||
60151142|NCT01488279|76275922|FG000|COMPLETED|Overall Study||5||
60151143|NCT01488279|76275923|FG001|COMPLETED|Overall Study||5||
60151144|NCT01488279|76275922|FG000|NOT COMPLETED|Overall Study||0||
60151145|NCT01488279|76275923|FG001|NOT COMPLETED|Overall Study||0||
60151146|NCT01490073|76275934|FG000|STARTED|Overall Study||12||
60151147|NCT01490073|76275935|FG001|STARTED|Overall Study||12||
60151148|NCT01490073|76275934|FG000|COMPLETED|Overall Study||12||
60151149|NCT01490073|76275935|FG001|COMPLETED|Overall Study||12||
60151150|NCT01490073|76275934|FG000|NOT COMPLETED|Overall Study||0||
60151151|NCT01490073|76275935|FG001|NOT COMPLETED|Overall Study||0||
60151152|NCT01490151|76275941|FG000|STARTED|Overall Study||22||
60151153|NCT01490151|76275941|FG000|COMPLETED|Overall Study||22||
60151154|NCT01490151|76275941|FG000|NOT COMPLETED|Overall Study||0||
60151155|NCT01556061|76275949|FG000|STARTED|Overall Study||25||
60151156|NCT01556061|76275950|FG001|STARTED|Overall Study||25||
60151157|NCT01556061|76275949|FG000|COMPLETED|Overall Study||25||
60151158|NCT01556061|76275950|FG001|COMPLETED|Overall Study||25||
60151159|NCT01556061|76275949|FG000|NOT COMPLETED|Overall Study||0||
60151160|NCT01556061|76275950|FG001|NOT COMPLETED|Overall Study||0||
60151161|NCT01490931|76275958|FG000|STARTED|Overall Study||25||
60151162|NCT01490931|76275958|FG000|COMPLETED|Overall Study||25||
60151163|NCT01490931|76275958|FG000|NOT COMPLETED|Overall Study||0||
60151164|NCT01556451|76275962|FG000|STARTED|Overall Study||180||
60151165|NCT01556451|76275962|FG000|COMPLETED|Overall Study||180||
60151166|NCT01556451|76275962|FG000|NOT COMPLETED|Overall Study||0||
60151167|NCT01557699|76275969|FG000|STARTED|Overall Study||20||
60151168|NCT01557699|76275970|FG001|STARTED|Overall Study||20||
60151169|NCT01557699|76275971|FG002|STARTED|Overall Study||20||
60151170|NCT01557699|76275969|FG000|COMPLETED|Overall Study||20||
60151171|NCT01557699|76275970|FG001|COMPLETED|Overall Study||20||
60151172|NCT01557699|76275971|FG002|COMPLETED|Overall Study||20||
60151173|NCT01557699|76275969|FG000|NOT COMPLETED|Overall Study||0||
60151174|NCT01557699|76275970|FG001|NOT COMPLETED|Overall Study||0||
60151175|NCT01557699|76275971|FG002|NOT COMPLETED|Overall Study||0||
60151176|NCT02608476|76275984|FG000|STARTED|Overall Study||369||
60151177|NCT02608476|76275985|FG001|STARTED|Overall Study||363||
60151178|NCT02608476|76275984|FG000|COMPLETED|Overall Study||302||
60151179|NCT02608476|76275985|FG001|COMPLETED|Overall Study||282||
60151180|NCT02608476|76275984|FG000|NOT COMPLETED|Overall Study||67||
60151181|NCT02608476|76275985|FG001|NOT COMPLETED|Overall Study||81||
60151182|NCT01491633|76275991|FG000|STARTED|Overall Study||5||
60151183|NCT01491633|76275991|FG000|COMPLETED|Overall Study||0||
60151184|NCT01491633|76275991|FG000|NOT COMPLETED|Overall Study||5||
60151185|NCT02539823|76275998|FG000|STARTED|Overall Study||15||
60151186|NCT02539823|76275999|FG001|STARTED|Overall Study||14||
60151187|NCT02539823|76276000|FG002|STARTED|Overall Study||13||
60151188|NCT02539823|76275998|FG000|COMPLETED|Overall Study||15||
60151189|NCT02539823|76275999|FG001|COMPLETED|Overall Study||14||
60151190|NCT02539823|76276000|FG002|COMPLETED|Overall Study||13||
60151191|NCT02539823|76275998|FG000|NOT COMPLETED|Overall Study||0||
60151192|NCT02539823|76275999|FG001|NOT COMPLETED|Overall Study||0||
60151193|NCT02539823|76276000|FG002|NOT COMPLETED|Overall Study||0||
60151194|NCT01433913|76276010|FG000|STARTED|Overall Study||10||
60151195|NCT01433913|76276011|FG001|STARTED|Overall Study||10||
60151196|NCT01433913|76276010|FG000|COMPLETED|Overall Study||9||
60151197|NCT01433913|76276011|FG001|COMPLETED|Overall Study||10||
60151198|NCT01433913|76276010|FG000|NOT COMPLETED|Overall Study||1||
60151199|NCT01433913|76276011|FG001|NOT COMPLETED|Overall Study||0||
60151200|NCT01558791|76276020|FG000|STARTED|Overall Study||607||
60151201|NCT01558791|76276021|FG001|STARTED|Overall Study||629||
60151202|NCT01558791|76276020|FG000|COMPLETED|Overall Study||607||
60151203|NCT01558791|76276021|FG001|COMPLETED|Overall Study||629||
60151204|NCT01558791|76276020|FG000|NOT COMPLETED|Overall Study||0||
60151205|NCT01558791|76276021|FG001|NOT COMPLETED|Overall Study||0||
60151206|NCT01559649|76276031|FG000|STARTED|Overall Study||269||
60151207|NCT01559649|76276032|FG001|STARTED|Overall Study|Started with 10 nurses. As an RN dropped out due to scheduling, etc, RN replaced with another RN|15||
60151208|NCT01559649|76276031|FG000|COMPLETED|Overall Study|Screening not completed in 11, VFSS not completed in 2, 6 excluded from analysis. N=250 analyzed|250||
60151209|NCT01559649|76276032|FG001|COMPLETED|Overall Study||9||
60151210|NCT01559649|76276031|FG000|NOT COMPLETED|Overall Study||19||
60151211|NCT01559649|76276032|FG001|NOT COMPLETED|Overall Study||6||
60151212|NCT01436799|76276041|FG000|STARTED|Overall Study||20||
60151213|NCT01436799|76276042|FG001|STARTED|Overall Study||20||
60151214|NCT01436799|76276041|FG000|COMPLETED|Overall Study||20||
60151215|NCT01436799|76276042|FG001|COMPLETED|Overall Study||20||
60151216|NCT01436799|76276041|FG000|NOT COMPLETED|Overall Study||0||
60151217|NCT01436799|76276042|FG001|NOT COMPLETED|Overall Study||0||
60151218|NCT01437501|76276050|FG000|STARTED|Overall Study||148||
60151219|NCT01437501|76276051|FG001|STARTED|Overall Study||143||
60151220|NCT01437501|76276050|FG000|COMPLETED|Overall Study||135||
60151221|NCT01437501|76276051|FG001|COMPLETED|Overall Study||132||
60151222|NCT01437501|76276050|FG000|NOT COMPLETED|Overall Study||13||
60151223|NCT01437501|76276051|FG001|NOT COMPLETED|Overall Study||11||
60151224|NCT01560975|76276059|FG000|STARTED|Overall Study||10||
60151225|NCT01560975|76276059|FG000|COMPLETED|Overall Study||10||
60151226|NCT01560975|76276059|FG000|NOT COMPLETED|Overall Study||0||
60151227|NCT01494051|76276069|FG000|STARTED|Overall Study||6||
60151228|NCT01494051|76276070|FG001|STARTED|Overall Study||7||
60151229|NCT01494051|76276069|FG000|COMPLETED|Overall Study||6||
59605789|NCT01995552|75715923|FG000|COMPLETED|Overall Study|There were 233 patients who were eligible for primary objective analysis|233||
59605790|NCT01995552|75715923|FG000|NOT COMPLETED|Overall Study||17||
60151230|NCT01494051|76276070|FG001|COMPLETED|Overall Study||7||
60151231|NCT01494051|76276069|FG000|NOT COMPLETED|Overall Study||0||
60151232|NCT01494051|76276070|FG001|NOT COMPLETED|Overall Study||0||
59605791|NCT01987830|75715929|FG000|STARTED|Overall Study||13||
60151233|NCT01494753|76276078|FG000|STARTED|Day0-Day42||15||
60151234|NCT01494753|76276079|FG001|STARTED|Day0-Day42||15||
60151235|NCT01494753|76276078|FG000|COMPLETED|Day0-Day42||15||
60151236|NCT01494753|76276079|FG001|COMPLETED|Day0-Day42||15||
60151237|NCT01494753|76276078|FG000|NOT COMPLETED|Day0-Day42||0||
60151238|NCT01494753|76276079|FG001|NOT COMPLETED|Day0-Day42||0||
60151239|NCT01494753|76276078|FG000|STARTED|Day42-Day84||15||
60151240|NCT01494753|76276079|FG001|STARTED|Day42-Day84||15||
60151241|NCT01494753|76276078|FG000|COMPLETED|Day42-Day84||15||
60151242|NCT01494753|76276079|FG001|COMPLETED|Day42-Day84||15||
60151243|NCT01494753|76276078|FG000|NOT COMPLETED|Day42-Day84||0||
60151244|NCT01494753|76276079|FG001|NOT COMPLETED|Day42-Day84||0||
60151245|NCT01495221|76276085|FG000|STARTED|Overall Study|First Patient enrolled December 2011.|9||
60151246|NCT01495221|76276085|FG000|COMPLETED|Overall Study|Last patient enrolled May 2012.|9||
60151247|NCT01495221|76276085|FG000|NOT COMPLETED|Overall Study||0||
60151248|NCT01561053|76276093|FG000|STARTED|Overall Study||86||
60151249|NCT01561053|76276094|FG001|STARTED|Overall Study||92||
60151250|NCT01561053|76276095|FG002|STARTED|Overall Study||82||
60151251|NCT01561053|76276096|FG003|STARTED|Overall Study||87||
60151252|NCT01561053|76276093|FG000|Patients With Baseline MMSE:18-21|Overall Study||47||
60151253|NCT01561053|76276094|FG001|Patients With Baseline MMSE:18-21|Overall Study||40||
59751582|NCT00969761|75870889|FG000|COMPLETED|Treated in and Beyond Treat. Cycle 2||0||
59751583|NCT00969761|75870890|FG001|COMPLETED|Treated in and Beyond Treat. Cycle 2||0||
59751584|NCT00969761|75870891|FG002|COMPLETED|Treated in and Beyond Treat. Cycle 2||0||
59751585|NCT00969761|75870892|FG003|COMPLETED|Treated in and Beyond Treat. Cycle 2||0||
60151254|NCT01561053|76276095|FG002|Patients With Baseline MMSE:18-21|Overall Study||47||
60151255|NCT01561053|76276096|FG003|Patients With Baseline MMSE:18-21|Overall Study||42||
60151256|NCT01561053|76276093|FG000|Patients With Baseline MMSE:22-26|Overall Study||39||
60151257|NCT01561053|76276094|FG001|Patients With Baseline MMSE:22-26|Overall Study||52||
60151258|NCT01561053|76276095|FG002|Patients With Baseline MMSE:22-26|Overall Study||35||
60151259|NCT01561053|76276096|FG003|Patients With Baseline MMSE:22-26|Overall Study||45||
60151260|NCT01561053|76276093|FG000|Randomized Not Treated|Overall Study||8||
60151261|NCT01561053|76276094|FG001|Randomized Not Treated|Overall Study||6||
60151262|NCT01561053|76276095|FG002|Randomized Not Treated|Overall Study||4||
60151263|NCT01561053|76276096|FG003|Randomized Not Treated|Overall Study||7||
60151264|NCT01561053|76276093|FG000|Evaluable Subjects|Overall Study||78||
60151265|NCT01561053|76276094|FG001|Evaluable Subjects|Overall Study||86||
60151266|NCT01561053|76276095|FG002|Evaluable Subjects|Overall Study||78||
60151267|NCT01561053|76276096|FG003|Evaluable Subjects|Overall Study||80||
60151268|NCT01561053|76276093|FG000|COMPLETED|Overall Study||51||
60151269|NCT01561053|76276094|FG001|COMPLETED|Overall Study||56||
60151270|NCT01561053|76276095|FG002|COMPLETED|Overall Study||61||
60151271|NCT01561053|76276096|FG003|COMPLETED|Overall Study||64||
60151272|NCT01561053|76276093|FG000|NOT COMPLETED|Overall Study||35||
60151273|NCT01561053|76276094|FG001|NOT COMPLETED|Overall Study||36||
60151274|NCT01561053|76276095|FG002|NOT COMPLETED|Overall Study||21||
60151275|NCT01561053|76276096|FG003|NOT COMPLETED|Overall Study||23||
60151276|NCT01440387|76276109|FG000|STARTED|Overall Study||56||
60151277|NCT01440387|76276110|FG001|STARTED|Overall Study||56||
60151278|NCT01440387|76276109|FG000|COMPLETED|Overall Study||56||
60151279|NCT01440387|76276110|FG001|COMPLETED|Overall Study||56||
60151280|NCT01440387|76276109|FG000|NOT COMPLETED|Overall Study||0||
60151281|NCT01440387|76276110|FG001|NOT COMPLETED|Overall Study||0||
60151282|NCT01561833|76276116|FG000|STARTED|Overall Study||12||
60151283|NCT01561833|76276116|FG000|COMPLETED|Overall Study||12||
60151284|NCT01561833|76276116|FG000|NOT COMPLETED|Overall Study||0||
60151285|NCT02607306|76276123|FG000|STARTED|Overall Study||275||
60151286|NCT02607306|76276124|FG001|STARTED|Overall Study||271||
60151287|NCT02607306|76276125|FG002|STARTED|Overall Study||273||
60151288|NCT02607306|76276123|FG000|COMPLETED|Overall Study||254||
60151289|NCT02607306|76276124|FG001|COMPLETED|Overall Study||248||
60151290|NCT02607306|76276125|FG002|COMPLETED|Overall Study||263||
60151291|NCT02607306|76276123|FG000|NOT COMPLETED|Overall Study||21||
60151292|NCT02607306|76276124|FG001|NOT COMPLETED|Overall Study||23||
60151293|NCT02607306|76276125|FG002|NOT COMPLETED|Overall Study||10||
60151294|NCT01562379|76276139|FG000|STARTED|Overall Study||1438||
60151295|NCT01562379|76276140|FG001|STARTED|Overall Study||1492||
60151296|NCT01562379|76276141|FG002|STARTED|Overall Study||851||
60151297|NCT01562379|76276142|FG003|STARTED|Overall Study||843||
60151298|NCT01562379|76276143|FG004|STARTED|Overall Study||825||
60151299|NCT01562379|76276139|FG000|COMPLETED|Overall Study||1312||
60151300|NCT01562379|76276140|FG001|COMPLETED|Overall Study||1395||
60151301|NCT01562379|76276141|FG002|COMPLETED|Overall Study||789||
59751586|NCT00969761|75870893|FG004|COMPLETED|Treated in and Beyond Treat. Cycle 2||0||
59751587|NCT00969761|75870894|FG005|COMPLETED|Treated in and Beyond Treat. Cycle 2||0||
59751588|NCT00969761|75870895|FG006|COMPLETED|Treated in and Beyond Treat. Cycle 2||0||
60151302|NCT01562379|76276142|FG003|COMPLETED|Overall Study||786||
60151303|NCT01562379|76276143|FG004|COMPLETED|Overall Study||785||
60151304|NCT01562379|76276139|FG000|NOT COMPLETED|Overall Study||126||
60151305|NCT01562379|76276140|FG001|NOT COMPLETED|Overall Study||97||
60151306|NCT01562379|76276141|FG002|NOT COMPLETED|Overall Study||62||
60151307|NCT01562379|76276142|FG003|NOT COMPLETED|Overall Study||57||
60151308|NCT01562379|76276143|FG004|NOT COMPLETED|Overall Study||40||
60151309|NCT01440543|76276159|FG000|STARTED|Overall Study||106||
60151310|NCT01440543|76276160|FG001|STARTED|Overall Study||105||
60151311|NCT01440543|76276161|FG002|STARTED|Overall Study||102||
60151312|NCT01440543|76276162|FG003|STARTED|Overall Study||107||
60151313|NCT01440543|76276159|FG000|COMPLETED|Overall Study||102||
60151314|NCT01440543|76276160|FG001|COMPLETED|Overall Study||101||
59762666|NCT01886963|75882518|FG001|STARTED|Overall Study||58||
60151315|NCT01440543|76276161|FG002|COMPLETED|Overall Study||100||
60151316|NCT01440543|76276162|FG003|COMPLETED|Overall Study||101||
60151317|NCT01440543|76276159|FG000|NOT COMPLETED|Overall Study||4||
60151318|NCT01440543|76276160|FG001|NOT COMPLETED|Overall Study||4||
60151319|NCT01440543|76276161|FG002|NOT COMPLETED|Overall Study||2||
60151320|NCT01440543|76276162|FG003|NOT COMPLETED|Overall Study||6||
60151321|NCT01495689|76276174|FG000|STARTED|Overall Study||26||
60151322|NCT01495689|76276175|FG001|STARTED|Overall Study||23||
60151323|NCT01495689|76276174|FG000|COMPLETED|Overall Study||16||
60151324|NCT01495689|76276175|FG001|COMPLETED|Overall Study||16||
60151325|NCT01495689|76276174|FG000|NOT COMPLETED|Overall Study||10||
60151326|NCT01495689|76276175|FG001|NOT COMPLETED|Overall Study||7||
60151327|NCT01563003|76276183|FG000|STARTED|Overall Study||16||
60151328|NCT01563003|76276184|FG001|STARTED|Overall Study||15||
60151329|NCT01563003|76276183|FG000|COMPLETED|Overall Study||16||
60151330|NCT01563003|76276184|FG001|COMPLETED|Overall Study||15||
60151331|NCT01563003|76276183|FG000|NOT COMPLETED|Overall Study||0||
60151332|NCT01563003|76276184|FG001|NOT COMPLETED|Overall Study||0||
60151333|NCT01441245|76276192|FG000|STARTED|Overall Study||30||
60151334|NCT01441245|76276193|FG001|STARTED|Overall Study||27||
60151335|NCT01441245|76276192|FG000|COMPLETED|Overall Study||30||
60151336|NCT01441245|76276193|FG001|COMPLETED|Overall Study||27||
60151337|NCT01441245|76276192|FG000|NOT COMPLETED|Overall Study||0||
60151338|NCT01441245|76276193|FG001|NOT COMPLETED|Overall Study||0||
60151339|NCT01563081|76276217|FG000|STARTED|Overall Study||30||
60151340|NCT01563081|76276218|FG001|STARTED|Overall Study||30||
60151341|NCT01563081|76276217|FG000|COMPLETED|Overall Study||30||
60151342|NCT01563081|76276218|FG001|COMPLETED|Overall Study||30||
60151343|NCT01563081|76276217|FG000|NOT COMPLETED|Overall Study||0||
60151344|NCT01563081|76276218|FG001|NOT COMPLETED|Overall Study||0||
60151345|NCT01441401|76276228|FG000|STARTED|Overall Study||82||
60151346|NCT01441401|76276228|FG000|COMPLETED|Overall Study|Number of participants whose survey form was collected was presented.|82||
60151347|NCT01441401|76276228|FG000|NOT COMPLETED|Overall Study||0||
60151348|NCT01495923|76276248|FG000|STARTED|Overall Study||73||
60151349|NCT01495923|76276249|FG001|STARTED|Overall Study||72||
60151350|NCT01495923|76276248|FG000|COMPLETED|Overall Study||73||
60151351|NCT01495923|76276249|FG001|COMPLETED|Overall Study||72||
60151352|NCT01495923|76276248|FG000|NOT COMPLETED|Overall Study||0||
60151353|NCT01495923|76276249|FG001|NOT COMPLETED|Overall Study||0||
60151354|NCT01496157|76276257|FG000|STARTED|Overall Study||13||
60151355|NCT01496157|76276257|FG000|COMPLETED|Overall Study||13||
60151356|NCT01496157|76276257|FG000|NOT COMPLETED|Overall Study||0||
60151357|NCT01564485|76276263|FG000|STARTED|Overall Study||92||
60151358|NCT01564485|76276264|FG001|STARTED|Overall Study||101||
60151359|NCT01564485|76276263|FG000|COMPLETED|Overall Study||84||
60151360|NCT01564485|76276264|FG001|COMPLETED|Overall Study||78||
60151361|NCT01564485|76276263|FG000|NOT COMPLETED|Overall Study||8||
60151362|NCT01564485|76276264|FG001|NOT COMPLETED|Overall Study||23||
60151363|NCT01564953|76276270|FG000|STARTED|Overall Study||143||
60151364|NCT01564953|76276270|FG000|COMPLETED|Overall Study||143||
60151365|NCT01564953|76276270|FG000|NOT COMPLETED|Overall Study||0||
60151366|NCT01444287|76276278|FG000|STARTED|Period 1||22||
60151367|NCT01444287|76276278|FG000|COMPLETED|Period 1||22||
60151368|NCT01444287|76276278|FG000|NOT COMPLETED|Period 1||0||
59605792|NCT01987830|75715929|FG000|COMPLETED|Overall Study||12||
59605793|NCT01987830|75715929|FG000|NOT COMPLETED|Overall Study||1||
59605794|NCT01987596|75715935|FG000|STARTED|Overall Study||12||
60151369|NCT01444287|76276278|FG000|STARTED|Period 2||22||
60151370|NCT01444287|76276278|FG000|COMPLETED|Period 2||22||
60151371|NCT01444287|76276278|FG000|NOT COMPLETED|Period 2||0||
60151372|NCT01444287|76276278|FG000|STARTED|Period 3||22||
60151373|NCT01444287|76276278|FG000|COMPLETED|Period 3||22||
60151374|NCT01444287|76276278|FG000|NOT COMPLETED|Period 3||0||
60151375|NCT01444287|76276278|FG000|STARTED|Period 4||22||
60151376|NCT01444287|76276278|FG000|COMPLETED|Period 4||22||
60151377|NCT01444287|76276278|FG000|NOT COMPLETED|Period 4||0||
60151378|NCT01444911|76276294|FG000|STARTED|Overall Study||16||
60151379|NCT01444911|76276295|FG001|STARTED|Overall Study||13||
60151380|NCT01444911|76276294|FG000|COMPLETED|Overall Study||8||
60151381|NCT01444911|76276295|FG001|COMPLETED|Overall Study||13||
60151382|NCT01444911|76276294|FG000|NOT COMPLETED|Overall Study||8||
60151383|NCT01444911|76276295|FG001|NOT COMPLETED|Overall Study||0||
60151384|NCT02205177|76276303|FG000|STARTED|Overall Study||8||
60151385|NCT02205177|76276304|FG001|STARTED|Overall Study||2||
60151386|NCT02205177|76276303|FG000|COMPLETED|Overall Study||6||
60151387|NCT02205177|76276304|FG001|COMPLETED|Overall Study||2||
60151388|NCT02205177|76276303|FG000|NOT COMPLETED|Overall Study||2||
60151389|NCT02205177|76276304|FG001|NOT COMPLETED|Overall Study||0||
60151390|NCT02254265|76276313|FG000|STARTED|Overall Study||151||
60151391|NCT02254265|76276314|FG001|STARTED|Overall Study||152||
60151392|NCT02254265|76276315|FG002|STARTED|Overall Study||152||
60151393|NCT02254265|76276313|FG000|COMPLETED|Overall Study||142||
60151394|NCT02254265|76276314|FG001|COMPLETED|Overall Study||140||
60151395|NCT02254265|76276315|FG002|COMPLETED|Overall Study||144||
60151396|NCT02254265|76276313|FG000|NOT COMPLETED|Overall Study||9||
60151397|NCT02254265|76276314|FG001|NOT COMPLETED|Overall Study||12||
60151398|NCT02254265|76276315|FG002|NOT COMPLETED|Overall Study||8||
60151399|NCT02215161|76276323|FG000|STARTED|Overall Study||14||
60151400|NCT02215161|76276323|FG000|COMPLETED|Overall Study||14||
60151401|NCT02215161|76276323|FG000|NOT COMPLETED|Overall Study||0||
60151402|NCT01446705|76276337|FG000|STARTED|Overall Study||50446||
60151403|NCT01446705|76276338|FG001|STARTED|Overall Study||6627||
60151404|NCT01446705|76276337|FG000|COMPLETED|Overall Study||50446||
60151405|NCT01446705|76276338|FG001|COMPLETED|Overall Study||6627||
60151406|NCT01446705|76276337|FG000|NOT COMPLETED|Overall Study||0||
60151407|NCT01446705|76276338|FG001|NOT COMPLETED|Overall Study||0||
60151408|NCT01447017|76276356|FG000|STARTED|Overall Study||45||
60151409|NCT01447017|76276357|FG001|STARTED|Overall Study||24||
60151410|NCT01447017|76276356|FG000|Performed Visit 2|Overall Study||43||
60151411|NCT01447017|76276357|FG001|Performed Visit 2|Overall Study||24||
60151412|NCT01447017|76276356|FG000|COMPLETED|Overall Study|In safety analysis: 42. In efficacy analyses: 40 in full analysis set, and 39 in per-protocol set.|35||
60151413|NCT01447017|76276357|FG001|COMPLETED|Overall Study|In safety analysis: 24. In efficacy analyses: 24 in full analysis set, and 22 in per-protocol set.|14||
60151414|NCT01447017|76276356|FG000|NOT COMPLETED|Overall Study||10||
60151415|NCT01447017|76276357|FG001|NOT COMPLETED|Overall Study||10||
60151416|NCT01498419|76276367|FG000|STARTED|Overall Study||60||
60151417|NCT01498419|76276368|FG001|STARTED|Overall Study||62||
60151418|NCT01498419|76276369|FG002|STARTED|Overall Study||59||
60151419|NCT01498419|76276370|FG003|STARTED|Overall Study||26||
60151420|NCT01498419|76276367|FG000|COMPLETED|Overall Study||42||
60151421|NCT01498419|76276368|FG001|COMPLETED|Overall Study||39||
60151422|NCT01498419|76276369|FG002|COMPLETED|Overall Study||41||
60151423|NCT01498419|76276370|FG003|COMPLETED|Overall Study||7||
60151424|NCT01498419|76276367|FG000|NOT COMPLETED|Overall Study||18||
60151425|NCT01498419|76276368|FG001|NOT COMPLETED|Overall Study||23||
60151426|NCT01498419|76276369|FG002|NOT COMPLETED|Overall Study||18||
60151427|NCT01498419|76276370|FG003|NOT COMPLETED|Overall Study||19||
60151428|NCT01567371|76276380|FG000|STARTED|Overall Study||30||
60151429|NCT01567371|76276380|FG000|COMPLETED|Overall Study||30||
60151430|NCT01567371|76276380|FG000|NOT COMPLETED|Overall Study||0||
60151431|NCT01448421|76276384|FG000|STARTED|Overall Study||37||
60151432|NCT01448421|76276384|FG000|COMPLETED|Overall Study||37||
60151433|NCT01448421|76276384|FG000|NOT COMPLETED|Overall Study||0||
60151434|NCT01567839|76276388|FG000|STARTED|Overall Study||60||
60151435|NCT01567839|76276388|FG000|COMPLETED|Overall Study||60||
60151436|NCT01567839|76276388|FG000|NOT COMPLETED|Overall Study||0||
60151437|NCT01500525|76276398|FG000|STARTED|Overall Study||286||
60151438|NCT01500525|76276399|FG001|STARTED|Overall Study||301||
60151439|NCT01500525|76276398|FG000|COMPLETED|Overall Study||286||
60151440|NCT01500525|76276399|FG001|COMPLETED|Overall Study||301||
60151441|NCT01500525|76276398|FG000|NOT COMPLETED|Overall Study||0||
60151442|NCT01500525|76276399|FG001|NOT COMPLETED|Overall Study||0||
60151443|NCT01568073|76276410|FG000|STARTED|Overall Study||121||
60151444|NCT01568073|76276411|FG001|STARTED|Overall Study||122||
60151445|NCT01568073|76276412|FG002|STARTED|Overall Study||122||
60151446|NCT01568073|76276413|FG003|STARTED|Overall Study||119||
60151447|NCT01568073|76276414|FG004|STARTED|Overall Study||116||
60151448|NCT01568073|76276410|FG000|COMPLETED|Overall Study||110||
60151449|NCT01568073|76276411|FG001|COMPLETED|Overall Study||107||
60151450|NCT01568073|76276412|FG002|COMPLETED|Overall Study||110||
60151451|NCT01568073|76276413|FG003|COMPLETED|Overall Study||108||
60151452|NCT01568073|76276414|FG004|COMPLETED|Overall Study||107||
60151453|NCT01568073|76276410|FG000|NOT COMPLETED|Overall Study||11||
60151454|NCT01568073|76276411|FG001|NOT COMPLETED|Overall Study||15||
60151455|NCT01568073|76276412|FG002|NOT COMPLETED|Overall Study||12||
60151456|NCT01568073|76276413|FG003|NOT COMPLETED|Overall Study||11||
60151457|NCT01568073|76276414|FG004|NOT COMPLETED|Overall Study||9||
60151458|NCT01500759|76276428|FG000|STARTED|Overall Study||3686||
60151459|NCT01500759|76276429|FG001|STARTED|Overall Study||3190||
60151460|NCT01500759|76276428|FG000|COMPLETED|Overall Study||3686||
60151461|NCT01500759|76276429|FG001|COMPLETED|Overall Study||3190||
60151462|NCT01500759|76276428|FG000|NOT COMPLETED|Overall Study||0||
60151463|NCT01500759|76276429|FG001|NOT COMPLETED|Overall Study||0||
60151464|NCT02603952|76276448|FG000|STARTED|Overall Study||32||
60151465|NCT02603952|76276449|FG001|STARTED|Overall Study||31||
60151466|NCT02603952|76276450|FG002|STARTED|Overall Study||31||
60151467|NCT02603952|76276451|FG003|STARTED|Overall Study||32||
60151468|NCT02603952|76276448|FG000|Treated|Overall Study||32||
60151469|NCT02603952|76276449|FG001|Treated|Overall Study||31||
60151470|NCT02603952|76276450|FG002|Treated|Overall Study||31||
60151471|NCT02603952|76276451|FG003|Treated|Overall Study||31||
60151472|NCT02603952|76276448|FG000|COMPLETED|Overall Study||31||
60151473|NCT02603952|76276449|FG001|COMPLETED|Overall Study||31||
60151474|NCT02603952|76276450|FG002|COMPLETED|Overall Study||31||
60151475|NCT02603952|76276451|FG003|COMPLETED|Overall Study||31||
60151476|NCT02603952|76276448|FG000|NOT COMPLETED|Overall Study||1||
60151477|NCT02603952|76276449|FG001|NOT COMPLETED|Overall Study||0||
60151478|NCT02603952|76276450|FG002|NOT COMPLETED|Overall Study||0||
60151479|NCT02603952|76276451|FG003|NOT COMPLETED|Overall Study||1||
60151480|NCT01501929|76276464|FG000|STARTED|First Intervention||8||
60151481|NCT01501929|76276465|FG001|STARTED|First Intervention||17||
60151482|NCT01501929|76276464|FG000|COMPLETED|First Intervention||8||
60151483|NCT01501929|76276465|FG001|COMPLETED|First Intervention||17||
60151484|NCT01501929|76276464|FG000|NOT COMPLETED|First Intervention||0||
60151485|NCT01501929|76276465|FG001|NOT COMPLETED|First Intervention||0||
60151486|NCT01501929|76276464|FG000|STARTED|Second Intervention||8||
60151487|NCT01501929|76276465|FG001|STARTED|Second Intervention||17||
60151488|NCT01501929|76276464|FG000|COMPLETED|Second Intervention||8||
60151489|NCT01501929|76276465|FG001|COMPLETED|Second Intervention||17||
60151490|NCT01501929|76276464|FG000|NOT COMPLETED|Second Intervention||0||
60151491|NCT01501929|76276465|FG001|NOT COMPLETED|Second Intervention||0||
60151492|NCT01449513|76276473|FG000|STARTED|Overall Study||16||
60151493|NCT01449513|76276474|FG001|STARTED|Overall Study||8||
60151494|NCT01449513|76276473|FG000|COMPLETED|Overall Study||16||
60151495|NCT01449513|76276474|FG001|COMPLETED|Overall Study||8||
60151496|NCT01449513|76276473|FG000|NOT COMPLETED|Overall Study||0||
60151497|NCT01449513|76276474|FG001|NOT COMPLETED|Overall Study||0||
60151498|NCT01449747|76276482|FG000|STARTED|Overall Study||12||
60151499|NCT01449747|76276483|FG001|STARTED|Overall Study||12||
60151500|NCT01449747|76276482|FG000|COMPLETED|Overall Study||12||
60151501|NCT01449747|76276483|FG001|COMPLETED|Overall Study||12||
60151502|NCT01449747|76276482|FG000|NOT COMPLETED|Overall Study||0||
60151503|NCT01449747|76276483|FG001|NOT COMPLETED|Overall Study||0||
60151504|NCT00054847|76276491|FG000|STARTED|Overall Study||367||
60151505|NCT00054847|76276492|FG001|STARTED|Overall Study||366||
60151506|NCT00054847|76276491|FG000|COMPLETED|Overall Study||269||
60151507|NCT00054847|76276492|FG001|COMPLETED|Overall Study||266||
60151508|NCT00054847|76276491|FG000|NOT COMPLETED|Overall Study||98||
60151509|NCT00054847|76276492|FG001|NOT COMPLETED|Overall Study||100||
60151510|NCT01569087|76276505|FG000|STARTED|Overall Study||21||
60151511|NCT01569087|76276506|FG001|STARTED|Overall Study||20||
60151512|NCT01569087|76276507|FG002|STARTED|Overall Study||19||
60151513|NCT01569087|76276505|FG000|COMPLETED|Overall Study||20||
60151514|NCT01569087|76276506|FG001|COMPLETED|Overall Study||20||
60151515|NCT01569087|76276507|FG002|COMPLETED|Overall Study||18||
60151516|NCT01569087|76276505|FG000|NOT COMPLETED|Overall Study||1||
60151517|NCT01569087|76276506|FG001|NOT COMPLETED|Overall Study||0||
60151518|NCT01569087|76276507|FG002|NOT COMPLETED|Overall Study||1||
60151519|NCT02024087|76276517|FG000|STARTED|Overall Study||5||
60151520|NCT02024087|76276518|FG001|STARTED|Overall Study|Dose change to 0.4 mg/kg and cohort expanded to 16 participants in total at this dose level|16||
60151521|NCT02024087|76276517|FG000|COMPLETED|Overall Study||5||
60151522|NCT02024087|76276518|FG001|COMPLETED|Overall Study||16||
60151523|NCT02024087|76276517|FG000|NOT COMPLETED|Overall Study||0||
60151524|NCT02024087|76276518|FG001|NOT COMPLETED|Overall Study||0||
60151525|NCT01517711|76276527|FG000|STARTED|Overall Study||22||
60151526|NCT01517711|76276528|FG001|STARTED|Overall Study||18||
60151527|NCT01517711|76276527|FG000|COMPLETED|Overall Study||20||
60151528|NCT01517711|76276528|FG001|COMPLETED|Overall Study||15||
60151529|NCT01517711|76276527|FG000|NOT COMPLETED|Overall Study||2||
60151530|NCT01517711|76276528|FG001|NOT COMPLETED|Overall Study||3||
60151531|NCT00055237|76276540|FG000|STARTED|Overall Study||17||
60151532|NCT00055237|76276541|FG001|STARTED|Overall Study||2||
60151533|NCT00055237|76276540|FG000|COMPLETED|Overall Study||17||
60151534|NCT00055237|76276541|FG001|COMPLETED|Overall Study||2||
60151535|NCT00055237|76276540|FG000|NOT COMPLETED|Overall Study||0||
60151536|NCT00055237|76276541|FG001|NOT COMPLETED|Overall Study||0||
60151537|NCT01451385|76276546|FG000|STARTED|Overall Study||376||
60151538|NCT01451385|76276546|FG000|COMPLETED|Overall Study||285||
60151539|NCT01451385|76276546|FG000|NOT COMPLETED|Overall Study||91||
60151540|NCT01451463|76276550|FG000|STARTED|Overall Study||11||
60151541|NCT01451463|76276550|FG000|COMPLETED|Overall Study||11||
60151542|NCT01451463|76276550|FG000|NOT COMPLETED|Overall Study||0||
60151543|NCT01502787|76276559|FG000|STARTED|Overall Study||11||
60151544|NCT01502787|76276560|FG001|STARTED|Overall Study||10||
60151545|NCT01502787|76276559|FG000|COMPLETED|Overall Study||11||
60151546|NCT01502787|76276560|FG001|COMPLETED|Overall Study||10||
60151547|NCT01502787|76276559|FG000|NOT COMPLETED|Overall Study||0||
60151548|NCT01502787|76276560|FG001|NOT COMPLETED|Overall Study||0||
60151549|NCT00056563|76276572|FG000|STARTED|Overall Study||121||
60151550|NCT00056563|76276573|FG001|STARTED|Overall Study||134||
60151551|NCT00056563|76276572|FG000|COMPLETED|Overall Study||121||
60151552|NCT00056563|76276573|FG001|COMPLETED|Overall Study||134||
60151553|NCT00056563|76276572|FG000|NOT COMPLETED|Overall Study||0||
60151554|NCT00056563|76276573|FG001|NOT COMPLETED|Overall Study||0||
60151555|NCT01503333|76276581|FG000|STARTED|Overall Study||777||
60151556|NCT01503333|76276582|FG001|STARTED|Overall Study||766||
60151557|NCT01503333|76276581|FG000|Completed Baseline|Overall Study||766||
60151558|NCT01503333|76276582|FG001|Completed Baseline|Overall Study||753||
60151559|NCT01503333|76276581|FG000|Completed Post-intervention|Overall Study||680||
60151560|NCT01503333|76276582|FG001|Completed Post-intervention|Overall Study||706||
60151561|NCT01503333|76276581|FG000|COMPLETED|Overall Study||437|Completed 9-month post-intervention follow-up measures|
60151562|NCT01503333|76276582|FG001|COMPLETED|Overall Study||461|Completed 9-month post-intervention follow-up measures|
60151563|NCT01503333|76276581|FG000|NOT COMPLETED|Overall Study||340||
60151564|NCT01503333|76276582|FG001|NOT COMPLETED|Overall Study||305||
60151565|NCT01571427|76276598|FG000|STARTED|Overall Study||41||
60151566|NCT01571427|76276599|FG001|STARTED|Overall Study||42||
60151567|NCT01571427|76276598|FG000|COMPLETED|Overall Study||41||
60151568|NCT01571427|76276599|FG001|COMPLETED|Overall Study||42||
60151569|NCT01571427|76276598|FG000|NOT COMPLETED|Overall Study||0||
60151570|NCT01571427|76276599|FG001|NOT COMPLETED|Overall Study||0||
60151571|NCT00153985|76276605|FG000|STARTED|Overall Study||2||
60151572|NCT00153985|76276605|FG000|COMPLETED|Overall Study||2||
60151573|NCT00153985|76276605|FG000|NOT COMPLETED|Overall Study||0||
60151574|NCT02318303|76276616|FG000|STARTED|Overall Study||159||
60151575|NCT02318303|76276617|FG001|STARTED|Overall Study||158||
60151576|NCT02318303|76276618|FG002|STARTED|Overall Study||160||
60151577|NCT02318303|76276619|FG003|STARTED|Overall Study||158||
60151578|NCT02318303|76276620|FG004|STARTED|Overall Study||157||
60151579|NCT02318303|76276621|FG005|STARTED|Overall Study||159||
60151580|NCT02318303|76276622|FG006|STARTED|Overall Study||160||
60151581|NCT02318303|76276616|FG000|COMPLETED|Overall Study||155||
60151582|NCT02318303|76276617|FG001|COMPLETED|Overall Study||155||
60151583|NCT02318303|76276618|FG002|COMPLETED|Overall Study||157||
60151584|NCT02318303|76276619|FG003|COMPLETED|Overall Study||155||
60151585|NCT02318303|76276620|FG004|COMPLETED|Overall Study||152||
60151586|NCT02318303|76276621|FG005|COMPLETED|Overall Study||153||
60151587|NCT02318303|76276622|FG006|COMPLETED|Overall Study||158||
60151588|NCT02318303|76276616|FG000|NOT COMPLETED|Overall Study||4||
60151589|NCT02318303|76276617|FG001|NOT COMPLETED|Overall Study||3||
60151590|NCT02318303|76276618|FG002|NOT COMPLETED|Overall Study||3||
60151591|NCT02318303|76276619|FG003|NOT COMPLETED|Overall Study||3||
60151592|NCT02318303|76276620|FG004|NOT COMPLETED|Overall Study||5||
60151593|NCT02318303|76276621|FG005|NOT COMPLETED|Overall Study||6||
60151594|NCT02318303|76276622|FG006|NOT COMPLETED|Overall Study||2||
60151595|NCT01451775|76276638|FG000|STARTED|Overall Study||3||
60151596|NCT01451775|76276639|FG001|STARTED|Overall Study||3||
60151597|NCT01451775|76276640|FG002|STARTED|Overall Study||3||
60151598|NCT01451775|76276641|FG003|STARTED|Overall Study||3||
60151599|NCT01451775|76276642|FG004|STARTED|Overall Study||3||
60151600|NCT01451775|76276643|FG005|STARTED|Overall Study||3||
60151601|NCT01451775|76276638|FG000|COMPLETED|Overall Study||3||
60151602|NCT01451775|76276639|FG001|COMPLETED|Overall Study||3||
60151603|NCT01451775|76276640|FG002|COMPLETED|Overall Study||3||
60151604|NCT01451775|76276641|FG003|COMPLETED|Overall Study||3||
60151605|NCT01451775|76276642|FG004|COMPLETED|Overall Study||3||
60151606|NCT01451775|76276643|FG005|COMPLETED|Overall Study||3||
60151607|NCT01451775|76276638|FG000|NOT COMPLETED|Overall Study||0||
60151608|NCT01451775|76276639|FG001|NOT COMPLETED|Overall Study||0||
60151609|NCT01451775|76276640|FG002|NOT COMPLETED|Overall Study||0||
60151610|NCT01451775|76276641|FG003|NOT COMPLETED|Overall Study||0||
60151611|NCT01451775|76276642|FG004|NOT COMPLETED|Overall Study||0||
60151612|NCT01451775|76276643|FG005|NOT COMPLETED|Overall Study||0||
60151613|NCT01453413|76276651|FG000|STARTED|Overall Study||297||
60151614|NCT01453413|76276651|FG000|COMPLETED|Overall Study||297||
60151615|NCT01453413|76276651|FG000|NOT COMPLETED|Overall Study||0||
60151616|NCT00156013|76276655|FG000|STARTED|Overall Study||33||
60151617|NCT00156013|76276655|FG000|COMPLETED|Overall Study||31||
60151618|NCT00156013|76276655|FG000|NOT COMPLETED|Overall Study||2||
60151619|NCT00156247|76276661|FG000|STARTED|Overall Study||9||
60151620|NCT00156247|76276661|FG000|COMPLETED|Overall Study||5||
60151621|NCT00156247|76276661|FG000|NOT COMPLETED|Overall Study||4||
60151622|NCT01453569|76276668|FG000|STARTED|Overall Study||86||
60151623|NCT01453569|76276669|FG001|STARTED|Overall Study||84||
60151624|NCT01453569|76276670|FG002|STARTED|Overall Study||85||
60151625|NCT01453569|76276668|FG000|COMPLETED|Overall Study||75||
60151626|NCT01453569|76276669|FG001|COMPLETED|Overall Study||70||
60151627|NCT01453569|76276670|FG002|COMPLETED|Overall Study||78||
60151628|NCT01453569|76276668|FG000|NOT COMPLETED|Overall Study||11||
60151629|NCT01453569|76276669|FG001|NOT COMPLETED|Overall Study||14||
60151630|NCT01453569|76276670|FG002|NOT COMPLETED|Overall Study||7||
60151631|NCT00156715|76276678|FG000|STARTED|Overall Study||23||
60151632|NCT00156715|76276678|FG000|COMPLETED|Overall Study||16||
60151633|NCT00156715|76276678|FG000|NOT COMPLETED|Overall Study||7||
60151634|NCT01326455|76276685|FG000|STARTED|Overall Study||25||
60151635|NCT01326455|76276686|FG001|STARTED|Overall Study||25||
60151636|NCT01326455|76276687|FG002|STARTED|Overall Study||25||
60151637|NCT01326455|76276685|FG000|COMPLETED|Overall Study||15||
60151638|NCT01326455|76276686|FG001|COMPLETED|Overall Study||20||
60151639|NCT01326455|76276687|FG002|COMPLETED|Overall Study||18||
60151640|NCT01326455|76276685|FG000|NOT COMPLETED|Overall Study||10||
60151641|NCT01326455|76276686|FG001|NOT COMPLETED|Overall Study||5||
60151642|NCT01326455|76276687|FG002|NOT COMPLETED|Overall Study||7||
60151643|NCT01573533|76276697|FG000|STARTED|Overall Study||9||
60151644|NCT01573533|76276697|FG000|COMPLETED|Overall Study||9||
60151645|NCT01573533|76276697|FG000|NOT COMPLETED|Overall Study||0||
60151646|NCT01454505|76276704|FG000|STARTED|Overall Study||35||
60151647|NCT01454505|76276705|FG001|STARTED|Overall Study||15||
60151648|NCT01454505|76276706|FG002|STARTED|Overall Study||40||
60151649|NCT01454505|76276707|FG003|STARTED|Overall Study||20||
60151650|NCT01454505|76276704|FG000|COMPLETED|Overall Study||35||
60151651|NCT01454505|76276705|FG001|COMPLETED|Overall Study||15||
60151652|NCT01454505|76276706|FG002|COMPLETED|Overall Study||40||
60151653|NCT01454505|76276707|FG003|COMPLETED|Overall Study||20||
60151654|NCT01454505|76276704|FG000|NOT COMPLETED|Overall Study||0||
60151655|NCT01454505|76276705|FG001|NOT COMPLETED|Overall Study||0||
60151656|NCT01454505|76276706|FG002|NOT COMPLETED|Overall Study||0||
60151657|NCT01454505|76276707|FG003|NOT COMPLETED|Overall Study||0||
60151658|NCT01455519|76276719|FG000|STARTED|Overall Study||12||
60151659|NCT01455519|76276720|FG001|STARTED|Overall Study||23||
60151660|NCT01455519|76276719|FG000|COMPLETED|Overall Study||8||
60151661|NCT01455519|76276720|FG001|COMPLETED|Overall Study||18||
60151662|NCT01455519|76276719|FG000|NOT COMPLETED|Overall Study||4||
60151663|NCT01455519|76276720|FG001|NOT COMPLETED|Overall Study||5||
59605795|NCT01987596|75715936|FG001|STARTED|Overall Study||11||
59751589|NCT00969761|75870896|FG007|COMPLETED|Treated in and Beyond Treat. Cycle 2||0||
60151664|NCT00157573|76276726|FG000|STARTED|Overall Study||35||
60151665|NCT00157573|76276727|FG001|STARTED|Overall Study||37||
60151666|NCT00157573|76276726|FG000|COMPLETED|Overall Study||35||
60151667|NCT00157573|76276727|FG001|COMPLETED|Overall Study||37||
60151668|NCT00157573|76276726|FG000|NOT COMPLETED|Overall Study||0||
60151669|NCT00157573|76276727|FG001|NOT COMPLETED|Overall Study||0||
60151670|NCT01576809|76276732|FG000|STARTED|Overall Study||51||
60151671|NCT01576809|76276732|FG000|COMPLETED|Overall Study||51||
60151672|NCT01576809|76276732|FG000|NOT COMPLETED|Overall Study||0||
60151673|NCT01456143|76276736|FG000|STARTED|Overall Study||33||
60151674|NCT01456143|76276736|FG000|COMPLETED|Overall Study||33||
60151675|NCT01456143|76276736|FG000|NOT COMPLETED|Overall Study||0||
60151676|NCT00158197|76276744|FG000|STARTED|Overall Study||32||
60151677|NCT00158197|76276745|FG001|STARTED|Overall Study||30||
60151678|NCT00158197|76276746|FG002|STARTED|Overall Study||28||
60151679|NCT00158197|76276747|FG003|STARTED|Overall Study||29||
60151680|NCT00158197|76276744|FG000|COMPLETED|Overall Study||32||
60151681|NCT00158197|76276745|FG001|COMPLETED|Overall Study||30||
60151682|NCT00158197|76276746|FG002|COMPLETED|Overall Study||28||
60151683|NCT00158197|76276747|FG003|COMPLETED|Overall Study||29||
60151684|NCT00158197|76276744|FG000|NOT COMPLETED|Overall Study||0||
60151685|NCT00158197|76276745|FG001|NOT COMPLETED|Overall Study||0||
60151686|NCT00158197|76276746|FG002|NOT COMPLETED|Overall Study||0||
60151687|NCT00158197|76276747|FG003|NOT COMPLETED|Overall Study||0||
60151688|NCT01456299|76276760|FG000|STARTED|Overall Study||34||
60151689|NCT01456299|76276761|FG001|STARTED|Overall Study||34||
60151690|NCT01456299|76276762|FG002|STARTED|Overall Study||34||
60151691|NCT01456299|76276760|FG000|COMPLETED|Overall Study||34||
60151692|NCT01456299|76276761|FG001|COMPLETED|Overall Study||33||
60151693|NCT01456299|76276762|FG002|COMPLETED|Overall Study||33||
60151694|NCT01456299|76276760|FG000|NOT COMPLETED|Overall Study||0||
60151695|NCT01456299|76276761|FG001|NOT COMPLETED|Overall Study||1||
60151696|NCT01456299|76276762|FG002|NOT COMPLETED|Overall Study||1||
60151697|NCT00158743|76276772|FG000|STARTED|Overall Study||24||
60151698|NCT00158743|76276773|FG001|STARTED|Overall Study||27||
60151699|NCT00158743|76276772|FG000|COMPLETED|Overall Study||15||
60151700|NCT00158743|76276773|FG001|COMPLETED|Overall Study||20||
60151701|NCT00158743|76276772|FG000|NOT COMPLETED|Overall Study||9||
60151702|NCT00158743|76276773|FG001|NOT COMPLETED|Overall Study||7||
60151703|NCT00161473|76276781|FG000|STARTED|Overall Study||12||
60151704|NCT00161473|76276782|FG001|STARTED|Overall Study||12||
60151705|NCT00161473|76276781|FG000|COMPLETED|Overall Study||7||
60151706|NCT00161473|76276782|FG001|COMPLETED|Overall Study||6||
60151707|NCT00161473|76276781|FG000|NOT COMPLETED|Overall Study||5||
60151708|NCT00161473|76276782|FG001|NOT COMPLETED|Overall Study||6||
60151709|NCT01319981|76276790|FG000|STARTED|Overall Study||15||
60151710|NCT01319981|76276791|FG001|STARTED|Overall Study||16||
59751590|NCT00969761|75870897|FG008|COMPLETED|Treated in and Beyond Treat. Cycle 2||0||
60151711|NCT01319981|76276790|FG000|COMPLETED|Overall Study||15||
59605796|NCT01987596|75715935|FG000|COMPLETED|Overall Study||11||
60151712|NCT01319981|76276791|FG001|COMPLETED|Overall Study||16||
60151713|NCT01319981|76276790|FG000|NOT COMPLETED|Overall Study||0||
60151714|NCT01319981|76276791|FG001|NOT COMPLETED|Overall Study||0||
60151715|NCT01458561|76276801|FG000|STARTED|Overall Study||0||
60151716|NCT01458561|76276802|FG001|STARTED|Overall Study||1||
60151717|NCT01458561|76276801|FG000|COMPLETED|Overall Study||0||
60151718|NCT01458561|76276802|FG001|COMPLETED|Overall Study||1||
60151719|NCT01458561|76276801|FG000|NOT COMPLETED|Overall Study||0||
60151720|NCT01458561|76276802|FG001|NOT COMPLETED|Overall Study||0||
60151721|NCT00065611|76276840|FG000|STARTED|Overall Study||4||
60151722|NCT00065611|76276841|FG001|STARTED|Overall Study||4||
60151723|NCT00065611|76276840|FG000|COMPLETED|Overall Study||4||
60151724|NCT00065611|76276841|FG001|COMPLETED|Overall Study||3||
60151725|NCT00065611|76276840|FG000|NOT COMPLETED|Overall Study||0||
60151726|NCT00065611|76276841|FG001|NOT COMPLETED|Overall Study||1||
60151727|NCT01459653|76276847|FG000|STARTED|Overall Study||1496||
60151728|NCT01459653|76276847|FG000|COMPLETED|Overall Study||828||
60151729|NCT01459653|76276847|FG000|NOT COMPLETED|Overall Study||668||
60151730|NCT01265459|76276921|FG000|STARTED|Overall Study||23||
60151731|NCT01265459|76276922|FG001|STARTED|Overall Study||23||
60151732|NCT01265459|76276923|FG002|STARTED|Overall Study||22||
60151733|NCT01265459|76276921|FG000|COMPLETED|Overall Study||23||
60151734|NCT01265459|76276922|FG001|COMPLETED|Overall Study||23||
60151735|NCT01265459|76276923|FG002|COMPLETED|Overall Study||20||
60151736|NCT01265459|76276921|FG000|NOT COMPLETED|Overall Study||0||
60151737|NCT01265459|76276922|FG001|NOT COMPLETED|Overall Study||0||
60151738|NCT01265459|76276923|FG002|NOT COMPLETED|Overall Study||2||
60151739|NCT01223963|76276943|FG000|STARTED|Overall Study|All subjects treated between May 1 2008 and Dec 31 2009 in selected clinics were to be asked.|93||
60151740|NCT01223963|76276943|FG000|COMPLETED|Overall Study||93||
60151741|NCT01223963|76276943|FG000|NOT COMPLETED|Overall Study||0||
60151742|NCT00066781|76276950|FG000|STARTED|Overall Study||14||
60151743|NCT00066781|76276951|FG001|STARTED|Overall Study||17||
60151744|NCT00066781|76276950|FG000|COMPLETED|Overall Study||14||
60151745|NCT00066781|76276951|FG001|COMPLETED|Overall Study||17||
60151746|NCT00066781|76276950|FG000|NOT COMPLETED|Overall Study||0||
60151747|NCT00066781|76276951|FG001|NOT COMPLETED|Overall Study||0||
60151748|NCT02603172|76276965|FG000|STARTED|Part A (Approximately 16 Weeks)||7||
60151749|NCT02603172|76276966|FG001|STARTED|Part A (Approximately 16 Weeks)||1||
60151750|NCT02603172|76276967|FG002|STARTED|Part A (Approximately 16 Weeks)||8||
60151751|NCT02603172|76276968|FG003|STARTED|Part A (Approximately 16 Weeks)||1||
60151752|NCT02603172|76276969|FG004|STARTED|Part A (Approximately 16 Weeks)||0||
60151753|NCT02603172|76276970|FG005|STARTED|Part A (Approximately 16 Weeks)||0||
60151754|NCT02603172|76276971|FG006|STARTED|Part A (Approximately 16 Weeks)||0||
60151755|NCT02603172|76276972|FG007|STARTED|Part A (Approximately 16 Weeks)||0||
60151756|NCT02603172|76276965|FG000|COMPLETED|Part A (Approximately 16 Weeks)||7||
60151757|NCT02603172|76276966|FG001|COMPLETED|Part A (Approximately 16 Weeks)||1||
60151758|NCT02603172|76276967|FG002|COMPLETED|Part A (Approximately 16 Weeks)||7||
60151759|NCT02603172|76276968|FG003|COMPLETED|Part A (Approximately 16 Weeks)||1||
60151760|NCT02603172|76276969|FG004|COMPLETED|Part A (Approximately 16 Weeks)||0||
60151761|NCT02603172|76276970|FG005|COMPLETED|Part A (Approximately 16 Weeks)||0||
60151762|NCT02603172|76276971|FG006|COMPLETED|Part A (Approximately 16 Weeks)||0||
59882156|NCT04053465|76005066|FG000|STARTED|Overall Study||22||
59882157|NCT04053465|76005067|FG001|STARTED|Overall Study||12||
59882158|NCT04053465|76005066|FG000|COMPLETED|Overall Study||18||
59882159|NCT04053465|76005067|FG001|COMPLETED|Overall Study||8||
59882160|NCT04053465|76005066|FG000|NOT COMPLETED|Overall Study||4||
59882161|NCT04053465|76005067|FG001|NOT COMPLETED|Overall Study||4||
59882162|NCT00143507|76005075|FG000|STARTED|Overall Study||5479||
59882163|NCT00143507|76005076|FG001|STARTED|Overall Study||5438||
59882164|NCT00143507|76005075|FG000|COMPLETED|Overall Study||4792||
59882165|NCT00143507|76005076|FG001|COMPLETED|Overall Study||4786||
59882166|NCT00143507|76005075|FG000|NOT COMPLETED|Overall Study||687||
59882167|NCT00143507|76005076|FG001|NOT COMPLETED|Overall Study||652||
59882168|NCT03988803|76005082|FG000|STARTED|Screening||16||
60151763|NCT02603172|76276972|FG007|COMPLETED|Part A (Approximately 16 Weeks)||0||
60151764|NCT02603172|76276965|FG000|NOT COMPLETED|Part A (Approximately 16 Weeks)||0||
60151765|NCT02603172|76276966|FG001|NOT COMPLETED|Part A (Approximately 16 Weeks)||0||
60151766|NCT02603172|76276967|FG002|NOT COMPLETED|Part A (Approximately 16 Weeks)||1||
60151767|NCT02603172|76276968|FG003|NOT COMPLETED|Part A (Approximately 16 Weeks)||0||
60151768|NCT02603172|76276969|FG004|NOT COMPLETED|Part A (Approximately 16 Weeks)||0||
59882169|NCT03988803|76005082|FG000|COMPLETED|Screening||16||
59882170|NCT03988803|76005082|FG000|NOT COMPLETED|Screening||0||
59882171|NCT03988803|76005082|FG000|STARTED|Period 1||16||
59882172|NCT03988803|76005082|FG000|COMPLETED|Period 1||16||
59882173|NCT03988803|76005082|FG000|NOT COMPLETED|Period 1||0||
60151769|NCT02603172|76276970|FG005|NOT COMPLETED|Part A (Approximately 16 Weeks)||0||
60151770|NCT02603172|76276971|FG006|NOT COMPLETED|Part A (Approximately 16 Weeks)||0||
60151771|NCT02603172|76276972|FG007|NOT COMPLETED|Part A (Approximately 16 Weeks)||0||
60151772|NCT02603172|76276965|FG000|STARTED|Part B (Approximately 7 Weeks)||0||
60151773|NCT02603172|76276966|FG001|STARTED|Part B (Approximately 7 Weeks)||1||
60151774|NCT02603172|76276967|FG002|STARTED|Part B (Approximately 7 Weeks)||0||
60151775|NCT02603172|76276968|FG003|STARTED|Part B (Approximately 7 Weeks)||1||
60151776|NCT02603172|76276969|FG004|STARTED|Part B (Approximately 7 Weeks)||6||
60151777|NCT02603172|76276970|FG005|STARTED|Part B (Approximately 7 Weeks)||0||
60151778|NCT02603172|76276971|FG006|STARTED|Part B (Approximately 7 Weeks)||0||
60151779|NCT02603172|76276972|FG007|STARTED|Part B (Approximately 7 Weeks)||0||
60151780|NCT02603172|76276965|FG000|COMPLETED|Part B (Approximately 7 Weeks)||0||
60151781|NCT02603172|76276966|FG001|COMPLETED|Part B (Approximately 7 Weeks)||1||
60151782|NCT02603172|76276967|FG002|COMPLETED|Part B (Approximately 7 Weeks)||0||
60151783|NCT02603172|76276968|FG003|COMPLETED|Part B (Approximately 7 Weeks)||1||
60151784|NCT02603172|76276969|FG004|COMPLETED|Part B (Approximately 7 Weeks)||6||
60151785|NCT02603172|76276970|FG005|COMPLETED|Part B (Approximately 7 Weeks)||0||
60151786|NCT02603172|76276971|FG006|COMPLETED|Part B (Approximately 7 Weeks)||0||
60151787|NCT02603172|76276972|FG007|COMPLETED|Part B (Approximately 7 Weeks)||0||
60151788|NCT02603172|76276965|FG000|NOT COMPLETED|Part B (Approximately 7 Weeks)||0||
59751591|NCT00969761|75870898|FG009|COMPLETED|Treated in and Beyond Treat. Cycle 2||0||
59751592|NCT00969761|75870899|FG010|COMPLETED|Treated in and Beyond Treat. Cycle 2||0||
59751593|NCT00969761|75870900|FG011|COMPLETED|Treated in and Beyond Treat. Cycle 2||0||
59751594|NCT00969761|75870889|FG000|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||2||
59751595|NCT00969761|75870890|FG001|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||3||
59751596|NCT00969761|75870891|FG002|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||10||
59751597|NCT00969761|75870892|FG003|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||5||
59751598|NCT00969761|75870893|FG004|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||3||
59882174|NCT03988803|76005082|FG000|STARTED|Period 2||16||
59882175|NCT03988803|76005082|FG000|Treated|Period 2||15||
60151789|NCT02603172|76276966|FG001|NOT COMPLETED|Part B (Approximately 7 Weeks)||0||
60151790|NCT02603172|76276967|FG002|NOT COMPLETED|Part B (Approximately 7 Weeks)||0||
60151791|NCT02603172|76276968|FG003|NOT COMPLETED|Part B (Approximately 7 Weeks)||0||
60151792|NCT02603172|76276969|FG004|NOT COMPLETED|Part B (Approximately 7 Weeks)||0||
60151793|NCT02603172|76276970|FG005|NOT COMPLETED|Part B (Approximately 7 Weeks)||0||
60151794|NCT02603172|76276971|FG006|NOT COMPLETED|Part B (Approximately 7 Weeks)||0||
60151795|NCT02603172|76276972|FG007|NOT COMPLETED|Part B (Approximately 7 Weeks)||0||
60151796|NCT02603172|76276965|FG000|STARTED|Part C (Approximately 13 Weeks)||0||
60151797|NCT02603172|76276966|FG001|STARTED|Part C (Approximately 13 Weeks)||0||
60151798|NCT02603172|76276967|FG002|STARTED|Part C (Approximately 13 Weeks)||0||
60151799|NCT02603172|76276968|FG003|STARTED|Part C (Approximately 13 Weeks)||0||
60151800|NCT02603172|76276969|FG004|STARTED|Part C (Approximately 13 Weeks)||0||
60151801|NCT02603172|76276970|FG005|STARTED|Part C (Approximately 13 Weeks)||0||
60151802|NCT02603172|76276971|FG006|STARTED|Part C (Approximately 13 Weeks)||0||
60151803|NCT02603172|76276972|FG007|STARTED|Part C (Approximately 13 Weeks)||0||
60151804|NCT02603172|76276965|FG000|COMPLETED|Part C (Approximately 13 Weeks)||0||
60151805|NCT02603172|76276966|FG001|COMPLETED|Part C (Approximately 13 Weeks)||0||
60151806|NCT02603172|76276967|FG002|COMPLETED|Part C (Approximately 13 Weeks)||0||
60151807|NCT02603172|76276968|FG003|COMPLETED|Part C (Approximately 13 Weeks)||0||
60151808|NCT02603172|76276969|FG004|COMPLETED|Part C (Approximately 13 Weeks)||0||
60151809|NCT02603172|76276970|FG005|COMPLETED|Part C (Approximately 13 Weeks)||0||
60151810|NCT02603172|76276971|FG006|COMPLETED|Part C (Approximately 13 Weeks)||0||
60151811|NCT02603172|76276972|FG007|COMPLETED|Part C (Approximately 13 Weeks)||0||
60151812|NCT02603172|76276965|FG000|NOT COMPLETED|Part C (Approximately 13 Weeks)||0||
60151813|NCT02603172|76276966|FG001|NOT COMPLETED|Part C (Approximately 13 Weeks)||0||
60151814|NCT02603172|76276967|FG002|NOT COMPLETED|Part C (Approximately 13 Weeks)||0||
60151815|NCT02603172|76276968|FG003|NOT COMPLETED|Part C (Approximately 13 Weeks)||0||
60151816|NCT02603172|76276969|FG004|NOT COMPLETED|Part C (Approximately 13 Weeks)||0||
60151817|NCT02603172|76276970|FG005|NOT COMPLETED|Part C (Approximately 13 Weeks)||0||
60151818|NCT02603172|76276971|FG006|NOT COMPLETED|Part C (Approximately 13 Weeks)||0||
60151819|NCT02603172|76276972|FG007|NOT COMPLETED|Part C (Approximately 13 Weeks)||0||
60151820|NCT01431755|76276988|FG000|STARTED|Overall Study||54||
60151821|NCT01431755|76276988|FG000|COMPLETED|Overall Study||49||
60151822|NCT01431755|76276988|FG000|NOT COMPLETED|Overall Study||5||
60151823|NCT01146275|76276994|FG000|STARTED|Overall Study||6||
60151824|NCT01146275|76276994|FG000|COMPLETED|Overall Study||6||
59882176|NCT03988803|76005082|FG000|Started Days 1 - 7: Multiple Doses of 5 mg Memantine qd|Period 2||15||
60151825|NCT01146275|76276994|FG000|NOT COMPLETED|Overall Study||0||
60151826|NCT00066937|76277003|FG000|STARTED|Treatment Phase||41||
60151827|NCT00066937|76277004|FG001|STARTED|Treatment Phase||38||
60151828|NCT00066937|76277005|FG002|STARTED|Treatment Phase||37||
60151829|NCT00066937|76277006|FG003|STARTED|Treatment Phase||24||
60151830|NCT00066937|76277003|FG000|COMPLETED|Treatment Phase||38||
60151831|NCT00066937|76277004|FG001|COMPLETED|Treatment Phase||33||
60151832|NCT00066937|76277005|FG002|COMPLETED|Treatment Phase||26||
60151833|NCT00066937|76277006|FG003|COMPLETED|Treatment Phase||19||
60151834|NCT00066937|76277003|FG000|NOT COMPLETED|Treatment Phase||3||
60151835|NCT00066937|76277004|FG001|NOT COMPLETED|Treatment Phase||5||
60151836|NCT00066937|76277005|FG002|NOT COMPLETED|Treatment Phase||11||
60151837|NCT00066937|76277006|FG003|NOT COMPLETED|Treatment Phase||5||
60151838|NCT00066937|76277003|FG000|STARTED|3 Month Follow-up||38||
60151839|NCT00066937|76277004|FG001|STARTED|3 Month Follow-up||33||
60151840|NCT00066937|76277005|FG002|STARTED|3 Month Follow-up||26||
60151841|NCT00066937|76277006|FG003|STARTED|3 Month Follow-up||19||
60151842|NCT00066937|76277003|FG000|COMPLETED|3 Month Follow-up||33||
60151843|NCT00066937|76277004|FG001|COMPLETED|3 Month Follow-up||32||
60151844|NCT00066937|76277005|FG002|COMPLETED|3 Month Follow-up||25||
60151845|NCT00066937|76277006|FG003|COMPLETED|3 Month Follow-up||15||
60151846|NCT00066937|76277003|FG000|NOT COMPLETED|3 Month Follow-up||5||
59605797|NCT01987596|75715936|FG001|COMPLETED|Overall Study||10||
60151847|NCT00066937|76277004|FG001|NOT COMPLETED|3 Month Follow-up||1||
60151848|NCT00066937|76277005|FG002|NOT COMPLETED|3 Month Follow-up||1||
60151849|NCT00066937|76277006|FG003|NOT COMPLETED|3 Month Follow-up||4||
60151850|NCT00066937|76277003|FG000|STARTED|6 Month Follow-up||33||
60151851|NCT00066937|76277004|FG001|STARTED|6 Month Follow-up||32||
60151852|NCT00066937|76277005|FG002|STARTED|6 Month Follow-up||25||
60151853|NCT00066937|76277006|FG003|STARTED|6 Month Follow-up||15||
60151854|NCT00066937|76277003|FG000|COMPLETED|6 Month Follow-up||26||
60151855|NCT00066937|76277004|FG001|COMPLETED|6 Month Follow-up||29||
60151856|NCT00066937|76277005|FG002|COMPLETED|6 Month Follow-up||22||
60151857|NCT00066937|76277006|FG003|COMPLETED|6 Month Follow-up||14||
60151858|NCT00066937|76277003|FG000|NOT COMPLETED|6 Month Follow-up||7||
60151859|NCT00066937|76277004|FG001|NOT COMPLETED|6 Month Follow-up||3||
60151860|NCT00066937|76277005|FG002|NOT COMPLETED|6 Month Follow-up||3||
60151861|NCT00066937|76277006|FG003|NOT COMPLETED|6 Month Follow-up||1||
60151862|NCT01505673|76277018|FG000|STARTED|Overall Study||35||
60151863|NCT01505673|76277019|FG001|STARTED|Overall Study||36||
60151864|NCT01505673|76277018|FG000|COMPLETED|Overall Study||32||
60151865|NCT01505673|76277019|FG001|COMPLETED|Overall Study||34||
60151866|NCT01505673|76277018|FG000|NOT COMPLETED|Overall Study||3||
60151867|NCT01505673|76277019|FG001|NOT COMPLETED|Overall Study||2||
60151868|NCT00057577|76277027|FG000|STARTED|Overall Study||227||
60151869|NCT00057577|76277028|FG001|STARTED|Overall Study||225||
60151870|NCT00057577|76277027|FG000|COMPLETED|Overall Study||227||
60151871|NCT00057577|76277028|FG001|COMPLETED|Overall Study||225||
60151872|NCT00057577|76277027|FG000|NOT COMPLETED|Overall Study||0||
60151873|NCT00057577|76277028|FG001|NOT COMPLETED|Overall Study||0||
60151874|NCT01507155|76277039|FG000|STARTED|Overall Study||625||
60151875|NCT01507155|76277040|FG001|STARTED|Overall Study||60||
60151876|NCT01507155|76277039|FG000|COMPLETED|Overall Study||625||
60151877|NCT01507155|76277040|FG001|COMPLETED|Overall Study||60||
60151878|NCT01507155|76277039|FG000|NOT COMPLETED|Overall Study||0||
60151879|NCT01507155|76277040|FG001|NOT COMPLETED|Overall Study||0||
60151880|NCT01507779|76277047|FG000|STARTED|Overall Study||23||
60151881|NCT01507779|76277048|FG001|STARTED|Overall Study||25||
60151882|NCT01507779|76277047|FG000|COMPLETED|Overall Study||23||
60151883|NCT01507779|76277048|FG001|COMPLETED|Overall Study||25||
60151884|NCT01507779|76277047|FG000|NOT COMPLETED|Overall Study||0||
60151885|NCT01507779|76277048|FG001|NOT COMPLETED|Overall Study||0||
60151886|NCT00068341|76277059|FG000|STARTED|Overall Study||15||
60151887|NCT00068341|76277060|FG001|STARTED|Overall Study||15||
60151888|NCT00068341|76277061|FG002|STARTED|Overall Study||44||
60151889|NCT00068341|76277059|FG000|COMPLETED|Overall Study||15||
60151890|NCT00068341|76277060|FG001|COMPLETED|Overall Study||15||
60151891|NCT00068341|76277061|FG002|COMPLETED|Overall Study||44||
60151892|NCT00068341|76277059|FG000|NOT COMPLETED|Overall Study||0||
60151893|NCT00068341|76277060|FG001|NOT COMPLETED|Overall Study||0||
60151894|NCT00068341|76277061|FG002|NOT COMPLETED|Overall Study||0||
60151895|NCT01462305|76277084|FG000|STARTED|Overall Study||18||
60151896|NCT01462305|76277085|FG001|STARTED|Overall Study||17||
60151897|NCT01462305|76277084|FG000|COMPLETED|Overall Study||16||
60151898|NCT01462305|76277085|FG001|COMPLETED|Overall Study||13||
60151899|NCT01462305|76277084|FG000|NOT COMPLETED|Overall Study||2||
60151900|NCT01462305|76277085|FG001|NOT COMPLETED|Overall Study||4||
60151901|NCT02605824|76277093|FG000|STARTED|Overall Study||1||
60151902|NCT02605824|76277094|FG001|STARTED|Overall Study||0||
60151903|NCT02605824|76277093|FG000|COMPLETED|Overall Study||0||
60151904|NCT02605824|76277094|FG001|COMPLETED|Overall Study||0||
60151905|NCT02605824|76277093|FG000|NOT COMPLETED|Overall Study||1||
60151906|NCT02605824|76277094|FG001|NOT COMPLETED|Overall Study||0||
60151907|NCT01578993|76277100|FG000|STARTED|Overall Study||101||
60151908|NCT01578993|76277100|FG000|COMPLETED|Overall Study||101||
60151909|NCT01578993|76277100|FG000|NOT COMPLETED|Overall Study||0||
60151910|NCT02095561|76277106|FG000|STARTED|Overall Study||3049||
60151911|NCT02095561|76277107|FG001|STARTED|Overall Study||2964||
60151912|NCT02095561|76277106|FG000|Self-testing Acceptability|Overall Study||2616||
60151913|NCT02095561|76277107|FG001|Self-testing Acceptability|Overall Study|Acceptablity only applies to the group of women being offered self-testing.|0||
60151914|NCT02095561|76277106|FG000|HPV Self-tested Women|Overall Study||2519||
60151915|NCT02095561|76277107|FG001|HPV Self-tested Women|Overall Study|HPV self-testing only applies to the HPV self-testing arm|0||
60151916|NCT02095561|76277106|FG000|HPV Tested at Health Centers|Overall Study||99||
60151917|NCT02095561|76277107|FG001|HPV Tested at Health Centers|Overall Study||599||
60151918|NCT02095561|76277106|FG000|COMPLETED|Overall Study|All women are part of the study, independently of whether they were tested or not.|3049||
60151919|NCT02095561|76277107|FG001|COMPLETED|Overall Study|All women are part of the study, independently of whether they were tested or not.|2964||
60151920|NCT02095561|76277106|FG000|NOT COMPLETED|Overall Study||0||
60151921|NCT02095561|76277107|FG001|NOT COMPLETED|Overall Study||0||
60151922|NCT01462773|76277113|FG000|STARTED|Overall Study||16||
60151923|NCT01462773|76277113|FG000|COMPLETED|Overall Study||16||
60151924|NCT01462773|76277113|FG000|NOT COMPLETED|Overall Study||0||
60151925|NCT02096029|76277120|FG000|STARTED|Overall Study||652||
60151926|NCT02096029|76277121|FG001|STARTED|Overall Study||593||
60151927|NCT02096029|76277120|FG000|COMPLETED|Overall Study||652||
60151928|NCT02096029|76277121|FG001|COMPLETED|Overall Study||593||
60151929|NCT02096029|76277120|FG000|NOT COMPLETED|Overall Study||0||
60151930|NCT02096029|76277121|FG001|NOT COMPLETED|Overall Study||0||
60151931|NCT02205801|76277131|FG000|STARTED|Overall Study||11||
60151932|NCT02205801|76277132|FG001|STARTED|Overall Study||8||
60151933|NCT02205801|76277133|FG002|STARTED|Overall Study||9||
60151934|NCT02205801|76277134|FG003|STARTED|Overall Study||8||
60151935|NCT02205801|76277131|FG000|COMPLETED|Overall Study||11||
60151936|NCT02205801|76277132|FG001|COMPLETED|Overall Study||8||
60151937|NCT02205801|76277133|FG002|COMPLETED|Overall Study||9||
60151938|NCT02205801|76277134|FG003|COMPLETED|Overall Study||8||
60151939|NCT02205801|76277131|FG000|NOT COMPLETED|Overall Study||0||
60151940|NCT02205801|76277132|FG001|NOT COMPLETED|Overall Study||0||
60151941|NCT02205801|76277133|FG002|NOT COMPLETED|Overall Study||0||
60151942|NCT02205801|76277134|FG003|NOT COMPLETED|Overall Study||0||
60151943|NCT02096107|76277146|FG000|STARTED|Overall Study||30||
60151944|NCT02096107|76277147|FG001|STARTED|Overall Study||30||
60151945|NCT02096107|76277146|FG000|COMPLETED|Overall Study||30||
60151946|NCT02096107|76277147|FG001|COMPLETED|Overall Study||30||
60151947|NCT02096107|76277146|FG000|NOT COMPLETED|Overall Study||0||
60151948|NCT02096107|76277147|FG001|NOT COMPLETED|Overall Study||0||
60151949|NCT01508013|76277155|FG000|STARTED|Overall Study||214||
60151950|NCT01508013|76277156|FG001|STARTED|Overall Study||229||
60151951|NCT01508013|76277155|FG000|COMPLETED|Overall Study||182||
60151952|NCT01508013|76277156|FG001|COMPLETED|Overall Study||206||
60151953|NCT01508013|76277155|FG000|NOT COMPLETED|Overall Study||32||
60151954|NCT01508013|76277156|FG001|NOT COMPLETED|Overall Study||23||
60151955|NCT00068575|76277162|FG000|STARTED|Overall Study||28||
60151956|NCT00068575|76277162|FG000|COMPLETED|Overall Study||28||
60151957|NCT00068575|76277162|FG000|NOT COMPLETED|Overall Study||0||
60151958|NCT00784823|76277170|FG000|STARTED|Overall Study||6||
60151959|NCT00784823|76277171|FG001|STARTED|Overall Study||3||
60151960|NCT00784823|76277172|FG002|STARTED|Overall Study||3||
60151961|NCT00784823|76277173|FG003|STARTED|Overall Study||20||
60151962|NCT00784823|76277170|FG000|COMPLETED|Overall Study||6||
60151963|NCT00784823|76277171|FG001|COMPLETED|Overall Study||3||
60151964|NCT00784823|76277172|FG002|COMPLETED|Overall Study||3||
60151965|NCT00784823|76277173|FG003|COMPLETED|Overall Study||20||
60151966|NCT00784823|76277170|FG000|NOT COMPLETED|Overall Study||0||
60151967|NCT00784823|76277171|FG001|NOT COMPLETED|Overall Study||0||
60151968|NCT00784823|76277172|FG002|NOT COMPLETED|Overall Study||0||
60151969|NCT00784823|76277173|FG003|NOT COMPLETED|Overall Study||0||
60151970|NCT01509105|76277178|FG000|STARTED|Overall Study||649||
60151971|NCT01509105|76277178|FG000|COMPLETED|Overall Study||649||
60151972|NCT01509105|76277178|FG000|NOT COMPLETED|Overall Study||0||
60151973|NCT00773357|76277184|FG000|STARTED|Overall Study||50||
60151974|NCT00773357|76277185|FG001|STARTED|Overall Study||50||
60151975|NCT00773357|76277184|FG000|COMPLETED|Overall Study||50||
60151976|NCT00773357|76277185|FG001|COMPLETED|Overall Study||50||
60151977|NCT00773357|76277184|FG000|NOT COMPLETED|Overall Study||0||
60151978|NCT00773357|76277185|FG001|NOT COMPLETED|Overall Study||0||
60151979|NCT01509183|76277193|FG000|STARTED|Overall Study||250||
60151980|NCT01509183|76277194|FG001|STARTED|Overall Study||245||
60151981|NCT01509183|76277193|FG000|COMPLETED|Overall Study||141||
60151982|NCT01509183|76277194|FG001|COMPLETED|Overall Study||134||
60151983|NCT01509183|76277193|FG000|NOT COMPLETED|Overall Study||109||
60151984|NCT01509183|76277194|FG001|NOT COMPLETED|Overall Study||111||
60151985|NCT02324673|76277203|FG000|STARTED|Overall Study||20||
60151986|NCT02324673|76277204|FG001|STARTED|Overall Study||20||
60151987|NCT02324673|76277205|FG002|STARTED|Overall Study||21||
60151988|NCT02324673|76277203|FG000|COMPLETED|Overall Study||20||
60151989|NCT02324673|76277204|FG001|COMPLETED|Overall Study||20||
60151990|NCT02324673|76277205|FG002|COMPLETED|Overall Study||21||
60151991|NCT02324673|76277203|FG000|NOT COMPLETED|Overall Study||0||
60151992|NCT02324673|76277204|FG001|NOT COMPLETED|Overall Study||0||
60151993|NCT02324673|76277205|FG002|NOT COMPLETED|Overall Study||0||
60151994|NCT00373217|76277215|FG000|STARTED|Overall Study||3||
60151995|NCT00373217|76277216|FG001|STARTED|Overall Study||3||
60151996|NCT00373217|76277215|FG000|COMPLETED|Overall Study||2||
60151997|NCT00373217|76277216|FG001|COMPLETED|Overall Study||3||
60151998|NCT00373217|76277215|FG000|NOT COMPLETED|Overall Study||1||
60151999|NCT00373217|76277216|FG001|NOT COMPLETED|Overall Study||0||
60152000|NCT02605122|76277224|FG000|STARTED|Overall Study||73||
60152001|NCT02605122|76277225|FG001|STARTED|Overall Study||24||
60152002|NCT02605122|76277224|FG000|Received Study Drug|Overall Study||70||
60152003|NCT02605122|76277225|FG001|Received Study Drug|Overall Study||24||
60152004|NCT02605122|76277224|FG000|COMPLETED|Overall Study||68||
60152005|NCT02605122|76277225|FG001|COMPLETED|Overall Study||22||
60152006|NCT02605122|76277224|FG000|NOT COMPLETED|Overall Study||5||
60152007|NCT02605122|76277225|FG001|NOT COMPLETED|Overall Study||2||
60152008|NCT01579305|76277233|FG000|STARTED|Overall Study|Subjects that signed Informed Consent, passed screening criteria, and were randomized.|139||
60152009|NCT01579305|76277234|FG001|STARTED|Overall Study|Subjects that signed Informed Consent, passed screening criteria, and were randomized.|142||
60152010|NCT01579305|76277233|FG000|Discontinued Before Treatment|Overall Study||0||
60152011|NCT01579305|76277234|FG001|Discontinued Before Treatment|Overall Study||1||
60152012|NCT01579305|76277233|FG000|Continued After Treatment|Overall Study||139||
60152013|NCT01579305|76277234|FG001|Continued After Treatment|Overall Study||141||
60152014|NCT01579305|76277233|FG000|COMPLETED|Overall Study||118||
60152015|NCT01579305|76277234|FG001|COMPLETED|Overall Study||115||
60152016|NCT01579305|76277233|FG000|NOT COMPLETED|Overall Study||21||
60152017|NCT01579305|76277234|FG001|NOT COMPLETED|Overall Study||27||
60152018|NCT02216097|76277242|FG000|STARTED|Overall Study||8||
60152019|NCT02216097|76277243|FG001|STARTED|Overall Study||6||
60152020|NCT02216097|76277242|FG000|COMPLETED|Overall Study||8||
60152021|NCT02216097|76277243|FG001|COMPLETED|Overall Study||6||
60152022|NCT02216097|76277242|FG000|NOT COMPLETED|Overall Study||0||
60152023|NCT02216097|76277243|FG001|NOT COMPLETED|Overall Study||0||
60152024|NCT01466751|76277251|FG000|STARTED|Overall Study||14||
60152025|NCT01466751|76277252|FG001|STARTED|Overall Study||14||
60152026|NCT01466751|76277251|FG000|COMPLETED|Overall Study||13||
60152027|NCT01466751|76277252|FG001|COMPLETED|Overall Study||14||
60152028|NCT01466751|76277251|FG000|NOT COMPLETED|Overall Study||1||
60152029|NCT01466751|76277252|FG001|NOT COMPLETED|Overall Study||0||
60152030|NCT01454102|76277276|FG000|STARTED|Overall Study||12||
60152031|NCT01454102|76277277|FG001|STARTED|Overall Study||15||
60152032|NCT01454102|76277278|FG002|STARTED|Overall Study||15||
60152033|NCT01454102|76277279|FG003|STARTED|Overall Study||12||
60152034|NCT01454102|76277280|FG004|STARTED|Overall Study||21||
60152035|NCT01454102|76277281|FG005|STARTED|Overall Study||52||
60152036|NCT01454102|76277282|FG006|STARTED|Overall Study||24||
60152037|NCT01454102|76277283|FG007|STARTED|Overall Study||25||
60152038|NCT01454102|76277284|FG008|STARTED|Overall Study||13||
60152039|NCT01454102|76277285|FG009|STARTED|Overall Study||13||
60152040|NCT01454102|76277286|FG010|STARTED|Overall Study||12||
60152041|NCT01454102|76277287|FG011|STARTED|Overall Study||31||
60152042|NCT01454102|76277288|FG012|STARTED|Overall Study||40||
60152043|NCT01454102|76277289|FG013|STARTED|Overall Study||38||
60152044|NCT01454102|76277290|FG014|STARTED|Overall Study||39||
60152045|NCT01454102|76277291|FG015|STARTED|Overall Study||14||
60152046|NCT01454102|76277276|FG000|COMPLETED|Overall Study||12||
60152047|NCT01454102|76277277|FG001|COMPLETED|Overall Study||15||
60152048|NCT01454102|76277278|FG002|COMPLETED|Overall Study||15||
60152049|NCT01454102|76277279|FG003|COMPLETED|Overall Study||12||
60152050|NCT01454102|76277280|FG004|COMPLETED|Overall Study||18||
60152051|NCT01454102|76277281|FG005|COMPLETED|Overall Study||49||
60152052|NCT01454102|76277282|FG006|COMPLETED|Overall Study||22||
60152053|NCT01454102|76277283|FG007|COMPLETED|Overall Study||25||
60152054|NCT01454102|76277284|FG008|COMPLETED|Overall Study||12||
60152055|NCT01454102|76277285|FG009|COMPLETED|Overall Study||13||
60152056|NCT01454102|76277286|FG010|COMPLETED|Overall Study||12||
60152057|NCT01454102|76277287|FG011|COMPLETED|Overall Study||27||
60152058|NCT01454102|76277288|FG012|COMPLETED|Overall Study||33||
60152059|NCT01454102|76277289|FG013|COMPLETED|Overall Study||34||
60152060|NCT01454102|76277290|FG014|COMPLETED|Overall Study||36||
60152061|NCT01454102|76277291|FG015|COMPLETED|Overall Study||13||
60152062|NCT01454102|76277276|FG000|NOT COMPLETED|Overall Study||0||
60152063|NCT01454102|76277277|FG001|NOT COMPLETED|Overall Study||0||
60152064|NCT01454102|76277278|FG002|NOT COMPLETED|Overall Study||0||
60152065|NCT01454102|76277279|FG003|NOT COMPLETED|Overall Study||0||
60152066|NCT01454102|76277280|FG004|NOT COMPLETED|Overall Study||3||
60152067|NCT01454102|76277281|FG005|NOT COMPLETED|Overall Study||3||
60152068|NCT01454102|76277282|FG006|NOT COMPLETED|Overall Study||2||
60152069|NCT01454102|76277283|FG007|NOT COMPLETED|Overall Study||0||
60152070|NCT01454102|76277284|FG008|NOT COMPLETED|Overall Study||1||
60152071|NCT01454102|76277285|FG009|NOT COMPLETED|Overall Study||0||
60152072|NCT01454102|76277286|FG010|NOT COMPLETED|Overall Study||0||
60152073|NCT01454102|76277287|FG011|NOT COMPLETED|Overall Study||4||
60152074|NCT01454102|76277288|FG012|NOT COMPLETED|Overall Study||7||
60152075|NCT01454102|76277289|FG013|NOT COMPLETED|Overall Study||4||
60152076|NCT01454102|76277290|FG014|NOT COMPLETED|Overall Study||3||
60152077|NCT01454102|76277291|FG015|NOT COMPLETED|Overall Study||1||
60152078|NCT01466985|76277329|FG000|STARTED|Overall Study||6||
60152079|NCT01466985|76277330|FG001|STARTED|Overall Study||6||
60152080|NCT01466985|76277331|FG002|STARTED|Overall Study||6||
60152081|NCT01466985|76277329|FG000|COMPLETED|Overall Study||6||
60152082|NCT01466985|76277330|FG001|COMPLETED|Overall Study||6||
60152083|NCT01466985|76277331|FG002|COMPLETED|Overall Study||6||
60152084|NCT01466985|76277329|FG000|NOT COMPLETED|Overall Study||0||
60152085|NCT01466985|76277330|FG001|NOT COMPLETED|Overall Study||0||
60152086|NCT01466985|76277331|FG002|NOT COMPLETED|Overall Study||0||
60152087|NCT01467063|76277340|FG000|STARTED|Overall Study||6||
60152088|NCT01467063|76277341|FG001|STARTED|Overall Study||7||
60152089|NCT01467063|76277340|FG000|COMPLETED|Overall Study||5||
60152090|NCT01467063|76277341|FG001|COMPLETED|Overall Study||7||
60152091|NCT01467063|76277340|FG000|NOT COMPLETED|Overall Study||1||
60152092|NCT01467063|76277341|FG001|NOT COMPLETED|Overall Study||0||
60152093|NCT01509807|76277349|FG000|STARTED|Overall Study||16||
60152094|NCT01509807|76277350|FG001|STARTED|Overall Study||17||
60152095|NCT01509807|76277349|FG000|COMPLETED|Overall Study||15||
60152096|NCT01509807|76277350|FG001|COMPLETED|Overall Study||16||
60152097|NCT01509807|76277349|FG000|NOT COMPLETED|Overall Study||1||
60152098|NCT01509807|76277350|FG001|NOT COMPLETED|Overall Study||1||
60152099|NCT00070135|76277356|FG000|STARTED|Overall Study||114||
60152100|NCT00070135|76277356|FG000|COMPLETED|Overall Study||114||
60152101|NCT00070135|76277356|FG000|NOT COMPLETED|Overall Study||0||
60152102|NCT01583985|76277362|FG000|STARTED|Overall Study||120||
60152103|NCT01583985|76277363|FG001|STARTED|Overall Study||120||
60152104|NCT01583985|76277362|FG000|Included in Primary Analysis|Overall Study||119|Provided patient-reported outcomes at least one post-randomization follow-up timepoint|
60152105|NCT01583985|76277363|FG001|Included in Primary Analysis|Overall Study||119|Provided patient-reported outcomes at least one post-randomization follow-up timepoint|
60152106|NCT01583985|76277362|FG000|COMPLETED|Overall Study||117|Main patient-reported outcomes at 12 months|
60152107|NCT01583985|76277363|FG001|COMPLETED|Overall Study||117|Main patient-reported outcomes at 12 months|
60152108|NCT01583985|76277362|FG000|NOT COMPLETED|Overall Study||3||
60152109|NCT01583985|76277363|FG001|NOT COMPLETED|Overall Study||3||
60152110|NCT00073333|76277372|FG000|STARTED|Overall Study||46||
60152111|NCT00073333|76277373|FG001|STARTED|Overall Study||41||
60152112|NCT00073333|76277374|FG002|STARTED|Overall Study||19||
60152113|NCT00073333|76277372|FG000|COMPLETED|Overall Study||32||
60152114|NCT00073333|76277373|FG001|COMPLETED|Overall Study||27||
60152115|NCT00073333|76277374|FG002|COMPLETED|Overall Study||19||
60152116|NCT00073333|76277372|FG000|NOT COMPLETED|Overall Study||14||
60152117|NCT00073333|76277373|FG001|NOT COMPLETED|Overall Study||14||
60152118|NCT00073333|76277374|FG002|NOT COMPLETED|Overall Study||0||
60152119|NCT02602080|76277385|FG000|STARTED|Overall Study||21||
60152120|NCT02602080|76277386|FG001|STARTED|Overall Study||16||
60152121|NCT02602080|76277387|FG002|STARTED|Overall Study||18||
60152122|NCT02602080|76277385|FG000|COMPLETED|Overall Study||15||
60152123|NCT02602080|76277386|FG001|COMPLETED|Overall Study||15||
60152124|NCT02602080|76277387|FG002|COMPLETED|Overall Study||15||
60152125|NCT02602080|76277385|FG000|NOT COMPLETED|Overall Study||6||
60152126|NCT02602080|76277386|FG001|NOT COMPLETED|Overall Study||1||
60152127|NCT02602080|76277387|FG002|NOT COMPLETED|Overall Study||3||
60152128|NCT01467999|76277395|FG000|STARTED|Overall Study||22||
60152129|NCT01467999|76277395|FG000|COMPLETED|Overall Study||9||
60152130|NCT01467999|76277395|FG000|NOT COMPLETED|Overall Study||13||
60152131|NCT01469715|76277399|FG000|STARTED|Overall Study||16||
60152132|NCT01469715|76277399|FG000|COMPLETED|Overall Study||16||
60152133|NCT01469715|76277399|FG000|NOT COMPLETED|Overall Study||0||
60152134|NCT01470027|76277409|FG000|STARTED|Overall Study||16||
59605798|NCT01987596|75715935|FG000|NOT COMPLETED|Overall Study||1||
60152135|NCT01470027|76277410|FG001|STARTED|Overall Study||15||
60152136|NCT01470027|76277411|FG002|STARTED|Overall Study||16||
60152137|NCT01470027|76277409|FG000|COMPLETED|Overall Study||15||
60152138|NCT01470027|76277410|FG001|COMPLETED|Overall Study||14||
60152139|NCT01470027|76277411|FG002|COMPLETED|Overall Study||15||
60152140|NCT01470027|76277409|FG000|NOT COMPLETED|Overall Study||1||
60152141|NCT01470027|76277410|FG001|NOT COMPLETED|Overall Study||1||
60152142|NCT01470027|76277411|FG002|NOT COMPLETED|Overall Study||1||
60152143|NCT01470651|76277427|FG000|STARTED|Overall Study||13||
60152144|NCT01470651|76277428|FG001|STARTED|Overall Study||13||
60152145|NCT01470651|76277427|FG000|COMPLETED|Overall Study||6||
60152146|NCT01470651|76277428|FG001|COMPLETED|Overall Study||10||
60152147|NCT01470651|76277427|FG000|NOT COMPLETED|Overall Study||7||
60152148|NCT01470651|76277428|FG001|NOT COMPLETED|Overall Study||3||
60152149|NCT01471041|76277434|FG000|STARTED|Overall Study||54||
60152150|NCT01471041|76277434|FG000|COMPLETED|Overall Study||47||
60152151|NCT01471041|76277434|FG000|NOT COMPLETED|Overall Study||7||
60152152|NCT01512225|76277440|FG000|STARTED|Overall Study||45||
60152153|NCT01512225|76277441|FG001|STARTED|Overall Study||45||
60152154|NCT01512225|76277440|FG000|Provided Day 14 Volume|Overall Study||45||
60152155|NCT01512225|76277441|FG001|Provided Day 14 Volume|Overall Study||40||
60152156|NCT01512225|76277440|FG000|COMPLETED|Overall Study||45||
60152157|NCT01512225|76277441|FG001|COMPLETED|Overall Study||45||
60152158|NCT01512225|76277440|FG000|NOT COMPLETED|Overall Study||0||
60152159|NCT01512225|76277441|FG001|NOT COMPLETED|Overall Study||0||
60152160|NCT01472445|76277451|FG000|STARTED|Overall Study||25||
60152161|NCT01472445|76277452|FG001|STARTED|Overall Study||16||
60152162|NCT01472445|76277451|FG000|COMPLETED|Overall Study||25||
60152163|NCT01472445|76277452|FG001|COMPLETED|Overall Study||16||
60152164|NCT01472445|76277451|FG000|NOT COMPLETED|Overall Study||0||
60152165|NCT01472445|76277452|FG001|NOT COMPLETED|Overall Study||0||
60152166|NCT01584609|76277462|FG000|STARTED|Overall Study||98||
60152167|NCT01584609|76277463|FG001|STARTED|Overall Study||100||
60152168|NCT01584609|76277462|FG000|COMPLETED|Overall Study||86||
60152169|NCT01584609|76277463|FG001|COMPLETED|Overall Study||96||
60152170|NCT01584609|76277462|FG000|NOT COMPLETED|Overall Study||12||
60152171|NCT01584609|76277463|FG001|NOT COMPLETED|Overall Study||4||
60152172|NCT02604342|76277471|FG000|STARTED|Overall Study||79||
60152173|NCT02604342|76277472|FG001|STARTED|Overall Study||40||
60152174|NCT02604342|76277471|FG000|COMPLETED|Overall Study||36||
60152175|NCT02604342|76277472|FG001|COMPLETED|Overall Study||17||
60152176|NCT02604342|76277471|FG000|NOT COMPLETED|Overall Study||43||
60152177|NCT02604342|76277472|FG001|NOT COMPLETED|Overall Study||23||
60152178|NCT01585779|76277480|FG000|STARTED|Overall Study||36||
60152179|NCT01585779|76277481|FG001|STARTED|Overall Study||28||
60152180|NCT01585779|76277480|FG000|COMPLETED|Overall Study||26||
60152181|NCT01585779|76277481|FG001|COMPLETED|Overall Study||21||
60152182|NCT01585779|76277480|FG000|NOT COMPLETED|Overall Study||10||
60152183|NCT01585779|76277481|FG001|NOT COMPLETED|Overall Study||7||
60152184|NCT04780919|76277490|FG000|STARTED|Overall Study||9||
60152185|NCT04780919|76277491|FG001|STARTED|Overall Study||9||
60152186|NCT04780919|76277490|FG000|COMPLETED|Overall Study||9||
60152187|NCT04780919|76277491|FG001|COMPLETED|Overall Study||9||
60152188|NCT04780919|76277490|FG000|NOT COMPLETED|Overall Study||0||
60152189|NCT04780919|76277491|FG001|NOT COMPLETED|Overall Study||0||
60152190|NCT02604264|76277501|FG000|STARTED|Run-In||618|The 1-mo run-in period data was used to determine pre-study demographics and PBC rate.|
60152191|NCT02604264|76277502|FG001|STARTED|Run-In|The 1-mo run-in period data was used to determine pre-study demographics and PBC rate.|611|The 1-mo run-in period data was used to determine pre-study demographics and PBC rate.|
60152192|NCT02604264|76277501|FG000|COMPLETED|Run-In||618||
60152193|NCT02604264|76277502|FG001|COMPLETED|Run-In||611||
60152194|NCT02604264|76277501|FG000|NOT COMPLETED|Run-In||0||
60152195|NCT02604264|76277502|FG001|NOT COMPLETED|Run-In||0||
60152196|NCT02604264|76277501|FG000|STARTED|Intervention||1445||
60152197|NCT02604264|76277502|FG001|STARTED|Intervention||1467||
60152198|NCT02604264|76277501|FG000|COMPLETED|Intervention||1245||
60152199|NCT02604264|76277502|FG001|COMPLETED|Intervention||1225||
60152200|NCT02604264|76277501|FG000|NOT COMPLETED|Intervention||200||
60152201|NCT02604264|76277502|FG001|NOT COMPLETED|Intervention||242||
60152202|NCT01512849|76277510|FG000|STARTED|Crossover Period 1||6||
60152203|NCT01512849|76277511|FG001|STARTED|Crossover Period 1||6||
60152204|NCT01512849|76277512|FG002|STARTED|Crossover Period 1||6||
60152205|NCT01512849|76277513|FG003|STARTED|Crossover Period 1||6||
60152206|NCT01512849|76277510|FG000|COMPLETED|Crossover Period 1||6||
60152207|NCT01512849|76277511|FG001|COMPLETED|Crossover Period 1||6||
60152208|NCT01512849|76277512|FG002|COMPLETED|Crossover Period 1||6||
60152209|NCT01512849|76277513|FG003|COMPLETED|Crossover Period 1||6||
60152210|NCT01512849|76277510|FG000|NOT COMPLETED|Crossover Period 1||0||
60152211|NCT01512849|76277511|FG001|NOT COMPLETED|Crossover Period 1||0||
60152212|NCT01512849|76277512|FG002|NOT COMPLETED|Crossover Period 1||0||
60152213|NCT01512849|76277513|FG003|NOT COMPLETED|Crossover Period 1||0||
60152214|NCT01512849|76277510|FG000|STARTED|Crossover Period 2||6||
60152215|NCT01512849|76277511|FG001|STARTED|Crossover Period 2||6||
60152216|NCT01512849|76277512|FG002|STARTED|Crossover Period 2||6||
60152217|NCT01512849|76277513|FG003|STARTED|Crossover Period 2||6||
60152218|NCT01512849|76277510|FG000|COMPLETED|Crossover Period 2||6||
60152219|NCT01512849|76277511|FG001|COMPLETED|Crossover Period 2||6||
60152220|NCT01512849|76277512|FG002|COMPLETED|Crossover Period 2||6||
60152221|NCT01512849|76277513|FG003|COMPLETED|Crossover Period 2||6||
60152222|NCT01512849|76277510|FG000|NOT COMPLETED|Crossover Period 2||0||
60152223|NCT01512849|76277511|FG001|NOT COMPLETED|Crossover Period 2||0||
60152224|NCT01512849|76277512|FG002|NOT COMPLETED|Crossover Period 2||0||
60152225|NCT01512849|76277513|FG003|NOT COMPLETED|Crossover Period 2||0||
60152226|NCT01586091|76277526|FG000|STARTED|Overall Study|9 Caucasian and 9 Asian participants, each received Levocetiricine, fexofenadine and Placebo.|6||
60152227|NCT01586091|76277527|FG001|STARTED|Overall Study|9 Caucasian and 9 Asian participants, each received Levocetiricine, fexofenadine and Placebo.|6||
60152228|NCT01586091|76277528|FG002|STARTED|Overall Study||6||
60152229|NCT01586091|76277526|FG000|COMPLETED|Overall Study|9 Caucasian and 9 Asian participants, each received Levocetiricine, fexofenadine and Placebo.|6||
60152230|NCT01586091|76277527|FG001|COMPLETED|Overall Study|9 Caucasian and 9 Asian participants, each received Levocetiricine, fexofenadine and Placebo.|6||
60152231|NCT01586091|76277528|FG002|COMPLETED|Overall Study||6||
60152232|NCT01586091|76277526|FG000|NOT COMPLETED|Overall Study||0||
60152233|NCT01586091|76277527|FG001|NOT COMPLETED|Overall Study||0||
60152234|NCT01586091|76277528|FG002|NOT COMPLETED|Overall Study||0||
60152235|NCT02601300|76277539|FG000|STARTED|Induction Phase||41||
60152236|NCT02601300|76277539|FG000|COMPLETED|Induction Phase||38||
60152237|NCT02601300|76277539|FG000|NOT COMPLETED|Induction Phase||3||
60152238|NCT02601300|76277539|FG000|STARTED|Extension Phase|3 completed induction phase; did not enter extension due to withdrawal and lack of efficacy|35||
60152239|NCT02601300|76277539|FG000|Treated With IP|Extension Phase||34||
60152240|NCT02601300|76277539|FG000|COMPLETED|Extension Phase||18||
60152241|NCT02601300|76277539|FG000|NOT COMPLETED|Extension Phase||17||
59605799|NCT01987596|75715936|FG001|NOT COMPLETED|Overall Study||1||
59751599|NCT00969761|75870894|FG005|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||3||
59751600|NCT00969761|75870895|FG006|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||3||
59751601|NCT00969761|75870896|FG007|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||6||
60152242|NCT01586871|76277548|FG000|STARTED|Overall Study||560||
60152243|NCT01586871|76277549|FG001|STARTED|Overall Study||554||
60152244|NCT01586871|76277550|FG002|STARTED|Overall Study||33||
60152245|NCT01586871|76277548|FG000|COMPLETED|Overall Study||560||
60152246|NCT01586871|76277549|FG001|COMPLETED|Overall Study||554||
60152247|NCT01586871|76277550|FG002|COMPLETED|Overall Study||33||
60152248|NCT01586871|76277548|FG000|NOT COMPLETED|Overall Study||0||
60152249|NCT01586871|76277549|FG001|NOT COMPLETED|Overall Study||0||
60152250|NCT01586871|76277550|FG002|NOT COMPLETED|Overall Study||0||
60152251|NCT01587027|76277560|FG000|STARTED|First Intervention (1 Day)||8||
60152252|NCT01587027|76277561|FG001|STARTED|First Intervention (1 Day)||8||
60152253|NCT01587027|76277560|FG000|COMPLETED|First Intervention (1 Day)||8||
60152254|NCT01587027|76277561|FG001|COMPLETED|First Intervention (1 Day)||8||
60152255|NCT01587027|76277560|FG000|NOT COMPLETED|First Intervention (1 Day)||0||
60152256|NCT01587027|76277561|FG001|NOT COMPLETED|First Intervention (1 Day)||0||
60152257|NCT01587027|76277560|FG000|STARTED|Washout (1 Day)||8||
60152258|NCT01587027|76277561|FG001|STARTED|Washout (1 Day)||8||
60152259|NCT01587027|76277560|FG000|COMPLETED|Washout (1 Day)||8||
60152260|NCT01587027|76277561|FG001|COMPLETED|Washout (1 Day)||8||
60152261|NCT01587027|76277560|FG000|NOT COMPLETED|Washout (1 Day)||0||
60152262|NCT01587027|76277561|FG001|NOT COMPLETED|Washout (1 Day)||0||
60152263|NCT01587027|76277560|FG000|STARTED|Second Intervention (1 Day)||8||
60152264|NCT01587027|76277561|FG001|STARTED|Second Intervention (1 Day)||8||
60152265|NCT01587027|76277560|FG000|COMPLETED|Second Intervention (1 Day)||8||
60152266|NCT01587027|76277561|FG001|COMPLETED|Second Intervention (1 Day)||8||
60152267|NCT01587027|76277560|FG000|NOT COMPLETED|Second Intervention (1 Day)||0||
60152268|NCT01587027|76277561|FG001|NOT COMPLETED|Second Intervention (1 Day)||0||
59613485|NCT01684878|75724610|FG000|Participants Mis-randomized|Part 2: Randomized Phase||0||
60152269|NCT01587027|76277560|FG000|STARTED|Washout (1 Day)||8||
60152270|NCT01587027|76277561|FG001|STARTED|Washout (1 Day)||8||
60152271|NCT01587027|76277560|FG000|COMPLETED|Washout (1 Day)||8||
60152272|NCT01587027|76277561|FG001|COMPLETED|Washout (1 Day)||8||
60152273|NCT01587027|76277560|FG000|NOT COMPLETED|Washout (1 Day)||0||
60152274|NCT01587027|76277561|FG001|NOT COMPLETED|Washout (1 Day)||0||
60152275|NCT01587027|76277560|FG000|STARTED|Third Intervention (1 Day)||8||
60152276|NCT01587027|76277561|FG001|STARTED|Third Intervention (1 Day)||8||
60152277|NCT01587027|76277560|FG000|COMPLETED|Third Intervention (1 Day)||8||
60152278|NCT01587027|76277561|FG001|COMPLETED|Third Intervention (1 Day)||8||
60152279|NCT01587027|76277560|FG000|NOT COMPLETED|Third Intervention (1 Day)||0||
60152280|NCT01587027|76277561|FG001|NOT COMPLETED|Third Intervention (1 Day)||0||
60152281|NCT01587027|76277560|FG000|STARTED|Discharge (1 Day)||8||
60152282|NCT01587027|76277561|FG001|STARTED|Discharge (1 Day)||8||
60152283|NCT01587027|76277560|FG000|COMPLETED|Discharge (1 Day)||8||
60152284|NCT01587027|76277561|FG001|COMPLETED|Discharge (1 Day)||8||
60152285|NCT01587027|76277560|FG000|NOT COMPLETED|Discharge (1 Day)||0||
60152286|NCT01587027|76277561|FG001|NOT COMPLETED|Discharge (1 Day)||0||
60152287|NCT01587105|76277569|FG000|STARTED|Overall Study||150||
60152288|NCT01587105|76277570|FG001|STARTED|Overall Study||181||
60152289|NCT01587105|76277569|FG000|COMPLETED|Overall Study||144||
60152290|NCT01587105|76277570|FG001|COMPLETED|Overall Study||138||
60152291|NCT01587105|76277569|FG000|NOT COMPLETED|Overall Study||6||
60152292|NCT01587105|76277570|FG001|NOT COMPLETED|Overall Study||43||
60152293|NCT01471340|76277578|FG000|STARTED|Overall Study|This value corresponds to randomized participants who received at least of dose of study medication|5868||
60152294|NCT01471340|76277579|FG001|STARTED|Overall Study|This value corresponds to randomized participants who received at least of dose of study medication|5861||
60152295|NCT01471340|76277578|FG000|COMPLETED|Overall Study||5862||
60152296|NCT01471340|76277579|FG001|COMPLETED|Overall Study||5855||
60152297|NCT01471340|76277578|FG000|NOT COMPLETED|Overall Study||6||
60152298|NCT01471340|76277579|FG001|NOT COMPLETED|Overall Study||6||
60152299|NCT01588821|76277585|FG000|STARTED|Overall Study||37||
60152300|NCT01588821|76277585|FG000|COMPLETED|Overall Study||37||
60152301|NCT01588821|76277585|FG000|NOT COMPLETED|Overall Study||0||
60152302|NCT01515345|76277592|FG000|STARTED|Overall Study||665||
60152303|NCT01515345|76277593|FG001|STARTED|Overall Study||343||
60152304|NCT01515345|76277592|FG000|COMPLETED|Overall Study||664||
60152305|NCT01515345|76277593|FG001|COMPLETED|Overall Study||343||
60152306|NCT01515345|76277592|FG000|NOT COMPLETED|Overall Study||1||
60152307|NCT01515345|76277593|FG001|NOT COMPLETED|Overall Study||0||
60152308|NCT01492400|76277601|FG000|STARTED|Overall Study||181||
60152309|NCT01492400|76277602|FG001|STARTED|Overall Study||182||
60152310|NCT01492400|76277601|FG000|COMPLETED|Overall Study||165||
60152311|NCT01492400|76277602|FG001|COMPLETED|Overall Study||166||
60152312|NCT01492400|76277601|FG000|NOT COMPLETED|Overall Study||16||
60152313|NCT01492400|76277602|FG001|NOT COMPLETED|Overall Study||16||
60152314|NCT00168337|76277611|FG000|STARTED|Overall Study||188||
60152315|NCT00168337|76277612|FG001|STARTED|Overall Study||181||
60152316|NCT00168337|76277613|FG002|STARTED|Overall Study||185||
60152317|NCT00168337|76277611|FG000|COMPLETED|Overall Study||118||
60152318|NCT00168337|76277612|FG001|COMPLETED|Overall Study||112||
60152319|NCT00168337|76277613|FG002|COMPLETED|Overall Study||82||
60152320|NCT00168337|76277611|FG000|NOT COMPLETED|Overall Study||70||
60152321|NCT00168337|76277612|FG001|NOT COMPLETED|Overall Study||69||
60152322|NCT00168337|76277613|FG002|NOT COMPLETED|Overall Study||103||
60152323|NCT01515657|76277621|FG000|STARTED|First Intervention||14||
60152324|NCT01515657|76277622|FG001|STARTED|First Intervention||13||
60152325|NCT01515657|76277623|FG002|STARTED|First Intervention||13||
60152326|NCT01515657|76277621|FG000|COMPLETED|First Intervention||14||
60152327|NCT01515657|76277622|FG001|COMPLETED|First Intervention||12||
60152328|NCT01515657|76277623|FG002|COMPLETED|First Intervention||13||
60152329|NCT01515657|76277621|FG000|NOT COMPLETED|First Intervention||0||
60152330|NCT01515657|76277622|FG001|NOT COMPLETED|First Intervention||1||
60152331|NCT01515657|76277623|FG002|NOT COMPLETED|First Intervention||0||
60152332|NCT01515657|76277621|FG000|STARTED|Second Intervention||14||
60152333|NCT01515657|76277622|FG001|STARTED|Second Intervention||12||
60152334|NCT01515657|76277623|FG002|STARTED|Second Intervention||13||
60152335|NCT01515657|76277621|FG000|COMPLETED|Second Intervention||14||
60152336|NCT01515657|76277622|FG001|COMPLETED|Second Intervention||11||
60152337|NCT01515657|76277623|FG002|COMPLETED|Second Intervention||13||
60152338|NCT01515657|76277621|FG000|NOT COMPLETED|Second Intervention||0||
60152339|NCT01515657|76277622|FG001|NOT COMPLETED|Second Intervention||1||
60152340|NCT01515657|76277623|FG002|NOT COMPLETED|Second Intervention||0||
60152341|NCT01515657|76277621|FG000|STARTED|Third Intervention||14||
60152342|NCT01515657|76277622|FG001|STARTED|Third Intervention||11||
60152343|NCT01515657|76277623|FG002|STARTED|Third Intervention||13||
60152344|NCT01515657|76277621|FG000|COMPLETED|Third Intervention||13||
60152345|NCT01515657|76277622|FG001|COMPLETED|Third Intervention||11||
60152346|NCT01515657|76277623|FG002|COMPLETED|Third Intervention||13||
60152347|NCT01515657|76277621|FG000|NOT COMPLETED|Third Intervention||1||
60152348|NCT01515657|76277622|FG001|NOT COMPLETED|Third Intervention||0||
60152349|NCT01515657|76277623|FG002|NOT COMPLETED|Third Intervention||0||
60152350|NCT01515891|76277631|FG000|STARTED|Overall Study||4||
60152351|NCT01515891|76277631|FG000|COMPLETED|Overall Study||4||
60152352|NCT01515891|76277631|FG000|NOT COMPLETED|Overall Study||0||
60152353|NCT00073957|76277635|FG000|STARTED|Overall Study||25||
60152354|NCT00073957|76277635|FG000|COMPLETED|Overall Study||25||
60152355|NCT00073957|76277635|FG000|NOT COMPLETED|Overall Study||0||
60152356|NCT04354428|76277646|FG000|STARTED|Overall Study||83||
60152357|NCT04354428|76277647|FG001|STARTED|Overall Study||71||
60152358|NCT04354428|76277648|FG002|STARTED|Overall Study||77||
60152359|NCT04354428|76277649|FG003|STARTED|Overall Study||29||
60152360|NCT04354428|76277650|FG004|STARTED|Overall Study||29||
60152361|NCT04354428|76277646|FG000|Completed Enrollment|Overall Study||80||
60152362|NCT04354428|76277647|FG001|Completed Enrollment|Overall Study||65||
60152363|NCT04354428|76277648|FG002|Completed Enrollment|Overall Study||74||
60152364|NCT04354428|76277649|FG003|Completed Enrollment|Overall Study||27||
60152365|NCT04354428|76277650|FG004|Completed Enrollment|Overall Study||28||
60152366|NCT04354428|76277646|FG000|COMPLETED|Overall Study||75||
60152367|NCT04354428|76277647|FG001|COMPLETED|Overall Study||62||
60152368|NCT04354428|76277648|FG002|COMPLETED|Overall Study||71||
60152369|NCT04354428|76277649|FG003|COMPLETED|Overall Study||19||
60152370|NCT04354428|76277650|FG004|COMPLETED|Overall Study||25||
60152371|NCT04354428|76277646|FG000|NOT COMPLETED|Overall Study||8||
60152372|NCT04354428|76277647|FG001|NOT COMPLETED|Overall Study||9||
60152373|NCT04354428|76277648|FG002|NOT COMPLETED|Overall Study||6||
60152374|NCT04354428|76277649|FG003|NOT COMPLETED|Overall Study||10||
60152375|NCT04354428|76277650|FG004|NOT COMPLETED|Overall Study||4||
60152376|NCT01517529|76277662|FG000|STARTED|Overall Study||10||
60152377|NCT01517529|76277662|FG000|COMPLETED|Overall Study||10||
60152378|NCT01517529|76277662|FG000|NOT COMPLETED|Overall Study||0||
60152379|NCT01589601|76277668|FG000|STARTED|Overall Study||75||
60152380|NCT01589601|76277669|FG001|STARTED|Overall Study||75||
60152381|NCT01589601|76277668|FG000|COMPLETED|Overall Study||28||
60152382|NCT01589601|76277669|FG001|COMPLETED|Overall Study||26||
60152383|NCT01589601|76277668|FG000|NOT COMPLETED|Overall Study||47||
60152384|NCT01589601|76277669|FG001|NOT COMPLETED|Overall Study||49||
60152385|NCT02090075|76277677|FG000|STARTED|Overall Study||33||
60152386|NCT02090075|76277678|FG001|STARTED|Overall Study||33||
60152387|NCT02090075|76277677|FG000|COMPLETED|Overall Study||26||
60152388|NCT02090075|76277678|FG001|COMPLETED|Overall Study||30||
60152389|NCT02090075|76277677|FG000|NOT COMPLETED|Overall Study||7||
60152390|NCT02090075|76277678|FG001|NOT COMPLETED|Overall Study||3||
60152391|NCT01591005|76277688|FG000|STARTED|Overall Study||53||
60152392|NCT01591005|76277689|FG001|STARTED|Overall Study||53||
60152393|NCT01591005|76277690|FG002|STARTED|Overall Study||68||
60152394|NCT01591005|76277691|FG003|STARTED|Overall Study||68||
60152395|NCT01591005|76277688|FG000|COMPLETED|Overall Study||53||
60152396|NCT01591005|76277689|FG001|COMPLETED|Overall Study||53||
60152397|NCT01591005|76277690|FG002|COMPLETED|Overall Study||68||
60152398|NCT01591005|76277691|FG003|COMPLETED|Overall Study||68||
60152399|NCT01591005|76277688|FG000|NOT COMPLETED|Overall Study||0||
60152400|NCT01591005|76277689|FG001|NOT COMPLETED|Overall Study||0||
60152401|NCT01591005|76277690|FG002|NOT COMPLETED|Overall Study||0||
60152402|NCT01591005|76277691|FG003|NOT COMPLETED|Overall Study||0||
60152403|NCT02210247|76277706|FG000|STARTED|Overall Study||12||
60152404|NCT02210247|76277707|FG001|STARTED|Overall Study||12||
60152405|NCT02210247|76277708|FG002|STARTED|Overall Study||12||
60152406|NCT02210247|76277709|FG003|STARTED|Overall Study||12||
60152407|NCT02210247|76277710|FG004|STARTED|Overall Study||12||
60152408|NCT02210247|76277706|FG000|COMPLETED|Overall Study||12||
60152409|NCT02210247|76277707|FG001|COMPLETED|Overall Study||12||
60152410|NCT02210247|76277708|FG002|COMPLETED|Overall Study||12||
60152411|NCT02210247|76277709|FG003|COMPLETED|Overall Study||12||
60152412|NCT02210247|76277710|FG004|COMPLETED|Overall Study||12||
60152413|NCT02210247|76277706|FG000|NOT COMPLETED|Overall Study||0||
60152414|NCT02210247|76277707|FG001|NOT COMPLETED|Overall Study||0||
60152415|NCT02210247|76277708|FG002|NOT COMPLETED|Overall Study||0||
60152416|NCT02210247|76277709|FG003|NOT COMPLETED|Overall Study||0||
60152417|NCT02210247|76277710|FG004|NOT COMPLETED|Overall Study||0||
60152418|NCT02596854|76277727|FG000|STARTED|Overall Study||117||
60152419|NCT02596854|76277727|FG000|COMPLETED|Overall Study||109||
60152420|NCT02596854|76277727|FG000|NOT COMPLETED|Overall Study||8||
60152421|NCT01591161|76277733|FG000|STARTED|Overall Study||245||
60152422|NCT01591161|76277734|FG001|STARTED|Overall Study||124||
60152423|NCT01591161|76277733|FG000|COMPLETED|Overall Study||174||
60152424|NCT01591161|76277734|FG001|COMPLETED|Overall Study||68||
60152425|NCT01591161|76277733|FG000|NOT COMPLETED|Overall Study||71||
60152426|NCT01591161|76277734|FG001|NOT COMPLETED|Overall Study||56||
60152427|NCT02211495|76277742|FG000|STARTED|Overall Study||4||
60152428|NCT02211495|76277743|FG001|STARTED|Overall Study||4||
60152429|NCT02211495|76277742|FG000|COMPLETED|Overall Study||4||
60152430|NCT02211495|76277743|FG001|COMPLETED|Overall Study||4||
60152431|NCT02211495|76277742|FG000|NOT COMPLETED|Overall Study||0||
60152432|NCT02211495|76277743|FG001|NOT COMPLETED|Overall Study||0||
60152433|NCT00074035|76277753|FG000|STARTED|Overall Study||38||
60152434|NCT00074035|76277753|FG000|COMPLETED|Overall Study||38||
60152435|NCT00074035|76277753|FG000|NOT COMPLETED|Overall Study||0||
60152436|NCT02319317|76277759|FG000|STARTED|Overall Study||31||
60152437|NCT02319317|76277760|FG001|STARTED|Overall Study||29||
60152438|NCT02319317|76277759|FG000|COMPLETED|Overall Study||31||
60152439|NCT02319317|76277760|FG001|COMPLETED|Overall Study||29||
60152440|NCT02319317|76277759|FG000|NOT COMPLETED|Overall Study||0||
60152441|NCT02319317|76277760|FG001|NOT COMPLETED|Overall Study||0||
60152442|NCT01591317|76277769|FG000|STARTED|Overall Study||10||
60152443|NCT01591317|76277770|FG001|STARTED|Overall Study||10||
60152444|NCT01591317|76277771|FG002|STARTED|Overall Study||10||
60152445|NCT01591317|76277769|FG000|COMPLETED|Overall Study||10||
60152446|NCT01591317|76277770|FG001|COMPLETED|Overall Study||10||
60152447|NCT01591317|76277771|FG002|COMPLETED|Overall Study||10||
60152448|NCT01591317|76277769|FG000|NOT COMPLETED|Overall Study||0||
60152449|NCT01591317|76277770|FG001|NOT COMPLETED|Overall Study||0||
60152450|NCT01591317|76277771|FG002|NOT COMPLETED|Overall Study||0||
60152451|NCT00074815|76277787|FG000|STARTED|Overall Study||42||
60152452|NCT00074815|76277788|FG001|STARTED|Overall Study||40||
60152453|NCT00074815|76277789|FG002|STARTED|Overall Study||42||
60152454|NCT00074815|76277787|FG000|COMPLETED|Overall Study||37||
60152455|NCT00074815|76277788|FG001|COMPLETED|Overall Study||34||
60152456|NCT00074815|76277789|FG002|COMPLETED|Overall Study||30||
60152457|NCT00074815|76277787|FG000|NOT COMPLETED|Overall Study||5||
60152458|NCT00074815|76277788|FG001|NOT COMPLETED|Overall Study||6||
60152459|NCT00074815|76277789|FG002|NOT COMPLETED|Overall Study||12||
60152460|NCT01592799|76277797|FG000|STARTED|Overall Study||501||
60152461|NCT01592799|76277797|FG000|COMPLETED|Overall Study||501||
60152462|NCT01592799|76277797|FG000|NOT COMPLETED|Overall Study||0||
60152463|NCT01519713|76277806|FG000|STARTED|Overall Study||194||
60152464|NCT01519713|76277807|FG001|STARTED|Overall Study||2||
60152465|NCT01519713|76277808|FG002|STARTED|Overall Study||4||
60152466|NCT01519713|76277806|FG000|COMPLETED|Overall Study||194||
60152467|NCT01519713|76277807|FG001|COMPLETED|Overall Study||2||
60152468|NCT01519713|76277808|FG002|COMPLETED|Overall Study||4||
60152469|NCT01519713|76277806|FG000|NOT COMPLETED|Overall Study||0||
60152470|NCT01519713|76277807|FG001|NOT COMPLETED|Overall Study||0||
60152471|NCT01519713|76277808|FG002|NOT COMPLETED|Overall Study||0||
60152472|NCT02090777|76277816|FG000|STARTED|Overall Study||4||
60152473|NCT02090777|76277816|FG000|COMPLETED|Overall Study||4||
60152474|NCT02090777|76277816|FG000|NOT COMPLETED|Overall Study||0||
60152475|NCT00075829|76277824|FG000|STARTED|Overall Study||436||
60152476|NCT00075829|76277825|FG001|STARTED|Overall Study||189||
60152477|NCT00075829|76277826|FG002|STARTED|Overall Study||48||
60152478|NCT00075829|76277827|FG003|STARTED|Overall Study||37||
60152479|NCT00075829|76277824|FG000|COMPLETED|Overall Study|Participants that were alive and free of disease progression at the end of follow-up (3 years)|178||
60152480|NCT00075829|76277825|FG001|COMPLETED|Overall Study|Participants that were alive and free of disease progression at the end of follow-up (3 years)|71||
60152481|NCT00075829|76277826|FG002|COMPLETED|Overall Study|Participants that were alive and free of disease progression at the end of follow-up (3 years)|14||
60152482|NCT00075829|76277827|FG003|COMPLETED|Overall Study|Participants that were alive and free of disease progression at the end of follow-up (3 years)|13||
60152483|NCT00075829|76277824|FG000|NOT COMPLETED|Overall Study||258||
60152484|NCT00075829|76277825|FG001|NOT COMPLETED|Overall Study||118||
60152485|NCT00075829|76277826|FG002|NOT COMPLETED|Overall Study||34||
60152486|NCT00075829|76277827|FG003|NOT COMPLETED|Overall Study||24||
60152487|NCT02218203|76277840|FG000|STARTED|Overall Study||26||
60010874|NCT00121719|76126560|FG009|NOT COMPLETED|Dose Escalation (4 Weeks)||0||
60010875|NCT00121719|76126561|FG010|NOT COMPLETED|Dose Escalation (4 Weeks)||0||
60010876|NCT00121719|76126562|FG011|NOT COMPLETED|Dose Escalation (4 Weeks)||0||
60010877|NCT00121719|76126563|FG012|NOT COMPLETED|Dose Escalation (4 Weeks)||0||
60010878|NCT00121719|76126564|FG013|NOT COMPLETED|Dose Escalation (4 Weeks)||0||
60010879|NCT00121719|76126551|FG000|STARTED|Food-Effect Pilot Study (4 Weeks)||0||
60010880|NCT00121719|76126552|FG001|STARTED|Food-Effect Pilot Study (4 Weeks)||0||
60010881|NCT00121719|76126553|FG002|STARTED|Food-Effect Pilot Study (4 Weeks)||0||
60010882|NCT00121719|76126554|FG003|STARTED|Food-Effect Pilot Study (4 Weeks)||0||
60010883|NCT00121719|76126555|FG004|STARTED|Food-Effect Pilot Study (4 Weeks)||0||
60010884|NCT00121719|76126556|FG005|STARTED|Food-Effect Pilot Study (4 Weeks)||0||
60010885|NCT00121719|76126557|FG006|STARTED|Food-Effect Pilot Study (4 Weeks)||0||
60010886|NCT00121719|76126558|FG007|STARTED|Food-Effect Pilot Study (4 Weeks)||0||
60010887|NCT00121719|76126559|FG008|STARTED|Food-Effect Pilot Study (4 Weeks)||0||
60010888|NCT00121719|76126560|FG009|STARTED|Food-Effect Pilot Study (4 Weeks)||0||
60010889|NCT00121719|76126561|FG010|STARTED|Food-Effect Pilot Study (4 Weeks)||6||
60010890|NCT00121719|76126562|FG011|STARTED|Food-Effect Pilot Study (4 Weeks)||5||
60010891|NCT00121719|76126563|FG012|STARTED|Food-Effect Pilot Study (4 Weeks)||0||
60010892|NCT00121719|76126564|FG013|STARTED|Food-Effect Pilot Study (4 Weeks)||0||
60010893|NCT00121719|76126551|FG000|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0||
60010894|NCT00121719|76126552|FG001|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0||
60010895|NCT00121719|76126553|FG002|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0||
60010896|NCT00121719|76126554|FG003|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0||
60010897|NCT00121719|76126555|FG004|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0||
60010898|NCT00121719|76126556|FG005|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0||
60010899|NCT00121719|76126557|FG006|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0||
60010900|NCT00121719|76126558|FG007|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0||
60010901|NCT00121719|76126559|FG008|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0||
60010902|NCT00121719|76126560|FG009|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0||
60010903|NCT00121719|76126561|FG010|COMPLETED|Food-Effect Pilot Study (4 Weeks)||6||
60010904|NCT00121719|76126562|FG011|COMPLETED|Food-Effect Pilot Study (4 Weeks)||5||
60010905|NCT00121719|76126563|FG012|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0||
60010906|NCT00121719|76126564|FG013|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0||
60010907|NCT00121719|76126551|FG000|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0||
60010908|NCT00121719|76126552|FG001|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0||
60010909|NCT00121719|76126553|FG002|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0||
60010910|NCT00121719|76126554|FG003|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0||
60010911|NCT00121719|76126555|FG004|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0||
60010912|NCT00121719|76126556|FG005|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0||
60010913|NCT00121719|76126557|FG006|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0||
60010914|NCT00121719|76126558|FG007|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0||
60010915|NCT00121719|76126559|FG008|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0||
60010916|NCT00121719|76126560|FG009|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0||
60010917|NCT00121719|76126561|FG010|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0||
60010918|NCT00121719|76126562|FG011|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0||
60010919|NCT00121719|76126563|FG012|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0||
60010920|NCT00121719|76126564|FG013|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0||
60010921|NCT03081767|76126606|FG000|STARTED|Overall Study||199||
60010922|NCT03081767|76126606|FG000|COMPLETED|Overall Study||199||
60010923|NCT03081767|76126606|FG000|NOT COMPLETED|Overall Study||0||
60010924|NCT02637557|76126616|FG000|STARTED|Overall Study||71||
60010925|NCT02637557|76126617|FG001|STARTED|Overall Study||71||
60010926|NCT02637557|76126618|FG002|STARTED|Overall Study||71||
60010927|NCT02637557|76126619|FG003|STARTED|Overall Study||69||
60010928|NCT02637557|76126616|FG000|COMPLETED|Overall Study||63||
60010929|NCT02637557|76126617|FG001|COMPLETED|Overall Study||66||
60010930|NCT02637557|76126618|FG002|COMPLETED|Overall Study||62||
60152488|NCT02218203|76277840|FG000|Placebo Dex v. 0mg/km LBM Lidocaine|Overall Study||24||
60152489|NCT02218203|76277840|FG000|Placebo Dex v. 1mg/km LBM Lidocaine|Overall Study||24||
60152490|NCT02218203|76277840|FG000|Placebo Dex v. 2mg/km LBM Lidocaine|Overall Study||24||
60152491|NCT02218203|76277840|FG000|Placebo Dex v. 4mg/km LBM Lidocaine|Overall Study||24||
60152492|NCT02218203|76277840|FG000|Low Dose Dex v. 0mg/km LBM Lidocaine|Overall Study||26||
60152493|NCT02218203|76277840|FG000|Low Dose Dex v. 1mg/km LBM Lidocaine|Overall Study||26||
60152494|NCT02218203|76277840|FG000|Low Dose Dex v. 2mg/km LBM Lidocaine|Overall Study||26||
60152495|NCT02218203|76277840|FG000|Low Dose Dex v. 4mg/km LBM Lidocaine|Overall Study||26||
60152496|NCT02218203|76277840|FG000|Medium Dose Dex v. 0mg/km LBM Lidocaine|Overall Study||24||
60152497|NCT02218203|76277840|FG000|Medium Dose Dex v. 1mg/km LBM Lidocaine|Overall Study||24||
60152498|NCT02218203|76277840|FG000|Medium Dose Dex v. 2mg/km LBM Lidocaine|Overall Study||24||
60152499|NCT02218203|76277840|FG000|Medium Dose Dex v. 4mg/km LBM Lidocaine|Overall Study||24||
60152500|NCT02218203|76277840|FG000|High Dose Dex v. 0mg/km LBM Lidocaine|Overall Study||24||
60152501|NCT02218203|76277840|FG000|High Dose Dex v. 1mg/km LBM Lidocaine|Overall Study||24||
60152502|NCT02218203|76277840|FG000|High Dose Dex v. 2mg/km LBM Lidocaine|Overall Study||24||
60152503|NCT02218203|76277840|FG000|High Dose Dex v. 4mg/km LBM Lidocaine|Overall Study||24||
60152504|NCT02218203|76277840|FG000|COMPLETED|Overall Study|2 subjects did not complete the placebo, medium dose, and high dose dex/lido combination arms.|26||
60152505|NCT02218203|76277840|FG000|NOT COMPLETED|Overall Study||0||
60152506|NCT02592876|76277864|FG000|STARTED|Overall Study||41||
60152507|NCT02592876|76277865|FG001|STARTED|Overall Study||40||
60152508|NCT02592876|76277864|FG000|Received Study Drug|Overall Study||40||
60152509|NCT02592876|76277865|FG001|Received Study Drug|Overall Study||40||
60152510|NCT02592876|76277864|FG000|Completed Treatment|Overall Study||34||
59751602|NCT00969761|75870897|FG008|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||11||
59751603|NCT00969761|75870898|FG009|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||2||
59751604|NCT00969761|75870899|FG010|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||3||
59751605|NCT00969761|75870900|FG011|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||3||
60152511|NCT02592876|76277865|FG001|Completed Treatment|Overall Study||32||
59605800|NCT01964976|75715950|FG000|STARTED|Overall Study|Data reports overall population,since data not collected separately per arm as specified in protocol|1096||
60010931|NCT02637557|76126619|FG003|COMPLETED|Overall Study||62||
59605801|NCT01964976|75715950|FG000|COMPLETED|Overall Study||1065||
59605802|NCT01964976|75715950|FG000|NOT COMPLETED|Overall Study||31||
59605803|NCT01964898|75715959|FG000|STARTED|Overall Study||31||
59751606|NCT00845871|75870926|FG000|STARTED|Run-in Period||65||
59751607|NCT00845871|75870926|FG000|COMPLETED|Run-in Period||65||
59751608|NCT00845871|75870926|FG000|NOT COMPLETED|Run-in Period||0||
59751609|NCT00845871|75870926|FG000|STARTED|Assessment Period||65||
59751610|NCT00845871|75870926|FG000|COMPLETED|Assessment Period||58||
59751611|NCT00845871|75870926|FG000|NOT COMPLETED|Assessment Period||7||
59751612|NCT00915278|75870956|FG000|STARTED|Overall Study||8||
59751613|NCT00915278|75870957|FG001|STARTED|Overall Study||5||
59751614|NCT00915278|75870958|FG002|STARTED|Overall Study||3||
59751615|NCT00915278|75870959|FG003|STARTED|Overall Study||5||
59751616|NCT00915278|75870960|FG004|STARTED|Overall Study||3||
59751617|NCT00915278|75870961|FG005|STARTED|Overall Study||9||
59751618|NCT00915278|75870956|FG000|COMPLETED|Overall Study||3||
59751619|NCT00915278|75870957|FG001|COMPLETED|Overall Study||2||
59751620|NCT00915278|75870958|FG002|COMPLETED|Overall Study||2||
60010932|NCT02637557|76126616|FG000|NOT COMPLETED|Overall Study||8||
60010933|NCT02637557|76126617|FG001|NOT COMPLETED|Overall Study||5||
60010934|NCT02637557|76126618|FG002|NOT COMPLETED|Overall Study||9||
60010935|NCT02637557|76126619|FG003|NOT COMPLETED|Overall Study||7||
60010936|NCT02638493|76126632|FG000|STARTED|Overall Study|Two men were not able to provide semen samples, and thus were replaced|10||
60010937|NCT02638493|76126633|FG001|STARTED|Overall Study||8||
60010938|NCT02638493|76126634|FG002|STARTED|Overall Study||8||
59751621|NCT00915278|75870959|FG003|COMPLETED|Overall Study||2||
59751622|NCT00915278|75870960|FG004|COMPLETED|Overall Study||1||
59751623|NCT00915278|75870961|FG005|COMPLETED|Overall Study||1||
59751624|NCT00915278|75870956|FG000|NOT COMPLETED|Overall Study||5||
59751625|NCT00915278|75870957|FG001|NOT COMPLETED|Overall Study||3||
59751626|NCT00915278|75870958|FG002|NOT COMPLETED|Overall Study||1||
59751627|NCT00915278|75870959|FG003|NOT COMPLETED|Overall Study||3||
59751628|NCT00915278|75870960|FG004|NOT COMPLETED|Overall Study||2||
59751629|NCT00915278|75870961|FG005|NOT COMPLETED|Overall Study||8||
59751630|NCT00844857|75870977|FG000|STARTED|Overall Study||194||
59751631|NCT00844857|75870978|FG001|STARTED|Overall Study||97||
59751632|NCT00844857|75870977|FG000|Population Analyzed|Overall Study|Randomized participants who took at least 1 dose of study drug excluding 2 GCP noncompliant sites.|170||
59751633|NCT00844857|75870978|FG001|Population Analyzed|Overall Study|randomized participants who took at least 1 dose of study drug excluding 2 GCP noncompliant sites.|85||
60010939|NCT02638493|76126632|FG000|COMPLETED|Overall Study||8||
60152512|NCT02592876|76277864|FG000|COMPLETED|Overall Study||0||
60152513|NCT02592876|76277865|FG001|COMPLETED|Overall Study||0||
60152514|NCT02592876|76277864|FG000|NOT COMPLETED|Overall Study||41||
60152515|NCT02592876|76277865|FG001|NOT COMPLETED|Overall Study||40||
60152516|NCT00176839|76277871|FG000|STARTED|Overall Study||11||
60152517|NCT00176839|76277871|FG000|COMPLETED|Overall Study||11||
60152518|NCT00176839|76277871|FG000|NOT COMPLETED|Overall Study||0||
60152519|NCT00176917|76277875|FG000|STARTED|Overall Study||41||
60152520|NCT00176917|76277875|FG000|COMPLETED|Overall Study||41||
60152521|NCT00176917|76277875|FG000|NOT COMPLETED|Overall Study||0||
60152522|NCT01492088|76277882|FG000|STARTED|Overall Study||3||
60152523|NCT01492088|76277883|FG001|STARTED|Overall Study||16||
60152524|NCT01492088|76277884|FG002|STARTED|Overall Study||17||
60152525|NCT01492088|76277882|FG000|COMPLETED|Overall Study||0||
60152526|NCT01492088|76277883|FG001|COMPLETED|Overall Study||2||
59751634|NCT00844857|75870977|FG000|COMPLETED|Overall Study||116||
59751635|NCT00844857|75870978|FG001|COMPLETED|Overall Study||60||
60010940|NCT02638493|76126633|FG001|COMPLETED|Overall Study||8||
60152527|NCT01492088|76277884|FG002|COMPLETED|Overall Study||3||
60152528|NCT01492088|76277882|FG000|NOT COMPLETED|Overall Study||3||
60152529|NCT01492088|76277883|FG001|NOT COMPLETED|Overall Study||14||
60152530|NCT01492088|76277884|FG002|NOT COMPLETED|Overall Study||14||
60152531|NCT01594515|76277905|FG000|STARTED|Overall Study||6||
60152532|NCT01594515|76277906|FG001|STARTED|Overall Study||6||
60152533|NCT01594515|76277907|FG002|STARTED|Overall Study||6||
60152534|NCT01594515|76277908|FG003|STARTED|Overall Study||6||
60152535|NCT01594515|76277909|FG004|STARTED|Overall Study||6||
59751636|NCT00844857|75870977|FG000|NOT COMPLETED|Overall Study||78||
59882177|NCT03988803|76005082|FG000|Started Days 8 - 14: Multiple Doses of 10 mg Memantine qd|Period 2||14||
60152536|NCT01594515|76277910|FG005|STARTED|Overall Study||6||
60152537|NCT01594515|76277911|FG006|STARTED|Overall Study||6||
60152538|NCT01594515|76277912|FG007|STARTED|Overall Study||6||
60152539|NCT01594515|76277913|FG008|STARTED|Overall Study||6||
60152540|NCT01594515|76277914|FG009|STARTED|Overall Study||16||
60152541|NCT01594515|76277905|FG000|COMPLETED|Overall Study||6||
60152542|NCT01594515|76277906|FG001|COMPLETED|Overall Study||6||
59751637|NCT00844857|75870978|FG001|NOT COMPLETED|Overall Study||37||
59751638|NCT00569803|75870995|FG000|STARTED|Overall Study||5||
59751639|NCT00569803|75870996|FG001|STARTED|Overall Study||5||
59751640|NCT00569803|75870997|FG002|STARTED|Overall Study||5||
59751641|NCT00569803|75870998|FG003|STARTED|Overall Study||6||
59751642|NCT00569803|75870999|FG004|STARTED|Overall Study||5||
59751643|NCT00569803|75871000|FG005|STARTED|Overall Study||5||
59882178|NCT03988803|76005082|FG000|Started Days 15 - 21: Multiple Doses of 15 mg Memantine qd|Period 2||13||
59882179|NCT03988803|76005082|FG000|Started Days 22 - 35: Multiple Doses of 20 mg Memantine qd|Period 2||13||
59882180|NCT03988803|76005082|FG000|COMPLETED|Period 2||13||
59882181|NCT03988803|76005082|FG000|NOT COMPLETED|Period 2||3||
59882182|NCT03988803|76005082|FG000|STARTED|Period 3||13||
59882183|NCT03988803|76005082|FG000|COMPLETED|Period 3||13||
59882184|NCT03988803|76005082|FG000|NOT COMPLETED|Period 3||0||
59882185|NCT00181883|76005090|FG000|STARTED|Overall Study||30||
60010941|NCT02638493|76126634|FG002|COMPLETED|Overall Study||8||
60010942|NCT02638493|76126632|FG000|NOT COMPLETED|Overall Study||2||
60010943|NCT02638493|76126633|FG001|NOT COMPLETED|Overall Study||0||
60010944|NCT02638493|76126634|FG002|NOT COMPLETED|Overall Study||0||
60010945|NCT02638337|76126644|FG000|STARTED|Overall Study||316||
60010946|NCT02638337|76126645|FG001|STARTED|Overall Study||315||
60010947|NCT02638337|76126644|FG000|Received Treatment|Overall Study||313||
60010948|NCT02638337|76126645|FG001|Received Treatment|Overall Study||315||
60010949|NCT02638337|76126644|FG000|COMPLETED|Overall Study||283||
60010950|NCT02638337|76126645|FG001|COMPLETED|Overall Study||279||
60010951|NCT02638337|76126644|FG000|NOT COMPLETED|Overall Study||33||
60010952|NCT02638337|76126645|FG001|NOT COMPLETED|Overall Study||36||
60010953|NCT02638259|76126653|FG000|STARTED|Treatment Period 1||186||
60010954|NCT02638259|76126654|FG001|STARTED|Treatment Period 1||190||
60010955|NCT02638259|76126653|FG000|COMPLETED|Treatment Period 1||181||
60010956|NCT02638259|76126654|FG001|COMPLETED|Treatment Period 1||172||
60010957|NCT02638259|76126653|FG000|NOT COMPLETED|Treatment Period 1||5||
60010958|NCT02638259|76126654|FG001|NOT COMPLETED|Treatment Period 1||18||
60010959|NCT02638259|76126653|FG000|STARTED|Treatment Period 2|6 patients did not proceed to TP2 (3 not eligible, 2 consent withdrawal, 1 IP delay)|175||
60010960|NCT02638259|76126654|FG001|STARTED|Treatment Period 2|6 patients did not proceed to TP2 (4 not eligible, 1 consent withdrawal, 1 adverse event).|166||
60010961|NCT02638259|76126653|FG000|COMPLETED|Treatment Period 2||169||
60010962|NCT02638259|76126654|FG001|COMPLETED|Treatment Period 2||155||
60010963|NCT02638259|76126653|FG000|NOT COMPLETED|Treatment Period 2||6||
60010964|NCT02638259|76126654|FG001|NOT COMPLETED|Treatment Period 2||11||
60010965|NCT02637323|76126666|FG000|STARTED|Overall Study||63||
60010966|NCT02637323|76126667|FG001|STARTED|Overall Study||18||
60010967|NCT02637323|76126666|FG000|COMPLETED|Overall Study||61||
60010968|NCT02637323|76126667|FG001|COMPLETED|Overall Study||17||
60010969|NCT02637323|76126666|FG000|NOT COMPLETED|Overall Study||2||
60010970|NCT02637323|76126667|FG001|NOT COMPLETED|Overall Study||1||
60010971|NCT03573817|76126676|FG000|STARTED|Overall Study||63||
60010972|NCT03573817|76126677|FG001|STARTED|Overall Study||59||
60152543|NCT01594515|76277907|FG002|COMPLETED|Overall Study||6||
60152544|NCT01594515|76277908|FG003|COMPLETED|Overall Study||6||
60152545|NCT01594515|76277909|FG004|COMPLETED|Overall Study||6||
60152546|NCT01594515|76277910|FG005|COMPLETED|Overall Study||6||
60152547|NCT01594515|76277911|FG006|COMPLETED|Overall Study||6||
60152548|NCT01594515|76277912|FG007|COMPLETED|Overall Study||6||
60152549|NCT01594515|76277913|FG008|COMPLETED|Overall Study||6||
60152550|NCT01594515|76277914|FG009|COMPLETED|Overall Study||16||
60152551|NCT01594515|76277905|FG000|NOT COMPLETED|Overall Study||0||
60152552|NCT01594515|76277906|FG001|NOT COMPLETED|Overall Study||0||
60152553|NCT01594515|76277907|FG002|NOT COMPLETED|Overall Study||0||
60152554|NCT01594515|76277908|FG003|NOT COMPLETED|Overall Study||0||
60152555|NCT01594515|76277909|FG004|NOT COMPLETED|Overall Study||0||
60152556|NCT01594515|76277910|FG005|NOT COMPLETED|Overall Study||0||
59751644|NCT00569803|75871001|FG006|STARTED|Overall Study||10||
59751645|NCT00569803|75871002|FG007|STARTED|Overall Study||6||
60010973|NCT03573817|76126676|FG000|Randomized and Treated With Study Drug|Overall Study||63||
60010974|NCT03573817|76126677|FG001|Randomized and Treated With Study Drug|Overall Study||59||
60010975|NCT03573817|76126676|FG000|COMPLETED|Overall Study||62||
60152557|NCT01594515|76277911|FG006|NOT COMPLETED|Overall Study||0||
60152558|NCT01594515|76277912|FG007|NOT COMPLETED|Overall Study||0||
60152559|NCT01594515|76277913|FG008|NOT COMPLETED|Overall Study||0||
60152560|NCT01594515|76277914|FG009|NOT COMPLETED|Overall Study||0||
60152561|NCT01520727|76277945|FG000|STARTED|Overall Study||6||
60152562|NCT01520727|76277946|FG001|STARTED|Overall Study||6||
60152563|NCT01520727|76277947|FG002|STARTED|Overall Study||6||
60152564|NCT01520727|76277948|FG003|STARTED|Overall Study||6||
60152565|NCT01520727|76277949|FG004|STARTED|Overall Study||6||
60152566|NCT01520727|76277950|FG005|STARTED|Overall Study||6||
60152567|NCT01520727|76277951|FG006|STARTED|Overall Study||6||
60152568|NCT01520727|76277952|FG007|STARTED|Overall Study||6||
60152569|NCT01520727|76277953|FG008|STARTED|Overall Study||16||
60152570|NCT01520727|76277945|FG000|COMPLETED|Overall Study||6||
60152571|NCT01520727|76277946|FG001|COMPLETED|Overall Study||6||
60152572|NCT01520727|76277947|FG002|COMPLETED|Overall Study||6||
60152573|NCT01520727|76277948|FG003|COMPLETED|Overall Study||6||
60152574|NCT01520727|76277949|FG004|COMPLETED|Overall Study||6||
60152575|NCT01520727|76277950|FG005|COMPLETED|Overall Study||6||
60152576|NCT01520727|76277951|FG006|COMPLETED|Overall Study||6||
60152577|NCT01520727|76277952|FG007|COMPLETED|Overall Study||6||
60152578|NCT01520727|76277953|FG008|COMPLETED|Overall Study||16||
60152579|NCT01520727|76277945|FG000|NOT COMPLETED|Overall Study||0||
60152580|NCT01520727|76277946|FG001|NOT COMPLETED|Overall Study||0||
60152581|NCT01520727|76277947|FG002|NOT COMPLETED|Overall Study||0||
60152582|NCT01520727|76277948|FG003|NOT COMPLETED|Overall Study||0||
60152583|NCT01520727|76277949|FG004|NOT COMPLETED|Overall Study||0||
60152584|NCT01520727|76277950|FG005|NOT COMPLETED|Overall Study||0||
60152585|NCT01520727|76277951|FG006|NOT COMPLETED|Overall Study||0||
60152586|NCT01520727|76277952|FG007|NOT COMPLETED|Overall Study||0||
60152587|NCT01520727|76277953|FG008|NOT COMPLETED|Overall Study||0||
60152588|NCT01596231|76277975|FG000|STARTED|Overall Study||10||
60152589|NCT01596231|76277976|FG001|STARTED|Overall Study||10||
60152590|NCT01596231|76277975|FG000|COMPLETED|Overall Study||10||
60152591|NCT01596231|76277976|FG001|COMPLETED|Overall Study||10||
60152592|NCT01596231|76277975|FG000|NOT COMPLETED|Overall Study||0||
60152593|NCT01596231|76277976|FG001|NOT COMPLETED|Overall Study||0||
60152594|NCT01596699|76277984|FG000|STARTED|Overall Study||10||
60152595|NCT01596699|76277985|FG001|STARTED|Overall Study||6||
60152596|NCT01596699|76277984|FG000|COMPLETED|Overall Study||10||
60152597|NCT01596699|76277985|FG001|COMPLETED|Overall Study||6||
60152598|NCT01596699|76277984|FG000|NOT COMPLETED|Overall Study||0||
60152599|NCT01596699|76277985|FG001|NOT COMPLETED|Overall Study||0||
60152600|NCT01522131|76277994|FG000|STARTED|Overall Study||16||
60152601|NCT01522131|76277995|FG001|STARTED|Overall Study||17||
60152602|NCT01522131|76277994|FG000|COMPLETED|Overall Study||14||
60152603|NCT01522131|76277995|FG001|COMPLETED|Overall Study||17||
59751646|NCT00569803|75870995|FG000|COMPLETED|Overall Study||4||
59751647|NCT00569803|75870996|FG001|COMPLETED|Overall Study||5||
59751648|NCT00569803|75870997|FG002|COMPLETED|Overall Study||5||
59751649|NCT00569803|75870998|FG003|COMPLETED|Overall Study||5||
59751650|NCT00569803|75870999|FG004|COMPLETED|Overall Study||5||
59751651|NCT00569803|75871000|FG005|COMPLETED|Overall Study||5||
59751652|NCT00569803|75871001|FG006|COMPLETED|Overall Study||10||
59882186|NCT00181883|76005090|FG000|COMPLETED|Overall Study||20||
59751653|NCT00569803|75871002|FG007|COMPLETED|Overall Study||5||
59751654|NCT00569803|75870995|FG000|NOT COMPLETED|Overall Study||1||
59751655|NCT00569803|75870996|FG001|NOT COMPLETED|Overall Study||0||
59882187|NCT00181883|76005090|FG000|NOT COMPLETED|Overall Study||10||
59882188|NCT00180713|76005096|FG000|STARTED|Overall Study||23||
60152604|NCT01522131|76277994|FG000|NOT COMPLETED|Overall Study||2||
60152605|NCT01522131|76277995|FG001|NOT COMPLETED|Overall Study||0||
60152606|NCT00076219|76278003|FG000|STARTED|Overall Study||563||
60152607|NCT00076219|76278004|FG001|STARTED|Overall Study||561||
60152608|NCT00076219|76278003|FG000|COMPLETED|Overall Study||545||
60152609|NCT00076219|76278004|FG001|COMPLETED|Overall Study||550||
60152610|NCT00076219|76278003|FG000|NOT COMPLETED|Overall Study||18||
60152611|NCT00076219|76278004|FG001|NOT COMPLETED|Overall Study||11||
60152612|NCT01522755|76278010|FG000|STARTED|Overall Study||409||
60152613|NCT01522755|76278010|FG000|COMPLETED|Overall Study||409||
60152614|NCT01522755|76278010|FG000|NOT COMPLETED|Overall Study||0||
60152615|NCT01523613|76278018|FG000|STARTED|Overall Study|- 30 single restorations (30 R)|30||30
60152616|NCT01523613|76278019|FG001|STARTED|Overall Study|- 30 single restorations (30 F)|30||30
60152617|NCT01523613|76278020|FG002|STARTED|Overall Study|- 66 paired restorations (33R + 33F)|33||66
60152618|NCT01523613|76278018|FG000|COMPLETED|Overall Study|- 23 single restorations (23R)|23||23
60152619|NCT01523613|76278019|FG001|COMPLETED|Overall Study|- 25 single restorations (25F)|25||25
60152620|NCT01523613|76278020|FG002|COMPLETED|Overall Study|- 42 paired restorations (21R and 21F)|21||42
60152621|NCT01523613|76278018|FG000|NOT COMPLETED|Overall Study||7||7
60152622|NCT01523613|76278019|FG001|NOT COMPLETED|Overall Study||5||5
60152623|NCT01523613|76278020|FG002|NOT COMPLETED|Overall Study||12||24
59751656|NCT00569803|75870997|FG002|NOT COMPLETED|Overall Study||0||
60152624|NCT00076687|76278031|FG000|STARTED|Overall Study||48||
60152625|NCT00076687|76278032|FG001|STARTED|Overall Study||52||
60152626|NCT00076687|76278033|FG002|STARTED|Overall Study||55||
60152627|NCT00076687|76278031|FG000|COMPLETED|Overall Study||42||
60152628|NCT00076687|76278032|FG001|COMPLETED|Overall Study||47||
60152629|NCT00076687|76278033|FG002|COMPLETED|Overall Study||51||
60152630|NCT00076687|76278031|FG000|NOT COMPLETED|Overall Study||6||
59882189|NCT00180713|76005097|FG001|STARTED|Overall Study||19||
59882190|NCT00180713|76005096|FG000|COMPLETED|Overall Study||18||
60152631|NCT00076687|76278032|FG001|NOT COMPLETED|Overall Study||5||
60152632|NCT00076687|76278033|FG002|NOT COMPLETED|Overall Study||4||
60152633|NCT01525173|76278043|FG000|STARTED|Overall Study||70||
60152634|NCT01525173|76278044|FG001|STARTED|Overall Study||67||
60152635|NCT01525173|76278043|FG000|COMPLETED|Overall Study||63||
60152636|NCT01525173|76278044|FG001|COMPLETED|Overall Study||62||
60152637|NCT01525173|76278043|FG000|NOT COMPLETED|Overall Study||7||
60152638|NCT01525173|76278044|FG001|NOT COMPLETED|Overall Study||5||
59882191|NCT00180713|76005097|FG001|COMPLETED|Overall Study||16||
59882192|NCT00180713|76005096|FG000|NOT COMPLETED|Overall Study||5||
59882193|NCT00180713|76005097|FG001|NOT COMPLETED|Overall Study||3||
59882194|NCT03988023|76005105|FG000|STARTED|Overall Study||520||
59882195|NCT03988023|76005106|FG001|STARTED|Overall Study||523||
59882196|NCT03988023|76005105|FG000|COMPLETED|Overall Study||235||
60152639|NCT01525563|76278050|FG000|STARTED|Overall Study||1000||
60152640|NCT01525563|76278050|FG000|End of Treatment|Overall Study|Only patients who had cycle regularization at end of treatment were allowed to continue.|910||
60152641|NCT01525563|76278050|FG000|3 Months Follow-up|Overall Study|Only patients who had cycle regularization at end of treatment were allowed to continue.|838||
60152642|NCT01525563|76278050|FG000|COMPLETED|Overall Study|6 Months Follow-up|788||
60152643|NCT01525563|76278050|FG000|NOT COMPLETED|Overall Study||212||
60152644|NCT01526343|76278054|FG000|STARTED|Overall Study||47||
60152645|NCT01526343|76278054|FG000|COMPLETED|Overall Study||47||
59882197|NCT03988023|76005106|FG001|COMPLETED|Overall Study||235||
59882198|NCT03988023|76005105|FG000|NOT COMPLETED|Overall Study||285||
59882199|NCT03988023|76005106|FG001|NOT COMPLETED|Overall Study||288||
59882200|NCT04052139|76005115|FG000|STARTED|Overall Study||15||
59882201|NCT04052139|76005116|FG001|STARTED|Overall Study||15||
59882202|NCT04052139|76005117|FG002|STARTED|Overall Study||15||
59882203|NCT04052139|76005115|FG000|4-weeks|Overall Study||14||
59882204|NCT04052139|76005116|FG001|4-weeks|Overall Study||15||
60152646|NCT01526343|76278054|FG000|NOT COMPLETED|Overall Study||0||
60152647|NCT01526577|76278063|FG000|STARTED|Overall Study|1 more subject enrolled as a substitute for 1 withdrawn subject before the administration.|49||
60152648|NCT01526577|76278064|FG001|STARTED|Overall Study||12||
60152649|NCT01526577|76278065|FG002|STARTED|Overall Study|1 more subject enrolled as a substitute for 1 withdrawn subject before the administration.|33||
60152650|NCT01526577|76278066|FG003|STARTED|Overall Study|1 more subject enrolled as a substitute for 1 withdrawn subject before the administration.|9||
60152651|NCT01526577|76278067|FG004|STARTED|Overall Study|2 more subjects were enrolled as the substitutes for 2 withdrawn subjects before the administration.|10||
60152652|NCT01526577|76278063|FG000|COMPLETED|Overall Study||48||
60152653|NCT01526577|76278064|FG001|COMPLETED|Overall Study||12||
60152654|NCT01526577|76278065|FG002|COMPLETED|Overall Study||32||
60152655|NCT01526577|76278066|FG003|COMPLETED|Overall Study||8||
59882205|NCT04052139|76005117|FG002|4-weeks|Overall Study||15||
59882206|NCT04052139|76005115|FG000|8-weeks|Overall Study||12||
59882207|NCT04052139|76005116|FG001|8-weeks|Overall Study||15||
60152656|NCT01526577|76278067|FG004|COMPLETED|Overall Study||8||
60152657|NCT01526577|76278063|FG000|NOT COMPLETED|Overall Study||1||
60152658|NCT01526577|76278064|FG001|NOT COMPLETED|Overall Study||0||
60152659|NCT01526577|76278065|FG002|NOT COMPLETED|Overall Study||1||
60152660|NCT01526577|76278066|FG003|NOT COMPLETED|Overall Study||1||
59882208|NCT04052139|76005117|FG002|8-weeks|Overall Study||15||
59882209|NCT04052139|76005115|FG000|12-weeks|Overall Study||12||
59882210|NCT04052139|76005116|FG001|12-weeks|Overall Study||15||
59882211|NCT04052139|76005117|FG002|12-weeks|Overall Study||15||
59882212|NCT04052139|76005115|FG000|COMPLETED|Overall Study||12||
59882213|NCT04052139|76005116|FG001|COMPLETED|Overall Study||15||
59882214|NCT04052139|76005117|FG002|COMPLETED|Overall Study||15||
59882215|NCT04052139|76005115|FG000|NOT COMPLETED|Overall Study||3||
59882216|NCT04052139|76005116|FG001|NOT COMPLETED|Overall Study||0||
59882217|NCT04052139|76005117|FG002|NOT COMPLETED|Overall Study||0||
59882218|NCT03984825|76005125|FG000|STARTED|Run-in Period (Day -3 to -1)||23||
59882219|NCT03984825|76005125|FG000|COMPLETED|Run-in Period (Day -3 to -1)||23||
59882220|NCT03984825|76005125|FG000|NOT COMPLETED|Run-in Period (Day -3 to -1)||0||
60152661|NCT01526577|76278067|FG004|NOT COMPLETED|Overall Study||2||
60152662|NCT01527045|76278078|FG000|STARTED|Overall Study||30||
60152663|NCT01527045|76278079|FG001|STARTED|Overall Study||5||
60152664|NCT01527045|76278080|FG002|STARTED|Overall Study||12||
60152665|NCT01527045|76278078|FG000|COMPLETED|Overall Study||29||
60152666|NCT01527045|76278079|FG001|COMPLETED|Overall Study||5||
60152667|NCT01527045|76278080|FG002|COMPLETED|Overall Study||12||
60152668|NCT01527045|76278078|FG000|NOT COMPLETED|Overall Study||1||
60152669|NCT01527045|76278079|FG001|NOT COMPLETED|Overall Study||0||
60152670|NCT01527045|76278080|FG002|NOT COMPLETED|Overall Study||0||
60152671|NCT00078403|76278091|FG000|STARTED|Overall Study|Eligible at pre-assignment (40), direct (2), Arm C week 36 non-response (1), EVR inadvertently (1).|44||
60152672|NCT00078403|76278092|FG001|STARTED|Overall Study|Eligible at pre-assignment (40), direct (1), Arm C week 36 non-response (1).|42||
60152673|NCT00078403|76278093|FG002|STARTED|Overall Study||169||
60152674|NCT00078403|76278091|FG000|COMPLETED|Overall Study||26||
60152675|NCT00078403|76278092|FG001|COMPLETED|Overall Study||26||
60152676|NCT00078403|76278093|FG002|COMPLETED|Overall Study||141||
60152677|NCT00078403|76278091|FG000|NOT COMPLETED|Overall Study||18||
60152678|NCT00078403|76278092|FG001|NOT COMPLETED|Overall Study||16||
60152679|NCT00078403|76278093|FG002|NOT COMPLETED|Overall Study||28||
60152680|NCT00178711|76278104|FG000|STARTED|Overall Study||52||
60152681|NCT00178711|76278105|FG001|STARTED|Overall Study||45||
60152682|NCT00178711|76278104|FG000|COMPLETED|Overall Study||52||
60152683|NCT00178711|76278105|FG001|COMPLETED|Overall Study||45||
60152684|NCT00178711|76278104|FG000|NOT COMPLETED|Overall Study||0||
60152685|NCT00178711|76278105|FG001|NOT COMPLETED|Overall Study||0||
60152686|NCT01527513|76278115|FG000|STARTED|Double Blind Period (DB) - Part I||40||
60152687|NCT01527513|76278116|FG001|STARTED|Double Blind Period (DB) - Part I||83||
60152688|NCT01527513|76278115|FG000|Randomized|Double Blind Period (DB) - Part I||40||
60152689|NCT01527513|76278116|FG001|Randomized|Double Blind Period (DB) - Part I||83||
60152690|NCT01527513|76278115|FG000|Safety Population|Double Blind Period (DB) - Part I||40||
60152691|NCT01527513|76278116|FG001|Safety Population|Double Blind Period (DB) - Part I||83||
60152692|NCT01527513|76278115|FG000|Entered Maintenance Period|Double Blind Period (DB) - Part I||40||
60152693|NCT01527513|76278116|FG001|Entered Maintenance Period|Double Blind Period (DB) - Part I||76||
60152694|NCT01527513|76278115|FG000|Completed the Double Blind (DB)- Part I|Double Blind Period (DB) - Part I||37||
60152695|NCT01527513|76278116|FG001|Completed the Double Blind (DB)- Part I|Double Blind Period (DB) - Part I||75||
60152696|NCT01527513|76278115|FG000|Eligible for Open Label Period (OL)|Double Blind Period (DB) - Part I||37||
60152697|NCT01527513|76278116|FG001|Eligible for Open Label Period (OL)|Double Blind Period (DB) - Part I||75||
60152698|NCT01527513|76278115|FG000|Efficacy PP Population|Double Blind Period (DB) - Part I||37||
60152699|NCT01527513|76278116|FG001|Efficacy PP Population|Double Blind Period (DB) - Part I||67||
60152700|NCT01527513|76278115|FG000|Per-protocol (PP) Population|Double Blind Period (DB) - Part I||36||
60152701|NCT01527513|76278116|FG001|Per-protocol (PP) Population|Double Blind Period (DB) - Part I||66||
60152702|NCT01527513|76278115|FG000|COMPLETED|Double Blind Period (DB) - Part I||37||
60152703|NCT01527513|76278116|FG001|COMPLETED|Double Blind Period (DB) - Part I||75||
60152704|NCT01527513|76278115|FG000|NOT COMPLETED|Double Blind Period (DB) - Part I||3||
60152705|NCT01527513|76278116|FG001|NOT COMPLETED|Double Blind Period (DB) - Part I||8||
60152706|NCT01527513|76278115|FG000|STARTED|Eligible for 1-Year Open Label Period||0||
60152707|NCT01527513|76278116|FG001|STARTED|Eligible for 1-Year Open Label Period|Participants that were eligible to participate in for 1-Year Open Label Period - Part II|112||
60152708|NCT01527513|76278115|FG000|COMPLETED|Eligible for 1-Year Open Label Period||0||
60152709|NCT01527513|76278116|FG001|COMPLETED|Eligible for 1-Year Open Label Period||95||
60152710|NCT01527513|76278115|FG000|NOT COMPLETED|Eligible for 1-Year Open Label Period||0||
60152711|NCT01527513|76278116|FG001|NOT COMPLETED|Eligible for 1-Year Open Label Period||17||
60152712|NCT02592798|76278126|FG000|STARTED|Double-Blind Period 1 (DB1)||17||
60152713|NCT02592798|76278127|FG001|STARTED|Double-Blind Period 1 (DB1)||19||
60152714|NCT02592798|76278126|FG000|COMPLETED|Double-Blind Period 1 (DB1)||14||
60152715|NCT02592798|76278127|FG001|COMPLETED|Double-Blind Period 1 (DB1)||13||
60152716|NCT02592798|76278126|FG000|NOT COMPLETED|Double-Blind Period 1 (DB1)||3||
60152717|NCT02592798|76278127|FG001|NOT COMPLETED|Double-Blind Period 1 (DB1)||6||
60152718|NCT02592798|76278126|FG000|STARTED|Transition From DB1 to DB2||14||
60152719|NCT02592798|76278127|FG001|STARTED|Transition From DB1 to DB2||13||
60152720|NCT02592798|76278126|FG000|COMPLETED|Transition From DB1 to DB2||11||
60152721|NCT02592798|76278127|FG001|COMPLETED|Transition From DB1 to DB2||11||
60152722|NCT02592798|76278126|FG000|NOT COMPLETED|Transition From DB1 to DB2||3||
60152723|NCT02592798|76278127|FG001|NOT COMPLETED|Transition From DB1 to DB2||2||
60152724|NCT02592798|76278126|FG000|STARTED|Double-Blind Period 2 (DB2)||11||
60152725|NCT02592798|76278127|FG001|STARTED|Double-Blind Period 2 (DB2)||11||
60152726|NCT02592798|76278126|FG000|COMPLETED|Double-Blind Period 2 (DB2)||6||
60152727|NCT02592798|76278127|FG001|COMPLETED|Double-Blind Period 2 (DB2)||9||
60152728|NCT02592798|76278126|FG000|NOT COMPLETED|Double-Blind Period 2 (DB2)||5||
60152729|NCT02592798|76278127|FG001|NOT COMPLETED|Double-Blind Period 2 (DB2)||2||
60152730|NCT02592798|76278126|FG000|STARTED|Transition From DB2 to OLE||6||
60152731|NCT02592798|76278127|FG001|STARTED|Transition From DB2 to OLE||9||
60152732|NCT02592798|76278126|FG000|COMPLETED|Transition From DB2 to OLE||5||
60152733|NCT02592798|76278127|FG001|COMPLETED|Transition From DB2 to OLE||9||
60152734|NCT02592798|76278126|FG000|NOT COMPLETED|Transition From DB2 to OLE||1||
60152735|NCT02592798|76278127|FG001|NOT COMPLETED|Transition From DB2 to OLE||0||
60152736|NCT02592798|76278126|FG000|STARTED|Open Label Period (OLE)||10|The starting pool of OLE period consists of participants who completed the Double-Blind Period + participants who escaped from DB1 and/or DB2 to OLE period|
60152737|NCT02592798|76278127|FG001|STARTED|Open Label Period (OLE)||13|The starting pool of OLE period consists of participants who completed the Double-Blind Period + participants who escaped from DB1 and/or DB2 to OLE period|
60152738|NCT02592798|76278126|FG000|COMPLETED|Open Label Period (OLE)||6||
60152739|NCT02592798|76278127|FG001|COMPLETED|Open Label Period (OLE)||4||
60152740|NCT02592798|76278126|FG000|NOT COMPLETED|Open Label Period (OLE)||4||
60152741|NCT02592798|76278127|FG001|NOT COMPLETED|Open Label Period (OLE)||9||
60152742|NCT01530243|76278144|FG000|STARTED|Overall Study||26||
60152743|NCT01530243|76278145|FG001|STARTED|Overall Study||26||
60152744|NCT01530243|76278146|FG002|STARTED|Overall Study||26||
60152745|NCT01530243|76278147|FG003|STARTED|Overall Study||26||
60152746|NCT01530243|76278144|FG000|COMPLETED|Overall Study||24||
60152747|NCT01530243|76278145|FG001|COMPLETED|Overall Study||23||
60152748|NCT01530243|76278146|FG002|COMPLETED|Overall Study||23||
60152749|NCT01530243|76278147|FG003|COMPLETED|Overall Study||24||
60152750|NCT01530243|76278144|FG000|NOT COMPLETED|Overall Study||2||
60152751|NCT01530243|76278145|FG001|NOT COMPLETED|Overall Study||3||
60152752|NCT01530243|76278146|FG002|NOT COMPLETED|Overall Study||3||
60152753|NCT01530243|76278147|FG003|NOT COMPLETED|Overall Study||2||
60152754|NCT00078559|76278158|FG000|STARTED|Overall Study||10||
60152755|NCT00078559|76278158|FG000|COMPLETED|Overall Study|1 subject stopped study drug due to a severe but non-serious AE, and completed the trial|10||
60152756|NCT00078559|76278158|FG000|NOT COMPLETED|Overall Study||0||
59751657|NCT00569803|75870998|FG003|NOT COMPLETED|Overall Study||1||
59751658|NCT00569803|75870999|FG004|NOT COMPLETED|Overall Study||0||
59882221|NCT03984825|76005125|FG000|STARTED|Treatment Period 1 (Day 1 to 10)||23||
60152757|NCT00081653|76278167|FG000|STARTED|Overall Study|Patients entering Study MA17903 from Study BM16549|358||
60152758|NCT00081653|76278168|FG001|STARTED|Overall Study|Patients entering Study MA17903 from Study BM16549|361||
60152759|NCT00081653|76278167|FG000|COMPLETED|Overall Study|Completed 3 years of treatment|311||
60152760|NCT00081653|76278168|FG001|COMPLETED|Overall Study|Completed 3 years of treatment|324||
60152761|NCT00081653|76278167|FG000|NOT COMPLETED|Overall Study||47||
60152762|NCT00081653|76278168|FG001|NOT COMPLETED|Overall Study||37||
60152763|NCT00078715|76278175|FG000|STARTED|First Intervention||2||
60152764|NCT00078715|76278176|FG001|STARTED|First Intervention||4||
60152765|NCT00078715|76278175|FG000|COMPLETED|First Intervention||2||
60152766|NCT00078715|76278176|FG001|COMPLETED|First Intervention||4||
60152767|NCT00078715|76278175|FG000|NOT COMPLETED|First Intervention||0||
60152768|NCT00078715|76278176|FG001|NOT COMPLETED|First Intervention||0||
60152769|NCT00078715|76278175|FG000|STARTED|Second Intervention||2||
60152770|NCT00078715|76278176|FG001|STARTED|Second Intervention||4||
60152771|NCT00078715|76278175|FG000|COMPLETED|Second Intervention||2||
60152772|NCT00078715|76278176|FG001|COMPLETED|Second Intervention||4||
60152773|NCT00078715|76278175|FG000|NOT COMPLETED|Second Intervention||0||
60152774|NCT00078715|76278176|FG001|NOT COMPLETED|Second Intervention||0||
60152775|NCT01530399|76278188|FG000|STARTED|Overall Study||8||
60152776|NCT01530399|76278189|FG001|STARTED|Overall Study||10||
60152777|NCT01530399|76278190|FG002|STARTED|Overall Study||8||
60152778|NCT01530399|76278191|FG003|STARTED|Overall Study||10||
60152779|NCT01530399|76278192|FG004|STARTED|Overall Study||6||
60152780|NCT01530399|76278193|FG005|STARTED|Overall Study||7||
60152781|NCT01530399|76278188|FG000|COMPLETED|Overall Study||7||
60152782|NCT01530399|76278189|FG001|COMPLETED|Overall Study||8||
60152783|NCT01530399|76278190|FG002|COMPLETED|Overall Study||7||
60152784|NCT01530399|76278191|FG003|COMPLETED|Overall Study||10||
60152785|NCT01530399|76278192|FG004|COMPLETED|Overall Study||6||
60152786|NCT01530399|76278193|FG005|COMPLETED|Overall Study||6||
60152787|NCT01530399|76278188|FG000|NOT COMPLETED|Overall Study||1||
60152788|NCT01530399|76278189|FG001|NOT COMPLETED|Overall Study||2||
60152789|NCT01530399|76278190|FG002|NOT COMPLETED|Overall Study||1||
60152790|NCT01530399|76278191|FG003|NOT COMPLETED|Overall Study||0||
60152791|NCT01530399|76278192|FG004|NOT COMPLETED|Overall Study||0||
60152792|NCT01530399|76278193|FG005|NOT COMPLETED|Overall Study||1||
60152793|NCT01530477|76278210|FG000|STARTED|Overall Study|17 subjects consented to the Skeletal cohort only.|17||
60152794|NCT01530477|76278211|FG001|STARTED|Overall Study|12 subjects consented to the Body Composition cohort only.|12||
59751659|NCT00569803|75871000|FG005|NOT COMPLETED|Overall Study||0||
60152795|NCT01530477|76278212|FG002|STARTED|Overall Study|53 subjects consented to both the Skeletal and body Composition cohorts.|53||
60152796|NCT01530477|76278210|FG000|COMPLETED|Overall Study|17 subjects completed imaging in the Skeletal cohort only.|17||
60152797|NCT01530477|76278211|FG001|COMPLETED|Overall Study|12 subjects completed imaging in the Body Composition cohort only.|12||
60152798|NCT01530477|76278212|FG002|COMPLETED|Overall Study|53 subjects completed the imaging in both the Skeletal and Body Composition cohorts.|53||
59751660|NCT00569803|75871001|FG006|NOT COMPLETED|Overall Study||0||
59751661|NCT00569803|75871002|FG007|NOT COMPLETED|Overall Study||1||
60152799|NCT01530477|76278210|FG000|NOT COMPLETED|Overall Study||0||
60152800|NCT01530477|76278211|FG001|NOT COMPLETED|Overall Study||0||
60152801|NCT01530477|76278212|FG002|NOT COMPLETED|Overall Study||0||
60152802|NCT01531335|76278220|FG000|STARTED|Overall Study||40||
60152803|NCT01531335|76278221|FG001|STARTED|Overall Study||40||
60152804|NCT01531335|76278220|FG000|COMPLETED|Overall Study||40||
60152805|NCT01531335|76278221|FG001|COMPLETED|Overall Study||40||
60152806|NCT01531335|76278220|FG000|NOT COMPLETED|Overall Study||0||
60152807|NCT01531335|76278221|FG001|NOT COMPLETED|Overall Study||0||
60152808|NCT02596620|76278229|FG000|STARTED|Overall Study|Started from 1st October 2013|82||
60152809|NCT02596620|76278230|FG001|STARTED|Overall Study|Started from 1st October 2013|82||
60152810|NCT02596620|76278229|FG000|COMPLETED|Overall Study|Completed on 30th September 2015|81||
60152811|NCT02596620|76278230|FG001|COMPLETED|Overall Study|Completed on 30th September 2015|81||
60152812|NCT02596620|76278229|FG000|NOT COMPLETED|Overall Study||1||
60152813|NCT02596620|76278230|FG001|NOT COMPLETED|Overall Study||1||
60152814|NCT00180271|76278238|FG000|STARTED|Overall Study||1089||
60152815|NCT00180271|76278239|FG001|STARTED|Overall Study||731||
60152816|NCT00180271|76278238|FG000|COMPLETED|Overall Study||1089||
60152817|NCT00180271|76278239|FG001|COMPLETED|Overall Study||731||
60152818|NCT00180271|76278238|FG000|NOT COMPLETED|Overall Study||0||
60152819|NCT00180271|76278239|FG001|NOT COMPLETED|Overall Study||0||
60152820|NCT00180661|76278249|FG000|STARTED|Overall Study||19||
60152821|NCT00180661|76278250|FG001|STARTED|Overall Study||20||
60152822|NCT00180661|76278249|FG000|COMPLETED|Overall Study||19||
60152823|NCT00180661|76278250|FG001|COMPLETED|Overall Study||20||
60152824|NCT00180661|76278249|FG000|NOT COMPLETED|Overall Study||0||
60152825|NCT00180661|76278250|FG001|NOT COMPLETED|Overall Study||0||
60152826|NCT01531959|76278258|FG000|STARTED|Overall Study||68||
60152827|NCT01531959|76278259|FG001|STARTED|Overall Study||68||
60152828|NCT01531959|76278258|FG000|COMPLETED|Overall Study||66||
60152829|NCT01531959|76278259|FG001|COMPLETED|Overall Study||66||
60152830|NCT01531959|76278258|FG000|NOT COMPLETED|Overall Study||2||
60152831|NCT01531959|76278259|FG001|NOT COMPLETED|Overall Study||2||
60152832|NCT00181207|76278267|FG000|STARTED|Overall Study||24||
60152833|NCT00181207|76278268|FG001|STARTED|Overall Study||26||
60152834|NCT00181207|76278267|FG000|COMPLETED|Overall Study||24||
60152835|NCT00181207|76278268|FG001|COMPLETED|Overall Study||26||
60152836|NCT00181207|76278267|FG000|NOT COMPLETED|Overall Study||0||
60152837|NCT00181207|76278268|FG001|NOT COMPLETED|Overall Study||0||
60152838|NCT02092441|76278276|FG000|STARTED|Overall Study||37||
60152839|NCT02092441|76278277|FG001|STARTED|Overall Study||43||
60152840|NCT02092441|76278276|FG000|COMPLETED|Overall Study||37||
60152841|NCT02092441|76278277|FG001|COMPLETED|Overall Study||43||
60152842|NCT02092441|76278276|FG000|NOT COMPLETED|Overall Study||0||
60152843|NCT02092441|76278277|FG001|NOT COMPLETED|Overall Study||0||
60152844|NCT01532349|76278285|FG000|STARTED|Overall Study||17||
60152845|NCT01532349|76278286|FG001|STARTED|Overall Study||17||
60152846|NCT01532349|76278285|FG000|COMPLETED|Overall Study||15||
60152847|NCT01532349|76278286|FG001|COMPLETED|Overall Study||12||
60152848|NCT01532349|76278285|FG000|NOT COMPLETED|Overall Study||2||
60152849|NCT01532349|76278286|FG001|NOT COMPLETED|Overall Study||5||
60152850|NCT00181285|76278294|FG000|STARTED|Overall Study||27||
60152851|NCT00181285|76278295|FG001|STARTED|Overall Study||25||
60152852|NCT00181285|76278294|FG000|COMPLETED|Overall Study||27||
60152853|NCT00181285|76278295|FG001|COMPLETED|Overall Study||25||
60152854|NCT00181285|76278294|FG000|NOT COMPLETED|Overall Study||0||
60152855|NCT00181285|76278295|FG001|NOT COMPLETED|Overall Study||0||
60152856|NCT00181363|76278301|FG000|STARTED|Overall Study|10|10||
60152857|NCT00181363|76278301|FG000|COMPLETED|Overall Study||10||
60152858|NCT00181363|76278301|FG000|NOT COMPLETED|Overall Study||0||
60152859|NCT01532817|76278308|FG000|STARTED|Overall Study||30||
60152860|NCT01532817|76278308|FG000|COMPLETED|Overall Study||30||
60152861|NCT01532817|76278308|FG000|NOT COMPLETED|Overall Study||0||
60152862|NCT01532973|76278321|FG000|STARTED|Part 1||6||
60152863|NCT01532973|76278322|FG001|STARTED|Part 1||6||
60152864|NCT01532973|76278323|FG002|STARTED|Part 1||6||
60152865|NCT01532973|76278324|FG003|STARTED|Part 1|Planned panel not performed. No participants were enrolled.|0||
60152866|NCT01532973|76278325|FG004|STARTED|Part 1||0||
60152867|NCT01532973|76278326|FG005|STARTED|Part 1||0||
60152868|NCT01532973|76278327|FG006|STARTED|Part 1||0||
60152869|NCT01532973|76278328|FG007|STARTED|Part 1||0||
60152870|NCT01532973|76278329|FG008|STARTED|Part 1||0||
60152871|NCT01532973|76278330|FG009|STARTED|Part 1||0||
60152872|NCT01532973|76278321|FG000|COMPLETED|Part 1||6||
60152873|NCT01532973|76278322|FG001|COMPLETED|Part 1||6||
60152874|NCT01532973|76278323|FG002|COMPLETED|Part 1||6||
60152875|NCT01532973|76278324|FG003|COMPLETED|Part 1||0||
60152876|NCT01532973|76278325|FG004|COMPLETED|Part 1||0||
60152877|NCT01532973|76278326|FG005|COMPLETED|Part 1||0||
60152878|NCT01532973|76278327|FG006|COMPLETED|Part 1||0||
60152879|NCT01532973|76278328|FG007|COMPLETED|Part 1||0||
60152880|NCT01532973|76278329|FG008|COMPLETED|Part 1||0||
60152881|NCT01532973|76278330|FG009|COMPLETED|Part 1||0||
60152882|NCT01532973|76278321|FG000|NOT COMPLETED|Part 1||0||
60152883|NCT01532973|76278322|FG001|NOT COMPLETED|Part 1||0||
60152884|NCT01532973|76278323|FG002|NOT COMPLETED|Part 1||0||
60152885|NCT01532973|76278324|FG003|NOT COMPLETED|Part 1||0||
60152886|NCT01532973|76278325|FG004|NOT COMPLETED|Part 1||0||
60152887|NCT01532973|76278326|FG005|NOT COMPLETED|Part 1||0||
60152888|NCT01532973|76278327|FG006|NOT COMPLETED|Part 1||0||
60152889|NCT01532973|76278328|FG007|NOT COMPLETED|Part 1||0||
60152890|NCT01532973|76278329|FG008|NOT COMPLETED|Part 1||0||
60152891|NCT01532973|76278330|FG009|NOT COMPLETED|Part 1||0||
60152892|NCT01532973|76278321|FG000|STARTED|Part 2||0||
60152893|NCT01532973|76278322|FG001|STARTED|Part 2||0||
60152894|NCT01532973|76278323|FG002|STARTED|Part 2||0||
60152895|NCT01532973|76278324|FG003|STARTED|Part 2||0||
60152896|NCT01532973|76278325|FG004|STARTED|Part 2||6||
60152897|NCT01532973|76278326|FG005|STARTED|Part 2||6||
60152898|NCT01532973|76278327|FG006|STARTED|Part 2||6||
60152899|NCT01532973|76278328|FG007|STARTED|Part 2|Planned panel not performed. No participants were enrolled.|0||
60152900|NCT01532973|76278329|FG008|STARTED|Part 2||0||
60152901|NCT01532973|76278330|FG009|STARTED|Part 2||0||
60152902|NCT01532973|76278321|FG000|COMPLETED|Part 2||0||
60152903|NCT01532973|76278322|FG001|COMPLETED|Part 2||0||
60152904|NCT01532973|76278323|FG002|COMPLETED|Part 2||0||
60152905|NCT01532973|76278324|FG003|COMPLETED|Part 2||0||
60152906|NCT01532973|76278325|FG004|COMPLETED|Part 2||6||
60152907|NCT01532973|76278326|FG005|COMPLETED|Part 2||6||
60152908|NCT01532973|76278327|FG006|COMPLETED|Part 2||6||
60152909|NCT01532973|76278328|FG007|COMPLETED|Part 2||0||
60152910|NCT01532973|76278329|FG008|COMPLETED|Part 2||0||
60152911|NCT01532973|76278330|FG009|COMPLETED|Part 2||0||
60152912|NCT01532973|76278321|FG000|NOT COMPLETED|Part 2||0||
60152913|NCT01532973|76278322|FG001|NOT COMPLETED|Part 2||0||
60152914|NCT01532973|76278323|FG002|NOT COMPLETED|Part 2||0||
60152915|NCT01532973|76278324|FG003|NOT COMPLETED|Part 2||0||
60152916|NCT01532973|76278325|FG004|NOT COMPLETED|Part 2||0||
60152917|NCT01532973|76278326|FG005|NOT COMPLETED|Part 2||0||
60152918|NCT01532973|76278327|FG006|NOT COMPLETED|Part 2||0||
60152919|NCT01532973|76278328|FG007|NOT COMPLETED|Part 2||0||
60152920|NCT01532973|76278329|FG008|NOT COMPLETED|Part 2||0||
60152921|NCT01532973|76278330|FG009|NOT COMPLETED|Part 2||0||
60152922|NCT01532973|76278321|FG000|STARTED|Part 3||0||
60152923|NCT01532973|76278322|FG001|STARTED|Part 3||0||
60152924|NCT01532973|76278323|FG002|STARTED|Part 3||0||
60152925|NCT01532973|76278324|FG003|STARTED|Part 3||0||
60152926|NCT01532973|76278325|FG004|STARTED|Part 3||0||
60152927|NCT01532973|76278326|FG005|STARTED|Part 3||0||
60152928|NCT01532973|76278327|FG006|STARTED|Part 3||0||
60152929|NCT01532973|76278328|FG007|STARTED|Part 3||0||
60152930|NCT01532973|76278329|FG008|STARTED|Part 3||6||
60152931|NCT01532973|76278330|FG009|STARTED|Part 3||6||
60152932|NCT01532973|76278321|FG000|COMPLETED|Part 3||0||
60152933|NCT01532973|76278322|FG001|COMPLETED|Part 3||0||
60152934|NCT01532973|76278323|FG002|COMPLETED|Part 3||0||
60152935|NCT01532973|76278324|FG003|COMPLETED|Part 3||0||
60152936|NCT01532973|76278325|FG004|COMPLETED|Part 3||0||
60152937|NCT01532973|76278326|FG005|COMPLETED|Part 3||0||
60152938|NCT01532973|76278327|FG006|COMPLETED|Part 3||0||
60152939|NCT01532973|76278328|FG007|COMPLETED|Part 3||0||
60152940|NCT01532973|76278329|FG008|COMPLETED|Part 3||6||
60152941|NCT01532973|76278330|FG009|COMPLETED|Part 3||6||
60152942|NCT01532973|76278321|FG000|NOT COMPLETED|Part 3||0||
60152943|NCT01532973|76278322|FG001|NOT COMPLETED|Part 3||0||
60152944|NCT01532973|76278323|FG002|NOT COMPLETED|Part 3||0||
60152945|NCT01532973|76278324|FG003|NOT COMPLETED|Part 3||0||
60152946|NCT01532973|76278325|FG004|NOT COMPLETED|Part 3||0||
60152947|NCT01532973|76278326|FG005|NOT COMPLETED|Part 3||0||
60152948|NCT01532973|76278327|FG006|NOT COMPLETED|Part 3||0||
60152949|NCT01532973|76278328|FG007|NOT COMPLETED|Part 3||0||
60152950|NCT01532973|76278329|FG008|NOT COMPLETED|Part 3||0||
60152951|NCT01532973|76278330|FG009|NOT COMPLETED|Part 3||0||
60152952|NCT01533207|76278356|FG000|STARTED|Overall Study||20||
60152953|NCT01533207|76278357|FG001|STARTED|Overall Study||18||
60152954|NCT01533207|76278356|FG000|COMPLETED|Overall Study||20||
60152955|NCT01533207|76278357|FG001|COMPLETED|Overall Study||18||
60152956|NCT01533207|76278356|FG000|NOT COMPLETED|Overall Study||0||
60152957|NCT01533207|76278357|FG001|NOT COMPLETED|Overall Study||0||
60152958|NCT00182767|76278363|FG000|STARTED|Overall Study||6||
60152959|NCT00182767|76278364|FG001|STARTED|Overall Study||6||
60152960|NCT00182767|76278365|FG002|STARTED|Overall Study||6||
60152961|NCT00182767|76278366|FG003|STARTED|Overall Study||3||
59605804|NCT01964898|75715960|FG001|STARTED|Overall Study||33||
60152962|NCT00182767|76278367|FG004|STARTED|Overall Study||24||
60152963|NCT00182767|76278363|FG000|COMPLETED|Overall Study||6||
60152964|NCT00182767|76278364|FG001|COMPLETED|Overall Study||6||
60152965|NCT00182767|76278365|FG002|COMPLETED|Overall Study||6||
60152966|NCT00182767|76278366|FG003|COMPLETED|Overall Study||3||
60152967|NCT00182767|76278367|FG004|COMPLETED|Overall Study||24||
60152968|NCT00182767|76278363|FG000|NOT COMPLETED|Overall Study||0||
60152969|NCT00182767|76278364|FG001|NOT COMPLETED|Overall Study||0||
60152970|NCT00182767|76278365|FG002|NOT COMPLETED|Overall Study||0||
60152971|NCT00182767|76278366|FG003|NOT COMPLETED|Overall Study||0||
60152972|NCT00182767|76278367|FG004|NOT COMPLETED|Overall Study||0||
60152973|NCT02596230|76278386|FG000|STARTED|Objective 1, One Visit During 14 Days||3714||
60152974|NCT02596230|76278387|FG001|STARTED|Objective 1, One Visit During 14 Days||1006||
60152975|NCT02596230|76278388|FG002|STARTED|Objective 1, One Visit During 14 Days||0||
60152976|NCT02596230|76278389|FG003|STARTED|Objective 1, One Visit During 14 Days||1375||
60152977|NCT02596230|76278390|FG004|STARTED|Objective 1, One Visit During 14 Days||0||
60152978|NCT02596230|76278386|FG000|COMPLETED|Objective 1, One Visit During 14 Days||3714||
60152979|NCT02596230|76278387|FG001|COMPLETED|Objective 1, One Visit During 14 Days||1006||
60152980|NCT02596230|76278388|FG002|COMPLETED|Objective 1, One Visit During 14 Days||0||
60152981|NCT02596230|76278389|FG003|COMPLETED|Objective 1, One Visit During 14 Days||1375||
60152982|NCT02596230|76278390|FG004|COMPLETED|Objective 1, One Visit During 14 Days||0||
60152983|NCT02596230|76278386|FG000|NOT COMPLETED|Objective 1, One Visit During 14 Days||0||
60152984|NCT02596230|76278387|FG001|NOT COMPLETED|Objective 1, One Visit During 14 Days||0||
60152985|NCT02596230|76278388|FG002|NOT COMPLETED|Objective 1, One Visit During 14 Days||0||
60152986|NCT02596230|76278389|FG003|NOT COMPLETED|Objective 1, One Visit During 14 Days||0||
60152987|NCT02596230|76278390|FG004|NOT COMPLETED|Objective 1, One Visit During 14 Days||0||
60152988|NCT02596230|76278386|FG000|STARTED|Screening Period for Objective 2||3714||
60152989|NCT02596230|76278387|FG001|STARTED|Screening Period for Objective 2||1006||
60152990|NCT02596230|76278388|FG002|STARTED|Screening Period for Objective 2|Participants entering the study after the completion of objective 1.|910||
60152991|NCT02596230|76278389|FG003|STARTED|Screening Period for Objective 2||1375||
60152992|NCT02596230|76278390|FG004|STARTED|Screening Period for Objective 2|Participants entering the study after the completion of objective 1.|792||
60152993|NCT02596230|76278386|FG000|COMPLETED|Screening Period for Objective 2||0||
60152994|NCT02596230|76278387|FG001|COMPLETED|Screening Period for Objective 2||778||
60152995|NCT02596230|76278388|FG002|COMPLETED|Screening Period for Objective 2||910||
60152996|NCT02596230|76278389|FG003|COMPLETED|Screening Period for Objective 2||529||
60152997|NCT02596230|76278390|FG004|COMPLETED|Screening Period for Objective 2||792||
60152998|NCT02596230|76278386|FG000|NOT COMPLETED|Screening Period for Objective 2||3714||
60152999|NCT02596230|76278387|FG001|NOT COMPLETED|Screening Period for Objective 2||228||
60153000|NCT02596230|76278388|FG002|NOT COMPLETED|Screening Period for Objective 2||0||
60153001|NCT02596230|76278389|FG003|NOT COMPLETED|Screening Period for Objective 2||846||
60153002|NCT02596230|76278390|FG004|NOT COMPLETED|Screening Period for Objective 2||0||
60153003|NCT02596230|76278386|FG000|STARTED|Objective 2, One Year||0||
60153004|NCT02596230|76278387|FG001|STARTED|Objective 2, One Year||778||
60153005|NCT02596230|76278388|FG002|STARTED|Objective 2, One Year||910||
60153006|NCT02596230|76278389|FG003|STARTED|Objective 2, One Year||529||
60153007|NCT02596230|76278390|FG004|STARTED|Objective 2, One Year||792||
60153008|NCT02596230|76278386|FG000|COMPLETED|Objective 2, One Year||0||
60153009|NCT02596230|76278387|FG001|COMPLETED|Objective 2, One Year||710||
60153010|NCT02596230|76278388|FG002|COMPLETED|Objective 2, One Year||812||
60153011|NCT02596230|76278389|FG003|COMPLETED|Objective 2, One Year||471||
59605805|NCT01964898|75715959|FG000|12 Week Assessment|Overall Study||25||
60153012|NCT02596230|76278390|FG004|COMPLETED|Objective 2, One Year||714||
60153013|NCT02596230|76278386|FG000|NOT COMPLETED|Objective 2, One Year||0||
60153014|NCT02596230|76278387|FG001|NOT COMPLETED|Objective 2, One Year||68||
60153015|NCT02596230|76278388|FG002|NOT COMPLETED|Objective 2, One Year||98||
60153016|NCT02596230|76278389|FG003|NOT COMPLETED|Objective 2, One Year||58||
60153017|NCT02596230|76278390|FG004|NOT COMPLETED|Objective 2, One Year||78||
60153018|NCT01533597|76278402|FG000|STARTED|Overall Study||35||
60153019|NCT01533597|76278403|FG001|STARTED|Overall Study||35||
60153020|NCT01533597|76278402|FG000|COMPLETED|Overall Study||29||
60153021|NCT01533597|76278403|FG001|COMPLETED|Overall Study||25||
60153022|NCT01533597|76278402|FG000|NOT COMPLETED|Overall Study||6||
60153023|NCT01533597|76278403|FG001|NOT COMPLETED|Overall Study||10||
60153024|NCT01534689|76278409|FG000|STARTED|Overall Study||105||
60153025|NCT01534689|76278409|FG000|COMPLETED|Overall Study||105||
60153026|NCT01534689|76278409|FG000|NOT COMPLETED|Overall Study||0||
60153027|NCT01535001|76278415|FG000|STARTED|Overall Study||50||
60153028|NCT01535001|76278416|FG001|STARTED|Overall Study||50||
60153029|NCT01535001|76278415|FG000|COMPLETED|Overall Study||47||
60153030|NCT01535001|76278416|FG001|COMPLETED|Overall Study||44||
60153031|NCT01535001|76278415|FG000|NOT COMPLETED|Overall Study||3||
60153032|NCT01535001|76278416|FG001|NOT COMPLETED|Overall Study||6||
60153033|NCT02212587|76278422|FG000|STARTED|Overall Study||10||
60153034|NCT02212587|76278422|FG000|COMPLETED|Overall Study||9||
60153035|NCT02212587|76278422|FG000|NOT COMPLETED|Overall Study||1||
60153036|NCT01535937|76278428|FG000|STARTED|Overall Study||27||
60153037|NCT01535937|76278429|FG001|STARTED|Overall Study||28||
60153038|NCT01535937|76278428|FG000|COMPLETED|Overall Study||27||
60153039|NCT01535937|76278429|FG001|COMPLETED|Overall Study||28||
60153040|NCT01535937|76278428|FG000|NOT COMPLETED|Overall Study||0||
60153041|NCT01535937|76278429|FG001|NOT COMPLETED|Overall Study||0||
60153042|NCT01537029|76278435|FG000|STARTED|Overall Study||15||
60153043|NCT01537029|76278435|FG000|COMPLETED|Overall Study||15||
60153044|NCT01537029|76278435|FG000|NOT COMPLETED|Overall Study||0||
60153045|NCT01667562|76278439|FG000|STARTED|Diagnostic Phase||375||
60153046|NCT01667562|76278440|FG001|STARTED|Diagnostic Phase||0||
60153047|NCT01667562|76278439|FG000|COMPLETED|Diagnostic Phase||345||
60153048|NCT01667562|76278440|FG001|COMPLETED|Diagnostic Phase||0||
60153049|NCT01667562|76278439|FG000|NOT COMPLETED|Diagnostic Phase||30||
60153050|NCT01667562|76278440|FG001|NOT COMPLETED|Diagnostic Phase||0||
60153051|NCT01667562|76278439|FG000|STARTED|Erlotinib Phase||0||
60153052|NCT01667562|76278440|FG001|STARTED|Erlotinib Phase||30||
60153053|NCT01667562|76278439|FG000|COMPLETED|Erlotinib Phase||0||
60153054|NCT01667562|76278440|FG001|COMPLETED|Erlotinib Phase||27||
60153055|NCT01667562|76278439|FG000|NOT COMPLETED|Erlotinib Phase||0||
60153056|NCT01667562|76278440|FG001|NOT COMPLETED|Erlotinib Phase||3||
60153057|NCT01537185|76278449|FG000|STARTED|Overall Study||10||
60153058|NCT01537185|76278450|FG001|STARTED|Overall Study||12||
60153059|NCT01537185|76278451|FG002|STARTED|Overall Study||10||
60153060|NCT01537185|76278452|FG003|STARTED|Overall Study||10||
60153061|NCT01537185|76278449|FG000|COMPLETED|Overall Study||7||
60153062|NCT01537185|76278450|FG001|COMPLETED|Overall Study||6||
60153063|NCT01537185|76278451|FG002|COMPLETED|Overall Study||4||
60153064|NCT01537185|76278452|FG003|COMPLETED|Overall Study||8||
60153065|NCT01537185|76278449|FG000|NOT COMPLETED|Overall Study||3||
60153066|NCT01537185|76278450|FG001|NOT COMPLETED|Overall Study||6||
60153067|NCT01537185|76278451|FG002|NOT COMPLETED|Overall Study||6||
60153068|NCT01537185|76278452|FG003|NOT COMPLETED|Overall Study||2||
60153069|NCT01537419|76278466|FG000|STARTED|Overall Study||63||
60153070|NCT01537419|76278467|FG001|STARTED|Overall Study||66||
60153071|NCT01537419|76278466|FG000|COMPLETED|Overall Study||52||
60153072|NCT01537419|76278467|FG001|COMPLETED|Overall Study||54||
60153073|NCT01537419|76278466|FG000|NOT COMPLETED|Overall Study||11||
60153074|NCT01537419|76278467|FG001|NOT COMPLETED|Overall Study||12||
60153075|NCT02595528|76278477|FG000|STARTED|Overall Study||41||
60153076|NCT02595528|76278478|FG001|STARTED|Overall Study||40||
60153077|NCT02595528|76278479|FG002|STARTED|Overall Study||42||
60153078|NCT02595528|76278480|FG003|STARTED|Overall Study||40||
60153079|NCT02595528|76278477|FG000|COMPLETED|Overall Study||39||
60153080|NCT02595528|76278478|FG001|COMPLETED|Overall Study||37||
60153081|NCT02595528|76278479|FG002|COMPLETED|Overall Study||41||
60153082|NCT02595528|76278480|FG003|COMPLETED|Overall Study||36||
60153083|NCT02595528|76278477|FG000|NOT COMPLETED|Overall Study||2||
60153084|NCT02595528|76278478|FG001|NOT COMPLETED|Overall Study||3||
60153085|NCT02595528|76278479|FG002|NOT COMPLETED|Overall Study||1||
60153086|NCT02595528|76278480|FG003|NOT COMPLETED|Overall Study||4||
60153087|NCT01538745|76278492|FG000|STARTED|Overall Study||24||
60153088|NCT01538745|76278493|FG001|STARTED|Overall Study||21||
60153089|NCT01538745|76278492|FG000|COMPLETED|Overall Study||24||
60153090|NCT01538745|76278493|FG001|COMPLETED|Overall Study||21||
60153091|NCT01538745|76278492|FG000|NOT COMPLETED|Overall Study||0||
60153092|NCT01538745|76278493|FG001|NOT COMPLETED|Overall Study||0||
60153093|NCT01539135|76278501|FG000|STARTED|Overall Study||43||
60153094|NCT01539135|76278502|FG001|STARTED|Overall Study||37||
60153095|NCT01539135|76278501|FG000|COMPLETED|Overall Study||43||
60153096|NCT01539135|76278502|FG001|COMPLETED|Overall Study||37||
60153097|NCT01539135|76278501|FG000|NOT COMPLETED|Overall Study||0||
60153098|NCT01539135|76278502|FG001|NOT COMPLETED|Overall Study||0||
60153099|NCT02595450|76278508|FG000|STARTED|Overall Study||299||
60153100|NCT02595450|76278508|FG000|Treated|Overall Study||291||
60153101|NCT02595450|76278508|FG000|COMPLETED|Overall Study||218||
60153102|NCT02595450|76278508|FG000|NOT COMPLETED|Overall Study||81||
60153103|NCT02592018|76278512|FG000|STARTED|Overall Study||15||
60153104|NCT02592018|76278512|FG000|COMPLETED|Overall Study||13||
60153105|NCT02592018|76278512|FG000|NOT COMPLETED|Overall Study||2||
60153106|NCT02591238|76278520|FG000|STARTED|Overall Study||16||
60153107|NCT02591238|76278521|FG001|STARTED|Overall Study||17||
60153108|NCT02591238|76278522|FG002|STARTED|Overall Study||17||
60153109|NCT02591238|76278523|FG003|STARTED|Overall Study||18||
60153110|NCT02591238|76278520|FG000|COMPLETED|Overall Study||15||
60153111|NCT02591238|76278521|FG001|COMPLETED|Overall Study||16||
60153112|NCT02591238|76278522|FG002|COMPLETED|Overall Study||17||
60153113|NCT02591238|76278523|FG003|COMPLETED|Overall Study||15||
60153114|NCT02591238|76278520|FG000|NOT COMPLETED|Overall Study||1||
60153115|NCT02591238|76278521|FG001|NOT COMPLETED|Overall Study||1||
60153116|NCT02591238|76278522|FG002|NOT COMPLETED|Overall Study||0||
60153117|NCT02591238|76278523|FG003|NOT COMPLETED|Overall Study||3||
60153118|NCT02221947|76278535|FG000|STARTED|Overall Study||6||
60153119|NCT02221947|76278536|FG001|STARTED|Overall Study||3||
60153120|NCT02221947|76278535|FG000|COMPLETED|Overall Study||6||
60153121|NCT02221947|76278536|FG001|COMPLETED|Overall Study||3||
60153122|NCT02221947|76278535|FG000|NOT COMPLETED|Overall Study||0||
60153123|NCT02221947|76278536|FG001|NOT COMPLETED|Overall Study||0||
60153124|NCT01322646|76278547|FG000|STARTED|Overall Study||86||
60153125|NCT01322646|76278548|FG001|STARTED|Overall Study||86||
60153126|NCT01322646|76278547|FG000|COMPLETED|Overall Study||83||
60153127|NCT01322646|76278548|FG001|COMPLETED|Overall Study||84||
60153128|NCT01322646|76278547|FG000|NOT COMPLETED|Overall Study||3||
60153129|NCT01322646|76278548|FG001|NOT COMPLETED|Overall Study||2||
60153130|NCT02222181|76278554|FG000|STARTED|Overall Study||163||
60153131|NCT02222181|76278554|FG000|COMPLETED|Overall Study||55||
60153132|NCT02222181|76278554|FG000|NOT COMPLETED|Overall Study||108||
60153133|NCT03422653|76278560|FG000|STARTED|Period 1: Double-blind Phase||189||
60153134|NCT03422653|76278561|FG001|STARTED|Period 1: Double-blind Phase||189||
60153135|NCT03422653|76278562|FG002|STARTED|Period 1: Double-blind Phase||0||
60153136|NCT03422653|76278560|FG000|COMPLETED|Period 1: Double-blind Phase||162||
60153137|NCT03422653|76278561|FG001|COMPLETED|Period 1: Double-blind Phase||170||
60153138|NCT03422653|76278562|FG002|COMPLETED|Period 1: Double-blind Phase||0||
60153139|NCT03422653|76278560|FG000|NOT COMPLETED|Period 1: Double-blind Phase||27||
60153140|NCT03422653|76278561|FG001|NOT COMPLETED|Period 1: Double-blind Phase||19||
60153141|NCT03422653|76278562|FG002|NOT COMPLETED|Period 1: Double-blind Phase||0||
60153142|NCT03422653|76278560|FG000|STARTED|Period 2: Open-label Phase||0||
60153143|NCT03422653|76278561|FG001|STARTED|Period 2: Open-label Phase||0||
60153144|NCT03422653|76278562|FG002|STARTED|Period 2: Open-label Phase||313||
60153145|NCT03422653|76278560|FG000|COMPLETED|Period 2: Open-label Phase||0||
60153146|NCT03422653|76278561|FG001|COMPLETED|Period 2: Open-label Phase||0||
60153147|NCT03422653|76278562|FG002|COMPLETED|Period 2: Open-label Phase||189||
60153148|NCT03422653|76278560|FG000|NOT COMPLETED|Period 2: Open-label Phase||0||
60153149|NCT03422653|76278561|FG001|NOT COMPLETED|Period 2: Open-label Phase||0||
60153150|NCT03422653|76278562|FG002|NOT COMPLETED|Period 2: Open-label Phase||124||
60153151|NCT02222337|76278573|FG000|STARTED|Overall Study||140||
60153152|NCT02222337|76278574|FG001|STARTED|Overall Study|132 participants were enrolled but 2 withdrew and never provided any data.|132||
60153153|NCT02222337|76278573|FG000|COMPLETED|Overall Study||114||
60153154|NCT02222337|76278574|FG001|COMPLETED|Overall Study||108||
60153155|NCT02222337|76278573|FG000|NOT COMPLETED|Overall Study||26||
60153156|NCT02222337|76278574|FG001|NOT COMPLETED|Overall Study||24||
59751662|NCT00920426|75871027|FG000|STARTED|ITZ111451||8||
59751663|NCT00920426|75871028|FG001|STARTED|ITZ111451||0||
59751664|NCT00920426|75871029|FG002|STARTED|ITZ111451||0||
59751665|NCT00920426|75871030|FG003|STARTED|ITZ111451||0||
59751666|NCT00920426|75871027|FG000|COMPLETED|ITZ111451||7||
59751667|NCT00920426|75871028|FG001|COMPLETED|ITZ111451||0||
59882222|NCT03984825|76005125|FG000|COMPLETED|Treatment Period 1 (Day 1 to 10)||21||
59882223|NCT03984825|76005125|FG000|NOT COMPLETED|Treatment Period 1 (Day 1 to 10)||2||
59882224|NCT03984825|76005125|FG000|STARTED|Treatment Period 2 (Day 11 to 21)||21||
59882225|NCT03984825|76005125|FG000|COMPLETED|Treatment Period 2 (Day 11 to 21)||17||
59882226|NCT03984825|76005125|FG000|NOT COMPLETED|Treatment Period 2 (Day 11 to 21)||4||
59882227|NCT03981861|76005134|FG000|STARTED|Overall Study||12||
59882228|NCT03981861|76005134|FG000|COMPLETED|Overall Study||9||
59882229|NCT03981861|76005134|FG000|NOT COMPLETED|Overall Study||3||
59882230|NCT01332266|76005143|FG000|STARTED|Phase 1b||4||
60010976|NCT03573817|76126677|FG001|COMPLETED|Overall Study||55||
60010977|NCT03573817|76126676|FG000|NOT COMPLETED|Overall Study||1||
60010978|NCT03573817|76126677|FG001|NOT COMPLETED|Overall Study||4||
60010979|NCT02638103|76126692|FG000|STARTED|Overall Study||419||
60010980|NCT02638103|76126693|FG001|STARTED|Overall Study||526||
60010981|NCT02638103|76126694|FG002|STARTED|Overall Study||420||
60010982|NCT02638103|76126695|FG003|STARTED|Overall Study||525||
60010983|NCT02638103|76126692|FG000|Safety Analysis Set|Overall Study||418|Received at least 1 dose of study drug|
60010984|NCT02638103|76126693|FG001|Safety Analysis Set|Overall Study||526|Received at least 1 dose of study drug|
60010985|NCT02638103|76126694|FG002|Safety Analysis Set|Overall Study||419|Received at least 1 dose of study drug|
60010986|NCT02638103|76126695|FG003|Safety Analysis Set|Overall Study||525|Received at least 1 dose of study drug|
60010987|NCT02638103|76126692|FG000|Full Analysis Set (FAS)|Overall Study||416|Participants in safety analysis set who had at least 10 days of post-baseline efficacy assessment.|
60010988|NCT02638103|76126693|FG001|Full Analysis Set (FAS)|Overall Study||520|Participants in safety analysis set who had at least 10 days of post-baseline efficacy assessment.|
60010989|NCT02638103|76126694|FG002|Full Analysis Set (FAS)|Overall Study||419|Participants in safety analysis set who had at least 10 days of post-baseline efficacy assessment.|
60010990|NCT02638103|76126695|FG003|Full Analysis Set (FAS)|Overall Study||523|Participants in safety analysis set who had at least 10 days of post-baseline efficacy assessment.|
60010991|NCT02638103|76126692|FG000|COMPLETED|Overall Study||313||
60010992|NCT02638103|76126693|FG001|COMPLETED|Overall Study||408||
60010993|NCT02638103|76126694|FG002|COMPLETED|Overall Study||335||
60010994|NCT02638103|76126695|FG003|COMPLETED|Overall Study||383||
60010995|NCT02638103|76126692|FG000|NOT COMPLETED|Overall Study||106||
60010996|NCT02638103|76126693|FG001|NOT COMPLETED|Overall Study||118||
60010997|NCT02638103|76126694|FG002|NOT COMPLETED|Overall Study||85||
60010998|NCT02638103|76126695|FG003|NOT COMPLETED|Overall Study||142||
59751668|NCT00920426|75871029|FG002|COMPLETED|ITZ111451||0||
59751669|NCT00920426|75871030|FG003|COMPLETED|ITZ111451||0||
59882231|NCT01332266|76005144|FG001|STARTED|Phase 1b||5||
59882232|NCT01332266|76005145|FG002|STARTED|Phase 1b||3||
60010999|NCT03551743|76126717|FG000|STARTED|Overall Study||10||
60011000|NCT03551743|76126718|FG001|STARTED|Overall Study||6||
59751670|NCT00920426|75871027|FG000|NOT COMPLETED|ITZ111451||1||
59751671|NCT00920426|75871028|FG001|NOT COMPLETED|ITZ111451||0||
59751672|NCT00920426|75871029|FG002|NOT COMPLETED|ITZ111451||0||
60153157|NCT02092987|76278586|FG000|STARTED|Overall Study||110||
60153158|NCT02092987|76278587|FG001|STARTED|Overall Study||111||
60153159|NCT02092987|76278586|FG000|COMPLETED|Overall Study||106||
60153160|NCT02092987|76278587|FG001|COMPLETED|Overall Study||103||
60153161|NCT02092987|76278586|FG000|NOT COMPLETED|Overall Study||4||
60153162|NCT02092987|76278587|FG001|NOT COMPLETED|Overall Study||8||
60153163|NCT00183469|76278598|FG000|STARTED|Overall Study||41||
59882233|NCT01332266|76005146|FG003|STARTED|Phase 1b||0||
59882234|NCT01332266|76005147|FG004|STARTED|Phase 1b||0||
59882235|NCT01332266|76005143|FG000|COMPLETED|Phase 1b||0||
59882236|NCT01332266|76005144|FG001|COMPLETED|Phase 1b||0||
59882237|NCT01332266|76005145|FG002|COMPLETED|Phase 1b||0||
59882238|NCT01332266|76005146|FG003|COMPLETED|Phase 1b||0||
59882239|NCT01332266|76005147|FG004|COMPLETED|Phase 1b||0||
59751673|NCT00920426|75871030|FG003|NOT COMPLETED|ITZ111451||0||
59882240|NCT01332266|76005143|FG000|NOT COMPLETED|Phase 1b||4||
59882241|NCT01332266|76005144|FG001|NOT COMPLETED|Phase 1b||5||
59882242|NCT01332266|76005145|FG002|NOT COMPLETED|Phase 1b||3||
59882243|NCT01332266|76005146|FG003|NOT COMPLETED|Phase 1b||0||
59751674|NCT00920426|75871027|FG000|STARTED|ITZ112929: Randomized Regimen||0||
59751675|NCT00920426|75871028|FG001|STARTED|ITZ112929: Randomized Regimen||7||
59751676|NCT00920426|75871029|FG002|STARTED|ITZ112929: Randomized Regimen||2||
59751677|NCT00920426|75871030|FG003|STARTED|ITZ112929: Randomized Regimen||0||
59751678|NCT00920426|75871027|FG000|COMPLETED|ITZ112929: Randomized Regimen||0||
59751679|NCT00920426|75871028|FG001|COMPLETED|ITZ112929: Randomized Regimen||7||
59751680|NCT00920426|75871029|FG002|COMPLETED|ITZ112929: Randomized Regimen||2||
59751681|NCT00920426|75871030|FG003|COMPLETED|ITZ112929: Randomized Regimen||0||
59751682|NCT00920426|75871027|FG000|NOT COMPLETED|ITZ112929: Randomized Regimen||0||
59751683|NCT00920426|75871028|FG001|NOT COMPLETED|ITZ112929: Randomized Regimen||0||
59751684|NCT00920426|75871029|FG002|NOT COMPLETED|ITZ112929: Randomized Regimen||0||
59751685|NCT00920426|75871030|FG003|NOT COMPLETED|ITZ112929: Randomized Regimen||0||
59882244|NCT01332266|76005147|FG004|NOT COMPLETED|Phase 1b||0||
59882245|NCT01332266|76005143|FG000|STARTED|Phase 2||0||
59882246|NCT01332266|76005144|FG001|STARTED|Phase 2||0||
59882247|NCT01332266|76005145|FG002|STARTED|Phase 2||0||
59882248|NCT01332266|76005146|FG003|STARTED|Phase 2||42||
59882249|NCT01332266|76005147|FG004|STARTED|Phase 2||41||
60153164|NCT00183469|76278599|FG001|STARTED|Overall Study||45||
59882250|NCT01332266|76005143|FG000|COMPLETED|Phase 2||0||
60153165|NCT00183469|76278598|FG000|COMPLETED|Overall Study||13||
60153166|NCT00183469|76278599|FG001|COMPLETED|Overall Study||16||
59882251|NCT01332266|76005144|FG001|COMPLETED|Phase 2||0||
59882252|NCT01332266|76005145|FG002|COMPLETED|Phase 2||0||
59882253|NCT01332266|76005146|FG003|COMPLETED|Phase 2||0||
60153167|NCT00183469|76278598|FG000|NOT COMPLETED|Overall Study||28||
60153168|NCT00183469|76278599|FG001|NOT COMPLETED|Overall Study||29||
60153169|NCT02597946|76278605|FG000|STARTED|Overall Study||18||
60153170|NCT02597946|76278605|FG000|COMPLETED|Overall Study||0||
60153171|NCT02597946|76278605|FG000|NOT COMPLETED|Overall Study||18||
60153172|NCT02597712|76278611|FG000|STARTED|Overall Study||13||
60153173|NCT02597712|76278612|FG001|STARTED|Overall Study||11||
60153174|NCT02597712|76278611|FG000|COMPLETED|Overall Study||10||
60153175|NCT02597712|76278612|FG001|COMPLETED|Overall Study||10||
60153176|NCT02597712|76278611|FG000|NOT COMPLETED|Overall Study||3||
60153177|NCT02597712|76278612|FG001|NOT COMPLETED|Overall Study||1||
59751686|NCT00920426|75871027|FG000|STARTED|ITZ112929: Optimized Therapy (OT)||0||
59751687|NCT00920426|75871028|FG001|STARTED|ITZ112929: Optimized Therapy (OT)||0||
59751688|NCT00920426|75871029|FG002|STARTED|ITZ112929: Optimized Therapy (OT)||0||
60153178|NCT02597478|76278620|FG000|STARTED|Overall Study||16||
60153179|NCT02597478|76278621|FG001|STARTED|Overall Study||18||
60153180|NCT02597478|76278620|FG000|COMPLETED|Overall Study||13||
60153181|NCT02597478|76278621|FG001|COMPLETED|Overall Study||17||
60153182|NCT02597478|76278620|FG000|NOT COMPLETED|Overall Study||3||
60153183|NCT02597478|76278621|FG001|NOT COMPLETED|Overall Study||1||
59751689|NCT00920426|75871030|FG003|STARTED|ITZ112929: Optimized Therapy (OT)|Out of 9 participants receiving randomized regimen, 8 participants continued to receive OT.|8||
59751690|NCT00920426|75871027|FG000|COMPLETED|ITZ112929: Optimized Therapy (OT)||0||
59751691|NCT00920426|75871028|FG001|COMPLETED|ITZ112929: Optimized Therapy (OT)||0||
59751692|NCT00920426|75871029|FG002|COMPLETED|ITZ112929: Optimized Therapy (OT)||0||
59882254|NCT01332266|76005147|FG004|COMPLETED|Phase 2||0||
60153184|NCT02221557|76278627|FG000|STARTED|Overall Study||8||
60153185|NCT02221557|76278627|FG000|COMPLETED|Overall Study||5||
60153186|NCT02221557|76278627|FG000|NOT COMPLETED|Overall Study||3||
60153187|NCT02219997|76278633|FG000|STARTED|First Filter||33||
60153188|NCT02219997|76278634|FG001|STARTED|First Filter||17||
60153189|NCT02219997|76278635|FG002|STARTED|First Filter||18||
60153190|NCT02219997|76278633|FG000|COMPLETED|First Filter||33||
60153191|NCT02219997|76278634|FG001|COMPLETED|First Filter||17||
60153192|NCT02219997|76278635|FG002|COMPLETED|First Filter||18||
60153193|NCT02219997|76278633|FG000|NOT COMPLETED|First Filter||0||
60153194|NCT02219997|76278634|FG001|NOT COMPLETED|First Filter||0||
60153195|NCT02219997|76278635|FG002|NOT COMPLETED|First Filter||0||
60153196|NCT02219997|76278633|FG000|STARTED|Second Filter||0||
60153197|NCT02219997|76278634|FG001|STARTED|Second Filter||17||
60153198|NCT02219997|76278635|FG002|STARTED|Second Filter||18||
60153199|NCT02219997|76278633|FG000|COMPLETED|Second Filter||0||
60153200|NCT02219997|76278634|FG001|COMPLETED|Second Filter||17||
59751693|NCT00920426|75871030|FG003|COMPLETED|ITZ112929: Optimized Therapy (OT)||8||
59882255|NCT01332266|76005143|FG000|NOT COMPLETED|Phase 2||0||
59882256|NCT01332266|76005144|FG001|NOT COMPLETED|Phase 2||0||
59882257|NCT01332266|76005145|FG002|NOT COMPLETED|Phase 2||0||
59882258|NCT01332266|76005146|FG003|NOT COMPLETED|Phase 2||42||
59882259|NCT01332266|76005147|FG004|NOT COMPLETED|Phase 2||41||
59882260|NCT03255824|76005162|FG000|STARTED|Overall Study||69||
59882261|NCT03255824|76005163|FG001|STARTED|Overall Study||75||
59882262|NCT03255824|76005162|FG000|COMPLETED|Overall Study||67||
59882263|NCT03255824|76005163|FG001|COMPLETED|Overall Study||74||
59882264|NCT03255824|76005162|FG000|NOT COMPLETED|Overall Study||2||
59882265|NCT03255824|76005163|FG001|NOT COMPLETED|Overall Study||1||
59882266|NCT03238352|76005172|FG000|STARTED|Overall Study||43||
59882267|NCT03238352|76005173|FG001|STARTED|Overall Study||23||
59882268|NCT03238352|76005174|FG002|STARTED|Overall Study||23||
59882269|NCT03238352|76005172|FG000|COMPLETED|Overall Study||43||
59882270|NCT03238352|76005173|FG001|COMPLETED|Overall Study||20||
59882271|NCT03238352|76005174|FG002|COMPLETED|Overall Study||22||
59882272|NCT03238352|76005172|FG000|NOT COMPLETED|Overall Study||0||
59882273|NCT03238352|76005173|FG001|NOT COMPLETED|Overall Study||3||
60153201|NCT02219997|76278635|FG002|COMPLETED|Second Filter||18||
60153202|NCT02219997|76278633|FG000|NOT COMPLETED|Second Filter||0||
60153203|NCT02219997|76278634|FG001|NOT COMPLETED|Second Filter||0||
60153204|NCT02219997|76278635|FG002|NOT COMPLETED|Second Filter||0||
60153205|NCT02223351|76278648|FG000|STARTED|Overall Study||24||
60153206|NCT02223351|76278649|FG001|STARTED|Overall Study||24||
60153207|NCT02223351|76278648|FG000|First Intervention (8 Days)|Overall Study||24||
60153208|NCT02223351|76278649|FG001|First Intervention (8 Days)|Overall Study||24||
60153209|NCT02223351|76278648|FG000|Wasout (2weeks)|Overall Study||24||
60153210|NCT02223351|76278649|FG001|Wasout (2weeks)|Overall Study||24||
60153211|NCT02223351|76278648|FG000|Second Intervention (8 Days)|Overall Study||24||
59882274|NCT03238352|76005174|FG002|NOT COMPLETED|Overall Study||1||
59882275|NCT05280782|76005182|FG000|STARTED|Overall Study||8||
59882276|NCT05280782|76005182|FG000|COMPLETED|Overall Study||8||
59751694|NCT00920426|75871027|FG000|NOT COMPLETED|ITZ112929: Optimized Therapy (OT)||0||
60153212|NCT02223351|76278649|FG001|Second Intervention (8 Days)|Overall Study||24||
60153213|NCT02223351|76278648|FG000|COMPLETED|Overall Study||24||
60153214|NCT02223351|76278649|FG001|COMPLETED|Overall Study||24||
60153215|NCT02223351|76278648|FG000|NOT COMPLETED|Overall Study||0||
60153216|NCT02223351|76278649|FG001|NOT COMPLETED|Overall Study||0||
60153217|NCT02223429|76278667|FG000|STARTED|Overall Study||8||
60153218|NCT02223429|76278668|FG001|STARTED|Overall Study||8||
60153219|NCT02223429|76278669|FG002|STARTED|Overall Study||8||
60153220|NCT02223429|76278670|FG003|STARTED|Overall Study||8||
60153221|NCT02223429|76278667|FG000|COMPLETED|Overall Study||7||
60153222|NCT02223429|76278668|FG001|COMPLETED|Overall Study||8||
60153223|NCT02223429|76278669|FG002|COMPLETED|Overall Study||8||
60153224|NCT02223429|76278670|FG003|COMPLETED|Overall Study||8||
60153225|NCT02223429|76278667|FG000|NOT COMPLETED|Overall Study||1||
60153226|NCT02223429|76278668|FG001|NOT COMPLETED|Overall Study||0||
60153227|NCT02223429|76278669|FG002|NOT COMPLETED|Overall Study||0||
60153228|NCT02223429|76278670|FG003|NOT COMPLETED|Overall Study||0||
59751695|NCT00920426|75871028|FG001|NOT COMPLETED|ITZ112929: Optimized Therapy (OT)||0||
59751696|NCT00920426|75871029|FG002|NOT COMPLETED|ITZ112929: Optimized Therapy (OT)||0||
59751697|NCT00920426|75871030|FG003|NOT COMPLETED|ITZ112929: Optimized Therapy (OT)||0||
59751698|NCT00644995|75871044|FG000|STARTED|Overall Study||25||
59751699|NCT00644995|75871045|FG001|STARTED|Overall Study||27||
59751700|NCT00644995|75871044|FG000|Completed 4 Month Assessment|Overall Study||23||
60153229|NCT02221869|76278688|FG000|STARTED|Overall Study||31||
60153230|NCT02221869|76278689|FG001|STARTED|Overall Study||32||
60153231|NCT02221869|76278690|FG002|STARTED|Overall Study||43||
60153232|NCT02221869|76278688|FG000|COMPLETED|Overall Study||30|Double-blind Period|
60153233|NCT02221869|76278689|FG001|COMPLETED|Overall Study||32|Double-blind Period|
60153234|NCT02221869|76278690|FG002|COMPLETED|Overall Study||33|Double-blind Period|
59751701|NCT00644995|75871045|FG001|Completed 4 Month Assessment|Overall Study||24||
60153235|NCT02221869|76278688|FG000|NOT COMPLETED|Overall Study||1||
60153236|NCT02221869|76278689|FG001|NOT COMPLETED|Overall Study||0||
60153237|NCT02221869|76278690|FG002|NOT COMPLETED|Overall Study||10||
60153238|NCT01625013|76278696|FG000|STARTED|Overall Study||51||
60011001|NCT03551743|76126719|FG002|STARTED|Overall Study||6||
60011002|NCT03551743|76126720|FG003|STARTED|Overall Study||6||
60011003|NCT03551743|76126717|FG000|COMPLETED|Overall Study||8||
60011004|NCT03551743|76126718|FG001|COMPLETED|Overall Study||6||
60011005|NCT03551743|76126719|FG002|COMPLETED|Overall Study||6||
60011006|NCT03551743|76126720|FG003|COMPLETED|Overall Study||6||
60011007|NCT03551743|76126717|FG000|NOT COMPLETED|Overall Study||2||
60011008|NCT03551743|76126718|FG001|NOT COMPLETED|Overall Study||0||
60011009|NCT03551743|76126719|FG002|NOT COMPLETED|Overall Study||0||
60011010|NCT03551743|76126720|FG003|NOT COMPLETED|Overall Study||0||
60011011|NCT02636699|76126732|FG000|STARTED|Overall Study||238||
60011012|NCT02636699|76126733|FG001|STARTED|Overall Study||118||
60011013|NCT02636699|76126732|FG000|COMPLETED|Overall Study||213||
60153239|NCT01625013|76278696|FG000|COMPLETED|Overall Study||48||
60153240|NCT01625013|76278696|FG000|NOT COMPLETED|Overall Study||3||
60153241|NCT00083551|76278703|FG000|STARTED|Overall Study||323||
60153242|NCT00083551|76278704|FG001|STARTED|Overall Study||345||
60153243|NCT00083551|76278703|FG000|COMPLETED|Overall Study||323||
60153244|NCT00083551|76278704|FG001|COMPLETED|Overall Study||345||
60153245|NCT00083551|76278703|FG000|NOT COMPLETED|Overall Study||0||
60153246|NCT00083551|76278704|FG001|NOT COMPLETED|Overall Study||0||
60153247|NCT01625169|76278710|FG000|STARTED|Overall Study||9||
60153248|NCT01625169|76278710|FG000|COMPLETED|Overall Study||9||
60153249|NCT01625169|76278710|FG000|NOT COMPLETED|Overall Study||0||
60153250|NCT01471028|76278716|FG000|STARTED|VTI-208||96||
60153251|NCT01471028|76278717|FG001|STARTED|VTI-208||107||
59882277|NCT05280782|76005182|FG000|NOT COMPLETED|Overall Study||0||
59882278|NCT00180479|76005188|FG000|STARTED|Overall Study||669||
59882279|NCT00180479|76005189|FG001|STARTED|Overall Study|1 patient randomized never signed consent, therefore no data collected. Analysis group = 332.|333||
59882280|NCT00180479|76005188|FG000|COMPLETED|Overall Study||653||
59882281|NCT00180479|76005189|FG001|COMPLETED|Overall Study||320||
59882282|NCT00180479|76005188|FG000|NOT COMPLETED|Overall Study||16||
59882283|NCT00180479|76005189|FG001|NOT COMPLETED|Overall Study||13||
59882284|NCT03224234|76005199|FG000|STARTED|Main Study||40||
60011014|NCT02636699|76126733|FG001|COMPLETED|Overall Study||107||
60011015|NCT02636699|76126732|FG000|NOT COMPLETED|Overall Study||25||
60011016|NCT02636699|76126733|FG001|NOT COMPLETED|Overall Study||11||
60153252|NCT01471028|76278716|FG000|COMPLETED|VTI-208||56||
60153253|NCT01471028|76278717|FG001|COMPLETED|VTI-208||63||
60011017|NCT02634983|76126739|FG000|STARTED|Period One (First Treatment, 8-10 Days)||16||
60011018|NCT02634983|76126740|FG001|STARTED|Period One (First Treatment, 8-10 Days)||15||
60153254|NCT01471028|76278716|FG000|NOT COMPLETED|VTI-208||40||
60153255|NCT01471028|76278717|FG001|NOT COMPLETED|VTI-208||44||
60153256|NCT01471028|76278716|FG000|STARTED|VTI-208E||56||
60153257|NCT01471028|76278717|FG001|STARTED|VTI-208E||63||
60153258|NCT01471028|76278716|FG000|Database Lock, 31 July 2015|VTI-208E||56||
59751702|NCT00644995|75871044|FG000|COMPLETED|Overall Study|Completed 6 month assessment|23||
60153259|NCT01471028|76278717|FG001|Database Lock, 31 July 2015|VTI-208E||63||
60153260|NCT01471028|76278716|FG000|COMPLETED|VTI-208E||48||
60153261|NCT01471028|76278717|FG001|COMPLETED|VTI-208E||51||
60153262|NCT01471028|76278716|FG000|NOT COMPLETED|VTI-208E||8||
60153263|NCT01471028|76278717|FG001|NOT COMPLETED|VTI-208E||12||
60153264|NCT01628523|76278726|FG000|STARTED|Overall Study||219||
60153265|NCT01628523|76278726|FG000|COMPLETED|Overall Study||219||
60153266|NCT01628523|76278726|FG000|NOT COMPLETED|Overall Study||0||
60153267|NCT01491854|76278731|FG000|STARTED|Overall Study||130||
60153268|NCT01491854|76278731|FG000|COMPLETED|Overall Study||0||
60153269|NCT01491854|76278731|FG000|NOT COMPLETED|Overall Study||130||
60153270|NCT01628601|76278735|FG000|STARTED|Overall Study||392||
60153271|NCT01628601|76278735|FG000|COMPLETED|Overall Study||351||
60153272|NCT01628601|76278735|FG000|NOT COMPLETED|Overall Study||41||
60153273|NCT01470248|76278739|FG000|STARTED|Overall Study||20||
60153274|NCT01470248|76278739|FG000|COMPLETED|Overall Study||19||
60153275|NCT01470248|76278739|FG000|NOT COMPLETED|Overall Study||1||
60153276|NCT01629615|76278743|FG000|STARTED|Overall Study||50||
60153277|NCT01629615|76278743|FG000|COMPLETED|Overall Study||50||
60153278|NCT01629615|76278743|FG000|NOT COMPLETED|Overall Study||0||
60153279|NCT01629771|76278749|FG000|STARTED|Overall Study||36||
60153280|NCT01629771|76278750|FG001|STARTED|Overall Study||36||
60153281|NCT01629771|76278749|FG000|COMPLETED|Overall Study||36||
60153282|NCT01629771|76278750|FG001|COMPLETED|Overall Study||36||
60153283|NCT01629771|76278749|FG000|NOT COMPLETED|Overall Study||0||
60153284|NCT01629771|76278750|FG001|NOT COMPLETED|Overall Study||0||
60153285|NCT01490918|76278759|FG000|STARTED|Overall Study||65||
60153286|NCT01490918|76278760|FG001|STARTED|Overall Study||66||
60153287|NCT01490918|76278761|FG002|STARTED|Overall Study||34||
60153288|NCT01490918|76278759|FG000|COMPLETED|Overall Study||52||
60153289|NCT01490918|76278760|FG001|COMPLETED|Overall Study||52||
60153290|NCT01490918|76278761|FG002|COMPLETED|Overall Study||22||
60153291|NCT01490918|76278759|FG000|NOT COMPLETED|Overall Study||13||
60153292|NCT01490918|76278760|FG001|NOT COMPLETED|Overall Study||14||
60153293|NCT01490918|76278761|FG002|NOT COMPLETED|Overall Study||12||
60153294|NCT02230761|76278775|FG000|STARTED|Overall Study||60||
60153295|NCT02230761|76278776|FG001|STARTED|Overall Study||30||
60153296|NCT02230761|76278775|FG000|COMPLETED|Overall Study||60||
60153297|NCT02230761|76278776|FG001|COMPLETED|Overall Study||29||
60153298|NCT02230761|76278775|FG000|NOT COMPLETED|Overall Study||0||
60153299|NCT02230761|76278776|FG001|NOT COMPLETED|Overall Study||1||
60153300|NCT02230995|76278784|FG000|STARTED|Period 1 + Washout||15||
60153301|NCT02230995|76278785|FG001|STARTED|Period 1 + Washout||15||
60153302|NCT02230995|76278784|FG000|COMPLETED|Period 1 + Washout||15||
60153303|NCT02230995|76278785|FG001|COMPLETED|Period 1 + Washout||15||
60153304|NCT02230995|76278784|FG000|NOT COMPLETED|Period 1 + Washout||0||
60153305|NCT02230995|76278785|FG001|NOT COMPLETED|Period 1 + Washout||0||
60153306|NCT02230995|76278784|FG000|STARTED|Period 2 + Washout||15||
60011019|NCT02634983|76126739|FG000|COMPLETED|Period One (First Treatment, 8-10 Days)||16||
60011020|NCT02634983|76126740|FG001|COMPLETED|Period One (First Treatment, 8-10 Days)||15||
60011021|NCT02634983|76126739|FG000|NOT COMPLETED|Period One (First Treatment, 8-10 Days)||0||
60011022|NCT02634983|76126740|FG001|NOT COMPLETED|Period One (First Treatment, 8-10 Days)||0||
60011023|NCT02634983|76126739|FG000|STARTED|Washout (Approximately 7-14 Days)||16||
60011024|NCT02634983|76126740|FG001|STARTED|Washout (Approximately 7-14 Days)||15||
60011025|NCT02634983|76126739|FG000|COMPLETED|Washout (Approximately 7-14 Days)||16||
60011026|NCT02634983|76126740|FG001|COMPLETED|Washout (Approximately 7-14 Days)||15||
60011027|NCT02634983|76126739|FG000|NOT COMPLETED|Washout (Approximately 7-14 Days)||0||
60153307|NCT02230995|76278785|FG001|STARTED|Period 2 + Washout||15||
60011028|NCT02634983|76126740|FG001|NOT COMPLETED|Washout (Approximately 7-14 Days)||0||
60153308|NCT02230995|76278784|FG000|COMPLETED|Period 2 + Washout||15||
60153309|NCT02230995|76278785|FG001|COMPLETED|Period 2 + Washout||15||
60153310|NCT02230995|76278784|FG000|NOT COMPLETED|Period 2 + Washout||0||
60153311|NCT02230995|76278785|FG001|NOT COMPLETED|Period 2 + Washout||0||
60153312|NCT01490840|76278793|FG000|STARTED|Phase 1||94||
60011029|NCT02634983|76126739|FG000|STARTED|Period 2 (Second Treatment, 8-10 Days)||16||
60011030|NCT02634983|76126740|FG001|STARTED|Period 2 (Second Treatment, 8-10 Days)||15||
60153313|NCT01490840|76278794|FG001|STARTED|Phase 1||84||
60153314|NCT01490840|76278793|FG000|Modified Full Analysis Set|Phase 1||56||
60153315|NCT01490840|76278794|FG001|Modified Full Analysis Set|Phase 1||83||
60153316|NCT01490840|76278793|FG000|COMPLETED|Phase 1||84||
60153317|NCT01490840|76278794|FG001|COMPLETED|Phase 1||78||
60153318|NCT01490840|76278793|FG000|NOT COMPLETED|Phase 1||10||
60153319|NCT01490840|76278794|FG001|NOT COMPLETED|Phase 1||6||
60153320|NCT01490840|76278793|FG000|STARTED|Phase 2|3 participants discontinued between phase 1 and phase 2|81||
60153321|NCT01490840|76278794|FG001|STARTED|Phase 2|4 participants discontinued between phase 1 and phase 2|74||
60153322|NCT01490840|76278793|FG000|COMPLETED|Phase 2||75||
60153323|NCT01490840|76278794|FG001|COMPLETED|Phase 2||68||
59751703|NCT00644995|75871045|FG001|COMPLETED|Overall Study||23||
59751704|NCT00644995|75871044|FG000|NOT COMPLETED|Overall Study||2||
59751705|NCT00644995|75871045|FG001|NOT COMPLETED|Overall Study||4||
59751706|NCT00914966|75871053|FG000|STARTED|Step 1: 1500 Units||20||
59751707|NCT00914966|75871053|FG000|COMPLETED|Step 1: 1500 Units|5/18 subjects completing Step 1 (1500 Units) entered the 3 month follow-up and did not dose escalate|18||
59751708|NCT00914966|75871053|FG000|NOT COMPLETED|Step 1: 1500 Units||2||
59751709|NCT00914966|75871053|FG000|STARTED|Step 2: 2000 Units||13||
59751710|NCT00914966|75871053|FG000|COMPLETED|Step 2: 2000 Units||12||
59751711|NCT00914966|75871053|FG000|NOT COMPLETED|Step 2: 2000 Units||1||
59751712|NCT00914966|75871053|FG000|STARTED|Step 3: 2500 Units||12||
59751713|NCT00914966|75871053|FG000|COMPLETED|Step 3: 2500 Units||12||
59751714|NCT00914966|75871053|FG000|NOT COMPLETED|Step 3: 2500 Units||0||
59751715|NCT00914810|75871064|FG000|STARTED|Overall Study||20||
59751716|NCT00914810|75871065|FG001|STARTED|Overall Study||19||
59751717|NCT00914810|75871064|FG000|COMPLETED|Overall Study||18||
59751718|NCT00914810|75871065|FG001|COMPLETED|Overall Study||18||
59751719|NCT00914810|75871064|FG000|NOT COMPLETED|Overall Study||2||
59751720|NCT00914810|75871065|FG001|NOT COMPLETED|Overall Study||1||
59751721|NCT00644917|75871071|FG000|STARTED|Overall Study||38||
59751722|NCT00644917|75871071|FG000|COMPLETED|Overall Study||36||
60153324|NCT01490840|76278793|FG000|NOT COMPLETED|Phase 2||6||
60153325|NCT01490840|76278794|FG001|NOT COMPLETED|Phase 2||6||
60153326|NCT03448185|76278804|FG000|STARTED|Overall Study||16||
60153327|NCT03448185|76278805|FG001|STARTED|Overall Study||24||
60153328|NCT03448185|76278806|FG002|STARTED|Overall Study||18||
60153329|NCT03448185|76278807|FG003|STARTED|Overall Study||22||
60153330|NCT03448185|76278804|FG000|COMPLETED|Overall Study||13||
60153331|NCT03448185|76278805|FG001|COMPLETED|Overall Study||13||
60153332|NCT03448185|76278806|FG002|COMPLETED|Overall Study||14||
60153333|NCT03448185|76278807|FG003|COMPLETED|Overall Study||16||
60153334|NCT03448185|76278804|FG000|NOT COMPLETED|Overall Study||3||
60153335|NCT03448185|76278805|FG001|NOT COMPLETED|Overall Study||11||
60153336|NCT03448185|76278806|FG002|NOT COMPLETED|Overall Study||4||
60153337|NCT03448185|76278807|FG003|NOT COMPLETED|Overall Study||6||
60153338|NCT01631331|76278817|FG000|STARTED|Overall Study||15||76
60153339|NCT01631331|76278817|FG000|COMPLETED|Overall Study||11||43
60153340|NCT01631331|76278817|FG000|NOT COMPLETED|Overall Study||4||33
60153341|NCT01490450|76278826|FG000|STARTED|Period 1||41||
60153342|NCT01490450|76278827|FG001|STARTED|Period 1||41||
60153343|NCT01490450|76278828|FG002|STARTED|Period 1||42||
60153344|NCT01490450|76278829|FG003|STARTED|Period 1||41||
60153345|NCT01490450|76278826|FG000|COMPLETED|Period 1||38||
60153346|NCT01490450|76278827|FG001|COMPLETED|Period 1||40||
60153347|NCT01490450|76278828|FG002|COMPLETED|Period 1||38||
60153348|NCT01490450|76278829|FG003|COMPLETED|Period 1||33||
60153349|NCT01490450|76278826|FG000|NOT COMPLETED|Period 1||3||
60153350|NCT01490450|76278827|FG001|NOT COMPLETED|Period 1||1||
60153351|NCT01490450|76278828|FG002|NOT COMPLETED|Period 1||4||
60153352|NCT01490450|76278829|FG003|NOT COMPLETED|Period 1||8||
60153353|NCT01490450|76278826|FG000|STARTED|Period 2||38||
60153354|NCT01490450|76278827|FG001|STARTED|Period 2||40||
60153355|NCT01490450|76278828|FG002|STARTED|Period 2||37||
60153356|NCT01490450|76278829|FG003|STARTED|Period 2||32||
60153357|NCT01490450|76278826|FG000|COMPLETED|Period 2||36||
60153358|NCT01490450|76278827|FG001|COMPLETED|Period 2||39||
60153359|NCT01490450|76278828|FG002|COMPLETED|Period 2||37||
60153360|NCT01490450|76278829|FG003|COMPLETED|Period 2||28||
60153361|NCT01490450|76278826|FG000|NOT COMPLETED|Period 2||2||
60153362|NCT01490450|76278827|FG001|NOT COMPLETED|Period 2||1||
60153363|NCT01490450|76278828|FG002|NOT COMPLETED|Period 2||0||
60153364|NCT01490450|76278829|FG003|NOT COMPLETED|Period 2||4||
60153365|NCT01632267|76278842|FG000|STARTED|Overall Study||104||
60153366|NCT01632267|76278842|FG000|COMPLETED|Overall Study||97||
60153367|NCT01632267|76278842|FG000|NOT COMPLETED|Overall Study||7||
60153368|NCT01632423|76278846|FG000|STARTED|Overall Study||10337||
60153369|NCT01632423|76278846|FG000|COMPLETED|Overall Study||10091||
60153370|NCT01632423|76278846|FG000|NOT COMPLETED|Overall Study||246||
59751723|NCT00644917|75871071|FG000|NOT COMPLETED|Overall Study||2||
59751724|NCT00914732|75871082|FG000|STARTED|Overall Study||165||
59751725|NCT00914732|75871083|FG001|STARTED|Overall Study||167||
59751726|NCT00914732|75871084|FG002|STARTED|Overall Study||191||
59751727|NCT00914732|75871082|FG000|Received Second Vaccination|Overall Study||150||
59751728|NCT00914732|75871083|FG001|Received Second Vaccination|Overall Study||157||
60153371|NCT01632735|76278852|FG000|STARTED|Overall Study||40||
60153372|NCT01632735|76278853|FG001|STARTED|Overall Study||40||
60153373|NCT01632735|76278852|FG000|COMPLETED|Overall Study||36||
60153374|NCT01632735|76278853|FG001|COMPLETED|Overall Study||37||
60153375|NCT01632735|76278852|FG000|NOT COMPLETED|Overall Study||4||
60153376|NCT01632735|76278853|FG001|NOT COMPLETED|Overall Study||3||
60153377|NCT01633827|76278859|FG000|STARTED|First Intervention||11||
60153378|NCT01633827|76278860|FG001|STARTED|First Intervention||11||
59605806|NCT01964898|75715960|FG001|12 Week Assessment|Overall Study||30||
60153379|NCT01633827|76278859|FG000|COMPLETED|First Intervention||11||
60153380|NCT01633827|76278860|FG001|COMPLETED|First Intervention||11||
60153381|NCT01633827|76278859|FG000|NOT COMPLETED|First Intervention||0||
60153382|NCT01633827|76278860|FG001|NOT COMPLETED|First Intervention||0||
60153383|NCT01633827|76278859|FG000|STARTED|Washout Period||11||
60153384|NCT01633827|76278860|FG001|STARTED|Washout Period||11||
60153385|NCT01633827|76278859|FG000|COMPLETED|Washout Period||11||
60153386|NCT01633827|76278860|FG001|COMPLETED|Washout Period||11||
60153387|NCT01633827|76278859|FG000|NOT COMPLETED|Washout Period||0||
60153388|NCT01633827|76278860|FG001|NOT COMPLETED|Washout Period||0||
60153389|NCT01633827|76278859|FG000|STARTED|Second Intervention||11||
60153390|NCT01633827|76278860|FG001|STARTED|Second Intervention||11||
60153391|NCT01633827|76278859|FG000|COMPLETED|Second Intervention||11||
60153392|NCT01633827|76278860|FG001|COMPLETED|Second Intervention||11||
60153393|NCT01633827|76278859|FG000|NOT COMPLETED|Second Intervention||0||
60153394|NCT01633827|76278860|FG001|NOT COMPLETED|Second Intervention||0||
60153395|NCT01469546|76278873|FG000|STARTED|Received 5 mg Dose||42||
60153396|NCT01469546|76278873|FG000|Completed First Cycle|Received 5 mg Dose||30||
60153397|NCT01469546|76278873|FG000|COMPLETED|Received 5 mg Dose||19||
60153398|NCT01469546|76278873|FG000|NOT COMPLETED|Received 5 mg Dose||23||
60153399|NCT01469546|76278873|FG000|STARTED|Dose Escalation to 10 mg||19||
60153400|NCT01469546|76278873|FG000|COMPLETED|Dose Escalation to 10 mg||19||
60153401|NCT01469546|76278873|FG000|NOT COMPLETED|Dose Escalation to 10 mg||0||
60153402|NCT00081497|76278879|FG000|STARTED|Overall Study|Patients who were randomized to placebo in AGAL-008-00 (NCT00074984).|28||
60153403|NCT00081497|76278880|FG001|STARTED|Overall Study|Patients who were randomized to Fabrazyme in AGAL-008-00 (NCT00074984).|39||
60153404|NCT00081497|76278879|FG000|COMPLETED|Overall Study||25||
60153405|NCT00081497|76278880|FG001|COMPLETED|Overall Study||37||
60153406|NCT00081497|76278879|FG000|NOT COMPLETED|Overall Study||3||
60153407|NCT00081497|76278880|FG001|NOT COMPLETED|Overall Study||2||
60153408|NCT00081263|76278894|FG000|STARTED|Overall Study||67||
60153409|NCT00081263|76278895|FG001|STARTED|Overall Study||63||
60153410|NCT00081263|76278894|FG000|COMPLETED|Overall Study||50||
60153411|NCT00081263|76278895|FG001|COMPLETED|Overall Study||41||
60153412|NCT00081263|76278894|FG000|NOT COMPLETED|Overall Study||17||
60153413|NCT00081263|76278895|FG001|NOT COMPLETED|Overall Study||22||
60153414|NCT01490294|76278905|FG000|STARTED|Overall Study||58||
59605807|NCT01964898|75715959|FG000|COMPLETED|Overall Study||24|Completed assessment 6 months post-discharge|
59605808|NCT01964898|75715960|FG001|COMPLETED|Overall Study||26|Completed assessment 6 months post-discharge|
60153415|NCT01490294|76278906|FG001|STARTED|Overall Study||60||
60153416|NCT01490294|76278907|FG002|STARTED|Overall Study||59||
60153417|NCT01490294|76278908|FG003|STARTED|Overall Study||55||
60153418|NCT01490294|76278905|FG000|Participant Received Treatment|Overall Study||54||
60153419|NCT01490294|76278906|FG001|Participant Received Treatment|Overall Study||60||
60153420|NCT01490294|76278907|FG002|Participant Received Treatment|Overall Study||58||
60153421|NCT01490294|76278908|FG003|Participant Received Treatment|Overall Study||54||
60153422|NCT01490294|76278905|FG000|COMPLETED|Overall Study||53||
60153423|NCT01490294|76278906|FG001|COMPLETED|Overall Study||60||
60153424|NCT01490294|76278907|FG002|COMPLETED|Overall Study||58||
60153425|NCT01490294|76278908|FG003|COMPLETED|Overall Study||54||
60153426|NCT01490294|76278905|FG000|NOT COMPLETED|Overall Study||5||
60153427|NCT01490294|76278906|FG001|NOT COMPLETED|Overall Study||0||
60153428|NCT01490294|76278907|FG002|NOT COMPLETED|Overall Study||1||
60153429|NCT01490294|76278908|FG003|NOT COMPLETED|Overall Study||1||
60153430|NCT01638507|76278918|FG000|STARTED|Overall Study||230||
60153431|NCT01638507|76278918|FG000|COMPLETED|Overall Study||224||
60153432|NCT01638507|76278918|FG000|NOT COMPLETED|Overall Study||6||
60153433|NCT01639443|76278926|FG000|STARTED|Overall Study|These individuals opted into Fast-tracked group and were consented.|180||
60153434|NCT01639443|76278927|FG001|STARTED|Overall Study|These individuals opted to not participate in Fast-tracked group, and were not consented.|4855||
60153435|NCT01639443|76278926|FG000|COMPLETED|Overall Study|Intervention is limited to appointment booking, and all completed.|180||
60153436|NCT01639443|76278927|FG001|COMPLETED|Overall Study|These individuals all booked appointments using typical booking.|4855||
60153437|NCT01639443|76278926|FG000|NOT COMPLETED|Overall Study||0||
60153438|NCT01639443|76278927|FG001|NOT COMPLETED|Overall Study||0||
60153439|NCT00080483|76278935|FG000|STARTED|Overall Study||17||
60011031|NCT02634983|76126739|FG000|COMPLETED|Period 2 (Second Treatment, 8-10 Days)||14||
60011032|NCT02634983|76126740|FG001|COMPLETED|Period 2 (Second Treatment, 8-10 Days)||15||
60011033|NCT02634983|76126739|FG000|NOT COMPLETED|Period 2 (Second Treatment, 8-10 Days)||2||
60011034|NCT02634983|76126740|FG001|NOT COMPLETED|Period 2 (Second Treatment, 8-10 Days)||0||
60011035|NCT02633501|76126752|FG000|STARTED|Overall Study||14||
60011036|NCT02633501|76126753|FG001|STARTED|Overall Study||14||
60011037|NCT02633501|76126754|FG002|STARTED|Overall Study||62||
60011038|NCT02633501|76126755|FG003|STARTED|Overall Study||63||
60011039|NCT02633501|76126756|FG004|STARTED|Overall Study||64||
60011040|NCT02633501|76126757|FG005|STARTED|Overall Study||63||
60011041|NCT02633501|76126752|FG000|COMPLETED|Overall Study||12||
60011042|NCT02633501|76126753|FG001|COMPLETED|Overall Study||11||
60011043|NCT02633501|76126754|FG002|COMPLETED|Overall Study||55||
60011044|NCT02633501|76126755|FG003|COMPLETED|Overall Study||59||
60011045|NCT02633501|76126756|FG004|COMPLETED|Overall Study||53||
60011046|NCT02633501|76126757|FG005|COMPLETED|Overall Study||48||
60011047|NCT02633501|76126752|FG000|NOT COMPLETED|Overall Study||2||
60011048|NCT02633501|76126753|FG001|NOT COMPLETED|Overall Study||3||
60011049|NCT02633501|76126754|FG002|NOT COMPLETED|Overall Study||7||
60011050|NCT02633501|76126755|FG003|NOT COMPLETED|Overall Study||4||
60011051|NCT02633501|76126756|FG004|NOT COMPLETED|Overall Study||11||
60011052|NCT02633501|76126757|FG005|NOT COMPLETED|Overall Study||15||
60011053|NCT03591107|76126778|FG000|STARTED|Overall Study||21||
60011054|NCT03591107|76126779|FG001|STARTED|Overall Study||21||
60011055|NCT03591107|76126778|FG000|COMPLETED|Overall Study||20||
60011056|NCT03591107|76126779|FG001|COMPLETED|Overall Study||16||
60011057|NCT03591107|76126778|FG000|NOT COMPLETED|Overall Study||1||
60011058|NCT03591107|76126779|FG001|NOT COMPLETED|Overall Study||5||
60011059|NCT03208985|76126785|FG000|STARTED|Overall Study||1270||
60011060|NCT03208985|76126785|FG000|COMPLETED|Overall Study||868||
60011061|NCT03208985|76126785|FG000|NOT COMPLETED|Overall Study||402||
60011062|NCT02922023|76126792|FG000|STARTED|Overall Study||2||
60011063|NCT02922023|76126793|FG001|STARTED|Overall Study||0||
60011064|NCT02922023|76126792|FG000|COMPLETED|Overall Study||0||
60011065|NCT02922023|76126793|FG001|COMPLETED|Overall Study||0||
60011066|NCT02922023|76126792|FG000|NOT COMPLETED|Overall Study||2||
60011067|NCT02922023|76126793|FG001|NOT COMPLETED|Overall Study||0||
60011068|NCT01672853|76126802|FG000|STARTED|Overall Study||79||
60011069|NCT01672853|76126803|FG001|STARTED|Overall Study||77||
60011070|NCT01672853|76126804|FG002|STARTED|Overall Study||79||
60011071|NCT01672853|76126802|FG000|COMPLETED|Overall Study||69||
60011072|NCT01672853|76126803|FG001|COMPLETED|Overall Study||60||
60011073|NCT01672853|76126804|FG002|COMPLETED|Overall Study||65||
60011074|NCT01672853|76126802|FG000|NOT COMPLETED|Overall Study||10||
60011075|NCT01672853|76126803|FG001|NOT COMPLETED|Overall Study||17||
60011076|NCT01672853|76126804|FG002|NOT COMPLETED|Overall Study||14||
60011077|NCT01603459|76126812|FG000|STARTED|Overall Study||155||
60011078|NCT01603459|76126812|FG000|COMPLETED|Overall Study||137||
60011079|NCT01603459|76126812|FG000|NOT COMPLETED|Overall Study||18||
60011080|NCT02926027|76126836|FG000|STARTED|Overall Study||40||
60011081|NCT02926027|76126837|FG001|STARTED|Overall Study||40||
60011082|NCT02926027|76126836|FG000|COMPLETED|Overall Study||31||
60011083|NCT02926027|76126837|FG001|COMPLETED|Overall Study||37||
60011084|NCT02926027|76126836|FG000|NOT COMPLETED|Overall Study||9||
60011085|NCT02926027|76126837|FG001|NOT COMPLETED|Overall Study||3||
60011086|NCT03726749|76126843|FG000|STARTED|Overall Study||30||
60011087|NCT03726749|76126843|FG000|COMPLETED|Overall Study||30||
60011088|NCT03726749|76126843|FG000|NOT COMPLETED|Overall Study||0||
60011089|NCT01678807|76126851|FG000|STARTED|Overall Study||65||
60011090|NCT01678807|76126852|FG001|STARTED|Overall Study||65||
60011091|NCT01678807|76126853|FG002|STARTED|Overall Study||65||
60011092|NCT01678807|76126851|FG000|COMPLETED|Overall Study||61||
60011093|NCT01678807|76126852|FG001|COMPLETED|Overall Study||60||
60011094|NCT01678807|76126853|FG002|COMPLETED|Overall Study||65||
60011095|NCT01678807|76126851|FG000|NOT COMPLETED|Overall Study||4||
60011096|NCT01678807|76126852|FG001|NOT COMPLETED|Overall Study||5||
60153440|NCT00080483|76278936|FG001|STARTED|Overall Study||18||
60153441|NCT00080483|76278935|FG000|COMPLETED|Overall Study||15||
60153442|NCT00080483|76278936|FG001|COMPLETED|Overall Study||16||
60153443|NCT00080483|76278935|FG000|NOT COMPLETED|Overall Study||2||
60153444|NCT00080483|76278936|FG001|NOT COMPLETED|Overall Study||2||
60011097|NCT01678807|76126853|FG002|NOT COMPLETED|Overall Study||0||
60011098|NCT03073525|76126864|FG000|STARTED|Overall Study||3||
60011099|NCT03073525|76126865|FG001|STARTED|Overall Study||11||
60011100|NCT03073525|76126866|FG002|STARTED|Overall Study||10||
60011101|NCT03073525|76126864|FG000|Part 3: Atezolizumab Alone|Overall Study||0|Part 3 did not apply to Participants who completed Part 1.|
60011102|NCT03073525|76126865|FG001|Part 3: Atezolizumab Alone|Overall Study||1|Part 3 did not apply to Participants who completed Part 1.|
60011103|NCT03073525|76126866|FG002|Part 3: Atezolizumab Alone|Overall Study||0|Part 3 did not apply to Participants who completed Part 1.|
60153445|NCT01639599|76278945|FG000|STARTED|Overall Study||50||
60153446|NCT01639599|76278946|FG001|STARTED|Overall Study||50||
60153447|NCT01639599|76278947|FG002|STARTED|Overall Study||50||
60153448|NCT01639599|76278945|FG000|COMPLETED|Overall Study||50||
60153449|NCT01639599|76278946|FG001|COMPLETED|Overall Study||49||
60153450|NCT01639599|76278947|FG002|COMPLETED|Overall Study||50||
60153451|NCT01639599|76278945|FG000|NOT COMPLETED|Overall Study||0||
60153452|NCT01639599|76278946|FG001|NOT COMPLETED|Overall Study||1||
60153453|NCT01639599|76278947|FG002|NOT COMPLETED|Overall Study||0||
60153454|NCT00089141|76278957|FG000|STARTED|Overall Study||74||
60153455|NCT00089141|76278958|FG001|STARTED|Overall Study||77||
60153456|NCT00089141|76278957|FG000|COMPLETED|Overall Study||56||
60153457|NCT00089141|76278958|FG001|COMPLETED|Overall Study||53||
60153458|NCT00089141|76278957|FG000|NOT COMPLETED|Overall Study||18||
60153459|NCT00089141|76278958|FG001|NOT COMPLETED|Overall Study||24||
60153460|NCT02227329|76278964|FG000|STARTED|Overall Study||18||
60153461|NCT02227329|76278965|FG001|STARTED|Overall Study||20||
60153462|NCT02227329|76278964|FG000|COMPLETED|Overall Study||18||
60153463|NCT02227329|76278965|FG001|COMPLETED|Overall Study||20||
60153464|NCT02227329|76278964|FG000|NOT COMPLETED|Overall Study||0||
60153465|NCT02227329|76278965|FG001|NOT COMPLETED|Overall Study||0||
60153466|NCT02227485|76278973|FG000|STARTED|First Follow-up||40||
59605809|NCT01964898|75715959|FG000|NOT COMPLETED|Overall Study||7||
60153467|NCT02227485|76278974|FG001|STARTED|First Follow-up||40||
60153468|NCT02227485|76278973|FG000|COMPLETED|First Follow-up|At the first follow-up we lost 4 patients.|36||
60153469|NCT02227485|76278974|FG001|COMPLETED|First Follow-up|After 2 weeks, 2 patients had withdrew the study.|38||
60153470|NCT02227485|76278973|FG000|NOT COMPLETED|First Follow-up||4||
60153471|NCT02227485|76278974|FG001|NOT COMPLETED|First Follow-up||2||
60153472|NCT02227485|76278973|FG000|STARTED|Second Follow-up||36||
60153473|NCT02227485|76278974|FG001|STARTED|Second Follow-up||38||
60153474|NCT02227485|76278973|FG000|COMPLETED|Second Follow-up|At the second follow-up we lost 2 patients.|34||
60153475|NCT02227485|76278974|FG001|COMPLETED|Second Follow-up|At the second follow-up we lost 2 patients.|36||
60153476|NCT02227485|76278973|FG000|NOT COMPLETED|Second Follow-up||2||
60153477|NCT02227485|76278974|FG001|NOT COMPLETED|Second Follow-up||2||
60153478|NCT01640379|76278983|FG000|STARTED|Overall Study||149||
60153479|NCT01640379|76278984|FG001|STARTED|Overall Study||137||
60153480|NCT01640379|76278983|FG000|COMPLETED|Overall Study||135||
60153481|NCT01640379|76278984|FG001|COMPLETED|Overall Study||125||
60153482|NCT01640379|76278983|FG000|NOT COMPLETED|Overall Study||14||
60153483|NCT01640379|76278984|FG001|NOT COMPLETED|Overall Study||12||
60153484|NCT00084409|76278993|FG000|STARTED|Overall Study|40 Current, 35 former|75||
59605810|NCT01964898|75715960|FG001|NOT COMPLETED|Overall Study||7||
59605811|NCT01964352|75715970|FG000|STARTED|Overall Study||204||
59605812|NCT01964352|75715971|FG001|STARTED|Overall Study||203||
60153485|NCT00084409|76278994|FG001|STARTED|Overall Study|41 current, 36 former|77||
60153486|NCT00084409|76278993|FG000|COMPLETED|Overall Study|9 current, 6 former|60||
60153487|NCT00084409|76278994|FG001|COMPLETED|Overall Study|4 Current, 8 former|65||
60153488|NCT00084409|76278993|FG000|NOT COMPLETED|Overall Study||15||
60153489|NCT00084409|76278994|FG001|NOT COMPLETED|Overall Study||12||
60153490|NCT02588664|76279004|FG000|STARTED|Overall Study||3193||
60153491|NCT02588664|76279005|FG001|STARTED|Overall Study||2689||
59605813|NCT01964352|75715972|FG002|STARTED|Overall Study||202||
60153492|NCT02588664|76279004|FG000|COMPLETED|Overall Study||1832||
60153493|NCT02588664|76279005|FG001|COMPLETED|Overall Study||1644||
60153494|NCT02588664|76279004|FG000|NOT COMPLETED|Overall Study||1361||
60153495|NCT02588664|76279005|FG001|NOT COMPLETED|Overall Study||1045||
60153496|NCT00088621|76279011|FG000|STARTED|Overall Study||61||
60153497|NCT00088621|76279011|FG000|COMPLETED|Overall Study||7||
60153498|NCT00088621|76279011|FG000|NOT COMPLETED|Overall Study||54||
60153499|NCT01642485|76279015|FG000|STARTED|Period 1, Day 1|crossover so all subjects had this treatment|4||
60153500|NCT01642485|76279016|FG001|STARTED|Period 1, Day 1||4||
60153501|NCT01642485|76279017|FG002|STARTED|Period 1, Day 1||4||
60153502|NCT01642485|76279018|FG003|STARTED|Period 1, Day 1||4||
60153503|NCT01642485|76279019|FG004|STARTED|Period 1, Day 1||4||
60153504|NCT01642485|76279020|FG005|STARTED|Period 1, Day 1||4||
60153505|NCT01642485|76279021|FG006|STARTED|Period 1, Day 1||4||
59882285|NCT03224234|76005200|FG001|STARTED|Main Study||40||
59882286|NCT03224234|76005199|FG000|COMPLETED|Main Study||35||
60153506|NCT01642485|76279022|FG007|STARTED|Period 1, Day 1||4||
60153507|NCT01642485|76279015|FG000|COMPLETED|Period 1, Day 1||4||
60153508|NCT01642485|76279016|FG001|COMPLETED|Period 1, Day 1||4||
60153509|NCT01642485|76279017|FG002|COMPLETED|Period 1, Day 1||4||
60153510|NCT01642485|76279018|FG003|COMPLETED|Period 1, Day 1||4||
60153511|NCT01642485|76279019|FG004|COMPLETED|Period 1, Day 1||4||
60153512|NCT01642485|76279020|FG005|COMPLETED|Period 1, Day 1||4||
60153513|NCT01642485|76279021|FG006|COMPLETED|Period 1, Day 1||4||
59882287|NCT03224234|76005200|FG001|COMPLETED|Main Study||35||
59882288|NCT03224234|76005199|FG000|NOT COMPLETED|Main Study||5||
59882289|NCT03224234|76005200|FG001|NOT COMPLETED|Main Study||5||
59882290|NCT03224234|76005199|FG000|STARTED|Pilot||11||
60153514|NCT01642485|76279022|FG007|COMPLETED|Period 1, Day 1||4||
60153515|NCT01642485|76279015|FG000|NOT COMPLETED|Period 1, Day 1||0||
60153516|NCT01642485|76279016|FG001|NOT COMPLETED|Period 1, Day 1||0||
60153517|NCT01642485|76279017|FG002|NOT COMPLETED|Period 1, Day 1||0||
60153518|NCT01642485|76279018|FG003|NOT COMPLETED|Period 1, Day 1||0||
60153519|NCT01642485|76279019|FG004|NOT COMPLETED|Period 1, Day 1||0||
60153520|NCT01642485|76279020|FG005|NOT COMPLETED|Period 1, Day 1||0||
60153521|NCT01642485|76279021|FG006|NOT COMPLETED|Period 1, Day 1||0||
60153522|NCT01642485|76279022|FG007|NOT COMPLETED|Period 1, Day 1||0||
60153523|NCT01642485|76279015|FG000|STARTED|Period 1, Day 2||4||
60153524|NCT01642485|76279016|FG001|STARTED|Period 1, Day 2||4||
60153525|NCT01642485|76279017|FG002|STARTED|Period 1, Day 2||4||
60153526|NCT01642485|76279018|FG003|STARTED|Period 1, Day 2||4||
60153527|NCT01642485|76279019|FG004|STARTED|Period 1, Day 2||4||
60153528|NCT01642485|76279020|FG005|STARTED|Period 1, Day 2||4||
60153529|NCT01642485|76279021|FG006|STARTED|Period 1, Day 2||4||
60153530|NCT01642485|76279022|FG007|STARTED|Period 1, Day 2||4||
60153531|NCT01642485|76279015|FG000|COMPLETED|Period 1, Day 2||4||
60153532|NCT01642485|76279016|FG001|COMPLETED|Period 1, Day 2||4||
60153533|NCT01642485|76279017|FG002|COMPLETED|Period 1, Day 2||4||
60153534|NCT01642485|76279018|FG003|COMPLETED|Period 1, Day 2||4||
60153535|NCT01642485|76279019|FG004|COMPLETED|Period 1, Day 2||4||
60153536|NCT01642485|76279020|FG005|COMPLETED|Period 1, Day 2||4||
60153537|NCT01642485|76279021|FG006|COMPLETED|Period 1, Day 2||4||
60153538|NCT01642485|76279022|FG007|COMPLETED|Period 1, Day 2||4||
60153539|NCT01642485|76279015|FG000|NOT COMPLETED|Period 1, Day 2||0||
60153540|NCT01642485|76279016|FG001|NOT COMPLETED|Period 1, Day 2||0||
60153541|NCT01642485|76279017|FG002|NOT COMPLETED|Period 1, Day 2||0||
59882291|NCT03224234|76005200|FG001|STARTED|Pilot||7||
60153542|NCT01642485|76279018|FG003|NOT COMPLETED|Period 1, Day 2||0||
60153543|NCT01642485|76279019|FG004|NOT COMPLETED|Period 1, Day 2||0||
60153544|NCT01642485|76279020|FG005|NOT COMPLETED|Period 1, Day 2||0||
60153545|NCT01642485|76279021|FG006|NOT COMPLETED|Period 1, Day 2||0||
60153546|NCT01642485|76279022|FG007|NOT COMPLETED|Period 1, Day 2||0||
60153547|NCT01642485|76279015|FG000|STARTED|Period 1, Day 3||4||
60153548|NCT01642485|76279016|FG001|STARTED|Period 1, Day 3||4||
60153549|NCT01642485|76279017|FG002|STARTED|Period 1, Day 3||4||
59882292|NCT03224234|76005199|FG000|COMPLETED|Pilot||11||
59882293|NCT03224234|76005200|FG001|COMPLETED|Pilot||7||
60153550|NCT01642485|76279018|FG003|STARTED|Period 1, Day 3||4||
60153551|NCT01642485|76279019|FG004|STARTED|Period 1, Day 3||4||
60153552|NCT01642485|76279020|FG005|STARTED|Period 1, Day 3||4||
60153553|NCT01642485|76279021|FG006|STARTED|Period 1, Day 3||4||
60153554|NCT01642485|76279022|FG007|STARTED|Period 1, Day 3||4||
60153555|NCT01642485|76279015|FG000|COMPLETED|Period 1, Day 3||4||
60153556|NCT01642485|76279016|FG001|COMPLETED|Period 1, Day 3||4||
60153557|NCT01642485|76279017|FG002|COMPLETED|Period 1, Day 3||4||
60153558|NCT01642485|76279018|FG003|COMPLETED|Period 1, Day 3||4||
60153559|NCT01642485|76279019|FG004|COMPLETED|Period 1, Day 3||4||
60153560|NCT01642485|76279020|FG005|COMPLETED|Period 1, Day 3||4||
60153561|NCT01642485|76279021|FG006|COMPLETED|Period 1, Day 3||4||
60153562|NCT01642485|76279022|FG007|COMPLETED|Period 1, Day 3||4||
60153563|NCT01642485|76279015|FG000|NOT COMPLETED|Period 1, Day 3||0||
60153564|NCT01642485|76279016|FG001|NOT COMPLETED|Period 1, Day 3||0||
60153565|NCT01642485|76279017|FG002|NOT COMPLETED|Period 1, Day 3||0||
60153566|NCT01642485|76279018|FG003|NOT COMPLETED|Period 1, Day 3||0||
60153567|NCT01642485|76279019|FG004|NOT COMPLETED|Period 1, Day 3||0||
60153568|NCT01642485|76279020|FG005|NOT COMPLETED|Period 1, Day 3||0||
60153569|NCT01642485|76279021|FG006|NOT COMPLETED|Period 1, Day 3||0||
60153570|NCT01642485|76279022|FG007|NOT COMPLETED|Period 1, Day 3||0||
60153571|NCT01642485|76279015|FG000|STARTED|Period 2, Day 1||4||
60153572|NCT01642485|76279016|FG001|STARTED|Period 2, Day 1||4||
60153573|NCT01642485|76279017|FG002|STARTED|Period 2, Day 1||4||
60153574|NCT01642485|76279018|FG003|STARTED|Period 2, Day 1||4||
60153575|NCT01642485|76279019|FG004|STARTED|Period 2, Day 1||4||
60153576|NCT01642485|76279020|FG005|STARTED|Period 2, Day 1||4||
60153577|NCT01642485|76279021|FG006|STARTED|Period 2, Day 1||4||
60153578|NCT01642485|76279022|FG007|STARTED|Period 2, Day 1||4||
60153579|NCT01642485|76279015|FG000|COMPLETED|Period 2, Day 1||4||
60153580|NCT01642485|76279016|FG001|COMPLETED|Period 2, Day 1||4||
60153581|NCT01642485|76279017|FG002|COMPLETED|Period 2, Day 1||4||
60153582|NCT01642485|76279018|FG003|COMPLETED|Period 2, Day 1||4||
60153583|NCT01642485|76279019|FG004|COMPLETED|Period 2, Day 1||4||
60153584|NCT01642485|76279020|FG005|COMPLETED|Period 2, Day 1||4||
60153585|NCT01642485|76279021|FG006|COMPLETED|Period 2, Day 1||4||
60153586|NCT01642485|76279022|FG007|COMPLETED|Period 2, Day 1||4||
60153587|NCT01642485|76279015|FG000|NOT COMPLETED|Period 2, Day 1||0||
60153588|NCT01642485|76279016|FG001|NOT COMPLETED|Period 2, Day 1||0||
60153589|NCT01642485|76279017|FG002|NOT COMPLETED|Period 2, Day 1||0||
60153590|NCT01642485|76279018|FG003|NOT COMPLETED|Period 2, Day 1||0||
60153591|NCT01642485|76279019|FG004|NOT COMPLETED|Period 2, Day 1||0||
60153592|NCT01642485|76279020|FG005|NOT COMPLETED|Period 2, Day 1||0||
60153593|NCT01642485|76279021|FG006|NOT COMPLETED|Period 2, Day 1||0||
60153594|NCT01642485|76279022|FG007|NOT COMPLETED|Period 2, Day 1||0||
60153595|NCT01642485|76279015|FG000|STARTED|Period 2, Day 2||4||
60153596|NCT01642485|76279016|FG001|STARTED|Period 2, Day 2||4||
60153597|NCT01642485|76279017|FG002|STARTED|Period 2, Day 2||4||
60153598|NCT01642485|76279018|FG003|STARTED|Period 2, Day 2||4||
60153599|NCT01642485|76279019|FG004|STARTED|Period 2, Day 2||4||
60153600|NCT01642485|76279020|FG005|STARTED|Period 2, Day 2||4||
60153601|NCT01642485|76279021|FG006|STARTED|Period 2, Day 2||4||
60153602|NCT01642485|76279022|FG007|STARTED|Period 2, Day 2||4||
60011104|NCT03073525|76126864|FG000|COMPLETED|Overall Study||3||
60153603|NCT01642485|76279015|FG000|COMPLETED|Period 2, Day 2||4||
60153604|NCT01642485|76279016|FG001|COMPLETED|Period 2, Day 2||4||
60153605|NCT01642485|76279017|FG002|COMPLETED|Period 2, Day 2||4||
60153606|NCT01642485|76279018|FG003|COMPLETED|Period 2, Day 2||4||
60153607|NCT01642485|76279019|FG004|COMPLETED|Period 2, Day 2||4||
60153608|NCT01642485|76279020|FG005|COMPLETED|Period 2, Day 2||4||
60153609|NCT01642485|76279021|FG006|COMPLETED|Period 2, Day 2||4||
60153610|NCT01642485|76279022|FG007|COMPLETED|Period 2, Day 2||4||
60153611|NCT01642485|76279015|FG000|NOT COMPLETED|Period 2, Day 2||0||
60153612|NCT01642485|76279016|FG001|NOT COMPLETED|Period 2, Day 2||0||
60153613|NCT01642485|76279017|FG002|NOT COMPLETED|Period 2, Day 2||0||
60011105|NCT03073525|76126865|FG001|COMPLETED|Overall Study||11||
60011106|NCT03073525|76126866|FG002|COMPLETED|Overall Study||7||
60153614|NCT01642485|76279018|FG003|NOT COMPLETED|Period 2, Day 2||0||
60153615|NCT01642485|76279019|FG004|NOT COMPLETED|Period 2, Day 2||0||
60153616|NCT01642485|76279020|FG005|NOT COMPLETED|Period 2, Day 2||0||
60153617|NCT01642485|76279021|FG006|NOT COMPLETED|Period 2, Day 2||0||
60153618|NCT01642485|76279022|FG007|NOT COMPLETED|Period 2, Day 2||0||
60153619|NCT01642485|76279015|FG000|STARTED|Period 2, Day 3||4||
60153620|NCT01642485|76279016|FG001|STARTED|Period 2, Day 3||4||
60153621|NCT01642485|76279017|FG002|STARTED|Period 2, Day 3||4||
60153622|NCT01642485|76279018|FG003|STARTED|Period 2, Day 3||4||
60153623|NCT01642485|76279019|FG004|STARTED|Period 2, Day 3||4||
60153624|NCT01642485|76279020|FG005|STARTED|Period 2, Day 3||4||
60153625|NCT01642485|76279021|FG006|STARTED|Period 2, Day 3||4||
60153626|NCT01642485|76279022|FG007|STARTED|Period 2, Day 3||4||
60153627|NCT01642485|76279015|FG000|COMPLETED|Period 2, Day 3||4||
60153628|NCT01642485|76279016|FG001|COMPLETED|Period 2, Day 3||4||
60153629|NCT01642485|76279017|FG002|COMPLETED|Period 2, Day 3||4||
60153630|NCT01642485|76279018|FG003|COMPLETED|Period 2, Day 3||4||
60153631|NCT01642485|76279019|FG004|COMPLETED|Period 2, Day 3||4||
60153632|NCT01642485|76279020|FG005|COMPLETED|Period 2, Day 3||4||
60153633|NCT01642485|76279021|FG006|COMPLETED|Period 2, Day 3||4||
60153634|NCT01642485|76279022|FG007|COMPLETED|Period 2, Day 3||4||
60153635|NCT01642485|76279015|FG000|NOT COMPLETED|Period 2, Day 3||0||
60153636|NCT01642485|76279016|FG001|NOT COMPLETED|Period 2, Day 3||0||
60153637|NCT01642485|76279017|FG002|NOT COMPLETED|Period 2, Day 3||0||
60153638|NCT01642485|76279018|FG003|NOT COMPLETED|Period 2, Day 3||0||
60153639|NCT01642485|76279019|FG004|NOT COMPLETED|Period 2, Day 3||0||
60153640|NCT01642485|76279020|FG005|NOT COMPLETED|Period 2, Day 3||0||
60153641|NCT01642485|76279021|FG006|NOT COMPLETED|Period 2, Day 3||0||
60153642|NCT01642485|76279022|FG007|NOT COMPLETED|Period 2, Day 3||0||
60153643|NCT00187369|76279042|FG000|STARTED|Mothers||1398||
60153644|NCT00187369|76279043|FG001|STARTED|Mothers||1406||
60153645|NCT00187369|76279042|FG000|Included in the Study|Mothers||1393||
60153646|NCT00187369|76279043|FG001|Included in the Study|Mothers||1393||
60153647|NCT00187369|76279042|FG000|COMPLETED|Mothers||1392||
60153648|NCT00187369|76279043|FG001|COMPLETED|Mothers||1392||
60153649|NCT00187369|76279042|FG000|NOT COMPLETED|Mothers||6||
59751729|NCT00914732|75871084|FG002|Received Second Vaccination|Overall Study||153||
59751730|NCT00914732|75871082|FG000|COMPLETED|Overall Study||155||
59751731|NCT00914732|75871083|FG001|COMPLETED|Overall Study||160||
59751732|NCT00914732|75871084|FG002|COMPLETED|Overall Study||180||
59882294|NCT03224234|76005199|FG000|NOT COMPLETED|Pilot||0||
60153650|NCT00187369|76279043|FG001|NOT COMPLETED|Mothers||14||
60153651|NCT00187369|76279042|FG000|STARTED|Fetuses or Infants||2795||
60153652|NCT00187369|76279043|FG001|STARTED|Fetuses or Infants||2812||
60153653|NCT00187369|76279042|FG000|Included in the Study|Fetuses or Infants||2785||
60153654|NCT00187369|76279043|FG001|Included in the Study|Fetuses or Infants||2786||
60153655|NCT00187369|76279042|FG000|COMPLETED|Fetuses or Infants||2783||
60153656|NCT00187369|76279043|FG001|COMPLETED|Fetuses or Infants||2782||
60153657|NCT00187369|76279042|FG000|NOT COMPLETED|Fetuses or Infants||12||
60153658|NCT00187369|76279043|FG001|NOT COMPLETED|Fetuses or Infants||30||
60153659|NCT00187681|76279057|FG000|STARTED|Overall Study||12||
60153660|NCT00187681|76279058|FG001|STARTED|Overall Study||8||
60153661|NCT00187681|76279057|FG000|COMPLETED|Overall Study||12||
60153662|NCT00187681|76279058|FG001|COMPLETED|Overall Study||8||
60153663|NCT00187681|76279057|FG000|NOT COMPLETED|Overall Study||0||
60153664|NCT00187681|76279058|FG001|NOT COMPLETED|Overall Study||0||
60153665|NCT00083759|76279068|FG000|STARTED|Overall Study|150 subjects enrolled, 137 (Modified Intention-to-Treat [MITT] Population) for efficacy analyses|150||
60153666|NCT00083759|76279069|FG001|STARTED|Overall Study|149 subjects enrolled, 136 (Modified Intention-to-Treat [MITT] Population) for efficacy analyses|149||
60153667|NCT00083759|76279068|FG000|COMPLETED|Overall Study||66||
60153668|NCT00083759|76279069|FG001|COMPLETED|Overall Study||66||
60153669|NCT00083759|76279068|FG000|NOT COMPLETED|Overall Study||84||
60153670|NCT00083759|76279069|FG001|NOT COMPLETED|Overall Study||83||
60153671|NCT01645059|76279073|FG000|STARTED|Overall Study||129||
60153672|NCT01645059|76279073|FG000|COMPLETED|Overall Study||129||
60153673|NCT01645059|76279073|FG000|NOT COMPLETED|Overall Study||0||
60153674|NCT02412228|76279082|FG000|STARTED|Overall Study||12||
59751733|NCT00914732|75871082|FG000|NOT COMPLETED|Overall Study||10||
59751734|NCT00914732|75871083|FG001|NOT COMPLETED|Overall Study||7||
59751735|NCT00914732|75871084|FG002|NOT COMPLETED|Overall Study||11||
59751736|NCT00844545|75871093|FG000|STARTED|Screening Period||17||
59751737|NCT00844545|75871093|FG000|COMPLETED|Screening Period||17||
59882295|NCT03224234|76005200|FG001|NOT COMPLETED|Pilot||0||
60153675|NCT02412228|76279082|FG000|COMPLETED|Overall Study||12||
60153676|NCT02412228|76279082|FG000|NOT COMPLETED|Overall Study||0||
60153677|NCT01646151|76279086|FG000|STARTED|Overall Study||2580||
60153678|NCT01646151|76279086|FG000|COMPLETED|Overall Study||2410||
60153679|NCT01646151|76279086|FG000|NOT COMPLETED|Overall Study||170||
60153680|NCT02232009|76279090|FG000|STARTED|Overall Study||9||
60153681|NCT02232009|76279090|FG000|COMPLETED|Overall Study||9||
60153682|NCT02232009|76279090|FG000|NOT COMPLETED|Overall Study||0||
60153683|NCT00088699|76279096|FG000|STARTED|Infusion 1||23||
60153684|NCT00088699|76279097|FG001|STARTED|Infusion 1||19||
60153685|NCT00088699|76279098|FG002|STARTED|Infusion 1||13||
60153686|NCT00088699|76279099|FG003|STARTED|Infusion 1||12||
60153687|NCT00088699|76279096|FG000|COMPLETED|Infusion 1||22||
59751738|NCT00844545|75871093|FG000|NOT COMPLETED|Screening Period||0||
59882296|NCT02955069|76005214|FG000|STARTED|Overall Study||95||
59882297|NCT02955069|76005215|FG001|STARTED|Overall Study||21||
60153688|NCT00088699|76279097|FG001|COMPLETED|Infusion 1||19||
60153689|NCT00088699|76279098|FG002|COMPLETED|Infusion 1||12||
60153690|NCT00088699|76279099|FG003|COMPLETED|Infusion 1||10||
60153691|NCT00088699|76279096|FG000|NOT COMPLETED|Infusion 1||1||
60153692|NCT00088699|76279097|FG001|NOT COMPLETED|Infusion 1||0||
60153693|NCT00088699|76279098|FG002|NOT COMPLETED|Infusion 1||1||
60153694|NCT00088699|76279099|FG003|NOT COMPLETED|Infusion 1||2||
60153695|NCT00088699|76279096|FG000|STARTED|Infusion 2||19||
60153696|NCT00088699|76279097|FG001|STARTED|Infusion 2||18||
60153697|NCT00088699|76279098|FG002|STARTED|Infusion 2||11||
60153698|NCT00088699|76279099|FG003|STARTED|Infusion 2||11||
60153699|NCT00088699|76279096|FG000|COMPLETED|Infusion 2||19||
60153700|NCT00088699|76279097|FG001|COMPLETED|Infusion 2||18||
60153701|NCT00088699|76279098|FG002|COMPLETED|Infusion 2||11||
60153702|NCT00088699|76279099|FG003|COMPLETED|Infusion 2||10||
60153703|NCT00088699|76279096|FG000|NOT COMPLETED|Infusion 2||0||
60153704|NCT00088699|76279097|FG001|NOT COMPLETED|Infusion 2||0||
60153705|NCT00088699|76279098|FG002|NOT COMPLETED|Infusion 2||0||
60153706|NCT00088699|76279099|FG003|NOT COMPLETED|Infusion 2||1||
60153707|NCT00089011|76279111|FG000|STARTED|Overall Study||100||
60153708|NCT00089011|76279112|FG001|STARTED|Overall Study||50||
60153709|NCT00089011|76279111|FG000|COMPLETED|Overall Study||100||
60153710|NCT00089011|76279112|FG001|COMPLETED|Overall Study||50||
60153711|NCT00089011|76279111|FG000|NOT COMPLETED|Overall Study||0||
60153712|NCT00089011|76279112|FG001|NOT COMPLETED|Overall Study||0||
60153713|NCT00189475|76279120|FG000|STARTED|Overall Study||42||
60153714|NCT00189475|76279121|FG001|STARTED|Overall Study||42||
60153715|NCT00189475|76279120|FG000|COMPLETED|Overall Study||42||
60153716|NCT00189475|76279121|FG001|COMPLETED|Overall Study||42||
60153717|NCT00189475|76279120|FG000|NOT COMPLETED|Overall Study||0||
60153718|NCT00189475|76279121|FG001|NOT COMPLETED|Overall Study||0||
60153719|NCT00091273|76279127|FG000|STARTED|Overall Study||9||
60153720|NCT00091273|76279127|FG000|COMPLETED|Overall Study||9||
60153721|NCT00091273|76279127|FG000|NOT COMPLETED|Overall Study||0||
60153722|NCT00193375|76279131|FG000|STARTED|Overall Study||60||
60153723|NCT00193375|76279131|FG000|COMPLETED|Overall Study||41||
60153724|NCT00193375|76279131|FG000|NOT COMPLETED|Overall Study||19||
60153725|NCT00193453|76279135|FG000|STARTED|Overall Study||69||
60153726|NCT00193453|76279135|FG000|COMPLETED|Overall Study||21||
59882298|NCT02955069|76005214|FG000|Full Analysis Set (FAS)|Overall Study||95|All subjects to whom study treatment was assigned and who received at least one dose of PDR001.|
59882299|NCT02955069|76005215|FG001|Full Analysis Set (FAS)|Overall Study||21|All subjects to whom study treatment was assigned and who received at least one dose of PDR001.|
59882300|NCT02955069|76005214|FG000|Safety Set|Overall Study||95|All subjects who received at least one dose of PDR001.|
59882301|NCT02955069|76005215|FG001|Safety Set|Overall Study||21|All subjects who received at least one dose of PDR001.|
59882302|NCT02955069|76005214|FG000|Pharmacokinetic Analysis Set (PAS)|Overall Study||94|All subjects who provide at least one evaluable PDR001 pharmacokinetic (PK) concentration.|
59882303|NCT02955069|76005215|FG001|Pharmacokinetic Analysis Set (PAS)|Overall Study||18|All subjects who provide at least one evaluable PDR001 pharmacokinetic (PK) concentration.|
59950823|NCT02408120|76069710|FG001|STARTED|Overall Study||112||
60153727|NCT00193453|76279135|FG000|NOT COMPLETED|Overall Study||48||
60153728|NCT00184717|76279142|FG000|STARTED|Main Period (GHLIQUID-1516)||39||
60153729|NCT00184717|76279143|FG001|STARTED|Main Period (GHLIQUID-1516)||38||
60153730|NCT00184717|76279144|FG002|STARTED|Main Period (GHLIQUID-1516)||21||
60153731|NCT00184717|76279145|FG003|STARTED|Main Period (GHLIQUID-1516)||0||
60153732|NCT00184717|76279146|FG004|STARTED|Main Period (GHLIQUID-1516)||0||
60153733|NCT00184717|76279142|FG000|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||38||
60153734|NCT00184717|76279143|FG001|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||38||
60153735|NCT00184717|76279144|FG002|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||21||
60153736|NCT00184717|76279145|FG003|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||0||
60153737|NCT00184717|76279146|FG004|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||0||
60153738|NCT00184717|76279142|FG000|COMPLETED|Main Period (GHLIQUID-1516)||36||
60153739|NCT00184717|76279143|FG001|COMPLETED|Main Period (GHLIQUID-1516)||36||
60153740|NCT00184717|76279144|FG002|COMPLETED|Main Period (GHLIQUID-1516)||20||
60153741|NCT00184717|76279145|FG003|COMPLETED|Main Period (GHLIQUID-1516)||0||
60153742|NCT00184717|76279146|FG004|COMPLETED|Main Period (GHLIQUID-1516)||0||
60153743|NCT00184717|76279142|FG000|NOT COMPLETED|Main Period (GHLIQUID-1516)||3||
60153744|NCT00184717|76279143|FG001|NOT COMPLETED|Main Period (GHLIQUID-1516)||2||
60153745|NCT00184717|76279144|FG002|NOT COMPLETED|Main Period (GHLIQUID-1516)||1||
60153746|NCT00184717|76279145|FG003|NOT COMPLETED|Main Period (GHLIQUID-1516)||0||
60153747|NCT00184717|76279146|FG004|NOT COMPLETED|Main Period (GHLIQUID-1516)||0||
60153748|NCT00184717|76279142|FG000|STARTED|Extension Period (GHLIQUID-1517)|Three subjects did not continue in extension period|33||
60153749|NCT00184717|76279143|FG001|STARTED|Extension Period (GHLIQUID-1517)|Three subjects did not continue in extension period|33||
60153750|NCT00184717|76279144|FG002|STARTED|Extension Period (GHLIQUID-1517)|Re-randomised to receive 0.033 or 0.067 mg|0||
60153751|NCT00184717|76279145|FG003|STARTED|Extension Period (GHLIQUID-1517)|Re-randomised from No treatment group|10||
60153752|NCT00184717|76279146|FG004|STARTED|Extension Period (GHLIQUID-1517)|Re-randomised from No treatment group|10||
60153753|NCT00184717|76279142|FG000|COMPLETED|Extension Period (GHLIQUID-1517)||23||
60153754|NCT00184717|76279143|FG001|COMPLETED|Extension Period (GHLIQUID-1517)||27||
60153755|NCT00184717|76279144|FG002|COMPLETED|Extension Period (GHLIQUID-1517)||0||
60153756|NCT00184717|76279145|FG003|COMPLETED|Extension Period (GHLIQUID-1517)||7||
60153757|NCT00184717|76279146|FG004|COMPLETED|Extension Period (GHLIQUID-1517)||5||
60153758|NCT00184717|76279142|FG000|NOT COMPLETED|Extension Period (GHLIQUID-1517)||10||
59882304|NCT02955069|76005214|FG000|Immunogenicity (IG) Prevalence Set|Overall Study||94|All subjects in the FAS with a baseline or at least one post-baseline IG sample.|
59882305|NCT02955069|76005215|FG001|Immunogenicity (IG) Prevalence Set|Overall Study||21|All subjects in the FAS with a baseline or at least one post-baseline IG sample.|
59882306|NCT02955069|76005214|FG000|IG Incidence Set|Overall Study||84|All subjects in the IG prevalence set with a baseline and at least one post-baseline IG sample.|
59882307|NCT02955069|76005215|FG001|IG Incidence Set|Overall Study||17|All subjects in the IG prevalence set with a baseline and at least one post-baseline IG sample.|
60153759|NCT00184717|76279143|FG001|NOT COMPLETED|Extension Period (GHLIQUID-1517)||6||
60153760|NCT00184717|76279144|FG002|NOT COMPLETED|Extension Period (GHLIQUID-1517)||0||
60153761|NCT00184717|76279145|FG003|NOT COMPLETED|Extension Period (GHLIQUID-1517)||3||
60153762|NCT00184717|76279146|FG004|NOT COMPLETED|Extension Period (GHLIQUID-1517)||5||
60153763|NCT00091507|76279158|FG000|STARTED|Overall Study||432||
60153764|NCT00091507|76279159|FG001|STARTED|Overall Study||479||
60153765|NCT00091507|76279158|FG000|COMPLETED|Overall Study||411||
60153766|NCT00091507|76279159|FG001|COMPLETED|Overall Study||460||
60153767|NCT00091507|76279158|FG000|NOT COMPLETED|Overall Study||21||
60153768|NCT00091507|76279159|FG001|NOT COMPLETED|Overall Study||19||
60153769|NCT00194779|76279165|FG000|STARTED|Overall Study||50||
60153770|NCT00194779|76279165|FG000|COMPLETED|Overall Study||50||
60153771|NCT00194779|76279165|FG000|NOT COMPLETED|Overall Study||0||
60153772|NCT00093847|76279171|FG000|STARTED|Overall Study||39||
60153773|NCT00093847|76279172|FG001|STARTED|Overall Study||34||
60153774|NCT00093847|76279171|FG000|COMPLETED|Overall Study||31||
60153775|NCT00093847|76279172|FG001|COMPLETED|Overall Study||24||
60153776|NCT00093847|76279171|FG000|NOT COMPLETED|Overall Study||8||
60153777|NCT00093847|76279172|FG001|NOT COMPLETED|Overall Study||10||
60153778|NCT02096575|76279180|FG000|STARTED|Overall Study||68||
60153779|NCT02096575|76279181|FG001|STARTED|Overall Study||67||
60153780|NCT02096575|76279182|FG002|STARTED|Overall Study||5||
60153781|NCT02096575|76279180|FG000|COMPLETED|Overall Study||68||
60153782|NCT02096575|76279181|FG001|COMPLETED|Overall Study||67||
60153783|NCT02096575|76279182|FG002|COMPLETED|Overall Study||0||
60153784|NCT02096575|76279180|FG000|NOT COMPLETED|Overall Study||0||
60153785|NCT02096575|76279181|FG001|NOT COMPLETED|Overall Study||0||
60153786|NCT02096575|76279182|FG002|NOT COMPLETED|Overall Study||5||
60153787|NCT00095563|76279189|FG000|STARTED|Overall Study||39||
60153788|NCT00095563|76279189|FG000|COMPLETED|Overall Study||39||
60153789|NCT00095563|76279189|FG000|NOT COMPLETED|Overall Study||0||
60153790|NCT00089609|76279195|FG000|STARTED|Overall Study||60||
60153791|NCT00089609|76279196|FG001|STARTED|Overall Study||13||
59882308|NCT02955069|76005214|FG000|COMPLETED|Overall Study||0||
59882309|NCT02955069|76005215|FG001|COMPLETED|Overall Study||0||
59882310|NCT02955069|76005214|FG000|NOT COMPLETED|Overall Study||95||
59882311|NCT02955069|76005215|FG001|NOT COMPLETED|Overall Study||21||
59882312|NCT03254108|76005228|FG000|STARTED|Overall Study||13||
60153792|NCT00089609|76279195|FG000|COMPLETED|Overall Study||57||
60153793|NCT00089609|76279196|FG001|COMPLETED|Overall Study||12||
60153794|NCT00089609|76279195|FG000|NOT COMPLETED|Overall Study||3||
60153795|NCT00089609|76279196|FG001|NOT COMPLETED|Overall Study||1||
60153796|NCT00195013|76279207|FG000|STARTED|Overall Study||14||
60153797|NCT00195013|76279208|FG001|STARTED|Overall Study||16||
60153798|NCT00195013|76279207|FG000|COMPLETED|Overall Study||12||
60153799|NCT00195013|76279208|FG001|COMPLETED|Overall Study||15||
60153800|NCT00195013|76279207|FG000|NOT COMPLETED|Overall Study||2||
60153801|NCT00195013|76279208|FG001|NOT COMPLETED|Overall Study||1||
60153802|NCT04678505|76279216|FG000|STARTED|Overall Study||4||
60153803|NCT04678505|76279217|FG001|STARTED|Overall Study||5||
60153804|NCT04678505|76279218|FG002|STARTED|Overall Study||0||
60153805|NCT04678505|76279219|FG003|STARTED|Overall Study||0||
60153806|NCT04678505|76279220|FG004|STARTED|Overall Study||0||
60153807|NCT04678505|76279216|FG000|COMPLETED|Overall Study||4||
60153808|NCT04678505|76279217|FG001|COMPLETED|Overall Study||5||
60153809|NCT04678505|76279218|FG002|COMPLETED|Overall Study||0||
60153810|NCT04678505|76279219|FG003|COMPLETED|Overall Study||0||
60153811|NCT04678505|76279220|FG004|COMPLETED|Overall Study||0||
60153812|NCT04678505|76279216|FG000|NOT COMPLETED|Overall Study||0||
60153813|NCT04678505|76279217|FG001|NOT COMPLETED|Overall Study||0||
60153814|NCT04678505|76279218|FG002|NOT COMPLETED|Overall Study||0||
60153815|NCT04678505|76279219|FG003|NOT COMPLETED|Overall Study||0||
60153816|NCT04678505|76279220|FG004|NOT COMPLETED|Overall Study||0||
60153817|NCT00195403|76279227|FG000|STARTED|Overall Study||1014||
60153818|NCT00195403|76279227|FG000|COMPLETED|Overall Study||1014||
60153819|NCT00195403|76279227|FG000|NOT COMPLETED|Overall Study||0||
60153820|NCT00197119|76279233|FG000|STARTED|Year 6||126||
60153821|NCT00197119|76279234|FG001|STARTED|Year 6||118||
60153822|NCT00197119|76279233|FG000|COMPLETED|Year 6||126||
60153823|NCT00197119|76279234|FG001|COMPLETED|Year 6||118||
60153824|NCT00197119|76279233|FG000|NOT COMPLETED|Year 6||0||
60153825|NCT00197119|76279234|FG001|NOT COMPLETED|Year 6||0||
60153826|NCT00197119|76279233|FG000|STARTED|Year 7|4 subjects who participated in the Year 6 follow-up time point did not return for this time point.|122||
60153827|NCT00197119|76279234|FG001|STARTED|Year 7|4 subjects who participated in the Year 6 follow-up time point did not return for this time point.|114||
60153828|NCT00197119|76279233|FG000|COMPLETED|Year 7||122||
60153829|NCT00197119|76279234|FG001|COMPLETED|Year 7||114||
60153830|NCT00197119|76279233|FG000|NOT COMPLETED|Year 7||0||
60153831|NCT00197119|76279234|FG001|NOT COMPLETED|Year 7||0||
60153832|NCT00197119|76279233|FG000|STARTED|Year 8||122||
60153833|NCT00197119|76279234|FG001|STARTED|Year 8|One additional subject (compared to Year 7) participated in the current follow-up time point.|115||
60153834|NCT00197119|76279233|FG000|COMPLETED|Year 8||122||
60153835|NCT00197119|76279234|FG001|COMPLETED|Year 8||115||
60153836|NCT00197119|76279233|FG000|NOT COMPLETED|Year 8||0||
60153837|NCT00197119|76279234|FG001|NOT COMPLETED|Year 8||0||
60153838|NCT00197119|76279233|FG000|STARTED|Year 9|One subject participating in the Year 8 time point did not return for the current time point.|121||
60153839|NCT00197119|76279234|FG001|STARTED|Year 9|One subject participating in the Year 8 time point did not return for the current time point.|114||
60153840|NCT00197119|76279233|FG000|COMPLETED|Year 9||121||
60153841|NCT00197119|76279234|FG001|COMPLETED|Year 9||114||
60153842|NCT00197119|76279233|FG000|NOT COMPLETED|Year 9||0||
60153843|NCT00197119|76279234|FG001|NOT COMPLETED|Year 9||0||
60153844|NCT00197119|76279233|FG000|STARTED|Year 10|One subject participating in the Year 9 time point did not return for the current time point.|120||
60153845|NCT00197119|76279234|FG001|STARTED|Year 10|Six subjects participating in the Year 9 time point did not return for the current time point.|108||
60153846|NCT00197119|76279233|FG000|COMPLETED|Year 10||120||
60153847|NCT00197119|76279234|FG001|COMPLETED|Year 10||108||
60153848|NCT00197119|76279233|FG000|NOT COMPLETED|Year 10||0||
60153849|NCT00197119|76279234|FG001|NOT COMPLETED|Year 10||0||
60153850|NCT00095875|76279242|FG000|STARTED|Overall Study||70||
60153851|NCT00095875|76279243|FG001|STARTED|Overall Study||75||
60153852|NCT00095875|76279242|FG000|COMPLETED|Overall Study||56||
60153853|NCT00095875|76279243|FG001|COMPLETED|Overall Study||66||
60153854|NCT00095875|76279242|FG000|NOT COMPLETED|Overall Study||14||
60153855|NCT00095875|76279243|FG001|NOT COMPLETED|Overall Study||9||
60153856|NCT00006227|76279249|FG000|STARTED|Overall Study||31||
60153857|NCT00006227|76279249|FG000|COMPLETED|Overall Study||31||
60153858|NCT00006227|76279249|FG000|NOT COMPLETED|Overall Study||0||
60153859|NCT00096109|76279253|FG000|STARTED|Overall Study||11||
60153860|NCT00096109|76279253|FG000|COMPLETED|Overall Study||11||
60153861|NCT00096109|76279253|FG000|NOT COMPLETED|Overall Study||0||
60153862|NCT00097669|76279259|FG000|STARTED|Overall Study||4089||
60153863|NCT00097669|76279260|FG001|STARTED|Overall Study||4075||
60153864|NCT00097669|76279259|FG000|COMPLETED|Overall Study||4089||
60153865|NCT00097669|76279260|FG001|COMPLETED|Overall Study||4075||
60153866|NCT00097669|76279259|FG000|NOT COMPLETED|Overall Study||0||
60153867|NCT00097669|76279260|FG001|NOT COMPLETED|Overall Study||0||
60153868|NCT00010439|76279266|FG000|STARTED|Overall Study||10||
60153869|NCT00010439|76279266|FG000|6 Months|Overall Study||10||
60153870|NCT00010439|76279266|FG000|COMPLETED|Overall Study||10||
60153871|NCT00010439|76279266|FG000|NOT COMPLETED|Overall Study||0||
60153872|NCT00200161|76279272|FG000|STARTED|Overall Study||43||
60153873|NCT00200161|76279273|FG001|STARTED|Overall Study||42||
60153874|NCT00200161|76279272|FG000|COMPLETED|Overall Study||43||
60153875|NCT00200161|76279273|FG001|COMPLETED|Overall Study||42||
60153876|NCT00200161|76279272|FG000|NOT COMPLETED|Overall Study||0||
60153877|NCT00200161|76279273|FG001|NOT COMPLETED|Overall Study||0||
60153878|NCT00200785|76279281|FG000|STARTED|First Intervention||9||
60153879|NCT00200785|76279282|FG001|STARTED|First Intervention||6||
60153880|NCT00200785|76279281|FG000|COMPLETED|First Intervention||9||
60153881|NCT00200785|76279282|FG001|COMPLETED|First Intervention||6||
60153882|NCT00200785|76279281|FG000|NOT COMPLETED|First Intervention||0||
60153883|NCT00200785|76279282|FG001|NOT COMPLETED|First Intervention||0||
60153884|NCT00200785|76279281|FG000|STARTED|Washout Period of 1 Week||9||
60153885|NCT00200785|76279282|FG001|STARTED|Washout Period of 1 Week||6||
60153886|NCT00200785|76279281|FG000|COMPLETED|Washout Period of 1 Week||9||
60153887|NCT00200785|76279282|FG001|COMPLETED|Washout Period of 1 Week||6||
60153888|NCT00200785|76279281|FG000|NOT COMPLETED|Washout Period of 1 Week||0||
60153889|NCT00200785|76279282|FG001|NOT COMPLETED|Washout Period of 1 Week||0||
60153890|NCT00200785|76279281|FG000|STARTED|Second Intervention||9||
60153891|NCT00200785|76279282|FG001|STARTED|Second Intervention||6||
60153892|NCT00200785|76279281|FG000|COMPLETED|Second Intervention||9||
60153893|NCT00200785|76279282|FG001|COMPLETED|Second Intervention||6||
60153894|NCT00200785|76279281|FG000|NOT COMPLETED|Second Intervention||0||
60153895|NCT00200785|76279282|FG001|NOT COMPLETED|Second Intervention||0||
60153896|NCT00016913|76279288|FG000|STARTED|Overall Study||27||
60153897|NCT00016913|76279288|FG000|COMPLETED|Overall Study||27||
60153898|NCT00016913|76279288|FG000|NOT COMPLETED|Overall Study||0||
60153899|NCT00201409|76279294|FG000|STARTED|Overall Study||65||
60153900|NCT00201409|76279295|FG001|STARTED|Overall Study||67||
60153901|NCT00201409|76279294|FG000|COMPLETED|Overall Study||64||
60153902|NCT00201409|76279295|FG001|COMPLETED|Overall Study||66||
60153903|NCT00201409|76279294|FG000|NOT COMPLETED|Overall Study||1||
60153904|NCT00201409|76279295|FG001|NOT COMPLETED|Overall Study||1||
60153905|NCT00023309|76279303|FG000|STARTED|Overall Study||22||
60153906|NCT00023309|76279304|FG001|STARTED|Overall Study||19||
60153907|NCT00023309|76279303|FG000|COMPLETED|Overall Study||22||
60153908|NCT00023309|76279304|FG001|COMPLETED|Overall Study||19||
60153909|NCT00023309|76279303|FG000|NOT COMPLETED|Overall Study||0||
60153910|NCT00023309|76279304|FG001|NOT COMPLETED|Overall Study||0||
60153911|NCT02233101|76279312|FG000|STARTED|Overall Study||86||
60153912|NCT02233101|76279313|FG001|STARTED|Overall Study||81||
60153913|NCT02233101|76279312|FG000|COMPLETED|Overall Study||74||
60153914|NCT02233101|76279313|FG001|COMPLETED|Overall Study||80||
60153915|NCT02233101|76279312|FG000|NOT COMPLETED|Overall Study||12||
60153916|NCT02233101|76279313|FG001|NOT COMPLETED|Overall Study||1||
60153917|NCT00098059|76279321|FG000|STARTED|Overall Study||27||
60153918|NCT00098059|76279322|FG001|STARTED|Overall Study||47||
60153919|NCT00098059|76279321|FG000|COMPLETED|Overall Study||27||
60153920|NCT00098059|76279322|FG001|COMPLETED|Overall Study||46||
60153921|NCT00098059|76279321|FG000|NOT COMPLETED|Overall Study||0||
60153922|NCT00098059|76279322|FG001|NOT COMPLETED|Overall Study||1||
60153923|NCT02440581|76279337|FG000|STARTED|Overall Study||37||
60153924|NCT02440581|76279338|FG001|STARTED|Overall Study||24||
60153925|NCT02440581|76279339|FG002|STARTED|Overall Study||50||
60153926|NCT02440581|76279340|FG003|STARTED|Overall Study||30||
60153927|NCT02440581|76279337|FG000|COMPLETED|Overall Study||32||
60153928|NCT02440581|76279338|FG001|COMPLETED|Overall Study||13||
60153929|NCT02440581|76279339|FG002|COMPLETED|Overall Study||37||
60153930|NCT02440581|76279340|FG003|COMPLETED|Overall Study||16||
60153931|NCT02440581|76279337|FG000|NOT COMPLETED|Overall Study||5||
60153932|NCT02440581|76279338|FG001|NOT COMPLETED|Overall Study||11||
60153933|NCT02440581|76279339|FG002|NOT COMPLETED|Overall Study||13||
60153934|NCT02440581|76279340|FG003|NOT COMPLETED|Overall Study||14||
60153935|NCT01359150|76279352|FG000|STARTED|Overall Study||112||
60153936|NCT01359150|76279353|FG001|STARTED|Overall Study||111||
60153937|NCT01359150|76279352|FG000|COMPLETED|Overall Study||105||
60153938|NCT01359150|76279353|FG001|COMPLETED|Overall Study||106||
60153939|NCT01359150|76279352|FG000|NOT COMPLETED|Overall Study||7||
60153940|NCT01359150|76279353|FG001|NOT COMPLETED|Overall Study||5||
60153941|NCT00098371|76279359|FG000|STARTED|Overall Study||64||
60153942|NCT00098371|76279359|FG000|COMPLETED|Overall Study||64||
60153943|NCT00098371|76279359|FG000|NOT COMPLETED|Overall Study||0||
60153944|NCT01647945|76279378|FG000|STARTED|Overall Study||6||
60153945|NCT01647945|76279379|FG001|STARTED|Overall Study||6||
60153946|NCT01647945|76279380|FG002|STARTED|Overall Study||5||
60153947|NCT01647945|76279381|FG003|STARTED|Overall Study||6||
60153948|NCT01647945|76279378|FG000|COMPLETED|Overall Study||6||
60153949|NCT01647945|76279379|FG001|COMPLETED|Overall Study||6||
60153950|NCT01647945|76279380|FG002|COMPLETED|Overall Study||3||
60153951|NCT01647945|76279381|FG003|COMPLETED|Overall Study||5||
60153952|NCT01647945|76279378|FG000|NOT COMPLETED|Overall Study||0||
60153953|NCT01647945|76279379|FG001|NOT COMPLETED|Overall Study||0||
60153954|NCT01647945|76279380|FG002|NOT COMPLETED|Overall Study||2||
60153955|NCT01647945|76279381|FG003|NOT COMPLETED|Overall Study||1||
60153956|NCT01648491|76279391|FG000|STARTED|Overall Study||1||
60153957|NCT01648491|76279391|FG000|COMPLETED|Overall Study||1||
60153958|NCT01648491|76279391|FG000|NOT COMPLETED|Overall Study||0||
60153959|NCT00100165|76279399|FG000|STARTED|Baseline||10||
60153960|NCT00100165|76279400|FG001|STARTED|Baseline||10||
60153961|NCT00100165|76279401|FG002|STARTED|Baseline||9||
60153962|NCT00100165|76279399|FG000|COMPLETED|Baseline||10||
60153963|NCT00100165|76279400|FG001|COMPLETED|Baseline||10||
60153964|NCT00100165|76279401|FG002|COMPLETED|Baseline||9||
60153965|NCT00100165|76279399|FG000|NOT COMPLETED|Baseline||0||
60153966|NCT00100165|76279400|FG001|NOT COMPLETED|Baseline||0||
60153967|NCT00100165|76279401|FG002|NOT COMPLETED|Baseline||0||
60153968|NCT00100165|76279399|FG000|STARTED|First Intervention (4 Weeks)||10||
60153969|NCT00100165|76279400|FG001|STARTED|First Intervention (4 Weeks)||10||
60153970|NCT00100165|76279401|FG002|STARTED|First Intervention (4 Weeks)||9||
60153971|NCT00100165|76279399|FG000|COMPLETED|First Intervention (4 Weeks)||10||
60153972|NCT00100165|76279400|FG001|COMPLETED|First Intervention (4 Weeks)||10||
60153973|NCT00100165|76279401|FG002|COMPLETED|First Intervention (4 Weeks)||9||
60153974|NCT00100165|76279399|FG000|NOT COMPLETED|First Intervention (4 Weeks)||0||
60153975|NCT00100165|76279400|FG001|NOT COMPLETED|First Intervention (4 Weeks)||0||
60153976|NCT00100165|76279401|FG002|NOT COMPLETED|First Intervention (4 Weeks)||0||
60153977|NCT00100165|76279399|FG000|STARTED|Washout (1 Week)||10||
60153978|NCT00100165|76279400|FG001|STARTED|Washout (1 Week)||10||
60153979|NCT00100165|76279401|FG002|STARTED|Washout (1 Week)||9||
60153980|NCT00100165|76279399|FG000|COMPLETED|Washout (1 Week)||10||
60153981|NCT00100165|76279400|FG001|COMPLETED|Washout (1 Week)||10||
60153982|NCT00100165|76279401|FG002|COMPLETED|Washout (1 Week)||9||
60153983|NCT00100165|76279399|FG000|NOT COMPLETED|Washout (1 Week)||0||
60153984|NCT00100165|76279400|FG001|NOT COMPLETED|Washout (1 Week)||0||
60153985|NCT00100165|76279401|FG002|NOT COMPLETED|Washout (1 Week)||0||
60153986|NCT00100165|76279399|FG000|STARTED|Second Intervention (4 Weeks)||10||
60153987|NCT00100165|76279400|FG001|STARTED|Second Intervention (4 Weeks)||10||
60153988|NCT00100165|76279401|FG002|STARTED|Second Intervention (4 Weeks)||9||
60153989|NCT00100165|76279399|FG000|COMPLETED|Second Intervention (4 Weeks)||10||
60153990|NCT00100165|76279400|FG001|COMPLETED|Second Intervention (4 Weeks)||10||
60153991|NCT00100165|76279401|FG002|COMPLETED|Second Intervention (4 Weeks)||9||
60153992|NCT00100165|76279399|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0||
60153993|NCT00100165|76279400|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||0||
60153994|NCT00100165|76279401|FG002|NOT COMPLETED|Second Intervention (4 Weeks)||0||
60153995|NCT00100165|76279399|FG000|STARTED|Washout (1 Week)||10||
60153996|NCT00100165|76279400|FG001|STARTED|Washout (1 Week)||10||
60153997|NCT00100165|76279401|FG002|STARTED|Washout (1 Week)||9||
60153998|NCT00100165|76279399|FG000|COMPLETED|Washout (1 Week)||10||
60153999|NCT00100165|76279400|FG001|COMPLETED|Washout (1 Week)||10||
60154000|NCT00100165|76279401|FG002|COMPLETED|Washout (1 Week)||9||
60154001|NCT00100165|76279399|FG000|NOT COMPLETED|Washout (1 Week)||0||
60154002|NCT00100165|76279400|FG001|NOT COMPLETED|Washout (1 Week)||0||
60154003|NCT00100165|76279401|FG002|NOT COMPLETED|Washout (1 Week)||0||
60154004|NCT00100165|76279399|FG000|STARTED|Third Intervention (4 Weeks)||10||
60154005|NCT00100165|76279400|FG001|STARTED|Third Intervention (4 Weeks)||10||
60154006|NCT00100165|76279401|FG002|STARTED|Third Intervention (4 Weeks)||9||
60154007|NCT00100165|76279399|FG000|COMPLETED|Third Intervention (4 Weeks)||10||
60154008|NCT00100165|76279400|FG001|COMPLETED|Third Intervention (4 Weeks)||10||
60154009|NCT00100165|76279401|FG002|COMPLETED|Third Intervention (4 Weeks)||9||
60154010|NCT00100165|76279399|FG000|NOT COMPLETED|Third Intervention (4 Weeks)||0||
60154011|NCT00100165|76279400|FG001|NOT COMPLETED|Third Intervention (4 Weeks)||0||
60154012|NCT00100165|76279401|FG002|NOT COMPLETED|Third Intervention (4 Weeks)||0||
60154013|NCT01469000|76279414|FG000|STARTED|Overall Study||129||
60154014|NCT01469000|76279415|FG001|STARTED|Overall Study||66||
60154015|NCT01469000|76279414|FG000|Received at Least 1 Dose of Study Drug|Overall Study||126||
60154016|NCT01469000|76279415|FG001|Received at Least 1 Dose of Study Drug|Overall Study||65||
60154017|NCT01469000|76279414|FG000|COMPLETED|Overall Study||109||
60154018|NCT01469000|76279415|FG001|COMPLETED|Overall Study||62||
60154019|NCT01469000|76279414|FG000|NOT COMPLETED|Overall Study||20||
60154020|NCT01469000|76279415|FG001|NOT COMPLETED|Overall Study||4||
60154021|NCT00201877|76279421|FG000|STARTED|Overall Study||25||
60154022|NCT00201877|76279421|FG000|COMPLETED|Overall Study||25||
60154023|NCT00201877|76279421|FG000|NOT COMPLETED|Overall Study||0||
60154024|NCT01490060|76279428|FG000|STARTED|Cycle 1||11||
60154025|NCT01490060|76279429|FG001|STARTED|Cycle 1||13||
60154026|NCT01490060|76279430|FG002|STARTED|Cycle 1||12||
60154027|NCT01490060|76279431|FG003|STARTED|Cycle 1||11||
60154028|NCT01490060|76279428|FG000|COMPLETED|Cycle 1||11||
60154029|NCT01490060|76279429|FG001|COMPLETED|Cycle 1||12||
60154030|NCT01490060|76279430|FG002|COMPLETED|Cycle 1||9||
60154031|NCT01490060|76279431|FG003|COMPLETED|Cycle 1||8||
60154032|NCT01490060|76279428|FG000|NOT COMPLETED|Cycle 1||0||
60154033|NCT01490060|76279429|FG001|NOT COMPLETED|Cycle 1||1||
60154034|NCT01490060|76279430|FG002|NOT COMPLETED|Cycle 1||3||
60154035|NCT01490060|76279431|FG003|NOT COMPLETED|Cycle 1||3||
60154036|NCT01490060|76279428|FG000|STARTED|Cycle 2||11||
60154037|NCT01490060|76279429|FG001|STARTED|Cycle 2||12||
60154038|NCT01490060|76279430|FG002|STARTED|Cycle 2||9||
60154039|NCT01490060|76279431|FG003|STARTED|Cycle 2||8||
60154040|NCT01490060|76279428|FG000|COMPLETED|Cycle 2||9||
60154041|NCT01490060|76279429|FG001|COMPLETED|Cycle 2||11||
59605814|NCT01964352|75715973|FG003|STARTED|Overall Study||203||
60154042|NCT01490060|76279430|FG002|COMPLETED|Cycle 2||8||
60154043|NCT01490060|76279431|FG003|COMPLETED|Cycle 2||8||
60154044|NCT01490060|76279428|FG000|NOT COMPLETED|Cycle 2||2||
60154045|NCT01490060|76279429|FG001|NOT COMPLETED|Cycle 2||1||
60154046|NCT01490060|76279430|FG002|NOT COMPLETED|Cycle 2||1||
60154047|NCT01490060|76279431|FG003|NOT COMPLETED|Cycle 2||0||
60154048|NCT01652001|76279441|FG000|STARTED|Overall Study||100||
60154049|NCT01652001|76279442|FG001|STARTED|Overall Study||85||
60154050|NCT01652001|76279441|FG000|COMPLETED|Overall Study||91||
60154051|NCT01652001|76279442|FG001|COMPLETED|Overall Study||79||
60154052|NCT01652001|76279441|FG000|NOT COMPLETED|Overall Study||9||
59605815|NCT01964352|75715970|FG000|COMPLETED|Overall Study||178||
60154053|NCT01652001|76279442|FG001|NOT COMPLETED|Overall Study||6||
60154054|NCT03557892|76279450|FG000|STARTED|Overall Study||14||
60154055|NCT03557892|76279451|FG001|STARTED|Overall Study||14||
60154056|NCT03557892|76279450|FG000|COMPLETED|Overall Study||14||
60154057|NCT03557892|76279451|FG001|COMPLETED|Overall Study||14||
60154058|NCT03557892|76279450|FG000|NOT COMPLETED|Overall Study||0||
60154059|NCT03557892|76279451|FG001|NOT COMPLETED|Overall Study||0||
60154060|NCT01653405|76279459|FG000|STARTED|Overall Study||11794||8
60154061|NCT01653405|76279460|FG001|STARTED|Overall Study||1248782||116
60154062|NCT01653405|76279459|FG000|COMPLETED|Overall Study|These patients had enough data to calculate TTR.|8029||8
60154063|NCT01653405|76279460|FG001|COMPLETED|Overall Study|These patients had enough data to calculate TTR.|179979||116
60154064|NCT01653405|76279459|FG000|NOT COMPLETED|Overall Study||3765||0
60154065|NCT01653405|76279460|FG001|NOT COMPLETED|Overall Study||1068803||0
60154066|NCT00101413|76279466|FG000|STARTED|Overall Study||52||
60154067|NCT00101413|76279466|FG000|COMPLETED|Overall Study|Safety data collected for 4 subjects after 30 Jun 2005 until 11 Apr 2008.|52||
60154068|NCT00101413|76279466|FG000|NOT COMPLETED|Overall Study||0||
60154069|NCT03515226|76279472|FG000|STARTED|Overall Study||10||
60154070|NCT03515226|76279473|FG001|STARTED|Overall Study||15||
60154071|NCT03515226|76279472|FG000|COMPLETED|Overall Study||8||
60154072|NCT03515226|76279473|FG001|COMPLETED|Overall Study||11||
60154073|NCT03515226|76279472|FG000|NOT COMPLETED|Overall Study||2||
60154074|NCT03515226|76279473|FG001|NOT COMPLETED|Overall Study||4||
60154075|NCT01452152|76279483|FG000|STARTED|Overall Study||5||
60154076|NCT01452152|76279484|FG001|STARTED|Overall Study||0||
60154077|NCT01452152|76279485|FG002|STARTED|Overall Study||4||
60154078|NCT01452152|76279483|FG000|COMPLETED|Overall Study||0||
60154079|NCT01452152|76279484|FG001|COMPLETED|Overall Study||0||
60154080|NCT01452152|76279485|FG002|COMPLETED|Overall Study||0||
60154081|NCT01452152|76279483|FG000|NOT COMPLETED|Overall Study||5||
60154082|NCT01452152|76279484|FG001|NOT COMPLETED|Overall Study||0||
60154083|NCT01452152|76279485|FG002|NOT COMPLETED|Overall Study||4||
60154084|NCT01451762|76279496|FG000|STARTED|Overall Study||30||
60154085|NCT01451762|76279497|FG001|STARTED|Overall Study||30||
60154086|NCT01451762|76279498|FG002|STARTED|Overall Study||30||
60154087|NCT01451762|76279496|FG000|COMPLETED|Overall Study||27||
60154088|NCT01451762|76279497|FG001|COMPLETED|Overall Study||24||
60154089|NCT01451762|76279498|FG002|COMPLETED|Overall Study||24||
60154090|NCT01451762|76279496|FG000|NOT COMPLETED|Overall Study||3||
60154091|NCT01451762|76279497|FG001|NOT COMPLETED|Overall Study||6||
60154092|NCT01451762|76279498|FG002|NOT COMPLETED|Overall Study||6||
60154093|NCT01654107|76279508|FG000|STARTED|Overall Study||28||
60154094|NCT01654107|76279509|FG001|STARTED|Overall Study||30||
60154095|NCT01654107|76279508|FG000|COMPLETED|Overall Study||25||
60154096|NCT01654107|76279509|FG001|COMPLETED|Overall Study||22||
60154097|NCT01654107|76279508|FG000|NOT COMPLETED|Overall Study||3||
60154098|NCT01654107|76279509|FG001|NOT COMPLETED|Overall Study||8||
60154099|NCT03253926|76279515|FG000|STARTED|Overall Study||7||
60154100|NCT03253926|76279516|FG001|STARTED|Overall Study||8||
60154101|NCT03253926|76279515|FG000|COMPLETED|Overall Study||7||
60154102|NCT03253926|76279516|FG001|COMPLETED|Overall Study||8||
60154103|NCT03253926|76279515|FG000|NOT COMPLETED|Overall Study||0||
60154104|NCT03253926|76279516|FG001|NOT COMPLETED|Overall Study||0||
60154105|NCT03085680|76279524|FG000|STARTED|Overall Study||9||
60154106|NCT03085680|76279525|FG001|STARTED|Overall Study||8||
60154107|NCT03085680|76279524|FG000|COMPLETED|Overall Study||9||
60154108|NCT03085680|76279525|FG001|COMPLETED|Overall Study||8||
60154109|NCT03085680|76279524|FG000|NOT COMPLETED|Overall Study||0||
60154110|NCT03085680|76279525|FG001|NOT COMPLETED|Overall Study||0||
60154111|NCT01468844|76279533|FG000|STARTED|Overall Study||4||
60154112|NCT01468844|76279534|FG001|STARTED|Overall Study||2||
60154113|NCT01468844|76279533|FG000|COMPLETED|Overall Study||2||
60154114|NCT01468844|76279534|FG001|COMPLETED|Overall Study||2||
60154115|NCT01468844|76279533|FG000|NOT COMPLETED|Overall Study||2||
60154116|NCT01468844|76279534|FG001|NOT COMPLETED|Overall Study||0||
60154117|NCT03029598|76279543|FG000|STARTED|Overall Study||29||
59751739|NCT00844545|75871093|FG000|STARTED|Treatment Period (26 Weeks)||17||
59751740|NCT00844545|75871093|FG000|COMPLETED|Treatment Period (26 Weeks)||15||
59751741|NCT00844545|75871093|FG000|NOT COMPLETED|Treatment Period (26 Weeks)||2||
59751742|NCT00844545|75871093|FG000|STARTED|Extension Treatment Period||13||
59751743|NCT00844545|75871093|FG000|COMPLETED|Extension Treatment Period||11||
60154118|NCT03029598|76279543|FG000|COMPLETED|Overall Study||29||
60154119|NCT03029598|76279543|FG000|NOT COMPLETED|Overall Study||0||
60154120|NCT00203203|76279549|FG000|STARTED|Overall Study||10||
60154121|NCT00203203|76279550|FG001|STARTED|Overall Study||20||
60154122|NCT00203203|76279549|FG000|COMPLETED|Overall Study||9||
59751744|NCT00844545|75871093|FG000|NOT COMPLETED|Extension Treatment Period||2||
60154123|NCT00203203|76279550|FG001|COMPLETED|Overall Study||20||
60154124|NCT00203203|76279549|FG000|NOT COMPLETED|Overall Study||1||
60154125|NCT00203203|76279550|FG001|NOT COMPLETED|Overall Study||0||
60154126|NCT01451606|76279558|FG000|STARTED|Overall Study||16||
60154127|NCT01451606|76279559|FG001|STARTED|Overall Study||18||
60154128|NCT01451606|76279558|FG000|COMPLETED|Overall Study||12||
60154129|NCT01451606|76279559|FG001|COMPLETED|Overall Study||15||
60154130|NCT01451606|76279558|FG000|NOT COMPLETED|Overall Study||4||
60154131|NCT01451606|76279559|FG001|NOT COMPLETED|Overall Study||3||
60154132|NCT00204373|76279565|FG000|STARTED|Overall Study||72||
60154133|NCT00204373|76279565|FG000|COMPLETED|Overall Study||72||
60154134|NCT00204373|76279565|FG000|NOT COMPLETED|Overall Study||0||
60154135|NCT01654263|76279575|FG000|STARTED|Overall Study||164||
60154136|NCT01654263|76279576|FG001|STARTED|Overall Study||147||
60154137|NCT01654263|76279577|FG002|STARTED|Overall Study||139||
60154138|NCT01654263|76279578|FG003|STARTED|Overall Study||145||
60154139|NCT01654263|76279579|FG004|STARTED|Overall Study||140||
60154140|NCT01654263|76279580|FG005|STARTED|Overall Study||149||
60154141|NCT01654263|76279575|FG000|COMPLETED|Overall Study||164||
60154142|NCT01654263|76279576|FG001|COMPLETED|Overall Study||147||
60154143|NCT01654263|76279577|FG002|COMPLETED|Overall Study||137||
60154144|NCT01654263|76279578|FG003|COMPLETED|Overall Study||144||
60154145|NCT01654263|76279579|FG004|COMPLETED|Overall Study||139||
60154146|NCT01654263|76279580|FG005|COMPLETED|Overall Study||148||
60154147|NCT01654263|76279575|FG000|NOT COMPLETED|Overall Study||0||
60154148|NCT01654263|76279576|FG001|NOT COMPLETED|Overall Study||0||
60154149|NCT01654263|76279577|FG002|NOT COMPLETED|Overall Study||2||
60154150|NCT01654263|76279578|FG003|NOT COMPLETED|Overall Study||1||
60154151|NCT01654263|76279579|FG004|NOT COMPLETED|Overall Study||1||
60154152|NCT01654263|76279580|FG005|NOT COMPLETED|Overall Study||1||
60154153|NCT01005615|76279593|FG000|STARTED|Intervention 1||5||
60154154|NCT01005615|76279594|FG001|STARTED|Intervention 1||12||
60154155|NCT01005615|76279593|FG000|COMPLETED|Intervention 1||1||
60154156|NCT01005615|76279594|FG001|COMPLETED|Intervention 1||9||
60154157|NCT01005615|76279593|FG000|NOT COMPLETED|Intervention 1||4||
60154158|NCT01005615|76279594|FG001|NOT COMPLETED|Intervention 1||3||
60154159|NCT01005615|76279593|FG000|STARTED|Washout ()||1||
60154160|NCT01005615|76279594|FG001|STARTED|Washout ()||9||
60154161|NCT01005615|76279593|FG000|COMPLETED|Washout ()||1||
60011107|NCT03073525|76126864|FG000|NOT COMPLETED|Overall Study||0||
60154162|NCT01005615|76279594|FG001|COMPLETED|Washout ()||9||
60154163|NCT01005615|76279593|FG000|NOT COMPLETED|Washout ()||0||
60154164|NCT01005615|76279594|FG001|NOT COMPLETED|Washout ()||0||
60154165|NCT01005615|76279593|FG000|STARTED|Intervention 2||1||
60154166|NCT01005615|76279594|FG001|STARTED|Intervention 2||9||
60154167|NCT01005615|76279593|FG000|COMPLETED|Intervention 2||1||
60154168|NCT01005615|76279594|FG001|COMPLETED|Intervention 2||9||
60154169|NCT01005615|76279593|FG000|NOT COMPLETED|Intervention 2||0||
60154170|NCT01005615|76279594|FG001|NOT COMPLETED|Intervention 2||0||
60154171|NCT01654887|76279602|FG000|STARTED|Overall Study||103||
60154172|NCT01654887|76279603|FG001|STARTED|Overall Study||88||
60154173|NCT01654887|76279602|FG000|COMPLETED|Overall Study||103||
60154174|NCT01654887|76279603|FG001|COMPLETED|Overall Study||88||
60154175|NCT01654887|76279602|FG000|NOT COMPLETED|Overall Study||0||
60154176|NCT01654887|76279603|FG001|NOT COMPLETED|Overall Study||0||
60154177|NCT01655043|76279610|FG000|STARTED|Overall Study||20||
60154178|NCT01655043|76279610|FG000|COMPLETED|Overall Study||20||
60154179|NCT01655043|76279610|FG000|NOT COMPLETED|Overall Study||0||
60154180|NCT00473343|76279614|FG000|STARTED|Overall Study||102||
60154181|NCT00473343|76279614|FG000|COMPLETED|Overall Study||52||
60154182|NCT00473343|76279614|FG000|NOT COMPLETED|Overall Study||50||
60154183|NCT00032591|76279620|FG000|STARTED|Screening|3745 patients provided informed consent and were screened for participation.|1873||
60154184|NCT00032591|76279621|FG001|STARTED|Screening|Treatment assigned at randomization; screening counts by arm represent half of the total screened.|1872||
60154185|NCT00032591|76279620|FG000|COMPLETED|Screening|823 were excluded from the study|1465||
60154186|NCT00032591|76279621|FG001|COMPLETED|Screening||1457||
60154187|NCT00032591|76279620|FG000|NOT COMPLETED|Screening||408||
60011108|NCT03073525|76126865|FG001|NOT COMPLETED|Overall Study||0||
60011109|NCT03073525|76126866|FG002|NOT COMPLETED|Overall Study||3||
60011110|NCT02631551|76126887|FG000|STARTED|Overall Study||302||
60011111|NCT02631551|76126888|FG001|STARTED|Overall Study||297||
60011112|NCT02631551|76126889|FG002|STARTED|Overall Study||294||
60011113|NCT02631551|76126890|FG003|STARTED|Overall Study||287||
60011114|NCT02631551|76126887|FG000|COMPLETED|Overall Study||289||
60011115|NCT02631551|76126888|FG001|COMPLETED|Overall Study||278||
60154188|NCT00032591|76279621|FG001|NOT COMPLETED|Screening||415||
60154189|NCT00032591|76279620|FG000|STARTED|Randomization|2922 underwent randomization|1465||
60154190|NCT00032591|76279621|FG001|STARTED|Randomization||1457||
60154191|NCT00032591|76279620|FG000|COMPLETED|Randomization|1465 were assigned to self-testing|1465||
60154192|NCT00032591|76279621|FG001|COMPLETED|Randomization|1457 were assigned to clinic testing|1457||
60154193|NCT00032591|76279620|FG000|NOT COMPLETED|Randomization||0||
60154194|NCT00032591|76279621|FG001|NOT COMPLETED|Randomization||0||
60154195|NCT00032591|76279620|FG000|STARTED|Follow-up|2 were lost to follow-up, both with Atrial Fibrillation, no Mechanical Heart Valves|1465||
60154196|NCT00032591|76279621|FG001|STARTED|Follow-up|5 were lost to follow-up, all with Atrial Fibrillation, no Mechanical Heart Valves|1457||
60154197|NCT00032591|76279620|FG000|COMPLETED|Follow-up|1463 were included in analysis with greater than 1 day of follow-up|1463||
60154198|NCT00032591|76279621|FG001|COMPLETED|Follow-up|1452 were included in analysis with greater than 1 day of follow-up|1452||
60011116|NCT02631551|76126889|FG002|COMPLETED|Overall Study||283||
60011117|NCT02631551|76126890|FG003|COMPLETED|Overall Study||276||
60154199|NCT00032591|76279620|FG000|NOT COMPLETED|Follow-up||2||
60154200|NCT00032591|76279621|FG001|NOT COMPLETED|Follow-up||5||
60154201|NCT01657617|76279627|FG000|STARTED|Overall Study||35||
60154202|NCT01657617|76279627|FG000|COMPLETED|Overall Study||35||
60154203|NCT01657617|76279627|FG000|NOT COMPLETED|Overall Study||0||
60154204|NCT01660191|76279634|FG000|STARTED|Enrollment and Washout||45||
60154205|NCT01660191|76279635|FG001|STARTED|Enrollment and Washout||45||
60154206|NCT01660191|76279636|FG002|STARTED|Enrollment and Washout||44||
60154207|NCT01660191|76279634|FG000|COMPLETED|Enrollment and Washout||45||
60154208|NCT01660191|76279635|FG001|COMPLETED|Enrollment and Washout||45||
60154209|NCT01660191|76279636|FG002|COMPLETED|Enrollment and Washout||44||
60154210|NCT01660191|76279634|FG000|NOT COMPLETED|Enrollment and Washout||0||
60154211|NCT01660191|76279635|FG001|NOT COMPLETED|Enrollment and Washout||0||
60154212|NCT01660191|76279636|FG002|NOT COMPLETED|Enrollment and Washout||0||
60154213|NCT01660191|76279634|FG000|STARTED|Randomization||45||
60154214|NCT01660191|76279635|FG001|STARTED|Randomization||45||
60154215|NCT01660191|76279636|FG002|STARTED|Randomization||44||
60154216|NCT01660191|76279634|FG000|COMPLETED|Randomization||45||
60154217|NCT01660191|76279635|FG001|COMPLETED|Randomization||45||
60154218|NCT01660191|76279636|FG002|COMPLETED|Randomization||44||
60154219|NCT01660191|76279634|FG000|NOT COMPLETED|Randomization||0||
60154220|NCT01660191|76279635|FG001|NOT COMPLETED|Randomization||0||
60154221|NCT01660191|76279636|FG002|NOT COMPLETED|Randomization||0||
60154222|NCT01660191|76279634|FG000|STARTED|End of Treatment||45||
60154223|NCT01660191|76279635|FG001|STARTED|End of Treatment||45||
60154224|NCT01660191|76279636|FG002|STARTED|End of Treatment||44||
60154225|NCT01660191|76279634|FG000|COMPLETED|End of Treatment||44||
60154226|NCT01660191|76279635|FG001|COMPLETED|End of Treatment||39||
60154227|NCT01660191|76279636|FG002|COMPLETED|End of Treatment||43||
60154228|NCT01660191|76279634|FG000|NOT COMPLETED|End of Treatment||1||
60154229|NCT01660191|76279635|FG001|NOT COMPLETED|End of Treatment||6||
60154230|NCT01660191|76279636|FG002|NOT COMPLETED|End of Treatment||1||
60154231|NCT00033917|76279646|FG000|STARTED|Overall Study||209||
60154232|NCT00033917|76279647|FG001|STARTED|Overall Study||222||
60154233|NCT00033917|76279646|FG000|COMPLETED|Overall Study||209||
60154234|NCT00033917|76279647|FG001|COMPLETED|Overall Study||222||
60154235|NCT00033917|76279646|FG000|NOT COMPLETED|Overall Study||0||
60154236|NCT00033917|76279647|FG001|NOT COMPLETED|Overall Study||0||
60154237|NCT02341287|76279659|FG000|STARTED|1st Intervention (2 Weeks)||7||
60154238|NCT02341287|76279660|FG001|STARTED|1st Intervention (2 Weeks)||6||
60154239|NCT02341287|76279659|FG000|COMPLETED|1st Intervention (2 Weeks)||7||
60154240|NCT02341287|76279660|FG001|COMPLETED|1st Intervention (2 Weeks)||6||
60154241|NCT02341287|76279659|FG000|NOT COMPLETED|1st Intervention (2 Weeks)||0||
60154242|NCT02341287|76279660|FG001|NOT COMPLETED|1st Intervention (2 Weeks)||0||
60154243|NCT02341287|76279659|FG000|STARTED|2nd Intervention (2 Weeks)||7||
60154244|NCT02341287|76279660|FG001|STARTED|2nd Intervention (2 Weeks)||6||
60154245|NCT02341287|76279659|FG000|COMPLETED|2nd Intervention (2 Weeks)||7||
60154246|NCT02341287|76279660|FG001|COMPLETED|2nd Intervention (2 Weeks)||6||
60154247|NCT02341287|76279659|FG000|NOT COMPLETED|2nd Intervention (2 Weeks)||0||
60154248|NCT02341287|76279660|FG001|NOT COMPLETED|2nd Intervention (2 Weeks)||0||
60154249|NCT01660737|76279666|FG000|STARTED|Overall Study||123||
60154250|NCT01660737|76279666|FG000|COMPLETED|Overall Study||123||
60154251|NCT01660737|76279666|FG000|NOT COMPLETED|Overall Study||0||
60154252|NCT00036569|76279670|FG000|STARTED|Overall Study||32||
60154253|NCT00036569|76279670|FG000|COMPLETED|Overall Study||32||
60154254|NCT00036569|76279670|FG000|NOT COMPLETED|Overall Study||0||
60154255|NCT01660815|76279676|FG000|STARTED|Overall Study||7||
60154256|NCT01660815|76279676|FG000|COMPLETED|Overall Study||7||
60154257|NCT01660815|76279676|FG000|NOT COMPLETED|Overall Study||0||
60154258|NCT01660893|76279684|FG000|STARTED|Overall Study||10||
60154259|NCT01660893|76279685|FG001|STARTED|Overall Study||10||
60154260|NCT01660893|76279686|FG002|STARTED|Overall Study||6||
60154261|NCT01660893|76279684|FG000|COMPLETED|Overall Study||10||
60154262|NCT01660893|76279685|FG001|COMPLETED|Overall Study||10||
60154263|NCT01660893|76279686|FG002|COMPLETED|Overall Study||6||
60154264|NCT01660893|76279684|FG000|NOT COMPLETED|Overall Study||0||
60154265|NCT01660893|76279685|FG001|NOT COMPLETED|Overall Study||0||
60154266|NCT01660893|76279686|FG002|NOT COMPLETED|Overall Study||0||
60154267|NCT01661283|76279694|FG000|STARTED|Overall Study|15 patients enrolled in the first stage; 10 patients enrolled in the second stage|25||
60154268|NCT01661283|76279694|FG000|COMPLETED|Overall Study||25||
60154269|NCT01661283|76279694|FG000|NOT COMPLETED|Overall Study||0||
60154270|NCT01662297|76279700|FG000|STARTED|Overall Study||0||
60154271|NCT01662297|76279701|FG001|STARTED|Overall Study||1||
60154272|NCT01662297|76279700|FG000|COMPLETED|Overall Study||0||
60154273|NCT01662297|76279701|FG001|COMPLETED|Overall Study||1||
60154274|NCT01662297|76279700|FG000|NOT COMPLETED|Overall Study||0||
60154275|NCT01662297|76279701|FG001|NOT COMPLETED|Overall Study||0||
60154276|NCT01662531|76279709|FG000|STARTED|Overall Study||27||
60154277|NCT01662531|76279709|FG000|COMPLETED|Overall Study||27||
60154278|NCT01662531|76279709|FG000|NOT COMPLETED|Overall Study||0||
60154279|NCT01600287|76279717|FG000|STARTED|Overall Study||20||
60154280|NCT01600287|76279718|FG001|STARTED|Overall Study||20||
60154281|NCT01600287|76279717|FG000|COMPLETED|Overall Study||20||
60154282|NCT01600287|76279718|FG001|COMPLETED|Overall Study||20||
60154283|NCT01600287|76279717|FG000|NOT COMPLETED|Overall Study||0||
60154284|NCT01600287|76279718|FG001|NOT COMPLETED|Overall Study||0||
60154285|NCT00040937|76279724|FG000|STARTED|Induction/PBSC Mobilization|147 registered to this period; 142 were eligible and analyzable; 140 were assessable for toxicity.|147||
60154286|NCT00040937|76279724|FG000|COMPLETED|Induction/PBSC Mobilization||110||
60154287|NCT00040937|76279724|FG000|NOT COMPLETED|Induction/PBSC Mobilization||37||
60154288|NCT00040937|76279724|FG000|STARTED|Autologous PBSCT|108 registered to this period; 105 were eligible and analyzable; 105 were assessable for toxicity.|108||
60154289|NCT00040937|76279724|FG000|COMPLETED|Autologous PBSCT||77||
60154290|NCT00040937|76279724|FG000|NOT COMPLETED|Autologous PBSCT||31||
60154291|NCT00040937|76279724|FG000|STARTED|Maintenance||76||
60154292|NCT00040937|76279724|FG000|COMPLETED|Maintenance|Patients remained on protocol therapy until progression.|76||
60154293|NCT00040937|76279724|FG000|NOT COMPLETED|Maintenance||0||
60154294|NCT01662765|76279733|FG000|STARTED|Overall Study||42||
60154295|NCT01662765|76279734|FG001|STARTED|Overall Study||42||
60154296|NCT01662765|76279733|FG000|COMPLETED|Overall Study||41||
60154297|NCT01662765|76279734|FG001|COMPLETED|Overall Study||40||
60154298|NCT01662765|76279733|FG000|NOT COMPLETED|Overall Study||1||
60154299|NCT01662765|76279734|FG001|NOT COMPLETED|Overall Study||2||
60154300|NCT02234115|76279745|FG000|STARTED|Overall Study||137||
60154301|NCT02234115|76279745|FG000|ITT|Overall Study||137||
60154302|NCT02234115|76279745|FG000|PP|Overall Study||124||
60154303|NCT02234115|76279745|FG000|PK Subgroup|Overall Study||31||
60154304|NCT02234115|76279745|FG000|COMPLETED|Overall Study||122||
60154305|NCT02234115|76279745|FG000|NOT COMPLETED|Overall Study||15||
60154306|NCT02234427|76279749|FG000|STARTED|Overall Study||34||
60154307|NCT02234427|76279749|FG000|COMPLETED|Overall Study|One individual withdrew after first visit|33||
60154308|NCT02234427|76279749|FG000|NOT COMPLETED|Overall Study||1||
60154309|NCT01663779|76279755|FG000|STARTED|Overall Study||27||
60154310|NCT01663779|76279756|FG001|STARTED|Overall Study||23||
60154311|NCT01663779|76279755|FG000|COMPLETED|Overall Study||27||
60154312|NCT01663779|76279756|FG001|COMPLETED|Overall Study||23||
60154313|NCT01663779|76279755|FG000|NOT COMPLETED|Overall Study||0||
60154314|NCT01663779|76279756|FG001|NOT COMPLETED|Overall Study||0||
60154315|NCT01692951|76279766|FG000|STARTED|Overall Study||37||
60154316|NCT01692951|76279767|FG001|STARTED|Overall Study||111||
60154317|NCT01692951|76279768|FG002|STARTED|Overall Study||18||
60154318|NCT01692951|76279769|FG003|STARTED|Overall Study||54||
60154319|NCT01692951|76279766|FG000|COMPLETED|Overall Study||37||
60154320|NCT01692951|76279767|FG001|COMPLETED|Overall Study||111||
60154321|NCT01692951|76279768|FG002|COMPLETED|Overall Study||18||
60154322|NCT01692951|76279769|FG003|COMPLETED|Overall Study||54||
60154323|NCT01692951|76279766|FG000|NOT COMPLETED|Overall Study||0||
60154324|NCT01692951|76279767|FG001|NOT COMPLETED|Overall Study||0||
60154325|NCT01692951|76279768|FG002|NOT COMPLETED|Overall Study||0||
60154326|NCT01692951|76279769|FG003|NOT COMPLETED|Overall Study||0||
60154327|NCT01600677|76279781|FG000|STARTED|Overall Study||7||
60154328|NCT01600677|76279782|FG001|STARTED|Overall Study||4||
60154329|NCT01600677|76279781|FG000|COMPLETED|Overall Study||7||
60154330|NCT01600677|76279782|FG001|COMPLETED|Overall Study||4||
60154331|NCT01600677|76279781|FG000|NOT COMPLETED|Overall Study||0||
60154332|NCT01600677|76279782|FG001|NOT COMPLETED|Overall Study||0||
60154333|NCT00041717|76279790|FG000|STARTED|Overall Study||114||
60154334|NCT00041717|76279791|FG001|STARTED|Overall Study||98||
60154335|NCT00041717|76279790|FG000|COMPLETED|Overall Study||81||
60154336|NCT00041717|76279791|FG001|COMPLETED|Overall Study||86||
60154337|NCT00041717|76279790|FG000|NOT COMPLETED|Overall Study||33||
60154338|NCT00041717|76279791|FG001|NOT COMPLETED|Overall Study||12||
60154339|NCT01694199|76279799|FG000|STARTED|Overall Study||71||
60154340|NCT01694199|76279800|FG001|STARTED|Overall Study||68||
60154341|NCT01694199|76279799|FG000|COMPLETED|Overall Study||71||
60154342|NCT01694199|76279800|FG001|COMPLETED|Overall Study||68||
60154343|NCT01694199|76279799|FG000|NOT COMPLETED|Overall Study||0||
60154344|NCT01694199|76279800|FG001|NOT COMPLETED|Overall Study||0||
60154345|NCT01694667|76279808|FG000|STARTED|Overall Study||29||
60154346|NCT01694667|76279809|FG001|STARTED|Overall Study||28||
60154347|NCT01694667|76279808|FG000|COMPLETED|Overall Study||29||
60154348|NCT01694667|76279809|FG001|COMPLETED|Overall Study||28||
60154349|NCT01694667|76279808|FG000|NOT COMPLETED|Overall Study||0||
60154350|NCT01694667|76279809|FG001|NOT COMPLETED|Overall Study||0||
60154351|NCT01663935|76279815|FG000|STARTED|Overall Study||20||
60154352|NCT01663935|76279815|FG000|COMPLETED|Overall Study||20||
60154353|NCT01663935|76279815|FG000|NOT COMPLETED|Overall Study||0||
60154354|NCT01664559|76279821|FG000|STARTED|Overall Study||34||
60154355|NCT01664559|76279822|FG001|STARTED|Overall Study||33||
60154356|NCT01664559|76279821|FG000|COMPLETED|Overall Study||34||
60154357|NCT01664559|76279822|FG001|COMPLETED|Overall Study||33||
60154358|NCT01664559|76279821|FG000|NOT COMPLETED|Overall Study||0||
60154359|NCT01664559|76279822|FG001|NOT COMPLETED|Overall Study||0||
60154360|NCT00046475|76279830|FG000|STARTED|Screening/Washout Period (Up to 2 Weeks)||140||
60154361|NCT00046475|76279831|FG001|STARTED|Screening/Washout Period (Up to 2 Weeks)||0||
60154362|NCT00046475|76279832|FG002|STARTED|Screening/Washout Period (Up to 2 Weeks)||0||
60154363|NCT00046475|76279830|FG000|COMPLETED|Screening/Washout Period (Up to 2 Weeks)||136||
60154364|NCT00046475|76279831|FG001|COMPLETED|Screening/Washout Period (Up to 2 Weeks)||0||
60154365|NCT00046475|76279832|FG002|COMPLETED|Screening/Washout Period (Up to 2 Weeks)||0||
60154366|NCT00046475|76279830|FG000|NOT COMPLETED|Screening/Washout Period (Up to 2 Weeks)||4||
60154367|NCT00046475|76279831|FG001|NOT COMPLETED|Screening/Washout Period (Up to 2 Weeks)||0||
60154368|NCT00046475|76279832|FG002|NOT COMPLETED|Screening/Washout Period (Up to 2 Weeks)||0||
60154369|NCT00046475|76279830|FG000|STARTED|Titration (1 Week)||136||
60154370|NCT00046475|76279831|FG001|STARTED|Titration (1 Week)||0||
60154371|NCT00046475|76279832|FG002|STARTED|Titration (1 Week)||0||
60154372|NCT00046475|76279830|FG000|COMPLETED|Titration (1 Week)||136||
60154373|NCT00046475|76279831|FG001|COMPLETED|Titration (1 Week)||0||
60154374|NCT00046475|76279832|FG002|COMPLETED|Titration (1 Week)||0||
60154375|NCT00046475|76279830|FG000|NOT COMPLETED|Titration (1 Week)||0||
60154376|NCT00046475|76279831|FG001|NOT COMPLETED|Titration (1 Week)||0||
60154377|NCT00046475|76279832|FG002|NOT COMPLETED|Titration (1 Week)||0||
60154378|NCT00046475|76279830|FG000|STARTED|Treatment Period 1 (Up to 2 Weeks)||0||
60154379|NCT00046475|76279831|FG001|STARTED|Treatment Period 1 (Up to 2 Weeks)|Patients did not meet the criteria for randomization, had an AE, or withdrew from the study.|45||
60154380|NCT00046475|76279832|FG002|STARTED|Treatment Period 1 (Up to 2 Weeks)|Patients did not meet the criteria for randomization, had an AE, or withdrew from the study.|60||
60154381|NCT00046475|76279830|FG000|COMPLETED|Treatment Period 1 (Up to 2 Weeks)||0||
60154382|NCT00046475|76279831|FG001|COMPLETED|Treatment Period 1 (Up to 2 Weeks)||45||
60154383|NCT00046475|76279832|FG002|COMPLETED|Treatment Period 1 (Up to 2 Weeks)||59||
60154384|NCT00046475|76279830|FG000|NOT COMPLETED|Treatment Period 1 (Up to 2 Weeks)||0||
60154385|NCT00046475|76279831|FG001|NOT COMPLETED|Treatment Period 1 (Up to 2 Weeks)||0||
60154386|NCT00046475|76279832|FG002|NOT COMPLETED|Treatment Period 1 (Up to 2 Weeks)||1||
60154387|NCT00046475|76279830|FG000|STARTED|Treatment Period 2 (Up to 2 Weeks)||0||
60154388|NCT00046475|76279831|FG001|STARTED|Treatment Period 2 (Up to 2 Weeks)||45||
60154389|NCT00046475|76279832|FG002|STARTED|Treatment Period 2 (Up to 2 Weeks)||59||
60154390|NCT00046475|76279830|FG000|COMPLETED|Treatment Period 2 (Up to 2 Weeks)||0||
60154391|NCT00046475|76279831|FG001|COMPLETED|Treatment Period 2 (Up to 2 Weeks)||44||
60154392|NCT00046475|76279832|FG002|COMPLETED|Treatment Period 2 (Up to 2 Weeks)||59||
60154393|NCT00046475|76279830|FG000|NOT COMPLETED|Treatment Period 2 (Up to 2 Weeks)||0||
60154394|NCT00046475|76279831|FG001|NOT COMPLETED|Treatment Period 2 (Up to 2 Weeks)||1||
60154395|NCT00046475|76279832|FG002|NOT COMPLETED|Treatment Period 2 (Up to 2 Weeks)||0||
60154396|NCT01664793|76279844|FG000|STARTED|Overall Study||49039||
59605816|NCT01964352|75715971|FG001|COMPLETED|Overall Study||192||
60154397|NCT01664793|76279845|FG001|STARTED|Overall Study||38626||
60154398|NCT01664793|76279844|FG000|COMPLETED|Overall Study||49039||
60154399|NCT01664793|76279845|FG001|COMPLETED|Overall Study||38626||
60154400|NCT01664793|76279844|FG000|NOT COMPLETED|Overall Study||0||
60154401|NCT01664793|76279845|FG001|NOT COMPLETED|Overall Study||0||
60154402|NCT01601067|76279855|FG000|STARTED|Overall Study||63||
60154403|NCT01601067|76279856|FG001|STARTED|Overall Study||56||
60154404|NCT01601067|76279855|FG000|COMPLETED|Overall Study||30||
60154405|NCT01601067|76279856|FG001|COMPLETED|Overall Study||34||
60154406|NCT01601067|76279855|FG000|NOT COMPLETED|Overall Study||33||
60154407|NCT01601067|76279856|FG001|NOT COMPLETED|Overall Study||22||
60154408|NCT01695291|76279864|FG000|STARTED|Overall Study||10||
60154409|NCT01695291|76279865|FG001|STARTED|Overall Study||21||
60154410|NCT01695291|76279864|FG000|COMPLETED|Overall Study||8||
60154411|NCT01695291|76279865|FG001|COMPLETED|Overall Study||14||
60154412|NCT01695291|76279864|FG000|NOT COMPLETED|Overall Study||2||
60154413|NCT01695291|76279865|FG001|NOT COMPLETED|Overall Study||7||
60154414|NCT01601691|76279871|FG000|STARTED|Overall Study||10||
60154415|NCT01601691|76279871|FG000|COMPLETED|Overall Study||10||
60154416|NCT01601691|76279871|FG000|NOT COMPLETED|Overall Study||0||
60154417|NCT00048737|76279875|FG000|STARTED|Overall Study||70||
60154418|NCT00048737|76279875|FG000|COMPLETED|Overall Study||70||
60154419|NCT00048737|76279875|FG000|NOT COMPLETED|Overall Study||0||
60154420|NCT01695369|76279879|FG000|STARTED|Overall Study||61||
60154421|NCT01695369|76279879|FG000|COMPLETED|Overall Study||61||
60154422|NCT01695369|76279879|FG000|NOT COMPLETED|Overall Study||0||
60154423|NCT01604109|76279887|FG000|STARTED|Overall Study||150||
59605817|NCT01964352|75715972|FG002|COMPLETED|Overall Study||196||
59605818|NCT01964352|75715973|FG003|COMPLETED|Overall Study||195||
59605819|NCT01964352|75715970|FG000|NOT COMPLETED|Overall Study||26||
60154424|NCT01604109|76279888|FG001|STARTED|Overall Study||146||
60154425|NCT01604109|76279887|FG000|COMPLETED|Overall Study||117||
60154426|NCT01604109|76279888|FG001|COMPLETED|Overall Study||112||
60154427|NCT01604109|76279887|FG000|NOT COMPLETED|Overall Study||33||
60154428|NCT01604109|76279888|FG001|NOT COMPLETED|Overall Study||34||
60154429|NCT01666197|76279896|FG000|STARTED|Overall Study||50||
60154430|NCT01666197|76279897|FG001|STARTED|Overall Study||50||
60154431|NCT01666197|76279896|FG000|COMPLETED|Overall Study||50||
60154432|NCT01666197|76279897|FG001|COMPLETED|Overall Study||50||
60154433|NCT01666197|76279896|FG000|NOT COMPLETED|Overall Study||0||
60154434|NCT01666197|76279897|FG001|NOT COMPLETED|Overall Study||0||
60154435|NCT01697709|76279905|FG000|STARTED|Overall Study||64||
60154436|NCT01697709|76279906|FG001|STARTED|Overall Study||66||
60154437|NCT01697709|76279905|FG000|COMPLETED|Overall Study||34||
60154438|NCT01697709|76279906|FG001|COMPLETED|Overall Study||38||
60154439|NCT01697709|76279905|FG000|NOT COMPLETED|Overall Study||30||
60154440|NCT01697709|76279906|FG001|NOT COMPLETED|Overall Study||28||
60154441|NCT00048815|76279915|FG000|STARTED|Overall Study||24||
60154442|NCT00048815|76279916|FG001|STARTED|Overall Study||26||
60154443|NCT00048815|76279917|FG002|STARTED|Overall Study||23||
60154444|NCT00048815|76279915|FG000|COMPLETED|Overall Study||18||
60154445|NCT00048815|76279916|FG001|COMPLETED|Overall Study||22||
60154446|NCT00048815|76279917|FG002|COMPLETED|Overall Study||19||
60154447|NCT00048815|76279915|FG000|NOT COMPLETED|Overall Study||6||
60154448|NCT00048815|76279916|FG001|NOT COMPLETED|Overall Study||4||
60154449|NCT00048815|76279917|FG002|NOT COMPLETED|Overall Study||4||
60154450|NCT01605435|76279925|FG000|STARTED|Overall Study||2||
60154451|NCT01605435|76279926|FG001|STARTED|Overall Study||3||
60154452|NCT01605435|76279925|FG000|COMPLETED|Overall Study||2||
60154453|NCT01605435|76279926|FG001|COMPLETED|Overall Study||3||
60154454|NCT01605435|76279925|FG000|NOT COMPLETED|Overall Study||0||
60154455|NCT01605435|76279926|FG001|NOT COMPLETED|Overall Study||0||
60154456|NCT01605669|76279943|FG000|STARTED|Overall Study||50||
60154457|NCT01605669|76279943|FG000|COMPLETED|Overall Study||50||
60154458|NCT01605669|76279943|FG000|NOT COMPLETED|Overall Study||0||
60154459|NCT01605903|76279950|FG000|STARTED|Overall Study||345||
60154460|NCT01605903|76279951|FG001|STARTED|Overall Study||343||
60154461|NCT01605903|76279950|FG000|COMPLETED|Overall Study||345||
60154462|NCT01605903|76279951|FG001|COMPLETED|Overall Study||343||
60154463|NCT01605903|76279950|FG000|NOT COMPLETED|Overall Study||0||
60154464|NCT01605903|76279951|FG001|NOT COMPLETED|Overall Study||0||
60154465|NCT02228499|76279959|FG000|STARTED|Overall Study||30||
60154466|NCT02228499|76279960|FG001|STARTED|Overall Study||36||
60154467|NCT02228499|76279959|FG000|COMPLETED|Overall Study||7||
60154468|NCT02228499|76279960|FG001|COMPLETED|Overall Study||10||
60154469|NCT02228499|76279959|FG000|NOT COMPLETED|Overall Study||23||
60154470|NCT02228499|76279960|FG001|NOT COMPLETED|Overall Study||26||
60154471|NCT01698333|76279966|FG000|STARTED|Overall Study||25||
60154472|NCT01698333|76279966|FG000|COMPLETED|Overall Study||25||
60154473|NCT01698333|76279966|FG000|NOT COMPLETED|Overall Study||0||
60154474|NCT00048893|76279970|FG000|STARTED|Overall Study||37||
60154475|NCT00048893|76279970|FG000|COMPLETED|Overall Study||37||
60154476|NCT00048893|76279970|FG000|NOT COMPLETED|Overall Study||0||
60154477|NCT01607853|76279974|FG000|STARTED|Overall Study||24||
60154478|NCT01607853|76279974|FG000|COMPLETED|Overall Study||24||
60154479|NCT01607853|76279974|FG000|NOT COMPLETED|Overall Study||0||
60154480|NCT01610427|76279981|FG000|STARTED|Overall Study||22||
60154481|NCT01610427|76279981|FG000|COMPLETED|Overall Study||22||
60154482|NCT01610427|76279981|FG000|NOT COMPLETED|Overall Study||0||
60154483|NCT01700517|76279988|FG000|STARTED|Overall Study||40||
60154484|NCT01700517|76279989|FG001|STARTED|Overall Study||40||
60154485|NCT01700517|76279990|FG002|STARTED|Overall Study||40||
60154486|NCT01700517|76279988|FG000|COMPLETED|Overall Study||40||
60154487|NCT01700517|76279989|FG001|COMPLETED|Overall Study||40||
60154488|NCT01700517|76279990|FG002|COMPLETED|Overall Study||40||
60154489|NCT01700517|76279988|FG000|NOT COMPLETED|Overall Study||0||
60154490|NCT01700517|76279989|FG001|NOT COMPLETED|Overall Study||0||
60154491|NCT01700517|76279990|FG002|NOT COMPLETED|Overall Study||0||
60154492|NCT00101647|76280000|FG000|STARTED|Overall Study|Randomized|13||
60154493|NCT00101647|76280001|FG001|STARTED|Overall Study|Randomized|161||
60154494|NCT00101647|76280000|FG000|COMPLETED|Overall Study||13||
60154495|NCT00101647|76280001|FG001|COMPLETED|Overall Study||161||
60154496|NCT00101647|76280000|FG000|NOT COMPLETED|Overall Study||0||
60154497|NCT00101647|76280001|FG001|NOT COMPLETED|Overall Study||0||
60154498|NCT01669785|76280020|FG000|STARTED|Overall Study||45||
60154499|NCT01669785|76280021|FG001|STARTED|Overall Study||48||
60154500|NCT01669785|76280022|FG002|STARTED|Overall Study||46||
60154501|NCT01669785|76280020|FG000|COMPLETED|Overall Study||45||
60154502|NCT01669785|76280021|FG001|COMPLETED|Overall Study||48||
60154503|NCT01669785|76280022|FG002|COMPLETED|Overall Study||46||
60154504|NCT01669785|76280020|FG000|NOT COMPLETED|Overall Study||0||
60154505|NCT01669785|76280021|FG001|NOT COMPLETED|Overall Study||0||
60154506|NCT01669785|76280022|FG002|NOT COMPLETED|Overall Study||0||
60154507|NCT01669863|76280031|FG000|STARTED|Overall Study||6||
60154508|NCT01669863|76280031|FG000|COMPLETED|Overall Study||6||
60154509|NCT01669863|76280031|FG000|NOT COMPLETED|Overall Study||0||
60154510|NCT00053495|76280041|FG000|STARTED|Overall Study||51||
60154511|NCT00053495|76280042|FG001|STARTED|Overall Study||101||
60154512|NCT00053495|76280043|FG002|STARTED|Overall Study||101||
60154513|NCT00053495|76280044|FG003|STARTED|Overall Study||51||
60154514|NCT00053495|76280045|FG004|STARTED|Overall Study||49||
60154515|NCT00053495|76280041|FG000|COMPLETED|Overall Study||51||
60154516|NCT00053495|76280042|FG001|COMPLETED|Overall Study||101||
60154517|NCT00053495|76280043|FG002|COMPLETED|Overall Study||101||
60154518|NCT00053495|76280044|FG003|COMPLETED|Overall Study||51||
60154519|NCT00053495|76280045|FG004|COMPLETED|Overall Study||49||
60154520|NCT00053495|76280041|FG000|NOT COMPLETED|Overall Study||0||
60154521|NCT00053495|76280042|FG001|NOT COMPLETED|Overall Study||0||
60154522|NCT00053495|76280043|FG002|NOT COMPLETED|Overall Study||0||
60154523|NCT00053495|76280044|FG003|NOT COMPLETED|Overall Study||0||
60154524|NCT00053495|76280045|FG004|NOT COMPLETED|Overall Study||0||
60154525|NCT01670487|76280059|FG000|STARTED|Overall Study||150||
60154526|NCT01670487|76280060|FG001|STARTED|Overall Study||150||
60154527|NCT01670487|76280059|FG000|COMPLETED|Overall Study||150||
60154528|NCT01670487|76280060|FG001|COMPLETED|Overall Study||150||
60154529|NCT01670487|76280059|FG000|NOT COMPLETED|Overall Study||0||
60154530|NCT01670487|76280060|FG001|NOT COMPLETED|Overall Study||0||
60154531|NCT02587962|76280071|FG000|STARTED|Overall Study||3||
60154532|NCT02587962|76280072|FG001|STARTED|Overall Study||3||
60154533|NCT02587962|76280073|FG002|STARTED|Overall Study||6||
60154534|NCT02587962|76280074|FG003|STARTED|Overall Study||7||
60154535|NCT02587962|76280075|FG004|STARTED|Overall Study||15||
60154536|NCT02587962|76280071|FG000|COMPLETED|Overall Study||1|Completed study treatment phase|
60154537|NCT02587962|76280072|FG001|COMPLETED|Overall Study||0|Completed study treatment phase|
60154538|NCT02587962|76280073|FG002|COMPLETED|Overall Study||0|Completed study treatment phase|
60154539|NCT02587962|76280074|FG003|COMPLETED|Overall Study||1|Completed study treatment phase|
60154540|NCT02587962|76280075|FG004|COMPLETED|Overall Study||0|Completed study treatment phase|
60154541|NCT02587962|76280071|FG000|NOT COMPLETED|Overall Study||2||
60154542|NCT02587962|76280072|FG001|NOT COMPLETED|Overall Study||3||
60154543|NCT02587962|76280073|FG002|NOT COMPLETED|Overall Study||6||
60154544|NCT02587962|76280074|FG003|NOT COMPLETED|Overall Study||6||
60154545|NCT02587962|76280075|FG004|NOT COMPLETED|Overall Study||15||
60154546|NCT02229513|76280092|FG000|STARTED|Overall Study||100||
60154547|NCT02229513|76280093|FG001|STARTED|Overall Study||100||
60154548|NCT02229513|76280092|FG000|COMPLETED|Overall Study||100||
60154549|NCT02229513|76280093|FG001|COMPLETED|Overall Study||100||
60154550|NCT02229513|76280092|FG000|NOT COMPLETED|Overall Study||0||
60154551|NCT02229513|76280093|FG001|NOT COMPLETED|Overall Study||0||
60154552|NCT01671423|76280101|FG000|STARTED|Overall Study||20||
60154553|NCT01671423|76280102|FG001|STARTED|Overall Study||20||
60154554|NCT01671423|76280101|FG000|COMPLETED|Overall Study||14||
59605820|NCT01964352|75715971|FG001|NOT COMPLETED|Overall Study||11||
59751745|NCT00844545|75871093|FG000|STARTED|Post Treatment Period||6||
60154555|NCT01671423|76280102|FG001|COMPLETED|Overall Study||9||
60154556|NCT01671423|76280101|FG000|NOT COMPLETED|Overall Study||6||
60154557|NCT01671423|76280102|FG001|NOT COMPLETED|Overall Study||11||
60154558|NCT02092181|76280110|FG000|STARTED|Overall Study||15||
60154559|NCT02092181|76280111|FG001|STARTED|Overall Study||15||
60154560|NCT02092181|76280110|FG000|COMPLETED|Overall Study||12||
60154561|NCT02092181|76280111|FG001|COMPLETED|Overall Study||14||
60154562|NCT02092181|76280110|FG000|NOT COMPLETED|Overall Study||3||
60154563|NCT02092181|76280111|FG001|NOT COMPLETED|Overall Study||1||
60154564|NCT01672827|76280117|FG000|STARTED|Overall Study||276||
60154565|NCT01672827|76280117|FG000|COMPLETED|Overall Study||276||
60154566|NCT01672827|76280117|FG000|NOT COMPLETED|Overall Study||0||
60154567|NCT01700907|76280125|FG000|STARTED|Overall Study||10||
60154568|NCT01700907|76280126|FG001|STARTED|Overall Study||10||
60154569|NCT01700907|76280125|FG000|COMPLETED|Overall Study||10||
60154570|NCT01700907|76280126|FG001|COMPLETED|Overall Study||10||
60154571|NCT01700907|76280125|FG000|NOT COMPLETED|Overall Study||0||
60154572|NCT01700907|76280126|FG001|NOT COMPLETED|Overall Study||0||
60154573|NCT01612221|76280134|FG000|STARTED|Overall Study||50||
60154574|NCT01612221|76280135|FG001|STARTED|Overall Study||50||
60154575|NCT01612221|76280134|FG000|COMPLETED|Overall Study||50||
60154576|NCT01612221|76280135|FG001|COMPLETED|Overall Study||50||
60154577|NCT01612221|76280134|FG000|NOT COMPLETED|Overall Study||0||
60154578|NCT01612221|76280135|FG001|NOT COMPLETED|Overall Study||0||
60154579|NCT00105001|76280144|FG000|STARTED|Overall Study||70||
60154580|NCT00105001|76280145|FG001|STARTED|Overall Study||71||
60154581|NCT00105001|76280146|FG002|STARTED|Overall Study||69||
60154582|NCT00105001|76280144|FG000|COMPLETED|Overall Study||70||
60154583|NCT00105001|76280145|FG001|COMPLETED|Overall Study||71||
60154584|NCT00105001|76280146|FG002|COMPLETED|Overall Study||69||
60154585|NCT00105001|76280144|FG000|NOT COMPLETED|Overall Study||0||
60154586|NCT00105001|76280145|FG001|NOT COMPLETED|Overall Study||0||
60154587|NCT00105001|76280146|FG002|NOT COMPLETED|Overall Study||0||
60154588|NCT01701375|76280154|FG000|STARTED|Overall Study||2||
60154589|NCT01701375|76280154|FG000|COMPLETED|Overall Study||2||
60154590|NCT01701375|76280154|FG000|NOT COMPLETED|Overall Study||0||
60154591|NCT00054353|76280160|FG000|STARTED|Overall Study||12||
60154592|NCT00054353|76280161|FG001|STARTED|Overall Study||4||
60154593|NCT00054353|76280160|FG000|COMPLETED|Overall Study||12||
60154594|NCT00054353|76280161|FG001|COMPLETED|Overall Study||4||
60154595|NCT00054353|76280160|FG000|NOT COMPLETED|Overall Study||0||
60154596|NCT00054353|76280161|FG001|NOT COMPLETED|Overall Study||0||
60154597|NCT00207883|76280173|FG000|STARTED|Overall Study||93||
60154598|NCT00207883|76280174|FG001|STARTED|Overall Study||119||
60154599|NCT00207883|76280173|FG000|COMPLETED|Overall Study||93||
60154600|NCT00207883|76280174|FG001|COMPLETED|Overall Study||119||
60154601|NCT00207883|76280173|FG000|NOT COMPLETED|Overall Study||0||
60154602|NCT00207883|76280174|FG001|NOT COMPLETED|Overall Study||0||
60154603|NCT01701999|76280182|FG000|STARTED|Overall Study||8||
60154604|NCT01701999|76280183|FG001|STARTED|Overall Study||37||
60154605|NCT01701999|76280182|FG000|COMPLETED|Overall Study||8||
60154606|NCT01701999|76280183|FG001|COMPLETED|Overall Study||37||
60154607|NCT01701999|76280182|FG000|NOT COMPLETED|Overall Study||0||
60154608|NCT01701999|76280183|FG001|NOT COMPLETED|Overall Study||0||
60154609|NCT00208975|76280189|FG000|STARTED|Overall Study||15||
60154610|NCT00208975|76280189|FG000|COMPLETED|Overall Study||15||
60154611|NCT00208975|76280189|FG000|NOT COMPLETED|Overall Study||0||
60154612|NCT01702233|76280197|FG000|STARTED|Overall Study||72||
60154613|NCT01702233|76280198|FG001|STARTED|Overall Study||67||
60154614|NCT01702233|76280199|FG002|STARTED|Overall Study||36||
60154615|NCT01702233|76280197|FG000|Full Analysis Set (ITT)|Overall Study||66||
60154616|NCT01702233|76280198|FG001|Full Analysis Set (ITT)|Overall Study||63||
60154617|NCT01702233|76280199|FG002|Full Analysis Set (ITT)|Overall Study||31||
60154618|NCT01702233|76280197|FG000|Per Protocol Set|Overall Study||58||
60154619|NCT01702233|76280198|FG001|Per Protocol Set|Overall Study||58||
60154620|NCT01702233|76280199|FG002|Per Protocol Set|Overall Study||27||
60154621|NCT01702233|76280197|FG000|COMPLETED|Overall Study||66||
60154622|NCT01702233|76280198|FG001|COMPLETED|Overall Study|One of these Patient completed the Trial but had no valid outcome measure after enrolment|64||
60154623|NCT01702233|76280199|FG002|COMPLETED|Overall Study||31||
60154624|NCT01702233|76280197|FG000|NOT COMPLETED|Overall Study||6||
60154625|NCT01702233|76280198|FG001|NOT COMPLETED|Overall Study||3||
60154626|NCT01702233|76280199|FG002|NOT COMPLETED|Overall Study||5||
60154627|NCT00214045|76280210|FG000|STARTED|Overall Study||18||
60154628|NCT00214045|76280211|FG001|STARTED|Overall Study||18||
60154629|NCT00214045|76280210|FG000|COMPLETED|Overall Study||18||
60154630|NCT00214045|76280211|FG001|COMPLETED|Overall Study||18||
60154631|NCT00214045|76280210|FG000|NOT COMPLETED|Overall Study||0||
60154632|NCT00214045|76280211|FG001|NOT COMPLETED|Overall Study||0||
60154633|NCT01440374|76280220|FG000|STARTED|Part 1: Open-label Phase||17||
60154634|NCT01440374|76280221|FG001|STARTED|Part 1: Open-label Phase||0||
60154635|NCT01440374|76280222|FG002|STARTED|Part 1: Open-label Phase||0||
60154636|NCT01440374|76280223|FG003|STARTED|Part 1: Open-label Phase||0||
60154637|NCT01440374|76280220|FG000|COMPLETED|Part 1: Open-label Phase||11||
60154638|NCT01440374|76280221|FG001|COMPLETED|Part 1: Open-label Phase||0||
60154639|NCT01440374|76280222|FG002|COMPLETED|Part 1: Open-label Phase||0||
60154640|NCT01440374|76280223|FG003|COMPLETED|Part 1: Open-label Phase||0||
60154641|NCT01440374|76280220|FG000|NOT COMPLETED|Part 1: Open-label Phase||6||
60154642|NCT01440374|76280221|FG001|NOT COMPLETED|Part 1: Open-label Phase||0||
60154643|NCT01440374|76280222|FG002|NOT COMPLETED|Part 1: Open-label Phase||0||
60154644|NCT01440374|76280223|FG003|NOT COMPLETED|Part 1: Open-label Phase||0||
60154645|NCT01440374|76280220|FG000|STARTED|Part 2; Double-blind Phase||0||
60154646|NCT01440374|76280221|FG001|STARTED|Part 2; Double-blind Phase||47||
60154647|NCT01440374|76280222|FG002|STARTED|Part 2; Double-blind Phase||98||
60154648|NCT01440374|76280223|FG003|STARTED|Part 2; Double-blind Phase||0||
60154649|NCT01440374|76280220|FG000|COMPLETED|Part 2; Double-blind Phase||0||
60154650|NCT01440374|76280221|FG001|COMPLETED|Part 2; Double-blind Phase||27||
60154651|NCT01440374|76280222|FG002|COMPLETED|Part 2; Double-blind Phase||43||
60154652|NCT01440374|76280223|FG003|COMPLETED|Part 2; Double-blind Phase||0||
60154653|NCT01440374|76280220|FG000|NOT COMPLETED|Part 2; Double-blind Phase||0||
59605821|NCT01964352|75715972|FG002|NOT COMPLETED|Overall Study||6||
59605822|NCT01964352|75715973|FG003|NOT COMPLETED|Overall Study||8||
60154654|NCT01440374|76280221|FG001|NOT COMPLETED|Part 2; Double-blind Phase||20||
60154655|NCT01440374|76280222|FG002|NOT COMPLETED|Part 2; Double-blind Phase||55||
60154656|NCT01440374|76280223|FG003|NOT COMPLETED|Part 2; Double-blind Phase||0||
60154657|NCT01440374|76280220|FG000|STARTED|Part 3: Extension||0||
60154658|NCT01440374|76280221|FG001|STARTED|Part 3: Extension||0||
60154659|NCT01440374|76280222|FG002|STARTED|Part 3: Extension||0||
60154660|NCT01440374|76280223|FG003|STARTED|Part 3: Extension||59||
60154661|NCT01440374|76280220|FG000|COMPLETED|Part 3: Extension||0||
60154662|NCT01440374|76280221|FG001|COMPLETED|Part 3: Extension||0||
60154663|NCT01440374|76280222|FG002|COMPLETED|Part 3: Extension||0||
60154664|NCT01440374|76280223|FG003|COMPLETED|Part 3: Extension||27||
60154665|NCT01440374|76280220|FG000|NOT COMPLETED|Part 3: Extension||0||
60154666|NCT01440374|76280221|FG001|NOT COMPLETED|Part 3: Extension||0||
60154667|NCT01440374|76280222|FG002|NOT COMPLETED|Part 3: Extension||0||
60154668|NCT01440374|76280223|FG003|NOT COMPLETED|Part 3: Extension||32||
60154669|NCT00107575|76280237|FG000|STARTED|Overall Study||119||
60154670|NCT00107575|76280238|FG001|STARTED|Overall Study||117||
60154671|NCT00107575|76280237|FG000|COMPLETED|Overall Study||108||
60154672|NCT00107575|76280238|FG001|COMPLETED|Overall Study||107||
60154673|NCT00107575|76280237|FG000|NOT COMPLETED|Overall Study||11||
60154674|NCT00107575|76280238|FG001|NOT COMPLETED|Overall Study||10||
60154675|NCT00214903|76280248|FG000|STARTED|Overall Study||10043||
60154676|NCT00214903|76280249|FG001|STARTED|Overall Study||13384||
60154677|NCT00214903|76280250|FG002|STARTED|Overall Study||4113||
60154678|NCT00214903|76280251|FG003|STARTED|Overall Study||3057||
60154679|NCT00214903|76280248|FG000|COMPLETED|Overall Study||10043||
60154680|NCT00214903|76280249|FG001|COMPLETED|Overall Study||13384||
60154681|NCT00214903|76280250|FG002|COMPLETED|Overall Study||4113||
60154682|NCT00214903|76280251|FG003|COMPLETED|Overall Study||3057||
60154683|NCT00214903|76280248|FG000|NOT COMPLETED|Overall Study||0||
60154684|NCT00214903|76280249|FG001|NOT COMPLETED|Overall Study||0||
59751746|NCT00844545|75871093|FG000|COMPLETED|Post Treatment Period||5||
60154685|NCT00214903|76280250|FG002|NOT COMPLETED|Overall Study||0||
60154686|NCT00214903|76280251|FG003|NOT COMPLETED|Overall Study||0||
59751747|NCT00844545|75871093|FG000|NOT COMPLETED|Post Treatment Period||1||
59751748|NCT00651157|75871098|FG000|STARTED|Overall Study||23||
59751749|NCT00651157|75871098|FG000|COMPLETED|Overall Study||21||
60154687|NCT00217399|76280261|FG000|STARTED|Overall Study||35||
60154688|NCT00217399|76280261|FG000|COMPLETED|Overall Study||35||
60154689|NCT00217399|76280261|FG000|NOT COMPLETED|Overall Study||0||
60154690|NCT00108277|76280270|FG000|STARTED|Overall Study||29||
60154691|NCT00108277|76280271|FG001|STARTED|Overall Study||28||
60154692|NCT00108277|76280272|FG002|STARTED|Overall Study||35||
60154693|NCT00108277|76280270|FG000|COMPLETED|Overall Study||19||
60154694|NCT00108277|76280271|FG001|COMPLETED|Overall Study||16||
60154695|NCT00108277|76280272|FG002|COMPLETED|Overall Study||19||
60154696|NCT00108277|76280270|FG000|NOT COMPLETED|Overall Study||10||
60154697|NCT00108277|76280271|FG001|NOT COMPLETED|Overall Study||12||
60154698|NCT00108277|76280272|FG002|NOT COMPLETED|Overall Study||16||
60154699|NCT00218023|76280284|FG000|STARTED|Overall Study||22|Number that started phase 2, the phase in which subjects were assigned to the 4 arms.|
60154700|NCT00218023|76280285|FG001|STARTED|Overall Study||25|Number that started phase 2, the phase in which subjects were assigned to the 4 arms.|
60154701|NCT00218023|76280286|FG002|STARTED|Overall Study||16|Number that started phase 2, the phase in which subjects were assigned to the 4 arms.|
60154702|NCT00218023|76280287|FG003|STARTED|Overall Study||18|Number that started phase 2, the phase in which subjects were assigned to the 4 arms.|
60154703|NCT00218023|76280284|FG000|Received Drug or Placebo in Phase II|Overall Study||18||
60154704|NCT00218023|76280285|FG001|Received Drug or Placebo in Phase II|Overall Study||24||
60154705|NCT00218023|76280286|FG002|Received Drug or Placebo in Phase II|Overall Study||15||
60154706|NCT00218023|76280287|FG003|Received Drug or Placebo in Phase II|Overall Study||18||
60154707|NCT00218023|76280284|FG000|COMPLETED|Overall Study||9||
60154708|NCT00218023|76280285|FG001|COMPLETED|Overall Study||10||
60154709|NCT00218023|76280286|FG002|COMPLETED|Overall Study||6||
60154710|NCT00218023|76280287|FG003|COMPLETED|Overall Study||11||
60154711|NCT00218023|76280284|FG000|NOT COMPLETED|Overall Study||13||
60154712|NCT00218023|76280285|FG001|NOT COMPLETED|Overall Study||15||
60154713|NCT00218023|76280286|FG002|NOT COMPLETED|Overall Study||10||
60154714|NCT00218023|76280287|FG003|NOT COMPLETED|Overall Study||7||
60154715|NCT00054665|76280297|FG000|STARTED|Part A|5 participants only received Part A and 18 participants received Part B after Part A.|23||
60154716|NCT00054665|76280298|FG001|STARTED|Part A||0||
60154717|NCT00054665|76280297|FG000|COMPLETED|Part A||23||
60154718|NCT00054665|76280298|FG001|COMPLETED|Part A||0||
60154719|NCT00054665|76280297|FG000|NOT COMPLETED|Part A||0||
60154720|NCT00054665|76280298|FG001|NOT COMPLETED|Part A||0||
60154721|NCT00054665|76280297|FG000|STARTED|Part B||0||
60154722|NCT00054665|76280298|FG001|STARTED|Part B|26 participants received only Part B|44||
60154723|NCT00054665|76280297|FG000|COMPLETED|Part B||0||
60154724|NCT00054665|76280298|FG001|COMPLETED|Part B||44||
60154725|NCT00054665|76280297|FG000|NOT COMPLETED|Part B||0||
60154726|NCT00054665|76280298|FG001|NOT COMPLETED|Part B||0||
60154727|NCT00218335|76280310|FG000|STARTED|Overall Study||114||
60154728|NCT00218335|76280311|FG001|STARTED|Overall Study||113||
60154729|NCT00218335|76280312|FG002|STARTED|Overall Study||373||
60154730|NCT00218335|76280313|FG003|STARTED|Overall Study||424||
60154731|NCT00218335|76280310|FG000|6 Month Follow-up|Overall Study||103||
60154732|NCT00218335|76280311|FG001|6 Month Follow-up|Overall Study||99||
60154733|NCT00218335|76280312|FG002|6 Month Follow-up|Overall Study||219||
60154734|NCT00218335|76280313|FG003|6 Month Follow-up|Overall Study||301||
60154735|NCT00218335|76280310|FG000|12 Month Follow-up|Overall Study||95||
60154736|NCT00218335|76280311|FG001|12 Month Follow-up|Overall Study||102||
60154737|NCT00218335|76280312|FG002|12 Month Follow-up|Overall Study||244||
60154738|NCT00218335|76280313|FG003|12 Month Follow-up|Overall Study||303||
60154739|NCT00218335|76280310|FG000|18 Month Follow-up|Overall Study||101||
60154740|NCT00218335|76280311|FG001|18 Month Follow-up|Overall Study||108||
60154741|NCT00218335|76280312|FG002|18 Month Follow-up|Overall Study||296||
60154742|NCT00218335|76280313|FG003|18 Month Follow-up|Overall Study||368||
60154743|NCT00218335|76280310|FG000|COMPLETED|Overall Study||108||
60154744|NCT00218335|76280311|FG001|COMPLETED|Overall Study||110||
60154745|NCT00218335|76280312|FG002|COMPLETED|Overall Study||319||
60154746|NCT00218335|76280313|FG003|COMPLETED|Overall Study||388||
60154747|NCT00218335|76280310|FG000|NOT COMPLETED|Overall Study||6||
60154748|NCT00218335|76280311|FG001|NOT COMPLETED|Overall Study||3||
60154749|NCT00218335|76280312|FG002|NOT COMPLETED|Overall Study||54||
60154750|NCT00218335|76280313|FG003|NOT COMPLETED|Overall Study||36||
60154751|NCT00057551|76280328|FG000|STARTED|Overall Study||200||
60154752|NCT00057551|76280329|FG001|STARTED|Overall Study||195||
60154753|NCT00057551|76280330|FG002|STARTED|Overall Study||96||
60154754|NCT00057551|76280328|FG000|COMPLETED|Overall Study||175||
60154755|NCT00057551|76280329|FG001|COMPLETED|Overall Study||168||
60154756|NCT00057551|76280330|FG002|COMPLETED|Overall Study||80||
60154757|NCT00057551|76280328|FG000|NOT COMPLETED|Overall Study||25||
60154758|NCT00057551|76280329|FG001|NOT COMPLETED|Overall Study||27||
60154759|NCT00057551|76280330|FG002|NOT COMPLETED|Overall Study||16||
60154760|NCT00218491|76280341|FG000|STARTED|Overall Study||40||
60154761|NCT00218491|76280342|FG001|STARTED|Overall Study||33||
60154762|NCT00218491|76280343|FG002|STARTED|Overall Study||38||
60154763|NCT00218491|76280341|FG000|COMPLETED|Overall Study||40||
60154764|NCT00218491|76280342|FG001|COMPLETED|Overall Study||33||
60154765|NCT00218491|76280343|FG002|COMPLETED|Overall Study||38||
60154766|NCT00218491|76280341|FG000|NOT COMPLETED|Overall Study||0||
60154767|NCT00218491|76280342|FG001|NOT COMPLETED|Overall Study||0||
60154768|NCT00218491|76280343|FG002|NOT COMPLETED|Overall Study||0||
60154769|NCT00221299|76280354|FG000|STARTED|Overall Study||11||
60154770|NCT00221299|76280355|FG001|STARTED|Overall Study||13||
60154771|NCT00221299|76280356|FG002|STARTED|Overall Study||14||
60154772|NCT00221299|76280357|FG003|STARTED|Overall Study||11||
60154773|NCT00221299|76280354|FG000|COMPLETED|Overall Study||10||
60154774|NCT00221299|76280355|FG001|COMPLETED|Overall Study||11||
60154775|NCT00221299|76280356|FG002|COMPLETED|Overall Study||14||
60154776|NCT00221299|76280357|FG003|COMPLETED|Overall Study||10||
60154777|NCT00221299|76280354|FG000|NOT COMPLETED|Overall Study||1||
60154778|NCT00221299|76280355|FG001|NOT COMPLETED|Overall Study||2||
60154779|NCT00221299|76280356|FG002|NOT COMPLETED|Overall Study||0||
60154780|NCT00221299|76280357|FG003|NOT COMPLETED|Overall Study||1||
60154781|NCT00057785|76280365|FG000|STARTED|Overall Study||68||
59605823|NCT01946412|75715983|FG000|STARTED|Overall Study||33||
59605824|NCT01946412|75715983|FG000|COMPLETED|Overall Study||28||
60154782|NCT00057785|76280365|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|68||
60154783|NCT00057785|76280365|FG000|NOT COMPLETED|Overall Study||0||
60154784|NCT01666782|76280371|FG000|STARTED|Overall Study||54||
60154785|NCT01666782|76280372|FG001|STARTED|Overall Study||51||
60154786|NCT01666782|76280371|FG000|COMPLETED|Overall Study||50||
60154787|NCT01666782|76280372|FG001|COMPLETED|Overall Study||50||
60154788|NCT01666782|76280371|FG000|NOT COMPLETED|Overall Study||4||
60154789|NCT01666782|76280372|FG001|NOT COMPLETED|Overall Study||1||
60154790|NCT00058019|76280380|FG000|STARTED|Overall Study||39||
60154791|NCT00058019|76280381|FG001|STARTED|Overall Study||12||
60154792|NCT00058019|76280380|FG000|COMPLETED|Overall Study||39||
60154793|NCT00058019|76280381|FG001|COMPLETED|Overall Study||12||
60154794|NCT00058019|76280380|FG000|NOT COMPLETED|Overall Study||0||
60154795|NCT00058019|76280381|FG001|NOT COMPLETED|Overall Study||0||
60154796|NCT01439360|76280388|FG000|STARTED|Overall Study||6006||
60154797|NCT01439360|76280389|FG001|STARTED|Overall Study||6012||
60154798|NCT01439360|76280388|FG000|COMPLETED|Overall Study||5808||
60154799|NCT01439360|76280389|FG001|COMPLETED|Overall Study||5804||
60154800|NCT01439360|76280388|FG000|NOT COMPLETED|Overall Study||198||
60154801|NCT01439360|76280389|FG001|NOT COMPLETED|Overall Study||208||
60154802|NCT00110461|76280398|FG000|STARTED|30-Week, Double-blind Treatment Phase||98||
60154803|NCT00110461|76280399|FG001|STARTED|30-Week, Double-blind Treatment Phase||99||
60154804|NCT00110461|76280400|FG002|STARTED|30-Week, Double-blind Treatment Phase||99||
60154805|NCT00110461|76280398|FG000|COMPLETED|30-Week, Double-blind Treatment Phase||34||
60154806|NCT00110461|76280399|FG001|COMPLETED|30-Week, Double-blind Treatment Phase||22||
60154807|NCT00110461|76280400|FG002|COMPLETED|30-Week, Double-blind Treatment Phase||12||
60154808|NCT00110461|76280398|FG000|NOT COMPLETED|30-Week, Double-blind Treatment Phase||64||
60154809|NCT00110461|76280399|FG001|NOT COMPLETED|30-Week, Double-blind Treatment Phase||77||
60154810|NCT00110461|76280400|FG002|NOT COMPLETED|30-Week, Double-blind Treatment Phase||87||
60154811|NCT00110461|76280398|FG000|STARTED|Acute Phase||98||
60154812|NCT00110461|76280399|FG001|STARTED|Acute Phase||99||
60154813|NCT00110461|76280400|FG002|STARTED|Acute Phase||99||
60154814|NCT00110461|76280398|FG000|COMPLETED|Acute Phase||84||
60154815|NCT00110461|76280399|FG001|COMPLETED|Acute Phase||77||
59605825|NCT01946412|75715983|FG000|NOT COMPLETED|Overall Study||5||
59605826|NCT01946178|75715989|FG000|STARTED|Overall Study||73||
60154816|NCT00110461|76280400|FG002|COMPLETED|Acute Phase||76||
60154817|NCT00110461|76280398|FG000|NOT COMPLETED|Acute Phase||14||
60154818|NCT00110461|76280399|FG001|NOT COMPLETED|Acute Phase||22||
60154819|NCT00110461|76280400|FG002|NOT COMPLETED|Acute Phase||23||
60154820|NCT00061373|76280410|FG000|STARTED|Overall Study||15||
60154821|NCT00061373|76280411|FG001|STARTED|Overall Study||3||
60154822|NCT00061373|76280410|FG000|Aspirin and Tinzaparin|Overall Study||15||
60154823|NCT00061373|76280411|FG001|Aspirin and Tinzaparin|Overall Study||3||
60154824|NCT00061373|76280410|FG000|COMPLETED|Overall Study||15||
60154825|NCT00061373|76280411|FG001|COMPLETED|Overall Study||3||
60154826|NCT00061373|76280410|FG000|NOT COMPLETED|Overall Study||0||
60154827|NCT00061373|76280411|FG001|NOT COMPLETED|Overall Study||0||
60154828|NCT00112723|76280417|FG000|STARTED|Overall Study||13||
60154829|NCT00112723|76280418|FG001|STARTED|Overall Study||19||
60154830|NCT00112723|76280419|FG002|STARTED|Overall Study||14||
60154831|NCT00112723|76280417|FG000|Patients Evaluable for Toxicity|Overall Study||11||
60154832|NCT00112723|76280418|FG001|Patients Evaluable for Toxicity|Overall Study||12||
60154833|NCT00112723|76280419|FG002|Patients Evaluable for Toxicity|Overall Study||12||
60154834|NCT00112723|76280417|FG000|COMPLETED|Overall Study||11||
60154835|NCT00112723|76280418|FG001|COMPLETED|Overall Study||12||
60154836|NCT00112723|76280419|FG002|COMPLETED|Overall Study||12||
60154837|NCT00112723|76280417|FG000|NOT COMPLETED|Overall Study||2||
60154838|NCT00112723|76280418|FG001|NOT COMPLETED|Overall Study||7||
60154839|NCT00112723|76280419|FG002|NOT COMPLETED|Overall Study||2||
60154840|NCT00113425|76280440|FG000|STARTED|Overall Study||44||
60154841|NCT00113425|76280440|FG000|COMPLETED|Overall Study||29||
60154842|NCT00113425|76280440|FG000|NOT COMPLETED|Overall Study||15||
60154843|NCT02096731|76280447|FG000|STARTED|Overall Study||26442||
60154844|NCT02096731|76280448|FG001|STARTED|Overall Study||88955||
60154845|NCT02096731|76280447|FG000|COMPLETED|Overall Study||26442||
60154846|NCT02096731|76280448|FG001|COMPLETED|Overall Study||88955||
60154847|NCT02096731|76280447|FG000|NOT COMPLETED|Overall Study||0||
60154848|NCT02096731|76280448|FG001|NOT COMPLETED|Overall Study||0||
60154849|NCT00115297|76280459|FG000|STARTED|Overall Study||30||
60154850|NCT00115297|76280460|FG001|STARTED|Overall Study||32||
60154851|NCT00115297|76280459|FG000|COMPLETED|Overall Study||30||
60154852|NCT00115297|76280460|FG001|COMPLETED|Overall Study||32||
60154853|NCT00115297|76280459|FG000|NOT COMPLETED|Overall Study||0||
60154854|NCT00115297|76280460|FG001|NOT COMPLETED|Overall Study||0||
60154855|NCT00116857|76280471|FG000|STARTED|Overall Study||62||
60154856|NCT00116857|76280472|FG001|STARTED|Overall Study||60||
60154857|NCT00116857|76280471|FG000|COMPLETED|Overall Study||59||
60154858|NCT00116857|76280472|FG001|COMPLETED|Overall Study||56||
60154859|NCT00116857|76280471|FG000|NOT COMPLETED|Overall Study||3||
60154860|NCT00116857|76280472|FG001|NOT COMPLETED|Overall Study||4||
60154861|NCT01672983|76280484|FG000|STARTED|Overall Study||18||
60154862|NCT01672983|76280485|FG001|STARTED|Overall Study||18||
60154863|NCT01672983|76280486|FG002|STARTED|Overall Study||19||
60154864|NCT01672983|76280487|FG003|STARTED|Overall Study||18||
60154865|NCT01672983|76280488|FG004|STARTED|Overall Study||19||
60154866|NCT01672983|76280489|FG005|STARTED|Overall Study||18||
60154867|NCT01672983|76280484|FG000|Completed Study Drug|Overall Study||18||
60154868|NCT01672983|76280485|FG001|Completed Study Drug|Overall Study||17||
60154869|NCT01672983|76280486|FG002|Completed Study Drug|Overall Study||18||
60154870|NCT01672983|76280487|FG003|Completed Study Drug|Overall Study||18||
60154871|NCT01672983|76280488|FG004|Completed Study Drug|Overall Study||12||
60154872|NCT01672983|76280489|FG005|Completed Study Drug|Overall Study||17||
60154873|NCT01672983|76280484|FG000|COMPLETED|Overall Study||18||
59882313|NCT03254108|76005229|FG001|STARTED|Overall Study||12||
59882314|NCT03254108|76005230|FG002|STARTED|Overall Study||12||
59882315|NCT03254108|76005231|FG003|STARTED|Overall Study||12||
59882316|NCT03254108|76005232|FG004|STARTED|Overall Study||12||
59882317|NCT03254108|76005228|FG000|Received Treatment|Overall Study||13||
59882318|NCT03254108|76005229|FG001|Received Treatment|Overall Study||12||
59882319|NCT03254108|76005230|FG002|Received Treatment|Overall Study||12||
59882320|NCT03254108|76005231|FG003|Received Treatment|Overall Study||11||
59882321|NCT03254108|76005232|FG004|Received Treatment|Overall Study||12||
59882322|NCT03254108|76005228|FG000|COMPLETED|Overall Study||13||
59882323|NCT03254108|76005229|FG001|COMPLETED|Overall Study||10||
59882324|NCT03254108|76005230|FG002|COMPLETED|Overall Study||12||
60154874|NCT01672983|76280485|FG001|COMPLETED|Overall Study||18||
60154875|NCT01672983|76280486|FG002|COMPLETED|Overall Study||19||
60154876|NCT01672983|76280487|FG003|COMPLETED|Overall Study||18||
60154877|NCT01672983|76280488|FG004|COMPLETED|Overall Study||19||
60154878|NCT01672983|76280489|FG005|COMPLETED|Overall Study||18||
60154879|NCT01672983|76280484|FG000|NOT COMPLETED|Overall Study||0||
60154880|NCT01672983|76280485|FG001|NOT COMPLETED|Overall Study||0||
60154881|NCT01672983|76280486|FG002|NOT COMPLETED|Overall Study||0||
60154882|NCT01672983|76280487|FG003|NOT COMPLETED|Overall Study||0||
60154883|NCT01672983|76280488|FG004|NOT COMPLETED|Overall Study||0||
60154884|NCT01672983|76280489|FG005|NOT COMPLETED|Overall Study||0||
60154885|NCT00117559|76280513|FG000|STARTED|Overall Study||9||
59882325|NCT03254108|76005231|FG003|COMPLETED|Overall Study||11||
59882326|NCT03254108|76005232|FG004|COMPLETED|Overall Study||9||
59882327|NCT03254108|76005228|FG000|NOT COMPLETED|Overall Study||0||
60154886|NCT00117559|76280514|FG001|STARTED|Overall Study||10||
60154887|NCT00117559|76280513|FG000|COMPLETED|Overall Study||8||
60154888|NCT00117559|76280514|FG001|COMPLETED|Overall Study||9||
60154889|NCT00117559|76280513|FG000|NOT COMPLETED|Overall Study||1||
60154890|NCT00117559|76280514|FG001|NOT COMPLETED|Overall Study||1||
59882328|NCT03254108|76005229|FG001|NOT COMPLETED|Overall Study||2||
59882329|NCT03254108|76005230|FG002|NOT COMPLETED|Overall Study||0||
59882330|NCT03254108|76005231|FG003|NOT COMPLETED|Overall Study||1||
59882331|NCT03254108|76005232|FG004|NOT COMPLETED|Overall Study||3||
59882332|NCT02585895|76005246|FG000|STARTED|Primary Period||20||
60154891|NCT00117715|76280520|FG000|STARTED|Overall Study||121||
60154892|NCT00117715|76280520|FG000|1 Year|Overall Study||88||
60154893|NCT00117715|76280520|FG000|1.5 Year|Overall Study||85||
60154894|NCT00117715|76280520|FG000|2 Year|Overall Study||76||
60154895|NCT00117715|76280520|FG000|2.5 Year|Overall Study||70||
60154896|NCT00117715|76280520|FG000|3 Year|Overall Study||61||
60154897|NCT00117715|76280520|FG000|3.5 Year|Overall Study||60||
60154898|NCT00117715|76280520|FG000|4 Year|Overall Study||58||
60154899|NCT00117715|76280520|FG000|4.5 Year|Overall Study||55||
60154900|NCT00117715|76280520|FG000|5 Year|Overall Study||49||
60154901|NCT00117715|76280520|FG000|COMPLETED|Overall Study||49||
60154902|NCT00117715|76280520|FG000|NOT COMPLETED|Overall Study||72||
60154903|NCT00119041|76280527|FG000|STARTED|Overall Study||199||
60154904|NCT00119041|76280528|FG001|STARTED|Overall Study||83||
60154905|NCT00119041|76280529|FG002|STARTED|Overall Study||22||
60154906|NCT00119041|76280527|FG000|COMPLETED|Overall Study||199||
60154907|NCT00119041|76280528|FG001|COMPLETED|Overall Study||83||
60154908|NCT00119041|76280529|FG002|COMPLETED|Overall Study||22||
60154909|NCT00119041|76280527|FG000|NOT COMPLETED|Overall Study||0||
60154910|NCT00119041|76280528|FG001|NOT COMPLETED|Overall Study||0||
60154911|NCT00119041|76280529|FG002|NOT COMPLETED|Overall Study||0||
60154912|NCT00228943|76280538|FG000|STARTED|Week 1||28||
60154913|NCT00228943|76280538|FG000|COMPLETED|Week 1||28||
60154914|NCT00228943|76280538|FG000|NOT COMPLETED|Week 1||0||
60154915|NCT00228943|76280538|FG000|STARTED|Week 2||28||
60154916|NCT00228943|76280538|FG000|COMPLETED|Week 2||27||
60154917|NCT00228943|76280538|FG000|NOT COMPLETED|Week 2||1||
60154918|NCT00229957|76280546|FG000|STARTED|Overall Study||152||
60154919|NCT00229957|76280547|FG001|STARTED|Overall Study||151||
60154920|NCT00229957|76280546|FG000|COMPLETED|Overall Study||132||
60154921|NCT00229957|76280547|FG001|COMPLETED|Overall Study||139||
60154922|NCT00229957|76280546|FG000|NOT COMPLETED|Overall Study||20||
60154923|NCT00229957|76280547|FG001|NOT COMPLETED|Overall Study||12||
60154924|NCT01879085|76280555|FG000|STARTED|Phase 1b||6||
60154925|NCT01879085|76280556|FG001|STARTED|Phase 1b||6||
60154926|NCT01879085|76280557|FG002|STARTED|Phase 1b||0||
60154927|NCT01879085|76280555|FG000|COMPLETED|Phase 1b||6||
60154928|NCT01879085|76280556|FG001|COMPLETED|Phase 1b||6||
60154929|NCT01879085|76280557|FG002|COMPLETED|Phase 1b||0||
60154930|NCT01879085|76280555|FG000|NOT COMPLETED|Phase 1b||0||
60154931|NCT01879085|76280556|FG001|NOT COMPLETED|Phase 1b||0||
60154932|NCT01879085|76280557|FG002|NOT COMPLETED|Phase 1b||0||
60154933|NCT01879085|76280555|FG000|STARTED|Phase 2||6||
60154934|NCT01879085|76280556|FG001|STARTED|Phase 2||0||
60154935|NCT01879085|76280557|FG002|STARTED|Phase 2||25||
60154936|NCT01879085|76280555|FG000|COMPLETED|Phase 2||6||
60154937|NCT01879085|76280556|FG001|COMPLETED|Phase 2||0||
60154938|NCT01879085|76280557|FG002|COMPLETED|Phase 2||25||
60154939|NCT01879085|76280555|FG000|NOT COMPLETED|Phase 2||0||
60154940|NCT01879085|76280556|FG001|NOT COMPLETED|Phase 2||0||
60154941|NCT01879085|76280557|FG002|NOT COMPLETED|Phase 2||0||
60154942|NCT01439204|76280566|FG000|STARTED|Overall Study||36||
60154943|NCT01439204|76280567|FG001|STARTED|Overall Study||36||
60154944|NCT01439204|76280566|FG000|COMPLETED|Overall Study||32||
60154945|NCT01439204|76280567|FG001|COMPLETED|Overall Study||33||
60154946|NCT01439204|76280566|FG000|NOT COMPLETED|Overall Study||4||
60154947|NCT01439204|76280567|FG001|NOT COMPLETED|Overall Study||3||
60154948|NCT01612767|76280573|FG000|STARTED|Overall Study||329||
60154949|NCT01612767|76280573|FG000|COMPLETED|Overall Study||287||
60154950|NCT01612767|76280573|FG000|NOT COMPLETED|Overall Study||42||
60154951|NCT00063635|76280601|FG000|STARTED|Overall Study||57||
60154952|NCT00063635|76280602|FG001|STARTED|Overall Study||58||
60154953|NCT00063635|76280603|FG002|STARTED|Overall Study||58||
60154954|NCT00063635|76280601|FG000|COMPLETED|Overall Study||51||
60154955|NCT00063635|76280602|FG001|COMPLETED|Overall Study||50||
60154956|NCT00063635|76280603|FG002|COMPLETED|Overall Study||49||
60154957|NCT00063635|76280601|FG000|NOT COMPLETED|Overall Study||6||
60154958|NCT00063635|76280602|FG001|NOT COMPLETED|Overall Study||8||
60154959|NCT00063635|76280603|FG002|NOT COMPLETED|Overall Study||9||
60154960|NCT01439126|76280613|FG000|STARTED|Overall Study||68||
60154961|NCT01439126|76280614|FG001|STARTED|Overall Study||67||
60154962|NCT01439126|76280613|FG000|COMPLETED|Overall Study||37||
60154963|NCT01439126|76280614|FG001|COMPLETED|Overall Study||25||
60154964|NCT01439126|76280613|FG000|NOT COMPLETED|Overall Study||31||
60154965|NCT01439126|76280614|FG001|NOT COMPLETED|Overall Study||42||
60154966|NCT01613313|76280624|FG000|STARTED|Overall Study||2||
60154967|NCT01613313|76280625|FG001|STARTED|Overall Study||4||
60154968|NCT01613313|76280626|FG002|STARTED|Overall Study||4||
60154969|NCT01613313|76280627|FG003|STARTED|Overall Study||4||
60154970|NCT01613313|76280624|FG000|COMPLETED|Overall Study||2||
60154971|NCT01613313|76280625|FG001|COMPLETED|Overall Study||4||
60154972|NCT01613313|76280626|FG002|COMPLETED|Overall Study||4||
60154973|NCT01613313|76280627|FG003|COMPLETED|Overall Study||4||
60154974|NCT01613313|76280624|FG000|NOT COMPLETED|Overall Study||0||
60154975|NCT01613313|76280625|FG001|NOT COMPLETED|Overall Study||0||
60154976|NCT01613313|76280626|FG002|NOT COMPLETED|Overall Study||0||
60154977|NCT01613313|76280627|FG003|NOT COMPLETED|Overall Study||0||
60154978|NCT01449812|76280640|FG000|STARTED|Overall Study||272||
60154979|NCT01449812|76280641|FG001|STARTED|Overall Study||273||
60154980|NCT01449812|76280642|FG002|STARTED|Overall Study||280||
60154981|NCT01449812|76280640|FG000|COMPLETED|Overall Study||270||
60154982|NCT01449812|76280641|FG001|COMPLETED|Overall Study||273||
60154983|NCT01449812|76280642|FG002|COMPLETED|Overall Study||279||
60154984|NCT01449812|76280640|FG000|NOT COMPLETED|Overall Study||2||
60154985|NCT01449812|76280641|FG001|NOT COMPLETED|Overall Study||0||
60154986|NCT01449812|76280642|FG002|NOT COMPLETED|Overall Study||1||
60154987|NCT01703169|76280650|FG000|STARTED|Overall Study||13||
60154988|NCT01703169|76280650|FG000|COMPLETED|Overall Study||13||
60154989|NCT01703169|76280650|FG000|NOT COMPLETED|Overall Study||0||
60154990|NCT00066677|76280656|FG000|STARTED|Overall Study||16||
60154991|NCT00066677|76280657|FG001|STARTED|Overall Study||16||
60154992|NCT00066677|76280656|FG000|COMPLETED|Overall Study||16||
60154993|NCT00066677|76280657|FG001|COMPLETED|Overall Study||16||
60154994|NCT00066677|76280656|FG000|NOT COMPLETED|Overall Study||0||
60154995|NCT00066677|76280657|FG001|NOT COMPLETED|Overall Study||0||
60154996|NCT01615731|76280665|FG000|STARTED|Overall Study||24||
60154997|NCT01615731|76280666|FG001|STARTED|Overall Study||26||
60154998|NCT01615731|76280665|FG000|COMPLETED|Overall Study||21||
60154999|NCT01615731|76280666|FG001|COMPLETED|Overall Study||24||
60155000|NCT01615731|76280665|FG000|NOT COMPLETED|Overall Study||3||
60155001|NCT01615731|76280666|FG001|NOT COMPLETED|Overall Study||2||
60155002|NCT02334800|76280676|FG000|STARTED|Overall Study||7||
60155003|NCT02334800|76280677|FG001|STARTED|Overall Study||7||
60155004|NCT02334800|76280678|FG002|STARTED|Overall Study||7||
60155005|NCT02334800|76280679|FG003|STARTED|Overall Study||7||
60155006|NCT02334800|76280676|FG000|Received Treatment|Overall Study||7||
60155007|NCT02334800|76280677|FG001|Received Treatment|Overall Study||7||
60155008|NCT02334800|76280678|FG002|Received Treatment|Overall Study||7||
60155009|NCT02334800|76280679|FG003|Received Treatment|Overall Study||7||
60155010|NCT02334800|76280676|FG000|COMPLETED|Overall Study||7||
60155011|NCT02334800|76280677|FG001|COMPLETED|Overall Study||7||
60155012|NCT02334800|76280678|FG002|COMPLETED|Overall Study||7||
60155013|NCT02334800|76280679|FG003|COMPLETED|Overall Study||7||
60155014|NCT02334800|76280676|FG000|NOT COMPLETED|Overall Study||0||
60155015|NCT02334800|76280677|FG001|NOT COMPLETED|Overall Study||0||
60155016|NCT02334800|76280678|FG002|NOT COMPLETED|Overall Study||0||
60155017|NCT02334800|76280679|FG003|NOT COMPLETED|Overall Study||0||
60155018|NCT01673919|76280689|FG000|STARTED|Overall Study||7||
60155019|NCT01673919|76280689|FG000|COMPLETED|Overall Study||7||
60155020|NCT01673919|76280689|FG000|NOT COMPLETED|Overall Study||0||
60155021|NCT01675635|76280695|FG000|STARTED|Overall Study||117||
60155022|NCT01675635|76280696|FG001|STARTED|Overall Study||117||
60155023|NCT01675635|76280695|FG000|COMPLETED|Overall Study||117||
60155024|NCT01675635|76280696|FG001|COMPLETED|Overall Study||117||
60155025|NCT01675635|76280695|FG000|NOT COMPLETED|Overall Study||0||
60155026|NCT01675635|76280696|FG001|NOT COMPLETED|Overall Study||0||
60155027|NCT01615809|76280707|FG000|STARTED|Overall Study|basal visit|32||
60155028|NCT01615809|76280707|FG000|COMPLETED|Overall Study||22||
60155029|NCT01615809|76280707|FG000|NOT COMPLETED|Overall Study||10||
60155030|NCT01617369|76280711|FG000|STARTED|Overall Study||12||
60155031|NCT01617369|76280711|FG000|COMPLETED|Overall Study||12||
60155032|NCT01617369|76280711|FG000|NOT COMPLETED|Overall Study||0||
60155033|NCT01676415|76280719|FG000|STARTED|Overall Study||4||
60155034|NCT01676415|76280720|FG001|STARTED|Overall Study||5||
60155035|NCT01676415|76280719|FG000|COMPLETED|Overall Study||4||
60155036|NCT01676415|76280720|FG001|COMPLETED|Overall Study||5||
60155037|NCT01676415|76280719|FG000|NOT COMPLETED|Overall Study||0||
60155038|NCT01676415|76280720|FG001|NOT COMPLETED|Overall Study||0||
60155039|NCT01617603|76280729|FG000|STARTED|Overall Study||20||
60155040|NCT01617603|76280730|FG001|STARTED|Overall Study||21||
60155041|NCT01617603|76280731|FG002|STARTED|Overall Study||21||
60155042|NCT01617603|76280729|FG000|COMPLETED|Overall Study||17||
60155043|NCT01617603|76280730|FG001|COMPLETED|Overall Study||19||
60155044|NCT01617603|76280731|FG002|COMPLETED|Overall Study||20||
60155045|NCT01617603|76280729|FG000|NOT COMPLETED|Overall Study||3||
60155046|NCT01617603|76280730|FG001|NOT COMPLETED|Overall Study||2||
60155047|NCT01617603|76280731|FG002|NOT COMPLETED|Overall Study||1||
60155048|NCT01618227|76280741|FG000|STARTED|Overall Study||2||
60155049|NCT01618227|76280742|FG001|STARTED|Overall Study||2||
60155050|NCT01618227|76280741|FG000|COMPLETED|Overall Study||2||
60155051|NCT01618227|76280742|FG001|COMPLETED|Overall Study||0||
60155052|NCT01618227|76280741|FG000|NOT COMPLETED|Overall Study||0||
60155053|NCT01618227|76280742|FG001|NOT COMPLETED|Overall Study||2||
60155054|NCT01620567|76280750|FG000|STARTED|Overall Study||23||
60155055|NCT01620567|76280751|FG001|STARTED|Overall Study||25||
60155056|NCT01620567|76280750|FG000|COMPLETED|Overall Study||20||
60155057|NCT01620567|76280751|FG001|COMPLETED|Overall Study||20||
60155058|NCT01620567|76280750|FG000|NOT COMPLETED|Overall Study||3||
60155059|NCT01620567|76280751|FG001|NOT COMPLETED|Overall Study||5||
60155060|NCT01678443|76280760|FG000|STARTED|Overall Study||2||
60155061|NCT01678443|76280760|FG000|COMPLETED|Overall Study||2||
60155062|NCT01678443|76280760|FG000|NOT COMPLETED|Overall Study||0||
60155063|NCT01707225|76280764|FG000|STARTED|Overall Study||10||
60155064|NCT01707225|76280764|FG000|COMPLETED|Overall Study||10||
60155065|NCT01707225|76280764|FG000|NOT COMPLETED|Overall Study||0||
60155066|NCT01707381|76280768|FG000|STARTED|Period 1||12||
60155067|NCT01707381|76280769|FG001|STARTED|Period 1||13||
60155068|NCT01707381|76280768|FG000|COMPLETED|Period 1||10||
60155069|NCT01707381|76280769|FG001|COMPLETED|Period 1||11||
60155070|NCT01707381|76280768|FG000|NOT COMPLETED|Period 1||2||
60155071|NCT01707381|76280769|FG001|NOT COMPLETED|Period 1||2||
60155072|NCT01707381|76280768|FG000|STARTED|Period 2||10||
60155073|NCT01707381|76280769|FG001|STARTED|Period 2||11||
60155074|NCT01707381|76280768|FG000|COMPLETED|Period 2||10||
60155075|NCT01707381|76280769|FG001|COMPLETED|Period 2||11||
60155076|NCT01707381|76280768|FG000|NOT COMPLETED|Period 2||0||
60155077|NCT01707381|76280769|FG001|NOT COMPLETED|Period 2||0||
60155078|NCT01708317|76280775|FG000|STARTED|2010 Control Period|# of ED patients eligible for ACASI, had it been available, in control period|3929||
60155079|NCT01708317|76280775|FG000|COMPLETED|2010 Control Period||3929||
60155080|NCT01708317|76280775|FG000|NOT COMPLETED|2010 Control Period||0||
60155081|NCT01708317|76280775|FG000|STARTED|Initial Education Period|# of ED patients eligible for ACASI, had it been available, in initial education period|982||
60155082|NCT01708317|76280775|FG000|COMPLETED|Initial Education Period||982||
60155083|NCT01708317|76280775|FG000|NOT COMPLETED|Initial Education Period||0||
60155084|NCT01708317|76280775|FG000|STARTED|ACASI + Education Period|# of ED patients eligible for ACASI in the period the ACASI was actually available.|2601||
60155085|NCT01708317|76280775|FG000|COMPLETED|ACASI + Education Period||2601||
60155086|NCT01708317|76280775|FG000|NOT COMPLETED|ACASI + Education Period||0||
60155087|NCT01708317|76280775|FG000|STARTED|Final Education Period|# of ED patients eligible for ACASI, had it been available, in final education period|909||
60155088|NCT01708317|76280775|FG000|COMPLETED|Final Education Period||909||
60155089|NCT01708317|76280775|FG000|NOT COMPLETED|Final Education Period||0||
60155090|NCT00069329|76280782|FG000|STARTED|Overall Study||43||
60155091|NCT00069329|76280782|FG000|COMPLETED|Overall Study||41||
60155092|NCT00069329|76280782|FG000|NOT COMPLETED|Overall Study||2||
60155093|NCT00072449|76280786|FG000|STARTED|Overall Study||12||
60155094|NCT00072449|76280786|FG000|COMPLETED|Overall Study||12||
60155095|NCT00072449|76280786|FG000|NOT COMPLETED|Overall Study||0||
60155096|NCT00072761|76280792|FG000|STARTED|Overall Study||99||
60155097|NCT00072761|76280793|FG001|STARTED|Overall Study||97||
60155098|NCT00072761|76280792|FG000|COMPLETED|Overall Study||90||
60155099|NCT00072761|76280793|FG001|COMPLETED|Overall Study||95||
60155100|NCT00072761|76280792|FG000|NOT COMPLETED|Overall Study||9||
60155101|NCT00072761|76280793|FG001|NOT COMPLETED|Overall Study||2||
60155102|NCT01708629|76280803|FG000|STARTED|Overall Study||624||
60155103|NCT01708629|76280804|FG001|STARTED|Overall Study||629||
60155104|NCT01708629|76280805|FG002|STARTED|Overall Study||313||
60155105|NCT01708629|76280806|FG003|STARTED|Overall Study||315||
60155106|NCT01708629|76280803|FG000|COMPLETED|Overall Study||608||
60155107|NCT01708629|76280804|FG001|COMPLETED|Overall Study||604||
60155108|NCT01708629|76280805|FG002|COMPLETED|Overall Study||303||
60155109|NCT01708629|76280806|FG003|COMPLETED|Overall Study||301||
60155110|NCT01708629|76280803|FG000|NOT COMPLETED|Overall Study||16||
60155111|NCT01708629|76280804|FG001|NOT COMPLETED|Overall Study||25||
60155112|NCT01708629|76280805|FG002|NOT COMPLETED|Overall Study||10||
60155113|NCT01708629|76280806|FG003|NOT COMPLETED|Overall Study||14||
60155114|NCT00073073|76280816|FG000|STARTED|Overall Study||46||
60155115|NCT00073073|76280816|FG000|COMPLETED|Overall Study||42||
60155116|NCT00073073|76280816|FG000|NOT COMPLETED|Overall Study||4||
60155117|NCT01466660|76280822|FG000|STARTED|Overall Study||160||
60155118|NCT01466660|76280823|FG001|STARTED|Overall Study||159||
60155119|NCT01466660|76280822|FG000|COMPLETED|Overall Study|On treatment at analysis cut-off date, 12 April 2019|0||
60155120|NCT01466660|76280823|FG001|COMPLETED|Overall Study|On treatment at analysis cut-off date, 12 April 2019|0||
60155121|NCT01466660|76280822|FG000|NOT COMPLETED|Overall Study||160||
60155122|NCT01466660|76280823|FG001|NOT COMPLETED|Overall Study||159||
60155123|NCT00075335|76280829|FG000|STARTED|Overall Study||8||
60155124|NCT00075335|76280829|FG000|COMPLETED|Overall Study||8||
60155125|NCT00075335|76280829|FG000|NOT COMPLETED|Overall Study||0||
60155126|NCT01680549|76280835|FG000|STARTED|Overall Study||25||
60155127|NCT01680549|76280836|FG001|STARTED|Overall Study||25||
60155128|NCT01680549|76280835|FG000|COMPLETED|Overall Study||20||
60155129|NCT01680549|76280836|FG001|COMPLETED|Overall Study||17||
60155130|NCT01680549|76280835|FG000|NOT COMPLETED|Overall Study||5||
60155131|NCT01680549|76280836|FG001|NOT COMPLETED|Overall Study||8||
60155132|NCT01466348|76280848|FG000|STARTED|Period I - First Intervention||36||
60155133|NCT01466348|76280849|FG001|STARTED|Period I - First Intervention||36||
60155134|NCT01466348|76280848|FG000|Intent To Treat (ITT) Population|Period I - First Intervention||36||
60155135|NCT01466348|76280849|FG001|Intent To Treat (ITT) Population|Period I - First Intervention|1 participant withdrew prior receiving the treatment|35||
60155136|NCT01466348|76280848|FG000|COMPLETED|Period I - First Intervention||36||
60155137|NCT01466348|76280849|FG001|COMPLETED|Period I - First Intervention||35||
60155138|NCT01466348|76280848|FG000|NOT COMPLETED|Period I - First Intervention||0||
60155139|NCT01466348|76280849|FG001|NOT COMPLETED|Period I - First Intervention||1||
60155140|NCT01466348|76280848|FG000|STARTED|Period II - Second Intervention||35||
60155141|NCT01466348|76280849|FG001|STARTED|Period II - Second Intervention||36||
60155142|NCT01466348|76280848|FG000|COMPLETED|Period II - Second Intervention||35||
60155143|NCT01466348|76280849|FG001|COMPLETED|Period II - Second Intervention||36||
60155144|NCT01466348|76280848|FG000|NOT COMPLETED|Period II - Second Intervention||0||
60155145|NCT01466348|76280849|FG001|NOT COMPLETED|Period II - Second Intervention||0||
60155146|NCT01680783|76280859|FG000|STARTED|Overall Study||39||
60155147|NCT01680783|76280860|FG001|STARTED|Overall Study||44||
60155148|NCT01680783|76280859|FG000|COMPLETED|Overall Study||39||
60155149|NCT01680783|76280860|FG001|COMPLETED|Overall Study||44||
60155150|NCT01680783|76280859|FG000|NOT COMPLETED|Overall Study||0||
60155151|NCT01680783|76280860|FG001|NOT COMPLETED|Overall Study||0||
60155152|NCT02235285|76280866|FG000|STARTED|Overall Study||162||
60155153|NCT02235285|76280866|FG000|COMPLETED|Overall Study||149||
60155154|NCT02235285|76280866|FG000|NOT COMPLETED|Overall Study||13||
60155155|NCT01466270|76280872|FG000|STARTED|Overall Study||31||
60155156|NCT01466270|76280873|FG001|STARTED|Overall Study||31||
60155157|NCT01466270|76280872|FG000|COMPLETED|Overall Study||19||
60155158|NCT01466270|76280873|FG001|COMPLETED|Overall Study||25||
60155159|NCT01466270|76280872|FG000|NOT COMPLETED|Overall Study||12||
60011118|NCT02631551|76126887|FG000|NOT COMPLETED|Overall Study||13||
60011119|NCT02631551|76126888|FG001|NOT COMPLETED|Overall Study||19||
60011120|NCT02631551|76126889|FG002|NOT COMPLETED|Overall Study||11||
60011121|NCT02631551|76126890|FG003|NOT COMPLETED|Overall Study||11||
60011122|NCT01680991|76126903|FG000|STARTED|Overall Study||12||
60011123|NCT01680991|76126904|FG001|STARTED|Overall Study||23||
60011124|NCT01680991|76126905|FG002|STARTED|Overall Study||13||
60011125|NCT01680991|76126903|FG000|COMPLETED|Overall Study||4||
60011126|NCT01680991|76126904|FG001|COMPLETED|Overall Study||4||
60011127|NCT01680991|76126905|FG002|COMPLETED|Overall Study||9||
60011128|NCT01680991|76126903|FG000|NOT COMPLETED|Overall Study||8||
60011129|NCT01680991|76126904|FG001|NOT COMPLETED|Overall Study||19||
60011130|NCT01680991|76126905|FG002|NOT COMPLETED|Overall Study||4||
60011131|NCT02819479|76126915|FG000|STARTED|Overall Study||10||
60011132|NCT02819479|76126915|FG000|COMPLETED|Overall Study|2 subjects experienced recurrence of radiation necrosis requiring intervention at approx. month 11.|8||
60011133|NCT02819479|76126915|FG000|NOT COMPLETED|Overall Study||2||
60011134|NCT04064411|76126922|FG000|STARTED|Overall Study||255|Intent-to-Treat (ITT) Population: Includes all participants randomized into this study.|
60011135|NCT04064411|76126923|FG001|STARTED|Overall Study||256|Intent-to-Treat (ITT) Population: Includes all participants randomized into this study.|
60011136|NCT04064411|76126922|FG000|Received at Least 1 Dose of Study Drug|Overall Study||254|Safety Population: Includes all participants who received at least 1 dose of study drug.|
60011137|NCT04064411|76126923|FG001|Received at Least 1 Dose of Study Drug|Overall Study||252|Safety Population: Includes all participants who received at least 1 dose of study drug.|
60011138|NCT04064411|76126922|FG000|COMPLETED|Overall Study||191||
60011139|NCT04064411|76126923|FG001|COMPLETED|Overall Study||201||
60011140|NCT04064411|76126922|FG000|NOT COMPLETED|Overall Study||64||
60011141|NCT04064411|76126923|FG001|NOT COMPLETED|Overall Study||55||
60011142|NCT02629133|76126931|FG000|STARTED|Overall Study||25||
60011143|NCT02629133|76126932|FG001|STARTED|Overall Study||25||
60011144|NCT02629133|76126931|FG000|COMPLETED|Overall Study||21||
60011145|NCT02629133|76126932|FG001|COMPLETED|Overall Study||23||
60011146|NCT02629133|76126931|FG000|NOT COMPLETED|Overall Study||4||
60011147|NCT02629133|76126932|FG001|NOT COMPLETED|Overall Study||2||
60011148|NCT02660359|76126941|FG000|STARTED|Overall Study||86|Subjects randomised and treated in DBPC cycle|
60011149|NCT02660359|76126942|FG001|STARTED|Overall Study||86|Subjects randomised and treated in DBPC cycle|
60011150|NCT02660359|76126943|FG002|STARTED|Overall Study||85|Subjects randomised and treated in DBPC cycle|
60011151|NCT02660359|76126941|FG000|Subjects Entered in the Dysport Cycles|Overall Study||56||
60011152|NCT02660359|76126942|FG001|Subjects Entered in the Dysport Cycles|Overall Study||86||
60011153|NCT02660359|76126943|FG002|Subjects Entered in the Dysport Cycles|Overall Study||85||
60011154|NCT02660359|76126941|FG000|COMPLETED|Overall Study||0|Subjects completed the study in the Dysport cycles|
60011155|NCT02660359|76126942|FG001|COMPLETED|Overall Study||0|Subjects completed the study in the Dysport cycles|
60011156|NCT02660359|76126943|FG002|COMPLETED|Overall Study||1|Subjects completed the study in the Dysport cycles|
60011157|NCT02660359|76126941|FG000|NOT COMPLETED|Overall Study||86||
60011158|NCT02660359|76126942|FG001|NOT COMPLETED|Overall Study||86||
60011159|NCT02660359|76126943|FG002|NOT COMPLETED|Overall Study||84||
60011160|NCT02628743|76126951|FG000|STARTED|Overall Study||131||
60155160|NCT01466270|76280873|FG001|NOT COMPLETED|Overall Study||6||
60155161|NCT02235831|76280881|FG000|STARTED|Period 1, First 5 Days of Wear||4||
60155162|NCT02235831|76280882|FG001|STARTED|Period 1, First 5 Days of Wear||4||
60155163|NCT02235831|76280883|FG002|STARTED|Period 1, First 5 Days of Wear||4||
60155164|NCT02235831|76280884|FG003|STARTED|Period 1, First 5 Days of Wear||4||
60155165|NCT02235831|76280885|FG004|STARTED|Period 1, First 5 Days of Wear||4||
60155166|NCT02235831|76280886|FG005|STARTED|Period 1, First 5 Days of Wear||4||
60155167|NCT02235831|76280881|FG000|COMPLETED|Period 1, First 5 Days of Wear||4||
60155168|NCT02235831|76280882|FG001|COMPLETED|Period 1, First 5 Days of Wear||4||
60155169|NCT02235831|76280883|FG002|COMPLETED|Period 1, First 5 Days of Wear||4||
60155170|NCT02235831|76280884|FG003|COMPLETED|Period 1, First 5 Days of Wear||4||
60155171|NCT02235831|76280885|FG004|COMPLETED|Period 1, First 5 Days of Wear||4||
60155172|NCT02235831|76280886|FG005|COMPLETED|Period 1, First 5 Days of Wear||4||
60155173|NCT02235831|76280881|FG000|NOT COMPLETED|Period 1, First 5 Days of Wear||0||
60155174|NCT02235831|76280882|FG001|NOT COMPLETED|Period 1, First 5 Days of Wear||0||
60155175|NCT02235831|76280883|FG002|NOT COMPLETED|Period 1, First 5 Days of Wear||0||
60155176|NCT02235831|76280884|FG003|NOT COMPLETED|Period 1, First 5 Days of Wear||0||
60155177|NCT02235831|76280885|FG004|NOT COMPLETED|Period 1, First 5 Days of Wear||0||
60155178|NCT02235831|76280886|FG005|NOT COMPLETED|Period 1, First 5 Days of Wear||0||
60155179|NCT02235831|76280881|FG000|STARTED|Period 2, Second 5 Days of Wear||4||
60155180|NCT02235831|76280882|FG001|STARTED|Period 2, Second 5 Days of Wear||4||
60155181|NCT02235831|76280883|FG002|STARTED|Period 2, Second 5 Days of Wear||4||
60155182|NCT02235831|76280884|FG003|STARTED|Period 2, Second 5 Days of Wear||4||
60155183|NCT02235831|76280885|FG004|STARTED|Period 2, Second 5 Days of Wear||4||
60155184|NCT02235831|76280886|FG005|STARTED|Period 2, Second 5 Days of Wear||4||
60155185|NCT02235831|76280881|FG000|COMPLETED|Period 2, Second 5 Days of Wear||4||
60155186|NCT02235831|76280882|FG001|COMPLETED|Period 2, Second 5 Days of Wear||4||
60155187|NCT02235831|76280883|FG002|COMPLETED|Period 2, Second 5 Days of Wear||4||
60155188|NCT02235831|76280884|FG003|COMPLETED|Period 2, Second 5 Days of Wear||4||
60155189|NCT02235831|76280885|FG004|COMPLETED|Period 2, Second 5 Days of Wear||4||
60155190|NCT02235831|76280886|FG005|COMPLETED|Period 2, Second 5 Days of Wear||4||
60155191|NCT02235831|76280881|FG000|NOT COMPLETED|Period 2, Second 5 Days of Wear||0||
60155192|NCT02235831|76280882|FG001|NOT COMPLETED|Period 2, Second 5 Days of Wear||0||
60155193|NCT02235831|76280883|FG002|NOT COMPLETED|Period 2, Second 5 Days of Wear||0||
60011161|NCT02628743|76126951|FG000|COMPLETED|Overall Study||0||
60011162|NCT02628743|76126951|FG000|NOT COMPLETED|Overall Study||131||
60011163|NCT03839459|76126955|FG000|STARTED|Overall Study||20||
60011164|NCT03839459|76126955|FG000|COMPLETED|Overall Study||15||
60011165|NCT03839459|76126955|FG000|NOT COMPLETED|Overall Study||5||
60011166|NCT05059301|76126962|FG000|STARTED|Overall Study||251||
60011167|NCT05059301|76126963|FG001|STARTED|Overall Study||253||
60011168|NCT05059301|76126964|FG002|STARTED|Overall Study||253||
60011169|NCT05059301|76126962|FG000|COMPLETED|Overall Study||249||
60155194|NCT02235831|76280884|FG003|NOT COMPLETED|Period 2, Second 5 Days of Wear||0||
60155195|NCT02235831|76280885|FG004|NOT COMPLETED|Period 2, Second 5 Days of Wear||0||
60155196|NCT02235831|76280886|FG005|NOT COMPLETED|Period 2, Second 5 Days of Wear||0||
60011170|NCT05059301|76126963|FG001|COMPLETED|Overall Study||248||
60011171|NCT05059301|76126964|FG002|COMPLETED|Overall Study||248||
60011172|NCT05059301|76126962|FG000|NOT COMPLETED|Overall Study||2||
60011173|NCT05059301|76126963|FG001|NOT COMPLETED|Overall Study||5||
60011174|NCT05059301|76126964|FG002|NOT COMPLETED|Overall Study||5||
60011175|NCT03450473|76126972|FG000|STARTED|Overall Study||24||
60011176|NCT03450473|76126972|FG000|COMPLETED|Overall Study||20||
60011177|NCT03450473|76126972|FG000|NOT COMPLETED|Overall Study||4||
60011178|NCT01938430|76126990|FG000|STARTED|Overall Study||30||
60011179|NCT01938430|76126991|FG001|STARTED|Overall Study||29||
60011180|NCT01938430|76126992|FG002|STARTED|Overall Study||23||
60011181|NCT01938430|76126993|FG003|STARTED|Overall Study||26||
60011182|NCT01938430|76126994|FG004|STARTED|Overall Study||55||
60011183|NCT01938430|76126995|FG005|STARTED|Overall Study||56||
60011184|NCT01938430|76126996|FG006|STARTED|Overall Study||26||
60011185|NCT01938430|76126997|FG007|STARTED|Overall Study||25||
60011186|NCT01938430|76126998|FG008|STARTED|Overall Study||26||
60011187|NCT01938430|76126999|FG009|STARTED|Overall Study||26||
60011188|NCT01938430|76127000|FG010|STARTED|Overall Study||6||
60011189|NCT01938430|76127001|FG011|STARTED|Overall Study||4||
60011190|NCT01938430|76127002|FG012|STARTED|Overall Study||4||
60011191|NCT01938430|76127003|FG013|STARTED|Overall Study||3||
60011192|NCT01938430|76126990|FG000|COMPLETED|Overall Study||26||
60011193|NCT01938430|76126991|FG001|COMPLETED|Overall Study||26||
60011194|NCT01938430|76126992|FG002|COMPLETED|Overall Study||18||
60011195|NCT01938430|76126993|FG003|COMPLETED|Overall Study||24||
60011196|NCT01938430|76126994|FG004|COMPLETED|Overall Study||55||
60011197|NCT01938430|76126995|FG005|COMPLETED|Overall Study||55||
60011198|NCT01938430|76126996|FG006|COMPLETED|Overall Study||24||
60155197|NCT02235831|76280881|FG000|STARTED|Period 3, Third 5 Days of Wear||4||
60155198|NCT02235831|76280882|FG001|STARTED|Period 3, Third 5 Days of Wear||4||
60155199|NCT02235831|76280883|FG002|STARTED|Period 3, Third 5 Days of Wear||4||
60155200|NCT02235831|76280884|FG003|STARTED|Period 3, Third 5 Days of Wear||4||
60155201|NCT02235831|76280885|FG004|STARTED|Period 3, Third 5 Days of Wear||4||
60155202|NCT02235831|76280886|FG005|STARTED|Period 3, Third 5 Days of Wear||4||
60155203|NCT02235831|76280881|FG000|COMPLETED|Period 3, Third 5 Days of Wear||4||
60155204|NCT02235831|76280882|FG001|COMPLETED|Period 3, Third 5 Days of Wear||4||
60155205|NCT02235831|76280883|FG002|COMPLETED|Period 3, Third 5 Days of Wear||4||
60155206|NCT02235831|76280884|FG003|COMPLETED|Period 3, Third 5 Days of Wear||4||
60155207|NCT02235831|76280885|FG004|COMPLETED|Period 3, Third 5 Days of Wear||4||
60155208|NCT02235831|76280886|FG005|COMPLETED|Period 3, Third 5 Days of Wear||4||
60155209|NCT02235831|76280881|FG000|NOT COMPLETED|Period 3, Third 5 Days of Wear||0||
60155210|NCT02235831|76280882|FG001|NOT COMPLETED|Period 3, Third 5 Days of Wear||0||
60155211|NCT02235831|76280883|FG002|NOT COMPLETED|Period 3, Third 5 Days of Wear||0||
60155212|NCT02235831|76280884|FG003|NOT COMPLETED|Period 3, Third 5 Days of Wear||0||
60155213|NCT02235831|76280885|FG004|NOT COMPLETED|Period 3, Third 5 Days of Wear||0||
60155214|NCT02235831|76280886|FG005|NOT COMPLETED|Period 3, Third 5 Days of Wear||0||
60155215|NCT02235987|76280893|FG000|STARTED|Overall Study||20||
60155216|NCT02235987|76280893|FG000|Received Octreotide|Overall Study||20||
60155217|NCT02235987|76280893|FG000|Received 100 µg DG3173|Overall Study||20||
60155218|NCT02235987|76280893|FG000|Received 300 µg DG3173|Overall Study||20||
60155219|NCT02235987|76280893|FG000|Received 900 µg DG3173|Overall Study||19||
60155220|NCT02235987|76280893|FG000|Received 1800 µg DG3173|Overall Study||19||
60155221|NCT02235987|76280893|FG000|COMPLETED|Overall Study||19||
60155222|NCT02235987|76280893|FG000|NOT COMPLETED|Overall Study||1||
60155223|NCT01466192|76280906|FG000|STARTED|Overall Study||108||
60155224|NCT01466192|76280906|FG000|COMPLETED|Overall Study||104||
60155225|NCT01466192|76280906|FG000|NOT COMPLETED|Overall Study||4||
60155226|NCT02236767|76280910|FG000|STARTED|Overall Study||1||
60155227|NCT02236767|76280910|FG000|COMPLETED|Overall Study||1||
60155228|NCT02236767|76280910|FG000|NOT COMPLETED|Overall Study||0||
60155229|NCT00120523|76280916|FG000|STARTED|Treatment Period||1205||
60155230|NCT00120523|76280917|FG001|STARTED|Treatment Period||1213||
60155231|NCT00120523|76280916|FG000|COMPLETED|Treatment Period||836||
60155232|NCT00120523|76280917|FG001|COMPLETED|Treatment Period||874||
60155233|NCT00120523|76280916|FG000|NOT COMPLETED|Treatment Period||369||
60155234|NCT00120523|76280917|FG001|NOT COMPLETED|Treatment Period||339||
60155235|NCT00120523|76280916|FG000|STARTED|Follow-Up Period|Patients discontinued due to lost to follow-up or who withdrew consent were not part of this period.|120||
60155236|NCT00120523|76280917|FG001|STARTED|Follow-Up Period|Patients discontinued due to lost to follow-up or who withdrew consent were not part of this period.|70||
60155237|NCT00120523|76280916|FG000|COMPLETED|Follow-Up Period||90||
60155238|NCT00120523|76280917|FG001|COMPLETED|Follow-Up Period||46||
60155239|NCT00120523|76280916|FG000|NOT COMPLETED|Follow-Up Period||30||
60155240|NCT00120523|76280917|FG001|NOT COMPLETED|Follow-Up Period||24||
60155241|NCT01438814|76280926|FG000|STARTED|Overall Study||344||
60155242|NCT01438814|76280927|FG001|STARTED|Overall Study||345||
60155243|NCT01438814|76280926|FG000|COMPLETED|Overall Study||330||
60155244|NCT01438814|76280927|FG001|COMPLETED|Overall Study||331||
60155245|NCT01438814|76280926|FG000|NOT COMPLETED|Overall Study||14||
60155246|NCT01438814|76280927|FG001|NOT COMPLETED|Overall Study||14||
60155247|NCT01681095|76280935|FG000|STARTED|Overall Study||55||
60155248|NCT01681095|76280936|FG001|STARTED|Overall Study||55||
60155249|NCT01681095|76280935|FG000|COMPLETED|Overall Study||55||
60155250|NCT01681095|76280936|FG001|COMPLETED|Overall Study||55||
60155251|NCT01681095|76280935|FG000|NOT COMPLETED|Overall Study||0||
60155252|NCT01681095|76280936|FG001|NOT COMPLETED|Overall Study||0||
60155253|NCT00121225|76280942|FG000|STARTED|Overall Study||32||
60155254|NCT00121225|76280942|FG000|COMPLETED|Overall Study||32||
60155255|NCT00121225|76280942|FG000|NOT COMPLETED|Overall Study||0||
60155256|NCT01684839|76280947|FG000|STARTED|Overall Study||9||
60155257|NCT01684839|76280947|FG000|COMPLETED|Overall Study||9||
60155258|NCT01684839|76280947|FG000|NOT COMPLETED|Overall Study||0||
60155259|NCT01684917|76280955|FG000|STARTED|Overall Study||11||
60155260|NCT01684917|76280956|FG001|STARTED|Overall Study||7||
60155261|NCT01684917|76280957|FG002|STARTED|Overall Study||13||
60155262|NCT01684917|76280958|FG003|STARTED|Overall Study||5||
60155263|NCT01684917|76280955|FG000|COMPLETED|Overall Study||11||
60155264|NCT01684917|76280956|FG001|COMPLETED|Overall Study||7||
60155265|NCT01684917|76280957|FG002|COMPLETED|Overall Study||13||
60155266|NCT01684917|76280958|FG003|COMPLETED|Overall Study||5||
60155267|NCT01684917|76280955|FG000|NOT COMPLETED|Overall Study||0||
60155268|NCT01684917|76280956|FG001|NOT COMPLETED|Overall Study||0||
60155269|NCT01684917|76280957|FG002|NOT COMPLETED|Overall Study||0||
60155270|NCT01684917|76280958|FG003|NOT COMPLETED|Overall Study||0||
60155271|NCT00230737|76280971|FG000|STARTED|Overall Study||9||
60155272|NCT00230737|76280972|FG001|STARTED|Overall Study||10||
60155273|NCT00230737|76280973|FG002|STARTED|Overall Study||8||
60155274|NCT00230737|76280971|FG000|COMPLETED|Overall Study||9||
60155275|NCT00230737|76280972|FG001|COMPLETED|Overall Study||10||
60155276|NCT00230737|76280973|FG002|COMPLETED|Overall Study||8||
60155277|NCT00230737|76280971|FG000|NOT COMPLETED|Overall Study||0||
60155278|NCT00230737|76280972|FG001|NOT COMPLETED|Overall Study||0||
60155279|NCT00230737|76280973|FG002|NOT COMPLETED|Overall Study||0||
60155280|NCT02325687|76280984|FG000|STARTED|Overall Study||16|1/19/2015|
60155281|NCT02325687|76280985|FG001|STARTED|Overall Study||15|1/19/2015|
60155282|NCT02325687|76280986|FG002|STARTED|Overall Study||19|1/19/2015|
60155283|NCT02325687|76280984|FG000|COMPLETED|Overall Study||12|11/15/16|
60155284|NCT02325687|76280985|FG001|COMPLETED|Overall Study||12|11/15/16|
60155285|NCT02325687|76280986|FG002|COMPLETED|Overall Study||13|11/15/16|
60155286|NCT02325687|76280984|FG000|NOT COMPLETED|Overall Study||4||
60155287|NCT02325687|76280985|FG001|NOT COMPLETED|Overall Study||3||
60155288|NCT02325687|76280986|FG002|NOT COMPLETED|Overall Study||6||
60155289|NCT00231283|76280994|FG000|STARTED|Overall Study||100||
60155290|NCT00231283|76280994|FG000|COMPLETED|Overall Study||95||
60155291|NCT00231283|76280994|FG000|NOT COMPLETED|Overall Study||5||
60155292|NCT01685463|76281000|FG000|STARTED|Overall Study||10||
60155293|NCT01685463|76281001|FG001|STARTED|Overall Study||8||
60155294|NCT01685463|76281000|FG000|COMPLETED|Overall Study||10||
60155295|NCT01685463|76281001|FG001|COMPLETED|Overall Study||8||
60155296|NCT01685463|76281000|FG000|NOT COMPLETED|Overall Study||0||
60155297|NCT01685463|76281001|FG001|NOT COMPLETED|Overall Study||0||
60155298|NCT00123409|76281009|FG000|STARTED|Overall Study||72||
60155299|NCT00123409|76281010|FG001|STARTED|Overall Study||74||
60155300|NCT00123409|76281009|FG000|COMPLETED|Overall Study||68||
60155301|NCT00123409|76281010|FG001|COMPLETED|Overall Study||71||
60155302|NCT00123409|76281009|FG000|NOT COMPLETED|Overall Study||4||
60155303|NCT00123409|76281010|FG001|NOT COMPLETED|Overall Study||3||
60155304|NCT01686165|76281018|FG000|STARTED|Overall Study||5||
60155305|NCT01686165|76281018|FG000|COMPLETED|Overall Study||5||
60155306|NCT01686165|76281018|FG000|NOT COMPLETED|Overall Study||0||
60155307|NCT00123643|76281024|FG000|STARTED|Overall Study||20||
60155308|NCT00123643|76281025|FG001|STARTED|Overall Study||16||
60155309|NCT00123643|76281024|FG000|COMPLETED|Overall Study||20||
60155310|NCT00123643|76281025|FG001|COMPLETED|Overall Study||16||
60155311|NCT00123643|76281024|FG000|NOT COMPLETED|Overall Study||0||
60155312|NCT00123643|76281025|FG001|NOT COMPLETED|Overall Study||0||
60155313|NCT00235573|76281031|FG000|STARTED|Overall Study|35 subjects screened; 14 not eligible; 21 started and completed study|21||
60155314|NCT00235573|76281031|FG000|COMPLETED|Overall Study||21||
60155315|NCT00235573|76281031|FG000|NOT COMPLETED|Overall Study||0||
60155316|NCT01687179|76281035|FG000|STARTED|Overall Study||3||
60155317|NCT01687179|76281036|FG001|STARTED|Overall Study||10||
60155318|NCT01687179|76281035|FG000|COMPLETED|Overall Study||2||
60155319|NCT01687179|76281036|FG001|COMPLETED|Overall Study||6||
60155320|NCT01687179|76281035|FG000|NOT COMPLETED|Overall Study||1||
60155321|NCT01687179|76281036|FG001|NOT COMPLETED|Overall Study||4||
60155322|NCT00124579|76281042|FG000|STARTED|Induction||7||
60155323|NCT00124579|76281042|FG000|COMPLETED|Induction||2||
60155324|NCT00124579|76281042|FG000|NOT COMPLETED|Induction||5||
60155325|NCT00124579|76281042|FG000|STARTED|Maintenance||2||
60155326|NCT00124579|76281042|FG000|COMPLETED|Maintenance||0||
60155327|NCT00124579|76281042|FG000|NOT COMPLETED|Maintenance||2||
60155328|NCT02326233|76281049|FG000|STARTED|Overall Study||95||
60155329|NCT02326233|76281050|FG001|STARTED|Overall Study||95||
60155330|NCT02326233|76281049|FG000|COMPLETED|Overall Study||95||
60155331|NCT02326233|76281050|FG001|COMPLETED|Overall Study||94||
60155332|NCT02326233|76281049|FG000|NOT COMPLETED|Overall Study||0||
60155333|NCT02326233|76281050|FG001|NOT COMPLETED|Overall Study||1||
60155334|NCT01688895|76281056|FG000|STARTED|Overall Study||150||
60155335|NCT01688895|76281056|FG000|COMPLETED|Overall Study||150||
60155336|NCT01688895|76281056|FG000|NOT COMPLETED|Overall Study||0||
60155337|NCT00124735|76281070|FG000|STARTED|Overall Study||5||
60155338|NCT00124735|76281071|FG001|STARTED|Overall Study||8||
60155339|NCT00124735|76281072|FG002|STARTED|Overall Study||18||
60155340|NCT00124735|76281073|FG003|STARTED|Overall Study||21||
60155341|NCT00124735|76281074|FG004|STARTED|Overall Study||19||
60155342|NCT00124735|76281075|FG005|STARTED|Overall Study||7||
60155343|NCT00124735|76281076|FG006|STARTED|Overall Study||6||
60155344|NCT00124735|76281077|FG007|STARTED|Overall Study||20||
60155345|NCT00124735|76281078|FG008|STARTED|Overall Study||25||
60155346|NCT00124735|76281079|FG009|STARTED|Overall Study||20||
60155347|NCT00124735|76281070|FG000|COMPLETED|Overall Study||4||
60155348|NCT00124735|76281071|FG001|COMPLETED|Overall Study||6||
60155349|NCT00124735|76281072|FG002|COMPLETED|Overall Study||18||
60155350|NCT00124735|76281073|FG003|COMPLETED|Overall Study||18||
60155351|NCT00124735|76281074|FG004|COMPLETED|Overall Study||17||
60155352|NCT00124735|76281075|FG005|COMPLETED|Overall Study||5||
60155353|NCT00124735|76281076|FG006|COMPLETED|Overall Study||6||
60155354|NCT00124735|76281077|FG007|COMPLETED|Overall Study||19||
60155355|NCT00124735|76281078|FG008|COMPLETED|Overall Study||22||
60155356|NCT00124735|76281079|FG009|COMPLETED|Overall Study||18||
60155357|NCT00124735|76281070|FG000|NOT COMPLETED|Overall Study||1||
60155358|NCT00124735|76281071|FG001|NOT COMPLETED|Overall Study||2||
60155359|NCT00124735|76281072|FG002|NOT COMPLETED|Overall Study||0||
60155360|NCT00124735|76281073|FG003|NOT COMPLETED|Overall Study||3||
60155361|NCT00124735|76281074|FG004|NOT COMPLETED|Overall Study||2||
60155362|NCT00124735|76281075|FG005|NOT COMPLETED|Overall Study||2||
60155363|NCT00124735|76281076|FG006|NOT COMPLETED|Overall Study||0||
60155364|NCT00124735|76281077|FG007|NOT COMPLETED|Overall Study||1||
60155365|NCT00124735|76281078|FG008|NOT COMPLETED|Overall Study||3||
60155366|NCT00124735|76281079|FG009|NOT COMPLETED|Overall Study||2||
60155367|NCT00125515|76281096|FG000|STARTED|Overall Study||27||
60155368|NCT00125515|76281097|FG001|STARTED|Overall Study||27||
60155369|NCT00125515|76281098|FG002|STARTED|Overall Study||27||
60155370|NCT00125515|76281096|FG000|COMPLETED|Overall Study||7||
60155371|NCT00125515|76281097|FG001|COMPLETED|Overall Study||7||
60155372|NCT00125515|76281098|FG002|COMPLETED|Overall Study||6||
60155373|NCT00125515|76281096|FG000|NOT COMPLETED|Overall Study||20||
60155374|NCT00125515|76281097|FG001|NOT COMPLETED|Overall Study||20||
60155375|NCT00125515|76281098|FG002|NOT COMPLETED|Overall Study||21||
60155376|NCT00125593|76281108|FG000|STARTED|Overall Study||4650||
60155377|NCT00125593|76281109|FG001|STARTED|Overall Study||4620||
60155378|NCT00125593|76281108|FG000|COMPLETED|Overall Study||4549||
60155379|NCT00125593|76281109|FG001|COMPLETED|Overall Study||4517||
60155380|NCT00125593|76281108|FG000|NOT COMPLETED|Overall Study||101||
60155381|NCT00125593|76281109|FG001|NOT COMPLETED|Overall Study||103||
60155382|NCT01689441|76281117|FG000|STARTED|Overall Study||36||
60155383|NCT01689441|76281118|FG001|STARTED|Overall Study||31||
60155384|NCT01689441|76281117|FG000|COMPLETED|Overall Study||36||
60155385|NCT01689441|76281118|FG001|COMPLETED|Overall Study||31||
60155386|NCT01689441|76281117|FG000|NOT COMPLETED|Overall Study||0||
60155387|NCT01689441|76281118|FG001|NOT COMPLETED|Overall Study||0||
60155388|NCT01690923|76281124|FG000|STARTED|Overall Study||10||
60155389|NCT01690923|76281125|FG001|STARTED|Overall Study|1 participant was withdrawn and excluded due to poor fit with the pillows mask|11||
60155390|NCT01690923|76281124|FG000|COMPLETED|Overall Study||10||
60155391|NCT01690923|76281125|FG001|COMPLETED|Overall Study||10||
60155392|NCT01690923|76281124|FG000|NOT COMPLETED|Overall Study||0||
60155393|NCT01690923|76281125|FG001|NOT COMPLETED|Overall Study||1||
60155394|NCT00236977|76281131|FG000|STARTED|Overall Study||91||
60155395|NCT00236977|76281132|FG001|STARTED|Overall Study||91||
60155396|NCT00236977|76281131|FG000|COMPLETED|Overall Study||70||
60155397|NCT00236977|76281132|FG001|COMPLETED|Overall Study||72||
60155398|NCT00236977|76281131|FG000|NOT COMPLETED|Overall Study||21||
60155399|NCT00236977|76281132|FG001|NOT COMPLETED|Overall Study||19||
60155400|NCT01691313|76281142|FG000|STARTED|Overall Study||22||
60155401|NCT01691313|76281143|FG001|STARTED|Overall Study||32||
59605827|NCT01946178|75715989|FG000|COMPLETED|Overall Study||71||
59605828|NCT01946178|75715989|FG000|NOT COMPLETED|Overall Study||2||
59605829|NCT01945944|75715999|FG000|STARTED|Overall Study||9||
59605830|NCT01945944|75716000|FG001|STARTED|Overall Study||9||
59605831|NCT01945944|75715999|FG000|COMPLETED|Overall Study||8||
60155402|NCT01691313|76281144|FG002|STARTED|Overall Study||25||
60155403|NCT01691313|76281145|FG003|STARTED|Overall Study||25||
60155404|NCT01691313|76281142|FG000|COMPLETED|Overall Study||22||
60155405|NCT01691313|76281143|FG001|COMPLETED|Overall Study||32||
60155406|NCT01691313|76281144|FG002|COMPLETED|Overall Study||25||
60155407|NCT01691313|76281145|FG003|COMPLETED|Overall Study||25||
60155408|NCT01691313|76281142|FG000|NOT COMPLETED|Overall Study||0||
60155409|NCT01691313|76281143|FG001|NOT COMPLETED|Overall Study||0||
60155410|NCT01691313|76281144|FG002|NOT COMPLETED|Overall Study||0||
60155411|NCT01691313|76281145|FG003|NOT COMPLETED|Overall Study||0||
60155412|NCT00127231|76281157|FG000|STARTED|Overall Study||74||
60155413|NCT00127231|76281158|FG001|STARTED|Overall Study||74||
60155414|NCT00127231|76281157|FG000|COMPLETED|Overall Study||68||
60155415|NCT00127231|76281158|FG001|COMPLETED|Overall Study||68||
60155416|NCT00127231|76281157|FG000|NOT COMPLETED|Overall Study||6||
60155417|NCT00127231|76281158|FG001|NOT COMPLETED|Overall Study||6||
60155418|NCT00079001|76281166|FG000|STARTED|Overall Study||323||
60155419|NCT00079001|76281167|FG001|STARTED|Overall Study||322||
60155420|NCT00079001|76281166|FG000|COMPLETED|Overall Study||323||
60155421|NCT00079001|76281167|FG001|COMPLETED|Overall Study||322||
60155422|NCT00079001|76281166|FG000|NOT COMPLETED|Overall Study||0||
60155423|NCT00079001|76281167|FG001|NOT COMPLETED|Overall Study||0||
60155424|NCT00238615|76281173|FG000|STARTED|Overall Study||13||
60155425|NCT00238615|76281173|FG000|COMPLETED|Overall Study||13||
60155426|NCT00238615|76281173|FG000|NOT COMPLETED|Overall Study||0||
60155427|NCT02243943|76281181|FG000|STARTED|Overall Study||50||
60155428|NCT02243943|76281182|FG001|STARTED|Overall Study||50||
60155429|NCT02243943|76281181|FG000|COMPLETED|Overall Study||50||
60155430|NCT02243943|76281182|FG001|COMPLETED|Overall Study||50||
60155431|NCT02243943|76281181|FG000|NOT COMPLETED|Overall Study||0||
60155432|NCT02243943|76281182|FG001|NOT COMPLETED|Overall Study||0||
60155433|NCT00131677|76281190|FG000|STARTED|Overall Study|201 randomized to active drug; 101 to start immediately and 100 after a 9 month delay.|201||
60155434|NCT00131677|76281191|FG001|STARTED|Overall Study|199 randomized to placebo; 99 to start immediately and 100 after a 9 month delay.|199||
60155435|NCT00131677|76281190|FG000|COMPLETED|Overall Study||171||
59605832|NCT01945944|75716000|FG001|COMPLETED|Overall Study||6||
60155436|NCT00131677|76281191|FG001|COMPLETED|Overall Study||160||
60155437|NCT00131677|76281190|FG000|NOT COMPLETED|Overall Study||30||
60155438|NCT00131677|76281191|FG001|NOT COMPLETED|Overall Study||39||
60155439|NCT02245815|76281204|FG000|STARTED|Overall Study||45||
60155440|NCT02245815|76281205|FG001|STARTED|Overall Study||45||
60155441|NCT02245815|76281204|FG000|COMPLETED|Overall Study||45||
60155442|NCT02245815|76281205|FG001|COMPLETED|Overall Study||45||
60155443|NCT02245815|76281204|FG000|NOT COMPLETED|Overall Study||0||
60155444|NCT02245815|76281205|FG001|NOT COMPLETED|Overall Study||0||
60155445|NCT02092415|76281213|FG000|STARTED|Overall Study||10||
60155446|NCT02092415|76281213|FG000|COMPLETED|Overall Study||10||
60155447|NCT02092415|76281213|FG000|NOT COMPLETED|Overall Study||0||
60155448|NCT00240487|76281220|FG000|STARTED|Overall Study||24||
60155449|NCT00240487|76281221|FG001|STARTED|Overall Study||28||
60155450|NCT00240487|76281220|FG000|COMPLETED|Overall Study||24||
59605833|NCT01945944|75715999|FG000|NOT COMPLETED|Overall Study||1||
59605834|NCT01945944|75716000|FG001|NOT COMPLETED|Overall Study||3||
59605835|NCT01945866|75716010|FG000|STARTED|Overall Study||65|Units in Eyes|65
59605836|NCT01945866|75716011|FG001|STARTED|Overall Study||64|Units in Eyes|64
59605837|NCT01945866|75716010|FG000|COMPLETED|Overall Study||63||63
59605838|NCT01945866|75716011|FG001|COMPLETED|Overall Study||64||64
59605839|NCT01945866|75716010|FG000|NOT COMPLETED|Overall Study||2||2
59605840|NCT01945866|75716011|FG001|NOT COMPLETED|Overall Study||0||0
60155451|NCT00240487|76281221|FG001|COMPLETED|Overall Study||28||
60155452|NCT00240487|76281220|FG000|NOT COMPLETED|Overall Study||0||
60155453|NCT00240487|76281221|FG001|NOT COMPLETED|Overall Study||0||
60155454|NCT00241969|76281229|FG000|STARTED|Overall Study||36||
59605841|NCT01986114|75716018|FG000|STARTED|Overall Study||495||
59605842|NCT01986114|75716018|FG000|COMPLETED|Overall Study||339||
59605843|NCT01986114|75716018|FG000|NOT COMPLETED|Overall Study||156||
59605844|NCT01945710|75716031|FG000|STARTED|Overall Study||7||
59605845|NCT01945710|75716032|FG001|STARTED|Overall Study||6||
59605846|NCT01945710|75716033|FG002|STARTED|Overall Study||7||
60155455|NCT00241969|76281230|FG001|STARTED|Overall Study||42||
60155456|NCT00241969|76281229|FG000|COMPLETED|Overall Study||36||
60155457|NCT00241969|76281230|FG001|COMPLETED|Overall Study||42||
60155458|NCT00241969|76281229|FG000|NOT COMPLETED|Overall Study||0||
60155459|NCT00241969|76281230|FG001|NOT COMPLETED|Overall Study||0||
60155460|NCT02092649|76281238|FG000|STARTED|Overall Study|13 participants recruited|13||
60155461|NCT02092649|76281239|FG001|STARTED|Overall Study|13 participants recruited|13||
60155462|NCT02092649|76281238|FG000|COMPLETED|Overall Study|13 participants finished study|13||
60155463|NCT02092649|76281239|FG001|COMPLETED|Overall Study|13 participants finished study|13||
60155464|NCT02092649|76281238|FG000|NOT COMPLETED|Overall Study||0||
60155465|NCT02092649|76281239|FG001|NOT COMPLETED|Overall Study||0||
60155466|NCT00084149|76281247|FG000|STARTED|Overall Study||36||
60155467|NCT00084149|76281248|FG001|STARTED|Overall Study||18||
60155468|NCT00084149|76281247|FG000|COMPLETED|Overall Study||28||
60155469|NCT00084149|76281248|FG001|COMPLETED|Overall Study||13||
60155470|NCT00084149|76281247|FG000|NOT COMPLETED|Overall Study||8||
60155471|NCT00084149|76281248|FG001|NOT COMPLETED|Overall Study||5||
60155472|NCT02247063|76281260|FG000|STARTED|Overall Study||12||
60155473|NCT02247063|76281261|FG001|STARTED|Overall Study||12||
60155474|NCT02247063|76281260|FG000|COMPLETED|Overall Study||12||
60155475|NCT02247063|76281261|FG001|COMPLETED|Overall Study||12||
60155476|NCT02247063|76281260|FG000|NOT COMPLETED|Overall Study||0||
60155477|NCT02247063|76281261|FG001|NOT COMPLETED|Overall Study||0||
60155478|NCT00134017|76281267|FG000|STARTED|Overall Study||142||
60155479|NCT00134017|76281267|FG000|COMPLETED|Overall Study||142||
60155480|NCT00134017|76281267|FG000|NOT COMPLETED|Overall Study||0||
60155481|NCT00084383|76281271|FG000|STARTED|Overall Study||60||
60155482|NCT00084383|76281271|FG000|COMPLETED|Overall Study||13||
60155483|NCT00084383|76281271|FG000|NOT COMPLETED|Overall Study||47||
60155484|NCT00243061|76281275|FG000|STARTED|Overall Study||24||
60155485|NCT00243061|76281275|FG000|COMPLETED|Overall Study||24||
60155486|NCT00243061|76281275|FG000|NOT COMPLETED|Overall Study||0||
60155487|NCT00139399|76281282|FG000|STARTED|Overall Study||60||
60155488|NCT00139399|76281283|FG001|STARTED|Overall Study||82||
60155489|NCT00139399|76281282|FG000|COMPLETED|Overall Study||44||
60155490|NCT00139399|76281283|FG001|COMPLETED|Overall Study||59||
60155491|NCT00139399|76281282|FG000|NOT COMPLETED|Overall Study||16||
60155492|NCT00139399|76281283|FG001|NOT COMPLETED|Overall Study||23||
60155493|NCT00245557|76281291|FG000|STARTED|Overall Study||17||
60155494|NCT00245557|76281292|FG001|STARTED|Overall Study||26||
59605847|NCT01945710|75716034|FG003|STARTED|Overall Study||3||
59605848|NCT01945710|75716035|FG004|STARTED|Overall Study||9||
60155495|NCT00245557|76281291|FG000|COMPLETED|Overall Study||11||
59605849|NCT01945710|75716036|FG005|STARTED|Overall Study||3||
59605850|NCT01945710|75716037|FG006|STARTED|Overall Study||23||
59605851|NCT01945710|75716031|FG000|COMPLETED|Overall Study||0||
59605852|NCT01945710|75716032|FG001|COMPLETED|Overall Study||0||
59605853|NCT01945710|75716033|FG002|COMPLETED|Overall Study||0||
60155496|NCT00245557|76281292|FG001|COMPLETED|Overall Study||10||
60155497|NCT00245557|76281291|FG000|NOT COMPLETED|Overall Study||6||
60155498|NCT00245557|76281292|FG001|NOT COMPLETED|Overall Study||16||
60155499|NCT00245635|76281301|FG000|STARTED|Overall Study||25||
60155500|NCT00245635|76281302|FG001|STARTED|Overall Study||18||
60155501|NCT00245635|76281301|FG000|COMPLETED|Overall Study||25||
60155502|NCT00245635|76281302|FG001|COMPLETED|Overall Study||18||
60155503|NCT00245635|76281301|FG000|NOT COMPLETED|Overall Study||0||
60155504|NCT00245635|76281302|FG001|NOT COMPLETED|Overall Study||0||
60155505|NCT00141115|76281308|FG000|STARTED|Overall Study||3||
60155506|NCT00141115|76281308|FG000|COMPLETED|Overall Study||2||
60155507|NCT00141115|76281308|FG000|NOT COMPLETED|Overall Study||1||
60155508|NCT00249379|76281315|FG000|STARTED|Overall Study||14||
60155509|NCT00249379|76281316|FG001|STARTED|Overall Study||12||
60155510|NCT00249379|76281315|FG000|COMPLETED|Overall Study||6||
60155511|NCT00249379|76281316|FG001|COMPLETED|Overall Study||4||
60155512|NCT00249379|76281315|FG000|NOT COMPLETED|Overall Study||8||
60155513|NCT00249379|76281316|FG001|NOT COMPLETED|Overall Study||8||
60155514|NCT00141739|76281322|FG000|STARTED|Overall Study|Number of evaluable patients|100||
60155515|NCT00141739|76281322|FG000|COMPLETED|Overall Study||100||
60155516|NCT00141739|76281322|FG000|NOT COMPLETED|Overall Study||0||
60155517|NCT00142597|76281330|FG000|STARTED|Overall Study|N=10 underwent PET imaging|23||
60155518|NCT00142597|76281331|FG001|STARTED|Overall Study|N=10 underwent PET imaging|23||
60155519|NCT00142597|76281330|FG000|COMPLETED|Overall Study|N=10 completed PET imaging|20||
59882333|NCT02585895|76005247|FG001|STARTED|Primary Period||19||
59882334|NCT02585895|76005246|FG000|COMPLETED|Primary Period||20||
59882335|NCT02585895|76005247|FG001|COMPLETED|Primary Period||19||
60155520|NCT00142597|76281331|FG001|COMPLETED|Overall Study|N=10 completed PET imaging|22||
60155521|NCT00142597|76281330|FG000|NOT COMPLETED|Overall Study||3||
60155522|NCT00142597|76281331|FG001|NOT COMPLETED|Overall Study||1||
60155523|NCT00143845|76281337|FG000|STARTED|Overall Study||54||
60155524|NCT00143845|76281337|FG000|COMPLETED|Overall Study||54||
60155525|NCT00143845|76281337|FG000|NOT COMPLETED|Overall Study||0||
60155526|NCT00086957|76281341|FG000|STARTED|Overall Study||2||
60155527|NCT00086957|76281342|FG001|STARTED|Overall Study||7||
60155528|NCT00086957|76281343|FG002|STARTED|Overall Study||22||
59882336|NCT02585895|76005246|FG000|NOT COMPLETED|Primary Period||0||
59882337|NCT02585895|76005247|FG001|NOT COMPLETED|Primary Period||0||
59882338|NCT02585895|76005246|FG000|STARTED|Post-primary Period||20||
60155529|NCT00086957|76281341|FG000|COMPLETED|Overall Study||2||
59882339|NCT02585895|76005247|FG001|STARTED|Post-primary Period||19||
60155530|NCT00086957|76281342|FG001|COMPLETED|Overall Study||7||
60155531|NCT00086957|76281343|FG002|COMPLETED|Overall Study||22||
60155532|NCT00086957|76281341|FG000|NOT COMPLETED|Overall Study||0||
60155533|NCT00086957|76281342|FG001|NOT COMPLETED|Overall Study||0||
60155534|NCT00086957|76281343|FG002|NOT COMPLETED|Overall Study||0||
60155535|NCT00144391|76281354|FG000|STARTED|Overall Study||11||
60155536|NCT00144391|76281355|FG001|STARTED|Overall Study||9||
60155537|NCT00144391|76281354|FG000|COMPLETED|Overall Study||11||
60155538|NCT00144391|76281355|FG001|COMPLETED|Overall Study||9||
59882340|NCT02585895|76005246|FG000|COMPLETED|Post-primary Period||20||
60155539|NCT00144391|76281354|FG000|NOT COMPLETED|Overall Study||0||
60155540|NCT00144391|76281355|FG001|NOT COMPLETED|Overall Study||0||
60155541|NCT00145249|76281364|FG000|STARTED|Overall Study|47 subjects randomized; 45 subjects treated|47||
60155542|NCT00145249|76281365|FG001|STARTED|Overall Study|48 subjects randomized; 47 subjects treated-2 subjects randomized to AmphoB rec'd AmphoB+Fluc400|48||
60155543|NCT00145249|76281366|FG002|STARTED|Overall Study|48 subjects randomized; 49 treated-3 subjects randomized to AmphoB+Fluc400 rec'd AmphoB+Fluc800|48||
60155544|NCT00145249|76281364|FG000|COMPLETED|Overall Study||36||
59882341|NCT02585895|76005247|FG001|COMPLETED|Post-primary Period||19||
60155545|NCT00145249|76281365|FG001|COMPLETED|Overall Study||33||
60155546|NCT00145249|76281366|FG002|COMPLETED|Overall Study||31||
60155547|NCT00145249|76281364|FG000|NOT COMPLETED|Overall Study||11||
60155548|NCT00145249|76281365|FG001|NOT COMPLETED|Overall Study||15||
60155549|NCT00145249|76281366|FG002|NOT COMPLETED|Overall Study||17||
60155550|NCT00153803|76281376|FG000|STARTED|Concurrent Chemoradiation||123|Patients randomized|
60155551|NCT00153803|76281377|FG001|STARTED|Concurrent Chemoradiation||122|Patients randomized|
60155552|NCT00153803|76281376|FG000|Received Chemoradiation|Concurrent Chemoradiation||118||
60155553|NCT00153803|76281377|FG001|Received Chemoradiation|Concurrent Chemoradiation||117||
60155554|NCT00153803|76281376|FG000|COMPLETED|Concurrent Chemoradiation||118||
60155555|NCT00153803|76281377|FG001|COMPLETED|Concurrent Chemoradiation||117||
60155556|NCT00153803|76281376|FG000|NOT COMPLETED|Concurrent Chemoradiation||5||
60155557|NCT00153803|76281377|FG001|NOT COMPLETED|Concurrent Chemoradiation||5||
60155558|NCT00153803|76281376|FG000|STARTED|Investigational Drug||118|Patients who participated in Period 1|
60155559|NCT00153803|76281377|FG001|STARTED|Investigational Drug||117|Patients who participated in Period 1|
60155560|NCT00153803|76281376|FG000|Investigational Drug Dispensed|Investigational Drug||77||
60155561|NCT00153803|76281377|FG001|Investigational Drug Dispensed|Investigational Drug||75||
60155562|NCT00153803|76281376|FG000|COMPLETED|Investigational Drug||77|Received at least one dose|
60155563|NCT00153803|76281377|FG001|COMPLETED|Investigational Drug||75|Received at least one dose|
60155564|NCT00153803|76281376|FG000|NOT COMPLETED|Investigational Drug||41||
60155565|NCT00153803|76281377|FG001|NOT COMPLETED|Investigational Drug||42||
60155566|NCT00252967|76281388|FG000|STARTED|Overall Study||31||
60155567|NCT00252967|76281389|FG001|STARTED|Overall Study||33||
60155568|NCT00252967|76281388|FG000|COMPLETED|Overall Study||31||
60155569|NCT00252967|76281389|FG001|COMPLETED|Overall Study||33||
60155570|NCT00252967|76281388|FG000|NOT COMPLETED|Overall Study||0||
60155571|NCT00252967|76281389|FG001|NOT COMPLETED|Overall Study||0||
60155572|NCT01783223|76281395|FG000|STARTED|Overall Study||668||
60155573|NCT01783223|76281395|FG000|COMPLETED|Overall Study||668||
60155574|NCT01783223|76281395|FG000|NOT COMPLETED|Overall Study||0||
60155575|NCT00088985|76281399|FG000|STARTED|Overall Study||7||
60155576|NCT00088985|76281399|FG000|COMPLETED|Overall Study||4||
60155577|NCT00088985|76281399|FG000|NOT COMPLETED|Overall Study||3||
60155578|NCT00156923|76281405|FG000|STARTED|Overall Study||56||
60155579|NCT00156923|76281406|FG001|STARTED|Overall Study||52||
60155580|NCT00156923|76281405|FG000|COMPLETED|Overall Study||22||
60155581|NCT00156923|76281406|FG001|COMPLETED|Overall Study||20||
60155582|NCT00156923|76281405|FG000|NOT COMPLETED|Overall Study||34||
60155583|NCT00156923|76281406|FG001|NOT COMPLETED|Overall Study||32||
60155584|NCT00093041|76281418|FG000|STARTED|Overall Study||4||
60155585|NCT00093041|76281419|FG001|STARTED|Overall Study||4||
60155586|NCT00093041|76281420|FG002|STARTED|Overall Study||5||
60155587|NCT00093041|76281421|FG003|STARTED|Overall Study||4||
60155588|NCT00093041|76281422|FG004|STARTED|Overall Study||4||
60155589|NCT00093041|76281423|FG005|STARTED|Overall Study||7||
60155590|NCT00093041|76281418|FG000|COMPLETED|Overall Study|One discontinued during single dose period and one during multiple dose period|2||
60155591|NCT00093041|76281419|FG001|COMPLETED|Overall Study|Three discontinued during single dose period|1||
60155592|NCT00093041|76281420|FG002|COMPLETED|Overall Study|Two discontinued during single dose period|3||
60155593|NCT00093041|76281421|FG003|COMPLETED|Overall Study|One discontinued during single dose period|3||
60155594|NCT00093041|76281422|FG004|COMPLETED|Overall Study|One discontinued during multiple dose period|3||
60155595|NCT00093041|76281423|FG005|COMPLETED|Overall Study|Three discontinued during multiple dose period|4||
60155596|NCT00093041|76281418|FG000|NOT COMPLETED|Overall Study||2||
60155597|NCT00093041|76281419|FG001|NOT COMPLETED|Overall Study||3||
60155598|NCT00093041|76281420|FG002|NOT COMPLETED|Overall Study||2||
60155599|NCT00093041|76281421|FG003|NOT COMPLETED|Overall Study||1||
60155600|NCT00093041|76281422|FG004|NOT COMPLETED|Overall Study||1||
60155601|NCT00093041|76281423|FG005|NOT COMPLETED|Overall Study||3||
60155602|NCT00158249|76281439|FG000|STARTED|Overall Study||11||
60155603|NCT00158249|76281440|FG001|STARTED|Overall Study||10||
60155604|NCT00158249|76281439|FG000|COMPLETED|Overall Study||9||
60155605|NCT00158249|76281440|FG001|COMPLETED|Overall Study||10||
60155606|NCT00158249|76281439|FG000|NOT COMPLETED|Overall Study||2||
60155607|NCT00158249|76281440|FG001|NOT COMPLETED|Overall Study||0||
60155608|NCT00094211|76281450|FG000|STARTED|Overall Study||221||
60155609|NCT00094211|76281451|FG001|STARTED|Overall Study||259||
60155610|NCT00094211|76281452|FG002|STARTED|Overall Study||230||
60155611|NCT00094211|76281453|FG003|STARTED|Overall Study||186||
60155612|NCT00094211|76281450|FG000|COMPLETED|Overall Study||212||
60155613|NCT00094211|76281451|FG001|COMPLETED|Overall Study||251||
60155614|NCT00094211|76281452|FG002|COMPLETED|Overall Study||220||
60155615|NCT00094211|76281453|FG003|COMPLETED|Overall Study||179||
60155616|NCT00094211|76281450|FG000|NOT COMPLETED|Overall Study||9||
60155617|NCT00094211|76281451|FG001|NOT COMPLETED|Overall Study||8||
60155618|NCT00094211|76281452|FG002|NOT COMPLETED|Overall Study||10||
60155619|NCT00094211|76281453|FG003|NOT COMPLETED|Overall Study||7||
60155620|NCT00159263|76281467|FG000|STARTED|First Intervention||1||
60155621|NCT00159263|76281468|FG001|STARTED|First Intervention||1||
60155622|NCT00159263|76281469|FG002|STARTED|First Intervention||2||
60155623|NCT00159263|76281470|FG003|STARTED|First Intervention||2||
60155624|NCT00159263|76281471|FG004|STARTED|First Intervention||2||
60155625|NCT00159263|76281472|FG005|STARTED|First Intervention||2||
60155626|NCT00159263|76281467|FG000|COMPLETED|First Intervention||1||
60155627|NCT00159263|76281468|FG001|COMPLETED|First Intervention||1||
60155628|NCT00159263|76281469|FG002|COMPLETED|First Intervention||2||
60155629|NCT00159263|76281470|FG003|COMPLETED|First Intervention||2||
60155630|NCT00159263|76281471|FG004|COMPLETED|First Intervention||2||
60155631|NCT00159263|76281472|FG005|COMPLETED|First Intervention||2||
60155632|NCT00159263|76281467|FG000|NOT COMPLETED|First Intervention||0||
60155633|NCT00159263|76281468|FG001|NOT COMPLETED|First Intervention||0||
60155634|NCT00159263|76281469|FG002|NOT COMPLETED|First Intervention||0||
60155635|NCT00159263|76281470|FG003|NOT COMPLETED|First Intervention||0||
60155636|NCT00159263|76281471|FG004|NOT COMPLETED|First Intervention||0||
60155637|NCT00159263|76281472|FG005|NOT COMPLETED|First Intervention||0||
60155638|NCT00159263|76281467|FG000|STARTED|Washout||1||
60155639|NCT00159263|76281468|FG001|STARTED|Washout||1||
60155640|NCT00159263|76281469|FG002|STARTED|Washout||2||
60155641|NCT00159263|76281470|FG003|STARTED|Washout||2||
60155642|NCT00159263|76281471|FG004|STARTED|Washout||2||
60155643|NCT00159263|76281472|FG005|STARTED|Washout||2||
60155644|NCT00159263|76281467|FG000|COMPLETED|Washout||1||
60155645|NCT00159263|76281468|FG001|COMPLETED|Washout||1||
60155646|NCT00159263|76281469|FG002|COMPLETED|Washout||2||
60155647|NCT00159263|76281470|FG003|COMPLETED|Washout||2||
60155648|NCT00159263|76281471|FG004|COMPLETED|Washout||2||
60155649|NCT00159263|76281472|FG005|COMPLETED|Washout||2||
60155650|NCT00159263|76281467|FG000|NOT COMPLETED|Washout||0||
60155651|NCT00159263|76281468|FG001|NOT COMPLETED|Washout||0||
60155652|NCT00159263|76281469|FG002|NOT COMPLETED|Washout||0||
60155653|NCT00159263|76281470|FG003|NOT COMPLETED|Washout||0||
60155654|NCT00159263|76281471|FG004|NOT COMPLETED|Washout||0||
60155655|NCT00159263|76281472|FG005|NOT COMPLETED|Washout||0||
60155656|NCT00159263|76281467|FG000|STARTED|Second Intervention||1||
60155657|NCT00159263|76281468|FG001|STARTED|Second Intervention||1||
60155658|NCT00159263|76281469|FG002|STARTED|Second Intervention||2||
60155659|NCT00159263|76281470|FG003|STARTED|Second Intervention||2||
60155660|NCT00159263|76281471|FG004|STARTED|Second Intervention||2||
60155661|NCT00159263|76281472|FG005|STARTED|Second Intervention||2||
60155662|NCT00159263|76281467|FG000|COMPLETED|Second Intervention||1||
60155663|NCT00159263|76281468|FG001|COMPLETED|Second Intervention||1||
60155664|NCT00159263|76281469|FG002|COMPLETED|Second Intervention||2||
60155665|NCT00159263|76281470|FG003|COMPLETED|Second Intervention||2||
60155666|NCT00159263|76281471|FG004|COMPLETED|Second Intervention||2||
60155667|NCT00159263|76281472|FG005|COMPLETED|Second Intervention||2||
60155668|NCT00159263|76281467|FG000|NOT COMPLETED|Second Intervention||0||
60155669|NCT00159263|76281468|FG001|NOT COMPLETED|Second Intervention||0||
60155670|NCT00159263|76281469|FG002|NOT COMPLETED|Second Intervention||0||
60155671|NCT00159263|76281470|FG003|NOT COMPLETED|Second Intervention||0||
60155672|NCT00159263|76281471|FG004|NOT COMPLETED|Second Intervention||0||
60155673|NCT00159263|76281472|FG005|NOT COMPLETED|Second Intervention||0||
60155674|NCT00159263|76281467|FG000|STARTED|Washout||1||
60155675|NCT00159263|76281468|FG001|STARTED|Washout||1||
60155676|NCT00159263|76281469|FG002|STARTED|Washout||2||
60155677|NCT00159263|76281470|FG003|STARTED|Washout||2||
60155678|NCT00159263|76281471|FG004|STARTED|Washout||2||
60155679|NCT00159263|76281472|FG005|STARTED|Washout||2||
60155680|NCT00159263|76281467|FG000|COMPLETED|Washout||1||
60155681|NCT00159263|76281468|FG001|COMPLETED|Washout||1||
60155682|NCT00159263|76281469|FG002|COMPLETED|Washout||2||
60155683|NCT00159263|76281470|FG003|COMPLETED|Washout||2||
60155684|NCT00159263|76281471|FG004|COMPLETED|Washout||2||
60155685|NCT00159263|76281472|FG005|COMPLETED|Washout||2||
60155686|NCT00159263|76281467|FG000|NOT COMPLETED|Washout||0||
60155687|NCT00159263|76281468|FG001|NOT COMPLETED|Washout||0||
60155688|NCT00159263|76281469|FG002|NOT COMPLETED|Washout||0||
60155689|NCT00159263|76281470|FG003|NOT COMPLETED|Washout||0||
60155690|NCT00159263|76281471|FG004|NOT COMPLETED|Washout||0||
60155691|NCT00159263|76281472|FG005|NOT COMPLETED|Washout||0||
60155692|NCT00159263|76281467|FG000|STARTED|Third Intervention||1||
60155693|NCT00159263|76281468|FG001|STARTED|Third Intervention||1||
60155694|NCT00159263|76281469|FG002|STARTED|Third Intervention||2||
60155695|NCT00159263|76281470|FG003|STARTED|Third Intervention||2||
60155696|NCT00159263|76281471|FG004|STARTED|Third Intervention||2||
60155697|NCT00159263|76281472|FG005|STARTED|Third Intervention||2||
60155698|NCT00159263|76281467|FG000|COMPLETED|Third Intervention||1||
60155699|NCT00159263|76281468|FG001|COMPLETED|Third Intervention||1||
60155700|NCT00159263|76281469|FG002|COMPLETED|Third Intervention||2||
60155701|NCT00159263|76281470|FG003|COMPLETED|Third Intervention||2||
60155702|NCT00159263|76281471|FG004|COMPLETED|Third Intervention||2||
60155703|NCT00159263|76281472|FG005|COMPLETED|Third Intervention||2||
60155704|NCT00159263|76281467|FG000|NOT COMPLETED|Third Intervention||0||
60155705|NCT00159263|76281468|FG001|NOT COMPLETED|Third Intervention||0||
60155706|NCT00159263|76281469|FG002|NOT COMPLETED|Third Intervention||0||
60155707|NCT00159263|76281470|FG003|NOT COMPLETED|Third Intervention||0||
60155708|NCT00159263|76281471|FG004|NOT COMPLETED|Third Intervention||0||
60155709|NCT00159263|76281472|FG005|NOT COMPLETED|Third Intervention||0||
60155710|NCT00159263|76281467|FG000|STARTED|Washout||1||
60155711|NCT00159263|76281468|FG001|STARTED|Washout||1||
60155712|NCT00159263|76281469|FG002|STARTED|Washout||2||
60155713|NCT00159263|76281470|FG003|STARTED|Washout||2||
60155714|NCT00159263|76281471|FG004|STARTED|Washout||2||
60155715|NCT00159263|76281472|FG005|STARTED|Washout||2||
60155716|NCT00159263|76281467|FG000|COMPLETED|Washout||1||
60155717|NCT00159263|76281468|FG001|COMPLETED|Washout||1||
60155718|NCT00159263|76281469|FG002|COMPLETED|Washout||2||
60155719|NCT00159263|76281470|FG003|COMPLETED|Washout||2||
60155720|NCT00159263|76281471|FG004|COMPLETED|Washout||2||
60155721|NCT00159263|76281472|FG005|COMPLETED|Washout||2||
60155722|NCT00159263|76281467|FG000|NOT COMPLETED|Washout||0||
60155723|NCT00159263|76281468|FG001|NOT COMPLETED|Washout||0||
60155724|NCT00159263|76281469|FG002|NOT COMPLETED|Washout||0||
60155725|NCT00159263|76281470|FG003|NOT COMPLETED|Washout||0||
60155726|NCT00159263|76281471|FG004|NOT COMPLETED|Washout||0||
60155727|NCT00159263|76281472|FG005|NOT COMPLETED|Washout||0||
60155728|NCT00159263|76281467|FG000|STARTED|Fourth Intervention||1||
60155729|NCT00159263|76281468|FG001|STARTED|Fourth Intervention||1||
60155730|NCT00159263|76281469|FG002|STARTED|Fourth Intervention||2||
60155731|NCT00159263|76281470|FG003|STARTED|Fourth Intervention||2||
60155732|NCT00159263|76281471|FG004|STARTED|Fourth Intervention||2||
60155733|NCT00159263|76281472|FG005|STARTED|Fourth Intervention||2||
60155734|NCT00159263|76281467|FG000|COMPLETED|Fourth Intervention||1||
60155735|NCT00159263|76281468|FG001|COMPLETED|Fourth Intervention||1||
60155736|NCT00159263|76281469|FG002|COMPLETED|Fourth Intervention||2||
60155737|NCT00159263|76281470|FG003|COMPLETED|Fourth Intervention||2||
60155738|NCT00159263|76281471|FG004|COMPLETED|Fourth Intervention||2||
60155739|NCT00159263|76281472|FG005|COMPLETED|Fourth Intervention||2||
60155740|NCT00159263|76281467|FG000|NOT COMPLETED|Fourth Intervention||0||
60155741|NCT00159263|76281468|FG001|NOT COMPLETED|Fourth Intervention||0||
60155742|NCT00159263|76281469|FG002|NOT COMPLETED|Fourth Intervention||0||
60155743|NCT00159263|76281470|FG003|NOT COMPLETED|Fourth Intervention||0||
60155744|NCT00159263|76281471|FG004|NOT COMPLETED|Fourth Intervention||0||
60155745|NCT00159263|76281472|FG005|NOT COMPLETED|Fourth Intervention||0||
60155746|NCT00159263|76281467|FG000|STARTED|Washout||1||
60155747|NCT00159263|76281468|FG001|STARTED|Washout||1||
60155748|NCT00159263|76281469|FG002|STARTED|Washout||2||
60155749|NCT00159263|76281470|FG003|STARTED|Washout||2||
60155750|NCT00159263|76281471|FG004|STARTED|Washout||2||
60155751|NCT00159263|76281472|FG005|STARTED|Washout||2||
60155752|NCT00159263|76281467|FG000|COMPLETED|Washout||1||
60155753|NCT00159263|76281468|FG001|COMPLETED|Washout||1||
60155754|NCT00159263|76281469|FG002|COMPLETED|Washout||2||
60155755|NCT00159263|76281470|FG003|COMPLETED|Washout||2||
60155756|NCT00159263|76281471|FG004|COMPLETED|Washout||2||
60155757|NCT00159263|76281472|FG005|COMPLETED|Washout||2||
60155758|NCT00159263|76281467|FG000|NOT COMPLETED|Washout||0||
60155759|NCT00159263|76281468|FG001|NOT COMPLETED|Washout||0||
60155760|NCT00159263|76281469|FG002|NOT COMPLETED|Washout||0||
60155761|NCT00159263|76281470|FG003|NOT COMPLETED|Washout||0||
60155762|NCT00159263|76281471|FG004|NOT COMPLETED|Washout||0||
60155763|NCT00159263|76281472|FG005|NOT COMPLETED|Washout||0||
60155764|NCT00159263|76281467|FG000|STARTED|Fifth Intervention||1||
60155765|NCT00159263|76281468|FG001|STARTED|Fifth Intervention||1||
60155766|NCT00159263|76281469|FG002|STARTED|Fifth Intervention||2||
60155767|NCT00159263|76281470|FG003|STARTED|Fifth Intervention||2||
60155768|NCT00159263|76281471|FG004|STARTED|Fifth Intervention||2||
60155769|NCT00159263|76281472|FG005|STARTED|Fifth Intervention||2||
60155770|NCT00159263|76281467|FG000|COMPLETED|Fifth Intervention||1||
60155771|NCT00159263|76281468|FG001|COMPLETED|Fifth Intervention||1||
60155772|NCT00159263|76281469|FG002|COMPLETED|Fifth Intervention||2||
60155773|NCT00159263|76281470|FG003|COMPLETED|Fifth Intervention||2||
60155774|NCT00159263|76281471|FG004|COMPLETED|Fifth Intervention||2||
60155775|NCT00159263|76281472|FG005|COMPLETED|Fifth Intervention||2||
60155776|NCT00159263|76281467|FG000|NOT COMPLETED|Fifth Intervention||0||
59882342|NCT02585895|76005246|FG000|NOT COMPLETED|Post-primary Period||0||
59882343|NCT02585895|76005247|FG001|NOT COMPLETED|Post-primary Period||0||
59882344|NCT03773978|76005256|FG000|STARTED|PK/Safety and OLLI Period||220||
59882345|NCT03773978|76005257|FG001|STARTED|PK/Safety and OLLI Period||0||
59882346|NCT03773978|76005256|FG000|PK/Safety Period|PK/Safety and OLLI Period|One participant was discontinued from this period due to the protocol violation.|29||
59882347|NCT03773978|76005257|FG001|PK/Safety Period|PK/Safety and OLLI Period||0||
59882348|NCT03773978|76005256|FG000|OLLI Period|PK/Safety and OLLI Period|191 participants entered into the Open-label lead-in period (OLLI) period, and during week 2, 28 participants from PK/Safety population entered into the OLLI period.|219||
59882349|NCT03773978|76005257|FG001|OLLI Period|PK/Safety and OLLI Period||0||
59882350|NCT03773978|76005256|FG000|Received at Least One Dose of Study Drug|PK/Safety and OLLI Period||220||
59882351|NCT03773978|76005257|FG001|Received at Least One Dose of Study Drug|PK/Safety and OLLI Period||0||
59882352|NCT03773978|76005256|FG000|COMPLETED|PK/Safety and OLLI Period||163||
59882353|NCT03773978|76005257|FG001|COMPLETED|PK/Safety and OLLI Period||0||
59882354|NCT03773978|76005256|FG000|NOT COMPLETED|PK/Safety and OLLI Period||57||
59882355|NCT03773978|76005257|FG001|NOT COMPLETED|PK/Safety and OLLI Period||0||
59882356|NCT03773978|76005256|FG000|STARTED|DBW Period|Participants who completed the OLLI period of the study were randomized to Baricitinib and placebo in DBW period.|82||
59882357|NCT03773978|76005257|FG001|STARTED|DBW Period|Participants who completed the OLLI period of the study were randomized to Baricitinib and placebo in DBW period.|81||
59882358|NCT03773978|76005256|FG000|COMPLETED|DBW Period||56||
59882359|NCT03773978|76005257|FG001|COMPLETED|DBW Period||32||
59882360|NCT03773978|76005256|FG000|NOT COMPLETED|DBW Period||26||
59882361|NCT03773978|76005257|FG001|NOT COMPLETED|DBW Period||49||
60155777|NCT00159263|76281468|FG001|NOT COMPLETED|Fifth Intervention||0||
60155778|NCT00159263|76281469|FG002|NOT COMPLETED|Fifth Intervention||0||
60155779|NCT00159263|76281470|FG003|NOT COMPLETED|Fifth Intervention||0||
60155780|NCT00159263|76281471|FG004|NOT COMPLETED|Fifth Intervention||0||
59882362|NCT03682107|76005273|FG000|STARTED|Overall Study||10||
59882363|NCT03682107|76005274|FG001|STARTED|Overall Study||10||
59882364|NCT03682107|76005275|FG002|STARTED|Overall Study||10||
60155781|NCT00159263|76281472|FG005|NOT COMPLETED|Fifth Intervention||0||
60155782|NCT00159263|76281467|FG000|STARTED|Washout||1||
60155783|NCT00159263|76281468|FG001|STARTED|Washout||1||
60155784|NCT00159263|76281469|FG002|STARTED|Washout||2||
60155785|NCT00159263|76281470|FG003|STARTED|Washout||2||
60155786|NCT00159263|76281471|FG004|STARTED|Washout||2||
60155787|NCT00159263|76281472|FG005|STARTED|Washout||2||
60155788|NCT00159263|76281467|FG000|COMPLETED|Washout||1||
60155789|NCT00159263|76281468|FG001|COMPLETED|Washout||1||
60155790|NCT00159263|76281469|FG002|COMPLETED|Washout||2||
60155791|NCT00159263|76281470|FG003|COMPLETED|Washout||2||
60155792|NCT00159263|76281471|FG004|COMPLETED|Washout||2||
60155793|NCT00159263|76281472|FG005|COMPLETED|Washout||2||
60155794|NCT00159263|76281467|FG000|NOT COMPLETED|Washout||0||
60155795|NCT00159263|76281468|FG001|NOT COMPLETED|Washout||0||
60155796|NCT00159263|76281469|FG002|NOT COMPLETED|Washout||0||
60155797|NCT00159263|76281470|FG003|NOT COMPLETED|Washout||0||
60155798|NCT00159263|76281471|FG004|NOT COMPLETED|Washout||0||
60155799|NCT00159263|76281472|FG005|NOT COMPLETED|Washout||0||
60155800|NCT00159263|76281467|FG000|STARTED|Sixth Intervention||1||
60155801|NCT00159263|76281468|FG001|STARTED|Sixth Intervention||1||
60155802|NCT00159263|76281469|FG002|STARTED|Sixth Intervention||2||
60155803|NCT00159263|76281470|FG003|STARTED|Sixth Intervention||2||
60155804|NCT00159263|76281471|FG004|STARTED|Sixth Intervention||2||
60155805|NCT00159263|76281472|FG005|STARTED|Sixth Intervention||2||
60155806|NCT00159263|76281467|FG000|COMPLETED|Sixth Intervention||1||
60155807|NCT00159263|76281468|FG001|COMPLETED|Sixth Intervention||1||
60155808|NCT00159263|76281469|FG002|COMPLETED|Sixth Intervention||2||
60155809|NCT00159263|76281470|FG003|COMPLETED|Sixth Intervention||2||
60155810|NCT00159263|76281471|FG004|COMPLETED|Sixth Intervention||2||
60155811|NCT00159263|76281472|FG005|COMPLETED|Sixth Intervention||2||
60155812|NCT00159263|76281467|FG000|NOT COMPLETED|Sixth Intervention||0||
60155813|NCT00159263|76281468|FG001|NOT COMPLETED|Sixth Intervention||0||
60155814|NCT00159263|76281469|FG002|NOT COMPLETED|Sixth Intervention||0||
60155815|NCT00159263|76281470|FG003|NOT COMPLETED|Sixth Intervention||0||
60155816|NCT00159263|76281471|FG004|NOT COMPLETED|Sixth Intervention||0||
60155817|NCT00159263|76281472|FG005|NOT COMPLETED|Sixth Intervention||0||
60155818|NCT00159419|76281488|FG000|STARTED|Overall Study||9||
60155819|NCT00159419|76281489|FG001|STARTED|Overall Study||9||
60155820|NCT00159419|76281488|FG000|COMPLETED|Overall Study||9||
60155821|NCT00159419|76281489|FG001|COMPLETED|Overall Study||9||
60155822|NCT00159419|76281488|FG000|NOT COMPLETED|Overall Study||0||
60155823|NCT00159419|76281489|FG001|NOT COMPLETED|Overall Study||0||
60155824|NCT00159965|76281497|FG000|STARTED|Overall Study||19||
60155825|NCT00159965|76281498|FG001|STARTED|Overall Study||19||
60155826|NCT00159965|76281497|FG000|COMPLETED|Overall Study||12||
60155827|NCT00159965|76281498|FG001|COMPLETED|Overall Study||14||
60155828|NCT00159965|76281497|FG000|NOT COMPLETED|Overall Study||7||
60155829|NCT00159965|76281498|FG001|NOT COMPLETED|Overall Study||5||
60155830|NCT02926833|76281508|FG000|STARTED|Overall Study||3||
60155831|NCT02926833|76281509|FG001|STARTED|Overall Study||4||
60155832|NCT02926833|76281510|FG002|STARTED|Overall Study||7||
60155833|NCT02926833|76281511|FG003|STARTED|Overall Study||23||
60155834|NCT02926833|76281508|FG000|COMPLETED|Overall Study||0||
60155835|NCT02926833|76281509|FG001|COMPLETED|Overall Study||0||
60155836|NCT02926833|76281510|FG002|COMPLETED|Overall Study||0||
60155837|NCT02926833|76281511|FG003|COMPLETED|Overall Study||0||
60155838|NCT02926833|76281508|FG000|NOT COMPLETED|Overall Study||3||
60155839|NCT02926833|76281509|FG001|NOT COMPLETED|Overall Study||4||
60155840|NCT02926833|76281510|FG002|NOT COMPLETED|Overall Study||7||
60155841|NCT02926833|76281511|FG003|NOT COMPLETED|Overall Study||23||
60155842|NCT00096161|76281526|FG000|STARTED|Overall Study||20||
60155843|NCT00096161|76281527|FG001|STARTED|Overall Study||10||
60155844|NCT00096161|76281528|FG002|STARTED|Overall Study||6||
60155845|NCT00096161|76281529|FG003|STARTED|Overall Study||0||
60155846|NCT00096161|76281526|FG000|COMPLETED|Overall Study||20||
60155847|NCT00096161|76281527|FG001|COMPLETED|Overall Study||10||
60155848|NCT00096161|76281528|FG002|COMPLETED|Overall Study||6||
60155849|NCT00096161|76281529|FG003|COMPLETED|Overall Study||0||
60155850|NCT00096161|76281526|FG000|NOT COMPLETED|Overall Study||0||
60155851|NCT00096161|76281527|FG001|NOT COMPLETED|Overall Study||0||
60155852|NCT00096161|76281528|FG002|NOT COMPLETED|Overall Study||0||
60155853|NCT00096161|76281529|FG003|NOT COMPLETED|Overall Study||0||
60155854|NCT00097253|76281539|FG000|STARTED|Lavender||56||
60155855|NCT00097253|76281539|FG000|COMPLETED|Lavender||56||
60155856|NCT00097253|76281539|FG000|NOT COMPLETED|Lavender||0||
60155857|NCT00097253|76281539|FG000|STARTED|Lemon||56||
60155858|NCT00097253|76281539|FG000|COMPLETED|Lemon||56||
60155859|NCT00097253|76281539|FG000|NOT COMPLETED|Lemon||0||
60155860|NCT00097253|76281539|FG000|STARTED|Water (Control)||56||
60155861|NCT00097253|76281539|FG000|COMPLETED|Water (Control)||56||
60155862|NCT00097253|76281539|FG000|NOT COMPLETED|Water (Control)||0||
60155863|NCT00099047|76281549|FG000|STARTED|Overall Study||11||
60155864|NCT00099047|76281550|FG001|STARTED|Overall Study||12||
60155865|NCT00099047|76281549|FG000|COMPLETED|Overall Study||11||
60155866|NCT00099047|76281550|FG001|COMPLETED|Overall Study||12||
60155867|NCT00099047|76281549|FG000|NOT COMPLETED|Overall Study||0||
60155868|NCT00099047|76281550|FG001|NOT COMPLETED|Overall Study||0||
60155869|NCT02851797|76281558|FG000|STARTED|Overall Study||118||
60155870|NCT02851797|76281559|FG001|STARTED|Overall Study||61||
60155871|NCT02851797|76281558|FG000|All Enrolled Subjects|Overall Study||118||
60155872|NCT02851797|76281559|FG001|All Enrolled Subjects|Overall Study||61||
60155873|NCT02851797|76281558|FG000|ITT Population|Overall Study||118||
60155874|NCT02851797|76281559|FG001|ITT Population|Overall Study||61||
60155875|NCT02851797|76281558|FG000|Safety Set|Overall Study||118||
60155876|NCT02851797|76281559|FG001|Safety Set|Overall Study||61||
60155877|NCT02851797|76281558|FG000|PK Analysis Set|Overall Study||117||
60155878|NCT02851797|76281559|FG001|PK Analysis Set|Overall Study||0||
60155879|NCT02851797|76281558|FG000|Target Population|Overall Study||81||
60155880|NCT02851797|76281559|FG001|Target Population|Overall Study||39||
60155881|NCT02851797|76281558|FG000|MR Cohort|Overall Study||77||
60155882|NCT02851797|76281559|FG001|MR Cohort|Overall Study||37||
60155883|NCT02851797|76281558|FG000|COMPLETED|Overall Study||111||
60155884|NCT02851797|76281559|FG001|COMPLETED|Overall Study||59||
60155885|NCT02851797|76281558|FG000|NOT COMPLETED|Overall Study||7||
60155886|NCT02851797|76281559|FG001|NOT COMPLETED|Overall Study||2||
60155887|NCT00166205|76281565|FG000|STARTED|Overall Study||276||
60155888|NCT00166205|76281565|FG000|Intervention - SAGB Surgery|Overall Study||276||
60155889|NCT00166205|76281565|FG000|COMPLETED|Overall Study||228||
60155890|NCT00166205|76281565|FG000|NOT COMPLETED|Overall Study||48||
60155891|NCT00253435|76281571|FG000|STARTED|Overall Study|Total number is 42|42||
60155892|NCT00253435|76281572|FG001|STARTED|Overall Study|This cohort opened as long as the poor risk group is open to accrual.|8||
60155893|NCT00253435|76281571|FG000|1st Interim Analysis|Overall Study|First interim analysis: need 2+ responses in first 15 patients. Goal met study continued.|15||
60155894|NCT00253435|76281572|FG001|1st Interim Analysis|Overall Study|Only interim analysis: need 1+ response in first 10 patients.|8||
60155895|NCT00253435|76281571|FG000|2nd Interim Analysis|Overall Study|Second interim analysis: need 3+ responses in first 25 patients. Goal met study continued.|10||
60155896|NCT00253435|76281572|FG001|2nd Interim Analysis|Overall Study|This cohort opened as long as the poor risk group is open to accrual.|0||
60155897|NCT00253435|76281571|FG000|3rd Interim Analysis|Overall Study|Third interim analysis: need 4+ responses in first 35 patients. Goal met study continued.|10||
60155898|NCT00253435|76281572|FG001|3rd Interim Analysis|Overall Study|This cohort opened as long as the poor risk group is open to accrual.|0||
60155899|NCT00253435|76281571|FG000|COMPLETED|Overall Study|Forty-two evaluable poor risk patients enrolled.|42||
60155900|NCT00253435|76281572|FG001|COMPLETED|Overall Study|Eight evaluable patients enrolled.|8||
60155901|NCT00253435|76281571|FG000|NOT COMPLETED|Overall Study||0||
60155902|NCT00253435|76281572|FG001|NOT COMPLETED|Overall Study||0||
60155903|NCT00253513|76281578|FG000|STARTED|Overall Study||60||
60155904|NCT00253513|76281578|FG000|COMPLETED|Overall Study||60||
60155905|NCT00253513|76281578|FG000|NOT COMPLETED|Overall Study||0||
60155906|NCT02098993|76281584|FG000|STARTED|Overall Study||4||
60155907|NCT02098993|76281585|FG001|STARTED|Overall Study||3||
60155908|NCT02098993|76281584|FG000|COMPLETED|Overall Study||4||
60155909|NCT02098993|76281585|FG001|COMPLETED|Overall Study||3||
60155910|NCT02098993|76281584|FG000|NOT COMPLETED|Overall Study||0||
60155911|NCT02098993|76281585|FG001|NOT COMPLETED|Overall Study||0||
60155912|NCT00147043|76281591|FG000|STARTED|Overall Study||5||
59882365|NCT03682107|76005276|FG003|STARTED|Overall Study||10||
59882366|NCT03682107|76005277|FG004|STARTED|Overall Study||8||
59882367|NCT03682107|76005273|FG000|COMPLETED|Overall Study||10||
59882368|NCT03682107|76005274|FG001|COMPLETED|Overall Study||9||
59882369|NCT03682107|76005275|FG002|COMPLETED|Overall Study||10||
60155913|NCT00147043|76281591|FG000|COMPLETED|Overall Study||5||
60155914|NCT00147043|76281591|FG000|NOT COMPLETED|Overall Study||0||
60155915|NCT00166361|76281598|FG000|STARTED|Overall Study||14||
60155916|NCT00166361|76281599|FG001|STARTED|Overall Study||10||
60155917|NCT00166361|76281598|FG000|COMPLETED|Overall Study||14||
60155918|NCT00166361|76281599|FG001|COMPLETED|Overall Study||10||
60155919|NCT00166361|76281598|FG000|NOT COMPLETED|Overall Study||0||
60155920|NCT00166361|76281599|FG001|NOT COMPLETED|Overall Study||0||
60155921|NCT00100841|76281605|FG000|STARTED|Overall Study||66||
59882370|NCT03682107|76005276|FG003|COMPLETED|Overall Study||10||
60155922|NCT00100841|76281605|FG000|COMPLETED|Overall Study||66||
60155923|NCT00100841|76281605|FG000|NOT COMPLETED|Overall Study||0||
60155924|NCT02094755|76281609|FG000|STARTED|Overall Study||100||
60155925|NCT02094755|76281609|FG000|COMPLETED|Overall Study||100||
60155926|NCT02094755|76281609|FG000|NOT COMPLETED|Overall Study||0||
60155927|NCT00101933|76281615|FG000|STARTED|Overall Study||54||
59882371|NCT03682107|76005277|FG004|COMPLETED|Overall Study||8||
60155928|NCT00101933|76281616|FG001|STARTED|Overall Study||55||
60155929|NCT00101933|76281615|FG000|COMPLETED|Overall Study||54||
60155930|NCT00101933|76281616|FG001|COMPLETED|Overall Study||55||
60155931|NCT00101933|76281615|FG000|NOT COMPLETED|Overall Study||0||
60155932|NCT00101933|76281616|FG001|NOT COMPLETED|Overall Study||0||
60155933|NCT00149227|76281625|FG000|STARTED|Overall Study||1517||
60155934|NCT00149227|76281626|FG001|STARTED|Overall Study||1514||
60155935|NCT00149227|76281625|FG000|COMPLETED|Overall Study||1517||
60155936|NCT00149227|76281626|FG001|COMPLETED|Overall Study||1514||
60155937|NCT00149227|76281625|FG000|NOT COMPLETED|Overall Study||0||
60155938|NCT00149227|76281626|FG001|NOT COMPLETED|Overall Study||0||
60155939|NCT02096081|76281634|FG000|STARTED|Overall Study||122||
60155940|NCT02096081|76281635|FG001|STARTED|Overall Study||128||
60155941|NCT02096081|76281634|FG000|COMPLETED|Overall Study||119||
60155942|NCT02096081|76281635|FG001|COMPLETED|Overall Study||124||
60155943|NCT02096081|76281634|FG000|NOT COMPLETED|Overall Study||3||
60155944|NCT02096081|76281635|FG001|NOT COMPLETED|Overall Study||4||
60155945|NCT01709799|76281644|FG000|STARTED|Overall Study||25||
60155946|NCT01709799|76281645|FG001|STARTED|Overall Study||21||
60155947|NCT01709799|76281646|FG002|STARTED|Overall Study||18||
60155948|NCT01709799|76281644|FG000|COMPLETED|Overall Study||22||
60155949|NCT01709799|76281645|FG001|COMPLETED|Overall Study||18||
60155950|NCT01709799|76281646|FG002|COMPLETED|Overall Study||15||
60155951|NCT01709799|76281644|FG000|NOT COMPLETED|Overall Study||3||
60155952|NCT01709799|76281645|FG001|NOT COMPLETED|Overall Study||3||
60155953|NCT01709799|76281646|FG002|NOT COMPLETED|Overall Study||3||
60155954|NCT01710891|76281656|FG000|STARTED|Overall Study||95||
60155955|NCT01710891|76281657|FG001|STARTED|Overall Study||103||
60155956|NCT01710891|76281656|FG000|COMPLETED|Overall Study||95||
60155957|NCT01710891|76281657|FG001|COMPLETED|Overall Study||103||
60155958|NCT01710891|76281656|FG000|NOT COMPLETED|Overall Study||0||
60155959|NCT01710891|76281657|FG001|NOT COMPLETED|Overall Study||0||
60155960|NCT00254995|76281665|FG000|STARTED|Overall Study||31561||
60155961|NCT00254995|76281666|FG001|STARTED|Overall Study||31065||
60155962|NCT00254995|76281665|FG000|COMPLETED|Overall Study||31561||
60155963|NCT00254995|76281666|FG001|COMPLETED|Overall Study||31065||
60155964|NCT00254995|76281665|FG000|NOT COMPLETED|Overall Study||0||
60155965|NCT00254995|76281666|FG001|NOT COMPLETED|Overall Study||0||
60155966|NCT02247765|76281674|FG000|STARTED|Overall Study||18||
60155967|NCT02247765|76281674|FG000|COMPLETED|Overall Study||18||
60155968|NCT02247765|76281674|FG000|NOT COMPLETED|Overall Study||0||
60155969|NCT04663945|76281680|FG000|STARTED|Overall Study||29||
60155970|NCT04663945|76281681|FG001|STARTED|Overall Study||15||
60155971|NCT04663945|76281680|FG000|Week 6 Evaluation|Overall Study||28||
60155972|NCT04663945|76281681|FG001|Week 6 Evaluation|Overall Study||13||
60155973|NCT04663945|76281680|FG000|Week 12 Evaluation|Overall Study||28||
60155974|NCT04663945|76281681|FG001|Week 12 Evaluation|Overall Study||12||
60155975|NCT04663945|76281680|FG000|COMPLETED|Overall Study||28||
60155976|NCT04663945|76281681|FG001|COMPLETED|Overall Study||12||
60155977|NCT04663945|76281680|FG000|NOT COMPLETED|Overall Study||1||
60155978|NCT04663945|76281681|FG001|NOT COMPLETED|Overall Study||3||
60155979|NCT02240589|76281689|FG000|STARTED|Overall Study||5||
60155980|NCT02240589|76281690|FG001|STARTED|Overall Study||6||
60155981|NCT02240589|76281689|FG000|COMPLETED|Overall Study||3||
60155982|NCT02240589|76281690|FG001|COMPLETED|Overall Study||4||
60155983|NCT02240589|76281689|FG000|NOT COMPLETED|Overall Study||2||
60155984|NCT02240589|76281690|FG001|NOT COMPLETED|Overall Study||2||
60155985|NCT02103127|76281696|FG000|STARTED|Overall Study||20||
60155986|NCT02103127|76281696|FG000|COMPLETED|Overall Study||17||
60155987|NCT02103127|76281696|FG000|NOT COMPLETED|Overall Study||3||
60155988|NCT00258349|76281700|FG000|STARTED|Overall Study||16||
60155989|NCT00258349|76281700|FG000|HER2-positive by Central Review|Overall Study||10||
60155990|NCT00258349|76281700|FG000|COMPLETED|Overall Study||16||
60155991|NCT00258349|76281700|FG000|NOT COMPLETED|Overall Study||0||
60155992|NCT01713621|76281708|FG000|STARTED|Overall Study||8||
60155993|NCT01713621|76281709|FG001|STARTED|Overall Study||17||
60155994|NCT01713621|76281708|FG000|COMPLETED|Overall Study||1||
60155995|NCT01713621|76281709|FG001|COMPLETED|Overall Study||1||
59605854|NCT01945710|75716034|FG003|COMPLETED|Overall Study||0||
60155996|NCT01713621|76281708|FG000|NOT COMPLETED|Overall Study||7||
60155997|NCT01713621|76281709|FG001|NOT COMPLETED|Overall Study||16||
60155998|NCT01714323|76281717|FG000|STARTED|Overall Study||677||
60155999|NCT01714323|76281718|FG001|STARTED|Overall Study||680||
60156000|NCT01714323|76281717|FG000|COMPLETED|Overall Study||513||
60156001|NCT01714323|76281718|FG001|COMPLETED|Overall Study||508||
60156002|NCT01714323|76281717|FG000|NOT COMPLETED|Overall Study||164||
60156003|NCT01714323|76281718|FG001|NOT COMPLETED|Overall Study||172||
60156004|NCT00258817|76281726|FG000|STARTED|Overall Study||15||
60156005|NCT00258817|76281727|FG001|STARTED|Overall Study||15||
60156006|NCT00258817|76281726|FG000|COMPLETED|Overall Study||15||
60156007|NCT00258817|76281727|FG001|COMPLETED|Overall Study||15||
60156008|NCT00258817|76281726|FG000|NOT COMPLETED|Overall Study||0||
60156009|NCT00258817|76281727|FG001|NOT COMPLETED|Overall Study||0||
60156010|NCT00259285|76281733|FG000|STARTED|Overall Study||10||
60156011|NCT00259285|76281733|FG000|COMPLETED|Overall Study||10||
60156012|NCT00259285|76281733|FG000|NOT COMPLETED|Overall Study||0||
60156013|NCT01715883|76281737|FG000|STARTED|Overall Study||3||
60156014|NCT01715883|76281737|FG000|COMPLETED|Overall Study||2||
60156015|NCT01715883|76281737|FG000|NOT COMPLETED|Overall Study||1||
60156016|NCT01716039|76281745|FG000|STARTED|Overall Study||4||
60156017|NCT01716039|76281746|FG001|STARTED|Overall Study||8||
60156018|NCT01716039|76281747|FG002|STARTED|Overall Study||10||
60156019|NCT01716039|76281745|FG000|COMPLETED|Overall Study||3||
60156020|NCT01716039|76281746|FG001|COMPLETED|Overall Study||6||
60156021|NCT01716039|76281747|FG002|COMPLETED|Overall Study||8||
60156022|NCT01716039|76281745|FG000|NOT COMPLETED|Overall Study||1||
60156023|NCT01716039|76281746|FG001|NOT COMPLETED|Overall Study||2||
60156024|NCT01716039|76281747|FG002|NOT COMPLETED|Overall Study||2||
60156025|NCT01716195|76281757|FG000|STARTED|Overall Study||18||
60156026|NCT01716195|76281757|FG000|COMPLETED|Overall Study||17||
60156027|NCT01716195|76281757|FG000|NOT COMPLETED|Overall Study||1||
60156028|NCT01717053|76281761|FG000|STARTED|Overall Study||37||
60156029|NCT01717053|76281761|FG000|COMPLETED|Overall Study||33||
60156030|NCT01717053|76281761|FG000|NOT COMPLETED|Overall Study||4||
60156031|NCT01666314|76281774|FG000|STARTED|Overall Study||33||
60156032|NCT01666314|76281775|FG001|STARTED|Overall Study||32||
60156033|NCT01666314|76281776|FG002|STARTED|Overall Study||36||
60156034|NCT01666314|76281777|FG003|STARTED|Overall Study||36||
60156035|NCT01666314|76281774|FG000|COMPLETED|Overall Study||0||
60156036|NCT01666314|76281775|FG001|COMPLETED|Overall Study||0||
60156037|NCT01666314|76281776|FG002|COMPLETED|Overall Study||0||
60156038|NCT01666314|76281777|FG003|COMPLETED|Overall Study||0||
60156039|NCT01666314|76281774|FG000|NOT COMPLETED|Overall Study||33||
60156040|NCT01666314|76281775|FG001|NOT COMPLETED|Overall Study||32||
60156041|NCT01666314|76281776|FG002|NOT COMPLETED|Overall Study||36||
60156042|NCT01666314|76281777|FG003|NOT COMPLETED|Overall Study||36||
60156043|NCT01717209|76281798|FG000|STARTED|Overall Study||14||
60156044|NCT01717209|76281798|FG000|COMPLETED|Overall Study||14||
60156045|NCT01717209|76281798|FG000|NOT COMPLETED|Overall Study||0||
60156046|NCT01717521|76281802|FG000|STARTED|Overall Study||20||
60156047|NCT01717521|76281802|FG000|COMPLETED|Overall Study||20||
60156048|NCT01717521|76281802|FG000|NOT COMPLETED|Overall Study||0||
60156049|NCT01666002|76281808|FG000|STARTED|Overall Study||17||
60156050|NCT01666002|76281809|FG001|STARTED|Overall Study||10||
60156051|NCT01666002|76281808|FG000|COMPLETED|Overall Study||12||
60156052|NCT01666002|76281809|FG001|COMPLETED|Overall Study||10||
60156053|NCT01666002|76281808|FG000|NOT COMPLETED|Overall Study||5||
60156054|NCT01666002|76281809|FG001|NOT COMPLETED|Overall Study||0||
60156055|NCT00260689|76281819|FG000|STARTED|Overall Study||60||
60156056|NCT00260689|76281820|FG001|STARTED|Overall Study||60||
60156057|NCT00260689|76281821|FG002|STARTED|Overall Study||16||
60156058|NCT00260689|76281819|FG000|COMPLETED|Overall Study||19||
60156059|NCT00260689|76281820|FG001|COMPLETED|Overall Study||11||
60156060|NCT00260689|76281821|FG002|COMPLETED|Overall Study||1||
60156061|NCT00260689|76281819|FG000|NOT COMPLETED|Overall Study||41||
60156062|NCT00260689|76281820|FG001|NOT COMPLETED|Overall Study||49||
60156063|NCT00260689|76281821|FG002|NOT COMPLETED|Overall Study||15||
60156064|NCT00262639|76281833|FG000|STARTED|Overall Study||18||
60156065|NCT00262639|76281834|FG001|STARTED|Overall Study||26||
60156066|NCT00262639|76281835|FG002|STARTED|Overall Study||9||
60156067|NCT00262639|76281836|FG003|STARTED|Overall Study||7||
60156068|NCT00262639|76281833|FG000|COMPLETED|Overall Study||18||
60156069|NCT00262639|76281834|FG001|COMPLETED|Overall Study||26||
60156070|NCT00262639|76281835|FG002|COMPLETED|Overall Study||9||
60156071|NCT00262639|76281836|FG003|COMPLETED|Overall Study||7||
60156072|NCT00262639|76281833|FG000|NOT COMPLETED|Overall Study||0||
60156073|NCT00262639|76281834|FG001|NOT COMPLETED|Overall Study||0||
60156074|NCT00262639|76281835|FG002|NOT COMPLETED|Overall Study||0||
60156075|NCT00262639|76281836|FG003|NOT COMPLETED|Overall Study||0||
60156076|NCT01718691|76281848|FG000|STARTED|Overall Study||60||
60156077|NCT01718691|76281849|FG001|STARTED|Overall Study||10||
60156078|NCT01718691|76281848|FG000|COMPLETED|Overall Study||42||
60156079|NCT01718691|76281849|FG001|COMPLETED|Overall Study||9||
60156080|NCT01718691|76281848|FG000|NOT COMPLETED|Overall Study||18||
60156081|NCT01718691|76281849|FG001|NOT COMPLETED|Overall Study||1||
60156082|NCT00266851|76281863|FG000|STARTED|Overall Study||37||
60156083|NCT00266851|76281864|FG001|STARTED|Overall Study||38||
60156084|NCT00266851|76281865|FG002|STARTED|Overall Study||22||
60156085|NCT00266851|76281863|FG000|Completed 3 Month Follow up|Overall Study||26||
60156086|NCT00266851|76281864|FG001|Completed 3 Month Follow up|Overall Study||22||
60156087|NCT00266851|76281865|FG002|Completed 3 Month Follow up|Overall Study||15||
60156088|NCT00266851|76281863|FG000|Completed 6 Month Follow up|Overall Study||27||
60156089|NCT00266851|76281864|FG001|Completed 6 Month Follow up|Overall Study||22||
60156090|NCT00266851|76281865|FG002|Completed 6 Month Follow up|Overall Study||17||
60156091|NCT00266851|76281863|FG000|Completed 9 Month Follow up|Overall Study||22||
60156092|NCT00266851|76281864|FG001|Completed 9 Month Follow up|Overall Study||23||
60156093|NCT00266851|76281865|FG002|Completed 9 Month Follow up|Overall Study||15||
60156094|NCT00266851|76281863|FG000|Completed 12 Month Follow up|Overall Study||25||
60156095|NCT00266851|76281864|FG001|Completed 12 Month Follow up|Overall Study||19||
60156096|NCT00266851|76281865|FG002|Completed 12 Month Follow up|Overall Study||13||
60156097|NCT00266851|76281863|FG000|COMPLETED|Overall Study||37|All participants received the intervention or participated in the open-label arm completed study.|
60156098|NCT00266851|76281864|FG001|COMPLETED|Overall Study||38|All participants received the intervention or participated in the open-label arm completed study.|
60156099|NCT00266851|76281865|FG002|COMPLETED|Overall Study||22|All participants received the intervention or participated in the open-label arm completed study.|
60156100|NCT00266851|76281863|FG000|NOT COMPLETED|Overall Study||0||
60156101|NCT00266851|76281864|FG001|NOT COMPLETED|Overall Study||0||
60156102|NCT00266851|76281865|FG002|NOT COMPLETED|Overall Study||0||
60156103|NCT00015847|76281877|FG000|STARTED|Overall Study||25||
60156104|NCT00015847|76281877|FG000|COMPLETED|Overall Study||25||
60156105|NCT00015847|76281877|FG000|NOT COMPLETED|Overall Study||0||
60156106|NCT01665768|76281881|FG000|STARTED|Overall Study||49||
60156107|NCT01665768|76281881|FG000|COMPLETED|Overall Study||26||
60156108|NCT01665768|76281881|FG000|NOT COMPLETED|Overall Study||23||
60156109|NCT01720173|76281885|FG000|STARTED|Overall Study||30||
60156110|NCT01720173|76281885|FG000|COMPLETED|Overall Study||30|Eligible and treated patients.|
60156111|NCT01720173|76281885|FG000|NOT COMPLETED|Overall Study||0||
60156112|NCT00017563|76281889|FG000|STARTED|Overall Study||57||
60156113|NCT00017563|76281889|FG000|COMPLETED|Overall Study||56||
60156114|NCT00017563|76281889|FG000|NOT COMPLETED|Overall Study||1||
60156115|NCT00018031|76281893|FG000|STARTED|Overall Study||36||
60156116|NCT00018031|76281893|FG000|COMPLETED|Overall Study||36||
60156117|NCT00018031|76281893|FG000|NOT COMPLETED|Overall Study||0||
60156118|NCT01720251|76281900|FG000|STARTED|Overall Study||79||
60156119|NCT01720251|76281901|FG001|STARTED|Overall Study||79||
60156120|NCT01720251|76281902|FG002|STARTED|Overall Study||82||
60156121|NCT01720251|76281900|FG000|COMPLETED|Overall Study||78||
60156122|NCT01720251|76281901|FG001|COMPLETED|Overall Study||77||
60156123|NCT01720251|76281902|FG002|COMPLETED|Overall Study||82||
60156124|NCT01720251|76281900|FG000|NOT COMPLETED|Overall Study||1||
60156125|NCT01720251|76281901|FG001|NOT COMPLETED|Overall Study||2||
60156126|NCT01720251|76281902|FG002|NOT COMPLETED|Overall Study||0||
60156127|NCT00267085|76281910|FG000|STARTED|Overall Study||10||
60156128|NCT00267085|76281910|FG000|COMPLETED|Overall Study||10||
60156129|NCT00267085|76281910|FG000|NOT COMPLETED|Overall Study||0||
60156130|NCT02249793|76281914|FG000|STARTED|Session 1, 48-hours Healthy Volunteers||6||
60156131|NCT02249793|76281914|FG000|COMPLETED|Session 1, 48-hours Healthy Volunteers||6||
60156132|NCT02249793|76281914|FG000|NOT COMPLETED|Session 1, 48-hours Healthy Volunteers||0||
60156133|NCT02249793|76281914|FG000|STARTED|Session 2, 48-Hours Healthy Volunteers||6||
60156134|NCT02249793|76281914|FG000|COMPLETED|Session 2, 48-Hours Healthy Volunteers||6||
60156135|NCT02249793|76281914|FG000|NOT COMPLETED|Session 2, 48-Hours Healthy Volunteers||0||
60156136|NCT00267631|76281921|FG000|STARTED|Overall Study||2361||
60156137|NCT00267631|76281922|FG001|STARTED|Overall Study||3031||
60156138|NCT00267631|76281921|FG000|COMPLETED|Overall Study||2361||
60156139|NCT00267631|76281922|FG001|COMPLETED|Overall Study||3031||
60156140|NCT00267631|76281921|FG000|NOT COMPLETED|Overall Study||0||
60156141|NCT00267631|76281922|FG001|NOT COMPLETED|Overall Study||0||
60156142|NCT02250417|76281928|FG000|STARTED|First Intervention (1 Night)||6||
60156143|NCT02250417|76281929|FG001|STARTED|First Intervention (1 Night)||6||
60156144|NCT02250417|76281928|FG000|COMPLETED|First Intervention (1 Night)||6||
60156145|NCT02250417|76281929|FG001|COMPLETED|First Intervention (1 Night)||6||
60156146|NCT02250417|76281928|FG000|NOT COMPLETED|First Intervention (1 Night)||0||
60156147|NCT02250417|76281929|FG001|NOT COMPLETED|First Intervention (1 Night)||0||
60156148|NCT02250417|76281928|FG000|STARTED|Second Intervention (1 Night)||6||
60156149|NCT02250417|76281929|FG001|STARTED|Second Intervention (1 Night)||6||
60156150|NCT02250417|76281928|FG000|COMPLETED|Second Intervention (1 Night)||6||
60156151|NCT02250417|76281929|FG001|COMPLETED|Second Intervention (1 Night)||6||
60156152|NCT02250417|76281928|FG000|NOT COMPLETED|Second Intervention (1 Night)||0||
60156153|NCT02250417|76281929|FG001|NOT COMPLETED|Second Intervention (1 Night)||0||
60156154|NCT00026221|76281941|FG000|STARTED|Overall Study||16||
60156155|NCT00026221|76281942|FG001|STARTED|Overall Study||16||
60156156|NCT00026221|76281943|FG002|STARTED|Overall Study||25||
60156157|NCT00026221|76281941|FG000|COMPLETED|Overall Study||16||
60156158|NCT00026221|76281942|FG001|COMPLETED|Overall Study||16||
60156159|NCT00026221|76281943|FG002|COMPLETED|Overall Study||25||
60156160|NCT00026221|76281941|FG000|NOT COMPLETED|Overall Study||0||
60156161|NCT00026221|76281942|FG001|NOT COMPLETED|Overall Study||0||
60156162|NCT00026221|76281943|FG002|NOT COMPLETED|Overall Study||0||
60156163|NCT00028093|76281953|FG000|STARTED|Overall Study||25||
60156164|NCT00028093|76281954|FG001|STARTED|Overall Study||25||
60156165|NCT00028093|76281953|FG000|COMPLETED|Overall Study||25||
60156166|NCT00028093|76281954|FG001|COMPLETED|Overall Study||25||
60156167|NCT00028093|76281953|FG000|NOT COMPLETED|Overall Study||0||
60156168|NCT00028093|76281954|FG001|NOT COMPLETED|Overall Study||0||
60156169|NCT01721967|76281960|FG000|STARTED|Overall Study||14||
60156170|NCT01721967|76281960|FG000|COMPLETED|Overall Study||11||
60156171|NCT01721967|76281960|FG000|NOT COMPLETED|Overall Study||3||
60156172|NCT01722435|76281964|FG000|STARTED|Overall Study||78||
60156173|NCT01722435|76281964|FG000|COMPLETED|Overall Study||78||
60156174|NCT01722435|76281964|FG000|NOT COMPLETED|Overall Study||0||
60156175|NCT00029107|76281974|FG000|STARTED|Overall Study||12||
60156176|NCT00029107|76281975|FG001|STARTED|Overall Study||12||
60156177|NCT00029107|76281974|FG000|COMPLETED|Overall Study||12||
60156178|NCT00029107|76281975|FG001|COMPLETED|Overall Study||12||
60156179|NCT00029107|76281974|FG000|NOT COMPLETED|Overall Study||0||
60156180|NCT00029107|76281975|FG001|NOT COMPLETED|Overall Study||0||
60156181|NCT00271219|76281983|FG000|STARTED|Overall Study||89||
60156182|NCT00271219|76281984|FG001|STARTED|Overall Study||86||
60156183|NCT00271219|76281983|FG000|COMPLETED|Overall Study||73||
60156184|NCT00271219|76281984|FG001|COMPLETED|Overall Study||58||
60156185|NCT00271219|76281983|FG000|NOT COMPLETED|Overall Study||16||
60156186|NCT00271219|76281984|FG001|NOT COMPLETED|Overall Study||28||
60156187|NCT00271375|76281997|FG000|STARTED|Overall Study||114||
60156188|NCT00271375|76281998|FG001|STARTED|Overall Study||83||
60156189|NCT00271375|76281999|FG002|STARTED|Overall Study||57||
60156190|NCT00271375|76281997|FG000|COMPLETED|Overall Study||114||
60156191|NCT00271375|76281998|FG001|COMPLETED|Overall Study||83||
60156192|NCT00271375|76281999|FG002|COMPLETED|Overall Study||57||
60156193|NCT00271375|76281997|FG000|NOT COMPLETED|Overall Study||0||
60156194|NCT00271375|76281998|FG001|NOT COMPLETED|Overall Study||0||
60156195|NCT00271375|76281999|FG002|NOT COMPLETED|Overall Study||0||
60156196|NCT02240667|76282010|FG000|STARTED|Overall Study||771||
60156197|NCT02240667|76282011|FG001|STARTED|Overall Study||650||
60156198|NCT02240667|76282010|FG000|COMPLETED|Overall Study||771||
60156199|NCT02240667|76282011|FG001|COMPLETED|Overall Study||650||
60156200|NCT02240667|76282010|FG000|NOT COMPLETED|Overall Study||0||
60156201|NCT02240667|76282011|FG001|NOT COMPLETED|Overall Study||0||
60156202|NCT01727895|76282019|FG000|STARTED|Overall Study||10||
60156203|NCT01727895|76282020|FG001|STARTED|Overall Study||5||
60156204|NCT01727895|76282019|FG000|COMPLETED|Overall Study||10||
60156205|NCT01727895|76282020|FG001|COMPLETED|Overall Study||5||
60156206|NCT01727895|76282019|FG000|NOT COMPLETED|Overall Study||0||
60156207|NCT01727895|76282020|FG001|NOT COMPLETED|Overall Study||0||
60156208|NCT00272311|76282031|FG000|STARTED|Overall Study||14||
60156209|NCT00272311|76282032|FG001|STARTED|Overall Study||14||
60156210|NCT00272311|76282033|FG002|STARTED|Overall Study||14||
60156211|NCT00272311|76282034|FG003|STARTED|Overall Study||14||
60156212|NCT00272311|76282035|FG004|STARTED|Overall Study||14||
60156213|NCT00272311|76282031|FG000|COMPLETED|Overall Study||14||
60156214|NCT00272311|76282032|FG001|COMPLETED|Overall Study||14||
60156215|NCT00272311|76282033|FG002|COMPLETED|Overall Study||14||
60156216|NCT00272311|76282034|FG003|COMPLETED|Overall Study||14||
60156217|NCT00272311|76282035|FG004|COMPLETED|Overall Study||14||
60156218|NCT00272311|76282031|FG000|NOT COMPLETED|Overall Study||0||
60156219|NCT00272311|76282032|FG001|NOT COMPLETED|Overall Study||0||
59751750|NCT00651157|75871098|FG000|NOT COMPLETED|Overall Study||2||
60156220|NCT00272311|76282033|FG002|NOT COMPLETED|Overall Study||0||
60156221|NCT00272311|76282034|FG003|NOT COMPLETED|Overall Study||0||
60156222|NCT00272311|76282035|FG004|NOT COMPLETED|Overall Study||0||
60156223|NCT00038857|76282047|FG000|STARTED|Overall Study||29||
60156224|NCT00038857|76282047|FG000|COMPLETED|Overall Study||28||
60156225|NCT00038857|76282047|FG000|NOT COMPLETED|Overall Study||1||
60156226|NCT03097068|76282051|FG000|STARTED|Overall Study||10||
60156227|NCT03097068|76282051|FG000|COMPLETED|Overall Study||10||
60156228|NCT03097068|76282051|FG000|NOT COMPLETED|Overall Study||0||
60156229|NCT04262947|76282058|FG000|STARTED|Overall Study||13||
60156230|NCT04262947|76282059|FG001|STARTED|Overall Study||13||
59518914|NCT03393208|75612805|FG001|STARTED|Treatment Period 1 (Day 1-Day 3)||13||
59518915|NCT03393208|75612806|FG002|STARTED|Treatment Period 1 (Day 1-Day 3)||9||
60156231|NCT04262947|76282060|FG002|STARTED|Overall Study||12||
60156232|NCT04262947|76282058|FG000|COMPLETED|Overall Study||13||
60156233|NCT04262947|76282059|FG001|COMPLETED|Overall Study||13||
59518916|NCT03393208|75612807|FG003|STARTED|Treatment Period 1 (Day 1-Day 3)||9||
60156234|NCT04262947|76282060|FG002|COMPLETED|Overall Study||12||
60156235|NCT04262947|76282058|FG000|NOT COMPLETED|Overall Study||0||
60156236|NCT04262947|76282059|FG001|NOT COMPLETED|Overall Study||0||
60156237|NCT04262947|76282060|FG002|NOT COMPLETED|Overall Study||0||
60156238|NCT01729845|76282071|FG000|STARTED|Safety/Tolerability of Dec/MEC||6||
60156239|NCT01729845|76282072|FG001|STARTED|Safety/Tolerability of Dec/MEC||34||
60156240|NCT01729845|76282073|FG002|STARTED|Safety/Tolerability of Dec/MEC||12||
60156241|NCT01729845|76282071|FG000|COMPLETED|Safety/Tolerability of Dec/MEC||6||
60156242|NCT01729845|76282072|FG001|COMPLETED|Safety/Tolerability of Dec/MEC||34||
60156243|NCT01729845|76282073|FG002|COMPLETED|Safety/Tolerability of Dec/MEC||12||
60156244|NCT01729845|76282071|FG000|NOT COMPLETED|Safety/Tolerability of Dec/MEC||0||
60156245|NCT01729845|76282072|FG001|NOT COMPLETED|Safety/Tolerability of Dec/MEC||0||
60156246|NCT01729845|76282073|FG002|NOT COMPLETED|Safety/Tolerability of Dec/MEC||0||
60156247|NCT01729845|76282071|FG000|STARTED|Efficacy of Dec/MEC||0||
60156248|NCT01729845|76282072|FG001|STARTED|Efficacy of Dec/MEC||22||
60156249|NCT01729845|76282073|FG002|STARTED|Efficacy of Dec/MEC||0||
60156250|NCT01729845|76282071|FG000|COMPLETED|Efficacy of Dec/MEC||0||
60156251|NCT01729845|76282072|FG001|COMPLETED|Efficacy of Dec/MEC||22||
60156252|NCT01729845|76282073|FG002|COMPLETED|Efficacy of Dec/MEC||0||
60156253|NCT01729845|76282071|FG000|NOT COMPLETED|Efficacy of Dec/MEC||0||
60156254|NCT01729845|76282072|FG001|NOT COMPLETED|Efficacy of Dec/MEC||0||
60156255|NCT01729845|76282073|FG002|NOT COMPLETED|Efficacy of Dec/MEC||0||
60156256|NCT01729923|76282083|FG000|STARTED|Overall Study||27||
60156257|NCT01729923|76282083|FG000|COMPLETED|Overall Study||0||
60156258|NCT01729923|76282083|FG000|NOT COMPLETED|Overall Study||27||
60156259|NCT02584452|76282089|FG000|STARTED|Overall Study||34||
60156260|NCT02584452|76282090|FG001|STARTED|Overall Study||23||
60156261|NCT02584452|76282089|FG000|COMPLETED|Overall Study||32||
60156262|NCT02584452|76282090|FG001|COMPLETED|Overall Study||21||
60156263|NCT02584452|76282089|FG000|NOT COMPLETED|Overall Study||2||
60156264|NCT02584452|76282090|FG001|NOT COMPLETED|Overall Study||2||
60156265|NCT01732263|76282099|FG000|STARTED|Overall Study||23||
60156266|NCT01732263|76282100|FG001|STARTED|Overall Study||20||
60156267|NCT01732263|76282099|FG000|COMPLETED|Overall Study||23||
60156268|NCT01732263|76282100|FG001|COMPLETED|Overall Study||20||
59605855|NCT01945710|75716035|FG004|COMPLETED|Overall Study||0||
60156269|NCT01732263|76282099|FG000|NOT COMPLETED|Overall Study||0||
60156270|NCT01732263|76282100|FG001|NOT COMPLETED|Overall Study||0||
60156271|NCT01732419|76282112|FG000|STARTED|Overall Study||45||
60156272|NCT01732419|76282113|FG001|STARTED|Overall Study||45||
60156273|NCT01732419|76282112|FG000|COMPLETED|Overall Study||37||
60156274|NCT01732419|76282113|FG001|COMPLETED|Overall Study||41||
60156275|NCT01732419|76282112|FG000|NOT COMPLETED|Overall Study||8||
60156276|NCT01732419|76282113|FG001|NOT COMPLETED|Overall Study||4||
60156277|NCT02243007|76282121|FG000|STARTED|Overall Study||4||
60156278|NCT02243007|76282122|FG001|STARTED|Overall Study||3||
60156279|NCT02243007|76282121|FG000|COMPLETED|Overall Study||4||
60156280|NCT02243007|76282122|FG001|COMPLETED|Overall Study||3||
60156281|NCT02243007|76282121|FG000|NOT COMPLETED|Overall Study||0||
60156282|NCT02243007|76282122|FG001|NOT COMPLETED|Overall Study||0||
60156283|NCT03430791|76282130|FG000|STARTED|Overall Study||4||
60156284|NCT03430791|76282131|FG001|STARTED|Overall Study||0||
60156285|NCT03430791|76282130|FG000|COMPLETED|Overall Study||4||
60156286|NCT03430791|76282131|FG001|COMPLETED|Overall Study||0||
60156287|NCT03430791|76282130|FG000|NOT COMPLETED|Overall Study||0||
60156288|NCT03430791|76282131|FG001|NOT COMPLETED|Overall Study||0||
60156289|NCT02586012|76282137|FG000|STARTED|Overall Study||5||
60156290|NCT02586012|76282138|FG001|STARTED|Overall Study||5||
60156291|NCT02586012|76282139|FG002|STARTED|Overall Study||5||
60156292|NCT02586012|76282140|FG003|STARTED|Overall Study||5||
60156293|NCT02586012|76282141|FG004|STARTED|Overall Study||5||
60156294|NCT02586012|76282142|FG005|STARTED|Overall Study||5||
60156295|NCT02586012|76282137|FG000|COMPLETED|Overall Study||4||
60156296|NCT02586012|76282138|FG001|COMPLETED|Overall Study||2||
60156297|NCT02586012|76282139|FG002|COMPLETED|Overall Study||4||
60156298|NCT02586012|76282140|FG003|COMPLETED|Overall Study||3||
60156299|NCT02586012|76282141|FG004|COMPLETED|Overall Study||4||
60156300|NCT02586012|76282142|FG005|COMPLETED|Overall Study||2||
60156301|NCT02586012|76282137|FG000|NOT COMPLETED|Overall Study||1||
60156302|NCT02586012|76282138|FG001|NOT COMPLETED|Overall Study||3||
60156303|NCT02586012|76282139|FG002|NOT COMPLETED|Overall Study||1||
60156304|NCT02586012|76282140|FG003|NOT COMPLETED|Overall Study||2||
60156305|NCT02586012|76282141|FG004|NOT COMPLETED|Overall Study||1||
60156306|NCT02586012|76282142|FG005|NOT COMPLETED|Overall Study||3||
60156307|NCT02582814|76282153|FG000|STARTED|Overall Study||76||
60156308|NCT02582814|76282154|FG001|STARTED|Overall Study||75||
60156309|NCT02582814|76282153|FG000|COMPLETED|Overall Study||67||
60156310|NCT02582814|76282154|FG001|COMPLETED|Overall Study||68||
60156311|NCT02582814|76282153|FG000|NOT COMPLETED|Overall Study||9||
60156312|NCT02582814|76282154|FG001|NOT COMPLETED|Overall Study||7||
60156313|NCT01736865|76282162|FG000|STARTED|Overall Study||61||
60156314|NCT01736865|76282163|FG001|STARTED|Overall Study||66||
60156315|NCT01736865|76282162|FG000|COMPLETED|Overall Study||61||
60156316|NCT01736865|76282163|FG001|COMPLETED|Overall Study||66||
60156317|NCT01736865|76282162|FG000|NOT COMPLETED|Overall Study||0||
60156318|NCT01736865|76282163|FG001|NOT COMPLETED|Overall Study||0||
60156319|NCT01736943|76282169|FG000|STARTED|Overall Study||25||
60156320|NCT01736943|76282169|FG000|COMPLETED|Overall Study||25||
60156321|NCT01736943|76282169|FG000|NOT COMPLETED|Overall Study||0||
60156322|NCT01738737|76282178|FG000|STARTED|Overall Study||29||
60156323|NCT01738737|76282179|FG001|STARTED|Overall Study||29||
60156324|NCT01738737|76282180|FG002|STARTED|Overall Study||29||
60156325|NCT01738737|76282181|FG003|STARTED|Overall Study||29||
60156326|NCT01738737|76282182|FG004|STARTED|Overall Study||29||
60156327|NCT01738737|76282178|FG000|COMPLETED|Overall Study||25||
60156328|NCT01738737|76282179|FG001|COMPLETED|Overall Study||25||
60156329|NCT01738737|76282180|FG002|COMPLETED|Overall Study||25||
60156330|NCT01738737|76282181|FG003|COMPLETED|Overall Study||25||
60156331|NCT01738737|76282182|FG004|COMPLETED|Overall Study||25||
60156332|NCT01738737|76282178|FG000|NOT COMPLETED|Overall Study||4||
60156333|NCT01738737|76282179|FG001|NOT COMPLETED|Overall Study||4||
60156334|NCT01738737|76282180|FG002|NOT COMPLETED|Overall Study||4||
60156335|NCT01738737|76282181|FG003|NOT COMPLETED|Overall Study||4||
60156336|NCT01738737|76282182|FG004|NOT COMPLETED|Overall Study||4||
60156337|NCT01739361|76282196|FG000|STARTED|Overall Study||21||
60156338|NCT01739361|76282197|FG001|STARTED|Overall Study||23||
60156339|NCT01739361|76282196|FG000|COMPLETED|Overall Study||18||
60156340|NCT01739361|76282197|FG001|COMPLETED|Overall Study||22||
60156341|NCT01739361|76282196|FG000|NOT COMPLETED|Overall Study||3||
60156342|NCT01739361|76282197|FG001|NOT COMPLETED|Overall Study||1||
60156343|NCT01742949|76282203|FG000|STARTED|Overall Study||20||
60156344|NCT01742949|76282204|FG001|STARTED|Overall Study||20||
60156345|NCT01742949|76282203|FG000|COMPLETED|Overall Study||20||
60156346|NCT01742949|76282204|FG001|COMPLETED|Overall Study||20||
60156347|NCT01742949|76282203|FG000|NOT COMPLETED|Overall Study||0||
60156348|NCT01742949|76282204|FG001|NOT COMPLETED|Overall Study||0||
60156349|NCT01743729|76282215|FG000|STARTED|Overall Study|One participant from placebo arm included in Lifitegrast arm for safety analysis set (N=359).|358||
60156350|NCT01743729|76282216|FG001|STARTED|Overall Study|One placebo participant was considered for Lifitegrast arm; Placebo safety analysis set (N= 359).|360||
60156351|NCT01743729|76282215|FG000|COMPLETED|Overall Study||321||
60156352|NCT01743729|76282216|FG001|COMPLETED|Overall Study||348||
60156353|NCT01743729|76282215|FG000|NOT COMPLETED|Overall Study||37||
60156354|NCT01743729|76282216|FG001|NOT COMPLETED|Overall Study||12||
60156355|NCT01743963|76282224|FG000|STARTED|Overall Study||21||
60156356|NCT01743963|76282225|FG001|STARTED|Overall Study||17||
60156357|NCT01743963|76282224|FG000|COMPLETED|Overall Study||21||
60156358|NCT01743963|76282225|FG001|COMPLETED|Overall Study||17||
60156359|NCT01743963|76282224|FG000|NOT COMPLETED|Overall Study||0||
60156360|NCT01743963|76282225|FG001|NOT COMPLETED|Overall Study||0||
60156361|NCT01744353|76282234|FG000|STARTED|Overall Study||6||
60156362|NCT01744353|76282235|FG001|STARTED|Overall Study||26||
60156363|NCT01744353|76282236|FG002|STARTED|Overall Study||3||
60156364|NCT01744353|76282234|FG000|COMPLETED|Overall Study||6||
60156365|NCT01744353|76282235|FG001|COMPLETED|Overall Study||26||
60156366|NCT01744353|76282236|FG002|COMPLETED|Overall Study||3||
60156367|NCT01744353|76282234|FG000|NOT COMPLETED|Overall Study||0||
60156368|NCT01744353|76282235|FG001|NOT COMPLETED|Overall Study||0||
60156369|NCT01744353|76282236|FG002|NOT COMPLETED|Overall Study||0||
60156370|NCT01744821|76282246|FG000|STARTED|Overall Study||1||
60156371|NCT01744821|76282247|FG001|STARTED|Overall Study||3||
60156372|NCT01744821|76282248|FG002|STARTED|Overall Study||2||
60156373|NCT01744821|76282249|FG003|STARTED|Overall Study||1||
60156374|NCT01744821|76282246|FG000|COMPLETED|Overall Study||1||
60156375|NCT01744821|76282247|FG001|COMPLETED|Overall Study||3||
60156376|NCT01744821|76282248|FG002|COMPLETED|Overall Study||2||
60156377|NCT01744821|76282249|FG003|COMPLETED|Overall Study||1||
60156378|NCT01744821|76282246|FG000|NOT COMPLETED|Overall Study||0||
60156379|NCT01744821|76282247|FG001|NOT COMPLETED|Overall Study||0||
60156380|NCT01744821|76282248|FG002|NOT COMPLETED|Overall Study||0||
60156381|NCT01744821|76282249|FG003|NOT COMPLETED|Overall Study||0||
60156382|NCT01745055|76282259|FG000|STARTED|Overall Study||12||
60156383|NCT01745055|76282259|FG000|COMPLETED|Overall Study||12||
60156384|NCT01745055|76282259|FG000|NOT COMPLETED|Overall Study||0||
60156385|NCT01745133|76282271|FG000|STARTED|Overall Study||19||
60156386|NCT01745133|76282272|FG001|STARTED|Overall Study||20||
60156387|NCT01745133|76282273|FG002|STARTED|Overall Study||19||
60156388|NCT01745133|76282271|FG000|COMPLETED|Overall Study||13||
60156389|NCT01745133|76282272|FG001|COMPLETED|Overall Study||16||
60156390|NCT01745133|76282273|FG002|COMPLETED|Overall Study||15||
60156391|NCT01745133|76282271|FG000|NOT COMPLETED|Overall Study||6||
60156392|NCT01745133|76282272|FG001|NOT COMPLETED|Overall Study||4||
60156393|NCT01745133|76282273|FG002|NOT COMPLETED|Overall Study||4||
60156394|NCT01745211|76282281|FG000|STARTED|Overall Study||45||104
60156395|NCT01745211|76282281|FG000|COMPLETED|Overall Study||27||64
60156396|NCT01745211|76282281|FG000|NOT COMPLETED|Overall Study||18||40
60156397|NCT02258139|76282285|FG000|STARTED|Overall Study||38||
60156398|NCT02258139|76282285|FG000|COMPLETED|Overall Study||30||
60156399|NCT02258139|76282285|FG000|NOT COMPLETED|Overall Study||8||
60156400|NCT01748643|76282293|FG000|STARTED|Overall Study||30||
60156401|NCT01748643|76282294|FG001|STARTED|Overall Study||30||
60156402|NCT01748643|76282293|FG000|COMPLETED|Overall Study||30||
60156403|NCT01748643|76282294|FG001|COMPLETED|Overall Study||30||
60156404|NCT01748643|76282293|FG000|NOT COMPLETED|Overall Study||0||
60156405|NCT01748643|76282294|FG001|NOT COMPLETED|Overall Study||0||
60156406|NCT02585934|76282302|FG000|STARTED|Overall Study||661||
60156407|NCT02585934|76282303|FG001|STARTED|Overall Study||654||
60156408|NCT02585934|76282302|FG000|Safety Population|Overall Study||656|The Safety population included subjects who took at least 1 dose of double-blind study drug|
60156409|NCT02585934|76282303|FG001|Safety Population|Overall Study||651|The Safety population included subjects who took at least 1 dose of double-blind study drug|
60156410|NCT02585934|76282302|FG000|Intent to Treat (ITT)|Overall Study||643|Subjects took at least 1 dose of double-blind study drug and had at least 1 post-baseline assessment|
60156411|NCT02585934|76282303|FG001|Intent to Treat (ITT)|Overall Study||633|Subjects took at least 1 dose of double-blind study drug and had at least 1 post-baseline assessment|
60156412|NCT02585934|76282302|FG000|Per Protocol (PP)|Overall Study||603|Subjects in the ITT population who had no major protocol violations|
60156413|NCT02585934|76282303|FG001|Per Protocol (PP)|Overall Study||582|Subjects in the ITT population who had no major protocol violations|
60156414|NCT02585934|76282302|FG000|COMPLETED|Overall Study||592|Subjects in the ITT population who completed the study|
60156415|NCT02585934|76282303|FG001|COMPLETED|Overall Study||581|Subjects in the ITT population who completed the study|
60156416|NCT02585934|76282302|FG000|NOT COMPLETED|Overall Study||69||
60156417|NCT02585934|76282303|FG001|NOT COMPLETED|Overall Study||73||
60156418|NCT00106535|76282317|FG000|STARTED|2-year Placebo Controlled Period||394||
60156419|NCT00106535|76282318|FG001|STARTED|2-year Placebo Controlled Period||401||
60156420|NCT00106535|76282319|FG002|STARTED|2-year Placebo Controlled Period||401||
60156421|NCT00106535|76282320|FG003|STARTED|2-year Placebo Controlled Period||0||
60156422|NCT00106535|76282317|FG000|Intent-to-treat: Received Study Drug|2-year Placebo Controlled Period||393||
60156423|NCT00106535|76282318|FG001|Intent-to-treat: Received Study Drug|2-year Placebo Controlled Period||399||
60156424|NCT00106535|76282319|FG002|Intent-to-treat: Received Study Drug|2-year Placebo Controlled Period||398||
60156425|NCT00106535|76282320|FG003|Intent-to-treat: Received Study Drug|2-year Placebo Controlled Period||0||
60156426|NCT00106535|76282317|FG000|Safety: Actual Treatment Received|2-year Placebo Controlled Period||392||
60156427|NCT00106535|76282318|FG001|Safety: Actual Treatment Received|2-year Placebo Controlled Period||399||
60156428|NCT00106535|76282319|FG002|Safety: Actual Treatment Received|2-year Placebo Controlled Period||399||
60156429|NCT00106535|76282320|FG003|Safety: Actual Treatment Received|2-year Placebo Controlled Period||0||
60156430|NCT00106535|76282317|FG000|Completed Week 24|2-year Placebo Controlled Period||356||
60156431|NCT00106535|76282318|FG001|Completed Week 24|2-year Placebo Controlled Period||373||
60156432|NCT00106535|76282319|FG002|Completed Week 24|2-year Placebo Controlled Period||366||
60156433|NCT00106535|76282320|FG003|Completed Week 24|2-year Placebo Controlled Period||0||
60156434|NCT00106535|76282317|FG000|Completed Week 52|2-year Placebo Controlled Period||326||
60156435|NCT00106535|76282318|FG001|Completed Week 52|2-year Placebo Controlled Period||342||
60156436|NCT00106535|76282319|FG002|Completed Week 52|2-year Placebo Controlled Period||338||
60156437|NCT00106535|76282320|FG003|Completed Week 52|2-year Placebo Controlled Period||0||
60156438|NCT00106535|76282317|FG000|COMPLETED|2-year Placebo Controlled Period|Completed Week 104 (Year 2). 284 participants randomized to the Placebo arm entered the LTE period.|287||
60156439|NCT00106535|76282318|FG001|COMPLETED|2-year Placebo Controlled Period|Completed Week 104. 304 participants randomized to the TCZ 4 mg/kg arm entered the LTE period.|309||
60156440|NCT00106535|76282319|FG002|COMPLETED|2-year Placebo Controlled Period|Completed Week 104. 306 participants randomized to the TCZ 8 mg/kg arm entered the LTE period.|310||
60156441|NCT00106535|76282320|FG003|COMPLETED|2-year Placebo Controlled Period||0||
60156442|NCT00106535|76282317|FG000|NOT COMPLETED|2-year Placebo Controlled Period||107||
60156443|NCT00106535|76282318|FG001|NOT COMPLETED|2-year Placebo Controlled Period||92||
60156444|NCT00106535|76282319|FG002|NOT COMPLETED|2-year Placebo Controlled Period||91||
60156445|NCT00106535|76282320|FG003|NOT COMPLETED|2-year Placebo Controlled Period||0||
60156446|NCT00106535|76282317|FG000|STARTED|Long-term Extension Period (Year 3 to 5)||0||
60156447|NCT00106535|76282318|FG001|STARTED|Long-term Extension Period (Year 3 to 5)||0||
60156448|NCT00106535|76282319|FG002|STARTED|Long-term Extension Period (Year 3 to 5)||0||
60156449|NCT00106535|76282320|FG003|STARTED|Long-term Extension Period (Year 3 to 5)|Entered the Long-term Extension.|894||
60156450|NCT00106535|76282317|FG000|COMPLETED|Long-term Extension Period (Year 3 to 5)||0||
60156451|NCT00106535|76282318|FG001|COMPLETED|Long-term Extension Period (Year 3 to 5)||0||
60156452|NCT00106535|76282319|FG002|COMPLETED|Long-term Extension Period (Year 3 to 5)||0||
60156453|NCT00106535|76282320|FG003|COMPLETED|Long-term Extension Period (Year 3 to 5)|Completed the study.|704||
60156454|NCT00106535|76282317|FG000|NOT COMPLETED|Long-term Extension Period (Year 3 to 5)||0||
60156455|NCT00106535|76282318|FG001|NOT COMPLETED|Long-term Extension Period (Year 3 to 5)||0||
60156456|NCT00106535|76282319|FG002|NOT COMPLETED|Long-term Extension Period (Year 3 to 5)||0||
60156457|NCT00106535|76282320|FG003|NOT COMPLETED|Long-term Extension Period (Year 3 to 5)||190||
60156458|NCT02582658|76282332|FG000|STARTED|Overall Study||171||
60156459|NCT02582658|76282332|FG000|COMPLETED|Overall Study||146||
60156460|NCT02582658|76282332|FG000|NOT COMPLETED|Overall Study||25||
60156461|NCT01748799|76282344|FG000|STARTED|Overall Study||6||
60156462|NCT01748799|76282345|FG001|STARTED|Overall Study||1||
60156463|NCT01748799|76282346|FG002|STARTED|Overall Study||1||
60156464|NCT01748799|76282347|FG003|STARTED|Overall Study||2||
60156465|NCT01748799|76282348|FG004|STARTED|Overall Study||1||
60156466|NCT01748799|76282349|FG005|STARTED|Overall Study||2||
60156467|NCT01748799|76282350|FG006|STARTED|Overall Study||2||
60156468|NCT01748799|76282351|FG007|STARTED|Overall Study||1||
60156469|NCT01748799|76282344|FG000|Completed SAU of Fixed Dose Placebo|Overall Study||2||
60156470|NCT01748799|76282345|FG001|Completed SAU of Fixed Dose Placebo|Overall Study||1||
60156471|NCT01748799|76282346|FG002|Completed SAU of Fixed Dose Placebo|Overall Study||1||
60156472|NCT01748799|76282347|FG003|Completed SAU of Fixed Dose Placebo|Overall Study||2||
60156473|NCT01748799|76282348|FG004|Completed SAU of Fixed Dose Placebo|Overall Study||1||
60156474|NCT01748799|76282349|FG005|Completed SAU of Fixed Dose Placebo|Overall Study||1||
60156475|NCT01748799|76282350|FG006|Completed SAU of Fixed Dose Placebo|Overall Study||1||
60156476|NCT01748799|76282351|FG007|Completed SAU of Fixed Dose Placebo|Overall Study||1||
60156477|NCT01748799|76282344|FG000|Completed Fixed Dose Placebo|Overall Study||2||
60156478|NCT01748799|76282345|FG001|Completed Fixed Dose Placebo|Overall Study||1||
60156479|NCT01748799|76282346|FG002|Completed Fixed Dose Placebo|Overall Study||1||
60156480|NCT01748799|76282347|FG003|Completed Fixed Dose Placebo|Overall Study||2||
60156481|NCT01748799|76282348|FG004|Completed Fixed Dose Placebo|Overall Study||1||
60156482|NCT01748799|76282349|FG005|Completed Fixed Dose Placebo|Overall Study||1||
60156483|NCT01748799|76282350|FG006|Completed Fixed Dose Placebo|Overall Study||1||
60156484|NCT01748799|76282351|FG007|Completed Fixed Dose Placebo|Overall Study||1||
60156485|NCT01748799|76282344|FG000|Completed SAU of Fixed Dose Sativex|Overall Study||1||
60156486|NCT01748799|76282345|FG001|Completed SAU of Fixed Dose Sativex|Overall Study||1||
60156487|NCT01748799|76282346|FG002|Completed SAU of Fixed Dose Sativex|Overall Study||1||
60156488|NCT01748799|76282347|FG003|Completed SAU of Fixed Dose Sativex|Overall Study||2||
60156489|NCT01748799|76282348|FG004|Completed SAU of Fixed Dose Sativex|Overall Study||1||
60156490|NCT01748799|76282349|FG005|Completed SAU of Fixed Dose Sativex|Overall Study||1||
60156491|NCT01748799|76282350|FG006|Completed SAU of Fixed Dose Sativex|Overall Study||1||
60156492|NCT01748799|76282351|FG007|Completed SAU of Fixed Dose Sativex|Overall Study||1||
60156493|NCT01748799|76282344|FG000|Completed Fixed Dose Sativex|Overall Study||1||
60156494|NCT01748799|76282345|FG001|Completed Fixed Dose Sativex|Overall Study||1||
60156495|NCT01748799|76282346|FG002|Completed Fixed Dose Sativex|Overall Study||1||
60156496|NCT01748799|76282347|FG003|Completed Fixed Dose Sativex|Overall Study||2||
60156497|NCT01748799|76282348|FG004|Completed Fixed Dose Sativex|Overall Study||1||
60156498|NCT01748799|76282349|FG005|Completed Fixed Dose Sativex|Overall Study||1||
60156499|NCT01748799|76282350|FG006|Completed Fixed Dose Sativex|Overall Study||1||
60156500|NCT01748799|76282351|FG007|Completed Fixed Dose Sativex|Overall Study||1||
60156501|NCT01748799|76282344|FG000|Completed SAU of Self-titrated Placebo|Overall Study||5||
60156502|NCT01748799|76282345|FG001|Completed SAU of Self-titrated Placebo|Overall Study||1||
60156503|NCT01748799|76282346|FG002|Completed SAU of Self-titrated Placebo|Overall Study||1||
60156504|NCT01748799|76282347|FG003|Completed SAU of Self-titrated Placebo|Overall Study||2||
59882372|NCT03682107|76005273|FG000|NOT COMPLETED|Overall Study||0||
59882373|NCT03682107|76005274|FG001|NOT COMPLETED|Overall Study||1||
60156505|NCT01748799|76282348|FG004|Completed SAU of Self-titrated Placebo|Overall Study||1||
60156506|NCT01748799|76282349|FG005|Completed SAU of Self-titrated Placebo|Overall Study||2||
60156507|NCT01748799|76282350|FG006|Completed SAU of Self-titrated Placebo|Overall Study||1||
60156508|NCT01748799|76282351|FG007|Completed SAU of Self-titrated Placebo|Overall Study||1||
60156509|NCT01748799|76282344|FG000|Completed Self-titrated Placebo|Overall Study||4||
60156510|NCT01748799|76282345|FG001|Completed Self-titrated Placebo|Overall Study||1||
60156511|NCT01748799|76282346|FG002|Completed Self-titrated Placebo|Overall Study||1||
60156512|NCT01748799|76282347|FG003|Completed Self-titrated Placebo|Overall Study||2||
60156513|NCT01748799|76282348|FG004|Completed Self-titrated Placebo|Overall Study||1||
60156514|NCT01748799|76282349|FG005|Completed Self-titrated Placebo|Overall Study||2||
60156515|NCT01748799|76282350|FG006|Completed Self-titrated Placebo|Overall Study||1||
60156516|NCT01748799|76282351|FG007|Completed Self-titrated Placebo|Overall Study||1||
60156517|NCT01748799|76282344|FG000|Completed SAU of Self-titrated Sativex|Overall Study||2||
60156518|NCT01748799|76282345|FG001|Completed SAU of Self-titrated Sativex|Overall Study||1||
60156519|NCT01748799|76282346|FG002|Completed SAU of Self-titrated Sativex|Overall Study||1||
60156520|NCT01748799|76282347|FG003|Completed SAU of Self-titrated Sativex|Overall Study||2||
60156521|NCT01748799|76282348|FG004|Completed SAU of Self-titrated Sativex|Overall Study||1||
59882374|NCT03682107|76005275|FG002|NOT COMPLETED|Overall Study||0||
60156522|NCT01748799|76282349|FG005|Completed SAU of Self-titrated Sativex|Overall Study||2||
60156523|NCT01748799|76282350|FG006|Completed SAU of Self-titrated Sativex|Overall Study||1||
60156524|NCT01748799|76282351|FG007|Completed SAU of Self-titrated Sativex|Overall Study||1||
60156525|NCT01748799|76282344|FG000|Completed Self-titrated Sativex|Overall Study||1||
60156526|NCT01748799|76282345|FG001|Completed Self-titrated Sativex|Overall Study||1||
60156527|NCT01748799|76282346|FG002|Completed Self-titrated Sativex|Overall Study||1||
60156528|NCT01748799|76282347|FG003|Completed Self-titrated Sativex|Overall Study||2||
60156529|NCT01748799|76282348|FG004|Completed Self-titrated Sativex|Overall Study||1||
60156530|NCT01748799|76282349|FG005|Completed Self-titrated Sativex|Overall Study||1||
60156531|NCT01748799|76282350|FG006|Completed Self-titrated Sativex|Overall Study||1||
60156532|NCT01748799|76282351|FG007|Completed Self-titrated Sativex|Overall Study||1||
59882375|NCT03682107|76005276|FG003|NOT COMPLETED|Overall Study||0||
60156533|NCT01748799|76282344|FG000|COMPLETED|Overall Study||1||
60156534|NCT01748799|76282345|FG001|COMPLETED|Overall Study||1||
60156535|NCT01748799|76282346|FG002|COMPLETED|Overall Study||1||
60156536|NCT01748799|76282347|FG003|COMPLETED|Overall Study||2||
60156537|NCT01748799|76282348|FG004|COMPLETED|Overall Study||1||
60156538|NCT01748799|76282349|FG005|COMPLETED|Overall Study||1||
60156539|NCT01748799|76282350|FG006|COMPLETED|Overall Study||1||
60156540|NCT01748799|76282351|FG007|COMPLETED|Overall Study||1||
60156541|NCT01748799|76282344|FG000|NOT COMPLETED|Overall Study||5||
60156542|NCT01748799|76282345|FG001|NOT COMPLETED|Overall Study||0||
60156543|NCT01748799|76282346|FG002|NOT COMPLETED|Overall Study||0||
60156544|NCT01748799|76282347|FG003|NOT COMPLETED|Overall Study||0||
60156545|NCT01748799|76282348|FG004|NOT COMPLETED|Overall Study||0||
60156546|NCT01748799|76282349|FG005|NOT COMPLETED|Overall Study||1||
60156547|NCT01748799|76282350|FG006|NOT COMPLETED|Overall Study||1||
60156548|NCT01748799|76282351|FG007|NOT COMPLETED|Overall Study||0||
60156549|NCT00168311|76282379|FG000|STARTED|Overall Study||12||
60156550|NCT00168311|76282380|FG001|STARTED|Overall Study||10||
60156551|NCT00168311|76282379|FG000|COMPLETED|Overall Study||12||
60156552|NCT00168311|76282380|FG001|COMPLETED|Overall Study||8||
60156553|NCT00168311|76282379|FG000|NOT COMPLETED|Overall Study||0||
60156554|NCT00168311|76282380|FG001|NOT COMPLETED|Overall Study||2||
60156555|NCT01748955|76282388|FG000|STARTED|Overall Study||6||
60156556|NCT01748955|76282389|FG001|STARTED|Overall Study||9||
60156557|NCT01748955|76282388|FG000|COMPLETED|Overall Study||3||
60156558|NCT01748955|76282389|FG001|COMPLETED|Overall Study||4||
60156559|NCT01748955|76282388|FG000|NOT COMPLETED|Overall Study||3||
60156560|NCT01748955|76282389|FG001|NOT COMPLETED|Overall Study||5||
60156561|NCT02253537|76282395|FG000|STARTED|Overall Study||15||
60156562|NCT02253537|76282395|FG000|COMPLETED|Overall Study||15||
60156563|NCT02253537|76282395|FG000|NOT COMPLETED|Overall Study||0||
60156564|NCT01749501|76282401|FG000|STARTED|Overall Study||22||
60156565|NCT01749501|76282402|FG001|STARTED|Overall Study||23||
60156566|NCT01749501|76282401|FG000|COMPLETED|Overall Study||22||
60156567|NCT01749501|76282402|FG001|COMPLETED|Overall Study||23||
59882376|NCT03682107|76005277|FG004|NOT COMPLETED|Overall Study||0||
60156568|NCT01749501|76282401|FG000|NOT COMPLETED|Overall Study||0||
60156569|NCT01749501|76282402|FG001|NOT COMPLETED|Overall Study||0||
60156570|NCT02254473|76282410|FG000|STARTED|Overall Study||9||
60156571|NCT02254473|76282411|FG001|STARTED|Overall Study||3||
60156572|NCT02254473|76282410|FG000|COMPLETED|Overall Study||7||
60156573|NCT02254473|76282411|FG001|COMPLETED|Overall Study||2||
60156574|NCT02254473|76282410|FG000|NOT COMPLETED|Overall Study||2||
60156575|NCT02254473|76282411|FG001|NOT COMPLETED|Overall Study||1||
60156576|NCT02255175|76282419|FG000|STARTED|Overall Study||33||
60156577|NCT02255175|76282420|FG001|STARTED|Overall Study||31||
60156578|NCT02255175|76282419|FG000|COMPLETED|Overall Study||16||
60156579|NCT02255175|76282420|FG001|COMPLETED|Overall Study||19||
60156580|NCT02255175|76282419|FG000|NOT COMPLETED|Overall Study||17||
60156581|NCT02255175|76282420|FG001|NOT COMPLETED|Overall Study||12||
60156582|NCT02585778|76282434|FG000|STARTED|Overall Study|Randomized|345||
60156583|NCT02585778|76282435|FG001|STARTED|Overall Study|Randomized|172||
60156584|NCT02585778|76282434|FG000|Treated (Safety Population)|Overall Study||344||
60156585|NCT02585778|76282435|FG001|Treated (Safety Population)|Overall Study||170||
60156586|NCT02585778|76282434|FG000|ITT Population|Overall Study||336||
60156587|NCT02585778|76282435|FG001|ITT Population|Overall Study||167||
60156588|NCT02585778|76282434|FG000|mITT Population|Overall Study||333||
60156589|NCT02585778|76282435|FG001|mITT Population|Overall Study||164||
60156590|NCT02585778|76282434|FG000|T1DM Participants|Overall Study||51|Randomized stratum: T1DM|
60156591|NCT02585778|76282435|FG001|T1DM Participants|Overall Study||25|Randomized stratum: T1DM|
60156592|NCT02585778|76282434|FG000|T2DM Participants|Overall Study||294|Randomized stratum: T2DM|
60156593|NCT02585778|76282435|FG001|T2DM Participants|Overall Study||147|Randomized stratum: T2DM|
60156594|NCT02585778|76282434|FG000|COMPLETED|Overall Study||312|Completed = treatment completion|
60156595|NCT02585778|76282435|FG001|COMPLETED|Overall Study||157|Completed = treatment completion|
60156596|NCT02585778|76282434|FG000|NOT COMPLETED|Overall Study||33||
60156597|NCT02585778|76282435|FG001|NOT COMPLETED|Overall Study||15||
60156598|NCT01751451|76282448|FG000|STARTED|Overall Study||42||
60156599|NCT01751451|76282449|FG001|STARTED|Overall Study||40||
60156600|NCT01751451|76282450|FG002|STARTED|Overall Study||42||
60156601|NCT01751451|76282448|FG000|COMPLETED|Overall Study||42||
60156602|NCT01751451|76282449|FG001|COMPLETED|Overall Study||40||
60156603|NCT01751451|76282450|FG002|COMPLETED|Overall Study||42||
60156604|NCT01751451|76282448|FG000|NOT COMPLETED|Overall Study||0||
60156605|NCT01751451|76282449|FG001|NOT COMPLETED|Overall Study||0||
60156606|NCT01751451|76282450|FG002|NOT COMPLETED|Overall Study||0||
60156607|NCT01438424|76282458|FG000|STARTED|Overall Study|Received treatment|1051||
60156608|NCT01438424|76282458|FG000|COMPLETED|Overall Study|Completed treatment|634||
60156609|NCT01438424|76282458|FG000|NOT COMPLETED|Overall Study||417||
60156610|NCT02580240|76282474|FG000|STARTED|Overall Study||62||
60156611|NCT02580240|76282475|FG001|STARTED|Overall Study||58||
60156612|NCT02580240|76282474|FG000|COMPLETED|Overall Study||60||
60156613|NCT02580240|76282475|FG001|COMPLETED|Overall Study||58||
59882377|NCT03673046|76005291|FG000|STARTED|Overall Study||40||
60156614|NCT02580240|76282474|FG000|NOT COMPLETED|Overall Study||2||
60156615|NCT02580240|76282475|FG001|NOT COMPLETED|Overall Study||0||
60156616|NCT01465958|76282481|FG000|STARTED|Run-in Phase||11||
60156617|NCT01465958|76282482|FG001|STARTED|Run-in Phase||0||
60156618|NCT01465958|76282481|FG000|COMPLETED|Run-in Phase||10||
60156619|NCT01465958|76282482|FG001|COMPLETED|Run-in Phase||0||
60156620|NCT01465958|76282481|FG000|NOT COMPLETED|Run-in Phase||1||
60156621|NCT01465958|76282482|FG001|NOT COMPLETED|Run-in Phase||0||
60156622|NCT01465958|76282481|FG000|STARTED|Intravenous (IV) Phase|One subject entered the IV phase directly.|11||
60156623|NCT01465958|76282482|FG001|STARTED|Intravenous (IV) Phase||0||
60156624|NCT01465958|76282481|FG000|COMPLETED|Intravenous (IV) Phase||11||
60156625|NCT01465958|76282482|FG001|COMPLETED|Intravenous (IV) Phase||0||
60156626|NCT01465958|76282481|FG000|NOT COMPLETED|Intravenous (IV) Phase||0||
60156627|NCT01465958|76282482|FG001|NOT COMPLETED|Intravenous (IV) Phase||0||
60156628|NCT01465958|76282481|FG000|STARTED|Subcutaneous (SC) Phase|After completing the intravenous (IV) phase, subjects entered the subcutaneous (SC) phase.|0||
60156629|NCT01465958|76282482|FG001|STARTED|Subcutaneous (SC) Phase|Eleven subjects completed the IV phase and entered the SC phase.|11||
60156630|NCT01465958|76282481|FG000|COMPLETED|Subcutaneous (SC) Phase||0||
60156631|NCT01465958|76282482|FG001|COMPLETED|Subcutaneous (SC) Phase||10||
60156632|NCT01465958|76282481|FG000|NOT COMPLETED|Subcutaneous (SC) Phase||0||
60156633|NCT01465958|76282482|FG001|NOT COMPLETED|Subcutaneous (SC) Phase||1||
60156634|NCT01753557|76282491|FG000|STARTED|Overall Study||35||
60156635|NCT01753557|76282492|FG001|STARTED|Overall Study||19||
60156636|NCT01753557|76282491|FG000|COMPLETED|Overall Study||35||
60156637|NCT01753557|76282492|FG001|COMPLETED|Overall Study||19||
60156638|NCT01753557|76282491|FG000|NOT COMPLETED|Overall Study||0||
60156639|NCT01753557|76282492|FG001|NOT COMPLETED|Overall Study||0||
60156640|NCT02250807|76282499|FG000|STARTED|Overall Study||40||
60156641|NCT02250807|76282499|FG000|COMPLETED|Overall Study||40||
60156642|NCT02250807|76282499|FG000|NOT COMPLETED|Overall Study||0||
60156643|NCT00168389|76282506|FG000|STARTED|Overall Study||163||
60156644|NCT00168389|76282507|FG001|STARTED|Overall Study||166||
60156645|NCT00168389|76282508|FG002|STARTED|Overall Study||165||
60156646|NCT00168389|76282506|FG000|COMPLETED|Overall Study||107||
60156647|NCT00168389|76282507|FG001|COMPLETED|Overall Study||118||
60156648|NCT00168389|76282508|FG002|COMPLETED|Overall Study||70||
59882378|NCT03673046|76005292|FG001|STARTED|Overall Study||40||
59882379|NCT03673046|76005291|FG000|COMPLETED|Overall Study||31||
59882380|NCT03673046|76005292|FG001|COMPLETED|Overall Study||37||
59882381|NCT03673046|76005291|FG000|NOT COMPLETED|Overall Study||9||
60156649|NCT00168389|76282506|FG000|NOT COMPLETED|Overall Study||56||
60156650|NCT00168389|76282507|FG001|NOT COMPLETED|Overall Study||48||
60156651|NCT00168389|76282508|FG002|NOT COMPLETED|Overall Study||95||
60156652|NCT02252133|76282516|FG000|STARTED|Period 1||23||
60156653|NCT02252133|76282517|FG001|STARTED|Period 1||24||
60156654|NCT02252133|76282516|FG000|COMPLETED|Period 1||23||
60156655|NCT02252133|76282517|FG001|COMPLETED|Period 1||24||
60156656|NCT02252133|76282516|FG000|NOT COMPLETED|Period 1||0||
60156657|NCT02252133|76282517|FG001|NOT COMPLETED|Period 1||0||
60156658|NCT02252133|76282516|FG000|STARTED|Period 2||23||
60156659|NCT02252133|76282517|FG001|STARTED|Period 2||24||
60156660|NCT02252133|76282516|FG000|COMPLETED|Period 2||23||
60156661|NCT02252133|76282517|FG001|COMPLETED|Period 2||24||
60156662|NCT02252133|76282516|FG000|NOT COMPLETED|Period 2||0||
60156663|NCT02252133|76282517|FG001|NOT COMPLETED|Period 2||0||
60156664|NCT02252445|76282525|FG000|STARTED|Overall Study||41||
60156665|NCT02252445|76282526|FG001|STARTED|Overall Study||41||
60156666|NCT02252445|76282525|FG000|COMPLETED|Overall Study||41||
60156667|NCT02252445|76282526|FG001|COMPLETED|Overall Study||41||
60156668|NCT02252445|76282525|FG000|NOT COMPLETED|Overall Study||0||
60156669|NCT02252445|76282526|FG001|NOT COMPLETED|Overall Study||0||
60156670|NCT02093819|76282540|FG000|STARTED|Overall Study||15||
60156671|NCT02093819|76282541|FG001|STARTED|Overall Study||6||
60156672|NCT02093819|76282542|FG002|STARTED|Overall Study||10||
60156673|NCT02093819|76282543|FG003|STARTED|Overall Study||6||
60156674|NCT02093819|76282544|FG004|STARTED|Overall Study||6||
60156675|NCT02093819|76282545|FG005|STARTED|Overall Study||6||
60156676|NCT02093819|76282546|FG006|STARTED|Overall Study||5||
60156677|NCT02093819|76282547|FG007|STARTED|Overall Study||6||
60156678|NCT02093819|76282540|FG000|COMPLETED|Overall Study||15||
60156679|NCT02093819|76282541|FG001|COMPLETED|Overall Study||6||
60156680|NCT02093819|76282542|FG002|COMPLETED|Overall Study||10||
60156681|NCT02093819|76282543|FG003|COMPLETED|Overall Study||6||
60156682|NCT02093819|76282544|FG004|COMPLETED|Overall Study||6||
60156683|NCT02093819|76282545|FG005|COMPLETED|Overall Study||6||
60156684|NCT02093819|76282546|FG006|COMPLETED|Overall Study||5||
60156685|NCT02093819|76282547|FG007|COMPLETED|Overall Study||6||
60156686|NCT02093819|76282540|FG000|NOT COMPLETED|Overall Study||0||
60156687|NCT02093819|76282541|FG001|NOT COMPLETED|Overall Study||0||
60156688|NCT02093819|76282542|FG002|NOT COMPLETED|Overall Study||0||
60156689|NCT02093819|76282543|FG003|NOT COMPLETED|Overall Study||0||
60156690|NCT02093819|76282544|FG004|NOT COMPLETED|Overall Study||0||
60156691|NCT02093819|76282545|FG005|NOT COMPLETED|Overall Study||0||
60156692|NCT02093819|76282546|FG006|NOT COMPLETED|Overall Study||0||
60156693|NCT02093819|76282547|FG007|NOT COMPLETED|Overall Study||0||
60156694|NCT00176423|76282576|FG000|STARTED|Overall Study||42||
60156695|NCT00176423|76282577|FG001|STARTED|Overall Study||44||
60156696|NCT00176423|76282576|FG000|COMPLETED|Overall Study||35||
60156697|NCT00176423|76282577|FG001|COMPLETED|Overall Study||38||
60156698|NCT00176423|76282576|FG000|NOT COMPLETED|Overall Study||7||
60156699|NCT00176423|76282577|FG001|NOT COMPLETED|Overall Study||6||
60156700|NCT02094443|76282585|FG000|STARTED|Overall Study||26||
60156701|NCT02094443|76282586|FG001|STARTED|Overall Study||26||
60011199|NCT01938430|76126997|FG007|COMPLETED|Overall Study||24||
60011200|NCT01938430|76126998|FG008|COMPLETED|Overall Study||22||
60011201|NCT01938430|76126999|FG009|COMPLETED|Overall Study||23||
60011202|NCT01938430|76127000|FG010|COMPLETED|Overall Study||3||
60011203|NCT01938430|76127001|FG011|COMPLETED|Overall Study||3||
60011204|NCT01938430|76127002|FG012|COMPLETED|Overall Study||4||
60011205|NCT01938430|76127003|FG013|COMPLETED|Overall Study||2||
60011206|NCT01938430|76126990|FG000|NOT COMPLETED|Overall Study||4||
60011207|NCT01938430|76126991|FG001|NOT COMPLETED|Overall Study||3||
60011208|NCT01938430|76126992|FG002|NOT COMPLETED|Overall Study||5||
60011209|NCT01938430|76126993|FG003|NOT COMPLETED|Overall Study||2||
60011210|NCT01938430|76126994|FG004|NOT COMPLETED|Overall Study||0||
60011211|NCT01938430|76126995|FG005|NOT COMPLETED|Overall Study||1||
60011212|NCT01938430|76126996|FG006|NOT COMPLETED|Overall Study||2||
60011213|NCT01938430|76126997|FG007|NOT COMPLETED|Overall Study||1||
60011214|NCT01938430|76126998|FG008|NOT COMPLETED|Overall Study||4||
60011215|NCT01938430|76126999|FG009|NOT COMPLETED|Overall Study||3||
60011216|NCT01938430|76127000|FG010|NOT COMPLETED|Overall Study||3||
60011217|NCT01938430|76127001|FG011|NOT COMPLETED|Overall Study||1||
60011218|NCT01938430|76127002|FG012|NOT COMPLETED|Overall Study||0||
60011219|NCT01938430|76127003|FG013|NOT COMPLETED|Overall Study||1||
60011220|NCT01937884|76127060|FG000|STARTED|Overall Study||7||
60011221|NCT01937884|76127061|FG001|STARTED|Overall Study||11||
60011222|NCT01937884|76127060|FG000|COMPLETED|Overall Study||6||
60011223|NCT01937884|76127061|FG001|COMPLETED|Overall Study||11||
60011224|NCT01937884|76127060|FG000|NOT COMPLETED|Overall Study||1||
60011225|NCT01937884|76127061|FG001|NOT COMPLETED|Overall Study||0||
60011226|NCT01916824|76127071|FG000|STARTED|Overall Study||24||
60011227|NCT01916824|76127072|FG001|STARTED|Overall Study||29||
60011228|NCT01916824|76127071|FG000|COMPLETED|Overall Study||17||
60011229|NCT01916824|76127072|FG001|COMPLETED|Overall Study||20||
60011230|NCT01916824|76127071|FG000|NOT COMPLETED|Overall Study||7||
60011231|NCT01916824|76127072|FG001|NOT COMPLETED|Overall Study||9||
60011232|NCT01915732|76127080|FG000|STARTED|Overall Study||500||
60011233|NCT01915732|76127081|FG001|STARTED|Overall Study||516||
60011234|NCT01915732|76127080|FG000|COMPLETED|Overall Study||430||
60011235|NCT01915732|76127081|FG001|COMPLETED|Overall Study||445||
60011236|NCT01915732|76127080|FG000|NOT COMPLETED|Overall Study||70||
60011237|NCT01915732|76127081|FG001|NOT COMPLETED|Overall Study||71||
60011238|NCT01936948|76127091|FG000|STARTED|Overall Study||227||
60011239|NCT01936948|76127092|FG001|STARTED|Overall Study||231||
60011240|NCT01936948|76127093|FG002|STARTED|Overall Study||237||
60011241|NCT01936948|76127094|FG003|STARTED|Overall Study||233||
60067894|NCT01785069|76183084|FG002|STARTED|Overall Study||104||
60067895|NCT01785069|76183085|FG003|STARTED|Overall Study||68||
60067896|NCT01785069|76183082|FG000|COMPLETED|Overall Study||95||
60067897|NCT01785069|76183083|FG001|COMPLETED|Overall Study||64||
60067898|NCT01785069|76183084|FG002|COMPLETED|Overall Study||91||
60067899|NCT01785069|76183085|FG003|COMPLETED|Overall Study||54||
60067900|NCT01785069|76183082|FG000|NOT COMPLETED|Overall Study||12||
60067901|NCT01785069|76183083|FG001|NOT COMPLETED|Overall Study||12||
60067902|NCT01785069|76183084|FG002|NOT COMPLETED|Overall Study||13||
60067903|NCT01785069|76183085|FG003|NOT COMPLETED|Overall Study||14||
60067904|NCT01784523|76183097|FG000|STARTED|Overall Study||7||
60067905|NCT01784523|76183098|FG001|STARTED|Overall Study||4||
60067906|NCT01784523|76183097|FG000|COMPLETED|Overall Study||0||
60067907|NCT01784523|76183098|FG001|COMPLETED|Overall Study||0||
60067908|NCT01784523|76183097|FG000|NOT COMPLETED|Overall Study||7||
60067909|NCT01784523|76183098|FG001|NOT COMPLETED|Overall Study||4||
60067910|NCT01784211|76183106|FG000|STARTED|Part A (Days 1-15)||38||
60067911|NCT01784211|76183107|FG001|STARTED|Part A (Days 1-15)||38||
60067912|NCT01784211|76183108|FG002|STARTED|Part A (Days 1-15)||0||
60067913|NCT01784211|76183109|FG003|STARTED|Part A (Days 1-15)||0||
60067914|NCT01784211|76183110|FG004|STARTED|Part A (Days 1-15)||0||
60067915|NCT01784211|76183111|FG005|STARTED|Part A (Days 1-15)||0||
60067916|NCT01784211|76183106|FG000|Received at Least 1 Dose of Study Drug|Part A (Days 1-15)||37||
60067917|NCT01784211|76183107|FG001|Received at Least 1 Dose of Study Drug|Part A (Days 1-15)||38||
60067918|NCT01784211|76183108|FG002|Received at Least 1 Dose of Study Drug|Part A (Days 1-15)||0||
60067919|NCT01784211|76183109|FG003|Received at Least 1 Dose of Study Drug|Part A (Days 1-15)||0||
60156702|NCT02094443|76282585|FG000|Completed at Week 12|Overall Study||0||
60156703|NCT02094443|76282586|FG001|Completed at Week 12|Overall Study||1||
60156704|NCT02094443|76282585|FG000|Completed at Week 24|Overall Study||11||
60156705|NCT02094443|76282586|FG001|Completed at Week 24|Overall Study||8||
60156706|NCT02094443|76282585|FG000|COMPLETED|Overall Study||11||
60156707|NCT02094443|76282586|FG001|COMPLETED|Overall Study||9||
60156708|NCT02094443|76282585|FG000|NOT COMPLETED|Overall Study||15||
60156709|NCT02094443|76282586|FG001|NOT COMPLETED|Overall Study||17||
60156710|NCT00110513|76282592|FG000|STARTED|Overall Study||18||
60156711|NCT00110513|76282592|FG000|COMPLETED|Overall Study||18||
60156712|NCT00110513|76282592|FG000|NOT COMPLETED|Overall Study||0||
60156713|NCT00176891|76282596|FG000|STARTED|Overall Study||25||
60156714|NCT00176891|76282596|FG000|COMPLETED|Overall Study||22||
60156715|NCT00176891|76282596|FG000|NOT COMPLETED|Overall Study||3||
60156716|NCT00112151|76282606|FG000|STARTED|Overall Study||28||
60156717|NCT00112151|76282607|FG001|STARTED|Overall Study||28||
59882382|NCT03673046|76005292|FG001|NOT COMPLETED|Overall Study||3||
59882383|NCT02956005|76005298|FG000|STARTED|Overall Study||18||
59882384|NCT02956005|76005298|FG000|COMPLETED|Overall Study||2||
60156718|NCT00112151|76282608|FG002|STARTED|Overall Study||28||
60156719|NCT00112151|76282609|FG003|STARTED|Overall Study||27||
60156720|NCT00112151|76282610|FG004|STARTED|Overall Study||28||
60156721|NCT00112151|76282611|FG005|STARTED|Overall Study||28||
60156722|NCT00112151|76282606|FG000|COMPLETED|Overall Study||24||
60156723|NCT00112151|76282607|FG001|COMPLETED|Overall Study||23||
60156724|NCT00112151|76282608|FG002|COMPLETED|Overall Study||25||
60156725|NCT00112151|76282609|FG003|COMPLETED|Overall Study||24||
60156726|NCT00112151|76282610|FG004|COMPLETED|Overall Study||22||
60156727|NCT00112151|76282611|FG005|COMPLETED|Overall Study||25||
60156728|NCT00112151|76282606|FG000|NOT COMPLETED|Overall Study||4||
60156729|NCT00112151|76282607|FG001|NOT COMPLETED|Overall Study||5||
60156730|NCT00112151|76282608|FG002|NOT COMPLETED|Overall Study||3||
60156731|NCT00112151|76282609|FG003|NOT COMPLETED|Overall Study||3||
60156732|NCT00112151|76282610|FG004|NOT COMPLETED|Overall Study||6||
60156733|NCT00112151|76282611|FG005|NOT COMPLETED|Overall Study||3||
60156734|NCT00113321|76282622|FG000|STARTED|Overall Study||16||
60156735|NCT00113321|76282622|FG000|COMPLETED|Overall Study||16||
60156736|NCT00113321|76282622|FG000|NOT COMPLETED|Overall Study||0||
60156737|NCT01753713|76282628|FG000|STARTED|Overall Study||14||
60156738|NCT01753713|76282629|FG001|STARTED|Overall Study||19||
60156739|NCT01753713|76282628|FG000|COMPLETED|Overall Study||14||
60156740|NCT01753713|76282629|FG001|COMPLETED|Overall Study||19||
60156741|NCT01753713|76282628|FG000|NOT COMPLETED|Overall Study||0||
60156742|NCT01753713|76282629|FG001|NOT COMPLETED|Overall Study||0||
60156743|NCT00177047|76282635|FG000|STARTED|Overall Study||363||
60156744|NCT00177047|76282635|FG000|COMPLETED|Overall Study||363||
60156745|NCT00177047|76282635|FG000|NOT COMPLETED|Overall Study||0||
60156746|NCT04198584|76282641|FG000|STARTED|Overall Study||24||
60156747|NCT04198584|76282642|FG001|STARTED|Overall Study||8||
60156748|NCT04198584|76282641|FG000|Randomized to Wave 1|Overall Study||5||
60156749|NCT04198584|76282642|FG001|Randomized to Wave 1|Overall Study||2||
60156750|NCT04198584|76282641|FG000|Randomized to Wave 2|Overall Study||7||
60156751|NCT04198584|76282642|FG001|Randomized to Wave 2|Overall Study||2||
60156752|NCT04198584|76282641|FG000|Randomized to Wave 3|Overall Study||6||
60156753|NCT04198584|76282642|FG001|Randomized to Wave 3|Overall Study||2||
60156754|NCT04198584|76282641|FG000|Randomized to Wave 4|Overall Study||6||
60156755|NCT04198584|76282642|FG001|Randomized to Wave 4|Overall Study||2||
60156756|NCT04198584|76282641|FG000|Total Randomized|Overall Study||24||
60156757|NCT04198584|76282642|FG001|Total Randomized|Overall Study||8||
60156758|NCT04198584|76282641|FG000|Actually Received Treatment|Overall Study||21||
60156759|NCT04198584|76282642|FG001|Actually Received Treatment|Overall Study||8||
60156760|NCT04198584|76282641|FG000|COMPLETED|Overall Study||19||
60156761|NCT04198584|76282642|FG001|COMPLETED|Overall Study||8||
59882385|NCT02956005|76005298|FG000|NOT COMPLETED|Overall Study||16||
60156762|NCT04198584|76282641|FG000|NOT COMPLETED|Overall Study||5||
60156763|NCT04198584|76282642|FG001|NOT COMPLETED|Overall Study||0||
60156764|NCT00178841|76282653|FG000|STARTED|Overall Study||4||
60156765|NCT00178841|76282653|FG000|COMPLETED|Overall Study||4||
60156766|NCT00178841|76282653|FG000|NOT COMPLETED|Overall Study||0||
60156767|NCT01756209|76282662|FG000|STARTED|Overall Study||40||
60156768|NCT01756209|76282663|FG001|STARTED|Overall Study||40||
60156769|NCT01756209|76282664|FG002|STARTED|Overall Study||40||
60156770|NCT01756209|76282665|FG003|STARTED|Overall Study||40||
60156771|NCT01756209|76282662|FG000|COMPLETED|Overall Study||40||
60156772|NCT01756209|76282663|FG001|COMPLETED|Overall Study||40||
60156773|NCT01756209|76282664|FG002|COMPLETED|Overall Study||40||
60156774|NCT01756209|76282665|FG003|COMPLETED|Overall Study||40||
60156775|NCT01756209|76282662|FG000|NOT COMPLETED|Overall Study||0||
60156776|NCT01756209|76282663|FG001|NOT COMPLETED|Overall Study||0||
60156777|NCT01756209|76282664|FG002|NOT COMPLETED|Overall Study||0||
60156778|NCT01756209|76282665|FG003|NOT COMPLETED|Overall Study||0||
60156779|NCT00116207|76282677|FG000|STARTED|Overall Study||22||
59882386|NCT03253094|76005308|FG000|STARTED|Overall Study||32||
60156780|NCT00116207|76282678|FG001|STARTED|Overall Study||22||
60156781|NCT00116207|76282677|FG000|COMPLETED|Overall Study||13||
60156782|NCT00116207|76282678|FG001|COMPLETED|Overall Study||18||
60156783|NCT00116207|76282677|FG000|NOT COMPLETED|Overall Study||9||
60156784|NCT00116207|76282678|FG001|NOT COMPLETED|Overall Study||4||
60156785|NCT00178919|76282686|FG000|STARTED|Overall Study||19||
60156786|NCT00178919|76282687|FG001|STARTED|Overall Study||93||
60156787|NCT00178919|76282686|FG000|COMPLETED|Overall Study||19||
60156788|NCT00178919|76282687|FG001|COMPLETED|Overall Study||68||
60156789|NCT00178919|76282686|FG000|NOT COMPLETED|Overall Study||0||
60156790|NCT00178919|76282687|FG001|NOT COMPLETED|Overall Study||25||
60156791|NCT02581488|76282695|FG000|STARTED|Overall Study||51||
60156792|NCT02581488|76282696|FG001|STARTED|Overall Study||51||
60156793|NCT02581488|76282695|FG000|COMPLETED|Overall Study||42||
60156794|NCT02581488|76282696|FG001|COMPLETED|Overall Study||40||
60156795|NCT02581488|76282695|FG000|NOT COMPLETED|Overall Study||9||
60156796|NCT02581488|76282696|FG001|NOT COMPLETED|Overall Study||11||
60156797|NCT01757067|76282704|FG000|STARTED|Overall Study||2|The study was closed due to low enrollment.|
60156798|NCT01757067|76282705|FG001|STARTED|Overall Study|The study was closed due to low enrollment.|1|The study was closed due to low enrollment.|
60156799|NCT01757067|76282704|FG000|COMPLETED|Overall Study|The study was closed due to low enrollment.|2|The study was closed due to low enrollment.|
60156800|NCT01757067|76282705|FG001|COMPLETED|Overall Study|The study was closed due to low enrollment.|1|The study was closed due to low enrollment.|
60156801|NCT01757067|76282704|FG000|NOT COMPLETED|Overall Study||0||
60156802|NCT01757067|76282705|FG001|NOT COMPLETED|Overall Study||0||
60156803|NCT00179777|76282713|FG000|STARTED|Overall Study||2613||
60156804|NCT00179777|76282714|FG001|STARTED|Overall Study||2543||
60156805|NCT00179777|76282713|FG000|COMPLETED|Overall Study||1081||
60156806|NCT00179777|76282714|FG001|COMPLETED|Overall Study||1078||
60156807|NCT00179777|76282713|FG000|NOT COMPLETED|Overall Study||1532||
60156808|NCT00179777|76282714|FG001|NOT COMPLETED|Overall Study||1465||
60156809|NCT01757301|76282724|FG000|STARTED|Overall Study||147||
60156810|NCT01757301|76282725|FG001|STARTED|Overall Study||147||
60156811|NCT01757301|76282724|FG000|COMPLETED|Overall Study||134||
60156812|NCT01757301|76282725|FG001|COMPLETED|Overall Study||133||
60156813|NCT01757301|76282724|FG000|NOT COMPLETED|Overall Study||13||
60156814|NCT01757301|76282725|FG001|NOT COMPLETED|Overall Study||14||
60156815|NCT01759251|76282733|FG000|STARTED|30 Days Treatment Period||309||
60156816|NCT01759251|76282733|FG000|COMPLETED|30 Days Treatment Period||305||
60156817|NCT01759251|76282733|FG000|NOT COMPLETED|30 Days Treatment Period||4||
60156818|NCT01759251|76282733|FG000|STARTED|60 Days Treatment Period||305||
60156819|NCT01759251|76282733|FG000|COMPLETED|60 Days Treatment Period||305||
60156820|NCT01759251|76282733|FG000|NOT COMPLETED|60 Days Treatment Period||0||
60156821|NCT01759251|76282733|FG000|STARTED|Follow-up Period||305||
60156822|NCT01759251|76282733|FG000|COMPLETED|Follow-up Period||305||
60156823|NCT01759251|76282733|FG000|NOT COMPLETED|Follow-up Period||0||
60156824|NCT02581410|76282739|FG000|STARTED|Vaccination Phase||215||
60156825|NCT02581410|76282740|FG001|STARTED|Vaccination Phase||215||
60156826|NCT02581410|76282739|FG000|COMPLETED|Vaccination Phase||213||
60156827|NCT02581410|76282740|FG001|COMPLETED|Vaccination Phase||212||
60156828|NCT02581410|76282739|FG000|NOT COMPLETED|Vaccination Phase||2||
60156829|NCT02581410|76282740|FG001|NOT COMPLETED|Vaccination Phase||3||
60156830|NCT02581410|76282739|FG000|STARTED|End of Study Phase||215||
60156831|NCT02581410|76282740|FG001|STARTED|End of Study Phase||215||
60156832|NCT02581410|76282739|FG000|COMPLETED|End of Study Phase||210||
60156833|NCT02581410|76282740|FG001|COMPLETED|End of Study Phase||204||
60156834|NCT02581410|76282739|FG000|NOT COMPLETED|End of Study Phase||5||
60156835|NCT02581410|76282740|FG001|NOT COMPLETED|End of Study Phase||11||
60156836|NCT00180323|76282747|FG000|STARTED|Overall Study||43||
60156837|NCT00180323|76282747|FG000|COMPLETED|Overall Study||43||
60156838|NCT00180323|76282747|FG000|NOT COMPLETED|Overall Study||0||
60156839|NCT00181961|76282755|FG000|STARTED|Overall Study||7|Protocol defined enrolled as screened participants. Baseline visit determined randomization.|
60156840|NCT00181961|76282756|FG001|STARTED|Overall Study||9|Protocol defined enrolled as screened participants. Baseline visit determined randomization.|
60156841|NCT00181961|76282755|FG000|COMPLETED|Overall Study||6||
60156842|NCT00181961|76282756|FG001|COMPLETED|Overall Study||4||
60156843|NCT00181961|76282755|FG000|NOT COMPLETED|Overall Study||1||
60156844|NCT00181961|76282756|FG001|NOT COMPLETED|Overall Study||5||
60156845|NCT00122369|76282765|FG000|STARTED|Overall Study||76||
60156846|NCT00122369|76282766|FG001|STARTED|Overall Study||82||
60156847|NCT00122369|76282767|FG002|STARTED|Overall Study||78||
60156848|NCT00122369|76282765|FG000|COMPLETED|Overall Study||76||
60156849|NCT00122369|76282766|FG001|COMPLETED|Overall Study||82||
60156850|NCT00122369|76282767|FG002|COMPLETED|Overall Study||78||
60156851|NCT00122369|76282765|FG000|NOT COMPLETED|Overall Study||0||
60156852|NCT00122369|76282766|FG001|NOT COMPLETED|Overall Study||0||
60156853|NCT00122369|76282767|FG002|NOT COMPLETED|Overall Study||0||
60156854|NCT00122447|76282782|FG000|STARTED|Overall Study||18||
60156855|NCT00122447|76282783|FG001|STARTED|Overall Study||18||
60156856|NCT00122447|76282784|FG002|STARTED|Overall Study||17||
60156857|NCT00122447|76282785|FG003|STARTED|Overall Study||17||
60156858|NCT00122447|76282782|FG000|COMPLETED|Overall Study||17||
60156859|NCT00122447|76282783|FG001|COMPLETED|Overall Study||13||
60156860|NCT00122447|76282784|FG002|COMPLETED|Overall Study||16||
60156861|NCT00122447|76282785|FG003|COMPLETED|Overall Study||14||
60156862|NCT00122447|76282782|FG000|NOT COMPLETED|Overall Study||1||
60156863|NCT00122447|76282783|FG001|NOT COMPLETED|Overall Study||5||
60156864|NCT00122447|76282784|FG002|NOT COMPLETED|Overall Study||1||
60156865|NCT00122447|76282785|FG003|NOT COMPLETED|Overall Study||3||
60156866|NCT01664130|76282799|FG000|STARTED|Overall Study||35||
60156867|NCT01664130|76282799|FG000|COMPLETED|Overall Study||33||
60156868|NCT01664130|76282799|FG000|NOT COMPLETED|Overall Study||2||
60156869|NCT00125957|76282808|FG000|STARTED|First Intervention (3 Weeks)||15||
60156870|NCT00125957|76282809|FG001|STARTED|First Intervention (3 Weeks)||17||
60156871|NCT00125957|76282808|FG000|COMPLETED|First Intervention (3 Weeks)||15||
60156872|NCT00125957|76282809|FG001|COMPLETED|First Intervention (3 Weeks)||17||
60156873|NCT00125957|76282808|FG000|NOT COMPLETED|First Intervention (3 Weeks)||0||
60156874|NCT00125957|76282809|FG001|NOT COMPLETED|First Intervention (3 Weeks)||0||
60156875|NCT00125957|76282808|FG000|STARTED|Second Intervention (3 Weeks)||15||
60156876|NCT00125957|76282809|FG001|STARTED|Second Intervention (3 Weeks)||17||
60156877|NCT00125957|76282808|FG000|COMPLETED|Second Intervention (3 Weeks)||15||
60156878|NCT00125957|76282809|FG001|COMPLETED|Second Intervention (3 Weeks)||17||
60156879|NCT00125957|76282808|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||0||
60156880|NCT00125957|76282809|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0||
60156881|NCT00183443|76282818|FG000|STARTED|Overall Study||24||
60156882|NCT00183443|76282819|FG001|STARTED|Overall Study||26||
60156883|NCT00183443|76282820|FG002|STARTED|Overall Study||25||
60156884|NCT00183443|76282818|FG000|COMPLETED|Overall Study|13 eligible participants were offered enrollment in the continuation phase|24||
60156885|NCT00183443|76282819|FG001|COMPLETED|Overall Study|8 eligible participants were offered enrollment in the continuation phase|26||
60156886|NCT00183443|76282820|FG002|COMPLETED|Overall Study|4 eligible participants were offered enrollment in the continuation phase|25||
60156887|NCT00183443|76282818|FG000|NOT COMPLETED|Overall Study||0||
60156888|NCT00183443|76282819|FG001|NOT COMPLETED|Overall Study||0||
60156889|NCT00183443|76282820|FG002|NOT COMPLETED|Overall Study||0||
60156890|NCT02579928|76282830|FG000|STARTED|Overall Study||6||
60156891|NCT02579928|76282831|FG001|STARTED|Overall Study||11||
60156892|NCT02579928|76282830|FG000|COMPLETED|Overall Study||5||
60156893|NCT02579928|76282831|FG001|COMPLETED|Overall Study||11||
60156894|NCT02579928|76282830|FG000|NOT COMPLETED|Overall Study||1||
60156895|NCT02579928|76282831|FG001|NOT COMPLETED|Overall Study||0||
60156896|NCT00183677|76282837|FG000|STARTED|Overall Study||97||
60156897|NCT00183677|76282837|FG000|COMPLETED|Overall Study||53||
60156898|NCT00183677|76282837|FG000|NOT COMPLETED|Overall Study||44||
60156899|NCT00186017|76282843|FG000|STARTED|Overall Study||25||
60156900|NCT00186017|76282844|FG001|STARTED|Overall Study||25||
60156901|NCT00186017|76282843|FG000|COMPLETED|Overall Study||23||
60156902|NCT00186017|76282844|FG001|COMPLETED|Overall Study||22||
60156903|NCT00186017|76282843|FG000|NOT COMPLETED|Overall Study||2||
60156904|NCT00186017|76282844|FG001|NOT COMPLETED|Overall Study||3||
60156905|NCT00041119|76282855|FG000|STARTED|Overall Study||1142||
60156906|NCT00041119|76282856|FG001|STARTED|Overall Study||789||
60156907|NCT00041119|76282857|FG002|STARTED|Overall Study||1151||
60156908|NCT00041119|76282858|FG003|STARTED|Overall Study||789||
60156909|NCT00041119|76282855|FG000|COMPLETED|Overall Study||1142||
60156910|NCT00041119|76282856|FG001|COMPLETED|Overall Study||789||
60156911|NCT00041119|76282857|FG002|COMPLETED|Overall Study||1151||
60156912|NCT00041119|76282858|FG003|COMPLETED|Overall Study||789||
60156913|NCT00041119|76282855|FG000|NOT COMPLETED|Overall Study||0||
60156914|NCT00041119|76282856|FG001|NOT COMPLETED|Overall Study||0||
60156915|NCT00041119|76282857|FG002|NOT COMPLETED|Overall Study||0||
60156916|NCT00041119|76282858|FG003|NOT COMPLETED|Overall Study||0||
60156917|NCT00126113|76282874|FG000|STARTED|Overall Study||37||
60156918|NCT00126113|76282875|FG001|STARTED|Overall Study||37||
60156919|NCT00126113|76282874|FG000|COMPLETED|Overall Study||34||
60156920|NCT00126113|76282875|FG001|COMPLETED|Overall Study||35||
60156921|NCT00126113|76282874|FG000|NOT COMPLETED|Overall Study||3||
60156922|NCT00126113|76282875|FG001|NOT COMPLETED|Overall Study||2||
60156923|NCT00186875|76282883|FG000|STARTED|Overall Study||26||
60156924|NCT00186875|76282884|FG001|STARTED|Overall Study||14||
60156925|NCT00186875|76282883|FG000|COMPLETED|Overall Study||26||
60156926|NCT00186875|76282884|FG001|COMPLETED|Overall Study||14||
60156927|NCT00186875|76282883|FG000|NOT COMPLETED|Overall Study||0||
60156928|NCT00186875|76282884|FG001|NOT COMPLETED|Overall Study||0||
60156929|NCT01760187|76282901|FG000|STARTED|Overall Study||20||
60156930|NCT01760187|76282902|FG001|STARTED|Overall Study||12||
60156931|NCT01760187|76282903|FG002|STARTED|Overall Study||12||
60156932|NCT01760187|76282904|FG003|STARTED|Overall Study||12||
60156933|NCT01760187|76282905|FG004|STARTED|Overall Study||16||
60156934|NCT01760187|76282901|FG000|COMPLETED|Overall Study||19||
60156935|NCT01760187|76282902|FG001|COMPLETED|Overall Study||12||
60156936|NCT01760187|76282903|FG002|COMPLETED|Overall Study||12||
60156937|NCT01760187|76282904|FG003|COMPLETED|Overall Study||10||
60156938|NCT01760187|76282905|FG004|COMPLETED|Overall Study||16||
60156939|NCT01760187|76282901|FG000|NOT COMPLETED|Overall Study||1||
59605856|NCT01945710|75716036|FG005|COMPLETED|Overall Study||0||
60156940|NCT01760187|76282902|FG001|NOT COMPLETED|Overall Study||0||
60156941|NCT01760187|76282903|FG002|NOT COMPLETED|Overall Study||0||
60156942|NCT01760187|76282904|FG003|NOT COMPLETED|Overall Study||2||
60156943|NCT01760187|76282905|FG004|NOT COMPLETED|Overall Study||0||
60156944|NCT00551460|76282925|FG000|STARTED|Overall Study||78||
60156945|NCT00551460|76282925|FG000|COMPLETED|Overall Study||60||
60156946|NCT00551460|76282925|FG000|NOT COMPLETED|Overall Study||18||
60156947|NCT00126737|76282933|FG000|STARTED|Overall Study||28||
60156948|NCT00126737|76282934|FG001|STARTED|Overall Study||27||
60156949|NCT00126737|76282935|FG002|STARTED|Overall Study||30||
60156950|NCT00126737|76282936|FG003|STARTED|Overall Study||25||
60156951|NCT00126737|76282933|FG000|COMPLETED|Overall Study||22||
60156952|NCT00126737|76282934|FG001|COMPLETED|Overall Study||24||
60156953|NCT00126737|76282935|FG002|COMPLETED|Overall Study||24||
60156954|NCT00126737|76282936|FG003|COMPLETED|Overall Study||18||
60156955|NCT00126737|76282933|FG000|NOT COMPLETED|Overall Study||6||
60156956|NCT00126737|76282934|FG001|NOT COMPLETED|Overall Study||3||
60156957|NCT00126737|76282935|FG002|NOT COMPLETED|Overall Study||6||
60156958|NCT00126737|76282936|FG003|NOT COMPLETED|Overall Study||7||
60156959|NCT00273793|76282955|FG000|STARTED|Overall Study||36||
60156960|NCT00273793|76282956|FG001|STARTED|Overall Study||38||
60156961|NCT00273793|76282957|FG002|STARTED|Overall Study||18||
60156962|NCT00273793|76282958|FG003|STARTED|Overall Study||60||
60156963|NCT00273793|76282959|FG004|STARTED|Overall Study||58||
60156964|NCT00273793|76282960|FG005|STARTED|Overall Study||29||
60156965|NCT00273793|76282955|FG000|COMPLETED|Overall Study||36||
60156966|NCT00273793|76282956|FG001|COMPLETED|Overall Study||38||
60156967|NCT00273793|76282957|FG002|COMPLETED|Overall Study||18||
60156968|NCT00273793|76282958|FG003|COMPLETED|Overall Study||60||
60156969|NCT00273793|76282959|FG004|COMPLETED|Overall Study||58||
60156970|NCT00273793|76282960|FG005|COMPLETED|Overall Study||29||
60156971|NCT00273793|76282955|FG000|NOT COMPLETED|Overall Study||0||
60156972|NCT00273793|76282956|FG001|NOT COMPLETED|Overall Study||0||
60156973|NCT00273793|76282957|FG002|NOT COMPLETED|Overall Study||0||
60156974|NCT00273793|76282958|FG003|NOT COMPLETED|Overall Study||0||
60156975|NCT00273793|76282959|FG004|NOT COMPLETED|Overall Study||0||
60156976|NCT00273793|76282960|FG005|NOT COMPLETED|Overall Study||0||
60156977|NCT00127439|76282976|FG000|STARTED|Overall Study||9||
60156978|NCT00127439|76282977|FG001|STARTED|Overall Study||10||
60156979|NCT00127439|76282976|FG000|COMPLETED|Overall Study||9||
60156980|NCT00127439|76282977|FG001|COMPLETED|Overall Study||10||
60156981|NCT00127439|76282976|FG000|NOT COMPLETED|Overall Study||0||
60156982|NCT00127439|76282977|FG001|NOT COMPLETED|Overall Study||0||
60156983|NCT02579772|76282986|FG000|STARTED|Overall Study||8||
60156984|NCT02579772|76282987|FG001|STARTED|Overall Study||5||
60156985|NCT02579772|76282986|FG000|COMPLETED|Overall Study||6||
60156986|NCT02579772|76282987|FG001|COMPLETED|Overall Study||3||
60156987|NCT02579772|76282986|FG000|NOT COMPLETED|Overall Study||2||
60156988|NCT02579772|76282987|FG001|NOT COMPLETED|Overall Study||2||
60156989|NCT01761279|76282993|FG000|STARTED|Overall Study||84||
60156990|NCT01761279|76282993|FG000|COMPLETED|Overall Study||84||
60156991|NCT01761279|76282993|FG000|NOT COMPLETED|Overall Study||0||
60156992|NCT00044005|76283001|FG000|STARTED|Overall Study||32||
60156993|NCT00044005|76283002|FG001|STARTED|Overall Study||33||
60156994|NCT00044005|76283003|FG002|STARTED|Overall Study||33||
60156995|NCT00044005|76283001|FG000|COMPLETED|Overall Study||13||
60156996|NCT00044005|76283002|FG001|COMPLETED|Overall Study||19||
60156997|NCT00044005|76283003|FG002|COMPLETED|Overall Study||11||
60156998|NCT00044005|76283001|FG000|NOT COMPLETED|Overall Study||19||
60156999|NCT00044005|76283002|FG001|NOT COMPLETED|Overall Study||14||
59605857|NCT01945710|75716037|FG006|COMPLETED|Overall Study||0||
59605858|NCT01945710|75716031|FG000|NOT COMPLETED|Overall Study||7||
60157000|NCT00044005|76283003|FG002|NOT COMPLETED|Overall Study||22||
60157001|NCT01761747|76283011|FG000|STARTED|Overall Study||3||
60157002|NCT01761747|76283011|FG000|COMPLETED|Overall Study||2||
60157003|NCT01761747|76283011|FG000|NOT COMPLETED|Overall Study||1||
60157004|NCT00045487|76283015|FG000|STARTED|Overall Study||41||
60157005|NCT00045487|76283015|FG000|COMPLETED|Overall Study||30||
60157006|NCT00045487|76283015|FG000|NOT COMPLETED|Overall Study||11||
60157007|NCT00278863|76283021|FG000|STARTED|Overall Study||49||
60157008|NCT00278863|76283022|FG001|STARTED|Overall Study||47||
60157009|NCT00278863|76283021|FG000|COMPLETED|Overall Study||44||
60157010|NCT00278863|76283022|FG001|COMPLETED|Overall Study||45||
60157011|NCT00278863|76283021|FG000|NOT COMPLETED|Overall Study||5||
60157012|NCT00278863|76283022|FG001|NOT COMPLETED|Overall Study||2||
60157013|NCT00128219|76283030|FG000|STARTED|Overall Study||333||
60157014|NCT00128219|76283031|FG001|STARTED|Overall Study||334||
60157015|NCT00128219|76283030|FG000|COMPLETED|Overall Study||264||
60157016|NCT00128219|76283031|FG001|COMPLETED|Overall Study||263||
60157017|NCT00128219|76283030|FG000|NOT COMPLETED|Overall Study||69||
60157018|NCT00128219|76283031|FG001|NOT COMPLETED|Overall Study||71||
60157019|NCT01762059|76283037|FG000|STARTED|Overall Study||20||
60157020|NCT01762059|76283037|FG000|COMPLETED|Overall Study||20||
60157021|NCT01762059|76283037|FG000|NOT COMPLETED|Overall Study||0||
60157022|NCT01808547|76283048|FG000|STARTED|Overall Study||174||
60157023|NCT01808547|76283049|FG001|STARTED|Overall Study||94||
60157024|NCT01808547|76283048|FG000|Safety Population|Overall Study||170||
60157025|NCT01808547|76283049|FG001|Safety Population|Overall Study||85||
60157026|NCT01808547|76283048|FG000|mITT Population|Overall Study||168||
60157027|NCT01808547|76283049|FG001|mITT Population|Overall Study||85||
60157028|NCT01808547|76283048|FG000|COMPLETED|Overall Study||137||
60157029|NCT01808547|76283049|FG001|COMPLETED|Overall Study||48||
60157030|NCT01808547|76283048|FG000|NOT COMPLETED|Overall Study||37||
60157031|NCT01808547|76283049|FG001|NOT COMPLETED|Overall Study||46||
60157032|NCT00187655|76283055|FG000|STARTED|Overall Study||24||
60157033|NCT00187655|76283055|FG000|COMPLETED|Overall Study||24||
60157034|NCT00187655|76283055|FG000|NOT COMPLETED|Overall Study||0||
60157035|NCT02579616|76283060|FG000|STARTED|Overall Study||29||
60157036|NCT02579616|76283060|FG000|Treated|Overall Study||26||
60157037|NCT02579616|76283060|FG000|COMPLETED|Overall Study||26||
60157038|NCT02579616|76283060|FG000|NOT COMPLETED|Overall Study||3||
60157039|NCT00131573|76283066|FG000|STARTED|Overall Study||46||
60157040|NCT00131573|76283067|FG001|STARTED|Overall Study||39||
60157041|NCT00131573|76283066|FG000|COMPLETED|Overall Study||13||
60157042|NCT00131573|76283067|FG001|COMPLETED|Overall Study||13||
60157043|NCT00131573|76283066|FG000|NOT COMPLETED|Overall Study||33||
60157044|NCT00131573|76283067|FG001|NOT COMPLETED|Overall Study||26||
60157045|NCT00279955|76283077|FG000|STARTED|Overall Study||157||
60157046|NCT00279955|76283078|FG001|STARTED|Overall Study||486||
60157047|NCT00279955|76283079|FG002|STARTED|Overall Study||358||
60157048|NCT00279955|76283077|FG000|COMPLETED|Overall Study||157||
60157049|NCT00279955|76283078|FG001|COMPLETED|Overall Study||486||
60157050|NCT00279955|76283079|FG002|COMPLETED|Overall Study|They are still counted as completes, though they are never used for the analyses of objectives.|358||
60157051|NCT00279955|76283077|FG000|NOT COMPLETED|Overall Study||0||
60157052|NCT00279955|76283078|FG001|NOT COMPLETED|Overall Study||0||
60157053|NCT00279955|76283079|FG002|NOT COMPLETED|Overall Study||0||
60157054|NCT00134381|76283086|FG000|STARTED|Overall Study||1||
60157055|NCT00134381|76283087|FG001|STARTED|Overall Study||2||
60157056|NCT00134381|76283088|FG002|STARTED|Overall Study||1||
60157057|NCT00134381|76283089|FG003|STARTED|Overall Study||2||
60157058|NCT00134381|76283090|FG004|STARTED|Overall Study||31||
60157059|NCT00134381|76283091|FG005|STARTED|Overall Study||31||
60157060|NCT00134381|76283086|FG000|COMPLETED|Overall Study||1||
60157061|NCT00134381|76283087|FG001|COMPLETED|Overall Study||2||
60157062|NCT00134381|76283088|FG002|COMPLETED|Overall Study||1||
60157063|NCT00134381|76283089|FG003|COMPLETED|Overall Study||2||
60157064|NCT00134381|76283090|FG004|COMPLETED|Overall Study||31||
60157065|NCT00134381|76283091|FG005|COMPLETED|Overall Study||29||
60157066|NCT00134381|76283086|FG000|NOT COMPLETED|Overall Study||0||
60157067|NCT00134381|76283087|FG001|NOT COMPLETED|Overall Study||0||
60157068|NCT00134381|76283088|FG002|NOT COMPLETED|Overall Study||0||
60157069|NCT00134381|76283089|FG003|NOT COMPLETED|Overall Study||0||
60157070|NCT00134381|76283090|FG004|NOT COMPLETED|Overall Study||0||
60157071|NCT00134381|76283091|FG005|NOT COMPLETED|Overall Study||2||
60157072|NCT02256111|76283110|FG000|STARTED|Overall Study||13||
60157073|NCT02256111|76283111|FG001|STARTED|Overall Study||13||
60157074|NCT02256111|76283110|FG000|COMPLETED|Overall Study||13||
60157075|NCT02256111|76283111|FG001|COMPLETED|Overall Study||13||
60157076|NCT02256111|76283110|FG000|NOT COMPLETED|Overall Study||0||
60157077|NCT02256111|76283111|FG001|NOT COMPLETED|Overall Study||0||
60157078|NCT04027608|76283120|FG000|STARTED|Overall Study||165||
60157079|NCT04027608|76283121|FG001|STARTED|Overall Study||36||
60157080|NCT04027608|76283120|FG000|COMPLETED|Overall Study||129||
60157081|NCT04027608|76283121|FG001|COMPLETED|Overall Study||29||
60157082|NCT04027608|76283120|FG000|NOT COMPLETED|Overall Study||36||
60157083|NCT04027608|76283121|FG001|NOT COMPLETED|Overall Study||7||
60157084|NCT00189137|76283129|FG000|STARTED|Overall Study||37||
60157085|NCT00189137|76283130|FG001|STARTED|Overall Study||43||
60157086|NCT00189137|76283129|FG000|COMPLETED|Overall Study||37||
60157087|NCT00189137|76283130|FG001|COMPLETED|Overall Study||43||
60157088|NCT00189137|76283129|FG000|NOT COMPLETED|Overall Study||0||
60157089|NCT00189137|76283130|FG001|NOT COMPLETED|Overall Study||0||
60157090|NCT02099461|76283139|FG000|STARTED|Overall Study||27||
60157091|NCT02099461|76283140|FG001|STARTED|Overall Study||27||
60157092|NCT02099461|76283141|FG002|STARTED|Overall Study||28||
60157093|NCT02099461|76283139|FG000|COMPLETED|Overall Study||27||
60157094|NCT02099461|76283140|FG001|COMPLETED|Overall Study||27||
60157095|NCT02099461|76283141|FG002|COMPLETED|Overall Study||28||
60157096|NCT02099461|76283139|FG000|NOT COMPLETED|Overall Study||0||
60157097|NCT02099461|76283140|FG001|NOT COMPLETED|Overall Study||0||
60157098|NCT02099461|76283141|FG002|NOT COMPLETED|Overall Study||0||
60157099|NCT02262039|76283151|FG000|STARTED|Overall Study||14||
60157100|NCT02262039|76283152|FG001|STARTED|Overall Study||27||
60157101|NCT02262039|76283151|FG000|COMPLETED|Overall Study||14||
60157102|NCT02262039|76283152|FG001|COMPLETED|Overall Study||27||
60157103|NCT02262039|76283151|FG000|NOT COMPLETED|Overall Study||0||
60157104|NCT02262039|76283152|FG001|NOT COMPLETED|Overall Study||0||
60157105|NCT02256189|76283160|FG000|STARTED|Overall Study||15||
60157106|NCT02256189|76283161|FG001|STARTED|Overall Study||13||
60157107|NCT02256189|76283160|FG000|COMPLETED|Overall Study||15||
60157108|NCT02256189|76283161|FG001|COMPLETED|Overall Study||13||
60157109|NCT02256189|76283160|FG000|NOT COMPLETED|Overall Study||0||
60157110|NCT02256189|76283161|FG001|NOT COMPLETED|Overall Study||0||
60157111|NCT02256345|76283171|FG000|STARTED|Overall Study||9||
60157112|NCT02256345|76283172|FG001|STARTED|Overall Study||3||
60157113|NCT02256345|76283171|FG000|COMPLETED|Overall Study||9||
60157114|NCT02256345|76283172|FG001|COMPLETED|Overall Study||3||
60157115|NCT02256345|76283171|FG000|NOT COMPLETED|Overall Study||0||
60157116|NCT02256345|76283172|FG001|NOT COMPLETED|Overall Study||0||
60157117|NCT00193037|76283180|FG000|STARTED|Randomized Treatment||50||
60157118|NCT00193037|76283181|FG001|STARTED|Randomized Treatment||52||
60157119|NCT00193037|76283180|FG000|COMPLETED|Randomized Treatment||32||
60157120|NCT00193037|76283181|FG001|COMPLETED|Randomized Treatment||24||
60157121|NCT00193037|76283180|FG000|NOT COMPLETED|Randomized Treatment||18||
60157122|NCT00193037|76283181|FG001|NOT COMPLETED|Randomized Treatment||28||
60157123|NCT00193037|76283180|FG000|STARTED|Crossover Treatment||32||
60157124|NCT00193037|76283181|FG001|STARTED|Crossover Treatment||24||
60157125|NCT00193037|76283180|FG000|COMPLETED|Crossover Treatment||32||
60157126|NCT00193037|76283181|FG001|COMPLETED|Crossover Treatment||24||
60157127|NCT00193037|76283180|FG000|NOT COMPLETED|Crossover Treatment||0||
60157128|NCT00193037|76283181|FG001|NOT COMPLETED|Crossover Treatment||0||
60157129|NCT02100007|76283187|FG000|STARTED|Overall Study||46||
60157130|NCT02100007|76283187|FG000|COMPLETED|Overall Study||46||
60157131|NCT02100007|76283187|FG000|NOT COMPLETED|Overall Study||0||
60157132|NCT01809639|76283194|FG000|STARTED|Overall Study||18||
60157133|NCT01809639|76283195|FG001|STARTED|Overall Study||7||
60157134|NCT01809639|76283194|FG000|COMPLETED|Overall Study||18||
60157135|NCT01809639|76283195|FG001|COMPLETED|Overall Study||7||
60157136|NCT01809639|76283194|FG000|NOT COMPLETED|Overall Study||0||
60157137|NCT01809639|76283195|FG001|NOT COMPLETED|Overall Study||0||
60157138|NCT01763931|76283203|FG000|STARTED|Overall Study||2||
60157139|NCT01763931|76283204|FG001|STARTED|Overall Study||4||
60157140|NCT01763931|76283203|FG000|COMPLETED|Overall Study||2||
60157141|NCT01763931|76283204|FG001|COMPLETED|Overall Study||3||
60157142|NCT01763931|76283203|FG000|NOT COMPLETED|Overall Study||0||
60157143|NCT01763931|76283204|FG001|NOT COMPLETED|Overall Study||1||
60157144|NCT01664052|76283212|FG000|STARTED|Phase 1|Screening and enrollment|31||
60157145|NCT01664052|76283213|FG001|STARTED|Phase 1||0||
60157146|NCT01664052|76283212|FG000|Insert Placed in at Least One Tube|Phase 1||25||
60157147|NCT01664052|76283213|FG001|Insert Placed in at Least One Tube|Phase 1||0||
60157148|NCT01664052|76283212|FG000|HSG 1 Hour Post Placement|Phase 1||24||
60157149|NCT01664052|76283213|FG001|HSG 1 Hour Post Placement|Phase 1||0||
60157150|NCT01664052|76283212|FG000|Repeat HSG and Hysterectomy at 30 Days|Phase 1||9||
60157151|NCT01664052|76283213|FG001|Repeat HSG and Hysterectomy at 30 Days|Phase 1||0||
60157152|NCT01664052|76283212|FG000|Repeat HSG and Hysterectomy at 60 Days|Phase 1||8||
60157153|NCT01664052|76283213|FG001|Repeat HSG and Hysterectomy at 60 Days|Phase 1||0||
60157154|NCT01664052|76283212|FG000|Repeat HSG and Hysterectomy at 90 Days|Phase 1||7||
60157155|NCT01664052|76283213|FG001|Repeat HSG and Hysterectomy at 90 Days|Phase 1||0||
60157156|NCT01664052|76283212|FG000|COMPLETED|Phase 1||24||
60157157|NCT01664052|76283213|FG001|COMPLETED|Phase 1||0||
60157158|NCT01664052|76283212|FG000|NOT COMPLETED|Phase 1||7||
60157159|NCT01664052|76283213|FG001|NOT COMPLETED|Phase 1||0||
60157160|NCT01664052|76283212|FG000|STARTED|Phase 2|Screened and enrolled|0||
60157161|NCT01664052|76283213|FG001|STARTED|Phase 2||35||
60157162|NCT01664052|76283212|FG000|Insert Placed|Phase 2||0||
60157163|NCT01664052|76283213|FG001|Insert Placed|Phase 2||31||
60157164|NCT01664052|76283212|FG000|HSG 1 Hour Post Placement|Phase 2||0||
60157165|NCT01664052|76283213|FG001|HSG 1 Hour Post Placement|Phase 2||31||
60157166|NCT01664052|76283212|FG000|Repeat HSG and Hysterectomy at 30 Days|Phase 2||0||
60157167|NCT01664052|76283213|FG001|Repeat HSG and Hysterectomy at 30 Days|Phase 2||10||
60157168|NCT01664052|76283212|FG000|Repeat HSG and Hysterectomy at 60 Days|Phase 2||0||
60157169|NCT01664052|76283213|FG001|Repeat HSG and Hysterectomy at 60 Days|Phase 2||10||
60157170|NCT01664052|76283212|FG000|Repeat HSG and Hysterectomy at 90 Days|Phase 2||0||
60157171|NCT01664052|76283213|FG001|Repeat HSG and Hysterectomy at 90 Days|Phase 2||10||
60157172|NCT01664052|76283212|FG000|COMPLETED|Phase 2||0||
60157173|NCT01664052|76283213|FG001|COMPLETED|Phase 2||31||
60157174|NCT01664052|76283212|FG000|NOT COMPLETED|Phase 2||0||
60157175|NCT01664052|76283213|FG001|NOT COMPLETED|Phase 2||4||
60157176|NCT01765647|76283220|FG000|STARTED|Overall Study|One began the run-in period, but was withdrawn prior to beginning treatment with AGY|10||
60157177|NCT01765647|76283220|FG000|COMPLETED|Overall Study|10 entered the AGY treatment phase and all 10 completed treatment.|10||
60157178|NCT01765647|76283220|FG000|NOT COMPLETED|Overall Study||0||
60157179|NCT01765803|76283224|FG000|STARTED|Overall Study||6||
60157180|NCT01765803|76283224|FG000|COMPLETED|Overall Study||6||
60157181|NCT01765803|76283224|FG000|NOT COMPLETED|Overall Study||0||
60157182|NCT01811355|76283228|FG000|STARTED|First Dose||11||
60157183|NCT01811355|76283229|FG001|STARTED|First Dose||12||
60157184|NCT01811355|76283228|FG000|COMPLETED|First Dose||9||
60157185|NCT01811355|76283229|FG001|COMPLETED|First Dose||12||
60157186|NCT01811355|76283228|FG000|NOT COMPLETED|First Dose||2||
60157187|NCT01811355|76283229|FG001|NOT COMPLETED|First Dose||0||
60157188|NCT01811355|76283228|FG000|STARTED|Washout||9||
60157189|NCT01811355|76283229|FG001|STARTED|Washout||12||
60157190|NCT01811355|76283228|FG000|COMPLETED|Washout||9||
60157191|NCT01811355|76283229|FG001|COMPLETED|Washout||12||
60157192|NCT01811355|76283228|FG000|NOT COMPLETED|Washout||0||
60157193|NCT01811355|76283229|FG001|NOT COMPLETED|Washout||0||
60157194|NCT01811355|76283228|FG000|STARTED|Second Dose||9||
60157195|NCT01811355|76283229|FG001|STARTED|Second Dose||12||
60157196|NCT01811355|76283228|FG000|COMPLETED|Second Dose||9||
60157197|NCT01811355|76283229|FG001|COMPLETED|Second Dose||12||
60157198|NCT01811355|76283228|FG000|NOT COMPLETED|Second Dose||0||
60157199|NCT01811355|76283229|FG001|NOT COMPLETED|Second Dose||0||
60157200|NCT01812681|76283239|FG000|STARTED|Overall Study||60||
60157201|NCT01812681|76283240|FG001|STARTED|Overall Study||24||
60157202|NCT01812681|76283239|FG000|COMPLETED|Overall Study||57||
60157203|NCT01812681|76283240|FG001|COMPLETED|Overall Study||24||
60157204|NCT01812681|76283239|FG000|NOT COMPLETED|Overall Study||3||
60157205|NCT01812681|76283240|FG001|NOT COMPLETED|Overall Study||0||
60157206|NCT01767285|76283248|FG000|STARTED|Overall Study||29||
60157207|NCT01767285|76283249|FG001|STARTED|Overall Study||30||
60157208|NCT01767285|76283248|FG000|COMPLETED|Overall Study||22||
60157209|NCT01767285|76283249|FG001|COMPLETED|Overall Study||24||
60157210|NCT01767285|76283248|FG000|NOT COMPLETED|Overall Study||7||
60157211|NCT01767285|76283249|FG001|NOT COMPLETED|Overall Study||6||
60157212|NCT01465802|76283260|FG000|STARTED|Overall Study||66||
60157213|NCT01465802|76283261|FG001|STARTED|Overall Study||66||
60157214|NCT01465802|76283262|FG002|STARTED|Overall Study||7||
60157215|NCT01465802|76283263|FG003|STARTED|Overall Study|An additional 5 participants were enrolled in Cohort II but not treated.|67||
60157216|NCT01465802|76283264|FG004|STARTED|Overall Study||25||
60157217|NCT01465802|76283260|FG000|COMPLETED|Overall Study||33||
60157218|NCT01465802|76283261|FG001|COMPLETED|Overall Study||42||
60157219|NCT01465802|76283262|FG002|COMPLETED|Overall Study||7||
60157220|NCT01465802|76283263|FG003|COMPLETED|Overall Study||38||
60157221|NCT01465802|76283264|FG004|COMPLETED|Overall Study||13||
60157222|NCT01465802|76283260|FG000|NOT COMPLETED|Overall Study||33||
60157223|NCT01465802|76283261|FG001|NOT COMPLETED|Overall Study||24||
60157224|NCT01465802|76283262|FG002|NOT COMPLETED|Overall Study||0||
60157225|NCT01465802|76283263|FG003|NOT COMPLETED|Overall Study||29||
60157226|NCT01465802|76283264|FG004|NOT COMPLETED|Overall Study||12||
60157227|NCT01813149|76283281|FG000|STARTED|Overall Study||90||
60157228|NCT01813149|76283282|FG001|STARTED|Overall Study||38||
60157229|NCT01813149|76283281|FG000|COMPLETED|Overall Study||90||
60157230|NCT01813149|76283282|FG001|COMPLETED|Overall Study||38||
60157231|NCT01813149|76283281|FG000|NOT COMPLETED|Overall Study||0||
60157232|NCT01813149|76283282|FG001|NOT COMPLETED|Overall Study||0||
60157233|NCT01814241|76283293|FG000|STARTED|Overall Study||20||
60157234|NCT01814241|76283293|FG000|COMPLETED|Overall Study||16||
60157235|NCT01814241|76283293|FG000|NOT COMPLETED|Overall Study||4||
60157236|NCT00137969|76283300|FG000|STARTED|Overall Study||174||
60157237|NCT00137969|76283301|FG001|STARTED|Overall Study||88||
60157238|NCT00137969|76283300|FG000|Received Study Drug|Overall Study||169||
60157239|NCT00137969|76283301|FG001|Received Study Drug|Overall Study||88||
60157240|NCT00137969|76283300|FG000|COMPLETED|Overall Study||107||
60157241|NCT00137969|76283301|FG001|COMPLETED|Overall Study||67||
60157242|NCT00137969|76283300|FG000|NOT COMPLETED|Overall Study||67||
60157243|NCT00137969|76283301|FG001|NOT COMPLETED|Overall Study||21||
59605859|NCT01945710|75716032|FG001|NOT COMPLETED|Overall Study||6||
59605860|NCT01945710|75716033|FG002|NOT COMPLETED|Overall Study||7||
59605861|NCT01945710|75716034|FG003|NOT COMPLETED|Overall Study||3||
60157244|NCT01437878|76283309|FG000|STARTED|Overall Study|Patient discontinued the study prior to initiation of study treatment|1||
60157245|NCT01437878|76283310|FG001|STARTED|Overall Study||1||
60157246|NCT01437878|76283309|FG000|COMPLETED|Overall Study||0||
60157247|NCT01437878|76283310|FG001|COMPLETED|Overall Study||1||
60157248|NCT01437878|76283309|FG000|NOT COMPLETED|Overall Study||1||
60157249|NCT01437878|76283310|FG001|NOT COMPLETED|Overall Study||0||
60157250|NCT01814787|76283318|FG000|STARTED|Overall Study||685||
60157251|NCT01814787|76283319|FG001|STARTED|Overall Study||684||
60157252|NCT01814787|76283318|FG000|COMPLETED|Overall Study||685||
60157253|NCT01814787|76283319|FG001|COMPLETED|Overall Study||684||
60157254|NCT01814787|76283318|FG000|NOT COMPLETED|Overall Study||0||
60157255|NCT01814787|76283319|FG001|NOT COMPLETED|Overall Study||0||
60157256|NCT00138125|76283325|FG000|STARTED|Overall Study||2||
60157257|NCT00138125|76283325|FG000|COMPLETED|Overall Study||2||
60157258|NCT00138125|76283325|FG000|NOT COMPLETED|Overall Study||0||
60157259|NCT01815333|76283330|FG000|STARTED|Overall Study||10||
60157260|NCT01815333|76283330|FG000|COMPLETED|Overall Study||10||
60157261|NCT01815333|76283330|FG000|NOT COMPLETED|Overall Study||0||
60157262|NCT01465178|76283336|FG000|STARTED|Overall Study||31||
60157263|NCT01465178|76283337|FG001|STARTED|Overall Study||31||
60157264|NCT01465178|76283336|FG000|COMPLETED|Overall Study||30||
60157265|NCT01465178|76283337|FG001|COMPLETED|Overall Study||31||
60157266|NCT01465178|76283336|FG000|NOT COMPLETED|Overall Study||1||
60157267|NCT01465178|76283337|FG001|NOT COMPLETED|Overall Study||0||
60157268|NCT00138203|76283343|FG000|STARTED|Overall Study||16||
60157269|NCT00138203|76283343|FG000|COMPLETED|Overall Study||16||
60157270|NCT00138203|76283343|FG000|NOT COMPLETED|Overall Study||0||
60157271|NCT01768845|76283348|FG000|STARTED|Overall Study||34||
60157272|NCT01768845|76283348|FG000|COMPLETED|Overall Study||11||
60157273|NCT01768845|76283348|FG000|NOT COMPLETED|Overall Study||23||
60157274|NCT00139997|76283354|FG000|STARTED|Overall Study||15||
60157275|NCT00139997|76283355|FG001|STARTED|Overall Study||11||
60157276|NCT00139997|76283354|FG000|COMPLETED|Overall Study||14||
60157277|NCT00139997|76283355|FG001|COMPLETED|Overall Study||9||
60157278|NCT00139997|76283354|FG000|NOT COMPLETED|Overall Study||1||
60157279|NCT00139997|76283355|FG001|NOT COMPLETED|Overall Study||2||
60157280|NCT01815645|76283363|FG000|STARTED|Overall Study||32||
60157281|NCT01815645|76283364|FG001|STARTED|Overall Study||33||
60157282|NCT01815645|76283363|FG000|COMPLETED|Overall Study||32||
60157283|NCT01815645|76283364|FG001|COMPLETED|Overall Study||33||
60157284|NCT01815645|76283363|FG000|NOT COMPLETED|Overall Study||0||
60157285|NCT01815645|76283364|FG001|NOT COMPLETED|Overall Study||0||
60157286|NCT00140231|76283374|FG000|STARTED|Fed State 1 Day- day5||7||
60157287|NCT00140231|76283375|FG001|STARTED|Fed State 1 Day- day5||6||
60157288|NCT00140231|76283374|FG000|COMPLETED|Fed State 1 Day- day5||7||
60157289|NCT00140231|76283375|FG001|COMPLETED|Fed State 1 Day- day5||6||
60157290|NCT00140231|76283374|FG000|NOT COMPLETED|Fed State 1 Day- day5||0||
60157291|NCT00140231|76283375|FG001|NOT COMPLETED|Fed State 1 Day- day5||0||
60157292|NCT00140231|76283374|FG000|STARTED|Washout 8weeks||7||
60157293|NCT00140231|76283375|FG001|STARTED|Washout 8weeks||6||
60157294|NCT00140231|76283374|FG000|COMPLETED|Washout 8weeks||7||
60157295|NCT00140231|76283375|FG001|COMPLETED|Washout 8weeks||6||
60157296|NCT00140231|76283374|FG000|NOT COMPLETED|Washout 8weeks||0||
60157297|NCT00140231|76283375|FG001|NOT COMPLETED|Washout 8weeks||0||
60157298|NCT00140231|76283374|FG000|STARTED|First Fasting State 3 Days With Placebo||7||
60157299|NCT00140231|76283375|FG001|STARTED|First Fasting State 3 Days With Placebo||6||
60157300|NCT00140231|76283374|FG000|COMPLETED|First Fasting State 3 Days With Placebo||7||
60157301|NCT00140231|76283375|FG001|COMPLETED|First Fasting State 3 Days With Placebo||6||
59605862|NCT01945710|75716035|FG004|NOT COMPLETED|Overall Study||9||
59605863|NCT01945710|75716036|FG005|NOT COMPLETED|Overall Study||3||
59605864|NCT01945710|75716037|FG006|NOT COMPLETED|Overall Study||23||
59605865|NCT01945242|75716057|FG000|STARTED|Overall Study||1251||
59605866|NCT01945242|75716058|FG001|STARTED|Overall Study||123||
59605867|NCT01945242|75716057|FG000|COMPLETED|Overall Study||1248||
59605868|NCT01945242|75716058|FG001|COMPLETED|Overall Study||120||
59605869|NCT01945242|75716057|FG000|NOT COMPLETED|Overall Study||3||
60157302|NCT00140231|76283374|FG000|NOT COMPLETED|First Fasting State 3 Days With Placebo||0||
60157303|NCT00140231|76283375|FG001|NOT COMPLETED|First Fasting State 3 Days With Placebo||0||
60157304|NCT00140231|76283374|FG000|STARTED|Washout 8 Weeks||7||
60157305|NCT00140231|76283375|FG001|STARTED|Washout 8 Weeks||6||
60157306|NCT00140231|76283374|FG000|COMPLETED|Washout 8 Weeks||7||
60157307|NCT00140231|76283375|FG001|COMPLETED|Washout 8 Weeks||6||
60157308|NCT00140231|76283374|FG000|NOT COMPLETED|Washout 8 Weeks||0||
60157309|NCT00140231|76283375|FG001|NOT COMPLETED|Washout 8 Weeks||0||
60157310|NCT00140231|76283374|FG000|STARTED|Fasting State With Leptin and Crossover||7||
60157311|NCT00140231|76283375|FG001|STARTED|Fasting State With Leptin and Crossover||6||
60157312|NCT00140231|76283374|FG000|COMPLETED|Fasting State With Leptin and Crossover||7||
60157313|NCT00140231|76283375|FG001|COMPLETED|Fasting State With Leptin and Crossover||6||
60157314|NCT00140231|76283374|FG000|NOT COMPLETED|Fasting State With Leptin and Crossover||0||
60157315|NCT00140231|76283375|FG001|NOT COMPLETED|Fasting State With Leptin and Crossover||0||
60157316|NCT01732809|76283383|FG000|STARTED|Overall Study||9||18
60157317|NCT01732809|76283384|FG001|STARTED|Overall Study||10||20
60157318|NCT01732809|76283383|FG000|COMPLETED|Overall Study||9||18
60157319|NCT01732809|76283384|FG001|COMPLETED|Overall Study||9||18
60157320|NCT01732809|76283383|FG000|NOT COMPLETED|Overall Study||0||0
60157321|NCT01732809|76283384|FG001|NOT COMPLETED|Overall Study||1||2
60157322|NCT00194129|76283392|FG000|STARTED|Overall Study||15||
60157323|NCT00194129|76283393|FG001|STARTED|Overall Study||16||
60157324|NCT00194129|76283392|FG000|COMPLETED|Overall Study||5||
60157325|NCT00194129|76283393|FG001|COMPLETED|Overall Study||3||
60157326|NCT00194129|76283392|FG000|NOT COMPLETED|Overall Study||10||
60157327|NCT00194129|76283393|FG001|NOT COMPLETED|Overall Study||13||
60157328|NCT01733277|76283408|FG000|STARTED|Overall Study||25||
60157329|NCT01733277|76283409|FG001|STARTED|Overall Study||25||
60157330|NCT01733277|76283408|FG000|COMPLETED|Overall Study||25||
60157331|NCT01733277|76283409|FG001|COMPLETED|Overall Study||25||
60157332|NCT01733277|76283408|FG000|NOT COMPLETED|Overall Study||0||
60157333|NCT01733277|76283409|FG001|NOT COMPLETED|Overall Study||0||
60157334|NCT01817907|76283417|FG000|STARTED|First Intervention||8||
60157335|NCT01817907|76283418|FG001|STARTED|First Intervention||7||
60157336|NCT01817907|76283417|FG000|COMPLETED|First Intervention||8||
60157337|NCT01817907|76283418|FG001|COMPLETED|First Intervention||7||
60157338|NCT01817907|76283417|FG000|NOT COMPLETED|First Intervention||0||
60157339|NCT01817907|76283418|FG001|NOT COMPLETED|First Intervention||0||
60157340|NCT01817907|76283417|FG000|STARTED|Washout Period||8||
60157341|NCT01817907|76283418|FG001|STARTED|Washout Period||7||
60157342|NCT01817907|76283417|FG000|COMPLETED|Washout Period||8||
60157343|NCT01817907|76283418|FG001|COMPLETED|Washout Period||7||
60157344|NCT01817907|76283417|FG000|NOT COMPLETED|Washout Period||0||
60157345|NCT01817907|76283418|FG001|NOT COMPLETED|Washout Period||0||
60157346|NCT01817907|76283417|FG000|STARTED|Second Intervention||8||
60157347|NCT01817907|76283418|FG001|STARTED|Second Intervention||7||
60157348|NCT01817907|76283417|FG000|COMPLETED|Second Intervention||8||
60157349|NCT01817907|76283418|FG001|COMPLETED|Second Intervention||7||
60157350|NCT01817907|76283417|FG000|NOT COMPLETED|Second Intervention||0||
60157351|NCT01817907|76283418|FG001|NOT COMPLETED|Second Intervention||0||
60157352|NCT00140621|76283424|FG000|STARTED|Overall Study||6||
60157353|NCT00140621|76283424|FG000|COMPLETED|Overall Study||6||
60157354|NCT00140621|76283424|FG000|NOT COMPLETED|Overall Study||0||
60157355|NCT00143819|76283430|FG000|STARTED|Overall Study||5||
60157356|NCT00143819|76283431|FG001|STARTED|Overall Study||8||
60157357|NCT00143819|76283430|FG000|COMPLETED|Overall Study||3||
60157358|NCT00143819|76283431|FG001|COMPLETED|Overall Study||5||
60157359|NCT00143819|76283430|FG000|NOT COMPLETED|Overall Study||2||
60157360|NCT00143819|76283431|FG001|NOT COMPLETED|Overall Study||3||
60157361|NCT01445678|76283443|FG000|STARTED|Overall Study||482||
60157362|NCT01445678|76283444|FG001|STARTED|Overall Study||497||
60157363|NCT01445678|76283443|FG000|COMPLETED|Overall Study||452||
60157364|NCT01445678|76283444|FG001|COMPLETED|Overall Study||476||
60157365|NCT01445678|76283443|FG000|NOT COMPLETED|Overall Study||30||
60157366|NCT01445678|76283444|FG001|NOT COMPLETED|Overall Study||21||
60157367|NCT01818063|76283452|FG000|STARTED|Overall Study||5||
60157368|NCT01818063|76283453|FG001|STARTED|Overall Study||4||
60157369|NCT01818063|76283452|FG000|COMPLETED|Overall Study||5||
60157370|NCT01818063|76283453|FG001|COMPLETED|Overall Study||4||
60157371|NCT01818063|76283452|FG000|NOT COMPLETED|Overall Study||0||
60157372|NCT01818063|76283453|FG001|NOT COMPLETED|Overall Study||0||
60157373|NCT03769194|76283463|FG000|STARTED|Overall Study||29||
60157374|NCT03769194|76283464|FG001|STARTED|Overall Study||214||
60157375|NCT03769194|76283465|FG002|STARTED|Overall Study||205||
60157376|NCT03769194|76283466|FG003|STARTED|Overall Study||124||
60157377|NCT03769194|76283463|FG000|COMPLETED|Overall Study||25|Subjects that completed Day 85 (Visit 4)|
60157378|NCT03769194|76283464|FG001|COMPLETED|Overall Study||196|Subjects that completed Day 85 (Visit 4)|
60157379|NCT03769194|76283465|FG002|COMPLETED|Overall Study||197|Subjects that completed Day 85 (Visit 4)|
60157380|NCT03769194|76283466|FG003|COMPLETED|Overall Study||115|Subjects that completed Day 85 (Visit 4)|
60157381|NCT03769194|76283463|FG000|NOT COMPLETED|Overall Study||4||
60157382|NCT03769194|76283464|FG001|NOT COMPLETED|Overall Study||18||
60157383|NCT03769194|76283465|FG002|NOT COMPLETED|Overall Study||8||
60157384|NCT03769194|76283466|FG003|NOT COMPLETED|Overall Study||9||
60157385|NCT00147017|76283479|FG000|STARTED|Overall Study||6||
60157386|NCT00147017|76283480|FG001|STARTED|Overall Study||7||
60157387|NCT00147017|76283481|FG002|STARTED|Overall Study||4||
60157388|NCT00147017|76283479|FG000|COMPLETED|Overall Study||6||
60157389|NCT00147017|76283480|FG001|COMPLETED|Overall Study||7||
60157390|NCT00147017|76283481|FG002|COMPLETED|Overall Study||4||
60157391|NCT00147017|76283479|FG000|NOT COMPLETED|Overall Study||0||
60157392|NCT00147017|76283480|FG001|NOT COMPLETED|Overall Study||0||
60157393|NCT00147017|76283481|FG002|NOT COMPLETED|Overall Study||0||
60157394|NCT01465022|76283492|FG000|STARTED|Overall Study||64||
60157395|NCT01465022|76283493|FG001|STARTED|Overall Study||63||
60157396|NCT01465022|76283494|FG002|STARTED|Overall Study||70||
60157397|NCT01465022|76283492|FG000|COMPLETED|Overall Study||41||
60157398|NCT01465022|76283493|FG001|COMPLETED|Overall Study||40||
60157399|NCT01465022|76283494|FG002|COMPLETED|Overall Study||0||
60157400|NCT01465022|76283492|FG000|NOT COMPLETED|Overall Study||23||
60157401|NCT01465022|76283493|FG001|NOT COMPLETED|Overall Study||23||
60157402|NCT01465022|76283494|FG002|NOT COMPLETED|Overall Study||70||
60157403|NCT02258217|76283500|FG000|STARTED|Overall Study||30||
60157404|NCT02258217|76283500|FG000|COMPLETED|Overall Study||30||
60157405|NCT02258217|76283500|FG000|NOT COMPLETED|Overall Study||0||
60157406|NCT00149669|76283506|FG000|STARTED|Overall Study||32||
60157407|NCT00149669|76283507|FG001|STARTED|Overall Study||35||
60157408|NCT00149669|76283506|FG000|COMPLETED|Overall Study||29||
60157409|NCT00149669|76283507|FG001|COMPLETED|Overall Study||30||
60157410|NCT00149669|76283506|FG000|NOT COMPLETED|Overall Study||3||
60157411|NCT00149669|76283507|FG001|NOT COMPLETED|Overall Study||5||
60157412|NCT00255125|76283517|FG000|STARTED|Overall Study||42||
60157413|NCT00255125|76283518|FG001|STARTED|Overall Study||44||
60157414|NCT00255125|76283517|FG000|COMPLETED|Overall Study||42||
60157415|NCT00255125|76283518|FG001|COMPLETED|Overall Study||44||
60157416|NCT00255125|76283517|FG000|NOT COMPLETED|Overall Study||0||
60157417|NCT00255125|76283518|FG001|NOT COMPLETED|Overall Study||0||
60157418|NCT02258373|76283528|FG000|STARTED|Overall Study||149||
60157419|NCT02258373|76283529|FG001|STARTED|Overall Study||77||
60157420|NCT02258373|76283528|FG000|COMPLETED|Overall Study||142||
60157421|NCT02258373|76283529|FG001|COMPLETED|Overall Study||75||
60157422|NCT02258373|76283528|FG000|NOT COMPLETED|Overall Study||7||
60157423|NCT02258373|76283529|FG001|NOT COMPLETED|Overall Study||2||
60157424|NCT01464788|76283538|FG000|STARTED|Overall Study||30||
60157425|NCT01464788|76283539|FG001|STARTED|Overall Study||31||
60157426|NCT01464788|76283540|FG002|STARTED|Overall Study||29||
60157427|NCT01464788|76283538|FG000|COMPLETED|Overall Study||30||
60157428|NCT01464788|76283539|FG001|COMPLETED|Overall Study||29||
60157429|NCT01464788|76283540|FG002|COMPLETED|Overall Study||29||
60157430|NCT01464788|76283538|FG000|NOT COMPLETED|Overall Study||0||
60157431|NCT01464788|76283539|FG001|NOT COMPLETED|Overall Study||2||
60157432|NCT01464788|76283540|FG002|NOT COMPLETED|Overall Study||0||
60157433|NCT01444898|76283550|FG000|STARTED|Overall Study||10||
60157434|NCT01444898|76283550|FG000|COMPLETED|Overall Study||9||
60157435|NCT01444898|76283550|FG000|NOT COMPLETED|Overall Study||1||
60157436|NCT00201773|76283554|FG000|STARTED|Overall Study||22||
60157437|NCT00201773|76283554|FG000|Completed 8 Weeks of Planned Therapy|Overall Study||16||
60157438|NCT00201773|76283554|FG000|Received All Exemestane Therapy|Overall Study||5||
60157439|NCT00201773|76283554|FG000|Stopped Exemestane After 4 Weeks|Overall Study||1||
60157440|NCT00201773|76283554|FG000|COMPLETED|Overall Study||16||
60157441|NCT00201773|76283554|FG000|NOT COMPLETED|Overall Study||6||
60157442|NCT01819233|76283561|FG000|STARTED|Overall Study||38||
60157443|NCT01819233|76283561|FG000|COMPLETED|Overall Study||32||
60157444|NCT01819233|76283561|FG000|NOT COMPLETED|Overall Study||6||
60157445|NCT00256217|76283565|FG000|STARTED|Overall Study||42||
60157446|NCT00256217|76283565|FG000|COMPLETED|Overall Study||34||
60157447|NCT00256217|76283565|FG000|NOT COMPLETED|Overall Study||8||
60157448|NCT01419626|76283572|FG000|STARTED|Overall Study||46||
60157449|NCT01419626|76283573|FG001|STARTED|Overall Study||47||
60157450|NCT01419626|76283574|FG002|STARTED|Overall Study||47||
60157451|NCT01419626|76283572|FG000|COMPLETED|Overall Study||42||
60157452|NCT01419626|76283573|FG001|COMPLETED|Overall Study||44||
60157453|NCT01419626|76283574|FG002|COMPLETED|Overall Study||44||
60157454|NCT01419626|76283572|FG000|NOT COMPLETED|Overall Study||4||
60157455|NCT01419626|76283573|FG001|NOT COMPLETED|Overall Study||3||
60157456|NCT01419626|76283574|FG002|NOT COMPLETED|Overall Study||3||
60157457|NCT00256451|76283582|FG000|STARTED|Session1||10|Crossover design: no of subjs who completed the PRIOR session|
60157458|NCT00256451|76283583|FG001|STARTED|Session1||11|Crossover design: no of subjs who completed the PRIOR session|
60157459|NCT00256451|76283584|FG002|STARTED|Session1||11|Crossover design: no of subjs who completed the PRIOR session|
60157460|NCT00256451|76283585|FG003|STARTED|Session1||11|Crossover design: no of subjs who completed the PRIOR session|
60157461|NCT00256451|76283582|FG000|COMPLETED|Session1||10||
60157462|NCT00256451|76283583|FG001|COMPLETED|Session1||11||
60157463|NCT00256451|76283584|FG002|COMPLETED|Session1||11||
60157464|NCT00256451|76283585|FG003|COMPLETED|Session1||11||
60157465|NCT00256451|76283582|FG000|NOT COMPLETED|Session1||0||
60157466|NCT00256451|76283583|FG001|NOT COMPLETED|Session1||0||
60157467|NCT00256451|76283584|FG002|NOT COMPLETED|Session1||0||
60157468|NCT00256451|76283585|FG003|NOT COMPLETED|Session1||0||
60157469|NCT00256451|76283582|FG000|STARTED|Session2||9|Crossover design: no of subjs who completed the PRIOR session|
60157470|NCT00256451|76283583|FG001|STARTED|Session2||11|Crossover design: no of subjs who completed the PRIOR session|
60157471|NCT00256451|76283584|FG002|STARTED|Session2||10|Crossover design: no of subjs who completed the PRIOR session|
60157472|NCT00256451|76283585|FG003|STARTED|Session2||10|Crossover design: no of subjs who completed the PRIOR session|
60157473|NCT00256451|76283582|FG000|COMPLETED|Session2||9||
60157474|NCT00256451|76283583|FG001|COMPLETED|Session2||11||
60157475|NCT00256451|76283584|FG002|COMPLETED|Session2||10||
60157476|NCT00256451|76283585|FG003|COMPLETED|Session2||10||
60157477|NCT00256451|76283582|FG000|NOT COMPLETED|Session2||0||
60157478|NCT00256451|76283583|FG001|NOT COMPLETED|Session2||0||
60157479|NCT00256451|76283584|FG002|NOT COMPLETED|Session2||0||
60157480|NCT00256451|76283585|FG003|NOT COMPLETED|Session2||0||
60157481|NCT00256451|76283582|FG000|STARTED|Session3||9|Crossover design: no of subjs who completed the PRIOR session|
60157482|NCT00256451|76283583|FG001|STARTED|Session3||9|Crossover design: no of subjs who completed the PRIOR session|
60157483|NCT00256451|76283584|FG002|STARTED|Session3||10|Crossover design: no of subjs who completed the PRIOR session|
60157484|NCT00256451|76283585|FG003|STARTED|Session3||9|Crossover design: no of subjs who completed the PRIOR session|
60157485|NCT00256451|76283582|FG000|COMPLETED|Session3||9||
60157486|NCT00256451|76283583|FG001|COMPLETED|Session3||9||
60157487|NCT00256451|76283584|FG002|COMPLETED|Session3||10||
60157488|NCT00256451|76283585|FG003|COMPLETED|Session3||9||
60157489|NCT00256451|76283582|FG000|NOT COMPLETED|Session3||0||
60157490|NCT00256451|76283583|FG001|NOT COMPLETED|Session3||0||
60157491|NCT00256451|76283584|FG002|NOT COMPLETED|Session3||0||
60157492|NCT00256451|76283585|FG003|NOT COMPLETED|Session3||0||
60157493|NCT00256451|76283582|FG000|STARTED|Session4||9|Crossover design: no of subjs who completed the PRIOR session|
60157494|NCT00256451|76283583|FG001|STARTED|Session4||8|Crossover design: no of subjs who completed the PRIOR session|
60157495|NCT00256451|76283584|FG002|STARTED|Session4||10|Crossover design: no of subjs who completed the PRIOR session|
60157496|NCT00256451|76283585|FG003|STARTED|Session4||8|Crossover design: no of subjs who completed the PRIOR session|
60157497|NCT00256451|76283582|FG000|COMPLETED|Session4||9||
60157498|NCT00256451|76283583|FG001|COMPLETED|Session4||8||
60157499|NCT00256451|76283584|FG002|COMPLETED|Session4||10||
60157500|NCT00256451|76283585|FG003|COMPLETED|Session4||8||
60157501|NCT00256451|76283582|FG000|NOT COMPLETED|Session4||0||
60157502|NCT00256451|76283583|FG001|NOT COMPLETED|Session4||0||
60157503|NCT00256451|76283584|FG002|NOT COMPLETED|Session4||0||
60157504|NCT00256451|76283585|FG003|NOT COMPLETED|Session4||0||
60157505|NCT01819311|76283597|FG000|STARTED|Treatment Phase (4 Weeks)||33||
60157506|NCT01819311|76283598|FG001|STARTED|Treatment Phase (4 Weeks)||31||
60157507|NCT01819311|76283597|FG000|COMPLETED|Treatment Phase (4 Weeks)||31||
60157508|NCT01819311|76283598|FG001|COMPLETED|Treatment Phase (4 Weeks)||30||
60157509|NCT01819311|76283597|FG000|NOT COMPLETED|Treatment Phase (4 Weeks)||2||
60157510|NCT01819311|76283598|FG001|NOT COMPLETED|Treatment Phase (4 Weeks)||1||
60157511|NCT01819311|76283597|FG000|STARTED|Follow-up Phase (8 Weeks)||31||
60157512|NCT01819311|76283598|FG001|STARTED|Follow-up Phase (8 Weeks)||30||
60157513|NCT01819311|76283597|FG000|COMPLETED|Follow-up Phase (8 Weeks)||24||
60157514|NCT01819311|76283598|FG001|COMPLETED|Follow-up Phase (8 Weeks)||23||
60157515|NCT01819311|76283597|FG000|NOT COMPLETED|Follow-up Phase (8 Weeks)||7||
60157516|NCT01819311|76283598|FG001|NOT COMPLETED|Follow-up Phase (8 Weeks)||7||
60157517|NCT00257309|76283606|FG000|STARTED|Overall Study||134||
60157518|NCT00257309|76283607|FG001|STARTED|Overall Study||132||
60157519|NCT00257309|76283606|FG000|COMPLETED|Overall Study||132||
60157520|NCT00257309|76283607|FG001|COMPLETED|Overall Study||130||
60157521|NCT00257309|76283606|FG000|NOT COMPLETED|Overall Study||2||
60157522|NCT00257309|76283607|FG001|NOT COMPLETED|Overall Study||2||
60157523|NCT01444742|76283613|FG000|STARTED|Overall Study||81||
60157524|NCT01444742|76283613|FG000|COMPLETED|Overall Study||80||
60157525|NCT01444742|76283613|FG000|NOT COMPLETED|Overall Study||1||
60157526|NCT01770483|76283619|FG000|STARTED|Overall Study||33||
60157527|NCT01770483|76283620|FG001|STARTED|Overall Study||33||
60157528|NCT01770483|76283619|FG000|COMPLETED|Overall Study||33||
60157529|NCT01770483|76283620|FG001|COMPLETED|Overall Study||33||
60157530|NCT01770483|76283619|FG000|NOT COMPLETED|Overall Study||0||
60157531|NCT01770483|76283620|FG001|NOT COMPLETED|Overall Study||0||
60157532|NCT00257933|76283628|FG000|STARTED|Overall Study||74||
60157533|NCT00257933|76283629|FG001|STARTED|Overall Study||78||
60157534|NCT00257933|76283628|FG000|COMPLETED|Overall Study||74||
60157535|NCT00257933|76283629|FG001|COMPLETED|Overall Study||78||
60157536|NCT00257933|76283628|FG000|NOT COMPLETED|Overall Study||0||
60157537|NCT00257933|76283629|FG001|NOT COMPLETED|Overall Study||0||
60157538|NCT01734525|76283635|FG000|STARTED|Overall Study||85||
60157539|NCT01734525|76283635|FG000|COMPLETED|Overall Study||85||
60157540|NCT01734525|76283635|FG000|NOT COMPLETED|Overall Study||0||
60157541|NCT01819935|76283641|FG000|STARTED|Overall Study||328||
60157542|NCT01819935|76283642|FG001|STARTED|Overall Study||4943||
60157543|NCT01819935|76283641|FG000|COMPLETED|Overall Study||328||
60157544|NCT01819935|76283642|FG001|COMPLETED|Overall Study||4943||
60157545|NCT01819935|76283641|FG000|NOT COMPLETED|Overall Study||0||
60157546|NCT01819935|76283642|FG001|NOT COMPLETED|Overall Study||0||
60157547|NCT00258011|76283648|FG000|STARTED|Overall Study||3||
60157548|NCT00258011|76283648|FG000|COMPLETED|Overall Study||3||
60157549|NCT00258011|76283648|FG000|NOT COMPLETED|Overall Study||0||
60157550|NCT00260195|76283654|FG000|STARTED|Overall Study||39||
60157551|NCT00260195|76283655|FG001|STARTED|Overall Study||37||
60157552|NCT00260195|76283654|FG000|COMPLETED|Overall Study||39||
60157553|NCT00260195|76283655|FG001|COMPLETED|Overall Study||37||
60157554|NCT00260195|76283654|FG000|NOT COMPLETED|Overall Study||0||
60157555|NCT00260195|76283655|FG001|NOT COMPLETED|Overall Study||0||
60157556|NCT01821105|76283662|FG000|STARTED|Overall Study||21||
60157557|NCT01821105|76283662|FG000|COMPLETED|Overall Study||21||
60157558|NCT01821105|76283662|FG000|NOT COMPLETED|Overall Study||0||
60157559|NCT00264641|76283668|FG000|STARTED|Overall Study||10||
60157560|NCT00264641|76283669|FG001|STARTED|Overall Study||10||
60157561|NCT00264641|76283668|FG000|Initiation of the Study|Overall Study||10||
60157562|NCT00264641|76283669|FG001|Initiation of the Study|Overall Study||10||
60157563|NCT00264641|76283668|FG000|COMPLETED|Overall Study||10||
60157564|NCT00264641|76283669|FG001|COMPLETED|Overall Study||10||
60157565|NCT00264641|76283668|FG000|NOT COMPLETED|Overall Study||0||
60157566|NCT00264641|76283669|FG001|NOT COMPLETED|Overall Study||0||
60157567|NCT01735617|76283674|FG000|STARTED|Overall Study||16||
60157568|NCT01735617|76283674|FG000|COMPLETED|Overall Study||16||
60157569|NCT01735617|76283674|FG000|NOT COMPLETED|Overall Study||0||
60157570|NCT00208091|76283681|FG000|STARTED|Overall Study||16||
60157571|NCT00208091|76283681|FG000|COMPLETED|Overall Study||16||
60157572|NCT00208091|76283681|FG000|NOT COMPLETED|Overall Study||0||
60157573|NCT00208949|76283691|FG000|STARTED|Overall Study||25||
60157574|NCT00208949|76283692|FG001|STARTED|Overall Study||25||
60157575|NCT00208949|76283691|FG000|COMPLETED|Overall Study||25||
60157576|NCT00208949|76283692|FG001|COMPLETED|Overall Study||25||
60157577|NCT00208949|76283691|FG000|NOT COMPLETED|Overall Study||0||
60157578|NCT00208949|76283692|FG001|NOT COMPLETED|Overall Study||0||
60157579|NCT01771965|76283700|FG000|STARTED|Overall Study||10||
60157580|NCT01771965|76283701|FG001|STARTED|Overall Study||9||
60157581|NCT01771965|76283700|FG000|COMPLETED|Overall Study||7||
60157582|NCT01771965|76283701|FG001|COMPLETED|Overall Study||4||
60157583|NCT01771965|76283700|FG000|NOT COMPLETED|Overall Study||3||
60157584|NCT01771965|76283701|FG001|NOT COMPLETED|Overall Study||5||
60157585|NCT00266279|76283707|FG000|STARTED|Overall Study||17||
60157586|NCT00266279|76283707|FG000|COMPLETED|Overall Study||15||
60157587|NCT00266279|76283707|FG000|NOT COMPLETED|Overall Study||2||
60157588|NCT01773135|76283714|FG000|STARTED|Overall Study||262||
60157589|NCT01773135|76283714|FG000|COMPLETED|Overall Study||262||
60157590|NCT01773135|76283714|FG000|NOT COMPLETED|Overall Study||0||
60157591|NCT01736085|76283725|FG000|STARTED|Overall Study||529||
60157592|NCT01736085|76283726|FG001|STARTED|Overall Study||530||
60157593|NCT01736085|76283727|FG002|STARTED|Overall Study||793||
60157594|NCT01736085|76283728|FG003|STARTED|Overall Study||530||
60157595|NCT01736085|76283729|FG004|STARTED|Overall Study||530||
60157596|NCT01736085|76283730|FG005|STARTED|Overall Study||794||
60157597|NCT01736085|76283725|FG000|COMPLETED|Overall Study||529||
60157598|NCT01736085|76283726|FG001|COMPLETED|Overall Study||530||
60157599|NCT01736085|76283727|FG002|COMPLETED|Overall Study||793||
60157600|NCT01736085|76283728|FG003|COMPLETED|Overall Study||530||
60157601|NCT01736085|76283729|FG004|COMPLETED|Overall Study||530||
60157602|NCT01736085|76283730|FG005|COMPLETED|Overall Study||794||
60157603|NCT01736085|76283725|FG000|NOT COMPLETED|Overall Study||0||
60157604|NCT01736085|76283726|FG001|NOT COMPLETED|Overall Study||0||
60157605|NCT01736085|76283727|FG002|NOT COMPLETED|Overall Study||0||
60157606|NCT01736085|76283728|FG003|NOT COMPLETED|Overall Study||0||
60157607|NCT01736085|76283729|FG004|NOT COMPLETED|Overall Study||0||
60157608|NCT01736085|76283730|FG005|NOT COMPLETED|Overall Study||0||
60157609|NCT00209417|76283743|FG000|STARTED|Overall Study||321||
60157610|NCT00209417|76283744|FG001|STARTED|Overall Study||327||
60157611|NCT00209417|76283743|FG000|COMPLETED|Overall Study||321||
60157612|NCT00209417|76283744|FG001|COMPLETED|Overall Study||327||
60157613|NCT00209417|76283743|FG000|NOT COMPLETED|Overall Study||0||
60157614|NCT00209417|76283744|FG001|NOT COMPLETED|Overall Study||0||
60157615|NCT00210353|76283753|FG000|STARTED|Overall Study||151||
60157616|NCT00210353|76283754|FG001|STARTED|Overall Study||152||
60157617|NCT00210353|76283755|FG002|STARTED|Overall Study||151||
60157618|NCT00210353|76283753|FG000|COMPLETED|Overall Study||113||
60157619|NCT00210353|76283754|FG001|COMPLETED|Overall Study||107||
60157620|NCT00210353|76283755|FG002|COMPLETED|Overall Study||125||
60157621|NCT00210353|76283753|FG000|NOT COMPLETED|Overall Study||38||
60157622|NCT00210353|76283754|FG001|NOT COMPLETED|Overall Study||45||
60157623|NCT00210353|76283755|FG002|NOT COMPLETED|Overall Study||26||
60157624|NCT00267059|76283768|FG000|STARTED|Overall Study||44||
60157625|NCT00267059|76283768|FG000|COMPLETED|Overall Study||44||
60157626|NCT00267059|76283768|FG000|NOT COMPLETED|Overall Study||0||
60157627|NCT01736241|76283779|FG000|STARTED|Overall Study||6||
60157628|NCT01736241|76283780|FG001|STARTED|Overall Study||6||
60157629|NCT01736241|76283781|FG002|STARTED|Overall Study||6||
60157630|NCT01736241|76283782|FG003|STARTED|Overall Study||5||
60157631|NCT01736241|76283783|FG004|STARTED|Overall Study||6||
60157632|NCT01736241|76283784|FG005|STARTED|Overall Study||6||
60157633|NCT01736241|76283785|FG006|STARTED|Overall Study||6||
60157634|NCT01736241|76283779|FG000|Received at Least One Dose of Study Drug|Overall Study||6||
60157635|NCT01736241|76283780|FG001|Received at Least One Dose of Study Drug|Overall Study||6||
60157636|NCT01736241|76283781|FG002|Received at Least One Dose of Study Drug|Overall Study||6||
60157637|NCT01736241|76283782|FG003|Received at Least One Dose of Study Drug|Overall Study||5||
60157638|NCT01736241|76283783|FG004|Received at Least One Dose of Study Drug|Overall Study||6||
60157639|NCT01736241|76283784|FG005|Received at Least One Dose of Study Drug|Overall Study||6||
60157640|NCT01736241|76283785|FG006|Received at Least One Dose of Study Drug|Overall Study||6||
60157641|NCT01736241|76283779|FG000|COMPLETED|Overall Study||6||
60157642|NCT01736241|76283780|FG001|COMPLETED|Overall Study||6||
60157643|NCT01736241|76283781|FG002|COMPLETED|Overall Study||6||
60157644|NCT01736241|76283782|FG003|COMPLETED|Overall Study||5||
60157645|NCT01736241|76283783|FG004|COMPLETED|Overall Study||6||
60157646|NCT01736241|76283784|FG005|COMPLETED|Overall Study||6||
60157647|NCT01736241|76283785|FG006|COMPLETED|Overall Study||6||
60157648|NCT01736241|76283779|FG000|NOT COMPLETED|Overall Study||0||
60157649|NCT01736241|76283780|FG001|NOT COMPLETED|Overall Study||0||
60157650|NCT01736241|76283781|FG002|NOT COMPLETED|Overall Study||0||
60157651|NCT01736241|76283782|FG003|NOT COMPLETED|Overall Study||0||
60157652|NCT01736241|76283783|FG004|NOT COMPLETED|Overall Study||0||
60157653|NCT01736241|76283784|FG005|NOT COMPLETED|Overall Study||0||
60157654|NCT01736241|76283785|FG006|NOT COMPLETED|Overall Study||0||
60157655|NCT00213239|76283804|FG000|STARTED|Overall Study||32||
60157656|NCT00213239|76283805|FG001|STARTED|Overall Study||32||
60157657|NCT00213239|76283804|FG000|COMPLETED|Overall Study||32||
60157658|NCT00213239|76283805|FG001|COMPLETED|Overall Study||32||
60157659|NCT00213239|76283804|FG000|NOT COMPLETED|Overall Study||0||
60157660|NCT00213239|76283805|FG001|NOT COMPLETED|Overall Study||0||
60157661|NCT01444430|76283813|FG000|STARTED|Overall Study||5846||
60157662|NCT01444430|76283814|FG001|STARTED|Overall Study||5847||
60157663|NCT01444430|76283813|FG000|COMPLETED|Overall Study||5785||
60157664|NCT01444430|76283814|FG001|COMPLETED|Overall Study||5766||
60157665|NCT01444430|76283813|FG000|NOT COMPLETED|Overall Study||61||
60157666|NCT01444430|76283814|FG001|NOT COMPLETED|Overall Study||81||
60157667|NCT01878825|76283822|FG000|STARTED|Overall Study||60||
60157668|NCT01878825|76283823|FG001|STARTED|Overall Study||60||
60157669|NCT01878825|76283822|FG000|COMPLETED|Overall Study||60||
60157670|NCT01878825|76283823|FG001|COMPLETED|Overall Study||60||
60157671|NCT01878825|76283822|FG000|NOT COMPLETED|Overall Study||0||
60157672|NCT01878825|76283823|FG001|NOT COMPLETED|Overall Study||0||
60157673|NCT00214097|76283841|FG000|STARTED|Overall Study|Escalation to the next higher level will occur when > 20 pt yrs of F/U and > 5 pts followed >1 yr|101||
60157674|NCT00214097|76283842|FG001|STARTED|Overall Study|Escalation to the next higher level will occur when > 20 pt yrs of F/U and > 5 pts followed >1 yr|111||
60157675|NCT00214097|76283843|FG002|STARTED|Overall Study||135||
60157676|NCT00214097|76283841|FG000|COMPLETED|Overall Study||101||
60157677|NCT00214097|76283842|FG001|COMPLETED|Overall Study||111||
60157678|NCT00214097|76283843|FG002|COMPLETED|Overall Study||135||
60157679|NCT00214097|76283841|FG000|NOT COMPLETED|Overall Study||0||
60157680|NCT00214097|76283842|FG001|NOT COMPLETED|Overall Study||0||
60157681|NCT00214097|76283843|FG002|NOT COMPLETED|Overall Study||0||
60157682|NCT00214487|76283859|FG000|STARTED|Overall Study||43||
60157683|NCT00214487|76283860|FG001|STARTED|Overall Study||43||
60157684|NCT00214487|76283859|FG000|COMPLETED|Overall Study||38||
60157685|NCT00214487|76283860|FG001|COMPLETED|Overall Study||40||
60157686|NCT00214487|76283859|FG000|NOT COMPLETED|Overall Study||5||
60157687|NCT00214487|76283860|FG001|NOT COMPLETED|Overall Study||3||
60157688|NCT01774149|76283868|FG000|STARTED|Overall Study||15||
60157689|NCT01774149|76283869|FG001|STARTED|Overall Study||15||
60157690|NCT01774149|76283868|FG000|COMPLETED|Overall Study||14||
60157691|NCT01774149|76283869|FG001|COMPLETED|Overall Study||12||
60157692|NCT01774149|76283868|FG000|NOT COMPLETED|Overall Study||1||
60157693|NCT01774149|76283869|FG001|NOT COMPLETED|Overall Study||3||
60157694|NCT00267293|76283878|FG000|STARTED|Overall Study||20||
60157695|NCT00267293|76283879|FG001|STARTED|Overall Study||20||
60157696|NCT00267293|76283880|FG002|STARTED|Overall Study||20||
60157697|NCT00267293|76283878|FG000|COMPLETED|Overall Study||20||
60157698|NCT00267293|76283879|FG001|COMPLETED|Overall Study||20||
60157699|NCT00267293|76283880|FG002|COMPLETED|Overall Study||20||
60157700|NCT00267293|76283878|FG000|NOT COMPLETED|Overall Study||0||
60157701|NCT00267293|76283879|FG001|NOT COMPLETED|Overall Study||0||
60157702|NCT00267293|76283880|FG002|NOT COMPLETED|Overall Study||0||
60157703|NCT01436162|76283890|FG000|STARTED|Single-blind Lead-in Phase|Ten subjects were enrolled but not dosed.|1105||
60157704|NCT01436162|76283891|FG001|STARTED|Single-blind Lead-in Phase||0||
60157705|NCT01436162|76283892|FG002|STARTED|Single-blind Lead-in Phase||0||
60157706|NCT01436162|76283890|FG000|COMPLETED|Single-blind Lead-in Phase||823||
60157707|NCT01436162|76283891|FG001|COMPLETED|Single-blind Lead-in Phase||0||
60157708|NCT01436162|76283892|FG002|COMPLETED|Single-blind Lead-in Phase||0||
60157709|NCT01436162|76283890|FG000|NOT COMPLETED|Single-blind Lead-in Phase||282||
60157710|NCT01436162|76283891|FG001|NOT COMPLETED|Single-blind Lead-in Phase||0||
60157711|NCT01436162|76283892|FG002|NOT COMPLETED|Single-blind Lead-in Phase||0||
60157712|NCT01436162|76283890|FG000|STARTED|Randomized Phase|These subjects were not included in the Safety Analysis Set or Full Analysis Set.|397||
60157713|NCT01436162|76283891|FG001|STARTED|Randomized Phase|One subject was randomized to this arm but did not receive at least 1 dose of double-blind treatment|212||
60157714|NCT01436162|76283892|FG002|STARTED|Randomized Phase|One subject was randomized to this arm but did not receive at least 1 dose of double-blind treatment|214||
60157715|NCT01436162|76283890|FG000|COMPLETED|Randomized Phase||353||
60157716|NCT01436162|76283891|FG001|COMPLETED|Randomized Phase||181||
60157717|NCT01436162|76283892|FG002|COMPLETED|Randomized Phase||189||
60157718|NCT01436162|76283890|FG000|NOT COMPLETED|Randomized Phase||44||
60157719|NCT01436162|76283891|FG001|NOT COMPLETED|Randomized Phase||31||
60157720|NCT01436162|76283892|FG002|NOT COMPLETED|Randomized Phase||25||
60157721|NCT02579382|76283904|FG000|STARTED|Main Study Phase||28||
60157722|NCT02579382|76283905|FG001|STARTED|Main Study Phase||53||
60157723|NCT02579382|76283906|FG002|STARTED|Main Study Phase||56||
60157724|NCT02579382|76283907|FG003|STARTED|Main Study Phase||55||
59882387|NCT03253094|76005309|FG001|STARTED|Overall Study||30||
60157725|NCT02579382|76283904|FG000|COMPLETED|Main Study Phase||28||
60157726|NCT02579382|76283905|FG001|COMPLETED|Main Study Phase||53||
60157727|NCT02579382|76283906|FG002|COMPLETED|Main Study Phase||54||
60157728|NCT02579382|76283907|FG003|COMPLETED|Main Study Phase||52||
60157729|NCT02579382|76283904|FG000|NOT COMPLETED|Main Study Phase||0||
60157730|NCT02579382|76283905|FG001|NOT COMPLETED|Main Study Phase||0||
60157731|NCT02579382|76283906|FG002|NOT COMPLETED|Main Study Phase||2||
60157732|NCT02579382|76283907|FG003|NOT COMPLETED|Main Study Phase||3||
60157733|NCT02579382|76283904|FG000|STARTED|Optional Treatment Extension Phase(OTEP)|1 participant who completed the Main Study Phase did not enter the OTEP.|27||
60157734|NCT02579382|76283905|FG001|STARTED|Optional Treatment Extension Phase(OTEP)|2 participants who completed the Main Study Phase did not enter the OTEP.|51||
59882388|NCT03253094|76005310|FG002|STARTED|Overall Study||28||
60157735|NCT02579382|76283906|FG002|STARTED|Optional Treatment Extension Phase(OTEP)||54||
60157736|NCT02579382|76283907|FG003|STARTED|Optional Treatment Extension Phase(OTEP)|3 participants who completed the Main Study Phase did not enter the OTEP.|49||
60157737|NCT02579382|76283904|FG000|COMPLETED|Optional Treatment Extension Phase(OTEP)||26||
60157738|NCT02579382|76283905|FG001|COMPLETED|Optional Treatment Extension Phase(OTEP)||44||
60157739|NCT02579382|76283906|FG002|COMPLETED|Optional Treatment Extension Phase(OTEP)||50||
60157740|NCT02579382|76283907|FG003|COMPLETED|Optional Treatment Extension Phase(OTEP)||44||
60157741|NCT02579382|76283904|FG000|NOT COMPLETED|Optional Treatment Extension Phase(OTEP)||1||
60157742|NCT02579382|76283905|FG001|NOT COMPLETED|Optional Treatment Extension Phase(OTEP)||7||
60157743|NCT02579382|76283906|FG002|NOT COMPLETED|Optional Treatment Extension Phase(OTEP)||4||
60157744|NCT02579382|76283907|FG003|NOT COMPLETED|Optional Treatment Extension Phase(OTEP)||5||
60157745|NCT01774851|76283927|FG000|STARTED|Overall Study||42||
60157746|NCT01774851|76283928|FG001|STARTED|Overall Study||42||
60157747|NCT01774851|76283927|FG000|COMPLETED|Overall Study||42||
60157748|NCT01774851|76283928|FG001|COMPLETED|Overall Study||42||
60157749|NCT01774851|76283927|FG000|NOT COMPLETED|Overall Study||0||
60157750|NCT01774851|76283928|FG001|NOT COMPLETED|Overall Study||0||
60157751|NCT01436084|76283934|FG000|STARTED|Overall Study||4||
60157752|NCT01436084|76283934|FG000|COMPLETED|Overall Study||0||
60157753|NCT01436084|76283934|FG000|NOT COMPLETED|Overall Study||4||
60157754|NCT02259699|76283940|FG000|STARTED|Overall Study||64||
60157755|NCT02259699|76283941|FG001|STARTED|Overall Study||60||
60157756|NCT02259699|76283940|FG000|COMPLETED|Overall Study||37||
60157757|NCT02259699|76283941|FG001|COMPLETED|Overall Study||40||
60157758|NCT02259699|76283940|FG000|NOT COMPLETED|Overall Study||27||
60157759|NCT02259699|76283941|FG001|NOT COMPLETED|Overall Study||20||
60157760|NCT01419314|76283949|FG000|STARTED|Start of Study|minor comfort issues were reported within the first 2 weeks of the trial|23||
60157761|NCT01419314|76283950|FG001|STARTED|Start of Study|No comfort issues reported.|22||
60157762|NCT01419314|76283949|FG000|COMPLETED|Start of Study||23||
60157763|NCT01419314|76283950|FG001|COMPLETED|Start of Study||22||
60157764|NCT01419314|76283949|FG000|NOT COMPLETED|Start of Study||0||
60157765|NCT01419314|76283950|FG001|NOT COMPLETED|Start of Study||0||
60157766|NCT01419314|76283949|FG000|STARTED|Follow-up at Week 3 of the Trial|3 participants discontinued the trial, 3 failed to return for additional follow-ups.|23||
60157767|NCT01419314|76283950|FG001|STARTED|Follow-up at Week 3 of the Trial|one participant failed to return for the 3 week follow-up|22||
60157768|NCT01419314|76283949|FG000|COMPLETED|Follow-up at Week 3 of the Trial||17||
60157769|NCT01419314|76283950|FG001|COMPLETED|Follow-up at Week 3 of the Trial||21||
60157770|NCT01419314|76283949|FG000|NOT COMPLETED|Follow-up at Week 3 of the Trial||6||
60157771|NCT01419314|76283950|FG001|NOT COMPLETED|Follow-up at Week 3 of the Trial||1||
60157772|NCT01419314|76283949|FG000|STARTED|Follow-up at Week 6 of the Trial||17||
60157773|NCT01419314|76283950|FG001|STARTED|Follow-up at Week 6 of the Trial|2 participants did not return for their final follow-up|21||
60157774|NCT01419314|76283949|FG000|COMPLETED|Follow-up at Week 6 of the Trial|2 people who missed the first follow-up, returned for the final follow-up at week 6 (n=18).|16||
60157775|NCT01419314|76283950|FG001|COMPLETED|Follow-up at Week 6 of the Trial||19||
60157776|NCT01419314|76283949|FG000|NOT COMPLETED|Follow-up at Week 6 of the Trial||1||
60157777|NCT01419314|76283950|FG001|NOT COMPLETED|Follow-up at Week 6 of the Trial||2||
60157778|NCT03440112|76283963|FG000|STARTED|Overall Study||11||
60157779|NCT03440112|76283964|FG001|STARTED|Overall Study||11||
60157780|NCT03440112|76283965|FG002|STARTED|Overall Study||3||
60157781|NCT03440112|76283963|FG000|COMPLETED|Overall Study||11||
60157782|NCT03440112|76283964|FG001|COMPLETED|Overall Study||11||
59518917|NCT03393208|75612804|FG000|COMPLETED|Treatment Period 1 (Day 1-Day 3)||13||
59751751|NCT00843843|75871104|FG000|STARTED|Overall Study||8||
59751752|NCT00843843|75871105|FG001|STARTED|Overall Study||8||
59751753|NCT00843843|75871104|FG000|COMPLETED|Overall Study||6||
59751754|NCT00843843|75871105|FG001|COMPLETED|Overall Study||6||
59751755|NCT00843843|75871104|FG000|NOT COMPLETED|Overall Study||2||
60157783|NCT03440112|76283965|FG002|COMPLETED|Overall Study||3||
60157784|NCT03440112|76283963|FG000|NOT COMPLETED|Overall Study||0||
60157785|NCT03440112|76283964|FG001|NOT COMPLETED|Overall Study||0||
60157786|NCT03440112|76283965|FG002|NOT COMPLETED|Overall Study||0||
60157787|NCT01775865|76283977|FG000|STARTED|Overall Study||14||
60157788|NCT01775865|76283978|FG001|STARTED|Overall Study||14||
60157789|NCT01775865|76283979|FG002|STARTED|Overall Study||17||
60157790|NCT01775865|76283977|FG000|COMPLETED|Overall Study||11||
60157791|NCT01775865|76283978|FG001|COMPLETED|Overall Study||13||
60157792|NCT01775865|76283979|FG002|COMPLETED|Overall Study||17||
60157793|NCT01775865|76283977|FG000|NOT COMPLETED|Overall Study||3||
60157794|NCT01775865|76283978|FG001|NOT COMPLETED|Overall Study||1||
60157795|NCT01775865|76283979|FG002|NOT COMPLETED|Overall Study||0||
60157796|NCT01821417|76283994|FG000|STARTED|Overall Study||37||
60157797|NCT01821417|76283995|FG001|STARTED|Overall Study||31||
60157798|NCT01821417|76283994|FG000|COMPLETED|Overall Study||37||
60157799|NCT01821417|76283995|FG001|COMPLETED|Overall Study||31||
60157800|NCT01821417|76283994|FG000|NOT COMPLETED|Overall Study||0||
60157801|NCT01821417|76283995|FG001|NOT COMPLETED|Overall Study||0||
60157802|NCT01822119|76284001|FG000|STARTED|Overall Study||27||
60157803|NCT01822119|76284001|FG000|COMPLETED|Overall Study||27||
60157804|NCT01822119|76284001|FG000|NOT COMPLETED|Overall Study||0||
60157805|NCT01419236|76284007|FG000|STARTED|Overall Study||36||
60157806|NCT01419236|76284008|FG001|STARTED|Overall Study||40||
60157807|NCT01419236|76284007|FG000|Received at Least 1 Dose of Study Drug|Overall Study||35||
60157808|NCT01419236|76284008|FG001|Received at Least 1 Dose of Study Drug|Overall Study||39||
60157809|NCT01419236|76284007|FG000|COMPLETED|Overall Study||31||
60157810|NCT01419236|76284008|FG001|COMPLETED|Overall Study||35||
60157811|NCT01419236|76284007|FG000|NOT COMPLETED|Overall Study||5||
60157812|NCT01419236|76284008|FG001|NOT COMPLETED|Overall Study||5||
60157813|NCT01822197|76284014|FG000|STARTED|Overall Study||30||
60157814|NCT01822197|76284014|FG000|COMPLETED|Overall Study||30||
60157815|NCT01822197|76284014|FG000|NOT COMPLETED|Overall Study||0||
60157816|NCT03323658|76284021|FG000|STARTED|Overall Study||10||
60157817|NCT03323658|76284022|FG001|STARTED|Overall Study||4||
60157818|NCT03323658|76284023|FG002|STARTED|Overall Study||10||
60157819|NCT03323658|76284021|FG000|COMPLETED|Overall Study||10||
60157820|NCT03323658|76284022|FG001|COMPLETED|Overall Study||3||
60157821|NCT03323658|76284023|FG002|COMPLETED|Overall Study||10||
60157822|NCT03323658|76284021|FG000|NOT COMPLETED|Overall Study||0||
60157823|NCT03323658|76284022|FG001|NOT COMPLETED|Overall Study||1||
60157824|NCT03323658|76284023|FG002|NOT COMPLETED|Overall Study||0||
60157825|NCT01776645|76284036|FG000|STARTED|Overall Study||28||
60157826|NCT01776645|76284037|FG001|STARTED|Overall Study||28||
60157827|NCT01776645|76284036|FG000|COMPLETED|Overall Study||14||
60157828|NCT01776645|76284037|FG001|COMPLETED|Overall Study||14||
60157829|NCT01776645|76284036|FG000|NOT COMPLETED|Overall Study||14||
60157830|NCT01776645|76284037|FG001|NOT COMPLETED|Overall Study||14||
60157831|NCT01879059|76284042|FG000|STARTED|Overall Study||13||
60157832|NCT01879059|76284042|FG000|COMPLETED|Overall Study||13||
60157833|NCT01879059|76284042|FG000|NOT COMPLETED|Overall Study||0||
60157834|NCT01443026|76284048|FG000|STARTED|Overall Study||29||
60157835|NCT01443026|76284049|FG001|STARTED|Overall Study||37||
60157836|NCT01443026|76284048|FG000|COMPLETED|Overall Study||26||
60157837|NCT01443026|76284049|FG001|COMPLETED|Overall Study||32||
60157838|NCT01443026|76284048|FG000|NOT COMPLETED|Overall Study||3||
60157839|NCT01443026|76284049|FG001|NOT COMPLETED|Overall Study||5||
60157840|NCT01879371|76284061|FG000|STARTED|Overall Study||6||
60157841|NCT01879371|76284062|FG001|STARTED|Overall Study||6||
60157842|NCT01879371|76284063|FG002|STARTED|Overall Study||6||
59751756|NCT00843843|75871105|FG001|NOT COMPLETED|Overall Study||2||
60157843|NCT01879371|76284064|FG003|STARTED|Overall Study||6||
60157844|NCT01879371|76284065|FG004|STARTED|Overall Study||6||
60157845|NCT01879371|76284066|FG005|STARTED|Overall Study||6||
59751757|NCT00650845|75871113|FG000|STARTED|Overall Study||75||
59751758|NCT00650845|75871114|FG001|STARTED|Overall Study||57||
59751759|NCT00650845|75871113|FG000|COMPLETED|Overall Study||70||
59751760|NCT00650845|75871114|FG001|COMPLETED|Overall Study||44||
59751761|NCT00650845|75871113|FG000|NOT COMPLETED|Overall Study||5||
60157846|NCT01879371|76284061|FG000|COMPLETED|Overall Study||6||
60157847|NCT01879371|76284062|FG001|COMPLETED|Overall Study||6||
60157848|NCT01879371|76284063|FG002|COMPLETED|Overall Study||6||
60157849|NCT01879371|76284064|FG003|COMPLETED|Overall Study||6||
60157850|NCT01879371|76284065|FG004|COMPLETED|Overall Study||6||
59751762|NCT00650845|75871114|FG001|NOT COMPLETED|Overall Study||13||
60157851|NCT01879371|76284066|FG005|COMPLETED|Overall Study||6||
59518918|NCT03393208|75612805|FG001|COMPLETED|Treatment Period 1 (Day 1-Day 3)||13||
60157852|NCT01879371|76284061|FG000|NOT COMPLETED|Overall Study||0||
60157853|NCT01879371|76284062|FG001|NOT COMPLETED|Overall Study||0||
59751763|NCT00842985|75871121|FG000|STARTED|Screening||53||
60157854|NCT01879371|76284063|FG002|NOT COMPLETED|Overall Study||0||
60157855|NCT01879371|76284064|FG003|NOT COMPLETED|Overall Study||0||
60157856|NCT01879371|76284065|FG004|NOT COMPLETED|Overall Study||0||
60157857|NCT01879371|76284066|FG005|NOT COMPLETED|Overall Study||0||
60157858|NCT01733745|76284076|FG000|STARTED|Overall Study||13||
60157859|NCT01733745|76284077|FG001|STARTED|Overall Study||13||
60157860|NCT01733745|76284076|FG000|COMPLETED|Overall Study||13||
60157861|NCT01733745|76284077|FG001|COMPLETED|Overall Study||13||
60157862|NCT01733745|76284076|FG000|NOT COMPLETED|Overall Study||0||
60157863|NCT01733745|76284077|FG001|NOT COMPLETED|Overall Study||0||
60157864|NCT01442714|76284083|FG000|STARTED|Overall Study||33||
60157865|NCT01442714|76284083|FG000|COMPLETED|Overall Study||21||
60157866|NCT01442714|76284083|FG000|NOT COMPLETED|Overall Study||12||
60157867|NCT01777425|76284089|FG000|STARTED|Overall Study||389||
60157868|NCT01777425|76284089|FG000|COMPLETED|Overall Study||389||
60157869|NCT01777425|76284089|FG000|NOT COMPLETED|Overall Study||0||
60157870|NCT01418378|76284096|FG000|STARTED|Overall Study|A total of 191 subjects were enrolled into the study. 13/191 did not receive a study implant|90||
60157871|NCT01418378|76284097|FG001|STARTED|Overall Study|A total of 191 subjects were enrolled into the study. 13/191 did not receive a study implant|88||
60157872|NCT01418378|76284096|FG000|Subjects Who Received Study Implant|Overall Study|the number of subjects implanted with study implant|90||
60157873|NCT01418378|76284097|FG001|Subjects Who Received Study Implant|Overall Study|the number of subjects implanted with study implant|88||
60157874|NCT01418378|76284096|FG000|COMPLETED|Overall Study||89||
60157875|NCT01418378|76284097|FG001|COMPLETED|Overall Study||83||
60157876|NCT01418378|76284096|FG000|NOT COMPLETED|Overall Study||1||
60157877|NCT01418378|76284097|FG001|NOT COMPLETED|Overall Study||5||
60157878|NCT01779141|76284103|FG000|STARTED|Overall Study||481||
60157879|NCT01779141|76284103|FG000|COMPLETED|Overall Study||300||
60157880|NCT01779141|76284103|FG000|NOT COMPLETED|Overall Study||181||
60157881|NCT01779219|76284109|FG000|STARTED|Overall Study|First interim analysis|21||
60157882|NCT01779219|76284110|FG001|STARTED|Overall Study|First interim analysis|21||
60157883|NCT01779219|76284109|FG000|COMPLETED|Overall Study|First interim analysis|21||
60157884|NCT01779219|76284110|FG001|COMPLETED|Overall Study|First interim analysis|21||
60157885|NCT01779219|76284109|FG000|NOT COMPLETED|Overall Study||0||
60157886|NCT01779219|76284110|FG001|NOT COMPLETED|Overall Study||0||
60157887|NCT01435928|76284118|FG000|STARTED|Open Label Phase - up to 24 Weeks||676||
60157888|NCT01435928|76284119|FG001|STARTED|Open Label Phase - up to 24 Weeks||0||
60157889|NCT01435928|76284120|FG002|STARTED|Open Label Phase - up to 24 Weeks||0||
60157890|NCT01435928|76284118|FG000|COMPLETED|Open Label Phase - up to 24 Weeks||287||
60157891|NCT01435928|76284119|FG001|COMPLETED|Open Label Phase - up to 24 Weeks||0||
60157892|NCT01435928|76284120|FG002|COMPLETED|Open Label Phase - up to 24 Weeks||0||
60157893|NCT01435928|76284118|FG000|NOT COMPLETED|Open Label Phase - up to 24 Weeks||389||
60157894|NCT01435928|76284119|FG001|NOT COMPLETED|Open Label Phase - up to 24 Weeks||0||
60157895|NCT01435928|76284120|FG002|NOT COMPLETED|Open Label Phase - up to 24 Weeks||0||
60157896|NCT01435928|76284118|FG000|STARTED|Double Blind Phase - 28 Weeks||0||
60157897|NCT01435928|76284119|FG001|STARTED|Double Blind Phase - 28 Weeks||144||
60157898|NCT01435928|76284120|FG002|STARTED|Double Blind Phase - 28 Weeks||141||
60157899|NCT01435928|76284118|FG000|COMPLETED|Double Blind Phase - 28 Weeks||0||
60157900|NCT01435928|76284119|FG001|COMPLETED|Double Blind Phase - 28 Weeks||28||
60157901|NCT01435928|76284120|FG002|COMPLETED|Double Blind Phase - 28 Weeks||20||
60157902|NCT01435928|76284118|FG000|NOT COMPLETED|Double Blind Phase - 28 Weeks||0||
60157903|NCT01435928|76284119|FG001|NOT COMPLETED|Double Blind Phase - 28 Weeks||116||
60157904|NCT01435928|76284120|FG002|NOT COMPLETED|Double Blind Phase - 28 Weeks||121||
60157905|NCT02262507|76284127|FG000|STARTED|Overall Study||410||
60157906|NCT02262507|76284127|FG000|COMPLETED|Overall Study||410||
60157907|NCT02262507|76284127|FG000|NOT COMPLETED|Overall Study||0||
60157908|NCT01416272|76284132|FG000|STARTED|Overall Study||12||
60157909|NCT01416272|76284132|FG000|COMPLETED|Overall Study||8||
60157910|NCT01416272|76284132|FG000|NOT COMPLETED|Overall Study||4||
60157911|NCT01828515|76284136|FG000|STARTED|First Intervention (19 Days)||13||
60157912|NCT01828515|76284137|FG001|STARTED|First Intervention (19 Days)||11||
60157913|NCT01828515|76284136|FG000|COMPLETED|First Intervention (19 Days)||11||
60157914|NCT01828515|76284137|FG001|COMPLETED|First Intervention (19 Days)||9||
60157915|NCT01828515|76284136|FG000|NOT COMPLETED|First Intervention (19 Days)||2||
60157916|NCT01828515|76284137|FG001|NOT COMPLETED|First Intervention (19 Days)||2||
60157917|NCT01828515|76284136|FG000|STARTED|Washout (23 Days)||11||
60157918|NCT01828515|76284137|FG001|STARTED|Washout (23 Days)||9||
60157919|NCT01828515|76284136|FG000|COMPLETED|Washout (23 Days)||6||
60157920|NCT01828515|76284137|FG001|COMPLETED|Washout (23 Days)||8||
60157921|NCT01828515|76284136|FG000|NOT COMPLETED|Washout (23 Days)||5||
60157922|NCT01828515|76284137|FG001|NOT COMPLETED|Washout (23 Days)||1||
60157923|NCT01828515|76284136|FG000|STARTED|Second Intervention (19 Days)||6||
60157924|NCT01828515|76284137|FG001|STARTED|Second Intervention (19 Days)||8||
60157925|NCT01828515|76284136|FG000|COMPLETED|Second Intervention (19 Days)||6||
60157926|NCT01828515|76284137|FG001|COMPLETED|Second Intervention (19 Days)||5||
60157927|NCT01828515|76284136|FG000|NOT COMPLETED|Second Intervention (19 Days)||0||
60157928|NCT01828515|76284137|FG001|NOT COMPLETED|Second Intervention (19 Days)||3||
60157929|NCT01828593|76284146|FG000|STARTED|Placebo-Controlled Phase||36||
60157930|NCT01828593|76284147|FG001|STARTED|Placebo-Controlled Phase||34||
60157931|NCT01828593|76284148|FG002|STARTED|Placebo-Controlled Phase||33||
60157932|NCT01828593|76284146|FG000|COMPLETED|Placebo-Controlled Phase||36||
60157933|NCT01828593|76284147|FG001|COMPLETED|Placebo-Controlled Phase||34||
60157934|NCT01828593|76284148|FG002|COMPLETED|Placebo-Controlled Phase||32||
60157935|NCT01828593|76284146|FG000|NOT COMPLETED|Placebo-Controlled Phase||0||
60157936|NCT01828593|76284147|FG001|NOT COMPLETED|Placebo-Controlled Phase||0||
60157937|NCT01828593|76284148|FG002|NOT COMPLETED|Placebo-Controlled Phase||1||
60157938|NCT01828593|76284146|FG000|STARTED|Placebo-Free Phase|Placebo subjects took either SBI 2.5 or 5.0 g in the placebo-free phase|0||
60157939|NCT01828593|76284147|FG001|STARTED|Placebo-Free Phase|SBI 2.5 g includes SBI 2.5 plus placebo who started taking SBI at Wk 4|55||
60157940|NCT01828593|76284148|FG002|STARTED|Placebo-Free Phase|SBI 5.0 g includes SBI 5.0 plus placebo who started taking SBI at Wk 4|47||
60157941|NCT01828593|76284146|FG000|COMPLETED|Placebo-Free Phase|Placebo subjects took either SBI 2.5 or 5.0 g in the placebo-free phase|0||
60157942|NCT01828593|76284147|FG001|COMPLETED|Placebo-Free Phase|SBI 2.5 g includes SBI 2.5 plus placebo who started taking SBI at Wk 4|49||
60157943|NCT01828593|76284148|FG002|COMPLETED|Placebo-Free Phase|SBI 5.0 g includes SBI 5.0 plus placebo who started taking SBI at Wk 4|41||
60157944|NCT01828593|76284146|FG000|NOT COMPLETED|Placebo-Free Phase||0||
60157945|NCT01828593|76284147|FG001|NOT COMPLETED|Placebo-Free Phase||6||
60157946|NCT01828593|76284148|FG002|NOT COMPLETED|Placebo-Free Phase||6||
60157947|NCT01828983|76284161|FG000|STARTED|Overall Study||80||
60157948|NCT01828983|76284162|FG001|STARTED|Overall Study||81||
60157949|NCT01828983|76284161|FG000|COMPLETED|Overall Study||80||
60157950|NCT01828983|76284162|FG001|COMPLETED|Overall Study||81||
60157951|NCT01828983|76284161|FG000|NOT COMPLETED|Overall Study||0||
60157952|NCT01828983|76284162|FG001|NOT COMPLETED|Overall Study||0||
60157953|NCT01781169|76284170|FG000|STARTED|Overall Study||22||
60011242|NCT01936948|76127091|FG000|Crossover|Overall Study||31|The number of patients who did not receive their designated intervention (clip/no clip).|
60011243|NCT01936948|76127092|FG001|Crossover|Overall Study||27|The number of patients who did not receive their designated intervention (clip/no clip).|
60011244|NCT01936948|76127093|FG002|Crossover|Overall Study||22|The number of patients who did not receive their designated intervention (clip/no clip).|
60011245|NCT01936948|76127094|FG003|Crossover|Overall Study||25|The number of patients who did not receive their designated intervention (clip/no clip).|
60011246|NCT01936948|76127091|FG000|COMPLETED|Overall Study||227||
60011247|NCT01936948|76127092|FG001|COMPLETED|Overall Study||228||
60011248|NCT01936948|76127093|FG002|COMPLETED|Overall Study||234||
60011249|NCT01936948|76127094|FG003|COMPLETED|Overall Study||230||
60011250|NCT01936948|76127091|FG000|NOT COMPLETED|Overall Study||0||
60011251|NCT01936948|76127092|FG001|NOT COMPLETED|Overall Study||3||
60011252|NCT01936948|76127093|FG002|NOT COMPLETED|Overall Study||3||
60011253|NCT01936948|76127094|FG003|NOT COMPLETED|Overall Study||3||
60011254|NCT01936870|76127102|FG000|STARTED|Overall Study||2492||
60011255|NCT01936870|76127102|FG000|COMPLETED|Overall Study||2303||
60011256|NCT01936870|76127102|FG000|NOT COMPLETED|Overall Study||189||
60011257|NCT01618864|76127106|FG000|STARTED|Overall Study||23||
60011258|NCT01618864|76127106|FG000|Completed 2 Weeks|Overall Study||19||
60011259|NCT01618864|76127106|FG000|COMPLETED|Overall Study|Completed 4 weeks and 8 weeks of treatment|19||
60011260|NCT01618864|76127106|FG000|NOT COMPLETED|Overall Study||4||
60011261|NCT01618708|76127117|FG000|STARTED|Overall Study||175||
60011262|NCT01618708|76127118|FG001|STARTED|Overall Study||182||
60011263|NCT01618708|76127117|FG000|Treated|Overall Study||172||
60011264|NCT01618708|76127118|FG001|Treated|Overall Study||180||
60011265|NCT01618708|76127117|FG000|COMPLETED|Overall Study||131||
60011266|NCT01618708|76127118|FG001|COMPLETED|Overall Study||136||
60011267|NCT01618708|76127117|FG000|NOT COMPLETED|Overall Study||44||
60011268|NCT01618708|76127118|FG001|NOT COMPLETED|Overall Study||46||
60011269|NCT03259295|76127125|FG000|STARTED|Overall Study||20||
60011270|NCT03259295|76127125|FG000|COMPLETED|Overall Study||20||
60011271|NCT03259295|76127125|FG000|NOT COMPLETED|Overall Study||0||
60011272|NCT00790933|76127134|FG000|STARTED|Overall Study||675||
60011273|NCT00790933|76127135|FG001|STARTED|Overall Study||726||
60011274|NCT00790933|76127136|FG002|STARTED|Overall Study||384||
60011275|NCT00790933|76127137|FG003|STARTED|Overall Study||37||
60011276|NCT00790933|76127138|FG004|STARTED|Overall Study||421||
60157954|NCT01781169|76284171|FG001|STARTED|Overall Study||21||
60157955|NCT01781169|76284170|FG000|COMPLETED|Overall Study||21||
60157956|NCT01781169|76284171|FG001|COMPLETED|Overall Study||21||
60157957|NCT01781169|76284170|FG000|NOT COMPLETED|Overall Study||1||
60157958|NCT01781169|76284171|FG001|NOT COMPLETED|Overall Study||0||
60157959|NCT00216125|76284177|FG000|STARTED|Pre-Randomization Phase||243||
60157960|NCT00216125|76284178|FG001|STARTED|Pre-Randomization Phase||0||
60157961|NCT00216125|76284179|FG002|STARTED|Pre-Randomization Phase||0||
60157962|NCT00216125|76284177|FG000|DSMB Cohort for Futility|Pre-Randomization Phase||203||
60157963|NCT00216125|76284178|FG001|DSMB Cohort for Futility|Pre-Randomization Phase||0||
60157964|NCT00216125|76284179|FG002|DSMB Cohort for Futility|Pre-Randomization Phase||0||
60157965|NCT00216125|76284177|FG000|COMPLETED|Pre-Randomization Phase||166||
60157966|NCT00216125|76284178|FG001|COMPLETED|Pre-Randomization Phase||0||
60157967|NCT00216125|76284179|FG002|COMPLETED|Pre-Randomization Phase||0||
60157968|NCT00216125|76284177|FG000|NOT COMPLETED|Pre-Randomization Phase||77||
60157969|NCT00216125|76284178|FG001|NOT COMPLETED|Pre-Randomization Phase||0||
60157970|NCT00216125|76284179|FG002|NOT COMPLETED|Pre-Randomization Phase||0||
60157971|NCT00216125|76284177|FG000|STARTED|Randomization Phase||0||
60157972|NCT00216125|76284178|FG001|STARTED|Randomization Phase||84||
59751764|NCT00842985|75871121|FG000|COMPLETED|Screening||26||
59751765|NCT00842985|75871121|FG000|NOT COMPLETED|Screening||27||
59751766|NCT00842985|75871121|FG000|STARTED|First Intervention|Signed Consent|26||
59751767|NCT00842985|75871121|FG000|COMPLETED|First Intervention|Completed 1st Intervention|20||
59751768|NCT00842985|75871121|FG000|NOT COMPLETED|First Intervention||6||
59751769|NCT00842985|75871121|FG000|STARTED|Washout Period of GE 4 Days||20||
60157973|NCT00216125|76284179|FG002|STARTED|Randomization Phase||82||
60157974|NCT00216125|76284177|FG000|DSMB Cohort for Futility|Randomization Phase||0||
60157975|NCT00216125|76284178|FG001|DSMB Cohort for Futility|Randomization Phase||73||
60157976|NCT00216125|76284179|FG002|DSMB Cohort for Futility|Randomization Phase||74||
60157977|NCT00216125|76284177|FG000|COMPLETED|Randomization Phase||0||
60157978|NCT00216125|76284178|FG001|COMPLETED|Randomization Phase||73||
60157979|NCT00216125|76284179|FG002|COMPLETED|Randomization Phase||74||
60157980|NCT00216125|76284177|FG000|NOT COMPLETED|Randomization Phase||0||
60157981|NCT00216125|76284178|FG001|NOT COMPLETED|Randomization Phase||11||
60157982|NCT00216125|76284179|FG002|NOT COMPLETED|Randomization Phase||8||
60157983|NCT01781403|76284186|FG000|STARTED|Overall Study||2||
60157984|NCT01781403|76284187|FG001|STARTED|Overall Study||2||
60157985|NCT01781403|76284188|FG002|STARTED|Overall Study||18||
60157986|NCT01781403|76284186|FG000|COMPLETED|Overall Study||2||
60157987|NCT01781403|76284187|FG001|COMPLETED|Overall Study||2||
60157988|NCT01781403|76284188|FG002|COMPLETED|Overall Study||18||
60157989|NCT01781403|76284186|FG000|NOT COMPLETED|Overall Study||0||
60157990|NCT01781403|76284187|FG001|NOT COMPLETED|Overall Study||0||
60157991|NCT01781403|76284188|FG002|NOT COMPLETED|Overall Study||0||
60157992|NCT01781481|76284198|FG000|STARTED|Overall Study||148||
60157993|NCT01781481|76284198|FG000|COMPLETED|Overall Study||148||
60157994|NCT01781481|76284198|FG000|NOT COMPLETED|Overall Study||0||
60157995|NCT00218387|76284246|FG000|STARTED|Overall Study||40||
60157996|NCT00218387|76284247|FG001|STARTED|Overall Study||43||
60157997|NCT00218387|76284248|FG002|STARTED|Overall Study||40||
60157998|NCT00218387|76284246|FG000|COMPLETED|Overall Study||25||
60157999|NCT00218387|76284247|FG001|COMPLETED|Overall Study||25||
60158000|NCT00218387|76284248|FG002|COMPLETED|Overall Study||17||
60158001|NCT00218387|76284246|FG000|NOT COMPLETED|Overall Study||15||
60158002|NCT00218387|76284247|FG001|NOT COMPLETED|Overall Study||18||
60158003|NCT00218387|76284248|FG002|NOT COMPLETED|Overall Study||23||
60158004|NCT00218465|76284258|FG000|STARTED|Overall Study||50||
60158005|NCT00218465|76284259|FG001|STARTED|Overall Study||48||
60158006|NCT00218465|76284258|FG000|COMPLETED|Overall Study||33||
60158007|NCT00218465|76284259|FG001|COMPLETED|Overall Study||30||
60158008|NCT00218465|76284258|FG000|NOT COMPLETED|Overall Study||17||
60158009|NCT00218465|76284259|FG001|NOT COMPLETED|Overall Study||18||
60158010|NCT00220961|76284267|FG000|STARTED|Overall Study||299||
60158011|NCT00220961|76284268|FG001|STARTED|Overall Study||303||
60158012|NCT00220961|76284267|FG000|COMPLETED|Overall Study||228||
60158013|NCT00220961|76284268|FG001|COMPLETED|Overall Study||213||
60158014|NCT00220961|76284267|FG000|NOT COMPLETED|Overall Study||71||
60158015|NCT00220961|76284268|FG001|NOT COMPLETED|Overall Study||90||
60158016|NCT00221117|76284276|FG000|STARTED|Overall Study||12||
60158017|NCT00221117|76284277|FG001|STARTED|Overall Study|One participant dropped out of the study after signing consent but prior to baseline assessments.|9||
60158018|NCT00221117|76284276|FG000|COMPLETED|Overall Study||12||
60158019|NCT00221117|76284277|FG001|COMPLETED|Overall Study||9||
60158020|NCT00221117|76284276|FG000|NOT COMPLETED|Overall Study||0||
60158021|NCT00221117|76284277|FG001|NOT COMPLETED|Overall Study||0||
60158022|NCT00222131|76284287|FG000|STARTED|Overall Study||38||
60158023|NCT00222131|76284288|FG001|STARTED|Overall Study||35||
60158024|NCT00222131|76284287|FG000|COMPLETED|Overall Study||38||
60158025|NCT00222131|76284288|FG001|COMPLETED|Overall Study||35||
60158026|NCT00222131|76284287|FG000|NOT COMPLETED|Overall Study||0||
60158027|NCT00222131|76284288|FG001|NOT COMPLETED|Overall Study||0||
60158028|NCT00225017|76284296|FG000|STARTED|Overall Study||26||
60158029|NCT00225017|76284297|FG001|STARTED|Overall Study||24||
60158030|NCT00225017|76284296|FG000|COMPLETED|Overall Study||26||
60158031|NCT00225017|76284297|FG001|COMPLETED|Overall Study|1 subject did not complete week 24 assessments|23||
60158032|NCT00225017|76284296|FG000|NOT COMPLETED|Overall Study||0||
60158033|NCT00225017|76284297|FG001|NOT COMPLETED|Overall Study||1||
60158034|NCT01782963|76284303|FG000|STARTED|Overall Study||50||
60158035|NCT01782963|76284303|FG000|COMPLETED|Overall Study||50||
60158036|NCT01782963|76284303|FG000|NOT COMPLETED|Overall Study||0||
60158037|NCT01829217|76284311|FG000|STARTED|Overall Study||13||
60158038|NCT01829217|76284311|FG000|COMPLETED|Overall Study||13||
60158039|NCT01829217|76284311|FG000|NOT COMPLETED|Overall Study||0||
60158040|NCT02096861|76284319|FG000|STARTED|Overall Study|CT-P13 followed by CT-P13 from Week 30|56||
60158041|NCT02096861|76284320|FG001|STARTED|Overall Study|CT-P13 followed by Remicade from Week 30|55||
60158042|NCT02096861|76284321|FG002|STARTED|Overall Study|Remicade followed by Remicade from Week 30|54||
60158043|NCT02096861|76284322|FG003|STARTED|Overall Study|Remicade followed by CT-P13 from Week 30|55||
60158044|NCT02096861|76284319|FG000|Drug Switching at Week 30|Overall Study||48||
60158045|NCT02096861|76284320|FG001|Drug Switching at Week 30|Overall Study||44||
60158046|NCT02096861|76284321|FG002|Drug Switching at Week 30|Overall Study||41||
60158047|NCT02096861|76284322|FG003|Drug Switching at Week 30|Overall Study||47||
60158048|NCT02096861|76284319|FG000|COMPLETED|Overall Study||44||
60158049|NCT02096861|76284320|FG001|COMPLETED|Overall Study||40||
60158050|NCT02096861|76284321|FG002|COMPLETED|Overall Study||37||
60158051|NCT02096861|76284322|FG003|COMPLETED|Overall Study||45||
60158052|NCT02096861|76284319|FG000|NOT COMPLETED|Overall Study||12||
60158053|NCT02096861|76284320|FG001|NOT COMPLETED|Overall Study||15||
60158054|NCT02096861|76284321|FG002|NOT COMPLETED|Overall Study||17||
60158055|NCT02096861|76284322|FG003|NOT COMPLETED|Overall Study||10||
60158056|NCT01829919|76284334|FG000|STARTED|Overall Study||24||
60158057|NCT01829919|76284334|FG000|COMPLETED|Overall Study||24||
60158058|NCT01829919|76284334|FG000|NOT COMPLETED|Overall Study||0||
60158059|NCT02097485|76284340|FG000|STARTED|Overall Study||25||
60158060|NCT02097485|76284341|FG001|STARTED|Overall Study||25||
60158061|NCT02097485|76284340|FG000|COMPLETED|Overall Study||25||
60158062|NCT02097485|76284341|FG001|COMPLETED|Overall Study||25||
60158063|NCT02097485|76284340|FG000|NOT COMPLETED|Overall Study||0||
60158064|NCT02097485|76284341|FG001|NOT COMPLETED|Overall Study||0||
60158065|NCT01829997|76284347|FG000|STARTED|Overall Study||22||
60158066|NCT01829997|76284347|FG000|COMPLETED|Overall Study||16||
60158067|NCT01829997|76284347|FG000|NOT COMPLETED|Overall Study||6||
60158068|NCT02097641|76284353|FG000|STARTED|Overall Study||40||
60158069|NCT02097641|76284354|FG001|STARTED|Overall Study||20||
60158070|NCT02097641|76284353|FG000|COMPLETED|Overall Study||40||
60158071|NCT02097641|76284354|FG001|COMPLETED|Overall Study||20||
60158072|NCT02097641|76284353|FG000|NOT COMPLETED|Overall Study||0||
60158073|NCT02097641|76284354|FG001|NOT COMPLETED|Overall Study||0||
60158074|NCT00274781|76284362|FG000|STARTED|Overall Study||30||
60158075|NCT00274781|76284362|FG000|COMPLETED|Overall Study||30||
60158076|NCT00274781|76284362|FG000|NOT COMPLETED|Overall Study||0||
60158077|NCT00278525|76284369|FG000|STARTED|Overall Study||9||
60158078|NCT00278525|76284370|FG001|STARTED|Overall Study||10||
60158079|NCT00278525|76284369|FG000|COMPLETED|Overall Study|7 participants crossed to HSCT arm in accordance with the protocol|9||
60158080|NCT00278525|76284370|FG001|COMPLETED|Overall Study|7 participant crossed over to the HSCT arm and underwent HSCT, in accordance with the protocol.|10||
60158081|NCT00278525|76284369|FG000|NOT COMPLETED|Overall Study||0||
60158082|NCT00278525|76284370|FG001|NOT COMPLETED|Overall Study||0||
60158083|NCT00226577|76284376|FG000|STARTED|Overall Study||52||
60158084|NCT00226577|76284376|FG000|COMPLETED|Overall Study||52||
60158085|NCT00226577|76284376|FG000|NOT COMPLETED|Overall Study||0||
60158086|NCT01830699|76284382|FG000|STARTED|Overall Study||13||
60158087|NCT01830699|76284383|FG001|STARTED|Overall Study||20||
60158088|NCT01830699|76284382|FG000|COMPLETED|Overall Study||13||
60158089|NCT01830699|76284383|FG001|COMPLETED|Overall Study||20||
60158090|NCT01830699|76284382|FG000|NOT COMPLETED|Overall Study||0||
60158091|NCT01830699|76284383|FG001|NOT COMPLETED|Overall Study||0||
60158092|NCT00280241|76284389|FG000|STARTED|Overall Study||65||
60158093|NCT00280241|76284389|FG000|COMPLETED|Overall Study||55||
60158094|NCT00280241|76284389|FG000|NOT COMPLETED|Overall Study||10||
60158095|NCT01830933|76284395|FG000|STARTED|Overall Study||823||
60158096|NCT01830933|76284396|FG001|STARTED|Overall Study||812||
60158097|NCT01830933|76284395|FG000|Completed Meet-up|Overall Study||675||
60158098|NCT01830933|76284396|FG001|Completed Meet-up|Overall Study||603||
60158099|NCT01830933|76284395|FG000|COMPLETED|Overall Study||655||
60158100|NCT01830933|76284396|FG001|COMPLETED|Overall Study||580||
60158101|NCT01830933|76284395|FG000|NOT COMPLETED|Overall Study||168||
60158102|NCT01830933|76284396|FG001|NOT COMPLETED|Overall Study||232||
60158103|NCT01784055|76284402|FG000|STARTED|Overall Study||126||
60158104|NCT01784055|76284402|FG000|COMPLETED|Overall Study||100||
60158105|NCT01784055|76284402|FG000|NOT COMPLETED|Overall Study||26||
60158106|NCT00229619|76284406|FG000|STARTED|Overall Study||11||
60158107|NCT00229619|76284406|FG000|COMPLETED|Overall Study||11||
60158108|NCT00229619|76284406|FG000|NOT COMPLETED|Overall Study||0||
60158109|NCT02260401|76284414|FG000|STARTED|Overall Study||80||
60158110|NCT02260401|76284415|FG001|STARTED|Overall Study||85||
60158111|NCT02260401|76284414|FG000|COMPLETED|Overall Study||75||
60158112|NCT02260401|76284415|FG001|COMPLETED|Overall Study||73||
60158113|NCT02260401|76284414|FG000|NOT COMPLETED|Overall Study||5||
60158114|NCT02260401|76284415|FG001|NOT COMPLETED|Overall Study||12||
60158115|NCT00281021|76284421|FG000|STARTED|Overall Study||26||
60158116|NCT00281021|76284421|FG000|COMPLETED|Overall Study||24||
60158117|NCT00281021|76284421|FG000|NOT COMPLETED|Overall Study||2||
60158118|NCT01786161|76284427|FG000|STARTED|Overall Study||22||
60158119|NCT01786161|76284428|FG001|STARTED|Overall Study||22||
60158120|NCT01786161|76284427|FG000|COMPLETED|Overall Study||22||
60158121|NCT01786161|76284428|FG001|COMPLETED|Overall Study||22||
60158122|NCT01786161|76284427|FG000|NOT COMPLETED|Overall Study||0||
60158123|NCT01786161|76284428|FG001|NOT COMPLETED|Overall Study||0||
60158124|NCT00230009|76284438|FG000|STARTED|Single Session Intervention/Control||50||
60158125|NCT00230009|76284439|FG001|STARTED|Single Session Intervention/Control||50||
60158126|NCT00230009|76284438|FG000|COMPLETED|Single Session Intervention/Control||50||
60158127|NCT00230009|76284439|FG001|COMPLETED|Single Session Intervention/Control||50||
60158128|NCT00230009|76284438|FG000|NOT COMPLETED|Single Session Intervention/Control||0||
60158129|NCT00230009|76284439|FG001|NOT COMPLETED|Single Session Intervention/Control||0||
60158130|NCT00230009|76284438|FG000|STARTED|Follow-up||50||
60158131|NCT00230009|76284439|FG001|STARTED|Follow-up||50||
60158132|NCT00230009|76284438|FG000|COMPLETED|Follow-up||19||
60158133|NCT00230009|76284439|FG001|COMPLETED|Follow-up||24||
60158134|NCT00230009|76284438|FG000|NOT COMPLETED|Follow-up||31||
60158135|NCT00230009|76284439|FG001|NOT COMPLETED|Follow-up||26||
60158136|NCT01786239|76284447|FG000|STARTED|Overall Study||25||
60158137|NCT01786239|76284448|FG001|STARTED|Overall Study||25||
60158138|NCT01786239|76284447|FG000|COMPLETED|Overall Study||14||
60158139|NCT01786239|76284448|FG001|COMPLETED|Overall Study||14||
60158140|NCT01786239|76284447|FG000|NOT COMPLETED|Overall Study||11||
60158141|NCT01786239|76284448|FG001|NOT COMPLETED|Overall Study||11||
60158142|NCT00282815|76284456|FG000|STARTED|Overall Study||15||
60158143|NCT00282815|76284457|FG001|STARTED|Overall Study||17||
60158144|NCT00282815|76284456|FG000|COMPLETED|Overall Study||8||
60158145|NCT00282815|76284457|FG001|COMPLETED|Overall Study||11||
60158146|NCT00282815|76284456|FG000|NOT COMPLETED|Overall Study||7||
60158147|NCT00282815|76284457|FG001|NOT COMPLETED|Overall Study||6||
60158148|NCT01787175|76284468|FG000|STARTED|Overall Study||30||
60158149|NCT01787175|76284469|FG001|STARTED|Overall Study||28||
60158150|NCT01787175|76284468|FG000|COMPLETED|Overall Study||30||
60158151|NCT01787175|76284469|FG001|COMPLETED|Overall Study||28||
60158152|NCT01787175|76284468|FG000|NOT COMPLETED|Overall Study||0||
60158153|NCT01787175|76284469|FG001|NOT COMPLETED|Overall Study||0||
60158154|NCT01832259|76284477|FG000|STARTED|Overall Study||15||
60158155|NCT01832259|76284478|FG001|STARTED|Overall Study||15||
60158156|NCT01832259|76284477|FG000|COMPLETED|Overall Study||15||
60158157|NCT01832259|76284478|FG001|COMPLETED|Overall Study||15||
60158158|NCT01832259|76284477|FG000|NOT COMPLETED|Overall Study||0||
60158159|NCT01832259|76284478|FG001|NOT COMPLETED|Overall Study||0||
60158160|NCT01832961|76284484|FG000|STARTED|First Intervention||8||
60158161|NCT01832961|76284485|FG001|STARTED|First Intervention||7||
60158162|NCT01832961|76284484|FG000|COMPLETED|First Intervention||8||
60158163|NCT01832961|76284485|FG001|COMPLETED|First Intervention||7||
60158164|NCT01832961|76284484|FG000|NOT COMPLETED|First Intervention||0||
60158165|NCT01832961|76284485|FG001|NOT COMPLETED|First Intervention||0||
60158166|NCT01832961|76284484|FG000|STARTED|Washout||8||
60158167|NCT01832961|76284485|FG001|STARTED|Washout||7||
60158168|NCT01832961|76284484|FG000|COMPLETED|Washout||8||
60158169|NCT01832961|76284485|FG001|COMPLETED|Washout||7||
60158170|NCT01832961|76284484|FG000|NOT COMPLETED|Washout||0||
60158171|NCT01832961|76284485|FG001|NOT COMPLETED|Washout||0||
60158172|NCT01832961|76284484|FG000|STARTED|Second Intervention||8||
60158173|NCT01832961|76284485|FG001|STARTED|Second Intervention||7||
60158174|NCT01832961|76284484|FG000|COMPLETED|Second Intervention||8||
60011277|NCT00790933|76127134|FG000|COMPLETED|Overall Study||237||
60011278|NCT00790933|76127135|FG001|COMPLETED|Overall Study||246||
60011279|NCT00790933|76127136|FG002|COMPLETED|Overall Study||115||
60011280|NCT00790933|76127137|FG003|COMPLETED|Overall Study||23||
60011281|NCT00790933|76127138|FG004|COMPLETED|Overall Study||145||
60011282|NCT00790933|76127134|FG000|NOT COMPLETED|Overall Study||438||
60011283|NCT00790933|76127135|FG001|NOT COMPLETED|Overall Study||480||
60011284|NCT00790933|76127136|FG002|NOT COMPLETED|Overall Study||269||
60011285|NCT00790933|76127137|FG003|NOT COMPLETED|Overall Study||14||
60011286|NCT00790933|76127138|FG004|NOT COMPLETED|Overall Study||276||
60011287|NCT02161211|76127157|FG000|STARTED|Overall Study||92||
60011288|NCT02161211|76127158|FG001|STARTED|Overall Study||94||
60011289|NCT02161211|76127159|FG002|STARTED|Overall Study||93||
60011290|NCT02161211|76127157|FG000|COMPLETED|Overall Study||59||
60011291|NCT02161211|76127158|FG001|COMPLETED|Overall Study||62||
60011292|NCT02161211|76127159|FG002|COMPLETED|Overall Study||63||
60011293|NCT02161211|76127157|FG000|NOT COMPLETED|Overall Study||33||
60011294|NCT02161211|76127158|FG001|NOT COMPLETED|Overall Study||32||
60011295|NCT02161211|76127159|FG002|NOT COMPLETED|Overall Study||30||
60011296|NCT01676701|76127169|FG000|STARTED|Overall Study||4||
60011297|NCT01676701|76127170|FG001|STARTED|Overall Study||4||
60011298|NCT01676701|76127169|FG000|Received at Least 1 Dose of Study Drug|Overall Study||4||
60011299|NCT01676701|76127170|FG001|Received at Least 1 Dose of Study Drug|Overall Study||4||
60011300|NCT01676701|76127169|FG000|Completed Post-Treatment Follow-Up|Overall Study||4||
60011301|NCT01676701|76127170|FG001|Completed Post-Treatment Follow-Up|Overall Study||4||
60011302|NCT01676701|76127169|FG000|COMPLETED|Overall Study||0||
60158175|NCT01832961|76284485|FG001|COMPLETED|Second Intervention||7||
60158176|NCT01832961|76284484|FG000|NOT COMPLETED|Second Intervention||0||
60158177|NCT01832961|76284485|FG001|NOT COMPLETED|Second Intervention||0||
60011303|NCT01676701|76127170|FG001|COMPLETED|Overall Study||0||
60011304|NCT01676701|76127169|FG000|NOT COMPLETED|Overall Study||4||
60011305|NCT01676701|76127170|FG001|NOT COMPLETED|Overall Study||4||
60011306|NCT01670279|76127181|FG000|STARTED|Overall Study||6||
60011307|NCT01670279|76127182|FG001|STARTED|Overall Study||7||
60011308|NCT01670279|76127183|FG002|STARTED|Overall Study||0||
60011309|NCT01670279|76127184|FG003|STARTED|Overall Study||5||
60011310|NCT01670279|76127181|FG000|COMPLETED|Overall Study||6||
60011311|NCT01670279|76127182|FG001|COMPLETED|Overall Study||5||
60011312|NCT01670279|76127183|FG002|COMPLETED|Overall Study||0||
60011313|NCT01670279|76127184|FG003|COMPLETED|Overall Study||4||
60011314|NCT01670279|76127181|FG000|NOT COMPLETED|Overall Study||0||
60158178|NCT01832961|76284484|FG000|STARTED|Third Intervention||8||
60158179|NCT01832961|76284485|FG001|STARTED|Third Intervention||7||
60158180|NCT01832961|76284484|FG000|COMPLETED|Third Intervention||8||
60158181|NCT01832961|76284485|FG001|COMPLETED|Third Intervention||7||
60158182|NCT01832961|76284484|FG000|NOT COMPLETED|Third Intervention||0||
60158183|NCT01832961|76284485|FG001|NOT COMPLETED|Third Intervention||0||
60158184|NCT01833117|76284502|FG000|STARTED|Overall Study||43||
60158185|NCT01833117|76284503|FG001|STARTED|Overall Study||19||
60158186|NCT01833117|76284502|FG000|COMPLETED|Overall Study||43||
60158187|NCT01833117|76284503|FG001|COMPLETED|Overall Study||19||
60158188|NCT01833117|76284502|FG000|NOT COMPLETED|Overall Study||0||
60158189|NCT01833117|76284503|FG001|NOT COMPLETED|Overall Study||0||
60011315|NCT01670279|76127182|FG001|NOT COMPLETED|Overall Study||2||
60011316|NCT01670279|76127183|FG002|NOT COMPLETED|Overall Study||0||
60011317|NCT01670279|76127184|FG003|NOT COMPLETED|Overall Study||1||
60011318|NCT02627495|76127192|FG000|STARTED|Overall Study||9||
60011319|NCT02627495|76127192|FG000|COMPLETED|Overall Study||5||
60011320|NCT02627495|76127192|FG000|NOT COMPLETED|Overall Study||4||
60011321|NCT01670045|76127196|FG000|STARTED|Overall Study||43||
60011322|NCT01670045|76127196|FG000|COMPLETED|Overall Study||27||
60011323|NCT01670045|76127196|FG000|NOT COMPLETED|Overall Study||16||
60011324|NCT01669421|76127200|FG000|STARTED|Phase 1: Standard Dose Therapy||10||
60158190|NCT01833741|76284509|FG000|STARTED|Overall Study||1137||
60158191|NCT01833741|76284509|FG000|COMPLETED|Overall Study||997||
60158192|NCT01833741|76284509|FG000|NOT COMPLETED|Overall Study||140||
60158193|NCT02261727|76284516|FG000|STARTED|Overall Study||568||
60158194|NCT02261727|76284517|FG001|STARTED|Overall Study||554||
60158195|NCT02261727|76284518|FG002|STARTED|Overall Study||548||
60158196|NCT02261727|76284516|FG000|COMPLETED|Overall Study||411||
60158197|NCT02261727|76284517|FG001|COMPLETED|Overall Study||408||
60011325|NCT01669421|76127200|FG000|COMPLETED|Phase 1: Standard Dose Therapy||8||
60011326|NCT01669421|76127200|FG000|NOT COMPLETED|Phase 1: Standard Dose Therapy||2||
60011327|NCT01669421|76127200|FG000|STARTED|Phase 2: Double Dose Therapy||8||
60011328|NCT01669421|76127200|FG000|COMPLETED|Phase 2: Double Dose Therapy||8||
60011329|NCT01669421|76127200|FG000|NOT COMPLETED|Phase 2: Double Dose Therapy||0||
60011330|NCT01669421|76127200|FG000|STARTED|Phase 3: Standard Dose Therapy||8||
60011331|NCT01669421|76127200|FG000|COMPLETED|Phase 3: Standard Dose Therapy||8||
60011332|NCT01669421|76127200|FG000|NOT COMPLETED|Phase 3: Standard Dose Therapy||0||
60158198|NCT02261727|76284518|FG002|COMPLETED|Overall Study||423||
59605870|NCT01945242|75716058|FG001|NOT COMPLETED|Overall Study||3||
59605871|NCT01945086|75716068|FG000|STARTED|Overall Study||27||
59605872|NCT01945086|75716069|FG001|STARTED|Overall Study||24||
59605873|NCT01945086|75716070|FG002|STARTED|Overall Study||28||
59605874|NCT01945086|75716068|FG000|COMPLETED|Overall Study||26||
59605875|NCT01945086|75716069|FG001|COMPLETED|Overall Study||24||
59605876|NCT01945086|75716070|FG002|COMPLETED|Overall Study||26||
59605877|NCT01945086|75716068|FG000|NOT COMPLETED|Overall Study||1||
59605878|NCT01945086|75716069|FG001|NOT COMPLETED|Overall Study||0||
59605879|NCT01945086|75716070|FG002|NOT COMPLETED|Overall Study||2||
60158199|NCT02261727|76284516|FG000|NOT COMPLETED|Overall Study||157||
60158200|NCT02261727|76284517|FG001|NOT COMPLETED|Overall Study||146||
59605880|NCT01963728|75716080|FG000|STARTED|Overall Study||0||
59605881|NCT01963728|75716081|FG001|STARTED|Overall Study||1||
60011333|NCT01671059|76127214|FG000|STARTED|Overall Study||80||
60011334|NCT01671059|76127214|FG000|COMPLETED|Overall Study||75||
60011335|NCT01671059|76127214|FG000|NOT COMPLETED|Overall Study||5||
60011336|NCT04342169|76127221|FG000|STARTED|Overall Study||185||
60011337|NCT04342169|76127222|FG001|STARTED|Overall Study||183||
60158201|NCT02261727|76284518|FG002|NOT COMPLETED|Overall Study||125||
60158202|NCT02261805|76284526|FG000|STARTED|Overall Study||3||
60158203|NCT02261805|76284527|FG001|STARTED|Overall Study||6||
60158204|NCT02261805|76284528|FG002|STARTED|Overall Study||2||
60158205|NCT02261805|76284526|FG000|COMPLETED|Overall Study||3||
60158206|NCT02261805|76284527|FG001|COMPLETED|Overall Study||6||
60158207|NCT02261805|76284528|FG002|COMPLETED|Overall Study||2||
59751770|NCT00842985|75871121|FG000|COMPLETED|Washout Period of GE 4 Days||18||
59751771|NCT00842985|75871121|FG000|NOT COMPLETED|Washout Period of GE 4 Days||2||
59751772|NCT00842985|75871121|FG000|STARTED|Second Intervention||18||
59751773|NCT00842985|75871121|FG000|COMPLETED|Second Intervention||17||
60158208|NCT02261805|76284526|FG000|NOT COMPLETED|Overall Study||0||
60158209|NCT02261805|76284527|FG001|NOT COMPLETED|Overall Study||0||
60158210|NCT02261805|76284528|FG002|NOT COMPLETED|Overall Study||0||
60158211|NCT02261961|76284536|FG000|STARTED|Overall Study||22||
60158212|NCT02261961|76284537|FG001|STARTED|Overall Study||22||
60158213|NCT02261961|76284536|FG000|COMPLETED|Overall Study||13||
60158214|NCT02261961|76284537|FG001|COMPLETED|Overall Study|One subject listed as completed who withdrew but finished training phase and has usable data.|20||
60158215|NCT02261961|76284536|FG000|NOT COMPLETED|Overall Study||9||
60158216|NCT02261961|76284537|FG001|NOT COMPLETED|Overall Study||2||
60158217|NCT01835379|76284556|FG000|STARTED|Overall Study||41||
60158218|NCT01835379|76284557|FG001|STARTED|Overall Study||41||
60158219|NCT01835379|76284556|FG000|COMPLETED|Overall Study||41||
60158220|NCT01835379|76284557|FG001|COMPLETED|Overall Study||41||
60158221|NCT01835379|76284556|FG000|NOT COMPLETED|Overall Study||0||
60158222|NCT01835379|76284557|FG001|NOT COMPLETED|Overall Study||0||
60158223|NCT00232505|76284565|FG000|STARTED|Overall Study||31||
60158224|NCT00232505|76284566|FG001|STARTED|Overall Study||71||
60158225|NCT00232505|76284565|FG000|Not Evaluable|Overall Study||0||
60158226|NCT00232505|76284566|FG001|Not Evaluable|Overall Study||6||
60158227|NCT00232505|76284565|FG000|Early Progressors|Overall Study||2||
60158228|NCT00232505|76284566|FG001|Early Progressors|Overall Study||5||
60158229|NCT00232505|76284565|FG000|Off Protocol|Overall Study||5||
60158230|NCT00232505|76284566|FG001|Off Protocol|Overall Study||0||
60158231|NCT00232505|76284565|FG000|COMPLETED|Overall Study||26||
60158232|NCT00232505|76284566|FG001|COMPLETED|Overall Study||60||
60158233|NCT00232505|76284565|FG000|NOT COMPLETED|Overall Study||5||
60158234|NCT00232505|76284566|FG001|NOT COMPLETED|Overall Study||11||
60158235|NCT01787799|76284576|FG000|STARTED|Overall Study||100||
60158236|NCT01787799|76284576|FG000|COMPLETED|Overall Study||100||
60158237|NCT01787799|76284576|FG000|NOT COMPLETED|Overall Study||0||
60158238|NCT00232583|76284582|FG000|STARTED|Overall Study||29||
60158239|NCT00232583|76284583|FG001|STARTED|Overall Study||29||
60158240|NCT00232583|76284582|FG000|COMPLETED|Overall Study||19||
60158241|NCT00232583|76284583|FG001|COMPLETED|Overall Study||16||
60158242|NCT00232583|76284582|FG000|NOT COMPLETED|Overall Study||10||
60158243|NCT00232583|76284583|FG001|NOT COMPLETED|Overall Study||13||
60158244|NCT00232739|76284593|FG000|STARTED|Overall Study||100||
60158245|NCT00232739|76284593|FG000|COMPLETED|Overall Study||91||
60158246|NCT00232739|76284593|FG000|NOT COMPLETED|Overall Study||9||
60158247|NCT01789905|76284597|FG000|STARTED|Overall Study||116||
60158248|NCT01789905|76284597|FG000|COMPLETED|Overall Study||116||
60158249|NCT01789905|76284597|FG000|NOT COMPLETED|Overall Study||0||
60158250|NCT01790685|76284603|FG000|STARTED|Overall Study||23||
60158251|NCT01790685|76284604|FG001|STARTED|Overall Study||17||
60158252|NCT01790685|76284603|FG000|COMPLETED|Overall Study||23||
60158253|NCT01790685|76284604|FG001|COMPLETED|Overall Study||17||
60158254|NCT01790685|76284603|FG000|NOT COMPLETED|Overall Study||0||
60158255|NCT01790685|76284604|FG001|NOT COMPLETED|Overall Study||0||
60158256|NCT00233519|76284612|FG000|STARTED|Overall Study||7||
60158257|NCT00233519|76284613|FG001|STARTED|Overall Study||10||
60158258|NCT00233519|76284612|FG000|COMPLETED|Overall Study||6||
60158259|NCT00233519|76284613|FG001|COMPLETED|Overall Study||9||
60158260|NCT00233519|76284612|FG000|NOT COMPLETED|Overall Study||1||
60158261|NCT00233519|76284613|FG001|NOT COMPLETED|Overall Study||1||
60158262|NCT01435772|76284622|FG000|STARTED|Overall Study||3||
60158263|NCT01435772|76284623|FG001|STARTED|Overall Study||3||
60158264|NCT01435772|76284624|FG002|STARTED|Overall Study||15||
60158265|NCT01435772|76284622|FG000|COMPLETED|Overall Study||0||
60158266|NCT01435772|76284623|FG001|COMPLETED|Overall Study||0||
60158267|NCT01435772|76284624|FG002|COMPLETED|Overall Study||0||
60158268|NCT01435772|76284622|FG000|NOT COMPLETED|Overall Study||3||
60158269|NCT01435772|76284623|FG001|NOT COMPLETED|Overall Study||3||
60158270|NCT01435772|76284624|FG002|NOT COMPLETED|Overall Study||15||
60158271|NCT01838655|76284633|FG000|STARTED|Overall Study||5||
60158272|NCT01838655|76284633|FG000|COMPLETED|Overall Study||5||
60158273|NCT01838655|76284633|FG000|NOT COMPLETED|Overall Study||0||
60158274|NCT00050089|76284641|FG000|STARTED|Overall Study||106||
60158275|NCT00050089|76284642|FG001|STARTED|Overall Study||98||
60158276|NCT00050089|76284643|FG002|STARTED|Overall Study||86||
60158277|NCT00050089|76284644|FG003|STARTED|Overall Study||78||
60158278|NCT00050089|76284641|FG000|Baseline|Overall Study|15 participants randomized in the UK Option scheme (not displayed in the 2X2 baseline data)|91||
60158279|NCT00050089|76284642|FG001|Baseline|Overall Study|14 participants randomized in the UK Option scheme (not shown in 2X2 baseline data)|84||
60158280|NCT00050089|76284643|FG002|Baseline|Overall Study||86||
60158281|NCT00050089|76284644|FG003|Baseline|Overall Study||78||
60158282|NCT00050089|76284641|FG000|COMPLETED|Overall Study|For primary outcome assessment|106||
60158283|NCT00050089|76284642|FG001|COMPLETED|Overall Study|For primary outcome assessment|98||
60158284|NCT00050089|76284643|FG002|COMPLETED|Overall Study|For primary outcome assessment|86||
60158285|NCT00050089|76284644|FG003|COMPLETED|Overall Study|For primary outcome assessment|78||
60158286|NCT00050089|76284641|FG000|NOT COMPLETED|Overall Study||0||
60158287|NCT00050089|76284642|FG001|NOT COMPLETED|Overall Study||0||
60158288|NCT00050089|76284643|FG002|NOT COMPLETED|Overall Study||0||
60158289|NCT00050089|76284644|FG003|NOT COMPLETED|Overall Study||0||
60158290|NCT00282971|76284660|FG000|STARTED|Overall Study||180||
60158291|NCT00282971|76284661|FG001|STARTED|Overall Study||171||
60158292|NCT00282971|76284660|FG000|COMPLETED|Overall Study||146||
60158293|NCT00282971|76284661|FG001|COMPLETED|Overall Study||149||
60158294|NCT00282971|76284660|FG000|NOT COMPLETED|Overall Study||34||
60158295|NCT00282971|76284661|FG001|NOT COMPLETED|Overall Study||22||
60158296|NCT01791465|76284667|FG000|STARTED|Overall Study||6||
60158297|NCT01791465|76284667|FG000|COMPLETED|Overall Study||6||
60158298|NCT01791465|76284667|FG000|NOT COMPLETED|Overall Study||0||
60158299|NCT00283283|76284676|FG000|STARTED|Overall Study||274||
60158300|NCT00283283|76284677|FG001|STARTED|Overall Study||284||
60158301|NCT00283283|76284678|FG002|STARTED|Overall Study||280||
60158302|NCT00283283|76284679|FG003|STARTED|Overall Study||276||
60158303|NCT00283283|76284676|FG000|COMPLETED|Overall Study||274||
60158304|NCT00283283|76284677|FG001|COMPLETED|Overall Study||284||
60158305|NCT00283283|76284678|FG002|COMPLETED|Overall Study||280||
60158306|NCT00283283|76284679|FG003|COMPLETED|Overall Study||276||
60158307|NCT00283283|76284676|FG000|NOT COMPLETED|Overall Study||0||
60158308|NCT00283283|76284677|FG001|NOT COMPLETED|Overall Study||0||
60158309|NCT00283283|76284678|FG002|NOT COMPLETED|Overall Study||0||
60158310|NCT00283283|76284679|FG003|NOT COMPLETED|Overall Study||0||
60158311|NCT00285467|76284696|FG000|STARTED|Overall Study||25||
60158312|NCT00285467|76284697|FG001|STARTED|Overall Study||22||
60158313|NCT00285467|76284696|FG000|COMPLETED|Overall Study||25||
60158314|NCT00285467|76284697|FG001|COMPLETED|Overall Study||22||
60158315|NCT00285467|76284696|FG000|NOT COMPLETED|Overall Study||0||
60158316|NCT00285467|76284697|FG001|NOT COMPLETED|Overall Study||0||
60158317|NCT00281671|76284703|FG000|STARTED|Overall Study||5||
60158318|NCT00281671|76284704|FG001|STARTED|Overall Study||4||
59882389|NCT03253094|76005311|FG003|STARTED|Overall Study||32||
59882390|NCT03253094|76005312|FG004|STARTED|Overall Study||32||
59882391|NCT03253094|76005313|FG005|STARTED|Overall Study||32||
59882392|NCT03253094|76005308|FG000|Subjects Discontinued|Overall Study||4||
60158319|NCT00281671|76284703|FG000|COMPLETED|Overall Study||5||
60158320|NCT00281671|76284704|FG001|COMPLETED|Overall Study||4||
60158321|NCT00281671|76284703|FG000|NOT COMPLETED|Overall Study||0||
60158322|NCT00281671|76284704|FG001|NOT COMPLETED|Overall Study||0||
59882393|NCT03253094|76005309|FG001|Subjects Discontinued|Overall Study||3||
59882394|NCT03253094|76005310|FG002|Subjects Discontinued|Overall Study||6||
59882395|NCT03253094|76005311|FG003|Subjects Discontinued|Overall Study||4||
60158323|NCT01794039|76284715|FG000|STARTED|Overall Study||5||
60158324|NCT01794039|76284716|FG001|STARTED|Overall Study||4||
60158325|NCT01794039|76284715|FG000|COMPLETED|Overall Study||5||
60158326|NCT01794039|76284716|FG001|COMPLETED|Overall Study||4||
60158327|NCT01794039|76284715|FG000|NOT COMPLETED|Overall Study||0||
60158328|NCT01794039|76284716|FG001|NOT COMPLETED|Overall Study||0||
60158329|NCT00281827|76284724|FG000|STARTED|Overall Study||22||
60158330|NCT00281827|76284724|FG000|COMPLETED|Overall Study|All patients received 3 cycles of therapy; 2 did not receive all 3 thalidomide cycles|22||
60158331|NCT00281827|76284724|FG000|NOT COMPLETED|Overall Study||0||
60158332|NCT00235547|76284732|FG000|STARTED|2 Month Follow-up Survey||154||
60158333|NCT00235547|76284733|FG001|STARTED|2 Month Follow-up Survey||144||
60158334|NCT00235547|76284732|FG000|COMPLETED|2 Month Follow-up Survey||108||
60158335|NCT00235547|76284733|FG001|COMPLETED|2 Month Follow-up Survey||104||
60158336|NCT00235547|76284732|FG000|NOT COMPLETED|2 Month Follow-up Survey||46||
60158337|NCT00235547|76284733|FG001|NOT COMPLETED|2 Month Follow-up Survey||40||
60158338|NCT00235547|76284732|FG000|STARTED|6 Month Follow-up Survey||154||
60158339|NCT00235547|76284733|FG001|STARTED|6 Month Follow-up Survey||144||
60158340|NCT00235547|76284732|FG000|COMPLETED|6 Month Follow-up Survey||83||
60158341|NCT00235547|76284733|FG001|COMPLETED|6 Month Follow-up Survey||76||
60158342|NCT00235547|76284732|FG000|NOT COMPLETED|6 Month Follow-up Survey||71||
60158343|NCT00235547|76284733|FG001|NOT COMPLETED|6 Month Follow-up Survey||68||
60158344|NCT00282841|76284739|FG000|STARTED|Overall Study|Anticipated recruitment 400; stopped due to funding and poor recruitment.|61||
60158345|NCT00282841|76284739|FG000|COMPLETED|Overall Study||61||
60158346|NCT00282841|76284739|FG000|NOT COMPLETED|Overall Study||0||
60158347|NCT00283075|76284744|FG000|STARTED|Overall Study||25||
60158348|NCT00283075|76284745|FG001|STARTED|Overall Study||6||
60158349|NCT00283075|76284744|FG000|COMPLETED|Overall Study||25||
60158350|NCT00283075|76284745|FG001|COMPLETED|Overall Study||6||
60158351|NCT00283075|76284744|FG000|NOT COMPLETED|Overall Study||0||
60158352|NCT00283075|76284745|FG001|NOT COMPLETED|Overall Study||0||
60158353|NCT01794741|76284758|FG000|STARTED|Overall Study||304||
60158354|NCT01794741|76284759|FG001|STARTED|Overall Study||101||
60158355|NCT01794741|76284758|FG000|COMPLETED|Overall Study||285||
60158356|NCT01794741|76284759|FG001|COMPLETED|Overall Study||92||
60158357|NCT01794741|76284758|FG000|NOT COMPLETED|Overall Study||19||
60158358|NCT01794741|76284759|FG001|NOT COMPLETED|Overall Study||9||
60158359|NCT00283933|76284765|FG000|STARTED|Treatment Period||5||
60158360|NCT00283933|76284765|FG000|Safety Population|Treatment Period||5|Received at least 1 dose of study drug|
60158361|NCT00283933|76284765|FG000|Pharmacodynamic (PD) Population|Treatment Period||5|Received study drug and had at least 1 non-missing postbaseline PD parameter recorded|
60158362|NCT00283933|76284765|FG000|COMPLETED|Treatment Period||5||
60158363|NCT00283933|76284765|FG000|NOT COMPLETED|Treatment Period||0||
60158364|NCT00283933|76284765|FG000|STARTED|Extension Period||5||
60158365|NCT00283933|76284765|FG000|COMPLETED|Extension Period||5||
60158366|NCT00283933|76284765|FG000|NOT COMPLETED|Extension Period||0||
60158367|NCT01795833|76284773|FG000|STARTED|Overall Study||1031||
60158368|NCT01795833|76284774|FG001|STARTED|Overall Study||1031||
60158369|NCT01795833|76284773|FG000|COMPLETED|Overall Study||881||
60158370|NCT01795833|76284774|FG001|COMPLETED|Overall Study||882||
60158371|NCT01795833|76284773|FG000|NOT COMPLETED|Overall Study||150||
60158372|NCT01795833|76284774|FG001|NOT COMPLETED|Overall Study||149||
60158373|NCT01841619|76284780|FG000|STARTED|Overall Study||16||
60158374|NCT01841619|76284780|FG000|COMPLETED|Overall Study||16||
60158375|NCT01841619|76284780|FG000|NOT COMPLETED|Overall Study||0||
60158376|NCT00284557|76284786|FG000|STARTED|Overall Study||67||
60158377|NCT00284557|76284787|FG001|STARTED|Overall Study||63||
60158378|NCT00284557|76284786|FG000|COMPLETED|Overall Study||58||
60158379|NCT00284557|76284787|FG001|COMPLETED|Overall Study||50||
60158380|NCT00284557|76284786|FG000|NOT COMPLETED|Overall Study||9||
60158381|NCT00284557|76284787|FG001|NOT COMPLETED|Overall Study||13||
60158382|NCT02263131|76284795|FG000|STARTED|Overall Study||347||
60158383|NCT02263131|76284796|FG001|STARTED|Overall Study||69||
60158384|NCT02263131|76284795|FG000|COMPLETED|Overall Study||337||
60158385|NCT02263131|76284796|FG001|COMPLETED|Overall Study||68||
60158386|NCT02263131|76284795|FG000|NOT COMPLETED|Overall Study||10||
60158387|NCT02263131|76284796|FG001|NOT COMPLETED|Overall Study||1||
60158388|NCT02033005|76284805|FG000|STARTED|Overall Study||80||
60158389|NCT02033005|76284806|FG001|STARTED|Overall Study||9||
60158390|NCT02033005|76284807|FG002|STARTED|Overall Study||35||
60158391|NCT02033005|76284805|FG000|COMPLETED|Overall Study||36||
60158392|NCT02033005|76284806|FG001|COMPLETED|Overall Study||9||
60158393|NCT02033005|76284807|FG002|COMPLETED|Overall Study||25||
60158394|NCT02033005|76284805|FG000|NOT COMPLETED|Overall Study||44||
60158395|NCT02033005|76284806|FG001|NOT COMPLETED|Overall Study||0||
60158396|NCT02033005|76284807|FG002|NOT COMPLETED|Overall Study||10||
60158397|NCT02263833|76284816|FG000|STARTED|Overall Study||742||
60158398|NCT02263833|76284816|FG000|COMPLETED|Overall Study||742||
60158399|NCT02263833|76284816|FG000|NOT COMPLETED|Overall Study||0||
60158400|NCT02263911|76284820|FG000|STARTED|Period 1||4||
60158401|NCT02263911|76284821|FG001|STARTED|Period 1||4||
60158402|NCT02263911|76284822|FG002|STARTED|Period 1||4||
60158403|NCT02263911|76284823|FG003|STARTED|Period 1||4||
60158404|NCT02263911|76284820|FG000|COMPLETED|Period 1||4||
60158405|NCT02263911|76284821|FG001|COMPLETED|Period 1||4||
60158406|NCT02263911|76284822|FG002|COMPLETED|Period 1||4||
60158407|NCT02263911|76284823|FG003|COMPLETED|Period 1||4||
60158408|NCT02263911|76284820|FG000|NOT COMPLETED|Period 1||0||
60158409|NCT02263911|76284821|FG001|NOT COMPLETED|Period 1||0||
60158410|NCT02263911|76284822|FG002|NOT COMPLETED|Period 1||0||
60158411|NCT02263911|76284823|FG003|NOT COMPLETED|Period 1||0||
60158412|NCT02263911|76284820|FG000|STARTED|Period 1 Washout||4||
60158413|NCT02263911|76284821|FG001|STARTED|Period 1 Washout||4||
60158414|NCT02263911|76284822|FG002|STARTED|Period 1 Washout||4||
60158415|NCT02263911|76284823|FG003|STARTED|Period 1 Washout||4||
60158416|NCT02263911|76284820|FG000|COMPLETED|Period 1 Washout||4||
60158417|NCT02263911|76284821|FG001|COMPLETED|Period 1 Washout||4||
60158418|NCT02263911|76284822|FG002|COMPLETED|Period 1 Washout||4||
60158419|NCT02263911|76284823|FG003|COMPLETED|Period 1 Washout||4||
60158420|NCT02263911|76284820|FG000|NOT COMPLETED|Period 1 Washout||0||
60158421|NCT02263911|76284821|FG001|NOT COMPLETED|Period 1 Washout||0||
60158422|NCT02263911|76284822|FG002|NOT COMPLETED|Period 1 Washout||0||
60158423|NCT02263911|76284823|FG003|NOT COMPLETED|Period 1 Washout||0||
60158424|NCT02263911|76284820|FG000|STARTED|Period 2||4||
60158425|NCT02263911|76284821|FG001|STARTED|Period 2||4||
60158426|NCT02263911|76284822|FG002|STARTED|Period 2||4||
60158427|NCT02263911|76284823|FG003|STARTED|Period 2||4||
60158428|NCT02263911|76284820|FG000|COMPLETED|Period 2||4||
60158429|NCT02263911|76284821|FG001|COMPLETED|Period 2||4||
60158430|NCT02263911|76284822|FG002|COMPLETED|Period 2||4||
60158431|NCT02263911|76284823|FG003|COMPLETED|Period 2||4||
60158432|NCT02263911|76284820|FG000|NOT COMPLETED|Period 2||0||
60158433|NCT02263911|76284821|FG001|NOT COMPLETED|Period 2||0||
60158434|NCT02263911|76284822|FG002|NOT COMPLETED|Period 2||0||
60158435|NCT02263911|76284823|FG003|NOT COMPLETED|Period 2||0||
60158436|NCT02263911|76284820|FG000|STARTED|Period 2 Washout||4||
60158437|NCT02263911|76284821|FG001|STARTED|Period 2 Washout||4||
60158438|NCT02263911|76284822|FG002|STARTED|Period 2 Washout||4||
60158439|NCT02263911|76284823|FG003|STARTED|Period 2 Washout||4||
60158440|NCT02263911|76284820|FG000|COMPLETED|Period 2 Washout||4||
60158441|NCT02263911|76284821|FG001|COMPLETED|Period 2 Washout||4||
60158442|NCT02263911|76284822|FG002|COMPLETED|Period 2 Washout||4||
60158443|NCT02263911|76284823|FG003|COMPLETED|Period 2 Washout||4||
60158444|NCT02263911|76284820|FG000|NOT COMPLETED|Period 2 Washout||0||
60158445|NCT02263911|76284821|FG001|NOT COMPLETED|Period 2 Washout||0||
60158446|NCT02263911|76284822|FG002|NOT COMPLETED|Period 2 Washout||0||
60158447|NCT02263911|76284823|FG003|NOT COMPLETED|Period 2 Washout||0||
60158448|NCT02263911|76284820|FG000|STARTED|Period 3||4||
60158449|NCT02263911|76284821|FG001|STARTED|Period 3||4||
60158450|NCT02263911|76284822|FG002|STARTED|Period 3||4||
60158451|NCT02263911|76284823|FG003|STARTED|Period 3||4||
60158452|NCT02263911|76284820|FG000|COMPLETED|Period 3||4||
60158453|NCT02263911|76284821|FG001|COMPLETED|Period 3||4||
60158454|NCT02263911|76284822|FG002|COMPLETED|Period 3||4||
60158455|NCT02263911|76284823|FG003|COMPLETED|Period 3||4||
60158456|NCT02263911|76284820|FG000|NOT COMPLETED|Period 3||0||
60158457|NCT02263911|76284821|FG001|NOT COMPLETED|Period 3||0||
60158458|NCT02263911|76284822|FG002|NOT COMPLETED|Period 3||0||
60158459|NCT02263911|76284823|FG003|NOT COMPLETED|Period 3||0||
60158460|NCT02263911|76284820|FG000|STARTED|Period 3 Washout||4||
60158461|NCT02263911|76284821|FG001|STARTED|Period 3 Washout||4||
60158462|NCT02263911|76284822|FG002|STARTED|Period 3 Washout||4||
60158463|NCT02263911|76284823|FG003|STARTED|Period 3 Washout||4||
60158464|NCT02263911|76284820|FG000|COMPLETED|Period 3 Washout||4||
60158465|NCT02263911|76284821|FG001|COMPLETED|Period 3 Washout||4||
60158466|NCT02263911|76284822|FG002|COMPLETED|Period 3 Washout||4||
60158467|NCT02263911|76284823|FG003|COMPLETED|Period 3 Washout||4||
60158468|NCT02263911|76284820|FG000|NOT COMPLETED|Period 3 Washout||0||
60158469|NCT02263911|76284821|FG001|NOT COMPLETED|Period 3 Washout||0||
60158470|NCT02263911|76284822|FG002|NOT COMPLETED|Period 3 Washout||0||
60158471|NCT02263911|76284823|FG003|NOT COMPLETED|Period 3 Washout||0||
60158472|NCT02263911|76284820|FG000|STARTED|Period 4||4||
60158473|NCT02263911|76284821|FG001|STARTED|Period 4||4||
60158474|NCT02263911|76284822|FG002|STARTED|Period 4||4||
60158475|NCT02263911|76284823|FG003|STARTED|Period 4||4||
60158476|NCT02263911|76284820|FG000|COMPLETED|Period 4||4||
60158477|NCT02263911|76284821|FG001|COMPLETED|Period 4||4||
60158478|NCT02263911|76284822|FG002|COMPLETED|Period 4||4||
60158479|NCT02263911|76284823|FG003|COMPLETED|Period 4||4||
60158480|NCT02263911|76284820|FG000|NOT COMPLETED|Period 4||0||
59605882|NCT01963728|75716080|FG000|COMPLETED|Overall Study|study terminated early|0||
59751774|NCT00842985|75871121|FG000|NOT COMPLETED|Second Intervention||1||
59751775|NCT00842985|75871121|FG000|STARTED|Washout Period of GE 4 Days||17||
59751776|NCT00842985|75871121|FG000|COMPLETED|Washout Period of GE 4 Days||15||
59751777|NCT00842985|75871121|FG000|NOT COMPLETED|Washout Period of GE 4 Days||2||
59751778|NCT00842985|75871121|FG000|STARTED|Third Intervention||15||
59882396|NCT03253094|76005312|FG004|Subjects Discontinued|Overall Study||5||
60158481|NCT02263911|76284821|FG001|NOT COMPLETED|Period 4||0||
60158482|NCT02263911|76284822|FG002|NOT COMPLETED|Period 4||0||
60158483|NCT02263911|76284823|FG003|NOT COMPLETED|Period 4||0||
60158484|NCT02263911|76284820|FG000|STARTED|Period 4 Washout||4||
60158485|NCT02263911|76284821|FG001|STARTED|Period 4 Washout||4||
60158486|NCT02263911|76284822|FG002|STARTED|Period 4 Washout||4||
60158487|NCT02263911|76284823|FG003|STARTED|Period 4 Washout||4||
60158488|NCT02263911|76284820|FG000|COMPLETED|Period 4 Washout||4||
60158489|NCT02263911|76284821|FG001|COMPLETED|Period 4 Washout||4||
60158490|NCT02263911|76284822|FG002|COMPLETED|Period 4 Washout||4||
60158491|NCT02263911|76284823|FG003|COMPLETED|Period 4 Washout||4||
60158492|NCT02263911|76284820|FG000|NOT COMPLETED|Period 4 Washout||0||
60158493|NCT02263911|76284821|FG001|NOT COMPLETED|Period 4 Washout||0||
60158494|NCT02263911|76284822|FG002|NOT COMPLETED|Period 4 Washout||0||
60158495|NCT02263911|76284823|FG003|NOT COMPLETED|Period 4 Washout||0||
60158496|NCT02263911|76284820|FG000|STARTED|Period 5||4||
60158497|NCT02263911|76284821|FG001|STARTED|Period 5||4||
60158498|NCT02263911|76284822|FG002|STARTED|Period 5||4||
60158499|NCT02263911|76284823|FG003|STARTED|Period 5||4||
60158500|NCT02263911|76284820|FG000|COMPLETED|Period 5||4||
60158501|NCT02263911|76284821|FG001|COMPLETED|Period 5||4||
60158502|NCT02263911|76284822|FG002|COMPLETED|Period 5||4||
60158503|NCT02263911|76284823|FG003|COMPLETED|Period 5||4||
60158504|NCT02263911|76284820|FG000|NOT COMPLETED|Period 5||0||
60158505|NCT02263911|76284821|FG001|NOT COMPLETED|Period 5||0||
60158506|NCT02263911|76284822|FG002|NOT COMPLETED|Period 5||0||
60158507|NCT02263911|76284823|FG003|NOT COMPLETED|Period 5||0||
60158508|NCT00052429|76284837|FG000|STARTED|Overall Study||25||
60158509|NCT00052429|76284837|FG000|COMPLETED|Overall Study||25||
60158510|NCT00052429|76284837|FG000|NOT COMPLETED|Overall Study||0||
60158511|NCT01435616|76284843|FG000|STARTED|Overall Study||1003||
60158512|NCT01435616|76284844|FG001|STARTED|Overall Study||535||
60158513|NCT01435616|76284843|FG000|Received at Least 1 Dose of Study Drug|Overall Study||1003||
60158514|NCT01435616|76284844|FG001|Received at Least 1 Dose of Study Drug|Overall Study||535||
60158515|NCT01435616|76284843|FG000|COMPLETED|Overall Study||832||
60158516|NCT01435616|76284844|FG001|COMPLETED|Overall Study||455||
60158517|NCT01435616|76284843|FG000|NOT COMPLETED|Overall Study||171||
60158518|NCT01435616|76284844|FG001|NOT COMPLETED|Overall Study||80||
60158519|NCT03972397|76284854|FG000|STARTED|Overall Study||10||
60158520|NCT03972397|76284855|FG001|STARTED|Overall Study||10||
60158521|NCT03972397|76284854|FG000|COMPLETED|Overall Study||10||
60158522|NCT03972397|76284855|FG001|COMPLETED|Overall Study||10||
60158523|NCT03972397|76284854|FG000|NOT COMPLETED|Overall Study||0||
60158524|NCT03972397|76284855|FG001|NOT COMPLETED|Overall Study||0||
60158525|NCT01797159|76284861|FG000|STARTED|Overall Study||20||
60158526|NCT01797159|76284861|FG000|COMPLETED|Overall Study||20||
60158527|NCT01797159|76284861|FG000|NOT COMPLETED|Overall Study||0||
60158528|NCT01797471|76284866|FG000|STARTED|Overall Study||1||
60158529|NCT01797471|76284866|FG000|COMPLETED|Overall Study||1||
60158530|NCT01797471|76284866|FG000|NOT COMPLETED|Overall Study||0||
60158531|NCT00286741|76284872|FG000|STARTED|Overall Study||133||
59605883|NCT01963728|75716081|FG001|COMPLETED|Overall Study|study terminated early|0||
59605884|NCT01963728|75716080|FG000|NOT COMPLETED|Overall Study||0||
59605885|NCT01963728|75716081|FG001|NOT COMPLETED|Overall Study||1||
59751779|NCT00842985|75871121|FG000|COMPLETED|Third Intervention||15||
59605886|NCT01963260|75716097|FG000|STARTED|Overall Study||6||
59882397|NCT03253094|76005313|FG005|Subjects Discontinued|Overall Study||4||
60158532|NCT00286741|76284873|FG001|STARTED|Overall Study||106||
60158533|NCT00286741|76284872|FG000|COMPLETED|Overall Study||122||
60158534|NCT00286741|76284873|FG001|COMPLETED|Overall Study||89||
60158535|NCT00286741|76284872|FG000|NOT COMPLETED|Overall Study||11||
60158536|NCT00286741|76284873|FG001|NOT COMPLETED|Overall Study||17||
60158537|NCT00287053|76284884|FG000|STARTED|Overall Study||30||
60158538|NCT00287053|76284885|FG001|STARTED|Overall Study||27||
60158539|NCT00287053|76284884|FG000|COMPLETED|Overall Study||26||
60158540|NCT00287053|76284885|FG001|COMPLETED|Overall Study||26||
60158541|NCT00287053|76284884|FG000|NOT COMPLETED|Overall Study||4||
60158542|NCT00287053|76284885|FG001|NOT COMPLETED|Overall Study||1||
59605887|NCT01963260|75716098|FG001|STARTED|Overall Study||6||
59751780|NCT00842985|75871121|FG000|NOT COMPLETED|Third Intervention||0||
59882398|NCT03253094|76005308|FG000|COMPLETED|Overall Study||28||
60158543|NCT01842789|76284893|FG000|STARTED|Overall Study||10||
60158544|NCT01842789|76284894|FG001|STARTED|Overall Study||8||
60158545|NCT01842789|76284893|FG000|COMPLETED|Overall Study||10||
60158546|NCT01842789|76284894|FG001|COMPLETED|Overall Study||8||
60158547|NCT01842789|76284893|FG000|NOT COMPLETED|Overall Study||0||
60158548|NCT01842789|76284894|FG001|NOT COMPLETED|Overall Study||0||
60158549|NCT01435460|76284903|FG000|STARTED|Overall Study||151||
60158550|NCT01435460|76284904|FG001|STARTED|Overall Study||149||
60158551|NCT01435460|76284903|FG000|COMPLETED|Overall Study||140||
60158552|NCT01435460|76284904|FG001|COMPLETED|Overall Study||143||
60158553|NCT01435460|76284903|FG000|NOT COMPLETED|Overall Study||11||
60158554|NCT01435460|76284904|FG001|NOT COMPLETED|Overall Study||6||
60158555|NCT00236951|76284914|FG000|STARTED|Overall Study||59||
60158556|NCT00236951|76284915|FG001|STARTED|Overall Study||77||
60158557|NCT00236951|76284916|FG002|STARTED|Overall Study||40||
60158558|NCT00236951|76284917|FG003|STARTED|Overall Study||48||
60158559|NCT00236951|76284914|FG000|COMPLETED|Overall Study||33||
60158560|NCT00236951|76284915|FG001|COMPLETED|Overall Study||46||
60158561|NCT00236951|76284916|FG002|COMPLETED|Overall Study||21||
60158562|NCT00236951|76284917|FG003|COMPLETED|Overall Study||17||
60158563|NCT00236951|76284914|FG000|NOT COMPLETED|Overall Study||26||
60158564|NCT00236951|76284915|FG001|NOT COMPLETED|Overall Study||31||
60158565|NCT00236951|76284916|FG002|NOT COMPLETED|Overall Study||19||
60158566|NCT00236951|76284917|FG003|NOT COMPLETED|Overall Study||31||
60158567|NCT00287287|76284927|FG000|STARTED|Overall Study||25||
60158568|NCT00287287|76284927|FG000|COMPLETED|Overall Study||25||
60158569|NCT00287287|76284927|FG000|NOT COMPLETED|Overall Study||0||
60158570|NCT01844193|76284933|FG000|STARTED|Overall Study||19||
60158571|NCT01844193|76284934|FG001|STARTED|Overall Study||21||
60158572|NCT01844193|76284933|FG000|COMPLETED|Overall Study||13||
60158573|NCT01844193|76284934|FG001|COMPLETED|Overall Study||15||
60158574|NCT01844193|76284933|FG000|NOT COMPLETED|Overall Study||6||
60158575|NCT01844193|76284934|FG001|NOT COMPLETED|Overall Study||6||
60158576|NCT00287989|76284943|FG000|STARTED|Overall Study||28||
60158577|NCT00287989|76284944|FG001|STARTED|Overall Study||29||
60158578|NCT00287989|76284945|FG002|STARTED|Overall Study||29||
60158579|NCT00287989|76284943|FG000|COMPLETED|Overall Study||28||
60158580|NCT00287989|76284944|FG001|COMPLETED|Overall Study||29||
60158581|NCT00287989|76284945|FG002|COMPLETED|Overall Study||29||
60158582|NCT00287989|76284943|FG000|NOT COMPLETED|Overall Study||0||
60158583|NCT00287989|76284944|FG001|NOT COMPLETED|Overall Study||0||
60158584|NCT00287989|76284945|FG002|NOT COMPLETED|Overall Study||0||
60158585|NCT01798641|76284955|FG000|STARTED|First Intervention (6 Weeks)||19||
60158586|NCT01798641|76284956|FG001|STARTED|First Intervention (6 Weeks)||19||
60158587|NCT01798641|76284955|FG000|COMPLETED|First Intervention (6 Weeks)||19||
60158588|NCT01798641|76284956|FG001|COMPLETED|First Intervention (6 Weeks)||19||
60158589|NCT01798641|76284955|FG000|NOT COMPLETED|First Intervention (6 Weeks)||0||
60158590|NCT01798641|76284956|FG001|NOT COMPLETED|First Intervention (6 Weeks)||0||
60158591|NCT01798641|76284955|FG000|STARTED|Second Intervention (6 Weeks)||19||
60158592|NCT01798641|76284956|FG001|STARTED|Second Intervention (6 Weeks)||19||
60158593|NCT01798641|76284955|FG000|COMPLETED|Second Intervention (6 Weeks)||19||
60158594|NCT01798641|76284956|FG001|COMPLETED|Second Intervention (6 Weeks)||19||
60158595|NCT01798641|76284955|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0||
60158596|NCT01798641|76284956|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||0||
60158597|NCT00288067|76284963|FG000|STARTED|Overall Study||32||
60158598|NCT00288067|76284963|FG000|COMPLETED|Overall Study||32||
60158599|NCT00288067|76284963|FG000|NOT COMPLETED|Overall Study||0||
60158600|NCT00285779|76284971|FG000|STARTED|Placebo-controlled Period (wk 1-12)||14||
60158601|NCT00285779|76284972|FG001|STARTED|Placebo-controlled Period (wk 1-12)||13||
60158602|NCT00285779|76284971|FG000|COMPLETED|Placebo-controlled Period (wk 1-12)||11||
60158603|NCT00285779|76284972|FG001|COMPLETED|Placebo-controlled Period (wk 1-12)||12||
60158604|NCT00285779|76284971|FG000|NOT COMPLETED|Placebo-controlled Period (wk 1-12)||3||
60158605|NCT00285779|76284972|FG001|NOT COMPLETED|Placebo-controlled Period (wk 1-12)||1||
60158606|NCT00285779|76284971|FG000|STARTED|Open Label Period (wk 12-24)||11||
60158607|NCT00285779|76284972|FG001|STARTED|Open Label Period (wk 12-24)||12||
60158608|NCT00285779|76284971|FG000|COMPLETED|Open Label Period (wk 12-24)||9||
60158609|NCT00285779|76284972|FG001|COMPLETED|Open Label Period (wk 12-24)||10||
60158610|NCT00285779|76284971|FG000|NOT COMPLETED|Open Label Period (wk 12-24)||2||
60158611|NCT00285779|76284972|FG001|NOT COMPLETED|Open Label Period (wk 12-24)||2||
60158612|NCT00285779|76284971|FG000|STARTED|Follow-up Period (wk 24-32)||9||
60158613|NCT00285779|76284972|FG001|STARTED|Follow-up Period (wk 24-32)||10||
60158614|NCT00285779|76284971|FG000|COMPLETED|Follow-up Period (wk 24-32)||8||
60158615|NCT00285779|76284972|FG001|COMPLETED|Follow-up Period (wk 24-32)||10||
60158616|NCT00285779|76284971|FG000|NOT COMPLETED|Follow-up Period (wk 24-32)||1||
60158617|NCT00285779|76284972|FG001|NOT COMPLETED|Follow-up Period (wk 24-32)||0||
60158618|NCT02104141|76284978|FG000|STARTED|Overall Study||51||
60158619|NCT02104141|76284978|FG000|COMPLETED|Overall Study||51||
60158620|NCT02104141|76284978|FG000|NOT COMPLETED|Overall Study||0||
60158621|NCT02104219|76284982|FG000|STARTED|Overall Study||32||
60158622|NCT02104219|76284982|FG000|COMPLETED|Overall Study||32||
60158623|NCT02104219|76284982|FG000|NOT COMPLETED|Overall Study||0||
60158624|NCT01435382|76284990|FG000|STARTED|Overall Study||12||
60158625|NCT01435382|76284991|FG001|STARTED|Overall Study||13||
60158626|NCT01435382|76284992|FG002|STARTED|Overall Study||13||
60158627|NCT01435382|76284993|FG003|STARTED|Overall Study||11||
60158628|NCT01435382|76284990|FG000|COMPLETED|Overall Study||11||
60158629|NCT01435382|76284991|FG001|COMPLETED|Overall Study||11||
60158630|NCT01435382|76284992|FG002|COMPLETED|Overall Study||12||
60158631|NCT01435382|76284993|FG003|COMPLETED|Overall Study||10||
60158632|NCT01435382|76284990|FG000|NOT COMPLETED|Overall Study||1||
60158633|NCT01435382|76284991|FG001|NOT COMPLETED|Overall Study||2||
60158634|NCT01435382|76284992|FG002|NOT COMPLETED|Overall Study||1||
60158635|NCT01435382|76284993|FG003|NOT COMPLETED|Overall Study||1||
60158636|NCT01801449|76285009|FG000|STARTED|Overall Study||6||
60158637|NCT01801449|76285009|FG000|COMPLETED|Overall Study||6||
60158638|NCT01801449|76285009|FG000|NOT COMPLETED|Overall Study||0||
60158639|NCT00286325|76285014|FG000|STARTED|Overall Study||8||
60158640|NCT00286325|76285014|FG000|COMPLETED|Overall Study||8||
60158641|NCT00286325|76285014|FG000|NOT COMPLETED|Overall Study||0||
60158642|NCT00289315|76285021|FG000|STARTED|Overall Study||713||
60158643|NCT00289315|76285022|FG001|STARTED|Overall Study||760||
60158644|NCT00289315|76285023|FG002|STARTED|Overall Study||587||
60158645|NCT00289315|76285021|FG000|COMPLETED|Overall Study||612||
60158646|NCT00289315|76285022|FG001|COMPLETED|Overall Study||638||
60158647|NCT00289315|76285023|FG002|COMPLETED|Overall Study||447||
60158648|NCT00289315|76285021|FG000|NOT COMPLETED|Overall Study||101||
60158649|NCT00289315|76285022|FG001|NOT COMPLETED|Overall Study||122||
60158650|NCT00289315|76285023|FG002|NOT COMPLETED|Overall Study||140||
60158651|NCT00238355|76285031|FG000|STARTED|Overall Study||13||
60158652|NCT00238355|76285031|FG000|COMPLETED|Overall Study||10||
60158653|NCT00238355|76285031|FG000|NOT COMPLETED|Overall Study||3||
60158654|NCT01802151|76285039|FG000|STARTED|Overall Study||20||
60158655|NCT01802151|76285040|FG001|STARTED|Overall Study||21||
60158656|NCT01802151|76285041|FG002|STARTED|Overall Study||22||
60158657|NCT01802151|76285042|FG003|STARTED|Overall Study||20||
60158658|NCT01802151|76285039|FG000|COMPLETED|Overall Study|Participants were enrolled and randomized in five waves. The final wave's data collection ended 9/20|20||
60158659|NCT01802151|76285040|FG001|COMPLETED|Overall Study|Participants were enrolled and randomized in five waves. The final wave's data collection ended 9/20|21||
60158660|NCT01802151|76285041|FG002|COMPLETED|Overall Study|Participants were enrolled and randomized in five waves. The final wave's data collection ended 9/20|20||
60158661|NCT01802151|76285042|FG003|COMPLETED|Overall Study|Participants were enrolled and randomized in five waves. The final wave's data collection ended 9/20|20||
60158662|NCT01802151|76285039|FG000|NOT COMPLETED|Overall Study||0||
60158663|NCT01802151|76285040|FG001|NOT COMPLETED|Overall Study||0||
60158664|NCT01802151|76285041|FG002|NOT COMPLETED|Overall Study||2||
60158665|NCT01802151|76285042|FG003|NOT COMPLETED|Overall Study||0||
60158666|NCT00289471|76285052|FG000|STARTED|Overall Study||630||
60158667|NCT00289471|76285052|FG000|COMPLETED|Overall Study||630||
60158668|NCT00289471|76285052|FG000|NOT COMPLETED|Overall Study||0||
60158669|NCT01414166|76285058|FG000|STARTED|Overall Study||122||
60158670|NCT01414166|76285059|FG001|STARTED|Overall Study||122||
60158671|NCT01414166|76285058|FG000|Treated|Overall Study||120||
60158672|NCT01414166|76285059|FG001|Treated|Overall Study||121||
60158673|NCT01414166|76285058|FG000|COMPLETED|Overall Study||31||
60158674|NCT01414166|76285059|FG001|COMPLETED|Overall Study||39||
60158675|NCT01414166|76285058|FG000|NOT COMPLETED|Overall Study||91||
60158676|NCT01414166|76285059|FG001|NOT COMPLETED|Overall Study||83||
60158677|NCT01434680|76285069|FG000|STARTED|Overall Study||299||
60158678|NCT01434680|76285070|FG001|STARTED|Overall Study||268||
60158679|NCT01434680|76285071|FG002|STARTED|Overall Study||306||
60158680|NCT01434680|76285072|FG003|STARTED|Overall Study||119||
60158681|NCT01434680|76285069|FG000|COMPLETED|Overall Study||296||
60158682|NCT01434680|76285070|FG001|COMPLETED|Overall Study||266||
60158683|NCT01434680|76285071|FG002|COMPLETED|Overall Study||304||
60158684|NCT01434680|76285072|FG003|COMPLETED|Overall Study||119||
60158685|NCT01434680|76285069|FG000|NOT COMPLETED|Overall Study||3||
60158686|NCT01434680|76285070|FG001|NOT COMPLETED|Overall Study||2||
60158687|NCT01434680|76285071|FG002|NOT COMPLETED|Overall Study||2||
60158688|NCT01434680|76285072|FG003|NOT COMPLETED|Overall Study||0||
60158689|NCT00290329|76285085|FG000|STARTED|Overall Study||102||
60158690|NCT00290329|76285086|FG001|STARTED|Overall Study||86||
60158691|NCT00290329|76285087|FG002|STARTED|Overall Study||61||
60158692|NCT00290329|76285085|FG000|COMPLETED|Overall Study||102||
60158693|NCT00290329|76285086|FG001|COMPLETED|Overall Study||86||
60158694|NCT00290329|76285087|FG002|COMPLETED|Overall Study||61||
60158695|NCT00290329|76285085|FG000|NOT COMPLETED|Overall Study||0||
60158696|NCT00290329|76285086|FG001|NOT COMPLETED|Overall Study||0||
60158697|NCT00290329|76285087|FG002|NOT COMPLETED|Overall Study||0||
60158698|NCT00286949|76285097|FG000|STARTED|Overall Study||12||
60158699|NCT00286949|76285097|FG000|COMPLETED|Overall Study||12||
60158700|NCT00286949|76285097|FG000|NOT COMPLETED|Overall Study||0||
60158701|NCT00291343|76285105|FG000|STARTED|Overall Study||203||
60158702|NCT00291343|76285106|FG001|STARTED|Overall Study||93||
60158703|NCT00291343|76285105|FG000|COMPLETED|Overall Study||203||
60158704|NCT00291343|76285106|FG001|COMPLETED|Overall Study||93||
60158705|NCT00291343|76285105|FG000|NOT COMPLETED|Overall Study||0||
60158706|NCT00291343|76285106|FG001|NOT COMPLETED|Overall Study||0||
60158707|NCT00287339|76285114|FG000|STARTED|Overall Study||22||
60158708|NCT00287339|76285115|FG001|STARTED|Overall Study||18||
60158709|NCT00287339|76285114|FG000|COMPLETED|Overall Study||22||
60158710|NCT00287339|76285115|FG001|COMPLETED|Overall Study||18||
60158711|NCT00287339|76285114|FG000|NOT COMPLETED|Overall Study||0||
60158712|NCT00287339|76285115|FG001|NOT COMPLETED|Overall Study||0||
60158713|NCT00291655|76285121|FG000|STARTED|Overall Study||130||
60158714|NCT00291655|76285121|FG000|COMPLETED|Overall Study||115||
60158715|NCT00291655|76285121|FG000|NOT COMPLETED|Overall Study||15||
60158716|NCT01846455|76285130|FG000|STARTED|Overall Study||9||
60158717|NCT01846455|76285131|FG001|STARTED|Overall Study||8||
60158718|NCT01846455|76285132|FG002|STARTED|Overall Study||8||
60158719|NCT01846455|76285133|FG003|STARTED|Overall Study||10||
60158720|NCT01846455|76285134|FG004|STARTED|Overall Study||8||
60158721|NCT01846455|76285130|FG000|PK Population|Overall Study||6||
60158722|NCT01846455|76285131|FG001|PK Population|Overall Study||7||
60158723|NCT01846455|76285132|FG002|PK Population|Overall Study||6||
60158724|NCT01846455|76285133|FG003|PK Population|Overall Study||6||
60158725|NCT01846455|76285134|FG004|PK Population|Overall Study||8||
60158726|NCT01846455|76285130|FG000|COMPLETED|Overall Study||9||
60158727|NCT01846455|76285131|FG001|COMPLETED|Overall Study||8||
60158728|NCT01846455|76285132|FG002|COMPLETED|Overall Study||8||
60158729|NCT01846455|76285133|FG003|COMPLETED|Overall Study||10||
60158730|NCT01846455|76285134|FG004|COMPLETED|Overall Study||8||
60158731|NCT01846455|76285130|FG000|NOT COMPLETED|Overall Study||0||
60158732|NCT01846455|76285131|FG001|NOT COMPLETED|Overall Study||0||
60158733|NCT01846455|76285132|FG002|NOT COMPLETED|Overall Study||0||
60158734|NCT01846455|76285133|FG003|NOT COMPLETED|Overall Study||0||
60158735|NCT01846455|76285134|FG004|NOT COMPLETED|Overall Study||0||
60158736|NCT00292591|76285149|FG000|STARTED|Overall Study||166||
60158737|NCT00292591|76285150|FG001|STARTED|Overall Study||167||
60158738|NCT00292591|76285151|FG002|STARTED|Overall Study||168||
60158739|NCT00292591|76285149|FG000|COMPLETED|Overall Study||102||
60158740|NCT00292591|76285150|FG001|COMPLETED|Overall Study||111||
60158741|NCT00292591|76285151|FG002|COMPLETED|Overall Study||110||
60158742|NCT00292591|76285149|FG000|NOT COMPLETED|Overall Study||64||
60158743|NCT00292591|76285150|FG001|NOT COMPLETED|Overall Study||56||
60158744|NCT00292591|76285151|FG002|NOT COMPLETED|Overall Study||58||
60158745|NCT01847001|76285159|FG000|STARTED|Overall Study||10||
60158746|NCT01847001|76285159|FG000|COMPLETED|Overall Study||10||
60158747|NCT01847001|76285159|FG000|NOT COMPLETED|Overall Study||0||
60158748|NCT01847469|76285166|FG000|STARTED|Overall Study||18||
60158749|NCT01847469|76285167|FG001|STARTED|Overall Study||6||
60158750|NCT01847469|76285166|FG000|COMPLETED|Overall Study||9||
60158751|NCT01847469|76285167|FG001|COMPLETED|Overall Study||3||
60158752|NCT01847469|76285166|FG000|NOT COMPLETED|Overall Study||9||
60158753|NCT01847469|76285167|FG001|NOT COMPLETED|Overall Study||3||
60158754|NCT01804101|76285175|FG000|STARTED|Overall Study||38||
60158755|NCT01804101|76285176|FG001|STARTED|Overall Study||10||
60158756|NCT01804101|76285175|FG000|COMPLETED|Overall Study||38||
60158757|NCT01804101|76285176|FG001|COMPLETED|Overall Study||10||
60158758|NCT01804101|76285175|FG000|NOT COMPLETED|Overall Study||0||
60158759|NCT01804101|76285176|FG001|NOT COMPLETED|Overall Study||0||
60158760|NCT01847547|76285186|FG000|STARTED|Overall Study||2991||
60158761|NCT01847547|76285187|FG001|STARTED|Overall Study||2991||
60158762|NCT01847547|76285186|FG000|COMPLETED|Overall Study||2991||
60158763|NCT01847547|76285187|FG001|COMPLETED|Overall Study||2991||
60158764|NCT01847547|76285186|FG000|NOT COMPLETED|Overall Study||0||
60158765|NCT01847547|76285187|FG001|NOT COMPLETED|Overall Study||0||
60158766|NCT00287729|76285196|FG000|STARTED|Overall Study||171||
60158767|NCT00287729|76285197|FG001|STARTED|Overall Study||173||
60158768|NCT00287729|76285196|FG000|COMPLETED|Overall Study||137||
60158769|NCT00287729|76285197|FG001|COMPLETED|Overall Study||142||
60158770|NCT00287729|76285196|FG000|NOT COMPLETED|Overall Study||34||
60158771|NCT00287729|76285197|FG001|NOT COMPLETED|Overall Study||31||
60158772|NCT01433978|76285205|FG000|STARTED|Core Study||11||
60158773|NCT01433978|76285206|FG001|STARTED|Core Study||12||
60158774|NCT01433978|76285207|FG002|STARTED|Core Study||0||
60158775|NCT01433978|76285205|FG000|COMPLETED|Core Study||0||
60158776|NCT01433978|76285206|FG001|COMPLETED|Core Study||1||
60158777|NCT01433978|76285207|FG002|COMPLETED|Core Study||0||
60158778|NCT01433978|76285205|FG000|NOT COMPLETED|Core Study||11||
60158779|NCT01433978|76285206|FG001|NOT COMPLETED|Core Study||11||
60158780|NCT01433978|76285207|FG002|NOT COMPLETED|Core Study||0||
60158781|NCT01433978|76285205|FG000|STARTED|Extension Phase||0||
60158782|NCT01433978|76285206|FG001|STARTED|Extension Phase||0||
60158783|NCT01433978|76285207|FG002|STARTED|Extension Phase||6||
60158784|NCT01433978|76285205|FG000|COMPLETED|Extension Phase||0||
60158785|NCT01433978|76285206|FG001|COMPLETED|Extension Phase||0||
60158786|NCT01433978|76285207|FG002|COMPLETED|Extension Phase||0||
60158787|NCT01433978|76285205|FG000|NOT COMPLETED|Extension Phase||0||
60158788|NCT01433978|76285206|FG001|NOT COMPLETED|Extension Phase||0||
60158789|NCT01433978|76285207|FG002|NOT COMPLETED|Extension Phase||6||
60158790|NCT01804257|76285214|FG000|STARTED|Overall Study||28||
60158791|NCT01804257|76285214|FG000|COMPLETED|Overall Study||27||
60158792|NCT01804257|76285214|FG000|NOT COMPLETED|Overall Study||1||
60158793|NCT00289211|76285221|FG000|STARTED|Overall Study||36||
60158794|NCT00289211|76285222|FG001|STARTED|Overall Study||35||
60158795|NCT00289211|76285223|FG002|STARTED|Overall Study||12||
60158796|NCT00289211|76285221|FG000|COMPLETED|Overall Study||36||
60158797|NCT00289211|76285222|FG001|COMPLETED|Overall Study||34||
60158798|NCT00289211|76285223|FG002|COMPLETED|Overall Study||2||
60158799|NCT00289211|76285221|FG000|NOT COMPLETED|Overall Study||0||
60158800|NCT00289211|76285222|FG001|NOT COMPLETED|Overall Study||1||
60158801|NCT00289211|76285223|FG002|NOT COMPLETED|Overall Study||10||
60158802|NCT01804881|76285231|FG000|STARTED|Overall Study||16||
60158803|NCT01804881|76285232|FG001|STARTED|Overall Study||14||
60158804|NCT01804881|76285231|FG000|COMPLETED|Overall Study||11||
60158805|NCT01804881|76285232|FG001|COMPLETED|Overall Study||10||
60158806|NCT01804881|76285231|FG000|NOT COMPLETED|Overall Study||5||
60158807|NCT01804881|76285232|FG001|NOT COMPLETED|Overall Study||4||
60158808|NCT02267577|76285240|FG000|STARTED|Overall Study||85||
60158809|NCT02267577|76285240|FG000|COMPLETED|Overall Study||81||
60158810|NCT02267577|76285240|FG000|NOT COMPLETED|Overall Study||4||
60158811|NCT02267811|76285247|FG000|STARTED|Overall Study||16||
60158812|NCT02267811|76285248|FG001|STARTED|Overall Study||17||
60158813|NCT02267811|76285247|FG000|COMPLETED|Overall Study||15||
60158814|NCT02267811|76285248|FG001|COMPLETED|Overall Study||15||
60158815|NCT02267811|76285247|FG000|NOT COMPLETED|Overall Study||1||
60158816|NCT02267811|76285248|FG001|NOT COMPLETED|Overall Study||2||
60158817|NCT01433354|76285256|FG000|STARTED|Overall Study|120 enrolled of which 119 were administered drug|119||
60158818|NCT01433354|76285256|FG000|COMPLETED|Overall Study||0||
60158819|NCT01433354|76285256|FG000|NOT COMPLETED|Overall Study||119||
60158820|NCT04430283|76285273|FG000|STARTED|Overall Study||2||
60158821|NCT04430283|76285274|FG001|STARTED|Overall Study||2||
60158822|NCT04430283|76285275|FG002|STARTED|Overall Study||4||
60158823|NCT04430283|76285273|FG000|COMPLETED|Overall Study||0||
60158824|NCT04430283|76285274|FG001|COMPLETED|Overall Study||0||
60158825|NCT04430283|76285275|FG002|COMPLETED|Overall Study||0||
60158826|NCT04430283|76285273|FG000|NOT COMPLETED|Overall Study||2||
60158827|NCT04430283|76285274|FG001|NOT COMPLETED|Overall Study||2||
60158828|NCT04430283|76285275|FG002|NOT COMPLETED|Overall Study||4||
60158829|NCT00240539|76285287|FG000|STARTED|Overall Study||2||
60158830|NCT00240539|76285288|FG001|STARTED|Overall Study||2||
60158831|NCT00240539|76285289|FG002|STARTED|Overall Study||31||
60158832|NCT00240539|76285290|FG003|STARTED|Overall Study||1||
60158833|NCT00240539|76285287|FG000|COMPLETED|Overall Study||2||
60158834|NCT00240539|76285288|FG001|COMPLETED|Overall Study||2||
60158835|NCT00240539|76285289|FG002|COMPLETED|Overall Study||31||
60158836|NCT00240539|76285290|FG003|COMPLETED|Overall Study||1||
60158837|NCT00240539|76285287|FG000|NOT COMPLETED|Overall Study||0||
60158838|NCT00240539|76285288|FG001|NOT COMPLETED|Overall Study||0||
60158839|NCT00240539|76285289|FG002|NOT COMPLETED|Overall Study||0||
60158840|NCT00240539|76285290|FG003|NOT COMPLETED|Overall Study||0||
60158841|NCT00295009|76285306|FG000|STARTED|Overall Study||93||
60158842|NCT00295009|76285307|FG001|STARTED|Overall Study||183||
60158843|NCT00295009|76285308|FG002|STARTED|Overall Study||51||
60158844|NCT00295009|76285309|FG003|STARTED|Overall Study||82||
60158845|NCT00295009|76285310|FG004|STARTED|Overall Study||174||
60158846|NCT00295009|76285311|FG005|STARTED|Overall Study||269||
60158847|NCT00295009|76285306|FG000|Treated|Overall Study||80||
60158848|NCT00295009|76285307|FG001|Treated|Overall Study||162||
60158849|NCT00295009|76285308|FG002|Treated|Overall Study||50||
60158850|NCT00295009|76285309|FG003|Treated|Overall Study||72||
60158851|NCT00295009|76285310|FG004|Treated|Overall Study||165||
60158852|NCT00295009|76285311|FG005|Treated|Overall Study||259||
60158853|NCT00295009|76285306|FG000|Completed 24 Month Analysis|Overall Study||71||
60158854|NCT00295009|76285307|FG001|Completed 24 Month Analysis|Overall Study||148||
60158855|NCT00295009|76285308|FG002|Completed 24 Month Analysis|Overall Study||45||
60158856|NCT00295009|76285309|FG003|Completed 24 Month Analysis|Overall Study||60||
60158857|NCT00295009|76285310|FG004|Completed 24 Month Analysis|Overall Study||133||
60158858|NCT00295009|76285311|FG005|Completed 24 Month Analysis|Overall Study||198||
60158859|NCT00295009|76285306|FG000|COMPLETED|Overall Study|Completed 60 month visit|52||
60158860|NCT00295009|76285307|FG001|COMPLETED|Overall Study|Completed 60 month visit|134||
60158861|NCT00295009|76285308|FG002|COMPLETED|Overall Study|Completed 60 month visit|39||
60158862|NCT00295009|76285309|FG003|COMPLETED|Overall Study|Completed 60 month visit|57||
60158863|NCT00295009|76285310|FG004|COMPLETED|Overall Study|Completed 60 month visit|116||
60158864|NCT00295009|76285311|FG005|COMPLETED|Overall Study|Continued Access patients were only followed out to 24 months|0||
60158865|NCT00295009|76285306|FG000|NOT COMPLETED|Overall Study||41||
60158866|NCT00295009|76285307|FG001|NOT COMPLETED|Overall Study||49||
60158867|NCT00295009|76285308|FG002|NOT COMPLETED|Overall Study||12||
60158868|NCT00295009|76285309|FG003|NOT COMPLETED|Overall Study||25||
60158869|NCT00295009|76285310|FG004|NOT COMPLETED|Overall Study||58||
60158870|NCT00295009|76285311|FG005|NOT COMPLETED|Overall Study||269||
60158871|NCT00289757|76285325|FG000|STARTED|Overall Study||78||
60158872|NCT00289757|76285325|FG000|COMPLETED|Overall Study||78||
60158873|NCT00289757|76285325|FG000|NOT COMPLETED|Overall Study||0||
60158874|NCT01849419|76285329|FG000|STARTED|Overall Study||65||
60158875|NCT01849419|76285329|FG000|COMPLETED|Overall Study||65||
60158876|NCT01849419|76285329|FG000|NOT COMPLETED|Overall Study||0||
60158877|NCT00295867|76285334|FG000|STARTED|Overall Study||45||
60158878|NCT00295867|76285334|FG000|COMPLETED|Overall Study||34||
60158879|NCT00295867|76285334|FG000|NOT COMPLETED|Overall Study||11||
60158880|NCT01850745|76285341|FG000|STARTED|Overall Study||147||
60158881|NCT01850745|76285342|FG001|STARTED|Overall Study||169||
60158882|NCT01850745|76285343|FG002|STARTED|Overall Study||131||
60158883|NCT01850745|76285341|FG000|COMPLETED|Overall Study||147||
60158884|NCT01850745|76285342|FG001|COMPLETED|Overall Study||169||
60158885|NCT01850745|76285343|FG002|COMPLETED|Overall Study||131||
60158886|NCT01850745|76285341|FG000|NOT COMPLETED|Overall Study||0||
60158887|NCT01850745|76285342|FG001|NOT COMPLETED|Overall Study||0||
60158888|NCT01850745|76285343|FG002|NOT COMPLETED|Overall Study||0||
60158889|NCT02271477|76285353|FG000|STARTED|Overall Study||80||
60158890|NCT02271477|76285354|FG001|STARTED|Overall Study||80||
60158891|NCT02271477|76285353|FG000|COMPLETED|Overall Study||80||
60158892|NCT02271477|76285354|FG001|COMPLETED|Overall Study||80||
60158893|NCT02271477|76285353|FG000|NOT COMPLETED|Overall Study||0||
60158894|NCT02271477|76285354|FG001|NOT COMPLETED|Overall Study||0||
60158895|NCT01852383|76285361|FG000|STARTED|Overall Study||30||
60158896|NCT01852383|76285361|FG000|COMPLETED|Overall Study||19||
60158897|NCT01852383|76285361|FG000|NOT COMPLETED|Overall Study||11||
60158898|NCT02273115|76285370|FG000|STARTED|Overall Study||94||
60158899|NCT02273115|76285371|FG001|STARTED|Overall Study||90||
60158900|NCT02273115|76285372|FG002|STARTED|Overall Study||67||
60158901|NCT02273115|76285373|FG003|STARTED|Overall Study||72||
60158902|NCT02273115|76285370|FG000|COMPLETED|Overall Study||94||
60158903|NCT02273115|76285371|FG001|COMPLETED|Overall Study||90||
60158904|NCT02273115|76285372|FG002|COMPLETED|Overall Study||67||
60158905|NCT02273115|76285373|FG003|COMPLETED|Overall Study||71||
60158906|NCT02273115|76285370|FG000|NOT COMPLETED|Overall Study||0||
60158907|NCT02273115|76285371|FG001|NOT COMPLETED|Overall Study||0||
60158908|NCT02273115|76285372|FG002|NOT COMPLETED|Overall Study||0||
60158909|NCT02273115|76285373|FG003|NOT COMPLETED|Overall Study||1||
60158910|NCT01853085|76285383|FG000|STARTED|Overall Study||1830||
60158911|NCT01853085|76285383|FG000|COMPLETED|Overall Study||1595||
60158912|NCT01853085|76285383|FG000|NOT COMPLETED|Overall Study||235||
60158913|NCT01853553|76285389|FG000|STARTED|Overall Study||29||
60158914|NCT01853553|76285390|FG001|STARTED|Overall Study||32||
60158915|NCT01853553|76285389|FG000|COMPLETED|Overall Study||28||
60158916|NCT01853553|76285390|FG001|COMPLETED|Overall Study||32||
60158917|NCT01853553|76285389|FG000|NOT COMPLETED|Overall Study||1||
60158918|NCT01853553|76285390|FG001|NOT COMPLETED|Overall Study||0||
60158919|NCT00290147|76285398|FG000|STARTED|Overall Study||10||
60158920|NCT00290147|76285399|FG001|STARTED|Overall Study||12||
60158921|NCT00290147|76285398|FG000|COMPLETED|Overall Study||10||
60158922|NCT00290147|76285399|FG001|COMPLETED|Overall Study||12||
60158923|NCT00290147|76285398|FG000|NOT COMPLETED|Overall Study||0||
60158924|NCT00290147|76285399|FG001|NOT COMPLETED|Overall Study||0||
60158925|NCT00290537|76285405|FG000|STARTED|Overall Study||4||
60158926|NCT00290537|76285406|FG001|STARTED|Overall Study||0||
60158927|NCT00290537|76285405|FG000|COMPLETED|Overall Study||4||
60158928|NCT00290537|76285406|FG001|COMPLETED|Overall Study||0||
60158929|NCT00290537|76285405|FG000|NOT COMPLETED|Overall Study||0||
60158930|NCT00290537|76285406|FG001|NOT COMPLETED|Overall Study||0||
60158931|NCT00290615|76285411|FG000|STARTED|Overall Study||30||
60158932|NCT00290615|76285411|FG000|COMPLETED|Overall Study||30||
60158933|NCT00290615|76285411|FG000|NOT COMPLETED|Overall Study||0||
60158934|NCT00291161|76285419|FG000|STARTED|Overall Study||316||
60158935|NCT00291161|76285420|FG001|STARTED|Overall Study||192||
60158936|NCT00291161|76285421|FG002|STARTED|Overall Study||299||
60158937|NCT00291161|76285422|FG003|STARTED|Overall Study||187||
60158938|NCT00291161|76285419|FG000|COMPLETED|Overall Study||235||
60158939|NCT00291161|76285420|FG001|COMPLETED|Overall Study||134||
60158940|NCT00291161|76285421|FG002|COMPLETED|Overall Study||206||
60158941|NCT00291161|76285422|FG003|COMPLETED|Overall Study||122||
60158942|NCT00291161|76285419|FG000|NOT COMPLETED|Overall Study||81||
60158943|NCT00291161|76285420|FG001|NOT COMPLETED|Overall Study||58||
60158944|NCT00291161|76285421|FG002|NOT COMPLETED|Overall Study||93||
60158945|NCT00291161|76285422|FG003|NOT COMPLETED|Overall Study||65||
60158946|NCT00297115|76285432|FG000|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|772||
60158947|NCT00297115|76285433|FG001|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|796||
60158948|NCT00297115|76285432|FG000|COMPLETED|Overall Study||527||
60158949|NCT00297115|76285433|FG001|COMPLETED|Overall Study||550||
60158950|NCT00297115|76285432|FG000|NOT COMPLETED|Overall Study||245||
59605888|NCT01963260|75716099|FG002|STARTED|Overall Study||6||
59605889|NCT01963260|75716100|FG003|STARTED|Overall Study||6||
59605890|NCT01963260|75716101|FG004|STARTED|Overall Study||6||
59605891|NCT01963260|75716102|FG005|STARTED|Overall Study||10||
59605892|NCT01963260|75716103|FG006|STARTED|Overall Study||3||
59605893|NCT01963260|75716104|FG007|STARTED|Overall Study||2||
59605894|NCT01963260|75716105|FG008|STARTED|Overall Study||1||
59605895|NCT01963260|75716106|FG009|STARTED|Overall Study||4||
59605896|NCT01963260|75716097|FG000|Treated|Overall Study||6||
59605897|NCT01963260|75716098|FG001|Treated|Overall Study||6||
59605898|NCT01963260|75716099|FG002|Treated|Overall Study||6||
59605899|NCT01963260|75716100|FG003|Treated|Overall Study||6||
60158951|NCT00297115|76285433|FG001|NOT COMPLETED|Overall Study||246||
60158952|NCT01854177|76285439|FG000|STARTED|Overall Study||10||
60158953|NCT01854177|76285439|FG000|COMPLETED|Overall Study||10||
60158954|NCT01854177|76285439|FG000|NOT COMPLETED|Overall Study||0||
60158955|NCT00291317|76285445|FG000|STARTED|Overall Study||6||
60158956|NCT00291317|76285445|FG000|COMPLETED|Overall Study||6||
60158957|NCT00291317|76285445|FG000|NOT COMPLETED|Overall Study||0||
60158958|NCT00243191|76285450|FG000|STARTED|Overall Study||18||
60158959|NCT00243191|76285450|FG000|COMPLETED|Overall Study||18||
60158960|NCT00243191|76285450|FG000|NOT COMPLETED|Overall Study||0||
60158961|NCT00299221|76285456|FG000|STARTED|Overall Study||79||
60158962|NCT00299221|76285457|FG001|STARTED|Overall Study||71||
60158963|NCT00299221|76285456|FG000|COMPLETED|Overall Study||79||
60158964|NCT00299221|76285457|FG001|COMPLETED|Overall Study||71||
60158965|NCT00299221|76285456|FG000|NOT COMPLETED|Overall Study||0||
60158966|NCT00299221|76285457|FG001|NOT COMPLETED|Overall Study||0||
60158967|NCT00299689|76285463|FG000|STARTED|Overall Study||69||
60158968|NCT00299689|76285463|FG000|COMPLETED|Overall Study||69||
60158969|NCT00299689|76285463|FG000|NOT COMPLETED|Overall Study||0||
60158970|NCT00244985|76285467|FG000|STARTED|Overall Study||42||
60158971|NCT00244985|76285467|FG000|COMPLETED|Overall Study||42||
60158972|NCT00244985|76285467|FG000|NOT COMPLETED|Overall Study||0||
60158973|NCT00300235|76285476|FG000|STARTED|Overall Study||208||
60158974|NCT00300235|76285477|FG001|STARTED|Overall Study||240||
60158975|NCT00300235|76285478|FG002|STARTED|Overall Study||398||
60158976|NCT00300235|76285479|FG003|STARTED|Overall Study||362||
60158977|NCT00300235|76285480|FG004|STARTED|Overall Study||251||
60158978|NCT00300235|76285476|FG000|COMPLETED|Overall Study||208||
60158979|NCT00300235|76285477|FG001|COMPLETED|Overall Study||240||
60158980|NCT00300235|76285478|FG002|COMPLETED|Overall Study||398||
60158981|NCT00300235|76285479|FG003|COMPLETED|Overall Study||362||
60158982|NCT00300235|76285480|FG004|COMPLETED|Overall Study||251||
60158983|NCT00300235|76285476|FG000|NOT COMPLETED|Overall Study||0||
60158984|NCT00300235|76285477|FG001|NOT COMPLETED|Overall Study||0||
60158985|NCT00300235|76285478|FG002|NOT COMPLETED|Overall Study||0||
60158986|NCT00300235|76285479|FG003|NOT COMPLETED|Overall Study||0||
60158987|NCT00300235|76285480|FG004|NOT COMPLETED|Overall Study||0||
60158988|NCT00245219|76285495|FG000|STARTED|Overall Study||91||
60158989|NCT00245219|76285496|FG001|STARTED|Overall Study||94||
60158990|NCT00245219|76285497|FG002|STARTED|Overall Study||60||
60158991|NCT00245219|76285495|FG000|COMPLETED|Overall Study||85||
60158992|NCT00245219|76285496|FG001|COMPLETED|Overall Study||88||
60158993|NCT00245219|76285497|FG002|COMPLETED|Overall Study||58||
60158994|NCT00245219|76285495|FG000|NOT COMPLETED|Overall Study||6||
60158995|NCT00245219|76285496|FG001|NOT COMPLETED|Overall Study||6||
60158996|NCT00245219|76285497|FG002|NOT COMPLETED|Overall Study||2||
60158997|NCT01857297|76285507|FG000|STARTED|Overall Study||60||
59605900|NCT01963260|75716101|FG004|Treated|Overall Study||6||
60158998|NCT01857297|76285508|FG001|STARTED|Overall Study||60||
60158999|NCT01857297|76285507|FG000|COMPLETED|Overall Study||60||
60159000|NCT01857297|76285508|FG001|COMPLETED|Overall Study||60||
60159001|NCT01857297|76285507|FG000|NOT COMPLETED|Overall Study||0||
60159002|NCT01857297|76285508|FG001|NOT COMPLETED|Overall Study||0||
60159003|NCT02274675|76285514|FG000|STARTED|Overall Study||7||
60159004|NCT02274675|76285514|FG000|COMPLETED|Overall Study||7||
60159005|NCT02274675|76285514|FG000|NOT COMPLETED|Overall Study||0||
60159006|NCT02265783|76285518|FG000|STARTED|Overall Study||20||
60159007|NCT02265783|76285518|FG000|COMPLETED|Overall Study|All subjects completed, one excluded from the analysis due to an issue with the data collection|20||
60159008|NCT02265783|76285518|FG000|NOT COMPLETED|Overall Study||0||
60159009|NCT00300391|76285524|FG000|STARTED|Overall Study||16||
60159010|NCT00300391|76285525|FG001|STARTED|Overall Study||14||
60159011|NCT00300391|76285524|FG000|COMPLETED|Overall Study||16||
60159012|NCT00300391|76285525|FG001|COMPLETED|Overall Study||14||
60159013|NCT00300391|76285524|FG000|NOT COMPLETED|Overall Study||0||
60159014|NCT00300391|76285525|FG001|NOT COMPLETED|Overall Study||0||
60159015|NCT01858545|76285534|FG000|STARTED|Overall Study||27||
60159016|NCT01858545|76285535|FG001|STARTED|Overall Study||29||
60159017|NCT01858545|76285534|FG000|COMPLETED|Overall Study||23||
60159018|NCT01858545|76285535|FG001|COMPLETED|Overall Study||23||
60159019|NCT01858545|76285534|FG000|NOT COMPLETED|Overall Study||4||
60159020|NCT01858545|76285535|FG001|NOT COMPLETED|Overall Study||6||
60159021|NCT01859013|76285543|FG000|STARTED|Overall Study||16||
60159022|NCT01859013|76285544|FG001|STARTED|Overall Study||14||
60159023|NCT01859013|76285543|FG000|COMPLETED|Overall Study||12||
60159024|NCT01859013|76285544|FG001|COMPLETED|Overall Study||9||
60159025|NCT01859013|76285543|FG000|NOT COMPLETED|Overall Study||4||
60159026|NCT01859013|76285544|FG001|NOT COMPLETED|Overall Study||5||
60159027|NCT01859247|76285558|FG000|STARTED|Overall Study||1||
60159028|NCT01859247|76285559|FG001|STARTED|Overall Study||1||
60159029|NCT01859247|76285560|FG002|STARTED|Overall Study||1||
59605901|NCT01963260|75716102|FG005|Treated|Overall Study||10||
59605902|NCT01963260|75716103|FG006|Treated|Overall Study||3||
59605903|NCT01963260|75716104|FG007|Treated|Overall Study||2||
59605904|NCT01963260|75716105|FG008|Treated|Overall Study||1||
59605905|NCT01963260|75716106|FG009|Treated|Overall Study||4||
59605906|NCT01963260|75716097|FG000|COMPLETED|Overall Study||4||
59605907|NCT01963260|75716098|FG001|COMPLETED|Overall Study||6||
59605908|NCT01963260|75716099|FG002|COMPLETED|Overall Study||6||
59605909|NCT01963260|75716100|FG003|COMPLETED|Overall Study||5||
59605910|NCT01963260|75716101|FG004|COMPLETED|Overall Study||4||
59605911|NCT01963260|75716102|FG005|COMPLETED|Overall Study||10||
59605912|NCT01963260|75716103|FG006|COMPLETED|Overall Study||3||
60159030|NCT01859247|76285561|FG003|STARTED|Overall Study||1||
60159031|NCT01859247|76285562|FG004|STARTED|Overall Study||1||
60159032|NCT01859247|76285563|FG005|STARTED|Overall Study||1||
60159033|NCT01859247|76285564|FG006|STARTED|Overall Study||1||
60159034|NCT01859247|76285565|FG007|STARTED|Overall Study||1||
60159035|NCT01859247|76285558|FG000|COMPLETED|Overall Study||1||
60159036|NCT01859247|76285559|FG001|COMPLETED|Overall Study||1||
60159037|NCT01859247|76285560|FG002|COMPLETED|Overall Study||1||
60159038|NCT01859247|76285561|FG003|COMPLETED|Overall Study||1||
60159039|NCT01859247|76285562|FG004|COMPLETED|Overall Study||1||
60159040|NCT01859247|76285563|FG005|COMPLETED|Overall Study||1||
60159041|NCT01859247|76285564|FG006|COMPLETED|Overall Study||1||
60159042|NCT01859247|76285565|FG007|COMPLETED|Overall Study||1||
60159043|NCT01859247|76285558|FG000|NOT COMPLETED|Overall Study||0||
60159044|NCT01859247|76285559|FG001|NOT COMPLETED|Overall Study||0||
60159045|NCT01859247|76285560|FG002|NOT COMPLETED|Overall Study||0||
60159046|NCT01859247|76285561|FG003|NOT COMPLETED|Overall Study||0||
60159047|NCT01859247|76285562|FG004|NOT COMPLETED|Overall Study||0||
60159048|NCT01859247|76285563|FG005|NOT COMPLETED|Overall Study||0||
60159049|NCT01859247|76285564|FG006|NOT COMPLETED|Overall Study||0||
60159050|NCT01859247|76285565|FG007|NOT COMPLETED|Overall Study||0||
60159051|NCT00294515|76285586|FG000|STARTED|Overall Study|Randomized|166||
60159052|NCT00294515|76285587|FG001|STARTED|Overall Study|Randomized|160||
60159053|NCT00294515|76285586|FG000|COMPLETED|Overall Study||132||
60159054|NCT00294515|76285587|FG001|COMPLETED|Overall Study||132||
60159055|NCT00294515|76285586|FG000|NOT COMPLETED|Overall Study||34||
60159056|NCT00294515|76285587|FG001|NOT COMPLETED|Overall Study||28||
60159057|NCT01859325|76285595|FG000|STARTED|Overall Study||15||
60159058|NCT01859325|76285596|FG001|STARTED|Overall Study||16||
60159059|NCT01859325|76285597|FG002|STARTED|Overall Study||2||
60159060|NCT01859325|76285595|FG000|COMPLETED|Overall Study||12||
60159061|NCT01859325|76285596|FG001|COMPLETED|Overall Study||12||
60159062|NCT01859325|76285597|FG002|COMPLETED|Overall Study||2||
60159063|NCT01859325|76285595|FG000|NOT COMPLETED|Overall Study||3||
60159064|NCT01859325|76285596|FG001|NOT COMPLETED|Overall Study||4||
60159065|NCT01859325|76285597|FG002|NOT COMPLETED|Overall Study||0||
60159066|NCT00300469|76285609|FG000|STARTED|Overall Study|"For all arms, started means treated."|110||
60159067|NCT00300469|76285610|FG001|STARTED|Overall Study||110||
60159068|NCT00300469|76285611|FG002|STARTED|Overall Study||112||
60159069|NCT00300469|76285612|FG003|STARTED|Overall Study||113||
60159070|NCT00300469|76285613|FG004|STARTED|Overall Study||109||
60159071|NCT00300469|76285614|FG005|STARTED|Overall Study||55||
60159072|NCT00300469|76285609|FG000|COMPLETED|Overall Study||89||
60159073|NCT00300469|76285610|FG001|COMPLETED|Overall Study||89||
60159074|NCT00300469|76285611|FG002|COMPLETED|Overall Study||95||
60159075|NCT00300469|76285612|FG003|COMPLETED|Overall Study||104||
60159076|NCT00300469|76285613|FG004|COMPLETED|Overall Study||95||
60159077|NCT00300469|76285614|FG005|COMPLETED|Overall Study||46||
60159078|NCT00300469|76285609|FG000|NOT COMPLETED|Overall Study||21||
60159079|NCT00300469|76285610|FG001|NOT COMPLETED|Overall Study||21||
60159080|NCT00300469|76285611|FG002|NOT COMPLETED|Overall Study||17||
60159081|NCT00300469|76285612|FG003|NOT COMPLETED|Overall Study||9||
60159082|NCT00300469|76285613|FG004|NOT COMPLETED|Overall Study||14||
59751781|NCT00842985|75871121|FG000|STARTED|Washout Period of GE 4 Days||15||
59751782|NCT00842985|75871121|FG000|COMPLETED|Washout Period of GE 4 Days||15||
59751783|NCT00842985|75871121|FG000|NOT COMPLETED|Washout Period of GE 4 Days||0||
59751784|NCT00842985|75871121|FG000|STARTED|Fourth Intervention||15||
59751785|NCT00842985|75871121|FG000|COMPLETED|Fourth Intervention||15||
59751786|NCT00842985|75871121|FG000|NOT COMPLETED|Fourth Intervention||0||
59751787|NCT00842829|75871130|FG000|STARTED|Dose Titration Period||156||
59751788|NCT00842829|75871131|FG001|STARTED|Dose Titration Period||174||
59751789|NCT00842829|75871132|FG002|STARTED|Dose Titration Period||0||
59751790|NCT00842829|75871130|FG000|Titration Safety Analysis Set|Dose Titration Period|Received at least one dose of study drug|145||
59751791|NCT00842829|75871131|FG001|Titration Safety Analysis Set|Dose Titration Period|Received at least one dose of study drug|167||
60159083|NCT00300469|76285614|FG005|NOT COMPLETED|Overall Study||9||
60159084|NCT01859637|76285628|FG000|STARTED|Overall Study||6||
60159085|NCT01859637|76285628|FG000|COMPLETED|Overall Study||6||
60159086|NCT01859637|76285628|FG000|NOT COMPLETED|Overall Study||0||
59882399|NCT03253094|76005309|FG001|COMPLETED|Overall Study||27||
60159087|NCT00295061|76285634|FG000|STARTED|Overall Study||12||
60159088|NCT00295061|76285635|FG001|STARTED|Overall Study||12||
60159089|NCT00295061|76285634|FG000|COMPLETED|Overall Study||12||
60159090|NCT00295061|76285635|FG001|COMPLETED|Overall Study||12||
60159091|NCT00295061|76285634|FG000|NOT COMPLETED|Overall Study||0||
60159092|NCT00295061|76285635|FG001|NOT COMPLETED|Overall Study||0||
60159093|NCT02101411|76285644|FG000|STARTED|Overall Study||111||
60159094|NCT02101411|76285645|FG001|STARTED|Overall Study||109||
59751792|NCT00842829|75871132|FG002|Titration Safety Analysis Set|Dose Titration Period||0||
59751793|NCT00842829|75871130|FG000|COMPLETED|Dose Titration Period||130||
60159095|NCT02101411|76285646|FG002|STARTED|Overall Study||114||
60159096|NCT02101411|76285644|FG000|COMPLETED|Overall Study||107||
60159097|NCT02101411|76285645|FG001|COMPLETED|Overall Study||102||
60159098|NCT02101411|76285646|FG002|COMPLETED|Overall Study||104||
59751794|NCT00842829|75871131|FG001|COMPLETED|Dose Titration Period||151||
59882400|NCT03253094|76005310|FG002|COMPLETED|Overall Study||22||
59882401|NCT03253094|76005311|FG003|COMPLETED|Overall Study||28||
59882402|NCT03253094|76005312|FG004|COMPLETED|Overall Study||27||
60159099|NCT02101411|76285644|FG000|NOT COMPLETED|Overall Study||4||
60159100|NCT02101411|76285645|FG001|NOT COMPLETED|Overall Study||7||
60159101|NCT02101411|76285646|FG002|NOT COMPLETED|Overall Study||10||
60159102|NCT00296231|76285654|FG000|STARTED|Overall Study||14||
60159103|NCT00296231|76285654|FG000|COMPLETED|Overall Study||14||
60159104|NCT00296231|76285654|FG000|NOT COMPLETED|Overall Study||0||
60159105|NCT01860573|76285660|FG000|STARTED|Overall Study||83||
60159106|NCT01860573|76285661|FG001|STARTED|Overall Study||85||
60159107|NCT01860573|76285660|FG000|COMPLETED|Overall Study||83||
60159108|NCT01860573|76285661|FG001|COMPLETED|Overall Study||85||
60159109|NCT01860573|76285660|FG000|NOT COMPLETED|Overall Study||0||
60159110|NCT01860573|76285661|FG001|NOT COMPLETED|Overall Study||0||
60159111|NCT00299741|76285667|FG000|STARTED|Overall Study||36||
60159112|NCT00299741|76285667|FG000|COMPLETED|Overall Study||36||
60159113|NCT00299741|76285667|FG000|NOT COMPLETED|Overall Study||0||
60159114|NCT01860651|76285673|FG000|STARTED|Overall Study||56||
60159115|NCT01860651|76285674|FG001|STARTED|Overall Study||47||
60159116|NCT01860651|76285673|FG000|COMPLETED|Overall Study||31||
60159117|NCT01860651|76285674|FG001|COMPLETED|Overall Study||39||
60159118|NCT01860651|76285673|FG000|NOT COMPLETED|Overall Study||25||
60159119|NCT01860651|76285674|FG001|NOT COMPLETED|Overall Study||8||
60159120|NCT00328861|76285688|FG000|STARTED|Overall Study||7||
60159121|NCT00328861|76285689|FG001|STARTED|Overall Study||1||
60159122|NCT00328861|76285688|FG000|COMPLETED|Overall Study||7||
60159123|NCT00328861|76285689|FG001|COMPLETED|Overall Study||1||
60159124|NCT00328861|76285688|FG000|NOT COMPLETED|Overall Study||0||
60159125|NCT00328861|76285689|FG001|NOT COMPLETED|Overall Study||0||
60159126|NCT00248807|76285697|FG000|STARTED|Overall Study||19||
60159127|NCT00248807|76285698|FG001|STARTED|Overall Study||11||
60159128|NCT00248807|76285697|FG000|COMPLETED|Overall Study||19||
60159129|NCT00248807|76285698|FG001|COMPLETED|Overall Study||11||
60159130|NCT00248807|76285697|FG000|NOT COMPLETED|Overall Study||0||
60159131|NCT00248807|76285698|FG001|NOT COMPLETED|Overall Study||0||
60159132|NCT01860807|76285712|FG000|STARTED|Overall Study||64||
60159133|NCT01860807|76285713|FG001|STARTED|Overall Study||61||
60159134|NCT01860807|76285712|FG000|COMPLETED|Overall Study||34||
60159135|NCT01860807|76285713|FG001|COMPLETED|Overall Study||32||
60159136|NCT01860807|76285712|FG000|NOT COMPLETED|Overall Study||30||
60159137|NCT01860807|76285713|FG001|NOT COMPLETED|Overall Study||29||
60159138|NCT00330421|76285719|FG000|STARTED|Overall Study||15||
60159139|NCT00330421|76285720|FG001|STARTED|Overall Study||0||
60159140|NCT00330421|76285719|FG000|COMPLETED|Overall Study||15||
60159141|NCT00330421|76285720|FG001|COMPLETED|Overall Study||0||
60159142|NCT00330421|76285719|FG000|NOT COMPLETED|Overall Study||0||
60159143|NCT00330421|76285720|FG001|NOT COMPLETED|Overall Study||0||
60159144|NCT01861587|76285726|FG000|STARTED|Overall Study||14||
60159145|NCT01861587|76285727|FG001|STARTED|Overall Study||13||
60159146|NCT01861587|76285726|FG000|COMPLETED|Overall Study||14||
60159147|NCT01861587|76285727|FG001|COMPLETED|Overall Study||13||
60159148|NCT01861587|76285726|FG000|NOT COMPLETED|Overall Study||0||
60159149|NCT01861587|76285727|FG001|NOT COMPLETED|Overall Study||0||
60159150|NCT00330733|76285739|FG000|STARTED|Overall Study||37||
60159151|NCT00330733|76285740|FG001|STARTED|Overall Study||34||
60159152|NCT00330733|76285739|FG000|Received Study Medication|Overall Study||36||
60159153|NCT00330733|76285740|FG001|Received Study Medication|Overall Study||34||
60159154|NCT00330733|76285739|FG000|COMPLETED|Overall Study||30||
60159155|NCT00330733|76285740|FG001|COMPLETED|Overall Study||29||
60159156|NCT00330733|76285739|FG000|NOT COMPLETED|Overall Study||7||
60159157|NCT00330733|76285740|FG001|NOT COMPLETED|Overall Study||5||
60159158|NCT01862133|76285746|FG000|STARTED|Overall Study||105||
60159159|NCT01862133|76285747|FG001|STARTED|Overall Study||31||
60159160|NCT01862133|76285746|FG000|Returned During 6 mo Study|Overall Study||92||
60159161|NCT01862133|76285747|FG001|Returned During 6 mo Study|Overall Study||31||
60159162|NCT01862133|76285746|FG000|COMPLETED|Overall Study|All 105 patients recorded preferences; 92 (88%) returned to the study clinic during the 6 mo. study|105||
60159163|NCT01862133|76285747|FG001|COMPLETED|Overall Study||31||
60159164|NCT01862133|76285746|FG000|NOT COMPLETED|Overall Study||0||
60159165|NCT01862133|76285747|FG001|NOT COMPLETED|Overall Study||0||
60159166|NCT00301873|76285753|FG000|STARTED|Overall Study||59||
60159167|NCT00301873|76285753|FG000|COMPLETED|Overall Study||59||
60159168|NCT00301873|76285753|FG000|NOT COMPLETED|Overall Study||0||
60159169|NCT00251225|76285757|FG000|STARTED|Overall Study||49||
60159170|NCT00251225|76285757|FG000|COMPLETED|Overall Study||49||
60159171|NCT00251225|76285757|FG000|NOT COMPLETED|Overall Study||0||
60159172|NCT00303511|76285761|FG000|STARTED|Overall Study||10||
60159173|NCT00303511|76285761|FG000|COMPLETED|Overall Study||10||
60159174|NCT00303511|76285761|FG000|NOT COMPLETED|Overall Study||0||
60159175|NCT05803096|76285767|FG000|STARTED|Overall Study||66||
60159176|NCT05803096|76285768|FG001|STARTED|Overall Study||67||
60159177|NCT05803096|76285767|FG000|COMPLETED|Overall Study||61||
60159178|NCT05803096|76285768|FG001|COMPLETED|Overall Study||67||
60159179|NCT05803096|76285767|FG000|NOT COMPLETED|Overall Study||5||
60159180|NCT05803096|76285768|FG001|NOT COMPLETED|Overall Study||0||
60159181|NCT05609604|76285776|FG000|STARTED|Overall Study||2||
60159182|NCT05609604|76285777|FG001|STARTED|Overall Study||2||
60159183|NCT05609604|76285776|FG000|COMPLETED|Overall Study||0||
60159184|NCT05609604|76285777|FG001|COMPLETED|Overall Study||0||
60159185|NCT05609604|76285776|FG000|NOT COMPLETED|Overall Study||2||
60159186|NCT05609604|76285777|FG001|NOT COMPLETED|Overall Study||2||
60159187|NCT05410964|76285783|FG000|STARTED|Overall Study||122||
60159188|NCT05410964|76285783|FG000|COMPLETED|Overall Study||122||
60159189|NCT05410964|76285783|FG000|NOT COMPLETED|Overall Study||0||
60159190|NCT05370326|76285789|FG000|STARTED|Overall Study||36||
60159191|NCT05370326|76285790|FG001|STARTED|Overall Study||16||
60159192|NCT05370326|76285789|FG000|Complete Clinical Data|Overall Study||36||
60159193|NCT05370326|76285790|FG001|Complete Clinical Data|Overall Study||16||
60159194|NCT05370326|76285789|FG000|Complete Self Report Data|Overall Study||31||
60159195|NCT05370326|76285790|FG001|Complete Self Report Data|Overall Study||14||
60159196|NCT05370326|76285789|FG000|COMPLETED|Overall Study||36||
60159197|NCT05370326|76285790|FG001|COMPLETED|Overall Study||16||
60159198|NCT05370326|76285789|FG000|NOT COMPLETED|Overall Study||0||
60159199|NCT05370326|76285790|FG001|NOT COMPLETED|Overall Study||0||
60159200|NCT05276401|76285801|FG000|STARTED|Overall Study||2||
60159201|NCT05276401|76285802|FG001|STARTED|Overall Study||1||
60159202|NCT05276401|76285803|FG002|STARTED|Overall Study||0||
60159203|NCT05276401|76285804|FG003|STARTED|Overall Study||0||
60159204|NCT05276401|76285801|FG000|COMPLETED|Overall Study||2||
60159205|NCT05276401|76285802|FG001|COMPLETED|Overall Study||1||
60159206|NCT05276401|76285803|FG002|COMPLETED|Overall Study||0||
60159207|NCT05276401|76285804|FG003|COMPLETED|Overall Study||0||
60159208|NCT05276401|76285801|FG000|NOT COMPLETED|Overall Study||0||
60159209|NCT05276401|76285802|FG001|NOT COMPLETED|Overall Study||0||
60159210|NCT05276401|76285803|FG002|NOT COMPLETED|Overall Study||0||
60159211|NCT05276401|76285804|FG003|NOT COMPLETED|Overall Study||0||
60159212|NCT05209360|76285816|FG000|STARTED|Overall Study||5||
60159213|NCT05209360|76285817|FG001|STARTED|Overall Study||3||
60159214|NCT05209360|76285818|FG002|STARTED|Overall Study||3||
60159215|NCT05209360|76285819|FG003|STARTED|Overall Study||5||
60159216|NCT05209360|76285820|FG004|STARTED|Overall Study||2||
60159217|NCT05209360|76285821|FG005|STARTED|Overall Study||2||
60159218|NCT05209360|76285816|FG000|COMPLETED|Overall Study||5||
60159219|NCT05209360|76285817|FG001|COMPLETED|Overall Study||3||
60159220|NCT05209360|76285818|FG002|COMPLETED|Overall Study||2||
60159221|NCT05209360|76285819|FG003|COMPLETED|Overall Study||5||
60159222|NCT05209360|76285820|FG004|COMPLETED|Overall Study||2||
60159223|NCT05209360|76285821|FG005|COMPLETED|Overall Study||2||
60159224|NCT05209360|76285816|FG000|NOT COMPLETED|Overall Study||0||
60159225|NCT05209360|76285817|FG001|NOT COMPLETED|Overall Study||0||
59751795|NCT00842829|75871132|FG002|COMPLETED|Dose Titration Period||0||
60159226|NCT05209360|76285818|FG002|NOT COMPLETED|Overall Study||1||
60159227|NCT05209360|76285819|FG003|NOT COMPLETED|Overall Study||0||
59751796|NCT00842829|75871130|FG000|NOT COMPLETED|Dose Titration Period||26||
60159228|NCT05209360|76285820|FG004|NOT COMPLETED|Overall Study||0||
60159229|NCT05209360|76285821|FG005|NOT COMPLETED|Overall Study||0||
60159230|NCT05005130|76285838|FG000|STARTED|Time Period 1 Baseline (T0)|SOC Control|227|Unique patient participants enrolled into each Time Period.|1
60159231|NCT05005130|76285839|FG001|STARTED|Time Period 1 Baseline (T0)|SOC Control|221|Unique patient participants enrolled into each Time Period.|1
60159232|NCT05005130|76285838|FG000|Healthcare Providers|Time Period 1 Baseline (T0)||20||1
60159233|NCT05005130|76285839|FG001|Healthcare Providers|Time Period 1 Baseline (T0)||0||0
60159234|NCT05005130|76285838|FG000|COMPLETED|Time Period 1 Baseline (T0)||226||1
60159235|NCT05005130|76285839|FG001|COMPLETED|Time Period 1 Baseline (T0)||221||1
60159236|NCT05005130|76285838|FG000|NOT COMPLETED|Time Period 1 Baseline (T0)||1||0
60159237|NCT05005130|76285839|FG001|NOT COMPLETED|Time Period 1 Baseline (T0)||0||0
60159238|NCT05005130|76285838|FG000|STARTED|Time Period 2 Midline Survey (T1)|TASKPEN Intervention|188|Unique patient participants enrolled into each time period.|1
60159239|NCT05005130|76285839|FG001|STARTED|Time Period 2 Midline Survey (T1)|SOC Control|188|Unique patient participants enrolled into each time period.|1
60159240|NCT05005130|76285838|FG000|COMPLETED|Time Period 2 Midline Survey (T1)||187||1
60159241|NCT05005130|76285839|FG001|COMPLETED|Time Period 2 Midline Survey (T1)||186||1
60159242|NCT05005130|76285838|FG000|NOT COMPLETED|Time Period 2 Midline Survey (T1)||1||0
60159243|NCT05005130|76285839|FG001|NOT COMPLETED|Time Period 2 Midline Survey (T1)||2||0
60159244|NCT05005130|76285838|FG000|STARTED|Time Period 3 Endline Survey (T2)|TASKPEN Intervention|158|Unique patient participants enrolled into each time period.|1
60159245|NCT05005130|76285839|FG001|STARTED|Time Period 3 Endline Survey (T2)|TASKPEN Intervention|119|Unique patient participants enrolled into each time period.|1
60159246|NCT05005130|76285838|FG000|Healthcare Providers|Time Period 3 Endline Survey (T2)||0||0
60159247|NCT05005130|76285839|FG001|Healthcare Providers|Time Period 3 Endline Survey (T2)||8||1
60159248|NCT05005130|76285838|FG000|COMPLETED|Time Period 3 Endline Survey (T2)||152||1
60159249|NCT05005130|76285839|FG001|COMPLETED|Time Period 3 Endline Survey (T2)||118||1
60159250|NCT05005130|76285838|FG000|NOT COMPLETED|Time Period 3 Endline Survey (T2)||6||0
60159251|NCT05005130|76285839|FG001|NOT COMPLETED|Time Period 3 Endline Survey (T2)||1||0
60159252|NCT04886479|76285854|FG000|STARTED|Period 1: Habitual Device, 6-8 Hours||10||20
60159253|NCT04886479|76285855|FG001|STARTED|Period 1: Habitual Device, 6-8 Hours||3||6
60159254|NCT04886479|76285856|FG002|STARTED|Period 1: Habitual Device, 6-8 Hours||9||18
60159255|NCT04886479|76285854|FG000|COMPLETED|Period 1: Habitual Device, 6-8 Hours||10||20
60159256|NCT04886479|76285855|FG001|COMPLETED|Period 1: Habitual Device, 6-8 Hours||3||6
60159257|NCT04886479|76285856|FG002|COMPLETED|Period 1: Habitual Device, 6-8 Hours||9||18
60159258|NCT04886479|76285854|FG000|NOT COMPLETED|Period 1: Habitual Device, 6-8 Hours||0||0
60159259|NCT04886479|76285855|FG001|NOT COMPLETED|Period 1: Habitual Device, 6-8 Hours||0||0
60159260|NCT04886479|76285856|FG002|NOT COMPLETED|Period 1: Habitual Device, 6-8 Hours||0||0
60159261|NCT04886479|76285854|FG000|STARTED|Period 2: Test Lens, 3 Hours||10||10
60159262|NCT04886479|76285855|FG001|STARTED|Period 2: Test Lens, 3 Hours||3||3
60159263|NCT04886479|76285856|FG002|STARTED|Period 2: Test Lens, 3 Hours|None of the participants in the control group were involved in Period 2|0||0
60159264|NCT04886479|76285854|FG000|COMPLETED|Period 2: Test Lens, 3 Hours||10||10
60159265|NCT04886479|76285855|FG001|COMPLETED|Period 2: Test Lens, 3 Hours||3||3
60159266|NCT04886479|76285856|FG002|COMPLETED|Period 2: Test Lens, 3 Hours||0||0
60159267|NCT04886479|76285854|FG000|NOT COMPLETED|Period 2: Test Lens, 3 Hours||0||0
60159268|NCT04886479|76285855|FG001|NOT COMPLETED|Period 2: Test Lens, 3 Hours||0||0
60159269|NCT04886479|76285856|FG002|NOT COMPLETED|Period 2: Test Lens, 3 Hours||0||0
60159270|NCT04883060|76285867|FG000|STARTED|Overall Study||40||
60159271|NCT04883060|76285867|FG000|COMPLETED|Overall Study||40||
60159272|NCT04883060|76285867|FG000|NOT COMPLETED|Overall Study||0||
60159273|NCT04870671|76285873|FG000|STARTED|Overall Study||7||
60159274|NCT04870671|76285874|FG001|STARTED|Overall Study||7||
60159275|NCT04870671|76285873|FG000|COMPLETED|Overall Study||7||
60159276|NCT04870671|76285874|FG001|COMPLETED|Overall Study||7||
60159277|NCT04870671|76285873|FG000|NOT COMPLETED|Overall Study||0||
60159278|NCT04870671|76285874|FG001|NOT COMPLETED|Overall Study||0||
60159279|NCT04644237|76285882|FG000|STARTED|Overall Study||102|Completed = Participants ongoing treatment as of 23 Dec 2022, Not Completed = Participants who discontinued treatment|
60159280|NCT04644237|76285883|FG001|STARTED|Overall Study||50|Completed = Participants ongoing treatment as of 23 Dec 2022, Not Completed = Participants who discontinued treatment|
60159281|NCT04644237|76285882|FG000|COMPLETED|Overall Study||27||
60159282|NCT04644237|76285883|FG001|COMPLETED|Overall Study||14||
60159283|NCT04644237|76285882|FG000|NOT COMPLETED|Overall Study||75||
60159284|NCT04644237|76285883|FG001|NOT COMPLETED|Overall Study||36||
60159285|NCT04594733|76285891|FG000|STARTED|First Intervention (8 Weeks)||7||
60159286|NCT04594733|76285892|FG001|STARTED|First Intervention (8 Weeks)||7||
60159287|NCT04594733|76285891|FG000|Received Intervention|First Intervention (8 Weeks)||7||
60159288|NCT04594733|76285892|FG001|Received Intervention|First Intervention (8 Weeks)||7||
60159289|NCT04594733|76285891|FG000|COMPLETED|First Intervention (8 Weeks)||7||
60159290|NCT04594733|76285892|FG001|COMPLETED|First Intervention (8 Weeks)||3||
60159291|NCT04594733|76285891|FG000|NOT COMPLETED|First Intervention (8 Weeks)||0||
60159292|NCT04594733|76285892|FG001|NOT COMPLETED|First Intervention (8 Weeks)||4||
60159293|NCT04594733|76285891|FG000|STARTED|First Washout (2 Weeks)||7||
60159294|NCT04594733|76285892|FG001|STARTED|First Washout (2 Weeks)||3||
60159295|NCT04594733|76285891|FG000|COMPLETED|First Washout (2 Weeks)||7||
60159296|NCT04594733|76285892|FG001|COMPLETED|First Washout (2 Weeks)||3||
60159297|NCT04594733|76285891|FG000|NOT COMPLETED|First Washout (2 Weeks)||0||
60159298|NCT04594733|76285892|FG001|NOT COMPLETED|First Washout (2 Weeks)||0||
60159299|NCT04594733|76285891|FG000|STARTED|Second Intervention (8 Weeks)||7||
60159300|NCT04594733|76285892|FG001|STARTED|Second Intervention (8 Weeks)||3||
60159301|NCT04594733|76285891|FG000|COMPLETED|Second Intervention (8 Weeks)||5||
60159302|NCT04594733|76285892|FG001|COMPLETED|Second Intervention (8 Weeks)||3||
60159303|NCT04594733|76285891|FG000|NOT COMPLETED|Second Intervention (8 Weeks)||2||
60159304|NCT04594733|76285892|FG001|NOT COMPLETED|Second Intervention (8 Weeks)||0||
60159305|NCT04594733|76285891|FG000|STARTED|Second Washout (2 Weeks)||5||
60159306|NCT04594733|76285892|FG001|STARTED|Second Washout (2 Weeks)||3||
60159307|NCT04594733|76285891|FG000|COMPLETED|Second Washout (2 Weeks)||5||
60159308|NCT04594733|76285892|FG001|COMPLETED|Second Washout (2 Weeks)||3||
60159309|NCT04594733|76285891|FG000|NOT COMPLETED|Second Washout (2 Weeks)||0||
60159310|NCT04594733|76285892|FG001|NOT COMPLETED|Second Washout (2 Weeks)||0||
60159311|NCT04570657|76285902|FG000|STARTED|Overall Study||77||
60159312|NCT04570657|76285903|FG001|STARTED|Overall Study||77||
60159313|NCT04570657|76285904|FG002|STARTED|Overall Study||81||
60159314|NCT04570657|76285902|FG000|Intent to Treat (ITT) Population|Overall Study||77||
60159315|NCT04570657|76285903|FG001|Intent to Treat (ITT) Population|Overall Study||77||
60159316|NCT04570657|76285904|FG002|Intent to Treat (ITT) Population|Overall Study||81||
60159317|NCT04570657|76285902|FG000|As-treated Population|Overall Study||77||
60159318|NCT04570657|76285903|FG001|As-treated Population|Overall Study||77||
60159319|NCT04570657|76285904|FG002|As-treated Population|Overall Study||81||
60159320|NCT04570657|76285902|FG000|Pharmacokinetic (PK) Population|Overall Study||75||
60159321|NCT04570657|76285903|FG001|Pharmacokinetic (PK) Population|Overall Study||77||
60159322|NCT04570657|76285904|FG002|Pharmacokinetic (PK) Population|Overall Study||0||
60159323|NCT04570657|76285902|FG000|COMPLETED|Overall Study||76||
60159324|NCT04570657|76285903|FG001|COMPLETED|Overall Study||74||
60159325|NCT04570657|76285904|FG002|COMPLETED|Overall Study||77||
60159326|NCT04570657|76285902|FG000|NOT COMPLETED|Overall Study||1||
60159327|NCT04570657|76285903|FG001|NOT COMPLETED|Overall Study||3||
60159328|NCT04570657|76285904|FG002|NOT COMPLETED|Overall Study||4||
60159329|NCT04566601|76285917|FG000|STARTED|Overall Study||128||
60159330|NCT04566601|76285918|FG001|STARTED|Overall Study||52||
60159331|NCT04566601|76285919|FG002|STARTED|Overall Study||53||
60159332|NCT04566601|76285920|FG003|STARTED|Overall Study||53||
60159333|NCT04566601|76285921|FG004|STARTED|Overall Study||104||
60159334|NCT04566601|76285917|FG000|COMPLETED|Overall Study||95|Completed planned trial treatment of 12 weeks.|
60159335|NCT04566601|76285918|FG001|COMPLETED|Overall Study||40|Completed planned trial treatment of 12 weeks.|
60159336|NCT04566601|76285919|FG002|COMPLETED|Overall Study||35|Completed planned trial treatment of 12 weeks.|
60159337|NCT04566601|76285920|FG003|COMPLETED|Overall Study||40|Completed planned trial treatment of 12 weeks.|
60159338|NCT04566601|76285921|FG004|COMPLETED|Overall Study||77|Completed planned trial treatment of 12 weeks.|
60159339|NCT04566601|76285917|FG000|NOT COMPLETED|Overall Study||33||
60159340|NCT04566601|76285918|FG001|NOT COMPLETED|Overall Study||12||
60159341|NCT04566601|76285919|FG002|NOT COMPLETED|Overall Study||18||
60159342|NCT04566601|76285920|FG003|NOT COMPLETED|Overall Study||13||
60159343|NCT04566601|76285921|FG004|NOT COMPLETED|Overall Study||27||
60159344|NCT04553068|76285935|FG000|STARTED|Overall Study||943||
60159345|NCT04553068|76285936|FG001|STARTED|Overall Study||949||
60159346|NCT04553068|76285935|FG000|COMPLETED|Overall Study||792||
60159347|NCT04553068|76285936|FG001|COMPLETED|Overall Study||805||
60159348|NCT04553068|76285935|FG000|NOT COMPLETED|Overall Study||151||
60159349|NCT04553068|76285936|FG001|NOT COMPLETED|Overall Study||144||
60159350|NCT04220554|76285944|FG000|STARTED|Overall Study||51||
60159351|NCT04220554|76285945|FG001|STARTED|Overall Study||52||
60159352|NCT04220554|76285944|FG000|COMPLETED|Overall Study||45||
60159353|NCT04220554|76285945|FG001|COMPLETED|Overall Study||47||
60159354|NCT04220554|76285944|FG000|NOT COMPLETED|Overall Study||6||
60159355|NCT04220554|76285945|FG001|NOT COMPLETED|Overall Study||5||
60159356|NCT04220489|76285953|FG000|STARTED|Overall Study||1||
60159357|NCT04220489|76285954|FG001|STARTED|Overall Study||0||
60159358|NCT04220489|76285953|FG000|COMPLETED|Overall Study||1||
60159359|NCT04220489|76285954|FG001|COMPLETED|Overall Study||0||
60159360|NCT04220489|76285953|FG000|NOT COMPLETED|Overall Study||0||
60159361|NCT04220489|76285954|FG001|NOT COMPLETED|Overall Study||0||
60159362|NCT04195061|76285962|FG000|STARTED|Overall Study||19||
60159363|NCT04195061|76285963|FG001|STARTED|Overall Study||9||
60159364|NCT04195061|76285962|FG000|COMPLETED|Overall Study||19||
60159365|NCT04195061|76285963|FG001|COMPLETED|Overall Study||9||
60159366|NCT04195061|76285962|FG000|NOT COMPLETED|Overall Study||0||
60159367|NCT04195061|76285963|FG001|NOT COMPLETED|Overall Study||0||
60159368|NCT04170621|76285969|FG000|STARTED|Overall Study||28||
60159369|NCT04170621|76285969|FG000|COMPLETED|Overall Study||28||
60159370|NCT04170621|76285969|FG000|NOT COMPLETED|Overall Study||0||
60159371|NCT04168112|76285975|FG000|STARTED|Overall Study||10||
60159372|NCT04168112|76285976|FG001|STARTED|Overall Study||10||
60159373|NCT04168112|76285975|FG000|COMPLETED|Overall Study||8||
60159374|NCT04168112|76285976|FG001|COMPLETED|Overall Study||10||
60159375|NCT04168112|76285975|FG000|NOT COMPLETED|Overall Study||2||
59751797|NCT00842829|75871131|FG001|NOT COMPLETED|Dose Titration Period||23||
59751798|NCT00842829|75871132|FG002|NOT COMPLETED|Dose Titration Period||0||
59751799|NCT00842829|75871130|FG000|STARTED|Treatment Period||0||
60159376|NCT04168112|76285976|FG001|NOT COMPLETED|Overall Study||0||
60159377|NCT04005352|76285984|FG000|STARTED|Overall Study||366||
60159378|NCT04005352|76285985|FG001|STARTED|Overall Study||368||
60159379|NCT04005352|76285984|FG000|COMPLETED|Overall Study||317||
60159380|NCT04005352|76285985|FG001|COMPLETED|Overall Study||307||
60159381|NCT04005352|76285984|FG000|NOT COMPLETED|Overall Study||49||
60159382|NCT04005352|76285985|FG001|NOT COMPLETED|Overall Study||61||
60159383|NCT03955081|76285992|FG000|STARTED|Overall Study||302||
60159384|NCT03955081|76285992|FG000|COMPLETED|Overall Study||302||
60159385|NCT03955081|76285992|FG000|NOT COMPLETED|Overall Study||0||
60159386|NCT03952039|76285998|FG000|STARTED|Overall Study||134||
60159387|NCT03952039|76285999|FG001|STARTED|Overall Study||67||
60159388|NCT03952039|76285998|FG000|Participants Who Crossed Over|Overall Study||0||
60159389|NCT03952039|76285999|FG001|Participants Who Crossed Over|Overall Study||46||
60159390|NCT03952039|76285998|FG000|COMPLETED|Overall Study||43|Completed = Treatment ongoing|
60159391|NCT03952039|76285999|FG001|COMPLETED|Overall Study||28|Completed = Treatment ongoing|
60159392|NCT03952039|76285998|FG000|NOT COMPLETED|Overall Study||91||
60159393|NCT03952039|76285999|FG001|NOT COMPLETED|Overall Study||39||
60159394|NCT03949517|76286008|FG000|STARTED|Pre-HIFU Period, Imaging Timepoint 1||7||
60159395|NCT03949517|76286009|FG001|STARTED|Pre-HIFU Period, Imaging Timepoint 1||7||
60159396|NCT03949517|76286008|FG000|COMPLETED|Pre-HIFU Period, Imaging Timepoint 1||7||
60159397|NCT03949517|76286009|FG001|COMPLETED|Pre-HIFU Period, Imaging Timepoint 1||7||
60159398|NCT03949517|76286008|FG000|NOT COMPLETED|Pre-HIFU Period, Imaging Timepoint 1||0||
60159399|NCT03949517|76286009|FG001|NOT COMPLETED|Pre-HIFU Period, Imaging Timepoint 1||0||
60159400|NCT03949517|76286008|FG000|STARTED|Pre-HIFU Period, Imaging Timepoint 2||7||
60159401|NCT03949517|76286009|FG001|STARTED|Pre-HIFU Period, Imaging Timepoint 2||7||
60159402|NCT03949517|76286008|FG000|COMPLETED|Pre-HIFU Period, Imaging Timepoint 2||7||
60159403|NCT03949517|76286009|FG001|COMPLETED|Pre-HIFU Period, Imaging Timepoint 2||7||
60159404|NCT03949517|76286008|FG000|NOT COMPLETED|Pre-HIFU Period, Imaging Timepoint 2||0||
60159405|NCT03949517|76286009|FG001|NOT COMPLETED|Pre-HIFU Period, Imaging Timepoint 2||0||
60159406|NCT03949517|76286008|FG000|STARTED|HIFU Treatment||7||
60159407|NCT03949517|76286009|FG001|STARTED|HIFU Treatment||7||
59751800|NCT00842829|75871131|FG001|STARTED|Treatment Period||0||
59751801|NCT00842829|75871132|FG002|STARTED|Treatment Period||281||
59751802|NCT00842829|75871130|FG000|Safety Analysis Set|Treatment Period||0||
59751803|NCT00842829|75871131|FG001|Safety Analysis Set|Treatment Period||0||
59751804|NCT00842829|75871132|FG002|Safety Analysis Set|Treatment Period|Received at least one dose of study drug|223||
59751805|NCT00842829|75871130|FG000|COMPLETED|Treatment Period||0||
59882403|NCT03253094|76005313|FG005|COMPLETED|Overall Study||28||
59882404|NCT03253094|76005308|FG000|NOT COMPLETED|Overall Study||4||
59882405|NCT03253094|76005309|FG001|NOT COMPLETED|Overall Study||3||
59882406|NCT03253094|76005310|FG002|NOT COMPLETED|Overall Study||6||
59751806|NCT00842829|75871131|FG001|COMPLETED|Treatment Period||0||
59751807|NCT00842829|75871132|FG002|COMPLETED|Treatment Period||218||
59882407|NCT03253094|76005311|FG003|NOT COMPLETED|Overall Study||4||
59882408|NCT03253094|76005312|FG004|NOT COMPLETED|Overall Study||5||
59882409|NCT03253094|76005313|FG005|NOT COMPLETED|Overall Study||4||
60159408|NCT03949517|76286008|FG000|COMPLETED|HIFU Treatment||7||
60159409|NCT03949517|76286009|FG001|COMPLETED|HIFU Treatment||7||
60159410|NCT03949517|76286008|FG000|NOT COMPLETED|HIFU Treatment||0||
60159411|NCT03949517|76286009|FG001|NOT COMPLETED|HIFU Treatment||0||
60159412|NCT03949517|76286008|FG000|STARTED|Post-HIFU Period, Imaging Timepoint 1||7||
60159413|NCT03949517|76286009|FG001|STARTED|Post-HIFU Period, Imaging Timepoint 1||7||
60159414|NCT03949517|76286008|FG000|COMPLETED|Post-HIFU Period, Imaging Timepoint 1||7||
60159415|NCT03949517|76286009|FG001|COMPLETED|Post-HIFU Period, Imaging Timepoint 1||7||
60159416|NCT03949517|76286008|FG000|NOT COMPLETED|Post-HIFU Period, Imaging Timepoint 1||0||
60159417|NCT03949517|76286009|FG001|NOT COMPLETED|Post-HIFU Period, Imaging Timepoint 1||0||
60159418|NCT03949517|76286008|FG000|STARTED|Post-HIFU Period, Imaging Timepoint 2||7||
60159419|NCT03949517|76286009|FG001|STARTED|Post-HIFU Period, Imaging Timepoint 2||7||
60159420|NCT03949517|76286008|FG000|COMPLETED|Post-HIFU Period, Imaging Timepoint 2||7||
60159421|NCT03949517|76286009|FG001|COMPLETED|Post-HIFU Period, Imaging Timepoint 2||7||
60159422|NCT03949517|76286008|FG000|NOT COMPLETED|Post-HIFU Period, Imaging Timepoint 2||0||
60159423|NCT03949517|76286009|FG001|NOT COMPLETED|Post-HIFU Period, Imaging Timepoint 2||0||
60159424|NCT03940586|76286018|FG000|STARTED|Overall Study||28|Randomized|
60159425|NCT03940586|76286019|FG001|STARTED|Overall Study||29|Randomized|
60159426|NCT03940586|76286020|FG002|STARTED|Overall Study||8|Randomized|
60159427|NCT03940586|76286018|FG000|Treated|Overall Study||28||
60159428|NCT03940586|76286019|FG001|Treated|Overall Study||27||
60159429|NCT03940586|76286020|FG002|Treated|Overall Study||8||
60159430|NCT03940586|76286018|FG000|COMPLETED|Overall Study||21|Through Week 48|
60159431|NCT03940586|76286019|FG001|COMPLETED|Overall Study||21|Through Week 48|
60159432|NCT03940586|76286020|FG002|COMPLETED|Overall Study||6|Through Week 48|
60159433|NCT03940586|76286018|FG000|NOT COMPLETED|Overall Study||7||
60159434|NCT03940586|76286019|FG001|NOT COMPLETED|Overall Study||8||
60159435|NCT03940586|76286020|FG002|NOT COMPLETED|Overall Study||2||
60159436|NCT03811535|76286063|FG000|STARTED|Overall Study||68||
60159437|NCT03811535|76286064|FG001|STARTED|Overall Study||132||
60159438|NCT03811535|76286063|FG000|COMPLETED|Overall Study||68||
60159439|NCT03811535|76286064|FG001|COMPLETED|Overall Study||132||
60159440|NCT03811535|76286063|FG000|NOT COMPLETED|Overall Study||0||
60159441|NCT03811535|76286064|FG001|NOT COMPLETED|Overall Study||0||
60159442|NCT03782974|76286072|FG000|STARTED|Overall Study||70||
60159443|NCT03782974|76286073|FG001|STARTED|Overall Study||68||
60159444|NCT03782974|76286072|FG000|COMPLETED|Overall Study||62||
60159445|NCT03782974|76286073|FG001|COMPLETED|Overall Study||61||
60159446|NCT03782974|76286072|FG000|NOT COMPLETED|Overall Study||8||
60159447|NCT03782974|76286073|FG001|NOT COMPLETED|Overall Study||7||
60159448|NCT03756168|76286081|FG000|STARTED|Overall Study||30||
60159449|NCT03756168|76286081|FG000|Had at Least 1 Treatment|Overall Study||29||
60159450|NCT03756168|76286081|FG000|COMPLETED|Overall Study||27||
60159451|NCT03756168|76286081|FG000|NOT COMPLETED|Overall Study||3||
60159452|NCT03698370|76286088|FG000|STARTED|First Scan||13||
60159453|NCT03698370|76286089|FG001|STARTED|First Scan||14||
60159454|NCT03698370|76286088|FG000|COMPLETED|First Scan||13||
60159455|NCT03698370|76286089|FG001|COMPLETED|First Scan||14||
60159456|NCT03698370|76286088|FG000|NOT COMPLETED|First Scan||0||
60159457|NCT03698370|76286089|FG001|NOT COMPLETED|First Scan||0||
60159458|NCT03698370|76286088|FG000|STARTED|Second Scan||13||
60159459|NCT03698370|76286089|FG001|STARTED|Second Scan||14||
60159460|NCT03698370|76286088|FG000|COMPLETED|Second Scan||13||
60159461|NCT03698370|76286089|FG001|COMPLETED|Second Scan||14||
60159462|NCT03698370|76286088|FG000|NOT COMPLETED|Second Scan||0||
60159463|NCT03698370|76286089|FG001|NOT COMPLETED|Second Scan||0||
60159464|NCT03674411|76286095|FG000|STARTED|Overall Study||22||
60159465|NCT03674411|76286095|FG000|COMPLETED|Overall Study||18||
60159466|NCT03674411|76286095|FG000|NOT COMPLETED|Overall Study||4||
60159467|NCT03655470|76286101|FG000|STARTED|Overall Study||29||
60159468|NCT03655470|76286102|FG001|STARTED|Overall Study||30||
60159469|NCT03655470|76286101|FG000|COMPLETED|Overall Study||23||
60159470|NCT03655470|76286102|FG001|COMPLETED|Overall Study||23||
60159471|NCT03655470|76286101|FG000|NOT COMPLETED|Overall Study||6||
60159472|NCT03655470|76286102|FG001|NOT COMPLETED|Overall Study||7||
60159473|NCT03570619|76286111|FG000|STARTED|Overall Study||33||
60159474|NCT03570619|76286112|FG001|STARTED|Overall Study||8||
60159475|NCT03570619|76286113|FG002|STARTED|Overall Study||15||
60159476|NCT03570619|76286111|FG000|COMPLETED|Overall Study||29||
60159477|NCT03570619|76286112|FG001|COMPLETED|Overall Study||5||
60159478|NCT03570619|76286113|FG002|COMPLETED|Overall Study||14||
60159479|NCT03570619|76286111|FG000|NOT COMPLETED|Overall Study||4||
60159480|NCT03570619|76286112|FG001|NOT COMPLETED|Overall Study||3||
60159481|NCT03570619|76286113|FG002|NOT COMPLETED|Overall Study||1||
60159482|NCT03568461|76286121|FG000|STARTED|Overall Study||98|Started = enrolled and entered pre-treatment phase|
60159483|NCT03568461|76286121|FG000|Treated|Overall Study||97|Treated = infused with tisagenlecleucel|
60159484|NCT03568461|76286121|FG000|Discontinued Prior to Infusion With Tisagenlecleucel|Overall Study||1||
60159485|NCT03568461|76286121|FG000|COMPLETED|Overall Study||80|Completed = Ongoing/in follow-up|
60159486|NCT03568461|76286121|FG000|NOT COMPLETED|Overall Study||18||
60159487|NCT03543254|76286125|FG000|STARTED|Overall Study||20||
60159488|NCT03543254|76286125|FG000|COMPLETED|Overall Study|The last patient being lost to follow up after the baseline period|19||
60159489|NCT03543254|76286125|FG000|NOT COMPLETED|Overall Study||1||
60159490|NCT03480282|76286130|FG000|STARTED|Overall Study||90||
60159491|NCT03480282|76286130|FG000|COMPLETED|Overall Study||90||
60159492|NCT03480282|76286130|FG000|NOT COMPLETED|Overall Study||0||
60159493|NCT03447769|76286136|FG000|STARTED|Overall Study||693||
60159494|NCT03447769|76286137|FG001|STARTED|Overall Study||689||
60159495|NCT03447769|76286136|FG000|Treated|Overall Study||692||
60159496|NCT03447769|76286137|FG001|Treated|Overall Study||689||
60159497|NCT03447769|76286136|FG000|COMPLETED|Overall Study||414|Participants who completed treatment|
60159498|NCT03447769|76286137|FG001|COMPLETED|Overall Study||420|Participants who completed treatment|
60159499|NCT03447769|76286136|FG000|NOT COMPLETED|Overall Study||279||
60159500|NCT03447769|76286137|FG001|NOT COMPLETED|Overall Study||269||
59751808|NCT00842829|75871130|FG000|NOT COMPLETED|Treatment Period||0||
59751809|NCT00842829|75871131|FG001|NOT COMPLETED|Treatment Period||0||
59751810|NCT00842829|75871132|FG002|NOT COMPLETED|Treatment Period||63||
60159501|NCT03446651|76286148|FG000|STARTED|Overall Study||22||
60159502|NCT03446651|76286149|FG001|STARTED|Overall Study||18||
60159503|NCT03446651|76286148|FG000|Participated in Open Label Portion|Overall Study||5||
60159504|NCT03446651|76286149|FG001|Participated in Open Label Portion|Overall Study||0||
60159505|NCT03446651|76286148|FG000|Completed 1st Visit|Overall Study||17||
60159506|NCT03446651|76286149|FG001|Completed 1st Visit|Overall Study||18||
60159507|NCT03446651|76286148|FG000|Completed Final Visit|Overall Study||13||
60159508|NCT03446651|76286149|FG001|Completed Final Visit|Overall Study||18||
60159509|NCT03446651|76286148|FG000|COMPLETED|Overall Study||13||
60159510|NCT03446651|76286149|FG001|COMPLETED|Overall Study||18||
60159511|NCT03446651|76286148|FG000|NOT COMPLETED|Overall Study||9||
60159512|NCT03446651|76286149|FG001|NOT COMPLETED|Overall Study||0||
60159513|NCT03442751|76286157|FG000|STARTED|Overall Study||156||189
60159514|NCT03442751|76286158|FG001|STARTED|Overall Study||83||90
60159515|NCT03442751|76286157|FG000|Month 6|Overall Study||153||186
60159516|NCT03442751|76286158|FG001|Month 6|Overall Study||82||89
60159517|NCT03442751|76286157|FG000|Month 12|Overall Study||150||183
60159518|NCT03442751|76286158|FG001|Month 12|Overall Study||0||0
60159519|NCT03442751|76286157|FG000|COMPLETED|Overall Study||150||183
60159520|NCT03442751|76286158|FG001|COMPLETED|Overall Study||82||89
60159521|NCT03442751|76286157|FG000|NOT COMPLETED|Overall Study||6||6
60159522|NCT03442751|76286158|FG001|NOT COMPLETED|Overall Study||1||1
60159523|NCT03304418|76286167|FG000|STARTED|Overall Study||20||
60159524|NCT03304418|76286167|FG000|COMPLETED|Overall Study||20||
60159525|NCT03304418|76286167|FG000|NOT COMPLETED|Overall Study||0||
60159526|NCT03255967|76286175|FG000|STARTED|Overall Study||238||
60159527|NCT03255967|76286176|FG001|STARTED|Overall Study||192||
60159528|NCT03255967|76286175|FG000|Number of Patients Started|Overall Study||119||
60159529|NCT03255967|76286176|FG001|Number of Patients Started|Overall Study||96||
60159530|NCT03255967|76286175|FG000|Number of Patients Completed|Overall Study||99||
60159531|NCT03255967|76286176|FG001|Number of Patients Completed|Overall Study||76||
60159532|NCT03255967|76286175|FG000|Number of Caregivers Started|Overall Study||119||
60159533|NCT03255967|76286176|FG001|Number of Caregivers Started|Overall Study||96||
60159534|NCT03255967|76286175|FG000|Number of Caregivers Completed|Overall Study||99||
60159535|NCT03255967|76286176|FG001|Number of Caregivers Completed|Overall Study||76||
60159536|NCT03255967|76286175|FG000|COMPLETED|Overall Study||198||
60159537|NCT03255967|76286176|FG001|COMPLETED|Overall Study||152||
60159538|NCT03255967|76286175|FG000|NOT COMPLETED|Overall Study||40||
60159539|NCT03255967|76286176|FG001|NOT COMPLETED|Overall Study||40||
60159540|NCT03151811|76286186|FG000|STARTED|Overall Study||246||
60159541|NCT03151811|76286187|FG001|STARTED|Overall Study||249||
60159542|NCT03151811|76286186|FG000|COMPLETED|Overall Study||0|Patients were to receive treatment until there was documented disease progression, unacceptable toxicity, or the patient/treating physician determined it was not in the patient's best interest to continue. The study Sponsor terminated the study before all patients reached one of these endpoints. Shown here are the reasons for study treatment discontinuation.|
60159543|NCT03151811|76286187|FG001|COMPLETED|Overall Study||0|Patients were to receive treatment until there was documented disease progression, unacceptable toxicity, or the patient/treating physician determined it was not in the patient's best interest to continue. The study Sponsor terminated the study before all patients reached one of these endpoints. Shown here are the reasons for study treatment discontinuation.|
60159544|NCT03151811|76286186|FG000|NOT COMPLETED|Overall Study||246||
60159545|NCT03151811|76286187|FG001|NOT COMPLETED|Overall Study||249||
60159546|NCT03110354|76286198|FG000|STARTED|Overall Study||4||
60159547|NCT03110354|76286199|FG001|STARTED|Overall Study||4||
60159548|NCT03110354|76286200|FG002|STARTED|Overall Study||3||
60159549|NCT03110354|76286201|FG003|STARTED|Overall Study||10||
59605913|NCT01963260|75716104|FG007|COMPLETED|Overall Study||2||
59605914|NCT01963260|75716105|FG008|COMPLETED|Overall Study||1||
60159550|NCT03110354|76286202|FG004|STARTED|Overall Study||7||
60159551|NCT03110354|76286198|FG000|COMPLETED|Overall Study||0||
60159552|NCT03110354|76286199|FG001|COMPLETED|Overall Study||0||
60159553|NCT03110354|76286200|FG002|COMPLETED|Overall Study||0||
60159554|NCT03110354|76286201|FG003|COMPLETED|Overall Study||0||
60159555|NCT03110354|76286202|FG004|COMPLETED|Overall Study||0||
60159556|NCT03110354|76286198|FG000|NOT COMPLETED|Overall Study||4||
60159557|NCT03110354|76286199|FG001|NOT COMPLETED|Overall Study||4||
60159558|NCT03110354|76286200|FG002|NOT COMPLETED|Overall Study||3||
60159559|NCT03110354|76286201|FG003|NOT COMPLETED|Overall Study||10||
60159560|NCT03110354|76286202|FG004|NOT COMPLETED|Overall Study||7||
60159561|NCT03064126|76286218|FG000|STARTED|Overall Study||278||
60159562|NCT03064126|76286219|FG001|STARTED|Overall Study||98||
60159563|NCT03064126|76286220|FG002|STARTED|Overall Study||52||
60159564|NCT03064126|76286221|FG003|STARTED|Overall Study||12||
60159565|NCT03064126|76286218|FG000|COMPLETED|Overall Study||252||
60159566|NCT03064126|76286219|FG001|COMPLETED|Overall Study||91||
60159567|NCT03064126|76286220|FG002|COMPLETED|Overall Study||49||
60159568|NCT03064126|76286221|FG003|COMPLETED|Overall Study||11||
60159569|NCT03064126|76286218|FG000|NOT COMPLETED|Overall Study||26||
60159570|NCT03064126|76286219|FG001|NOT COMPLETED|Overall Study||7||
60159571|NCT03064126|76286220|FG002|NOT COMPLETED|Overall Study||3||
60159572|NCT03064126|76286221|FG003|NOT COMPLETED|Overall Study||1||
60159573|NCT02950259|76286234|FG000|STARTED|Overall Study||16||
60159574|NCT02950259|76286235|FG001|STARTED|Overall Study||0||
60159575|NCT02950259|76286234|FG000|COMPLETED|Overall Study||16||
60159576|NCT02950259|76286235|FG001|COMPLETED|Overall Study||0||
60159577|NCT02950259|76286234|FG000|NOT COMPLETED|Overall Study||0||
60159578|NCT02950259|76286235|FG001|NOT COMPLETED|Overall Study||0||
60159579|NCT02887586|76286243|FG000|STARTED|Overall Study||30||
60159580|NCT02887586|76286244|FG001|STARTED|Overall Study||30||
60159581|NCT02887586|76286243|FG000|COMPLETED|Overall Study||27||
60159582|NCT02887586|76286244|FG001|COMPLETED|Overall Study||28||
60159583|NCT02887586|76286243|FG000|NOT COMPLETED|Overall Study||3||
60159584|NCT02887586|76286244|FG001|NOT COMPLETED|Overall Study||2||
60159585|NCT02737566|76286253|FG000|STARTED|Overall Study||159||
60159586|NCT02737566|76286254|FG001|STARTED|Overall Study||161||
60159587|NCT02737566|76286253|FG000|COMPLETED|Overall Study||104||
60159588|NCT02737566|76286254|FG001|COMPLETED|Overall Study||105||
60159589|NCT02737566|76286253|FG000|NOT COMPLETED|Overall Study||55||
60159590|NCT02737566|76286254|FG001|NOT COMPLETED|Overall Study||56||
60159591|NCT02706951|76286263|FG000|STARTED|Period 1||216||
60159592|NCT02706951|76286264|FG001|STARTED|Period 1||217||
60159593|NCT02706951|76286265|FG002|STARTED|Period 1||215||
60159594|NCT02706951|76286266|FG003|STARTED|Period 1||0||
60159595|NCT02706951|76286267|FG004|STARTED|Period 1||0||
60159596|NCT02706951|76286263|FG000|COMPLETED|Period 1||203|Completed Period 1 (Week 14) study participation|
60159597|NCT02706951|76286264|FG001|COMPLETED|Period 1||201|Completed Period 1 (Week 14) study participation|
60159598|NCT02706951|76286265|FG002|COMPLETED|Period 1||205|Completed Period 1 (Week 14) study participation|
60159599|NCT02706951|76286266|FG003|COMPLETED|Period 1||0|Completed Period 1 (Week 14) study participation|
60159600|NCT02706951|76286267|FG004|COMPLETED|Period 1||0|Completed Period 1 (Week 14) study participation|
60159601|NCT02706951|76286263|FG000|NOT COMPLETED|Period 1||13||
60159602|NCT02706951|76286264|FG001|NOT COMPLETED|Period 1||16||
60159603|NCT02706951|76286265|FG002|NOT COMPLETED|Period 1||10||
60159604|NCT02706951|76286266|FG003|NOT COMPLETED|Period 1||0||
60159605|NCT02706951|76286267|FG004|NOT COMPLETED|Period 1||0||
60159606|NCT02706951|76286263|FG000|STARTED|Period 2||0||
60159607|NCT02706951|76286264|FG001|STARTED|Period 2||0||
60159608|NCT02706951|76286265|FG002|STARTED|Period 2||0||
60159609|NCT02706951|76286266|FG003|STARTED|Period 2||302||
60159610|NCT02706951|76286267|FG004|STARTED|Period 2||300||
60159611|NCT02706951|76286263|FG000|COMPLETED|Period 2||0||
60159612|NCT02706951|76286264|FG001|COMPLETED|Period 2||0||
60159613|NCT02706951|76286265|FG002|COMPLETED|Period 2||0||
60159614|NCT02706951|76286266|FG003|COMPLETED|Period 2||184||
60159615|NCT02706951|76286267|FG004|COMPLETED|Period 2||180||
60159616|NCT02706951|76286263|FG000|NOT COMPLETED|Period 2||0||
60159617|NCT02706951|76286264|FG001|NOT COMPLETED|Period 2||0||
60159618|NCT02706951|76286265|FG002|NOT COMPLETED|Period 2||0||
60159619|NCT02706951|76286266|FG003|NOT COMPLETED|Period 2||118||
60159620|NCT02706951|76286267|FG004|NOT COMPLETED|Period 2||120||
60159621|NCT02609386|76286280|FG000|STARTED|Overall Study||70||
60159622|NCT02609386|76286281|FG001|STARTED|Overall Study||35||
60159623|NCT02609386|76286280|FG000|COMPLETED|Overall Study||42||
60159624|NCT02609386|76286281|FG001|COMPLETED|Overall Study||18||
60159625|NCT02609386|76286280|FG000|NOT COMPLETED|Overall Study||28||
59751811|NCT00842829|75871130|FG000|STARTED|Continuation Period||0||
60159626|NCT02609386|76286281|FG001|NOT COMPLETED|Overall Study||17||
60159627|NCT02576717|76286291|FG000|STARTED|Overall Study||740|Started = ITT Participants were included in the treatment group based on the planned treatment (received at randomization) in the parent study.|
60159628|NCT02576717|76286292|FG001|STARTED|Overall Study||875|Started = ITT Participants were included in the treatment group based on the planned treatment (received at randomization) in the parent study.|
60159629|NCT02576717|76286293|FG002|STARTED|Overall Study||879|Started = ITT Participants were included in the treatment group based on the planned treatment (received at randomization) in the parent study.|
60159630|NCT02576717|76286291|FG000|Transferred From IFN β-1a Parent Group|Overall Study||0||
60159631|NCT02576717|76286292|FG001|Transferred From IFN β-1a Parent Group|Overall Study|Participants were planned for IFN β-1a received RPC1063 0.5 mg|3||
60159632|NCT02576717|76286293|FG002|Transferred From IFN β-1a Parent Group|Overall Study|Participant was planned for IFN β 1a but received RPC1063 1 mg|1||
60159633|NCT02576717|76286291|FG000|Transferred From RPC1063 0.5 mg Parent Group|Overall Study||0||
60159634|NCT02576717|76286292|FG001|Transferred From RPC1063 0.5 mg Parent Group|Overall Study||0||
60159635|NCT02576717|76286293|FG002|Transferred From RPC1063 0.5 mg Parent Group|Overall Study|Participant was planned for RPC1063 0.5 mg but received RPC1063 1 mg|1||
60159636|NCT02576717|76286291|FG000|Randomized to Placebo in the Parent Study|Overall Study||0||
60159637|NCT02576717|76286292|FG001|Randomized to Placebo in the Parent Study|Overall Study||37||
60159638|NCT02576717|76286293|FG002|Randomized to Placebo in the Parent Study|Overall Study||35||
60159639|NCT02576717|76286291|FG000|Safety Population|Overall Study||736|Participants were included in the treatment group based on the treatment that they actually received in the parent study.|
59950824|NCT02408120|76069709|FG000|COMPLETED|Overall Study||108||
60159640|NCT02576717|76286292|FG001|Safety Population|Overall Study||877|Participants were included in the treatment group based on the treatment that they actually received in the parent study.|
60159641|NCT02576717|76286293|FG002|Safety Population|Overall Study||881|Participants were included in the treatment group based on the treatment that they actually received in the parent study.|
60159642|NCT02576717|76286291|FG000|COMPLETED|Overall Study||564||
60159643|NCT02576717|76286292|FG001|COMPLETED|Overall Study||691||
60159644|NCT02576717|76286293|FG002|COMPLETED|Overall Study||695||
60159645|NCT02576717|76286291|FG000|NOT COMPLETED|Overall Study||176||
60159646|NCT02576717|76286292|FG001|NOT COMPLETED|Overall Study||184||
60159647|NCT02576717|76286293|FG002|NOT COMPLETED|Overall Study||184||
60159648|NCT02554474|76286306|FG000|STARTED|Overall Study||59||
60159649|NCT02554474|76286307|FG001|STARTED|Overall Study||59||
60159650|NCT02554474|76286306|FG000|COMPLETED|Overall Study|Indicates number of participants who completed assessment at the primary endpoint.|56||
60159651|NCT02554474|76286307|FG001|COMPLETED|Overall Study|Indicates number of participants who completed assessment at the primary endpoint.|57||
60159652|NCT02554474|76286306|FG000|NOT COMPLETED|Overall Study||3||
60159653|NCT02554474|76286307|FG001|NOT COMPLETED|Overall Study||2||
60159654|NCT02535845|76286317|FG000|STARTED|Overall Study||7||
60159655|NCT02535845|76286318|FG001|STARTED|Overall Study||7||
60159656|NCT02535845|76286319|FG002|STARTED|Overall Study||4||
60159657|NCT02535845|76286320|FG003|STARTED|Overall Study||4||
60159658|NCT02535845|76286317|FG000|COMPLETED|Overall Study||7||
60159659|NCT02535845|76286318|FG001|COMPLETED|Overall Study||7||
60159660|NCT02535845|76286319|FG002|COMPLETED|Overall Study||4||
60159661|NCT02535845|76286320|FG003|COMPLETED|Overall Study||4||
60159662|NCT02535845|76286317|FG000|NOT COMPLETED|Overall Study||0||
60159663|NCT02535845|76286318|FG001|NOT COMPLETED|Overall Study||0||
60159664|NCT02535845|76286319|FG002|NOT COMPLETED|Overall Study||0||
60159665|NCT02535845|76286320|FG003|NOT COMPLETED|Overall Study||0||
60159666|NCT02517307|76286336|FG000|STARTED|Overall Study||11||
60159667|NCT02517307|76286337|FG001|STARTED|Overall Study||8||
60159668|NCT02517307|76286338|FG002|STARTED|Overall Study||11||
60159669|NCT02517307|76286339|FG003|STARTED|Overall Study||11||
60159670|NCT02517307|76286336|FG000|COMPLETED|Overall Study||10||
60159671|NCT02517307|76286337|FG001|COMPLETED|Overall Study||8||
60159672|NCT02517307|76286338|FG002|COMPLETED|Overall Study||9||
60159673|NCT02517307|76286339|FG003|COMPLETED|Overall Study||10||
60159674|NCT02517307|76286336|FG000|NOT COMPLETED|Overall Study||1||
60159675|NCT02517307|76286337|FG001|NOT COMPLETED|Overall Study||0||
60159676|NCT02517307|76286338|FG002|NOT COMPLETED|Overall Study||2||
60159677|NCT02517307|76286339|FG003|NOT COMPLETED|Overall Study||1||
60159678|NCT02499354|76286351|FG000|STARTED|Overall Study||46||
60159679|NCT02499354|76286352|FG001|STARTED|Overall Study||47||
60159680|NCT02499354|76286351|FG000|COMPLETED|Overall Study||45||
60159681|NCT02499354|76286352|FG001|COMPLETED|Overall Study||47||
60159682|NCT02499354|76286351|FG000|NOT COMPLETED|Overall Study||1||
60159683|NCT02499354|76286352|FG001|NOT COMPLETED|Overall Study||0||
60159684|NCT02369835|76286360|FG000|STARTED|Overall Study||64||
60159685|NCT02369835|76286361|FG001|STARTED|Overall Study||68||
60159686|NCT02369835|76286360|FG000|COMPLETED|Overall Study|Reasons that participants did not complete for the Primary Outcome are not available.|53||
60159687|NCT02369835|76286361|FG001|COMPLETED|Overall Study|Reasons that participants did not complete for the Primary Outcome are not available.|55||
60159688|NCT02369835|76286360|FG000|NOT COMPLETED|Overall Study||11||
60159689|NCT02369835|76286361|FG001|NOT COMPLETED|Overall Study||13||
60159690|NCT02367859|76286367|FG000|STARTED|Overall Study||1||
60159691|NCT02367859|76286367|FG000|COMPLETED|Overall Study||1||
60159692|NCT02367859|76286367|FG000|NOT COMPLETED|Overall Study||0||
60011338|NCT04342169|76127221|FG000|COMPLETED|Overall Study||89||
60011339|NCT04342169|76127222|FG001|COMPLETED|Overall Study||89||
60011340|NCT04342169|76127221|FG000|NOT COMPLETED|Overall Study||96||
60159693|NCT02362503|76286374|FG000|STARTED|Double-blind Period-Up to 8 Days||69||
60159694|NCT02362503|76286375|FG001|STARTED|Double-blind Period-Up to 8 Days||203||
60159695|NCT02362503|76286376|FG002|STARTED|Double-blind Period-Up to 8 Days||0||
60159696|NCT02362503|76286374|FG000|COMPLETED|Double-blind Period-Up to 8 Days||68||
60159697|NCT02362503|76286375|FG001|COMPLETED|Double-blind Period-Up to 8 Days||199||
60159698|NCT02362503|76286376|FG002|COMPLETED|Double-blind Period-Up to 8 Days||0||
60159699|NCT02362503|76286374|FG000|NOT COMPLETED|Double-blind Period-Up to 8 Days||1||
60159700|NCT02362503|76286375|FG001|NOT COMPLETED|Double-blind Period-Up to 8 Days||4||
60159701|NCT02362503|76286376|FG002|NOT COMPLETED|Double-blind Period-Up to 8 Days||0||
60159702|NCT02362503|76286374|FG000|STARTED|Open Label Period-Up to 96 Weeks||68||
60159703|NCT02362503|76286375|FG001|STARTED|Open Label Period-Up to 96 Weeks||199||
60159704|NCT02362503|76286376|FG002|STARTED|Open Label Period-Up to 96 Weeks||99||
60159705|NCT02362503|76286374|FG000|COMPLETED|Open Label Period-Up to 96 Weeks||0||
60159706|NCT02362503|76286375|FG001|COMPLETED|Open Label Period-Up to 96 Weeks||0||
60159707|NCT02362503|76286376|FG002|COMPLETED|Open Label Period-Up to 96 Weeks||0||
60159708|NCT02362503|76286374|FG000|NOT COMPLETED|Open Label Period-Up to 96 Weeks||68||
60159709|NCT02362503|76286375|FG001|NOT COMPLETED|Open Label Period-Up to 96 Weeks||199||
60011341|NCT04342169|76127222|FG001|NOT COMPLETED|Overall Study||94||
60011342|NCT01669811|76127230|FG000|STARTED|Overall Study||145||
59751812|NCT00842829|75871131|FG001|STARTED|Continuation Period||0||
59751813|NCT00842829|75871132|FG002|STARTED|Continuation Period|Eligible for Continuation Period|88||
59751814|NCT00842829|75871130|FG000|Continuation Safety Analysis Set|Continuation Period||0||
60011343|NCT01669811|76127231|FG001|STARTED|Overall Study||142||
60011344|NCT01669811|76127230|FG000|COMPLETED|Overall Study||142||
60011345|NCT01669811|76127231|FG001|COMPLETED|Overall Study||131||
60011346|NCT01669811|76127230|FG000|NOT COMPLETED|Overall Study||3||
60011347|NCT01669811|76127231|FG001|NOT COMPLETED|Overall Study||11||
60011348|NCT01669577|76127237|FG000|STARTED|Overall Study|calculated ISS<16, no informed consent, not enough data(complete case analysis), were excluded|334||
60011349|NCT01669577|76127237|FG000|COMPLETED|Overall Study|complete case analysis (data missing completely at random)|200||
60159710|NCT02362503|76286376|FG002|NOT COMPLETED|Open Label Period-Up to 96 Weeks||99||
60159711|NCT02224924|76286389|FG000|STARTED|Overall Study||226||
60159712|NCT02224924|76286390|FG001|STARTED|Overall Study||228||
60159713|NCT02224924|76286389|FG000|COMPLETED|Overall Study||156||
60159714|NCT02224924|76286390|FG001|COMPLETED|Overall Study||162||
60159715|NCT02224924|76286389|FG000|NOT COMPLETED|Overall Study||70||
60159716|NCT02224924|76286390|FG001|NOT COMPLETED|Overall Study||66||
60159717|NCT02152956|76286409|FG000|STARTED|Overall Study||1||
60159718|NCT02152956|76286410|FG001|STARTED|Overall Study||4||
60159719|NCT02152956|76286411|FG002|STARTED|Overall Study||5||
60159720|NCT02152956|76286412|FG003|STARTED|Overall Study||4||
60159721|NCT02152956|76286413|FG004|STARTED|Overall Study||3||
60159722|NCT02152956|76286414|FG005|STARTED|Overall Study||4||
60159723|NCT02152956|76286415|FG006|STARTED|Overall Study||6||
60159724|NCT02152956|76286416|FG007|STARTED|Overall Study||6||
60159725|NCT02152956|76286417|FG008|STARTED|Overall Study||6||
60159726|NCT02152956|76286418|FG009|STARTED|Overall Study||5||
60159727|NCT02152956|76286419|FG010|STARTED|Overall Study||3||
60159728|NCT02152956|76286420|FG011|STARTED|Overall Study||185||
60159729|NCT02152956|76286421|FG012|STARTED|Overall Study||12||
60159730|NCT02152956|76286409|FG000|COMPLETED|Overall Study||0||
60159731|NCT02152956|76286410|FG001|COMPLETED|Overall Study||0||
60159732|NCT02152956|76286411|FG002|COMPLETED|Overall Study||1||
60159733|NCT02152956|76286412|FG003|COMPLETED|Overall Study||0||
60159734|NCT02152956|76286413|FG004|COMPLETED|Overall Study||0||
60159735|NCT02152956|76286414|FG005|COMPLETED|Overall Study||0||
60159736|NCT02152956|76286415|FG006|COMPLETED|Overall Study||0||
60159737|NCT02152956|76286416|FG007|COMPLETED|Overall Study||0||
60159738|NCT02152956|76286417|FG008|COMPLETED|Overall Study||0||
60159739|NCT02152956|76286418|FG009|COMPLETED|Overall Study||0||
60159740|NCT02152956|76286419|FG010|COMPLETED|Overall Study||0||
60159741|NCT02152956|76286420|FG011|COMPLETED|Overall Study||0||
60159742|NCT02152956|76286421|FG012|COMPLETED|Overall Study||0||
60159743|NCT02152956|76286409|FG000|NOT COMPLETED|Overall Study||1||
60159744|NCT02152956|76286410|FG001|NOT COMPLETED|Overall Study||4||
60159745|NCT02152956|76286411|FG002|NOT COMPLETED|Overall Study||4||
60159746|NCT02152956|76286412|FG003|NOT COMPLETED|Overall Study||4||
60159747|NCT02152956|76286413|FG004|NOT COMPLETED|Overall Study||3||
60159748|NCT02152956|76286414|FG005|NOT COMPLETED|Overall Study||4||
60159749|NCT02152956|76286415|FG006|NOT COMPLETED|Overall Study||6||
60159750|NCT02152956|76286416|FG007|NOT COMPLETED|Overall Study||6||
60159751|NCT02152956|76286417|FG008|NOT COMPLETED|Overall Study||6||
60159752|NCT02152956|76286418|FG009|NOT COMPLETED|Overall Study||5||
60159753|NCT02152956|76286419|FG010|NOT COMPLETED|Overall Study||3||
60159754|NCT02152956|76286420|FG011|NOT COMPLETED|Overall Study||185||
60159755|NCT02152956|76286421|FG012|NOT COMPLETED|Overall Study||12||
60159756|NCT02127164|76286487|FG000|STARTED|Overall Study||18||
60159757|NCT02127164|76286487|FG000|COMPLETED|Overall Study||18||
60159758|NCT02127164|76286487|FG000|NOT COMPLETED|Overall Study||0||
60159759|NCT02096549|76286491|FG000|STARTED|Overall Study||20||
60159760|NCT02096549|76286491|FG000|COMPLETED|Overall Study||20||
60159761|NCT02096549|76286491|FG000|NOT COMPLETED|Overall Study||0||
59751815|NCT00842829|75871131|FG001|Continuation Safety Analysis Set|Continuation Period||0||
60011350|NCT01669577|76127237|FG000|NOT COMPLETED|Overall Study||134||
60159762|NCT01841736|76286497|FG000|STARTED|Overall Study||97||
60159763|NCT01841736|76286498|FG001|STARTED|Overall Study||74||
60159764|NCT01841736|76286497|FG000|Crossover|Overall Study||0|Crossed over for pazopanib following disease progression on placebo|
60159765|NCT01841736|76286498|FG001|Crossover|Overall Study||49|Crossed over for pazopanib following disease progression on placebo|
60159766|NCT01841736|76286497|FG000|COMPLETED|Overall Study||97|Included in efficacy analysis|
60159767|NCT01841736|76286498|FG001|COMPLETED|Overall Study||74|Included in efficacy analysis|
60159768|NCT01841736|76286497|FG000|NOT COMPLETED|Overall Study||0||
60159769|NCT01841736|76286498|FG001|NOT COMPLETED|Overall Study||0||
60159770|NCT01811498|76286505|FG000|STARTED|Overall Study||31||
60159771|NCT01811498|76286505|FG000|COMPLETED|Overall Study||23||
60159772|NCT01811498|76286505|FG000|NOT COMPLETED|Overall Study||8||
60159773|NCT01553149|76286511|FG000|STARTED|Overall Study||37||
60159774|NCT01553149|76286512|FG001|STARTED|Overall Study||38||
60159775|NCT01553149|76286511|FG000|COMPLETED|Overall Study||32||
60159776|NCT01553149|76286512|FG001|COMPLETED|Overall Study||18||
60159777|NCT01553149|76286511|FG000|NOT COMPLETED|Overall Study||5||
60159778|NCT01553149|76286512|FG001|NOT COMPLETED|Overall Study||20||
60159779|NCT01522469|76286520|FG000|STARTED|Overall Study||9||
60159780|NCT01522469|76286521|FG001|STARTED|Overall Study||4||
60159781|NCT01522469|76286520|FG000|COMPLETED|Overall Study||9||
60159782|NCT01522469|76286521|FG001|COMPLETED|Overall Study||4||
60159783|NCT01522469|76286520|FG000|NOT COMPLETED|Overall Study||0||
60159784|NCT01522469|76286521|FG001|NOT COMPLETED|Overall Study||0||
60159785|NCT01468337|76286527|FG000|STARTED|Overall Study||5||
60159786|NCT01468337|76286527|FG000|Week 2|Overall Study||5||
60159787|NCT01468337|76286527|FG000|Received Interferon Gamma-1b at Week 4|Overall Study|One participant received additional Interferon gamma-1b dosing at Week 4 and after Week 8|2||
60159788|NCT01468337|76286527|FG000|Received Interferon Gamma-1b After Wk 8|Overall Study|Two participants had 2 Interferon gamma-1b dosing cycles after Wk 8|4||
60159789|NCT01468337|76286527|FG000|Week 48|Overall Study|Two participants did not have a Week 48 visit but completed the study.|3||
60159790|NCT01468337|76286527|FG000|COMPLETED|Overall Study||5||
60159791|NCT01468337|76286527|FG000|NOT COMPLETED|Overall Study||0||
60159792|NCT01437449|76286531|FG000|STARTED|Overall Study||27||
60159793|NCT01437449|76286531|FG000|COMPLETED|Overall Study||27||
60159794|NCT01437449|76286531|FG000|NOT COMPLETED|Overall Study||0||
60159795|NCT01437189|76286535|FG000|STARTED|Overall Study||35||
60159796|NCT01437189|76286535|FG000|COMPLETED|Overall Study||20||
60159797|NCT01437189|76286535|FG000|NOT COMPLETED|Overall Study||15||
60159798|NCT01341600|76286542|FG000|STARTED|Clopidogrel 75 mg||6||
60159799|NCT01341600|76286543|FG001|STARTED|Clopidogrel 75 mg||6||
60159800|NCT01341600|76286544|FG002|STARTED|Clopidogrel 75 mg||6||
60159801|NCT01341600|76286542|FG000|COMPLETED|Clopidogrel 75 mg||6||
60159802|NCT01341600|76286543|FG001|COMPLETED|Clopidogrel 75 mg||6||
60159803|NCT01341600|76286544|FG002|COMPLETED|Clopidogrel 75 mg||6||
60159804|NCT01341600|76286542|FG000|NOT COMPLETED|Clopidogrel 75 mg||0||
60159805|NCT01341600|76286543|FG001|NOT COMPLETED|Clopidogrel 75 mg||0||
60159806|NCT01341600|76286544|FG002|NOT COMPLETED|Clopidogrel 75 mg||0||
60159807|NCT01341600|76286542|FG000|STARTED|Clopidogrel 150 mg||6||
60159808|NCT01341600|76286543|FG001|STARTED|Clopidogrel 150 mg||6||
60159809|NCT01341600|76286544|FG002|STARTED|Clopidogrel 150 mg||6||
60159810|NCT01341600|76286542|FG000|COMPLETED|Clopidogrel 150 mg||6||
60159811|NCT01341600|76286543|FG001|COMPLETED|Clopidogrel 150 mg||6||
60159812|NCT01341600|76286544|FG002|COMPLETED|Clopidogrel 150 mg||6||
60159813|NCT01341600|76286542|FG000|NOT COMPLETED|Clopidogrel 150 mg||0||
60159814|NCT01341600|76286543|FG001|NOT COMPLETED|Clopidogrel 150 mg||0||
60159815|NCT01341600|76286544|FG002|NOT COMPLETED|Clopidogrel 150 mg||0||
60159816|NCT01341600|76286542|FG000|STARTED|Clopidogrel 225 mg||6||
60159817|NCT01341600|76286543|FG001|STARTED|Clopidogrel 225 mg||6||
60159818|NCT01341600|76286544|FG002|STARTED|Clopidogrel 225 mg||6||
60159819|NCT01341600|76286542|FG000|COMPLETED|Clopidogrel 225 mg||6||
60159820|NCT01341600|76286543|FG001|COMPLETED|Clopidogrel 225 mg||6||
60159821|NCT01341600|76286544|FG002|COMPLETED|Clopidogrel 225 mg||6||
60159822|NCT01341600|76286542|FG000|NOT COMPLETED|Clopidogrel 225 mg||0||
60159823|NCT01341600|76286543|FG001|NOT COMPLETED|Clopidogrel 225 mg||0||
60159824|NCT01341600|76286544|FG002|NOT COMPLETED|Clopidogrel 225 mg||0||
60159825|NCT01341600|76286542|FG000|STARTED|Clopidogrel Plus Omeprazole||5||
60159826|NCT01341600|76286543|FG001|STARTED|Clopidogrel Plus Omeprazole||5||
60159827|NCT01341600|76286544|FG002|STARTED|Clopidogrel Plus Omeprazole||4||
60159828|NCT01341600|76286542|FG000|COMPLETED|Clopidogrel Plus Omeprazole||5||
60159829|NCT01341600|76286543|FG001|COMPLETED|Clopidogrel Plus Omeprazole||5||
60159830|NCT01341600|76286544|FG002|COMPLETED|Clopidogrel Plus Omeprazole||4||
60159831|NCT01341600|76286542|FG000|NOT COMPLETED|Clopidogrel Plus Omeprazole||0||
60159832|NCT01341600|76286543|FG001|NOT COMPLETED|Clopidogrel Plus Omeprazole||0||
60159833|NCT01341600|76286544|FG002|NOT COMPLETED|Clopidogrel Plus Omeprazole||0||
60159834|NCT01311713|76286559|FG000|STARTED|Overall Study||3||
60159835|NCT01311713|76286560|FG001|STARTED|Overall Study||7||
60159836|NCT01311713|76286561|FG002|STARTED|Overall Study||9||
60159837|NCT01311713|76286562|FG003|STARTED|Overall Study||6||
60159838|NCT01311713|76286563|FG004|STARTED|Overall Study||5||
60159839|NCT01311713|76286564|FG005|STARTED|Overall Study||6||
60159840|NCT01311713|76286565|FG006|STARTED|Overall Study||9||
60159841|NCT01311713|76286559|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3||
60159842|NCT01311713|76286560|FG001|Received at Least 1 Dose of Study Drug|Overall Study||7||
60159843|NCT01311713|76286561|FG002|Received at Least 1 Dose of Study Drug|Overall Study||8||
60159844|NCT01311713|76286562|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6||
60159845|NCT01311713|76286563|FG004|Received at Least 1 Dose of Study Drug|Overall Study||5||
60159846|NCT01311713|76286564|FG005|Received at Least 1 Dose of Study Drug|Overall Study||6||
60159847|NCT01311713|76286565|FG006|Received at Least 1 Dose of Study Drug|Overall Study||9||
60159848|NCT01311713|76286559|FG000|COMPLETED|Overall Study||0||
60159849|NCT01311713|76286560|FG001|COMPLETED|Overall Study||0||
60159850|NCT01311713|76286561|FG002|COMPLETED|Overall Study||0||
60159851|NCT01311713|76286562|FG003|COMPLETED|Overall Study||0||
60159852|NCT01311713|76286563|FG004|COMPLETED|Overall Study||0||
60159853|NCT01311713|76286564|FG005|COMPLETED|Overall Study||0||
60159854|NCT01311713|76286565|FG006|COMPLETED|Overall Study||0||
60159855|NCT01311713|76286559|FG000|NOT COMPLETED|Overall Study||3||
60159856|NCT01311713|76286560|FG001|NOT COMPLETED|Overall Study||7||
60159857|NCT01311713|76286561|FG002|NOT COMPLETED|Overall Study||9||
60159858|NCT01311713|76286562|FG003|NOT COMPLETED|Overall Study||6||
60159859|NCT01311713|76286563|FG004|NOT COMPLETED|Overall Study||5||
60159860|NCT01311713|76286564|FG005|NOT COMPLETED|Overall Study||6||
60159861|NCT01311713|76286565|FG006|NOT COMPLETED|Overall Study||9||
60159862|NCT01303068|76286584|FG000|STARTED|Overall Study||6||
60159863|NCT01303068|76286585|FG001|STARTED|Overall Study||6||
60159864|NCT01303068|76286584|FG000|COMPLETED|Overall Study||6||
60159865|NCT01303068|76286585|FG001|COMPLETED|Overall Study||6||
60159866|NCT01303068|76286584|FG000|NOT COMPLETED|Overall Study||0||
60159867|NCT01303068|76286585|FG001|NOT COMPLETED|Overall Study||0||
60159868|NCT01038765|76286593|FG000|STARTED|Overall Study||111||
60159869|NCT01038765|76286594|FG001|STARTED|Overall Study||108||
60159870|NCT01038765|76286593|FG000|COMPLETED|Overall Study||102||
60159871|NCT01038765|76286594|FG001|COMPLETED|Overall Study||103||
60159872|NCT01038765|76286593|FG000|NOT COMPLETED|Overall Study||9||
60159873|NCT01038765|76286594|FG001|NOT COMPLETED|Overall Study||5||
60159874|NCT00928226|76286605|FG000|STARTED|Overall Study||20||
60159875|NCT00928226|76286606|FG001|STARTED|Overall Study||12||
60159876|NCT00928226|76286607|FG002|STARTED|Overall Study||12||
60159877|NCT00928226|76286608|FG003|STARTED|Overall Study||12||
60159878|NCT00928226|76286605|FG000|Strata A: Small Tumor, Resected|Overall Study||6||
60159879|NCT00928226|76286606|FG001|Strata A: Small Tumor, Resected|Overall Study||6||
60159880|NCT00928226|76286607|FG002|Strata A: Small Tumor, Resected|Overall Study||6||
60159881|NCT00928226|76286608|FG003|Strata A: Small Tumor, Resected|Overall Study||6||
60159882|NCT00928226|76286605|FG000|Strata B: Small Tumor, Not Resected|Overall Study||5||
60159883|NCT00928226|76286606|FG001|Strata B: Small Tumor, Not Resected|Overall Study||0||
60159884|NCT00928226|76286607|FG002|Strata B: Small Tumor, Not Resected|Overall Study||0||
60159885|NCT00928226|76286608|FG003|Strata B: Small Tumor, Not Resected|Overall Study||0||
60159886|NCT00928226|76286605|FG000|Strata C: Large Tumor, Resected|Overall Study||8||
60159887|NCT00928226|76286606|FG001|Strata C: Large Tumor, Resected|Overall Study||6||
60159888|NCT00928226|76286607|FG002|Strata C: Large Tumor, Resected|Overall Study||6||
60159889|NCT00928226|76286608|FG003|Strata C: Large Tumor, Resected|Overall Study||6||
60159890|NCT00928226|76286605|FG000|Strata D: Large Tumor, Not Resected|Overall Study||1||
60159891|NCT00928226|76286606|FG001|Strata D: Large Tumor, Not Resected|Overall Study||0||
60159892|NCT00928226|76286607|FG002|Strata D: Large Tumor, Not Resected|Overall Study||0||
60159893|NCT00928226|76286608|FG003|Strata D: Large Tumor, Not Resected|Overall Study||0||
60159894|NCT00928226|76286605|FG000|COMPLETED|Overall Study||20||
60159895|NCT00928226|76286606|FG001|COMPLETED|Overall Study||12||
60159896|NCT00928226|76286607|FG002|COMPLETED|Overall Study||12||
60159897|NCT00928226|76286608|FG003|COMPLETED|Overall Study||12||
60159898|NCT00928226|76286605|FG000|NOT COMPLETED|Overall Study||0||
60159899|NCT00928226|76286606|FG001|NOT COMPLETED|Overall Study||0||
60159900|NCT00928226|76286607|FG002|NOT COMPLETED|Overall Study||0||
60159901|NCT00928226|76286608|FG003|NOT COMPLETED|Overall Study||0||
60159902|NCT00728884|76286618|FG000|STARTED|Implant Placement Surgery||162||
60159903|NCT00728884|76286618|FG000|COMPLETED|Implant Placement Surgery||162||
60159904|NCT00728884|76286618|FG000|NOT COMPLETED|Implant Placement Surgery||0||
60159905|NCT00728884|76286618|FG000|STARTED|Permanent Prosthesis Placement||162||
60159906|NCT00728884|76286618|FG000|COMPLETED|Permanent Prosthesis Placement||149||
60159907|NCT00728884|76286618|FG000|NOT COMPLETED|Permanent Prosthesis Placement||13||
60159908|NCT00728884|76286618|FG000|STARTED|One Year Post Placement Follow-up||149||
60159909|NCT00728884|76286618|FG000|COMPLETED|One Year Post Placement Follow-up||145||
60159910|NCT00728884|76286618|FG000|NOT COMPLETED|One Year Post Placement Follow-up||4||
60159911|NCT00728884|76286618|FG000|STARTED|Two Year Post Placement Follow-up||145||
60159912|NCT00728884|76286618|FG000|COMPLETED|Two Year Post Placement Follow-up||145||
60159913|NCT00728884|76286618|FG000|NOT COMPLETED|Two Year Post Placement Follow-up||0||
60159914|NCT00659776|76286625|FG000|STARTED|Overall Study||230||
60159915|NCT00659776|76286626|FG001|STARTED|Overall Study||25||
60159916|NCT00659776|76286627|FG002|STARTED|Overall Study||0||
60159917|NCT00659776|76286625|FG000|Number of Lesions Gadolinium|Overall Study||145||
60159918|NCT00659776|76286626|FG001|Number of Lesions Gadolinium|Overall Study||0||
60159919|NCT00659776|76286627|FG002|Number of Lesions Gadolinium|Overall Study||0||
60159920|NCT00659776|76286625|FG000|Number of Lesions Ferumoxytol|Overall Study||152||
60159921|NCT00659776|76286626|FG001|Number of Lesions Ferumoxytol|Overall Study||0||
60159922|NCT00659776|76286627|FG002|Number of Lesions Ferumoxytol|Overall Study||0||
60159923|NCT00659776|76286625|FG000|Degree of Contrast Enhancement Gadolinium|Overall Study||128||
60159924|NCT00659776|76286626|FG001|Degree of Contrast Enhancement Gadolinium|Overall Study||0||
60159925|NCT00659776|76286627|FG002|Degree of Contrast Enhancement Gadolinium|Overall Study||0||
60159926|NCT00659776|76286625|FG000|Degree of Contrast Enhancement Ferumoxytol|Overall Study||131||
60159927|NCT00659776|76286626|FG001|Degree of Contrast Enhancement Ferumoxytol|Overall Study||0||
60159928|NCT00659776|76286627|FG002|Degree of Contrast Enhancement Ferumoxytol|Overall Study||0||
60159929|NCT00659776|76286625|FG000|Border Delineation Gadolinium|Overall Study||128||
60159930|NCT00659776|76286626|FG001|Border Delineation Gadolinium|Overall Study||0||
60159931|NCT00659776|76286627|FG002|Border Delineation Gadolinium|Overall Study||0||
60159932|NCT00659776|76286625|FG000|Border Delineation Ferumoxytol|Overall Study||131||
60159933|NCT00659776|76286626|FG001|Border Delineation Ferumoxytol|Overall Study||0||
60159934|NCT00659776|76286627|FG002|Border Delineation Ferumoxytol|Overall Study||0||
60159935|NCT00659776|76286625|FG000|Internal Morphology of Lesions Gadolinium|Overall Study||128||
60159936|NCT00659776|76286626|FG001|Internal Morphology of Lesions Gadolinium|Overall Study||0||
60159937|NCT00659776|76286627|FG002|Internal Morphology of Lesions Gadolinium|Overall Study||0||
60159938|NCT00659776|76286625|FG000|Internal Morphology of Lesions Ferumoxytol|Overall Study||131||
60159939|NCT00659776|76286626|FG001|Internal Morphology of Lesions Ferumoxytol|Overall Study||0||
60159940|NCT00659776|76286627|FG002|Internal Morphology of Lesions Ferumoxytol|Overall Study||0||
60159941|NCT00659776|76286625|FG000|COMPLETED|Overall Study||218||
60159942|NCT00659776|76286626|FG001|COMPLETED|Overall Study||23||
60159943|NCT00659776|76286627|FG002|COMPLETED|Overall Study||0||
60159944|NCT00659776|76286625|FG000|NOT COMPLETED|Overall Study||12||
60159945|NCT00659776|76286626|FG001|NOT COMPLETED|Overall Study||2||
60159946|NCT00659776|76286627|FG002|NOT COMPLETED|Overall Study||0||
60159947|NCT00617656|76286637|FG000|STARTED|Overall Study||190||
60159948|NCT00617656|76286638|FG001|STARTED|Overall Study||81||
60159949|NCT00617656|76286639|FG002|STARTED|Overall Study||62||
60159950|NCT00617656|76286640|FG003|STARTED|Overall Study||49||
60159951|NCT00617656|76286637|FG000|COMPLETED|Overall Study||142||
60159952|NCT00617656|76286638|FG001|COMPLETED|Overall Study||45||
60159953|NCT00617656|76286639|FG002|COMPLETED|Overall Study||49||
60159954|NCT00617656|76286640|FG003|COMPLETED|Overall Study||43||
60159955|NCT00617656|76286637|FG000|NOT COMPLETED|Overall Study||48||
60159956|NCT00617656|76286638|FG001|NOT COMPLETED|Overall Study||36||
60159957|NCT00617656|76286639|FG002|NOT COMPLETED|Overall Study||13||
60159958|NCT00617656|76286640|FG003|NOT COMPLETED|Overall Study||6||
59605915|NCT01963260|75716106|FG009|COMPLETED|Overall Study||4||
59605916|NCT01963260|75716097|FG000|NOT COMPLETED|Overall Study||2||
59605917|NCT01963260|75716098|FG001|NOT COMPLETED|Overall Study||0||
59605918|NCT01963260|75716099|FG002|NOT COMPLETED|Overall Study||0||
59605919|NCT01963260|75716100|FG003|NOT COMPLETED|Overall Study||1||
59605920|NCT01963260|75716101|FG004|NOT COMPLETED|Overall Study||2||
59605921|NCT01963260|75716102|FG005|NOT COMPLETED|Overall Study||0||
59605922|NCT01963260|75716103|FG006|NOT COMPLETED|Overall Study||0||
59605923|NCT01963260|75716104|FG007|NOT COMPLETED|Overall Study||0||
59882410|NCT03654885|76005329|FG000|STARTED|Overall Study|One eye, the worse eye, from each participant was selected as the study eye.|107||107
59882411|NCT03654885|76005330|FG001|STARTED|Overall Study|One eye, the worse eye, from each participant was selected as the study eye.|51||51
59882412|NCT03654885|76005329|FG000|Intent-to-Treat (ITT) Population|Overall Study||95|Intent-to-Treat (ITT) Population included all enrolled eyes/participants that were randomized to and received study glaucoma surgery (XEN-45 or trabeculectomy). Analyses were based on the randomized surgery.|95
59950825|NCT02408120|76069710|FG001|COMPLETED|Overall Study||107||
59950826|NCT02408120|76069709|FG000|NOT COMPLETED|Overall Study||4||
59605924|NCT01963260|75716105|FG008|NOT COMPLETED|Overall Study||0||
59605925|NCT01963260|75716106|FG009|NOT COMPLETED|Overall Study||0||
59751816|NCT00842829|75871132|FG002|Continuation Safety Analysis Set|Continuation Period|Received at least one dose of study drug|87||
59751817|NCT00842829|75871130|FG000|COMPLETED|Continuation Period||0||
59751818|NCT00842829|75871131|FG001|COMPLETED|Continuation Period||0||
59751819|NCT00842829|75871132|FG002|COMPLETED|Continuation Period||27||
59751820|NCT00842829|75871130|FG000|NOT COMPLETED|Continuation Period||0||
59751821|NCT00842829|75871131|FG001|NOT COMPLETED|Continuation Period||0||
59751822|NCT00842829|75871132|FG002|NOT COMPLETED|Continuation Period||61||
59751823|NCT00653263|75871144|FG000|STARTED|Overall Study|1 dropped out of treatment and the other had untreated hypertension|8||
59751824|NCT00653263|75871144|FG000|COMPLETED|Overall Study||6||
59751825|NCT00653263|75871144|FG000|NOT COMPLETED|Overall Study||2||
59751826|NCT00842361|75871150|FG000|STARTED|Overall Study||33||
59751827|NCT00842361|75871151|FG001|STARTED|Overall Study||33||
59751828|NCT00842361|75871150|FG000|Exposed|Overall Study||33||
59751829|NCT00842361|75871151|FG001|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|32||
59751830|NCT00842361|75871150|FG000|COMPLETED|Overall Study||32||
59751831|NCT00842361|75871151|FG001|COMPLETED|Overall Study||31||
59751832|NCT00842361|75871150|FG000|NOT COMPLETED|Overall Study||1||
59751833|NCT00842361|75871151|FG001|NOT COMPLETED|Overall Study||2||
59751834|NCT00841035|75871157|FG000|STARTED|Phase 1 Overall Study|2 phase enrollment,1st phase enrolled with cancer by fine needle aspiration in endoscopic ultrasound|19||
59751835|NCT00841035|75871157|FG000|COMPLETED|Phase 1 Overall Study||6||
59751836|NCT00841035|75871157|FG000|NOT COMPLETED|Phase 1 Overall Study||13||
59751837|NCT00841035|75871157|FG000|STARTED|Phase 2 of Overall Study||6||
59751838|NCT00841035|75871157|FG000|COMPLETED|Phase 2 of Overall Study||6||
59751839|NCT00841035|75871157|FG000|NOT COMPLETED|Phase 2 of Overall Study||0||
59751840|NCT00642811|75871168|FG000|STARTED|Overall Study||20||
59751841|NCT00642811|75871169|FG001|STARTED|Overall Study||21||
59751842|NCT00642811|75871170|FG002|STARTED|Overall Study||13||
59751843|NCT00642811|75871171|FG003|STARTED|Overall Study||16||
59751844|NCT00642811|75871172|FG004|STARTED|Overall Study||14||
59751845|NCT00642811|75871173|FG005|STARTED|Overall Study||14||
59751846|NCT00642811|75871168|FG000|COMPLETED|Overall Study||17||
59751847|NCT00642811|75871169|FG001|COMPLETED|Overall Study||17||
59751848|NCT00642811|75871170|FG002|COMPLETED|Overall Study||13||
59751849|NCT00642811|75871171|FG003|COMPLETED|Overall Study||15||
59751850|NCT00642811|75871172|FG004|COMPLETED|Overall Study||13||
59751851|NCT00642811|75871173|FG005|COMPLETED|Overall Study||13||
59751852|NCT00642811|75871168|FG000|NOT COMPLETED|Overall Study||3||
59751853|NCT00642811|75871169|FG001|NOT COMPLETED|Overall Study||4||
59751854|NCT00642811|75871170|FG002|NOT COMPLETED|Overall Study||0||
59751855|NCT00642811|75871171|FG003|NOT COMPLETED|Overall Study||1||
59751856|NCT00642811|75871172|FG004|NOT COMPLETED|Overall Study||1||
59751857|NCT00642811|75871173|FG005|NOT COMPLETED|Overall Study||1||
59751858|NCT00838929|75871190|FG000|STARTED|Overall Study||3||
59751859|NCT00838929|75871191|FG001|STARTED|Overall Study||8||
59751860|NCT00838929|75871192|FG002|STARTED|Overall Study||6||
59751861|NCT00838929|75871190|FG000|COMPLETED|Overall Study||3||
59751862|NCT00838929|75871191|FG001|COMPLETED|Overall Study||5||
59751863|NCT00838929|75871192|FG002|COMPLETED|Overall Study||5||
59751864|NCT00838929|75871190|FG000|NOT COMPLETED|Overall Study||0||
59751865|NCT00838929|75871191|FG001|NOT COMPLETED|Overall Study||3||
59751866|NCT00838929|75871192|FG002|NOT COMPLETED|Overall Study||1||
59751867|NCT00916058|75871205|FG000|STARTED|Phase 1||3||
59751868|NCT00916058|75871206|FG001|STARTED|Phase 1||6||
59882413|NCT03654885|76005330|FG001|Intent-to-Treat (ITT) Population|Overall Study||44|Intent-to-Treat (ITT) Population included all enrolled eyes/participants that were randomized to and received study glaucoma surgery (XEN-45 or trabeculectomy). Analyses were based on the randomized surgery.|44
59882414|NCT03654885|76005329|FG000|Safety Population|Overall Study||95|Safety Population included all enrolled participants that have undergone study glaucoma surgery.|95
59882415|NCT03654885|76005330|FG001|Safety Population|Overall Study||44|Safety Population included all enrolled participants that have undergone study glaucoma surgery.|44
59882416|NCT03654885|76005329|FG000|COMPLETED|Overall Study||77||77
59882417|NCT03654885|76005330|FG001|COMPLETED|Overall Study||38||38
59882418|NCT03654885|76005329|FG000|NOT COMPLETED|Overall Study||30||30
59882419|NCT03654885|76005330|FG001|NOT COMPLETED|Overall Study||13||13
59882420|NCT03236246|76005338|FG000|STARTED|24-Week Dose Titration Period||104||
59882421|NCT03236246|76005339|FG001|STARTED|24-Week Dose Titration Period||102||
59882422|NCT03236246|76005338|FG000|COMPLETED|24-Week Dose Titration Period||80||
59882423|NCT03236246|76005339|FG001|COMPLETED|24-Week Dose Titration Period||75||
59882424|NCT03236246|76005338|FG000|NOT COMPLETED|24-Week Dose Titration Period||24||
59882425|NCT03236246|76005339|FG001|NOT COMPLETED|24-Week Dose Titration Period||27||
59882426|NCT03236246|76005338|FG000|STARTED|24-Week Dose Maintenance Period|Not all participants completing the Dose Titration Period opted to enter the Dose Maintenance Period|76||
59882427|NCT03236246|76005339|FG001|STARTED|24-Week Dose Maintenance Period|Not all participants completing the Dose Titration Period opted to enter the Dose Maintenance Period|72||
59882428|NCT03236246|76005338|FG000|COMPLETED|24-Week Dose Maintenance Period||73||
59882429|NCT03236246|76005339|FG001|COMPLETED|24-Week Dose Maintenance Period||66||
59882430|NCT03236246|76005338|FG000|NOT COMPLETED|24-Week Dose Maintenance Period||3||
59882431|NCT03236246|76005339|FG001|NOT COMPLETED|24-Week Dose Maintenance Period||6||
59882432|NCT02937584|76005345|FG000|STARTED|Period 1||11||
59882433|NCT02937584|76005346|FG001|STARTED|Period 1||12||
59882434|NCT02937584|76005345|FG000|COMPLETED|Period 1||10||
59882435|NCT02937584|76005346|FG001|COMPLETED|Period 1||10||
59882436|NCT02937584|76005345|FG000|NOT COMPLETED|Period 1||1||
59882437|NCT02937584|76005346|FG001|NOT COMPLETED|Period 1||2||
59882438|NCT02937584|76005345|FG000|STARTED|Washout||10||
59882439|NCT02937584|76005346|FG001|STARTED|Washout||10||
59882440|NCT02937584|76005345|FG000|COMPLETED|Washout||10||
59882441|NCT02937584|76005346|FG001|COMPLETED|Washout||9||
59882442|NCT02937584|76005345|FG000|NOT COMPLETED|Washout||0||
59882443|NCT02937584|76005346|FG001|NOT COMPLETED|Washout||1||
59751869|NCT00916058|75871207|FG002|STARTED|Phase 1||3||
59751870|NCT00916058|75871208|FG003|STARTED|Phase 1||3||
59751871|NCT00916058|75871209|FG004|STARTED|Phase 1||3||
59751872|NCT00916058|75871210|FG005|STARTED|Phase 1||8||
59751873|NCT00916058|75871211|FG006|STARTED|Phase 1||0||
59751874|NCT00916058|75871205|FG000|COMPLETED|Phase 1||3||
59751875|NCT00916058|75871206|FG001|COMPLETED|Phase 1||6||
59882444|NCT02937584|76005345|FG000|STARTED|Period 2||10||
59882445|NCT02937584|76005346|FG001|STARTED|Period 2||9||
59882446|NCT02937584|76005345|FG000|COMPLETED|Period 2||10||
59882447|NCT02937584|76005346|FG001|COMPLETED|Period 2||9||
59882448|NCT02937584|76005345|FG000|NOT COMPLETED|Period 2||0||
59751876|NCT00916058|75871207|FG002|COMPLETED|Phase 1||3||
59751877|NCT00916058|75871208|FG003|COMPLETED|Phase 1||3||
59882449|NCT02937584|76005346|FG001|NOT COMPLETED|Period 2||0||
59882450|NCT00179621|76005355|FG000|STARTED|Double-Blind Period||67||
59751878|NCT00916058|75871209|FG004|COMPLETED|Phase 1||3||
59751879|NCT00916058|75871210|FG005|COMPLETED|Phase 1||7||
59882451|NCT00179621|76005356|FG001|STARTED|Double-Blind Period||69||
59882452|NCT00179621|76005357|FG002|STARTED|Double-Blind Period||69||
59882453|NCT00179621|76005358|FG003|STARTED|Double-Blind Period||0||
59882454|NCT00179621|76005355|FG000|COMPLETED|Double-Blind Period||3||
59751880|NCT00916058|75871211|FG006|COMPLETED|Phase 1||0||
59751881|NCT00916058|75871205|FG000|NOT COMPLETED|Phase 1||0||
59751882|NCT00916058|75871206|FG001|NOT COMPLETED|Phase 1||0||
59751883|NCT00916058|75871207|FG002|NOT COMPLETED|Phase 1||0||
59751884|NCT00916058|75871208|FG003|NOT COMPLETED|Phase 1||0||
59751885|NCT00916058|75871209|FG004|NOT COMPLETED|Phase 1||0||
59751886|NCT00916058|75871210|FG005|NOT COMPLETED|Phase 1||1||
59751887|NCT00916058|75871211|FG006|NOT COMPLETED|Phase 1||0||
59882455|NCT00179621|76005356|FG001|COMPLETED|Double-Blind Period||23||
59882456|NCT00179621|76005357|FG002|COMPLETED|Double-Blind Period||39||
59882457|NCT00179621|76005358|FG003|COMPLETED|Double-Blind Period||0||
59882458|NCT00179621|76005355|FG000|NOT COMPLETED|Double-Blind Period||64||
59882459|NCT00179621|76005356|FG001|NOT COMPLETED|Double-Blind Period||46||
59882460|NCT00179621|76005357|FG002|NOT COMPLETED|Double-Blind Period||30||
59882461|NCT00179621|76005358|FG003|NOT COMPLETED|Double-Blind Period||0||
59882462|NCT00179621|76005355|FG000|STARTED|Open-Label Period||0||
59882463|NCT00179621|76005356|FG001|STARTED|Open-Label Period|'Started' includes 23 participants who completed double-blind and 19 who discontinued double-blind.|42||
59882464|NCT00179621|76005357|FG002|STARTED|Open-Label Period|'Started' includes 39 participants who completed double-blind and 8 who discontinued double-blind.|47||
59950827|NCT02408120|76069710|FG001|NOT COMPLETED|Overall Study||5||
59950828|NCT02391545|76069718|FG000|STARTED|Overall Study||27||
59950829|NCT02391545|76069719|FG001|STARTED|Overall Study||28||
59950830|NCT02391545|76069718|FG000|COMPLETED|Overall Study||1||
59950831|NCT02391545|76069719|FG001|COMPLETED|Overall Study||0||
59950832|NCT02391545|76069718|FG000|NOT COMPLETED|Overall Study||26||
59950833|NCT02391545|76069719|FG001|NOT COMPLETED|Overall Study||28||
59950834|NCT01920932|76069726|FG000|STARTED|Overall Study||77||
59950835|NCT01920932|76069726|FG000|COMPLETED|Overall Study||75||
59950836|NCT01920932|76069726|FG000|NOT COMPLETED|Overall Study||2||
59751888|NCT00916058|75871205|FG000|STARTED|Phase 2||0||
59751889|NCT00916058|75871206|FG001|STARTED|Phase 2||0||
59751890|NCT00916058|75871207|FG002|STARTED|Phase 2||0||
59751891|NCT00916058|75871208|FG003|STARTED|Phase 2||0||
59751892|NCT00916058|75871209|FG004|STARTED|Phase 2||0||
59751893|NCT00916058|75871210|FG005|STARTED|Phase 2||0||
59751894|NCT00916058|75871211|FG006|STARTED|Phase 2||31||
59751895|NCT00916058|75871205|FG000|COMPLETED|Phase 2||0||
59751896|NCT00916058|75871206|FG001|COMPLETED|Phase 2||0||
59751897|NCT00916058|75871207|FG002|COMPLETED|Phase 2||0||
59751898|NCT00916058|75871208|FG003|COMPLETED|Phase 2||0||
59751899|NCT00916058|75871209|FG004|COMPLETED|Phase 2||0||
59751900|NCT00916058|75871210|FG005|COMPLETED|Phase 2||0||
59751901|NCT00916058|75871211|FG006|COMPLETED|Phase 2||28||
59751902|NCT00916058|75871205|FG000|NOT COMPLETED|Phase 2||0||
59751903|NCT00916058|75871206|FG001|NOT COMPLETED|Phase 2||0||
59950837|NCT01774253|76069747|FG000|STARTED|Overall Study||9||
59751904|NCT00916058|75871207|FG002|NOT COMPLETED|Phase 2||0||
59751905|NCT00916058|75871208|FG003|NOT COMPLETED|Phase 2||0||
59751906|NCT00916058|75871209|FG004|NOT COMPLETED|Phase 2||0||
59751907|NCT00916058|75871210|FG005|NOT COMPLETED|Phase 2||0||
59751908|NCT00916058|75871211|FG006|NOT COMPLETED|Phase 2||3||
59751909|NCT00912782|75871231|FG000|STARTED|Overall Study||27||
59751910|NCT00912782|75871232|FG001|STARTED|Overall Study||25||
59751911|NCT00912782|75871231|FG000|COMPLETED|Overall Study||24||
59751912|NCT00912782|75871232|FG001|COMPLETED|Overall Study||20||
59751913|NCT00912782|75871231|FG000|NOT COMPLETED|Overall Study||3||
59751914|NCT00912782|75871232|FG001|NOT COMPLETED|Overall Study||5||
59751915|NCT03444038|75871238|FG000|STARTED|Overall Study||85||
59751916|NCT03444038|75871238|FG000|COMPLETED|Overall Study||56||
59751917|NCT03444038|75871238|FG000|NOT COMPLETED|Overall Study||29||
59751918|NCT00911534|75871244|FG000|STARTED|Overall Study|Randomized (treated)|147||
59882465|NCT00179621|76005358|FG003|STARTED|Open-Label Period|'Started' includes 1 participant who completed double-blind and 55 who discontinued double-blind.|56||
59882466|NCT00179621|76005355|FG000|COMPLETED|Open-Label Period||0||
59882467|NCT00179621|76005356|FG001|COMPLETED|Open-Label Period||14||
59882468|NCT00179621|76005357|FG002|COMPLETED|Open-Label Period||19||
59882469|NCT00179621|76005358|FG003|COMPLETED|Open-Label Period||13||
59882470|NCT00179621|76005355|FG000|NOT COMPLETED|Open-Label Period||0||
59882471|NCT00179621|76005356|FG001|NOT COMPLETED|Open-Label Period||28||
59882472|NCT00179621|76005357|FG002|NOT COMPLETED|Open-Label Period||28||
59882473|NCT00179621|76005358|FG003|NOT COMPLETED|Open-Label Period||43||
59882474|NCT00179309|76005369|FG000|STARTED|Treatment||25||
59882475|NCT00179309|76005370|FG001|STARTED|Treatment||23||
59882476|NCT00179309|76005369|FG000|COMPLETED|Treatment||21||
59882477|NCT00179309|76005370|FG001|COMPLETED|Treatment||18||
59882478|NCT00179309|76005369|FG000|NOT COMPLETED|Treatment||4||
59882479|NCT00179309|76005370|FG001|NOT COMPLETED|Treatment||5||
59882480|NCT00179309|76005369|FG000|STARTED|Crossover||0||
59882481|NCT00179309|76005370|FG001|STARTED|Crossover|Crossover was allowed so that patients randomized to B could receive the vaccine upon progression.|3||
59882482|NCT00179309|76005369|FG000|COMPLETED|Crossover||0||
59882483|NCT00179309|76005370|FG001|COMPLETED|Crossover||3||
59882484|NCT00179309|76005369|FG000|NOT COMPLETED|Crossover||0||
59882485|NCT00179309|76005370|FG001|NOT COMPLETED|Crossover||0||
59882486|NCT03594500|76005378|FG000|STARTED|Overall Study||66||
59882487|NCT03594500|76005379|FG001|STARTED|Overall Study||67||
59751919|NCT00911534|75871245|FG001|STARTED|Overall Study|Randomized (treated)|153||
59751920|NCT00911534|75871244|FG000|COMPLETED|Overall Study||132||
59751921|NCT00911534|75871245|FG001|COMPLETED|Overall Study||137||
59751922|NCT00911534|75871244|FG000|NOT COMPLETED|Overall Study||15||
59751923|NCT00911534|75871245|FG001|NOT COMPLETED|Overall Study||16||
59751924|NCT00911300|75871253|FG000|STARTED|Overall Study||175||
59751925|NCT00911300|75871254|FG001|STARTED|Overall Study||174||
59751926|NCT00911300|75871253|FG000|COMPLETED|Overall Study||140||
59751927|NCT00911300|75871254|FG001|COMPLETED|Overall Study||131||
59751928|NCT00911300|75871253|FG000|NOT COMPLETED|Overall Study||35||
59751929|NCT00911300|75871254|FG001|NOT COMPLETED|Overall Study||43||
59751930|NCT00911144|75871263|FG000|STARTED|Overall Study||335||
59751931|NCT00911144|75871264|FG001|STARTED|Overall Study||113||
59751932|NCT00911144|75871263|FG000|COMPLETED|Overall Study||319||
59751933|NCT00911144|75871264|FG001|COMPLETED|Overall Study||108||
59751934|NCT00911144|75871263|FG000|NOT COMPLETED|Overall Study||16||
59751935|NCT00911144|75871264|FG001|NOT COMPLETED|Overall Study||5||
59751936|NCT00910988|75871274|FG000|STARTED|Overall Study||16||
59751937|NCT00910988|75871275|FG001|STARTED|Overall Study||16||
59751938|NCT00910988|75871276|FG002|STARTED|Overall Study||8||
59751939|NCT00910988|75871277|FG003|STARTED|Overall Study||6||
59751940|NCT00910988|75871274|FG000|COMPLETED|Overall Study||14||
59751941|NCT00910988|75871275|FG001|COMPLETED|Overall Study||12||
59751942|NCT00910988|75871276|FG002|COMPLETED|Overall Study||5||
59751943|NCT00910988|75871277|FG003|COMPLETED|Overall Study||6||
59751944|NCT00910988|75871274|FG000|NOT COMPLETED|Overall Study||2||
59751945|NCT00910988|75871275|FG001|NOT COMPLETED|Overall Study||4||
59751946|NCT00910988|75871276|FG002|NOT COMPLETED|Overall Study||3||
59751947|NCT00910988|75871277|FG003|NOT COMPLETED|Overall Study||0||
59751948|NCT00644059|75871306|FG000|STARTED|Overall Study||2019||
59751949|NCT00644059|75871307|FG001|STARTED|Overall Study||1849||
59751950|NCT00644059|75871308|FG002|STARTED|Overall Study||1034||
59751951|NCT00644059|75871306|FG000|COMPLETED|Overall Study||1895||
59751952|NCT00644059|75871307|FG001|COMPLETED|Overall Study||1726||
59751953|NCT00644059|75871308|FG002|COMPLETED|Overall Study||969||
59751954|NCT00644059|75871306|FG000|NOT COMPLETED|Overall Study||124||
59751955|NCT00644059|75871307|FG001|NOT COMPLETED|Overall Study||123||
59751956|NCT00644059|75871308|FG002|NOT COMPLETED|Overall Study||65||
59751957|NCT00910910|75871359|FG000|STARTED|Overall Study||225||
59751958|NCT00910910|75871360|FG001|STARTED|Overall Study||225||
59751959|NCT00910910|75871359|FG000|Safety Population|Overall Study|All randomized participants who received at least 1 dose of the either lenalidomide or chlorambucil|224||
59751960|NCT00910910|75871360|FG001|Safety Population|Overall Study|All randomized participants who received at least 1 dose of the either lenalidomide or chlorambucil|223||
59751961|NCT00910910|75871359|FG000|COMPLETED|Overall Study|Completed includes participants who continued with ongoing treatment|0||
59751962|NCT00910910|75871360|FG001|COMPLETED|Overall Study|Completed includes participants who continued with ongoing treatment|1||
59751963|NCT00910910|75871359|FG000|NOT COMPLETED|Overall Study||225||
59751964|NCT00910910|75871360|FG001|NOT COMPLETED|Overall Study||224||
59751965|NCT00911768|75871368|FG000|STARTED|Overall Study||50||
59751966|NCT00911768|75871369|FG001|STARTED|Overall Study||50||
59751967|NCT00911768|75871368|FG000|COMPLETED|Overall Study||44||
59751968|NCT00911768|75871369|FG001|COMPLETED|Overall Study||46||
59751969|NCT00911768|75871368|FG000|NOT COMPLETED|Overall Study||6||
59751970|NCT00911768|75871369|FG001|NOT COMPLETED|Overall Study||4||
59751971|NCT00909038|75871375|FG000|STARTED|Overall Study||2411||
59751972|NCT00909038|75871375|FG000|COMPLETED|Overall Study||1994||
59751973|NCT00909038|75871375|FG000|NOT COMPLETED|Overall Study||417||
59751974|NCT00909428|75871382|FG000|STARTED|Overall Study||18||
59751975|NCT00909428|75871383|FG001|STARTED|Overall Study||15||
59751976|NCT00909428|75871384|FG002|STARTED|Overall Study||9||
59751977|NCT00909428|75871382|FG000|COMPLETED|Overall Study||5||
59751978|NCT00909428|75871383|FG001|COMPLETED|Overall Study||5||
59751979|NCT00909428|75871384|FG002|COMPLETED|Overall Study||0||
59751980|NCT00909428|75871382|FG000|NOT COMPLETED|Overall Study||13||
59751981|NCT00909428|75871383|FG001|NOT COMPLETED|Overall Study||10||
59751982|NCT00909428|75871384|FG002|NOT COMPLETED|Overall Study||9||
59751983|NCT00908960|75871394|FG000|STARTED|Overall Study||24||
59751984|NCT00908960|75871395|FG001|STARTED|Overall Study||12||
59751985|NCT00908960|75871396|FG002|STARTED|Overall Study||34||
59751986|NCT00908960|75871394|FG000|Evaluable|Overall Study||23||
59751987|NCT00908960|75871395|FG001|Evaluable|Overall Study||11||
59751988|NCT00908960|75871396|FG002|Evaluable|Overall Study||32||
59751989|NCT00908960|75871394|FG000|COMPLETED|Overall Study||23||
59751990|NCT00908960|75871395|FG001|COMPLETED|Overall Study||11||
59751991|NCT00908960|75871396|FG002|COMPLETED|Overall Study||32||
59751992|NCT00908960|75871394|FG000|NOT COMPLETED|Overall Study||1||
59882488|NCT03594500|76005378|FG000|COMPLETED|Overall Study||60||
59882489|NCT03594500|76005379|FG001|COMPLETED|Overall Study||63||
59882490|NCT03594500|76005378|FG000|NOT COMPLETED|Overall Study||6||
59882491|NCT03594500|76005379|FG001|NOT COMPLETED|Overall Study||4||
59882492|NCT00178685|76005391|FG000|STARTED|Overall Study||172||
59882493|NCT00178685|76005392|FG001|STARTED|Overall Study||324||
59882494|NCT00178685|76005393|FG002|STARTED|Overall Study||324||
59882495|NCT00178685|76005391|FG000|COMPLETED|Overall Study||61||
59882496|NCT00178685|76005392|FG001|COMPLETED|Overall Study||120||
59882497|NCT00178685|76005393|FG002|COMPLETED|Overall Study||128||
59882498|NCT00178685|76005391|FG000|NOT COMPLETED|Overall Study||111||
59882499|NCT00178685|76005392|FG001|NOT COMPLETED|Overall Study||204||
59882500|NCT00178685|76005393|FG002|NOT COMPLETED|Overall Study||196||
59882501|NCT02933528|76005401|FG000|STARTED|Overall Study||24||
59882502|NCT02933528|76005401|FG000|COMPLETED|Overall Study||22||
59882503|NCT02933528|76005401|FG000|NOT COMPLETED|Overall Study||2||
59882504|NCT00177671|76005407|FG000|STARTED|Overall Study||67||
59882505|NCT00177671|76005408|FG001|STARTED|Overall Study||63||
59882506|NCT00177671|76005407|FG000|Month 12|Overall Study||45||
59882507|NCT00177671|76005408|FG001|Month 12|Overall Study||57||
59882508|NCT00177671|76005407|FG000|Month 24|Overall Study||42||
59882509|NCT00177671|76005408|FG001|Month 24|Overall Study||49||
59882510|NCT00177671|76005407|FG000|COMPLETED|Overall Study||42||
59882511|NCT00177671|76005408|FG001|COMPLETED|Overall Study||49||
59882512|NCT00177671|76005407|FG000|NOT COMPLETED|Overall Study||25||
59882513|NCT00177671|76005408|FG001|NOT COMPLETED|Overall Study||14||
59882514|NCT02933060|76005416|FG000|STARTED|Overall Study||25||
59882515|NCT02933060|76005417|FG001|STARTED|Overall Study||25||
59882516|NCT02933060|76005416|FG000|COMPLETED|Overall Study||25||
59882517|NCT02933060|76005417|FG001|COMPLETED|Overall Study||24||
59882518|NCT02933060|76005416|FG000|NOT COMPLETED|Overall Study||0||
59882519|NCT02933060|76005417|FG001|NOT COMPLETED|Overall Study||1||
59882520|NCT03235154|76005423|FG000|STARTED|Overall Study||11||
59882521|NCT03235154|76005423|FG000|Completed Epclusa. Treatment|Overall Study||8||
59882522|NCT03235154|76005423|FG000|12-wk Post-treatment HCV RNA Measured|Overall Study||7||
59882523|NCT03235154|76005423|FG000|COMPLETED|Overall Study||7||
59882524|NCT03235154|76005423|FG000|NOT COMPLETED|Overall Study||4||
59882525|NCT03234608|76005431|FG000|STARTED|Overall Study||127||
59882526|NCT03234608|76005432|FG001|STARTED|Overall Study||117||
59882527|NCT03234608|76005431|FG000|COMPLETED|Overall Study||104||
59882528|NCT03234608|76005432|FG001|COMPLETED|Overall Study||96||
59882529|NCT03234608|76005431|FG000|NOT COMPLETED|Overall Study||23||
59882530|NCT03234608|76005432|FG001|NOT COMPLETED|Overall Study||21||
59882531|NCT03248882|76005443|FG000|STARTED|Overall Study||61||
59882532|NCT03248882|76005444|FG001|STARTED|Overall Study||63||
59882533|NCT03248882|76005445|FG002|STARTED|Overall Study||62||
59882534|NCT03248882|76005446|FG003|STARTED|Overall Study||58||
59882535|NCT03248882|76005447|FG004|STARTED|Overall Study||61||
59882536|NCT03248882|76005443|FG000|Received Treatment|Overall Study||61||
59882537|NCT03248882|76005444|FG001|Received Treatment|Overall Study||63||
59882538|NCT03248882|76005445|FG002|Received Treatment|Overall Study||62||
59882539|NCT03248882|76005446|FG003|Received Treatment|Overall Study||58||
59882540|NCT03248882|76005447|FG004|Received Treatment|Overall Study||61||
59882541|NCT03248882|76005443|FG000|COMPLETED|Overall Study||54||
59882542|NCT03248882|76005444|FG001|COMPLETED|Overall Study||58||
59882543|NCT03248882|76005445|FG002|COMPLETED|Overall Study||55||
59882544|NCT03248882|76005446|FG003|COMPLETED|Overall Study||48||
59882545|NCT03248882|76005447|FG004|COMPLETED|Overall Study||48||
59882546|NCT03248882|76005443|FG000|NOT COMPLETED|Overall Study||7||
59882547|NCT03248882|76005444|FG001|NOT COMPLETED|Overall Study||5||
59751993|NCT00908960|75871395|FG001|NOT COMPLETED|Overall Study||1||
59751994|NCT00908960|75871396|FG002|NOT COMPLETED|Overall Study||2||
59751995|NCT03933020|75871404|FG000|STARTED|Overall Study||0||
59751996|NCT03933020|75871404|FG000|Received an Intervention|Overall Study||0||
59751997|NCT03933020|75871404|FG000|COMPLETED|Overall Study||0||
59751998|NCT03933020|75871404|FG000|NOT COMPLETED|Overall Study||0||
59751999|NCT00650767|75871414|FG000|STARTED|Overall Study||51||
59752000|NCT00650767|75871415|FG001|STARTED|Overall Study||50||
59752001|NCT00650767|75871416|FG002|STARTED|Overall Study||50||
59752002|NCT00650767|75871417|FG003|STARTED|Overall Study||50||
59752003|NCT00650767|75871414|FG000|COMPLETED|Overall Study||46||
59752004|NCT00650767|75871415|FG001|COMPLETED|Overall Study||41||
59752005|NCT00650767|75871416|FG002|COMPLETED|Overall Study||36||
59752006|NCT00650767|75871417|FG003|COMPLETED|Overall Study||39||
59752007|NCT00650767|75871414|FG000|NOT COMPLETED|Overall Study||5||
59752008|NCT00650767|75871415|FG001|NOT COMPLETED|Overall Study||9||
59752009|NCT00650767|75871416|FG002|NOT COMPLETED|Overall Study||14||
59752010|NCT00650767|75871417|FG003|NOT COMPLETED|Overall Study||11||
59752011|NCT00973349|75871443|FG000|STARTED|Overall Study||170||
59752012|NCT00973349|75871444|FG001|STARTED|Overall Study||168||
59752013|NCT00973349|75871445|FG002|STARTED|Overall Study||171||
59752014|NCT00973349|75871446|FG003|STARTED|Overall Study||168||
59882548|NCT03248882|76005445|FG002|NOT COMPLETED|Overall Study||7||
59882549|NCT03248882|76005446|FG003|NOT COMPLETED|Overall Study||10||
59882550|NCT03248882|76005447|FG004|NOT COMPLETED|Overall Study||13||
59882551|NCT03233438|76005461|FG000|STARTED|Overall Study||48||
59882552|NCT03233438|76005462|FG001|STARTED|Overall Study||43||
59882553|NCT03233438|76005461|FG000|COMPLETED|Overall Study||42||
59882554|NCT03233438|76005462|FG001|COMPLETED|Overall Study||32||
59882555|NCT03233438|76005461|FG000|NOT COMPLETED|Overall Study||6||
59882556|NCT03233438|76005462|FG001|NOT COMPLETED|Overall Study||11||
59882557|NCT01368406|76005470|FG000|STARTED|Overall Study||81||
59882558|NCT01368406|76005471|FG001|STARTED|Overall Study||79||
59882559|NCT01368406|76005470|FG000|COMPLETED|Overall Study||60||
59882560|NCT01368406|76005471|FG001|COMPLETED|Overall Study||66||
59882561|NCT01368406|76005470|FG000|NOT COMPLETED|Overall Study||21||
59882562|NCT01368406|76005471|FG001|NOT COMPLETED|Overall Study||13||
59882563|NCT00175877|76005477|FG000|STARTED|Overall Study||846||
59882564|NCT00175877|76005477|FG000|COMPLETED|Overall Study||497||
59882565|NCT00175877|76005477|FG000|NOT COMPLETED|Overall Study||349||
59882566|NCT03247556|76005484|FG000|STARTED|Overall Study||97|"The total number of subjects started (N=296) is based on the Safety Population (defined as subjects who were randomized and took at least one dose of study medication). The total number of subjects enrolled (N=297) is based on the Randomized Population (defined as subjects who were randomized)."|
59882567|NCT03247556|76005485|FG001|STARTED|Overall Study||100|"The total number of subjects started (N=296) is based on the Safety Population (defined as subjects who were randomized and took at least one dose of study medication). The total number of subjects enrolled (N=297) is based on the Randomized Population (defined as subjects who were randomized)."|
59950838|NCT01774253|76069747|FG000|COMPLETED|Overall Study||0||
59950839|NCT01774253|76069747|FG000|NOT COMPLETED|Overall Study||9||
59752015|NCT00973349|75871447|FG004|STARTED|Overall Study||170||
59752016|NCT00973349|75871448|FG005|STARTED|Overall Study||169||
59752017|NCT00973349|75871449|FG006|STARTED|Overall Study||174||
59752018|NCT00973349|75871450|FG007|STARTED|Overall Study||169||
59752019|NCT00973349|75871451|FG008|STARTED|Overall Study||171||
59752020|NCT00973349|75871452|FG009|STARTED|Overall Study||169||
59752021|NCT00973349|75871453|FG010|STARTED|Overall Study||174||
59882568|NCT03247556|76005486|FG002|STARTED|Overall Study||99|"The total number of subjects started (N=296) is based on the Safety Population (defined as subjects who were randomized and took at least one dose of study medication). The total number of subjects enrolled (N=297) is based on the Randomized Population (defined as subjects who were randomized)."|
59882569|NCT03247556|76005484|FG000|COMPLETED|Overall Study||85||
59882570|NCT03247556|76005485|FG001|COMPLETED|Overall Study||88||
59882571|NCT03247556|76005486|FG002|COMPLETED|Overall Study||81||
59882572|NCT03247556|76005484|FG000|NOT COMPLETED|Overall Study||12||
59882573|NCT03247556|76005485|FG001|NOT COMPLETED|Overall Study||12||
59882574|NCT03247556|76005486|FG002|NOT COMPLETED|Overall Study||18||
59882575|NCT03216746|76005498|FG000|STARTED|Overall Study||72||
59882576|NCT03216746|76005499|FG001|STARTED|Overall Study||79||
59882577|NCT03216746|76005500|FG002|STARTED|Overall Study||68||
59882578|NCT03216746|76005501|FG003|STARTED|Overall Study||69||
59882579|NCT03216746|76005498|FG000|COMPLETED|Overall Study||66||
59882580|NCT03216746|76005499|FG001|COMPLETED|Overall Study||71||
59882581|NCT03216746|76005500|FG002|COMPLETED|Overall Study||63||
59882582|NCT03216746|76005501|FG003|COMPLETED|Overall Study||63||
59882583|NCT03216746|76005498|FG000|NOT COMPLETED|Overall Study||6||
59882584|NCT03216746|76005499|FG001|NOT COMPLETED|Overall Study||8||
59882585|NCT03216746|76005500|FG002|NOT COMPLETED|Overall Study||5||
59882586|NCT03216746|76005501|FG003|NOT COMPLETED|Overall Study||6||
59882587|NCT02787304|76005515|FG000|STARTED|Overall Study||49||
59951254|NCT03743415|76070175|FG000|NOT COMPLETED|Overall Study||8||
59752022|NCT00973349|75871454|FG011|STARTED|Overall Study||169||
59752023|NCT00973349|75871455|FG012|STARTED|Overall Study||169||
59752024|NCT00973349|75871456|FG013|STARTED|Overall Study||171||
59752025|NCT00973349|75871457|FG014|STARTED|Overall Study||170||
59752026|NCT00973349|75871458|FG015|STARTED|Overall Study||167||
59752027|NCT00973349|75871443|FG000|COMPLETED|Overall Study||166||
59752028|NCT00973349|75871444|FG001|COMPLETED|Overall Study||165||
59752029|NCT00973349|75871445|FG002|COMPLETED|Overall Study||166||
59752030|NCT00973349|75871446|FG003|COMPLETED|Overall Study||163||
59752031|NCT00973349|75871447|FG004|COMPLETED|Overall Study||165||
59951255|NCT03743415|76070176|FG001|NOT COMPLETED|Overall Study||3||
59752032|NCT00973349|75871448|FG005|COMPLETED|Overall Study||165||
59752033|NCT00973349|75871449|FG006|COMPLETED|Overall Study||172||
59752034|NCT00973349|75871450|FG007|COMPLETED|Overall Study||166||
59752035|NCT00973349|75871451|FG008|COMPLETED|Overall Study||167||
59752036|NCT00973349|75871452|FG009|COMPLETED|Overall Study||163||
59752037|NCT00973349|75871453|FG010|COMPLETED|Overall Study||174||
59752038|NCT00973349|75871454|FG011|COMPLETED|Overall Study||167||
59882588|NCT02787304|76005516|FG001|STARTED|Overall Study|One subject was randomized and received 1 dose of study drug but withdrew from the study.|50||
59882589|NCT02787304|76005517|FG002|STARTED|Overall Study||49||
59882590|NCT02787304|76005518|FG003|STARTED|Overall Study||49||
59882591|NCT02787304|76005515|FG000|COMPLETED|Overall Study||13||
59882592|NCT02787304|76005516|FG001|COMPLETED|Overall Study||12||
59882593|NCT02787304|76005517|FG002|COMPLETED|Overall Study||8||
59882594|NCT02787304|76005518|FG003|COMPLETED|Overall Study||15||
59882595|NCT02787304|76005515|FG000|NOT COMPLETED|Overall Study||36||
59882596|NCT02787304|76005516|FG001|NOT COMPLETED|Overall Study||38||
59752039|NCT00973349|75871455|FG012|COMPLETED|Overall Study||168||
59752040|NCT00973349|75871456|FG013|COMPLETED|Overall Study||171||
59752041|NCT00973349|75871457|FG014|COMPLETED|Overall Study||168||
59752042|NCT00973349|75871458|FG015|COMPLETED|Overall Study||165||
59752043|NCT00973349|75871443|FG000|NOT COMPLETED|Overall Study||4||
59752044|NCT00973349|75871444|FG001|NOT COMPLETED|Overall Study||3||
59752045|NCT00973349|75871445|FG002|NOT COMPLETED|Overall Study||5||
59752046|NCT00973349|75871446|FG003|NOT COMPLETED|Overall Study||5||
59752047|NCT00973349|75871447|FG004|NOT COMPLETED|Overall Study||5||
59752048|NCT00973349|75871448|FG005|NOT COMPLETED|Overall Study||4||
59752049|NCT00973349|75871449|FG006|NOT COMPLETED|Overall Study||2||
59752050|NCT00973349|75871450|FG007|NOT COMPLETED|Overall Study||3||
59752051|NCT00973349|75871451|FG008|NOT COMPLETED|Overall Study||4||
59752052|NCT00973349|75871452|FG009|NOT COMPLETED|Overall Study||6||
59752053|NCT00973349|75871453|FG010|NOT COMPLETED|Overall Study||0||
59752054|NCT00973349|75871454|FG011|NOT COMPLETED|Overall Study||2||
59752055|NCT00973349|75871455|FG012|NOT COMPLETED|Overall Study||1||
59752056|NCT00973349|75871456|FG013|NOT COMPLETED|Overall Study||0||
59752057|NCT00973349|75871457|FG014|NOT COMPLETED|Overall Study||2||
59752058|NCT00973349|75871458|FG015|NOT COMPLETED|Overall Study||2||
59752059|NCT00643201|75871486|FG000|STARTED|Randomized, Completed 6 Months of Study|15 participants were randomized to treatment but not treated.|2691||
59752060|NCT00643201|75871487|FG001|STARTED|Randomized, Completed 6 Months of Study|15 participants were randomized to treatment but not treated.|2704||
59752061|NCT00643201|75871486|FG000|COMPLETED|Randomized, Completed 6 Months of Study||2314||
59752062|NCT00643201|75871487|FG001|COMPLETED|Randomized, Completed 6 Months of Study||2291||
59752063|NCT00643201|75871486|FG000|NOT COMPLETED|Randomized, Completed 6 Months of Study||377||
59752064|NCT00643201|75871487|FG001|NOT COMPLETED|Randomized, Completed 6 Months of Study||413||
59752065|NCT00643201|75871486|FG000|STARTED|Completed Study Follow Up||2617||
59752066|NCT00643201|75871487|FG001|STARTED|Completed Study Follow Up||2639||
59752067|NCT00643201|75871486|FG000|COMPLETED|Completed Study Follow Up|Of 70 who did not complete follow up: 7 completed treatment; 63 discontinued treatment|2547||
59752068|NCT00643201|75871487|FG001|COMPLETED|Completed Study Follow Up|Of 79 who did not complete follow up: 3 completed treatment, 76 discontinued treatment|2560||
59752069|NCT00643201|75871486|FG000|NOT COMPLETED|Completed Study Follow Up||70||
59752070|NCT00643201|75871487|FG001|NOT COMPLETED|Completed Study Follow Up||79||
59752071|NCT00643123|75871497|FG000|STARTED|Overall Study||15||
59752072|NCT00643123|75871498|FG001|STARTED|Overall Study||12||
59752073|NCT00643123|75871497|FG000|COMPLETED|Overall Study||10||
59752074|NCT00643123|75871498|FG001|COMPLETED|Overall Study||11||
59752075|NCT00643123|75871497|FG000|NOT COMPLETED|Overall Study||5||
59752076|NCT00643123|75871498|FG001|NOT COMPLETED|Overall Study||1||
59752077|NCT00968981|75871507|FG000|STARTED|Overall Study||23||
59752078|NCT00968981|75871508|FG001|STARTED|Overall Study||22||
59752079|NCT00968981|75871509|FG002|STARTED|Overall Study||22||
59752080|NCT00968981|75871507|FG000|Pharmacokinetic(PK) Evaluable Population|Overall Study|Participants with sufficient data to ensure reliable estimation of PK for at least Day 1 PK profile.|20||
59752081|NCT00968981|75871508|FG001|Pharmacokinetic(PK) Evaluable Population|Overall Study|Participants with sufficient data to ensure reliable estimation of PK for at least Day 1 PK profile.|21||
59752082|NCT00968981|75871509|FG002|Pharmacokinetic(PK) Evaluable Population|Overall Study|Participants with sufficient data to ensure reliable estimation of PK for at least Day 1 PK profile.|22||
59752083|NCT00968981|75871507|FG000|COMPLETED|Overall Study||1||
59882597|NCT02787304|76005517|FG002|NOT COMPLETED|Overall Study||41||
59882598|NCT02787304|76005518|FG003|NOT COMPLETED|Overall Study||34||
59882599|NCT02932904|76005532|FG000|STARTED|Overall Study||92||
59882600|NCT02932904|76005533|FG001|STARTED|Overall Study||85||
59882601|NCT02932904|76005534|FG002|STARTED|Overall Study||91||
59882602|NCT02932904|76005535|FG003|STARTED|Overall Study||93||
59882603|NCT02932904|76005532|FG000|Treated|Overall Study||91||
59882604|NCT02932904|76005533|FG001|Treated|Overall Study||84||
59882605|NCT02932904|76005534|FG002|Treated|Overall Study||91||
59882606|NCT02932904|76005535|FG003|Treated|Overall Study||91||
59882607|NCT02932904|76005532|FG000|COMPLETED|Overall Study||76||
59882608|NCT02932904|76005533|FG001|COMPLETED|Overall Study||67||
59882609|NCT02932904|76005534|FG002|COMPLETED|Overall Study||68||
59882610|NCT02932904|76005535|FG003|COMPLETED|Overall Study||79||
59882611|NCT02932904|76005532|FG000|NOT COMPLETED|Overall Study||16||
59882612|NCT02932904|76005533|FG001|NOT COMPLETED|Overall Study||18||
59882613|NCT02932904|76005534|FG002|NOT COMPLETED|Overall Study||23||
59882614|NCT02932904|76005535|FG003|NOT COMPLETED|Overall Study||14||
59882615|NCT00688376|76005550|FG000|STARTED|Double-Blind Phase||40||
59882616|NCT00688376|76005551|FG001|STARTED|Double-Blind Phase||32||
59882617|NCT00688376|76005550|FG000|Safety Population|Double-Blind Phase||40||
59882618|NCT00688376|76005551|FG001|Safety Population|Double-Blind Phase||31||
59882619|NCT00688376|76005550|FG000|COMPLETED|Double-Blind Phase||34||
59882620|NCT00688376|76005551|FG001|COMPLETED|Double-Blind Phase||25||
59882621|NCT00688376|76005550|FG000|NOT COMPLETED|Double-Blind Phase||6||
59882622|NCT00688376|76005551|FG001|NOT COMPLETED|Double-Blind Phase||7||
59882623|NCT00688376|76005550|FG000|STARTED|Blinded Extension Phase||34||
59882624|NCT00688376|76005551|FG001|STARTED|Blinded Extension Phase||25||
59882625|NCT00688376|76005550|FG000|COMPLETED|Blinded Extension Phase||29||
59882626|NCT00688376|76005551|FG001|COMPLETED|Blinded Extension Phase||20||
59882627|NCT00688376|76005550|FG000|NOT COMPLETED|Blinded Extension Phase||5||
59882628|NCT00688376|76005551|FG001|NOT COMPLETED|Blinded Extension Phase||5||
59882629|NCT03214952|76005559|FG000|STARTED|Overall Study||3183||
59882630|NCT03214952|76005559|FG000|COMPLETED|Overall Study||3125||
59882631|NCT03214952|76005559|FG000|NOT COMPLETED|Overall Study||58||
59882632|NCT01367704|76005565|FG000|STARTED|Overall Study||998||
59882633|NCT01367704|76005566|FG001|STARTED|Overall Study||1008||
59882634|NCT01367704|76005565|FG000|COMPLETED|Overall Study||951||
59882635|NCT01367704|76005566|FG001|COMPLETED|Overall Study||847||
60011351|NCT02658175|76127244|FG000|STARTED|Treatment Period: Weeks 1 to 52||51||
59882636|NCT01367704|76005565|FG000|NOT COMPLETED|Overall Study||47||
59882637|NCT01367704|76005566|FG001|NOT COMPLETED|Overall Study||161||
59882638|NCT03214094|76005572|FG000|STARTED|Overall Study||1119||
59882639|NCT03214094|76005572|FG000|COMPLETED|Overall Study||1059||
59882640|NCT03214094|76005572|FG000|NOT COMPLETED|Overall Study||60||
60011352|NCT02658175|76127245|FG001|STARTED|Treatment Period: Weeks 1 to 52||14||
60011353|NCT02658175|76127246|FG002|STARTED|Treatment Period: Weeks 1 to 52||3||
60011354|NCT02658175|76127244|FG000|COMPLETED|Treatment Period: Weeks 1 to 52||36||
60011355|NCT02658175|76127245|FG001|COMPLETED|Treatment Period: Weeks 1 to 52||7||
60011356|NCT02658175|76127246|FG002|COMPLETED|Treatment Period: Weeks 1 to 52||3||
60011357|NCT02658175|76127244|FG000|NOT COMPLETED|Treatment Period: Weeks 1 to 52||15||
60011358|NCT02658175|76127245|FG001|NOT COMPLETED|Treatment Period: Weeks 1 to 52||7||
60011359|NCT02658175|76127246|FG002|NOT COMPLETED|Treatment Period: Weeks 1 to 52||0||
60011360|NCT02658175|76127244|FG000|STARTED|1st Extended Treatment: Weeks 53 to 104||36||
59752084|NCT00968981|75871508|FG001|COMPLETED|Overall Study||0||
59752085|NCT00968981|75871509|FG002|COMPLETED|Overall Study||0||
59752086|NCT00968981|75871507|FG000|NOT COMPLETED|Overall Study||22||
59752087|NCT00968981|75871508|FG001|NOT COMPLETED|Overall Study||22||
59752088|NCT00968981|75871509|FG002|NOT COMPLETED|Overall Study||22||
59752089|NCT00641719|75871520|FG000|STARTED|Overall Study||129||
59752090|NCT00641719|75871521|FG001|STARTED|Overall Study||129||
59752091|NCT00641719|75871520|FG000|COMPLETED|Overall Study||99||
59752092|NCT00641719|75871521|FG001|COMPLETED|Overall Study|1 participant discontinued during taper phase, not during treatment phase.|92||
59752093|NCT00641719|75871520|FG000|NOT COMPLETED|Overall Study||30||
59752094|NCT00641719|75871521|FG001|NOT COMPLETED|Overall Study||37||
59752095|NCT00648895|75871529|FG000|STARTED|Overall Study||6||
59752096|NCT00648895|75871530|FG001|STARTED|Overall Study||6||
59752097|NCT00648895|75871529|FG000|COMPLETED|Overall Study||6||
59752098|NCT00648895|75871530|FG001|COMPLETED|Overall Study||5||
59752099|NCT00648895|75871529|FG000|NOT COMPLETED|Overall Study||0||
59882641|NCT05516082|76005576|FG000|STARTED|Period 1: Lens A, 15 Minutes||41||
59882642|NCT05516082|76005577|FG001|STARTED|Period 1: Lens A, 15 Minutes|All participants received Lens A in Period 1.|0||
59882643|NCT05516082|76005576|FG000|COMPLETED|Period 1: Lens A, 15 Minutes||41||
59882644|NCT05516082|76005577|FG001|COMPLETED|Period 1: Lens A, 15 Minutes||0||
59882645|NCT05516082|76005576|FG000|NOT COMPLETED|Period 1: Lens A, 15 Minutes||0||
59882646|NCT05516082|76005577|FG001|NOT COMPLETED|Period 1: Lens A, 15 Minutes||0||
59882647|NCT05516082|76005576|FG000|STARTED|Period 2: Lens B, 15 Minutes|All participants received Lens B in Period 2.|0||
59882648|NCT05516082|76005577|FG001|STARTED|Period 2: Lens B, 15 Minutes||41||
59882649|NCT05516082|76005576|FG000|COMPLETED|Period 2: Lens B, 15 Minutes||0||
59882650|NCT05516082|76005577|FG001|COMPLETED|Period 2: Lens B, 15 Minutes||41||
59882651|NCT05516082|76005576|FG000|NOT COMPLETED|Period 2: Lens B, 15 Minutes||0||
59882652|NCT05516082|76005577|FG001|NOT COMPLETED|Period 2: Lens B, 15 Minutes||0||
59882653|NCT05299359|76005583|FG000|STARTED|Overall Study||150||
59882654|NCT05299359|76005583|FG000|COMPLETED|Overall Study||0||
59882655|NCT05299359|76005583|FG000|NOT COMPLETED|Overall Study||150||
59882656|NCT05096247|76005591|FG000|STARTED|Overall Study||13||
59882657|NCT05096247|76005592|FG001|STARTED|Overall Study||35||
59882658|NCT05096247|76005591|FG000|COMPLETED|Overall Study||13||
59882659|NCT05096247|76005592|FG001|COMPLETED|Overall Study||35||
59882660|NCT05096247|76005591|FG000|NOT COMPLETED|Overall Study||0||
59882661|NCT05096247|76005592|FG001|NOT COMPLETED|Overall Study||0||
59882662|NCT05069155|76005600|FG000|STARTED|Overall Study||50||
59882663|NCT05069155|76005601|FG001|STARTED|Overall Study||44||
59882664|NCT05069155|76005600|FG000|COMPLETED|Overall Study||49||
59882665|NCT05069155|76005601|FG001|COMPLETED|Overall Study||41||
59882666|NCT05069155|76005600|FG000|NOT COMPLETED|Overall Study||1||
60011361|NCT02658175|76127245|FG001|STARTED|1st Extended Treatment: Weeks 53 to 104||7||
60011362|NCT02658175|76127246|FG002|STARTED|1st Extended Treatment: Weeks 53 to 104||3||
60011363|NCT02658175|76127244|FG000|COMPLETED|1st Extended Treatment: Weeks 53 to 104||15||
60011364|NCT02658175|76127245|FG001|COMPLETED|1st Extended Treatment: Weeks 53 to 104||5||
60011365|NCT02658175|76127246|FG002|COMPLETED|1st Extended Treatment: Weeks 53 to 104||1||
60011366|NCT02658175|76127244|FG000|NOT COMPLETED|1st Extended Treatment: Weeks 53 to 104||21||
60011367|NCT02658175|76127245|FG001|NOT COMPLETED|1st Extended Treatment: Weeks 53 to 104||2||
60011368|NCT02658175|76127246|FG002|NOT COMPLETED|1st Extended Treatment: Weeks 53 to 104||2||
60011369|NCT02658175|76127244|FG000|STARTED|2nd Extended Treatment: Weeks 105 to156||1|Only those participants in France who continued into the 2nd extended treatment period.|
60011370|NCT02658175|76127245|FG001|STARTED|2nd Extended Treatment: Weeks 105 to156||0|Only those participants in France who continued into the 2nd extended treatment period.|
60011371|NCT02658175|76127246|FG002|STARTED|2nd Extended Treatment: Weeks 105 to156||1|Only those participants in France who continued into the 2nd extended treatment period.|
60011372|NCT02658175|76127244|FG000|COMPLETED|2nd Extended Treatment: Weeks 105 to156||0||
60011373|NCT02658175|76127245|FG001|COMPLETED|2nd Extended Treatment: Weeks 105 to156||0||
60011374|NCT02658175|76127246|FG002|COMPLETED|2nd Extended Treatment: Weeks 105 to156||0||
60011375|NCT02658175|76127244|FG000|NOT COMPLETED|2nd Extended Treatment: Weeks 105 to156||1||
60011376|NCT02658175|76127245|FG001|NOT COMPLETED|2nd Extended Treatment: Weeks 105 to156||0||
60011377|NCT02658175|76127246|FG002|NOT COMPLETED|2nd Extended Treatment: Weeks 105 to156||1||
59882667|NCT05069155|76005601|FG001|NOT COMPLETED|Overall Study||3||
60011378|NCT02625623|76127256|FG000|STARTED|Overall Study||186||
60011379|NCT02625623|76127257|FG001|STARTED|Overall Study||185||
60011380|NCT02625623|76127256|FG000|Treated|Overall Study||177||
60011381|NCT02625623|76127257|FG001|Treated|Overall Study||184||
60011382|NCT02625623|76127256|FG000|COMPLETED|Overall Study||177||
60011383|NCT02625623|76127257|FG001|COMPLETED|Overall Study||184||
60011384|NCT02625623|76127256|FG000|NOT COMPLETED|Overall Study||9||
60011385|NCT02625623|76127257|FG001|NOT COMPLETED|Overall Study||1||
60011386|NCT02658019|76127265|FG000|STARTED|Overall Study||29||
60011387|NCT02658019|76127265|FG000|COMPLETED|Overall Study||28||
60011388|NCT02658019|76127265|FG000|NOT COMPLETED|Overall Study||1||
60011389|NCT02624687|76127271|FG000|STARTED|Overall Study||13||
60011390|NCT02624687|76127272|FG001|STARTED|Overall Study||14||
60011391|NCT02624687|76127271|FG000|COMPLETED|Overall Study||12||
60011392|NCT02624687|76127272|FG001|COMPLETED|Overall Study||12||
60011393|NCT02624687|76127271|FG000|NOT COMPLETED|Overall Study||1||
60011394|NCT02624687|76127272|FG001|NOT COMPLETED|Overall Study||2||
60011395|NCT01675765|76127280|FG000|STARTED|Overall Study||38||
60011396|NCT01675765|76127281|FG001|STARTED|Overall Study||22||
60011397|NCT01675765|76127280|FG000|COMPLETED|Overall Study||27||
60011398|NCT01675765|76127281|FG001|COMPLETED|Overall Study||14||
60011399|NCT01675765|76127280|FG000|NOT COMPLETED|Overall Study||11||
60011400|NCT01675765|76127281|FG001|NOT COMPLETED|Overall Study||8||
60011401|NCT02625233|76127289|FG000|STARTED|Overall Study||49||
60011402|NCT02625233|76127290|FG001|STARTED|Overall Study||56||
60011403|NCT02625233|76127289|FG000|COMPLETED|Overall Study||47||
60011404|NCT02625233|76127290|FG001|COMPLETED|Overall Study||56||
60011405|NCT02625233|76127289|FG000|NOT COMPLETED|Overall Study||2||
60011406|NCT02625233|76127290|FG001|NOT COMPLETED|Overall Study||0||
60011407|NCT02656693|76127299|FG000|STARTED|Overall Study||326||
60011408|NCT02656693|76127300|FG001|STARTED|Overall Study||216||
60011409|NCT02656693|76127301|FG002|STARTED|Overall Study||298||
59752100|NCT00648895|75871530|FG001|NOT COMPLETED|Overall Study||1||
59752101|NCT00975221|75871538|FG000|STARTED|Titration Phase (Weeks 1-12)||34||
59752102|NCT00975221|75871539|FG001|STARTED|Titration Phase (Weeks 1-12)||33||
59752103|NCT00975221|75871538|FG000|Received Study Drug|Titration Phase (Weeks 1-12)||34||
59752104|NCT00975221|75871539|FG001|Received Study Drug|Titration Phase (Weeks 1-12)||33||
59752105|NCT00975221|75871538|FG000|COMPLETED|Titration Phase (Weeks 1-12)||31||
59752106|NCT00975221|75871539|FG001|COMPLETED|Titration Phase (Weeks 1-12)||29||
59752107|NCT00975221|75871538|FG000|NOT COMPLETED|Titration Phase (Weeks 1-12)||3||
59752108|NCT00975221|75871539|FG001|NOT COMPLETED|Titration Phase (Weeks 1-12)||4||
59752109|NCT00975221|75871538|FG000|STARTED|Efficacy Assessment Phase (Weeks 13-28)|1 participant who completed the Titration Phase did not enter the EAP|30||
59752110|NCT00975221|75871539|FG001|STARTED|Efficacy Assessment Phase (Weeks 13-28)||29||
59752111|NCT00975221|75871538|FG000|COMPLETED|Efficacy Assessment Phase (Weeks 13-28)||30||
59752112|NCT00975221|75871539|FG001|COMPLETED|Efficacy Assessment Phase (Weeks 13-28)||28||
59752113|NCT00975221|75871538|FG000|NOT COMPLETED|Efficacy Assessment Phase (Weeks 13-28)||0||
59752114|NCT00975221|75871539|FG001|NOT COMPLETED|Efficacy Assessment Phase (Weeks 13-28)||1||
59752115|NCT00975221|75871538|FG000|STARTED|Open-label Extension Phase (Weeks 29-52)|1 participant who completed the EAP did not enter the open-label phase|29||
59752116|NCT00975221|75871539|FG001|STARTED|Open-label Extension Phase (Weeks 29-52)||28||
59752117|NCT00975221|75871538|FG000|COMPLETED|Open-label Extension Phase (Weeks 29-52)||27||
59752118|NCT00975221|75871539|FG001|COMPLETED|Open-label Extension Phase (Weeks 29-52)||27||
59752119|NCT00975221|75871538|FG000|NOT COMPLETED|Open-label Extension Phase (Weeks 29-52)||2||
59752120|NCT00975221|75871539|FG001|NOT COMPLETED|Open-label Extension Phase (Weeks 29-52)||1||
59752121|NCT00972179|75871554|FG000|STARTED|Overall Study||6||
59752122|NCT00972179|75871555|FG001|STARTED|Overall Study||6||
59752123|NCT00972179|75871556|FG002|STARTED|Overall Study||6||
59752124|NCT00972179|75871557|FG003|STARTED|Overall Study||6||
59752125|NCT00972179|75871558|FG004|STARTED|Overall Study||7||
59752126|NCT00972179|75871559|FG005|STARTED|Overall Study||6||
59752127|NCT00972179|75871560|FG006|STARTED|Overall Study||12||
59752128|NCT00972179|75871554|FG000|COMPLETED|Overall Study||5||
59752129|NCT00972179|75871555|FG001|COMPLETED|Overall Study||3||
59752130|NCT00972179|75871556|FG002|COMPLETED|Overall Study||5||
59752131|NCT00972179|75871557|FG003|COMPLETED|Overall Study||5||
59752132|NCT00972179|75871558|FG004|COMPLETED|Overall Study||5||
59752133|NCT00972179|75871559|FG005|COMPLETED|Overall Study||3||
59752134|NCT00972179|75871560|FG006|COMPLETED|Overall Study||8||
59752135|NCT00972179|75871554|FG000|NOT COMPLETED|Overall Study||1||
59752136|NCT00972179|75871555|FG001|NOT COMPLETED|Overall Study||3||
59752137|NCT00972179|75871556|FG002|NOT COMPLETED|Overall Study||1||
59752138|NCT00972179|75871557|FG003|NOT COMPLETED|Overall Study||1||
59752139|NCT00972179|75871558|FG004|NOT COMPLETED|Overall Study||2||
59752140|NCT00972179|75871559|FG005|NOT COMPLETED|Overall Study||3||
59752141|NCT00972179|75871560|FG006|NOT COMPLETED|Overall Study||4||
59752142|NCT00906698|75871586|FG000|STARTED|Overall Study||3||
59752143|NCT00906698|75871587|FG001|STARTED|Overall Study||19||
59752144|NCT00906698|75871588|FG002|STARTED|Overall Study||6||
59752145|NCT00906698|75871589|FG003|STARTED|Overall Study||4||
59752146|NCT00906698|75871590|FG004|STARTED|Overall Study||18||
59752147|NCT00906698|75871591|FG005|STARTED|Overall Study||5||
59752148|NCT00906698|75871586|FG000|COMPLETED|Overall Study||0||
59752149|NCT00906698|75871587|FG001|COMPLETED|Overall Study||0||
59752150|NCT00906698|75871588|FG002|COMPLETED|Overall Study||0||
59752151|NCT00906698|75871589|FG003|COMPLETED|Overall Study||0||
59752152|NCT00906698|75871590|FG004|COMPLETED|Overall Study||0||
59752153|NCT00906698|75871591|FG005|COMPLETED|Overall Study||0||
59752154|NCT00906698|75871586|FG000|NOT COMPLETED|Overall Study||3||
59882668|NCT04875533|76005609|FG000|STARTED|Overall Study||711|Participants Vaccinated with Vaccination 1|
59882669|NCT04875533|76005610|FG001|STARTED|Overall Study||710|Participants Vaccinated with Vaccination 1|
59752155|NCT00906698|75871587|FG001|NOT COMPLETED|Overall Study||19||
59752156|NCT00906698|75871588|FG002|NOT COMPLETED|Overall Study||6||
59752157|NCT00906698|75871589|FG003|NOT COMPLETED|Overall Study||4||
59752158|NCT00906698|75871590|FG004|NOT COMPLETED|Overall Study||18||
59752159|NCT00906698|75871591|FG005|NOT COMPLETED|Overall Study||5||
59882670|NCT04875533|76005609|FG000|Vaccinated With Vaccination 2|Overall Study||695||
59752160|NCT00972023|75871623|FG000|STARTED|Overall Study||1||
59752161|NCT00972023|75871623|FG000|COMPLETED|Overall Study||0||
59752162|NCT00972023|75871623|FG000|NOT COMPLETED|Overall Study||1||
59752163|NCT00971945|75871629|FG000|STARTED|Overall Study||6||
59752164|NCT00971945|75871629|FG000|COMPLETED|Overall Study||0||
59752165|NCT00971945|75871629|FG000|NOT COMPLETED|Overall Study||6||
59752166|NCT00971867|75871633|FG000|STARTED|Overall Study||11||
59752167|NCT00971867|75871633|FG000|COMPLETED|Overall Study||0||
59752168|NCT00971867|75871633|FG000|NOT COMPLETED|Overall Study||11||
59752169|NCT00971321|75871639|FG000|STARTED|Up to Day 42||104||
59752170|NCT00971321|75871640|FG001|STARTED|Up to Day 42||53||
59752171|NCT00971321|75871639|FG000|COMPLETED|Up to Day 42||104||
59752172|NCT00971321|75871640|FG001|COMPLETED|Up to Day 42||53||
59752173|NCT00971321|75871639|FG000|NOT COMPLETED|Up to Day 42||0||
59752174|NCT00971321|75871640|FG001|NOT COMPLETED|Up to Day 42||0||
59752175|NCT00971321|75871639|FG000|STARTED|Up to Month 7||104||
59752176|NCT00971321|75871640|FG001|STARTED|Up to Month 7||53||
59752177|NCT00971321|75871639|FG000|COMPLETED|Up to Month 7||100||
59752178|NCT00971321|75871640|FG001|COMPLETED|Up to Month 7||51||
59752179|NCT00971321|75871639|FG000|NOT COMPLETED|Up to Month 7||4||
59882671|NCT04875533|76005610|FG001|Vaccinated With Vaccination 2|Overall Study||699||
59882672|NCT04875533|76005609|FG000|COMPLETED|Overall Study||692||
59882673|NCT04875533|76005610|FG001|COMPLETED|Overall Study||699||
59605926|NCT01962948|75716139|FG000|STARTED|Overall Study||3||
59605927|NCT01962948|75716140|FG001|STARTED|Overall Study||3||
59605928|NCT01962948|75716141|FG002|STARTED|Overall Study||6||
59882674|NCT04875533|76005609|FG000|NOT COMPLETED|Overall Study||19||
59882675|NCT04875533|76005610|FG001|NOT COMPLETED|Overall Study||11||
59882676|NCT04854551|76005620|FG000|STARTED|Overall Study||7||
59882677|NCT04854551|76005621|FG001|STARTED|Overall Study||6||
59882678|NCT04854551|76005620|FG000|COMPLETED|Overall Study||6||
59882679|NCT04854551|76005621|FG001|COMPLETED|Overall Study||5||
59882680|NCT04854551|76005620|FG000|NOT COMPLETED|Overall Study||1||
59882681|NCT04854551|76005621|FG001|NOT COMPLETED|Overall Study||1||
59882682|NCT04672941|76005628|FG000|STARTED|Overall Study||1396||
59882683|NCT04672941|76005628|FG000|COMPLETED|Overall Study||1388||
59882684|NCT04672941|76005628|FG000|NOT COMPLETED|Overall Study||8||
59882685|NCT04625673|76005637|FG000|STARTED|Overall Study||3||
59882686|NCT04625673|76005638|FG001|STARTED|Overall Study||9||
59882687|NCT04625673|76005639|FG002|STARTED|Overall Study||11||
59605929|NCT01962948|75716142|FG003|STARTED|Overall Study||0||
59605930|NCT01962948|75716139|FG000|COMPLETED|Overall Study||0||
59882688|NCT04625673|76005637|FG000|COMPLETED|Overall Study||3||
59882689|NCT04625673|76005638|FG001|COMPLETED|Overall Study||9||
59605931|NCT01962948|75716140|FG001|COMPLETED|Overall Study||0||
59605932|NCT01962948|75716141|FG002|COMPLETED|Overall Study||0||
59605933|NCT01962948|75716142|FG003|COMPLETED|Overall Study||0||
59605934|NCT01962948|75716139|FG000|NOT COMPLETED|Overall Study||3||
59605935|NCT01962948|75716140|FG001|NOT COMPLETED|Overall Study||3||
59605936|NCT01962948|75716141|FG002|NOT COMPLETED|Overall Study||6||
59605937|NCT01962948|75716142|FG003|NOT COMPLETED|Overall Study||0||
59605938|NCT01985334|75716157|FG000|STARTED|Overall Study||130||
59605939|NCT01985334|75716158|FG001|STARTED|Overall Study||387||
59605940|NCT01985334|75716159|FG002|STARTED|Overall Study||420||
59605941|NCT01985334|75716160|FG003|STARTED|Overall Study||1262||
59605942|NCT01985334|75716161|FG004|STARTED|Overall Study||274||
59605943|NCT01985334|75716162|FG005|STARTED|Overall Study||822||
59605944|NCT01985334|75716163|FG006|STARTED|Overall Study||274||
59605945|NCT01985334|75716164|FG007|STARTED|Overall Study||820||
59605946|NCT01985334|75716157|FG000|The Intention-to-treat (ITT) Population|Overall Study||122||
59605947|NCT01985334|75716158|FG001|The Intention-to-treat (ITT) Population|Overall Study||369||
59882690|NCT04625673|76005639|FG002|COMPLETED|Overall Study||10||
59882691|NCT04625673|76005637|FG000|NOT COMPLETED|Overall Study||0||
59882692|NCT04625673|76005638|FG001|NOT COMPLETED|Overall Study||0||
59882693|NCT04625673|76005639|FG002|NOT COMPLETED|Overall Study||1||
59882694|NCT04599972|76005653|FG000|STARTED|Overall Study|One subject was randomized to CSF-1 and inadvertently received Vehicle.|154||
59882695|NCT04599972|76005654|FG001|STARTED|Overall Study||150||
59882696|NCT04599972|76005653|FG000|COMPLETED|Overall Study||144||
59882697|NCT04599972|76005654|FG001|COMPLETED|Overall Study||142||
59882698|NCT04599972|76005653|FG000|NOT COMPLETED|Overall Study||10||
59882699|NCT04599972|76005654|FG001|NOT COMPLETED|Overall Study||8||
59752180|NCT00971321|75871640|FG001|NOT COMPLETED|Up to Month 7||2||
59752181|NCT00971321|75871639|FG000|STARTED|Up to Month 11-12||104||
59752182|NCT00971321|75871640|FG001|STARTED|Up to Month 11-12||53||
59752183|NCT00971321|75871639|FG000|COMPLETED|Up to Month 11-12||99||
59752184|NCT00971321|75871640|FG001|COMPLETED|Up to Month 11-12||50||
59752185|NCT00971321|75871639|FG000|NOT COMPLETED|Up to Month 11-12||5||
59752186|NCT00971321|75871640|FG001|NOT COMPLETED|Up to Month 11-12||3||
59882700|NCT04599933|76005662|FG000|STARTED|Overall Study||155||
59882701|NCT04599933|76005663|FG001|STARTED|Overall Study||154||
59752187|NCT00648739|75871646|FG000|STARTED|Overall Study||4||
59752188|NCT00648739|75871647|FG001|STARTED|Overall Study||5||
59882702|NCT04599933|76005662|FG000|COMPLETED|Overall Study||146||
59752189|NCT00648739|75871648|FG002|STARTED|Overall Study||3||
59752190|NCT00648739|75871649|FG003|STARTED|Overall Study||3||
59882703|NCT04599933|76005663|FG001|COMPLETED|Overall Study||147||
59752191|NCT00648739|75871650|FG004|STARTED|Overall Study||3||
59605948|NCT01985334|75716159|FG002|The Intention-to-treat (ITT) Population|Overall Study||420||
59605949|NCT01985334|75716160|FG003|The Intention-to-treat (ITT) Population|Overall Study||1254||
59752192|NCT00648739|75871651|FG005|STARTED|Overall Study||7||
59752193|NCT00648739|75871652|FG006|STARTED|Overall Study||1||
59605950|NCT01985334|75716161|FG004|The Intention-to-treat (ITT) Population|Overall Study||269||
59752194|NCT00648739|75871646|FG000|Received at Least 1 Dose of Study Drug|Overall Study||4||
59605951|NCT01985334|75716162|FG005|The Intention-to-treat (ITT) Population|Overall Study||811||
59605952|NCT01985334|75716163|FG006|The Intention-to-treat (ITT) Population|Overall Study||268||
59605953|NCT01985334|75716164|FG007|The Intention-to-treat (ITT) Population|Overall Study||811||
59882704|NCT04599933|76005662|FG000|NOT COMPLETED|Overall Study||9||
59752195|NCT00648739|75871647|FG001|Received at Least 1 Dose of Study Drug|Overall Study||5||
59752196|NCT00648739|75871648|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3||
59882705|NCT04599933|76005663|FG001|NOT COMPLETED|Overall Study||7||
59752197|NCT00648739|75871649|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3||
59752198|NCT00648739|75871650|FG004|Received at Least 1 Dose of Study Drug|Overall Study||3||
59752199|NCT00648739|75871651|FG005|Received at Least 1 Dose of Study Drug|Overall Study||7||
59752200|NCT00648739|75871652|FG006|Received at Least 1 Dose of Study Drug|Overall Study||1||
59882706|NCT04558918|76005671|FG000|STARTED|Randomized Treatment Period||62||
59752201|NCT00648739|75871646|FG000|COMPLETED|Overall Study||2||
59882707|NCT04558918|76005672|FG001|STARTED|Randomized Treatment Period||35||
59752202|NCT00648739|75871647|FG001|COMPLETED|Overall Study||3||
59752203|NCT00648739|75871648|FG002|COMPLETED|Overall Study||0||
59752204|NCT00648739|75871649|FG003|COMPLETED|Overall Study||1||
59752205|NCT00648739|75871650|FG004|COMPLETED|Overall Study||1||
59752206|NCT00648739|75871651|FG005|COMPLETED|Overall Study||2||
59752207|NCT00648739|75871652|FG006|COMPLETED|Overall Study||0||
59752208|NCT00648739|75871646|FG000|NOT COMPLETED|Overall Study||2||
59752209|NCT00648739|75871647|FG001|NOT COMPLETED|Overall Study||2||
59752210|NCT00648739|75871648|FG002|NOT COMPLETED|Overall Study||3||
59752211|NCT00648739|75871649|FG003|NOT COMPLETED|Overall Study||2||
59752212|NCT00648739|75871650|FG004|NOT COMPLETED|Overall Study||2||
59752213|NCT00648739|75871651|FG005|NOT COMPLETED|Overall Study||5||
59752214|NCT00648739|75871652|FG006|NOT COMPLETED|Overall Study||1||
59752215|NCT00648037|75871673|FG000|STARTED|Overall Study||26||
59752216|NCT00648037|75871673|FG000|COMPLETED|Overall Study||10||
59752217|NCT00648037|75871673|FG000|NOT COMPLETED|Overall Study||16||
59752218|NCT00627523|75871679|FG000|STARTED|Overall Study|22 assigned to Genotropin and 21 in Control; 1 did not take Genotropin, so considered as Control.|21||
59519083|NCT01093651|75612960|FG001|NOT COMPLETED|Overall Study||0||
59752219|NCT00627523|75871680|FG001|STARTED|Overall Study||22||
59752220|NCT00627523|75871679|FG000|COMPLETED|Overall Study||19||
59752221|NCT00627523|75871680|FG001|COMPLETED|Overall Study||20||
59752222|NCT00627523|75871679|FG000|NOT COMPLETED|Overall Study||2||
59752223|NCT00627523|75871680|FG001|NOT COMPLETED|Overall Study||2||
59752224|NCT00640393|75871686|FG000|STARTED|Part 1||99||
59752225|NCT00640393|75871687|FG001|STARTED|Part 1||0||
59752226|NCT00640393|75871688|FG002|STARTED|Part 1||0||
59752227|NCT00640393|75871686|FG000|COMPLETED|Part 1||94||
59752228|NCT00640393|75871687|FG001|COMPLETED|Part 1||0||
59752229|NCT00640393|75871688|FG002|COMPLETED|Part 1||0||
59752230|NCT00640393|75871686|FG000|NOT COMPLETED|Part 1||5||
59752231|NCT00640393|75871687|FG001|NOT COMPLETED|Part 1||0||
59752232|NCT00640393|75871688|FG002|NOT COMPLETED|Part 1||0||
59752233|NCT00640393|75871686|FG000|STARTED|Randomization||94||
59752234|NCT00640393|75871687|FG001|STARTED|Randomization||0||
59752235|NCT00640393|75871688|FG002|STARTED|Randomization||0||
59752236|NCT00640393|75871686|FG000|COMPLETED|Randomization||75||
59752237|NCT00640393|75871687|FG001|COMPLETED|Randomization||0||
59752238|NCT00640393|75871688|FG002|COMPLETED|Randomization||0||
59752239|NCT00640393|75871686|FG000|NOT COMPLETED|Randomization||19||
59752240|NCT00640393|75871687|FG001|NOT COMPLETED|Randomization||0||
59752241|NCT00640393|75871688|FG002|NOT COMPLETED|Randomization||0||
59752242|NCT00640393|75871686|FG000|STARTED|Part 2||0||
59752243|NCT00640393|75871687|FG001|STARTED|Part 2||37||
59752244|NCT00640393|75871688|FG002|STARTED|Part 2||38||
59752245|NCT00640393|75871686|FG000|COMPLETED|Part 2||0||
59752246|NCT00640393|75871687|FG001|COMPLETED|Part 2|Per Protocol analysis is of 7 participants that were compliant to protocol|27||
59752247|NCT00640393|75871688|FG002|COMPLETED|Part 2|Per protocol analysis of 27 to 29 participants that were compliant depending on evaluation or visit|35||
59752248|NCT00640393|75871686|FG000|NOT COMPLETED|Part 2||0||
59752249|NCT00640393|75871687|FG001|NOT COMPLETED|Part 2||10||
59752250|NCT00640393|75871688|FG002|NOT COMPLETED|Part 2||3||
59752251|NCT00907478|75871699|FG000|STARTED|Overall Study||50||
59752252|NCT00907478|75871700|FG001|STARTED|Overall Study||50||
59752253|NCT00907478|75871701|FG002|STARTED|Overall Study||69||
59752254|NCT00907478|75871699|FG000|COMPLETED|Overall Study|Defined as participants who completed the full 3 years and completed the end of study visit.|23||
59752255|NCT00907478|75871700|FG001|COMPLETED|Overall Study|Defined as participants who completed the full 3 years and completed the end of study visit.|33||
59752256|NCT00907478|75871701|FG002|COMPLETED|Overall Study|Defined as participants who completed the full 3 years and completed the end of study visit.|47||
59752257|NCT00907478|75871699|FG000|NOT COMPLETED|Overall Study||27||
59752258|NCT00907478|75871700|FG001|NOT COMPLETED|Overall Study||17||
59752259|NCT00907478|75871701|FG002|NOT COMPLETED|Overall Study||22||
59752260|NCT00627445|75871713|FG000|STARTED|Overall Study||219||
59752261|NCT00627445|75871714|FG001|STARTED|Overall Study||222||
59752262|NCT00627445|75871713|FG000|Exposed to Study Drug|Overall Study||219||
59752263|NCT00627445|75871714|FG001|Exposed to Study Drug|Overall Study||222||
59752264|NCT00627445|75871713|FG000|COMPLETED|Overall Study||210||
59752265|NCT00627445|75871714|FG001|COMPLETED|Overall Study||210||
59752266|NCT00627445|75871713|FG000|NOT COMPLETED|Overall Study||9||
59752267|NCT00627445|75871714|FG001|NOT COMPLETED|Overall Study||12||
59752268|NCT00905840|75871722|FG000|STARTED|Overall Study||91||
59752269|NCT00905840|75871722|FG000|COMPLETED|Overall Study||75||
59752270|NCT00905840|75871722|FG000|NOT COMPLETED|Overall Study||16||
59752271|NCT00626821|75871729|FG000|STARTED|Overall Study||3017||
59752272|NCT00626821|75871729|FG000|Quality of Life|Overall Study|Attended both visit 1 and visit 2|2672||
59752273|NCT00626821|75871729|FG000|COMPLETED|Overall Study||2796||
59752274|NCT00626821|75871729|FG000|NOT COMPLETED|Overall Study||221||
59752275|NCT00625183|75871733|FG000|STARTED|Overall Study||5||
59752276|NCT00625183|75871733|FG000|COMPLETED|Overall Study||4||
59752277|NCT00625183|75871733|FG000|NOT COMPLETED|Overall Study||1||
59882708|NCT04558918|76005671|FG000|COMPLETED|Randomized Treatment Period||61|completed the randomized treatment period on treatment|
59882709|NCT04558918|76005672|FG001|COMPLETED|Randomized Treatment Period||35|completed the randomized treatment period on treatment|
59882710|NCT04558918|76005671|FG000|NOT COMPLETED|Randomized Treatment Period||1||
59882711|NCT04558918|76005672|FG001|NOT COMPLETED|Randomized Treatment Period||0||
59882712|NCT04558918|76005671|FG000|STARTED|Extension Treatment Period||61||
59882713|NCT04558918|76005672|FG001|STARTED|Extension Treatment Period||33||
59950840|NCT01505608|76069753|FG000|STARTED|Phase I|Randomization to Arm A began in Phase 2. All patients in Phase I were enrolled to receive TPI 287.|0||
59882714|NCT04558918|76005671|FG000|COMPLETED|Extension Treatment Period||32|Completed the extension treatment period on iptacopan, as of the data cut-off (26-Sep-2022).|
59882715|NCT04558918|76005672|FG001|COMPLETED|Extension Treatment Period||19|Completed the extension treatment period on iptacopan, as of the data cut-off (26-Sep-2022).|
59882716|NCT04558918|76005671|FG000|NOT COMPLETED|Extension Treatment Period||29||
59882717|NCT04558918|76005672|FG001|NOT COMPLETED|Extension Treatment Period||14||
59882718|NCT04498910|76005682|FG000|STARTED|Overall Study||19||
59882719|NCT04498910|76005683|FG001|STARTED|Overall Study||19||
59882720|NCT04498910|76005682|FG000|Received at Least One Dose of Study Drug|Overall Study||19||
59882721|NCT04498910|76005683|FG001|Received at Least One Dose of Study Drug|Overall Study||19||
59882722|NCT04498910|76005682|FG000|COMPLETED|Overall Study||16||
59882723|NCT04498910|76005683|FG001|COMPLETED|Overall Study||17||
59882724|NCT04498910|76005682|FG000|NOT COMPLETED|Overall Study||3||
59882725|NCT04498910|76005683|FG001|NOT COMPLETED|Overall Study||2||
59882726|NCT04439344|76005690|FG000|STARTED|Overall Study||53||
59882727|NCT04439344|76005690|FG000|Started Protocol Therapy|Overall Study||50||
59882728|NCT04439344|76005690|FG000|Eligible|Overall Study||47||
59882729|NCT04439344|76005690|FG000|COMPLETED|Overall Study||0|Treatment continued until disease progression or intolerability.|
59882730|NCT04439344|76005690|FG000|NOT COMPLETED|Overall Study||53||
59882731|NCT04439110|76005694|FG000|STARTED|Overall Study||38||
59882732|NCT04439110|76005694|FG000|Eligible|Overall Study||36||
59882733|NCT04439110|76005694|FG000|COMPLETED|Overall Study||0|Treatment continued until disease progression or intolerability.|
59882734|NCT04439110|76005694|FG000|NOT COMPLETED|Overall Study||38||
59882735|NCT04392167|76005698|FG000|STARTED|Overall Study||37||
59882736|NCT04392167|76005698|FG000|COMPLETED|Overall Study||31||
59882737|NCT04392167|76005698|FG000|NOT COMPLETED|Overall Study||6||
59882738|NCT04358406|76005705|FG000|STARTED|Overall Study||33|Randomized|
59882739|NCT04358406|76005706|FG001|STARTED|Overall Study||31|Randomized|
59882740|NCT04358406|76005705|FG000|Randomized|Overall Study||33||
59882741|NCT04358406|76005706|FG001|Randomized|Overall Study||31||
59882742|NCT04358406|76005705|FG000|Treated|Overall Study||31||
59882743|NCT04358406|76005706|FG001|Treated|Overall Study||30||
59882744|NCT04358406|76005705|FG000|COMPLETED|Overall Study||27||
59519084|NCT00939731|75612966|FG000|STARTED|First Intervention Period||12||
59752278|NCT00904982|75871743|FG000|STARTED|Overall Study||68||
59752279|NCT00904982|75871744|FG001|STARTED|Overall Study||67||
59752280|NCT00904982|75871745|FG002|STARTED|Overall Study||67||
59752281|NCT00904982|75871746|FG003|STARTED|Overall Study||68||
59752282|NCT00904982|75871743|FG000|COMPLETED|Overall Study||66||
59752283|NCT00904982|75871744|FG001|COMPLETED|Overall Study||67||
59752284|NCT00904982|75871745|FG002|COMPLETED|Overall Study||67||
59752285|NCT00904982|75871746|FG003|COMPLETED|Overall Study||68||
59752286|NCT00904982|75871743|FG000|NOT COMPLETED|Overall Study||2||
59752287|NCT00904982|75871744|FG001|NOT COMPLETED|Overall Study||0||
59752288|NCT00904982|75871745|FG002|NOT COMPLETED|Overall Study||0||
59752289|NCT00904982|75871746|FG003|NOT COMPLETED|Overall Study||0||
59752290|NCT00640315|75871758|FG000|STARTED|Overall Study||10||
59519085|NCT00939731|75612967|FG001|STARTED|First Intervention Period||12||
59752291|NCT00640315|75871759|FG001|STARTED|Overall Study||13||
59752292|NCT00640315|75871758|FG000|Participants Received Treatment|Overall Study||10||
59752293|NCT00640315|75871759|FG001|Participants Received Treatment|Overall Study||13||
59752294|NCT00640315|75871758|FG000|COMPLETED|Overall Study||10||
59752295|NCT00640315|75871759|FG001|COMPLETED|Overall Study||12||
59752296|NCT00640315|75871758|FG000|NOT COMPLETED|Overall Study||0||
59752297|NCT00640315|75871759|FG001|NOT COMPLETED|Overall Study||1||
59605954|NCT01985334|75716157|FG000|COMPLETED|Overall Study||107||
59752298|NCT00904748|75871765|FG000|STARTED|Overall Study||8||
59752299|NCT00904748|75871766|FG001|STARTED|Overall Study||8||
59752300|NCT00904748|75871767|FG002|STARTED|Overall Study||8||
59752301|NCT00904748|75871768|FG003|STARTED|Overall Study||8||
59752302|NCT00904748|75871769|FG004|STARTED|Overall Study|1 participant randomized to this sequence discontinued prior to receipt of study medication.|8||
59752303|NCT00904748|75871770|FG005|STARTED|Overall Study||8||
59752304|NCT00904748|75871765|FG000|Received Treatment|Overall Study||8||
59752305|NCT00904748|75871766|FG001|Received Treatment|Overall Study||8||
59605955|NCT01985334|75716158|FG001|COMPLETED|Overall Study||303||
59752306|NCT00904748|75871767|FG002|Received Treatment|Overall Study||8||
59752307|NCT00904748|75871768|FG003|Received Treatment|Overall Study||8||
59752308|NCT00904748|75871769|FG004|Received Treatment|Overall Study||7||
59752309|NCT00904748|75871770|FG005|Received Treatment|Overall Study||8||
59752310|NCT00904748|75871765|FG000|COMPLETED|Overall Study||7||
59752311|NCT00904748|75871766|FG001|COMPLETED|Overall Study||7||
59752312|NCT00904748|75871767|FG002|COMPLETED|Overall Study||7||
59752313|NCT00904748|75871768|FG003|COMPLETED|Overall Study||6||
59752314|NCT00904748|75871769|FG004|COMPLETED|Overall Study||7||
59752315|NCT00904748|75871770|FG005|COMPLETED|Overall Study||8||
59752316|NCT00904748|75871765|FG000|NOT COMPLETED|Overall Study||1||
59752317|NCT00904748|75871766|FG001|NOT COMPLETED|Overall Study||1||
59752318|NCT00904748|75871767|FG002|NOT COMPLETED|Overall Study||1||
59752319|NCT00904748|75871768|FG003|NOT COMPLETED|Overall Study||2||
59752320|NCT00904748|75871769|FG004|NOT COMPLETED|Overall Study||1||
59752321|NCT00904748|75871770|FG005|NOT COMPLETED|Overall Study||0||
59882745|NCT04358406|76005706|FG001|COMPLETED|Overall Study||27||
59882746|NCT04358406|76005705|FG000|NOT COMPLETED|Overall Study||6||
59882747|NCT04358406|76005706|FG001|NOT COMPLETED|Overall Study||4||
59882748|NCT04321356|76005717|FG000|STARTED|Overall Study||31||
59882749|NCT04321356|76005718|FG001|STARTED|Overall Study||26||
59882750|NCT04321356|76005719|FG002|STARTED|Overall Study||29||
59882751|NCT04321356|76005720|FG003|STARTED|Overall Study||14||
59882752|NCT04321356|76005717|FG000|COMPLETED|Overall Study||31||
59882753|NCT04321356|76005718|FG001|COMPLETED|Overall Study||26||
59882754|NCT04321356|76005719|FG002|COMPLETED|Overall Study||29||
59882755|NCT04321356|76005720|FG003|COMPLETED|Overall Study||14||
59882756|NCT04321356|76005717|FG000|NOT COMPLETED|Overall Study||0||
59882757|NCT04321356|76005718|FG001|NOT COMPLETED|Overall Study||0||
59882758|NCT04321356|76005719|FG002|NOT COMPLETED|Overall Study||0||
59882759|NCT04321356|76005720|FG003|NOT COMPLETED|Overall Study||0||
59882760|NCT04203056|76005732|FG000|STARTED|Overall Study||6||
59882761|NCT04203056|76005733|FG001|STARTED|Overall Study||9||
59882762|NCT04203056|76005732|FG000|COMPLETED|Overall Study||3||
59882763|NCT04203056|76005733|FG001|COMPLETED|Overall Study||5||
59882764|NCT04203056|76005732|FG000|NOT COMPLETED|Overall Study||3||
59882765|NCT04203056|76005733|FG001|NOT COMPLETED|Overall Study||4||
59882766|NCT03813147|76005741|FG000|STARTED|Overall Study||6||
59882767|NCT03813147|76005742|FG001|STARTED|Overall Study||6||
59752322|NCT00574405|75871781|FG000|STARTED|Overall Study||12||
59752323|NCT00574405|75871782|FG001|STARTED|Overall Study||12||
59752324|NCT00574405|75871781|FG000|COMPLETED|Overall Study||9||
59752325|NCT00574405|75871782|FG001|COMPLETED|Overall Study||10||
59752326|NCT00574405|75871781|FG000|NOT COMPLETED|Overall Study||3||
59752327|NCT00574405|75871782|FG001|NOT COMPLETED|Overall Study||2||
59752328|NCT00971243|75871793|FG000|STARTED|Double Blind Period||87||
59752329|NCT00971243|75871794|FG001|STARTED|Double Blind Period||93||
59752330|NCT00971243|75871795|FG002|STARTED|Double Blind Period||91||
59752331|NCT00971243|75871796|FG003|STARTED|Double Blind Period|One subject who did not receive any study drug was excluded from the ITT|88||
59752332|NCT00971243|75871797|FG004|STARTED|Double Blind Period||88||
59752333|NCT00971243|75871793|FG000|COMPLETED|Double Blind Period||68||
59752334|NCT00971243|75871794|FG001|COMPLETED|Double Blind Period||82||
59752335|NCT00971243|75871795|FG002|COMPLETED|Double Blind Period||72||
59752336|NCT00971243|75871796|FG003|COMPLETED|Double Blind Period||74||
59882768|NCT03813147|76005741|FG000|COMPLETED|Overall Study||0||
59752337|NCT00971243|75871797|FG004|COMPLETED|Double Blind Period||70||
59752338|NCT00971243|75871793|FG000|NOT COMPLETED|Double Blind Period||19||
59752339|NCT00971243|75871794|FG001|NOT COMPLETED|Double Blind Period||11||
59752340|NCT00971243|75871795|FG002|NOT COMPLETED|Double Blind Period||19||
59752341|NCT00971243|75871796|FG003|NOT COMPLETED|Double Blind Period||14||
59752342|NCT00971243|75871797|FG004|NOT COMPLETED|Double Blind Period||18||
59752343|NCT00971243|75871793|FG000|STARTED|Open-label Period||68||
59752344|NCT00971243|75871794|FG001|STARTED|Open-label Period|One Subject did not entered because of the failure of inclusion/exclusion criteria.|81||
59752345|NCT00971243|75871795|FG002|STARTED|Open-label Period|One Subject did not entered the Open-label Period because of the withdrawal of consent.|71||
59882769|NCT03813147|76005742|FG001|COMPLETED|Overall Study||1||
59752346|NCT00971243|75871796|FG003|STARTED|Open-label Period||74||
59605956|NCT01985334|75716159|FG002|COMPLETED|Overall Study||367||
59605957|NCT01985334|75716160|FG003|COMPLETED|Overall Study||1033||
59882770|NCT03813147|76005741|FG000|NOT COMPLETED|Overall Study||6||
59882771|NCT03813147|76005742|FG001|NOT COMPLETED|Overall Study||5||
59882772|NCT03805932|76005750|FG000|STARTED|Overall Study||3||
59882773|NCT03805932|76005751|FG001|STARTED|Overall Study||15||
59882774|NCT03805932|76005750|FG000|COMPLETED|Overall Study||3||
59882775|NCT03805932|76005751|FG001|COMPLETED|Overall Study||15||
59882776|NCT03805932|76005750|FG000|NOT COMPLETED|Overall Study||0||
59882777|NCT03805932|76005751|FG001|NOT COMPLETED|Overall Study||0||
59882778|NCT03774186|76005762|FG000|STARTED|Overall Study||12||
59882779|NCT03774186|76005763|FG001|STARTED|Overall Study||12||
59882780|NCT03774186|76005762|FG000|COMPLETED|Overall Study||12||
59882781|NCT03774186|76005763|FG001|COMPLETED|Overall Study||11||
59882782|NCT03774186|76005762|FG000|NOT COMPLETED|Overall Study||0||
59882783|NCT03774186|76005763|FG001|NOT COMPLETED|Overall Study||1||
59882784|NCT03759639|76005770|FG000|STARTED|Treatment With IB1001||33||
59882785|NCT03759639|76005770|FG000|COMPLETED|Treatment With IB1001||31||
59882786|NCT03759639|76005770|FG000|NOT COMPLETED|Treatment With IB1001||2||
59882787|NCT03759639|76005770|FG000|STARTED|Post-Treatment Washout||31||
59882788|NCT03759639|76005770|FG000|COMPLETED|Post-Treatment Washout||31||
59882789|NCT03759639|76005770|FG000|NOT COMPLETED|Post-Treatment Washout||0||
59882790|NCT03738228|76005783|FG000|STARTED|Overall Study||21||
59882791|NCT03738228|76005784|FG001|STARTED|Overall Study||19||
59882792|NCT03738228|76005783|FG000|COMPLETED|Overall Study||19||
59882793|NCT03738228|76005784|FG001|COMPLETED|Overall Study||17||
59882794|NCT03738228|76005783|FG000|NOT COMPLETED|Overall Study||2||
59882795|NCT03738228|76005784|FG001|NOT COMPLETED|Overall Study||2||
59882796|NCT03689894|76005790|FG000|STARTED|Overall Study||2||
59882797|NCT03689894|76005790|FG000|Completed Study Treatment|Overall Study||1||
59882798|NCT03689894|76005790|FG000|COMPLETED|Overall Study||1||
59882799|NCT03689894|76005790|FG000|NOT COMPLETED|Overall Study||1||
59882800|NCT03640754|76005797|FG000|STARTED|Overall Study||31||
59882801|NCT03640754|76005798|FG001|STARTED|Overall Study||30||
59882802|NCT03640754|76005797|FG000|COMPLETED|Overall Study||30||
59882803|NCT03640754|76005798|FG001|COMPLETED|Overall Study||29||
59882804|NCT03640754|76005797|FG000|NOT COMPLETED|Overall Study||1||
59882805|NCT03640754|76005798|FG001|NOT COMPLETED|Overall Study||1||
59882806|NCT03345784|76005819|FG000|STARTED|Overall Study||5||
59882807|NCT03345784|76005820|FG001|STARTED|Overall Study||5||
59882808|NCT03345784|76005819|FG000|COMPLETED|Overall Study||3||
59882809|NCT03345784|76005820|FG001|COMPLETED|Overall Study||4||
59882810|NCT03345784|76005819|FG000|NOT COMPLETED|Overall Study||2||
59882811|NCT03345784|76005820|FG001|NOT COMPLETED|Overall Study||1||
59882812|NCT03255018|76005828|FG000|STARTED|Overall Study||2||
59882813|NCT03255018|76005829|FG001|STARTED|Overall Study||10||
59882814|NCT03255018|76005828|FG000|COMPLETED|Overall Study||2||
59882815|NCT03255018|76005829|FG001|COMPLETED|Overall Study||3||
59882816|NCT03255018|76005828|FG000|NOT COMPLETED|Overall Study||0||
59882817|NCT03255018|76005829|FG001|NOT COMPLETED|Overall Study||7||
59882818|NCT03204188|76005835|FG000|STARTED|Conditioning Phase (12 Weeks)||15||
59882819|NCT03204188|76005835|FG000|COMPLETED|Conditioning Phase (12 Weeks)||15||
59882820|NCT03204188|76005835|FG000|NOT COMPLETED|Conditioning Phase (12 Weeks)||0||
59882821|NCT03204188|76005835|FG000|STARTED|Immunotherapy Phase (1 Year)||15||
59882822|NCT03204188|76005835|FG000|COMPLETED|Immunotherapy Phase (1 Year)||10||
59882823|NCT03204188|76005835|FG000|NOT COMPLETED|Immunotherapy Phase (1 Year)||5||
59882824|NCT03204188|76005835|FG000|STARTED|Follow-up Phase (Extension Study)||10||
59882825|NCT03204188|76005835|FG000|COMPLETED|Follow-up Phase (Extension Study)||4||
59882826|NCT03204188|76005835|FG000|NOT COMPLETED|Follow-up Phase (Extension Study)||6||
59882827|NCT03159754|76005842|FG000|STARTED|Overall Study||24||
59882828|NCT03159754|76005843|FG001|STARTED|Overall Study||12||
59882829|NCT03159754|76005844|FG002|STARTED|Overall Study||4||
59882830|NCT03159754|76005842|FG000|COMPLETED|Overall Study||23||
59605958|NCT01985334|75716161|FG004|COMPLETED|Overall Study||234||
59882831|NCT03159754|76005843|FG001|COMPLETED|Overall Study||12||
59605959|NCT01985334|75716162|FG005|COMPLETED|Overall Study||666||
59605960|NCT01985334|75716163|FG006|COMPLETED|Overall Study||237||
59752347|NCT00971243|75871797|FG004|STARTED|Open-label Period||70||
59752348|NCT00971243|75871793|FG000|COMPLETED|Open-label Period||60||
59752349|NCT00971243|75871794|FG001|COMPLETED|Open-label Period||71||
59752350|NCT00971243|75871795|FG002|COMPLETED|Open-label Period||66||
59752351|NCT00971243|75871796|FG003|COMPLETED|Open-label Period||64||
59752352|NCT00971243|75871797|FG004|COMPLETED|Open-label Period||64||
59752353|NCT00971243|75871793|FG000|NOT COMPLETED|Open-label Period||8||
59752354|NCT00971243|75871794|FG001|NOT COMPLETED|Open-label Period||10||
59752355|NCT00971243|75871795|FG002|NOT COMPLETED|Open-label Period||5||
59752356|NCT00971243|75871796|FG003|NOT COMPLETED|Open-label Period||10||
59752357|NCT00971243|75871797|FG004|NOT COMPLETED|Open-label Period||6||
59752358|NCT00568555|75871811|FG000|STARTED|Overall Study||16||
59752359|NCT00568555|75871812|FG001|STARTED|Overall Study||15||
59752360|NCT00568555|75871811|FG000|COMPLETED|Overall Study||15||
59752361|NCT00568555|75871812|FG001|COMPLETED|Overall Study||14||
59752362|NCT00568555|75871811|FG000|NOT COMPLETED|Overall Study||1||
59752363|NCT00568555|75871812|FG001|NOT COMPLETED|Overall Study||1||
59752364|NCT00904670|75871820|FG000|STARTED|Open Label Phase||23||
59752365|NCT00904670|75871821|FG001|STARTED|Open Label Phase||22||
59752366|NCT00904670|75871820|FG000|COMPLETED|Open Label Phase||17||
59752367|NCT00904670|75871821|FG001|COMPLETED|Open Label Phase||22||
59752368|NCT00904670|75871820|FG000|NOT COMPLETED|Open Label Phase||6||
59752369|NCT00904670|75871821|FG001|NOT COMPLETED|Open Label Phase||0||
59752370|NCT00904670|75871820|FG000|STARTED|First Intervention Period||17||
59752371|NCT00904670|75871821|FG001|STARTED|First Intervention Period||22||
59752372|NCT00904670|75871820|FG000|COMPLETED|First Intervention Period||17||
59752373|NCT00904670|75871821|FG001|COMPLETED|First Intervention Period||22||
59752374|NCT00904670|75871820|FG000|NOT COMPLETED|First Intervention Period||0||
59752375|NCT00904670|75871821|FG001|NOT COMPLETED|First Intervention Period||0||
59752376|NCT00904670|75871820|FG000|STARTED|Second Intervention Period||17||
59752377|NCT00904670|75871821|FG001|STARTED|Second Intervention Period||22||
59752378|NCT00904670|75871820|FG000|COMPLETED|Second Intervention Period||17||
59752379|NCT00904670|75871821|FG001|COMPLETED|Second Intervention Period||22||
59752380|NCT00904670|75871820|FG000|NOT COMPLETED|Second Intervention Period||0||
59752381|NCT00904670|75871821|FG001|NOT COMPLETED|Second Intervention Period||0||
59752382|NCT00638443|75871829|FG000|STARTED|First Intervention||14||
59752383|NCT00638443|75871830|FG001|STARTED|First Intervention||15||
59752384|NCT00638443|75871829|FG000|COMPLETED|First Intervention||12||
59752385|NCT00638443|75871830|FG001|COMPLETED|First Intervention||14||
59752386|NCT00638443|75871829|FG000|NOT COMPLETED|First Intervention||2||
59752387|NCT00638443|75871830|FG001|NOT COMPLETED|First Intervention||1||
59752388|NCT00638443|75871829|FG000|STARTED|Washout||12||
59752389|NCT00638443|75871830|FG001|STARTED|Washout||14||
59752390|NCT00638443|75871829|FG000|COMPLETED|Washout||12||
59752391|NCT00638443|75871830|FG001|COMPLETED|Washout||14||
59752392|NCT00638443|75871829|FG000|NOT COMPLETED|Washout||0||
59752393|NCT00638443|75871830|FG001|NOT COMPLETED|Washout||0||
59752394|NCT00638443|75871829|FG000|STARTED|Second Intervention||12||
59752395|NCT00638443|75871830|FG001|STARTED|Second Intervention||14||
59752396|NCT00638443|75871829|FG000|COMPLETED|Second Intervention||12||
59752397|NCT00638443|75871830|FG001|COMPLETED|Second Intervention||14||
59752398|NCT00638443|75871829|FG000|NOT COMPLETED|Second Intervention||0||
59752399|NCT00638443|75871830|FG001|NOT COMPLETED|Second Intervention||0||
59752400|NCT00636181|75871841|FG000|STARTED|Overall Study||54||
59752401|NCT00636181|75871842|FG001|STARTED|Overall Study||53||
59752402|NCT00636181|75871843|FG002|STARTED|Overall Study||57||
59752403|NCT00636181|75871841|FG000|COMPLETED|Overall Study||46||
59752404|NCT00636181|75871842|FG001|COMPLETED|Overall Study||47||
59752405|NCT00636181|75871843|FG002|COMPLETED|Overall Study||47||
59752406|NCT00636181|75871841|FG000|NOT COMPLETED|Overall Study||8||
59752407|NCT00636181|75871842|FG001|NOT COMPLETED|Overall Study||6||
59752408|NCT00636181|75871843|FG002|NOT COMPLETED|Overall Study||10||
59752409|NCT00968669|75871855|FG000|STARTED|Overall Study||82||
59752410|NCT00968669|75871856|FG001|STARTED|Overall Study||81||
59752411|NCT00968669|75871857|FG002|STARTED|Overall Study||83||
59752412|NCT00968669|75871858|FG003|STARTED|Overall Study||81||
59752413|NCT00968669|75871855|FG000|COMPLETED|Overall Study||64||
59752414|NCT00968669|75871856|FG001|COMPLETED|Overall Study||63||
59752415|NCT00968669|75871857|FG002|COMPLETED|Overall Study||72||
59752416|NCT00968669|75871858|FG003|COMPLETED|Overall Study||72||
59605961|NCT01985334|75716164|FG007|COMPLETED|Overall Study||699||
59605962|NCT01985334|75716157|FG000|NOT COMPLETED|Overall Study||23||
59752417|NCT00968669|75871855|FG000|NOT COMPLETED|Overall Study||18||
59752418|NCT00968669|75871856|FG001|NOT COMPLETED|Overall Study||18||
59752419|NCT00968669|75871857|FG002|NOT COMPLETED|Overall Study||11||
59752420|NCT00968669|75871858|FG003|NOT COMPLETED|Overall Study||9||
59752421|NCT00568399|75871868|FG000|STARTED|Overall Study||37||
59752422|NCT00568399|75871868|FG000|COMPLETED|Overall Study|Of 48 subject enrolled, 37 initiated sodium thiosulfate treatment. 22 completed the entire protocol|22||
59752423|NCT00568399|75871868|FG000|NOT COMPLETED|Overall Study||15||
59752424|NCT00975143|75871874|FG000|STARTED|Overall Study||464||
59752425|NCT00975143|75871875|FG001|STARTED|Overall Study||461||
59752426|NCT00975143|75871874|FG000|Completed Treatment (Week 20)|Overall Study||403||
59752427|NCT00975143|75871875|FG001|Completed Treatment (Week 20)|Overall Study||410||
59752428|NCT00975143|75871874|FG000|COMPLETED|Overall Study||394||
59752429|NCT00975143|75871875|FG001|COMPLETED|Overall Study||401||
59752430|NCT00975143|75871874|FG000|NOT COMPLETED|Overall Study||70||
59752431|NCT00975143|75871875|FG001|NOT COMPLETED|Overall Study||60||
59752432|NCT03796091|75871884|FG000|STARTED|Overall Study||60||
59752433|NCT03796091|75871885|FG001|STARTED|Overall Study||60||
59752434|NCT03796091|75871886|FG002|STARTED|Overall Study||60||
59752435|NCT03796091|75871884|FG000|COMPLETED|Overall Study||40||
59882832|NCT03159754|76005844|FG002|COMPLETED|Overall Study||4||
59882833|NCT03159754|76005842|FG000|NOT COMPLETED|Overall Study||1||
59882834|NCT03159754|76005843|FG001|NOT COMPLETED|Overall Study||0||
59882835|NCT03159754|76005844|FG002|NOT COMPLETED|Overall Study||0||
59882836|NCT03000530|76005857|FG000|STARTED|Overall Study||13||
59882837|NCT03000530|76005858|FG001|STARTED|Overall Study||44||
59605963|NCT01985334|75716158|FG001|NOT COMPLETED|Overall Study||84||
59605964|NCT01985334|75716159|FG002|NOT COMPLETED|Overall Study||53||
59882838|NCT03000530|76005859|FG002|STARTED|Overall Study||45||
59882839|NCT03000530|76005857|FG000|COMPLETED|Overall Study||13||
59882840|NCT03000530|76005858|FG001|COMPLETED|Overall Study||39||
59882841|NCT03000530|76005859|FG002|COMPLETED|Overall Study||41||
59882842|NCT03000530|76005857|FG000|NOT COMPLETED|Overall Study||0||
59605965|NCT01985334|75716160|FG003|NOT COMPLETED|Overall Study||229||
59882843|NCT03000530|76005858|FG001|NOT COMPLETED|Overall Study||5||
59882844|NCT03000530|76005859|FG002|NOT COMPLETED|Overall Study||4||
59882845|NCT02978781|76005873|FG000|STARTED|Part A||2||
59882846|NCT02978781|76005874|FG001|STARTED|Part A||14||
59882847|NCT02978781|76005875|FG002|STARTED|Part A||0||
59605966|NCT01985334|75716161|FG004|NOT COMPLETED|Overall Study||40||
59605967|NCT01985334|75716162|FG005|NOT COMPLETED|Overall Study||156||
59605968|NCT01985334|75716163|FG006|NOT COMPLETED|Overall Study||37||
59605969|NCT01985334|75716164|FG007|NOT COMPLETED|Overall Study||121||
59605970|NCT01944774|75716199|FG000|STARTED|Overall Study||69||
59605971|NCT01944774|75716200|FG001|STARTED|Overall Study||68||
59605972|NCT01944774|75716201|FG002|STARTED|Overall Study||70||
59605973|NCT01944774|75716199|FG000|Received Treatment|Overall Study||68||
59752436|NCT03796091|75871885|FG001|COMPLETED|Overall Study||38||
59752437|NCT03796091|75871886|FG002|COMPLETED|Overall Study||45||
59752438|NCT03796091|75871884|FG000|NOT COMPLETED|Overall Study||20||
59752439|NCT03796091|75871885|FG001|NOT COMPLETED|Overall Study||22||
59752440|NCT03796091|75871886|FG002|NOT COMPLETED|Overall Study||15||
59752441|NCT00974675|75871898|FG000|STARTED|Overall Study||8||
59752442|NCT00974675|75871899|FG001|STARTED|Overall Study||8||
59752443|NCT00974675|75871900|FG002|STARTED|Overall Study||3||
59752444|NCT00974675|75871901|FG003|STARTED|Overall Study||4||
59752445|NCT00974675|75871898|FG000|COMPLETED|Overall Study||6||
59752446|NCT00974675|75871899|FG001|COMPLETED|Overall Study||7||
59752447|NCT00974675|75871900|FG002|COMPLETED|Overall Study||1||
59752448|NCT00974675|75871901|FG003|COMPLETED|Overall Study||2||
59752449|NCT00974675|75871898|FG000|NOT COMPLETED|Overall Study||2||
59752450|NCT00974675|75871899|FG001|NOT COMPLETED|Overall Study||1||
59752451|NCT00974675|75871900|FG002|NOT COMPLETED|Overall Study||2||
59752452|NCT00974675|75871901|FG003|NOT COMPLETED|Overall Study||2||
59752453|NCT00634933|75871914|FG000|STARTED|Part A: Baseline to Week 24||74||
59752454|NCT00634933|75871915|FG001|STARTED|Part A: Baseline to Week 24||75||
59752455|NCT00634933|75871916|FG002|STARTED|Part A: Baseline to Week 24||73||
59752456|NCT00634933|75871917|FG003|STARTED|Part A: Baseline to Week 24||0||
59752457|NCT00634933|75871918|FG004|STARTED|Part A: Baseline to Week 24||0||
59752458|NCT00634933|75871914|FG000|COMPLETED|Part A: Baseline to Week 24||63||
59752459|NCT00634933|75871915|FG001|COMPLETED|Part A: Baseline to Week 24||57||
59752460|NCT00634933|75871916|FG002|COMPLETED|Part A: Baseline to Week 24||55||
59605974|NCT01944774|75716200|FG001|Received Treatment|Overall Study||67||
59605975|NCT01944774|75716201|FG002|Received Treatment|Overall Study||70||
59605976|NCT01944774|75716199|FG000|COMPLETED|Overall Study||63||
59605977|NCT01944774|75716200|FG001|COMPLETED|Overall Study||60||
59752461|NCT00634933|75871917|FG003|COMPLETED|Part A: Baseline to Week 24||0||
59752462|NCT00634933|75871918|FG004|COMPLETED|Part A: Baseline to Week 24||0||
59752463|NCT00634933|75871914|FG000|NOT COMPLETED|Part A: Baseline to Week 24||11||
59752464|NCT00634933|75871915|FG001|NOT COMPLETED|Part A: Baseline to Week 24||18||
59752465|NCT00634933|75871916|FG002|NOT COMPLETED|Part A: Baseline to Week 24||18||
59752466|NCT00634933|75871917|FG003|NOT COMPLETED|Part A: Baseline to Week 24||0||
59752467|NCT00634933|75871918|FG004|NOT COMPLETED|Part A: Baseline to Week 24||0||
59752468|NCT00634933|75871914|FG000|STARTED|Between Part A and Part B||0||
59752469|NCT00634933|75871915|FG001|STARTED|Between Part A and Part B||57||
59752470|NCT00634933|75871916|FG002|STARTED|Between Part A and Part B||55||
59752471|NCT00634933|75871917|FG003|STARTED|Between Part A and Part B||31||
59752472|NCT00634933|75871918|FG004|STARTED|Between Part A and Part B||32||
59752473|NCT00634933|75871914|FG000|COMPLETED|Between Part A and Part B||0||
59752474|NCT00634933|75871915|FG001|COMPLETED|Between Part A and Part B||56||
59752475|NCT00634933|75871916|FG002|COMPLETED|Between Part A and Part B||55||
59752476|NCT00634933|75871917|FG003|COMPLETED|Between Part A and Part B||31||
59752477|NCT00634933|75871918|FG004|COMPLETED|Between Part A and Part B||32||
59752478|NCT00634933|75871914|FG000|NOT COMPLETED|Between Part A and Part B||0||
59752479|NCT00634933|75871915|FG001|NOT COMPLETED|Between Part A and Part B||1||
59752480|NCT00634933|75871916|FG002|NOT COMPLETED|Between Part A and Part B||0||
59752481|NCT00634933|75871917|FG003|NOT COMPLETED|Between Part A and Part B||0||
59752482|NCT00634933|75871918|FG004|NOT COMPLETED|Between Part A and Part B||0||
59752483|NCT00634933|75871914|FG000|STARTED|Part B: Week 24 to Week 52||0||
59752484|NCT00634933|75871915|FG001|STARTED|Part B: Week 24 to Week 52||56||
59752485|NCT00634933|75871916|FG002|STARTED|Part B: Week 24 to Week 52||55||
59605978|NCT01944774|75716201|FG002|COMPLETED|Overall Study||62||
59605979|NCT01944774|75716199|FG000|NOT COMPLETED|Overall Study||6||
59605980|NCT01944774|75716200|FG001|NOT COMPLETED|Overall Study||8||
59605981|NCT01944774|75716201|FG002|NOT COMPLETED|Overall Study||8||
59752486|NCT00634933|75871917|FG003|STARTED|Part B: Week 24 to Week 52||31||
59752487|NCT00634933|75871918|FG004|STARTED|Part B: Week 24 to Week 52||32||
59752488|NCT00634933|75871914|FG000|COMPLETED|Part B: Week 24 to Week 52||0||
59752489|NCT00634933|75871915|FG001|COMPLETED|Part B: Week 24 to Week 52||42||
59752490|NCT00634933|75871916|FG002|COMPLETED|Part B: Week 24 to Week 52||33||
59752491|NCT00634933|75871917|FG003|COMPLETED|Part B: Week 24 to Week 52||25||
59605982|NCT01944462|75716212|FG000|STARTED|PPPP Educational Program||203||
59605983|NCT01944462|75716212|FG000|Baseline|PPPP Educational Program||203||
59605984|NCT01944462|75716212|FG000|Post-Test|PPPP Educational Program||187||
59752492|NCT00634933|75871918|FG004|COMPLETED|Part B: Week 24 to Week 52||22||
59752493|NCT00634933|75871914|FG000|NOT COMPLETED|Part B: Week 24 to Week 52||0||
59752494|NCT00634933|75871915|FG001|NOT COMPLETED|Part B: Week 24 to Week 52||14||
59752495|NCT00634933|75871916|FG002|NOT COMPLETED|Part B: Week 24 to Week 52||22||
59752496|NCT00634933|75871917|FG003|NOT COMPLETED|Part B: Week 24 to Week 52||6||
59882848|NCT02978781|76005876|FG003|STARTED|Part A||0||
59752497|NCT00634933|75871918|FG004|NOT COMPLETED|Part B: Week 24 to Week 52||10||
59752498|NCT00967499|75871932|FG000|STARTED|Overall Study||111||
59752499|NCT00967499|75871933|FG001|STARTED|Overall Study||109||
59752500|NCT00967499|75871932|FG000|Treated (Full Analysis Set)|Overall Study||48||
59882849|NCT02978781|76005877|FG004|STARTED|Part A||0||
59882850|NCT02978781|76005873|FG000|COMPLETED|Part A||1||
59882851|NCT02978781|76005874|FG001|COMPLETED|Part A||12||
59882852|NCT02978781|76005875|FG002|COMPLETED|Part A||0||
59882853|NCT02978781|76005876|FG003|COMPLETED|Part A||0||
59882854|NCT02978781|76005877|FG004|COMPLETED|Part A||0||
59882855|NCT02978781|76005873|FG000|NOT COMPLETED|Part A||1||
59882856|NCT02978781|76005874|FG001|NOT COMPLETED|Part A||2||
59882857|NCT02978781|76005875|FG002|NOT COMPLETED|Part A||0||
59882858|NCT02978781|76005876|FG003|NOT COMPLETED|Part A||0||
59882859|NCT02978781|76005877|FG004|NOT COMPLETED|Part A||0||
59882860|NCT02978781|76005873|FG000|STARTED|Part B||0||
59882861|NCT02978781|76005874|FG001|STARTED|Part B||0||
59882862|NCT02978781|76005875|FG002|STARTED|Part B|Include participants who tolerated a dose ≥10 mg in Part A and achieved response on Day 8.|4||
59950841|NCT01505608|76069754|FG001|STARTED|Phase I||8||
59752501|NCT00967499|75871933|FG001|Treated (Full Analysis Set)|Overall Study||50||
59752502|NCT00967499|75871932|FG000|COMPLETED|Overall Study||46||
59752503|NCT00967499|75871933|FG001|COMPLETED|Overall Study||49||
59752504|NCT00967499|75871932|FG000|NOT COMPLETED|Overall Study||65||
59752505|NCT00967499|75871933|FG001|NOT COMPLETED|Overall Study||60||
59752506|NCT03909971|75871941|FG000|STARTED|Overall Study||67||
59752507|NCT03909971|75871942|FG001|STARTED|Overall Study||42||
59752508|NCT03909971|75871941|FG000|COMPLETED|Overall Study||57||
59752509|NCT03909971|75871942|FG001|COMPLETED|Overall Study||20||
59752510|NCT03909971|75871941|FG000|NOT COMPLETED|Overall Study||10||
59752511|NCT03909971|75871942|FG001|NOT COMPLETED|Overall Study||22||
59752512|NCT00967343|75871949|FG000|STARTED|Overall Study||40||
59752513|NCT00967343|75871949|FG000|COMPLETED|Overall Study||2||
59752514|NCT00967343|75871949|FG000|NOT COMPLETED|Overall Study||38||
59752515|NCT00973973|75871955|FG000|STARTED|Double-blind Treatment Phase (Weeks 1-8)||69||
59752516|NCT00973973|75871956|FG001|STARTED|Double-blind Treatment Phase (Weeks 1-8)||68||
59752517|NCT00973973|75871955|FG000|Received Study Drug|Double-blind Treatment Phase (Weeks 1-8)||69||
59762667|NCT01886963|75882517|FG000|2 Week Follow Up|Overall Study||55||
59882863|NCT02978781|76005876|FG003|STARTED|Part B|Include participants who tolerated a dose ≥10 mg in Part A and achieved response on Day 8.|4||
59882864|NCT02978781|76005877|FG004|STARTED|Part B||0||
59882865|NCT02978781|76005873|FG000|COMPLETED|Part B||0||
59882866|NCT02978781|76005874|FG001|COMPLETED|Part B||0||
59882867|NCT02978781|76005875|FG002|COMPLETED|Part B||4||
59882868|NCT02978781|76005876|FG003|COMPLETED|Part B||3||
59605985|NCT01944462|75716212|FG000|3 Month Follow-Up|PPPP Educational Program||143||
59882869|NCT02978781|76005877|FG004|COMPLETED|Part B||0||
59882870|NCT02978781|76005873|FG000|NOT COMPLETED|Part B||0||
59605986|NCT01944462|75716212|FG000|COMPLETED|PPPP Educational Program||143||
59605987|NCT01944462|75716212|FG000|NOT COMPLETED|PPPP Educational Program||60||
59882871|NCT02978781|76005874|FG001|NOT COMPLETED|Part B||0||
59882872|NCT02978781|76005875|FG002|NOT COMPLETED|Part B||0||
59882873|NCT02978781|76005876|FG003|NOT COMPLETED|Part B||1||
59882874|NCT02978781|76005877|FG004|NOT COMPLETED|Part B||0||
59752518|NCT00973973|75871956|FG001|Received Study Drug|Double-blind Treatment Phase (Weeks 1-8)||68||
59752519|NCT00973973|75871955|FG000|COMPLETED|Double-blind Treatment Phase (Weeks 1-8)||63||
59752520|NCT00973973|75871956|FG001|COMPLETED|Double-blind Treatment Phase (Weeks 1-8)||60||
59752521|NCT00973973|75871955|FG000|NOT COMPLETED|Double-blind Treatment Phase (Weeks 1-8)||6||
59752522|NCT00973973|75871956|FG001|NOT COMPLETED|Double-blind Treatment Phase (Weeks 1-8)||8||
59752523|NCT00973973|75871955|FG000|STARTED|Open-label Treatment Phase (Weeks 8-24)||63||
59752524|NCT00973973|75871956|FG001|STARTED|Open-label Treatment Phase (Weeks 8-24)||60||
59752525|NCT00973973|75871955|FG000|COMPLETED|Open-label Treatment Phase (Weeks 8-24)||57||
59752526|NCT00973973|75871956|FG001|COMPLETED|Open-label Treatment Phase (Weeks 8-24)||55||
59752527|NCT00973973|75871955|FG000|NOT COMPLETED|Open-label Treatment Phase (Weeks 8-24)||6||
59752528|NCT00973973|75871956|FG001|NOT COMPLETED|Open-label Treatment Phase (Weeks 8-24)||5||
59752529|NCT00633139|75871965|FG000|STARTED|Overall Study||4||
59752530|NCT00633139|75871966|FG001|STARTED|Overall Study||5||
59752531|NCT00633139|75871967|FG002|STARTED|Overall Study||4||
59752532|NCT00633139|75871965|FG000|COMPLETED|Overall Study||4||
59752533|NCT00633139|75871966|FG001|COMPLETED|Overall Study||4||
59752534|NCT00633139|75871967|FG002|COMPLETED|Overall Study||3||
59752535|NCT00633139|75871965|FG000|NOT COMPLETED|Overall Study||0||
59752536|NCT00633139|75871966|FG001|NOT COMPLETED|Overall Study||1||
59752537|NCT00633139|75871967|FG002|NOT COMPLETED|Overall Study||1||
59752538|NCT00965081|75871977|FG000|STARTED|Overall Study|2 randomized participants had no post-baseline measures and are not included in outcome measures.|155||
59752539|NCT00965081|75871978|FG001|STARTED|Overall Study||153||
59752540|NCT00965081|75871977|FG000|COMPLETED|Overall Study|In addition, 16/17 rescue participants completed study on protocol-specified study medication.|121||
59752541|NCT00965081|75871978|FG001|COMPLETED|Overall Study||110||
59752542|NCT00965081|75871977|FG000|NOT COMPLETED|Overall Study||34||
59752543|NCT00965081|75871978|FG001|NOT COMPLETED|Overall Study||43||
59752544|NCT00961649|75871989|FG000|STARTED|Overall Study||41||
59752545|NCT00961649|75871990|FG001|STARTED|Overall Study||44||
59752546|NCT00961649|75871991|FG002|STARTED|Overall Study||44||
59752547|NCT00961649|75871992|FG003|STARTED|Overall Study||41||
59752548|NCT00961649|75871989|FG000|COMPLETED|Overall Study||32||
59752549|NCT00961649|75871990|FG001|COMPLETED|Overall Study||40||
59752550|NCT00961649|75871991|FG002|COMPLETED|Overall Study||39||
59752551|NCT00961649|75871992|FG003|COMPLETED|Overall Study||37||
59752552|NCT00961649|75871989|FG000|NOT COMPLETED|Overall Study||9||
59752553|NCT00961649|75871990|FG001|NOT COMPLETED|Overall Study||4||
59752554|NCT00961649|75871991|FG002|NOT COMPLETED|Overall Study||5||
59752555|NCT00961649|75871992|FG003|NOT COMPLETED|Overall Study||4||
59752556|NCT00632125|75872002|FG000|STARTED|Overall Study|1,698 patients were enrolled but 3 patients did not receive any study medication.|1695||
59752557|NCT00632125|75872002|FG000|COMPLETED|Overall Study||1393||
59752558|NCT00632125|75872002|FG000|NOT COMPLETED|Overall Study||302||
59752559|NCT00903968|75872008|FG000|STARTED|Overall Study||3||
59752560|NCT00903968|75872009|FG001|STARTED|Overall Study||3||
59752561|NCT00903968|75872010|FG002|STARTED|Overall Study||3||
59752562|NCT00903968|75872011|FG003|STARTED|Overall Study||3||
59882875|NCT02978781|76005873|FG000|STARTED|Part C||0||
59882876|NCT02978781|76005874|FG001|STARTED|Part C||0||
59882877|NCT02978781|76005875|FG002|STARTED|Part C||0||
59752563|NCT00903968|75872012|FG004|STARTED|Overall Study||4||
59752564|NCT00903968|75872013|FG005|STARTED|Overall Study||6||
59752565|NCT00903968|75872014|FG006|STARTED|Overall Study||3||
59752566|NCT00903968|75872015|FG007|STARTED|Overall Study||33||
59752567|NCT00903968|75872008|FG000|COMPLETED|Overall Study||0||
59752568|NCT00903968|75872009|FG001|COMPLETED|Overall Study||0||
59752569|NCT00903968|75872010|FG002|COMPLETED|Overall Study||0||
59882878|NCT02978781|76005876|FG003|STARTED|Part C||0||
59882879|NCT02978781|76005877|FG004|STARTED|Part C||18||
59882880|NCT02978781|76005873|FG000|COMPLETED|Part C||0||
59752570|NCT00903968|75872011|FG003|COMPLETED|Overall Study||0||
59752571|NCT00903968|75872012|FG004|COMPLETED|Overall Study||0||
59752572|NCT00903968|75872013|FG005|COMPLETED|Overall Study||0||
59882881|NCT02978781|76005874|FG001|COMPLETED|Part C||0||
59882882|NCT02978781|76005875|FG002|COMPLETED|Part C||0||
59882883|NCT02978781|76005876|FG003|COMPLETED|Part C||0||
59882884|NCT02978781|76005877|FG004|COMPLETED|Part C||14||
59882885|NCT02978781|76005873|FG000|NOT COMPLETED|Part C||0||
59882886|NCT02978781|76005874|FG001|NOT COMPLETED|Part C||0||
59882887|NCT02978781|76005875|FG002|NOT COMPLETED|Part C||0||
59882888|NCT02978781|76005876|FG003|NOT COMPLETED|Part C||0||
59882889|NCT02978781|76005877|FG004|NOT COMPLETED|Part C||4||
59882890|NCT02556736|76005903|FG000|STARTED|Overall Study||14||
59882891|NCT02556736|76005903|FG000|COMPLETED|Overall Study||14||
59882892|NCT02556736|76005903|FG000|NOT COMPLETED|Overall Study||0||
59882893|NCT02551679|76005909|FG000|STARTED|Overall Study||46||
59882894|NCT02551679|76005910|FG001|STARTED|Overall Study||21||
59518919|NCT03393208|75612806|FG002|COMPLETED|Treatment Period 1 (Day 1-Day 3)||9||
59518920|NCT03393208|75612807|FG003|COMPLETED|Treatment Period 1 (Day 1-Day 3)||9||
59518921|NCT03393208|75612804|FG000|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0||
59518922|NCT03393208|75612805|FG001|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0||
59518923|NCT03393208|75612806|FG002|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0||
59518924|NCT03393208|75612807|FG003|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0||
59518925|NCT03393208|75612804|FG000|STARTED|Treatment Period 2 (Day 8- Day 10)||13||
59518926|NCT03393208|75612805|FG001|STARTED|Treatment Period 2 (Day 8- Day 10)||13||
59518927|NCT03393208|75612806|FG002|STARTED|Treatment Period 2 (Day 8- Day 10)||9||
59518928|NCT03393208|75612807|FG003|STARTED|Treatment Period 2 (Day 8- Day 10)||9||
59518929|NCT03393208|75612804|FG000|COMPLETED|Treatment Period 2 (Day 8- Day 10)||13||
59518930|NCT03393208|75612805|FG001|COMPLETED|Treatment Period 2 (Day 8- Day 10)||13||
59518931|NCT03393208|75612806|FG002|COMPLETED|Treatment Period 2 (Day 8- Day 10)||9||
59518932|NCT03393208|75612807|FG003|COMPLETED|Treatment Period 2 (Day 8- Day 10)||9||
59518933|NCT03393208|75612804|FG000|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0||
59518934|NCT03393208|75612805|FG001|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0||
59518935|NCT03393208|75612806|FG002|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0||
59518936|NCT03393208|75612807|FG003|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0||
59518937|NCT01092559|75612819|FG000|STARTED|Overall Study||10||
59518938|NCT01092559|75612819|FG000|COMPLETED|Overall Study||10||
59518939|NCT01092559|75612819|FG000|NOT COMPLETED|Overall Study||0||
59518940|NCT01093027|75612825|FG000|STARTED|Visit 1||10||
59518941|NCT01093027|75612826|FG001|STARTED|Visit 1||10||
59518942|NCT01093027|75612825|FG000|COMPLETED|Visit 1||10||
59518943|NCT01093027|75612826|FG001|COMPLETED|Visit 1||10||
59518944|NCT01093027|75612825|FG000|NOT COMPLETED|Visit 1||0||
59882895|NCT02551679|76005909|FG000|COMPLETED|Overall Study||27||
59882896|NCT02551679|76005910|FG001|COMPLETED|Overall Study||19||
59882897|NCT02551679|76005909|FG000|NOT COMPLETED|Overall Study||19||
59882898|NCT02551679|76005910|FG001|NOT COMPLETED|Overall Study||2||
59882899|NCT02549092|76005920|FG000|STARTED|Treatment Period||44|Randomized|
59882900|NCT02549092|76005921|FG001|STARTED|Treatment Period||45|Randomized|
59882901|NCT02549092|76005920|FG000|COMPLETED|Treatment Period||41|Completed 26-week Treatment Period|
59882902|NCT02549092|76005921|FG001|COMPLETED|Treatment Period||38|Completed 26-week Treatment Period|
59882903|NCT02549092|76005920|FG000|NOT COMPLETED|Treatment Period||3||
59882904|NCT02549092|76005921|FG001|NOT COMPLETED|Treatment Period||7||
59882905|NCT02549092|76005920|FG000|STARTED|Extension/Transition Period||10||
59752573|NCT00903968|75872014|FG006|COMPLETED|Overall Study||0||
59752574|NCT00903968|75872015|FG007|COMPLETED|Overall Study||0||
59752575|NCT00903968|75872008|FG000|NOT COMPLETED|Overall Study||3||
59752576|NCT00903968|75872009|FG001|NOT COMPLETED|Overall Study||3||
59752577|NCT00903968|75872010|FG002|NOT COMPLETED|Overall Study||3||
59752578|NCT00903968|75872011|FG003|NOT COMPLETED|Overall Study||3||
59752579|NCT00903968|75872012|FG004|NOT COMPLETED|Overall Study||4||
59752580|NCT00903968|75872013|FG005|NOT COMPLETED|Overall Study||6||
59752581|NCT00903968|75872014|FG006|NOT COMPLETED|Overall Study||3||
59752582|NCT00903968|75872015|FG007|NOT COMPLETED|Overall Study||33||
59752583|NCT00903344|75872038|FG000|STARTED|Overall Study||12||
59752584|NCT00903344|75872039|FG001|STARTED|Overall Study||10||
59752585|NCT00903344|75872038|FG000|3 Month Visit|Overall Study||10||
59752586|NCT00903344|75872039|FG001|3 Month Visit|Overall Study||10||
59752587|NCT00903344|75872038|FG000|6 Month Visit|Overall Study||9||
59752588|NCT00903344|75872039|FG001|6 Month Visit|Overall Study||10||
59752589|NCT00903344|75872038|FG000|COMPLETED|Overall Study||7||
59752590|NCT00903344|75872039|FG001|COMPLETED|Overall Study||7||
59752591|NCT00903344|75872038|FG000|NOT COMPLETED|Overall Study||5||
59752592|NCT00903344|75872039|FG001|NOT COMPLETED|Overall Study||3||
59752593|NCT00903032|75872047|FG000|STARTED|Overall Study||129||
59752594|NCT00903032|75872048|FG001|STARTED|Overall Study||124||
59752595|NCT00903032|75872047|FG000|COMPLETED|Overall Study||122||
59752596|NCT00903032|75872048|FG001|COMPLETED|Overall Study||119||
59752597|NCT00903032|75872047|FG000|NOT COMPLETED|Overall Study||7||
59752598|NCT00903032|75872048|FG001|NOT COMPLETED|Overall Study||5||
59752599|NCT02113592|75872056|FG000|STARTED|Overall Study||433||53
59882906|NCT02549092|76005921|FG001|STARTED|Extension/Transition Period||14||
59882907|NCT02549092|76005920|FG000|Transitioned to Commercial LCIG|Extension/Transition Period||5||
59882908|NCT02549092|76005921|FG001|Transitioned to Commercial LCIG|Extension/Transition Period||7||
59882909|NCT02549092|76005920|FG000|COMPLETED|Extension/Transition Period||5||
59882910|NCT02549092|76005921|FG001|COMPLETED|Extension/Transition Period||10||
59882911|NCT02549092|76005920|FG000|NOT COMPLETED|Extension/Transition Period||5||
59752600|NCT02113592|75872057|FG001|STARTED|Overall Study||417||53
59752601|NCT02113592|75872056|FG000|COMPLETED|Overall Study||414||53
59752602|NCT02113592|75872057|FG001|COMPLETED|Overall Study||402||53
59752603|NCT02113592|75872056|FG000|NOT COMPLETED|Overall Study||19||0
59752604|NCT02113592|75872057|FG001|NOT COMPLETED|Overall Study||15||0
59752605|NCT00902564|75872063|FG000|STARTED|Overall Study||30||
59752606|NCT00902564|75872063|FG000|COMPLETED|Overall Study||28||
59752607|NCT00902564|75872063|FG000|NOT COMPLETED|Overall Study||2||
59882912|NCT02549092|76005921|FG001|NOT COMPLETED|Extension/Transition Period||4||
59752608|NCT00626197|75872070|FG000|STARTED|Overall Study||127||
59752609|NCT00626197|75872071|FG001|STARTED|Overall Study||128||
59752610|NCT00626197|75872072|FG002|STARTED|Overall Study||126||
59882913|NCT02543281|76005933|FG000|STARTED|Overall Study||15||
59882914|NCT02543281|76005934|FG001|STARTED|Overall Study||12||
59882915|NCT02543281|76005935|FG002|STARTED|Overall Study||5||
59882916|NCT02543281|76005933|FG000|COMPLETED|Overall Study||15||
59882917|NCT02543281|76005934|FG001|COMPLETED|Overall Study||12||
59882918|NCT02543281|76005935|FG002|COMPLETED|Overall Study||4||
59752611|NCT00626197|75872070|FG000|COMPLETED|Overall Study||83||
59752612|NCT00626197|75872071|FG001|COMPLETED|Overall Study||74||
59752613|NCT00626197|75872072|FG002|COMPLETED|Overall Study||49||
59752614|NCT00626197|75872070|FG000|NOT COMPLETED|Overall Study||44||
59752615|NCT00626197|75872071|FG001|NOT COMPLETED|Overall Study||54||
59752616|NCT00626197|75872072|FG002|NOT COMPLETED|Overall Study||77||
59752617|NCT00626275|75872086|FG000|STARTED|Part A - Treatment Period 1||7||
59752618|NCT00626275|75872087|FG001|STARTED|Part A - Treatment Period 1||7||
59752619|NCT00626275|75872088|FG002|STARTED|Part A - Treatment Period 1||7||
59882919|NCT02543281|76005933|FG000|NOT COMPLETED|Overall Study||0||
59882920|NCT02543281|76005934|FG001|NOT COMPLETED|Overall Study||0||
59752620|NCT00626275|75872089|FG003|STARTED|Part A - Treatment Period 1||8||
59752621|NCT00626275|75872090|FG004|STARTED|Part A - Treatment Period 1||9||
59762668|NCT01886963|75882518|FG001|2 Week Follow Up|Overall Study||55||
59882921|NCT02543281|76005935|FG002|NOT COMPLETED|Overall Study||1||
59605988|NCT01944462|75716212|FG000|STARTED|Optional Vaccination||20||
59605989|NCT01944462|75716212|FG000|COMPLETED|Optional Vaccination||20||
59605990|NCT01944462|75716212|FG000|NOT COMPLETED|Optional Vaccination||0||
59605991|NCT01943292|75716220|FG000|STARTED|Overall Study||3||
59605992|NCT01943292|75716221|FG001|STARTED|Overall Study||3||
59605993|NCT01943292|75716222|FG002|STARTED|Overall Study||3||
59605994|NCT01943292|75716220|FG000|Completed Cycle 1|Overall Study||3||
59605995|NCT01943292|75716221|FG001|Completed Cycle 1|Overall Study||3||
59605996|NCT01943292|75716222|FG002|Completed Cycle 1|Overall Study||3||
59605997|NCT01943292|75716220|FG000|Completed Treatment|Overall Study||3||
59605998|NCT01943292|75716221|FG001|Completed Treatment|Overall Study||3||
59605999|NCT01943292|75716222|FG002|Completed Treatment|Overall Study||3||
59882922|NCT02429791|76005945|FG000|STARTED|Early Switch Phase (Up to Week 52)||252||
59882923|NCT02429791|76005946|FG001|STARTED|Early Switch Phase (Up to Week 52)||256||
59882924|NCT02429791|76005945|FG000|COMPLETED|Early Switch Phase (Up to Week 52)||239||
59882925|NCT02429791|76005946|FG001|COMPLETED|Early Switch Phase (Up to Week 52)||238||
59882926|NCT02429791|76005945|FG000|NOT COMPLETED|Early Switch Phase (Up to Week 52)||13||
59882927|NCT02429791|76005946|FG001|NOT COMPLETED|Early Switch Phase (Up to Week 52)||18||
59882928|NCT02429791|76005945|FG000|STARTED|Late Switch Phase (Week 52 to Week 148)||239||
59882929|NCT02429791|76005946|FG001|STARTED|Late Switch Phase (Week 52 to Week 148)||238||
59882930|NCT02429791|76005945|FG000|COMPLETED|Late Switch Phase (Week 52 to Week 148)||214||
59882931|NCT02429791|76005946|FG001|COMPLETED|Late Switch Phase (Week 52 to Week 148)||210||
59882932|NCT02429791|76005945|FG000|NOT COMPLETED|Late Switch Phase (Week 52 to Week 148)||25||
59882933|NCT02429791|76005946|FG001|NOT COMPLETED|Late Switch Phase (Week 52 to Week 148)||28||
59882934|NCT02428192|76005961|FG000|STARTED|Overall Study||12||
59882935|NCT02428192|76005962|FG001|STARTED|Overall Study||8||
59882936|NCT02428192|76005961|FG000|COMPLETED|Overall Study||0||
59882937|NCT02428192|76005962|FG001|COMPLETED|Overall Study||7||
59882938|NCT02428192|76005961|FG000|NOT COMPLETED|Overall Study||12||
59882939|NCT02428192|76005962|FG001|NOT COMPLETED|Overall Study||1||
59882940|NCT02422797|76005971|FG000|STARTED|Early Switch Phase (Up to Week 52)||261||
59882941|NCT02422797|76005972|FG001|STARTED|Early Switch Phase (Up to Week 52)||255||
59882942|NCT02422797|76005971|FG000|COMPLETED|Early Switch Phase (Up to Week 52)||245||
59882943|NCT02422797|76005972|FG001|COMPLETED|Early Switch Phase (Up to Week 52)||239||
59882944|NCT02422797|76005971|FG000|NOT COMPLETED|Early Switch Phase (Up to Week 52)||16||
59882945|NCT02422797|76005972|FG001|NOT COMPLETED|Early Switch Phase (Up to Week 52)||16||
59882946|NCT02422797|76005971|FG000|STARTED|Late Switch Phase (Week 52 to Week 148)||245||
59882947|NCT02422797|76005972|FG001|STARTED|Late Switch Phase (Week 52 to Week 148)||239||
59882948|NCT02422797|76005971|FG000|COMPLETED|Late Switch Phase (Week 52 to Week 148)||222||
59882949|NCT02422797|76005972|FG001|COMPLETED|Late Switch Phase (Week 52 to Week 148)||221||
59882950|NCT02422797|76005971|FG000|NOT COMPLETED|Late Switch Phase (Week 52 to Week 148)||23||
59882951|NCT02422797|76005972|FG001|NOT COMPLETED|Late Switch Phase (Week 52 to Week 148)||18||
59882952|NCT02181738|76005992|FG000|STARTED|Overall Study||63||
59882953|NCT02181738|76005993|FG001|STARTED|Overall Study||80||
59882954|NCT02181738|76005994|FG002|STARTED|Overall Study||100||
59882955|NCT02181738|76005995|FG003|STARTED|Overall Study||51||
59882956|NCT02181738|76005992|FG000|N-AVD Combination Therapy Phase|Overall Study||0|Received N-AVD|
59606000|NCT01943292|75716220|FG000|Completed Follow-Up|Overall Study||2||
59752622|NCT00626275|75872091|FG005|STARTED|Part A - Treatment Period 1||8||
59752623|NCT00626275|75872092|FG006|STARTED|Part A - Treatment Period 1||0||
59752624|NCT00626275|75872093|FG007|STARTED|Part A - Treatment Period 1||0||
59752625|NCT00626275|75872086|FG000|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||7||
59752626|NCT00626275|75872087|FG001|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||7||
59752627|NCT00626275|75872088|FG002|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||7||
59752628|NCT00626275|75872089|FG003|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||8||
59752629|NCT00626275|75872090|FG004|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||9||
59752630|NCT00626275|75872091|FG005|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||8||
59752631|NCT00626275|75872092|FG006|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||0||
59752632|NCT00626275|75872093|FG007|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||0||
59752633|NCT00626275|75872086|FG000|COMPLETED|Part A - Treatment Period 1||6||
59752634|NCT00626275|75872087|FG001|COMPLETED|Part A - Treatment Period 1||7||
59752635|NCT00626275|75872088|FG002|COMPLETED|Part A - Treatment Period 1||6||
59752636|NCT00626275|75872089|FG003|COMPLETED|Part A - Treatment Period 1||8||
59752637|NCT00626275|75872090|FG004|COMPLETED|Part A - Treatment Period 1||9||
59752638|NCT00626275|75872091|FG005|COMPLETED|Part A - Treatment Period 1||8||
59752639|NCT00626275|75872092|FG006|COMPLETED|Part A - Treatment Period 1||0||
59752640|NCT00626275|75872093|FG007|COMPLETED|Part A - Treatment Period 1||0||
59752641|NCT00626275|75872086|FG000|NOT COMPLETED|Part A - Treatment Period 1||1||
59752642|NCT00626275|75872087|FG001|NOT COMPLETED|Part A - Treatment Period 1||0||
59752643|NCT00626275|75872088|FG002|NOT COMPLETED|Part A - Treatment Period 1||1||
59882957|NCT02181738|76005993|FG001|N-AVD Combination Therapy Phase|Overall Study||0|Received N-AVD|
59882958|NCT02181738|76005994|FG002|N-AVD Combination Therapy Phase|Overall Study||0|Received N-AVD|
59882959|NCT02181738|76005995|FG003|N-AVD Combination Therapy Phase|Overall Study||49|Received N-AVD|
59882960|NCT02181738|76005992|FG000|N-AVD Combination Therapy Phase|Overall Study||0|Received only AVD|
59882961|NCT02181738|76005993|FG001|N-AVD Combination Therapy Phase|Overall Study||0|Received only AVD|
59882962|NCT02181738|76005994|FG002|N-AVD Combination Therapy Phase|Overall Study||0|Received only AVD|
59882963|NCT02181738|76005995|FG003|N-AVD Combination Therapy Phase|Overall Study||1|Received only AVD|
59882964|NCT02181738|76005992|FG000|COMPLETED|Overall Study||0|Completed = completed treatment as per protocol|
59882965|NCT02181738|76005993|FG001|COMPLETED|Overall Study||0|Completed = completed treatment as per protocol|
59882966|NCT02181738|76005994|FG002|COMPLETED|Overall Study||13|Completed = completed treatment as per protocol|
59882967|NCT02181738|76005995|FG003|COMPLETED|Overall Study||45|Completed = completed treatment as per protocol|
59882968|NCT02181738|76005992|FG000|NOT COMPLETED|Overall Study||63||
59882969|NCT02181738|76005993|FG001|NOT COMPLETED|Overall Study||80||
59882970|NCT02181738|76005994|FG002|NOT COMPLETED|Overall Study||87||
59882971|NCT02181738|76005995|FG003|NOT COMPLETED|Overall Study||6||
59882972|NCT02142803|76006014|FG000|STARTED|Registration to Initiation of Therapy||3||
59882973|NCT02142803|76006015|FG001|STARTED|Registration to Initiation of Therapy||3||
59882974|NCT02142803|76006016|FG002|STARTED|Registration to Initiation of Therapy||6||
59882975|NCT02142803|76006017|FG003|STARTED|Registration to Initiation of Therapy||38||
59882976|NCT02142803|76006014|FG000|COMPLETED|Registration to Initiation of Therapy||3||
59882977|NCT02142803|76006015|FG001|COMPLETED|Registration to Initiation of Therapy||3||
59752644|NCT00626275|75872089|FG003|NOT COMPLETED|Part A - Treatment Period 1||0||
59752645|NCT00626275|75872090|FG004|NOT COMPLETED|Part A - Treatment Period 1||0||
59752646|NCT00626275|75872091|FG005|NOT COMPLETED|Part A - Treatment Period 1||0||
59752647|NCT00626275|75872092|FG006|NOT COMPLETED|Part A - Treatment Period 1||0||
59752648|NCT00626275|75872093|FG007|NOT COMPLETED|Part A - Treatment Period 1||0||
59882978|NCT02142803|76006016|FG002|COMPLETED|Registration to Initiation of Therapy||6||
59882979|NCT02142803|76006017|FG003|COMPLETED|Registration to Initiation of Therapy||37||
59752649|NCT00626275|75872086|FG000|STARTED|Part A - Washout Period 1||6||
59752650|NCT00626275|75872087|FG001|STARTED|Part A - Washout Period 1||7||
59752651|NCT00626275|75872088|FG002|STARTED|Part A - Washout Period 1||6||
59882980|NCT02142803|76006014|FG000|NOT COMPLETED|Registration to Initiation of Therapy||0||
59882981|NCT02142803|76006015|FG001|NOT COMPLETED|Registration to Initiation of Therapy||0||
59882982|NCT02142803|76006016|FG002|NOT COMPLETED|Registration to Initiation of Therapy||0||
59882983|NCT02142803|76006017|FG003|NOT COMPLETED|Registration to Initiation of Therapy||1||
59882984|NCT02142803|76006014|FG000|STARTED|Study Therapy||3||
59882985|NCT02142803|76006015|FG001|STARTED|Study Therapy||3||
59882986|NCT02142803|76006016|FG002|STARTED|Study Therapy||6||
59752652|NCT00626275|75872089|FG003|STARTED|Part A - Washout Period 1||8||
59752653|NCT00626275|75872090|FG004|STARTED|Part A - Washout Period 1||9||
59752654|NCT00626275|75872091|FG005|STARTED|Part A - Washout Period 1||8||
59752655|NCT00626275|75872092|FG006|STARTED|Part A - Washout Period 1||0||
59752656|NCT00626275|75872093|FG007|STARTED|Part A - Washout Period 1||0||
59752657|NCT00626275|75872086|FG000|COMPLETED|Part A - Washout Period 1||6||
59752658|NCT00626275|75872087|FG001|COMPLETED|Part A - Washout Period 1||7||
59752659|NCT00626275|75872088|FG002|COMPLETED|Part A - Washout Period 1||6||
59752660|NCT00626275|75872089|FG003|COMPLETED|Part A - Washout Period 1||8||
59752661|NCT00626275|75872090|FG004|COMPLETED|Part A - Washout Period 1||9||
59752662|NCT00626275|75872091|FG005|COMPLETED|Part A - Washout Period 1||8||
59752663|NCT00626275|75872092|FG006|COMPLETED|Part A - Washout Period 1||0||
59752664|NCT00626275|75872093|FG007|COMPLETED|Part A - Washout Period 1||0||
59752665|NCT00626275|75872086|FG000|NOT COMPLETED|Part A - Washout Period 1||0||
59752666|NCT00626275|75872087|FG001|NOT COMPLETED|Part A - Washout Period 1||0||
59752667|NCT00626275|75872088|FG002|NOT COMPLETED|Part A - Washout Period 1||0||
59752668|NCT00626275|75872089|FG003|NOT COMPLETED|Part A - Washout Period 1||0||
59752669|NCT00626275|75872090|FG004|NOT COMPLETED|Part A - Washout Period 1||0||
59752670|NCT00626275|75872091|FG005|NOT COMPLETED|Part A - Washout Period 1||0||
59752671|NCT00626275|75872092|FG006|NOT COMPLETED|Part A - Washout Period 1||0||
59752672|NCT00626275|75872093|FG007|NOT COMPLETED|Part A - Washout Period 1||0||
59752673|NCT00626275|75872086|FG000|STARTED|Part A - Treatment Period 2||6||
59752674|NCT00626275|75872087|FG001|STARTED|Part A - Treatment Period 2||7||
59752675|NCT00626275|75872088|FG002|STARTED|Part A - Treatment Period 2||6||
59752676|NCT00626275|75872089|FG003|STARTED|Part A - Treatment Period 2||8||
59752677|NCT00626275|75872090|FG004|STARTED|Part A - Treatment Period 2||9||
59752678|NCT00626275|75872091|FG005|STARTED|Part A - Treatment Period 2||8||
59752679|NCT00626275|75872092|FG006|STARTED|Part A - Treatment Period 2||0||
59752680|NCT00626275|75872093|FG007|STARTED|Part A - Treatment Period 2||0||
59752681|NCT00626275|75872086|FG000|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||6||
59752682|NCT00626275|75872087|FG001|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||7||
59752683|NCT00626275|75872088|FG002|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||6||
59752684|NCT00626275|75872089|FG003|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||8||
59752685|NCT00626275|75872090|FG004|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||9||
59752686|NCT00626275|75872091|FG005|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||8||
59752687|NCT00626275|75872092|FG006|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||0||
59752688|NCT00626275|75872093|FG007|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||0||
59752689|NCT00626275|75872086|FG000|COMPLETED|Part A - Treatment Period 2||6||
59752690|NCT00626275|75872087|FG001|COMPLETED|Part A - Treatment Period 2||7||
59752691|NCT00626275|75872088|FG002|COMPLETED|Part A - Treatment Period 2||6||
59752692|NCT00626275|75872089|FG003|COMPLETED|Part A - Treatment Period 2||8||
59752693|NCT00626275|75872090|FG004|COMPLETED|Part A - Treatment Period 2||9||
59752694|NCT00626275|75872091|FG005|COMPLETED|Part A - Treatment Period 2||8||
59752695|NCT00626275|75872092|FG006|COMPLETED|Part A - Treatment Period 2||0||
59752696|NCT00626275|75872093|FG007|COMPLETED|Part A - Treatment Period 2||0||
59752697|NCT00626275|75872086|FG000|NOT COMPLETED|Part A - Treatment Period 2||0||
59752698|NCT00626275|75872087|FG001|NOT COMPLETED|Part A - Treatment Period 2||0||
59752699|NCT00626275|75872088|FG002|NOT COMPLETED|Part A - Treatment Period 2||0||
59752700|NCT00626275|75872089|FG003|NOT COMPLETED|Part A - Treatment Period 2||0||
59752701|NCT00626275|75872090|FG004|NOT COMPLETED|Part A - Treatment Period 2||0||
59752702|NCT00626275|75872091|FG005|NOT COMPLETED|Part A - Treatment Period 2||0||
59752703|NCT00626275|75872092|FG006|NOT COMPLETED|Part A - Treatment Period 2||0||
59752704|NCT00626275|75872093|FG007|NOT COMPLETED|Part A - Treatment Period 2||0||
59752705|NCT00626275|75872086|FG000|STARTED|Part A - Washout Period 2||6||
59752706|NCT00626275|75872087|FG001|STARTED|Part A - Washout Period 2||7||
59752707|NCT00626275|75872088|FG002|STARTED|Part A - Washout Period 2||6||
59752708|NCT00626275|75872089|FG003|STARTED|Part A - Washout Period 2||8||
59752709|NCT00626275|75872090|FG004|STARTED|Part A - Washout Period 2||9||
59752710|NCT00626275|75872091|FG005|STARTED|Part A - Washout Period 2||8||
59752711|NCT00626275|75872092|FG006|STARTED|Part A - Washout Period 2||0||
59752712|NCT00626275|75872093|FG007|STARTED|Part A - Washout Period 2||0||
59752713|NCT00626275|75872086|FG000|COMPLETED|Part A - Washout Period 2||6||
59752714|NCT00626275|75872087|FG001|COMPLETED|Part A - Washout Period 2||7||
59752715|NCT00626275|75872088|FG002|COMPLETED|Part A - Washout Period 2||6||
59762669|NCT01886963|75882517|FG000|4 Week Follow Up|Overall Study||50||
59752716|NCT00626275|75872089|FG003|COMPLETED|Part A - Washout Period 2||8||
59752717|NCT00626275|75872090|FG004|COMPLETED|Part A - Washout Period 2||9||
59882987|NCT02142803|76006017|FG003|STARTED|Study Therapy||37||
59882988|NCT02142803|76006014|FG000|COMPLETED|Study Therapy||3||
59882989|NCT02142803|76006015|FG001|COMPLETED|Study Therapy||3||
59882990|NCT02142803|76006016|FG002|COMPLETED|Study Therapy||6||
59882991|NCT02142803|76006017|FG003|COMPLETED|Study Therapy||37||
59752718|NCT00626275|75872091|FG005|COMPLETED|Part A - Washout Period 2||8||
59752719|NCT00626275|75872092|FG006|COMPLETED|Part A - Washout Period 2||0||
59752720|NCT00626275|75872093|FG007|COMPLETED|Part A - Washout Period 2||0||
59752721|NCT00626275|75872086|FG000|NOT COMPLETED|Part A - Washout Period 2||0||
59752722|NCT00626275|75872087|FG001|NOT COMPLETED|Part A - Washout Period 2||0||
59752723|NCT00626275|75872088|FG002|NOT COMPLETED|Part A - Washout Period 2||0||
59752724|NCT00626275|75872089|FG003|NOT COMPLETED|Part A - Washout Period 2||0||
59752725|NCT00626275|75872090|FG004|NOT COMPLETED|Part A - Washout Period 2||0||
59752726|NCT00626275|75872091|FG005|NOT COMPLETED|Part A - Washout Period 2||0||
59752727|NCT00626275|75872092|FG006|NOT COMPLETED|Part A - Washout Period 2||0||
59752728|NCT00626275|75872093|FG007|NOT COMPLETED|Part A - Washout Period 2||0||
59882992|NCT02142803|76006014|FG000|NOT COMPLETED|Study Therapy||0||
59882993|NCT02142803|76006015|FG001|NOT COMPLETED|Study Therapy||0||
59882994|NCT02142803|76006016|FG002|NOT COMPLETED|Study Therapy||0||
59882995|NCT02142803|76006017|FG003|NOT COMPLETED|Study Therapy||0||
59606001|NCT01943292|75716221|FG001|Completed Follow-Up|Overall Study||3||
59606002|NCT01943292|75716222|FG002|Completed Follow-Up|Overall Study||3||
59606003|NCT01943292|75716220|FG000|COMPLETED|Overall Study||2||
59606004|NCT01943292|75716221|FG001|COMPLETED|Overall Study||3||
59606005|NCT01943292|75716222|FG002|COMPLETED|Overall Study||3||
59606006|NCT01943292|75716220|FG000|NOT COMPLETED|Overall Study||1||
59882996|NCT01844986|76006034|FG000|STARTED|Overall Study (Global Cohort)||260|(Randomised to study treatment)|
59882997|NCT01844986|76006035|FG001|STARTED|Overall Study (Global Cohort)||131|(Randomised to study treatment)|
59882998|NCT01844986|76006034|FG000|COMPLETED|Overall Study (Global Cohort)||183|(Ongoing study at time of PFS analysis DCO:17 May 2018)|
59882999|NCT01844986|76006035|FG001|COMPLETED|Overall Study (Global Cohort)||91|(Ongoing study at time of PFS analysis DCO:17 May 2018)|
59883000|NCT01844986|76006034|FG000|NOT COMPLETED|Overall Study (Global Cohort)||77||
59883001|NCT01844986|76006035|FG001|NOT COMPLETED|Overall Study (Global Cohort)||40||
59883002|NCT01844986|76006034|FG000|STARTED|Overall Study (China Cohort)||44|(Randomised to study treatment)|
59883003|NCT01844986|76006035|FG001|STARTED|Overall Study (China Cohort)||20|(Randomised to study treatment)|
59883004|NCT01844986|76006034|FG000|COMPLETED|Overall Study (China Cohort)||33|(Ongoing study at time of PFS analysis DCO:17 May 2018)|
59883005|NCT01844986|76006035|FG001|COMPLETED|Overall Study (China Cohort)||14|(Ongoing study at time of PFS analysis DCO:17 May 2018)|
59883006|NCT01844986|76006034|FG000|NOT COMPLETED|Overall Study (China Cohort)||11||
59883007|NCT01844986|76006035|FG001|NOT COMPLETED|Overall Study (China Cohort)||6||
59752729|NCT00626275|75872086|FG000|STARTED|Part A - Treatment Period 3||6||
59752730|NCT00626275|75872087|FG001|STARTED|Part A - Treatment Period 3||7||
59752731|NCT00626275|75872088|FG002|STARTED|Part A - Treatment Period 3||6||
59752732|NCT00626275|75872089|FG003|STARTED|Part A - Treatment Period 3||8||
59752733|NCT00626275|75872090|FG004|STARTED|Part A - Treatment Period 3||9||
59752734|NCT00626275|75872091|FG005|STARTED|Part A - Treatment Period 3||8||
59752735|NCT00626275|75872092|FG006|STARTED|Part A - Treatment Period 3||0||
59752736|NCT00626275|75872093|FG007|STARTED|Part A - Treatment Period 3||0||
59752737|NCT00626275|75872086|FG000|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||6||
59752738|NCT00626275|75872087|FG001|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||7||
59752739|NCT00626275|75872088|FG002|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||6||
59752740|NCT00626275|75872089|FG003|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||8||
59752741|NCT00626275|75872090|FG004|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||9||
59752742|NCT00626275|75872091|FG005|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||8||
59752743|NCT00626275|75872092|FG006|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||0||
59752744|NCT00626275|75872093|FG007|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||0||
59752745|NCT00626275|75872086|FG000|COMPLETED|Part A - Treatment Period 3||6||
59752746|NCT00626275|75872087|FG001|COMPLETED|Part A - Treatment Period 3||7||
59752747|NCT00626275|75872088|FG002|COMPLETED|Part A - Treatment Period 3||6||
59752748|NCT00626275|75872089|FG003|COMPLETED|Part A - Treatment Period 3||8||
59752749|NCT00626275|75872090|FG004|COMPLETED|Part A - Treatment Period 3||9||
59752750|NCT00626275|75872091|FG005|COMPLETED|Part A - Treatment Period 3||8||
59752751|NCT00626275|75872092|FG006|COMPLETED|Part A - Treatment Period 3||0||
59752752|NCT00626275|75872093|FG007|COMPLETED|Part A - Treatment Period 3||0||
59752753|NCT00626275|75872086|FG000|NOT COMPLETED|Part A - Treatment Period 3||0||
59752754|NCT00626275|75872087|FG001|NOT COMPLETED|Part A - Treatment Period 3||0||
59752755|NCT00626275|75872088|FG002|NOT COMPLETED|Part A - Treatment Period 3||0||
59752756|NCT00626275|75872089|FG003|NOT COMPLETED|Part A - Treatment Period 3||0||
59752757|NCT00626275|75872090|FG004|NOT COMPLETED|Part A - Treatment Period 3||0||
59752758|NCT00626275|75872091|FG005|NOT COMPLETED|Part A - Treatment Period 3||0||
59752759|NCT00626275|75872092|FG006|NOT COMPLETED|Part A - Treatment Period 3||0||
59752760|NCT00626275|75872093|FG007|NOT COMPLETED|Part A - Treatment Period 3||0||
59752761|NCT00626275|75872086|FG000|STARTED|Re-randomization Period for Part B||0||
59752762|NCT00626275|75872087|FG001|STARTED|Re-randomization Period for Part B||0||
59752763|NCT00626275|75872088|FG002|STARTED|Re-randomization Period for Part B||0||
59752764|NCT00626275|75872089|FG003|STARTED|Re-randomization Period for Part B||0||
59752765|NCT00626275|75872090|FG004|STARTED|Re-randomization Period for Part B||0||
59752766|NCT00626275|75872091|FG005|STARTED|Re-randomization Period for Part B||0||
59752767|NCT00626275|75872092|FG006|STARTED|Re-randomization Period for Part B||20||
59752768|NCT00626275|75872093|FG007|STARTED|Re-randomization Period for Part B||24||
59752769|NCT00626275|75872086|FG000|COMPLETED|Re-randomization Period for Part B||0||
59752770|NCT00626275|75872087|FG001|COMPLETED|Re-randomization Period for Part B||0||
59752771|NCT00626275|75872088|FG002|COMPLETED|Re-randomization Period for Part B||0||
59752772|NCT00626275|75872089|FG003|COMPLETED|Re-randomization Period for Part B||0||
59752773|NCT00626275|75872090|FG004|COMPLETED|Re-randomization Period for Part B||0||
59752774|NCT00626275|75872091|FG005|COMPLETED|Re-randomization Period for Part B||0||
59883014|NCT01145209|76006056|FG000|STARTED|Overall Study||13||
59752775|NCT00626275|75872092|FG006|COMPLETED|Re-randomization Period for Part B||20||
59752776|NCT00626275|75872093|FG007|COMPLETED|Re-randomization Period for Part B||24||
59752777|NCT00626275|75872086|FG000|NOT COMPLETED|Re-randomization Period for Part B||0||
59752778|NCT00626275|75872087|FG001|NOT COMPLETED|Re-randomization Period for Part B||0||
59752779|NCT00626275|75872088|FG002|NOT COMPLETED|Re-randomization Period for Part B||0||
59752780|NCT00626275|75872089|FG003|NOT COMPLETED|Re-randomization Period for Part B||0||
59752781|NCT00626275|75872090|FG004|NOT COMPLETED|Re-randomization Period for Part B||0||
59752782|NCT00626275|75872091|FG005|NOT COMPLETED|Re-randomization Period for Part B||0||
59752783|NCT00626275|75872092|FG006|NOT COMPLETED|Re-randomization Period for Part B||0||
59752784|NCT00626275|75872093|FG007|NOT COMPLETED|Re-randomization Period for Part B||0||
59752785|NCT00626275|75872086|FG000|STARTED|Part B||0||
59752786|NCT00626275|75872087|FG001|STARTED|Part B||0||
59752787|NCT00626275|75872088|FG002|STARTED|Part B||0||
59752788|NCT00626275|75872089|FG003|STARTED|Part B||0||
59752789|NCT00626275|75872090|FG004|STARTED|Part B||0||
59752790|NCT00626275|75872091|FG005|STARTED|Part B||0||
59752791|NCT00626275|75872092|FG006|STARTED|Part B||20||
59752792|NCT00626275|75872093|FG007|STARTED|Part B||24||
59883015|NCT01145209|76006057|FG001|STARTED|Overall Study||19||
59883016|NCT01145209|76006056|FG000|COMPLETED|Overall Study||10||
59883017|NCT01145209|76006057|FG001|COMPLETED|Overall Study||18||
59883018|NCT01145209|76006056|FG000|NOT COMPLETED|Overall Study||3||
59883019|NCT01145209|76006057|FG001|NOT COMPLETED|Overall Study||1||
59883020|NCT01144494|76006071|FG000|STARTED|Overall Study||15||
59883021|NCT01144494|76006072|FG001|STARTED|Overall Study||18||
59883022|NCT01144494|76006071|FG000|COMPLETED|Overall Study||15||
59883023|NCT01144494|76006072|FG001|COMPLETED|Overall Study||14||
59883024|NCT01144494|76006071|FG000|NOT COMPLETED|Overall Study||0||
59883025|NCT01144494|76006072|FG001|NOT COMPLETED|Overall Study||4||
59883026|NCT00977691|76006086|FG000|STARTED|Overall Study||3||
59752793|NCT00626275|75872086|FG000|COMPLETED|Part B||0||
59752794|NCT00626275|75872087|FG001|COMPLETED|Part B||0||
59752795|NCT00626275|75872088|FG002|COMPLETED|Part B||0||
59752796|NCT00626275|75872089|FG003|COMPLETED|Part B||0||
59752797|NCT00626275|75872090|FG004|COMPLETED|Part B||0||
59752798|NCT00626275|75872091|FG005|COMPLETED|Part B||0||
59752799|NCT00626275|75872092|FG006|COMPLETED|Part B||19||
59752800|NCT00626275|75872093|FG007|COMPLETED|Part B||23||
59752801|NCT00626275|75872086|FG000|NOT COMPLETED|Part B||0||
59752802|NCT00626275|75872087|FG001|NOT COMPLETED|Part B||0||
60011410|NCT02656693|76127299|FG000|COMPLETED|Overall Study||325||
60011411|NCT02656693|76127300|FG001|COMPLETED|Overall Study||214||
60011412|NCT02656693|76127301|FG002|COMPLETED|Overall Study||295||
60011413|NCT02656693|76127299|FG000|NOT COMPLETED|Overall Study||1||
60011414|NCT02656693|76127300|FG001|NOT COMPLETED|Overall Study||2||
60011415|NCT02656693|76127301|FG002|NOT COMPLETED|Overall Study||3||
60011416|NCT02633293|76127309|FG000|STARTED|Overall Study||243||
60011417|NCT02633293|76127309|FG000|Received Inhaled Treprostinil in RIN-PH-202 (Safety Population)|Overall Study||242||
59752803|NCT00626275|75872088|FG002|NOT COMPLETED|Part B||0||
59752804|NCT00626275|75872089|FG003|NOT COMPLETED|Part B||0||
60011418|NCT02633293|76127309|FG000|COMPLETED|Overall Study||70||
60011419|NCT02633293|76127309|FG000|NOT COMPLETED|Overall Study||173||
59752805|NCT00626275|75872090|FG004|NOT COMPLETED|Part B||0||
59752806|NCT00626275|75872091|FG005|NOT COMPLETED|Part B||0||
59752807|NCT00626275|75872092|FG006|NOT COMPLETED|Part B||1||
60011420|NCT02623829|76127315|FG000|STARTED|Overall Study||21||
59606007|NCT01943292|75716221|FG001|NOT COMPLETED|Overall Study||0||
59883027|NCT00977691|76006087|FG001|STARTED|Overall Study||8||
59752808|NCT00626275|75872093|FG007|NOT COMPLETED|Part B||1||
59752809|NCT00623935|75872107|FG000|STARTED|Overall Study||56||
59752810|NCT00623935|75872107|FG000|COMPLETED|Overall Study||54||
59606008|NCT01943292|75716222|FG002|NOT COMPLETED|Overall Study||0||
59606009|NCT01961544|75716230|FG000|STARTED|Overall Study||101||
59606010|NCT01961544|75716230|FG000|COMPLETED|Overall Study||88||
59752811|NCT00623935|75872107|FG000|NOT COMPLETED|Overall Study||2||
59752812|NCT00623779|75872114|FG000|STARTED|Overall Study||41||
59606011|NCT01961544|75716230|FG000|NOT COMPLETED|Overall Study||13||
59606012|NCT01942590|75716236|FG000|STARTED|Overall Study||8||
59606013|NCT01942590|75716237|FG001|STARTED|Overall Study||5||
59606014|NCT01942590|75716236|FG000|COMPLETED|Overall Study||7||
59606015|NCT01942590|75716237|FG001|COMPLETED|Overall Study||4||
59752813|NCT00623779|75872115|FG001|STARTED|Overall Study||42||
59752814|NCT00623779|75872116|FG002|STARTED|Overall Study||45||
59752815|NCT00623779|75872114|FG000|COMPLETED|Overall Study||38||
59606016|NCT01942590|75716236|FG000|NOT COMPLETED|Overall Study||1||
59606017|NCT01942590|75716237|FG001|NOT COMPLETED|Overall Study||1||
59752816|NCT00623779|75872115|FG001|COMPLETED|Overall Study||39||
59606018|NCT01984242|75716247|FG000|STARTED|Overall Study||101||
59606019|NCT01984242|75716248|FG001|STARTED|Overall Study||103||
59606020|NCT01984242|75716249|FG002|STARTED|Overall Study||101||
59606021|NCT01984242|75716247|FG000|Treated|Overall Study||101||
59606022|NCT01984242|75716248|FG001|Treated|Overall Study||103||
59606023|NCT01984242|75716249|FG002|Treated|Overall Study||100||
59606024|NCT01984242|75716247|FG000|COMPLETED|Overall Study||0||
59606025|NCT01984242|75716248|FG001|COMPLETED|Overall Study||0||
59606026|NCT01984242|75716249|FG002|COMPLETED|Overall Study||0||
59606027|NCT01984242|75716247|FG000|NOT COMPLETED|Overall Study||101||
59606028|NCT01984242|75716248|FG001|NOT COMPLETED|Overall Study||103||
59606029|NCT01984242|75716249|FG002|NOT COMPLETED|Overall Study||101||
59606030|NCT01941498|75716265|FG000|STARTED|Overall Study||97||
59606031|NCT01941498|75716265|FG000|COMPLETED|Overall Study||96||
59606032|NCT01941498|75716265|FG000|NOT COMPLETED|Overall Study||1||
59606033|NCT01960998|75716286|FG000|STARTED|Overall Study||101||
59606034|NCT01960998|75716287|FG001|STARTED|Overall Study||96||
59606035|NCT01960998|75716286|FG000|COMPLETED|Overall Study||90||
59606036|NCT01960998|75716287|FG001|COMPLETED|Overall Study||85||
59606037|NCT01960998|75716286|FG000|NOT COMPLETED|Overall Study||11||
59606038|NCT01960998|75716287|FG001|NOT COMPLETED|Overall Study||11||
59606039|NCT01941186|75716297|FG000|STARTED|Randomization/Allocation to Study Group||31||
59606040|NCT01941186|75716298|FG001|STARTED|Randomization/Allocation to Study Group||33||
59606041|NCT01941186|75716297|FG000|COMPLETED|Randomization/Allocation to Study Group||31||
59606042|NCT01941186|75716298|FG001|COMPLETED|Randomization/Allocation to Study Group||33||
59752817|NCT00623779|75872116|FG002|COMPLETED|Overall Study||44||
59752818|NCT00623779|75872114|FG000|NOT COMPLETED|Overall Study||3||
59752819|NCT00623779|75872115|FG001|NOT COMPLETED|Overall Study||3||
59752820|NCT00623779|75872116|FG002|NOT COMPLETED|Overall Study||1||
59762509|NCT02913131|75882267|FG001|STARTED|Overall Study|Two of the five participants enrolled in Part B were previously enrolled in Part A.|5||
59762510|NCT02913131|75882266|FG000|COMPLETED|Overall Study||18||
59762511|NCT02913131|75882267|FG001|COMPLETED|Overall Study||5||
59883028|NCT00977691|76006088|FG002|STARTED|Overall Study||12||
59883029|NCT00977691|76006086|FG000|COMPLETED|Overall Study||3||
59762512|NCT02913131|75882266|FG000|NOT COMPLETED|Overall Study||0||
59762513|NCT02913131|75882267|FG001|NOT COMPLETED|Overall Study||0||
59762514|NCT00884390|75882276|FG000|STARTED|Overall Study||146||
59762515|NCT00884390|75882277|FG001|STARTED|Overall Study||62||
59762516|NCT00884390|75882276|FG000|COMPLETED|Overall Study||123||
59762517|NCT00884390|75882277|FG001|COMPLETED|Overall Study||54||
59762518|NCT00884390|75882276|FG000|NOT COMPLETED|Overall Study||23||
59762519|NCT00884390|75882277|FG001|NOT COMPLETED|Overall Study||8||
59883030|NCT00977691|76006087|FG001|COMPLETED|Overall Study||7||
59883031|NCT00977691|76006088|FG002|COMPLETED|Overall Study||12||
59883032|NCT00977691|76006086|FG000|NOT COMPLETED|Overall Study||0||
59883033|NCT00977691|76006087|FG001|NOT COMPLETED|Overall Study||1||
59883034|NCT00977691|76006088|FG002|NOT COMPLETED|Overall Study||0||
59883035|NCT00924482|76006098|FG000|STARTED|Overall Study||261||
59883036|NCT00924482|76006098|FG000|COMPLETED|Overall Study||261||
59883037|NCT00924482|76006098|FG000|NOT COMPLETED|Overall Study||0||
59883038|NCT01367236|76006105|FG000|STARTED|Overall Study||30||
59883039|NCT01367236|76006106|FG001|STARTED|Overall Study||30||
59762520|NCT02379247|75882295|FG000|STARTED|Overall Study||3||
59762521|NCT02379247|75882296|FG001|STARTED|Overall Study||3||
59762522|NCT02379247|75882297|FG002|STARTED|Overall Study||7||
59883040|NCT01367236|76006105|FG000|COMPLETED|Overall Study||27||
59762523|NCT02379247|75882298|FG003|STARTED|Overall Study||30||
59762524|NCT02379247|75882295|FG000|COMPLETED|Overall Study||3||
59883041|NCT01367236|76006106|FG001|COMPLETED|Overall Study||29||
59883042|NCT01367236|76006105|FG000|NOT COMPLETED|Overall Study||3||
59606043|NCT01941186|75716297|FG000|NOT COMPLETED|Randomization/Allocation to Study Group||0||
59606044|NCT01941186|75716298|FG001|NOT COMPLETED|Randomization/Allocation to Study Group||0||
59606045|NCT01941186|75716297|FG000|STARTED|Follow-up||31||
59606046|NCT01941186|75716298|FG001|STARTED|Follow-up||33||
59606047|NCT01941186|75716297|FG000|COMPLETED|Follow-up||30||
59606048|NCT01941186|75716298|FG001|COMPLETED|Follow-up||33||
59606049|NCT01941186|75716297|FG000|NOT COMPLETED|Follow-up||1||
59606050|NCT01941186|75716298|FG001|NOT COMPLETED|Follow-up||0||
59606051|NCT01960842|75716317|FG000|STARTED|Overall Study||31||
59606052|NCT01960842|75716317|FG000|COMPLETED|Overall Study||28||
59606053|NCT01960842|75716317|FG000|NOT COMPLETED|Overall Study||3||
59752821|NCT03573518|75872128|FG000|STARTED|Overall Study||92||
59752822|NCT03573518|75872129|FG001|STARTED|Overall Study||92||
59752823|NCT03573518|75872130|FG002|STARTED|Overall Study||92||
59752824|NCT03573518|75872131|FG003|STARTED|Overall Study||92||
59752825|NCT03573518|75872128|FG000|COMPLETED|Overall Study||69||
59752826|NCT03573518|75872129|FG001|COMPLETED|Overall Study||77||
59752827|NCT03573518|75872130|FG002|COMPLETED|Overall Study||70||
59752828|NCT03573518|75872131|FG003|COMPLETED|Overall Study||81||
59752829|NCT03573518|75872128|FG000|NOT COMPLETED|Overall Study||23||
59752830|NCT03573518|75872129|FG001|NOT COMPLETED|Overall Study||15||
59752831|NCT03573518|75872130|FG002|NOT COMPLETED|Overall Study||22||
59752832|NCT03573518|75872131|FG003|NOT COMPLETED|Overall Study||11||
59752833|NCT01351766|75872141|FG000|STARTED|Overall Study||39||
59752834|NCT01351766|75872141|FG000|COMPLETED|Overall Study||36||
59752835|NCT01351766|75872141|FG000|NOT COMPLETED|Overall Study||3||
59606054|NCT01984164|75716323|FG000|STARTED|Overall Study||87||
59606055|NCT01984164|75716324|FG001|STARTED|Overall Study||89||
59606056|NCT01984164|75716323|FG000|COMPLETED|Overall Study||77||
59606057|NCT01984164|75716324|FG001|COMPLETED|Overall Study||64||
59606058|NCT01984164|75716323|FG000|NOT COMPLETED|Overall Study||10||
59606059|NCT01984164|75716324|FG001|NOT COMPLETED|Overall Study||25||
59752836|NCT00629707|75872147|FG000|STARTED|Overall Study||10||
59752837|NCT00629707|75872148|FG001|STARTED|Overall Study||10||
59752838|NCT00629707|75872147|FG000|COMPLETED|Overall Study||10||
59752839|NCT00629707|75872148|FG001|COMPLETED|Overall Study||8||
59752840|NCT00629707|75872147|FG000|NOT COMPLETED|Overall Study||0||
59752841|NCT00629707|75872148|FG001|NOT COMPLETED|Overall Study||2||
59752842|NCT00902330|75872156|FG000|STARTED|Overall Study||81||
59752843|NCT00902330|75872157|FG001|STARTED|Overall Study||80||
59752844|NCT00902330|75872156|FG000|COMPLETED|Overall Study||77||
59883043|NCT01367236|76006106|FG001|NOT COMPLETED|Overall Study||1||
59752845|NCT00902330|75872157|FG001|COMPLETED|Overall Study||75||
59752846|NCT00902330|75872156|FG000|NOT COMPLETED|Overall Study||4||
59752847|NCT00902330|75872157|FG001|NOT COMPLETED|Overall Study||5||
59752848|NCT00187226|75872172|FG000|STARTED|Overall Study||88||
59752849|NCT00187226|75872173|FG001|STARTED|Overall Study||49||
59752850|NCT00187226|75872174|FG002|STARTED|Overall Study||28||
59752851|NCT00187226|75872175|FG003|STARTED|Overall Study||2||
59883044|NCT03681951|76006120|FG000|STARTED|Part1: Monotherapy DE (Up to Day 95)||8||
59883045|NCT03681951|76006121|FG001|STARTED|Part1: Monotherapy DE (Up to Day 95)|"No participant was enrolled in this arm as study was terminated during cohort GSK3145095 50mg BID"|0||
59883046|NCT03681951|76006122|FG002|STARTED|Part1: Monotherapy DE (Up to Day 95)|"No participant was enrolled in this arm as study was terminated during cohort GSK3145095 50mg BID."|0||
59883047|NCT03681951|76006123|FG003|STARTED|Part1: Monotherapy DE (Up to Day 95)|"No participant was enrolled in this arm as study was terminated during cohort GSK3145095 50mg BID"|0||
59883048|NCT03681951|76006124|FG004|STARTED|Part1: Monotherapy DE (Up to Day 95)|"No participant was enrolled in this arm as study was terminated during cohort GSK3145095 50mg BID"|0||
59883049|NCT03681951|76006125|FG005|STARTED|Part1: Monotherapy DE (Up to Day 95)|Part 2 was not initiated as this study was terminated during Part 1|0||
59883050|NCT03681951|76006126|FG006|STARTED|Part1: Monotherapy DE (Up to Day 95)|Part 3 was not initiated as this study was terminated during Part 1|0||
59752852|NCT00187226|75872176|FG004|STARTED|Overall Study||34||
59752853|NCT00187226|75872177|FG005|STARTED|Overall Study||1||
59752854|NCT00187226|75872172|FG000|COMPLETED|Overall Study||88||
59752855|NCT00187226|75872173|FG001|COMPLETED|Overall Study||49||
59752856|NCT00187226|75872174|FG002|COMPLETED|Overall Study||28||
59752857|NCT00187226|75872175|FG003|COMPLETED|Overall Study||2||
59752858|NCT00187226|75872176|FG004|COMPLETED|Overall Study||34||
59752859|NCT00187226|75872177|FG005|COMPLETED|Overall Study||1||
59752860|NCT00187226|75872172|FG000|NOT COMPLETED|Overall Study||0||
59752861|NCT00187226|75872173|FG001|NOT COMPLETED|Overall Study||0||
59752862|NCT00187226|75872174|FG002|NOT COMPLETED|Overall Study||0||
59752863|NCT00187226|75872175|FG003|NOT COMPLETED|Overall Study||0||
59752864|NCT00187226|75872176|FG004|NOT COMPLETED|Overall Study||0||
59752865|NCT00187226|75872177|FG005|NOT COMPLETED|Overall Study||0||
59752866|NCT00901394|75872194|FG000|STARTED|Overall Study||21||
59752867|NCT00901394|75872195|FG001|STARTED|Overall Study||20||
59752868|NCT00901394|75872196|FG002|STARTED|Overall Study||22||
59752869|NCT00901394|75872194|FG000|COMPLETED|Overall Study||20||
59752870|NCT00901394|75872195|FG001|COMPLETED|Overall Study||19||
59752871|NCT00901394|75872196|FG002|COMPLETED|Overall Study||20||
59752872|NCT00901394|75872194|FG000|NOT COMPLETED|Overall Study||1||
59752873|NCT00901394|75872195|FG001|NOT COMPLETED|Overall Study||1||
59752874|NCT00901394|75872196|FG002|NOT COMPLETED|Overall Study||2||
59752875|NCT00896532|75872212|FG000|STARTED|Months 1-24: Romosozumab Treatment Phase||52||
59752876|NCT00896532|75872213|FG001|STARTED|Months 1-24: Romosozumab Treatment Phase||51||
59752877|NCT00896532|75872214|FG002|STARTED|Months 1-24: Romosozumab Treatment Phase||55||
59752878|NCT00896532|75872215|FG003|STARTED|Months 1-24: Romosozumab Treatment Phase||51||
59752879|NCT00896532|75872216|FG004|STARTED|Months 1-24: Romosozumab Treatment Phase||54||
59752880|NCT00896532|75872217|FG005|STARTED|Months 1-24: Romosozumab Treatment Phase||51||
59752881|NCT00896532|75872218|FG006|STARTED|Months 1-24: Romosozumab Treatment Phase||53||
59752882|NCT00896532|75872219|FG007|STARTED|Months 1-24: Romosozumab Treatment Phase||52||
59752883|NCT00896532|75872220|FG008|STARTED|Months 1-24: Romosozumab Treatment Phase||0||
59752884|NCT00896532|75872221|FG009|STARTED|Months 1-24: Romosozumab Treatment Phase||0||
59752885|NCT00896532|75872222|FG010|STARTED|Months 1-24: Romosozumab Treatment Phase||0||
59752886|NCT00896532|75872223|FG011|STARTED|Months 1-24: Romosozumab Treatment Phase||0||
59752887|NCT00896532|75872224|FG012|STARTED|Months 1-24: Romosozumab Treatment Phase||0||
59883051|NCT03681951|76006127|FG007|STARTED|Part1: Monotherapy DE (Up to Day 95)|Part 4 was not initiated as this study was terminated during Part 1|0||
59883052|NCT03681951|76006120|FG000|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0||
59883053|NCT03681951|76006121|FG001|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0||
59883054|NCT03681951|76006122|FG002|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0||
59752888|NCT00896532|75872225|FG013|STARTED|Months 1-24: Romosozumab Treatment Phase||0||
59883055|NCT03681951|76006123|FG003|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0||
59883056|NCT03681951|76006124|FG004|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0||
59752889|NCT00896532|75872226|FG014|STARTED|Months 1-24: Romosozumab Treatment Phase||0||
59752890|NCT00896532|75872227|FG015|STARTED|Months 1-24: Romosozumab Treatment Phase||0||
59762525|NCT02379247|75882296|FG001|COMPLETED|Overall Study||3||
59752891|NCT00896532|75872228|FG016|STARTED|Months 1-24: Romosozumab Treatment Phase||0||
59752892|NCT00896532|75872229|FG017|STARTED|Months 1-24: Romosozumab Treatment Phase||0||
59752893|NCT00896532|75872230|FG018|STARTED|Months 1-24: Romosozumab Treatment Phase||0||
59752894|NCT00896532|75872231|FG019|STARTED|Months 1-24: Romosozumab Treatment Phase||0||
59752895|NCT00896532|75872232|FG020|STARTED|Months 1-24: Romosozumab Treatment Phase||0||
59752896|NCT00896532|75872233|FG021|STARTED|Months 1-24: Romosozumab Treatment Phase||0||
59752897|NCT00896532|75872234|FG022|STARTED|Months 1-24: Romosozumab Treatment Phase||0||
59752898|NCT00896532|75872212|FG000|Received Treatment|Months 1-24: Romosozumab Treatment Phase|One participant received 1 dose of romosozumab 70 mg in error|51||
59752899|NCT00896532|75872213|FG001|Received Treatment|Months 1-24: Romosozumab Treatment Phase||51||
59752900|NCT00896532|75872214|FG002|Received Treatment|Months 1-24: Romosozumab Treatment Phase||54||
59752901|NCT00896532|75872215|FG003|Received Treatment|Months 1-24: Romosozumab Treatment Phase||49||
59752902|NCT00896532|75872216|FG004|Received Treatment|Months 1-24: Romosozumab Treatment Phase||53||
59752903|NCT00896532|75872217|FG005|Received Treatment|Months 1-24: Romosozumab Treatment Phase||48||
59752904|NCT00896532|75872218|FG006|Received Treatment|Months 1-24: Romosozumab Treatment Phase||53||
59752905|NCT00896532|75872219|FG007|Received Treatment|Months 1-24: Romosozumab Treatment Phase||51||
59752906|NCT00896532|75872220|FG008|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0||
59762526|NCT02379247|75882297|FG002|COMPLETED|Overall Study||7||
59883057|NCT03681951|76006125|FG005|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0||
59883058|NCT03681951|76006126|FG006|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0||
59883059|NCT03681951|76006127|FG007|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0||
59883060|NCT03681951|76006120|FG000|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||8||
59883061|NCT03681951|76006121|FG001|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0||
59883062|NCT03681951|76006122|FG002|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0||
59883063|NCT03681951|76006123|FG003|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0||
59883064|NCT03681951|76006124|FG004|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0||
59883065|NCT03681951|76006125|FG005|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0||
59883066|NCT03681951|76006126|FG006|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0||
59883067|NCT03681951|76006127|FG007|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0||
59883068|NCT03681951|76006120|FG000|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0||
59883069|NCT03681951|76006121|FG001|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0||
59883070|NCT03681951|76006122|FG002|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0||
59883071|NCT03681951|76006123|FG003|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0||
59883072|NCT03681951|76006124|FG004|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0||
59883073|NCT03681951|76006125|FG005|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0||
59883074|NCT03681951|76006126|FG006|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0||
59752907|NCT00896532|75872221|FG009|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0||
59752908|NCT00896532|75872222|FG010|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0||
59752909|NCT00896532|75872223|FG011|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0||
59752910|NCT00896532|75872224|FG012|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0||
59752911|NCT00896532|75872225|FG013|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0||
59752912|NCT00896532|75872226|FG014|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0||
59752913|NCT00896532|75872227|FG015|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0||
59752914|NCT00896532|75872228|FG016|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0||
59752915|NCT00896532|75872229|FG017|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0||
59752916|NCT00896532|75872230|FG018|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0||
59752917|NCT00896532|75872231|FG019|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0||
59752918|NCT00896532|75872232|FG020|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0||
59752919|NCT00896532|75872233|FG021|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0||
59752920|NCT00896532|75872234|FG022|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0||
59752921|NCT00896532|75872212|FG000|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||47||
59752922|NCT00896532|75872213|FG001|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||49||
59752923|NCT00896532|75872214|FG002|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||46||
59752924|NCT00896532|75872215|FG003|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||45||
59752925|NCT00896532|75872216|FG004|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||50||
59752926|NCT00896532|75872217|FG005|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||46||
59752927|NCT00896532|75872218|FG006|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||51||
59752928|NCT00896532|75872219|FG007|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||49||
59752929|NCT00896532|75872220|FG008|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0||
59752930|NCT00896532|75872221|FG009|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0||
59883075|NCT03681951|76006127|FG007|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0||
59883076|NCT03681951|76006120|FG000|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0||
59883077|NCT03681951|76006121|FG001|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0||
59883078|NCT03681951|76006122|FG002|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0||
59950842|NCT01505608|76069753|FG000|COMPLETED|Phase I||0||
59752931|NCT00896532|75872222|FG010|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0||
59752932|NCT00896532|75872223|FG011|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0||
59752933|NCT00896532|75872224|FG012|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0||
59752934|NCT00896532|75872225|FG013|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0||
59752935|NCT00896532|75872226|FG014|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0||
59752936|NCT00896532|75872227|FG015|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0||
59752937|NCT00896532|75872228|FG016|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0||
59752938|NCT00896532|75872229|FG017|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0||
59752939|NCT00896532|75872230|FG018|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0||
59752940|NCT00896532|75872231|FG019|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0||
59752941|NCT00896532|75872232|FG020|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0||
59752942|NCT00896532|75872233|FG021|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0||
59752943|NCT00896532|75872234|FG022|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0||
59752944|NCT00896532|75872212|FG000|COMPLETED|Months 1-24: Romosozumab Treatment Phase||46||
59752945|NCT00896532|75872213|FG001|COMPLETED|Months 1-24: Romosozumab Treatment Phase||45||
59752946|NCT00896532|75872214|FG002|COMPLETED|Months 1-24: Romosozumab Treatment Phase||46||
59752947|NCT00896532|75872215|FG003|COMPLETED|Months 1-24: Romosozumab Treatment Phase||39||
59752948|NCT00896532|75872216|FG004|COMPLETED|Months 1-24: Romosozumab Treatment Phase||46||
59606060|NCT01983930|75716332|FG000|STARTED|Overall Study||41||
59606061|NCT01983930|75716333|FG001|STARTED|Overall Study||38||
59606062|NCT01983930|75716332|FG000|COMPLETED|Overall Study||32||
59606063|NCT01983930|75716333|FG001|COMPLETED|Overall Study||29||
59606064|NCT01983930|75716332|FG000|NOT COMPLETED|Overall Study||9||
59606065|NCT01983930|75716333|FG001|NOT COMPLETED|Overall Study||9||
59606066|NCT04636398|75716340|FG000|STARTED|Overall Study||29||
59606067|NCT04636398|75716340|FG000|COMPLETED|Overall Study||29||
59606068|NCT04636398|75716340|FG000|NOT COMPLETED|Overall Study||0||
59606069|NCT01983774|75716346|FG000|STARTED|Overall Study||9||
59606070|NCT01983774|75716347|FG001|STARTED|Overall Study||8||
59606071|NCT01983774|75716346|FG000|COMPLETED|Overall Study||8||
59752949|NCT00896532|75872217|FG005|COMPLETED|Months 1-24: Romosozumab Treatment Phase||43||
59752950|NCT00896532|75872218|FG006|COMPLETED|Months 1-24: Romosozumab Treatment Phase||48||
59752951|NCT00896532|75872219|FG007|COMPLETED|Months 1-24: Romosozumab Treatment Phase||48||
59752952|NCT00896532|75872220|FG008|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0||
59752953|NCT00896532|75872221|FG009|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0||
59752954|NCT00896532|75872222|FG010|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0||
59752955|NCT00896532|75872223|FG011|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0||
59752956|NCT00896532|75872224|FG012|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0||
59752957|NCT00896532|75872225|FG013|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0||
59752958|NCT00896532|75872226|FG014|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0||
59752959|NCT00896532|75872227|FG015|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0||
59752960|NCT00896532|75872228|FG016|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0||
59752961|NCT00896532|75872229|FG017|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0||
59752962|NCT00896532|75872230|FG018|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0||
59752963|NCT00896532|75872231|FG019|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0||
59752964|NCT00896532|75872232|FG020|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0||
59752965|NCT00896532|75872233|FG021|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0||
59752966|NCT00896532|75872234|FG022|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0||
59752967|NCT00896532|75872212|FG000|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||6||
59752968|NCT00896532|75872213|FG001|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||6||
59752969|NCT00896532|75872214|FG002|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||9||
59752970|NCT00896532|75872215|FG003|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||12||
59752971|NCT00896532|75872216|FG004|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||8||
59752972|NCT00896532|75872217|FG005|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||8||
59752973|NCT00896532|75872218|FG006|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||5||
59752974|NCT00896532|75872219|FG007|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||4||
59752975|NCT00896532|75872220|FG008|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0||
59752976|NCT00896532|75872221|FG009|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0||
59752977|NCT00896532|75872222|FG010|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0||
59752978|NCT00896532|75872223|FG011|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0||
59606072|NCT01983774|75716347|FG001|COMPLETED|Overall Study||7||
59606073|NCT01983774|75716346|FG000|NOT COMPLETED|Overall Study||1||
59606074|NCT01983774|75716347|FG001|NOT COMPLETED|Overall Study||1||
59606075|NCT01982682|75716355|FG000|STARTED|Overall Study||41||
59606076|NCT01982682|75716355|FG000|COMPLETED|Overall Study||40||
59606077|NCT01982682|75716355|FG000|NOT COMPLETED|Overall Study||1||
59606078|NCT01940484|75716360|FG000|STARTED|Overall Study||98||
59606079|NCT01940484|75716360|FG000|COMPLETED|Overall Study||88||
59752979|NCT00896532|75872224|FG012|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0||
59752980|NCT00896532|75872225|FG013|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0||
59752981|NCT00896532|75872226|FG014|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0||
59752982|NCT00896532|75872227|FG015|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0||
59752983|NCT00896532|75872228|FG016|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0||
59752984|NCT00896532|75872229|FG017|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0||
59752985|NCT00896532|75872230|FG018|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0||
59752986|NCT00896532|75872231|FG019|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0||
59752987|NCT00896532|75872232|FG020|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0||
59752988|NCT00896532|75872233|FG021|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0||
59752989|NCT00896532|75872234|FG022|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0||
59752990|NCT00896532|75872212|FG000|STARTED|Months 24-36: Denosumab Extension Phase||0||
59752991|NCT00896532|75872213|FG001|STARTED|Months 24-36: Denosumab Extension Phase||0||
59752992|NCT00896532|75872214|FG002|STARTED|Months 24-36: Denosumab Extension Phase||0||
59752993|NCT00896532|75872215|FG003|STARTED|Months 24-36: Denosumab Extension Phase||0||
59752994|NCT00896532|75872216|FG004|STARTED|Months 24-36: Denosumab Extension Phase||0||
59752995|NCT00896532|75872217|FG005|STARTED|Months 24-36: Denosumab Extension Phase||0||
59752996|NCT00896532|75872218|FG006|STARTED|Months 24-36: Denosumab Extension Phase||0||
59752997|NCT00896532|75872219|FG007|STARTED|Months 24-36: Denosumab Extension Phase||0||
59752998|NCT00896532|75872220|FG008|STARTED|Months 24-36: Denosumab Extension Phase||18||
59752999|NCT00896532|75872221|FG009|STARTED|Months 24-36: Denosumab Extension Phase||18||
59753000|NCT00896532|75872222|FG010|STARTED|Months 24-36: Denosumab Extension Phase||20||
59753001|NCT00896532|75872223|FG011|STARTED|Months 24-36: Denosumab Extension Phase||21||
59753002|NCT00896532|75872224|FG012|STARTED|Months 24-36: Denosumab Extension Phase||93||
59753003|NCT00896532|75872225|FG013|STARTED|Months 24-36: Denosumab Extension Phase||90||
59753004|NCT00896532|75872226|FG014|STARTED|Months 24-36: Denosumab Extension Phase||0||
59753005|NCT00896532|75872227|FG015|STARTED|Months 24-36: Denosumab Extension Phase||0||
59753006|NCT00896532|75872228|FG016|STARTED|Months 24-36: Denosumab Extension Phase||0||
59753007|NCT00896532|75872229|FG017|STARTED|Months 24-36: Denosumab Extension Phase||0||
59753008|NCT00896532|75872230|FG018|STARTED|Months 24-36: Denosumab Extension Phase||0||
59753009|NCT00896532|75872231|FG019|STARTED|Months 24-36: Denosumab Extension Phase||0||
59753010|NCT00896532|75872232|FG020|STARTED|Months 24-36: Denosumab Extension Phase||0||
59753011|NCT00896532|75872233|FG021|STARTED|Months 24-36: Denosumab Extension Phase||0||
59753012|NCT00896532|75872234|FG022|STARTED|Months 24-36: Denosumab Extension Phase||0||
59753013|NCT00896532|75872212|FG000|Received Treatment|Months 24-36: Denosumab Extension Phase||0||
59753014|NCT00896532|75872213|FG001|Received Treatment|Months 24-36: Denosumab Extension Phase||0||
59753015|NCT00896532|75872214|FG002|Received Treatment|Months 24-36: Denosumab Extension Phase||0||
59753016|NCT00896532|75872215|FG003|Received Treatment|Months 24-36: Denosumab Extension Phase||0||
59753017|NCT00896532|75872216|FG004|Received Treatment|Months 24-36: Denosumab Extension Phase||0||
59753018|NCT00896532|75872217|FG005|Received Treatment|Months 24-36: Denosumab Extension Phase||0||
59753019|NCT00896532|75872218|FG006|Received Treatment|Months 24-36: Denosumab Extension Phase||0||
59753020|NCT00896532|75872219|FG007|Received Treatment|Months 24-36: Denosumab Extension Phase||0||
59753021|NCT00896532|75872220|FG008|Received Treatment|Months 24-36: Denosumab Extension Phase||18||
59753022|NCT00896532|75872221|FG009|Received Treatment|Months 24-36: Denosumab Extension Phase|Includes one participant who received 1 dose of romosozumab 70 mg in error in first 12 months|18||
59753023|NCT00896532|75872222|FG010|Received Treatment|Months 24-36: Denosumab Extension Phase||19||
59753024|NCT00896532|75872223|FG011|Received Treatment|Months 24-36: Denosumab Extension Phase||19||
59753025|NCT00896532|75872224|FG012|Received Treatment|Months 24-36: Denosumab Extension Phase||90||
59753026|NCT00896532|75872225|FG013|Received Treatment|Months 24-36: Denosumab Extension Phase||88||
59753027|NCT00896532|75872226|FG014|Received Treatment|Months 24-36: Denosumab Extension Phase||0||
59753028|NCT00896532|75872227|FG015|Received Treatment|Months 24-36: Denosumab Extension Phase||0||
59753029|NCT00896532|75872228|FG016|Received Treatment|Months 24-36: Denosumab Extension Phase||0||
59753030|NCT00896532|75872229|FG017|Received Treatment|Months 24-36: Denosumab Extension Phase||0||
59753031|NCT00896532|75872230|FG018|Received Treatment|Months 24-36: Denosumab Extension Phase||0||
59753032|NCT00896532|75872231|FG019|Received Treatment|Months 24-36: Denosumab Extension Phase||0||
59753033|NCT00896532|75872232|FG020|Received Treatment|Months 24-36: Denosumab Extension Phase||0||
59753034|NCT00896532|75872233|FG021|Received Treatment|Months 24-36: Denosumab Extension Phase||0||
59753035|NCT00896532|75872234|FG022|Received Treatment|Months 24-36: Denosumab Extension Phase||0||
59753036|NCT00896532|75872212|FG000|COMPLETED|Months 24-36: Denosumab Extension Phase||0||
59753037|NCT00896532|75872213|FG001|COMPLETED|Months 24-36: Denosumab Extension Phase||0||
59753038|NCT00896532|75872214|FG002|COMPLETED|Months 24-36: Denosumab Extension Phase||0||
59753039|NCT00896532|75872215|FG003|COMPLETED|Months 24-36: Denosumab Extension Phase||0||
59753040|NCT00896532|75872216|FG004|COMPLETED|Months 24-36: Denosumab Extension Phase||0||
59753041|NCT00896532|75872217|FG005|COMPLETED|Months 24-36: Denosumab Extension Phase||0||
59753042|NCT00896532|75872218|FG006|COMPLETED|Months 24-36: Denosumab Extension Phase||0||
59753043|NCT00896532|75872219|FG007|COMPLETED|Months 24-36: Denosumab Extension Phase||0||
59753044|NCT00896532|75872220|FG008|COMPLETED|Months 24-36: Denosumab Extension Phase||17||
59753045|NCT00896532|75872221|FG009|COMPLETED|Months 24-36: Denosumab Extension Phase||18||
59753046|NCT00896532|75872222|FG010|COMPLETED|Months 24-36: Denosumab Extension Phase||18||
59753047|NCT00896532|75872223|FG011|COMPLETED|Months 24-36: Denosumab Extension Phase||19||
59753048|NCT00896532|75872224|FG012|COMPLETED|Months 24-36: Denosumab Extension Phase||88||
59753049|NCT00896532|75872225|FG013|COMPLETED|Months 24-36: Denosumab Extension Phase||88||
59883079|NCT03681951|76006123|FG003|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0||
59883080|NCT03681951|76006124|FG004|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0||
59883081|NCT03681951|76006125|FG005|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0||
59883082|NCT03681951|76006126|FG006|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0||
59883083|NCT03681951|76006127|FG007|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0||
59883084|NCT03681951|76006120|FG000|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0||
59883085|NCT03681951|76006121|FG001|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0||
59883086|NCT03681951|76006122|FG002|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0||
59883087|NCT03681951|76006123|FG003|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0||
59883088|NCT03681951|76006124|FG004|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0||
59883089|NCT03681951|76006125|FG005|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0||
59883090|NCT03681951|76006126|FG006|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0||
59883091|NCT03681951|76006127|FG007|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0||
59883092|NCT03681951|76006120|FG000|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0||
59883093|NCT03681951|76006121|FG001|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0||
59883094|NCT03681951|76006122|FG002|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0||
59883095|NCT03681951|76006123|FG003|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0||
59883096|NCT03681951|76006124|FG004|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0||
59883097|NCT03681951|76006125|FG005|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0||
59883098|NCT03681951|76006126|FG006|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0||
59883099|NCT03681951|76006127|FG007|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0||
59883100|NCT03681951|76006120|FG000|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0||
59883101|NCT03681951|76006121|FG001|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0||
59883102|NCT03681951|76006122|FG002|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0||
59883103|NCT03681951|76006123|FG003|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0||
59883104|NCT03681951|76006124|FG004|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0||
59883105|NCT03681951|76006125|FG005|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0||
59883106|NCT03681951|76006126|FG006|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0||
59883107|NCT03681951|76006127|FG007|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0||
59883108|NCT03681951|76006120|FG000|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0||
59950843|NCT01505608|76069754|FG001|COMPLETED|Phase I||2||
59753050|NCT00896532|75872226|FG014|COMPLETED|Months 24-36: Denosumab Extension Phase||0||
59753051|NCT00896532|75872227|FG015|COMPLETED|Months 24-36: Denosumab Extension Phase||0||
59753052|NCT00896532|75872228|FG016|COMPLETED|Months 24-36: Denosumab Extension Phase||0||
59753053|NCT00896532|75872229|FG017|COMPLETED|Months 24-36: Denosumab Extension Phase||0||
59753054|NCT00896532|75872230|FG018|COMPLETED|Months 24-36: Denosumab Extension Phase||0||
59753055|NCT00896532|75872231|FG019|COMPLETED|Months 24-36: Denosumab Extension Phase||0||
59753056|NCT00896532|75872232|FG020|COMPLETED|Months 24-36: Denosumab Extension Phase||0||
59753057|NCT00896532|75872233|FG021|COMPLETED|Months 24-36: Denosumab Extension Phase||0||
59753058|NCT00896532|75872234|FG022|COMPLETED|Months 24-36: Denosumab Extension Phase||0||
59753059|NCT00896532|75872212|FG000|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0||
59753060|NCT00896532|75872213|FG001|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0||
59753061|NCT00896532|75872214|FG002|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0||
59753062|NCT00896532|75872215|FG003|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0||
59753063|NCT00896532|75872216|FG004|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0||
59753064|NCT00896532|75872217|FG005|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0||
59753065|NCT00896532|75872218|FG006|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0||
59753066|NCT00896532|75872219|FG007|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0||
59753067|NCT00896532|75872220|FG008|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||1||
59753068|NCT00896532|75872221|FG009|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0||
59753069|NCT00896532|75872222|FG010|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||2||
59753070|NCT00896532|75872223|FG011|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||2||
59753071|NCT00896532|75872224|FG012|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||5||
59753072|NCT00896532|75872225|FG013|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||2||
59753073|NCT00896532|75872226|FG014|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0||
59753074|NCT00896532|75872227|FG015|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0||
59753075|NCT00896532|75872228|FG016|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0||
59753076|NCT00896532|75872229|FG017|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0||
59753077|NCT00896532|75872230|FG018|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0||
59753078|NCT00896532|75872231|FG019|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0||
59753079|NCT00896532|75872232|FG020|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0||
59753080|NCT00896532|75872233|FG021|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0||
59753081|NCT00896532|75872234|FG022|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0||
59753082|NCT00896532|75872212|FG000|STARTED|Months 36-48: Romosozumab Retreatment||0||
59753083|NCT00896532|75872213|FG001|STARTED|Months 36-48: Romosozumab Retreatment||0||
59753084|NCT00896532|75872214|FG002|STARTED|Months 36-48: Romosozumab Retreatment||0||
59753085|NCT00896532|75872215|FG003|STARTED|Months 36-48: Romosozumab Retreatment||0||
59753086|NCT00896532|75872216|FG004|STARTED|Months 36-48: Romosozumab Retreatment||0||
59753087|NCT00896532|75872217|FG005|STARTED|Months 36-48: Romosozumab Retreatment||0||
59753088|NCT00896532|75872218|FG006|STARTED|Months 36-48: Romosozumab Retreatment||0||
59753089|NCT00896532|75872219|FG007|STARTED|Months 36-48: Romosozumab Retreatment||0||
59753090|NCT00896532|75872220|FG008|STARTED|Months 36-48: Romosozumab Retreatment||0||
59753091|NCT00896532|75872221|FG009|STARTED|Months 36-48: Romosozumab Retreatment||0||
59753092|NCT00896532|75872222|FG010|STARTED|Months 36-48: Romosozumab Retreatment||0||
59753093|NCT00896532|75872223|FG011|STARTED|Months 36-48: Romosozumab Retreatment||0||
59753094|NCT00896532|75872224|FG012|STARTED|Months 36-48: Romosozumab Retreatment||0||
59753095|NCT00896532|75872225|FG013|STARTED|Months 36-48: Romosozumab Retreatment||0||
59753096|NCT00896532|75872226|FG014|STARTED|Months 36-48: Romosozumab Retreatment||12||
59753097|NCT00896532|75872227|FG015|STARTED|Months 36-48: Romosozumab Retreatment||16||
59753098|NCT00896532|75872228|FG016|STARTED|Months 36-48: Romosozumab Retreatment||72||
59753099|NCT00896532|75872229|FG017|STARTED|Months 36-48: Romosozumab Retreatment||67||
59753100|NCT00896532|75872230|FG018|STARTED|Months 36-48: Romosozumab Retreatment||0||
59753101|NCT00896532|75872231|FG019|STARTED|Months 36-48: Romosozumab Retreatment||0||
59753102|NCT00896532|75872232|FG020|STARTED|Months 36-48: Romosozumab Retreatment||0||
59753103|NCT00896532|75872233|FG021|STARTED|Months 36-48: Romosozumab Retreatment||0||
59753104|NCT00896532|75872234|FG022|STARTED|Months 36-48: Romosozumab Retreatment||0||
59753105|NCT00896532|75872212|FG000|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0||
59606080|NCT01940484|75716360|FG000|NOT COMPLETED|Overall Study||10||
59606081|NCT01939548|75716367|FG000|STARTED|Overall Study||78||
59606082|NCT01939548|75716368|FG001|STARTED|Overall Study||82||
59606083|NCT01939548|75716369|FG002|STARTED|Overall Study||80||
59606084|NCT01939548|75716367|FG000|COMPLETED|Overall Study||41||
59606085|NCT01939548|75716368|FG001|COMPLETED|Overall Study||33||
59606086|NCT01939548|75716369|FG002|COMPLETED|Overall Study||50||
59606087|NCT01939548|75716367|FG000|NOT COMPLETED|Overall Study||37||
59606088|NCT01939548|75716368|FG001|NOT COMPLETED|Overall Study||49||
59606089|NCT01939548|75716369|FG002|NOT COMPLETED|Overall Study||30||
59606090|NCT01960296|75716379|FG000|STARTED|Overall Study||23||
59606091|NCT01960296|75716380|FG001|STARTED|Overall Study||25||
59753106|NCT00896532|75872213|FG001|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0||
59753107|NCT00896532|75872214|FG002|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0||
59753108|NCT00896532|75872215|FG003|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0||
59753109|NCT00896532|75872216|FG004|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0||
59753110|NCT00896532|75872217|FG005|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0||
59753111|NCT00896532|75872218|FG006|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0||
59753112|NCT00896532|75872219|FG007|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0||
59753113|NCT00896532|75872220|FG008|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0||
59753114|NCT00896532|75872221|FG009|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0||
59753115|NCT00896532|75872222|FG010|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0||
59753116|NCT00896532|75872223|FG011|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0||
59753117|NCT00896532|75872224|FG012|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0||
59753118|NCT00896532|75872225|FG013|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0||
59753119|NCT00896532|75872226|FG014|Received Romosozumab|Months 36-48: Romosozumab Retreatment||12||
59753120|NCT00896532|75872227|FG015|Received Romosozumab|Months 36-48: Romosozumab Retreatment|Includes one participant who received 1 dose of romosozumab 70 mg in error in first 12 months|16||
59753121|NCT00896532|75872228|FG016|Received Romosozumab|Months 36-48: Romosozumab Retreatment||72||
59753122|NCT00896532|75872229|FG017|Received Romosozumab|Months 36-48: Romosozumab Retreatment||67||
59606092|NCT01960296|75716379|FG000|COMPLETED|Overall Study||21||
59606093|NCT01960296|75716380|FG001|COMPLETED|Overall Study||22||
59606094|NCT01960296|75716379|FG000|NOT COMPLETED|Overall Study||2||
59606095|NCT01960296|75716380|FG001|NOT COMPLETED|Overall Study||3||
59606096|NCT01982292|75716388|FG000|STARTED|Overall Study|"Started indicates Randomized set"|215||
59606097|NCT01982292|75716389|FG001|STARTED|Overall Study||108||
59753123|NCT00896532|75872230|FG018|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0||
59753124|NCT00896532|75872231|FG019|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0||
59753125|NCT00896532|75872232|FG020|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0||
59753126|NCT00896532|75872233|FG021|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0||
59753127|NCT00896532|75872234|FG022|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0||
59753128|NCT00896532|75872212|FG000|COMPLETED|Months 36-48: Romosozumab Retreatment||0||
59753129|NCT00896532|75872213|FG001|COMPLETED|Months 36-48: Romosozumab Retreatment||0||
59753130|NCT00896532|75872214|FG002|COMPLETED|Months 36-48: Romosozumab Retreatment||0||
59753131|NCT00896532|75872215|FG003|COMPLETED|Months 36-48: Romosozumab Retreatment||0||
59753132|NCT00896532|75872216|FG004|COMPLETED|Months 36-48: Romosozumab Retreatment||0||
59753133|NCT00896532|75872217|FG005|COMPLETED|Months 36-48: Romosozumab Retreatment||0||
59753134|NCT00896532|75872218|FG006|COMPLETED|Months 36-48: Romosozumab Retreatment||0||
59753135|NCT00896532|75872219|FG007|COMPLETED|Months 36-48: Romosozumab Retreatment||0||
59753136|NCT00896532|75872220|FG008|COMPLETED|Months 36-48: Romosozumab Retreatment||0||
59753137|NCT00896532|75872221|FG009|COMPLETED|Months 36-48: Romosozumab Retreatment||0||
59753138|NCT00896532|75872222|FG010|COMPLETED|Months 36-48: Romosozumab Retreatment||0||
59753139|NCT00896532|75872223|FG011|COMPLETED|Months 36-48: Romosozumab Retreatment||0||
59753140|NCT00896532|75872224|FG012|COMPLETED|Months 36-48: Romosozumab Retreatment||0||
59753141|NCT00896532|75872225|FG013|COMPLETED|Months 36-48: Romosozumab Retreatment||0||
59753142|NCT00896532|75872226|FG014|COMPLETED|Months 36-48: Romosozumab Retreatment||12||
59753143|NCT00896532|75872227|FG015|COMPLETED|Months 36-48: Romosozumab Retreatment||14||
59753144|NCT00896532|75872228|FG016|COMPLETED|Months 36-48: Romosozumab Retreatment||65||
59753145|NCT00896532|75872229|FG017|COMPLETED|Months 36-48: Romosozumab Retreatment||64||
59753146|NCT00896532|75872230|FG018|COMPLETED|Months 36-48: Romosozumab Retreatment||0||
59753147|NCT00896532|75872231|FG019|COMPLETED|Months 36-48: Romosozumab Retreatment||0||
59753148|NCT00896532|75872232|FG020|COMPLETED|Months 36-48: Romosozumab Retreatment||0||
59753149|NCT00896532|75872233|FG021|COMPLETED|Months 36-48: Romosozumab Retreatment||0||
59753150|NCT00896532|75872234|FG022|COMPLETED|Months 36-48: Romosozumab Retreatment||0||
59753151|NCT00896532|75872212|FG000|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0||
59753152|NCT00896532|75872213|FG001|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0||
59753153|NCT00896532|75872214|FG002|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0||
59753154|NCT00896532|75872215|FG003|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0||
59753155|NCT00896532|75872216|FG004|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0||
59753156|NCT00896532|75872217|FG005|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0||
59883109|NCT03681951|76006121|FG001|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0||
59883110|NCT03681951|76006122|FG002|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0||
59883111|NCT03681951|76006123|FG003|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0||
59753157|NCT00896532|75872218|FG006|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0||
59753158|NCT00896532|75872219|FG007|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0||
59753159|NCT00896532|75872220|FG008|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0||
59753160|NCT00896532|75872221|FG009|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0||
59753161|NCT00896532|75872222|FG010|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0||
59753162|NCT00896532|75872223|FG011|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0||
59753163|NCT00896532|75872224|FG012|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0||
59753164|NCT00896532|75872225|FG013|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0||
59753165|NCT00896532|75872226|FG014|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0||
59753166|NCT00896532|75872227|FG015|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||2||
59753167|NCT00896532|75872228|FG016|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||7||
59753168|NCT00896532|75872229|FG017|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||3||
59753169|NCT00896532|75872230|FG018|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0||
59753170|NCT00896532|75872231|FG019|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0||
59753171|NCT00896532|75872232|FG020|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0||
59753172|NCT00896532|75872233|FG021|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0||
59753173|NCT00896532|75872234|FG022|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0||
59753174|NCT00896532|75872212|FG000|STARTED|Months 48-72: Follow-on Phase||0||
59753175|NCT00896532|75872213|FG001|STARTED|Months 48-72: Follow-on Phase||0||
59883112|NCT03681951|76006124|FG004|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0||
59753176|NCT00896532|75872214|FG002|STARTED|Months 48-72: Follow-on Phase||0||
59753177|NCT00896532|75872215|FG003|STARTED|Months 48-72: Follow-on Phase||0||
59753178|NCT00896532|75872216|FG004|STARTED|Months 48-72: Follow-on Phase||0||
59753179|NCT00896532|75872217|FG005|STARTED|Months 48-72: Follow-on Phase||0||
59753180|NCT00896532|75872218|FG006|STARTED|Months 48-72: Follow-on Phase||0||
59753181|NCT00896532|75872219|FG007|STARTED|Months 48-72: Follow-on Phase||0||
59883113|NCT03681951|76006125|FG005|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0||
59883114|NCT03681951|76006126|FG006|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0||
59883115|NCT03681951|76006127|FG007|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0||
59883116|NCT03681951|76006120|FG000|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0||
59883117|NCT03681951|76006121|FG001|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0||
59883118|NCT03681951|76006122|FG002|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0||
59883119|NCT03681951|76006123|FG003|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0||
59883120|NCT03681951|76006124|FG004|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0||
59883121|NCT03681951|76006125|FG005|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0||
59883122|NCT03681951|76006126|FG006|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0||
59883123|NCT03681951|76006127|FG007|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0||
59883124|NCT03681951|76006120|FG000|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0||
59883125|NCT03681951|76006121|FG001|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0||
59753182|NCT00896532|75872220|FG008|STARTED|Months 48-72: Follow-on Phase||0||
59753183|NCT00896532|75872221|FG009|STARTED|Months 48-72: Follow-on Phase||0||
59753184|NCT00896532|75872222|FG010|STARTED|Months 48-72: Follow-on Phase||0||
59753185|NCT00896532|75872223|FG011|STARTED|Months 48-72: Follow-on Phase||0||
59753186|NCT00896532|75872224|FG012|STARTED|Months 48-72: Follow-on Phase||0||
59753187|NCT00896532|75872225|FG013|STARTED|Months 48-72: Follow-on Phase||0||
59753188|NCT00896532|75872226|FG014|STARTED|Months 48-72: Follow-on Phase||0||
59753189|NCT00896532|75872227|FG015|STARTED|Months 48-72: Follow-on Phase||0||
59753190|NCT00896532|75872228|FG016|STARTED|Months 48-72: Follow-on Phase||0||
59753191|NCT00896532|75872229|FG017|STARTED|Months 48-72: Follow-on Phase||0||
59753192|NCT00896532|75872230|FG018|STARTED|Months 48-72: Follow-on Phase||51||
59883126|NCT03681951|76006122|FG002|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0||
59883127|NCT03681951|76006123|FG003|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0||
59883128|NCT03681951|76006124|FG004|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0||
59883129|NCT03681951|76006125|FG005|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0||
59883130|NCT03681951|76006126|FG006|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0||
59883131|NCT03681951|76006127|FG007|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0||
59883132|NCT03681951|76006120|FG000|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0||
59883133|NCT03681951|76006121|FG001|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0||
59883134|NCT03681951|76006122|FG002|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0||
59883135|NCT03681951|76006123|FG003|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0||
59883136|NCT03681951|76006124|FG004|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0||
59883137|NCT03681951|76006125|FG005|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0||
59883138|NCT03681951|76006126|FG006|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0||
59883139|NCT03681951|76006127|FG007|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0||
59883140|NCT03681405|76006152|FG000|STARTED|Overall Study||14||
59883141|NCT03681405|76006153|FG001|STARTED|Overall Study||17||
59883142|NCT03681405|76006152|FG000|COMPLETED|Overall Study||13||
59883143|NCT03681405|76006153|FG001|COMPLETED|Overall Study||17||
59883144|NCT03681405|76006152|FG000|NOT COMPLETED|Overall Study||1||
59883145|NCT03681405|76006153|FG001|NOT COMPLETED|Overall Study||0||
59883146|NCT00174785|76006163|FG000|STARTED|Overall Study|randomized patients; among them, 10 patients did not receive any study drug in the dronedarone group|2301||
59753193|NCT00896532|75872231|FG019|STARTED|Months 48-72: Follow-on Phase||11||
59753194|NCT00896532|75872232|FG020|STARTED|Months 48-72: Follow-on Phase||12||
59753195|NCT00896532|75872233|FG021|STARTED|Months 48-72: Follow-on Phase||59||
59753196|NCT00896532|75872234|FG022|STARTED|Months 48-72: Follow-on Phase||8||
59753197|NCT00896532|75872212|FG000|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0||
59753198|NCT00896532|75872213|FG001|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0||
59753199|NCT00896532|75872214|FG002|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0||
59753200|NCT00896532|75872215|FG003|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0||
59753201|NCT00896532|75872216|FG004|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0||
59753202|NCT00896532|75872217|FG005|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0||
59753203|NCT00896532|75872218|FG006|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0||
59753204|NCT00896532|75872219|FG007|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0||
59753205|NCT00896532|75872220|FG008|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0||
59753206|NCT00896532|75872221|FG009|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0||
59753207|NCT00896532|75872222|FG010|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0||
59753208|NCT00896532|75872223|FG011|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0||
59753209|NCT00896532|75872224|FG012|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0||
59753210|NCT00896532|75872225|FG013|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0||
59883147|NCT00174785|76006164|FG001|STARTED|Overall Study|randomized patients; among them, 14 patients did not receive any study drug in the placebo group|2327||
59883148|NCT00174785|76006163|FG000|COMPLETED|Overall Study|completed study drug|1605||
59883149|NCT00174785|76006164|FG001|COMPLETED|Overall Study|completed study drug|1611||
59883150|NCT00174785|76006163|FG000|NOT COMPLETED|Overall Study||696||
59518945|NCT01093027|75612826|FG001|NOT COMPLETED|Visit 1||0||
59753211|NCT00896532|75872226|FG014|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0||
59753212|NCT00896532|75872227|FG015|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0||
59753213|NCT00896532|75872228|FG016|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0||
59753214|NCT00896532|75872229|FG017|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0||
60011421|NCT02623829|76127316|FG001|STARTED|Overall Study||21||
60011422|NCT02623829|76127315|FG000|COMPLETED|Overall Study||20||
60011423|NCT02623829|76127316|FG001|COMPLETED|Overall Study||20||
60011424|NCT02623829|76127315|FG000|NOT COMPLETED|Overall Study||1||
60011425|NCT02623829|76127316|FG001|NOT COMPLETED|Overall Study||1||
60011426|NCT02655679|76127327|FG000|STARTED|Overall Study||21||
60011427|NCT02655679|76127328|FG001|STARTED|Overall Study||19||
60011428|NCT02655679|76127329|FG002|STARTED|Overall Study||20||
60011429|NCT02655679|76127330|FG003|STARTED|Overall Study||24||
60011430|NCT02655679|76127331|FG004|STARTED|Overall Study||20||
60011431|NCT02655679|76127327|FG000|Received Study Drug (Safety Population)|Overall Study||20||
60011432|NCT02655679|76127328|FG001|Received Study Drug (Safety Population)|Overall Study||19||
60011433|NCT02655679|76127329|FG002|Received Study Drug (Safety Population)|Overall Study||20||
60011434|NCT02655679|76127330|FG003|Received Study Drug (Safety Population)|Overall Study||24||
60011435|NCT02655679|76127331|FG004|Received Study Drug (Safety Population)|Overall Study||20||
59753215|NCT00896532|75872230|FG018|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0||
59753216|NCT00896532|75872231|FG019|Received Zoledronic Acid|Months 48-72: Follow-on Phase||11||
59753217|NCT00896532|75872232|FG020|Received Zoledronic Acid|Months 48-72: Follow-on Phase||12||
59753218|NCT00896532|75872233|FG021|Received Zoledronic Acid|Months 48-72: Follow-on Phase||56||
59753219|NCT00896532|75872234|FG022|Received Zoledronic Acid|Months 48-72: Follow-on Phase||8||
59753220|NCT00896532|75872212|FG000|COMPLETED|Months 48-72: Follow-on Phase||0||
59753221|NCT00896532|75872213|FG001|COMPLETED|Months 48-72: Follow-on Phase||0||
59753222|NCT00896532|75872214|FG002|COMPLETED|Months 48-72: Follow-on Phase||0||
59753223|NCT00896532|75872215|FG003|COMPLETED|Months 48-72: Follow-on Phase||0||
59753224|NCT00896532|75872216|FG004|COMPLETED|Months 48-72: Follow-on Phase||0||
59753225|NCT00896532|75872217|FG005|COMPLETED|Months 48-72: Follow-on Phase||0||
59753226|NCT00896532|75872218|FG006|COMPLETED|Months 48-72: Follow-on Phase||0||
59753227|NCT00896532|75872219|FG007|COMPLETED|Months 48-72: Follow-on Phase||0||
59753228|NCT00896532|75872220|FG008|COMPLETED|Months 48-72: Follow-on Phase||0||
59753229|NCT00896532|75872221|FG009|COMPLETED|Months 48-72: Follow-on Phase||0||
59753230|NCT00896532|75872222|FG010|COMPLETED|Months 48-72: Follow-on Phase||0||
59753231|NCT00896532|75872223|FG011|COMPLETED|Months 48-72: Follow-on Phase||0||
59753232|NCT00896532|75872224|FG012|COMPLETED|Months 48-72: Follow-on Phase||0||
59753233|NCT00896532|75872225|FG013|COMPLETED|Months 48-72: Follow-on Phase||0||
59753234|NCT00896532|75872226|FG014|COMPLETED|Months 48-72: Follow-on Phase||0||
59753235|NCT00896532|75872227|FG015|COMPLETED|Months 48-72: Follow-on Phase||0||
59753236|NCT00896532|75872228|FG016|COMPLETED|Months 48-72: Follow-on Phase||0||
59753237|NCT00896532|75872229|FG017|COMPLETED|Months 48-72: Follow-on Phase||0||
59753238|NCT00896532|75872230|FG018|COMPLETED|Months 48-72: Follow-on Phase||50||
59753239|NCT00896532|75872231|FG019|COMPLETED|Months 48-72: Follow-on Phase||11||
59753240|NCT00896532|75872232|FG020|COMPLETED|Months 48-72: Follow-on Phase||12||
59753241|NCT00896532|75872233|FG021|COMPLETED|Months 48-72: Follow-on Phase||57||
59753242|NCT00896532|75872234|FG022|COMPLETED|Months 48-72: Follow-on Phase||8||
59753243|NCT00896532|75872212|FG000|NOT COMPLETED|Months 48-72: Follow-on Phase||0||
59753244|NCT00896532|75872213|FG001|NOT COMPLETED|Months 48-72: Follow-on Phase||0||
59753245|NCT00896532|75872214|FG002|NOT COMPLETED|Months 48-72: Follow-on Phase||0||
59753246|NCT00896532|75872215|FG003|NOT COMPLETED|Months 48-72: Follow-on Phase||0||
59753247|NCT00896532|75872216|FG004|NOT COMPLETED|Months 48-72: Follow-on Phase||0||
59753248|NCT00896532|75872217|FG005|NOT COMPLETED|Months 48-72: Follow-on Phase||0||
59753249|NCT00896532|75872218|FG006|NOT COMPLETED|Months 48-72: Follow-on Phase||0||
59753250|NCT00896532|75872219|FG007|NOT COMPLETED|Months 48-72: Follow-on Phase||0||
59753251|NCT00896532|75872220|FG008|NOT COMPLETED|Months 48-72: Follow-on Phase||0||
59613486|NCT01684878|75724611|FG001|Participants Mis-randomized|Part 2: Randomized Phase||0||
59613487|NCT01684878|75724612|FG002|Participants Mis-randomized|Part 2: Randomized Phase||2||
59606098|NCT01982292|75716388|FG000|Full Analaysis Set (FAS)|Overall Study|FAS excludes mis-randomized patients|213||
59753252|NCT00896532|75872221|FG009|NOT COMPLETED|Months 48-72: Follow-on Phase||0||
59753253|NCT00896532|75872222|FG010|NOT COMPLETED|Months 48-72: Follow-on Phase||0||
59753254|NCT00896532|75872223|FG011|NOT COMPLETED|Months 48-72: Follow-on Phase||0||
59753255|NCT00896532|75872224|FG012|NOT COMPLETED|Months 48-72: Follow-on Phase||0||
59753256|NCT00896532|75872225|FG013|NOT COMPLETED|Months 48-72: Follow-on Phase||0||
59753257|NCT00896532|75872226|FG014|NOT COMPLETED|Months 48-72: Follow-on Phase||0||
59753258|NCT00896532|75872227|FG015|NOT COMPLETED|Months 48-72: Follow-on Phase||0||
59883151|NCT00174785|76006164|FG001|NOT COMPLETED|Overall Study||716||
59883152|NCT03681093|76006173|FG000|STARTED|Overall Study||32|All subjects who were randomized|
59606099|NCT01982292|75716389|FG001|Full Analaysis Set (FAS)|Overall Study||108||
59606100|NCT01982292|75716388|FG000|Safety Set|Overall Study||212||
59606101|NCT01982292|75716389|FG001|Safety Set|Overall Study||108||
59753259|NCT00896532|75872228|FG016|NOT COMPLETED|Months 48-72: Follow-on Phase||0||
59753260|NCT00896532|75872229|FG017|NOT COMPLETED|Months 48-72: Follow-on Phase||0||
59753261|NCT00896532|75872230|FG018|NOT COMPLETED|Months 48-72: Follow-on Phase||1||
59753262|NCT00896532|75872231|FG019|NOT COMPLETED|Months 48-72: Follow-on Phase||0||
59753263|NCT00896532|75872232|FG020|NOT COMPLETED|Months 48-72: Follow-on Phase||0||
59753264|NCT00896532|75872233|FG021|NOT COMPLETED|Months 48-72: Follow-on Phase||2||
59753265|NCT00896532|75872234|FG022|NOT COMPLETED|Months 48-72: Follow-on Phase||0||
59753266|NCT00574873|75872283|FG000|STARTED|Overall Study||250||
59753267|NCT00574873|75872284|FG001|STARTED|Overall Study||252||
59753268|NCT00574873|75872283|FG000|Treated|Overall Study||248||
59753269|NCT00574873|75872284|FG001|Treated|Overall Study||251||
59753270|NCT00574873|75872283|FG000|COMPLETED|Overall Study||12||
59753271|NCT00574873|75872284|FG001|COMPLETED|Overall Study||1||
59753272|NCT00574873|75872283|FG000|NOT COMPLETED|Overall Study||238||
59883153|NCT03681093|76006174|FG001|STARTED|Overall Study||34|All subjects who were randomized|
59883154|NCT03681093|76006175|FG002|STARTED|Overall Study||32|All subjects who were randomized|
59883155|NCT03681093|76006173|FG000|Full Analysis Set (FAS)|Overall Study||31|All randomized subjects who received at least one dose of study treatment AND had baseline NPS score >=4|
59753273|NCT00574873|75872284|FG001|NOT COMPLETED|Overall Study||251||
59753274|NCT00902174|75872292|FG000|STARTED|Overall Study||103||
59606102|NCT01982292|75716388|FG000|COMPLETED|Overall Study||203||
59606103|NCT01982292|75716389|FG001|COMPLETED|Overall Study||107||
59606104|NCT01982292|75716388|FG000|NOT COMPLETED|Overall Study||12||
59606105|NCT01982292|75716389|FG001|NOT COMPLETED|Overall Study||1||
59883156|NCT03681093|76006174|FG001|Full Analysis Set (FAS)|Overall Study||32|All randomized subjects who received at least one dose of study treatment AND had baseline NPS score >=4|
59883157|NCT03681093|76006175|FG002|Full Analysis Set (FAS)|Overall Study||28|All randomized subjects who received at least one dose of study treatment AND had baseline NPS score >=4|
59883158|NCT03681093|76006173|FG000|Safety Analysis Set (SAF)|Overall Study||32|All subjects who received at least one dose of study treatment|
59883159|NCT03681093|76006174|FG001|Safety Analysis Set (SAF)|Overall Study||34|All subjects who received at least one dose of study treatment|
59883160|NCT03681093|76006175|FG002|Safety Analysis Set (SAF)|Overall Study||32|All subjects who received at least one dose of study treatment|
59883161|NCT03681093|76006173|FG000|COMPLETED|Overall Study||32||
59883162|NCT03681093|76006174|FG001|COMPLETED|Overall Study||32||
59883163|NCT03681093|76006175|FG002|COMPLETED|Overall Study||31||
59883164|NCT03681093|76006173|FG000|NOT COMPLETED|Overall Study||0||
59883165|NCT03681093|76006174|FG001|NOT COMPLETED|Overall Study||2||
59883166|NCT03681093|76006175|FG002|NOT COMPLETED|Overall Study||1||
59883167|NCT00166517|76006185|FG000|STARTED|Overall Study||115||
59883168|NCT00166517|76006186|FG001|STARTED|Overall Study||63||
59883169|NCT00166517|76006185|FG000|Vaccinated at Visit 1|Overall Study||115||
59753275|NCT00902174|75872293|FG001|STARTED|Overall Study||99||
59753276|NCT00902174|75872292|FG000|COMPLETED|Overall Study||69||
59753277|NCT00902174|75872293|FG001|COMPLETED|Overall Study||81||
59753278|NCT00902174|75872292|FG000|NOT COMPLETED|Overall Study||34||
59753279|NCT00902174|75872293|FG001|NOT COMPLETED|Overall Study||18||
59753316|NCT00623623|75872317|FG000|STARTED|Overall Study||950||
59753317|NCT00623623|75872318|FG001|STARTED|Overall Study||949||
59753318|NCT00623623|75872317|FG000|COMPLETED|Overall Study||949||
59753319|NCT00623623|75872318|FG001|COMPLETED|Overall Study||948||
59753320|NCT00623623|75872317|FG000|NOT COMPLETED|Overall Study||1||
59753321|NCT00623623|75872318|FG001|NOT COMPLETED|Overall Study||1||
59753322|NCT00896454|75872324|FG000|STARTED|Overall Study||33||
59753323|NCT00896454|75872324|FG000|COMPLETED|Overall Study||0||
59753324|NCT00896454|75872324|FG000|NOT COMPLETED|Overall Study||33||
59753325|NCT00629239|75872330|FG000|STARTED|Overall Study||34||
59753326|NCT00629239|75872331|FG001|STARTED|Overall Study||32||
59518946|NCT01093027|75612825|FG000|STARTED|Visit 2||10||
59753327|NCT00629239|75872330|FG000|COMPLETED|Overall Study||26||
59753328|NCT00629239|75872331|FG001|COMPLETED|Overall Study||28||
59753329|NCT00629239|75872330|FG000|NOT COMPLETED|Overall Study||8||
59606106|NCT01939314|75716397|FG000|STARTED|Overall Study||45||
59606107|NCT01939314|75716398|FG001|STARTED|Overall Study||48||
59883170|NCT00166517|76006186|FG001|Vaccinated at Visit 1|Overall Study||63||
59883171|NCT00166517|76006185|FG000|Vaccinated at Visit 2|Overall Study||112||
59883172|NCT00166517|76006186|FG001|Vaccinated at Visit 2|Overall Study||61||
59883173|NCT00166517|76006185|FG000|Vaccinated at Visit 3|Overall Study||110||
59883174|NCT00166517|76006186|FG001|Vaccinated at Visit 3|Overall Study||61||
59883175|NCT00166517|76006185|FG000|COMPLETED|Overall Study||110||
59883176|NCT00166517|76006186|FG001|COMPLETED|Overall Study||61||
59883177|NCT00166517|76006185|FG000|NOT COMPLETED|Overall Study||5||
59883178|NCT00166517|76006186|FG001|NOT COMPLETED|Overall Study||2||
59883179|NCT00166439|76006192|FG000|STARTED|Overall Study||50||
59883180|NCT00166439|76006192|FG000|COMPLETED|Overall Study||45||
59883181|NCT00166439|76006192|FG000|NOT COMPLETED|Overall Study||5||
59883182|NCT00138671|76006198|FG000|STARTED|Overall Study||59||
59883183|NCT00138671|76006199|FG001|STARTED|Overall Study||46||
59883184|NCT00138671|76006198|FG000|COMPLETED|Overall Study||46||
59883185|NCT00138671|76006199|FG001|COMPLETED|Overall Study||30||
59883186|NCT00138671|76006198|FG000|NOT COMPLETED|Overall Study||13||
59883187|NCT00138671|76006199|FG001|NOT COMPLETED|Overall Study||16||
59883188|NCT01367158|76006218|FG000|STARTED|Overall Study||25||
59883189|NCT01367158|76006219|FG001|STARTED|Overall Study||49||
59883190|NCT01367158|76006220|FG002|STARTED|Overall Study||24||
59606108|NCT01939314|75716397|FG000|15 Minute Endpoint|Overall Study||41||
59606109|NCT01939314|75716398|FG001|15 Minute Endpoint|Overall Study||46||
59606110|NCT01939314|75716397|FG000|24 Hour Endpoint|Overall Study||36||
59753330|NCT00629239|75872331|FG001|NOT COMPLETED|Overall Study||4||
60011436|NCT02655679|76127327|FG000|COMPLETED|Overall Study||18||
60011437|NCT02655679|76127328|FG001|COMPLETED|Overall Study||16||
60011438|NCT02655679|76127329|FG002|COMPLETED|Overall Study||19||
60011439|NCT02655679|76127330|FG003|COMPLETED|Overall Study||20||
60011440|NCT02655679|76127331|FG004|COMPLETED|Overall Study||19||
60011441|NCT02655679|76127327|FG000|NOT COMPLETED|Overall Study||3||
60011442|NCT02655679|76127328|FG001|NOT COMPLETED|Overall Study||3||
60011443|NCT02655679|76127329|FG002|NOT COMPLETED|Overall Study||1||
60011444|NCT02655679|76127330|FG003|NOT COMPLETED|Overall Study||4||
60011445|NCT02655679|76127331|FG004|NOT COMPLETED|Overall Study||1||
60011446|NCT02623361|76127346|FG000|STARTED|Overall Study||40||
60011447|NCT02623361|76127347|FG001|STARTED|Overall Study||40||
60011448|NCT02623361|76127346|FG000|COMPLETED|Overall Study||40||
60011449|NCT02623361|76127347|FG001|COMPLETED|Overall Study||38||
60011450|NCT02623361|76127346|FG000|NOT COMPLETED|Overall Study||0||
60011451|NCT02623361|76127347|FG001|NOT COMPLETED|Overall Study||2||
60011452|NCT04985383|76127353|FG000|STARTED|Overall Study||10||
60011453|NCT04985383|76127353|FG000|Week 1 AKST1210 S-15 at 250 mL/Min|Overall Study||9||
60011454|NCT04985383|76127353|FG000|Week 2 AKST1210 S-15 at up to 450 mL/Min|Overall Study||9||
60011455|NCT04985383|76127353|FG000|Week 3 AKST1210 S-25 at 250 mL/Min|Overall Study||9||
60011456|NCT04985383|76127353|FG000|Week 4 AKST1210 S-25 at up to 450 mL/Min|Overall Study||9||
60011457|NCT04985383|76127353|FG000|Week 5 AKST1210 S-35 at 250 mL/Min|Overall Study||9||
60011458|NCT04985383|76127353|FG000|Week 6 AKST1210 S-35 at up to 450 mL/Min|Overall Study||9||
59606111|NCT01939314|75716398|FG001|24 Hour Endpoint|Overall Study||40||
59606112|NCT01939314|75716397|FG000|COMPLETED|Overall Study||36||
59606113|NCT01939314|75716398|FG001|COMPLETED|Overall Study||40||
59606114|NCT01939314|75716397|FG000|NOT COMPLETED|Overall Study||9||
59606115|NCT01939314|75716398|FG001|NOT COMPLETED|Overall Study||8||
59606116|NCT01939158|75716410|FG000|STARTED|Overall Study||203||
59606117|NCT01939158|75716411|FG001|STARTED|Overall Study||198||
59606118|NCT01939158|75716412|FG002|STARTED|Overall Study||201||
59606119|NCT01939158|75716413|FG003|STARTED|Overall Study||201||
59606120|NCT01939158|75716410|FG000|Vaccinated|Overall Study||203||
59883191|NCT01367158|76006221|FG003|STARTED|Overall Study||49||
60011459|NCT04985383|76127353|FG000|COMPLETED|Overall Study||9||
59883192|NCT01367158|76006222|FG004|STARTED|Overall Study||25||
59883193|NCT01367158|76006223|FG005|STARTED|Overall Study||48||
59883194|NCT01367158|76006224|FG006|STARTED|Overall Study||25||
59883195|NCT01367158|76006225|FG007|STARTED|Overall Study||49||
59883196|NCT01367158|76006226|FG008|STARTED|Overall Study||23||
59883197|NCT01367158|76006227|FG009|STARTED|Overall Study||50||
59883198|NCT01367158|76006228|FG010|STARTED|Overall Study||73||
59883199|NCT01367158|76006218|FG000|COMPLETED|Overall Study||25||
59883200|NCT01367158|76006219|FG001|COMPLETED|Overall Study||46||
60011460|NCT04985383|76127353|FG000|NOT COMPLETED|Overall Study||1||
60011461|NCT04391959|76127374|FG000|STARTED|Overall Study||16||
60011462|NCT04391959|76127375|FG001|STARTED|Overall Study|One subject should have been excluded based upon Schirmer test = 0 mm at baseline < 5mm. Subject was removed from the study.|15||
60011463|NCT04391959|76127374|FG000|COMPLETED|Overall Study||15||
60011464|NCT04391959|76127375|FG001|COMPLETED|Overall Study||10||
60011465|NCT04391959|76127374|FG000|NOT COMPLETED|Overall Study||1||
60011466|NCT04391959|76127375|FG001|NOT COMPLETED|Overall Study||5||
60011467|NCT04509739|76127381|FG000|STARTED|Overall Study||16|We enrolled 17 participants and conducted pre-test on them. One participant failed the pre-test (couldn't get through the procedure to produce data) and was therefore not started on the intervention.|
60011468|NCT04509739|76127381|FG000|COMPLETED|Overall Study||15|One infants could not complete all 12 intervention sessions within the 5-week period due to repeated colds.|
60011469|NCT04509739|76127381|FG000|NOT COMPLETED|Overall Study||1||
60011470|NCT01966263|76127387|FG000|STARTED|Overall Study||40||
60011471|NCT01966263|76127388|FG001|STARTED|Overall Study||40||
60011472|NCT01966263|76127387|FG000|COMPLETED|Overall Study||40||
60011473|NCT01966263|76127388|FG001|COMPLETED|Overall Study||40||
60011474|NCT01966263|76127387|FG000|NOT COMPLETED|Overall Study||0||
60011475|NCT01966263|76127388|FG001|NOT COMPLETED|Overall Study||0||
60011476|NCT01675531|76127394|FG000|STARTED|Overall Study||66||
60011477|NCT01675531|76127394|FG000|COMPLETED|Overall Study||41||
60011478|NCT01675531|76127394|FG000|NOT COMPLETED|Overall Study||25||
60011479|NCT02532543|76127403|FG000|STARTED|Overall Study||3||
59606121|NCT01939158|75716411|FG001|Vaccinated|Overall Study||197||
59606122|NCT01939158|75716412|FG002|Vaccinated|Overall Study||201||
59883201|NCT01367158|76006220|FG002|COMPLETED|Overall Study||23||
60011480|NCT02532543|76127404|FG001|STARTED|Overall Study||4||
60011481|NCT02532543|76127405|FG002|STARTED|Overall Study||5||
60011482|NCT02532543|76127406|FG003|STARTED|Overall Study||4||
60011483|NCT02532543|76127403|FG000|COMPLETED|Overall Study||3||
59883202|NCT01367158|76006221|FG003|COMPLETED|Overall Study||48||
59883203|NCT01367158|76006222|FG004|COMPLETED|Overall Study||23||
59883204|NCT01367158|76006223|FG005|COMPLETED|Overall Study||46||
59883205|NCT01367158|76006224|FG006|COMPLETED|Overall Study||25||
59883206|NCT01367158|76006225|FG007|COMPLETED|Overall Study||47||
59606123|NCT01939158|75716413|FG003|Vaccinated|Overall Study||201||
59606124|NCT01939158|75716410|FG000|COMPLETED|Overall Study||156||
59606125|NCT01939158|75716411|FG001|COMPLETED|Overall Study||146||
59606126|NCT01939158|75716412|FG002|COMPLETED|Overall Study||160||
59606127|NCT01939158|75716413|FG003|COMPLETED|Overall Study||157||
59606128|NCT01939158|75716410|FG000|NOT COMPLETED|Overall Study||47||
59753331|NCT00625807|75872339|FG000|STARTED|Overall Study||22||
59606129|NCT01939158|75716411|FG001|NOT COMPLETED|Overall Study||52||
59606130|NCT01939158|75716412|FG002|NOT COMPLETED|Overall Study||41||
59606131|NCT01939158|75716413|FG003|NOT COMPLETED|Overall Study||44||
59753332|NCT00625807|75872340|FG001|STARTED|Overall Study||28||
59753333|NCT00625807|75872339|FG000|COMPLETED|Overall Study||20||
59606132|NCT01939002|75716429|FG000|STARTED|Overall Study||103||
59606133|NCT01939002|75716430|FG001|STARTED|Overall Study||98||
59606134|NCT01939002|75716429|FG000|COMPLETED|Overall Study||84||
60011484|NCT02532543|76127404|FG001|COMPLETED|Overall Study||4||
60011485|NCT02532543|76127405|FG002|COMPLETED|Overall Study||4||
60011486|NCT02532543|76127406|FG003|COMPLETED|Overall Study||4||
59753334|NCT00625807|75872340|FG001|COMPLETED|Overall Study||20||
59753335|NCT00625807|75872339|FG000|NOT COMPLETED|Overall Study||2||
59753336|NCT00625807|75872340|FG001|NOT COMPLETED|Overall Study||8||
59753337|NCT00629083|75872350|FG000|STARTED|Overall Study||228||
59753338|NCT00629083|75872351|FG001|STARTED|Overall Study||117||
59753339|NCT00629083|75872350|FG000|COMPLETED|Overall Study||200||
59753340|NCT00629083|75872351|FG001|COMPLETED|Overall Study||103||
59753341|NCT00629083|75872350|FG000|NOT COMPLETED|Overall Study||28||
59753342|NCT00629083|75872351|FG001|NOT COMPLETED|Overall Study||14||
59753343|NCT00901628|75872361|FG000|STARTED|Overall Study||49||
59753344|NCT00901628|75872362|FG001|STARTED|Overall Study||52||
59753345|NCT00901628|75872361|FG000|COMPLETED|Overall Study||45||
59753346|NCT00901628|75872362|FG001|COMPLETED|Overall Study||42||
59753347|NCT00901628|75872361|FG000|NOT COMPLETED|Overall Study||4||
59753348|NCT00901628|75872362|FG001|NOT COMPLETED|Overall Study||10||
59883207|NCT01367158|76006226|FG008|COMPLETED|Overall Study||23||
59753349|NCT00623545|75872368|FG000|STARTED|Overall Study||28||
59753350|NCT00623545|75872368|FG000|COMPLETED|Overall Study||18||
59753351|NCT00623545|75872368|FG000|NOT COMPLETED|Overall Study||10||
59753352|NCT00628927|75872375|FG000|STARTED|Overall Study||183||
59753353|NCT00628927|75872376|FG001|STARTED|Overall Study||30||
59753354|NCT00628927|75872375|FG000|COMPLETED|Overall Study||175||
59753355|NCT00628927|75872376|FG001|COMPLETED|Overall Study||30||
59753356|NCT00628927|75872375|FG000|NOT COMPLETED|Overall Study||8||
59753357|NCT00628927|75872376|FG001|NOT COMPLETED|Overall Study||0||
59753358|NCT00623467|75872387|FG000|STARTED|Overall Study||343||
59753359|NCT00623467|75872387|FG000|COMPLETED|Overall Study||336||
59753360|NCT00623467|75872387|FG000|NOT COMPLETED|Overall Study||7||
59753361|NCT00838539|75872405|FG000|STARTED|Overall Study||3||
59883208|NCT01367158|76006227|FG009|COMPLETED|Overall Study||50||
59753362|NCT00838539|75872406|FG001|STARTED|Overall Study||6||
59753363|NCT00838539|75872407|FG002|STARTED|Overall Study||5||
59753364|NCT00838539|75872408|FG003|STARTED|Overall Study||4||
59753365|NCT00838539|75872409|FG004|STARTED|Overall Study||6||
59753366|NCT00838539|75872410|FG005|STARTED|Overall Study||4||
59753367|NCT00838539|75872411|FG006|STARTED|Overall Study||7||
59753368|NCT00838539|75872412|FG007|STARTED|Overall Study||6||
59753369|NCT00838539|75872413|FG008|STARTED|Overall Study||5||
59883209|NCT01367158|76006228|FG010|COMPLETED|Overall Study||72||
59606135|NCT01939002|75716430|FG001|COMPLETED|Overall Study||80||
59606136|NCT01939002|75716429|FG000|NOT COMPLETED|Overall Study||19||
59606137|NCT01939002|75716430|FG001|NOT COMPLETED|Overall Study||18||
59883210|NCT01367158|76006218|FG000|NOT COMPLETED|Overall Study||0||
59883211|NCT01367158|76006219|FG001|NOT COMPLETED|Overall Study||3||
59606138|NCT01938846|75716444|FG000|STARTED|Overall Study||41|Entered/randomised|
59753370|NCT00838539|75872414|FG009|STARTED|Overall Study||8||
59753371|NCT00838539|75872415|FG010|STARTED|Overall Study||5||
59753372|NCT00838539|75872416|FG011|STARTED|Overall Study||4||
59753373|NCT00838539|75872405|FG000|Received Treatment|Overall Study||3||
59753374|NCT00838539|75872406|FG001|Received Treatment|Overall Study||5||
59753375|NCT00838539|75872407|FG002|Received Treatment|Overall Study||5||
59753376|NCT00838539|75872408|FG003|Received Treatment|Overall Study||4||
59518947|NCT01093027|75612826|FG001|STARTED|Visit 2||10||
59753377|NCT00838539|75872409|FG004|Received Treatment|Overall Study||4||
59753378|NCT00838539|75872410|FG005|Received Treatment|Overall Study||4||
59753379|NCT00838539|75872411|FG006|Received Treatment|Overall Study||7||
59753380|NCT00838539|75872412|FG007|Received Treatment|Overall Study||6||
59753381|NCT00838539|75872413|FG008|Received Treatment|Overall Study||5||
59753382|NCT00838539|75872414|FG009|Received Treatment|Overall Study||8||
59753383|NCT00838539|75872415|FG010|Received Treatment|Overall Study||5||
59753384|NCT00838539|75872416|FG011|Received Treatment|Overall Study||4||
59883212|NCT01367158|76006220|FG002|NOT COMPLETED|Overall Study||1||
59518948|NCT01093027|75612825|FG000|COMPLETED|Visit 2||10||
59753385|NCT00838539|75872405|FG000|COMPLETED|Overall Study||0||
59753386|NCT00838539|75872406|FG001|COMPLETED|Overall Study||0||
59883213|NCT01367158|76006221|FG003|NOT COMPLETED|Overall Study||1||
59753387|NCT00838539|75872407|FG002|COMPLETED|Overall Study||0||
59883214|NCT01367158|76006222|FG004|NOT COMPLETED|Overall Study||2||
59883215|NCT01367158|76006223|FG005|NOT COMPLETED|Overall Study||2||
59883216|NCT01367158|76006224|FG006|NOT COMPLETED|Overall Study||0||
59883217|NCT01367158|76006225|FG007|NOT COMPLETED|Overall Study||2||
59883218|NCT01367158|76006226|FG008|NOT COMPLETED|Overall Study||0||
59606139|NCT01938846|75716445|FG001|STARTED|Overall Study||25|Entered/randomised|
59606140|NCT01938846|75716446|FG002|STARTED|Overall Study||24|Entered/randomised|
59606141|NCT01938846|75716444|FG000|COMPLETED|Overall Study||0|Not discontinued from last trial medication|
59606142|NCT01938846|75716445|FG001|COMPLETED|Overall Study||0|Not discontinued from last trial medication|
59606143|NCT01938846|75716446|FG002|COMPLETED|Overall Study||0|Not discontinued from last trial medication|
59606144|NCT01938846|75716444|FG000|NOT COMPLETED|Overall Study||41||
59606145|NCT01938846|75716445|FG001|NOT COMPLETED|Overall Study||25||
59606146|NCT01938846|75716446|FG002|NOT COMPLETED|Overall Study||24||
59606147|NCT01960140|75716487|FG000|STARTED|Period 1 (Days 1-2)||40||
59518949|NCT01093027|75612826|FG001|COMPLETED|Visit 2||10||
59518950|NCT01093027|75612825|FG000|NOT COMPLETED|Visit 2||0||
59518951|NCT01093027|75612826|FG001|NOT COMPLETED|Visit 2||0||
59753388|NCT00838539|75872408|FG003|COMPLETED|Overall Study||0||
59753389|NCT00838539|75872409|FG004|COMPLETED|Overall Study||0||
59753390|NCT00838539|75872410|FG005|COMPLETED|Overall Study||0||
59753391|NCT00838539|75872411|FG006|COMPLETED|Overall Study||2||
59753392|NCT00838539|75872412|FG007|COMPLETED|Overall Study||0||
59753393|NCT00838539|75872413|FG008|COMPLETED|Overall Study||0||
59753394|NCT00838539|75872414|FG009|COMPLETED|Overall Study||0||
59753395|NCT00838539|75872415|FG010|COMPLETED|Overall Study||0||
59753396|NCT00838539|75872416|FG011|COMPLETED|Overall Study||0||
59753397|NCT00838539|75872405|FG000|NOT COMPLETED|Overall Study||3||
59753398|NCT00838539|75872406|FG001|NOT COMPLETED|Overall Study||6||
59753399|NCT00838539|75872407|FG002|NOT COMPLETED|Overall Study||5||
59753400|NCT00838539|75872408|FG003|NOT COMPLETED|Overall Study||4||
59753401|NCT00838539|75872409|FG004|NOT COMPLETED|Overall Study||6||
59753402|NCT00838539|75872410|FG005|NOT COMPLETED|Overall Study||4||
59753403|NCT00838539|75872411|FG006|NOT COMPLETED|Overall Study||5||
59753404|NCT00838539|75872412|FG007|NOT COMPLETED|Overall Study||6||
59753405|NCT00838539|75872413|FG008|NOT COMPLETED|Overall Study||5||
59753406|NCT00838539|75872414|FG009|NOT COMPLETED|Overall Study||8||
59753407|NCT00838539|75872415|FG010|NOT COMPLETED|Overall Study||5||
59753408|NCT00838539|75872416|FG011|NOT COMPLETED|Overall Study||4||
59753409|NCT00837759|75872456|FG000|STARTED|Overall Study||7||
59753410|NCT00837759|75872456|FG000|COMPLETED|Overall Study||3||
59753411|NCT00837759|75872456|FG000|NOT COMPLETED|Overall Study||4||
59753412|NCT00891774|75872460|FG000|STARTED|Overall Study||172||
59753413|NCT00891774|75872460|FG000|COMPLETED|Overall Study||158||
59753414|NCT00891774|75872460|FG000|NOT COMPLETED|Overall Study||14||
59753415|NCT05421754|75872464|FG000|STARTED|Overall Study||30||
59753416|NCT05421754|75872464|FG000|COMPLETED|Overall Study||29||
59518952|NCT01116661|75612832|FG000|STARTED|Overall Study||199||
59518953|NCT01116661|75612832|FG000|COMPLETED|Overall Study||197||
59753417|NCT05421754|75872464|FG000|NOT COMPLETED|Overall Study||1||
59753418|NCT05037578|75872470|FG000|STARTED|Overall Study||62||
59753419|NCT05037578|75872471|FG001|STARTED|Overall Study||37||
59753420|NCT05037578|75872470|FG000|COMPLETED|Overall Study||54||
59753421|NCT05037578|75872471|FG001|COMPLETED|Overall Study||33||
59753422|NCT05037578|75872470|FG000|NOT COMPLETED|Overall Study||8||
59753423|NCT05037578|75872471|FG001|NOT COMPLETED|Overall Study||4||
59753424|NCT04644276|75872477|FG000|STARTED|Overall Study||2||
59753425|NCT04644276|75872478|FG001|STARTED|Overall Study||3||
59753426|NCT04644276|75872479|FG002|STARTED|Overall Study||2||
59753427|NCT04644276|75872477|FG000|COMPLETED|Overall Study||2||
59753428|NCT04644276|75872478|FG001|COMPLETED|Overall Study||3||
59753429|NCT04644276|75872479|FG002|COMPLETED|Overall Study||1||
59753430|NCT04644276|75872477|FG000|NOT COMPLETED|Overall Study||0||
59753431|NCT04644276|75872478|FG001|NOT COMPLETED|Overall Study||0||
59753432|NCT04644276|75872479|FG002|NOT COMPLETED|Overall Study||1||
59753433|NCT04380116|75872490|FG000|STARTED|Overall Study||48||
59753434|NCT04380116|75872491|FG001|STARTED|Overall Study||48||
59753435|NCT04380116|75872490|FG000|COMPLETED|Overall Study||43||
59753436|NCT04380116|75872491|FG001|COMPLETED|Overall Study||32||
59753437|NCT04380116|75872490|FG000|NOT COMPLETED|Overall Study||5||
59753438|NCT04380116|75872491|FG001|NOT COMPLETED|Overall Study||16||
59753439|NCT04240093|75872499|FG000|STARTED|Overall Study||16||
59606148|NCT01960140|75716487|FG000|Received Simvastatin|Period 1 (Days 1-2)||40||
59606149|NCT01960140|75716487|FG000|COMPLETED|Period 1 (Days 1-2)||40||
59606150|NCT01960140|75716487|FG000|NOT COMPLETED|Period 1 (Days 1-2)||0||
59518954|NCT01116661|75612832|FG000|NOT COMPLETED|Overall Study||2||
59606151|NCT01960140|75716487|FG000|STARTED|Period 2 (Days 3-18)||40||
59753440|NCT04240093|75872500|FG001|STARTED|Overall Study||16||
59753441|NCT04240093|75872499|FG000|3 Month Follow-Up|Overall Study||14||
59753442|NCT04240093|75872500|FG001|3 Month Follow-Up|Overall Study||16||
59753443|NCT04240093|75872499|FG000|6 Month Follow Up|Overall Study||16||
59753444|NCT04240093|75872500|FG001|6 Month Follow Up|Overall Study||16||
59753445|NCT04240093|75872499|FG000|COMPLETED|Overall Study||16||
59753446|NCT04240093|75872500|FG001|COMPLETED|Overall Study||16||
59753447|NCT04240093|75872499|FG000|NOT COMPLETED|Overall Study||0||
59753448|NCT04240093|75872500|FG001|NOT COMPLETED|Overall Study||0||
59753449|NCT03813108|75872512|FG000|STARTED|Overall Study||10||
59753450|NCT03813108|75872513|FG001|STARTED|Overall Study||10||
59753451|NCT03813108|75872514|FG002|STARTED|Overall Study||20||
59753452|NCT03813108|75872515|FG003|STARTED|Overall Study||3||
59753453|NCT03813108|75872516|FG004|STARTED|Overall Study||0||
59753454|NCT03813108|75872517|FG005|STARTED|Overall Study||0||
59753455|NCT03813108|75872512|FG000|COMPLETED|Overall Study||8||
59753456|NCT03813108|75872513|FG001|COMPLETED|Overall Study||9||
59753457|NCT03813108|75872514|FG002|COMPLETED|Overall Study||0||
59753458|NCT03813108|75872515|FG003|COMPLETED|Overall Study||3||
59753459|NCT03813108|75872516|FG004|COMPLETED|Overall Study||0||
59753460|NCT03813108|75872517|FG005|COMPLETED|Overall Study||0||
59753461|NCT03813108|75872512|FG000|NOT COMPLETED|Overall Study||2||
59753462|NCT03813108|75872513|FG001|NOT COMPLETED|Overall Study||1||
59753463|NCT03813108|75872514|FG002|NOT COMPLETED|Overall Study||20||
59753464|NCT03813108|75872515|FG003|NOT COMPLETED|Overall Study||0||
59753465|NCT03813108|75872516|FG004|NOT COMPLETED|Overall Study||0||
59753466|NCT03813108|75872517|FG005|NOT COMPLETED|Overall Study||0||
59753467|NCT03694652|75872529|FG000|STARTED|Overall Study||13||
59753468|NCT03694652|75872530|FG001|STARTED|Overall Study||16||
59753469|NCT03694652|75872529|FG000|COMPLETED|Overall Study||11||
59753470|NCT03694652|75872530|FG001|COMPLETED|Overall Study||14||
59606152|NCT01960140|75716487|FG000|Received At Least 1 Dose of Baricitinib|Period 2 (Days 3-18)||40||
59606153|NCT01960140|75716487|FG000|Received Simvastatin|Period 2 (Days 3-18)||38||
59606154|NCT01960140|75716487|FG000|COMPLETED|Period 2 (Days 3-18)||38||
59606155|NCT01960140|75716487|FG000|NOT COMPLETED|Period 2 (Days 3-18)||2||
59606156|NCT01981356|75716497|FG000|STARTED|Overall Study||12||
59753471|NCT03694652|75872529|FG000|NOT COMPLETED|Overall Study||2||
59753472|NCT03694652|75872530|FG001|NOT COMPLETED|Overall Study||2||
59753473|NCT03417154|75872538|FG000|STARTED|Overall Study||6||
59753474|NCT03417154|75872539|FG001|STARTED|Overall Study||6||
59753475|NCT03417154|75872538|FG000|COMPLETED|Overall Study||0||
59753476|NCT03417154|75872539|FG001|COMPLETED|Overall Study||0||
59753477|NCT03417154|75872538|FG000|NOT COMPLETED|Overall Study||6||
59753478|NCT03417154|75872539|FG001|NOT COMPLETED|Overall Study||6||
59753479|NCT01596621|75872545|FG000|STARTED|Overall Study||102||
59753480|NCT01596621|75872545|FG000|Received at Least 1 Dose of Study Drug|Overall Study||102||
59753481|NCT01596621|75872545|FG000|COMPLETED|Overall Study||24||
59753482|NCT01596621|75872545|FG000|NOT COMPLETED|Overall Study||78||
59753483|NCT01337245|75872549|FG000|STARTED|Overall Study||26||
59883219|NCT01367158|76006227|FG009|NOT COMPLETED|Overall Study||0||
59883220|NCT01367158|76006228|FG010|NOT COMPLETED|Overall Study||1||
59883221|NCT00130637|76006263|FG000|STARTED|Overall Study||6||
59883222|NCT00130637|76006263|FG000|COMPLETED|Overall Study||3||
59883223|NCT00130637|76006263|FG000|NOT COMPLETED|Overall Study||3||
59883224|NCT03679767|76006271|FG000|STARTED|Overall Study||35||
59883225|NCT03679767|76006272|FG001|STARTED|Overall Study||23||
59883226|NCT03679767|76006273|FG002|STARTED|Overall Study||29||
59883227|NCT03679767|76006274|FG003|STARTED|Overall Study||34||
59753484|NCT01337245|75872549|FG000|COMPLETED|Overall Study||25||
59753485|NCT01337245|75872549|FG000|NOT COMPLETED|Overall Study||1||
59753486|NCT00813982|75872553|FG000|STARTED|Overall Study||59||
59883228|NCT03679767|76006271|FG000|COMPLETED|Overall Study||0||
59883229|NCT03679767|76006272|FG001|COMPLETED|Overall Study||0||
59883230|NCT03679767|76006273|FG002|COMPLETED|Overall Study||0||
59883231|NCT03679767|76006274|FG003|COMPLETED|Overall Study||0||
59883232|NCT03679767|76006271|FG000|NOT COMPLETED|Overall Study||35||
59883233|NCT03679767|76006272|FG001|NOT COMPLETED|Overall Study||23||
59883234|NCT03679767|76006273|FG002|NOT COMPLETED|Overall Study||29||
59883235|NCT03679767|76006274|FG003|NOT COMPLETED|Overall Study||34||
59753487|NCT00813982|75872553|FG000|COMPLETED|Overall Study||59||
59883236|NCT00130247|76006288|FG000|STARTED|Overall Study||196||
59518955|NCT00944021|75612841|FG000|STARTED|Overall Study||15||
59753488|NCT00813982|75872553|FG000|NOT COMPLETED|Overall Study||0||
59753489|NCT00566098|75872559|FG000|STARTED|Collection of MILs||25||
59753490|NCT00566098|75872559|FG000|COMPLETED|Collection of MILs||23||
59753491|NCT00566098|75872559|FG000|NOT COMPLETED|Collection of MILs||2||
59753492|NCT00566098|75872559|FG000|STARTED|Generation of MILs Product||23||
59753493|NCT00566098|75872559|FG000|COMPLETED|Generation of MILs Product||22||
59753494|NCT00566098|75872559|FG000|NOT COMPLETED|Generation of MILs Product||1||
59753495|NCT00566098|75872559|FG000|STARTED|Administration of ASCT+MILs||22||
59753496|NCT00566098|75872559|FG000|COMPLETED|Administration of ASCT+MILs||4||
59883237|NCT00130247|76006289|FG001|STARTED|Overall Study||198||
59883238|NCT00130247|76006288|FG000|COMPLETED|Overall Study||194||
59518956|NCT00944021|75612842|FG001|STARTED|Overall Study||15||
59883239|NCT00130247|76006289|FG001|COMPLETED|Overall Study||194||
59883240|NCT00130247|76006288|FG000|NOT COMPLETED|Overall Study||2||
59883241|NCT00130247|76006289|FG001|NOT COMPLETED|Overall Study||4||
59883242|NCT03678285|76006295|FG000|STARTED|Overall Study||42||
59883243|NCT03678285|76006295|FG000|Started Workout|Overall Study||40||
59883244|NCT03678285|76006295|FG000|COMPLETED|Overall Study||38||
59883245|NCT03678285|76006295|FG000|NOT COMPLETED|Overall Study||4||
59883246|NCT04032171|76006301|FG000|STARTED|Overall Study||1||
59883247|NCT04032171|76006302|FG001|STARTED|Overall Study||0||
59883248|NCT04032171|76006301|FG000|COMPLETED|Overall Study||0||
59883249|NCT04032171|76006302|FG001|COMPLETED|Overall Study||0||
59883250|NCT04032171|76006301|FG000|NOT COMPLETED|Overall Study||1||
59883251|NCT04032171|76006302|FG001|NOT COMPLETED|Overall Study||0||
59883252|NCT00137423|76006310|FG000|STARTED|Overall Study||54||
59883253|NCT00137423|76006311|FG001|STARTED|Overall Study||53||
59883254|NCT00137423|76006310|FG000|COMPLETED|Overall Study||15||
59883255|NCT00137423|76006311|FG001|COMPLETED|Overall Study||9||
59883256|NCT00137423|76006310|FG000|NOT COMPLETED|Overall Study||39||
59883257|NCT00137423|76006311|FG001|NOT COMPLETED|Overall Study||44||
59883258|NCT02786836|76006321|FG000|STARTED|Overall Study||76||
59883259|NCT02786836|76006321|FG000|Eligible Patients Enrolled Into the Stud|Overall Study||76||
59883260|NCT02786836|76006321|FG000|COMPLETED|Overall Study||62||
59883261|NCT02786836|76006321|FG000|NOT COMPLETED|Overall Study||14||
59883262|NCT00137267|76006328|FG000|STARTED|Overall Study||55||
59883263|NCT00137267|76006329|FG001|STARTED|Overall Study||47||
59518957|NCT00944021|75612843|FG002|STARTED|Overall Study||15||
59883264|NCT00137267|76006328|FG000|COMPLETED|Overall Study||40||
59883265|NCT00137267|76006329|FG001|COMPLETED|Overall Study||26||
59883266|NCT00137267|76006328|FG000|NOT COMPLETED|Overall Study||15||
59753497|NCT00566098|75872559|FG000|NOT COMPLETED|Administration of ASCT+MILs||18||
59753498|NCT00248287|75872566|FG000|STARTED|Overall Study||75||
59753499|NCT00248287|75872567|FG001|STARTED|Overall Study||79||
59753500|NCT00248287|75872566|FG000|COMPLETED|Overall Study||51||
59753501|NCT00248287|75872567|FG001|COMPLETED|Overall Study||60||
59753502|NCT00248287|75872566|FG000|NOT COMPLETED|Overall Study||24||
59753503|NCT00248287|75872567|FG001|NOT COMPLETED|Overall Study||19||
59753504|NCT00837213|75872575|FG000|STARTED|Overall Study||16||
59753505|NCT00837213|75872576|FG001|STARTED|Overall Study||17||
59753506|NCT00837213|75872575|FG000|COMPLETED|Overall Study||10||
59753507|NCT00837213|75872576|FG001|COMPLETED|Overall Study||12||
59753508|NCT00837213|75872575|FG000|NOT COMPLETED|Overall Study||6||
59883267|NCT00137267|76006329|FG001|NOT COMPLETED|Overall Study||21||
59883268|NCT00137111|76006339|FG000|STARTED|Window Therapy||0||
59883269|NCT00137111|76006340|FG001|STARTED|Window Therapy||176||
59883270|NCT00137111|76006341|FG002|STARTED|Window Therapy||180||
59883271|NCT00137111|76006342|FG003|STARTED|Window Therapy||142||
59883272|NCT00137111|76006339|FG000|COMPLETED|Window Therapy||0||
59883273|NCT00137111|76006340|FG001|COMPLETED|Window Therapy||176||
59606157|NCT01981356|75716498|FG001|STARTED|Overall Study||6||
59606158|NCT01981356|75716497|FG000|COMPLETED|Overall Study||5||
59606159|NCT01981356|75716498|FG001|COMPLETED|Overall Study||4||
59606160|NCT01981356|75716497|FG000|NOT COMPLETED|Overall Study||7||
59883274|NCT00137111|76006341|FG002|COMPLETED|Window Therapy||180||
59883275|NCT00137111|76006342|FG003|COMPLETED|Window Therapy||142||
59883276|NCT00137111|76006339|FG000|NOT COMPLETED|Window Therapy||0||
59883277|NCT00137111|76006340|FG001|NOT COMPLETED|Window Therapy||0||
59883278|NCT00137111|76006341|FG002|NOT COMPLETED|Window Therapy||0||
59883279|NCT00137111|76006342|FG003|NOT COMPLETED|Window Therapy||0||
59883280|NCT00137111|76006339|FG000|STARTED|Total Therapy||498||
59883281|NCT00137111|76006340|FG001|STARTED|Total Therapy||0||
59883282|NCT00137111|76006341|FG002|STARTED|Total Therapy||0||
59883283|NCT00137111|76006342|FG003|STARTED|Total Therapy||0||
59883284|NCT00137111|76006339|FG000|COMPLETED|Total Therapy||458||
59883285|NCT00137111|76006340|FG001|COMPLETED|Total Therapy||0||
59883286|NCT00137111|76006341|FG002|COMPLETED|Total Therapy||0||
59883287|NCT00137111|76006342|FG003|COMPLETED|Total Therapy||0||
59883288|NCT00137111|76006339|FG000|NOT COMPLETED|Total Therapy||40||
59883289|NCT00137111|76006340|FG001|NOT COMPLETED|Total Therapy||0||
59883290|NCT00137111|76006341|FG002|NOT COMPLETED|Total Therapy||0||
59883291|NCT00137111|76006342|FG003|NOT COMPLETED|Total Therapy||0||
59883292|NCT00136955|76006349|FG000|STARTED|Overall Study||41||
59883293|NCT00136955|76006349|FG000|COMPLETED|Overall Study||18||
59883294|NCT00136955|76006349|FG000|NOT COMPLETED|Overall Study||23||
59883295|NCT00135707|76006355|FG000|STARTED|Overall Study||5088||
59883296|NCT00135707|76006356|FG001|STARTED|Overall Study||5066||
59883297|NCT00135707|76006355|FG000|COMPLETED|Overall Study||4993||
59883298|NCT00135707|76006356|FG001|COMPLETED|Overall Study||4976||
59883299|NCT00135707|76006355|FG000|NOT COMPLETED|Overall Study||95||
59883300|NCT00135707|76006356|FG001|NOT COMPLETED|Overall Study||90||
59883301|NCT00129623|76006368|FG000|STARTED|Overall Study||83||
59883302|NCT00129623|76006369|FG001|STARTED|Overall Study||77||
59883303|NCT00129623|76006368|FG000|Intent-to-treat (ITT)/ Safety Population|Overall Study||83||
59883304|NCT00129623|76006369|FG001|Intent-to-treat (ITT)/ Safety Population|Overall Study||77||
59883305|NCT00129623|76006368|FG000|COMPLETED|Overall Study||73||
59606161|NCT01981356|75716498|FG001|NOT COMPLETED|Overall Study||2||
59606162|NCT01981122|75716507|FG000|STARTED|Overall Study||25||
59606163|NCT01981122|75716508|FG001|STARTED|Overall Study||27||
59606164|NCT01981122|75716507|FG000|COMPLETED|Overall Study||11||
60011487|NCT02532543|76127403|FG000|NOT COMPLETED|Overall Study||0||
60011488|NCT02532543|76127404|FG001|NOT COMPLETED|Overall Study||0||
60011489|NCT02532543|76127405|FG002|NOT COMPLETED|Overall Study||1||
60011490|NCT02532543|76127406|FG003|NOT COMPLETED|Overall Study||0||
60011491|NCT02532465|76127418|FG000|STARTED|Overall Study||25||
60011492|NCT02532465|76127419|FG001|STARTED|Overall Study||25||
60011493|NCT02532465|76127418|FG000|COMPLETED|Overall Study||24||
60011494|NCT02532465|76127419|FG001|COMPLETED|Overall Study||24||
60011495|NCT02532465|76127418|FG000|NOT COMPLETED|Overall Study||1||
60011496|NCT02532465|76127419|FG001|NOT COMPLETED|Overall Study||1||
60011497|NCT02528331|76127425|FG000|STARTED|Overall Study||2||
60011498|NCT02528331|76127425|FG000|COMPLETED|Overall Study||0||
60011499|NCT02528331|76127425|FG000|NOT COMPLETED|Overall Study||2||
60011500|NCT02654977|76127429|FG000|STARTED|Overall Study||11||
60011501|NCT02654977|76127429|FG000|COMPLETED|Overall Study||4||
60011502|NCT02654977|76127429|FG000|NOT COMPLETED|Overall Study||7||
60011503|NCT01362517|76127433|FG000|STARTED|Overall Study||131||
60011504|NCT01362517|76127433|FG000|COMPLETED|Overall Study||129||
60011505|NCT01362517|76127433|FG000|NOT COMPLETED|Overall Study||2||
59753509|NCT00837213|75872576|FG001|NOT COMPLETED|Overall Study||5||
59753510|NCT00902486|75872586|FG000|STARTED|Treatment Period (Weeks 0 Through 12)||31||
59753511|NCT00902486|75872587|FG001|STARTED|Treatment Period (Weeks 0 Through 12)||0||
59753512|NCT00902486|75872588|FG002|STARTED|Treatment Period (Weeks 0 Through 12)||0||
59753513|NCT00902486|75872589|FG003|STARTED|Treatment Period (Weeks 0 Through 12)||32||
59753514|NCT00902486|75872590|FG004|STARTED|Treatment Period (Weeks 0 Through 12)||32||
59753515|NCT00902486|75872591|FG005|STARTED|Treatment Period (Weeks 0 Through 12)||32||
59753516|NCT00902486|75872586|FG000|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||31||
59753517|NCT00902486|75872587|FG001|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||0||
59753518|NCT00902486|75872588|FG002|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||0||
59753519|NCT00902486|75872589|FG003|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||31||
59606165|NCT01981122|75716508|FG001|COMPLETED|Overall Study||7||
59606166|NCT01981122|75716507|FG000|NOT COMPLETED|Overall Study||14||
59606167|NCT01981122|75716508|FG001|NOT COMPLETED|Overall Study||20||
59606168|NCT01980888|75716516|FG000|STARTED|Overall Study||157||
59606169|NCT01980888|75716517|FG001|STARTED|Overall Study||154||
59606170|NCT01980888|75716516|FG000|COMPLETED|Overall Study|Completed = reached primary efficacy endpoint of progressive disease or death.|13||
59606171|NCT01980888|75716517|FG001|COMPLETED|Overall Study|Completed = reached primary efficacy endpoint of progressive disease or death.|21||
59606172|NCT01980888|75716516|FG000|NOT COMPLETED|Overall Study||144||
59606173|NCT01980888|75716517|FG001|NOT COMPLETED|Overall Study||133||
59606174|NCT04650282|75716525|FG000|STARTED|Overall Study||1||
59606175|NCT04650282|75716526|FG001|STARTED|Overall Study||1||
59606176|NCT04650282|75716525|FG000|COMPLETED|Overall Study||1||
59606177|NCT04650282|75716526|FG001|COMPLETED|Overall Study||1||
59606178|NCT04650282|75716525|FG000|NOT COMPLETED|Overall Study||0||
59606179|NCT04650282|75716526|FG001|NOT COMPLETED|Overall Study||0||
59606180|NCT01937364|75716534|FG000|STARTED|Overall Study||9||
59606181|NCT01937364|75716535|FG001|STARTED|Overall Study||8||
59606182|NCT01937364|75716534|FG000|COMPLETED|Overall Study||7||
59606183|NCT01937364|75716535|FG001|COMPLETED|Overall Study||7||
59606184|NCT01937364|75716534|FG000|NOT COMPLETED|Overall Study||2||
59883306|NCT00129623|76006369|FG001|COMPLETED|Overall Study||65||
59883307|NCT00129623|76006368|FG000|NOT COMPLETED|Overall Study||10||
59883308|NCT00129623|76006369|FG001|NOT COMPLETED|Overall Study||12||
59883309|NCT00129545|76006380|FG000|STARTED|Overall Study||93||
59883310|NCT00129545|76006381|FG001|STARTED|Overall Study|2:1 randomization WATCHMAN to warfarin|463||
59883311|NCT00129545|76006382|FG002|STARTED|Overall Study||244||
59883312|NCT00129545|76006380|FG000|COMPLETED|Overall Study||67||
59883313|NCT00129545|76006381|FG001|COMPLETED|Overall Study||299||
59883314|NCT00129545|76006382|FG002|COMPLETED|Overall Study||133||
59883315|NCT00129545|76006380|FG000|NOT COMPLETED|Overall Study||26||
59883316|NCT00129545|76006381|FG001|NOT COMPLETED|Overall Study||164||
59883317|NCT00129545|76006382|FG002|NOT COMPLETED|Overall Study||111||
59883318|NCT00129467|76006392|FG000|STARTED|Received Intervention||15||
59883319|NCT00129467|76006393|FG001|STARTED|Received Intervention||17||
59883320|NCT00129467|76006392|FG000|COMPLETED|Received Intervention||9||
59883321|NCT00129467|76006393|FG001|COMPLETED|Received Intervention||13||
59883322|NCT00129467|76006392|FG000|NOT COMPLETED|Received Intervention||6||
59883323|NCT00129467|76006393|FG001|NOT COMPLETED|Received Intervention||4||
59883324|NCT00129467|76006392|FG000|STARTED|Open Label for SSRI+Methylphenidate Arm|Eligible if in methylphenidate arm & had 50% reduction in Montgomery-Asberg Depression Rating score|4||
59883325|NCT00129467|76006393|FG001|STARTED|Open Label for SSRI+Methylphenidate Arm||0||
59883326|NCT00129467|76006392|FG000|COMPLETED|Open Label for SSRI+Methylphenidate Arm||2||
59883327|NCT00129467|76006393|FG001|COMPLETED|Open Label for SSRI+Methylphenidate Arm||0||
59883328|NCT00129467|76006392|FG000|NOT COMPLETED|Open Label for SSRI+Methylphenidate Arm||2||
59883329|NCT00129467|76006393|FG001|NOT COMPLETED|Open Label for SSRI+Methylphenidate Arm||0||
59883330|NCT00129311|76006401|FG000|STARTED|Overall Study||51||
59883331|NCT00129311|76006402|FG001|STARTED|Overall Study||50||
59883332|NCT00129311|76006401|FG000|COMPLETED|Overall Study||39||
59883333|NCT00129311|76006402|FG001|COMPLETED|Overall Study||31||
59883334|NCT00129311|76006401|FG000|NOT COMPLETED|Overall Study||12||
59883335|NCT00129311|76006402|FG001|NOT COMPLETED|Overall Study||19||
59883336|NCT00133991|76006408|FG000|STARTED|Overall Study||21||
59883337|NCT00133991|76006408|FG000|COMPLETED|Overall Study||17||
59883338|NCT00133991|76006408|FG000|NOT COMPLETED|Overall Study||4||
59883339|NCT02784106|76006414|FG000|STARTED|Double-Blind Treatment Period (12 Weeks)||32||
59883340|NCT02784106|76006415|FG001|STARTED|Double-Blind Treatment Period (12 Weeks)||33||
59883341|NCT02784106|76006416|FG002|STARTED|Double-Blind Treatment Period (12 Weeks)||0||
59883342|NCT02784106|76006417|FG003|STARTED|Double-Blind Treatment Period (12 Weeks)||0||
59883343|NCT02784106|76006414|FG000|COMPLETED|Double-Blind Treatment Period (12 Weeks)||24||
59883344|NCT02784106|76006415|FG001|COMPLETED|Double-Blind Treatment Period (12 Weeks)||27||
59883345|NCT02784106|76006416|FG002|COMPLETED|Double-Blind Treatment Period (12 Weeks)||0||
59883346|NCT02784106|76006417|FG003|COMPLETED|Double-Blind Treatment Period (12 Weeks)||0||
59883347|NCT02784106|76006414|FG000|NOT COMPLETED|Double-Blind Treatment Period (12 Weeks)||8||
59883348|NCT02784106|76006415|FG001|NOT COMPLETED|Double-Blind Treatment Period (12 Weeks)||6||
59883349|NCT02784106|76006416|FG002|NOT COMPLETED|Double-Blind Treatment Period (12 Weeks)||0||
59883350|NCT02784106|76006417|FG003|NOT COMPLETED|Double-Blind Treatment Period (12 Weeks)||0||
59883351|NCT02784106|76006414|FG000|STARTED|Open-Label Extension Period (26 Weeks)||0||
59883352|NCT02784106|76006415|FG001|STARTED|Open-Label Extension Period (26 Weeks)||0||
59883353|NCT02784106|76006416|FG002|STARTED|Open-Label Extension Period (26 Weeks)||18||
59883354|NCT02784106|76006417|FG003|STARTED|Open-Label Extension Period (26 Weeks)||21||
59883355|NCT02784106|76006414|FG000|COMPLETED|Open-Label Extension Period (26 Weeks)||0||
59883356|NCT02784106|76006415|FG001|COMPLETED|Open-Label Extension Period (26 Weeks)||0||
59883357|NCT02784106|76006416|FG002|COMPLETED|Open-Label Extension Period (26 Weeks)||15||
59883358|NCT02784106|76006417|FG003|COMPLETED|Open-Label Extension Period (26 Weeks)||19||
59883359|NCT02784106|76006414|FG000|NOT COMPLETED|Open-Label Extension Period (26 Weeks)||0||
59883360|NCT02784106|76006415|FG001|NOT COMPLETED|Open-Label Extension Period (26 Weeks)||0||
59883361|NCT02784106|76006416|FG002|NOT COMPLETED|Open-Label Extension Period (26 Weeks)||3||
59883362|NCT02784106|76006417|FG003|NOT COMPLETED|Open-Label Extension Period (26 Weeks)||2||
59883363|NCT02785900|76006428|FG000|STARTED|Overall Study||117||
59883364|NCT02785900|76006429|FG001|STARTED|Overall Study||123||
59883365|NCT02785900|76006428|FG000|COMPLETED|Overall Study||0||
59883366|NCT02785900|76006429|FG001|COMPLETED|Overall Study||0||
59883367|NCT02785900|76006428|FG000|NOT COMPLETED|Overall Study||117||
59883368|NCT02785900|76006429|FG001|NOT COMPLETED|Overall Study||123||
59883369|NCT00127205|76006438|FG000|STARTED|Overall Study||2262||
59883370|NCT00127205|76006439|FG001|STARTED|Overall Study||2268||
59883371|NCT00127205|76006440|FG002|STARTED|Overall Study||1567||
59883372|NCT00127205|76006438|FG000|COMPLETED|Overall Study||1433||
59883373|NCT00127205|76006439|FG001|COMPLETED|Overall Study||1295||
59883374|NCT00127205|76006440|FG002|COMPLETED|Overall Study||955||
59883375|NCT00127205|76006438|FG000|NOT COMPLETED|Overall Study||829||
59883376|NCT00127205|76006439|FG001|NOT COMPLETED|Overall Study||973||
59883377|NCT00127205|76006440|FG002|NOT COMPLETED|Overall Study||612||
59883378|NCT02785588|76006450|FG000|STARTED|Phase 1: Initial Feasibility Assessment||49||
59883379|NCT02785588|76006450|FG000|COMPLETED|Phase 1: Initial Feasibility Assessment||47||
59883380|NCT02785588|76006450|FG000|NOT COMPLETED|Phase 1: Initial Feasibility Assessment||2||
59883381|NCT02785588|76006450|FG000|STARTED|Phase2 Controlled Image &Data Collection|Phase 2 participants represent newly enrolled participants.|5||
59883382|NCT02785588|76006450|FG000|COMPLETED|Phase2 Controlled Image &Data Collection||5||
59883383|NCT02785588|76006450|FG000|NOT COMPLETED|Phase2 Controlled Image &Data Collection||0||
59883384|NCT03670641|76006454|FG000|STARTED|Overall Study||10||
59883385|NCT03670641|76006454|FG000|COMPLETED|Overall Study|3 participants were lost to follow up by 12 months|7||
59883386|NCT03670641|76006454|FG000|NOT COMPLETED|Overall Study||3||
59883387|NCT04029519|76006461|FG000|STARTED|Overall Study||84||
59883388|NCT04029519|76006461|FG000|COMPLETED|Overall Study||79||
59883389|NCT04029519|76006461|FG000|NOT COMPLETED|Overall Study||5||
59883390|NCT03669861|76006465|FG000|STARTED|Overall Study||10||
59883391|NCT03669861|76006465|FG000|COMPLETED|Overall Study||3||
59883392|NCT03669861|76006465|FG000|NOT COMPLETED|Overall Study||7||
59883393|NCT00127127|76006473|FG000|STARTED|Overall Study||3||
59883394|NCT00127127|76006474|FG001|STARTED|Overall Study||6||
59883395|NCT00127127|76006475|FG002|STARTED|Overall Study||3||
59883396|NCT00127127|76006476|FG003|STARTED|Overall Study||6||
59883397|NCT00127127|76006473|FG000|COMPLETED|Overall Study||2||
59883398|NCT00127127|76006474|FG001|COMPLETED|Overall Study||1||
59883399|NCT00127127|76006475|FG002|COMPLETED|Overall Study||3||
59883400|NCT00127127|76006476|FG003|COMPLETED|Overall Study||3||
59883401|NCT00127127|76006473|FG000|NOT COMPLETED|Overall Study||1||
59883402|NCT00127127|76006474|FG001|NOT COMPLETED|Overall Study||5||
59883403|NCT00127127|76006475|FG002|NOT COMPLETED|Overall Study||0||
59883404|NCT00127127|76006476|FG003|NOT COMPLETED|Overall Study||3||
59883405|NCT03669549|76006513|FG000|STARTED|Overall Study||15||
59883406|NCT03669549|76006513|FG000|COMPLETED|Overall Study||9||
59883407|NCT03669549|76006513|FG000|NOT COMPLETED|Overall Study||6||
59883408|NCT00126659|76006524|FG000|STARTED|Overall Study||3||
59883409|NCT00126659|76006525|FG001|STARTED|Overall Study||3||
59883410|NCT00126659|76006526|FG002|STARTED|Overall Study||4||
59883411|NCT00126659|76006524|FG000|COMPLETED|Overall Study||3||
59883412|NCT00126659|76006525|FG001|COMPLETED|Overall Study||3||
59883413|NCT00126659|76006526|FG002|COMPLETED|Overall Study||2||
59883414|NCT00126659|76006524|FG000|NOT COMPLETED|Overall Study||0||
59883415|NCT00126659|76006525|FG001|NOT COMPLETED|Overall Study||0||
59883416|NCT00126659|76006526|FG002|NOT COMPLETED|Overall Study||2||
59883417|NCT03669081|76006534|FG000|STARTED|Overall Study||34||
60011506|NCT01362439|76127440|FG000|STARTED|Overall Study||133||
59883418|NCT03669081|76006535|FG001|STARTED|Overall Study||30||
59883419|NCT03669081|76006534|FG000|COMPLETED|Overall Study||33||
59883420|NCT03669081|76006535|FG001|COMPLETED|Overall Study||29||
59883421|NCT03669081|76006534|FG000|NOT COMPLETED|Overall Study||1||
59883422|NCT03669081|76006535|FG001|NOT COMPLETED|Overall Study||1||
59883423|NCT03667053|76006544|FG000|STARTED|Overall Study||21|Randomized subjects|
59883424|NCT03667053|76006545|FG001|STARTED|Overall Study||11|Randomized subjects|
59883425|NCT03667053|76006546|FG002|STARTED|Overall Study||10|Randomized subjects|
59883426|NCT03667053|76006544|FG000|Randomized and Treated|Overall Study||20||
59883427|NCT03667053|76006545|FG001|Randomized and Treated|Overall Study||11||
59883428|NCT03667053|76006546|FG002|Randomized and Treated|Overall Study||10||
59883429|NCT03667053|76006544|FG000|COMPLETED|Overall Study||20||
59883430|NCT03667053|76006545|FG001|COMPLETED|Overall Study||11||
59883431|NCT03667053|76006546|FG002|COMPLETED|Overall Study||10||
59883432|NCT03667053|76006544|FG000|NOT COMPLETED|Overall Study||1||
59883433|NCT03667053|76006545|FG001|NOT COMPLETED|Overall Study||0||
59883434|NCT03667053|76006546|FG002|NOT COMPLETED|Overall Study||0||
59883435|NCT03631407|76006563|FG000|STARTED|Overall Study||21||
59883436|NCT03631407|76006564|FG001|STARTED|Overall Study||20||
59883437|NCT03631407|76006563|FG000|Treated|Overall Study||20||
59883438|NCT03631407|76006564|FG001|Treated|Overall Study||20||
59883439|NCT03631407|76006563|FG000|COMPLETED|Overall Study||1||
59883440|NCT03631407|76006564|FG001|COMPLETED|Overall Study||0||
59883441|NCT03631407|76006563|FG000|NOT COMPLETED|Overall Study||20||
59883442|NCT03631407|76006564|FG001|NOT COMPLETED|Overall Study||20||
59883443|NCT04019704|76006572|FG000|STARTED|Overall Study||163||
59883444|NCT04019704|76006573|FG001|STARTED|Overall Study||164||
59883445|NCT04019704|76006572|FG000|COMPLETED|Overall Study||123||
59883446|NCT04019704|76006573|FG001|COMPLETED|Overall Study||147||
59883447|NCT04019704|76006572|FG000|NOT COMPLETED|Overall Study||40||
59883448|NCT04019704|76006573|FG001|NOT COMPLETED|Overall Study||17||
59883449|NCT03630393|76006581|FG000|STARTED|Overall Study||68||
59883450|NCT03630393|76006582|FG001|STARTED|Overall Study||71||
59883451|NCT03630393|76006581|FG000|COMPLETED|Overall Study||67||
59883452|NCT03630393|76006582|FG001|COMPLETED|Overall Study||71||
59883453|NCT03630393|76006581|FG000|NOT COMPLETED|Overall Study||1||
59883454|NCT03630393|76006582|FG001|NOT COMPLETED|Overall Study||0||
59606185|NCT01937364|75716535|FG001|NOT COMPLETED|Overall Study||1||
59606186|NCT01979952|75716543|FG000|STARTED|Overall Study||56||
59606187|NCT01979952|75716544|FG001|STARTED|Overall Study||57||
59606188|NCT01979952|75716543|FG000|COMPLETED|Overall Study||48||
59606189|NCT01979952|75716544|FG001|COMPLETED|Overall Study||51||
59606190|NCT01979952|75716543|FG000|NOT COMPLETED|Overall Study||8||
59606191|NCT01979952|75716544|FG001|NOT COMPLETED|Overall Study||6||
59606192|NCT01999218|75716553|FG000|STARTED|Overall Study||448||
59606193|NCT01999218|75716554|FG001|STARTED|Overall Study||441||
59606194|NCT01999218|75716555|FG002|STARTED|Overall Study||437||
59606195|NCT01999218|75716553|FG000|Treated|Overall Study||448||
59606196|NCT01999218|75716554|FG001|Treated|Overall Study||440||
59606197|NCT01999218|75716555|FG002|Treated|Overall Study||437||
59606198|NCT01999218|75716553|FG000|Site Issue|Overall Study||445|Treated (excluding 1 trial site)|
59606199|NCT01999218|75716554|FG001|Site Issue|Overall Study||435|Treated (excluding 1 trial site)|
59606200|NCT01999218|75716555|FG002|Site Issue|Overall Study||435|Treated (excluding 1 trial site)|
59606201|NCT01999218|75716553|FG000|COMPLETED|Overall Study||339||
59606202|NCT01999218|75716554|FG001|COMPLETED|Overall Study||340||
59606203|NCT01999218|75716555|FG002|COMPLETED|Overall Study||327||
59606204|NCT01999218|75716553|FG000|NOT COMPLETED|Overall Study||109||
60011507|NCT01362439|76127440|FG000|COMPLETED|Overall Study||118||
60011508|NCT01362439|76127440|FG000|NOT COMPLETED|Overall Study||15||
60011509|NCT02653495|76127447|FG000|STARTED|Overall Study||15||
60011510|NCT02653495|76127448|FG001|STARTED|Overall Study||2||
60011511|NCT02653495|76127447|FG000|COMPLETED|Overall Study||3||
60011512|NCT02653495|76127448|FG001|COMPLETED|Overall Study||2||
60011513|NCT02653495|76127447|FG000|NOT COMPLETED|Overall Study||12||
60011514|NCT02653495|76127448|FG001|NOT COMPLETED|Overall Study||0||
60011515|NCT01675141|76127454|FG000|STARTED|Overall Study||11||
60011516|NCT01675141|76127454|FG000|COMPLETED|Overall Study||0||
60011517|NCT01675141|76127454|FG000|NOT COMPLETED|Overall Study||11||
60011518|NCT04497883|76127460|FG000|STARTED|Treatment Period 1 (2 Days)||12||
60011519|NCT04497883|76127461|FG001|STARTED|Treatment Period 1 (2 Days)||12||
60011520|NCT04497883|76127462|FG002|STARTED|Treatment Period 1 (2 Days)||0||
59606205|NCT01999218|75716554|FG001|NOT COMPLETED|Overall Study||101||
59883455|NCT03983980|76006590|FG000|STARTED|Overall Study||343||
59883456|NCT03983980|76006591|FG001|STARTED|Overall Study||172||
59883457|NCT03983980|76006590|FG000|COMPLETED|Overall Study||282||
59883458|NCT03983980|76006591|FG001|COMPLETED|Overall Study||142||
59883459|NCT03983980|76006590|FG000|NOT COMPLETED|Overall Study||61||
59883460|NCT03983980|76006591|FG001|NOT COMPLETED|Overall Study||30||
59883461|NCT03628599|76006599|FG000|STARTED|Overall Study||18||
59883462|NCT03628599|76006600|FG001|STARTED|Overall Study||19||
59883463|NCT03628599|76006599|FG000|COMPLETED|Overall Study||18||
59883464|NCT03628599|76006600|FG001|COMPLETED|Overall Study||18||
59883465|NCT03628599|76006599|FG000|NOT COMPLETED|Overall Study||0||
59883466|NCT03628599|76006600|FG001|NOT COMPLETED|Overall Study||1||
59883467|NCT03875950|76006612|FG000|STARTED|Overall Study||125||
59883468|NCT03875950|76006613|FG001|STARTED|Overall Study||107||
59883469|NCT03875950|76006612|FG000|COMPLETED|Overall Study||125||
59883470|NCT03875950|76006613|FG001|COMPLETED|Overall Study||107||
59883471|NCT03875950|76006612|FG000|NOT COMPLETED|Overall Study||0||
59883472|NCT03875950|76006613|FG001|NOT COMPLETED|Overall Study||0||
59883473|NCT03627195|76006626|FG000|STARTED|Overall Study||6||
59883474|NCT03627195|76006627|FG001|STARTED|Overall Study||6||
59883475|NCT03627195|76006628|FG002|STARTED|Overall Study||6||
59883476|NCT03627195|76006629|FG003|STARTED|Overall Study||6||
59883477|NCT03627195|76006630|FG004|STARTED|Overall Study||6||
59883478|NCT03627195|76006631|FG005|STARTED|Overall Study||10||
59883479|NCT03627195|76006626|FG000|COMPLETED|Overall Study||5||
59883480|NCT03627195|76006627|FG001|COMPLETED|Overall Study||6||
59883481|NCT03627195|76006628|FG002|COMPLETED|Overall Study||6||
59883482|NCT03627195|76006629|FG003|COMPLETED|Overall Study||6||
59883483|NCT03627195|76006630|FG004|COMPLETED|Overall Study||6||
59883484|NCT03627195|76006631|FG005|COMPLETED|Overall Study||10||
59883485|NCT03627195|76006626|FG000|NOT COMPLETED|Overall Study||1||
59883486|NCT03627195|76006627|FG001|NOT COMPLETED|Overall Study||0||
59883487|NCT03627195|76006628|FG002|NOT COMPLETED|Overall Study||0||
59883488|NCT03627195|76006629|FG003|NOT COMPLETED|Overall Study||0||
59883489|NCT03627195|76006630|FG004|NOT COMPLETED|Overall Study||0||
59883490|NCT03627195|76006631|FG005|NOT COMPLETED|Overall Study||0||
59883491|NCT00126581|76006647|FG000|STARTED|Overall Study||81||
59883492|NCT00126581|76006648|FG001|STARTED|Overall Study||100||
59883493|NCT00126581|76006647|FG000|COMPLETED|Overall Study||68||
59883494|NCT00126581|76006648|FG001|COMPLETED|Overall Study||80||
59883495|NCT00126581|76006647|FG000|NOT COMPLETED|Overall Study||13||
59883496|NCT00126581|76006648|FG001|NOT COMPLETED|Overall Study||20||
59883497|NCT03704584|76006658|FG000|STARTED|Overall Study||36||43
59883498|NCT03704584|76006659|FG001|STARTED|Overall Study||26||31
59883499|NCT03704584|76006658|FG000|COMPLETED|Overall Study||35||42
59753520|NCT00902486|75872590|FG004|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||32||
59753521|NCT00902486|75872591|FG005|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||31||
59753522|NCT00902486|75872586|FG000|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||31||
59753523|NCT00902486|75872587|FG001|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||0||
59883500|NCT03704584|76006659|FG001|COMPLETED|Overall Study||26||31
59883501|NCT03704584|76006658|FG000|NOT COMPLETED|Overall Study||1||1
59883502|NCT03704584|76006659|FG001|NOT COMPLETED|Overall Study||0||0
59883503|NCT03662997|76006669|FG000|STARTED|Overall Study||11||
59606206|NCT01999218|75716555|FG002|NOT COMPLETED|Overall Study||110||
59606207|NCT01937130|75716567|FG000|STARTED|Overall Study||5||
59606208|NCT01937130|75716568|FG001|STARTED|Overall Study||7||
59606209|NCT01937130|75716569|FG002|STARTED|Overall Study||5||
59606210|NCT01937130|75716570|FG003|STARTED|Overall Study||4||
59606211|NCT01937130|75716567|FG000|COMPLETED|Overall Study||0||
59606212|NCT01937130|75716568|FG001|COMPLETED|Overall Study||3||
59606213|NCT01937130|75716569|FG002|COMPLETED|Overall Study||2||
59606214|NCT01937130|75716570|FG003|COMPLETED|Overall Study||2||
59883504|NCT03662997|76006670|FG001|STARTED|Overall Study||10||
59883505|NCT03662997|76006671|FG002|STARTED|Overall Study||11||
59518958|NCT00944021|75612844|FG003|STARTED|Overall Study||16||
59518959|NCT00944021|75612845|FG004|STARTED|Overall Study||8||
59518960|NCT00944021|75612841|FG000|COMPLETED|Overall Study||14||
59518961|NCT00944021|75612842|FG001|COMPLETED|Overall Study||15||
59518962|NCT00944021|75612843|FG002|COMPLETED|Overall Study||15||
59518963|NCT00944021|75612844|FG003|COMPLETED|Overall Study||16||
59518964|NCT00944021|75612845|FG004|COMPLETED|Overall Study||8||
59518965|NCT00944021|75612841|FG000|NOT COMPLETED|Overall Study||1||
59518966|NCT00944021|75612842|FG001|NOT COMPLETED|Overall Study||0||
59518967|NCT00944021|75612843|FG002|NOT COMPLETED|Overall Study||0||
59518968|NCT00944021|75612844|FG003|NOT COMPLETED|Overall Study||0||
59518969|NCT00944021|75612845|FG004|NOT COMPLETED|Overall Study||0||
59518970|NCT03393754|75612859|FG000|STARTED|Overall Study||811||
59606215|NCT01937130|75716567|FG000|NOT COMPLETED|Overall Study||5||
59753524|NCT00902486|75872588|FG002|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||0||
59883506|NCT03662997|76006672|FG003|STARTED|Overall Study||8||
59883507|NCT03662997|76006669|FG000|COMPLETED|Overall Study||11||
59883508|NCT03662997|76006670|FG001|COMPLETED|Overall Study||8||
59883509|NCT03662997|76006671|FG002|COMPLETED|Overall Study||11||
59883510|NCT03662997|76006672|FG003|COMPLETED|Overall Study||8||
59883511|NCT03662997|76006669|FG000|NOT COMPLETED|Overall Study||0||
59883512|NCT03662997|76006670|FG001|NOT COMPLETED|Overall Study||2||
59883513|NCT03662997|76006671|FG002|NOT COMPLETED|Overall Study||0||
59883514|NCT03662997|76006672|FG003|NOT COMPLETED|Overall Study||0||
59883515|NCT03648879|76006684|FG000|STARTED|Overall Study||37||
59883516|NCT03648879|76006684|FG000|COMPLETED|Overall Study||36||
59883517|NCT03648879|76006684|FG000|NOT COMPLETED|Overall Study||1||
59883518|NCT03647709|76006688|FG000|STARTED|Overall Study||400||
59883519|NCT03647709|76006688|FG000|COMPLETED|Overall Study||386||
59883520|NCT03647709|76006688|FG000|NOT COMPLETED|Overall Study||14||
59883521|NCT03661983|76006694|FG000|STARTED|Open Label Stabilization Phase||36||
59883522|NCT03661983|76006695|FG001|STARTED|Open Label Stabilization Phase||0||
59883523|NCT03661983|76006696|FG002|STARTED|Open Label Stabilization Phase||0||
59883524|NCT03661983|76006697|FG003|STARTED|Open Label Stabilization Phase||0||
59883525|NCT03661983|76006694|FG000|COMPLETED|Open Label Stabilization Phase||25||
59883526|NCT03661983|76006695|FG001|COMPLETED|Open Label Stabilization Phase||0||
59883527|NCT03661983|76006696|FG002|COMPLETED|Open Label Stabilization Phase||0||
59883528|NCT03661983|76006697|FG003|COMPLETED|Open Label Stabilization Phase||0||
59883529|NCT03661983|76006694|FG000|NOT COMPLETED|Open Label Stabilization Phase||11||
59883530|NCT03661983|76006695|FG001|NOT COMPLETED|Open Label Stabilization Phase||0||
59883531|NCT03661983|76006696|FG002|NOT COMPLETED|Open Label Stabilization Phase||0||
59883532|NCT03661983|76006697|FG003|NOT COMPLETED|Open Label Stabilization Phase||0||
59883533|NCT03661983|76006694|FG000|STARTED|Double-blind Randomized Phase||0||
59753525|NCT00902486|75872589|FG003|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||31||
59753526|NCT00902486|75872590|FG004|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||32||
59753527|NCT00902486|75872591|FG005|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||30||
59753528|NCT00902486|75872586|FG000|COMPLETED|Treatment Period (Weeks 0 Through 12)||29|Participants completing Week 12|
59753529|NCT00902486|75872587|FG001|COMPLETED|Treatment Period (Weeks 0 Through 12)||0|Participants completing Week 12|
59753530|NCT00902486|75872588|FG002|COMPLETED|Treatment Period (Weeks 0 Through 12)||0|Participants completing Week 12|
59753531|NCT00902486|75872589|FG003|COMPLETED|Treatment Period (Weeks 0 Through 12)||29|Participants completing Week 12|
59753532|NCT00902486|75872590|FG004|COMPLETED|Treatment Period (Weeks 0 Through 12)||30|Participants completing Week 12|
59753533|NCT00902486|75872591|FG005|COMPLETED|Treatment Period (Weeks 0 Through 12)||27|Participants completing Week 12|
59753534|NCT00902486|75872586|FG000|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||2||
59753535|NCT00902486|75872587|FG001|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||0||
59883534|NCT03661983|76006695|FG001|STARTED|Double-blind Randomized Phase||9||
59883535|NCT03661983|76006696|FG002|STARTED|Double-blind Randomized Phase||8||
59883536|NCT03661983|76006697|FG003|STARTED|Double-blind Randomized Phase||8||
59883537|NCT03661983|76006694|FG000|COMPLETED|Double-blind Randomized Phase||0||
59883538|NCT03661983|76006695|FG001|COMPLETED|Double-blind Randomized Phase||7||
59883539|NCT03661983|76006696|FG002|COMPLETED|Double-blind Randomized Phase||7||
59883540|NCT03661983|76006697|FG003|COMPLETED|Double-blind Randomized Phase||0||
59883541|NCT03661983|76006694|FG000|NOT COMPLETED|Double-blind Randomized Phase||0||
59883542|NCT03661983|76006695|FG001|NOT COMPLETED|Double-blind Randomized Phase||2||
59883543|NCT03661983|76006696|FG002|NOT COMPLETED|Double-blind Randomized Phase||1||
59883544|NCT03661983|76006697|FG003|NOT COMPLETED|Double-blind Randomized Phase||8||
59883545|NCT02783170|76006708|FG000|STARTED|Overall Study||43||
59883546|NCT02783170|76006709|FG001|STARTED|Overall Study||38||
59883547|NCT02783170|76006708|FG000|Safety Population|Overall Study|Added subject randomized to sequential but got simultaneous.|42||
59883548|NCT02783170|76006709|FG001|Safety Population|Overall Study|Excluded sub. randomized but not vaccinated. Excluded sub. randomized to seq. but got simultaneous.|38||
59883549|NCT02783170|76006708|FG000|COMPLETED|Overall Study||42||
59883550|NCT02783170|76006709|FG001|COMPLETED|Overall Study||38||
59883551|NCT02783170|76006708|FG000|NOT COMPLETED|Overall Study||1||
59883552|NCT02783170|76006709|FG001|NOT COMPLETED|Overall Study||0||
59883553|NCT03646305|76006720|FG000|STARTED|Overall Study||32||
59883554|NCT03646305|76006721|FG001|STARTED|Overall Study||35||
59883555|NCT03646305|76006722|FG002|STARTED|Overall Study||33||
59606216|NCT01937130|75716568|FG001|NOT COMPLETED|Overall Study||4||
59606217|NCT01937130|75716569|FG002|NOT COMPLETED|Overall Study||3||
59606218|NCT01937130|75716570|FG003|NOT COMPLETED|Overall Study||2||
59606219|NCT01936974|75716582|FG000|STARTED|Overall Study||2||
59606220|NCT01936974|75716583|FG001|STARTED|Overall Study||5||
59606221|NCT01936974|75716582|FG000|COMPLETED|Overall Study||0||
59753536|NCT00902486|75872588|FG002|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||0||
59753537|NCT00902486|75872589|FG003|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||3||
59753538|NCT00902486|75872590|FG004|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||2||
59753539|NCT00902486|75872591|FG005|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||5||
59753540|NCT00902486|75872586|FG000|STARTED|Extension Period (Weeks 12 Through 24)||0||
59753541|NCT00902486|75872587|FG001|STARTED|Extension Period (Weeks 12 Through 24)||14||
59753542|NCT00902486|75872588|FG002|STARTED|Extension Period (Weeks 12 Through 24)||15||
59753543|NCT00902486|75872589|FG003|STARTED|Extension Period (Weeks 12 Through 24)||29||
59753544|NCT00902486|75872590|FG004|STARTED|Extension Period (Weeks 12 Through 24)||30||
59883556|NCT03646305|76006723|FG003|STARTED|Overall Study||33||
59883557|NCT03646305|76006720|FG000|Received Treatment|Overall Study||31||
59606222|NCT01936974|75716583|FG001|COMPLETED|Overall Study||0||
59606223|NCT01936974|75716582|FG000|NOT COMPLETED|Overall Study||2||
59753545|NCT00902486|75872591|FG005|STARTED|Extension Period (Weeks 12 Through 24)||27||
59753546|NCT00902486|75872586|FG000|COMPLETED|Extension Period (Weeks 12 Through 24)||0||
59883558|NCT03646305|76006721|FG001|Received Treatment|Overall Study||35||
59883559|NCT03646305|76006722|FG002|Received Treatment|Overall Study||32||
59883560|NCT03646305|76006723|FG003|Received Treatment|Overall Study||32||
59883561|NCT03646305|76006720|FG000|No Treatment Recieved|Overall Study||1||
59606224|NCT01936974|75716583|FG001|NOT COMPLETED|Overall Study||5||
59753547|NCT00902486|75872587|FG001|COMPLETED|Extension Period (Weeks 12 Through 24)||14||
59883562|NCT03646305|76006721|FG001|No Treatment Recieved|Overall Study||0||
59606225|NCT01959516|75716589|FG000|STARTED|Epoch 1||63||
59606226|NCT01959516|75716590|FG001|STARTED|Epoch 1||63||
59606227|NCT01959516|75716589|FG000|Safety Population|Epoch 1||62||
59606228|NCT01959516|75716590|FG001|Safety Population|Epoch 1||62||
59606229|NCT01959516|75716589|FG000|ITT Population|Epoch 1||62||
59606230|NCT01959516|75716590|FG001|ITT Population|Epoch 1||62||
59606231|NCT01959516|75716589|FG000|COMPLETED|Epoch 1||53||
59606232|NCT01959516|75716590|FG001|COMPLETED|Epoch 1||58||
59606233|NCT01959516|75716589|FG000|NOT COMPLETED|Epoch 1||10||
59606234|NCT01959516|75716590|FG001|NOT COMPLETED|Epoch 1||5||
59606235|NCT01959516|75716589|FG000|STARTED|Epoch 2||63||
59606236|NCT01959516|75716590|FG001|STARTED|Epoch 2||63||
59606237|NCT01959516|75716589|FG000|COMPLETED|Epoch 2||61||
59606238|NCT01959516|75716590|FG001|COMPLETED|Epoch 2||62||
59606239|NCT01959516|75716589|FG000|NOT COMPLETED|Epoch 2||2||
59753548|NCT00902486|75872588|FG002|COMPLETED|Extension Period (Weeks 12 Through 24)||13||
59753549|NCT00902486|75872589|FG003|COMPLETED|Extension Period (Weeks 12 Through 24)||27||
59753550|NCT00902486|75872590|FG004|COMPLETED|Extension Period (Weeks 12 Through 24)||29||
59606240|NCT01959516|75716590|FG001|NOT COMPLETED|Epoch 2||1||
59753551|NCT00902486|75872591|FG005|COMPLETED|Extension Period (Weeks 12 Through 24)||24||
59753552|NCT00902486|75872586|FG000|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||0||
59606241|NCT01979016|75716598|FG000|STARTED|Overall Study||27||
59606242|NCT01979016|75716599|FG001|STARTED|Overall Study||27||
59606243|NCT01979016|75716598|FG000|COMPLETED|Overall Study||25||
59606244|NCT01979016|75716599|FG001|COMPLETED|Overall Study||26||
59606245|NCT01979016|75716598|FG000|NOT COMPLETED|Overall Study||2||
59606246|NCT01979016|75716599|FG001|NOT COMPLETED|Overall Study||1||
59606247|NCT01935336|75716609|FG000|STARTED|Overall Study|Only one subject was treated due to the black box warning RE: ponatinib-associated vascular issues. The protocol was modified with additional inclusion and exclusion criteria, which severely limited the number of cases treated with the drug|6||
59606248|NCT01935336|75716610|FG001|STARTED|Overall Study|no subjects were treated in this arm|3||
59613488|NCT01684878|75724613|FG003|Participants Mis-randomized|Part 2: Randomized Phase||0||
59613489|NCT01684878|75724610|FG000|COMPLETED|Part 2: Randomized Phase||0||
59883563|NCT03646305|76006722|FG002|No Treatment Recieved|Overall Study||1||
59753553|NCT00902486|75872587|FG001|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||0||
59753554|NCT00902486|75872588|FG002|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||2||
59753555|NCT00902486|75872589|FG003|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||2||
59753556|NCT00902486|75872590|FG004|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||1||
59753557|NCT00902486|75872591|FG005|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||3||
59753558|NCT00902486|75872586|FG000|STARTED|Follow-up (After Week 24)||0|Number of participants completed treatment|
59753559|NCT00902486|75872587|FG001|STARTED|Follow-up (After Week 24)||14|Number of participants completed treatment|
59753560|NCT00902486|75872588|FG002|STARTED|Follow-up (After Week 24)||13|Number of participants completed treatment|
59753561|NCT00902486|75872589|FG003|STARTED|Follow-up (After Week 24)||27|Number of participants completed treatment|
59753562|NCT00902486|75872590|FG004|STARTED|Follow-up (After Week 24)||29|Number of participants completed treatment|
59753563|NCT00902486|75872591|FG005|STARTED|Follow-up (After Week 24)||24|Number of participants completed treatment|
59762527|NCT02379247|75882298|FG003|COMPLETED|Overall Study||30||
59883564|NCT03646305|76006723|FG003|No Treatment Recieved|Overall Study||1||
59883565|NCT03646305|76006720|FG000|COMPLETED|Overall Study||27||
59883566|NCT03646305|76006721|FG001|COMPLETED|Overall Study||33||
59883567|NCT03646305|76006722|FG002|COMPLETED|Overall Study||31||
59883568|NCT03646305|76006723|FG003|COMPLETED|Overall Study||31||
59883569|NCT03646305|76006720|FG000|NOT COMPLETED|Overall Study||5||
59883570|NCT03646305|76006721|FG001|NOT COMPLETED|Overall Study||2||
59883571|NCT03646305|76006722|FG002|NOT COMPLETED|Overall Study||2||
59883572|NCT03646305|76006723|FG003|NOT COMPLETED|Overall Study||2||
59883573|NCT02782780|76006739|FG000|STARTED|Overall Study||46||
59883574|NCT02782780|76006740|FG001|STARTED|Overall Study||39||
59883575|NCT02782780|76006739|FG000|COMPLETED|Overall Study||39||
59883576|NCT02782780|76006740|FG001|COMPLETED|Overall Study||32||
59883577|NCT02782780|76006739|FG000|NOT COMPLETED|Overall Study||7||
59883578|NCT02782780|76006740|FG001|NOT COMPLETED|Overall Study||7||
59883579|NCT03396952|76006746|FG000|STARTED|Overall Study||27||
59883580|NCT03396952|76006746|FG000|COMPLETED|Overall Study||27||
59883581|NCT03396952|76006746|FG000|NOT COMPLETED|Overall Study||0||
59883582|NCT00126503|76006752|FG000|STARTED|Overall Study||48||
59883583|NCT00126503|76006753|FG001|STARTED|Overall Study||21||
59883584|NCT00126503|76006752|FG000|COMPLETED|Overall Study||1||
59883585|NCT00126503|76006753|FG001|COMPLETED|Overall Study||0||
59883586|NCT00126503|76006752|FG000|NOT COMPLETED|Overall Study||47||
59883587|NCT00126503|76006753|FG001|NOT COMPLETED|Overall Study||21||
59883588|NCT00126425|76006765|FG000|STARTED|Overall Study||539||
59883589|NCT00126425|76006766|FG001|STARTED|Overall Study||48||
59883590|NCT00126425|76006765|FG000|COMPLETED|Overall Study||498||
59883591|NCT00126425|76006766|FG001|COMPLETED|Overall Study||37||
59883592|NCT00126425|76006765|FG000|NOT COMPLETED|Overall Study||41||
59883593|NCT00126425|76006766|FG001|NOT COMPLETED|Overall Study||11||
59883594|NCT00126191|76006774|FG000|STARTED|Overall Study||2||
59883595|NCT00126191|76006775|FG001|STARTED|Overall Study||8||
59883596|NCT00126191|76006774|FG000|COMPLETED|Overall Study||2||
59883597|NCT00126191|76006775|FG001|COMPLETED|Overall Study|1 pt off study during cycle 1 due to toxicity|6||
59883598|NCT00126191|76006774|FG000|NOT COMPLETED|Overall Study||0||
59753564|NCT00902486|75872586|FG000|Safety Evaluable Participants|Follow-up (After Week 24)||0|Population is inclusive of all safety participants continuing after Week 12.|
59753565|NCT00902486|75872587|FG001|Safety Evaluable Participants|Follow-up (After Week 24)||14|Population is inclusive of all safety participants continuing after Week 12.|
59753566|NCT00902486|75872588|FG002|Safety Evaluable Participants|Follow-up (After Week 24)||15|Population is inclusive of all safety participants continuing after Week 12.|
59753567|NCT00902486|75872589|FG003|Safety Evaluable Participants|Follow-up (After Week 24)||29|Population is inclusive of all safety participants continuing after Week 12.|
59753568|NCT00902486|75872590|FG004|Safety Evaluable Participants|Follow-up (After Week 24)||30|Population is inclusive of all safety participants continuing after Week 12.|
59883599|NCT00126191|76006775|FG001|NOT COMPLETED|Overall Study||2||
59883600|NCT00124943|76006785|FG000|STARTED|Phase I||3||
59883601|NCT00124943|76006786|FG001|STARTED|Phase I||3||
59883602|NCT00124943|76006787|FG002|STARTED|Phase I||3||
59883603|NCT00124943|76006788|FG003|STARTED|Phase I||3||
59883604|NCT00124943|76006785|FG000|COMPLETED|Phase I||3||
59883605|NCT00124943|76006786|FG001|COMPLETED|Phase I||3||
59883606|NCT00124943|76006787|FG002|COMPLETED|Phase I||3||
59883607|NCT00124943|76006788|FG003|COMPLETED|Phase I||3||
59883608|NCT00124943|76006785|FG000|NOT COMPLETED|Phase I||0||
59883609|NCT00124943|76006786|FG001|NOT COMPLETED|Phase I||0||
59883610|NCT00124943|76006787|FG002|NOT COMPLETED|Phase I||0||
59883611|NCT00124943|76006788|FG003|NOT COMPLETED|Phase I||0||
59883612|NCT00124943|76006785|FG000|STARTED|Phase II|Includes participants from Phase I who were followed for efficacy but not retreated in Phase II.|3||
59883613|NCT00124943|76006786|FG001|STARTED|Phase II|Includes participants from Phase I who were followed for efficacy but not retreated in Phase II.|51||
59883614|NCT00124943|76006787|FG002|STARTED|Phase II|Includes participants from Phase I who were followed for efficacy but not retreated in Phase II.|3||
59883615|NCT00124943|76006788|FG003|STARTED|Phase II|Includes participants from Phase I who were followed for efficacy but not retreated in Phase II.|55||
59883616|NCT00124943|76006785|FG000|COMPLETED|Phase II||3||
59883617|NCT00124943|76006786|FG001|COMPLETED|Phase II||49||
59883618|NCT00124943|76006787|FG002|COMPLETED|Phase II||3||
59883619|NCT00124943|76006788|FG003|COMPLETED|Phase II||50||
59883620|NCT00124943|76006785|FG000|NOT COMPLETED|Phase II||0||
59883621|NCT00124943|76006786|FG001|NOT COMPLETED|Phase II||2||
59883622|NCT00124943|76006787|FG002|NOT COMPLETED|Phase II||0||
59883623|NCT00124943|76006788|FG003|NOT COMPLETED|Phase II||5||
59883624|NCT00124709|76006800|FG000|STARTED|Overall Study||546||
59883625|NCT00124709|76006801|FG001|STARTED|Overall Study||545||
59883626|NCT00124709|76006800|FG000|Patients Who Received Study Medication|Overall Study||543||
59883627|NCT00124709|76006801|FG001|Patients Who Received Study Medication|Overall Study||544||
59883628|NCT00124709|76006800|FG000|COMPLETED|Overall Study|232 Participants entered the OL phase of the study.|291||
59883629|NCT00124709|76006801|FG001|COMPLETED|Overall Study|232 Participants entered the OL phase of the study.|273||
59883630|NCT00124709|76006800|FG000|NOT COMPLETED|Overall Study||255||
59883631|NCT00124709|76006801|FG001|NOT COMPLETED|Overall Study||272||
59883632|NCT00108862|76006809|FG000|STARTED|Overall Study||405||
59883633|NCT00108862|76006810|FG001|STARTED|Overall Study|Three participants who were deemed clinically ineligible and taken off study were omitted.|401||
59883634|NCT00108862|76006809|FG000|COMPLETED|Overall Study||337||
59883635|NCT00108862|76006810|FG001|COMPLETED|Overall Study||339||
59883636|NCT00108862|76006809|FG000|NOT COMPLETED|Overall Study||68||
59883637|NCT00108862|76006810|FG001|NOT COMPLETED|Overall Study||62||
59883638|NCT00564850|76006816|FG000|STARTED|Overall Study||37||
59883639|NCT00564850|76006816|FG000|COMPLETED|Overall Study||35||
59883640|NCT00564850|76006816|FG000|NOT COMPLETED|Overall Study||2||
59883641|NCT00108628|76006822|FG000|STARTED|Overall Study||61||
59883642|NCT00108628|76006823|FG001|STARTED|Overall Study||63||
59883643|NCT00108628|76006822|FG000|Received One or More Sessions|Overall Study||53||
59883644|NCT00108628|76006823|FG001|Received One or More Sessions|Overall Study||58||
59883645|NCT00108628|76006822|FG000|Completed Treatment|Overall Study||42||
59883646|NCT00108628|76006823|FG001|Completed Treatment|Overall Study||57||
59883647|NCT00108628|76006822|FG000|COMPLETED|Overall Study||41||
59883648|NCT00108628|76006823|FG001|COMPLETED|Overall Study||53||
59883649|NCT00108628|76006822|FG000|NOT COMPLETED|Overall Study||20||
59883650|NCT00108628|76006823|FG001|NOT COMPLETED|Overall Study||10||
59883651|NCT02715856|76006831|FG000|STARTED|Overall Study||18||
59883652|NCT02715856|76006832|FG001|STARTED|Overall Study||52||
59883653|NCT02715856|76006831|FG000|COMPLETED|Overall Study||0||
59883654|NCT02715856|76006832|FG001|COMPLETED|Overall Study||0||
59883655|NCT02715856|76006831|FG000|NOT COMPLETED|Overall Study||18||
59883656|NCT02715856|76006832|FG001|NOT COMPLETED|Overall Study||52||
59883657|NCT00108160|76006840|FG000|STARTED|Overall Study||83||
59883658|NCT00108160|76006841|FG001|STARTED|Overall Study||63||
59883659|NCT00108160|76006840|FG000|Completed Visit 0 (Baseline)|Overall Study|4 patients who signed consent and were randomized did not complete the initial visit to start drug|79||
59883660|NCT00108160|76006841|FG001|Completed Visit 0 (Baseline)|Overall Study|3 patients who signed a consent and were randomized did not complete the initial visit to start drug|60||
59883661|NCT00108160|76006840|FG000|Completed Visit 1 (2 Wks)|Overall Study||72||
59883662|NCT00108160|76006841|FG001|Completed Visit 1 (2 Wks)|Overall Study||54||
59883663|NCT00108160|76006840|FG000|Completed Visit 2 (3 mo)|Overall Study||54||
59883664|NCT00108160|76006841|FG001|Completed Visit 2 (3 mo)|Overall Study||46||
59883665|NCT00108160|76006840|FG000|Completed Visit 3 (6 mo)|Overall Study||44||
59883666|NCT00108160|76006841|FG001|Completed Visit 3 (6 mo)|Overall Study||38||
59883667|NCT00108160|76006840|FG000|Completed Visit 4 (9 mo)|Overall Study||38||
59883668|NCT00108160|76006841|FG001|Completed Visit 4 (9 mo)|Overall Study||37||
59883669|NCT00108160|76006840|FG000|Completed Visit 5 (12 mo)|Overall Study||37||
59753569|NCT00902486|75872591|FG005|Safety Evaluable Participants|Follow-up (After Week 24)||27|Population is inclusive of all safety participants continuing after Week 12.|
59753570|NCT00902486|75872586|FG000|COMPLETED|Follow-up (After Week 24)||0||
59753571|NCT00902486|75872587|FG001|COMPLETED|Follow-up (After Week 24)||14||
59753572|NCT00902486|75872588|FG002|COMPLETED|Follow-up (After Week 24)||13||
59753573|NCT00902486|75872589|FG003|COMPLETED|Follow-up (After Week 24)||26||
59753574|NCT00902486|75872590|FG004|COMPLETED|Follow-up (After Week 24)||29||
59753575|NCT00902486|75872591|FG005|COMPLETED|Follow-up (After Week 24)||24||
59753576|NCT00902486|75872586|FG000|NOT COMPLETED|Follow-up (After Week 24)||0||
59753577|NCT00902486|75872587|FG001|NOT COMPLETED|Follow-up (After Week 24)||0||
59753578|NCT00902486|75872588|FG002|NOT COMPLETED|Follow-up (After Week 24)||0||
59753579|NCT00902486|75872589|FG003|NOT COMPLETED|Follow-up (After Week 24)||1||
59753580|NCT00902486|75872590|FG004|NOT COMPLETED|Follow-up (After Week 24)||0||
59753581|NCT00902486|75872591|FG005|NOT COMPLETED|Follow-up (After Week 24)||0||
59753582|NCT00836745|75872621|FG000|STARTED|Overall Study||36||
59753583|NCT00836745|75872621|FG000|COMPLETED|Overall Study||15||
59753584|NCT00836745|75872621|FG000|NOT COMPLETED|Overall Study||21||
59753585|NCT00891618|75872625|FG000|STARTED|Overall Study||21||
59753586|NCT00891618|75872625|FG000|COMPLETED|Overall Study||20||
59753587|NCT00891618|75872625|FG000|NOT COMPLETED|Overall Study||1||
59753588|NCT00836589|75872629|FG000|STARTED|Overall Study||1997||
59753589|NCT00836589|75872629|FG000|COMPLETED|Overall Study||731||
59753590|NCT00836589|75872629|FG000|NOT COMPLETED|Overall Study||1266||
59753591|NCT00574795|75872641|FG000|STARTED|Infant Series||193||
59753592|NCT00574795|75872641|FG000|Vaccinated Dose 1|Infant Series||193||
59753593|NCT00574795|75872641|FG000|Vaccinated Dose 2|Infant Series||190||
59753594|NCT00574795|75872641|FG000|Vaccinated Dose 3|Infant Series||190||
59753595|NCT00574795|75872641|FG000|COMPLETED|Infant Series||188||
59753596|NCT00574795|75872641|FG000|NOT COMPLETED|Infant Series||5||
59753597|NCT00574795|75872641|FG000|STARTED|After Infant Series||188||
59753598|NCT00574795|75872641|FG000|COMPLETED|After Infant Series||185||
59753599|NCT00574795|75872641|FG000|NOT COMPLETED|After Infant Series||3||
59753600|NCT00574795|75872641|FG000|STARTED|Toddler Dose||185||
59606249|NCT01935336|75716611|FG002|STARTED|Overall Study|Only three subjects were treated due to the black box warning RE: ponatinib-associated vascular issues. The protocol was modified with additional inclusion and exclusion criteria, which severely limited the number of cases treated with the drug|47||
59753601|NCT00574795|75872641|FG000|COMPLETED|Toddler Dose||184||
59753602|NCT00574795|75872641|FG000|NOT COMPLETED|Toddler Dose||1||
59753603|NCT02297516|75872658|FG000|STARTED|Single Treatment Phase (6 Months)||32||
59883670|NCT00108160|76006841|FG001|Completed Visit 5 (12 mo)|Overall Study||37||
59606250|NCT01935336|75716612|FG003|STARTED|Overall Study|No subjects were treated in this arm|66||
59606251|NCT01935336|75716609|FG000|Started Treatment|Overall Study||1||
59606252|NCT01935336|75716610|FG001|Started Treatment|Overall Study||0||
59606253|NCT01935336|75716611|FG002|Started Treatment|Overall Study||3||
59606254|NCT01935336|75716612|FG003|Started Treatment|Overall Study||0||
59606255|NCT01935336|75716609|FG000|COMPLETED|Overall Study||0||
59606256|NCT01935336|75716610|FG001|COMPLETED|Overall Study||0||
59606257|NCT01935336|75716611|FG002|COMPLETED|Overall Study||0||
59606258|NCT01935336|75716612|FG003|COMPLETED|Overall Study||0||
59883671|NCT00108160|76006840|FG000|Completed Visit 6 (15 mo)|Overall Study||36||
59518971|NCT03393754|75612860|FG001|STARTED|Overall Study||796||
59883672|NCT00108160|76006841|FG001|Completed Visit 6 (15 mo)|Overall Study||33||
59883673|NCT00108160|76006840|FG000|Completed Visit 7 (18 mo)|Overall Study||34||
59883674|NCT00108160|76006841|FG001|Completed Visit 7 (18 mo)|Overall Study||31||
59883675|NCT00108160|76006840|FG000|COMPLETED|Overall Study|Patients who completed 18 months of mupirocin or developed new (recurrent) S. aureus infection.|44||
59883676|NCT00108160|76006841|FG001|COMPLETED|Overall Study|Participants who completed 18 months of placebo or developed new (recurrent) S. aureus infection.|42||
59883677|NCT00108160|76006840|FG000|NOT COMPLETED|Overall Study||39||
59883678|NCT00108160|76006841|FG001|NOT COMPLETED|Overall Study||21||
59883679|NCT01366846|76006853|FG000|STARTED|Overall Study||235||
59883680|NCT01366846|76006854|FG001|STARTED|Overall Study||228||
59883681|NCT01366846|76006855|FG002|STARTED|Overall Study||47||
59883682|NCT01366846|76006856|FG003|STARTED|Overall Study||46||
59883683|NCT01366846|76006853|FG000|COMPLETED|Overall Study||232||
59883684|NCT01366846|76006854|FG001|COMPLETED|Overall Study||224||
59883685|NCT01366846|76006855|FG002|COMPLETED|Overall Study||46||
59518972|NCT03393754|75612859|FG000|COMPLETED|Overall Study||785||
59883686|NCT01366846|76006856|FG003|COMPLETED|Overall Study||45||
59883687|NCT01366846|76006853|FG000|NOT COMPLETED|Overall Study||3||
59883688|NCT01366846|76006854|FG001|NOT COMPLETED|Overall Study||4||
59883689|NCT01366846|76006855|FG002|NOT COMPLETED|Overall Study||1||
59883690|NCT01366846|76006856|FG003|NOT COMPLETED|Overall Study||1||
59883691|NCT00108082|76006872|FG000|STARTED|Overall Study||91||
59883692|NCT00108082|76006873|FG001|STARTED|Overall Study||100||
59883693|NCT00108082|76006874|FG002|STARTED|Overall Study||96||
59883694|NCT00108082|76006872|FG000|COMPLETED|Overall Study|Per protocol Amendment 4, participants who had completed Month 12 prior to amendment were withdrawn.|53||
59883695|NCT00108082|76006873|FG001|COMPLETED|Overall Study|Per protocol Amendment 4, participants who had completed Month 12 prior to amendment were withdrawn.|68||
59883696|NCT00108082|76006874|FG002|COMPLETED|Overall Study|Per protocol Amendment 4, participants who had completed Month 12 prior to amendment were withdrawn.|53||
59883697|NCT00108082|76006872|FG000|NOT COMPLETED|Overall Study||38||
59883698|NCT00108082|76006873|FG001|NOT COMPLETED|Overall Study||32||
59883699|NCT00108082|76006874|FG002|NOT COMPLETED|Overall Study||43||
59883700|NCT03543826|76006882|FG000|STARTED|Overall Study||163||
59883701|NCT03543826|76006882|FG000|COMPLETED|Overall Study||163||
59883702|NCT03543826|76006882|FG000|NOT COMPLETED|Overall Study||0||
59883703|NCT00104728|76006886|FG000|STARTED|Overall Study|42 consented on study|42||
59883704|NCT00104728|76006886|FG000|COMPLETED|Overall Study||23||
59883705|NCT00104728|76006886|FG000|NOT COMPLETED|Overall Study||19||
59883706|NCT02781844|76006894|FG000|STARTED|Treatment Period 1||5||
59883707|NCT02781844|76006895|FG001|STARTED|Treatment Period 1||4||
59883708|NCT02781844|76006896|FG002|STARTED|Treatment Period 1||4||
59883709|NCT02781844|76006897|FG003|STARTED|Treatment Period 1||4||
59883710|NCT02781844|76006898|FG004|STARTED|Treatment Period 1||4||
59883711|NCT02781844|76006899|FG005|STARTED|Treatment Period 1||5||
59883712|NCT02781844|76006900|FG006|STARTED|Treatment Period 1||4||
59883713|NCT02781844|76006901|FG007|STARTED|Treatment Period 1||4||
59883714|NCT02781844|76006894|FG000|COMPLETED|Treatment Period 1||5||
59883715|NCT02781844|76006895|FG001|COMPLETED|Treatment Period 1||4||
59883716|NCT02781844|76006896|FG002|COMPLETED|Treatment Period 1||4||
59883717|NCT02781844|76006897|FG003|COMPLETED|Treatment Period 1||4||
59883718|NCT02781844|76006898|FG004|COMPLETED|Treatment Period 1||4||
59883719|NCT02781844|76006899|FG005|COMPLETED|Treatment Period 1||4||
59883720|NCT02781844|76006900|FG006|COMPLETED|Treatment Period 1||4||
59883721|NCT02781844|76006901|FG007|COMPLETED|Treatment Period 1||4||
59883722|NCT02781844|76006894|FG000|NOT COMPLETED|Treatment Period 1||0||
59883723|NCT02781844|76006895|FG001|NOT COMPLETED|Treatment Period 1||0||
59883724|NCT02781844|76006896|FG002|NOT COMPLETED|Treatment Period 1||0||
59883725|NCT02781844|76006897|FG003|NOT COMPLETED|Treatment Period 1||0||
59883726|NCT02781844|76006898|FG004|NOT COMPLETED|Treatment Period 1||0||
59883727|NCT02781844|76006899|FG005|NOT COMPLETED|Treatment Period 1||1||
59883728|NCT02781844|76006900|FG006|NOT COMPLETED|Treatment Period 1||0||
60011521|NCT04497883|76127463|FG003|STARTED|Treatment Period 1 (2 Days)||0||
60011522|NCT04497883|76127460|FG000|COMPLETED|Treatment Period 1 (2 Days)||12||
59883729|NCT02781844|76006901|FG007|NOT COMPLETED|Treatment Period 1||0||
59883730|NCT02781844|76006894|FG000|STARTED|Treatment Period 2||5||
59883731|NCT02781844|76006895|FG001|STARTED|Treatment Period 2||4||
59883732|NCT02781844|76006896|FG002|STARTED|Treatment Period 2||4||
59883733|NCT02781844|76006897|FG003|STARTED|Treatment Period 2||4||
59883734|NCT02781844|76006898|FG004|STARTED|Treatment Period 2||4||
59883735|NCT02781844|76006899|FG005|STARTED|Treatment Period 2||4||
59883736|NCT02781844|76006900|FG006|STARTED|Treatment Period 2||4||
59883737|NCT02781844|76006901|FG007|STARTED|Treatment Period 2||4||
59883738|NCT02781844|76006894|FG000|COMPLETED|Treatment Period 2||5||
59606259|NCT01935336|75716609|FG000|NOT COMPLETED|Overall Study||6||
59606260|NCT01935336|75716610|FG001|NOT COMPLETED|Overall Study||3||
59606261|NCT01935336|75716611|FG002|NOT COMPLETED|Overall Study||47||
59883739|NCT02781844|76006895|FG001|COMPLETED|Treatment Period 2||4||
59883740|NCT02781844|76006896|FG002|COMPLETED|Treatment Period 2||4||
59883741|NCT02781844|76006897|FG003|COMPLETED|Treatment Period 2||4||
59883742|NCT02781844|76006898|FG004|COMPLETED|Treatment Period 2||4||
59883743|NCT02781844|76006899|FG005|COMPLETED|Treatment Period 2||4||
59883744|NCT02781844|76006900|FG006|COMPLETED|Treatment Period 2||4||
59883745|NCT02781844|76006901|FG007|COMPLETED|Treatment Period 2||4||
59883746|NCT02781844|76006894|FG000|NOT COMPLETED|Treatment Period 2||0||
59883747|NCT02781844|76006895|FG001|NOT COMPLETED|Treatment Period 2||0||
59883748|NCT02781844|76006896|FG002|NOT COMPLETED|Treatment Period 2||0||
59883749|NCT02781844|76006897|FG003|NOT COMPLETED|Treatment Period 2||0||
59883750|NCT02781844|76006898|FG004|NOT COMPLETED|Treatment Period 2||0||
59883751|NCT02781844|76006899|FG005|NOT COMPLETED|Treatment Period 2||0||
59883752|NCT02781844|76006900|FG006|NOT COMPLETED|Treatment Period 2||0||
59883753|NCT02781844|76006901|FG007|NOT COMPLETED|Treatment Period 2||0||
59883754|NCT02775916|76006919|FG000|STARTED|Overall Study||20||
59883755|NCT02775916|76006920|FG001|STARTED|Overall Study||10||
59883756|NCT02775916|76006919|FG000|COMPLETED|Overall Study||17||
59883757|NCT02775916|76006920|FG001|COMPLETED|Overall Study||10||
59883758|NCT02775916|76006919|FG000|NOT COMPLETED|Overall Study||3||
59883759|NCT02775916|76006920|FG001|NOT COMPLETED|Overall Study||0||
59883760|NCT00122681|76006928|FG000|STARTED|Overall Study||9325||
59883761|NCT00122681|76006929|FG001|STARTED|Overall Study||9319||
59883762|NCT00122681|76006928|FG000|COMPLETED|Overall Study||7811||
59883763|NCT00122681|76006929|FG001|COMPLETED|Overall Study||7798||
59883764|NCT00122681|76006928|FG000|NOT COMPLETED|Overall Study||1514||
59883765|NCT00122681|76006929|FG001|NOT COMPLETED|Overall Study||1521||
59883766|NCT02774278|76006943|FG000|STARTED|Overall Study||264||
59883767|NCT02774278|76006943|FG000|Safety Analysis Population (SAP)|Overall Study|SAP: all participants who received at least 1 dose of trial medication and had a safety follow-up.|261||
59883768|NCT02774278|76006943|FG000|COMPLETED|Overall Study||0||
59883769|NCT02774278|76006943|FG000|NOT COMPLETED|Overall Study||264||
59883770|NCT00122135|76006949|FG000|STARTED|Overall Study||60||
59883771|NCT00122135|76006950|FG001|STARTED|Overall Study||60||
59606262|NCT01935336|75716612|FG003|NOT COMPLETED|Overall Study||66||
59883772|NCT00122135|76006949|FG000|COMPLETED|Overall Study||57||
59883773|NCT00122135|76006950|FG001|COMPLETED|Overall Study||60||
59883774|NCT00122135|76006949|FG000|NOT COMPLETED|Overall Study||3||
59883775|NCT00122135|76006950|FG001|NOT COMPLETED|Overall Study||0||
59883776|NCT03645057|76006960|FG000|STARTED|Randomization to Baseline||23|46 patient/caregiver dyads were randomized to crisaborole or tacrolimus 0.03% study arms (i.e., 92 subjects total = 46 child patients and 46 caregivers).|
59883777|NCT03645057|76006961|FG001|STARTED|Randomization to Baseline||23|46 patient/caregiver dyads were randomized to crisaborole or tacrolimus 0.03% study arms (i.e., 92 subjects total = 46 child patients and 46 caregivers).|
59883778|NCT03645057|76006962|FG002|STARTED|Randomization to Baseline||23|46 patient/caregiver dyads were randomized to crisaborole or tacrolimus 0.03% study arms (i.e., 92 subjects total = 46 child patients and 46 caregivers).|
59883779|NCT03645057|76006963|FG003|STARTED|Randomization to Baseline||23|46 patient/caregiver dyads were randomized to crisaborole or tacrolimus 0.03% study arms (i.e., 92 subjects total = 46 child patients and 46 caregivers).|
59883780|NCT03645057|76006960|FG000|COMPLETED|Randomization to Baseline||22|One dyad (i.e., 1 child patient with 1 caregiver) was lost to followup after randomization (i.e., crisaborole arm) but before baseline assessment. This dyad was one that required a washout prior to baseline assessment. The Baseline Assessment included clinician-rated severity of the child patient's atopic dermatitis. completion of five outcome measures by the child patient, and completion of three outcome measures by the caregiver.|
59950844|NCT01505608|76069753|FG000|NOT COMPLETED|Phase I||0||
59950845|NCT01505608|76069754|FG001|NOT COMPLETED|Phase I||6||
59606263|NCT01978236|75716628|FG000|STARTED|Overall Study||6||
59606264|NCT01978236|75716628|FG000|COMPLETED|Overall Study||4||
59606265|NCT01978236|75716628|FG000|NOT COMPLETED|Overall Study||2||
59606266|NCT01977846|75716634|FG000|STARTED|Total Study - Retrospective||251||
59606267|NCT01977846|75716635|FG001|STARTED|Total Study - Retrospective||0||
59606268|NCT01977846|75716634|FG000|COMPLETED|Total Study - Retrospective||251||
59606269|NCT01977846|75716635|FG001|COMPLETED|Total Study - Retrospective||0||
59606270|NCT01977846|75716634|FG000|NOT COMPLETED|Total Study - Retrospective||0||
59951256|NCT03743415|76070177|FG002|NOT COMPLETED|Overall Study||7||
59606271|NCT01977846|75716635|FG001|NOT COMPLETED|Total Study - Retrospective||0||
59883781|NCT03645057|76006961|FG001|COMPLETED|Randomization to Baseline||23|One dyad (i.e., 1 child patient with 1 caregiver) was lost to followup after randomization (i.e., crisaborole arm) but before baseline assessment. This dyad was one that required a washout prior to baseline assessment. The Baseline Assessment included clinician-rated severity of the child patient's atopic dermatitis. completion of five outcome measures by the child patient, and completion of three outcome measures by the caregiver.|
59883782|NCT03645057|76006962|FG002|COMPLETED|Randomization to Baseline||22|One dyad (i.e., 1 child patient with 1 caregiver) was lost to followup after randomization (i.e., crisaborole arm) but before baseline assessment. This dyad was one that required a washout prior to baseline assessment. The Baseline Assessment included clinician-rated severity of the child patient's atopic dermatitis. completion of five outcome measures by the child patient, and completion of three outcome measures by the caregiver.|
59883783|NCT03645057|76006963|FG003|COMPLETED|Randomization to Baseline||23|One dyad (i.e., 1 child patient with 1 caregiver) was lost to followup after randomization (i.e., crisaborole arm) but before baseline assessment. This dyad was one that required a washout prior to baseline assessment. The Baseline Assessment included clinician-rated severity of the child patient's atopic dermatitis. completion of five outcome measures by the child patient, and completion of three outcome measures by the caregiver.|
59883784|NCT03645057|76006960|FG000|NOT COMPLETED|Randomization to Baseline||1||
59883785|NCT03645057|76006961|FG001|NOT COMPLETED|Randomization to Baseline||0||
59883786|NCT03645057|76006962|FG002|NOT COMPLETED|Randomization to Baseline||1||
59883787|NCT03645057|76006963|FG003|NOT COMPLETED|Randomization to Baseline||0||
59883788|NCT03645057|76006960|FG000|STARTED|Baseline to Six Weeks||22|45 dyads (i.e., 90 subjects total = 45 child patients and 45 caregivers) completed Baseline Assessment. Child patient used the assigned study medication for 6 weeks (baseline visit to 6 week study visit). The 6 week study visit included clinician-rated severity of child patient's atopic dermatitis, completion of five outcome measure by the child patient, and completion of three outcome measure by the caregiver.|
59606272|NCT01977846|75716634|FG000|STARTED|Total Study - Prospective||0||
59606273|NCT01977846|75716635|FG001|STARTED|Total Study - Prospective||259||
59606274|NCT01977846|75716634|FG000|COMPLETED|Total Study - Prospective||0||
59606275|NCT01977846|75716635|FG001|COMPLETED|Total Study - Prospective||230||
59606276|NCT01977846|75716634|FG000|NOT COMPLETED|Total Study - Prospective||0||
59606277|NCT01977846|75716635|FG001|NOT COMPLETED|Total Study - Prospective||29||
59606278|NCT01934790|75716642|FG000|STARTED|Treatment|Eligible for treatment|45||
59606279|NCT01934790|75716642|FG000|Participants Received Study Treatment|Treatment||44||
59606280|NCT01934790|75716642|FG000|COMPLETED|Treatment||29||
59606281|NCT01934790|75716642|FG000|NOT COMPLETED|Treatment||16||
59606282|NCT01934790|75716642|FG000|STARTED|Active Follow up||34||
59753604|NCT02297516|75872659|FG001|STARTED|Single Treatment Phase (6 Months)||33||
59753605|NCT02297516|75872658|FG000|COMPLETED|Single Treatment Phase (6 Months)||31||
59753606|NCT02297516|75872659|FG001|COMPLETED|Single Treatment Phase (6 Months)||31||
59753607|NCT02297516|75872658|FG000|NOT COMPLETED|Single Treatment Phase (6 Months)||1||
59753608|NCT02297516|75872659|FG001|NOT COMPLETED|Single Treatment Phase (6 Months)||2||
59753609|NCT02297516|75872658|FG000|STARTED|Combination Treatment Phase (up to 18 m)||31||
59753610|NCT02297516|75872659|FG001|STARTED|Combination Treatment Phase (up to 18 m)||31||
59753611|NCT02297516|75872658|FG000|COMPLETED|Combination Treatment Phase (up to 18 m)||31||
59753612|NCT02297516|75872659|FG001|COMPLETED|Combination Treatment Phase (up to 18 m)||30||
59753613|NCT02297516|75872658|FG000|NOT COMPLETED|Combination Treatment Phase (up to 18 m)||0||
59753614|NCT02297516|75872659|FG001|NOT COMPLETED|Combination Treatment Phase (up to 18 m)||1||
59753615|NCT00836277|75872672|FG000|STARTED|Overall Study||24||
59753616|NCT00836277|75872672|FG000|COMPLETED|Overall Study||18||
59753617|NCT00836277|75872672|FG000|NOT COMPLETED|Overall Study||6||
59753618|NCT00835731|75872678|FG000|STARTED|Overall Study||64||
59753619|NCT00835731|75872679|FG001|STARTED|Overall Study||61||
59753620|NCT00835731|75872678|FG000|COMPLETED|Overall Study||62||
59753621|NCT00835731|75872679|FG001|COMPLETED|Overall Study||60||
59753622|NCT00835731|75872678|FG000|NOT COMPLETED|Overall Study||2||
59753623|NCT00835731|75872679|FG001|NOT COMPLETED|Overall Study||1||
59753624|NCT00835341|75872687|FG000|STARTED|Overall Study||35||
59753625|NCT00835341|75872688|FG001|STARTED|Overall Study||58||
59883789|NCT03645057|76006961|FG001|STARTED|Baseline to Six Weeks||23|45 dyads (i.e., 90 subjects total = 45 child patients and 45 caregivers) completed Baseline Assessment. Child patient used the assigned study medication for 6 weeks (baseline visit to 6 week study visit). The 6 week study visit included clinician-rated severity of child patient's atopic dermatitis, completion of five outcome measure by the child patient, and completion of three outcome measure by the caregiver.|
59883790|NCT03645057|76006962|FG002|STARTED|Baseline to Six Weeks||22|45 dyads (i.e., 90 subjects total = 45 child patients and 45 caregivers) completed Baseline Assessment. Child patient used the assigned study medication for 6 weeks (baseline visit to 6 week study visit). The 6 week study visit included clinician-rated severity of child patient's atopic dermatitis, completion of five outcome measure by the child patient, and completion of three outcome measure by the caregiver.|
59950846|NCT01505608|76069753|FG000|STARTED|Phase II|Phase 2 was new enrollment, not the same patients from Phase 1.|2||
59950847|NCT01505608|76069754|FG001|STARTED|Phase II|Phase 2 was new enrollment, not the same patients from Phase 1.|4||
59753626|NCT00835341|75872687|FG000|COMPLETED|Overall Study||32||
59753627|NCT00835341|75872688|FG001|COMPLETED|Overall Study||46||
59753628|NCT00835341|75872687|FG000|NOT COMPLETED|Overall Study||3||
59753629|NCT00835341|75872688|FG001|NOT COMPLETED|Overall Study||12||
59753630|NCT00574249|75872696|FG000|STARTED|Overall Study||364||
59753631|NCT00574249|75872697|FG001|STARTED|Overall Study||366||
59753632|NCT00574249|75872696|FG000|COMPLETED|Overall Study||338||
59753633|NCT00574249|75872697|FG001|COMPLETED|Overall Study||338||
59753634|NCT00574249|75872696|FG000|NOT COMPLETED|Overall Study||26||
59753635|NCT00574249|75872697|FG001|NOT COMPLETED|Overall Study||28||
59753636|NCT00891228|75872706|FG000|STARTED|Overall Study||32||
59753637|NCT00891228|75872707|FG001|STARTED|Overall Study||33||
59753638|NCT00891228|75872708|FG002|STARTED|Overall Study||34||
59753639|NCT00891228|75872706|FG000|COMPLETED|Overall Study||21||
59753640|NCT00891228|75872707|FG001|COMPLETED|Overall Study||20||
59753641|NCT00891228|75872708|FG002|COMPLETED|Overall Study||19||
59753642|NCT00891228|75872706|FG000|NOT COMPLETED|Overall Study||11||
59753643|NCT00891228|75872707|FG001|NOT COMPLETED|Overall Study||13||
59753644|NCT00891228|75872708|FG002|NOT COMPLETED|Overall Study||15||
59753645|NCT00896168|75872718|FG000|STARTED|Overall Study||104||
59753646|NCT00896168|75872719|FG001|STARTED|Overall Study||130||
59606283|NCT01934790|75716642|FG000|COMPLETED|Active Follow up||10||
59753647|NCT00896168|75872718|FG000|COMPLETED|Overall Study||90||
59753648|NCT00896168|75872719|FG001|COMPLETED|Overall Study||111||
59753649|NCT00896168|75872718|FG000|NOT COMPLETED|Overall Study||14||
59753650|NCT00896168|75872719|FG001|NOT COMPLETED|Overall Study||19||
59753651|NCT00833703|75872727|FG000|STARTED|Overall Study|Included|23||
59753652|NCT00833703|75872728|FG001|STARTED|Overall Study|Included|26||
59753653|NCT00833703|75872727|FG000|Treated|Overall Study||23||
59753654|NCT00833703|75872728|FG001|Treated|Overall Study||26||
59753655|NCT00833703|75872727|FG000|Completed Treatment|Overall Study||22||
59753656|NCT00833703|75872728|FG001|Completed Treatment|Overall Study||24||
59753657|NCT00833703|75872727|FG000|COMPLETED|Overall Study|Completed follow-up|23||
59753658|NCT00833703|75872728|FG001|COMPLETED|Overall Study|Completed follow-up|25||
59753659|NCT00833703|75872727|FG000|NOT COMPLETED|Overall Study||0||
59753660|NCT00833703|75872728|FG001|NOT COMPLETED|Overall Study||1||
59753661|NCT00833547|75872736|FG000|STARTED|Overall Study||13||
59753662|NCT00833547|75872737|FG001|STARTED|Overall Study||12||
59753663|NCT00833547|75872736|FG000|COMPLETED|Overall Study||11||
59753664|NCT00833547|75872737|FG001|COMPLETED|Overall Study||10||
59753665|NCT00833547|75872736|FG000|NOT COMPLETED|Overall Study||2||
59753666|NCT00833547|75872737|FG001|NOT COMPLETED|Overall Study||2||
59753667|NCT00833469|75872743|FG000|STARTED|Overall Study||5||
59753668|NCT00833469|75872743|FG000|COMPLETED|Overall Study||3||
59753669|NCT00833469|75872743|FG000|NOT COMPLETED|Overall Study||2||
59753670|NCT00832377|75872747|FG000|STARTED|Overall Study||37||
59753671|NCT00832377|75872747|FG000|COMPLETED|Overall Study||36||
59753672|NCT00832377|75872747|FG000|NOT COMPLETED|Overall Study||1||
59753673|NCT00892008|75872751|FG000|STARTED|Overall Study||2278||
59753674|NCT00892008|75872751|FG000|COMPLETED|Overall Study||1713||
59753675|NCT00892008|75872751|FG000|NOT COMPLETED|Overall Study||565||
59753676|NCT00623233|75872755|FG000|STARTED|Overall Study||52||
59753677|NCT00623233|75872755|FG000|COMPLETED|Overall Study|Included those who discontinued due to PD or death and those who achieved complete response (CR).|28||
59753678|NCT00623233|75872755|FG000|NOT COMPLETED|Overall Study||24||
59753679|NCT02548754|75872761|FG000|STARTED|Overall Study||26||
59753680|NCT02548754|75872762|FG001|STARTED|Overall Study||27||
59753681|NCT02548754|75872761|FG000|COMPLETED|Overall Study||24||
59753682|NCT02548754|75872762|FG001|COMPLETED|Overall Study||23||
59753683|NCT02548754|75872761|FG000|NOT COMPLETED|Overall Study||2||
59753684|NCT02548754|75872762|FG001|NOT COMPLETED|Overall Study||4||
59753685|NCT03369236|75872770|FG000|STARTED|Double-blind Treatment Period||6||
59753686|NCT03369236|75872771|FG001|STARTED|Double-blind Treatment Period||7||
59950848|NCT01505608|76069753|FG000|COMPLETED|Phase II||0||
59753687|NCT03369236|75872770|FG000|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||6||
59753688|NCT03369236|75872771|FG001|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||7||
59753689|NCT03369236|75872770|FG000|COMPLETED|Double-blind Treatment Period||6||
59753690|NCT03369236|75872771|FG001|COMPLETED|Double-blind Treatment Period||6||
59753691|NCT03369236|75872770|FG000|NOT COMPLETED|Double-blind Treatment Period||0||
59753692|NCT03369236|75872771|FG001|NOT COMPLETED|Double-blind Treatment Period||1||
59753693|NCT03369236|75872770|FG000|STARTED|Open-label Extension Period||6||
59753694|NCT03369236|75872771|FG001|STARTED|Open-label Extension Period||6||
59753695|NCT03369236|75872770|FG000|Received at Least 1 Dose of Study Drug|Open-label Extension Period|All participants received danicopan in the open-label extension period.|6||
59753696|NCT03369236|75872771|FG001|Received at Least 1 Dose of Study Drug|Open-label Extension Period|All participants received danicopan in the open-label extension period.|6||
59753697|NCT03369236|75872770|FG000|COMPLETED|Open-label Extension Period||1||
59753698|NCT03369236|75872771|FG001|COMPLETED|Open-label Extension Period||0||
59753699|NCT03369236|75872770|FG000|NOT COMPLETED|Open-label Extension Period||5||
59753700|NCT03369236|75872771|FG001|NOT COMPLETED|Open-label Extension Period||6||
59753701|NCT00621751|75872785|FG000|STARTED|Overall Study||35||
59753702|NCT00621751|75872786|FG001|STARTED|Overall Study||35||
59753703|NCT00621751|75872785|FG000|COMPLETED|Overall Study||35||
59753704|NCT00621751|75872786|FG001|COMPLETED|Overall Study||34||
59753705|NCT00621751|75872785|FG000|NOT COMPLETED|Overall Study||0||
59753706|NCT00621751|75872786|FG001|NOT COMPLETED|Overall Study||1||
59753707|NCT00254462|75872794|FG000|STARTED|Overall Study||44||
59753708|NCT00254462|75872795|FG001|STARTED|Overall Study||49||
59753709|NCT00254462|75872794|FG000|COMPLETED|Overall Study||36||
59753710|NCT00254462|75872795|FG001|COMPLETED|Overall Study||39||
59753711|NCT00254462|75872794|FG000|NOT COMPLETED|Overall Study||8||
59753712|NCT00254462|75872795|FG001|NOT COMPLETED|Overall Study||10||
59753713|NCT00891930|75872803|FG000|STARTED|Part 1: Panitumumab +Irinotecan||76||
59753714|NCT00891930|75872803|FG000|Received Treatment|Part 1: Panitumumab +Irinotecan||74||
59753715|NCT00891930|75872803|FG000|COMPLETED|Part 1: Panitumumab +Irinotecan||36||
59753716|NCT00891930|75872803|FG000|NOT COMPLETED|Part 1: Panitumumab +Irinotecan||40||
59753717|NCT00891930|75872803|FG000|STARTED|Part 2: Panitumumab + Ganitumab||36||
59753718|NCT00891930|75872803|FG000|COMPLETED|Part 2: Panitumumab + Ganitumab||5||
59753719|NCT00891930|75872803|FG000|NOT COMPLETED|Part 2: Panitumumab + Ganitumab||31||
59753720|NCT00891462|75872814|FG000|STARTED|Overall Study||186||
59950849|NCT01505608|76069754|FG001|COMPLETED|Phase II||2||
59950850|NCT01505608|76069753|FG000|NOT COMPLETED|Phase II||2||
59753721|NCT00891462|75872815|FG001|STARTED|Overall Study||185||
59753722|NCT00891462|75872816|FG002|STARTED|Overall Study||190||
59950851|NCT01505608|76069754|FG001|NOT COMPLETED|Phase II||2||
59606284|NCT01934790|75716642|FG000|NOT COMPLETED|Active Follow up||24||
59606285|NCT01934790|75716642|FG000|STARTED|Long Term Follow up||12||
59606286|NCT01934790|75716642|FG000|COMPLETED|Long Term Follow up||12||
59606287|NCT01934790|75716642|FG000|NOT COMPLETED|Long Term Follow up||0||
59606288|NCT01934556|75716649|FG000|STARTED|Overall Study||30||30
59606289|NCT01934556|75716650|FG001|STARTED|Overall Study||60||60
59606290|NCT01934556|75716651|FG002|STARTED|Overall Study||60||60
59606291|NCT01934556|75716649|FG000|COMPLETED|Overall Study||25||25
59606292|NCT01934556|75716650|FG001|COMPLETED|Overall Study||44||44
59606293|NCT01934556|75716651|FG002|COMPLETED|Overall Study||50||50
59606294|NCT01934556|75716649|FG000|NOT COMPLETED|Overall Study||5||5
59606295|NCT01934556|75716650|FG001|NOT COMPLETED|Overall Study||16||16
59606296|NCT01934556|75716651|FG002|NOT COMPLETED|Overall Study||10||10
59883791|NCT03645057|76006963|FG003|STARTED|Baseline to Six Weeks||23|45 dyads (i.e., 90 subjects total = 45 child patients and 45 caregivers) completed Baseline Assessment. Child patient used the assigned study medication for 6 weeks (baseline visit to 6 week study visit). The 6 week study visit included clinician-rated severity of child patient's atopic dermatitis, completion of five outcome measure by the child patient, and completion of three outcome measure by the caregiver.|
59883792|NCT03645057|76006960|FG000|COMPLETED|Baseline to Six Weeks||16|Child subjects used their assigned topical medication for 6 weeks (baseline to 6 week study visits). 1 dyad (i.e., 2 subject total = 1 child patient and 1 caregiver) in the crisaborole arm withdrew from the study because the caregiver no longer wanted to participate. 5 dyads (i.e., 10 subject total = 5 child patients and 5 caregivers) in the crisaborole arm were lost to followup. 1 dyad (i.e., 2 subjects total = 1 child patient and 1 caregiver) in the tacrolimus arm was lost to follow-up.|
59883793|NCT03645057|76006961|FG001|COMPLETED|Baseline to Six Weeks||21|Child subjects used their assigned topical medication for 6 weeks (baseline to 6 week study visits). 1 dyad (i.e., 2 subject total = 1 child patient and 1 caregiver) in the crisaborole arm withdrew from the study because the caregiver no longer wanted to participate. 5 dyads (i.e., 10 subject total = 5 child patients and 5 caregivers) in the crisaborole arm were lost to followup. 1 dyad (i.e., 2 subjects total = 1 child patient and 1 caregiver) in the tacrolimus arm was lost to follow-up.|
59883794|NCT03645057|76006962|FG002|COMPLETED|Baseline to Six Weeks||16|Child subjects used their assigned topical medication for 6 weeks (baseline to 6 week study visits). 1 dyad (i.e., 2 subject total = 1 child patient and 1 caregiver) in the crisaborole arm withdrew from the study because the caregiver no longer wanted to participate. 5 dyads (i.e., 10 subject total = 5 child patients and 5 caregivers) in the crisaborole arm were lost to followup. 1 dyad (i.e., 2 subjects total = 1 child patient and 1 caregiver) in the tacrolimus arm was lost to follow-up.|
59950852|NCT01491893|76069763|FG000|STARTED|Overall Study||1||
59950853|NCT01491893|76069764|FG001|STARTED|Overall Study||1||
59753723|NCT00891462|75872814|FG000|COMPLETED|Overall Study||149||
59753724|NCT00891462|75872815|FG001|COMPLETED|Overall Study||152||
59753725|NCT00891462|75872816|FG002|COMPLETED|Overall Study||166||
59753726|NCT00891462|75872814|FG000|NOT COMPLETED|Overall Study||37||
59753727|NCT00891462|75872815|FG001|NOT COMPLETED|Overall Study||33||
59753728|NCT00891462|75872816|FG002|NOT COMPLETED|Overall Study||24||
59753729|NCT00900146|75872831|FG000|STARTED|Dose Finding: Period II (4 Months)||93||
59753730|NCT00900146|75872832|FG001|STARTED|Dose Finding: Period II (4 Months)||95||
59753731|NCT00900146|75872833|FG002|STARTED|Dose Finding: Period II (4 Months)||92||
59762528|NCT02379247|75882295|FG000|NOT COMPLETED|Overall Study||0||
59753732|NCT00900146|75872834|FG003|STARTED|Dose Finding: Period II (4 Months)||92||
59753733|NCT00900146|75872835|FG004|STARTED|Dose Finding: Period II (4 Months)||179||
59753734|NCT00900146|75872831|FG000|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||93||
59753735|NCT00900146|75872832|FG001|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||95||
59753736|NCT00900146|75872833|FG002|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||92||
59753737|NCT00900146|75872834|FG003|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||92||
59753738|NCT00900146|75872835|FG004|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||179||
59753739|NCT00900146|75872831|FG000|COMPLETED|Dose Finding: Period II (4 Months)||88||
59753740|NCT00900146|75872832|FG001|COMPLETED|Dose Finding: Period II (4 Months)||93||
59753741|NCT00900146|75872833|FG002|COMPLETED|Dose Finding: Period II (4 Months)||87||
59753742|NCT00900146|75872834|FG003|COMPLETED|Dose Finding: Period II (4 Months)||90||
59753743|NCT00900146|75872835|FG004|COMPLETED|Dose Finding: Period II (4 Months)|Placebo also included 1 patient with no study completion page.|167||
59753744|NCT00900146|75872831|FG000|NOT COMPLETED|Dose Finding: Period II (4 Months)||5||
59753745|NCT00900146|75872832|FG001|NOT COMPLETED|Dose Finding: Period II (4 Months)||2||
59753746|NCT00900146|75872833|FG002|NOT COMPLETED|Dose Finding: Period II (4 Months)||5||
59753747|NCT00900146|75872834|FG003|NOT COMPLETED|Dose Finding: Period II (4 Months)||2||
59753748|NCT00900146|75872835|FG004|NOT COMPLETED|Dose Finding: Period II (4 Months)||12||
59753749|NCT00900146|75872831|FG000|STARTED|Intermediate: Period III||87||
59753750|NCT00900146|75872832|FG001|STARTED|Intermediate: Period III||93||
59883795|NCT03645057|76006963|FG003|COMPLETED|Baseline to Six Weeks||21|Child subjects used their assigned topical medication for 6 weeks (baseline to 6 week study visits). 1 dyad (i.e., 2 subject total = 1 child patient and 1 caregiver) in the crisaborole arm withdrew from the study because the caregiver no longer wanted to participate. 5 dyads (i.e., 10 subject total = 5 child patients and 5 caregivers) in the crisaborole arm were lost to followup. 1 dyad (i.e., 2 subjects total = 1 child patient and 1 caregiver) in the tacrolimus arm was lost to follow-up.|
59883796|NCT03645057|76006960|FG000|NOT COMPLETED|Baseline to Six Weeks||6||
59883797|NCT03645057|76006961|FG001|NOT COMPLETED|Baseline to Six Weeks||2||
59883798|NCT03645057|76006962|FG002|NOT COMPLETED|Baseline to Six Weeks||6||
59883799|NCT03645057|76006963|FG003|NOT COMPLETED|Baseline to Six Weeks||2||
59883800|NCT03645057|76006960|FG000|STARTED|6 Weeks to 12 Weeks||16|37 dyads (i.e., 74 subject total = 37 child patients and 37 caregivers) completed the 6 week assessment. The child patients continued using their assigned topical medication for 6 weeks until the 12 week study visit.|
59883801|NCT03645057|76006961|FG001|STARTED|6 Weeks to 12 Weeks||21|37 dyads (i.e., 74 subject total = 37 child patients and 37 caregivers) completed the 6 week assessment. The child patients continued using their assigned topical medication for 6 weeks until the 12 week study visit.|
59883802|NCT03645057|76006962|FG002|STARTED|6 Weeks to 12 Weeks||16|37 dyads (i.e., 74 subject total = 37 child patients and 37 caregivers) completed the 6 week assessment. The child patients continued using their assigned topical medication for 6 weeks until the 12 week study visit.|
59883803|NCT03645057|76006963|FG003|STARTED|6 Weeks to 12 Weeks||21|37 dyads (i.e., 74 subject total = 37 child patients and 37 caregivers) completed the 6 week assessment. The child patients continued using their assigned topical medication for 6 weeks until the 12 week study visit.|
59883804|NCT03645057|76006960|FG000|COMPLETED|6 Weeks to 12 Weeks||16|36 dyads (i.e., 72 subjects total = 36 child patients and 36 caregivers) completed their assigned topical medication for 12 weeks and completed the 12 week study visit. 1 dyad (i.e., 2 subject total = 1 child patient and 1 caregiver) in the tacrolimus arm was lost to followup. The 12 week study visit included clinician-rated severity of the child patient's atopic dermatitis, completion of five outcome measures by the child patient, and completion of three outcome measures by the caregiver.|
59950854|NCT01491893|76069765|FG002|STARTED|Overall Study||1||
59950855|NCT01491893|76069766|FG003|STARTED|Overall Study||1||
59950856|NCT01491893|76069767|FG004|STARTED|Overall Study||4||
59950857|NCT01491893|76069768|FG005|STARTED|Overall Study||1||
59753751|NCT00900146|75872833|FG002|STARTED|Intermediate: Period III||84||
59753752|NCT00900146|75872834|FG003|STARTED|Intermediate: Period III||90||
59753753|NCT00900146|75872835|FG004|STARTED|Intermediate: Period III||167||
59883805|NCT03645057|76006961|FG001|COMPLETED|6 Weeks to 12 Weeks||20|36 dyads (i.e., 72 subjects total = 36 child patients and 36 caregivers) completed their assigned topical medication for 12 weeks and completed the 12 week study visit. 1 dyad (i.e., 2 subject total = 1 child patient and 1 caregiver) in the tacrolimus arm was lost to followup. The 12 week study visit included clinician-rated severity of the child patient's atopic dermatitis, completion of five outcome measures by the child patient, and completion of three outcome measures by the caregiver.|
59950858|NCT01491893|76069769|FG006|STARTED|Overall Study||6||
59606297|NCT01977690|75716661|FG000|STARTED|Overall Study||15||
59606298|NCT01977690|75716662|FG001|STARTED|Overall Study||15||
59950859|NCT01491893|76069770|FG007|STARTED|Overall Study||24||
59753754|NCT00900146|75872831|FG000|Safety Set|Intermediate: Period III||86||
59753755|NCT00900146|75872832|FG001|Safety Set|Intermediate: Period III||92||
59753756|NCT00900146|75872833|FG002|Safety Set|Intermediate: Period III||84||
59753757|NCT00900146|75872834|FG003|Safety Set|Intermediate: Period III||90||
59753758|NCT00900146|75872835|FG004|Safety Set|Intermediate: Period III||166||
59762529|NCT02379247|75882296|FG001|NOT COMPLETED|Overall Study||0||
59950860|NCT01491893|76069771|FG008|STARTED|Overall Study||15||
59950861|NCT01491893|76069772|FG009|STARTED|Overall Study||7||
59950862|NCT01491893|76069763|FG000|COMPLETED|Overall Study||1||
59950863|NCT01491893|76069764|FG001|COMPLETED|Overall Study||1||
59950864|NCT01491893|76069765|FG002|COMPLETED|Overall Study||1||
59950865|NCT01491893|76069766|FG003|COMPLETED|Overall Study||1||
59950866|NCT01491893|76069767|FG004|COMPLETED|Overall Study||4||
59950867|NCT01491893|76069768|FG005|COMPLETED|Overall Study||1||
59950868|NCT01491893|76069769|FG006|COMPLETED|Overall Study||6||
59753759|NCT00900146|75872831|FG000|COMPLETED|Intermediate: Period III||0||
59753760|NCT00900146|75872832|FG001|COMPLETED|Intermediate: Period III||0||
59753761|NCT00900146|75872833|FG002|COMPLETED|Intermediate: Period III||0||
60011523|NCT04497883|76127461|FG001|COMPLETED|Treatment Period 1 (2 Days)||12||
59753762|NCT00900146|75872834|FG003|COMPLETED|Intermediate: Period III||0||
59753763|NCT00900146|75872835|FG004|COMPLETED|Intermediate: Period III||0||
59753764|NCT00900146|75872831|FG000|NOT COMPLETED|Intermediate: Period III||87||
59753765|NCT00900146|75872832|FG001|NOT COMPLETED|Intermediate: Period III||93||
60011524|NCT04497883|76127462|FG002|COMPLETED|Treatment Period 1 (2 Days)||0||
59606299|NCT01977690|75716661|FG000|COMPLETED|Overall Study||15||
59606300|NCT01977690|75716662|FG001|COMPLETED|Overall Study||11||
59606301|NCT01977690|75716661|FG000|NOT COMPLETED|Overall Study||0||
59606302|NCT01977690|75716662|FG001|NOT COMPLETED|Overall Study||4||
59606303|NCT04646148|75716684|FG000|STARTED|Overall Study||0||
59606304|NCT04646148|75716685|FG001|STARTED|Overall Study||1||
59606305|NCT04646148|75716686|FG002|STARTED|Overall Study||0||
59606306|NCT04646148|75716687|FG003|STARTED|Overall Study||1||
59606307|NCT04646148|75716688|FG004|STARTED|Overall Study||1||
59606308|NCT04646148|75716689|FG005|STARTED|Overall Study||2||
59606309|NCT04646148|75716690|FG006|STARTED|Overall Study||1||
59606310|NCT04646148|75716691|FG007|STARTED|Overall Study||2||
59753766|NCT00900146|75872833|FG002|NOT COMPLETED|Intermediate: Period III||84||
59753767|NCT00900146|75872834|FG003|NOT COMPLETED|Intermediate: Period III||90||
60011525|NCT04497883|76127463|FG003|COMPLETED|Treatment Period 1 (2 Days)||0||
59753768|NCT00900146|75872835|FG004|NOT COMPLETED|Intermediate: Period III||167||
59753769|NCT00895310|75872847|FG000|STARTED|Overall Study||30||
59753770|NCT00895310|75872847|FG000|COMPLETED|Overall Study||29||
59753771|NCT00895310|75872847|FG000|NOT COMPLETED|Overall Study||1||
59753772|NCT00895154|75872853|FG000|STARTED|Overall Study||8||
59883806|NCT03645057|76006962|FG002|COMPLETED|6 Weeks to 12 Weeks||16|36 dyads (i.e., 72 subjects total = 36 child patients and 36 caregivers) completed their assigned topical medication for 12 weeks and completed the 12 week study visit. 1 dyad (i.e., 2 subject total = 1 child patient and 1 caregiver) in the tacrolimus arm was lost to followup. The 12 week study visit included clinician-rated severity of the child patient's atopic dermatitis, completion of five outcome measures by the child patient, and completion of three outcome measures by the caregiver.|
59883807|NCT03645057|76006963|FG003|COMPLETED|6 Weeks to 12 Weeks||20|36 dyads (i.e., 72 subjects total = 36 child patients and 36 caregivers) completed their assigned topical medication for 12 weeks and completed the 12 week study visit. 1 dyad (i.e., 2 subject total = 1 child patient and 1 caregiver) in the tacrolimus arm was lost to followup. The 12 week study visit included clinician-rated severity of the child patient's atopic dermatitis, completion of five outcome measures by the child patient, and completion of three outcome measures by the caregiver.|
59883808|NCT03645057|76006960|FG000|NOT COMPLETED|6 Weeks to 12 Weeks||0||
59883809|NCT03645057|76006961|FG001|NOT COMPLETED|6 Weeks to 12 Weeks||1||
59883810|NCT03645057|76006962|FG002|NOT COMPLETED|6 Weeks to 12 Weeks||0||
59883811|NCT03645057|76006963|FG003|NOT COMPLETED|6 Weeks to 12 Weeks||1||
59883812|NCT00132041|76006969|FG000|STARTED|Baseline||51||
59883813|NCT00132041|76006969|FG000|Eligible|Baseline||45||
59883814|NCT00132041|76006969|FG000|COMPLETED|Baseline||45||
59883815|NCT00132041|76006969|FG000|NOT COMPLETED|Baseline||6||
59883816|NCT00132041|76006969|FG000|STARTED|3 Months Post Ablation||45||
59753773|NCT00895154|75872854|FG001|STARTED|Overall Study||10||
59753774|NCT00895154|75872853|FG000|Follow Up|Overall Study||7||
59753775|NCT00895154|75872854|FG001|Follow Up|Overall Study||8||
59753776|NCT00895154|75872853|FG000|COMPLETED|Overall Study||7||
59753777|NCT00895154|75872854|FG001|COMPLETED|Overall Study||8||
59753778|NCT00895154|75872853|FG000|NOT COMPLETED|Overall Study||1||
59753779|NCT00895154|75872854|FG001|NOT COMPLETED|Overall Study||2||
59753780|NCT00888654|75872860|FG000|STARTED|Overall Study||41||
59753781|NCT00888654|75872860|FG000|COMPLETED|Overall Study||31||
59753782|NCT00888654|75872860|FG000|NOT COMPLETED|Overall Study||10||
59753783|NCT00899678|75872867|FG000|STARTED|Induction Period (Weeks 0 to 6)|Induction only includes subjects that discontinued before Maintenance Period.|27||
59753784|NCT00899678|75872868|FG001|STARTED|Induction Period (Weeks 0 to 6)||37||
59753785|NCT00899678|75872869|FG002|STARTED|Induction Period (Weeks 0 to 6)||35||
59883817|NCT00132041|76006969|FG000|COMPLETED|3 Months Post Ablation||42||
59883818|NCT00132041|76006969|FG000|NOT COMPLETED|3 Months Post Ablation||3||
59883819|NCT00132041|76006969|FG000|STARTED|6 Months Post Ablation||42||
59883820|NCT00132041|76006969|FG000|COMPLETED|6 Months Post Ablation||32||
59883821|NCT00132041|76006969|FG000|NOT COMPLETED|6 Months Post Ablation||10||
59883822|NCT00132041|76006969|FG000|STARTED|9 Months Post Ablation||32||
59883823|NCT00132041|76006969|FG000|COMPLETED|9 Months Post Ablation||30||
59883824|NCT00132041|76006969|FG000|NOT COMPLETED|9 Months Post Ablation||2||
59883825|NCT00132041|76006969|FG000|STARTED|12 Months Post Ablation||30||
59883826|NCT00132041|76006969|FG000|COMPLETED|12 Months Post Ablation||26||
59883827|NCT00132041|76006969|FG000|NOT COMPLETED|12 Months Post Ablation||4||
59883828|NCT00132041|76006969|FG000|STARTED|15 Months Post Ablation||26||
59883829|NCT00132041|76006969|FG000|COMPLETED|15 Months Post Ablation||18||
59883830|NCT00132041|76006969|FG000|NOT COMPLETED|15 Months Post Ablation||8||
59883831|NCT00132041|76006969|FG000|STARTED|18 Months Post Ablation||18||
59883832|NCT00132041|76006969|FG000|COMPLETED|18 Months Post Ablation||12||
59883833|NCT00132041|76006969|FG000|NOT COMPLETED|18 Months Post Ablation||6||
59883834|NCT03643575|76006979|FG000|STARTED|Period 1||5||
59883835|NCT03643575|76006980|FG001|STARTED|Period 1||5||
59883836|NCT03643575|76006981|FG002|STARTED|Period 1||5||
59883837|NCT03643575|76006982|FG003|STARTED|Period 1||5||
59883838|NCT03643575|76006983|FG004|STARTED|Period 1||5||
59753786|NCT00899678|75872867|FG000|COMPLETED|Induction Period (Weeks 0 to 6)|2 subjects completed the Induction Phase, but discontinued prior to receiving any Maintenance doses.|2||
59753787|NCT00899678|75872868|FG001|COMPLETED|Induction Period (Weeks 0 to 6)||37||
59753788|NCT00899678|75872869|FG002|COMPLETED|Induction Period (Weeks 0 to 6)||35||
59753789|NCT00899678|75872867|FG000|NOT COMPLETED|Induction Period (Weeks 0 to 6)||25||
59753790|NCT00899678|75872868|FG001|NOT COMPLETED|Induction Period (Weeks 0 to 6)||0||
59753791|NCT00899678|75872869|FG002|NOT COMPLETED|Induction Period (Weeks 0 to 6)||0||
59762530|NCT02379247|75882297|FG002|NOT COMPLETED|Overall Study||0||
59753792|NCT00899678|75872867|FG000|STARTED|Maintenance Period (Weeks 8 to 62)|Induction only includes subjects that discontinued before Maintenance Period.|0||
59753793|NCT00899678|75872868|FG001|STARTED|Maintenance Period (Weeks 8 to 62)||37||
59753794|NCT00899678|75872869|FG002|STARTED|Maintenance Period (Weeks 8 to 62)||35||
59753795|NCT00899678|75872867|FG000|COMPLETED|Maintenance Period (Weeks 8 to 62)||0||
59753796|NCT00899678|75872868|FG001|COMPLETED|Maintenance Period (Weeks 8 to 62)||12||
59753797|NCT00899678|75872869|FG002|COMPLETED|Maintenance Period (Weeks 8 to 62)||7||
59753798|NCT00899678|75872867|FG000|NOT COMPLETED|Maintenance Period (Weeks 8 to 62)||0||
59762531|NCT02379247|75882298|FG003|NOT COMPLETED|Overall Study||0||
60011526|NCT04497883|76127460|FG000|NOT COMPLETED|Treatment Period 1 (2 Days)||0||
60011527|NCT04497883|76127461|FG001|NOT COMPLETED|Treatment Period 1 (2 Days)||0||
60011528|NCT04497883|76127462|FG002|NOT COMPLETED|Treatment Period 1 (2 Days)||0||
60011529|NCT04497883|76127463|FG003|NOT COMPLETED|Treatment Period 1 (2 Days)||0||
60011530|NCT04497883|76127460|FG000|STARTED|Washout Period 1 (72 Hours)||12||
60011531|NCT04497883|76127461|FG001|STARTED|Washout Period 1 (72 Hours)||12||
60011532|NCT04497883|76127462|FG002|STARTED|Washout Period 1 (72 Hours)||0||
60011533|NCT04497883|76127463|FG003|STARTED|Washout Period 1 (72 Hours)||0||
60011534|NCT04497883|76127460|FG000|COMPLETED|Washout Period 1 (72 Hours)||12||
60011535|NCT04497883|76127461|FG001|COMPLETED|Washout Period 1 (72 Hours)||12||
60011536|NCT04497883|76127462|FG002|COMPLETED|Washout Period 1 (72 Hours)||0||
60011537|NCT04497883|76127463|FG003|COMPLETED|Washout Period 1 (72 Hours)||0||
60011538|NCT04497883|76127460|FG000|NOT COMPLETED|Washout Period 1 (72 Hours)||0||
60011539|NCT04497883|76127461|FG001|NOT COMPLETED|Washout Period 1 (72 Hours)||0||
60011540|NCT04497883|76127462|FG002|NOT COMPLETED|Washout Period 1 (72 Hours)||0||
60011541|NCT04497883|76127463|FG003|NOT COMPLETED|Washout Period 1 (72 Hours)||0||
60011542|NCT04497883|76127460|FG000|STARTED|Treatment Period 2 (2 Days)||0||
60011543|NCT04497883|76127461|FG001|STARTED|Treatment Period 2 (2 Days)||0||
60011544|NCT04497883|76127462|FG002|STARTED|Treatment Period 2 (2 Days)||6||
60011545|NCT04497883|76127463|FG003|STARTED|Treatment Period 2 (2 Days)||6||
60011546|NCT04497883|76127460|FG000|COMPLETED|Treatment Period 2 (2 Days)||0||
60011547|NCT04497883|76127461|FG001|COMPLETED|Treatment Period 2 (2 Days)||0||
60011548|NCT04497883|76127462|FG002|COMPLETED|Treatment Period 2 (2 Days)||6||
60011549|NCT04497883|76127463|FG003|COMPLETED|Treatment Period 2 (2 Days)||6||
60011550|NCT04497883|76127460|FG000|NOT COMPLETED|Treatment Period 2 (2 Days)||0||
60011551|NCT04497883|76127461|FG001|NOT COMPLETED|Treatment Period 2 (2 Days)||0||
60011552|NCT04497883|76127462|FG002|NOT COMPLETED|Treatment Period 2 (2 Days)||0||
60011553|NCT04497883|76127463|FG003|NOT COMPLETED|Treatment Period 2 (2 Days)||0||
60011554|NCT04497883|76127460|FG000|STARTED|Washout Period 2 (72 Hours)||0||
60011555|NCT04497883|76127461|FG001|STARTED|Washout Period 2 (72 Hours)||0||
60011556|NCT04497883|76127462|FG002|STARTED|Washout Period 2 (72 Hours)||6||
60011557|NCT04497883|76127463|FG003|STARTED|Washout Period 2 (72 Hours)||6||
60011558|NCT04497883|76127460|FG000|COMPLETED|Washout Period 2 (72 Hours)||0||
60011559|NCT04497883|76127461|FG001|COMPLETED|Washout Period 2 (72 Hours)||0||
60011560|NCT04497883|76127462|FG002|COMPLETED|Washout Period 2 (72 Hours)||6||
60011561|NCT04497883|76127463|FG003|COMPLETED|Washout Period 2 (72 Hours)||6||
60011562|NCT04497883|76127460|FG000|NOT COMPLETED|Washout Period 2 (72 Hours)||0||
60011563|NCT04497883|76127461|FG001|NOT COMPLETED|Washout Period 2 (72 Hours)||0||
60011564|NCT04497883|76127462|FG002|NOT COMPLETED|Washout Period 2 (72 Hours)||0||
60011565|NCT04497883|76127463|FG003|NOT COMPLETED|Washout Period 2 (72 Hours)||0||
60011566|NCT04497883|76127460|FG000|STARTED|Treatment Period 3 (2 Days)||0||
60011567|NCT04497883|76127461|FG001|STARTED|Treatment Period 3 (2 Days)||0||
60011568|NCT04497883|76127462|FG002|STARTED|Treatment Period 3 (2 Days)||6||
59753799|NCT00899678|75872868|FG001|NOT COMPLETED|Maintenance Period (Weeks 8 to 62)||25||
59753800|NCT00899678|75872869|FG002|NOT COMPLETED|Maintenance Period (Weeks 8 to 62)||28||
59753801|NCT00887484|75872877|FG000|STARTED|Split Face Treatment (Weeks 1 and 2)||48||
59753802|NCT00887484|75872877|FG000|COMPLETED|Split Face Treatment (Weeks 1 and 2)||48||
59753803|NCT00887484|75872877|FG000|NOT COMPLETED|Split Face Treatment (Weeks 1 and 2)||0||
59753804|NCT00887484|75872877|FG000|STARTED|Full Face Treatment (Weeks 5 and 8)||48||
59762670|NCT01886963|75882518|FG001|4 Week Follow Up|Overall Study||51||
60011569|NCT04497883|76127463|FG003|STARTED|Treatment Period 3 (2 Days)||6||
60011570|NCT04497883|76127460|FG000|COMPLETED|Treatment Period 3 (2 Days)||0||
60011571|NCT04497883|76127461|FG001|COMPLETED|Treatment Period 3 (2 Days)||0||
60011572|NCT04497883|76127462|FG002|COMPLETED|Treatment Period 3 (2 Days)||6||
60011573|NCT04497883|76127463|FG003|COMPLETED|Treatment Period 3 (2 Days)||6||
60011574|NCT04497883|76127460|FG000|NOT COMPLETED|Treatment Period 3 (2 Days)||0||
60011575|NCT04497883|76127461|FG001|NOT COMPLETED|Treatment Period 3 (2 Days)||0||
60011576|NCT04497883|76127462|FG002|NOT COMPLETED|Treatment Period 3 (2 Days)||0||
60011577|NCT04497883|76127463|FG003|NOT COMPLETED|Treatment Period 3 (2 Days)||0||
60011578|NCT03963895|76127477|FG000|STARTED|Pre-dose Period (Study Days -7, -5, -2)||12||
60011579|NCT03963895|76127478|FG001|STARTED|Pre-dose Period (Study Days -7, -5, -2)||12||
59518973|NCT03393754|75612860|FG001|COMPLETED|Overall Study||758||
59883839|NCT03643575|76006984|FG005|STARTED|Period 1||5||
59883840|NCT03643575|76006979|FG000|COMPLETED|Period 1||5||
59883841|NCT03643575|76006980|FG001|COMPLETED|Period 1||5||
59883842|NCT03643575|76006981|FG002|COMPLETED|Period 1||5||
59883843|NCT03643575|76006982|FG003|COMPLETED|Period 1||5||
59883844|NCT03643575|76006983|FG004|COMPLETED|Period 1||5||
59883845|NCT03643575|76006984|FG005|COMPLETED|Period 1||5||
59883846|NCT03643575|76006979|FG000|NOT COMPLETED|Period 1||0||
59753805|NCT00887484|75872877|FG000|COMPLETED|Full Face Treatment (Weeks 5 and 8)||45||
59753806|NCT00887484|75872877|FG000|NOT COMPLETED|Full Face Treatment (Weeks 5 and 8)||3||
59753807|NCT00886938|75872886|FG000|STARTED|Overall Study||12||
59753808|NCT00886938|75872886|FG000|COMPLETED|Overall Study||10||
59753809|NCT00886938|75872886|FG000|NOT COMPLETED|Overall Study||2||
59753810|NCT00620659|75872890|FG000|STARTED|Treatment Period 1||21||
59753811|NCT00620659|75872891|FG001|STARTED|Treatment Period 1||21||
59753812|NCT00620659|75872892|FG002|STARTED|Treatment Period 1||21||
59753813|NCT00620659|75872893|FG003|STARTED|Treatment Period 1||21||
60011580|NCT03963895|76127479|FG002|STARTED|Pre-dose Period (Study Days -7, -5, -2)||12||
60011581|NCT03963895|76127477|FG000|COMPLETED|Pre-dose Period (Study Days -7, -5, -2)||12||
60011582|NCT03963895|76127478|FG001|COMPLETED|Pre-dose Period (Study Days -7, -5, -2)||12||
60011583|NCT03963895|76127479|FG002|COMPLETED|Pre-dose Period (Study Days -7, -5, -2)||12||
60011584|NCT03963895|76127477|FG000|NOT COMPLETED|Pre-dose Period (Study Days -7, -5, -2)||0||
60011585|NCT03963895|76127478|FG001|NOT COMPLETED|Pre-dose Period (Study Days -7, -5, -2)||0||
60011586|NCT03963895|76127479|FG002|NOT COMPLETED|Pre-dose Period (Study Days -7, -5, -2)||0||
60011587|NCT03963895|76127477|FG000|STARTED|Dosing Period (Study Day 1)||12||
60011588|NCT03963895|76127478|FG001|STARTED|Dosing Period (Study Day 1)||12||
59753814|NCT00620659|75872894|FG004|STARTED|Treatment Period 1||21||
60011589|NCT03963895|76127479|FG002|STARTED|Dosing Period (Study Day 1)||12||
60011590|NCT03963895|76127477|FG000|COMPLETED|Dosing Period (Study Day 1)||12||
60011591|NCT03963895|76127478|FG001|COMPLETED|Dosing Period (Study Day 1)||12||
60011592|NCT03963895|76127479|FG002|COMPLETED|Dosing Period (Study Day 1)||12||
60011593|NCT03963895|76127477|FG000|NOT COMPLETED|Dosing Period (Study Day 1)||0||
59753815|NCT00620659|75872895|FG005|STARTED|Treatment Period 1||20||
59753816|NCT00620659|75872890|FG000|COMPLETED|Treatment Period 1||18||
59753817|NCT00620659|75872891|FG001|COMPLETED|Treatment Period 1||21||
59753818|NCT00620659|75872892|FG002|COMPLETED|Treatment Period 1||20||
59753819|NCT00620659|75872893|FG003|COMPLETED|Treatment Period 1|1 patient discontinued from MK0249, but continued in following periods, & completed the study|18||
59753820|NCT00620659|75872894|FG004|COMPLETED|Treatment Period 1||20||
59753821|NCT00620659|75872895|FG005|COMPLETED|Treatment Period 1||20||
59753822|NCT00620659|75872890|FG000|NOT COMPLETED|Treatment Period 1||3||
59753823|NCT00620659|75872891|FG001|NOT COMPLETED|Treatment Period 1||0||
59753824|NCT00620659|75872892|FG002|NOT COMPLETED|Treatment Period 1||1||
60011594|NCT03963895|76127478|FG001|NOT COMPLETED|Dosing Period (Study Day 1)||0||
59753825|NCT00620659|75872893|FG003|NOT COMPLETED|Treatment Period 1||3||
59753826|NCT00620659|75872894|FG004|NOT COMPLETED|Treatment Period 1||1||
59753827|NCT00620659|75872895|FG005|NOT COMPLETED|Treatment Period 1||0||
59753828|NCT00620659|75872890|FG000|STARTED|Placebo Washout Period 1||18||
59753829|NCT00620659|75872891|FG001|STARTED|Placebo Washout Period 1||21||
59753830|NCT00620659|75872892|FG002|STARTED|Placebo Washout Period 1||20||
59753831|NCT00620659|75872893|FG003|STARTED|Placebo Washout Period 1||19||
59753832|NCT00620659|75872894|FG004|STARTED|Placebo Washout Period 1||20||
59753833|NCT00620659|75872895|FG005|STARTED|Placebo Washout Period 1||20||
59753834|NCT00620659|75872890|FG000|COMPLETED|Placebo Washout Period 1||18||
59753835|NCT00620659|75872891|FG001|COMPLETED|Placebo Washout Period 1||21||
59753836|NCT00620659|75872892|FG002|COMPLETED|Placebo Washout Period 1||20||
59753837|NCT00620659|75872893|FG003|COMPLETED|Placebo Washout Period 1||18||
59753838|NCT00620659|75872894|FG004|COMPLETED|Placebo Washout Period 1||20||
59753839|NCT00620659|75872895|FG005|COMPLETED|Placebo Washout Period 1||20||
59753840|NCT00620659|75872890|FG000|NOT COMPLETED|Placebo Washout Period 1||0||
59753841|NCT00620659|75872891|FG001|NOT COMPLETED|Placebo Washout Period 1||0||
59753842|NCT00620659|75872892|FG002|NOT COMPLETED|Placebo Washout Period 1||0||
59753843|NCT00620659|75872893|FG003|NOT COMPLETED|Placebo Washout Period 1||1||
59753844|NCT00620659|75872894|FG004|NOT COMPLETED|Placebo Washout Period 1||0||
59753845|NCT00620659|75872895|FG005|NOT COMPLETED|Placebo Washout Period 1||0||
59753846|NCT00620659|75872890|FG000|STARTED|Treatment Period 2||18||
59753847|NCT00620659|75872891|FG001|STARTED|Treatment Period 2||21||
59753848|NCT00620659|75872892|FG002|STARTED|Treatment Period 2||20||
59753849|NCT00620659|75872893|FG003|STARTED|Treatment Period 2||18||
59753850|NCT00620659|75872894|FG004|STARTED|Treatment Period 2||20||
59753851|NCT00620659|75872895|FG005|STARTED|Treatment Period 2||20||
59753852|NCT00620659|75872890|FG000|COMPLETED|Treatment Period 2||18||
59753853|NCT00620659|75872891|FG001|COMPLETED|Treatment Period 2||18||
59753854|NCT00620659|75872892|FG002|COMPLETED|Treatment Period 2||19||
59753855|NCT00620659|75872893|FG003|COMPLETED|Treatment Period 2||18||
59753856|NCT00620659|75872894|FG004|COMPLETED|Treatment Period 2||15||
59753857|NCT00620659|75872895|FG005|COMPLETED|Treatment Period 2||20||
59753858|NCT00620659|75872890|FG000|NOT COMPLETED|Treatment Period 2||0||
59753859|NCT00620659|75872891|FG001|NOT COMPLETED|Treatment Period 2||3||
59753860|NCT00620659|75872892|FG002|NOT COMPLETED|Treatment Period 2||1||
59753861|NCT00620659|75872893|FG003|NOT COMPLETED|Treatment Period 2||0||
59753862|NCT00620659|75872894|FG004|NOT COMPLETED|Treatment Period 2||5||
59753863|NCT00620659|75872895|FG005|NOT COMPLETED|Treatment Period 2||0||
59753864|NCT00620659|75872890|FG000|STARTED|Placebo Washout Period 2||18||
59753865|NCT00620659|75872891|FG001|STARTED|Placebo Washout Period 2||18||
59753866|NCT00620659|75872892|FG002|STARTED|Placebo Washout Period 2||19||
59753867|NCT00620659|75872893|FG003|STARTED|Placebo Washout Period 2||18||
59753868|NCT00620659|75872894|FG004|STARTED|Placebo Washout Period 2||15||
59753869|NCT00620659|75872895|FG005|STARTED|Placebo Washout Period 2||20||
59883847|NCT03643575|76006980|FG001|NOT COMPLETED|Period 1||0||
59883848|NCT03643575|76006981|FG002|NOT COMPLETED|Period 1||0||
59883849|NCT03643575|76006982|FG003|NOT COMPLETED|Period 1||0||
59883850|NCT03643575|76006983|FG004|NOT COMPLETED|Period 1||0||
59883851|NCT03643575|76006984|FG005|NOT COMPLETED|Period 1||0||
59883852|NCT03643575|76006979|FG000|STARTED|Washout: 7 Days||5||
59883853|NCT03643575|76006980|FG001|STARTED|Washout: 7 Days||5||
59883854|NCT03643575|76006981|FG002|STARTED|Washout: 7 Days||5||
59883855|NCT03643575|76006982|FG003|STARTED|Washout: 7 Days||5||
59883856|NCT03643575|76006983|FG004|STARTED|Washout: 7 Days||5||
59883857|NCT03643575|76006984|FG005|STARTED|Washout: 7 Days||5||
59883858|NCT03643575|76006979|FG000|COMPLETED|Washout: 7 Days||4||
59883859|NCT03643575|76006980|FG001|COMPLETED|Washout: 7 Days||5||
59883860|NCT03643575|76006981|FG002|COMPLETED|Washout: 7 Days||5||
59883861|NCT03643575|76006982|FG003|COMPLETED|Washout: 7 Days||4||
59883862|NCT03643575|76006983|FG004|COMPLETED|Washout: 7 Days||5||
59883863|NCT03643575|76006984|FG005|COMPLETED|Washout: 7 Days||5||
59883864|NCT03643575|76006979|FG000|NOT COMPLETED|Washout: 7 Days||1||
59883865|NCT03643575|76006980|FG001|NOT COMPLETED|Washout: 7 Days||0||
59883866|NCT03643575|76006981|FG002|NOT COMPLETED|Washout: 7 Days||0||
59883867|NCT03643575|76006982|FG003|NOT COMPLETED|Washout: 7 Days||1||
59883868|NCT03643575|76006983|FG004|NOT COMPLETED|Washout: 7 Days||0||
59883869|NCT03643575|76006984|FG005|NOT COMPLETED|Washout: 7 Days||0||
59883870|NCT03643575|76006979|FG000|STARTED|Period 2||4||
59883871|NCT03643575|76006980|FG001|STARTED|Period 2||5||
59883872|NCT03643575|76006981|FG002|STARTED|Period 2||5||
59883873|NCT03643575|76006982|FG003|STARTED|Period 2||4||
59883874|NCT03643575|76006983|FG004|STARTED|Period 2||5||
59883875|NCT03643575|76006984|FG005|STARTED|Period 2||5||
59883876|NCT03643575|76006979|FG000|COMPLETED|Period 2||4||
59883877|NCT03643575|76006980|FG001|COMPLETED|Period 2||5||
59883878|NCT03643575|76006981|FG002|COMPLETED|Period 2||5||
59883879|NCT03643575|76006982|FG003|COMPLETED|Period 2||4||
59883880|NCT03643575|76006983|FG004|COMPLETED|Period 2||5||
59883881|NCT03643575|76006984|FG005|COMPLETED|Period 2||5||
59883882|NCT03643575|76006979|FG000|NOT COMPLETED|Period 2||0||
59883883|NCT03643575|76006980|FG001|NOT COMPLETED|Period 2||0||
59883884|NCT03643575|76006981|FG002|NOT COMPLETED|Period 2||0||
59883885|NCT03643575|76006982|FG003|NOT COMPLETED|Period 2||0||
59883886|NCT03643575|76006983|FG004|NOT COMPLETED|Period 2||0||
59883887|NCT03643575|76006984|FG005|NOT COMPLETED|Period 2||0||
59883888|NCT03643575|76006979|FG000|STARTED|Washout: 7 Days||4||
59883889|NCT03643575|76006980|FG001|STARTED|Washout: 7 Days||5||
59883890|NCT03643575|76006981|FG002|STARTED|Washout: 7 Days||5||
59883891|NCT03643575|76006982|FG003|STARTED|Washout: 7 Days||4||
59883892|NCT03643575|76006983|FG004|STARTED|Washout: 7 Days||5||
59753870|NCT00620659|75872890|FG000|COMPLETED|Placebo Washout Period 2||16||
59753871|NCT00620659|75872891|FG001|COMPLETED|Placebo Washout Period 2||18||
59753872|NCT00620659|75872892|FG002|COMPLETED|Placebo Washout Period 2||19||
59753873|NCT00620659|75872893|FG003|COMPLETED|Placebo Washout Period 2||18||
59753874|NCT00620659|75872894|FG004|COMPLETED|Placebo Washout Period 2||15||
59753875|NCT00620659|75872895|FG005|COMPLETED|Placebo Washout Period 2||20||
59753876|NCT00620659|75872890|FG000|NOT COMPLETED|Placebo Washout Period 2||2||
59753877|NCT00620659|75872891|FG001|NOT COMPLETED|Placebo Washout Period 2||0||
59753878|NCT00620659|75872892|FG002|NOT COMPLETED|Placebo Washout Period 2||0||
59753879|NCT00620659|75872893|FG003|NOT COMPLETED|Placebo Washout Period 2||0||
59753880|NCT00620659|75872894|FG004|NOT COMPLETED|Placebo Washout Period 2||0||
59883893|NCT03643575|76006984|FG005|STARTED|Washout: 7 Days||5||
59883894|NCT03643575|76006979|FG000|COMPLETED|Washout: 7 Days||4||
59883895|NCT03643575|76006980|FG001|COMPLETED|Washout: 7 Days||4||
59883896|NCT03643575|76006981|FG002|COMPLETED|Washout: 7 Days||5||
59883897|NCT03643575|76006982|FG003|COMPLETED|Washout: 7 Days||4||
59883898|NCT03643575|76006983|FG004|COMPLETED|Washout: 7 Days||5||
59883899|NCT03643575|76006984|FG005|COMPLETED|Washout: 7 Days||5||
59883900|NCT03643575|76006979|FG000|NOT COMPLETED|Washout: 7 Days||0||
59883901|NCT03643575|76006980|FG001|NOT COMPLETED|Washout: 7 Days||1||
59883902|NCT03643575|76006981|FG002|NOT COMPLETED|Washout: 7 Days||0||
59883903|NCT03643575|76006982|FG003|NOT COMPLETED|Washout: 7 Days||0||
59883904|NCT03643575|76006983|FG004|NOT COMPLETED|Washout: 7 Days||0||
59883905|NCT03643575|76006984|FG005|NOT COMPLETED|Washout: 7 Days||0||
59883906|NCT03643575|76006979|FG000|STARTED|Period 3||4||
59883907|NCT03643575|76006980|FG001|STARTED|Period 3||4||
59883908|NCT03643575|76006981|FG002|STARTED|Period 3||5||
59883909|NCT03643575|76006982|FG003|STARTED|Period 3||4||
59883910|NCT03643575|76006983|FG004|STARTED|Period 3||5||
59883911|NCT03643575|76006984|FG005|STARTED|Period 3||5||
59883912|NCT03643575|76006979|FG000|COMPLETED|Period 3||4||
59883913|NCT03643575|76006980|FG001|COMPLETED|Period 3||4||
59883914|NCT03643575|76006981|FG002|COMPLETED|Period 3||5||
59883915|NCT03643575|76006982|FG003|COMPLETED|Period 3||4||
59883916|NCT03643575|76006983|FG004|COMPLETED|Period 3||5||
59883917|NCT03643575|76006984|FG005|COMPLETED|Period 3||5||
59883918|NCT03643575|76006979|FG000|NOT COMPLETED|Period 3||0||
59883919|NCT03643575|76006980|FG001|NOT COMPLETED|Period 3||0||
59883920|NCT03643575|76006981|FG002|NOT COMPLETED|Period 3||0||
59883921|NCT03643575|76006982|FG003|NOT COMPLETED|Period 3||0||
59883922|NCT03643575|76006983|FG004|NOT COMPLETED|Period 3||0||
59883923|NCT03643575|76006984|FG005|NOT COMPLETED|Period 3||0||
59883924|NCT02768194|76006992|FG000|STARTED|Period 1||4||
59883925|NCT02768194|76006993|FG001|STARTED|Period 1||4||
59883926|NCT02768194|76006994|FG002|STARTED|Period 1||4||
59883927|NCT02768194|76006995|FG003|STARTED|Period 1||4||
59883928|NCT02768194|76006996|FG004|STARTED|Period 1||4||
59883929|NCT02768194|76006997|FG005|STARTED|Period 1||4||
59883930|NCT02768194|76006992|FG000|COMPLETED|Period 1||4||
59883931|NCT02768194|76006993|FG001|COMPLETED|Period 1||4||
59883932|NCT02768194|76006994|FG002|COMPLETED|Period 1||4||
59883933|NCT02768194|76006995|FG003|COMPLETED|Period 1||3||
59883934|NCT02768194|76006996|FG004|COMPLETED|Period 1||4||
59883935|NCT02768194|76006997|FG005|COMPLETED|Period 1||4||
59883936|NCT02768194|76006992|FG000|NOT COMPLETED|Period 1||0||
59883937|NCT02768194|76006993|FG001|NOT COMPLETED|Period 1||0||
59883938|NCT02768194|76006994|FG002|NOT COMPLETED|Period 1||0||
59883939|NCT02768194|76006995|FG003|NOT COMPLETED|Period 1||1||
59883940|NCT02768194|76006996|FG004|NOT COMPLETED|Period 1||0||
59883941|NCT02768194|76006997|FG005|NOT COMPLETED|Period 1||0||
59883942|NCT02768194|76006992|FG000|STARTED|Period 2||4||
59883943|NCT02768194|76006993|FG001|STARTED|Period 2||4||
59883944|NCT02768194|76006994|FG002|STARTED|Period 2||4||
59883945|NCT02768194|76006995|FG003|STARTED|Period 2||3||
59883946|NCT02768194|76006996|FG004|STARTED|Period 2||4||
59883947|NCT02768194|76006997|FG005|STARTED|Period 2||4||
59883948|NCT02768194|76006992|FG000|COMPLETED|Period 2||3||
59883949|NCT02768194|76006993|FG001|COMPLETED|Period 2||4||
59883950|NCT02768194|76006994|FG002|COMPLETED|Period 2||4||
59883951|NCT02768194|76006995|FG003|COMPLETED|Period 2||3||
59883952|NCT02768194|76006996|FG004|COMPLETED|Period 2||4||
59883953|NCT02768194|76006997|FG005|COMPLETED|Period 2||4||
59883954|NCT02768194|76006992|FG000|NOT COMPLETED|Period 2||1||
59883955|NCT02768194|76006993|FG001|NOT COMPLETED|Period 2||0||
59883956|NCT02768194|76006994|FG002|NOT COMPLETED|Period 2||0||
59883957|NCT02768194|76006995|FG003|NOT COMPLETED|Period 2||0||
59883958|NCT02768194|76006996|FG004|NOT COMPLETED|Period 2||0||
59883959|NCT02768194|76006997|FG005|NOT COMPLETED|Period 2||0||
59883960|NCT02768194|76006992|FG000|STARTED|Period 3||3||
59883961|NCT02768194|76006993|FG001|STARTED|Period 3||4||
59883962|NCT02768194|76006994|FG002|STARTED|Period 3||4||
59883963|NCT02768194|76006995|FG003|STARTED|Period 3||3||
59883964|NCT02768194|76006996|FG004|STARTED|Period 3||4||
59883965|NCT02768194|76006997|FG005|STARTED|Period 3||4||
59883966|NCT02768194|76006992|FG000|COMPLETED|Period 3||3||
59883967|NCT02768194|76006993|FG001|COMPLETED|Period 3||3||
59883968|NCT02768194|76006994|FG002|COMPLETED|Period 3||4||
59883969|NCT02768194|76006995|FG003|COMPLETED|Period 3||3||
59883970|NCT02768194|76006996|FG004|COMPLETED|Period 3||4||
59883971|NCT02768194|76006997|FG005|COMPLETED|Period 3||4||
59883972|NCT02768194|76006992|FG000|NOT COMPLETED|Period 3||0||
59883973|NCT02768194|76006993|FG001|NOT COMPLETED|Period 3||1||
59883974|NCT02768194|76006994|FG002|NOT COMPLETED|Period 3||0||
59883975|NCT02768194|76006995|FG003|NOT COMPLETED|Period 3||0||
59883976|NCT02768194|76006996|FG004|NOT COMPLETED|Period 3||0||
59883977|NCT02768194|76006997|FG005|NOT COMPLETED|Period 3||0||
59883978|NCT00130793|76007007|FG000|STARTED|Overall Study||183||
59883979|NCT00130793|76007008|FG001|STARTED|Overall Study||185||
59883980|NCT00130793|76007007|FG000|Vaccinated|Overall Study|One subject was allocated but not vaccinated.|182||
59883981|NCT00130793|76007008|FG001|Vaccinated|Overall Study||185||
59883982|NCT00130793|76007007|FG000|COMPLETED|Overall Study|Subject received vaccine, completed blood draws, returned vaccination report card (VRC) at Week 4|180||
59883983|NCT00130793|76007008|FG001|COMPLETED|Overall Study|Subject received vaccine, completed blood draws, returned VRC at Week 4|181||
59883984|NCT00130793|76007007|FG000|NOT COMPLETED|Overall Study||3||
59883985|NCT00130793|76007008|FG001|NOT COMPLETED|Overall Study||4||
59883986|NCT03818399|76007015|FG000|STARTED|Overall Study||19||
59883987|NCT03818399|76007015|FG000|COMPLETED|Overall Study||5||
59883988|NCT03818399|76007015|FG000|NOT COMPLETED|Overall Study||14||
59883989|NCT03642873|76007019|FG000|STARTED|First Intervention (1 Day)||4||
59883990|NCT03642873|76007020|FG001|STARTED|First Intervention (1 Day)||4||
59883991|NCT03642873|76007021|FG002|STARTED|First Intervention (1 Day)||4||
59883992|NCT03642873|76007022|FG003|STARTED|First Intervention (1 Day)||4||
59883993|NCT03642873|76007023|FG004|STARTED|First Intervention (1 Day)||4||
59883994|NCT03642873|76007024|FG005|STARTED|First Intervention (1 Day)||4||
59883995|NCT03642873|76007019|FG000|COMPLETED|First Intervention (1 Day)||4||
59883996|NCT03642873|76007020|FG001|COMPLETED|First Intervention (1 Day)||4||
59883997|NCT03642873|76007021|FG002|COMPLETED|First Intervention (1 Day)||4||
59883998|NCT03642873|76007022|FG003|COMPLETED|First Intervention (1 Day)||4||
59883999|NCT03642873|76007023|FG004|COMPLETED|First Intervention (1 Day)||4||
59884000|NCT03642873|76007024|FG005|COMPLETED|First Intervention (1 Day)||4||
59884001|NCT03642873|76007019|FG000|NOT COMPLETED|First Intervention (1 Day)||0||
59884002|NCT03642873|76007020|FG001|NOT COMPLETED|First Intervention (1 Day)||0||
59884003|NCT03642873|76007021|FG002|NOT COMPLETED|First Intervention (1 Day)||0||
59884004|NCT03642873|76007022|FG003|NOT COMPLETED|First Intervention (1 Day)||0||
59884005|NCT03642873|76007023|FG004|NOT COMPLETED|First Intervention (1 Day)||0||
59884006|NCT03642873|76007024|FG005|NOT COMPLETED|First Intervention (1 Day)||0||
59884007|NCT03642873|76007019|FG000|STARTED|Washout (7 Days)||4||
59884008|NCT03642873|76007020|FG001|STARTED|Washout (7 Days)||4||
60011595|NCT03963895|76127479|FG002|NOT COMPLETED|Dosing Period (Study Day 1)||0||
60011596|NCT03963895|76127477|FG000|STARTED|Recovery Period (Study Day 3)||12||
60011597|NCT03963895|76127478|FG001|STARTED|Recovery Period (Study Day 3)||12||
60011598|NCT03963895|76127479|FG002|STARTED|Recovery Period (Study Day 3)||12||
60011599|NCT03963895|76127477|FG000|COMPLETED|Recovery Period (Study Day 3)||12||
60011600|NCT03963895|76127478|FG001|COMPLETED|Recovery Period (Study Day 3)||12||
60011601|NCT03963895|76127479|FG002|COMPLETED|Recovery Period (Study Day 3)||12||
60011602|NCT03963895|76127477|FG000|NOT COMPLETED|Recovery Period (Study Day 3)||0||
60011603|NCT03963895|76127478|FG001|NOT COMPLETED|Recovery Period (Study Day 3)||0||
60011604|NCT03963895|76127479|FG002|NOT COMPLETED|Recovery Period (Study Day 3)||0||
60011605|NCT03963895|76127477|FG000|STARTED|Follow-up Period (Study Day 14)||12||
60011606|NCT03963895|76127478|FG001|STARTED|Follow-up Period (Study Day 14)||12||
60011607|NCT03963895|76127479|FG002|STARTED|Follow-up Period (Study Day 14)||12||
60011608|NCT03963895|76127477|FG000|COMPLETED|Follow-up Period (Study Day 14)||12||
59884009|NCT03642873|76007021|FG002|STARTED|Washout (7 Days)||4||
59884010|NCT03642873|76007022|FG003|STARTED|Washout (7 Days)||4||
59884011|NCT03642873|76007023|FG004|STARTED|Washout (7 Days)||4||
59884012|NCT03642873|76007024|FG005|STARTED|Washout (7 Days)||4||
59884013|NCT03642873|76007019|FG000|COMPLETED|Washout (7 Days)||4||
59884014|NCT03642873|76007020|FG001|COMPLETED|Washout (7 Days)||4||
59884015|NCT03642873|76007021|FG002|COMPLETED|Washout (7 Days)||4||
59884016|NCT03642873|76007022|FG003|COMPLETED|Washout (7 Days)||4||
59884017|NCT03642873|76007023|FG004|COMPLETED|Washout (7 Days)||4||
59884018|NCT03642873|76007024|FG005|COMPLETED|Washout (7 Days)||4||
59884019|NCT03642873|76007019|FG000|NOT COMPLETED|Washout (7 Days)||0||
59884020|NCT03642873|76007020|FG001|NOT COMPLETED|Washout (7 Days)||0||
60011609|NCT03963895|76127478|FG001|COMPLETED|Follow-up Period (Study Day 14)||11||
59884021|NCT03642873|76007021|FG002|NOT COMPLETED|Washout (7 Days)||0||
59884022|NCT03642873|76007022|FG003|NOT COMPLETED|Washout (7 Days)||0||
59884023|NCT03642873|76007023|FG004|NOT COMPLETED|Washout (7 Days)||0||
59884024|NCT03642873|76007024|FG005|NOT COMPLETED|Washout (7 Days)||0||
59884025|NCT03642873|76007019|FG000|STARTED|Second Intervention (1 Day)||4||
59884026|NCT03642873|76007020|FG001|STARTED|Second Intervention (1 Day)||4||
59884027|NCT03642873|76007021|FG002|STARTED|Second Intervention (1 Day)||4||
59884028|NCT03642873|76007022|FG003|STARTED|Second Intervention (1 Day)||4||
60011610|NCT03963895|76127479|FG002|COMPLETED|Follow-up Period (Study Day 14)||12||
60011611|NCT03963895|76127477|FG000|NOT COMPLETED|Follow-up Period (Study Day 14)||0||
60011612|NCT03963895|76127478|FG001|NOT COMPLETED|Follow-up Period (Study Day 14)||1||
60011613|NCT03963895|76127479|FG002|NOT COMPLETED|Follow-up Period (Study Day 14)||0||
60011614|NCT03367819|76127489|FG000|STARTED|Overall Study||24||
60011615|NCT03367819|76127490|FG001|STARTED|Overall Study||20||
60011616|NCT03367819|76127489|FG000|COMPLETED|Overall Study||0||
60011617|NCT03367819|76127490|FG001|COMPLETED|Overall Study||1||
60011618|NCT03367819|76127489|FG000|NOT COMPLETED|Overall Study||24||
60011619|NCT03367819|76127490|FG001|NOT COMPLETED|Overall Study||19||
60011620|NCT02002819|76127503|FG000|STARTED|Overall Study||17||
60011621|NCT02002819|76127504|FG001|STARTED|Overall Study||17||
60011622|NCT02002819|76127503|FG000|COMPLETED|Overall Study|4 Discontinued intervention because of participant's decision|13||
60011623|NCT02002819|76127504|FG001|COMPLETED|Overall Study|"1 Discontinued intervention because of participant's decision~1 Excluded per protocol because of biomarkers inconsistent with AD"|15||
60011624|NCT02002819|76127503|FG000|NOT COMPLETED|Overall Study||4||
60011625|NCT02002819|76127504|FG001|NOT COMPLETED|Overall Study||2||
60011626|NCT01597193|76127533|FG000|STARTED|Stage 1: Dose Escalation (141 Days)||7||
59884029|NCT03642873|76007023|FG004|STARTED|Second Intervention (1 Day)||4||
59884030|NCT03642873|76007024|FG005|STARTED|Second Intervention (1 Day)||4||
59884031|NCT03642873|76007019|FG000|COMPLETED|Second Intervention (1 Day)||4||
59884032|NCT03642873|76007020|FG001|COMPLETED|Second Intervention (1 Day)||4||
59884033|NCT03642873|76007021|FG002|COMPLETED|Second Intervention (1 Day)||4||
59884034|NCT03642873|76007022|FG003|COMPLETED|Second Intervention (1 Day)||4||
59884035|NCT03642873|76007023|FG004|COMPLETED|Second Intervention (1 Day)||4||
59884036|NCT03642873|76007024|FG005|COMPLETED|Second Intervention (1 Day)||4||
59884037|NCT03642873|76007019|FG000|NOT COMPLETED|Second Intervention (1 Day)||0||
59884038|NCT03642873|76007020|FG001|NOT COMPLETED|Second Intervention (1 Day)||0||
59884039|NCT03642873|76007021|FG002|NOT COMPLETED|Second Intervention (1 Day)||0||
59884040|NCT03642873|76007022|FG003|NOT COMPLETED|Second Intervention (1 Day)||0||
59884041|NCT03642873|76007023|FG004|NOT COMPLETED|Second Intervention (1 Day)||0||
59884042|NCT03642873|76007024|FG005|NOT COMPLETED|Second Intervention (1 Day)||0||
59884043|NCT03642873|76007019|FG000|STARTED|Washout (7 Days)||4||
59884044|NCT03642873|76007020|FG001|STARTED|Washout (7 Days)||4||
59884045|NCT03642873|76007021|FG002|STARTED|Washout (7 Days)||4||
59884046|NCT03642873|76007022|FG003|STARTED|Washout (7 Days)||4||
59884047|NCT03642873|76007023|FG004|STARTED|Washout (7 Days)||4||
59884048|NCT03642873|76007024|FG005|STARTED|Washout (7 Days)||4||
59606311|NCT04646148|75716692|FG008|STARTED|Overall Study||1||
59606312|NCT04646148|75716693|FG009|STARTED|Overall Study||2||
59606313|NCT04646148|75716694|FG010|STARTED|Overall Study||1||
59606314|NCT04646148|75716695|FG011|STARTED|Overall Study||2||
59606315|NCT04646148|75716696|FG012|STARTED|Overall Study||1||
59606316|NCT04646148|75716697|FG013|STARTED|Overall Study||1||
59606317|NCT04646148|75716698|FG014|STARTED|Overall Study||2||
59606318|NCT04646148|75716699|FG015|STARTED|Overall Study||2||
59606319|NCT04646148|75716684|FG000|COMPLETED|Overall Study||0||
59606320|NCT04646148|75716685|FG001|COMPLETED|Overall Study||0||
59606321|NCT04646148|75716686|FG002|COMPLETED|Overall Study||0||
59606322|NCT04646148|75716687|FG003|COMPLETED|Overall Study||1||
59606323|NCT04646148|75716688|FG004|COMPLETED|Overall Study||0||
59753881|NCT00620659|75872895|FG005|NOT COMPLETED|Placebo Washout Period 2||0||
59753882|NCT00620659|75872890|FG000|STARTED|Treatment Period 3||16||
59884049|NCT03642873|76007019|FG000|COMPLETED|Washout (7 Days)||4||
59884050|NCT03642873|76007020|FG001|COMPLETED|Washout (7 Days)||4||
59884051|NCT03642873|76007021|FG002|COMPLETED|Washout (7 Days)||4||
59884052|NCT03642873|76007022|FG003|COMPLETED|Washout (7 Days)||4||
59606324|NCT04646148|75716689|FG005|COMPLETED|Overall Study||1||
59606325|NCT04646148|75716690|FG006|COMPLETED|Overall Study||0||
59753883|NCT00620659|75872891|FG001|STARTED|Treatment Period 3||18||
59753884|NCT00620659|75872892|FG002|STARTED|Treatment Period 3||19||
59753885|NCT00620659|75872893|FG003|STARTED|Treatment Period 3||18||
59753886|NCT00620659|75872894|FG004|STARTED|Treatment Period 3||15||
59753887|NCT00620659|75872895|FG005|STARTED|Treatment Period 3||20||
59753888|NCT00620659|75872890|FG000|COMPLETED|Treatment Period 3||16||
59753889|NCT00620659|75872891|FG001|COMPLETED|Treatment Period 3||16||
59753890|NCT00620659|75872892|FG002|COMPLETED|Treatment Period 3||19||
59753891|NCT00620659|75872893|FG003|COMPLETED|Treatment Period 3||17||
59753892|NCT00620659|75872894|FG004|COMPLETED|Treatment Period 3||15||
59753893|NCT00620659|75872895|FG005|COMPLETED|Treatment Period 3||20||
59606326|NCT04646148|75716691|FG007|COMPLETED|Overall Study||1||
59884053|NCT03642873|76007023|FG004|COMPLETED|Washout (7 Days)||4||
59884054|NCT03642873|76007024|FG005|COMPLETED|Washout (7 Days)||4||
59884055|NCT03642873|76007019|FG000|NOT COMPLETED|Washout (7 Days)||0||
59884056|NCT03642873|76007020|FG001|NOT COMPLETED|Washout (7 Days)||0||
59884057|NCT03642873|76007021|FG002|NOT COMPLETED|Washout (7 Days)||0||
59884058|NCT03642873|76007022|FG003|NOT COMPLETED|Washout (7 Days)||0||
59884059|NCT03642873|76007023|FG004|NOT COMPLETED|Washout (7 Days)||0||
59884060|NCT03642873|76007024|FG005|NOT COMPLETED|Washout (7 Days)||0||
59884061|NCT03642873|76007019|FG000|STARTED|Third Intervention (1 Day)||4||
59884062|NCT03642873|76007020|FG001|STARTED|Third Intervention (1 Day)||4||
59884063|NCT03642873|76007021|FG002|STARTED|Third Intervention (1 Day)||4||
59884064|NCT03642873|76007022|FG003|STARTED|Third Intervention (1 Day)||4||
59884065|NCT03642873|76007023|FG004|STARTED|Third Intervention (1 Day)||4||
59884066|NCT03642873|76007024|FG005|STARTED|Third Intervention (1 Day)||4||
59884067|NCT03642873|76007019|FG000|COMPLETED|Third Intervention (1 Day)||4||
59884068|NCT03642873|76007020|FG001|COMPLETED|Third Intervention (1 Day)||4||
59884069|NCT03642873|76007021|FG002|COMPLETED|Third Intervention (1 Day)||4||
59884070|NCT03642873|76007022|FG003|COMPLETED|Third Intervention (1 Day)||4||
59884071|NCT03642873|76007023|FG004|COMPLETED|Third Intervention (1 Day)||3||
59884072|NCT03642873|76007024|FG005|COMPLETED|Third Intervention (1 Day)||4||
59884073|NCT03642873|76007019|FG000|NOT COMPLETED|Third Intervention (1 Day)||0||
59884074|NCT03642873|76007020|FG001|NOT COMPLETED|Third Intervention (1 Day)||0||
59884075|NCT03642873|76007021|FG002|NOT COMPLETED|Third Intervention (1 Day)||0||
59884076|NCT03642873|76007022|FG003|NOT COMPLETED|Third Intervention (1 Day)||0||
59884077|NCT03642873|76007023|FG004|NOT COMPLETED|Third Intervention (1 Day)||1||
59884078|NCT03642873|76007024|FG005|NOT COMPLETED|Third Intervention (1 Day)||0||
59884079|NCT03818321|76007038|FG000|STARTED|Overall Study||94||
59884080|NCT03818321|76007039|FG001|STARTED|Overall Study||91||
59884081|NCT03818321|76007038|FG000|COMPLETED|Overall Study||93||
59884082|NCT03818321|76007039|FG001|COMPLETED|Overall Study||89||
59884083|NCT03818321|76007038|FG000|NOT COMPLETED|Overall Study||1||
59884084|NCT03818321|76007039|FG001|NOT COMPLETED|Overall Study||2||
59753894|NCT00620659|75872890|FG000|NOT COMPLETED|Treatment Period 3||0||
59753895|NCT00620659|75872891|FG001|NOT COMPLETED|Treatment Period 3||2||
59753896|NCT00620659|75872892|FG002|NOT COMPLETED|Treatment Period 3||0||
59753897|NCT00620659|75872893|FG003|NOT COMPLETED|Treatment Period 3||1||
59753898|NCT00620659|75872894|FG004|NOT COMPLETED|Treatment Period 3||0||
59884085|NCT03616977|76007045|FG000|STARTED|Period 1||34||
59884086|NCT03616977|76007046|FG001|STARTED|Period 1||35||
59884087|NCT03616977|76007045|FG000|Received at Least One Dose of Study Drug|Period 1||34||
59884088|NCT03616977|76007046|FG001|Received at Least One Dose of Study Drug|Period 1||34||
59753899|NCT00620659|75872895|FG005|NOT COMPLETED|Treatment Period 3||0||
59753900|NCT00894686|75872908|FG000|STARTED|Overall Study||179||
59753901|NCT00894686|75872908|FG000|COMPLETED|Overall Study||123||
59753902|NCT00894686|75872908|FG000|NOT COMPLETED|Overall Study||56||
59753903|NCT00885846|75872915|FG000|STARTED|Overall Study|Cohort 1 = 5 Cohort 2 = 6|11||
59884089|NCT03616977|76007045|FG000|COMPLETED|Period 1||34||
59753904|NCT00885846|75872916|FG001|STARTED|Overall Study|Cohort 1 = 6 Cohort 2 = 5|11||
59753905|NCT00885846|75872917|FG002|STARTED|Overall Study|Cohort 1 = 4 Cohort 2 = 6|10||
59884090|NCT03616977|76007046|FG001|COMPLETED|Period 1||34||
59884091|NCT03616977|76007045|FG000|NOT COMPLETED|Period 1||0||
59884092|NCT03616977|76007046|FG001|NOT COMPLETED|Period 1||1||
59884093|NCT03616977|76007045|FG000|STARTED|Period 2||34||
59884094|NCT03616977|76007046|FG001|STARTED|Period 2||34||
59884095|NCT03616977|76007045|FG000|COMPLETED|Period 2||34||
59884096|NCT03616977|76007046|FG001|COMPLETED|Period 2||34||
59884097|NCT03616977|76007045|FG000|NOT COMPLETED|Period 2||0||
59884098|NCT03616977|76007046|FG001|NOT COMPLETED|Period 2||0||
59884099|NCT03616977|76007045|FG000|STARTED|Period 3||34||
59884100|NCT03616977|76007046|FG001|STARTED|Period 3|Participant completed Period 2 and withdrew from the study.|33||
59884101|NCT03616977|76007045|FG000|Received Study Drug|Period 3|Participant not dosed due to adverse event.|33||
59884102|NCT03616977|76007046|FG001|Received Study Drug|Period 3|Participant not dosed due to adverse event.|32||
59884103|NCT03616977|76007045|FG000|COMPLETED|Period 3||33||
59884104|NCT03616977|76007046|FG001|COMPLETED|Period 3||32||
59884105|NCT03616977|76007045|FG000|NOT COMPLETED|Period 3||1||
59884106|NCT03616977|76007046|FG001|NOT COMPLETED|Period 3||1||
59884107|NCT03616977|76007045|FG000|STARTED|Period 4||33||
59884108|NCT03616977|76007046|FG001|STARTED|Period 4||32||
59884109|NCT03616977|76007045|FG000|COMPLETED|Period 4||33||
59884110|NCT03616977|76007046|FG001|COMPLETED|Period 4||32||
59884111|NCT03616977|76007045|FG000|NOT COMPLETED|Period 4||0||
59884112|NCT03616977|76007046|FG001|NOT COMPLETED|Period 4||0||
59884113|NCT02767570|76007055|FG000|STARTED|Overall Study||34||
59884114|NCT02767570|76007056|FG001|STARTED|Overall Study||34||
59884115|NCT02767570|76007055|FG000|Per Protocol Week 6|Overall Study||31||
59606327|NCT04646148|75716692|FG008|COMPLETED|Overall Study||1||
59606328|NCT04646148|75716693|FG009|COMPLETED|Overall Study||2||
59606329|NCT04646148|75716694|FG010|COMPLETED|Overall Study||1||
59606330|NCT04646148|75716695|FG011|COMPLETED|Overall Study||2||
59753906|NCT00885846|75872915|FG000|COMPLETED|Overall Study|Cohort 1 = 3 Cohort 2 = 6|9||
59606331|NCT04646148|75716696|FG012|COMPLETED|Overall Study||1||
59753907|NCT00885846|75872916|FG001|COMPLETED|Overall Study|Cohort 1 = 1 Cohort 2 = 5|6||
59753908|NCT00885846|75872917|FG002|COMPLETED|Overall Study|Cohort 1 = 4 Cohort 2 = 6|8||
59753909|NCT00885846|75872915|FG000|NOT COMPLETED|Overall Study||2||
59606332|NCT04646148|75716697|FG013|COMPLETED|Overall Study||1||
59753910|NCT00885846|75872916|FG001|NOT COMPLETED|Overall Study||5||
59753911|NCT00885846|75872917|FG002|NOT COMPLETED|Overall Study||2||
59753912|NCT00621517|75872927|FG000|STARTED|Overall Study||29||
59753913|NCT00621517|75872928|FG001|STARTED|Overall Study||31||
59753914|NCT00621517|75872927|FG000|COMPLETED|Overall Study||22||
59753915|NCT00621517|75872928|FG001|COMPLETED|Overall Study||24||
59753916|NCT00621517|75872927|FG000|NOT COMPLETED|Overall Study||7||
59753917|NCT00621517|75872928|FG001|NOT COMPLETED|Overall Study||7||
59884116|NCT02767570|76007056|FG001|Per Protocol Week 6|Overall Study||33||
59884117|NCT02767570|76007055|FG000|COMPLETED|Overall Study||25||
59884118|NCT02767570|76007056|FG001|COMPLETED|Overall Study||24||
59884119|NCT02767570|76007055|FG000|NOT COMPLETED|Overall Study||9||
59884120|NCT02767570|76007056|FG001|NOT COMPLETED|Overall Study||10||
59884121|NCT03816761|76007065|FG000|STARTED|First Treatment Period (7 Days)||4||
59950869|NCT01491893|76069770|FG007|COMPLETED|Overall Study||24||
59950870|NCT01491893|76069771|FG008|COMPLETED|Overall Study||15||
59950871|NCT01491893|76069772|FG009|COMPLETED|Overall Study||7||
59950872|NCT01491893|76069763|FG000|NOT COMPLETED|Overall Study||0||
59950873|NCT01491893|76069764|FG001|NOT COMPLETED|Overall Study||0||
59950874|NCT01491893|76069765|FG002|NOT COMPLETED|Overall Study||0||
59950875|NCT01491893|76069766|FG003|NOT COMPLETED|Overall Study||0||
59950876|NCT01491893|76069767|FG004|NOT COMPLETED|Overall Study||0||
59950877|NCT01491893|76069768|FG005|NOT COMPLETED|Overall Study||0||
59950878|NCT01491893|76069769|FG006|NOT COMPLETED|Overall Study||0||
59950879|NCT01491893|76069770|FG007|NOT COMPLETED|Overall Study||0||
59950880|NCT01491893|76069771|FG008|NOT COMPLETED|Overall Study||0||
59950881|NCT01491893|76069772|FG009|NOT COMPLETED|Overall Study||0||
59950882|NCT01483820|76069788|FG000|STARTED|Overall Study||8||
59950883|NCT01483820|76069788|FG000|COMPLETED|Overall Study||0||
59753918|NCT05333900|75872936|FG000|STARTED|Overall Study||7||
59753919|NCT05333900|75872937|FG001|STARTED|Overall Study||8||
59753920|NCT05333900|75872936|FG000|COMPLETED|Overall Study||6||
59753921|NCT05333900|75872937|FG001|COMPLETED|Overall Study||5||
59753922|NCT05333900|75872936|FG000|NOT COMPLETED|Overall Study||1||
59753923|NCT05333900|75872937|FG001|NOT COMPLETED|Overall Study||3||
59753924|NCT00573937|75872945|FG000|STARTED|Overall Study||0||
59753925|NCT00573937|75872946|FG001|STARTED|Overall Study||1||
59884122|NCT03816761|76007066|FG001|STARTED|First Treatment Period (7 Days)||4||
59884123|NCT03816761|76007067|FG002|STARTED|First Treatment Period (7 Days)||4||
59884124|NCT03816761|76007068|FG003|STARTED|First Treatment Period (7 Days)||4||
59884125|NCT03816761|76007069|FG004|STARTED|First Treatment Period (7 Days)||4||
59884126|NCT03816761|76007070|FG005|STARTED|First Treatment Period (7 Days)||4||
59884127|NCT03816761|76007065|FG000|COMPLETED|First Treatment Period (7 Days)||4||
59884128|NCT03816761|76007066|FG001|COMPLETED|First Treatment Period (7 Days)||4||
59884129|NCT03816761|76007067|FG002|COMPLETED|First Treatment Period (7 Days)||4||
59884130|NCT03816761|76007068|FG003|COMPLETED|First Treatment Period (7 Days)||4||
59884131|NCT03816761|76007069|FG004|COMPLETED|First Treatment Period (7 Days)||4||
59884132|NCT03816761|76007070|FG005|COMPLETED|First Treatment Period (7 Days)||3||
59884133|NCT03816761|76007065|FG000|NOT COMPLETED|First Treatment Period (7 Days)||0||
59884134|NCT03816761|76007066|FG001|NOT COMPLETED|First Treatment Period (7 Days)||0||
59884135|NCT03816761|76007067|FG002|NOT COMPLETED|First Treatment Period (7 Days)||0||
59884136|NCT03816761|76007068|FG003|NOT COMPLETED|First Treatment Period (7 Days)||0||
59884137|NCT03816761|76007069|FG004|NOT COMPLETED|First Treatment Period (7 Days)||0||
59884138|NCT03816761|76007070|FG005|NOT COMPLETED|First Treatment Period (7 Days)||1||
59884139|NCT03816761|76007065|FG000|STARTED|Second Treatment Period (7 Days)||4||
59884140|NCT03816761|76007066|FG001|STARTED|Second Treatment Period (7 Days)||4||
59884141|NCT03816761|76007067|FG002|STARTED|Second Treatment Period (7 Days)||4||
59884142|NCT03816761|76007068|FG003|STARTED|Second Treatment Period (7 Days)||4||
59884143|NCT03816761|76007069|FG004|STARTED|Second Treatment Period (7 Days)||4||
59753926|NCT00573937|75872945|FG000|COMPLETED|Overall Study||0||
59753927|NCT00573937|75872946|FG001|COMPLETED|Overall Study||0||
59753928|NCT00573937|75872945|FG000|NOT COMPLETED|Overall Study||0||
59753929|NCT00573937|75872946|FG001|NOT COMPLETED|Overall Study||1||
59753930|NCT00573859|75872952|FG000|STARTED|Medication Versus Placebo||27||
59753931|NCT00573859|75872952|FG000|COMPLETED|Medication Versus Placebo||15||
59753932|NCT00573859|75872952|FG000|NOT COMPLETED|Medication Versus Placebo||12||
59753933|NCT00573859|75872952|FG000|STARTED|Smoking Versus Abstinence||27||
59753934|NCT00573859|75872952|FG000|COMPLETED|Smoking Versus Abstinence||15||
59884144|NCT03816761|76007070|FG005|STARTED|Second Treatment Period (7 Days)||3||
59884145|NCT03816761|76007065|FG000|COMPLETED|Second Treatment Period (7 Days)||4||
59884146|NCT03816761|76007066|FG001|COMPLETED|Second Treatment Period (7 Days)||4||
59884147|NCT03816761|76007067|FG002|COMPLETED|Second Treatment Period (7 Days)||4||
59884148|NCT03816761|76007068|FG003|COMPLETED|Second Treatment Period (7 Days)||3||
59884149|NCT03816761|76007069|FG004|COMPLETED|Second Treatment Period (7 Days)||4||
59884150|NCT03816761|76007070|FG005|COMPLETED|Second Treatment Period (7 Days)||3||
59884151|NCT03816761|76007065|FG000|NOT COMPLETED|Second Treatment Period (7 Days)||0||
59753935|NCT00573859|75872952|FG000|NOT COMPLETED|Smoking Versus Abstinence||12||
59753936|NCT00831441|75872958|FG000|STARTED|Randomized||3687||
59753937|NCT00831441|75872959|FG001|STARTED|Randomized||3705||
59884152|NCT03816761|76007066|FG001|NOT COMPLETED|Second Treatment Period (7 Days)||0||
59884153|NCT03816761|76007067|FG002|NOT COMPLETED|Second Treatment Period (7 Days)||0||
59884154|NCT03816761|76007068|FG003|NOT COMPLETED|Second Treatment Period (7 Days)||1||
59884155|NCT03816761|76007069|FG004|NOT COMPLETED|Second Treatment Period (7 Days)||0||
59884156|NCT03816761|76007070|FG005|NOT COMPLETED|Second Treatment Period (7 Days)||0||
59884157|NCT02770612|76007092|FG000|STARTED|Overall Study||51||
59884158|NCT02770612|76007092|FG000|COMPLETED|Overall Study||50||
59884159|NCT02770612|76007092|FG000|NOT COMPLETED|Overall Study||1||
59884160|NCT03575871|76007099|FG000|STARTED|Overall Study||158||
59884161|NCT03575871|76007100|FG001|STARTED|Overall Study||155||
59753938|NCT00831441|75872958|FG000|Treated|Randomized||3643||
59753939|NCT00831441|75872959|FG001|Treated|Randomized||3672||
59884162|NCT03575871|76007101|FG002|STARTED|Overall Study||78||
59884163|NCT03575871|76007099|FG000|COMPLETED|Overall Study||137||
59884164|NCT03575871|76007100|FG001|COMPLETED|Overall Study||141||
59884165|NCT03575871|76007101|FG002|COMPLETED|Overall Study||52||
59884166|NCT03575871|76007099|FG000|NOT COMPLETED|Overall Study||21||
59884167|NCT03575871|76007100|FG001|NOT COMPLETED|Overall Study||14||
59884168|NCT03575871|76007101|FG002|NOT COMPLETED|Overall Study||26||
59884169|NCT03642717|76007109|FG000|STARTED|Overall Study||658||
59884170|NCT03642717|76007109|FG000|COMPLETED|Overall Study||620||
59884171|NCT03642717|76007109|FG000|NOT COMPLETED|Overall Study||38||
59884172|NCT02766478|76007116|FG000|STARTED|Overall Study||6||
59884173|NCT02766478|76007117|FG001|STARTED|Overall Study||4||
59884174|NCT02766478|76007116|FG000|COMPLETED|Overall Study||5||
59753940|NCT00831441|75872958|FG000|COMPLETED|Randomized||0||
59753941|NCT00831441|75872959|FG001|COMPLETED|Randomized||0||
59753942|NCT00831441|75872958|FG000|NOT COMPLETED|Randomized||3687||
59753943|NCT00831441|75872959|FG001|NOT COMPLETED|Randomized||3705||
59762671|NCT01886963|75882517|FG000|12 Week Follow Up|Overall Study||46||
59884175|NCT02766478|76007117|FG001|COMPLETED|Overall Study||3||
59884176|NCT02766478|76007116|FG000|NOT COMPLETED|Overall Study||1||
59884177|NCT02766478|76007117|FG001|NOT COMPLETED|Overall Study||1||
59884178|NCT02766400|76007125|FG000|STARTED|Overall Study||21||
59884179|NCT02766400|76007126|FG001|STARTED|Overall Study||22||
59753944|NCT00831441|75872958|FG000|STARTED|Follow Up (30 Days)|3508 participants entered the follow up period.|3508||
59753945|NCT00831441|75872959|FG001|STARTED|Follow Up (30 Days)|3529 participants entered the follow up period.|3529||
59753946|NCT00831441|75872958|FG000|COMPLETED|Follow Up (30 Days)||3375||
59753947|NCT00831441|75872959|FG001|COMPLETED|Follow Up (30 Days)||3355||
59753948|NCT00831441|75872958|FG000|NOT COMPLETED|Follow Up (30 Days)||133||
59753949|NCT00831441|75872959|FG001|NOT COMPLETED|Follow Up (30 Days)||174||
59753950|NCT00831129|75872968|FG000|STARTED|Overall Study||20||
59753951|NCT00831129|75872969|FG001|STARTED|Overall Study||33||
59753952|NCT00831129|75872968|FG000|COMPLETED|Overall Study||20||
59753953|NCT00831129|75872969|FG001|COMPLETED|Overall Study||23||
59753954|NCT00831129|75872968|FG000|NOT COMPLETED|Overall Study||0||
59753955|NCT00831129|75872969|FG001|NOT COMPLETED|Overall Study||10||
59753956|NCT00620113|75872979|FG000|STARTED|Overall Study||73||
59753957|NCT00620113|75872980|FG001|STARTED|Overall Study||74||
59753958|NCT00620113|75872981|FG002|STARTED|Overall Study|Includes 1 participant who also received 50 mg dose by accident during study.|71||
59753959|NCT00620113|75872982|FG003|STARTED|Overall Study||69||
59753960|NCT00620113|75872979|FG000|Efficacy/Safety Population|Overall Study||73||
59753961|NCT00620113|75872980|FG001|Efficacy/Safety Population|Overall Study||74||
59753962|NCT00620113|75872981|FG002|Efficacy/Safety Population|Overall Study||70||
59753963|NCT00620113|75872982|FG003|Efficacy/Safety Population|Overall Study||69||
59753964|NCT00620113|75872979|FG000|COMPLETED|Overall Study||60||
59753965|NCT00620113|75872980|FG001|COMPLETED|Overall Study||67||
59753966|NCT00620113|75872981|FG002|COMPLETED|Overall Study|Includes 1 participant who also received 50 mg dose by accident during study.|66||
59753967|NCT00620113|75872982|FG003|COMPLETED|Overall Study||59||
59753968|NCT00620113|75872979|FG000|NOT COMPLETED|Overall Study||13||
59753969|NCT00620113|75872980|FG001|NOT COMPLETED|Overall Study||7||
59753970|NCT00620113|75872981|FG002|NOT COMPLETED|Overall Study||5||
59753971|NCT00620113|75872982|FG003|NOT COMPLETED|Overall Study||10||
59753972|NCT00830115|75872992|FG000|STARTED|Overall Study||1045||
59753973|NCT00830115|75872992|FG000|COMPLETED|Overall Study||1042||
59753974|NCT00830115|75872992|FG000|NOT COMPLETED|Overall Study||3||
59753975|NCT00830037|75873000|FG000|STARTED|Overall Study||67||
59753976|NCT00830037|75873001|FG001|STARTED|Overall Study||69||
59753977|NCT00830037|75873000|FG000|COMPLETED|Overall Study||49||
59753978|NCT00830037|75873001|FG001|COMPLETED|Overall Study||50||
59753979|NCT00830037|75873000|FG000|NOT COMPLETED|Overall Study||18||
59753980|NCT00830037|75873001|FG001|NOT COMPLETED|Overall Study||19||
59753981|NCT00829413|75873007|FG000|STARTED|Overall Study||353||
59753982|NCT00829413|75873007|FG000|COMPLETED|Overall Study||259||
59753983|NCT00829413|75873007|FG000|NOT COMPLETED|Overall Study||94||
59753984|NCT00829179|75873018|FG000|STARTED|Overall Study||20||
59753985|NCT00829179|75873018|FG000|COMPLETED|Overall Study||19||
59753986|NCT00829179|75873018|FG000|NOT COMPLETED|Overall Study||1||
59753987|NCT00591591|75873024|FG000|STARTED|Overall Study||176||
59753988|NCT00591591|75873025|FG001|STARTED|Overall Study||133||
59753989|NCT00591591|75873024|FG000|COMPLETED|Overall Study||165||
59753990|NCT00591591|75873025|FG001|COMPLETED|Overall Study||94||
59753991|NCT00591591|75873024|FG000|NOT COMPLETED|Overall Study||11||
59753992|NCT00591591|75873025|FG001|NOT COMPLETED|Overall Study||39||
59753993|NCT00828945|75873031|FG000|STARTED|Overall Study||257||
59753994|NCT00828945|75873031|FG000|COMPLETED|Overall Study||216||
59753995|NCT00828945|75873031|FG000|NOT COMPLETED|Overall Study||41||
59753996|NCT00966875|75873044|FG000|STARTED|Part A||54||
59753997|NCT00966875|75873045|FG001|STARTED|Part A||40||
59753998|NCT00966875|75873046|FG002|STARTED|Part A||35||
59753999|NCT00966875|75873047|FG003|STARTED|Part A||37||
59754000|NCT00966875|75873048|FG004|STARTED|Part A||57||
59754001|NCT00966875|75873049|FG005|STARTED|Part A||37||
59754002|NCT00966875|75873050|FG006|STARTED|Part A||64||
59754003|NCT00966875|75873051|FG007|STARTED|Part A||65||
59754004|NCT00966875|75873052|FG008|STARTED|Part A||59||
59754005|NCT00966875|75873044|FG000|Received ≥1 Doses of Study Drug|Part A||54||
59754006|NCT00966875|75873045|FG001|Received ≥1 Doses of Study Drug|Part A||40||
59754007|NCT00966875|75873046|FG002|Received ≥1 Doses of Study Drug|Part A||35||
59754008|NCT00966875|75873047|FG003|Received ≥1 Doses of Study Drug|Part A||37||
59754009|NCT00966875|75873048|FG004|Received ≥1 Doses of Study Drug|Part A||57||
59754010|NCT00966875|75873049|FG005|Received ≥1 Doses of Study Drug|Part A||37||
59754011|NCT00966875|75873050|FG006|Received ≥1 Doses of Study Drug|Part A||64||
59754012|NCT00966875|75873051|FG007|Received ≥1 Doses of Study Drug|Part A||65||
59754013|NCT00966875|75873052|FG008|Received ≥1 Doses of Study Drug|Part A||59||
59754014|NCT00966875|75873044|FG000|COMPLETED|Part A||48||
59754015|NCT00966875|75873045|FG001|COMPLETED|Part A||36||
59754016|NCT00966875|75873046|FG002|COMPLETED|Part A||33||
59754017|NCT00966875|75873047|FG003|COMPLETED|Part A||34||
59754018|NCT00966875|75873048|FG004|COMPLETED|Part A||52||
59754019|NCT00966875|75873049|FG005|COMPLETED|Part A||33||
59754020|NCT00966875|75873050|FG006|COMPLETED|Part A||52||
59754021|NCT00966875|75873051|FG007|COMPLETED|Part A||58||
59754022|NCT00966875|75873052|FG008|COMPLETED|Part A||51||
59754023|NCT00966875|75873044|FG000|NOT COMPLETED|Part A||6||
59754024|NCT00966875|75873045|FG001|NOT COMPLETED|Part A||4||
59754025|NCT00966875|75873046|FG002|NOT COMPLETED|Part A||2||
59754026|NCT00966875|75873047|FG003|NOT COMPLETED|Part A||3||
59754027|NCT00966875|75873048|FG004|NOT COMPLETED|Part A||5||
59754028|NCT00966875|75873049|FG005|NOT COMPLETED|Part A||4||
59754029|NCT00966875|75873050|FG006|NOT COMPLETED|Part A||12||
59754030|NCT00966875|75873051|FG007|NOT COMPLETED|Part A||7||
59754031|NCT00966875|75873052|FG008|NOT COMPLETED|Part A||8||
59754032|NCT00966875|75873044|FG000|STARTED|Part B|Two (2) participants who completed Part A did not enter Part B.|46||
59754033|NCT00966875|75873045|FG001|STARTED|Part B||36||
59754034|NCT00966875|75873046|FG002|STARTED|Part B||33||
59754035|NCT00966875|75873047|FG003|STARTED|Part B||34||
59754036|NCT00966875|75873048|FG004|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|51||
59754037|NCT00966875|75873049|FG005|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|32||
59754038|NCT00966875|75873050|FG006|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|51||
59762672|NCT01886963|75882518|FG001|12 Week Follow Up|Overall Study||49||
59754039|NCT00966875|75873051|FG007|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|57||
59754040|NCT00966875|75873052|FG008|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|50||
59754041|NCT00966875|75873044|FG000|COMPLETED|Part B||41||
59754042|NCT00966875|75873045|FG001|COMPLETED|Part B||33||
59754043|NCT00966875|75873046|FG002|COMPLETED|Part B||27||
59754044|NCT00966875|75873047|FG003|COMPLETED|Part B||31||
59754045|NCT00966875|75873048|FG004|COMPLETED|Part B||44||
59754046|NCT00966875|75873049|FG005|COMPLETED|Part B||26||
59754047|NCT00966875|75873050|FG006|COMPLETED|Part B||29||
59754048|NCT00966875|75873051|FG007|COMPLETED|Part B||38||
59754049|NCT00966875|75873052|FG008|COMPLETED|Part B||32||
59754050|NCT00966875|75873044|FG000|NOT COMPLETED|Part B||5||
59754051|NCT00966875|75873045|FG001|NOT COMPLETED|Part B||3||
59754052|NCT00966875|75873046|FG002|NOT COMPLETED|Part B||6||
59754053|NCT00966875|75873047|FG003|NOT COMPLETED|Part B||3||
59754054|NCT00966875|75873048|FG004|NOT COMPLETED|Part B||7||
59754055|NCT00966875|75873049|FG005|NOT COMPLETED|Part B||6||
59754056|NCT00966875|75873050|FG006|NOT COMPLETED|Part B||22||
59754057|NCT00966875|75873051|FG007|NOT COMPLETED|Part B||19||
59754058|NCT00966875|75873052|FG008|NOT COMPLETED|Part B||18||
59754059|NCT00828711|75873128|FG000|STARTED|Overall Study||118||
59754060|NCT00828711|75873129|FG001|STARTED|Overall Study||125||
59754061|NCT00828711|75873130|FG002|STARTED|Overall Study||131||
59754062|NCT00828711|75873128|FG000|COMPLETED|Overall Study||117||
59754063|NCT00828711|75873129|FG001|COMPLETED|Overall Study||125||
59754064|NCT00828711|75873130|FG002|COMPLETED|Overall Study||131||
59754065|NCT00828711|75873128|FG000|NOT COMPLETED|Overall Study||1||
59754066|NCT00828711|75873129|FG001|NOT COMPLETED|Overall Study||0||
59754067|NCT00828711|75873130|FG002|NOT COMPLETED|Overall Study||0||
59754068|NCT00966719|75873140|FG000|STARTED|Overall Study||50||
59754069|NCT00966719|75873141|FG001|STARTED|Overall Study||49||
59754070|NCT00966719|75873140|FG000|COMPLETED|Overall Study||44||
59754071|NCT00966719|75873141|FG001|COMPLETED|Overall Study||38||
59754072|NCT00966719|75873140|FG000|NOT COMPLETED|Overall Study||6||
59754073|NCT00966719|75873141|FG001|NOT COMPLETED|Overall Study||11||
59754074|NCT00818649|75873147|FG000|STARTED|Overall Study||16||
60011627|NCT01597193|76127534|FG001|STARTED|Stage 1: Dose Escalation (141 Days)||8||
60011628|NCT01597193|76127535|FG002|STARTED|Stage 1: Dose Escalation (141 Days)||0||
60011629|NCT01597193|76127536|FG003|STARTED|Stage 1: Dose Escalation (141 Days)||0||
60011630|NCT01597193|76127537|FG004|STARTED|Stage 1: Dose Escalation (141 Days)||0||
60011631|NCT01597193|76127538|FG005|STARTED|Stage 1: Dose Escalation (141 Days)||0||
60011632|NCT01597193|76127539|FG006|STARTED|Stage 1: Dose Escalation (141 Days)||0||
60011633|NCT01597193|76127533|FG000|COMPLETED|Stage 1: Dose Escalation (141 Days)||0||
60011634|NCT01597193|76127534|FG001|COMPLETED|Stage 1: Dose Escalation (141 Days)||0||
60011635|NCT01597193|76127535|FG002|COMPLETED|Stage 1: Dose Escalation (141 Days)||0||
60011636|NCT01597193|76127536|FG003|COMPLETED|Stage 1: Dose Escalation (141 Days)||0||
60011637|NCT01597193|76127537|FG004|COMPLETED|Stage 1: Dose Escalation (141 Days)||0||
60011638|NCT01597193|76127538|FG005|COMPLETED|Stage 1: Dose Escalation (141 Days)||0||
60011639|NCT01597193|76127539|FG006|COMPLETED|Stage 1: Dose Escalation (141 Days)||0||
60011640|NCT01597193|76127533|FG000|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||7||
60011641|NCT01597193|76127534|FG001|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||8||
60011642|NCT01597193|76127535|FG002|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||0||
60011643|NCT01597193|76127536|FG003|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||0||
60011644|NCT01597193|76127537|FG004|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||0||
60011645|NCT01597193|76127538|FG005|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||0||
60011646|NCT01597193|76127539|FG006|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||0||
60011647|NCT01597193|76127533|FG000|STARTED|Stage 2: Dose Expansion (1067 Days)||0||
60011648|NCT01597193|76127534|FG001|STARTED|Stage 2: Dose Expansion (1067 Days)||0||
60011649|NCT01597193|76127535|FG002|STARTED|Stage 2: Dose Expansion (1067 Days)||14||
60011650|NCT01597193|76127536|FG003|STARTED|Stage 2: Dose Expansion (1067 Days)||20||
60011651|NCT01597193|76127537|FG004|STARTED|Stage 2: Dose Expansion (1067 Days)||16||
59754075|NCT00818649|75873147|FG000|COMPLETED|Overall Study||12||
59754076|NCT00818649|75873147|FG000|NOT COMPLETED|Overall Study||4||
59754077|NCT00961571|75873152|FG000|STARTED|Overall Study||50||
59754078|NCT00961571|75873152|FG000|COMPLETED|Overall Study|high percentage of patient drop-off study prior cancer progression|11||
59754079|NCT00961571|75873152|FG000|NOT COMPLETED|Overall Study||39||
59754080|NCT00964223|75873156|FG000|STARTED|Split Face Treatment (Weeks 1 and 2)||28||
59754081|NCT00964223|75873156|FG000|COMPLETED|Split Face Treatment (Weeks 1 and 2)||28||
59754082|NCT00964223|75873156|FG000|NOT COMPLETED|Split Face Treatment (Weeks 1 and 2)||0||
59754083|NCT00964223|75873156|FG000|STARTED|Full Face Treatment (Weeks 5 and 8)||28||
59754084|NCT00964223|75873156|FG000|COMPLETED|Full Face Treatment (Weeks 5 and 8)||27||
59754085|NCT00964223|75873156|FG000|NOT COMPLETED|Full Face Treatment (Weeks 5 and 8)||1||
59754086|NCT00620815|75873164|FG000|STARTED|Overall Study||199||
59754087|NCT00620815|75873165|FG001|STARTED|Overall Study||203||
59754088|NCT00620815|75873166|FG002|STARTED|Overall Study||199||
59754089|NCT00620815|75873164|FG000|COMPLETED|Overall Study||195||
59754090|NCT00620815|75873165|FG001|COMPLETED|Overall Study||192||
59754091|NCT00620815|75873166|FG002|COMPLETED|Overall Study||192||
59754092|NCT00620815|75873164|FG000|NOT COMPLETED|Overall Study||4||
59754093|NCT00620815|75873165|FG001|NOT COMPLETED|Overall Study||11||
59754094|NCT00620815|75873166|FG002|NOT COMPLETED|Overall Study||7||
59754095|NCT03372941|75873192|FG000|STARTED|Overall Study||6||
59754096|NCT03372941|75873193|FG001|STARTED|Overall Study||5||
59754097|NCT03372941|75873192|FG000|COMPLETED|Overall Study||4||
59754098|NCT03372941|75873193|FG001|COMPLETED|Overall Study||1||
59754099|NCT03372941|75873192|FG000|NOT COMPLETED|Overall Study||2||
59754100|NCT03372941|75873193|FG001|NOT COMPLETED|Overall Study||4||
59754101|NCT00619957|75873201|FG000|STARTED|Month 24 Double-Blind||93||
59754102|NCT00619957|75873202|FG001|STARTED|Month 24 Double-Blind||192||
59754103|NCT00619957|75873201|FG000|Intent to Treat (ITT Population)|Month 24 Double-Blind||93||
59754104|NCT00619957|75873202|FG001|Intent to Treat (ITT Population)|Month 24 Double-Blind|One subject did not take any study medication.|191||
59884180|NCT02766400|76007125|FG000|COMPLETED|Overall Study||19||
59884181|NCT02766400|76007126|FG001|COMPLETED|Overall Study||20||
59884182|NCT02766400|76007125|FG000|NOT COMPLETED|Overall Study||2||
59884183|NCT02766400|76007126|FG001|NOT COMPLETED|Overall Study||2||
59884184|NCT00104650|76007135|FG000|STARTED|Treatment Period (25 Weeks)||37||
59884185|NCT00104650|76007136|FG001|STARTED|Treatment Period (25 Weeks)||36||
59884186|NCT00104650|76007137|FG002|STARTED|Treatment Period (25 Weeks)||38||
59884187|NCT00104650|76007135|FG000|Received Investigational Product|Treatment Period (25 Weeks)||35||
59884188|NCT00104650|76007136|FG001|Received Investigational Product|Treatment Period (25 Weeks)||35||
59884189|NCT00104650|76007137|FG002|Received Investigational Product|Treatment Period (25 Weeks)||38||
59754105|NCT00619957|75873201|FG000|COMPLETED|Month 24 Double-Blind||75||
59754106|NCT00619957|75873202|FG001|COMPLETED|Month 24 Double-Blind||175||
59754107|NCT00619957|75873201|FG000|NOT COMPLETED|Month 24 Double-Blind||18||
59754108|NCT00619957|75873202|FG001|NOT COMPLETED|Month 24 Double-Blind||17||
59754109|NCT00619957|75873201|FG000|STARTED|Month 48 Open-Label||67||
59754110|NCT00619957|75873202|FG001|STARTED|Month 48 Open-Label||151||
59754111|NCT00619957|75873201|FG000|COMPLETED|Month 48 Open-Label||55||
59754112|NCT00619957|75873202|FG001|COMPLETED|Month 48 Open-Label||134||
59754113|NCT00619957|75873201|FG000|NOT COMPLETED|Month 48 Open-Label||12||
59754114|NCT00619957|75873202|FG001|NOT COMPLETED|Month 48 Open-Label||17||
59754115|NCT00961415|75873212|FG000|STARTED|Induction Treatment Phase||376||
59754116|NCT00961415|75873213|FG001|STARTED|Induction Treatment Phase||0||
59884190|NCT00104650|76007135|FG000|COMPLETED|Treatment Period (25 Weeks)||25||
59754117|NCT00961415|75873214|FG002|STARTED|Induction Treatment Phase||0||
59884191|NCT00104650|76007136|FG001|COMPLETED|Treatment Period (25 Weeks)||25||
59606333|NCT04646148|75716698|FG014|COMPLETED|Overall Study||2||
60011652|NCT01597193|76127538|FG005|STARTED|Stage 2: Dose Expansion (1067 Days)||23||
60011653|NCT01597193|76127539|FG006|STARTED|Stage 2: Dose Expansion (1067 Days)||11||
60011654|NCT01597193|76127533|FG000|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0||
60011655|NCT01597193|76127534|FG001|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0||
60011656|NCT01597193|76127535|FG002|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0||
60011657|NCT01597193|76127536|FG003|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0||
60011658|NCT01597193|76127537|FG004|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0||
60011659|NCT01597193|76127538|FG005|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0||
60011660|NCT01597193|76127539|FG006|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0||
60011661|NCT01597193|76127533|FG000|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||0||
60011662|NCT01597193|76127534|FG001|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||0||
60011663|NCT01597193|76127535|FG002|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||14||
60011664|NCT01597193|76127536|FG003|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||20||
60011665|NCT01597193|76127537|FG004|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||16||
60011666|NCT01597193|76127538|FG005|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||23||
60011667|NCT01597193|76127539|FG006|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||11||
60011668|NCT02649439|76127562|FG000|STARTED|Overall Study||40||
60011669|NCT02649439|76127563|FG001|STARTED|Overall Study||40||
60011670|NCT02649439|76127562|FG000|COMPLETED|Overall Study||13||
60011671|NCT02649439|76127563|FG001|COMPLETED|Overall Study||12||
60011672|NCT02649439|76127562|FG000|NOT COMPLETED|Overall Study||27||
60011673|NCT02649439|76127563|FG001|NOT COMPLETED|Overall Study||28||
60011674|NCT02622113|76127578|FG000|STARTED|Overall Study||67||
60011675|NCT02622113|76127579|FG001|STARTED|Overall Study||76||
60011676|NCT02622113|76127578|FG000|COMPLETED|Overall Study||62||
60011677|NCT02622113|76127579|FG001|COMPLETED|Overall Study||66||
60011678|NCT02622113|76127578|FG000|NOT COMPLETED|Overall Study||5||
60011679|NCT02622113|76127579|FG001|NOT COMPLETED|Overall Study||10||
60011680|NCT02651467|76127588|FG000|STARTED|Overall Study||74||
60011681|NCT02651467|76127589|FG001|STARTED|Overall Study||74||
60011682|NCT02651467|76127590|FG002|STARTED|Overall Study||73||
59754118|NCT00961415|75873212|FG000|COMPLETED|Induction Treatment Phase||253||
59754119|NCT00961415|75873213|FG001|COMPLETED|Induction Treatment Phase||0||
59754120|NCT00961415|75873214|FG002|COMPLETED|Induction Treatment Phase||0||
59754121|NCT00961415|75873212|FG000|NOT COMPLETED|Induction Treatment Phase||123||
59754122|NCT00961415|75873213|FG001|NOT COMPLETED|Induction Treatment Phase||0||
59754123|NCT00961415|75873214|FG002|NOT COMPLETED|Induction Treatment Phase||0||
59754124|NCT00961415|75873212|FG000|STARTED|Maintenance Treatment Phase||0||
59754125|NCT00961415|75873213|FG001|STARTED|Maintenance Treatment Phase||125||
59754126|NCT00961415|75873214|FG002|STARTED|Maintenance Treatment Phase||128||
59754127|NCT00961415|75873212|FG000|COMPLETED|Maintenance Treatment Phase||0||
59754128|NCT00961415|75873213|FG001|COMPLETED|Maintenance Treatment Phase||77||
59754129|NCT00961415|75873214|FG002|COMPLETED|Maintenance Treatment Phase||83||
59754130|NCT00961415|75873212|FG000|NOT COMPLETED|Maintenance Treatment Phase||0||
59754131|NCT00961415|75873213|FG001|NOT COMPLETED|Maintenance Treatment Phase||48||
59754132|NCT00961415|75873214|FG002|NOT COMPLETED|Maintenance Treatment Phase||45||
59754133|NCT00963599|75873232|FG000|STARTED|Overall Study||149||
59754134|NCT00963599|75873233|FG001|STARTED|Overall Study||155||
59754135|NCT00963599|75873234|FG002|STARTED|Overall Study||301||
59754136|NCT00963599|75873235|FG003|STARTED|Overall Study||302||
59884192|NCT00104650|76007137|FG002|COMPLETED|Treatment Period (25 Weeks)||28||
59884193|NCT00104650|76007135|FG000|NOT COMPLETED|Treatment Period (25 Weeks)||12||
59884194|NCT00104650|76007136|FG001|NOT COMPLETED|Treatment Period (25 Weeks)||11||
59884195|NCT00104650|76007137|FG002|NOT COMPLETED|Treatment Period (25 Weeks)||10||
59884196|NCT00104650|76007135|FG000|STARTED|Follow-up Period||25||
59884197|NCT00104650|76007136|FG001|STARTED|Follow-up Period||25||
59606334|NCT04646148|75716699|FG015|COMPLETED|Overall Study||0||
59606335|NCT04646148|75716684|FG000|NOT COMPLETED|Overall Study||0||
59884198|NCT00104650|76007137|FG002|STARTED|Follow-up Period||28||
59884199|NCT00104650|76007135|FG000|COMPLETED|Follow-up Period||14||
59884200|NCT00104650|76007136|FG001|COMPLETED|Follow-up Period||12||
59884201|NCT00104650|76007137|FG002|COMPLETED|Follow-up Period||18||
59884202|NCT00104650|76007135|FG000|NOT COMPLETED|Follow-up Period||11||
59884203|NCT00104650|76007136|FG001|NOT COMPLETED|Follow-up Period||13||
59884204|NCT00104650|76007137|FG002|NOT COMPLETED|Follow-up Period||10||
59884205|NCT03732807|76007152|FG000|STARTED|Treatment Period (up to Week 24)||132||
59884206|NCT03732807|76007153|FG001|STARTED|Treatment Period (up to Week 24)||130||
59884207|NCT03732807|76007154|FG002|STARTED|Treatment Period (up to Week 24)||130||
59884208|NCT03732807|76007155|FG003|STARTED|Treatment Period (up to Week 24)||132||
59884209|NCT03732807|76007156|FG004|STARTED|Treatment Period (up to Week 24)||63||
59884210|NCT03732807|76007157|FG005|STARTED|Treatment Period (up to Week 24)||65||
59884211|NCT03732807|76007158|FG006|STARTED|Treatment Period (up to Week 24)||66||
59884212|NCT03732807|76007152|FG000|COMPLETED|Treatment Period (up to Week 24)||122||
59884213|NCT03732807|76007153|FG001|COMPLETED|Treatment Period (up to Week 24)||124||
59884214|NCT03732807|76007154|FG002|COMPLETED|Treatment Period (up to Week 24)||121||
59884215|NCT03732807|76007155|FG003|COMPLETED|Treatment Period (up to Week 24)||117||
59884216|NCT03732807|76007156|FG004|COMPLETED|Treatment Period (up to Week 24)||58||
59884217|NCT03732807|76007157|FG005|COMPLETED|Treatment Period (up to Week 24)||63||
59884218|NCT03732807|76007158|FG006|COMPLETED|Treatment Period (up to Week 24)||61||
59884219|NCT03732807|76007152|FG000|NOT COMPLETED|Treatment Period (up to Week 24)||10||
59884220|NCT03732807|76007153|FG001|NOT COMPLETED|Treatment Period (up to Week 24)||6||
59884221|NCT03732807|76007154|FG002|NOT COMPLETED|Treatment Period (up to Week 24)||9||
59884222|NCT03732807|76007155|FG003|NOT COMPLETED|Treatment Period (up to Week 24)||15||
59884223|NCT03732807|76007156|FG004|NOT COMPLETED|Treatment Period (up to Week 24)||5||
59884224|NCT03732807|76007157|FG005|NOT COMPLETED|Treatment Period (up to Week 24)||2||
59884225|NCT03732807|76007158|FG006|NOT COMPLETED|Treatment Period (up to Week 24)||5||
59884226|NCT03732807|76007152|FG000|STARTED|Treatment Extension (Week 25 up to 48)|Participants continued dosing according to their assigned sequence in the preceding period.|113||
59884227|NCT03732807|76007153|FG001|STARTED|Treatment Extension (Week 25 up to 48)|Participants continued dosing according to their assigned sequence in the preceding period.|111||
59884228|NCT03732807|76007154|FG002|STARTED|Treatment Extension (Week 25 up to 48)|Participants continued dosing according to their assigned sequence in the preceding period.|108||
59884229|NCT03732807|76007155|FG003|STARTED|Treatment Extension (Week 25 up to 48)|Participants continued dosing according to their assigned sequence in the preceding period.|106||
59884230|NCT03732807|76007156|FG004|STARTED|Treatment Extension (Week 25 up to 48)|Participants continued dosing according to their assigned sequence in the preceding period.|49||
59754137|NCT00963599|75873232|FG000|COMPLETED|Overall Study||143||
59754138|NCT00963599|75873233|FG001|COMPLETED|Overall Study||149||
59754139|NCT00963599|75873234|FG002|COMPLETED|Overall Study||292||
59754140|NCT00963599|75873235|FG003|COMPLETED|Overall Study||288||
59754141|NCT00963599|75873232|FG000|NOT COMPLETED|Overall Study||6||
59754142|NCT00963599|75873233|FG001|NOT COMPLETED|Overall Study||6||
59754143|NCT00963599|75873234|FG002|NOT COMPLETED|Overall Study||9||
59754144|NCT00963599|75873235|FG003|NOT COMPLETED|Overall Study||14||
59754145|NCT00619801|75873247|FG000|STARTED|Overall Study||59||
59754146|NCT00619801|75873248|FG001|STARTED|Overall Study||114||
59754147|NCT00619801|75873247|FG000|Safety Population|Overall Study||59||
59884231|NCT03732807|76007157|FG005|STARTED|Treatment Extension (Week 25 up to 48)|Participants continued dosing according to their assigned sequence in the preceding period.|59||
59884232|NCT03732807|76007158|FG006|STARTED|Treatment Extension (Week 25 up to 48)|Participants continued dosing according to their assigned sequence in the preceding period.|57||
59884233|NCT03732807|76007152|FG000|COMPLETED|Treatment Extension (Week 25 up to 48)||107||
59884234|NCT03732807|76007153|FG001|COMPLETED|Treatment Extension (Week 25 up to 48)||100||
59884235|NCT03732807|76007154|FG002|COMPLETED|Treatment Extension (Week 25 up to 48)||103||
59606336|NCT04646148|75716685|FG001|NOT COMPLETED|Overall Study||1||
59606337|NCT04646148|75716686|FG002|NOT COMPLETED|Overall Study||0||
59606338|NCT04646148|75716687|FG003|NOT COMPLETED|Overall Study||0||
59606339|NCT04646148|75716688|FG004|NOT COMPLETED|Overall Study||1||
59754148|NCT00619801|75873248|FG001|Safety Population|Overall Study||114||
59754149|NCT00619801|75873247|FG000|COMPLETED|Overall Study||58||
59754150|NCT00619801|75873248|FG001|COMPLETED|Overall Study||111||
59754151|NCT00619801|75873247|FG000|NOT COMPLETED|Overall Study||1||
59754152|NCT00619801|75873248|FG001|NOT COMPLETED|Overall Study||3||
59754153|NCT00962741|75873254|FG000|STARTED|Overall Study||127||
59754154|NCT00962741|75873254|FG000|COMPLETED|Overall Study||119||
59754155|NCT00962741|75873254|FG000|NOT COMPLETED|Overall Study||8||
59754156|NCT00619645|75873258|FG000|STARTED|Overall Study||8||
59754157|NCT00619645|75873258|FG000|COMPLETED|Overall Study||7||
59884236|NCT03732807|76007155|FG003|COMPLETED|Treatment Extension (Week 25 up to 48)||97||
59884237|NCT03732807|76007156|FG004|COMPLETED|Treatment Extension (Week 25 up to 48)||44||
59884238|NCT03732807|76007157|FG005|COMPLETED|Treatment Extension (Week 25 up to 48)||56||
59884239|NCT03732807|76007158|FG006|COMPLETED|Treatment Extension (Week 25 up to 48)||53||
59884240|NCT03732807|76007152|FG000|NOT COMPLETED|Treatment Extension (Week 25 up to 48)||6||
59884241|NCT03732807|76007153|FG001|NOT COMPLETED|Treatment Extension (Week 25 up to 48)||11||
59884242|NCT03732807|76007154|FG002|NOT COMPLETED|Treatment Extension (Week 25 up to 48)||5||
59884243|NCT03732807|76007155|FG003|NOT COMPLETED|Treatment Extension (Week 25 up to 48)||9||
59884244|NCT03732807|76007156|FG004|NOT COMPLETED|Treatment Extension (Week 25 up to 48)||5||
59884245|NCT03732807|76007157|FG005|NOT COMPLETED|Treatment Extension (Week 25 up to 48)||3||
59884246|NCT03732807|76007158|FG006|NOT COMPLETED|Treatment Extension (Week 25 up to 48)||4||
59884247|NCT00104416|76007177|FG000|STARTED|Double-Blind Phase||77||
59884248|NCT00104416|76007178|FG001|STARTED|Double-Blind Phase||76||
59884249|NCT00104416|76007179|FG002|STARTED|Double-Blind Phase||0||
59884250|NCT00104416|76007180|FG003|STARTED|Double-Blind Phase||0||
59884251|NCT00104416|76007181|FG004|STARTED|Double-Blind Phase||0||
59884252|NCT00104416|76007177|FG000|COMPLETED|Double-Blind Phase||69||
59884253|NCT00104416|76007178|FG001|COMPLETED|Double-Blind Phase||66||
59884254|NCT00104416|76007179|FG002|COMPLETED|Double-Blind Phase||0||
59884255|NCT00104416|76007180|FG003|COMPLETED|Double-Blind Phase||0||
59884256|NCT00104416|76007181|FG004|COMPLETED|Double-Blind Phase||0||
59884257|NCT00104416|76007177|FG000|NOT COMPLETED|Double-Blind Phase||8||
59884258|NCT00104416|76007178|FG001|NOT COMPLETED|Double-Blind Phase||10||
59884259|NCT00104416|76007179|FG002|NOT COMPLETED|Double-Blind Phase||0||
59884260|NCT00104416|76007180|FG003|NOT COMPLETED|Double-Blind Phase||0||
59884261|NCT00104416|76007181|FG004|NOT COMPLETED|Double-Blind Phase||0||
59884262|NCT00104416|76007177|FG000|STARTED|Continuation Phase||0||
59884263|NCT00104416|76007178|FG001|STARTED|Continuation Phase||0||
59884264|NCT00104416|76007179|FG002|STARTED|Continuation Phase||69||
59884265|NCT00104416|76007180|FG003|STARTED|Continuation Phase|One participant did not complete the Double-Blind Phase but was enrolled in the Continuation Phase.|67||
59884266|NCT00104416|76007181|FG004|STARTED|Continuation Phase||32||
59884267|NCT00104416|76007177|FG000|COMPLETED|Continuation Phase||0||
59884268|NCT00104416|76007178|FG001|COMPLETED|Continuation Phase||0||
59606340|NCT04646148|75716689|FG005|NOT COMPLETED|Overall Study||1||
60011683|NCT02651467|76127588|FG000|COMPLETED|Overall Study||73||
60011684|NCT02651467|76127589|FG001|COMPLETED|Overall Study||74||
60011685|NCT02651467|76127590|FG002|COMPLETED|Overall Study||69||
60011686|NCT02651467|76127588|FG000|NOT COMPLETED|Overall Study||1||
60011687|NCT02651467|76127589|FG001|NOT COMPLETED|Overall Study||0||
60011688|NCT02651467|76127590|FG002|NOT COMPLETED|Overall Study||4||
60011689|NCT01865539|76127601|FG000|STARTED|Overall Study||21||
60011690|NCT01865539|76127602|FG001|STARTED|Overall Study||30||
60011691|NCT01865539|76127601|FG000|COMPLETED|Overall Study||21||
60011692|NCT01865539|76127602|FG001|COMPLETED|Overall Study||30||
60011693|NCT01865539|76127601|FG000|NOT COMPLETED|Overall Study||0||
60011694|NCT01865539|76127602|FG001|NOT COMPLETED|Overall Study||0||
60011695|NCT04910165|76127610|FG000|STARTED|Overall Study||50||
60011696|NCT04910165|76127611|FG001|STARTED|Overall Study||50||
60011697|NCT04910165|76127610|FG000|COMPLETED|Overall Study||50||
60011698|NCT04910165|76127611|FG001|COMPLETED|Overall Study||50||
60011699|NCT04910165|76127610|FG000|NOT COMPLETED|Overall Study||0||
60011700|NCT04910165|76127611|FG001|NOT COMPLETED|Overall Study||0||
60011701|NCT02620787|76127619|FG000|STARTED|Overall Study||12||
60011702|NCT02620787|76127620|FG001|STARTED|Overall Study||6||
60011703|NCT02620787|76127619|FG000|COMPLETED|Overall Study||10||
60011704|NCT02620787|76127620|FG001|COMPLETED|Overall Study||6||
60011705|NCT02620787|76127619|FG000|NOT COMPLETED|Overall Study||2||
60011706|NCT02620787|76127620|FG001|NOT COMPLETED|Overall Study||0||
60011707|NCT02651155|76127628|FG000|STARTED|Overall Study||99||
60011708|NCT02651155|76127629|FG001|STARTED|Overall Study||105||
60011709|NCT02651155|76127628|FG000|COMPLETED|Overall Study||93||
60011710|NCT02651155|76127629|FG001|COMPLETED|Overall Study||103||
60011711|NCT02651155|76127628|FG000|NOT COMPLETED|Overall Study||6||
60011712|NCT02651155|76127629|FG001|NOT COMPLETED|Overall Study||2||
60011713|NCT02619617|76127635|FG000|STARTED|Period 1 Placebo - 1st AttacK||28||
60011714|NCT02619617|76127636|FG001|STARTED|Period 1 Placebo - 1st AttacK||0||
60011715|NCT02619617|76127635|FG000|Participants Included in PD Analysis|Period 1 Placebo - 1st AttacK||20||
60011716|NCT02619617|76127636|FG001|Participants Included in PD Analysis|Period 1 Placebo - 1st AttacK||0||
60011717|NCT02619617|76127635|FG000|Participants in Safety Set for Period 1|Period 1 Placebo - 1st AttacK||28|participants in Cohort 1 in Period 1 received placebo s.c.|
60011718|NCT02619617|76127636|FG001|Participants in Safety Set for Period 1|Period 1 Placebo - 1st AttacK||0|participants in Cohort 1 in Period 1 received placebo s.c.|
60011719|NCT02619617|76127635|FG000|COMPLETED|Period 1 Placebo - 1st AttacK||28||
60011720|NCT02619617|76127636|FG001|COMPLETED|Period 1 Placebo - 1st AttacK||0||
60011721|NCT02619617|76127635|FG000|NOT COMPLETED|Period 1 Placebo - 1st AttacK||0||
60011722|NCT02619617|76127636|FG001|NOT COMPLETED|Period 1 Placebo - 1st AttacK||0||
60011723|NCT02619617|76127635|FG000|STARTED|Period 2 SOM230 - 2nd Attack||0||
60011724|NCT02619617|76127636|FG001|STARTED|Period 2 SOM230 - 2nd Attack||28||
59754158|NCT00619645|75873258|FG000|NOT COMPLETED|Overall Study||1||
59754159|NCT00619177|75873262|FG000|STARTED|Overall Study|treated set = 3569 (treated with Movalis)|3569||
59762532|NCT00872898|75882314|FG000|STARTED|Part One - Open Label, Pharmacokinetics||0||
59884269|NCT00104416|76007179|FG002|COMPLETED|Continuation Phase||63||
60011725|NCT02619617|76127635|FG000|Participants in Safety Set for Period 2|Period 2 SOM230 - 2nd Attack||0||
60011726|NCT02619617|76127636|FG001|Participants in Safety Set for Period 2|Period 2 SOM230 - 2nd Attack||28||
60011727|NCT02619617|76127635|FG000|COMPLETED|Period 2 SOM230 - 2nd Attack||0||
60011728|NCT02619617|76127636|FG001|COMPLETED|Period 2 SOM230 - 2nd Attack||24||
60011729|NCT02619617|76127635|FG000|NOT COMPLETED|Period 2 SOM230 - 2nd Attack||0||
60011730|NCT02619617|76127636|FG001|NOT COMPLETED|Period 2 SOM230 - 2nd Attack||4||
60011731|NCT04901897|76127647|FG000|STARTED|Overall Study||398||
59518974|NCT03393754|75612859|FG000|NOT COMPLETED|Overall Study||26||
59754160|NCT00619177|75873262|FG000|COMPLETED|Overall Study|"Due to some missing termination information, the number of completed may be larger than 3061."|3061||
59754161|NCT00619177|75873262|FG000|NOT COMPLETED|Overall Study||508||
59754162|NCT00818259|75873273|FG000|STARTED|Randomization||12||
59754163|NCT00818259|75873274|FG001|STARTED|Randomization||11||
59754164|NCT00818259|75873275|FG002|STARTED|Randomization||19||
59754165|NCT00818259|75873276|FG003|STARTED|Randomization||20||
59754166|NCT00818259|75873277|FG004|STARTED|Randomization||19||
59754167|NCT00818259|75873278|FG005|STARTED|Randomization||0||
59754168|NCT00818259|75873279|FG006|STARTED|Randomization||5||
59754169|NCT00818259|75873280|FG007|STARTED|Randomization||0||
59754170|NCT00818259|75873281|FG008|STARTED|Randomization||6||
60011732|NCT04901897|76127648|FG001|STARTED|Overall Study||202||
60011733|NCT04901897|76127649|FG002|STARTED|Overall Study||205||
60011734|NCT04901897|76127647|FG000|COMPLETED|Overall Study||393||
60011735|NCT04901897|76127648|FG001|COMPLETED|Overall Study||200||
60011736|NCT04901897|76127649|FG002|COMPLETED|Overall Study||203||
60011737|NCT04901897|76127647|FG000|NOT COMPLETED|Overall Study||5||
59754171|NCT00818259|75873273|FG000|COMPLETED|Randomization||12||
59754172|NCT00818259|75873274|FG001|COMPLETED|Randomization||11||
59754173|NCT00818259|75873275|FG002|COMPLETED|Randomization||19||
59754174|NCT00818259|75873276|FG003|COMPLETED|Randomization||20||
59754175|NCT00818259|75873277|FG004|COMPLETED|Randomization||19||
59754176|NCT00818259|75873278|FG005|COMPLETED|Randomization||0||
59884270|NCT00104416|76007180|FG003|COMPLETED|Continuation Phase||65||
59884271|NCT00104416|76007181|FG004|COMPLETED|Continuation Phase||27||
59884272|NCT00104416|76007177|FG000|NOT COMPLETED|Continuation Phase||0||
59884273|NCT00104416|76007178|FG001|NOT COMPLETED|Continuation Phase||0||
59884274|NCT00104416|76007179|FG002|NOT COMPLETED|Continuation Phase||6||
59884275|NCT00104416|76007180|FG003|NOT COMPLETED|Continuation Phase||2||
59884276|NCT00104416|76007181|FG004|NOT COMPLETED|Continuation Phase||5||
59884277|NCT03639987|76007195|FG000|STARTED|Overall Study||26||
60011738|NCT04901897|76127648|FG001|NOT COMPLETED|Overall Study||2||
60011739|NCT04901897|76127649|FG002|NOT COMPLETED|Overall Study||2||
60011740|NCT02650921|76127657|FG000|STARTED|Overall Study||92||184
60011741|NCT02650921|76127657|FG000|COMPLETED|Overall Study||84||168
59884278|NCT03639987|76007196|FG001|STARTED|Overall Study||26||
59884279|NCT03639987|76007195|FG000|COMPLETED|Overall Study||0||
59884280|NCT03639987|76007196|FG001|COMPLETED|Overall Study||0||
59884281|NCT03639987|76007195|FG000|NOT COMPLETED|Overall Study||26||
59884282|NCT03639987|76007196|FG001|NOT COMPLETED|Overall Study||26||
59884283|NCT02766088|76007202|FG000|STARTED|Overall Study||850||
60011742|NCT02650921|76127657|FG000|NOT COMPLETED|Overall Study||8||16
59884284|NCT02766088|76007202|FG000|COMPLETED|Overall Study||344||
59884285|NCT02766088|76007202|FG000|NOT COMPLETED|Overall Study||506||
60011743|NCT01596335|76127665|FG000|STARTED|Overall Study||16||
60011744|NCT01596335|76127666|FG001|STARTED|Overall Study||15||
60011745|NCT01596335|76127665|FG000|COMPLETED|Overall Study||11||
60011746|NCT01596335|76127666|FG001|COMPLETED|Overall Study||6||
60011747|NCT01596335|76127665|FG000|NOT COMPLETED|Overall Study||5||
60011748|NCT01596335|76127666|FG001|NOT COMPLETED|Overall Study||9||
59884286|NCT03639675|76007206|FG000|STARTED|Overall Study||16||
60011749|NCT02618759|76127674|FG000|STARTED|Overall Study||60||
60011750|NCT02618759|76127675|FG001|STARTED|Overall Study||59||
60011751|NCT02618759|76127674|FG000|COMPLETED|Overall Study||58||
60011752|NCT02618759|76127675|FG001|COMPLETED|Overall Study||54||
60011753|NCT02618759|76127674|FG000|NOT COMPLETED|Overall Study||2||
59884287|NCT03639675|76007206|FG000|Received Treatment|Overall Study||16||
60011754|NCT02618759|76127675|FG001|NOT COMPLETED|Overall Study||5||
59884288|NCT03639675|76007206|FG000|COMPLETED|Overall Study||15||
59884289|NCT03639675|76007206|FG000|NOT COMPLETED|Overall Study||1||
59884290|NCT03635775|76007214|FG000|STARTED|Overall Study||5||
59884291|NCT03635775|76007215|FG001|STARTED|Overall Study||0||
59884292|NCT03635775|76007216|FG002|STARTED|Overall Study||5||
59884293|NCT03635775|76007217|FG003|STARTED|Overall Study||10||
59884294|NCT03635775|76007214|FG000|COMPLETED|Overall Study||5||
59884295|NCT03635775|76007215|FG001|COMPLETED|Overall Study||0||
59884296|NCT03635775|76007216|FG002|COMPLETED|Overall Study||5||
59884297|NCT03635775|76007217|FG003|COMPLETED|Overall Study||9||
59884298|NCT03635775|76007214|FG000|NOT COMPLETED|Overall Study||0||
59884299|NCT03635775|76007215|FG001|NOT COMPLETED|Overall Study||0||
59884300|NCT03635775|76007216|FG002|NOT COMPLETED|Overall Study||0||
59884301|NCT03635775|76007217|FG003|NOT COMPLETED|Overall Study||1||
59884302|NCT03610581|76007229|FG000|STARTED|Overall Study||5||
59884303|NCT03610581|76007230|FG001|STARTED|Overall Study||4||
59884304|NCT03610581|76007229|FG000|Vaccinated|Overall Study||4||
59884305|NCT03610581|76007230|FG001|Vaccinated|Overall Study||4||
59884306|NCT03610581|76007229|FG000|COMPLETED|Overall Study||2||
59884307|NCT03610581|76007230|FG001|COMPLETED|Overall Study||3||
59884308|NCT03610581|76007229|FG000|NOT COMPLETED|Overall Study||3||
59884309|NCT03610581|76007230|FG001|NOT COMPLETED|Overall Study||1||
59884310|NCT03610269|76007236|FG000|STARTED|Overall Study||143||
59884311|NCT03610269|76007236|FG000|COMPLETED|Overall Study||127||
59884312|NCT03610269|76007236|FG000|NOT COMPLETED|Overall Study||16||
59884313|NCT00121667|76007244|FG000|STARTED|Short Term (ST) Period||192||
59884314|NCT00121667|76007245|FG001|STARTED|Short Term (ST) Period||191||
59884315|NCT00121667|76007246|FG002|STARTED|Short Term (ST) Period||181||
59884316|NCT00121667|76007247|FG003|STARTED|Short Term (ST) Period||179||
59884317|NCT00121667|76007244|FG000|COMPLETED|Short Term (ST) Period||148||
59884318|NCT00121667|76007245|FG001|COMPLETED|Short Term (ST) Period||143||
59884319|NCT00121667|76007246|FG002|COMPLETED|Short Term (ST) Period||140||
59884320|NCT00121667|76007247|FG003|COMPLETED|Short Term (ST) Period||112||
59884321|NCT00121667|76007244|FG000|NOT COMPLETED|Short Term (ST) Period||44||
59884322|NCT00121667|76007245|FG001|NOT COMPLETED|Short Term (ST) Period||48||
59884323|NCT00121667|76007246|FG002|NOT COMPLETED|Short Term (ST) Period||41||
59884324|NCT00121667|76007247|FG003|NOT COMPLETED|Short Term (ST) Period||67||
59884325|NCT00121667|76007244|FG000|STARTED|Short Term (ST) + Long Term (LT) Period||192||
59884326|NCT00121667|76007245|FG001|STARTED|Short Term (ST) + Long Term (LT) Period||191||
59884327|NCT00121667|76007246|FG002|STARTED|Short Term (ST) + Long Term (LT) Period||181||
59884328|NCT00121667|76007247|FG003|STARTED|Short Term (ST) + Long Term (LT) Period||179||
59884329|NCT00121667|76007244|FG000|Completed Study Without Being Rescued|Short Term (ST) + Long Term (LT) Period||14||
59884330|NCT00121667|76007245|FG001|Completed Study Without Being Rescued|Short Term (ST) + Long Term (LT) Period||18||
59884331|NCT00121667|76007246|FG002|Completed Study Without Being Rescued|Short Term (ST) + Long Term (LT) Period||23||
59884332|NCT00121667|76007247|FG003|Completed Study Without Being Rescued|Short Term (ST) + Long Term (LT) Period||7||
59884333|NCT00121667|76007244|FG000|COMPLETED|Short Term (ST) + Long Term (LT) Period||64||
59884334|NCT00121667|76007245|FG001|COMPLETED|Short Term (ST) + Long Term (LT) Period||58||
59884335|NCT00121667|76007246|FG002|COMPLETED|Short Term (ST) + Long Term (LT) Period||68||
59884336|NCT00121667|76007247|FG003|COMPLETED|Short Term (ST) + Long Term (LT) Period||39||
59884337|NCT00121667|76007244|FG000|NOT COMPLETED|Short Term (ST) + Long Term (LT) Period||128||
59884338|NCT00121667|76007245|FG001|NOT COMPLETED|Short Term (ST) + Long Term (LT) Period||133||
59884339|NCT00121667|76007246|FG002|NOT COMPLETED|Short Term (ST) + Long Term (LT) Period||113||
59884340|NCT00121667|76007247|FG003|NOT COMPLETED|Short Term (ST) + Long Term (LT) Period||140||
59884341|NCT02954601|76007261|FG000|STARTED|First Intervention (Five Days)||11||
59884342|NCT02954601|76007262|FG001|STARTED|First Intervention (Five Days)||6||
59884343|NCT02954601|76007263|FG002|STARTED|First Intervention (Five Days)||8||
59884344|NCT02954601|76007264|FG003|STARTED|First Intervention (Five Days)||7||
59884345|NCT02954601|76007261|FG000|COMPLETED|First Intervention (Five Days)||11||
59884346|NCT02954601|76007262|FG001|COMPLETED|First Intervention (Five Days)||6||
59884347|NCT02954601|76007263|FG002|COMPLETED|First Intervention (Five Days)||7||
59884348|NCT02954601|76007264|FG003|COMPLETED|First Intervention (Five Days)||7||
59884349|NCT02954601|76007261|FG000|NOT COMPLETED|First Intervention (Five Days)||0||
59884350|NCT02954601|76007262|FG001|NOT COMPLETED|First Intervention (Five Days)||0||
59884351|NCT02954601|76007263|FG002|NOT COMPLETED|First Intervention (Five Days)||1||
59606341|NCT04646148|75716690|FG006|NOT COMPLETED|Overall Study||1||
59606342|NCT04646148|75716691|FG007|NOT COMPLETED|Overall Study||1||
59754177|NCT00818259|75873279|FG006|COMPLETED|Randomization||5||
60011755|NCT04396847|76127683|FG000|STARTED|Overall Study||1||
60011756|NCT04396847|76127684|FG001|STARTED|Overall Study||0||
60011757|NCT04396847|76127683|FG000|COMPLETED|Overall Study||1||
60011758|NCT04396847|76127684|FG001|COMPLETED|Overall Study||0||
59606343|NCT04646148|75716692|FG008|NOT COMPLETED|Overall Study||0||
59606344|NCT04646148|75716693|FG009|NOT COMPLETED|Overall Study||0||
59606345|NCT04646148|75716694|FG010|NOT COMPLETED|Overall Study||0||
59606346|NCT04646148|75716695|FG011|NOT COMPLETED|Overall Study||0||
59606347|NCT04646148|75716696|FG012|NOT COMPLETED|Overall Study||0||
59606348|NCT04646148|75716697|FG013|NOT COMPLETED|Overall Study||0||
59606349|NCT04646148|75716698|FG014|NOT COMPLETED|Overall Study||0||
59606350|NCT04646148|75716699|FG015|NOT COMPLETED|Overall Study||2||
59606351|NCT01934010|75716737|FG000|STARTED|Overall Study||114||
59606352|NCT01934010|75716738|FG001|STARTED|Overall Study||67||
59606353|NCT01934010|75716739|FG002|STARTED|Overall Study||76||
59606354|NCT01934010|75716737|FG000|COMPLETED|Overall Study||91||
59606355|NCT01934010|75716738|FG001|COMPLETED|Overall Study||56||
59606356|NCT01934010|75716739|FG002|COMPLETED|Overall Study||74||
59606357|NCT01934010|75716737|FG000|NOT COMPLETED|Overall Study||23||
59606358|NCT01934010|75716738|FG001|NOT COMPLETED|Overall Study||11||
59606359|NCT01934010|75716739|FG002|NOT COMPLETED|Overall Study||2||
59606360|NCT01620138|75716758|FG000|STARTED|Overall Study||12||
59606361|NCT01620138|75716759|FG001|STARTED|Overall Study||9||
59606362|NCT01620138|75716758|FG000|COMPLETED|Overall Study||6||
59606363|NCT01620138|75716759|FG001|COMPLETED|Overall Study||9||
59606364|NCT01620138|75716758|FG000|NOT COMPLETED|Overall Study||6||
59606365|NCT01620138|75716759|FG001|NOT COMPLETED|Overall Study||0||
59606366|NCT01977612|75716767|FG000|STARTED|Overall Study||85||
59606367|NCT01977612|75716768|FG001|STARTED|Overall Study||80||
59606368|NCT01977612|75716767|FG000|COMPLETED|Overall Study||84||
59606369|NCT01977612|75716768|FG001|COMPLETED|Overall Study||79||
59606370|NCT01977612|75716767|FG000|NOT COMPLETED|Overall Study||1||
59606371|NCT01977612|75716768|FG001|NOT COMPLETED|Overall Study||1||
59606372|NCT01932996|75716776|FG000|STARTED|Overall Study||172||
59606373|NCT01932996|75716777|FG001|STARTED|Overall Study||180||
59606374|NCT01932996|75716776|FG000|COMPLETED|Overall Study||170||
59606375|NCT01932996|75716777|FG001|COMPLETED|Overall Study||180||
59606376|NCT01932996|75716776|FG000|NOT COMPLETED|Overall Study||2||
59606377|NCT01932996|75716777|FG001|NOT COMPLETED|Overall Study||0||
59606378|NCT01932762|75716787|FG000|STARTED|Overall Study||30||
59606379|NCT01932762|75716788|FG001|STARTED|Overall Study||30||
59606380|NCT01932762|75716789|FG002|STARTED|Overall Study||19||
59606381|NCT01932762|75716790|FG003|STARTED|Overall Study||19||
59606382|NCT01932762|75716787|FG000|COMPLETED|Overall Study||24||
59606383|NCT01932762|75716788|FG001|COMPLETED|Overall Study||28||
59606384|NCT01932762|75716789|FG002|COMPLETED|Overall Study||19||
59606385|NCT01932762|75716790|FG003|COMPLETED|Overall Study||18||
59606386|NCT01932762|75716787|FG000|NOT COMPLETED|Overall Study||6||
59606387|NCT01932762|75716788|FG001|NOT COMPLETED|Overall Study||2||
59606388|NCT01932762|75716789|FG002|NOT COMPLETED|Overall Study||0||
59606389|NCT01932762|75716790|FG003|NOT COMPLETED|Overall Study||1||
59606390|NCT01618968|75716804|FG000|STARTED|Overall Study||13||
59606391|NCT01618968|75716805|FG001|STARTED|Overall Study||12||
59606392|NCT01618968|75716806|FG002|STARTED|Overall Study||12||
59606393|NCT01618968|75716807|FG003|STARTED|Overall Study||12||
59606394|NCT01618968|75716804|FG000|Received Treatment A|Overall Study||12||
59606395|NCT01618968|75716805|FG001|Received Treatment A|Overall Study||12||
59606396|NCT01618968|75716806|FG002|Received Treatment A|Overall Study||12||
59606397|NCT01618968|75716807|FG003|Received Treatment A|Overall Study||11||
59606398|NCT01618968|75716804|FG000|Received Treatment B|Overall Study||13||
59606399|NCT01618968|75716805|FG001|Received Treatment B|Overall Study||12||
59606400|NCT01618968|75716806|FG002|Received Treatment B|Overall Study||12||
59606401|NCT01618968|75716807|FG003|Received Treatment B|Overall Study||12||
59606402|NCT01618968|75716804|FG000|Received Treatment C|Overall Study||12||
59884352|NCT02954601|76007264|FG003|NOT COMPLETED|First Intervention (Five Days)||0||
59884353|NCT02954601|76007261|FG000|STARTED|Second Intervention (Five Days)||11||
59884354|NCT02954601|76007262|FG001|STARTED|Second Intervention (Five Days)||6||
59606403|NCT01618968|75716805|FG001|Received Treatment C|Overall Study||12||
59606404|NCT01618968|75716806|FG002|Received Treatment C|Overall Study||12||
59606405|NCT01618968|75716807|FG003|Received Treatment C|Overall Study||11||
59606406|NCT01618968|75716804|FG000|COMPLETED|Overall Study||12||
59606407|NCT01618968|75716805|FG001|COMPLETED|Overall Study||12||
59606408|NCT01618968|75716806|FG002|COMPLETED|Overall Study||12||
59606409|NCT01618968|75716807|FG003|COMPLETED|Overall Study||11||
59606410|NCT01618968|75716804|FG000|NOT COMPLETED|Overall Study||1||
59606411|NCT01618968|75716805|FG001|NOT COMPLETED|Overall Study||0||
59606412|NCT01618968|75716806|FG002|NOT COMPLETED|Overall Study||0||
59606413|NCT01618968|75716807|FG003|NOT COMPLETED|Overall Study||1||
59606414|NCT01932294|75716816|FG000|STARTED|Overall Study||171||
59606415|NCT01932294|75716816|FG000|COMPLETED|Overall Study||72||
59606416|NCT01932294|75716816|FG000|NOT COMPLETED|Overall Study||99||
59606417|NCT01931670|75716824|FG000|STARTED|Treatment Period||360||
59606418|NCT01931670|75716825|FG001|STARTED|Treatment Period||226||
59606419|NCT01931670|75716826|FG002|STARTED|Treatment Period||229||
59606420|NCT01931670|75716824|FG000|COMPLETED|Treatment Period||270||
59606421|NCT01931670|75716825|FG001|COMPLETED|Treatment Period||178||
59606422|NCT01931670|75716826|FG002|COMPLETED|Treatment Period||184||
59606423|NCT01931670|75716824|FG000|NOT COMPLETED|Treatment Period||90||
59606424|NCT01931670|75716825|FG001|NOT COMPLETED|Treatment Period||48||
59606425|NCT01931670|75716826|FG002|NOT COMPLETED|Treatment Period||45||
59606426|NCT01931670|75716824|FG000|STARTED|Post-Treatment Follow-Up (PTFU) Period||61|Participants who elected to enter the PTFU Period in this study for up to an additional 12 months.|
59606427|NCT01931670|75716825|FG001|STARTED|Post-Treatment Follow-Up (PTFU) Period||40|Participants who elected to enter the PTFU Period in this study for up to an additional 12 months.|
59606428|NCT01931670|75716826|FG002|STARTED|Post-Treatment Follow-Up (PTFU) Period||54|Participants who elected to enter the PTFU Period in this study for up to an additional 12 months.|
59884355|NCT02954601|76007263|FG002|STARTED|Second Intervention (Five Days)||8||
59606429|NCT01931670|75716824|FG000|Completed PTFU Month 6|Post-Treatment Follow-Up (PTFU) Period||42||
59606430|NCT01931670|75716825|FG001|Completed PTFU Month 6|Post-Treatment Follow-Up (PTFU) Period||24||
59606431|NCT01931670|75716826|FG002|Completed PTFU Month 6|Post-Treatment Follow-Up (PTFU) Period||18||
59606432|NCT01931670|75716824|FG000|Completed PTFU Month 12|Post-Treatment Follow-Up (PTFU) Period||0||
59606433|NCT01931670|75716825|FG001|Completed PTFU Month 12|Post-Treatment Follow-Up (PTFU) Period||4||
59606434|NCT01931670|75716826|FG002|Completed PTFU Month 12|Post-Treatment Follow-Up (PTFU) Period||15||
59606435|NCT01931670|75716824|FG000|COMPLETED|Post-Treatment Follow-Up (PTFU) Period||42||
59884356|NCT02954601|76007264|FG003|STARTED|Second Intervention (Five Days)||6||
59884357|NCT02954601|76007261|FG000|COMPLETED|Second Intervention (Five Days)||11||
59884358|NCT02954601|76007262|FG001|COMPLETED|Second Intervention (Five Days)||6||
59606436|NCT01931670|75716825|FG001|COMPLETED|Post-Treatment Follow-Up (PTFU) Period||28||
59606437|NCT01931670|75716826|FG002|COMPLETED|Post-Treatment Follow-Up (PTFU) Period||33||
59606438|NCT01931670|75716824|FG000|NOT COMPLETED|Post-Treatment Follow-Up (PTFU) Period||19||
59606439|NCT01931670|75716825|FG001|NOT COMPLETED|Post-Treatment Follow-Up (PTFU) Period||12||
59606440|NCT01931670|75716826|FG002|NOT COMPLETED|Post-Treatment Follow-Up (PTFU) Period||21||
59606441|NCT01977456|75716834|FG000|STARTED|Overall Study||27||
59606442|NCT01977456|75716834|FG000|COMPLETED|Overall Study||22||
59606443|NCT01977456|75716834|FG000|NOT COMPLETED|Overall Study||5||
59606444|NCT01957644|75716843|FG000|STARTED|Overall Study||6||
59606445|NCT01957644|75716844|FG001|STARTED|Overall Study||6||
59606446|NCT01957644|75716845|FG002|STARTED|Overall Study||1||
59606447|NCT01957644|75716846|FG003|STARTED|Overall Study||2||
59606448|NCT01957644|75716847|FG004|STARTED|Overall Study||1||
59606449|NCT01957644|75716843|FG000|COMPLETED|Overall Study||0||
59606450|NCT01957644|75716844|FG001|COMPLETED|Overall Study||0||
59606451|NCT01957644|75716845|FG002|COMPLETED|Overall Study||0||
59606452|NCT01957644|75716846|FG003|COMPLETED|Overall Study||0||
59606453|NCT01957644|75716847|FG004|COMPLETED|Overall Study||0||
59606454|NCT01957644|75716843|FG000|NOT COMPLETED|Overall Study||6||
59606455|NCT01957644|75716844|FG001|NOT COMPLETED|Overall Study||6||
59606456|NCT01957644|75716845|FG002|NOT COMPLETED|Overall Study||1||
59606457|NCT01957644|75716846|FG003|NOT COMPLETED|Overall Study||2||
59606458|NCT01957644|75716847|FG004|NOT COMPLETED|Overall Study||1||
59606459|NCT01931202|75716864|FG000|STARTED|Overall Study||8||
59606460|NCT01931202|75716865|FG001|STARTED|Overall Study||51||
59606461|NCT01931202|75716866|FG002|STARTED|Overall Study||49||
59606462|NCT01931202|75716864|FG000|COMPLETED|Overall Study||8||
59606463|NCT01931202|75716865|FG001|COMPLETED|Overall Study||46||
59606464|NCT01931202|75716866|FG002|COMPLETED|Overall Study||45||
59606465|NCT01931202|75716864|FG000|NOT COMPLETED|Overall Study||0||
59606466|NCT01931202|75716865|FG001|NOT COMPLETED|Overall Study||5||
59606467|NCT01931202|75716866|FG002|NOT COMPLETED|Overall Study||4||
59606468|NCT01930890|75716881|FG000|STARTED|Overall Study||14||
59606469|NCT01930890|75716882|FG001|STARTED|Overall Study||33||
59606470|NCT01930890|75716883|FG002|STARTED|Overall Study||13||
59606471|NCT01930890|75716884|FG003|STARTED|Overall Study||27||
59606472|NCT01930890|75716881|FG000|COMPLETED|Overall Study||0||
59606473|NCT01930890|75716882|FG001|COMPLETED|Overall Study||0||
59606474|NCT01930890|75716883|FG002|COMPLETED|Overall Study||0||
59606475|NCT01930890|75716884|FG003|COMPLETED|Overall Study||0||
59606476|NCT01930890|75716881|FG000|NOT COMPLETED|Overall Study||14||
59606477|NCT01930890|75716882|FG001|NOT COMPLETED|Overall Study||33||
59606478|NCT01930890|75716883|FG002|NOT COMPLETED|Overall Study||13||
59606479|NCT01930890|75716884|FG003|NOT COMPLETED|Overall Study||27||
59606480|NCT01930188|75716897|FG000|STARTED|Overall Study||409||
59606481|NCT01930188|75716898|FG001|STARTED|Overall Study||409||
59606482|NCT01930188|75716899|FG002|STARTED|Overall Study||407||
59606483|NCT01930188|75716897|FG000|Premature Discontinuation of Treatment|Overall Study|Subjects prematurely discontinued treatment were allowed to continue participation in the trial.|53||
59606484|NCT01930188|75716898|FG001|Premature Discontinuation of Treatment|Overall Study|Subjects prematurely discontinued treatment were allowed to continue participation in the trial.|61||
59606485|NCT01930188|75716899|FG002|Premature Discontinuation of Treatment|Overall Study|Subjects prematurely discontinued treatment were allowed to continue participation in the trial.|32||
59606486|NCT01930188|75716897|FG000|COMPLETED|Overall Study||387||
59606487|NCT01930188|75716898|FG001|COMPLETED|Overall Study||388||
59606488|NCT01930188|75716899|FG002|COMPLETED|Overall Study||388||
59606489|NCT01930188|75716897|FG000|NOT COMPLETED|Overall Study||22||
59606490|NCT01930188|75716898|FG001|NOT COMPLETED|Overall Study||21||
59606491|NCT01930188|75716899|FG002|NOT COMPLETED|Overall Study||19||
59606492|NCT01977222|75716908|FG000|STARTED|Overall Study||12||
59606493|NCT01977222|75716908|FG000|COMPLETED|Overall Study||11||
59606494|NCT01977222|75716908|FG000|NOT COMPLETED|Overall Study||1||
59606495|NCT01957488|75716912|FG000|STARTED|Test Period 1 (2 Weeks)||30||
59606496|NCT01957488|75716913|FG001|STARTED|Test Period 1 (2 Weeks)||31||
59606497|NCT01957488|75716914|FG002|STARTED|Test Period 1 (2 Weeks)||30||
59606498|NCT01957488|75716915|FG003|STARTED|Test Period 1 (2 Weeks)||32||
59606499|NCT01957488|75716916|FG004|STARTED|Test Period 1 (2 Weeks)||30||
59606500|NCT01957488|75716917|FG005|STARTED|Test Period 1 (2 Weeks)||30||
59606501|NCT01957488|75716912|FG000|COMPLETED|Test Period 1 (2 Weeks)||27||
59606502|NCT01957488|75716913|FG001|COMPLETED|Test Period 1 (2 Weeks)||28||
59606503|NCT01957488|75716914|FG002|COMPLETED|Test Period 1 (2 Weeks)||26||
59606504|NCT01957488|75716915|FG003|COMPLETED|Test Period 1 (2 Weeks)||29||
59606505|NCT01957488|75716916|FG004|COMPLETED|Test Period 1 (2 Weeks)||27||
59606506|NCT01957488|75716917|FG005|COMPLETED|Test Period 1 (2 Weeks)||24||
59606507|NCT01957488|75716912|FG000|NOT COMPLETED|Test Period 1 (2 Weeks)||3||
59606508|NCT01957488|75716913|FG001|NOT COMPLETED|Test Period 1 (2 Weeks)||3||
59606509|NCT01957488|75716914|FG002|NOT COMPLETED|Test Period 1 (2 Weeks)||4||
59606510|NCT01957488|75716915|FG003|NOT COMPLETED|Test Period 1 (2 Weeks)||3||
59606511|NCT01957488|75716916|FG004|NOT COMPLETED|Test Period 1 (2 Weeks)||3||
59606512|NCT01957488|75716917|FG005|NOT COMPLETED|Test Period 1 (2 Weeks)||6||
59606513|NCT01957488|75716912|FG000|STARTED|Test Period 2 (2 Weeks)||27||
59606514|NCT01957488|75716913|FG001|STARTED|Test Period 2 (2 Weeks)||28||
59606515|NCT01957488|75716914|FG002|STARTED|Test Period 2 (2 Weeks)||26||
59606516|NCT01957488|75716915|FG003|STARTED|Test Period 2 (2 Weeks)||29||
59606517|NCT01957488|75716916|FG004|STARTED|Test Period 2 (2 Weeks)||27||
59606518|NCT01957488|75716917|FG005|STARTED|Test Period 2 (2 Weeks)||24||
59606519|NCT01957488|75716912|FG000|COMPLETED|Test Period 2 (2 Weeks)||24||
59606520|NCT01957488|75716913|FG001|COMPLETED|Test Period 2 (2 Weeks)||27||
59606521|NCT01957488|75716914|FG002|COMPLETED|Test Period 2 (2 Weeks)||25||
59606522|NCT01957488|75716915|FG003|COMPLETED|Test Period 2 (2 Weeks)||28||
59606523|NCT01957488|75716916|FG004|COMPLETED|Test Period 2 (2 Weeks)||25||
59606524|NCT01957488|75716917|FG005|COMPLETED|Test Period 2 (2 Weeks)||23||
59606525|NCT01957488|75716912|FG000|NOT COMPLETED|Test Period 2 (2 Weeks)||3||
59606526|NCT01957488|75716913|FG001|NOT COMPLETED|Test Period 2 (2 Weeks)||1||
59606527|NCT01957488|75716914|FG002|NOT COMPLETED|Test Period 2 (2 Weeks)||1||
59606528|NCT01957488|75716915|FG003|NOT COMPLETED|Test Period 2 (2 Weeks)||1||
59606529|NCT01957488|75716916|FG004|NOT COMPLETED|Test Period 2 (2 Weeks)||2||
59606530|NCT01957488|75716917|FG005|NOT COMPLETED|Test Period 2 (2 Weeks)||1||
59606531|NCT01957488|75716912|FG000|STARTED|Test Period 3 (2 Weeks)||24||
59606532|NCT01957488|75716913|FG001|STARTED|Test Period 3 (2 Weeks)||27||
59606533|NCT01957488|75716914|FG002|STARTED|Test Period 3 (2 Weeks)||25||
59606534|NCT01957488|75716915|FG003|STARTED|Test Period 3 (2 Weeks)||28||
59606535|NCT01957488|75716916|FG004|STARTED|Test Period 3 (2 Weeks)||25||
59606536|NCT01957488|75716917|FG005|STARTED|Test Period 3 (2 Weeks)||23||
59606537|NCT01957488|75716912|FG000|COMPLETED|Test Period 3 (2 Weeks)||23||
59606538|NCT01957488|75716913|FG001|COMPLETED|Test Period 3 (2 Weeks)||26||
59606539|NCT01957488|75716914|FG002|COMPLETED|Test Period 3 (2 Weeks)||25||
59606540|NCT01957488|75716915|FG003|COMPLETED|Test Period 3 (2 Weeks)||28||
59606541|NCT01957488|75716916|FG004|COMPLETED|Test Period 3 (2 Weeks)||25||
59606542|NCT01957488|75716917|FG005|COMPLETED|Test Period 3 (2 Weeks)||23||
59606543|NCT01957488|75716912|FG000|NOT COMPLETED|Test Period 3 (2 Weeks)||1||
59606544|NCT01957488|75716913|FG001|NOT COMPLETED|Test Period 3 (2 Weeks)||1||
59606545|NCT01957488|75716914|FG002|NOT COMPLETED|Test Period 3 (2 Weeks)||0||
59606546|NCT01957488|75716915|FG003|NOT COMPLETED|Test Period 3 (2 Weeks)||0||
59606547|NCT01957488|75716916|FG004|NOT COMPLETED|Test Period 3 (2 Weeks)||0||
59606548|NCT01957488|75716917|FG005|NOT COMPLETED|Test Period 3 (2 Weeks)||0||
59606549|NCT01976364|75716925|FG000|STARTED|Main Study (36 Months)||686||
59606550|NCT01976364|75716926|FG001|STARTED|Main Study (36 Months)||0||
59606551|NCT01976364|75716927|FG002|STARTED|Main Study (36 Months)||0||
59606552|NCT01976364|75716925|FG000|COMPLETED|Main Study (36 Months)||465||
59606553|NCT01976364|75716926|FG001|COMPLETED|Main Study (36 Months)||0||
59606554|NCT01976364|75716927|FG002|COMPLETED|Main Study (36 Months)||0||
59606555|NCT01976364|75716925|FG000|NOT COMPLETED|Main Study (36 Months)||221||
59606556|NCT01976364|75716926|FG001|NOT COMPLETED|Main Study (36 Months)||0||
59606557|NCT01976364|75716927|FG002|NOT COMPLETED|Main Study (36 Months)||0||
59606558|NCT01976364|75716925|FG000|STARTED|Sub-study (12 Months)||0||
59606559|NCT01976364|75716926|FG001|STARTED|Sub-study (12 Months)|Participants from main study who consented to take part in sub-study, continued into sub-study.|89||
59606560|NCT01976364|75716927|FG002|STARTED|Sub-study (12 Months)|Participants from main study who consented to take part in sub-study, continued into sub-study.|90||
59606561|NCT01976364|75716925|FG000|COMPLETED|Sub-study (12 Months)||0||
59606562|NCT01976364|75716926|FG001|COMPLETED|Sub-study (12 Months)||83||
59606563|NCT01976364|75716927|FG002|COMPLETED|Sub-study (12 Months)||85||
59606564|NCT01976364|75716925|FG000|NOT COMPLETED|Sub-study (12 Months)||0||
59606565|NCT01976364|75716926|FG001|NOT COMPLETED|Sub-study (12 Months)||6||
59606566|NCT01976364|75716927|FG002|NOT COMPLETED|Sub-study (12 Months)||5||
59606567|NCT01956240|75716938|FG000|STARTED|Overall Study||48||
59606568|NCT01956240|75716939|FG001|STARTED|Overall Study||49||
59606569|NCT01956240|75716938|FG000|COMPLETED|Overall Study||25||
59606570|NCT01956240|75716939|FG001|COMPLETED|Overall Study||25||
59606571|NCT01956240|75716938|FG000|NOT COMPLETED|Overall Study||23||
59606572|NCT01956240|75716939|FG001|NOT COMPLETED|Overall Study||24||
59606573|NCT01929876|75716945|FG000|STARTED|Period 1||16||
59606574|NCT01929876|75716945|FG000|COMPLETED|Period 1||16||
59606575|NCT01929876|75716945|FG000|NOT COMPLETED|Period 1||0||
59606576|NCT01929876|75716945|FG000|STARTED|Period 2||16||
59606577|NCT01929876|75716945|FG000|COMPLETED|Period 2||15||
59606578|NCT01929876|75716945|FG000|NOT COMPLETED|Period 2||1||
59606579|NCT01929408|75716949|FG000|STARTED|Overall Study||703|Number Ss enrolled|
59606580|NCT01929408|75716949|FG000|COMPLETED|Overall Study||695|Total Ss with analyzable data. Incomplete follow-up data could still be included in analyses.|
59606581|NCT01929408|75716949|FG000|NOT COMPLETED|Overall Study||8||
59606582|NCT01929018|75716955|FG000|STARTED|Overall Study||19||
59606583|NCT01929018|75716956|FG001|STARTED|Overall Study||19||
59606584|NCT01929018|75716955|FG000|COMPLETED|Overall Study||18||
59606585|NCT01929018|75716956|FG001|COMPLETED|Overall Study||18||
59606586|NCT01929018|75716955|FG000|NOT COMPLETED|Overall Study||1||
59606587|NCT01929018|75716956|FG001|NOT COMPLETED|Overall Study||1||
59606588|NCT01928940|75716964|FG000|STARTED|Overall Study||6||
59606589|NCT01928940|75716965|FG001|STARTED|Overall Study||6||
59606590|NCT01928940|75716964|FG000|COMPLETED|Overall Study||6||
59606591|NCT01928940|75716965|FG001|COMPLETED|Overall Study||5||
59606592|NCT01928940|75716964|FG000|NOT COMPLETED|Overall Study||0||
59606593|NCT01928940|75716965|FG001|NOT COMPLETED|Overall Study||1||
59754178|NCT00818259|75873280|FG007|COMPLETED|Randomization||0||
59606594|NCT01928862|75716977|FG000|STARTED|Overall Study||16||
59606595|NCT01928862|75716978|FG001|STARTED|Overall Study||16||
59606596|NCT01928862|75716979|FG002|STARTED|Overall Study||16||
59606597|NCT01928862|75716980|FG003|STARTED|Overall Study||16||
59606598|NCT01928862|75716981|FG004|STARTED|Overall Study||14||
59606599|NCT01928862|75716977|FG000|COMPLETED|Overall Study||15||
59606600|NCT01928862|75716978|FG001|COMPLETED|Overall Study||16||
59606601|NCT01928862|75716979|FG002|COMPLETED|Overall Study||16||
59606602|NCT01928862|75716980|FG003|COMPLETED|Overall Study||16||
59606603|NCT01928862|75716981|FG004|COMPLETED|Overall Study||13||
59606604|NCT01928862|75716977|FG000|NOT COMPLETED|Overall Study||1||
59606605|NCT01928862|75716978|FG001|NOT COMPLETED|Overall Study||0||
59606606|NCT01928862|75716979|FG002|NOT COMPLETED|Overall Study||0||
59606607|NCT01928862|75716980|FG003|NOT COMPLETED|Overall Study||0||
59606608|NCT01928862|75716981|FG004|NOT COMPLETED|Overall Study||1||
59606609|NCT01954056|75716996|FG000|STARTED|Birth to 60 Days of Life||6||
59606610|NCT01954056|75716997|FG001|STARTED|Birth to 60 Days of Life||6||
59606611|NCT01954056|75716996|FG000|COMPLETED|Birth to 60 Days of Life||6||
59606612|NCT01954056|75716997|FG001|COMPLETED|Birth to 60 Days of Life||6||
59606613|NCT01954056|75716996|FG000|NOT COMPLETED|Birth to 60 Days of Life||0||
59606614|NCT01954056|75716997|FG001|NOT COMPLETED|Birth to 60 Days of Life||0||
59606615|NCT01954056|75716996|FG000|STARTED|Birth to 22-26 Mos. Corrected GA||6||
59606616|NCT01954056|75716997|FG001|STARTED|Birth to 22-26 Mos. Corrected GA||6||
59606617|NCT01954056|75716996|FG000|COMPLETED|Birth to 22-26 Mos. Corrected GA||5||
59606618|NCT01954056|75716997|FG001|COMPLETED|Birth to 22-26 Mos. Corrected GA||6||
59606619|NCT01954056|75716996|FG000|NOT COMPLETED|Birth to 22-26 Mos. Corrected GA||1||
59606620|NCT01954056|75716997|FG001|NOT COMPLETED|Birth to 22-26 Mos. Corrected GA||0||
59606621|NCT01953354|75717005|FG000|STARTED|Overall Study||9||
59606622|NCT01953354|75717006|FG001|STARTED|Overall Study||7||
59606623|NCT01953354|75717005|FG000|COMPLETED|Overall Study||8||
59606624|NCT01953354|75717006|FG001|COMPLETED|Overall Study||5||
59606625|NCT01953354|75717005|FG000|NOT COMPLETED|Overall Study||1||
59606626|NCT01953354|75717006|FG001|NOT COMPLETED|Overall Study||2||
59606627|NCT01975272|75717015|FG000|STARTED|Overall Study||9||
59606628|NCT01975272|75717016|FG001|STARTED|Overall Study||10||
59606629|NCT01975272|75717017|FG002|STARTED|Overall Study||8||
59606630|NCT01975272|75717015|FG000|COMPLETED|Overall Study||8||
59606631|NCT01975272|75717016|FG001|COMPLETED|Overall Study||9||
59606632|NCT01975272|75717017|FG002|COMPLETED|Overall Study||6||
59606633|NCT01975272|75717015|FG000|NOT COMPLETED|Overall Study||1||
59606634|NCT01975272|75717016|FG001|NOT COMPLETED|Overall Study||1||
59606635|NCT01975272|75717017|FG002|NOT COMPLETED|Overall Study||2||
59606636|NCT01951638|75717030|FG000|STARTED|Treatment Period||93||
59606637|NCT01951638|75717031|FG001|STARTED|Treatment Period||96||
59606638|NCT01951638|75717032|FG002|STARTED|Treatment Period||96||
59606639|NCT01951638|75717033|FG003|STARTED|Treatment Period||96||
59606640|NCT01951638|75717034|FG004|STARTED|Treatment Period||96||
59606641|NCT01951638|75717030|FG000|COMPLETED|Treatment Period||80||
59606642|NCT01951638|75717031|FG001|COMPLETED|Treatment Period||82||
59606643|NCT01951638|75717032|FG002|COMPLETED|Treatment Period||83||
59606644|NCT01951638|75717033|FG003|COMPLETED|Treatment Period||80||
59606645|NCT01951638|75717034|FG004|COMPLETED|Treatment Period||86||
59606646|NCT01951638|75717030|FG000|NOT COMPLETED|Treatment Period||13||
59606647|NCT01951638|75717031|FG001|NOT COMPLETED|Treatment Period||14||
59606648|NCT01951638|75717032|FG002|NOT COMPLETED|Treatment Period||13||
59606649|NCT01951638|75717033|FG003|NOT COMPLETED|Treatment Period||16||
59606650|NCT01951638|75717034|FG004|NOT COMPLETED|Treatment Period||10||
59606651|NCT01951638|75717030|FG000|STARTED|Follow-up Period||89||
59606652|NCT01951638|75717031|FG001|STARTED|Follow-up Period||95||
59606653|NCT01951638|75717032|FG002|STARTED|Follow-up Period||95||
59606654|NCT01951638|75717033|FG003|STARTED|Follow-up Period||88||
59606655|NCT01951638|75717034|FG004|STARTED|Follow-up Period||94||
59606656|NCT01951638|75717030|FG000|COMPLETED|Follow-up Period||87||
59606657|NCT01951638|75717031|FG001|COMPLETED|Follow-up Period||86||
59606658|NCT01951638|75717032|FG002|COMPLETED|Follow-up Period||90||
59606659|NCT01951638|75717033|FG003|COMPLETED|Follow-up Period||80||
59606660|NCT01951638|75717034|FG004|COMPLETED|Follow-up Period||89||
59606661|NCT01951638|75717030|FG000|NOT COMPLETED|Follow-up Period||2||
59606662|NCT01951638|75717031|FG001|NOT COMPLETED|Follow-up Period||9||
59606663|NCT01951638|75717032|FG002|NOT COMPLETED|Follow-up Period||5||
59606664|NCT01951638|75717033|FG003|NOT COMPLETED|Follow-up Period||8||
59606665|NCT01951638|75717034|FG004|NOT COMPLETED|Follow-up Period||5||
59606666|NCT01928472|75717050|FG000|STARTED|Overall Study||98||
59606667|NCT01928472|75717051|FG001|STARTED|Overall Study||104||
59606668|NCT01928472|75717052|FG002|STARTED|Overall Study||98||
59606669|NCT01928472|75717053|FG003|STARTED|Overall Study||102||
59606670|NCT01928472|75717050|FG000|COMPLETED|Overall Study||90||
59606671|NCT01928472|75717051|FG001|COMPLETED|Overall Study||96||
59606672|NCT01928472|75717052|FG002|COMPLETED|Overall Study||91||
59606673|NCT01928472|75717053|FG003|COMPLETED|Overall Study||100||
59606674|NCT01928472|75717050|FG000|NOT COMPLETED|Overall Study||8||
59606675|NCT01928472|75717051|FG001|NOT COMPLETED|Overall Study||8||
59606676|NCT01928472|75717052|FG002|NOT COMPLETED|Overall Study||7||
59606677|NCT01928472|75717053|FG003|NOT COMPLETED|Overall Study||2||
59606678|NCT03563183|75717064|FG000|STARTED|Overall Study||26976||
59606679|NCT03563183|75717064|FG000|COMPLETED|Overall Study||26976||
59606680|NCT03563183|75717064|FG000|NOT COMPLETED|Overall Study||0||
59606681|NCT03565679|75717083|FG000|STARTED|Overall Study||10||
59606682|NCT03565679|75717083|FG000|COMPLETED|Overall Study||10||
59606683|NCT03565679|75717083|FG000|NOT COMPLETED|Overall Study||0||
59606684|NCT03965039|75717094|FG000|STARTED|Overall Study||30||
59606685|NCT03965039|75717095|FG001|STARTED|Overall Study||30||
59606686|NCT03965039|75717096|FG002|STARTED|Overall Study||30||
59606687|NCT03965039|75717097|FG003|STARTED|Overall Study||30||
59606688|NCT03965039|75717094|FG000|COMPLETED|Overall Study||30||
59606689|NCT03965039|75717095|FG001|COMPLETED|Overall Study||29||
59606690|NCT03965039|75717096|FG002|COMPLETED|Overall Study||30||
59606691|NCT03965039|75717097|FG003|COMPLETED|Overall Study||29||
59606692|NCT03965039|75717094|FG000|NOT COMPLETED|Overall Study||0||
59606693|NCT03965039|75717095|FG001|NOT COMPLETED|Overall Study||1||
59606694|NCT03965039|75717096|FG002|NOT COMPLETED|Overall Study||0||
59606695|NCT03965039|75717097|FG003|NOT COMPLETED|Overall Study||1||
59606696|NCT03961295|75717109|FG000|STARTED|Overall Study||12||
59606697|NCT03961295|75717110|FG001|STARTED|Overall Study||12||
59606698|NCT03961295|75717109|FG000|COMPLETED|Overall Study||12||
59606699|NCT03961295|75717110|FG001|COMPLETED|Overall Study||12||
59606700|NCT03961295|75717109|FG000|NOT COMPLETED|Overall Study||0||
59606701|NCT03961295|75717110|FG001|NOT COMPLETED|Overall Study||0||
59606702|NCT03567005|75717116|FG000|STARTED|Period 1, First 7 Days of Wear||29||
59606703|NCT03567005|75717117|FG001|STARTED|Period 1, First 7 Days of Wear||31||
59606704|NCT03567005|75717116|FG000|COMPLETED|Period 1, First 7 Days of Wear||29||
59606705|NCT03567005|75717117|FG001|COMPLETED|Period 1, First 7 Days of Wear||31||
59606706|NCT03567005|75717116|FG000|NOT COMPLETED|Period 1, First 7 Days of Wear||0||
59606707|NCT03567005|75717117|FG001|NOT COMPLETED|Period 1, First 7 Days of Wear||0||
59754179|NCT00818259|75873281|FG008|COMPLETED|Randomization||6||
59754180|NCT00818259|75873273|FG000|NOT COMPLETED|Randomization||0||
59754181|NCT00818259|75873274|FG001|NOT COMPLETED|Randomization||0||
59754182|NCT00818259|75873275|FG002|NOT COMPLETED|Randomization||0||
59754183|NCT00818259|75873276|FG003|NOT COMPLETED|Randomization||0||
59754184|NCT00818259|75873277|FG004|NOT COMPLETED|Randomization||0||
59754185|NCT00818259|75873278|FG005|NOT COMPLETED|Randomization||0||
59754186|NCT00818259|75873279|FG006|NOT COMPLETED|Randomization||0||
59606708|NCT03567005|75717116|FG000|STARTED|Period 2, Second 7 Days of Wear||29||
59606709|NCT03567005|75717117|FG001|STARTED|Period 2, Second 7 Days of Wear||31||
59606710|NCT03567005|75717116|FG000|COMPLETED|Period 2, Second 7 Days of Wear||29||
59606711|NCT03567005|75717117|FG001|COMPLETED|Period 2, Second 7 Days of Wear||31||
59754187|NCT00818259|75873280|FG007|NOT COMPLETED|Randomization||0||
59754188|NCT00818259|75873281|FG008|NOT COMPLETED|Randomization||0||
59754189|NCT00818259|75873273|FG000|STARTED|Part I|Newly enrolled participants|12||
59754190|NCT00818259|75873274|FG001|STARTED|Part I|Newly enrolled participants|11||
59754191|NCT00818259|75873275|FG002|STARTED|Part I||0||
59754192|NCT00818259|75873276|FG003|STARTED|Part I||0||
59754193|NCT00818259|75873277|FG004|STARTED|Part I||0||
59884359|NCT02954601|76007263|FG002|COMPLETED|Second Intervention (Five Days)||8||
59884360|NCT02954601|76007264|FG003|COMPLETED|Second Intervention (Five Days)||6||
59754194|NCT00818259|75873278|FG005|STARTED|Part I||0||
59754195|NCT00818259|75873279|FG006|STARTED|Part I||0||
59606712|NCT03567005|75717116|FG000|NOT COMPLETED|Period 2, Second 7 Days of Wear||0||
59606713|NCT03567005|75717117|FG001|NOT COMPLETED|Period 2, Second 7 Days of Wear||0||
59606714|NCT03569033|75717125|FG000|STARTED|Overall Study||23||
59606715|NCT03569033|75717126|FG001|STARTED|Overall Study||23||
59606716|NCT03569033|75717125|FG000|COMPLETED|Overall Study||23||
59606717|NCT03569033|75717126|FG001|COMPLETED|Overall Study||23||
59606718|NCT03569033|75717125|FG000|NOT COMPLETED|Overall Study||0||
59606719|NCT03569033|75717126|FG001|NOT COMPLETED|Overall Study||0||
59606720|NCT03955133|75717132|FG000|STARTED|Overall Study|participants recruited from 3 care homes|19|participants recruited|3
59754196|NCT00818259|75873280|FG007|STARTED|Part I||0||
59754197|NCT00818259|75873281|FG008|STARTED|Part I||0||
59884361|NCT02954601|76007261|FG000|NOT COMPLETED|Second Intervention (Five Days)||0||
59884362|NCT02954601|76007262|FG001|NOT COMPLETED|Second Intervention (Five Days)||0||
59754198|NCT00818259|75873273|FG000|COMPLETED|Part I||11||
59754199|NCT00818259|75873274|FG001|COMPLETED|Part I||11||
59754200|NCT00818259|75873275|FG002|COMPLETED|Part I||0||
59884363|NCT02954601|76007263|FG002|NOT COMPLETED|Second Intervention (Five Days)||0||
59613490|NCT01684878|75724611|FG001|COMPLETED|Part 2: Randomized Phase||0||
59754201|NCT00818259|75873276|FG003|COMPLETED|Part I||0||
59754202|NCT00818259|75873277|FG004|COMPLETED|Part I||0||
59754203|NCT00818259|75873278|FG005|COMPLETED|Part I||0||
59754204|NCT00818259|75873279|FG006|COMPLETED|Part I||0||
59606721|NCT03955133|75717132|FG000|COMPLETED|Overall Study|End of study funding|19|All care homes that started the intervention completed the study. However, numbers of care homes and participants fell far short of planned.|3
59606722|NCT03955133|75717132|FG000|NOT COMPLETED|Overall Study||0||0
59606723|NCT03991715|75717137|FG000|STARTED|Overall Study||5||
59606724|NCT03991715|75717137|FG000|COMPLETED|Overall Study||5||
59606725|NCT03991715|75717137|FG000|NOT COMPLETED|Overall Study||0||
59606726|NCT03570047|75717146|FG000|STARTED|Overall Study||15902||
59606727|NCT03570047|75717147|FG001|STARTED|Overall Study||22336||
59606728|NCT03570047|75717148|FG002|STARTED|Overall Study||6925||
59606729|NCT03570047|75717149|FG003|STARTED|Overall Study||16564||
59606730|NCT03570047|75717150|FG004|STARTED|Overall Study||12262||
59606731|NCT03570047|75717146|FG000|COMPLETED|Overall Study||15902||
59606732|NCT03570047|75717147|FG001|COMPLETED|Overall Study||22336||
59606733|NCT03570047|75717148|FG002|COMPLETED|Overall Study||6925||
59606734|NCT03570047|75717149|FG003|COMPLETED|Overall Study||16564||
59606735|NCT03570047|75717150|FG004|COMPLETED|Overall Study||12262||
59606736|NCT03570047|75717146|FG000|NOT COMPLETED|Overall Study||0||
59606737|NCT03570047|75717147|FG001|NOT COMPLETED|Overall Study||0||
59606738|NCT03570047|75717148|FG002|NOT COMPLETED|Overall Study||0||
59606739|NCT03570047|75717149|FG003|NOT COMPLETED|Overall Study||0||
59606740|NCT03570047|75717150|FG004|NOT COMPLETED|Overall Study||0||
59606741|NCT04002791|75717164|FG000|STARTED|Overall Study||127||
59606742|NCT04002791|75717165|FG001|STARTED|Overall Study||126||
59606743|NCT04002791|75717164|FG000|COMPLETED|Overall Study||127||
59606744|NCT04002791|75717165|FG001|COMPLETED|Overall Study||126||
59606745|NCT04002791|75717164|FG000|NOT COMPLETED|Overall Study||0||
59606746|NCT04002791|75717165|FG001|NOT COMPLETED|Overall Study||0||
59606747|NCT03935399|75717173|FG000|STARTED|First Study Day||5||
59606748|NCT03935399|75717174|FG001|STARTED|First Study Day||5||
59606749|NCT03935399|75717173|FG000|COMPLETED|First Study Day||5||
59606750|NCT03935399|75717174|FG001|COMPLETED|First Study Day||5||
59606751|NCT03935399|75717173|FG000|NOT COMPLETED|First Study Day||0||
59606752|NCT03935399|75717174|FG001|NOT COMPLETED|First Study Day||0||
59606753|NCT03935399|75717173|FG000|STARTED|Second Study Day||5||
59606754|NCT03935399|75717174|FG001|STARTED|Second Study Day||5||
59606755|NCT03935399|75717173|FG000|COMPLETED|Second Study Day||5||
59606756|NCT03935399|75717174|FG001|COMPLETED|Second Study Day||5||
59606757|NCT03935399|75717173|FG000|NOT COMPLETED|Second Study Day||0||
59606758|NCT03935399|75717174|FG001|NOT COMPLETED|Second Study Day||0||
59606759|NCT03571607|75717182|FG000|STARTED|Overall Study||53||
59606760|NCT03571607|75717183|FG001|STARTED|Overall Study||153||
59606761|NCT03571607|75717182|FG000|Vaccinated|Overall Study||53||
59606762|NCT03571607|75717183|FG001|Vaccinated|Overall Study||153||
59606763|NCT03571607|75717182|FG000|COMPLETED|Overall Study||53||
59606764|NCT03571607|75717183|FG001|COMPLETED|Overall Study||153||
59606765|NCT03571607|75717182|FG000|NOT COMPLETED|Overall Study||0||
59606766|NCT03571607|75717183|FG001|NOT COMPLETED|Overall Study||0||
59606767|NCT03993119|75717195|FG000|STARTED|Overall Study||192||
59606768|NCT03993119|75717196|FG001|STARTED|Overall Study||76||
59606769|NCT03993119|75717197|FG002|STARTED|Overall Study||166||
59606770|NCT03993119|75717198|FG003|STARTED|Overall Study||66||
59606771|NCT03993119|75717195|FG000|COMPLETED|Overall Study||192||
59606772|NCT03993119|75717196|FG001|COMPLETED|Overall Study||76||
59606773|NCT03993119|75717197|FG002|COMPLETED|Overall Study||166||
59606774|NCT03993119|75717198|FG003|COMPLETED|Overall Study||66||
59606775|NCT03993119|75717195|FG000|NOT COMPLETED|Overall Study||0||
59606776|NCT03993119|75717196|FG001|NOT COMPLETED|Overall Study||0||
59606777|NCT03993119|75717197|FG002|NOT COMPLETED|Overall Study||0||
59606778|NCT03993119|75717198|FG003|NOT COMPLETED|Overall Study||0||
59606779|NCT03574181|75717223|FG000|STARTED|Overall Study||9||
59606780|NCT03574181|75717223|FG000|COMPLETED|Overall Study||0||
59606781|NCT03574181|75717223|FG000|NOT COMPLETED|Overall Study||9||
59606782|NCT03988049|75717229|FG000|STARTED|Overall Study||22||22
59606783|NCT03988049|75717230|FG001|STARTED|Overall Study||22||22
59606784|NCT03988049|75717229|FG000|COMPLETED|Overall Study||22||22
59606785|NCT03988049|75717230|FG001|COMPLETED|Overall Study||22||22
59606786|NCT03988049|75717229|FG000|NOT COMPLETED|Overall Study||0||0
59606787|NCT03988049|75717230|FG001|NOT COMPLETED|Overall Study||0||0
59606788|NCT03930641|75717236|FG000|STARTED|Overall Study||34||
59606789|NCT03930641|75717236|FG000|COMPLETED|Overall Study||34||
59606790|NCT03930641|75717236|FG000|NOT COMPLETED|Overall Study||0||
59606791|NCT03910439|75717240|FG000|STARTED|Overall Study||4||
59606792|NCT03910439|75717240|FG000|COMPLETED|Overall Study||4||
59606793|NCT03910439|75717240|FG000|NOT COMPLETED|Overall Study||0||
59606794|NCT03907241|75717251|FG000|STARTED|Overall Study||27||
59606795|NCT03907241|75717251|FG000|COMPLETED|Overall Study||23||
59606796|NCT03907241|75717251|FG000|NOT COMPLETED|Overall Study||4||
59606797|NCT03137225|75717268|FG000|STARTED|First 4 Hour Measurement Period||1||
59606798|NCT03137225|75717269|FG001|STARTED|First 4 Hour Measurement Period||0||
59606799|NCT03137225|75717268|FG000|COMPLETED|First 4 Hour Measurement Period||1||
59606800|NCT03137225|75717269|FG001|COMPLETED|First 4 Hour Measurement Period||0||
59606801|NCT03137225|75717268|FG000|NOT COMPLETED|First 4 Hour Measurement Period||0||
59606802|NCT03137225|75717269|FG001|NOT COMPLETED|First 4 Hour Measurement Period||0||
59606803|NCT03137225|75717268|FG000|STARTED|Second 4 Hour Measurement Period||1||
59606804|NCT03137225|75717269|FG001|STARTED|Second 4 Hour Measurement Period||0||
59884364|NCT02954601|76007264|FG003|NOT COMPLETED|Second Intervention (Five Days)||0||
59884365|NCT02954601|76007261|FG000|STARTED|Third Intervention (Five Days)||9||
59884366|NCT02954601|76007262|FG001|STARTED|Third Intervention (Five Days)||8||
59884367|NCT02954601|76007263|FG002|STARTED|Third Intervention (Five Days)||6||
59884368|NCT02954601|76007264|FG003|STARTED|Third Intervention (Five Days)||8||
59606805|NCT03137225|75717268|FG000|COMPLETED|Second 4 Hour Measurement Period||1||
59606806|NCT03137225|75717269|FG001|COMPLETED|Second 4 Hour Measurement Period||0||
59884369|NCT02954601|76007261|FG000|COMPLETED|Third Intervention (Five Days)||9||
59884370|NCT02954601|76007262|FG001|COMPLETED|Third Intervention (Five Days)||8||
59884371|NCT02954601|76007263|FG002|COMPLETED|Third Intervention (Five Days)||6||
59884372|NCT02954601|76007264|FG003|COMPLETED|Third Intervention (Five Days)||8||
59884373|NCT02954601|76007261|FG000|NOT COMPLETED|Third Intervention (Five Days)||0||
59884374|NCT02954601|76007262|FG001|NOT COMPLETED|Third Intervention (Five Days)||0||
59884375|NCT02954601|76007263|FG002|NOT COMPLETED|Third Intervention (Five Days)||0||
59884376|NCT02954601|76007264|FG003|NOT COMPLETED|Third Intervention (Five Days)||0||
59606807|NCT03137225|75717268|FG000|NOT COMPLETED|Second 4 Hour Measurement Period||0||
59606808|NCT03137225|75717269|FG001|NOT COMPLETED|Second 4 Hour Measurement Period||0||
59606809|NCT03927209|75717277|FG000|STARTED|Overall Study||5||
59606810|NCT03927209|75717278|FG001|STARTED|Overall Study||5||
59606811|NCT03927209|75717277|FG000|COMPLETED|Overall Study||5||
59606812|NCT03927209|75717278|FG001|COMPLETED|Overall Study||5||
59606813|NCT03927209|75717277|FG000|NOT COMPLETED|Overall Study||0||
59606814|NCT03927209|75717278|FG001|NOT COMPLETED|Overall Study||0||
59606815|NCT03895307|75717290|FG000|STARTED|Overall Study||21||
59606816|NCT03895307|75717291|FG001|STARTED|Overall Study||20||
59606817|NCT03895307|75717292|FG002|STARTED|Overall Study||22||
59606818|NCT03895307|75717293|FG003|STARTED|Overall Study||21||
59606819|NCT03895307|75717290|FG000|COMPLETED|Overall Study||19||
59606820|NCT03895307|75717291|FG001|COMPLETED|Overall Study||20||
59606821|NCT03895307|75717292|FG002|COMPLETED|Overall Study||20||
59606822|NCT03895307|75717293|FG003|COMPLETED|Overall Study||21||
59606823|NCT03895307|75717290|FG000|NOT COMPLETED|Overall Study||2||
59606824|NCT03895307|75717291|FG001|NOT COMPLETED|Overall Study||0||
59606825|NCT03895307|75717292|FG002|NOT COMPLETED|Overall Study||2||
59606826|NCT03895307|75717293|FG003|NOT COMPLETED|Overall Study||0||
59606827|NCT01511081|75717305|FG000|STARTED|Overall Study||8||
59606828|NCT01511081|75717306|FG001|STARTED|Overall Study||9||
59606829|NCT01511081|75717305|FG000|COMPLETED|Overall Study||8||
59606830|NCT01511081|75717306|FG001|COMPLETED|Overall Study||9||
60011759|NCT04396847|76127683|FG000|NOT COMPLETED|Overall Study||0||
60011760|NCT04396847|76127684|FG001|NOT COMPLETED|Overall Study||0||
60011761|NCT02614079|76127690|FG000|STARTED|Overall Study||6||
60011762|NCT02614079|76127690|FG000|COMPLETED|Overall Study|1 participant withdrew from the study prior to completion of DSSEP testing|5||
60011763|NCT02614079|76127690|FG000|NOT COMPLETED|Overall Study||1||
60011764|NCT02616029|76127696|FG000|STARTED|Overall Study||38||
60011765|NCT02616029|76127697|FG001|STARTED|Overall Study||28||
60011766|NCT02616029|76127696|FG000|COMPLETED|Overall Study||34||
60011767|NCT02616029|76127697|FG001|COMPLETED|Overall Study||26||
60011768|NCT02616029|76127696|FG000|NOT COMPLETED|Overall Study||4||
60011769|NCT02616029|76127697|FG001|NOT COMPLETED|Overall Study||2||
60011770|NCT02614859|76127705|FG000|STARTED|Overall Study||9||
60011771|NCT02614859|76127706|FG001|STARTED|Overall Study||20||
60011772|NCT02614859|76127705|FG000|COMPLETED|Overall Study||9||
59606831|NCT01511081|75717305|FG000|NOT COMPLETED|Overall Study||0||
59606832|NCT01511081|75717306|FG001|NOT COMPLETED|Overall Study||0||
60011773|NCT02614859|76127706|FG001|COMPLETED|Overall Study||19||
60011774|NCT02614859|76127705|FG000|NOT COMPLETED|Overall Study||0||
60011775|NCT02614859|76127706|FG001|NOT COMPLETED|Overall Study||1||
60011776|NCT02615249|76127714|FG000|STARTED|Overall Study||122||
60011777|NCT02615249|76127714|FG000|COMPLETED|Overall Study||121||
60011778|NCT02615249|76127714|FG000|NOT COMPLETED|Overall Study||1||
60011779|NCT02615171|76127721|FG000|STARTED|Overall Study||32||
60011780|NCT02615171|76127722|FG001|STARTED|Overall Study||32||
60011781|NCT02615171|76127721|FG000|COMPLETED|Overall Study||30||
59606833|NCT03115853|75717312|FG000|STARTED|Overall Study||31||
59606834|NCT03115853|75717312|FG000|COMPLETED|Overall Study||31||
59606835|NCT03115853|75717312|FG000|NOT COMPLETED|Overall Study||0||
59606836|NCT01498991|75717318|FG000|STARTED|Overall Study||2||
60011782|NCT02615171|76127722|FG001|COMPLETED|Overall Study||31||
60011783|NCT02615171|76127721|FG000|NOT COMPLETED|Overall Study||2||
60011784|NCT02615171|76127722|FG001|NOT COMPLETED|Overall Study||1||
60011785|NCT02648347|76127730|FG000|STARTED|Overall Study||879||
60011786|NCT02648347|76127731|FG001|STARTED|Overall Study||872||
60011787|NCT02648347|76127730|FG000|COMPLETED|Overall Study||670||
59606837|NCT01498991|75717318|FG000|COMPLETED|Overall Study||2||
59606838|NCT01498991|75717318|FG000|NOT COMPLETED|Overall Study||0||
59606839|NCT03895853|75717324|FG000|STARTED|Overall Study||0||
60011788|NCT02648347|76127731|FG001|COMPLETED|Overall Study||675||
59606840|NCT03895853|75717325|FG001|STARTED|Overall Study||2||
59606841|NCT03895853|75717324|FG000|COMPLETED|Overall Study||0||
59606842|NCT03895853|75717325|FG001|COMPLETED|Overall Study||2||
59606843|NCT03895853|75717324|FG000|NOT COMPLETED|Overall Study||0||
59606844|NCT03895853|75717325|FG001|NOT COMPLETED|Overall Study||0||
59606845|NCT03901313|75717331|FG000|STARTED|Overall Study||4||
59606846|NCT03901313|75717332|FG001|STARTED|Overall Study||4||
59606847|NCT03901313|75717333|FG002|STARTED|Overall Study||4||
60011789|NCT02648347|76127730|FG000|NOT COMPLETED|Overall Study||209||
60011790|NCT02648347|76127731|FG001|NOT COMPLETED|Overall Study||197||
60011791|NCT02614703|76127739|FG000|STARTED|Overall Study||31||
60011792|NCT02614703|76127740|FG001|STARTED|Overall Study||29||
59606848|NCT03901313|75717334|FG003|STARTED|Overall Study||4||
59606849|NCT03901313|75717335|FG004|STARTED|Overall Study||4||
59606850|NCT03901313|75717336|FG005|STARTED|Overall Study||4||
59606851|NCT03901313|75717331|FG000|COMPLETED|Overall Study||4||
59606852|NCT03901313|75717332|FG001|COMPLETED|Overall Study||4||
59606853|NCT03901313|75717333|FG002|COMPLETED|Overall Study||4||
59606854|NCT03901313|75717334|FG003|COMPLETED|Overall Study||4||
60011793|NCT02614703|76127739|FG000|COMPLETED|Overall Study||24||
60011794|NCT02614703|76127740|FG001|COMPLETED|Overall Study||28||
60011795|NCT02614703|76127739|FG000|NOT COMPLETED|Overall Study||7||
59606855|NCT03901313|75717335|FG004|COMPLETED|Overall Study||4||
59606856|NCT03901313|75717336|FG005|COMPLETED|Overall Study||4||
59606857|NCT03901313|75717331|FG000|NOT COMPLETED|Overall Study||0||
59606858|NCT03901313|75717332|FG001|NOT COMPLETED|Overall Study||0||
59606859|NCT03901313|75717333|FG002|NOT COMPLETED|Overall Study||0||
59606860|NCT03901313|75717334|FG003|NOT COMPLETED|Overall Study||0||
59606861|NCT03901313|75717335|FG004|NOT COMPLETED|Overall Study||0||
59606862|NCT03901313|75717336|FG005|NOT COMPLETED|Overall Study||0||
59606863|NCT03900299|75717346|FG000|STARTED|Overall Study||56||
59606864|NCT03900299|75717347|FG001|STARTED|Overall Study||58||
59606865|NCT03900299|75717346|FG000|COMPLETED|Overall Study||56||
59606866|NCT03900299|75717347|FG001|COMPLETED|Overall Study||58||
59606867|NCT03900299|75717346|FG000|NOT COMPLETED|Overall Study||0||
59606868|NCT03900299|75717347|FG001|NOT COMPLETED|Overall Study||0||
59606869|NCT03898349|75717356|FG000|STARTED|Overall Study||125||
59606870|NCT03898349|75717357|FG001|STARTED|Overall Study||625||
59606871|NCT03898349|75717356|FG000|COMPLETED|Overall Study||15||
59606872|NCT03898349|75717357|FG001|COMPLETED|Overall Study||15||
59606873|NCT03898349|75717356|FG000|NOT COMPLETED|Overall Study||110||
59606874|NCT03898349|75717357|FG001|NOT COMPLETED|Overall Study||610||
59606875|NCT03894449|75717368|FG000|STARTED|Overall Study||15||
59606876|NCT03894449|75717369|FG001|STARTED|Overall Study||15||
59606877|NCT03894449|75717370|FG002|STARTED|Overall Study||15||
59606878|NCT03894449|75717371|FG003|STARTED|Overall Study||15||
59606879|NCT03894449|75717372|FG004|STARTED|Overall Study||15||
59606880|NCT03894449|75717368|FG000|COMPLETED|Overall Study||15||
59606881|NCT03894449|75717369|FG001|COMPLETED|Overall Study||15||
59606882|NCT03894449|75717370|FG002|COMPLETED|Overall Study||15||
59606883|NCT03894449|75717371|FG003|COMPLETED|Overall Study||15||
59606884|NCT03894449|75717372|FG004|COMPLETED|Overall Study||15||
59606885|NCT03894449|75717368|FG000|NOT COMPLETED|Overall Study||0||
59606886|NCT03894449|75717369|FG001|NOT COMPLETED|Overall Study||0||
59606887|NCT03894449|75717370|FG002|NOT COMPLETED|Overall Study||0||
59606888|NCT03894449|75717371|FG003|NOT COMPLETED|Overall Study||0||
59606889|NCT03894449|75717372|FG004|NOT COMPLETED|Overall Study||0||
59606890|NCT03888755|75717384|FG000|STARTED|Overall Study||8||
59606891|NCT03888755|75717384|FG000|COMPLETED|Overall Study||8||
59606892|NCT03888755|75717384|FG000|NOT COMPLETED|Overall Study||0||
59606893|NCT02995967|75717392|FG000|STARTED|Overall Study||1||
59606894|NCT02995967|75717393|FG001|STARTED|Overall Study||2||
59606895|NCT02995967|75717392|FG000|COMPLETED|Overall Study||1||
59606896|NCT02995967|75717393|FG001|COMPLETED|Overall Study||2||
59606897|NCT02995967|75717392|FG000|NOT COMPLETED|Overall Study||0||
59606898|NCT02995967|75717393|FG001|NOT COMPLETED|Overall Study||0||
59606899|NCT03888365|75717402|FG000|STARTED|Cohort A Peak Level/Cohort B Period 1||20|All Participants: Participants who consented to the study protocol.|
59606900|NCT03888365|75717403|FG001|STARTED|Cohort A Peak Level/Cohort B Period 1||23|All Participants: Participants who consented to the study protocol.|
59606901|NCT03888365|75717402|FG000|Safety Population|Cohort A Peak Level/Cohort B Period 1||20|All participants who initiated an ISWT at Screening.|
59606902|NCT03888365|75717403|FG001|Safety Population|Cohort A Peak Level/Cohort B Period 1||23|All participants who initiated an ISWT at Screening.|
59606903|NCT03888365|75717402|FG000|COMPLETED|Cohort A Peak Level/Cohort B Period 1||20||
59606904|NCT03888365|75717403|FG001|COMPLETED|Cohort A Peak Level/Cohort B Period 1||23||
59606905|NCT03888365|75717402|FG000|NOT COMPLETED|Cohort A Peak Level/Cohort B Period 1||0||
59606906|NCT03888365|75717403|FG001|NOT COMPLETED|Cohort A Peak Level/Cohort B Period 1||0||
60011796|NCT02614703|76127740|FG001|NOT COMPLETED|Overall Study||1||
60011797|NCT01669343|76127746|FG000|STARTED|Part A: All Patients||121||
60011798|NCT01669343|76127746|FG000|COMPLETED|Part A: All Patients||112||
60011799|NCT01669343|76127746|FG000|NOT COMPLETED|Part A: All Patients||9||
60011800|NCT01669343|76127746|FG000|STARTED|Part B: Patients With BMI>=25||48|By study design, only patients with BMI>=25 was eligible for Part B|
60011801|NCT01669343|76127746|FG000|COMPLETED|Part B: Patients With BMI>=25||31||
60011802|NCT01669343|76127746|FG000|NOT COMPLETED|Part B: Patients With BMI>=25||17||
60011803|NCT01594931|76127756|FG000|STARTED|Overall Study||160||
60011804|NCT01594931|76127757|FG001|STARTED|Overall Study||157||
60011805|NCT01594931|76127758|FG002|STARTED|Overall Study|One randomized subject was not treated.|160||
60011806|NCT01594931|76127756|FG000|COMPLETED|Overall Study||131||
60011807|NCT01594931|76127757|FG001|COMPLETED|Overall Study||145||
60011808|NCT01594931|76127758|FG002|COMPLETED|Overall Study||146||
60011809|NCT01594931|76127756|FG000|NOT COMPLETED|Overall Study||29||
60011810|NCT01594931|76127757|FG001|NOT COMPLETED|Overall Study||12||
60011811|NCT01594931|76127758|FG002|NOT COMPLETED|Overall Study||14||
60011812|NCT01594853|76127768|FG000|STARTED|Overall Study||16||
59606907|NCT03888365|75717402|FG000|STARTED|Rest - At Least 1 h||20||
59606908|NCT03888365|75717403|FG001|STARTED|Rest - At Least 1 h||23||
59606909|NCT03888365|75717402|FG000|COMPLETED|Rest - At Least 1 h||20||
59606910|NCT03888365|75717403|FG001|COMPLETED|Rest - At Least 1 h||23||
60011813|NCT01594853|76127769|FG001|STARTED|Overall Study||15||
60011814|NCT01594853|76127768|FG000|COMPLETED|Overall Study||14||
60011815|NCT01594853|76127769|FG001|COMPLETED|Overall Study||12||
60011816|NCT01594853|76127768|FG000|NOT COMPLETED|Overall Study||2||
59606911|NCT03888365|75717402|FG000|NOT COMPLETED|Rest - At Least 1 h||0||
59606912|NCT03888365|75717403|FG001|NOT COMPLETED|Rest - At Least 1 h||0||
59606913|NCT03888365|75717402|FG000|STARTED|Cohort A Trough Level/Cohort B Period 2||20||
59606914|NCT03888365|75717403|FG001|STARTED|Cohort A Trough Level/Cohort B Period 2||23||
59606915|NCT03888365|75717402|FG000|COMPLETED|Cohort A Trough Level/Cohort B Period 2||20||
59606916|NCT03888365|75717403|FG001|COMPLETED|Cohort A Trough Level/Cohort B Period 2||23||
59606917|NCT03888365|75717402|FG000|NOT COMPLETED|Cohort A Trough Level/Cohort B Period 2||0||
59606918|NCT03888365|75717403|FG001|NOT COMPLETED|Cohort A Trough Level/Cohort B Period 2||0||
59606919|NCT03870893|75717412|FG000|STARTED|Overall Study||23||
59606920|NCT03870893|75717413|FG001|STARTED|Overall Study||24||
59606921|NCT03870893|75717412|FG000|COMPLETED|Overall Study||23||
59606922|NCT03870893|75717413|FG001|COMPLETED|Overall Study||23||
59606923|NCT03870893|75717412|FG000|NOT COMPLETED|Overall Study||0||
59606924|NCT03870893|75717413|FG001|NOT COMPLETED|Overall Study||1||
59606925|NCT02994251|75717420|FG000|STARTED|Overall Study||0||
59606926|NCT02994251|75717420|FG000|COMPLETED|Overall Study||0||
60011817|NCT01594853|76127769|FG001|NOT COMPLETED|Overall Study||3||
59606927|NCT02994251|75717420|FG000|NOT COMPLETED|Overall Study||0||
59606928|NCT03887429|75717428|FG000|STARTED|Overall Study||8||
59606929|NCT03887429|75717429|FG001|STARTED|Overall Study||9||
59754205|NCT00818259|75873280|FG007|COMPLETED|Part I||0||
60011818|NCT04581811|76127777|FG000|STARTED|Overall Study||26||
60011819|NCT04581811|76127778|FG001|STARTED|Overall Study||26||
59606930|NCT03887429|75717430|FG002|STARTED|Overall Study||9||
60011820|NCT04581811|76127777|FG000|COMPLETED|Overall Study||26||
60011821|NCT04581811|76127778|FG001|COMPLETED|Overall Study||26||
60011822|NCT04581811|76127777|FG000|NOT COMPLETED|Overall Study||0||
60011823|NCT04581811|76127778|FG001|NOT COMPLETED|Overall Study||0||
60011824|NCT01668797|76127786|FG000|STARTED|Phase A (Conversion Phase)||406||
59754206|NCT00818259|75873281|FG008|COMPLETED|Part I||0||
60011825|NCT01668797|76127787|FG001|STARTED|Phase A (Conversion Phase)||0||
60011826|NCT01668797|76127788|FG002|STARTED|Phase A (Conversion Phase)||0||
60011827|NCT01668797|76127789|FG003|STARTED|Phase A (Conversion Phase)||0||
60011828|NCT01668797|76127786|FG000|COMPLETED|Phase A (Conversion Phase)||346||
59754207|NCT00818259|75873273|FG000|NOT COMPLETED|Part I||1||
59606931|NCT03887429|75717431|FG003|STARTED|Overall Study||8||
59606932|NCT03887429|75717428|FG000|Completed First Intervention (5 Days)|Overall Study||7||
59754208|NCT00818259|75873274|FG001|NOT COMPLETED|Part I||0||
59754209|NCT00818259|75873275|FG002|NOT COMPLETED|Part I||0||
59884377|NCT03633903|76007276|FG000|STARTED|Overall Study||22||
59884378|NCT03633903|76007277|FG001|STARTED|Overall Study||18||
59884379|NCT03633903|76007276|FG000|Intent to Treat|Overall Study||0||
59884380|NCT03633903|76007277|FG001|Intent to Treat|Overall Study||18||
59884381|NCT03633903|76007276|FG000|COMPLETED|Overall Study||16||
59884382|NCT03633903|76007277|FG001|COMPLETED|Overall Study||11||
59884383|NCT03633903|76007276|FG000|NOT COMPLETED|Overall Study||6||
59884384|NCT03633903|76007277|FG001|NOT COMPLETED|Overall Study||7||
59884385|NCT03607695|76007283|FG000|STARTED|2 Week||19||
59884386|NCT03607695|76007283|FG000|COMPLETED|2 Week||19||
59884387|NCT03607695|76007283|FG000|NOT COMPLETED|2 Week||0||
59884388|NCT03607695|76007283|FG000|STARTED|10 Week||19||
59884389|NCT03607695|76007283|FG000|COMPLETED|10 Week||18||
59884390|NCT03607695|76007283|FG000|NOT COMPLETED|10 Week||1||
59884391|NCT03607695|76007283|FG000|STARTED|16 Week||18||
59884392|NCT03607695|76007283|FG000|COMPLETED|16 Week||16||
59884393|NCT03607695|76007283|FG000|NOT COMPLETED|16 Week||2||
59884394|NCT03557775|76007290|FG000|STARTED|Overall Study||5||
59884395|NCT03557775|76007291|FG001|STARTED|Overall Study||7||
59884396|NCT03557775|76007292|FG002|STARTED|Overall Study||8||
59884397|NCT03557775|76007290|FG000|COMPLETED|Overall Study||4||
59884398|NCT03557775|76007291|FG001|COMPLETED|Overall Study||4||
59884399|NCT03557775|76007292|FG002|COMPLETED|Overall Study||4||
59884400|NCT03557775|76007290|FG000|NOT COMPLETED|Overall Study||1||
59884401|NCT03557775|76007291|FG001|NOT COMPLETED|Overall Study||3||
59606933|NCT03887429|75717429|FG001|Completed First Intervention (5 Days)|Overall Study||8||
59606934|NCT03887429|75717430|FG002|Completed First Intervention (5 Days)|Overall Study||7||
59606935|NCT03887429|75717431|FG003|Completed First Intervention (5 Days)|Overall Study||7||
59606936|NCT03887429|75717428|FG000|Completed Washout (9 Days)|Overall Study||7||
59754210|NCT00818259|75873276|FG003|NOT COMPLETED|Part I||0||
59518975|NCT03393754|75612860|FG001|NOT COMPLETED|Overall Study||38||
59606937|NCT03887429|75717429|FG001|Completed Washout (9 Days)|Overall Study||8||
59754211|NCT00818259|75873277|FG004|NOT COMPLETED|Part I||0||
59754212|NCT00818259|75873278|FG005|NOT COMPLETED|Part I||0||
59754213|NCT00818259|75873279|FG006|NOT COMPLETED|Part I||0||
59754214|NCT00818259|75873280|FG007|NOT COMPLETED|Part I||0||
59754215|NCT00818259|75873281|FG008|NOT COMPLETED|Part I||0||
59754216|NCT00818259|75873273|FG000|STARTED|Part II||0||
59754217|NCT00818259|75873274|FG001|STARTED|Part II||0||
59754218|NCT00818259|75873275|FG002|STARTED|Part II|Newly enrolled participants|19||
59754219|NCT00818259|75873276|FG003|STARTED|Part II|Newly enrolled participants|20||
59754220|NCT00818259|75873277|FG004|STARTED|Part II||0||
59754221|NCT00818259|75873278|FG005|STARTED|Part II||0||
59754222|NCT00818259|75873279|FG006|STARTED|Part II||0||
59754223|NCT00818259|75873280|FG007|STARTED|Part II||0||
59754224|NCT00818259|75873281|FG008|STARTED|Part II||0||
59754225|NCT00818259|75873273|FG000|Treated|Part II||0||
59754226|NCT00818259|75873274|FG001|Treated|Part II||0||
59754227|NCT00818259|75873275|FG002|Treated|Part II||19||
59754228|NCT00818259|75873276|FG003|Treated|Part II||19||
59754229|NCT00818259|75873277|FG004|Treated|Part II||0||
59754230|NCT00818259|75873278|FG005|Treated|Part II||0||
59754231|NCT00818259|75873279|FG006|Treated|Part II||0||
59754232|NCT00818259|75873280|FG007|Treated|Part II||0||
59754233|NCT00818259|75873281|FG008|Treated|Part II||0||
59754234|NCT00818259|75873273|FG000|COMPLETED|Part II||0||
59754235|NCT00818259|75873274|FG001|COMPLETED|Part II||0||
59754236|NCT00818259|75873275|FG002|COMPLETED|Part II||18||
59754237|NCT00818259|75873276|FG003|COMPLETED|Part II||18||
59754238|NCT00818259|75873277|FG004|COMPLETED|Part II||0||
59754239|NCT00818259|75873278|FG005|COMPLETED|Part II||0||
59884402|NCT03557775|76007292|FG002|NOT COMPLETED|Overall Study||4||
59884403|NCT00121199|76007300|FG000|STARTED|Overall Study||73||
59884404|NCT00121199|76007300|FG000|Eligible|Overall Study||64||
59754240|NCT00818259|75873279|FG006|COMPLETED|Part II||0||
59754241|NCT00818259|75873280|FG007|COMPLETED|Part II||0||
59754242|NCT00818259|75873281|FG008|COMPLETED|Part II||0||
59754243|NCT00818259|75873273|FG000|NOT COMPLETED|Part II||0||
59754244|NCT00818259|75873274|FG001|NOT COMPLETED|Part II||0||
59754245|NCT00818259|75873275|FG002|NOT COMPLETED|Part II||1||
59754246|NCT00818259|75873276|FG003|NOT COMPLETED|Part II||2||
59754247|NCT00818259|75873277|FG004|NOT COMPLETED|Part II||0||
59754248|NCT00818259|75873278|FG005|NOT COMPLETED|Part II||0||
59884405|NCT00121199|76007300|FG000|Eligible and Began Protocol Therapy|Overall Study||64||
59884406|NCT00121199|76007300|FG000|COMPLETED|Overall Study||45||
59884407|NCT00121199|76007300|FG000|NOT COMPLETED|Overall Study||28||
59884408|NCT00119405|76007304|FG000|STARTED|Overall Study||18||
59884409|NCT00119405|76007304|FG000|COMPLETED|Overall Study||17||
59884410|NCT00119405|76007304|FG000|NOT COMPLETED|Overall Study||1||
59884411|NCT00119015|76007310|FG000|STARTED|Open-Label Phase (2 Weeks)||102||
59884412|NCT00119015|76007311|FG001|STARTED|Open-Label Phase (2 Weeks)||0||
59884413|NCT00119015|76007312|FG002|STARTED|Open-Label Phase (2 Weeks)||0||
59884414|NCT00119015|76007310|FG000|COMPLETED|Open-Label Phase (2 Weeks)||54||
59884415|NCT00119015|76007311|FG001|COMPLETED|Open-Label Phase (2 Weeks)||0||
59884416|NCT00119015|76007312|FG002|COMPLETED|Open-Label Phase (2 Weeks)||0||
59884417|NCT00119015|76007310|FG000|NOT COMPLETED|Open-Label Phase (2 Weeks)||48||
59884418|NCT00119015|76007311|FG001|NOT COMPLETED|Open-Label Phase (2 Weeks)||0||
59884419|NCT00119015|76007312|FG002|NOT COMPLETED|Open-Label Phase (2 Weeks)||0||
59884420|NCT00119015|76007310|FG000|STARTED|Double-Blind, Randomized Phase (2 Weeks)||0||
59884421|NCT00119015|76007311|FG001|STARTED|Double-Blind, Randomized Phase (2 Weeks)|Baseline Analysis Population|28||
59884422|NCT00119015|76007312|FG002|STARTED|Double-Blind, Randomized Phase (2 Weeks)|Baseline Analysis Population|26||
59754249|NCT00818259|75873279|FG006|NOT COMPLETED|Part II||0||
59754250|NCT00818259|75873280|FG007|NOT COMPLETED|Part II||0||
59754251|NCT00818259|75873281|FG008|NOT COMPLETED|Part II||0||
59754252|NCT00818259|75873273|FG000|STARTED|Part III||0||
59754253|NCT00818259|75873274|FG001|STARTED|Part III||0||
59754254|NCT00818259|75873275|FG002|STARTED|Part III||0||
59754255|NCT00818259|75873276|FG003|STARTED|Part III||0||
59754256|NCT00818259|75873277|FG004|STARTED|Part III|Newly enrolled participants|19||
59754257|NCT00818259|75873278|FG005|STARTED|Part III||0||
59754258|NCT00818259|75873279|FG006|STARTED|Part III||0||
59884423|NCT00119015|76007310|FG000|COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||0||
59884424|NCT00119015|76007311|FG001|COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||28||
59884425|NCT00119015|76007312|FG002|COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||26||
59884426|NCT00119015|76007310|FG000|NOT COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||0||
59884427|NCT00119015|76007311|FG001|NOT COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||0||
59884428|NCT00119015|76007312|FG002|NOT COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||0||
59884429|NCT01981850|76007325|FG000|STARTED|Main Phase Stage 1||8||
59884430|NCT01981850|76007326|FG001|STARTED|Main Phase Stage 1||7||
59884431|NCT01981850|76007327|FG002|STARTED|Main Phase Stage 1||6||
59884432|NCT01981850|76007328|FG003|STARTED|Main Phase Stage 1||6||
59884433|NCT01981850|76007329|FG004|STARTED|Main Phase Stage 1||0||
59884434|NCT01981850|76007330|FG005|STARTED|Main Phase Stage 1||0||
59884435|NCT01981850|76007331|FG006|STARTED|Main Phase Stage 1||0||
59884436|NCT01981850|76007332|FG007|STARTED|Main Phase Stage 1||0||
59884437|NCT01981850|76007333|FG008|STARTED|Main Phase Stage 1||0||
59884438|NCT01981850|76007334|FG009|STARTED|Main Phase Stage 1||0||
59884439|NCT01981850|76007325|FG000|COMPLETED|Main Phase Stage 1||5|Main Study|
59884440|NCT01981850|76007326|FG001|COMPLETED|Main Phase Stage 1||5|Main Study|
59754259|NCT00818259|75873280|FG007|STARTED|Part III||0||
59754260|NCT00818259|75873281|FG008|STARTED|Part III||0||
59754261|NCT00818259|75873273|FG000|COMPLETED|Part III||0||
59754262|NCT00818259|75873274|FG001|COMPLETED|Part III||0||
59754263|NCT00818259|75873275|FG002|COMPLETED|Part III||0||
59754264|NCT00818259|75873276|FG003|COMPLETED|Part III||0||
59754265|NCT00818259|75873277|FG004|COMPLETED|Part III||19||
59754266|NCT00818259|75873278|FG005|COMPLETED|Part III||0||
59754267|NCT00818259|75873279|FG006|COMPLETED|Part III||0||
59754268|NCT00818259|75873280|FG007|COMPLETED|Part III||0||
59754269|NCT00818259|75873281|FG008|COMPLETED|Part III||0||
59754270|NCT00818259|75873273|FG000|NOT COMPLETED|Part III||0||
59754271|NCT00818259|75873274|FG001|NOT COMPLETED|Part III||0||
59754272|NCT00818259|75873275|FG002|NOT COMPLETED|Part III||0||
59754273|NCT00818259|75873276|FG003|NOT COMPLETED|Part III||0||
59754274|NCT00818259|75873277|FG004|NOT COMPLETED|Part III||0||
59754275|NCT00818259|75873278|FG005|NOT COMPLETED|Part III||0||
59754276|NCT00818259|75873279|FG006|NOT COMPLETED|Part III||0||
59754277|NCT00818259|75873280|FG007|NOT COMPLETED|Part III||0||
59754278|NCT00818259|75873281|FG008|NOT COMPLETED|Part III||0||
59754279|NCT00818259|75873273|FG000|STARTED|Part IV||0||
59754280|NCT00818259|75873274|FG001|STARTED|Part IV||0||
59754281|NCT00818259|75873275|FG002|STARTED|Part IV||0||
59754282|NCT00818259|75873276|FG003|STARTED|Part IV||0||
59754283|NCT00818259|75873277|FG004|STARTED|Part IV||0||
59754284|NCT00818259|75873278|FG005|STARTED|Part IV|Participants continuing from Part III|15||
59754285|NCT00818259|75873279|FG006|STARTED|Part IV|Newly enrolled participants|5||
59754286|NCT00818259|75873280|FG007|STARTED|Part IV||0||
59754287|NCT00818259|75873281|FG008|STARTED|Part IV||0||
59754288|NCT00818259|75873273|FG000|COMPLETED|Part IV||0||
59754289|NCT00818259|75873274|FG001|COMPLETED|Part IV||0||
59754290|NCT00818259|75873275|FG002|COMPLETED|Part IV||0||
59754291|NCT00818259|75873276|FG003|COMPLETED|Part IV||0||
59754292|NCT00818259|75873277|FG004|COMPLETED|Part IV||0||
59754293|NCT00818259|75873278|FG005|COMPLETED|Part IV||14||
59754294|NCT00818259|75873279|FG006|COMPLETED|Part IV||5||
59754295|NCT00818259|75873280|FG007|COMPLETED|Part IV||0||
59754296|NCT00818259|75873281|FG008|COMPLETED|Part IV||0||
59754297|NCT00818259|75873273|FG000|NOT COMPLETED|Part IV||0||
59754298|NCT00818259|75873274|FG001|NOT COMPLETED|Part IV||0||
59754299|NCT00818259|75873275|FG002|NOT COMPLETED|Part IV||0||
59754300|NCT00818259|75873276|FG003|NOT COMPLETED|Part IV||0||
59754301|NCT00818259|75873277|FG004|NOT COMPLETED|Part IV||0||
59754302|NCT00818259|75873278|FG005|NOT COMPLETED|Part IV||1||
59606938|NCT03887429|75717430|FG002|Completed Washout (9 Days)|Overall Study||7||
59606939|NCT03887429|75717431|FG003|Completed Washout (9 Days)|Overall Study||7||
59606940|NCT03887429|75717428|FG000|Completed Second Intervention (5 Days)|Overall Study||7||
59518976|NCT03394768|75612866|FG000|STARTED|Overall Study||26||
59754303|NCT00818259|75873279|FG006|NOT COMPLETED|Part IV||0||
59754304|NCT00818259|75873280|FG007|NOT COMPLETED|Part IV||0||
59754305|NCT00818259|75873281|FG008|NOT COMPLETED|Part IV||0||
59754306|NCT00818259|75873273|FG000|STARTED|Part V||0||
59606941|NCT03887429|75717429|FG001|Completed Second Intervention (5 Days)|Overall Study||8||
59606942|NCT03887429|75717430|FG002|Completed Second Intervention (5 Days)|Overall Study||7||
59884441|NCT01981850|76007327|FG002|COMPLETED|Main Phase Stage 1||4|Main Study|
59884442|NCT01981850|76007328|FG003|COMPLETED|Main Phase Stage 1||6|Main Study|
59884443|NCT01981850|76007329|FG004|COMPLETED|Main Phase Stage 1||0|Main Study|
59884444|NCT01981850|76007330|FG005|COMPLETED|Main Phase Stage 1||0|Main Study|
59884445|NCT01981850|76007331|FG006|COMPLETED|Main Phase Stage 1||0|Main Study|
59884446|NCT01981850|76007332|FG007|COMPLETED|Main Phase Stage 1||0|Main Study|
59884447|NCT01981850|76007333|FG008|COMPLETED|Main Phase Stage 1||0|Main Study|
59884448|NCT01981850|76007334|FG009|COMPLETED|Main Phase Stage 1||0|Main Study|
59884449|NCT01981850|76007325|FG000|NOT COMPLETED|Main Phase Stage 1||3||
59884450|NCT01981850|76007326|FG001|NOT COMPLETED|Main Phase Stage 1||2||
59884451|NCT01981850|76007327|FG002|NOT COMPLETED|Main Phase Stage 1||2||
59884452|NCT01981850|76007328|FG003|NOT COMPLETED|Main Phase Stage 1||0||
59884453|NCT01981850|76007329|FG004|NOT COMPLETED|Main Phase Stage 1||0||
59884454|NCT01981850|76007330|FG005|NOT COMPLETED|Main Phase Stage 1||0||
59884455|NCT01981850|76007331|FG006|NOT COMPLETED|Main Phase Stage 1||0||
59884456|NCT01981850|76007332|FG007|NOT COMPLETED|Main Phase Stage 1||0||
59884457|NCT01981850|76007333|FG008|NOT COMPLETED|Main Phase Stage 1||0||
59884458|NCT01981850|76007334|FG009|NOT COMPLETED|Main Phase Stage 1||0||
59884459|NCT01981850|76007325|FG000|STARTED|Main Phase Stage 2||0||
59884460|NCT01981850|76007326|FG001|STARTED|Main Phase Stage 2||0||
59884461|NCT01981850|76007327|FG002|STARTED|Main Phase Stage 2||0||
59884462|NCT01981850|76007328|FG003|STARTED|Main Phase Stage 2||0||
59884463|NCT01981850|76007329|FG004|STARTED|Main Phase Stage 2||33||
59884464|NCT01981850|76007330|FG005|STARTED|Main Phase Stage 2||32||
59754307|NCT00818259|75873274|FG001|STARTED|Part V||0||
59754308|NCT00818259|75873275|FG002|STARTED|Part V||0||
59754309|NCT00818259|75873276|FG003|STARTED|Part V||0||
59754310|NCT00818259|75873277|FG004|STARTED|Part V||0||
59754311|NCT00818259|75873278|FG005|STARTED|Part V||0||
59754312|NCT00818259|75873279|FG006|STARTED|Part V||0||
59754313|NCT00818259|75873280|FG007|STARTED|Part V|Participants continuing from Part IV|17||
59754314|NCT00818259|75873281|FG008|STARTED|Part V|Newly enrolled participants|6||
59754315|NCT00818259|75873273|FG000|COMPLETED|Part V||0||
59754316|NCT00818259|75873274|FG001|COMPLETED|Part V||0||
59754317|NCT00818259|75873275|FG002|COMPLETED|Part V||0||
59754318|NCT00818259|75873276|FG003|COMPLETED|Part V||0||
59754319|NCT00818259|75873277|FG004|COMPLETED|Part V||0||
59754320|NCT00818259|75873278|FG005|COMPLETED|Part V||0||
59754321|NCT00818259|75873279|FG006|COMPLETED|Part V||0||
59754322|NCT00818259|75873280|FG007|COMPLETED|Part V||16||
59754323|NCT00818259|75873281|FG008|COMPLETED|Part V||6||
59754324|NCT00818259|75873273|FG000|NOT COMPLETED|Part V||0||
59754325|NCT00818259|75873274|FG001|NOT COMPLETED|Part V||0||
59754326|NCT00818259|75873275|FG002|NOT COMPLETED|Part V||0||
59754327|NCT00818259|75873276|FG003|NOT COMPLETED|Part V||0||
59606943|NCT03887429|75717431|FG003|Completed Second Intervention (5 Days)|Overall Study||7||
59606944|NCT03887429|75717428|FG000|COMPLETED|Overall Study||7||
60011829|NCT01668797|76127787|FG001|COMPLETED|Phase A (Conversion Phase)||0||
60011830|NCT01668797|76127788|FG002|COMPLETED|Phase A (Conversion Phase)||0||
60011831|NCT01668797|76127789|FG003|COMPLETED|Phase A (Conversion Phase)||0||
60011832|NCT01668797|76127786|FG000|NOT COMPLETED|Phase A (Conversion Phase)||60||
60011833|NCT01668797|76127787|FG001|NOT COMPLETED|Phase A (Conversion Phase)||0||
59606945|NCT03887429|75717429|FG001|COMPLETED|Overall Study||8||
60011834|NCT01668797|76127788|FG002|NOT COMPLETED|Phase A (Conversion Phase)||0||
60011835|NCT01668797|76127789|FG003|NOT COMPLETED|Phase A (Conversion Phase)||0||
60011836|NCT01668797|76127786|FG000|STARTED|Phase B (Stabilization Phase)||0||
59606946|NCT03887429|75717430|FG002|COMPLETED|Overall Study||7||
59606947|NCT03887429|75717431|FG003|COMPLETED|Overall Study||7||
60011837|NCT01668797|76127787|FG001|STARTED|Phase B (Stabilization Phase)|N= 464; 346 rolled over from Phase A and 118 entered directly into Phase B|464||
60011838|NCT01668797|76127788|FG002|STARTED|Phase B (Stabilization Phase)||0||
60011839|NCT01668797|76127789|FG003|STARTED|Phase B (Stabilization Phase)||0||
60011840|NCT01668797|76127786|FG000|COMPLETED|Phase B (Stabilization Phase)||0||
60011841|NCT01668797|76127787|FG001|COMPLETED|Phase B (Stabilization Phase)||202||
59606948|NCT03887429|75717428|FG000|NOT COMPLETED|Overall Study||1||
60011842|NCT01668797|76127788|FG002|COMPLETED|Phase B (Stabilization Phase)||0||
60011843|NCT01668797|76127789|FG003|COMPLETED|Phase B (Stabilization Phase)||0||
60011844|NCT01668797|76127786|FG000|NOT COMPLETED|Phase B (Stabilization Phase)||0||
60011845|NCT01668797|76127787|FG001|NOT COMPLETED|Phase B (Stabilization Phase)||262||
60011846|NCT01668797|76127788|FG002|NOT COMPLETED|Phase B (Stabilization Phase)||0||
60011847|NCT01668797|76127789|FG003|NOT COMPLETED|Phase B (Stabilization Phase)||0||
60011848|NCT01668797|76127786|FG000|STARTED|Phase C (Double-Blind Maintenance Phase)||0||
60011849|NCT01668797|76127787|FG001|STARTED|Phase C (Double-Blind Maintenance Phase)||0||
60011850|NCT01668797|76127788|FG002|STARTED|Phase C (Double-Blind Maintenance Phase)|N= 202 rolled over from Phase B|97||
60011851|NCT01668797|76127789|FG003|STARTED|Phase C (Double-Blind Maintenance Phase)||105||
59884465|NCT01981850|76007331|FG006|STARTED|Main Phase Stage 2||32||
59884466|NCT01981850|76007332|FG007|STARTED|Main Phase Stage 2||0||
59884467|NCT01981850|76007333|FG008|STARTED|Main Phase Stage 2||0||
59884468|NCT01981850|76007334|FG009|STARTED|Main Phase Stage 2||0||
59884469|NCT01981850|76007325|FG000|COMPLETED|Main Phase Stage 2||0|Main Study|
59884470|NCT01981850|76007326|FG001|COMPLETED|Main Phase Stage 2||0|Main Study|
59884471|NCT01981850|76007327|FG002|COMPLETED|Main Phase Stage 2||0|Main Study|
59884472|NCT01981850|76007328|FG003|COMPLETED|Main Phase Stage 2||0|Main Study|
60011852|NCT01668797|76127786|FG000|COMPLETED|Phase C (Double-Blind Maintenance Phase)||0||
60011853|NCT01668797|76127787|FG001|COMPLETED|Phase C (Double-Blind Maintenance Phase)||0||
60011854|NCT01668797|76127788|FG002|COMPLETED|Phase C (Double-Blind Maintenance Phase)||14||
60011855|NCT01668797|76127789|FG003|COMPLETED|Phase C (Double-Blind Maintenance Phase)||9||
60011856|NCT01668797|76127786|FG000|NOT COMPLETED|Phase C (Double-Blind Maintenance Phase)||0||
60011857|NCT01668797|76127787|FG001|NOT COMPLETED|Phase C (Double-Blind Maintenance Phase)||0||
60011858|NCT01668797|76127788|FG002|NOT COMPLETED|Phase C (Double-Blind Maintenance Phase)||83||
60011859|NCT01668797|76127789|FG003|NOT COMPLETED|Phase C (Double-Blind Maintenance Phase)||96||
60011860|NCT02613221|76127796|FG000|STARTED|Overall Study||56||
60011861|NCT02613221|76127796|FG000|Safety Population: Received Study Drug|Overall Study||55||
60011862|NCT02613221|76127796|FG000|COMPLETED|Overall Study||1||
60011863|NCT02613221|76127796|FG000|NOT COMPLETED|Overall Study||55||
60011864|NCT01362049|76127804|FG000|STARTED|Follow-Up at 7 Weeks||26|Subjects who signed consent forms|
60011865|NCT01362049|76127805|FG001|STARTED|Follow-Up at 7 Weeks||19|Subjects who signed consent forms|
60011866|NCT01362049|76127806|FG002|STARTED|Follow-Up at 7 Weeks||32|Subjects who signed consent forms|
60011867|NCT01362049|76127807|FG003|STARTED|Follow-Up at 7 Weeks||25|Subjects who signed consent forms|
60011868|NCT01362049|76127804|FG000|Randomized and Started PT Treatment|Follow-Up at 7 Weeks||26||
60011869|NCT01362049|76127805|FG001|Randomized and Started PT Treatment|Follow-Up at 7 Weeks||18||
60011870|NCT01362049|76127806|FG002|Randomized and Started PT Treatment|Follow-Up at 7 Weeks||32||
59884473|NCT01981850|76007329|FG004|COMPLETED|Main Phase Stage 2||20|Main Study|
59884474|NCT01981850|76007330|FG005|COMPLETED|Main Phase Stage 2||16|Main Study|
60011871|NCT01362049|76127807|FG003|Randomized and Started PT Treatment|Follow-Up at 7 Weeks||25||
60011872|NCT01362049|76127804|FG000|COMPLETED|Follow-Up at 7 Weeks||23||
60011873|NCT01362049|76127805|FG001|COMPLETED|Follow-Up at 7 Weeks||16||
59606949|NCT03887429|75717429|FG001|NOT COMPLETED|Overall Study||1||
59606950|NCT03887429|75717430|FG002|NOT COMPLETED|Overall Study||2||
59606951|NCT03887429|75717431|FG003|NOT COMPLETED|Overall Study||1||
59606952|NCT02978885|75717448|FG000|STARTED|Overall Study||0||
59606953|NCT02978885|75717449|FG001|STARTED|Overall Study||1||
59606954|NCT02978885|75717448|FG000|COMPLETED|Overall Study||0||
59606955|NCT02978885|75717449|FG001|COMPLETED|Overall Study||1||
59606956|NCT02978885|75717448|FG000|NOT COMPLETED|Overall Study||0||
59606957|NCT02978885|75717449|FG001|NOT COMPLETED|Overall Study||0||
59606958|NCT02936999|75717455|FG000|STARTED|Overall Study||8||
59606959|NCT02936999|75717455|FG000|COMPLETED|Overall Study||8||
59606960|NCT02936999|75717455|FG000|NOT COMPLETED|Overall Study||0||
59606961|NCT01385033|75717463|FG000|STARTED|Part I|These subjects did not participate in Part II or III|6||
59606962|NCT01385033|75717464|FG001|STARTED|Part I|These subjects did not participate in Part II or III|14||
59754328|NCT00818259|75873277|FG004|NOT COMPLETED|Part V||0||
59606963|NCT01385033|75717465|FG002|STARTED|Part I||0||
59606964|NCT01385033|75717466|FG003|STARTED|Part I||0||
59884475|NCT01981850|76007331|FG006|COMPLETED|Main Phase Stage 2||15|Main Study|
59884476|NCT01981850|76007332|FG007|COMPLETED|Main Phase Stage 2||0|Main Study|
59884477|NCT01981850|76007333|FG008|COMPLETED|Main Phase Stage 2||0|Main Study|
59884478|NCT01981850|76007334|FG009|COMPLETED|Main Phase Stage 2||0|Main Study|
59884479|NCT01981850|76007325|FG000|NOT COMPLETED|Main Phase Stage 2||0||
59884480|NCT01981850|76007326|FG001|NOT COMPLETED|Main Phase Stage 2||0||
59884481|NCT01981850|76007327|FG002|NOT COMPLETED|Main Phase Stage 2||0||
59884482|NCT01981850|76007328|FG003|NOT COMPLETED|Main Phase Stage 2||0||
59884483|NCT01981850|76007329|FG004|NOT COMPLETED|Main Phase Stage 2||13||
59884484|NCT01981850|76007330|FG005|NOT COMPLETED|Main Phase Stage 2||16||
59884485|NCT01981850|76007331|FG006|NOT COMPLETED|Main Phase Stage 2||17||
59884486|NCT01981850|76007332|FG007|NOT COMPLETED|Main Phase Stage 2||0||
59884487|NCT01981850|76007333|FG008|NOT COMPLETED|Main Phase Stage 2||0||
59884488|NCT01981850|76007334|FG009|NOT COMPLETED|Main Phase Stage 2||0||
59884489|NCT01981850|76007325|FG000|STARTED|Open Label Extension (OLE)||0|Continued in OLE|
59884490|NCT01981850|76007326|FG001|STARTED|Open Label Extension (OLE)||0|Continued in OLE|
59884491|NCT01981850|76007327|FG002|STARTED|Open Label Extension (OLE)||0|Continued in OLE|
59884492|NCT01981850|76007328|FG003|STARTED|Open Label Extension (OLE)||0|Continued in OLE|
59884493|NCT01981850|76007329|FG004|STARTED|Open Label Extension (OLE)||0|Continued in OLE|
59884494|NCT01981850|76007330|FG005|STARTED|Open Label Extension (OLE)||0|Continued in OLE|
59950884|NCT01483820|76069788|FG000|NOT COMPLETED|Overall Study||8||
59950885|NCT01143766|76069794|FG000|STARTED|Overall Study||25||
59950886|NCT01143766|76069795|FG001|STARTED|Overall Study||31||
59950887|NCT01143766|76069794|FG000|COMPLETED|Overall Study||25||
59754329|NCT00818259|75873278|FG005|NOT COMPLETED|Part V||0||
59754330|NCT00818259|75873279|FG006|NOT COMPLETED|Part V||0||
59754331|NCT00818259|75873280|FG007|NOT COMPLETED|Part V||1||
59754332|NCT00818259|75873281|FG008|NOT COMPLETED|Part V||0||
59754333|NCT00619099|75873299|FG000|STARTED|Overall Study|All randomized subjects|44||
59754334|NCT00619099|75873300|FG001|STARTED|Overall Study|All randomized subjects|23||
59754335|NCT00619099|75873299|FG000|Received at Least 2 Cycles of Treatment|Overall Study|Subjects included in the Modified Intent to Treat Population|43||
59754336|NCT00619099|75873300|FG001|Received at Least 2 Cycles of Treatment|Overall Study|Subjects included in the Modified Intent to Treat Population|22||
59754337|NCT00619099|75873299|FG000|COMPLETED|Overall Study||11||
59754338|NCT00619099|75873300|FG001|COMPLETED|Overall Study||4||
59754339|NCT00619099|75873299|FG000|NOT COMPLETED|Overall Study||33||
59754340|NCT00619099|75873300|FG001|NOT COMPLETED|Overall Study||19||
59754341|NCT00962585|75873310|FG000|STARTED|Overall Study||43||
59754342|NCT00962585|75873311|FG001|STARTED|Overall Study||42||
59754343|NCT00962585|75873312|FG002|STARTED|Overall Study||42||
59754344|NCT00962585|75873313|FG003|STARTED|Overall Study||42||
59754345|NCT00962585|75873310|FG000|COMPLETED|Overall Study||37||
59754346|NCT00962585|75873311|FG001|COMPLETED|Overall Study||40||
59754347|NCT00962585|75873312|FG002|COMPLETED|Overall Study||39||
59754348|NCT00962585|75873313|FG003|COMPLETED|Overall Study||42||
59754349|NCT00962585|75873310|FG000|NOT COMPLETED|Overall Study||6||
59754350|NCT00962585|75873311|FG001|NOT COMPLETED|Overall Study||2||
59754351|NCT00962585|75873312|FG002|NOT COMPLETED|Overall Study||3||
59754352|NCT00962585|75873313|FG003|NOT COMPLETED|Overall Study||0||
59754353|NCT00621985|75873325|FG000|STARTED|Hydrocortisone Admission||5||
59754354|NCT00621985|75873325|FG000|COMPLETED|Hydrocortisone Admission||5||
59884495|NCT01981850|76007331|FG006|STARTED|Open Label Extension (OLE)||0|Continued in OLE|
59754355|NCT00621985|75873325|FG000|NOT COMPLETED|Hydrocortisone Admission||0||
59754356|NCT00621985|75873325|FG000|STARTED|Dexamethasone Admission||5||
59754357|NCT00621985|75873325|FG000|COMPLETED|Dexamethasone Admission||4||
59754358|NCT00621985|75873325|FG000|NOT COMPLETED|Dexamethasone Admission||1||
59754359|NCT03312257|75873331|FG000|STARTED|Overall Study||49||
59754360|NCT03312257|75873331|FG000|COMPLETED|Overall Study||46||
59754361|NCT03312257|75873331|FG000|NOT COMPLETED|Overall Study||3||
59754362|NCT00961259|75873335|FG000|STARTED|First Intervention||18||
59884496|NCT01981850|76007332|FG007|STARTED|Open Label Extension (OLE)||13|Continued in OLE|
59754363|NCT00961259|75873336|FG001|STARTED|First Intervention||18||
59754364|NCT00961259|75873337|FG002|STARTED|First Intervention||18||
59884497|NCT01981850|76007333|FG008|STARTED|Open Label Extension (OLE)||5|Continued in OLE|
59754365|NCT00961259|75873335|FG000|COMPLETED|First Intervention||18||
59754366|NCT00961259|75873336|FG001|COMPLETED|First Intervention||18||
59754367|NCT00961259|75873337|FG002|COMPLETED|First Intervention||18||
59754368|NCT00961259|75873335|FG000|NOT COMPLETED|First Intervention||0||
59754369|NCT00961259|75873336|FG001|NOT COMPLETED|First Intervention||0||
59754370|NCT00961259|75873337|FG002|NOT COMPLETED|First Intervention||0||
59754371|NCT00961259|75873335|FG000|STARTED|Washout Period of 7 Days||18||
59754372|NCT00961259|75873336|FG001|STARTED|Washout Period of 7 Days||18||
59754373|NCT00961259|75873337|FG002|STARTED|Washout Period of 7 Days||18||
59754374|NCT00961259|75873335|FG000|COMPLETED|Washout Period of 7 Days||18||
59754375|NCT00961259|75873336|FG001|COMPLETED|Washout Period of 7 Days|dropped due to concomitant medication used prior to admission.|17||
59754376|NCT00961259|75873337|FG002|COMPLETED|Washout Period of 7 Days||18||
59754377|NCT00961259|75873335|FG000|NOT COMPLETED|Washout Period of 7 Days||0||
59754378|NCT00961259|75873336|FG001|NOT COMPLETED|Washout Period of 7 Days||1||
59754379|NCT00961259|75873337|FG002|NOT COMPLETED|Washout Period of 7 Days||0||
59754380|NCT00961259|75873335|FG000|STARTED|Second Intervention||18||
59754381|NCT00961259|75873336|FG001|STARTED|Second Intervention||17||
59754382|NCT00961259|75873337|FG002|STARTED|Second Intervention||18||
59754383|NCT00961259|75873335|FG000|COMPLETED|Second Intervention||18||
59754384|NCT00961259|75873336|FG001|COMPLETED|Second Intervention||17||
59754385|NCT00961259|75873337|FG002|COMPLETED|Second Intervention||18||
59754386|NCT00961259|75873335|FG000|NOT COMPLETED|Second Intervention||0||
59754387|NCT00961259|75873336|FG001|NOT COMPLETED|Second Intervention||0||
59754388|NCT00961259|75873337|FG002|NOT COMPLETED|Second Intervention||0||
59754389|NCT00961259|75873335|FG000|STARTED|Washout Period of 7 Days||18||
59754390|NCT00961259|75873336|FG001|STARTED|Washout Period of 7 Days||17||
59754391|NCT00961259|75873337|FG002|STARTED|Washout Period of 7 Days||18||
59754392|NCT00961259|75873335|FG000|COMPLETED|Washout Period of 7 Days||18||
59754393|NCT00961259|75873336|FG001|COMPLETED|Washout Period of 7 Days||17||
59754394|NCT00961259|75873337|FG002|COMPLETED|Washout Period of 7 Days||18||
59754395|NCT00961259|75873335|FG000|NOT COMPLETED|Washout Period of 7 Days||0||
59754396|NCT00961259|75873336|FG001|NOT COMPLETED|Washout Period of 7 Days||0||
59754397|NCT00961259|75873337|FG002|NOT COMPLETED|Washout Period of 7 Days||0||
59754398|NCT00961259|75873335|FG000|STARTED|Third Intervention||18||
59754399|NCT00961259|75873336|FG001|STARTED|Third Intervention||17||
59754400|NCT00961259|75873337|FG002|STARTED|Third Intervention||18||
59754401|NCT00961259|75873335|FG000|COMPLETED|Third Intervention||18||
59754402|NCT00961259|75873336|FG001|COMPLETED|Third Intervention||17||
59754403|NCT00961259|75873337|FG002|COMPLETED|Third Intervention||18||
59754404|NCT00961259|75873335|FG000|NOT COMPLETED|Third Intervention||0||
59754405|NCT00961259|75873336|FG001|NOT COMPLETED|Third Intervention||0||
59754406|NCT00961259|75873337|FG002|NOT COMPLETED|Third Intervention||0||
59754407|NCT00961181|75873346|FG000|STARTED|Overall Study||81||
59754408|NCT00961181|75873346|FG000|COMPLETED|Overall Study||76||
59754409|NCT00961181|75873346|FG000|NOT COMPLETED|Overall Study||5||
59754410|NCT00817635|75873355|FG000|STARTED|Overall Study||32||
59754411|NCT00817635|75873356|FG001|STARTED|Overall Study||26||
59754412|NCT00817635|75873357|FG002|STARTED|Overall Study||31||
59754413|NCT00817635|75873358|FG003|STARTED|Overall Study||33||
59754414|NCT00817635|75873359|FG004|STARTED|Overall Study||33||
59754415|NCT00817635|75873355|FG000|COMPLETED|Overall Study||23||
59754416|NCT00817635|75873356|FG001|COMPLETED|Overall Study||22||
59754417|NCT00817635|75873357|FG002|COMPLETED|Overall Study||28||
59754418|NCT00817635|75873358|FG003|COMPLETED|Overall Study||28||
59754419|NCT00817635|75873359|FG004|COMPLETED|Overall Study||25||
59754420|NCT00817635|75873355|FG000|NOT COMPLETED|Overall Study||9||
59754421|NCT00817635|75873356|FG001|NOT COMPLETED|Overall Study||4||
59754422|NCT00817635|75873357|FG002|NOT COMPLETED|Overall Study||3||
59754423|NCT00817635|75873358|FG003|NOT COMPLETED|Overall Study||5||
59754424|NCT00817635|75873359|FG004|NOT COMPLETED|Overall Study||8||
59754425|NCT00817479|75873380|FG000|STARTED|Overall Study||6||
59754426|NCT00817479|75873381|FG001|STARTED|Overall Study||14||
59754427|NCT00817479|75873380|FG000|COMPLETED|Overall Study||5||
59754428|NCT00817479|75873381|FG001|COMPLETED|Overall Study||13||
59754429|NCT00817479|75873380|FG000|NOT COMPLETED|Overall Study||1||
59754430|NCT00817479|75873381|FG001|NOT COMPLETED|Overall Study||1||
59754431|NCT00961961|75873391|FG000|STARTED|Phase I||177||
59754432|NCT00961961|75873392|FG001|STARTED|Phase I||0||
59754433|NCT00961961|75873393|FG002|STARTED|Phase I||0||
59754434|NCT00961961|75873394|FG003|STARTED|Phase I||0||
59754435|NCT00961961|75873391|FG000|COMPLETED|Phase I||51||
59754436|NCT00961961|75873392|FG001|COMPLETED|Phase I||0||
59754437|NCT00961961|75873393|FG002|COMPLETED|Phase I||0||
59754438|NCT00961961|75873394|FG003|COMPLETED|Phase I||0||
59754439|NCT00961961|75873391|FG000|NOT COMPLETED|Phase I||126||
59754440|NCT00961961|75873392|FG001|NOT COMPLETED|Phase I||0||
59754441|NCT00961961|75873393|FG002|NOT COMPLETED|Phase I||0||
59754442|NCT00961961|75873394|FG003|NOT COMPLETED|Phase I||0||
59754443|NCT00961961|75873391|FG000|STARTED|Phase II|This is a Phase I category. Not relevant in Phase II.|0||
59754444|NCT00961961|75873392|FG001|STARTED|Phase II|This is a Phase I category. Not relevant in Phase II.|0||
59754445|NCT00961961|75873393|FG002|STARTED|Phase II||29||
59754446|NCT00961961|75873394|FG003|STARTED|Phase II||22||
59754447|NCT00961961|75873391|FG000|COMPLETED|Phase II||0||
59754448|NCT00961961|75873392|FG001|COMPLETED|Phase II||0||
59754449|NCT00961961|75873393|FG002|COMPLETED|Phase II||17||
59754450|NCT00961961|75873394|FG003|COMPLETED|Phase II||14||
59754451|NCT00961961|75873391|FG000|NOT COMPLETED|Phase II||0||
59754452|NCT00961961|75873392|FG001|NOT COMPLETED|Phase II||0||
59754453|NCT00961961|75873393|FG002|NOT COMPLETED|Phase II||12||
59754454|NCT00961961|75873394|FG003|NOT COMPLETED|Phase II||8||
59754455|NCT00817089|75873418|FG000|STARTED|First Alcohol Challenge||6||
59754456|NCT00817089|75873419|FG001|STARTED|First Alcohol Challenge||8||
59754457|NCT00817089|75873420|FG002|STARTED|First Alcohol Challenge||4||
59754458|NCT00817089|75873421|FG003|STARTED|First Alcohol Challenge||6||
59754459|NCT00817089|75873418|FG000|COMPLETED|First Alcohol Challenge||6||
59754460|NCT00817089|75873419|FG001|COMPLETED|First Alcohol Challenge||8||
59754461|NCT00817089|75873420|FG002|COMPLETED|First Alcohol Challenge||4||
59754462|NCT00817089|75873421|FG003|COMPLETED|First Alcohol Challenge||5||
59754463|NCT00817089|75873418|FG000|NOT COMPLETED|First Alcohol Challenge||0||
59754464|NCT00817089|75873419|FG001|NOT COMPLETED|First Alcohol Challenge||0||
59754465|NCT00817089|75873420|FG002|NOT COMPLETED|First Alcohol Challenge||0||
59754466|NCT00817089|75873421|FG003|NOT COMPLETED|First Alcohol Challenge||1||
59754467|NCT00817089|75873418|FG000|STARTED|Second Alcohol Challenge||6||
59754468|NCT00817089|75873419|FG001|STARTED|Second Alcohol Challenge||8||
59754469|NCT00817089|75873420|FG002|STARTED|Second Alcohol Challenge||4||
59754470|NCT00817089|75873421|FG003|STARTED|Second Alcohol Challenge||5||
59754471|NCT00817089|75873418|FG000|COMPLETED|Second Alcohol Challenge||6||
59754472|NCT00817089|75873419|FG001|COMPLETED|Second Alcohol Challenge||7||
59754473|NCT00817089|75873420|FG002|COMPLETED|Second Alcohol Challenge||4||
59754474|NCT00817089|75873421|FG003|COMPLETED|Second Alcohol Challenge||5||
59754475|NCT00817089|75873418|FG000|NOT COMPLETED|Second Alcohol Challenge||0||
59754476|NCT00817089|75873419|FG001|NOT COMPLETED|Second Alcohol Challenge||1||
59754477|NCT00817089|75873420|FG002|NOT COMPLETED|Second Alcohol Challenge||0||
59754478|NCT00817089|75873421|FG003|NOT COMPLETED|Second Alcohol Challenge||0||
59754479|NCT00815919|75873435|FG000|STARTED|Overall Study||22||
59754480|NCT00815919|75873435|FG000|COMPLETED|Overall Study||18||
59754481|NCT00815919|75873435|FG000|NOT COMPLETED|Overall Study||4||
59754482|NCT00957905|75873441|FG000|STARTED|Part A||7||
59754483|NCT00957905|75873442|FG001|STARTED|Part A||0||
59754484|NCT00957905|75873441|FG000|COMPLETED|Part A||7||
59754485|NCT00957905|75873442|FG001|COMPLETED|Part A||0||
59754486|NCT00957905|75873441|FG000|NOT COMPLETED|Part A||0||
59754487|NCT00957905|75873442|FG001|NOT COMPLETED|Part A||0||
59754488|NCT00957905|75873441|FG000|STARTED|Part B||0||
59754489|NCT00957905|75873442|FG001|STARTED|Part B||29||
59754490|NCT00957905|75873441|FG000|COMPLETED|Part B||0||
59754491|NCT00957905|75873442|FG001|COMPLETED|Part B||25||
59754492|NCT00957905|75873441|FG000|NOT COMPLETED|Part B||0||
59754493|NCT00957905|75873442|FG001|NOT COMPLETED|Part B||4||
59754494|NCT00960323|75873448|FG000|STARTED|Colchicine Alone||24||
59754495|NCT00960323|75873448|FG000|COMPLETED|Colchicine Alone||24||
59754496|NCT00960323|75873448|FG000|NOT COMPLETED|Colchicine Alone||0||
59754497|NCT00960323|75873448|FG000|STARTED|14 Day Washout Period||24||
59754498|NCT00960323|75873448|FG000|COMPLETED|14 Day Washout Period||24||
59754499|NCT00960323|75873448|FG000|NOT COMPLETED|14 Day Washout Period||0||
59754500|NCT00960323|75873448|FG000|STARTED|Atorvastatin Alone||24||
59754501|NCT00960323|75873448|FG000|COMPLETED|Atorvastatin Alone||23||
59754502|NCT00960323|75873448|FG000|NOT COMPLETED|Atorvastatin Alone||1||
59754503|NCT00960323|75873448|FG000|STARTED|Colchicine and Atorvastatin||23||
59754504|NCT00960323|75873448|FG000|COMPLETED|Colchicine and Atorvastatin||23||
59754505|NCT00960323|75873448|FG000|NOT COMPLETED|Colchicine and Atorvastatin||0||
59754506|NCT00617929|75873456|FG000|STARTED|Overall Study||12||
59754507|NCT00617929|75873456|FG000|COMPLETED|Overall Study||11||
59754508|NCT00617929|75873456|FG000|NOT COMPLETED|Overall Study||1||
59754509|NCT00815295|75873463|FG000|STARTED|Overall Study||8||
59754510|NCT00815295|75873464|FG001|STARTED|Overall Study||8||
59754511|NCT00815295|75873465|FG002|STARTED|Overall Study||12||
59754512|NCT00815295|75873463|FG000|COMPLETED|Overall Study||8||
59754513|NCT00815295|75873464|FG001|COMPLETED|Overall Study||7||
59754514|NCT00815295|75873465|FG002|COMPLETED|Overall Study||9||
59754515|NCT00815295|75873463|FG000|NOT COMPLETED|Overall Study||0||
59754516|NCT00815295|75873464|FG001|NOT COMPLETED|Overall Study||1||
59754517|NCT00815295|75873465|FG002|NOT COMPLETED|Overall Study||3||
59884498|NCT01981850|76007334|FG009|STARTED|Open Label Extension (OLE)||48|Continued in OLE|
59754518|NCT00814983|75873475|FG000|STARTED|Overall Study||15||
59754519|NCT00814983|75873476|FG001|STARTED|Overall Study||0||
59754520|NCT00814983|75873475|FG000|COMPLETED|Overall Study||12||
59884499|NCT01981850|76007325|FG000|COMPLETED|Open Label Extension (OLE)||0||
59884500|NCT01981850|76007326|FG001|COMPLETED|Open Label Extension (OLE)||0||
59754521|NCT00814983|75873476|FG001|COMPLETED|Overall Study||0||
59754522|NCT00814983|75873475|FG000|NOT COMPLETED|Overall Study||3||
59754523|NCT00814983|75873476|FG001|NOT COMPLETED|Overall Study||0||
59754524|NCT00960869|75873484|FG000|STARTED|Overall Study||259||
59754525|NCT00960869|75873485|FG001|STARTED|Overall Study||260||
59754526|NCT00960869|75873484|FG000|Intent-to-Treat Population (ITT)|Overall Study||259||
59754527|NCT00960869|75873485|FG001|Intent-to-Treat Population (ITT)|Overall Study||260||
59754528|NCT00960869|75873484|FG000|Safety Popluation|Overall Study|3 rand to PA32540 took EC-ASA 325mg/3 rand to EC-ASA 325mg took PA32540 counted by actual treatment.|257||
59754529|NCT00960869|75873485|FG001|Safety Popluation|Overall Study|3 rand to PA32540 took EC-ASA 325mg/3 rand to EC-ASA 325mg took PA32540 counted by actual treatment.|259||
59754530|NCT00960869|75873484|FG000|COMPLETED|Overall Study||206||
59754531|NCT00960869|75873485|FG001|COMPLETED|Overall Study||198||
59884501|NCT01981850|76007327|FG002|COMPLETED|Open Label Extension (OLE)||0||
59754532|NCT00960869|75873484|FG000|NOT COMPLETED|Overall Study||53||
59754533|NCT00960869|75873485|FG001|NOT COMPLETED|Overall Study||62||
59754534|NCT00618787|75873493|FG000|STARTED|Overall Study||22||
59754535|NCT00618787|75873494|FG001|STARTED|Overall Study||23||
59754536|NCT00618787|75873493|FG000|COMPLETED|Overall Study||19||
59754537|NCT00618787|75873494|FG001|COMPLETED|Overall Study||21||
59754538|NCT00618787|75873493|FG000|NOT COMPLETED|Overall Study||3||
59754539|NCT00618787|75873494|FG001|NOT COMPLETED|Overall Study||2||
59754540|NCT00813813|75873502|FG000|STARTED|Overall Study||7||
59754541|NCT00813813|75873503|FG001|STARTED|Overall Study||25||
59754542|NCT00813813|75873502|FG000|COMPLETED|Overall Study||4||
59754543|NCT00813813|75873503|FG001|COMPLETED|Overall Study||16||
59754544|NCT00813813|75873502|FG000|NOT COMPLETED|Overall Study||3||
59754545|NCT00813813|75873503|FG001|NOT COMPLETED|Overall Study||9||
59754546|NCT05317312|75873513|FG000|STARTED|Overall Study||28||
59754547|NCT05317312|75873514|FG001|STARTED|Overall Study||28||
59754548|NCT05317312|75873515|FG002|STARTED|Overall Study||27||
59754549|NCT05317312|75873516|FG003|STARTED|Overall Study||27||
59754550|NCT05317312|75873513|FG000|COMPLETED|Overall Study||28||
59754551|NCT05317312|75873514|FG001|COMPLETED|Overall Study||27||
59754552|NCT05317312|75873515|FG002|COMPLETED|Overall Study||26||
59754553|NCT05317312|75873516|FG003|COMPLETED|Overall Study||26||
59754554|NCT05317312|75873513|FG000|NOT COMPLETED|Overall Study||0||
59754555|NCT05317312|75873514|FG001|NOT COMPLETED|Overall Study||1||
59754556|NCT05317312|75873515|FG002|NOT COMPLETED|Overall Study||1||
59754557|NCT05317312|75873516|FG003|NOT COMPLETED|Overall Study||1||
59754558|NCT04644315|75873526|FG000|STARTED|Overall Study||1||
59754559|NCT04644315|75873526|FG000|COMPLETED|Overall Study||0||
59754560|NCT04644315|75873526|FG000|NOT COMPLETED|Overall Study||1||
59754561|NCT04410523|75873536|FG000|STARTED|Overall Study||36||
59754562|NCT04410523|75873537|FG001|STARTED|Overall Study||37||
59754563|NCT04410523|75873538|FG002|STARTED|Overall Study||37||
59754564|NCT04410523|75873539|FG003|STARTED|Overall Study||76||
59754565|NCT04410523|75873540|FG004|STARTED|Overall Study||74||
59754566|NCT04410523|75873541|FG005|STARTED|Overall Study||75||
59754567|NCT04410523|75873536|FG000|COMPLETED|Overall Study||32||
59754568|NCT04410523|75873537|FG001|COMPLETED|Overall Study||32||
59754569|NCT04410523|75873538|FG002|COMPLETED|Overall Study||35||
59754570|NCT04410523|75873539|FG003|COMPLETED|Overall Study||69||
59754571|NCT04410523|75873540|FG004|COMPLETED|Overall Study||71||
59754572|NCT04410523|75873541|FG005|COMPLETED|Overall Study||65||
59754573|NCT04410523|75873536|FG000|NOT COMPLETED|Overall Study||4||
59754574|NCT04410523|75873537|FG001|NOT COMPLETED|Overall Study||5||
59754575|NCT04410523|75873538|FG002|NOT COMPLETED|Overall Study||2||
59754576|NCT04410523|75873539|FG003|NOT COMPLETED|Overall Study||7||
59754577|NCT04410523|75873540|FG004|NOT COMPLETED|Overall Study||3||
59754578|NCT04410523|75873541|FG005|NOT COMPLETED|Overall Study||10||
59754579|NCT04390568|75873560|FG000|STARTED|Overall Study||10||
59950888|NCT01143766|76069795|FG001|COMPLETED|Overall Study||31||
59754580|NCT04390568|75873561|FG001|STARTED|Overall Study||10||
59754581|NCT04390568|75873562|FG002|STARTED|Overall Study||10||
59754582|NCT04390568|75873563|FG003|STARTED|Overall Study||10||
59754583|NCT04390568|75873564|FG004|STARTED|Overall Study||10||
59754584|NCT04390568|75873560|FG000|Treated|Overall Study||10||
59754585|NCT04390568|75873561|FG001|Treated|Overall Study||10||
59754586|NCT04390568|75873562|FG002|Treated|Overall Study||10||
59754587|NCT04390568|75873563|FG003|Treated|Overall Study||10||
59754588|NCT04390568|75873564|FG004|Treated|Overall Study||10||
59754589|NCT04390568|75873560|FG000|COMPLETED|Overall Study||10||
59754590|NCT04390568|75873561|FG001|COMPLETED|Overall Study||10||
59754591|NCT04390568|75873562|FG002|COMPLETED|Overall Study||10||
59754592|NCT04390568|75873563|FG003|COMPLETED|Overall Study||10||
59754593|NCT04390568|75873564|FG004|COMPLETED|Overall Study||10||
59754594|NCT04390568|75873560|FG000|NOT COMPLETED|Overall Study||0||
59754595|NCT04390568|75873561|FG001|NOT COMPLETED|Overall Study||0||
59754596|NCT04390568|75873562|FG002|NOT COMPLETED|Overall Study||0||
59754597|NCT04390568|75873563|FG003|NOT COMPLETED|Overall Study||0||
59754598|NCT04390568|75873564|FG004|NOT COMPLETED|Overall Study||0||
59754599|NCT03889418|75873580|FG000|STARTED|April-June 2019 (Months 0-3)||48|[EMR-CDS with CCM] participants started enrollment in region 1 in period 1. In Region 2, 3, 4 & 5, only EMR-CDS (usual care) matched controls were identified. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|1
59754600|NCT03889418|75873581|FG001|STARTED|April-June 2019 (Months 0-3)||10|[EMR-CDS with CCM] participants started enrollment in region 1 in period 1. In Region 2, 3, 4 & 5, only EMR-CDS (usual care) matched controls were identified. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|1
59754601|NCT03889418|75873582|FG002|STARTED|April-June 2019 (Months 0-3)||21|[EMR-CDS with CCM] participants started enrollment in region 1 in period 1. In Region 2, 3, 4 & 5, only EMR-CDS (usual care) matched controls were identified. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|1
59754602|NCT03889418|75873583|FG003|STARTED|April-June 2019 (Months 0-3)||0|[EMR-CDS with CCM] participants started enrollment in region 1 in period 1. In Region 2, 3, 4 & 5, only EMR-CDS (usual care) matched controls were identified. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|0
59754603|NCT03889418|75873584|FG004|STARTED|April-June 2019 (Months 0-3)||14|[EMR-CDS with CCM] participants started enrollment in region 1 in period 1. In Region 2, 3, 4 & 5, only EMR-CDS (usual care) matched controls were identified. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|1
59762533|NCT00872898|75882315|FG001|STARTED|Part One - Open Label, Pharmacokinetics||4||
59762534|NCT00872898|75882314|FG000|COMPLETED|Part One - Open Label, Pharmacokinetics||0||
59754604|NCT03889418|75873585|FG005|STARTED|April-June 2019 (Months 0-3)||0|[EMR-CDS with CCM] participants started enrollment in region 1 in period 1. In Region 2, 3, 4 & 5, only EMR-CDS (usual care) matched controls were identified. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|0
59754605|NCT03889418|75873586|FG006|STARTED|April-June 2019 (Months 0-3)||10|[EMR-CDS with CCM] participants started enrollment in region 1 in period 1. In Region 2, 3, 4 & 5, only EMR-CDS (usual care) matched controls were identified. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|1
59754606|NCT03889418|75873587|FG007|STARTED|April-June 2019 (Months 0-3)||0|[EMR-CDS with CCM] participants started enrollment in region 1 in period 1. In Region 2, 3, 4 & 5, only EMR-CDS (usual care) matched controls were identified. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|0
59754607|NCT03889418|75873588|FG008|STARTED|April-June 2019 (Months 0-3)||12|[EMR-CDS with CCM] participants started enrollment in region 1 in period 1. In Region 2, 3, 4 & 5, only EMR-CDS (usual care) matched controls were identified. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|1
59754608|NCT03889418|75873589|FG009|STARTED|April-June 2019 (Months 0-3)||0|[EMR-CDS with CCM] participants started enrollment in region 1 in period 1. In Region 2, 3, 4 & 5, only EMR-CDS (usual care) matched controls were identified. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|0
59754609|NCT03889418|75873580|FG000|COMPLETED|April-June 2019 (Months 0-3)||47||1
59754610|NCT03889418|75873581|FG001|COMPLETED|April-June 2019 (Months 0-3)||10||1
59754611|NCT03889418|75873582|FG002|COMPLETED|April-June 2019 (Months 0-3)||21||1
59754612|NCT03889418|75873583|FG003|COMPLETED|April-June 2019 (Months 0-3)||0||0
59754613|NCT03889418|75873584|FG004|COMPLETED|April-June 2019 (Months 0-3)||14||1
59754614|NCT03889418|75873585|FG005|COMPLETED|April-June 2019 (Months 0-3)||0||0
59754615|NCT03889418|75873586|FG006|COMPLETED|April-June 2019 (Months 0-3)||10||1
59754616|NCT03889418|75873587|FG007|COMPLETED|April-June 2019 (Months 0-3)||0||0
59754617|NCT03889418|75873588|FG008|COMPLETED|April-June 2019 (Months 0-3)||12||1
59884502|NCT01981850|76007328|FG003|COMPLETED|Open Label Extension (OLE)||0||
59884503|NCT01981850|76007329|FG004|COMPLETED|Open Label Extension (OLE)||0||
59884504|NCT01981850|76007330|FG005|COMPLETED|Open Label Extension (OLE)||0||
59884505|NCT01981850|76007331|FG006|COMPLETED|Open Label Extension (OLE)||0||
59884506|NCT01981850|76007332|FG007|COMPLETED|Open Label Extension (OLE)||1||
59884507|NCT01981850|76007333|FG008|COMPLETED|Open Label Extension (OLE)||0||
59884508|NCT01981850|76007334|FG009|COMPLETED|Open Label Extension (OLE)||0||
59884509|NCT01981850|76007325|FG000|NOT COMPLETED|Open Label Extension (OLE)||0||
59884510|NCT01981850|76007326|FG001|NOT COMPLETED|Open Label Extension (OLE)||0||
59884511|NCT01981850|76007327|FG002|NOT COMPLETED|Open Label Extension (OLE)||0||
59884512|NCT01981850|76007328|FG003|NOT COMPLETED|Open Label Extension (OLE)||0||
59884513|NCT01981850|76007329|FG004|NOT COMPLETED|Open Label Extension (OLE)||0||
59884514|NCT01981850|76007330|FG005|NOT COMPLETED|Open Label Extension (OLE)||0||
59884515|NCT01981850|76007331|FG006|NOT COMPLETED|Open Label Extension (OLE)||0||
59884516|NCT01981850|76007332|FG007|NOT COMPLETED|Open Label Extension (OLE)||12||
59884517|NCT01981850|76007333|FG008|NOT COMPLETED|Open Label Extension (OLE)||5||
59884518|NCT01981850|76007334|FG009|NOT COMPLETED|Open Label Extension (OLE)||48||
59884519|NCT03557307|76007366|FG000|STARTED|Period 1: To End of OCS Reduction Phase||598|Received study drug|
59884520|NCT03557307|76007366|FG000|COMPLETED|Period 1: To End of OCS Reduction Phase||563|Could not reduce OCS dose further according to protocol.|
59884521|NCT03557307|76007366|FG000|NOT COMPLETED|Period 1: To End of OCS Reduction Phase||35||
59884522|NCT03557307|76007366|FG000|STARTED|Period 2: Maintenance Phase||563|Completed OCS reduction phase.|
59884523|NCT03557307|76007366|FG000|COMPLETED|Period 2: Maintenance Phase||536|Marked 'Completed' to subject's status on the Disposition CRF|
60011874|NCT01362049|76127806|FG002|COMPLETED|Follow-Up at 7 Weeks||30||
60011875|NCT01362049|76127807|FG003|COMPLETED|Follow-Up at 7 Weeks||24||
60011876|NCT01362049|76127804|FG000|NOT COMPLETED|Follow-Up at 7 Weeks||3||
60011877|NCT01362049|76127805|FG001|NOT COMPLETED|Follow-Up at 7 Weeks||3||
60011878|NCT01362049|76127806|FG002|NOT COMPLETED|Follow-Up at 7 Weeks||2||
60011879|NCT01362049|76127807|FG003|NOT COMPLETED|Follow-Up at 7 Weeks||1||
60011880|NCT01362049|76127804|FG000|STARTED|Follow-Up at 52 Weeks (12 Months)||23||
60011881|NCT01362049|76127805|FG001|STARTED|Follow-Up at 52 Weeks (12 Months)||16||
60011882|NCT01362049|76127806|FG002|STARTED|Follow-Up at 52 Weeks (12 Months)||30||
60011883|NCT01362049|76127807|FG003|STARTED|Follow-Up at 52 Weeks (12 Months)||24||
60011884|NCT01362049|76127804|FG000|COMPLETED|Follow-Up at 52 Weeks (12 Months)||18||
59754618|NCT03889418|75873589|FG009|COMPLETED|April-June 2019 (Months 0-3)||0||0
59754619|NCT03889418|75873580|FG000|NOT COMPLETED|April-June 2019 (Months 0-3)||1||0
59754620|NCT03889418|75873581|FG001|NOT COMPLETED|April-June 2019 (Months 0-3)||0||0
59754621|NCT03889418|75873582|FG002|NOT COMPLETED|April-June 2019 (Months 0-3)||0||0
59754622|NCT03889418|75873583|FG003|NOT COMPLETED|April-June 2019 (Months 0-3)||0||0
59754623|NCT03889418|75873584|FG004|NOT COMPLETED|April-June 2019 (Months 0-3)||0||0
59754624|NCT03889418|75873585|FG005|NOT COMPLETED|April-June 2019 (Months 0-3)||0||0
59754625|NCT03889418|75873586|FG006|NOT COMPLETED|April-June 2019 (Months 0-3)||0||0
59754626|NCT03889418|75873587|FG007|NOT COMPLETED|April-June 2019 (Months 0-3)||0||0
59754627|NCT03889418|75873588|FG008|NOT COMPLETED|April-June 2019 (Months 0-3)||0||0
59754628|NCT03889418|75873589|FG009|NOT COMPLETED|April-June 2019 (Months 0-3)||0||0
59884524|NCT03557307|76007366|FG000|NOT COMPLETED|Period 2: Maintenance Phase||27||
59884525|NCT03557307|76007366|FG000|STARTED|Period 3: Long Term Follow up Substudy||195|Patients enrolled in long term follow up substudy|
59884526|NCT03557307|76007366|FG000|Asthma Treatment as Per Healthcare Provider Discretion|Period 3: Long Term Follow up Substudy||195|Treated as per healthcare provider's discretion, including Benra 30 mg administered subcutaneously every 4-8 weeks or other biologics. IP or medications were not provided by the sponsor.|
59884527|NCT03557307|76007366|FG000|>=50% Any Biologic|Period 3: Long Term Follow up Substudy||78|>=50% exposure to any biologic treatment for asthma from the end of maintenance phase of the main study to the Long Term Follow Up visit|
59884528|NCT03557307|76007366|FG000|>=50% Benra|Period 3: Long Term Follow up Substudy||69|>=50% exposure to benralizumab from the end of maintenance phase of the main study to the Long Term follow Up visit, and no previous or concurrent exposure to any other biologic during this period|
59884529|NCT03557307|76007366|FG000|COMPLETED|Period 3: Long Term Follow up Substudy||195||
59884530|NCT03557307|76007366|FG000|NOT COMPLETED|Period 3: Long Term Follow up Substudy||0||
59884531|NCT00118703|76007378|FG000|STARTED|Overall Study||173||
59884532|NCT00118703|76007379|FG001|STARTED|Overall Study||174||
59884533|NCT00118703|76007378|FG000|COMPLETED|Overall Study||168||
59884534|NCT00118703|76007379|FG001|COMPLETED|Overall Study||165||
59884535|NCT00118703|76007378|FG000|NOT COMPLETED|Overall Study||5||
59884536|NCT00118703|76007379|FG001|NOT COMPLETED|Overall Study||9||
59884537|NCT00104104|76007387|FG000|STARTED|Overall Study|2 Participants in the 15-minute infusion group did not receive study drug.|90||
59884538|NCT00104104|76007388|FG001|STARTED|Overall Study|1 Participants in the 30-minute infusion group did not receive study drug.|89||
59884539|NCT00104104|76007387|FG000|Safety Population (Including Site 74)|Overall Study||88||
59884540|NCT00104104|76007388|FG001|Safety Population (Including Site 74)|Overall Study||88||
59884541|NCT00104104|76007387|FG000|Safety Population (Excluding Site 74)|Overall Study|Because of GCP violations at Site 74, post-baseline data for 3 patients in this arm were excluded.|85||
59950889|NCT01143766|76069794|FG000|NOT COMPLETED|Overall Study||0||
59950890|NCT01143766|76069795|FG001|NOT COMPLETED|Overall Study||0||
59950891|NCT01106898|76069803|FG000|STARTED|Overall Study||100||
59950892|NCT01106898|76069803|FG000|COMPLETED|Overall Study||94||
59950893|NCT01106898|76069803|FG000|NOT COMPLETED|Overall Study||6||
59950894|NCT01059071|76069807|FG000|STARTED|Overall Study||4||
59950895|NCT01059071|76069808|FG001|STARTED|Overall Study||5||
59950896|NCT01059071|76069809|FG002|STARTED|Overall Study||3||
59950897|NCT01059071|76069810|FG003|STARTED|Overall Study||9||
59950898|NCT01059071|76069807|FG000|COMPLETED|Overall Study||2||
59950899|NCT01059071|76069808|FG001|COMPLETED|Overall Study||1||
59950900|NCT01059071|76069809|FG002|COMPLETED|Overall Study||1||
59950901|NCT01059071|76069810|FG003|COMPLETED|Overall Study||3||
59950902|NCT01059071|76069807|FG000|NOT COMPLETED|Overall Study||2||
59950903|NCT01059071|76069808|FG001|NOT COMPLETED|Overall Study||4||
59950904|NCT01059071|76069809|FG002|NOT COMPLETED|Overall Study||2||
59950905|NCT01059071|76069810|FG003|NOT COMPLETED|Overall Study||6||
59950906|NCT00923702|76069823|FG000|STARTED|Overall Study||4348||
59950907|NCT00923702|76069824|FG001|STARTED|Overall Study||4979||
59950908|NCT00923702|76069825|FG002|STARTED|Overall Study||3452||
59950909|NCT00923702|76069826|FG003|STARTED|Overall Study||4950||
59950910|NCT00923702|76069827|FG004|STARTED|Overall Study||5000||
59950911|NCT00923702|76069823|FG000|COMPLETED|Overall Study||4348||
59950912|NCT00923702|76069824|FG001|COMPLETED|Overall Study||4979||
59950913|NCT00923702|76069825|FG002|COMPLETED|Overall Study||3452||
59950914|NCT00923702|76069826|FG003|COMPLETED|Overall Study||4950||
59950915|NCT00923702|76069827|FG004|COMPLETED|Overall Study||4646||
59950916|NCT00923702|76069823|FG000|NOT COMPLETED|Overall Study||0||
59950917|NCT00923702|76069824|FG001|NOT COMPLETED|Overall Study||0||
59950918|NCT00923702|76069825|FG002|NOT COMPLETED|Overall Study||0||
59950919|NCT00923702|76069826|FG003|NOT COMPLETED|Overall Study||0||
59950920|NCT00923702|76069827|FG004|NOT COMPLETED|Overall Study||354||
59950921|NCT00867568|76069839|FG000|STARTED|Overall Study||18||
59950922|NCT00867568|76069839|FG000|COMPLETED|Overall Study||3||
59950923|NCT00867568|76069839|FG000|NOT COMPLETED|Overall Study||15||
59950924|NCT00737698|76069846|FG000|STARTED|Overall Study||23||
59950925|NCT00737698|76069847|FG001|STARTED|Overall Study||42||
59950926|NCT00737698|76069848|FG002|STARTED|Overall Study||21||
59950927|NCT00737698|76069846|FG000|COMPLETED|Overall Study||17||
59950928|NCT00737698|76069847|FG001|COMPLETED|Overall Study||37||
59950929|NCT00737698|76069848|FG002|COMPLETED|Overall Study||17||
59950930|NCT00737698|76069846|FG000|NOT COMPLETED|Overall Study||6||
59950931|NCT00737698|76069847|FG001|NOT COMPLETED|Overall Study||5||
59950932|NCT00737698|76069848|FG002|NOT COMPLETED|Overall Study||4||
59950933|NCT00626366|76069858|FG000|STARTED|Overall Study||9||
59950934|NCT00626366|76069859|FG001|STARTED|Overall Study||9||
59950935|NCT00626366|76069858|FG000|COMPLETED|Overall Study||9||
59950936|NCT00626366|76069859|FG001|COMPLETED|Overall Study||9||
59950937|NCT00626366|76069858|FG000|NOT COMPLETED|Overall Study||0||
59950938|NCT00626366|76069859|FG001|NOT COMPLETED|Overall Study||0||
59950939|NCT00601003|76069865|FG000|STARTED|Overall Study||112||
59950940|NCT00601003|76069865|FG000|COMPLETED|Overall Study||76||
59606965|NCT01385033|75717467|FG004|STARTED|Part I||0||
59606966|NCT01385033|75717468|FG005|STARTED|Part I||0||
59606967|NCT01385033|75717463|FG000|COMPLETED|Part I||6||
59884542|NCT00104104|76007388|FG001|Safety Population (Excluding Site 74)|Overall Study|Because of GCP violations at Site 74, post-baseline data for 4 patients in this arm were excluded.|84||
59884543|NCT00104104|76007387|FG000|COMPLETED|Overall Study||15||
59884544|NCT00104104|76007388|FG001|COMPLETED|Overall Study||17||
59884545|NCT00104104|76007387|FG000|NOT COMPLETED|Overall Study||75||
59884546|NCT00104104|76007388|FG001|NOT COMPLETED|Overall Study||72||
59884547|NCT03557151|76007396|FG000|STARTED|Randomization to 3 Months||74||
59884548|NCT03557151|76007397|FG001|STARTED|Randomization to 3 Months||134||
59884549|NCT03557151|76007396|FG000|Adolescent Participants|Randomization to 3 Months||37||
59884550|NCT03557151|76007397|FG001|Adolescent Participants|Randomization to 3 Months||67||
59884551|NCT03557151|76007396|FG000|Caregiver Participants|Randomization to 3 Months||37||
59884552|NCT03557151|76007397|FG001|Caregiver Participants|Randomization to 3 Months||67||
59884553|NCT03557151|76007396|FG000|COMPLETED|Randomization to 3 Months||72||
59606968|NCT01385033|75717464|FG001|COMPLETED|Part I||14||
59606969|NCT01385033|75717465|FG002|COMPLETED|Part I||0||
60011885|NCT01362049|76127805|FG001|COMPLETED|Follow-Up at 52 Weeks (12 Months)||13||
60011886|NCT01362049|76127806|FG002|COMPLETED|Follow-Up at 52 Weeks (12 Months)||28||
60011887|NCT01362049|76127807|FG003|COMPLETED|Follow-Up at 52 Weeks (12 Months)||21||
60011888|NCT01362049|76127804|FG000|NOT COMPLETED|Follow-Up at 52 Weeks (12 Months)||5||
60011889|NCT01362049|76127805|FG001|NOT COMPLETED|Follow-Up at 52 Weeks (12 Months)||3||
59762535|NCT00872898|75882315|FG001|COMPLETED|Part One - Open Label, Pharmacokinetics||4||
59762536|NCT00872898|75882314|FG000|NOT COMPLETED|Part One - Open Label, Pharmacokinetics||0||
59754629|NCT03889418|75873580|FG000|STARTED|July-September 2019 (Months 4-6)||54|[EMR-CDS with CCM] participants started enrollment in region 2 in period 2. In Region 3, 4 & 5, only EMR-CDS (usual care) matched controls were identified. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|1
59754630|NCT03889418|75873581|FG001|STARTED|July-September 2019 (Months 4-6)||20|[EMR-CDS with CCM] participants started enrollment in region 2 in period 2. In Region 3, 4 & 5, only EMR-CDS (usual care) matched controls were identified. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|1
59754631|NCT03889418|75873582|FG002|STARTED|July-September 2019 (Months 4-6)||23|[EMR-CDS with CCM] participants started enrollment in region 2 in period 2. In Region 3, 4 & 5, only EMR-CDS (usual care) matched controls were identified. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|1
59754632|NCT03889418|75873583|FG003|STARTED|July-September 2019 (Months 4-6)||2|[EMR-CDS with CCM] participants started enrollment in region 2 in period 2. In Region 3, 4 & 5, only EMR-CDS (usual care) matched controls were identified. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|1
59754633|NCT03889418|75873584|FG004|STARTED|July-September 2019 (Months 4-6)||16|[EMR-CDS with CCM] participants started enrollment in region 2 in period 2. In Region 3, 4 & 5, only EMR-CDS (usual care) matched controls were identified. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|1
59754634|NCT03889418|75873585|FG005|STARTED|July-September 2019 (Months 4-6)||1|[EMR-CDS with CCM] participants started enrollment in region 2 in period 2. In Region 3, 4 & 5, only EMR-CDS (usual care) matched controls were identified. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|0
59754635|NCT03889418|75873586|FG006|STARTED|July-September 2019 (Months 4-6)||10|[EMR-CDS with CCM] participants started enrollment in region 2 in period 2. In Region 3, 4 & 5, only EMR-CDS (usual care) matched controls were identified. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|1
59754636|NCT03889418|75873587|FG007|STARTED|July-September 2019 (Months 4-6)||0|[EMR-CDS with CCM] participants started enrollment in region 2 in period 2. In Region 3, 4 & 5, only EMR-CDS (usual care) matched controls were identified. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|0
59754637|NCT03889418|75873588|FG008|STARTED|July-September 2019 (Months 4-6)||13|[EMR-CDS with CCM] participants started enrollment in region 2 in period 2. In Region 3, 4 & 5, only EMR-CDS (usual care) matched controls were identified. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|1
59762537|NCT00872898|75882315|FG001|NOT COMPLETED|Part One - Open Label, Pharmacokinetics||0||
59762538|NCT00872898|75882314|FG000|STARTED|Part Two - Double Blind||61||
59762539|NCT00872898|75882315|FG001|STARTED|Part Two - Double Blind||60||
59606970|NCT01385033|75717466|FG003|COMPLETED|Part I||0||
59606971|NCT01385033|75717467|FG004|COMPLETED|Part I||0||
59606972|NCT01385033|75717468|FG005|COMPLETED|Part I||0||
59606973|NCT01385033|75717463|FG000|NOT COMPLETED|Part I||0||
59884554|NCT03557151|76007397|FG001|COMPLETED|Randomization to 3 Months||132||
59606974|NCT01385033|75717464|FG001|NOT COMPLETED|Part I||0||
59606975|NCT01385033|75717465|FG002|NOT COMPLETED|Part I||0||
59606976|NCT01385033|75717466|FG003|NOT COMPLETED|Part I||0||
59884555|NCT03557151|76007396|FG000|NOT COMPLETED|Randomization to 3 Months||2||
59884556|NCT03557151|76007397|FG001|NOT COMPLETED|Randomization to 3 Months||2||
59884557|NCT03557151|76007396|FG000|STARTED|3 to 6 Months||72||
59884558|NCT03557151|76007397|FG001|STARTED|3 to 6 Months||132||
59884559|NCT03557151|76007396|FG000|Adolescent Participants|3 to 6 Months||36||
59884560|NCT03557151|76007397|FG001|Adolescent Participants|3 to 6 Months||66||
59884561|NCT03557151|76007396|FG000|Caregiver Participants|3 to 6 Months||36||
59950941|NCT00601003|76069865|FG000|NOT COMPLETED|Overall Study||36||
59606977|NCT01385033|75717467|FG004|NOT COMPLETED|Part I||0||
59606978|NCT01385033|75717468|FG005|NOT COMPLETED|Part I||0||
59606979|NCT01385033|75717463|FG000|STARTED|Part II||0||
59606980|NCT01385033|75717464|FG001|STARTED|Part II||0||
59606981|NCT01385033|75717465|FG002|STARTED|Part II||0||
59762540|NCT00872898|75882314|FG000|COMPLETED|Part Two - Double Blind||50||
60011890|NCT01362049|76127806|FG002|NOT COMPLETED|Follow-Up at 52 Weeks (12 Months)||2||
60011891|NCT01362049|76127807|FG003|NOT COMPLETED|Follow-Up at 52 Weeks (12 Months)||3||
60011892|NCT02996305|76127824|FG000|STARTED|Overall Study||29||
60011893|NCT02996305|76127825|FG001|STARTED|Overall Study||29||
60011894|NCT02996305|76127826|FG002|STARTED|Overall Study||30||
60011895|NCT02996305|76127824|FG000|COMPLETED|Overall Study||26||
60011896|NCT02996305|76127825|FG001|COMPLETED|Overall Study||27||
60011897|NCT02996305|76127826|FG002|COMPLETED|Overall Study||25||
60011898|NCT02996305|76127824|FG000|NOT COMPLETED|Overall Study||3||
60011899|NCT02996305|76127825|FG001|NOT COMPLETED|Overall Study||2||
60011900|NCT02996305|76127826|FG002|NOT COMPLETED|Overall Study||5||
60011901|NCT02612909|76127839|FG000|STARTED|Phase 2||100||
60011902|NCT02612909|76127840|FG001|STARTED|Phase 2||100||
60011903|NCT02612909|76127841|FG002|STARTED|Phase 2||100||
60011904|NCT02612909|76127842|FG003|STARTED|Phase 2||0||
60011905|NCT02612909|76127843|FG004|STARTED|Phase 2||0||
60011906|NCT02612909|76127839|FG000|Received Injection 1|Phase 2||100||
60011907|NCT02612909|76127840|FG001|Received Injection 1|Phase 2||100||
60011908|NCT02612909|76127841|FG002|Received Injection 1|Phase 2||100||
60011909|NCT02612909|76127842|FG003|Received Injection 1|Phase 2||0||
60011910|NCT02612909|76127843|FG004|Received Injection 1|Phase 2||0||
60011911|NCT02612909|76127839|FG000|Received Injection 2|Phase 2||98||
60011912|NCT02612909|76127840|FG001|Received Injection 2|Phase 2||95||
60011913|NCT02612909|76127841|FG002|Received Injection 2|Phase 2||99||
60011914|NCT02612909|76127842|FG003|Received Injection 2|Phase 2||0||
60011915|NCT02612909|76127843|FG004|Received Injection 2|Phase 2||0||
60011916|NCT02612909|76127839|FG000|Completed Day 29 Clinic Visit|Phase 2||98|8 days after injection 2|
60011917|NCT02612909|76127840|FG001|Completed Day 29 Clinic Visit|Phase 2||95|8 days after injection 2|
60011918|NCT02612909|76127841|FG002|Completed Day 29 Clinic Visit|Phase 2||99|8 days after injection 2|
60011919|NCT02612909|76127842|FG003|Completed Day 29 Clinic Visit|Phase 2||0|8 days after injection 2|
60011920|NCT02612909|76127843|FG004|Completed Day 29 Clinic Visit|Phase 2||0|8 days after injection 2|
60011921|NCT02612909|76127839|FG000|Completed Day 43 Clinic Visit|Phase 2||97|22 days after injection 2 (immunogenicity assessed)|
60011922|NCT02612909|76127840|FG001|Completed Day 43 Clinic Visit|Phase 2||94|22 days after injection 2 (immunogenicity assessed)|
60011923|NCT02612909|76127841|FG002|Completed Day 43 Clinic Visit|Phase 2||99|22 days after injection 2 (immunogenicity assessed)|
60011924|NCT02612909|76127842|FG003|Completed Day 43 Clinic Visit|Phase 2||0|22 days after injection 2 (immunogenicity assessed)|
60011925|NCT02612909|76127843|FG004|Completed Day 43 Clinic Visit|Phase 2||0|22 days after injection 2 (immunogenicity assessed)|
60011926|NCT02612909|76127839|FG000|COMPLETED|Phase 2||98||
60011927|NCT02612909|76127840|FG001|COMPLETED|Phase 2||95||
60011928|NCT02612909|76127841|FG002|COMPLETED|Phase 2||99||
60011929|NCT02612909|76127842|FG003|COMPLETED|Phase 2||0||
60011930|NCT02612909|76127843|FG004|COMPLETED|Phase 2||0||
60011931|NCT02612909|76127839|FG000|NOT COMPLETED|Phase 2||2||
60011932|NCT02612909|76127840|FG001|NOT COMPLETED|Phase 2||5||
60011933|NCT02612909|76127841|FG002|NOT COMPLETED|Phase 2||1||
60011934|NCT02612909|76127842|FG003|NOT COMPLETED|Phase 2||0||
60011935|NCT02612909|76127843|FG004|NOT COMPLETED|Phase 2||0||
60011936|NCT02612909|76127839|FG000|STARTED|Phase 3||0||
60011937|NCT02612909|76127840|FG001|STARTED|Phase 3||0||
60011938|NCT02612909|76127841|FG002|STARTED|Phase 3||0||
60011939|NCT02612909|76127842|FG003|STARTED|Phase 3||105||
60011940|NCT02612909|76127843|FG004|STARTED|Phase 3||525||
60011941|NCT02612909|76127839|FG000|Received Injection 1|Phase 3||0||
60011942|NCT02612909|76127840|FG001|Received Injection 1|Phase 3||0||
60011943|NCT02612909|76127841|FG002|Received Injection 1|Phase 3||0||
60011944|NCT02612909|76127842|FG003|Received Injection 1|Phase 3||105||
60011945|NCT02612909|76127843|FG004|Received Injection 1|Phase 3||525||
60011946|NCT02612909|76127839|FG000|Received Injection 2|Phase 3||0||
60011947|NCT02612909|76127840|FG001|Received Injection 2|Phase 3||0||
60011948|NCT02612909|76127841|FG002|Received Injection 2|Phase 3||0||
60011949|NCT02612909|76127842|FG003|Received Injection 2|Phase 3||103||
60011950|NCT02612909|76127843|FG004|Received Injection 2|Phase 3||520||
60011951|NCT02612909|76127839|FG000|Completed Day 29 Clinic Visit|Phase 3||0||
60011952|NCT02612909|76127840|FG001|Completed Day 29 Clinic Visit|Phase 3||0||
60011953|NCT02612909|76127841|FG002|Completed Day 29 Clinic Visit|Phase 3||0||
60011954|NCT02612909|76127842|FG003|Completed Day 29 Clinic Visit|Phase 3||104||
60011955|NCT02612909|76127843|FG004|Completed Day 29 Clinic Visit|Phase 3||525||
60011956|NCT02612909|76127839|FG000|Completed Day 43 Clinic Visit|Phase 3||0||
60011957|NCT02612909|76127840|FG001|Completed Day 43 Clinic Visit|Phase 3||0||
60011958|NCT02612909|76127841|FG002|Completed Day 43 Clinic Visit|Phase 3||0||
60011959|NCT02612909|76127842|FG003|Completed Day 43 Clinic Visit|Phase 3||104||
60011960|NCT02612909|76127843|FG004|Completed Day 43 Clinic Visit|Phase 3||524||
60011961|NCT02612909|76127839|FG000|COMPLETED|Phase 3||0||
60011962|NCT02612909|76127840|FG001|COMPLETED|Phase 3||0||
60011963|NCT02612909|76127841|FG002|COMPLETED|Phase 3||0||
60011964|NCT02612909|76127842|FG003|COMPLETED|Phase 3||104||
60011965|NCT02612909|76127843|FG004|COMPLETED|Phase 3||525||
60011966|NCT02612909|76127839|FG000|NOT COMPLETED|Phase 3||0||
60011967|NCT02612909|76127840|FG001|NOT COMPLETED|Phase 3||0||
60011968|NCT02612909|76127841|FG002|NOT COMPLETED|Phase 3||0||
60011969|NCT02612909|76127842|FG003|NOT COMPLETED|Phase 3||1||
60011970|NCT02612909|76127843|FG004|NOT COMPLETED|Phase 3||0||
60011971|NCT02612285|76127857|FG000|STARTED|Overall Study||1||
60011972|NCT02612285|76127857|FG000|COMPLETED|Overall Study|Subject did not complete Cycle 1; no data points recorded|0||
60011973|NCT02612285|76127857|FG000|NOT COMPLETED|Overall Study||1||
60011974|NCT02609633|76127863|FG000|STARTED|Overall Study||42||
60011975|NCT02609633|76127864|FG001|STARTED|Overall Study||56||
60011976|NCT02609633|76127863|FG000|Full Analysis Set (FAS)|Overall Study||32||
60011977|NCT02609633|76127864|FG001|Full Analysis Set (FAS)|Overall Study||46||
60011978|NCT02609633|76127863|FG000|COMPLETED|Overall Study||37||
60011979|NCT02609633|76127864|FG001|COMPLETED|Overall Study||54||
60011980|NCT02609633|76127863|FG000|NOT COMPLETED|Overall Study||5||
60011981|NCT02609633|76127864|FG001|NOT COMPLETED|Overall Study||2||
60011982|NCT04108429|76127871|FG000|STARTED|Overall Study||117||
60011983|NCT04108429|76127871|FG000|COMPLETED|Overall Study||117||
60011984|NCT04108429|76127871|FG000|NOT COMPLETED|Overall Study||0||
60011985|NCT02845453|76127879|FG000|STARTED|Overall Study||13||
60011986|NCT02845453|76127880|FG001|STARTED|Overall Study||11||
60011987|NCT02845453|76127879|FG000|Took One Dose of Study Medication|Overall Study||11||
60011988|NCT02845453|76127880|FG001|Took One Dose of Study Medication|Overall Study||10||
60011989|NCT02845453|76127879|FG000|Took One Week of Study Medication|Overall Study||10||
60011990|NCT02845453|76127880|FG001|Took One Week of Study Medication|Overall Study||9||
60011991|NCT02845453|76127879|FG000|COMPLETED|Overall Study||7||
60011992|NCT02845453|76127880|FG001|COMPLETED|Overall Study||6||
60011993|NCT02845453|76127879|FG000|NOT COMPLETED|Overall Study||6||
60011994|NCT02845453|76127880|FG001|NOT COMPLETED|Overall Study||5||
60011995|NCT01597375|76127886|FG000|STARTED|First Intervention (4 Weeks)||23||
60011996|NCT01597375|76127887|FG001|STARTED|First Intervention (4 Weeks)||23||
60011997|NCT01597375|76127886|FG000|COMPLETED|First Intervention (4 Weeks)||21||
60011998|NCT01597375|76127887|FG001|COMPLETED|First Intervention (4 Weeks)||22||
60011999|NCT01597375|76127886|FG000|NOT COMPLETED|First Intervention (4 Weeks)||2||
60012000|NCT01597375|76127887|FG001|NOT COMPLETED|First Intervention (4 Weeks)||1||
59884562|NCT03557151|76007397|FG001|Caregiver Participants|3 to 6 Months||66||
59884563|NCT03557151|76007396|FG000|COMPLETED|3 to 6 Months||72||
59884564|NCT03557151|76007397|FG001|COMPLETED|3 to 6 Months||132||
59884565|NCT03557151|76007396|FG000|NOT COMPLETED|3 to 6 Months||0||
59884566|NCT03557151|76007397|FG001|NOT COMPLETED|3 to 6 Months||0||
59884567|NCT03557151|76007396|FG000|STARTED|6 to 9 Months||72||
59884568|NCT03557151|76007397|FG001|STARTED|6 to 9 Months||132||
59884569|NCT03557151|76007396|FG000|Adolescent Participants|6 to 9 Months||36||
59884570|NCT03557151|76007397|FG001|Adolescent Participants|6 to 9 Months||66||
59884571|NCT03557151|76007396|FG000|Caregiver Participants|6 to 9 Months||36||
59884572|NCT03557151|76007397|FG001|Caregiver Participants|6 to 9 Months||66||
59884573|NCT03557151|76007396|FG000|COMPLETED|6 to 9 Months||70||
59884574|NCT03557151|76007397|FG001|COMPLETED|6 to 9 Months||132||
59884575|NCT03557151|76007396|FG000|NOT COMPLETED|6 to 9 Months||2||
59884576|NCT03557151|76007397|FG001|NOT COMPLETED|6 to 9 Months||0||
59884577|NCT03557151|76007396|FG000|STARTED|9 to 12 Months (End of Study)||70||
59884578|NCT03557151|76007397|FG001|STARTED|9 to 12 Months (End of Study)||132||
59884579|NCT03557151|76007396|FG000|Adolescent Participants|9 to 12 Months (End of Study)||35||
59884580|NCT03557151|76007397|FG001|Adolescent Participants|9 to 12 Months (End of Study)||66||
59884581|NCT03557151|76007396|FG000|Caregiver Participants|9 to 12 Months (End of Study)||35||
59884582|NCT03557151|76007397|FG001|Caregiver Participants|9 to 12 Months (End of Study)||66||
59884583|NCT03557151|76007396|FG000|COMPLETED|9 to 12 Months (End of Study)||70||
59884584|NCT03557151|76007397|FG001|COMPLETED|9 to 12 Months (End of Study)||130||
59884585|NCT03557151|76007396|FG000|NOT COMPLETED|9 to 12 Months (End of Study)||0||
59884586|NCT03557151|76007397|FG001|NOT COMPLETED|9 to 12 Months (End of Study)||2||
59884587|NCT00115739|76007405|FG000|STARTED|Overall Study||11||
59884588|NCT00115739|76007405|FG000|COMPLETED|Overall Study||8||
59884589|NCT00115739|76007405|FG000|NOT COMPLETED|Overall Study||3||
59884590|NCT01347086|76007421|FG000|STARTED|Overall Study||2||
59884591|NCT01347086|76007422|FG001|STARTED|Overall Study||6||
59950942|NCT00571493|76069869|FG000|STARTED|Overall Study||3||
59950943|NCT00571493|76069870|FG001|STARTED|Overall Study||4||
59950944|NCT00571493|76069871|FG002|STARTED|Overall Study||3||
59950945|NCT00571493|76069872|FG003|STARTED|Overall Study||3||
59754638|NCT03889418|75873589|FG009|STARTED|July-September 2019 (Months 4-6)||0|[EMR-CDS with CCM] participants started enrollment in region 2 in period 2. In Region 3, 4 & 5, only EMR-CDS (usual care) matched controls were identified. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|0
59754639|NCT03889418|75873580|FG000|COMPLETED|July-September 2019 (Months 4-6)||54||1
59754640|NCT03889418|75873581|FG001|COMPLETED|July-September 2019 (Months 4-6)||19||1
59754641|NCT03889418|75873582|FG002|COMPLETED|July-September 2019 (Months 4-6)||22||1
59754642|NCT03889418|75873583|FG003|COMPLETED|July-September 2019 (Months 4-6)||2||1
59884592|NCT01347086|76007423|FG002|STARTED|Overall Study|"2 participants were treated together with each dose level of Deleobuvir.~1 subject was not treated."|7||
59884593|NCT01347086|76007424|FG003|STARTED|Overall Study||6||
59884594|NCT01347086|76007425|FG004|STARTED|Overall Study||6||
59884595|NCT01347086|76007426|FG005|STARTED|Overall Study||6||
59884596|NCT01347086|76007427|FG006|STARTED|Overall Study|"2 participants treated together with each dose level of Deleobuvir.~1 subject was not treated."|7||
59884597|NCT01347086|76007428|FG007|STARTED|Overall Study|One subject was not treated.|7||
59884598|NCT01347086|76007429|FG008|STARTED|Overall Study||6||
59884599|NCT01347086|76007430|FG009|STARTED|Overall Study|One subject was not treated.|7||
59884600|NCT01347086|76007421|FG000|COMPLETED|Overall Study||2||
59884601|NCT01347086|76007422|FG001|COMPLETED|Overall Study||6||
59884602|NCT01347086|76007423|FG002|COMPLETED|Overall Study||6||
59884603|NCT01347086|76007424|FG003|COMPLETED|Overall Study||6||
59884604|NCT01347086|76007425|FG004|COMPLETED|Overall Study||6||
59884605|NCT01347086|76007426|FG005|COMPLETED|Overall Study||6||
59884606|NCT01347086|76007427|FG006|COMPLETED|Overall Study||6||
59884607|NCT01347086|76007428|FG007|COMPLETED|Overall Study||6||
59884608|NCT01347086|76007429|FG008|COMPLETED|Overall Study||6||
59884609|NCT01347086|76007430|FG009|COMPLETED|Overall Study||6||
59884610|NCT01347086|76007421|FG000|NOT COMPLETED|Overall Study||0||
59884611|NCT01347086|76007422|FG001|NOT COMPLETED|Overall Study||0||
59884612|NCT01347086|76007423|FG002|NOT COMPLETED|Overall Study||1||
59884613|NCT01347086|76007424|FG003|NOT COMPLETED|Overall Study||0||
59884614|NCT01347086|76007425|FG004|NOT COMPLETED|Overall Study||0||
59884615|NCT01347086|76007426|FG005|NOT COMPLETED|Overall Study||0||
59884616|NCT01347086|76007427|FG006|NOT COMPLETED|Overall Study||1||
59884617|NCT01347086|76007428|FG007|NOT COMPLETED|Overall Study||1||
59884618|NCT01347086|76007429|FG008|NOT COMPLETED|Overall Study||0||
59884619|NCT01347086|76007430|FG009|NOT COMPLETED|Overall Study||1||
59884620|NCT03605745|76007462|FG000|STARTED|Overall Study||47||
59884621|NCT03605745|76007462|FG000|2 Weeks|Overall Study||47||
59884622|NCT03605745|76007462|FG000|6 Weeks|Overall Study||47||
59884623|NCT03605745|76007462|FG000|3 Months|Overall Study||47||
59884624|NCT03605745|76007462|FG000|6 Months|Overall Study||47||
59884625|NCT03605745|76007462|FG000|12 Months|Overall Study||40||
59884626|NCT03605745|76007462|FG000|24 Months|Overall Study||1||
59884627|NCT03605745|76007462|FG000|COMPLETED|Overall Study||0||
59884628|NCT03605745|76007462|FG000|NOT COMPLETED|Overall Study||47||
59884629|NCT03246152|76007466|FG000|STARTED|Overall Study||31||
59884630|NCT03246152|76007466|FG000|COMPLETED|Overall Study||28||
59754643|NCT03889418|75873584|FG004|COMPLETED|July-September 2019 (Months 4-6)||16||1
59884631|NCT03246152|76007466|FG000|NOT COMPLETED|Overall Study||3||
59884632|NCT03571581|76007470|FG000|STARTED|Overall Study||33||
59884633|NCT03571581|76007470|FG000|COMPLETED|Overall Study||29||
59884634|NCT03571581|76007470|FG000|NOT COMPLETED|Overall Study||4||
59884635|NCT00115349|76007479|FG000|STARTED|Overall Study|Target was 43 subjects in this arm.|11||
59884636|NCT00115349|76007480|FG001|STARTED|Overall Study|Target was 43 subjects in this arm.|9||
59884637|NCT00115349|76007479|FG000|COMPLETED|Overall Study|Study closed due to low enrollment.|0||
59884638|NCT00115349|76007480|FG001|COMPLETED|Overall Study|study closed due to low enrollment.|0||
59884639|NCT00115349|76007479|FG000|NOT COMPLETED|Overall Study||11||
59884640|NCT00115349|76007480|FG001|NOT COMPLETED|Overall Study||9||
59884641|NCT00115037|76007488|FG000|STARTED|Phase1||152||
59884642|NCT00115037|76007489|FG001|STARTED|Phase1||150||
59884643|NCT00115037|76007490|FG002|STARTED|Phase1||0||
59884644|NCT00115037|76007491|FG003|STARTED|Phase1||0||
59884645|NCT00115037|76007492|FG004|STARTED|Phase1||0||
59606982|NCT01385033|75717466|FG003|STARTED|Part II||0||
59606983|NCT01385033|75717467|FG004|STARTED|Part II||0||
59606984|NCT01385033|75717468|FG005|STARTED|Part II||0||
59606985|NCT01385033|75717463|FG000|COMPLETED|Part II||0||
59606986|NCT01385033|75717464|FG001|COMPLETED|Part II||0||
59606987|NCT01385033|75717465|FG002|COMPLETED|Part II||0||
59884646|NCT00115037|76007493|FG005|STARTED|Phase1||0||
59884647|NCT00115037|76007488|FG000|COMPLETED|Phase1||127||
59884648|NCT00115037|76007489|FG001|COMPLETED|Phase1||123||
59884649|NCT00115037|76007490|FG002|COMPLETED|Phase1||0||
59884650|NCT00115037|76007491|FG003|COMPLETED|Phase1||0||
59884651|NCT00115037|76007492|FG004|COMPLETED|Phase1||0||
59884652|NCT00115037|76007493|FG005|COMPLETED|Phase1||0||
59606988|NCT01385033|75717466|FG003|COMPLETED|Part II||0||
59606989|NCT01385033|75717467|FG004|COMPLETED|Part II||0||
59884653|NCT00115037|76007488|FG000|NOT COMPLETED|Phase1||25||
59884654|NCT00115037|76007489|FG001|NOT COMPLETED|Phase1||27||
59754644|NCT03889418|75873585|FG005|COMPLETED|July-September 2019 (Months 4-6)||1||0
59754645|NCT03889418|75873586|FG006|COMPLETED|July-September 2019 (Months 4-6)||10||1
59754646|NCT03889418|75873587|FG007|COMPLETED|July-September 2019 (Months 4-6)||0||0
59754647|NCT03889418|75873588|FG008|COMPLETED|July-September 2019 (Months 4-6)||13||1
59754648|NCT03889418|75873589|FG009|COMPLETED|July-September 2019 (Months 4-6)||0||0
59606990|NCT01385033|75717468|FG005|COMPLETED|Part II||0||
59606991|NCT01385033|75717463|FG000|NOT COMPLETED|Part II||0||
59606992|NCT01385033|75717464|FG001|NOT COMPLETED|Part II||0||
59884655|NCT00115037|76007490|FG002|NOT COMPLETED|Phase1||0||
59884656|NCT00115037|76007491|FG003|NOT COMPLETED|Phase1||0||
59884657|NCT00115037|76007492|FG004|NOT COMPLETED|Phase1||0||
59884658|NCT00115037|76007493|FG005|NOT COMPLETED|Phase1||0||
59884659|NCT00115037|76007488|FG000|STARTED|Phase2||0||
59884660|NCT00115037|76007489|FG001|STARTED|Phase2||0||
59884661|NCT00115037|76007490|FG002|STARTED|Phase2||91||
59884662|NCT00115037|76007491|FG003|STARTED|Phase2||92||
59884663|NCT00115037|76007492|FG004|STARTED|Phase2||34||
59884664|NCT00115037|76007493|FG005|STARTED|Phase2||33||
59884665|NCT00115037|76007488|FG000|COMPLETED|Phase2||0||
59884666|NCT00115037|76007489|FG001|COMPLETED|Phase2||0||
59884667|NCT00115037|76007490|FG002|COMPLETED|Phase2||76||
59884668|NCT00115037|76007491|FG003|COMPLETED|Phase2||77||
59884669|NCT00115037|76007492|FG004|COMPLETED|Phase2||28||
59884670|NCT00115037|76007493|FG005|COMPLETED|Phase2||21||
59884671|NCT00115037|76007488|FG000|NOT COMPLETED|Phase2||0||
59884672|NCT00115037|76007489|FG001|NOT COMPLETED|Phase2||0||
59884673|NCT00115037|76007490|FG002|NOT COMPLETED|Phase2||15||
59884674|NCT00115037|76007491|FG003|NOT COMPLETED|Phase2||15||
59884675|NCT00115037|76007492|FG004|NOT COMPLETED|Phase2||6||
59884676|NCT00115037|76007493|FG005|NOT COMPLETED|Phase2||12||
59884677|NCT03214640|76007511|FG000|STARTED|Overall Study||31||
59884678|NCT03214640|76007512|FG001|STARTED|Overall Study||32||
60012001|NCT01597375|76127886|FG000|STARTED|Washout (2 Weeks)||21||
60012002|NCT01597375|76127887|FG001|STARTED|Washout (2 Weeks)||22||
59884679|NCT03214640|76007513|FG002|STARTED|Overall Study||31||
59884680|NCT03214640|76007514|FG003|STARTED|Overall Study||34||
59884681|NCT03214640|76007511|FG000|COMPLETED|Overall Study||30||
59884682|NCT03214640|76007512|FG001|COMPLETED|Overall Study||30||
59884683|NCT03214640|76007513|FG002|COMPLETED|Overall Study||30||
59884684|NCT03214640|76007514|FG003|COMPLETED|Overall Study||30||
59884685|NCT03214640|76007511|FG000|NOT COMPLETED|Overall Study||1||
59884686|NCT03214640|76007512|FG001|NOT COMPLETED|Overall Study||2||
59884687|NCT03214640|76007513|FG002|NOT COMPLETED|Overall Study||1||
59884688|NCT03214640|76007514|FG003|NOT COMPLETED|Overall Study||4||
59884689|NCT03214406|76007526|FG000|STARTED|Overall Study||88||
59884690|NCT03214406|76007527|FG001|STARTED|Overall Study||93||
59884691|NCT03214406|76007526|FG000|COMPLETED|Overall Study||78||
59884692|NCT03214406|76007527|FG001|COMPLETED|Overall Study||78||
59884693|NCT03214406|76007526|FG000|NOT COMPLETED|Overall Study||10||
59884694|NCT03214406|76007527|FG001|NOT COMPLETED|Overall Study||15||
59884695|NCT03213938|76007535|FG000|STARTED|Overall Study||220||
59884696|NCT03213938|76007536|FG001|STARTED|Overall Study||220||
59884697|NCT03213938|76007535|FG000|COMPLETED|Overall Study||206||
59884698|NCT03213938|76007536|FG001|COMPLETED|Overall Study||208||
59884699|NCT03213938|76007535|FG000|NOT COMPLETED|Overall Study||14||
59884700|NCT03213938|76007536|FG001|NOT COMPLETED|Overall Study||12||
59884701|NCT03604497|76007542|FG000|STARTED|Overall Study||437||
59884702|NCT03604497|76007542|FG000|COMPLETED|Overall Study||385||
59884703|NCT03604497|76007542|FG000|NOT COMPLETED|Overall Study||52||
59884704|NCT03213626|76007550|FG000|STARTED|Overall Study||7||
59884705|NCT03213626|76007550|FG000|COMPLETED|Overall Study||0||
59884706|NCT03213626|76007550|FG000|NOT COMPLETED|Overall Study||7||
59884707|NCT03604341|76007556|FG000|STARTED|Overall Study||35||
59884708|NCT03604341|76007557|FG001|STARTED|Overall Study||35||
59884709|NCT03604341|76007556|FG000|COMPLETED|Overall Study||33||
59884710|NCT03604341|76007557|FG001|COMPLETED|Overall Study||33||
59884711|NCT03604341|76007556|FG000|NOT COMPLETED|Overall Study||2||
59884712|NCT03604341|76007557|FG001|NOT COMPLETED|Overall Study||2||
59884713|NCT03603639|76007563|FG000|STARTED|Treatment Period 1 (Day 1)||1||
59884714|NCT03603639|76007564|FG001|STARTED|Treatment Period 1 (Day 1)||1||
59884715|NCT03603639|76007565|FG002|STARTED|Treatment Period 1 (Day 1)||1||
59884716|NCT03603639|76007566|FG003|STARTED|Treatment Period 1 (Day 1)||1||
59884717|NCT03603639|76007567|FG004|STARTED|Treatment Period 1 (Day 1)||1||
59884718|NCT03603639|76007568|FG005|STARTED|Treatment Period 1 (Day 1)||1||
59884719|NCT03603639|76007563|FG000|COMPLETED|Treatment Period 1 (Day 1)||1||
59884720|NCT03603639|76007564|FG001|COMPLETED|Treatment Period 1 (Day 1)||1||
59884721|NCT03603639|76007565|FG002|COMPLETED|Treatment Period 1 (Day 1)||1||
59884722|NCT03603639|76007566|FG003|COMPLETED|Treatment Period 1 (Day 1)||1||
59884723|NCT03603639|76007567|FG004|COMPLETED|Treatment Period 1 (Day 1)||1||
59884724|NCT03603639|76007568|FG005|COMPLETED|Treatment Period 1 (Day 1)||1||
59884725|NCT03603639|76007563|FG000|NOT COMPLETED|Treatment Period 1 (Day 1)||0||
59884726|NCT03603639|76007564|FG001|NOT COMPLETED|Treatment Period 1 (Day 1)||0||
60012003|NCT01597375|76127886|FG000|COMPLETED|Washout (2 Weeks)||20||
60012004|NCT01597375|76127887|FG001|COMPLETED|Washout (2 Weeks)||22||
60012005|NCT01597375|76127886|FG000|NOT COMPLETED|Washout (2 Weeks)||1||
59884727|NCT03603639|76007565|FG002|NOT COMPLETED|Treatment Period 1 (Day 1)||0||
59884728|NCT03603639|76007566|FG003|NOT COMPLETED|Treatment Period 1 (Day 1)||0||
59884729|NCT03603639|76007567|FG004|NOT COMPLETED|Treatment Period 1 (Day 1)||0||
59884730|NCT03603639|76007568|FG005|NOT COMPLETED|Treatment Period 1 (Day 1)||0||
59884731|NCT03603639|76007563|FG000|STARTED|Washout Period (at Least 3 Weeks)||1||
59754649|NCT03889418|75873580|FG000|NOT COMPLETED|July-September 2019 (Months 4-6)||0||0
59754650|NCT03889418|75873581|FG001|NOT COMPLETED|July-September 2019 (Months 4-6)||1||0
59754651|NCT03889418|75873582|FG002|NOT COMPLETED|July-September 2019 (Months 4-6)||1||0
59754652|NCT03889418|75873583|FG003|NOT COMPLETED|July-September 2019 (Months 4-6)||0||0
59754653|NCT03889418|75873584|FG004|NOT COMPLETED|July-September 2019 (Months 4-6)||0||0
59754654|NCT03889418|75873585|FG005|NOT COMPLETED|July-September 2019 (Months 4-6)||0||0
60012006|NCT01597375|76127887|FG001|NOT COMPLETED|Washout (2 Weeks)||0||
60012007|NCT01597375|76127886|FG000|STARTED|Second Intervention||20||
60012008|NCT01597375|76127887|FG001|STARTED|Second Intervention||22||
60012009|NCT01597375|76127886|FG000|COMPLETED|Second Intervention||19||
59606993|NCT01385033|75717465|FG002|NOT COMPLETED|Part II||0||
59606994|NCT01385033|75717466|FG003|NOT COMPLETED|Part II||0||
59606995|NCT01385033|75717467|FG004|NOT COMPLETED|Part II||0||
59606996|NCT01385033|75717468|FG005|NOT COMPLETED|Part II||0||
59606997|NCT01385033|75717463|FG000|STARTED|Part III||0||
59606998|NCT01385033|75717464|FG001|STARTED|Part III||0||
59606999|NCT01385033|75717465|FG002|STARTED|Part III||0||
59607000|NCT01385033|75717466|FG003|STARTED|Part III||0||
60012010|NCT01597375|76127887|FG001|COMPLETED|Second Intervention||21||
60012011|NCT01597375|76127886|FG000|NOT COMPLETED|Second Intervention||1||
60012012|NCT01597375|76127887|FG001|NOT COMPLETED|Second Intervention||1||
60012013|NCT02527161|76127894|FG000|STARTED|Overall Study|All results are reported by knee throughout record. Participant=knee.|205||
60067712|NCT01617187|76182894|FG003|COMPLETED|Randomization Through Start Treatment||101||
60067713|NCT01617187|76182891|FG000|NOT COMPLETED|Randomization Through Start Treatment||1||
59754655|NCT03889418|75873586|FG006|NOT COMPLETED|July-September 2019 (Months 4-6)||0||0
59754656|NCT03889418|75873587|FG007|NOT COMPLETED|July-September 2019 (Months 4-6)||0||0
59754657|NCT03889418|75873588|FG008|NOT COMPLETED|July-September 2019 (Months 4-6)||0||0
59754658|NCT03889418|75873589|FG009|NOT COMPLETED|July-September 2019 (Months 4-6)||0||0
59493847|NCT04508023|75584237|FG000|STARTED|Overall Study||641||
59493848|NCT04508023|75584238|FG001|STARTED|Overall Study||643||
59493849|NCT04508023|75584237|FG000|Treated (Safety Analysis Set)|Overall Study||599||
59493850|NCT04508023|75584238|FG001|Treated (Safety Analysis Set)|Overall Study||598||
59493851|NCT04508023|75584237|FG000|COMPLETED|Overall Study||640|This also included participants who were not treated with study drug, but were still followed-up as per the planned visits.|
59493852|NCT04508023|75584238|FG001|COMPLETED|Overall Study||641|This also included participants who were not treated with study drug, but were still followed-up as per the planned visits.|
59493853|NCT04508023|75584237|FG000|NOT COMPLETED|Overall Study||1||
59493854|NCT04508023|75584238|FG001|NOT COMPLETED|Overall Study||2||
59493855|NCT04187144|75584246|FG000|STARTED|Overall Study||805|Participants randomly assigned to the study treatment were included in Intent-to-Treat (ITT) population|
59493856|NCT04187144|75584247|FG001|STARTED|Overall Study||800|Participants randomly assigned to the study treatment were included in Intent-to-Treat (ITT) population|
59493857|NCT04187144|75584246|FG000|Safety Population|Overall Study||804|Safety population included all randomized participants who receive at least 1 dose of study treatment.|
59493858|NCT04187144|75584247|FG001|Safety Population|Overall Study||798|Safety population included all randomized participants who receive at least 1 dose of study treatment.|
59493859|NCT04187144|75584246|FG000|Microbiological ITT (Micro ITT) Population|Overall Study||331|Microbiological ITT (micro-ITT) population included all participants randomly assigned to study treatment who receive at least 1 dose of study treatment and have a qualifying baseline uropathogen [10^5 CFU/mL] from a quantitative bacteriological culture of a pretreatment clean catch midstream urine specimen.|
59493860|NCT04187144|75584247|FG001|Microbiological ITT (Micro ITT) Population|Overall Study||324|Microbiological ITT (micro-ITT) population included all participants randomly assigned to study treatment who receive at least 1 dose of study treatment and have a qualifying baseline uropathogen [10^5 CFU/mL] from a quantitative bacteriological culture of a pretreatment clean catch midstream urine specimen.|
59493861|NCT04187144|75584246|FG000|Micro-ITT NTF-S Population|Overall Study||292|Micro-ITT NTF-S population is defined as all participants in the micro-ITT population whose baseline qualifying uropathogens [10^5 CFU/mL] are all susceptible to nitrofurantoin (NTF-S).|
59493862|NCT04187144|75584247|FG001|Micro-ITT NTF-S Population|Overall Study||275|Micro-ITT NTF-S population is defined as all participants in the micro-ITT population whose baseline qualifying uropathogens [10^5 CFU/mL] are all susceptible to nitrofurantoin (NTF-S).|
59518977|NCT03394768|75612866|FG000|COMPLETED|Overall Study||26||
59607001|NCT01385033|75717467|FG004|STARTED|Part III||0||
59607002|NCT01385033|75717468|FG005|STARTED|Part III||0||
59607003|NCT01385033|75717463|FG000|COMPLETED|Part III||0||
59884732|NCT03603639|76007564|FG001|STARTED|Washout Period (at Least 3 Weeks)||1||
59884733|NCT03603639|76007565|FG002|STARTED|Washout Period (at Least 3 Weeks)||1||
59884734|NCT03603639|76007566|FG003|STARTED|Washout Period (at Least 3 Weeks)||1||
59884735|NCT03603639|76007567|FG004|STARTED|Washout Period (at Least 3 Weeks)||1||
59884736|NCT03603639|76007568|FG005|STARTED|Washout Period (at Least 3 Weeks)||1||
59884737|NCT03603639|76007563|FG000|COMPLETED|Washout Period (at Least 3 Weeks)||1||
59884738|NCT03603639|76007564|FG001|COMPLETED|Washout Period (at Least 3 Weeks)||1||
59884739|NCT03603639|76007565|FG002|COMPLETED|Washout Period (at Least 3 Weeks)||1||
59884740|NCT03603639|76007566|FG003|COMPLETED|Washout Period (at Least 3 Weeks)||1||
59884741|NCT03603639|76007567|FG004|COMPLETED|Washout Period (at Least 3 Weeks)||1||
60012014|NCT02527161|76127894|FG000|COMPLETED|Overall Study|Completed/Not completed counts are for knees at the 5 year outcome interval.|73||
60012015|NCT02527161|76127894|FG000|NOT COMPLETED|Overall Study||132||
60012016|NCT02609399|76127901|FG000|STARTED|Influenza Season 2015-2016||27||
60012017|NCT02609399|76127902|FG001|STARTED|Influenza Season 2015-2016||31||
59754659|NCT03889418|75873580|FG000|STARTED|October-December 2019 (Month 7-9)||60|[EMR-CDS with CCM] participants started enrollment in region 3 in period 3. In Regions 4 & 5, EMR-CDS (usual care) matched controls were identified. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|1
59754660|NCT03889418|75873581|FG001|STARTED|October-December 2019 (Month 7-9)||36|[EMR-CDS with CCM] participants started enrollment in region 3 in period 3. In Regions 4 & 5, EMR-CDS (usual care) matched controls were identified. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|1
60012018|NCT02609399|76127901|FG000|COMPLETED|Influenza Season 2015-2016||24||
60012019|NCT02609399|76127902|FG001|COMPLETED|Influenza Season 2015-2016||29||
60012020|NCT02609399|76127901|FG000|NOT COMPLETED|Influenza Season 2015-2016||3||
60012021|NCT02609399|76127902|FG001|NOT COMPLETED|Influenza Season 2015-2016||2||
60012022|NCT02609399|76127901|FG000|STARTED|Influenza Season 2016-2017||58||
60012023|NCT02609399|76127902|FG001|STARTED|Influenza Season 2016-2017||64||
60012024|NCT02609399|76127901|FG000|COMPLETED|Influenza Season 2016-2017||49||
60012025|NCT02609399|76127902|FG001|COMPLETED|Influenza Season 2016-2017||59||
60012026|NCT02609399|76127901|FG000|NOT COMPLETED|Influenza Season 2016-2017||9||
59518978|NCT03394768|75612866|FG000|NOT COMPLETED|Overall Study||0||
59754661|NCT03889418|75873582|FG002|STARTED|October-December 2019 (Month 7-9)||28|[EMR-CDS with CCM] participants started enrollment in region 3 in period 3. In Regions 4 & 5, EMR-CDS (usual care) matched controls were identified. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|1
59754662|NCT03889418|75873583|FG003|STARTED|October-December 2019 (Month 7-9)||11|[EMR-CDS with CCM] participants started enrollment in region 3 in period 3. In Regions 4 & 5, EMR-CDS (usual care) matched controls were identified. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|1
59754663|NCT03889418|75873584|FG004|STARTED|October-December 2019 (Month 7-9)||16|[EMR-CDS with CCM] participants started enrollment in region 3 in period 3. In Regions 4 & 5, EMR-CDS (usual care) matched controls were identified. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|1
59762541|NCT00872898|75882315|FG001|COMPLETED|Part Two - Double Blind||54||
59493863|NCT04187144|75584246|FG000|Micro-ITT NTF-S (IA Set) Population|Overall Study||277|Microbiological intent-to-treat susceptible to nitrofurantoin (micro-ITT NTF-S) (IA Set) population included participants in the micro ITT NTF-S who per the interim analysis data had the opportunity to reach their Test of Cure (TOC) visit, or had not yet reached their TOC visit, but were already known to be failures.|
59493864|NCT04187144|75584247|FG001|Micro-ITT NTF-S (IA Set) Population|Overall Study||264|Microbiological intent-to-treat susceptible to nitrofurantoin (micro-ITT NTF-S) (IA Set) population included participants in the micro ITT NTF-S who per the interim analysis data had the opportunity to reach their Test of Cure (TOC) visit, or had not yet reached their TOC visit, but were already known to be failures.|
59493865|NCT04187144|75584246|FG000|COMPLETED|Overall Study||748||
59493866|NCT04187144|75584247|FG001|COMPLETED|Overall Study||759||
59493867|NCT04187144|75584246|FG000|NOT COMPLETED|Overall Study||57||
59493868|NCT04187144|75584247|FG001|NOT COMPLETED|Overall Study||41||
59493869|NCT04027946|75584253|FG000|STARTED|Overall Study||6||
59493870|NCT04027946|75584253|FG000|COMPLETED|Overall Study||3||
59493871|NCT04027946|75584253|FG000|NOT COMPLETED|Overall Study||3||
59493872|NCT03943160|75584263|FG000|STARTED|Overall Study||50||
59493873|NCT03943160|75584263|FG000|COMPLETED|Overall Study||50||
59493874|NCT03943160|75584263|FG000|NOT COMPLETED|Overall Study||0||
59493875|NCT03856047|75584274|FG000|STARTED|Overall Study||101||
59493876|NCT03856047|75584275|FG001|STARTED|Overall Study||100||
59493877|NCT03856047|75584276|FG002|STARTED|Overall Study||102||
59493878|NCT03856047|75584277|FG003|STARTED|Overall Study||102||
59493879|NCT03856047|75584278|FG004|STARTED|Overall Study||101||
59493880|NCT03856047|75584279|FG005|STARTED|Overall Study||99||
59754664|NCT03889418|75873585|FG005|STARTED|October-December 2019 (Month 7-9)||1|[EMR-CDS with CCM] participants started enrollment in region 3 in period 3. In Regions 4 & 5, EMR-CDS (usual care) matched controls were identified. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|1
59754665|NCT03889418|75873586|FG006|STARTED|October-December 2019 (Month 7-9)||12|[EMR-CDS with CCM] participants started enrollment in region 3 in period 3. In Regions 4 & 5, EMR-CDS (usual care) matched controls were identified. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|1
59754666|NCT03889418|75873587|FG007|STARTED|October-December 2019 (Month 7-9)||0|[EMR-CDS with CCM] participants started enrollment in region 3 in period 3. In Regions 4 & 5, EMR-CDS (usual care) matched controls were identified. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|0
59762542|NCT00872898|75882314|FG000|NOT COMPLETED|Part Two - Double Blind||11||
59762543|NCT00872898|75882315|FG001|NOT COMPLETED|Part Two - Double Blind||6||
60012027|NCT02609399|76127902|FG001|NOT COMPLETED|Influenza Season 2016-2017||5||
60012028|NCT02720185|76127910|FG000|STARTED|Overall Study||5||
60012029|NCT02720185|76127910|FG000|COMPLETED|Overall Study||4||
60012030|NCT02720185|76127910|FG000|NOT COMPLETED|Overall Study||1||
60012031|NCT04498273|76127918|FG000|STARTED|Overall Study||165||
60012032|NCT04498273|76127919|FG001|STARTED|Overall Study||164||
60012033|NCT04498273|76127920|FG002|STARTED|Overall Study||164||
60012034|NCT04498273|76127921|FG003|STARTED|Overall Study||164||
60012035|NCT04498273|76127918|FG000|COMPLETED|Overall Study||134||
60012036|NCT04498273|76127919|FG001|COMPLETED|Overall Study||140||
60012037|NCT04498273|76127920|FG002|COMPLETED|Overall Study||143||
60012038|NCT04498273|76127921|FG003|COMPLETED|Overall Study||133||
60012039|NCT04498273|76127918|FG000|NOT COMPLETED|Overall Study||31||
60012040|NCT04498273|76127919|FG001|NOT COMPLETED|Overall Study||24||
60012041|NCT04498273|76127920|FG002|NOT COMPLETED|Overall Study||21||
60012042|NCT04498273|76127921|FG003|NOT COMPLETED|Overall Study||31||
59493881|NCT03856047|75584280|FG006|STARTED|Overall Study||101||
59493882|NCT03856047|75584274|FG000|Full Analysis Set|Overall Study||101||
60012043|NCT02526693|76127933|FG000|STARTED|Overall Study||53||
60012044|NCT02526693|76127934|FG001|STARTED|Overall Study||51||
60012045|NCT02526693|76127933|FG000|COMPLETED|Overall Study||50||
60012046|NCT02526693|76127934|FG001|COMPLETED|Overall Study||50||
59884742|NCT03603639|76007568|FG005|COMPLETED|Washout Period (at Least 3 Weeks)||1||
59884743|NCT03603639|76007563|FG000|NOT COMPLETED|Washout Period (at Least 3 Weeks)||0||
59884744|NCT03603639|76007564|FG001|NOT COMPLETED|Washout Period (at Least 3 Weeks)||0||
59884745|NCT03603639|76007565|FG002|NOT COMPLETED|Washout Period (at Least 3 Weeks)||0||
59884746|NCT03603639|76007566|FG003|NOT COMPLETED|Washout Period (at Least 3 Weeks)||0||
59884747|NCT03603639|76007567|FG004|NOT COMPLETED|Washout Period (at Least 3 Weeks)||0||
59884748|NCT03603639|76007568|FG005|NOT COMPLETED|Washout Period (at Least 3 Weeks)||0||
59884749|NCT03603639|76007563|FG000|STARTED|Treatment Period 2 (Day 1)||1||
59884750|NCT03603639|76007564|FG001|STARTED|Treatment Period 2 (Day 1)||1||
59884751|NCT03603639|76007565|FG002|STARTED|Treatment Period 2 (Day 1)||1||
59884752|NCT03603639|76007566|FG003|STARTED|Treatment Period 2 (Day 1)||1||
59884753|NCT03603639|76007567|FG004|STARTED|Treatment Period 2 (Day 1)||1||
59884754|NCT03603639|76007568|FG005|STARTED|Treatment Period 2 (Day 1)||1||
59884755|NCT03603639|76007563|FG000|COMPLETED|Treatment Period 2 (Day 1)||1||
59884756|NCT03603639|76007564|FG001|COMPLETED|Treatment Period 2 (Day 1)||1||
59884757|NCT03603639|76007565|FG002|COMPLETED|Treatment Period 2 (Day 1)||1||
59884758|NCT03603639|76007566|FG003|COMPLETED|Treatment Period 2 (Day 1)||1||
59884759|NCT03603639|76007567|FG004|COMPLETED|Treatment Period 2 (Day 1)||1||
59884760|NCT03603639|76007568|FG005|COMPLETED|Treatment Period 2 (Day 1)||1||
59884761|NCT03603639|76007563|FG000|NOT COMPLETED|Treatment Period 2 (Day 1)||0||
59884762|NCT03603639|76007564|FG001|NOT COMPLETED|Treatment Period 2 (Day 1)||0||
59884763|NCT03603639|76007565|FG002|NOT COMPLETED|Treatment Period 2 (Day 1)||0||
59884764|NCT03603639|76007566|FG003|NOT COMPLETED|Treatment Period 2 (Day 1)||0||
59884765|NCT03603639|76007567|FG004|NOT COMPLETED|Treatment Period 2 (Day 1)||0||
59884766|NCT03603639|76007568|FG005|NOT COMPLETED|Treatment Period 2 (Day 1)||0||
59884767|NCT03603639|76007563|FG000|STARTED|Washout Period (at Least 3 Weeks)||1||
59884768|NCT03603639|76007564|FG001|STARTED|Washout Period (at Least 3 Weeks)||1||
59884769|NCT03603639|76007565|FG002|STARTED|Washout Period (at Least 3 Weeks)||1||
59884770|NCT03603639|76007566|FG003|STARTED|Washout Period (at Least 3 Weeks)||1||
59884771|NCT03603639|76007567|FG004|STARTED|Washout Period (at Least 3 Weeks)||1||
59884772|NCT03603639|76007568|FG005|STARTED|Washout Period (at Least 3 Weeks)||1||
59884773|NCT03603639|76007563|FG000|COMPLETED|Washout Period (at Least 3 Weeks)||1||
59884774|NCT03603639|76007564|FG001|COMPLETED|Washout Period (at Least 3 Weeks)||1||
59884775|NCT03603639|76007565|FG002|COMPLETED|Washout Period (at Least 3 Weeks)||0||
59884776|NCT03603639|76007566|FG003|COMPLETED|Washout Period (at Least 3 Weeks)||0||
59884777|NCT03603639|76007567|FG004|COMPLETED|Washout Period (at Least 3 Weeks)||0||
59884778|NCT03603639|76007568|FG005|COMPLETED|Washout Period (at Least 3 Weeks)||0||
59884779|NCT03603639|76007563|FG000|NOT COMPLETED|Washout Period (at Least 3 Weeks)||0||
59884780|NCT03603639|76007564|FG001|NOT COMPLETED|Washout Period (at Least 3 Weeks)||0||
59884781|NCT03603639|76007565|FG002|NOT COMPLETED|Washout Period (at Least 3 Weeks)||1||
59884782|NCT03603639|76007566|FG003|NOT COMPLETED|Washout Period (at Least 3 Weeks)||1||
59884783|NCT03603639|76007567|FG004|NOT COMPLETED|Washout Period (at Least 3 Weeks)||1||
59884784|NCT03603639|76007568|FG005|NOT COMPLETED|Washout Period (at Least 3 Weeks)||1||
59884785|NCT03603639|76007563|FG000|STARTED|Treatment Period 3 (Day 1)||1||
59884786|NCT03603639|76007564|FG001|STARTED|Treatment Period 3 (Day 1)||1||
59884787|NCT03603639|76007565|FG002|STARTED|Treatment Period 3 (Day 1)||0||
59884788|NCT03603639|76007566|FG003|STARTED|Treatment Period 3 (Day 1)||0||
59884789|NCT03603639|76007567|FG004|STARTED|Treatment Period 3 (Day 1)||0||
59884790|NCT03603639|76007568|FG005|STARTED|Treatment Period 3 (Day 1)||0||
59884791|NCT03603639|76007563|FG000|COMPLETED|Treatment Period 3 (Day 1)||1||
59884792|NCT03603639|76007564|FG001|COMPLETED|Treatment Period 3 (Day 1)||1||
59884793|NCT03603639|76007565|FG002|COMPLETED|Treatment Period 3 (Day 1)||0||
59884794|NCT03603639|76007566|FG003|COMPLETED|Treatment Period 3 (Day 1)||0||
59884795|NCT03603639|76007567|FG004|COMPLETED|Treatment Period 3 (Day 1)||0||
59884796|NCT03603639|76007568|FG005|COMPLETED|Treatment Period 3 (Day 1)||0||
59884797|NCT03603639|76007563|FG000|NOT COMPLETED|Treatment Period 3 (Day 1)||0||
59884798|NCT03603639|76007564|FG001|NOT COMPLETED|Treatment Period 3 (Day 1)||0||
59884799|NCT03603639|76007565|FG002|NOT COMPLETED|Treatment Period 3 (Day 1)||0||
59884800|NCT03603639|76007566|FG003|NOT COMPLETED|Treatment Period 3 (Day 1)||0||
59884801|NCT03603639|76007567|FG004|NOT COMPLETED|Treatment Period 3 (Day 1)||0||
59493883|NCT03856047|75584275|FG001|Full Analysis Set|Overall Study||100||
59493884|NCT03856047|75584276|FG002|Full Analysis Set|Overall Study||102||
59493885|NCT03856047|75584277|FG003|Full Analysis Set|Overall Study||102||
59493886|NCT03856047|75584278|FG004|Full Analysis Set|Overall Study||101||
59493887|NCT03856047|75584279|FG005|Full Analysis Set|Overall Study||99||
59493888|NCT03856047|75584280|FG006|Full Analysis Set|Overall Study||101||
59493889|NCT03856047|75584274|FG000|Safety Analysis Set|Overall Study||101||
59493890|NCT03856047|75584275|FG001|Safety Analysis Set|Overall Study||100||
59493891|NCT03856047|75584276|FG002|Safety Analysis Set|Overall Study||102||
59493892|NCT03856047|75584277|FG003|Safety Analysis Set|Overall Study||102||
59493893|NCT03856047|75584278|FG004|Safety Analysis Set|Overall Study||101||
59493894|NCT03856047|75584279|FG005|Safety Analysis Set|Overall Study||99||
59493895|NCT03856047|75584280|FG006|Safety Analysis Set|Overall Study||101||
59493896|NCT03856047|75584274|FG000|COMPLETED|Overall Study||97||
59493897|NCT03856047|75584275|FG001|COMPLETED|Overall Study||97||
59493898|NCT03856047|75584276|FG002|COMPLETED|Overall Study||98||
59493899|NCT03856047|75584277|FG003|COMPLETED|Overall Study||101||
59493900|NCT03856047|75584278|FG004|COMPLETED|Overall Study||94||
59493901|NCT03856047|75584279|FG005|COMPLETED|Overall Study||95||
59493902|NCT03856047|75584280|FG006|COMPLETED|Overall Study||95||
59493903|NCT03856047|75584274|FG000|NOT COMPLETED|Overall Study||4||
59493904|NCT03856047|75584275|FG001|NOT COMPLETED|Overall Study||3||
59493905|NCT03856047|75584276|FG002|NOT COMPLETED|Overall Study||4||
59493906|NCT03856047|75584277|FG003|NOT COMPLETED|Overall Study||1||
59493907|NCT03856047|75584278|FG004|NOT COMPLETED|Overall Study||7||
59493908|NCT03856047|75584279|FG005|NOT COMPLETED|Overall Study||4||
59493909|NCT03856047|75584280|FG006|NOT COMPLETED|Overall Study||6||
59493910|NCT03525431|75584297|FG000|STARTED|Overall Study||529||
59493911|NCT03525431|75584297|FG000|COMPLETED|Overall Study||529||
59493912|NCT03525431|75584297|FG000|NOT COMPLETED|Overall Study||0||
59493913|NCT03456115|75584301|FG000|STARTED|Overall Study||36||
59493914|NCT03456115|75584301|FG000|COMPLETED|Overall Study||36||
59493915|NCT03456115|75584301|FG000|NOT COMPLETED|Overall Study||0||
59493916|NCT03374956|75584322|FG000|STARTED|Overall Study||93||
59493917|NCT03374956|75584323|FG001|STARTED|Overall Study||100||
59493918|NCT03374956|75584322|FG000|COMPLETED|Overall Study||93||
59493919|NCT03374956|75584323|FG001|COMPLETED|Overall Study||100||
59493920|NCT03374956|75584322|FG000|NOT COMPLETED|Overall Study||0||
59493921|NCT03374956|75584323|FG001|NOT COMPLETED|Overall Study||0||
59493922|NCT03112603|75584331|FG000|STARTED|End of Randomization Period||165||
59493923|NCT03112603|75584332|FG001|STARTED|End of Randomization Period||164||
59493924|NCT03112603|75584333|FG002|STARTED|End of Randomization Period||0||
59493925|NCT03112603|75584331|FG000|COMPLETED|End of Randomization Period||29||
59493926|NCT03112603|75584332|FG001|COMPLETED|End of Randomization Period||24||
59493927|NCT03112603|75584333|FG002|COMPLETED|End of Randomization Period||0||
59493928|NCT03112603|75584331|FG000|NOT COMPLETED|End of Randomization Period||136||
59493929|NCT03112603|75584332|FG001|NOT COMPLETED|End of Randomization Period||140||
59493930|NCT03112603|75584333|FG002|NOT COMPLETED|End of Randomization Period||0||
59493931|NCT03112603|75584331|FG000|STARTED|End of Cross Over Period||0||
59493932|NCT03112603|75584332|FG001|STARTED|End of Cross Over Period||0||
59493933|NCT03112603|75584333|FG002|STARTED|End of Cross Over Period||70||
59493934|NCT03112603|75584331|FG000|COMPLETED|End of Cross Over Period||0||
59493935|NCT03112603|75584332|FG001|COMPLETED|End of Cross Over Period||0||
59493936|NCT03112603|75584333|FG002|COMPLETED|End of Cross Over Period||16||
59493937|NCT03112603|75584331|FG000|NOT COMPLETED|End of Cross Over Period||0||
59493938|NCT03112603|75584332|FG001|NOT COMPLETED|End of Cross Over Period||0||
59493939|NCT03112603|75584333|FG002|NOT COMPLETED|End of Cross Over Period||54||
59493940|NCT03050216|75584342|FG000|STARTED|Overall Study||8||
59493941|NCT03050216|75584342|FG000|COMPLETED|Overall Study||8||
59493942|NCT03050216|75584342|FG000|NOT COMPLETED|Overall Study||0||
59493943|NCT02725528|75584348|FG000|STARTED|Overall Study|Number of participant's randomized to this group.|8||
59493944|NCT02725528|75584349|FG001|STARTED|Overall Study|Number of participant's randomized to this group.|14||
59493945|NCT02725528|75584348|FG000|COMPLETED|Overall Study|Completed primary outcome at 12 months (i.e., Michigan Hand Questionnaire).|7||
59493946|NCT02725528|75584349|FG001|COMPLETED|Overall Study|Completed primary outcome at 12 months (i.e., Michigan Hand Questionnaire).|9||
59493947|NCT02725528|75584348|FG000|NOT COMPLETED|Overall Study||1||
59493948|NCT02725528|75584349|FG001|NOT COMPLETED|Overall Study||5||
59493949|NCT02629614|75584357|FG000|STARTED|Overall Study||48||
59493950|NCT02629614|75584358|FG001|STARTED|Overall Study||45||
59493951|NCT02629614|75584357|FG000|COMPLETED|Overall Study||48||
59493952|NCT02629614|75584358|FG001|COMPLETED|Overall Study||44||
59493953|NCT02629614|75584357|FG000|NOT COMPLETED|Overall Study||0||
59493954|NCT02629614|75584358|FG001|NOT COMPLETED|Overall Study||1||
59493955|NCT02627963|75584366|FG000|STARTED|Overall Study||175||
59493956|NCT02627963|75584367|FG001|STARTED|Overall Study||175||
59493957|NCT02627963|75584366|FG000|COMPLETED|Overall Study||173||
59493958|NCT02627963|75584367|FG001|COMPLETED|Overall Study||169||
59493959|NCT02627963|75584366|FG000|NOT COMPLETED|Overall Study||2||
59493960|NCT02627963|75584367|FG001|NOT COMPLETED|Overall Study||6||
59493961|NCT02585258|75584375|FG000|STARTED|Overall Study||226||
59493962|NCT02585258|75584376|FG001|STARTED|Overall Study||225||
59493963|NCT02585258|75584375|FG000|Started Study Meds: Safety Population|Overall Study||224||
59493964|NCT02585258|75584376|FG001|Started Study Meds: Safety Population|Overall Study||225||
59493965|NCT02585258|75584375|FG000|Returned for Follow up: Modified Intention-to-treat (ITT) Population|Overall Study||221||
59493966|NCT02585258|75584376|FG001|Returned for Follow up: Modified Intention-to-treat (ITT) Population|Overall Study||223||
59493967|NCT02585258|75584375|FG000|COMPLETED|Overall Study||141||
59493968|NCT02585258|75584376|FG001|COMPLETED|Overall Study||137||
59493969|NCT02585258|75584375|FG000|NOT COMPLETED|Overall Study||85||
59493970|NCT02585258|75584376|FG001|NOT COMPLETED|Overall Study||88||
59493971|NCT02339545|75584382|FG000|STARTED|Overall Study||15||
59493972|NCT02339545|75584382|FG000|COMPLETED|Overall Study||15||
59493973|NCT02339545|75584382|FG000|NOT COMPLETED|Overall Study||0||
59493974|NCT02203604|75584387|FG000|STARTED|Overall Study||9||
59493975|NCT02203604|75584387|FG000|COMPLETED|Overall Study||9||
59493976|NCT02203604|75584387|FG000|NOT COMPLETED|Overall Study||0||
59493977|NCT02132611|75584393|FG000|STARTED|Overall Study||100||
59493978|NCT02132611|75584393|FG000|COMPLETED|Overall Study||98||
59493979|NCT02132611|75584393|FG000|NOT COMPLETED|Overall Study||2||
59493980|NCT01941030|75584399|FG000|STARTED|Overall Study||25||
59493981|NCT01941030|75584400|FG001|STARTED|Overall Study||26||
59493982|NCT01941030|75584399|FG000|COMPLETED|Overall Study||12||
59493983|NCT01941030|75584400|FG001|COMPLETED|Overall Study||13||
59493984|NCT01941030|75584399|FG000|NOT COMPLETED|Overall Study||13||
59493985|NCT01941030|75584400|FG001|NOT COMPLETED|Overall Study||13||
59493986|NCT01366417|75584406|FG000|STARTED|Overall Study||43||
59518979|NCT03587428|75612870|FG000|STARTED|Period 1||3||
59493987|NCT01366417|75584406|FG000|Signed Informed Consent|Overall Study|Microbial samples were taken from 43 subjects for screening baseline.|43||
59493988|NCT01366417|75584406|FG000|Completed Screen Visit|Overall Study|33 subjects had qualifying screening bacterial counts and were eligible for the Treatment Visit|33||
59493989|NCT01366417|75584406|FG000|Completed Treatment Visit|Overall Study|28 subjects were treated with ChloraPrep and 70% Isopropyl Alcohol (single topical treatment)|28||
59493990|NCT01366417|75584406|FG000|Completed the Study|Overall Study|treatment baseline microbial counts not available until after treatment; subjects not evaluable|28||
59493991|NCT01366417|75584406|FG000|Discontinued Prior to Treatment|Overall Study|5 eligible subjects were not treated because enrollment target of 25 was met and enrollment closed.|5||
59493992|NCT01366417|75584406|FG000|Excluded From Analysis|Overall Study|3 subjects did not have qualifying Treatment Day microbial counts and were excluded from analysis|3||
59493993|NCT01366417|75584406|FG000|COMPLETED|Overall Study|25 subjects included in the analysis|25||
59493994|NCT01366417|75584406|FG000|NOT COMPLETED|Overall Study||18||
59493995|NCT01092416|75584411|FG000|STARTED|Enrollment||443||
59493996|NCT01092416|75584411|FG000|COMPLETED|Enrollment||440||
59493997|NCT01092416|75584411|FG000|NOT COMPLETED|Enrollment||3||
59493998|NCT01092416|75584411|FG000|STARTED|30-Day Follow-up||440||
59493999|NCT01092416|75584411|FG000|COMPLETED|30-Day Follow-up||430||
59494000|NCT01092416|75584411|FG000|NOT COMPLETED|30-Day Follow-up||10||
59494001|NCT01092416|75584411|FG000|STARTED|12-Month Follow-up||438||
59494002|NCT01092416|75584411|FG000|COMPLETED|12-Month Follow-up||413||
59494003|NCT01092416|75584411|FG000|NOT COMPLETED|12-Month Follow-up||25||
59494004|NCT00701220|75584420|FG000|STARTED|Overall Study||3||
59494005|NCT00701220|75584421|FG001|STARTED|Overall Study||6||
59494006|NCT00701220|75584420|FG000|COMPLETED|Overall Study||1||
59494007|NCT00701220|75584421|FG001|COMPLETED|Overall Study||4||
59494008|NCT00701220|75584420|FG000|NOT COMPLETED|Overall Study||2||
59494009|NCT00701220|75584421|FG001|NOT COMPLETED|Overall Study||2||
59494010|NCT00677924|75584429|FG000|STARTED|Overall Study||3||
59494011|NCT00677924|75584430|FG001|STARTED|Overall Study||6||
59494012|NCT00677924|75584429|FG000|COMPLETED|Overall Study||3||
59494013|NCT00677924|75584430|FG001|COMPLETED|Overall Study||6||
59494014|NCT00677924|75584429|FG000|NOT COMPLETED|Overall Study||0||
59494015|NCT00677924|75584430|FG001|NOT COMPLETED|Overall Study||0||
59494016|NCT00251303|75584438|FG000|STARTED|Overall Study|78 subjects signed any consent. 60 started drug (30 riluzole & 30 placebo).|30||
59494017|NCT00251303|75584439|FG001|STARTED|Overall Study||30||
59494018|NCT00251303|75584438|FG000|COMPLETED|Overall Study||22||
59494019|NCT00251303|75584439|FG001|COMPLETED|Overall Study||29||
59494020|NCT00251303|75584438|FG000|NOT COMPLETED|Overall Study||8||
59494021|NCT00251303|75584439|FG001|NOT COMPLETED|Overall Study||1||
59494022|NCT00303823|75584449|FG000|STARTED|Overall Study||50||
59494023|NCT00303823|75584450|FG001|STARTED|Overall Study||48||
59494024|NCT00303823|75584449|FG000|COMPLETED|Overall Study||35||
59494025|NCT00303823|75584450|FG001|COMPLETED|Overall Study||38||
59494026|NCT00303823|75584449|FG000|NOT COMPLETED|Overall Study||15||
59494027|NCT00303823|75584450|FG001|NOT COMPLETED|Overall Study||10||
59494028|NCT00300677|75584456|FG000|STARTED|Overall Study||12||
59494029|NCT00300677|75584456|FG000|COMPLETED|Overall Study||12||
59494030|NCT00300677|75584456|FG000|NOT COMPLETED|Overall Study||0||
59494031|NCT00303901|75584460|FG000|STARTED|Overall Study||40||
59494032|NCT00303901|75584460|FG000|COMPLETED|Overall Study||40||
59494033|NCT00303901|75584460|FG000|NOT COMPLETED|Overall Study||0||
59762544|NCT00884312|75882326|FG000|STARTED|Overall Study||9||
59494034|NCT00252629|75584467|FG000|STARTED|Overall Study||9||
59494035|NCT00252629|75584468|FG001|STARTED|Overall Study||9||
59762545|NCT00884312|75882327|FG001|STARTED|Overall Study||92||
59494036|NCT00252629|75584469|FG002|STARTED|Overall Study|We used data from the 18 veterans with GWS in addition to the 11 control|11||
59494037|NCT00252629|75584467|FG000|COMPLETED|Overall Study|One participant assigned to therapeutic CPAP was excluded from the trial before starting treatment.|8||
59494038|NCT00252629|75584468|FG001|COMPLETED|Overall Study||9||
59494039|NCT00252629|75584469|FG002|COMPLETED|Overall Study|We used data from the 18 veterans with GWS in addition to the 11 control|11||
59494040|NCT00252629|75584467|FG000|NOT COMPLETED|Overall Study||1||
59494041|NCT00252629|75584468|FG001|NOT COMPLETED|Overall Study||0||
59494042|NCT00252629|75584469|FG002|NOT COMPLETED|Overall Study||0||
59494043|NCT00253019|75584485|FG000|STARTED|Overall Study||111||
59494044|NCT00253019|75584486|FG001|STARTED|Overall Study||109||
59494045|NCT00253019|75584487|FG002|STARTED|Overall Study||101||
59494046|NCT00253019|75584485|FG000|COMPLETED|Overall Study||82||
59494047|NCT00253019|75584486|FG001|COMPLETED|Overall Study||78||
59494048|NCT00253019|75584487|FG002|COMPLETED|Overall Study||83||
59494049|NCT00253019|75584485|FG000|NOT COMPLETED|Overall Study||29||
59494050|NCT00253019|75584486|FG001|NOT COMPLETED|Overall Study||31||
59494051|NCT00253019|75584487|FG002|NOT COMPLETED|Overall Study||18||
59494052|NCT00559845|75584495|FG000|STARTED|Overall Study||56||
59494053|NCT00559845|75584495|FG000|COMPLETED|Overall Study||49||
59494054|NCT00559845|75584495|FG000|NOT COMPLETED|Overall Study||7||
59494055|NCT00303979|75584502|FG000|STARTED|Overall Study|at baseline|15177||
59494056|NCT00303979|75584503|FG001|STARTED|Overall Study|at 6 months|9992||
59494057|NCT00303979|75584504|FG002|STARTED|Overall Study|at 18 months|9641||
59494058|NCT00303979|75584502|FG000|COMPLETED|Overall Study|at 24 Months|7605||
59494059|NCT00303979|75584503|FG001|COMPLETED|Overall Study|at 6 months|9992||
59494060|NCT00303979|75584504|FG002|COMPLETED|Overall Study|at 18 months|9641||
59494061|NCT00303979|75584502|FG000|NOT COMPLETED|Overall Study||7572||
59494062|NCT00303979|75584503|FG001|NOT COMPLETED|Overall Study||0||
59494063|NCT00303979|75584504|FG002|NOT COMPLETED|Overall Study||0||
59494064|NCT00304187|75584523|FG000|STARTED|Overall Study||15||
59494065|NCT00304187|75584524|FG001|STARTED|Overall Study||14||
59494066|NCT00304187|75584523|FG000|COMPLETED|Overall Study||13||
59494067|NCT00304187|75584524|FG001|COMPLETED|Overall Study||13||
59494068|NCT00304187|75584523|FG000|NOT COMPLETED|Overall Study||2||
59494069|NCT00304187|75584524|FG001|NOT COMPLETED|Overall Study||1||
59494070|NCT01867515|75584535|FG000|STARTED|Overall Study||13||
59494071|NCT01867515|75584536|FG001|STARTED|Overall Study||12||
59494072|NCT01867515|75584537|FG002|STARTED|Overall Study||25||
59494073|NCT01867515|75584535|FG000|COMPLETED|Overall Study||13||
59494074|NCT01867515|75584536|FG001|COMPLETED|Overall Study||11||
59494075|NCT01867515|75584537|FG002|COMPLETED|Overall Study||14||
59494076|NCT01867515|75584535|FG000|NOT COMPLETED|Overall Study||0||
59494077|NCT01867515|75584536|FG001|NOT COMPLETED|Overall Study||1||
59494078|NCT01867515|75584537|FG002|NOT COMPLETED|Overall Study||11||
59494079|NCT00324701|75584547|FG000|STARTED|Overall Study||120||
59494080|NCT00324701|75584548|FG001|STARTED|Overall Study||121||
59494081|NCT00324701|75584547|FG000|Week 8 Assessment|Overall Study||108||
59494082|NCT00324701|75584548|FG001|Week 8 Assessment|Overall Study||107||
59494083|NCT00324701|75584547|FG000|COMPLETED|Overall Study||100||
59494084|NCT00324701|75584548|FG001|COMPLETED|Overall Study||104||
59494085|NCT00324701|75584547|FG000|NOT COMPLETED|Overall Study||20||
59494086|NCT00324701|75584548|FG001|NOT COMPLETED|Overall Study||17||
59494087|NCT02482389|75584554|FG000|STARTED|Overall Study||3||
59494088|NCT02482389|75584554|FG000|COMPLETED|Overall Study||3||
59494089|NCT02482389|75584554|FG000|NOT COMPLETED|Overall Study||0||
59607004|NCT01385033|75717464|FG001|COMPLETED|Part III||0||
59494090|NCT00324857|75584562|FG000|STARTED|Overall Study||167||
59494091|NCT00324857|75584563|FG001|STARTED|Overall Study||168||
59494092|NCT00324857|75584564|FG002|STARTED|Overall Study||165||
59494093|NCT00324857|75584565|FG003|STARTED|Overall Study||163||
59494094|NCT00324857|75584562|FG000|COMPLETED|Overall Study||161||
59494095|NCT00324857|75584563|FG001|COMPLETED|Overall Study||162||
59884802|NCT03603639|76007568|FG005|NOT COMPLETED|Treatment Period 3 (Day 1)||0||
59884803|NCT00114959|76007578|FG000|STARTED|Overall Study||15||
59884804|NCT00114959|76007578|FG000|COMPLETED|Overall Study|protocol definition of completed study is having received >= 4 cycles of treatment|7||
59884805|NCT00114959|76007578|FG000|NOT COMPLETED|Overall Study||8||
59884806|NCT02778100|76007584|FG000|STARTED|Period 1 (Common Cold)||18||
59884807|NCT02778100|76007585|FG001|STARTED|Period 1 (Common Cold)||18||
59884808|NCT02778100|76007584|FG000|COMPLETED|Period 1 (Common Cold)||17||
59884809|NCT02778100|76007585|FG001|COMPLETED|Period 1 (Common Cold)||18||
59884810|NCT02778100|76007584|FG000|NOT COMPLETED|Period 1 (Common Cold)||1||
59884811|NCT02778100|76007585|FG001|NOT COMPLETED|Period 1 (Common Cold)||0||
59884812|NCT02778100|76007584|FG000|STARTED|Period 2 (No Cold Symptoms)||17||
59884813|NCT02778100|76007585|FG001|STARTED|Period 2 (No Cold Symptoms)|Cohort 2 only administered NG to participants with a common cold who are taking oxymetazoline.|0||
59884814|NCT02778100|76007584|FG000|COMPLETED|Period 2 (No Cold Symptoms)||17||
59884815|NCT02778100|76007585|FG001|COMPLETED|Period 2 (No Cold Symptoms)||0||
59884816|NCT02778100|76007584|FG000|NOT COMPLETED|Period 2 (No Cold Symptoms)||0||
59884817|NCT02778100|76007585|FG001|NOT COMPLETED|Period 2 (No Cold Symptoms)||0||
59884818|NCT00118157|76007593|FG000|STARTED|Overall Study||19||
59884819|NCT00118157|76007593|FG000|COMPLETED|Overall Study||7||
59884820|NCT00118157|76007593|FG000|NOT COMPLETED|Overall Study||12||
59884821|NCT02762500|76007600|FG000|STARTED|Overall Study||62||
59884822|NCT02762500|76007601|FG001|STARTED|Overall Study||62||
59884823|NCT02762500|76007600|FG000|COMPLETED|Overall Study||60||
59884824|NCT02762500|76007601|FG001|COMPLETED|Overall Study||59||
59884825|NCT02762500|76007600|FG000|NOT COMPLETED|Overall Study||2||
59884826|NCT02762500|76007601|FG001|NOT COMPLETED|Overall Study||3||
59884827|NCT03552549|76007609|FG000|STARTED|Overall Study||63||
59884828|NCT03552549|76007610|FG001|STARTED|Overall Study||63||
59884829|NCT03552549|76007609|FG000|Treated|Overall Study||62||
59884830|NCT03552549|76007610|FG001|Treated|Overall Study||62||
59494096|NCT00324857|75584564|FG002|COMPLETED|Overall Study||158||
59884831|NCT03552549|76007609|FG000|COMPLETED|Overall Study||10||
59884832|NCT03552549|76007610|FG001|COMPLETED|Overall Study||11||
59884833|NCT03552549|76007609|FG000|NOT COMPLETED|Overall Study||53||
59884834|NCT03552549|76007610|FG001|NOT COMPLETED|Overall Study||52||
59884835|NCT00117845|76007616|FG000|STARTED|Overall Study||17||
59884836|NCT00117845|76007616|FG000|COMPLETED|Overall Study||16||
59754667|NCT03889418|75873588|FG008|STARTED|October-December 2019 (Month 7-9)||16|[EMR-CDS with CCM] participants started enrollment in region 3 in period 3. In Regions 4 & 5, EMR-CDS (usual care) matched controls were identified. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|1
59494097|NCT00324857|75584565|FG003|COMPLETED|Overall Study||158||
59494098|NCT00324857|75584562|FG000|NOT COMPLETED|Overall Study||6||
59494099|NCT00324857|75584563|FG001|NOT COMPLETED|Overall Study||6||
59494100|NCT00324857|75584564|FG002|NOT COMPLETED|Overall Study||7||
59494101|NCT00324857|75584565|FG003|NOT COMPLETED|Overall Study||5||
59494102|NCT00334633|75584582|FG000|STARTED|Overall Study||197||
59494103|NCT00334633|75584583|FG001|STARTED|Overall Study||200||
59494104|NCT00334633|75584584|FG002|STARTED|Overall Study||196||
59494105|NCT00334633|75584582|FG000|COMPLETED|Overall Study||117||
59494106|NCT00334633|75584583|FG001|COMPLETED|Overall Study||118||
59494107|NCT00334633|75584584|FG002|COMPLETED|Overall Study||114||
59494108|NCT00334633|75584582|FG000|NOT COMPLETED|Overall Study||80||
59494109|NCT00334633|75584583|FG001|NOT COMPLETED|Overall Study||82||
59494110|NCT00334633|75584584|FG002|NOT COMPLETED|Overall Study||82||
59494111|NCT01393964|75584598|FG000|STARTED|Overall Study||8||
59494112|NCT01393964|75584599|FG001|STARTED|Overall Study||9||
59494113|NCT01393964|75584600|FG002|STARTED|Overall Study||9||
59494114|NCT01393964|75584598|FG000|COMPLETED|Overall Study|Completed=treatment on-going|0||
59494115|NCT01393964|75584599|FG001|COMPLETED|Overall Study|Completed=treatment on-going|0||
59494116|NCT01393964|75584600|FG002|COMPLETED|Overall Study|Completed=treatment on-going|0||
59494117|NCT01393964|75584598|FG000|NOT COMPLETED|Overall Study||8||
59494118|NCT01393964|75584599|FG001|NOT COMPLETED|Overall Study||9||
59494119|NCT01393964|75584600|FG002|NOT COMPLETED|Overall Study||9||
59494120|NCT04721171|75584616|FG000|STARTED|Overall Study||2||
59494121|NCT04721171|75584617|FG001|STARTED|Overall Study||2||
59494122|NCT04721171|75584616|FG000|COMPLETED|Overall Study||2||
59494123|NCT04721171|75584617|FG001|COMPLETED|Overall Study||2||
59494124|NCT04721171|75584616|FG000|NOT COMPLETED|Overall Study||0||
59494125|NCT04721171|75584617|FG001|NOT COMPLETED|Overall Study||0||
59494126|NCT01869075|75584631|FG000|STARTED|Phase 0 (Baseline)|Phase 0 was the baseline phase. No intervention had been started.|0||
59494127|NCT01869075|75584632|FG001|STARTED|Phase 0 (Baseline)||418||
59494128|NCT01869075|75584633|FG002|STARTED|Phase 0 (Baseline)|Phase 0 was the baseline phase. No intervention had been started.|0||
59494129|NCT01869075|75584634|FG003|STARTED|Phase 0 (Baseline)||416||
59494130|NCT01869075|75584635|FG004|STARTED|Phase 0 (Baseline)|Phase 0 was the baseline phase. No intervention had been started.|0||
59494131|NCT01869075|75584636|FG005|STARTED|Phase 0 (Baseline)||341||
59494132|NCT01869075|75584631|FG000|COMPLETED|Phase 0 (Baseline)||0||
59494133|NCT01869075|75584632|FG001|COMPLETED|Phase 0 (Baseline)||418||
59494134|NCT01869075|75584633|FG002|COMPLETED|Phase 0 (Baseline)||0||
59494135|NCT01869075|75584634|FG003|COMPLETED|Phase 0 (Baseline)||416||
59494136|NCT01869075|75584635|FG004|COMPLETED|Phase 0 (Baseline)||0||
59494137|NCT01869075|75584636|FG005|COMPLETED|Phase 0 (Baseline)||341||
59494138|NCT01869075|75584631|FG000|NOT COMPLETED|Phase 0 (Baseline)||0||
59494139|NCT01869075|75584632|FG001|NOT COMPLETED|Phase 0 (Baseline)||0||
59494140|NCT01869075|75584633|FG002|NOT COMPLETED|Phase 0 (Baseline)||0||
59494141|NCT01869075|75584634|FG003|NOT COMPLETED|Phase 0 (Baseline)||0||
59494142|NCT01869075|75584635|FG004|NOT COMPLETED|Phase 0 (Baseline)||0||
59494143|NCT01869075|75584636|FG005|NOT COMPLETED|Phase 0 (Baseline)||0||
59494144|NCT01869075|75584631|FG000|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|45||
59494145|NCT01869075|75584632|FG001|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|75||
59494146|NCT01869075|75584633|FG002|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|45||
59494147|NCT01869075|75584634|FG003|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|75||
59494148|NCT01869075|75584635|FG004|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|30||
59494149|NCT01869075|75584636|FG005|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|90||
59494150|NCT01869075|75584631|FG000|COMPLETED|Phase 1||45||
59494151|NCT01869075|75584632|FG001|COMPLETED|Phase 1||75||
59494152|NCT01869075|75584633|FG002|COMPLETED|Phase 1||45||
59494153|NCT01869075|75584634|FG003|COMPLETED|Phase 1||75||
59494154|NCT01869075|75584635|FG004|COMPLETED|Phase 1||30||
59494155|NCT01869075|75584636|FG005|COMPLETED|Phase 1||90||
59494156|NCT01869075|75584631|FG000|NOT COMPLETED|Phase 1||0||
59607005|NCT01385033|75717465|FG002|COMPLETED|Part III||0||
59494157|NCT01869075|75584632|FG001|NOT COMPLETED|Phase 1||0||
59494158|NCT01869075|75584633|FG002|NOT COMPLETED|Phase 1||0||
59494159|NCT01869075|75584634|FG003|NOT COMPLETED|Phase 1||0||
59494160|NCT01869075|75584635|FG004|NOT COMPLETED|Phase 1||0||
59494161|NCT01869075|75584636|FG005|NOT COMPLETED|Phase 1||0||
59494162|NCT01869075|75584631|FG000|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|90||
59494163|NCT01869075|75584632|FG001|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|30||
59494164|NCT01869075|75584633|FG002|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|75||
59494165|NCT01869075|75584634|FG003|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|45||
59494166|NCT01869075|75584635|FG004|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|75||
59494167|NCT01869075|75584636|FG005|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|45||
59494168|NCT01869075|75584631|FG000|COMPLETED|Phase 2||90||
59494169|NCT01869075|75584632|FG001|COMPLETED|Phase 2||30||
59494170|NCT01869075|75584633|FG002|COMPLETED|Phase 2||75||
59494171|NCT01869075|75584634|FG003|COMPLETED|Phase 2||45||
59494172|NCT01869075|75584635|FG004|COMPLETED|Phase 2||75||
59494173|NCT01869075|75584636|FG005|COMPLETED|Phase 2||45||
59494174|NCT01869075|75584631|FG000|NOT COMPLETED|Phase 2||0||
59494175|NCT01869075|75584632|FG001|NOT COMPLETED|Phase 2||0||
59494176|NCT01869075|75584633|FG002|NOT COMPLETED|Phase 2||0||
59494177|NCT01869075|75584634|FG003|NOT COMPLETED|Phase 2||0||
59494178|NCT01869075|75584635|FG004|NOT COMPLETED|Phase 2||0||
59494179|NCT01869075|75584636|FG005|NOT COMPLETED|Phase 2||0||
59494180|NCT00335257|75584653|FG000|STARTED|Overall Study||15542||
59494181|NCT00335257|75584654|FG001|STARTED|Overall Study||9377||
59494182|NCT00335257|75584655|FG002|STARTED|Overall Study||60190||
59494183|NCT00335257|75584653|FG000|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 0.5 and 6.0 years.|15542||
59494184|NCT00335257|75584654|FG001|COMPLETED|Overall Study||9377||
59494185|NCT00335257|75584655|FG002|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 0.5 and 6.0 years.|60190||
59494186|NCT00335257|75584653|FG000|NOT COMPLETED|Overall Study||0||
59494187|NCT00335257|75584654|FG001|NOT COMPLETED|Overall Study||0||
59494188|NCT00335257|75584655|FG002|NOT COMPLETED|Overall Study||0||
59494189|NCT00304265|75584671|FG000|STARTED|Overall Study||117||
59494190|NCT00304265|75584672|FG001|STARTED|Overall Study||98||
59494191|NCT00304265|75584671|FG000|COMPLETED|Overall Study||117||
59494192|NCT00304265|75584672|FG001|COMPLETED|Overall Study||98||
59494193|NCT00304265|75584671|FG000|NOT COMPLETED|Overall Study||0||
59494194|NCT00304265|75584672|FG001|NOT COMPLETED|Overall Study||0||
59494195|NCT00335725|75584680|FG000|STARTED|Overall Study||75||
59494196|NCT00335725|75584681|FG001|STARTED|Overall Study||76||
59494197|NCT00335725|75584680|FG000|COMPLETED|Overall Study||71||
59494198|NCT00335725|75584681|FG001|COMPLETED|Overall Study||71||
59494199|NCT00335725|75584680|FG000|NOT COMPLETED|Overall Study||4||
59494200|NCT00335725|75584681|FG001|NOT COMPLETED|Overall Study||5||
59494201|NCT01393730|75584688|FG000|STARTED|Overall Study||40||
59494202|NCT01393730|75584688|FG000|Treated|Overall Study||38||
59494203|NCT01393730|75584688|FG000|Evaluable AR Amplification|Overall Study||21||
59494204|NCT01393730|75584688|FG000|Evaluable AR Mutation|Overall Study||14||
59494205|NCT01393730|75584688|FG000|COMPLETED|Overall Study||34||
59494206|NCT01393730|75584688|FG000|NOT COMPLETED|Overall Study||6||
59494207|NCT00336817|75584694|FG000|STARTED|Overall Study||15||
59494208|NCT00336817|75584695|FG001|STARTED|Overall Study||15||
59494209|NCT00336817|75584694|FG000|COMPLETED|Overall Study||14||
59494210|NCT00336817|75584695|FG001|COMPLETED|Overall Study||13||
59607006|NCT01385033|75717466|FG003|COMPLETED|Part III||0||
59494211|NCT00336817|75584694|FG000|NOT COMPLETED|Overall Study||1||
59494212|NCT00336817|75584695|FG001|NOT COMPLETED|Overall Study||2||
59494213|NCT00337987|75584703|FG000|STARTED|Overall Study||49||
59494214|NCT00337987|75584703|FG000|COMPLETED|Overall Study||49||
59494215|NCT00337987|75584703|FG000|NOT COMPLETED|Overall Study||0||
59494216|NCT01393106|75584707|FG000|STARTED|Overall Study||25||
59494217|NCT01393106|75584707|FG000|COMPLETED|Overall Study|Completed: Disease Progression/Death|20||
59494218|NCT01393106|75584707|FG000|NOT COMPLETED|Overall Study||5||
59494219|NCT00553059|75584713|FG000|STARTED|Overall Study||31||
59494220|NCT00553059|75584714|FG001|STARTED|Overall Study||31||
59494221|NCT00553059|75584713|FG000|COMPLETED|Overall Study||30||
59494222|NCT00553059|75584714|FG001|COMPLETED|Overall Study||29||
59494223|NCT00553059|75584713|FG000|NOT COMPLETED|Overall Study||1||
59494224|NCT00553059|75584714|FG001|NOT COMPLETED|Overall Study||2||
59494225|NCT02015611|75584722|FG000|STARTED|Overall Study||70||
59494226|NCT02015611|75584723|FG001|STARTED|Overall Study||66||
59607007|NCT01385033|75717467|FG004|COMPLETED|Part III||0||
59607008|NCT01385033|75717468|FG005|COMPLETED|Part III||0||
59607009|NCT01385033|75717463|FG000|NOT COMPLETED|Part III||0||
59494227|NCT02015611|75584722|FG000|COMPLETED|Overall Study||65||
59494228|NCT02015611|75584723|FG001|COMPLETED|Overall Study||64||
59494229|NCT02015611|75584722|FG000|NOT COMPLETED|Overall Study||5||
59494230|NCT02015611|75584723|FG001|NOT COMPLETED|Overall Study||2||
59494231|NCT01872819|75584729|FG000|STARTED|Overall Study||14||
59494232|NCT01872819|75584729|FG000|COMPLETED|Overall Study||14||
59494233|NCT01872819|75584729|FG000|NOT COMPLETED|Overall Study||0||
59494234|NCT01413542|75584736|FG000|STARTED|Overall Study||6||
59494235|NCT01413542|75584737|FG001|STARTED|Overall Study||6||
59494236|NCT01413542|75584738|FG002|STARTED|Overall Study||9||
59494237|NCT01413542|75584739|FG003|STARTED|Overall Study||8||
59494238|NCT01413542|75584736|FG000|COMPLETED|Overall Study||5||
59494239|NCT01413542|75584737|FG001|COMPLETED|Overall Study||6||
59494240|NCT01413542|75584738|FG002|COMPLETED|Overall Study||6||
59494241|NCT01413542|75584739|FG003|COMPLETED|Overall Study||7||
59494242|NCT01413542|75584736|FG000|NOT COMPLETED|Overall Study||1||
59494243|NCT01413542|75584737|FG001|NOT COMPLETED|Overall Study||0||
59494244|NCT01413542|75584738|FG002|NOT COMPLETED|Overall Study||3||
59494245|NCT01413542|75584739|FG003|NOT COMPLETED|Overall Study||1||
59494246|NCT01873287|75584753|FG000|STARTED|Overall Study||2006||
59494247|NCT01873287|75584754|FG001|STARTED|Overall Study||1057||
59494248|NCT01873287|75584753|FG000|COMPLETED|Overall Study||1701||
59494249|NCT01873287|75584754|FG001|COMPLETED|Overall Study||883||
59494250|NCT01873287|75584753|FG000|NOT COMPLETED|Overall Study||305||
59494251|NCT01873287|75584754|FG001|NOT COMPLETED|Overall Study||174||
59494252|NCT01873989|75584764|FG000|STARTED|Overall Study||8||
59494253|NCT01873989|75584765|FG001|STARTED|Overall Study||7||
59494254|NCT01873989|75584764|FG000|COMPLETED|Overall Study||7||
59494255|NCT01873989|75584765|FG001|COMPLETED|Overall Study||6||
59494256|NCT01873989|75584764|FG000|NOT COMPLETED|Overall Study||1||
59494257|NCT01873989|75584765|FG001|NOT COMPLETED|Overall Study||1||
59494258|NCT01432730|75584771|FG000|STARTED|Period 1||12||
59494259|NCT01432730|75584772|FG001|STARTED|Period 1||12||
59494260|NCT01432730|75584771|FG000|COMPLETED|Period 1||10||
59494261|NCT01432730|75584772|FG001|COMPLETED|Period 1||12||
59494262|NCT01432730|75584771|FG000|NOT COMPLETED|Period 1||2||
59494263|NCT01432730|75584772|FG001|NOT COMPLETED|Period 1||0||
59494264|NCT01432730|75584771|FG000|STARTED|Period 2||10||
59494265|NCT01432730|75584772|FG001|STARTED|Period 2||12||
59494266|NCT01432730|75584771|FG000|COMPLETED|Period 2||10||
59494267|NCT01432730|75584772|FG001|COMPLETED|Period 2||8||
59494268|NCT01432730|75584771|FG000|NOT COMPLETED|Period 2||0||
59494269|NCT01432730|75584772|FG001|NOT COMPLETED|Period 2||4||
59494270|NCT01875159|75584780|FG000|STARTED|Overall Study||45||
59494271|NCT01875159|75584781|FG001|STARTED|Overall Study||53||
59494272|NCT01875159|75584780|FG000|COMPLETED|Overall Study||42||
59494273|NCT01875159|75584781|FG001|COMPLETED|Overall Study||53||
59494274|NCT01875159|75584780|FG000|NOT COMPLETED|Overall Study||3||
59494275|NCT01875159|75584781|FG001|NOT COMPLETED|Overall Study||0||
59494276|NCT01432574|75584787|FG000|STARTED|Overall Study||150||
59494277|NCT01432574|75584787|FG000|COMPLETED|Overall Study||147||
59494278|NCT01432574|75584787|FG000|NOT COMPLETED|Overall Study||3||
59494279|NCT01875783|75584793|FG000|STARTED|Overall Study||385||
59494280|NCT01875783|75584793|FG000|COMPLETED|Overall Study||385||
59494281|NCT01875783|75584793|FG000|NOT COMPLETED|Overall Study||0||
59494282|NCT00339079|75584803|FG000|STARTED|Overall Study||53||
59494283|NCT00339079|75584804|FG001|STARTED|Overall Study||44||
59494284|NCT00339079|75584805|FG002|STARTED|Overall Study||45||
59494285|NCT00339079|75584806|FG003|STARTED|Overall Study||53||
59494286|NCT00339079|75584803|FG000|COMPLETED|Overall Study||20||
59494287|NCT00339079|75584804|FG001|COMPLETED|Overall Study||21||
59494288|NCT00339079|75584805|FG002|COMPLETED|Overall Study||27||
59494289|NCT00339079|75584806|FG003|COMPLETED|Overall Study||29||
59494290|NCT00339079|75584803|FG000|NOT COMPLETED|Overall Study||33||
59494291|NCT00339079|75584804|FG001|NOT COMPLETED|Overall Study||23||
59494292|NCT00339079|75584805|FG002|NOT COMPLETED|Overall Study||18||
59494293|NCT00339079|75584806|FG003|NOT COMPLETED|Overall Study||24||
59494294|NCT01392560|75584820|FG000|STARTED|Overall Study||52||
59494295|NCT01392560|75584820|FG000|COMPLETED|Overall Study||40||
59494296|NCT01392560|75584820|FG000|NOT COMPLETED|Overall Study||12||
59494297|NCT01875861|75584828|FG000|STARTED|Pre-implementation||4779||6
59494298|NCT01875861|75584829|FG001|STARTED|Pre-implementation||3714||6
59494299|NCT01875861|75584828|FG000|COMPLETED|Pre-implementation||4779||6
59494300|NCT01875861|75584829|FG001|COMPLETED|Pre-implementation||3714||6
59494301|NCT01875861|75584828|FG000|NOT COMPLETED|Pre-implementation||0||0
59494302|NCT01875861|75584829|FG001|NOT COMPLETED|Pre-implementation||0||0
59494303|NCT01875861|75584828|FG000|STARTED|Implementation||4546|The number of patients within each period is independent of the number in other periods.|6
59494304|NCT01875861|75584829|FG001|STARTED|Implementation||3444|The number of patients within each period is independent of the number in other periods.|6
59494305|NCT01875861|75584828|FG000|COMPLETED|Implementation||4546||6
59494306|NCT01875861|75584829|FG001|COMPLETED|Implementation||3444||6
59494307|NCT01875861|75584828|FG000|NOT COMPLETED|Implementation||0||0
59494308|NCT01875861|75584829|FG001|NOT COMPLETED|Implementation||0||0
59494309|NCT01875861|75584828|FG000|STARTED|Sustainability||4306||6
59494310|NCT01875861|75584829|FG001|STARTED|Sustainability||3444||6
59494311|NCT01875861|75584828|FG000|COMPLETED|Sustainability||4306||6
59494312|NCT01875861|75584829|FG001|COMPLETED|Sustainability||3444||6
59494313|NCT01875861|75584828|FG000|NOT COMPLETED|Sustainability||0||0
59494314|NCT01875861|75584829|FG001|NOT COMPLETED|Sustainability||0||0
59494315|NCT00329771|75584836|FG000|STARTED|Overall Study||28||
59494316|NCT00329771|75584836|FG000|COMPLETED|Overall Study|3 subjects withdrew or were lost to follow-up|25||
59494317|NCT00329771|75584836|FG000|NOT COMPLETED|Overall Study||3||
59494318|NCT00342355|75584844|FG000|STARTED|Overall Study||444||
59494319|NCT00342355|75584845|FG001|STARTED|Overall Study||440||
59494320|NCT00342355|75584846|FG002|STARTED|Overall Study||444||
59494321|NCT00342355|75584847|FG003|STARTED|Overall Study||443||
59494322|NCT00342355|75584844|FG000|COMPLETED|Overall Study||444||
59494323|NCT00342355|75584845|FG001|COMPLETED|Overall Study||440||
59494324|NCT00342355|75584846|FG002|COMPLETED|Overall Study||444||
59494325|NCT00342355|75584847|FG003|COMPLETED|Overall Study||443||
59494326|NCT00342355|75584844|FG000|NOT COMPLETED|Overall Study||0||
59494327|NCT00342355|75584845|FG001|NOT COMPLETED|Overall Study||0||
59494328|NCT00342355|75584846|FG002|NOT COMPLETED|Overall Study||0||
59494329|NCT00342355|75584847|FG003|NOT COMPLETED|Overall Study||0||
59494330|NCT00306163|75584859|FG000|STARTED|Overall Study||19||
59494331|NCT00306163|75584860|FG001|STARTED|Overall Study||18||
59494332|NCT00306163|75584859|FG000|COMPLETED|Overall Study||19||
59494333|NCT00306163|75584860|FG001|COMPLETED|Overall Study||18||
59494334|NCT00306163|75584859|FG000|NOT COMPLETED|Overall Study||0||
59494335|NCT00306163|75584860|FG001|NOT COMPLETED|Overall Study||0||
59494336|NCT01861665|75584868|FG000|STARTED|Overall Study||10||
59494337|NCT01861665|75584869|FG001|STARTED|Overall Study||17||
59494338|NCT01861665|75584868|FG000|COMPLETED|Overall Study||10||
59494339|NCT01861665|75584869|FG001|COMPLETED|Overall Study||17||
59494340|NCT01861665|75584868|FG000|NOT COMPLETED|Overall Study||0||
59494341|NCT01861665|75584869|FG001|NOT COMPLETED|Overall Study||0||
59494342|NCT00330161|75584875|FG000|STARTED|Overall Study||29||
59494343|NCT00330161|75584875|FG000|COMPLETED|Overall Study||29||
59494344|NCT00330161|75584875|FG000|NOT COMPLETED|Overall Study||0||
59494345|NCT00552279|75584881|FG000|STARTED|Overall Study||403||
59494346|NCT00552279|75584882|FG001|STARTED|Overall Study||401||
59494347|NCT00552279|75584881|FG000|COMPLETED|Overall Study||389||
59494348|NCT00552279|75584882|FG001|COMPLETED|Overall Study||398||
59494349|NCT00552279|75584881|FG000|NOT COMPLETED|Overall Study||14||
59494350|NCT00552279|75584882|FG001|NOT COMPLETED|Overall Study||3||
59494351|NCT00309751|75584890|FG000|STARTED|Overall Study||279||
59494352|NCT00309751|75584891|FG001|STARTED|Overall Study||139||
59494353|NCT00309751|75584890|FG000|Safety Population|Overall Study|Subjects who received at least 1 dose of study drug|275||
59494354|NCT00309751|75584891|FG001|Safety Population|Overall Study|Subjects who received at least 1 dose of study drug|137||
59494355|NCT00309751|75584890|FG000|COMPLETED|Overall Study||248||
59494356|NCT00309751|75584891|FG001|COMPLETED|Overall Study||124||
59494357|NCT00309751|75584890|FG000|NOT COMPLETED|Overall Study||31||
59494358|NCT00309751|75584891|FG001|NOT COMPLETED|Overall Study||15||
59494359|NCT01876329|75584900|FG000|STARTED|Overall Study||45||
59494360|NCT01876329|75584901|FG001|STARTED|Overall Study||36||
59494361|NCT01876329|75584902|FG002|STARTED|Overall Study||44||
59494362|NCT01876329|75584900|FG000|COMPLETED|Overall Study||45||
59494363|NCT01876329|75584901|FG001|COMPLETED|Overall Study||36||
59494364|NCT01876329|75584902|FG002|COMPLETED|Overall Study||44||
59494365|NCT01876329|75584900|FG000|NOT COMPLETED|Overall Study||0||
59494366|NCT01876329|75584901|FG001|NOT COMPLETED|Overall Study||0||
59494367|NCT01876329|75584902|FG002|NOT COMPLETED|Overall Study||0||
59884837|NCT00117845|76007616|FG000|NOT COMPLETED|Overall Study||1||
59884838|NCT02761642|76007620|FG000|STARTED|Overall Study||200||
59494368|NCT01876485|75584912|FG000|STARTED|Overall Study||140||
59494369|NCT01876485|75584913|FG001|STARTED|Overall Study||140||
59494370|NCT01876485|75584912|FG000|Post-Intervention|Overall Study||125|4 months after baseline|
59494371|NCT01876485|75584913|FG001|Post-Intervention|Overall Study||129|4 months after baseline|
59494372|NCT01876485|75584912|FG000|Maintenance|Overall Study||116|10 months after baseline|
59494373|NCT01876485|75584913|FG001|Maintenance|Overall Study||114|10 months after baseline|
59494374|NCT01876485|75584912|FG000|COMPLETED|Overall Study||116||
59494375|NCT01876485|75584913|FG001|COMPLETED|Overall Study||114||
59494376|NCT01876485|75584912|FG000|NOT COMPLETED|Overall Study||24||
59494377|NCT01876485|75584913|FG001|NOT COMPLETED|Overall Study||26||
59494378|NCT00313729|75584919|FG000|STARTED|Overall Study||120||
59494379|NCT00313729|75584919|FG000|COMPLETED|Overall Study||120||
59494380|NCT00313729|75584919|FG000|NOT COMPLETED|Overall Study||0||
59494381|NCT00559377|75584923|FG000|STARTED|Overall Study||16||
59494382|NCT00559377|75584923|FG000|COMPLETED|Overall Study||7||
59494383|NCT00559377|75584923|FG000|NOT COMPLETED|Overall Study||9||
59494384|NCT01412060|75584930|FG000|STARTED|Open-label Run-in Period (RIP)||765||
59494385|NCT01412060|75584931|FG001|STARTED|Open-label Run-in Period (RIP)||0||
59494386|NCT01412060|75584932|FG002|STARTED|Open-label Run-in Period (RIP)||0||
59494387|NCT01412060|75584930|FG000|COMPLETED|Open-label Run-in Period (RIP)||418||
59494388|NCT01412060|75584931|FG001|COMPLETED|Open-label Run-in Period (RIP)||0||
59494389|NCT01412060|75584932|FG002|COMPLETED|Open-label Run-in Period (RIP)||0||
59494390|NCT01412060|75584930|FG000|NOT COMPLETED|Open-label Run-in Period (RIP)||347||
59884839|NCT02761642|76007620|FG000|Treated|Overall Study||197||
59494391|NCT01412060|75584931|FG001|NOT COMPLETED|Open-label Run-in Period (RIP)||0||
59494392|NCT01412060|75584932|FG002|NOT COMPLETED|Open-label Run-in Period (RIP)||0||
59494393|NCT01412060|75584930|FG000|STARTED|Period Between RIP and SP||418||
59494394|NCT01412060|75584931|FG001|STARTED|Period Between RIP and SP||0||
59494395|NCT01412060|75584932|FG002|STARTED|Period Between RIP and SP||0||
59494396|NCT01412060|75584930|FG000|COMPLETED|Period Between RIP and SP||364||
59494397|NCT01412060|75584931|FG001|COMPLETED|Period Between RIP and SP||0||
59494398|NCT01412060|75584932|FG002|COMPLETED|Period Between RIP and SP||0||
59494399|NCT01412060|75584930|FG000|NOT COMPLETED|Period Between RIP and SP||54||
59494400|NCT01412060|75584931|FG001|NOT COMPLETED|Period Between RIP and SP||0||
59494401|NCT01412060|75584932|FG002|NOT COMPLETED|Period Between RIP and SP||0||
59494402|NCT01412060|75584930|FG000|STARTED|Open-label Stabilization Period (SP)||364||
59494403|NCT01412060|75584931|FG001|STARTED|Open-label Stabilization Period (SP)||0||
59494404|NCT01412060|75584932|FG002|STARTED|Open-label Stabilization Period (SP)||0||
59494405|NCT01412060|75584930|FG000|COMPLETED|Open-label Stabilization Period (SP)||264||
59494406|NCT01412060|75584931|FG001|COMPLETED|Open-label Stabilization Period (SP)||0||
59494407|NCT01412060|75584932|FG002|COMPLETED|Open-label Stabilization Period (SP)||0||
59494408|NCT01412060|75584930|FG000|NOT COMPLETED|Open-label Stabilization Period (SP)||100||
59494409|NCT01412060|75584931|FG001|NOT COMPLETED|Open-label Stabilization Period (SP)||0||
59494410|NCT01412060|75584932|FG002|NOT COMPLETED|Open-label Stabilization Period (SP)||0||
59494411|NCT01412060|75584930|FG000|STARTED|Period Between SP and DBP||264||
59494412|NCT01412060|75584931|FG001|STARTED|Period Between SP and DBP||0||
59494413|NCT01412060|75584932|FG002|STARTED|Period Between SP and DBP||0||
59494414|NCT01412060|75584930|FG000|COMPLETED|Period Between SP and DBP||200||
59494415|NCT01412060|75584931|FG001|COMPLETED|Period Between SP and DBP||0||
59494416|NCT01412060|75584932|FG002|COMPLETED|Period Between SP and DBP||0||
59494417|NCT01412060|75584930|FG000|NOT COMPLETED|Period Between SP and DBP||64||
59494418|NCT01412060|75584931|FG001|NOT COMPLETED|Period Between SP and DBP||0||
59494419|NCT01412060|75584932|FG002|NOT COMPLETED|Period Between SP and DBP||0||
59494420|NCT01412060|75584930|FG000|STARTED|Double-blind Treatment Phase (DBP)||0||
59494421|NCT01412060|75584931|FG001|STARTED|Double-blind Treatment Phase (DBP)||99||
59494422|NCT01412060|75584932|FG002|STARTED|Double-blind Treatment Phase (DBP)||101||
59494423|NCT01412060|75584930|FG000|COMPLETED|Double-blind Treatment Phase (DBP)||0||
59494424|NCT01412060|75584931|FG001|COMPLETED|Double-blind Treatment Phase (DBP)||16||
59494425|NCT01412060|75584932|FG002|COMPLETED|Double-blind Treatment Phase (DBP)||18||
59494426|NCT01412060|75584930|FG000|NOT COMPLETED|Double-blind Treatment Phase (DBP)||0||
59494427|NCT01412060|75584931|FG001|NOT COMPLETED|Double-blind Treatment Phase (DBP)||83||
59494428|NCT01412060|75584932|FG002|NOT COMPLETED|Double-blind Treatment Phase (DBP)||83||
59884840|NCT02761642|76007620|FG000|COMPLETED|Overall Study||130||
59494429|NCT00345865|75584947|FG000|STARTED|Overall Study||171||
59494430|NCT00345865|75584948|FG001|STARTED|Overall Study||149||
59494431|NCT00345865|75584949|FG002|STARTED|Overall Study||2||
59494432|NCT00345865|75584950|FG003|STARTED|Overall Study||5||
59494433|NCT00345865|75584951|FG004|STARTED|Overall Study||146||
59494434|NCT00345865|75584947|FG000|COMPLETED|Overall Study||171||
59494435|NCT00345865|75584948|FG001|COMPLETED|Overall Study||149||
59494436|NCT00345865|75584949|FG002|COMPLETED|Overall Study||2||
59884841|NCT02761642|76007620|FG000|NOT COMPLETED|Overall Study||70||
59494437|NCT00345865|75584950|FG003|COMPLETED|Overall Study||5||
59494438|NCT00345865|75584951|FG004|COMPLETED|Overall Study||146||
59494439|NCT00345865|75584947|FG000|NOT COMPLETED|Overall Study||0||
59494440|NCT00345865|75584948|FG001|NOT COMPLETED|Overall Study||0||
59494441|NCT00345865|75584949|FG002|NOT COMPLETED|Overall Study||0||
59494442|NCT00345865|75584950|FG003|NOT COMPLETED|Overall Study||0||
59494443|NCT00345865|75584951|FG004|NOT COMPLETED|Overall Study||0||
59494444|NCT00551421|75584963|FG000|STARTED|Original Protocol, Dose Level 1||3||
59494445|NCT00551421|75584963|FG000|COMPLETED|Original Protocol, Dose Level 1|1 subject developed Grade 3 diarrhea, all 3 subjects experienced significant skin toxicity.|3||
59494446|NCT00551421|75584963|FG000|NOT COMPLETED|Original Protocol, Dose Level 1||0||
59494447|NCT00551421|75584963|FG000|STARTED|Amended Protocol (Cetuximab-refr. mCRC)||14||
59494448|NCT00551421|75584963|FG000|COMPLETED|Amended Protocol (Cetuximab-refr. mCRC)||13||
59494449|NCT00551421|75584963|FG000|NOT COMPLETED|Amended Protocol (Cetuximab-refr. mCRC)||1||
59494450|NCT00348205|75584968|FG000|STARTED|Overall Study||80||
59494451|NCT00348205|75584968|FG000|COMPLETED|Overall Study||78||
59494452|NCT00348205|75584968|FG000|NOT COMPLETED|Overall Study||2||
59494453|NCT00317239|75584974|FG000|STARTED|Overall Study||147||
59494454|NCT00317239|75584975|FG001|STARTED|Overall Study||103||
59494455|NCT00317239|75584974|FG000|COMPLETED|Overall Study||134||
59494456|NCT00317239|75584975|FG001|COMPLETED|Overall Study||84||
59494457|NCT00317239|75584974|FG000|NOT COMPLETED|Overall Study||13||
59494458|NCT00317239|75584975|FG001|NOT COMPLETED|Overall Study||19||
59494459|NCT01891643|75584983|FG000|STARTED|Overall Study||13||
59494460|NCT01891643|75584984|FG001|STARTED|Overall Study||10||
59494461|NCT01891643|75584983|FG000|COMPLETED|Overall Study||3|Completed = continuing treatment in the main CA204-006 study (NCT01335399)|
59494462|NCT01891643|75584984|FG001|COMPLETED|Overall Study||0|Completed = continuing treatment in the main CA204-006 study (NCT01335399)|
59494463|NCT01891643|75584983|FG000|NOT COMPLETED|Overall Study||10||
59494464|NCT01891643|75584984|FG001|NOT COMPLETED|Overall Study||10||
59494465|NCT00330863|75584992|FG000|STARTED|Overall Study||153||
59494466|NCT00330863|75584993|FG001|STARTED|Overall Study||152||
59494467|NCT00330863|75584992|FG000|COMPLETED|Overall Study||72||
59494468|NCT00330863|75584993|FG001|COMPLETED|Overall Study||72||
59494469|NCT00330863|75584992|FG000|NOT COMPLETED|Overall Study||81||
59494470|NCT00330863|75584993|FG001|NOT COMPLETED|Overall Study||80||
59494471|NCT02106065|75585002|FG000|STARTED|Overall Study||6||
59494472|NCT02106065|75585003|FG001|STARTED|Overall Study||11||
59494473|NCT02106065|75585004|FG002|STARTED|Overall Study||15||
59494474|NCT02106065|75585002|FG000|6 Month Completion|Overall Study||3||
59494475|NCT02106065|75585003|FG001|6 Month Completion|Overall Study||8||
59494476|NCT02106065|75585004|FG002|6 Month Completion|Overall Study||5||
59494477|NCT02106065|75585002|FG000|COMPLETED|Overall Study||3||
59494478|NCT02106065|75585003|FG001|COMPLETED|Overall Study||8||
59494479|NCT02106065|75585004|FG002|COMPLETED|Overall Study||5||
59494480|NCT02106065|75585002|FG000|NOT COMPLETED|Overall Study||3||
59494481|NCT02106065|75585003|FG001|NOT COMPLETED|Overall Study||3||
59494482|NCT02106065|75585004|FG002|NOT COMPLETED|Overall Study||10||
59494483|NCT00317941|75585014|FG000|STARTED|Overall Study||73||
59494484|NCT00317941|75585015|FG001|STARTED|Overall Study||79||
59494485|NCT00317941|75585016|FG002|STARTED|Overall Study||68||
59494486|NCT00317941|75585014|FG000|Participants Received Treatment|Overall Study||73||
59494487|NCT00317941|75585015|FG001|Participants Received Treatment|Overall Study||79||
59494488|NCT00317941|75585016|FG002|Participants Received Treatment|Overall Study||68||
59494489|NCT00317941|75585014|FG000|Fulfilled Requirement Safety Population|Overall Study||73||
59494490|NCT00317941|75585015|FG001|Fulfilled Requirement Safety Population|Overall Study||77||
59494491|NCT00317941|75585016|FG002|Fulfilled Requirement Safety Population|Overall Study||65||
59494492|NCT00317941|75585014|FG000|Fulfilled Requirements PP Population|Overall Study||66||
59494493|NCT00317941|75585015|FG001|Fulfilled Requirements PP Population|Overall Study||76||
59494494|NCT00317941|75585016|FG002|Fulfilled Requirements PP Population|Overall Study||63||
59494495|NCT00317941|75585014|FG000|COMPLETED|Overall Study||66||
59494496|NCT00317941|75585015|FG001|COMPLETED|Overall Study||74||
59494497|NCT00317941|75585016|FG002|COMPLETED|Overall Study||60||
59494498|NCT00317941|75585014|FG000|NOT COMPLETED|Overall Study||7||
59494499|NCT00317941|75585015|FG001|NOT COMPLETED|Overall Study||5||
59494500|NCT00317941|75585016|FG002|NOT COMPLETED|Overall Study||8||
59494501|NCT02277639|75585027|FG000|STARTED|Overall Study||0||
59494502|NCT02277639|75585028|FG001|STARTED|Overall Study||2||
59494503|NCT02277639|75585027|FG000|COMPLETED|Overall Study||0||
59494504|NCT02277639|75585028|FG001|COMPLETED|Overall Study||2||
59494505|NCT02277639|75585027|FG000|NOT COMPLETED|Overall Study||0||
59494506|NCT02277639|75585028|FG001|NOT COMPLETED|Overall Study||0||
59494507|NCT00332579|75585036|FG000|STARTED|Overall Study||12||
59494508|NCT00332579|75585037|FG001|STARTED|Overall Study||13||
59494509|NCT00332579|75585036|FG000|COMPLETED|Overall Study||11||
59762546|NCT00884312|75882326|FG000|Received Treatment|Overall Study||9||
59762547|NCT00884312|75882327|FG001|Received Treatment|Overall Study||91||
59494510|NCT00332579|75585037|FG001|COMPLETED|Overall Study||12||
59494511|NCT00332579|75585036|FG000|NOT COMPLETED|Overall Study||1||
59762673|NCT01886963|75882517|FG000|COMPLETED|Overall Study||46||
59494512|NCT00332579|75585037|FG001|NOT COMPLETED|Overall Study||1||
59494513|NCT00318409|75585045|FG000|STARTED|Overall Study||20||
59494514|NCT00318409|75585046|FG001|STARTED|Overall Study||10||
59494515|NCT00318409|75585045|FG000|COMPLETED|Overall Study||18||
59494516|NCT00318409|75585046|FG001|COMPLETED|Overall Study||9||
59494517|NCT00318409|75585045|FG000|NOT COMPLETED|Overall Study||2||
59494518|NCT00318409|75585046|FG001|NOT COMPLETED|Overall Study||1||
59494519|NCT00333437|75585053|FG000|STARTED|Overall Study||7||
59494520|NCT00333437|75585053|FG000|COMPLETED|Overall Study||7||
59494521|NCT00333437|75585053|FG000|NOT COMPLETED|Overall Study||0||
59494522|NCT00334061|75585058|FG000|STARTED|Overall Study|June 2006|125||
59494523|NCT00334061|75585058|FG000|COMPLETED|Overall Study|November 2007|125||
59494524|NCT00334061|75585058|FG000|NOT COMPLETED|Overall Study||0||
59494525|NCT00353119|75585064|FG000|STARTED|First Intervention Day 0 to Week 12||5||
59494526|NCT00353119|75585065|FG001|STARTED|First Intervention Day 0 to Week 12||10||
59494527|NCT00353119|75585064|FG000|COMPLETED|First Intervention Day 0 to Week 12||5||
59884842|NCT00113555|76007624|FG000|STARTED|Overall Study||221||
59884843|NCT00113555|76007624|FG000|TREATED|Overall Study|1 Additional Patient was treated on a compassionate use basis.|162||
59884844|NCT00113555|76007624|FG000|COMPLETED|Overall Study|All treated patients were considered in the Intent to Treat analysis.|142||
59884845|NCT00113555|76007624|FG000|NOT COMPLETED|Overall Study||79||
59884846|NCT03189524|76007632|FG000|STARTED|Overall Study||11||
59884847|NCT03189524|76007633|FG001|STARTED|Overall Study||10||
59884848|NCT03189524|76007634|FG002|STARTED|Overall Study||23||
59884849|NCT03189524|76007632|FG000|Received at Least 1 Dose of Study Drug|Overall Study||11||
59884850|NCT03189524|76007633|FG001|Received at Least 1 Dose of Study Drug|Overall Study||10||
59754668|NCT03889418|75873589|FG009|STARTED|October-December 2019 (Month 7-9)|Patient recruited out of sequence but retained in study.|1|[EMR-CDS with CCM] participants started enrollment in region 3 in period 3. In Regions 4 & 5, EMR-CDS (usual care) matched controls were identified. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|0
59884851|NCT03189524|76007634|FG002|Received at Least 1 Dose of Study Drug|Overall Study||23||
59884852|NCT03189524|76007632|FG000|COMPLETED|Overall Study||0||
59884853|NCT03189524|76007633|FG001|COMPLETED|Overall Study||0||
59884854|NCT03189524|76007634|FG002|COMPLETED|Overall Study||0||
59884855|NCT03189524|76007632|FG000|NOT COMPLETED|Overall Study||11||
59884856|NCT03189524|76007633|FG001|NOT COMPLETED|Overall Study||10||
59884857|NCT03189524|76007634|FG002|NOT COMPLETED|Overall Study||23||
59884858|NCT03600909|76007649|FG000|STARTED|Overall Study||0||
59884859|NCT03600909|76007650|FG001|STARTED|Overall Study||3||
59884860|NCT03600909|76007651|FG002|STARTED|Overall Study||0||
59884861|NCT03600909|76007649|FG000|COMPLETED|Overall Study||0||
59884862|NCT03600909|76007650|FG001|COMPLETED|Overall Study||0||
59884863|NCT03600909|76007651|FG002|COMPLETED|Overall Study||0||
59884864|NCT03600909|76007649|FG000|NOT COMPLETED|Overall Study||0||
59884865|NCT03600909|76007650|FG001|NOT COMPLETED|Overall Study||3||
59884866|NCT03600909|76007651|FG002|NOT COMPLETED|Overall Study||0||
59884867|NCT03189446|76007659|FG000|STARTED|Overall Study||32||
59884868|NCT03189446|76007659|FG000|COMPLETED|Overall Study||27||
59884869|NCT03189446|76007659|FG000|NOT COMPLETED|Overall Study||5||
59884870|NCT03212690|76007663|FG000|STARTED|Overall Study||57||
59754669|NCT03889418|75873580|FG000|COMPLETED|October-December 2019 (Month 7-9)||60||1
59754670|NCT03889418|75873581|FG001|COMPLETED|October-December 2019 (Month 7-9)||36||1
59754671|NCT03889418|75873582|FG002|COMPLETED|October-December 2019 (Month 7-9)||28||1
59754672|NCT03889418|75873583|FG003|COMPLETED|October-December 2019 (Month 7-9)||11||1
59754673|NCT03889418|75873584|FG004|COMPLETED|October-December 2019 (Month 7-9)||16||1
59754674|NCT03889418|75873585|FG005|COMPLETED|October-December 2019 (Month 7-9)||1||1
59754675|NCT03889418|75873586|FG006|COMPLETED|October-December 2019 (Month 7-9)||12||1
59884871|NCT03212690|76007663|FG000|COMPLETED|Overall Study||56||
59884872|NCT03212690|76007663|FG000|NOT COMPLETED|Overall Study||1||
59884873|NCT03188120|76007667|FG000|STARTED|Overall Study||193|Case Report Form collected (treated)|
59884874|NCT03188120|76007667|FG000|COMPLETED|Overall Study||146||
59884875|NCT03188120|76007667|FG000|NOT COMPLETED|Overall Study||47||
59884876|NCT02895945|76007673|FG000|STARTED|Overall Study||7||
59494528|NCT00353119|75585065|FG001|COMPLETED|First Intervention Day 0 to Week 12||10||
59494529|NCT00353119|75585064|FG000|NOT COMPLETED|First Intervention Day 0 to Week 12||0||
59494530|NCT00353119|75585065|FG001|NOT COMPLETED|First Intervention Day 0 to Week 12||0||
59494531|NCT00353119|75585064|FG000|STARTED|Second Intervention Week 12 to Week 28||5||
59494532|NCT00353119|75585065|FG001|STARTED|Second Intervention Week 12 to Week 28||10||
59884877|NCT02895945|76007674|FG001|STARTED|Overall Study||1||
59607010|NCT01385033|75717464|FG001|NOT COMPLETED|Part III||0||
59607011|NCT01385033|75717465|FG002|NOT COMPLETED|Part III||0||
59607012|NCT01385033|75717466|FG003|NOT COMPLETED|Part III||0||
59607013|NCT01385033|75717467|FG004|NOT COMPLETED|Part III||0||
59607014|NCT01385033|75717468|FG005|NOT COMPLETED|Part III||0||
59607015|NCT02826551|75717477|FG000|STARTED|Overall Study||11||
59607016|NCT02826551|75717478|FG001|STARTED|Overall Study||12||
59607017|NCT02826551|75717477|FG000|COMPLETED|Overall Study||11||
59607018|NCT02826551|75717478|FG001|COMPLETED|Overall Study||12||
59607019|NCT02826551|75717477|FG000|NOT COMPLETED|Overall Study||0||
59607020|NCT02826551|75717478|FG001|NOT COMPLETED|Overall Study||0||
59607021|NCT01337609|75717487|FG000|STARTED|Overall Study||1||
59607022|NCT01337609|75717488|FG001|STARTED|Overall Study||2||
59607023|NCT01337609|75717489|FG002|STARTED|Overall Study||2||
59607024|NCT01337609|75717487|FG000|COMPLETED|Overall Study||0||
59607025|NCT01337609|75717488|FG001|COMPLETED|Overall Study||2||
59607026|NCT01337609|75717489|FG002|COMPLETED|Overall Study||2||
59607027|NCT01337609|75717487|FG000|NOT COMPLETED|Overall Study||1||
59607028|NCT01337609|75717488|FG001|NOT COMPLETED|Overall Study||0||
59607029|NCT01337609|75717489|FG002|NOT COMPLETED|Overall Study||0||
59607030|NCT01340573|75717497|FG000|STARTED|Overall Study||3||
59607031|NCT01340573|75717497|FG000|COMPLETED|Overall Study||0||
59607032|NCT01340573|75717497|FG000|NOT COMPLETED|Overall Study||3||
59607033|NCT01340885|75717505|FG000|STARTED|Overall Study||0||
59607034|NCT01340885|75717506|FG001|STARTED|Overall Study||0||
59607035|NCT01340885|75717507|FG002|STARTED|Overall Study||0||
59607036|NCT01340885|75717505|FG000|COMPLETED|Overall Study||0||
59607037|NCT01340885|75717506|FG001|COMPLETED|Overall Study||0||
59607038|NCT01340885|75717507|FG002|COMPLETED|Overall Study||0||
59607039|NCT01340885|75717505|FG000|NOT COMPLETED|Overall Study||0||
59607040|NCT01340885|75717506|FG001|NOT COMPLETED|Overall Study||0||
59607041|NCT01340885|75717507|FG002|NOT COMPLETED|Overall Study||0||
59607042|NCT01326923|75717515|FG000|STARTED|Overall Study||7||
59607043|NCT01326923|75717515|FG000|COMPLETED|Overall Study||7||
59607044|NCT01326923|75717515|FG000|NOT COMPLETED|Overall Study||0||
59607045|NCT03855059|75717521|FG000|STARTED|Overall Study||25||
59607046|NCT03855059|75717522|FG001|STARTED|Overall Study||25||
59607047|NCT03855059|75717521|FG000|COMPLETED|Overall Study||23||
59607048|NCT03855059|75717522|FG001|COMPLETED|Overall Study||25||
59607049|NCT03855059|75717521|FG000|NOT COMPLETED|Overall Study||2||
59607050|NCT03855059|75717522|FG001|NOT COMPLETED|Overall Study||0||
59607051|NCT03863795|75717532|FG000|STARTED|Overall Study||306||
59607052|NCT03863795|75717533|FG001|STARTED|Overall Study||269||
59607053|NCT03863795|75717534|FG002|STARTED|Overall Study||244||
59607054|NCT03863795|75717535|FG003|STARTED|Overall Study||281||
59607055|NCT03863795|75717532|FG000|COMPLETED|Overall Study||306||
59607056|NCT03863795|75717533|FG001|COMPLETED|Overall Study||269||
59607057|NCT03863795|75717534|FG002|COMPLETED|Overall Study||244||
59607058|NCT03863795|75717535|FG003|COMPLETED|Overall Study||281||
59607059|NCT03863795|75717532|FG000|NOT COMPLETED|Overall Study||0||
59607060|NCT03863795|75717533|FG001|NOT COMPLETED|Overall Study||0||
59607061|NCT03863795|75717534|FG002|NOT COMPLETED|Overall Study||0||
59607062|NCT03863795|75717535|FG003|NOT COMPLETED|Overall Study||0||
59607063|NCT03858335|75717547|FG000|STARTED|Overall Study||16||
59607064|NCT03858335|75717548|FG001|STARTED|Overall Study||16||
59607065|NCT03858335|75717547|FG000|COMPLETED|Overall Study||12||
59607066|NCT03858335|75717548|FG001|COMPLETED|Overall Study||12||
59607067|NCT03858335|75717547|FG000|NOT COMPLETED|Overall Study||4||
59607068|NCT03858335|75717548|FG001|NOT COMPLETED|Overall Study||4||
59607069|NCT03857243|75717556|FG000|STARTED|Overall Study||1||
59607070|NCT03857243|75717557|FG001|STARTED|Overall Study||1||
59607071|NCT03857243|75717556|FG000|COMPLETED|Overall Study||1||
59607072|NCT03857243|75717557|FG001|COMPLETED|Overall Study||1||
59607073|NCT03857243|75717556|FG000|NOT COMPLETED|Overall Study||0||
59607074|NCT03857243|75717557|FG001|NOT COMPLETED|Overall Study||0||
59607075|NCT01301963|75717565|FG000|STARTED|Overall Study||5||
59607076|NCT01301963|75717566|FG001|STARTED|Overall Study||4||
59607077|NCT01301963|75717565|FG000|COMPLETED|Overall Study||5||
59607078|NCT01301963|75717566|FG001|COMPLETED|Overall Study||4||
59607079|NCT01301963|75717565|FG000|NOT COMPLETED|Overall Study||0||
59607080|NCT01301963|75717566|FG001|NOT COMPLETED|Overall Study||0||
59607081|NCT01298921|75717574|FG000|STARTED|Overall Study||0||
59607082|NCT01298921|75717575|FG001|STARTED|Overall Study||0||
59494533|NCT00353119|75585064|FG000|COMPLETED|Second Intervention Week 12 to Week 28||5||
59494534|NCT00353119|75585065|FG001|COMPLETED|Second Intervention Week 12 to Week 28||10||
59494535|NCT00353119|75585064|FG000|NOT COMPLETED|Second Intervention Week 12 to Week 28||0||
59494536|NCT00353119|75585065|FG001|NOT COMPLETED|Second Intervention Week 12 to Week 28||0||
59494537|NCT00353431|75585076|FG000|STARTED|Overall Study||63||
59494538|NCT00353431|75585077|FG001|STARTED|Overall Study||67||
59494539|NCT00353431|75585076|FG000|COMPLETED|Overall Study||63||
59494540|NCT00353431|75585077|FG001|COMPLETED|Overall Study||67||
59494541|NCT00353431|75585076|FG000|NOT COMPLETED|Overall Study||0||
59494542|NCT00353431|75585077|FG001|NOT COMPLETED|Overall Study||0||
59494543|NCT00353977|75585083|FG000|STARTED|Overall Study||38||
59494544|NCT00353977|75585083|FG000|COMPLETED|Overall Study||38||
59494545|NCT00353977|75585083|FG000|NOT COMPLETED|Overall Study||0||
59494546|NCT00320281|75585089|FG000|STARTED|Overall Study||10||
59494547|NCT00320281|75585090|FG001|STARTED|Overall Study||9||
59494548|NCT00320281|75585089|FG000|COMPLETED|Overall Study||10||
59494549|NCT00320281|75585090|FG001|COMPLETED|Overall Study||9||
59494550|NCT00320281|75585089|FG000|NOT COMPLETED|Overall Study||0||
59494551|NCT00320281|75585090|FG001|NOT COMPLETED|Overall Study||0||
59494552|NCT02108821|75585098|FG000|STARTED|Overall Study||23|March 12, 2014|
59494553|NCT02108821|75585098|FG000|COMPLETED|Overall Study||23|September 30th, 2016|
59494554|NCT02108821|75585098|FG000|NOT COMPLETED|Overall Study||0||
59494555|NCT02108977|75585106|FG000|STARTED|Overall Study||18||
59494556|NCT02108977|75585107|FG001|STARTED|Overall Study||20||
59494557|NCT02108977|75585106|FG000|COMPLETED|Overall Study||8||
59494558|NCT02108977|75585107|FG001|COMPLETED|Overall Study||19||
59494559|NCT02108977|75585106|FG000|NOT COMPLETED|Overall Study||10||
59494560|NCT02108977|75585107|FG001|NOT COMPLETED|Overall Study||1||
59494561|NCT01392326|75585118|FG000|STARTED|Overall Study||202||
59494562|NCT01392326|75585119|FG001|STARTED|Overall Study||202||
59494563|NCT01392326|75585120|FG002|STARTED|Overall Study||202||
59494564|NCT01392326|75585118|FG000|COMPLETED|Overall Study||155||
59494565|NCT01392326|75585119|FG001|COMPLETED|Overall Study||167||
59494566|NCT01392326|75585120|FG002|COMPLETED|Overall Study||154||
59494567|NCT01392326|75585118|FG000|NOT COMPLETED|Overall Study||47||
59494568|NCT01392326|75585119|FG001|NOT COMPLETED|Overall Study||35||
59494569|NCT01392326|75585120|FG002|NOT COMPLETED|Overall Study||48||
59494570|NCT00320671|75585130|FG000|STARTED|Overall Study||102||
59494571|NCT00320671|75585131|FG001|STARTED|Overall Study||96||
59494572|NCT00320671|75585130|FG000|COMPLETED|Overall Study||69||
59494573|NCT00320671|75585131|FG001|COMPLETED|Overall Study||58||
59494574|NCT00320671|75585130|FG000|NOT COMPLETED|Overall Study||33||
59494575|NCT00320671|75585131|FG001|NOT COMPLETED|Overall Study||38||
59494576|NCT00320749|75585137|FG000|STARTED|Overall Study||3||
59607083|NCT01298921|75717574|FG000|COMPLETED|Overall Study||0||
59607084|NCT01298921|75717575|FG001|COMPLETED|Overall Study||0||
59607085|NCT01298921|75717574|FG000|NOT COMPLETED|Overall Study||0||
59607086|NCT01298921|75717575|FG001|NOT COMPLETED|Overall Study||0||
59607087|NCT03870737|75717583|FG000|STARTED|Overall Study||22||
59607088|NCT03870737|75717583|FG000|COMPLETED|Overall Study||20||
59607089|NCT03870737|75717583|FG000|NOT COMPLETED|Overall Study||2||
59607090|NCT01269749|75717589|FG000|STARTED|Overall Study||16||
59607091|NCT01269749|75717590|FG001|STARTED|Overall Study||3||
59607092|NCT01269749|75717589|FG000|COMPLETED|Overall Study||16||
59494577|NCT00320749|75585138|FG001|STARTED|Overall Study||8||
59494578|NCT00320749|75585139|FG002|STARTED|Overall Study||10||
59494579|NCT00320749|75585137|FG000|COMPLETED|Overall Study||3||
59494580|NCT00320749|75585138|FG001|COMPLETED|Overall Study||6||
59494581|NCT00320749|75585139|FG002|COMPLETED|Overall Study||1||
59494582|NCT00320749|75585137|FG000|NOT COMPLETED|Overall Study||0||
59494583|NCT00320749|75585138|FG001|NOT COMPLETED|Overall Study||2||
59494584|NCT00320749|75585139|FG002|NOT COMPLETED|Overall Study||9||
59494585|NCT00322231|75585146|FG000|STARTED|Period 1||51||
59494586|NCT00322231|75585147|FG001|STARTED|Period 1||50||
59494587|NCT00322231|75585146|FG000|COMPLETED|Period 1||51||
59494588|NCT00322231|75585147|FG001|COMPLETED|Period 1||50||
59494589|NCT00322231|75585146|FG000|NOT COMPLETED|Period 1||0||
59494590|NCT00322231|75585147|FG001|NOT COMPLETED|Period 1||0||
59494591|NCT00322231|75585146|FG000|STARTED|Period 2||51||
59494592|NCT00322231|75585147|FG001|STARTED|Period 2|One participant was lost between Period 1 and Period 2|49||
59494593|NCT00322231|75585146|FG000|COMPLETED|Period 2||51||
59494594|NCT00322231|75585147|FG001|COMPLETED|Period 2||49||
59494595|NCT00322231|75585146|FG000|NOT COMPLETED|Period 2||0||
59494596|NCT00322231|75585147|FG001|NOT COMPLETED|Period 2||0||
59494597|NCT00354913|75585157|FG000|STARTED|Overall Study||21||
59494598|NCT00354913|75585157|FG000|COMPLETED|Overall Study||21||
59494599|NCT00354913|75585157|FG000|NOT COMPLETED|Overall Study||0||
59494600|NCT01432262|75585163|FG000|STARTED|Overall Study||162||
59494601|NCT01432262|75585164|FG001|STARTED|Overall Study||162||
59494602|NCT01432262|75585163|FG000|Vaccinated|Overall Study||162||
59494603|NCT01432262|75585164|FG001|Vaccinated|Overall Study||161||
59494604|NCT01432262|75585163|FG000|COMPLETED|Overall Study||160||
59607093|NCT01269749|75717590|FG001|COMPLETED|Overall Study||3||
59607094|NCT01269749|75717589|FG000|NOT COMPLETED|Overall Study||0||
59607095|NCT01269749|75717590|FG001|NOT COMPLETED|Overall Study||0||
59607096|NCT02757053|75717598|FG000|STARTED|Overall Study||3||
59607097|NCT02757053|75717599|FG001|STARTED|Overall Study||5||
59607098|NCT02757053|75717598|FG000|COMPLETED|Overall Study||0||
59607099|NCT02757053|75717599|FG001|COMPLETED|Overall Study||0||
59754676|NCT03889418|75873587|FG007|COMPLETED|October-December 2019 (Month 7-9)||0||0
59754677|NCT03889418|75873588|FG008|COMPLETED|October-December 2019 (Month 7-9)||15||1
59754678|NCT03889418|75873589|FG009|COMPLETED|October-December 2019 (Month 7-9)||1||0
59754679|NCT03889418|75873580|FG000|NOT COMPLETED|October-December 2019 (Month 7-9)||0||0
59754680|NCT03889418|75873581|FG001|NOT COMPLETED|October-December 2019 (Month 7-9)||0||0
59754681|NCT03889418|75873582|FG002|NOT COMPLETED|October-December 2019 (Month 7-9)||0||0
59754682|NCT03889418|75873583|FG003|NOT COMPLETED|October-December 2019 (Month 7-9)||0||0
60012047|NCT02526693|76127933|FG000|NOT COMPLETED|Overall Study||3||
60012048|NCT02526693|76127934|FG001|NOT COMPLETED|Overall Study||1||
60012049|NCT03691909|76127944|FG000|STARTED|Overall Study||15||
60012050|NCT03691909|76127944|FG000|Per Protocol Population Day 1|Overall Study||15||
59607100|NCT02757053|75717598|FG000|NOT COMPLETED|Overall Study||3||
59607101|NCT02757053|75717599|FG001|NOT COMPLETED|Overall Study||5||
60012051|NCT03691909|76127944|FG000|Per Protocol Population Week 1|Overall Study||15||
60012052|NCT03691909|76127944|FG000|Per Protocol Population Week 4|Overall Study||14||
60012053|NCT03691909|76127944|FG000|Per Protocol Population Week 8|Overall Study||13||
60012054|NCT03691909|76127944|FG000|Per Protocol Population Week 12|Overall Study||15||
60012055|NCT03691909|76127944|FG000|Per Protocol Population Week 26|Overall Study||14||
60012056|NCT03691909|76127944|FG000|Per Protocol Population Week 52|Overall Study||13||
60012057|NCT03691909|76127944|FG000|COMPLETED|Overall Study||15||
60012058|NCT03691909|76127944|FG000|NOT COMPLETED|Overall Study||0||
60012059|NCT02710669|76127952|FG000|STARTED|Overall Study||85||
60012060|NCT02710669|76127953|FG001|STARTED|Overall Study||86||
60012061|NCT02710669|76127954|FG002|STARTED|Overall Study||21||
60012062|NCT02710669|76127952|FG000|COMPLETED|Overall Study||71||
60012063|NCT02710669|76127953|FG001|COMPLETED|Overall Study||75||
60012064|NCT02710669|76127954|FG002|COMPLETED|Overall Study||19||
60012065|NCT02710669|76127952|FG000|NOT COMPLETED|Overall Study||14||
60012066|NCT02710669|76127953|FG001|NOT COMPLETED|Overall Study||11||
60012067|NCT02710669|76127954|FG002|NOT COMPLETED|Overall Study||2||
60012068|NCT02610725|76127962|FG000|STARTED|Overall Study||281||
60012069|NCT02610725|76127962|FG000|COMPLETED|Overall Study||75||
60012070|NCT02610725|76127962|FG000|NOT COMPLETED|Overall Study||206||
60012071|NCT02684461|76127969|FG000|STARTED|Overall Study||7||
60012072|NCT02684461|76127970|FG001|STARTED|Overall Study||7||
60012073|NCT02684461|76127971|FG002|STARTED|Overall Study||6||
60012074|NCT02684461|76127969|FG000|COMPLETED|Overall Study||5||
59494605|NCT01432262|75585164|FG001|COMPLETED|Overall Study||161||
59754683|NCT03889418|75873584|FG004|NOT COMPLETED|October-December 2019 (Month 7-9)||0||0
59754684|NCT03889418|75873585|FG005|NOT COMPLETED|October-December 2019 (Month 7-9)||0||0
59754685|NCT03889418|75873586|FG006|NOT COMPLETED|October-December 2019 (Month 7-9)||0||0
59754686|NCT03889418|75873587|FG007|NOT COMPLETED|October-December 2019 (Month 7-9)||0||0
59754687|NCT03889418|75873588|FG008|NOT COMPLETED|October-December 2019 (Month 7-9)||1||0
59754688|NCT03889418|75873589|FG009|NOT COMPLETED|October-December 2019 (Month 7-9)||0||0
59494606|NCT01432262|75585163|FG000|NOT COMPLETED|Overall Study||2||
59494607|NCT01432262|75585164|FG001|NOT COMPLETED|Overall Study||1||
59494608|NCT00322309|75585172|FG000|STARTED|Overall Study||11||
59494609|NCT00322309|75585173|FG001|STARTED|Overall Study||13||
59494610|NCT00322309|75585172|FG000|COMPLETED|Overall Study||9||
59494611|NCT00322309|75585173|FG001|COMPLETED|Overall Study||9||
59494612|NCT00322309|75585172|FG000|NOT COMPLETED|Overall Study||2||
59494613|NCT00322309|75585173|FG001|NOT COMPLETED|Overall Study||4||
59494614|NCT01410890|75585184|FG000|STARTED|Overall Study||10||
59494615|NCT01410890|75585185|FG001|STARTED|Overall Study||11||
59494616|NCT01410890|75585184|FG000|Treated|Overall Study||10||
59494617|NCT01410890|75585185|FG001|Treated|Overall Study||10||
59494618|NCT01410890|75585184|FG000|COMPLETED|Overall Study||10||
59494619|NCT01410890|75585185|FG001|COMPLETED|Overall Study||10||
59494620|NCT01410890|75585184|FG000|NOT COMPLETED|Overall Study||0||
59494621|NCT01410890|75585185|FG001|NOT COMPLETED|Overall Study||1||
59494622|NCT01431950|75585195|FG000|STARTED|Overall Study||119||
59494623|NCT01431950|75585196|FG001|STARTED|Overall Study||119||
59494624|NCT01431950|75585195|FG000|COMPLETED|Overall Study||100||
59494625|NCT01431950|75585196|FG001|COMPLETED|Overall Study||104||
59494626|NCT01431950|75585195|FG000|NOT COMPLETED|Overall Study||19||
59494627|NCT01431950|75585196|FG001|NOT COMPLETED|Overall Study||15||
59494628|NCT00551031|75585207|FG000|STARTED|Overall Study||637||
59494629|NCT00551031|75585208|FG001|STARTED|Overall Study||636||
59494630|NCT00551031|75585209|FG002|STARTED|Overall Study||319||
59494631|NCT00551031|75585210|FG003|STARTED|Overall Study||320||
59494632|NCT00551031|75585211|FG004|STARTED|Overall Study||186||
59494633|NCT00551031|75585207|FG000|COMPLETED|Overall Study||635||
59494634|NCT00551031|75585208|FG001|COMPLETED|Overall Study||625||
59494635|NCT00551031|75585209|FG002|COMPLETED|Overall Study||317||
59494636|NCT00551031|75585210|FG003|COMPLETED|Overall Study||317||
59494637|NCT00551031|75585211|FG004|COMPLETED|Overall Study||185||
59494638|NCT00551031|75585207|FG000|NOT COMPLETED|Overall Study||2||
59494639|NCT00551031|75585208|FG001|NOT COMPLETED|Overall Study||11||
59494640|NCT00551031|75585209|FG002|NOT COMPLETED|Overall Study||2||
59494641|NCT00551031|75585210|FG003|NOT COMPLETED|Overall Study||3||
59494642|NCT00551031|75585211|FG004|NOT COMPLETED|Overall Study||1||
59494643|NCT01431716|75585223|FG000|STARTED|Overall Study||42||
59494644|NCT01431716|75585223|FG000|COMPLETED|Overall Study||41||
59494645|NCT01431716|75585223|FG000|NOT COMPLETED|Overall Study||1||
59494646|NCT00550953|75585229|FG000|STARTED|Overall Study||156||
59494647|NCT00550953|75585230|FG001|STARTED|Overall Study||158||
59494648|NCT00550953|75585229|FG000|COMPLETED|Overall Study||150||
59494649|NCT00550953|75585230|FG001|COMPLETED|Overall Study||152||
59494650|NCT00550953|75585229|FG000|NOT COMPLETED|Overall Study||6||
59494651|NCT00550953|75585230|FG001|NOT COMPLETED|Overall Study||6||
59494652|NCT00322465|75585240|FG000|STARTED|Overall Study|Randomized|76||
59494653|NCT00322465|75585241|FG001|STARTED|Overall Study|Randomized|73||
59494654|NCT00322465|75585242|FG002|STARTED|Overall Study|Randomized|77||
59494655|NCT00322465|75585243|FG003|STARTED|Overall Study|Randomized|79||
59494656|NCT00322465|75585240|FG000|COMPLETED|Overall Study|Second follow-up visit or clinical failure at first follow-up visit|56||
59494657|NCT00322465|75585241|FG001|COMPLETED|Overall Study|Second follow-up visit or clinical failure at first follow-up visit|49||
59494658|NCT00322465|75585242|FG002|COMPLETED|Overall Study|Second follow-up visit or clinical failure at first follow-up visit|51||
59494659|NCT00322465|75585243|FG003|COMPLETED|Overall Study|Second follow-up visit or clinical failure at first follow-up visit|53||
59494660|NCT00322465|75585240|FG000|NOT COMPLETED|Overall Study||20||
59494661|NCT00322465|75585241|FG001|NOT COMPLETED|Overall Study||24||
59494662|NCT00322465|75585242|FG002|NOT COMPLETED|Overall Study||26||
59494663|NCT00322465|75585243|FG003|NOT COMPLETED|Overall Study||26||
59494664|NCT00322777|75585258|FG000|STARTED|Overall Study||39||
59494665|NCT00322777|75585259|FG001|STARTED|Overall Study||45||
59494666|NCT00322777|75585258|FG000|"Data Collection at BASELINE|"|Overall Study||39||
59754689|NCT03889418|75873580|FG000|STARTED|January - March 2020 (Month 10-12)||67|[EMR-CDS with CCM] participants started enrollment in region 4 in period 4. In Region 5, only EMR-CDS (usual care) matched controls were identified. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|1
59762548|NCT00884312|75882326|FG000|COMPLETED|Overall Study||7|Completed final visit|
59494667|NCT00322777|75585259|FG001|"Data Collection at BASELINE|"|Overall Study||45||
59494668|NCT00322777|75585258|FG000|Data Collection at Week 8|Overall Study||39||
59494669|NCT00322777|75585259|FG001|Data Collection at Week 8|Overall Study||45||
59494670|NCT00322777|75585258|FG000|Data Collection at Week 16|Overall Study||39||
59494671|NCT00322777|75585259|FG001|Data Collection at Week 16|Overall Study||45||
59494672|NCT00322777|75585258|FG000|Data Collection at Week 24|Overall Study||39||
59494673|NCT00322777|75585259|FG001|Data Collection at Week 24|Overall Study||45||
59494674|NCT00322777|75585258|FG000|COMPLETED|Overall Study||39||
59494675|NCT00322777|75585259|FG001|COMPLETED|Overall Study||45||
59494676|NCT00322777|75585258|FG000|NOT COMPLETED|Overall Study||0||
59494677|NCT00322777|75585259|FG001|NOT COMPLETED|Overall Study||0||
59494678|NCT00558831|75585265|FG000|STARTED|Overall Study||11||
59494679|NCT00558831|75585265|FG000|COMPLETED|Overall Study||10||
59494680|NCT00558831|75585265|FG000|NOT COMPLETED|Overall Study||1||
59494681|NCT01431638|75585274|FG000|STARTED|Overall Study||133|Core study|
59494682|NCT01431638|75585275|FG001|STARTED|Overall Study||132|Core study|
59494683|NCT01431638|75585276|FG002|STARTED|Overall Study||132|Core study|
59494684|NCT01431638|75585274|FG000|Completed Core Study|Overall Study||124||
59494685|NCT01431638|75585275|FG001|Completed Core Study|Overall Study||117||
59494686|NCT01431638|75585276|FG002|Completed Core Study|Overall Study||108||
59494687|NCT01431638|75585274|FG000|Entered Extension 1 Study|Overall Study||85||
59494688|NCT01431638|75585275|FG001|Entered Extension 1 Study|Overall Study||71||
59494689|NCT01431638|75585276|FG002|Entered Extension 1 Study|Overall Study||76||
59494690|NCT01431638|75585274|FG000|COMPLETED|Overall Study||67|Completed Extension Study|
59494691|NCT01431638|75585275|FG001|COMPLETED|Overall Study||61|Completed Extension Study|
59494692|NCT01431638|75585276|FG002|COMPLETED|Overall Study||70|Completed Extension Study|
59494693|NCT01431638|75585274|FG000|NOT COMPLETED|Overall Study||66||
59494694|NCT01431638|75585275|FG001|NOT COMPLETED|Overall Study||71||
59494695|NCT01431638|75585276|FG002|NOT COMPLETED|Overall Study||62||
59494696|NCT01392170|75585284|FG000|STARTED|Overall Study||2||
59494697|NCT01392170|75585284|FG000|COMPLETED|Overall Study||0||
59494698|NCT01392170|75585284|FG000|NOT COMPLETED|Overall Study||2||
59494699|NCT00558753|75585290|FG000|STARTED|Overall Study||120||
59494700|NCT00558753|75585291|FG001|STARTED|Overall Study||120||
59494701|NCT00558753|75585290|FG000|COMPLETED|Overall Study||115||
59494702|NCT00558753|75585291|FG001|COMPLETED|Overall Study||113||
59494703|NCT00558753|75585290|FG000|NOT COMPLETED|Overall Study||5||
59494704|NCT00558753|75585291|FG001|NOT COMPLETED|Overall Study||7||
59494705|NCT01391546|75585299|FG000|STARTED|Overall Study||177||
59494706|NCT01391546|75585300|FG001|STARTED|Overall Study||177||
59494707|NCT01391546|75585299|FG000|Vaccinated|Overall Study||176||
59494708|NCT01391546|75585300|FG001|Vaccinated|Overall Study||177||
59494709|NCT01391546|75585299|FG000|COMPLETED|Overall Study||176||
59494710|NCT01391546|75585300|FG001|COMPLETED|Overall Study||177||
59494711|NCT01391546|75585299|FG000|NOT COMPLETED|Overall Study||1||
59494712|NCT01391546|75585300|FG001|NOT COMPLETED|Overall Study||0||
59884878|NCT02895945|76007673|FG000|SAS|Overall Study||7|Safety analysis set (SAS) comprised of all participants who received any amount of BAX 802.|
59494713|NCT01410110|75585309|FG000|STARTED|Overall Study||24||
59950946|NCT00571493|76069873|FG004|STARTED|Overall Study||11||
59494714|NCT01410110|75585310|FG001|STARTED|Overall Study||24||
59494715|NCT01410110|75585309|FG000|Randomization|Overall Study||24||
59494716|NCT01410110|75585310|FG001|Randomization|Overall Study||24||
59494717|NCT01410110|75585309|FG000|3 Months (End of Intervention)|Overall Study||20||
59494718|NCT01410110|75585310|FG001|3 Months (End of Intervention)|Overall Study||22||
59494719|NCT01410110|75585309|FG000|6 Month Follow-up|Overall Study||20||
59494720|NCT01410110|75585310|FG001|6 Month Follow-up|Overall Study||22||
59494721|NCT01410110|75585309|FG000|COMPLETED|Overall Study||20||
59494722|NCT01410110|75585310|FG001|COMPLETED|Overall Study||22||
59494723|NCT01410110|75585309|FG000|NOT COMPLETED|Overall Study||4||
59494724|NCT01410110|75585310|FG001|NOT COMPLETED|Overall Study||2||
59494725|NCT01391000|75585318|FG000|STARTED|Overall Study||35||
59494726|NCT01391000|75585319|FG001|STARTED|Overall Study||35||
59494727|NCT01391000|75585318|FG000|COMPLETED|Overall Study||33||
59494728|NCT01391000|75585319|FG001|COMPLETED|Overall Study||35||
59494729|NCT01391000|75585318|FG000|NOT COMPLETED|Overall Study||2||
59494730|NCT01391000|75585319|FG001|NOT COMPLETED|Overall Study||0||
59494731|NCT02275767|75585328|FG000|STARTED|Overall Study||22||
59494732|NCT02275767|75585329|FG001|STARTED|Overall Study||22||
59494733|NCT02275767|75585330|FG002|STARTED|Overall Study||22||
59494734|NCT02275767|75585328|FG000|COMPLETED|Overall Study||20||
59494735|NCT02275767|75585329|FG001|COMPLETED|Overall Study||18||
59494736|NCT02275767|75585330|FG002|COMPLETED|Overall Study||19||
59494737|NCT02275767|75585328|FG000|NOT COMPLETED|Overall Study||2||
59494738|NCT02275767|75585329|FG001|NOT COMPLETED|Overall Study||4||
59494739|NCT02275767|75585330|FG002|NOT COMPLETED|Overall Study||3||
59494740|NCT00324259|75585340|FG000|STARTED|Overall Study||34||
59494741|NCT00324259|75585341|FG001|STARTED|Overall Study||32||
59494742|NCT00324259|75585340|FG000|COMPLETED|Overall Study||34||
59494743|NCT00324259|75585341|FG001|COMPLETED|Overall Study||32||
59494744|NCT00324259|75585340|FG000|NOT COMPLETED|Overall Study||0||
59494745|NCT00324259|75585341|FG001|NOT COMPLETED|Overall Study||0||
59494746|NCT00324415|75585348|FG000|STARTED|Overall Study||45||
59494747|NCT00324415|75585348|FG000|COMPLETED|Overall Study||45||
59494748|NCT00324415|75585348|FG000|NOT COMPLETED|Overall Study||0||
59494749|NCT00390559|75585353|FG000|STARTED|Overall Study||124||
59494750|NCT00390559|75585353|FG000|Received PlaceboP/Active C|Overall Study||93||
59494751|NCT00390559|75585353|FG000|ActiveP/ActiveC|Overall Study||87||
59494752|NCT00390559|75585353|FG000|PlaceboP/PlaceboC|Overall Study||93||
59494753|NCT00390559|75585353|FG000|ActiveP/PlaceboC|Overall Study||90||
59494754|NCT00390559|75585353|FG000|COMPLETED|Overall Study||80||
59494755|NCT00390559|75585353|FG000|NOT COMPLETED|Overall Study||44||
59494756|NCT02107339|75585365|FG000|STARTED|Overall Study||63||
59494757|NCT02107339|75585366|FG001|STARTED|Overall Study||57||
59494758|NCT02107339|75585365|FG000|COMPLETED|Overall Study||62||
59494759|NCT02107339|75585366|FG001|COMPLETED|Overall Study||53||
59494760|NCT02107339|75585365|FG000|NOT COMPLETED|Overall Study||1||
59494761|NCT02107339|75585366|FG001|NOT COMPLETED|Overall Study||4||
59494762|NCT00390949|75585374|FG000|STARTED|Overall Study||4662||
59494763|NCT00390949|75585375|FG001|STARTED|Overall Study||4792||
59494764|NCT00390949|75585374|FG000|COMPLETED|Overall Study||2564||
59494765|NCT00390949|75585375|FG001|COMPLETED|Overall Study||2664||
59494766|NCT00390949|75585374|FG000|NOT COMPLETED|Overall Study||2098||
59494767|NCT00390949|75585375|FG001|NOT COMPLETED|Overall Study||2128||
59494768|NCT00392041|75585383|FG000|STARTED|First 4 Weeks||19||
59494769|NCT00392041|75585384|FG001|STARTED|First 4 Weeks||17||
59494770|NCT00392041|75585383|FG000|COMPLETED|First 4 Weeks||11||
59494771|NCT00392041|75585384|FG001|COMPLETED|First 4 Weeks||14||
59494772|NCT00392041|75585383|FG000|NOT COMPLETED|First 4 Weeks||8||
59494773|NCT00392041|75585384|FG001|NOT COMPLETED|First 4 Weeks||3||
59494774|NCT00392041|75585383|FG000|STARTED|Weeks 5 - 12||11||
59494775|NCT00392041|75585384|FG001|STARTED|Weeks 5 - 12||14||
59494776|NCT00392041|75585383|FG000|COMPLETED|Weeks 5 - 12||7||
59494777|NCT00392041|75585384|FG001|COMPLETED|Weeks 5 - 12||9||
59494778|NCT00392041|75585383|FG000|NOT COMPLETED|Weeks 5 - 12||4||
59494779|NCT00392041|75585384|FG001|NOT COMPLETED|Weeks 5 - 12||5||
59494780|NCT01390844|75585394|FG000|STARTED|Treatment Phase||133||
59494781|NCT01390844|75585395|FG001|STARTED|Treatment Phase||65||
59494782|NCT01390844|75585396|FG002|STARTED|Treatment Phase||57||
59494783|NCT01390844|75585397|FG003|STARTED|Treatment Phase||27||
59494784|NCT01390844|75585394|FG000|Followed Good Clinical Practice (GCP)|Treatment Phase||133||
59494785|NCT01390844|75585395|FG001|Followed Good Clinical Practice (GCP)|Treatment Phase||65||
59494786|NCT01390844|75585396|FG002|Followed Good Clinical Practice (GCP)|Treatment Phase||47||
59494787|NCT01390844|75585397|FG003|Followed Good Clinical Practice (GCP)|Treatment Phase||24||
59494788|NCT01390844|75585394|FG000|COMPLETED|Treatment Phase||93||
59494789|NCT01390844|75585395|FG001|COMPLETED|Treatment Phase||37||
59494790|NCT01390844|75585396|FG002|COMPLETED|Treatment Phase||26||
59494791|NCT01390844|75585397|FG003|COMPLETED|Treatment Phase||8||
59494792|NCT01390844|75585394|FG000|NOT COMPLETED|Treatment Phase||40||
59494793|NCT01390844|75585395|FG001|NOT COMPLETED|Treatment Phase||28||
59494794|NCT01390844|75585396|FG002|NOT COMPLETED|Treatment Phase||31||
59494795|NCT01390844|75585397|FG003|NOT COMPLETED|Treatment Phase||19||
59494796|NCT01390844|75585394|FG000|STARTED|Follow-Up Phase||93||
59494797|NCT01390844|75585395|FG001|STARTED|Follow-Up Phase||37||
59494798|NCT01390844|75585396|FG002|STARTED|Follow-Up Phase||26||
59494799|NCT01390844|75585397|FG003|STARTED|Follow-Up Phase||8||
59494800|NCT01390844|75585394|FG000|COMPLETED|Follow-Up Phase||92||
59494801|NCT01390844|75585395|FG001|COMPLETED|Follow-Up Phase||36||
59762549|NCT00884312|75882327|FG001|COMPLETED|Overall Study||67|Completed final visit|
60012075|NCT02684461|76127970|FG001|COMPLETED|Overall Study||5||
60012076|NCT02684461|76127971|FG002|COMPLETED|Overall Study||6||
60012077|NCT02684461|76127969|FG000|NOT COMPLETED|Overall Study||2||
60012078|NCT02684461|76127970|FG001|NOT COMPLETED|Overall Study||2||
60012079|NCT02684461|76127971|FG002|NOT COMPLETED|Overall Study||0||
60012080|NCT05224453|76127987|FG000|STARTED|Overall Study||38||
60012081|NCT05224453|76127988|FG001|STARTED|Overall Study||38||
59762550|NCT00884312|75882326|FG000|NOT COMPLETED|Overall Study||2||
60012082|NCT05224453|76127987|FG000|COMPLETED|Overall Study||36||
59754690|NCT03889418|75873581|FG001|STARTED|January - March 2020 (Month 10-12)||48|[EMR-CDS with CCM] participants started enrollment in region 4 in period 4. In Region 5, only EMR-CDS (usual care) matched controls were identified. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|1
59762551|NCT00884312|75882327|FG001|NOT COMPLETED|Overall Study||25||
59762552|NCT00534313|75882337|FG000|STARTED|Short-term Period||43||
59762553|NCT00534313|75882338|FG001|STARTED|Short-term Period||40||
59607102|NCT01270919|75717605|FG000|STARTED|Overall Study|One participant was enrolled but was censored.|0||
59607103|NCT01270919|75717605|FG000|COMPLETED|Overall Study||0||
59607104|NCT01270919|75717605|FG000|NOT COMPLETED|Overall Study||0||
59607105|NCT01262339|75717609|FG000|STARTED|Overall Study||2||
59494802|NCT01390844|75585396|FG002|COMPLETED|Follow-Up Phase||25||
59494803|NCT01390844|75585397|FG003|COMPLETED|Follow-Up Phase||8||
59494804|NCT01390844|75585394|FG000|NOT COMPLETED|Follow-Up Phase||1||
59494805|NCT01390844|75585395|FG001|NOT COMPLETED|Follow-Up Phase||1||
59494806|NCT01390844|75585396|FG002|NOT COMPLETED|Follow-Up Phase||1||
59494807|NCT01390844|75585397|FG003|NOT COMPLETED|Follow-Up Phase||0||
59494808|NCT01430624|75585410|FG000|STARTED|Overall Study|Initial potential eligible screened enrolled|82||
59494809|NCT01430624|75585411|FG001|STARTED|Overall Study||82||
59494810|NCT01430624|75585412|FG002|STARTED|Overall Study||81||
59494811|NCT01430624|75585410|FG000|Eligible Baseline Completes|Overall Study||77||
59494812|NCT01430624|75585411|FG001|Eligible Baseline Completes|Overall Study||77||
59494813|NCT01430624|75585412|FG002|Eligible Baseline Completes|Overall Study||79||
59494814|NCT01430624|75585410|FG000|COMPLETED|Overall Study|Completed one or more follow-ups|54||
59494815|NCT01430624|75585411|FG001|COMPLETED|Overall Study|Completed one or more follow-ups|48||
59494816|NCT01430624|75585412|FG002|COMPLETED|Overall Study|Completed one or more follow-ups|52||
59494817|NCT01430624|75585410|FG000|NOT COMPLETED|Overall Study||28||
59494818|NCT01430624|75585411|FG001|NOT COMPLETED|Overall Study||34||
59494819|NCT01430624|75585412|FG002|NOT COMPLETED|Overall Study||29||
59494820|NCT00395161|75585426|FG000|STARTED|Overall Study||149||
59494821|NCT00395161|75585427|FG001|STARTED|Overall Study||144||
59494822|NCT00395161|75585426|FG000|COMPLETED|Overall Study||149||
59607106|NCT01262339|75717609|FG000|COMPLETED|Overall Study||2||
59607107|NCT01262339|75717609|FG000|NOT COMPLETED|Overall Study||0||
59607108|NCT03861845|75717616|FG000|STARTED|Overall Study||6||
59494823|NCT00395161|75585427|FG001|COMPLETED|Overall Study||144||
59754691|NCT03889418|75873582|FG002|STARTED|January - March 2020 (Month 10-12)||34|[EMR-CDS with CCM] participants started enrollment in region 4 in period 4. In Region 5, only EMR-CDS (usual care) matched controls were identified. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|1
59754692|NCT03889418|75873583|FG003|STARTED|January - March 2020 (Month 10-12)||24|[EMR-CDS with CCM] participants started enrollment in region 4 in period 4. In Region 5, only EMR-CDS (usual care) matched controls were identified. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|1
59762554|NCT00534313|75882339|FG002|STARTED|Short-term Period||45||
59762555|NCT00534313|75882340|FG003|STARTED|Short-term Period||42||
59884879|NCT02895945|76007674|FG001|SAS|Overall Study||1|Safety analysis set (SAS) comprised of all participants who received any amount of BAX 802.|
59884880|NCT02895945|76007673|FG000|FAS|Overall Study||7|Full analysis set (FAS) comprised of all participants with at least one available hemostatic assessment.|
59884881|NCT02895945|76007674|FG001|FAS|Overall Study||0|Full analysis set (FAS) comprised of all participants with at least one available hemostatic assessment.|
59884882|NCT02895945|76007673|FG000|COMPLETED|Overall Study||5||
59884883|NCT02895945|76007674|FG001|COMPLETED|Overall Study||0||
59884884|NCT02895945|76007673|FG000|NOT COMPLETED|Overall Study||2||
59884885|NCT02895945|76007674|FG001|NOT COMPLETED|Overall Study||1||
59884886|NCT02777554|76007682|FG000|STARTED|Overall Study||62||
59884887|NCT02777554|76007683|FG001|STARTED|Overall Study||62||
59884888|NCT02777554|76007684|FG002|STARTED|Overall Study||5||
59884889|NCT02777554|76007685|FG003|STARTED|Overall Study||5||
59884890|NCT02777554|76007686|FG004|STARTED|Overall Study||5||
59884891|NCT02777554|76007687|FG005|STARTED|Overall Study||5||
59884892|NCT02777554|76007682|FG000|COMPLETED|Overall Study||32||
59884893|NCT02777554|76007683|FG001|COMPLETED|Overall Study||37||
59884894|NCT02777554|76007684|FG002|COMPLETED|Overall Study||4||
59884895|NCT02777554|76007685|FG003|COMPLETED|Overall Study||4||
59884896|NCT02777554|76007686|FG004|COMPLETED|Overall Study||5||
59884897|NCT02777554|76007687|FG005|COMPLETED|Overall Study||5||
59884898|NCT02777554|76007682|FG000|NOT COMPLETED|Overall Study||30||
59884899|NCT02777554|76007683|FG001|NOT COMPLETED|Overall Study||25||
59884900|NCT02777554|76007684|FG002|NOT COMPLETED|Overall Study||1||
59884901|NCT02777554|76007685|FG003|NOT COMPLETED|Overall Study||1||
59884902|NCT02777554|76007686|FG004|NOT COMPLETED|Overall Study||0||
59884903|NCT02777554|76007687|FG005|NOT COMPLETED|Overall Study||0||
59884904|NCT03550209|76007711|FG000|STARTED|Overall Study||12||
59884905|NCT03550209|76007712|FG001|STARTED|Overall Study||12||
59884906|NCT03550209|76007713|FG002|STARTED|Overall Study||13||
59884907|NCT03550209|76007714|FG003|STARTED|Overall Study||35||
59884908|NCT03550209|76007711|FG000|COMPLETED|Overall Study||11||
59884909|NCT03550209|76007712|FG001|COMPLETED|Overall Study||9||
59884910|NCT03550209|76007713|FG002|COMPLETED|Overall Study||11||
59884911|NCT03550209|76007714|FG003|COMPLETED|Overall Study||31||
59884912|NCT03550209|76007711|FG000|NOT COMPLETED|Overall Study||1||
59884913|NCT03550209|76007712|FG001|NOT COMPLETED|Overall Study||3||
59884914|NCT03550209|76007713|FG002|NOT COMPLETED|Overall Study||2||
59884915|NCT03550209|76007714|FG003|NOT COMPLETED|Overall Study||4||
59884916|NCT03032510|76007726|FG000|STARTED|Overall Study||603||
59884917|NCT03032510|76007727|FG001|STARTED|Overall Study||602||
59884918|NCT03032510|76007726|FG000|COMPLETED|Overall Study||576||
59884919|NCT03032510|76007727|FG001|COMPLETED|Overall Study||584||
59884920|NCT03032510|76007726|FG000|NOT COMPLETED|Overall Study||27||
59884921|NCT03032510|76007727|FG001|NOT COMPLETED|Overall Study||18||
59884922|NCT03599349|76007737|FG000|STARTED|Overall Study||20||
59884923|NCT03599349|76007737|FG000|Treated|Overall Study||20||
59884924|NCT03599349|76007737|FG000|COMPLETED|Overall Study||19||
59884925|NCT03599349|76007737|FG000|NOT COMPLETED|Overall Study||1||
59884926|NCT03022292|76007741|FG000|STARTED|Overall Study||26||
59884927|NCT03022292|76007741|FG000|COMPLETED|Overall Study||24||
59494824|NCT00395161|75585426|FG000|NOT COMPLETED|Overall Study||0||
59494825|NCT00395161|75585427|FG001|NOT COMPLETED|Overall Study||0||
59494826|NCT01430468|75585437|FG000|STARTED|Overall Study||22||
59494827|NCT01430468|75585438|FG001|STARTED|Overall Study||22||
59494828|NCT01430468|75585437|FG000|COMPLETED|Overall Study||15||
59494829|NCT01430468|75585438|FG001|COMPLETED|Overall Study||16||
59494830|NCT01430468|75585437|FG000|NOT COMPLETED|Overall Study||7||
59494831|NCT01430468|75585438|FG001|NOT COMPLETED|Overall Study||6||
59494832|NCT02076776|75585447|FG000|STARTED|Overall Study||6||
59494833|NCT02076776|75585448|FG001|STARTED|Overall Study||8||
59494834|NCT02076776|75585449|FG002|STARTED|Overall Study||6||
60012083|NCT05224453|76127988|FG001|COMPLETED|Overall Study||35||
60012084|NCT05224453|76127987|FG000|NOT COMPLETED|Overall Study||2||
60012085|NCT05224453|76127988|FG001|NOT COMPLETED|Overall Study||3||
60012086|NCT02647645|76127996|FG000|STARTED|Overall Study||11||
60012087|NCT02647645|76127997|FG001|STARTED|Overall Study||10||
60012088|NCT02647645|76127996|FG000|COMPLETED|Overall Study||9||
59494835|NCT02076776|75585447|FG000|COMPLETED|Overall Study||5||
59494836|NCT02076776|75585448|FG001|COMPLETED|Overall Study||6||
59494837|NCT02076776|75585449|FG002|COMPLETED|Overall Study||6||
59494838|NCT02076776|75585447|FG000|NOT COMPLETED|Overall Study||1||
59494839|NCT02076776|75585448|FG001|NOT COMPLETED|Overall Study||2||
59494840|NCT02076776|75585449|FG002|NOT COMPLETED|Overall Study||0||
59494841|NCT01409564|75585459|FG000|STARTED|Overall Study||23||
59494842|NCT01409564|75585460|FG001|STARTED|Overall Study||23||
59494843|NCT01409564|75585459|FG000|COMPLETED|Overall Study||18||
59494844|NCT01409564|75585460|FG001|COMPLETED|Overall Study||18||
59494845|NCT01409564|75585459|FG000|NOT COMPLETED|Overall Study||5||
59494846|NCT01409564|75585460|FG001|NOT COMPLETED|Overall Study||5||
59494847|NCT01390298|75585470|FG000|STARTED|Overall Study||55||
59494848|NCT01390298|75585470|FG000|COMPLETED|Overall Study||31||
59494849|NCT01390298|75585470|FG000|NOT COMPLETED|Overall Study||24||
59494850|NCT00396019|75585477|FG000|STARTED|Overall Study||27||
59494851|NCT00396019|75585478|FG001|STARTED|Overall Study||29||
59494852|NCT00396019|75585479|FG002|STARTED|Overall Study||30||
60012089|NCT02647645|76127997|FG001|COMPLETED|Overall Study||9||
60012090|NCT02647645|76127996|FG000|NOT COMPLETED|Overall Study||2||
60012091|NCT02647645|76127997|FG001|NOT COMPLETED|Overall Study||1||
60012092|NCT02531373|76128012|FG000|STARTED|Overall Study||20||
60012093|NCT02531373|76128013|FG001|STARTED|Overall Study||20||
60012094|NCT02531373|76128014|FG002|STARTED|Overall Study||20||
60012095|NCT02531373|76128015|FG003|STARTED|Overall Study||20||
60012096|NCT02531373|76128016|FG004|STARTED|Overall Study||51||
60012097|NCT02531373|76128017|FG005|STARTED|Overall Study||51||
60012098|NCT02531373|76128018|FG006|STARTED|Overall Study||52||
59494853|NCT00396019|75585477|FG000|COMPLETED|Overall Study||27||
59762556|NCT00534313|75882337|FG000|COMPLETED|Short-term Period|Completed the short-term study|37||
60012099|NCT02531373|76128019|FG007|STARTED|Overall Study||52||
60012100|NCT02531373|76128020|FG008|STARTED|Overall Study||52||
60012101|NCT02531373|76128012|FG000|Vaccination 1|Overall Study||20||
59494854|NCT00396019|75585478|FG001|COMPLETED|Overall Study||26||
59494855|NCT00396019|75585479|FG002|COMPLETED|Overall Study||29||
59494856|NCT00396019|75585477|FG000|NOT COMPLETED|Overall Study||0||
59494857|NCT00396019|75585478|FG001|NOT COMPLETED|Overall Study||3||
59494858|NCT00396019|75585479|FG002|NOT COMPLETED|Overall Study||1||
59494859|NCT01390220|75585488|FG000|STARTED|Test Dose Phase||292||
59494860|NCT01390220|75585489|FG001|STARTED|Test Dose Phase|This arm not applicable in TDP.|0||
59494861|NCT01390220|75585490|FG002|STARTED|Test Dose Phase|This arm not applicable in TDP.|0||
60012102|NCT02531373|76128013|FG001|Vaccination 1|Overall Study||20||
59762674|NCT01886963|75882518|FG001|COMPLETED|Overall Study||49||
59607109|NCT03861845|75717617|FG001|STARTED|Overall Study||5||
59607110|NCT03861845|75717618|FG002|STARTED|Overall Study||4||
59607111|NCT03861845|75717616|FG000|COMPLETED|Overall Study||6||
59607112|NCT03861845|75717617|FG001|COMPLETED|Overall Study||5||
59607113|NCT03861845|75717618|FG002|COMPLETED|Overall Study||4||
59607114|NCT03861845|75717616|FG000|NOT COMPLETED|Overall Study||0||
59607115|NCT03861845|75717617|FG001|NOT COMPLETED|Overall Study||0||
59607116|NCT03861845|75717618|FG002|NOT COMPLETED|Overall Study||0||
59607117|NCT02708849|75717628|FG000|STARTED|Overall Study||2||
59607118|NCT02708849|75717629|FG001|STARTED|Overall Study||1||
59494862|NCT01390220|75585488|FG000|COMPLETED|Test Dose Phase||201||
59494863|NCT01390220|75585489|FG001|COMPLETED|Test Dose Phase||0||
59494864|NCT01390220|75585490|FG002|COMPLETED|Test Dose Phase||0||
59494865|NCT01390220|75585488|FG000|NOT COMPLETED|Test Dose Phase||91||
59494866|NCT01390220|75585489|FG001|NOT COMPLETED|Test Dose Phase||0||
59494867|NCT01390220|75585490|FG002|NOT COMPLETED|Test Dose Phase||0||
59494868|NCT01390220|75585488|FG000|STARTED|Comparative Phase|This arm not applicable in CP|0|Patients completing TDP, were randomized, and received double-blind dose in CP|
59494869|NCT01390220|75585489|FG001|STARTED|Comparative Phase||134|Patients completing TDP, were randomized, and received double-blind dose in CP|
59494870|NCT01390220|75585490|FG002|STARTED|Comparative Phase||67|Patients completing TDP, were randomized, and received double-blind dose in CP|
59494871|NCT01390220|75585488|FG000|COMPLETED|Comparative Phase|This arm not applicable in CP|0||
59494872|NCT01390220|75585489|FG001|COMPLETED|Comparative Phase||133||
59494873|NCT01390220|75585490|FG002|COMPLETED|Comparative Phase||67||
59494874|NCT01390220|75585488|FG000|NOT COMPLETED|Comparative Phase||0||
59494875|NCT01390220|75585489|FG001|NOT COMPLETED|Comparative Phase||1||
59494876|NCT01390220|75585490|FG002|NOT COMPLETED|Comparative Phase||0||
59494877|NCT00357331|75585501|FG000|STARTED|Overall Study||42||
59494878|NCT00357331|75585502|FG001|STARTED|Overall Study||41||
59494879|NCT00357331|75585501|FG000|COMPLETED|Overall Study||42||
59494880|NCT00357331|75585502|FG001|COMPLETED|Overall Study||41||
59494881|NCT00357331|75585501|FG000|NOT COMPLETED|Overall Study||0||
59494882|NCT00357331|75585502|FG001|NOT COMPLETED|Overall Study||0||
59494883|NCT00357955|75585510|FG000|STARTED|Overall Study||64||
59494884|NCT00357955|75585511|FG001|STARTED|Overall Study||54||
59494885|NCT00357955|75585510|FG000|COMPLETED|Overall Study||58||
59494886|NCT00357955|75585511|FG001|COMPLETED|Overall Study||51||
59494887|NCT00357955|75585510|FG000|NOT COMPLETED|Overall Study||6||
59494888|NCT00357955|75585511|FG001|NOT COMPLETED|Overall Study||3||
59494889|NCT00550173|75585520|FG000|STARTED|Overall Study||81||
59494890|NCT00550173|75585521|FG001|STARTED|Overall Study||82||
59494891|NCT00550173|75585522|FG002|STARTED|Overall Study||84||
59494892|NCT00550173|75585520|FG000|Qualified Participants|Overall Study|Participants with tumors of nonsquamous histology|78||
59494893|NCT00550173|75585521|FG001|Qualified Participants|Overall Study|Participants with tumors of nonsquamous histology|82||
59494894|NCT00550173|75585522|FG002|Qualified Participants|Overall Study|Participants with tumors of nonsquamous histology|80||
59494895|NCT00550173|75585520|FG000|Not Discontinued at 18 Months|Overall Study||9||
59494896|NCT00550173|75585521|FG001|Not Discontinued at 18 Months|Overall Study||19||
59494897|NCT00550173|75585522|FG002|Not Discontinued at 18 Months|Overall Study||11||
59494898|NCT00550173|75585520|FG000|COMPLETED|Overall Study||9||
59494899|NCT00550173|75585521|FG001|COMPLETED|Overall Study||19||
59494900|NCT00550173|75585522|FG002|COMPLETED|Overall Study||11||
59494901|NCT00550173|75585520|FG000|NOT COMPLETED|Overall Study||72||
59494902|NCT00550173|75585521|FG001|NOT COMPLETED|Overall Study||63||
59494903|NCT00550173|75585522|FG002|NOT COMPLETED|Overall Study||73||
59494904|NCT01429298|75585533|FG000|STARTED|Overall Study||175||
59494905|NCT01429298|75585534|FG001|STARTED|Overall Study||175||
59494906|NCT01429298|75585533|FG000|Given IV Opioids|Overall Study|4 never given IV opioids|171||
59494907|NCT01429298|75585534|FG001|Given IV Opioids|Overall Study|6 never given IV opioids|169||
59494908|NCT01429298|75585533|FG000|COMPLETED|Overall Study||171||
59494909|NCT01429298|75585534|FG001|COMPLETED|Overall Study||169||
59607119|NCT02708849|75717628|FG000|COMPLETED|Overall Study||1||
59494910|NCT01429298|75585533|FG000|NOT COMPLETED|Overall Study||4||
59494911|NCT01429298|75585534|FG001|NOT COMPLETED|Overall Study||6||
59494912|NCT00397579|75585540|FG000|STARTED|Overall Study||11||
59494913|NCT00397579|75585540|FG000|COMPLETED|Overall Study||11||
59494914|NCT00397579|75585540|FG000|NOT COMPLETED|Overall Study||0||
59494915|NCT01408706|75585546|FG000|STARTED|Overall Study||30||
59494916|NCT01408706|75585547|FG001|STARTED|Overall Study||30||
59494917|NCT01408706|75585546|FG000|COMPLETED|Overall Study||29||
59494918|NCT01408706|75585547|FG001|COMPLETED|Overall Study||30||
59494919|NCT01408706|75585546|FG000|NOT COMPLETED|Overall Study||1||
59494920|NCT01408706|75585547|FG001|NOT COMPLETED|Overall Study||0||
59494921|NCT01408628|75585555|FG000|STARTED|Consented||51||
59494922|NCT01408628|75585555|FG000|COMPLETED|Consented||39||
59494923|NCT01408628|75585555|FG000|NOT COMPLETED|Consented||12||
59494924|NCT01408628|75585555|FG000|STARTED|Started Classes/Intervention||39||
59494925|NCT01408628|75585555|FG000|COMPLETED|Started Classes/Intervention||39||
59494926|NCT01408628|75585555|FG000|NOT COMPLETED|Started Classes/Intervention||0||
59494927|NCT01408628|75585555|FG000|STARTED|Completed 6 Month Follow-Up||39||
59494928|NCT01408628|75585555|FG000|COMPLETED|Completed 6 Month Follow-Up||25||
59494929|NCT01408628|75585555|FG000|NOT COMPLETED|Completed 6 Month Follow-Up||14||
59494930|NCT01389752|75585560|FG000|STARTED|Study Period 1||11||
59494931|NCT01389752|75585561|FG001|STARTED|Study Period 1||11||
59494932|NCT01389752|75585560|FG000|COMPLETED|Study Period 1||11||
59494933|NCT01389752|75585561|FG001|COMPLETED|Study Period 1||9||
59494934|NCT01389752|75585560|FG000|NOT COMPLETED|Study Period 1||0||
59494935|NCT01389752|75585561|FG001|NOT COMPLETED|Study Period 1||2||
59494936|NCT01389752|75585560|FG000|STARTED|Study Period 2||11||
59494937|NCT01389752|75585561|FG001|STARTED|Study Period 2||9||
59494938|NCT01389752|75585560|FG000|COMPLETED|Study Period 2||10||
59494939|NCT01389752|75585561|FG001|COMPLETED|Study Period 2||9||
59494940|NCT01389752|75585560|FG000|NOT COMPLETED|Study Period 2||1||
59494941|NCT01389752|75585561|FG001|NOT COMPLETED|Study Period 2||0||
59494942|NCT01428128|75585568|FG000|STARTED|Overall Study||50||
59494943|NCT01428128|75585568|FG000|COMPLETED|Overall Study||33||
59494944|NCT01428128|75585568|FG000|NOT COMPLETED|Overall Study||17||
59494945|NCT01407926|75585573|FG000|STARTED|Overall Study||142||
59494946|NCT01407926|75585573|FG000|COMPLETED|Overall Study||87||
59494947|NCT01407926|75585573|FG000|NOT COMPLETED|Overall Study||55||
59494948|NCT00358501|75585580|FG000|STARTED|Overall Study||102||
59494949|NCT00358501|75585581|FG001|STARTED|Overall Study||32||
59494950|NCT00358501|75585580|FG000|COMPLETED|Overall Study||102||
59494951|NCT00358501|75585581|FG001|COMPLETED|Overall Study||32||
59494952|NCT00358501|75585580|FG000|NOT COMPLETED|Overall Study||0||
59494953|NCT00358501|75585581|FG001|NOT COMPLETED|Overall Study||0||
59494954|NCT01427972|75585600|FG000|STARTED|Treatment Period 1 (21 Days)||3||
59494955|NCT01427972|75585601|FG001|STARTED|Treatment Period 1 (21 Days)||4||
59494956|NCT01427972|75585602|FG002|STARTED|Treatment Period 1 (21 Days)||4||
59494957|NCT01427972|75585603|FG003|STARTED|Treatment Period 1 (21 Days)||3||
59494958|NCT01427972|75585604|FG004|STARTED|Treatment Period 1 (21 Days)||4||
59494959|NCT01427972|75585605|FG005|STARTED|Treatment Period 1 (21 Days)||3||
59494960|NCT01427972|75585606|FG006|STARTED|Treatment Period 1 (21 Days)||3||
59494961|NCT01427972|75585607|FG007|STARTED|Treatment Period 1 (21 Days)||5||
59494962|NCT01427972|75585608|FG008|STARTED|Treatment Period 1 (21 Days)||3||
59494963|NCT01427972|75585609|FG009|STARTED|Treatment Period 1 (21 Days)||3||
59494964|NCT01427972|75585610|FG010|STARTED|Treatment Period 1 (21 Days)||3||
59494965|NCT01427972|75585611|FG011|STARTED|Treatment Period 1 (21 Days)||4||
59494966|NCT01427972|75585600|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3||
59494967|NCT01427972|75585601|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||4||
59494968|NCT01427972|75585602|FG002|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||4||
59607120|NCT02708849|75717629|FG001|COMPLETED|Overall Study||1||
59607121|NCT02708849|75717628|FG000|NOT COMPLETED|Overall Study||1||
59607122|NCT02708849|75717629|FG001|NOT COMPLETED|Overall Study||0||
59607123|NCT03859739|75717639|FG000|STARTED|Overall Study||5||
60012103|NCT02531373|76128014|FG002|Vaccination 1|Overall Study||20||
60012104|NCT02531373|76128015|FG003|Vaccination 1|Overall Study||20||
60012105|NCT02531373|76128016|FG004|Vaccination 1|Overall Study||50||
60012106|NCT02531373|76128017|FG005|Vaccination 1|Overall Study||50||
60012107|NCT02531373|76128018|FG006|Vaccination 1|Overall Study||52||
60012108|NCT02531373|76128019|FG007|Vaccination 1|Overall Study||52||
60012109|NCT02531373|76128020|FG008|Vaccination 1|Overall Study||52||
60012110|NCT02531373|76128012|FG000|Vaccination 2|Overall Study||0||
60012111|NCT02531373|76128013|FG001|Vaccination 2|Overall Study||0||
60012112|NCT02531373|76128014|FG002|Vaccination 2|Overall Study||0||
60012113|NCT02531373|76128015|FG003|Vaccination 2|Overall Study||0||
60012114|NCT02531373|76128016|FG004|Vaccination 2|Overall Study||49||
60012115|NCT02531373|76128017|FG005|Vaccination 2|Overall Study||48||
60012116|NCT02531373|76128018|FG006|Vaccination 2|Overall Study||50||
60012117|NCT02531373|76128019|FG007|Vaccination 2|Overall Study||51||
60012118|NCT02531373|76128020|FG008|Vaccination 2|Overall Study||51||
60012119|NCT02531373|76128012|FG000|Vaccination 3|Overall Study||0||
60012120|NCT02531373|76128013|FG001|Vaccination 3|Overall Study||0||
60012121|NCT02531373|76128014|FG002|Vaccination 3|Overall Study||0||
60012122|NCT02531373|76128015|FG003|Vaccination 3|Overall Study||0||
59494969|NCT01427972|75585603|FG003|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3||
59494970|NCT01427972|75585604|FG004|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||4||
59494971|NCT01427972|75585605|FG005|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3||
59494972|NCT01427972|75585606|FG006|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3||
59494973|NCT01427972|75585607|FG007|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||5||
59494974|NCT01427972|75585608|FG008|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3||
59494975|NCT01427972|75585609|FG009|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3||
59494976|NCT01427972|75585610|FG010|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3||
59518980|NCT03587428|75612871|FG001|STARTED|Period 1||2||
60012123|NCT02531373|76128016|FG004|Vaccination 3|Overall Study||48||
60012124|NCT02531373|76128017|FG005|Vaccination 3|Overall Study||47||
59494977|NCT01427972|75585611|FG011|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||4||
59494978|NCT01427972|75585600|FG000|COMPLETED|Treatment Period 1 (21 Days)||3||
59494979|NCT01427972|75585601|FG001|COMPLETED|Treatment Period 1 (21 Days)||4||
59494980|NCT01427972|75585602|FG002|COMPLETED|Treatment Period 1 (21 Days)||4||
59494981|NCT01427972|75585603|FG003|COMPLETED|Treatment Period 1 (21 Days)||3||
59494982|NCT01427972|75585604|FG004|COMPLETED|Treatment Period 1 (21 Days)||4||
59494983|NCT01427972|75585605|FG005|COMPLETED|Treatment Period 1 (21 Days)||3||
59494984|NCT01427972|75585606|FG006|COMPLETED|Treatment Period 1 (21 Days)||3||
59494985|NCT01427972|75585607|FG007|COMPLETED|Treatment Period 1 (21 Days)||4||
59494986|NCT01427972|75585608|FG008|COMPLETED|Treatment Period 1 (21 Days)||3||
59494987|NCT01427972|75585609|FG009|COMPLETED|Treatment Period 1 (21 Days)||3||
59494988|NCT01427972|75585610|FG010|COMPLETED|Treatment Period 1 (21 Days)||3||
59494989|NCT01427972|75585611|FG011|COMPLETED|Treatment Period 1 (21 Days)||4||
59494990|NCT01427972|75585600|FG000|NOT COMPLETED|Treatment Period 1 (21 Days)||0||
59494991|NCT01427972|75585601|FG001|NOT COMPLETED|Treatment Period 1 (21 Days)||0||
59494992|NCT01427972|75585602|FG002|NOT COMPLETED|Treatment Period 1 (21 Days)||0||
59494993|NCT01427972|75585603|FG003|NOT COMPLETED|Treatment Period 1 (21 Days)||0||
59494994|NCT01427972|75585604|FG004|NOT COMPLETED|Treatment Period 1 (21 Days)||0||
59494995|NCT01427972|75585605|FG005|NOT COMPLETED|Treatment Period 1 (21 Days)||0||
59494996|NCT01427972|75585606|FG006|NOT COMPLETED|Treatment Period 1 (21 Days)||0||
59494997|NCT01427972|75585607|FG007|NOT COMPLETED|Treatment Period 1 (21 Days)||1||
59494998|NCT01427972|75585608|FG008|NOT COMPLETED|Treatment Period 1 (21 Days)||0||
59494999|NCT01427972|75585609|FG009|NOT COMPLETED|Treatment Period 1 (21 Days)||0||
59495000|NCT01427972|75585610|FG010|NOT COMPLETED|Treatment Period 1 (21 Days)||0||
59495001|NCT01427972|75585611|FG011|NOT COMPLETED|Treatment Period 1 (21 Days)||0||
59495002|NCT01427972|75585600|FG000|STARTED|Washout (at Least 28 Days)||3||
59495003|NCT01427972|75585601|FG001|STARTED|Washout (at Least 28 Days)||4||
59495004|NCT01427972|75585602|FG002|STARTED|Washout (at Least 28 Days)||4||
59495005|NCT01427972|75585603|FG003|STARTED|Washout (at Least 28 Days)||3||
59495006|NCT01427972|75585604|FG004|STARTED|Washout (at Least 28 Days)||4||
59495007|NCT01427972|75585605|FG005|STARTED|Washout (at Least 28 Days)||3||
59495008|NCT01427972|75585606|FG006|STARTED|Washout (at Least 28 Days)||3||
59495009|NCT01427972|75585607|FG007|STARTED|Washout (at Least 28 Days)||4||
59495010|NCT01427972|75585608|FG008|STARTED|Washout (at Least 28 Days)||3||
59495011|NCT01427972|75585609|FG009|STARTED|Washout (at Least 28 Days)||3||
59495012|NCT01427972|75585610|FG010|STARTED|Washout (at Least 28 Days)||3||
59495013|NCT01427972|75585611|FG011|STARTED|Washout (at Least 28 Days)||4||
59495014|NCT01427972|75585600|FG000|COMPLETED|Washout (at Least 28 Days)||3||
59495015|NCT01427972|75585601|FG001|COMPLETED|Washout (at Least 28 Days)||4||
59495016|NCT01427972|75585602|FG002|COMPLETED|Washout (at Least 28 Days)||4||
59495017|NCT01427972|75585603|FG003|COMPLETED|Washout (at Least 28 Days)||3||
59495018|NCT01427972|75585604|FG004|COMPLETED|Washout (at Least 28 Days)||4||
59495019|NCT01427972|75585605|FG005|COMPLETED|Washout (at Least 28 Days)||1||
59495020|NCT01427972|75585606|FG006|COMPLETED|Washout (at Least 28 Days)||3||
59495021|NCT01427972|75585607|FG007|COMPLETED|Washout (at Least 28 Days)||4||
59495022|NCT01427972|75585608|FG008|COMPLETED|Washout (at Least 28 Days)||3||
59495023|NCT01427972|75585609|FG009|COMPLETED|Washout (at Least 28 Days)||3||
59495024|NCT01427972|75585610|FG010|COMPLETED|Washout (at Least 28 Days)||3||
59495025|NCT01427972|75585611|FG011|COMPLETED|Washout (at Least 28 Days)||4||
59495026|NCT01427972|75585600|FG000|NOT COMPLETED|Washout (at Least 28 Days)||0||
59495027|NCT01427972|75585601|FG001|NOT COMPLETED|Washout (at Least 28 Days)||0||
59495028|NCT01427972|75585602|FG002|NOT COMPLETED|Washout (at Least 28 Days)||0||
59495029|NCT01427972|75585603|FG003|NOT COMPLETED|Washout (at Least 28 Days)||0||
59495030|NCT01427972|75585604|FG004|NOT COMPLETED|Washout (at Least 28 Days)||0||
59495031|NCT01427972|75585605|FG005|NOT COMPLETED|Washout (at Least 28 Days)||2||
59495032|NCT01427972|75585606|FG006|NOT COMPLETED|Washout (at Least 28 Days)||0||
59495033|NCT01427972|75585607|FG007|NOT COMPLETED|Washout (at Least 28 Days)||0||
59495034|NCT01427972|75585608|FG008|NOT COMPLETED|Washout (at Least 28 Days)||0||
59495035|NCT01427972|75585609|FG009|NOT COMPLETED|Washout (at Least 28 Days)||0||
59495036|NCT01427972|75585610|FG010|NOT COMPLETED|Washout (at Least 28 Days)||0||
59762557|NCT00534313|75882338|FG001|COMPLETED|Short-term Period|Completed the short-term study|34||
59495037|NCT01427972|75585611|FG011|NOT COMPLETED|Washout (at Least 28 Days)||0||
59495038|NCT01427972|75585600|FG000|STARTED|Treatment Period 2 (21 Days)||3||
59495039|NCT01427972|75585601|FG001|STARTED|Treatment Period 2 (21 Days)||4||
59495040|NCT01427972|75585602|FG002|STARTED|Treatment Period 2 (21 Days)||4||
59495041|NCT01427972|75585603|FG003|STARTED|Treatment Period 2 (21 Days)||3||
59495042|NCT01427972|75585604|FG004|STARTED|Treatment Period 2 (21 Days)||4||
59495043|NCT01427972|75585605|FG005|STARTED|Treatment Period 2 (21 Days)||1||
59495044|NCT01427972|75585606|FG006|STARTED|Treatment Period 2 (21 Days)||3||
59495045|NCT01427972|75585607|FG007|STARTED|Treatment Period 2 (21 Days)||4||
59495046|NCT01427972|75585608|FG008|STARTED|Treatment Period 2 (21 Days)||3||
59495047|NCT01427972|75585609|FG009|STARTED|Treatment Period 2 (21 Days)||3||
59495048|NCT01427972|75585610|FG010|STARTED|Treatment Period 2 (21 Days)||3||
59495049|NCT01427972|75585611|FG011|STARTED|Treatment Period 2 (21 Days)||4||
59495050|NCT01427972|75585600|FG000|COMPLETED|Treatment Period 2 (21 Days)||3||
59495051|NCT01427972|75585601|FG001|COMPLETED|Treatment Period 2 (21 Days)||3||
59495052|NCT01427972|75585602|FG002|COMPLETED|Treatment Period 2 (21 Days)||4||
59495053|NCT01427972|75585603|FG003|COMPLETED|Treatment Period 2 (21 Days)||3||
59495054|NCT01427972|75585604|FG004|COMPLETED|Treatment Period 2 (21 Days)||4||
59495055|NCT01427972|75585605|FG005|COMPLETED|Treatment Period 2 (21 Days)||1||
59495056|NCT01427972|75585606|FG006|COMPLETED|Treatment Period 2 (21 Days)||3||
59495057|NCT01427972|75585607|FG007|COMPLETED|Treatment Period 2 (21 Days)||4||
59495058|NCT01427972|75585608|FG008|COMPLETED|Treatment Period 2 (21 Days)||3||
59495059|NCT01427972|75585609|FG009|COMPLETED|Treatment Period 2 (21 Days)||3||
59495060|NCT01427972|75585610|FG010|COMPLETED|Treatment Period 2 (21 Days)||3||
59495061|NCT01427972|75585611|FG011|COMPLETED|Treatment Period 2 (21 Days)||4||
59495062|NCT01427972|75585600|FG000|NOT COMPLETED|Treatment Period 2 (21 Days)||0||
59495063|NCT01427972|75585601|FG001|NOT COMPLETED|Treatment Period 2 (21 Days)||1||
59495064|NCT01427972|75585602|FG002|NOT COMPLETED|Treatment Period 2 (21 Days)||0||
59495065|NCT01427972|75585603|FG003|NOT COMPLETED|Treatment Period 2 (21 Days)||0||
59495066|NCT01427972|75585604|FG004|NOT COMPLETED|Treatment Period 2 (21 Days)||0||
59495067|NCT01427972|75585605|FG005|NOT COMPLETED|Treatment Period 2 (21 Days)||0||
59495068|NCT01427972|75585606|FG006|NOT COMPLETED|Treatment Period 2 (21 Days)||0||
59495069|NCT01427972|75585607|FG007|NOT COMPLETED|Treatment Period 2 (21 Days)||0||
59495070|NCT01427972|75585608|FG008|NOT COMPLETED|Treatment Period 2 (21 Days)||0||
59495071|NCT01427972|75585609|FG009|NOT COMPLETED|Treatment Period 2 (21 Days)||0||
59495072|NCT01427972|75585610|FG010|NOT COMPLETED|Treatment Period 2 (21 Days)||0||
59495073|NCT01427972|75585611|FG011|NOT COMPLETED|Treatment Period 2 (21 Days)||0||
59495074|NCT00336323|75585626|FG000|STARTED|Overall Study||19||
59495075|NCT00336323|75585627|FG001|STARTED|Overall Study||22||
59495076|NCT00336323|75585628|FG002|STARTED|Overall Study||24||
59495077|NCT00336323|75585629|FG003|STARTED|Overall Study||22||
59495078|NCT00336323|75585630|FG004|STARTED|Overall Study||22||
59607124|NCT03859739|75717640|FG001|STARTED|Overall Study||6||
59495079|NCT00336323|75585626|FG000|3 Week Visit|Overall Study||18||
59495080|NCT00336323|75585627|FG001|3 Week Visit|Overall Study||21||
59495081|NCT00336323|75585628|FG002|3 Week Visit|Overall Study||24||
59495082|NCT00336323|75585629|FG003|3 Week Visit|Overall Study||22||
59495083|NCT00336323|75585630|FG004|3 Week Visit|Overall Study|Laser given late at six weeks for one patient|20||
59495084|NCT00336323|75585626|FG000|6 Week Visit|Overall Study||18||
59495085|NCT00336323|75585627|FG001|6 Week Visit|Overall Study||22||
59495086|NCT00336323|75585628|FG002|6 Week Visit|Overall Study||24||
59495087|NCT00336323|75585629|FG003|6 Week Visit|Overall Study||22||
59495088|NCT00336323|75585630|FG004|6 Week Visit|Overall Study|1 patient was dropped - injection was given late at 9 wks for one patient|20||
59495089|NCT00336323|75585626|FG000|9 Week Visit|Overall Study||18||
59495090|NCT00336323|75585627|FG001|9 Week Visit|Overall Study||21||
59495091|NCT00336323|75585628|FG002|9 Week Visit|Overall Study||23||
59495092|NCT00336323|75585629|FG003|9 Week Visit|Overall Study||21||
59495093|NCT00336323|75585630|FG004|9 Week Visit|Overall Study||19||
59495094|NCT00336323|75585626|FG000|12 Week Visit|Overall Study||19||
59495095|NCT00336323|75585627|FG001|12 Week Visit|Overall Study||21||
59495096|NCT00336323|75585628|FG002|12 Week Visit|Overall Study||24||
59495097|NCT00336323|75585629|FG003|12 Week Visit|Overall Study||22||
59495098|NCT00336323|75585630|FG004|12 Week Visit|Overall Study|1 patient was dropped from study|20||
59495099|NCT00336323|75585626|FG000|18 Week Visit|Overall Study||19||
59495100|NCT00336323|75585627|FG001|18 Week Visit|Overall Study||22||
59495101|NCT00336323|75585628|FG002|18 Week Visit|Overall Study||23||
59607125|NCT03859739|75717641|FG002|STARTED|Overall Study||6||
59607126|NCT03859739|75717642|FG003|STARTED|Overall Study||4||
59607127|NCT03859739|75717639|FG000|COMPLETED|Overall Study||5||
59607128|NCT03859739|75717640|FG001|COMPLETED|Overall Study||6||
59495102|NCT00336323|75585629|FG003|18 Week Visit|Overall Study||21||
59495103|NCT00336323|75585630|FG004|18 Week Visit|Overall Study|1 patient was dropped from the study|18||
59495104|NCT00336323|75585626|FG000|24 Week Visit|Overall Study||18||
59495105|NCT00336323|75585627|FG001|24 Week Visit|Overall Study|1 patient was dropped from the study|20||
59495106|NCT00336323|75585628|FG002|24 Week Visit|Overall Study|1 patient was dropped from the study|22||
59495107|NCT00336323|75585629|FG003|24 Week Visit|Overall Study||22||
59495108|NCT00336323|75585630|FG004|24 Week Visit|Overall Study||19||
59495109|NCT00336323|75585626|FG000|COMPLETED|Overall Study||19||
59495110|NCT00336323|75585627|FG001|COMPLETED|Overall Study||21||
59495111|NCT00336323|75585628|FG002|COMPLETED|Overall Study||23||
59495112|NCT00336323|75585629|FG003|COMPLETED|Overall Study||22||
59495113|NCT00336323|75585630|FG004|COMPLETED|Overall Study||19||
59495114|NCT00336323|75585626|FG000|NOT COMPLETED|Overall Study||0||
59495115|NCT00336323|75585627|FG001|NOT COMPLETED|Overall Study||1||
59495116|NCT00336323|75585628|FG002|NOT COMPLETED|Overall Study||1||
59495117|NCT00336323|75585629|FG003|NOT COMPLETED|Overall Study||0||
59495118|NCT00336323|75585630|FG004|NOT COMPLETED|Overall Study||3||
59495119|NCT01427738|75585648|FG000|STARTED|Overall Study||110||
59495120|NCT01427738|75585649|FG001|STARTED|Overall Study||111||
59495121|NCT01427738|75585648|FG000|COMPLETED|Overall Study||91||
59495122|NCT01427738|75585649|FG001|COMPLETED|Overall Study||90||
59495123|NCT01427738|75585648|FG000|NOT COMPLETED|Overall Study||19||
59495124|NCT01427738|75585649|FG001|NOT COMPLETED|Overall Study||21||
59495125|NCT01426958|75585655|FG000|STARTED|Overall Study||24||
59495126|NCT01426958|75585655|FG000|COMPLETED|Overall Study||22||
59495127|NCT01426958|75585655|FG000|NOT COMPLETED|Overall Study||2||
59495128|NCT00337181|75585665|FG000|STARTED|Overall Study||49||
59495129|NCT00337181|75585666|FG001|STARTED|Overall Study||65||
59495130|NCT00337181|75585665|FG000|COMPLETED|Overall Study||49||
59495131|NCT00337181|75585666|FG001|COMPLETED|Overall Study||65||
59495132|NCT00337181|75585665|FG000|NOT COMPLETED|Overall Study||0||
59495133|NCT00337181|75585666|FG001|NOT COMPLETED|Overall Study||0||
59495134|NCT00397813|75585678|FG000|STARTED|Overall Study||36||
59495135|NCT00397813|75585679|FG001|STARTED|Overall Study||0||
59495136|NCT00397813|75585680|FG002|STARTED|Overall Study||0||
59495137|NCT00397813|75585681|FG003|STARTED|Overall Study||12||
59495138|NCT00397813|75585682|FG004|STARTED|Overall Study||5||
59495139|NCT00397813|75585683|FG005|STARTED|Overall Study||24||
59495140|NCT00397813|75585678|FG000|COMPLETED|Overall Study||36||
59495141|NCT00397813|75585679|FG001|COMPLETED|Overall Study||0||
59495142|NCT00397813|75585680|FG002|COMPLETED|Overall Study||0||
59495143|NCT00397813|75585681|FG003|COMPLETED|Overall Study||12||
59495144|NCT00397813|75585682|FG004|COMPLETED|Overall Study||5||
59495145|NCT00397813|75585683|FG005|COMPLETED|Overall Study||24||
59495146|NCT00397813|75585678|FG000|NOT COMPLETED|Overall Study||0||
59495147|NCT00397813|75585679|FG001|NOT COMPLETED|Overall Study||0||
59495148|NCT00397813|75585680|FG002|NOT COMPLETED|Overall Study||0||
59495149|NCT00397813|75585681|FG003|NOT COMPLETED|Overall Study||0||
59495150|NCT00397813|75585682|FG004|NOT COMPLETED|Overall Study||0||
59495151|NCT00397813|75585683|FG005|NOT COMPLETED|Overall Study||0||
59495152|NCT00398983|75585699|FG000|STARTED|Overall Study||20||
59495153|NCT00398983|75585700|FG001|STARTED|Overall Study||25||
59495154|NCT00398983|75585699|FG000|COMPLETED|Overall Study||20||
59495155|NCT00398983|75585700|FG001|COMPLETED|Overall Study||25||
59495156|NCT00398983|75585699|FG000|NOT COMPLETED|Overall Study||0||
59495157|NCT00398983|75585700|FG001|NOT COMPLETED|Overall Study||0||
59495158|NCT00358579|75585708|FG000|STARTED|Overall Study||353||
59495159|NCT00358579|75585709|FG001|STARTED|Overall Study||374||
59495160|NCT00358579|75585708|FG000|COMPLETED|Overall Study||353||
59495161|NCT00358579|75585709|FG001|COMPLETED|Overall Study||374||
59495162|NCT00358579|75585708|FG000|NOT COMPLETED|Overall Study||0||
59495163|NCT00358579|75585709|FG001|NOT COMPLETED|Overall Study||0||
59495164|NCT00338039|75585715|FG000|STARTED|Overall Study||69||
59495165|NCT00338039|75585715|FG000|COMPLETED|Overall Study||69||
59495166|NCT00338039|75585715|FG000|NOT COMPLETED|Overall Study||0||
59495167|NCT00358657|75585719|FG000|STARTED|Overall Study||14||
59495168|NCT00358657|75585719|FG000|COMPLETED|Overall Study||14||
59495169|NCT00358657|75585719|FG000|NOT COMPLETED|Overall Study||0||
59495170|NCT00340379|75585725|FG000|STARTED|Overall Study||35||
59495171|NCT00340379|75585726|FG001|STARTED|Overall Study||37||
59495172|NCT00340379|75585725|FG000|COMPLETED|Overall Study||27||
59495173|NCT00340379|75585726|FG001|COMPLETED|Overall Study||28||
59495174|NCT00340379|75585725|FG000|NOT COMPLETED|Overall Study||8||
59495175|NCT00340379|75585726|FG001|NOT COMPLETED|Overall Study||9||
59495176|NCT00342563|75585736|FG000|STARTED|Overall Study||41||
59495177|NCT00342563|75585737|FG001|STARTED|Overall Study||27||
59495178|NCT00342563|75585738|FG002|STARTED|Overall Study||40||
59495179|NCT00342563|75585739|FG003|STARTED|Overall Study||28||
59495180|NCT00342563|75585736|FG000|COMPLETED|Overall Study||35||
59495181|NCT00342563|75585737|FG001|COMPLETED|Overall Study||19||
59495182|NCT00342563|75585738|FG002|COMPLETED|Overall Study||26||
59495183|NCT00342563|75585739|FG003|COMPLETED|Overall Study||22||
59495184|NCT00342563|75585736|FG000|NOT COMPLETED|Overall Study||6||
59495185|NCT00342563|75585737|FG001|NOT COMPLETED|Overall Study||8||
59495186|NCT00342563|75585738|FG002|NOT COMPLETED|Overall Study||14||
59495187|NCT00342563|75585739|FG003|NOT COMPLETED|Overall Study||6||
59495188|NCT00358735|75585753|FG000|STARTED|Overall Study||204||
59495189|NCT00358735|75585754|FG001|STARTED|Overall Study||207||
59495190|NCT00358735|75585753|FG000|Completed Safety|Overall Study||198||
59495191|NCT00358735|75585754|FG001|Completed Safety|Overall Study||194||
60012125|NCT02531373|76128018|FG006|Vaccination 3|Overall Study||49||
60012126|NCT02531373|76128019|FG007|Vaccination 3|Overall Study||51||
60012127|NCT02531373|76128020|FG008|Vaccination 3|Overall Study||49||
60012128|NCT02531373|76128012|FG000|Vaccination 4|Overall Study||0||
60012129|NCT02531373|76128013|FG001|Vaccination 4|Overall Study||0||
60012130|NCT02531373|76128014|FG002|Vaccination 4|Overall Study||0||
59495192|NCT00358735|75585753|FG000|Not Completed Safety|Overall Study||6||
59495193|NCT00358735|75585754|FG001|Not Completed Safety|Overall Study||13||
59495194|NCT00358735|75585753|FG000|COMPLETED|Overall Study|Efficacy|196||
59495195|NCT00358735|75585754|FG001|COMPLETED|Overall Study|Efficacy|190||
59495196|NCT00358735|75585753|FG000|NOT COMPLETED|Overall Study||8||
59495197|NCT00358735|75585754|FG001|NOT COMPLETED|Overall Study||17||
59495198|NCT00359203|75585762|FG000|STARTED|Overall Study||39||
59495199|NCT00359203|75585763|FG001|STARTED|Overall Study||38||
59495200|NCT00359203|75585762|FG000|COMPLETED|Overall Study||39||
59495201|NCT00359203|75585763|FG001|COMPLETED|Overall Study||38||
59495202|NCT00359203|75585762|FG000|NOT COMPLETED|Overall Study||0||
59495203|NCT00359203|75585763|FG001|NOT COMPLETED|Overall Study||0||
59495204|NCT02109419|75585769|FG000|STARTED|Overall Study||57||
59495205|NCT02109419|75585769|FG000|COMPLETED|Overall Study||57||
59495206|NCT02109419|75585769|FG000|NOT COMPLETED|Overall Study||0||
59495207|NCT00359983|75585778|FG000|STARTED|Year 1 Persistence Follow-up||138||
59495208|NCT00359983|75585779|FG001|STARTED|Year 1 Persistence Follow-up||70||
59495209|NCT00359983|75585780|FG002|STARTED|Year 1 Persistence Follow-up||62||
59495210|NCT00359983|75585778|FG000|COMPLETED|Year 1 Persistence Follow-up||138||
59495211|NCT00359983|75585779|FG001|COMPLETED|Year 1 Persistence Follow-up||70||
59495212|NCT00359983|75585780|FG002|COMPLETED|Year 1 Persistence Follow-up||62||
59495213|NCT00359983|75585778|FG000|NOT COMPLETED|Year 1 Persistence Follow-up||0||
59495214|NCT00359983|75585779|FG001|NOT COMPLETED|Year 1 Persistence Follow-up||0||
59495215|NCT00359983|75585780|FG002|NOT COMPLETED|Year 1 Persistence Follow-up||0||
59495216|NCT00359983|75585778|FG000|STARTED|Year 3 Persistence Follow-up||103||
59495217|NCT00359983|75585779|FG001|STARTED|Year 3 Persistence Follow-up||47||
59495218|NCT00359983|75585780|FG002|STARTED|Year 3 Persistence Follow-up||51||
59495219|NCT00359983|75585778|FG000|COMPLETED|Year 3 Persistence Follow-up||103||
59495220|NCT00359983|75585779|FG001|COMPLETED|Year 3 Persistence Follow-up||47||
59495221|NCT00359983|75585780|FG002|COMPLETED|Year 3 Persistence Follow-up||51||
59495222|NCT00359983|75585778|FG000|NOT COMPLETED|Year 3 Persistence Follow-up||0||
59495223|NCT00359983|75585779|FG001|NOT COMPLETED|Year 3 Persistence Follow-up||0||
59495224|NCT00359983|75585780|FG002|NOT COMPLETED|Year 3 Persistence Follow-up||0||
59607129|NCT03859739|75717641|FG002|COMPLETED|Overall Study||6||
60012131|NCT02531373|76128015|FG003|Vaccination 4|Overall Study||0||
60012132|NCT02531373|76128016|FG004|Vaccination 4|Overall Study||44||
60012133|NCT02531373|76128017|FG005|Vaccination 4|Overall Study||43||
59495225|NCT00359983|75585778|FG000|STARTED|Year 5 Persistence Follow-up||95||
60012134|NCT02531373|76128018|FG006|Vaccination 4|Overall Study||43||
60012135|NCT02531373|76128019|FG007|Vaccination 4|Overall Study||43||
60012136|NCT02531373|76128020|FG008|Vaccination 4|Overall Study||43||
59495226|NCT00359983|75585779|FG001|STARTED|Year 5 Persistence Follow-up||44||
59518981|NCT03587428|75612872|FG002|STARTED|Period 1||3||
59607130|NCT03859739|75717642|FG003|COMPLETED|Overall Study||4||
59884928|NCT03022292|76007741|FG000|NOT COMPLETED|Overall Study||2||
59884929|NCT03599193|76007747|FG000|STARTED|Overall Study||34||
59884930|NCT03599193|76007748|FG001|STARTED|Overall Study||24||
59884931|NCT03599193|76007747|FG000|COMPLETED|Overall Study||32||
59884932|NCT03599193|76007748|FG001|COMPLETED|Overall Study||21||
59884933|NCT03599193|76007747|FG000|NOT COMPLETED|Overall Study||2||
60012137|NCT02531373|76128012|FG000|COMPLETED|Overall Study||20||
60012138|NCT02531373|76128013|FG001|COMPLETED|Overall Study||20||
60012139|NCT02531373|76128014|FG002|COMPLETED|Overall Study||20||
60012140|NCT02531373|76128015|FG003|COMPLETED|Overall Study||20||
60012141|NCT02531373|76128016|FG004|COMPLETED|Overall Study||43||
60012142|NCT02531373|76128017|FG005|COMPLETED|Overall Study||42||
60012143|NCT02531373|76128018|FG006|COMPLETED|Overall Study||41||
60012144|NCT02531373|76128019|FG007|COMPLETED|Overall Study||43||
60012145|NCT02531373|76128020|FG008|COMPLETED|Overall Study||43||
60012146|NCT02531373|76128012|FG000|NOT COMPLETED|Overall Study||0||
60012147|NCT02531373|76128013|FG001|NOT COMPLETED|Overall Study||0||
60012148|NCT02531373|76128014|FG002|NOT COMPLETED|Overall Study||0||
60012149|NCT02531373|76128015|FG003|NOT COMPLETED|Overall Study||0||
59495227|NCT00359983|75585780|FG002|STARTED|Year 5 Persistence Follow-up||42||
59495228|NCT00359983|75585778|FG000|COMPLETED|Year 5 Persistence Follow-up||95||
59495229|NCT00359983|75585779|FG001|COMPLETED|Year 5 Persistence Follow-up||44||
59495230|NCT00359983|75585780|FG002|COMPLETED|Year 5 Persistence Follow-up||42||
59495231|NCT00359983|75585778|FG000|NOT COMPLETED|Year 5 Persistence Follow-up||0||
59495232|NCT00359983|75585779|FG001|NOT COMPLETED|Year 5 Persistence Follow-up||0||
59495233|NCT00359983|75585780|FG002|NOT COMPLETED|Year 5 Persistence Follow-up||0||
59884934|NCT03599193|76007748|FG001|NOT COMPLETED|Overall Study||3||
60012150|NCT02531373|76128016|FG004|NOT COMPLETED|Overall Study||8||
60012151|NCT02531373|76128017|FG005|NOT COMPLETED|Overall Study||9||
60012152|NCT02531373|76128018|FG006|NOT COMPLETED|Overall Study||11||
60012153|NCT02531373|76128019|FG007|NOT COMPLETED|Overall Study||9||
59495234|NCT00345371|75585790|FG000|STARTED|Overall Study||69||
59495235|NCT00345371|75585791|FG001|STARTED|Overall Study||71||
59884935|NCT03166124|76007757|FG000|STARTED|Treatment Period 1||20||
59884936|NCT03166124|76007758|FG001|STARTED|Treatment Period 1||20||
59884937|NCT03166124|76007759|FG002|STARTED|Treatment Period 1||19||
60012154|NCT02531373|76128020|FG008|NOT COMPLETED|Overall Study||9||
60012155|NCT02606279|76128043|FG000|STARTED|Overall Study||0||
60012156|NCT02606279|76128044|FG001|STARTED|Overall Study||1||
60012157|NCT02606279|76128043|FG000|COMPLETED|Overall Study||0||
60012158|NCT02606279|76128044|FG001|COMPLETED|Overall Study||0||
60012159|NCT02606279|76128043|FG000|NOT COMPLETED|Overall Study||0||
60012160|NCT02606279|76128044|FG001|NOT COMPLETED|Overall Study||1||
60012161|NCT03538717|76128050|FG000|STARTED|Overall Study||157||
60012162|NCT03538717|76128050|FG000|COMPLETED|Overall Study||157||
60012163|NCT03538717|76128050|FG000|NOT COMPLETED|Overall Study||0||
60012164|NCT02643355|76128058|FG000|STARTED|Overall Study||34||
60012165|NCT02643355|76128059|FG001|STARTED|Overall Study||35||
60012166|NCT02643355|76128058|FG000|COMPLETED|Overall Study||33||
60012167|NCT02643355|76128059|FG001|COMPLETED|Overall Study||30||
60012168|NCT02643355|76128058|FG000|NOT COMPLETED|Overall Study||1||
60012169|NCT02643355|76128059|FG001|NOT COMPLETED|Overall Study||5||
60012170|NCT02604017|76128067|FG000|STARTED|Overall Study||352|Intent-to-treat population: all participants who received at least 1 dose of study drug.|
60012171|NCT02604017|76128068|FG001|STARTED|Overall Study||351|Intent-to-treat population: all participants who received at least 1 dose of study drug.|
60012172|NCT02604017|76128067|FG000|COMPLETED|Overall Study||346||
60012173|NCT02604017|76128068|FG001|COMPLETED|Overall Study||343||
60012174|NCT02604017|76128067|FG000|NOT COMPLETED|Overall Study||6||
60012175|NCT02604017|76128068|FG001|NOT COMPLETED|Overall Study||8||
60012176|NCT02640547|76128074|FG000|STARTED|Overall Study||394||
60012177|NCT02640547|76128074|FG000|COMPLETED|Overall Study||383|HCV ribonucleic acid (RNA) treatment assessment performed at least 10 weeks post-treatment|
60012178|NCT02640547|76128074|FG000|NOT COMPLETED|Overall Study||11||
60012179|NCT02530905|76128088|FG000|STARTED|Double-Blind Period (12 Weeks)||4||
60012180|NCT02530905|76128089|FG001|STARTED|Double-Blind Period (12 Weeks)||8||
60012181|NCT02530905|76128090|FG002|STARTED|Double-Blind Period (12 Weeks)||0||
60012182|NCT02530905|76128088|FG000|Received 4 mg/kg|Double-Blind Period (12 Weeks)||0||
60012183|NCT02530905|76128089|FG001|Received 4 mg/kg|Double-Blind Period (12 Weeks)||8||
59495236|NCT00345371|75585790|FG000|COMPLETED|Overall Study||39||
59495237|NCT00345371|75585791|FG001|COMPLETED|Overall Study||38||
59495238|NCT00345371|75585790|FG000|NOT COMPLETED|Overall Study||30||
59495239|NCT00345371|75585791|FG001|NOT COMPLETED|Overall Study||33||
60012184|NCT02530905|76128090|FG002|Received 4 mg/kg|Double-Blind Period (12 Weeks)||0||
60012185|NCT02530905|76128088|FG000|Received 10 mg/kg|Double-Blind Period (12 Weeks)||0||
60012186|NCT02530905|76128089|FG001|Received 10 mg/kg|Double-Blind Period (12 Weeks)||8||
60012187|NCT02530905|76128090|FG002|Received 10 mg/kg|Double-Blind Period (12 Weeks)||0||
60012188|NCT02530905|76128088|FG000|Received 20 mg/kg|Double-Blind Period (12 Weeks)||0||
60012189|NCT02530905|76128089|FG001|Received 20 mg/kg|Double-Blind Period (12 Weeks)||8||
60012190|NCT02530905|76128090|FG002|Received 20 mg/kg|Double-Blind Period (12 Weeks)||0||
60012191|NCT02530905|76128088|FG000|Received 30 mg/kg|Double-Blind Period (12 Weeks)||0||
60012192|NCT02530905|76128089|FG001|Received 30 mg/kg|Double-Blind Period (12 Weeks)||8||
60012193|NCT02530905|76128090|FG002|Received 30 mg/kg|Double-Blind Period (12 Weeks)||0||
60012194|NCT02530905|76128088|FG000|COMPLETED|Double-Blind Period (12 Weeks)||4||
60012195|NCT02530905|76128089|FG001|COMPLETED|Double-Blind Period (12 Weeks)||8||
59495240|NCT03006276|75585799|FG000|STARTED|Double-blind Period 1 (DB1)||311|Randomized in DB1|
59495241|NCT03006276|75585800|FG001|STARTED|Double-blind Period 1 (DB1)||311|Randomized in DB1|
59762675|NCT01886963|75882517|FG000|NOT COMPLETED|Overall Study||11||
60012196|NCT02530905|76128090|FG002|COMPLETED|Double-Blind Period (12 Weeks)||0||
60012197|NCT02530905|76128088|FG000|NOT COMPLETED|Double-Blind Period (12 Weeks)||0||
60012198|NCT02530905|76128089|FG001|NOT COMPLETED|Double-Blind Period (12 Weeks)||0||
60012199|NCT02530905|76128090|FG002|NOT COMPLETED|Double-Blind Period (12 Weeks)||0||
60012200|NCT02530905|76128088|FG000|STARTED|Open Label Extension Period (132 Weeks)||0||
60012201|NCT02530905|76128089|FG001|STARTED|Open Label Extension Period (132 Weeks)||0||
60012202|NCT02530905|76128090|FG002|STARTED|Open Label Extension Period (132 Weeks)|All participants from the double-blind period amenable to exon 45 skipping were enrolled to open-label extension period.|12||
60012203|NCT02530905|76128088|FG000|COMPLETED|Open Label Extension Period (132 Weeks)||0||
60012204|NCT02530905|76128089|FG001|COMPLETED|Open Label Extension Period (132 Weeks)||0||
60012205|NCT02530905|76128090|FG002|COMPLETED|Open Label Extension Period (132 Weeks)||11||
60012206|NCT02530905|76128088|FG000|NOT COMPLETED|Open Label Extension Period (132 Weeks)||0||
60012207|NCT02530905|76128089|FG001|NOT COMPLETED|Open Label Extension Period (132 Weeks)||0||
60012208|NCT02530905|76128090|FG002|NOT COMPLETED|Open Label Extension Period (132 Weeks)||1||
60012209|NCT02530671|76128114|FG000|STARTED|Overall Study||55||
60012210|NCT02530671|76128115|FG001|STARTED|Overall Study||55||
60012211|NCT02530671|76128114|FG000|COMPLETED|Overall Study||52||
60012212|NCT02530671|76128115|FG001|COMPLETED|Overall Study||55||
60012213|NCT02530671|76128114|FG000|NOT COMPLETED|Overall Study||3||
60012214|NCT02530671|76128115|FG001|NOT COMPLETED|Overall Study||0||
60012215|NCT02603393|76128123|FG000|STARTED|Overall Study||527||
60012216|NCT02603393|76128124|FG001|STARTED|Overall Study||526||
60012217|NCT02603393|76128123|FG000|COMPLETED|Overall Study||456||
60012218|NCT02603393|76128124|FG001|COMPLETED|Overall Study||472||
60012219|NCT02603393|76128123|FG000|NOT COMPLETED|Overall Study||71||
60012220|NCT02603393|76128124|FG001|NOT COMPLETED|Overall Study||54||
60012221|NCT02642653|76128132|FG000|STARTED|Overall Study||14||
60012222|NCT02642653|76128133|FG001|STARTED|Overall Study||16||
60012223|NCT02642653|76128132|FG000|COMPLETED|Overall Study||12||
60012224|NCT02642653|76128133|FG001|COMPLETED|Overall Study||16||
60012225|NCT02642653|76128132|FG000|NOT COMPLETED|Overall Study||2||
60012226|NCT02642653|76128133|FG001|NOT COMPLETED|Overall Study||0||
60012227|NCT01659567|76128139|FG000|STARTED|Overall Study||516||
60012228|NCT01659567|76128139|FG000|COMPLETED|Overall Study||393||
60012229|NCT01659567|76128139|FG000|NOT COMPLETED|Overall Study||123||
60012230|NCT03100435|76128143|FG000|STARTED|Overall Study||8||64
59495242|NCT03006276|75585799|FG000|Not Completed|Double-blind Period 1 (DB1)|2 subjects were randomized who were neither recorded as having completed nor discontinued DB1|43||
59495243|NCT03006276|75585800|FG001|Not Completed|Double-blind Period 1 (DB1)|4 subjects were randomized who were neither recorded as having completed nor discontinued DB1|42||
59495244|NCT03006276|75585799|FG000|COMPLETED|Double-blind Period 1 (DB1)||266|Completed DB1|
59495245|NCT03006276|75585800|FG001|COMPLETED|Double-blind Period 1 (DB1)||265|Completed DB1|
59495246|NCT03006276|75585799|FG000|NOT COMPLETED|Double-blind Period 1 (DB1)||45||
59495247|NCT03006276|75585800|FG001|NOT COMPLETED|Double-blind Period 1 (DB1)||46||
59495248|NCT03006276|75585799|FG000|STARTED|Double-blind Period 2 (DB2)||278|Randomized in DB2|
59495249|NCT03006276|75585800|FG001|STARTED|Double-blind Period 2 (DB2)||267|Randomized in DB2|
59495250|NCT03006276|75585799|FG000|Not Completed|Double-blind Period 2 (DB2)|There is a 13 subject discrepancy that is accounted for by erroneous randomization entries and subjects who were randomized but not dosed in DB2.|16||
59495251|NCT03006276|75585800|FG001|Not Completed|Double-blind Period 2 (DB2)|There is a 5 subject discrepancy that is accounted for by erroneous randomization entries and subjects who were randomized but not dosed in DB2.|20||
59495252|NCT03006276|75585799|FG000|COMPLETED|Double-blind Period 2 (DB2)||249|Completed DB2|
59495253|NCT03006276|75585800|FG001|COMPLETED|Double-blind Period 2 (DB2)||242|Completed DB2|
59495254|NCT03006276|75585799|FG000|NOT COMPLETED|Double-blind Period 2 (DB2)||29||
59495255|NCT03006276|75585800|FG001|NOT COMPLETED|Double-blind Period 2 (DB2)||25||
59495256|NCT00350363|75585827|FG000|STARTED|Overall Study||60||
59495257|NCT00350363|75585827|FG000|COMPLETED|Overall Study||60||
59495258|NCT00350363|75585827|FG000|NOT COMPLETED|Overall Study||0||
59495259|NCT02578992|75585833|FG000|STARTED|Overall Study|November 2014|65||
59495260|NCT02578992|75585834|FG001|STARTED|Overall Study|November 2014|65||
59495261|NCT02578992|75585833|FG000|COMPLETED|Overall Study|October 2015|62||
59495262|NCT02578992|75585834|FG001|COMPLETED|Overall Study|October 2015|62||
59495263|NCT02578992|75585833|FG000|NOT COMPLETED|Overall Study||3||
59495264|NCT02578992|75585834|FG001|NOT COMPLETED|Overall Study||3||
59495265|NCT00351299|75585848|FG000|STARTED|Overall Study||25||
59495266|NCT00351299|75585849|FG001|STARTED|Overall Study||28||
59495267|NCT00351299|75585848|FG000|COMPLETED|Overall Study||25||
59495268|NCT00351299|75585849|FG001|COMPLETED|Overall Study||28||
59495269|NCT00351299|75585848|FG000|NOT COMPLETED|Overall Study||0||
59495270|NCT00351299|75585849|FG001|NOT COMPLETED|Overall Study||0||
59495271|NCT00352001|75585859|FG000|STARTED|Overall Study||37||
59495272|NCT00352001|75585859|FG000|Azacitidine 75mg/Lenalidomide 5mg-14 Day|Overall Study||3||
59495273|NCT00352001|75585859|FG000|Azacitidine 75mg/Lenalidomide 5mg-21 Day|Overall Study||3||
59495274|NCT00352001|75585859|FG000|Azacitidine 75mg/Lenalidomide 10mg-14day|Overall Study||3||
59495275|NCT00352001|75585859|FG000|COMPLETED|Overall Study||37||
59495276|NCT00352001|75585859|FG000|NOT COMPLETED|Overall Study||0||
59495277|NCT00401401|75585867|FG000|STARTED|Overall Study||6||
59495278|NCT00401401|75585868|FG001|STARTED|Overall Study||6||
59495279|NCT00401401|75585869|FG002|STARTED|Overall Study||6||
59495280|NCT00401401|75585870|FG003|STARTED|Overall Study||12||
59495281|NCT00401401|75585867|FG000|COMPLETED|Overall Study||6||
59495282|NCT00401401|75585868|FG001|COMPLETED|Overall Study||6||
59495283|NCT00401401|75585869|FG002|COMPLETED|Overall Study||5||
59495284|NCT00401401|75585870|FG003|COMPLETED|Overall Study||9||
59495285|NCT00401401|75585867|FG000|NOT COMPLETED|Overall Study||0||
59495286|NCT00401401|75585868|FG001|NOT COMPLETED|Overall Study||0||
59495287|NCT00401401|75585869|FG002|NOT COMPLETED|Overall Study||1||
59495288|NCT00401401|75585870|FG003|NOT COMPLETED|Overall Study||3||
59495289|NCT00352781|75585884|FG000|STARTED|Overall Study||1767||
59495290|NCT00352781|75585884|FG000|COMPLETED|Overall Study||884||
59495291|NCT00352781|75585884|FG000|NOT COMPLETED|Overall Study||883||
59495292|NCT00360685|75585890|FG000|STARTED|Overall Study||47||
59495293|NCT00360685|75585891|FG001|STARTED|Overall Study||42||
59495294|NCT00360685|75585890|FG000|COMPLETED|Overall Study||47||
59495295|NCT00360685|75585891|FG001|COMPLETED|Overall Study||42||
59495296|NCT00360685|75585890|FG000|NOT COMPLETED|Overall Study||0||
59495297|NCT00360685|75585891|FG001|NOT COMPLETED|Overall Study||0||
60012231|NCT03100435|76128143|FG000|YAG Laser|Overall Study||8||16
60012232|NCT03100435|76128143|FG000|Carbon Fiber Curette|Overall Study||8||16
59495298|NCT00558519|75585898|FG000|STARTED|Overall Study||318||
59495299|NCT00558519|75585898|FG000|COMPLETED|Overall Study||295||
59495300|NCT00558519|75585898|FG000|NOT COMPLETED|Overall Study||23||
59495301|NCT00403117|75585902|FG000|STARTED|Overall Study||49||
59495302|NCT00403117|75585902|FG000|COMPLETED|Overall Study||29||
59495303|NCT00403117|75585902|FG000|NOT COMPLETED|Overall Study||20||
60012233|NCT03100435|76128143|FG000|Titanium Brush|Overall Study||8||16
60012234|NCT03100435|76128143|FG000|Not Decontaminated|Overall Study||8||16
59495304|NCT00353795|75585933|FG000|STARTED|Overall Study||179||
59495305|NCT00353795|75585933|FG000|COMPLETED|Overall Study||179||
59495306|NCT00353795|75585933|FG000|NOT COMPLETED|Overall Study||0||
59495307|NCT00558285|75585942|FG000|STARTED|Overall Study||50||
59495308|NCT00558285|75585943|FG001|STARTED|Overall Study||51||
59495309|NCT00558285|75585944|FG002|STARTED|Overall Study||51||
59495310|NCT00558285|75585945|FG003|STARTED|Overall Study||52||
59495311|NCT00558285|75585946|FG004|STARTED|Overall Study||53||
59495312|NCT00558285|75585942|FG000|Safety: Received Study Drug|Overall Study||49||
59495313|NCT00558285|75585943|FG001|Safety: Received Study Drug|Overall Study||51||
59495314|NCT00558285|75585944|FG002|Safety: Received Study Drug|Overall Study||51||
59495315|NCT00558285|75585945|FG003|Safety: Received Study Drug|Overall Study||51||
59495316|NCT00558285|75585946|FG004|Safety: Received Study Drug|Overall Study||53||
59495317|NCT00558285|75585942|FG000|COMPLETED|Overall Study||44||
59495318|NCT00558285|75585943|FG001|COMPLETED|Overall Study||48||
59495319|NCT00558285|75585944|FG002|COMPLETED|Overall Study||46||
59495320|NCT00558285|75585945|FG003|COMPLETED|Overall Study||48||
59495321|NCT00558285|75585946|FG004|COMPLETED|Overall Study||49||
59495322|NCT00558285|75585942|FG000|NOT COMPLETED|Overall Study||6||
59495323|NCT00558285|75585943|FG001|NOT COMPLETED|Overall Study||3||
59495324|NCT00558285|75585944|FG002|NOT COMPLETED|Overall Study||5||
59495325|NCT00558285|75585945|FG003|NOT COMPLETED|Overall Study||4||
59495326|NCT00558285|75585946|FG004|NOT COMPLETED|Overall Study||4||
59495327|NCT01389596|75585961|FG000|STARTED|Overall Study||104||
59495328|NCT01389596|75585962|FG001|STARTED|Overall Study||97||
59495329|NCT01389596|75585963|FG002|STARTED|Overall Study||94||
59495330|NCT01389596|75585961|FG000|COMPLETED|Overall Study||94||
59495331|NCT01389596|75585962|FG001|COMPLETED|Overall Study||81||
59495332|NCT01389596|75585963|FG002|COMPLETED|Overall Study||84||
59495333|NCT01389596|75585961|FG000|NOT COMPLETED|Overall Study||10||
59495334|NCT01389596|75585962|FG001|NOT COMPLETED|Overall Study||16||
59495335|NCT01389596|75585963|FG002|NOT COMPLETED|Overall Study||10||
59495336|NCT00407485|75585971|FG000|STARTED|Overall Study||22||
59495337|NCT00407485|75585971|FG000|COMPLETED|Overall Study||22||
59495338|NCT00407485|75585971|FG000|NOT COMPLETED|Overall Study||0||
59495339|NCT00354887|75585976|FG000|STARTED|Overall Study||30||
59495340|NCT00354887|75585976|FG000|COMPLETED|Overall Study||29||
59495341|NCT00354887|75585976|FG000|NOT COMPLETED|Overall Study||1||
59495342|NCT02111863|75585980|FG000|STARTED|Overall Study||6||
59495343|NCT02111863|75585980|FG000|COMPLETED|Overall Study||6||
59495344|NCT02111863|75585980|FG000|NOT COMPLETED|Overall Study||0||
59495345|NCT02078492|75585987|FG000|STARTED|Overall Study||80||
59495346|NCT02078492|75585988|FG001|STARTED|Overall Study||80||
59495347|NCT02078492|75585989|FG002|STARTED|Overall Study||80||
59495348|NCT02078492|75585987|FG000|COMPLETED|Overall Study||80||
59495349|NCT02078492|75585988|FG001|COMPLETED|Overall Study||80||
59495350|NCT02078492|75585989|FG002|COMPLETED|Overall Study||80||
59495351|NCT02078492|75585987|FG000|NOT COMPLETED|Overall Study||0||
59495352|NCT02078492|75585988|FG001|NOT COMPLETED|Overall Study||0||
59495353|NCT02078492|75585989|FG002|NOT COMPLETED|Overall Study||0||
59495354|NCT01405898|75585999|FG000|STARTED|Overall Study||34||
59495355|NCT01405898|75586000|FG001|STARTED|Overall Study||34||
59495356|NCT01405898|75585999|FG000|COMPLETED|Overall Study||32||
59495357|NCT01405898|75586000|FG001|COMPLETED|Overall Study||32||
59495358|NCT01405898|75585999|FG000|NOT COMPLETED|Overall Study||2||
59495359|NCT01405898|75586000|FG001|NOT COMPLETED|Overall Study||2||
59495360|NCT03086317|75586008|FG000|STARTED|Overall Study||10||
59495361|NCT03086317|75586009|FG001|STARTED|Overall Study||8||
59495362|NCT03086317|75586008|FG000|COMPLETED|Overall Study||10||
59495363|NCT03086317|75586009|FG001|COMPLETED|Overall Study||8||
59495364|NCT03086317|75586008|FG000|NOT COMPLETED|Overall Study||0||
59495365|NCT03086317|75586009|FG001|NOT COMPLETED|Overall Study||0||
59495366|NCT00355199|75586017|FG000|STARTED|Overall Study||120||
59495367|NCT00355199|75586018|FG001|STARTED|Overall Study||126||
59495368|NCT00355199|75586017|FG000|COMPLETED|Overall Study||113||
59495369|NCT00355199|75586018|FG001|COMPLETED|Overall Study||122||
59495370|NCT00355199|75586017|FG000|NOT COMPLETED|Overall Study||7||
59495371|NCT00355199|75586018|FG001|NOT COMPLETED|Overall Study||4||
59495372|NCT01389128|75586026|FG000|STARTED|Overall Study||40||
59495373|NCT01389128|75586027|FG001|STARTED|Overall Study||40||
59495374|NCT01389128|75586026|FG000|COMPLETED|Overall Study||35||
59495375|NCT01389128|75586027|FG001|COMPLETED|Overall Study||34||
59495376|NCT01389128|75586026|FG000|NOT COMPLETED|Overall Study||5||
59495377|NCT01389128|75586027|FG001|NOT COMPLETED|Overall Study||6||
59495378|NCT01961531|75586037|FG000|STARTED|Overall Study||40||
59495379|NCT01961531|75586037|FG000|COMPLETED|Overall Study||40||
59495380|NCT01961531|75586037|FG000|NOT COMPLETED|Overall Study||0||
59495381|NCT00363805|75586044|FG000|STARTED|Overall Study||42||
59495382|NCT00363805|75586045|FG001|STARTED|Overall Study||63||
59495383|NCT00363805|75586046|FG002|STARTED|Overall Study||73||
59495384|NCT00363805|75586044|FG000|COMPLETED|Overall Study||38||
59495385|NCT00363805|75586045|FG001|COMPLETED|Overall Study||57||
59495386|NCT00363805|75586046|FG002|COMPLETED|Overall Study||70||
59495387|NCT00363805|75586044|FG000|NOT COMPLETED|Overall Study||4||
59495388|NCT00363805|75586045|FG001|NOT COMPLETED|Overall Study||6||
59495389|NCT00363805|75586046|FG002|NOT COMPLETED|Overall Study||3||
59495390|NCT01388816|75586058|FG000|STARTED|Overall Study||45||
59495391|NCT01388816|75586059|FG001|STARTED|Overall Study||43||
59495392|NCT01388816|75586060|FG002|STARTED|Overall Study||44||
59495393|NCT01388816|75586061|FG003|STARTED|Overall Study||44||
59495394|NCT01388816|75586058|FG000|COMPLETED|Overall Study||43||
59495395|NCT01388816|75586059|FG001|COMPLETED|Overall Study||39||
59495396|NCT01388816|75586060|FG002|COMPLETED|Overall Study||41||
59495397|NCT01388816|75586061|FG003|COMPLETED|Overall Study||44||
59607131|NCT03859739|75717639|FG000|NOT COMPLETED|Overall Study||0||
59607132|NCT03859739|75717640|FG001|NOT COMPLETED|Overall Study||0||
59495398|NCT01388816|75586058|FG000|NOT COMPLETED|Overall Study||2||
59495399|NCT01388816|75586059|FG001|NOT COMPLETED|Overall Study||4||
59495400|NCT01388816|75586060|FG002|NOT COMPLETED|Overall Study||3||
59495401|NCT01388816|75586061|FG003|NOT COMPLETED|Overall Study||0||
59495402|NCT00363883|75586074|FG000|STARTED|Overall Study||14||
59607133|NCT03859739|75717641|FG002|NOT COMPLETED|Overall Study||0||
59495403|NCT00363883|75586074|FG000|COMPLETED|Overall Study||14||
59495404|NCT00363883|75586074|FG000|NOT COMPLETED|Overall Study||0||
59495405|NCT00356057|75586081|FG000|STARTED|Overall Study||58||
59495406|NCT00356057|75586082|FG001|STARTED|Overall Study||61||
59495407|NCT00356057|75586083|FG002|STARTED|Overall Study||34||
59495408|NCT00356057|75586081|FG000|IMPLANTED|Overall Study||49||
59495409|NCT00356057|75586082|FG001|IMPLANTED|Overall Study||52||
59607134|NCT03859739|75717642|FG003|NOT COMPLETED|Overall Study||0||
59495410|NCT00356057|75586083|FG002|IMPLANTED|Overall Study||25||
59495411|NCT00356057|75586081|FG000|COMPLETED|Overall Study||45||
59495412|NCT00356057|75586082|FG001|COMPLETED|Overall Study||47||
59495413|NCT00356057|75586083|FG002|COMPLETED|Overall Study||22||
59495414|NCT00356057|75586081|FG000|NOT COMPLETED|Overall Study||13||
59495415|NCT00356057|75586082|FG001|NOT COMPLETED|Overall Study||14||
59495416|NCT00356057|75586083|FG002|NOT COMPLETED|Overall Study||12||
59495417|NCT00364819|75586095|FG000|STARTED|Overall Study||6||
59495418|NCT00364819|75586095|FG000|COMPLETED|Overall Study||6||
59495419|NCT00364819|75586095|FG000|NOT COMPLETED|Overall Study||0||
59495420|NCT04524351|75586107|FG000|STARTED|Overall Study||10||
59495421|NCT04524351|75586108|FG001|STARTED|Overall Study||10||
59495422|NCT04524351|75586109|FG002|STARTED|Overall Study||11||
59495423|NCT04524351|75586110|FG003|STARTED|Overall Study||10||
59495424|NCT04524351|75586111|FG004|STARTED|Overall Study||12||
59495425|NCT04524351|75586112|FG005|STARTED|Overall Study||5||
59495426|NCT04524351|75586113|FG006|STARTED|Overall Study||6||
59495427|NCT04524351|75586114|FG007|STARTED|Overall Study||10||
59495428|NCT04524351|75586107|FG000|COMPLETED|Overall Study||9||
59495429|NCT04524351|75586108|FG001|COMPLETED|Overall Study||9||
59495430|NCT04524351|75586109|FG002|COMPLETED|Overall Study||11||
59495431|NCT04524351|75586110|FG003|COMPLETED|Overall Study||9||
59495432|NCT04524351|75586111|FG004|COMPLETED|Overall Study||11||
59495433|NCT04524351|75586112|FG005|COMPLETED|Overall Study||5||
59495434|NCT04524351|75586113|FG006|COMPLETED|Overall Study||5||
59495435|NCT04524351|75586114|FG007|COMPLETED|Overall Study||10||
59495436|NCT04524351|75586107|FG000|NOT COMPLETED|Overall Study||1||
59495437|NCT04524351|75586108|FG001|NOT COMPLETED|Overall Study||1||
59495438|NCT04524351|75586109|FG002|NOT COMPLETED|Overall Study||0||
59495439|NCT04524351|75586110|FG003|NOT COMPLETED|Overall Study||1||
59495440|NCT04524351|75586111|FG004|NOT COMPLETED|Overall Study||1||
59495441|NCT04524351|75586112|FG005|NOT COMPLETED|Overall Study||0||
59495442|NCT04524351|75586113|FG006|NOT COMPLETED|Overall Study||1||
59495443|NCT04524351|75586114|FG007|NOT COMPLETED|Overall Study||0||
59495444|NCT02107157|75586135|FG000|STARTED|Overall Study||11||
59495445|NCT02107157|75586136|FG001|STARTED|Overall Study||12||
59495446|NCT02107157|75586137|FG002|STARTED|Overall Study||4||
59495447|NCT02107157|75586135|FG000|COMPLETED|Overall Study||6||
59495448|NCT02107157|75586136|FG001|COMPLETED|Overall Study||11||
59495449|NCT02107157|75586137|FG002|COMPLETED|Overall Study||4||
59495450|NCT02107157|75586135|FG000|NOT COMPLETED|Overall Study||5||
59495451|NCT02107157|75586136|FG001|NOT COMPLETED|Overall Study||1||
59495452|NCT02107157|75586137|FG002|NOT COMPLETED|Overall Study||0||
59495453|NCT00365053|75586145|FG000|STARTED|Overall Study||13||
59495454|NCT00365053|75586145|FG000|COMPLETED|Overall Study||13||
59495455|NCT00365053|75586145|FG000|NOT COMPLETED|Overall Study||0||
59495456|NCT00365209|75586149|FG000|STARTED|Stage 1: Receiving 2g Curcumin||23||
59495457|NCT00365209|75586149|FG000|COMPLETED|Stage 1: Receiving 2g Curcumin||21||
59495458|NCT00365209|75586149|FG000|NOT COMPLETED|Stage 1: Receiving 2g Curcumin||2||
59495459|NCT00365209|75586149|FG000|STARTED|Stage 2: Receiving 4g Curcumin||21||
59495460|NCT00365209|75586149|FG000|COMPLETED|Stage 2: Receiving 4g Curcumin||19||
59495461|NCT00365209|75586149|FG000|NOT COMPLETED|Stage 2: Receiving 4g Curcumin||2||
59495462|NCT02109497|75586154|FG000|STARTED|Overall Study||18||
59495463|NCT02109497|75586154|FG000|COMPLETED|Overall Study|One participant completed the safety assessments but did not complete all doses of the study drugs.|17||
59495464|NCT02109497|75586154|FG000|NOT COMPLETED|Overall Study||1||
59495465|NCT00409825|75586158|FG000|STARTED|Overall Study||61||
59495466|NCT00409825|75586158|FG000|COMPLETED|Overall Study||61||
59495467|NCT00409825|75586158|FG000|NOT COMPLETED|Overall Study||0||
59495468|NCT02104427|75586162|FG000|STARTED|Overall Study||12||
59495469|NCT02104427|75586162|FG000|COMPLETED|Overall Study||12||
59495470|NCT02104427|75586162|FG000|NOT COMPLETED|Overall Study||0||
59495471|NCT00410059|75586184|FG000|STARTED|Overall Study||59||
59495472|NCT00410059|75586184|FG000|COMPLETED|Overall Study||59||
59495473|NCT00410059|75586184|FG000|NOT COMPLETED|Overall Study||0||
59495474|NCT00310427|75586190|FG000|STARTED|Overall Study||27||
59495475|NCT00310427|75586191|FG001|STARTED|Overall Study||26||
59495476|NCT00310427|75586190|FG000|COMPLETED|Overall Study||25||
59495477|NCT00310427|75586191|FG001|COMPLETED|Overall Study||25||
59495478|NCT00310427|75586190|FG000|NOT COMPLETED|Overall Study||2||
59495479|NCT00310427|75586191|FG001|NOT COMPLETED|Overall Study||1||
59495480|NCT00411463|75586199|FG000|STARTED|Overall Study||14||
59495481|NCT00411463|75586200|FG001|STARTED|Overall Study||11||
59495482|NCT00411463|75586199|FG000|COMPLETED|Overall Study||11||
59495483|NCT00411463|75586200|FG001|COMPLETED|Overall Study||8||
59495484|NCT00411463|75586199|FG000|NOT COMPLETED|Overall Study||3||
59495485|NCT00411463|75586200|FG001|NOT COMPLETED|Overall Study||3||
59495486|NCT00356993|75586209|FG000|STARTED|Overall Study||6009||
59495487|NCT00356993|75586209|FG000|COMPLETED|Overall Study||2088||
59495488|NCT00356993|75586209|FG000|NOT COMPLETED|Overall Study||3921||
59495489|NCT00555477|75586215|FG000|STARTED|Overall Study||14||
59495490|NCT00555477|75586216|FG001|STARTED|Overall Study||45||
59495491|NCT00555477|75586215|FG000|COMPLETED|Overall Study||12||
59495492|NCT00555477|75586216|FG001|COMPLETED|Overall Study||32||
59495493|NCT00555477|75586215|FG000|NOT COMPLETED|Overall Study||2||
59495494|NCT00555477|75586216|FG001|NOT COMPLETED|Overall Study||13||
59495495|NCT02109731|75586221|FG000|STARTED|Overall Study||15||
59495496|NCT02109731|75586221|FG000|COMPLETED|Overall Study||15||
59495497|NCT02109731|75586221|FG000|NOT COMPLETED|Overall Study||0||
59495498|NCT00365599|75586225|FG000|STARTED|Overall Study||43||
59495499|NCT00365599|75586225|FG000|COMPLETED|Overall Study||43||
59495500|NCT00365599|75586225|FG000|NOT COMPLETED|Overall Study||0||
59495501|NCT00358007|75586229|FG000|STARTED|Overall Study||30||
59495502|NCT00358007|75586229|FG000|COMPLETED|Overall Study||28||
59495503|NCT00358007|75586229|FG000|NOT COMPLETED|Overall Study||2||
59495504|NCT00554619|75586233|FG000|STARTED|Overall Study||21||
59495505|NCT00554619|75586233|FG000|COMPLETED|Overall Study||18||
59495506|NCT00554619|75586233|FG000|NOT COMPLETED|Overall Study||3||
59495507|NCT02104739|75586237|FG000|STARTED|First Intervention (1 Day)||2||
59495508|NCT02104739|75586238|FG001|STARTED|First Intervention (1 Day)||5||
59495509|NCT02104739|75586239|FG002|STARTED|First Intervention (1 Day)||2||
59495510|NCT02104739|75586240|FG003|STARTED|First Intervention (1 Day)||8||
59495511|NCT02104739|75586241|FG004|STARTED|First Intervention (1 Day)||0||
59495512|NCT02104739|75586242|FG005|STARTED|First Intervention (1 Day)||3||
59495513|NCT02104739|75586243|FG006|STARTED|First Intervention (1 Day)||0||
59495514|NCT02104739|75586237|FG000|COMPLETED|First Intervention (1 Day)||2||
59495515|NCT02104739|75586238|FG001|COMPLETED|First Intervention (1 Day)||4||
59495516|NCT02104739|75586239|FG002|COMPLETED|First Intervention (1 Day)||2||
59495517|NCT02104739|75586240|FG003|COMPLETED|First Intervention (1 Day)||7||
59495518|NCT02104739|75586241|FG004|COMPLETED|First Intervention (1 Day)||0||
59495519|NCT02104739|75586242|FG005|COMPLETED|First Intervention (1 Day)||3||
59495520|NCT02104739|75586243|FG006|COMPLETED|First Intervention (1 Day)||0||
59495521|NCT02104739|75586237|FG000|NOT COMPLETED|First Intervention (1 Day)||0||
59495522|NCT02104739|75586238|FG001|NOT COMPLETED|First Intervention (1 Day)||1||
59495523|NCT02104739|75586239|FG002|NOT COMPLETED|First Intervention (1 Day)||0||
59495524|NCT02104739|75586240|FG003|NOT COMPLETED|First Intervention (1 Day)||1||
59495525|NCT02104739|75586241|FG004|NOT COMPLETED|First Intervention (1 Day)||0||
59495526|NCT02104739|75586242|FG005|NOT COMPLETED|First Intervention (1 Day)||0||
59495527|NCT02104739|75586243|FG006|NOT COMPLETED|First Intervention (1 Day)||0||
59495528|NCT02104739|75586237|FG000|STARTED|Washout (Min of 10 and Max of 107 Days)||1||
59495529|NCT02104739|75586238|FG001|STARTED|Washout (Min of 10 and Max of 107 Days)||4||
59495530|NCT02104739|75586239|FG002|STARTED|Washout (Min of 10 and Max of 107 Days)||2||
59495531|NCT02104739|75586240|FG003|STARTED|Washout (Min of 10 and Max of 107 Days)||7||
59495532|NCT02104739|75586241|FG004|STARTED|Washout (Min of 10 and Max of 107 Days)||0||
59495533|NCT02104739|75586242|FG005|STARTED|Washout (Min of 10 and Max of 107 Days)||2||
59495534|NCT02104739|75586243|FG006|STARTED|Washout (Min of 10 and Max of 107 Days)||0||
59495535|NCT02104739|75586237|FG000|COMPLETED|Washout (Min of 10 and Max of 107 Days)||1||
59495536|NCT02104739|75586238|FG001|COMPLETED|Washout (Min of 10 and Max of 107 Days)||4||
59495537|NCT02104739|75586239|FG002|COMPLETED|Washout (Min of 10 and Max of 107 Days)||2||
59495538|NCT02104739|75586240|FG003|COMPLETED|Washout (Min of 10 and Max of 107 Days)||7||
59495539|NCT02104739|75586241|FG004|COMPLETED|Washout (Min of 10 and Max of 107 Days)||0||
59495540|NCT02104739|75586242|FG005|COMPLETED|Washout (Min of 10 and Max of 107 Days)||2||
59495541|NCT02104739|75586243|FG006|COMPLETED|Washout (Min of 10 and Max of 107 Days)||0||
59495542|NCT02104739|75586237|FG000|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0||
59495543|NCT02104739|75586238|FG001|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0||
59495544|NCT02104739|75586239|FG002|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0||
59495545|NCT02104739|75586240|FG003|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0||
59495546|NCT02104739|75586241|FG004|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0||
59495547|NCT02104739|75586242|FG005|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0||
59495548|NCT02104739|75586243|FG006|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0||
59495549|NCT02104739|75586237|FG000|STARTED|Second Intervention (1 Day)||1||
59495550|NCT02104739|75586238|FG001|STARTED|Second Intervention (1 Day)||4||
59495551|NCT02104739|75586239|FG002|STARTED|Second Intervention (1 Day)||2||
59495552|NCT02104739|75586240|FG003|STARTED|Second Intervention (1 Day)||7||
59495553|NCT02104739|75586241|FG004|STARTED|Second Intervention (1 Day)||0||
59495554|NCT02104739|75586242|FG005|STARTED|Second Intervention (1 Day)||2||
59495555|NCT02104739|75586243|FG006|STARTED|Second Intervention (1 Day)||0||
59495556|NCT02104739|75586237|FG000|COMPLETED|Second Intervention (1 Day)||1||
59495557|NCT02104739|75586238|FG001|COMPLETED|Second Intervention (1 Day)||4||
59495558|NCT02104739|75586239|FG002|COMPLETED|Second Intervention (1 Day)||2||
59495559|NCT02104739|75586240|FG003|COMPLETED|Second Intervention (1 Day)||7||
59495560|NCT02104739|75586241|FG004|COMPLETED|Second Intervention (1 Day)||0||
59495561|NCT02104739|75586242|FG005|COMPLETED|Second Intervention (1 Day)||2||
59495562|NCT02104739|75586243|FG006|COMPLETED|Second Intervention (1 Day)||0||
59495563|NCT02104739|75586237|FG000|NOT COMPLETED|Second Intervention (1 Day)||0||
59495564|NCT02104739|75586238|FG001|NOT COMPLETED|Second Intervention (1 Day)||0||
59495565|NCT02104739|75586239|FG002|NOT COMPLETED|Second Intervention (1 Day)||0||
59495566|NCT02104739|75586240|FG003|NOT COMPLETED|Second Intervention (1 Day)||0||
59495567|NCT02104739|75586241|FG004|NOT COMPLETED|Second Intervention (1 Day)||0||
59495568|NCT02104739|75586242|FG005|NOT COMPLETED|Second Intervention (1 Day)||0||
59495569|NCT02104739|75586243|FG006|NOT COMPLETED|Second Intervention (1 Day)||0||
59495570|NCT02104739|75586237|FG000|STARTED|Washout (Min of 10 and Max of 107 Days)||1||
59495571|NCT02104739|75586238|FG001|STARTED|Washout (Min of 10 and Max of 107 Days)||4||
59495572|NCT02104739|75586239|FG002|STARTED|Washout (Min of 10 and Max of 107 Days)||2||
59495573|NCT02104739|75586240|FG003|STARTED|Washout (Min of 10 and Max of 107 Days)||7||
59495574|NCT02104739|75586241|FG004|STARTED|Washout (Min of 10 and Max of 107 Days)||0||
59495575|NCT02104739|75586242|FG005|STARTED|Washout (Min of 10 and Max of 107 Days)||2||
59495576|NCT02104739|75586243|FG006|STARTED|Washout (Min of 10 and Max of 107 Days)||0||
59495577|NCT02104739|75586237|FG000|COMPLETED|Washout (Min of 10 and Max of 107 Days)||1||
59495578|NCT02104739|75586238|FG001|COMPLETED|Washout (Min of 10 and Max of 107 Days)||4||
59495579|NCT02104739|75586239|FG002|COMPLETED|Washout (Min of 10 and Max of 107 Days)||2||
59495580|NCT02104739|75586240|FG003|COMPLETED|Washout (Min of 10 and Max of 107 Days)||7||
59495581|NCT02104739|75586241|FG004|COMPLETED|Washout (Min of 10 and Max of 107 Days)||0||
59495582|NCT02104739|75586242|FG005|COMPLETED|Washout (Min of 10 and Max of 107 Days)||2||
59495583|NCT02104739|75586243|FG006|COMPLETED|Washout (Min of 10 and Max of 107 Days)||0||
59495584|NCT02104739|75586237|FG000|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0||
59495585|NCT02104739|75586238|FG001|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0||
59495586|NCT02104739|75586239|FG002|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0||
59495587|NCT02104739|75586240|FG003|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0||
59495588|NCT02104739|75586241|FG004|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0||
59495589|NCT02104739|75586242|FG005|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0||
59495590|NCT02104739|75586243|FG006|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0||
59495591|NCT02104739|75586237|FG000|STARTED|Third Intervention (1 Day)||1||
59495592|NCT02104739|75586238|FG001|STARTED|Third Intervention (1 Day)||4||
59495593|NCT02104739|75586239|FG002|STARTED|Third Intervention (1 Day)||2||
59495594|NCT02104739|75586240|FG003|STARTED|Third Intervention (1 Day)||7||
59495595|NCT02104739|75586241|FG004|STARTED|Third Intervention (1 Day)||0||
59495596|NCT02104739|75586242|FG005|STARTED|Third Intervention (1 Day)||2||
59495597|NCT02104739|75586243|FG006|STARTED|Third Intervention (1 Day)||0||
59495598|NCT02104739|75586237|FG000|COMPLETED|Third Intervention (1 Day)||1||
59495599|NCT02104739|75586238|FG001|COMPLETED|Third Intervention (1 Day)||4||
59495600|NCT02104739|75586239|FG002|COMPLETED|Third Intervention (1 Day)||2||
59495601|NCT02104739|75586240|FG003|COMPLETED|Third Intervention (1 Day)||7||
59495602|NCT02104739|75586241|FG004|COMPLETED|Third Intervention (1 Day)||0||
59495603|NCT02104739|75586242|FG005|COMPLETED|Third Intervention (1 Day)||2||
59495604|NCT02104739|75586243|FG006|COMPLETED|Third Intervention (1 Day)||0||
59495605|NCT02104739|75586237|FG000|NOT COMPLETED|Third Intervention (1 Day)||0||
59495606|NCT02104739|75586238|FG001|NOT COMPLETED|Third Intervention (1 Day)||0||
59495607|NCT02104739|75586239|FG002|NOT COMPLETED|Third Intervention (1 Day)||0||
59495608|NCT02104739|75586240|FG003|NOT COMPLETED|Third Intervention (1 Day)||0||
59495609|NCT02104739|75586241|FG004|NOT COMPLETED|Third Intervention (1 Day)||0||
59495610|NCT02104739|75586242|FG005|NOT COMPLETED|Third Intervention (1 Day)||0||
59495611|NCT02104739|75586243|FG006|NOT COMPLETED|Third Intervention (1 Day)||0||
59495612|NCT02104739|75586237|FG000|STARTED|Washout (Min of 10 and Max of 323 Days)||0||
59495613|NCT02104739|75586238|FG001|STARTED|Washout (Min of 10 and Max of 323 Days)||0||
59495614|NCT02104739|75586239|FG002|STARTED|Washout (Min of 10 and Max of 323 Days)||0||
60012235|NCT03100435|76128143|FG000|COMPLETED|Overall Study||8||59
60012236|NCT03100435|76128143|FG000|NOT COMPLETED|Overall Study||0||5
60012237|NCT02605967|76128155|FG000|STARTED|Overall Study||82|All participants to whom study treatment was assigned by randomization|
60012238|NCT02605967|76128156|FG001|STARTED|Overall Study||40|All participants to whom study treatment was assigned by randomization|
60067714|NCT01617187|76182892|FG001|NOT COMPLETED|Randomization Through Start Treatment||0||
59495615|NCT02104739|75586240|FG003|STARTED|Washout (Min of 10 and Max of 323 Days)||0||
59495616|NCT02104739|75586241|FG004|STARTED|Washout (Min of 10 and Max of 323 Days)||0||
59495617|NCT02104739|75586242|FG005|STARTED|Washout (Min of 10 and Max of 323 Days)||0||
59495618|NCT02104739|75586243|FG006|STARTED|Washout (Min of 10 and Max of 323 Days)||8||
59495619|NCT02104739|75586237|FG000|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0||
59495620|NCT02104739|75586238|FG001|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0||
59495621|NCT02104739|75586239|FG002|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0||
59607135|NCT01237613|75717652|FG000|STARTED|Overall Study||4||
59607136|NCT01237613|75717652|FG000|COMPLETED|Overall Study||4||
59495622|NCT02104739|75586240|FG003|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0||
59495623|NCT02104739|75586241|FG004|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0||
59495624|NCT02104739|75586242|FG005|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0||
59495625|NCT02104739|75586243|FG006|COMPLETED|Washout (Min of 10 and Max of 323 Days)||7||
59495626|NCT02104739|75586237|FG000|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0||
59495627|NCT02104739|75586238|FG001|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0||
59495628|NCT02104739|75586239|FG002|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0||
59495629|NCT02104739|75586240|FG003|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0||
59495630|NCT02104739|75586241|FG004|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0||
59495631|NCT02104739|75586242|FG005|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0||
59607137|NCT01237613|75717652|FG000|NOT COMPLETED|Overall Study||0||
59607138|NCT01234103|75717659|FG000|STARTED|Overall Study||542||
59495632|NCT02104739|75586243|FG006|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||1||
59495633|NCT02104739|75586237|FG000|STARTED|Extension Phase (6 Weeks)||0||
59495634|NCT02104739|75586238|FG001|STARTED|Extension Phase (6 Weeks)||0||
59495635|NCT02104739|75586239|FG002|STARTED|Extension Phase (6 Weeks)||0||
59495636|NCT02104739|75586240|FG003|STARTED|Extension Phase (6 Weeks)||0||
59495637|NCT02104739|75586241|FG004|STARTED|Extension Phase (6 Weeks)||0||
59495638|NCT02104739|75586242|FG005|STARTED|Extension Phase (6 Weeks)||0||
59495639|NCT02104739|75586243|FG006|STARTED|Extension Phase (6 Weeks)||8||
59495640|NCT02104739|75586237|FG000|COMPLETED|Extension Phase (6 Weeks)||0||
59495641|NCT02104739|75586238|FG001|COMPLETED|Extension Phase (6 Weeks)||0||
59495642|NCT02104739|75586239|FG002|COMPLETED|Extension Phase (6 Weeks)||0||
59495643|NCT02104739|75586240|FG003|COMPLETED|Extension Phase (6 Weeks)||0||
59495644|NCT02104739|75586241|FG004|COMPLETED|Extension Phase (6 Weeks)||0||
59495645|NCT02104739|75586242|FG005|COMPLETED|Extension Phase (6 Weeks)||0||
59495646|NCT02104739|75586243|FG006|COMPLETED|Extension Phase (6 Weeks)||7||
59495647|NCT02104739|75586237|FG000|NOT COMPLETED|Extension Phase (6 Weeks)||0||
59495648|NCT02104739|75586238|FG001|NOT COMPLETED|Extension Phase (6 Weeks)||0||
59495649|NCT02104739|75586239|FG002|NOT COMPLETED|Extension Phase (6 Weeks)||0||
59495650|NCT02104739|75586240|FG003|NOT COMPLETED|Extension Phase (6 Weeks)||0||
59495651|NCT02104739|75586241|FG004|NOT COMPLETED|Extension Phase (6 Weeks)||0||
59495652|NCT02104739|75586242|FG005|NOT COMPLETED|Extension Phase (6 Weeks)||0||
59495653|NCT02104739|75586243|FG006|NOT COMPLETED|Extension Phase (6 Weeks)||1||
59495654|NCT00411619|75586253|FG000|STARTED|Overall Study||28||
59495655|NCT00411619|75586253|FG000|COMPLETED|Overall Study||22||
59495656|NCT00411619|75586253|FG000|NOT COMPLETED|Overall Study||6||
59495657|NCT02277093|75586258|FG000|STARTED|Overall Study||11||
59495658|NCT02277093|75586258|FG000|COMPLETED|Overall Study||11||
59495659|NCT02277093|75586258|FG000|NOT COMPLETED|Overall Study||0||
59495660|NCT00412087|75586264|FG000|STARTED|Overall Study||134||
60012239|NCT02605967|76128155|FG000|Safety Set|Overall Study||82|All participants who received at least one dose of study medication and had at least one valid post-screening/post-baseline safety assessment.|
60012240|NCT02605967|76128156|FG001|Safety Set|Overall Study||39|All participants who received at least one dose of study medication and had at least one valid post-screening/post-baseline safety assessment.|
60012241|NCT02605967|76128155|FG000|Crossover to Spartalizumab|Overall Study||0|Participants in Chemotherapy arm were allowed to crossover to spartalizumab treatment if they had radiological progression as per RECIST v1.1 by independent central review.|
60012242|NCT02605967|76128156|FG001|Crossover to Spartalizumab|Overall Study||27|Participants in Chemotherapy arm were allowed to crossover to spartalizumab treatment if they had radiological progression as per RECIST v1.1 by independent central review.|
60012243|NCT02605967|76128155|FG000|COMPLETED|Overall Study||0||
59495661|NCT00412087|75586265|FG001|STARTED|Overall Study||131||
59495662|NCT00412087|75586264|FG000|COMPLETED|Overall Study||72||
59495663|NCT00412087|75586265|FG001|COMPLETED|Overall Study||66||
59495664|NCT00412087|75586264|FG000|NOT COMPLETED|Overall Study||62||
59495665|NCT00412087|75586265|FG001|NOT COMPLETED|Overall Study||65||
59495666|NCT00312923|75586273|FG000|STARTED|Overall Study||28||
59495667|NCT00312923|75586274|FG001|STARTED|Overall Study||26||
59495668|NCT00312923|75586273|FG000|COMPLETED|Overall Study||19||
59495669|NCT00312923|75586274|FG001|COMPLETED|Overall Study||20||
59495670|NCT00312923|75586273|FG000|NOT COMPLETED|Overall Study||9||
59495671|NCT00312923|75586274|FG001|NOT COMPLETED|Overall Study||6||
59495672|NCT00412243|75586280|FG000|STARTED|Overall Study||50||
59495673|NCT00412243|75586280|FG000|COMPLETED|Overall Study||50||
59495674|NCT00412243|75586280|FG000|NOT COMPLETED|Overall Study||0||
59495675|NCT01426412|75586293|FG000|STARTED|Overall Study||6||
59495676|NCT01426412|75586294|FG001|STARTED|Overall Study||6||
59495677|NCT01426412|75586295|FG002|STARTED|Overall Study||6||
59495678|NCT01426412|75586296|FG003|STARTED|Overall Study||6||
59495679|NCT01426412|75586297|FG004|STARTED|Overall Study||6||
59495680|NCT01426412|75586298|FG005|STARTED|Overall Study||6||
59495681|NCT01426412|75586299|FG006|STARTED|Overall Study||6||
59495682|NCT01426412|75586300|FG007|STARTED|Overall Study||10||
59495683|NCT01426412|75586301|FG008|STARTED|Overall Study||17||
59495684|NCT01426412|75586293|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6||
59495685|NCT01426412|75586294|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6||
59495686|NCT01426412|75586295|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6||
59495687|NCT01426412|75586296|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6||
59495688|NCT01426412|75586297|FG004|Received at Least 1 Dose of Study Drug|Overall Study||6||
59495689|NCT01426412|75586298|FG005|Received at Least 1 Dose of Study Drug|Overall Study||6||
59495690|NCT01426412|75586299|FG006|Received at Least 1 Dose of Study Drug|Overall Study||6||
59495691|NCT01426412|75586300|FG007|Received at Least 1 Dose of Study Drug|Overall Study||10||
59495692|NCT01426412|75586301|FG008|Received at Least 1 Dose of Study Drug|Overall Study||17||
59495693|NCT01426412|75586293|FG000|COMPLETED|Overall Study||5||
59495694|NCT01426412|75586294|FG001|COMPLETED|Overall Study||6||
59495695|NCT01426412|75586295|FG002|COMPLETED|Overall Study||6||
59495696|NCT01426412|75586296|FG003|COMPLETED|Overall Study||6||
59495697|NCT01426412|75586297|FG004|COMPLETED|Overall Study||5||
59495698|NCT01426412|75586298|FG005|COMPLETED|Overall Study||6||
59495699|NCT01426412|75586299|FG006|COMPLETED|Overall Study||6||
59495700|NCT01426412|75586300|FG007|COMPLETED|Overall Study||7||
59495701|NCT01426412|75586301|FG008|COMPLETED|Overall Study||16||
59495702|NCT01426412|75586293|FG000|NOT COMPLETED|Overall Study||1||
59495703|NCT01426412|75586294|FG001|NOT COMPLETED|Overall Study||0||
59495704|NCT01426412|75586295|FG002|NOT COMPLETED|Overall Study||0||
59495705|NCT01426412|75586296|FG003|NOT COMPLETED|Overall Study||0||
59495706|NCT01426412|75586297|FG004|NOT COMPLETED|Overall Study||1||
59495707|NCT01426412|75586298|FG005|NOT COMPLETED|Overall Study||0||
59495708|NCT01426412|75586299|FG006|NOT COMPLETED|Overall Study||0||
59495709|NCT01426412|75586300|FG007|NOT COMPLETED|Overall Study||3||
59495710|NCT01426412|75586301|FG008|NOT COMPLETED|Overall Study||1||
59495711|NCT00315341|75586334|FG000|STARTED|Overall Study||740||
59495712|NCT00315341|75586335|FG001|STARTED|Overall Study||529||
59495713|NCT00315341|75586334|FG000|COMPLETED|Overall Study||340||
59495714|NCT00315341|75586335|FG001|COMPLETED|Overall Study||391||
59495715|NCT00315341|75586334|FG000|NOT COMPLETED|Overall Study||400||
59495716|NCT00315341|75586335|FG001|NOT COMPLETED|Overall Study||138||
59495717|NCT02277249|75586343|FG000|STARTED|Overall Study||30||
59495718|NCT02277249|75586344|FG001|STARTED|Overall Study||30||
59495719|NCT02277249|75586343|FG000|COMPLETED|Overall Study||30||
59495720|NCT02277249|75586344|FG001|COMPLETED|Overall Study||30||
59495721|NCT02277249|75586343|FG000|NOT COMPLETED|Overall Study||0||
59495722|NCT02277249|75586344|FG001|NOT COMPLETED|Overall Study||0||
59495723|NCT00316355|75586352|FG000|STARTED|Overall Study||15||
59495724|NCT00316355|75586353|FG001|STARTED|Overall Study||19||
59495725|NCT00316355|75586352|FG000|Started Treatment|Overall Study||12||
59495726|NCT00316355|75586353|FG001|Started Treatment|Overall Study||18||
59495727|NCT00316355|75586352|FG000|COMPLETED|Overall Study||10||
59495728|NCT00316355|75586353|FG001|COMPLETED|Overall Study||12||
59495729|NCT00316355|75586352|FG000|NOT COMPLETED|Overall Study||5||
59495730|NCT00316355|75586353|FG001|NOT COMPLETED|Overall Study||7||
59495731|NCT00412867|75586359|FG000|STARTED|Overall Study||58||
59495732|NCT00412867|75586359|FG000|COMPLETED|Overall Study||58||
59495733|NCT00412867|75586359|FG000|NOT COMPLETED|Overall Study||0||
59495734|NCT01730833|75586366|FG000|STARTED|Overall Study||18||
59495735|NCT01730833|75586367|FG001|STARTED|Overall Study||45||
59495736|NCT01730833|75586366|FG000|COMPLETED|Overall Study||18||
59495737|NCT01730833|75586367|FG001|COMPLETED|Overall Study||45||
59495738|NCT01730833|75586366|FG000|NOT COMPLETED|Overall Study||0||
59495739|NCT01730833|75586367|FG001|NOT COMPLETED|Overall Study||0||
59495740|NCT00413335|75586375|FG000|STARTED|Overall Study||12||
59495741|NCT00413335|75586376|FG001|STARTED|Overall Study||9||
59495742|NCT00413335|75586375|FG000|COMPLETED|Overall Study||12||
59495743|NCT00413335|75586376|FG001|COMPLETED|Overall Study||9||
59495744|NCT00413335|75586375|FG000|NOT COMPLETED|Overall Study||0||
59495745|NCT00413335|75586376|FG001|NOT COMPLETED|Overall Study||0||
59495746|NCT00414271|75586382|FG000|STARTED|Overall Study||18||
59495747|NCT00414271|75586382|FG000|COMPLETED|Overall Study||18||
59495748|NCT00414271|75586382|FG000|NOT COMPLETED|Overall Study||0||
59495749|NCT02110147|75586386|FG000|STARTED|Overall Study||4||
59495750|NCT02110147|75586386|FG000|COMPLETED|Overall Study||4||
59495751|NCT02110147|75586386|FG000|NOT COMPLETED|Overall Study||0||
59495752|NCT00414817|75586392|FG000|STARTED|Overall Study||7033||
59495753|NCT00414817|75586393|FG001|STARTED|Overall Study||7031||
59495754|NCT00414817|75586392|FG000|Never Started on ICS|Overall Study|Not initial users of ICS and not starting during study, hence don't qualify for analysis sample.|1465||
59495755|NCT00414817|75586393|FG001|Never Started on ICS|Overall Study|Not initial users of ICS and not starting during study, hence don't qualify for analysis sample.|1392||
59495756|NCT00414817|75586392|FG000|Died or Left Health Plan|Overall Study|These individuals died or terminated Health Plan membership prior to ever qualifying for a call.|451||
59495757|NCT00414817|75586393|FG001|Died or Left Health Plan|Overall Study|These individuals died or terminated Health Plan membership prior to ever qualifying for a call.|417||
59495758|NCT00414817|75586392|FG000|Adherent ICS User|Overall Study|Fully adherent ICS users who never qualified for an intervention call.|922||
59495759|NCT00414817|75586393|FG001|Adherent ICS User|Overall Study|Fully adherent ICS users who never qualified for an intervention call.|900||
59495760|NCT00414817|75586392|FG000|Daily Oral Steroid User|Overall Study|qualified for analysis sample, but excluded due to subsequent determination of oral steroid use.|117||
59495761|NCT00414817|75586393|FG001|Daily Oral Steroid User|Overall Study|qualified for analysis sample, but excluded due to subsequent determination of oral steroid use.|123||
59495762|NCT00414817|75586392|FG000|<3 Months Follow-up|Overall Study|qualified for analysis sample, but excluded since follow-up too short to assess adherence reliably.|175||
59495763|NCT00414817|75586393|FG001|<3 Months Follow-up|Overall Study|qualified for analysis sample, but excluded since follow-up too short to assess adherence reliably.|184||
59495764|NCT00414817|75586392|FG000|COMPLETED|Overall Study|Qualified for primary analysis (3171 prior ICS users) or secondary analysis (732 new users) samples.|3903||
59495765|NCT00414817|75586393|FG001|COMPLETED|Overall Study|Qualified for primary analysis (3260 prior ICS users) or secondary analysis (755 new users) samples.|4015||
59495766|NCT00414817|75586392|FG000|NOT COMPLETED|Overall Study||3130||
59495767|NCT00414817|75586393|FG001|NOT COMPLETED|Overall Study||3016||
59495768|NCT00360971|75586401|FG000|STARTED|Overall Study||10||
59495769|NCT00360971|75586402|FG001|STARTED|Overall Study||11||
59495770|NCT00360971|75586401|FG000|COMPLETED|Overall Study|Subjects with data for planned primary analysis are considered to have completed the study.|10||
59495771|NCT00360971|75586402|FG001|COMPLETED|Overall Study|Subjects with data for planned primary analysis are considered to have completed the study.|11||
59495772|NCT00360971|75586401|FG000|NOT COMPLETED|Overall Study||0||
59495773|NCT00360971|75586402|FG001|NOT COMPLETED|Overall Study||0||
59495774|NCT00371293|75586411|FG000|STARTED|Overall Study||58||
59495775|NCT00371293|75586412|FG001|STARTED|Overall Study||61||
59495776|NCT00371293|75586413|FG002|STARTED|Overall Study||62||
59495777|NCT00371293|75586411|FG000|COMPLETED|Overall Study||48||
59495778|NCT00371293|75586412|FG001|COMPLETED|Overall Study||42||
59495779|NCT00371293|75586413|FG002|COMPLETED|Overall Study||46||
59495780|NCT00371293|75586411|FG000|NOT COMPLETED|Overall Study||10||
59495781|NCT00371293|75586412|FG001|NOT COMPLETED|Overall Study||19||
59495782|NCT00371293|75586413|FG002|NOT COMPLETED|Overall Study||16||
59495783|NCT00361439|75586424|FG000|STARTED|Overall Study||8||
59495784|NCT00361439|75586425|FG001|STARTED|Overall Study||9||
59495785|NCT00361439|75586424|FG000|COMPLETED|Overall Study||8||
59495786|NCT00361439|75586425|FG001|COMPLETED|Overall Study||9||
59495787|NCT00361439|75586424|FG000|NOT COMPLETED|Overall Study||0||
59495788|NCT00361439|75586425|FG001|NOT COMPLETED|Overall Study||0||
59495789|NCT00371449|75586431|FG000|STARTED|Overall Study||120||
59495790|NCT00371449|75586431|FG000|COMPLETED|Overall Study||120||
59495791|NCT00371449|75586431|FG000|NOT COMPLETED|Overall Study||0||
59495792|NCT00361595|75586437|FG000|STARTED|Overall Study||35||
59495793|NCT00361595|75586437|FG000|COMPLETED|Overall Study||35||
59495794|NCT00361595|75586437|FG000|NOT COMPLETED|Overall Study||0||
59495795|NCT00417859|75586443|FG000|STARTED|Overall Study||26||
59495796|NCT00417859|75586444|FG001|STARTED|Overall Study||30||
59495797|NCT00417859|75586443|FG000|COMPLETED|Overall Study||26||
59495798|NCT00417859|75586444|FG001|COMPLETED|Overall Study||29||
59495799|NCT00417859|75586443|FG000|NOT COMPLETED|Overall Study||0||
59495800|NCT00417859|75586444|FG001|NOT COMPLETED|Overall Study||1||
59495801|NCT00373399|75586452|FG000|STARTED|Overall Study||5||
59495802|NCT00373399|75586453|FG001|STARTED|Overall Study||7||
59495803|NCT00373399|75586454|FG002|STARTED|Overall Study||4||
59495804|NCT00373399|75586455|FG003|STARTED|Overall Study||6||
59495805|NCT00373399|75586456|FG004|STARTED|Overall Study||7||
59495806|NCT00373399|75586457|FG005|STARTED|Overall Study||7||
59495807|NCT00373399|75586452|FG000|COMPLETED|Overall Study||5||
59495808|NCT00373399|75586453|FG001|COMPLETED|Overall Study||7||
59495809|NCT00373399|75586454|FG002|COMPLETED|Overall Study||4||
59495810|NCT00373399|75586455|FG003|COMPLETED|Overall Study||6||
59495811|NCT00373399|75586456|FG004|COMPLETED|Overall Study||7||
59495812|NCT00373399|75586457|FG005|COMPLETED|Overall Study||7||
59495813|NCT00373399|75586452|FG000|NOT COMPLETED|Overall Study||0||
59495814|NCT00373399|75586453|FG001|NOT COMPLETED|Overall Study||0||
59495815|NCT00373399|75586454|FG002|NOT COMPLETED|Overall Study||0||
59495816|NCT00373399|75586455|FG003|NOT COMPLETED|Overall Study||0||
59495817|NCT00373399|75586456|FG004|NOT COMPLETED|Overall Study||0||
59495818|NCT00373399|75586457|FG005|NOT COMPLETED|Overall Study||0||
59495819|NCT00318929|75586465|FG000|STARTED|Overall Study||14||
59495820|NCT00318929|75586465|FG000|COMPLETED|Overall Study||14||
59495821|NCT00318929|75586465|FG000|NOT COMPLETED|Overall Study||0||
59495822|NCT00418015|75586473|FG000|STARTED|Overall Study||144||
59495823|NCT00418015|75586474|FG001|STARTED|Overall Study||46||
59495824|NCT00418015|75586475|FG002|STARTED|Overall Study||78||
59495825|NCT00418015|75586476|FG003|STARTED|Overall Study||25||
59495826|NCT00418015|75586473|FG000|COMPLETED|Overall Study||144||
59495827|NCT00418015|75586474|FG001|COMPLETED|Overall Study||46||
59495828|NCT00418015|75586475|FG002|COMPLETED|Overall Study||78||
59495829|NCT00418015|75586476|FG003|COMPLETED|Overall Study||25||
59495830|NCT00418015|75586473|FG000|NOT COMPLETED|Overall Study||0||
59495831|NCT00418015|75586474|FG001|NOT COMPLETED|Overall Study||0||
59495832|NCT00418015|75586475|FG002|NOT COMPLETED|Overall Study||0||
59495833|NCT00418015|75586476|FG003|NOT COMPLETED|Overall Study||0||
59495834|NCT00362453|75586488|FG000|STARTED|Overall Study||20||
59495835|NCT00362453|75586489|FG001|STARTED|Overall Study||20||
59495836|NCT00362453|75586488|FG000|COMPLETED|Overall Study|No patient withdrew from the study (20/20 participants completed follow-ups at 12, 24 and 48 weeks).|20||
59495837|NCT00362453|75586489|FG001|COMPLETED|Overall Study|No patient withdrew from the study (20/20 participants completed follow-ups at 12, 24 and 48 weeks).|20||
59495838|NCT00362453|75586488|FG000|NOT COMPLETED|Overall Study||0||
59495839|NCT00362453|75586489|FG001|NOT COMPLETED|Overall Study||0||
59495840|NCT00418093|75586495|FG000|STARTED|Overall Study||19||
59495841|NCT00418093|75586495|FG000|Completed Study|Overall Study||19||
59495842|NCT00418093|75586495|FG000|COMPLETED|Overall Study||19||
59495843|NCT00418093|75586495|FG000|NOT COMPLETED|Overall Study||0||
59495844|NCT00374335|75586499|FG000|STARTED|Overall Study||261||
59495845|NCT00374335|75586499|FG000|COMPLETED|Overall Study||261||
59495846|NCT00374335|75586499|FG000|NOT COMPLETED|Overall Study||0||
59495847|NCT00554229|75586505|FG000|STARTED|Overall Study||299||
59495848|NCT00554229|75586506|FG001|STARTED|Overall Study||295||
59495849|NCT00554229|75586505|FG000|Patients Who Received Treatment|Overall Study||298||
59495850|NCT00554229|75586506|FG001|Patients Who Received Treatment|Overall Study||295||
59495851|NCT00554229|75586505|FG000|COMPLETED|Overall Study||73||
59495852|NCT00554229|75586506|FG001|COMPLETED|Overall Study||70||
59495853|NCT00554229|75586505|FG000|NOT COMPLETED|Overall Study||226||
59495854|NCT00554229|75586506|FG001|NOT COMPLETED|Overall Study||225||
59495855|NCT00374803|75586514|FG000|STARTED|Overall Study||22||
59495856|NCT00374803|75586515|FG001|STARTED|Overall Study||23||
59495857|NCT00374803|75586514|FG000|COMPLETED|Overall Study||22||
59495858|NCT00374803|75586515|FG001|COMPLETED|Overall Study||23||
59495859|NCT00374803|75586514|FG000|NOT COMPLETED|Overall Study||0||
59495860|NCT00374803|75586515|FG001|NOT COMPLETED|Overall Study||0||
59495861|NCT00418951|75586526|FG000|STARTED|Overall Study||39||
59884938|NCT03166124|76007760|FG003|STARTED|Treatment Period 1||21||
59884939|NCT03166124|76007757|FG000|Received at Least One Dose of Study Drug|Treatment Period 1||20||
59884940|NCT03166124|76007758|FG001|Received at Least One Dose of Study Drug|Treatment Period 1||20||
59884941|NCT03166124|76007759|FG002|Received at Least One Dose of Study Drug|Treatment Period 1||18||
59884942|NCT03166124|76007760|FG003|Received at Least One Dose of Study Drug|Treatment Period 1||21||
59884943|NCT03166124|76007757|FG000|COMPLETED|Treatment Period 1||20||
59884944|NCT03166124|76007758|FG001|COMPLETED|Treatment Period 1||20||
59884945|NCT03166124|76007759|FG002|COMPLETED|Treatment Period 1||18||
59884946|NCT03166124|76007760|FG003|COMPLETED|Treatment Period 1||21||
59884947|NCT03166124|76007757|FG000|NOT COMPLETED|Treatment Period 1||0||
59884948|NCT03166124|76007758|FG001|NOT COMPLETED|Treatment Period 1||0||
59884949|NCT03166124|76007759|FG002|NOT COMPLETED|Treatment Period 1||1||
59884950|NCT03166124|76007760|FG003|NOT COMPLETED|Treatment Period 1||0||
59884951|NCT03166124|76007757|FG000|STARTED|Wash-out Period||20||
59884952|NCT03166124|76007758|FG001|STARTED|Wash-out Period||20||
59884953|NCT03166124|76007759|FG002|STARTED|Wash-out Period||18||
59884954|NCT03166124|76007760|FG003|STARTED|Wash-out Period||21||
59884955|NCT03166124|76007757|FG000|COMPLETED|Wash-out Period||20||
59884956|NCT03166124|76007758|FG001|COMPLETED|Wash-out Period||18||
59884957|NCT03166124|76007759|FG002|COMPLETED|Wash-out Period||17||
59884958|NCT03166124|76007760|FG003|COMPLETED|Wash-out Period||20||
59884959|NCT03166124|76007757|FG000|NOT COMPLETED|Wash-out Period||0||
59884960|NCT03166124|76007758|FG001|NOT COMPLETED|Wash-out Period||2||
59884961|NCT03166124|76007759|FG002|NOT COMPLETED|Wash-out Period||1||
59884962|NCT03166124|76007760|FG003|NOT COMPLETED|Wash-out Period||1||
59884963|NCT03166124|76007757|FG000|STARTED|Treatment Period 2||20||
59884964|NCT03166124|76007758|FG001|STARTED|Treatment Period 2||18||
59884965|NCT03166124|76007759|FG002|STARTED|Treatment Period 2||17||
59884966|NCT03166124|76007760|FG003|STARTED|Treatment Period 2||20||
59884967|NCT03166124|76007757|FG000|COMPLETED|Treatment Period 2||20||
59884968|NCT03166124|76007758|FG001|COMPLETED|Treatment Period 2||18||
59884969|NCT03166124|76007759|FG002|COMPLETED|Treatment Period 2||17||
59884970|NCT03166124|76007760|FG003|COMPLETED|Treatment Period 2||20||
59884971|NCT03166124|76007757|FG000|NOT COMPLETED|Treatment Period 2||0||
59884972|NCT03166124|76007758|FG001|NOT COMPLETED|Treatment Period 2||0||
59884973|NCT03166124|76007759|FG002|NOT COMPLETED|Treatment Period 2||0||
59884974|NCT03166124|76007760|FG003|NOT COMPLETED|Treatment Period 2||0||
59884975|NCT03567291|76007771|FG000|STARTED|Period I||228||
59884976|NCT03567291|76007772|FG001|STARTED|Period I||0||
59884977|NCT03567291|76007773|FG002|STARTED|Period I||0||
59884978|NCT03567291|76007774|FG003|STARTED|Period I||0||
59884979|NCT03567291|76007771|FG000|Safety Set|Period I||227||
59884980|NCT03567291|76007772|FG001|Safety Set|Period I||0||
59884981|NCT03567291|76007773|FG002|Safety Set|Period I||0||
59884982|NCT03567291|76007774|FG003|Safety Set|Period I||0||
59884983|NCT03567291|76007771|FG000|Intent to Treat Set|Period I||228||
60012244|NCT02605967|76128156|FG001|COMPLETED|Overall Study||0||
60012245|NCT02605967|76128155|FG000|NOT COMPLETED|Overall Study||82||
60012246|NCT02605967|76128156|FG001|NOT COMPLETED|Overall Study||40||
60012247|NCT01668173|76128166|FG000|STARTED|Overall Study||7||
59884984|NCT03567291|76007772|FG001|Intent to Treat Set|Period I||0||
59884985|NCT03567291|76007773|FG002|Intent to Treat Set|Period I||0||
59884986|NCT03567291|76007774|FG003|Intent to Treat Set|Period I||0||
59884987|NCT03567291|76007771|FG000|COMPLETED|Period I||137||
60012248|NCT01668173|76128166|FG000|COMPLETED|Overall Study||0||
59884988|NCT03567291|76007772|FG001|COMPLETED|Period I||0||
59884989|NCT03567291|76007773|FG002|COMPLETED|Period I||0||
60012249|NCT01668173|76128166|FG000|NOT COMPLETED|Overall Study||7||
60012250|NCT01505465|76128172|FG000|STARTED|Overall Study||25||
59495862|NCT00418951|75586527|FG001|STARTED|Overall Study||33||
59495863|NCT00418951|75586528|FG002|STARTED|Overall Study||40||
59495864|NCT00418951|75586526|FG000|COMPLETED|Overall Study||39||
59495865|NCT00418951|75586527|FG001|COMPLETED|Overall Study||33||
59495866|NCT00418951|75586528|FG002|COMPLETED|Overall Study||40||
59607139|NCT01234103|75717660|FG001|STARTED|Overall Study||391||
59607140|NCT01234103|75717659|FG000|COMPLETED|Overall Study||542|Each was enrolled at baseline, completed all intervention sessions, but no follow-up sessions.|
59613491|NCT01684878|75724612|FG002|COMPLETED|Part 2: Randomized Phase||0||
59754693|NCT03889418|75873584|FG004|STARTED|January - March 2020 (Month 10-12)||16|[EMR-CDS with CCM] participants started enrollment in region 4 in period 4. In Region 5, only EMR-CDS (usual care) matched controls were identified. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|1
59754694|NCT03889418|75873585|FG005|STARTED|January - March 2020 (Month 10-12)||2|[EMR-CDS with CCM] participants started enrollment in region 4 in period 4. In Region 5, only EMR-CDS (usual care) matched controls were identified. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|1
59754695|NCT03889418|75873586|FG006|STARTED|January - March 2020 (Month 10-12)||13|[EMR-CDS with CCM] participants started enrollment in region 4 in period 4. In Region 5, only EMR-CDS (usual care) matched controls were identified. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|1
59762558|NCT00534313|75882339|FG002|COMPLETED|Short-term Period|Completed the short-term study|43||
59762676|NCT01886963|75882518|FG001|NOT COMPLETED|Overall Study||9||
60012251|NCT01505465|76128173|FG001|STARTED|Overall Study||25||
60012252|NCT01505465|76128172|FG000|COMPLETED|Overall Study||19||
60012253|NCT01505465|76128173|FG001|COMPLETED|Overall Study||18||
60012254|NCT01505465|76128172|FG000|NOT COMPLETED|Overall Study||6||
60012255|NCT01505465|76128173|FG001|NOT COMPLETED|Overall Study||7||
60012256|NCT02600351|76128183|FG000|STARTED|Overall Study||17||
60012257|NCT02600351|76128184|FG001|STARTED|Overall Study||17||
60012258|NCT02600351|76128185|FG002|STARTED|Overall Study||26||
60012259|NCT02600351|76128186|FG003|STARTED|Overall Study||27||
60012260|NCT02600351|76128183|FG000|COMPLETED|Overall Study||12||
60012261|NCT02600351|76128184|FG001|COMPLETED|Overall Study||17||
60012262|NCT02600351|76128185|FG002|COMPLETED|Overall Study||20||
60012263|NCT02600351|76128186|FG003|COMPLETED|Overall Study||22||
60012264|NCT02600351|76128183|FG000|NOT COMPLETED|Overall Study||5||
60012265|NCT02600351|76128184|FG001|NOT COMPLETED|Overall Study||0||
60012266|NCT02600351|76128185|FG002|NOT COMPLETED|Overall Study||6||
60012267|NCT02600351|76128186|FG003|NOT COMPLETED|Overall Study||5||
60012268|NCT02640235|76128200|FG000|STARTED|Overall Study||131|Number of Subjects randomized or treated (Intent-to-Treat population).|
60012269|NCT02640235|76128201|FG001|STARTED|Overall Study||129|Number of Subjects randomized or treated (Intent-to-Treat population).|
60012270|NCT02640235|76128200|FG000|COMPLETED|Overall Study||117||
60012271|NCT02640235|76128201|FG001|COMPLETED|Overall Study||115||
60012272|NCT02640235|76128200|FG000|NOT COMPLETED|Overall Study||14||
60012273|NCT02640235|76128201|FG001|NOT COMPLETED|Overall Study||14||
60012274|NCT02599961|76128207|FG000|STARTED|Overall Study||15||
60012275|NCT02599961|76128207|FG000|COMPLETED|Overall Study||0||
60012276|NCT02599961|76128207|FG000|NOT COMPLETED|Overall Study||15||
60012277|NCT04814459|76128213|FG000|STARTED|Overall Study||72||
60012278|NCT04814459|76128214|FG001|STARTED|Overall Study||72||
60012279|NCT04814459|76128213|FG000|COMPLETED|Overall Study||72||
60012280|NCT04814459|76128214|FG001|COMPLETED|Overall Study||72||
60012281|NCT04814459|76128213|FG000|NOT COMPLETED|Overall Study||0||
60012282|NCT04814459|76128214|FG001|NOT COMPLETED|Overall Study||0||
60012283|NCT04812977|76128222|FG000|STARTED|Overall Study||15||
60012284|NCT04812977|76128223|FG001|STARTED|Overall Study||15||
60012285|NCT04812977|76128222|FG000|COMPLETED|Overall Study||15||
60012286|NCT04812977|76128223|FG001|COMPLETED|Overall Study||15||
60012287|NCT04812977|76128222|FG000|NOT COMPLETED|Overall Study||0||
60012288|NCT04812977|76128223|FG001|NOT COMPLETED|Overall Study||0||
60012289|NCT02640157|76128232|FG000|STARTED|Overall Study|Intent-to-treat population: all participants who received at least 1 dose of study drug|233||
60012290|NCT02640157|76128233|FG001|STARTED|Overall Study||116||
60012291|NCT02640157|76128234|FG002|STARTED|Overall Study|Intent-to-treat population: all participants who received at least 1 dose of study drug|157||
60012292|NCT02640157|76128232|FG000|Received Study Drug|Overall Study||233||
60012293|NCT02640157|76128233|FG001|Received Study Drug|Overall Study|One participant in Arm B was randomized in error and never dispensed study drug.|115||
60012294|NCT02640157|76128234|FG002|Received Study Drug|Overall Study||157||
60012295|NCT02640157|76128232|FG000|Completed Study Drug|Overall Study||225||
60012296|NCT02640157|76128233|FG001|Completed Study Drug|Overall Study||112||
60012297|NCT02640157|76128234|FG002|Completed Study Drug|Overall Study||154||
60012298|NCT02640157|76128232|FG000|Discontinued Study Drug|Overall Study||8||
60012299|NCT02640157|76128233|FG001|Discontinued Study Drug|Overall Study||3||
60012300|NCT02640157|76128234|FG002|Discontinued Study Drug|Overall Study||3||
60012301|NCT02640157|76128232|FG000|COMPLETED|Overall Study||220||
60012302|NCT02640157|76128233|FG001|COMPLETED|Overall Study||111||
60012303|NCT02640157|76128234|FG002|COMPLETED|Overall Study||147||
60012304|NCT02640157|76128232|FG000|NOT COMPLETED|Overall Study||13||
59495867|NCT00418951|75586526|FG000|NOT COMPLETED|Overall Study||0||
59495868|NCT00418951|75586527|FG001|NOT COMPLETED|Overall Study||0||
59495869|NCT00418951|75586528|FG002|NOT COMPLETED|Overall Study||0||
59495870|NCT00363077|75586538|FG000|STARTED|Overall Study||75||
59495871|NCT00363077|75586539|FG001|STARTED|Overall Study||75||
59495872|NCT00363077|75586538|FG000|COMPLETED|Overall Study||75||
59495873|NCT00363077|75586539|FG001|COMPLETED|Overall Study||75||
59495874|NCT00363077|75586538|FG000|NOT COMPLETED|Overall Study||0||
59495875|NCT00363077|75586539|FG001|NOT COMPLETED|Overall Study||0||
59495876|NCT00375973|75586547|FG000|STARTED|Overall Study||30||
59495877|NCT00375973|75586548|FG001|STARTED|Overall Study||30||
59495878|NCT00375973|75586547|FG000|COMPLETED|Overall Study||20||
59495879|NCT00375973|75586548|FG001|COMPLETED|Overall Study||28||
59495880|NCT00375973|75586547|FG000|NOT COMPLETED|Overall Study||10||
59495881|NCT00375973|75586548|FG001|NOT COMPLETED|Overall Study||2||
59495882|NCT03235817|75586557|FG000|STARTED|Overall Study||13||
59495883|NCT03235817|75586558|FG001|STARTED|Overall Study||13||
59495884|NCT03235817|75586559|FG002|STARTED|Overall Study||13||
59495885|NCT03235817|75586557|FG000|COMPLETED|Overall Study||10||
59495886|NCT03235817|75586558|FG001|COMPLETED|Overall Study||12||
59495887|NCT03235817|75586559|FG002|COMPLETED|Overall Study||11||
59495888|NCT03235817|75586557|FG000|NOT COMPLETED|Overall Study||3||
59495889|NCT03235817|75586558|FG001|NOT COMPLETED|Overall Study||1||
59495890|NCT03235817|75586559|FG002|NOT COMPLETED|Overall Study||2||
59495891|NCT02110121|75586570|FG000|STARTED|Overall Study||58||
59495892|NCT02110121|75586571|FG001|STARTED|Overall Study||5||
59495893|NCT02110121|75586570|FG000|COMPLETED|Overall Study||42||
59495894|NCT02110121|75586571|FG001|COMPLETED|Overall Study||5||
59495895|NCT02110121|75586570|FG000|NOT COMPLETED|Overall Study||16||
59495896|NCT02110121|75586571|FG001|NOT COMPLETED|Overall Study||0||
59495897|NCT00421603|75586579|FG000|STARTED|Overall Study||39||
59495898|NCT00421603|75586580|FG001|STARTED|Overall Study||42||
59495899|NCT00421603|75586579|FG000|COMPLETED|Overall Study|Completed all 14 week sof trial|28||
59495900|NCT00421603|75586580|FG001|COMPLETED|Overall Study|Completed all 14 week sof trial|30||
59495901|NCT00421603|75586579|FG000|NOT COMPLETED|Overall Study||11||
59495902|NCT00421603|75586580|FG001|NOT COMPLETED|Overall Study||12||
59495903|NCT00376363|75586588|FG000|STARTED|Overall Study||143||
59495904|NCT00376363|75586589|FG001|STARTED|Overall Study||133||
59495905|NCT00376363|75586588|FG000|COMPLETED|Overall Study||87||
59495906|NCT00376363|75586589|FG001|COMPLETED|Overall Study||87||
59495907|NCT00376363|75586588|FG000|NOT COMPLETED|Overall Study||56||
59495908|NCT00376363|75586589|FG001|NOT COMPLETED|Overall Study||46||
59495909|NCT00363779|75586595|FG000|STARTED|Overall Study||5||
59495910|NCT00363779|75586595|FG000|COMPLETED|Overall Study||5||
59495911|NCT00363779|75586595|FG000|NOT COMPLETED|Overall Study||0||
59495912|NCT00376597|75586601|FG000|STARTED|Overall Study||253||
59495913|NCT00376597|75586602|FG001|STARTED|Overall Study||315||
59495914|NCT00376597|75586601|FG000|COMPLETED|Overall Study||242||
59495915|NCT00376597|75586602|FG001|COMPLETED|Overall Study||312||
59495916|NCT00376597|75586601|FG000|NOT COMPLETED|Overall Study||11||
59495917|NCT00376597|75586602|FG001|NOT COMPLETED|Overall Study||3||
59495918|NCT01405820|75586616|FG000|STARTED|Randomized Treatment Period||54||
59495919|NCT01405820|75586617|FG001|STARTED|Randomized Treatment Period||45||
59495920|NCT01405820|75586618|FG002|STARTED|Randomized Treatment Period||52||
59495921|NCT01405820|75586619|FG003|STARTED|Randomized Treatment Period||54||
59495922|NCT01405820|75586620|FG004|STARTED|Randomized Treatment Period||47||
59495923|NCT01405820|75586621|FG005|STARTED|Randomized Treatment Period||38||
59495924|NCT01405820|75586616|FG000|Safety Population|Randomized Treatment Period||54||
59495925|NCT01405820|75586617|FG001|Safety Population|Randomized Treatment Period||45||
59495926|NCT01405820|75586618|FG002|Safety Population|Randomized Treatment Period||52||
59495927|NCT01405820|75586619|FG003|Safety Population|Randomized Treatment Period|1 participant did not receive any study medication.|53||
59495928|NCT01405820|75586620|FG004|Safety Population|Randomized Treatment Period||47||
59495929|NCT01405820|75586621|FG005|Safety Population|Randomized Treatment Period||38||
59495930|NCT01405820|75586616|FG000|COMPLETED|Randomized Treatment Period||43||
59495931|NCT01405820|75586617|FG001|COMPLETED|Randomized Treatment Period||35||
59495932|NCT01405820|75586618|FG002|COMPLETED|Randomized Treatment Period||9||
59495933|NCT01405820|75586619|FG003|COMPLETED|Randomized Treatment Period||3||
59495934|NCT01405820|75586620|FG004|COMPLETED|Randomized Treatment Period||2||
59495935|NCT01405820|75586621|FG005|COMPLETED|Randomized Treatment Period||1||
59495936|NCT01405820|75586616|FG000|NOT COMPLETED|Randomized Treatment Period||11||
59495937|NCT01405820|75586617|FG001|NOT COMPLETED|Randomized Treatment Period||10||
59495938|NCT01405820|75586618|FG002|NOT COMPLETED|Randomized Treatment Period||43||
59495939|NCT01405820|75586619|FG003|NOT COMPLETED|Randomized Treatment Period||51||
59495940|NCT01405820|75586620|FG004|NOT COMPLETED|Randomized Treatment Period||45||
59495941|NCT01405820|75586621|FG005|NOT COMPLETED|Randomized Treatment Period||37||
59495942|NCT01405820|75586616|FG000|STARTED|Open-Label Treatment Period|1 participant discontinued randomized period due to an adverse event but entered open-label period.|44||
59495943|NCT01405820|75586617|FG001|STARTED|Open-Label Treatment Period||35||
59495944|NCT01405820|75586618|FG002|STARTED|Open-Label Treatment Period||42||
59495945|NCT01405820|75586619|FG003|STARTED|Open-Label Treatment Period||42||
59495946|NCT01405820|75586620|FG004|STARTED|Open-Label Treatment Period||42||
59495947|NCT01405820|75586621|FG005|STARTED|Open-Label Treatment Period||32||
59495948|NCT01405820|75586616|FG000|COMPLETED|Open-Label Treatment Period||40||
59495949|NCT01405820|75586617|FG001|COMPLETED|Open-Label Treatment Period||33||
59495950|NCT01405820|75586618|FG002|COMPLETED|Open-Label Treatment Period||39||
59495951|NCT01405820|75586619|FG003|COMPLETED|Open-Label Treatment Period||37||
59495952|NCT01405820|75586620|FG004|COMPLETED|Open-Label Treatment Period||40||
59495953|NCT01405820|75586621|FG005|COMPLETED|Open-Label Treatment Period||30||
59495954|NCT01405820|75586616|FG000|NOT COMPLETED|Open-Label Treatment Period||4||
59495955|NCT01405820|75586617|FG001|NOT COMPLETED|Open-Label Treatment Period||2||
59495956|NCT01405820|75586618|FG002|NOT COMPLETED|Open-Label Treatment Period||3||
59495957|NCT01405820|75586619|FG003|NOT COMPLETED|Open-Label Treatment Period||5||
59495958|NCT01405820|75586620|FG004|NOT COMPLETED|Open-Label Treatment Period||2||
59495959|NCT01405820|75586621|FG005|NOT COMPLETED|Open-Label Treatment Period||2||
59495960|NCT00364949|75586643|FG000|STARTED|Overall Study||31||
59495961|NCT00364949|75586644|FG001|STARTED|Overall Study||39||
59495962|NCT00364949|75586643|FG000|COMPLETED|Overall Study||31||
59495963|NCT00364949|75586644|FG001|COMPLETED|Overall Study||39||
59495964|NCT00364949|75586643|FG000|NOT COMPLETED|Overall Study||0||
59495965|NCT00364949|75586644|FG001|NOT COMPLETED|Overall Study||0||
59495966|NCT01405742|75586650|FG000|STARTED|Overall Study||2||
59495967|NCT01405742|75586651|FG001|STARTED|Overall Study||2||
59495968|NCT01405742|75586650|FG000|COMPLETED|Overall Study||1||
59495969|NCT01405742|75586651|FG001|COMPLETED|Overall Study||2||
59495970|NCT01405742|75586650|FG000|NOT COMPLETED|Overall Study||1||
59495971|NCT01405742|75586651|FG001|NOT COMPLETED|Overall Study||0||
59495972|NCT00321269|75586659|FG000|STARTED|Overall Study||74||
59495973|NCT00321269|75586660|FG001|STARTED|Overall Study||74||
59495974|NCT00321269|75586659|FG000|COMPLETED|Overall Study||66||
59495975|NCT00321269|75586660|FG001|COMPLETED|Overall Study||68||
59495976|NCT00321269|75586659|FG000|NOT COMPLETED|Overall Study||8||
59495977|NCT00321269|75586660|FG001|NOT COMPLETED|Overall Study||6||
59495978|NCT00422695|75586670|FG000|STARTED|Overall Study||105||
59495979|NCT00422695|75586671|FG001|STARTED|Overall Study||38||
59495980|NCT00422695|75586670|FG000|COMPLETED|Overall Study||105||
59495981|NCT00422695|75586671|FG001|COMPLETED|Overall Study||38||
59495982|NCT00422695|75586670|FG000|NOT COMPLETED|Overall Study||0||
59495983|NCT00422695|75586671|FG001|NOT COMPLETED|Overall Study||0||
59495984|NCT01425632|75586680|FG000|STARTED|Overall Study||161||
59495985|NCT01425632|75586681|FG001|STARTED|Overall Study||166||
59495986|NCT01425632|75586682|FG002|STARTED|Overall Study||163||
59495987|NCT01425632|75586680|FG000|COMPLETED|Overall Study||160||
59495988|NCT01425632|75586681|FG001|COMPLETED|Overall Study||165||
59495989|NCT01425632|75586682|FG002|COMPLETED|Overall Study||159||
59495990|NCT01425632|75586680|FG000|NOT COMPLETED|Overall Study||1||
59495991|NCT01425632|75586681|FG001|NOT COMPLETED|Overall Study||1||
59495992|NCT01425632|75586682|FG002|NOT COMPLETED|Overall Study||4||
59495993|NCT00321971|75586692|FG000|STARTED|Overall Study|Subject recruitment began in February 2007 and ended in December 2011|36||
59495994|NCT00321971|75586693|FG001|STARTED|Overall Study||37||
59495995|NCT00321971|75586692|FG000|COMPLETED|Overall Study||28||
59495996|NCT00321971|75586693|FG001|COMPLETED|Overall Study||26||
59495997|NCT00321971|75586692|FG000|NOT COMPLETED|Overall Study||8||
59495998|NCT00321971|75586693|FG001|NOT COMPLETED|Overall Study||11||
59495999|NCT02076152|75586701|FG000|STARTED|Overall Study||2||
59496000|NCT02076152|75586702|FG001|STARTED|Overall Study||9||
59496001|NCT02076152|75586701|FG000|COMPLETED|Overall Study||2||
59496002|NCT02076152|75586702|FG001|COMPLETED|Overall Study||9||
59496003|NCT02076152|75586701|FG000|NOT COMPLETED|Overall Study||0||
59496004|NCT02076152|75586702|FG001|NOT COMPLETED|Overall Study||0||
59496005|NCT00380029|75586707|FG000|STARTED|Overall Study||20||
59496006|NCT00380029|75586707|FG000|COMPLETED|Overall Study||20||
59496007|NCT00380029|75586707|FG000|NOT COMPLETED|Overall Study||0||
59496008|NCT01405508|75586719|FG000|STARTED|Overall Study||26||
59496009|NCT01405508|75586720|FG001|STARTED|Overall Study||26||
59496010|NCT01405508|75586721|FG002|STARTED|Overall Study||27||
59496011|NCT01405508|75586722|FG003|STARTED|Overall Study||26||
59496012|NCT01405508|75586719|FG000|COMPLETED|Overall Study||25||
59496013|NCT01405508|75586720|FG001|COMPLETED|Overall Study||25||
59496014|NCT01405508|75586721|FG002|COMPLETED|Overall Study||27||
59496015|NCT01405508|75586722|FG003|COMPLETED|Overall Study||26||
59496016|NCT01405508|75586719|FG000|NOT COMPLETED|Overall Study||1||
59496017|NCT01405508|75586720|FG001|NOT COMPLETED|Overall Study||1||
59496018|NCT01405508|75586721|FG002|NOT COMPLETED|Overall Study||0||
59496019|NCT01405508|75586722|FG003|NOT COMPLETED|Overall Study||0||
59496020|NCT00426283|75586734|FG000|STARTED|Overall Study||28||
59496021|NCT00426283|75586735|FG001|STARTED|Overall Study||14||
59496022|NCT00426283|75586734|FG000|COMPLETED|Overall Study||23||
59496023|NCT00426283|75586735|FG001|COMPLETED|Overall Study||13||
59496024|NCT00426283|75586734|FG000|NOT COMPLETED|Overall Study||5||
59496025|NCT00426283|75586735|FG001|NOT COMPLETED|Overall Study||1||
59496026|NCT00383071|75586749|FG000|STARTED|Overall Study||25||
59496027|NCT00383071|75586750|FG001|STARTED|Overall Study||25||
59496028|NCT00383071|75586751|FG002|STARTED|Overall Study||51||
59496029|NCT00383071|75586752|FG003|STARTED|Overall Study||25||
59496030|NCT00383071|75586749|FG000|COMPLETED|Overall Study||25||
59496031|NCT00383071|75586750|FG001|COMPLETED|Overall Study||21||
59496032|NCT00383071|75586751|FG002|COMPLETED|Overall Study||44||
59496033|NCT00383071|75586752|FG003|COMPLETED|Overall Study||22||
59496034|NCT00383071|75586749|FG000|NOT COMPLETED|Overall Study||0||
59496035|NCT00383071|75586750|FG001|NOT COMPLETED|Overall Study||4||
59496036|NCT00383071|75586751|FG002|NOT COMPLETED|Overall Study||7||
59496037|NCT00383071|75586752|FG003|NOT COMPLETED|Overall Study||3||
59496038|NCT00322439|75586762|FG000|STARTED|Overall Study||2511||
59496039|NCT00322439|75586762|FG000|Received at Least 1 Dose of Etanercept|Overall Study||2510||
59496040|NCT00322439|75586762|FG000|COMPLETED|Overall Study||1455||
59496041|NCT00322439|75586762|FG000|NOT COMPLETED|Overall Study||1056||
59496042|NCT00365261|75586768|FG000|STARTED|Overall Study||23||
59496043|NCT00365261|75586769|FG001|STARTED|Overall Study||22||
59496044|NCT00365261|75586768|FG000|COMPLETED|Overall Study||20||
59496045|NCT00365261|75586769|FG001|COMPLETED|Overall Study||19||
59496046|NCT00365261|75586768|FG000|NOT COMPLETED|Overall Study||3||
59496047|NCT00365261|75586769|FG001|NOT COMPLETED|Overall Study||3||
59496048|NCT00426517|75586781|FG000|STARTED|Overall Study||7||
59496049|NCT00426517|75586782|FG001|STARTED|Overall Study||36||
59496050|NCT00426517|75586783|FG002|STARTED|Overall Study||3||
59496051|NCT00426517|75586784|FG003|STARTED|Overall Study||2||
59496052|NCT00426517|75586781|FG000|COMPLETED|Overall Study||7||
59496053|NCT00426517|75586782|FG001|COMPLETED|Overall Study||36||
59496054|NCT00426517|75586783|FG002|COMPLETED|Overall Study||3||
59496055|NCT00426517|75586784|FG003|COMPLETED|Overall Study||2||
59496056|NCT00426517|75586781|FG000|NOT COMPLETED|Overall Study||0||
59496057|NCT00426517|75586782|FG001|NOT COMPLETED|Overall Study||0||
59496058|NCT00426517|75586783|FG002|NOT COMPLETED|Overall Study||0||
59496059|NCT00426517|75586784|FG003|NOT COMPLETED|Overall Study||0||
59496060|NCT00365417|75586794|FG000|STARTED|Overall Study||45||
59496061|NCT00365417|75586794|FG000|COMPLETED|Overall Study||45||
59496062|NCT00365417|75586794|FG000|NOT COMPLETED|Overall Study||0||
59496063|NCT00427297|75586801|FG000|STARTED|Overall Study||17||
59496064|NCT00427297|75586802|FG001|STARTED|Overall Study||17||
59496065|NCT00427297|75586801|FG000|COMPLETED|Overall Study||17||
59496066|NCT00427297|75586802|FG001|COMPLETED|Overall Study||17||
59496067|NCT00427297|75586801|FG000|NOT COMPLETED|Overall Study||0||
59496068|NCT00427297|75586802|FG001|NOT COMPLETED|Overall Study||0||
59496069|NCT00384241|75586810|FG000|STARTED|Overall Study||500||
59496070|NCT00384241|75586811|FG001|STARTED|Overall Study||599||
59496071|NCT00384241|75586810|FG000|COMPLETED|Overall Study||500||
59496072|NCT00384241|75586811|FG001|COMPLETED|Overall Study||599||
59496073|NCT00384241|75586810|FG000|NOT COMPLETED|Overall Study||0||
59496074|NCT00384241|75586811|FG001|NOT COMPLETED|Overall Study||0||
59496075|NCT00427765|75586816|FG000|STARTED|Overall Study||164||
59496076|NCT00427765|75586816|FG000|COMPLETED|Overall Study||164||
59496077|NCT00427765|75586816|FG000|NOT COMPLETED|Overall Study||0||
59496078|NCT00366275|75586820|FG000|STARTED|Overall Study||64||
59496079|NCT00366275|75586820|FG000|COMPLETED|Overall Study||58||
59496080|NCT00366275|75586820|FG000|NOT COMPLETED|Overall Study||6||
59496081|NCT00384865|75586828|FG000|STARTED|Overall Study||16||
59496082|NCT00384865|75586829|FG001|STARTED|Overall Study||16||
59496083|NCT00384865|75586830|FG002|STARTED|Overall Study||16||
59496084|NCT00384865|75586831|FG003|STARTED|Overall Study||16||
59496085|NCT00384865|75586828|FG000|Completed Six Month Assessment|Overall Study||11||
59496086|NCT00384865|75586829|FG001|Completed Six Month Assessment|Overall Study||12||
59496087|NCT00384865|75586830|FG002|Completed Six Month Assessment|Overall Study||15||
59496088|NCT00384865|75586831|FG003|Completed Six Month Assessment|Overall Study||11||
59496089|NCT00384865|75586828|FG000|COMPLETED|Overall Study||16||
59496090|NCT00384865|75586829|FG001|COMPLETED|Overall Study||16||
59496091|NCT00384865|75586830|FG002|COMPLETED|Overall Study||16||
59496092|NCT00384865|75586831|FG003|COMPLETED|Overall Study||16||
59496093|NCT00384865|75586828|FG000|NOT COMPLETED|Overall Study||0||
59496094|NCT00384865|75586829|FG001|NOT COMPLETED|Overall Study||0||
59754696|NCT03889418|75873587|FG007|STARTED|January - March 2020 (Month 10-12)||5|[EMR-CDS with CCM] participants started enrollment in region 4 in period 4. In Region 5, only EMR-CDS (usual care) matched controls were identified. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|1
59754697|NCT03889418|75873588|FG008|STARTED|January - March 2020 (Month 10-12)||16|[EMR-CDS with CCM] participants started enrollment in region 4 in period 4. In Region 5, only EMR-CDS (usual care) matched controls were identified. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|1
59496095|NCT00384865|75586830|FG002|NOT COMPLETED|Overall Study||0||
59496096|NCT00384865|75586831|FG003|NOT COMPLETED|Overall Study||0||
59496097|NCT00323453|75586843|FG000|STARTED|Overall Study||61||
59496098|NCT00323453|75586844|FG001|STARTED|Overall Study||48||
59496099|NCT00323453|75586843|FG000|COMPLETED|Overall Study||61||
59496100|NCT00323453|75586844|FG001|COMPLETED|Overall Study||48||
59496101|NCT00323453|75586843|FG000|NOT COMPLETED|Overall Study||0||
59496102|NCT00323453|75586844|FG001|NOT COMPLETED|Overall Study||0||
59496103|NCT00428077|75586850|FG000|STARTED|Overall Study||4||
59496104|NCT00428077|75586850|FG000|COMPLETED|Overall Study||4||
59496105|NCT00428077|75586850|FG000|NOT COMPLETED|Overall Study||0||
59496106|NCT01405196|75586858|FG000|STARTED|Overall Study||45||
59496107|NCT01405196|75586859|FG001|STARTED|Overall Study||47||
59496108|NCT01405196|75586860|FG002|STARTED|Overall Study||46||
59496109|NCT01405196|75586861|FG003|STARTED|Overall Study||45||
59496110|NCT01405196|75586858|FG000|COMPLETED|Overall Study||34||
59496111|NCT01405196|75586859|FG001|COMPLETED|Overall Study||35||
59496112|NCT01405196|75586860|FG002|COMPLETED|Overall Study||23||
59762677|NCT00857259|75882527|FG000|STARTED|Overall Study||8||
59496113|NCT01405196|75586861|FG003|COMPLETED|Overall Study||36||
59496114|NCT01405196|75586858|FG000|NOT COMPLETED|Overall Study||11||
60012305|NCT02640157|76128233|FG001|NOT COMPLETED|Overall Study||5||
60012306|NCT02640157|76128234|FG002|NOT COMPLETED|Overall Study||10||
60012307|NCT01673347|76128243|FG000|STARTED|Overall Study||24||
60012308|NCT01673347|76128243|FG000|COMPLETED|Overall Study||17||
60012309|NCT01673347|76128243|FG000|NOT COMPLETED|Overall Study||7||
60012310|NCT02528253|76128252|FG000|STARTED|Overall Study||205||
60012311|NCT02528253|76128253|FG001|STARTED|Overall Study||204||
60012312|NCT02528253|76128254|FG002|STARTED|Overall Study||407||
59496115|NCT01405196|75586859|FG001|NOT COMPLETED|Overall Study||12||
59496116|NCT01405196|75586860|FG002|NOT COMPLETED|Overall Study||23||
59496117|NCT01405196|75586861|FG003|NOT COMPLETED|Overall Study||9||
59496118|NCT00367601|75586872|FG000|STARTED|Overall Study||25||
59496119|NCT00367601|75586872|FG000|COMPLETED|Overall Study||25||
59496120|NCT00367601|75586872|FG000|NOT COMPLETED|Overall Study||0||
59496121|NCT00385801|75586879|FG000|STARTED|Overall Study||15||
59496122|NCT00385801|75586880|FG001|STARTED|Overall Study||16||
59496123|NCT00385801|75586879|FG000|COMPLETED|Overall Study||6||
60012313|NCT02528253|76128255|FG003|STARTED|Overall Study||407||
60012314|NCT02528253|76128256|FG004|STARTED|Overall Study||602||
60012315|NCT02528253|76128252|FG000|Intent to Treat Population|Overall Study||202||
59496124|NCT00385801|75586880|FG001|COMPLETED|Overall Study||8||
59496125|NCT00385801|75586879|FG000|NOT COMPLETED|Overall Study||9||
59496126|NCT00385801|75586880|FG001|NOT COMPLETED|Overall Study||8||
59496127|NCT00429403|75586889|FG000|STARTED|Overall Study||1||
59496128|NCT00429403|75586890|FG001|STARTED|Overall Study||0||
59496129|NCT00429403|75586889|FG000|COMPLETED|Overall Study||1||
59496130|NCT00429403|75586890|FG001|COMPLETED|Overall Study||0||
60012316|NCT02528253|76128253|FG001|Intent to Treat Population|Overall Study||204||
60012317|NCT02528253|76128254|FG002|Intent to Treat Population|Overall Study||407||
60012318|NCT02528253|76128255|FG003|Intent to Treat Population|Overall Study||407||
60012319|NCT02528253|76128256|FG004|Intent to Treat Population|Overall Study|3 participants randomized to placebo arm received tramadol during the course of study|605||
60012320|NCT02528253|76128252|FG000|Treated at Week 16|Overall Study||99||
59607141|NCT01234103|75717660|FG001|COMPLETED|Overall Study||391|Each was enrolled at baseline, completed all intervention sessions, but no follow-up sessions.|
59607142|NCT01234103|75717659|FG000|NOT COMPLETED|Overall Study||0||
59607143|NCT01234103|75717660|FG001|NOT COMPLETED|Overall Study||0||
59607144|NCT01222871|75717668|FG000|STARTED|Overall Study||0||
59496131|NCT00429403|75586889|FG000|NOT COMPLETED|Overall Study||0||
60012321|NCT02528253|76128253|FG001|Treated at Week 16|Overall Study||95||
60012322|NCT02528253|76128254|FG002|Treated at Week 16|Overall Study||236||
60012323|NCT02528253|76128255|FG003|Treated at Week 16|Overall Study||242||
60012324|NCT02528253|76128256|FG004|Treated at Week 16|Overall Study||307||
59496132|NCT00429403|75586890|FG001|NOT COMPLETED|Overall Study||0||
59496133|NCT00367679|75586896|FG000|STARTED|Overall Study||35||
59496134|NCT00367679|75586896|FG000|COMPLETED|Overall Study||35||
59496135|NCT00367679|75586896|FG000|NOT COMPLETED|Overall Study||0||
59496136|NCT00368459|75586904|FG000|STARTED|Overall Study||21||
59496137|NCT00368459|75586905|FG001|STARTED|Overall Study||21||
59496138|NCT00368459|75586904|FG000|COMPLETED|Overall Study||19||
59607145|NCT01222871|75717669|FG001|STARTED|Overall Study||0||
60012325|NCT02528253|76128252|FG000|COMPLETED|Overall Study||130||
60012326|NCT02528253|76128253|FG001|COMPLETED|Overall Study||134||
60012327|NCT02528253|76128254|FG002|COMPLETED|Overall Study||267||
60012328|NCT02528253|76128255|FG003|COMPLETED|Overall Study||271||
60012329|NCT02528253|76128256|FG004|COMPLETED|Overall Study||379||
59607146|NCT01222871|75717668|FG000|COMPLETED|Overall Study||0||
59607147|NCT01222871|75717669|FG001|COMPLETED|Overall Study||0||
59607148|NCT01222871|75717668|FG000|NOT COMPLETED|Overall Study||0||
59607149|NCT01222871|75717669|FG001|NOT COMPLETED|Overall Study||0||
59607150|NCT01219673|75717684|FG000|STARTED|Overall Study||0||
59607151|NCT01219673|75717685|FG001|STARTED|Overall Study||0||
59607152|NCT01219673|75717686|FG002|STARTED|Overall Study||1||
59607153|NCT01219673|75717687|FG003|STARTED|Overall Study||0||
59607154|NCT01219673|75717688|FG004|STARTED|Overall Study||0||
59607155|NCT01219673|75717689|FG005|STARTED|Overall Study||0||
59607156|NCT01219673|75717690|FG006|STARTED|Overall Study||0||
59607157|NCT01219673|75717691|FG007|STARTED|Overall Study||0||
59607158|NCT01219673|75717684|FG000|COMPLETED|Overall Study||0||
59607159|NCT01219673|75717685|FG001|COMPLETED|Overall Study||0||
59496139|NCT00368459|75586905|FG001|COMPLETED|Overall Study||20||
59496140|NCT00368459|75586904|FG000|NOT COMPLETED|Overall Study||2||
59496141|NCT00368459|75586905|FG001|NOT COMPLETED|Overall Study||1||
59496142|NCT01402700|75586911|FG000|STARTED|Overall Study||75||
59496143|NCT01402700|75586911|FG000|COMPLETED|Overall Study||68||
59496144|NCT01402700|75586911|FG000|NOT COMPLETED|Overall Study||7||
59496145|NCT00429949|75586915|FG000|STARTED|Overall Study||21||
59496146|NCT00429949|75586915|FG000|COMPLETED|Overall Study||21||
59496147|NCT00429949|75586915|FG000|NOT COMPLETED|Overall Study||0||
59496148|NCT02078726|75586923|FG000|STARTED|Overall Study||64||
59496149|NCT02078726|75586924|FG001|STARTED|Overall Study||36||
59496150|NCT02078726|75586923|FG000|COMPLETED|Overall Study||64||
59496151|NCT02078726|75586924|FG001|COMPLETED|Overall Study||36||
59496152|NCT02078726|75586923|FG000|NOT COMPLETED|Overall Study||0||
59496153|NCT02078726|75586924|FG001|NOT COMPLETED|Overall Study||0||
59496154|NCT00431041|75586932|FG000|STARTED|Overall Study|Data represents Intention To Treat(ITT) Population: All randomized subjects|68||
59496155|NCT00431041|75586933|FG001|STARTED|Overall Study|Data represents ITT Population: All randomized subjects|64||
59496156|NCT00431041|75586932|FG000|COMPLETED|Overall Study||52||
59496157|NCT00431041|75586933|FG001|COMPLETED|Overall Study||40||
59496158|NCT00431041|75586932|FG000|NOT COMPLETED|Overall Study||16||
59496159|NCT00431041|75586933|FG001|NOT COMPLETED|Overall Study||24||
59496160|NCT00390611|75586941|FG000|STARTED|6 Cycles of Study Treatment||43||
59496161|NCT00390611|75586942|FG001|STARTED|6 Cycles of Study Treatment||42||
59496162|NCT00390611|75586941|FG000|COMPLETED|6 Cycles of Study Treatment||34||
59884990|NCT03567291|76007774|FG003|COMPLETED|Period I||0||
59884991|NCT03567291|76007771|FG000|NOT COMPLETED|Period I||91||
59884992|NCT03567291|76007772|FG001|NOT COMPLETED|Period I||0||
59884993|NCT03567291|76007773|FG002|NOT COMPLETED|Period I||0||
59884994|NCT03567291|76007774|FG003|NOT COMPLETED|Period I||0||
59884995|NCT03567291|76007771|FG000|STARTED|Period II||0||
59884996|NCT03567291|76007772|FG001|STARTED|Period II||91||
59884997|NCT03567291|76007773|FG002|STARTED|Period II||46||
59884998|NCT03567291|76007774|FG003|STARTED|Period II||0||
59884999|NCT03567291|76007771|FG000|COMPLETED|Period II||0||
59885000|NCT03567291|76007772|FG001|COMPLETED|Period II||88||
59885001|NCT03567291|76007773|FG002|COMPLETED|Period II||45||
59885002|NCT03567291|76007774|FG003|COMPLETED|Period II||0||
59885003|NCT03567291|76007771|FG000|NOT COMPLETED|Period II||0||
59885004|NCT03567291|76007772|FG001|NOT COMPLETED|Period II||3||
59885005|NCT03567291|76007773|FG002|NOT COMPLETED|Period II||1||
59885006|NCT03567291|76007774|FG003|NOT COMPLETED|Period II||0||
59885007|NCT03567291|76007771|FG000|STARTED|Period III||0||
59885008|NCT03567291|76007772|FG001|STARTED|Period III||0||
59885009|NCT03567291|76007773|FG002|STARTED|Period III||0||
59885010|NCT03567291|76007774|FG003|STARTED|Period III||133||
59885011|NCT03567291|76007771|FG000|COMPLETED|Period III||0||
59885012|NCT03567291|76007772|FG001|COMPLETED|Period III||0||
59885013|NCT03567291|76007773|FG002|COMPLETED|Period III||0||
59885014|NCT03567291|76007774|FG003|COMPLETED|Period III||48||
59496163|NCT00390611|75586942|FG001|COMPLETED|6 Cycles of Study Treatment||37||
59496164|NCT00390611|75586941|FG000|NOT COMPLETED|6 Cycles of Study Treatment||9||
59496165|NCT00390611|75586942|FG001|NOT COMPLETED|6 Cycles of Study Treatment||5||
59496166|NCT00390611|75586941|FG000|STARTED|Maintenance Sorafenib to Month 12|11 patients came off-study between the end of cycle 6 and the start of maintenance|23||
59496167|NCT00390611|75586942|FG001|STARTED|Maintenance Sorafenib to Month 12|Patients in the Paclitaxel/carboplatin arm did not recieve maintenance sorafenib|0||
59885015|NCT03567291|76007771|FG000|NOT COMPLETED|Period III||0||
59885016|NCT03567291|76007772|FG001|NOT COMPLETED|Period III||0||
59885017|NCT03567291|76007773|FG002|NOT COMPLETED|Period III||0||
59885018|NCT03567291|76007774|FG003|NOT COMPLETED|Period III||85||
59496168|NCT00390611|75586941|FG000|COMPLETED|Maintenance Sorafenib to Month 12||13||
59496169|NCT00390611|75586942|FG001|COMPLETED|Maintenance Sorafenib to Month 12||0||
59496170|NCT00390611|75586941|FG000|NOT COMPLETED|Maintenance Sorafenib to Month 12||10||
59496171|NCT00390611|75586942|FG001|NOT COMPLETED|Maintenance Sorafenib to Month 12||0||
59496172|NCT00432601|75586952|FG000|STARTED|Time 1 to Time 2||510||
59496173|NCT00432601|75586953|FG001|STARTED|Time 1 to Time 2||512||
59885019|NCT02777242|76007780|FG000|STARTED|Overall Study||65||
59885020|NCT02777242|76007780|FG000|COMPLETED|Overall Study||59||
59885021|NCT02777242|76007780|FG000|NOT COMPLETED|Overall Study||6||
59885022|NCT03212144|76007786|FG000|STARTED|First Sequence (4 Weeks)||2||
59885023|NCT03212144|76007787|FG001|STARTED|First Sequence (4 Weeks)||1||
59885024|NCT03212144|76007786|FG000|COMPLETED|First Sequence (4 Weeks)||1||
59496174|NCT00432601|75586952|FG000|COMPLETED|Time 1 to Time 2|There is large drop-off as only one-third of subjects enrolled were eligible to continue the study|141||
59496175|NCT00432601|75586953|FG001|COMPLETED|Time 1 to Time 2|There is large drop-off as only one-third of subjects enrolled were eligible to continue the study|144||
59496176|NCT00432601|75586952|FG000|NOT COMPLETED|Time 1 to Time 2||369||
59496177|NCT00432601|75586953|FG001|NOT COMPLETED|Time 1 to Time 2||368||
59496178|NCT00432601|75586952|FG000|STARTED|Time 2 to Time 3||141||
59885025|NCT03212144|76007787|FG001|COMPLETED|First Sequence (4 Weeks)||1||
59885026|NCT03212144|76007786|FG000|NOT COMPLETED|First Sequence (4 Weeks)||1||
59885027|NCT03212144|76007787|FG001|NOT COMPLETED|First Sequence (4 Weeks)||0||
59885028|NCT03212144|76007786|FG000|STARTED|Washout (4 Weeks)||1||
59496179|NCT00432601|75586953|FG001|STARTED|Time 2 to Time 3||144||
59496180|NCT00432601|75586952|FG000|COMPLETED|Time 2 to Time 3||122||
59496181|NCT00432601|75586953|FG001|COMPLETED|Time 2 to Time 3||122||
59496182|NCT00432601|75586952|FG000|NOT COMPLETED|Time 2 to Time 3||19||
59496183|NCT00432601|75586953|FG001|NOT COMPLETED|Time 2 to Time 3||22||
59496184|NCT00391079|75586961|FG000|STARTED|Overall Study||167||
59496185|NCT00391079|75586962|FG001|STARTED|Overall Study||172||
59496186|NCT00391079|75586961|FG000|COMPLETED|Overall Study||141||
59496187|NCT00391079|75586962|FG001|COMPLETED|Overall Study||156||
59496188|NCT00391079|75586961|FG000|NOT COMPLETED|Overall Study||26||
59496189|NCT00391079|75586962|FG001|NOT COMPLETED|Overall Study||16||
59496190|NCT00387751|75586968|FG000|STARTED|Overall Study||14||
59496191|NCT00387751|75586968|FG000|COMPLETED|Overall Study||14||
59496192|NCT00387751|75586968|FG000|NOT COMPLETED|Overall Study||0||
59496193|NCT00391469|75586978|FG000|STARTED|Overall Study||688||
59496194|NCT00391469|75586979|FG001|STARTED|Overall Study||671||
59496195|NCT00391469|75586978|FG000|COMPLETED|Overall Study|5 patients were found to be incarcerated at time of randomization, thus data was not included|688||
59496196|NCT00391469|75586979|FG001|COMPLETED|Overall Study||671||
59496197|NCT00391469|75586978|FG000|NOT COMPLETED|Overall Study||0||
59496198|NCT00391469|75586979|FG001|NOT COMPLETED|Overall Study||0||
59496199|NCT00387829|75586989|FG000|STARTED|Safety Population||178||
59496200|NCT00387829|75586990|FG001|STARTED|Safety Population||169||
59496201|NCT00387829|75586989|FG000|COMPLETED|Safety Population||139||
59496202|NCT00387829|75586990|FG001|COMPLETED|Safety Population||136||
59496203|NCT00387829|75586989|FG000|NOT COMPLETED|Safety Population||39||
59496204|NCT00387829|75586990|FG001|NOT COMPLETED|Safety Population||33||
59496205|NCT00387829|75586989|FG000|STARTED|Intent-to-treat Population||177||
59496206|NCT00387829|75586990|FG001|STARTED|Intent-to-treat Population||166||
59496207|NCT00387829|75586989|FG000|COMPLETED|Intent-to-treat Population||139||
59496208|NCT00387829|75586990|FG001|COMPLETED|Intent-to-treat Population||136||
59496209|NCT00387829|75586989|FG000|NOT COMPLETED|Intent-to-treat Population||38||
59496210|NCT00387829|75586990|FG001|NOT COMPLETED|Intent-to-treat Population||30||
59496211|NCT00388453|75586999|FG000|STARTED|Overall Study||20||
59496212|NCT00388453|75587000|FG001|STARTED|Overall Study||17||
59496213|NCT00388453|75587001|FG002|STARTED|Overall Study||10||
59496214|NCT00388453|75586999|FG000|COMPLETED|Overall Study||20||
59496215|NCT00388453|75587000|FG001|COMPLETED|Overall Study||17||
59496216|NCT00388453|75587001|FG002|COMPLETED|Overall Study||10||
59496217|NCT00388453|75586999|FG000|NOT COMPLETED|Overall Study||0||
59496218|NCT00388453|75587000|FG001|NOT COMPLETED|Overall Study||0||
59496219|NCT00388453|75587001|FG002|NOT COMPLETED|Overall Study||0||
59496220|NCT00392951|75587009|FG000|STARTED|Overall Study||30||
59496221|NCT00392951|75587009|FG000|COMPLETED|Overall Study||30||
59496222|NCT00392951|75587009|FG000|NOT COMPLETED|Overall Study||0||
59496223|NCT00389467|75587017|FG000|STARTED|Overall Study||34||
59496224|NCT00389467|75587018|FG001|STARTED|Overall Study||34||
59496225|NCT00389467|75587019|FG002|STARTED|Overall Study||30||
59496226|NCT00389467|75587020|FG003|STARTED|Overall Study||20||
59496227|NCT00389467|75587017|FG000|COMPLETED|Overall Study||34||
59496228|NCT00389467|75587018|FG001|COMPLETED|Overall Study||34||
59496229|NCT00389467|75587019|FG002|COMPLETED|Overall Study||30||
59496230|NCT00389467|75587020|FG003|COMPLETED|Overall Study||20||
59496231|NCT00389467|75587017|FG000|NOT COMPLETED|Overall Study||0||
59496232|NCT00389467|75587018|FG001|NOT COMPLETED|Overall Study||0||
59496233|NCT00389467|75587019|FG002|NOT COMPLETED|Overall Study||0||
59496234|NCT00389467|75587020|FG003|NOT COMPLETED|Overall Study||0||
59496235|NCT01424930|75587033|FG000|STARTED|Overall Study||7||
59496236|NCT01424930|75587034|FG001|STARTED|Overall Study||18||
59496237|NCT01424930|75587033|FG000|Completed Food Safety Evaluation|Overall Study||6||
59496238|NCT01424930|75587034|FG001|Completed Food Safety Evaluation|Overall Study||18||
59496239|NCT01424930|75587033|FG000|COMPLETED|Overall Study||3||
59496240|NCT01424930|75587034|FG001|COMPLETED|Overall Study||4||
59762559|NCT00534313|75882340|FG003|COMPLETED|Short-term Period|Completed the short-term study|33||
59496241|NCT01424930|75587033|FG000|NOT COMPLETED|Overall Study||4||
59496242|NCT01424930|75587034|FG001|NOT COMPLETED|Overall Study||14||
59496243|NCT00389857|75587042|FG000|STARTED|Overall Study||14||
59496244|NCT00389857|75587043|FG001|STARTED|Overall Study||17||
59496245|NCT00389857|75587042|FG000|COMPLETED|Overall Study||14||
59496246|NCT00389857|75587043|FG001|COMPLETED|Overall Study||17||
59496247|NCT00389857|75587042|FG000|NOT COMPLETED|Overall Study||0||
59496248|NCT00389857|75587043|FG001|NOT COMPLETED|Overall Study||0||
59496249|NCT01424306|75587049|FG000|STARTED|Overall Study||4||
59496250|NCT01424306|75587050|FG001|STARTED|Overall Study||4||
59496251|NCT01424306|75587051|FG002|STARTED|Overall Study||3||
59496252|NCT01424306|75587052|FG003|STARTED|Overall Study||3||
59496253|NCT01424306|75587053|FG004|STARTED|Overall Study||5||
59496254|NCT01424306|75587054|FG005|STARTED|Overall Study||6||
59496255|NCT01424306|75587049|FG000|COMPLETED|Overall Study||4||
59496256|NCT01424306|75587050|FG001|COMPLETED|Overall Study||4||
59496257|NCT01424306|75587051|FG002|COMPLETED|Overall Study||3||
59496258|NCT01424306|75587052|FG003|COMPLETED|Overall Study||3||
59496259|NCT01424306|75587053|FG004|COMPLETED|Overall Study||4||
59496260|NCT01424306|75587054|FG005|COMPLETED|Overall Study||6||
59496261|NCT01424306|75587049|FG000|NOT COMPLETED|Overall Study||0||
59496262|NCT01424306|75587050|FG001|NOT COMPLETED|Overall Study||0||
59496263|NCT01424306|75587051|FG002|NOT COMPLETED|Overall Study||0||
59496264|NCT01424306|75587052|FG003|NOT COMPLETED|Overall Study||0||
59496265|NCT01424306|75587053|FG004|NOT COMPLETED|Overall Study||1||
59496266|NCT01424306|75587054|FG005|NOT COMPLETED|Overall Study||0||
59496267|NCT02110381|75587088|FG000|STARTED|Single Modality||9||
59496268|NCT02110381|75587089|FG001|STARTED|Single Modality||9||
59496269|NCT02110381|75587088|FG000|COMPLETED|Single Modality||7||
59496270|NCT02110381|75587089|FG001|COMPLETED|Single Modality||8||
59496271|NCT02110381|75587088|FG000|NOT COMPLETED|Single Modality||2||
59496272|NCT02110381|75587089|FG001|NOT COMPLETED|Single Modality||1||
59496273|NCT02110381|75587088|FG000|STARTED|Dual Modality||7||
59496274|NCT02110381|75587089|FG001|STARTED|Dual Modality||8||
59496275|NCT02110381|75587088|FG000|Began Active Treatment|Dual Modality||7||
59496276|NCT02110381|75587089|FG001|Began Active Treatment|Dual Modality||7||
59496277|NCT02110381|75587088|FG000|COMPLETED|Dual Modality||5||
59496278|NCT02110381|75587089|FG001|COMPLETED|Dual Modality||7||
59496279|NCT02110381|75587088|FG000|NOT COMPLETED|Dual Modality||2||
59496280|NCT02110381|75587089|FG001|NOT COMPLETED|Dual Modality||1||
59496281|NCT01424228|75587098|FG000|STARTED|Overall Study||182||
59496282|NCT01424228|75587099|FG001|STARTED|Overall Study||182||
59496283|NCT01424228|75587098|FG000|COMPLETED|Overall Study||126||
59496284|NCT01424228|75587099|FG001|COMPLETED|Overall Study||135||
59496285|NCT01424228|75587098|FG000|NOT COMPLETED|Overall Study||56||
59496286|NCT01424228|75587099|FG001|NOT COMPLETED|Overall Study||47||
59496287|NCT01423916|75587108|FG000|STARTED|Overall Study||74||
59496288|NCT01423916|75587109|FG001|STARTED|Overall Study||73||
59496289|NCT01423916|75587110|FG002|STARTED|Overall Study||71||
59496290|NCT01423916|75587108|FG000|COMPLETED|Overall Study||63||
59496291|NCT01423916|75587109|FG001|COMPLETED|Overall Study||53||
59496292|NCT01423916|75587110|FG002|COMPLETED|Overall Study||64||
59496293|NCT01423916|75587108|FG000|NOT COMPLETED|Overall Study||11||
59496294|NCT01423916|75587109|FG001|NOT COMPLETED|Overall Study||20||
59496295|NCT01423916|75587110|FG002|NOT COMPLETED|Overall Study||7||
59496296|NCT00436969|75587131|FG000|STARTED|Overall Study||88||
59496297|NCT00436969|75587132|FG001|STARTED|Overall Study||186||
59496298|NCT00436969|75587131|FG000|Randomized But Not Treated|Overall Study||1||
59496299|NCT00436969|75587132|FG001|Randomized But Not Treated|Overall Study||3||
59496300|NCT00436969|75587131|FG000|COMPLETED|Overall Study||66||
59496301|NCT00436969|75587132|FG001|COMPLETED|Overall Study||134||
59496302|NCT00436969|75587131|FG000|NOT COMPLETED|Overall Study||22||
59496303|NCT00436969|75587132|FG001|NOT COMPLETED|Overall Study||52||
59496304|NCT00455689|75587140|FG000|STARTED|Overall Study||14||
59496305|NCT00455689|75587141|FG001|STARTED|Overall Study||6||
59496306|NCT00455689|75587140|FG000|COMPLETED|Overall Study||14||
59496307|NCT00455689|75587141|FG001|COMPLETED|Overall Study||6||
59496308|NCT00455689|75587140|FG000|NOT COMPLETED|Overall Study||0||
59496309|NCT00455689|75587141|FG001|NOT COMPLETED|Overall Study||0||
59496310|NCT00394277|75587150|FG000|STARTED|Overall Study||195||
59496311|NCT00394277|75587151|FG001|STARTED|Overall Study||196||
59496312|NCT00394277|75587152|FG002|STARTED|Overall Study||393||
59496313|NCT00394277|75587153|FG003|STARTED|Overall Study||391||
59496314|NCT00394277|75587150|FG000|COMPLETED|Overall Study||137||
59496315|NCT00394277|75587151|FG001|COMPLETED|Overall Study||136||
59496316|NCT00394277|75587152|FG002|COMPLETED|Overall Study||273||
59496317|NCT00394277|75587153|FG003|COMPLETED|Overall Study||266||
59496318|NCT00394277|75587150|FG000|NOT COMPLETED|Overall Study||58||
59496319|NCT00394277|75587151|FG001|NOT COMPLETED|Overall Study||60||
59496320|NCT00394277|75587152|FG002|NOT COMPLETED|Overall Study||120||
59496321|NCT00394277|75587153|FG003|NOT COMPLETED|Overall Study||125||
59496322|NCT00395057|75587167|FG000|STARTED|Overall Study||34||
59496323|NCT00395057|75587168|FG001|STARTED|Overall Study||35||
59496324|NCT00395057|75587169|FG002|STARTED|Overall Study||35||
59496325|NCT00395057|75587170|FG003|STARTED|Overall Study||34||
59496326|NCT00395057|75587167|FG000|COMPLETED|Overall Study||2||
59496327|NCT00395057|75587168|FG001|COMPLETED|Overall Study||1||
59496328|NCT00395057|75587169|FG002|COMPLETED|Overall Study||2||
59496329|NCT00395057|75587170|FG003|COMPLETED|Overall Study||1||
59496330|NCT00395057|75587167|FG000|NOT COMPLETED|Overall Study||32||
59496331|NCT00395057|75587168|FG001|NOT COMPLETED|Overall Study||34||
59496332|NCT00395057|75587169|FG002|NOT COMPLETED|Overall Study||33||
59496333|NCT00395057|75587170|FG003|NOT COMPLETED|Overall Study||33||
59496334|NCT00371267|75587182|FG000|STARTED|Overall Study||48||
59496335|NCT00371267|75587183|FG001|STARTED|Overall Study||50||
59496336|NCT00371267|75587182|FG000|COMPLETED|Overall Study||39||
59496337|NCT00371267|75587183|FG001|COMPLETED|Overall Study||32||
59496338|NCT00371267|75587182|FG000|NOT COMPLETED|Overall Study||9||
59496339|NCT00371267|75587183|FG001|NOT COMPLETED|Overall Study||18||
59496340|NCT00438451|75587192|FG000|STARTED|Overall Study||122||
59496341|NCT00438451|75587193|FG001|STARTED|Overall Study||121||
59496342|NCT00438451|75587194|FG002|STARTED|Overall Study||118||
59496343|NCT00438451|75587192|FG000|Safety Population|Overall Study||122||
59496344|NCT00438451|75587193|FG001|Safety Population|Overall Study||121||
59496345|NCT00438451|75587194|FG002|Safety Population|Overall Study||117||
59496346|NCT00438451|75587192|FG000|ITT Population|Overall Study||122||
59496347|NCT00438451|75587193|FG001|ITT Population|Overall Study||120||
59496348|NCT00438451|75587194|FG002|ITT Population|Overall Study||117||
59496349|NCT00438451|75587192|FG000|Maintenance Phase (Week 7-58)|Overall Study||93||
59496350|NCT00438451|75587193|FG001|Maintenance Phase (Week 7-58)|Overall Study||89||
59496351|NCT00438451|75587194|FG002|Maintenance Phase (Week 7-58)|Overall Study||93||
59496352|NCT00438451|75587192|FG000|COMPLETED|Overall Study||75||
59496353|NCT00438451|75587193|FG001|COMPLETED|Overall Study||55||
59496354|NCT00438451|75587194|FG002|COMPLETED|Overall Study||65||
59496355|NCT00438451|75587192|FG000|NOT COMPLETED|Overall Study||47||
59496356|NCT00438451|75587193|FG001|NOT COMPLETED|Overall Study||66||
59496357|NCT00438451|75587194|FG002|NOT COMPLETED|Overall Study||53||
59496358|NCT00456547|75587204|FG000|STARTED|Overall Study||12||
59496359|NCT00456547|75587205|FG001|STARTED|Overall Study||12||
59496360|NCT00456547|75587204|FG000|COMPLETED|Overall Study||12||
59496361|NCT00456547|75587205|FG001|COMPLETED|Overall Study||12||
59496362|NCT00456547|75587204|FG000|NOT COMPLETED|Overall Study||0||
59496363|NCT00456547|75587205|FG001|NOT COMPLETED|Overall Study||0||
59496364|NCT00456625|75587211|FG000|STARTED|Overall Study||76||
59496365|NCT00456625|75587211|FG000|COMPLETED|Overall Study||76||
59496366|NCT00456625|75587211|FG000|NOT COMPLETED|Overall Study||0||
59496367|NCT00439465|75587215|FG000|STARTED|Overall Study||23||
59496368|NCT00439465|75587215|FG000|COMPLETED|Overall Study||19||
59496369|NCT00439465|75587215|FG000|NOT COMPLETED|Overall Study||4||
59496370|NCT00457795|75587222|FG000|STARTED|Overall Study||15||
59496371|NCT00457795|75587222|FG000|COMPLETED|Overall Study||15||
59496372|NCT00457795|75587222|FG000|NOT COMPLETED|Overall Study||0||
59496373|NCT01423604|75587229|FG000|STARTED|Safety Run-In||9||
59496374|NCT01423604|75587230|FG001|STARTED|Safety Run-In||0||
59496375|NCT01423604|75587229|FG000|COMPLETED|Safety Run-In||0||
59496376|NCT01423604|75587230|FG001|COMPLETED|Safety Run-In||0||
59496377|NCT01423604|75587229|FG000|NOT COMPLETED|Safety Run-In||9||
59496378|NCT01423604|75587230|FG001|NOT COMPLETED|Safety Run-In||0||
59496379|NCT01423604|75587229|FG000|STARTED|Randomized||64||
59496380|NCT01423604|75587230|FG001|STARTED|Randomized||63||
59496381|NCT01423604|75587229|FG000|COMPLETED|Randomized|As of 07August2015, 1 subject was receiving treatment in the randomized portion.|1||
59496382|NCT01423604|75587230|FG001|COMPLETED|Randomized||0||
59496383|NCT01423604|75587229|FG000|NOT COMPLETED|Randomized||63||
59496384|NCT01423604|75587230|FG001|NOT COMPLETED|Randomized||63||
59496385|NCT00441259|75587239|FG000|STARTED|Overall Study||48||
59496386|NCT00441259|75587240|FG001|STARTED|Overall Study||48||
59496387|NCT00441259|75587239|FG000|COMPLETED|Overall Study||48||
59496388|NCT00441259|75587240|FG001|COMPLETED|Overall Study||48||
59496389|NCT00441259|75587239|FG000|NOT COMPLETED|Overall Study||0||
59496390|NCT00441259|75587240|FG001|NOT COMPLETED|Overall Study||0||
59496391|NCT01402544|75587246|FG000|STARTED|Overall Study||12||
59496392|NCT01402544|75587246|FG000|COMPLETED|Overall Study||6||
59496393|NCT01402544|75587246|FG000|NOT COMPLETED|Overall Study||6||
59496394|NCT01401842|75587252|FG000|STARTED|Overall Study||298||
59496395|NCT01401842|75587253|FG001|STARTED|Overall Study||284||
59607160|NCT01219673|75717686|FG002|COMPLETED|Overall Study||1||
59607161|NCT01219673|75717687|FG003|COMPLETED|Overall Study||0||
59496396|NCT01401842|75587252|FG000|COMPLETED|Overall Study||230||
59496397|NCT01401842|75587253|FG001|COMPLETED|Overall Study||217||
59496398|NCT01401842|75587252|FG000|NOT COMPLETED|Overall Study||68||
59496399|NCT01401842|75587253|FG001|NOT COMPLETED|Overall Study||67||
59496400|NCT01422824|75587259|FG000|STARTED|Overall Study||185||
59496401|NCT01422824|75587259|FG000|Treated|Overall Study||184||
59496402|NCT01422824|75587259|FG000|COMPLETED|Overall Study||147||
59496403|NCT01422824|75587259|FG000|NOT COMPLETED|Overall Study||38||
59496404|NCT00460525|75587265|FG000|STARTED|Overall Study||201||
59496405|NCT00460525|75587266|FG001|STARTED|Overall Study||199||
59496406|NCT00460525|75587265|FG000|COMPLETED|Overall Study||190||
59496407|NCT00460525|75587266|FG001|COMPLETED|Overall Study||194||
59496408|NCT00460525|75587265|FG000|NOT COMPLETED|Overall Study||11||
59496409|NCT00460525|75587266|FG001|NOT COMPLETED|Overall Study||5||
59496410|NCT00460993|75587274|FG000|STARTED|Phase 1 (6 Days)||14||
59496411|NCT00460993|75587275|FG001|STARTED|Phase 1 (6 Days)||17||
59496412|NCT00460993|75587274|FG000|COMPLETED|Phase 1 (6 Days)||14||
59496413|NCT00460993|75587275|FG001|COMPLETED|Phase 1 (6 Days)||17||
59496414|NCT00460993|75587274|FG000|NOT COMPLETED|Phase 1 (6 Days)||0||
59496415|NCT00460993|75587275|FG001|NOT COMPLETED|Phase 1 (6 Days)||0||
59496416|NCT00460993|75587274|FG000|STARTED|Phase 2 (6 Days)||14||
59496417|NCT00460993|75587275|FG001|STARTED|Phase 2 (6 Days)||17||
59496418|NCT00460993|75587274|FG000|COMPLETED|Phase 2 (6 Days)||14||
59496419|NCT00460993|75587275|FG001|COMPLETED|Phase 2 (6 Days)||17||
59496420|NCT00460993|75587274|FG000|NOT COMPLETED|Phase 2 (6 Days)||0||
59496421|NCT00460993|75587275|FG001|NOT COMPLETED|Phase 2 (6 Days)||0||
59496422|NCT00441883|75587286|FG000|STARTED|Overall Study||43||
59496423|NCT00441883|75587287|FG001|STARTED|Overall Study||32||
59496424|NCT00441883|75587288|FG002|STARTED|Overall Study||28||
59496425|NCT00441883|75587289|FG003|STARTED|Overall Study||28||
59496426|NCT00441883|75587290|FG004|STARTED|Overall Study||45||
59496427|NCT00441883|75587286|FG000|ITT Population|Overall Study||43|Participants randomized and at least 1 dose of study medication; by randomized treatment.|
59496428|NCT00441883|75587287|FG001|ITT Population|Overall Study||30|Participants randomized and at least 1 dose of study medication; by randomized treatment.|
59496429|NCT00441883|75587288|FG002|ITT Population|Overall Study||30|Participants randomized and at least 1 dose of study medication; by randomized treatment.|
59496430|NCT00441883|75587289|FG003|ITT Population|Overall Study||30|Participants randomized and at least 1 dose of study medication; by randomized treatment.|
59496431|NCT00441883|75587290|FG004|ITT Population|Overall Study||43|Participants randomized and at least 1 dose of study medication; by randomized treatment.|
59496432|NCT00441883|75587286|FG000|Per Protocol Population|Overall Study||38|Participant randomized with no major protocol violations; by treatment received.|
59496433|NCT00441883|75587287|FG001|Per Protocol Population|Overall Study||29|Participant randomized with no major protocol violations; by treatment received.|
59496434|NCT00441883|75587288|FG002|Per Protocol Population|Overall Study||25|Participant randomized with no major protocol violations; by treatment received.|
59496435|NCT00441883|75587289|FG003|Per Protocol Population|Overall Study||24|Participant randomized with no major protocol violations; by treatment received.|
59496436|NCT00441883|75587290|FG004|Per Protocol Population|Overall Study||38|Participant randomized with no major protocol violations; by treatment received.|
59496437|NCT00441883|75587286|FG000|Safety Population|Overall Study||43|Participants randomized with at least 1 dose of study medication; by treatment received.|
59496438|NCT00441883|75587287|FG001|Safety Population|Overall Study||32|Participants randomized with at least 1 dose of study medication; by treatment received.|
59496439|NCT00441883|75587288|FG002|Safety Population|Overall Study||28|Participants randomized with at least 1 dose of study medication; by treatment received.|
59496440|NCT00441883|75587289|FG003|Safety Population|Overall Study||28|Participants randomized with at least 1 dose of study medication; by treatment received.|
59496441|NCT00441883|75587290|FG004|Safety Population|Overall Study||45|Participants randomized with at least 1 dose of study medication; by treatment received.|
59496442|NCT00441883|75587286|FG000|COMPLETED|Overall Study||42||
59496443|NCT00441883|75587287|FG001|COMPLETED|Overall Study||32||
59496444|NCT00441883|75587288|FG002|COMPLETED|Overall Study||28||
59496445|NCT00441883|75587289|FG003|COMPLETED|Overall Study||28||
59496446|NCT00441883|75587290|FG004|COMPLETED|Overall Study||43||
59496447|NCT00441883|75587286|FG000|NOT COMPLETED|Overall Study||1||
59496448|NCT00441883|75587287|FG001|NOT COMPLETED|Overall Study||0||
59496449|NCT00441883|75587288|FG002|NOT COMPLETED|Overall Study||0||
59496450|NCT00441883|75587289|FG003|NOT COMPLETED|Overall Study||0||
59496451|NCT00441883|75587290|FG004|NOT COMPLETED|Overall Study||2||
59496452|NCT00461773|75587304|FG000|STARTED|Overall Study||3||
59496453|NCT00461773|75587305|FG001|STARTED|Overall Study||2||
59496454|NCT00461773|75587304|FG000|COMPLETED|Overall Study||3||
59496455|NCT00461773|75587305|FG001|COMPLETED|Overall Study||2||
59496456|NCT00461773|75587304|FG000|NOT COMPLETED|Overall Study||0||
59496457|NCT00461773|75587305|FG001|NOT COMPLETED|Overall Study||0||
59496458|NCT00461851|75587311|FG000|STARTED|Overall Study||17||
59496459|NCT00461851|75587311|FG000|COMPLETED|Overall Study||17||
59496460|NCT00461851|75587311|FG000|NOT COMPLETED|Overall Study||0||
59496461|NCT00442507|75587315|FG000|STARTED|Overall Study||6||
59496462|NCT00442507|75587315|FG000|COMPLETED|Overall Study||6||
59496463|NCT00442507|75587315|FG000|NOT COMPLETED|Overall Study||0||
59496464|NCT01401530|75587322|FG000|STARTED|Overall Study||3||
59496465|NCT01401530|75587323|FG001|STARTED|Overall Study||7||
59496466|NCT01401530|75587324|FG002|STARTED|Overall Study||3||
59496467|NCT01401530|75587322|FG000|COMPLETED|Overall Study||0||
59496468|NCT01401530|75587323|FG001|COMPLETED|Overall Study||1||
59496469|NCT01401530|75587324|FG002|COMPLETED|Overall Study||0||
59496470|NCT01401530|75587322|FG000|NOT COMPLETED|Overall Study||3||
59496471|NCT01401530|75587323|FG001|NOT COMPLETED|Overall Study||6||
59496472|NCT01401530|75587324|FG002|NOT COMPLETED|Overall Study||3||
59496473|NCT01387022|75587336|FG000|STARTED|Overall Study||29||
59496474|NCT01387022|75587337|FG001|STARTED|Overall Study||30||
59496475|NCT01387022|75587336|FG000|COMPLETED|Overall Study||28||
59496476|NCT01387022|75587337|FG001|COMPLETED|Overall Study||26||
59496477|NCT01387022|75587336|FG000|NOT COMPLETED|Overall Study||1||
59496478|NCT01387022|75587337|FG001|NOT COMPLETED|Overall Study||4||
59496479|NCT00395135|75587345|FG000|STARTED|Year 1||1595||
59496480|NCT00395135|75587346|FG001|STARTED|Year 1||1587||
59496481|NCT00395135|75587347|FG002|STARTED|Year 1||0||
59496482|NCT00395135|75587348|FG003|STARTED|Year 1||0||
59496483|NCT00395135|75587349|FG004|STARTED|Year 1||0||
59496484|NCT00395135|75587345|FG000|COMPLETED|Year 1||883||
59496485|NCT00395135|75587346|FG001|COMPLETED|Year 1||716||
59496486|NCT00395135|75587347|FG002|COMPLETED|Year 1||0||
59496487|NCT00395135|75587348|FG003|COMPLETED|Year 1||0||
59496488|NCT00395135|75587349|FG004|COMPLETED|Year 1||0||
59496489|NCT00395135|75587345|FG000|NOT COMPLETED|Year 1||712||
59496490|NCT00395135|75587346|FG001|NOT COMPLETED|Year 1||871||
59496491|NCT00395135|75587347|FG002|NOT COMPLETED|Year 1||0||
59496492|NCT00395135|75587348|FG003|NOT COMPLETED|Year 1||0||
59496493|NCT00395135|75587349|FG004|NOT COMPLETED|Year 1||0||
59496494|NCT00395135|75587345|FG000|STARTED|Year 2||0||
59496495|NCT00395135|75587346|FG001|STARTED|Year 2||0||
59496496|NCT00395135|75587347|FG002|STARTED|Year 2||573||
59496497|NCT00395135|75587348|FG003|STARTED|Year 2||283||
59496498|NCT00395135|75587349|FG004|STARTED|Year 2||697||
59496499|NCT00395135|75587345|FG000|COMPLETED|Year 2||0||
59496500|NCT00395135|75587346|FG001|COMPLETED|Year 2||0||
59496501|NCT00395135|75587347|FG002|COMPLETED|Year 2||426||
59496502|NCT00395135|75587348|FG003|COMPLETED|Year 2||195||
59496503|NCT00395135|75587349|FG004|COMPLETED|Year 2||507||
59496504|NCT00395135|75587345|FG000|NOT COMPLETED|Year 2||0||
59496505|NCT00395135|75587346|FG001|NOT COMPLETED|Year 2||0||
59496506|NCT00395135|75587347|FG002|NOT COMPLETED|Year 2||147||
59496507|NCT00395135|75587348|FG003|NOT COMPLETED|Year 2||88||
59496508|NCT00395135|75587349|FG004|NOT COMPLETED|Year 2||190||
59496509|NCT01386944|75587363|FG000|STARTED|Overall Study||102||
59496510|NCT01386944|75587363|FG000|COMPLETED|Overall Study||46||
59496511|NCT01386944|75587363|FG000|NOT COMPLETED|Overall Study||56||
59496512|NCT00395291|75587367|FG000|STARTED|First Intervention||17||
59496513|NCT00395291|75587368|FG001|STARTED|First Intervention||9||
59496514|NCT00395291|75587367|FG000|COMPLETED|First Intervention||15||
59496515|NCT00395291|75587368|FG001|COMPLETED|First Intervention||9||
59496516|NCT00395291|75587367|FG000|NOT COMPLETED|First Intervention||2||
59496517|NCT00395291|75587368|FG001|NOT COMPLETED|First Intervention||0||
59496518|NCT00395291|75587367|FG000|STARTED|Washout Period for 30 Days||15||
59496519|NCT00395291|75587368|FG001|STARTED|Washout Period for 30 Days||9||
59496520|NCT00395291|75587367|FG000|COMPLETED|Washout Period for 30 Days||13||
59496521|NCT00395291|75587368|FG001|COMPLETED|Washout Period for 30 Days||9||
59496522|NCT00395291|75587367|FG000|NOT COMPLETED|Washout Period for 30 Days||2||
59496523|NCT00395291|75587368|FG001|NOT COMPLETED|Washout Period for 30 Days||0||
59496524|NCT00395291|75587367|FG000|STARTED|Second Intervention||13||
59496525|NCT00395291|75587368|FG001|STARTED|Second Intervention||9||
59496526|NCT00395291|75587367|FG000|COMPLETED|Second Intervention||13||
59496527|NCT00395291|75587368|FG001|COMPLETED|Second Intervention||9||
59496528|NCT00395291|75587367|FG000|NOT COMPLETED|Second Intervention||0||
59496529|NCT00395291|75587368|FG001|NOT COMPLETED|Second Intervention||0||
59496530|NCT01386788|75587374|FG000|STARTED|Overall Study||102||
59496531|NCT01386788|75587374|FG000|COMPLETED|Overall Study||100||
59496532|NCT01386788|75587374|FG000|NOT COMPLETED|Overall Study||2||
59496533|NCT00445315|75587383|FG000|STARTED|Overall Study||6||
59496534|NCT00445315|75587384|FG001|STARTED|Overall Study||6||
59496535|NCT00445315|75587385|FG002|STARTED|Overall Study||6||
59496536|NCT00445315|75587386|FG003|STARTED|Overall Study||6||
59496537|NCT00445315|75587387|FG004|STARTED|Overall Study||8||
59496538|NCT00445315|75587383|FG000|COMPLETED|Overall Study||6||
59496539|NCT00445315|75587384|FG001|COMPLETED|Overall Study||6||
59496540|NCT00445315|75587385|FG002|COMPLETED|Overall Study||6||
59496541|NCT00445315|75587386|FG003|COMPLETED|Overall Study||6||
59496542|NCT00445315|75587387|FG004|COMPLETED|Overall Study||8||
59496543|NCT00445315|75587383|FG000|NOT COMPLETED|Overall Study||0||
59496544|NCT00445315|75587384|FG001|NOT COMPLETED|Overall Study||0||
59496545|NCT00445315|75587385|FG002|NOT COMPLETED|Overall Study||0||
59496546|NCT00445315|75587386|FG003|NOT COMPLETED|Overall Study||0||
59496547|NCT00445315|75587387|FG004|NOT COMPLETED|Overall Study||0||
59496548|NCT00395993|75587402|FG000|STARTED|Overall Study||246||
59496549|NCT00395993|75587403|FG001|STARTED|Overall Study||231||
59496550|NCT00395993|75587402|FG000|COMPLETED|Overall Study||211||
59496551|NCT00395993|75587403|FG001|COMPLETED|Overall Study||212||
59496552|NCT00395993|75587402|FG000|NOT COMPLETED|Overall Study||35||
59496553|NCT00395993|75587403|FG001|NOT COMPLETED|Overall Study||19||
59496554|NCT00374231|75587409|FG000|STARTED|Overall Study||40||
59496555|NCT00374231|75587409|FG000|COMPLETED|Overall Study||40||
59496556|NCT00374231|75587409|FG000|NOT COMPLETED|Overall Study||0||
59496557|NCT00400205|75587414|FG000|STARTED|Overall Study||14||
59496558|NCT00400205|75587414|FG000|COMPLETED|Overall Study||9||
59496559|NCT00400205|75587414|FG000|NOT COMPLETED|Overall Study||5||
59496560|NCT00445705|75587423|FG000|STARTED|Overall Study||53||
59496561|NCT00445705|75587424|FG001|STARTED|Overall Study||53||
59496562|NCT00445705|75587425|FG002|STARTED|Overall Study||52||
59496563|NCT00445705|75587426|FG003|STARTED|Overall Study||53||
59496564|NCT00445705|75587423|FG000|COMPLETED|Overall Study||44||
59496565|NCT00445705|75587424|FG001|COMPLETED|Overall Study||42||
59496566|NCT00445705|75587425|FG002|COMPLETED|Overall Study||41||
59496567|NCT00445705|75587426|FG003|COMPLETED|Overall Study||39||
59496568|NCT00445705|75587423|FG000|NOT COMPLETED|Overall Study||9||
59496569|NCT00445705|75587424|FG001|NOT COMPLETED|Overall Study||11||
59496570|NCT00445705|75587425|FG002|NOT COMPLETED|Overall Study||11||
59496571|NCT00445705|75587426|FG003|NOT COMPLETED|Overall Study||14||
59496572|NCT01386554|75587439|FG000|STARTED|Overall Study||4||
59496573|NCT01386554|75587440|FG001|STARTED|Overall Study||35||
59496574|NCT01386554|75587441|FG002|STARTED|Overall Study||21||
59496575|NCT01386554|75587439|FG000|COMPLETED|Overall Study||1||
59496576|NCT01386554|75587440|FG001|COMPLETED|Overall Study||26||
59496577|NCT01386554|75587441|FG002|COMPLETED|Overall Study||15||
59496578|NCT01386554|75587439|FG000|NOT COMPLETED|Overall Study||3||
59496579|NCT01386554|75587440|FG001|NOT COMPLETED|Overall Study||9||
59496580|NCT01386554|75587441|FG002|NOT COMPLETED|Overall Study||6||
59496581|NCT00400439|75587453|FG000|STARTED|Overall Study||52||
59496582|NCT00400439|75587454|FG001|STARTED|Overall Study||25||
59496583|NCT00400439|75587453|FG000|COMPLETED|Overall Study||47||
59496584|NCT00400439|75587454|FG001|COMPLETED|Overall Study||23||
59496585|NCT00400439|75587453|FG000|NOT COMPLETED|Overall Study||5||
59496586|NCT00400439|75587454|FG001|NOT COMPLETED|Overall Study||2||
59496587|NCT00448201|75587460|FG000|STARTED|Overall Study||71||
59496588|NCT00448201|75587460|FG000|COMPLETED|Overall Study||71||
59496589|NCT00448201|75587460|FG000|NOT COMPLETED|Overall Study||0||
59496590|NCT01386008|75587466|FG000|STARTED|Overall Study||20||
59496591|NCT01386008|75587466|FG000|COMPLETED|Overall Study||0||
59496592|NCT01386008|75587466|FG000|NOT COMPLETED|Overall Study||20||
59496593|NCT00375167|75587472|FG000|STARTED|Overall Study|Clients were already receiving ACT services and this continued after study completion|16||
59496594|NCT00375167|75587473|FG001|STARTED|Overall Study|Participants were already clients of ACT and continued receiving services following this period|17||
59496595|NCT00375167|75587472|FG000|COMPLETED|Overall Study||16||
59496596|NCT00375167|75587473|FG001|COMPLETED|Overall Study||17||
59496597|NCT00375167|75587472|FG000|NOT COMPLETED|Overall Study||0||
59496598|NCT00375167|75587473|FG001|NOT COMPLETED|Overall Study||0||
59496599|NCT00375713|75587483|FG000|STARTED|Overall Study|Randomized population (N=232).|232||
59496600|NCT00375713|75587484|FG001|STARTED|Overall Study|Randomized population (N=234).|234||
59496601|NCT00375713|75587483|FG000|COMPLETED|Overall Study|20 Patients were not treated or discontinued after randomization in Levocetirizine group.|212||
59496602|NCT00375713|75587484|FG001|COMPLETED|Overall Study|23 Patients were not treated or discontinued after randomization in Cetirizine group.|211||
59496603|NCT00375713|75587483|FG000|NOT COMPLETED|Overall Study||20||
59496604|NCT00375713|75587484|FG001|NOT COMPLETED|Overall Study||23||
59496605|NCT00465595|75587492|FG000|STARTED|Overall Study||27||
59496606|NCT00465595|75587493|FG001|STARTED|Overall Study||29||
59496607|NCT00465595|75587492|FG000|COMPLETED|Overall Study||22||
59496608|NCT00465595|75587493|FG001|COMPLETED|Overall Study||24||
59496609|NCT00465595|75587492|FG000|NOT COMPLETED|Overall Study||5||
59496610|NCT00465595|75587493|FG001|NOT COMPLETED|Overall Study||5||
59496611|NCT00376805|75587505|FG000|STARTED|Overall Study||6||
59496612|NCT00376805|75587505|FG000|COMPLETED|Overall Study||6||
59496613|NCT00376805|75587505|FG000|NOT COMPLETED|Overall Study||0||
59496614|NCT00448357|75587509|FG000|STARTED|Overall Study||54||
59496615|NCT00448357|75587509|FG000|COMPLETED|Overall Study||54||
59496616|NCT00448357|75587509|FG000|NOT COMPLETED|Overall Study||0||
59496617|NCT00450073|75587528|FG000|STARTED|Overall Study||10||
59496618|NCT00450073|75587529|FG001|STARTED|Overall Study||10||
59496619|NCT00450073|75587530|FG002|STARTED|Overall Study||10||
59496620|NCT00450073|75587528|FG000|COMPLETED|Overall Study||9||
59496621|NCT00450073|75587529|FG001|COMPLETED|Overall Study||10||
59496622|NCT00450073|75587530|FG002|COMPLETED|Overall Study||9||
59496623|NCT00450073|75587528|FG000|NOT COMPLETED|Overall Study||1||
59496624|NCT00450073|75587529|FG001|NOT COMPLETED|Overall Study||0||
59496625|NCT00450073|75587530|FG002|NOT COMPLETED|Overall Study||1||
59496626|NCT00467077|75587538|FG000|STARTED|Overall Study||21||
59496627|NCT00467077|75587538|FG000|COMPLETED|Overall Study||21||
59496628|NCT00467077|75587538|FG000|NOT COMPLETED|Overall Study||0||
59496629|NCT00400829|75587542|FG000|STARTED|Overall Study||66||
59496630|NCT00400829|75587542|FG000|COMPLETED|Overall Study||66||
59496631|NCT00400829|75587542|FG000|NOT COMPLETED|Overall Study||0||
59496632|NCT00467389|75587546|FG000|STARTED|Overall Study||6||
59607162|NCT01219673|75717688|FG004|COMPLETED|Overall Study||0||
59496633|NCT00467389|75587547|FG001|STARTED|Overall Study||6||
59496634|NCT00467389|75587546|FG000|COMPLETED|Overall Study||6||
59496635|NCT00467389|75587547|FG001|COMPLETED|Overall Study||6||
59496636|NCT00467389|75587546|FG000|NOT COMPLETED|Overall Study||0||
59496637|NCT00467389|75587547|FG001|NOT COMPLETED|Overall Study||0||
59496638|NCT00377741|75587555|FG000|STARTED|Overall Study||16||
59496639|NCT00377741|75587556|FG001|STARTED|Overall Study||15||
59496640|NCT00377741|75587555|FG000|COMPLETED|Overall Study||16||
59496641|NCT00377741|75587556|FG001|COMPLETED|Overall Study||15||
59496642|NCT00377741|75587555|FG000|NOT COMPLETED|Overall Study||0||
59496643|NCT00377741|75587556|FG001|NOT COMPLETED|Overall Study||0||
59496644|NCT00379145|75587562|FG000|STARTED|Overall Study||20||
59496645|NCT00379145|75587562|FG000|COMPLETED|Overall Study||20|Eligible and treated patients|
59496646|NCT00379145|75587562|FG000|NOT COMPLETED|Overall Study||0||
59496647|NCT00382031|75587573|FG000|STARTED|Overall Study|Of the 191 randomized patients 189 received at least one infusion of zalutumumab|191||
59496648|NCT00382031|75587574|FG001|STARTED|Overall Study|Of the 95 randomized patients 94 attended Visit2.|95||
59496649|NCT00382031|75587573|FG000|COMPLETED|Overall Study||191||
59496650|NCT00382031|75587574|FG001|COMPLETED|Overall Study||95||
59496651|NCT00382031|75587573|FG000|NOT COMPLETED|Overall Study||0||
59496652|NCT00382031|75587574|FG001|NOT COMPLETED|Overall Study||0||
59496653|NCT00382265|75587582|FG000|STARTED|Overall Study||267||
59496654|NCT00382265|75587583|FG001|STARTED|Overall Study||245||
59885029|NCT03212144|76007787|FG001|STARTED|Washout (4 Weeks)||1||
59885030|NCT03212144|76007786|FG000|COMPLETED|Washout (4 Weeks)||1||
59885031|NCT03212144|76007787|FG001|COMPLETED|Washout (4 Weeks)||1||
59885032|NCT03212144|76007786|FG000|NOT COMPLETED|Washout (4 Weeks)||0||
59885033|NCT03212144|76007787|FG001|NOT COMPLETED|Washout (4 Weeks)||0||
59885034|NCT03212144|76007786|FG000|STARTED|Second Sequence (4 Weeks)||1||
59885035|NCT03212144|76007787|FG001|STARTED|Second Sequence (4 Weeks)||1||
59885036|NCT03212144|76007786|FG000|COMPLETED|Second Sequence (4 Weeks)||0||
59885037|NCT03212144|76007787|FG001|COMPLETED|Second Sequence (4 Weeks)||0||
59885038|NCT03212144|76007786|FG000|NOT COMPLETED|Second Sequence (4 Weeks)||1||
59885039|NCT03212144|76007787|FG001|NOT COMPLETED|Second Sequence (4 Weeks)||1||
59885040|NCT03566979|76007797|FG000|STARTED|Overall Study||58||
59885041|NCT03566979|76007798|FG001|STARTED|Overall Study||152||
59885042|NCT03566979|76007799|FG002|STARTED|Overall Study||142||
59885043|NCT03566979|76007800|FG003|STARTED|Overall Study||149||
59885044|NCT03566979|76007797|FG000|COMPLETED|Overall Study||53||
59885045|NCT03566979|76007798|FG001|COMPLETED|Overall Study||145||
59885046|NCT03566979|76007799|FG002|COMPLETED|Overall Study||132||
59885047|NCT03566979|76007800|FG003|COMPLETED|Overall Study||143||
59885048|NCT03566979|76007797|FG000|NOT COMPLETED|Overall Study||5||
59885049|NCT03566979|76007798|FG001|NOT COMPLETED|Overall Study||7||
59885050|NCT03566979|76007799|FG002|NOT COMPLETED|Overall Study||10||
59496655|NCT00382265|75587582|FG000|COMPLETED|Overall Study||258||
59496656|NCT00382265|75587583|FG001|COMPLETED|Overall Study||239||
59496657|NCT00382265|75587582|FG000|NOT COMPLETED|Overall Study||9||
59496658|NCT00382265|75587583|FG001|NOT COMPLETED|Overall Study||6||
59496659|NCT00383747|75587595|FG000|STARTED|Visit 1||14||
59496660|NCT00383747|75587596|FG001|STARTED|Visit 1||14||
59496661|NCT00383747|75587597|FG002|STARTED|Visit 1||16||
59885051|NCT03566979|76007800|FG003|NOT COMPLETED|Overall Study||6||
59885052|NCT00116831|76007812|FG000|STARTED|Overall Study||337||
59496662|NCT00383747|75587598|FG003|STARTED|Visit 1||16||
59496663|NCT00383747|75587595|FG000|COMPLETED|Visit 1||14||
59496664|NCT00383747|75587596|FG001|COMPLETED|Visit 1||14||
59885053|NCT00116831|76007813|FG001|STARTED|Overall Study||331||
59885054|NCT00116831|76007812|FG000|COMPLETED|Overall Study||264||
59885055|NCT00116831|76007813|FG001|COMPLETED|Overall Study||259||
59496665|NCT00383747|75587597|FG002|COMPLETED|Visit 1||16||
59496666|NCT00383747|75587598|FG003|COMPLETED|Visit 1||16||
59496667|NCT00383747|75587595|FG000|NOT COMPLETED|Visit 1||0||
59496668|NCT00383747|75587596|FG001|NOT COMPLETED|Visit 1||0||
59496669|NCT00383747|75587597|FG002|NOT COMPLETED|Visit 1||0||
59496670|NCT00383747|75587598|FG003|NOT COMPLETED|Visit 1||0||
59496671|NCT00383747|75587595|FG000|STARTED|Visit 2||14||
59496672|NCT00383747|75587596|FG001|STARTED|Visit 2||14||
59496673|NCT00383747|75587597|FG002|STARTED|Visit 2||16||
59496674|NCT00383747|75587598|FG003|STARTED|Visit 2||16||
59496675|NCT00383747|75587595|FG000|COMPLETED|Visit 2||14||
59496676|NCT00383747|75587596|FG001|COMPLETED|Visit 2||14||
59496677|NCT00383747|75587597|FG002|COMPLETED|Visit 2||16||
59496678|NCT00383747|75587598|FG003|COMPLETED|Visit 2||16||
59496679|NCT00383747|75587595|FG000|NOT COMPLETED|Visit 2||0||
59496680|NCT00383747|75587596|FG001|NOT COMPLETED|Visit 2||0||
59496681|NCT00383747|75587597|FG002|NOT COMPLETED|Visit 2||0||
59496682|NCT00383747|75587598|FG003|NOT COMPLETED|Visit 2||0||
59496683|NCT01421342|75587614|FG000|STARTED|Acute Treatment Phase (12 Weeks)||511||
59496684|NCT01421342|75587615|FG001|STARTED|Acute Treatment Phase (12 Weeks)||506||
59496685|NCT01421342|75587616|FG002|STARTED|Acute Treatment Phase (12 Weeks)||505||
59496686|NCT01421342|75587614|FG000|COMPLETED|Acute Treatment Phase (12 Weeks)||353||
59496687|NCT01421342|75587615|FG001|COMPLETED|Acute Treatment Phase (12 Weeks)||378||
59496688|NCT01421342|75587616|FG002|COMPLETED|Acute Treatment Phase (12 Weeks)||406||
59496689|NCT01421342|75587614|FG000|NOT COMPLETED|Acute Treatment Phase (12 Weeks)||158||
59496690|NCT01421342|75587615|FG001|NOT COMPLETED|Acute Treatment Phase (12 Weeks)||128||
59496691|NCT01421342|75587616|FG002|NOT COMPLETED|Acute Treatment Phase (12 Weeks)||99||
59496692|NCT01421342|75587614|FG000|STARTED|Completed to Week 12 But Then Withdrawn||353||
59496693|NCT01421342|75587615|FG001|STARTED|Completed to Week 12 But Then Withdrawn||378||
59496694|NCT01421342|75587616|FG002|STARTED|Completed to Week 12 But Then Withdrawn||406||
59496695|NCT01421342|75587614|FG000|COMPLETED|Completed to Week 12 But Then Withdrawn||204||
59496696|NCT01421342|75587615|FG001|COMPLETED|Completed to Week 12 But Then Withdrawn||253||
59496697|NCT01421342|75587616|FG002|COMPLETED|Completed to Week 12 But Then Withdrawn||268||
59496698|NCT01421342|75587614|FG000|NOT COMPLETED|Completed to Week 12 But Then Withdrawn||149||
59496699|NCT01421342|75587615|FG001|NOT COMPLETED|Completed to Week 12 But Then Withdrawn||125||
59496700|NCT01421342|75587616|FG002|NOT COMPLETED|Completed to Week 12 But Then Withdrawn||138||
59496701|NCT01421342|75587614|FG000|STARTED|Continuation of Treatment (Week 12 - 36)||204||
59496702|NCT01421342|75587615|FG001|STARTED|Continuation of Treatment (Week 12 - 36)||253||
59496703|NCT01421342|75587616|FG002|STARTED|Continuation of Treatment (Week 12 - 36)||268||
59496704|NCT01421342|75587614|FG000|COMPLETED|Continuation of Treatment (Week 12 - 36)||152||
59496705|NCT01421342|75587615|FG001|COMPLETED|Continuation of Treatment (Week 12 - 36)||194||
59496706|NCT01421342|75587616|FG002|COMPLETED|Continuation of Treatment (Week 12 - 36)||203||
59496707|NCT01421342|75587614|FG000|NOT COMPLETED|Continuation of Treatment (Week 12 - 36)||52||
59496708|NCT01421342|75587615|FG001|NOT COMPLETED|Continuation of Treatment (Week 12 - 36)||59||
59496709|NCT01421342|75587616|FG002|NOT COMPLETED|Continuation of Treatment (Week 12 - 36)||65||
59496710|NCT00403403|75587626|FG000|STARTED|Overall Study||50||
59496711|NCT00403403|75587627|FG001|STARTED|Overall Study||52||
59496712|NCT00403403|75587626|FG000|Safety-Evaluable Patients|Overall Study||47||
59496713|NCT00403403|75587627|FG001|Safety-Evaluable Patients|Overall Study||51||
59496714|NCT00403403|75587626|FG000|COMPLETED|Overall Study||50||
59496715|NCT00403403|75587627|FG001|COMPLETED|Overall Study||52||
59496716|NCT00403403|75587626|FG000|NOT COMPLETED|Overall Study||0||
59496717|NCT00403403|75587627|FG001|NOT COMPLETED|Overall Study||0||
59496718|NCT00405353|75587633|FG000|STARTED|Overall Study||10||
59496719|NCT00405353|75587633|FG000|COMPLETED|Overall Study||10||
59496720|NCT00405353|75587633|FG000|NOT COMPLETED|Overall Study||0||
59496721|NCT01384760|75587639|FG000|STARTED|Overall Study||61||
59496722|NCT01384760|75587640|FG001|STARTED|Overall Study||43||
59496723|NCT01384760|75587639|FG000|Randomized|Overall Study||61||
59496724|NCT01384760|75587640|FG001|Randomized|Overall Study||43||
59496725|NCT01384760|75587639|FG000|COMPLETED|Overall Study||45||
59496726|NCT01384760|75587640|FG001|COMPLETED|Overall Study||37||
59496727|NCT01384760|75587639|FG000|NOT COMPLETED|Overall Study||16||
59496728|NCT01384760|75587640|FG001|NOT COMPLETED|Overall Study||6||
59496729|NCT00405509|75587648|FG000|STARTED|Overall Study||11||
59496730|NCT00405509|75587649|FG001|STARTED|Overall Study||22||
59496731|NCT00405509|75587648|FG000|COMPLETED|Overall Study||11||
59496732|NCT00405509|75587649|FG001|COMPLETED|Overall Study||22||
59496733|NCT00405509|75587648|FG000|NOT COMPLETED|Overall Study||0||
59496734|NCT00405509|75587649|FG001|NOT COMPLETED|Overall Study||0||
59496735|NCT00406133|75587659|FG000|STARTED|Phase 1 (First 26 Week Period)||165||
60012330|NCT02528253|76128252|FG000|NOT COMPLETED|Overall Study||75||
60012331|NCT02528253|76128253|FG001|NOT COMPLETED|Overall Study||70||
59496736|NCT00406133|75587660|FG001|STARTED|Phase 1 (First 26 Week Period)||157||
59496737|NCT00406133|75587661|FG002|STARTED|Phase 1 (First 26 Week Period)||67||
59496738|NCT00406133|75587662|FG003|STARTED|Phase 1 (First 26 Week Period)||62||
59496739|NCT00406133|75587659|FG000|COMPLETED|Phase 1 (First 26 Week Period)||162||
59496740|NCT00406133|75587660|FG001|COMPLETED|Phase 1 (First 26 Week Period)||155||
59496741|NCT00406133|75587661|FG002|COMPLETED|Phase 1 (First 26 Week Period)||67||
59496742|NCT00406133|75587662|FG003|COMPLETED|Phase 1 (First 26 Week Period)||60||
59496743|NCT00406133|75587659|FG000|NOT COMPLETED|Phase 1 (First 26 Week Period)||3||
59496744|NCT00406133|75587660|FG001|NOT COMPLETED|Phase 1 (First 26 Week Period)||2||
59496745|NCT00406133|75587661|FG002|NOT COMPLETED|Phase 1 (First 26 Week Period)||0||
59496746|NCT00406133|75587662|FG003|NOT COMPLETED|Phase 1 (First 26 Week Period)||2||
59496747|NCT00406133|75587659|FG000|STARTED|Phase 2 (Second 26 Week Period)|3 subjects completed phase 1 but elected not to go into phase 2.|159||
59496748|NCT00406133|75587660|FG001|STARTED|Phase 2 (Second 26 Week Period)||155||
59496749|NCT00406133|75587661|FG002|STARTED|Phase 2 (Second 26 Week Period)||67||
59496750|NCT00406133|75587662|FG003|STARTED|Phase 2 (Second 26 Week Period)||60||
59496751|NCT00406133|75587659|FG000|COMPLETED|Phase 2 (Second 26 Week Period)||157||
59496752|NCT00406133|75587660|FG001|COMPLETED|Phase 2 (Second 26 Week Period)||152||
59496753|NCT00406133|75587661|FG002|COMPLETED|Phase 2 (Second 26 Week Period)||67||
59496754|NCT00406133|75587662|FG003|COMPLETED|Phase 2 (Second 26 Week Period)||60||
59496755|NCT00406133|75587659|FG000|NOT COMPLETED|Phase 2 (Second 26 Week Period)||2||
59496756|NCT00406133|75587660|FG001|NOT COMPLETED|Phase 2 (Second 26 Week Period)||3||
59496757|NCT00406133|75587661|FG002|NOT COMPLETED|Phase 2 (Second 26 Week Period)||0||
59496758|NCT00406133|75587662|FG003|NOT COMPLETED|Phase 2 (Second 26 Week Period)||0||
59496759|NCT01384292|75587680|FG000|STARTED|Part A||5||
59496760|NCT01384292|75587681|FG001|STARTED|Part A||5||
59496761|NCT01384292|75587682|FG002|STARTED|Part A||4||
59496762|NCT01384292|75587680|FG000|COMPLETED|Part A||5||
59496763|NCT01384292|75587681|FG001|COMPLETED|Part A||5||
59496764|NCT01384292|75587682|FG002|COMPLETED|Part A||4||
59496765|NCT01384292|75587680|FG000|NOT COMPLETED|Part A||0||
59496766|NCT01384292|75587681|FG001|NOT COMPLETED|Part A||0||
59496767|NCT01384292|75587682|FG002|NOT COMPLETED|Part A||0||
59496768|NCT01384292|75587680|FG000|STARTED|Part B||3||
59496769|NCT01384292|75587681|FG001|STARTED|Part B||6||
59496770|NCT01384292|75587682|FG002|STARTED|Part B||0||
59496771|NCT01384292|75587680|FG000|COMPLETED|Part B||2||
59496772|NCT01384292|75587681|FG001|COMPLETED|Part B||6||
59496773|NCT01384292|75587682|FG002|COMPLETED|Part B||0||
59496774|NCT01384292|75587680|FG000|NOT COMPLETED|Part B||1||
59496775|NCT01384292|75587681|FG001|NOT COMPLETED|Part B||0||
59496776|NCT01384292|75587682|FG002|NOT COMPLETED|Part B||0||
59496777|NCT01401452|75587692|FG000|STARTED|Overall Study||246||
59496778|NCT01401452|75587692|FG000|Visit 1 (Baseline)|Overall Study||246||
59496779|NCT01401452|75587692|FG000|Visit 2 (1 Month)|Overall Study||225||
59496780|NCT01401452|75587692|FG000|Visit 3 (3 Months)|Overall Study||217||
59496781|NCT01401452|75587692|FG000|Visit 4 (6 Months)|Overall Study||172||
59496782|NCT01401452|75587692|FG000|Visit 5 (9 Months)|Overall Study||175||
59496783|NCT01401452|75587692|FG000|COMPLETED|Overall Study||174||
59496784|NCT01401452|75587692|FG000|NOT COMPLETED|Overall Study||72||
59496785|NCT00450463|75587698|FG000|STARTED|Initial Drug Administration||33||
59496786|NCT00450463|75587699|FG001|STARTED|Initial Drug Administration||31||
59496787|NCT00450463|75587698|FG000|COMPLETED|Initial Drug Administration||33||
59496788|NCT00450463|75587699|FG001|COMPLETED|Initial Drug Administration||31||
59496789|NCT00450463|75587698|FG000|NOT COMPLETED|Initial Drug Administration||0||
59496790|NCT00450463|75587699|FG001|NOT COMPLETED|Initial Drug Administration||0||
59496791|NCT00450463|75587698|FG000|STARTED|Progressed to Receive Vaccine Alone||11||
59496792|NCT00450463|75587699|FG001|STARTED|Progressed to Receive Vaccine Alone||0||
59496793|NCT00450463|75587698|FG000|COMPLETED|Progressed to Receive Vaccine Alone||11||
59496794|NCT00450463|75587699|FG001|COMPLETED|Progressed to Receive Vaccine Alone||0||
59496795|NCT00450463|75587698|FG000|NOT COMPLETED|Progressed to Receive Vaccine Alone||0||
59496796|NCT00450463|75587699|FG001|NOT COMPLETED|Progressed to Receive Vaccine Alone||0||
59496797|NCT00407381|75587711|FG000|STARTED|Overall Study||42||
59496798|NCT00407381|75587712|FG001|STARTED|Overall Study||42||
59762560|NCT00534313|75882337|FG000|NOT COMPLETED|Short-term Period||6||
59762561|NCT00534313|75882338|FG001|NOT COMPLETED|Short-term Period||6||
59885056|NCT00116831|76007812|FG000|NOT COMPLETED|Overall Study||73||
59496799|NCT00407381|75587713|FG002|STARTED|Overall Study||42||
59496800|NCT00407381|75587711|FG000|COMPLETED|Overall Study||39||
59496801|NCT00407381|75587712|FG001|COMPLETED|Overall Study||38||
59496802|NCT00407381|75587713|FG002|COMPLETED|Overall Study||40||
59496803|NCT00407381|75587711|FG000|NOT COMPLETED|Overall Study||3||
59496804|NCT00407381|75587712|FG001|NOT COMPLETED|Overall Study||4||
59885057|NCT00116831|76007813|FG001|NOT COMPLETED|Overall Study||72||
59496805|NCT00407381|75587713|FG002|NOT COMPLETED|Overall Study||2||
59496806|NCT00384449|75587721|FG000|STARTED|Overall Study||1||
59496807|NCT00384449|75587721|FG000|COMPLETED|Overall Study||1||
59496808|NCT00384449|75587721|FG000|NOT COMPLETED|Overall Study||0||
59496809|NCT01401062|75587727|FG000|STARTED|Overall Study||11||
59496810|NCT01401062|75587728|FG001|STARTED|Overall Study||12||
59496811|NCT01401062|75587727|FG000|COMPLETED|Overall Study||0||
59496812|NCT01401062|75587728|FG001|COMPLETED|Overall Study|At time of data entry, these 4 patients are still undergoing follow-up|4||
59496813|NCT01401062|75587727|FG000|NOT COMPLETED|Overall Study||11||
59496814|NCT01401062|75587728|FG001|NOT COMPLETED|Overall Study||8||
59496815|NCT00452335|75587737|FG000|STARTED|Overall Study||27||
59496816|NCT00452335|75587738|FG001|STARTED|Overall Study||65||
59496817|NCT00452335|75587739|FG002|STARTED|Overall Study||32||
59496818|NCT00452335|75587737|FG000|COMPLETED|Overall Study||25||
59496819|NCT00452335|75587738|FG001|COMPLETED|Overall Study||61||
59496820|NCT00452335|75587739|FG002|COMPLETED|Overall Study||23||
59496821|NCT00452335|75587737|FG000|NOT COMPLETED|Overall Study||2||
59496822|NCT00452335|75587738|FG001|NOT COMPLETED|Overall Study||4||
59496823|NCT00452335|75587739|FG002|NOT COMPLETED|Overall Study||9||
59496824|NCT00386243|75587752|FG000|STARTED|Overall Study||121||
59496825|NCT00386243|75587753|FG001|STARTED|Overall Study||121||
59496826|NCT00386243|75587752|FG000|COMPLETED|Overall Study||114||
59496827|NCT00386243|75587753|FG001|COMPLETED|Overall Study||108||
59496828|NCT00386243|75587752|FG000|NOT COMPLETED|Overall Study||7||
59496829|NCT00386243|75587753|FG001|NOT COMPLETED|Overall Study||13||
59496830|NCT01400516|75587761|FG000|STARTED|Primary Trial||12||
59496831|NCT01400516|75587762|FG001|STARTED|Primary Trial||14||
59496832|NCT01400516|75587761|FG000|COMPLETED|Primary Trial||12||
59496833|NCT01400516|75587762|FG001|COMPLETED|Primary Trial||12||
59496834|NCT01400516|75587761|FG000|NOT COMPLETED|Primary Trial||0||
59496835|NCT01400516|75587762|FG001|NOT COMPLETED|Primary Trial||2||
59496836|NCT01400516|75587761|FG000|STARTED|Extension Trial|Only 6 participants in the Control arm entered the Extension Trial.|6||
59496837|NCT01400516|75587762|FG001|STARTED|Extension Trial|Only 7 participants in the Teriparatide arm entered the Extension Trial.|7||
59496838|NCT01400516|75587761|FG000|COMPLETED|Extension Trial||6||
59496839|NCT01400516|75587762|FG001|COMPLETED|Extension Trial||7||
59496840|NCT01400516|75587761|FG000|NOT COMPLETED|Extension Trial||0||
59496841|NCT01400516|75587762|FG001|NOT COMPLETED|Extension Trial||0||
59496842|NCT01383356|75587768|FG000|STARTED|Period 1|Entered and treated.|29||
59496843|NCT01383356|75587769|FG001|STARTED|Period 1|Entered and treated.|29||
59496844|NCT01383356|75587768|FG000|COMPLETED|Period 1|Completed period 1.|21||
59496845|NCT01383356|75587769|FG001|COMPLETED|Period 1|Completed period 1.|23||
59496846|NCT01383356|75587768|FG000|NOT COMPLETED|Period 1||8||
59496847|NCT01383356|75587769|FG001|NOT COMPLETED|Period 1||6||
59496848|NCT01383356|75587768|FG000|STARTED|Washout Period (at Least 35 Days)||21||
59496849|NCT01383356|75587769|FG001|STARTED|Washout Period (at Least 35 Days)||23||
59496850|NCT01383356|75587768|FG000|COMPLETED|Washout Period (at Least 35 Days)||21||
59496851|NCT01383356|75587769|FG001|COMPLETED|Washout Period (at Least 35 Days)||23||
59496852|NCT01383356|75587768|FG000|NOT COMPLETED|Washout Period (at Least 35 Days)||0||
59496853|NCT01383356|75587769|FG001|NOT COMPLETED|Washout Period (at Least 35 Days)||0||
59496854|NCT01383356|75587768|FG000|STARTED|Period 2|Entered and treated.|21||
59496855|NCT01383356|75587769|FG001|STARTED|Period 2|Entered and treated.|23||
59496856|NCT01383356|75587768|FG000|COMPLETED|Period 2|Completed period 2.|21||
59496857|NCT01383356|75587769|FG001|COMPLETED|Period 2|Completed period 2.|23||
59496858|NCT01383356|75587768|FG000|NOT COMPLETED|Period 2||0||
59496859|NCT01383356|75587769|FG001|NOT COMPLETED|Period 2||0||
59496860|NCT02111447|75587779|FG000|STARTED|Overall Study||0||
59496861|NCT02111447|75587780|FG001|STARTED|Overall Study||5||
59496862|NCT02111447|75587781|FG002|STARTED|Overall Study||1||
59496863|NCT02111447|75587782|FG003|STARTED|Overall Study||0||
59496864|NCT02111447|75587779|FG000|COMPLETED|Overall Study||0||
59496865|NCT02111447|75587780|FG001|COMPLETED|Overall Study||5||
59496866|NCT02111447|75587781|FG002|COMPLETED|Overall Study||1||
59496867|NCT02111447|75587782|FG003|COMPLETED|Overall Study||0||
59496868|NCT02111447|75587779|FG000|NOT COMPLETED|Overall Study||0||
59496869|NCT02111447|75587780|FG001|NOT COMPLETED|Overall Study||0||
59496870|NCT02111447|75587781|FG002|NOT COMPLETED|Overall Study||0||
59496871|NCT02111447|75587782|FG003|NOT COMPLETED|Overall Study||0||
59496872|NCT05740098|75587795|FG000|STARTED|Overall Study||68||
59496873|NCT05740098|75587796|FG001|STARTED|Overall Study||63||
59496874|NCT05740098|75587797|FG002|STARTED|Overall Study||67||
59496875|NCT05740098|75587795|FG000|COMPLETED|Overall Study||42||
59496876|NCT05740098|75587796|FG001|COMPLETED|Overall Study||46||
59496877|NCT05740098|75587797|FG002|COMPLETED|Overall Study||46||
59496878|NCT05740098|75587795|FG000|NOT COMPLETED|Overall Study||26||
59496879|NCT05740098|75587796|FG001|NOT COMPLETED|Overall Study||17||
59496880|NCT05740098|75587797|FG002|NOT COMPLETED|Overall Study||21||
59496881|NCT05059080|75587808|FG000|STARTED|Overall Study||72||
59496882|NCT05059080|75587808|FG000|COMPLETED|Overall Study||5||
59496883|NCT05059080|75587808|FG000|NOT COMPLETED|Overall Study||67||
59496884|NCT05012163|75587816|FG000|STARTED|Overall Study||14394||
59496885|NCT05012163|75587817|FG001|STARTED|Overall Study||14394||
59496886|NCT05012163|75587818|FG002|STARTED|Overall Study||14394||
59496887|NCT05012163|75587819|FG003|STARTED|Overall Study||14399||
59496888|NCT05012163|75587816|FG000|COMPLETED|Overall Study||14394||
59496889|NCT05012163|75587817|FG001|COMPLETED|Overall Study||14394||
59496890|NCT05012163|75587818|FG002|COMPLETED|Overall Study||14393||
59496891|NCT05012163|75587819|FG003|COMPLETED|Overall Study||14398||
59496892|NCT05012163|75587816|FG000|NOT COMPLETED|Overall Study||0||
59496893|NCT05012163|75587817|FG001|NOT COMPLETED|Overall Study||0||
59496894|NCT05012163|75587818|FG002|NOT COMPLETED|Overall Study||1||
59496895|NCT05012163|75587819|FG003|NOT COMPLETED|Overall Study||1||
59496896|NCT05009251|75587834|FG000|STARTED|Overall Study||9017||
59496897|NCT05009251|75587835|FG001|STARTED|Overall Study||9013||
59496898|NCT05009251|75587836|FG002|STARTED|Overall Study||9011||
59496899|NCT05009251|75587837|FG003|STARTED|Overall Study||9003||
60012332|NCT02528253|76128254|FG002|NOT COMPLETED|Overall Study||140||
60012333|NCT02528253|76128255|FG003|NOT COMPLETED|Overall Study||136||
60012334|NCT02528253|76128256|FG004|NOT COMPLETED|Overall Study||223||
60012335|NCT01672957|76128287|FG000|STARTED|Overall Study||128||
60012336|NCT01672957|76128287|FG000|Intent-to-treat (ITT) Population|Overall Study|All enrolled participants who had no major protocol violation.|123||
60012337|NCT01672957|76128287|FG000|COMPLETED|Overall Study||73||
60012338|NCT01672957|76128287|FG000|NOT COMPLETED|Overall Study||55||
60012339|NCT02525133|76128293|FG000|STARTED|Overall Study||213||
60012340|NCT02525133|76128294|FG001|STARTED|Overall Study||106||
59496900|NCT05009251|75587838|FG004|STARTED|Overall Study||9017||
60012341|NCT02525133|76128293|FG000|Randomized But Not Treated|Overall Study||4||
60012342|NCT02525133|76128294|FG001|Randomized But Not Treated|Overall Study||0||
60012343|NCT02525133|76128293|FG000|COMPLETED|Overall Study||203||
60012344|NCT02525133|76128294|FG001|COMPLETED|Overall Study||103||
60012345|NCT02525133|76128293|FG000|NOT COMPLETED|Overall Study||10||
59496901|NCT05009251|75587834|FG000|COMPLETED|Overall Study||8892||
59496902|NCT05009251|75587835|FG001|COMPLETED|Overall Study||8886||
60012346|NCT02525133|76128294|FG001|NOT COMPLETED|Overall Study||3||
59496903|NCT05009251|75587836|FG002|COMPLETED|Overall Study||8868||
59496904|NCT05009251|75587837|FG003|COMPLETED|Overall Study||8864||
59496905|NCT05009251|75587838|FG004|COMPLETED|Overall Study||8883||
59496906|NCT05009251|75587834|FG000|NOT COMPLETED|Overall Study||125||
59496907|NCT05009251|75587835|FG001|NOT COMPLETED|Overall Study||127||
59496908|NCT05009251|75587836|FG002|NOT COMPLETED|Overall Study||143||
59496909|NCT05009251|75587837|FG003|NOT COMPLETED|Overall Study||139||
59496910|NCT05009251|75587838|FG004|NOT COMPLETED|Overall Study||134||
59496911|NCT04839692|75587852|FG000|STARTED|Overall Study||23||
59496912|NCT04839692|75587853|FG001|STARTED|Overall Study||14||
59496913|NCT04839692|75587852|FG000|COMPLETED|Overall Study||22||
59496914|NCT04839692|75587853|FG001|COMPLETED|Overall Study||11||
59496915|NCT04839692|75587852|FG000|NOT COMPLETED|Overall Study||1||
59496916|NCT04839692|75587853|FG001|NOT COMPLETED|Overall Study||3||
59496917|NCT04646668|75587861|FG000|STARTED|Overall Study||11||
59496918|NCT04646668|75587862|FG001|STARTED|Overall Study||11||
59496919|NCT04646668|75587861|FG000|COMPLETED|Overall Study||11||
59496920|NCT04646668|75587862|FG001|COMPLETED|Overall Study||11||
59496921|NCT04646668|75587861|FG000|NOT COMPLETED|Overall Study||0||
59496922|NCT04646668|75587862|FG001|NOT COMPLETED|Overall Study||0||
59496923|NCT04486625|75587872|FG000|STARTED|Overall Study||6||
59496924|NCT04486625|75587873|FG001|STARTED|Overall Study||5||
59496925|NCT04486625|75587872|FG000|COMPLETED|Overall Study||6||
59496926|NCT04486625|75587873|FG001|COMPLETED|Overall Study||5||
59496927|NCT04486625|75587872|FG000|NOT COMPLETED|Overall Study||0||
59496928|NCT04486625|75587873|FG001|NOT COMPLETED|Overall Study||0||
59496929|NCT04476017|75587881|FG000|STARTED|Part A (28 Days)||11||
59496930|NCT04476017|75587882|FG001|STARTED|Part A (28 Days)||0||
59496931|NCT04476017|75587881|FG000|COMPLETED|Part A (28 Days)||10||
59496932|NCT04476017|75587882|FG001|COMPLETED|Part A (28 Days)||0||
59496933|NCT04476017|75587881|FG000|NOT COMPLETED|Part A (28 Days)||1||
59496934|NCT04476017|75587882|FG001|NOT COMPLETED|Part A (28 Days)||0||
59496935|NCT04476017|75587881|FG000|STARTED|Part B (42 Days)||0|Part B of this study was started after completion of Part A. Participants who completed Part A of the study were not included in Part B of the study. Unique participants were enrolled in Part B.|
59496936|NCT04476017|75587882|FG001|STARTED|Part B (42 Days)||7|Part B of this study was started after completion of Part A. Participants who completed Part A of the study were not included in Part B of the study. Unique participants were enrolled in Part B.|
59496937|NCT04476017|75587881|FG000|COMPLETED|Part B (42 Days)||0||
59496938|NCT04476017|75587882|FG001|COMPLETED|Part B (42 Days)||7||
59496939|NCT04476017|75587881|FG000|NOT COMPLETED|Part B (42 Days)||0||
59496940|NCT04476017|75587882|FG001|NOT COMPLETED|Part B (42 Days)||0||
59496941|NCT04422639|75587891|FG000|STARTED|Overall Study||1||
59496942|NCT04422639|75587892|FG001|STARTED|Overall Study||2||
59496943|NCT04422639|75587891|FG000|COMPLETED|Overall Study||0||
59496944|NCT04422639|75587892|FG001|COMPLETED|Overall Study||0||
59496945|NCT04422639|75587891|FG000|NOT COMPLETED|Overall Study||1||
59496946|NCT04422639|75587892|FG001|NOT COMPLETED|Overall Study||2||
59496947|NCT04384107|75587900|FG000|STARTED|Overall Study||347||
59496948|NCT04384107|75587901|FG001|STARTED|Overall Study||347||
59496949|NCT04384107|75587900|FG000|Dose 1|Overall Study||347||
59496950|NCT04384107|75587901|FG001|Dose 1|Overall Study||346||
59496951|NCT04384107|75587900|FG000|Dose 2|Overall Study||344||
59496952|NCT04384107|75587901|FG001|Dose 2|Overall Study||346||
59496953|NCT04384107|75587900|FG000|Dose 3|Overall Study||343||
59496954|NCT04384107|75587901|FG001|Dose 3|Overall Study||346||
59496955|NCT04384107|75587900|FG000|Dose 4|Overall Study||340||
59496956|NCT04384107|75587901|FG001|Dose 4|Overall Study||342||
59496957|NCT04384107|75587900|FG000|COMPLETED|Overall Study||338||
59496958|NCT04384107|75587901|FG001|COMPLETED|Overall Study||341||
59496959|NCT04384107|75587900|FG000|NOT COMPLETED|Overall Study||9||
59496960|NCT04384107|75587901|FG001|NOT COMPLETED|Overall Study||6||
59496961|NCT04275089|75587907|FG000|STARTED|Overall Study||15||
59496962|NCT04275089|75587907|FG000|COMPLETED|Overall Study||14||
59496963|NCT04275089|75587907|FG000|NOT COMPLETED|Overall Study||1||
59496964|NCT04182113|75587917|FG000|STARTED|First Intervention (Week 1)||4||
59496965|NCT04182113|75587918|FG001|STARTED|First Intervention (Week 1)||5||
59496966|NCT04182113|75587919|FG002|STARTED|First Intervention (Week 1)||4||
59496967|NCT04182113|75587920|FG003|STARTED|First Intervention (Week 1)||4||
59496968|NCT04182113|75587921|FG004|STARTED|First Intervention (Week 1)||3||
59496969|NCT04182113|75587922|FG005|STARTED|First Intervention (Week 1)||4||
59496970|NCT04182113|75587917|FG000|COMPLETED|First Intervention (Week 1)||4||
59496971|NCT04182113|75587918|FG001|COMPLETED|First Intervention (Week 1)||5||
59496972|NCT04182113|75587919|FG002|COMPLETED|First Intervention (Week 1)||4||
59496973|NCT04182113|75587920|FG003|COMPLETED|First Intervention (Week 1)||4||
59496974|NCT04182113|75587921|FG004|COMPLETED|First Intervention (Week 1)||3||
59496975|NCT04182113|75587922|FG005|COMPLETED|First Intervention (Week 1)||4||
59496976|NCT04182113|75587917|FG000|NOT COMPLETED|First Intervention (Week 1)||0||
59496977|NCT04182113|75587918|FG001|NOT COMPLETED|First Intervention (Week 1)||0||
59496978|NCT04182113|75587919|FG002|NOT COMPLETED|First Intervention (Week 1)||0||
59496979|NCT04182113|75587920|FG003|NOT COMPLETED|First Intervention (Week 1)||0||
59496980|NCT04182113|75587921|FG004|NOT COMPLETED|First Intervention (Week 1)||0||
59496981|NCT04182113|75587922|FG005|NOT COMPLETED|First Intervention (Week 1)||0||
59496982|NCT04182113|75587917|FG000|STARTED|Second Intervention (Week 2)||4||
59496983|NCT04182113|75587918|FG001|STARTED|Second Intervention (Week 2)||5||
59496984|NCT04182113|75587919|FG002|STARTED|Second Intervention (Week 2)||4||
59496985|NCT04182113|75587920|FG003|STARTED|Second Intervention (Week 2)||4||
59496986|NCT04182113|75587921|FG004|STARTED|Second Intervention (Week 2)||3||
59496987|NCT04182113|75587922|FG005|STARTED|Second Intervention (Week 2)||4||
59496988|NCT04182113|75587917|FG000|COMPLETED|Second Intervention (Week 2)||4||
59496989|NCT04182113|75587918|FG001|COMPLETED|Second Intervention (Week 2)||5||
59496990|NCT04182113|75587919|FG002|COMPLETED|Second Intervention (Week 2)||4||
59496991|NCT04182113|75587920|FG003|COMPLETED|Second Intervention (Week 2)||4||
59496992|NCT04182113|75587921|FG004|COMPLETED|Second Intervention (Week 2)||3||
59496993|NCT04182113|75587922|FG005|COMPLETED|Second Intervention (Week 2)||4||
59496994|NCT04182113|75587917|FG000|NOT COMPLETED|Second Intervention (Week 2)||0||
59496995|NCT04182113|75587918|FG001|NOT COMPLETED|Second Intervention (Week 2)||0||
59496996|NCT04182113|75587919|FG002|NOT COMPLETED|Second Intervention (Week 2)||0||
59496997|NCT04182113|75587920|FG003|NOT COMPLETED|Second Intervention (Week 2)||0||
59496998|NCT04182113|75587921|FG004|NOT COMPLETED|Second Intervention (Week 2)||0||
59496999|NCT04182113|75587922|FG005|NOT COMPLETED|Second Intervention (Week 2)||0||
59497000|NCT04182113|75587917|FG000|STARTED|Third Intervention (Week 3)||4||
59497001|NCT04182113|75587918|FG001|STARTED|Third Intervention (Week 3)||5||
59497002|NCT04182113|75587919|FG002|STARTED|Third Intervention (Week 3)||4||
59497003|NCT04182113|75587920|FG003|STARTED|Third Intervention (Week 3)||4||
59497004|NCT04182113|75587921|FG004|STARTED|Third Intervention (Week 3)||3||
59497005|NCT04182113|75587922|FG005|STARTED|Third Intervention (Week 3)||3||
59497006|NCT04182113|75587917|FG000|COMPLETED|Third Intervention (Week 3)||4||
59497007|NCT04182113|75587918|FG001|COMPLETED|Third Intervention (Week 3)||5||
59497008|NCT04182113|75587919|FG002|COMPLETED|Third Intervention (Week 3)||4||
59497009|NCT04182113|75587920|FG003|COMPLETED|Third Intervention (Week 3)||4||
59497010|NCT04182113|75587921|FG004|COMPLETED|Third Intervention (Week 3)||3||
59497011|NCT04182113|75587922|FG005|COMPLETED|Third Intervention (Week 3)||3||
59497012|NCT04182113|75587917|FG000|NOT COMPLETED|Third Intervention (Week 3)||0||
59497013|NCT04182113|75587918|FG001|NOT COMPLETED|Third Intervention (Week 3)||0||
59497014|NCT04182113|75587919|FG002|NOT COMPLETED|Third Intervention (Week 3)||0||
59497015|NCT04182113|75587920|FG003|NOT COMPLETED|Third Intervention (Week 3)||0||
59497016|NCT04182113|75587921|FG004|NOT COMPLETED|Third Intervention (Week 3)||0||
59497017|NCT04182113|75587922|FG005|NOT COMPLETED|Third Intervention (Week 3)||0||
59497018|NCT04096326|75587942|FG000|STARTED|Overall Study||8||
59497019|NCT04096326|75587943|FG001|STARTED|Overall Study||32||
59497020|NCT04096326|75587944|FG002|STARTED|Overall Study||12||
59497021|NCT04096326|75587945|FG003|STARTED|Overall Study||28||
59497022|NCT04096326|75587946|FG004|STARTED|Overall Study||11||
59885058|NCT02777086|76007821|FG000|STARTED|Overall Study||261||
59885059|NCT02777086|76007822|FG001|STARTED|Overall Study||250||
59885060|NCT02777086|76007821|FG000|COMPLETED|Overall Study||165||
59885061|NCT02777086|76007822|FG001|COMPLETED|Overall Study||151||
59885062|NCT02777086|76007821|FG000|NOT COMPLETED|Overall Study||96||
59885063|NCT02777086|76007822|FG001|NOT COMPLETED|Overall Study||99||
59497023|NCT04096326|75587947|FG005|STARTED|Overall Study||27||
59497024|NCT04096326|75587948|FG006|STARTED|Overall Study||10||
59497025|NCT04096326|75587949|FG007|STARTED|Overall Study||30||
59497026|NCT04096326|75587950|FG008|STARTED|Overall Study||9||
59497027|NCT04096326|75587951|FG009|STARTED|Overall Study||31||
59497028|NCT04096326|75587942|FG000|COMPLETED|Overall Study||8||
59497029|NCT04096326|75587943|FG001|COMPLETED|Overall Study||31||
59497030|NCT04096326|75587944|FG002|COMPLETED|Overall Study||12||
59497031|NCT04096326|75587945|FG003|COMPLETED|Overall Study||28||
59497032|NCT04096326|75587946|FG004|COMPLETED|Overall Study||10||
59497033|NCT04096326|75587947|FG005|COMPLETED|Overall Study||22||
59497034|NCT04096326|75587948|FG006|COMPLETED|Overall Study||9||
59497035|NCT04096326|75587949|FG007|COMPLETED|Overall Study||30||
59497036|NCT04096326|75587950|FG008|COMPLETED|Overall Study||9||
59497037|NCT04096326|75587951|FG009|COMPLETED|Overall Study||31||
59497038|NCT04096326|75587942|FG000|NOT COMPLETED|Overall Study||0||
59497039|NCT04096326|75587943|FG001|NOT COMPLETED|Overall Study||1||
59497040|NCT04096326|75587944|FG002|NOT COMPLETED|Overall Study||0||
59497041|NCT04096326|75587945|FG003|NOT COMPLETED|Overall Study||0||
59497042|NCT04096326|75587946|FG004|NOT COMPLETED|Overall Study||1||
59497043|NCT04096326|75587947|FG005|NOT COMPLETED|Overall Study||5||
59497044|NCT04096326|75587948|FG006|NOT COMPLETED|Overall Study||1||
59497045|NCT04096326|75587949|FG007|NOT COMPLETED|Overall Study||0||
59497046|NCT04096326|75587950|FG008|NOT COMPLETED|Overall Study||0||
59497047|NCT04096326|75587951|FG009|NOT COMPLETED|Overall Study||0||
59497048|NCT04072822|75587975|FG000|STARTED|Treatment||73||
59497049|NCT04072822|75587976|FG001|STARTED|Treatment||74||
59497050|NCT04072822|75587975|FG000|COMPLETED|Treatment||30||
59497051|NCT04072822|75587976|FG001|COMPLETED|Treatment||20||
59497052|NCT04072822|75587975|FG000|NOT COMPLETED|Treatment||43||
59497053|NCT04072822|75587976|FG001|NOT COMPLETED|Treatment||54||
59497054|NCT04072822|75587975|FG000|STARTED|Follow-up||30||
59497055|NCT04072822|75587976|FG001|STARTED|Follow-up||20||
59497056|NCT04072822|75587975|FG000|COMPLETED|Follow-up||24||
59497057|NCT04072822|75587976|FG001|COMPLETED|Follow-up||16||
59497058|NCT04072822|75587975|FG000|NOT COMPLETED|Follow-up||6||
59497059|NCT04072822|75587976|FG001|NOT COMPLETED|Follow-up||4||
59497060|NCT04031846|75587984|FG000|STARTED|Overall Study||591||
59497061|NCT04031846|75587985|FG001|STARTED|Overall Study||593||
59885064|NCT03549429|76007830|FG000|STARTED|Overall Study||81||
59885065|NCT03549429|76007831|FG001|STARTED|Overall Study||78||
59885066|NCT03549429|76007830|FG000|COMPLETED|Overall Study||76||
59885067|NCT03549429|76007831|FG001|COMPLETED|Overall Study||75||
59885068|NCT03549429|76007830|FG000|NOT COMPLETED|Overall Study||5||
59885069|NCT03549429|76007831|FG001|NOT COMPLETED|Overall Study||3||
59885070|NCT02784704|76007841|FG000|STARTED|Overall Study||250||
59885071|NCT02784704|76007842|FG001|STARTED|Overall Study||250||
59885072|NCT02784704|76007841|FG000|Treated|Overall Study||250||
59885073|NCT02784704|76007842|FG001|Treated|Overall Study||249||
59885074|NCT02784704|76007841|FG000|COMPLETED|Overall Study||237||
59885075|NCT02784704|76007842|FG001|COMPLETED|Overall Study||241||
60012347|NCT05380635|76128300|FG000|STARTED|Overall Study||9||
60012348|NCT05380635|76128300|FG000|COMPLETED|Overall Study||9||
60012349|NCT05380635|76128300|FG000|NOT COMPLETED|Overall Study||0||
60012350|NCT01659255|76128321|FG000|STARTED|Overall Study||3||
60012351|NCT01659255|76128322|FG001|STARTED|Overall Study||3||
60012352|NCT01659255|76128323|FG002|STARTED|Overall Study||4||
59497062|NCT04031846|75587984|FG000|Vaccinated|Overall Study|One participant was vaccinated with Prevenar 13™|588||
59497063|NCT04031846|75587985|FG001|Vaccinated|Overall Study||591||
59497064|NCT04031846|75587984|FG000|All Participants As Treated|Overall Study|Excluded one vaccinated with Prevenar 13™|587||
59497065|NCT04031846|75587985|FG001|All Participants As Treated|Overall Study||591||
59497066|NCT04031846|75587984|FG000|PCV Dose at Age 2 Months|Overall Study||588||
60012353|NCT01659255|76128324|FG003|STARTED|Overall Study||3||
60012354|NCT01659255|76128325|FG004|STARTED|Overall Study||3||
60012355|NCT01659255|76128326|FG005|STARTED|Overall Study||3||
60012356|NCT01659255|76128327|FG006|STARTED|Overall Study||3||
60012357|NCT01659255|76128328|FG007|STARTED|Overall Study||3||
60012358|NCT01659255|76128329|FG008|STARTED|Overall Study||3||
60012359|NCT01659255|76128330|FG009|STARTED|Overall Study||3||
60012360|NCT01659255|76128331|FG010|STARTED|Overall Study||3||
59497067|NCT04031846|75587985|FG001|PCV Dose at Age 2 Months|Overall Study||591||
59497068|NCT04031846|75587984|FG000|PCV Dose at Age 3 Months|Overall Study||32||
59497069|NCT04031846|75587985|FG001|PCV Dose at Age 3 Months|Overall Study||35||
59497070|NCT04031846|75587984|FG000|PCV Dose at Age 4 Months|Overall Study||582||
59497071|NCT04031846|75587985|FG001|PCV Dose at Age 4 Months|Overall Study||584||
59497072|NCT04031846|75587984|FG000|PCV Dose at Age 11-15 Months|Overall Study||571||
59885076|NCT02784704|76007841|FG000|NOT COMPLETED|Overall Study||13||
59885077|NCT02784704|76007842|FG001|NOT COMPLETED|Overall Study||9||
59885078|NCT03566823|76007853|FG000|STARTED|Overall Study||6||
59885079|NCT03566823|76007854|FG001|STARTED|Overall Study||15||
59885080|NCT03566823|76007855|FG002|STARTED|Overall Study||13||
59885081|NCT03566823|76007853|FG000|COMPLETED|Overall Study||4||
59885082|NCT03566823|76007854|FG001|COMPLETED|Overall Study||12||
60012361|NCT01659255|76128332|FG011|STARTED|Overall Study||5||
60012362|NCT01659255|76128333|FG012|STARTED|Overall Study||8||
59497073|NCT04031846|75587985|FG001|PCV Dose at Age 11-15 Months|Overall Study||574||
59497074|NCT04031846|75587984|FG000|COMPLETED|Overall Study||569||
59497075|NCT04031846|75587985|FG001|COMPLETED|Overall Study||570||
59497076|NCT04031846|75587984|FG000|NOT COMPLETED|Overall Study||22||
59497077|NCT04031846|75587985|FG001|NOT COMPLETED|Overall Study||23||
59497078|NCT03893448|75587994|FG000|STARTED|Overall Study||860||
59497079|NCT03893448|75587995|FG001|STARTED|Overall Study||860||
59497080|NCT03893448|75587994|FG000|Treated|Overall Study||858||
59497081|NCT03893448|75587995|FG001|Treated|Overall Study||856||
59497082|NCT03893448|75587994|FG000|COMPLETED|Overall Study||758||
59497083|NCT03893448|75587995|FG001|COMPLETED|Overall Study||734||
59497084|NCT03893448|75587994|FG000|NOT COMPLETED|Overall Study||102||
59497085|NCT03893448|75587995|FG001|NOT COMPLETED|Overall Study||126||
59497086|NCT03848455|75588005|FG000|STARTED|Overall Study||125||
59497087|NCT03848455|75588006|FG001|STARTED|Overall Study||90||
59497088|NCT03848455|75588007|FG002|STARTED|Overall Study||23||
59497089|NCT03848455|75588005|FG000|COMPLETED|Overall Study||125||
59497090|NCT03848455|75588006|FG001|COMPLETED|Overall Study||90||
59497091|NCT03848455|75588007|FG002|COMPLETED|Overall Study||23||
59497092|NCT03848455|75588005|FG000|NOT COMPLETED|Overall Study||0||
59497093|NCT03848455|75588006|FG001|NOT COMPLETED|Overall Study||0||
59497094|NCT03848455|75588007|FG002|NOT COMPLETED|Overall Study||0||
59497095|NCT03692871|75588018|FG000|STARTED|Overall Study||1972||
59497096|NCT03692871|75588019|FG001|STARTED|Overall Study||437||
59497097|NCT03692871|75588018|FG000|COMPLETED|Overall Study||1847||
59497098|NCT03692871|75588019|FG001|COMPLETED|Overall Study||400||
59497099|NCT03692871|75588018|FG000|NOT COMPLETED|Overall Study||125||
59497100|NCT03692871|75588019|FG001|NOT COMPLETED|Overall Study||37||
59497101|NCT03565900|75588027|FG000|STARTED|Overall Study||139||
59497102|NCT03565900|75588028|FG001|STARTED|Overall Study||138||
59885083|NCT03566823|76007855|FG002|COMPLETED|Overall Study||11||
59885084|NCT03566823|76007853|FG000|NOT COMPLETED|Overall Study||2||
59497103|NCT03565900|75588027|FG000|Vaccination 1 With V114 or Prevnar 13™ (PCV) (Day 1)|Overall Study||139||
59497104|NCT03565900|75588028|FG001|Vaccination 1 With V114 or Prevnar 13™ (PCV) (Day 1)|Overall Study||135||
59497105|NCT03565900|75588027|FG000|Vaccination 2 With PCV (Day 30)|Overall Study||135||
59497106|NCT03565900|75588028|FG001|Vaccination 2 With PCV (Day 30)|Overall Study||128||
59497107|NCT03565900|75588027|FG000|Vaccination 3 With PCV (Day 60)|Overall Study||130||
59754698|NCT03889418|75873589|FG009|STARTED|January - March 2020 (Month 10-12)||1|[EMR-CDS with CCM] participants started enrollment in region 4 in period 4. In Region 5, only EMR-CDS (usual care) matched controls were identified. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|0
59754699|NCT03889418|75873580|FG000|COMPLETED|January - March 2020 (Month 10-12)||67||1
59754700|NCT03889418|75873581|FG001|COMPLETED|January - March 2020 (Month 10-12)||48||1
59754701|NCT03889418|75873582|FG002|COMPLETED|January - March 2020 (Month 10-12)||34||1
59754702|NCT03889418|75873583|FG003|COMPLETED|January - March 2020 (Month 10-12)||23||1
59754703|NCT03889418|75873584|FG004|COMPLETED|January - March 2020 (Month 10-12)||16||1
59754704|NCT03889418|75873585|FG005|COMPLETED|January - March 2020 (Month 10-12)||2||1
59885085|NCT03566823|76007854|FG001|NOT COMPLETED|Overall Study||3||
59885086|NCT03566823|76007855|FG002|NOT COMPLETED|Overall Study||2||
59885087|NCT03549117|76007865|FG000|STARTED|Overall Study||70||
59885088|NCT03549117|76007866|FG001|STARTED|Overall Study||70||
59885089|NCT03549117|76007865|FG000|COMPLETED|Overall Study||69||
59885090|NCT03549117|76007866|FG001|COMPLETED|Overall Study||70||
59885091|NCT03549117|76007865|FG000|NOT COMPLETED|Overall Study||1||
60012363|NCT01659255|76128334|FG013|STARTED|Overall Study||21||
60012364|NCT01659255|76128335|FG014|STARTED|Overall Study||10||
60012365|NCT01659255|76128336|FG015|STARTED|Overall Study||9||
60012366|NCT01659255|76128337|FG016|STARTED|Overall Study||3||
60012367|NCT01659255|76128321|FG000|COMPLETED|Overall Study||1||
60012368|NCT01659255|76128322|FG001|COMPLETED|Overall Study||2||
60012369|NCT01659255|76128323|FG002|COMPLETED|Overall Study||4||
60012370|NCT01659255|76128324|FG003|COMPLETED|Overall Study||3||
60012371|NCT01659255|76128325|FG004|COMPLETED|Overall Study||3||
60012372|NCT01659255|76128326|FG005|COMPLETED|Overall Study||2||
60012373|NCT01659255|76128327|FG006|COMPLETED|Overall Study||1||
60012374|NCT01659255|76128328|FG007|COMPLETED|Overall Study||1||
60012375|NCT01659255|76128329|FG008|COMPLETED|Overall Study||2||
60012376|NCT01659255|76128330|FG009|COMPLETED|Overall Study||0||
60012377|NCT01659255|76128331|FG010|COMPLETED|Overall Study||0||
60012378|NCT01659255|76128332|FG011|COMPLETED|Overall Study||1||
60012379|NCT01659255|76128333|FG012|COMPLETED|Overall Study||0||
60012380|NCT01659255|76128334|FG013|COMPLETED|Overall Study||3||
60012381|NCT01659255|76128335|FG014|COMPLETED|Overall Study||2||
60012382|NCT01659255|76128336|FG015|COMPLETED|Overall Study||4||
60012383|NCT01659255|76128337|FG016|COMPLETED|Overall Study||0||
60012384|NCT01659255|76128321|FG000|NOT COMPLETED|Overall Study||2||
60012385|NCT01659255|76128322|FG001|NOT COMPLETED|Overall Study||1||
60012386|NCT01659255|76128323|FG002|NOT COMPLETED|Overall Study||0||
60012387|NCT01659255|76128324|FG003|NOT COMPLETED|Overall Study||0||
60012388|NCT01659255|76128325|FG004|NOT COMPLETED|Overall Study||0||
60012389|NCT01659255|76128326|FG005|NOT COMPLETED|Overall Study||1||
60012390|NCT01659255|76128327|FG006|NOT COMPLETED|Overall Study||2||
60012391|NCT01659255|76128328|FG007|NOT COMPLETED|Overall Study||2||
60012392|NCT01659255|76128329|FG008|NOT COMPLETED|Overall Study||1||
60012393|NCT01659255|76128330|FG009|NOT COMPLETED|Overall Study||3||
60012394|NCT01659255|76128331|FG010|NOT COMPLETED|Overall Study||3||
60012395|NCT01659255|76128332|FG011|NOT COMPLETED|Overall Study||4||
60012396|NCT01659255|76128333|FG012|NOT COMPLETED|Overall Study||8||
60012397|NCT01659255|76128334|FG013|NOT COMPLETED|Overall Study||18||
60012398|NCT01659255|76128335|FG014|NOT COMPLETED|Overall Study||8||
60012399|NCT01659255|76128336|FG015|NOT COMPLETED|Overall Study||5||
60012400|NCT01659255|76128337|FG016|NOT COMPLETED|Overall Study||3||
60012401|NCT02637037|76128377|FG000|STARTED|Overall Study||40||
59497108|NCT03565900|75588028|FG001|Vaccination 3 With PCV (Day 60)|Overall Study||124||
59497109|NCT03565900|75588027|FG000|Vaccination 4 With PNEUMOVAX™23 (PPV23) (12 Months After Allo-HSCT, Without Chronic GVHD)|Overall Study||89||
60012402|NCT02637037|76128378|FG001|STARTED|Overall Study||40||
60012403|NCT02637037|76128377|FG000|COMPLETED|Overall Study||36||
59885092|NCT03549117|76007866|FG001|NOT COMPLETED|Overall Study||0||
59885093|NCT03183908|76007874|FG000|STARTED|Overall Study||378|Full Analysis Population 2|
59885094|NCT03183908|76007875|FG001|STARTED|Overall Study||379|Full Analysis Population 2|
59885095|NCT03183908|76007874|FG000|COMPLETED|Overall Study||378|Full Analysis Population 1|
59885096|NCT03183908|76007875|FG001|COMPLETED|Overall Study||377|Full Analysis Population 1|
59518982|NCT03587428|75612873|FG003|STARTED|Period 1||3||
59885097|NCT03183908|76007874|FG000|NOT COMPLETED|Overall Study||0||
59497110|NCT03565900|75588028|FG001|Vaccination 4 With PNEUMOVAX™23 (PPV23) (12 Months After Allo-HSCT, Without Chronic GVHD)|Overall Study||75||
59497111|NCT03565900|75588027|FG000|Vaccination 4 With PCV (12 Months After Allo-HSCT, With Chronic GVHD)|Overall Study||29||
59497112|NCT03565900|75588028|FG001|Vaccination 4 With PCV (12 Months After Allo-HSCT, With Chronic GVHD)|Overall Study||37||
59497113|NCT03565900|75588027|FG000|COMPLETED|Overall Study||115||
59497114|NCT03565900|75588028|FG001|COMPLETED|Overall Study||111||
59497115|NCT03565900|75588027|FG000|NOT COMPLETED|Overall Study||24||
59497116|NCT03565900|75588028|FG001|NOT COMPLETED|Overall Study||27||
59497117|NCT03531762|75588050|FG000|STARTED|Treatment Period 1 (8-12 Days)||2||
59497118|NCT03531762|75588051|FG001|STARTED|Treatment Period 1 (8-12 Days)||2||
59497119|NCT03531762|75588052|FG002|STARTED|Treatment Period 1 (8-12 Days)||2||
59497120|NCT03531762|75588053|FG003|STARTED|Treatment Period 1 (8-12 Days)||2||
59497121|NCT03531762|75588054|FG004|STARTED|Treatment Period 1 (8-12 Days)||2||
59497122|NCT03531762|75588055|FG005|STARTED|Treatment Period 1 (8-12 Days)||2||
59497123|NCT03531762|75588050|FG000|COMPLETED|Treatment Period 1 (8-12 Days)||2||
59497124|NCT03531762|75588051|FG001|COMPLETED|Treatment Period 1 (8-12 Days)||2||
59497125|NCT03531762|75588052|FG002|COMPLETED|Treatment Period 1 (8-12 Days)||2||
59497126|NCT03531762|75588053|FG003|COMPLETED|Treatment Period 1 (8-12 Days)||2||
59497127|NCT03531762|75588054|FG004|COMPLETED|Treatment Period 1 (8-12 Days)||2||
59497128|NCT03531762|75588055|FG005|COMPLETED|Treatment Period 1 (8-12 Days)||2||
59497129|NCT03531762|75588050|FG000|NOT COMPLETED|Treatment Period 1 (8-12 Days)||0||
59497130|NCT03531762|75588051|FG001|NOT COMPLETED|Treatment Period 1 (8-12 Days)||0||
59497131|NCT03531762|75588052|FG002|NOT COMPLETED|Treatment Period 1 (8-12 Days)||0||
59497132|NCT03531762|75588053|FG003|NOT COMPLETED|Treatment Period 1 (8-12 Days)||0||
59497133|NCT03531762|75588054|FG004|NOT COMPLETED|Treatment Period 1 (8-12 Days)||0||
59497134|NCT03531762|75588055|FG005|NOT COMPLETED|Treatment Period 1 (8-12 Days)||0||
59497135|NCT03531762|75588050|FG000|STARTED|Treatment Period 2 (8-12 Days)||2||
59497136|NCT03531762|75588051|FG001|STARTED|Treatment Period 2 (8-12 Days)||2||
59518983|NCT03587428|75612874|FG004|STARTED|Period 1||2||
59497137|NCT03531762|75588052|FG002|STARTED|Treatment Period 2 (8-12 Days)||2||
59497138|NCT03531762|75588053|FG003|STARTED|Treatment Period 2 (8-12 Days)||2||
59497139|NCT03531762|75588054|FG004|STARTED|Treatment Period 2 (8-12 Days)||2||
60012404|NCT02637037|76128378|FG001|COMPLETED|Overall Study||39||
60012405|NCT02637037|76128377|FG000|NOT COMPLETED|Overall Study||4||
60012406|NCT02637037|76128378|FG001|NOT COMPLETED|Overall Study||1||
60012407|NCT02637895|76128398|FG000|STARTED|Overall Study||21||
60012408|NCT02637895|76128399|FG001|STARTED|Overall Study||20||
60012409|NCT02637895|76128398|FG000|COMPLETED|Overall Study||15||
60012410|NCT02637895|76128399|FG001|COMPLETED|Overall Study||17||
60012411|NCT02637895|76128398|FG000|NOT COMPLETED|Overall Study||6||
60012412|NCT02637895|76128399|FG001|NOT COMPLETED|Overall Study||3||
60012413|NCT02522481|76128406|FG000|STARTED|Overall Study||175||
60012414|NCT02522481|76128406|FG000|COMPLETED|Overall Study||172||
60012415|NCT02522481|76128406|FG000|NOT COMPLETED|Overall Study||3||
60012416|NCT02522403|76128419|FG000|STARTED|Overall Study||17||
60012417|NCT02522403|76128420|FG001|STARTED|Overall Study||19||
60012418|NCT02522403|76128419|FG000|COMPLETED|Overall Study||13||
60012419|NCT02522403|76128420|FG001|COMPLETED|Overall Study||13||
60012420|NCT02522403|76128419|FG000|NOT COMPLETED|Overall Study||4||
60012421|NCT02522403|76128420|FG001|NOT COMPLETED|Overall Study||6||
60012422|NCT02522325|76128426|FG000|STARTED|Overall Study||15||
60012423|NCT02522325|76128427|FG001|STARTED|Overall Study||15||
60012424|NCT02522325|76128426|FG000|COMPLETED|Overall Study||15||
60012425|NCT02522325|76128427|FG001|COMPLETED|Overall Study||14||
60012426|NCT02522325|76128426|FG000|NOT COMPLETED|Overall Study||0||
60012427|NCT02522325|76128427|FG001|NOT COMPLETED|Overall Study||1||
60012428|NCT01672879|76128436|FG000|STARTED|Blinded Phase (Up to 240 Weeks)||87||
60012429|NCT01672879|76128437|FG001|STARTED|Blinded Phase (Up to 240 Weeks)||86||
60012430|NCT01672879|76128438|FG002|STARTED|Blinded Phase (Up to 240 Weeks)||86||
60012431|NCT01672879|76128436|FG000|COMPLETED|Blinded Phase (Up to 240 Weeks)||0||
60012432|NCT01672879|76128437|FG001|COMPLETED|Blinded Phase (Up to 240 Weeks)||0||
60012433|NCT01672879|76128438|FG002|COMPLETED|Blinded Phase (Up to 240 Weeks)||0||
60012434|NCT01672879|76128436|FG000|NOT COMPLETED|Blinded Phase (Up to 240 Weeks)||87||
60012435|NCT01672879|76128437|FG001|NOT COMPLETED|Blinded Phase (Up to 240 Weeks)||86||
60012436|NCT01672879|76128438|FG002|NOT COMPLETED|Blinded Phase (Up to 240 Weeks)||86||
60012437|NCT01672879|76128436|FG000|STARTED|Open-Label Phase (Up to 240 Weeks)|Met protocol-specified reason(s) for study discontinuation during Blinded Phase & entered Open-Label|15||
60012438|NCT01672879|76128437|FG001|STARTED|Open-Label Phase (Up to 240 Weeks)|Met protocol-specified reason(s) for study discontinuation during Blinded Phase & entered Open-Label|17||
60012439|NCT01672879|76128438|FG002|STARTED|Open-Label Phase (Up to 240 Weeks)|Met protocol-specified reason(s) for study discontinuation during Blinded Phase & entered Open-Label|8||
60012440|NCT01672879|76128436|FG000|COMPLETED|Open-Label Phase (Up to 240 Weeks)||0||
60012441|NCT01672879|76128437|FG001|COMPLETED|Open-Label Phase (Up to 240 Weeks)||0||
60012442|NCT01672879|76128438|FG002|COMPLETED|Open-Label Phase (Up to 240 Weeks)||0||
60012443|NCT01672879|76128436|FG000|NOT COMPLETED|Open-Label Phase (Up to 240 Weeks)||15||
60012444|NCT01672879|76128437|FG001|NOT COMPLETED|Open-Label Phase (Up to 240 Weeks)||17||
60012445|NCT01672879|76128438|FG002|NOT COMPLETED|Open-Label Phase (Up to 240 Weeks)||8||
60012446|NCT02601209|76128454|FG000|STARTED|Initial Treatment (Up to 4 Months)|Pre-registered|4||
60012447|NCT02601209|76128455|FG001|STARTED|Initial Treatment (Up to 4 Months)|Pre-registered|4||
60012448|NCT02601209|76128456|FG002|STARTED|Initial Treatment (Up to 4 Months)|Pre-registered|4||
60012449|NCT02601209|76128457|FG003|STARTED|Initial Treatment (Up to 4 Months)|Randomized|6||
60012450|NCT02601209|76128458|FG004|STARTED|Initial Treatment (Up to 4 Months)|Randomized|13||
60012451|NCT02601209|76128459|FG005|STARTED|Initial Treatment (Up to 4 Months)|Randomized|15||
60012452|NCT02601209|76128460|FG006|STARTED|Initial Treatment (Up to 4 Months)|Randomized|56||
59497140|NCT03531762|75588055|FG005|STARTED|Treatment Period 2 (8-12 Days)||2||
59497141|NCT03531762|75588050|FG000|COMPLETED|Treatment Period 2 (8-12 Days)||2||
59497142|NCT03531762|75588051|FG001|COMPLETED|Treatment Period 2 (8-12 Days)||2||
59497143|NCT03531762|75588052|FG002|COMPLETED|Treatment Period 2 (8-12 Days)||2||
59497144|NCT03531762|75588053|FG003|COMPLETED|Treatment Period 2 (8-12 Days)||2||
59497145|NCT03531762|75588054|FG004|COMPLETED|Treatment Period 2 (8-12 Days)||2||
59497146|NCT03531762|75588055|FG005|COMPLETED|Treatment Period 2 (8-12 Days)||2||
59497147|NCT03531762|75588050|FG000|NOT COMPLETED|Treatment Period 2 (8-12 Days)||0||
59497148|NCT03531762|75588051|FG001|NOT COMPLETED|Treatment Period 2 (8-12 Days)||0||
59497149|NCT03531762|75588052|FG002|NOT COMPLETED|Treatment Period 2 (8-12 Days)||0||
59497150|NCT03531762|75588053|FG003|NOT COMPLETED|Treatment Period 2 (8-12 Days)||0||
59497151|NCT03531762|75588054|FG004|NOT COMPLETED|Treatment Period 2 (8-12 Days)||0||
59497152|NCT03531762|75588055|FG005|NOT COMPLETED|Treatment Period 2 (8-12 Days)||0||
59497153|NCT03531762|75588050|FG000|STARTED|Treatment Period 3 (8-12 Days)||2||
59497154|NCT03531762|75588051|FG001|STARTED|Treatment Period 3 (8-12 Days)||2||
59497155|NCT03531762|75588052|FG002|STARTED|Treatment Period 3 (8-12 Days)||2||
59497156|NCT03531762|75588053|FG003|STARTED|Treatment Period 3 (8-12 Days)||2||
59497157|NCT03531762|75588054|FG004|STARTED|Treatment Period 3 (8-12 Days)||2||
59497158|NCT03531762|75588055|FG005|STARTED|Treatment Period 3 (8-12 Days)||2||
59497159|NCT03531762|75588050|FG000|COMPLETED|Treatment Period 3 (8-12 Days)||2||
59497160|NCT03531762|75588051|FG001|COMPLETED|Treatment Period 3 (8-12 Days)||2||
59497161|NCT03531762|75588052|FG002|COMPLETED|Treatment Period 3 (8-12 Days)||2||
59497162|NCT03531762|75588053|FG003|COMPLETED|Treatment Period 3 (8-12 Days)||2||
59497163|NCT03531762|75588054|FG004|COMPLETED|Treatment Period 3 (8-12 Days)||2||
59497164|NCT03531762|75588055|FG005|COMPLETED|Treatment Period 3 (8-12 Days)||2||
59497165|NCT03531762|75588050|FG000|NOT COMPLETED|Treatment Period 3 (8-12 Days)||0||
59497166|NCT03531762|75588051|FG001|NOT COMPLETED|Treatment Period 3 (8-12 Days)||0||
59497167|NCT03531762|75588052|FG002|NOT COMPLETED|Treatment Period 3 (8-12 Days)||0||
59497168|NCT03531762|75588053|FG003|NOT COMPLETED|Treatment Period 3 (8-12 Days)||0||
59497169|NCT03531762|75588054|FG004|NOT COMPLETED|Treatment Period 3 (8-12 Days)||0||
59497170|NCT03531762|75588055|FG005|NOT COMPLETED|Treatment Period 3 (8-12 Days)||0||
59497171|NCT03443869|75588067|FG000|STARTED|Overall Study||301||
59497172|NCT03443869|75588068|FG001|STARTED|Overall Study||300||
59497173|NCT03443869|75588067|FG000|Treated|Overall Study||292||
59497174|NCT03443869|75588068|FG001|Treated|Overall Study||297||
59497175|NCT03443869|75588067|FG000|COMPLETED|Overall Study||256||
59497176|NCT03443869|75588068|FG001|COMPLETED|Overall Study||266||
59497177|NCT03443869|75588067|FG000|NOT COMPLETED|Overall Study||45||
59497178|NCT03443869|75588068|FG001|NOT COMPLETED|Overall Study||34||
59497179|NCT03260140|75588076|FG000|STARTED|Overall Study||254||
59497180|NCT03260140|75588077|FG001|STARTED|Overall Study||257||
59497181|NCT03260140|75588076|FG000|COMPLETED|Overall Study||249||
59497182|NCT03260140|75588077|FG001|COMPLETED|Overall Study||252||
59497183|NCT03260140|75588076|FG000|NOT COMPLETED|Overall Study||5||
59497184|NCT03260140|75588077|FG001|NOT COMPLETED|Overall Study||5||
59497185|NCT03253796|75588088|FG000|STARTED|Period 1: Run-In||323||
59497186|NCT03253796|75588089|FG001|STARTED|Period 1: Run-In||0||
59607163|NCT01219673|75717689|FG005|COMPLETED|Overall Study||0||
59885098|NCT03183908|76007875|FG001|NOT COMPLETED|Overall Study||2||
59885099|NCT03565887|76007887|FG000|STARTED|Overall Study||109||
59885100|NCT03565887|76007888|FG001|STARTED|Overall Study||55||
59885101|NCT03565887|76007887|FG000|COMPLETED|Overall Study||108||
59885102|NCT03565887|76007888|FG001|COMPLETED|Overall Study||53||
59497187|NCT03253796|75588090|FG002|STARTED|Period 1: Run-In||0||
59497188|NCT03253796|75588091|FG003|STARTED|Period 1: Run-In||0||
59497189|NCT03253796|75588092|FG004|STARTED|Period 1: Run-In||0||
59497190|NCT03253796|75588088|FG000|COMPLETED|Period 1: Run-In||207||
59497191|NCT03253796|75588089|FG001|COMPLETED|Period 1: Run-In||0||
59497192|NCT03253796|75588090|FG002|COMPLETED|Period 1: Run-In||0||
59497193|NCT03253796|75588091|FG003|COMPLETED|Period 1: Run-In||0||
59497194|NCT03253796|75588092|FG004|COMPLETED|Period 1: Run-In||0||
59497195|NCT03253796|75588088|FG000|NOT COMPLETED|Period 1: Run-In||116||
59497196|NCT03253796|75588089|FG001|NOT COMPLETED|Period 1: Run-In||0||
59607164|NCT01219673|75717690|FG006|COMPLETED|Overall Study||0||
59885103|NCT03565887|76007887|FG000|NOT COMPLETED|Overall Study||1||
59885104|NCT03565887|76007888|FG001|NOT COMPLETED|Overall Study||2||
59885105|NCT03183518|76007894|FG000|STARTED|Overall Study||36||
59885106|NCT03183518|76007894|FG000|Test Product|Overall Study||36|All participants received both the study treatments in single semi-occlusive patch|
59885107|NCT03183518|76007894|FG000|Negative Control|Overall Study||36|All participants received both the study treatments in single semi-occlusive patch|
59497197|NCT03253796|75588090|FG002|NOT COMPLETED|Period 1: Run-In||0||
59497198|NCT03253796|75588091|FG003|NOT COMPLETED|Period 1: Run-In||0||
59497199|NCT03253796|75588092|FG004|NOT COMPLETED|Period 1: Run-In||0||
59497200|NCT03253796|75588088|FG000|STARTED|Period 2: Withdrawal vs Continued Tx||0|18 participants did not continue into Period 2|
59497201|NCT03253796|75588089|FG001|STARTED|Period 2: Withdrawal vs Continued Tx||63|18 participants did not continue into Period 2|
59497202|NCT03253796|75588090|FG002|STARTED|Period 2: Withdrawal vs Continued Tx||64|18 participants did not continue into Period 2|
59497203|NCT03253796|75588091|FG003|STARTED|Period 2: Withdrawal vs Continued Tx||62|18 participants did not continue into Period 2|
59497204|NCT03253796|75588092|FG004|STARTED|Period 2: Withdrawal vs Continued Tx||0|18 participants did not continue into Period 2|
59497205|NCT03253796|75588088|FG000|COMPLETED|Period 2: Withdrawal vs Continued Tx||0||
59497206|NCT03253796|75588089|FG001|COMPLETED|Period 2: Withdrawal vs Continued Tx||53||
59497207|NCT03253796|75588090|FG002|COMPLETED|Period 2: Withdrawal vs Continued Tx||43||
59497208|NCT03253796|75588091|FG003|COMPLETED|Period 2: Withdrawal vs Continued Tx||21||
59497209|NCT03253796|75588092|FG004|COMPLETED|Period 2: Withdrawal vs Continued Tx||0||
59497210|NCT03253796|75588088|FG000|NOT COMPLETED|Period 2: Withdrawal vs Continued Tx||0||
59497211|NCT03253796|75588089|FG001|NOT COMPLETED|Period 2: Withdrawal vs Continued Tx||10||
59497212|NCT03253796|75588090|FG002|NOT COMPLETED|Period 2: Withdrawal vs Continued Tx||21||
59497213|NCT03253796|75588091|FG003|NOT COMPLETED|Period 2: Withdrawal vs Continued Tx||41||
59497214|NCT03253796|75588092|FG004|NOT COMPLETED|Period 2: Withdrawal vs Continued Tx||0||
59497215|NCT03253796|75588088|FG000|STARTED|Period 2: Open-Label Retreatment||0||
59497216|NCT03253796|75588089|FG001|STARTED|Period 2: Open-Label Retreatment||0||
59497217|NCT03253796|75588090|FG002|STARTED|Period 2: Open-Label Retreatment||0||
59497218|NCT03253796|75588091|FG003|STARTED|Period 2: Open-Label Retreatment||0||
59497219|NCT03253796|75588092|FG004|STARTED|Period 2: Open-Label Retreatment||63||
59497220|NCT03253796|75588088|FG000|COMPLETED|Period 2: Open-Label Retreatment||0||
59497221|NCT03253796|75588089|FG001|COMPLETED|Period 2: Open-Label Retreatment||0||
59754705|NCT03889418|75873586|FG006|COMPLETED|January - March 2020 (Month 10-12)||13||1
59754706|NCT03889418|75873587|FG007|COMPLETED|January - March 2020 (Month 10-12)||3||1
59754707|NCT03889418|75873588|FG008|COMPLETED|January - March 2020 (Month 10-12)||16||1
59754708|NCT03889418|75873589|FG009|COMPLETED|January - March 2020 (Month 10-12)||1||0
59885108|NCT03183518|76007894|FG000|COMPLETED|Overall Study||33||
59885109|NCT03183518|76007894|FG000|NOT COMPLETED|Overall Study||3||
59497222|NCT03253796|75588090|FG002|COMPLETED|Period 2: Open-Label Retreatment||0||
59497223|NCT03253796|75588091|FG003|COMPLETED|Period 2: Open-Label Retreatment||0||
59497224|NCT03253796|75588092|FG004|COMPLETED|Period 2: Open-Label Retreatment||58||
59497225|NCT03253796|75588088|FG000|NOT COMPLETED|Period 2: Open-Label Retreatment||0||
59497226|NCT03253796|75588089|FG001|NOT COMPLETED|Period 2: Open-Label Retreatment||0||
59497227|NCT03253796|75588090|FG002|NOT COMPLETED|Period 2: Open-Label Retreatment||0||
59497228|NCT03253796|75588091|FG003|NOT COMPLETED|Period 2: Open-Label Retreatment||0||
59754709|NCT03889418|75873580|FG000|NOT COMPLETED|January - March 2020 (Month 10-12)||0||0
59754710|NCT03889418|75873581|FG001|NOT COMPLETED|January - March 2020 (Month 10-12)||0||0
59754711|NCT03889418|75873582|FG002|NOT COMPLETED|January - March 2020 (Month 10-12)||0||0
59885110|NCT00116753|76007902|FG000|STARTED|Overall Study|Randomised.|153||
59885111|NCT00116753|76007903|FG001|STARTED|Overall Study||155||
59497229|NCT03253796|75588092|FG004|NOT COMPLETED|Period 2: Open-Label Retreatment||5||
59885112|NCT00116753|76007904|FG002|STARTED|Overall Study||152||
59497230|NCT03073733|75588110|FG000|STARTED|Overall Study||29||
59497231|NCT03073733|75588111|FG001|STARTED|Overall Study||27||
59497232|NCT03073733|75588112|FG002|STARTED|Overall Study||27||
59497233|NCT03073733|75588110|FG000|COMPLETED|Overall Study||28||
59497234|NCT03073733|75588111|FG001|COMPLETED|Overall Study||26||
59497235|NCT03073733|75588112|FG002|COMPLETED|Overall Study||26||
59497236|NCT03073733|75588110|FG000|NOT COMPLETED|Overall Study||1||
59497237|NCT03073733|75588111|FG001|NOT COMPLETED|Overall Study||1||
59497238|NCT03073733|75588112|FG002|NOT COMPLETED|Overall Study||1||
59497239|NCT03029143|75588122|FG000|STARTED|Lead-in Period (6 Weeks)||278||
59497240|NCT03029143|75588123|FG001|STARTED|Lead-in Period (6 Weeks)||0||
59497241|NCT03029143|75588124|FG002|STARTED|Lead-in Period (6 Weeks)||0||
59497242|NCT03029143|75588122|FG000|COMPLETED|Lead-in Period (6 Weeks)||109|Completed = Participants who were eligible for randomization or randomized in error; Not completed = Participants who were Lead-In Failure. One participant was randomized to Randomized Treatment Period: Standard Treatment Arm, but was not treated and was thus presented in the Lead-in failure vedolizumab arm for the Safety Analysis Set (N=170).|
59497243|NCT03029143|75588123|FG001|COMPLETED|Lead-in Period (6 Weeks)||0|Completed = Participants who were eligible for randomization or randomized in error; Not completed = Participants who were Lead-In Failure. One participant was randomized to Randomized Treatment Period: Standard Treatment Arm, but was not treated and was thus presented in the Lead-in failure vedolizumab arm for the Safety Analysis Set (N=170).|
59497244|NCT03029143|75588124|FG002|COMPLETED|Lead-in Period (6 Weeks)||0|Completed = Participants who were eligible for randomization or randomized in error; Not completed = Participants who were Lead-In Failure. One participant was randomized to Randomized Treatment Period: Standard Treatment Arm, but was not treated and was thus presented in the Lead-in failure vedolizumab arm for the Safety Analysis Set (N=170).|
59497245|NCT03029143|75588122|FG000|NOT COMPLETED|Lead-in Period (6 Weeks)||169||
59497246|NCT03029143|75588123|FG001|NOT COMPLETED|Lead-in Period (6 Weeks)||0||
59497247|NCT03029143|75588124|FG002|NOT COMPLETED|Lead-in Period (6 Weeks)||0||
59497248|NCT03029143|75588122|FG000|STARTED|Randomized Treatment Period (24 Weeks)||0||
59497249|NCT03029143|75588123|FG001|STARTED|Randomized Treatment Period (24 Weeks)||54||
59497250|NCT03029143|75588124|FG002|STARTED|Randomized Treatment Period (24 Weeks)||55||
59497251|NCT03029143|75588122|FG000|Not Treated Post Randomization|Randomized Treatment Period (24 Weeks)||0||
59497252|NCT03029143|75588123|FG001|Not Treated Post Randomization|Randomized Treatment Period (24 Weeks)|One participant was randomized to Randomized Treatment Period: Standard Treatment Arm, but was not treated and was thus included in the Lead-in failure vedolizumab arm for the Safety Analysis Set (N=170).|1||
59497253|NCT03029143|75588124|FG002|Not Treated Post Randomization|Randomized Treatment Period (24 Weeks)||0||
59497254|NCT03029143|75588122|FG000|Safety Population|Randomized Treatment Period (24 Weeks)||0|Safety Analysis Set included all participants who were enrolled and received at least one dose of study medication.|
59607165|NCT01219673|75717691|FG007|COMPLETED|Overall Study||0||
59607166|NCT01219673|75717684|FG000|NOT COMPLETED|Overall Study||0||
59754712|NCT03889418|75873583|FG003|NOT COMPLETED|January - March 2020 (Month 10-12)||1||0
59754713|NCT03889418|75873584|FG004|NOT COMPLETED|January - March 2020 (Month 10-12)||0||0
59754714|NCT03889418|75873585|FG005|NOT COMPLETED|January - March 2020 (Month 10-12)||0||0
59754715|NCT03889418|75873586|FG006|NOT COMPLETED|January - March 2020 (Month 10-12)||0||0
59754716|NCT03889418|75873587|FG007|NOT COMPLETED|January - March 2020 (Month 10-12)||2||0
59754717|NCT03889418|75873588|FG008|NOT COMPLETED|January - March 2020 (Month 10-12)||0||0
60012453|NCT02601209|76128461|FG007|STARTED|Initial Treatment (Up to 4 Months)|Randomized|6||
60012454|NCT02601209|76128462|FG008|STARTED|Initial Treatment (Up to 4 Months)|Randomized|43||
60012455|NCT02601209|76128454|FG000|COMPLETED|Initial Treatment (Up to 4 Months)|Registered|3||
60012456|NCT02601209|76128455|FG001|COMPLETED|Initial Treatment (Up to 4 Months)|Registered|3||
60012457|NCT02601209|76128456|FG002|COMPLETED|Initial Treatment (Up to 4 Months)|Registered|3||
60012458|NCT02601209|76128457|FG003|COMPLETED|Initial Treatment (Up to 4 Months)|Received treatment; included in safety analysis|6||
60012459|NCT02601209|76128458|FG004|COMPLETED|Initial Treatment (Up to 4 Months)|Received treatment; included in safety analysis|12||
60012460|NCT02601209|76128459|FG005|COMPLETED|Initial Treatment (Up to 4 Months)|Received treatment; included in safety analysis|13||
60012461|NCT02601209|76128460|FG006|COMPLETED|Initial Treatment (Up to 4 Months)|Received treatment; included in safety analysis|55||
60012462|NCT02601209|76128461|FG007|COMPLETED|Initial Treatment (Up to 4 Months)|Received treatment; included in safety analysis|6||
60012463|NCT02601209|76128462|FG008|COMPLETED|Initial Treatment (Up to 4 Months)|Received treatment; included in safety analysis|43||
60012464|NCT02601209|76128454|FG000|NOT COMPLETED|Initial Treatment (Up to 4 Months)||1||
60012465|NCT02601209|76128455|FG001|NOT COMPLETED|Initial Treatment (Up to 4 Months)||1||
60012466|NCT02601209|76128456|FG002|NOT COMPLETED|Initial Treatment (Up to 4 Months)||1||
59497255|NCT03029143|75588123|FG001|Safety Population|Randomized Treatment Period (24 Weeks)||53|Safety Analysis Set included all participants who were enrolled and received at least one dose of study medication.|
59497256|NCT03029143|75588124|FG002|Safety Population|Randomized Treatment Period (24 Weeks)|Regimen A = 28 Regimen B = 27|55|Safety Analysis Set included all participants who were enrolled and received at least one dose of study medication.|
59497257|NCT03029143|75588122|FG000|COMPLETED|Randomized Treatment Period (24 Weeks)||0||
59497258|NCT03029143|75588123|FG001|COMPLETED|Randomized Treatment Period (24 Weeks)||31||
59497259|NCT03029143|75588124|FG002|COMPLETED|Randomized Treatment Period (24 Weeks)||31||
59497260|NCT03029143|75588122|FG000|NOT COMPLETED|Randomized Treatment Period (24 Weeks)||0||
59497261|NCT03029143|75588123|FG001|NOT COMPLETED|Randomized Treatment Period (24 Weeks)||23||
59497262|NCT03029143|75588124|FG002|NOT COMPLETED|Randomized Treatment Period (24 Weeks)||24||
59497263|NCT02971137|75588135|FG000|STARTED|Overall Study||189||
59497264|NCT02971137|75588136|FG001|STARTED|Overall Study||182||
59497265|NCT02971137|75588135|FG000|COMPLETED|Overall Study||145||
59607167|NCT01219673|75717685|FG001|NOT COMPLETED|Overall Study||0||
59754718|NCT03889418|75873589|FG009|NOT COMPLETED|January - March 2020 (Month 10-12)||0||0
59754719|NCT03889418|75873580|FG000|STARTED|April - June 2020 (Month 13-15)||75|[EMR-CDS with CCM] participants started enrollment in region 5 in period 5. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|1
59754720|NCT03889418|75873581|FG001|STARTED|April - June 2020 (Month 13-15)||60|[EMR-CDS with CCM] participants started enrollment in region 5 in period 5. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|1
59762562|NCT00534313|75882339|FG002|NOT COMPLETED|Short-term Period||2||
59762563|NCT00534313|75882340|FG003|NOT COMPLETED|Short-term Period||9||
59762564|NCT00534313|75882337|FG000|STARTED|Long-term Period||37||
60012467|NCT02601209|76128457|FG003|NOT COMPLETED|Initial Treatment (Up to 4 Months)||0||
60012468|NCT02601209|76128458|FG004|NOT COMPLETED|Initial Treatment (Up to 4 Months)||1||
60012469|NCT02601209|76128459|FG005|NOT COMPLETED|Initial Treatment (Up to 4 Months)||2||
60012470|NCT02601209|76128460|FG006|NOT COMPLETED|Initial Treatment (Up to 4 Months)||1||
59497266|NCT02971137|75588136|FG001|COMPLETED|Overall Study||126||
59497267|NCT02971137|75588135|FG000|NOT COMPLETED|Overall Study||44||
59497268|NCT02971137|75588136|FG001|NOT COMPLETED|Overall Study||56||
59497269|NCT02953262|75588146|FG000|STARTED|Overall Study||68||
59497270|NCT02953262|75588147|FG001|STARTED|Overall Study||69||
59497271|NCT02953262|75588148|FG002|STARTED|Overall Study||68||
60012471|NCT02601209|76128461|FG007|NOT COMPLETED|Initial Treatment (Up to 4 Months)||0||
60012472|NCT02601209|76128462|FG008|NOT COMPLETED|Initial Treatment (Up to 4 Months)||0||
60012473|NCT02601209|76128454|FG000|STARTED|Optional Crossover (Up to 2 Months)||0||
60012474|NCT02601209|76128455|FG001|STARTED|Optional Crossover (Up to 2 Months)||0||
60012475|NCT02601209|76128456|FG002|STARTED|Optional Crossover (Up to 2 Months)||0||
60012476|NCT02601209|76128457|FG003|STARTED|Optional Crossover (Up to 2 Months)||0||
60012477|NCT02601209|76128458|FG004|STARTED|Optional Crossover (Up to 2 Months)||0||
60012478|NCT02601209|76128459|FG005|STARTED|Optional Crossover (Up to 2 Months)||0||
60012479|NCT02601209|76128460|FG006|STARTED|Optional Crossover (Up to 2 Months)||0||
60012480|NCT02601209|76128461|FG007|STARTED|Optional Crossover (Up to 2 Months)|PD on pazopanib|6||
60012481|NCT02601209|76128462|FG008|STARTED|Optional Crossover (Up to 2 Months)|PD on pazopanib|43||
59497272|NCT02953262|75588149|FG003|STARTED|Overall Study||70||
59497273|NCT02953262|75588146|FG000|COMPLETED|Overall Study||65||
59497274|NCT02953262|75588147|FG001|COMPLETED|Overall Study||63||
60012482|NCT02601209|76128454|FG000|COMPLETED|Optional Crossover (Up to 2 Months)||0||
60012483|NCT02601209|76128455|FG001|COMPLETED|Optional Crossover (Up to 2 Months)||0||
60012484|NCT02601209|76128456|FG002|COMPLETED|Optional Crossover (Up to 2 Months)||0||
60012485|NCT02601209|76128457|FG003|COMPLETED|Optional Crossover (Up to 2 Months)||0||
60012486|NCT02601209|76128458|FG004|COMPLETED|Optional Crossover (Up to 2 Months)||0||
60012487|NCT02601209|76128459|FG005|COMPLETED|Optional Crossover (Up to 2 Months)||0||
60012488|NCT02601209|76128460|FG006|COMPLETED|Optional Crossover (Up to 2 Months)||0||
60012489|NCT02601209|76128461|FG007|COMPLETED|Optional Crossover (Up to 2 Months)|Initiated crossover to MLN0128 following PD on pazopanib|4||
59497275|NCT02953262|75588148|FG002|COMPLETED|Overall Study||65||
59497276|NCT02953262|75588149|FG003|COMPLETED|Overall Study||67||
59607168|NCT01219673|75717686|FG002|NOT COMPLETED|Overall Study||0||
59607169|NCT01219673|75717687|FG003|NOT COMPLETED|Overall Study||0||
59607170|NCT01219673|75717688|FG004|NOT COMPLETED|Overall Study||0||
59607171|NCT01219673|75717689|FG005|NOT COMPLETED|Overall Study||0||
59607172|NCT01219673|75717690|FG006|NOT COMPLETED|Overall Study||0||
59607173|NCT01219673|75717691|FG007|NOT COMPLETED|Overall Study||0||
59607174|NCT01216631|75717712|FG000|STARTED|Overall Study||0||
59607175|NCT01216631|75717713|FG001|STARTED|Overall Study||0||
59497277|NCT02953262|75588146|FG000|NOT COMPLETED|Overall Study||3||
59497278|NCT02953262|75588147|FG001|NOT COMPLETED|Overall Study||6||
59497279|NCT02953262|75588148|FG002|NOT COMPLETED|Overall Study||3||
59497280|NCT02953262|75588149|FG003|NOT COMPLETED|Overall Study||3||
59497281|NCT02763579|75588165|FG000|STARTED|Global Period||202||
59497282|NCT02763579|75588166|FG001|STARTED|Global Period||201||
59497283|NCT02763579|75588167|FG002|STARTED|Global Period||0||
59497284|NCT02763579|75588168|FG003|STARTED|Global Period||0||
59497285|NCT02763579|75588165|FG000|COMPLETED|Global Period||0||
59497286|NCT02763579|75588166|FG001|COMPLETED|Global Period||0||
59497287|NCT02763579|75588167|FG002|COMPLETED|Global Period||0||
59497288|NCT02763579|75588168|FG003|COMPLETED|Global Period||0||
59497289|NCT02763579|75588165|FG000|NOT COMPLETED|Global Period||202||
59607176|NCT01216631|75717714|FG002|STARTED|Overall Study||1||
59607177|NCT01216631|75717712|FG000|COMPLETED|Overall Study||0||
59607178|NCT01216631|75717713|FG001|COMPLETED|Overall Study||0||
59607179|NCT01216631|75717714|FG002|COMPLETED|Overall Study||1||
59607180|NCT01216631|75717712|FG000|NOT COMPLETED|Overall Study||0||
59607181|NCT01216631|75717713|FG001|NOT COMPLETED|Overall Study||0||
59607182|NCT01216631|75717714|FG002|NOT COMPLETED|Overall Study||0||
59885113|NCT00116753|76007902|FG000|ITT Population|Overall Study||150||
59607183|NCT02693717|75717722|FG000|STARTED|Overall Study||7||
59607184|NCT02693717|75717722|FG000|COMPLETED|Overall Study||7||
59607185|NCT02693717|75717722|FG000|NOT COMPLETED|Overall Study||0||
59607186|NCT03860753|75717728|FG000|STARTED|Overall Study||4||
59607187|NCT03860753|75717729|FG001|STARTED|Overall Study||0||
59607188|NCT03860753|75717728|FG000|COMPLETED|Overall Study||4||
59607189|NCT03860753|75717729|FG001|COMPLETED|Overall Study||0||
59497290|NCT02763579|75588166|FG001|NOT COMPLETED|Global Period||201||
59497291|NCT02763579|75588167|FG002|NOT COMPLETED|Global Period||0||
59497292|NCT02763579|75588168|FG003|NOT COMPLETED|Global Period||0||
59497293|NCT02763579|75588165|FG000|STARTED|China Period||0||
59497294|NCT02763579|75588166|FG001|STARTED|China Period||0||
59497295|NCT02763579|75588167|FG002|STARTED|China Period|n=4 Chinese participants from the Global population are included in the China population.|53||
59497296|NCT02763579|75588168|FG003|STARTED|China Period|n=6 Chinese participants from the Global population are included in the China population.|57||
59497297|NCT02763579|75588165|FG000|COMPLETED|China Period||0||
59607190|NCT03860753|75717728|FG000|NOT COMPLETED|Overall Study||0||
59607191|NCT03860753|75717729|FG001|NOT COMPLETED|Overall Study||0||
59607192|NCT02687165|75717735|FG000|STARTED|Overall Study||0||
59497298|NCT02763579|75588166|FG001|COMPLETED|China Period||0||
59497299|NCT02763579|75588167|FG002|COMPLETED|China Period||0||
59497300|NCT02763579|75588168|FG003|COMPLETED|China Period||0||
59497301|NCT02763579|75588165|FG000|NOT COMPLETED|China Period||0||
59497302|NCT02763579|75588166|FG001|NOT COMPLETED|China Period||0||
59497303|NCT02763579|75588167|FG002|NOT COMPLETED|China Period||53||
59497304|NCT02763579|75588168|FG003|NOT COMPLETED|China Period||57||
59497305|NCT02737748|75588179|FG000|STARTED|Overall Study||20||
59497306|NCT02737748|75588180|FG001|STARTED|Overall Study||20||
59497307|NCT02737748|75588179|FG000|Phase I|Overall Study||3||
59497308|NCT02737748|75588180|FG001|Phase I|Overall Study||4||
59497309|NCT02737748|75588179|FG000|Phase II|Overall Study||17||
59497310|NCT02737748|75588180|FG001|Phase II|Overall Study||16||
59497311|NCT02737748|75588179|FG000|COMPLETED|Overall Study||19||
59497312|NCT02737748|75588180|FG001|COMPLETED|Overall Study||18||
59497313|NCT02737748|75588179|FG000|NOT COMPLETED|Overall Study||1||
59497314|NCT02737748|75588180|FG001|NOT COMPLETED|Overall Study||2||
59607193|NCT02687165|75717736|FG001|STARTED|Overall Study||0||
59607194|NCT02687165|75717735|FG000|COMPLETED|Overall Study||0||
59607195|NCT02687165|75717736|FG001|COMPLETED|Overall Study||0||
59497315|NCT02730299|75588190|FG000|STARTED|Overall Study||62||
59497316|NCT02730299|75588191|FG001|STARTED|Overall Study||63||
59497317|NCT02730299|75588190|FG000|COMPLETED|Overall Study||62||
59497318|NCT02730299|75588191|FG001|COMPLETED|Overall Study||63||
59497319|NCT02730299|75588190|FG000|NOT COMPLETED|Overall Study||0||
59497320|NCT02730299|75588191|FG001|NOT COMPLETED|Overall Study||0||
59497321|NCT02623699|75588212|FG000|STARTED|Part A (Up to 63 Days)||5||
59497322|NCT02623699|75588213|FG001|STARTED|Part A (Up to 63 Days)||3||
59497323|NCT02623699|75588214|FG002|STARTED|Part A (Up to 63 Days)||3||
59497324|NCT02623699|75588215|FG003|STARTED|Part A (Up to 63 Days)||3||
59497325|NCT02623699|75588216|FG004|STARTED|Part A (Up to 63 Days)||6||
59497326|NCT02623699|75588217|FG005|STARTED|Part A (Up to 63 Days)||0||
59497327|NCT02623699|75588218|FG006|STARTED|Part A (Up to 63 Days)||0||
59497328|NCT02623699|75588219|FG007|STARTED|Part A (Up to 63 Days)||0||
59497329|NCT02623699|75588220|FG008|STARTED|Part A (Up to 63 Days)||0||
59497330|NCT02623699|75588221|FG009|STARTED|Part A (Up to 63 Days)||0||
59497331|NCT02623699|75588222|FG010|STARTED|Part A (Up to 63 Days)||0||
59497332|NCT02623699|75588223|FG011|STARTED|Part A (Up to 63 Days)||0||
59497333|NCT02623699|75588212|FG000|COMPLETED|Part A (Up to 63 Days)||5||
59754721|NCT03889418|75873582|FG002|STARTED|April - June 2020 (Month 13-15)||38|[EMR-CDS with CCM] participants started enrollment in region 5 in period 5. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|1
59754722|NCT03889418|75873583|FG003|STARTED|April - June 2020 (Month 13-15)||27|[EMR-CDS with CCM] participants started enrollment in region 5 in period 5. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|1
59754723|NCT03889418|75873584|FG004|STARTED|April - June 2020 (Month 13-15)||19|[EMR-CDS with CCM] participants started enrollment in region 5 in period 5. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|1
59754724|NCT03889418|75873585|FG005|STARTED|April - June 2020 (Month 13-15)||2|[EMR-CDS with CCM] participants started enrollment in region 5 in period 5. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|1
59754725|NCT03889418|75873586|FG006|STARTED|April - June 2020 (Month 13-15)||16|[EMR-CDS with CCM] participants started enrollment in region 5 in period 5. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|1
59754726|NCT03889418|75873587|FG007|STARTED|April - June 2020 (Month 13-15)||3|[EMR-CDS with CCM] participants started enrollment in region 5 in period 5. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|1
59754727|NCT03889418|75873588|FG008|STARTED|April - June 2020 (Month 13-15)||19|[EMR-CDS with CCM] participants started enrollment in region 5 in period 5. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|1
59754728|NCT03889418|75873589|FG009|STARTED|April - June 2020 (Month 13-15)||4|[EMR-CDS with CCM] participants started enrollment in region 5 in period 5. Note: Number of participants to start a period includes number that completed the previous period and newly enrolled participants.|1
59754729|NCT03889418|75873580|FG000|COMPLETED|April - June 2020 (Month 13-15)||75||1
59754730|NCT03889418|75873581|FG001|COMPLETED|April - June 2020 (Month 13-15)||59||1
59754731|NCT03889418|75873582|FG002|COMPLETED|April - June 2020 (Month 13-15)||38||1
59754732|NCT03889418|75873583|FG003|COMPLETED|April - June 2020 (Month 13-15)||26||1
59762565|NCT00534313|75882338|FG001|STARTED|Long-term Period||34||
59885114|NCT00116753|76007903|FG001|ITT Population|Overall Study||150||
59885115|NCT00116753|76007904|FG002|ITT Population|Overall Study||147||
59885116|NCT00116753|76007902|FG000|COMPLETED|Overall Study||121||
59885117|NCT00116753|76007903|FG001|COMPLETED|Overall Study||125||
59885118|NCT00116753|76007904|FG002|COMPLETED|Overall Study||128||
59885119|NCT00116753|76007902|FG000|NOT COMPLETED|Overall Study||32||
59885120|NCT00116753|76007903|FG001|NOT COMPLETED|Overall Study||30||
59885121|NCT00116753|76007904|FG002|NOT COMPLETED|Overall Study||24||
59885122|NCT00113399|76007914|FG000|STARTED|Overall Study||7||
59885123|NCT00113399|76007915|FG001|STARTED|Overall Study||8||
59885124|NCT00113399|76007914|FG000|COMPLETED|Overall Study||5||
60012490|NCT02601209|76128462|FG008|COMPLETED|Optional Crossover (Up to 2 Months)|Initiated crossover to MLN0128 following PD on pazopanib|26||
60012491|NCT02601209|76128454|FG000|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0||
60012492|NCT02601209|76128455|FG001|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0||
59497334|NCT02623699|75588213|FG001|COMPLETED|Part A (Up to 63 Days)||2||
59497335|NCT02623699|75588214|FG002|COMPLETED|Part A (Up to 63 Days)||3||
59497336|NCT02623699|75588215|FG003|COMPLETED|Part A (Up to 63 Days)||3||
59497337|NCT02623699|75588216|FG004|COMPLETED|Part A (Up to 63 Days)||6||
59497338|NCT02623699|75588217|FG005|COMPLETED|Part A (Up to 63 Days)||0||
59497339|NCT02623699|75588218|FG006|COMPLETED|Part A (Up to 63 Days)||0||
59497340|NCT02623699|75588219|FG007|COMPLETED|Part A (Up to 63 Days)||0||
59497341|NCT02623699|75588220|FG008|COMPLETED|Part A (Up to 63 Days)||0||
59497342|NCT02623699|75588221|FG009|COMPLETED|Part A (Up to 63 Days)||0||
59497343|NCT02623699|75588222|FG010|COMPLETED|Part A (Up to 63 Days)||0||
59497344|NCT02623699|75588223|FG011|COMPLETED|Part A (Up to 63 Days)||0||
59497345|NCT02623699|75588212|FG000|NOT COMPLETED|Part A (Up to 63 Days)||0||
59497346|NCT02623699|75588213|FG001|NOT COMPLETED|Part A (Up to 63 Days)||1||
59497347|NCT02623699|75588214|FG002|NOT COMPLETED|Part A (Up to 63 Days)||0||
59497348|NCT02623699|75588215|FG003|NOT COMPLETED|Part A (Up to 63 Days)||0||
59497349|NCT02623699|75588216|FG004|NOT COMPLETED|Part A (Up to 63 Days)||0||
59497350|NCT02623699|75588217|FG005|NOT COMPLETED|Part A (Up to 63 Days)||0||
59497351|NCT02623699|75588218|FG006|NOT COMPLETED|Part A (Up to 63 Days)||0||
59497352|NCT02623699|75588219|FG007|NOT COMPLETED|Part A (Up to 63 Days)||0||
59497353|NCT02623699|75588220|FG008|NOT COMPLETED|Part A (Up to 63 Days)||0||
59497354|NCT02623699|75588221|FG009|NOT COMPLETED|Part A (Up to 63 Days)||0||
59497355|NCT02623699|75588222|FG010|NOT COMPLETED|Part A (Up to 63 Days)||0||
59497356|NCT02623699|75588223|FG011|NOT COMPLETED|Part A (Up to 63 Days)||0||
59497357|NCT02623699|75588212|FG000|STARTED|Part B (Up to 289 Days)|Participants who completed Part A did not enter Part B of the study.|0||
59497358|NCT02623699|75588213|FG001|STARTED|Part B (Up to 289 Days)|Participants who completed Part A did not enter Part B of the study.|0||
59497359|NCT02623699|75588214|FG002|STARTED|Part B (Up to 289 Days)|Participants who completed Part A did not enter Part B of the study.|0||
59497360|NCT02623699|75588215|FG003|STARTED|Part B (Up to 289 Days)|Participants who completed Part A did not enter Part B of the study.|0||
59497361|NCT02623699|75588216|FG004|STARTED|Part B (Up to 289 Days)|Participants who completed Part A did not enter Part B of the study.|0||
59497362|NCT02623699|75588217|FG005|STARTED|Part B (Up to 289 Days)|Started indicates the number of participants who were enrolled into Part B of the study.|12||
59497363|NCT02623699|75588218|FG006|STARTED|Part B (Up to 289 Days)|Started indicates the number of participants who were enrolled into Part B of the study.|10||
59497364|NCT02623699|75588219|FG007|STARTED|Part B (Up to 289 Days)|Started indicates the number of participants who were enrolled into Part B of the study.|9||
59497365|NCT02623699|75588220|FG008|STARTED|Part B (Up to 289 Days)|Started indicates the number of participants who were enrolled into Part B of the study.|9||
59497366|NCT02623699|75588221|FG009|STARTED|Part B (Up to 289 Days)|Started indicates the number of participants who were enrolled into Part B of the study.|10||
59497367|NCT02623699|75588222|FG010|STARTED|Part B (Up to 289 Days)||0||
59497368|NCT02623699|75588223|FG011|STARTED|Part B (Up to 289 Days)||0||
59497369|NCT02623699|75588212|FG000|COMPLETED|Part B (Up to 289 Days)||0||
59497370|NCT02623699|75588213|FG001|COMPLETED|Part B (Up to 289 Days)||0||
59497371|NCT02623699|75588214|FG002|COMPLETED|Part B (Up to 289 Days)||0||
59497372|NCT02623699|75588215|FG003|COMPLETED|Part B (Up to 289 Days)||0||
59497373|NCT02623699|75588216|FG004|COMPLETED|Part B (Up to 289 Days)||0||
59497374|NCT02623699|75588217|FG005|COMPLETED|Part B (Up to 289 Days)||10||
59497375|NCT02623699|75588218|FG006|COMPLETED|Part B (Up to 289 Days)||8||
59497376|NCT02623699|75588219|FG007|COMPLETED|Part B (Up to 289 Days)||9||
59497377|NCT02623699|75588220|FG008|COMPLETED|Part B (Up to 289 Days)||8||
59497378|NCT02623699|75588221|FG009|COMPLETED|Part B (Up to 289 Days)||10||
59497379|NCT02623699|75588222|FG010|COMPLETED|Part B (Up to 289 Days)||0||
59497380|NCT02623699|75588223|FG011|COMPLETED|Part B (Up to 289 Days)||0||
59497381|NCT02623699|75588212|FG000|NOT COMPLETED|Part B (Up to 289 Days)||0||
59497382|NCT02623699|75588213|FG001|NOT COMPLETED|Part B (Up to 289 Days)||0||
59497383|NCT02623699|75588214|FG002|NOT COMPLETED|Part B (Up to 289 Days)||0||
59497384|NCT02623699|75588215|FG003|NOT COMPLETED|Part B (Up to 289 Days)||0||
59497385|NCT02623699|75588216|FG004|NOT COMPLETED|Part B (Up to 289 Days)||0||
59497386|NCT02623699|75588217|FG005|NOT COMPLETED|Part B (Up to 289 Days)||2||
59497387|NCT02623699|75588218|FG006|NOT COMPLETED|Part B (Up to 289 Days)||2||
59497388|NCT02623699|75588219|FG007|NOT COMPLETED|Part B (Up to 289 Days)||0||
59497389|NCT02623699|75588220|FG008|NOT COMPLETED|Part B (Up to 289 Days)||1||
59497390|NCT02623699|75588221|FG009|NOT COMPLETED|Part B (Up to 289 Days)||0||
59497391|NCT02623699|75588222|FG010|NOT COMPLETED|Part B (Up to 289 Days)||0||
59497392|NCT02623699|75588223|FG011|NOT COMPLETED|Part B (Up to 289 Days)||0||
59497393|NCT02623699|75588212|FG000|STARTED|Part C (Up to 236 Days)||0||
59497394|NCT02623699|75588213|FG001|STARTED|Part C (Up to 236 Days)||0||
59497395|NCT02623699|75588214|FG002|STARTED|Part C (Up to 236 Days)||0||
59497396|NCT02623699|75588215|FG003|STARTED|Part C (Up to 236 Days)||0||
59497397|NCT02623699|75588216|FG004|STARTED|Part C (Up to 236 Days)||0||
59754733|NCT03889418|75873584|FG004|COMPLETED|April - June 2020 (Month 13-15)||19||1
59754734|NCT03889418|75873585|FG005|COMPLETED|April - June 2020 (Month 13-15)||2||1
59754735|NCT03889418|75873586|FG006|COMPLETED|April - June 2020 (Month 13-15)||16||1
59754736|NCT03889418|75873587|FG007|COMPLETED|April - June 2020 (Month 13-15)||3||1
59754737|NCT03889418|75873588|FG008|COMPLETED|April - June 2020 (Month 13-15)||19||1
59754738|NCT03889418|75873589|FG009|COMPLETED|April - June 2020 (Month 13-15)||4||1
60012493|NCT02601209|76128456|FG002|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0||
60012494|NCT02601209|76128457|FG003|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0||
60012495|NCT02601209|76128458|FG004|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0||
60012496|NCT02601209|76128459|FG005|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0||
60012497|NCT02601209|76128460|FG006|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0||
60012498|NCT02601209|76128461|FG007|NOT COMPLETED|Optional Crossover (Up to 2 Months)||2||
59754739|NCT03889418|75873580|FG000|NOT COMPLETED|April - June 2020 (Month 13-15)||0||0
59754740|NCT03889418|75873581|FG001|NOT COMPLETED|April - June 2020 (Month 13-15)||1||0
59754741|NCT03889418|75873582|FG002|NOT COMPLETED|April - June 2020 (Month 13-15)||0||0
59754742|NCT03889418|75873583|FG003|NOT COMPLETED|April - June 2020 (Month 13-15)||1||0
59754743|NCT03889418|75873584|FG004|NOT COMPLETED|April - June 2020 (Month 13-15)||0||0
59754744|NCT03889418|75873585|FG005|NOT COMPLETED|April - June 2020 (Month 13-15)||0||0
59754745|NCT03889418|75873586|FG006|NOT COMPLETED|April - June 2020 (Month 13-15)||0||0
60012499|NCT02601209|76128462|FG008|NOT COMPLETED|Optional Crossover (Up to 2 Months)||17||
60012500|NCT01659021|76128478|FG000|STARTED|Main Study||174||
60012501|NCT01659021|76128479|FG001|STARTED|Main Study||87||
59497398|NCT02623699|75588217|FG005|STARTED|Part C (Up to 236 Days)|Participants who completed Part B did not enter Part C of the study.|0||
59497399|NCT02623699|75588218|FG006|STARTED|Part C (Up to 236 Days)|Participants who completed Part B did not enter Part C of the study.|0||
59497400|NCT02623699|75588219|FG007|STARTED|Part C (Up to 236 Days)|Participants who completed Part B did not enter Part C of the study.|0||
59754746|NCT03889418|75873587|FG007|NOT COMPLETED|April - June 2020 (Month 13-15)||0||0
60012502|NCT01659021|76128478|FG000|Randomized and Treated|Main Study||173||
60012503|NCT01659021|76128479|FG001|Randomized and Treated|Main Study||86||
60012504|NCT01659021|76128478|FG000|COMPLETED|Main Study||100|Study completion was defined as disease progression or death.|
60012505|NCT01659021|76128479|FG001|COMPLETED|Main Study||50|Study completion was defined as disease progression or death.|
60012506|NCT01659021|76128478|FG000|NOT COMPLETED|Main Study||74||
60012507|NCT01659021|76128479|FG001|NOT COMPLETED|Main Study||37||
60012508|NCT01659021|76128478|FG000|STARTED|Long-Term Follow Up|Participants did not have to complete the main study to enter the Long-Term Follow Up period.|138||
60012509|NCT01659021|76128479|FG001|STARTED|Long-Term Follow Up|Participants did not have to complete the main study to enter the Long-Term Follow Up period.|69||
59497401|NCT02623699|75588220|FG008|STARTED|Part C (Up to 236 Days)|Participants who completed Part B did not enter Part C of the study.|0||
59497402|NCT02623699|75588221|FG009|STARTED|Part C (Up to 236 Days)|Participants who completed Part B did not enter Part C of the study.|0||
59497403|NCT02623699|75588222|FG010|STARTED|Part C (Up to 236 Days)|Started indicates the number of participants who were enrolled into Part C of the study.|36||
59497404|NCT02623699|75588223|FG011|STARTED|Part C (Up to 236 Days)|Started indicates the number of participants who were enrolled into Part C of the study.|72||
59497405|NCT02623699|75588212|FG000|COMPLETED|Part C (Up to 236 Days)||0||
59497406|NCT02623699|75588213|FG001|COMPLETED|Part C (Up to 236 Days)||0||
59497407|NCT02623699|75588214|FG002|COMPLETED|Part C (Up to 236 Days)||0||
59497408|NCT02623699|75588215|FG003|COMPLETED|Part C (Up to 236 Days)||0||
59497409|NCT02623699|75588216|FG004|COMPLETED|Part C (Up to 236 Days)||0||
59497410|NCT02623699|75588217|FG005|COMPLETED|Part C (Up to 236 Days)||0||
59497411|NCT02623699|75588218|FG006|COMPLETED|Part C (Up to 236 Days)||0||
59497412|NCT02623699|75588219|FG007|COMPLETED|Part C (Up to 236 Days)||0||
59497413|NCT02623699|75588220|FG008|COMPLETED|Part C (Up to 236 Days)||0||
59497414|NCT02623699|75588221|FG009|COMPLETED|Part C (Up to 236 Days)||0||
59497415|NCT02623699|75588222|FG010|COMPLETED|Part C (Up to 236 Days)||33||
59497416|NCT02623699|75588223|FG011|COMPLETED|Part C (Up to 236 Days)||64||
59497417|NCT02623699|75588212|FG000|NOT COMPLETED|Part C (Up to 236 Days)||0||
59497418|NCT02623699|75588213|FG001|NOT COMPLETED|Part C (Up to 236 Days)||0||
59497419|NCT02623699|75588214|FG002|NOT COMPLETED|Part C (Up to 236 Days)||0||
59497420|NCT02623699|75588215|FG003|NOT COMPLETED|Part C (Up to 236 Days)||0||
59497421|NCT02623699|75588216|FG004|NOT COMPLETED|Part C (Up to 236 Days)||0||
59497422|NCT02623699|75588217|FG005|NOT COMPLETED|Part C (Up to 236 Days)||0||
59497423|NCT02623699|75588218|FG006|NOT COMPLETED|Part C (Up to 236 Days)||0||
59497424|NCT02623699|75588219|FG007|NOT COMPLETED|Part C (Up to 236 Days)||0||
59497425|NCT02623699|75588220|FG008|NOT COMPLETED|Part C (Up to 236 Days)||0||
59497426|NCT02623699|75588221|FG009|NOT COMPLETED|Part C (Up to 236 Days)||0||
59497427|NCT02623699|75588222|FG010|NOT COMPLETED|Part C (Up to 236 Days)||3||
59497428|NCT02623699|75588223|FG011|NOT COMPLETED|Part C (Up to 236 Days)||8||
59497429|NCT02501642|75588264|FG000|STARTED|Overall Study|Start of study: 10.1.2014|238||
59497430|NCT02501642|75588265|FG001|STARTED|Overall Study|Start of study: 10.1.2014|241||
59497431|NCT02501642|75588264|FG000|COMPLETED|Overall Study|Study ended 9.30.2018|231||
59497432|NCT02501642|75588265|FG001|COMPLETED|Overall Study|Study ended 9.30.2018|230||
59497433|NCT02501642|75588264|FG000|NOT COMPLETED|Overall Study||7||
59497434|NCT02501642|75588265|FG001|NOT COMPLETED|Overall Study||11||
59497435|NCT02475954|75588273|FG000|STARTED|Overall Study||87||
59497436|NCT02475954|75588274|FG001|STARTED|Overall Study||87||
59607196|NCT02687165|75717735|FG000|NOT COMPLETED|Overall Study||0||
59497437|NCT02475954|75588273|FG000|COMPLETED|Overall Study||73||
59607197|NCT02687165|75717736|FG001|NOT COMPLETED|Overall Study||0||
59607198|NCT02672033|75717742|FG000|STARTED|Overall Study||2||
59497438|NCT02475954|75588274|FG001|COMPLETED|Overall Study||75||
59497439|NCT02475954|75588273|FG000|NOT COMPLETED|Overall Study||14||
59497440|NCT02475954|75588274|FG001|NOT COMPLETED|Overall Study||12||
59497441|NCT02459587|75588283|FG000|STARTED|3-Month Follow-up Assessment||157||
59607199|NCT02672033|75717742|FG000|COMPLETED|Overall Study||2||
59497442|NCT02459587|75588284|FG001|STARTED|3-Month Follow-up Assessment||150||
59497443|NCT02459587|75588283|FG000|COMPLETED|3-Month Follow-up Assessment||125||
59607200|NCT02672033|75717742|FG000|NOT COMPLETED|Overall Study||0||
59607201|NCT02656199|75717746|FG000|STARTED|Overall Study|0 analyzed.PI left the institution.Effort to contact PI unsuccessful.No study data available|0||
59497444|NCT02459587|75588284|FG001|COMPLETED|3-Month Follow-up Assessment||119||
59497445|NCT02459587|75588283|FG000|NOT COMPLETED|3-Month Follow-up Assessment||32||
59497446|NCT02459587|75588284|FG001|NOT COMPLETED|3-Month Follow-up Assessment||31||
59497447|NCT02459587|75588283|FG000|STARTED|6-month Follow-up Assessment|Total excludes participants who withdrew participation or were deceased prior to follow-up.|152||
59497448|NCT02459587|75588284|FG001|STARTED|6-month Follow-up Assessment|Total excludes participants who withdrew participation or were deceased prior to follow-up.|141||
59497449|NCT02459587|75588283|FG000|COMPLETED|6-month Follow-up Assessment||128||
59497450|NCT02459587|75588284|FG001|COMPLETED|6-month Follow-up Assessment||116||
59497451|NCT02459587|75588283|FG000|NOT COMPLETED|6-month Follow-up Assessment||24||
59497452|NCT02459587|75588284|FG001|NOT COMPLETED|6-month Follow-up Assessment||25||
59497453|NCT02459587|75588283|FG000|STARTED|12-month Follow-up Assessment|Total excludes participants who withdrew participation or were deceased prior to follow-up.|149||
59497454|NCT02459587|75588284|FG001|STARTED|12-month Follow-up Assessment|Total excludes participants who withdrew participation or were deceased prior to follow-up.|138||
59497455|NCT02459587|75588283|FG000|COMPLETED|12-month Follow-up Assessment||127||
59497456|NCT02459587|75588284|FG001|COMPLETED|12-month Follow-up Assessment||111||
59497457|NCT02459587|75588283|FG000|NOT COMPLETED|12-month Follow-up Assessment||22||
59497458|NCT02459587|75588284|FG001|NOT COMPLETED|12-month Follow-up Assessment||27||
59497459|NCT02281084|75588295|FG000|STARTED|Overall Study||32||
59497460|NCT02281084|75588296|FG001|STARTED|Overall Study||22||
59497461|NCT02281084|75588297|FG002|STARTED|Overall Study||6||
59497462|NCT02281084|75588298|FG003|STARTED|Overall Study||5||
59497463|NCT02281084|75588295|FG000|COMPLETED|Overall Study||10|Completed = participants ongoing|
59497464|NCT02281084|75588296|FG001|COMPLETED|Overall Study||4|Completed = participants ongoing|
59497465|NCT02281084|75588297|FG002|COMPLETED|Overall Study||2|Completed = participants ongoing|
59497466|NCT02281084|75588298|FG003|COMPLETED|Overall Study||0|Completed = participants ongoing|
59497467|NCT02281084|75588295|FG000|NOT COMPLETED|Overall Study||22||
59497468|NCT02281084|75588296|FG001|NOT COMPLETED|Overall Study||18||
59497469|NCT02281084|75588297|FG002|NOT COMPLETED|Overall Study||4||
59497470|NCT02281084|75588298|FG003|NOT COMPLETED|Overall Study||5||
59497471|NCT01973972|75588310|FG000|STARTED|Overall Study||127||
59497472|NCT01973972|75588311|FG001|STARTED|Overall Study||136||
59497473|NCT01973972|75588310|FG000|COMPLETED|Overall Study||109||
59497474|NCT01973972|75588311|FG001|COMPLETED|Overall Study||117||
59497475|NCT01973972|75588310|FG000|NOT COMPLETED|Overall Study||18||
59497476|NCT01973972|75588311|FG001|NOT COMPLETED|Overall Study||19||
59497477|NCT01966120|75588319|FG000|STARTED|Overall Study||55||
59497478|NCT01966120|75588320|FG001|STARTED|Overall Study||32||
59497479|NCT01966120|75588319|FG000|COMPLETED|Overall Study||54||
59497480|NCT01966120|75588320|FG001|COMPLETED|Overall Study||26||
59497481|NCT01966120|75588319|FG000|NOT COMPLETED|Overall Study||1||
59497482|NCT01966120|75588320|FG001|NOT COMPLETED|Overall Study||6||
59497483|NCT01798589|75588327|FG000|STARTED|Overall Study||16||
59497484|NCT01798589|75588327|FG000|COMPLETED|Overall Study||16||
59497485|NCT01798589|75588327|FG000|NOT COMPLETED|Overall Study||0||
59497486|NCT00386477|75588337|FG000|STARTED|Overall Study||155||
59497487|NCT00386477|75588338|FG001|STARTED|Overall Study||145||
59497488|NCT00386477|75588337|FG000|COMPLETED|Overall Study||155||
59497489|NCT00386477|75588338|FG001|COMPLETED|Overall Study||145||
59497490|NCT00386477|75588337|FG000|NOT COMPLETED|Overall Study||0||
59497491|NCT00386477|75588338|FG001|NOT COMPLETED|Overall Study||0||
59497492|NCT00453193|75588344|FG000|STARTED|Overall Study||24||
59497493|NCT00453193|75588344|FG000|COMPLETED|Overall Study||24||
59497494|NCT00453193|75588344|FG000|NOT COMPLETED|Overall Study||0||
59497495|NCT00387023|75588348|FG000|STARTED|Overall Study||12||
59497496|NCT00387023|75588348|FG000|COMPLETED|Overall Study||12||
59497497|NCT00387023|75588348|FG000|NOT COMPLETED|Overall Study||0||
59497498|NCT00472849|75588354|FG000|STARTED|Overall Study||12||
59497499|NCT00472849|75588355|FG001|STARTED|Overall Study||78||
59497500|NCT00472849|75588354|FG000|COMPLETED|Overall Study||12||
59497501|NCT00472849|75588355|FG001|COMPLETED|Overall Study||78||
59497502|NCT00472849|75588354|FG000|NOT COMPLETED|Overall Study||0||
59497503|NCT00472849|75588355|FG001|NOT COMPLETED|Overall Study||0||
59497504|NCT01399736|75588363|FG000|STARTED|Overall Study||295||
59497505|NCT01399736|75588364|FG001|STARTED|Overall Study||590||
59497506|NCT01399736|75588363|FG000|COMPLETED|Overall Study||291||
59497507|NCT01399736|75588364|FG001|COMPLETED|Overall Study||586||
59497508|NCT01399736|75588363|FG000|NOT COMPLETED|Overall Study||4||
59497509|NCT01399736|75588364|FG001|NOT COMPLETED|Overall Study||4||
59497510|NCT00453895|75588378|FG000|STARTED|Overall Study||39||
59497511|NCT00453895|75588378|FG000|COMPLETED|Overall Study||39||
59497512|NCT00453895|75588378|FG000|NOT COMPLETED|Overall Study||0||
59497513|NCT00528541|75588384|FG000|STARTED|Overall Study||75||
59497514|NCT00528541|75588385|FG001|STARTED|Overall Study||70||
59497515|NCT00528541|75588384|FG000|COMPLETED|Overall Study||73||
59497516|NCT00528541|75588385|FG001|COMPLETED|Overall Study||69||
59497517|NCT00528541|75588384|FG000|NOT COMPLETED|Overall Study||2||
59497518|NCT00528541|75588385|FG001|NOT COMPLETED|Overall Study||1||
59497519|NCT00409565|75588391|FG000|STARTED|Overall Study||46||
59497520|NCT00409565|75588391|FG000|Overall Response Rate|Overall Study||7||
59497521|NCT00409565|75588391|FG000|COMPLETED|Overall Study||45||
59497522|NCT00409565|75588391|FG000|NOT COMPLETED|Overall Study||1||
59497523|NCT00475501|75588399|FG000|STARTED|Overall Study||14||
59497524|NCT00475501|75588400|FG001|STARTED|Overall Study||13||
59497525|NCT00475501|75588401|FG002|STARTED|Overall Study||17||
59497526|NCT00475501|75588402|FG003|STARTED|Overall Study||16||
59497527|NCT00475501|75588399|FG000|COMPLETED|Overall Study||7||
59497528|NCT00475501|75588400|FG001|COMPLETED|Overall Study||8||
59497529|NCT00475501|75588401|FG002|COMPLETED|Overall Study||13||
59497530|NCT00475501|75588402|FG003|COMPLETED|Overall Study||12||
59497531|NCT00475501|75588399|FG000|NOT COMPLETED|Overall Study||7||
59497532|NCT00475501|75588400|FG001|NOT COMPLETED|Overall Study||5||
59497533|NCT00475501|75588401|FG002|NOT COMPLETED|Overall Study||4||
59497534|NCT00475501|75588402|FG003|NOT COMPLETED|Overall Study||4||
59497535|NCT00529555|75588447|FG000|STARTED|Overall Study||200||
59497536|NCT00529555|75588448|FG001|STARTED|Overall Study||202||
59497537|NCT00529555|75588449|FG002|STARTED|Overall Study||200||
59497538|NCT00529555|75588447|FG000|COMPLETED|Overall Study||171||
59497539|NCT00529555|75588448|FG001|COMPLETED|Overall Study||172||
59497540|NCT00529555|75588449|FG002|COMPLETED|Overall Study||174||
59497541|NCT00529555|75588447|FG000|NOT COMPLETED|Overall Study||29||
59497542|NCT00529555|75588448|FG001|NOT COMPLETED|Overall Study||30||
59497543|NCT00529555|75588449|FG002|NOT COMPLETED|Overall Study||26||
59497544|NCT00387335|75588459|FG000|STARTED|Overall Study||15||
59497545|NCT00387335|75588460|FG001|STARTED|Overall Study||7||
59497546|NCT00387335|75588459|FG000|COMPLETED|Overall Study||15||
59497547|NCT00387335|75588460|FG001|COMPLETED|Overall Study||7||
59497548|NCT00387335|75588459|FG000|NOT COMPLETED|Overall Study||0||
59497549|NCT00387335|75588460|FG001|NOT COMPLETED|Overall Study||0||
59497550|NCT00477451|75588470|FG000|STARTED|Overall Study||20||
59497551|NCT00477451|75588471|FG001|STARTED|Overall Study||20||
59497552|NCT00477451|75588472|FG002|STARTED|Overall Study||7||
59497553|NCT00477451|75588473|FG003|STARTED|Overall Study||2||
59497554|NCT00477451|75588470|FG000|COMPLETED|Overall Study||20||
59497555|NCT00477451|75588471|FG001|COMPLETED|Overall Study||20||
59497556|NCT00477451|75588472|FG002|COMPLETED|Overall Study||7||
59497557|NCT00477451|75588473|FG003|COMPLETED|Overall Study||2||
59497558|NCT00477451|75588470|FG000|NOT COMPLETED|Overall Study||0||
59497559|NCT00477451|75588471|FG001|NOT COMPLETED|Overall Study||0||
59497560|NCT00477451|75588472|FG002|NOT COMPLETED|Overall Study||0||
59497561|NCT00477451|75588473|FG003|NOT COMPLETED|Overall Study||0||
59497562|NCT00477685|75588481|FG000|STARTED|Overall Study||10||
59497563|NCT00477685|75588481|FG000|COMPLETED|Overall Study||10||
59497564|NCT00477685|75588481|FG000|NOT COMPLETED|Overall Study||0||
59497565|NCT00530803|75588487|FG000|STARTED|Overall Study||50||
59497566|NCT00530803|75588488|FG001|STARTED|Overall Study||50||
59497567|NCT00530803|75588487|FG000|COMPLETED|Overall Study||50||
59497568|NCT00530803|75588488|FG001|COMPLETED|Overall Study||50||
59497569|NCT00530803|75588487|FG000|NOT COMPLETED|Overall Study||0||
59497570|NCT00530803|75588488|FG001|NOT COMPLETED|Overall Study||0||
59497571|NCT04372927|75588494|FG000|STARTED|Overall Study||1||
59497572|NCT04372927|75588494|FG000|COMPLETED|Overall Study||0||
59497573|NCT04372927|75588494|FG000|NOT COMPLETED|Overall Study||1||
59497574|NCT01381874|75588501|FG000|STARTED|Overall Study||102||
59497575|NCT01381874|75588502|FG001|STARTED|Overall Study||89||
59497576|NCT01381874|75588503|FG002|STARTED|Overall Study||106||
59497577|NCT01381874|75588501|FG000|Treated|Overall Study||102||
59497578|NCT01381874|75588502|FG001|Treated|Overall Study||87||
59497579|NCT01381874|75588503|FG002|Treated|Overall Study||104||
59497580|NCT01381874|75588501|FG000|COMPLETED|Overall Study||25||
59497581|NCT01381874|75588502|FG001|COMPLETED|Overall Study||26||
59497582|NCT01381874|75588503|FG002|COMPLETED|Overall Study||30||
59497583|NCT01381874|75588501|FG000|NOT COMPLETED|Overall Study||77||
59497584|NCT01381874|75588502|FG001|NOT COMPLETED|Overall Study||63||
59497585|NCT01381874|75588503|FG002|NOT COMPLETED|Overall Study||76||
59497586|NCT01399190|75588511|FG000|STARTED|Overall Study||68||
59497587|NCT01399190|75588511|FG000|Included in Final Analysis|Overall Study||63||
59497588|NCT01399190|75588511|FG000|Evaluable for Primary Endpoint Analysis|Overall Study||60||
59497589|NCT01399190|75588511|FG000|COMPLETED|Overall Study||48||
59497590|NCT01399190|75588511|FG000|NOT COMPLETED|Overall Study||20||
59497591|NCT00531661|75588517|FG000|STARTED|6 Months||270||
59497592|NCT00531661|75588518|FG001|STARTED|6 Months||280||
59497593|NCT00531661|75588517|FG000|COMPLETED|6 Months||244||
59497594|NCT00531661|75588518|FG001|COMPLETED|6 Months||254||
59497595|NCT00531661|75588517|FG000|NOT COMPLETED|6 Months||26||
59497596|NCT00531661|75588518|FG001|NOT COMPLETED|6 Months||26||
59497597|NCT00531661|75588517|FG000|STARTED|Study Duration: 15 Months Avg. Follow-up||244||
59497598|NCT00531661|75588518|FG001|STARTED|Study Duration: 15 Months Avg. Follow-up||254||
59497599|NCT00531661|75588517|FG000|COMPLETED|Study Duration: 15 Months Avg. Follow-up||186||
59497600|NCT00531661|75588518|FG001|COMPLETED|Study Duration: 15 Months Avg. Follow-up||197||
59497601|NCT00531661|75588517|FG000|NOT COMPLETED|Study Duration: 15 Months Avg. Follow-up||58||
59497602|NCT00531661|75588518|FG001|NOT COMPLETED|Study Duration: 15 Months Avg. Follow-up||57||
59885125|NCT00113399|76007915|FG001|COMPLETED|Overall Study||3||
59497603|NCT01381718|75588529|FG000|STARTED|Overall Study||56||
59497604|NCT01381718|75588530|FG001|STARTED|Overall Study||56||
59497605|NCT01381718|75588529|FG000|COMPLETED|Overall Study||51||
59497606|NCT01381718|75588530|FG001|COMPLETED|Overall Study||43||
59497607|NCT01381718|75588529|FG000|NOT COMPLETED|Overall Study||5||
59497608|NCT01381718|75588530|FG001|NOT COMPLETED|Overall Study||13||
59497609|NCT00410189|75588536|FG000|STARTED|Overall Study||54||
59497610|NCT00410189|75588536|FG000|COMPLETED|Overall Study||54||
59497611|NCT00410189|75588536|FG000|NOT COMPLETED|Overall Study||0||
60012510|NCT01659021|76128478|FG000|COMPLETED|Long-Term Follow Up||133||
60012511|NCT01659021|76128479|FG001|COMPLETED|Long-Term Follow Up||65||
60012512|NCT01659021|76128478|FG000|NOT COMPLETED|Long-Term Follow Up||5||
60012513|NCT01659021|76128479|FG001|NOT COMPLETED|Long-Term Follow Up||4||
60012514|NCT05387434|76128491|FG000|STARTED|Overall Study||16||
60012515|NCT05387434|76128492|FG001|STARTED|Overall Study||15||
60012516|NCT05387434|76128491|FG000|COMPLETED|Overall Study||14||
60012517|NCT05387434|76128492|FG001|COMPLETED|Overall Study||13||
60012518|NCT05387434|76128491|FG000|NOT COMPLETED|Overall Study||2||
60012519|NCT05387434|76128492|FG001|NOT COMPLETED|Overall Study||2||
60012520|NCT05188261|76128503|FG000|STARTED|Overall Study||8||
60012521|NCT05188261|76128504|FG001|STARTED|Overall Study||6||
60012522|NCT05188261|76128505|FG002|STARTED|Overall Study||6||
59497612|NCT00479089|75588542|FG000|STARTED|Overall Study||25||
59497613|NCT00479089|75588543|FG001|STARTED|Overall Study||25||
59497614|NCT00479089|75588542|FG000|COMPLETED|Overall Study||25||
59497615|NCT00479089|75588543|FG001|COMPLETED|Overall Study||25||
59497616|NCT00479089|75588542|FG000|NOT COMPLETED|Overall Study||0||
59497617|NCT00479089|75588543|FG001|NOT COMPLETED|Overall Study||0||
59497618|NCT01398956|75588549|FG000|STARTED|Overall Study||44||
59497619|NCT01398956|75588549|FG000|COMPLETED|Overall Study||34||
59497620|NCT01398956|75588549|FG000|NOT COMPLETED|Overall Study||10||
59497621|NCT00410423|75588554|FG000|STARTED|Phase 1 - Dose Level 1||3||
59497622|NCT00410423|75588555|FG001|STARTED|Phase 1 - Dose Level 1||0||
59497623|NCT00410423|75588556|FG002|STARTED|Phase 1 - Dose Level 1||0||
59497624|NCT00410423|75588557|FG003|STARTED|Phase 1 - Dose Level 1||0||
59497625|NCT00410423|75588554|FG000|COMPLETED|Phase 1 - Dose Level 1||3||
59497626|NCT00410423|75588555|FG001|COMPLETED|Phase 1 - Dose Level 1||0||
59497627|NCT00410423|75588556|FG002|COMPLETED|Phase 1 - Dose Level 1||0||
59497628|NCT00410423|75588557|FG003|COMPLETED|Phase 1 - Dose Level 1||0||
59497629|NCT00410423|75588554|FG000|NOT COMPLETED|Phase 1 - Dose Level 1||0||
59497630|NCT00410423|75588555|FG001|NOT COMPLETED|Phase 1 - Dose Level 1||0||
59497631|NCT00410423|75588556|FG002|NOT COMPLETED|Phase 1 - Dose Level 1||0||
59497632|NCT00410423|75588557|FG003|NOT COMPLETED|Phase 1 - Dose Level 1||0||
59497633|NCT00410423|75588554|FG000|STARTED|Phase 1 - Dose Level 2||0||
59497634|NCT00410423|75588555|FG001|STARTED|Phase 1 - Dose Level 2||5||
59497635|NCT00410423|75588556|FG002|STARTED|Phase 1 - Dose Level 2||0||
59497636|NCT00410423|75588557|FG003|STARTED|Phase 1 - Dose Level 2||0||
59497637|NCT00410423|75588554|FG000|COMPLETED|Phase 1 - Dose Level 2||0||
59497638|NCT00410423|75588555|FG001|COMPLETED|Phase 1 - Dose Level 2||5||
59497639|NCT00410423|75588556|FG002|COMPLETED|Phase 1 - Dose Level 2||0||
59497640|NCT00410423|75588557|FG003|COMPLETED|Phase 1 - Dose Level 2||0||
59497641|NCT00410423|75588554|FG000|NOT COMPLETED|Phase 1 - Dose Level 2||0||
59497642|NCT00410423|75588555|FG001|NOT COMPLETED|Phase 1 - Dose Level 2||0||
59497643|NCT00410423|75588556|FG002|NOT COMPLETED|Phase 1 - Dose Level 2||0||
59497644|NCT00410423|75588557|FG003|NOT COMPLETED|Phase 1 - Dose Level 2||0||
59497645|NCT00410423|75588554|FG000|STARTED|Phase 1 - Dose Level 3||0||
59497646|NCT00410423|75588555|FG001|STARTED|Phase 1 - Dose Level 3||0||
59497647|NCT00410423|75588556|FG002|STARTED|Phase 1 - Dose Level 3||3||
59885126|NCT00113399|76007914|FG000|NOT COMPLETED|Overall Study||2||
59885127|NCT00113399|76007915|FG001|NOT COMPLETED|Overall Study||5||
59885128|NCT00113087|76007923|FG000|STARTED|Overall Study||115||
59497648|NCT00410423|75588557|FG003|STARTED|Phase 1 - Dose Level 3||0||
59497649|NCT00410423|75588554|FG000|COMPLETED|Phase 1 - Dose Level 3||0||
59885129|NCT00113087|76007924|FG001|STARTED|Overall Study||115||
59497650|NCT00410423|75588555|FG001|COMPLETED|Phase 1 - Dose Level 3||0||
59497651|NCT00410423|75588556|FG002|COMPLETED|Phase 1 - Dose Level 3||3||
59497652|NCT00410423|75588557|FG003|COMPLETED|Phase 1 - Dose Level 3||0||
59497653|NCT00410423|75588554|FG000|NOT COMPLETED|Phase 1 - Dose Level 3||0||
59497654|NCT00410423|75588555|FG001|NOT COMPLETED|Phase 1 - Dose Level 3||0||
59497655|NCT00410423|75588556|FG002|NOT COMPLETED|Phase 1 - Dose Level 3||0||
59885130|NCT00113087|76007923|FG000|COMPLETED|Overall Study||91||
59885131|NCT00113087|76007924|FG001|COMPLETED|Overall Study||94||
59885132|NCT00113087|76007923|FG000|NOT COMPLETED|Overall Study||24||
59885133|NCT00113087|76007924|FG001|NOT COMPLETED|Overall Study||21||
59885134|NCT00112463|76007930|FG000|STARTED|Overall Study||40||
59885135|NCT00112463|76007930|FG000|COMPLETED|Overall Study||1||
59885136|NCT00112463|76007930|FG000|NOT COMPLETED|Overall Study||39||
59885137|NCT03548415|76007940|FG000|STARTED|Overall Study||12||
59885138|NCT03548415|76007941|FG001|STARTED|Overall Study||12||
59497656|NCT00410423|75588557|FG003|NOT COMPLETED|Phase 1 - Dose Level 3||0||
59497657|NCT00410423|75588554|FG000|STARTED|Phase 2||0||
59497658|NCT00410423|75588555|FG001|STARTED|Phase 2||0||
59497659|NCT00410423|75588556|FG002|STARTED|Phase 2||0||
59497660|NCT00410423|75588557|FG003|STARTED|Phase 2||44||
59497661|NCT00410423|75588554|FG000|COMPLETED|Phase 2||0||
59497662|NCT00410423|75588555|FG001|COMPLETED|Phase 2||0||
59497663|NCT00410423|75588556|FG002|COMPLETED|Phase 2||0||
59497664|NCT00410423|75588557|FG003|COMPLETED|Phase 2||44||
59497665|NCT00410423|75588554|FG000|NOT COMPLETED|Phase 2||0||
59497666|NCT00410423|75588555|FG001|NOT COMPLETED|Phase 2||0||
59497667|NCT00410423|75588556|FG002|NOT COMPLETED|Phase 2||0||
59497668|NCT00410423|75588557|FG003|NOT COMPLETED|Phase 2||0||
59497669|NCT00387959|75588564|FG000|STARTED|Overall Study||17||
59497670|NCT00387959|75588564|FG000|COMPLETED|Overall Study||16||
59497671|NCT00387959|75588564|FG000|NOT COMPLETED|Overall Study||1||
59497672|NCT00410891|75588568|FG000|STARTED|Overall Study||129||
59497673|NCT00410891|75588568|FG000|COMPLETED|Overall Study||129||
59497674|NCT00410891|75588568|FG000|NOT COMPLETED|Overall Study||0||
59497675|NCT01381562|75588575|FG000|STARTED|Overall Study||5||
59497676|NCT01381562|75588576|FG001|STARTED|Overall Study||4||
59497677|NCT01381562|75588577|FG002|STARTED|Overall Study||5||
59497678|NCT01381562|75588575|FG000|COMPLETED|Overall Study||5||
59497679|NCT01381562|75588576|FG001|COMPLETED|Overall Study||3||
59497680|NCT01381562|75588577|FG002|COMPLETED|Overall Study||5||
59497681|NCT01381562|75588575|FG000|NOT COMPLETED|Overall Study||0||
59497682|NCT01381562|75588576|FG001|NOT COMPLETED|Overall Study||1||
59497683|NCT01381562|75588577|FG002|NOT COMPLETED|Overall Study||0||
59497684|NCT00411749|75588587|FG000|STARTED|Overall Study||82||
59497685|NCT00411749|75588588|FG001|STARTED|Overall Study||25||
59497686|NCT00411749|75588587|FG000|Vaccinated|Overall Study||82||
59497687|NCT00411749|75588588|FG001|Vaccinated|Overall Study||25||
59497688|NCT00411749|75588587|FG000|COMPLETED|Overall Study|Completed at 24 month after vaccination series (Month 30). Subjects were followed until Month 30|82||
59497689|NCT00411749|75588588|FG001|COMPLETED|Overall Study|Completed at 1 month after vaccination series (Month 7). Subjects were followed until Month 7|25||
59497690|NCT00411749|75588587|FG000|NOT COMPLETED|Overall Study||0||
59497691|NCT00411749|75588588|FG001|NOT COMPLETED|Overall Study||0||
59497692|NCT01381016|75588600|FG000|STARTED|Overall Study||13||
59497693|NCT01381016|75588601|FG001|STARTED|Overall Study||17||
59497694|NCT01381016|75588600|FG000|COMPLETED|Overall Study||10||
59497695|NCT01381016|75588601|FG001|COMPLETED|Overall Study||11||
59497696|NCT01381016|75588600|FG000|NOT COMPLETED|Overall Study||3||
59497697|NCT01381016|75588601|FG001|NOT COMPLETED|Overall Study||6||
59497698|NCT00412451|75588613|FG000|STARTED|Overall Study||8||
59497699|NCT00412451|75588614|FG001|STARTED|Overall Study||15||
59497700|NCT00412451|75588615|FG002|STARTED|Overall Study||15||
59497701|NCT00412451|75588616|FG003|STARTED|Overall Study||13||
59497702|NCT00412451|75588613|FG000|COMPLETED|Overall Study||8||
59497703|NCT00412451|75588614|FG001|COMPLETED|Overall Study||15||
59497704|NCT00412451|75588615|FG002|COMPLETED|Overall Study||14||
59497705|NCT00412451|75588616|FG003|COMPLETED|Overall Study||11||
59497706|NCT00412451|75588613|FG000|NOT COMPLETED|Overall Study||0||
59497707|NCT00412451|75588614|FG001|NOT COMPLETED|Overall Study||0||
59497708|NCT00412451|75588615|FG002|NOT COMPLETED|Overall Study||1||
59497709|NCT00412451|75588616|FG003|NOT COMPLETED|Overall Study||2||
59497710|NCT01398410|75588628|FG000|STARTED|Overall Study|Treated participants (all participants who received at least one dose of rabeprazole).|201||
59497711|NCT01398410|75588629|FG001|STARTED|Overall Study||204||
59497712|NCT01398410|75588628|FG000|COMPLETED|Overall Study||143||
59497713|NCT01398410|75588629|FG001|COMPLETED|Overall Study||148||
59497714|NCT01398410|75588628|FG000|NOT COMPLETED|Overall Study||58||
59497715|NCT01398410|75588629|FG001|NOT COMPLETED|Overall Study||56||
59497716|NCT00412529|75588637|FG000|STARTED|Overall Study||23||
59497717|NCT00412529|75588638|FG001|STARTED|Overall Study||21||
59497718|NCT00412529|75588637|FG000|COMPLETED|Overall Study||23||
59497719|NCT00412529|75588638|FG001|COMPLETED|Overall Study||21||
59497720|NCT00412529|75588637|FG000|NOT COMPLETED|Overall Study||0||
59497721|NCT00412529|75588638|FG001|NOT COMPLETED|Overall Study||0||
59497722|NCT00412841|75588646|FG000|STARTED|Overall Study||22||
59497723|NCT00412841|75588647|FG001|STARTED|Overall Study||21||
59497724|NCT00412841|75588646|FG000|COMPLETED|Overall Study||12||
60012523|NCT05188261|76128506|FG003|STARTED|Overall Study||6||
59497725|NCT00412841|75588647|FG001|COMPLETED|Overall Study||16||
59497726|NCT00412841|75588646|FG000|NOT COMPLETED|Overall Study||10||
59497727|NCT00412841|75588647|FG001|NOT COMPLETED|Overall Study||5||
59497728|NCT00414167|75588656|FG000|STARTED|Overall Study||31||
59497729|NCT00414167|75588657|FG001|STARTED|Overall Study||30||
59497730|NCT00414167|75588656|FG000|COMPLETED|Overall Study||27||
59497731|NCT00414167|75588657|FG001|COMPLETED|Overall Study||27||
59497732|NCT00414167|75588656|FG000|NOT COMPLETED|Overall Study||4||
59497733|NCT00414167|75588657|FG001|NOT COMPLETED|Overall Study||3||
59497734|NCT00414635|75588667|FG000|STARTED|Overall Study||30||
59497735|NCT00414635|75588668|FG001|STARTED|Overall Study||30||
59497736|NCT00414635|75588667|FG000|COMPLETED|Overall Study||25||
59497737|NCT00414635|75588668|FG001|COMPLETED|Overall Study||28||
59497738|NCT00414635|75588667|FG000|NOT COMPLETED|Overall Study||5||
59497739|NCT00414635|75588668|FG001|NOT COMPLETED|Overall Study||2||
59497740|NCT00531817|75588676|FG000|STARTED|Randomized||412||
59497741|NCT00531817|75588677|FG001|STARTED|Randomized||207||
59497742|NCT00531817|75588676|FG000|Received Study Drug in Core Study|Randomized|3 patients did not receive any study medication. Intent-to-treat population = 409.|409||
59497743|NCT00531817|75588677|FG001|Received Study Drug in Core Study|Randomized|2 patients did not receive any study medication. Intent-to-treat population = 205.|205||
59497744|NCT00531817|75588676|FG000|COMPLETED|Randomized||353||
59497745|NCT00531817|75588677|FG001|COMPLETED|Randomized||173||
59497746|NCT00531817|75588676|FG000|NOT COMPLETED|Randomized||59||
59497747|NCT00531817|75588677|FG001|NOT COMPLETED|Randomized||34||
59497748|NCT00531817|75588676|FG000|STARTED|Entered Extended Treatment Period|Eligible patients completing core study could participate in extension at investigator's discretion.|343||
59497749|NCT00531817|75588677|FG001|STARTED|Entered Extended Treatment Period|Eligible patients completing core study could participate in extension at investigator's discretion.|170||
59497750|NCT00531817|75588676|FG000|COMPLETED|Entered Extended Treatment Period||206||
59497751|NCT00531817|75588677|FG001|COMPLETED|Entered Extended Treatment Period||113||
59497752|NCT00531817|75588676|FG000|NOT COMPLETED|Entered Extended Treatment Period||137||
59497753|NCT00531817|75588677|FG001|NOT COMPLETED|Entered Extended Treatment Period||57||
59497754|NCT00415493|75588686|FG000|STARTED|Overall Study||12||
59497755|NCT00415493|75588687|FG001|STARTED|Overall Study||12||
59497756|NCT00415493|75588686|FG000|COMPLETED|Overall Study||12||
59497757|NCT00415493|75588687|FG001|COMPLETED|Overall Study||12||
59497758|NCT00415493|75588686|FG000|NOT COMPLETED|Overall Study||0||
59497759|NCT00415493|75588687|FG001|NOT COMPLETED|Overall Study||0||
59497760|NCT01380782|75588695|FG000|STARTED|Overall Study||12||
59497761|NCT01380782|75588696|FG001|STARTED|Overall Study||10||
59497762|NCT01380782|75588697|FG002|STARTED|Overall Study||11||
59497763|NCT01380782|75588698|FG003|STARTED|Overall Study||4||
59497764|NCT01380782|75588695|FG000|COMPLETED|Overall Study||0||
59497765|NCT01380782|75588696|FG001|COMPLETED|Overall Study||0||
59497766|NCT01380782|75588697|FG002|COMPLETED|Overall Study||0||
59497767|NCT01380782|75588698|FG003|COMPLETED|Overall Study||0||
59497768|NCT01380782|75588695|FG000|NOT COMPLETED|Overall Study||12||
59497769|NCT01380782|75588696|FG001|NOT COMPLETED|Overall Study||10||
59497770|NCT01380782|75588697|FG002|NOT COMPLETED|Overall Study||11||
59497771|NCT01380782|75588698|FG003|NOT COMPLETED|Overall Study||4||
59497772|NCT01398176|75588712|FG000|STARTED|Overall Study||26||
59497773|NCT01398176|75588713|FG001|STARTED|Overall Study||25||
59497774|NCT01398176|75588712|FG000|COMPLETED|Overall Study||23||
59497775|NCT01398176|75588713|FG001|COMPLETED|Overall Study||19||
59497776|NCT01398176|75588712|FG000|NOT COMPLETED|Overall Study||3||
59497777|NCT01398176|75588713|FG001|NOT COMPLETED|Overall Study||6||
59497778|NCT00455663|75588722|FG000|STARTED|Overall Study||37||
59497779|NCT00455663|75588723|FG001|STARTED|Overall Study||36||
59497780|NCT00455663|75588724|FG002|STARTED|Overall Study||32||
59497781|NCT00455663|75588722|FG000|COMPLETED|Overall Study||34||
59497782|NCT00455663|75588723|FG001|COMPLETED|Overall Study||32||
59497783|NCT00455663|75588724|FG002|COMPLETED|Overall Study||29||
59497784|NCT00455663|75588722|FG000|NOT COMPLETED|Overall Study||3||
59497785|NCT00455663|75588723|FG001|NOT COMPLETED|Overall Study||4||
59497786|NCT00455663|75588724|FG002|NOT COMPLETED|Overall Study||3||
59497787|NCT00534001|75588738|FG000|STARTED|Overall Study||48||
59497788|NCT00534001|75588739|FG001|STARTED|Overall Study||47||
59497789|NCT00534001|75588738|FG000|COMPLETED|Overall Study||43||
59497790|NCT00534001|75588739|FG001|COMPLETED|Overall Study||43||
59497791|NCT00534001|75588738|FG000|NOT COMPLETED|Overall Study||5||
59497792|NCT00534001|75588739|FG001|NOT COMPLETED|Overall Study||4||
59497793|NCT00481351|75588747|FG000|STARTED|Overall Study||13||
59497794|NCT00481351|75588748|FG001|STARTED|Overall Study||12||
59497795|NCT00481351|75588747|FG000|COMPLETED|Overall Study||13||
59497796|NCT00481351|75588748|FG001|COMPLETED|Overall Study||12||
59497797|NCT00481351|75588747|FG000|NOT COMPLETED|Overall Study||0||
59497798|NCT00481351|75588748|FG001|NOT COMPLETED|Overall Study||0||
59497799|NCT00481507|75588756|FG000|STARTED|Overall Study||64||
59497800|NCT00481507|75588757|FG001|STARTED|Overall Study||61||
59497801|NCT00481507|75588756|FG000|COMPLETED|Overall Study||64||
59497802|NCT00481507|75588757|FG001|COMPLETED|Overall Study||61||
59497803|NCT00481507|75588756|FG000|NOT COMPLETED|Overall Study||0||
59497804|NCT00481507|75588757|FG001|NOT COMPLETED|Overall Study||0||
59497805|NCT01397786|75588766|FG000|STARTED|Phase A|Subjects in NCT01668797 Phase A at IA-related study termination rolled over to NCT01397786 Phase A.|12||
59497806|NCT01397786|75588767|FG001|STARTED|Phase A||0||
59497807|NCT01397786|75588768|FG002|STARTED|Phase A||227||
59497808|NCT01397786|75588766|FG000|COMPLETED|Phase A||12||
59497809|NCT01397786|75588767|FG001|COMPLETED|Phase A||0||
59497810|NCT01397786|75588768|FG002|COMPLETED|Phase A||199||
59497811|NCT01397786|75588766|FG000|NOT COMPLETED|Phase A||0||
59497812|NCT01397786|75588767|FG001|NOT COMPLETED|Phase A||0||
59497813|NCT01397786|75588768|FG002|NOT COMPLETED|Phase A||28||
59497814|NCT01397786|75588766|FG000|STARTED|Phase B||611||
59497815|NCT01397786|75588767|FG001|STARTED|Phase B||204||
59497816|NCT01397786|75588768|FG002|STARTED|Phase B||229||
59497817|NCT01397786|75588766|FG000|COMPLETED|Phase B||308||
59497818|NCT01397786|75588767|FG001|COMPLETED|Phase B||109||
59497819|NCT01397786|75588768|FG002|COMPLETED|Phase B||91||
59497820|NCT01397786|75588766|FG000|NOT COMPLETED|Phase B||303||
59497821|NCT01397786|75588767|FG001|NOT COMPLETED|Phase B||95||
60012524|NCT05188261|76128507|FG004|STARTED|Overall Study||6||
60012525|NCT05188261|76128503|FG000|COMPLETED|Overall Study||8||
60012526|NCT05188261|76128504|FG001|COMPLETED|Overall Study||6||
60012527|NCT05188261|76128505|FG002|COMPLETED|Overall Study||6||
60012528|NCT05188261|76128506|FG003|COMPLETED|Overall Study||6||
60012529|NCT05188261|76128507|FG004|COMPLETED|Overall Study||6||
60012530|NCT05188261|76128503|FG000|NOT COMPLETED|Overall Study||0||
60012531|NCT05188261|76128504|FG001|NOT COMPLETED|Overall Study||0||
60012532|NCT05188261|76128505|FG002|NOT COMPLETED|Overall Study||0||
60012533|NCT05188261|76128506|FG003|NOT COMPLETED|Overall Study||0||
60012534|NCT05188261|76128507|FG004|NOT COMPLETED|Overall Study||0||
59497822|NCT01397786|75588768|FG002|NOT COMPLETED|Phase B||138||
59497823|NCT00455975|75588782|FG000|STARTED|Overall Study||58||
59497824|NCT00455975|75588783|FG001|STARTED|Overall Study||61||
59497825|NCT00455975|75588782|FG000|COMPLETED|Overall Study||40||
59497826|NCT00455975|75588783|FG001|COMPLETED|Overall Study||40||
59497827|NCT00455975|75588782|FG000|NOT COMPLETED|Overall Study||18||
59497828|NCT00455975|75588783|FG001|NOT COMPLETED|Overall Study||21||
59497829|NCT02078882|75588789|FG000|STARTED|Overall Study||16||
59497830|NCT02078882|75588789|FG000|COMPLETED|Overall Study||16||
59497831|NCT02078882|75588789|FG000|NOT COMPLETED|Overall Study||0||
59497832|NCT00458237|75588796|FG000|STARTED|Overall Study||3||
59497833|NCT00458237|75588797|FG001|STARTED|Overall Study||3||
59497834|NCT00458237|75588798|FG002|STARTED|Overall Study||5||
59497835|NCT00458237|75588796|FG000|COMPLETED|Overall Study||3||
60012535|NCT04654468|76128519|FG000|STARTED|Overall Study||51||
60012536|NCT04654468|76128519|FG000|COMPLETED|Overall Study||0||
60012537|NCT04654468|76128519|FG000|NOT COMPLETED|Overall Study||51||
60012538|NCT04478266|76128525|FG000|STARTED|Overall Study||534||
60012539|NCT04478266|76128526|FG001|STARTED|Overall Study||534||
60012540|NCT04478266|76128525|FG000|Treated|Overall Study||533||
60012541|NCT04478266|76128526|FG001|Treated|Overall Study||533||
60012542|NCT04478266|76128525|FG000|COMPLETED|Overall Study||0||
60012543|NCT04478266|76128526|FG001|COMPLETED|Overall Study||0||
60012544|NCT04478266|76128525|FG000|NOT COMPLETED|Overall Study||534||
59497836|NCT00458237|75588797|FG001|COMPLETED|Overall Study||3||
59497837|NCT00458237|75588798|FG002|COMPLETED|Overall Study||5||
59497838|NCT00458237|75588796|FG000|NOT COMPLETED|Overall Study||0||
59497839|NCT00458237|75588797|FG001|NOT COMPLETED|Overall Study||0||
59497840|NCT00458237|75588798|FG002|NOT COMPLETED|Overall Study||0||
59497841|NCT00418457|75588809|FG000|STARTED|Overall Study||1065||
59497842|NCT00418457|75588810|FG001|STARTED|Overall Study||1043||
59497843|NCT00418457|75588809|FG000|COMPLETED|Overall Study||1065||
59497844|NCT00418457|75588810|FG001|COMPLETED|Overall Study||1043||
59497845|NCT00418457|75588809|FG000|NOT COMPLETED|Overall Study||0||
59497846|NCT00418457|75588810|FG001|NOT COMPLETED|Overall Study||0||
59497847|NCT00482911|75588818|FG000|STARTED|Dosing Schedule 1: Len & Cyc|All received Dose A-QD in cycle 1|3||
59497848|NCT00482911|75588819|FG001|STARTED|Dosing Schedule 1: Len & Cyc||0||
59497849|NCT00482911|75588818|FG000|COMPLETED|Dosing Schedule 1: Len & Cyc||3||
59497850|NCT00482911|75588819|FG001|COMPLETED|Dosing Schedule 1: Len & Cyc||0||
59497851|NCT00482911|75588818|FG000|NOT COMPLETED|Dosing Schedule 1: Len & Cyc||0||
59497852|NCT00482911|75588819|FG001|NOT COMPLETED|Dosing Schedule 1: Len & Cyc||0||
59497853|NCT00482911|75588818|FG000|STARTED|Dosing Schedule 1: Len, Cyc, & Sun|All received Dose B-QD in cycle 2|3||
59497854|NCT00482911|75588819|FG001|STARTED|Dosing Schedule 1: Len, Cyc, & Sun|All received Dose B-QD in cycle 1|2||
59497855|NCT00482911|75588818|FG000|COMPLETED|Dosing Schedule 1: Len, Cyc, & Sun|1 stopped at Dose B-QD, 1 stopped at Dose C-QD, 1 stopped at Dose C-QOD|3||
59497856|NCT00482911|75588819|FG001|COMPLETED|Dosing Schedule 1: Len, Cyc, & Sun|1 stopped at Dose B-QD, 1 stopped at Dose C-QOD|2||
59497857|NCT00482911|75588818|FG000|NOT COMPLETED|Dosing Schedule 1: Len, Cyc, & Sun||0||
59497858|NCT00482911|75588819|FG001|NOT COMPLETED|Dosing Schedule 1: Len, Cyc, & Sun||0||
59497859|NCT00482911|75588818|FG000|STARTED|Dosing Schedule 2: Len, Cyc, & Sun||0||
59497860|NCT00482911|75588819|FG001|STARTED|Dosing Schedule 2: Len, Cyc, & Sun|All received Dose D-QD in cycle 1|7||
59497861|NCT00482911|75588818|FG000|COMPLETED|Dosing Schedule 2: Len, Cyc, & Sun||0||
59497862|NCT00482911|75588819|FG001|COMPLETED|Dosing Schedule 2: Len, Cyc, & Sun|5 stopped at Dose D-QOD, 2 stopped at Dose D-QD (1 after first increasing to Dose E-QD)|7||
59497863|NCT00482911|75588818|FG000|NOT COMPLETED|Dosing Schedule 2: Len, Cyc, & Sun||0||
59497864|NCT00482911|75588819|FG001|NOT COMPLETED|Dosing Schedule 2: Len, Cyc, & Sun||0||
59497865|NCT01397162|75588830|FG000|STARTED|Overall Study||8||
59497866|NCT01397162|75588831|FG001|STARTED|Overall Study||5||
59497867|NCT01397162|75588832|FG002|STARTED|Overall Study||4||
59497868|NCT01397162|75588833|FG003|STARTED|Overall Study||6||
59497869|NCT01397162|75588834|FG004|STARTED|Overall Study||6||
59497870|NCT01397162|75588830|FG000|COMPLETED|Overall Study||1||
59497871|NCT01397162|75588831|FG001|COMPLETED|Overall Study||1||
59497872|NCT01397162|75588832|FG002|COMPLETED|Overall Study||1||
59497873|NCT01397162|75588833|FG003|COMPLETED|Overall Study||1||
59497874|NCT01397162|75588834|FG004|COMPLETED|Overall Study||3||
59497875|NCT01397162|75588830|FG000|NOT COMPLETED|Overall Study||7||
59497876|NCT01397162|75588831|FG001|NOT COMPLETED|Overall Study||4||
59497877|NCT01397162|75588832|FG002|NOT COMPLETED|Overall Study||3||
59497878|NCT01397162|75588833|FG003|NOT COMPLETED|Overall Study||5||
59497879|NCT01397162|75588834|FG004|NOT COMPLETED|Overall Study||3||
59497880|NCT00460421|75588854|FG000|STARTED|Overall Study||9||
59497881|NCT00460421|75588855|FG001|STARTED|Overall Study||9||
59497882|NCT00460421|75588856|FG002|STARTED|Overall Study||9||
59497883|NCT00460421|75588854|FG000|COMPLETED|Overall Study||9||
59497884|NCT00460421|75588855|FG001|COMPLETED|Overall Study||9||
59497885|NCT00460421|75588856|FG002|COMPLETED|Overall Study||9||
59497886|NCT00460421|75588854|FG000|NOT COMPLETED|Overall Study||0||
59497887|NCT00460421|75588855|FG001|NOT COMPLETED|Overall Study||0||
59497888|NCT00460421|75588856|FG002|NOT COMPLETED|Overall Study||0||
59497889|NCT00483223|75588863|FG000|STARTED|Overall Study||86||
59497890|NCT00483223|75588863|FG000|COMPLETED|Overall Study||86||
59497891|NCT00483223|75588863|FG000|NOT COMPLETED|Overall Study||0||
59497892|NCT01397084|75588867|FG000|STARTED|Overall Study||108||
59497893|NCT01397084|75588867|FG000|COMPLETED|Overall Study||100||
59497894|NCT01397084|75588867|FG000|NOT COMPLETED|Overall Study||8||
59497895|NCT00419315|75588873|FG000|STARTED|Overall Study||85||
59497896|NCT00419315|75588874|FG001|STARTED|Overall Study||78||
59497897|NCT00419315|75588873|FG000|COMPLETED|Overall Study||85||
59497898|NCT00419315|75588874|FG001|COMPLETED|Overall Study||78||
59497899|NCT00419315|75588873|FG000|NOT COMPLETED|Overall Study||0||
59497900|NCT00419315|75588874|FG001|NOT COMPLETED|Overall Study||0||
59497901|NCT00420017|75588882|FG000|STARTED|Overall Study||40||
59497902|NCT00420017|75588883|FG001|STARTED|Overall Study||40||
59497903|NCT00420017|75588882|FG000|COMPLETED|Overall Study|40 completed analysis|38||
59497904|NCT00420017|75588883|FG001|COMPLETED|Overall Study||40||
59497905|NCT00420017|75588882|FG000|NOT COMPLETED|Overall Study||2||
59497906|NCT00420017|75588883|FG001|NOT COMPLETED|Overall Study||0||
59497907|NCT00484393|75588891|FG000|STARTED|Overall Study||4||
59497908|NCT00484393|75588892|FG001|STARTED|Overall Study||3||
59497909|NCT00484393|75588891|FG000|COMPLETED|Overall Study||4||
59497910|NCT00484393|75588892|FG001|COMPLETED|Overall Study||3||
59497911|NCT00484393|75588891|FG000|NOT COMPLETED|Overall Study||0||
59497912|NCT00484393|75588892|FG001|NOT COMPLETED|Overall Study||0||
59497913|NCT00485485|75588898|FG000|STARTED|Overall Study||7||
59497914|NCT00485485|75588898|FG000|COMPLETED|Overall Study||7||
59497915|NCT00485485|75588898|FG000|NOT COMPLETED|Overall Study||0||
59497916|NCT00422201|75588902|FG000|STARTED|Overall Study||18||
59497917|NCT00422201|75588902|FG000|COMPLETED|Overall Study||7||
59497918|NCT00422201|75588902|FG000|NOT COMPLETED|Overall Study||11||
59497919|NCT01396148|75588907|FG000|STARTED|Overall Study||6||
59497920|NCT01396148|75588907|FG000|COMPLETED|Overall Study||5||
59497921|NCT01396148|75588907|FG000|NOT COMPLETED|Overall Study||1||
59497922|NCT00485953|75588915|FG000|STARTED|Overall Study||55||
59497923|NCT00485953|75588916|FG001|STARTED|Overall Study||54||
59497924|NCT00485953|75588915|FG000|COMPLETED|Overall Study||48||
59497925|NCT00485953|75588916|FG001|COMPLETED|Overall Study||47||
59497926|NCT00485953|75588915|FG000|NOT COMPLETED|Overall Study||7||
59497927|NCT00485953|75588916|FG001|NOT COMPLETED|Overall Study||7||
59497928|NCT00422279|75588926|FG000|STARTED|Overall Study||2||
59497929|NCT00422279|75588927|FG001|STARTED|Overall Study||2||
59497930|NCT00422279|75588926|FG000|24 Month After Loading Period|Overall Study||2||
59497931|NCT00422279|75588927|FG001|24 Month After Loading Period|Overall Study||2||
59497932|NCT00422279|75588926|FG000|COMPLETED|Overall Study||2||
59497933|NCT00422279|75588927|FG001|COMPLETED|Overall Study||2||
59497934|NCT00422279|75588926|FG000|NOT COMPLETED|Overall Study||0||
59497935|NCT00422279|75588927|FG001|NOT COMPLETED|Overall Study||0||
59497936|NCT00486031|75588935|FG000|STARTED|Overall Study||443||
59497937|NCT00486031|75588935|FG000|COMPLETED|Overall Study||440||
59497938|NCT00486031|75588935|FG000|NOT COMPLETED|Overall Study||3||
59497939|NCT01396070|75588940|FG000|STARTED|Overall Study||36||
59497940|NCT01396070|75588940|FG000|COMPLETED|Overall Study||17||
59497941|NCT01396070|75588940|FG000|NOT COMPLETED|Overall Study||19||
59497942|NCT02108171|75588947|FG000|STARTED|Overall Study||40||
59497943|NCT02108171|75588948|FG001|STARTED|Overall Study||41||
59497944|NCT02108171|75588947|FG000|COMPLETED|Overall Study||40||
59497945|NCT02108171|75588948|FG001|COMPLETED|Overall Study||41||
59497946|NCT02108171|75588947|FG000|NOT COMPLETED|Overall Study||0||
59497947|NCT02108171|75588948|FG001|NOT COMPLETED|Overall Study||0||
59497948|NCT01395914|75588957|FG000|STARTED|Overall Study||345||
59497949|NCT01395914|75588958|FG001|STARTED|Overall Study||168||
59497950|NCT01395914|75588957|FG000|ITT Population|Overall Study||345||
59497951|NCT01395914|75588958|FG001|ITT Population|Overall Study||168||
59497952|NCT01395914|75588957|FG000|Safety Population|Overall Study||343||
59497953|NCT01395914|75588958|FG001|Safety Population|Overall Study||167||
59497954|NCT01395914|75588957|FG000|COMPLETED|Overall Study||273||
59497955|NCT01395914|75588958|FG001|COMPLETED|Overall Study||131||
59497956|NCT01395914|75588957|FG000|NOT COMPLETED|Overall Study||72||
59497957|NCT01395914|75588958|FG001|NOT COMPLETED|Overall Study||37||
59497958|NCT00534235|75588966|FG000|STARTED|Overall Study||107||
59497959|NCT00534235|75588967|FG001|STARTED|Overall Study||215||
59497960|NCT00534235|75588966|FG000|COMPLETED|Overall Study||91||
59497961|NCT00534235|75588967|FG001|COMPLETED|Overall Study||192||
59497962|NCT00534235|75588966|FG000|NOT COMPLETED|Overall Study||16||
59497963|NCT00534235|75588967|FG001|NOT COMPLETED|Overall Study||23||
59497964|NCT00534937|75588976|FG000|STARTED|Overall Study||42||
59497965|NCT00534937|75588977|FG001|STARTED|Overall Study||47||
59497966|NCT00534937|75588976|FG000|COMPLETED|Overall Study||34||
59497967|NCT00534937|75588977|FG001|COMPLETED|Overall Study||35||
59497968|NCT00534937|75588976|FG000|NOT COMPLETED|Overall Study||8||
59497969|NCT00534937|75588977|FG001|NOT COMPLETED|Overall Study||12||
59497970|NCT00461045|75588985|FG000|STARTED|Overall Study||15||
59497971|NCT00461045|75588985|FG000|COMPLETED|Overall Study||15||
59497972|NCT00461045|75588985|FG000|NOT COMPLETED|Overall Study||0||
59497973|NCT00535873|75588989|FG000|STARTED|Overall Study||60||
59497974|NCT00535873|75588989|FG000|COMPLETED|Overall Study||60||
59497975|NCT00535873|75588989|FG000|NOT COMPLETED|Overall Study||0||
59497976|NCT00461513|75588995|FG000|STARTED|Overall Study|6 patients dropped at time of randomization|187||
59497977|NCT00461513|75588996|FG001|STARTED|Overall Study|2 patients dropped at time of randomization|197||
59497978|NCT00461513|75588995|FG000|COMPLETED|Overall Study||165||
59497979|NCT00461513|75588996|FG001|COMPLETED|Overall Study||172||
59497980|NCT00461513|75588995|FG000|NOT COMPLETED|Overall Study||22||
59497981|NCT00461513|75588996|FG001|NOT COMPLETED|Overall Study||25||
59497982|NCT00487669|75589006|FG000|STARTED|Overall Study||12||
59497983|NCT00487669|75589006|FG000|COMPLETED|Overall Study||12||
59497984|NCT00487669|75589006|FG000|NOT COMPLETED|Overall Study||0||
59497985|NCT00488059|75589012|FG000|STARTED|Phase I: ENF 90mg SC BID||29||
59607202|NCT02656199|75717746|FG000|COMPLETED|Overall Study|0 analyzed.PI left the institution.Effort to contact PI unsuccessful.No study data available|0||
59607203|NCT02656199|75717746|FG000|NOT COMPLETED|Overall Study||0||
59497986|NCT00488059|75589013|FG001|STARTED|Phase I: ENF 90mg SC BID||0||
59497987|NCT00488059|75589014|FG002|STARTED|Phase I: ENF 90mg SC BID||0||
59497988|NCT00488059|75589012|FG000|COMPLETED|Phase I: ENF 90mg SC BID||14||
59497989|NCT00488059|75589013|FG001|COMPLETED|Phase I: ENF 90mg SC BID||0||
59497990|NCT00488059|75589014|FG002|COMPLETED|Phase I: ENF 90mg SC BID||0||
59497991|NCT00488059|75589012|FG000|NOT COMPLETED|Phase I: ENF 90mg SC BID||15||
59497992|NCT00488059|75589013|FG001|NOT COMPLETED|Phase I: ENF 90mg SC BID||0||
59497993|NCT00488059|75589014|FG002|NOT COMPLETED|Phase I: ENF 90mg SC BID||0||
59497994|NCT00488059|75589012|FG000|STARTED|Phase II Arm A:Phase I Then ENF 90mg BID||0||
59497995|NCT00488059|75589013|FG001|STARTED|Phase II Arm A:Phase I Then ENF 90mg BID||9||
59497996|NCT00488059|75589014|FG002|STARTED|Phase II Arm A:Phase I Then ENF 90mg BID||0||
59497997|NCT00488059|75589012|FG000|COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||0||
59497998|NCT00488059|75589013|FG001|COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||7||
59497999|NCT00488059|75589014|FG002|COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||0||
59498000|NCT00488059|75589012|FG000|NOT COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||0||
59607204|NCT03845933|75717752|FG000|STARTED|Overall Study||131||
59498001|NCT00488059|75589013|FG001|NOT COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||2||
59498002|NCT00488059|75589014|FG002|NOT COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||0||
59498003|NCT00488059|75589012|FG000|STARTED|Phase II Arm B:Phase I Then ENF 180mg QD||0||
59498004|NCT00488059|75589013|FG001|STARTED|Phase II Arm B:Phase I Then ENF 180mg QD||0||
59518984|NCT03587428|75612875|FG005|STARTED|Period 1||2||
59607205|NCT03845933|75717753|FG001|STARTED|Overall Study||131||
59607206|NCT03845933|75717752|FG000|COMPLETED|Overall Study||131||
59607207|NCT03845933|75717753|FG001|COMPLETED|Overall Study||131||
59607208|NCT03845933|75717752|FG000|NOT COMPLETED|Overall Study||0||
59607209|NCT03845933|75717753|FG001|NOT COMPLETED|Overall Study||0||
59607210|NCT03817775|75717761|FG000|STARTED|Overall Study||22||
59607211|NCT03817775|75717762|FG001|STARTED|Overall Study||54||
59607212|NCT03817775|75717761|FG000|COMPLETED|Overall Study||22||
59607213|NCT03817775|75717762|FG001|COMPLETED|Overall Study||54||
59607214|NCT03817775|75717761|FG000|NOT COMPLETED|Overall Study||0||
59498005|NCT00488059|75589014|FG002|STARTED|Phase II Arm B:Phase I Then ENF 180mg QD||5||
59498006|NCT00488059|75589012|FG000|COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||0||
59498007|NCT00488059|75589013|FG001|COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||0||
59498008|NCT00488059|75589014|FG002|COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||1||
59498009|NCT00488059|75589012|FG000|NOT COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||0||
59498010|NCT00488059|75589013|FG001|NOT COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||0||
59498011|NCT00488059|75589014|FG002|NOT COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||4||
59498012|NCT02124889|75589029|FG000|STARTED|Overall Study||12||
59498013|NCT02124889|75589030|FG001|STARTED|Overall Study||12||
59498014|NCT02124889|75589029|FG000|COMPLETED|Overall Study||12||
59498015|NCT02124889|75589030|FG001|COMPLETED|Overall Study||12||
59498016|NCT02124889|75589029|FG000|NOT COMPLETED|Overall Study||0||
59498017|NCT02124889|75589030|FG001|NOT COMPLETED|Overall Study||0||
59498018|NCT02319967|75589039|FG000|STARTED|Overall Study||126||
59498019|NCT02319967|75589040|FG001|STARTED|Overall Study||126||
59498020|NCT02319967|75589041|FG002|STARTED|Overall Study||121||
59498021|NCT02319967|75589039|FG000|COMPLETED|Overall Study||78||
59498022|NCT02319967|75589040|FG001|COMPLETED|Overall Study||82||
59498023|NCT02319967|75589041|FG002|COMPLETED|Overall Study||76||
59498024|NCT02319967|75589039|FG000|NOT COMPLETED|Overall Study||48||
59498025|NCT02319967|75589040|FG001|NOT COMPLETED|Overall Study||44||
59498026|NCT02319967|75589041|FG002|NOT COMPLETED|Overall Study||45||
59498027|NCT02120443|75589049|FG000|STARTED|Overall Study||43||
59498028|NCT02120443|75589049|FG000|COMPLETED|Overall Study||43||
59498029|NCT02120443|75589049|FG000|NOT COMPLETED|Overall Study||0||
59498030|NCT00536341|75589055|FG000|STARTED|Overall Study||10||
59498031|NCT00536341|75589056|FG001|STARTED|Overall Study||54||
59498032|NCT00536341|75589055|FG000|COMPLETED|Overall Study||5||
59498033|NCT00536341|75589056|FG001|COMPLETED|Overall Study||43||
59498034|NCT00536341|75589055|FG000|NOT COMPLETED|Overall Study||5||
59498035|NCT00536341|75589056|FG001|NOT COMPLETED|Overall Study||11||
59498036|NCT02122471|75589066|FG000|STARTED|Overall Study||445||
59498037|NCT02122471|75589067|FG001|STARTED|Overall Study||443||
59498038|NCT02122471|75589068|FG002|STARTED|Overall Study||449||
59498039|NCT02122471|75589066|FG000|COMPLETED|Overall Study||406||
59498040|NCT02122471|75589067|FG001|COMPLETED|Overall Study||392||
59498041|NCT02122471|75589068|FG002|COMPLETED|Overall Study||405||
59498042|NCT02122471|75589066|FG000|NOT COMPLETED|Overall Study||39||
59498043|NCT02122471|75589067|FG001|NOT COMPLETED|Overall Study||51||
59498044|NCT02122471|75589068|FG002|NOT COMPLETED|Overall Study||44||
59498045|NCT00461591|75589079|FG000|STARTED|Overall Study||406||
59498046|NCT00461591|75589080|FG001|STARTED|Overall Study||396||
59498047|NCT00461591|75589079|FG000|COMPLETED|Overall Study||317||
59498048|NCT00461591|75589080|FG001|COMPLETED|Overall Study||311||
59498049|NCT00461591|75589079|FG000|NOT COMPLETED|Overall Study||89||
59498050|NCT00461591|75589080|FG001|NOT COMPLETED|Overall Study||85||
59498051|NCT00462449|75589088|FG000|STARTED|Overall Study||13||
59498052|NCT00462449|75589089|FG001|STARTED|Overall Study||10||
59498053|NCT00462449|75589088|FG000|COMPLETED|Overall Study||13||
59498054|NCT00462449|75589089|FG001|COMPLETED|Overall Study||10||
59498055|NCT00462449|75589088|FG000|NOT COMPLETED|Overall Study||0||
59498056|NCT00462449|75589089|FG001|NOT COMPLETED|Overall Study||0||
59498057|NCT00534209|75589095|FG000|STARTED|Overall Study||1||
59498058|NCT00534209|75589095|FG000|COMPLETED|Overall Study||1||
59498059|NCT00534209|75589095|FG000|NOT COMPLETED|Overall Study||0||
59498060|NCT00534365|75589103|FG000|STARTED|Overall Study||127||
59498061|NCT00534365|75589104|FG001|STARTED|Overall Study||136||
59498062|NCT00534365|75589103|FG000|Received Procedure|Overall Study||127||
59498063|NCT00534365|75589104|FG001|Received Procedure|Overall Study|7 patients excluded due to receipt of sling other than mini-sling|129||
59498064|NCT00534365|75589103|FG000|Any Follow up|Overall Study||126||
59498065|NCT00534365|75589104|FG001|Any Follow up|Overall Study||135||
59498066|NCT00534365|75589103|FG000|Follow up at 12 Months or More|Overall Study||119||
59498067|NCT00534365|75589104|FG001|Follow up at 12 Months or More|Overall Study||128||
59498068|NCT00534365|75589103|FG000|Included in Intent to Treat Analysis|Overall Study||127||
59607215|NCT03817775|75717762|FG001|NOT COMPLETED|Overall Study||0||
59498069|NCT00534365|75589104|FG001|Included in Intent to Treat Analysis|Overall Study||136||
59498070|NCT00534365|75589103|FG000|COMPLETED|Overall Study||127|Included in per protocol|
59498071|NCT00534365|75589104|FG001|COMPLETED|Overall Study||129|Included in per protocol|
59498072|NCT00534365|75589103|FG000|NOT COMPLETED|Overall Study||0||
59498073|NCT00534365|75589104|FG001|NOT COMPLETED|Overall Study||7||
59498074|NCT00423683|75589114|FG000|STARTED|Overall Study||31||
59498075|NCT00423683|75589115|FG001|STARTED|Overall Study||33||
59498076|NCT00423683|75589114|FG000|COMPLETED|Overall Study||30||
59498077|NCT00423683|75589115|FG001|COMPLETED|Overall Study||33||
59498078|NCT00423683|75589114|FG000|NOT COMPLETED|Overall Study||1||
59498079|NCT00423683|75589115|FG001|NOT COMPLETED|Overall Study||0||
59498080|NCT00424619|75589126|FG000|STARTED|Baseline||22||
59498081|NCT00424619|75589127|FG001|STARTED|Baseline||22||
59498082|NCT00424619|75589128|FG002|STARTED|Baseline|n=21 but one participant was lost as a screen failure|21||
59498083|NCT00424619|75589126|FG000|COMPLETED|Baseline||22||
59607216|NCT01169753|75717770|FG000|STARTED|Overall Study||0||
60012545|NCT04478266|76128526|FG001|NOT COMPLETED|Overall Study||534||
59498084|NCT00424619|75589127|FG001|COMPLETED|Baseline||22||
59498085|NCT00424619|75589128|FG002|COMPLETED|Baseline||20||
59498086|NCT00424619|75589126|FG000|NOT COMPLETED|Baseline||0||
59498087|NCT00424619|75589127|FG001|NOT COMPLETED|Baseline||0||
59498088|NCT00424619|75589128|FG002|NOT COMPLETED|Baseline||1||
59498089|NCT00424619|75589126|FG000|STARTED|4 Week||18||
59498090|NCT00424619|75589127|FG001|STARTED|4 Week||17||
59498091|NCT00424619|75589128|FG002|STARTED|4 Week||17||
60012546|NCT04233216|76128538|FG000|STARTED|Overall Study||7||
60012547|NCT04233216|76128539|FG001|STARTED|Overall Study||14||
60012548|NCT04233216|76128540|FG002|STARTED|Overall Study||7||
60012549|NCT04233216|76128541|FG003|STARTED|Overall Study||7||
59498092|NCT00424619|75589126|FG000|COMPLETED|4 Week||18||
60012550|NCT04233216|76128538|FG000|COMPLETED|Overall Study||0||
60012551|NCT04233216|76128539|FG001|COMPLETED|Overall Study||0||
60012552|NCT04233216|76128540|FG002|COMPLETED|Overall Study||0||
59498093|NCT00424619|75589127|FG001|COMPLETED|4 Week||17||
59498094|NCT00424619|75589128|FG002|COMPLETED|4 Week||17||
59498095|NCT00424619|75589126|FG000|NOT COMPLETED|4 Week||0||
60012553|NCT04233216|76128541|FG003|COMPLETED|Overall Study||0||
60012554|NCT04233216|76128538|FG000|NOT COMPLETED|Overall Study||7||
60012555|NCT04233216|76128539|FG001|NOT COMPLETED|Overall Study||14||
60012556|NCT04233216|76128540|FG002|NOT COMPLETED|Overall Study||7||
59498096|NCT00424619|75589127|FG001|NOT COMPLETED|4 Week||0||
59498097|NCT00424619|75589128|FG002|NOT COMPLETED|4 Week||0||
59498098|NCT00424619|75589126|FG000|STARTED|3 Month||12||
59498099|NCT00424619|75589127|FG001|STARTED|3 Month||18||
59885139|NCT03548415|76007942|FG002|STARTED|Overall Study||11||
59885140|NCT03548415|76007943|FG003|STARTED|Overall Study||2||
59885141|NCT03548415|76007944|FG004|STARTED|Overall Study||6||
59885142|NCT03548415|76007940|FG000|Per-Protocol Set|Overall Study||12|The Per-Protocol Set included all randomized participants who received at least 5 of the 6 doses of Study Drug and had at least one post-baseline efficacy or pharmacodynamic assessment, with the first 3 doses administered on schedule, and had no significant protocol deviations that would have been expected to affect efficacy.|
59885143|NCT03548415|76007941|FG001|Per-Protocol Set|Overall Study||11|The Per-Protocol Set included all randomized participants who received at least 5 of the 6 doses of Study Drug and had at least one post-baseline efficacy or pharmacodynamic assessment, with the first 3 doses administered on schedule, and had no significant protocol deviations that would have been expected to affect efficacy.|
59885144|NCT03548415|76007942|FG002|Per-Protocol Set|Overall Study||11|The Per-Protocol Set included all randomized participants who received at least 5 of the 6 doses of Study Drug and had at least one post-baseline efficacy or pharmacodynamic assessment, with the first 3 doses administered on schedule, and had no significant protocol deviations that would have been expected to affect efficacy.|
59885145|NCT03548415|76007943|FG003|Per-Protocol Set|Overall Study||2|The Per-Protocol Set included all randomized participants who received at least 5 of the 6 doses of Study Drug and had at least one post-baseline efficacy or pharmacodynamic assessment, with the first 3 doses administered on schedule, and had no significant protocol deviations that would have been expected to affect efficacy.|
59885146|NCT03548415|76007944|FG004|Per-Protocol Set|Overall Study||5|The Per-Protocol Set included all randomized participants who received at least 5 of the 6 doses of Study Drug and had at least one post-baseline efficacy or pharmacodynamic assessment, with the first 3 doses administered on schedule, and had no significant protocol deviations that would have been expected to affect efficacy.|
59885147|NCT03548415|76007940|FG000|COMPLETED|Overall Study||12||
59885148|NCT03548415|76007941|FG001|COMPLETED|Overall Study||11||
59885149|NCT03548415|76007942|FG002|COMPLETED|Overall Study||11||
59885150|NCT03548415|76007943|FG003|COMPLETED|Overall Study||2||
59885151|NCT03548415|76007944|FG004|COMPLETED|Overall Study||5||
59885152|NCT03548415|76007940|FG000|NOT COMPLETED|Overall Study||0||
59885153|NCT03548415|76007941|FG001|NOT COMPLETED|Overall Study||1||
59885154|NCT03548415|76007942|FG002|NOT COMPLETED|Overall Study||0||
59885155|NCT03548415|76007943|FG003|NOT COMPLETED|Overall Study||0||
59885156|NCT03548415|76007944|FG004|NOT COMPLETED|Overall Study||1||
59885157|NCT00112385|76007960|FG000|STARTED|Overall Study||11||
59885158|NCT00112385|76007961|FG001|STARTED|Overall Study||5||
59885159|NCT00112385|76007960|FG000|COMPLETED|Overall Study||10||
59885160|NCT00112385|76007961|FG001|COMPLETED|Overall Study||4||
59885161|NCT00112385|76007960|FG000|NOT COMPLETED|Overall Study||1||
59885162|NCT00112385|76007961|FG001|NOT COMPLETED|Overall Study||1||
59885163|NCT03548337|76007969|FG000|STARTED|Infant Series||151||
59885164|NCT03548337|76007970|FG001|STARTED|Infant Series||150||
59885165|NCT03548337|76007969|FG000|Vaccination 1|Infant Series||150||
59885166|NCT03548337|76007970|FG001|Vaccination 1|Infant Series||150||
59885167|NCT03548337|76007969|FG000|Vaccination 2|Infant Series||144||
59885168|NCT03548337|76007970|FG001|Vaccination 2|Infant Series||144||
59885169|NCT03548337|76007969|FG000|Vaccination 3|Infant Series||144||
59885170|NCT03548337|76007970|FG001|Vaccination 3|Infant Series||141||
59498100|NCT00424619|75589128|FG002|STARTED|3 Month||17||
59498101|NCT00424619|75589126|FG000|COMPLETED|3 Month||12||
59498102|NCT00424619|75589127|FG001|COMPLETED|3 Month||18||
59754747|NCT03889418|75873588|FG008|NOT COMPLETED|April - June 2020 (Month 13-15)||0||0
59754748|NCT03889418|75873589|FG009|NOT COMPLETED|April - June 2020 (Month 13-15)||0||0
59754749|NCT03889418|75873580|FG000|STARTED|July 2020 - January 2022 (Month 16-28)||101||1
59754750|NCT03889418|75873581|FG001|STARTED|July 2020 - January 2022 (Month 16-28)||112||1
59754751|NCT03889418|75873582|FG002|STARTED|July 2020 - January 2022 (Month 16-28)||67||1
59754752|NCT03889418|75873583|FG003|STARTED|July 2020 - January 2022 (Month 16-28)||52||1
59754753|NCT03889418|75873584|FG004|STARTED|July 2020 - January 2022 (Month 16-28)||21||1
59754754|NCT03889418|75873585|FG005|STARTED|July 2020 - January 2022 (Month 16-28)||6||1
59754755|NCT03889418|75873586|FG006|STARTED|July 2020 - January 2022 (Month 16-28)||24||1
59754756|NCT03889418|75873587|FG007|STARTED|July 2020 - January 2022 (Month 16-28)||21||1
59754757|NCT03889418|75873588|FG008|STARTED|July 2020 - January 2022 (Month 16-28)||23||1
59754758|NCT03889418|75873589|FG009|STARTED|July 2020 - January 2022 (Month 16-28)||42||1
59754759|NCT03889418|75873580|FG000|COMPLETED|July 2020 - January 2022 (Month 16-28)||100||1
59754760|NCT03889418|75873581|FG001|COMPLETED|July 2020 - January 2022 (Month 16-28)||108||1
59754761|NCT03889418|75873582|FG002|COMPLETED|July 2020 - January 2022 (Month 16-28)||63||1
59754762|NCT03889418|75873583|FG003|COMPLETED|July 2020 - January 2022 (Month 16-28)||50||1
59754763|NCT03889418|75873584|FG004|COMPLETED|July 2020 - January 2022 (Month 16-28)||21||1
59754764|NCT03889418|75873585|FG005|COMPLETED|July 2020 - January 2022 (Month 16-28)||6||1
59754765|NCT03889418|75873586|FG006|COMPLETED|July 2020 - January 2022 (Month 16-28)||24||1
59754766|NCT03889418|75873587|FG007|COMPLETED|July 2020 - January 2022 (Month 16-28)||19||1
59754767|NCT03889418|75873588|FG008|COMPLETED|July 2020 - January 2022 (Month 16-28)||23||1
59498103|NCT00424619|75589128|FG002|COMPLETED|3 Month||17||
59498104|NCT00424619|75589126|FG000|NOT COMPLETED|3 Month||0||
59754768|NCT03889418|75873589|FG009|COMPLETED|July 2020 - January 2022 (Month 16-28)||38||1
59754769|NCT03889418|75873580|FG000|NOT COMPLETED|July 2020 - January 2022 (Month 16-28)||1||0
59754770|NCT03889418|75873581|FG001|NOT COMPLETED|July 2020 - January 2022 (Month 16-28)||4||0
59754771|NCT03889418|75873582|FG002|NOT COMPLETED|July 2020 - January 2022 (Month 16-28)||4||0
59754772|NCT03889418|75873583|FG003|NOT COMPLETED|July 2020 - January 2022 (Month 16-28)||2||0
59754773|NCT03889418|75873584|FG004|NOT COMPLETED|July 2020 - January 2022 (Month 16-28)||0||0
59754774|NCT03889418|75873585|FG005|NOT COMPLETED|July 2020 - January 2022 (Month 16-28)||0||0
59754775|NCT03889418|75873586|FG006|NOT COMPLETED|July 2020 - January 2022 (Month 16-28)||0||0
59754776|NCT03889418|75873587|FG007|NOT COMPLETED|July 2020 - January 2022 (Month 16-28)||2||0
59754777|NCT03889418|75873588|FG008|NOT COMPLETED|July 2020 - January 2022 (Month 16-28)||0||0
59754778|NCT03889418|75873589|FG009|NOT COMPLETED|July 2020 - January 2022 (Month 16-28)||4||0
59754779|NCT03749109|75873599|FG000|STARTED|Overall Study||35||
59754780|NCT03749109|75873600|FG001|STARTED|Overall Study||32||
59754781|NCT03749109|75873599|FG000|COMPLETED|Overall Study||33||
59754782|NCT03749109|75873600|FG001|COMPLETED|Overall Study||32||
59754783|NCT03749109|75873599|FG000|NOT COMPLETED|Overall Study||2||
59754784|NCT03749109|75873600|FG001|NOT COMPLETED|Overall Study||0||
59754785|NCT03709706|75873609|FG000|STARTED|Overall Study||20||
59754786|NCT03709706|75873610|FG001|STARTED|Overall Study||14||
59762566|NCT00534313|75882339|FG002|STARTED|Long-term Period||43||
59498105|NCT00424619|75589127|FG001|NOT COMPLETED|3 Month||0||
59498106|NCT00424619|75589128|FG002|NOT COMPLETED|3 Month||0||
59498107|NCT00425477|75589136|FG000|STARTED|Overall Study||26||
59498108|NCT00425477|75589136|FG000|COMPLETED|Overall Study||13||
59498109|NCT00425477|75589136|FG000|NOT COMPLETED|Overall Study||13||
59498110|NCT00427037|75589142|FG000|STARTED|Overall Study||17||
59498111|NCT00427037|75589143|FG001|STARTED|Overall Study||17||
59498112|NCT00427037|75589142|FG000|COMPLETED|Overall Study||10||
59498113|NCT00427037|75589143|FG001|COMPLETED|Overall Study||10||
59498114|NCT00427037|75589142|FG000|NOT COMPLETED|Overall Study||7||
59498115|NCT00427037|75589143|FG001|NOT COMPLETED|Overall Study||7||
59498116|NCT02113241|75589153|FG000|STARTED|Overall Study||12||
59498117|NCT02113241|75589154|FG001|STARTED|Overall Study||12||
59498118|NCT02113241|75589153|FG000|COMPLETED|Overall Study||12||
59498119|NCT02113241|75589154|FG001|COMPLETED|Overall Study||11||
59498120|NCT02113241|75589153|FG000|NOT COMPLETED|Overall Study||0||
59754787|NCT03709706|75873609|FG000|Intent-to-Treat (ITT) Population|Overall Study||20|Intent-to-Treat population includes all participants who started the leukapheresis procedure.|
59754788|NCT03709706|75873610|FG001|Intent-to-Treat (ITT) Population|Overall Study||14|Intent-to-Treat population includes all participants who started the leukapheresis procedure.|
59754789|NCT03709706|75873609|FG000|Modified - Intent to Treat Population|Overall Study||7|Includes all participants in ITT population who received Lete-cel infusion.|
59754790|NCT03709706|75873610|FG001|Modified - Intent to Treat Population|Overall Study||6|Includes all participants in ITT population who received Lete-cel infusion.|
59498121|NCT02113241|75589154|FG001|NOT COMPLETED|Overall Study||1||
59498122|NCT00427661|75589160|FG000|STARTED|Overall Study||8||
59498123|NCT00427661|75589160|FG000|COMPLETED|Overall Study||8||
59498124|NCT00427661|75589160|FG000|NOT COMPLETED|Overall Study||0||
59498125|NCT00427973|75589165|FG000|STARTED|Overall Study||17||
59498126|NCT00427973|75589165|FG000|COMPLETED|Overall Study||17||
59498127|NCT00427973|75589165|FG000|NOT COMPLETED|Overall Study||0||
59498128|NCT00429143|75589169|FG000|STARTED|Overall Study||27||
59498129|NCT00429143|75589169|FG000|COMPLETED|Overall Study||27||
59498130|NCT00429143|75589169|FG000|NOT COMPLETED|Overall Study||0||
59498131|NCT00430625|75589175|FG000|STARTED|Overall Study||13||
59498132|NCT00430625|75589176|FG001|STARTED|Overall Study||12||
59498133|NCT00430625|75589175|FG000|COMPLETED|Overall Study||13||
59498134|NCT00430625|75589176|FG001|COMPLETED|Overall Study||12||
59498135|NCT00430625|75589175|FG000|NOT COMPLETED|Overall Study||0||
59498136|NCT00430625|75589176|FG001|NOT COMPLETED|Overall Study||0||
59498137|NCT00432341|75589185|FG000|STARTED|Overall Study||24||
59498138|NCT00432341|75589186|FG001|STARTED|Overall Study||30||
59498139|NCT00432341|75589185|FG000|COMPLETED|Overall Study||24||
59498140|NCT00432341|75589186|FG001|COMPLETED|Overall Study||30||
59498141|NCT00432341|75589185|FG000|NOT COMPLETED|Overall Study||0||
59498142|NCT00432341|75589186|FG001|NOT COMPLETED|Overall Study||0||
59498143|NCT00433745|75589192|FG000|STARTED|Overall Study||4||
59498144|NCT00433745|75589192|FG000|COMPLETED|Overall Study||4||
59498145|NCT00433745|75589192|FG000|NOT COMPLETED|Overall Study||0||
59498146|NCT01395758|75589199|FG000|STARTED|Open-label Treatment Period||51||
59498147|NCT01395758|75589200|FG001|STARTED|Open-label Treatment Period||45||
59498148|NCT01395758|75589201|FG002|STARTED|Open-label Treatment Period||0||
59498149|NCT01395758|75589199|FG000|COMPLETED|Open-label Treatment Period||47||
59498150|NCT01395758|75589200|FG001|COMPLETED|Open-label Treatment Period||45||
59607217|NCT01169753|75717771|FG001|STARTED|Overall Study||1||
59607218|NCT01169753|75717770|FG000|COMPLETED|Overall Study||0||
59498151|NCT01395758|75589201|FG002|COMPLETED|Open-label Treatment Period||0||
59498152|NCT01395758|75589199|FG000|NOT COMPLETED|Open-label Treatment Period||4||
59498153|NCT01395758|75589200|FG001|NOT COMPLETED|Open-label Treatment Period||0||
59607219|NCT01169753|75717771|FG001|COMPLETED|Overall Study||0||
59498154|NCT01395758|75589201|FG002|NOT COMPLETED|Open-label Treatment Period||0||
59498155|NCT01395758|75589199|FG000|STARTED|Crossover Period||0||
59498156|NCT01395758|75589200|FG001|STARTED|Crossover Period||0||
59498157|NCT01395758|75589201|FG002|STARTED|Crossover Period||26||
59498158|NCT01395758|75589199|FG000|COMPLETED|Crossover Period||0||
59498159|NCT01395758|75589200|FG001|COMPLETED|Crossover Period||0||
59498160|NCT01395758|75589201|FG002|COMPLETED|Crossover Period||26||
59498161|NCT01395758|75589199|FG000|NOT COMPLETED|Crossover Period||0||
59498162|NCT01395758|75589200|FG001|NOT COMPLETED|Crossover Period||0||
59498163|NCT01395758|75589201|FG002|NOT COMPLETED|Crossover Period||0||
59498164|NCT00462605|75589208|FG000|STARTED|Overall Study||24||
59498165|NCT00462605|75589208|FG000|COMPLETED|Overall Study||10||
59498166|NCT00462605|75589208|FG000|NOT COMPLETED|Overall Study||14||
59498167|NCT02120287|75589212|FG000|STARTED|Overall Study||16||
59498168|NCT02120287|75589212|FG000|COMPLETED|Overall Study||16||
59498169|NCT02120287|75589212|FG000|NOT COMPLETED|Overall Study||0||
59498170|NCT00534833|75589218|FG000|STARTED|Overall Study||182||
59498171|NCT00534833|75589219|FG001|STARTED|Overall Study||180||
59498172|NCT00534833|75589218|FG000|COMPLETED|Overall Study||182||
59498173|NCT00534833|75589219|FG001|COMPLETED|Overall Study||180||
59498174|NCT00534833|75589218|FG000|NOT COMPLETED|Overall Study||0||
59607220|NCT01169753|75717770|FG000|NOT COMPLETED|Overall Study||0||
59498175|NCT00534833|75589219|FG001|NOT COMPLETED|Overall Study||0||
59498176|NCT00462839|75589229|FG000|STARTED|Viewed First||53||
59498177|NCT00462839|75589230|FG001|STARTED|Viewed First||53||
59498178|NCT00462839|75589229|FG000|COMPLETED|Viewed First||53||
59498179|NCT00462839|75589230|FG001|COMPLETED|Viewed First||53||
59498180|NCT00462839|75589229|FG000|NOT COMPLETED|Viewed First||0||
59498181|NCT00462839|75589230|FG001|NOT COMPLETED|Viewed First||0||
59498182|NCT00462839|75589229|FG000|STARTED|Viewed Second||53||
59498183|NCT00462839|75589230|FG001|STARTED|Viewed Second||53||
59498184|NCT00462839|75589229|FG000|COMPLETED|Viewed Second||53||
59498185|NCT00462839|75589230|FG001|COMPLETED|Viewed Second||53||
59498186|NCT00462839|75589229|FG000|NOT COMPLETED|Viewed Second||0||
59498187|NCT00462839|75589230|FG001|NOT COMPLETED|Viewed Second||0||
59498188|NCT00535301|75589238|FG000|STARTED|Overall Study||38||
59498189|NCT00535301|75589239|FG001|STARTED|Overall Study||38||
59498190|NCT00535301|75589238|FG000|COMPLETED|Overall Study||33||
59498191|NCT00535301|75589239|FG001|COMPLETED|Overall Study||33||
59498192|NCT00535301|75589238|FG000|NOT COMPLETED|Overall Study||5||
59498193|NCT00535301|75589239|FG001|NOT COMPLETED|Overall Study||5||
59498194|NCT00434993|75589249|FG000|STARTED|Overall Study||152||
59498195|NCT00434993|75589250|FG001|STARTED|Overall Study||130||
59498196|NCT00434993|75589249|FG000|COMPLETED|Overall Study||152||
59498197|NCT00434993|75589250|FG001|COMPLETED|Overall Study||130||
59498198|NCT00434993|75589249|FG000|NOT COMPLETED|Overall Study||0||
59498199|NCT00434993|75589250|FG001|NOT COMPLETED|Overall Study||0||
59498200|NCT01395524|75589259|FG000|STARTED|Overall Study||97||
59498201|NCT01395524|75589260|FG001|STARTED|Overall Study||99||
59498202|NCT01395524|75589261|FG002|STARTED|Overall Study||106||
59498203|NCT01395524|75589259|FG000|COMPLETED|Overall Study||79||
59498204|NCT01395524|75589260|FG001|COMPLETED|Overall Study||83||
59498205|NCT01395524|75589261|FG002|COMPLETED|Overall Study||89||
59498206|NCT01395524|75589259|FG000|NOT COMPLETED|Overall Study||18||
59498207|NCT01395524|75589260|FG001|NOT COMPLETED|Overall Study||16||
59498208|NCT01395524|75589261|FG002|NOT COMPLETED|Overall Study||17||
59498209|NCT01395368|75589269|FG000|STARTED|Overall Study||108||
59754791|NCT03709706|75873609|FG000|No Treatment|Overall Study||13|Participants who underwent leukapheresis but did not go on to receive lymphodepletion chemotherapy or Lete-cell infusion.|
60012557|NCT04233216|76128541|FG003|NOT COMPLETED|Overall Study||7||
60012558|NCT04173507|76128552|FG000|STARTED|Overall Study||42||
60012559|NCT04173507|76128552|FG000|COMPLETED|Overall Study||0||
60012560|NCT04173507|76128552|FG000|NOT COMPLETED|Overall Study||42||
60012561|NCT03971474|76128558|FG000|STARTED|Overall Study||67||
59498210|NCT01395368|75589269|FG000|COMPLETED|Overall Study||92||
59498211|NCT01395368|75589269|FG000|NOT COMPLETED|Overall Study||16||
59498212|NCT01394978|75589276|FG000|STARTED|Overall Study||168||
59498213|NCT01394978|75589277|FG001|STARTED|Overall Study||276||
59498214|NCT01394978|75589276|FG000|COMPLETED|Overall Study||147||
59498215|NCT01394978|75589277|FG001|COMPLETED|Overall Study||245||
59498216|NCT01394978|75589276|FG000|NOT COMPLETED|Overall Study||21||
59498217|NCT01394978|75589277|FG001|NOT COMPLETED|Overall Study||31||
59498218|NCT01394276|75589284|FG000|STARTED|Overall Study||322||
59498219|NCT01394276|75589284|FG000|COMPLETED|Overall Study||260||
59498220|NCT01394276|75589284|FG000|NOT COMPLETED|Overall Study||62||
59498221|NCT00435539|75589298|FG000|STARTED|Overall Study||12||
59498222|NCT00435539|75589299|FG001|STARTED|Overall Study||13||
59498223|NCT00435539|75589300|FG002|STARTED|Overall Study||11||
59498224|NCT00435539|75589301|FG003|STARTED|Overall Study||12||
59498225|NCT00435539|75589302|FG004|STARTED|Overall Study||12||
59498226|NCT00435539|75589298|FG000|COMPLETED|Overall Study||12||
59498227|NCT00435539|75589299|FG001|COMPLETED|Overall Study||13||
59498228|NCT00435539|75589300|FG002|COMPLETED|Overall Study||11||
59498229|NCT00435539|75589301|FG003|COMPLETED|Overall Study||12||
59498230|NCT00435539|75589302|FG004|COMPLETED|Overall Study||12||
59498231|NCT00435539|75589298|FG000|NOT COMPLETED|Overall Study||0||
59498232|NCT00435539|75589299|FG001|NOT COMPLETED|Overall Study||0||
59498233|NCT00435539|75589300|FG002|NOT COMPLETED|Overall Study||0||
59498234|NCT00435539|75589301|FG003|NOT COMPLETED|Overall Study||0||
59498235|NCT00435539|75589302|FG004|NOT COMPLETED|Overall Study||0||
59498236|NCT00462917|75589317|FG000|STARTED|Overall Study||72||
59498237|NCT00462917|75589318|FG001|STARTED|Overall Study||75||
59498238|NCT00462917|75589319|FG002|STARTED|Overall Study||66||
59498239|NCT00462917|75589320|FG003|STARTED|Overall Study||77||
59498240|NCT00462917|75589317|FG000|Met With Genetic Counselor|Overall Study||66||
59498241|NCT00462917|75589318|FG001|Met With Genetic Counselor|Overall Study||71||
59498242|NCT00462917|75589319|FG002|Met With Genetic Counselor|Overall Study||56||
59498243|NCT00462917|75589320|FG003|Met With Genetic Counselor|Overall Study||71||
59498244|NCT00462917|75589317|FG000|Received Risk Information|Overall Study||64||
59498245|NCT00462917|75589318|FG001|Received Risk Information|Overall Study||70||
59498246|NCT00462917|75589319|FG002|Received Risk Information|Overall Study||55||
59498247|NCT00462917|75589320|FG003|Received Risk Information|Overall Study||68||
59498248|NCT00462917|75589317|FG000|Completed 6 Week Follow-up|Overall Study||63||
59498249|NCT00462917|75589318|FG001|Completed 6 Week Follow-up|Overall Study||70||
59498250|NCT00462917|75589319|FG002|Completed 6 Week Follow-up|Overall Study||55||
59498251|NCT00462917|75589320|FG003|Completed 6 Week Follow-up|Overall Study||68||
59498252|NCT00462917|75589317|FG000|Completed 6 Month Follow-up|Overall Study||63||
59498253|NCT00462917|75589318|FG001|Completed 6 Month Follow-up|Overall Study||68||
59498254|NCT00462917|75589319|FG002|Completed 6 Month Follow-up|Overall Study||55||
59498255|NCT00462917|75589320|FG003|Completed 6 Month Follow-up|Overall Study||66||
59498256|NCT00462917|75589317|FG000|COMPLETED|Overall Study||62||
59498257|NCT00462917|75589318|FG001|COMPLETED|Overall Study||65||
59498258|NCT00462917|75589319|FG002|COMPLETED|Overall Study||54||
59498259|NCT00462917|75589320|FG003|COMPLETED|Overall Study||66||
59498260|NCT00462917|75589317|FG000|NOT COMPLETED|Overall Study||10||
59498261|NCT00462917|75589318|FG001|NOT COMPLETED|Overall Study||10||
59498262|NCT00462917|75589319|FG002|NOT COMPLETED|Overall Study||12||
59498263|NCT00462917|75589320|FG003|NOT COMPLETED|Overall Study||11||
59498264|NCT00464711|75589330|FG000|STARTED|Overall Study||40||
59498265|NCT00464711|75589330|FG000|COMPLETED|Overall Study||25||
59498266|NCT00464711|75589330|FG000|NOT COMPLETED|Overall Study||15||
59498267|NCT02078180|75589334|FG000|STARTED|Overall Study||34||
59498268|NCT02078180|75589334|FG000|IR75|Overall Study||30||
59498269|NCT02078180|75589334|FG000|IR100|Overall Study||31||
59498270|NCT02078180|75589334|FG000|SR100|Overall Study||31||
59498271|NCT02078180|75589334|FG000|SR150|Overall Study||32||
59498272|NCT02078180|75589334|FG000|XL 150|Overall Study||31||
59498273|NCT02078180|75589334|FG000|XL 300|Overall Study||32||
59498274|NCT02078180|75589334|FG000|COMPLETED|Overall Study||29||
59498275|NCT02078180|75589334|FG000|NOT COMPLETED|Overall Study||5||
59498276|NCT00535613|75589345|FG000|STARTED|Overall Study||49||
59498277|NCT00535613|75589346|FG001|STARTED|Overall Study||50||
59498278|NCT00535613|75589345|FG000|COMPLETED|Overall Study||49||
59498279|NCT00535613|75589346|FG001|COMPLETED|Overall Study||50||
59498280|NCT00535613|75589345|FG000|NOT COMPLETED|Overall Study||0||
59498281|NCT00535613|75589346|FG001|NOT COMPLETED|Overall Study||0||
59498282|NCT00535769|75589354|FG000|STARTED|Overall Study||35||
59498283|NCT00535769|75589355|FG001|STARTED|Overall Study||35||
59498284|NCT00535769|75589354|FG000|COMPLETED|Overall Study||35||
59498285|NCT00535769|75589355|FG001|COMPLETED|Overall Study||35||
59498286|NCT00535769|75589354|FG000|NOT COMPLETED|Overall Study||0||
59498287|NCT00535769|75589355|FG001|NOT COMPLETED|Overall Study||0||
59498288|NCT00466661|75589364|FG000|STARTED|Overall Study||16||
59498289|NCT00466661|75589365|FG001|STARTED|Overall Study||17||
59498290|NCT00466661|75589364|FG000|At Least 1 Postrandomization Visit|Overall Study||14|Defines modified Intention to Treat (mITT) sample|
59754792|NCT03709706|75873610|FG001|No Treatment|Overall Study||8|Participants who underwent leukapheresis but did not go on to receive lymphodepletion chemotherapy or Lete-cell infusion.|
59754793|NCT03709706|75873609|FG000|COMPLETED|Overall Study|Three participants died after Lete-cel infusion.|3|Participants who received Lete-cel infusion and were followed-up in this study until death or for 15 years after infusion, or until transfer to a separate long-term follow-up (LTFU) study and participants who completed the treatment but did not transfer to LTFU study because Protocol amendment 06 was not in place to allow the transfer, are considered to have completed the study.|
59762567|NCT00534313|75882340|FG003|STARTED|Long-term Period||33||
59762568|NCT00534313|75882337|FG000|COMPLETED|Long-term Period||0||
59762569|NCT00534313|75882338|FG001|COMPLETED|Long-term Period||0||
59762570|NCT00534313|75882339|FG002|COMPLETED|Long-term Period||0||
59762571|NCT00534313|75882340|FG003|COMPLETED|Long-term Period||0||
59762572|NCT00534313|75882337|FG000|NOT COMPLETED|Long-term Period||37||
59885171|NCT03548337|76007969|FG000|COMPLETED|Infant Series||139||
59885172|NCT03548337|76007970|FG001|COMPLETED|Infant Series||139||
59885173|NCT03548337|76007969|FG000|NOT COMPLETED|Infant Series||12||
59885174|NCT03548337|76007970|FG001|NOT COMPLETED|Infant Series||11||
59885175|NCT03548337|76007969|FG000|STARTED|Toddler Dose||139||
59885176|NCT03548337|76007970|FG001|STARTED|Toddler Dose||139||
59885177|NCT03548337|76007969|FG000|Vaccination 4|Toddler Dose||139||
59885178|NCT03548337|76007970|FG001|Vaccination 4|Toddler Dose||139||
59885179|NCT03548337|76007969|FG000|COMPLETED|Toddler Dose||138||
59885180|NCT03548337|76007970|FG001|COMPLETED|Toddler Dose||138||
59885181|NCT03548337|76007969|FG000|NOT COMPLETED|Toddler Dose||1||
59885182|NCT03548337|76007970|FG001|NOT COMPLETED|Toddler Dose||1||
59885183|NCT03596151|76007982|FG000|STARTED|Overall Study||295||
59885184|NCT03596151|76007982|FG000|COMPLETED|Overall Study||294||
59885185|NCT03596151|76007982|FG000|NOT COMPLETED|Overall Study||1||
59885186|NCT03547635|76007989|FG000|STARTED|Overall Study||41||
59885187|NCT03547635|76007990|FG001|STARTED|Overall Study||38||
59885188|NCT03547635|76007991|FG002|STARTED|Overall Study||37||
59885189|NCT03547635|76007989|FG000|COMPLETED|Overall Study||33||
59885190|NCT03547635|76007990|FG001|COMPLETED|Overall Study||31||
59885191|NCT03547635|76007991|FG002|COMPLETED|Overall Study||29||
59885192|NCT03547635|76007989|FG000|NOT COMPLETED|Overall Study||8||
59885193|NCT03547635|76007990|FG001|NOT COMPLETED|Overall Study||7||
59885194|NCT03547635|76007991|FG002|NOT COMPLETED|Overall Study||8||
59885195|NCT03133676|76008008|FG000|STARTED|Overall Study||6||
59885196|NCT03133676|76008009|FG001|STARTED|Overall Study||3||
59885197|NCT03133676|76008010|FG002|STARTED|Overall Study||3||
59885198|NCT03133676|76008011|FG003|STARTED|Overall Study||6||
60012562|NCT03971474|76128559|FG001|STARTED|Overall Study||69||
59885199|NCT03133676|76008012|FG004|STARTED|Overall Study||6||
59885200|NCT03133676|76008013|FG005|STARTED|Overall Study||9||
59885201|NCT03133676|76008014|FG006|STARTED|Overall Study||9||
59885202|NCT03133676|76008015|FG007|STARTED|Overall Study||9||
59885203|NCT03133676|76008016|FG008|STARTED|Overall Study||9||
59885204|NCT03133676|76008008|FG000|COMPLETED|Overall Study||6||
59885205|NCT03133676|76008009|FG001|COMPLETED|Overall Study||3||
60012563|NCT03971474|76128558|FG000|COMPLETED|Overall Study||0||
60012564|NCT03971474|76128559|FG001|COMPLETED|Overall Study||0||
60012565|NCT03971474|76128558|FG000|NOT COMPLETED|Overall Study||67||
60012566|NCT03971474|76128559|FG001|NOT COMPLETED|Overall Study||69||
60012567|NCT03901079|76128566|FG000|STARTED|Overall Study|There were 20 subjects enrolled totally.Due to the HGRAC approval letter expiration in August 2020 and cannot be extended on time，8 of the 20 subjects already enrolled were unable to complete the follow-up|20||
60012568|NCT03901079|76128566|FG000|COMPLETED|Overall Study||12||
60012569|NCT03901079|76128566|FG000|NOT COMPLETED|Overall Study||8||
60012570|NCT03845296|76128572|FG000|STARTED|Overall Study||25||
59885206|NCT03133676|76008010|FG002|COMPLETED|Overall Study||3||
59885207|NCT03133676|76008011|FG003|COMPLETED|Overall Study||6||
59885208|NCT03133676|76008012|FG004|COMPLETED|Overall Study||6||
59885209|NCT03133676|76008013|FG005|COMPLETED|Overall Study||9||
59885210|NCT03133676|76008014|FG006|COMPLETED|Overall Study||9||
59885211|NCT03133676|76008015|FG007|COMPLETED|Overall Study||9||
59885212|NCT03133676|76008016|FG008|COMPLETED|Overall Study||9||
59885213|NCT03133676|76008008|FG000|NOT COMPLETED|Overall Study||0||
59885214|NCT03133676|76008009|FG001|NOT COMPLETED|Overall Study||0||
59885215|NCT03133676|76008010|FG002|NOT COMPLETED|Overall Study||0||
59885216|NCT03133676|76008011|FG003|NOT COMPLETED|Overall Study||0||
59885217|NCT03133676|76008012|FG004|NOT COMPLETED|Overall Study||0||
59498291|NCT00466661|75589365|FG001|At Least 1 Postrandomization Visit|Overall Study||16|Defines modified Intention to Treat (mITT) sample|
59498292|NCT00466661|75589364|FG000|COMPLETED|Overall Study||12||
59498293|NCT00466661|75589365|FG001|COMPLETED|Overall Study||11||
59498294|NCT00466661|75589364|FG000|NOT COMPLETED|Overall Study||4||
59498295|NCT00466661|75589365|FG001|NOT COMPLETED|Overall Study||6||
59498296|NCT00535925|75589373|FG000|STARTED|Overall Study||188||
59498297|NCT00535925|75589374|FG001|STARTED|Overall Study||207||
59498298|NCT00535925|75589373|FG000|COMPLETED|Overall Study||169||
59498299|NCT00535925|75589374|FG001|COMPLETED|Overall Study||199||
59498300|NCT00535925|75589373|FG000|NOT COMPLETED|Overall Study||19||
59498301|NCT00535925|75589374|FG001|NOT COMPLETED|Overall Study||8||
59498302|NCT00211172|75589384|FG000|STARTED|Overall Study||449||
59498303|NCT00211172|75589385|FG001|STARTED|Overall Study||458||
59498304|NCT00211172|75589384|FG000|COMPLETED|Overall Study|39 patients died or lost health plan eligibility|410||
59498305|NCT00211172|75589385|FG001|COMPLETED|Overall Study|32 patients died or lost health plan eligibility|426||
59498306|NCT00211172|75589384|FG000|NOT COMPLETED|Overall Study||39||
59498307|NCT00211172|75589385|FG001|NOT COMPLETED|Overall Study||32||
59498308|NCT00537511|75589391|FG000|STARTED|Treatment Period (Combination)||22||
59498309|NCT00537511|75589391|FG000|Intent-to-Treat (ITT) Populaton|Treatment Period (Combination)|ITT = all participants enrolled in the study.|22||
59498310|NCT00537511|75589391|FG000|Safety Population|Treatment Period (Combination)|Safety = All participants who took ≥1 dose of study treatment.|22||
59498311|NCT00537511|75589391|FG000|COMPLETED|Treatment Period (Combination)||17||
59498312|NCT00537511|75589391|FG000|NOT COMPLETED|Treatment Period (Combination)||5||
59498313|NCT00537511|75589391|FG000|STARTED|Extension Period (Combination)||17||
59498314|NCT00537511|75589391|FG000|COMPLETED|Extension Period (Combination)||11||
59498315|NCT00537511|75589391|FG000|NOT COMPLETED|Extension Period (Combination)||6||
59498316|NCT00537511|75589391|FG000|STARTED|Recovery Period (Monotherapy)||11||
59498317|NCT00537511|75589391|FG000|COMPLETED|Recovery Period (Monotherapy)||3||
59498318|NCT00537511|75589391|FG000|NOT COMPLETED|Recovery Period (Monotherapy)||8||
59498319|NCT00537511|75589391|FG000|STARTED|Maintenance Phase (Monotherapy)||8||
59498320|NCT00537511|75589391|FG000|COMPLETED|Maintenance Phase (Monotherapy)||0||
59498321|NCT00537511|75589391|FG000|NOT COMPLETED|Maintenance Phase (Monotherapy)||8||
59498322|NCT00435929|75589410|FG000|STARTED|Overall Study||7||
59498323|NCT00435929|75589411|FG001|STARTED|Overall Study||9||
59498324|NCT00435929|75589410|FG000|COMPLETED|Overall Study||7||
59498325|NCT00435929|75589411|FG001|COMPLETED|Overall Study||9||
59498326|NCT00435929|75589410|FG000|NOT COMPLETED|Overall Study||0||
59498327|NCT00435929|75589411|FG001|NOT COMPLETED|Overall Study||0||
59498328|NCT00436475|75589421|FG000|STARTED|Overall Study||23||
59498329|NCT00436475|75589422|FG001|STARTED|Overall Study||23||
59498330|NCT00436475|75589423|FG002|STARTED|Overall Study||22||
59498331|NCT00436475|75589424|FG003|STARTED|Overall Study||24||
59498332|NCT00436475|75589421|FG000|COMPLETED|Overall Study||23||
59498333|NCT00436475|75589422|FG001|COMPLETED|Overall Study||22||
59498334|NCT00436475|75589423|FG002|COMPLETED|Overall Study||21||
59498335|NCT00436475|75589424|FG003|COMPLETED|Overall Study||22||
59498336|NCT00436475|75589421|FG000|NOT COMPLETED|Overall Study||0||
59498337|NCT00436475|75589422|FG001|NOT COMPLETED|Overall Study||1||
59498338|NCT00436475|75589423|FG002|NOT COMPLETED|Overall Study||1||
59498339|NCT00436475|75589424|FG003|NOT COMPLETED|Overall Study||2||
59498340|NCT00210626|75589436|FG000|STARTED|Overall Study||97||
59498341|NCT00210626|75589437|FG001|STARTED|Overall Study||95||
59498342|NCT00210626|75589436|FG000|COMPLETED|Overall Study||49||
59498343|NCT00210626|75589437|FG001|COMPLETED|Overall Study||50||
59498344|NCT00210626|75589436|FG000|NOT COMPLETED|Overall Study||48||
59498345|NCT00210626|75589437|FG001|NOT COMPLETED|Overall Study||45||
59498346|NCT00538213|75589446|FG000|STARTED|Overall Study||55||
59498347|NCT00538213|75589447|FG001|STARTED|Overall Study||40||
59498348|NCT00538213|75589448|FG002|STARTED|Overall Study||38||
59498349|NCT00538213|75589446|FG000|COMPLETED|Overall Study||55||
59498350|NCT00538213|75589447|FG001|COMPLETED|Overall Study||40||
59498351|NCT00538213|75589448|FG002|COMPLETED|Overall Study||38||
59498352|NCT00538213|75589446|FG000|NOT COMPLETED|Overall Study||0||
59498353|NCT00538213|75589447|FG001|NOT COMPLETED|Overall Study||0||
59498354|NCT00538213|75589448|FG002|NOT COMPLETED|Overall Study||0||
59498355|NCT00217022|75589459|FG000|STARTED|Overall Study||12||
59498356|NCT00217022|75589460|FG001|STARTED|Overall Study||4||
59498357|NCT00217022|75589459|FG000|COMPLETED|Overall Study||11||
59498358|NCT00217022|75589460|FG001|COMPLETED|Overall Study||3||
59498359|NCT00217022|75589459|FG000|NOT COMPLETED|Overall Study||1||
59498360|NCT00217022|75589460|FG001|NOT COMPLETED|Overall Study||1||
59498361|NCT00538759|75589468|FG000|STARTED|Overall Study||13||
59498362|NCT00538759|75589469|FG001|STARTED|Overall Study||8||
59498363|NCT00538759|75589468|FG000|COMPLETED|Overall Study||13||
59498364|NCT00538759|75589469|FG001|COMPLETED|Overall Study||8||
59498365|NCT00538759|75589468|FG000|NOT COMPLETED|Overall Study||0||
59498366|NCT00538759|75589469|FG001|NOT COMPLETED|Overall Study||0||
59498367|NCT00538915|75589475|FG000|STARTED|Overall Study||63||
59498368|NCT00538915|75589475|FG000|COMPLETED|Overall Study||52||
59498369|NCT00538915|75589475|FG000|NOT COMPLETED|Overall Study||11||
59498370|NCT00490009|75589479|FG000|STARTED|Overall Study||9||
59498371|NCT00490009|75589479|FG000|COMPLETED|Overall Study||9||
59498372|NCT00490009|75589479|FG000|NOT COMPLETED|Overall Study||0||
59498373|NCT00490477|75589486|FG000|STARTED|Overall Study||8||
59498374|NCT00490477|75589487|FG001|STARTED|Overall Study||8||
59498375|NCT00490477|75589486|FG000|COMPLETED|Overall Study||8||
59498376|NCT00490477|75589487|FG001|COMPLETED|Overall Study||8||
59498377|NCT00490477|75589486|FG000|NOT COMPLETED|Overall Study||0||
59498378|NCT00490477|75589487|FG001|NOT COMPLETED|Overall Study||0||
59498379|NCT00491491|75589495|FG000|STARTED|Overall Study||22||
59498380|NCT00491491|75589496|FG001|STARTED|Overall Study||21||
59498381|NCT00491491|75589495|FG000|COMPLETED|Overall Study||22||
59498382|NCT00491491|75589496|FG001|COMPLETED|Overall Study||21||
59498383|NCT00491491|75589495|FG000|NOT COMPLETED|Overall Study||0||
59498384|NCT00491491|75589496|FG001|NOT COMPLETED|Overall Study||0||
59498385|NCT00492583|75589504|FG000|STARTED|Overall Study||95||
59498386|NCT00492583|75589505|FG001|STARTED|Overall Study||87||
59498387|NCT00492583|75589504|FG000|COMPLETED|Overall Study||95||
59498388|NCT00492583|75589505|FG001|COMPLETED|Overall Study||87||
59498389|NCT00492583|75589504|FG000|NOT COMPLETED|Overall Study||0||
59498390|NCT00492583|75589505|FG001|NOT COMPLETED|Overall Study||0||
59498391|NCT00492973|75589513|FG000|STARTED|Overall Study||37||
59498392|NCT00492973|75589514|FG001|STARTED|Overall Study||39||
59498393|NCT00492973|75589513|FG000|COMPLETED|Overall Study||37||
59498394|NCT00492973|75589514|FG001|COMPLETED|Overall Study|One patient died of complications related to deep joint sepsis in the early postoperative period.|38||
59498395|NCT00492973|75589513|FG000|NOT COMPLETED|Overall Study||0||
59498396|NCT00492973|75589514|FG001|NOT COMPLETED|Overall Study||1||
59498397|NCT00494143|75589520|FG000|STARTED|Overall Study||1||
59498398|NCT00494143|75589521|FG001|STARTED|Overall Study||2||
59498399|NCT00494143|75589522|FG002|STARTED|Overall Study||3||
59498400|NCT00494143|75589523|FG003|STARTED|Overall Study||0||
60012571|NCT03845296|76128573|FG001|STARTED|Overall Study||34||
59498401|NCT00494143|75589524|FG004|STARTED|Overall Study||1||
59498402|NCT00494143|75589525|FG005|STARTED|Overall Study||0||
59498403|NCT00494143|75589520|FG000|COMPLETED|Overall Study||1||
59498404|NCT00494143|75589521|FG001|COMPLETED|Overall Study||2||
59498405|NCT00494143|75589522|FG002|COMPLETED|Overall Study||3||
59607221|NCT01169753|75717771|FG001|NOT COMPLETED|Overall Study||1||
59607222|NCT02654639|75717777|FG000|STARTED|Overall Study||4||
59607223|NCT02654639|75717777|FG000|COMPLETED|Overall Study||4||
59607224|NCT02654639|75717777|FG000|NOT COMPLETED|Overall Study||0||
59607225|NCT02634827|75717781|FG000|STARTED|Overall Study||1||
59607226|NCT02634827|75717781|FG000|COMPLETED|Overall Study||1||
59607227|NCT02634827|75717781|FG000|NOT COMPLETED|Overall Study||0||
59607228|NCT02506985|75717787|FG000|STARTED|Overall Study||4||
59607229|NCT02506985|75717788|FG001|STARTED|Overall Study||6||
59498406|NCT00494143|75589523|FG003|COMPLETED|Overall Study||0||
59498407|NCT00494143|75589524|FG004|COMPLETED|Overall Study||1||
59498408|NCT00494143|75589525|FG005|COMPLETED|Overall Study||0||
59498409|NCT00494143|75589520|FG000|NOT COMPLETED|Overall Study||0||
59498410|NCT00494143|75589521|FG001|NOT COMPLETED|Overall Study||0||
59498411|NCT00494143|75589522|FG002|NOT COMPLETED|Overall Study||0||
59498412|NCT00494143|75589523|FG003|NOT COMPLETED|Overall Study||0||
59498413|NCT00494143|75589524|FG004|NOT COMPLETED|Overall Study||0||
59498414|NCT00494143|75589525|FG005|NOT COMPLETED|Overall Study||0||
59498415|NCT00495079|75589537|FG000|STARTED|Overall Study||65||
59498416|NCT00495079|75589537|FG000|COMPLETED|Overall Study||65||
59498417|NCT00495079|75589537|FG000|NOT COMPLETED|Overall Study||0||
59498418|NCT00495157|75589547|FG000|STARTED|Overall Study||113||
59498419|NCT00495157|75589548|FG001|STARTED|Overall Study||115||
59498420|NCT00495157|75589549|FG002|STARTED|Overall Study||114||
59498421|NCT00495157|75589547|FG000|COMPLETED|Overall Study||97||
59498422|NCT00495157|75589548|FG001|COMPLETED|Overall Study||92||
59498423|NCT00495157|75589549|FG002|COMPLETED|Overall Study||101||
59498424|NCT00495157|75589547|FG000|NOT COMPLETED|Overall Study||16||
59498425|NCT00495157|75589548|FG001|NOT COMPLETED|Overall Study||23||
59498426|NCT00495157|75589549|FG002|NOT COMPLETED|Overall Study||13||
59498427|NCT00539539|75589559|FG000|STARTED|Overall Study||815||
59498428|NCT00539539|75589560|FG001|STARTED|Overall Study||771||
59498429|NCT00539539|75589559|FG000|COMPLETED|Overall Study||815||
59498430|NCT00539539|75589560|FG001|COMPLETED|Overall Study||771||
59498431|NCT00539539|75589559|FG000|NOT COMPLETED|Overall Study||0||
59498432|NCT00539539|75589560|FG001|NOT COMPLETED|Overall Study||0||
59498433|NCT00539695|75589566|FG000|STARTED|Overall Study||25||
59498434|NCT00539695|75589566|FG000|Evaluable Patients|Overall Study|Patients who received IL-2.|22||
59498435|NCT00539695|75589566|FG000|COMPLETED|Overall Study||12||
59498436|NCT00539695|75589566|FG000|NOT COMPLETED|Overall Study||13||
59498437|NCT00466817|75589572|FG000|STARTED|Overall Study||49||
59498438|NCT00466817|75589573|FG001|STARTED|Overall Study||47||
59498439|NCT00466817|75589572|FG000|COMPLETED|Overall Study||44||
59498440|NCT00466817|75589573|FG001|COMPLETED|Overall Study||43||
59498441|NCT00466817|75589572|FG000|NOT COMPLETED|Overall Study||5||
59498442|NCT00466817|75589573|FG001|NOT COMPLETED|Overall Study||4||
59498443|NCT00438191|75589590|FG000|STARTED|Overall Study||43||
59885218|NCT03133676|76008013|FG005|NOT COMPLETED|Overall Study||0||
59885219|NCT03133676|76008014|FG006|NOT COMPLETED|Overall Study||0||
59885220|NCT03133676|76008015|FG007|NOT COMPLETED|Overall Study||0||
59885221|NCT03133676|76008016|FG008|NOT COMPLETED|Overall Study||0||
60012572|NCT03845296|76128572|FG000|COMPLETED|Overall Study||0||
60012573|NCT03845296|76128573|FG001|COMPLETED|Overall Study||0||
60012574|NCT03845296|76128572|FG000|NOT COMPLETED|Overall Study||25||
60012575|NCT03845296|76128573|FG001|NOT COMPLETED|Overall Study||34||
59498444|NCT00438191|75589591|FG001|STARTED|Overall Study||40||
59498445|NCT00438191|75589590|FG000|COMPLETED|Overall Study||32||
60012576|NCT03841448|76128581|FG000|STARTED|Double Blind Treatment Period||9||
59498446|NCT00438191|75589591|FG001|COMPLETED|Overall Study||26||
59498447|NCT00438191|75589590|FG000|NOT COMPLETED|Overall Study||11||
59498448|NCT00438191|75589591|FG001|NOT COMPLETED|Overall Study||14||
59498449|NCT00540007|75589599|FG000|STARTED|Overall Study||38||
59498450|NCT00540007|75589600|FG001|STARTED|Overall Study||42||
59498451|NCT00540007|75589599|FG000|COMPLETED|Overall Study||38||
59498452|NCT00540007|75589600|FG001|COMPLETED|Overall Study||42||
59498453|NCT00540007|75589599|FG000|NOT COMPLETED|Overall Study||0||
59498454|NCT00540007|75589600|FG001|NOT COMPLETED|Overall Study||0||
59885222|NCT03182738|76008045|FG000|STARTED|Overall Study||50||
59885223|NCT03182738|76008046|FG001|STARTED|Overall Study||50||
59885224|NCT03182738|76008045|FG000|COMPLETED|Overall Study||41||
59885225|NCT03182738|76008046|FG001|COMPLETED|Overall Study||45||
60012577|NCT03841448|76128582|FG001|STARTED|Double Blind Treatment Period||22||
60012578|NCT03841448|76128583|FG002|STARTED|Double Blind Treatment Period||0||
60012579|NCT03841448|76128584|FG003|STARTED|Double Blind Treatment Period||0||
59885226|NCT03182738|76008045|FG000|NOT COMPLETED|Overall Study||9||
59885227|NCT03182738|76008046|FG001|NOT COMPLETED|Overall Study||5||
59498455|NCT00499447|75589607|FG000|STARTED|Overall Study||13||
59498456|NCT00499447|75589607|FG000|COMPLETED|Overall Study||13||
59498457|NCT00499447|75589607|FG000|NOT COMPLETED|Overall Study||0||
59607230|NCT02506985|75717787|FG000|COMPLETED|Overall Study||4||
59607231|NCT02506985|75717788|FG001|COMPLETED|Overall Study||6||
59607232|NCT02506985|75717787|FG000|NOT COMPLETED|Overall Study||0||
59754794|NCT03709706|75873610|FG001|COMPLETED|Overall Study|One participant was transferred to the long-term follow-up study, NCT03391778 (208750). Another participant died after Lete-cel infusion. A third participant completed the treatment but did not transfer to the LTFU study because the protocol amendment 06 was not in place to allow the transfer.|3|Participants who received Lete-cel infusion and were followed-up in this study until death or for 15 years after infusion, or until transfer to a separate long-term follow-up (LTFU) study and participants who completed the treatment but did not transfer to LTFU study because Protocol amendment 06 was not in place to allow the transfer, are considered to have completed the study.|
59498458|NCT00499915|75589613|FG000|STARTED|Overall Study||83||
59498459|NCT00499915|75589614|FG001|STARTED|Overall Study||82||
59498460|NCT00499915|75589613|FG000|COMPLETED|Overall Study||68||
59498461|NCT00499915|75589614|FG001|COMPLETED|Overall Study||76||
59498462|NCT00499915|75589613|FG000|NOT COMPLETED|Overall Study||15||
59498463|NCT00499915|75589614|FG001|NOT COMPLETED|Overall Study||6||
59498464|NCT00501631|75589622|FG000|STARTED|Part A (Double-blind Period)||152||
59498465|NCT00501631|75589623|FG001|STARTED|Part A (Double-blind Period)||148||
59498466|NCT00501631|75589622|FG000|COMPLETED|Part A (Double-blind Period)||90||
59498467|NCT00501631|75589623|FG001|COMPLETED|Part A (Double-blind Period)||99||
59498468|NCT00501631|75589622|FG000|NOT COMPLETED|Part A (Double-blind Period)||62||
59498469|NCT00501631|75589623|FG001|NOT COMPLETED|Part A (Double-blind Period)||49||
59498470|NCT00501631|75589622|FG000|STARTED|Part B (Open-label Period)||90||
59498471|NCT00501631|75589623|FG001|STARTED|Part B (Open-label Period)||99||
59498472|NCT00501631|75589622|FG000|COMPLETED|Part B (Open-label Period)||37||
59498473|NCT00501631|75589623|FG001|COMPLETED|Part B (Open-label Period)||48||
59498474|NCT00501631|75589622|FG000|NOT COMPLETED|Part B (Open-label Period)||53||
59498475|NCT00501631|75589623|FG001|NOT COMPLETED|Part B (Open-label Period)||51||
59498476|NCT00501943|75589631|FG000|STARTED|Overall Study||22||
59498477|NCT00501943|75589632|FG001|STARTED|Overall Study||21||
59498478|NCT00501943|75589631|FG000|COMPLETED|Overall Study||20||
59498479|NCT00501943|75589632|FG001|COMPLETED|Overall Study||18||
59498480|NCT00501943|75589631|FG000|NOT COMPLETED|Overall Study||2||
59498481|NCT00501943|75589632|FG001|NOT COMPLETED|Overall Study||3||
59498482|NCT00503113|75589643|FG000|STARTED|Overall Study||268||
59498483|NCT00503113|75589644|FG001|STARTED|Overall Study||264||
59498484|NCT00503113|75589645|FG002|STARTED|Overall Study||269||
59498485|NCT00503113|75589643|FG000|Intent to Treat Population (ITT)|Overall Study||262||
59498486|NCT00503113|75589644|FG001|Intent to Treat Population (ITT)|Overall Study||261||
59498487|NCT00503113|75589645|FG002|Intent to Treat Population (ITT)|Overall Study||268||
59498488|NCT00503113|75589643|FG000|Per Protocol Population (PP)|Overall Study||246||
59498489|NCT00503113|75589644|FG001|Per Protocol Population (PP)|Overall Study||243||
59498490|NCT00503113|75589645|FG002|Per Protocol Population (PP)|Overall Study||241||
59498491|NCT00503113|75589643|FG000|Safety Population|Overall Study||263||
59498492|NCT00503113|75589644|FG001|Safety Population|Overall Study||263||
59498493|NCT00503113|75589645|FG002|Safety Population|Overall Study||267||
59498494|NCT00503113|75589643|FG000|COMPLETED|Overall Study||235||
59498495|NCT00503113|75589644|FG001|COMPLETED|Overall Study||236||
59498496|NCT00503113|75589645|FG002|COMPLETED|Overall Study||241||
59498497|NCT00503113|75589643|FG000|NOT COMPLETED|Overall Study||33||
59498498|NCT00503113|75589644|FG001|NOT COMPLETED|Overall Study||28||
59498499|NCT00503113|75589645|FG002|NOT COMPLETED|Overall Study||28||
59498500|NCT00542971|75589653|FG000|STARTED|Overall Study||75||
59498501|NCT00542971|75589653|FG000|COMPLETED|Overall Study||75||
59498502|NCT00542971|75589653|FG000|NOT COMPLETED|Overall Study||0||
59498503|NCT00504751|75589657|FG000|STARTED|Overall Study||15||
59498504|NCT00504751|75589657|FG000|COMPLETED|Overall Study||15||
59754795|NCT03709706|75873609|FG000|NOT COMPLETED|Overall Study||17||
59754796|NCT03709706|75873610|FG001|NOT COMPLETED|Overall Study||11||
59885228|NCT03547167|76008054|FG000|STARTED|Overall Study||1135||
59885229|NCT03547167|76008055|FG001|STARTED|Overall Study||380||
59950947|NCT00571493|76069874|FG005|STARTED|Overall Study||12||
59950948|NCT00571493|76069875|FG006|STARTED|Overall Study||6||
59950949|NCT00571493|76069869|FG000|COMPLETED|Overall Study||3||
59498505|NCT00504751|75589657|FG000|NOT COMPLETED|Overall Study||0||
59498506|NCT00557947|75589661|FG000|STARTED|Overall Study||83||
59498507|NCT00557947|75589661|FG000|COMPLETED|Overall Study||83||
59498508|NCT00557947|75589661|FG000|NOT COMPLETED|Overall Study||0||
59498509|NCT00506155|75589669|FG000|STARTED|Overall Study||60||
59607233|NCT02506985|75717788|FG001|NOT COMPLETED|Overall Study||0||
59607234|NCT01150409|75717796|FG000|STARTED|Overall Study||11||
59498510|NCT00506155|75589669|FG000|COMPLETED|Overall Study||60||
59498511|NCT00506155|75589669|FG000|NOT COMPLETED|Overall Study||0||
59498512|NCT00506857|75589673|FG000|STARTED|Overall Study||80||
59498513|NCT00506857|75589673|FG000|COMPLETED|Overall Study||80||
59498514|NCT00506857|75589673|FG000|NOT COMPLETED|Overall Study||0||
59498515|NCT00507559|75589678|FG000|STARTED|Overall Study||155||
59498516|NCT00507559|75589678|FG000|COMPLETED|Overall Study||84||
59498517|NCT00507559|75589678|FG000|NOT COMPLETED|Overall Study||71||
59498518|NCT00508105|75589684|FG000|STARTED|Overall Study||44||
59607235|NCT01150409|75717797|FG001|STARTED|Overall Study||0||
59498519|NCT00508105|75589685|FG001|STARTED|Overall Study||43||
59498520|NCT00508105|75589684|FG000|COMPLETED|Overall Study||40||
59498521|NCT00508105|75589685|FG001|COMPLETED|Overall Study||37||
59498522|NCT00508105|75589684|FG000|NOT COMPLETED|Overall Study||4||
59498523|NCT00508105|75589685|FG001|NOT COMPLETED|Overall Study||6||
59498524|NCT03598088|75589692|FG000|STARTED|Screening/Baseline PCT Visits 1-4||38||
60012580|NCT03841448|76128581|FG000|Modified Intent-to-treat (mITT) Analysis Set|Double Blind Treatment Period||9|mITT Analysis Set included all participants who received any amount of study drug and had at least one post baseline 24-hour urine protein/creatinine ratio (UPCR) assessment.|
60012581|NCT03841448|76128582|FG001|Modified Intent-to-treat (mITT) Analysis Set|Double Blind Treatment Period||22|mITT Analysis Set included all participants who received any amount of study drug and had at least one post baseline 24-hour urine protein/creatinine ratio (UPCR) assessment.|
60012582|NCT03841448|76128583|FG002|Modified Intent-to-treat (mITT) Analysis Set|Double Blind Treatment Period||0|mITT Analysis Set included all participants who received any amount of study drug and had at least one post baseline 24-hour urine protein/creatinine ratio (UPCR) assessment.|
60067715|NCT01617187|76182893|FG002|NOT COMPLETED|Randomization Through Start Treatment||0||
59498525|NCT03598088|75589692|FG000|COMPLETED|Screening/Baseline PCT Visits 1-4||38||
59498526|NCT03598088|75589692|FG000|NOT COMPLETED|Screening/Baseline PCT Visits 1-4||0||
59607236|NCT01150409|75717796|FG000|COMPLETED|Overall Study||11||
59607237|NCT01150409|75717797|FG001|COMPLETED|Overall Study||0||
59607238|NCT01150409|75717796|FG000|NOT COMPLETED|Overall Study||0||
59607239|NCT01150409|75717797|FG001|NOT COMPLETED|Overall Study||0||
59613492|NCT01684878|75724613|FG003|COMPLETED|Part 2: Randomized Phase||0||
59754797|NCT03497689|75873617|FG000|STARTED|Overall Study||35||
59754798|NCT03497689|75873617|FG000|COMPLETED|Overall Study||28||
59754799|NCT03497689|75873617|FG000|NOT COMPLETED|Overall Study||7||
59754800|NCT03492437|75873621|FG000|STARTED|Treatment Period 1||20||
59754801|NCT03492437|75873622|FG001|STARTED|Treatment Period 1||0||
59754802|NCT03492437|75873621|FG000|COMPLETED|Treatment Period 1||20||
59754803|NCT03492437|75873622|FG001|COMPLETED|Treatment Period 1||0||
59754804|NCT03492437|75873621|FG000|NOT COMPLETED|Treatment Period 1||0||
59754805|NCT03492437|75873622|FG001|NOT COMPLETED|Treatment Period 1||0||
59754806|NCT03492437|75873621|FG000|STARTED|Treatment Period 2||0||
59754807|NCT03492437|75873622|FG001|STARTED|Treatment Period 2||20||
59754808|NCT03492437|75873621|FG000|COMPLETED|Treatment Period 2||0||
59754809|NCT03492437|75873622|FG001|COMPLETED|Treatment Period 2||19||
59754810|NCT03492437|75873621|FG000|NOT COMPLETED|Treatment Period 2||0||
59754811|NCT03492437|75873622|FG001|NOT COMPLETED|Treatment Period 2||1||
59754812|NCT03193853|75873628|FG000|STARTED|Overall Study||10||
59754813|NCT03193853|75873628|FG000|COMPLETED|Overall Study||4||
59754814|NCT03193853|75873628|FG000|NOT COMPLETED|Overall Study||6||
59754815|NCT02756637|75873634|FG000|STARTED|Overall Study||317||
59754816|NCT02756637|75873635|FG001|STARTED|Overall Study||317||
59754817|NCT02756637|75873634|FG000|Eligible for SWOG 8710|Overall Study||307||
59754818|NCT02756637|75873635|FG001|Eligible for SWOG 8710|Overall Study||307||
59754819|NCT02756637|75873634|FG000|Had NLR Value|Overall Study||263||
59754820|NCT02756637|75873635|FG001|Had NLR Value|Overall Study||263||
59754821|NCT02756637|75873634|FG000|Completed Curative Treatment|Overall Study||230||
59754822|NCT02756637|75873635|FG001|Completed Curative Treatment|Overall Study||0||
59754823|NCT02756637|75873634|FG000|COMPLETED|Overall Study||230||
59754824|NCT02756637|75873635|FG001|COMPLETED|Overall Study||263||
59885230|NCT03547167|76008054|FG000|Vaccination 1 - (V114 or Prevnar 13™, Day 1)|Overall Study||1133||
59754825|NCT02756637|75873634|FG000|NOT COMPLETED|Overall Study||87||
59754826|NCT02756637|75873635|FG001|NOT COMPLETED|Overall Study||54||
59754827|NCT02041195|75873649|FG000|STARTED|Overall Study||10||
59754828|NCT02041195|75873650|FG001|STARTED|Overall Study||9||
59754829|NCT02041195|75873651|FG002|STARTED|Overall Study||3||
59885231|NCT03547167|76008055|FG001|Vaccination 1 - (V114 or Prevnar 13™, Day 1)|Overall Study||379||
59885232|NCT03547167|76008054|FG000|Vaccination 2 - (PNEUMOVAX™23, Month 6)|Overall Study||1035||
59885233|NCT03547167|76008055|FG001|Vaccination 2 - (PNEUMOVAX™23, Month 6)|Overall Study||346||
59885234|NCT03547167|76008054|FG000|COMPLETED|Overall Study||1038||
59885235|NCT03547167|76008055|FG001|COMPLETED|Overall Study||350||
59885236|NCT03547167|76008054|FG000|NOT COMPLETED|Overall Study||97||
59885237|NCT03547167|76008055|FG001|NOT COMPLETED|Overall Study||30||
59885238|NCT03560739|76008069|FG000|STARTED|Overall Study||128||
59885239|NCT03560739|76008070|FG001|STARTED|Overall Study||130||
59885240|NCT03560739|76008071|FG002|STARTED|Overall Study||13||
59885241|NCT03560739|76008072|FG003|STARTED|Overall Study||13||
59885242|NCT03560739|76008069|FG000|COMPLETED|Overall Study||128||
59885243|NCT03560739|76008070|FG001|COMPLETED|Overall Study||129||
59498527|NCT03598088|75589692|FG000|STARTED|Caya PCT Cycle, Visit 5 & 6||38||
59498528|NCT03598088|75589692|FG000|COMPLETED|Caya PCT Cycle, Visit 5 & 6||35||
59498529|NCT03598088|75589692|FG000|NOT COMPLETED|Caya PCT Cycle, Visit 5 & 6||3||
59498530|NCT03598088|75589692|FG000|STARTED|OVP Safety Cycle Visits 7-11||33||
59498531|NCT03598088|75589692|FG000|Used the OVP Device During the Study|OVP Safety Cycle Visits 7-11|Any subject that used the OVP device at least one time during the study.|33||
59498532|NCT03598088|75589692|FG000|COMPLETED|OVP Safety Cycle Visits 7-11||28|2 subjects completed Visit 6, but discontinued prior to Visit 7|
59498533|NCT03598088|75589692|FG000|NOT COMPLETED|OVP Safety Cycle Visits 7-11||5||
59498534|NCT03598088|75589692|FG000|STARTED|OVP PCT Cycle A Visits 12-16||28||
59498535|NCT03598088|75589692|FG000|Completed 1 OVP PCT Cycle|OVP PCT Cycle A Visits 12-16|Subjects Completed One PCT Visit|26||
59498536|NCT03598088|75589692|FG000|COMPLETED|OVP PCT Cycle A Visits 12-16||24||
59498537|NCT03598088|75589692|FG000|NOT COMPLETED|OVP PCT Cycle A Visits 12-16||4||
59498538|NCT03598088|75589692|FG000|STARTED|OVP PCT Cycle B Visits 17-21||24||
59498539|NCT03598088|75589692|FG000|COMPLETED|OVP PCT Cycle B Visits 17-21||23||
59498540|NCT03598088|75589692|FG000|NOT COMPLETED|OVP PCT Cycle B Visits 17-21||1||
59498541|NCT00558571|75589733|FG000|STARTED|Overall Study||16||
59498542|NCT00558571|75589734|FG001|STARTED|Overall Study||16||
59498543|NCT00558571|75589735|FG002|STARTED|Overall Study||16||
59498544|NCT00558571|75589736|FG003|STARTED|Overall Study||30||
59498545|NCT00558571|75589733|FG000|COMPLETED|Overall Study||16||
59498546|NCT00558571|75589734|FG001|COMPLETED|Overall Study||16||
59498547|NCT00558571|75589735|FG002|COMPLETED|Overall Study||16||
59498548|NCT00558571|75589736|FG003|COMPLETED|Overall Study||30||
59498549|NCT00558571|75589733|FG000|NOT COMPLETED|Overall Study||0||
59498550|NCT00558571|75589734|FG001|NOT COMPLETED|Overall Study||0||
59498551|NCT00558571|75589735|FG002|NOT COMPLETED|Overall Study||0||
59498552|NCT00558571|75589736|FG003|NOT COMPLETED|Overall Study||0||
59498553|NCT00508183|75589759|FG000|STARTED|Overall Study||48||
59498554|NCT00508183|75589760|FG001|STARTED|Overall Study||42||
59498555|NCT00508183|75589759|FG000|COMPLETED|Overall Study||39||
59498556|NCT00508183|75589760|FG001|COMPLETED|Overall Study||34||
59498557|NCT00508183|75589759|FG000|NOT COMPLETED|Overall Study||9||
59498558|NCT00508183|75589760|FG001|NOT COMPLETED|Overall Study||8||
59498559|NCT00537407|75589771|FG000|STARTED|Part 1 Weeks 1-4||10||
59498560|NCT00537407|75589772|FG001|STARTED|Part 1 Weeks 1-4||9||
59498561|NCT00537407|75589773|FG002|STARTED|Part 1 Weeks 1-4||11||
59498562|NCT00537407|75589774|FG003|STARTED|Part 1 Weeks 1-4||10||
59498563|NCT00537407|75589775|FG004|STARTED|Part 1 Weeks 1-4||10||
59498564|NCT00537407|75589771|FG000|COMPLETED|Part 1 Weeks 1-4||10||
59498565|NCT00537407|75589772|FG001|COMPLETED|Part 1 Weeks 1-4||9||
59498566|NCT00537407|75589773|FG002|COMPLETED|Part 1 Weeks 1-4||11||
59498567|NCT00537407|75589774|FG003|COMPLETED|Part 1 Weeks 1-4||10||
59498568|NCT00537407|75589775|FG004|COMPLETED|Part 1 Weeks 1-4||10||
59498569|NCT00537407|75589771|FG000|NOT COMPLETED|Part 1 Weeks 1-4||0||
59498570|NCT00537407|75589772|FG001|NOT COMPLETED|Part 1 Weeks 1-4||0||
59498571|NCT00537407|75589773|FG002|NOT COMPLETED|Part 1 Weeks 1-4||0||
59498572|NCT00537407|75589774|FG003|NOT COMPLETED|Part 1 Weeks 1-4||0||
59498573|NCT00537407|75589775|FG004|NOT COMPLETED|Part 1 Weeks 1-4||0||
59498574|NCT00537407|75589771|FG000|STARTED|Part 2 Weeks 5-48 or 72||10||
59498575|NCT00537407|75589772|FG001|STARTED|Part 2 Weeks 5-48 or 72||9||
59498576|NCT00537407|75589773|FG002|STARTED|Part 2 Weeks 5-48 or 72||11||
59498577|NCT00537407|75589774|FG003|STARTED|Part 2 Weeks 5-48 or 72||10||
59498578|NCT00537407|75589775|FG004|STARTED|Part 2 Weeks 5-48 or 72||10||
59498579|NCT00537407|75589771|FG000|COMPLETED|Part 2 Weeks 5-48 or 72||2||
59498580|NCT00537407|75589772|FG001|COMPLETED|Part 2 Weeks 5-48 or 72||1||
59498581|NCT00537407|75589773|FG002|COMPLETED|Part 2 Weeks 5-48 or 72||2||
59498582|NCT00537407|75589774|FG003|COMPLETED|Part 2 Weeks 5-48 or 72||4||
59498583|NCT00537407|75589775|FG004|COMPLETED|Part 2 Weeks 5-48 or 72||3||
59498584|NCT00537407|75589771|FG000|NOT COMPLETED|Part 2 Weeks 5-48 or 72||8||
59498585|NCT00537407|75589772|FG001|NOT COMPLETED|Part 2 Weeks 5-48 or 72||8||
59607240|NCT01133639|75717805|FG000|STARTED|Overall Study|18 total subjects were enrolled, study was terminated prematurely and data was not analyzed|0|See comments in Recruitment Details section above. Maximum length is too short to explain here.|
59613493|NCT01684878|75724610|FG000|NOT COMPLETED|Part 2: Randomized Phase||0||
59498586|NCT00537407|75589773|FG002|NOT COMPLETED|Part 2 Weeks 5-48 or 72||9||
59498587|NCT00537407|75589774|FG003|NOT COMPLETED|Part 2 Weeks 5-48 or 72||6||
59498588|NCT00537407|75589775|FG004|NOT COMPLETED|Part 2 Weeks 5-48 or 72||7||
59498589|NCT00469391|75589793|FG000|STARTED|Overall Study||27||
59498590|NCT00469391|75589794|FG001|STARTED|Overall Study||29||
59498591|NCT00469391|75589793|FG000|Discontinued Prior to Procedure|Overall Study||2||
59498592|NCT00469391|75589794|FG001|Discontinued Prior to Procedure|Overall Study||3||
59498593|NCT00469391|75589793|FG000|Unsuccessful Implant Procedure|Overall Study||4||
59498594|NCT00469391|75589794|FG001|Unsuccessful Implant Procedure|Overall Study||0||
59498595|NCT00469391|75589793|FG000|Adverse Event|Overall Study||8||
59498596|NCT00469391|75589794|FG001|Adverse Event|Overall Study||0||
59498597|NCT00469391|75589793|FG000|Lost to Follow up|Overall Study||0||
59498598|NCT00469391|75589794|FG001|Lost to Follow up|Overall Study||1||
59498599|NCT00469391|75589793|FG000|Patient Preference|Overall Study||0||
59498600|NCT00469391|75589794|FG001|Patient Preference|Overall Study||1||
59498601|NCT00469391|75589793|FG000|COMPLETED|Overall Study||13||
59498602|NCT00469391|75589794|FG001|COMPLETED|Overall Study||24||
59498603|NCT00469391|75589793|FG000|NOT COMPLETED|Overall Study||14||
59498604|NCT00469391|75589794|FG001|NOT COMPLETED|Overall Study||5||
59498605|NCT00438971|75589800|FG000|STARTED|Overall Study||17||
59498606|NCT00438971|75589800|FG000|COMPLETED|Overall Study||15||
59498607|NCT00438971|75589800|FG000|NOT COMPLETED|Overall Study||2||
59498608|NCT00219284|75589807|FG000|STARTED|Treatment Phase - 16 Weeks||180||
59498609|NCT00219284|75589808|FG001|STARTED|Treatment Phase - 16 Weeks||179||
59498610|NCT00219284|75589807|FG000|COMPLETED|Treatment Phase - 16 Weeks||136||
59498611|NCT00219284|75589808|FG001|COMPLETED|Treatment Phase - 16 Weeks||128||
59498612|NCT00219284|75589807|FG000|NOT COMPLETED|Treatment Phase - 16 Weeks||44||
59498613|NCT00219284|75589808|FG001|NOT COMPLETED|Treatment Phase - 16 Weeks||51||
59498614|NCT00219284|75589807|FG000|STARTED|Extension Phase - 8 Weeks|Not all subjects who completed the treatment phase chose to enter this optional extension phase.|114||
59498615|NCT00219284|75589808|FG001|STARTED|Extension Phase - 8 Weeks|Not all subjects who completed the treatment phase chose to enter this optional extension phase.|106||
59498616|NCT00219284|75589807|FG000|COMPLETED|Extension Phase - 8 Weeks||112||
59498617|NCT00219284|75589808|FG001|COMPLETED|Extension Phase - 8 Weeks||99||
59498618|NCT00219284|75589807|FG000|NOT COMPLETED|Extension Phase - 8 Weeks||2||
59498619|NCT00219284|75589808|FG001|NOT COMPLETED|Extension Phase - 8 Weeks||7||
59498620|NCT00509041|75589814|FG000|STARTED|Overall Study||43||
59498621|NCT00509041|75589814|FG000|COMPLETED|Overall Study||43||
59498622|NCT00509041|75589814|FG000|NOT COMPLETED|Overall Study||0||
59498623|NCT00470717|75589818|FG000|STARTED|Overall Study|Each participant could be called up to 4 times weekly for 13 weeks (38x4x13)|38|Milestone is beginning enrollment|1976
59498624|NCT00470717|75589818|FG000|COMPLETED|Overall Study||38|End of calling attempts|813
59498625|NCT00470717|75589818|FG000|NOT COMPLETED|Overall Study||0||1163
59498626|NCT00545155|75589822|FG000|STARTED|Overall Study||187||
59498627|NCT00545155|75589822|FG000|COMPLETED|Overall Study||187||
59498628|NCT00545155|75589822|FG000|NOT COMPLETED|Overall Study||0||
59498629|NCT00439673|75589826|FG000|STARTED|Overall Study||62||
59498630|NCT00439673|75589826|FG000|COMPLETED|Overall Study||26||
59498631|NCT00439673|75589826|FG000|NOT COMPLETED|Overall Study||36||
59498632|NCT00473837|75589832|FG000|STARTED|Overall Study||50||
59498633|NCT00473837|75589833|FG001|STARTED|Overall Study||46||
59498634|NCT00473837|75589832|FG000|COMPLETED|Overall Study||49||
59498635|NCT00473837|75589833|FG001|COMPLETED|Overall Study||43||
59498636|NCT00473837|75589832|FG000|NOT COMPLETED|Overall Study||1||
59498637|NCT00473837|75589833|FG001|NOT COMPLETED|Overall Study||3||
59498638|NCT02122549|75589839|FG000|STARTED|Overall Study||59||
59498639|NCT02122549|75589839|FG000|COMPLETED|Overall Study||59||
59498640|NCT02122549|75589839|FG000|NOT COMPLETED|Overall Study||0||
59498641|NCT00509197|75589845|FG000|STARTED|Overall Study||6||
59498642|NCT00509197|75589846|FG001|STARTED|Overall Study||6||
59498643|NCT00509197|75589845|FG000|COMPLETED|Overall Study||6||
59498644|NCT00509197|75589846|FG001|COMPLETED|Overall Study||6||
59498645|NCT00509197|75589845|FG000|NOT COMPLETED|Overall Study||0||
59498646|NCT00509197|75589846|FG001|NOT COMPLETED|Overall Study||0||
59498647|NCT00442013|75589856|FG000|STARTED|Overall Study||157||
59498648|NCT00442013|75589857|FG001|STARTED|Overall Study||149||
59498649|NCT00442013|75589856|FG000|COMPLETED|Overall Study||131||
59498650|NCT00442013|75589857|FG001|COMPLETED|Overall Study||132||
59498651|NCT00442013|75589856|FG000|NOT COMPLETED|Overall Study||26||
59498652|NCT00442013|75589857|FG001|NOT COMPLETED|Overall Study||17||
59498653|NCT02121067|75589864|FG000|STARTED|Overall Study||50||
59498654|NCT02121067|75589864|FG000|COMPLETED|Overall Study||50||
59498655|NCT02121067|75589864|FG000|NOT COMPLETED|Overall Study||0||
59498656|NCT00509587|75589869|FG000|STARTED|Overall Study||21||
59613494|NCT01684878|75724611|FG001|NOT COMPLETED|Part 2: Randomized Phase||0||
59613495|NCT01684878|75724612|FG002|NOT COMPLETED|Part 2: Randomized Phase||78||
59498657|NCT00509587|75589869|FG000|COMPLETED|Overall Study||21||
59498658|NCT00509587|75589869|FG000|NOT COMPLETED|Overall Study||0||
59498659|NCT00509665|75589873|FG000|STARTED|Overall Study||18||
59498660|NCT00509665|75589873|FG000|COMPLETED|Overall Study||18||
59498661|NCT00509665|75589873|FG000|NOT COMPLETED|Overall Study||0||
59498662|NCT00513799|75589881|FG000|STARTED|One-Month Follow-Up||75||
59498663|NCT00513799|75589882|FG001|STARTED|One-Month Follow-Up||75||
59498664|NCT00513799|75589883|FG002|STARTED|One-Month Follow-Up||75||
59498665|NCT00513799|75589884|FG003|STARTED|One-Month Follow-Up||75||
59498666|NCT00513799|75589881|FG000|COMPLETED|One-Month Follow-Up||64||
59498667|NCT00513799|75589882|FG001|COMPLETED|One-Month Follow-Up||62||
59498668|NCT00513799|75589883|FG002|COMPLETED|One-Month Follow-Up||64||
59498669|NCT00513799|75589884|FG003|COMPLETED|One-Month Follow-Up||54||
59498670|NCT00513799|75589881|FG000|NOT COMPLETED|One-Month Follow-Up||11||
59498671|NCT00513799|75589882|FG001|NOT COMPLETED|One-Month Follow-Up||13||
59498672|NCT00513799|75589883|FG002|NOT COMPLETED|One-Month Follow-Up||11||
59498673|NCT00513799|75589884|FG003|NOT COMPLETED|One-Month Follow-Up||21||
59498674|NCT00513799|75589881|FG000|STARTED|Four-Month Follow-Up||64||
59498675|NCT00513799|75589882|FG001|STARTED|Four-Month Follow-Up||62||
59498676|NCT00513799|75589883|FG002|STARTED|Four-Month Follow-Up||64||
59498677|NCT00513799|75589884|FG003|STARTED|Four-Month Follow-Up||54||
59498678|NCT00513799|75589881|FG000|COMPLETED|Four-Month Follow-Up||64||
59498679|NCT00513799|75589882|FG001|COMPLETED|Four-Month Follow-Up||57||
59498680|NCT00513799|75589883|FG002|COMPLETED|Four-Month Follow-Up||57||
59498681|NCT00513799|75589884|FG003|COMPLETED|Four-Month Follow-Up||51||
59498682|NCT00513799|75589881|FG000|NOT COMPLETED|Four-Month Follow-Up||0||
59498683|NCT00513799|75589882|FG001|NOT COMPLETED|Four-Month Follow-Up||5||
59498684|NCT00513799|75589883|FG002|NOT COMPLETED|Four-Month Follow-Up||7||
59498685|NCT00513799|75589884|FG003|NOT COMPLETED|Four-Month Follow-Up||3||
59498686|NCT00514501|75589898|FG000|STARTED|Overall Study||510||
59498687|NCT00514501|75589898|FG000|COMPLETED|Overall Study||507||
59498688|NCT00514501|75589898|FG000|NOT COMPLETED|Overall Study||3||
59498689|NCT00561145|75589904|FG000|STARTED|Overall Study||15||
59498690|NCT00561145|75589905|FG001|STARTED|Overall Study||17||
59498691|NCT00561145|75589904|FG000|COMPLETED|Overall Study||15||
59498692|NCT00561145|75589905|FG001|COMPLETED|Overall Study||17||
59498693|NCT00561145|75589904|FG000|NOT COMPLETED|Overall Study||0||
59498694|NCT00561145|75589905|FG001|NOT COMPLETED|Overall Study||0||
59498695|NCT00442169|75589917|FG000|STARTED|Part 1||17||
59498696|NCT00442169|75589918|FG001|STARTED|Part 1||24||
59498697|NCT00442169|75589919|FG002|STARTED|Part 1||40||
59498698|NCT00442169|75589920|FG003|STARTED|Part 1||31||
59498699|NCT00442169|75589921|FG004|STARTED|Part 1|Participants in Part 2 are not the same as those in Part 1|0||
59498700|NCT00442169|75589922|FG005|STARTED|Part 1|Participants in Part 2 are not the same as those in Part 1|0||
59498701|NCT00442169|75589917|FG000|COMPLETED|Part 1||17||
59498702|NCT00442169|75589918|FG001|COMPLETED|Part 1||24||
59498703|NCT00442169|75589919|FG002|COMPLETED|Part 1||40||
59498704|NCT00442169|75589920|FG003|COMPLETED|Part 1||31||
59498705|NCT00442169|75589921|FG004|COMPLETED|Part 1||0||
59498706|NCT00442169|75589922|FG005|COMPLETED|Part 1||0||
59498707|NCT00442169|75589917|FG000|NOT COMPLETED|Part 1||0||
59498708|NCT00442169|75589918|FG001|NOT COMPLETED|Part 1||0||
59498709|NCT00442169|75589919|FG002|NOT COMPLETED|Part 1||0||
59498710|NCT00442169|75589920|FG003|NOT COMPLETED|Part 1||0||
59498711|NCT00442169|75589921|FG004|NOT COMPLETED|Part 1||0||
59498712|NCT00442169|75589922|FG005|NOT COMPLETED|Part 1||0||
59498713|NCT00442169|75589917|FG000|STARTED|Part 2|Participants in Part 1 are not the same as those in Part 2|0||
59498714|NCT00442169|75589918|FG001|STARTED|Part 2|Participants in Part 1 are not the same as those in Part 2|0||
59498715|NCT00442169|75589919|FG002|STARTED|Part 2|Participants in Part 1 are not the same as those in Part 2|0||
59498716|NCT00442169|75589920|FG003|STARTED|Part 2|Participants in Part 1 are not the same as those in Part 2|0||
59498717|NCT00442169|75589921|FG004|STARTED|Part 2||25||
59498718|NCT00442169|75589922|FG005|STARTED|Part 2||57||
59498719|NCT00442169|75589917|FG000|COMPLETED|Part 2||0||
59498720|NCT00442169|75589918|FG001|COMPLETED|Part 2||0||
59498721|NCT00442169|75589919|FG002|COMPLETED|Part 2||0||
59498722|NCT00442169|75589920|FG003|COMPLETED|Part 2||0||
59498723|NCT00442169|75589921|FG004|COMPLETED|Part 2||25||
59498724|NCT00442169|75589922|FG005|COMPLETED|Part 2||57||
59498725|NCT00442169|75589917|FG000|NOT COMPLETED|Part 2||0||
59498726|NCT00442169|75589918|FG001|NOT COMPLETED|Part 2||0||
59498727|NCT00442169|75589919|FG002|NOT COMPLETED|Part 2||0||
59498728|NCT00442169|75589920|FG003|NOT COMPLETED|Part 2||0||
59498729|NCT00442169|75589921|FG004|NOT COMPLETED|Part 2||0||
59498730|NCT00442169|75589922|FG005|NOT COMPLETED|Part 2||0||
59498731|NCT00515203|75589938|FG000|STARTED|Overall Study||17||
59498732|NCT00515203|75589939|FG001|STARTED|Overall Study||5||
59498733|NCT00515203|75589938|FG000|COMPLETED|Overall Study||17||
59498734|NCT00515203|75589939|FG001|COMPLETED|Overall Study||5||
60012583|NCT03841448|76128584|FG003|Modified Intent-to-treat (mITT) Analysis Set|Double Blind Treatment Period||0|mITT Analysis Set included all participants who received any amount of study drug and had at least one post baseline 24-hour urine protein/creatinine ratio (UPCR) assessment.|
60012584|NCT03841448|76128581|FG000|COMPLETED|Double Blind Treatment Period||8||
59498735|NCT00515203|75589938|FG000|NOT COMPLETED|Overall Study||0||
59498736|NCT00515203|75589939|FG001|NOT COMPLETED|Overall Study||0||
59498737|NCT00216476|75589947|FG000|STARTED|Overall Study||329||
59498738|NCT00216476|75589948|FG001|STARTED|Overall Study||337||
59498739|NCT00216476|75589949|FG002|STARTED|Overall Study||45||
59498740|NCT00216476|75589947|FG000|COMPLETED|Overall Study||224||
59498741|NCT00216476|75589948|FG001|COMPLETED|Overall Study||230||
59498742|NCT00216476|75589949|FG002|COMPLETED|Overall Study||28||
59498743|NCT00216476|75589947|FG000|NOT COMPLETED|Overall Study||105||
59498744|NCT00216476|75589948|FG001|NOT COMPLETED|Overall Study||107||
59498745|NCT00216476|75589949|FG002|NOT COMPLETED|Overall Study||17||
59498746|NCT00561457|75589960|FG000|STARTED|Overall Study||134||
59498747|NCT00561457|75589960|FG000|COMPLETED|Overall Study||110||
59498748|NCT00561457|75589960|FG000|NOT COMPLETED|Overall Study||24||
59498749|NCT00515437|75589968|FG000|STARTED|Overall Study||14||
59498750|NCT00515437|75589969|FG001|STARTED|Overall Study||12||
59498751|NCT00515437|75589970|FG002|STARTED|Overall Study||13||
59498752|NCT00515437|75589971|FG003|STARTED|Overall Study||15||
59498753|NCT00515437|75589968|FG000|COMPLETED|Overall Study||14||
59498754|NCT00515437|75589969|FG001|COMPLETED|Overall Study||12||
59498755|NCT00515437|75589970|FG002|COMPLETED|Overall Study||13||
59498756|NCT00515437|75589971|FG003|COMPLETED|Overall Study||14||
59498757|NCT00515437|75589968|FG000|NOT COMPLETED|Overall Study||0||
59498758|NCT00515437|75589969|FG001|NOT COMPLETED|Overall Study||0||
59498759|NCT00515437|75589970|FG002|NOT COMPLETED|Overall Study||0||
59498760|NCT00515437|75589971|FG003|NOT COMPLETED|Overall Study||1||
59498761|NCT00474617|75589984|FG000|STARTED|Overall Study||56||
59498762|NCT00474617|75589985|FG001|STARTED|Overall Study||64||
59498763|NCT00474617|75589986|FG002|STARTED|Overall Study||42||
59498764|NCT00474617|75589984|FG000|Treated|Overall Study||48||
59498765|NCT00474617|75589985|FG001|Treated|Overall Study||62||
59498766|NCT00474617|75589986|FG002|Treated|Overall Study||40||
59498767|NCT00474617|75589984|FG000|COMPLETED|Overall Study||48||
59498768|NCT00474617|75589985|FG001|COMPLETED|Overall Study||61||
59498769|NCT00474617|75589986|FG002|COMPLETED|Overall Study||40||
59498770|NCT00474617|75589984|FG000|NOT COMPLETED|Overall Study||8||
59498771|NCT00474617|75589985|FG001|NOT COMPLETED|Overall Study||3||
59498772|NCT00474617|75589986|FG002|NOT COMPLETED|Overall Study||2||
59498773|NCT00562315|75589994|FG000|STARTED|Overall Study||93||
59498774|NCT00562315|75589994|FG000|COMPLETED|Overall Study||93||
59498775|NCT00562315|75589994|FG000|NOT COMPLETED|Overall Study||0||
59498776|NCT00216086|75590000|FG000|STARTED|Overall Study||22||
59498777|NCT00216086|75590000|FG000|COMPLETED|Overall Study||18||
59498778|NCT00216086|75590000|FG000|NOT COMPLETED|Overall Study||4||
59498779|NCT00474851|75590006|FG000|STARTED|Overall Study||26||
60012585|NCT03841448|76128582|FG001|COMPLETED|Double Blind Treatment Period||21||
60012586|NCT03841448|76128583|FG002|COMPLETED|Double Blind Treatment Period||0||
60012587|NCT03841448|76128584|FG003|COMPLETED|Double Blind Treatment Period||0||
60012588|NCT03841448|76128581|FG000|NOT COMPLETED|Double Blind Treatment Period||1||
60012589|NCT03841448|76128582|FG001|NOT COMPLETED|Double Blind Treatment Period||1||
60012590|NCT03841448|76128583|FG002|NOT COMPLETED|Double Blind Treatment Period||0||
60012591|NCT03841448|76128584|FG003|NOT COMPLETED|Double Blind Treatment Period||0||
59498780|NCT00474851|75590007|FG001|STARTED|Overall Study||27||
59498781|NCT00474851|75590006|FG000|Completed Baseline|Overall Study||25||
59498782|NCT00474851|75590007|FG001|Completed Baseline|Overall Study||26||
59498783|NCT00474851|75590006|FG000|COMPLETED|Overall Study||18||
59498784|NCT00474851|75590007|FG001|COMPLETED|Overall Study||16||
59498785|NCT00474851|75590006|FG000|NOT COMPLETED|Overall Study||8||
59498786|NCT00474851|75590007|FG001|NOT COMPLETED|Overall Study||11||
59498787|NCT00545623|75590018|FG000|STARTED|Overall Study||32||
59498788|NCT00545623|75590019|FG001|STARTED|Overall Study||31||
59498789|NCT00545623|75590020|FG002|STARTED|Overall Study||33||
59498790|NCT00545623|75590021|FG003|STARTED|Overall Study||34||
59498791|NCT00545623|75590018|FG000|COMPLETED|Overall Study||25||
59498792|NCT00545623|75590019|FG001|COMPLETED|Overall Study||21||
59498793|NCT00545623|75590020|FG002|COMPLETED|Overall Study||20||
59498794|NCT00545623|75590021|FG003|COMPLETED|Overall Study||23||
59498795|NCT00545623|75590018|FG000|NOT COMPLETED|Overall Study||7||
59607241|NCT01133639|75717806|FG001|STARTED|Overall Study|18 total subjects were enrolled, study was terminated prematurely and data was not analyzed|0|See comments in Recruitment Details section above. Maximum length is too short to explain here.|
59607242|NCT01133639|75717805|FG000|COMPLETED|Overall Study|18 total subjects were enrolled, study was terminated prematurely and data was not analyzed|0|See comments in Recruitment Details section above. Maximum length is too short to explain here.|
59607243|NCT01133639|75717806|FG001|COMPLETED|Overall Study|18 total subjects were enrolled,study was terminated prematurely and data was not analyzed|0|See comments in Recruitment Details section above. Maximum length is too short to explain here.|
59607244|NCT01133639|75717805|FG000|NOT COMPLETED|Overall Study||0||
59607245|NCT01133639|75717806|FG001|NOT COMPLETED|Overall Study||0||
59607246|NCT01115699|75717811|FG000|STARTED|Overall Study||2||
59607247|NCT01115699|75717811|FG000|COMPLETED|Overall Study||2||
59754830|NCT02041195|75873652|FG003|STARTED|Overall Study||3||
59754831|NCT02041195|75873653|FG004|STARTED|Overall Study||11||
59754832|NCT02041195|75873654|FG005|STARTED|Overall Study||6||
59754833|NCT02041195|75873655|FG006|STARTED|Overall Study||29||
59607248|NCT01115699|75717811|FG000|NOT COMPLETED|Overall Study||0||
59607249|NCT03819491|75717817|FG000|STARTED|Before Randomization||24||
59607250|NCT03819491|75717818|FG001|STARTED|Before Randomization||0||
59607251|NCT03819491|75717817|FG000|COMPLETED|Before Randomization||24||
59607252|NCT03819491|75717818|FG001|COMPLETED|Before Randomization||0||
59607253|NCT03819491|75717817|FG000|NOT COMPLETED|Before Randomization||0||
59607254|NCT03819491|75717818|FG001|NOT COMPLETED|Before Randomization||0||
59607255|NCT03819491|75717817|FG000|STARTED|After Randomization||12||
60012592|NCT03841448|76128581|FG000|STARTED|Open-Label Extension Period||0||
60012593|NCT03841448|76128582|FG001|STARTED|Open-Label Extension Period||0||
60012594|NCT03841448|76128583|FG002|STARTED|Open-Label Extension Period||8||
60012595|NCT03841448|76128584|FG003|STARTED|Open-Label Extension Period||20||
60012596|NCT03841448|76128581|FG000|COMPLETED|Open-Label Extension Period||0||
60012597|NCT03841448|76128582|FG001|COMPLETED|Open-Label Extension Period||0||
59607256|NCT03819491|75717818|FG001|STARTED|After Randomization||12||
59607257|NCT03819491|75717817|FG000|COMPLETED|After Randomization||12||
59607258|NCT03819491|75717818|FG001|COMPLETED|After Randomization||12||
60012598|NCT03841448|76128583|FG002|COMPLETED|Open-Label Extension Period||0||
60012599|NCT03841448|76128584|FG003|COMPLETED|Open-Label Extension Period||0||
60012600|NCT03841448|76128581|FG000|NOT COMPLETED|Open-Label Extension Period||0||
60012601|NCT03841448|76128582|FG001|NOT COMPLETED|Open-Label Extension Period||0||
60012602|NCT03841448|76128583|FG002|NOT COMPLETED|Open-Label Extension Period||8||
60012603|NCT03841448|76128584|FG003|NOT COMPLETED|Open-Label Extension Period||20||
60012604|NCT03382782|76128595|FG000|STARTED|Cohort 1||41|The sum of number of participants who started in Cohorts 1, 2, and 3 = 234 participants initially enrolled|
60012605|NCT03382782|76128596|FG001|STARTED|Cohort 1||35|The sum of number of participants who started in Cohorts 1, 2, and 3 = 234 participants initially enrolled|
60012606|NCT03382782|76128597|FG002|STARTED|Cohort 1||30|The sum of number of participants who started in Cohorts 1, 2, and 3 = 234 participants initially enrolled|
60012607|NCT03382782|76128595|FG000|COMPLETED|Cohort 1||30|The sum of number of participants who completed Cohorts 1, 2, and 3 = 213 participants assigned to a group|
60012608|NCT03382782|76128596|FG001|COMPLETED|Cohort 1||30|The sum of number of participants who completed Cohorts 1, 2, and 3 = 213 participants assigned to a group|
60012609|NCT03382782|76128597|FG002|COMPLETED|Cohort 1||30|The sum of number of participants who completed Cohorts 1, 2, and 3 = 213 participants assigned to a group|
60012610|NCT03382782|76128595|FG000|NOT COMPLETED|Cohort 1||11||
60012611|NCT03382782|76128596|FG001|NOT COMPLETED|Cohort 1||5||
60012612|NCT03382782|76128597|FG002|NOT COMPLETED|Cohort 1||0||
60012613|NCT03382782|76128595|FG000|STARTED|Cohort 2||24||
60012614|NCT03382782|76128596|FG001|STARTED|Cohort 2||28||
60012615|NCT03382782|76128597|FG002|STARTED|Cohort 2||27||
60012616|NCT03382782|76128595|FG000|COMPLETED|Cohort 2||23||
60012617|NCT03382782|76128596|FG001|COMPLETED|Cohort 2||27||
60012618|NCT03382782|76128597|FG002|COMPLETED|Cohort 2||27||
60012619|NCT03382782|76128595|FG000|NOT COMPLETED|Cohort 2||1||
60012620|NCT03382782|76128596|FG001|NOT COMPLETED|Cohort 2||1||
59607259|NCT03819491|75717817|FG000|NOT COMPLETED|After Randomization||0||
59607260|NCT03819491|75717818|FG001|NOT COMPLETED|After Randomization||0||
59607261|NCT03801473|75717827|FG000|STARTED|Overall Study||21||
59607262|NCT03801473|75717828|FG001|STARTED|Overall Study||21||
60012621|NCT03382782|76128597|FG002|NOT COMPLETED|Cohort 2||0||
59607263|NCT03801473|75717827|FG000|COMPLETED|Overall Study||18||
59498796|NCT00545623|75590019|FG001|NOT COMPLETED|Overall Study||10||
59498797|NCT00545623|75590020|FG002|NOT COMPLETED|Overall Study||13||
59498798|NCT00545623|75590021|FG003|NOT COMPLETED|Overall Study||11||
59498799|NCT00215150|75590031|FG000|STARTED|Open Label Phase|Number of subjects consented|51||
59498800|NCT00215150|75590031|FG000|COMPLETED|Open Label Phase||21||
59498801|NCT00215150|75590031|FG000|NOT COMPLETED|Open Label Phase||30||
59498802|NCT00215150|75590031|FG000|STARTED|Randomization Phase Ziprasidone||10||
59498803|NCT00215150|75590031|FG000|COMPLETED|Randomization Phase Ziprasidone||7||
59498804|NCT00215150|75590031|FG000|NOT COMPLETED|Randomization Phase Ziprasidone||3||
59498805|NCT00215150|75590031|FG000|STARTED|Randomization Phase Placebo||11||
59498806|NCT00215150|75590031|FG000|COMPLETED|Randomization Phase Placebo||10||
59498807|NCT00215150|75590031|FG000|NOT COMPLETED|Randomization Phase Placebo||1||
59498808|NCT00214136|75590039|FG000|STARTED|Overall Study||30||
59498809|NCT00214136|75590039|FG000|COMPLETED|Overall Study||25|All participants completed treatment per protocol; 5 died greater than 30 days after last treatment.|
59498810|NCT00214136|75590039|FG000|NOT COMPLETED|Overall Study||5||
59498811|NCT00213980|75590045|FG000|STARTED|Overall Study||32||
59498812|NCT00213980|75590046|FG001|STARTED|Overall Study||36||
59498813|NCT00213980|75590045|FG000|COMPLETED|Overall Study||26||
59498814|NCT00213980|75590046|FG001|COMPLETED|Overall Study||29||
59498815|NCT00213980|75590045|FG000|NOT COMPLETED|Overall Study||6||
59498816|NCT00213980|75590046|FG001|NOT COMPLETED|Overall Study||7||
59498817|NCT00516217|75590052|FG000|STARTED|Overall Study||29||
59498818|NCT00516217|75590052|FG000|COMPLETED|Overall Study||29||
59498819|NCT00516217|75590052|FG000|NOT COMPLETED|Overall Study||0||
59498820|NCT00564265|75590056|FG000|STARTED|Overall Study||24||
59498821|NCT00564265|75590056|FG000|COMPLETED|Overall Study||24||
59498822|NCT00564265|75590056|FG000|NOT COMPLETED|Overall Study||0||
59498823|NCT00516919|75590060|FG000|STARTED|Overall Study||40||
59498824|NCT00516919|75590061|FG001|STARTED|Overall Study||39||
59498825|NCT00516919|75590060|FG000|COMPLETED|Overall Study||30||
59498826|NCT00516919|75590061|FG001|COMPLETED|Overall Study||32||
59498827|NCT00516919|75590060|FG000|NOT COMPLETED|Overall Study||10||
59498828|NCT00516919|75590061|FG001|NOT COMPLETED|Overall Study||7||
59498829|NCT00547105|75590067|FG000|STARTED|Overall Study||24||
59498830|NCT00547105|75590067|FG000|COMPLETED|Overall Study||24||
59498831|NCT00547105|75590067|FG000|NOT COMPLETED|Overall Study||0||
59498832|NCT05129475|75590073|FG000|STARTED|Period 1||6||
59498833|NCT05129475|75590074|FG001|STARTED|Period 1||6||
59498834|NCT05129475|75590073|FG000|COMPLETED|Period 1||6||
59498835|NCT05129475|75590074|FG001|COMPLETED|Period 1||6||
59498836|NCT05129475|75590073|FG000|NOT COMPLETED|Period 1||0||
59498837|NCT05129475|75590074|FG001|NOT COMPLETED|Period 1||0||
59498838|NCT05129475|75590073|FG000|STARTED|Washout Period||6||
59498839|NCT05129475|75590074|FG001|STARTED|Washout Period||6||
59498840|NCT05129475|75590073|FG000|COMPLETED|Washout Period||6||
59498841|NCT05129475|75590074|FG001|COMPLETED|Washout Period||6||
59498842|NCT05129475|75590073|FG000|NOT COMPLETED|Washout Period||0||
59498843|NCT05129475|75590074|FG001|NOT COMPLETED|Washout Period||0||
59498844|NCT05129475|75590073|FG000|STARTED|Period 2||6||
59498845|NCT05129475|75590074|FG001|STARTED|Period 2||6||
59498846|NCT05129475|75590073|FG000|COMPLETED|Period 2||6||
59498847|NCT05129475|75590074|FG001|COMPLETED|Period 2||6||
59498848|NCT05129475|75590073|FG000|NOT COMPLETED|Period 2||0||
59498849|NCT05129475|75590074|FG001|NOT COMPLETED|Period 2||0||
59498850|NCT05123742|75590084|FG000|STARTED|Overall Study||13||
59498851|NCT05123742|75590085|FG001|STARTED|Overall Study||16||
59498852|NCT05123742|75590086|FG002|STARTED|Overall Study||20||
59607264|NCT03801473|75717828|FG001|COMPLETED|Overall Study||19||
59607265|NCT03801473|75717827|FG000|NOT COMPLETED|Overall Study||3||
59498853|NCT05123742|75590087|FG003|STARTED|Overall Study||23||
59498854|NCT05123742|75590084|FG000|COMPLETED|Overall Study||13||
59498855|NCT05123742|75590085|FG001|COMPLETED|Overall Study||15||
59607266|NCT03801473|75717828|FG001|NOT COMPLETED|Overall Study||2||
59498856|NCT05123742|75590086|FG002|COMPLETED|Overall Study||19||
59498857|NCT05123742|75590087|FG003|COMPLETED|Overall Study||22||
59498858|NCT05123742|75590084|FG000|NOT COMPLETED|Overall Study||0||
59498859|NCT05123742|75590085|FG001|NOT COMPLETED|Overall Study||1||
59498860|NCT05123742|75590086|FG002|NOT COMPLETED|Overall Study||1||
59498861|NCT05123742|75590087|FG003|NOT COMPLETED|Overall Study||1||
59498862|NCT05086289|75590105|FG000|STARTED|Overall Study||105||
59498863|NCT05086289|75590106|FG001|STARTED|Overall Study||54||
59498864|NCT05086289|75590105|FG000|Received at Least One Dose of Study Drug (Safety Population Week 1-4)|Overall Study||105||
59498865|NCT05086289|75590106|FG001|Received at Least One Dose of Study Drug (Safety Population Week 1-4)|Overall Study||54||
59498866|NCT05086289|75590105|FG000|Safety Population Week 5-8|Overall Study||92|All participants who took at least 1 dose of study drug and who did not discontinue at or prior to week 4.|
59498867|NCT05086289|75590106|FG001|Safety Population Week 5-8|Overall Study||50|All participants who took at least 1 dose of study drug and who did not discontinue at or prior to week 4.|
59498868|NCT05086289|75590105|FG000|COMPLETED|Overall Study||90||
59498869|NCT05086289|75590106|FG001|COMPLETED|Overall Study||49||
59498870|NCT05086289|75590105|FG000|NOT COMPLETED|Overall Study||15||
59498871|NCT05086289|75590106|FG001|NOT COMPLETED|Overall Study||5||
59607267|NCT03828149|75717836|FG000|STARTED|First Intervention (Single Dose)||9||
59607268|NCT03828149|75717837|FG001|STARTED|First Intervention (Single Dose)||8||
59607269|NCT03828149|75717836|FG000|COMPLETED|First Intervention (Single Dose)||9||
59498872|NCT05045144|75590119|FG000|STARTED|Overall Study||220||
59498873|NCT05045144|75590120|FG001|STARTED|Overall Study||223||
59498874|NCT05045144|75590121|FG002|STARTED|Overall Study||218||
59498875|NCT05045144|75590122|FG003|STARTED|Overall Study||438||
59498876|NCT05045144|75590123|FG004|STARTED|Overall Study||440||
59498877|NCT05045144|75590119|FG000|COMPLETED|Overall Study||217||
59498878|NCT05045144|75590120|FG001|COMPLETED|Overall Study||220||
59498879|NCT05045144|75590121|FG002|COMPLETED|Overall Study||214||
59498880|NCT05045144|75590122|FG003|COMPLETED|Overall Study||433||
59498881|NCT05045144|75590123|FG004|COMPLETED|Overall Study||427||
59498882|NCT05045144|75590119|FG000|NOT COMPLETED|Overall Study||3||
59498883|NCT05045144|75590120|FG001|NOT COMPLETED|Overall Study||3||
59498884|NCT05045144|75590121|FG002|NOT COMPLETED|Overall Study||4||
59498885|NCT05045144|75590122|FG003|NOT COMPLETED|Overall Study||5||
59498886|NCT05045144|75590123|FG004|NOT COMPLETED|Overall Study||13||
59498887|NCT05016765|75590139|FG000|STARTED|Overall Study||31||
59498888|NCT05016765|75590139|FG000|Completed At Least 1 EMA (Ecological Momentary Assessment) Survey|Overall Study||30||
59498889|NCT05016765|75590139|FG000|COMPLETED|Overall Study||27||
59498890|NCT05016765|75590139|FG000|NOT COMPLETED|Overall Study||4||
59498891|NCT04982029|75590146|FG000|STARTED|Overall Study||7||
59498892|NCT04982029|75590147|FG001|STARTED|Overall Study||8||
60012622|NCT03382782|76128595|FG000|STARTED|Cohort 3||17||
60012623|NCT03382782|76128596|FG001|STARTED|Cohort 3||19||
60012624|NCT03382782|76128597|FG002|STARTED|Cohort 3||13||
60012625|NCT03382782|76128595|FG000|COMPLETED|Cohort 3||16||
60012626|NCT03382782|76128596|FG001|COMPLETED|Cohort 3||17||
60012627|NCT03382782|76128597|FG002|COMPLETED|Cohort 3||13||
60012628|NCT03382782|76128595|FG000|NOT COMPLETED|Cohort 3||1||
60012629|NCT03382782|76128596|FG001|NOT COMPLETED|Cohort 3||2||
60012630|NCT03382782|76128597|FG002|NOT COMPLETED|Cohort 3||0||
60012631|NCT03195140|76128607|FG000|STARTED|Overall Study||52||
60012632|NCT03195140|76128608|FG001|STARTED|Overall Study||51||
60012633|NCT03195140|76128607|FG000|COMPLETED|Overall Study||52||
60012634|NCT03195140|76128608|FG001|COMPLETED|Overall Study||51||
60012635|NCT03195140|76128607|FG000|NOT COMPLETED|Overall Study||0||
60012636|NCT03195140|76128608|FG001|NOT COMPLETED|Overall Study||0||
59498893|NCT04982029|75590146|FG000|Baseline|Overall Study||7|This milestone represents the baseline measures and initial study visit.|
59498894|NCT04982029|75590147|FG001|Baseline|Overall Study||8|This milestone represents the baseline measures and initial study visit.|
59498895|NCT04982029|75590146|FG000|First Intervention|Overall Study||5|This is the visit where participants receive their first intervention.|
59498896|NCT04982029|75590147|FG001|First Intervention|Overall Study||5|This is the visit where participants receive their first intervention.|
59498897|NCT04982029|75590146|FG000|Second Intervention|Overall Study||5|This is the study visit where participants receive their second intervention after the 7-day washout period.|
59498898|NCT04982029|75590147|FG001|Second Intervention|Overall Study||5|This is the study visit where participants receive their second intervention after the 7-day washout period.|
59498899|NCT04982029|75590146|FG000|COMPLETED|Overall Study||5||
60012637|NCT02877693|76128615|FG000|STARTED|Overall Study||205||
60012638|NCT02877693|76128616|FG001|STARTED|Overall Study|This arm was not completed. As of the data cut-off date for this clinical study report subject enrollment criteria was met for the 1st arm of the study and the sponsor decided not to move forward with 3T arm of the study.|0||
60012639|NCT02877693|76128615|FG000|COMPLETED|Overall Study||177||
60012640|NCT02877693|76128616|FG001|COMPLETED|Overall Study||0||
60012641|NCT02877693|76128615|FG000|NOT COMPLETED|Overall Study||28||
60012642|NCT02877693|76128616|FG001|NOT COMPLETED|Overall Study||0||
60012643|NCT02876328|76128644|FG000|STARTED|Overall Study||396||
59498900|NCT04982029|75590147|FG001|COMPLETED|Overall Study||5||
59498901|NCT04982029|75590146|FG000|NOT COMPLETED|Overall Study||2||
59498902|NCT04982029|75590147|FG001|NOT COMPLETED|Overall Study||3||
59498903|NCT04897867|75590161|FG000|STARTED|Overall Study||110||
59498904|NCT04897867|75590161|FG000|Safety Population|Overall Study||110|Safety Population consisted of all enrolled participants who received at least one cryolipolysis treatment cycle (started or completed).|
59498905|NCT04897867|75590161|FG000|Received Treatment in Session 2|Overall Study||100||
59498906|NCT04897867|75590161|FG000|Evaluable Population 1|Overall Study||96|Evaluable Population 1 consisted of all participants who completed the cryolipolysis treatment plan to the midsection and completed the Cryolipolysis Satisfaction Questionnaire (CSQ)-Midsection Item #1 at 12 weeks after the final treatment session and who do not have any significant protocol deviation or violation.|
60012644|NCT02876328|76128645|FG001|STARTED|Overall Study||221||
60012645|NCT02876328|76128646|FG002|STARTED|Overall Study||395||
60012646|NCT02876328|76128647|FG003|STARTED|Overall Study||197||
60012647|NCT02876328|76128648|FG004|STARTED|Overall Study||191||
60012648|NCT02876328|76128649|FG005|STARTED|Overall Study||403||
60012649|NCT02876328|76128650|FG006|STARTED|Overall Study||179||
60012650|NCT02876328|76128651|FG007|STARTED|Overall Study||407||
60012651|NCT02876328|76128652|FG008|STARTED|Overall Study||202||
60012652|NCT02876328|76128653|FG009|STARTED|Overall Study||210||
60012653|NCT02876328|76128654|FG010|STARTED|Overall Study||187||
60012654|NCT02876328|76128655|FG011|STARTED|Overall Study||99||
60012655|NCT02876328|76128656|FG012|STARTED|Overall Study||177||
60012656|NCT02876328|76128657|FG013|STARTED|Overall Study||99||
60012657|NCT02876328|76128658|FG014|STARTED|Overall Study||100||
60012658|NCT02876328|76128659|FG015|STARTED|Overall Study||227||
60012659|NCT02876328|76128660|FG016|STARTED|Overall Study||107||
60012660|NCT02876328|76128661|FG017|STARTED|Overall Study||237||
60012661|NCT02876328|76128662|FG018|STARTED|Overall Study||108||
60012662|NCT02876328|76128663|FG019|STARTED|Overall Study||107||
60012663|NCT02876328|76128664|FG020|STARTED|Overall Study||324||
60012664|NCT02876328|76128665|FG021|STARTED|Overall Study||172||
60012665|NCT02876328|76128666|FG022|STARTED|Overall Study||34||
59498907|NCT04897867|75590161|FG000|Evaluable Population 3|Overall Study||107|Evaluable Population 3 consisted of all participants who completed the cryolipolysis treatment plan for any body areas (Midsection, Upper Arms, Inner Thighs, Outer Thighs and Submental Area) and do not have any significant protocol deviation or violation.|
59498908|NCT04897867|75590161|FG000|COMPLETED|Overall Study||99||
59754834|NCT02041195|75873656|FG007|STARTED|Overall Study||28||
59754835|NCT02041195|75873649|FG000|COMPLETED|Overall Study||8||
59754836|NCT02041195|75873650|FG001|COMPLETED|Overall Study||6||
59754837|NCT02041195|75873651|FG002|COMPLETED|Overall Study||3||
59754838|NCT02041195|75873652|FG003|COMPLETED|Overall Study||3||
59754839|NCT02041195|75873653|FG004|COMPLETED|Overall Study||10||
59754840|NCT02041195|75873654|FG005|COMPLETED|Overall Study||6||
59754841|NCT02041195|75873655|FG006|COMPLETED|Overall Study||22||
59754842|NCT02041195|75873656|FG007|COMPLETED|Overall Study||25||
59754843|NCT02041195|75873649|FG000|NOT COMPLETED|Overall Study||2||
59754844|NCT02041195|75873650|FG001|NOT COMPLETED|Overall Study||3||
59754845|NCT02041195|75873651|FG002|NOT COMPLETED|Overall Study||0||
59885244|NCT03560739|76008071|FG002|COMPLETED|Overall Study||13||
59498909|NCT04897867|75590161|FG000|NOT COMPLETED|Overall Study||11||
59498910|NCT04731714|75590170|FG000|STARTED|Overall Study||16||
59498911|NCT04731714|75590171|FG001|STARTED|Overall Study||16||
59498912|NCT04731714|75590170|FG000|Completed Study Visit 1|Overall Study||16||
59498913|NCT04731714|75590171|FG001|Completed Study Visit 1|Overall Study||16||
59498914|NCT04731714|75590170|FG000|Completed Study Visit 2|Overall Study||16||
59498915|NCT04731714|75590171|FG001|Completed Study Visit 2|Overall Study||16||
59498916|NCT04731714|75590170|FG000|COMPLETED|Overall Study||16||
59498917|NCT04731714|75590171|FG001|COMPLETED|Overall Study||16||
59498918|NCT04731714|75590170|FG000|NOT COMPLETED|Overall Study||0||
59498919|NCT04731714|75590171|FG001|NOT COMPLETED|Overall Study||0||
59498920|NCT04671329|75590176|FG000|STARTED|Overall Study||67||
59498921|NCT04671329|75590176|FG000|COMPLETED|Overall Study||60||
59498922|NCT04671329|75590176|FG000|NOT COMPLETED|Overall Study||7||
59498923|NCT04571242|75590182|FG000|STARTED|3 Months||51||
59498924|NCT04571242|75590183|FG001|STARTED|3 Months||54||
59498925|NCT04571242|75590182|FG000|COMPLETED|3 Months||46||
59498926|NCT04571242|75590183|FG001|COMPLETED|3 Months||44||
59498927|NCT04571242|75590182|FG000|NOT COMPLETED|3 Months||5||
59498928|NCT04571242|75590183|FG001|NOT COMPLETED|3 Months||10||
59498929|NCT04571242|75590182|FG000|STARTED|6 Months||46||
59498930|NCT04571242|75590183|FG001|STARTED|6 Months||44||
59498931|NCT04571242|75590182|FG000|COMPLETED|6 Months||42||
59498932|NCT04571242|75590183|FG001|COMPLETED|6 Months||43||
59498933|NCT04571242|75590182|FG000|NOT COMPLETED|6 Months||4||
59498934|NCT04571242|75590183|FG001|NOT COMPLETED|6 Months||1||
59498935|NCT04571242|75590182|FG000|STARTED|9 Months|14 subjects from Conventional-SCS crossed over to DTM-SCS after the 6 months visit.|56||
59498936|NCT04571242|75590183|FG001|STARTED|9 Months|0 subjects from DTM-SCS programming crossed over to Conventional SCS programming.|29||
59498937|NCT04571242|75590182|FG000|COMPLETED|9 Months||56||
59498938|NCT04571242|75590183|FG001|COMPLETED|9 Months||28||
59498939|NCT04571242|75590182|FG000|NOT COMPLETED|9 Months||0||
59498940|NCT04571242|75590183|FG001|NOT COMPLETED|9 Months||1||
59498941|NCT04571242|75590182|FG000|STARTED|12 Months||56||
59498942|NCT04571242|75590183|FG001|STARTED|12 Months||28||
59498943|NCT04571242|75590182|FG000|COMPLETED|12 Months||55||
59498944|NCT04571242|75590183|FG001|COMPLETED|12 Months||28||
59498945|NCT04571242|75590182|FG000|NOT COMPLETED|12 Months||1||
59885245|NCT03560739|76008072|FG003|COMPLETED|Overall Study||13||
59498946|NCT04571242|75590183|FG001|NOT COMPLETED|12 Months||0||
59498947|NCT04406857|75590189|FG000|STARTED|Overall Study||1||
59498948|NCT04406857|75590189|FG000|COMPLETED|Overall Study||1||
59498949|NCT04406857|75590189|FG000|NOT COMPLETED|Overall Study||0||
59498950|NCT04222712|75590195|FG000|STARTED|Overall Study||8||
59498951|NCT04222712|75590196|FG001|STARTED|Overall Study||8||
59498952|NCT04222712|75590195|FG000|COMPLETED|Overall Study||8||
59754846|NCT02041195|75873652|FG003|NOT COMPLETED|Overall Study||0||
59754847|NCT02041195|75873653|FG004|NOT COMPLETED|Overall Study||1||
59754848|NCT02041195|75873654|FG005|NOT COMPLETED|Overall Study||0||
59885246|NCT03560739|76008069|FG000|NOT COMPLETED|Overall Study||0||
59498953|NCT04222712|75590196|FG001|COMPLETED|Overall Study||8||
59498954|NCT04222712|75590195|FG000|NOT COMPLETED|Overall Study||0||
59885247|NCT03560739|76008070|FG001|NOT COMPLETED|Overall Study||1||
59885248|NCT03560739|76008071|FG002|NOT COMPLETED|Overall Study||0||
59885249|NCT03560739|76008072|FG003|NOT COMPLETED|Overall Study||0||
59885250|NCT00101686|76008092|FG000|STARTED|Overall Study||71||
59885251|NCT00101686|76008093|FG001|STARTED|Overall Study||73||
59885252|NCT00101686|76008094|FG002|STARTED|Overall Study||69||
59885253|NCT00101686|76008095|FG003|STARTED|Overall Study||72||
59885254|NCT00101686|76008096|FG004|STARTED|Overall Study||73||
59885255|NCT00101686|76008097|FG005|STARTED|Overall Study||72||
59885256|NCT00101686|76008098|FG006|STARTED|Overall Study||27||
59885257|NCT00101686|76008099|FG007|STARTED|Overall Study||30||
59885258|NCT00101686|76008100|FG008|STARTED|Overall Study||30||
59885259|NCT00101686|76008101|FG009|STARTED|Overall Study||30||
59885260|NCT00101686|76008092|FG000|Received Treatment|Overall Study||70||
59885261|NCT00101686|76008093|FG001|Received Treatment|Overall Study||67||
59885262|NCT00101686|76008094|FG002|Received Treatment|Overall Study||67||
59885263|NCT00101686|76008095|FG003|Received Treatment|Overall Study||70||
59885264|NCT00101686|76008096|FG004|Received Treatment|Overall Study||71||
59885265|NCT00101686|76008097|FG005|Received Treatment|Overall Study||70||
59885266|NCT00101686|76008098|FG006|Received Treatment|Overall Study||27||
59885267|NCT00101686|76008099|FG007|Received Treatment|Overall Study||29||
59885268|NCT00101686|76008100|FG008|Received Treatment|Overall Study||30||
59885269|NCT00101686|76008101|FG009|Received Treatment|Overall Study||29||
59885270|NCT00101686|76008092|FG000|COMPLETED|Overall Study|Patients treated until disease progression.|0||
59885271|NCT00101686|76008093|FG001|COMPLETED|Overall Study|Patients treated until disease progression.|0||
59885272|NCT00101686|76008094|FG002|COMPLETED|Overall Study|Patients treated until disease progression.|0||
59885273|NCT00101686|76008095|FG003|COMPLETED|Overall Study|Patients treated until disease progression.|0||
59885274|NCT00101686|76008096|FG004|COMPLETED|Overall Study|Patients treated until disease progression.|0||
59885275|NCT00101686|76008097|FG005|COMPLETED|Overall Study|Patients treated until disease progression.|0||
59885276|NCT00101686|76008098|FG006|COMPLETED|Overall Study|Patients treated until disease progression.|0||
59885277|NCT00101686|76008099|FG007|COMPLETED|Overall Study|Patients treated until disease progression.|0||
59885278|NCT00101686|76008100|FG008|COMPLETED|Overall Study|Patients treated until disease progression.|0||
59885279|NCT00101686|76008101|FG009|COMPLETED|Overall Study|Patients treated until disease progression.|0||
59885280|NCT00101686|76008092|FG000|NOT COMPLETED|Overall Study||71||
59885281|NCT00101686|76008093|FG001|NOT COMPLETED|Overall Study||73||
59885282|NCT00101686|76008094|FG002|NOT COMPLETED|Overall Study||69||
59885283|NCT00101686|76008095|FG003|NOT COMPLETED|Overall Study||72||
59885284|NCT00101686|76008096|FG004|NOT COMPLETED|Overall Study||73||
59885285|NCT00101686|76008097|FG005|NOT COMPLETED|Overall Study||72||
59885286|NCT00101686|76008098|FG006|NOT COMPLETED|Overall Study||27||
59498955|NCT04222712|75590196|FG001|NOT COMPLETED|Overall Study||0||
59498956|NCT04161157|75590202|FG000|STARTED|Overall Study||53||
59498957|NCT04161157|75590202|FG000|COMPLETED|Overall Study||40||
59498958|NCT04161157|75590202|FG000|NOT COMPLETED|Overall Study||13||
59885287|NCT00101686|76008099|FG007|NOT COMPLETED|Overall Study||30||
59885288|NCT00101686|76008100|FG008|NOT COMPLETED|Overall Study||30||
59885289|NCT00101686|76008101|FG009|NOT COMPLETED|Overall Study||30||
59885290|NCT00101452|76008121|FG000|STARTED|Overall Study||65||
59885291|NCT00101452|76008122|FG001|STARTED|Overall Study||69||
59885292|NCT00101452|76008123|FG002|STARTED|Overall Study||65||
59885293|NCT00101452|76008121|FG000|COMPLETED|Overall Study||21||
59885294|NCT00101452|76008122|FG001|COMPLETED|Overall Study||26||
59885295|NCT00101452|76008123|FG002|COMPLETED|Overall Study||22||
59885296|NCT00101452|76008121|FG000|NOT COMPLETED|Overall Study||44||
59885297|NCT00101452|76008122|FG001|NOT COMPLETED|Overall Study||43||
59498959|NCT04035187|75590210|FG000|STARTED|Overall Study||4||
59498960|NCT04035187|75590211|FG001|STARTED|Overall Study||4||
59498961|NCT04035187|75590212|FG002|STARTED|Overall Study||4||
59498962|NCT04035187|75590213|FG003|STARTED|Overall Study||5||
59498963|NCT04035187|75590210|FG000|COMPLETED|Overall Study||2||
59498964|NCT04035187|75590211|FG001|COMPLETED|Overall Study||2||
59498965|NCT04035187|75590212|FG002|COMPLETED|Overall Study||4||
59498966|NCT04035187|75590213|FG003|COMPLETED|Overall Study||4||
59498967|NCT04035187|75590210|FG000|NOT COMPLETED|Overall Study||2||
59498968|NCT04035187|75590211|FG001|NOT COMPLETED|Overall Study||2||
59498969|NCT04035187|75590212|FG002|NOT COMPLETED|Overall Study||0||
59498970|NCT04035187|75590213|FG003|NOT COMPLETED|Overall Study||1||
59498971|NCT03852719|75590226|FG000|STARTED|Overall Study||51||
59498972|NCT03852719|75590227|FG001|STARTED|Overall Study||49||
59498973|NCT03852719|75590228|FG002|STARTED|Overall Study||50||
59498974|NCT03852719|75590226|FG000|Did Not Receive Study Drug|Overall Study||1||
59498975|NCT03852719|75590227|FG001|Did Not Receive Study Drug|Overall Study||0||
59498976|NCT03852719|75590228|FG002|Did Not Receive Study Drug|Overall Study||0||
59498977|NCT03852719|75590226|FG000|COMPLETED|Overall Study||0||
59498978|NCT03852719|75590227|FG001|COMPLETED|Overall Study||0||
59498979|NCT03852719|75590228|FG002|COMPLETED|Overall Study||0||
59498980|NCT03852719|75590226|FG000|NOT COMPLETED|Overall Study||51||
59498981|NCT03852719|75590227|FG001|NOT COMPLETED|Overall Study||49||
59498982|NCT03852719|75590228|FG002|NOT COMPLETED|Overall Study||50||
59498983|NCT03785145|75590245|FG000|STARTED|Cycle 1 - Double Blind (Days 1-180)|Note: 1 participant was randomized to the placebo group but was not treated. While 77 participants were randomized only 76 were treated in the placebo group.|77||
59498984|NCT03785145|75590246|FG001|STARTED|Cycle 1 - Double Blind (Days 1-180)||158||
59498985|NCT03785145|75590245|FG000|COMPLETED|Cycle 1 - Double Blind (Days 1-180)||68||
59498986|NCT03785145|75590246|FG001|COMPLETED|Cycle 1 - Double Blind (Days 1-180)||145||
59498987|NCT03785145|75590245|FG000|NOT COMPLETED|Cycle 1 - Double Blind (Days 1-180)||9||
59498988|NCT03785145|75590246|FG001|NOT COMPLETED|Cycle 1 - Double Blind (Days 1-180)||13||
59498989|NCT03785145|75590245|FG000|STARTED|Cycle 2 - Open Label Treatment 1||65||
59498990|NCT03785145|75590246|FG001|STARTED|Cycle 2 - Open Label Treatment 1||144||
59498991|NCT03785145|75590245|FG000|COMPLETED|Cycle 2 - Open Label Treatment 1||61||
59498992|NCT03785145|75590246|FG001|COMPLETED|Cycle 2 - Open Label Treatment 1||130||
59498993|NCT03785145|75590245|FG000|NOT COMPLETED|Cycle 2 - Open Label Treatment 1||4||
59498994|NCT03785145|75590246|FG001|NOT COMPLETED|Cycle 2 - Open Label Treatment 1||14||
59498995|NCT03785145|75590245|FG000|STARTED|Cycle 3 - Open Label Treatment 2||49||
59498996|NCT03785145|75590246|FG001|STARTED|Cycle 3 - Open Label Treatment 2||91||
59498997|NCT03785145|75590245|FG000|COMPLETED|Cycle 3 - Open Label Treatment 2||49||
59498998|NCT03785145|75590246|FG001|COMPLETED|Cycle 3 - Open Label Treatment 2||88||
59498999|NCT03785145|75590245|FG000|NOT COMPLETED|Cycle 3 - Open Label Treatment 2||0||
59499000|NCT03785145|75590246|FG001|NOT COMPLETED|Cycle 3 - Open Label Treatment 2||3||
59499001|NCT03616184|75590252|FG000|STARTED|Overall Study||47||
59499002|NCT03616184|75590252|FG000|COMPLETED|Overall Study||34||
59499003|NCT03616184|75590252|FG000|NOT COMPLETED|Overall Study||13||
59499004|NCT03574610|75590256|FG000|STARTED|Overall Study||11||
59499005|NCT03574610|75590256|FG000|COMPLETED|Overall Study||10||
59499006|NCT03574610|75590256|FG000|NOT COMPLETED|Overall Study||1||
59499007|NCT03452891|75590262|FG000|STARTED|Overall Study|25 subjects|25||
59499008|NCT03452891|75590263|FG001|STARTED|Overall Study||25||
59499009|NCT03452891|75590262|FG000|Subjects Enrolled|Overall Study||25||
59499010|NCT03452891|75590263|FG001|Subjects Enrolled|Overall Study||25||
59499011|NCT03452891|75590262|FG000|Subjects Completing Study|Overall Study||25||
59499012|NCT03452891|75590263|FG001|Subjects Completing Study|Overall Study||25||
59499013|NCT03452891|75590262|FG000|COMPLETED|Overall Study||25||
59499014|NCT03452891|75590263|FG001|COMPLETED|Overall Study||25||
59499015|NCT03452891|75590262|FG000|NOT COMPLETED|Overall Study||0||
59499016|NCT03452891|75590263|FG001|NOT COMPLETED|Overall Study||0||
59499017|NCT03320330|75590272|FG000|STARTED|Overall Study||6||
59499018|NCT03320330|75590273|FG001|STARTED|Overall Study||6||
59499019|NCT03320330|75590274|FG002|STARTED|Overall Study||14||
59499020|NCT03320330|75590272|FG000|COMPLETED|Overall Study||0||
59499021|NCT03320330|75590273|FG001|COMPLETED|Overall Study||1||
59499022|NCT03320330|75590274|FG002|COMPLETED|Overall Study||0||
59499023|NCT03320330|75590272|FG000|NOT COMPLETED|Overall Study||6||
59499024|NCT03320330|75590273|FG001|NOT COMPLETED|Overall Study||5||
59499025|NCT03320330|75590274|FG002|NOT COMPLETED|Overall Study||14||
59499026|NCT03300258|75590283|FG000|STARTED|Overall Study||44||
59499027|NCT03300258|75590284|FG001|STARTED|Overall Study||0||
59499028|NCT03300258|75590285|FG002|STARTED|Overall Study||0||
59499029|NCT03300258|75590286|FG003|STARTED|Overall Study||0||
59499030|NCT03300258|75590283|FG000|Group 1: Reaching Against a Spring-Like Torque|Overall Study||12||
59499031|NCT03300258|75590284|FG001|Group 1: Reaching Against a Spring-Like Torque|Overall Study||0||
59499032|NCT03300258|75590285|FG002|Group 1: Reaching Against a Spring-Like Torque|Overall Study||0||
59499033|NCT03300258|75590286|FG003|Group 1: Reaching Against a Spring-Like Torque|Overall Study||0||
59499034|NCT03300258|75590283|FG000|Group 2: Reaching Against a Damper-like Force|Overall Study||11||
59499035|NCT03300258|75590284|FG001|Group 2: Reaching Against a Damper-like Force|Overall Study||0||
59499036|NCT03300258|75590285|FG002|Group 2: Reaching Against a Damper-like Force|Overall Study||0||
59499037|NCT03300258|75590286|FG003|Group 2: Reaching Against a Damper-like Force|Overall Study||0||
59499038|NCT03300258|75590283|FG000|Group 3: Half-Reversed Cycling Task|Overall Study||21||
59499039|NCT03300258|75590284|FG001|Group 3: Half-Reversed Cycling Task|Overall Study||0||
59499040|NCT03300258|75590285|FG002|Group 3: Half-Reversed Cycling Task|Overall Study||0||
59499041|NCT03300258|75590286|FG003|Group 3: Half-Reversed Cycling Task|Overall Study||0||
59499042|NCT03300258|75590283|FG000|COMPLETED|Overall Study||44||
59499043|NCT03300258|75590284|FG001|COMPLETED|Overall Study||0||
59499044|NCT03300258|75590285|FG002|COMPLETED|Overall Study||0||
59499045|NCT03300258|75590286|FG003|COMPLETED|Overall Study||0||
59499046|NCT03300258|75590283|FG000|NOT COMPLETED|Overall Study||0||
59499047|NCT03300258|75590284|FG001|NOT COMPLETED|Overall Study||0||
59499048|NCT03300258|75590285|FG002|NOT COMPLETED|Overall Study||0||
59499049|NCT03300258|75590286|FG003|NOT COMPLETED|Overall Study||0||
59499050|NCT03296033|75590298|FG000|STARTED|Overall Study||60||
59499051|NCT03296033|75590299|FG001|STARTED|Overall Study||62||
59499052|NCT03296033|75590298|FG000|COMPLETED|Overall Study||51||
59499053|NCT03296033|75590299|FG001|COMPLETED|Overall Study||52||
59499054|NCT03296033|75590298|FG000|NOT COMPLETED|Overall Study||9||
59499055|NCT03296033|75590299|FG001|NOT COMPLETED|Overall Study||10||
59499056|NCT03284788|75590307|FG000|STARTED|Overall Study||13||
59499057|NCT03284788|75590307|FG000|COMPLETED|Overall Study||11||
59499058|NCT03284788|75590307|FG000|NOT COMPLETED|Overall Study||2||
59499059|NCT03082612|75590313|FG000|STARTED|Overall Study||17||
59499060|NCT03082612|75590314|FG001|STARTED|Overall Study||5||
59499061|NCT03082612|75590313|FG000|COMPLETED|Overall Study||15||
59499062|NCT03082612|75590314|FG001|COMPLETED|Overall Study||5||
59499063|NCT03082612|75590313|FG000|NOT COMPLETED|Overall Study||2||
59499064|NCT03082612|75590314|FG001|NOT COMPLETED|Overall Study||0||
59499065|NCT03018418|75590320|FG000|STARTED|Overall Study||14||
59499066|NCT03018418|75590320|FG000|COMPLETED|Overall Study||14||
59499067|NCT03018418|75590320|FG000|NOT COMPLETED|Overall Study||0||
59499068|NCT02874404|75590329|FG000|STARTED|Overall Study||13||
59499069|NCT02874404|75590329|FG000|COMPLETED|Overall Study||13||
59499070|NCT02874404|75590329|FG000|NOT COMPLETED|Overall Study||0||
59499071|NCT02866669|75590338|FG000|STARTED|Overall Study||406|Practices Randomized|18
59499072|NCT02866669|75590339|FG001|STARTED|Overall Study||382|Practices Randomized|16
59499073|NCT02866669|75590340|FG002|STARTED|Overall Study||424|Practices Randomized|19
59499074|NCT02866669|75590341|FG003|STARTED|Overall Study||380|Practices Randomized|16
59499075|NCT02866669|75590338|FG000|COMPLETED|Overall Study||342||16
59499076|NCT02866669|75590339|FG001|COMPLETED|Overall Study||260||12
59499077|NCT02866669|75590340|FG002|COMPLETED|Overall Study||332||17
59499078|NCT02866669|75590341|FG003|COMPLETED|Overall Study||275||15
59499079|NCT02866669|75590338|FG000|NOT COMPLETED|Overall Study||64||2
59499080|NCT02866669|75590339|FG001|NOT COMPLETED|Overall Study||122||4
59499081|NCT02866669|75590340|FG002|NOT COMPLETED|Overall Study||92||2
59499082|NCT02866669|75590341|FG003|NOT COMPLETED|Overall Study||105||1
59499083|NCT02824627|75590353|FG000|STARTED|Overall Study||28||
59499084|NCT02824627|75590354|FG001|STARTED|Overall Study||30||
59499085|NCT02824627|75590353|FG000|COMPLETED|Overall Study||25||
59499086|NCT02824627|75590354|FG001|COMPLETED|Overall Study||27||
59499087|NCT02824627|75590353|FG000|NOT COMPLETED|Overall Study||3||
59499088|NCT02824627|75590354|FG001|NOT COMPLETED|Overall Study||3||
59499089|NCT02743611|75590360|FG000|STARTED|Overall Study||4|All 4 enrolled subjects were enrolled into Arm 1 and started w/ the 1.25 x 10E6 cells/kg dose.|
59499090|NCT02743611|75590361|FG001|STARTED|Overall Study|This study was terminated early. No subjects were enrolled in Arm 2 per Sponsor discretion.|0|All 4 enrolled subjects were enrolled into Arm 1 and started w/ the 1.25 x 10E6 cells/kg dose.|
59499091|NCT02743611|75590362|FG002|STARTED|Overall Study|This study was terminated early. No subjects were enrolled in Arm 1 Part 2 per Sponsor discretion.|0|All 4 enrolled subjects were enrolled into Arm 1 and started w/ the 1.25 x 10E6 cells/kg dose.|
59499092|NCT02743611|75590363|FG003|STARTED|Overall Study|This study was terminated early. No subjects were enrolled in Arm 2 Part 2 per Sponsor discretion.|0|All 4 enrolled subjects were enrolled into Arm 1 and started w/ the 1.25 x 10E6 cells/kg dose.|
59499093|NCT02743611|75590360|FG000|COMPLETED|Overall Study||0||
59499094|NCT02743611|75590361|FG001|COMPLETED|Overall Study||0||
59499095|NCT02743611|75590362|FG002|COMPLETED|Overall Study||0||
59499096|NCT02743611|75590363|FG003|COMPLETED|Overall Study||0||
59499097|NCT02743611|75590360|FG000|NOT COMPLETED|Overall Study||4||
59499098|NCT02743611|75590361|FG001|NOT COMPLETED|Overall Study||0||
59499099|NCT02743611|75590362|FG002|NOT COMPLETED|Overall Study||0||
59499100|NCT02743611|75590363|FG003|NOT COMPLETED|Overall Study||0||
59499101|NCT02186600|75590371|FG000|STARTED|Overall Study||93||
59499102|NCT02186600|75590372|FG001|STARTED|Overall Study||91||
59499103|NCT02186600|75590373|FG002|STARTED|Overall Study||92||
59499104|NCT02186600|75590371|FG000|COMPLETED|Overall Study||77||
59499105|NCT02186600|75590372|FG001|COMPLETED|Overall Study||78||
59499106|NCT02186600|75590373|FG002|COMPLETED|Overall Study||72||
59499107|NCT02186600|75590371|FG000|NOT COMPLETED|Overall Study||16||
59499108|NCT02186600|75590372|FG001|NOT COMPLETED|Overall Study||13||
59499109|NCT02186600|75590373|FG002|NOT COMPLETED|Overall Study||20||
59499110|NCT01873833|75590381|FG000|STARTED|Overall Study||10||
59499111|NCT01873833|75590381|FG000|COMPLETED|Overall Study||9||
59499112|NCT01873833|75590381|FG000|NOT COMPLETED|Overall Study||1||
59499113|NCT01431209|75590387|FG000|STARTED|Overall Study||47||
59499114|NCT01431209|75590388|FG001|STARTED|Overall Study||13||
59499115|NCT01431209|75590387|FG000|COMPLETED|Overall Study||43||
59499116|NCT01431209|75590388|FG001|COMPLETED|Overall Study||12||
59499117|NCT01431209|75590387|FG000|NOT COMPLETED|Overall Study||4||
59499118|NCT01431209|75590388|FG001|NOT COMPLETED|Overall Study||1||
59499119|NCT00826020|75590394|FG000|STARTED|Overall Study||72||
59499120|NCT00826020|75590394|FG000|COMPLETED|Overall Study||72||
59499121|NCT00826020|75590394|FG000|NOT COMPLETED|Overall Study||0||
59499122|NCT00754208|75590398|FG000|STARTED|Overall Study||7||
59499123|NCT00754208|75590398|FG000|COMPLETED|Overall Study||7||
59499124|NCT00754208|75590398|FG000|NOT COMPLETED|Overall Study||0||
59499125|NCT00547729|75590403|FG000|STARTED|Overall Study||71||
59499126|NCT00547729|75590403|FG000|COMPLETED|Overall Study||71||
59499127|NCT00547729|75590403|FG000|NOT COMPLETED|Overall Study||0||
59499128|NCT00518089|75590409|FG000|STARTED|Overall Study||430||
59499129|NCT00518089|75590410|FG001|STARTED|Overall Study||429||
59499130|NCT00518089|75590409|FG000|COMPLETED|Overall Study||402||
59499131|NCT00518089|75590410|FG001|COMPLETED|Overall Study||398||
59499132|NCT00518089|75590409|FG000|NOT COMPLETED|Overall Study||28||
59499133|NCT00518089|75590410|FG001|NOT COMPLETED|Overall Study||31||
59499134|NCT00518713|75590420|FG000|STARTED|Overall Study||58||
59499135|NCT00518713|75590421|FG001|STARTED|Overall Study||62||
59499136|NCT00518713|75590422|FG002|STARTED|Overall Study||59||
59499137|NCT00518713|75590423|FG003|STARTED|Overall Study||59||
59499138|NCT00518713|75590420|FG000|Modified Intent-to-Treat Population|Overall Study||53||
59499139|NCT00518713|75590421|FG001|Modified Intent-to-Treat Population|Overall Study||58||
59499140|NCT00518713|75590422|FG002|Modified Intent-to-Treat Population|Overall Study||49||
59499141|NCT00518713|75590423|FG003|Modified Intent-to-Treat Population|Overall Study||57||
59499142|NCT00518713|75590420|FG000|COMPLETED|Overall Study||50||
59499143|NCT00518713|75590421|FG001|COMPLETED|Overall Study||45||
59499144|NCT00518713|75590422|FG002|COMPLETED|Overall Study||41||
59499145|NCT00518713|75590423|FG003|COMPLETED|Overall Study||41||
59499146|NCT00518713|75590420|FG000|NOT COMPLETED|Overall Study||8||
59499147|NCT00518713|75590421|FG001|NOT COMPLETED|Overall Study||17||
59499148|NCT00518713|75590422|FG002|NOT COMPLETED|Overall Study||18||
59499149|NCT00518713|75590423|FG003|NOT COMPLETED|Overall Study||18||
59499150|NCT00521989|75590438|FG000|STARTED|Overall Study||56||
59499151|NCT00521989|75590439|FG001|STARTED|Overall Study||54||
59499152|NCT00521989|75590440|FG002|STARTED|Overall Study||57||
59499153|NCT00521989|75590441|FG003|STARTED|Overall Study||54||
59499154|NCT00521989|75590442|FG004|STARTED|Overall Study||58||
59499155|NCT00521989|75590438|FG000|COMPLETED|Overall Study||36||
59499156|NCT00521989|75590439|FG001|COMPLETED|Overall Study||37||
59499157|NCT00521989|75590440|FG002|COMPLETED|Overall Study||41||
59499158|NCT00521989|75590441|FG003|COMPLETED|Overall Study||42||
59499159|NCT00521989|75590442|FG004|COMPLETED|Overall Study||35||
59499160|NCT00521989|75590438|FG000|NOT COMPLETED|Overall Study||20||
59499161|NCT00521989|75590439|FG001|NOT COMPLETED|Overall Study||17||
59499162|NCT00521989|75590440|FG002|NOT COMPLETED|Overall Study||16||
59885298|NCT00101452|76008123|FG002|NOT COMPLETED|Overall Study||43||
59885299|NCT03546621|76008139|FG000|STARTED|Overall Study||28||
59885300|NCT03546621|76008140|FG001|STARTED|Overall Study||32||
59885301|NCT03546621|76008141|FG002|STARTED|Overall Study||30||
59885302|NCT03546621|76008142|FG003|STARTED|Overall Study|2 patients from Tenofovir only group withdrew from the study before treatment.|28||
60012666|NCT02876328|76128667|FG023|STARTED|Overall Study||7||
60012667|NCT02876328|76128644|FG000|COMPLETED|Overall Study||379|For the primary outcome, Completed is defined as attending the 12 month visit.|
59499163|NCT00521989|75590441|FG003|NOT COMPLETED|Overall Study||12||
59499164|NCT00521989|75590442|FG004|NOT COMPLETED|Overall Study||23||
59499165|NCT00548041|75590454|FG000|STARTED|Overall Study||100||
59885303|NCT03546621|76008139|FG000|COMPLETED|Overall Study||28||
59885304|NCT03546621|76008140|FG001|COMPLETED|Overall Study||29||
59499166|NCT00548041|75590454|FG000|COMPLETED|Overall Study||100||
59499167|NCT00548041|75590454|FG000|NOT COMPLETED|Overall Study||0||
59607270|NCT03828149|75717837|FG001|COMPLETED|First Intervention (Single Dose)||8||
59885305|NCT03546621|76008141|FG002|COMPLETED|Overall Study||28||
59885306|NCT03546621|76008142|FG003|COMPLETED|Overall Study||25||
59499168|NCT00548197|75590460|FG000|STARTED|Overall Study||18||
59499169|NCT00548197|75590461|FG001|STARTED|Overall Study||22||
59499170|NCT00548197|75590460|FG000|COMPLETED|Overall Study||18||
59499171|NCT00548197|75590461|FG001|COMPLETED|Overall Study||22||
59499172|NCT00548197|75590460|FG000|NOT COMPLETED|Overall Study||0||
59885307|NCT03546621|76008139|FG000|NOT COMPLETED|Overall Study||0||
59499173|NCT00548197|75590461|FG001|NOT COMPLETED|Overall Study||0||
59499174|NCT00548431|75590469|FG000|STARTED|Overall Study||38||
59499175|NCT00548431|75590469|FG000|COMPLETED|Overall Study||38||
59885308|NCT03546621|76008140|FG001|NOT COMPLETED|Overall Study||3||
59499176|NCT00548431|75590469|FG000|NOT COMPLETED|Overall Study||0||
59499177|NCT00522925|75590476|FG000|STARTED|Overall Study||36||
59499178|NCT00522925|75590477|FG001|STARTED|Overall Study||39||
59499179|NCT00522925|75590478|FG002|STARTED|Overall Study||38||
59499180|NCT00522925|75590476|FG000|COMPLETED|Overall Study||28||
59499181|NCT00522925|75590477|FG001|COMPLETED|Overall Study||38||
59499182|NCT00522925|75590478|FG002|COMPLETED|Overall Study||36||
59499183|NCT00522925|75590476|FG000|NOT COMPLETED|Overall Study||8||
59499184|NCT00522925|75590477|FG001|NOT COMPLETED|Overall Study||1||
59499185|NCT00522925|75590478|FG002|NOT COMPLETED|Overall Study||2||
59499186|NCT00524017|75590488|FG000|STARTED|Overall Study||13||
59499187|NCT00524017|75590489|FG001|STARTED|Overall Study||6||
59499188|NCT00524017|75590488|FG000|COMPLETED|Overall Study||13||
59499189|NCT00524017|75590489|FG001|COMPLETED|Overall Study||5||
59499190|NCT00524017|75590488|FG000|NOT COMPLETED|Overall Study||0||
59499191|NCT00524017|75590489|FG001|NOT COMPLETED|Overall Study||1||
59499192|NCT00525421|75590497|FG000|STARTED|Overall Study|Enrollment started october 2007|10||
59499193|NCT00525421|75590498|FG001|STARTED|Overall Study||10||
59499194|NCT00525421|75590497|FG000|COMPLETED|Overall Study||10||
59499195|NCT00525421|75590498|FG001|COMPLETED|Overall Study||10||
59499196|NCT00525421|75590497|FG000|NOT COMPLETED|Overall Study||0||
59499197|NCT00525421|75590498|FG001|NOT COMPLETED|Overall Study||0||
59499198|NCT02128867|75590507|FG000|STARTED|Overall Study||53||
59499199|NCT02128867|75590508|FG001|STARTED|Overall Study||52||
59499200|NCT02128867|75590509|FG002|STARTED|Overall Study||54||
59499201|NCT02128867|75590507|FG000|COMPLETED|Overall Study||50||
59499202|NCT02128867|75590508|FG001|COMPLETED|Overall Study||50||
59499203|NCT02128867|75590509|FG002|COMPLETED|Overall Study||50||
59499204|NCT02128867|75590507|FG000|NOT COMPLETED|Overall Study||3||
59499205|NCT02128867|75590508|FG001|NOT COMPLETED|Overall Study||2||
59499206|NCT02128867|75590509|FG002|NOT COMPLETED|Overall Study||4||
59499207|NCT00525733|75590519|FG000|STARTED|Overall Study||14||
59499208|NCT00525733|75590520|FG001|STARTED|Overall Study||26||
59499209|NCT00525733|75590519|FG000|COMPLETED|Overall Study||11||
59499210|NCT00525733|75590520|FG001|COMPLETED|Overall Study||23||
59499211|NCT00525733|75590519|FG000|NOT COMPLETED|Overall Study||3||
59499212|NCT00525733|75590520|FG001|NOT COMPLETED|Overall Study||3||
59499213|NCT00526123|75590528|FG000|STARTED|Overall Study|Intent-to-Treat population|303||
59499214|NCT00526123|75590529|FG001|STARTED|Overall Study|Intent-to-Treat population|296||
59499215|NCT00526123|75590528|FG000|COMPLETED|Overall Study||39||
59885309|NCT03546621|76008141|FG002|NOT COMPLETED|Overall Study||2||
59499216|NCT00526123|75590529|FG001|COMPLETED|Overall Study||50||
59499217|NCT00526123|75590528|FG000|NOT COMPLETED|Overall Study||264||
59499218|NCT00526123|75590529|FG001|NOT COMPLETED|Overall Study||246||
59885310|NCT03546621|76008142|FG003|NOT COMPLETED|Overall Study||3||
59499219|NCT00444821|75590537|FG000|STARTED|Overall Study||362||
59499220|NCT00444821|75590538|FG001|STARTED|Overall Study||366||
59499221|NCT00444821|75590537|FG000|Received AAA Repair|Overall Study|Crossed over to AAA repair|122||
59499222|NCT00444821|75590538|FG001|Received AAA Repair|Overall Study|Underwent AAA repair per protocol|326||
59499223|NCT00444821|75590537|FG000|COMPLETED|Overall Study||0||
59499224|NCT00444821|75590538|FG001|COMPLETED|Overall Study||0||
59499225|NCT00444821|75590537|FG000|NOT COMPLETED|Overall Study||362||
59499226|NCT00444821|75590538|FG001|NOT COMPLETED|Overall Study||366||
59499227|NCT00526591|75590546|FG000|STARTED|Overall Study||8||
59499228|NCT00526591|75590547|FG001|STARTED|Overall Study||9||
59499229|NCT00526591|75590546|FG000|COMPLETED|Overall Study||8||
59499230|NCT00526591|75590547|FG001|COMPLETED|Overall Study||9||
59499231|NCT00526591|75590546|FG000|NOT COMPLETED|Overall Study||0||
59499232|NCT00526591|75590547|FG001|NOT COMPLETED|Overall Study||0||
59499233|NCT00475085|75590559|FG000|STARTED|Overall Study||253||
59499234|NCT00475085|75590560|FG001|STARTED|Overall Study||254||
59499235|NCT00475085|75590561|FG002|STARTED|Overall Study||260||
59499236|NCT00475085|75590562|FG003|STARTED|Overall Study||254||
59499237|NCT00475085|75590559|FG000|COMPLETED|Overall Study||235||
59499238|NCT00475085|75590560|FG001|COMPLETED|Overall Study||234||
59499239|NCT00475085|75590561|FG002|COMPLETED|Overall Study||241||
59499240|NCT00475085|75590562|FG003|COMPLETED|Overall Study||234||
59499241|NCT00475085|75590559|FG000|NOT COMPLETED|Overall Study||18||
59499242|NCT00475085|75590560|FG001|NOT COMPLETED|Overall Study||20||
59499243|NCT00475085|75590561|FG002|NOT COMPLETED|Overall Study||19||
59499244|NCT00475085|75590562|FG003|NOT COMPLETED|Overall Study||20||
59499245|NCT00551707|75590577|FG000|STARTED|Overall Study||4||
59499246|NCT00551707|75590578|FG001|STARTED|Overall Study||22||
59499247|NCT00551707|75590579|FG002|STARTED|Overall Study||13||
59499248|NCT00551707|75590580|FG003|STARTED|Overall Study||8||
59499249|NCT00551707|75590581|FG004|STARTED|Overall Study||4||
59499250|NCT00551707|75590577|FG000|COMPLETED|Overall Study||4||
59499251|NCT00551707|75590578|FG001|COMPLETED|Overall Study||16||
59499252|NCT00551707|75590579|FG002|COMPLETED|Overall Study||10||
59499253|NCT00551707|75590580|FG003|COMPLETED|Overall Study||4||
59499254|NCT00551707|75590581|FG004|COMPLETED|Overall Study||3||
59499255|NCT00551707|75590577|FG000|NOT COMPLETED|Overall Study||0||
59499256|NCT00551707|75590578|FG001|NOT COMPLETED|Overall Study||6||
59499257|NCT00551707|75590579|FG002|NOT COMPLETED|Overall Study||3||
59499258|NCT00551707|75590580|FG003|NOT COMPLETED|Overall Study||4||
59499259|NCT00551707|75590581|FG004|NOT COMPLETED|Overall Study||1||
59499260|NCT04028648|75590595|FG000|STARTED|Overall Study||150||
59499261|NCT04028648|75590595|FG000|COMPLETED|Overall Study||150||
59499262|NCT04028648|75590595|FG000|NOT COMPLETED|Overall Study||0||
59499263|NCT00445211|75590602|FG000|STARTED|Overall Study||23||
59499264|NCT00445211|75590603|FG001|STARTED|Overall Study||23||
59499265|NCT00445211|75590602|FG000|COMPLETED|Overall Study||23||
59499266|NCT00445211|75590603|FG001|COMPLETED|Overall Study||23||
59499267|NCT00445211|75590602|FG000|NOT COMPLETED|Overall Study||0||
59499268|NCT00445211|75590603|FG001|NOT COMPLETED|Overall Study||0||
59499269|NCT00552409|75590611|FG000|STARTED|Overall Study||11||
59499270|NCT00552409|75590612|FG001|STARTED|Overall Study||11||
59607271|NCT03828149|75717836|FG000|NOT COMPLETED|First Intervention (Single Dose)||0||
59607272|NCT03828149|75717837|FG001|NOT COMPLETED|First Intervention (Single Dose)||0||
59607273|NCT03828149|75717836|FG000|STARTED|Washout (6 Days)||9||
59754849|NCT02041195|75873655|FG006|NOT COMPLETED|Overall Study||7||
59499271|NCT00552409|75590611|FG000|COMPLETED|Overall Study||10||
59499272|NCT00552409|75590612|FG001|COMPLETED|Overall Study||9||
59499273|NCT00552409|75590611|FG000|NOT COMPLETED|Overall Study||1||
59499274|NCT00552409|75590612|FG001|NOT COMPLETED|Overall Study||2||
59499275|NCT00553735|75590618|FG000|STARTED|Overall Study||8||
59754850|NCT02041195|75873656|FG007|NOT COMPLETED|Overall Study||3||
59499276|NCT00553735|75590618|FG000|COMPLETED|Overall Study||1||
59499277|NCT00553735|75590618|FG000|NOT COMPLETED|Overall Study||7||
59499278|NCT00523237|75590625|FG000|STARTED|Overall Study||14||
59499279|NCT00523237|75590625|FG000|COMPLETED|Overall Study||14||
59607274|NCT03828149|75717837|FG001|STARTED|Washout (6 Days)||8||
59754851|NCT01980355|75873677|FG000|STARTED|Overall Study||39||
59885311|NCT02761330|76008152|FG000|STARTED|Treatment Week 1||2||
59885312|NCT02761330|76008153|FG001|STARTED|Treatment Week 1||3||
59885313|NCT02761330|76008154|FG002|STARTED|Treatment Week 1||2||
59607275|NCT03828149|75717836|FG000|COMPLETED|Washout (6 Days)||9||
59607276|NCT03828149|75717837|FG001|COMPLETED|Washout (6 Days)||8||
59607277|NCT03828149|75717836|FG000|NOT COMPLETED|Washout (6 Days)||0||
59607278|NCT03828149|75717837|FG001|NOT COMPLETED|Washout (6 Days)||0||
59607279|NCT03828149|75717836|FG000|STARTED|Second Intervention (Single Dose)||9||
59607280|NCT03828149|75717837|FG001|STARTED|Second Intervention (Single Dose)||8||
59885314|NCT02761330|76008155|FG003|STARTED|Treatment Week 1||3||
59607281|NCT03828149|75717836|FG000|COMPLETED|Second Intervention (Single Dose)||9||
59885315|NCT02761330|76008156|FG004|STARTED|Treatment Week 1||1||
59885316|NCT02761330|76008157|FG005|STARTED|Treatment Week 1||3||
59885317|NCT02761330|76008152|FG000|COMPLETED|Treatment Week 1||2||
59885318|NCT02761330|76008153|FG001|COMPLETED|Treatment Week 1||3||
59885319|NCT02761330|76008154|FG002|COMPLETED|Treatment Week 1||2||
59885320|NCT02761330|76008155|FG003|COMPLETED|Treatment Week 1||2||
59885321|NCT02761330|76008156|FG004|COMPLETED|Treatment Week 1||1||
59885322|NCT02761330|76008157|FG005|COMPLETED|Treatment Week 1||2||
59885323|NCT02761330|76008152|FG000|NOT COMPLETED|Treatment Week 1||0||
59885324|NCT02761330|76008153|FG001|NOT COMPLETED|Treatment Week 1||0||
59885325|NCT02761330|76008154|FG002|NOT COMPLETED|Treatment Week 1||0||
59885326|NCT02761330|76008155|FG003|NOT COMPLETED|Treatment Week 1||1||
59885327|NCT02761330|76008156|FG004|NOT COMPLETED|Treatment Week 1||0||
59885328|NCT02761330|76008157|FG005|NOT COMPLETED|Treatment Week 1||1||
59885329|NCT02761330|76008152|FG000|STARTED|Treatment Week 2||2||
59885330|NCT02761330|76008153|FG001|STARTED|Treatment Week 2||3||
60012668|NCT02876328|76128645|FG001|COMPLETED|Overall Study||208|For the primary outcome, Completed is defined as attending the 12 month visit.|
60012669|NCT02876328|76128646|FG002|COMPLETED|Overall Study||378|For the primary outcome, Completed is defined as attending the 12 month visit.|
60012670|NCT02876328|76128647|FG003|COMPLETED|Overall Study||188|For the primary outcome, Completed is defined as attending the 12 month visit.|
60012671|NCT02876328|76128648|FG004|COMPLETED|Overall Study||181|For the primary outcome, Completed is defined as attending the 12 month visit.|
60012672|NCT02876328|76128649|FG005|COMPLETED|Overall Study||388|For the primary outcome, Completed is defined as attending the 12 month visit.|
60012673|NCT02876328|76128650|FG006|COMPLETED|Overall Study||175|For the primary outcome, Completed is defined as attending the 12 month visit.|
60012674|NCT02876328|76128651|FG007|COMPLETED|Overall Study||395|For the primary outcome, Completed is defined as attending the 12 month visit.|
60012675|NCT02876328|76128652|FG008|COMPLETED|Overall Study||192|For the primary outcome, Completed is defined as attending the 12 month visit.|
60012676|NCT02876328|76128653|FG009|COMPLETED|Overall Study||202|For the primary outcome, Completed is defined as attending the 12 month visit.|
60012677|NCT02876328|76128654|FG010|COMPLETED|Overall Study||182|For the primary outcome, Completed is defined as attending the 12 month visit.|
60012678|NCT02876328|76128655|FG011|COMPLETED|Overall Study||98|For the primary outcome, Completed is defined as attending the 12 month visit.|
60012679|NCT02876328|76128656|FG012|COMPLETED|Overall Study||172|For the primary outcome, Completed is defined as attending the 12 month visit.|
60012680|NCT02876328|76128657|FG013|COMPLETED|Overall Study||95|For the primary outcome, Completed is defined as attending the 12 month visit.|
60012681|NCT02876328|76128658|FG014|COMPLETED|Overall Study||96|For the primary outcome, Completed is defined as attending the 12 month visit.|
60012682|NCT02876328|76128659|FG015|COMPLETED|Overall Study||223|For the primary outcome, Completed is defined as attending the 12 month visit.|
60012683|NCT02876328|76128660|FG016|COMPLETED|Overall Study||102|For the primary outcome, Completed is defined as attending the 12 month visit.|
60012684|NCT02876328|76128661|FG017|COMPLETED|Overall Study||227|For the primary outcome, Completed is defined as attending the 12 month visit.|
60012685|NCT02876328|76128662|FG018|COMPLETED|Overall Study||106|For the primary outcome, Completed is defined as attending the 12 month visit.|
60012686|NCT02876328|76128663|FG019|COMPLETED|Overall Study||105|For the primary outcome, Completed is defined as attending the 12 month visit.|
60012687|NCT02876328|76128664|FG020|COMPLETED|Overall Study||312|For the primary outcome, Completed is defined as attending the 12 month visit.|
60012688|NCT02876328|76128665|FG021|COMPLETED|Overall Study||164|For the primary outcome, Completed is defined as attending the 12 month visit.|
60012689|NCT02876328|76128666|FG022|COMPLETED|Overall Study||33|For the primary outcome, Completed is defined as attending the 12 month visit.|
60012690|NCT02876328|76128667|FG023|COMPLETED|Overall Study||7|For the primary outcome, Completed is defined as attending the 12 month visit.|
59607282|NCT03828149|75717837|FG001|COMPLETED|Second Intervention (Single Dose)||8||
59607283|NCT03828149|75717836|FG000|NOT COMPLETED|Second Intervention (Single Dose)||0||
59607284|NCT03828149|75717837|FG001|NOT COMPLETED|Second Intervention (Single Dose)||0||
59607285|NCT03832907|75717843|FG000|STARTED|Overall Study||101||
59885331|NCT02761330|76008154|FG002|STARTED|Treatment Week 2||2||
59885332|NCT02761330|76008155|FG003|STARTED|Treatment Week 2|1 pt. in this group completed Week 1, but did not begin Week 2 due to withdraw.|1||
59885333|NCT02761330|76008156|FG004|STARTED|Treatment Week 2||1||
59499280|NCT00523237|75590625|FG000|NOT COMPLETED|Overall Study||0||
59499281|NCT00543101|75590631|FG000|STARTED|Overall Study||12||
59499282|NCT00543101|75590632|FG001|STARTED|Overall Study||12||
59499283|NCT00543101|75590631|FG000|COMPLETED|Overall Study||12||
59499284|NCT00543101|75590632|FG001|COMPLETED|Overall Study||12||
59499285|NCT00543101|75590631|FG000|NOT COMPLETED|Overall Study||0||
59499286|NCT00543101|75590632|FG001|NOT COMPLETED|Overall Study||0||
59499287|NCT00553969|75590643|FG000|STARTED|Overall Study||31||
59499288|NCT00553969|75590644|FG001|STARTED|Overall Study||24||
59499289|NCT00553969|75590645|FG002|STARTED|Overall Study||22||
59499290|NCT00553969|75590646|FG003|STARTED|Overall Study||24||
59499291|NCT00553969|75590643|FG000|COMPLETED|Overall Study||23||
59499292|NCT00553969|75590644|FG001|COMPLETED|Overall Study||24||
59499293|NCT00553969|75590645|FG002|COMPLETED|Overall Study||21||
59499294|NCT00553969|75590646|FG003|COMPLETED|Overall Study||23||
59499295|NCT00553969|75590643|FG000|NOT COMPLETED|Overall Study||8||
59499296|NCT00553969|75590644|FG001|NOT COMPLETED|Overall Study||0||
59499297|NCT00553969|75590645|FG002|NOT COMPLETED|Overall Study||1||
59499298|NCT00553969|75590646|FG003|NOT COMPLETED|Overall Study||1||
59499299|NCT00475241|75590658|FG000|STARTED|Overall Study||18||
59499300|NCT00475241|75590659|FG001|STARTED|Overall Study||18||
59499301|NCT00475241|75590658|FG000|COMPLETED|Overall Study||11||
59499302|NCT00475241|75590659|FG001|COMPLETED|Overall Study||15||
59499303|NCT00475241|75590658|FG000|NOT COMPLETED|Overall Study||7||
59499304|NCT00475241|75590659|FG001|NOT COMPLETED|Overall Study||3||
59499305|NCT00554671|75590668|FG000|STARTED|Overall Study||117||
59499306|NCT00554671|75590669|FG001|STARTED|Overall Study||133||
59499307|NCT00554671|75590668|FG000|COMPLETED|Overall Study||97||
59499308|NCT00554671|75590669|FG001|COMPLETED|Overall Study||117||
59499309|NCT00554671|75590668|FG000|NOT COMPLETED|Overall Study||20||
59499310|NCT00554671|75590669|FG001|NOT COMPLETED|Overall Study||16||
59499311|NCT00554749|75590676|FG000|STARTED|Overall Study||7||
59499312|NCT00554749|75590676|FG000|COMPLETED|Overall Study||7||
59499313|NCT00554749|75590676|FG000|NOT COMPLETED|Overall Study||0||
59499314|NCT00475319|75590683|FG000|STARTED|Overall Study||103||
59499315|NCT00475319|75590684|FG001|STARTED|Overall Study||102||
59499316|NCT00475319|75590685|FG002|STARTED|Overall Study||103||
59499317|NCT00475319|75590683|FG000|COMPLETED|Overall Study||101||
59499318|NCT00475319|75590684|FG001|COMPLETED|Overall Study||101||
59499319|NCT00475319|75590685|FG002|COMPLETED|Overall Study||99||
59499320|NCT00475319|75590683|FG000|NOT COMPLETED|Overall Study||2||
59499321|NCT00475319|75590684|FG001|NOT COMPLETED|Overall Study||1||
59499322|NCT00475319|75590685|FG002|NOT COMPLETED|Overall Study||4||
59499323|NCT00555997|75590699|FG000|STARTED|Phase 1 SPCD||29||
59499324|NCT00555997|75590700|FG001|STARTED|Phase 1 SPCD||91||
59499325|NCT00555997|75590701|FG002|STARTED|Phase 1 SPCD||0||
59499326|NCT00555997|75590702|FG003|STARTED|Phase 1 SPCD||0||
59499327|NCT00555997|75590699|FG000|COMPLETED|Phase 1 SPCD||17||
59499328|NCT00555997|75590700|FG001|COMPLETED|Phase 1 SPCD||76||
59499329|NCT00555997|75590701|FG002|COMPLETED|Phase 1 SPCD||0||
59499330|NCT00555997|75590702|FG003|COMPLETED|Phase 1 SPCD||0||
59499331|NCT00555997|75590699|FG000|NOT COMPLETED|Phase 1 SPCD||12||
59499332|NCT00555997|75590700|FG001|NOT COMPLETED|Phase 1 SPCD||15||
59499333|NCT00555997|75590701|FG002|NOT COMPLETED|Phase 1 SPCD||0||
59499334|NCT00555997|75590702|FG003|NOT COMPLETED|Phase 1 SPCD||0||
59499335|NCT00555997|75590699|FG000|STARTED|Phase 2 SPCD||0||
59499336|NCT00555997|75590700|FG001|STARTED|Phase 2 SPCD||0||
59499337|NCT00555997|75590701|FG002|STARTED|Phase 2 SPCD||38||
59499338|NCT00555997|75590702|FG003|STARTED|Phase 2 SPCD||25||
59499339|NCT00555997|75590699|FG000|COMPLETED|Phase 2 SPCD||0||
59499340|NCT00555997|75590700|FG001|COMPLETED|Phase 2 SPCD||0||
59499341|NCT00555997|75590701|FG002|COMPLETED|Phase 2 SPCD||31||
59499342|NCT00555997|75590702|FG003|COMPLETED|Phase 2 SPCD||22||
59499343|NCT00555997|75590699|FG000|NOT COMPLETED|Phase 2 SPCD||0||
59499344|NCT00555997|75590700|FG001|NOT COMPLETED|Phase 2 SPCD||0||
59499345|NCT00555997|75590701|FG002|NOT COMPLETED|Phase 2 SPCD||7||
59499346|NCT00555997|75590702|FG003|NOT COMPLETED|Phase 2 SPCD||3||
59499347|NCT00475787|75590716|FG000|STARTED|Overall Study||69||
59499348|NCT00475787|75590717|FG001|STARTED|Overall Study||67||
59499349|NCT00475787|75590716|FG000|COMPLETED|Overall Study||61||
59499350|NCT00475787|75590717|FG001|COMPLETED|Overall Study||60||
59499351|NCT00475787|75590716|FG000|NOT COMPLETED|Overall Study||8||
59499352|NCT00475787|75590717|FG001|NOT COMPLETED|Overall Study||7||
59499353|NCT00446147|75590727|FG000|STARTED|Overall Study||195||
59499354|NCT00446147|75590728|FG001|STARTED|Overall Study||194||
59499355|NCT00446147|75590727|FG000|COMPLETED|Overall Study||180||
59499356|NCT00446147|75590728|FG001|COMPLETED|Overall Study||180||
59499357|NCT00446147|75590727|FG000|NOT COMPLETED|Overall Study||15||
59499358|NCT00446147|75590728|FG001|NOT COMPLETED|Overall Study||14||
59499359|NCT00476021|75590736|FG000|STARTED|Overall Study||51||
59499360|NCT00476021|75590737|FG001|STARTED|Overall Study||51||
59499361|NCT00476021|75590736|FG000|COMPLETED|Overall Study||51||
59499362|NCT00476021|75590737|FG001|COMPLETED|Overall Study||51||
59499363|NCT00476021|75590736|FG000|NOT COMPLETED|Overall Study||0||
59499364|NCT00476021|75590737|FG001|NOT COMPLETED|Overall Study||0||
59499365|NCT00447083|75590751|FG000|STARTED|Phase I||10||
59499366|NCT00447083|75590752|FG001|STARTED|Phase I||9||
59885334|NCT02761330|76008157|FG005|STARTED|Treatment Week 2|1 pt. in this group completed Week 1, but did not begin Week 2 due to cancellation of treatment.|1||
59885335|NCT02761330|76008152|FG000|COMPLETED|Treatment Week 2||2||
59885336|NCT02761330|76008153|FG001|COMPLETED|Treatment Week 2||3||
59885337|NCT02761330|76008154|FG002|COMPLETED|Treatment Week 2||2||
59885338|NCT02761330|76008155|FG003|COMPLETED|Treatment Week 2||1||
59885339|NCT02761330|76008156|FG004|COMPLETED|Treatment Week 2||1||
59885340|NCT02761330|76008157|FG005|COMPLETED|Treatment Week 2||1||
59885341|NCT02761330|76008152|FG000|NOT COMPLETED|Treatment Week 2||0||
59885342|NCT02761330|76008153|FG001|NOT COMPLETED|Treatment Week 2||0||
59885343|NCT02761330|76008154|FG002|NOT COMPLETED|Treatment Week 2||0||
59885344|NCT02761330|76008155|FG003|NOT COMPLETED|Treatment Week 2||0||
59885345|NCT02761330|76008156|FG004|NOT COMPLETED|Treatment Week 2||0||
59885346|NCT02761330|76008157|FG005|NOT COMPLETED|Treatment Week 2||0||
59885347|NCT03559257|76008173|FG000|STARTED|Double Blind Treatment Period||230||
59885348|NCT03559257|76008174|FG001|STARTED|Double Blind Treatment Period||233||
59885349|NCT03559257|76008173|FG000|Received at Least One Dose of Study Drug|Double Blind Treatment Period||230||
59885350|NCT03559257|76008174|FG001|Received at Least One Dose of Study Drug|Double Blind Treatment Period||232||
59885351|NCT03559257|76008173|FG000|COMPLETED|Double Blind Treatment Period||226||
59885352|NCT03559257|76008174|FG001|COMPLETED|Double Blind Treatment Period||225||
59885353|NCT03559257|76008173|FG000|NOT COMPLETED|Double Blind Treatment Period||4||
59885354|NCT03559257|76008174|FG001|NOT COMPLETED|Double Blind Treatment Period||8||
59885355|NCT03559257|76008173|FG000|STARTED|Open-label Treatment Period|One participant who completed double blind period has withdrawn from the study.|225||
59885356|NCT03559257|76008174|FG001|STARTED|Open-label Treatment Period|One participant who completed double blind period had discontinued due to adverse event.|224||
59885357|NCT03559257|76008173|FG000|COMPLETED|Open-label Treatment Period||215||
59885358|NCT03559257|76008174|FG001|COMPLETED|Open-label Treatment Period||217||
59885359|NCT03559257|76008173|FG000|NOT COMPLETED|Open-label Treatment Period||10||
59499367|NCT00447083|75590753|FG002|STARTED|Phase I||0||
59499368|NCT00447083|75590754|FG003|STARTED|Phase I||0||
59499369|NCT00447083|75590751|FG000|COMPLETED|Phase I|2 participants did not acclimate to phase II|10||
59499370|NCT00447083|75590752|FG001|COMPLETED|Phase I|1 participant did not acclimate to phase II|9||
59499371|NCT00447083|75590753|FG002|COMPLETED|Phase I||0||
59499372|NCT00447083|75590754|FG003|COMPLETED|Phase I||0||
59499373|NCT00447083|75590751|FG000|NOT COMPLETED|Phase I||0||
59885360|NCT03559257|76008174|FG001|NOT COMPLETED|Open-label Treatment Period||7||
59885361|NCT02892513|76008185|FG000|STARTED|Overall Study||28||
59885362|NCT02892513|76008186|FG001|STARTED|Overall Study|did not receive allocated intervention = 1 (withdrew per participant request)|25||
59885363|NCT02892513|76008185|FG000|COMPLETED|Overall Study|Discontinued intervention early = 5; excluded from analysis = 0|28||
59885364|NCT02892513|76008186|FG001|COMPLETED|Overall Study|Discontinued intervention early = 6; excluded from analysis = 1|24||
59885365|NCT02892513|76008185|FG000|NOT COMPLETED|Overall Study||0||
59885366|NCT02892513|76008186|FG001|NOT COMPLETED|Overall Study||1||
59885367|NCT03558555|76008194|FG000|STARTED|Overall Study||58||
59885368|NCT03558555|76008195|FG001|STARTED|Overall Study||45||
59885369|NCT03558555|76008194|FG000|COMPLETED|Overall Study||56||
59885370|NCT03558555|76008195|FG001|COMPLETED|Overall Study||44||
59885371|NCT03558555|76008194|FG000|NOT COMPLETED|Overall Study||2||
59885372|NCT03558555|76008195|FG001|NOT COMPLETED|Overall Study||1||
59885373|NCT03541317|76008203|FG000|STARTED|Stage 1 of the Implementation||6||5
59885374|NCT03541317|76008204|FG001|STARTED|Stage 1 of the Implementation||37||21
59885375|NCT03541317|76008205|FG002|STARTED|Stage 1 of the Implementation||38||21
59885376|NCT03541317|76008206|FG003|STARTED|Stage 1 of the Implementation||9||6
59885377|NCT03541317|76008207|FG004|STARTED|Stage 1 of the Implementation||43||21
59885378|NCT03541317|76008208|FG005|STARTED|Stage 1 of the Implementation||36||20
59885379|NCT03541317|76008203|FG000|COMPLETED|Stage 1 of the Implementation||6||5
59885380|NCT03541317|76008204|FG001|COMPLETED|Stage 1 of the Implementation||37||21
59885381|NCT03541317|76008205|FG002|COMPLETED|Stage 1 of the Implementation||38||21
59499374|NCT00447083|75590752|FG001|NOT COMPLETED|Phase I||0||
59499375|NCT00447083|75590753|FG002|NOT COMPLETED|Phase I||0||
59499376|NCT00447083|75590754|FG003|NOT COMPLETED|Phase I||0||
59499377|NCT00447083|75590751|FG000|STARTED|Phase II|Participants in this group will then be randomized to a phase 2 group in phase2|0||
59885382|NCT03541317|76008206|FG003|COMPLETED|Stage 1 of the Implementation||9||6
59885383|NCT03541317|76008207|FG004|COMPLETED|Stage 1 of the Implementation||43||21
59499378|NCT00447083|75590752|FG001|STARTED|Phase II|Participants in this group will then be randomized to a phase 2 group in phase2|0||
59754852|NCT01980355|75873678|FG001|STARTED|Overall Study||37||
59754853|NCT01980355|75873677|FG000|COMPLETED|Overall Study||39||
59754854|NCT01980355|75873678|FG001|COMPLETED|Overall Study||37||
59754855|NCT01980355|75873677|FG000|NOT COMPLETED|Overall Study||0||
59754856|NCT01980355|75873678|FG001|NOT COMPLETED|Overall Study||0||
59754857|NCT01758432|75873691|FG000|STARTED|Overall Study||18||
59754858|NCT01758432|75873692|FG001|STARTED|Overall Study||6||
59885384|NCT03541317|76008208|FG005|COMPLETED|Stage 1 of the Implementation||36||20
59499379|NCT00447083|75590753|FG002|STARTED|Phase II|Only 8 participants qualified from the end of phase 1|8||
59499380|NCT00447083|75590754|FG003|STARTED|Phase II|Only 8 participants qualified from the end of phase 1|8||
59499381|NCT00447083|75590751|FG000|COMPLETED|Phase II||0||
59499382|NCT00447083|75590752|FG001|COMPLETED|Phase II||0||
59499383|NCT00447083|75590753|FG002|COMPLETED|Phase II||7||
59499384|NCT00447083|75590754|FG003|COMPLETED|Phase II||7||
59499385|NCT00447083|75590751|FG000|NOT COMPLETED|Phase II||0||
59499386|NCT00447083|75590752|FG001|NOT COMPLETED|Phase II||0||
59754859|NCT01758432|75873693|FG002|STARTED|Overall Study||6||
59499387|NCT00447083|75590753|FG002|NOT COMPLETED|Phase II||1||
59499388|NCT00447083|75590754|FG003|NOT COMPLETED|Phase II||1||
59754860|NCT01758432|75873694|FG003|STARTED|Overall Study||6||
59499389|NCT00556543|75590762|FG000|STARTED|Overall Study||10||
59499390|NCT00556543|75590762|FG000|COMPLETED|Overall Study|Subjects completed 180 days of study enrollment|10||
59499391|NCT00556543|75590762|FG000|NOT COMPLETED|Overall Study||0||
59499392|NCT00448175|75590771|FG000|STARTED|12 Weeks PTNS vs. Drug||50||
59499393|NCT00448175|75590772|FG001|STARTED|12 Weeks PTNS vs. Drug||50||
59499394|NCT00448175|75590771|FG000|COMPLETED|12 Weeks PTNS vs. Drug||41||
59499395|NCT00448175|75590772|FG001|COMPLETED|12 Weeks PTNS vs. Drug||43||
59499396|NCT00448175|75590771|FG000|NOT COMPLETED|12 Weeks PTNS vs. Drug||9||
59499397|NCT00448175|75590772|FG001|NOT COMPLETED|12 Weeks PTNS vs. Drug||7||
59499398|NCT00448175|75590771|FG000|STARTED|Continued PTNS Through 12 Months||35||
59499399|NCT00448175|75590772|FG001|STARTED|Continued PTNS Through 12 Months||0||
59499400|NCT00448175|75590771|FG000|COMPLETED|Continued PTNS Through 12 Months||25||
59499401|NCT00448175|75590772|FG001|COMPLETED|Continued PTNS Through 12 Months||0||
59499402|NCT00448175|75590771|FG000|NOT COMPLETED|Continued PTNS Through 12 Months||10||
59499403|NCT00448175|75590772|FG001|NOT COMPLETED|Continued PTNS Through 12 Months||0||
59499404|NCT00476645|75590778|FG000|STARTED|Overall Study||10||
59499405|NCT00476645|75590778|FG000|COMPLETED|Overall Study||10||
59499406|NCT00476645|75590778|FG000|NOT COMPLETED|Overall Study||0||
59499407|NCT01846195|75590784|FG000|STARTED|Overall Study||5||
59499408|NCT01846195|75590785|FG001|STARTED|Overall Study||45||
59499409|NCT01846195|75590784|FG000|COMPLETED|Overall Study||5||
59499410|NCT01846195|75590785|FG001|COMPLETED|Overall Study||45||
59499411|NCT01846195|75590784|FG000|NOT COMPLETED|Overall Study||0||
59499412|NCT01846195|75590785|FG001|NOT COMPLETED|Overall Study||0||
59499413|NCT00477191|75590791|FG000|STARTED|Overall Study||18||
59499414|NCT00477191|75590791|FG000|COMPLETED|Overall Study||13||
59499415|NCT00477191|75590791|FG000|NOT COMPLETED|Overall Study||5||
59499416|NCT02115347|75590797|FG000|STARTED|Overall Study||8||
59499417|NCT02115347|75590798|FG001|STARTED|Overall Study||8||
59499418|NCT02115347|75590799|FG002|STARTED|Overall Study||0||
59499419|NCT02115347|75590797|FG000|COMPLETED|Overall Study||8||
59499420|NCT02115347|75590798|FG001|COMPLETED|Overall Study||8||
59499421|NCT02115347|75590799|FG002|COMPLETED|Overall Study||0||
59499422|NCT02115347|75590797|FG000|NOT COMPLETED|Overall Study||0||
59499423|NCT02115347|75590798|FG001|NOT COMPLETED|Overall Study||0||
59499424|NCT02115347|75590799|FG002|NOT COMPLETED|Overall Study||0||
59499425|NCT02115581|75590807|FG000|STARTED|Overall Study||17||
59499426|NCT02115581|75590808|FG001|STARTED|Overall Study||21||
59499427|NCT02115581|75590807|FG000|COMPLETED|Overall Study||17||
59499428|NCT02115581|75590808|FG001|COMPLETED|Overall Study||21||
59499429|NCT02115581|75590807|FG000|NOT COMPLETED|Overall Study||0||
59499430|NCT02115581|75590808|FG001|NOT COMPLETED|Overall Study||0||
59499431|NCT00477659|75590814|FG000|STARTED|Overall Study||14||
59499432|NCT00477659|75590814|FG000|COMPLETED|Overall Study||14||
59499433|NCT00477659|75590814|FG000|NOT COMPLETED|Overall Study||0||
59499434|NCT04388527|75590818|FG000|STARTED|Overall Study||32||
59499435|NCT04388527|75590818|FG000|COMPLETED|Overall Study||15||
59499436|NCT04388527|75590818|FG000|NOT COMPLETED|Overall Study||17||
59499437|NCT00478361|75590822|FG000|STARTED|Overall Study||39||
59499438|NCT00478361|75590822|FG000|COMPLETED|Overall Study||39||
59499439|NCT00478361|75590822|FG000|NOT COMPLETED|Overall Study||0||
59499440|NCT02129725|75590828|FG000|STARTED|Overall Study||8||
59499441|NCT02129725|75590829|FG001|STARTED|Overall Study||7||
59499442|NCT02129725|75590828|FG000|COMPLETED|Overall Study||6||
59499443|NCT02129725|75590829|FG001|COMPLETED|Overall Study||4||
59499444|NCT02129725|75590828|FG000|NOT COMPLETED|Overall Study||2||
59499445|NCT02129725|75590829|FG001|NOT COMPLETED|Overall Study||3||
59499446|NCT00483509|75590835|FG000|STARTED|Overall Study||28||
59499447|NCT00483509|75590835|FG000|COMPLETED|Overall Study||28||
59499448|NCT00483509|75590835|FG000|NOT COMPLETED|Overall Study||0||
59499449|NCT00450983|75590839|FG000|STARTED|Overall Study||1||
59499450|NCT00450983|75590839|FG000|COMPLETED|Overall Study||1||
59499451|NCT00450983|75590839|FG000|NOT COMPLETED|Overall Study||0||
59499452|NCT03649321|75590845|FG000|STARTED|Overall Study||9||
59499453|NCT03649321|75590846|FG001|STARTED|Overall Study||0||
59499454|NCT03649321|75590845|FG000|COMPLETED|Overall Study||7||
59499455|NCT03649321|75590846|FG001|COMPLETED|Overall Study||0||
59499456|NCT03649321|75590845|FG000|NOT COMPLETED|Overall Study||2||
59499457|NCT03649321|75590846|FG001|NOT COMPLETED|Overall Study||0||
59499458|NCT02123017|75590855|FG000|STARTED|Overall Study||8||
59499459|NCT02123017|75590856|FG001|STARTED|Overall Study||12||
59499460|NCT02123017|75590857|FG002|STARTED|Overall Study||12||
59499461|NCT02123017|75590855|FG000|COMPLETED|Overall Study||8||
59499462|NCT02123017|75590856|FG001|COMPLETED|Overall Study||12||
59499463|NCT02123017|75590857|FG002|COMPLETED|Overall Study||12||
59499464|NCT02123017|75590855|FG000|NOT COMPLETED|Overall Study||0||
59499465|NCT02123017|75590856|FG001|NOT COMPLETED|Overall Study||0||
59885385|NCT03541317|76008203|FG000|NOT COMPLETED|Stage 1 of the Implementation||0||0
59885386|NCT03541317|76008204|FG001|NOT COMPLETED|Stage 1 of the Implementation||0||0
59885387|NCT03541317|76008205|FG002|NOT COMPLETED|Stage 1 of the Implementation||0||0
59885388|NCT03541317|76008206|FG003|NOT COMPLETED|Stage 1 of the Implementation||0||0
59885389|NCT03541317|76008207|FG004|NOT COMPLETED|Stage 1 of the Implementation||0||0
59885390|NCT03541317|76008208|FG005|NOT COMPLETED|Stage 1 of the Implementation||0||0
60012691|NCT02876328|76128644|FG000|NOT COMPLETED|Overall Study||17||
60012692|NCT02876328|76128645|FG001|NOT COMPLETED|Overall Study||13||
60012693|NCT02876328|76128646|FG002|NOT COMPLETED|Overall Study||17||
60012694|NCT02876328|76128647|FG003|NOT COMPLETED|Overall Study||9||
60012695|NCT02876328|76128648|FG004|NOT COMPLETED|Overall Study||10||
60012696|NCT02876328|76128649|FG005|NOT COMPLETED|Overall Study||15||
60012697|NCT02876328|76128650|FG006|NOT COMPLETED|Overall Study||4||
60012698|NCT02876328|76128651|FG007|NOT COMPLETED|Overall Study||12||
60012699|NCT02876328|76128652|FG008|NOT COMPLETED|Overall Study||10||
60012700|NCT02876328|76128653|FG009|NOT COMPLETED|Overall Study||8||
60012701|NCT02876328|76128654|FG010|NOT COMPLETED|Overall Study||5||
60012702|NCT02876328|76128655|FG011|NOT COMPLETED|Overall Study||1||
60012703|NCT02876328|76128656|FG012|NOT COMPLETED|Overall Study||5||
60012704|NCT02876328|76128657|FG013|NOT COMPLETED|Overall Study||4||
60012705|NCT02876328|76128658|FG014|NOT COMPLETED|Overall Study||4||
60012706|NCT02876328|76128659|FG015|NOT COMPLETED|Overall Study||4||
60012707|NCT02876328|76128660|FG016|NOT COMPLETED|Overall Study||5||
60012708|NCT02876328|76128661|FG017|NOT COMPLETED|Overall Study||10||
60012709|NCT02876328|76128662|FG018|NOT COMPLETED|Overall Study||2||
60012710|NCT02876328|76128663|FG019|NOT COMPLETED|Overall Study||2||
60012711|NCT02876328|76128664|FG020|NOT COMPLETED|Overall Study||12||
60012712|NCT02876328|76128665|FG021|NOT COMPLETED|Overall Study||8||
60012713|NCT02876328|76128666|FG022|NOT COMPLETED|Overall Study||1||
60012714|NCT02876328|76128667|FG023|NOT COMPLETED|Overall Study||0||
60012715|NCT02870920|76128695|FG000|STARTED|Overall Study||61||
60012716|NCT02870920|76128696|FG001|STARTED|Overall Study||119||
60012717|NCT02870920|76128695|FG000|COMPLETED|Overall Study||61||
60012718|NCT02870920|76128696|FG001|COMPLETED|Overall Study||119||
60012719|NCT02870920|76128695|FG000|NOT COMPLETED|Overall Study||0||
60012720|NCT02870920|76128696|FG001|NOT COMPLETED|Overall Study||0||
60012721|NCT02863523|76128704|FG000|STARTED|Overall Study||67||
60012722|NCT02863523|76128705|FG001|STARTED|Overall Study||72||
60012723|NCT02863523|76128704|FG000|COMPLETED|Overall Study||67||
60012724|NCT02863523|76128705|FG001|COMPLETED|Overall Study||72||
60012725|NCT02863523|76128704|FG000|NOT COMPLETED|Overall Study||0||
60012726|NCT02863523|76128705|FG001|NOT COMPLETED|Overall Study||0||
60012727|NCT02577354|76128713|FG000|STARTED|Overall Study||102||
60012728|NCT02577354|76128714|FG001|STARTED|Overall Study||102||
60012729|NCT02577354|76128713|FG000|120 Day Primary Endpoint|Overall Study||100|Three participants in total lost to follow-up|
60012730|NCT02577354|76128714|FG001|120 Day Primary Endpoint|Overall Study||101|Three participants in total lost to follow-up|
60012731|NCT02577354|76128713|FG000|COMPLETED|Overall Study||87|Completed 1 year follow-up for FDA PMA report (a minimum of 150 participants required)|
60012732|NCT02577354|76128714|FG001|COMPLETED|Overall Study||89|Completed 1 year follow-up for FDA PMA report (a minimum of 150 participants required)|
59885391|NCT03541317|76008203|FG000|STARTED|Stage 2 of the Implementation||6||5
59885392|NCT03541317|76008204|FG001|STARTED|Stage 2 of the Implementation||37||21
59885393|NCT03541317|76008205|FG002|STARTED|Stage 2 of the Implementation||38||21
59885394|NCT03541317|76008206|FG003|STARTED|Stage 2 of the Implementation||9||6
60012733|NCT02577354|76128713|FG000|NOT COMPLETED|Overall Study||15||
60012734|NCT02577354|76128714|FG001|NOT COMPLETED|Overall Study||13||
60012735|NCT02477696|76128732|FG000|STARTED|Overall Study||268||
60012736|NCT02477696|76128733|FG001|STARTED|Overall Study||265||
60012737|NCT02477696|76128732|FG000|Treated|Overall Study||265||
60012738|NCT02477696|76128733|FG001|Treated|Overall Study||264||
60012739|NCT02477696|76128732|FG000|COMPLETED|Overall Study||0||
60012740|NCT02477696|76128733|FG001|COMPLETED|Overall Study||0||
60012741|NCT02477696|76128732|FG000|NOT COMPLETED|Overall Study||268||
60012742|NCT02477696|76128733|FG001|NOT COMPLETED|Overall Study||265||
60012743|NCT02468232|76128743|FG000|STARTED|Core Part of Study||112|Started = Enrolled in Core|
60012744|NCT02468232|76128744|FG001|STARTED|Core Part of Study||113|Started = Enrolled in Core|
60012745|NCT02468232|76128745|FG002|STARTED|Core Part of Study||0|Started = Enrolled in Core|
60012746|NCT02468232|76128746|FG003|STARTED|Core Part of Study||0|Started = Enrolled in Core|
60012747|NCT02468232|76128743|FG000|Randomized Patients|Core Part of Study||112||
60012748|NCT02468232|76128744|FG001|Randomized Patients|Core Part of Study||113||
60012749|NCT02468232|76128745|FG002|Randomized Patients|Core Part of Study||0||
60012750|NCT02468232|76128746|FG003|Randomized Patients|Core Part of Study||0||
60012751|NCT02468232|76128743|FG000|Mis-randomized Patients|Core Part of Study||1||
60012752|NCT02468232|76128744|FG001|Mis-randomized Patients|Core Part of Study||1||
60012753|NCT02468232|76128745|FG002|Mis-randomized Patients|Core Part of Study||0||
60012754|NCT02468232|76128746|FG003|Mis-randomized Patients|Core Part of Study||0||
60012755|NCT02468232|76128743|FG000|Discont. From Randomized Treatment (Rand. Set)|Core Part of Study||21||
60012756|NCT02468232|76128744|FG001|Discont. From Randomized Treatment (Rand. Set)|Core Part of Study||19||
60012757|NCT02468232|76128745|FG002|Discont. From Randomized Treatment (Rand. Set)|Core Part of Study||0||
60012758|NCT02468232|76128746|FG003|Discont. From Randomized Treatment (Rand. Set)|Core Part of Study||0||
60012759|NCT02468232|76128743|FG000|Discont. From Rand. Treatment (Full Analysis Set)|Core Part of Study||20||
60012760|NCT02468232|76128744|FG001|Discont. From Rand. Treatment (Full Analysis Set)|Core Part of Study||18||
60012761|NCT02468232|76128745|FG002|Discont. From Rand. Treatment (Full Analysis Set)|Core Part of Study||0||
60012762|NCT02468232|76128746|FG003|Discont. From Rand. Treatment (Full Analysis Set)|Core Part of Study||0||
60012763|NCT02468232|76128743|FG000|COMPLETED|Core Part of Study||91|Completed = Completed Core|
60012764|NCT02468232|76128744|FG001|COMPLETED|Core Part of Study||94|Completed = Completed Core|
60012765|NCT02468232|76128745|FG002|COMPLETED|Core Part of Study||0|Completed = Completed Core|
60012766|NCT02468232|76128746|FG003|COMPLETED|Core Part of Study||0|Completed = Completed Core|
60012767|NCT02468232|76128743|FG000|NOT COMPLETED|Core Part of Study||21||
60012768|NCT02468232|76128744|FG001|NOT COMPLETED|Core Part of Study||19||
60012769|NCT02468232|76128745|FG002|NOT COMPLETED|Core Part of Study||0||
60012770|NCT02468232|76128746|FG003|NOT COMPLETED|Core Part of Study||0||
60012771|NCT02468232|76128743|FG000|STARTED|OLE Part of Study||0||
60012772|NCT02468232|76128744|FG001|STARTED|OLE Part of Study||0||
60012773|NCT02468232|76128745|FG002|STARTED|OLE Part of Study||79||
60012774|NCT02468232|76128746|FG003|STARTED|OLE Part of Study||71||
60012775|NCT02468232|76128743|FG000|COMPLETED|OLE Part of Study||0||
60012776|NCT02468232|76128744|FG001|COMPLETED|OLE Part of Study||0||
60012777|NCT02468232|76128745|FG002|COMPLETED|OLE Part of Study||65||
60012778|NCT02468232|76128746|FG003|COMPLETED|OLE Part of Study||59||
60012779|NCT02468232|76128743|FG000|NOT COMPLETED|OLE Part of Study||0||
60012780|NCT02468232|76128744|FG001|NOT COMPLETED|OLE Part of Study||0||
60012781|NCT02468232|76128745|FG002|NOT COMPLETED|OLE Part of Study||14||
60012782|NCT02468232|76128746|FG003|NOT COMPLETED|OLE Part of Study||12||
60012783|NCT01804816|76128756|FG000|STARTED|No Acupuncture (Initial 5 Weeks)||14||
60012784|NCT01804816|76128756|FG000|COMPLETED|No Acupuncture (Initial 5 Weeks)||11|Completed all study procedures.|
60012785|NCT01804816|76128756|FG000|NOT COMPLETED|No Acupuncture (Initial 5 Weeks)||3||
60012786|NCT01804816|76128756|FG000|STARTED|Acupuncture (Second 5 Weeks)||11||
60012787|NCT01804816|76128756|FG000|COMPLETED|Acupuncture (Second 5 Weeks)||10||
60012788|NCT01804816|76128756|FG000|NOT COMPLETED|Acupuncture (Second 5 Weeks)||1||
60012789|NCT01803555|76128765|FG000|STARTED|Overall Study||303||
60012790|NCT01803555|76128766|FG001|STARTED|Overall Study||302||
60012791|NCT01803555|76128765|FG000|Received at Least 1 Dose of Study Drug|Overall Study||303||
60012792|NCT01803555|76128766|FG001|Received at Least 1 Dose of Study Drug|Overall Study||299||
60012793|NCT01803555|76128765|FG000|COMPLETED|Overall Study||290||
60012794|NCT01803555|76128766|FG001|COMPLETED|Overall Study||284||
60012795|NCT01803555|76128765|FG000|NOT COMPLETED|Overall Study||13||
60012796|NCT01803555|76128766|FG001|NOT COMPLETED|Overall Study||18||
60012797|NCT01112306|76128772|FG000|STARTED|Overall Study||709||
60012798|NCT01112306|76128772|FG000|COMPLETED|Overall Study||424||
60012799|NCT01112306|76128772|FG000|NOT COMPLETED|Overall Study||285||
60012800|NCT02524665|76128776|FG000|STARTED|Overall Study||20||
60012801|NCT02524665|76128776|FG000|COMPLETED|Overall Study||19||
60012802|NCT02524665|76128776|FG000|NOT COMPLETED|Overall Study||1||
60012803|NCT02638129|76128783|FG000|STARTED|Overall Study||28||
60012804|NCT02638129|76128784|FG001|STARTED|Overall Study||30||
60012805|NCT02638129|76128783|FG000|COMPLETED|Overall Study||0||
60012806|NCT02638129|76128784|FG001|COMPLETED|Overall Study||0||
59499466|NCT02123017|75590857|FG002|NOT COMPLETED|Overall Study||0||
59499467|NCT00486863|75590867|FG000|STARTED|Overall Study||184||
59499468|NCT00486863|75590868|FG001|STARTED|Overall Study||186||
59499469|NCT00486863|75590867|FG000|COMPLETED|Overall Study||183||
59499470|NCT00486863|75590868|FG001|COMPLETED|Overall Study||183||
59499471|NCT00486863|75590867|FG000|NOT COMPLETED|Overall Study||1||
59499472|NCT00486863|75590868|FG001|NOT COMPLETED|Overall Study||3||
59499473|NCT02123329|75590877|FG000|STARTED|3 Month Outcome Measure||147||
59499474|NCT02123329|75590878|FG001|STARTED|3 Month Outcome Measure||167||
59499475|NCT02123329|75590877|FG000|COMPLETED|3 Month Outcome Measure||98||
59499476|NCT02123329|75590878|FG001|COMPLETED|3 Month Outcome Measure||101||
59499477|NCT02123329|75590877|FG000|NOT COMPLETED|3 Month Outcome Measure||49||
59499478|NCT02123329|75590878|FG001|NOT COMPLETED|3 Month Outcome Measure||66||
59499479|NCT02123329|75590877|FG000|STARTED|6 Month Outcome Measure||147||
59499480|NCT02123329|75590878|FG001|STARTED|6 Month Outcome Measure||167||
59499481|NCT02123329|75590877|FG000|COMPLETED|6 Month Outcome Measure||99||
59499482|NCT02123329|75590878|FG001|COMPLETED|6 Month Outcome Measure||100||
59499483|NCT02123329|75590877|FG000|NOT COMPLETED|6 Month Outcome Measure||48||
59499484|NCT02123329|75590878|FG001|NOT COMPLETED|6 Month Outcome Measure||67||
59499485|NCT02123329|75590877|FG000|STARTED|12 Month Outcome Measure||147||
59499486|NCT02123329|75590878|FG001|STARTED|12 Month Outcome Measure||167||
59499487|NCT02123329|75590877|FG000|COMPLETED|12 Month Outcome Measure||83||
59499488|NCT02123329|75590878|FG001|COMPLETED|12 Month Outcome Measure||88||
59499489|NCT02123329|75590877|FG000|NOT COMPLETED|12 Month Outcome Measure||64||
59499490|NCT02123329|75590878|FG001|NOT COMPLETED|12 Month Outcome Measure||79||
59499491|NCT02123485|75590886|FG000|STARTED|Overall Study||18||
59499492|NCT02123485|75590887|FG001|STARTED|Overall Study||17||
59499493|NCT02123485|75590886|FG000|COMPLETED|Overall Study||17||
59499494|NCT02123485|75590887|FG001|COMPLETED|Overall Study||17||
59499495|NCT02123485|75590886|FG000|NOT COMPLETED|Overall Study||1||
59499496|NCT02123485|75590887|FG001|NOT COMPLETED|Overall Study||0||
59499497|NCT00452387|75590893|FG000|STARTED|Overall Study||22||
59499498|NCT00452387|75590893|FG000|COMPLETED|Overall Study||22||
59499499|NCT00452387|75590893|FG000|NOT COMPLETED|Overall Study||0||
59499500|NCT00452543|75590901|FG000|STARTED|Overall Study||12||
59499501|NCT00452543|75590902|FG001|STARTED|Overall Study||11||
59499502|NCT00452543|75590901|FG000|COMPLETED|Overall Study||7||
59499503|NCT00452543|75590902|FG001|COMPLETED|Overall Study||5||
59499504|NCT00452543|75590901|FG000|NOT COMPLETED|Overall Study||5||
59499505|NCT00452543|75590902|FG001|NOT COMPLETED|Overall Study||6||
59499506|NCT00565045|75590910|FG000|STARTED|Overall Study||10||
59499507|NCT00565045|75590911|FG001|STARTED|Overall Study||11||
59499508|NCT00565045|75590910|FG000|COMPLETED|Overall Study||9||
59499509|NCT00565045|75590911|FG001|COMPLETED|Overall Study||8||
59499510|NCT00565045|75590910|FG000|NOT COMPLETED|Overall Study||1||
59499511|NCT00565045|75590911|FG001|NOT COMPLETED|Overall Study||3||
59499512|NCT00565669|75590919|FG000|STARTED|Overall Study||11||
59499513|NCT00565669|75590920|FG001|STARTED|Overall Study||9||
59499514|NCT00565669|75590919|FG000|COMPLETED|Overall Study||11||
59499515|NCT00565669|75590920|FG001|COMPLETED|Overall Study||9||
59499516|NCT00565669|75590919|FG000|NOT COMPLETED|Overall Study||0||
59607286|NCT03832907|75717843|FG000|COMPLETED|Overall Study||91||
59607287|NCT03832907|75717843|FG000|NOT COMPLETED|Overall Study||10||
59499517|NCT00565669|75590920|FG001|NOT COMPLETED|Overall Study||0||
59499518|NCT00453479|75590929|FG000|STARTED|Overall Study||6||
59499519|NCT00453479|75590930|FG001|STARTED|Overall Study||9||
59499520|NCT00453479|75590931|FG002|STARTED|Overall Study||8||
59499521|NCT00453479|75590929|FG000|COMPLETED|Overall Study||6||
59499522|NCT00453479|75590930|FG001|COMPLETED|Overall Study||9||
59499523|NCT00453479|75590931|FG002|COMPLETED|Overall Study||8||
59499524|NCT00453479|75590929|FG000|NOT COMPLETED|Overall Study||0||
59499525|NCT00453479|75590930|FG001|NOT COMPLETED|Overall Study||0||
59499526|NCT00453479|75590931|FG002|NOT COMPLETED|Overall Study||0||
59499527|NCT02132533|75590943|FG000|STARTED|Overall Study||46||
59499528|NCT02132533|75590944|FG001|STARTED|Overall Study||42||
59499529|NCT02132533|75590943|FG000|COMPLETED|Overall Study||46||
59499530|NCT02132533|75590944|FG001|COMPLETED|Overall Study||42||
59499531|NCT02132533|75590943|FG000|NOT COMPLETED|Overall Study||0||
59499532|NCT02132533|75590944|FG001|NOT COMPLETED|Overall Study||0||
59499533|NCT03927482|75590952|FG000|STARTED|Overall Study||118||
59499534|NCT03927482|75590953|FG001|STARTED|Overall Study||121||
59499535|NCT03927482|75590952|FG000|COMPLETED|Overall Study||110||
59499536|NCT03927482|75590953|FG001|COMPLETED|Overall Study||115||
59499537|NCT03927482|75590952|FG000|NOT COMPLETED|Overall Study||8||
59499538|NCT03927482|75590953|FG001|NOT COMPLETED|Overall Study||6||
59499539|NCT00567229|75590959|FG000|STARTED|Overall Study||3||
59499540|NCT00567229|75590959|FG000|COMPLETED|Overall Study||3||
59499541|NCT00567229|75590959|FG000|NOT COMPLETED|Overall Study||0||
59499542|NCT00567307|75590965|FG000|STARTED|Overall Study||111||
59499543|NCT00567307|75590966|FG001|STARTED|Overall Study||105||
59499544|NCT00567307|75590965|FG000|COMPLETED|Overall Study||99||
59499545|NCT00567307|75590966|FG001|COMPLETED|Overall Study||104||
59499546|NCT00567307|75590965|FG000|NOT COMPLETED|Overall Study||12||
59499547|NCT00567307|75590966|FG001|NOT COMPLETED|Overall Study||1||
59499548|NCT00487565|75590972|FG000|STARTED|Overall Study||210||
59499549|NCT00487565|75590972|FG000|COMPLETED|Overall Study||182||
59499550|NCT00487565|75590972|FG000|NOT COMPLETED|Overall Study||28||
59499551|NCT00568087|75590978|FG000|STARTED|Overall Study||22||
59499552|NCT00568087|75590979|FG001|STARTED|Overall Study||24||
59499553|NCT00568087|75590978|FG000|Received Intervention|Overall Study||21||
59499554|NCT00568087|75590979|FG001|Received Intervention|Overall Study||23||
59499555|NCT00568087|75590978|FG000|COMPLETED|Overall Study||15||
59499556|NCT00568087|75590979|FG001|COMPLETED|Overall Study||17||
59499557|NCT00568087|75590978|FG000|NOT COMPLETED|Overall Study||7||
59499558|NCT00568087|75590979|FG001|NOT COMPLETED|Overall Study||7||
59499559|NCT00487721|75590987|FG000|STARTED|Overall Study||6||
59499560|NCT00487721|75590988|FG001|STARTED|Overall Study||6||
59499561|NCT00487721|75590987|FG000|COMPLETED|Overall Study||6||
59499562|NCT00487721|75590988|FG001|COMPLETED|Overall Study||6||
59499563|NCT00487721|75590987|FG000|NOT COMPLETED|Overall Study||0||
59499564|NCT00487721|75590988|FG001|NOT COMPLETED|Overall Study||0||
59499565|NCT00568633|75590995|FG000|STARTED|Overall Study||25||
59499566|NCT00568633|75590996|FG001|STARTED|Overall Study||33||
59499567|NCT00568633|75590995|FG000|COMPLETED|Overall Study||25||
59499568|NCT00568633|75590996|FG001|COMPLETED|Overall Study||33||
59499569|NCT00568633|75590995|FG000|NOT COMPLETED|Overall Study||0||
59499570|NCT00568633|75590996|FG001|NOT COMPLETED|Overall Study||0||
59499571|NCT00489281|75591004|FG000|STARTED|Overall Study||29||
59499572|NCT00489281|75591005|FG001|STARTED|Overall Study||13||
59499573|NCT00489281|75591004|FG000|COMPLETED|Overall Study||29||
59499574|NCT00489281|75591005|FG001|COMPLETED|Overall Study||13||
59499575|NCT00489281|75591004|FG000|NOT COMPLETED|Overall Study||0||
59499576|NCT00489281|75591005|FG001|NOT COMPLETED|Overall Study||0||
59499577|NCT02117999|75591013|FG000|STARTED|Overall Study||20||22
59499578|NCT02117999|75591014|FG001|STARTED|Overall Study||10||12
59499579|NCT02117999|75591013|FG000|Mean Kmax Change in Corneal Topography|Overall Study||20||22
59499580|NCT02117999|75591014|FG001|Mean Kmax Change in Corneal Topography|Overall Study||10||12
59499581|NCT02117999|75591013|FG000|COMPLETED|Overall Study||20||22
59499582|NCT02117999|75591014|FG001|COMPLETED|Overall Study||10||12
59499583|NCT02117999|75591013|FG000|NOT COMPLETED|Overall Study||0||0
59499584|NCT02117999|75591014|FG001|NOT COMPLETED|Overall Study||0||0
59499585|NCT04146116|75591022|FG000|STARTED|Overall Study||65||
59499586|NCT04146116|75591022|FG000|COMPLETED|Overall Study||51||
59499587|NCT04146116|75591022|FG000|NOT COMPLETED|Overall Study||14||
59499588|NCT02119871|75591028|FG000|STARTED|Overall Study||10||
59499589|NCT02119871|75591029|FG001|STARTED|Overall Study||10||
59499590|NCT02119871|75591028|FG000|COMPLETED|Overall Study||10||
59499591|NCT02119871|75591029|FG001|COMPLETED|Overall Study||10||
59499592|NCT02119871|75591028|FG000|NOT COMPLETED|Overall Study||0||
59499593|NCT02119871|75591029|FG001|NOT COMPLETED|Overall Study||0||
59499594|NCT02130583|75591037|FG000|STARTED|Overall Study||26||
59499595|NCT02130583|75591038|FG001|STARTED|Overall Study||26||
59499596|NCT02130583|75591037|FG000|COMPLETED|Overall Study||17||
59499597|NCT02130583|75591038|FG001|COMPLETED|Overall Study||19||
59499598|NCT02130583|75591037|FG000|NOT COMPLETED|Overall Study||9||
59499599|NCT02130583|75591038|FG001|NOT COMPLETED|Overall Study||7||
59499600|NCT02120261|75591046|FG000|STARTED|Overall Study||23||
59499601|NCT02120261|75591047|FG001|STARTED|Overall Study||25||
59499602|NCT02120261|75591046|FG000|COMPLETED|Overall Study||23||
59499603|NCT02120261|75591047|FG001|COMPLETED|Overall Study||25||
59499604|NCT02120261|75591046|FG000|NOT COMPLETED|Overall Study||0||
59499605|NCT02120261|75591047|FG001|NOT COMPLETED|Overall Study||0||
59499606|NCT00492089|75591055|FG000|STARTED|First Intervention (6 Weeks)||5||
59499607|NCT00492089|75591056|FG001|STARTED|First Intervention (6 Weeks)||6||
59499608|NCT00492089|75591055|FG000|COMPLETED|First Intervention (6 Weeks)||5||
59499609|NCT00492089|75591056|FG001|COMPLETED|First Intervention (6 Weeks)||6||
59499610|NCT00492089|75591055|FG000|NOT COMPLETED|First Intervention (6 Weeks)||0||
59499611|NCT00492089|75591056|FG001|NOT COMPLETED|First Intervention (6 Weeks)||0||
59499612|NCT00492089|75591055|FG000|STARTED|Second Intervention (6 Weeks)||5||
59499613|NCT00492089|75591056|FG001|STARTED|Second Intervention (6 Weeks)||6||
59499614|NCT00492089|75591055|FG000|COMPLETED|Second Intervention (6 Weeks)||5||
59499615|NCT00492089|75591056|FG001|COMPLETED|Second Intervention (6 Weeks)||6||
59499616|NCT00492089|75591055|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0||
59499617|NCT00492089|75591056|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||0||
59499618|NCT00548171|75591064|FG000|STARTED|Overall Study||164||
59499619|NCT00548171|75591065|FG001|STARTED|Overall Study||39||
59499620|NCT00548171|75591064|FG000|COMPLETED|Overall Study||164||
59499621|NCT00548171|75591065|FG001|COMPLETED|Overall Study||39||
59499622|NCT00548171|75591064|FG000|NOT COMPLETED|Overall Study||0||
59499623|NCT00548171|75591065|FG001|NOT COMPLETED|Overall Study||0||
59499624|NCT00492401|75591071|FG000|STARTED|Overall Study||55||
59499625|NCT00492401|75591071|FG000|COMPLETED|Overall Study||55||
59499626|NCT00492401|75591071|FG000|NOT COMPLETED|Overall Study||0||
59499627|NCT04149002|75591079|FG000|STARTED|Overall Study||14||
59499628|NCT04149002|75591080|FG001|STARTED|Overall Study||16||
59499629|NCT04149002|75591079|FG000|COMPLETED|Overall Study||12||
59499630|NCT04149002|75591080|FG001|COMPLETED|Overall Study||16||
59499631|NCT04149002|75591079|FG000|NOT COMPLETED|Overall Study||2||
59499632|NCT04149002|75591080|FG001|NOT COMPLETED|Overall Study||0||
59499633|NCT00493181|75591087|FG000|STARTED|Overall Study||8||
59499634|NCT00493181|75591087|FG000|COMPLETED|Overall Study||8||
59499635|NCT00493181|75591087|FG000|NOT COMPLETED|Overall Study||0||
59499636|NCT00493805|75591091|FG000|STARTED|Overall Study||17||
59499637|NCT00493805|75591092|FG001|STARTED|Overall Study||42||
59499638|NCT00493805|75591091|FG000|COMPLETED|Overall Study||17||
59499639|NCT00493805|75591092|FG001|COMPLETED|Overall Study||42||
59499640|NCT00493805|75591091|FG000|NOT COMPLETED|Overall Study||0||
59499641|NCT00493805|75591092|FG001|NOT COMPLETED|Overall Study||0||
59499642|NCT00494585|75591098|FG000|STARTED|Overall Study||22||
59499643|NCT00494585|75591098|FG000|COMPLETED|Overall Study||22||
59499644|NCT00494585|75591098|FG000|NOT COMPLETED|Overall Study||0||
59499645|NCT00494975|75591104|FG000|STARTED|Overall Study||10||
59499646|NCT00494975|75591105|FG001|STARTED|Overall Study||11||
59499647|NCT00494975|75591104|FG000|COMPLETED|Overall Study||8||
59499648|NCT00494975|75591105|FG001|COMPLETED|Overall Study||10||
59499649|NCT00494975|75591104|FG000|NOT COMPLETED|Overall Study||2||
59499650|NCT00494975|75591105|FG001|NOT COMPLETED|Overall Study||1||
59499651|NCT00550277|75591111|FG000|STARTED|Overall Study||20||
59499652|NCT00550277|75591111|FG000|COMPLETED|Overall Study||11||
59499653|NCT00550277|75591111|FG000|NOT COMPLETED|Overall Study||9||
59499654|NCT00550589|75591115|FG000|STARTED|Overall Study||33||
59499655|NCT00550589|75591115|FG000|COMPLETED|Overall Study||33||
59499656|NCT00550589|75591115|FG000|NOT COMPLETED|Overall Study||0||
59499657|NCT00496379|75591121|FG000|STARTED|Overall Study||15||
59499658|NCT00496379|75591121|FG000|COMPLETED|Overall Study||15||
59499659|NCT00496379|75591121|FG000|NOT COMPLETED|Overall Study||0||
59499660|NCT02124863|75591125|FG000|STARTED|Overall Study||67||
59499661|NCT02124863|75591125|FG000|COMPLETED|Overall Study||50||
59499662|NCT02124863|75591125|FG000|NOT COMPLETED|Overall Study||17||
59499663|NCT00497081|75591133|FG000|STARTED|Overall Study||30||
59499664|NCT00497081|75591134|FG001|STARTED|Overall Study||30||
59499665|NCT00497081|75591133|FG000|COMPLETED|Overall Study||28||
59499666|NCT00497081|75591134|FG001|COMPLETED|Overall Study||28||
59499667|NCT00497081|75591133|FG000|NOT COMPLETED|Overall Study||2||
59499668|NCT00497081|75591134|FG001|NOT COMPLETED|Overall Study||2||
59499669|NCT00604045|75591142|FG000|STARTED|Overall Study||15||
59499670|NCT00604045|75591143|FG001|STARTED|Overall Study||10||
59499671|NCT00604045|75591142|FG000|COMPLETED|Overall Study||14||
59499672|NCT00604045|75591143|FG001|COMPLETED|Overall Study||9||
59499673|NCT00604045|75591142|FG000|NOT COMPLETED|Overall Study||1||
59499674|NCT00604045|75591143|FG001|NOT COMPLETED|Overall Study||1||
59499675|NCT00555321|75591154|FG000|STARTED|Treatment Phase up to 12-months||52||
59499676|NCT00555321|75591155|FG001|STARTED|Treatment Phase up to 12-months||51||
59499677|NCT00555321|75591156|FG002|STARTED|Treatment Phase up to 12-months||50||
59499678|NCT00555321|75591157|FG003|STARTED|Treatment Phase up to 12-months||53||
59499679|NCT00555321|75591158|FG004|STARTED|Treatment Phase up to 12-months||54||
59499680|NCT00555321|75591154|FG000|Received Transplant and Treated|Treatment Phase up to 12-months||50||
59499681|NCT00555321|75591155|FG001|Received Transplant and Treated|Treatment Phase up to 12-months||48||
59499682|NCT00555321|75591156|FG002|Received Transplant and Treated|Treatment Phase up to 12-months||49||
59499683|NCT00555321|75591157|FG003|Received Transplant and Treated|Treatment Phase up to 12-months||53||
59499684|NCT00555321|75591158|FG004|Received Transplant and Treated|Treatment Phase up to 12-months||50||
59499685|NCT00555321|75591154|FG000|COMPLETED|Treatment Phase up to 12-months||31||
59499686|NCT00555321|75591155|FG001|COMPLETED|Treatment Phase up to 12-months||29||
59499687|NCT00555321|75591156|FG002|COMPLETED|Treatment Phase up to 12-months||26||
59499688|NCT00555321|75591157|FG003|COMPLETED|Treatment Phase up to 12-months||46||
59499689|NCT00555321|75591158|FG004|COMPLETED|Treatment Phase up to 12-months||32||
59499690|NCT00555321|75591154|FG000|NOT COMPLETED|Treatment Phase up to 12-months||21||
59499691|NCT00555321|75591155|FG001|NOT COMPLETED|Treatment Phase up to 12-months||22||
59499692|NCT00555321|75591156|FG002|NOT COMPLETED|Treatment Phase up to 12-months||24||
59499693|NCT00555321|75591157|FG003|NOT COMPLETED|Treatment Phase up to 12-months||7||
59499694|NCT00555321|75591158|FG004|NOT COMPLETED|Treatment Phase up to 12-months||22||
59499695|NCT00555321|75591154|FG000|STARTED|Long-term Extension Phase|1 participant did not enter LTE|30||
59499696|NCT00555321|75591155|FG001|STARTED|Long-term Extension Phase|2 participants did not enter LTE|27||
59499697|NCT00555321|75591156|FG002|STARTED|Long-term Extension Phase|2 participants did not enter LTE|24||
59499698|NCT00555321|75591157|FG003|STARTED|Long-term Extension Phase|8 participants did not enter LTE|38||
59499699|NCT00555321|75591158|FG004|STARTED|Long-term Extension Phase|6 participants did not enter LTE|26||
59499700|NCT00555321|75591154|FG000|COMPLETED|Long-term Extension Phase||0||
59499701|NCT00555321|75591155|FG001|COMPLETED|Long-term Extension Phase||0||
59499702|NCT00555321|75591156|FG002|COMPLETED|Long-term Extension Phase||0||
59499703|NCT00555321|75591157|FG003|COMPLETED|Long-term Extension Phase||0||
59499704|NCT00555321|75591158|FG004|COMPLETED|Long-term Extension Phase||0||
59499705|NCT00555321|75591154|FG000|NOT COMPLETED|Long-term Extension Phase||30||
59499706|NCT00555321|75591155|FG001|NOT COMPLETED|Long-term Extension Phase||27||
59499707|NCT00555321|75591156|FG002|NOT COMPLETED|Long-term Extension Phase||24||
59499708|NCT00555321|75591157|FG003|NOT COMPLETED|Long-term Extension Phase||38||
59499709|NCT00555321|75591158|FG004|NOT COMPLETED|Long-term Extension Phase||26||
59499710|NCT02133235|75591177|FG000|STARTED|Overall Study||55||
59499711|NCT02133235|75591178|FG001|STARTED|Overall Study||57||
59499712|NCT02133235|75591177|FG000|COMPLETED|Overall Study||55||
59754861|NCT01758432|75873695|FG004|STARTED|Overall Study||6||
59885395|NCT03541317|76008207|FG004|STARTED|Stage 2 of the Implementation||43||21
59499713|NCT02133235|75591178|FG001|COMPLETED|Overall Study||57||
59499714|NCT02133235|75591177|FG000|NOT COMPLETED|Overall Study||0||
59499715|NCT02133235|75591178|FG001|NOT COMPLETED|Overall Study||0||
59499716|NCT00607243|75591192|FG000|STARTED|Initial Post-vaccination Period||82||
59499717|NCT00607243|75591193|FG001|STARTED|Initial Post-vaccination Period||41||
59499718|NCT00607243|75591192|FG000|COMPLETED|Initial Post-vaccination Period||82||
59499719|NCT00607243|75591193|FG001|COMPLETED|Initial Post-vaccination Period||41||
59499720|NCT00607243|75591192|FG000|NOT COMPLETED|Initial Post-vaccination Period||0||
59499721|NCT00607243|75591193|FG001|NOT COMPLETED|Initial Post-vaccination Period||0||
59499722|NCT00607243|75591192|FG000|STARTED|Telephone Safety Assessment Period||82||
59499723|NCT00607243|75591193|FG001|STARTED|Telephone Safety Assessment Period||41||
59499724|NCT00607243|75591192|FG000|COMPLETED|Telephone Safety Assessment Period|80 Available for 3 months 77 Available for 6 months|77||
59499725|NCT00607243|75591193|FG001|COMPLETED|Telephone Safety Assessment Period|40 Available for 3 months 39 Available for 6 months|39||
59499726|NCT00607243|75591192|FG000|NOT COMPLETED|Telephone Safety Assessment Period||5||
59499727|NCT00607243|75591193|FG001|NOT COMPLETED|Telephone Safety Assessment Period||2||
59499728|NCT00607321|75591199|FG000|STARTED|Overall Study||60||
59499729|NCT00607321|75591199|FG000|COMPLETED|Overall Study||60||
59499730|NCT00607321|75591199|FG000|NOT COMPLETED|Overall Study||0||
59499731|NCT00607867|75591207|FG000|STARTED|Overall Study||7||
59499732|NCT00607867|75591208|FG001|STARTED|Overall Study||7||
59499733|NCT00607867|75591207|FG000|COMPLETED|Overall Study||7||
59499734|NCT00607867|75591208|FG001|COMPLETED|Overall Study||7||
59499735|NCT00607867|75591207|FG000|NOT COMPLETED|Overall Study||0||
59499736|NCT00607867|75591208|FG001|NOT COMPLETED|Overall Study||0||
59499737|NCT02138227|75591216|FG000|STARTED|Overall Study||55||
59499738|NCT02138227|75591217|FG001|STARTED|Overall Study||218||
59499739|NCT02138227|75591216|FG000|COMPLETED|Overall Study||55||
59499740|NCT02138227|75591217|FG001|COMPLETED|Overall Study||218||
59499741|NCT02138227|75591216|FG000|NOT COMPLETED|Overall Study||0||
59499742|NCT02138227|75591217|FG001|NOT COMPLETED|Overall Study||0||
59499743|NCT02138461|75591250|FG000|STARTED|Overall Study||101||
59499744|NCT02138461|75591251|FG001|STARTED|Overall Study||110||
59499745|NCT02138461|75591250|FG000|COMPLETED|Overall Study||101||
59499746|NCT02138461|75591251|FG001|COMPLETED|Overall Study||110||
59499747|NCT02138461|75591250|FG000|NOT COMPLETED|Overall Study||0||
59499748|NCT02138461|75591251|FG001|NOT COMPLETED|Overall Study||0||
59499749|NCT02275923|75591257|FG000|STARTED|Overall Study||9||
59499750|NCT02275923|75591257|FG000|COMPLETED|Overall Study||7||
59499751|NCT02275923|75591257|FG000|NOT COMPLETED|Overall Study||2||
59499752|NCT02139007|75591263|FG000|STARTED|Study Site Recruitment||4||
59499753|NCT02139007|75591264|FG001|STARTED|Study Site Recruitment||5||
59499754|NCT02139007|75591263|FG000|COMPLETED|Study Site Recruitment||1||
59499755|NCT02139007|75591264|FG001|COMPLETED|Study Site Recruitment||1||
59499756|NCT02139007|75591263|FG000|NOT COMPLETED|Study Site Recruitment||3||
59499757|NCT02139007|75591264|FG001|NOT COMPLETED|Study Site Recruitment||4||
59499758|NCT02139007|75591263|FG000|STARTED|Patient Participant Recruitment||13||
59499759|NCT02139007|75591264|FG001|STARTED|Patient Participant Recruitment||14||
59754862|NCT01758432|75873696|FG005|STARTED|Overall Study||6||
59885396|NCT03541317|76008208|FG005|STARTED|Stage 2 of the Implementation||36||20
59885397|NCT03541317|76008203|FG000|COMPLETED|Stage 2 of the Implementation||5||5
59885398|NCT03541317|76008204|FG001|COMPLETED|Stage 2 of the Implementation||37||21
59885399|NCT03541317|76008205|FG002|COMPLETED|Stage 2 of the Implementation||38||21
59885400|NCT03541317|76008206|FG003|COMPLETED|Stage 2 of the Implementation||9||6
59885401|NCT03541317|76008207|FG004|COMPLETED|Stage 2 of the Implementation||43||21
59885402|NCT03541317|76008208|FG005|COMPLETED|Stage 2 of the Implementation||36||20
59885403|NCT03541317|76008203|FG000|NOT COMPLETED|Stage 2 of the Implementation||1||0
59885404|NCT03541317|76008204|FG001|NOT COMPLETED|Stage 2 of the Implementation||0||0
59885405|NCT03541317|76008205|FG002|NOT COMPLETED|Stage 2 of the Implementation||0||0
59885406|NCT03541317|76008206|FG003|NOT COMPLETED|Stage 2 of the Implementation||0||0
59499760|NCT02139007|75591263|FG000|COMPLETED|Patient Participant Recruitment||11||
59499761|NCT02139007|75591264|FG001|COMPLETED|Patient Participant Recruitment||13||
59499762|NCT02139007|75591263|FG000|NOT COMPLETED|Patient Participant Recruitment||2||
59499763|NCT02139007|75591264|FG001|NOT COMPLETED|Patient Participant Recruitment||1||
59499764|NCT00570349|75591276|FG000|STARTED|Overall Study||6||
59499765|NCT00570349|75591277|FG001|STARTED|Overall Study||6||
59499766|NCT00570349|75591278|FG002|STARTED|Overall Study||6||
59499767|NCT00570349|75591276|FG000|COMPLETED|Overall Study||6||
59499768|NCT00570349|75591277|FG001|COMPLETED|Overall Study||6||
59499769|NCT00570349|75591278|FG002|COMPLETED|Overall Study||6||
59499770|NCT00570349|75591276|FG000|NOT COMPLETED|Overall Study||0||
59754863|NCT01758432|75873697|FG006|STARTED|Overall Study||6||
59754864|NCT01758432|75873691|FG000|COMPLETED|Overall Study||18||
59754865|NCT01758432|75873692|FG001|COMPLETED|Overall Study||6||
59754866|NCT01758432|75873693|FG002|COMPLETED|Overall Study||6||
59754867|NCT01758432|75873694|FG003|COMPLETED|Overall Study||6||
59754868|NCT01758432|75873695|FG004|COMPLETED|Overall Study||6||
59754869|NCT01758432|75873696|FG005|COMPLETED|Overall Study||6||
59754870|NCT01758432|75873697|FG006|COMPLETED|Overall Study||6||
59754871|NCT01758432|75873691|FG000|NOT COMPLETED|Overall Study||0||
59754872|NCT01758432|75873692|FG001|NOT COMPLETED|Overall Study||0||
59754873|NCT01758432|75873693|FG002|NOT COMPLETED|Overall Study||0||
59754874|NCT01758432|75873694|FG003|NOT COMPLETED|Overall Study||0||
59499771|NCT00570349|75591277|FG001|NOT COMPLETED|Overall Study||0||
59499772|NCT00570349|75591278|FG002|NOT COMPLETED|Overall Study||0||
59499773|NCT00608491|75591288|FG000|STARTED|Overall Study||94||
59499774|NCT00608491|75591289|FG001|STARTED|Overall Study||94||
59499775|NCT00608491|75591288|FG000|COMPLETED|Overall Study||73||
59754875|NCT01758432|75873695|FG004|NOT COMPLETED|Overall Study||0||
59754876|NCT01758432|75873696|FG005|NOT COMPLETED|Overall Study||0||
59754877|NCT01758432|75873697|FG006|NOT COMPLETED|Overall Study||0||
59499776|NCT00608491|75591289|FG001|COMPLETED|Overall Study||72||
59754878|NCT01583218|75873715|FG000|STARTED|Overall Study||3759||
59885407|NCT03541317|76008207|FG004|NOT COMPLETED|Stage 2 of the Implementation||0||0
59499777|NCT00608491|75591288|FG000|NOT COMPLETED|Overall Study||21||
59499778|NCT00608491|75591289|FG001|NOT COMPLETED|Overall Study||22||
59499779|NCT00609271|75591297|FG000|STARTED|Overall Study||75||
59499780|NCT00609271|75591298|FG001|STARTED|Overall Study||73||
59499781|NCT00609271|75591297|FG000|COMPLETED|Overall Study||59||
59499782|NCT00609271|75591298|FG001|COMPLETED|Overall Study||60||
59499783|NCT00609271|75591297|FG000|NOT COMPLETED|Overall Study||16||
59499784|NCT00609271|75591298|FG001|NOT COMPLETED|Overall Study||13||
59499785|NCT00609739|75591304|FG000|STARTED|Overall Study||1||
59499786|NCT00609739|75591304|FG000|COMPLETED|Overall Study||1||
59499787|NCT00609739|75591304|FG000|NOT COMPLETED|Overall Study||0||
59499788|NCT00571987|75591308|FG000|STARTED|Overall Study||107||
59499789|NCT00571987|75591308|FG000|COMPLETED|Overall Study||100||
59499790|NCT00571987|75591308|FG000|NOT COMPLETED|Overall Study||7||
59499791|NCT00610987|75591315|FG000|STARTED|Overall Study||75||
59499792|NCT00610987|75591316|FG001|STARTED|Overall Study||71||
59499793|NCT00610987|75591315|FG000|COMPLETED|Overall Study||75||
59499794|NCT00610987|75591316|FG001|COMPLETED|Overall Study||71||
59499795|NCT00610987|75591315|FG000|NOT COMPLETED|Overall Study||0||
59499796|NCT00610987|75591316|FG001|NOT COMPLETED|Overall Study||0||
59499797|NCT00574171|75591322|FG000|STARTED|Overall Study||29||
59499798|NCT00574171|75591322|FG000|COMPLETED|Overall Study||29||
59499799|NCT00574171|75591322|FG000|NOT COMPLETED|Overall Study||0||
59499800|NCT00612235|75591330|FG000|STARTED|Overall Study||20||
59499801|NCT00612235|75591331|FG001|STARTED|Overall Study||20||
59499802|NCT00612235|75591332|FG002|STARTED|Overall Study||20||
59499803|NCT00612235|75591333|FG003|STARTED|Overall Study||20||
59499804|NCT00612235|75591330|FG000|COMPLETED|Overall Study||20||
59499805|NCT00612235|75591331|FG001|COMPLETED|Overall Study||20||
59499806|NCT00612235|75591332|FG002|COMPLETED|Overall Study||20||
59499807|NCT00612235|75591333|FG003|COMPLETED|Overall Study||20||
59499808|NCT00612235|75591330|FG000|NOT COMPLETED|Overall Study||0||
59499809|NCT00612235|75591331|FG001|NOT COMPLETED|Overall Study||0||
59499810|NCT00612235|75591332|FG002|NOT COMPLETED|Overall Study||0||
59499811|NCT00612235|75591333|FG003|NOT COMPLETED|Overall Study||0||
59499812|NCT00613405|75591346|FG000|STARTED|Overall Study||45||
59499813|NCT00613405|75591347|FG001|STARTED|Overall Study||42||
59499814|NCT00613405|75591346|FG000|COMPLETED|Overall Study||45||
59499815|NCT00613405|75591347|FG001|COMPLETED|Overall Study||42||
59499816|NCT00613405|75591346|FG000|NOT COMPLETED|Overall Study||0||
59499817|NCT00613405|75591347|FG001|NOT COMPLETED|Overall Study||0||
59499818|NCT00575029|75591353|FG000|STARTED|Overall Study||7||
59499819|NCT00575029|75591353|FG000|COMPLETED|Overall Study||7||
59499820|NCT00575029|75591353|FG000|NOT COMPLETED|Overall Study||0||
59499821|NCT03912584|75591357|FG000|STARTED|Overall Study||10||
59499822|NCT03912584|75591357|FG000|COMPLETED|Overall Study||10||
59499823|NCT03912584|75591357|FG000|NOT COMPLETED|Overall Study||0||
59499824|NCT00499109|75591366|FG000|STARTED|Overall Study||183||
59499825|NCT00499109|75591367|FG001|STARTED|Overall Study||92||
59499826|NCT00499109|75591366|FG000|COMPLETED|Overall Study||165||
59499827|NCT00499109|75591367|FG001|COMPLETED|Overall Study||85||
59499828|NCT00499109|75591366|FG000|NOT COMPLETED|Overall Study||18||
59499829|NCT00499109|75591367|FG001|NOT COMPLETED|Overall Study||7||
59499830|NCT02125721|75591376|FG000|STARTED|Overall Study||10||
59499831|NCT02125721|75591376|FG000|COMPLETED|Overall Study||10||
59499832|NCT02125721|75591376|FG000|NOT COMPLETED|Overall Study||0||
59499833|NCT00552695|75591382|FG000|STARTED|Overall Study|August 2007|22||
59499834|NCT00552695|75591383|FG001|STARTED|Overall Study|August 2007|23||
59499835|NCT00552695|75591382|FG000|COMPLETED|Overall Study|September 2007|22||
59499836|NCT00552695|75591383|FG001|COMPLETED|Overall Study|September 2007|23||
59499837|NCT00552695|75591382|FG000|NOT COMPLETED|Overall Study||0||
59499838|NCT00552695|75591383|FG001|NOT COMPLETED|Overall Study||0||
59499839|NCT00615433|75591393|FG000|STARTED|Overall Study||120||
59499840|NCT00615433|75591394|FG001|STARTED|Overall Study||119||
59499841|NCT00615433|75591395|FG002|STARTED|Overall Study||123||
59499842|NCT00615433|75591396|FG003|STARTED|Overall Study||116||
59499843|NCT00615433|75591393|FG000|COMPLETED|Overall Study||77||
59499844|NCT00615433|75591394|FG001|COMPLETED|Overall Study||66||
59499845|NCT00615433|75591395|FG002|COMPLETED|Overall Study||84||
59499846|NCT00615433|75591396|FG003|COMPLETED|Overall Study||71||
59499847|NCT00615433|75591393|FG000|NOT COMPLETED|Overall Study||43||
59754879|NCT01583218|75873716|FG001|STARTED|Overall Study||3754||
59754880|NCT01583218|75873715|FG000|COMPLETED|Overall Study||3470||
59754881|NCT01583218|75873716|FG001|COMPLETED|Overall Study||3471||
59754882|NCT01583218|75873715|FG000|NOT COMPLETED|Overall Study||289||
59754883|NCT01583218|75873716|FG001|NOT COMPLETED|Overall Study||283||
59499848|NCT00615433|75591394|FG001|NOT COMPLETED|Overall Study||53||
59754884|NCT00742859|75873726|FG000|STARTED|Overall Study||127||
59754885|NCT00742859|75873727|FG001|STARTED|Overall Study||127||
59754886|NCT00742859|75873728|FG002|STARTED|Overall Study||127||
59754887|NCT00742859|75873729|FG003|STARTED|Overall Study||127||
60012807|NCT02638129|76128783|FG000|NOT COMPLETED|Overall Study||28||
60012808|NCT02638129|76128784|FG001|NOT COMPLETED|Overall Study||30||
60012809|NCT01658943|76128792|FG000|STARTED|Overall Study||70||
60012810|NCT01658943|76128793|FG001|STARTED|Overall Study||67||
60012811|NCT01658943|76128792|FG000|Eligible|Overall Study||63||
60012812|NCT01658943|76128793|FG001|Eligible|Overall Study||58||
60012813|NCT01658943|76128792|FG000|Eligible and Began Protocol Therapy|Overall Study||62||
60012814|NCT01658943|76128793|FG001|Eligible and Began Protocol Therapy|Overall Study||58||
59754888|NCT00742859|75873726|FG000|COMPLETED|Overall Study||116||
59754889|NCT00742859|75873727|FG001|COMPLETED|Overall Study||115||
59754890|NCT00742859|75873728|FG002|COMPLETED|Overall Study||116||
59754891|NCT00742859|75873729|FG003|COMPLETED|Overall Study||119||
59754892|NCT00742859|75873726|FG000|NOT COMPLETED|Overall Study||11||
59754893|NCT00742859|75873727|FG001|NOT COMPLETED|Overall Study||12||
59754894|NCT00742859|75873728|FG002|NOT COMPLETED|Overall Study||11||
60012815|NCT01658943|76128792|FG000|COMPLETED|Overall Study||0||
59499849|NCT00615433|75591395|FG002|NOT COMPLETED|Overall Study||39||
59499850|NCT00615433|75591396|FG003|NOT COMPLETED|Overall Study||45||
59499851|NCT00553163|75591409|FG000|STARTED|Overall Study||16||
59499852|NCT00553163|75591410|FG001|STARTED|Overall Study||10||
59499853|NCT00553163|75591409|FG000|COMPLETED|Overall Study||16||
59499854|NCT00553163|75591410|FG001|COMPLETED|Overall Study||10||
59499855|NCT00553163|75591409|FG000|NOT COMPLETED|Overall Study||0||
59499856|NCT00553163|75591410|FG001|NOT COMPLETED|Overall Study||0||
59499857|NCT00499343|75591423|FG000|STARTED|Overall Study||41||
59499858|NCT00499343|75591424|FG001|STARTED|Overall Study||43||
59499859|NCT00499343|75591423|FG000|COMPLETED|Overall Study||41||
59499860|NCT00499343|75591424|FG001|COMPLETED|Overall Study||43||
59499861|NCT00499343|75591423|FG000|NOT COMPLETED|Overall Study||0||
59499862|NCT00499343|75591424|FG001|NOT COMPLETED|Overall Study||0||
59499863|NCT00615589|75591430|FG000|STARTED|Overall Study||22||
59499864|NCT00615589|75591430|FG000|COMPLETED|Overall Study||22||
59499865|NCT00615589|75591430|FG000|NOT COMPLETED|Overall Study||0||
59499866|NCT00575185|75591437|FG000|STARTED|Overall Study||12||
59499867|NCT00575185|75591438|FG001|STARTED|Overall Study||11||
59499868|NCT00575185|75591437|FG000|COMPLETED|Overall Study||12||
59499869|NCT00575185|75591438|FG001|COMPLETED|Overall Study||11||
59499870|NCT00575185|75591437|FG000|NOT COMPLETED|Overall Study||0||
59499871|NCT00575185|75591438|FG001|NOT COMPLETED|Overall Study||0||
59754895|NCT00742859|75873729|FG003|NOT COMPLETED|Overall Study||8||
59754896|NCT00667342|75873742|FG000|STARTED|Overall Study||31||
59754897|NCT00667342|75873743|FG001|STARTED|Overall Study||0||
59499872|NCT00499655|75591448|FG000|STARTED|Overall Study||53||
59499873|NCT00499655|75591449|FG001|STARTED|Overall Study||54||
59499874|NCT00499655|75591448|FG000|COMPLETED|Overall Study||53||
59499875|NCT00499655|75591449|FG001|COMPLETED|Overall Study||54||
59499876|NCT00499655|75591448|FG000|NOT COMPLETED|Overall Study||0||
59499877|NCT00499655|75591449|FG001|NOT COMPLETED|Overall Study||0||
59499878|NCT00575887|75591456|FG000|STARTED|Overall Study||25||
59499879|NCT00575887|75591456|FG000|COMPLETED|Overall Study||25||
59499880|NCT00575887|75591456|FG000|NOT COMPLETED|Overall Study||0||
59499881|NCT00575965|75591460|FG000|STARTED|Overall Study||18||
59499882|NCT00575965|75591460|FG000|COMPLETED|Overall Study||18||
59754898|NCT00667342|75873744|FG002|STARTED|Overall Study||12||
59754899|NCT00667342|75873742|FG000|COMPLETED|Overall Study||17||
59499883|NCT00575965|75591460|FG000|NOT COMPLETED|Overall Study||0||
59499884|NCT00501995|75591464|FG000|STARTED|Overall Study||6||
59499885|NCT00501995|75591464|FG000|COMPLETED|Overall Study||5||
59499886|NCT00501995|75591464|FG000|NOT COMPLETED|Overall Study||1||
59499887|NCT00577135|75591472|FG000|STARTED|Overall Study||74||
59499888|NCT00577135|75591473|FG001|STARTED|Overall Study||82||
59499889|NCT00577135|75591474|FG002|STARTED|Overall Study||77||
59499890|NCT00577135|75591475|FG003|STARTED|Overall Study||75||
59499891|NCT00577135|75591472|FG000|COMPLETED|Overall Study||74||
59499892|NCT00577135|75591473|FG001|COMPLETED|Overall Study||82||
59499893|NCT00577135|75591474|FG002|COMPLETED|Overall Study||77||
59499894|NCT00577135|75591475|FG003|COMPLETED|Overall Study||75||
59499895|NCT00577135|75591472|FG000|NOT COMPLETED|Overall Study||0||
59499896|NCT00577135|75591473|FG001|NOT COMPLETED|Overall Study||0||
59499897|NCT00577135|75591474|FG002|NOT COMPLETED|Overall Study||0||
59499898|NCT00577135|75591475|FG003|NOT COMPLETED|Overall Study||0||
59499899|NCT00502853|75591485|FG000|STARTED|Overall Study||10||
59499900|NCT00502853|75591485|FG000|COMPLETED|Overall Study||10||
59499901|NCT00502853|75591485|FG000|NOT COMPLETED|Overall Study||0||
59499902|NCT00617539|75591490|FG000|STARTED|Overall Study||30||
59499903|NCT00617539|75591490|FG000|COMPLETED|Overall Study||30||
59499904|NCT00617539|75591490|FG000|NOT COMPLETED|Overall Study||0||
59499905|NCT00578071|75591495|FG000|STARTED|Overall Study||29||
59499906|NCT00578071|75591495|FG000|COMPLETED|Overall Study||29||
59499907|NCT00578071|75591495|FG000|NOT COMPLETED|Overall Study||0||
59499908|NCT00555581|75591500|FG000|STARTED|Overall Study||30||
59499909|NCT00555581|75591500|FG000|COMPLETED|Overall Study||24||
59499910|NCT00555581|75591500|FG000|NOT COMPLETED|Overall Study||6||
59499911|NCT00504023|75591504|FG000|STARTED|Overall Study||8||
59499912|NCT00504023|75591504|FG000|COMPLETED|Overall Study||8||
59754900|NCT00667342|75873743|FG001|COMPLETED|Overall Study||0||
59754901|NCT00667342|75873744|FG002|COMPLETED|Overall Study||3||
59885408|NCT03541317|76008208|FG005|NOT COMPLETED|Stage 2 of the Implementation||0||0
60012816|NCT01658943|76128793|FG001|COMPLETED|Overall Study||0||
60012817|NCT01658943|76128792|FG000|NOT COMPLETED|Overall Study||70||
60012818|NCT01658943|76128793|FG001|NOT COMPLETED|Overall Study||67||
60012819|NCT02600819|76128799|FG000|STARTED|GEN Phase||55||
60012820|NCT02600819|76128800|FG001|STARTED|GEN Phase||0||
60012821|NCT02600819|76128799|FG000|COMPLETED|GEN Phase||39||
60012822|NCT02600819|76128800|FG001|COMPLETED|GEN Phase||0||
60012823|NCT02600819|76128799|FG000|NOT COMPLETED|GEN Phase||16||
59754902|NCT00667342|75873742|FG000|NOT COMPLETED|Overall Study||14||
59754903|NCT00667342|75873743|FG001|NOT COMPLETED|Overall Study||0||
59754904|NCT00667342|75873744|FG002|NOT COMPLETED|Overall Study||9||
59885409|NCT03557931|76008223|FG000|STARTED|Overall Study||100||
59885410|NCT03557931|76008224|FG001|STARTED|Overall Study||65||
59885411|NCT03557931|76008225|FG002|STARTED|Overall Study||68||
59885412|NCT03557931|76008223|FG000|COMPLETED|Overall Study||69||
59885413|NCT03557931|76008224|FG001|COMPLETED|Overall Study||46||
59885414|NCT03557931|76008225|FG002|COMPLETED|Overall Study||55||
59885415|NCT03557931|76008223|FG000|NOT COMPLETED|Overall Study||31||
60012824|NCT02600819|76128800|FG001|NOT COMPLETED|GEN Phase||0||
60012825|NCT02600819|76128799|FG000|STARTED|BVY OL Extension Phase|Only US participants were eligible to roll over into the Extension Phase per the study protocol.|0||
60012826|NCT02600819|76128800|FG001|STARTED|BVY OL Extension Phase|Only US participants were eligible to roll over into the Extension Phase per the study protocol.|10||
60012827|NCT02600819|76128799|FG000|COMPLETED|BVY OL Extension Phase||0||
60012828|NCT02600819|76128800|FG001|COMPLETED|BVY OL Extension Phase||10||
60012829|NCT02600819|76128799|FG000|NOT COMPLETED|BVY OL Extension Phase||0||
60012830|NCT02600819|76128800|FG001|NOT COMPLETED|BVY OL Extension Phase||0||
59499913|NCT00504023|75591504|FG000|NOT COMPLETED|Overall Study||0||
59499914|NCT03503474|75591510|FG000|STARTED|Overall Study|The number of participant with a diarrhoeal sample that returned a positive test result at the coordinating laboratory. There is no intervention as this is an observational study only.|103||
59499915|NCT03503474|75591511|FG001|STARTED|Overall Study|The number of participant with a diarrhoeal sample that returned a negative test result at the coordinating laboratory. There is no intervention as this is an observational study only.|3050||
59499916|NCT03503474|75591510|FG000|COMPLETED|Overall Study||103||
59499917|NCT03503474|75591511|FG001|COMPLETED|Overall Study||3050||
59499918|NCT03503474|75591510|FG000|NOT COMPLETED|Overall Study||0||
59754905|NCT00375609|75873761|FG000|STARTED|Overall Study||88||
59754906|NCT00375609|75873762|FG001|STARTED|Overall Study||84||
59754907|NCT00375609|75873763|FG002|STARTED|Overall Study||43||
59754908|NCT00375609|75873761|FG000|COMPLETED|Overall Study||84||
59754909|NCT00375609|75873762|FG001|COMPLETED|Overall Study||77||
59885416|NCT03557931|76008224|FG001|NOT COMPLETED|Overall Study||19||
59885417|NCT03557931|76008225|FG002|NOT COMPLETED|Overall Study||13||
60012831|NCT02597933|76128808|FG000|STARTED|Overall Study|Started are randomised|290||
60012832|NCT02597933|76128809|FG001|STARTED|Overall Study|Started are randomised|290||
59499919|NCT03503474|75591511|FG001|NOT COMPLETED|Overall Study||0||
59499920|NCT00578305|75591520|FG000|STARTED|Double-blind Treatment Phase||62||
59499921|NCT00578305|75591521|FG001|STARTED|Double-blind Treatment Phase||60||
59499922|NCT00578305|75591522|FG002|STARTED|Double-blind Treatment Phase||63||
59499923|NCT00578305|75591520|FG000|Treated|Double-blind Treatment Phase||62||
59499924|NCT00578305|75591521|FG001|Treated|Double-blind Treatment Phase||60||
59499925|NCT00578305|75591522|FG002|Treated|Double-blind Treatment Phase||63||
59499926|NCT00578305|75591520|FG000|COMPLETED|Double-blind Treatment Phase||59||
59499927|NCT00578305|75591521|FG001|COMPLETED|Double-blind Treatment Phase||56||
59499928|NCT00578305|75591522|FG002|COMPLETED|Double-blind Treatment Phase||49||
59499929|NCT00578305|75591520|FG000|NOT COMPLETED|Double-blind Treatment Phase||3||
59499930|NCT00578305|75591521|FG001|NOT COMPLETED|Double-blind Treatment Phase||4||
59499931|NCT00578305|75591522|FG002|NOT COMPLETED|Double-blind Treatment Phase||14||
59499932|NCT00578305|75591520|FG000|STARTED|Extension Phase||53||
59499933|NCT00578305|75591521|FG001|STARTED|Extension Phase||50||
59499934|NCT00578305|75591522|FG002|STARTED|Extension Phase||43||
59499935|NCT00578305|75591520|FG000|COMPLETED|Extension Phase|Some participants completed the study in this period and did not enter the safety follow-up period.|49||
59499936|NCT00578305|75591521|FG001|COMPLETED|Extension Phase|Some participants completed the study in this period and did not enter the safety follow-up period.|49||
59499937|NCT00578305|75591522|FG002|COMPLETED|Extension Phase|Some participants completed the study in this period and did not enter the safety follow-up period.|40||
59499938|NCT00578305|75591520|FG000|NOT COMPLETED|Extension Phase||4||
59499939|NCT00578305|75591521|FG001|NOT COMPLETED|Extension Phase||1||
59499940|NCT00578305|75591522|FG002|NOT COMPLETED|Extension Phase||3||
59499941|NCT00578305|75591520|FG000|STARTED|Safety Follow-up Phase|Some participants entered safety follow-up directly from the double-blind treatment period.|57||
59499942|NCT00578305|75591521|FG001|STARTED|Safety Follow-up Phase|Some participants entered safety follow-up directly from the double-blind treatment period.|54||
59499943|NCT00578305|75591522|FG002|STARTED|Safety Follow-up Phase|Some participants entered safety follow-up directly from the double-blind treatment period.|54||
59499944|NCT00578305|75591520|FG000|COMPLETED|Safety Follow-up Phase||11||
59499945|NCT00578305|75591521|FG001|COMPLETED|Safety Follow-up Phase||9||
59499946|NCT00578305|75591522|FG002|COMPLETED|Safety Follow-up Phase||8||
59499947|NCT00578305|75591520|FG000|NOT COMPLETED|Safety Follow-up Phase||46||
59499948|NCT00578305|75591521|FG001|NOT COMPLETED|Safety Follow-up Phase||45||
59754910|NCT00375609|75873763|FG002|COMPLETED|Overall Study||42||
59754911|NCT00375609|75873761|FG000|NOT COMPLETED|Overall Study||4||
59754912|NCT00375609|75873762|FG001|NOT COMPLETED|Overall Study||7||
59754913|NCT00375609|75873763|FG002|NOT COMPLETED|Overall Study||1||
59499949|NCT00578305|75591522|FG002|NOT COMPLETED|Safety Follow-up Phase||46||
59499950|NCT00578383|75591540|FG000|STARTED|Overall Study||37||
59499951|NCT00578383|75591541|FG001|STARTED|Overall Study||36||
59499952|NCT00578383|75591542|FG002|STARTED|Overall Study||19||
59499953|NCT00578383|75591543|FG003|STARTED|Overall Study||15||
59499954|NCT00578383|75591540|FG000|COMPLETED|Overall Study||21||
59499955|NCT00578383|75591541|FG001|COMPLETED|Overall Study||20||
59499956|NCT00578383|75591542|FG002|COMPLETED|Overall Study||13||
59499957|NCT00578383|75591543|FG003|COMPLETED|Overall Study||9||
59499958|NCT00578383|75591540|FG000|NOT COMPLETED|Overall Study||16||
59499959|NCT00578383|75591541|FG001|NOT COMPLETED|Overall Study||16||
59499960|NCT00578383|75591542|FG002|NOT COMPLETED|Overall Study||6||
59499961|NCT00578383|75591543|FG003|NOT COMPLETED|Overall Study||6||
59499962|NCT00578461|75591557|FG000|STARTED|Overall Study||26||
59499963|NCT00578461|75591557|FG000|COMPLETED|Overall Study||26||
59499964|NCT00578461|75591557|FG000|NOT COMPLETED|Overall Study||0||
59499965|NCT00578539|75591561|FG000|STARTED|Overall Study||24||
59499966|NCT00578539|75591561|FG000|COMPLETED|Overall Study||24||
59499967|NCT00578539|75591561|FG000|NOT COMPLETED|Overall Study||0||
59499968|NCT03517085|75591569|FG000|STARTED|Overall Study||3||
59499969|NCT03517085|75591570|FG001|STARTED|Overall Study||3||
59499970|NCT03517085|75591571|FG002|STARTED|Overall Study||3||
59754914|NCT00960011|75873773|FG000|STARTED|Overall Study||33||
59754915|NCT00960011|75873774|FG001|STARTED|Overall Study||25||
59754916|NCT00960011|75873773|FG000|COMPLETED|Overall Study||22||
59754917|NCT00960011|75873774|FG001|COMPLETED|Overall Study||23||
59754918|NCT00960011|75873773|FG000|NOT COMPLETED|Overall Study||11||
59754919|NCT00960011|75873774|FG001|NOT COMPLETED|Overall Study||2||
59499971|NCT03517085|75591572|FG003|STARTED|Overall Study||3||
59499972|NCT03517085|75591569|FG000|COMPLETED|Overall Study||3||
59499973|NCT03517085|75591570|FG001|COMPLETED|Overall Study||3||
59499974|NCT03517085|75591571|FG002|COMPLETED|Overall Study||3||
59499975|NCT03517085|75591572|FG003|COMPLETED|Overall Study||3||
59499976|NCT03517085|75591569|FG000|NOT COMPLETED|Overall Study||0||
59499977|NCT03517085|75591570|FG001|NOT COMPLETED|Overall Study||0||
59499978|NCT03517085|75591571|FG002|NOT COMPLETED|Overall Study||0||
59499979|NCT03517085|75591572|FG003|NOT COMPLETED|Overall Study||0||
59499980|NCT00619255|75591585|FG000|STARTED|Overall Study||59||
59499981|NCT00619255|75591586|FG001|STARTED|Overall Study||61||
59499982|NCT00619255|75591585|FG000|COMPLETED|Overall Study||57||
59499983|NCT00619255|75591586|FG001|COMPLETED|Overall Study||61||
59499984|NCT00619255|75591585|FG000|NOT COMPLETED|Overall Study||2||
59499985|NCT00619255|75591586|FG001|NOT COMPLETED|Overall Study||0||
59499986|NCT00578617|75591594|FG000|STARTED|Overall Study||31||
59499987|NCT00578617|75591595|FG001|STARTED|Overall Study||29||
59499988|NCT00578617|75591594|FG000|COMPLETED|Overall Study||31||
59499989|NCT00578617|75591595|FG001|COMPLETED|Overall Study||29||
59499990|NCT00578617|75591594|FG000|NOT COMPLETED|Overall Study||0||
59499991|NCT00578617|75591595|FG001|NOT COMPLETED|Overall Study||0||
59499992|NCT00505895|75591603|FG000|STARTED|Overall Study||27||
59499993|NCT00505895|75591604|FG001|STARTED|Overall Study||23||
59499994|NCT00505895|75591603|FG000|COMPLETED|Overall Study||27||
59499995|NCT00505895|75591604|FG001|COMPLETED|Overall Study||23||
59499996|NCT00505895|75591603|FG000|NOT COMPLETED|Overall Study||0||
59499997|NCT00505895|75591604|FG001|NOT COMPLETED|Overall Study||0||
59499998|NCT00619723|75591612|FG000|STARTED|Overall Study||63||
59499999|NCT00619723|75591613|FG001|STARTED|Overall Study||67||
59500000|NCT00619723|75591612|FG000|COMPLETED|Overall Study||61||
59500001|NCT00619723|75591613|FG001|COMPLETED|Overall Study||61||
59500002|NCT00619723|75591612|FG000|NOT COMPLETED|Overall Study||2||
59500003|NCT00619723|75591613|FG001|NOT COMPLETED|Overall Study||6||
59500004|NCT00555893|75591621|FG000|STARTED|Overall Study||130||
59500005|NCT00555893|75591622|FG001|STARTED|Overall Study||63||
59500006|NCT00555893|75591621|FG000|Final Analysis|Overall Study|n=16 excluded from number started because >119 hrs|114||
59500007|NCT00555893|75591622|FG001|Final Analysis|Overall Study|n=12 excluded from number started because >119 hrs|51||
59500008|NCT00555893|75591621|FG000|COMPLETED|Overall Study||130||
59500009|NCT00555893|75591622|FG001|COMPLETED|Overall Study||63||
59500010|NCT00555893|75591621|FG000|NOT COMPLETED|Overall Study||0||
59500011|NCT00555893|75591622|FG001|NOT COMPLETED|Overall Study||0||
59500012|NCT00578929|75591632|FG000|STARTED|Vehicle Run-In Period||0||
59500013|NCT00578929|75591633|FG001|STARTED|Vehicle Run-In Period||2388||
59500014|NCT00578929|75591634|FG002|STARTED|Vehicle Run-In Period||0||
59500015|NCT00578929|75591635|FG003|STARTED|Vehicle Run-In Period||0||
59500016|NCT00578929|75591632|FG000|COMPLETED|Vehicle Run-In Period||0||
59500017|NCT00578929|75591633|FG001|COMPLETED|Vehicle Run-In Period||2388||
59500018|NCT00578929|75591634|FG002|COMPLETED|Vehicle Run-In Period||0||
59500019|NCT00578929|75591635|FG003|COMPLETED|Vehicle Run-In Period||0||
59500020|NCT00578929|75591632|FG000|NOT COMPLETED|Vehicle Run-In Period||0||
59500021|NCT00578929|75591633|FG001|NOT COMPLETED|Vehicle Run-In Period||0||
59500022|NCT00578929|75591634|FG002|NOT COMPLETED|Vehicle Run-In Period||0||
59500023|NCT00578929|75591635|FG003|NOT COMPLETED|Vehicle Run-In Period||0||
59500024|NCT00578929|75591632|FG000|STARTED|Randomized Period||298||
59500025|NCT00578929|75591633|FG001|STARTED|Randomized Period||297||
59500026|NCT00578929|75591634|FG002|STARTED|Randomized Period||296||
59500027|NCT00578929|75591635|FG003|STARTED|Randomized Period||297||
59500028|NCT00578929|75591632|FG000|COMPLETED|Randomized Period||281||
59500029|NCT00578929|75591633|FG001|COMPLETED|Randomized Period||283||
59500030|NCT00578929|75591634|FG002|COMPLETED|Randomized Period||288||
59500031|NCT00578929|75591635|FG003|COMPLETED|Randomized Period||283||
59500032|NCT00578929|75591632|FG000|NOT COMPLETED|Randomized Period||17||
59500033|NCT00578929|75591633|FG001|NOT COMPLETED|Randomized Period||14||
59500034|NCT00578929|75591634|FG002|NOT COMPLETED|Randomized Period||8||
59500035|NCT00578929|75591635|FG003|NOT COMPLETED|Randomized Period||14||
59500036|NCT00556049|75591646|FG000|STARTED|Overall Study||72||
59500037|NCT00556049|75591646|FG000|COMPLETED|Overall Study||72||
59500038|NCT00556049|75591646|FG000|NOT COMPLETED|Overall Study||0||
59500039|NCT00620191|75591652|FG000|STARTED|Overall Study||40||
59500040|NCT00620191|75591653|FG001|STARTED|Overall Study||40||
59500041|NCT00620191|75591652|FG000|3 Month Follow-up|Overall Study||39||
59500042|NCT00620191|75591653|FG001|3 Month Follow-up|Overall Study||39||
59500043|NCT00620191|75591652|FG000|6 Month Follow-up|Overall Study||38||
59500044|NCT00620191|75591653|FG001|6 Month Follow-up|Overall Study||36||
59500045|NCT00620191|75591652|FG000|9 Month Follow-up|Overall Study||37||
59500046|NCT00620191|75591653|FG001|9 Month Follow-up|Overall Study||34||
59500047|NCT00620191|75591652|FG000|COMPLETED|Overall Study|12 month follow-up|33||
59500048|NCT00620191|75591653|FG001|COMPLETED|Overall Study|12 month follow-up|32||
59500049|NCT00620191|75591652|FG000|NOT COMPLETED|Overall Study||7||
59500050|NCT00620191|75591653|FG001|NOT COMPLETED|Overall Study||8||
59500051|NCT00506597|75591664|FG000|STARTED|Overall Study||33||
59500052|NCT00506597|75591664|FG000|COMPLETED|Overall Study||33||
59500053|NCT00506597|75591664|FG000|NOT COMPLETED|Overall Study||0||
59500054|NCT03589976|75591670|FG000|STARTED|Overall Study||35||
59500055|NCT03589976|75591671|FG001|STARTED|Overall Study||12||
59500056|NCT03589976|75591670|FG000|COMPLETED|Overall Study||16||
59500057|NCT03589976|75591671|FG001|COMPLETED|Overall Study||6||
59500058|NCT03589976|75591670|FG000|NOT COMPLETED|Overall Study||19||
59500059|NCT03589976|75591671|FG001|NOT COMPLETED|Overall Study||6||
59500060|NCT00620503|75591677|FG000|STARTED|Screening (up to 21 Days)||2||
59500061|NCT00620503|75591678|FG001|STARTED|Screening (up to 21 Days)||2||
59500062|NCT00620503|75591679|FG002|STARTED|Screening (up to 21 Days)||2||
59500063|NCT00620503|75591680|FG003|STARTED|Screening (up to 21 Days)||2||
59500064|NCT00620503|75591681|FG004|STARTED|Screening (up to 21 Days)||2||
59500065|NCT00620503|75591682|FG005|STARTED|Screening (up to 21 Days)||2||
59500066|NCT00620503|75591677|FG000|COMPLETED|Screening (up to 21 Days)||2||
59500067|NCT00620503|75591678|FG001|COMPLETED|Screening (up to 21 Days)||2||
60012833|NCT02597933|76128808|FG000|Treated Patients|Overall Study||288||
60012834|NCT02597933|76128809|FG001|Treated Patients|Overall Study||288||
60012835|NCT02597933|76128808|FG000|COMPLETED|Overall Study||252||
59500068|NCT00620503|75591679|FG002|COMPLETED|Screening (up to 21 Days)||2||
59500069|NCT00620503|75591680|FG003|COMPLETED|Screening (up to 21 Days)||2||
59500070|NCT00620503|75591681|FG004|COMPLETED|Screening (up to 21 Days)||2||
59500071|NCT00620503|75591682|FG005|COMPLETED|Screening (up to 21 Days)||2||
59500072|NCT00620503|75591677|FG000|NOT COMPLETED|Screening (up to 21 Days)||0||
59500073|NCT00620503|75591678|FG001|NOT COMPLETED|Screening (up to 21 Days)||0||
59500074|NCT00620503|75591679|FG002|NOT COMPLETED|Screening (up to 21 Days)||0||
60012836|NCT02597933|76128809|FG001|COMPLETED|Overall Study||239||
59607288|NCT03831971|75717847|FG000|STARTED|Overall Study||12||
59885418|NCT03522675|76008235|FG000|STARTED|Overall Study||22||
59885419|NCT03522675|76008235|FG000|COMPLETED|Overall Study||20||
59885420|NCT03522675|76008235|FG000|NOT COMPLETED|Overall Study||2||
59885421|NCT00294047|76008245|FG000|STARTED|Month 48||2881||
59885422|NCT00294047|76008246|FG001|STARTED|Month 48||2871||
59885423|NCT00294047|76008245|FG000|Participated up to Month 48|Month 48||2305||
59885424|NCT00294047|76008246|FG001|Participated up to Month 48|Month 48||2281||
59885425|NCT00294047|76008245|FG000|COMPLETED|Month 48||2456||
59885426|NCT00294047|76008246|FG001|COMPLETED|Month 48||2438||
59885427|NCT00294047|76008245|FG000|NOT COMPLETED|Month 48||425||
59885428|NCT00294047|76008246|FG001|NOT COMPLETED|Month 48||433||
59885429|NCT00294047|76008245|FG000|STARTED|Month 84||2877||
59885430|NCT00294047|76008246|FG001|STARTED|Month 84||2870||
59885431|NCT00294047|76008245|FG000|COMPLETED|Month 84|The number of subjects who remained up to Month 48 in the Cervarix Group = 2146|1904||
59885432|NCT00294047|76008246|FG001|COMPLETED|Month 84|The number of subjects who remained up to Month 48 in the Aluminium Hydroxide Group = 2116|1881||
59885433|NCT00294047|76008245|FG000|NOT COMPLETED|Month 84||973||
59885434|NCT00294047|76008246|FG001|NOT COMPLETED|Month 84||989||
60012837|NCT02597933|76128808|FG000|NOT COMPLETED|Overall Study||38||
59607289|NCT03831971|75717847|FG000|COMPLETED|Overall Study||12||
59885435|NCT00293813|76008256|FG000|STARTED|Overall Study||82||
59885436|NCT00293813|76008257|FG001|STARTED|Overall Study||83||
59885437|NCT00293813|76008258|FG002|STARTED|Overall Study||82||
59885438|NCT00293813|76008256|FG000|COMPLETED|Overall Study||69||
59885439|NCT00293813|76008257|FG001|COMPLETED|Overall Study||74||
59885440|NCT00293813|76008258|FG002|COMPLETED|Overall Study||74||
59885441|NCT00293813|76008256|FG000|NOT COMPLETED|Overall Study||13||
59885442|NCT00293813|76008257|FG001|NOT COMPLETED|Overall Study||9||
60012838|NCT02597933|76128809|FG001|NOT COMPLETED|Overall Study||51||
60012839|NCT02597855|76128817|FG000|STARTED|Overall Study||18||
60012840|NCT02597855|76128818|FG001|STARTED|Overall Study||14||
60012841|NCT02597855|76128817|FG000|COMPLETED|Overall Study||16||
60012842|NCT02597855|76128818|FG001|COMPLETED|Overall Study||13||
60012843|NCT02597855|76128817|FG000|NOT COMPLETED|Overall Study||2||
60012844|NCT02597855|76128818|FG001|NOT COMPLETED|Overall Study||1||
60012845|NCT02604407|76128827|FG000|STARTED|Overall Study||91||
60012846|NCT02604407|76128828|FG001|STARTED|Overall Study||92||
60012847|NCT02604407|76128829|FG002|STARTED|Overall Study||92||
60012848|NCT02604407|76128827|FG000|TREATED|Overall Study||89||
60012849|NCT02604407|76128828|FG001|TREATED|Overall Study||92||
60012850|NCT02604407|76128829|FG002|TREATED|Overall Study||90||
60012851|NCT02604407|76128827|FG000|COMPLETED|Overall Study||80||
60012852|NCT02604407|76128828|FG001|COMPLETED|Overall Study||80||
60012853|NCT02604407|76128829|FG002|COMPLETED|Overall Study||76||
60012854|NCT02604407|76128827|FG000|NOT COMPLETED|Overall Study||11||
60012855|NCT02604407|76128828|FG001|NOT COMPLETED|Overall Study||12||
60012856|NCT02604407|76128829|FG002|NOT COMPLETED|Overall Study||16||
60012857|NCT02593097|76128839|FG000|STARTED|First Intervention (12 Weeks)||14||
60012858|NCT02593097|76128840|FG001|STARTED|First Intervention (12 Weeks)||20||
60012859|NCT02593097|76128839|FG000|Received Intervention|First Intervention (12 Weeks)||14||
60012860|NCT02593097|76128840|FG001|Received Intervention|First Intervention (12 Weeks)||20||
60012861|NCT02593097|76128839|FG000|COMPLETED|First Intervention (12 Weeks)||12||
60012862|NCT02593097|76128840|FG001|COMPLETED|First Intervention (12 Weeks)||16||
60012863|NCT02593097|76128839|FG000|NOT COMPLETED|First Intervention (12 Weeks)||2||
60012864|NCT02593097|76128840|FG001|NOT COMPLETED|First Intervention (12 Weeks)||4||
60012865|NCT02593097|76128839|FG000|STARTED|Washout (4 Weeks)||12||
60012866|NCT02593097|76128840|FG001|STARTED|Washout (4 Weeks)||16||
60012867|NCT02593097|76128839|FG000|COMPLETED|Washout (4 Weeks)||12||
60012868|NCT02593097|76128840|FG001|COMPLETED|Washout (4 Weeks)||16||
60012869|NCT02593097|76128839|FG000|NOT COMPLETED|Washout (4 Weeks)||0||
60012870|NCT02593097|76128840|FG001|NOT COMPLETED|Washout (4 Weeks)||0||
60012871|NCT02593097|76128839|FG000|STARTED|Second Intervention (12 Weeks)||12||
60012872|NCT02593097|76128840|FG001|STARTED|Second Intervention (12 Weeks)||16||
60012873|NCT02593097|76128839|FG000|COMPLETED|Second Intervention (12 Weeks)||9||
60012874|NCT02593097|76128840|FG001|COMPLETED|Second Intervention (12 Weeks)||15||
60012875|NCT02593097|76128839|FG000|NOT COMPLETED|Second Intervention (12 Weeks)||3||
60012876|NCT02593097|76128840|FG001|NOT COMPLETED|Second Intervention (12 Weeks)||1||
60012877|NCT01657461|76128848|FG000|STARTED|Overall Study||98||
60012878|NCT01657461|76128849|FG001|STARTED|Overall Study||98||
60012879|NCT01657461|76128848|FG000|COMPLETED|Overall Study||88||
60012880|NCT01657461|76128849|FG001|COMPLETED|Overall Study||78||
60012881|NCT01657461|76128848|FG000|NOT COMPLETED|Overall Study||10||
59607290|NCT03831971|75717847|FG000|NOT COMPLETED|Overall Study||0||
59754920|NCT00617851|75873818|FG000|STARTED|Overall Study||430||
59754921|NCT00617851|75873819|FG001|STARTED|Overall Study||431||
59754922|NCT00617851|75873820|FG002|STARTED|Overall Study||429||
59754923|NCT00617851|75873821|FG003|STARTED|Overall Study||217||
59754924|NCT00617851|75873818|FG000|COMPLETED|Overall Study||383||
59754925|NCT00617851|75873819|FG001|COMPLETED|Overall Study||391||
59754926|NCT00617851|75873820|FG002|COMPLETED|Overall Study||384||
59885443|NCT00293813|76008258|FG002|NOT COMPLETED|Overall Study||8||
59885444|NCT00293579|76008266|FG000|STARTED|Overall Study||5||
59607291|NCT03823937|75717853|FG000|STARTED|Overall Study||30||
59754927|NCT00617851|75873821|FG003|COMPLETED|Overall Study||192||
59754928|NCT00617851|75873818|FG000|NOT COMPLETED|Overall Study||47||
59754929|NCT00617851|75873819|FG001|NOT COMPLETED|Overall Study||40||
59754930|NCT00617851|75873820|FG002|NOT COMPLETED|Overall Study||45||
59754931|NCT00617851|75873821|FG003|NOT COMPLETED|Overall Study||25||
59754932|NCT00812955|75873845|FG000|STARTED|Overall Study||119||
59754933|NCT00812955|75873846|FG001|STARTED|Overall Study||118||
59607292|NCT03823937|75717854|FG001|STARTED|Overall Study||20||
59607293|NCT03823937|75717853|FG000|COMPLETED|Overall Study||30||
59754934|NCT00812955|75873847|FG002|STARTED|Overall Study||119||
59754935|NCT00812955|75873848|FG003|STARTED|Overall Study||118||
59885445|NCT00293579|76008266|FG000|COMPLETED|Overall Study||4||
59885446|NCT00293579|76008266|FG000|NOT COMPLETED|Overall Study||1||
59754936|NCT00812955|75873845|FG000|COMPLETED|Overall Study||109||
59754937|NCT00812955|75873846|FG001|COMPLETED|Overall Study||111||
59754938|NCT00812955|75873847|FG002|COMPLETED|Overall Study||113||
59754939|NCT00812955|75873848|FG003|COMPLETED|Overall Study||110||
59754940|NCT00812955|75873845|FG000|NOT COMPLETED|Overall Study||10||
59754941|NCT00812955|75873846|FG001|NOT COMPLETED|Overall Study||7||
59754942|NCT00812955|75873847|FG002|NOT COMPLETED|Overall Study||6||
59607294|NCT03823937|75717854|FG001|COMPLETED|Overall Study||20||
59607295|NCT03823937|75717853|FG000|NOT COMPLETED|Overall Study||0||
59607296|NCT03823937|75717854|FG001|NOT COMPLETED|Overall Study||0||
59607297|NCT03807089|75717862|FG000|STARTED|Overall Study||101||
59607298|NCT03807089|75717863|FG001|STARTED|Overall Study||93||
59607299|NCT03807089|75717862|FG000|COMPLETED|Overall Study||101||
59607300|NCT03807089|75717863|FG001|COMPLETED|Overall Study||93||
59754943|NCT00812955|75873848|FG003|NOT COMPLETED|Overall Study||8||
59754944|NCT00619489|75873864|FG000|STARTED|Overall Study||37||
59754945|NCT00619489|75873865|FG001|STARTED|Overall Study||35||
59607301|NCT03807089|75717862|FG000|NOT COMPLETED|Overall Study||0||
59607302|NCT03807089|75717863|FG001|NOT COMPLETED|Overall Study||0||
59500075|NCT00620503|75591680|FG003|NOT COMPLETED|Screening (up to 21 Days)||0||
59500076|NCT00620503|75591681|FG004|NOT COMPLETED|Screening (up to 21 Days)||0||
59500077|NCT00620503|75591682|FG005|NOT COMPLETED|Screening (up to 21 Days)||0||
59754946|NCT00619489|75873864|FG000|COMPLETED|Overall Study||14||
59754947|NCT00619489|75873865|FG001|COMPLETED|Overall Study||1||
59754948|NCT00619489|75873864|FG000|NOT COMPLETED|Overall Study||23||
59500078|NCT00620503|75591677|FG000|STARTED|Treatment Period 1 (TP1) (7days)||2||
59500079|NCT00620503|75591678|FG001|STARTED|Treatment Period 1 (TP1) (7days)||2||
59500080|NCT00620503|75591679|FG002|STARTED|Treatment Period 1 (TP1) (7days)||2||
59500081|NCT00620503|75591680|FG003|STARTED|Treatment Period 1 (TP1) (7days)||2||
59500082|NCT00620503|75591681|FG004|STARTED|Treatment Period 1 (TP1) (7days)||2||
59500083|NCT00620503|75591682|FG005|STARTED|Treatment Period 1 (TP1) (7days)||2||
59500084|NCT00620503|75591677|FG000|COMPLETED|Treatment Period 1 (TP1) (7days)||2||
59500085|NCT00620503|75591678|FG001|COMPLETED|Treatment Period 1 (TP1) (7days)||2||
59500086|NCT00620503|75591679|FG002|COMPLETED|Treatment Period 1 (TP1) (7days)||2||
59500087|NCT00620503|75591680|FG003|COMPLETED|Treatment Period 1 (TP1) (7days)||2||
59500088|NCT00620503|75591681|FG004|COMPLETED|Treatment Period 1 (TP1) (7days)||2||
59500089|NCT00620503|75591682|FG005|COMPLETED|Treatment Period 1 (TP1) (7days)||2||
59500090|NCT00620503|75591677|FG000|NOT COMPLETED|Treatment Period 1 (TP1) (7days)||0||
59500091|NCT00620503|75591678|FG001|NOT COMPLETED|Treatment Period 1 (TP1) (7days)||0||
59500092|NCT00620503|75591679|FG002|NOT COMPLETED|Treatment Period 1 (TP1) (7days)||0||
59500093|NCT00620503|75591680|FG003|NOT COMPLETED|Treatment Period 1 (TP1) (7days)||0||
59500094|NCT00620503|75591681|FG004|NOT COMPLETED|Treatment Period 1 (TP1) (7days)||0||
59500095|NCT00620503|75591682|FG005|NOT COMPLETED|Treatment Period 1 (TP1) (7days)||0||
59500096|NCT00620503|75591677|FG000|STARTED|Washout (at Least 1 Day)||2||
59500097|NCT00620503|75591678|FG001|STARTED|Washout (at Least 1 Day)||2||
59500098|NCT00620503|75591679|FG002|STARTED|Washout (at Least 1 Day)||2||
59500099|NCT00620503|75591680|FG003|STARTED|Washout (at Least 1 Day)||2||
59500100|NCT00620503|75591681|FG004|STARTED|Washout (at Least 1 Day)||2||
59500101|NCT00620503|75591682|FG005|STARTED|Washout (at Least 1 Day)||2||
59500102|NCT00620503|75591677|FG000|COMPLETED|Washout (at Least 1 Day)||2||
59500103|NCT00620503|75591678|FG001|COMPLETED|Washout (at Least 1 Day)||2||
59500104|NCT00620503|75591679|FG002|COMPLETED|Washout (at Least 1 Day)||2||
59500105|NCT00620503|75591680|FG003|COMPLETED|Washout (at Least 1 Day)||2||
59500106|NCT00620503|75591681|FG004|COMPLETED|Washout (at Least 1 Day)||2||
59500107|NCT00620503|75591682|FG005|COMPLETED|Washout (at Least 1 Day)||2||
59500108|NCT00620503|75591677|FG000|NOT COMPLETED|Washout (at Least 1 Day)||0||
59500109|NCT00620503|75591678|FG001|NOT COMPLETED|Washout (at Least 1 Day)||0||
59500110|NCT00620503|75591679|FG002|NOT COMPLETED|Washout (at Least 1 Day)||0||
59500111|NCT00620503|75591680|FG003|NOT COMPLETED|Washout (at Least 1 Day)||0||
59500112|NCT00620503|75591681|FG004|NOT COMPLETED|Washout (at Least 1 Day)||0||
59500113|NCT00620503|75591682|FG005|NOT COMPLETED|Washout (at Least 1 Day)||0||
59500114|NCT00620503|75591677|FG000|STARTED|Treatment Period 2 (TP2) (7days)||2||
59500115|NCT00620503|75591678|FG001|STARTED|Treatment Period 2 (TP2) (7days)||2||
59500116|NCT00620503|75591679|FG002|STARTED|Treatment Period 2 (TP2) (7days)||2||
59500117|NCT00620503|75591680|FG003|STARTED|Treatment Period 2 (TP2) (7days)||2||
59500118|NCT00620503|75591681|FG004|STARTED|Treatment Period 2 (TP2) (7days)||2||
59500119|NCT00620503|75591682|FG005|STARTED|Treatment Period 2 (TP2) (7days)||2||
59500120|NCT00620503|75591677|FG000|COMPLETED|Treatment Period 2 (TP2) (7days)||2||
59500121|NCT00620503|75591678|FG001|COMPLETED|Treatment Period 2 (TP2) (7days)||2||
59500122|NCT00620503|75591679|FG002|COMPLETED|Treatment Period 2 (TP2) (7days)||2||
59754949|NCT00619489|75873865|FG001|NOT COMPLETED|Overall Study||34||
59754950|NCT00959699|75873873|FG000|STARTED|Treatment Period||34||
59754951|NCT00959699|75873874|FG001|STARTED|Treatment Period||65||
59754952|NCT00959699|75873873|FG000|Treated|Treatment Period||34||
59754953|NCT00959699|75873874|FG001|Treated|Treatment Period||64||
59885447|NCT00293423|76008273|FG000|STARTED|Surgical Resection||28||
59885448|NCT00293423|76008274|FG001|STARTED|Surgical Resection||68||
59885449|NCT00293423|76008273|FG000|COMPLETED|Surgical Resection||12|All patients underwent aggressive resection with intra-operative collection of tissue to generate autologous vaccine. Only participants with adequate tissue collected to generate enough vaccine and whose vaccines passed quality control standards received the vaccine and constituted the intent-to-treat group|
59950950|NCT00571493|76069870|FG001|COMPLETED|Overall Study||4||
59754954|NCT00959699|75873873|FG000|COMPLETED|Treatment Period|At TW24, 4 participants not achieving undetectable HCV-RNA crossed-over and received boceprevir.|11||
59950951|NCT00571493|76069871|FG002|COMPLETED|Overall Study||3||
59950952|NCT00571493|76069872|FG003|COMPLETED|Overall Study||3||
59500123|NCT00620503|75591680|FG003|COMPLETED|Treatment Period 2 (TP2) (7days)||2||
59500124|NCT00620503|75591681|FG004|COMPLETED|Treatment Period 2 (TP2) (7days)||2||
59500125|NCT00620503|75591682|FG005|COMPLETED|Treatment Period 2 (TP2) (7days)||2||
59500126|NCT00620503|75591677|FG000|NOT COMPLETED|Treatment Period 2 (TP2) (7days)||0||
59500127|NCT00620503|75591678|FG001|NOT COMPLETED|Treatment Period 2 (TP2) (7days)||0||
59500128|NCT00620503|75591679|FG002|NOT COMPLETED|Treatment Period 2 (TP2) (7days)||0||
59500129|NCT00620503|75591680|FG003|NOT COMPLETED|Treatment Period 2 (TP2) (7days)||0||
59500130|NCT00620503|75591681|FG004|NOT COMPLETED|Treatment Period 2 (TP2) (7days)||0||
59500131|NCT00620503|75591682|FG005|NOT COMPLETED|Treatment Period 2 (TP2) (7days)||0||
59500132|NCT00620503|75591677|FG000|STARTED|Washout (at Least 1 Day)||2||
59500133|NCT00620503|75591678|FG001|STARTED|Washout (at Least 1 Day)||2||
59500134|NCT00620503|75591679|FG002|STARTED|Washout (at Least 1 Day)||2||
59500135|NCT00620503|75591680|FG003|STARTED|Washout (at Least 1 Day)||2||
59500136|NCT00620503|75591681|FG004|STARTED|Washout (at Least 1 Day)||2||
59500137|NCT00620503|75591682|FG005|STARTED|Washout (at Least 1 Day)||2||
59500138|NCT00620503|75591677|FG000|COMPLETED|Washout (at Least 1 Day)||2||
59500139|NCT00620503|75591678|FG001|COMPLETED|Washout (at Least 1 Day)||2||
59500140|NCT00620503|75591679|FG002|COMPLETED|Washout (at Least 1 Day)||2||
59500141|NCT00620503|75591680|FG003|COMPLETED|Washout (at Least 1 Day)||2||
59500142|NCT00620503|75591681|FG004|COMPLETED|Washout (at Least 1 Day)||2||
59500143|NCT00620503|75591682|FG005|COMPLETED|Washout (at Least 1 Day)||2||
59754955|NCT00959699|75873874|FG001|COMPLETED|Treatment Period||40||
59754956|NCT00959699|75873873|FG000|NOT COMPLETED|Treatment Period||23||
59754957|NCT00959699|75873874|FG001|NOT COMPLETED|Treatment Period||25||
59500144|NCT00620503|75591677|FG000|NOT COMPLETED|Washout (at Least 1 Day)||0||
59500145|NCT00620503|75591678|FG001|NOT COMPLETED|Washout (at Least 1 Day)||0||
59754958|NCT00959699|75873873|FG000|STARTED|Follow-up Period|1 participant didn't enter Follow-up; participants discontinuing treatment could enter Follow-up.|33||
59754959|NCT00959699|75873874|FG001|STARTED|Follow-up Period|2 participants didn't enter Follow-up; participants discontinuing treatment could enter Follow-up.|62||
59754960|NCT00959699|75873873|FG000|COMPLETED|Follow-up Period||27||
59754961|NCT00959699|75873874|FG001|COMPLETED|Follow-up Period||56||
59754962|NCT00959699|75873873|FG000|NOT COMPLETED|Follow-up Period||6||
59754963|NCT00959699|75873874|FG001|NOT COMPLETED|Follow-up Period||6||
59500146|NCT00620503|75591679|FG002|NOT COMPLETED|Washout (at Least 1 Day)||0||
59500147|NCT00620503|75591680|FG003|NOT COMPLETED|Washout (at Least 1 Day)||0||
59500148|NCT00620503|75591681|FG004|NOT COMPLETED|Washout (at Least 1 Day)||0||
59500149|NCT00620503|75591682|FG005|NOT COMPLETED|Washout (at Least 1 Day)||0||
59754964|NCT00617773|75873881|FG000|STARTED|Overall Study||31||
59500150|NCT00620503|75591677|FG000|STARTED|Treatment Period 3 (TP3) (7 Days)||2||
59500151|NCT00620503|75591678|FG001|STARTED|Treatment Period 3 (TP3) (7 Days)||2||
59500152|NCT00620503|75591679|FG002|STARTED|Treatment Period 3 (TP3) (7 Days)||2||
59500153|NCT00620503|75591680|FG003|STARTED|Treatment Period 3 (TP3) (7 Days)||2||
59500154|NCT00620503|75591681|FG004|STARTED|Treatment Period 3 (TP3) (7 Days)||2||
59500155|NCT00620503|75591682|FG005|STARTED|Treatment Period 3 (TP3) (7 Days)||2||
59500156|NCT00620503|75591677|FG000|COMPLETED|Treatment Period 3 (TP3) (7 Days)||2||
59500157|NCT00620503|75591678|FG001|COMPLETED|Treatment Period 3 (TP3) (7 Days)||2||
59500158|NCT00620503|75591679|FG002|COMPLETED|Treatment Period 3 (TP3) (7 Days)||2||
59500159|NCT00620503|75591680|FG003|COMPLETED|Treatment Period 3 (TP3) (7 Days)||2||
59500160|NCT00620503|75591681|FG004|COMPLETED|Treatment Period 3 (TP3) (7 Days)||2||
59500161|NCT00620503|75591682|FG005|COMPLETED|Treatment Period 3 (TP3) (7 Days)||2||
59500162|NCT00620503|75591677|FG000|NOT COMPLETED|Treatment Period 3 (TP3) (7 Days)||0||
59500163|NCT00620503|75591678|FG001|NOT COMPLETED|Treatment Period 3 (TP3) (7 Days)||0||
59500164|NCT00620503|75591679|FG002|NOT COMPLETED|Treatment Period 3 (TP3) (7 Days)||0||
59500165|NCT00620503|75591680|FG003|NOT COMPLETED|Treatment Period 3 (TP3) (7 Days)||0||
59500166|NCT00620503|75591681|FG004|NOT COMPLETED|Treatment Period 3 (TP3) (7 Days)||0||
59500167|NCT00620503|75591682|FG005|NOT COMPLETED|Treatment Period 3 (TP3) (7 Days)||0||
59500168|NCT00620503|75591677|FG000|STARTED|Follow-up (up to 14 Days)||2||
59500169|NCT00620503|75591678|FG001|STARTED|Follow-up (up to 14 Days)||2||
59500170|NCT00620503|75591679|FG002|STARTED|Follow-up (up to 14 Days)||2||
59500171|NCT00620503|75591680|FG003|STARTED|Follow-up (up to 14 Days)||2||
59500172|NCT00620503|75591681|FG004|STARTED|Follow-up (up to 14 Days)||2||
59500173|NCT00620503|75591682|FG005|STARTED|Follow-up (up to 14 Days)||2||
59500174|NCT00620503|75591677|FG000|COMPLETED|Follow-up (up to 14 Days)||2||
59500175|NCT00620503|75591678|FG001|COMPLETED|Follow-up (up to 14 Days)||2||
59500176|NCT00620503|75591679|FG002|COMPLETED|Follow-up (up to 14 Days)||2||
59500177|NCT00620503|75591680|FG003|COMPLETED|Follow-up (up to 14 Days)||2||
59500178|NCT00620503|75591681|FG004|COMPLETED|Follow-up (up to 14 Days)||2||
59500179|NCT00620503|75591682|FG005|COMPLETED|Follow-up (up to 14 Days)||2||
59500180|NCT00620503|75591677|FG000|NOT COMPLETED|Follow-up (up to 14 Days)||0||
59500181|NCT00620503|75591678|FG001|NOT COMPLETED|Follow-up (up to 14 Days)||0||
59500182|NCT00620503|75591679|FG002|NOT COMPLETED|Follow-up (up to 14 Days)||0||
59500183|NCT00620503|75591680|FG003|NOT COMPLETED|Follow-up (up to 14 Days)||0||
59500184|NCT00620503|75591681|FG004|NOT COMPLETED|Follow-up (up to 14 Days)||0||
59500185|NCT00620503|75591682|FG005|NOT COMPLETED|Follow-up (up to 14 Days)||0||
59500186|NCT00506675|75591692|FG000|STARTED|Overall Study||27||
59500187|NCT00506675|75591693|FG001|STARTED|Overall Study||28||
59500188|NCT00506675|75591692|FG000|COMPLETED|Overall Study||27||
59500189|NCT00506675|75591693|FG001|COMPLETED|Overall Study||28||
59500190|NCT00506675|75591692|FG000|NOT COMPLETED|Overall Study||0||
59500191|NCT00506675|75591693|FG001|NOT COMPLETED|Overall Study||0||
59500192|NCT00507767|75591699|FG000|STARTED|Overall Study||15||
59500193|NCT00507767|75591699|FG000|COMPLETED|Overall Study||15||
59500194|NCT00507767|75591699|FG000|NOT COMPLETED|Overall Study||0||
59500195|NCT00621049|75591705|FG000|STARTED|Adjuvant Treatment||55||
59500196|NCT00621049|75591706|FG001|STARTED|Adjuvant Treatment||57||
59500197|NCT00621049|75591705|FG000|COMPLETED|Adjuvant Treatment||52||
59500198|NCT00621049|75591706|FG001|COMPLETED|Adjuvant Treatment||47||
59500199|NCT00621049|75591705|FG000|NOT COMPLETED|Adjuvant Treatment||3||
59500200|NCT00621049|75591706|FG001|NOT COMPLETED|Adjuvant Treatment||10||
59500201|NCT00621049|75591705|FG000|STARTED|Maintenance Treatment|3 patients came off study between the end of adjuvant therapy and the start of maintenance|49||
59500202|NCT00621049|75591706|FG001|STARTED|Maintenance Treatment|Per protocol, only the Docetaxel/Carboplatin/Bevacizumab/Erlotinib arm enters maintenance therapy|0||
59500203|NCT00621049|75591705|FG000|COMPLETED|Maintenance Treatment||34||
59500204|NCT00621049|75591706|FG001|COMPLETED|Maintenance Treatment||0||
59500205|NCT00621049|75591705|FG000|NOT COMPLETED|Maintenance Treatment||15||
59500206|NCT00621049|75591706|FG001|NOT COMPLETED|Maintenance Treatment||0||
59500207|NCT00508469|75591714|FG000|STARTED|Overall Study||52||
59500208|NCT00508469|75591715|FG001|STARTED|Overall Study||50||
59500209|NCT00508469|75591714|FG000|COMPLETED|Overall Study||35||
59500210|NCT00508469|75591715|FG001|COMPLETED|Overall Study||40||
59500211|NCT00508469|75591714|FG000|NOT COMPLETED|Overall Study||17||
59500212|NCT00508469|75591715|FG001|NOT COMPLETED|Overall Study||10||
59500213|NCT00580333|75591721|FG000|STARTED|Overall Study||51||
59500214|NCT00580333|75591721|FG000|COMPLETED|Overall Study||51||
59500215|NCT00580333|75591721|FG000|NOT COMPLETED|Overall Study||0||
59500216|NCT00509171|75591728|FG000|STARTED|Overall Study||11||
59500217|NCT00509171|75591729|FG001|STARTED|Overall Study||11||
59500218|NCT00509171|75591728|FG000|COMPLETED|Overall Study||11||
59500219|NCT00509171|75591729|FG001|COMPLETED|Overall Study||11||
59500220|NCT00509171|75591728|FG000|NOT COMPLETED|Overall Study||0||
59500221|NCT00509171|75591729|FG001|NOT COMPLETED|Overall Study||0||
59500222|NCT00580645|75591738|FG000|STARTED|Overall Study||20||
59500223|NCT00580645|75591739|FG001|STARTED|Overall Study||20||
59500224|NCT00580645|75591740|FG002|STARTED|Overall Study||20||
59500225|NCT00580645|75591738|FG000|COMPLETED|Overall Study||20||
59500226|NCT00580645|75591739|FG001|COMPLETED|Overall Study||20||
59500227|NCT00580645|75591740|FG002|COMPLETED|Overall Study||20||
59500228|NCT00580645|75591738|FG000|NOT COMPLETED|Overall Study||0||
59500229|NCT00580645|75591739|FG001|NOT COMPLETED|Overall Study||0||
59500230|NCT00580645|75591740|FG002|NOT COMPLETED|Overall Study||0||
59500231|NCT00580957|75591750|FG000|STARTED|Overall Study||28||
59500232|NCT00580957|75591751|FG001|STARTED|Overall Study||28||
59500233|NCT00580957|75591750|FG000|COMPLETED|Overall Study||21||
59500234|NCT00580957|75591751|FG001|COMPLETED|Overall Study||21||
59500235|NCT00580957|75591750|FG000|NOT COMPLETED|Overall Study||7||
59500236|NCT00580957|75591751|FG001|NOT COMPLETED|Overall Study||7||
59500237|NCT00581347|75591759|FG000|STARTED|Overall Study||3839||
59500238|NCT00581347|75591760|FG001|STARTED|Overall Study||3707||
59500239|NCT00581347|75591759|FG000|COMPLETED|Overall Study||3839||
59500240|NCT00581347|75591760|FG001|COMPLETED|Overall Study||3707||
59500241|NCT00581347|75591759|FG000|NOT COMPLETED|Overall Study||0||
59500242|NCT00581347|75591760|FG001|NOT COMPLETED|Overall Study||0||
59500243|NCT00509249|75591766|FG000|STARTED|Overall Study||18||
59500244|NCT00509249|75591766|FG000|COMPLETED|Overall Study||18||
59500245|NCT00509249|75591766|FG000|NOT COMPLETED|Overall Study||0||
60012882|NCT01657461|76128849|FG001|NOT COMPLETED|Overall Study||20||
60012883|NCT02592551|76128858|FG000|STARTED|Overall Study||9||
60012884|NCT02592551|76128859|FG001|STARTED|Overall Study||11||
60012885|NCT02592551|76128860|FG002|STARTED|Overall Study||4||
60012886|NCT02592551|76128858|FG000|COMPLETED|Overall Study|One participant completed all study procedures and got the tumor sample for analysis. However, the sample was too small to analyze in the lab and so that it was not evaluable for primary and secondary analysis.|8||
60012887|NCT02592551|76128859|FG001|COMPLETED|Overall Study||8||
60012888|NCT02592551|76128860|FG002|COMPLETED|Overall Study||4||
60012889|NCT02592551|76128858|FG000|NOT COMPLETED|Overall Study||1||
60012890|NCT02592551|76128859|FG001|NOT COMPLETED|Overall Study||3||
60012891|NCT02592551|76128860|FG002|NOT COMPLETED|Overall Study||0||
60012892|NCT02595749|76128871|FG000|STARTED|Overall Study||45||
60012893|NCT02595749|76128872|FG001|STARTED|Overall Study||38||
60012894|NCT02595749|76128871|FG000|COMPLETED|Overall Study||33||
60012895|NCT02595749|76128872|FG001|COMPLETED|Overall Study||31||
60012896|NCT02595749|76128871|FG000|NOT COMPLETED|Overall Study||12||
60012897|NCT02595749|76128872|FG001|NOT COMPLETED|Overall Study||7||
60012898|NCT01657305|76128878|FG000|STARTED|Overall Study||107||
60012899|NCT01657305|76128878|FG000|COMPLETED|Overall Study||82||
59500246|NCT00624013|75591772|FG000|STARTED|Overall Study||44||
59500247|NCT00624013|75591773|FG001|STARTED|Overall Study||45||
59500248|NCT00624013|75591772|FG000|COMPLETED|Overall Study||36||
59500249|NCT00624013|75591773|FG001|COMPLETED|Overall Study||39||
59500250|NCT00624013|75591772|FG000|NOT COMPLETED|Overall Study||8||
59500251|NCT00624013|75591773|FG001|NOT COMPLETED|Overall Study||6||
59500252|NCT02121041|75591783|FG000|STARTED|Overall Study||14||
59500253|NCT02121041|75591784|FG001|STARTED|Overall Study||14||
59500254|NCT02121041|75591783|FG000|COMPLETED|Overall Study||13||
59500255|NCT02121041|75591784|FG001|COMPLETED|Overall Study||8||
59500256|NCT02121041|75591783|FG000|NOT COMPLETED|Overall Study||1||
59500257|NCT02121041|75591784|FG001|NOT COMPLETED|Overall Study||6||
59500258|NCT00509873|75591792|FG000|STARTED|Overall Study||287||
59500259|NCT00509873|75591793|FG001|STARTED|Overall Study||291||
59500260|NCT00509873|75591792|FG000|COMPLETED|Overall Study||276||
59500261|NCT00509873|75591793|FG001|COMPLETED|Overall Study||276||
59500262|NCT00509873|75591792|FG000|NOT COMPLETED|Overall Study||11||
59500263|NCT00509873|75591793|FG001|NOT COMPLETED|Overall Study||15||
59500264|NCT02133781|75591802|FG000|STARTED|Overall Study||6||
59500265|NCT02133781|75591803|FG001|STARTED|Overall Study||24||
60012900|NCT01657305|76128878|FG000|NOT COMPLETED|Overall Study||25||
60012901|NCT02634307|76128921|FG000|STARTED|Overall Study||593||
59500266|NCT02133781|75591804|FG002|STARTED|Overall Study||21||
59500267|NCT02133781|75591802|FG000|COMPLETED|Overall Study||6||
59500268|NCT02133781|75591803|FG001|COMPLETED|Overall Study||24||
59500269|NCT02133781|75591804|FG002|COMPLETED|Overall Study||21||
59500270|NCT02133781|75591802|FG000|NOT COMPLETED|Overall Study||0||
59500271|NCT02133781|75591803|FG001|NOT COMPLETED|Overall Study||0||
59500272|NCT02133781|75591804|FG002|NOT COMPLETED|Overall Study||0||
59500273|NCT02134951|75591814|FG000|STARTED|Overall Study||39||
59500274|NCT02134951|75591815|FG001|STARTED|Overall Study||20||
59500275|NCT02134951|75591814|FG000|COMPLETED|Overall Study|number of subjects with at least one valid scan|39||
59500276|NCT02134951|75591815|FG001|COMPLETED|Overall Study|number of subjects with at least one valid scan|20||
59500277|NCT02134951|75591814|FG000|NOT COMPLETED|Overall Study||0||
59500278|NCT02134951|75591815|FG001|NOT COMPLETED|Overall Study||0||
59500279|NCT00510497|75591821|FG000|STARTED|Overall Study||11||
59500280|NCT00510497|75591821|FG000|COMPLETED|Overall Study||8||
59500281|NCT00510497|75591821|FG000|NOT COMPLETED|Overall Study||3||
59500282|NCT03029780|75591827|FG000|STARTED|Overall Study||52||
59500283|NCT03029780|75591828|FG001|STARTED|Overall Study||52||
59500284|NCT03029780|75591827|FG000|COMPLETED|Overall Study||1||
59500285|NCT03029780|75591828|FG001|COMPLETED|Overall Study||1||
59500286|NCT03029780|75591827|FG000|NOT COMPLETED|Overall Study||51||
59500287|NCT03029780|75591828|FG001|NOT COMPLETED|Overall Study||51||
59500288|NCT00624559|75591839|FG000|STARTED|Overall Study|Celebrex 1st: 3days baseline(100mmol), 7days high(350mmol) followed by 7days low(20mmol) sodium/day|3||
59500289|NCT00624559|75591840|FG001|STARTED|Overall Study|Celebrex 1st: 3days baseline(100mmol), 7days low(20mmol) followed by 7days high(350mmol) sodium/day|3||
59500290|NCT00624559|75591841|FG002|STARTED|Overall Study|Placebo 1st: 3days baseline(100mmol), 7days low(20mmol) followed by 7days high(350mmol) sodium/day|3||
59500291|NCT00624559|75591842|FG003|STARTED|Overall Study|Placebo 1st: 3days baseline(100mmol), 7days high(350mmol) followed by 7days low(20mmol) sodium/day|3||
59500292|NCT00624559|75591839|FG000|COMPLETED|Overall Study||3||
59500293|NCT00624559|75591840|FG001|COMPLETED|Overall Study||3||
59500294|NCT00624559|75591841|FG002|COMPLETED|Overall Study||3||
59500295|NCT00624559|75591842|FG003|COMPLETED|Overall Study||3||
59500296|NCT00624559|75591839|FG000|NOT COMPLETED|Overall Study||0||
59500297|NCT00624559|75591840|FG001|NOT COMPLETED|Overall Study||0||
59500298|NCT00624559|75591841|FG002|NOT COMPLETED|Overall Study||0||
59500299|NCT00624559|75591842|FG003|NOT COMPLETED|Overall Study||0||
59500300|NCT00581581|75591854|FG000|STARTED|Overall Study||32||
59500301|NCT00581581|75591855|FG001|STARTED|Overall Study||30||
59500302|NCT00581581|75591854|FG000|COMPLETED|Overall Study||32||
59500303|NCT00581581|75591855|FG001|COMPLETED|Overall Study||30||
59500304|NCT00581581|75591854|FG000|NOT COMPLETED|Overall Study||0||
59500305|NCT00581581|75591855|FG001|NOT COMPLETED|Overall Study||0||
59500306|NCT00510809|75591864|FG000|STARTED|Overall Study||18||
59500307|NCT00510809|75591865|FG001|STARTED|Overall Study||18||
59500308|NCT00510809|75591866|FG002|STARTED|Overall Study||18||
59500309|NCT00510809|75591864|FG000|COMPLETED|Overall Study||18||
59500310|NCT00510809|75591865|FG001|COMPLETED|Overall Study||18||
59500311|NCT00510809|75591866|FG002|COMPLETED|Overall Study||18||
59500312|NCT00510809|75591864|FG000|NOT COMPLETED|Overall Study||0||
59500313|NCT00510809|75591865|FG001|NOT COMPLETED|Overall Study||0||
59500314|NCT00510809|75591866|FG002|NOT COMPLETED|Overall Study||0||
59500315|NCT00625729|75591874|FG000|STARTED|Overall Study||6||
59500316|NCT00625729|75591874|FG000|COMPLETED|Overall Study||6||
59500317|NCT00625729|75591874|FG000|NOT COMPLETED|Overall Study||0||
59500318|NCT02335502|75591879|FG000|STARTED|Overall Study||66||
59500319|NCT02335502|75591879|FG000|Received Trial System|Overall Study||65||
59500320|NCT02335502|75591879|FG000|Receiving Permanent System|Overall Study||56||
59500321|NCT02335502|75591879|FG000|COMPLETED|Overall Study||49||
59500322|NCT02335502|75591879|FG000|NOT COMPLETED|Overall Study||17||
59500323|NCT00581971|75591883|FG000|STARTED|Overall Study||30||
59500324|NCT00581971|75591883|FG000|COMPLETED|Overall Study||30||
59500325|NCT00581971|75591883|FG000|NOT COMPLETED|Overall Study||0||
59500326|NCT03029234|75591888|FG000|STARTED|Overall Study||126||
59500327|NCT03029234|75591888|FG000|Received Carfilzomib|Overall Study||123||
59500328|NCT03029234|75591888|FG000|COMPLETED|Overall Study||27||
59500329|NCT03029234|75591888|FG000|NOT COMPLETED|Overall Study||99||
59500330|NCT00626431|75591894|FG000|STARTED|Overall Study|Separate groups of subjects received Formulation A and B and data were not compared between groups.|151||
59500331|NCT00626431|75591895|FG001|STARTED|Overall Study|Separate groups of subjects received Formulation A and B and data were not compared between groups.|159||
59500332|NCT00626431|75591894|FG000|COMPLETED|Overall Study||134||
59500333|NCT00626431|75591895|FG001|COMPLETED|Overall Study||114||
59500334|NCT00626431|75591894|FG000|NOT COMPLETED|Overall Study||17||
59500335|NCT00626431|75591895|FG001|NOT COMPLETED|Overall Study||45||
59500336|NCT00582205|75591901|FG000|STARTED|Overall Study||21||
59500337|NCT00582205|75591901|FG000|COMPLETED|Overall Study||11||
59500338|NCT00582205|75591901|FG000|NOT COMPLETED|Overall Study||10||
59500339|NCT00626743|75591907|FG000|STARTED|Treatment Period 1||6||
59500340|NCT00626743|75591908|FG001|STARTED|Treatment Period 1||7||
59500341|NCT00626743|75591907|FG000|COMPLETED|Treatment Period 1||6||
59500342|NCT00626743|75591908|FG001|COMPLETED|Treatment Period 1||6||
59500343|NCT00626743|75591907|FG000|NOT COMPLETED|Treatment Period 1||0||
59500344|NCT00626743|75591908|FG001|NOT COMPLETED|Treatment Period 1||1||
59500345|NCT00626743|75591907|FG000|STARTED|Wash-out Period of 6 Days||6||
59500346|NCT00626743|75591908|FG001|STARTED|Wash-out Period of 6 Days||6||
59500347|NCT00626743|75591907|FG000|COMPLETED|Wash-out Period of 6 Days||6||
59500348|NCT00626743|75591908|FG001|COMPLETED|Wash-out Period of 6 Days||6||
59500349|NCT00626743|75591907|FG000|NOT COMPLETED|Wash-out Period of 6 Days||0||
59500350|NCT00626743|75591908|FG001|NOT COMPLETED|Wash-out Period of 6 Days||0||
59500351|NCT00626743|75591907|FG000|STARTED|Treatment Period 2||6||
59500352|NCT00626743|75591908|FG001|STARTED|Treatment Period 2||6||
59500353|NCT00626743|75591907|FG000|COMPLETED|Treatment Period 2||6||
59500354|NCT00626743|75591908|FG001|COMPLETED|Treatment Period 2||6||
59500355|NCT00626743|75591907|FG000|NOT COMPLETED|Treatment Period 2||0||
59500356|NCT00626743|75591908|FG001|NOT COMPLETED|Treatment Period 2||0||
59500357|NCT00582361|75591916|FG000|STARTED|Overall Study||25||
59500358|NCT00582361|75591917|FG001|STARTED|Overall Study||38||
59500359|NCT00582361|75591916|FG000|COMPLETED|Overall Study||25||
59500360|NCT00582361|75591917|FG001|COMPLETED|Overall Study||38||
59500361|NCT00582361|75591916|FG000|NOT COMPLETED|Overall Study||0||
59500362|NCT00582361|75591917|FG001|NOT COMPLETED|Overall Study||0||
59500363|NCT00582517|75591925|FG000|STARTED|Overall Study||45||
59500364|NCT00582517|75591926|FG001|STARTED|Overall Study||55||
59500365|NCT00582517|75591925|FG000|COMPLETED|Overall Study||45||
59500366|NCT00582517|75591926|FG001|COMPLETED|Overall Study||55||
59500367|NCT00582517|75591925|FG000|NOT COMPLETED|Overall Study||0||
59500368|NCT00582517|75591926|FG001|NOT COMPLETED|Overall Study||0||
59500369|NCT00513461|75591934|FG000|STARTED|Overall Study||57||
59500370|NCT00513461|75591935|FG001|STARTED|Overall Study||53||
59500371|NCT00513461|75591934|FG000|COMPLETED|Overall Study||44||
59500372|NCT00513461|75591935|FG001|COMPLETED|Overall Study||43||
59500373|NCT00513461|75591934|FG000|NOT COMPLETED|Overall Study||13||
59500374|NCT00513461|75591935|FG001|NOT COMPLETED|Overall Study||10||
59500375|NCT00627367|75591943|FG000|STARTED|Overall Study||112||
59500376|NCT00627367|75591944|FG001|STARTED|Overall Study||112||
59500377|NCT00627367|75591943|FG000|COMPLETED|Overall Study||112||
59500378|NCT00627367|75591944|FG001|COMPLETED|Overall Study||112||
59500379|NCT00627367|75591943|FG000|NOT COMPLETED|Overall Study||0||
59500380|NCT00627367|75591944|FG001|NOT COMPLETED|Overall Study||0||
59500381|NCT00559013|75591951|FG000|STARTED|Overall Study||38||
59500382|NCT00559013|75591951|FG000|COMPLETED|Overall Study||38||
59500383|NCT00559013|75591951|FG000|NOT COMPLETED|Overall Study||0||
59500384|NCT00627679|75591955|FG000|STARTED|Overall Study||4||
59500385|NCT00627679|75591956|FG001|STARTED|Overall Study||4||
59500386|NCT00627679|75591957|FG002|STARTED|Overall Study||4||
59500387|NCT00627679|75591958|FG003|STARTED|Overall Study||4||
59500388|NCT00627679|75591955|FG000|COMPLETED|Overall Study||4||
59500389|NCT00627679|75591956|FG001|COMPLETED|Overall Study||4||
59500390|NCT00627679|75591957|FG002|COMPLETED|Overall Study||4||
59500391|NCT00627679|75591958|FG003|COMPLETED|Overall Study||4||
59500392|NCT00627679|75591955|FG000|NOT COMPLETED|Overall Study||0||
59500393|NCT00627679|75591956|FG001|NOT COMPLETED|Overall Study||0||
59500394|NCT00627679|75591957|FG002|NOT COMPLETED|Overall Study||0||
59500395|NCT00627679|75591958|FG003|NOT COMPLETED|Overall Study||0||
59500396|NCT00514709|75591970|FG000|STARTED|Overall Study||1230||
59500397|NCT00514709|75591971|FG001|STARTED|Overall Study||613||
59500398|NCT00514709|75591970|FG000|COMPLETED|Overall Study||1230||
59500399|NCT00514709|75591971|FG001|COMPLETED|Overall Study||613||
59500400|NCT00514709|75591970|FG000|NOT COMPLETED|Overall Study||0||
59500401|NCT00514709|75591971|FG001|NOT COMPLETED|Overall Study||0||
59500402|NCT00561431|75591981|FG000|STARTED|Overall Study||100||
59500403|NCT00561431|75591982|FG001|STARTED|Overall Study||100||
59500404|NCT00561431|75591981|FG000|COMPLETED|Overall Study||100||
59500405|NCT00561431|75591982|FG001|COMPLETED|Overall Study||100||
59500406|NCT00561431|75591981|FG000|NOT COMPLETED|Overall Study||0||
59500407|NCT00561431|75591982|FG001|NOT COMPLETED|Overall Study||0||
59500408|NCT00515021|75591990|FG000|STARTED|Overall Study||9||
59500409|NCT00515021|75591991|FG001|STARTED|Overall Study||11||
59500410|NCT00515021|75591990|FG000|COMPLETED|Overall Study||9||
59500411|NCT00515021|75591991|FG001|COMPLETED|Overall Study||11||
59500412|NCT00515021|75591990|FG000|NOT COMPLETED|Overall Study||0||
59500413|NCT00515021|75591991|FG001|NOT COMPLETED|Overall Study||0||
59500414|NCT00515177|75592001|FG000|STARTED|Overall Study||20||
59500415|NCT00515177|75592002|FG001|STARTED|Overall Study||10||
59500416|NCT00515177|75592001|FG000|COMPLETED|Overall Study||18||
59500417|NCT00515177|75592002|FG001|COMPLETED|Overall Study||9||
59500418|NCT00515177|75592001|FG000|NOT COMPLETED|Overall Study||2||
59500419|NCT00515177|75592002|FG001|NOT COMPLETED|Overall Study||1||
59500420|NCT00583375|75592011|FG000|STARTED|Overall Study||142||
59500421|NCT00583375|75592012|FG001|STARTED|Overall Study||272||
59500422|NCT00583375|75592011|FG000|COMPLETED|Overall Study||142||
59500423|NCT00583375|75592012|FG001|COMPLETED|Overall Study||272||
59500424|NCT00583375|75592011|FG000|NOT COMPLETED|Overall Study||0||
59500425|NCT00583375|75592012|FG001|NOT COMPLETED|Overall Study||0||
59500426|NCT00628147|75592020|FG000|STARTED|Overall Study||142||
59500427|NCT00628147|75592021|FG001|STARTED|Overall Study||142||
59500428|NCT00628147|75592020|FG000|COMPLETED|Overall Study||135||
59754965|NCT00617773|75873881|FG000|COMPLETED|Overall Study|Patients COMPLETED were evaluated as having no disease progression at the end of cycle 3.|7||
59754966|NCT00617773|75873881|FG000|NOT COMPLETED|Overall Study||24||
59754967|NCT00956813|75873887|FG000|STARTED|Flaxseed and Placebo||105||
59754968|NCT00956813|75873888|FG001|STARTED|Flaxseed and Placebo||105||
59754969|NCT00956813|75873887|FG000|COMPLETED|Flaxseed and Placebo||97||
60012902|NCT02634307|76128922|FG001|STARTED|Overall Study||239||
60012903|NCT02634307|76128923|FG002|STARTED|Overall Study||225||
60012904|NCT02634307|76128921|FG000|Safety Population|Overall Study||593||
60012905|NCT02634307|76128922|FG001|Safety Population|Overall Study||239||
60012906|NCT02634307|76128923|FG002|Safety Population|Overall Study||225||
59754970|NCT00956813|75873888|FG001|COMPLETED|Flaxseed and Placebo||100||
59754971|NCT00956813|75873887|FG000|NOT COMPLETED|Flaxseed and Placebo||8||
59754972|NCT00956813|75873888|FG001|NOT COMPLETED|Flaxseed and Placebo||5||
59754973|NCT00956813|75873887|FG000|STARTED|Continuation Phase||80||
59754974|NCT00956813|75873888|FG001|STARTED|Continuation Phase||0||
59754975|NCT00956813|75873887|FG000|COMPLETED|Continuation Phase||80||
59500429|NCT00628147|75592021|FG001|COMPLETED|Overall Study||141||
59500430|NCT00628147|75592020|FG000|NOT COMPLETED|Overall Study||7||
59500431|NCT00628147|75592021|FG001|NOT COMPLETED|Overall Study||1||
59500432|NCT00584077|75592027|FG000|STARTED|Overall Study||15||
59500433|NCT00584077|75592027|FG000|COMPLETED|Overall Study||15||
59500434|NCT00584077|75592027|FG000|NOT COMPLETED|Overall Study||0||
59500435|NCT00630253|75592035|FG000|STARTED|Overall Study||16||
59500436|NCT00630253|75592036|FG001|STARTED|Overall Study||9||
59500437|NCT00630253|75592037|FG002|STARTED|Overall Study||6||
59500438|NCT00630253|75592035|FG000|COMPLETED|Overall Study||16||
59500439|NCT00630253|75592036|FG001|COMPLETED|Overall Study||9||
59500440|NCT00630253|75592037|FG002|COMPLETED|Overall Study||6||
59500441|NCT00630253|75592035|FG000|NOT COMPLETED|Overall Study||0||
59500442|NCT00630253|75592036|FG001|NOT COMPLETED|Overall Study||0||
59754976|NCT00956813|75873888|FG001|COMPLETED|Continuation Phase||0||
59754977|NCT00956813|75873887|FG000|NOT COMPLETED|Continuation Phase||0||
59754978|NCT00956813|75873888|FG001|NOT COMPLETED|Continuation Phase||0||
59754979|NCT00955955|75873898|FG000|STARTED|Overall Study||19||
59754980|NCT00955955|75873899|FG001|STARTED|Overall Study||28||
59754981|NCT00955955|75873900|FG002|STARTED|Overall Study||28||
59754982|NCT00955955|75873898|FG000|COMPLETED|Overall Study||17||
59754983|NCT00955955|75873899|FG001|COMPLETED|Overall Study||28||
59500443|NCT00630253|75592037|FG002|NOT COMPLETED|Overall Study||0||
59500444|NCT00584701|75592045|FG000|STARTED|Active Risperidone||49||
59500445|NCT00584701|75592045|FG000|COMPLETED|Active Risperidone||46||
59500446|NCT00584701|75592045|FG000|NOT COMPLETED|Active Risperidone||3||
60012907|NCT02634307|76128921|FG000|Full Analysis Set (FAS) Population|Overall Study||582||
60012908|NCT02634307|76128922|FG001|Full Analysis Set (FAS) Population|Overall Study||235||
60012909|NCT02634307|76128923|FG002|Full Analysis Set (FAS) Population|Overall Study||224||
59500447|NCT00584701|75592045|FG000|STARTED|Follow-up||46||
59754984|NCT00955955|75873900|FG002|COMPLETED|Overall Study||28||
59754985|NCT00955955|75873898|FG000|NOT COMPLETED|Overall Study||2||
60012910|NCT02634307|76128921|FG000|COMPLETED|Overall Study||468||
60012911|NCT02634307|76128922|FG001|COMPLETED|Overall Study||168||
60012912|NCT02634307|76128923|FG002|COMPLETED|Overall Study||164||
60012913|NCT02634307|76128921|FG000|NOT COMPLETED|Overall Study||125||
59754986|NCT00955955|75873899|FG001|NOT COMPLETED|Overall Study||0||
59754987|NCT00955955|75873900|FG002|NOT COMPLETED|Overall Study||0||
60012914|NCT02634307|76128922|FG001|NOT COMPLETED|Overall Study||71||
60012915|NCT02634307|76128923|FG002|NOT COMPLETED|Overall Study||61||
60012916|NCT01365273|76128933|FG000|STARTED|Overall Study||22||
59500448|NCT00584701|75592045|FG000|COMPLETED|Follow-up||34||
59500449|NCT00584701|75592045|FG000|NOT COMPLETED|Follow-up||12||
59500450|NCT00630409|75592050|FG000|STARTED|Overall Study||5||
59500451|NCT00630409|75592050|FG000|COMPLETED|Overall Study||4||
59500452|NCT00630409|75592050|FG000|NOT COMPLETED|Overall Study||1||
59500453|NCT00630955|75592058|FG000|STARTED|Overall Study||34||
59500454|NCT00630955|75592059|FG001|STARTED|Overall Study||37||
59500455|NCT00630955|75592060|FG002|STARTED|Overall Study||40||
59500456|NCT00630955|75592058|FG000|COMPLETED|Overall Study||31||
59500457|NCT00630955|75592059|FG001|COMPLETED|Overall Study||31||
59500458|NCT00630955|75592060|FG002|COMPLETED|Overall Study||28||
59500459|NCT00630955|75592058|FG000|NOT COMPLETED|Overall Study||3||
59500460|NCT00630955|75592059|FG001|NOT COMPLETED|Overall Study||6||
59500461|NCT00630955|75592060|FG002|NOT COMPLETED|Overall Study||12||
59500462|NCT00584857|75592068|FG000|STARTED|Overall Study||30||
59500463|NCT00584857|75592068|FG000|COMPLETED|Overall Study||30||
59500464|NCT00584857|75592068|FG000|NOT COMPLETED|Overall Study||0||
59500465|NCT00585013|75592074|FG000|STARTED|Overall Study||8||
59500466|NCT00585013|75592075|FG001|STARTED|Overall Study||8||
59500467|NCT00585013|75592074|FG000|COMPLETED|Overall Study||8||
59500468|NCT00585013|75592075|FG001|COMPLETED|Overall Study||8||
59500469|NCT00585013|75592074|FG000|NOT COMPLETED|Overall Study||0||
59500470|NCT00585013|75592075|FG001|NOT COMPLETED|Overall Study||0||
59500471|NCT00632281|75592083|FG000|STARTED|Overall Study||38||
59500472|NCT00632281|75592083|FG000|COMPLETED|Overall Study||38||
59500473|NCT00632281|75592083|FG000|NOT COMPLETED|Overall Study||0||
59500474|NCT00585637|75592091|FG000|STARTED|Baseline||81||
59500475|NCT00585637|75592092|FG001|STARTED|Baseline||81||
59500476|NCT00585637|75592093|FG002|STARTED|Baseline||83||
59500477|NCT00585637|75592094|FG003|STARTED|Baseline||83||
59500478|NCT00585637|75592091|FG000|COMPLETED|Baseline||81||
59500479|NCT00585637|75592092|FG001|COMPLETED|Baseline||81||
59500480|NCT00585637|75592093|FG002|COMPLETED|Baseline||83||
59500481|NCT00585637|75592094|FG003|COMPLETED|Baseline||83||
59500482|NCT00585637|75592091|FG000|NOT COMPLETED|Baseline||0||
59500483|NCT00585637|75592092|FG001|NOT COMPLETED|Baseline||0||
59500484|NCT00585637|75592093|FG002|NOT COMPLETED|Baseline||0||
59500485|NCT00585637|75592094|FG003|NOT COMPLETED|Baseline||0||
59500486|NCT00585637|75592091|FG000|STARTED|3-month Time Point||81||
59500487|NCT00585637|75592092|FG001|STARTED|3-month Time Point||81||
59500488|NCT00585637|75592093|FG002|STARTED|3-month Time Point||83||
59500489|NCT00585637|75592094|FG003|STARTED|3-month Time Point||83||
59500490|NCT00585637|75592091|FG000|COMPLETED|3-month Time Point||71||
59500491|NCT00585637|75592092|FG001|COMPLETED|3-month Time Point||67||
59500492|NCT00585637|75592093|FG002|COMPLETED|3-month Time Point||76||
59500493|NCT00585637|75592094|FG003|COMPLETED|3-month Time Point||78||
59500494|NCT00585637|75592091|FG000|NOT COMPLETED|3-month Time Point||10||
59500495|NCT00585637|75592092|FG001|NOT COMPLETED|3-month Time Point||14||
59500496|NCT00585637|75592093|FG002|NOT COMPLETED|3-month Time Point||7||
59500497|NCT00585637|75592094|FG003|NOT COMPLETED|3-month Time Point||5||
59500498|NCT00585637|75592091|FG000|STARTED|6-month Time Point||81||
59500499|NCT00585637|75592092|FG001|STARTED|6-month Time Point||81||
59500500|NCT00585637|75592093|FG002|STARTED|6-month Time Point||83||
59500501|NCT00585637|75592094|FG003|STARTED|6-month Time Point||83||
59500502|NCT00585637|75592091|FG000|COMPLETED|6-month Time Point||75||
59500503|NCT00585637|75592092|FG001|COMPLETED|6-month Time Point||68||
59500504|NCT00585637|75592093|FG002|COMPLETED|6-month Time Point||72||
59500505|NCT00585637|75592094|FG003|COMPLETED|6-month Time Point||77||
59500506|NCT00585637|75592091|FG000|NOT COMPLETED|6-month Time Point||6||
59500507|NCT00585637|75592092|FG001|NOT COMPLETED|6-month Time Point||13||
59500508|NCT00585637|75592093|FG002|NOT COMPLETED|6-month Time Point||11||
59500509|NCT00585637|75592094|FG003|NOT COMPLETED|6-month Time Point||6||
59500510|NCT00633919|75592106|FG000|STARTED|Overall Study||63||
59500511|NCT00633919|75592107|FG001|STARTED|Overall Study||61||
59500512|NCT00633919|75592106|FG000|COMPLETED|Overall Study||36||
59500513|NCT00633919|75592107|FG001|COMPLETED|Overall Study||39||
59500514|NCT00633919|75592106|FG000|NOT COMPLETED|Overall Study||27||
59500515|NCT00633919|75592107|FG001|NOT COMPLETED|Overall Study||22||
59500516|NCT00515411|75592116|FG000|STARTED|Overall Study||54||
59500517|NCT00515411|75592117|FG001|STARTED|Overall Study||31||
59500518|NCT00515411|75592118|FG002|STARTED|Overall Study||26||
59500519|NCT00515411|75592116|FG000|COMPLETED|Overall Study||54||
59500520|NCT00515411|75592117|FG001|COMPLETED|Overall Study||31||
59500521|NCT00515411|75592118|FG002|COMPLETED|Overall Study||26||
59500522|NCT00515411|75592116|FG000|NOT COMPLETED|Overall Study||0||
59500523|NCT00515411|75592117|FG001|NOT COMPLETED|Overall Study||0||
59500524|NCT00515411|75592118|FG002|NOT COMPLETED|Overall Study||0||
59500525|NCT00586261|75592128|FG000|STARTED|Overall Study||17||
59500526|NCT00586261|75592129|FG001|STARTED|Overall Study||19||
59500527|NCT00586261|75592128|FG000|COMPLETED|Overall Study||17||
59500528|NCT00586261|75592129|FG001|COMPLETED|Overall Study||19||
59500529|NCT00586261|75592128|FG000|NOT COMPLETED|Overall Study||0||
59500530|NCT00586261|75592129|FG001|NOT COMPLETED|Overall Study||0||
59500531|NCT00634621|75592135|FG000|STARTED|Overall Study||283||
59500532|NCT00634621|75592135|FG000|COMPLETED|Overall Study||283||
59500533|NCT00634621|75592135|FG000|NOT COMPLETED|Overall Study||0||
59500534|NCT00515723|75592147|FG000|STARTED|Overall Study||25||
59754988|NCT00955721|75873916|FG000|STARTED|Overall Study||9||
59500535|NCT00515723|75592148|FG001|STARTED|Overall Study||22||
59500536|NCT00515723|75592149|FG002|STARTED|Overall Study||22||
59500537|NCT00515723|75592150|FG003|STARTED|Overall Study||27||
59500538|NCT00515723|75592147|FG000|COMPLETED|Overall Study||20||
59500539|NCT00515723|75592148|FG001|COMPLETED|Overall Study||21||
59500540|NCT00515723|75592149|FG002|COMPLETED|Overall Study||21||
59500541|NCT00515723|75592150|FG003|COMPLETED|Overall Study||21||
59500542|NCT00515723|75592147|FG000|NOT COMPLETED|Overall Study||5||
59500543|NCT00515723|75592148|FG001|NOT COMPLETED|Overall Study||1||
59500544|NCT00515723|75592149|FG002|NOT COMPLETED|Overall Study||1||
59500545|NCT00515723|75592150|FG003|NOT COMPLETED|Overall Study||6||
59500546|NCT00586573|75592161|FG000|STARTED|Overall Study||34||
59500547|NCT00586573|75592161|FG000|COMPLETED|Overall Study||28||
59500548|NCT00586573|75592161|FG000|NOT COMPLETED|Overall Study||6||
59500549|NCT00515879|75592167|FG000|STARTED|Overall Study||87||
59500550|NCT00515879|75592168|FG001|STARTED|Overall Study||82||
59500551|NCT00515879|75592167|FG000|COMPLETED|Overall Study||62||
59500552|NCT00515879|75592168|FG001|COMPLETED|Overall Study||62||
59500553|NCT00515879|75592167|FG000|NOT COMPLETED|Overall Study||25||
59500554|NCT00515879|75592168|FG001|NOT COMPLETED|Overall Study||20||
59500555|NCT00586729|75592178|FG000|STARTED|Overall Study||14||
59500556|NCT00586729|75592179|FG001|STARTED|Overall Study||9||
59500557|NCT00586729|75592178|FG000|COMPLETED|Overall Study||11||
59500558|NCT00586729|75592179|FG001|COMPLETED|Overall Study||8||
59500559|NCT00586729|75592178|FG000|NOT COMPLETED|Overall Study||3||
59500560|NCT00586729|75592179|FG001|NOT COMPLETED|Overall Study||1||
59500561|NCT00635479|75592187|FG000|STARTED|Overall Study||55||
59500562|NCT00635479|75592188|FG001|STARTED|Overall Study||60||
59500563|NCT00635479|75592187|FG000|COMPLETED|Overall Study||49||
59500564|NCT00635479|75592188|FG001|COMPLETED|Overall Study||42||
59500565|NCT00635479|75592187|FG000|NOT COMPLETED|Overall Study||6||
59500566|NCT00635479|75592188|FG001|NOT COMPLETED|Overall Study||18||
59500567|NCT00516503|75592196|FG000|STARTED|Overall Study||101||
59500568|NCT00516503|75592197|FG001|STARTED|Overall Study||102||
59500569|NCT00516503|75592196|FG000|COMPLETED|Overall Study||101||
59500570|NCT00516503|75592197|FG001|COMPLETED|Overall Study||102||
59500571|NCT00516503|75592196|FG000|NOT COMPLETED|Overall Study||0||
59500572|NCT00516503|75592197|FG001|NOT COMPLETED|Overall Study||0||
59500573|NCT00587041|75592206|FG000|STARTED|Overall Study||12||
59500574|NCT00587041|75592207|FG001|STARTED|Overall Study||14||
59500575|NCT00587041|75592208|FG002|STARTED|Overall Study||14||
59500576|NCT00587041|75592206|FG000|COMPLETED|Overall Study||12||
59500577|NCT00587041|75592207|FG001|COMPLETED|Overall Study||14||
59500578|NCT00587041|75592208|FG002|COMPLETED|Overall Study||14||
59500579|NCT00587041|75592206|FG000|NOT COMPLETED|Overall Study||0||
59500580|NCT00587041|75592207|FG001|NOT COMPLETED|Overall Study||0||
59500581|NCT00587041|75592208|FG002|NOT COMPLETED|Overall Study||0||
59500582|NCT02135653|75592218|FG000|STARTED|Overall Study||35||
59607303|NCT03822377|75717871|FG000|STARTED|Overall Study||65||
59607304|NCT03822377|75717872|FG001|STARTED|Overall Study||65||
60012917|NCT01365273|76128934|FG001|STARTED|Overall Study||21||
60012918|NCT01365273|76128933|FG000|Compl. Pts, Not Evaluable for Pain.|Overall Study||2||
60012919|NCT01365273|76128934|FG001|Compl. Pts, Not Evaluable for Pain.|Overall Study||4||
59754989|NCT00955721|75873917|FG001|STARTED|Overall Study||0||
59754990|NCT00955721|75873916|FG000|COMPLETED|Overall Study||6||
59754991|NCT00955721|75873917|FG001|COMPLETED|Overall Study||0||
59754992|NCT00955721|75873916|FG000|NOT COMPLETED|Overall Study||3||
60012920|NCT01365273|76128933|FG000|COMPLETED|Overall Study||20||
60012921|NCT01365273|76128934|FG001|COMPLETED|Overall Study||20||
60012922|NCT01365273|76128933|FG000|NOT COMPLETED|Overall Study||2||
60012923|NCT01365273|76128934|FG001|NOT COMPLETED|Overall Study||1||
59500583|NCT02135653|75592219|FG001|STARTED|Overall Study||33||
59500584|NCT02135653|75592218|FG000|COMPLETED|Overall Study||22||
59500585|NCT02135653|75592219|FG001|COMPLETED|Overall Study||28||
59500586|NCT02135653|75592218|FG000|NOT COMPLETED|Overall Study||13||
59500587|NCT02135653|75592219|FG001|NOT COMPLETED|Overall Study||5||
59500588|NCT00636649|75592229|FG000|STARTED|Overall Study||20||
59500589|NCT00636649|75592230|FG001|STARTED|Overall Study||20||
59500590|NCT00636649|75592229|FG000|COMPLETED|Overall Study||20||
59500591|NCT00636649|75592230|FG001|COMPLETED|Overall Study||20||
59500592|NCT00636649|75592229|FG000|NOT COMPLETED|Overall Study||0||
59500593|NCT00636649|75592230|FG001|NOT COMPLETED|Overall Study||0||
59500594|NCT00636805|75592240|FG000|STARTED|Overall Study||63||
59500595|NCT00636805|75592240|FG000|COMPLETED|Overall Study||63||
59500596|NCT00636805|75592240|FG000|NOT COMPLETED|Overall Study||0||
59500597|NCT02137447|75592244|FG000|STARTED|Overall Study||10||
59500598|NCT02137447|75592244|FG000|COMPLETED|Overall Study||10||
59500599|NCT02137447|75592244|FG000|NOT COMPLETED|Overall Study||0||
59500600|NCT00517595|75592248|FG000|STARTED|Overall Study||48||
59500601|NCT00517595|75592248|FG000|COMPLETED|Overall Study||48||
59500602|NCT00517595|75592248|FG000|NOT COMPLETED|Overall Study||0||
60012924|NCT02595437|76128940|FG000|STARTED|Triferic Via IV||22||
59500603|NCT00638365|75592255|FG000|STARTED|Overall Study||9||
59500604|NCT00638365|75592256|FG001|STARTED|Overall Study||10||
59500605|NCT00638365|75592257|FG002|STARTED|Overall Study||8||
59500606|NCT00638365|75592255|FG000|COMPLETED|Overall Study||9||
59500607|NCT00638365|75592256|FG001|COMPLETED|Overall Study||10||
59500608|NCT00638365|75592257|FG002|COMPLETED|Overall Study||8||
59500609|NCT00638365|75592255|FG000|NOT COMPLETED|Overall Study||0||
59500610|NCT00638365|75592256|FG001|NOT COMPLETED|Overall Study||0||
59500611|NCT00638365|75592257|FG002|NOT COMPLETED|Overall Study||0||
59500612|NCT00524225|75592265|FG000|STARTED|Overall Study||3||
59500613|NCT00524225|75592265|FG000|COMPLETED|Overall Study||3||
59500614|NCT00524225|75592265|FG000|NOT COMPLETED|Overall Study||0||
59500615|NCT00669019|75592270|FG000|STARTED|Overall Study||23||
59500616|NCT00669019|75592270|FG000|COMPLETED|Overall Study||23||
59500617|NCT00669019|75592270|FG000|NOT COMPLETED|Overall Study||0||
59500618|NCT02140957|75592276|FG000|STARTED|Overall Study||129||
59500619|NCT02140957|75592277|FG001|STARTED|Overall Study||122||
59500620|NCT02140957|75592276|FG000|COMPLETED|Overall Study||102||
59500621|NCT02140957|75592277|FG001|COMPLETED|Overall Study||99||
59500622|NCT02140957|75592276|FG000|NOT COMPLETED|Overall Study||27||
59500623|NCT02140957|75592277|FG001|NOT COMPLETED|Overall Study||23||
59500624|NCT00670267|75592283|FG000|STARTED|Overall Study||10||
59500625|NCT00670267|75592283|FG000|COMPLETED|Overall Study||9||
59500626|NCT00670267|75592283|FG000|NOT COMPLETED|Overall Study||1||
59500627|NCT00641563|75592289|FG000|STARTED|Infusion 1||5||
59500628|NCT00641563|75592290|FG001|STARTED|Infusion 1||5||
59500629|NCT00641563|75592289|FG000|COMPLETED|Infusion 1||5||
59500630|NCT00641563|75592290|FG001|COMPLETED|Infusion 1||5||
59500631|NCT00641563|75592289|FG000|NOT COMPLETED|Infusion 1||0||
59500632|NCT00641563|75592290|FG001|NOT COMPLETED|Infusion 1||0||
59500633|NCT00641563|75592289|FG000|STARTED|Infusion 2||5||
59500634|NCT00641563|75592290|FG001|STARTED|Infusion 2||5||
59500635|NCT00641563|75592289|FG000|COMPLETED|Infusion 2||5||
59500636|NCT00641563|75592290|FG001|COMPLETED|Infusion 2||5||
59500637|NCT00641563|75592289|FG000|NOT COMPLETED|Infusion 2||0||
59500638|NCT00641563|75592290|FG001|NOT COMPLETED|Infusion 2||0||
59500639|NCT00641641|75592296|FG000|STARTED|Overall Study||16||
59500640|NCT00641641|75592296|FG000|COMPLETED|Overall Study||16||
59500641|NCT00641641|75592296|FG000|NOT COMPLETED|Overall Study||0||
59500642|NCT00641797|75592302|FG000|STARTED|Overall Study||11||
60012925|NCT02595437|76128940|FG000|COMPLETED|Triferic Via IV||21||
60012926|NCT02595437|76128940|FG000|NOT COMPLETED|Triferic Via IV||1||
60012927|NCT02595437|76128940|FG000|STARTED|Triferic Via Hemodialysate||21||
59500643|NCT00641797|75592303|FG001|STARTED|Overall Study||15||
59500644|NCT00641797|75592302|FG000|COMPLETED|Overall Study||11||
59500645|NCT00641797|75592303|FG001|COMPLETED|Overall Study||15||
59500646|NCT00641797|75592302|FG000|NOT COMPLETED|Overall Study||0||
59500647|NCT00641797|75592303|FG001|NOT COMPLETED|Overall Study||0||
59500648|NCT00671515|75592309|FG000|STARTED|Phase 1||23||
59500649|NCT00671515|75592309|FG000|COMPLETED|Phase 1||20||
60012928|NCT02595437|76128940|FG000|COMPLETED|Triferic Via Hemodialysate||21||
60012929|NCT02595437|76128940|FG000|NOT COMPLETED|Triferic Via Hemodialysate||0||
59500650|NCT00671515|75592309|FG000|NOT COMPLETED|Phase 1||3||
59500651|NCT00671515|75592309|FG000|STARTED|Phase 2||13||
59500652|NCT00671515|75592309|FG000|COMPLETED|Phase 2||9||
59500653|NCT00671515|75592309|FG000|NOT COMPLETED|Phase 2||4||
59500654|NCT00671671|75592315|FG000|STARTED|Overall Study||10||
59500655|NCT00671671|75592316|FG001|STARTED|Overall Study||10||
59500656|NCT00671671|75592315|FG000|COMPLETED|Overall Study||10||
59500657|NCT00671671|75592316|FG001|COMPLETED|Overall Study||10||
59500658|NCT00671671|75592315|FG000|NOT COMPLETED|Overall Study||0||
59500659|NCT00671671|75592316|FG001|NOT COMPLETED|Overall Study||0||
59500660|NCT01893320|75592325|FG000|STARTED|Overall Study||7||
59500661|NCT01893320|75592326|FG001|STARTED|Overall Study||59||
59500662|NCT01893320|75592325|FG000|COMPLETED|Overall Study||7||
59500663|NCT01893320|75592326|FG001|COMPLETED|Overall Study||59||
59500664|NCT01893320|75592325|FG000|NOT COMPLETED|Overall Study||0||
59500665|NCT01893320|75592326|FG001|NOT COMPLETED|Overall Study||0||
59500666|NCT00648115|75592335|FG000|STARTED|Overall Study||42||
59500667|NCT00648115|75592336|FG001|STARTED|Overall Study||42||
59500668|NCT00648115|75592337|FG002|STARTED|Overall Study||27||
59500669|NCT00648115|75592335|FG000|COMPLETED|Overall Study||42||
59500670|NCT00648115|75592336|FG001|COMPLETED|Overall Study||42||
59500671|NCT00648115|75592337|FG002|COMPLETED|Overall Study||27||
59500672|NCT00648115|75592335|FG000|NOT COMPLETED|Overall Study||0||
59500673|NCT00648115|75592336|FG001|NOT COMPLETED|Overall Study||0||
59500674|NCT00648115|75592337|FG002|NOT COMPLETED|Overall Study||0||
59500675|NCT00672451|75592347|FG000|STARTED|Overall Study||1||
59500676|NCT00672451|75592348|FG001|STARTED|Overall Study||2||
59500677|NCT00672451|75592347|FG000|COMPLETED|Overall Study||1||
59500678|NCT00672451|75592348|FG001|COMPLETED|Overall Study||2||
59500679|NCT00672451|75592347|FG000|NOT COMPLETED|Overall Study||0||
59500680|NCT00672451|75592348|FG001|NOT COMPLETED|Overall Study||0||
59500681|NCT00673075|75592356|FG000|STARTED|Overall Study||21||
59500682|NCT00673075|75592357|FG001|STARTED|Overall Study||18||
59500683|NCT00673075|75592356|FG000|COMPLETED|Overall Study||12||
59607305|NCT03822377|75717871|FG000|COMPLETED|Overall Study||65||
59607306|NCT03822377|75717872|FG001|COMPLETED|Overall Study||65||
59607307|NCT03822377|75717871|FG000|NOT COMPLETED|Overall Study||0||
59607308|NCT03822377|75717872|FG001|NOT COMPLETED|Overall Study||0||
59607309|NCT02501759|75717880|FG000|STARTED|Overall Study||2||
59607310|NCT02501759|75717880|FG000|COMPLETED|Overall Study||1||
59607311|NCT02501759|75717880|FG000|NOT COMPLETED|Overall Study||1||
59607312|NCT03808493|75717888|FG000|STARTED|Overall Study||12||
59607313|NCT03808493|75717889|FG001|STARTED|Overall Study||12||
59607314|NCT03808493|75717890|FG002|STARTED|Overall Study||12||
59607315|NCT03808493|75717891|FG003|STARTED|Overall Study||12||
59607316|NCT03808493|75717888|FG000|COMPLETED|Overall Study||12|Here, completed means completion of all periods, that means Period 1, Washout period, and Period 2.|
59607317|NCT03808493|75717889|FG001|COMPLETED|Overall Study||12|Here, completed means completion of all periods, that means Period 1, Washout period, and Period 2.|
59613496|NCT01684878|75724613|FG003|NOT COMPLETED|Part 2: Randomized Phase||78||
59885450|NCT00293423|76008274|FG001|COMPLETED|Surgical Resection||41|All patients underwent aggressive resection with intra-operative collection of tissue to generate autologous vaccine. Only participants with adequate tissue collected to generate enough vaccine and whose vaccines passed quality control standards received the vaccine and constituted the intent-to-treat group|
59885451|NCT00293423|76008273|FG000|NOT COMPLETED|Surgical Resection||16||
59885452|NCT00293423|76008274|FG001|NOT COMPLETED|Surgical Resection||27||
59885453|NCT00293423|76008273|FG000|STARTED|Vaccination Treatment Period||12||
59885454|NCT00293423|76008274|FG001|STARTED|Vaccination Treatment Period||41||
59885455|NCT00293423|76008273|FG000|COMPLETED|Vaccination Treatment Period||12||
59885456|NCT00293423|76008274|FG001|COMPLETED|Vaccination Treatment Period||38||
59885457|NCT00293423|76008273|FG000|NOT COMPLETED|Vaccination Treatment Period||0||
59885458|NCT00293423|76008274|FG001|NOT COMPLETED|Vaccination Treatment Period||3||
59885459|NCT03538743|76008289|FG000|STARTED|Overall Study||25||
59885460|NCT03538743|76008290|FG001|STARTED|Overall Study||9||
59885461|NCT03538743|76008291|FG002|STARTED|Overall Study||9||
59885462|NCT03538743|76008292|FG003|STARTED|Overall Study||10||
59885463|NCT03538743|76008293|FG004|STARTED|Overall Study||9||
59885464|NCT03538743|76008294|FG005|STARTED|Overall Study||9||
59885465|NCT03538743|76008295|FG006|STARTED|Overall Study||9||
59500684|NCT00673075|75592357|FG001|COMPLETED|Overall Study||11||
59500685|NCT00673075|75592356|FG000|NOT COMPLETED|Overall Study||9||
59500686|NCT00673075|75592357|FG001|NOT COMPLETED|Overall Study||7||
59500687|NCT00651625|75592367|FG000|STARTED|Overall Study||219||
59500688|NCT00651625|75592368|FG001|STARTED|Overall Study||218||
59500689|NCT00651625|75592367|FG000|COMPLETED|Overall Study||219||
59500690|NCT00651625|75592368|FG001|COMPLETED|Overall Study||218||
59500691|NCT00651625|75592367|FG000|NOT COMPLETED|Overall Study||0||
59500692|NCT00651625|75592368|FG001|NOT COMPLETED|Overall Study||0||
59500693|NCT00673153|75592374|FG000|STARTED|Overall Study||31||
59500694|NCT00673153|75592374|FG000|COMPLETED|Overall Study||30||
59500695|NCT00673153|75592374|FG000|NOT COMPLETED|Overall Study||1||
59500696|NCT00673855|75592378|FG000|STARTED|First Intervention||10||
59500697|NCT00673855|75592379|FG001|STARTED|First Intervention||10||
59885466|NCT03538743|76008296|FG007|STARTED|Overall Study||8||
59885467|NCT03538743|76008297|FG008|STARTED|Overall Study||10||
59885468|NCT03538743|76008289|FG000|Received Treatment|Overall Study||25||
59885469|NCT03538743|76008290|FG001|Received Treatment|Overall Study||9||
59885470|NCT03538743|76008291|FG002|Received Treatment|Overall Study||9||
59885471|NCT03538743|76008292|FG003|Received Treatment|Overall Study||10||
59885472|NCT03538743|76008293|FG004|Received Treatment|Overall Study||9||
59885473|NCT03538743|76008294|FG005|Received Treatment|Overall Study||9||
59885474|NCT03538743|76008295|FG006|Received Treatment|Overall Study||9||
59885475|NCT03538743|76008296|FG007|Received Treatment|Overall Study||8||
59885476|NCT03538743|76008297|FG008|Received Treatment|Overall Study||10||
59885477|NCT03538743|76008289|FG000|COMPLETED|Overall Study||25||
59885478|NCT03538743|76008290|FG001|COMPLETED|Overall Study||9||
59885479|NCT03538743|76008291|FG002|COMPLETED|Overall Study||8||
59885480|NCT03538743|76008292|FG003|COMPLETED|Overall Study||8||
59885481|NCT03538743|76008293|FG004|COMPLETED|Overall Study||9||
59885482|NCT03538743|76008294|FG005|COMPLETED|Overall Study||9||
59885483|NCT03538743|76008295|FG006|COMPLETED|Overall Study||9||
59885484|NCT03538743|76008296|FG007|COMPLETED|Overall Study||8||
59885485|NCT03538743|76008297|FG008|COMPLETED|Overall Study||7||
59885486|NCT03538743|76008289|FG000|NOT COMPLETED|Overall Study||0||
59885487|NCT03538743|76008290|FG001|NOT COMPLETED|Overall Study||0||
59885488|NCT03538743|76008291|FG002|NOT COMPLETED|Overall Study||1||
59885489|NCT03538743|76008292|FG003|NOT COMPLETED|Overall Study||2||
59885490|NCT03538743|76008293|FG004|NOT COMPLETED|Overall Study||0||
59607318|NCT03808493|75717890|FG002|COMPLETED|Overall Study||12|Here, completed means completion of all periods, that means Period 1, Washout period, and Period 2.|
59613497|NCT01684722|75724627|FG000|STARTED|Overall Study||333||
59754993|NCT00955721|75873917|FG001|NOT COMPLETED|Overall Study||0||
59754994|NCT00573469|75873927|FG000|STARTED|Overall Study||26||
59754995|NCT00573469|75873928|FG001|STARTED|Overall Study||25||
59754996|NCT00573469|75873929|FG002|STARTED|Overall Study||26||
59754997|NCT00573469|75873927|FG000|COMPLETED|Overall Study||20||
59754998|NCT00573469|75873928|FG001|COMPLETED|Overall Study||21||
59754999|NCT00573469|75873929|FG002|COMPLETED|Overall Study||22||
59755000|NCT00573469|75873927|FG000|NOT COMPLETED|Overall Study||6||
59755001|NCT00573469|75873928|FG001|NOT COMPLETED|Overall Study||4||
59755002|NCT00573469|75873929|FG002|NOT COMPLETED|Overall Study||4||
59885491|NCT03538743|76008294|FG005|NOT COMPLETED|Overall Study||0||
59885492|NCT03538743|76008295|FG006|NOT COMPLETED|Overall Study||0||
59500698|NCT00673855|75592378|FG000|COMPLETED|First Intervention||10||
59500699|NCT00673855|75592379|FG001|COMPLETED|First Intervention||10||
59500700|NCT00673855|75592378|FG000|NOT COMPLETED|First Intervention||0||
59500701|NCT00673855|75592379|FG001|NOT COMPLETED|First Intervention||0||
59500702|NCT00673855|75592378|FG000|STARTED|Second Intervention||10||
59500703|NCT00673855|75592379|FG001|STARTED|Second Intervention||10||
59500704|NCT00673855|75592378|FG000|COMPLETED|Second Intervention||10||
59500705|NCT00673855|75592379|FG001|COMPLETED|Second Intervention||10||
59500706|NCT00673855|75592378|FG000|NOT COMPLETED|Second Intervention||0||
59500707|NCT00673855|75592379|FG001|NOT COMPLETED|Second Intervention||0||
59500708|NCT00654511|75592389|FG000|STARTED|Overall Study||26||
59500709|NCT00654511|75592390|FG001|STARTED|Overall Study||25||
59500710|NCT00654511|75592391|FG002|STARTED|Overall Study||25||
59500711|NCT00654511|75592392|FG003|STARTED|Overall Study||25||
59500712|NCT00654511|75592389|FG000|COMPLETED|Overall Study||26||
59500713|NCT00654511|75592390|FG001|COMPLETED|Overall Study||25||
59500714|NCT00654511|75592391|FG002|COMPLETED|Overall Study||25||
59500715|NCT00654511|75592392|FG003|COMPLETED|Overall Study||25||
59500716|NCT00654511|75592389|FG000|NOT COMPLETED|Overall Study||0||
59500717|NCT00654511|75592390|FG001|NOT COMPLETED|Overall Study||0||
59500718|NCT00654511|75592391|FG002|NOT COMPLETED|Overall Study||0||
59500719|NCT00654511|75592392|FG003|NOT COMPLETED|Overall Study||0||
59500720|NCT02142361|75592406|FG000|STARTED|Overall Study||20||
59500721|NCT02142361|75592407|FG001|STARTED|Overall Study||20||
59500722|NCT02142361|75592408|FG002|STARTED|Overall Study||20||
59500723|NCT02142361|75592406|FG000|COMPLETED|Overall Study||20||
59500724|NCT02142361|75592407|FG001|COMPLETED|Overall Study||20||
59500725|NCT02142361|75592408|FG002|COMPLETED|Overall Study||20||
59500726|NCT02142361|75592406|FG000|NOT COMPLETED|Overall Study||0||
59500727|NCT02142361|75592407|FG001|NOT COMPLETED|Overall Study||0||
59500728|NCT02142361|75592408|FG002|NOT COMPLETED|Overall Study||0||
59500729|NCT00675259|75592419|FG000|STARTED|Overall Study||33||
59500730|NCT00675259|75592419|FG000|COMPLETED|Overall Study||19||
59500731|NCT00675259|75592419|FG000|NOT COMPLETED|Overall Study||14||
59500732|NCT00656305|75592429|FG000|STARTED|Overall Study||87||
59500733|NCT00656305|75592430|FG001|STARTED|Overall Study||28||
59500734|NCT00656305|75592429|FG000|COMPLETED|Overall Study||65||
59500735|NCT00656305|75592430|FG001|COMPLETED|Overall Study||21||
59500736|NCT00656305|75592429|FG000|NOT COMPLETED|Overall Study||22||
59500737|NCT00656305|75592430|FG001|NOT COMPLETED|Overall Study||7||
59500738|NCT00675415|75592438|FG000|STARTED|Overall Study||132||
59500739|NCT00675415|75592439|FG001|STARTED|Overall Study||131||
59500740|NCT00675415|75592438|FG000|COMPLETED|Overall Study||124||
59755003|NCT00812565|75873945|FG000|STARTED|Overall Study||8||
59755004|NCT00812565|75873946|FG001|STARTED|Overall Study||7||
59500741|NCT00675415|75592439|FG001|COMPLETED|Overall Study||123||
59500742|NCT00675415|75592438|FG000|NOT COMPLETED|Overall Study||8||
59500743|NCT00675415|75592439|FG001|NOT COMPLETED|Overall Study||8||
59500744|NCT00676585|75592447|FG000|STARTED|Overall Study||25||
59500745|NCT00676585|75592448|FG001|STARTED|Overall Study||25||
59500746|NCT00676585|75592447|FG000|COMPLETED|Overall Study||25||
59500747|NCT00676585|75592448|FG001|COMPLETED|Overall Study||25||
59500748|NCT00676585|75592447|FG000|NOT COMPLETED|Overall Study||0||
59500749|NCT00676585|75592448|FG001|NOT COMPLETED|Overall Study||0||
59500750|NCT00658411|75592454|FG000|STARTED|Overall Study||5||
59500751|NCT00658411|75592454|FG000|COMPLETED|Overall Study||5||
59500752|NCT00658411|75592454|FG000|NOT COMPLETED|Overall Study||0||
59500753|NCT00676897|75592464|FG000|STARTED|Overall Study||8||
59500754|NCT00676897|75592465|FG001|STARTED|Overall Study||10||
59500755|NCT00676897|75592464|FG000|COMPLETED|Overall Study||8||
59500756|NCT00676897|75592465|FG001|COMPLETED|Overall Study||10||
59500757|NCT00676897|75592464|FG000|NOT COMPLETED|Overall Study||0||
59500758|NCT00676897|75592465|FG001|NOT COMPLETED|Overall Study||0||
59500759|NCT02082392|75592473|FG000|STARTED|Overall Study||2||
59500760|NCT02082392|75592474|FG001|STARTED|Overall Study||1||
59500761|NCT02082392|75592473|FG000|COMPLETED|Overall Study||2||
59500762|NCT02082392|75592474|FG001|COMPLETED|Overall Study||1||
59500763|NCT02082392|75592473|FG000|NOT COMPLETED|Overall Study||0||
59500764|NCT02082392|75592474|FG001|NOT COMPLETED|Overall Study||0||
59885493|NCT03538743|76008296|FG007|NOT COMPLETED|Overall Study||0||
60012930|NCT03660475|76128954|FG000|STARTED|Overall Study||30||
60012931|NCT03660475|76128955|FG001|STARTED|Overall Study||30||
60012932|NCT03660475|76128954|FG000|COMPLETED|Overall Study||30||
60012933|NCT03660475|76128955|FG001|COMPLETED|Overall Study||30||
60012934|NCT03660475|76128954|FG000|NOT COMPLETED|Overall Study||0||
60012935|NCT03660475|76128955|FG001|NOT COMPLETED|Overall Study||0||
60012936|NCT02594735|76128961|FG000|STARTED|Overall Study||10||
60012937|NCT02594735|76128961|FG000|COMPLETED|Overall Study|One patient did not receive Abatacept at week 24 due to worsening pre-existing ILD.|9||
60012938|NCT02594735|76128961|FG000|NOT COMPLETED|Overall Study||1||
60012939|NCT02634151|76128969|FG000|STARTED|Overall Study||53||
60012940|NCT02634151|76128970|FG001|STARTED|Overall Study||52||
60012941|NCT02634151|76128969|FG000|Full Analysis Set|Overall Study||53||
60012942|NCT02634151|76128970|FG001|Full Analysis Set|Overall Study||52||
60012943|NCT02634151|76128969|FG000|Safety Set|Overall Study||54||
60012944|NCT02634151|76128970|FG001|Safety Set|Overall Study||51||
60012945|NCT02634151|76128969|FG000|COMPLETED|Overall Study||52||
60012946|NCT02634151|76128970|FG001|COMPLETED|Overall Study||50||
60012947|NCT02634151|76128969|FG000|NOT COMPLETED|Overall Study||1||
59607319|NCT03808493|75717891|FG003|COMPLETED|Overall Study||12|Here, completed means completion of all periods, that means Period 1, Washout period, and Period 2.|
59607320|NCT03808493|75717888|FG000|NOT COMPLETED|Overall Study||0||
59607321|NCT03808493|75717889|FG001|NOT COMPLETED|Overall Study||0||
60012948|NCT02634151|76128970|FG001|NOT COMPLETED|Overall Study||2||
60012949|NCT01655823|76128981|FG000|STARTED|Overall Study||25||
60012950|NCT01655823|76128982|FG001|STARTED|Overall Study||25||
60012951|NCT01655823|76128983|FG002|STARTED|Overall Study||24||
60012952|NCT01655823|76128984|FG003|STARTED|Overall Study||25||
60012953|NCT01655823|76128985|FG004|STARTED|Overall Study||26||
60012954|NCT01655823|76128981|FG000|COMPLETED|Overall Study||25||
60012955|NCT01655823|76128982|FG001|COMPLETED|Overall Study||23||
60012956|NCT01655823|76128983|FG002|COMPLETED|Overall Study||24||
59607322|NCT03808493|75717890|FG002|NOT COMPLETED|Overall Study||0||
59607323|NCT03808493|75717891|FG003|NOT COMPLETED|Overall Study||0||
59607324|NCT02499887|75717903|FG000|STARTED|Overall Study||3||
59607325|NCT02499887|75717904|FG001|STARTED|Overall Study||3||
59607326|NCT02499887|75717903|FG000|COMPLETED|Overall Study||3||
59607327|NCT02499887|75717904|FG001|COMPLETED|Overall Study||3||
59607328|NCT02499887|75717903|FG000|NOT COMPLETED|Overall Study||0||
59607329|NCT02499887|75717904|FG001|NOT COMPLETED|Overall Study||0||
59607330|NCT02504099|75717910|FG000|STARTED|Overall Study||3||
59607331|NCT02504099|75717910|FG000|COMPLETED|Overall Study||3||
59607332|NCT02504099|75717910|FG000|NOT COMPLETED|Overall Study||0||
59607333|NCT02450591|75717914|FG000|STARTED|Overall Study||4||
59607334|NCT02450591|75717914|FG000|COMPLETED|Overall Study||4||
59607335|NCT02450591|75717914|FG000|NOT COMPLETED|Overall Study||0||
59607336|NCT01094561|75717918|FG000|STARTED|Overall Study||23||
59607337|NCT01094561|75717918|FG000|COMPLETED|Overall Study||17||
59607338|NCT01094561|75717918|FG000|NOT COMPLETED|Overall Study||6||
59607339|NCT01074437|75717924|FG000|STARTED|Overall Study||4||
59607340|NCT01074437|75717925|FG001|STARTED|Overall Study||5||
59607341|NCT01074437|75717924|FG000|COMPLETED|Overall Study||4||
59607342|NCT01074437|75717925|FG001|COMPLETED|Overall Study||5||
59607343|NCT01074437|75717924|FG000|NOT COMPLETED|Overall Study||0||
59607344|NCT01074437|75717925|FG001|NOT COMPLETED|Overall Study||0||
59607345|NCT03807245|75717934|FG000|STARTED|Overall Study||24||
59607346|NCT03807245|75717935|FG001|STARTED|Overall Study||24||
59607347|NCT03807245|75717936|FG002|STARTED|Overall Study||12||
59607348|NCT03807245|75717934|FG000|COMPLETED|Overall Study||23||
59607349|NCT03807245|75717935|FG001|COMPLETED|Overall Study||24||
60012957|NCT01655823|76128984|FG003|COMPLETED|Overall Study||24||
60012958|NCT01655823|76128985|FG004|COMPLETED|Overall Study||25||
60012959|NCT01655823|76128981|FG000|NOT COMPLETED|Overall Study||0||
60012960|NCT01655823|76128982|FG001|NOT COMPLETED|Overall Study||2||
60012961|NCT01655823|76128983|FG002|NOT COMPLETED|Overall Study||0||
60012962|NCT01655823|76128984|FG003|NOT COMPLETED|Overall Study||1||
60012963|NCT01655823|76128985|FG004|NOT COMPLETED|Overall Study||1||
60012964|NCT01360645|76128999|FG000|STARTED|Placebo+ADT Prospective Phase-A(8 Weeks)|826 participants were enrolled but 2 participants discontinued trial before taking study medication.|824||
60012965|NCT01360645|76129000|FG001|STARTED|Placebo+ADT Prospective Phase-A(8 Weeks)||0||
60012966|NCT01360645|76129001|FG002|STARTED|Placebo+ADT Prospective Phase-A(8 Weeks)||0||
60012967|NCT01360645|76129002|FG003|STARTED|Placebo+ADT Prospective Phase-A(8 Weeks)||0||
60012968|NCT01360645|76128999|FG000|COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||710||
59607350|NCT03807245|75717936|FG002|COMPLETED|Overall Study||12||
59607351|NCT03807245|75717934|FG000|NOT COMPLETED|Overall Study||1||
59607352|NCT03807245|75717935|FG001|NOT COMPLETED|Overall Study||0||
59607353|NCT03807245|75717936|FG002|NOT COMPLETED|Overall Study||0||
59607354|NCT02461355|75717944|FG000|STARTED|Overall Study||2||
60012969|NCT01360645|76129000|FG001|COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0||
60012970|NCT01360645|76129001|FG002|COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0||
60012971|NCT01360645|76129002|FG003|COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0||
60012972|NCT01360645|76128999|FG000|NOT COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||114||
60012973|NCT01360645|76129000|FG001|NOT COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0||
59755005|NCT00812565|75873947|FG002|STARTED|Overall Study||7||
59755006|NCT00812565|75873948|FG003|STARTED|Overall Study||7||
59755007|NCT00812565|75873949|FG004|STARTED|Overall Study||7||
59755008|NCT00812565|75873950|FG005|STARTED|Overall Study||7||
59755009|NCT00812565|75873951|FG006|STARTED|Overall Study||8||
59755010|NCT00812565|75873952|FG007|STARTED|Overall Study||7||
59755011|NCT00812565|75873945|FG000|COMPLETED|Overall Study||5||
59755012|NCT00812565|75873946|FG001|COMPLETED|Overall Study||6||
59500765|NCT00678535|75592482|FG000|STARTED|Overall Study|ITT population|455||
59755013|NCT00812565|75873947|FG002|COMPLETED|Overall Study||7||
59755014|NCT00812565|75873948|FG003|COMPLETED|Overall Study||5||
59755015|NCT00812565|75873949|FG004|COMPLETED|Overall Study||6||
59755016|NCT00812565|75873950|FG005|COMPLETED|Overall Study||6||
59755017|NCT00812565|75873951|FG006|COMPLETED|Overall Study||8||
59755018|NCT00812565|75873952|FG007|COMPLETED|Overall Study||6||
59755019|NCT00812565|75873945|FG000|NOT COMPLETED|Overall Study||3||
59755020|NCT00812565|75873946|FG001|NOT COMPLETED|Overall Study||1||
59755021|NCT00812565|75873947|FG002|NOT COMPLETED|Overall Study||0||
59755022|NCT00812565|75873948|FG003|NOT COMPLETED|Overall Study||2||
59755023|NCT00812565|75873949|FG004|NOT COMPLETED|Overall Study||1||
59755024|NCT00812565|75873950|FG005|NOT COMPLETED|Overall Study||1||
59755025|NCT00812565|75873951|FG006|NOT COMPLETED|Overall Study||0||
59755026|NCT00812565|75873952|FG007|NOT COMPLETED|Overall Study||1||
59755027|NCT00812487|75873972|FG000|STARTED|Overall Study||32||
59755028|NCT00812487|75873973|FG001|STARTED|Overall Study||42||
59755029|NCT00812487|75873972|FG000|COMPLETED|Overall Study||26||
59755030|NCT00812487|75873973|FG001|COMPLETED|Overall Study||39||
59755031|NCT00812487|75873972|FG000|NOT COMPLETED|Overall Study||6||
59755032|NCT00812487|75873973|FG001|NOT COMPLETED|Overall Study||3||
59755033|NCT04034043|75873979|FG000|STARTED|Overall Study||68||
59755034|NCT04034043|75873979|FG000|COMPLETED|Overall Study||68||
59755035|NCT04034043|75873979|FG000|NOT COMPLETED|Overall Study||0||
59755036|NCT00617461|75873983|FG000|STARTED|First Treatment Intervention Period|2 par. (1 withdrawal due to inv. discretion, 1 withdrawal by subject) did not take study drug.|52||
59755037|NCT00617461|75873984|FG001|STARTED|First Treatment Intervention Period||44||
59755038|NCT00617461|75873983|FG000|COMPLETED|First Treatment Intervention Period||42||
59755039|NCT00617461|75873984|FG001|COMPLETED|First Treatment Intervention Period||41||
59755040|NCT00617461|75873983|FG000|NOT COMPLETED|First Treatment Intervention Period||10||
59755041|NCT00617461|75873984|FG001|NOT COMPLETED|First Treatment Intervention Period||3||
59755042|NCT00617461|75873983|FG000|STARTED|4-Day Crossover Period||42||
59755043|NCT00617461|75873984|FG001|STARTED|4-Day Crossover Period|One 3600:1200 participant skipped the Crossover period, going directly to second Treatment Period.|40||
59755044|NCT00617461|75873983|FG000|COMPLETED|4-Day Crossover Period||41||
59755045|NCT00617461|75873984|FG001|COMPLETED|4-Day Crossover Period||40||
59755046|NCT00617461|75873983|FG000|NOT COMPLETED|4-Day Crossover Period||1||
59755047|NCT00617461|75873984|FG001|NOT COMPLETED|4-Day Crossover Period||0||
59755048|NCT00617461|75873983|FG000|STARTED|Second Treatment Intervention Period||41||
59500766|NCT00678535|75592483|FG001|STARTED|Overall Study|ITT population|449||
59500767|NCT00678535|75592482|FG000|COMPLETED|Overall Study|subjects who died before or at 31 March 2012|362||
59500768|NCT00678535|75592483|FG001|COMPLETED|Overall Study|subjects who died before or at 31 March 2012|351||
59500769|NCT00678535|75592482|FG000|NOT COMPLETED|Overall Study||93||
59500770|NCT00678535|75592483|FG001|NOT COMPLETED|Overall Study||98||
59500771|NCT00659737|75592491|FG000|STARTED|Overall Study||57||
59755049|NCT00617461|75873984|FG001|STARTED|Second Treatment Intervention Period||41||
59755050|NCT00617461|75873983|FG000|COMPLETED|Second Treatment Intervention Period||41||
59755051|NCT00617461|75873984|FG001|COMPLETED|Second Treatment Intervention Period||37||
59885494|NCT03538743|76008297|FG008|NOT COMPLETED|Overall Study||3||
59885495|NCT03521817|76008327|FG000|STARTED|Overall Study||7||
59885496|NCT03521817|76008328|FG001|STARTED|Overall Study||5||
59885497|NCT03521817|76008327|FG000|COMPLETED|Overall Study||7||
59500772|NCT00659737|75592492|FG001|STARTED|Overall Study||58||
59500773|NCT00659737|75592491|FG000|COMPLETED|Overall Study||57||
59500774|NCT00659737|75592492|FG001|COMPLETED|Overall Study||58||
59500775|NCT00659737|75592491|FG000|NOT COMPLETED|Overall Study||0||
59500776|NCT00659737|75592492|FG001|NOT COMPLETED|Overall Study||0||
59500777|NCT00660049|75592498|FG000|STARTED|Overall Study||12||
59500778|NCT00660049|75592498|FG000|COMPLETED|Overall Study||6||
59500779|NCT00660049|75592498|FG000|NOT COMPLETED|Overall Study||6||
59607355|NCT02461355|75717944|FG000|COMPLETED|Overall Study||2||
59607356|NCT02461355|75717944|FG000|NOT COMPLETED|Overall Study||0||
59607357|NCT02410577|75717948|FG000|STARTED|Overall Study||2||
59607358|NCT02410577|75717948|FG000|COMPLETED|Overall Study||2||
59500780|NCT00680797|75592506|FG000|STARTED|Overall Study||9||
59500781|NCT00680797|75592507|FG001|STARTED|Overall Study||8||
59500782|NCT00680797|75592508|FG002|STARTED|Overall Study||8||
59500783|NCT00680797|75592509|FG003|STARTED|Overall Study||8||
59607359|NCT02410577|75717948|FG000|NOT COMPLETED|Overall Study||0||
59607360|NCT01066637|75717954|FG000|STARTED|Overall Study||16||
59607361|NCT01066637|75717955|FG001|STARTED|Overall Study||10||
59607362|NCT01066637|75717954|FG000|COMPLETED|Overall Study||16||
59607363|NCT01066637|75717955|FG001|COMPLETED|Overall Study||10||
59607364|NCT01066637|75717954|FG000|NOT COMPLETED|Overall Study||0||
59607365|NCT01066637|75717955|FG001|NOT COMPLETED|Overall Study||0||
59607366|NCT03796013|75717963|FG000|STARTED|Period 1||14||
59607367|NCT03796013|75717964|FG001|STARTED|Period 1||14||
59607368|NCT03796013|75717963|FG000|COMPLETED|Period 1||14||
59607369|NCT03796013|75717964|FG001|COMPLETED|Period 1||14||
59607370|NCT03796013|75717963|FG000|NOT COMPLETED|Period 1||0||
59607371|NCT03796013|75717964|FG001|NOT COMPLETED|Period 1||0||
59607372|NCT03796013|75717963|FG000|STARTED|Period 2||14||
59607373|NCT03796013|75717964|FG001|STARTED|Period 2||14||
59607374|NCT03796013|75717963|FG000|COMPLETED|Period 2||14||
59607375|NCT03796013|75717964|FG001|COMPLETED|Period 2||14||
59607376|NCT03796013|75717963|FG000|NOT COMPLETED|Period 2||0||
59755052|NCT00617461|75873983|FG000|NOT COMPLETED|Second Treatment Intervention Period||0||
59755053|NCT00617461|75873984|FG001|NOT COMPLETED|Second Treatment Intervention Period||4||
59755054|NCT00617461|75873983|FG000|STARTED|6-Day Down-Titration Period||41||
59755055|NCT00617461|75873984|FG001|STARTED|6-Day Down-Titration Period||37||
59755056|NCT00617461|75873983|FG000|COMPLETED|6-Day Down-Titration Period||39||
59755057|NCT00617461|75873984|FG001|COMPLETED|6-Day Down-Titration Period||35||
59755058|NCT00617461|75873983|FG000|NOT COMPLETED|6-Day Down-Titration Period||2||
59755059|NCT00617461|75873984|FG001|NOT COMPLETED|6-Day Down-Titration Period||2||
59755060|NCT00812331|75874011|FG000|STARTED|Overall Study||6||
59755061|NCT00812331|75874012|FG001|STARTED|Overall Study||8||
59755062|NCT00812331|75874013|FG002|STARTED|Overall Study||8||
59755063|NCT00812331|75874014|FG003|STARTED|Overall Study||7||
59755064|NCT00812331|75874015|FG004|STARTED|Overall Study||8||
59755065|NCT00812331|75874011|FG000|COMPLETED|Overall Study||5||
59755066|NCT00812331|75874012|FG001|COMPLETED|Overall Study||8||
59755067|NCT00812331|75874013|FG002|COMPLETED|Overall Study||8||
59755068|NCT00812331|75874014|FG003|COMPLETED|Overall Study||7||
59755069|NCT00812331|75874015|FG004|COMPLETED|Overall Study||8||
59755070|NCT00812331|75874011|FG000|NOT COMPLETED|Overall Study||1||
59755071|NCT00812331|75874012|FG001|NOT COMPLETED|Overall Study||0||
59755072|NCT00812331|75874013|FG002|NOT COMPLETED|Overall Study||0||
59755073|NCT00812331|75874014|FG003|NOT COMPLETED|Overall Study||0||
59755074|NCT00812331|75874015|FG004|NOT COMPLETED|Overall Study||0||
59755075|NCT00812253|75874025|FG000|STARTED|Overall Study||32||
59755076|NCT00812253|75874026|FG001|STARTED|Overall Study||42||
59755077|NCT00812253|75874025|FG000|COMPLETED|Overall Study||26||
59755078|NCT00812253|75874026|FG001|COMPLETED|Overall Study||39||
59885498|NCT03521817|76008328|FG001|COMPLETED|Overall Study|1 completer was non adherent based on weekly intervention body weight|4||
59885499|NCT03521817|76008327|FG000|NOT COMPLETED|Overall Study||0||
59885500|NCT03521817|76008328|FG001|NOT COMPLETED|Overall Study||1||
59885501|NCT03538431|76008334|FG000|STARTED|Overall Study||13||
59885502|NCT03538431|76008335|FG001|STARTED|Overall Study||13||
59885503|NCT03538431|76008334|FG000|COMPLETED|Overall Study||12||
59885504|NCT03538431|76008335|FG001|COMPLETED|Overall Study||12||
59885505|NCT03538431|76008334|FG000|NOT COMPLETED|Overall Study||1||
59885506|NCT03538431|76008335|FG001|NOT COMPLETED|Overall Study||1||
59885507|NCT03521193|76008345|FG000|STARTED|Overall Study|enrolled on the PFO closure hospitalization|78||
59885508|NCT03521193|76008346|FG001|STARTED|Overall Study||12||
59885509|NCT03521193|76008345|FG000|COMPLETED|Overall Study|8 pts refused to continue the study; 8 patients were non compliant to ASA treatment|62||
59885510|NCT03521193|76008346|FG001|COMPLETED|Overall Study||12||
59885511|NCT03521193|76008345|FG000|NOT COMPLETED|Overall Study||16||
59885512|NCT03521193|76008346|FG001|NOT COMPLETED|Overall Study||0||
59885513|NCT00293267|76008355|FG000|STARTED|Primary Study - Double-Blind Week 0-48||234||
59500784|NCT00680797|75592506|FG000|COMPLETED|Overall Study||9||
59500785|NCT00680797|75592507|FG001|COMPLETED|Overall Study||8||
59500786|NCT00680797|75592508|FG002|COMPLETED|Overall Study||8||
59500787|NCT00680797|75592509|FG003|COMPLETED|Overall Study||8||
59500788|NCT00680797|75592506|FG000|NOT COMPLETED|Overall Study||0||
59500789|NCT00680797|75592507|FG001|NOT COMPLETED|Overall Study||0||
59500790|NCT00680797|75592508|FG002|NOT COMPLETED|Overall Study||0||
59500791|NCT00680797|75592509|FG003|NOT COMPLETED|Overall Study||0||
59500792|NCT02081456|75592521|FG000|STARTED|Overall Study||11||
59607377|NCT03796013|75717964|FG001|NOT COMPLETED|Period 2||0||
59607378|NCT02399111|75717974|FG000|STARTED|Overall Study||4||
59950953|NCT00571493|76069873|FG004|COMPLETED|Overall Study||11||
59500793|NCT02081456|75592522|FG001|STARTED|Overall Study||12||
59500794|NCT02081456|75592521|FG000|COMPLETED|Overall Study||11||
60012974|NCT01360645|76129001|FG002|NOT COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0||
60012975|NCT01360645|76129002|FG003|NOT COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0||
60012976|NCT01360645|76128999|FG000|STARTED|Phase B (6 Weeks)||0||
60012977|NCT01360645|76129000|FG001|STARTED|Phase B (6 Weeks)||188||
60012978|NCT01360645|76129001|FG002|STARTED|Phase B (6 Weeks)||191||
60012979|NCT01360645|76129002|FG003|STARTED|Phase B (6 Weeks)||0||
60012980|NCT01360645|76128999|FG000|COMPLETED|Phase B (6 Weeks)||0||
59755079|NCT00812253|75874025|FG000|NOT COMPLETED|Overall Study||6||
59755080|NCT00812253|75874026|FG001|NOT COMPLETED|Overall Study||3||
59755081|NCT00616759|75874034|FG000|STARTED|Overall Study||10||
59755082|NCT00616759|75874035|FG001|STARTED|Overall Study||10||
59755083|NCT00616759|75874034|FG000|COMPLETED|Overall Study||7||
59755084|NCT00616759|75874035|FG001|COMPLETED|Overall Study||8||
59755085|NCT00616759|75874034|FG000|NOT COMPLETED|Overall Study||3||
59755086|NCT00616759|75874035|FG001|NOT COMPLETED|Overall Study||2||
59755087|NCT00812097|75874045|FG000|STARTED|Overall Study||572||
59885514|NCT00293267|76008356|FG001|STARTED|Primary Study - Double-Blind Week 0-48||118||
59885515|NCT00293267|76008355|FG000|Treated|Primary Study - Double-Blind Week 0-48||232||
60012981|NCT01360645|76129000|FG001|COMPLETED|Phase B (6 Weeks)||174||
60012982|NCT01360645|76129001|FG002|COMPLETED|Phase B (6 Weeks)||178||
60012983|NCT01360645|76129002|FG003|COMPLETED|Phase B (6 Weeks)||0||
60012984|NCT01360645|76128999|FG000|NOT COMPLETED|Phase B (6 Weeks)||0||
60012985|NCT01360645|76129000|FG001|NOT COMPLETED|Phase B (6 Weeks)||14||
60012986|NCT01360645|76129001|FG002|NOT COMPLETED|Phase B (6 Weeks)||13||
60012987|NCT01360645|76129002|FG003|NOT COMPLETED|Phase B (6 Weeks)||0||
59607379|NCT02399111|75717975|FG001|STARTED|Overall Study||1||
59607380|NCT02399111|75717976|FG002|STARTED|Overall Study||4||
59607381|NCT02399111|75717977|FG003|STARTED|Overall Study||0||
59607382|NCT02399111|75717974|FG000|COMPLETED|Overall Study||4||
59607383|NCT02399111|75717975|FG001|COMPLETED|Overall Study||1||
59607384|NCT02399111|75717976|FG002|COMPLETED|Overall Study||4||
59607385|NCT02399111|75717977|FG003|COMPLETED|Overall Study||0||
59607386|NCT02399111|75717974|FG000|NOT COMPLETED|Overall Study||0||
59607387|NCT02399111|75717975|FG001|NOT COMPLETED|Overall Study||0||
59755088|NCT00812097|75874046|FG001|STARTED|Overall Study||190||
59755089|NCT00812097|75874047|FG002|STARTED|Overall Study||124||
59755090|NCT00812097|75874048|FG003|STARTED|Overall Study||69||
59755091|NCT00812097|75874045|FG000|COMPLETED|Overall Study||327||
59755092|NCT00812097|75874046|FG001|COMPLETED|Overall Study||101||
59755093|NCT00812097|75874047|FG002|COMPLETED|Overall Study||67||
59755094|NCT00812097|75874048|FG003|COMPLETED|Overall Study||34||
59755095|NCT00812097|75874045|FG000|NOT COMPLETED|Overall Study||245||
59885516|NCT00293267|76008356|FG001|Treated|Primary Study - Double-Blind Week 0-48||118||
59885517|NCT00293267|76008355|FG000|Continuing in Double-Blind|Primary Study - Double-Blind Week 0-48|Excludes participants who entered the open-label post virological failure (OLPVF) phase|193||
59885518|NCT00293267|76008356|FG001|Continuing in Double-Blind|Primary Study - Double-Blind Week 0-48||50||
59885519|NCT00293267|76008355|FG000|COMPLETED|Primary Study - Double-Blind Week 0-48||193||
59885520|NCT00293267|76008356|FG001|COMPLETED|Primary Study - Double-Blind Week 0-48||50||
59885521|NCT00293267|76008355|FG000|NOT COMPLETED|Primary Study - Double-Blind Week 0-48||41||
59885522|NCT00293267|76008356|FG001|NOT COMPLETED|Primary Study - Double-Blind Week 0-48||68||
59885523|NCT00293267|76008355|FG000|STARTED|Extension - Double-Blind Week 49-156|2 participants who completed Week 48 did not enter the extension study|191||
60012988|NCT01360645|76128999|FG000|STARTED|Phase A+||0||
60012989|NCT01360645|76129000|FG001|STARTED|Phase A+||0||
60012990|NCT01360645|76129001|FG002|STARTED|Phase A+||0||
59500795|NCT02081456|75592522|FG001|COMPLETED|Overall Study||12||
60012991|NCT01360645|76129002|FG003|STARTED|Phase A+||331||
59500796|NCT02081456|75592521|FG000|NOT COMPLETED|Overall Study||0||
59500797|NCT02081456|75592522|FG001|NOT COMPLETED|Overall Study||0||
59500798|NCT00660517|75592532|FG000|STARTED|Overall Study||153||
59500799|NCT00660517|75592533|FG001|STARTED|Overall Study||152||
59500800|NCT00660517|75592534|FG002|STARTED|Overall Study||151||
59500801|NCT00660517|75592535|FG003|STARTED|Overall Study||151||
59500802|NCT00660517|75592532|FG000|COMPLETED|Overall Study||145||
59500803|NCT00660517|75592533|FG001|COMPLETED|Overall Study||144||
59500804|NCT00660517|75592534|FG002|COMPLETED|Overall Study||144||
59500805|NCT00660517|75592535|FG003|COMPLETED|Overall Study||144||
59500806|NCT00660517|75592532|FG000|NOT COMPLETED|Overall Study||8||
59500807|NCT00660517|75592533|FG001|NOT COMPLETED|Overall Study||8||
59500808|NCT00660517|75592534|FG002|NOT COMPLETED|Overall Study||7||
59500809|NCT00660517|75592535|FG003|NOT COMPLETED|Overall Study||7||
59500810|NCT02141581|75592549|FG000|STARTED|Overall Study||42||
59500811|NCT02141581|75592550|FG001|STARTED|Overall Study||19||
59500812|NCT02141581|75592551|FG002|STARTED|Overall Study||25||
59500813|NCT02141581|75592549|FG000|COMPLETED|Overall Study||42||
59500814|NCT02141581|75592550|FG001|COMPLETED|Overall Study||19||
59500815|NCT02141581|75592551|FG002|COMPLETED|Overall Study||25||
59500816|NCT02141581|75592549|FG000|NOT COMPLETED|Overall Study||0||
59500817|NCT02141581|75592550|FG001|NOT COMPLETED|Overall Study||0||
59500818|NCT02141581|75592551|FG002|NOT COMPLETED|Overall Study||0||
59500819|NCT03991299|75592559|FG000|STARTED|Overall Study||4||
59500820|NCT03991299|75592559|FG000|COMPLETED|Overall Study||0||
59500821|NCT03991299|75592559|FG000|NOT COMPLETED|Overall Study||4||
59607388|NCT02399111|75717976|FG002|NOT COMPLETED|Overall Study||0||
59607389|NCT02399111|75717977|FG003|NOT COMPLETED|Overall Study||0||
59607390|NCT03793751|75717991|FG000|STARTED|Overall Study||60||
59607391|NCT03793751|75717992|FG001|STARTED|Overall Study||60||
59607392|NCT03793751|75717991|FG000|COMPLETED|Overall Study||60||
59607393|NCT03793751|75717992|FG001|COMPLETED|Overall Study||60||
59607394|NCT03793751|75717991|FG000|NOT COMPLETED|Overall Study||0||
59607395|NCT03793751|75717992|FG001|NOT COMPLETED|Overall Study||0||
59607396|NCT01030757|75717998|FG000|STARTED|Overall Study||2||
59607397|NCT01030757|75717998|FG000|COMPLETED|Overall Study||2||
59607398|NCT01030757|75717998|FG000|NOT COMPLETED|Overall Study||0||
59607399|NCT01016561|75718002|FG000|STARTED|Overall Study|Despite all possible efforts to contact the PI/study team, no data are available to be reported|0||
59607400|NCT01016561|75718002|FG000|COMPLETED|Overall Study|Despite all possible efforts to contact the PI/study team, no data are available to be reported|0||
59607401|NCT01016561|75718002|FG000|NOT COMPLETED|Overall Study||0||
59607402|NCT01009931|75718006|FG000|STARTED|Overall Study||1||
59607403|NCT01009931|75718006|FG000|COMPLETED|Overall Study||0||
59607404|NCT01009931|75718006|FG000|NOT COMPLETED|Overall Study||1||
59607405|NCT03792191|75718012|FG000|STARTED|Overall Study||140||
59607406|NCT03792191|75718013|FG001|STARTED|Overall Study||140||
59607407|NCT03792191|75718012|FG000|COMPLETED|Overall Study||140||
59607408|NCT03792191|75718013|FG001|COMPLETED|Overall Study||140||
59607409|NCT03792191|75718012|FG000|NOT COMPLETED|Overall Study||0||
59607410|NCT03792191|75718013|FG001|NOT COMPLETED|Overall Study||0||
59500822|NCT02279667|75592566|FG000|STARTED|Overall Study||6||
59500823|NCT02279667|75592567|FG001|STARTED|Overall Study||6||
59500824|NCT02279667|75592568|FG002|STARTED|Overall Study||6||
59500825|NCT02279667|75592566|FG000|COMPLETED|Overall Study||6||
59500826|NCT02279667|75592567|FG001|COMPLETED|Overall Study||6||
59500827|NCT02279667|75592568|FG002|COMPLETED|Overall Study||6||
59500828|NCT02279667|75592566|FG000|NOT COMPLETED|Overall Study||0||
59500829|NCT02279667|75592567|FG001|NOT COMPLETED|Overall Study||0||
59500830|NCT02279667|75592568|FG002|NOT COMPLETED|Overall Study||0||
59500831|NCT03155373|75592577|FG000|STARTED|Overall Study||50||
59500832|NCT03155373|75592577|FG000|COMPLETED|Overall Study||43||
59500833|NCT03155373|75592577|FG000|NOT COMPLETED|Overall Study||7||
59607411|NCT03791489|75718019|FG000|STARTED|30 Days||30||
59607412|NCT03791489|75718019|FG000|COMPLETED|30 Days||30||
59607413|NCT03791489|75718019|FG000|NOT COMPLETED|30 Days||0||
59607414|NCT03791489|75718019|FG000|STARTED|90 Days (Primary Endpoint)||30||
59755096|NCT00812097|75874046|FG001|NOT COMPLETED|Overall Study||89||
59755097|NCT00812097|75874047|FG002|NOT COMPLETED|Overall Study||57||
59755098|NCT00812097|75874048|FG003|NOT COMPLETED|Overall Study||35||
59755099|NCT00811941|75874060|FG000|STARTED|All Randomised Patients||166||
59755100|NCT00811941|75874061|FG001|STARTED|All Randomised Patients||509||
59755101|NCT00811941|75874060|FG000|COMPLETED|All Randomised Patients||164||
59755102|NCT00811941|75874061|FG001|COMPLETED|All Randomised Patients||501||
59755103|NCT00811941|75874060|FG000|NOT COMPLETED|All Randomised Patients||2||
59755104|NCT00811941|75874061|FG001|NOT COMPLETED|All Randomised Patients||8||
59885524|NCT00293267|76008356|FG001|STARTED|Extension - Double-Blind Week 49-156||50||
59885525|NCT00293267|76008355|FG000|COMPLETED|Extension - Double-Blind Week 49-156||139||
59885526|NCT00293267|76008356|FG001|COMPLETED|Extension - Double-Blind Week 49-156||35||
59885527|NCT00293267|76008355|FG000|NOT COMPLETED|Extension - Double-Blind Week 49-156||52||
59885528|NCT00293267|76008356|FG001|NOT COMPLETED|Extension - Double-Blind Week 49-156||15||
59885529|NCT00293267|76008355|FG000|STARTED|Extension - Open-Label Week 157-240|8 of 139 participants who completed the double-blind phase did not enter this open-label phase|131||
59885530|NCT00293267|76008356|FG001|STARTED|Extension - Open-Label Week 157-240|7 of 35 participants who completed the double-blind phase did not enter this open-label phase|28||
59885531|NCT00293267|76008355|FG000|COMPLETED|Extension - Open-Label Week 157-240||111||
59885532|NCT00293267|76008356|FG001|COMPLETED|Extension - Open-Label Week 157-240||26||
59885533|NCT00293267|76008355|FG000|NOT COMPLETED|Extension - Open-Label Week 157-240||20||
59885534|NCT00293267|76008356|FG001|NOT COMPLETED|Extension - Open-Label Week 157-240||2||
59885535|NCT00293267|76008355|FG000|STARTED|Open-Label Post Virologic Failure Phase|Number of participants who failed treatment and consented to enter the OLPVF phase|48||
59885536|NCT00293267|76008356|FG001|STARTED|Open-Label Post Virologic Failure Phase|Number of participants who failed treatment and consented to enter the OLPVF phase|66||
59885537|NCT00293267|76008355|FG000|COMPLETED|Open-Label Post Virologic Failure Phase||15||
59885538|NCT00293267|76008356|FG001|COMPLETED|Open-Label Post Virologic Failure Phase||29||
59885539|NCT00293267|76008355|FG000|NOT COMPLETED|Open-Label Post Virologic Failure Phase||33||
59885540|NCT00293267|76008356|FG001|NOT COMPLETED|Open-Label Post Virologic Failure Phase||37||
59885541|NCT03520959|76008366|FG000|STARTED|Overall Study||0||
59885542|NCT03520959|76008367|FG001|STARTED|Overall Study||1||
59885543|NCT03520959|76008366|FG000|COMPLETED|Overall Study||0||
59885544|NCT03520959|76008367|FG001|COMPLETED|Overall Study||0||
59885545|NCT03520959|76008366|FG000|NOT COMPLETED|Overall Study||0||
59885546|NCT03520959|76008367|FG001|NOT COMPLETED|Overall Study||1||
59885547|NCT03537261|76008375|FG000|STARTED|Overall Study||41||
59885548|NCT03537261|76008376|FG001|STARTED|Overall Study||39||
59950954|NCT00571493|76069874|FG005|COMPLETED|Overall Study||12||
59500834|NCT01931163|75592581|FG000|STARTED|Overall Study||22||
60012992|NCT01360645|76128999|FG000|COMPLETED|Phase A+||0||
60012993|NCT01360645|76129000|FG001|COMPLETED|Phase A+||0||
60012994|NCT01360645|76129001|FG002|COMPLETED|Phase A+||0||
59755105|NCT00811941|75874060|FG000|STARTED|All Treated Patients||164||
59755106|NCT00811941|75874061|FG001|STARTED|All Treated Patients||501||
59755107|NCT00811941|75874060|FG000|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|112||
59755108|NCT00811941|75874061|FG001|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|310||
59755109|NCT00811941|75874060|FG000|NOT COMPLETED|All Treated Patients||52||
59755110|NCT00811941|75874061|FG001|NOT COMPLETED|All Treated Patients||191||
60012995|NCT01360645|76129002|FG003|COMPLETED|Phase A+||307||
60012996|NCT01360645|76128999|FG000|NOT COMPLETED|Phase A+||0||
60012997|NCT01360645|76129000|FG001|NOT COMPLETED|Phase A+||0||
60012998|NCT01360645|76129001|FG002|NOT COMPLETED|Phase A+||0||
60012999|NCT01360645|76129002|FG003|NOT COMPLETED|Phase A+||24||
60013000|NCT05105711|76129008|FG000|STARTED|Overall Study||21||
60013001|NCT05105711|76129008|FG000|COMPLETED|Overall Study||19||
60013002|NCT05105711|76129008|FG000|NOT COMPLETED|Overall Study||2||
60013003|NCT04336163|76129014|FG000|STARTED|Overall Study||55||
60013004|NCT04336163|76129015|FG001|STARTED|Overall Study||0||
60013005|NCT04336163|76129014|FG000|COMPLETED|Overall Study||0||
60013006|NCT04336163|76129015|FG001|COMPLETED|Overall Study||0||
60013007|NCT04336163|76129014|FG000|NOT COMPLETED|Overall Study||55||
60013008|NCT04336163|76129015|FG001|NOT COMPLETED|Overall Study||0||
60013009|NCT02633527|76129026|FG000|STARTED|Overall Study||24||
60013010|NCT02633527|76129027|FG001|STARTED|Overall Study||48||
60013011|NCT02633527|76129028|FG002|STARTED|Overall Study||50||
60013012|NCT02633527|76129029|FG003|STARTED|Overall Study||49||
60013013|NCT02633527|76129030|FG004|STARTED|Overall Study||51||
60013014|NCT02633527|76129026|FG000|COMPLETED|Overall Study||21||
60013015|NCT02633527|76129027|FG001|COMPLETED|Overall Study||37||
60013016|NCT02633527|76129028|FG002|COMPLETED|Overall Study||33||
60013017|NCT02633527|76129029|FG003|COMPLETED|Overall Study||35||
60013018|NCT02633527|76129030|FG004|COMPLETED|Overall Study||34||
59607415|NCT03791489|75718019|FG000|COMPLETED|90 Days (Primary Endpoint)||30||
59607416|NCT03791489|75718019|FG000|NOT COMPLETED|90 Days (Primary Endpoint)||0||
59607417|NCT03790865|75718026|FG000|STARTED|Overall Study||52||
59607418|NCT03790865|75718027|FG001|STARTED|Overall Study||52||
59607419|NCT03790865|75718028|FG002|STARTED|Overall Study||54||
59607420|NCT03790865|75718026|FG000|COMPLETED|Overall Study||52||
59607421|NCT03790865|75718027|FG001|COMPLETED|Overall Study||50||
59607422|NCT03790865|75718028|FG002|COMPLETED|Overall Study||54||
59607423|NCT03790865|75718026|FG000|NOT COMPLETED|Overall Study||0||
59607424|NCT03790865|75718027|FG001|NOT COMPLETED|Overall Study||2||
59607425|NCT03790865|75718028|FG002|NOT COMPLETED|Overall Study||0||
59607426|NCT00986999|75718036|FG000|STARTED|Overall Study||7||
59607427|NCT00986999|75718036|FG000|COMPLETED|Overall Study||6||
59607428|NCT00986999|75718036|FG000|NOT COMPLETED|Overall Study||1||
59607429|NCT02345369|75718042|FG000|STARTED|Overall Study||0||
59607430|NCT02345369|75718043|FG001|STARTED|Overall Study||0||
59607431|NCT02345369|75718042|FG000|COMPLETED|Overall Study||0||
59755111|NCT00811473|75874069|FG000|STARTED|Overall Study||93||
59755112|NCT00811473|75874070|FG001|STARTED|Overall Study||100||
59755113|NCT00811473|75874069|FG000|COMPLETED|Overall Study||70||
59755114|NCT00811473|75874070|FG001|COMPLETED|Overall Study||74||
59755115|NCT00811473|75874069|FG000|NOT COMPLETED|Overall Study||23||
59755116|NCT00811473|75874070|FG001|NOT COMPLETED|Overall Study||26||
60013019|NCT02633527|76129026|FG000|NOT COMPLETED|Overall Study||3||
60013020|NCT02633527|76129027|FG001|NOT COMPLETED|Overall Study||11||
60013021|NCT02633527|76129028|FG002|NOT COMPLETED|Overall Study||17||
60013022|NCT02633527|76129029|FG003|NOT COMPLETED|Overall Study||14||
60013023|NCT02633527|76129030|FG004|NOT COMPLETED|Overall Study||17||
59607432|NCT02345369|75718043|FG001|COMPLETED|Overall Study||0||
59607433|NCT02345369|75718042|FG000|NOT COMPLETED|Overall Study||0||
59755117|NCT03618420|75874076|FG000|STARTED|Overall Study||50|Study Start and IRB Approval|
59755118|NCT03618420|75874076|FG000|COMPLETED|Overall Study||50||
59755119|NCT03618420|75874076|FG000|NOT COMPLETED|Overall Study||0||
59755120|NCT00617305|75874083|FG000|STARTED|Overall Study||33||
59755121|NCT00617305|75874084|FG001|STARTED|Overall Study||4||
59755122|NCT00617305|75874085|FG002|STARTED|Overall Study||1||
60013024|NCT01667549|76129047|FG000|STARTED|Overall Study|20 dyads=20 infants, 20 mothers|20||
60013025|NCT01667549|76129048|FG001|STARTED|Overall Study|20 dyads=20 infants, 20 mothers|20||
60013026|NCT01667549|76129049|FG002|STARTED|Overall Study|21 dyads=21 infants, 21 mothers|21||
60013027|NCT01667549|76129050|FG003|STARTED|Overall Study|20 dyads= 20 infants, 20 mothers|20||
60013028|NCT01667549|76129051|FG004|STARTED|Overall Study|16 dyads=16 infants, 16 mothers|16||
60013029|NCT01667549|76129047|FG000|COMPLETED|Overall Study|17 dyads=17 infants, 17 mothers|17||
60013030|NCT01667549|76129048|FG001|COMPLETED|Overall Study|15 dyads=15 infants, 15 mothers|15||
60013031|NCT01667549|76129049|FG002|COMPLETED|Overall Study|14 dyads=14 infants, 14 mothers|14||
60013032|NCT01667549|76129050|FG003|COMPLETED|Overall Study|14 dyads= 14 infants, 14 mothers|14||
60013033|NCT01667549|76129051|FG004|COMPLETED|Overall Study|15 dyads=15 infants, 15 mothers|15||
59607434|NCT02345369|75718043|FG001|NOT COMPLETED|Overall Study||0||
59613498|NCT01684722|75724628|FG001|STARTED|Overall Study||289||
59607435|NCT03784001|75718052|FG000|STARTED|Overall Study||46|The number of participants who completed their baseline questionnaire and first list.|
59607436|NCT03784001|75718053|FG001|STARTED|Overall Study||38|The number of participants who completed their baseline questionnaire and first list.|
59607437|NCT03784001|75718054|FG002|STARTED|Overall Study||41|The number of participants who completed their baseline questionnaire and first list.|
59607438|NCT03784001|75718052|FG000|COMPLETED|Overall Study||44||
59607439|NCT03784001|75718053|FG001|COMPLETED|Overall Study||38||
59607440|NCT03784001|75718054|FG002|COMPLETED|Overall Study||40||
59607441|NCT03784001|75718052|FG000|NOT COMPLETED|Overall Study||2||
59607442|NCT03784001|75718053|FG001|NOT COMPLETED|Overall Study||0||
59607443|NCT03784001|75718054|FG002|NOT COMPLETED|Overall Study||1||
59607444|NCT03781037|75718062|FG000|STARTED|Overall Study||18||
59607445|NCT03781037|75718062|FG000|COMPLETED|Overall Study||18||
59755123|NCT00617305|75874083|FG000|Completed 24-week Primary Analysis|Overall Study||31||
59755124|NCT00617305|75874084|FG001|Completed 24-week Primary Analysis|Overall Study||4||
59755125|NCT00617305|75874085|FG002|Completed 24-week Primary Analysis|Overall Study||0||
59755126|NCT00617305|75874083|FG000|COMPLETED|Overall Study||25||
59755127|NCT00617305|75874084|FG001|COMPLETED|Overall Study||4||
59755128|NCT00617305|75874085|FG002|COMPLETED|Overall Study||0||
59755129|NCT00617305|75874083|FG000|NOT COMPLETED|Overall Study||8||
59755130|NCT00617305|75874084|FG001|NOT COMPLETED|Overall Study||0||
59755131|NCT00617305|75874085|FG002|NOT COMPLETED|Overall Study||1||
59755132|NCT00811395|75874102|FG000|STARTED|Initial Treatment (PDY6045 or PDY6046)||41||
59755133|NCT00811395|75874103|FG001|STARTED|Initial Treatment (PDY6045 or PDY6046)|One participant received 7 mg instead of 14 mg as per randomization|37||
59755134|NCT00811395|75874104|FG002|STARTED|Initial Treatment (PDY6045 or PDY6046)||38||
59755135|NCT00811395|75874105|FG003|STARTED|Initial Treatment (PDY6045 or PDY6046)||40||
59755136|NCT00811395|75874106|FG004|STARTED|Initial Treatment (PDY6045 or PDY6046)||42||
59755137|NCT00811395|75874107|FG005|STARTED|Initial Treatment (PDY6045 or PDY6046)||41||
59755138|NCT00811395|75874102|FG000|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6045/NCT00489489 record)|38||
59755139|NCT00811395|75874103|FG001|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6045/NCT00489489 record)|33||
59755140|NCT00811395|75874104|FG002|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6045/NCT00489489 record)|36||
60013034|NCT01667549|76129047|FG000|NOT COMPLETED|Overall Study||3||
60013035|NCT01667549|76129048|FG001|NOT COMPLETED|Overall Study||5||
60013036|NCT01667549|76129049|FG002|NOT COMPLETED|Overall Study||7||
60013037|NCT01667549|76129050|FG003|NOT COMPLETED|Overall Study||6||
60013038|NCT01667549|76129051|FG004|NOT COMPLETED|Overall Study||1||
60013039|NCT04805515|76129070|FG000|STARTED|Overall Study||393||
60013040|NCT04805515|76129071|FG001|STARTED|Overall Study||401||
60013041|NCT04805515|76129070|FG000|Wave 2 Survey|Overall Study||313||
59607446|NCT03781037|75718062|FG000|NOT COMPLETED|Overall Study||0||
59607447|NCT02319005|75718069|FG000|STARTED|Overall Study||140||
59607448|NCT02319005|75718070|FG001|STARTED|Overall Study||66||
59607449|NCT02319005|75718069|FG000|COMPLETED|Overall Study||92||
59755141|NCT00811395|75874105|FG003|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6046/NCT00475865 record)|38||
59755142|NCT00811395|75874106|FG004|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6046/NCT00475865 record)|37||
59755143|NCT00811395|75874107|FG005|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6046/NCT00475865 record)|35||
59755144|NCT00811395|75874102|FG000|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||3||
59755145|NCT00811395|75874103|FG001|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||4||
59755146|NCT00811395|75874104|FG002|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||2||
60013042|NCT04805515|76129071|FG001|Wave 2 Survey|Overall Study||318||
60013043|NCT04805515|76129070|FG000|COMPLETED|Overall Study||290||
60013044|NCT04805515|76129071|FG001|COMPLETED|Overall Study||319||
60013045|NCT04805515|76129070|FG000|NOT COMPLETED|Overall Study||103||
60013046|NCT04805515|76129071|FG001|NOT COMPLETED|Overall Study||82||
60013047|NCT02866643|76129079|FG000|STARTED|Overall Study||48||
60013048|NCT02866643|76129080|FG001|STARTED|Overall Study||47||
60013049|NCT02866643|76129079|FG000|Intent-to-Treat (ITT) Population|Overall Study||38|ITT population includes participants who were randomized and received the Nexplanon implant|
60013050|NCT02866643|76129080|FG001|Intent-to-Treat (ITT) Population|Overall Study||39|ITT population includes participants who were randomized and received the Nexplanon implant|
60013051|NCT02866643|76129079|FG000|Per Protocol Population|Overall Study||35|Received implant at protocol-specified time point|
60013052|NCT02866643|76129080|FG001|Per Protocol Population|Overall Study||35|Received implant at protocol-specified time point|
60013053|NCT02866643|76129079|FG000|COMPLETED|Overall Study||35||
60013054|NCT02866643|76129080|FG001|COMPLETED|Overall Study||35||
60013055|NCT02866643|76129079|FG000|NOT COMPLETED|Overall Study||13||
60013056|NCT02866643|76129080|FG001|NOT COMPLETED|Overall Study||12||
60013057|NCT01672801|76129090|FG000|STARTED|Overall Study||9||
59607450|NCT02319005|75718070|FG001|COMPLETED|Overall Study||51||
59607451|NCT02319005|75718069|FG000|NOT COMPLETED|Overall Study||48||
59607452|NCT02319005|75718070|FG001|NOT COMPLETED|Overall Study||15||
59607453|NCT03784079|75718083|FG000|STARTED|Part 1: Up to Day 24||6||
59607454|NCT03784079|75718084|FG001|STARTED|Part 1: Up to Day 24||6||
59607455|NCT03784079|75718085|FG002|STARTED|Part 1: Up to Day 24||2||
59607456|NCT03784079|75718086|FG003|STARTED|Part 1: Up to Day 24||0||
59607457|NCT03784079|75718087|FG004|STARTED|Part 1: Up to Day 24||0||
59607458|NCT03784079|75718088|FG005|STARTED|Part 1: Up to Day 24||0||
59607459|NCT03784079|75718089|FG006|STARTED|Part 1: Up to Day 24||0||
59607460|NCT03784079|75718083|FG000|COMPLETED|Part 1: Up to Day 24||6||
59607461|NCT03784079|75718084|FG001|COMPLETED|Part 1: Up to Day 24||6||
59607462|NCT03784079|75718085|FG002|COMPLETED|Part 1: Up to Day 24||2||
59607463|NCT03784079|75718086|FG003|COMPLETED|Part 1: Up to Day 24||0||
59607464|NCT03784079|75718087|FG004|COMPLETED|Part 1: Up to Day 24||0||
59607465|NCT03784079|75718088|FG005|COMPLETED|Part 1: Up to Day 24||0||
59607466|NCT03784079|75718089|FG006|COMPLETED|Part 1: Up to Day 24||0||
59607467|NCT03784079|75718083|FG000|NOT COMPLETED|Part 1: Up to Day 24||0||
59607468|NCT03784079|75718084|FG001|NOT COMPLETED|Part 1: Up to Day 24||0||
59607469|NCT03784079|75718085|FG002|NOT COMPLETED|Part 1: Up to Day 24||0||
59607470|NCT03784079|75718086|FG003|NOT COMPLETED|Part 1: Up to Day 24||0||
59607471|NCT03784079|75718087|FG004|NOT COMPLETED|Part 1: Up to Day 24||0||
59607472|NCT03784079|75718088|FG005|NOT COMPLETED|Part 1: Up to Day 24||0||
59607473|NCT03784079|75718089|FG006|NOT COMPLETED|Part 1: Up to Day 24||0||
59607474|NCT03784079|75718083|FG000|STARTED|Part 2: Up to Day 12||0||
59607475|NCT03784079|75718084|FG001|STARTED|Part 2: Up to Day 12||0||
59607476|NCT03784079|75718085|FG002|STARTED|Part 2: Up to Day 12||0||
59607477|NCT03784079|75718086|FG003|STARTED|Part 2: Up to Day 12||6||
59607478|NCT03784079|75718087|FG004|STARTED|Part 2: Up to Day 12||6||
59607479|NCT03784079|75718088|FG005|STARTED|Part 2: Up to Day 12||6||
59607480|NCT03784079|75718089|FG006|STARTED|Part 2: Up to Day 12||2||
59607481|NCT03784079|75718083|FG000|COMPLETED|Part 2: Up to Day 12||0||
59607482|NCT03784079|75718084|FG001|COMPLETED|Part 2: Up to Day 12||0||
59607483|NCT03784079|75718085|FG002|COMPLETED|Part 2: Up to Day 12||0||
59607484|NCT03784079|75718086|FG003|COMPLETED|Part 2: Up to Day 12||6||
59607485|NCT03784079|75718087|FG004|COMPLETED|Part 2: Up to Day 12||6||
59607486|NCT03784079|75718088|FG005|COMPLETED|Part 2: Up to Day 12||6||
59607487|NCT03784079|75718089|FG006|COMPLETED|Part 2: Up to Day 12||2||
59607488|NCT03784079|75718083|FG000|NOT COMPLETED|Part 2: Up to Day 12||0||
59755147|NCT00811395|75874105|FG003|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||2||
59755148|NCT00811395|75874106|FG004|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||5||
59755149|NCT00811395|75874107|FG005|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||6||
59755150|NCT00811395|75874102|FG000|STARTED|Extension Treatment|continued initial treatment|31||
59755151|NCT00811395|75874103|FG001|STARTED|Extension Treatment|continued initial treatment|28||
59755152|NCT00811395|75874104|FG002|STARTED|Extension Treatment|continued initial treatment|27||
59755153|NCT00811395|75874105|FG003|STARTED|Extension Treatment|continued initial treatment|37||
59755154|NCT00811395|75874106|FG004|STARTED|Extension Treatment|continued initial treatment|30||
59755155|NCT00811395|75874107|FG005|STARTED|Extension Treatment|continued initial treatment|29||
59755156|NCT00811395|75874102|FG000|COMPLETED|Extension Treatment|completed 48-week treatment|29||
59755157|NCT00811395|75874103|FG001|COMPLETED|Extension Treatment|completed 48-week treatment|22||
59755158|NCT00811395|75874104|FG002|COMPLETED|Extension Treatment|completed 48-week treatment|24||
59755159|NCT00811395|75874105|FG003|COMPLETED|Extension Treatment|completed 48-week treatment|34||
59755160|NCT00811395|75874106|FG004|COMPLETED|Extension Treatment|completed 48-week treatment|30||
59607489|NCT03784079|75718084|FG001|NOT COMPLETED|Part 2: Up to Day 12||0||
59755161|NCT00811395|75874107|FG005|COMPLETED|Extension Treatment|completed 48-week treatment|27||
59755162|NCT00811395|75874102|FG000|NOT COMPLETED|Extension Treatment||2||
59885549|NCT03537261|76008375|FG000|Completed Baseline Assessment|Overall Study|One participant did not attend the CPI-Parent training but remained in the study.|35||
59885550|NCT03537261|76008376|FG001|Completed Baseline Assessment|Overall Study||28||
59885551|NCT03537261|76008375|FG000|COMPLETED|Overall Study|One participant did not attend the CPI-Parent training but remained in the study.|33||
59885552|NCT03537261|76008376|FG001|COMPLETED|Overall Study||27||
59607490|NCT03784079|75718085|FG002|NOT COMPLETED|Part 2: Up to Day 12||0||
59607491|NCT03784079|75718086|FG003|NOT COMPLETED|Part 2: Up to Day 12||0||
59607492|NCT03784079|75718087|FG004|NOT COMPLETED|Part 2: Up to Day 12||0||
59607493|NCT03784079|75718088|FG005|NOT COMPLETED|Part 2: Up to Day 12||0||
59607494|NCT03784079|75718089|FG006|NOT COMPLETED|Part 2: Up to Day 12||0||
59607495|NCT00983645|75718112|FG000|STARTED|Overall Study||8||
59607496|NCT00983645|75718113|FG001|STARTED|Overall Study||7||
59607497|NCT00983645|75718112|FG000|COMPLETED|Overall Study||8||
59607498|NCT00983645|75718113|FG001|COMPLETED|Overall Study||7||
59607499|NCT00983645|75718112|FG000|NOT COMPLETED|Overall Study||0||
59607500|NCT00983645|75718113|FG001|NOT COMPLETED|Overall Study||0||
59607501|NCT02308475|75718119|FG000|STARTED|Overall Study||2||
59607502|NCT02308475|75718119|FG000|COMPLETED|Overall Study||2||
59607503|NCT02308475|75718119|FG000|NOT COMPLETED|Overall Study||0||
59755163|NCT00811395|75874103|FG001|NOT COMPLETED|Extension Treatment||6||
59755164|NCT00811395|75874104|FG002|NOT COMPLETED|Extension Treatment||3||
59755165|NCT00811395|75874105|FG003|NOT COMPLETED|Extension Treatment||3||
59885553|NCT03537261|76008375|FG000|NOT COMPLETED|Overall Study||8||
59885554|NCT03537261|76008376|FG001|NOT COMPLETED|Overall Study||12||
59885555|NCT03536949|76008384|FG000|STARTED|Overall Study||157||
60013058|NCT01672801|76129091|FG001|STARTED|Overall Study||9||
60013059|NCT01672801|76129090|FG000|COMPLETED|Overall Study||9||
60013060|NCT01672801|76129091|FG001|COMPLETED|Overall Study||8||
60013061|NCT01672801|76129090|FG000|NOT COMPLETED|Overall Study||0||
60013062|NCT01672801|76129091|FG001|NOT COMPLETED|Overall Study||1||
60013063|NCT01655901|76129097|FG000|STARTED|First Intervention (Hour 1)||5||
60013064|NCT01655901|76129098|FG001|STARTED|First Intervention (Hour 1)||5||
60013065|NCT01655901|76129099|FG002|STARTED|First Intervention (Hour 1)||5||
59755166|NCT00811395|75874106|FG004|NOT COMPLETED|Extension Treatment||0||
59755167|NCT00811395|75874107|FG005|NOT COMPLETED|Extension Treatment||2||
59755168|NCT00955409|75874134|FG000|STARTED|Overall Study|Started=Randomized|21||
59755169|NCT00955409|75874135|FG001|STARTED|Overall Study|Started=Randomized|6||
59755170|NCT00955409|75874136|FG002|STARTED|Overall Study|Started=Randomized|41||
59755171|NCT00955409|75874137|FG003|STARTED|Overall Study|Started=Randomized.|25||
60013066|NCT01655901|76129100|FG003|STARTED|First Intervention (Hour 1)||5||
60013067|NCT01655901|76129101|FG004|STARTED|First Intervention (Hour 1)||5||
60013068|NCT01655901|76129102|FG005|STARTED|First Intervention (Hour 1)||5||
59607504|NCT02234687|75718126|FG000|STARTED|Overall Study|Study Terminated. No outcome measures were analyzed|6||
59607505|NCT02234687|75718127|FG001|STARTED|Overall Study||4||
59607506|NCT02234687|75718128|FG002|STARTED|Overall Study||4||
59607507|NCT02234687|75718126|FG000|COMPLETED|Overall Study|Study Terminated. No outcome measures were analyzed|0||
59607508|NCT02234687|75718127|FG001|COMPLETED|Overall Study||0||
59607509|NCT02234687|75718128|FG002|COMPLETED|Overall Study||0||
59607510|NCT02234687|75718126|FG000|NOT COMPLETED|Overall Study||6||
59607511|NCT02234687|75718127|FG001|NOT COMPLETED|Overall Study||4||
59607512|NCT02234687|75718128|FG002|NOT COMPLETED|Overall Study||4||
59607513|NCT00978419|75718138|FG000|STARTED|Overall Study||0||
59607514|NCT00978419|75718139|FG001|STARTED|Overall Study||0||
59607515|NCT00978419|75718138|FG000|COMPLETED|Overall Study||0||
59607516|NCT00978419|75718139|FG001|COMPLETED|Overall Study||0||
59607517|NCT00978419|75718138|FG000|NOT COMPLETED|Overall Study||0||
59607518|NCT00978419|75718139|FG001|NOT COMPLETED|Overall Study||0||
59607519|NCT00957827|75718147|FG000|STARTED|Overall Study||2||
59607520|NCT00957827|75718148|FG001|STARTED|Overall Study||2||
59607521|NCT00957827|75718147|FG000|COMPLETED|Overall Study||2||
59607522|NCT00957827|75718148|FG001|COMPLETED|Overall Study||2||
59607523|NCT00957827|75718147|FG000|NOT COMPLETED|Overall Study||0||
59607524|NCT00957827|75718148|FG001|NOT COMPLETED|Overall Study||0||
59607525|NCT00962429|75718156|FG000|STARTED|Overall Study||0||
59607526|NCT00962429|75718157|FG001|STARTED|Overall Study||0||
59885556|NCT03536949|76008385|FG001|STARTED|Overall Study||77||
59885557|NCT03536949|76008384|FG000|COMPLETED|Overall Study||143||
59885558|NCT03536949|76008385|FG001|COMPLETED|Overall Study||75||
59885559|NCT03536949|76008384|FG000|NOT COMPLETED|Overall Study||14||
60013069|NCT01655901|76129097|FG000|COMPLETED|First Intervention (Hour 1)||5||
60013070|NCT01655901|76129098|FG001|COMPLETED|First Intervention (Hour 1)||5||
60013071|NCT01655901|76129099|FG002|COMPLETED|First Intervention (Hour 1)||5||
60013072|NCT01655901|76129100|FG003|COMPLETED|First Intervention (Hour 1)||5||
60013073|NCT01655901|76129101|FG004|COMPLETED|First Intervention (Hour 1)||5||
59755172|NCT00955409|75874138|FG004|STARTED|Overall Study|Started=Randomized|5||
59755173|NCT00955409|75874139|FG005|STARTED|Overall Study|Started=Randomized|9||
59607527|NCT00962429|75718156|FG000|COMPLETED|Overall Study||0||
59607528|NCT00962429|75718157|FG001|COMPLETED|Overall Study||0||
59607529|NCT00962429|75718156|FG000|NOT COMPLETED|Overall Study||0||
59607530|NCT00962429|75718157|FG001|NOT COMPLETED|Overall Study||0||
59607531|NCT00950183|75718163|FG000|STARTED|Overall Study||36||
59607532|NCT00950183|75718163|FG000|COMPLETED|Overall Study||0||
59607533|NCT00950183|75718163|FG000|NOT COMPLETED|Overall Study||36||
59607534|NCT00949403|75718167|FG000|STARTED|Overall Study||9||
59607535|NCT00949403|75718167|FG000|COMPLETED|Overall Study||9||
59755174|NCT00955409|75874140|FG006|STARTED|Overall Study|Started=Randomized|27||
59755175|NCT00955409|75874141|FG007|STARTED|Overall Study|Started=Randomized|6||
59755176|NCT00955409|75874142|FG008|STARTED|Overall Study|Started=Randomized|16||
59755177|NCT00955409|75874143|FG009|STARTED|Overall Study|Started=Randomized|4||
59755178|NCT00955409|75874134|FG000|Treated|Overall Study||21||
59885560|NCT03536949|76008385|FG001|NOT COMPLETED|Overall Study||2||
59885561|NCT03588741|76008391|FG000|STARTED|Overall Study||1||
59885562|NCT03588741|76008391|FG000|COMPLETED|Overall Study||0||
59885563|NCT03588741|76008391|FG000|NOT COMPLETED|Overall Study||1||
60013074|NCT01655901|76129102|FG005|COMPLETED|First Intervention (Hour 1)||5||
60013075|NCT01655901|76129097|FG000|NOT COMPLETED|First Intervention (Hour 1)||0||
60013076|NCT01655901|76129098|FG001|NOT COMPLETED|First Intervention (Hour 1)||0||
60013077|NCT01655901|76129099|FG002|NOT COMPLETED|First Intervention (Hour 1)||0||
60013078|NCT01655901|76129100|FG003|NOT COMPLETED|First Intervention (Hour 1)||0||
60013079|NCT01655901|76129101|FG004|NOT COMPLETED|First Intervention (Hour 1)||0||
60013080|NCT01655901|76129102|FG005|NOT COMPLETED|First Intervention (Hour 1)||0||
59607536|NCT00949403|75718167|FG000|NOT COMPLETED|Overall Study||0||
59607537|NCT03767153|75718173|FG000|STARTED|Overall Study||14||
60013081|NCT01655901|76129097|FG000|STARTED|Washout (1 Week)||5||
60013082|NCT01655901|76129098|FG001|STARTED|Washout (1 Week)||5||
59885564|NCT00111917|76008397|FG000|STARTED|Overall Study||9||
59607538|NCT03767153|75718174|FG001|STARTED|Overall Study||11||
59607539|NCT03767153|75718173|FG000|COMPLETED|Overall Study||14||
59607540|NCT03767153|75718174|FG001|COMPLETED|Overall Study||11||
59607541|NCT03767153|75718173|FG000|NOT COMPLETED|Overall Study||0||
59607542|NCT03767153|75718174|FG001|NOT COMPLETED|Overall Study||0||
59607543|NCT03766373|75718182|FG000|STARTED|Overall Study||12||
59607544|NCT03766373|75718183|FG001|STARTED|Overall Study||12||
59607545|NCT03766373|75718182|FG000|COMPLETED|Overall Study||12||
59607546|NCT03766373|75718183|FG001|COMPLETED|Overall Study||12||
59607547|NCT03766373|75718182|FG000|NOT COMPLETED|Overall Study||0||
59607548|NCT03766373|75718183|FG001|NOT COMPLETED|Overall Study||0||
59607549|NCT02110277|75718189|FG000|STARTED|Overall Study||2|Two participants enrolled and started but did not complete due to study premature termination.|
59607550|NCT02110277|75718189|FG000|COMPLETED|Overall Study||0|no results obtained. study terminated prematurely.|
59607551|NCT02110277|75718189|FG000|NOT COMPLETED|Overall Study||2||
60013083|NCT01655901|76129099|FG002|STARTED|Washout (1 Week)||5||
60013084|NCT01655901|76129100|FG003|STARTED|Washout (1 Week)||5||
59755179|NCT00955409|75874135|FG001|Treated|Overall Study||6||
59755180|NCT00955409|75874136|FG002|Treated|Overall Study||41||
59755181|NCT00955409|75874137|FG003|Treated|Overall Study||24||
59755182|NCT00955409|75874138|FG004|Treated|Overall Study||5||
59755183|NCT00955409|75874139|FG005|Treated|Overall Study||9||
59755184|NCT00955409|75874140|FG006|Treated|Overall Study||27||
59755185|NCT00955409|75874141|FG007|Treated|Overall Study||6||
59755186|NCT00955409|75874142|FG008|Treated|Overall Study||16||
59755187|NCT00955409|75874143|FG009|Treated|Overall Study||4||
60013085|NCT01655901|76129101|FG004|STARTED|Washout (1 Week)||5||
60013086|NCT01655901|76129102|FG005|STARTED|Washout (1 Week)||5||
59607552|NCT03760913|75718212|FG000|STARTED|Overall Study||17||
59607553|NCT03760913|75718213|FG001|STARTED|Overall Study||3||
59607554|NCT03760913|75718214|FG002|STARTED|Overall Study||6||
59607555|NCT03760913|75718215|FG003|STARTED|Overall Study||3||
59755188|NCT00955409|75874134|FG000|Completed Treatment|Overall Study||12||
59755189|NCT00955409|75874135|FG001|Completed Treatment|Overall Study||5||
60013087|NCT01655901|76129097|FG000|COMPLETED|Washout (1 Week)||5||
60013088|NCT01655901|76129098|FG001|COMPLETED|Washout (1 Week)||5||
60013089|NCT01655901|76129099|FG002|COMPLETED|Washout (1 Week)||5||
60013090|NCT01655901|76129100|FG003|COMPLETED|Washout (1 Week)||5||
59755190|NCT00955409|75874136|FG002|Completed Treatment|Overall Study||15||
60013091|NCT01655901|76129101|FG004|COMPLETED|Washout (1 Week)||5||
60013092|NCT01655901|76129102|FG005|COMPLETED|Washout (1 Week)||5||
59607556|NCT03760913|75718216|FG004|STARTED|Overall Study||6||
59607557|NCT03760913|75718217|FG005|STARTED|Overall Study||3||
59607558|NCT03760913|75718218|FG006|STARTED|Overall Study||6||
59607559|NCT03760913|75718219|FG007|STARTED|Overall Study||3||
59607560|NCT03760913|75718220|FG008|STARTED|Overall Study||3||
59755191|NCT00955409|75874137|FG003|Completed Treatment|Overall Study||17||
59755192|NCT00955409|75874138|FG004|Completed Treatment|Overall Study||3||
59755193|NCT00955409|75874139|FG005|Completed Treatment|Overall Study||7||
59755194|NCT00955409|75874140|FG006|Completed Treatment|Overall Study||4||
59755195|NCT00955409|75874141|FG007|Completed Treatment|Overall Study||3||
59755196|NCT00955409|75874142|FG008|Completed Treatment|Overall Study||2||
59755197|NCT00955409|75874143|FG009|Completed Treatment|Overall Study||4||
59755198|NCT00955409|75874134|FG000|COMPLETED|Overall Study|Completed study|11||
59755199|NCT00955409|75874135|FG001|COMPLETED|Overall Study|Completed study|5||
59755200|NCT00955409|75874136|FG002|COMPLETED|Overall Study|Completed study|15||
59755201|NCT00955409|75874137|FG003|COMPLETED|Overall Study|Completed study|17||
59755202|NCT00955409|75874138|FG004|COMPLETED|Overall Study|Completed study|3||
59755203|NCT00955409|75874139|FG005|COMPLETED|Overall Study|Completed study|6||
59755204|NCT00955409|75874140|FG006|COMPLETED|Overall Study|Completed study|3||
59755205|NCT00955409|75874141|FG007|COMPLETED|Overall Study|Completed study|2||
59755206|NCT00955409|75874142|FG008|COMPLETED|Overall Study|Completed study|2||
59755207|NCT00955409|75874143|FG009|COMPLETED|Overall Study|Completed study|3||
59755208|NCT00955409|75874134|FG000|NOT COMPLETED|Overall Study||10||
59755209|NCT00955409|75874135|FG001|NOT COMPLETED|Overall Study||1||
59755210|NCT00955409|75874136|FG002|NOT COMPLETED|Overall Study||26||
59755211|NCT00955409|75874137|FG003|NOT COMPLETED|Overall Study||8||
59755212|NCT00955409|75874138|FG004|NOT COMPLETED|Overall Study||2||
59755213|NCT00955409|75874139|FG005|NOT COMPLETED|Overall Study||3||
59755214|NCT00955409|75874140|FG006|NOT COMPLETED|Overall Study||24||
59755215|NCT00955409|75874141|FG007|NOT COMPLETED|Overall Study||4||
59755216|NCT00955409|75874142|FG008|NOT COMPLETED|Overall Study||14||
59755217|NCT00955409|75874143|FG009|NOT COMPLETED|Overall Study||1||
59755218|NCT00615901|75874169|FG000|STARTED|Overall Study||38||
59755219|NCT00615901|75874169|FG000|COMPLETED|Overall Study||29||
59755220|NCT00615901|75874169|FG000|NOT COMPLETED|Overall Study||9||
59755221|NCT03842683|75874173|FG000|STARTED|Overall Study||472||
59755222|NCT03842683|75874173|FG000|COMPLETED|Overall Study||472||
59755223|NCT03842683|75874173|FG000|NOT COMPLETED|Overall Study||0||
59755224|NCT00616603|75874181|FG000|STARTED|Overall Study||14||
60013093|NCT01655901|76129097|FG000|NOT COMPLETED|Washout (1 Week)||0||
60013094|NCT01655901|76129098|FG001|NOT COMPLETED|Washout (1 Week)||0||
60013095|NCT01655901|76129099|FG002|NOT COMPLETED|Washout (1 Week)||0||
59755225|NCT00616603|75874182|FG001|STARTED|Overall Study||14||
59755226|NCT00616603|75874183|FG002|STARTED|Overall Study||15||
59755227|NCT00616603|75874181|FG000|COMPLETED|Overall Study||12||
59755228|NCT00616603|75874182|FG001|COMPLETED|Overall Study||14||
59755229|NCT00616603|75874183|FG002|COMPLETED|Overall Study||13||
59755230|NCT00616603|75874181|FG000|NOT COMPLETED|Overall Study||2||
59755231|NCT00616603|75874182|FG001|NOT COMPLETED|Overall Study||0||
60013096|NCT01655901|76129100|FG003|NOT COMPLETED|Washout (1 Week)||0||
60013097|NCT01655901|76129101|FG004|NOT COMPLETED|Washout (1 Week)||0||
60013098|NCT01655901|76129102|FG005|NOT COMPLETED|Washout (1 Week)||0||
60013099|NCT01655901|76129097|FG000|STARTED|Second Intervention (Hour 2)||5||
59755232|NCT00616603|75874183|FG002|NOT COMPLETED|Overall Study||2||
59755233|NCT00573313|75874195|FG000|STARTED|Overall Study|Eighteen participants recruited to start.|18||
59755234|NCT00573313|75874196|FG001|STARTED|Overall Study||28||
59755235|NCT00573313|75874197|FG002|STARTED|Overall Study|Nineteen recruited to start.|19||
59755236|NCT00573313|75874198|FG003|STARTED|Overall Study||26||
59755237|NCT00573313|75874195|FG000|COMPLETED|Overall Study||13||
59755238|NCT00573313|75874196|FG001|COMPLETED|Overall Study||28||
59755239|NCT00573313|75874197|FG002|COMPLETED|Overall Study||13||
59755240|NCT00573313|75874198|FG003|COMPLETED|Overall Study||26||
59755241|NCT00573313|75874195|FG000|NOT COMPLETED|Overall Study||5||
59755242|NCT00573313|75874196|FG001|NOT COMPLETED|Overall Study||0||
59755243|NCT00573313|75874197|FG002|NOT COMPLETED|Overall Study||6||
59755244|NCT00573313|75874198|FG003|NOT COMPLETED|Overall Study||0||
59755245|NCT00953615|75874205|FG000|STARTED|Overall Study||1||
59755246|NCT00953615|75874205|FG000|COMPLETED|Overall Study||0||
59755247|NCT00953615|75874205|FG000|NOT COMPLETED|Overall Study||1||
59755248|NCT00810615|75874211|FG000|STARTED|Overall Study||25||
59755249|NCT00810615|75874212|FG001|STARTED|Overall Study||25||
59755250|NCT00810615|75874211|FG000|COMPLETED|Overall Study|One male withdrawal due to personal reasons.|24||
59755251|NCT00810615|75874212|FG001|COMPLETED|Overall Study|One male withdrawal due to personal reasons.|24||
59755252|NCT00810615|75874211|FG000|NOT COMPLETED|Overall Study||1||
59755253|NCT00810615|75874212|FG001|NOT COMPLETED|Overall Study||1||
59755254|NCT00573391|75874232|FG000|STARTED|Overall Study||3||
59755255|NCT00573391|75874233|FG001|STARTED|Overall Study||2||
59755256|NCT00573391|75874232|FG000|COMPLETED|Overall Study||0||
59755257|NCT00573391|75874233|FG001|COMPLETED|Overall Study||0||
59755258|NCT00573391|75874232|FG000|NOT COMPLETED|Overall Study||3||
59755259|NCT00573391|75874233|FG001|NOT COMPLETED|Overall Study||2||
59755260|NCT00590967|75874241|FG000|STARTED|Overall Study||44||
59755261|NCT00590967|75874242|FG001|STARTED|Overall Study||25||
59755262|NCT00590967|75874241|FG000|COMPLETED|Overall Study||41||
59755263|NCT00590967|75874242|FG001|COMPLETED|Overall Study||20||
59755264|NCT00590967|75874241|FG000|NOT COMPLETED|Overall Study||3||
59755265|NCT00590967|75874242|FG001|NOT COMPLETED|Overall Study||5||
59755266|NCT06076694|75874253|FG000|STARTED|Overall Study||20||
59755267|NCT06076694|75874254|FG001|STARTED|Overall Study||20||
59755268|NCT06076694|75874255|FG002|STARTED|Overall Study||10||
59755269|NCT06076694|75874256|FG003|STARTED|Overall Study||10||
59755270|NCT06076694|75874257|FG004|STARTED|Overall Study||20||
59755271|NCT06076694|75874253|FG000|COMPLETED|Overall Study||19||
59755272|NCT06076694|75874254|FG001|COMPLETED|Overall Study||18||
59755273|NCT06076694|75874255|FG002|COMPLETED|Overall Study||10||
59755274|NCT06076694|75874256|FG003|COMPLETED|Overall Study||10||
59755275|NCT06076694|75874257|FG004|COMPLETED|Overall Study||20||
59755276|NCT06076694|75874253|FG000|NOT COMPLETED|Overall Study||1||
59755277|NCT06076694|75874254|FG001|NOT COMPLETED|Overall Study||2||
59755278|NCT06076694|75874255|FG002|NOT COMPLETED|Overall Study||0||
59755279|NCT06076694|75874256|FG003|NOT COMPLETED|Overall Study||0||
59755280|NCT06076694|75874257|FG004|NOT COMPLETED|Overall Study||0||
59755281|NCT05102162|75874271|FG000|STARTED|Overall Study||19||
59755282|NCT05102162|75874272|FG001|STARTED|Overall Study||16||
59755283|NCT05102162|75874271|FG000|COMPLETED|Overall Study||5||
59755284|NCT05102162|75874272|FG001|COMPLETED|Overall Study||13||
59755285|NCT05102162|75874271|FG000|NOT COMPLETED|Overall Study||14||
59755286|NCT05102162|75874272|FG001|NOT COMPLETED|Overall Study||3||
59755287|NCT04899349|75874280|FG000|STARTED|Overall Study||2||
59755288|NCT04899349|75874281|FG001|STARTED|Overall Study||0||
59755289|NCT04899349|75874280|FG000|COMPLETED|Overall Study||0||
59755290|NCT04899349|75874281|FG001|COMPLETED|Overall Study||0||
59755291|NCT04899349|75874280|FG000|NOT COMPLETED|Overall Study||2||
59755292|NCT04899349|75874281|FG001|NOT COMPLETED|Overall Study||0||
59755293|NCT04891107|75874287|FG000|STARTED|Overall Study||26||
59755294|NCT04891107|75874287|FG000|COMPLETED|Overall Study||23||
59755295|NCT04891107|75874287|FG000|NOT COMPLETED|Overall Study||3||
59755296|NCT04848220|75874294|FG000|STARTED|Overall Study||10||
59755297|NCT04848220|75874295|FG001|STARTED|Overall Study||10||
59755298|NCT04848220|75874296|FG002|STARTED|Overall Study||9||
59755299|NCT04848220|75874294|FG000|Treated|Overall Study||10||
60013100|NCT01655901|76129098|FG001|STARTED|Second Intervention (Hour 2)||5||
60013101|NCT01655901|76129099|FG002|STARTED|Second Intervention (Hour 2)||5||
60013102|NCT01655901|76129100|FG003|STARTED|Second Intervention (Hour 2)||5||
60013103|NCT01655901|76129101|FG004|STARTED|Second Intervention (Hour 2)||5||
60013104|NCT01655901|76129102|FG005|STARTED|Second Intervention (Hour 2)||5||
60013105|NCT01655901|76129097|FG000|COMPLETED|Second Intervention (Hour 2)||5||
60013106|NCT01655901|76129098|FG001|COMPLETED|Second Intervention (Hour 2)||5||
60013107|NCT01655901|76129099|FG002|COMPLETED|Second Intervention (Hour 2)||5||
60013108|NCT01655901|76129100|FG003|COMPLETED|Second Intervention (Hour 2)||5||
60013109|NCT01655901|76129101|FG004|COMPLETED|Second Intervention (Hour 2)||5||
60013110|NCT01655901|76129102|FG005|COMPLETED|Second Intervention (Hour 2)||5||
60013111|NCT01655901|76129097|FG000|NOT COMPLETED|Second Intervention (Hour 2)||0||
60013112|NCT01655901|76129098|FG001|NOT COMPLETED|Second Intervention (Hour 2)||0||
60013113|NCT01655901|76129099|FG002|NOT COMPLETED|Second Intervention (Hour 2)||0||
60013114|NCT01655901|76129100|FG003|NOT COMPLETED|Second Intervention (Hour 2)||0||
60013115|NCT01655901|76129101|FG004|NOT COMPLETED|Second Intervention (Hour 2)||0||
59607561|NCT03760913|75718221|FG009|STARTED|Overall Study||6||
59607562|NCT03760913|75718222|FG010|STARTED|Overall Study||6||
59607563|NCT03760913|75718223|FG011|STARTED|Overall Study||6||
59607564|NCT03760913|75718224|FG012|STARTED|Overall Study||12||
59607565|NCT03760913|75718225|FG013|STARTED|Overall Study||6||
59607566|NCT03760913|75718226|FG014|STARTED|Overall Study||6||
59607567|NCT03760913|75718227|FG015|STARTED|Overall Study||6||
59607568|NCT03760913|75718228|FG016|STARTED|Overall Study||6||
59607569|NCT03760913|75718229|FG017|STARTED|Overall Study||6||
59607570|NCT03760913|75718230|FG018|STARTED|Overall Study||6||
59607571|NCT03760913|75718212|FG000|COMPLETED|Overall Study||17||
59607572|NCT03760913|75718213|FG001|COMPLETED|Overall Study||3||
59607573|NCT03760913|75718214|FG002|COMPLETED|Overall Study||6||
59607574|NCT03760913|75718215|FG003|COMPLETED|Overall Study||3||
59607575|NCT03760913|75718216|FG004|COMPLETED|Overall Study||6||
59607576|NCT03760913|75718217|FG005|COMPLETED|Overall Study||3||
59607577|NCT03760913|75718218|FG006|COMPLETED|Overall Study||6||
59607578|NCT03760913|75718219|FG007|COMPLETED|Overall Study||3||
59607579|NCT03760913|75718220|FG008|COMPLETED|Overall Study||3||
59607580|NCT03760913|75718221|FG009|COMPLETED|Overall Study||6||
59755300|NCT04848220|75874295|FG001|Treated|Overall Study||8||
59755301|NCT04848220|75874296|FG002|Treated|Overall Study||9||
59755302|NCT04848220|75874294|FG000|COMPLETED|Overall Study||10||
59755303|NCT04848220|75874295|FG001|COMPLETED|Overall Study||8||
59755304|NCT04848220|75874296|FG002|COMPLETED|Overall Study||9||
59755305|NCT04848220|75874294|FG000|NOT COMPLETED|Overall Study||0||
60013116|NCT01655901|76129102|FG005|NOT COMPLETED|Second Intervention (Hour 2)||0||
60013117|NCT01655901|76129097|FG000|STARTED|Washout (1 Week)||5||
60013118|NCT01655901|76129098|FG001|STARTED|Washout (1 Week)||5||
60013119|NCT01655901|76129099|FG002|STARTED|Washout (1 Week)||5||
60013120|NCT01655901|76129100|FG003|STARTED|Washout (1 Week)||5||
60013121|NCT01655901|76129101|FG004|STARTED|Washout (1 Week)||5||
60013122|NCT01655901|76129102|FG005|STARTED|Washout (1 Week)||5||
60013123|NCT01655901|76129097|FG000|COMPLETED|Washout (1 Week)||5||
60013124|NCT01655901|76129098|FG001|COMPLETED|Washout (1 Week)||5||
60013125|NCT01655901|76129099|FG002|COMPLETED|Washout (1 Week)||5||
60013126|NCT01655901|76129100|FG003|COMPLETED|Washout (1 Week)||5||
60013127|NCT01655901|76129101|FG004|COMPLETED|Washout (1 Week)||5||
60013128|NCT01655901|76129102|FG005|COMPLETED|Washout (1 Week)||5||
59607581|NCT03760913|75718222|FG010|COMPLETED|Overall Study||6||
59607582|NCT03760913|75718223|FG011|COMPLETED|Overall Study||6||
59607583|NCT03760913|75718224|FG012|COMPLETED|Overall Study||12||
59607584|NCT03760913|75718225|FG013|COMPLETED|Overall Study||6||
59607585|NCT03760913|75718226|FG014|COMPLETED|Overall Study||6||
59755306|NCT04848220|75874295|FG001|NOT COMPLETED|Overall Study||2||
59755307|NCT04848220|75874296|FG002|NOT COMPLETED|Overall Study||0||
59607586|NCT03760913|75718227|FG015|COMPLETED|Overall Study||6||
59607587|NCT03760913|75718228|FG016|COMPLETED|Overall Study||6||
59607588|NCT03760913|75718229|FG017|COMPLETED|Overall Study||6||
59607589|NCT03760913|75718230|FG018|COMPLETED|Overall Study||6||
59607590|NCT03760913|75718212|FG000|NOT COMPLETED|Overall Study||0||
59607591|NCT03760913|75718213|FG001|NOT COMPLETED|Overall Study||0||
59607592|NCT03760913|75718214|FG002|NOT COMPLETED|Overall Study||0||
59607593|NCT03760913|75718215|FG003|NOT COMPLETED|Overall Study||0||
59607594|NCT03760913|75718216|FG004|NOT COMPLETED|Overall Study||0||
59607595|NCT03760913|75718217|FG005|NOT COMPLETED|Overall Study||0||
59607596|NCT03760913|75718218|FG006|NOT COMPLETED|Overall Study||0||
59607597|NCT03760913|75718219|FG007|NOT COMPLETED|Overall Study||0||
59607598|NCT03760913|75718220|FG008|NOT COMPLETED|Overall Study||0||
59607599|NCT03760913|75718221|FG009|NOT COMPLETED|Overall Study||0||
59607600|NCT03760913|75718222|FG010|NOT COMPLETED|Overall Study||0||
59755308|NCT04743804|75874306|FG000|STARTED|Overall Study||9||
59755309|NCT04743804|75874307|FG001|STARTED|Overall Study||7||
59755310|NCT04743804|75874306|FG000|Received at Least 1 Dose of Study Drug|Overall Study||9||
59755311|NCT04743804|75874307|FG001|Received at Least 1 Dose of Study Drug|Overall Study||7||
60013129|NCT01655901|76129097|FG000|NOT COMPLETED|Washout (1 Week)||0||
60013130|NCT01655901|76129098|FG001|NOT COMPLETED|Washout (1 Week)||0||
60013131|NCT01655901|76129099|FG002|NOT COMPLETED|Washout (1 Week)||0||
60013132|NCT01655901|76129100|FG003|NOT COMPLETED|Washout (1 Week)||0||
60013133|NCT01655901|76129101|FG004|NOT COMPLETED|Washout (1 Week)||0||
60013134|NCT01655901|76129102|FG005|NOT COMPLETED|Washout (1 Week)||0||
59607601|NCT03760913|75718223|FG011|NOT COMPLETED|Overall Study||0||
59607602|NCT03760913|75718224|FG012|NOT COMPLETED|Overall Study||0||
59607603|NCT03760913|75718225|FG013|NOT COMPLETED|Overall Study||0||
59607604|NCT03760913|75718226|FG014|NOT COMPLETED|Overall Study||0||
59607605|NCT03760913|75718227|FG015|NOT COMPLETED|Overall Study||0||
59607606|NCT03760913|75718228|FG016|NOT COMPLETED|Overall Study||0||
59607607|NCT03760913|75718229|FG017|NOT COMPLETED|Overall Study||0||
59607608|NCT03760913|75718230|FG018|NOT COMPLETED|Overall Study||0||
59607609|NCT00920309|75718283|FG000|STARTED|Overall Study||14||
59755312|NCT04743804|75874306|FG000|COMPLETED|Overall Study||4||
59755313|NCT04743804|75874307|FG001|COMPLETED|Overall Study||1||
59755314|NCT04743804|75874306|FG000|NOT COMPLETED|Overall Study||5||
59755315|NCT04743804|75874307|FG001|NOT COMPLETED|Overall Study||6||
59755316|NCT04659161|75874315|FG000|STARTED|Overall Study||126||
59755317|NCT04659161|75874316|FG001|STARTED|Overall Study||126||
59755318|NCT04659161|75874315|FG000|COMPLETED|Overall Study||94||
59755319|NCT04659161|75874316|FG001|COMPLETED|Overall Study||100||
59755320|NCT04659161|75874315|FG000|NOT COMPLETED|Overall Study||32||
60013135|NCT01655901|76129097|FG000|STARTED|Third Intervention (Hour 3)||5||
60013136|NCT01655901|76129098|FG001|STARTED|Third Intervention (Hour 3)||5||
59500835|NCT01931163|75592581|FG000|COMPLETED|Overall Study||22||
59500836|NCT01931163|75592581|FG000|NOT COMPLETED|Overall Study||0||
59500837|NCT03815006|75592587|FG000|STARTED|Overall Study||78||
59500838|NCT03815006|75592588|FG001|STARTED|Overall Study||78||
59500839|NCT03815006|75592587|FG000|COMPLETED|Overall Study||78||
59500840|NCT03815006|75592588|FG001|COMPLETED|Overall Study||78||
59500841|NCT03815006|75592587|FG000|NOT COMPLETED|Overall Study||0||
59500842|NCT03815006|75592588|FG001|NOT COMPLETED|Overall Study||0||
59607610|NCT00920309|75718284|FG001|STARTED|Overall Study||7||
59607611|NCT00920309|75718283|FG000|COMPLETED|Overall Study||14||
59607612|NCT00920309|75718284|FG001|COMPLETED|Overall Study||7||
59607613|NCT00920309|75718283|FG000|NOT COMPLETED|Overall Study||0||
59607614|NCT00920309|75718284|FG001|NOT COMPLETED|Overall Study||0||
59755321|NCT04659161|75874316|FG001|NOT COMPLETED|Overall Study||26||
59755322|NCT04640766|75874322|FG000|STARTED|Overall Study||9||
59755323|NCT04640766|75874322|FG000|COMPLETED|Overall Study||7||
59755324|NCT04640766|75874322|FG000|NOT COMPLETED|Overall Study||2||
59755325|NCT04214288|75874330|FG000|STARTED|Overall Study||74||
59755326|NCT04214288|75874331|FG001|STARTED|Overall Study||73||
60013137|NCT01655901|76129099|FG002|STARTED|Third Intervention (Hour 3)||5||
60013138|NCT01655901|76129100|FG003|STARTED|Third Intervention (Hour 3)||5||
60013139|NCT01655901|76129101|FG004|STARTED|Third Intervention (Hour 3)||5||
60013140|NCT01655901|76129102|FG005|STARTED|Third Intervention (Hour 3)||5||
59755327|NCT04214288|75874332|FG002|STARTED|Overall Study||20||
59755328|NCT04214288|75874333|FG003|STARTED|Overall Study||73||
59755329|NCT04214288|75874330|FG000|COMPLETED|Overall Study||0||
59755330|NCT04214288|75874331|FG001|COMPLETED|Overall Study||0||
59755331|NCT04214288|75874332|FG002|COMPLETED|Overall Study||0||
59755332|NCT04214288|75874333|FG003|COMPLETED|Overall Study||0||
59500843|NCT03874754|75592596|FG000|STARTED|Overall Study||22||
59500844|NCT03874754|75592597|FG001|STARTED|Overall Study||12||
59500845|NCT03874754|75592596|FG000|COMPLETED|Overall Study||14||
59500846|NCT03874754|75592597|FG001|COMPLETED|Overall Study||6||
59500847|NCT03874754|75592596|FG000|NOT COMPLETED|Overall Study||8||
59500848|NCT03874754|75592597|FG001|NOT COMPLETED|Overall Study||6||
59500849|NCT03869450|75592607|FG000|STARTED|Overall Study||31||
59607615|NCT00928499|75718293|FG000|STARTED|Overall Study||18||
59607616|NCT00928499|75718294|FG001|STARTED|Overall Study||14||
59607617|NCT00928499|75718293|FG000|COMPLETED|Overall Study||18||
59607618|NCT00928499|75718294|FG001|COMPLETED|Overall Study||14||
59607619|NCT00928499|75718293|FG000|NOT COMPLETED|Overall Study||0||
59607620|NCT00928499|75718294|FG001|NOT COMPLETED|Overall Study||0||
59607621|NCT02109809|75718300|FG000|STARTED|Overall Study||4||
59607622|NCT02109809|75718300|FG000|COMPLETED|Overall Study||1||
59755333|NCT04214288|75874330|FG000|NOT COMPLETED|Overall Study||74||
59500850|NCT03869450|75592608|FG001|STARTED|Overall Study||25||
59500851|NCT03869450|75592609|FG002|STARTED|Overall Study||34||
59500852|NCT03869450|75592607|FG000|COMPLETED|Overall Study||30||
59755334|NCT04214288|75874331|FG001|NOT COMPLETED|Overall Study||73||
60013141|NCT01655901|76129097|FG000|COMPLETED|Third Intervention (Hour 3)||4||
59500853|NCT03869450|75592608|FG001|COMPLETED|Overall Study||23||
59500854|NCT03869450|75592609|FG002|COMPLETED|Overall Study||34||
59500855|NCT03869450|75592607|FG000|NOT COMPLETED|Overall Study||1||
60013142|NCT01655901|76129098|FG001|COMPLETED|Third Intervention (Hour 3)||4||
60013143|NCT01655901|76129099|FG002|COMPLETED|Third Intervention (Hour 3)||4||
60013144|NCT01655901|76129100|FG003|COMPLETED|Third Intervention (Hour 3)||5||
60013145|NCT01655901|76129101|FG004|COMPLETED|Third Intervention (Hour 3)||4||
60013146|NCT01655901|76129102|FG005|COMPLETED|Third Intervention (Hour 3)||5||
60013147|NCT01655901|76129097|FG000|NOT COMPLETED|Third Intervention (Hour 3)||1||
60013148|NCT01655901|76129098|FG001|NOT COMPLETED|Third Intervention (Hour 3)||1||
60013149|NCT01655901|76129099|FG002|NOT COMPLETED|Third Intervention (Hour 3)||1||
60013150|NCT01655901|76129100|FG003|NOT COMPLETED|Third Intervention (Hour 3)||0||
60013151|NCT01655901|76129101|FG004|NOT COMPLETED|Third Intervention (Hour 3)||1||
60013152|NCT01655901|76129102|FG005|NOT COMPLETED|Third Intervention (Hour 3)||0||
60013153|NCT01656759|76129113|FG000|STARTED|Overall Study||27||
60013154|NCT01656759|76129114|FG001|STARTED|Overall Study||25||
60013155|NCT01656759|76129113|FG000|COMPLETED|Overall Study||25||
60013156|NCT01656759|76129114|FG001|COMPLETED|Overall Study||22||
60013157|NCT01656759|76129113|FG000|NOT COMPLETED|Overall Study||2||
60013158|NCT01656759|76129114|FG001|NOT COMPLETED|Overall Study||3||
60013159|NCT02631577|76129122|FG000|STARTED|Overall Study||4||
60013160|NCT02631577|76129123|FG001|STARTED|Overall Study||34||
60013161|NCT02631577|76129122|FG000|COMPLETED|Overall Study||3||
60013162|NCT02631577|76129123|FG001|COMPLETED|Overall Study||24||
60013163|NCT02631577|76129122|FG000|NOT COMPLETED|Overall Study||1||
60013164|NCT02631577|76129123|FG001|NOT COMPLETED|Overall Study||10||
60013165|NCT01667081|76129131|FG000|STARTED|Overall Study||1909||
60013166|NCT01667081|76129132|FG001|STARTED|Overall Study||526||
60013167|NCT01667081|76129131|FG000|COMPLETED|Overall Study||132||
60013168|NCT01667081|76129132|FG001|COMPLETED|Overall Study||169||
60013169|NCT01667081|76129131|FG000|NOT COMPLETED|Overall Study||1777||
60013170|NCT01667081|76129132|FG001|NOT COMPLETED|Overall Study||357||
60013171|NCT04545619|76129149|FG000|STARTED|Overall Study||40||
60013172|NCT04545619|76129149|FG000|QDOT nGEN Catheter Inserted|Overall Study||39||
60013173|NCT04545619|76129149|FG000|COMPLETED|Overall Study||39||
60013174|NCT04545619|76129149|FG000|NOT COMPLETED|Overall Study||1||
60013175|NCT02518971|76129155|FG000|STARTED|Overall Study||87||
60013176|NCT02518971|76129156|FG001|STARTED|Overall Study||87||
60013177|NCT02518971|76129155|FG000|COMPLETED|Overall Study||64||
60013178|NCT02518971|76129156|FG001|COMPLETED|Overall Study||67||
60013179|NCT02518971|76129155|FG000|NOT COMPLETED|Overall Study||23||
60013180|NCT02518971|76129156|FG001|NOT COMPLETED|Overall Study||20||
60013181|NCT01365039|76129165|FG000|STARTED|Overall Study||86||
60013182|NCT01365039|76129166|FG001|STARTED|Overall Study||87||
60013183|NCT01365039|76129165|FG000|COMPLETED|Overall Study||85||
60013184|NCT01365039|76129166|FG001|COMPLETED|Overall Study||87||
60013185|NCT01365039|76129165|FG000|NOT COMPLETED|Overall Study||1||
60013186|NCT01365039|76129166|FG001|NOT COMPLETED|Overall Study||0||
60013187|NCT01364727|76129173|FG000|STARTED|Overall Study||35||
60013188|NCT01364727|76129173|FG000|COMPLETED|Overall Study||33||
60013189|NCT01364727|76129173|FG000|NOT COMPLETED|Overall Study||2||
60013190|NCT02633215|76129181|FG000|STARTED|Overall Study||18||
60013191|NCT02633215|76129182|FG001|STARTED|Overall Study||18||
60013192|NCT02633215|76129181|FG000|COMPLETED|Overall Study||16||
60013193|NCT02633215|76129182|FG001|COMPLETED|Overall Study||15||
60013194|NCT02633215|76129181|FG000|NOT COMPLETED|Overall Study||2||
60013195|NCT02633215|76129182|FG001|NOT COMPLETED|Overall Study||3||
60013196|NCT01364649|76129190|FG000|STARTED|Overall Study||225||
60013197|NCT01364649|76129191|FG001|STARTED|Overall Study||222||
60013198|NCT01364649|76129190|FG000|COMPLETED|Overall Study||169||
60013199|NCT01364649|76129191|FG001|COMPLETED|Overall Study||179||
60013200|NCT01364649|76129190|FG000|NOT COMPLETED|Overall Study||56||
60013201|NCT01364649|76129191|FG001|NOT COMPLETED|Overall Study||43||
60013202|NCT02588261|76129199|FG000|STARTED|Overall Study||267||
60013203|NCT02588261|76129200|FG001|STARTED|Overall Study||263||
60013204|NCT02588261|76129199|FG000|Treated|Overall Study||265||
60013205|NCT02588261|76129200|FG001|Treated|Overall Study||262||
60013206|NCT02588261|76129199|FG000|COMPLETED|Overall Study||0||
60013207|NCT02588261|76129200|FG001|COMPLETED|Overall Study||0||
60013208|NCT02588261|76129199|FG000|NOT COMPLETED|Overall Study||267||
60013209|NCT02588261|76129200|FG001|NOT COMPLETED|Overall Study||263||
60013210|NCT01359449|76129208|FG000|STARTED|Overall Study||61||
60013211|NCT01359449|76129209|FG001|STARTED|Overall Study||62||
60013212|NCT01359449|76129208|FG000|COMPLETED|Overall Study||57||
60013213|NCT01359449|76129209|FG001|COMPLETED|Overall Study||58||
60013214|NCT01359449|76129208|FG000|NOT COMPLETED|Overall Study||4||
60013215|NCT01359449|76129209|FG001|NOT COMPLETED|Overall Study||4||
60013216|NCT01672723|76129215|FG000|STARTED|First Intervention||19||
60013217|NCT01672723|76129216|FG001|STARTED|First Intervention||15||
60013218|NCT01672723|76129215|FG000|COMPLETED|First Intervention||16||
60013219|NCT01672723|76129216|FG001|COMPLETED|First Intervention||15||
60013220|NCT01672723|76129215|FG000|NOT COMPLETED|First Intervention||3||
60013221|NCT01672723|76129216|FG001|NOT COMPLETED|First Intervention||0||
60013222|NCT01672723|76129215|FG000|STARTED|Washout Period of 10 Days||16||
60013223|NCT01672723|76129216|FG001|STARTED|Washout Period of 10 Days||15||
60013224|NCT01672723|76129215|FG000|COMPLETED|Washout Period of 10 Days||16||
60013225|NCT01672723|76129216|FG001|COMPLETED|Washout Period of 10 Days||15||
60013226|NCT01672723|76129215|FG000|NOT COMPLETED|Washout Period of 10 Days||0||
60013227|NCT01672723|76129216|FG001|NOT COMPLETED|Washout Period of 10 Days||0||
60013228|NCT01672723|76129215|FG000|STARTED|Second Intervention||16||
60013229|NCT01672723|76129216|FG001|STARTED|Second Intervention||15||
60013230|NCT01672723|76129215|FG000|COMPLETED|Second Intervention||16||
60013231|NCT01672723|76129216|FG001|COMPLETED|Second Intervention||15||
60013232|NCT01672723|76129215|FG000|NOT COMPLETED|Second Intervention||0||
59500856|NCT03869450|75592608|FG001|NOT COMPLETED|Overall Study||2||
59500857|NCT03869450|75592609|FG002|NOT COMPLETED|Overall Study||0||
59500858|NCT03794882|75592619|FG000|STARTED|Overall Study||8||
59500859|NCT03794882|75592620|FG001|STARTED|Overall Study||6||
59500860|NCT03794882|75592619|FG000|COMPLETED|Overall Study||8||
59607623|NCT02109809|75718300|FG000|NOT COMPLETED|Overall Study||3||
60013233|NCT01672723|76129216|FG001|NOT COMPLETED|Second Intervention||0||
60013234|NCT02632747|76129224|FG000|STARTED|Treatment Period 1||16||
60013235|NCT02632747|76129225|FG001|STARTED|Treatment Period 1||15||
60013236|NCT02632747|76129224|FG000|COMPLETED|Treatment Period 1||16||
60013237|NCT02632747|76129225|FG001|COMPLETED|Treatment Period 1||15||
60013238|NCT02632747|76129224|FG000|NOT COMPLETED|Treatment Period 1||0||
60013239|NCT02632747|76129225|FG001|NOT COMPLETED|Treatment Period 1||0||
60013240|NCT02632747|76129224|FG000|STARTED|Wash-out Period||16||
60013241|NCT02632747|76129225|FG001|STARTED|Wash-out Period||15||
60013242|NCT02632747|76129224|FG000|COMPLETED|Wash-out Period||15||
60013243|NCT02632747|76129225|FG001|COMPLETED|Wash-out Period||15||
60013244|NCT02632747|76129224|FG000|NOT COMPLETED|Wash-out Period||1||
60013245|NCT02632747|76129225|FG001|NOT COMPLETED|Wash-out Period||0||
60013246|NCT02632747|76129224|FG000|STARTED|Treatment Period 2||15||
60013247|NCT02632747|76129225|FG001|STARTED|Treatment Period 2||15||
60013248|NCT02632747|76129224|FG000|COMPLETED|Treatment Period 2||15||
60013249|NCT02632747|76129225|FG001|COMPLETED|Treatment Period 2||15||
60013250|NCT02632747|76129224|FG000|NOT COMPLETED|Treatment Period 2||0||
60013251|NCT02632747|76129225|FG001|NOT COMPLETED|Treatment Period 2||0||
60013252|NCT04209075|76129233|FG000|STARTED|Overall Study||4||
60013253|NCT04209075|76129234|FG001|STARTED|Overall Study||2||
60013254|NCT04209075|76129233|FG000|COMPLETED|Overall Study||4||
60013255|NCT04209075|76129234|FG001|COMPLETED|Overall Study||2||
60013256|NCT04209075|76129233|FG000|NOT COMPLETED|Overall Study||0||
60013257|NCT04209075|76129234|FG001|NOT COMPLETED|Overall Study||0||
60013258|NCT02520531|76129244|FG000|STARTED|Overall Study||42||
60013259|NCT02520531|76129245|FG001|STARTED|Overall Study||42||
60013260|NCT02520531|76129244|FG000|COMPLETED|Overall Study||36||
60013261|NCT02520531|76129245|FG001|COMPLETED|Overall Study||36||
60013262|NCT02520531|76129244|FG000|NOT COMPLETED|Overall Study||6||
60013263|NCT02520531|76129245|FG001|NOT COMPLETED|Overall Study||6||
59500861|NCT03794882|75592620|FG001|COMPLETED|Overall Study||6||
59500862|NCT03794882|75592619|FG000|NOT COMPLETED|Overall Study||0||
59500863|NCT03794882|75592620|FG001|NOT COMPLETED|Overall Study||0||
59500864|NCT03736928|75592632|FG000|STARTED|Overall Study||80||
59500865|NCT03736928|75592633|FG001|STARTED|Overall Study||80||
60013264|NCT01671319|76129251|FG000|STARTED|Overall Study||42||
60013265|NCT01671319|76129251|FG000|COMPLETED|Overall Study||41||
60013266|NCT01671319|76129251|FG000|NOT COMPLETED|Overall Study||1||
60013267|NCT01670539|76129255|FG000|STARTED|Overall Study||26||
60013268|NCT01670539|76129256|FG001|STARTED|Overall Study||21||
60013269|NCT01670539|76129255|FG000|COMPLETED|Overall Study||20||
60013270|NCT01670539|76129256|FG001|COMPLETED|Overall Study||16||
60013271|NCT01670539|76129255|FG000|NOT COMPLETED|Overall Study||6||
60013272|NCT01670539|76129256|FG001|NOT COMPLETED|Overall Study||5||
60013273|NCT02516163|76129263|FG000|STARTED|Overall Study||52||
60013274|NCT02516163|76129263|FG000|COMPLETED|Overall Study||24||
60013275|NCT02516163|76129263|FG000|NOT COMPLETED|Overall Study||28||
60013276|NCT02589665|76129271|FG000|STARTED|Induction Period||63||
60013277|NCT02589665|76129272|FG001|STARTED|Induction Period||63||
60013278|NCT02589665|76129273|FG002|STARTED|Induction Period||62||
60013279|NCT02589665|76129274|FG003|STARTED|Induction Period||61||
60013280|NCT02589665|76129275|FG004|STARTED|Induction Period|Participants were assigned to this arm during maintenance period.|0||
60013281|NCT02589665|76129276|FG005|STARTED|Induction Period|Participants were assigned to this arm during maintenance period.|0||
60013282|NCT02589665|76129277|FG006|STARTED|Induction Period|Participants were assigned to this arm during maintenance period.|0||
59500866|NCT03736928|75592634|FG002|STARTED|Overall Study||80||
59500867|NCT03736928|75592635|FG003|STARTED|Overall Study||81||
59500868|NCT03736928|75592636|FG004|STARTED|Overall Study||78||
59500869|NCT03736928|75592632|FG000|COMPLETED|Overall Study||73||
59500870|NCT03736928|75592633|FG001|COMPLETED|Overall Study||78||
59500871|NCT03736928|75592634|FG002|COMPLETED|Overall Study||75||
59500872|NCT03736928|75592635|FG003|COMPLETED|Overall Study||76||
59500873|NCT03736928|75592636|FG004|COMPLETED|Overall Study||67||
59500874|NCT03736928|75592632|FG000|NOT COMPLETED|Overall Study||7||
59500875|NCT03736928|75592633|FG001|NOT COMPLETED|Overall Study||2||
59500876|NCT03736928|75592634|FG002|NOT COMPLETED|Overall Study||5||
59500877|NCT03736928|75592635|FG003|NOT COMPLETED|Overall Study||5||
59500878|NCT03736928|75592636|FG004|NOT COMPLETED|Overall Study||11||
59500879|NCT01101464|75592650|FG000|STARTED|Day 1 Through AM Dose of Day 5||4||
59500880|NCT01101464|75592651|FG001|STARTED|Day 1 Through AM Dose of Day 5||4||
59500881|NCT01101464|75592650|FG000|COMPLETED|Day 1 Through AM Dose of Day 5||4||
59500882|NCT01101464|75592651|FG001|COMPLETED|Day 1 Through AM Dose of Day 5||4||
59500883|NCT01101464|75592650|FG000|NOT COMPLETED|Day 1 Through AM Dose of Day 5||0||
59500884|NCT01101464|75592651|FG001|NOT COMPLETED|Day 1 Through AM Dose of Day 5||0||
59500885|NCT01101464|75592650|FG000|STARTED|PM Dose of Day 5 Through AM Dose of Day7||4||
59500886|NCT01101464|75592651|FG001|STARTED|PM Dose of Day 5 Through AM Dose of Day7||4||
59500887|NCT01101464|75592650|FG000|COMPLETED|PM Dose of Day 5 Through AM Dose of Day7||4||
59500888|NCT01101464|75592651|FG001|COMPLETED|PM Dose of Day 5 Through AM Dose of Day7||4||
59500889|NCT01101464|75592650|FG000|NOT COMPLETED|PM Dose of Day 5 Through AM Dose of Day7||0||
59500890|NCT01101464|75592651|FG001|NOT COMPLETED|PM Dose of Day 5 Through AM Dose of Day7||0||
59500891|NCT01077830|75592661|FG000|STARTED|Overall Study||677||
59500892|NCT01077830|75592662|FG001|STARTED|Overall Study||682||
59500893|NCT01077830|75592661|FG000|COMPLETED|Overall Study||677||
59500894|NCT01077830|75592662|FG001|COMPLETED|Overall Study||682||
59500895|NCT01077830|75592661|FG000|NOT COMPLETED|Overall Study||0||
59500896|NCT01077830|75592662|FG001|NOT COMPLETED|Overall Study||0||
59500897|NCT02083406|75592671|FG000|STARTED|Overall Study||7||
59500898|NCT02083406|75592672|FG001|STARTED|Overall Study||8||
59500899|NCT02083406|75592673|FG002|STARTED|Overall Study||7||
59500900|NCT02083406|75592671|FG000|COMPLETED|Overall Study||7||
59500901|NCT02083406|75592672|FG001|COMPLETED|Overall Study||8||
59500902|NCT02083406|75592673|FG002|COMPLETED|Overall Study||7||
59500903|NCT02083406|75592671|FG000|NOT COMPLETED|Overall Study||0||
59500904|NCT02083406|75592672|FG001|NOT COMPLETED|Overall Study||0||
59500905|NCT02083406|75592673|FG002|NOT COMPLETED|Overall Study||0||
59500906|NCT00003644|75592683|FG000|STARTED|Overall Study||289||
59500907|NCT00003644|75592684|FG001|STARTED|Overall Study||282||
59500908|NCT00003644|75592683|FG000|COMPLETED|Overall Study||274||
59500909|NCT00003644|75592684|FG001|COMPLETED|Overall Study||268||
59500910|NCT00003644|75592683|FG000|NOT COMPLETED|Overall Study||15||
59500911|NCT00003644|75592684|FG001|NOT COMPLETED|Overall Study||14||
59500912|NCT02142049|75592697|FG000|STARTED|Overall Study||3||
59500913|NCT02142049|75592698|FG001|STARTED|Overall Study||3||
59500914|NCT02142049|75592699|FG002|STARTED|Overall Study||3||
59500915|NCT02142049|75592700|FG003|STARTED|Overall Study||6||
59500916|NCT02142049|75592701|FG004|STARTED|Overall Study||20||
59500917|NCT02142049|75592697|FG000|COMPLETED|Overall Study||3||
59500918|NCT02142049|75592698|FG001|COMPLETED|Overall Study||3||
59500919|NCT02142049|75592699|FG002|COMPLETED|Overall Study||3||
59500920|NCT02142049|75592700|FG003|COMPLETED|Overall Study||6||
59500921|NCT02142049|75592701|FG004|COMPLETED|Overall Study||20||
59500922|NCT02142049|75592697|FG000|NOT COMPLETED|Overall Study||0||
59500923|NCT02142049|75592698|FG001|NOT COMPLETED|Overall Study||0||
59500924|NCT02142049|75592699|FG002|NOT COMPLETED|Overall Study||0||
59500925|NCT02142049|75592700|FG003|NOT COMPLETED|Overall Study||0||
59500926|NCT02142049|75592701|FG004|NOT COMPLETED|Overall Study||0||
59500927|NCT03714620|75592720|FG000|STARTED|Overall Study||49||
59500928|NCT03714620|75592721|FG001|STARTED|Overall Study||49||
59500929|NCT03714620|75592720|FG000|COMPLETED|Overall Study||49||
59500930|NCT03714620|75592721|FG001|COMPLETED|Overall Study||49||
59500931|NCT03714620|75592720|FG000|NOT COMPLETED|Overall Study||0||
59500932|NCT03714620|75592721|FG001|NOT COMPLETED|Overall Study||0||
59500933|NCT03631550|75592729|FG000|STARTED|Overall Study||94|Full Analysis set (FA) include all the subjects randomized, including the subjects treated with the device up to May 31, 2019|
59500934|NCT03631550|75592730|FG001|STARTED|Overall Study||93|Full Analysis set (FA) include all the subjects randomized, including the subjects treated with the device up to May 31, 2019|
59518985|NCT03587428|75612870|FG000|COMPLETED|Period 1||3||
59500935|NCT03631550|75592729|FG000|The ITT Analysis Set|Overall Study||67|The Intent to Treat (ITT) analysis set which includes all randomized subjects who were treated with the device after May 31, 2019 (including self-practice). Per ITT principles, all subjects were analyzed as randomized.|
59500936|NCT03631550|75592730|FG001|The ITT Analysis Set|Overall Study||64|The Intent to Treat (ITT) analysis set which includes all randomized subjects who were treated with the device after May 31, 2019 (including self-practice). Per ITT principles, all subjects were analyzed as randomized.|
59500937|NCT03631550|75592729|FG000|The mITT Analysis Set|Overall Study||50|"The mITT analysis set which includes all subjects from the ITT analysis set who treat at least one eligible attack (excluding the self-practice test) analyzed as treated."|
59500938|NCT03631550|75592730|FG001|The mITT Analysis Set|Overall Study||59|"The mITT analysis set which includes all subjects from the ITT analysis set who treat at least one eligible attack (excluding the self-practice test) analyzed as treated."|
59500939|NCT03631550|75592729|FG000|COMPLETED|Overall Study||67|from FA set|
59500940|NCT03631550|75592730|FG001|COMPLETED|Overall Study||64|from FA set|
59500941|NCT03631550|75592729|FG000|NOT COMPLETED|Overall Study||27||
59500942|NCT03631550|75592730|FG001|NOT COMPLETED|Overall Study||29||
59500943|NCT00680953|75592739|FG000|STARTED|Overall Study||500||
59500944|NCT00680953|75592740|FG001|STARTED|Overall Study||511||
59500945|NCT00680953|75592741|FG002|STARTED|Overall Study||251||
59500946|NCT00680953|75592739|FG000|COMPLETED|Overall Study||414||
59500947|NCT00680953|75592740|FG001|COMPLETED|Overall Study||416||
59500948|NCT00680953|75592741|FG002|COMPLETED|Overall Study||204||
59500949|NCT00680953|75592739|FG000|NOT COMPLETED|Overall Study||86||
59500950|NCT00680953|75592740|FG001|NOT COMPLETED|Overall Study||95||
59500951|NCT00680953|75592741|FG002|NOT COMPLETED|Overall Study||47||
59500952|NCT00681031|75592749|FG000|STARTED|Overall Study||96||
59500953|NCT00681031|75592749|FG000|COMPLETED|Overall Study||96||
59500954|NCT00681031|75592749|FG000|NOT COMPLETED|Overall Study||0||
59500955|NCT00660985|75592755|FG000|STARTED|Overall Study||26||
59500956|NCT00660985|75592756|FG001|STARTED|Overall Study||25||
59500957|NCT00660985|75592755|FG000|COMPLETED|Overall Study||25||
59500958|NCT00660985|75592756|FG001|COMPLETED|Overall Study||25||
59500959|NCT00660985|75592755|FG000|NOT COMPLETED|Overall Study||1||
59500960|NCT00660985|75592756|FG001|NOT COMPLETED|Overall Study||0||
59500961|NCT03551522|75592766|FG000|STARTED|DB Phase||53||
59500962|NCT03551522|75592767|FG001|STARTED|DB Phase||51||
59500963|NCT03551522|75592768|FG002|STARTED|DB Phase||50||
59500964|NCT03551522|75592769|FG003|STARTED|DB Phase||27||
59500965|NCT03551522|75592770|FG004|STARTED|DB Phase||0||
59500966|NCT03551522|75592766|FG000|COMPLETED|DB Phase||27||
59500967|NCT03551522|75592767|FG001|COMPLETED|DB Phase||34||
59500968|NCT03551522|75592768|FG002|COMPLETED|DB Phase||32||
59500969|NCT03551522|75592769|FG003|COMPLETED|DB Phase||17||
59500970|NCT03551522|75592770|FG004|COMPLETED|DB Phase||0||
59500971|NCT03551522|75592766|FG000|NOT COMPLETED|DB Phase||26||
59500972|NCT03551522|75592767|FG001|NOT COMPLETED|DB Phase||17||
59500973|NCT03551522|75592768|FG002|NOT COMPLETED|DB Phase||18||
59500974|NCT03551522|75592769|FG003|NOT COMPLETED|DB Phase||10||
59500975|NCT03551522|75592770|FG004|NOT COMPLETED|DB Phase||0||
59500976|NCT03551522|75592766|FG000|STARTED|OLE Phase||0||
59500977|NCT03551522|75592767|FG001|STARTED|OLE Phase||0||
59500978|NCT03551522|75592768|FG002|STARTED|OLE Phase||0||
59500979|NCT03551522|75592769|FG003|STARTED|OLE Phase||0||
59500980|NCT03551522|75592770|FG004|STARTED|OLE Phase||12||
59500981|NCT03551522|75592766|FG000|COMPLETED|OLE Phase||0||
59885565|NCT00111917|76008398|FG001|STARTED|Overall Study||4||
59885566|NCT00111917|76008397|FG000|COMPLETED|Overall Study||8||
59885567|NCT00111917|76008398|FG001|COMPLETED|Overall Study||3||
59885568|NCT00111917|76008397|FG000|NOT COMPLETED|Overall Study||1||
59885569|NCT00111917|76008398|FG001|NOT COMPLETED|Overall Study||1||
59885570|NCT03520569|76008408|FG000|STARTED|Overall Study||15||
59885571|NCT03520569|76008408|FG000|Octreotide-Euglycemia|Overall Study||13||
59885572|NCT03520569|76008408|FG000|Octreotide-Euglycemia-Insulin Clamp|Overall Study||14||
59885573|NCT03520569|76008408|FG000|Octreotide-Hyperglycemia|Overall Study||10||
59885574|NCT03520569|76008408|FG000|Octreotide-Hyperglycemia-Insulin Clamp|Overall Study||12||
59885575|NCT03520569|76008408|FG000|COMPLETED|Overall Study||14||
59885576|NCT03520569|76008408|FG000|NOT COMPLETED|Overall Study||1||
59885577|NCT00111839|76008421|FG000|STARTED|Overall Study||50||
59885578|NCT00111839|76008422|FG001|STARTED|Overall Study||51||
59885579|NCT00111839|76008423|FG002|STARTED|Overall Study||49||
59885580|NCT00111839|76008421|FG000|Treated|Overall Study||50||
59885581|NCT00111839|76008422|FG001|Treated|Overall Study||51||
59885582|NCT00111839|76008423|FG002|Treated|Overall Study||47||
59885583|NCT00111839|76008421|FG000|COMPLETED|Overall Study||2||
59885584|NCT00111839|76008422|FG001|COMPLETED|Overall Study||5||
59885585|NCT00111839|76008423|FG002|COMPLETED|Overall Study||0||
59885586|NCT00111839|76008421|FG000|NOT COMPLETED|Overall Study||48||
59885587|NCT00111839|76008422|FG001|NOT COMPLETED|Overall Study||46||
59885588|NCT00111839|76008423|FG002|NOT COMPLETED|Overall Study||49||
59885589|NCT00111761|76008433|FG000|STARTED|Part 1|This treatment group was not initiated until Part 2|0||
59885590|NCT00111761|76008434|FG001|STARTED|Part 1||19||
59885591|NCT00111761|76008433|FG000|COMPLETED|Part 1||0||
59885592|NCT00111761|76008434|FG001|COMPLETED|Part 1|Completed through safety followup|14||
59885593|NCT00111761|76008433|FG000|NOT COMPLETED|Part 1||0||
59885594|NCT00111761|76008434|FG001|NOT COMPLETED|Part 1||5||
59885595|NCT00111761|76008433|FG000|STARTED|Part 2||24||
59885596|NCT00111761|76008434|FG001|STARTED|Part 2|This treatment group was used in Part 1 only|0||
59885597|NCT00111761|76008433|FG000|COMPLETED|Part 2||16||
59885598|NCT00111761|76008434|FG001|COMPLETED|Part 2||0||
59885599|NCT00111761|76008433|FG000|NOT COMPLETED|Part 2||8||
59885600|NCT00111761|76008434|FG001|NOT COMPLETED|Part 2||0||
59885601|NCT03519867|76008450|FG000|STARTED|Overall Study||6||
59885602|NCT03519867|76008451|FG001|STARTED|Overall Study|One participant randomized to receive MK-8616 8.0 mg/kg received MK-8616 0.8 mg/kg.|7||
59885603|NCT03519867|76008452|FG002|STARTED|Overall Study||6||
59885604|NCT03519867|76008453|FG003|STARTED|Overall Study||4||
59885605|NCT03519867|76008454|FG004|STARTED|Overall Study||5||
59885606|NCT03519867|76008455|FG005|STARTED|Overall Study||5||
59885607|NCT03519867|76008456|FG006|STARTED|Overall Study||4||
59885608|NCT03519867|76008457|FG007|STARTED|Overall Study||5||
59885609|NCT03519867|76008458|FG008|STARTED|Overall Study||4||
59885610|NCT03519867|76008459|FG009|STARTED|Overall Study||4||
59885611|NCT03519867|76008450|FG000|Treated|Overall Study||5||
59885612|NCT03519867|76008451|FG001|Treated|Overall Study||6||
59885613|NCT03519867|76008452|FG002|Treated|Overall Study||5||
59885614|NCT03519867|76008453|FG003|Treated|Overall Study||3||
59500982|NCT03551522|75592767|FG001|COMPLETED|OLE Phase||0||
59885615|NCT03519867|76008454|FG004|Treated|Overall Study||5||
59885616|NCT03519867|76008455|FG005|Treated|Overall Study||4||
59885617|NCT03519867|76008456|FG006|Treated|Overall Study||4||
59885618|NCT03519867|76008457|FG007|Treated|Overall Study||4||
59885619|NCT03519867|76008458|FG008|Treated|Overall Study||3||
59885620|NCT03519867|76008459|FG009|Treated|Overall Study||4||
59885621|NCT03519867|76008450|FG000|COMPLETED|Overall Study||3||
59885622|NCT03519867|76008451|FG001|COMPLETED|Overall Study||4||
59885623|NCT03519867|76008452|FG002|COMPLETED|Overall Study||5||
59500983|NCT03551522|75592768|FG002|COMPLETED|OLE Phase||0||
59885624|NCT03519867|76008453|FG003|COMPLETED|Overall Study||3||
59885625|NCT03519867|76008454|FG004|COMPLETED|Overall Study||5||
59885626|NCT03519867|76008455|FG005|COMPLETED|Overall Study||2||
59885627|NCT03519867|76008456|FG006|COMPLETED|Overall Study||3||
59885628|NCT03519867|76008457|FG007|COMPLETED|Overall Study||4||
59885629|NCT03519867|76008458|FG008|COMPLETED|Overall Study||3||
59885630|NCT03519867|76008459|FG009|COMPLETED|Overall Study||4||
59885631|NCT03519867|76008450|FG000|NOT COMPLETED|Overall Study||3||
59885632|NCT03519867|76008451|FG001|NOT COMPLETED|Overall Study||3||
59885633|NCT03519867|76008452|FG002|NOT COMPLETED|Overall Study||1||
59885634|NCT03519867|76008453|FG003|NOT COMPLETED|Overall Study||1||
59885635|NCT03519867|76008454|FG004|NOT COMPLETED|Overall Study||0||
59885636|NCT03519867|76008455|FG005|NOT COMPLETED|Overall Study||3||
59885637|NCT03519867|76008456|FG006|NOT COMPLETED|Overall Study||1||
59885638|NCT03519867|76008457|FG007|NOT COMPLETED|Overall Study||1||
59885639|NCT03519867|76008458|FG008|NOT COMPLETED|Overall Study||1||
59885640|NCT03519867|76008459|FG009|NOT COMPLETED|Overall Study||0||
59885641|NCT03519087|76008483|FG000|STARTED|Clinic Evaluation||55||
59885642|NCT03519087|76008484|FG001|STARTED|Clinic Evaluation||57||
59885643|NCT03519087|76008485|FG002|STARTED|Clinic Evaluation||0||
59885644|NCT03519087|76008486|FG003|STARTED|Clinic Evaluation||0||
59885645|NCT03519087|76008487|FG004|STARTED|Clinic Evaluation||0||
59885646|NCT03519087|76008483|FG000|Received Assigned Intervention|Clinic Evaluation||54||
59885647|NCT03519087|76008484|FG001|Received Assigned Intervention|Clinic Evaluation||57||
59885648|NCT03519087|76008485|FG002|Received Assigned Intervention|Clinic Evaluation||0||
59885649|NCT03519087|76008486|FG003|Received Assigned Intervention|Clinic Evaluation||0||
59885650|NCT03519087|76008487|FG004|Received Assigned Intervention|Clinic Evaluation||0||
59885651|NCT03519087|76008483|FG000|Confirmed Diagnosis by Physician|Clinic Evaluation||39||
59885652|NCT03519087|76008484|FG001|Confirmed Diagnosis by Physician|Clinic Evaluation||39||
59885653|NCT03519087|76008485|FG002|Confirmed Diagnosis by Physician|Clinic Evaluation||0||
59885654|NCT03519087|76008486|FG003|Confirmed Diagnosis by Physician|Clinic Evaluation||0||
59885655|NCT03519087|76008487|FG004|Confirmed Diagnosis by Physician|Clinic Evaluation||0||
59885656|NCT03519087|76008483|FG000|COMPLETED|Clinic Evaluation||39||
59885657|NCT03519087|76008484|FG001|COMPLETED|Clinic Evaluation||39||
59885658|NCT03519087|76008485|FG002|COMPLETED|Clinic Evaluation||0||
59885659|NCT03519087|76008486|FG003|COMPLETED|Clinic Evaluation||0||
59885660|NCT03519087|76008487|FG004|COMPLETED|Clinic Evaluation||0||
59885661|NCT03519087|76008483|FG000|NOT COMPLETED|Clinic Evaluation||16||
59885662|NCT03519087|76008484|FG001|NOT COMPLETED|Clinic Evaluation||18||
59885663|NCT03519087|76008485|FG002|NOT COMPLETED|Clinic Evaluation||0||
59885664|NCT03519087|76008486|FG003|NOT COMPLETED|Clinic Evaluation||0||
59885665|NCT03519087|76008487|FG004|NOT COMPLETED|Clinic Evaluation||0||
59885666|NCT03519087|76008483|FG000|STARTED|Re-randomization for Treatment||39||
59885667|NCT03519087|76008484|FG001|STARTED|Re-randomization for Treatment||39||
59885668|NCT03519087|76008485|FG002|STARTED|Re-randomization for Treatment||0||
59885669|NCT03519087|76008486|FG003|STARTED|Re-randomization for Treatment||0||
59885670|NCT03519087|76008487|FG004|STARTED|Re-randomization for Treatment||0||
59885671|NCT03519087|76008483|FG000|COMPLETED|Re-randomization for Treatment||12||
59885672|NCT03519087|76008484|FG001|COMPLETED|Re-randomization for Treatment||7||
59885673|NCT03519087|76008485|FG002|COMPLETED|Re-randomization for Treatment||0||
59885674|NCT03519087|76008486|FG003|COMPLETED|Re-randomization for Treatment||0||
59885675|NCT03519087|76008487|FG004|COMPLETED|Re-randomization for Treatment||0||
59885676|NCT03519087|76008483|FG000|NOT COMPLETED|Re-randomization for Treatment||27||
59885677|NCT03519087|76008484|FG001|NOT COMPLETED|Re-randomization for Treatment||32||
59885678|NCT03519087|76008485|FG002|NOT COMPLETED|Re-randomization for Treatment||0||
59885679|NCT03519087|76008486|FG003|NOT COMPLETED|Re-randomization for Treatment||0||
59885680|NCT03519087|76008487|FG004|NOT COMPLETED|Re-randomization for Treatment||0||
59885681|NCT03519087|76008483|FG000|STARTED|Laboratory Testing||0||
59885682|NCT03519087|76008484|FG001|STARTED|Laboratory Testing||0||
59885683|NCT03519087|76008485|FG002|STARTED|Laboratory Testing|From interdisciplinary (4) or standard (2) evaluation from Period 1|6||
59885684|NCT03519087|76008486|FG003|STARTED|Laboratory Testing|From interdisciplinary (4) or standard (2) evaluation from Period 1|6||
59885685|NCT03519087|76008487|FG004|STARTED|Laboratory Testing|From interdisciplinary (4) or standard (3) evaluation from Period 1|7||
59885686|NCT03519087|76008483|FG000|Baseline Lab Testing|Laboratory Testing||0||
59885687|NCT03519087|76008484|FG001|Baseline Lab Testing|Laboratory Testing||0||
59885688|NCT03519087|76008485|FG002|Baseline Lab Testing|Laboratory Testing||5||
59885689|NCT03519087|76008486|FG003|Baseline Lab Testing|Laboratory Testing||4||
59885690|NCT03519087|76008487|FG004|Baseline Lab Testing|Laboratory Testing||3||
59885691|NCT03519087|76008483|FG000|COMPLETED|Laboratory Testing||0||
59885692|NCT03519087|76008484|FG001|COMPLETED|Laboratory Testing||0||
59885693|NCT03519087|76008485|FG002|COMPLETED|Laboratory Testing||4||
59885694|NCT03519087|76008486|FG003|COMPLETED|Laboratory Testing||2||
60013283|NCT02589665|76129278|FG007|STARTED|Induction Period||0||
60013284|NCT02589665|76129279|FG008|STARTED|Induction Period||0||
60013285|NCT02589665|76129280|FG009|STARTED|Induction Period||0||
60013286|NCT02589665|76129271|FG000|Received at Least One Dose of Study Drug|Induction Period||63||
60013287|NCT02589665|76129272|FG001|Received at Least One Dose of Study Drug|Induction Period||63||
60013288|NCT02589665|76129273|FG002|Received at Least One Dose of Study Drug|Induction Period||62||
60013289|NCT02589665|76129274|FG003|Received at Least One Dose of Study Drug|Induction Period||60||
60013290|NCT02589665|76129275|FG004|Received at Least One Dose of Study Drug|Induction Period||0||
60013291|NCT02589665|76129276|FG005|Received at Least One Dose of Study Drug|Induction Period||0||
60013292|NCT02589665|76129277|FG006|Received at Least One Dose of Study Drug|Induction Period||0||
60013293|NCT02589665|76129278|FG007|Received at Least One Dose of Study Drug|Induction Period||0||
60013294|NCT02589665|76129279|FG008|Received at Least One Dose of Study Drug|Induction Period||0||
60013295|NCT02589665|76129280|FG009|Received at Least One Dose of Study Drug|Induction Period||0||
59885695|NCT03519087|76008487|FG004|COMPLETED|Laboratory Testing||1||
59885696|NCT03519087|76008483|FG000|NOT COMPLETED|Laboratory Testing||0||
59885697|NCT03519087|76008484|FG001|NOT COMPLETED|Laboratory Testing||0||
59885698|NCT03519087|76008485|FG002|NOT COMPLETED|Laboratory Testing||2||
59885699|NCT03519087|76008486|FG003|NOT COMPLETED|Laboratory Testing||4||
60013296|NCT02589665|76129271|FG000|COMPLETED|Induction Period||60||
59500984|NCT03551522|75592769|FG003|COMPLETED|OLE Phase||0||
59500985|NCT03551522|75592770|FG004|COMPLETED|OLE Phase||0||
59500986|NCT03551522|75592766|FG000|NOT COMPLETED|OLE Phase||0||
59500987|NCT03551522|75592767|FG001|NOT COMPLETED|OLE Phase||0||
59500988|NCT03551522|75592768|FG002|NOT COMPLETED|OLE Phase||0||
59500989|NCT03551522|75592769|FG003|NOT COMPLETED|OLE Phase||0||
59500990|NCT03551522|75592770|FG004|NOT COMPLETED|OLE Phase||12||
59500991|NCT02336360|75592780|FG000|STARTED|Overall Study||6||
59500992|NCT02336360|75592780|FG000|COMPLETED|Overall Study||6||
59500993|NCT02336360|75592780|FG000|NOT COMPLETED|Overall Study||0||
59500994|NCT00661141|75592787|FG000|STARTED|Overall Study||8||
59500995|NCT00661141|75592788|FG001|STARTED|Overall Study||8||
59500996|NCT00661141|75592789|FG002|STARTED|Overall Study||4||
59500997|NCT00661141|75592790|FG003|STARTED|Overall Study||4||
59500998|NCT00661141|75592791|FG004|STARTED|Overall Study||4||
59500999|NCT00661141|75592792|FG005|STARTED|Overall Study||4||
59501000|NCT00661141|75592787|FG000|Administered 30 Minutes Prior to Ethanol|Overall Study||6||
59501001|NCT00661141|75592788|FG001|Administered 30 Minutes Prior to Ethanol|Overall Study||6||
59501002|NCT00661141|75592789|FG002|Administered 30 Minutes Prior to Ethanol|Overall Study||2||
59501003|NCT00661141|75592790|FG003|Administered 30 Minutes Prior to Ethanol|Overall Study||2||
59501004|NCT00661141|75592791|FG004|Administered 30 Minutes Prior to Ethanol|Overall Study||4||
59501005|NCT00661141|75592792|FG005|Administered 30 Minutes Prior to Ethanol|Overall Study||4||
59501006|NCT00661141|75592787|FG000|Administered 30 Minutes After Ethanol|Overall Study||2||
59501007|NCT00661141|75592788|FG001|Administered 30 Minutes After Ethanol|Overall Study||2||
59501008|NCT00661141|75592789|FG002|Administered 30 Minutes After Ethanol|Overall Study||2||
59501009|NCT00661141|75592790|FG003|Administered 30 Minutes After Ethanol|Overall Study||2||
59501010|NCT00661141|75592791|FG004|Administered 30 Minutes After Ethanol|Overall Study||0||
59501011|NCT00661141|75592792|FG005|Administered 30 Minutes After Ethanol|Overall Study||0||
59501012|NCT00661141|75592787|FG000|COMPLETED|Overall Study||8||
59501013|NCT00661141|75592788|FG001|COMPLETED|Overall Study||8||
59501014|NCT00661141|75592789|FG002|COMPLETED|Overall Study||4||
59501015|NCT00661141|75592790|FG003|COMPLETED|Overall Study||4||
59501016|NCT00661141|75592791|FG004|COMPLETED|Overall Study||4||
59501017|NCT00661141|75592792|FG005|COMPLETED|Overall Study||4||
59501018|NCT00661141|75592787|FG000|NOT COMPLETED|Overall Study||0||
59501019|NCT00661141|75592788|FG001|NOT COMPLETED|Overall Study||0||
59501020|NCT00661141|75592789|FG002|NOT COMPLETED|Overall Study||0||
59501021|NCT00661141|75592790|FG003|NOT COMPLETED|Overall Study||0||
59501022|NCT00661141|75592791|FG004|NOT COMPLETED|Overall Study||0||
59501023|NCT00661141|75592792|FG005|NOT COMPLETED|Overall Study||0||
59501024|NCT00681265|75592811|FG000|STARTED|Overall Study||16||
59501025|NCT00681265|75592811|FG000|COMPLETED|Overall Study||16||
59501026|NCT00681265|75592811|FG000|NOT COMPLETED|Overall Study||0||
59501027|NCT00661453|75592817|FG000|STARTED|Overall Study||38||
59501028|NCT00661453|75592817|FG000|COMPLETED|Overall Study||25||
59501029|NCT00661453|75592817|FG000|NOT COMPLETED|Overall Study||13||
59501030|NCT03547622|75592823|FG000|STARTED|Overall Study||3||
59501031|NCT03547622|75592824|FG001|STARTED|Overall Study||3||
59501032|NCT03547622|75592823|FG000|COMPLETED|Overall Study||3||
59501033|NCT03547622|75592824|FG001|COMPLETED|Overall Study||2||
59501034|NCT03547622|75592823|FG000|NOT COMPLETED|Overall Study||0||
59501035|NCT03547622|75592824|FG001|NOT COMPLETED|Overall Study||1||
59501036|NCT00681889|75592830|FG000|STARTED|Overall Study||9||
59501037|NCT00681889|75592830|FG000|COMPLETED|Overall Study||9||
59501038|NCT00681889|75592830|FG000|NOT COMPLETED|Overall Study||0||
59501039|NCT00682357|75592837|FG000|STARTED|Overall Study||10||
59501040|NCT00682357|75592838|FG001|STARTED|Overall Study||10||
59501041|NCT00682357|75592839|FG002|STARTED|Overall Study||5||
59501042|NCT00682357|75592837|FG000|COMPLETED|Overall Study||10||
59501043|NCT00682357|75592838|FG001|COMPLETED|Overall Study||10||
59501044|NCT00682357|75592839|FG002|COMPLETED|Overall Study||5||
59501045|NCT00682357|75592837|FG000|NOT COMPLETED|Overall Study||0||
59501046|NCT00682357|75592838|FG001|NOT COMPLETED|Overall Study||0||
59501047|NCT00682357|75592839|FG002|NOT COMPLETED|Overall Study||0||
59501048|NCT00662155|75592851|FG000|STARTED|Overall Study||16||
59501049|NCT00662155|75592852|FG001|STARTED|Overall Study||20||
59501050|NCT00662155|75592853|FG002|STARTED|Overall Study||20||
59501051|NCT00662155|75592854|FG003|STARTED|Overall Study||18||
59501052|NCT00662155|75592851|FG000|COMPLETED|Overall Study||13||
59501053|NCT00662155|75592852|FG001|COMPLETED|Overall Study||15||
59501054|NCT00662155|75592853|FG002|COMPLETED|Overall Study||13||
59501055|NCT00662155|75592854|FG003|COMPLETED|Overall Study||14||
59501056|NCT00662155|75592851|FG000|NOT COMPLETED|Overall Study||3||
59885700|NCT03519087|76008487|FG004|NOT COMPLETED|Laboratory Testing||6||
59885701|NCT02763046|76008506|FG000|STARTED|Overall Study||71||
59885702|NCT02763046|76008507|FG001|STARTED|Overall Study||70||
59885703|NCT02763046|76008508|FG002|STARTED|Overall Study||70||
59885704|NCT02763046|76008506|FG000|COMPLETED|Overall Study||62||
59885705|NCT02763046|76008507|FG001|COMPLETED|Overall Study||65||
59885706|NCT02763046|76008508|FG002|COMPLETED|Overall Study||62||
59885707|NCT02763046|76008506|FG000|NOT COMPLETED|Overall Study||9||
59885708|NCT02763046|76008507|FG001|NOT COMPLETED|Overall Study||5||
59885709|NCT02763046|76008508|FG002|NOT COMPLETED|Overall Study||8||
59885710|NCT03518073|76008525|FG000|STARTED|Overall Study||118||
59885711|NCT03518073|76008526|FG001|STARTED|Overall Study||126||
59885712|NCT03518073|76008527|FG002|STARTED|Overall Study||116||
59885713|NCT03518073|76008525|FG000|Received at Least One Dose of Study Drug|Overall Study||118||
59885714|NCT03518073|76008526|FG001|Received at Least One Dose of Study Drug|Overall Study||126||
59885715|NCT03518073|76008527|FG002|Received at Least One Dose of Study Drug|Overall Study||116||
59885716|NCT03518073|76008525|FG000|COMPLETED|Overall Study||74||
59885717|NCT03518073|76008526|FG001|COMPLETED|Overall Study||78||
59885718|NCT03518073|76008527|FG002|COMPLETED|Overall Study||70||
59885719|NCT03518073|76008525|FG000|NOT COMPLETED|Overall Study||44||
59885720|NCT03518073|76008526|FG001|NOT COMPLETED|Overall Study||48||
59885721|NCT03518073|76008527|FG002|NOT COMPLETED|Overall Study||46||
59885722|NCT02759692|76008537|FG000|STARTED|Period 1||141||
59885723|NCT02759692|76008538|FG001|STARTED|Period 1||142||
59885724|NCT02759692|76008537|FG000|COMPLETED|Period 1||138||
59885725|NCT02759692|76008538|FG001|COMPLETED|Period 1||140||
59885726|NCT02759692|76008537|FG000|NOT COMPLETED|Period 1||3||
59885727|NCT02759692|76008538|FG001|NOT COMPLETED|Period 1||2||
59885728|NCT02759692|76008537|FG000|STARTED|Period 2||138||
59885729|NCT02759692|76008538|FG001|STARTED|Period 2||140||
59885730|NCT02759692|76008537|FG000|COMPLETED|Period 2||137||
59885731|NCT02759692|76008538|FG001|COMPLETED|Period 2||139||
59885732|NCT02759692|76008537|FG000|NOT COMPLETED|Period 2||1||
59885733|NCT02759692|76008538|FG001|NOT COMPLETED|Period 2||1||
59885734|NCT02759692|76008537|FG000|STARTED|Period 3||137||
59885735|NCT02759692|76008538|FG001|STARTED|Period 3||139||
59885736|NCT02759692|76008537|FG000|COMPLETED|Period 3||137||
59885737|NCT02759692|76008538|FG001|COMPLETED|Period 3||139||
59885738|NCT02759692|76008537|FG000|NOT COMPLETED|Period 3||0||
59885739|NCT02759692|76008538|FG001|NOT COMPLETED|Period 3||0||
59885740|NCT03586167|76008546|FG000|STARTED|Overall Study||58|Randomized and Treated|116
59885741|NCT03586167|76008547|FG001|STARTED|Overall Study||28|Randomized and Treated|56
59501057|NCT00662155|75592852|FG001|NOT COMPLETED|Overall Study||5||
59501058|NCT00662155|75592853|FG002|NOT COMPLETED|Overall Study||7||
59501059|NCT00662155|75592854|FG003|NOT COMPLETED|Overall Study||4||
59885742|NCT03586167|76008546|FG000|COMPLETED|Overall Study||57||114
59885743|NCT03586167|76008547|FG001|COMPLETED|Overall Study||28||56
59885744|NCT03586167|76008546|FG000|NOT COMPLETED|Overall Study||1||2
59885745|NCT03586167|76008547|FG001|NOT COMPLETED|Overall Study||0||0
59501060|NCT00684541|75592866|FG000|STARTED|Overall Study||23||
59607624|NCT02075411|75718308|FG000|STARTED|Overall Study||0||
59885746|NCT02762578|76008555|FG000|STARTED|Overall Study||361||
59885747|NCT02762578|76008556|FG001|STARTED|Overall Study||182||
59885748|NCT02762578|76008555|FG000|Exposed|Overall Study||360||
60013297|NCT02589665|76129272|FG001|COMPLETED|Induction Period||61||
59885749|NCT02762578|76008556|FG001|Exposed|Overall Study||181||
59885750|NCT02762578|76008555|FG000|COMPLETED|Overall Study||346||
59885751|NCT02762578|76008556|FG001|COMPLETED|Overall Study||172||
59885752|NCT02762578|76008555|FG000|NOT COMPLETED|Overall Study||15||
59501061|NCT00684541|75592867|FG001|STARTED|Overall Study||26||
59501062|NCT00684541|75592866|FG000|COMPLETED|Overall Study||20||
59885753|NCT02762578|76008556|FG001|NOT COMPLETED|Overall Study||10||
59885754|NCT03514641|76008566|FG000|STARTED|603A: 0-12 Week Study Period||334||
59885755|NCT03514641|76008567|FG001|STARTED|603A: 0-12 Week Study Period||339||
59501063|NCT00684541|75592867|FG001|COMPLETED|Overall Study||23||
59501064|NCT00684541|75592866|FG000|NOT COMPLETED|Overall Study||3||
59501065|NCT00684541|75592867|FG001|NOT COMPLETED|Overall Study||3||
59501066|NCT00662545|75592876|FG000|STARTED|Overall Study||5||
59501067|NCT00662545|75592877|FG001|STARTED|Overall Study||5||
59501068|NCT00662545|75592876|FG000|COMPLETED|Overall Study||5||
59501069|NCT00662545|75592877|FG001|COMPLETED|Overall Study||5||
59501070|NCT00662545|75592876|FG000|NOT COMPLETED|Overall Study||0||
59501071|NCT00662545|75592877|FG001|NOT COMPLETED|Overall Study||0||
59501072|NCT00663169|75592885|FG000|STARTED|Overall Study||3||
59501073|NCT00663169|75592886|FG001|STARTED|Overall Study||3||
59501074|NCT00663169|75592885|FG000|COMPLETED|Overall Study||3||
59501075|NCT00663169|75592886|FG001|COMPLETED|Overall Study||3||
59501076|NCT00663169|75592885|FG000|NOT COMPLETED|Overall Study||0||
59501077|NCT00663169|75592886|FG001|NOT COMPLETED|Overall Study||0||
59501078|NCT00663403|75592892|FG000|STARTED|Overall Study||8||
59501079|NCT00663403|75592892|FG000|COMPLETED|Overall Study||8||
59501080|NCT00663403|75592892|FG000|NOT COMPLETED|Overall Study||0||
59501081|NCT00004418|75592896|FG000|STARTED|Overall Study||126||
59501082|NCT00004418|75592896|FG000|COMPLETED|Overall Study|The definition of completed is until the subject wished to stop taking the oil.|126||
59501083|NCT00004418|75592896|FG000|NOT COMPLETED|Overall Study||0||
59501084|NCT00663793|75592902|FG000|STARTED|Overall Study||8||
59501085|NCT00663793|75592903|FG001|STARTED|Overall Study||8||
59501086|NCT00663793|75592902|FG000|COMPLETED|Overall Study||8||
59501087|NCT00663793|75592903|FG001|COMPLETED|Overall Study||8||
59501088|NCT00663793|75592902|FG000|NOT COMPLETED|Overall Study||0||
59501089|NCT00663793|75592903|FG001|NOT COMPLETED|Overall Study||0||
59501090|NCT00667381|75592911|FG000|STARTED|Overall Study||501||
59501091|NCT00667381|75592912|FG001|STARTED|Overall Study||503||
59501092|NCT00667381|75592911|FG000|COMPLETED|Overall Study||501||
59501093|NCT00667381|75592912|FG001|COMPLETED|Overall Study||503||
59501094|NCT00667381|75592911|FG000|NOT COMPLETED|Overall Study||0||
59501095|NCT00667381|75592912|FG001|NOT COMPLETED|Overall Study||0||
59501096|NCT02336438|75592918|FG000|STARTED|Overall Study||11||
59501097|NCT02336438|75592918|FG000|COMPLETED|Overall Study||10||
59501098|NCT02336438|75592918|FG000|NOT COMPLETED|Overall Study||1||
59501099|NCT00667615|75592922|FG000|STARTED|Overall Study||30||
59501100|NCT00667615|75592922|FG000|COMPLETED|Overall Study||30||
59501101|NCT00667615|75592922|FG000|NOT COMPLETED|Overall Study||0||
59501102|NCT00667693|75592928|FG000|STARTED|Overall Study||49||
59501103|NCT00667693|75592929|FG001|STARTED|Overall Study||52||
59501104|NCT00667693|75592928|FG000|COMPLETED|Overall Study||49||
59501105|NCT00667693|75592929|FG001|COMPLETED|Overall Study||50||
59501106|NCT00667693|75592928|FG000|NOT COMPLETED|Overall Study||0||
59501107|NCT00667693|75592929|FG001|NOT COMPLETED|Overall Study||2||
59501108|NCT00667849|75592937|FG000|STARTED|Overall Study||250||
59501109|NCT00667849|75592938|FG001|STARTED|Overall Study||251||
59501110|NCT00667849|75592937|FG000|COMPLETED|Overall Study||142||
59501111|NCT00667849|75592938|FG001|COMPLETED|Overall Study||130||
59501112|NCT00667849|75592937|FG000|NOT COMPLETED|Overall Study||108||
59501113|NCT00667849|75592938|FG001|NOT COMPLETED|Overall Study||121||
59501114|NCT00705133|75592947|FG000|STARTED|Overall Study||15||
59501115|NCT00705133|75592947|FG000|COMPLETED|Overall Study||15||
59501116|NCT00705133|75592947|FG000|NOT COMPLETED|Overall Study||0||
59501117|NCT00684775|75592953|FG000|STARTED|Overall Study||19||
59501118|NCT00684775|75592954|FG001|STARTED|Overall Study||19||
59501119|NCT00684775|75592953|FG000|COMPLETED|Overall Study||19||
59501120|NCT00684775|75592954|FG001|COMPLETED|Overall Study||19||
59501121|NCT00684775|75592953|FG000|NOT COMPLETED|Overall Study||0||
59501122|NCT00684775|75592954|FG001|NOT COMPLETED|Overall Study||0||
59501123|NCT00685477|75592968|FG000|STARTED|Overall Study||10||
59501124|NCT00685477|75592969|FG001|STARTED|Overall Study||10||
59501125|NCT00685477|75592970|FG002|STARTED|Overall Study||10||
59501126|NCT00685477|75592971|FG003|STARTED|Overall Study||10||
59501127|NCT00685477|75592972|FG004|STARTED|Overall Study||10||
59501128|NCT00685477|75592973|FG005|STARTED|Overall Study||10||
59501129|NCT00685477|75592968|FG000|COMPLETED|Overall Study||10||
59501130|NCT00685477|75592969|FG001|COMPLETED|Overall Study||10||
59501131|NCT00685477|75592970|FG002|COMPLETED|Overall Study||10||
59501132|NCT00685477|75592971|FG003|COMPLETED|Overall Study||10||
59501133|NCT00685477|75592972|FG004|COMPLETED|Overall Study||10||
59501134|NCT00685477|75592973|FG005|COMPLETED|Overall Study||10||
59501135|NCT00685477|75592968|FG000|NOT COMPLETED|Overall Study||0||
59501136|NCT00685477|75592969|FG001|NOT COMPLETED|Overall Study||0||
59501137|NCT00685477|75592970|FG002|NOT COMPLETED|Overall Study||0||
59501138|NCT00685477|75592971|FG003|NOT COMPLETED|Overall Study||0||
59501139|NCT00685477|75592972|FG004|NOT COMPLETED|Overall Study||0||
59501140|NCT00685477|75592973|FG005|NOT COMPLETED|Overall Study||0||
59501141|NCT00686257|75592984|FG000|STARTED|Overall Study||29||
59501142|NCT00686257|75592985|FG001|STARTED|Overall Study||31||
59501143|NCT00686257|75592984|FG000|COMPLETED|Overall Study||29||
59501144|NCT00686257|75592985|FG001|COMPLETED|Overall Study||31||
59501145|NCT00686257|75592984|FG000|NOT COMPLETED|Overall Study||0||
59501146|NCT00686257|75592985|FG001|NOT COMPLETED|Overall Study||0||
59501147|NCT05310084|75592995|FG000|STARTED|Overall Study||568||
59501148|NCT05310084|75592996|FG001|STARTED|Overall Study||566||
59501149|NCT05310084|75592995|FG000|Vaccinated|Overall Study||564||
59501150|NCT05310084|75592996|FG001|Vaccinated|Overall Study||564||
59501151|NCT05310084|75592995|FG000|COMPLETED|Overall Study||560||
59501152|NCT05310084|75592996|FG001|COMPLETED|Overall Study||555||
59501153|NCT05310084|75592995|FG000|NOT COMPLETED|Overall Study||8||
59501154|NCT05310084|75592996|FG001|NOT COMPLETED|Overall Study||11||
59501155|NCT04859114|75593010|FG000|STARTED|Overall Study||176||
59501156|NCT04859114|75593011|FG001|STARTED|Overall Study||177||
59501157|NCT04859114|75593012|FG002|STARTED|Overall Study||179||
59501158|NCT04859114|75593013|FG003|STARTED|Overall Study||177||
59501159|NCT04859114|75593014|FG004|STARTED|Overall Study||176||
59501160|NCT04859114|75593015|FG005|STARTED|Overall Study||167||
59501161|NCT04859114|75593010|FG000|COMPLETED|Overall Study||176||
59501162|NCT04859114|75593011|FG001|COMPLETED|Overall Study||177||
59501163|NCT04859114|75593012|FG002|COMPLETED|Overall Study||179||
59501164|NCT04859114|75593013|FG003|COMPLETED|Overall Study||177||
59501165|NCT04859114|75593014|FG004|COMPLETED|Overall Study||176||
59501166|NCT04859114|75593015|FG005|COMPLETED|Overall Study||167||
59501167|NCT04859114|75593010|FG000|NOT COMPLETED|Overall Study||0||
59501168|NCT04859114|75593011|FG001|NOT COMPLETED|Overall Study||0||
59501169|NCT04859114|75593012|FG002|NOT COMPLETED|Overall Study||0||
59501170|NCT04859114|75593013|FG003|NOT COMPLETED|Overall Study||0||
59501171|NCT04859114|75593014|FG004|NOT COMPLETED|Overall Study||0||
59501172|NCT04859114|75593015|FG005|NOT COMPLETED|Overall Study||0||
59501173|NCT04581863|75593031|FG000|STARTED|Overall Study||1041||
59501174|NCT04581863|75593032|FG001|STARTED|Overall Study||1056||
59501175|NCT04581863|75593031|FG000|COMPLETED|Overall Study||1024||
59501176|NCT04581863|75593032|FG001|COMPLETED|Overall Study||1025||
59501177|NCT04581863|75593031|FG000|NOT COMPLETED|Overall Study||17||
59501178|NCT04581863|75593032|FG001|NOT COMPLETED|Overall Study||31||
59501179|NCT04349891|75593049|FG000|STARTED|First Intervention - 4 Weeks||15||
59501180|NCT04349891|75593050|FG001|STARTED|First Intervention - 4 Weeks||12||
59501181|NCT04349891|75593049|FG000|COMPLETED|First Intervention - 4 Weeks||11||
59501182|NCT04349891|75593050|FG001|COMPLETED|First Intervention - 4 Weeks||7||
59501183|NCT04349891|75593049|FG000|NOT COMPLETED|First Intervention - 4 Weeks||4||
59501184|NCT04349891|75593050|FG001|NOT COMPLETED|First Intervention - 4 Weeks||5||
59501185|NCT04349891|75593049|FG000|STARTED|Washout - 2 Weeks||11||
59501186|NCT04349891|75593050|FG001|STARTED|Washout - 2 Weeks||7||
59501187|NCT04349891|75593049|FG000|COMPLETED|Washout - 2 Weeks||10||
59501188|NCT04349891|75593050|FG001|COMPLETED|Washout - 2 Weeks||7||
59501189|NCT04349891|75593049|FG000|NOT COMPLETED|Washout - 2 Weeks||1||
59501190|NCT04349891|75593050|FG001|NOT COMPLETED|Washout - 2 Weeks||0||
59501191|NCT04349891|75593049|FG000|STARTED|Second Intervention - 4 Weeks||10||
59501192|NCT04349891|75593050|FG001|STARTED|Second Intervention - 4 Weeks||7||
59501193|NCT04349891|75593049|FG000|COMPLETED|Second Intervention - 4 Weeks||8||
59501194|NCT04349891|75593050|FG001|COMPLETED|Second Intervention - 4 Weeks||7||
59501195|NCT04349891|75593049|FG000|NOT COMPLETED|Second Intervention - 4 Weeks||2||
59501196|NCT04349891|75593050|FG001|NOT COMPLETED|Second Intervention - 4 Weeks||0||
59501197|NCT02258451|75593058|FG000|STARTED|Overall Study||142|Randomized|
59501198|NCT02258451|75593059|FG001|STARTED|Overall Study||141|Randomized|
59501199|NCT02258451|75593058|FG000|COMPLETED|Overall Study||0|As exemestane and everolimus given in this study as study treatment was of indefinite duration and ended only at progression, withdrawal, death, or study termination, no participants were considered to have completed their respective treatment regimen. However, all participants discontinued all study treatments.|
59501200|NCT02258451|75593059|FG001|COMPLETED|Overall Study||0|As exemestane and everolimus given in this study as study treatment was of indefinite duration and ended only at progression, withdrawal, death, or study termination, no participants were considered to have completed their respective treatment regimen. However, all participants discontinued all study treatments.|
59501201|NCT02258451|75593058|FG000|NOT COMPLETED|Overall Study||142||
59501202|NCT02258451|75593059|FG001|NOT COMPLETED|Overall Study||141||
59501203|NCT02168270|75593067|FG000|STARTED|Overall Study||4||
59501204|NCT02168270|75593067|FG000|COMPLETED|Overall Study||0||
59501205|NCT02168270|75593067|FG000|NOT COMPLETED|Overall Study||4||
59501206|NCT00686803|75593074|FG000|STARTED|Overall Study||6||
59501207|NCT00686803|75593075|FG001|STARTED|Overall Study||12||
59501208|NCT00686803|75593076|FG002|STARTED|Overall Study||3||
59501209|NCT00686803|75593074|FG000|COMPLETED|Overall Study||6||
59501210|NCT00686803|75593075|FG001|COMPLETED|Overall Study||12||
59501211|NCT00686803|75593076|FG002|COMPLETED|Overall Study||3||
59501212|NCT00686803|75593074|FG000|NOT COMPLETED|Overall Study||0||
59501213|NCT00686803|75593075|FG001|NOT COMPLETED|Overall Study||0||
59501214|NCT00686803|75593076|FG002|NOT COMPLETED|Overall Study||0||
59501215|NCT02144233|75593086|FG000|STARTED|Overall Study||39||
59501216|NCT02144233|75593087|FG001|STARTED|Overall Study||38||
59501217|NCT02144233|75593086|FG000|COMPLETED|Overall Study|The last participant was assessed at month 3 due to early study stop|39||
59501218|NCT02144233|75593087|FG001|COMPLETED|Overall Study||38||
59501219|NCT02144233|75593086|FG000|NOT COMPLETED|Overall Study||0||
59501220|NCT02144233|75593087|FG001|NOT COMPLETED|Overall Study||0||
59501221|NCT00690235|75593095|FG000|STARTED|Overall Study||17||
59501222|NCT00690235|75593096|FG001|STARTED|Overall Study||16||
59501223|NCT00690235|75593095|FG000|COMPLETED|Overall Study||12||
59501224|NCT00690235|75593096|FG001|COMPLETED|Overall Study||12||
59501225|NCT00690235|75593095|FG000|NOT COMPLETED|Overall Study||5||
59501226|NCT00690235|75593096|FG001|NOT COMPLETED|Overall Study||4||
59501227|NCT00006110|75593104|FG000|STARTED|Overall Study||52||
59607625|NCT02075411|75718309|FG001|STARTED|Overall Study||0||
59607626|NCT02075411|75718310|FG002|STARTED|Overall Study||0||
59501228|NCT00006110|75593105|FG001|STARTED|Overall Study||30||
59501229|NCT00006110|75593104|FG000|COMPLETED|Overall Study||52||
59607627|NCT02075411|75718311|FG003|STARTED|Overall Study||1||
59607628|NCT02075411|75718308|FG000|COMPLETED|Overall Study||0||
59607629|NCT02075411|75718309|FG001|COMPLETED|Overall Study||0||
59607630|NCT02075411|75718310|FG002|COMPLETED|Overall Study||0||
59607631|NCT02075411|75718311|FG003|COMPLETED|Overall Study||1||
59501230|NCT00006110|75593105|FG001|COMPLETED|Overall Study||30||
59501231|NCT00006110|75593104|FG000|NOT COMPLETED|Overall Study||0||
59501232|NCT00006110|75593105|FG001|NOT COMPLETED|Overall Study||0||
59501233|NCT00691327|75593119|FG000|STARTED|Overall Study||45055||
59501234|NCT00691327|75593120|FG001|STARTED|Overall Study||39274||
59501235|NCT00691327|75593119|FG000|COMPLETED|Overall Study||42214||
60013298|NCT02589665|76129273|FG002|COMPLETED|Induction Period||60||
60013299|NCT02589665|76129274|FG003|COMPLETED|Induction Period||57||
60013300|NCT02589665|76129275|FG004|COMPLETED|Induction Period||0||
60013301|NCT02589665|76129276|FG005|COMPLETED|Induction Period||0||
60013302|NCT02589665|76129277|FG006|COMPLETED|Induction Period||0||
60013303|NCT02589665|76129278|FG007|COMPLETED|Induction Period||0||
60013304|NCT02589665|76129279|FG008|COMPLETED|Induction Period||0||
60013305|NCT02589665|76129280|FG009|COMPLETED|Induction Period||0||
60013306|NCT02589665|76129271|FG000|NOT COMPLETED|Induction Period||3||
60013307|NCT02589665|76129272|FG001|NOT COMPLETED|Induction Period||2||
60013308|NCT02589665|76129273|FG002|NOT COMPLETED|Induction Period||2||
60013309|NCT02589665|76129274|FG003|NOT COMPLETED|Induction Period||4||
60013310|NCT02589665|76129275|FG004|NOT COMPLETED|Induction Period||0||
60013311|NCT02589665|76129276|FG005|NOT COMPLETED|Induction Period||0||
60013312|NCT02589665|76129277|FG006|NOT COMPLETED|Induction Period||0||
60013313|NCT02589665|76129278|FG007|NOT COMPLETED|Induction Period||0||
60013314|NCT02589665|76129279|FG008|NOT COMPLETED|Induction Period||0||
60013315|NCT02589665|76129280|FG009|NOT COMPLETED|Induction Period||0||
60013316|NCT02589665|76129271|FG000|STARTED|Maintenance Period|Participants were assigned to this arm only during induction period.|0||
60013317|NCT02589665|76129272|FG001|STARTED|Maintenance Period|Participants were assigned to this arm only during induction period.|0||
60013318|NCT02589665|76129273|FG002|STARTED|Maintenance Period|Participants were assigned to this arm only during induction period.|0||
60013319|NCT02589665|76129274|FG003|STARTED|Maintenance Period|Participants were assigned to this arm only during induction period.|0||
60013320|NCT02589665|76129275|FG004|STARTED|Maintenance Period|Only participants with a response were re-randomized in maintenance period.|13||
60013321|NCT02589665|76129276|FG005|STARTED|Maintenance Period|Only participants with a response were re-randomized in maintenance period.|47||
60013322|NCT02589665|76129277|FG006|STARTED|Maintenance Period|Only participants with a response were re-randomized in maintenance period.|46||
60013323|NCT02589665|76129278|FG007|STARTED|Maintenance Period||0||
60013324|NCT02589665|76129279|FG008|STARTED|Maintenance Period||0||
60013325|NCT02589665|76129280|FG009|STARTED|Maintenance Period||0||
60013326|NCT02589665|76129271|FG000|COMPLETED|Maintenance Period||0||
60013327|NCT02589665|76129272|FG001|COMPLETED|Maintenance Period||0||
60013328|NCT02589665|76129273|FG002|COMPLETED|Maintenance Period||0||
60013329|NCT02589665|76129274|FG003|COMPLETED|Maintenance Period||0||
60013330|NCT02589665|76129275|FG004|COMPLETED|Maintenance Period||0||
60013331|NCT02589665|76129276|FG005|COMPLETED|Maintenance Period||0||
60013332|NCT02589665|76129277|FG006|COMPLETED|Maintenance Period||0||
59501236|NCT00691327|75593120|FG001|COMPLETED|Overall Study||36766||
59501237|NCT00691327|75593119|FG000|NOT COMPLETED|Overall Study||2841||
59501238|NCT00691327|75593120|FG001|NOT COMPLETED|Overall Study||2508||
59501239|NCT00692185|75593128|FG000|STARTED|Overall Study||11||
59501240|NCT00692185|75593129|FG001|STARTED|Overall Study||12||
59501241|NCT00692185|75593128|FG000|COMPLETED|Overall Study||8||
59501242|NCT00692185|75593129|FG001|COMPLETED|Overall Study||9||
59501243|NCT00692185|75593128|FG000|NOT COMPLETED|Overall Study||3||
59501244|NCT00692185|75593129|FG001|NOT COMPLETED|Overall Study||3||
59501245|NCT00692341|75593140|FG000|STARTED|Overall Study||8||
59501246|NCT00692341|75593141|FG001|STARTED|Overall Study||8||
59501247|NCT00692341|75593142|FG002|STARTED|Overall Study||8||
59501248|NCT00692341|75593140|FG000|COMPLETED|Overall Study||8||
59501249|NCT00692341|75593141|FG001|COMPLETED|Overall Study||8||
59501250|NCT00692341|75593142|FG002|COMPLETED|Overall Study||8||
59501251|NCT00692341|75593140|FG000|NOT COMPLETED|Overall Study||0||
59501252|NCT00692341|75593141|FG001|NOT COMPLETED|Overall Study||0||
59501253|NCT00692341|75593142|FG002|NOT COMPLETED|Overall Study||0||
59501254|NCT00524537|75593150|FG000|STARTED|Overall Study|All Treated Population: All participants who received at least 1 injection of Humira in the registry|5025||
59885756|NCT03514641|76008568|FG002|STARTED|603A: 0-12 Week Study Period||0||
59885757|NCT03514641|76008569|FG003|STARTED|603A: 0-12 Week Study Period||0||
59885758|NCT03514641|76008566|FG000|COMPLETED|603A: 0-12 Week Study Period||307||
59885759|NCT03514641|76008567|FG001|COMPLETED|603A: 0-12 Week Study Period||319||
59885760|NCT03514641|76008568|FG002|COMPLETED|603A: 0-12 Week Study Period||0||
59885761|NCT03514641|76008569|FG003|COMPLETED|603A: 0-12 Week Study Period||0||
59885762|NCT03514641|76008566|FG000|NOT COMPLETED|603A: 0-12 Week Study Period||27||
59885763|NCT03514641|76008567|FG001|NOT COMPLETED|603A: 0-12 Week Study Period||20||
59885764|NCT03514641|76008568|FG002|NOT COMPLETED|603A: 0-12 Week Study Period||0||
59885765|NCT03514641|76008569|FG003|NOT COMPLETED|603A: 0-12 Week Study Period||0||
59885766|NCT03514641|76008566|FG000|STARTED|603B: 24-36 Week Study Period|The second part of study only applies to subjects in 603B|0||
59885767|NCT03514641|76008567|FG001|STARTED|603B: 24-36 Week Study Period|The second part of study only applies to subjects in 603B|0||
59885768|NCT03514641|76008568|FG002|STARTED|603B: 24-36 Week Study Period|The subjects were re-randomized in 603B|281||
59885769|NCT03514641|76008569|FG003|STARTED|603B: 24-36 Week Study Period|The subjects were re-randomized in 603B|281||
59885770|NCT03514641|76008566|FG000|COMPLETED|603B: 24-36 Week Study Period||0||
59885771|NCT03514641|76008567|FG001|COMPLETED|603B: 24-36 Week Study Period||0||
59885772|NCT03514641|76008568|FG002|COMPLETED|603B: 24-36 Week Study Period||267||
59885773|NCT03514641|76008569|FG003|COMPLETED|603B: 24-36 Week Study Period||266||
59885774|NCT03514641|76008566|FG000|NOT COMPLETED|603B: 24-36 Week Study Period||0||
59885775|NCT03514641|76008567|FG001|NOT COMPLETED|603B: 24-36 Week Study Period||0||
59885776|NCT03514641|76008568|FG002|NOT COMPLETED|603B: 24-36 Week Study Period||14||
59885777|NCT03514641|76008569|FG003|NOT COMPLETED|603B: 24-36 Week Study Period||15||
59885778|NCT00100828|76008581|FG000|STARTED|Overall Study||6||
59885779|NCT00100828|76008581|FG000|COMPLETED|Overall Study||0|Trial closed due to early stopping rule and low enrollment.|
59885780|NCT00100828|76008581|FG000|NOT COMPLETED|Overall Study||6||
59885781|NCT00100048|76008590|FG000|STARTED|Cohort I-Monotherapy Phase 10 Days||7||
59885782|NCT00100048|76008591|FG001|STARTED|Cohort I-Monotherapy Phase 10 Days||7||
59885783|NCT00100048|76008592|FG002|STARTED|Cohort I-Monotherapy Phase 10 Days||6||
59885784|NCT00100048|76008593|FG003|STARTED|Cohort I-Monotherapy Phase 10 Days||8||
59885785|NCT00100048|76008594|FG004|STARTED|Cohort I-Monotherapy Phase 10 Days||7||
59885786|NCT00100048|76008595|FG005|STARTED|Cohort I-Monotherapy Phase 10 Days|participants only assigned Efavirenz 600 mg q.h.s in Cohort II Combined-Combination Therapy Phase|0||
59885787|NCT00100048|76008590|FG000|Treated|Cohort I-Monotherapy Phase 10 Days||7||
59885788|NCT00100048|76008591|FG001|Treated|Cohort I-Monotherapy Phase 10 Days||7||
59885789|NCT00100048|76008592|FG002|Treated|Cohort I-Monotherapy Phase 10 Days||6||
59885790|NCT00100048|76008593|FG003|Treated|Cohort I-Monotherapy Phase 10 Days||8||
59885791|NCT00100048|76008594|FG004|Treated|Cohort I-Monotherapy Phase 10 Days||7||
59501255|NCT00524537|75593150|FG000|Discontinued|Overall Study|Discontinued from study|2811||
59501256|NCT00524537|75593150|FG000|Re-enrolled|Overall Study|Discontinued from study and later re-enrolled in study|339||
59501257|NCT00524537|75593150|FG000|Discontinued After Re-enrollment|Overall Study|Discontinued from study after re-enrollment|102||
59501258|NCT00524537|75593150|FG000|COMPLETED|Overall Study|Still enrolled in study at the end of study|2451||
59501259|NCT00524537|75593150|FG000|NOT COMPLETED|Overall Study||2574||
59885792|NCT00100048|76008595|FG005|Treated|Cohort I-Monotherapy Phase 10 Days||0||
59885793|NCT00100048|76008590|FG000|COMPLETED|Cohort I-Monotherapy Phase 10 Days|7 Subjects Continued to Cohort II Combined-Combination Therapy Phase (48 Weeks)|7||
59885794|NCT00100048|76008591|FG001|COMPLETED|Cohort I-Monotherapy Phase 10 Days|7 Subjects Continued to Cohort II Combined-Combination Therapy Phase (48 Weeks)|7||
59885795|NCT00100048|76008592|FG002|COMPLETED|Cohort I-Monotherapy Phase 10 Days|6 Subjects Continued to Cohort II Combined-Combination Therapy Phase (48 Weeks)|6||
59885796|NCT00100048|76008593|FG003|COMPLETED|Cohort I-Monotherapy Phase 10 Days|6 Subjects Continued to Cohort II Combined-Combination Therapy Phase (48 Weeks)|8||
59885797|NCT00100048|76008594|FG004|COMPLETED|Cohort I-Monotherapy Phase 10 Days|4 Subjects Continued to Cohort II, as part of the Efavirenz 600 mg q.d. arm|7||
60013333|NCT02589665|76129278|FG007|COMPLETED|Maintenance Period||0||
59501260|NCT03514394|75593157|FG000|STARTED|Overall Study||17||
59501261|NCT03514394|75593158|FG001|STARTED|Overall Study||16||
59501262|NCT03514394|75593159|FG002|STARTED|Overall Study||11||
59501263|NCT03514394|75593157|FG000|COMPLETED|Overall Study||17||
59501264|NCT03514394|75593158|FG001|COMPLETED|Overall Study||16||
59501265|NCT03514394|75593159|FG002|COMPLETED|Overall Study||10||
59501266|NCT03514394|75593157|FG000|NOT COMPLETED|Overall Study||0||
59501267|NCT03514394|75593158|FG001|NOT COMPLETED|Overall Study||0||
59501268|NCT03514394|75593159|FG002|NOT COMPLETED|Overall Study||1||
59501269|NCT00589849|75593166|FG000|STARTED|Overall Study||32||
59501270|NCT00589849|75593166|FG000|COMPLETED|Overall Study||32||
59501271|NCT00589849|75593166|FG000|NOT COMPLETED|Overall Study||0||
59501272|NCT00525629|75593170|FG000|STARTED|First Intervention||20||
59501273|NCT00525629|75593171|FG001|STARTED|First Intervention||20||
59501274|NCT00525629|75593170|FG000|COMPLETED|First Intervention||15||
59501275|NCT00525629|75593171|FG001|COMPLETED|First Intervention||15||
59501276|NCT00525629|75593170|FG000|NOT COMPLETED|First Intervention||5||
59501277|NCT00525629|75593171|FG001|NOT COMPLETED|First Intervention||5||
59501278|NCT00525629|75593170|FG000|STARTED|Washout||15||
59501279|NCT00525629|75593171|FG001|STARTED|Washout||15||
59501280|NCT00525629|75593170|FG000|COMPLETED|Washout||15||
59501281|NCT00525629|75593171|FG001|COMPLETED|Washout||15||
59501282|NCT00525629|75593170|FG000|NOT COMPLETED|Washout||0||
59501283|NCT00525629|75593171|FG001|NOT COMPLETED|Washout||0||
59501284|NCT00525629|75593170|FG000|STARTED|Second Intervention||15||
59501285|NCT00525629|75593171|FG001|STARTED|Second Intervention||15||
59501286|NCT00525629|75593170|FG000|COMPLETED|Second Intervention||0||
59501287|NCT00525629|75593171|FG001|COMPLETED|Second Intervention||0||
59501288|NCT00525629|75593170|FG000|NOT COMPLETED|Second Intervention||15||
59501289|NCT00525629|75593171|FG001|NOT COMPLETED|Second Intervention||15||
59501290|NCT00692419|75593179|FG000|STARTED|Overall Study||100||
59501291|NCT00692419|75593180|FG001|STARTED|Overall Study||120||
59501292|NCT00692419|75593179|FG000|COMPLETED|Overall Study||84||
59501293|NCT00692419|75593180|FG001|COMPLETED|Overall Study||102||
59501294|NCT00692419|75593179|FG000|NOT COMPLETED|Overall Study||16||
59501295|NCT00692419|75593180|FG001|NOT COMPLETED|Overall Study||18||
59501296|NCT02122445|75593190|FG000|STARTED|Overall Study||20||
59501297|NCT02122445|75593190|FG000|COMPLETED|Overall Study||20||
59501298|NCT02122445|75593190|FG000|NOT COMPLETED|Overall Study||0||
59501299|NCT00694603|75593194|FG000|STARTED|Overall Study||18||
59501300|NCT00694603|75593194|FG000|COMPLETED|Overall Study||18||
59501301|NCT00694603|75593194|FG000|NOT COMPLETED|Overall Study||0||
59501302|NCT00590005|75593198|FG000|STARTED|Overall Study||106||
59501303|NCT00590005|75593199|FG001|STARTED|Overall Study||119||
59501304|NCT00590005|75593198|FG000|COMPLETED|Overall Study||106||
59501305|NCT00590005|75593199|FG001|COMPLETED|Overall Study||119||
59501306|NCT00590005|75593198|FG000|NOT COMPLETED|Overall Study||0||
59501307|NCT00590005|75593199|FG001|NOT COMPLETED|Overall Study||0||
59501308|NCT00590161|75593207|FG000|STARTED|Overall Study||26||
59501309|NCT00590161|75593208|FG001|STARTED|Overall Study||29||
59501310|NCT00590161|75593207|FG000|COMPLETED|Overall Study||23||
59501311|NCT00590161|75593208|FG001|COMPLETED|Overall Study||26||
59501312|NCT00590161|75593207|FG000|NOT COMPLETED|Overall Study||3||
59501313|NCT00590161|75593208|FG001|NOT COMPLETED|Overall Study||3||
59501314|NCT00590395|75593214|FG000|STARTED|Overall Study||19||
59501315|NCT00590395|75593214|FG000|COMPLETED|Overall Study||19||
59501316|NCT00590395|75593214|FG000|NOT COMPLETED|Overall Study||0||
59501317|NCT00006170|75593222|FG000|STARTED|Overall Study||106||
59501318|NCT00006170|75593223|FG001|STARTED|Overall Study||87||
59501319|NCT00006170|75593224|FG002|STARTED|Overall Study||89||
59607632|NCT02075411|75718308|FG000|NOT COMPLETED|Overall Study||0||
59501320|NCT00006170|75593225|FG003|STARTED|Overall Study||67||
59501321|NCT00006170|75593222|FG000|COMPLETED|Overall Study||57||
59501322|NCT00006170|75593223|FG001|COMPLETED|Overall Study||37||
59501323|NCT00006170|75593224|FG002|COMPLETED|Overall Study||46||
59501324|NCT00006170|75593225|FG003|COMPLETED|Overall Study||28||
59501325|NCT00006170|75593222|FG000|NOT COMPLETED|Overall Study||49||
59501326|NCT00006170|75593223|FG001|NOT COMPLETED|Overall Study||50||
59501327|NCT00006170|75593224|FG002|NOT COMPLETED|Overall Study||43||
59501328|NCT00006170|75593225|FG003|NOT COMPLETED|Overall Study||39||
59501329|NCT02123849|75593237|FG000|STARTED|Overall Study||27||
59501330|NCT02123849|75593238|FG001|STARTED|Overall Study||27||
59501331|NCT02123849|75593237|FG000|COMPLETED|Overall Study||23||
59501332|NCT02123849|75593238|FG001|COMPLETED|Overall Study||18||
59607633|NCT02075411|75718309|FG001|NOT COMPLETED|Overall Study||0||
59607634|NCT02075411|75718310|FG002|NOT COMPLETED|Overall Study||0||
59501333|NCT02123849|75593237|FG000|NOT COMPLETED|Overall Study||4||
59501334|NCT02123849|75593238|FG001|NOT COMPLETED|Overall Study||9||
59501335|NCT00590707|75593248|FG000|STARTED|Overall Study||100||
59501336|NCT00590707|75593249|FG001|STARTED|Overall Study||100||
59501337|NCT00590707|75593248|FG000|COMPLETED|Overall Study||100||
59607635|NCT02075411|75718311|FG003|NOT COMPLETED|Overall Study||0||
59501338|NCT00590707|75593249|FG001|COMPLETED|Overall Study||100||
59501339|NCT00590707|75593248|FG000|NOT COMPLETED|Overall Study||0||
59501340|NCT00590707|75593249|FG001|NOT COMPLETED|Overall Study||0||
59501341|NCT00671528|75593258|FG000|STARTED|Overall Study||1||
59501342|NCT00671528|75593259|FG001|STARTED|Overall Study||1||
59501343|NCT00671528|75593260|FG002|STARTED|Overall Study||1||
59501344|NCT00671528|75593258|FG000|COMPLETED|Overall Study||1||
59501345|NCT00671528|75593259|FG001|COMPLETED|Overall Study||1||
59501346|NCT00671528|75593260|FG002|COMPLETED|Overall Study||1||
59501347|NCT00671528|75593258|FG000|NOT COMPLETED|Overall Study||0||
59501348|NCT00671528|75593259|FG001|NOT COMPLETED|Overall Study||0||
59501349|NCT00671528|75593260|FG002|NOT COMPLETED|Overall Study||0||
59501350|NCT00590863|75593271|FG000|STARTED|Overall Study||221||
59501351|NCT00590863|75593272|FG001|STARTED|Overall Study||220||
59501352|NCT00590863|75593273|FG002|STARTED|Overall Study||224||
59501353|NCT00590863|75593271|FG000|COMPLETED|Overall Study||137||
59501354|NCT00590863|75593272|FG001|COMPLETED|Overall Study||138||
59501355|NCT00590863|75593273|FG002|COMPLETED|Overall Study||146||
59501356|NCT00590863|75593271|FG000|NOT COMPLETED|Overall Study||84||
59501357|NCT00590863|75593272|FG001|NOT COMPLETED|Overall Study||82||
59501358|NCT00590863|75593273|FG002|NOT COMPLETED|Overall Study||78||
59501359|NCT00591019|75593282|FG000|STARTED|Baseline (1 Day)||3||
59501360|NCT00591019|75593283|FG001|STARTED|Baseline (1 Day)||4||
59501361|NCT00591019|75593282|FG000|COMPLETED|Baseline (1 Day)||3||
59501362|NCT00591019|75593283|FG001|COMPLETED|Baseline (1 Day)||4||
59501363|NCT00591019|75593282|FG000|NOT COMPLETED|Baseline (1 Day)||0||
59501364|NCT00591019|75593283|FG001|NOT COMPLETED|Baseline (1 Day)||0||
59501365|NCT00591019|75593282|FG000|STARTED|Intervention 1 (14 Days)|One subject dropped out after baseline|2||
59501366|NCT00591019|75593283|FG001|STARTED|Intervention 1 (14 Days)|One subject dropped out after baseline|3||
59501367|NCT00591019|75593282|FG000|COMPLETED|Intervention 1 (14 Days)||2||
59501368|NCT00591019|75593283|FG001|COMPLETED|Intervention 1 (14 Days)||3||
59501369|NCT00591019|75593282|FG000|NOT COMPLETED|Intervention 1 (14 Days)||0||
59501370|NCT00591019|75593283|FG001|NOT COMPLETED|Intervention 1 (14 Days)||0||
59501371|NCT00591019|75593282|FG000|STARTED|Intevention 2 (14 Days)||2||
59501372|NCT00591019|75593283|FG001|STARTED|Intevention 2 (14 Days)||3||
59501373|NCT00591019|75593282|FG000|COMPLETED|Intevention 2 (14 Days)||2||
59501374|NCT00591019|75593283|FG001|COMPLETED|Intevention 2 (14 Days)||3||
59501375|NCT00591019|75593282|FG000|NOT COMPLETED|Intevention 2 (14 Days)||0||
59501376|NCT00591019|75593283|FG001|NOT COMPLETED|Intevention 2 (14 Days)||0||
59501377|NCT02128919|75593293|FG000|STARTED|Overall Study||17||
59501378|NCT02128919|75593294|FG001|STARTED|Overall Study||16||
59501379|NCT02128919|75593293|FG000|COMPLETED|Overall Study||14||
59501380|NCT02128919|75593294|FG001|COMPLETED|Overall Study||15||
59501381|NCT02128919|75593293|FG000|NOT COMPLETED|Overall Study||3||
59501382|NCT02128919|75593294|FG001|NOT COMPLETED|Overall Study||1||
59501383|NCT00359138|75593304|FG000|STARTED|Overall Study||12||
59501384|NCT00359138|75593305|FG001|STARTED|Overall Study||12||
59501385|NCT00359138|75593306|FG002|STARTED|Overall Study||12||
59501386|NCT00359138|75593304|FG000|COMPLETED|Overall Study||12||
59501387|NCT00359138|75593305|FG001|COMPLETED|Overall Study||12||
59501388|NCT00359138|75593306|FG002|COMPLETED|Overall Study||12||
59501389|NCT00359138|75593304|FG000|NOT COMPLETED|Overall Study||0||
59501390|NCT00359138|75593305|FG001|NOT COMPLETED|Overall Study||0||
59501391|NCT00359138|75593306|FG002|NOT COMPLETED|Overall Study||0||
59501392|NCT00003404|75593314|FG000|STARTED|Overall Study||46||
59501393|NCT00003404|75593314|FG000|COMPLETED|Overall Study||46||
59501394|NCT00003404|75593314|FG000|NOT COMPLETED|Overall Study||0||
59501395|NCT00697801|75593322|FG000|STARTED|Overall Study||69||
59501396|NCT00697801|75593323|FG001|STARTED|Overall Study||70||
59501397|NCT00697801|75593324|FG002|STARTED|Overall Study||69||
59501398|NCT00697801|75593322|FG000|COMPLETED|Overall Study||57||
59501399|NCT00697801|75593323|FG001|COMPLETED|Overall Study||58||
59501400|NCT00697801|75593324|FG002|COMPLETED|Overall Study||45||
59501401|NCT00697801|75593322|FG000|NOT COMPLETED|Overall Study||12||
59501402|NCT00697801|75593323|FG001|NOT COMPLETED|Overall Study||12||
59501403|NCT00697801|75593324|FG002|NOT COMPLETED|Overall Study||24||
59501404|NCT00698035|75593334|FG000|STARTED|Overall Study||39||
59501405|NCT00698035|75593335|FG001|STARTED|Overall Study||36||
59501406|NCT00698035|75593334|FG000|COMPLETED|Overall Study||35||
59501407|NCT00698035|75593335|FG001|COMPLETED|Overall Study||34||
59501408|NCT00698035|75593334|FG000|NOT COMPLETED|Overall Study||4||
59501409|NCT00698035|75593335|FG001|NOT COMPLETED|Overall Study||2||
59501410|NCT03496844|75593344|FG000|STARTED|Overall Study||15||
59501411|NCT03496844|75593344|FG000|COMPLETED|Overall Study||15||
59501412|NCT03496844|75593344|FG000|NOT COMPLETED|Overall Study||0||
59501413|NCT02339389|75593348|FG000|STARTED|Overall Study||57||
59501414|NCT02339389|75593348|FG000|COMPLETED|Overall Study||41||
59755335|NCT04214288|75874332|FG002|NOT COMPLETED|Overall Study||20||
59501415|NCT02339389|75593348|FG000|NOT COMPLETED|Overall Study||16||
59501416|NCT02129075|75593355|FG000|STARTED|Overall Study||30||
59501417|NCT02129075|75593356|FG001|STARTED|Overall Study||30||
59501418|NCT02129075|75593355|FG000|COMPLETED|Overall Study||30||
59501419|NCT02129075|75593356|FG001|COMPLETED|Overall Study||30||
59501420|NCT02129075|75593355|FG000|NOT COMPLETED|Overall Study||0||
59501421|NCT02129075|75593356|FG001|NOT COMPLETED|Overall Study||0||
59501422|NCT02775903|75593368|FG000|STARTED|Overall Study||42||
59501423|NCT02775903|75593369|FG001|STARTED|Overall Study||42||
59501424|NCT02775903|75593370|FG002|STARTED|Overall Study||64||
59501425|NCT02775903|75593371|FG003|STARTED|Overall Study||65||
59501426|NCT02775903|75593368|FG000|COMPLETED|Overall Study||4||
59501427|NCT02775903|75593369|FG001|COMPLETED|Overall Study||1||
59501428|NCT02775903|75593370|FG002|COMPLETED|Overall Study||1||
59501429|NCT02775903|75593371|FG003|COMPLETED|Overall Study||5||
59501430|NCT02775903|75593368|FG000|NOT COMPLETED|Overall Study||38||
59501431|NCT02775903|75593369|FG001|NOT COMPLETED|Overall Study||41||
59501432|NCT02775903|75593370|FG002|NOT COMPLETED|Overall Study||63||
59501433|NCT02775903|75593371|FG003|NOT COMPLETED|Overall Study||60||
59501434|NCT00700063|75593392|FG000|STARTED|Overall Study||33||
59501435|NCT00700063|75593393|FG001|STARTED|Overall Study||34||
59501436|NCT00700063|75593394|FG002|STARTED|Overall Study||33||
59501437|NCT00700063|75593395|FG003|STARTED|Overall Study||33||
59501438|NCT00700063|75593396|FG004|STARTED|Overall Study||33||
59501439|NCT00700063|75593397|FG005|STARTED|Overall Study||34||
59501440|NCT00700063|75593398|FG006|STARTED|Overall Study||32||
59501441|NCT00700063|75593399|FG007|STARTED|Overall Study||33||
59501442|NCT00700063|75593392|FG000|COMPLETED|Overall Study||32||
59501443|NCT00700063|75593393|FG001|COMPLETED|Overall Study||34||
59501444|NCT00700063|75593394|FG002|COMPLETED|Overall Study||33||
59501445|NCT00700063|75593395|FG003|COMPLETED|Overall Study||31||
59501446|NCT00700063|75593396|FG004|COMPLETED|Overall Study||31||
59501447|NCT00700063|75593397|FG005|COMPLETED|Overall Study||34||
59501448|NCT00700063|75593398|FG006|COMPLETED|Overall Study||32||
59501449|NCT00700063|75593399|FG007|COMPLETED|Overall Study||33||
59501450|NCT00700063|75593392|FG000|NOT COMPLETED|Overall Study||1||
59501451|NCT00700063|75593393|FG001|NOT COMPLETED|Overall Study||0||
59501452|NCT00700063|75593394|FG002|NOT COMPLETED|Overall Study||0||
59501453|NCT00700063|75593395|FG003|NOT COMPLETED|Overall Study||2||
59501454|NCT00700063|75593396|FG004|NOT COMPLETED|Overall Study||2||
59501455|NCT00700063|75593397|FG005|NOT COMPLETED|Overall Study||0||
59501456|NCT00700063|75593398|FG006|NOT COMPLETED|Overall Study||0||
59501457|NCT00700063|75593399|FG007|NOT COMPLETED|Overall Study||0||
59501458|NCT01933425|75593417|FG000|STARTED|Overall Study||7||
59501459|NCT01933425|75593418|FG001|STARTED|Overall Study||7||
59755336|NCT04214288|75874333|FG003|NOT COMPLETED|Overall Study||73||
59501460|NCT01933425|75593417|FG000|COMPLETED|Overall Study||7||
59501461|NCT01933425|75593418|FG001|COMPLETED|Overall Study||7||
59501462|NCT01933425|75593417|FG000|NOT COMPLETED|Overall Study||0||
59501463|NCT01933425|75593418|FG001|NOT COMPLETED|Overall Study||0||
59501464|NCT00594061|75593426|FG000|STARTED|Overall Study||9||
59501465|NCT00594061|75593426|FG000|COMPLETED|Overall Study||9||
59501466|NCT00594061|75593426|FG000|NOT COMPLETED|Overall Study||0||
59501467|NCT01934517|75593430|FG000|STARTED|Overall Study||25||
59501468|NCT01934517|75593430|FG000|COMPLETED|Overall Study||25||
59501469|NCT01934517|75593430|FG000|NOT COMPLETED|Overall Study||0||
59501470|NCT02723019|75593440|FG000|STARTED|Overall Study||271||
59501471|NCT02723019|75593441|FG001|STARTED|Overall Study||265||
59501472|NCT02723019|75593440|FG000|COMPLETED|Overall Study||186||
59501473|NCT02723019|75593441|FG001|COMPLETED|Overall Study||175||
59501474|NCT02723019|75593440|FG000|NOT COMPLETED|Overall Study||85||
59501475|NCT02723019|75593441|FG001|NOT COMPLETED|Overall Study||90||
59501476|NCT02622295|75593449|FG000|STARTED|Overall Study||40||
59501477|NCT02622295|75593450|FG001|STARTED|Overall Study||31||
59501478|NCT02622295|75593449|FG000|COMPLETED|Overall Study||40||
59501479|NCT02622295|75593450|FG001|COMPLETED|Overall Study||31||
59501480|NCT02622295|75593449|FG000|NOT COMPLETED|Overall Study||0||
59501481|NCT02622295|75593450|FG001|NOT COMPLETED|Overall Study||0||
59501482|NCT01936389|75593458|FG000|STARTED|Overall Study||5||
59501483|NCT01936389|75593459|FG001|STARTED|Overall Study||5||
59501484|NCT01936389|75593458|FG000|COMPLETED|Overall Study||4||
59501485|NCT01936389|75593459|FG001|COMPLETED|Overall Study||5||
59501486|NCT01936389|75593458|FG000|NOT COMPLETED|Overall Study||1||
59501487|NCT01936389|75593459|FG001|NOT COMPLETED|Overall Study||0||
59501488|NCT00700141|75593465|FG000|STARTED|Overall Study||482||
59501489|NCT00700141|75593465|FG000|COMPLETED|Overall Study||482||
59501490|NCT00700141|75593465|FG000|NOT COMPLETED|Overall Study||0||
59501491|NCT01936467|75593471|FG000|STARTED|Overall Study||60||
59501492|NCT01936467|75593472|FG001|STARTED|Overall Study||61||
59501493|NCT01936467|75593471|FG000|COMPLETED|Overall Study||60||
59501494|NCT01936467|75593472|FG001|COMPLETED|Overall Study||61||
59501495|NCT01936467|75593471|FG000|NOT COMPLETED|Overall Study||0||
59501496|NCT01936467|75593472|FG001|NOT COMPLETED|Overall Study||0||
59885798|NCT00100048|76008595|FG005|COMPLETED|Cohort I-Monotherapy Phase 10 Days||0||
59607636|NCT03753113|75718323|FG000|STARTED|Overall Study||12||
59885799|NCT00100048|76008590|FG000|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0||
59885800|NCT00100048|76008591|FG001|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0||
59501497|NCT00594685|75593482|FG000|STARTED|Overall Study||10||
59501498|NCT00594685|75593482|FG000|COMPLETED|Overall Study||10||
59501499|NCT00594685|75593482|FG000|NOT COMPLETED|Overall Study||0||
59501500|NCT00594997|75593488|FG000|STARTED|Overall Study||1562||
59501501|NCT00594997|75593489|FG001|STARTED|Overall Study||2008||
59501502|NCT00594997|75593488|FG000|COMPLETED|Overall Study||1562||
59501503|NCT00594997|75593489|FG001|COMPLETED|Overall Study||2008||
59501504|NCT00594997|75593488|FG000|NOT COMPLETED|Overall Study||0||
59501505|NCT00594997|75593489|FG001|NOT COMPLETED|Overall Study||0||
59501506|NCT00700375|75593499|FG000|STARTED|Overall Study||30||
59501507|NCT00700375|75593500|FG001|STARTED|Overall Study||29||
59501508|NCT00700375|75593499|FG000|2 Days After Creatinine Mesurement|Overall Study||30||
59501509|NCT00700375|75593500|FG001|2 Days After Creatinine Mesurement|Overall Study||29||
59501510|NCT00700375|75593499|FG000|COMPLETED|Overall Study||30||
59501511|NCT00700375|75593500|FG001|COMPLETED|Overall Study||29||
59501512|NCT00700375|75593499|FG000|NOT COMPLETED|Overall Study||0||
59501513|NCT00700375|75593500|FG001|NOT COMPLETED|Overall Study||0||
59501514|NCT02124083|75593506|FG000|STARTED|Overall Study||12||
59501515|NCT02124083|75593506|FG000|COMPLETED|Overall Study||11||
59501516|NCT02124083|75593506|FG000|NOT COMPLETED|Overall Study||1||
59501517|NCT00701389|75593510|FG000|STARTED|Period 1||6||
59501518|NCT00701389|75593511|FG001|STARTED|Period 1||6||
59501519|NCT00701389|75593512|FG002|STARTED|Period 1||6||
59501520|NCT00701389|75593513|FG003|STARTED|Period 1||6||
59501521|NCT00701389|75593510|FG000|COMPLETED|Period 1||6||
59501522|NCT00701389|75593511|FG001|COMPLETED|Period 1||6||
59501523|NCT00701389|75593512|FG002|COMPLETED|Period 1||6||
59501524|NCT00701389|75593513|FG003|COMPLETED|Period 1||6||
59501525|NCT00701389|75593510|FG000|NOT COMPLETED|Period 1||0||
59501526|NCT00701389|75593511|FG001|NOT COMPLETED|Period 1||0||
59501527|NCT00701389|75593512|FG002|NOT COMPLETED|Period 1||0||
59501528|NCT00701389|75593513|FG003|NOT COMPLETED|Period 1||0||
59755337|NCT04118166|75874343|FG000|STARTED|Overall Study||30||
59755338|NCT04118166|75874343|FG000|COMPLETED|Overall Study||29||
59755339|NCT04118166|75874343|FG000|NOT COMPLETED|Overall Study||1||
59501529|NCT00701389|75593510|FG000|STARTED|Period 2||6||
59501530|NCT00701389|75593511|FG001|STARTED|Period 2||6||
59501531|NCT00701389|75593512|FG002|STARTED|Period 2||6||
59501532|NCT00701389|75593513|FG003|STARTED|Period 2||6||
59501533|NCT00701389|75593510|FG000|COMPLETED|Period 2||6||
59501534|NCT00701389|75593511|FG001|COMPLETED|Period 2||6||
59501535|NCT00701389|75593512|FG002|COMPLETED|Period 2||6||
59501536|NCT00701389|75593513|FG003|COMPLETED|Period 2||6||
59501537|NCT00701389|75593510|FG000|NOT COMPLETED|Period 2||0||
59501538|NCT00701389|75593511|FG001|NOT COMPLETED|Period 2||0||
59501539|NCT00701389|75593512|FG002|NOT COMPLETED|Period 2||0||
59501540|NCT00701389|75593513|FG003|NOT COMPLETED|Period 2||0||
59501541|NCT00701389|75593510|FG000|STARTED|Period 3||6||
59501542|NCT00701389|75593511|FG001|STARTED|Period 3||6||
59501543|NCT00701389|75593512|FG002|STARTED|Period 3||6||
59501544|NCT00701389|75593513|FG003|STARTED|Period 3||6||
59501545|NCT00701389|75593510|FG000|COMPLETED|Period 3||6||
59501546|NCT00701389|75593511|FG001|COMPLETED|Period 3||6||
59501547|NCT00701389|75593512|FG002|COMPLETED|Period 3||6||
59501548|NCT00701389|75593513|FG003|COMPLETED|Period 3||6||
59501549|NCT00701389|75593510|FG000|NOT COMPLETED|Period 3||0||
59501550|NCT00701389|75593511|FG001|NOT COMPLETED|Period 3||0||
59501551|NCT00701389|75593512|FG002|NOT COMPLETED|Period 3||0||
59501552|NCT00701389|75593513|FG003|NOT COMPLETED|Period 3||0||
59501553|NCT00701389|75593510|FG000|STARTED|Period 4||6||
59501554|NCT00701389|75593511|FG001|STARTED|Period 4||6||
59501555|NCT00701389|75593512|FG002|STARTED|Period 4||6||
59501556|NCT00701389|75593513|FG003|STARTED|Period 4||6||
59501557|NCT00701389|75593510|FG000|COMPLETED|Period 4||6||
59501558|NCT00701389|75593511|FG001|COMPLETED|Period 4||6||
59501559|NCT00701389|75593512|FG002|COMPLETED|Period 4||6||
59755340|NCT04103749|75874348|FG000|STARTED|Overall Study||551||
59755341|NCT04103749|75874348|FG000|COMPLETED|Overall Study||495||
59755342|NCT04103749|75874348|FG000|NOT COMPLETED|Overall Study||56||
59755343|NCT04072315|75874360|FG000|STARTED|Overall Study||1||
59755344|NCT04072315|75874361|FG001|STARTED|Overall Study||1||
59501560|NCT00701389|75593513|FG003|COMPLETED|Period 4||6||
59501561|NCT00701389|75593510|FG000|NOT COMPLETED|Period 4||0||
59501562|NCT00701389|75593511|FG001|NOT COMPLETED|Period 4||0||
59501563|NCT00701389|75593512|FG002|NOT COMPLETED|Period 4||0||
59501564|NCT00701389|75593513|FG003|NOT COMPLETED|Period 4||0||
59501565|NCT02336594|75593531|FG000|STARTED|Overall Study||3||
59501566|NCT02336594|75593532|FG001|STARTED|Overall Study||4||
59501567|NCT02336594|75593533|FG002|STARTED|Overall Study||4||
59501568|NCT02336594|75593534|FG003|STARTED|Overall Study||4||
59501569|NCT02336594|75593531|FG000|COMPLETED|Overall Study||3||
59501570|NCT02336594|75593532|FG001|COMPLETED|Overall Study||4||
59501571|NCT02336594|75593533|FG002|COMPLETED|Overall Study||4||
59501572|NCT02336594|75593534|FG003|COMPLETED|Overall Study||4||
59501573|NCT02336594|75593531|FG000|NOT COMPLETED|Overall Study||0||
59501574|NCT02336594|75593532|FG001|NOT COMPLETED|Overall Study||0||
59501575|NCT02336594|75593533|FG002|NOT COMPLETED|Overall Study||0||
59501576|NCT02336594|75593534|FG003|NOT COMPLETED|Overall Study||0||
59501577|NCT00595153|75593550|FG000|STARTED|Overall Study||24||
59607637|NCT03753113|75718324|FG001|STARTED|Overall Study||12||
59607638|NCT03753113|75718323|FG000|COMPLETED|Overall Study||12||
59607639|NCT03753113|75718324|FG001|COMPLETED|Overall Study||12||
59607640|NCT03753113|75718323|FG000|NOT COMPLETED|Overall Study||0||
59607641|NCT03753113|75718324|FG001|NOT COMPLETED|Overall Study||0||
59755345|NCT04072315|75874362|FG002|STARTED|Overall Study||1||
59755346|NCT04072315|75874363|FG003|STARTED|Overall Study||2||
59755347|NCT04072315|75874364|FG004|STARTED|Overall Study||1||
59755348|NCT04072315|75874365|FG005|STARTED|Overall Study||1||
59755349|NCT04072315|75874366|FG006|STARTED|Overall Study||1||
59755350|NCT04072315|75874367|FG007|STARTED|Overall Study||1||
59755351|NCT04072315|75874360|FG000|COMPLETED|Overall Study||1||
59755352|NCT04072315|75874361|FG001|COMPLETED|Overall Study||1||
59755353|NCT04072315|75874362|FG002|COMPLETED|Overall Study||0||
59755354|NCT04072315|75874363|FG003|COMPLETED|Overall Study||2||
59755355|NCT04072315|75874364|FG004|COMPLETED|Overall Study||1||
59755356|NCT04072315|75874365|FG005|COMPLETED|Overall Study||1||
59755357|NCT04072315|75874366|FG006|COMPLETED|Overall Study||1||
59755358|NCT04072315|75874367|FG007|COMPLETED|Overall Study||1||
59755359|NCT04072315|75874360|FG000|NOT COMPLETED|Overall Study||0||
59885801|NCT00100048|76008592|FG002|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0||
59885802|NCT00100048|76008593|FG003|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0||
59885803|NCT00100048|76008594|FG004|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0||
59885804|NCT00100048|76008595|FG005|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0||
59885805|NCT00100048|76008590|FG000|STARTED|Cohort I & II-Combination Therapy Phase|7 subjects from the Monotherapy Phase and 34 new subjects|41||
59885806|NCT00100048|76008591|FG001|STARTED|Cohort I & II-Combination Therapy Phase|7 subjects from the Monotherapy Phase and 33 new subjects|40||
59885807|NCT00100048|76008592|FG002|STARTED|Cohort I & II-Combination Therapy Phase|6 subjects from the Monotherapy Phase and 35 new subjects|41||
59885808|NCT00100048|76008593|FG003|STARTED|Cohort I & II-Combination Therapy Phase|8 subjects from the Monotherapy Phase and 32 new subjects|40||
59885809|NCT00100048|76008594|FG004|STARTED|Cohort I & II-Combination Therapy Phase|participants only assigned Placebo in Cohort I-Monotherapy Phase.|0||
59885810|NCT00100048|76008595|FG005|STARTED|Cohort I & II-Combination Therapy Phase|4 subjects from the Monotherapy Phase (Placebo)and 35 new subjects|39||
59885811|NCT00100048|76008590|FG000|Treated|Cohort I & II-Combination Therapy Phase||39||
59885812|NCT00100048|76008591|FG001|Treated|Cohort I & II-Combination Therapy Phase||40||
59501578|NCT00595153|75593551|FG001|STARTED|Overall Study||42||
59501579|NCT00595153|75593552|FG002|STARTED|Overall Study||61||
59501580|NCT00595153|75593550|FG000|COMPLETED|Overall Study||20||
59501581|NCT00595153|75593551|FG001|COMPLETED|Overall Study||26||
59501582|NCT00595153|75593552|FG002|COMPLETED|Overall Study||36||
59501583|NCT00595153|75593550|FG000|NOT COMPLETED|Overall Study||4||
59501584|NCT00595153|75593551|FG001|NOT COMPLETED|Overall Study||16||
59501585|NCT00595153|75593552|FG002|NOT COMPLETED|Overall Study||25||
59501586|NCT00595231|75593562|FG000|STARTED|Overall Study||120||
59501587|NCT00595231|75593563|FG001|STARTED|Overall Study||119||
59501588|NCT00595231|75593562|FG000|COMPLETED|Overall Study||115||
59501589|NCT00595231|75593563|FG001|COMPLETED|Overall Study||114||
59501590|NCT00595231|75593562|FG000|NOT COMPLETED|Overall Study||5||
59501591|NCT00595231|75593563|FG001|NOT COMPLETED|Overall Study||5||
59501592|NCT00701935|75593571|FG000|STARTED|Overall Study||43||
59885813|NCT00100048|76008592|FG002|Treated|Cohort I & II-Combination Therapy Phase||41||
59885814|NCT00100048|76008593|FG003|Treated|Cohort I & II-Combination Therapy Phase||40||
60013334|NCT02589665|76129279|FG008|COMPLETED|Maintenance Period||0||
59607642|NCT02084147|75718330|FG000|STARTED|Overall Study||72||
59607643|NCT02084147|75718330|FG000|COMPLETED|Overall Study||72||
59607644|NCT02084147|75718330|FG000|NOT COMPLETED|Overall Study||0||
59607645|NCT02067611|75718334|FG000|STARTED|Overall Study||72||
59607646|NCT02067611|75718335|FG001|STARTED|Overall Study||72||
59501593|NCT00701935|75593572|FG001|STARTED|Overall Study||37||
59501594|NCT00701935|75593571|FG000|COMPLETED|Overall Study||27||
59501595|NCT00701935|75593572|FG001|COMPLETED|Overall Study||26||
59501596|NCT00701935|75593571|FG000|NOT COMPLETED|Overall Study||16||
59755360|NCT04072315|75874361|FG001|NOT COMPLETED|Overall Study||0||
59755361|NCT04072315|75874362|FG002|NOT COMPLETED|Overall Study||1||
59755362|NCT04072315|75874363|FG003|NOT COMPLETED|Overall Study||0||
59755363|NCT04072315|75874364|FG004|NOT COMPLETED|Overall Study||0||
59755364|NCT04072315|75874365|FG005|NOT COMPLETED|Overall Study||0||
59755365|NCT04072315|75874366|FG006|NOT COMPLETED|Overall Study||0||
59501597|NCT00701935|75593572|FG001|NOT COMPLETED|Overall Study||11||
59755366|NCT04072315|75874367|FG007|NOT COMPLETED|Overall Study||0||
59755367|NCT04034251|75874395|FG000|STARTED|Overall Study||5||
59501598|NCT00596167|75593578|FG000|STARTED|Overall Study|All recruited subjects completed the study.|6||
59755368|NCT04034251|75874396|FG001|STARTED|Overall Study||7||
59885815|NCT00100048|76008594|FG004|Treated|Cohort I & II-Combination Therapy Phase||0||
59501599|NCT00596167|75593578|FG000|COMPLETED|Overall Study||6||
59501600|NCT00596167|75593578|FG000|NOT COMPLETED|Overall Study||0||
59501601|NCT00703261|75593584|FG000|STARTED|Overall Study||42||
59501602|NCT00703261|75593585|FG001|STARTED|Overall Study||41||
59501603|NCT00703261|75593584|FG000|COMPLETED|Overall Study||36||
59501604|NCT00703261|75593585|FG001|COMPLETED|Overall Study||35||
59501605|NCT00703261|75593584|FG000|NOT COMPLETED|Overall Study||6||
59501606|NCT00703261|75593585|FG001|NOT COMPLETED|Overall Study||6||
59501607|NCT00703729|75593594|FG000|STARTED|Overall Study||25||
59501608|NCT00703729|75593595|FG001|STARTED|Overall Study||24||
59501609|NCT00703729|75593594|FG000|COMPLETED|Overall Study||25||
59501610|NCT00703729|75593595|FG001|COMPLETED|Overall Study||21||
59501611|NCT00703729|75593594|FG000|NOT COMPLETED|Overall Study||0||
59501612|NCT00703729|75593595|FG001|NOT COMPLETED|Overall Study||3||
59501613|NCT04200833|75593601|FG000|STARTED|Overall Study||10||
59501614|NCT04200833|75593601|FG000|COMPLETED|Overall Study||10||
59501615|NCT04200833|75593601|FG000|NOT COMPLETED|Overall Study||0||
59501616|NCT00597493|75593605|FG000|STARTED|Overall Study||32||
59501617|NCT00597493|75593605|FG000|COMPLETED|Overall Study||32||
59501618|NCT00597493|75593605|FG000|NOT COMPLETED|Overall Study||0||
59501619|NCT00597727|75593617|FG000|STARTED|12 Month Blinded Phase||14||
59501620|NCT00597727|75593618|FG001|STARTED|12 Month Blinded Phase||15||
59501621|NCT00597727|75593619|FG002|STARTED|12 Month Blinded Phase||0||
59501622|NCT00597727|75593620|FG003|STARTED|12 Month Blinded Phase||27||
59501623|NCT00597727|75593621|FG004|STARTED|12 Month Blinded Phase||4||
59501624|NCT00597727|75593617|FG000|COMPLETED|12 Month Blinded Phase||14||
59501625|NCT00597727|75593618|FG001|COMPLETED|12 Month Blinded Phase||15||
59501626|NCT00597727|75593619|FG002|COMPLETED|12 Month Blinded Phase||0||
59501627|NCT00597727|75593620|FG003|COMPLETED|12 Month Blinded Phase||17||
59501628|NCT00597727|75593621|FG004|COMPLETED|12 Month Blinded Phase||3||
59501629|NCT00597727|75593617|FG000|NOT COMPLETED|12 Month Blinded Phase||0||
59501630|NCT00597727|75593618|FG001|NOT COMPLETED|12 Month Blinded Phase||0||
59501631|NCT00597727|75593619|FG002|NOT COMPLETED|12 Month Blinded Phase||0||
59501632|NCT00597727|75593620|FG003|NOT COMPLETED|12 Month Blinded Phase||10||
59885816|NCT00100048|76008595|FG005|Treated|Cohort I & II-Combination Therapy Phase||38||
59885817|NCT00100048|76008590|FG000|Never Treated|Cohort I & II-Combination Therapy Phase|Randomised in Cohort II did not start Period|2||
59885818|NCT00100048|76008591|FG001|Never Treated|Cohort I & II-Combination Therapy Phase||0||
59885819|NCT00100048|76008592|FG002|Never Treated|Cohort I & II-Combination Therapy Phase||0||
59885820|NCT00100048|76008593|FG003|Never Treated|Cohort I & II-Combination Therapy Phase||0||
59885821|NCT00100048|76008594|FG004|Never Treated|Cohort I & II-Combination Therapy Phase||0||
59950955|NCT00571493|76069875|FG006|COMPLETED|Overall Study||6||
59501633|NCT00597727|75593621|FG004|NOT COMPLETED|12 Month Blinded Phase||1||
59501634|NCT00597727|75593617|FG000|STARTED|Open-label Extended Maintenance Phase|Blinded peanut SLIT + blinded placebo SLIT continued in Ext Open Label Peanut SLIT after unblinding|0||
59501635|NCT00597727|75593618|FG001|STARTED|Open-label Extended Maintenance Phase|Blinded peanut SLIT + blinded placebo SLIT continued in Ext Open Label Peanut SLIT after unblinding|0||
59501636|NCT00597727|75593619|FG002|STARTED|Open-label Extended Maintenance Phase|Blinded peanut SLIT + blinded placebo SLIT continued in Ext Open Label Peanut SLIT after unblinding.|29||
59501637|NCT00597727|75593620|FG003|STARTED|Open-label Extended Maintenance Phase||17||
59501638|NCT00597727|75593621|FG004|STARTED|Open-label Extended Maintenance Phase||3||
59501639|NCT00597727|75593617|FG000|COMPLETED|Open-label Extended Maintenance Phase||0||
59501640|NCT00597727|75593618|FG001|COMPLETED|Open-label Extended Maintenance Phase||0||
59501641|NCT00597727|75593619|FG002|COMPLETED|Open-label Extended Maintenance Phase||23||
59501642|NCT00597727|75593620|FG003|COMPLETED|Open-label Extended Maintenance Phase||14||
59501643|NCT00597727|75593621|FG004|COMPLETED|Open-label Extended Maintenance Phase||1||
59501644|NCT00597727|75593617|FG000|NOT COMPLETED|Open-label Extended Maintenance Phase||0||
59501645|NCT00597727|75593618|FG001|NOT COMPLETED|Open-label Extended Maintenance Phase||0||
59501646|NCT00597727|75593619|FG002|NOT COMPLETED|Open-label Extended Maintenance Phase||6||
59501647|NCT00597727|75593620|FG003|NOT COMPLETED|Open-label Extended Maintenance Phase||3||
59501648|NCT00597727|75593621|FG004|NOT COMPLETED|Open-label Extended Maintenance Phase||2||
59501649|NCT00707863|75593637|FG000|STARTED|Overall Study||6||
59501650|NCT00707863|75593638|FG001|STARTED|Overall Study||11||
59501651|NCT00707863|75593637|FG000|COMPLETED|Overall Study||6||
59501652|NCT00707863|75593638|FG001|COMPLETED|Overall Study||8||
59501653|NCT00707863|75593637|FG000|NOT COMPLETED|Overall Study||0||
59501654|NCT00707863|75593638|FG001|NOT COMPLETED|Overall Study||3||
59501655|NCT00565643|75593646|FG000|STARTED|Overall Study||380||
59501656|NCT00565643|75593647|FG001|STARTED|Overall Study||373||
59501657|NCT00565643|75593646|FG000|Safety Data|Overall Study||380||
59501658|NCT00565643|75593647|FG001|Safety Data|Overall Study||373||
59501659|NCT00565643|75593646|FG000|Primary Outcome (Subsequent Cesarean)|Overall Study||80||
59501660|NCT00565643|75593647|FG001|Primary Outcome (Subsequent Cesarean)|Overall Study||92||
59501661|NCT00565643|75593646|FG000|COMPLETED|Overall Study||380||
59501662|NCT00565643|75593647|FG001|COMPLETED|Overall Study||373||
59501663|NCT00565643|75593646|FG000|NOT COMPLETED|Overall Study||0||
59501664|NCT00565643|75593647|FG001|NOT COMPLETED|Overall Study||0||
59501665|NCT00708019|75593656|FG000|STARTED|Overall Study||92||
59501666|NCT00708019|75593657|FG001|STARTED|Overall Study||93||
59501667|NCT00708019|75593656|FG000|COMPLETED|Overall Study||77||
59501668|NCT00708019|75593657|FG001|COMPLETED|Overall Study||78||
59501669|NCT00708019|75593656|FG000|NOT COMPLETED|Overall Study||15||
59501670|NCT00708019|75593657|FG001|NOT COMPLETED|Overall Study||15||
59501671|NCT02321527|75593663|FG000|STARTED|Overall Study||21||
59501672|NCT02321527|75593663|FG000|COMPLETED|Overall Study||20||
59501673|NCT02321527|75593663|FG000|NOT COMPLETED|Overall Study||1||
59501674|NCT00598507|75593667|FG000|STARTED|Overall Study||35||
59501675|NCT00598507|75593667|FG000|COMPLETED|Overall Study||35||
59501676|NCT00598507|75593667|FG000|NOT COMPLETED|Overall Study||0||
59501677|NCT00566579|75593673|FG000|STARTED|Overall Study||29||
59501678|NCT00566579|75593674|FG001|STARTED|Overall Study||31||
59501679|NCT00566579|75593673|FG000|COMPLETED|Overall Study||29||
59501680|NCT00566579|75593674|FG001|COMPLETED|Overall Study||31||
59885822|NCT00100048|76008595|FG005|Never Treated|Cohort I & II-Combination Therapy Phase|Randomised in Cohort II did not start Period|1||
59885823|NCT00100048|76008590|FG000|COMPLETED|Cohort I & II-Combination Therapy Phase||27||
59885824|NCT00100048|76008591|FG001|COMPLETED|Cohort I & II-Combination Therapy Phase||31||
59885825|NCT00100048|76008592|FG002|COMPLETED|Cohort I & II-Combination Therapy Phase||28||
59885826|NCT00100048|76008593|FG003|COMPLETED|Cohort I & II-Combination Therapy Phase||30||
59885827|NCT00100048|76008594|FG004|COMPLETED|Cohort I & II-Combination Therapy Phase||0||
59885828|NCT00100048|76008595|FG005|COMPLETED|Cohort I & II-Combination Therapy Phase||26||
59885829|NCT00100048|76008590|FG000|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||14||
59501681|NCT00566579|75593673|FG000|NOT COMPLETED|Overall Study||0||
59501682|NCT00566579|75593674|FG001|NOT COMPLETED|Overall Study||0||
59501683|NCT00566813|75593682|FG000|STARTED|Overall Study||4||
59501684|NCT00566813|75593683|FG001|STARTED|Overall Study||6||
59501685|NCT00566813|75593682|FG000|COMPLETED|Overall Study||4||
59501686|NCT00566813|75593683|FG001|COMPLETED|Overall Study||6||
59950956|NCT00571493|76069869|FG000|NOT COMPLETED|Overall Study||0||
59950957|NCT00571493|76069870|FG001|NOT COMPLETED|Overall Study||0||
59950958|NCT00571493|76069871|FG002|NOT COMPLETED|Overall Study||0||
59885830|NCT00100048|76008591|FG001|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||9||
59885831|NCT00100048|76008592|FG002|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||13||
59885832|NCT00100048|76008593|FG003|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||10||
59885833|NCT00100048|76008594|FG004|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||0||
59885834|NCT00100048|76008595|FG005|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||13||
59885835|NCT02757430|76008620|FG000|STARTED|Overall Study||515||
59501687|NCT00566813|75593682|FG000|NOT COMPLETED|Overall Study||0||
59501688|NCT00566813|75593683|FG001|NOT COMPLETED|Overall Study||0||
59501689|NCT00088166|75593691|FG000|STARTED|Overall Study||100||
59501690|NCT00088166|75593692|FG001|STARTED|Overall Study||100||
59501691|NCT00088166|75593691|FG000|COMPLETED|Overall Study||47||
59501692|NCT00088166|75593692|FG001|COMPLETED|Overall Study||39||
59501693|NCT00088166|75593691|FG000|NOT COMPLETED|Overall Study||53||
59501694|NCT00088166|75593692|FG001|NOT COMPLETED|Overall Study||61||
59501695|NCT00566969|75593701|FG000|STARTED|Overall Study||34||
59501696|NCT00566969|75593702|FG001|STARTED|Overall Study||37||
59501697|NCT00566969|75593703|FG002|STARTED|Overall Study||35||
59501698|NCT00566969|75593701|FG000|COMPLETED|Overall Study||19||
59501699|NCT00566969|75593702|FG001|COMPLETED|Overall Study||28||
59501700|NCT00566969|75593703|FG002|COMPLETED|Overall Study||23||
59501701|NCT00566969|75593701|FG000|NOT COMPLETED|Overall Study||15||
59501702|NCT00566969|75593702|FG001|NOT COMPLETED|Overall Study||9||
59501703|NCT00566969|75593703|FG002|NOT COMPLETED|Overall Study||12||
59501704|NCT00598663|75593713|FG000|STARTED|First Intervention (6 Months)||76||
59501705|NCT00598663|75593714|FG001|STARTED|First Intervention (6 Months)||77||
59885836|NCT02757430|76008620|FG000|Baseline Visits|Overall Study||503||
59885837|NCT02757430|76008620|FG000|EP Mapping/Ablation Procedure|Overall Study||503||
59885838|NCT02757430|76008620|FG000|COMPLETED|Overall Study|Subjects with pre-discharge visit were considered completed.|503||
59885839|NCT02757430|76008620|FG000|NOT COMPLETED|Overall Study||12||
59885840|NCT02757352|76008636|FG000|STARTED|Double-Blind Period (Week 0 - Week 16)||105||
59885841|NCT02757352|76008637|FG001|STARTED|Double-Blind Period (Week 0 - Week 16)||96||
59885842|NCT02757352|76008638|FG002|STARTED|Double-Blind Period (Week 0 - Week 16)||102||
59885843|NCT02757352|76008639|FG003|STARTED|Double-Blind Period (Week 0 - Week 16)||0||
59885844|NCT02757352|76008640|FG004|STARTED|Double-Blind Period (Week 0 - Week 16)||0||
59607647|NCT02067611|75718336|FG002|STARTED|Overall Study||72||
59607648|NCT02067611|75718334|FG000|COMPLETED|Overall Study||66||
59885845|NCT02757352|76008641|FG005|STARTED|Double-Blind Period (Week 0 - Week 16)||0||
59885846|NCT02757352|76008642|FG006|STARTED|Double-Blind Period (Week 0 - Week 16)||0||
59885847|NCT02757352|76008643|FG007|STARTED|Double-Blind Period (Week 0 - Week 16)||0||
59885848|NCT02757352|76008644|FG008|STARTED|Double-Blind Period (Week 0 - Week 16)||0||
59885849|NCT02757352|76008645|FG009|STARTED|Double-Blind Period (Week 0 - Week 16)||0||
59885850|NCT02757352|76008636|FG000|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||104||
59885851|NCT02757352|76008637|FG001|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||96||
59501706|NCT00598663|75593713|FG000|COMPLETED|First Intervention (6 Months)||73||
59501707|NCT00598663|75593714|FG001|COMPLETED|First Intervention (6 Months)||71||
59501708|NCT00598663|75593713|FG000|NOT COMPLETED|First Intervention (6 Months)||3||
59501709|NCT00598663|75593714|FG001|NOT COMPLETED|First Intervention (6 Months)||6||
59501710|NCT00598663|75593713|FG000|STARTED|Washout (4 Months)||73||
59501711|NCT00598663|75593714|FG001|STARTED|Washout (4 Months)||71||
59501712|NCT00598663|75593713|FG000|COMPLETED|Washout (4 Months)||73||
59501713|NCT00598663|75593714|FG001|COMPLETED|Washout (4 Months)||70||
59885852|NCT02757352|76008638|FG002|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||102||
59885853|NCT02757352|76008639|FG003|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0||
59885854|NCT02757352|76008640|FG004|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0||
59885855|NCT02757352|76008641|FG005|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0||
59885856|NCT02757352|76008642|FG006|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0||
59501714|NCT00598663|75593713|FG000|NOT COMPLETED|Washout (4 Months)||0||
59501715|NCT00598663|75593714|FG001|NOT COMPLETED|Washout (4 Months)||1||
59501716|NCT00598663|75593713|FG000|STARTED|Second Intervention (6 Months)||73||
59501717|NCT00598663|75593714|FG001|STARTED|Second Intervention (6 Months)||70||
59501718|NCT00598663|75593713|FG000|COMPLETED|Second Intervention (6 Months)||69||
59501719|NCT00598663|75593714|FG001|COMPLETED|Second Intervention (6 Months)||69||
59607649|NCT02067611|75718335|FG001|COMPLETED|Overall Study||66||
59607650|NCT02067611|75718336|FG002|COMPLETED|Overall Study||68||
59607651|NCT02067611|75718334|FG000|NOT COMPLETED|Overall Study||6||
59607652|NCT02067611|75718335|FG001|NOT COMPLETED|Overall Study||6||
59501720|NCT00598663|75593713|FG000|NOT COMPLETED|Second Intervention (6 Months)||4||
59501721|NCT00598663|75593714|FG001|NOT COMPLETED|Second Intervention (6 Months)||1||
59501722|NCT00704353|75593725|FG000|STARTED|Overall Study||366||
59501723|NCT00704353|75593726|FG001|STARTED|Overall Study||369||
59501724|NCT00704353|75593725|FG000|COMPLETED|Overall Study||268||
59501725|NCT00704353|75593726|FG001|COMPLETED|Overall Study||255||
59501726|NCT00704353|75593725|FG000|NOT COMPLETED|Overall Study||98||
59501727|NCT00704353|75593726|FG001|NOT COMPLETED|Overall Study||114||
59501728|NCT00598819|75593732|FG000|STARTED|Overall Study||14||
59501729|NCT00598819|75593732|FG000|COMPLETED|Overall Study||14||
59501730|NCT00598819|75593732|FG000|NOT COMPLETED|Overall Study||0||
59501731|NCT00087698|75593736|FG000|STARTED|Overall Study||77||
59501732|NCT00087698|75593736|FG000|COMPLETED|Overall Study||41||
59501733|NCT00087698|75593736|FG000|NOT COMPLETED|Overall Study||36||
59501734|NCT00708721|75593740|FG000|STARTED|Overall Study||2||
59501735|NCT00708721|75593741|FG001|STARTED|Overall Study||4||
59501736|NCT00708721|75593742|FG002|STARTED|Overall Study||3||
59501737|NCT00708721|75593743|FG003|STARTED|Overall Study||2||
59501738|NCT00708721|75593740|FG000|COMPLETED|Overall Study||2||
59501739|NCT00708721|75593741|FG001|COMPLETED|Overall Study||4||
59501740|NCT00708721|75593742|FG002|COMPLETED|Overall Study||3||
59501741|NCT00708721|75593743|FG003|COMPLETED|Overall Study||2||
59501742|NCT00708721|75593740|FG000|NOT COMPLETED|Overall Study||0||
59501743|NCT00708721|75593741|FG001|NOT COMPLETED|Overall Study||0||
59501744|NCT00708721|75593742|FG002|NOT COMPLETED|Overall Study||0||
59501745|NCT00708721|75593743|FG003|NOT COMPLETED|Overall Study||0||
59501746|NCT00087152|75593754|FG000|STARTED|Overall Study||27||
59501747|NCT00087152|75593754|FG000|COMPLETED|Overall Study||21||
59501748|NCT00087152|75593754|FG000|NOT COMPLETED|Overall Study||6||
59501749|NCT01940523|75593761|FG000|STARTED|Overall Study||320||
59501750|NCT01940523|75593762|FG001|STARTED|Overall Study||320||
59501751|NCT01940523|75593761|FG000|COMPLETED|Overall Study||320||
59501752|NCT01940523|75593762|FG001|COMPLETED|Overall Study||320||
59501753|NCT01940523|75593761|FG000|NOT COMPLETED|Overall Study||0||
59501754|NCT01940523|75593762|FG001|NOT COMPLETED|Overall Study||0||
59501755|NCT02281851|75593772|FG000|STARTED|Overall Study||4||
59501756|NCT02281851|75593773|FG001|STARTED|Overall Study||10||
59501757|NCT02281851|75593772|FG000|COMPLETED|Overall Study||4||
59501758|NCT02281851|75593773|FG001|COMPLETED|Overall Study||10||
59501759|NCT02281851|75593772|FG000|NOT COMPLETED|Overall Study||0||
59501760|NCT02281851|75593773|FG001|NOT COMPLETED|Overall Study||0||
59501761|NCT00599053|75593781|FG000|STARTED|Overall Study||5||
59607653|NCT02067611|75718336|FG002|NOT COMPLETED|Overall Study||4||
59501762|NCT00599053|75593782|FG001|STARTED|Overall Study||2||
59607654|NCT02075021|75718346|FG000|STARTED|Overall Study||3||
59607655|NCT02075021|75718346|FG000|COMPLETED|Overall Study||3||
59501763|NCT00599053|75593781|FG000|COMPLETED|Overall Study||5||
59501764|NCT00599053|75593782|FG001|COMPLETED|Overall Study||2||
59501765|NCT00599053|75593781|FG000|NOT COMPLETED|Overall Study||0||
59501766|NCT00599053|75593782|FG001|NOT COMPLETED|Overall Study||0||
59501767|NCT01941927|75593790|FG000|STARTED|Overall Study||10||
59501768|NCT01941927|75593791|FG001|STARTED|Overall Study||10||
59501769|NCT01941927|75593790|FG000|COMPLETED|Overall Study||10||
59501770|NCT01941927|75593791|FG001|COMPLETED|Overall Study||10||
59501771|NCT01941927|75593790|FG000|NOT COMPLETED|Overall Study||0||
59501772|NCT01941927|75593791|FG001|NOT COMPLETED|Overall Study||0||
59501773|NCT01942707|75593799|FG000|STARTED|Overall Study||23||
59501774|NCT01942707|75593800|FG001|STARTED|Overall Study||23||
59501775|NCT01942707|75593799|FG000|COMPLETED|Overall Study||23||
59501776|NCT01942707|75593800|FG001|COMPLETED|Overall Study||23||
59501777|NCT01942707|75593799|FG000|NOT COMPLETED|Overall Study||0||
59501778|NCT01942707|75593800|FG001|NOT COMPLETED|Overall Study||0||
59501779|NCT00086996|75593806|FG000|STARTED|Overall Study||98||
59501780|NCT00086996|75593806|FG000|Eligible|Overall Study||93||
59501781|NCT00086996|75593806|FG000|Eligible and Began Protocol Therapy|Overall Study||93||
59501782|NCT00086996|75593806|FG000|COMPLETED|Overall Study||34||
59501783|NCT00086996|75593806|FG000|NOT COMPLETED|Overall Study||64||
59501784|NCT01943565|75593813|FG000|STARTED|Overall Study||11||
59501785|NCT01943565|75593814|FG001|STARTED|Overall Study||9||
59501786|NCT01943565|75593815|FG002|STARTED|Overall Study||9||
59501787|NCT01943565|75593813|FG000|COMPLETED|Overall Study||11||
59501788|NCT01943565|75593814|FG001|COMPLETED|Overall Study||9||
59501789|NCT01943565|75593815|FG002|COMPLETED|Overall Study||9||
59501790|NCT01943565|75593813|FG000|NOT COMPLETED|Overall Study||0||
59501791|NCT01943565|75593814|FG001|NOT COMPLETED|Overall Study||0||
59501792|NCT01943565|75593815|FG002|NOT COMPLETED|Overall Study||0||
59501793|NCT01880073|75593823|FG000|STARTED|Overall Study||24||
59501794|NCT01880073|75593823|FG000|COMPLETED|Overall Study||24||
59501795|NCT01880073|75593823|FG000|NOT COMPLETED|Overall Study||0||
59501796|NCT01880697|75593829|FG000|STARTED|Overall Study||63||
59501797|NCT01880697|75593830|FG001|STARTED|Overall Study||63||
59501798|NCT01880697|75593829|FG000|COMPLETED|Overall Study||63||
59501799|NCT01880697|75593830|FG001|COMPLETED|Overall Study||62||
59501800|NCT01880697|75593829|FG000|NOT COMPLETED|Overall Study||0||
59501801|NCT01880697|75593830|FG001|NOT COMPLETED|Overall Study||1||
59501802|NCT01944345|75593836|FG000|STARTED|Overall Study||69||
59501803|NCT01944345|75593836|FG000|COMPLETED|Overall Study||69||
59501804|NCT01944345|75593836|FG000|NOT COMPLETED|Overall Study||0||
59501805|NCT01881087|75593843|FG000|STARTED|Overall Study||60||
59501806|NCT01881087|75593844|FG001|STARTED|Overall Study||61||
59501807|NCT01881087|75593845|FG002|STARTED|Overall Study||62||
59501808|NCT01881087|75593843|FG000|COMPLETED|Overall Study||59||
59501809|NCT01881087|75593844|FG001|COMPLETED|Overall Study||61||
59501810|NCT01881087|75593845|FG002|COMPLETED|Overall Study||60||
59501811|NCT01881087|75593843|FG000|NOT COMPLETED|Overall Study||1||
59501812|NCT01881087|75593844|FG001|NOT COMPLETED|Overall Study||0||
59501813|NCT01881087|75593845|FG002|NOT COMPLETED|Overall Study||2||
59501814|NCT01944423|75593855|FG000|STARTED|Overall Study||27||
59501815|NCT01944423|75593856|FG001|STARTED|Overall Study||26||
59501816|NCT01944423|75593855|FG000|End of Treatment|Overall Study||21||
59501817|NCT01944423|75593856|FG001|End of Treatment|Overall Study||20||
59501818|NCT01944423|75593855|FG000|1-month Follow-up|Overall Study||22||
59501819|NCT01944423|75593856|FG001|1-month Follow-up|Overall Study||19||
59501820|NCT01944423|75593855|FG000|4-month Follow-up|Overall Study||19||
59501821|NCT01944423|75593856|FG001|4-month Follow-up|Overall Study||16||
59501822|NCT01944423|75593855|FG000|COMPLETED|Overall Study|6-month follow-up|19||
59501823|NCT01944423|75593856|FG001|COMPLETED|Overall Study|6-month follow-up|17||
59501824|NCT01944423|75593855|FG000|NOT COMPLETED|Overall Study||8||
59501825|NCT01944423|75593856|FG001|NOT COMPLETED|Overall Study||9||
59501826|NCT00600925|75593864|FG000|STARTED|Overall Study||300||
59607656|NCT02075021|75718346|FG000|NOT COMPLETED|Overall Study||0||
59501827|NCT00600925|75593865|FG001|STARTED|Overall Study||302||
59501828|NCT00600925|75593864|FG000|COMPLETED|Overall Study||300||
59501829|NCT00600925|75593865|FG001|COMPLETED|Overall Study||302||
59501830|NCT00600925|75593864|FG000|NOT COMPLETED|Overall Study||0||
59501831|NCT00600925|75593865|FG001|NOT COMPLETED|Overall Study||0||
59501832|NCT02673203|75593873|FG000|STARTED|Overall Study||16||
59501833|NCT02673203|75593874|FG001|STARTED|Overall Study||15||
59501834|NCT02673203|75593873|FG000|COMPLETED|Overall Study||16||
59501835|NCT02673203|75593874|FG001|COMPLETED|Overall Study||15||
59501836|NCT02673203|75593873|FG000|NOT COMPLETED|Overall Study||0||
59501837|NCT02673203|75593874|FG001|NOT COMPLETED|Overall Study||0||
59501838|NCT01881867|75593882|FG000|STARTED|Overall Study||26||
59501839|NCT01881867|75593883|FG001|STARTED|Overall Study||28||
59501840|NCT01881867|75593882|FG000|COMPLETED|Overall Study||14||
59501841|NCT01881867|75593883|FG001|COMPLETED|Overall Study||15||
59501842|NCT01881867|75593882|FG000|NOT COMPLETED|Overall Study||12||
59501843|NCT01881867|75593883|FG001|NOT COMPLETED|Overall Study||13||
59501844|NCT01882413|75593891|FG000|STARTED|Overall Study||204||
59501845|NCT01882413|75593891|FG000|COMPLETED|Overall Study||204||
59501846|NCT01882413|75593891|FG000|NOT COMPLETED|Overall Study||0||
59501847|NCT02338973|75593895|FG000|STARTED|Overall Study||4||
59501848|NCT02338973|75593895|FG000|Rod-cone Dystrophy (RCD)|Overall Study||2||
59501849|NCT02338973|75593895|FG000|Enhanced S-Cone Syndrome (ESCS)|Overall Study||2||
59501850|NCT02338973|75593895|FG000|COMPLETED|Overall Study||4||
59501851|NCT02338973|75593895|FG000|NOT COMPLETED|Overall Study||0||
59501852|NCT00601627|75593976|FG000|STARTED|Overall Study||51||
59501853|NCT00601627|75593976|FG000|COMPLETED|Overall Study||51||
59501854|NCT00601627|75593976|FG000|NOT COMPLETED|Overall Study||0||
59501855|NCT01882725|75593980|FG000|STARTED|Overall Study||14||
59501856|NCT01882725|75593980|FG000|COMPLETED|Overall Study||14||
59501857|NCT01882725|75593980|FG000|NOT COMPLETED|Overall Study||0||
59501858|NCT01883427|75593986|FG000|STARTED|Overall Study||20||
59501859|NCT01883427|75593987|FG001|STARTED|Overall Study||20||
59501860|NCT01883427|75593986|FG000|COMPLETED|Overall Study||20||
59501861|NCT01883427|75593987|FG001|COMPLETED|Overall Study||20||
59501862|NCT01883427|75593986|FG000|NOT COMPLETED|Overall Study||0||
59501863|NCT01883427|75593987|FG001|NOT COMPLETED|Overall Study||0||
59501864|NCT02527187|75593995|FG000|STARTED|Overall Study||75||
59501865|NCT02527187|75593996|FG001|STARTED|Overall Study||126||
59501866|NCT02527187|75593995|FG000|COMPLETED|Overall Study||75||
59501867|NCT02527187|75593996|FG001|COMPLETED|Overall Study||126||
59501868|NCT02527187|75593995|FG000|NOT COMPLETED|Overall Study||0||
59501869|NCT02527187|75593996|FG001|NOT COMPLETED|Overall Study||0||
59501870|NCT01947153|75594004|FG000|STARTED|Test Period 1||18||
59501871|NCT01947153|75594005|FG001|STARTED|Test Period 1||18||
59501872|NCT01947153|75594004|FG000|COMPLETED|Test Period 1||18||
59501873|NCT01947153|75594005|FG001|COMPLETED|Test Period 1||18||
59501874|NCT01947153|75594004|FG000|NOT COMPLETED|Test Period 1||0||
59501875|NCT01947153|75594005|FG001|NOT COMPLETED|Test Period 1||0||
59501876|NCT01947153|75594004|FG000|STARTED|Test Period 2||18||
59501877|NCT01947153|75594005|FG001|STARTED|Test Period 2||18||
59501878|NCT01947153|75594004|FG000|COMPLETED|Test Period 2||18||
59501879|NCT01947153|75594005|FG001|COMPLETED|Test Period 2||18||
59501880|NCT01947153|75594004|FG000|NOT COMPLETED|Test Period 2||0||
59501881|NCT01947153|75594005|FG001|NOT COMPLETED|Test Period 2||0||
59501882|NCT02476409|75594013|FG000|STARTED|Overall Study||19||
59501883|NCT02476409|75594014|FG001|STARTED|Overall Study||21||
59501884|NCT02476409|75594013|FG000|COMPLETED|Overall Study||19||
59501885|NCT02476409|75594014|FG001|COMPLETED|Overall Study||21||
59501886|NCT02476409|75594013|FG000|NOT COMPLETED|Overall Study||0||
59501887|NCT02476409|75594014|FG001|NOT COMPLETED|Overall Study||0||
59501888|NCT01884519|75594026|FG000|STARTED|Overall Study||60||
59501889|NCT01884519|75594027|FG001|STARTED|Overall Study||60||
59501890|NCT01884519|75594026|FG000|COMPLETED|Overall Study||60||
59501891|NCT01884519|75594027|FG001|COMPLETED|Overall Study||60||
59501892|NCT01884519|75594026|FG000|NOT COMPLETED|Overall Study||0||
59501893|NCT01884519|75594027|FG001|NOT COMPLETED|Overall Study||0||
59501894|NCT01886235|75594041|FG000|STARTED|Overall Study||10||
59501895|NCT01886235|75594041|FG000|COMPLETED|Overall Study||10||
59501896|NCT01886235|75594041|FG000|NOT COMPLETED|Overall Study||0||
59607657|NCT02057237|75718350|FG000|STARTED|Overall Study||1||
59607658|NCT02057237|75718350|FG000|COMPLETED|Overall Study||1||
59755369|NCT04034251|75874397|FG002|STARTED|Overall Study|No participants were enrolled on Cohort B.|0||
59607659|NCT02057237|75718350|FG000|NOT COMPLETED|Overall Study||0||
59607660|NCT03752567|75718355|FG000|STARTED|Overall Study||40||
59755370|NCT04034251|75874395|FG000|COMPLETED|Overall Study||4||
59501897|NCT00602953|75594050|FG000|STARTED|Overall Study||15||
59501898|NCT00602953|75594051|FG001|STARTED|Overall Study||26||
59501899|NCT00602953|75594052|FG002|STARTED|Overall Study||47||
59501900|NCT00602953|75594053|FG003|STARTED|Overall Study||13||
59501901|NCT00602953|75594054|FG004|STARTED|Overall Study||0||
59501902|NCT00602953|75594050|FG000|COMPLETED|Overall Study||15||
59501903|NCT00602953|75594051|FG001|COMPLETED|Overall Study||26||
59501904|NCT00602953|75594052|FG002|COMPLETED|Overall Study||47||
59501905|NCT00602953|75594053|FG003|COMPLETED|Overall Study||13||
59501906|NCT00602953|75594054|FG004|COMPLETED|Overall Study||0||
59501907|NCT00602953|75594050|FG000|NOT COMPLETED|Overall Study||0||
59501908|NCT00602953|75594051|FG001|NOT COMPLETED|Overall Study||0||
59501909|NCT00602953|75594052|FG002|NOT COMPLETED|Overall Study||0||
59501910|NCT00602953|75594053|FG003|NOT COMPLETED|Overall Study||0||
59501911|NCT00602953|75594054|FG004|NOT COMPLETED|Overall Study||0||
59501912|NCT02329587|75594068|FG000|STARTED|Baseline Thru Post-treatment Assessment||5||
59501913|NCT02329587|75594069|FG001|STARTED|Baseline Thru Post-treatment Assessment||7||
59501914|NCT02329587|75594068|FG000|Completed All Intervention Sessions|Baseline Thru Post-treatment Assessment||3||
59501915|NCT02329587|75594069|FG001|Completed All Intervention Sessions|Baseline Thru Post-treatment Assessment||4||
59501916|NCT02329587|75594068|FG000|COMPLETED|Baseline Thru Post-treatment Assessment||4||
59501917|NCT02329587|75594069|FG001|COMPLETED|Baseline Thru Post-treatment Assessment||6||
59501918|NCT02329587|75594068|FG000|NOT COMPLETED|Baseline Thru Post-treatment Assessment||1||
59501919|NCT02329587|75594069|FG001|NOT COMPLETED|Baseline Thru Post-treatment Assessment||1||
59501920|NCT02329587|75594068|FG000|STARTED|1-month Follow-up||4||
59501921|NCT02329587|75594069|FG001|STARTED|1-month Follow-up||6||
59501922|NCT02329587|75594068|FG000|COMPLETED|1-month Follow-up||4||
59501923|NCT02329587|75594069|FG001|COMPLETED|1-month Follow-up||5||
59501924|NCT02329587|75594068|FG000|NOT COMPLETED|1-month Follow-up||0||
59501925|NCT02329587|75594069|FG001|NOT COMPLETED|1-month Follow-up||1||
59501926|NCT00603187|75594075|FG000|STARTED|Overall Study||4||
59501927|NCT00603187|75594075|FG000|COMPLETED|Overall Study||4||
59501928|NCT00603187|75594075|FG000|NOT COMPLETED|Overall Study||0||
59501929|NCT00603889|75594079|FG000|STARTED|Overall Study||12||
59501930|NCT00603889|75594079|FG000|COMPLETED|Overall Study||12||
59501931|NCT00603889|75594079|FG000|NOT COMPLETED|Overall Study||0||
59501932|NCT01886937|75594085|FG000|STARTED|Overall Study||7||
59501933|NCT01886937|75594086|FG001|STARTED|Overall Study||6||
59501934|NCT01886937|75594085|FG000|COMPLETED|Overall Study||7||
59501935|NCT01886937|75594086|FG001|COMPLETED|Overall Study||6||
59501936|NCT01886937|75594085|FG000|NOT COMPLETED|Overall Study||0||
59501937|NCT01886937|75594086|FG001|NOT COMPLETED|Overall Study||0||
59501938|NCT00708877|75594092|FG000|STARTED|Overall Study||5||
59501939|NCT00708877|75594092|FG000|COMPLETED|Overall Study||5||
59501940|NCT00708877|75594092|FG000|NOT COMPLETED|Overall Study||0||
59501941|NCT01948947|75594098|FG000|STARTED|Overall Study||14||
59501942|NCT01948947|75594099|FG001|STARTED|Overall Study||15||
59501943|NCT01948947|75594098|FG000|COMPLETED|Overall Study||14||
59501944|NCT01948947|75594099|FG001|COMPLETED|Overall Study||15||
59501945|NCT01948947|75594098|FG000|NOT COMPLETED|Overall Study||0||
59501946|NCT01948947|75594099|FG001|NOT COMPLETED|Overall Study||0||
59501947|NCT00086684|75594108|FG000|STARTED|Overall Study||118||
59501948|NCT00086684|75594109|FG001|STARTED|Overall Study||129||
59501949|NCT00086684|75594110|FG002|STARTED|Overall Study||122||
59501950|NCT00086684|75594108|FG000|COMPLETED|Overall Study||63||
59501951|NCT00086684|75594109|FG001|COMPLETED|Overall Study||74||
59501952|NCT00086684|75594110|FG002|COMPLETED|Overall Study||69||
59501953|NCT00086684|75594108|FG000|NOT COMPLETED|Overall Study||55||
59501954|NCT00086684|75594109|FG001|NOT COMPLETED|Overall Study||55||
59501955|NCT00086684|75594110|FG002|NOT COMPLETED|Overall Study||53||
59501956|NCT01887171|75594120|FG000|STARTED|Overall Study||43||
59501957|NCT01887171|75594121|FG001|STARTED|Overall Study||43||
59501958|NCT01887171|75594120|FG000|COMPLETED|Overall Study||43||
59501959|NCT01887171|75594121|FG001|COMPLETED|Overall Study||43||
59501960|NCT01887171|75594120|FG000|NOT COMPLETED|Overall Study||0||
59501961|NCT01887171|75594121|FG001|NOT COMPLETED|Overall Study||0||
59501962|NCT00713479|75594127|FG000|STARTED|First Medication Condition||6||
59501963|NCT00713479|75594128|FG001|STARTED|First Medication Condition||6||
59501964|NCT00713479|75594127|FG000|COMPLETED|First Medication Condition||2||
59501965|NCT00713479|75594128|FG001|COMPLETED|First Medication Condition||6||
59501966|NCT00713479|75594127|FG000|NOT COMPLETED|First Medication Condition||4||
59501967|NCT00713479|75594128|FG001|NOT COMPLETED|First Medication Condition||0||
59501968|NCT00713479|75594127|FG000|STARTED|Washout||2||
59501969|NCT00713479|75594128|FG001|STARTED|Washout||6||
59501970|NCT00713479|75594127|FG000|COMPLETED|Washout||2||
59501971|NCT00713479|75594128|FG001|COMPLETED|Washout||6||
59501972|NCT00713479|75594127|FG000|NOT COMPLETED|Washout||0||
59501973|NCT00713479|75594128|FG001|NOT COMPLETED|Washout||0||
59501974|NCT00713479|75594127|FG000|STARTED|Next Medication Condition||2||
59501975|NCT00713479|75594128|FG001|STARTED|Next Medication Condition||6||
59501976|NCT00713479|75594127|FG000|COMPLETED|Next Medication Condition||2||
59501977|NCT00713479|75594128|FG001|COMPLETED|Next Medication Condition||6||
59501978|NCT00713479|75594127|FG000|NOT COMPLETED|Next Medication Condition||0||
59755371|NCT04034251|75874396|FG001|COMPLETED|Overall Study||7||
59755372|NCT04034251|75874397|FG002|COMPLETED|Overall Study||0||
59755373|NCT04034251|75874395|FG000|NOT COMPLETED|Overall Study||1||
59755374|NCT04034251|75874396|FG001|NOT COMPLETED|Overall Study||0||
59755375|NCT04034251|75874397|FG002|NOT COMPLETED|Overall Study||0||
59755376|NCT03845504|75874403|FG000|STARTED|Overall Study||2||
59755377|NCT03845504|75874403|FG000|COMPLETED|Overall Study||2||
59755378|NCT03845504|75874403|FG000|NOT COMPLETED|Overall Study||0||
59755379|NCT03783078|75874407|FG000|STARTED|Overall Study||55||
59755380|NCT03783078|75874407|FG000|COMPLETED|Overall Study||0||
59755381|NCT03783078|75874407|FG000|NOT COMPLETED|Overall Study||55||
59755382|NCT03778294|75874411|FG000|STARTED|Overall Study||43||
59755383|NCT03778294|75874411|FG000|COMPLETED|Overall Study||39||
59755384|NCT03778294|75874411|FG000|NOT COMPLETED|Overall Study||4||
59755385|NCT03734601|75874415|FG000|STARTED|Overall Study||22||
59755386|NCT03734601|75874415|FG000|COMPLETED|Overall Study||22||
59885857|NCT02757352|76008643|FG007|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0||
59885858|NCT02757352|76008644|FG008|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0||
59755387|NCT03734601|75874415|FG000|NOT COMPLETED|Overall Study||0||
59755388|NCT03662542|75874422|FG000|STARTED|Combination Phase ( Week 0- Week 12)||72||
59607661|NCT03752567|75718355|FG000|COMPLETED|Overall Study||40||
59501979|NCT00713479|75594128|FG001|NOT COMPLETED|Next Medication Condition||0||
59501980|NCT00709891|75594136|FG000|STARTED|Baseline, Cross-sectional Phase||47208||
59501981|NCT00709891|75594136|FG000|COMPLETED|Baseline, Cross-sectional Phase||45758||
59501982|NCT00709891|75594136|FG000|NOT COMPLETED|Baseline, Cross-sectional Phase||1450||
59501983|NCT00709891|75594136|FG000|STARTED|Longitudinal Follow-up Phase|Only participants who met study criteria in the Baseline phase started the Follow-up phase.|10002||
59885859|NCT02757352|76008645|FG009|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0||
59885860|NCT02757352|76008636|FG000|COMPLETED|Double-Blind Period (Week 0 - Week 16)||97||
59885861|NCT02757352|76008637|FG001|COMPLETED|Double-Blind Period (Week 0 - Week 16)||95||
59885862|NCT02757352|76008638|FG002|COMPLETED|Double-Blind Period (Week 0 - Week 16)||98||
59885863|NCT02757352|76008639|FG003|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0||
59885864|NCT02757352|76008640|FG004|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0||
59885865|NCT02757352|76008641|FG005|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0||
60013335|NCT02589665|76129280|FG009|COMPLETED|Maintenance Period||0||
60013336|NCT02589665|76129271|FG000|NOT COMPLETED|Maintenance Period||0||
60013337|NCT02589665|76129272|FG001|NOT COMPLETED|Maintenance Period||0||
60013338|NCT02589665|76129273|FG002|NOT COMPLETED|Maintenance Period||0||
60013339|NCT02589665|76129274|FG003|NOT COMPLETED|Maintenance Period||0||
60013340|NCT02589665|76129275|FG004|NOT COMPLETED|Maintenance Period||13||
60013341|NCT02589665|76129276|FG005|NOT COMPLETED|Maintenance Period||47||
60013342|NCT02589665|76129277|FG006|NOT COMPLETED|Maintenance Period||46||
60013343|NCT02589665|76129278|FG007|NOT COMPLETED|Maintenance Period||0||
60013344|NCT02589665|76129279|FG008|NOT COMPLETED|Maintenance Period||0||
60013345|NCT02589665|76129280|FG009|NOT COMPLETED|Maintenance Period||0||
60013346|NCT02589665|76129271|FG000|STARTED|Induction Extension Period||0||
60013347|NCT02589665|76129272|FG001|STARTED|Induction Extension Period||0||
60013348|NCT02589665|76129273|FG002|STARTED|Induction Extension Period||0||
60013349|NCT02589665|76129274|FG003|STARTED|Induction Extension Period||0||
60013350|NCT02589665|76129275|FG004|STARTED|Induction Extension Period||0||
60013351|NCT02589665|76129276|FG005|STARTED|Induction Extension Period||0||
60013352|NCT02589665|76129277|FG006|STARTED|Induction Extension Period||0||
60013353|NCT02589665|76129278|FG007|STARTED|Induction Extension Period||32||
60013354|NCT02589665|76129279|FG008|STARTED|Induction Extension Period||96||
60013355|NCT02589665|76129280|FG009|STARTED|Induction Extension Period||0||
60013356|NCT02589665|76129271|FG000|COMPLETED|Induction Extension Period||0||
60013357|NCT02589665|76129272|FG001|COMPLETED|Induction Extension Period||0||
60013358|NCT02589665|76129273|FG002|COMPLETED|Induction Extension Period||0||
60013359|NCT02589665|76129274|FG003|COMPLETED|Induction Extension Period||0||
60013360|NCT02589665|76129275|FG004|COMPLETED|Induction Extension Period||0||
60013361|NCT02589665|76129276|FG005|COMPLETED|Induction Extension Period||0||
60013362|NCT02589665|76129277|FG006|COMPLETED|Induction Extension Period||0||
60013363|NCT02589665|76129278|FG007|COMPLETED|Induction Extension Period||30||
59885866|NCT02757352|76008642|FG006|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0||
59885867|NCT02757352|76008643|FG007|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0||
60013364|NCT02589665|76129279|FG008|COMPLETED|Induction Extension Period||84||
60013365|NCT02589665|76129280|FG009|COMPLETED|Induction Extension Period||0||
60013366|NCT02589665|76129271|FG000|NOT COMPLETED|Induction Extension Period||0||
60013367|NCT02589665|76129272|FG001|NOT COMPLETED|Induction Extension Period||0||
60013368|NCT02589665|76129273|FG002|NOT COMPLETED|Induction Extension Period||0||
59501984|NCT00709891|75594136|FG000|COMPLETED|Longitudinal Follow-up Phase||5020||
59501985|NCT00709891|75594136|FG000|NOT COMPLETED|Longitudinal Follow-up Phase||4982||
59501986|NCT00710203|75594140|FG000|STARTED|Overall Study||10||
59501987|NCT00710203|75594140|FG000|COMPLETED|Overall Study||10||
59501988|NCT00710203|75594140|FG000|NOT COMPLETED|Overall Study||0||
59501989|NCT00710905|75594150|FG000|STARTED|Overall Study||50||
59501990|NCT00710905|75594150|FG000|COMPLETED|Overall Study||34||
59501991|NCT00710905|75594150|FG000|NOT COMPLETED|Overall Study||16||
59501992|NCT01887327|75594157|FG000|STARTED|Overall Study||30||
59501993|NCT01887327|75594158|FG001|STARTED|Overall Study||31||
59501994|NCT01887327|75594159|FG002|STARTED|Overall Study||30||
59501995|NCT01887327|75594157|FG000|COMPLETED|Overall Study||29||
59501996|NCT01887327|75594158|FG001|COMPLETED|Overall Study||27||
59501997|NCT01887327|75594159|FG002|COMPLETED|Overall Study||27||
59501998|NCT01887327|75594157|FG000|NOT COMPLETED|Overall Study||1||
59501999|NCT01887327|75594158|FG001|NOT COMPLETED|Overall Study||4||
59502000|NCT01887327|75594159|FG002|NOT COMPLETED|Overall Study||3||
59502001|NCT01889355|75594168|FG000|STARTED|Overall Study||115||
59502002|NCT01889355|75594168|FG000|COMPLETED|Overall Study||113||
59502003|NCT01889355|75594168|FG000|NOT COMPLETED|Overall Study||2||
59502004|NCT00082628|75594174|FG000|STARTED|Treatment Period I (Week 1 to Week 12)||81||
59502005|NCT00082628|75594175|FG001|STARTED|Treatment Period I (Week 1 to Week 12)||245||
59502006|NCT00082628|75594176|FG002|STARTED|Treatment Period I (Week 1 to Week 12)||0||
59502007|NCT00082628|75594177|FG003|STARTED|Treatment Period I (Week 1 to Week 12)||0||
59502008|NCT00082628|75594178|FG004|STARTED|Treatment Period I (Week 1 to Week 12)||0||
59502009|NCT00082628|75594174|FG000|COMPLETED|Treatment Period I (Week 1 to Week 12)||73||
59502010|NCT00082628|75594175|FG001|COMPLETED|Treatment Period I (Week 1 to Week 12)||185||
59502011|NCT00082628|75594176|FG002|COMPLETED|Treatment Period I (Week 1 to Week 12)||0||
59502012|NCT00082628|75594177|FG003|COMPLETED|Treatment Period I (Week 1 to Week 12)||0||
59502013|NCT00082628|75594178|FG004|COMPLETED|Treatment Period I (Week 1 to Week 12)||0||
59502014|NCT00082628|75594174|FG000|NOT COMPLETED|Treatment Period I (Week 1 to Week 12)||8||
59502015|NCT00082628|75594175|FG001|NOT COMPLETED|Treatment Period I (Week 1 to Week 12)||60||
59502016|NCT00082628|75594176|FG002|NOT COMPLETED|Treatment Period I (Week 1 to Week 12)||0||
59502017|NCT00082628|75594177|FG003|NOT COMPLETED|Treatment Period I (Week 1 to Week 12)||0||
59502018|NCT00082628|75594178|FG004|NOT COMPLETED|Treatment Period I (Week 1 to Week 12)||0||
59502019|NCT00082628|75594174|FG000|STARTED|Treatment Period II: Week 12 to Week 36||0||
59502020|NCT00082628|75594175|FG001|STARTED|Treatment Period II: Week 12 to Week 36||0||
59502021|NCT00082628|75594176|FG002|STARTED|Treatment Period II: Week 12 to Week 36||93||
59502022|NCT00082628|75594177|FG003|STARTED|Treatment Period II: Week 12 to Week 36||92||
59502023|NCT00082628|75594178|FG004|STARTED|Treatment Period II: Week 12 to Week 36||73||
59502024|NCT00082628|75594174|FG000|COMPLETED|Treatment Period II: Week 12 to Week 36||0||
59502025|NCT00082628|75594175|FG001|COMPLETED|Treatment Period II: Week 12 to Week 36||0||
59502026|NCT00082628|75594176|FG002|COMPLETED|Treatment Period II: Week 12 to Week 36||78||
59502027|NCT00082628|75594177|FG003|COMPLETED|Treatment Period II: Week 12 to Week 36||76||
59502028|NCT00082628|75594178|FG004|COMPLETED|Treatment Period II: Week 12 to Week 36||55||
59502029|NCT00082628|75594174|FG000|NOT COMPLETED|Treatment Period II: Week 12 to Week 36||0||
59885868|NCT02757352|76008644|FG008|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0||
59502030|NCT00082628|75594175|FG001|NOT COMPLETED|Treatment Period II: Week 12 to Week 36||0||
59607662|NCT03752567|75718355|FG000|NOT COMPLETED|Overall Study||0||
59502031|NCT00082628|75594176|FG002|NOT COMPLETED|Treatment Period II: Week 12 to Week 36||15||
59502032|NCT00082628|75594177|FG003|NOT COMPLETED|Treatment Period II: Week 12 to Week 36||16||
59502033|NCT00082628|75594178|FG004|NOT COMPLETED|Treatment Period II: Week 12 to Week 36||18||
59502034|NCT01950039|75594192|FG000|STARTED|Overall Study||15||
59502035|NCT01950039|75594193|FG001|STARTED|Overall Study||13||
59502036|NCT01950039|75594192|FG000|Study Drug Initiated|Overall Study||14||
59502037|NCT01950039|75594193|FG001|Study Drug Initiated|Overall Study||13||
59502038|NCT01950039|75594192|FG000|Completed Clamp|Overall Study||13||
59502039|NCT01950039|75594193|FG001|Completed Clamp|Overall Study||12||
59502040|NCT01950039|75594192|FG000|Completed MRI|Overall Study||13||
59502041|NCT01950039|75594193|FG001|Completed MRI|Overall Study||12||
59502042|NCT01950039|75594192|FG000|Completed Endothelial Evaluation|Overall Study||14||
59502043|NCT01950039|75594193|FG001|Completed Endothelial Evaluation|Overall Study||12||
59502044|NCT01950039|75594192|FG000|COMPLETED|Overall Study||14||
59502045|NCT01950039|75594193|FG001|COMPLETED|Overall Study||13||
59502046|NCT01950039|75594192|FG000|NOT COMPLETED|Overall Study||1||
59502047|NCT01950039|75594193|FG001|NOT COMPLETED|Overall Study||0||
59502048|NCT01889667|75594202|FG000|STARTED|Overall Study||10||
59502049|NCT01889667|75594203|FG001|STARTED|Overall Study||10||
59502050|NCT01889667|75594204|FG002|STARTED|Overall Study||10||
59502051|NCT01889667|75594202|FG000|COMPLETED|Overall Study||10||
59502052|NCT01889667|75594203|FG001|COMPLETED|Overall Study||10||
59502053|NCT01889667|75594204|FG002|COMPLETED|Overall Study||10||
59502054|NCT01889667|75594202|FG000|NOT COMPLETED|Overall Study||0||
59502055|NCT01889667|75594203|FG001|NOT COMPLETED|Overall Study||0||
59502056|NCT01889667|75594204|FG002|NOT COMPLETED|Overall Study||0||
59502057|NCT00711997|75594216|FG000|STARTED|Overall Study||3||
59502058|NCT00711997|75594217|FG001|STARTED|Overall Study||6||
59502059|NCT00711997|75594216|FG000|COMPLETED|Overall Study||3||
59502060|NCT00711997|75594217|FG001|COMPLETED|Overall Study||6||
59502061|NCT00711997|75594216|FG000|NOT COMPLETED|Overall Study||0||
59502062|NCT00711997|75594217|FG001|NOT COMPLETED|Overall Study||0||
59502063|NCT00712075|75594228|FG000|STARTED|Overall Study||22||
59502064|NCT00712075|75594229|FG001|STARTED|Overall Study||30||
59502065|NCT00712075|75594230|FG002|STARTED|Overall Study||25||
59502066|NCT00712075|75594228|FG000|COMPLETED|Overall Study||17||
59502067|NCT00712075|75594229|FG001|COMPLETED|Overall Study||26||
59502068|NCT00712075|75594230|FG002|COMPLETED|Overall Study||14||
59502069|NCT00712075|75594228|FG000|NOT COMPLETED|Overall Study||5||
59502070|NCT00712075|75594229|FG001|NOT COMPLETED|Overall Study||4||
59502071|NCT00712075|75594230|FG002|NOT COMPLETED|Overall Study||11||
59502072|NCT01891305|75594242|FG000|STARTED|Overall Study||12||
59502073|NCT01891305|75594243|FG001|STARTED|Overall Study||12||
59502074|NCT01891305|75594244|FG002|STARTED|Overall Study||14||
59502075|NCT01891305|75594245|FG003|STARTED|Overall Study||12||
59502076|NCT01891305|75594242|FG000|COMPLETED|Overall Study||9||
59502077|NCT01891305|75594243|FG001|COMPLETED|Overall Study||11||
59502078|NCT01891305|75594244|FG002|COMPLETED|Overall Study||11||
59502079|NCT01891305|75594245|FG003|COMPLETED|Overall Study||12||
59502080|NCT01891305|75594242|FG000|NOT COMPLETED|Overall Study||3||
59502081|NCT01891305|75594243|FG001|NOT COMPLETED|Overall Study||1||
59502082|NCT01891305|75594244|FG002|NOT COMPLETED|Overall Study||3||
59502083|NCT01891305|75594245|FG003|NOT COMPLETED|Overall Study||0||
59885869|NCT02757352|76008645|FG009|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0||
59885870|NCT02757352|76008636|FG000|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||8||
59885871|NCT02757352|76008637|FG001|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||1||
59885872|NCT02757352|76008638|FG002|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||4||
59885873|NCT02757352|76008639|FG003|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0||
59885874|NCT02757352|76008640|FG004|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0||
59885875|NCT02757352|76008641|FG005|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0||
59885876|NCT02757352|76008642|FG006|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0||
59885877|NCT02757352|76008643|FG007|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0||
59885878|NCT02757352|76008644|FG008|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0||
59885879|NCT02757352|76008645|FG009|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0||
59885880|NCT02757352|76008636|FG000|STARTED|Double-Blind Period (Week 16 - Week 52)||97||
59885881|NCT02757352|76008637|FG001|STARTED|Double-Blind Period (Week 16 - Week 52)||95||
59885882|NCT02757352|76008638|FG002|STARTED|Double-Blind Period (Week 16 - Week 52)||98||
59885883|NCT02757352|76008639|FG003|STARTED|Double-Blind Period (Week 16 - Week 52)||0||
59885884|NCT02757352|76008640|FG004|STARTED|Double-Blind Period (Week 16 - Week 52)||0||
59885885|NCT02757352|76008641|FG005|STARTED|Double-Blind Period (Week 16 - Week 52)||0||
59885886|NCT02757352|76008642|FG006|STARTED|Double-Blind Period (Week 16 - Week 52)||0||
59885887|NCT02757352|76008643|FG007|STARTED|Double-Blind Period (Week 16 - Week 52)||0||
59885888|NCT02757352|76008644|FG008|STARTED|Double-Blind Period (Week 16 - Week 52)||0||
59885889|NCT02757352|76008645|FG009|STARTED|Double-Blind Period (Week 16 - Week 52)||0||
59885890|NCT02757352|76008636|FG000|COMPLETED|Double-Blind Period (Week 16 - Week 52)||34||
59885891|NCT02757352|76008637|FG001|COMPLETED|Double-Blind Period (Week 16 - Week 52)||52||
59885892|NCT02757352|76008638|FG002|COMPLETED|Double-Blind Period (Week 16 - Week 52)||52||
59885893|NCT02757352|76008639|FG003|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0||
59885894|NCT02757352|76008640|FG004|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0||
60013369|NCT02589665|76129274|FG003|NOT COMPLETED|Induction Extension Period||0||
60013370|NCT02589665|76129275|FG004|NOT COMPLETED|Induction Extension Period||0||
60013371|NCT02589665|76129276|FG005|NOT COMPLETED|Induction Extension Period||0||
60013372|NCT02589665|76129277|FG006|NOT COMPLETED|Induction Extension Period||0||
60013373|NCT02589665|76129278|FG007|NOT COMPLETED|Induction Extension Period||2||
60013374|NCT02589665|76129279|FG008|NOT COMPLETED|Induction Extension Period||12||
60013375|NCT02589665|76129280|FG009|NOT COMPLETED|Induction Extension Period||0||
60013376|NCT02589665|76129271|FG000|STARTED|Maintenance Extension Period||0||
60013377|NCT02589665|76129272|FG001|STARTED|Maintenance Extension Period||0||
60013378|NCT02589665|76129273|FG002|STARTED|Maintenance Extension Period||0||
60013379|NCT02589665|76129274|FG003|STARTED|Maintenance Extension Period||0||
60013380|NCT02589665|76129275|FG004|STARTED|Maintenance Extension Period||0||
60013381|NCT02589665|76129276|FG005|STARTED|Maintenance Extension Period||0||
59502084|NCT01950663|75594255|FG000|STARTED|Overall Study||468||
59502085|NCT01950663|75594255|FG000|COMPLETED|Overall Study||467||
59502086|NCT01950663|75594255|FG000|NOT COMPLETED|Overall Study||1||
59502087|NCT02130635|75594268|FG000|STARTED|Part A-Safety and Tolerability||7||
59502088|NCT02130635|75594269|FG001|STARTED|Part A-Safety and Tolerability||21||
59885895|NCT02757352|76008641|FG005|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0||
59885896|NCT02757352|76008642|FG006|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0||
59885897|NCT02757352|76008643|FG007|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0||
59885898|NCT02757352|76008644|FG008|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0||
59885899|NCT02757352|76008645|FG009|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0||
59885900|NCT02757352|76008636|FG000|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||63||
59885901|NCT02757352|76008637|FG001|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||43||
59885902|NCT02757352|76008638|FG002|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||46||
59885903|NCT02757352|76008639|FG003|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0||
59885904|NCT02757352|76008640|FG004|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0||
59885905|NCT02757352|76008641|FG005|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0||
59885906|NCT02757352|76008642|FG006|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0||
59885907|NCT02757352|76008643|FG007|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0||
59885908|NCT02757352|76008644|FG008|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0||
59885909|NCT02757352|76008645|FG009|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0||
59885910|NCT02757352|76008636|FG000|STARTED|IR-Open Label Period (Week 16 - Week 52)|Participants continued with original assigned treatment without switching to open label ixeQ2W.|0||
59885911|NCT02757352|76008637|FG001|STARTED|IR-Open Label Period (Week 16 - Week 52)|Participants continued with original assigned treatment without switching to open label ixeQ2W.|0||
59885912|NCT02757352|76008638|FG002|STARTED|IR-Open Label Period (Week 16 - Week 52)|Participants continued with original assigned treatment without switching to open label ixeQ2W.|0||
59885913|NCT02757352|76008639|FG003|STARTED|IR-Open Label Period (Week 16 - Week 52)|IR based on the investigator's opinion switched to ixekizumab open label 80 mg Q2W.|62||
59885914|NCT02757352|76008640|FG004|STARTED|IR-Open Label Period (Week 16 - Week 52)|IR based on the investigator's opinion switched to ixekizumab open label 80 mg Q2W.|40||
59885915|NCT02757352|76008641|FG005|STARTED|IR-Open Label Period (Week 16 - Week 52)|IR based on the investigator's opinion switched to ixekizumab open label 80 mg Q2W.|42||
59885916|NCT02757352|76008642|FG006|STARTED|IR-Open Label Period (Week 16 - Week 52)||0||
59885917|NCT02757352|76008643|FG007|STARTED|IR-Open Label Period (Week 16 - Week 52)||0||
59755389|NCT03662542|75874423|FG001|STARTED|Combination Phase ( Week 0- Week 12)||71||
59755390|NCT03662542|75874424|FG002|STARTED|Combination Phase ( Week 0- Week 12)||71||
59755391|NCT03662542|75874425|FG003|STARTED|Combination Phase ( Week 0- Week 12)||0||
59755392|NCT03662542|75874426|FG004|STARTED|Combination Phase ( Week 0- Week 12)||0||
59755393|NCT03662542|75874427|FG005|STARTED|Combination Phase ( Week 0- Week 12)||0||
59755394|NCT03662542|75874428|FG006|STARTED|Combination Phase ( Week 0- Week 12)||0||
59755395|NCT03662542|75874429|FG007|STARTED|Combination Phase ( Week 0- Week 12)||0||
59755396|NCT03662542|75874430|FG008|STARTED|Combination Phase ( Week 0- Week 12)||0||
59885918|NCT02757352|76008644|FG008|STARTED|IR-Open Label Period (Week 16 - Week 52)||0||
59885919|NCT02757352|76008645|FG009|STARTED|IR-Open Label Period (Week 16 - Week 52)||0||
59885920|NCT02757352|76008636|FG000|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0||
59885921|NCT02757352|76008637|FG001|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0||
59885922|NCT02757352|76008638|FG002|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0||
59885923|NCT02757352|76008639|FG003|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||2||
59885924|NCT02757352|76008640|FG004|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0||
59885925|NCT02757352|76008641|FG005|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||3||
59885926|NCT02757352|76008642|FG006|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0||
59885927|NCT02757352|76008643|FG007|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0||
59885928|NCT02757352|76008644|FG008|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0||
59885929|NCT02757352|76008645|FG009|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0||
59885930|NCT02757352|76008636|FG000|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0||
59885931|NCT02757352|76008637|FG001|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0||
59885932|NCT02757352|76008638|FG002|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0||
59885933|NCT02757352|76008639|FG003|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||55||
59502089|NCT02130635|75594270|FG002|STARTED|Part A-Safety and Tolerability||0||
59502090|NCT02130635|75594271|FG003|STARTED|Part A-Safety and Tolerability||0||
59885934|NCT02757352|76008640|FG004|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||37||
59885935|NCT02757352|76008641|FG005|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||35||
59885936|NCT02757352|76008642|FG006|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0||
59885937|NCT02757352|76008643|FG007|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0||
59502091|NCT02130635|75594272|FG004|STARTED|Part A-Safety and Tolerability||0||
59502092|NCT02130635|75594273|FG005|STARTED|Part A-Safety and Tolerability||0||
59755397|NCT03662542|75874422|FG000|COMPLETED|Combination Phase ( Week 0- Week 12)||67||
59755398|NCT03662542|75874423|FG001|COMPLETED|Combination Phase ( Week 0- Week 12)||70||
59762573|NCT00534313|75882338|FG001|NOT COMPLETED|Long-term Period||34||
59502093|NCT02130635|75594274|FG006|STARTED|Part A-Safety and Tolerability||0||
59502094|NCT02130635|75594275|FG007|STARTED|Part A-Safety and Tolerability||0||
59502095|NCT02130635|75594276|FG008|STARTED|Part A-Safety and Tolerability||0||
59502096|NCT02130635|75594268|FG000|COMPLETED|Part A-Safety and Tolerability||7||
59502097|NCT02130635|75594269|FG001|COMPLETED|Part A-Safety and Tolerability||21||
59502098|NCT02130635|75594270|FG002|COMPLETED|Part A-Safety and Tolerability||0||
59885938|NCT02757352|76008644|FG008|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0||
59885939|NCT02757352|76008645|FG009|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0||
59885940|NCT02757352|76008636|FG000|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0||
59885941|NCT02757352|76008637|FG001|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0||
59885942|NCT02757352|76008638|FG002|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0||
59885943|NCT02757352|76008639|FG003|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||7||
59885944|NCT02757352|76008640|FG004|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||3||
59950959|NCT00571493|76069872|FG003|NOT COMPLETED|Overall Study||0||
60013382|NCT02589665|76129277|FG006|STARTED|Maintenance Extension Period||0||
60013383|NCT02589665|76129278|FG007|STARTED|Maintenance Extension Period||0||
60013384|NCT02589665|76129279|FG008|STARTED|Maintenance Extension Period||0||
60013385|NCT02589665|76129280|FG009|STARTED|Maintenance Extension Period||68||
60013386|NCT02589665|76129271|FG000|COMPLETED|Maintenance Extension Period||0||
60013387|NCT02589665|76129272|FG001|COMPLETED|Maintenance Extension Period||0||
60013388|NCT02589665|76129273|FG002|COMPLETED|Maintenance Extension Period||0||
60013389|NCT02589665|76129274|FG003|COMPLETED|Maintenance Extension Period||0||
60013390|NCT02589665|76129275|FG004|COMPLETED|Maintenance Extension Period||0||
60013391|NCT02589665|76129276|FG005|COMPLETED|Maintenance Extension Period||0||
60013392|NCT02589665|76129277|FG006|COMPLETED|Maintenance Extension Period||0||
60013393|NCT02589665|76129278|FG007|COMPLETED|Maintenance Extension Period||0||
60013394|NCT02589665|76129279|FG008|COMPLETED|Maintenance Extension Period||0||
60013395|NCT02589665|76129280|FG009|COMPLETED|Maintenance Extension Period||0||
60013396|NCT02589665|76129271|FG000|NOT COMPLETED|Maintenance Extension Period||0||
60013397|NCT02589665|76129272|FG001|NOT COMPLETED|Maintenance Extension Period||0||
60013398|NCT02589665|76129273|FG002|NOT COMPLETED|Maintenance Extension Period||0||
60013399|NCT02589665|76129274|FG003|NOT COMPLETED|Maintenance Extension Period||0||
60013400|NCT02589665|76129275|FG004|NOT COMPLETED|Maintenance Extension Period||0||
60013401|NCT02589665|76129276|FG005|NOT COMPLETED|Maintenance Extension Period||0||
60013402|NCT02589665|76129277|FG006|NOT COMPLETED|Maintenance Extension Period||0||
60013403|NCT02589665|76129278|FG007|NOT COMPLETED|Maintenance Extension Period||0||
60013404|NCT02589665|76129279|FG008|NOT COMPLETED|Maintenance Extension Period||0||
60013405|NCT02589665|76129280|FG009|NOT COMPLETED|Maintenance Extension Period||68||
60013406|NCT01905397|76129306|FG000|STARTED|Overall Study||82||
60013407|NCT01905397|76129307|FG001|STARTED|Overall Study||82||
60013408|NCT01905397|76129306|FG000|COMPLETED|Overall Study||63||
60013409|NCT01905397|76129307|FG001|COMPLETED|Overall Study||75||
60013410|NCT01905397|76129306|FG000|NOT COMPLETED|Overall Study||19||
60013411|NCT01905397|76129307|FG001|NOT COMPLETED|Overall Study||7||
60013412|NCT01362595|76129313|FG000|STARTED|Overall Study||55||
60013413|NCT01362595|76129313|FG000|COMPLETED|Overall Study||43||
60013414|NCT01362595|76129313|FG000|NOT COMPLETED|Overall Study||12||
60013415|NCT02519595|76129320|FG000|STARTED|Overall Study||58||
60013416|NCT02519595|76129321|FG001|STARTED|Overall Study||57||
60013417|NCT02519595|76129322|FG002|STARTED|Overall Study||56||
60013418|NCT02519595|76129320|FG000|COMPLETED|Overall Study||50||
60013419|NCT02519595|76129321|FG001|COMPLETED|Overall Study||35||
60013420|NCT02519595|76129322|FG002|COMPLETED|Overall Study||40||
60013421|NCT02519595|76129320|FG000|NOT COMPLETED|Overall Study||8||
60013422|NCT02519595|76129321|FG001|NOT COMPLETED|Overall Study||22||
60013423|NCT02519595|76129322|FG002|NOT COMPLETED|Overall Study||16||
60013424|NCT04278755|76129330|FG000|STARTED|Overall Study||8||
60013425|NCT04278755|76129330|FG000|COMPLETED|Overall Study||7||
60013426|NCT04278755|76129330|FG000|NOT COMPLETED|Overall Study||1||
60013427|NCT00660673|76129334|FG000|STARTED|Overall Study||262||
60013428|NCT00660673|76129334|FG000|COMPLETED|Overall Study||145||
60013429|NCT00660673|76129334|FG000|NOT COMPLETED|Overall Study||117||
60013430|NCT02630563|76129349|FG000|STARTED|Overall Study||9||
60013431|NCT02630563|76129349|FG000|COMPLETED|Overall Study||8||
60013432|NCT02630563|76129349|FG000|NOT COMPLETED|Overall Study||1||
60013433|NCT02521415|76129356|FG000|STARTED|Overall Study||43||
60013434|NCT02521415|76129357|FG001|STARTED|Overall Study||44||
60013435|NCT02521415|76129356|FG000|COMPLETED|Overall Study||43||
60013436|NCT02521415|76129357|FG001|COMPLETED|Overall Study||44||
60013437|NCT02521415|76129356|FG000|NOT COMPLETED|Overall Study||0||
60013438|NCT02521415|76129357|FG001|NOT COMPLETED|Overall Study||0||
60013439|NCT02588339|76129363|FG000|STARTED|Overall Study||42||
60013440|NCT02588339|76129363|FG000|COMPLETED|Overall Study||39||
60013441|NCT02588339|76129363|FG000|NOT COMPLETED|Overall Study||3||
60013442|NCT02629159|76129370|FG000|STARTED|Overall Study||651||
60013443|NCT02629159|76129371|FG001|STARTED|Overall Study||327||
60013444|NCT02629159|76129372|FG002|STARTED|Overall Study||651||
60013445|NCT02629159|76129370|FG000|Received Assigned Study Drug|Overall Study||651||
60013446|NCT02629159|76129371|FG001|Received Assigned Study Drug|Overall Study||327||
60013447|NCT02629159|76129372|FG002|Received Assigned Study Drug|Overall Study|One participant received a placebo injection but no oral study drug before discontinuing the study|650||
60013448|NCT02629159|76129370|FG000|Completed Week 14 on Study Drug|Overall Study||620||
60013449|NCT02629159|76129371|FG001|Completed Week 14 on Study Drug|Overall Study||300||
60013450|NCT02629159|76129372|FG002|Completed Week 14 on Study Drug|Overall Study||620||
60013451|NCT02629159|76129370|FG000|Rescued at Week 14|Overall Study||231||
60013452|NCT02629159|76129371|FG001|Rescued at Week 14|Overall Study||56||
60013453|NCT02629159|76129372|FG002|Rescued at Week 14|Overall Study||78||
60013454|NCT02629159|76129370|FG000|Rescued at Week 18|Overall Study|One participant rescued at week 18 did not receive any dose of upadacitinib|48||
60013455|NCT02629159|76129371|FG001|Rescued at Week 18|Overall Study||14||
60013456|NCT02629159|76129372|FG002|Rescued at Week 18|Overall Study||29||
59885945|NCT02757352|76008641|FG005|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||7||
59885946|NCT02757352|76008642|FG006|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0||
59885947|NCT02757352|76008643|FG007|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0||
59885948|NCT02757352|76008644|FG008|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0||
59885949|NCT02757352|76008645|FG009|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0||
59885950|NCT02757352|76008636|FG000|STARTED|Follow-Up Period||0||
59885951|NCT02757352|76008637|FG001|STARTED|Follow-Up Period||0||
59885952|NCT02757352|76008638|FG002|STARTED|Follow-Up Period||0||
59885953|NCT02757352|76008639|FG003|STARTED|Follow-Up Period|Participants who completed the study were eligible to enroll in RHBY or enter follow up period.|0||
59885954|NCT02757352|76008640|FG004|STARTED|Follow-Up Period|Participants who completed the study were eligible to enroll in RHBY or enter follow up period.|0||
59885955|NCT02757352|76008641|FG005|STARTED|Follow-Up Period|Participants who completed the study were eligible to enroll in RHBY or enter follow up period.|0||
59885956|NCT02757352|76008642|FG006|STARTED|Follow-Up Period|Participants who completed the study were eligible to enroll in RHBY or enter follow up period.|3||
59885957|NCT02757352|76008643|FG007|STARTED|Follow-Up Period|Participants who completed the study were eligible to enroll in RHBY or enter follow up period.|5||
59885958|NCT02757352|76008644|FG008|STARTED|Follow-Up Period|Participants who completed the study were eligible to enroll in RHBY or enter follow up period.|28||
59885959|NCT02757352|76008645|FG009|STARTED|Follow-Up Period||5||
59885960|NCT02757352|76008636|FG000|COMPLETED|Follow-Up Period||0||
59885961|NCT02757352|76008637|FG001|COMPLETED|Follow-Up Period||0||
59885962|NCT02757352|76008638|FG002|COMPLETED|Follow-Up Period||0||
59885963|NCT02757352|76008639|FG003|COMPLETED|Follow-Up Period||0||
59885964|NCT02757352|76008640|FG004|COMPLETED|Follow-Up Period||0||
59885965|NCT02757352|76008641|FG005|COMPLETED|Follow-Up Period||0||
59502099|NCT02130635|75594271|FG003|COMPLETED|Part A-Safety and Tolerability||0||
59502100|NCT02130635|75594272|FG004|COMPLETED|Part A-Safety and Tolerability||0||
59502101|NCT02130635|75594273|FG005|COMPLETED|Part A-Safety and Tolerability||0||
59502102|NCT02130635|75594274|FG006|COMPLETED|Part A-Safety and Tolerability||0||
59502103|NCT02130635|75594275|FG007|COMPLETED|Part A-Safety and Tolerability||0||
59502104|NCT02130635|75594276|FG008|COMPLETED|Part A-Safety and Tolerability||0||
59502105|NCT02130635|75594268|FG000|NOT COMPLETED|Part A-Safety and Tolerability||0||
59502106|NCT02130635|75594269|FG001|NOT COMPLETED|Part A-Safety and Tolerability||0||
59502107|NCT02130635|75594270|FG002|NOT COMPLETED|Part A-Safety and Tolerability||0||
59502108|NCT02130635|75594271|FG003|NOT COMPLETED|Part A-Safety and Tolerability||0||
59502109|NCT02130635|75594272|FG004|NOT COMPLETED|Part A-Safety and Tolerability||0||
59502110|NCT02130635|75594273|FG005|NOT COMPLETED|Part A-Safety and Tolerability||0||
59502111|NCT02130635|75594274|FG006|NOT COMPLETED|Part A-Safety and Tolerability||0||
59502112|NCT02130635|75594275|FG007|NOT COMPLETED|Part A-Safety and Tolerability||0||
59502113|NCT02130635|75594276|FG008|NOT COMPLETED|Part A-Safety and Tolerability||0||
59502114|NCT02130635|75594268|FG000|STARTED|Part B-Dose-Response Relationship||0||
59502115|NCT02130635|75594269|FG001|STARTED|Part B-Dose-Response Relationship||0||
59502116|NCT02130635|75594270|FG002|STARTED|Part B-Dose-Response Relationship||5||
59502117|NCT02130635|75594271|FG003|STARTED|Part B-Dose-Response Relationship||5||
59502118|NCT02130635|75594272|FG004|STARTED|Part B-Dose-Response Relationship||5||
59502119|NCT02130635|75594273|FG005|STARTED|Part B-Dose-Response Relationship||5||
59502120|NCT02130635|75594274|FG006|STARTED|Part B-Dose-Response Relationship||6||
59502121|NCT02130635|75594275|FG007|STARTED|Part B-Dose-Response Relationship||5||
59502122|NCT02130635|75594276|FG008|STARTED|Part B-Dose-Response Relationship||5||
59502123|NCT02130635|75594268|FG000|COMPLETED|Part B-Dose-Response Relationship||0||
59502124|NCT02130635|75594269|FG001|COMPLETED|Part B-Dose-Response Relationship||0||
59502125|NCT02130635|75594270|FG002|COMPLETED|Part B-Dose-Response Relationship||5||
59502126|NCT02130635|75594271|FG003|COMPLETED|Part B-Dose-Response Relationship||5||
59502127|NCT02130635|75594272|FG004|COMPLETED|Part B-Dose-Response Relationship||5||
59502128|NCT02130635|75594273|FG005|COMPLETED|Part B-Dose-Response Relationship||5||
59502129|NCT02130635|75594274|FG006|COMPLETED|Part B-Dose-Response Relationship||6||
59502130|NCT02130635|75594275|FG007|COMPLETED|Part B-Dose-Response Relationship||5||
59502131|NCT02130635|75594276|FG008|COMPLETED|Part B-Dose-Response Relationship||5||
59502132|NCT02130635|75594268|FG000|NOT COMPLETED|Part B-Dose-Response Relationship||0||
59502133|NCT02130635|75594269|FG001|NOT COMPLETED|Part B-Dose-Response Relationship||0||
59502134|NCT02130635|75594270|FG002|NOT COMPLETED|Part B-Dose-Response Relationship||0||
59502135|NCT02130635|75594271|FG003|NOT COMPLETED|Part B-Dose-Response Relationship||0||
59502136|NCT02130635|75594272|FG004|NOT COMPLETED|Part B-Dose-Response Relationship||0||
59502137|NCT02130635|75594273|FG005|NOT COMPLETED|Part B-Dose-Response Relationship||0||
59502138|NCT02130635|75594274|FG006|NOT COMPLETED|Part B-Dose-Response Relationship||0||
59502139|NCT02130635|75594275|FG007|NOT COMPLETED|Part B-Dose-Response Relationship||0||
59502140|NCT02130635|75594276|FG008|NOT COMPLETED|Part B-Dose-Response Relationship||0||
59502141|NCT01892007|75594305|FG000|STARTED|Overall Study||27||
59502142|NCT01892007|75594306|FG001|STARTED|Overall Study||30||
59502143|NCT01892007|75594305|FG000|COMPLETED|Overall Study||27||
59502144|NCT01892007|75594306|FG001|COMPLETED|Overall Study||30||
59502145|NCT01892007|75594305|FG000|NOT COMPLETED|Overall Study||0||
59502146|NCT01892007|75594306|FG001|NOT COMPLETED|Overall Study||0||
59502147|NCT00725959|75594314|FG000|STARTED|Overall Study||942||
59502148|NCT00725959|75594315|FG001|STARTED|Overall Study||636||
59502149|NCT00725959|75594314|FG000|COMPLETED|Overall Study||653||
59502150|NCT00725959|75594315|FG001|COMPLETED|Overall Study||439||
59502151|NCT00725959|75594314|FG000|NOT COMPLETED|Overall Study||289||
59502152|NCT00725959|75594315|FG001|NOT COMPLETED|Overall Study||197||
59502153|NCT01892865|75594323|FG000|STARTED|Overall Study|107 operative days scheduled with the Historical Means method were included|356||107
59502154|NCT01892865|75594324|FG001|STARTED|Overall Study|100 operative days scheduled with the Predictive Modeling System method were included|379||100
59502155|NCT01892865|75594323|FG000|COMPLETED|Overall Study||356||107
59502156|NCT01892865|75594324|FG001|COMPLETED|Overall Study||379||100
59502157|NCT01892865|75594323|FG000|NOT COMPLETED|Overall Study||0||0
59502158|NCT01892865|75594324|FG001|NOT COMPLETED|Overall Study||0||0
59502159|NCT00726739|75594332|FG000|STARTED|Overall Study||11||
59502160|NCT00726739|75594333|FG001|STARTED|Overall Study||10||
59502161|NCT00726739|75594332|FG000|COMPLETED|Overall Study|1 patient failed during screening due to brain metastasis.|10||
59502162|NCT00726739|75594333|FG001|COMPLETED|Overall Study||10||
59885966|NCT02757352|76008642|FG006|COMPLETED|Follow-Up Period||2||
59502163|NCT00726739|75594332|FG000|NOT COMPLETED|Overall Study||1||
59502164|NCT00726739|75594333|FG001|NOT COMPLETED|Overall Study||0||
59502165|NCT00569309|75594340|FG000|STARTED|Overall Study||30||
59502166|NCT00569309|75594340|FG000|COMPLETED|Overall Study||30||
59502167|NCT00569309|75594340|FG000|NOT COMPLETED|Overall Study||0||
59502168|NCT01952301|75594344|FG000|STARTED|Overall Study|We designed and implemented a single-blind, randomized, controlled, split-mouth study of 30 subjects|30||
59502169|NCT01952301|75594344|FG000|COMPLETED|Overall Study||30||
59502170|NCT01952301|75594344|FG000|NOT COMPLETED|Overall Study||0||
59502171|NCT00714571|75594356|FG000|STARTED|Stage 1||12||
59502172|NCT00714571|75594357|FG001|STARTED|Stage 1|11 allocated to intervention, but 1 withdrew before the first intervention session|15||
59502173|NCT00714571|75594358|FG002|STARTED|Stage 1||11||
59502174|NCT00714571|75594359|FG003|STARTED|Stage 1||14||
59502175|NCT00714571|75594360|FG004|STARTED|Stage 1||0||
59502176|NCT00714571|75594361|FG005|STARTED|Stage 1||0||
59502177|NCT00714571|75594356|FG000|COMPLETED|Stage 1|1 patient excluded who completed training but did not disclose ongoing chemotherapy for cancer|12||
59502178|NCT00714571|75594357|FG001|COMPLETED|Stage 1||15||
59502179|NCT00714571|75594358|FG002|COMPLETED|Stage 1||10||
59502180|NCT00714571|75594359|FG003|COMPLETED|Stage 1||14||
59502181|NCT00714571|75594360|FG004|COMPLETED|Stage 1||0||
59502182|NCT00714571|75594361|FG005|COMPLETED|Stage 1||0||
59502183|NCT00714571|75594356|FG000|NOT COMPLETED|Stage 1||0||
59502184|NCT00714571|75594357|FG001|NOT COMPLETED|Stage 1||0||
59502185|NCT00714571|75594358|FG002|NOT COMPLETED|Stage 1||1||
59502186|NCT00714571|75594359|FG003|NOT COMPLETED|Stage 1||0||
59502187|NCT00714571|75594360|FG004|NOT COMPLETED|Stage 1||0||
59502188|NCT00714571|75594361|FG005|NOT COMPLETED|Stage 1||0||
59502189|NCT00714571|75594356|FG000|STARTED|Stage 2||0||
59502190|NCT00714571|75594357|FG001|STARTED|Stage 2||0||
59502191|NCT00714571|75594358|FG002|STARTED|Stage 2||0||
59502192|NCT00714571|75594359|FG003|STARTED|Stage 2||0||
59502193|NCT00714571|75594360|FG004|STARTED|Stage 2||15||
59502194|NCT00714571|75594361|FG005|STARTED|Stage 2||15||
59502195|NCT00714571|75594356|FG000|COMPLETED|Stage 2||0||
59502196|NCT00714571|75594357|FG001|COMPLETED|Stage 2||0||
59885967|NCT02757352|76008643|FG007|COMPLETED|Follow-Up Period||4||
59885968|NCT02757352|76008644|FG008|COMPLETED|Follow-Up Period||18||
59885969|NCT02757352|76008645|FG009|COMPLETED|Follow-Up Period||2||
59502197|NCT00714571|75594358|FG002|COMPLETED|Stage 2||0||
59502198|NCT00714571|75594359|FG003|COMPLETED|Stage 2||0||
59502199|NCT00714571|75594360|FG004|COMPLETED|Stage 2||15||
59502200|NCT00714571|75594361|FG005|COMPLETED|Stage 2||15||
59502201|NCT00714571|75594356|FG000|NOT COMPLETED|Stage 2||0||
59502202|NCT00714571|75594357|FG001|NOT COMPLETED|Stage 2||0||
59502203|NCT00714571|75594358|FG002|NOT COMPLETED|Stage 2||0||
59502204|NCT00714571|75594359|FG003|NOT COMPLETED|Stage 2||0||
59502205|NCT00714571|75594360|FG004|NOT COMPLETED|Stage 2||0||
59502206|NCT00714571|75594361|FG005|NOT COMPLETED|Stage 2||0||
59502207|NCT00569855|75594375|FG000|STARTED|Overall Study|832 subjects enrolled; however, study records only available for analysis from 2004 =446 subjects|785||
59502208|NCT00569855|75594375|FG000|COMPLETED|Overall Study|785 subjects treated with study drug|785||
59885970|NCT02757352|76008636|FG000|NOT COMPLETED|Follow-Up Period||0||
59885971|NCT02757352|76008637|FG001|NOT COMPLETED|Follow-Up Period||0||
59502209|NCT00569855|75594375|FG000|NOT COMPLETED|Overall Study||0||
59502210|NCT01893801|75594379|FG000|STARTED|Overall Study||25||
59502211|NCT01893801|75594379|FG000|COMPLETED|Overall Study||25||
59502212|NCT01893801|75594379|FG000|NOT COMPLETED|Overall Study||0||
59502213|NCT00570089|75594385|FG000|STARTED|Period 1||10||
59502214|NCT00570089|75594386|FG001|STARTED|Period 1||10||
59502215|NCT00570089|75594385|FG000|COMPLETED|Period 1||10||
59502216|NCT00570089|75594386|FG001|COMPLETED|Period 1||10||
59502217|NCT00570089|75594385|FG000|NOT COMPLETED|Period 1||0||
59502218|NCT00570089|75594386|FG001|NOT COMPLETED|Period 1||0||
59502219|NCT00570089|75594385|FG000|STARTED|Perod 2||10||
59502220|NCT00570089|75594386|FG001|STARTED|Perod 2||10||
59502221|NCT00570089|75594385|FG000|COMPLETED|Perod 2||10||
59502222|NCT00570089|75594386|FG001|COMPLETED|Perod 2||10||
59607663|NCT03748979|75718370|FG000|STARTED|Overall Study||6||
59755399|NCT03662542|75874424|FG002|COMPLETED|Combination Phase ( Week 0- Week 12)||71||
59755400|NCT03662542|75874425|FG003|COMPLETED|Combination Phase ( Week 0- Week 12)||0||
59755401|NCT03662542|75874426|FG004|COMPLETED|Combination Phase ( Week 0- Week 12)||0||
59755402|NCT03662542|75874427|FG005|COMPLETED|Combination Phase ( Week 0- Week 12)||0||
59755403|NCT03662542|75874428|FG006|COMPLETED|Combination Phase ( Week 0- Week 12)||0||
59885972|NCT02757352|76008638|FG002|NOT COMPLETED|Follow-Up Period||0||
59502223|NCT00570089|75594385|FG000|NOT COMPLETED|Perod 2||0||
59502224|NCT00570089|75594386|FG001|NOT COMPLETED|Perod 2||0||
59755404|NCT03662542|75874429|FG007|COMPLETED|Combination Phase ( Week 0- Week 12)||0||
59885973|NCT02757352|76008639|FG003|NOT COMPLETED|Follow-Up Period||0||
59502225|NCT00727597|75594396|FG000|STARTED|Overall Study||51||
59885974|NCT02757352|76008640|FG004|NOT COMPLETED|Follow-Up Period||0||
59502226|NCT00727597|75594397|FG001|STARTED|Overall Study||50||
59502227|NCT00727597|75594396|FG000|COMPLETED|Overall Study||51||
59502228|NCT00727597|75594397|FG001|COMPLETED|Overall Study||50||
59502229|NCT00727597|75594396|FG000|NOT COMPLETED|Overall Study||0||
59502230|NCT00727597|75594397|FG001|NOT COMPLETED|Overall Study||0||
59502231|NCT00571259|75594405|FG000|STARTED|Overall Study||148||
59502232|NCT00571259|75594406|FG001|STARTED|Overall Study||155||
59607664|NCT03748979|75718371|FG001|STARTED|Overall Study||6||
59885975|NCT02757352|76008641|FG005|NOT COMPLETED|Follow-Up Period||0||
59885976|NCT02757352|76008642|FG006|NOT COMPLETED|Follow-Up Period||1||
59885977|NCT02757352|76008643|FG007|NOT COMPLETED|Follow-Up Period||1||
59885978|NCT02757352|76008644|FG008|NOT COMPLETED|Follow-Up Period||10||
59885979|NCT02757352|76008645|FG009|NOT COMPLETED|Follow-Up Period||3||
59885980|NCT04588480|76008678|FG000|STARTED|Blinded Phase: Up to 6 Months||119||
59885981|NCT04588480|76008679|FG001|STARTED|Blinded Phase: Up to 6 Months||41||
59885982|NCT04588480|76008680|FG002|STARTED|Blinded Phase: Up to 6 Months||0||
59885983|NCT04588480|76008678|FG000|COMPLETED|Blinded Phase: Up to 6 Months||119||
59885984|NCT04588480|76008679|FG001|COMPLETED|Blinded Phase: Up to 6 Months||41||
59885985|NCT04588480|76008680|FG002|COMPLETED|Blinded Phase: Up to 6 Months||0||
59885986|NCT04588480|76008678|FG000|NOT COMPLETED|Blinded Phase: Up to 6 Months||0||
59885987|NCT04588480|76008679|FG001|NOT COMPLETED|Blinded Phase: Up to 6 Months||0||
59885988|NCT04588480|76008680|FG002|NOT COMPLETED|Blinded Phase: Up to 6 Months||0||
59885989|NCT04588480|76008678|FG000|STARTED|Unblinded Phase: From 6 to 12 Months||119||
59885990|NCT04588480|76008679|FG001|STARTED|Unblinded Phase: From 6 to 12 Months|Participants who declined BNT162b2 30 mcg after unblinding.|6||
59885991|NCT04588480|76008680|FG002|STARTED|Unblinded Phase: From 6 to 12 Months||35||
59885992|NCT04588480|76008678|FG000|COMPLETED|Unblinded Phase: From 6 to 12 Months||117||
59885993|NCT04588480|76008679|FG001|COMPLETED|Unblinded Phase: From 6 to 12 Months||3||
59885994|NCT04588480|76008680|FG002|COMPLETED|Unblinded Phase: From 6 to 12 Months||35||
59885995|NCT04588480|76008678|FG000|NOT COMPLETED|Unblinded Phase: From 6 to 12 Months||2||
59885996|NCT04588480|76008679|FG001|NOT COMPLETED|Unblinded Phase: From 6 to 12 Months||3||
59502233|NCT00571259|75594405|FG000|COMPLETED|Overall Study||4||
59502234|NCT00571259|75594406|FG001|COMPLETED|Overall Study||14||
59502235|NCT00571259|75594405|FG000|NOT COMPLETED|Overall Study||144||
59502236|NCT00571259|75594406|FG001|NOT COMPLETED|Overall Study||141||
59502237|NCT01893879|75594416|FG000|STARTED|Overall Study||7||
59502238|NCT01893879|75594417|FG001|STARTED|Overall Study||7||
59502239|NCT01893879|75594416|FG000|COMPLETED|Overall Study||5||
59502240|NCT01893879|75594417|FG001|COMPLETED|Overall Study||4||
59502241|NCT01893879|75594416|FG000|NOT COMPLETED|Overall Study||2||
59502242|NCT01893879|75594417|FG001|NOT COMPLETED|Overall Study||3||
59502243|NCT01894503|75594423|FG000|STARTED|Overall Study||5||
59502244|NCT01894503|75594423|FG000|COMPLETED|Overall Study||5||
59502245|NCT01894503|75594423|FG000|NOT COMPLETED|Overall Study||0||
59502246|NCT00571961|75594428|FG000|STARTED|Overall Study||12||
59502247|NCT00571961|75594428|FG000|COMPLETED|Overall Study||12||
59502248|NCT00571961|75594428|FG000|NOT COMPLETED|Overall Study||0||
59502249|NCT00572117|75594434|FG000|STARTED|Overall Study||5||
59502250|NCT00572117|75594435|FG001|STARTED|Overall Study||7||
59502251|NCT00572117|75594434|FG000|COMPLETED|Overall Study||3||
59502252|NCT00572117|75594435|FG001|COMPLETED|Overall Study||5||
59502253|NCT00572117|75594434|FG000|NOT COMPLETED|Overall Study||2||
59502254|NCT00572117|75594435|FG001|NOT COMPLETED|Overall Study||2||
59502255|NCT01895127|75594445|FG000|STARTED|Screening||4||
59502256|NCT01895127|75594446|FG001|STARTED|Screening||7||
59502257|NCT01895127|75594445|FG000|COMPLETED|Screening|One subject was found to be pregnant at screening so was withdrawn from the study prior to treatment|4||
59502258|NCT01895127|75594446|FG001|COMPLETED|Screening||7||
59502259|NCT01895127|75594445|FG000|NOT COMPLETED|Screening||0||
59502260|NCT01895127|75594446|FG001|NOT COMPLETED|Screening||0||
59502261|NCT01895127|75594445|FG000|STARTED|Treatment Period (Week 0-Month 3)||3||
59502262|NCT01895127|75594446|FG001|STARTED|Treatment Period (Week 0-Month 3)||7||
59502263|NCT01895127|75594445|FG000|COMPLETED|Treatment Period (Week 0-Month 3)||3||
59502264|NCT01895127|75594446|FG001|COMPLETED|Treatment Period (Week 0-Month 3)||7||
59502265|NCT01895127|75594445|FG000|NOT COMPLETED|Treatment Period (Week 0-Month 3)||0||
59502266|NCT01895127|75594446|FG001|NOT COMPLETED|Treatment Period (Week 0-Month 3)||0||
59502267|NCT01895127|75594445|FG000|STARTED|Month 3 Follow-up & Biopsy||3||
59502268|NCT01895127|75594446|FG001|STARTED|Month 3 Follow-up & Biopsy||7||
59502269|NCT01895127|75594445|FG000|COMPLETED|Month 3 Follow-up & Biopsy||3||
59502270|NCT01895127|75594446|FG001|COMPLETED|Month 3 Follow-up & Biopsy||7||
59502271|NCT01895127|75594445|FG000|NOT COMPLETED|Month 3 Follow-up & Biopsy||0||
59502272|NCT01895127|75594446|FG001|NOT COMPLETED|Month 3 Follow-up & Biopsy||0||
59502273|NCT01895127|75594445|FG000|STARTED|Long Term Follow-up (Month 3-12)||3||
59885997|NCT04588480|76008680|FG002|NOT COMPLETED|Unblinded Phase: From 6 to 12 Months||0||
59885998|NCT02756650|76008687|FG000|STARTED|Overall Study||8||
59885999|NCT02756650|76008687|FG000|COMPLETED|Overall Study||6||
59886000|NCT02756650|76008687|FG000|NOT COMPLETED|Overall Study||2||
59886001|NCT00110357|76008693|FG000|STARTED|Overall Study||27||
59886002|NCT00110357|76008694|FG001|STARTED|Overall Study||19||
59886003|NCT00110357|76008693|FG000|COMPLETED|Overall Study|Number Still on Study|0||
59886004|NCT00110357|76008694|FG001|COMPLETED|Overall Study|Number Still on Study|0||
59886005|NCT00110357|76008693|FG000|NOT COMPLETED|Overall Study||27||
59886006|NCT00110357|76008694|FG001|NOT COMPLETED|Overall Study||19||
59886007|NCT02752906|76008729|FG000|STARTED|Overall Study||403||
59886008|NCT02752906|76008730|FG001|STARTED|Overall Study||407||
59886009|NCT02752906|76008729|FG000|Vaccinated|Overall Study||402||
59886010|NCT02752906|76008730|FG001|Vaccinated|Overall Study||407||
59886011|NCT02752906|76008729|FG000|COMPLETED|Overall Study||396||
59886012|NCT02752906|76008730|FG001|COMPLETED|Overall Study||402||
59886013|NCT02752906|76008729|FG000|NOT COMPLETED|Overall Study||7||
59886014|NCT02752906|76008730|FG001|NOT COMPLETED|Overall Study||5||
59886015|NCT02756338|76008736|FG000|STARTED|Overall Study||77||
59886016|NCT02756338|76008736|FG000|COMPLETED|Overall Study||72||
59886017|NCT02756338|76008736|FG000|NOT COMPLETED|Overall Study||5||
59886018|NCT00293033|76008740|FG000|STARTED|Open-label Titration Period|152 subjects enrolled; 151 subjects received at least one dose of study drug|151||
59886019|NCT00293033|76008740|FG000|COMPLETED|Open-label Titration Period||82||
59886020|NCT00293033|76008740|FG000|NOT COMPLETED|Open-label Titration Period||69||
59886021|NCT00293033|76008740|FG000|STARTED|Double-blind Treatment Period|82 randomized; 1 didn't take double-blind drug; 1 didn't report a pain assessment within 30 minutes|82||
59886022|NCT00293033|76008740|FG000|COMPLETED|Double-blind Treatment Period||70||
59502274|NCT01895127|75594446|FG001|STARTED|Long Term Follow-up (Month 3-12)||7||
59502275|NCT01895127|75594445|FG000|COMPLETED|Long Term Follow-up (Month 3-12)||1||
59502276|NCT01895127|75594446|FG001|COMPLETED|Long Term Follow-up (Month 3-12)||4||
59502277|NCT01895127|75594445|FG000|NOT COMPLETED|Long Term Follow-up (Month 3-12)||2||
59502278|NCT01895127|75594446|FG001|NOT COMPLETED|Long Term Follow-up (Month 3-12)||3||
59502279|NCT01953081|75594455|FG000|STARTED|Overall Study||7||
59502280|NCT01953081|75594456|FG001|STARTED|Overall Study||6||
59502281|NCT01953081|75594455|FG000|COMPLETED|Overall Study||5||
59502282|NCT01953081|75594456|FG001|COMPLETED|Overall Study||3||
59502283|NCT01953081|75594455|FG000|NOT COMPLETED|Overall Study||2||
59502284|NCT01953081|75594456|FG001|NOT COMPLETED|Overall Study||3||
59502285|NCT00572897|75594464|FG000|STARTED|Overall Study||32||
59755405|NCT03662542|75874430|FG008|COMPLETED|Combination Phase ( Week 0- Week 12)||0||
59755406|NCT03662542|75874422|FG000|NOT COMPLETED|Combination Phase ( Week 0- Week 12)||5||
59762574|NCT00534313|75882339|FG002|NOT COMPLETED|Long-term Period||43||
59502286|NCT00572897|75594465|FG001|STARTED|Overall Study||34||
59502287|NCT00572897|75594464|FG000|COMPLETED|Overall Study||32||
59502288|NCT00572897|75594465|FG001|COMPLETED|Overall Study||34||
59755407|NCT03662542|75874423|FG001|NOT COMPLETED|Combination Phase ( Week 0- Week 12)||1||
59755408|NCT03662542|75874424|FG002|NOT COMPLETED|Combination Phase ( Week 0- Week 12)||0||
59755409|NCT03662542|75874425|FG003|NOT COMPLETED|Combination Phase ( Week 0- Week 12)||0||
59755410|NCT03662542|75874426|FG004|NOT COMPLETED|Combination Phase ( Week 0- Week 12)||0||
59755411|NCT03662542|75874427|FG005|NOT COMPLETED|Combination Phase ( Week 0- Week 12)||0||
59755412|NCT03662542|75874428|FG006|NOT COMPLETED|Combination Phase ( Week 0- Week 12)||0||
59755413|NCT03662542|75874429|FG007|NOT COMPLETED|Combination Phase ( Week 0- Week 12)||0||
59755414|NCT03662542|75874430|FG008|NOT COMPLETED|Combination Phase ( Week 0- Week 12)||0||
59755415|NCT03662542|75874422|FG000|STARTED|Monotherapy Phase (Week 12-Week 38)||0||
59755416|NCT03662542|75874423|FG001|STARTED|Monotherapy Phase (Week 12-Week 38)||0||
59755417|NCT03662542|75874424|FG002|STARTED|Monotherapy Phase (Week 12-Week 38)||0||
59755418|NCT03662542|75874425|FG003|STARTED|Monotherapy Phase (Week 12-Week 38)||67||
59755419|NCT03662542|75874426|FG004|STARTED|Monotherapy Phase (Week 12-Week 38)||70||
59755420|NCT03662542|75874427|FG005|STARTED|Monotherapy Phase (Week 12-Week 38)||71||
59755421|NCT03662542|75874428|FG006|STARTED|Monotherapy Phase (Week 12-Week 38)||0||
59755422|NCT03662542|75874429|FG007|STARTED|Monotherapy Phase (Week 12-Week 38)||0||
59755423|NCT03662542|75874430|FG008|STARTED|Monotherapy Phase (Week 12-Week 38)||0||
59755424|NCT03662542|75874422|FG000|COMPLETED|Monotherapy Phase (Week 12-Week 38)||0||
59755425|NCT03662542|75874423|FG001|COMPLETED|Monotherapy Phase (Week 12-Week 38)||0||
59755426|NCT03662542|75874424|FG002|COMPLETED|Monotherapy Phase (Week 12-Week 38)||0||
59755427|NCT03662542|75874425|FG003|COMPLETED|Monotherapy Phase (Week 12-Week 38)||62||
59755428|NCT03662542|75874426|FG004|COMPLETED|Monotherapy Phase (Week 12-Week 38)||67||
59755429|NCT03662542|75874427|FG005|COMPLETED|Monotherapy Phase (Week 12-Week 38)||65||
59755430|NCT03662542|75874428|FG006|COMPLETED|Monotherapy Phase (Week 12-Week 38)||0||
59502289|NCT00572897|75594464|FG000|NOT COMPLETED|Overall Study||0||
59755431|NCT03662542|75874429|FG007|COMPLETED|Monotherapy Phase (Week 12-Week 38)||0||
59762575|NCT00534313|75882340|FG003|NOT COMPLETED|Long-term Period||33||
59502290|NCT00572897|75594465|FG001|NOT COMPLETED|Overall Study||0||
59502291|NCT01953237|75594473|FG000|STARTED|Overall Study||10||
59502292|NCT01953237|75594474|FG001|STARTED|Overall Study||21||
59502293|NCT01953237|75594473|FG000|COMPLETED|Overall Study||10||
59502294|NCT01953237|75594474|FG001|COMPLETED|Overall Study||21||
59502295|NCT01953237|75594473|FG000|NOT COMPLETED|Overall Study||0||
59502296|NCT01953237|75594474|FG001|NOT COMPLETED|Overall Study||0||
59502297|NCT01896687|75594482|FG000|STARTED|Overall Study||15||
59502298|NCT01896687|75594483|FG001|STARTED|Overall Study||15||
59502299|NCT01896687|75594482|FG000|COMPLETED|Overall Study||15||
59502300|NCT01896687|75594483|FG001|COMPLETED|Overall Study||15||
59502301|NCT01896687|75594482|FG000|NOT COMPLETED|Overall Study||0||
59502302|NCT01896687|75594483|FG001|NOT COMPLETED|Overall Study||0||
59502303|NCT00573287|75594491|FG000|STARTED|Overall Study||7||
59502304|NCT00573287|75594492|FG001|STARTED|Overall Study||7||
59502305|NCT00573287|75594491|FG000|COMPLETED|Overall Study||3||
59502306|NCT00573287|75594492|FG001|COMPLETED|Overall Study||4||
59502307|NCT00573287|75594491|FG000|NOT COMPLETED|Overall Study||4||
59886023|NCT00293033|76008740|FG000|NOT COMPLETED|Double-blind Treatment Period||12||
59886024|NCT02756182|76008748|FG000|STARTED|Overall Study||25||
59886025|NCT02756182|76008748|FG000|COMPLETED|Overall Study||21||
59886026|NCT02756182|76008748|FG000|NOT COMPLETED|Overall Study||4||
59886027|NCT03823703|76008757|FG000|STARTED|Overall Study||3||
59886028|NCT03823703|76008758|FG001|STARTED|Overall Study||5||
59886029|NCT03823703|76008759|FG002|STARTED|Overall Study||4||
59886030|NCT03823703|76008757|FG000|Treated|Overall Study||3||
59886031|NCT03823703|76008758|FG001|Treated|Overall Study||5||
59886032|NCT03823703|76008759|FG002|Treated|Overall Study||4||
59886033|NCT03823703|76008757|FG000|COMPLETED|Overall Study||0||
59502308|NCT00573287|75594492|FG001|NOT COMPLETED|Overall Study||3||
59502309|NCT01896921|75594498|FG000|STARTED|Overall Study||7||
59502310|NCT01896921|75594498|FG000|COMPLETED|Overall Study||5||
59502311|NCT01896921|75594498|FG000|NOT COMPLETED|Overall Study||2||
59502312|NCT01897077|75594504|FG000|STARTED|Overall Study||0||
59502313|NCT01897077|75594505|FG001|STARTED|Overall Study||5||
59502314|NCT01897077|75594504|FG000|COMPLETED|Overall Study||0||
59607665|NCT03748979|75718372|FG002|STARTED|Overall Study||6||
59755432|NCT03662542|75874430|FG008|COMPLETED|Monotherapy Phase (Week 12-Week 38)||0||
59755433|NCT03662542|75874422|FG000|NOT COMPLETED|Monotherapy Phase (Week 12-Week 38)||0||
59755434|NCT03662542|75874423|FG001|NOT COMPLETED|Monotherapy Phase (Week 12-Week 38)||0||
59755435|NCT03662542|75874424|FG002|NOT COMPLETED|Monotherapy Phase (Week 12-Week 38)||0||
59755436|NCT03662542|75874425|FG003|NOT COMPLETED|Monotherapy Phase (Week 12-Week 38)||5||
59755437|NCT03662542|75874426|FG004|NOT COMPLETED|Monotherapy Phase (Week 12-Week 38)||3||
59755438|NCT03662542|75874427|FG005|NOT COMPLETED|Monotherapy Phase (Week 12-Week 38)||6||
59755439|NCT03662542|75874428|FG006|NOT COMPLETED|Monotherapy Phase (Week 12-Week 38)||0||
59755440|NCT03662542|75874429|FG007|NOT COMPLETED|Monotherapy Phase (Week 12-Week 38)||0||
59755441|NCT03662542|75874430|FG008|NOT COMPLETED|Monotherapy Phase (Week 12-Week 38)||0||
59886034|NCT03823703|76008758|FG001|COMPLETED|Overall Study||0||
59886035|NCT03823703|76008759|FG002|COMPLETED|Overall Study||0||
59886036|NCT03823703|76008757|FG000|NOT COMPLETED|Overall Study||3||
59886037|NCT03823703|76008758|FG001|NOT COMPLETED|Overall Study||5||
59886038|NCT03823703|76008759|FG002|NOT COMPLETED|Overall Study||4||
59886039|NCT00109577|76008769|FG000|STARTED|Overall Study||20||
59886040|NCT00109577|76008770|FG001|STARTED|Overall Study||20||
59502315|NCT01897077|75594505|FG001|COMPLETED|Overall Study||5||
59502316|NCT01897077|75594504|FG000|NOT COMPLETED|Overall Study||0||
59502317|NCT01897077|75594505|FG001|NOT COMPLETED|Overall Study||0||
59502318|NCT00749749|75594513|FG000|STARTED|Overall Study||14||
59502319|NCT00749749|75594514|FG001|STARTED|Overall Study||13||
59502320|NCT00749749|75594513|FG000|COMPLETED|Overall Study||14||
59502321|NCT00749749|75594514|FG001|COMPLETED|Overall Study||13||
59502322|NCT00749749|75594513|FG000|NOT COMPLETED|Overall Study||0||
59502323|NCT00749749|75594514|FG001|NOT COMPLETED|Overall Study||0||
59502324|NCT02993263|75594520|FG000|STARTED|Overall Study||323||
59502325|NCT02993263|75594520|FG000|COMPLETED|Overall Study||0||
59502326|NCT02993263|75594520|FG000|NOT COMPLETED|Overall Study||323||
59502327|NCT01898013|75594526|FG000|STARTED|Visit 3 (Randomization Visit)||45||
59502328|NCT01898013|75594527|FG001|STARTED|Visit 3 (Randomization Visit)||49||
59502329|NCT01898013|75594526|FG000|COMPLETED|Visit 3 (Randomization Visit)||45||
59502330|NCT01898013|75594527|FG001|COMPLETED|Visit 3 (Randomization Visit)||49||
59502331|NCT01898013|75594526|FG000|NOT COMPLETED|Visit 3 (Randomization Visit)||0||
59502332|NCT01898013|75594527|FG001|NOT COMPLETED|Visit 3 (Randomization Visit)||0||
59502333|NCT01898013|75594526|FG000|STARTED|Visit 4||45||
59502334|NCT01898013|75594527|FG001|STARTED|Visit 4||49||
59502335|NCT01898013|75594526|FG000|COMPLETED|Visit 4||45||
59502336|NCT01898013|75594527|FG001|COMPLETED|Visit 4||48||
59502337|NCT01898013|75594526|FG000|NOT COMPLETED|Visit 4||0||
59502338|NCT01898013|75594527|FG001|NOT COMPLETED|Visit 4||1||
59502339|NCT01898013|75594526|FG000|STARTED|Visit 5||45||
59502340|NCT01898013|75594527|FG001|STARTED|Visit 5||48||
59502341|NCT01898013|75594526|FG000|COMPLETED|Visit 5||44||
59502342|NCT01898013|75594527|FG001|COMPLETED|Visit 5||47||
59502343|NCT01898013|75594526|FG000|NOT COMPLETED|Visit 5||1||
59502344|NCT01898013|75594527|FG001|NOT COMPLETED|Visit 5||1||
59502345|NCT01898013|75594526|FG000|STARTED|Visit 6||44||
59502346|NCT01898013|75594527|FG001|STARTED|Visit 6||47||
59502347|NCT01898013|75594526|FG000|COMPLETED|Visit 6||41||
59502348|NCT01898013|75594527|FG001|COMPLETED|Visit 6||42||
59502349|NCT01898013|75594526|FG000|NOT COMPLETED|Visit 6||3||
59502350|NCT01898013|75594527|FG001|NOT COMPLETED|Visit 6||5||
59502351|NCT02991937|75594535|FG000|STARTED|Overall Study||20||
59502352|NCT02991937|75594536|FG001|STARTED|Overall Study||19||
59502353|NCT02991937|75594535|FG000|COMPLETED|Overall Study||20||
59502354|NCT02991937|75594536|FG001|COMPLETED|Overall Study||19||
59502355|NCT02991937|75594535|FG000|NOT COMPLETED|Overall Study||0||
59502356|NCT02991937|75594536|FG001|NOT COMPLETED|Overall Study||0||
59502357|NCT02328807|75594542|FG000|STARTED|Overall Study||6||
59502358|NCT02328807|75594542|FG000|COMPLETED|Overall Study||6||
59502359|NCT02328807|75594542|FG000|NOT COMPLETED|Overall Study||0||
59502360|NCT01274533|75594548|FG000|STARTED|Overall Study||4||
59502361|NCT01274533|75594548|FG000|COMPLETED|Overall Study||0||
59502362|NCT01274533|75594548|FG000|NOT COMPLETED|Overall Study||4||
59502363|NCT01273597|75594552|FG000|STARTED|Overall Study||60||
59502364|NCT01273597|75594552|FG000|COMPLETED|Overall Study||52||
59502365|NCT01273597|75594552|FG000|NOT COMPLETED|Overall Study||8||
59502366|NCT01273519|75594559|FG000|STARTED|Overall Study||78||
59502367|NCT01273519|75594560|FG001|STARTED|Overall Study||30||
59502368|NCT01273519|75594561|FG002|STARTED|Overall Study||47||
59502369|NCT01273519|75594559|FG000|COMPLETED|Overall Study||59||
59502370|NCT01273519|75594560|FG001|COMPLETED|Overall Study||25||
59502371|NCT01273519|75594561|FG002|COMPLETED|Overall Study||39||
59502372|NCT01273519|75594559|FG000|NOT COMPLETED|Overall Study||19||
59502373|NCT01273519|75594560|FG001|NOT COMPLETED|Overall Study||5||
59502374|NCT01273519|75594561|FG002|NOT COMPLETED|Overall Study||8||
59502375|NCT01956279|75594574|FG000|STARTED|Overall Study||82||
59502376|NCT01956279|75594575|FG001|STARTED|Overall Study||88||
59502377|NCT01956279|75594574|FG000|COMPLETED|Overall Study||68||
59502378|NCT01956279|75594575|FG001|COMPLETED|Overall Study||74||
59502379|NCT01956279|75594574|FG000|NOT COMPLETED|Overall Study||14||
59502380|NCT01956279|75594575|FG001|NOT COMPLETED|Overall Study||14||
59502381|NCT01956435|75594581|FG000|STARTED|Overall Study||3||
59502382|NCT01956435|75594582|FG001|STARTED|Overall Study||3||
59502383|NCT01956435|75594581|FG000|COMPLETED|Overall Study||3||
59502384|NCT01956435|75594582|FG001|COMPLETED|Overall Study||3||
59502385|NCT01956435|75594581|FG000|NOT COMPLETED|Overall Study||0||
59502386|NCT01956435|75594582|FG001|NOT COMPLETED|Overall Study||0||
59502387|NCT01957761|75594589|FG000|STARTED|Overall Study||189||
59502388|NCT01957761|75594589|FG000|COMPLETED|Overall Study||189||
59502389|NCT01957761|75594589|FG000|NOT COMPLETED|Overall Study||0||
59502390|NCT01958073|75594595|FG000|STARTED|Randomized Period||9||
59502391|NCT01958073|75594596|FG001|STARTED|Randomized Period||9||
59502392|NCT01958073|75594597|FG002|STARTED|Randomized Period||17||
59502393|NCT01958073|75594598|FG003|STARTED|Randomized Period||0||
59502394|NCT01958073|75594599|FG004|STARTED|Randomized Period||0||
59502395|NCT01958073|75594595|FG000|COMPLETED|Randomized Period||7||
59607666|NCT03748979|75718373|FG003|STARTED|Overall Study||6||
59502396|NCT01958073|75594596|FG001|COMPLETED|Randomized Period||8||
59502397|NCT01958073|75594597|FG002|COMPLETED|Randomized Period||11||
59502398|NCT01958073|75594598|FG003|COMPLETED|Randomized Period||0||
59502399|NCT01958073|75594599|FG004|COMPLETED|Randomized Period||0||
59502400|NCT01958073|75594595|FG000|NOT COMPLETED|Randomized Period||2||
59502401|NCT01958073|75594596|FG001|NOT COMPLETED|Randomized Period||1||
59502402|NCT01958073|75594597|FG002|NOT COMPLETED|Randomized Period||6||
59502403|NCT01958073|75594598|FG003|NOT COMPLETED|Randomized Period||0||
59502404|NCT01958073|75594599|FG004|NOT COMPLETED|Randomized Period||0||
59502405|NCT01958073|75594595|FG000|STARTED|Open Label Period||0||
59502406|NCT01958073|75594596|FG001|STARTED|Open Label Period||0||
59502407|NCT01958073|75594597|FG002|STARTED|Open Label Period||0||
59502408|NCT01958073|75594598|FG003|STARTED|Open Label Period||5||
59502409|NCT01958073|75594599|FG004|STARTED|Open Label Period||17||
59502410|NCT01958073|75594595|FG000|COMPLETED|Open Label Period||0||
59502411|NCT01958073|75594596|FG001|COMPLETED|Open Label Period||0||
59502412|NCT01958073|75594597|FG002|COMPLETED|Open Label Period||0||
59502413|NCT01958073|75594598|FG003|COMPLETED|Open Label Period||5||
59502414|NCT01958073|75594599|FG004|COMPLETED|Open Label Period||17||
59502415|NCT01958073|75594595|FG000|NOT COMPLETED|Open Label Period||0||
59502416|NCT01958073|75594596|FG001|NOT COMPLETED|Open Label Period||0||
59502417|NCT01958073|75594597|FG002|NOT COMPLETED|Open Label Period||0||
59502418|NCT01958073|75594598|FG003|NOT COMPLETED|Open Label Period||0||
59502419|NCT01958073|75594599|FG004|NOT COMPLETED|Open Label Period||0||
59502420|NCT01272661|75594618|FG000|STARTED|Overall Study||413||
59502421|NCT01272661|75594619|FG001|STARTED|Overall Study||497||
59502422|NCT01272661|75594620|FG002|STARTED|Overall Study||386||
59502423|NCT01272661|75594618|FG000|COMPLETED|Overall Study||287||
59502424|NCT01272661|75594619|FG001|COMPLETED|Overall Study||288||
59502425|NCT01272661|75594620|FG002|COMPLETED|Overall Study||314||
59502426|NCT01272661|75594618|FG000|NOT COMPLETED|Overall Study||126||
59502427|NCT01272661|75594619|FG001|NOT COMPLETED|Overall Study||209||
59502428|NCT01272661|75594620|FG002|NOT COMPLETED|Overall Study||72||
59502429|NCT02283333|75594630|FG000|STARTED|Overall Study||77||
59502430|NCT02283333|75594631|FG001|STARTED|Overall Study||78||
59502431|NCT02283333|75594630|FG000|COMPLETED|Overall Study||63||
59502432|NCT02283333|75594631|FG001|COMPLETED|Overall Study||64||
59502433|NCT02283333|75594630|FG000|NOT COMPLETED|Overall Study||14||
59502434|NCT02283333|75594631|FG001|NOT COMPLETED|Overall Study||14||
59502435|NCT00728923|75594637|FG000|STARTED|Overall Study||9||
59502436|NCT00728923|75594637|FG000|COMPLETED|Overall Study||9||
59502437|NCT00728923|75594637|FG000|NOT COMPLETED|Overall Study||0||
59502438|NCT01898403|75594641|FG000|STARTED|Overall Study||50||
59502439|NCT01898403|75594641|FG000|COMPLETED|Overall Study||50||
59502440|NCT01898403|75594641|FG000|NOT COMPLETED|Overall Study||0||
59502441|NCT01901211|75594649|FG000|STARTED|First Ten-week Period||6||
59502442|NCT01901211|75594650|FG001|STARTED|First Ten-week Period||5||
59502443|NCT01901211|75594649|FG000|COMPLETED|First Ten-week Period||6||
59502444|NCT01901211|75594650|FG001|COMPLETED|First Ten-week Period||5||
59502445|NCT01901211|75594649|FG000|NOT COMPLETED|First Ten-week Period||0||
59502446|NCT01901211|75594650|FG001|NOT COMPLETED|First Ten-week Period||0||
59502447|NCT01901211|75594649|FG000|STARTED|Washout (6 Weeks)||6||
59502448|NCT01901211|75594650|FG001|STARTED|Washout (6 Weeks)||5||
59502449|NCT01901211|75594649|FG000|COMPLETED|Washout (6 Weeks)||6||
59502450|NCT01901211|75594650|FG001|COMPLETED|Washout (6 Weeks)||5||
59502451|NCT01901211|75594649|FG000|NOT COMPLETED|Washout (6 Weeks)||0||
59502452|NCT01901211|75594650|FG001|NOT COMPLETED|Washout (6 Weeks)||0||
59502453|NCT01901211|75594649|FG000|STARTED|Second Ten-week Period||6||
59502454|NCT01901211|75594650|FG001|STARTED|Second Ten-week Period||5||
59502455|NCT01901211|75594649|FG000|COMPLETED|Second Ten-week Period||6||
59502456|NCT01901211|75594650|FG001|COMPLETED|Second Ten-week Period||5||
59502457|NCT01901211|75594649|FG000|NOT COMPLETED|Second Ten-week Period||0||
59886041|NCT00109577|76008769|FG000|COMPLETED|Overall Study||17||
59886042|NCT00109577|76008770|FG001|COMPLETED|Overall Study||17||
59886043|NCT00109577|76008769|FG000|NOT COMPLETED|Overall Study||3||
59886044|NCT00109577|76008770|FG001|NOT COMPLETED|Overall Study||3||
59502458|NCT01901211|75594650|FG001|NOT COMPLETED|Second Ten-week Period||0||
59502459|NCT00715741|75594660|FG000|STARTED|Overall Study||25||
59502460|NCT00715741|75594661|FG001|STARTED|Overall Study||25||
59502461|NCT00715741|75594662|FG002|STARTED|Overall Study||25||
59502462|NCT00715741|75594663|FG003|STARTED|Overall Study||25||
59502463|NCT00715741|75594660|FG000|COMPLETED|Overall Study||25||
59886045|NCT02755090|76008778|FG000|STARTED|Overall Study||19||
59886046|NCT02755090|76008779|FG001|STARTED|Overall Study||20||
59502464|NCT00715741|75594661|FG001|COMPLETED|Overall Study||25||
59502465|NCT00715741|75594662|FG002|COMPLETED|Overall Study||25||
59502466|NCT00715741|75594663|FG003|COMPLETED|Overall Study||25||
59502467|NCT00715741|75594660|FG000|NOT COMPLETED|Overall Study||0||
59502468|NCT00715741|75594661|FG001|NOT COMPLETED|Overall Study||0||
59502469|NCT00715741|75594662|FG002|NOT COMPLETED|Overall Study||0||
59886047|NCT02755090|76008778|FG000|COMPLETED|Overall Study||18||
59886048|NCT02755090|76008779|FG001|COMPLETED|Overall Study||20||
59502470|NCT00715741|75594663|FG003|NOT COMPLETED|Overall Study||0||
59502471|NCT00750373|75594675|FG000|STARTED|Overall Study||39||
59502472|NCT00750373|75594676|FG001|STARTED|Overall Study||37||
59502473|NCT00750373|75594675|FG000|COMPLETED|Overall Study||39||
59502474|NCT00750373|75594676|FG001|COMPLETED|Overall Study||37||
59502475|NCT00750373|75594675|FG000|NOT COMPLETED|Overall Study||0||
59502476|NCT00750373|75594676|FG001|NOT COMPLETED|Overall Study||0||
59502477|NCT00751777|75594684|FG000|STARTED|Overall Study||81||
59502478|NCT00751777|75594685|FG001|STARTED|Overall Study||39||
59502479|NCT00751777|75594684|FG000|COMPLETED|Overall Study|Day 380: study completion for LT group|70||
59502480|NCT00751777|75594685|FG001|COMPLETED|Overall Study|Day 194: study completion for placebo group|36||
59502481|NCT00751777|75594684|FG000|NOT COMPLETED|Overall Study||11||
59502482|NCT00751777|75594685|FG001|NOT COMPLETED|Overall Study||3||
59502483|NCT01902459|75594693|FG000|STARTED|Overall Study||75||
59502484|NCT01902459|75594694|FG001|STARTED|Overall Study||75||
59502485|NCT01902459|75594693|FG000|COMPLETED|Overall Study||75||
59502486|NCT01902459|75594694|FG001|COMPLETED|Overall Study||75||
59502487|NCT01902459|75594693|FG000|NOT COMPLETED|Overall Study||0||
59502488|NCT01902459|75594694|FG001|NOT COMPLETED|Overall Study||0||
59502489|NCT01274611|75594700|FG000|STARTED|Overall Study||20||
59502490|NCT01274611|75594700|FG000|COMPLETED|Overall Study||20||
59502491|NCT01274611|75594700|FG000|NOT COMPLETED|Overall Study||0||
59502492|NCT00729781|75594706|FG000|STARTED|Original Study||45||
59502493|NCT00729781|75594706|FG000|COMPLETED|Original Study||45||
59502494|NCT00729781|75594706|FG000|NOT COMPLETED|Original Study||0||
59502495|NCT00729781|75594706|FG000|STARTED|Long-term Follow-up Study|Enrollment in the long-term follow-up required contact and a new Informed Consent.|42||
59502496|NCT00729781|75594706|FG000|COMPLETED|Long-term Follow-up Study|All subjects completed the original study, but 3 did not consent to enroll in the follow-up study.|42||
59502497|NCT00729781|75594706|FG000|NOT COMPLETED|Long-term Follow-up Study||0||
59502498|NCT01903005|75594712|FG000|STARTED|Overall Study|Primary study OX219-006 (n=475); Primary study OX219-007 (n=190)|665||
59502499|NCT01903005|75594712|FG000|COMPLETED|Overall Study|Primary study OX219-006 (n=194); Primary study OX219-007 (n=98)|292||
59502500|NCT01903005|75594712|FG000|NOT COMPLETED|Overall Study||373||
59502501|NCT01905423|75594722|FG000|STARTED|Overall Study||4456||
59502502|NCT01905423|75594723|FG001|STARTED|Overall Study||3297||
59755442|NCT03662542|75874422|FG000|STARTED|Safety Follow-up (Week 38- Week 50)||0||
59755443|NCT03662542|75874423|FG001|STARTED|Safety Follow-up (Week 38- Week 50)||0||
59502503|NCT01905423|75594724|FG002|STARTED|Overall Study||4111||
59502504|NCT01905423|75594725|FG003|STARTED|Overall Study||2757||
59502505|NCT01905423|75594726|FG004|STARTED|Overall Study||2487||
59502506|NCT01905423|75594722|FG000|Baseline|Overall Study||1443||
59502507|NCT01905423|75594723|FG001|Baseline|Overall Study||722||
59502508|NCT01905423|75594724|FG002|Baseline|Overall Study||1033||
59755444|NCT03662542|75874424|FG002|STARTED|Safety Follow-up (Week 38- Week 50)||0||
59502509|NCT01905423|75594725|FG003|Baseline|Overall Study||1482||
59502510|NCT01905423|75594726|FG004|Baseline|Overall Study||1326||
59502511|NCT01905423|75594722|FG000|Year 1 Follow-up|Overall Study||994||
59502512|NCT01905423|75594723|FG001|Year 1 Follow-up|Overall Study||846||
59502513|NCT01905423|75594724|FG002|Year 1 Follow-up|Overall Study||1007||
59502514|NCT01905423|75594725|FG003|Year 1 Follow-up|Overall Study||1275||
59502515|NCT01905423|75594726|FG004|Year 1 Follow-up|Overall Study||1161||
59502516|NCT01905423|75594722|FG000|Year 2 Follow-up|Overall Study||1114||
59502517|NCT01905423|75594723|FG001|Year 2 Follow-up|Overall Study||858||
59502518|NCT01905423|75594724|FG002|Year 2 Follow-up|Overall Study||1043||
59502519|NCT01905423|75594725|FG003|Year 2 Follow-up|Overall Study||0||
59502520|NCT01905423|75594726|FG004|Year 2 Follow-up|Overall Study||0||
59502521|NCT01905423|75594722|FG000|Year 3 Follow-up|Overall Study||905||
59502522|NCT01905423|75594723|FG001|Year 3 Follow-up|Overall Study||871||
59502523|NCT01905423|75594724|FG002|Year 3 Follow-up|Overall Study||1028||
59502524|NCT01905423|75594725|FG003|Year 3 Follow-up|Overall Study||0||
59502525|NCT01905423|75594726|FG004|Year 3 Follow-up|Overall Study||0||
59502526|NCT01905423|75594722|FG000|COMPLETED|Overall Study||4456||
59502527|NCT01905423|75594723|FG001|COMPLETED|Overall Study||3297||
59502528|NCT01905423|75594724|FG002|COMPLETED|Overall Study||4111||
59502529|NCT01905423|75594725|FG003|COMPLETED|Overall Study||2757||
59502530|NCT01905423|75594726|FG004|COMPLETED|Overall Study||2487||
59502531|NCT01905423|75594722|FG000|NOT COMPLETED|Overall Study||0||
59502532|NCT01905423|75594723|FG001|NOT COMPLETED|Overall Study||0||
59502533|NCT01905423|75594724|FG002|NOT COMPLETED|Overall Study||0||
59502534|NCT01905423|75594725|FG003|NOT COMPLETED|Overall Study||0||
59502535|NCT01905423|75594726|FG004|NOT COMPLETED|Overall Study||0||
59502536|NCT01906515|75594740|FG000|STARTED|Overall Study||45||
59502537|NCT01906515|75594741|FG001|STARTED|Overall Study||61||
59502538|NCT01906515|75594740|FG000|COMPLETED|Overall Study||45||
59502539|NCT01906515|75594741|FG001|COMPLETED|Overall Study||61||
59502540|NCT01906515|75594740|FG000|NOT COMPLETED|Overall Study||0||
59502541|NCT01906515|75594741|FG001|NOT COMPLETED|Overall Study||0||
59502542|NCT00730483|75594748|FG000|STARTED|Overall Study||13||
59502543|NCT00730483|75594748|FG000|1 Month After First DEB-TACE|Overall Study||13||
59502544|NCT00730483|75594748|FG000|6 Months After First DEB-TACE|Overall Study||10||
59502545|NCT00730483|75594748|FG000|COMPLETED|Overall Study||6|12 months after first DEB-TACE|
59502546|NCT00730483|75594748|FG000|NOT COMPLETED|Overall Study||7||
59502547|NCT01907607|75594753|FG000|STARTED|Overall Study||29||
59502548|NCT01907607|75594753|FG000|COMPLETED|Overall Study||29||
59502549|NCT01907607|75594753|FG000|NOT COMPLETED|Overall Study||0||
59502550|NCT01909011|75594759|FG000|STARTED|Overall Study||7||
59502551|NCT01909011|75594760|FG001|STARTED|Overall Study||9||
59502552|NCT01909011|75594759|FG000|COMPLETED|Overall Study||7||
59502553|NCT01909011|75594760|FG001|COMPLETED|Overall Study||9||
59502554|NCT01909011|75594759|FG000|NOT COMPLETED|Overall Study||0||
59502555|NCT01909011|75594760|FG001|NOT COMPLETED|Overall Study||0||
59607667|NCT03748979|75718374|FG004|STARTED|Overall Study||4||
59502556|NCT00753337|75594766|FG000|STARTED|Overall Study||123||
59502557|NCT00753337|75594766|FG000|COMPLETED|Overall Study||123||
59502558|NCT00753337|75594766|FG000|NOT COMPLETED|Overall Study||0||
59502559|NCT00731341|75594771|FG000|STARTED|Overall Study||3||
59502560|NCT00731341|75594771|FG000|COMPLETED|Overall Study||3||
59502561|NCT00731341|75594771|FG000|NOT COMPLETED|Overall Study||0||
59502562|NCT01911351|75594777|FG000|STARTED|Overall Study||39||
59607668|NCT03748979|75718375|FG005|STARTED|Overall Study||4||
59502563|NCT01911351|75594778|FG001|STARTED|Overall Study||43||
59502564|NCT01911351|75594777|FG000|COMPLETED|Overall Study||39||
59502565|NCT01911351|75594778|FG001|COMPLETED|Overall Study||43||
59502566|NCT01911351|75594777|FG000|NOT COMPLETED|Overall Study||0||
59502567|NCT01911351|75594778|FG001|NOT COMPLETED|Overall Study||0||
59502568|NCT04276051|75594786|FG000|STARTED|Overall Study||2||
59502569|NCT04276051|75594787|FG001|STARTED|Overall Study||3||
59502570|NCT04276051|75594786|FG000|COMPLETED|Overall Study||1||
59502571|NCT04276051|75594787|FG001|COMPLETED|Overall Study||0||
59502572|NCT04276051|75594786|FG000|NOT COMPLETED|Overall Study||1||
59502573|NCT04276051|75594787|FG001|NOT COMPLETED|Overall Study||3||
59502574|NCT00731653|75594793|FG000|STARTED|Overall Study||81||
59502575|NCT00731653|75594793|FG000|COMPLETED|Overall Study||72||
59502576|NCT00731653|75594793|FG000|NOT COMPLETED|Overall Study||9||
59502577|NCT00573989|75594797|FG000|STARTED|Erlotinib Phase I||4||
59502578|NCT00573989|75594798|FG001|STARTED|Erlotinib Phase I||6||
59502579|NCT00573989|75594799|FG002|STARTED|Erlotinib Phase I||5||
59502580|NCT00573989|75594800|FG003|STARTED|Erlotinib Phase I||0||
59502581|NCT00573989|75594797|FG000|COMPLETED|Erlotinib Phase I||4||
59502582|NCT00573989|75594798|FG001|COMPLETED|Erlotinib Phase I||6||
59502583|NCT00573989|75594799|FG002|COMPLETED|Erlotinib Phase I||5||
59502584|NCT00573989|75594800|FG003|COMPLETED|Erlotinib Phase I||0||
59502585|NCT00573989|75594797|FG000|NOT COMPLETED|Erlotinib Phase I||0||
59502586|NCT00573989|75594798|FG001|NOT COMPLETED|Erlotinib Phase I||0||
59502587|NCT00573989|75594799|FG002|NOT COMPLETED|Erlotinib Phase I||0||
59502588|NCT00573989|75594800|FG003|NOT COMPLETED|Erlotinib Phase I||0||
59502589|NCT00573989|75594797|FG000|STARTED|Erlotinib 125mg- Phase II||0||
59502590|NCT00573989|75594798|FG001|STARTED|Erlotinib 125mg- Phase II||0||
59502591|NCT00573989|75594799|FG002|STARTED|Erlotinib 125mg- Phase II||0||
59502592|NCT00573989|75594800|FG003|STARTED|Erlotinib 125mg- Phase II||12||
59502593|NCT00573989|75594797|FG000|COMPLETED|Erlotinib 125mg- Phase II||0||
59502594|NCT00573989|75594798|FG001|COMPLETED|Erlotinib 125mg- Phase II||0||
59502595|NCT00573989|75594799|FG002|COMPLETED|Erlotinib 125mg- Phase II||0||
59502596|NCT00573989|75594800|FG003|COMPLETED|Erlotinib 125mg- Phase II||12||
59502597|NCT00573989|75594797|FG000|NOT COMPLETED|Erlotinib 125mg- Phase II||0||
59502598|NCT00573989|75594798|FG001|NOT COMPLETED|Erlotinib 125mg- Phase II||0||
59502599|NCT00573989|75594799|FG002|NOT COMPLETED|Erlotinib 125mg- Phase II||0||
59502600|NCT00573989|75594800|FG003|NOT COMPLETED|Erlotinib 125mg- Phase II||0||
59502601|NCT02286921|75594809|FG000|STARTED|Overall Study||94||
59502602|NCT02286921|75594810|FG001|STARTED|Overall Study||101||
59502603|NCT02286921|75594809|FG000|COMPLETED|Overall Study||94||
59502604|NCT02286921|75594810|FG001|COMPLETED|Overall Study||101||
59502605|NCT02286921|75594809|FG000|NOT COMPLETED|Overall Study||0||
59502606|NCT02286921|75594810|FG001|NOT COMPLETED|Overall Study||0||
59502607|NCT00574067|75594820|FG000|STARTED|Overall Study||53||
59502608|NCT00574067|75594821|FG001|STARTED|Overall Study||53||
59502609|NCT00574067|75594822|FG002|STARTED|Overall Study||54||
59502610|NCT00574067|75594823|FG003|STARTED|Overall Study||53||
59502611|NCT00574067|75594820|FG000|COMPLETED|Overall Study||52||
59502612|NCT00574067|75594821|FG001|COMPLETED|Overall Study||52||
59502613|NCT00574067|75594822|FG002|COMPLETED|Overall Study||54||
59502614|NCT00574067|75594823|FG003|COMPLETED|Overall Study||53||
59502615|NCT00574067|75594820|FG000|NOT COMPLETED|Overall Study||1||
59502616|NCT00574067|75594821|FG001|NOT COMPLETED|Overall Study||1||
59502617|NCT00574067|75594822|FG002|NOT COMPLETED|Overall Study||0||
59502618|NCT00574067|75594823|FG003|NOT COMPLETED|Overall Study||0||
59502619|NCT01913535|75594842|FG000|STARTED|Phase 1 (Days 0-2)||2||
59502620|NCT01913535|75594843|FG001|STARTED|Phase 1 (Days 0-2)||2||
59502621|NCT01913535|75594844|FG002|STARTED|Phase 1 (Days 0-2)||1||
59502622|NCT01913535|75594845|FG003|STARTED|Phase 1 (Days 0-2)||2||
59502623|NCT01913535|75594846|FG004|STARTED|Phase 1 (Days 0-2)||1||
59502624|NCT01913535|75594842|FG000|COMPLETED|Phase 1 (Days 0-2)||2||
59502625|NCT01913535|75594843|FG001|COMPLETED|Phase 1 (Days 0-2)||2||
59502626|NCT01913535|75594844|FG002|COMPLETED|Phase 1 (Days 0-2)||1||
59502627|NCT01913535|75594845|FG003|COMPLETED|Phase 1 (Days 0-2)||2||
59502628|NCT01913535|75594846|FG004|COMPLETED|Phase 1 (Days 0-2)||1||
59502629|NCT01913535|75594842|FG000|NOT COMPLETED|Phase 1 (Days 0-2)||0||
59502630|NCT01913535|75594843|FG001|NOT COMPLETED|Phase 1 (Days 0-2)||0||
59502631|NCT01913535|75594844|FG002|NOT COMPLETED|Phase 1 (Days 0-2)||0||
59502632|NCT01913535|75594845|FG003|NOT COMPLETED|Phase 1 (Days 0-2)||0||
59502633|NCT01913535|75594846|FG004|NOT COMPLETED|Phase 1 (Days 0-2)||0||
59502634|NCT01913535|75594842|FG000|STARTED|Phase 2 (Days 3-5)||2||
59502635|NCT01913535|75594843|FG001|STARTED|Phase 2 (Days 3-5)||2||
59502636|NCT01913535|75594844|FG002|STARTED|Phase 2 (Days 3-5)||1||
59502637|NCT01913535|75594845|FG003|STARTED|Phase 2 (Days 3-5)||2||
59502638|NCT01913535|75594846|FG004|STARTED|Phase 2 (Days 3-5)||1||
59502639|NCT01913535|75594842|FG000|COMPLETED|Phase 2 (Days 3-5)||2||
59502640|NCT01913535|75594843|FG001|COMPLETED|Phase 2 (Days 3-5)||2||
59502641|NCT01913535|75594844|FG002|COMPLETED|Phase 2 (Days 3-5)||1||
59502642|NCT01913535|75594845|FG003|COMPLETED|Phase 2 (Days 3-5)||2||
59502643|NCT01913535|75594846|FG004|COMPLETED|Phase 2 (Days 3-5)||1||
59502644|NCT01913535|75594842|FG000|NOT COMPLETED|Phase 2 (Days 3-5)||0||
59502645|NCT01913535|75594843|FG001|NOT COMPLETED|Phase 2 (Days 3-5)||0||
59502646|NCT01913535|75594844|FG002|NOT COMPLETED|Phase 2 (Days 3-5)||0||
59502647|NCT01913535|75594845|FG003|NOT COMPLETED|Phase 2 (Days 3-5)||0||
59502648|NCT01913535|75594846|FG004|NOT COMPLETED|Phase 2 (Days 3-5)||0||
59502649|NCT01914003|75594861|FG000|STARTED|Overall Study||27||
59502650|NCT01914003|75594862|FG001|STARTED|Overall Study||26||
59502651|NCT01914003|75594861|FG000|COMPLETED|Overall Study|Number of subjects who completed through study and qualify as evaluable|19||
59502652|NCT01914003|75594862|FG001|COMPLETED|Overall Study|Number of subjects who completed through study and qualify as evaluable|14||
59502653|NCT01914003|75594861|FG000|NOT COMPLETED|Overall Study||8||
59502654|NCT01914003|75594862|FG001|NOT COMPLETED|Overall Study||12||
59502655|NCT01914159|75594868|FG000|STARTED|Overall Study||24||
59502656|NCT01914159|75594868|FG000|COMPLETED|Overall Study||21||
59502657|NCT01914159|75594868|FG000|NOT COMPLETED|Overall Study||3||
59502658|NCT00575159|75594872|FG000|STARTED|Overall Study||10||
59502659|NCT00575159|75594872|FG000|COMPLETED|Overall Study||10||
59502660|NCT00575159|75594872|FG000|NOT COMPLETED|Overall Study||0||
59502661|NCT01915173|75594892|FG000|STARTED|Overall Study||6||
59502662|NCT01915173|75594893|FG001|STARTED|Overall Study||6||
59502663|NCT01915173|75594894|FG002|STARTED|Overall Study||6||
59502664|NCT01915173|75594895|FG003|STARTED|Overall Study||6||
59502665|NCT01915173|75594892|FG000|COMPLETED|Overall Study||6||
59502666|NCT01915173|75594893|FG001|COMPLETED|Overall Study||6||
59502667|NCT01915173|75594894|FG002|COMPLETED|Overall Study||6||
59502668|NCT01915173|75594895|FG003|COMPLETED|Overall Study||6||
59502669|NCT01915173|75594892|FG000|NOT COMPLETED|Overall Study||0||
59502670|NCT01915173|75594893|FG001|NOT COMPLETED|Overall Study||0||
59502671|NCT01915173|75594894|FG002|NOT COMPLETED|Overall Study||0||
59502672|NCT01915173|75594895|FG003|NOT COMPLETED|Overall Study||0||
59502673|NCT01915563|75594907|FG000|STARTED|Overall Study||243||
59502674|NCT01915563|75594908|FG001|STARTED|Overall Study||227||
59502675|NCT01915563|75594907|FG000|COMPLETED|Overall Study||243||
59502676|NCT01915563|75594908|FG001|COMPLETED|Overall Study||227||
59502677|NCT01915563|75594907|FG000|NOT COMPLETED|Overall Study||0||
59502678|NCT01915563|75594908|FG001|NOT COMPLETED|Overall Study||0||
59502679|NCT00576251|75594916|FG000|STARTED|Overall Study||109||
59502680|NCT00576251|75594917|FG001|STARTED|Overall Study||112||
59502681|NCT00576251|75594916|FG000|COMPLETED|Overall Study||108||
59502682|NCT00576251|75594917|FG001|COMPLETED|Overall Study||111||
59502683|NCT00576251|75594916|FG000|NOT COMPLETED|Overall Study||1||
59755445|NCT03662542|75874425|FG003|STARTED|Safety Follow-up (Week 38- Week 50)||0||
59755446|NCT03662542|75874426|FG004|STARTED|Safety Follow-up (Week 38- Week 50)||0||
59502684|NCT00576251|75594917|FG001|NOT COMPLETED|Overall Study||1||
59502685|NCT00578279|75594925|FG000|STARTED|Overall Study||10||
59502686|NCT00578279|75594926|FG001|STARTED|Overall Study||10||
59502687|NCT00578279|75594925|FG000|COMPLETED|Overall Study||10||
59502688|NCT00578279|75594926|FG001|COMPLETED|Overall Study||10||
59502689|NCT00578279|75594925|FG000|NOT COMPLETED|Overall Study||0||
59502690|NCT00578279|75594926|FG001|NOT COMPLETED|Overall Study||0||
59502691|NCT01916655|75594935|FG000|STARTED|Overall Study||131||
59502692|NCT01916655|75594936|FG001|STARTED|Overall Study||109||
59502693|NCT01916655|75594937|FG002|STARTED|Overall Study||120||
59502694|NCT01916655|75594935|FG000|COMPLETED|Overall Study||116||
59502695|NCT01916655|75594936|FG001|COMPLETED|Overall Study||89||
59502696|NCT01916655|75594937|FG002|COMPLETED|Overall Study||91||
59502697|NCT01916655|75594935|FG000|NOT COMPLETED|Overall Study||15||
59502698|NCT01916655|75594936|FG001|NOT COMPLETED|Overall Study||20||
59502699|NCT01916655|75594937|FG002|NOT COMPLETED|Overall Study||29||
59502700|NCT00578669|75594947|FG000|STARTED|Overall Study||107||
59502701|NCT00578669|75594948|FG001|STARTED|Overall Study||99||
59502702|NCT00578669|75594947|FG000|COMPLETED|Overall Study||107||
59502703|NCT00578669|75594948|FG001|COMPLETED|Overall Study||99||
59502704|NCT00578669|75594947|FG000|NOT COMPLETED|Overall Study||0||
59886049|NCT02755090|76008778|FG000|NOT COMPLETED|Overall Study||1||
59886050|NCT02755090|76008779|FG001|NOT COMPLETED|Overall Study||0||
59886051|NCT00109343|76008788|FG000|STARTED|Overall Study||510||
59886052|NCT00109343|76008789|FG001|STARTED|Overall Study||258||
59886053|NCT00109343|76008790|FG002|STARTED|Overall Study||259||
59886054|NCT00109343|76008788|FG000|Vaccinated at Visit 1|Overall Study||510||
59886055|NCT00109343|76008789|FG001|Vaccinated at Visit 1|Overall Study||258||
59886056|NCT00109343|76008790|FG002|Vaccinated at Visit 1|Overall Study||259||
59886057|NCT00109343|76008788|FG000|Vaccinated at Visit 2|Overall Study|Per-protocol, subjects in Group 1 were not vaccinated at Visit 2|0||
60013457|NCT02629159|76129370|FG000|Rescued at Week 22|Overall Study||26||
60013458|NCT02629159|76129371|FG001|Rescued at Week 22|Overall Study||7||
60013459|NCT02629159|76129372|FG002|Rescued at Week 22|Overall Study||18||
60013460|NCT02629159|76129370|FG000|COMPLETED|Overall Study||595|Participants who completed Week 26|
60013461|NCT02629159|76129371|FG001|COMPLETED|Overall Study||288|Participants who completed Week 26|
60013462|NCT02629159|76129372|FG002|COMPLETED|Overall Study||600|Participants who completed Week 26|
60013463|NCT02629159|76129370|FG000|NOT COMPLETED|Overall Study||56||
60013464|NCT02629159|76129371|FG001|NOT COMPLETED|Overall Study||39||
60013465|NCT02629159|76129372|FG002|NOT COMPLETED|Overall Study||51||
60013466|NCT02628769|76129383|FG000|STARTED|First Intervention||3||
60013467|NCT02628769|76129384|FG001|STARTED|First Intervention||3||
60013468|NCT02628769|76129383|FG000|COMPLETED|First Intervention||2||
60013469|NCT02628769|76129384|FG001|COMPLETED|First Intervention||2||
60013470|NCT02628769|76129383|FG000|NOT COMPLETED|First Intervention||1||
60013471|NCT02628769|76129384|FG001|NOT COMPLETED|First Intervention||1||
60013472|NCT02628769|76129383|FG000|STARTED|Wash Out (28 Days)||2||
60013473|NCT02628769|76129384|FG001|STARTED|Wash Out (28 Days)||2||
60013474|NCT02628769|76129383|FG000|COMPLETED|Wash Out (28 Days)||2||
60013475|NCT02628769|76129384|FG001|COMPLETED|Wash Out (28 Days)||2||
60013476|NCT02628769|76129383|FG000|NOT COMPLETED|Wash Out (28 Days)||0||
60013477|NCT02628769|76129384|FG001|NOT COMPLETED|Wash Out (28 Days)||0||
60013478|NCT02628769|76129383|FG000|STARTED|Second Intervention||2||
60013479|NCT02628769|76129384|FG001|STARTED|Second Intervention||2||
60013480|NCT02628769|76129383|FG000|COMPLETED|Second Intervention||0||
60013481|NCT02628769|76129384|FG001|COMPLETED|Second Intervention||1||
60013482|NCT02628769|76129383|FG000|NOT COMPLETED|Second Intervention||2||
60013483|NCT02628769|76129384|FG001|NOT COMPLETED|Second Intervention||1||
60013484|NCT02626819|76129392|FG000|STARTED|Overall Study||22||
60013485|NCT02626819|76129393|FG001|STARTED|Overall Study||23||
60013486|NCT02626819|76129392|FG000|COMPLETED|Overall Study||18||
60013487|NCT02626819|76129393|FG001|COMPLETED|Overall Study||20||
59886058|NCT00109343|76008789|FG001|Vaccinated at Visit 2|Overall Study||246||
59886059|NCT00109343|76008790|FG002|Vaccinated at Visit 2|Overall Study||246||
60013488|NCT02626819|76129392|FG000|NOT COMPLETED|Overall Study||4||
59502705|NCT00578669|75594948|FG001|NOT COMPLETED|Overall Study||0||
59502706|NCT01917513|75594956|FG000|STARTED|Overall Study||502||
59502707|NCT01917513|75594957|FG001|STARTED|Overall Study||498||
59502708|NCT01917513|75594956|FG000|COMPLETED|Overall Study||407||
59502709|NCT01917513|75594957|FG001|COMPLETED|Overall Study||396||
59502710|NCT01917513|75594956|FG000|NOT COMPLETED|Overall Study||95||
59502711|NCT01917513|75594957|FG001|NOT COMPLETED|Overall Study||102||
59502712|NCT00578903|75594963|FG000|STARTED|Overall Study||22||
59502713|NCT00578903|75594963|FG000|COMPLETED|Overall Study||22||
59502714|NCT00578903|75594963|FG000|NOT COMPLETED|Overall Study||0||
59502715|NCT01918761|75594967|FG000|STARTED|Overall Study||5||
59502716|NCT01918761|75594967|FG000|COMPLETED|Overall Study||5||
59502717|NCT01918761|75594967|FG000|NOT COMPLETED|Overall Study||0||
59502718|NCT00579137|75594971|FG000|STARTED|Overall Study||3||
59502719|NCT00579137|75594971|FG000|COMPLETED|Overall Study||3||
59502720|NCT00579137|75594971|FG000|NOT COMPLETED|Overall Study||0||
59502721|NCT00580073|75594975|FG000|STARTED|Overall Study||6||
59502722|NCT00580073|75594975|FG000|COMPLETED|Overall Study||6||
59502723|NCT00580073|75594975|FG000|NOT COMPLETED|Overall Study||0||
59502724|NCT00580151|75594981|FG000|STARTED|Overall Study||9||
59502725|NCT00580151|75594982|FG001|STARTED|Overall Study||0||
59502726|NCT00580151|75594981|FG000|COMPLETED|Overall Study||9||
59502727|NCT00580151|75594982|FG001|COMPLETED|Overall Study||0||
59502728|NCT00580151|75594981|FG000|NOT COMPLETED|Overall Study||0||
59502729|NCT00580151|75594982|FG001|NOT COMPLETED|Overall Study||0||
59502730|NCT01919697|75594990|FG000|STARTED|Overall Study||224||
59502731|NCT01919697|75594991|FG001|STARTED|Overall Study||2146||
59502732|NCT01919697|75594990|FG000|COMPLETED|Overall Study||171||
59502733|NCT01919697|75594991|FG001|COMPLETED|Overall Study||1761||
59502734|NCT01919697|75594990|FG000|NOT COMPLETED|Overall Study||53||
59502735|NCT01919697|75594991|FG001|NOT COMPLETED|Overall Study||385||
59502736|NCT00580229|75594998|FG000|STARTED|Overall Study||50||
59502737|NCT00580229|75594998|FG000|COMPLETED|Overall Study||50||
59502738|NCT00580229|75594998|FG000|NOT COMPLETED|Overall Study||0||
59502739|NCT00580853|75595005|FG000|STARTED|Overall Study||20||
59502740|NCT00580853|75595006|FG001|STARTED|Overall Study||21||
59502741|NCT00580853|75595007|FG002|STARTED|Overall Study||21||
59502742|NCT00580853|75595005|FG000|COMPLETED|Overall Study||20||
59502743|NCT00580853|75595006|FG001|COMPLETED|Overall Study||21||
59502744|NCT00580853|75595007|FG002|COMPLETED|Overall Study||21||
59502745|NCT00580853|75595005|FG000|NOT COMPLETED|Overall Study||0||
59502746|NCT00580853|75595006|FG001|NOT COMPLETED|Overall Study||0||
59502747|NCT00580853|75595007|FG002|NOT COMPLETED|Overall Study||0||
59502748|NCT00604019|75595017|FG000|STARTED|Overall Study||134||
59502749|NCT00604019|75595018|FG001|STARTED|Overall Study||118||
59502750|NCT00604019|75595017|FG000|COMPLETED|Overall Study||134||
59502751|NCT00604019|75595018|FG001|COMPLETED|Overall Study||118||
59502752|NCT00604019|75595017|FG000|NOT COMPLETED|Overall Study||0||
59502753|NCT00604019|75595018|FG001|NOT COMPLETED|Overall Study||0||
59502754|NCT00581399|75595028|FG000|STARTED|Overall Study||46||
59607669|NCT03748979|75718376|FG006|STARTED|Overall Study||5||
59607670|NCT03748979|75718377|FG007|STARTED|Overall Study||5||
59607671|NCT03748979|75718378|FG008|STARTED|Overall Study||4||
59607672|NCT03748979|75718379|FG009|STARTED|Overall Study||5||
59607673|NCT03748979|75718380|FG010|STARTED|Overall Study||6||
59607674|NCT03748979|75718370|FG000|COMPLETED|Overall Study||6||
59502755|NCT00581399|75595029|FG001|STARTED|Overall Study||48||
59502756|NCT00581399|75595028|FG000|COMPLETED|Overall Study||46||
59502757|NCT00581399|75595029|FG001|COMPLETED|Overall Study||48||
59502758|NCT00581399|75595028|FG000|NOT COMPLETED|Overall Study||0||
59502759|NCT00581399|75595029|FG001|NOT COMPLETED|Overall Study||0||
59502760|NCT01922115|75595037|FG000|STARTED|Overall Study||28||
59502761|NCT01922115|75595038|FG001|STARTED|Overall Study||31||
59607675|NCT03748979|75718371|FG001|COMPLETED|Overall Study||6||
59607676|NCT03748979|75718372|FG002|COMPLETED|Overall Study||6||
59607677|NCT03748979|75718373|FG003|COMPLETED|Overall Study||6||
59502762|NCT01922115|75595037|FG000|COMPLETED|Overall Study||21||
59502763|NCT01922115|75595038|FG001|COMPLETED|Overall Study||24||
59502764|NCT01922115|75595037|FG000|NOT COMPLETED|Overall Study||7||
59502765|NCT01922115|75595038|FG001|NOT COMPLETED|Overall Study||7||
59502766|NCT00081770|75595047|FG000|STARTED|Overall Study||1019||
59502767|NCT00081770|75595048|FG001|STARTED|Overall Study||1016||
59502768|NCT00081770|75595049|FG002|STARTED|Overall Study||1035||
59502769|NCT00081770|75595047|FG000|COMPLETED|Overall Study|Patients who discontinued treatment but continued in study are considered Not Completed|517||
59502770|NCT00081770|75595048|FG001|COMPLETED|Overall Study|Patients who discontinued treatment but continued in study are considered Not Completed|470||
59502771|NCT00081770|75595049|FG002|COMPLETED|Overall Study|Patients who discontinued treatment but continued in study are considered Not Completed|579||
59502772|NCT00081770|75595047|FG000|NOT COMPLETED|Overall Study||502||
59502773|NCT00081770|75595048|FG001|NOT COMPLETED|Overall Study||546||
59502774|NCT00081770|75595049|FG002|NOT COMPLETED|Overall Study||456||
59502775|NCT00605423|75595059|FG000|STARTED|Overall Study||4||
59502776|NCT00605423|75595060|FG001|STARTED|Overall Study||2||
59502777|NCT00605423|75595059|FG000|COMPLETED|Overall Study||4||
59502778|NCT00605423|75595060|FG001|COMPLETED|Overall Study||2||
59502779|NCT00605423|75595059|FG000|NOT COMPLETED|Overall Study||0||
59502780|NCT00605423|75595060|FG001|NOT COMPLETED|Overall Study||0||
59502781|NCT00606047|75595066|FG000|STARTED|Overall Study||200||
59502782|NCT00606047|75595066|FG000|COMPLETED|Overall Study||200||
59502783|NCT00606047|75595066|FG000|NOT COMPLETED|Overall Study||0||
59502784|NCT01923129|75595072|FG000|STARTED|Overall Study||71||
59502785|NCT01923129|75595073|FG001|STARTED|Overall Study||71||
59502786|NCT01923129|75595072|FG000|COMPLETED|Overall Study||71||
59502787|NCT01923129|75595073|FG001|COMPLETED|Overall Study||71||
59502788|NCT01923129|75595072|FG000|NOT COMPLETED|Overall Study||0||
59502789|NCT01923129|75595073|FG001|NOT COMPLETED|Overall Study||0||
59502790|NCT00581867|75595079|FG000|STARTED|First Intervention||16||
59502791|NCT00581867|75595080|FG001|STARTED|First Intervention||15||
59502792|NCT00581867|75595079|FG000|COMPLETED|First Intervention||16||
59502793|NCT00581867|75595080|FG001|COMPLETED|First Intervention||15||
59502794|NCT00581867|75595079|FG000|NOT COMPLETED|First Intervention||0||
59502795|NCT00581867|75595080|FG001|NOT COMPLETED|First Intervention||0||
59502796|NCT00581867|75595079|FG000|STARTED|Second Intervention|n=1 completed period 1 (placebo) but not period 2 (insulin). This individuals died between periods.|15||
59502797|NCT00581867|75595080|FG001|STARTED|Second Intervention|1 individual completed period 1 (Intranasal Insulin) but did not complete period 2 (Placebo).|14||
59502798|NCT00581867|75595079|FG000|COMPLETED|Second Intervention||15||
59502799|NCT00581867|75595080|FG001|COMPLETED|Second Intervention||14||
59502800|NCT00581867|75595079|FG000|NOT COMPLETED|Second Intervention||0||
59502801|NCT00581867|75595080|FG001|NOT COMPLETED|Second Intervention||0||
59502802|NCT01925469|75595088|FG000|STARTED|Overall Study||15||
59502803|NCT01925469|75595089|FG001|STARTED|Overall Study||15||
59502804|NCT01925469|75595088|FG000|COMPLETED|Overall Study||14||
59502805|NCT01925469|75595089|FG001|COMPLETED|Overall Study||15||
59502806|NCT01925469|75595088|FG000|NOT COMPLETED|Overall Study||1||
59502807|NCT01925469|75595089|FG001|NOT COMPLETED|Overall Study||0||
59502808|NCT02139137|75595097|FG000|STARTED|Overall Study||22||
59502809|NCT02139137|75595098|FG001|STARTED|Overall Study||20||
59502810|NCT02139137|75595097|FG000|COMPLETED|Overall Study||15||
59502811|NCT02139137|75595098|FG001|COMPLETED|Overall Study||10||
59502812|NCT02139137|75595097|FG000|NOT COMPLETED|Overall Study||7||
59502813|NCT02139137|75595098|FG001|NOT COMPLETED|Overall Study||10||
59502814|NCT00583661|75595104|FG000|STARTED|Overall Study||48||
59502815|NCT00583661|75595104|FG000|COMPLETED|Overall Study||48||
59502816|NCT00583661|75595104|FG000|NOT COMPLETED|Overall Study||0||
59502817|NCT01925781|75595111|FG000|STARTED|Overall Study||5||
59502818|NCT01925781|75595112|FG001|STARTED|Overall Study||5||
59502819|NCT01925781|75595111|FG000|COMPLETED|Overall Study||3||
59502820|NCT01925781|75595112|FG001|COMPLETED|Overall Study||1||
59502821|NCT01925781|75595111|FG000|NOT COMPLETED|Overall Study||2||
59502822|NCT01925781|75595112|FG001|NOT COMPLETED|Overall Study||4||
59502823|NCT00584285|75595118|FG000|STARTED|Overall Study||18||
59502824|NCT00584285|75595118|FG000|COMPLETED|Overall Study||18||
59502825|NCT00584285|75595118|FG000|NOT COMPLETED|Overall Study||0||
59502826|NCT01927575|75595122|FG000|STARTED|Overall Study||1||
59502827|NCT01927575|75595122|FG000|COMPLETED|Overall Study||1||
59502828|NCT01927575|75595122|FG000|NOT COMPLETED|Overall Study||0||
59607678|NCT03748979|75718374|FG004|COMPLETED|Overall Study||4||
59607679|NCT03748979|75718375|FG005|COMPLETED|Overall Study||4||
59502829|NCT01927887|75595130|FG000|STARTED|Overall Study||12||
59502830|NCT01927887|75595130|FG000|COMPLETED|Overall Study||12||
59502831|NCT01927887|75595130|FG000|NOT COMPLETED|Overall Study||0||
59502832|NCT01929057|75595137|FG000|STARTED|Overall Study||31||
59502833|NCT01929057|75595138|FG001|STARTED|Overall Study||3||
59502834|NCT01929057|75595137|FG000|COMPLETED|Overall Study||31||
59502835|NCT01929057|75595138|FG001|COMPLETED|Overall Study||3||
59502836|NCT01929057|75595137|FG000|NOT COMPLETED|Overall Study||0||
59502837|NCT01929057|75595138|FG001|NOT COMPLETED|Overall Study||0||
59502838|NCT00081458|75595149|FG000|STARTED|Overall Study||16||
59502839|NCT00081458|75595150|FG001|STARTED|Overall Study||35||
59502840|NCT00081458|75595151|FG002|STARTED|Overall Study||33||
59502841|NCT00081458|75595149|FG000|Received Treatment|Overall Study||16||
59502842|NCT00081458|75595150|FG001|Received Treatment|Overall Study||35||
59502843|NCT00081458|75595151|FG002|Received Treatment|Overall Study|1 subject was randomized but did not receive the study drug|32||
59502844|NCT00081458|75595149|FG000|COMPLETED|Overall Study||15||
59502845|NCT00081458|75595150|FG001|COMPLETED|Overall Study||27||
59502846|NCT00081458|75595151|FG002|COMPLETED|Overall Study||29||
59502847|NCT00081458|75595149|FG000|NOT COMPLETED|Overall Study||1||
59502848|NCT00081458|75595150|FG001|NOT COMPLETED|Overall Study||8||
59502849|NCT00081458|75595151|FG002|NOT COMPLETED|Overall Study||4||
59502850|NCT00610727|75595166|FG000|STARTED|Overall Study||14||
59502851|NCT00610727|75595167|FG001|STARTED|Overall Study||8||
59502852|NCT00610727|75595168|FG002|STARTED|Overall Study||8||
59502853|NCT00610727|75595169|FG003|STARTED|Overall Study||8||
59502854|NCT00610727|75595170|FG004|STARTED|Overall Study||8||
59502855|NCT00610727|75595171|FG005|STARTED|Overall Study||8||
59502856|NCT00610727|75595166|FG000|COMPLETED|Overall Study||14||
59502857|NCT00610727|75595167|FG001|COMPLETED|Overall Study||8||
59502858|NCT00610727|75595168|FG002|COMPLETED|Overall Study||8||
59607680|NCT03748979|75718376|FG006|COMPLETED|Overall Study||5||
59502859|NCT00610727|75595169|FG003|COMPLETED|Overall Study||8||
59502860|NCT00610727|75595170|FG004|COMPLETED|Overall Study||8||
59502861|NCT00610727|75595171|FG005|COMPLETED|Overall Study||8||
59502862|NCT00610727|75595166|FG000|NOT COMPLETED|Overall Study||0||
59502863|NCT00610727|75595167|FG001|NOT COMPLETED|Overall Study||0||
59502864|NCT00610727|75595168|FG002|NOT COMPLETED|Overall Study||0||
59502865|NCT00610727|75595169|FG003|NOT COMPLETED|Overall Study||0||
59502866|NCT00610727|75595170|FG004|NOT COMPLETED|Overall Study||0||
59502867|NCT00610727|75595171|FG005|NOT COMPLETED|Overall Study||0||
59502868|NCT00584831|75595189|FG000|STARTED|Intervention 1||1||
59502869|NCT00584831|75595190|FG001|STARTED|Intervention 1||3||
59502870|NCT00584831|75595191|FG002|STARTED|Intervention 1||2||
59502871|NCT00584831|75595192|FG003|STARTED|Intervention 1||1||
59502872|NCT00584831|75595193|FG004|STARTED|Intervention 1||2||
59502873|NCT00584831|75595194|FG005|STARTED|Intervention 1||1||
59502874|NCT00584831|75595195|FG006|STARTED|Intervention 1||6||
59502875|NCT00584831|75595196|FG007|STARTED|Intervention 1||2||
59502876|NCT00584831|75595197|FG008|STARTED|Intervention 1||4||
59502877|NCT00584831|75595198|FG009|STARTED|Intervention 1||2||
59502878|NCT00584831|75595199|FG010|STARTED|Intervention 1||2||
59502879|NCT00584831|75595200|FG011|STARTED|Intervention 1||1||
59502880|NCT00584831|75595201|FG012|STARTED|Intervention 1||2||
59502881|NCT00584831|75595202|FG013|STARTED|Intervention 1||1||
59502882|NCT00584831|75595203|FG014|STARTED|Intervention 1||3||
59502883|NCT00584831|75595204|FG015|STARTED|Intervention 1||1||
59502884|NCT00584831|75595205|FG016|STARTED|Intervention 1||4||
59502885|NCT00584831|75595206|FG017|STARTED|Intervention 1||1||
59502886|NCT00584831|75595207|FG018|STARTED|Intervention 1||1||
59502887|NCT00584831|75595189|FG000|COMPLETED|Intervention 1||1||
59502888|NCT00584831|75595190|FG001|COMPLETED|Intervention 1||3||
59502889|NCT00584831|75595191|FG002|COMPLETED|Intervention 1||2||
59502890|NCT00584831|75595192|FG003|COMPLETED|Intervention 1||1||
59502891|NCT00584831|75595193|FG004|COMPLETED|Intervention 1||2||
59502892|NCT00584831|75595194|FG005|COMPLETED|Intervention 1||1||
59502893|NCT00584831|75595195|FG006|COMPLETED|Intervention 1||6||
59502894|NCT00584831|75595196|FG007|COMPLETED|Intervention 1||2||
59502895|NCT00584831|75595197|FG008|COMPLETED|Intervention 1||4||
59502896|NCT00584831|75595198|FG009|COMPLETED|Intervention 1||2||
59502897|NCT00584831|75595199|FG010|COMPLETED|Intervention 1||2||
59607681|NCT03748979|75718377|FG007|COMPLETED|Overall Study||5||
59607682|NCT03748979|75718378|FG008|COMPLETED|Overall Study||4||
59607683|NCT03748979|75718379|FG009|COMPLETED|Overall Study||5||
59502898|NCT00584831|75595200|FG011|COMPLETED|Intervention 1||1||
59502899|NCT00584831|75595201|FG012|COMPLETED|Intervention 1||2||
59502900|NCT00584831|75595202|FG013|COMPLETED|Intervention 1||1||
59502901|NCT00584831|75595203|FG014|COMPLETED|Intervention 1||3||
59502902|NCT00584831|75595204|FG015|COMPLETED|Intervention 1||1||
59502903|NCT00584831|75595205|FG016|COMPLETED|Intervention 1||4||
59502904|NCT00584831|75595206|FG017|COMPLETED|Intervention 1||1||
59502905|NCT00584831|75595207|FG018|COMPLETED|Intervention 1||1||
59502906|NCT00584831|75595189|FG000|NOT COMPLETED|Intervention 1||0||
59502907|NCT00584831|75595190|FG001|NOT COMPLETED|Intervention 1||0||
59502908|NCT00584831|75595191|FG002|NOT COMPLETED|Intervention 1||0||
59502909|NCT00584831|75595192|FG003|NOT COMPLETED|Intervention 1||0||
59502910|NCT00584831|75595193|FG004|NOT COMPLETED|Intervention 1||0||
59502911|NCT00584831|75595194|FG005|NOT COMPLETED|Intervention 1||0||
59502912|NCT00584831|75595195|FG006|NOT COMPLETED|Intervention 1||0||
59502913|NCT00584831|75595196|FG007|NOT COMPLETED|Intervention 1||0||
59502914|NCT00584831|75595197|FG008|NOT COMPLETED|Intervention 1||0||
59502915|NCT00584831|75595198|FG009|NOT COMPLETED|Intervention 1||0||
59502916|NCT00584831|75595199|FG010|NOT COMPLETED|Intervention 1||0||
59502917|NCT00584831|75595200|FG011|NOT COMPLETED|Intervention 1||0||
59502918|NCT00584831|75595201|FG012|NOT COMPLETED|Intervention 1||0||
59502919|NCT00584831|75595202|FG013|NOT COMPLETED|Intervention 1||0||
59502920|NCT00584831|75595203|FG014|NOT COMPLETED|Intervention 1||0||
59502921|NCT00584831|75595204|FG015|NOT COMPLETED|Intervention 1||0||
59502922|NCT00584831|75595205|FG016|NOT COMPLETED|Intervention 1||0||
59502923|NCT00584831|75595206|FG017|NOT COMPLETED|Intervention 1||0||
59502924|NCT00584831|75595207|FG018|NOT COMPLETED|Intervention 1||0||
59502925|NCT00584831|75595189|FG000|STARTED|Intervention 2||1||
59502926|NCT00584831|75595190|FG001|STARTED|Intervention 2||3||
59502927|NCT00584831|75595191|FG002|STARTED|Intervention 2||2||
59502928|NCT00584831|75595192|FG003|STARTED|Intervention 2||1||
59502929|NCT00584831|75595193|FG004|STARTED|Intervention 2||2||
59502930|NCT00584831|75595194|FG005|STARTED|Intervention 2||1||
59502931|NCT00584831|75595195|FG006|STARTED|Intervention 2||6||
59502932|NCT00584831|75595196|FG007|STARTED|Intervention 2||2||
59502933|NCT00584831|75595197|FG008|STARTED|Intervention 2||4||
59502934|NCT00584831|75595198|FG009|STARTED|Intervention 2||2||
59502935|NCT00584831|75595199|FG010|STARTED|Intervention 2||2||
59502936|NCT00584831|75595200|FG011|STARTED|Intervention 2||1||
59502937|NCT00584831|75595201|FG012|STARTED|Intervention 2||2||
59502938|NCT00584831|75595202|FG013|STARTED|Intervention 2||1||
59502939|NCT00584831|75595203|FG014|STARTED|Intervention 2||3||
59502940|NCT00584831|75595204|FG015|STARTED|Intervention 2||1||
59502941|NCT00584831|75595205|FG016|STARTED|Intervention 2||4||
59502942|NCT00584831|75595206|FG017|STARTED|Intervention 2||1||
59502943|NCT00584831|75595207|FG018|STARTED|Intervention 2||1||
59502944|NCT00584831|75595189|FG000|COMPLETED|Intervention 2||1||
59502945|NCT00584831|75595190|FG001|COMPLETED|Intervention 2||3||
59502946|NCT00584831|75595191|FG002|COMPLETED|Intervention 2||2||
59502947|NCT00584831|75595192|FG003|COMPLETED|Intervention 2||1||
59502948|NCT00584831|75595193|FG004|COMPLETED|Intervention 2||2||
59502949|NCT00584831|75595194|FG005|COMPLETED|Intervention 2||1||
59502950|NCT00584831|75595195|FG006|COMPLETED|Intervention 2||6||
59502951|NCT00584831|75595196|FG007|COMPLETED|Intervention 2||2||
59502952|NCT00584831|75595197|FG008|COMPLETED|Intervention 2||4||
59502953|NCT00584831|75595198|FG009|COMPLETED|Intervention 2||2||
59502954|NCT00584831|75595199|FG010|COMPLETED|Intervention 2||2||
59502955|NCT00584831|75595200|FG011|COMPLETED|Intervention 2||1||
59502956|NCT00584831|75595201|FG012|COMPLETED|Intervention 2||2||
59502957|NCT00584831|75595202|FG013|COMPLETED|Intervention 2||1||
59502958|NCT00584831|75595203|FG014|COMPLETED|Intervention 2||3||
59502959|NCT00584831|75595204|FG015|COMPLETED|Intervention 2||1||
59502960|NCT00584831|75595205|FG016|COMPLETED|Intervention 2||4||
59502961|NCT00584831|75595206|FG017|COMPLETED|Intervention 2||1||
59502962|NCT00584831|75595207|FG018|COMPLETED|Intervention 2||1||
59502963|NCT00584831|75595189|FG000|NOT COMPLETED|Intervention 2||0||
59502964|NCT00584831|75595190|FG001|NOT COMPLETED|Intervention 2||0||
59502965|NCT00584831|75595191|FG002|NOT COMPLETED|Intervention 2||0||
59502966|NCT00584831|75595192|FG003|NOT COMPLETED|Intervention 2||0||
59502967|NCT00584831|75595193|FG004|NOT COMPLETED|Intervention 2||0||
59502968|NCT00584831|75595194|FG005|NOT COMPLETED|Intervention 2||0||
59502969|NCT00584831|75595195|FG006|NOT COMPLETED|Intervention 2||0||
59502970|NCT00584831|75595196|FG007|NOT COMPLETED|Intervention 2||0||
59502971|NCT00584831|75595197|FG008|NOT COMPLETED|Intervention 2||0||
59502972|NCT00584831|75595198|FG009|NOT COMPLETED|Intervention 2||0||
59502973|NCT00584831|75595199|FG010|NOT COMPLETED|Intervention 2||0||
59502974|NCT00584831|75595200|FG011|NOT COMPLETED|Intervention 2||0||
59502975|NCT00584831|75595201|FG012|NOT COMPLETED|Intervention 2||0||
59502976|NCT00584831|75595202|FG013|NOT COMPLETED|Intervention 2||0||
59502977|NCT00584831|75595203|FG014|NOT COMPLETED|Intervention 2||0||
59502978|NCT00584831|75595204|FG015|NOT COMPLETED|Intervention 2||0||
59886060|NCT00109343|76008788|FG000|Vaccinated at Visit 4|Overall Study||466||
59886061|NCT00109343|76008789|FG001|Vaccinated at Visit 4|Overall Study||235||
59886062|NCT00109343|76008790|FG002|Vaccinated at Visit 4|Overall Study||240||
59502979|NCT00584831|75595205|FG016|NOT COMPLETED|Intervention 2||0||
59502980|NCT00584831|75595206|FG017|NOT COMPLETED|Intervention 2||0||
59502981|NCT00584831|75595207|FG018|NOT COMPLETED|Intervention 2||0||
59502982|NCT00584831|75595189|FG000|STARTED|Intervention 3||1||
59502983|NCT00584831|75595190|FG001|STARTED|Intervention 3||3||
59502984|NCT00584831|75595191|FG002|STARTED|Intervention 3||2||
59502985|NCT00584831|75595192|FG003|STARTED|Intervention 3||1||
59502986|NCT00584831|75595193|FG004|STARTED|Intervention 3||2||
59502987|NCT00584831|75595194|FG005|STARTED|Intervention 3||1||
59502988|NCT00584831|75595195|FG006|STARTED|Intervention 3||6||
59502989|NCT00584831|75595196|FG007|STARTED|Intervention 3||2||
59502990|NCT00584831|75595197|FG008|STARTED|Intervention 3||4||
59502991|NCT00584831|75595198|FG009|STARTED|Intervention 3||2||
59502992|NCT00584831|75595199|FG010|STARTED|Intervention 3||2||
59502993|NCT00584831|75595200|FG011|STARTED|Intervention 3||1||
59607684|NCT03748979|75718380|FG010|COMPLETED|Overall Study||6||
59502994|NCT00584831|75595201|FG012|STARTED|Intervention 3||2||
59502995|NCT00584831|75595202|FG013|STARTED|Intervention 3||1||
59502996|NCT00584831|75595203|FG014|STARTED|Intervention 3||3||
59502997|NCT00584831|75595204|FG015|STARTED|Intervention 3||1||
59502998|NCT00584831|75595205|FG016|STARTED|Intervention 3||4||
59502999|NCT00584831|75595206|FG017|STARTED|Intervention 3||1||
59503000|NCT00584831|75595207|FG018|STARTED|Intervention 3||1||
59503001|NCT00584831|75595189|FG000|COMPLETED|Intervention 3||1||
59503002|NCT00584831|75595190|FG001|COMPLETED|Intervention 3||3||
59886063|NCT00109343|76008788|FG000|COMPLETED|Overall Study||446||
59503003|NCT00584831|75595191|FG002|COMPLETED|Intervention 3||2||
59503004|NCT00584831|75595192|FG003|COMPLETED|Intervention 3||1||
59503005|NCT00584831|75595193|FG004|COMPLETED|Intervention 3||2||
59503006|NCT00584831|75595194|FG005|COMPLETED|Intervention 3||1||
59503007|NCT00584831|75595195|FG006|COMPLETED|Intervention 3||6||
59503008|NCT00584831|75595196|FG007|COMPLETED|Intervention 3||2||
59503009|NCT00584831|75595197|FG008|COMPLETED|Intervention 3||4||
59503010|NCT00584831|75595198|FG009|COMPLETED|Intervention 3||2||
59503011|NCT00584831|75595199|FG010|COMPLETED|Intervention 3||2||
59503012|NCT00584831|75595200|FG011|COMPLETED|Intervention 3||1||
60013489|NCT02626819|76129393|FG001|NOT COMPLETED|Overall Study||3||
59503013|NCT00584831|75595201|FG012|COMPLETED|Intervention 3||2||
59503014|NCT00584831|75595202|FG013|COMPLETED|Intervention 3||1||
59755447|NCT03662542|75874427|FG005|STARTED|Safety Follow-up (Week 38- Week 50)||0||
59755448|NCT03662542|75874428|FG006|STARTED|Safety Follow-up (Week 38- Week 50)|Participants could be followed up even if they did not complete treatment.|58||
59755449|NCT03662542|75874429|FG007|STARTED|Safety Follow-up (Week 38- Week 50)|Participants could be followed up even if they did not complete treatment.|65||
59755450|NCT03662542|75874430|FG008|STARTED|Safety Follow-up (Week 38- Week 50)|Participants could be followed up even if they did not complete treatment.|60||
59755451|NCT03662542|75874422|FG000|COMPLETED|Safety Follow-up (Week 38- Week 50)||0||
59755452|NCT03662542|75874423|FG001|COMPLETED|Safety Follow-up (Week 38- Week 50)||0||
59755453|NCT03662542|75874424|FG002|COMPLETED|Safety Follow-up (Week 38- Week 50)||0||
59755454|NCT03662542|75874425|FG003|COMPLETED|Safety Follow-up (Week 38- Week 50)||0||
59755455|NCT03662542|75874426|FG004|COMPLETED|Safety Follow-up (Week 38- Week 50)||0||
59755456|NCT03662542|75874427|FG005|COMPLETED|Safety Follow-up (Week 38- Week 50)||0||
59755457|NCT03662542|75874428|FG006|COMPLETED|Safety Follow-up (Week 38- Week 50)||55||
59755458|NCT03662542|75874429|FG007|COMPLETED|Safety Follow-up (Week 38- Week 50)||58||
59755459|NCT03662542|75874430|FG008|COMPLETED|Safety Follow-up (Week 38- Week 50)||55||
59755460|NCT03662542|75874422|FG000|NOT COMPLETED|Safety Follow-up (Week 38- Week 50)||0||
59755461|NCT03662542|75874423|FG001|NOT COMPLETED|Safety Follow-up (Week 38- Week 50)||0||
59755462|NCT03662542|75874424|FG002|NOT COMPLETED|Safety Follow-up (Week 38- Week 50)||0||
59755463|NCT03662542|75874425|FG003|NOT COMPLETED|Safety Follow-up (Week 38- Week 50)||0||
59755464|NCT03662542|75874426|FG004|NOT COMPLETED|Safety Follow-up (Week 38- Week 50)||0||
59755465|NCT03662542|75874427|FG005|NOT COMPLETED|Safety Follow-up (Week 38- Week 50)||0||
59755466|NCT03662542|75874428|FG006|NOT COMPLETED|Safety Follow-up (Week 38- Week 50)||3||
59755467|NCT03662542|75874429|FG007|NOT COMPLETED|Safety Follow-up (Week 38- Week 50)||7||
59503015|NCT00584831|75595203|FG014|COMPLETED|Intervention 3||3||
59503016|NCT00584831|75595204|FG015|COMPLETED|Intervention 3||1||
59503017|NCT00584831|75595205|FG016|COMPLETED|Intervention 3||4||
59755468|NCT03662542|75874430|FG008|NOT COMPLETED|Safety Follow-up (Week 38- Week 50)||5||
59755469|NCT03660553|75874446|FG000|STARTED|Overall Study||3||
59755470|NCT03660553|75874447|FG001|STARTED|Overall Study||4||
59755471|NCT03660553|75874446|FG000|COMPLETED|Overall Study||3||
59755472|NCT03660553|75874447|FG001|COMPLETED|Overall Study||4||
59755473|NCT03660553|75874446|FG000|NOT COMPLETED|Overall Study||0||
59755474|NCT03660553|75874447|FG001|NOT COMPLETED|Overall Study||0||
59755475|NCT03555591|75874453|FG000|STARTED|Overall Study||3198||
59755476|NCT03555591|75874453|FG000|COMPLETED|Overall Study||3121||
59755477|NCT03555591|75874453|FG000|NOT COMPLETED|Overall Study||77||
59755478|NCT03525392|75874462|FG000|STARTED|Overall Study||2||
59755479|NCT03525392|75874463|FG001|STARTED|Overall Study||3||
59755480|NCT03525392|75874464|FG002|STARTED|Overall Study||5||
59755481|NCT03525392|75874465|FG003|STARTED|Overall Study||3||
59755482|NCT03525392|75874466|FG004|STARTED|Overall Study||1||
59755483|NCT03525392|75874462|FG000|COMPLETED|Overall Study||1|Completed the EOCT.|
59755484|NCT03525392|75874463|FG001|COMPLETED|Overall Study||2|Completed the EOCT.|
59755485|NCT03525392|75874464|FG002|COMPLETED|Overall Study||2|Completed the EOCT.|
59755486|NCT03525392|75874465|FG003|COMPLETED|Overall Study||0|Completed the EOCT.|
59755487|NCT03525392|75874466|FG004|COMPLETED|Overall Study||0|Completed the EOCT.|
59755488|NCT03525392|75874462|FG000|NOT COMPLETED|Overall Study||1||
59755489|NCT03525392|75874463|FG001|NOT COMPLETED|Overall Study||1||
59755490|NCT03525392|75874464|FG002|NOT COMPLETED|Overall Study||3||
59755491|NCT03525392|75874465|FG003|NOT COMPLETED|Overall Study||3||
59755492|NCT03525392|75874466|FG004|NOT COMPLETED|Overall Study||1||
59755493|NCT03496662|75874482|FG000|STARTED|Overall Study||7||
59755494|NCT03496662|75874483|FG001|STARTED|Overall Study||8||
59755495|NCT03496662|75874484|FG002|STARTED|Overall Study||25||
59755496|NCT03496662|75874482|FG000|COMPLETED|Overall Study||5|Completion indicates the participant receiving 4 full cycles of treatment.|
59755497|NCT03496662|75874483|FG001|COMPLETED|Overall Study||8|Completion indicates the participant receiving 4 full cycles of treatment.|
59755498|NCT03496662|75874484|FG002|COMPLETED|Overall Study||16|Completion indicates the participant receiving 4 full cycles of treatment.|
59755499|NCT03496662|75874482|FG000|NOT COMPLETED|Overall Study||2||
59755500|NCT03496662|75874483|FG001|NOT COMPLETED|Overall Study||0||
59755501|NCT03496662|75874484|FG002|NOT COMPLETED|Overall Study||9||
59755502|NCT03472885|75874492|FG000|STARTED|24-Week Treatment Period||12||
59755503|NCT03472885|75874492|FG000|Safety Population: Received at Least 1 Dose of Study Drug|24-Week Treatment Period||12||
59762576|NCT03888391|75882385|FG000|STARTED|Overall Study||18||
60013490|NCT02630251|76129403|FG000|STARTED|Overall Study||2||
59503018|NCT00584831|75595206|FG017|COMPLETED|Intervention 3||1||
59503019|NCT00584831|75595207|FG018|COMPLETED|Intervention 3||1||
59503020|NCT00584831|75595189|FG000|NOT COMPLETED|Intervention 3||0||
59503021|NCT00584831|75595190|FG001|NOT COMPLETED|Intervention 3||0||
59503022|NCT00584831|75595191|FG002|NOT COMPLETED|Intervention 3||0||
59503023|NCT00584831|75595192|FG003|NOT COMPLETED|Intervention 3||0||
59503024|NCT00584831|75595193|FG004|NOT COMPLETED|Intervention 3||0||
59503025|NCT00584831|75595194|FG005|NOT COMPLETED|Intervention 3||0||
59503026|NCT00584831|75595195|FG006|NOT COMPLETED|Intervention 3||0||
59503027|NCT00584831|75595196|FG007|NOT COMPLETED|Intervention 3||0||
59503028|NCT00584831|75595197|FG008|NOT COMPLETED|Intervention 3||0||
59503029|NCT00584831|75595198|FG009|NOT COMPLETED|Intervention 3||0||
59503030|NCT00584831|75595199|FG010|NOT COMPLETED|Intervention 3||0||
59503031|NCT00584831|75595200|FG011|NOT COMPLETED|Intervention 3||0||
59503032|NCT00584831|75595201|FG012|NOT COMPLETED|Intervention 3||0||
59503033|NCT00584831|75595202|FG013|NOT COMPLETED|Intervention 3||0||
59503034|NCT00584831|75595203|FG014|NOT COMPLETED|Intervention 3||0||
59503035|NCT00584831|75595204|FG015|NOT COMPLETED|Intervention 3||0||
59503036|NCT00584831|75595205|FG016|NOT COMPLETED|Intervention 3||0||
59503037|NCT00584831|75595206|FG017|NOT COMPLETED|Intervention 3||0||
59503038|NCT00584831|75595207|FG018|NOT COMPLETED|Intervention 3||0||
59503039|NCT00584831|75595189|FG000|STARTED|Intervention 4||1||
59503040|NCT00584831|75595190|FG001|STARTED|Intervention 4||3||
59503041|NCT00584831|75595191|FG002|STARTED|Intervention 4||2||
59503042|NCT00584831|75595192|FG003|STARTED|Intervention 4||1||
59503043|NCT00584831|75595193|FG004|STARTED|Intervention 4||2||
59503044|NCT00584831|75595194|FG005|STARTED|Intervention 4||1||
59503045|NCT00584831|75595195|FG006|STARTED|Intervention 4||6||
59503046|NCT00584831|75595196|FG007|STARTED|Intervention 4||2||
59503047|NCT00584831|75595197|FG008|STARTED|Intervention 4||3||
59503048|NCT00584831|75595198|FG009|STARTED|Intervention 4||2||
59503049|NCT00584831|75595199|FG010|STARTED|Intervention 4||2||
59503050|NCT00584831|75595200|FG011|STARTED|Intervention 4||1||
59503051|NCT00584831|75595201|FG012|STARTED|Intervention 4||2||
59503052|NCT00584831|75595202|FG013|STARTED|Intervention 4||1||
59503053|NCT00584831|75595203|FG014|STARTED|Intervention 4||2||
59503054|NCT00584831|75595204|FG015|STARTED|Intervention 4||1||
59503055|NCT00584831|75595205|FG016|STARTED|Intervention 4||4||
59503056|NCT00584831|75595206|FG017|STARTED|Intervention 4||1||
59503057|NCT00584831|75595207|FG018|STARTED|Intervention 4||1||
59503058|NCT00584831|75595189|FG000|COMPLETED|Intervention 4||1||
59503059|NCT00584831|75595190|FG001|COMPLETED|Intervention 4||3||
59503060|NCT00584831|75595191|FG002|COMPLETED|Intervention 4||2||
59503061|NCT00584831|75595192|FG003|COMPLETED|Intervention 4||1||
59503062|NCT00584831|75595193|FG004|COMPLETED|Intervention 4||2||
59503063|NCT00584831|75595194|FG005|COMPLETED|Intervention 4||1||
59503064|NCT00584831|75595195|FG006|COMPLETED|Intervention 4||6||
59503065|NCT00584831|75595196|FG007|COMPLETED|Intervention 4||2||
59503066|NCT00584831|75595197|FG008|COMPLETED|Intervention 4||3||
59503067|NCT00584831|75595198|FG009|COMPLETED|Intervention 4||2||
59503068|NCT00584831|75595199|FG010|COMPLETED|Intervention 4||2||
59503069|NCT00584831|75595200|FG011|COMPLETED|Intervention 4||1||
59503070|NCT00584831|75595201|FG012|COMPLETED|Intervention 4||2||
59503071|NCT00584831|75595202|FG013|COMPLETED|Intervention 4||1||
59503072|NCT00584831|75595203|FG014|COMPLETED|Intervention 4||2||
59503073|NCT00584831|75595204|FG015|COMPLETED|Intervention 4||1||
59503074|NCT00584831|75595205|FG016|COMPLETED|Intervention 4||4||
59503075|NCT00584831|75595206|FG017|COMPLETED|Intervention 4||1||
59503076|NCT00584831|75595207|FG018|COMPLETED|Intervention 4||1||
59503077|NCT00584831|75595189|FG000|NOT COMPLETED|Intervention 4||0||
59503078|NCT00584831|75595190|FG001|NOT COMPLETED|Intervention 4||0||
59503079|NCT00584831|75595191|FG002|NOT COMPLETED|Intervention 4||0||
59503080|NCT00584831|75595192|FG003|NOT COMPLETED|Intervention 4||0||
59503081|NCT00584831|75595193|FG004|NOT COMPLETED|Intervention 4||0||
59503082|NCT00584831|75595194|FG005|NOT COMPLETED|Intervention 4||0||
59503083|NCT00584831|75595195|FG006|NOT COMPLETED|Intervention 4||0||
59503084|NCT00584831|75595196|FG007|NOT COMPLETED|Intervention 4||0||
59503085|NCT00584831|75595197|FG008|NOT COMPLETED|Intervention 4||0||
59503086|NCT00584831|75595198|FG009|NOT COMPLETED|Intervention 4||0||
59503087|NCT00584831|75595199|FG010|NOT COMPLETED|Intervention 4||0||
59503088|NCT00584831|75595200|FG011|NOT COMPLETED|Intervention 4||0||
59503089|NCT00584831|75595201|FG012|NOT COMPLETED|Intervention 4||0||
59503090|NCT00584831|75595202|FG013|NOT COMPLETED|Intervention 4||0||
59503091|NCT00584831|75595203|FG014|NOT COMPLETED|Intervention 4||0||
59503092|NCT00584831|75595204|FG015|NOT COMPLETED|Intervention 4||0||
59503093|NCT00584831|75595205|FG016|NOT COMPLETED|Intervention 4||0||
59503094|NCT00584831|75595206|FG017|NOT COMPLETED|Intervention 4||0||
59503095|NCT00584831|75595207|FG018|NOT COMPLETED|Intervention 4||0||
59503096|NCT01929291|75595217|FG000|STARTED|Overall Study||672||
59503097|NCT01929291|75595217|FG000|COMPLETED|Overall Study||672||
59503098|NCT01929291|75595217|FG000|NOT COMPLETED|Overall Study||0||
59503099|NCT01929759|75595221|FG000|STARTED|Overall Study||10||
59503100|NCT01929759|75595221|FG000|COMPLETED|Overall Study||10||
59503101|NCT01929759|75595221|FG000|NOT COMPLETED|Overall Study||0||
59503102|NCT01271803|75595228|FG000|STARTED|Overall Study||66||
59503103|NCT01271803|75595229|FG001|STARTED|Overall Study||63||
59503104|NCT01271803|75595230|FG002|STARTED|Overall Study||2||
59503105|NCT01271803|75595228|FG000|COMPLETED|Overall Study||11||
59503106|NCT01271803|75595229|FG001|COMPLETED|Overall Study||24||
59503107|NCT01271803|75595230|FG002|COMPLETED|Overall Study||0||
59503108|NCT01271803|75595228|FG000|NOT COMPLETED|Overall Study||55||
59503109|NCT01271803|75595229|FG001|NOT COMPLETED|Overall Study||39||
59503110|NCT01271803|75595230|FG002|NOT COMPLETED|Overall Study||2||
59503111|NCT00585377|75595275|FG000|STARTED|Overall Study||50||
59503112|NCT00585377|75595275|FG000|COMPLETED|Overall Study||50||
59886064|NCT00109343|76008789|FG001|COMPLETED|Overall Study||221||
59886065|NCT00109343|76008790|FG002|COMPLETED|Overall Study||229||
59886066|NCT00109343|76008788|FG000|NOT COMPLETED|Overall Study||64||
59886067|NCT00109343|76008789|FG001|NOT COMPLETED|Overall Study||37||
59886068|NCT00109343|76008790|FG002|NOT COMPLETED|Overall Study||30||
60013491|NCT02630251|76129404|FG001|STARTED|Overall Study||1||
60013492|NCT02630251|76129405|FG002|STARTED|Overall Study||1||
59886069|NCT00108485|76008800|FG000|STARTED|Overall Study||5||
59886070|NCT00108485|76008801|FG001|STARTED|Overall Study||4||
59886071|NCT00108485|76008800|FG000|COMPLETED|Overall Study||2||
59886072|NCT00108485|76008801|FG001|COMPLETED|Overall Study||2||
59886073|NCT00108485|76008800|FG000|NOT COMPLETED|Overall Study||3||
59886074|NCT00108485|76008801|FG001|NOT COMPLETED|Overall Study||2||
59886075|NCT00107783|76008809|FG000|STARTED|Overall Study||20||
59886076|NCT00107783|76008810|FG001|STARTED|Overall Study||20||
59886077|NCT00107783|76008809|FG000|COMPLETED|Overall Study||17||
59886078|NCT00107783|76008810|FG001|COMPLETED|Overall Study||16||
59886079|NCT00107783|76008809|FG000|NOT COMPLETED|Overall Study||3||
59886080|NCT00107783|76008810|FG001|NOT COMPLETED|Overall Study||4||
59886081|NCT00095303|76008818|FG000|STARTED|Main Study||245||
59886082|NCT00095303|76008819|FG001|STARTED|Main Study||235||
59886083|NCT00095303|76008818|FG000|COMPLETED|Main Study||154||
59886084|NCT00095303|76008819|FG001|COMPLETED|Main Study||148||
59886085|NCT00095303|76008818|FG000|NOT COMPLETED|Main Study||91||
59886086|NCT00095303|76008819|FG001|NOT COMPLETED|Main Study||87||
59886087|NCT00095303|76008818|FG000|STARTED|Follow Up Study|199 (BSFT) gave permission for future contact; not a requirement to finish Main to start Follow up|199||
59886088|NCT00095303|76008819|FG001|STARTED|Follow Up Study|179 (TAU) gave permission for future contact; not a requirement to finish Main to start Follow up|179||
59886089|NCT00095303|76008818|FG000|COMPLETED|Follow Up Study||140||
59886090|NCT00095303|76008819|FG001|COMPLETED|Follow Up Study||121||
59886091|NCT00095303|76008818|FG000|NOT COMPLETED|Follow Up Study||59||
59886092|NCT00095303|76008819|FG001|NOT COMPLETED|Follow Up Study||58||
59886093|NCT00105521|76008829|FG000|STARTED|Overall Study||98||
59886094|NCT00105521|76008830|FG001|STARTED|Overall Study||101||
59886095|NCT00105521|76008831|FG002|STARTED|Overall Study||97||
60013493|NCT02630251|76129406|FG003|STARTED|Overall Study||1||
60013494|NCT02630251|76129403|FG000|COMPLETED|Overall Study||2||
60013495|NCT02630251|76129404|FG001|COMPLETED|Overall Study||1||
60013496|NCT02630251|76129405|FG002|COMPLETED|Overall Study||0||
60013497|NCT02630251|76129406|FG003|COMPLETED|Overall Study||1||
60013498|NCT02630251|76129403|FG000|NOT COMPLETED|Overall Study||0||
60013499|NCT02630251|76129404|FG001|NOT COMPLETED|Overall Study||0||
60013500|NCT02630251|76129405|FG002|NOT COMPLETED|Overall Study||1||
60013501|NCT02630251|76129406|FG003|NOT COMPLETED|Overall Study||0||
60013502|NCT02518113|76129420|FG000|STARTED|Overall Study||6||
60013503|NCT02518113|76129421|FG001|STARTED|Overall Study||12||
60013504|NCT02518113|76129422|FG002|STARTED|Overall Study||15||
60013505|NCT02518113|76129423|FG003|STARTED|Overall Study||3||
60013506|NCT02518113|76129420|FG000|COMPLETED|Overall Study||3||
60013507|NCT02518113|76129421|FG001|COMPLETED|Overall Study||7||
60013508|NCT02518113|76129422|FG002|COMPLETED|Overall Study||11||
60013509|NCT02518113|76129423|FG003|COMPLETED|Overall Study||3||
60013510|NCT02518113|76129420|FG000|NOT COMPLETED|Overall Study||3||
60013511|NCT02518113|76129421|FG001|NOT COMPLETED|Overall Study||5||
60013512|NCT02518113|76129422|FG002|NOT COMPLETED|Overall Study||4||
60013513|NCT02518113|76129423|FG003|NOT COMPLETED|Overall Study||0||
60013514|NCT02629861|76129439|FG000|STARTED|Overall Study||294||
60013515|NCT02629861|76129440|FG001|STARTED|Overall Study||291||
60013516|NCT02629861|76129441|FG002|STARTED|Overall Study||290||
60013517|NCT02629861|76129439|FG000|Intent to Treat (ITT)|Overall Study||294||
60013518|NCT02629861|76129440|FG001|Intent to Treat (ITT)|Overall Study||291||
60013519|NCT02629861|76129441|FG002|Intent to Treat (ITT)|Overall Study||290||
60013520|NCT02629861|76129439|FG000|Safety Population|Overall Study||294||
60013521|NCT02629861|76129440|FG001|Safety Population|Overall Study||291||
60013522|NCT02629861|76129441|FG002|Safety Population|Overall Study||289||
60013523|NCT02629861|76129439|FG000|Full Analysis Set|Overall Study||290||
60013524|NCT02629861|76129440|FG001|Full Analysis Set|Overall Study||288||
60013525|NCT02629861|76129441|FG002|Full Analysis Set|Overall Study||287||
60013526|NCT02629861|76129439|FG000|COMPLETED|Overall Study||265||
60013527|NCT02629861|76129440|FG001|COMPLETED|Overall Study||264||
60013528|NCT02629861|76129441|FG002|COMPLETED|Overall Study||262||
60013529|NCT02629861|76129439|FG000|NOT COMPLETED|Overall Study||29||
60013530|NCT02629861|76129440|FG001|NOT COMPLETED|Overall Study||27||
60013531|NCT02629861|76129441|FG002|NOT COMPLETED|Overall Study||28||
59886096|NCT00105521|76008832|FG003|STARTED|Overall Study||102||
59886097|NCT00105521|76008829|FG000|COMPLETED|Overall Study||83||
59886098|NCT00105521|76008830|FG001|COMPLETED|Overall Study||90||
59886099|NCT00105521|76008831|FG002|COMPLETED|Overall Study||80||
59886100|NCT00105521|76008832|FG003|COMPLETED|Overall Study||85||
59886101|NCT00105521|76008829|FG000|NOT COMPLETED|Overall Study||15||
59886102|NCT00105521|76008830|FG001|NOT COMPLETED|Overall Study||11||
60013532|NCT02482935|76129449|FG000|STARTED|Period 1||15||
59503113|NCT00585377|75595275|FG000|NOT COMPLETED|Overall Study||0||
59503114|NCT00080288|75595281|FG000|STARTED|Overall Study||127||
59503115|NCT00080288|75595282|FG001|STARTED|Overall Study||127||
59886103|NCT00105521|76008831|FG002|NOT COMPLETED|Overall Study||17||
59886104|NCT00105521|76008832|FG003|NOT COMPLETED|Overall Study||17||
59886105|NCT00291551|76008842|FG000|STARTED|Overall Study||39||
59886106|NCT00291551|76008842|FG000|COMPLETED|Overall Study||26||
59503116|NCT00080288|75595281|FG000|COMPLETED|Overall Study||97||
59503117|NCT00080288|75595282|FG001|COMPLETED|Overall Study||89||
59503118|NCT00080288|75595281|FG000|NOT COMPLETED|Overall Study||30||
59503119|NCT00080288|75595282|FG001|NOT COMPLETED|Overall Study||38||
59503120|NCT00586001|75595290|FG000|STARTED|Overall Study||26||
59503121|NCT00586001|75595291|FG001|STARTED|Overall Study||11||
59503122|NCT00586001|75595290|FG000|COMPLETED|Overall Study||22||
59503123|NCT00586001|75595291|FG001|COMPLETED|Overall Study||10||
59503124|NCT00586001|75595290|FG000|NOT COMPLETED|Overall Study||4||
59503125|NCT00586001|75595291|FG001|NOT COMPLETED|Overall Study||1||
59503126|NCT00611897|75595298|FG000|STARTED|Day 1: Initial Treatment||8||
59503127|NCT00611897|75595299|FG001|STARTED|Day 1: Initial Treatment||8||
59503128|NCT00611897|75595298|FG000|COMPLETED|Day 1: Initial Treatment||8||
59503129|NCT00611897|75595299|FG001|COMPLETED|Day 1: Initial Treatment||8||
59503130|NCT00611897|75595298|FG000|NOT COMPLETED|Day 1: Initial Treatment||0||
59503131|NCT00611897|75595299|FG001|NOT COMPLETED|Day 1: Initial Treatment||0||
59503132|NCT00611897|75595298|FG000|STARTED|Day 2: Crossover Treatment||8||
59503133|NCT00611897|75595299|FG001|STARTED|Day 2: Crossover Treatment||8||
59503134|NCT00611897|75595298|FG000|COMPLETED|Day 2: Crossover Treatment||8||
59503135|NCT00611897|75595299|FG001|COMPLETED|Day 2: Crossover Treatment||8||
59503136|NCT00611897|75595298|FG000|NOT COMPLETED|Day 2: Crossover Treatment||0||
59503137|NCT00611897|75595299|FG001|NOT COMPLETED|Day 2: Crossover Treatment||0||
59503138|NCT03402230|75595307|FG000|STARTED|Overall Study||25||
59503139|NCT03402230|75595308|FG001|STARTED|Overall Study||24||
59503140|NCT03402230|75595307|FG000|COMPLETED|Overall Study||25||
59503141|NCT03402230|75595308|FG001|COMPLETED|Overall Study||23||
59503142|NCT03402230|75595307|FG000|NOT COMPLETED|Overall Study||0||
59503143|NCT03402230|75595308|FG001|NOT COMPLETED|Overall Study||1||
59503144|NCT02780609|75595320|FG000|STARTED|Overall Study||3||
59503145|NCT02780609|75595321|FG001|STARTED|Overall Study||3||
59503146|NCT02780609|75595322|FG002|STARTED|Overall Study||6||
59503147|NCT02780609|75595323|FG003|STARTED|Overall Study||10||
59503148|NCT02780609|75595320|FG000|COMPLETED|Overall Study||3||
59503149|NCT02780609|75595321|FG001|COMPLETED|Overall Study||3||
59503150|NCT02780609|75595322|FG002|COMPLETED|Overall Study||6||
59503151|NCT02780609|75595323|FG003|COMPLETED|Overall Study||10||
59503152|NCT02780609|75595320|FG000|NOT COMPLETED|Overall Study||0||
59503153|NCT02780609|75595321|FG001|NOT COMPLETED|Overall Study||0||
59503154|NCT02780609|75595322|FG002|NOT COMPLETED|Overall Study||0||
59503155|NCT02780609|75595323|FG003|NOT COMPLETED|Overall Study||0||
59503156|NCT00613379|75595338|FG000|STARTED|Overall Study||10||
59503157|NCT00613379|75595339|FG001|STARTED|Overall Study||10||
59503158|NCT00613379|75595340|FG002|STARTED|Overall Study||11||
59503159|NCT00613379|75595338|FG000|COMPLETED|Overall Study||10||
59503160|NCT00613379|75595339|FG001|COMPLETED|Overall Study||10||
59503161|NCT00613379|75595340|FG002|COMPLETED|Overall Study||11||
59503162|NCT00613379|75595338|FG000|NOT COMPLETED|Overall Study||0||
59503163|NCT00613379|75595339|FG001|NOT COMPLETED|Overall Study||0||
59503164|NCT00613379|75595340|FG002|NOT COMPLETED|Overall Study||0||
59503165|NCT01271725|75595348|FG000|STARTED|Part A|Started are the treated patients|74||
59503166|NCT01271725|75595349|FG001|STARTED|Part A||0||
59503167|NCT01271725|75595348|FG000|COMPLETED|Part A||39||
59886107|NCT00291551|76008842|FG000|NOT COMPLETED|Overall Study||13||
59503168|NCT01271725|75595349|FG001|COMPLETED|Part A||0||
59503169|NCT01271725|75595348|FG000|NOT COMPLETED|Part A||35||
59503170|NCT01271725|75595349|FG001|NOT COMPLETED|Part A||0||
59503171|NCT01271725|75595348|FG000|STARTED|Part B||0||
59503172|NCT01271725|75595349|FG001|STARTED|Part B||39||
59503173|NCT01271725|75595348|FG000|COMPLETED|Part B||0||
59503174|NCT01271725|75595349|FG001|COMPLETED|Part B|Patient deemed to have completed the trial once they showed progressive disease according to RECIST|27||
59886108|NCT01081223|76008847|FG000|STARTED|Overall Study||12||
59886109|NCT01081223|76008847|FG000|COMPLETED|Overall Study||12||
59503175|NCT01271725|75595348|FG000|NOT COMPLETED|Part B||0||
59503176|NCT01271725|75595349|FG001|NOT COMPLETED|Part B||12||
59503177|NCT00587483|75595361|FG000|STARTED|Overall Study||115||
59503178|NCT00587483|75595362|FG001|STARTED|Overall Study||115||
59503179|NCT00587483|75595363|FG002|STARTED|Overall Study||112||
59503180|NCT00587483|75595361|FG000|COMPLETED|Overall Study||115||
59503181|NCT00587483|75595362|FG001|COMPLETED|Overall Study||115||
59503182|NCT00587483|75595363|FG002|COMPLETED|Overall Study||112||
59886110|NCT01081223|76008847|FG000|NOT COMPLETED|Overall Study||0||
59503183|NCT00587483|75595361|FG000|NOT COMPLETED|Overall Study||0||
59503184|NCT00587483|75595362|FG001|NOT COMPLETED|Overall Study||0||
59503185|NCT00587483|75595363|FG002|NOT COMPLETED|Overall Study||0||
59503186|NCT01270321|75595374|FG000|STARTED|Overall Study||19||
59503187|NCT01270321|75595375|FG001|STARTED|Overall Study||11||
59886111|NCT04870138|76008855|FG000|STARTED|Overall Study||5||
59503188|NCT01270321|75595376|FG002|STARTED|Overall Study||12||
59503189|NCT01270321|75595374|FG000|COMPLETED|Overall Study||9||
59503190|NCT01270321|75595375|FG001|COMPLETED|Overall Study||1||
59503191|NCT01270321|75595376|FG002|COMPLETED|Overall Study||3||
59503192|NCT01270321|75595374|FG000|NOT COMPLETED|Overall Study||10||
59503193|NCT01270321|75595375|FG001|NOT COMPLETED|Overall Study||10||
59503194|NCT01270321|75595376|FG002|NOT COMPLETED|Overall Study||9||
59503195|NCT03086486|75595388|FG000|STARTED|Overall Study||45||
59503196|NCT03086486|75595389|FG001|STARTED|Overall Study||46||
59503197|NCT03086486|75595390|FG002|STARTED|Overall Study||45||
59503198|NCT03086486|75595391|FG003|STARTED|Overall Study||45||
59503199|NCT03086486|75595388|FG000|COMPLETED|Overall Study||44|Treatment|
59503200|NCT03086486|75595389|FG001|COMPLETED|Overall Study||42|Treatment|
59503201|NCT03086486|75595390|FG002|COMPLETED|Overall Study||43|Treatment|
59503202|NCT03086486|75595391|FG003|COMPLETED|Overall Study||40|Treatment|
59503203|NCT03086486|75595388|FG000|NOT COMPLETED|Overall Study||1||
59503204|NCT03086486|75595389|FG001|NOT COMPLETED|Overall Study||4||
59503205|NCT03086486|75595390|FG002|NOT COMPLETED|Overall Study||2||
59503206|NCT03086486|75595391|FG003|NOT COMPLETED|Overall Study||5||
59503207|NCT00614315|75595403|FG000|STARTED|Overall Study||30||
59886112|NCT04870138|76008856|FG001|STARTED|Overall Study||5||
59886113|NCT04870138|76008857|FG002|STARTED|Overall Study||6||
59886114|NCT04870138|76008855|FG000|COMPLETED|Overall Study||5||
59886115|NCT04870138|76008856|FG001|COMPLETED|Overall Study||5||
59886116|NCT04870138|76008857|FG002|COMPLETED|Overall Study||6||
59886117|NCT04870138|76008855|FG000|NOT COMPLETED|Overall Study||0||
59886118|NCT04870138|76008856|FG001|NOT COMPLETED|Overall Study||0||
59886119|NCT04870138|76008857|FG002|NOT COMPLETED|Overall Study||0||
59886120|NCT02752048|76008871|FG000|STARTED|Overall Study||11||
59886121|NCT02752048|76008872|FG001|STARTED|Overall Study||12||
59886122|NCT02752048|76008873|FG002|STARTED|Overall Study||13||
59886123|NCT02752048|76008871|FG000|COMPLETED|Overall Study||11||
59886124|NCT02752048|76008872|FG001|COMPLETED|Overall Study||12||
59886125|NCT02752048|76008873|FG002|COMPLETED|Overall Study||10||
59886126|NCT02752048|76008871|FG000|NOT COMPLETED|Overall Study||0||
59886127|NCT02752048|76008872|FG001|NOT COMPLETED|Overall Study||0||
59886128|NCT02752048|76008873|FG002|NOT COMPLETED|Overall Study||3||
59886129|NCT04308694|76008881|FG000|STARTED|Overall Study||20||
59886130|NCT04308694|76008881|FG000|COMPLETED|Overall Study||16||
59886131|NCT04308694|76008881|FG000|NOT COMPLETED|Overall Study||4||
59886132|NCT00095147|76008888|FG000|STARTED|Double-blind Period 1 (Days 1-197)||156||
59886133|NCT00095147|76008889|FG001|STARTED|Double-blind Period 1 (Days 1-197)||165||
59886134|NCT00095147|76008890|FG002|STARTED|Double-blind Period 1 (Days 1-197)||110||
59886135|NCT00095147|76008891|FG003|STARTED|Double-blind Period 1 (Days 1-197)||0||
59886136|NCT00095147|76008892|FG004|STARTED|Double-blind Period 1 (Days 1-197)||0||
59886137|NCT00095147|76008888|FG000|COMPLETED|Double-blind Period 1 (Days 1-197)||147||
59886138|NCT00095147|76008889|FG001|COMPLETED|Double-blind Period 1 (Days 1-197)||152||
59886139|NCT00095147|76008890|FG002|COMPLETED|Double-blind Period 1 (Days 1-197)||107||
59886140|NCT00095147|76008891|FG003|COMPLETED|Double-blind Period 1 (Days 1-197)||0||
59886141|NCT00095147|76008892|FG004|COMPLETED|Double-blind Period 1 (Days 1-197)||0||
59886142|NCT00095147|76008888|FG000|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||9||
59886143|NCT00095147|76008889|FG001|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||13||
59886144|NCT00095147|76008890|FG002|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||3||
59886145|NCT00095147|76008891|FG003|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||0||
59886146|NCT00095147|76008892|FG004|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||0||
59886147|NCT00095147|76008888|FG000|STARTED|Double-blind Period 2 (Days 198-365)||147||
59886148|NCT00095147|76008889|FG001|STARTED|Double-blind Period 2 (Days 198-365)||152||
59886149|NCT00095147|76008890|FG002|STARTED|Double-blind Period 2 (Days 198-365)||0||
59886150|NCT00095147|76008891|FG003|STARTED|Double-blind Period 2 (Days 198-365)||107||
59886151|NCT00095147|76008892|FG004|STARTED|Double-blind Period 2 (Days 198-365)||0||
59503208|NCT00614315|75595403|FG000|COMPLETED|Overall Study||30||
59503209|NCT00614315|75595403|FG000|NOT COMPLETED|Overall Study||0||
59886152|NCT00095147|76008888|FG000|COMPLETED|Double-blind Period 2 (Days 198-365)||139||
59886153|NCT00095147|76008889|FG001|COMPLETED|Double-blind Period 2 (Days 198-365)||141||
59886154|NCT00095147|76008890|FG002|COMPLETED|Double-blind Period 2 (Days 198-365)||0||
59886155|NCT00095147|76008891|FG003|COMPLETED|Double-blind Period 2 (Days 198-365)||104||
59503210|NCT02287779|75595415|FG000|STARTED|Overall Study||21||
59503211|NCT02287779|75595416|FG001|STARTED|Overall Study||9||
59503212|NCT02287779|75595417|FG002|STARTED|Overall Study||9||
59503213|NCT02287779|75595418|FG003|STARTED|Overall Study||9||
59503214|NCT02287779|75595419|FG004|STARTED|Overall Study||9||
59503215|NCT02287779|75595420|FG005|STARTED|Overall Study||9||
59503216|NCT02287779|75595421|FG006|STARTED|Overall Study||9||
59886156|NCT00095147|76008892|FG004|COMPLETED|Double-blind Period 2 (Days 198-365)||0||
59886157|NCT00095147|76008888|FG000|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||8||
59886158|NCT00095147|76008889|FG001|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||11||
59886159|NCT00095147|76008890|FG002|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||0||
59886160|NCT00095147|76008891|FG003|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||3||
59503217|NCT02287779|75595422|FG007|STARTED|Overall Study||9||
59503218|NCT02287779|75595415|FG000|COMPLETED|Overall Study||21||
59503219|NCT02287779|75595416|FG001|COMPLETED|Overall Study||9||
59503220|NCT02287779|75595417|FG002|COMPLETED|Overall Study||9||
59503221|NCT02287779|75595418|FG003|COMPLETED|Overall Study||9||
59503222|NCT02287779|75595419|FG004|COMPLETED|Overall Study||9||
59503223|NCT02287779|75595420|FG005|COMPLETED|Overall Study||9||
59503224|NCT02287779|75595421|FG006|COMPLETED|Overall Study||9||
59503225|NCT02287779|75595422|FG007|COMPLETED|Overall Study||9||
59503226|NCT02287779|75595415|FG000|NOT COMPLETED|Overall Study||0||
59503227|NCT02287779|75595416|FG001|NOT COMPLETED|Overall Study||0||
59503228|NCT02287779|75595417|FG002|NOT COMPLETED|Overall Study||0||
59503229|NCT02287779|75595418|FG003|NOT COMPLETED|Overall Study||0||
59503230|NCT02287779|75595419|FG004|NOT COMPLETED|Overall Study||0||
59503231|NCT02287779|75595420|FG005|NOT COMPLETED|Overall Study||0||
59503232|NCT02287779|75595421|FG006|NOT COMPLETED|Overall Study||0||
59503233|NCT02287779|75595422|FG007|NOT COMPLETED|Overall Study||0||
59503234|NCT00732901|75595446|FG000|STARTED|Overall Study||11||
59503235|NCT00732901|75595447|FG001|STARTED|Overall Study||12||
59503236|NCT00732901|75595446|FG000|COMPLETED|Overall Study||11||
59503237|NCT00732901|75595447|FG001|COMPLETED|Overall Study||12||
59503238|NCT00732901|75595446|FG000|NOT COMPLETED|Overall Study||0||
59503239|NCT00732901|75595447|FG001|NOT COMPLETED|Overall Study||0||
59503240|NCT00616109|75595453|FG000|STARTED|Overall Study||16||
59503241|NCT00616109|75595453|FG000|COMPLETED|Overall Study||16||
59503242|NCT00616109|75595453|FG000|NOT COMPLETED|Overall Study||0||
59503243|NCT02330523|75595460|FG000|STARTED|Overall Study||21||
59503244|NCT02330523|75595461|FG001|STARTED|Overall Study||19||
59503245|NCT02330523|75595460|FG000|COMPLETED|Overall Study||21||
59503246|NCT02330523|75595461|FG001|COMPLETED|Overall Study||19||
59503247|NCT02330523|75595460|FG000|NOT COMPLETED|Overall Study||0||
59503248|NCT02330523|75595461|FG001|NOT COMPLETED|Overall Study||0||
59503249|NCT00249769|75595470|FG000|STARTED|Overall Study||100||
59503250|NCT00249769|75595471|FG001|STARTED|Overall Study||250||
59503251|NCT00249769|75595472|FG002|STARTED|Overall Study||250||
59503252|NCT00249769|75595470|FG000|Received LJEV|Overall Study||100|Live Japanese encephalitis vaccine (LJEV)|
59503253|NCT00249769|75595471|FG001|Received LJEV|Overall Study||236|Live Japanese encephalitis vaccine (LJEV)|
59607685|NCT03748979|75718370|FG000|NOT COMPLETED|Overall Study||0||
59886161|NCT00095147|76008892|FG004|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||0||
59886162|NCT00095147|76008888|FG000|STARTED|Long-term Extension Period||0||
59886163|NCT00095147|76008889|FG001|STARTED|Long-term Extension Period||0||
59886164|NCT00095147|76008890|FG002|STARTED|Long-term Extension Period||0||
59886165|NCT00095147|76008891|FG003|STARTED|Long-term Extension Period||0||
59886166|NCT00095147|76008892|FG004|STARTED|Long-term Extension Period||372||
59886167|NCT00095147|76008888|FG000|COMPLETED|Long-term Extension Period||0||
59886168|NCT00095147|76008889|FG001|COMPLETED|Long-term Extension Period||0||
59886169|NCT00095147|76008890|FG002|COMPLETED|Long-term Extension Period||0||
59886170|NCT00095147|76008891|FG003|COMPLETED|Long-term Extension Period||0||
59886171|NCT00095147|76008892|FG004|COMPLETED|Long-term Extension Period||327||
59886172|NCT00095147|76008888|FG000|NOT COMPLETED|Long-term Extension Period||0||
59886173|NCT00095147|76008889|FG001|NOT COMPLETED|Long-term Extension Period||0||
59886174|NCT00095147|76008890|FG002|NOT COMPLETED|Long-term Extension Period||0||
59886175|NCT00095147|76008891|FG003|NOT COMPLETED|Long-term Extension Period||0||
59886176|NCT00095147|76008892|FG004|NOT COMPLETED|Long-term Extension Period||45||
59886177|NCT02751502|76008910|FG000|STARTED|Overall Study||4||
59886178|NCT02751502|76008910|FG000|COMPLETED|Overall Study||0||
59886179|NCT02751502|76008910|FG000|NOT COMPLETED|Overall Study||4||
59886180|NCT02257918|76008917|FG000|STARTED|Overall Study||72||
59886181|NCT02257918|76008918|FG001|STARTED|Overall Study||67||
59886182|NCT02257918|76008919|FG002|STARTED|Overall Study||41||
59886183|NCT02257918|76008917|FG000|Test of Cure Visit|Overall Study||72||
59886184|NCT02257918|76008918|FG001|Test of Cure Visit|Overall Study||67||
59886185|NCT02257918|76008919|FG002|Test of Cure Visit|Overall Study||40||
59886186|NCT02257918|76008917|FG000|COMPLETED|Overall Study||68||
59886187|NCT02257918|76008918|FG001|COMPLETED|Overall Study||66||
59886188|NCT02257918|76008919|FG002|COMPLETED|Overall Study||39||
59503254|NCT00249769|75595472|FG002|Received LJEV|Overall Study||224|Live Japanese encephalitis vaccine (LJEV)|
59503255|NCT00249769|75595470|FG000|Received Measles Vaccine|Overall Study||97||
59607686|NCT03748979|75718371|FG001|NOT COMPLETED|Overall Study||0||
59607687|NCT03748979|75718372|FG002|NOT COMPLETED|Overall Study||0||
59886189|NCT02257918|76008917|FG000|NOT COMPLETED|Overall Study||4||
59886190|NCT02257918|76008918|FG001|NOT COMPLETED|Overall Study||1||
59886191|NCT02257918|76008919|FG002|NOT COMPLETED|Overall Study||2||
59503256|NCT00249769|75595471|FG001|Received Measles Vaccine|Overall Study||236||
59503257|NCT00249769|75595472|FG002|Received Measles Vaccine|Overall Study||235||
59503258|NCT00249769|75595470|FG000|COMPLETED|Overall Study||98||
59503259|NCT00249769|75595471|FG001|COMPLETED|Overall Study||235||
59503260|NCT00249769|75595472|FG002|COMPLETED|Overall Study||222||
59503261|NCT00249769|75595470|FG000|NOT COMPLETED|Overall Study||2||
59607688|NCT03748979|75718373|FG003|NOT COMPLETED|Overall Study||0||
59503262|NCT00249769|75595471|FG001|NOT COMPLETED|Overall Study||15||
59503263|NCT00249769|75595472|FG002|NOT COMPLETED|Overall Study||28||
59503264|NCT00249613|75595482|FG000|STARTED|Baseline||152||
59503265|NCT00249613|75595483|FG001|STARTED|Baseline||139||
59503266|NCT00249613|75595482|FG000|COMPLETED|Baseline||152||
59503267|NCT00249613|75595483|FG001|COMPLETED|Baseline||139||
59503268|NCT00249613|75595482|FG000|NOT COMPLETED|Baseline||0||
59503269|NCT00249613|75595483|FG001|NOT COMPLETED|Baseline||0||
59503270|NCT00249613|75595482|FG000|STARTED|12 Month Follow-up||152||
59503271|NCT00249613|75595483|FG001|STARTED|12 Month Follow-up||139||
59503272|NCT00249613|75595482|FG000|COMPLETED|12 Month Follow-up||135||
59503273|NCT00249613|75595483|FG001|COMPLETED|12 Month Follow-up||124||
59503274|NCT00249613|75595482|FG000|NOT COMPLETED|12 Month Follow-up||17||
59503275|NCT00249613|75595483|FG001|NOT COMPLETED|12 Month Follow-up||15||
59503276|NCT00733135|75595492|FG000|STARTED|Overall Study||133||
59503277|NCT00733135|75595492|FG000|COMPLETED|Overall Study||131||
59503278|NCT00733135|75595492|FG000|NOT COMPLETED|Overall Study||2||
59503279|NCT00617981|75595500|FG000|STARTED|Overall Study||354||
59503280|NCT00617981|75595501|FG001|STARTED|Overall Study||347||
59503281|NCT00617981|75595500|FG000|COMPLETED|Overall Study||244||
59503282|NCT00617981|75595501|FG001|COMPLETED|Overall Study||245||
59503283|NCT00617981|75595500|FG000|NOT COMPLETED|Overall Study||110||
59503284|NCT00617981|75595501|FG001|NOT COMPLETED|Overall Study||102||
59503285|NCT03432650|75595509|FG000|STARTED|Overall Study||48||
59503286|NCT03432650|75595510|FG001|STARTED|Overall Study||48||
59503287|NCT03432650|75595509|FG000|COMPLETED|Overall Study||48||
59503288|NCT03432650|75595510|FG001|COMPLETED|Overall Study||48||
59503289|NCT03432650|75595509|FG000|NOT COMPLETED|Overall Study||0||
59503290|NCT03432650|75595510|FG001|NOT COMPLETED|Overall Study||0||
59503291|NCT00248833|75595519|FG000|STARTED|Overall Study||12||
59503292|NCT00248833|75595520|FG001|STARTED|Overall Study||11||
59503293|NCT00248833|75595521|FG002|STARTED|Overall Study||11||
59503294|NCT00248833|75595519|FG000|COMPLETED|Overall Study||9||
59503295|NCT00248833|75595520|FG001|COMPLETED|Overall Study||8||
59503296|NCT00248833|75595521|FG002|COMPLETED|Overall Study||9||
59503297|NCT00248833|75595519|FG000|NOT COMPLETED|Overall Study||3||
59503298|NCT00248833|75595520|FG001|NOT COMPLETED|Overall Study||3||
59503299|NCT00248833|75595521|FG002|NOT COMPLETED|Overall Study||2||
59503300|NCT00668525|75595534|FG000|STARTED|Overall Study|The number of patients started are based on the Randomized Population.|325||
59503301|NCT00668525|75595535|FG001|STARTED|Overall Study|The number of patients started are based on the Randomized Population.|332||
59503302|NCT00668525|75595536|FG002|STARTED|Overall Study|The number of patients started are based on the Randomized Population.|220||
59503303|NCT00668525|75595534|FG000|COMPLETED|Overall Study|The number of patients completed are based on the Randomized Population.|248||
59503304|NCT00668525|75595535|FG001|COMPLETED|Overall Study|The number of patients completed are based on the Randomized Population.|239||
59503305|NCT00668525|75595536|FG002|COMPLETED|Overall Study|The number of patients completed are based on the Randomized Population.|167||
59503306|NCT00668525|75595534|FG000|NOT COMPLETED|Overall Study||77||
59503307|NCT00668525|75595535|FG001|NOT COMPLETED|Overall Study||93||
59503308|NCT00668525|75595536|FG002|NOT COMPLETED|Overall Study||53||
59503309|NCT00669383|75595546|FG000|STARTED|Overall Study||44||
59503310|NCT00669383|75595547|FG001|STARTED|Overall Study||41||
59503311|NCT00669383|75595546|FG000|COMPLETED|Overall Study||44||
59503312|NCT00669383|75595547|FG001|COMPLETED|Overall Study||41||
59503313|NCT00669383|75595546|FG000|NOT COMPLETED|Overall Study||0||
59503314|NCT00669383|75595547|FG001|NOT COMPLETED|Overall Study||0||
59503315|NCT00733993|75595555|FG000|STARTED|Overall Study||13||
59503316|NCT00733993|75595556|FG001|STARTED|Overall Study||10||
59503317|NCT00733993|75595555|FG000|COMPLETED|Overall Study||13||
59503318|NCT00733993|75595556|FG001|COMPLETED|Overall Study||10||
59503319|NCT00733993|75595555|FG000|NOT COMPLETED|Overall Study||0||
59503320|NCT00733993|75595556|FG001|NOT COMPLETED|Overall Study||0||
59503321|NCT00669539|75595569|FG000|STARTED|Overall Study||94||
59503322|NCT00669539|75595570|FG001|STARTED|Overall Study||52||
59503323|NCT00669539|75595569|FG000|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|86||
59503324|NCT00669539|75595570|FG001|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|43||
59503325|NCT00669539|75595569|FG000|NOT COMPLETED|Overall Study||8||
59503326|NCT00669539|75595570|FG001|NOT COMPLETED|Overall Study||9||
59503327|NCT02290509|75595578|FG000|STARTED|Overall Study||1011||
59503328|NCT02290509|75595579|FG001|STARTED|Overall Study||339||
59503329|NCT02290509|75595578|FG000|COMPLETED|Overall Study||962||
59503330|NCT02290509|75595579|FG001|COMPLETED|Overall Study||325||
59503331|NCT02290509|75595578|FG000|NOT COMPLETED|Overall Study||49||
59503332|NCT02290509|75595579|FG001|NOT COMPLETED|Overall Study||14||
59503333|NCT00618839|75595585|FG000|STARTED|Overall Study||15||
59503334|NCT00618839|75595585|FG000|COMPLETED|Overall Study||15||
59503335|NCT00618839|75595585|FG000|NOT COMPLETED|Overall Study||0||
59503336|NCT02285283|75595594|FG000|STARTED|Overall Study||29||
59503337|NCT02285283|75595595|FG001|STARTED|Overall Study||29||
59503338|NCT02285283|75595594|FG000|COMPLETED|Overall Study||25||
59503339|NCT02285283|75595595|FG001|COMPLETED|Overall Study||20||
59503340|NCT02285283|75595594|FG000|NOT COMPLETED|Overall Study||4||
59503341|NCT02285283|75595595|FG001|NOT COMPLETED|Overall Study||9||
59503342|NCT02285907|75595601|FG000|STARTED|Overall Study||21||
59503343|NCT02285907|75595601|FG000|Began 1st Intervention|Overall Study||21||
59503344|NCT02285907|75595601|FG000|Began 2nd Intervention|Overall Study||21||
59503345|NCT02285907|75595601|FG000|Began 3rd Intervention|Overall Study||21||
59503346|NCT02285907|75595601|FG000|Began 4th Intervention|Overall Study||21||
59503347|NCT02285907|75595601|FG000|COMPLETED|Overall Study||21||
59503348|NCT02285907|75595601|FG000|NOT COMPLETED|Overall Study||0||
59503349|NCT00618917|75595617|FG000|STARTED|Overall Study||4||
59503350|NCT00618917|75595618|FG001|STARTED|Overall Study||3||
59503351|NCT00618917|75595619|FG002|STARTED|Overall Study||11||
59503352|NCT00618917|75595617|FG000|COMPLETED|Overall Study||3||
59503353|NCT00618917|75595618|FG001|COMPLETED|Overall Study||3||
59503354|NCT00618917|75595619|FG002|COMPLETED|Overall Study||11||
59503355|NCT00618917|75595617|FG000|NOT COMPLETED|Overall Study||1||
59503356|NCT00618917|75595618|FG001|NOT COMPLETED|Overall Study||0||
59503357|NCT00618917|75595619|FG002|NOT COMPLETED|Overall Study||0||
59886192|NCT02751424|76008936|FG000|STARTED|Part 1||6||
59886193|NCT02751424|76008937|FG001|STARTED|Part 1||6||
59886194|NCT02751424|76008938|FG002|STARTED|Part 1||6||
59886195|NCT02751424|76008939|FG003|STARTED|Part 1||6||
59886196|NCT02751424|76008940|FG004|STARTED|Part 1||6||
59886197|NCT02751424|76008941|FG005|STARTED|Part 1||6||
59886198|NCT02751424|76008942|FG006|STARTED|Part 1||12||
59886199|NCT02751424|76008943|FG007|STARTED|Part 1||0||
59886200|NCT02751424|76008944|FG008|STARTED|Part 1||0||
59886201|NCT02751424|76008936|FG000|COMPLETED|Part 1||6||
59886202|NCT02751424|76008937|FG001|COMPLETED|Part 1||6||
59886203|NCT02751424|76008938|FG002|COMPLETED|Part 1||6||
59886204|NCT02751424|76008939|FG003|COMPLETED|Part 1||6||
59886205|NCT02751424|76008940|FG004|COMPLETED|Part 1||6||
59886206|NCT02751424|76008941|FG005|COMPLETED|Part 1||6||
59886207|NCT02751424|76008942|FG006|COMPLETED|Part 1||12||
59886208|NCT02751424|76008943|FG007|COMPLETED|Part 1||0||
59886209|NCT02751424|76008944|FG008|COMPLETED|Part 1||0||
59886210|NCT02751424|76008936|FG000|NOT COMPLETED|Part 1||0||
59886211|NCT02751424|76008937|FG001|NOT COMPLETED|Part 1||0||
59886212|NCT02751424|76008938|FG002|NOT COMPLETED|Part 1||0||
59886213|NCT02751424|76008939|FG003|NOT COMPLETED|Part 1||0||
59886214|NCT02751424|76008940|FG004|NOT COMPLETED|Part 1||0||
59886215|NCT02751424|76008941|FG005|NOT COMPLETED|Part 1||0||
59886216|NCT02751424|76008942|FG006|NOT COMPLETED|Part 1||0||
59886217|NCT02751424|76008943|FG007|NOT COMPLETED|Part 1||0||
59886218|NCT02751424|76008944|FG008|NOT COMPLETED|Part 1||0||
59886219|NCT02751424|76008936|FG000|STARTED|Part 2||0||
59886220|NCT02751424|76008937|FG001|STARTED|Part 2||0||
59886221|NCT02751424|76008938|FG002|STARTED|Part 2||0||
59886222|NCT02751424|76008939|FG003|STARTED|Part 2||0||
59886223|NCT02751424|76008940|FG004|STARTED|Part 2||0||
59886224|NCT02751424|76008941|FG005|STARTED|Part 2||0||
59886225|NCT02751424|76008942|FG006|STARTED|Part 2||0||
59886226|NCT02751424|76008943|FG007|STARTED|Part 2||11||
59886227|NCT02751424|76008944|FG008|STARTED|Part 2||3||
59886228|NCT02751424|76008936|FG000|COMPLETED|Part 2||0||
59886229|NCT02751424|76008937|FG001|COMPLETED|Part 2||0||
59886230|NCT02751424|76008938|FG002|COMPLETED|Part 2||0||
59886231|NCT02751424|76008939|FG003|COMPLETED|Part 2||0||
59886232|NCT02751424|76008940|FG004|COMPLETED|Part 2||0||
59886233|NCT02751424|76008941|FG005|COMPLETED|Part 2||0||
59886234|NCT02751424|76008942|FG006|COMPLETED|Part 2||0||
59886235|NCT02751424|76008943|FG007|COMPLETED|Part 2||6||
59886236|NCT02751424|76008944|FG008|COMPLETED|Part 2||3||
59503358|NCT00619073|75595627|FG000|STARTED|First Intervention - 60 Days||8||
59503359|NCT00619073|75595628|FG001|STARTED|First Intervention - 60 Days||8||
59886237|NCT02751424|76008936|FG000|NOT COMPLETED|Part 2||0||
59886238|NCT02751424|76008937|FG001|NOT COMPLETED|Part 2||0||
59886239|NCT02751424|76008938|FG002|NOT COMPLETED|Part 2||0||
59886240|NCT02751424|76008939|FG003|NOT COMPLETED|Part 2||0||
59886241|NCT02751424|76008940|FG004|NOT COMPLETED|Part 2||0||
59886242|NCT02751424|76008941|FG005|NOT COMPLETED|Part 2||0||
59886243|NCT02751424|76008942|FG006|NOT COMPLETED|Part 2||0||
59886244|NCT02751424|76008943|FG007|NOT COMPLETED|Part 2||5||
59886245|NCT02751424|76008944|FG008|NOT COMPLETED|Part 2||0||
59950960|NCT00571493|76069873|FG004|NOT COMPLETED|Overall Study||0||
59950961|NCT00571493|76069874|FG005|NOT COMPLETED|Overall Study||0||
59503360|NCT00619073|75595627|FG000|COMPLETED|First Intervention - 60 Days||8||
59503361|NCT00619073|75595628|FG001|COMPLETED|First Intervention - 60 Days||8||
60013533|NCT02482935|76129450|FG001|STARTED|Period 1||15||
59503362|NCT00619073|75595627|FG000|NOT COMPLETED|First Intervention - 60 Days||0||
59503363|NCT00619073|75595628|FG001|NOT COMPLETED|First Intervention - 60 Days||0||
59503364|NCT00619073|75595627|FG000|STARTED|Washout Period (30 Days)||8||
59503365|NCT00619073|75595628|FG001|STARTED|Washout Period (30 Days)||8||
59503366|NCT00619073|75595627|FG000|COMPLETED|Washout Period (30 Days)||8||
59503367|NCT00619073|75595628|FG001|COMPLETED|Washout Period (30 Days)||8||
59503368|NCT00619073|75595627|FG000|NOT COMPLETED|Washout Period (30 Days)||0||
59503369|NCT00619073|75595628|FG001|NOT COMPLETED|Washout Period (30 Days)||0||
59503370|NCT00619073|75595627|FG000|STARTED|Second Intervention - 60 Days||8||
59755504|NCT03472885|75874492|FG000|Efficacy Population: Received Study Drug for at Least 4 Weeks|24-Week Treatment Period||11||
59755505|NCT03472885|75874492|FG000|COMPLETED|24-Week Treatment Period||11||
59755506|NCT03472885|75874492|FG000|NOT COMPLETED|24-Week Treatment Period||1||
59755507|NCT03472885|75874492|FG000|STARTED|LTE Period (Maximum Exposure: 1463 Days)||11||
59755508|NCT03472885|75874492|FG000|COMPLETED|LTE Period (Maximum Exposure: 1463 Days)||11||
59755509|NCT03472885|75874492|FG000|NOT COMPLETED|LTE Period (Maximum Exposure: 1463 Days)||0||
59755510|NCT03160859|75874501|FG000|STARTED|Overall Study||137||
59755511|NCT03160859|75874502|FG001|STARTED|Overall Study||143||
59755512|NCT03160859|75874501|FG000|COMPLETED|Overall Study||137||
59755513|NCT03160859|75874502|FG001|COMPLETED|Overall Study||143||
59755514|NCT03160859|75874501|FG000|NOT COMPLETED|Overall Study||0||
59755515|NCT03160859|75874502|FG001|NOT COMPLETED|Overall Study||0||
59755516|NCT03117049|75874510|FG000|STARTED|Overall Study||275|Randomized|
59755517|NCT03117049|75874511|FG001|STARTED|Overall Study||275|Randomized|
59755518|NCT03117049|75874510|FG000|COMPLETED|Overall Study||74|Continued at least one study treatment at the time of cut-off|
59755519|NCT03117049|75874511|FG001|COMPLETED|Overall Study||44|Continued at least one study treatment at the time of cut-off|
59755520|NCT03117049|75874510|FG000|NOT COMPLETED|Overall Study||201||
59755521|NCT03117049|75874511|FG001|NOT COMPLETED|Overall Study||231||
59755522|NCT03113617|75874517|FG000|STARTED|Overall Study||44||
59755523|NCT03113617|75874517|FG000|COMPLETED|Overall Study||44||
59755524|NCT03113617|75874517|FG000|NOT COMPLETED|Overall Study||0||
59755525|NCT02771093|75874523|FG000|STARTED|Overall Study||13||
59755526|NCT02771093|75874524|FG001|STARTED|Overall Study||14||
59755527|NCT02771093|75874523|FG000|COMPLETED|Overall Study||13||
59755528|NCT02771093|75874524|FG001|COMPLETED|Overall Study||14||
59755529|NCT02771093|75874523|FG000|NOT COMPLETED|Overall Study||0||
59755530|NCT02771093|75874524|FG001|NOT COMPLETED|Overall Study||0||
59755531|NCT02716038|75874530|FG000|STARTED|Overall Study||31||
59755532|NCT02716038|75874530|FG000|COMPLETED|Overall Study||26||
59755533|NCT02716038|75874530|FG000|NOT COMPLETED|Overall Study||5||
59755534|NCT02512068|75874536|FG000|STARTED|Overall Study||55||
59755535|NCT02512068|75874537|FG001|STARTED|Overall Study||52||
59755536|NCT02512068|75874536|FG000|COMPLETED|Overall Study||43||
59755537|NCT02512068|75874537|FG001|COMPLETED|Overall Study||39||
59755538|NCT02512068|75874536|FG000|NOT COMPLETED|Overall Study||12||
59755539|NCT02512068|75874537|FG001|NOT COMPLETED|Overall Study||13||
59755540|NCT02439749|75874545|FG000|STARTED|Overall Study||182||
59755541|NCT02439749|75874546|FG001|STARTED|Overall Study||184||
59755542|NCT02439749|75874545|FG000|COMPLETED|Overall Study||153||
59755543|NCT02439749|75874546|FG001|COMPLETED|Overall Study||147||
59755544|NCT02439749|75874545|FG000|NOT COMPLETED|Overall Study||29||
59755545|NCT02439749|75874546|FG001|NOT COMPLETED|Overall Study||37||
59755546|NCT02324569|75874554|FG000|STARTED|Overall Study||116||
59755547|NCT02324569|75874555|FG001|STARTED|Overall Study||124||
59755548|NCT02324569|75874554|FG000|COMPLETED|Overall Study||100||
59755549|NCT02324569|75874555|FG001|COMPLETED|Overall Study||103||
59755550|NCT02324569|75874554|FG000|NOT COMPLETED|Overall Study||16||
59755551|NCT02324569|75874555|FG001|NOT COMPLETED|Overall Study||21||
59755552|NCT02312622|75874564|FG000|STARTED|Overall Study||12||
59755553|NCT02312622|75874565|FG001|STARTED|Overall Study||3||
59755554|NCT02312622|75874566|FG002|STARTED|Overall Study||12||
59755555|NCT02312622|75874564|FG000|COMPLETED|Overall Study||12||
59755556|NCT02312622|75874565|FG001|COMPLETED|Overall Study||3||
59755557|NCT02312622|75874566|FG002|COMPLETED|Overall Study||12||
59755558|NCT02312622|75874564|FG000|NOT COMPLETED|Overall Study||0||
59755559|NCT02312622|75874565|FG001|NOT COMPLETED|Overall Study||0||
59755560|NCT02312622|75874566|FG002|NOT COMPLETED|Overall Study||0||
59755561|NCT02297698|75874579|FG000|STARTED|Overall Study||50||
59755562|NCT02297698|75874580|FG001|STARTED|Overall Study||50||
59755563|NCT02297698|75874579|FG000|COMPLETED|Overall Study||31||
59755564|NCT02297698|75874580|FG001|COMPLETED|Overall Study||36||
59755565|NCT02297698|75874579|FG000|NOT COMPLETED|Overall Study||19||
59755566|NCT02297698|75874580|FG001|NOT COMPLETED|Overall Study||14||
59755567|NCT02060890|75874586|FG000|STARTED|Overall Study||20||
59755568|NCT02060890|75874586|FG000|COMPLETED|Overall Study||16||
59503371|NCT00619073|75595628|FG001|STARTED|Second Intervention - 60 Days||8||
59503372|NCT00619073|75595627|FG000|COMPLETED|Second Intervention - 60 Days||8||
59755569|NCT02060890|75874586|FG000|NOT COMPLETED|Overall Study||4||
59755570|NCT02038075|75874593|FG000|STARTED|Overall Study||76||
59503373|NCT00619073|75595628|FG001|COMPLETED|Second Intervention - 60 Days||8||
59503374|NCT00619073|75595627|FG000|NOT COMPLETED|Second Intervention - 60 Days||0||
59503375|NCT00619073|75595628|FG001|NOT COMPLETED|Second Intervention - 60 Days||0||
59607689|NCT03748979|75718374|FG004|NOT COMPLETED|Overall Study||0||
59755571|NCT02038075|75874594|FG001|STARTED|Overall Study||76||
59755572|NCT02038075|75874593|FG000|COMPLETED|Overall Study||73||
59755573|NCT02038075|75874594|FG001|COMPLETED|Overall Study||76||
59755574|NCT02038075|75874593|FG000|NOT COMPLETED|Overall Study||3||
59755575|NCT02038075|75874594|FG001|NOT COMPLETED|Overall Study||0||
59755576|NCT01864746|75874602|FG000|STARTED|Overall Study||631|Randomly assigned to each arm|
59755577|NCT01864746|75874603|FG001|STARTED|Overall Study||619|Randomly assigned to each arm|
59755578|NCT01864746|75874602|FG000|Started Treatment|Overall Study||628|Started treatment in each arm|
59755579|NCT01864746|75874603|FG001|Started Treatment|Overall Study||616|Started treatment in each arm|
59755580|NCT01864746|75874602|FG000|Safety Population|Overall Study||633|N=5 patients who started treatment with placebo received palbociclib once; hence, they were analyzed for safety in the palbociclib arm.|
59755581|NCT01864746|75874603|FG001|Safety Population|Overall Study||611|N=5 patients who started treatment with placebo received palbociclib once; hence, they were analyzed for safety in the palbociclib arm.|
59755582|NCT01864746|75874602|FG000|COMPLETED|Overall Study||508||
59755583|NCT01864746|75874603|FG001|COMPLETED|Overall Study||523||
59755584|NCT01864746|75874602|FG000|NOT COMPLETED|Overall Study||123||
59755585|NCT01864746|75874603|FG001|NOT COMPLETED|Overall Study||96||
59755586|NCT01473992|75874611|FG000|STARTED|Overall Study||10||
59755587|NCT01473992|75874612|FG001|STARTED|Overall Study||10||
59755588|NCT01473992|75874613|FG002|STARTED|Overall Study||5||
59755589|NCT01473992|75874611|FG000|COMPLETED|Overall Study||10||
59755590|NCT01473992|75874612|FG001|COMPLETED|Overall Study||10||
59503376|NCT00620711|75595634|FG000|STARTED|Overall Study||4||
59503377|NCT00620711|75595634|FG000|COMPLETED|Overall Study||4||
59503378|NCT00620711|75595634|FG000|NOT COMPLETED|Overall Study||0||
59503379|NCT00670241|75595641|FG000|STARTED|Overall Study||183||
59503380|NCT00670241|75595642|FG001|STARTED|Overall Study||184||
59503381|NCT00670241|75595643|FG002|STARTED|Overall Study||91||
59503382|NCT00670241|75595641|FG000|COMPLETED|Overall Study||171||
59607690|NCT03748979|75718375|FG005|NOT COMPLETED|Overall Study||0||
59607691|NCT03748979|75718376|FG006|NOT COMPLETED|Overall Study||0||
59607692|NCT03748979|75718377|FG007|NOT COMPLETED|Overall Study||0||
59607693|NCT03748979|75718378|FG008|NOT COMPLETED|Overall Study||0||
59755591|NCT01473992|75874613|FG002|COMPLETED|Overall Study||5||
59755592|NCT01473992|75874611|FG000|NOT COMPLETED|Overall Study||0||
59755593|NCT01473992|75874612|FG001|NOT COMPLETED|Overall Study||0||
59755594|NCT01473992|75874613|FG002|NOT COMPLETED|Overall Study||0||
59755595|NCT00375830|75874624|FG000|STARTED|Overall Study||10||
59755596|NCT00375830|75874625|FG001|STARTED|Overall Study||30||
59755597|NCT00375830|75874626|FG002|STARTED|Overall Study||74||
59755598|NCT00375830|75874624|FG000|COMPLETED|Overall Study||10||
59755599|NCT00375830|75874625|FG001|COMPLETED|Overall Study||30||
59755600|NCT00375830|75874626|FG002|COMPLETED|Overall Study||74||
59755601|NCT00375830|75874624|FG000|NOT COMPLETED|Overall Study||0||
59755602|NCT00375830|75874625|FG001|NOT COMPLETED|Overall Study||0||
59755603|NCT00375830|75874626|FG002|NOT COMPLETED|Overall Study||0||
59755604|NCT00590577|75874650|FG000|STARTED|Overall Study||160||
59755605|NCT00590577|75874651|FG001|STARTED|Overall Study||165||
59755606|NCT00590577|75874652|FG002|STARTED|Overall Study||163||
59755607|NCT00590577|75874653|FG003|STARTED|Overall Study||164||
59755608|NCT00590577|75874650|FG000|COMPLETED|Overall Study||83||
59755609|NCT00590577|75874651|FG001|COMPLETED|Overall Study||89||
59755610|NCT00590577|75874652|FG002|COMPLETED|Overall Study||90||
59755611|NCT00590577|75874653|FG003|COMPLETED|Overall Study||71||
59755612|NCT00590577|75874650|FG000|NOT COMPLETED|Overall Study||77||
59755613|NCT00590577|75874651|FG001|NOT COMPLETED|Overall Study||76||
59755614|NCT00590577|75874652|FG002|NOT COMPLETED|Overall Study||73||
59755615|NCT00590577|75874653|FG003|NOT COMPLETED|Overall Study||93||
59755616|NCT00614575|75874663|FG000|STARTED|Overall Study|The number of patients enrolled.|1089||
59755617|NCT00614575|75874663|FG000|COMPLETED|Overall Study||861||
59755618|NCT00614575|75874663|FG000|NOT COMPLETED|Overall Study||228||
59755619|NCT00805935|75874671|FG000|STARTED|Overall Study||25||
59755620|NCT00805935|75874672|FG001|STARTED|Overall Study||27||
59755621|NCT00805935|75874673|FG002|STARTED|Overall Study||28||
59755622|NCT00805935|75874674|FG003|STARTED|Overall Study||30||
59755623|NCT00805935|75874671|FG000|COMPLETED|Overall Study||12||
59755624|NCT00805935|75874672|FG001|COMPLETED|Overall Study||8||
59755625|NCT00805935|75874673|FG002|COMPLETED|Overall Study||13||
60013534|NCT02482935|76129449|FG000|Received Abemaciclib|Period 1||15||
59755626|NCT00805935|75874674|FG003|COMPLETED|Overall Study||19||
59755627|NCT00805935|75874671|FG000|NOT COMPLETED|Overall Study||13||
59755628|NCT00805935|75874672|FG001|NOT COMPLETED|Overall Study||19||
59755629|NCT00805935|75874673|FG002|NOT COMPLETED|Overall Study||15||
59755630|NCT00805935|75874674|FG003|NOT COMPLETED|Overall Study||11||
59755631|NCT00805545|75874688|FG000|STARTED|Overall Study||200||
59755632|NCT00805545|75874689|FG001|STARTED|Overall Study||200||
59755633|NCT00805545|75874688|FG000|COMPLETED|Overall Study||194||
59755634|NCT00805545|75874689|FG001|COMPLETED|Overall Study||197||
59755635|NCT00805545|75874688|FG000|NOT COMPLETED|Overall Study||6||
59755636|NCT00805545|75874689|FG001|NOT COMPLETED|Overall Study||3||
59755637|NCT02845440|75874700|FG000|STARTED|Overall Study||333||
59755638|NCT02845440|75874701|FG001|STARTED|Overall Study||336||
59755639|NCT02845440|75874702|FG002|STARTED|Overall Study||341||
59755640|NCT02845440|75874703|FG003|STARTED|Overall Study||78||
59755641|NCT02845440|75874704|FG004|STARTED|Overall Study||77||
59755642|NCT02845440|75874700|FG000|COMPLETED|Overall Study||201||
59755643|NCT02845440|75874701|FG001|COMPLETED|Overall Study||203||
59755644|NCT02845440|75874702|FG002|COMPLETED|Overall Study||204||
59755645|NCT02845440|75874703|FG003|COMPLETED|Overall Study||49||
59755646|NCT02845440|75874704|FG004|COMPLETED|Overall Study||39||
59755647|NCT02845440|75874700|FG000|NOT COMPLETED|Overall Study||132||
59755648|NCT02845440|75874701|FG001|NOT COMPLETED|Overall Study||133||
59755649|NCT02845440|75874702|FG002|NOT COMPLETED|Overall Study||137||
59755650|NCT02845440|75874703|FG003|NOT COMPLETED|Overall Study||29||
59755651|NCT02845440|75874704|FG004|NOT COMPLETED|Overall Study||38||
59755652|NCT00590031|75874721|FG000|STARTED|Overall Study||61||
59755653|NCT00590031|75874721|FG000|COMPLETED|Overall Study||55||
59755654|NCT00590031|75874721|FG000|NOT COMPLETED|Overall Study||6||
59755655|NCT00615199|75874729|FG000|STARTED|Overall Study||34||
59755656|NCT00615199|75874730|FG001|STARTED|Overall Study||36||
59755657|NCT00615199|75874731|FG002|STARTED|Overall Study||34||
59755658|NCT00615199|75874732|FG003|STARTED|Overall Study||35||
59755659|NCT00615199|75874729|FG000|COMPLETED|Overall Study||26||
59755660|NCT00615199|75874730|FG001|COMPLETED|Overall Study||34||
59755661|NCT00615199|75874731|FG002|COMPLETED|Overall Study||33||
59755662|NCT00615199|75874732|FG003|COMPLETED|Overall Study||33||
59755663|NCT00615199|75874729|FG000|NOT COMPLETED|Overall Study||8||
59755664|NCT00615199|75874730|FG001|NOT COMPLETED|Overall Study||2||
59755665|NCT00615199|75874731|FG002|NOT COMPLETED|Overall Study||1||
59755666|NCT00615199|75874732|FG003|NOT COMPLETED|Overall Study||2||
59755667|NCT00613951|75874745|FG000|STARTED|Overall Study||61||
59755668|NCT00613951|75874746|FG001|STARTED|Overall Study||59||
59755669|NCT00613951|75874747|FG002|STARTED|Overall Study||62||
59755670|NCT00613951|75874745|FG000|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|60||
59755671|NCT00613951|75874746|FG001|Exposed|Overall Study||59||
59755672|NCT00613951|75874747|FG002|Exposed|Overall Study||62||
59755673|NCT00613951|75874745|FG000|COMPLETED|Overall Study||54||
59755674|NCT00613951|75874746|FG001|COMPLETED|Overall Study||54||
59755675|NCT00613951|75874747|FG002|COMPLETED|Overall Study||57||
59755676|NCT00613951|75874745|FG000|NOT COMPLETED|Overall Study||7||
59755677|NCT00613951|75874746|FG001|NOT COMPLETED|Overall Study||5||
59755678|NCT00613951|75874747|FG002|NOT COMPLETED|Overall Study||5||
59755679|NCT00805467|75874762|FG000|STARTED|Overall Study|Patients who received treatment|1||
59755680|NCT00805467|75874763|FG001|STARTED|Overall Study|Patients who received treatment|59||
59755681|NCT00805467|75874764|FG002|STARTED|Overall Study|Patients who received treatment|183||
59755682|NCT00805467|75874765|FG003|STARTED|Overall Study|Patients who received treatment|381||
59755683|NCT00805467|75874762|FG000|Enrolled But Did Not Receive Treatment|Overall Study||0||
59755684|NCT00805467|75874763|FG001|Enrolled But Did Not Receive Treatment|Overall Study||0||
59755685|NCT00805467|75874764|FG002|Enrolled But Did Not Receive Treatment|Overall Study||0||
59755686|NCT00805467|75874765|FG003|Enrolled But Did Not Receive Treatment|Overall Study||0||
59755687|NCT00805467|75874762|FG000|COMPLETED|Overall Study|Ongoing when study terminated|1||
59755688|NCT00805467|75874763|FG001|COMPLETED|Overall Study|Ongoing when study terminated|25||
59755689|NCT00805467|75874764|FG002|COMPLETED|Overall Study|Ongoing when study terminated|80||
59755690|NCT00805467|75874765|FG003|COMPLETED|Overall Study|Ongoing when study terminated|144||
59755691|NCT00805467|75874762|FG000|NOT COMPLETED|Overall Study||0||
59755692|NCT00805467|75874763|FG001|NOT COMPLETED|Overall Study||34||
59755693|NCT00805467|75874764|FG002|NOT COMPLETED|Overall Study||103||
59755694|NCT00805467|75874765|FG003|NOT COMPLETED|Overall Study||237||
59755695|NCT00958841|75874775|FG000|STARTED|Overall Study||118||
59503383|NCT00670241|75595642|FG001|COMPLETED|Overall Study||163||
59503384|NCT00670241|75595643|FG002|COMPLETED|Overall Study||64||
59503385|NCT00670241|75595641|FG000|NOT COMPLETED|Overall Study||12||
59503386|NCT00670241|75595642|FG001|NOT COMPLETED|Overall Study||21||
59503387|NCT00670241|75595643|FG002|NOT COMPLETED|Overall Study||27||
59503388|NCT00671177|75595653|FG000|STARTED|Overall Study||114||
59503389|NCT00671177|75595654|FG001|STARTED|Overall Study||115||
59503390|NCT00671177|75595653|FG000|COMPLETED|Overall Study||112||
59503391|NCT00671177|75595654|FG001|COMPLETED|Overall Study||114||
59503392|NCT00671177|75595653|FG000|NOT COMPLETED|Overall Study||2||
59503393|NCT00671177|75595654|FG001|NOT COMPLETED|Overall Study||1||
59503394|NCT00620945|75595660|FG000|STARTED|Overall Study|Total number in the study|87||
59503395|NCT00620945|75595660|FG000|COMPLETED|Overall Study||87||
59503396|NCT00620945|75595660|FG000|NOT COMPLETED|Overall Study||0||
59503397|NCT00621179|75595668|FG000|STARTED|Overall Study||12||
59503398|NCT00621179|75595669|FG001|STARTED|Overall Study||8||
59503399|NCT00621179|75595670|FG002|STARTED|Overall Study||7||
59503400|NCT00621179|75595671|FG003|STARTED|Overall Study||10||
59503401|NCT00621179|75595668|FG000|COMPLETED|Overall Study||12||
59503402|NCT00621179|75595669|FG001|COMPLETED|Overall Study||8||
59503403|NCT00621179|75595670|FG002|COMPLETED|Overall Study||6||
59503404|NCT00621179|75595671|FG003|COMPLETED|Overall Study||9||
59503405|NCT00621179|75595668|FG000|NOT COMPLETED|Overall Study||0||
59503406|NCT00621179|75595669|FG001|NOT COMPLETED|Overall Study||0||
59503407|NCT00621179|75595670|FG002|NOT COMPLETED|Overall Study||1||
59503408|NCT00621179|75595671|FG003|NOT COMPLETED|Overall Study||1||
59503409|NCT00247273|75595683|FG000|STARTED|Overall Study||644||
59503410|NCT00247273|75595684|FG001|STARTED|Overall Study||650||
59503411|NCT00247273|75595683|FG000|Intent to Treat Population|Overall Study|Two subjects not included as they did not take any study medication.|642||
59503412|NCT00247273|75595684|FG001|Intent to Treat Population|Overall Study||650||
59503413|NCT00247273|75595683|FG000|COMPLETED|Overall Study||498||
59503414|NCT00247273|75595684|FG001|COMPLETED|Overall Study||513||
59503415|NCT00247273|75595683|FG000|NOT COMPLETED|Overall Study||146||
59503416|NCT00247273|75595684|FG001|NOT COMPLETED|Overall Study||137||
59503417|NCT00671723|75595693|FG000|STARTED|Overall Study||11||
59503418|NCT00671723|75595694|FG001|STARTED|Overall Study||11||
59503419|NCT00671723|75595695|FG002|STARTED|Overall Study||11||
59503420|NCT00671723|75595693|FG000|COMPLETED|Overall Study||11||
59503421|NCT00671723|75595694|FG001|COMPLETED|Overall Study||11||
59503422|NCT00671723|75595695|FG002|COMPLETED|Overall Study||11||
59503423|NCT00671723|75595693|FG000|NOT COMPLETED|Overall Study||0||
59503424|NCT00671723|75595694|FG001|NOT COMPLETED|Overall Study||0||
59503425|NCT00671723|75595695|FG002|NOT COMPLETED|Overall Study||0||
59503426|NCT02289105|75595705|FG000|STARTED|Overall Study||642||
59503427|NCT02289105|75595706|FG001|STARTED|Overall Study||637||
59503428|NCT02289105|75595705|FG000|COMPLETED|Overall Study||642||
59503429|NCT02289105|75595706|FG001|COMPLETED|Overall Study||637||
59503430|NCT02289105|75595705|FG000|NOT COMPLETED|Overall Study||0||
59503431|NCT02289105|75595706|FG001|NOT COMPLETED|Overall Study||0||
59503432|NCT00622427|75595714|FG000|STARTED|Overall Study||16||
59503433|NCT00622427|75595715|FG001|STARTED|Overall Study||16||
59503434|NCT00622427|75595714|FG000|COMPLETED|Overall Study|each subject received 2 weeks of Ramelteon, then 2 weeks of placebo after a two week wash out period|16||
59503435|NCT00622427|75595715|FG001|COMPLETED|Overall Study|each subject received 2 weeks of placebo, then 2 weeks of Ramelteon after a two week wash out period|16||
59607694|NCT03748979|75718379|FG009|NOT COMPLETED|Overall Study||0||
59607695|NCT03748979|75718380|FG010|NOT COMPLETED|Overall Study||0||
59607696|NCT00850421|75718417|FG000|STARTED|Overall Study||35||
59607697|NCT00850421|75718417|FG000|COMPLETED|Overall Study||18||
59607698|NCT00850421|75718417|FG000|NOT COMPLETED|Overall Study||17||
59503436|NCT00622427|75595714|FG000|NOT COMPLETED|Overall Study||0||
59503437|NCT00622427|75595715|FG001|NOT COMPLETED|Overall Study||0||
59503438|NCT00622895|75595723|FG000|STARTED|Overall Study||3||
59503439|NCT00622895|75595723|FG000|COMPLETED|Overall Study||3||
59503440|NCT00622895|75595723|FG000|NOT COMPLETED|Overall Study||0||
59503441|NCT00734305|75595732|FG000|STARTED|Overall Study||7||
59607699|NCT02017379|75718425|FG000|STARTED|Overall Study||0||
59503442|NCT00734305|75595733|FG001|STARTED|Overall Study||3||
59503443|NCT00734305|75595734|FG002|STARTED|Overall Study||4||
59503444|NCT00734305|75595735|FG003|STARTED|Overall Study||3||
59503445|NCT00734305|75595736|FG004|STARTED|Overall Study||5||
59503446|NCT00734305|75595737|FG005|STARTED|Overall Study||4||
59503447|NCT00734305|75595738|FG006|STARTED|Overall Study||18||
59503448|NCT00734305|75595732|FG000|COMPLETED|Overall Study|1 patient was enrolled but did not meet eligibility criteria at C1W1, and thus was never dosed|6||
59503449|NCT00734305|75595733|FG001|COMPLETED|Overall Study||3||
59503450|NCT00734305|75595734|FG002|COMPLETED|Overall Study||4||
59503451|NCT00734305|75595735|FG003|COMPLETED|Overall Study||3||
59503452|NCT00734305|75595736|FG004|COMPLETED|Overall Study||5||
59607700|NCT02017379|75718426|FG001|STARTED|Overall Study||0||
59607701|NCT02017379|75718427|FG002|STARTED|Overall Study||0||
59607702|NCT02017379|75718425|FG000|COMPLETED|Overall Study||0||
59607703|NCT02017379|75718426|FG001|COMPLETED|Overall Study||0||
59503453|NCT00734305|75595737|FG005|COMPLETED|Overall Study||4||
59503454|NCT00734305|75595738|FG006|COMPLETED|Overall Study||18||
59503455|NCT00734305|75595732|FG000|NOT COMPLETED|Overall Study||1||
59886246|NCT00094835|76008974|FG000|STARTED|Overall Study||9||
59886247|NCT00094835|76008975|FG001|STARTED|Overall Study||11||
59886248|NCT00094835|76008976|FG002|STARTED|Overall Study||7||
59886249|NCT00094835|76008977|FG003|STARTED|Overall Study||5||
59886250|NCT00094835|76008978|FG004|STARTED|Overall Study||7||
59886251|NCT00094835|76008979|FG005|STARTED|Overall Study||6||
59886252|NCT00094835|76008980|FG006|STARTED|Overall Study||6||
59886253|NCT00094835|76008974|FG000|Treated With Motesanib|Overall Study||6||
59886254|NCT00094835|76008975|FG001|Treated With Motesanib|Overall Study||11||
59886255|NCT00094835|76008976|FG002|Treated With Motesanib|Overall Study||6||
59886256|NCT00094835|76008977|FG003|Treated With Motesanib|Overall Study||4||
59886257|NCT00094835|76008978|FG004|Treated With Motesanib|Overall Study||7||
59886258|NCT00094835|76008979|FG005|Treated With Motesanib|Overall Study||5||
59886259|NCT00094835|76008980|FG006|Treated With Motesanib|Overall Study||6||
59886260|NCT00094835|76008974|FG000|COMPLETED|Overall Study||5||
59886261|NCT00094835|76008975|FG001|COMPLETED|Overall Study||8||
59886262|NCT00094835|76008976|FG002|COMPLETED|Overall Study||4||
59886263|NCT00094835|76008977|FG003|COMPLETED|Overall Study||4||
59886264|NCT00094835|76008978|FG004|COMPLETED|Overall Study||3||
59886265|NCT00094835|76008979|FG005|COMPLETED|Overall Study||3||
59886266|NCT00094835|76008980|FG006|COMPLETED|Overall Study||4||
59886267|NCT00094835|76008974|FG000|NOT COMPLETED|Overall Study||4||
59886268|NCT00094835|76008975|FG001|NOT COMPLETED|Overall Study||3||
59886269|NCT00094835|76008976|FG002|NOT COMPLETED|Overall Study||3||
59886270|NCT00094835|76008977|FG003|NOT COMPLETED|Overall Study||1||
59886271|NCT00094835|76008978|FG004|NOT COMPLETED|Overall Study||4||
59886272|NCT00094835|76008979|FG005|NOT COMPLETED|Overall Study||3||
59886273|NCT00094835|76008980|FG006|NOT COMPLETED|Overall Study||2||
59886274|NCT00094757|76009004|FG000|STARTED|Overall Study||205||
59886275|NCT00094757|76009005|FG001|STARTED|Overall Study||206||
59886276|NCT00094757|76009006|FG002|STARTED|Overall Study||110||
59886277|NCT00094757|76009004|FG000|COMPLETED|Overall Study||152||
59503456|NCT00734305|75595733|FG001|NOT COMPLETED|Overall Study||0||
59503457|NCT00734305|75595734|FG002|NOT COMPLETED|Overall Study||0||
59503458|NCT00734305|75595735|FG003|NOT COMPLETED|Overall Study||0||
59503459|NCT00734305|75595736|FG004|NOT COMPLETED|Overall Study||0||
59886278|NCT00094757|76009005|FG001|COMPLETED|Overall Study||144||
59886279|NCT00094757|76009006|FG002|COMPLETED|Overall Study||80||
59886280|NCT00094757|76009004|FG000|NOT COMPLETED|Overall Study||53||
59886281|NCT00094757|76009005|FG001|NOT COMPLETED|Overall Study||62||
59886282|NCT00094757|76009006|FG002|NOT COMPLETED|Overall Study||30||
59886283|NCT04378114|76009014|FG000|STARTED|Overall Study||102||
59886284|NCT04378114|76009014|FG000|COMPLETED|Overall Study||97||
59886285|NCT04378114|76009014|FG000|NOT COMPLETED|Overall Study||5||
59886286|NCT00082433|76009023|FG000|STARTED|Overall Study||609||
59886287|NCT00082433|76009024|FG001|STARTED|Overall Study||612||
59886288|NCT00082433|76009023|FG000|COMPLETED|Overall Study|Participants who received 18 or more cycles of treatment.|15||
59886289|NCT00082433|76009024|FG001|COMPLETED|Overall Study|Participants who received 18 or more cycles of treatment.|15||
59886290|NCT00082433|76009023|FG000|NOT COMPLETED|Overall Study||594||
59886291|NCT00082433|76009024|FG001|NOT COMPLETED|Overall Study||597||
59886292|NCT00094445|76009030|FG000|STARTED|Overall Study||50||
59886293|NCT00094445|76009030|FG000|COMPLETED|Overall Study||44||
59886294|NCT00094445|76009030|FG000|NOT COMPLETED|Overall Study||6||
59886295|NCT00082355|76009034|FG000|STARTED|Initial Results of Thrombolytic Therapy||30||
59886296|NCT00082355|76009034|FG000|COMPLETED|Initial Results of Thrombolytic Therapy||28||
59886297|NCT00082355|76009034|FG000|NOT COMPLETED|Initial Results of Thrombolytic Therapy||2||
59886298|NCT00082355|76009034|FG000|STARTED|5 Year Recurrent Thromboembolism Rate||28||
59886299|NCT00082355|76009034|FG000|COMPLETED|5 Year Recurrent Thromboembolism Rate|data will not be complied until 2014|0||
59950962|NCT00571493|76069875|FG006|NOT COMPLETED|Overall Study||0||
59503460|NCT00734305|75595737|FG005|NOT COMPLETED|Overall Study||0||
59503461|NCT00734305|75595738|FG006|NOT COMPLETED|Overall Study||0||
59503462|NCT00623441|75595756|FG000|STARTED|Overall Study||8314||
59503463|NCT00623441|75595756|FG000|COMPLETED|Overall Study|12 months follow-up compliance was 94.2%|8314||
59503464|NCT00623441|75595756|FG000|NOT COMPLETED|Overall Study||0||
59503465|NCT00672737|75595760|FG000|STARTED|Overall Study||56||
59503466|NCT00672737|75595760|FG000|COMPLETED|Overall Study||48||
59503467|NCT00672737|75595760|FG000|NOT COMPLETED|Overall Study||8||
59503468|NCT00673127|75595765|FG000|STARTED|Overall Study||57||
59503469|NCT00673127|75595765|FG000|COMPLETED|Overall Study||57||
59886300|NCT00082355|76009034|FG000|NOT COMPLETED|5 Year Recurrent Thromboembolism Rate||28||
59886301|NCT00094055|76009038|FG000|STARTED|Overall Study||60||
59886302|NCT00094055|76009038|FG000|COMPLETED|Overall Study||0||
59886303|NCT00094055|76009038|FG000|NOT COMPLETED|Overall Study||60||
59886304|NCT00099983|76009044|FG000|STARTED|Overall Study||147||
59886305|NCT00099983|76009045|FG001|STARTED|Overall Study||149||
59886306|NCT00099983|76009044|FG000|COMPLETED|Overall Study||123||
59886307|NCT00099983|76009045|FG001|COMPLETED|Overall Study||124||
59886308|NCT00099983|76009044|FG000|NOT COMPLETED|Overall Study||24||
59886309|NCT00099983|76009045|FG001|NOT COMPLETED|Overall Study||25||
59886310|NCT00099359|76009054|FG000|STARTED|Overall Study||581||
59886311|NCT00099359|76009055|FG001|STARTED|Overall Study||580||
59886312|NCT00099359|76009056|FG002|STARTED|Overall Study||574||
59886313|NCT00099359|76009054|FG000|COMPLETED|Overall Study||527||
59886314|NCT00099359|76009055|FG001|COMPLETED|Overall Study||515||
59886315|NCT00099359|76009056|FG002|COMPLETED|Overall Study||506||
59886316|NCT00099359|76009054|FG000|NOT COMPLETED|Overall Study||54||
59886317|NCT00099359|76009055|FG001|NOT COMPLETED|Overall Study||65||
59886318|NCT00099359|76009056|FG002|NOT COMPLETED|Overall Study||68||
59886319|NCT00092495|76009078|FG000|STARTED|Base Study Vaccination Period||504||
59886320|NCT00092495|76009079|FG001|STARTED|Base Study Vaccination Period||514||
59886321|NCT00092495|76009080|FG002|STARTED|Base Study Vaccination Period||508||
59886322|NCT00092495|76009081|FG003|STARTED|Base Study Vaccination Period||1529||
59886323|NCT00092495|76009082|FG004|STARTED|Base Study Vaccination Period||0||
59886324|NCT00092495|76009078|FG000|With Long-term Follow-up *|Base Study Vaccination Period|Subjects received fewer than 3 doses of vaccinations and entered the long-term follow-up period|2||
59886325|NCT00092495|76009079|FG001|With Long-term Follow-up *|Base Study Vaccination Period|Subjects received fewer than 3 doses of vaccinations and entered the long-term follow-up period|2||
59886326|NCT00092495|76009080|FG002|With Long-term Follow-up *|Base Study Vaccination Period|Subjects received fewer than 3 doses of vaccinations and entered the long-term follow-up period|6||
59886327|NCT00092495|76009081|FG003|With Long-term Follow-up *|Base Study Vaccination Period|Subjects received fewer than 3 doses of vaccinations and entered the long-term follow-up period|10||
59886328|NCT00092495|76009082|FG004|With Long-term Follow-up *|Base Study Vaccination Period||0||
59886329|NCT00092495|76009078|FG000|Without Long-term Follow-up|Base Study Vaccination Period|Subjects discontinued on or before Month 7 and did not enter the long-term follow-up period|34||
59886330|NCT00092495|76009079|FG001|Without Long-term Follow-up|Base Study Vaccination Period|Subjects discontinued on or before Month 7 and did not enter the long-term follow-up period|20||
59886331|NCT00092495|76009080|FG002|Without Long-term Follow-up|Base Study Vaccination Period|Subjects discontinued on or before Month 7 and did not enter the long-term follow-up period|28||
59886332|NCT00092495|76009081|FG003|Without Long-term Follow-up|Base Study Vaccination Period|Subjects discontinued on or before Month 7 and did not enter the long-term follow-up period|73||
59886333|NCT00092495|76009082|FG004|Without Long-term Follow-up|Base Study Vaccination Period||0||
59886334|NCT00092495|76009078|FG000|COMPLETED|Base Study Vaccination Period|Completed 3 vaccinations; entered the long-term follow-up or completed the study per-protocol|467||
59886335|NCT00092495|76009079|FG001|COMPLETED|Base Study Vaccination Period|Completed 3 vaccinations; entered the long-term follow-up or completed the study per-protocol|492||
59886336|NCT00092495|76009080|FG002|COMPLETED|Base Study Vaccination Period|Completed 3 vaccinations; entered the long-term follow-up or completed the study per-protocol|474||
59503470|NCT00673127|75595765|FG000|NOT COMPLETED|Overall Study||0||
59503471|NCT00246259|75595772|FG000|STARTED|Overall Study||44||
59503472|NCT00246259|75595773|FG001|STARTED|Overall Study||41||
59503473|NCT00246259|75595772|FG000|Eligible for Intent-to-treat (ITT)|Overall Study||42||
59503474|NCT00246259|75595773|FG001|Eligible for Intent-to-treat (ITT)|Overall Study||35||
59503475|NCT00246259|75595772|FG000|COMPLETED|Overall Study||16||
59503476|NCT00246259|75595773|FG001|COMPLETED|Overall Study||15||
59503477|NCT00246259|75595772|FG000|NOT COMPLETED|Overall Study||28||
59503478|NCT00246259|75595773|FG001|NOT COMPLETED|Overall Study||26||
59503479|NCT00624221|75595781|FG000|STARTED|Overall Study||20||
59503480|NCT00624221|75595782|FG001|STARTED|Overall Study||20||
59503481|NCT00624221|75595781|FG000|COMPLETED|Overall Study||20||
59503482|NCT00624221|75595782|FG001|COMPLETED|Overall Study||20||
59503483|NCT00624221|75595781|FG000|NOT COMPLETED|Overall Study||0||
59503484|NCT00624221|75595782|FG001|NOT COMPLETED|Overall Study||0||
59503485|NCT00673439|75595788|FG000|STARTED|Overall Study||3||
59503486|NCT00673439|75595788|FG000|COMPLETED|Overall Study||3||
59503487|NCT00673439|75595788|FG000|NOT COMPLETED|Overall Study||0||
59503488|NCT03316118|75595795|FG000|STARTED|Overall Study||2||
59503489|NCT03316118|75595796|FG001|STARTED|Overall Study||0||
59503490|NCT03316118|75595795|FG000|COMPLETED|Overall Study||2||
59503491|NCT03316118|75595796|FG001|COMPLETED|Overall Study||0||
59503492|NCT03316118|75595795|FG000|NOT COMPLETED|Overall Study||0||
59503493|NCT03316118|75595796|FG001|NOT COMPLETED|Overall Study||0||
59503494|NCT00674219|75595804|FG000|STARTED|Overall Study||10||
59503495|NCT00674219|75595805|FG001|STARTED|Overall Study||7||
59503496|NCT00674219|75595804|FG000|COMPLETED|Overall Study||10||
59503497|NCT00674219|75595805|FG001|COMPLETED|Overall Study||7||
59503498|NCT00674219|75595804|FG000|NOT COMPLETED|Overall Study||0||
59503499|NCT00674219|75595805|FG001|NOT COMPLETED|Overall Study||0||
59503500|NCT00674297|75595811|FG000|STARTED|Overall Study||18|41 patients recruited.|
59503501|NCT00674297|75595812|FG001|STARTED|Overall Study||7|41 patients recruited.|
59503502|NCT00674297|75595813|FG002|STARTED|Overall Study||9|41 patients recruited.|
59503503|NCT00674297|75595814|FG003|STARTED|Overall Study||7|41 patients recruited.|
59503504|NCT00674297|75595811|FG000|COMPLETED|Overall Study||8|24 patients completed the study.|
59503505|NCT00674297|75595812|FG001|COMPLETED|Overall Study||7|24 patients completed the study.|
59503506|NCT00674297|75595813|FG002|COMPLETED|Overall Study||5|24 patients completed the study.|
59503507|NCT00674297|75595814|FG003|COMPLETED|Overall Study||4|24 patients completed the study.|
59503508|NCT00674297|75595811|FG000|NOT COMPLETED|Overall Study||10||
59503509|NCT00674297|75595812|FG001|NOT COMPLETED|Overall Study||0||
59503510|NCT00674297|75595813|FG002|NOT COMPLETED|Overall Study||4||
59503511|NCT00674297|75595814|FG003|NOT COMPLETED|Overall Study||3||
59503512|NCT00246025|75595825|FG000|STARTED|Overall Study||124||
59503513|NCT00246025|75595826|FG001|STARTED|Overall Study||133||
59886337|NCT00092495|76009081|FG003|COMPLETED|Base Study Vaccination Period|Completed 3 vaccinations; entered the long-term follow-up or completed the study per-protocol|1441||
59503514|NCT00246025|75595827|FG002|STARTED|Overall Study||126||
59503515|NCT00246025|75595828|FG003|STARTED|Overall Study||129||
59503516|NCT00246025|75595825|FG000|COMPLETED|Overall Study||114||
59503517|NCT00246025|75595826|FG001|COMPLETED|Overall Study||124||
59607704|NCT02017379|75718427|FG002|COMPLETED|Overall Study||0||
59607705|NCT02017379|75718425|FG000|NOT COMPLETED|Overall Study||0||
59607706|NCT02017379|75718426|FG001|NOT COMPLETED|Overall Study||0||
59607707|NCT02017379|75718427|FG002|NOT COMPLETED|Overall Study||0||
59607708|NCT01997567|75718437|FG000|STARTED|Overall Study||0||
59607709|NCT01997567|75718438|FG001|STARTED|Overall Study||0||
59607710|NCT01997567|75718437|FG000|COMPLETED|Overall Study||0||
59503518|NCT00246025|75595827|FG002|COMPLETED|Overall Study||116||
59503519|NCT00246025|75595828|FG003|COMPLETED|Overall Study||116||
59503520|NCT00246025|75595825|FG000|NOT COMPLETED|Overall Study||10||
59503521|NCT00246025|75595826|FG001|NOT COMPLETED|Overall Study||9||
59607711|NCT01997567|75718438|FG001|COMPLETED|Overall Study||0||
59607712|NCT01997567|75718437|FG000|NOT COMPLETED|Overall Study||0||
59607713|NCT01997567|75718438|FG001|NOT COMPLETED|Overall Study||0||
59607714|NCT03742973|75718446|FG000|STARTED|Overall Study||0||
59607715|NCT03742973|75718447|FG001|STARTED|Overall Study||0||
59607716|NCT03742973|75718446|FG000|COMPLETED|Overall Study||0||
59607717|NCT03742973|75718447|FG001|COMPLETED|Overall Study||0||
59503522|NCT00246025|75595827|FG002|NOT COMPLETED|Overall Study||10||
59503523|NCT00246025|75595828|FG003|NOT COMPLETED|Overall Study||13||
59503524|NCT00624923|75595840|FG000|STARTED|Overall Study||127||
59503525|NCT00624923|75595841|FG001|STARTED|Overall Study||124||
59503526|NCT00624923|75595840|FG000|COMPLETED|Overall Study||89||
59503527|NCT00624923|75595841|FG001|COMPLETED|Overall Study||101||
59503528|NCT00624923|75595840|FG000|NOT COMPLETED|Overall Study||38||
59503529|NCT00624923|75595841|FG001|NOT COMPLETED|Overall Study||23||
59503530|NCT00625391|75595853|FG000|STARTED|Overall Study||44||
59503531|NCT00625391|75595854|FG001|STARTED|Overall Study||47||
59503532|NCT00625391|75595855|FG002|STARTED|Overall Study||42||
59503533|NCT00625391|75595856|FG003|STARTED|Overall Study||38||
59503534|NCT00625391|75595853|FG000|COMPLETED|Overall Study||37||
59503535|NCT00625391|75595854|FG001|COMPLETED|Overall Study||39||
59503536|NCT00625391|75595855|FG002|COMPLETED|Overall Study||37||
59503537|NCT00625391|75595856|FG003|COMPLETED|Overall Study||37||
59503538|NCT00625391|75595853|FG000|NOT COMPLETED|Overall Study||7||
59503539|NCT00625391|75595854|FG001|NOT COMPLETED|Overall Study||8||
59503540|NCT00625391|75595855|FG002|NOT COMPLETED|Overall Study||5||
59503541|NCT00625391|75595856|FG003|NOT COMPLETED|Overall Study||1||
59503542|NCT00735787|75595868|FG000|STARTED|Period 1||23||
59503543|NCT00735787|75595869|FG001|STARTED|Period 1||49||
59503544|NCT00735787|75595868|FG000|COMPLETED|Period 1|Per visit window, 18 completed; 17 completed per subject case report form.|17||
59503545|NCT00735787|75595869|FG001|COMPLETED|Period 1||41||
59503546|NCT00735787|75595868|FG000|NOT COMPLETED|Period 1||6||
59503547|NCT00735787|75595869|FG001|NOT COMPLETED|Period 1||8||
59503548|NCT00735787|75595868|FG000|STARTED|Period 2||18||
59503549|NCT00735787|75595869|FG001|STARTED|Period 2||41||
59503550|NCT00735787|75595868|FG000|COMPLETED|Period 2||13||
59503551|NCT00735787|75595869|FG001|COMPLETED|Period 2||40||
59503552|NCT00735787|75595868|FG000|NOT COMPLETED|Period 2||5||
59503553|NCT00735787|75595869|FG001|NOT COMPLETED|Period 2||1||
59503554|NCT00628589|75595878|FG000|STARTED|Overall Study||115||
59503555|NCT00628589|75595879|FG001|STARTED|Overall Study||116||
59503556|NCT00628589|75595880|FG002|STARTED|Overall Study||113||
59503557|NCT00628589|75595878|FG000|COMPLETED|Overall Study||114||
59503558|NCT00628589|75595879|FG001|COMPLETED|Overall Study||114||
59503559|NCT00628589|75595880|FG002|COMPLETED|Overall Study||110||
59503560|NCT00628589|75595878|FG000|NOT COMPLETED|Overall Study||1||
59503561|NCT00628589|75595879|FG001|NOT COMPLETED|Overall Study||2||
59503562|NCT00628589|75595880|FG002|NOT COMPLETED|Overall Study||3||
59503563|NCT00755131|75595890|FG000|STARTED|Overall Study||37||
59503564|NCT00755131|75595891|FG001|STARTED|Overall Study||38||
59503565|NCT00755131|75595890|FG000|COMPLETED|Overall Study||37||
59503566|NCT00755131|75595891|FG001|COMPLETED|Overall Study||38||
59503567|NCT00755131|75595890|FG000|NOT COMPLETED|Overall Study||0||
59503568|NCT00755131|75595891|FG001|NOT COMPLETED|Overall Study||0||
59503569|NCT00755755|75595900|FG000|STARTED|Overall Study|Safety population|95||
59503570|NCT00755755|75595901|FG001|STARTED|Overall Study|Safety population|98||
59503571|NCT00755755|75595902|FG002|STARTED|Overall Study|Safety population|48||
59503572|NCT00755755|75595900|FG000|COMPLETED|Overall Study|Patients who completed the overall study up to the follow-up visit (visit 6)|89||
59503573|NCT00755755|75595901|FG001|COMPLETED|Overall Study|Patients who completed the overall study up to the follow-up visit (visit 6)|90||
59503574|NCT00755755|75595902|FG002|COMPLETED|Overall Study|Patients who completed the overall study up to the follow-up visit (visit 6)|45||
59503575|NCT00755755|75595900|FG000|NOT COMPLETED|Overall Study||6||
59503576|NCT00755755|75595901|FG001|NOT COMPLETED|Overall Study||8||
59503577|NCT00755755|75595902|FG002|NOT COMPLETED|Overall Study||3||
59503578|NCT02292537|75595912|FG000|STARTED|Overall Study||42||
59503579|NCT02292537|75595913|FG001|STARTED|Overall Study||84||
59503580|NCT02292537|75595912|FG000|Completed Treatment|Overall Study||42||
59503581|NCT02292537|75595913|FG001|Completed Treatment|Overall Study|1 participant completed the study but did not complete treatments due to early study closure|83||
59503582|NCT02292537|75595912|FG000|COMPLETED|Overall Study||42||
59503583|NCT02292537|75595913|FG001|COMPLETED|Overall Study||84||
59503584|NCT02292537|75595912|FG000|NOT COMPLETED|Overall Study||0||
59503585|NCT02292537|75595913|FG001|NOT COMPLETED|Overall Study||0||
59503586|NCT00674765|75595921|FG000|STARTED|Overall Study||81||
59503587|NCT00674765|75595922|FG001|STARTED|Overall Study||75||
59503588|NCT00674765|75595921|FG000|COMPLETED|Overall Study||45||
59503589|NCT00674765|75595922|FG001|COMPLETED|Overall Study||46||
59503590|NCT00674765|75595921|FG000|NOT COMPLETED|Overall Study||36||
59503591|NCT00674765|75595922|FG001|NOT COMPLETED|Overall Study||29||
59503592|NCT00676013|75595928|FG000|STARTED|Overall Study||158||
59503593|NCT00676013|75595928|FG000|COMPLETED|Overall Study||157||
59503594|NCT00676013|75595928|FG000|NOT COMPLETED|Overall Study||1||
59503595|NCT00755911|75595937|FG000|STARTED|Overall Study||12||
59503596|NCT00755911|75595938|FG001|STARTED|Overall Study||12||
59503597|NCT00755911|75595937|FG000|COMPLETED|Overall Study||12||
59503598|NCT00755911|75595938|FG001|COMPLETED|Overall Study||12||
59503599|NCT00755911|75595937|FG000|NOT COMPLETED|Overall Study||0||
59503600|NCT00755911|75595938|FG001|NOT COMPLETED|Overall Study||0||
59503601|NCT00676793|75595944|FG000|STARTED|Overall Study||32||
59503602|NCT00676793|75595944|FG000|COMPLETED|Overall Study||19||
59886338|NCT00092495|76009082|FG004|COMPLETED|Base Study Vaccination Period||0||
59886339|NCT00092495|76009078|FG000|NOT COMPLETED|Base Study Vaccination Period||37||
59886340|NCT00092495|76009079|FG001|NOT COMPLETED|Base Study Vaccination Period||22||
59886341|NCT00092495|76009080|FG002|NOT COMPLETED|Base Study Vaccination Period||34||
59886342|NCT00092495|76009081|FG003|NOT COMPLETED|Base Study Vaccination Period||88||
59886343|NCT00092495|76009082|FG004|NOT COMPLETED|Base Study Vaccination Period||0||
59886344|NCT00092495|76009078|FG000|STARTED|Base Study Follow-up Period|Protocol amended to extend follow-up for 10-15 year old subjects to Month 12 (6 months Postdose 3)|115||
59886345|NCT00092495|76009079|FG001|STARTED|Base Study Follow-up Period|Protocol amended to extend follow-up for 10-15 year old subjects to Month 12 (6 months Postdose 3)|125||
59886346|NCT00092495|76009080|FG002|STARTED|Base Study Follow-up Period|Protocol amended to extend follow-up for 10-15 year old subjects to Month 12 (6 months Postdose 3)|130||
59755696|NCT00958841|75874775|FG000|Completed Month 6 (M6)|Overall Study||90||
59755697|NCT00958841|75874775|FG000|Entered in Extension|Overall Study||63||
59755698|NCT00958841|75874775|FG000|COMPLETED|Overall Study|Completed = Completed extension|22||
59503603|NCT00676793|75595944|FG000|NOT COMPLETED|Overall Study||13||
59503604|NCT00737737|75595951|FG000|STARTED|Overall Study||2||
59503605|NCT00737737|75595952|FG001|STARTED|Overall Study||2||
59503606|NCT00737737|75595951|FG000|COMPLETED|Overall Study||2||
59503607|NCT00737737|75595952|FG001|COMPLETED|Overall Study||2||
59503608|NCT00737737|75595951|FG000|NOT COMPLETED|Overall Study||0||
59503609|NCT00737737|75595952|FG001|NOT COMPLETED|Overall Study||0||
59503610|NCT00245011|75595958|FG000|STARTED|Overall Study||11||
59503611|NCT00245011|75595958|FG000|COMPLETED|Overall Study|Subject had disease progression prior to completing study.|10||
59503612|NCT00245011|75595958|FG000|NOT COMPLETED|Overall Study||1||
59503613|NCT00628901|75595964|FG000|STARTED|Overall Study||30||
59503614|NCT00628901|75595965|FG001|STARTED|Overall Study||30||
59503615|NCT00628901|75595964|FG000|COMPLETED|Overall Study||27||
59503616|NCT00628901|75595965|FG001|COMPLETED|Overall Study||29||
59503617|NCT00628901|75595964|FG000|NOT COMPLETED|Overall Study||3||
59503618|NCT00628901|75595965|FG001|NOT COMPLETED|Overall Study||1||
59503619|NCT00629525|75595971|FG000|STARTED|Overall Study||35||
59503620|NCT00629525|75595971|FG000|COMPLETED|Overall Study||32||
59503621|NCT00629525|75595971|FG000|NOT COMPLETED|Overall Study||3||
59503622|NCT00244855|75595977|FG000|STARTED|Overall Study||7||
59503623|NCT00244855|75595978|FG001|STARTED|Overall Study||25||
59503624|NCT00244855|75595977|FG000|COMPLETED|Overall Study||7||
59503625|NCT00244855|75595978|FG001|COMPLETED|Overall Study||24||
59503626|NCT00244855|75595977|FG000|NOT COMPLETED|Overall Study||0||
59503627|NCT00244855|75595978|FG001|NOT COMPLETED|Overall Study||1||
59503628|NCT00737893|75595988|FG000|STARTED|Overall Study||29||
59503629|NCT00737893|75595989|FG001|STARTED|Overall Study||27||
59503630|NCT00737893|75595988|FG000|COMPLETED|Overall Study||29||
59503631|NCT00737893|75595989|FG001|COMPLETED|Overall Study||27||
59503632|NCT00737893|75595988|FG000|NOT COMPLETED|Overall Study||0||
59503633|NCT00737893|75595989|FG001|NOT COMPLETED|Overall Study||0||
59503634|NCT00631319|75595997|FG000|STARTED|Conversion and Titration Phase||343||
59503635|NCT00631319|75595998|FG001|STARTED|Conversion and Titration Phase|Per the study design, no patients received placebo during this phase.|0||
59503636|NCT00631319|75595997|FG000|COMPLETED|Conversion and Titration Phase||200||
59503637|NCT00631319|75595998|FG001|COMPLETED|Conversion and Titration Phase||0||
59503638|NCT00631319|75595997|FG000|NOT COMPLETED|Conversion and Titration Phase||143||
59503639|NCT00631319|75595998|FG001|NOT COMPLETED|Conversion and Titration Phase||0||
59503640|NCT00631319|75595997|FG000|STARTED|Double-blind Phase||100|Patients who completed titration and conversion were allowed in the double-blind phase.|
59503641|NCT00631319|75595998|FG001|STARTED|Double-blind Phase||100|Patients who completed titration and conversion were allowed in the double-blind phase.|
59503642|NCT00631319|75595997|FG000|COMPLETED|Double-blind Phase||60||
59503643|NCT00631319|75595998|FG001|COMPLETED|Double-blind Phase||65||
59503644|NCT00631319|75595997|FG000|NOT COMPLETED|Double-blind Phase||40||
59503645|NCT00631319|75595998|FG001|NOT COMPLETED|Double-blind Phase||35||
59503646|NCT00244621|75596008|FG000|STARTED|Double-blind Treatment Period||29||
59503647|NCT00244621|75596009|FG001|STARTED|Double-blind Treatment Period||32||
59503648|NCT00244621|75596010|FG002|STARTED|Double-blind Treatment Period||32||
59503649|NCT00244621|75596008|FG000|COMPLETED|Double-blind Treatment Period||27||
59503650|NCT00244621|75596009|FG001|COMPLETED|Double-blind Treatment Period||29||
59503651|NCT00244621|75596010|FG002|COMPLETED|Double-blind Treatment Period||30||
59503652|NCT00244621|75596008|FG000|NOT COMPLETED|Double-blind Treatment Period||2||
59755699|NCT00958841|75874775|FG000|NOT COMPLETED|Overall Study||96||
59755700|NCT02937116|75874801|FG000|STARTED|Overall Study||3||
59503653|NCT00244621|75596009|FG001|NOT COMPLETED|Double-blind Treatment Period||3||
59755701|NCT02937116|75874802|FG001|STARTED|Overall Study||3||
59503654|NCT00244621|75596010|FG002|NOT COMPLETED|Double-blind Treatment Period||2||
59755702|NCT02937116|75874803|FG002|STARTED|Overall Study||3||
59503655|NCT00244621|75596008|FG000|STARTED|Open-label Treatment Period|One participant discontinued study due to Adverse Event after completing the double-blind period.|26||
59503656|NCT00244621|75596009|FG001|STARTED|Open-label Treatment Period||29||
59503657|NCT00244621|75596010|FG002|STARTED|Open-label Treatment Period||30||
59503658|NCT00244621|75596008|FG000|COMPLETED|Open-label Treatment Period||25||
59503659|NCT00244621|75596009|FG001|COMPLETED|Open-label Treatment Period||28||
59503660|NCT00244621|75596010|FG002|COMPLETED|Open-label Treatment Period||28||
59503661|NCT00244621|75596008|FG000|NOT COMPLETED|Open-label Treatment Period||1||
59503662|NCT00244621|75596009|FG001|NOT COMPLETED|Open-label Treatment Period||1||
59503663|NCT00244621|75596010|FG002|NOT COMPLETED|Open-label Treatment Period||2||
59503664|NCT00680225|75596018|FG000|STARTED|Overall Study||10||
59503665|NCT00680225|75596018|FG000|COMPLETED|Overall Study||8||
59503666|NCT00680225|75596018|FG000|NOT COMPLETED|Overall Study||2||
59503667|NCT00738049|75596024|FG000|STARTED|1st Intervention(14 Days)||13||
59503668|NCT00738049|75596025|FG001|STARTED|1st Intervention(14 Days)||7||
59503669|NCT00738049|75596024|FG000|COMPLETED|1st Intervention(14 Days)||13||
59503670|NCT00738049|75596025|FG001|COMPLETED|1st Intervention(14 Days)||7||
59503671|NCT00738049|75596024|FG000|NOT COMPLETED|1st Intervention(14 Days)||0||
59503672|NCT00738049|75596025|FG001|NOT COMPLETED|1st Intervention(14 Days)||0||
59503673|NCT00738049|75596024|FG000|STARTED|2nd Intervention(14 Days)||13||
59503674|NCT00738049|75596025|FG001|STARTED|2nd Intervention(14 Days)||7||
59503675|NCT00738049|75596024|FG000|COMPLETED|2nd Intervention(14 Days)||13||
59503676|NCT00738049|75596025|FG001|COMPLETED|2nd Intervention(14 Days)||7||
59503677|NCT00738049|75596024|FG000|NOT COMPLETED|2nd Intervention(14 Days)||0||
59503678|NCT00738049|75596025|FG001|NOT COMPLETED|2nd Intervention(14 Days)||0||
59503679|NCT00738049|75596024|FG000|STARTED|Washout||13||
59503680|NCT00738049|75596025|FG001|STARTED|Washout||7||
59503681|NCT00738049|75596024|FG000|COMPLETED|Washout||13||
59503682|NCT00738049|75596025|FG001|COMPLETED|Washout||7||
59503683|NCT00738049|75596024|FG000|NOT COMPLETED|Washout||0||
59503684|NCT00738049|75596025|FG001|NOT COMPLETED|Washout||0||
59503685|NCT04536935|75596041|FG000|STARTED|RCT Baseline||204||
59503686|NCT04536935|75596042|FG001|STARTED|RCT Baseline||212||
59503687|NCT04536935|75596043|FG002|STARTED|RCT Baseline||209||
59503688|NCT04536935|75596044|FG003|STARTED|RCT Baseline||213||
59503689|NCT04536935|75596041|FG000|COMPLETED|RCT Baseline||204||
59503690|NCT04536935|75596042|FG001|COMPLETED|RCT Baseline||212||
59503691|NCT04536935|75596043|FG002|COMPLETED|RCT Baseline||209||
59503692|NCT04536935|75596044|FG003|COMPLETED|RCT Baseline||213||
59503693|NCT04536935|75596041|FG000|NOT COMPLETED|RCT Baseline||0||
59503694|NCT04536935|75596042|FG001|NOT COMPLETED|RCT Baseline||0||
59503695|NCT04536935|75596043|FG002|NOT COMPLETED|RCT Baseline||0||
59503696|NCT04536935|75596044|FG003|NOT COMPLETED|RCT Baseline||0||
59503697|NCT04536935|75596041|FG000|STARTED|RCT Follow-Up||204||
59503698|NCT04536935|75596042|FG001|STARTED|RCT Follow-Up||212||
59503699|NCT04536935|75596043|FG002|STARTED|RCT Follow-Up||209||
59503700|NCT04536935|75596044|FG003|STARTED|RCT Follow-Up||213||
59503701|NCT04536935|75596041|FG000|COMPLETED|RCT Follow-Up||155||
59503702|NCT04536935|75596042|FG001|COMPLETED|RCT Follow-Up||168||
59503703|NCT04536935|75596043|FG002|COMPLETED|RCT Follow-Up||152||
59503704|NCT04536935|75596044|FG003|COMPLETED|RCT Follow-Up||168||
59503705|NCT04536935|75596041|FG000|NOT COMPLETED|RCT Follow-Up||49||
59503706|NCT04536935|75596042|FG001|NOT COMPLETED|RCT Follow-Up||44||
59503707|NCT04536935|75596043|FG002|NOT COMPLETED|RCT Follow-Up||57||
59503708|NCT04536935|75596044|FG003|NOT COMPLETED|RCT Follow-Up||45||
59503709|NCT02291133|75596055|FG000|STARTED|Overall Study||25||
59503710|NCT02291133|75596055|FG000|COMPLETED|Overall Study||24||
59503711|NCT02291133|75596055|FG000|NOT COMPLETED|Overall Study||1||
59503712|NCT00680459|75596061|FG000|STARTED|Overall Study||7||
59503713|NCT00680459|75596062|FG001|STARTED|Overall Study||6||
59503714|NCT00680459|75596061|FG000|COMPLETED|Overall Study||7||
59503715|NCT00680459|75596062|FG001|COMPLETED|Overall Study||6||
59503716|NCT00680459|75596061|FG000|NOT COMPLETED|Overall Study||0||
59503717|NCT00680459|75596062|FG001|NOT COMPLETED|Overall Study||0||
59503718|NCT00632411|75596070|FG000|STARTED|Overall Study||649||
59503719|NCT00632411|75596071|FG001|STARTED|Overall Study||649||
59503720|NCT00632411|75596070|FG000|COMPLETED|Overall Study||489||
59503721|NCT00632411|75596071|FG001|COMPLETED|Overall Study||473||
59503722|NCT00632411|75596070|FG000|NOT COMPLETED|Overall Study||160||
59503723|NCT00632411|75596071|FG001|NOT COMPLETED|Overall Study||176||
59503724|NCT00632489|75596080|FG000|STARTED|Overall Study||15||
59503725|NCT00632489|75596081|FG001|STARTED|Overall Study||5||
59503726|NCT00632489|75596082|FG002|STARTED|Overall Study||0||
59503727|NCT00632489|75596080|FG000|COMPLETED|Overall Study|Pts remained on study until disease progression, intolerable toxicity or other reason to discontinue|0||
59503728|NCT00632489|75596081|FG001|COMPLETED|Overall Study|Pts remained on study until disease progression, intolerable toxicity or other reason to discontinue|0||
59503729|NCT00632489|75596082|FG002|COMPLETED|Overall Study|Pts remained on study until disease progression, intolerable toxicity or other reason to discontinue|0||
59503730|NCT00632489|75596080|FG000|NOT COMPLETED|Overall Study||15||
59503731|NCT00632489|75596081|FG001|NOT COMPLETED|Overall Study||5||
59503732|NCT00632489|75596082|FG002|NOT COMPLETED|Overall Study||0||
59503733|NCT00243841|75596093|FG000|STARTED|Overall Study||3||
59503734|NCT00243841|75596094|FG001|STARTED|Overall Study||6||
59503735|NCT00243841|75596095|FG002|STARTED|Overall Study||5||
59503736|NCT00243841|75596096|FG003|STARTED|Overall Study||3||
59503737|NCT00243841|75596097|FG004|STARTED|Overall Study||39||
59503738|NCT00243841|75596098|FG005|STARTED|Overall Study||21||
59503739|NCT00243841|75596093|FG000|COMPLETED|Overall Study||3||
59503740|NCT00243841|75596094|FG001|COMPLETED|Overall Study||6||
59503741|NCT00243841|75596095|FG002|COMPLETED|Overall Study||4||
59503742|NCT00243841|75596096|FG003|COMPLETED|Overall Study||3||
59503743|NCT00243841|75596097|FG004|COMPLETED|Overall Study||39||
59503744|NCT00243841|75596098|FG005|COMPLETED|Overall Study||19||
59503745|NCT00243841|75596093|FG000|NOT COMPLETED|Overall Study||0||
59503746|NCT00243841|75596094|FG001|NOT COMPLETED|Overall Study||0||
59503747|NCT00243841|75596095|FG002|NOT COMPLETED|Overall Study||1||
59503748|NCT00243841|75596096|FG003|NOT COMPLETED|Overall Study||0||
59503749|NCT00243841|75596097|FG004|NOT COMPLETED|Overall Study||0||
59503750|NCT00243841|75596098|FG005|NOT COMPLETED|Overall Study||2||
59503751|NCT00681083|75596114|FG000|STARTED|Night 1|26 participants were initially consented (this is the total for the study).|13||
59503752|NCT00681083|75596115|FG001|STARTED|Night 1|26 participants were initially consented (this is the total for the study).|13||
59503753|NCT00681083|75596114|FG000|COMPLETED|Night 1|20 in total completed study. 10 randomized to arm 1 and arm 2 then crossed over to other arm.|10||
59503754|NCT00681083|75596115|FG001|COMPLETED|Night 1|20 in total completed study. 10 randomized to arm 1 and arm 2 then crossed over to other arm.|10||
59503755|NCT00681083|75596114|FG000|NOT COMPLETED|Night 1||3||
59503756|NCT00681083|75596115|FG001|NOT COMPLETED|Night 1||3||
59503757|NCT00681083|75596114|FG000|STARTED|Night 2 (Crossover of Night 1)||10||
59503758|NCT00681083|75596115|FG001|STARTED|Night 2 (Crossover of Night 1)||10||
59503759|NCT00681083|75596114|FG000|COMPLETED|Night 2 (Crossover of Night 1)||10||
59503760|NCT00681083|75596115|FG001|COMPLETED|Night 2 (Crossover of Night 1)||10||
59503761|NCT00681083|75596114|FG000|NOT COMPLETED|Night 2 (Crossover of Night 1)||0||
59503762|NCT00681083|75596115|FG001|NOT COMPLETED|Night 2 (Crossover of Night 1)||0||
59503763|NCT00738361|75596121|FG000|STARTED|Overall Study||4||
59503764|NCT00738361|75596121|FG000|COMPLETED|Overall Study||4||
59503765|NCT00738361|75596121|FG000|NOT COMPLETED|Overall Study||0||
59503766|NCT02337062|75596128|FG000|STARTED|Overall Study||572||
59503767|NCT02337062|75596129|FG001|STARTED|Overall Study||575||
59503768|NCT02337062|75596128|FG000|COMPLETED|Overall Study||555||
59503769|NCT02337062|75596129|FG001|COMPLETED|Overall Study||556||
59503770|NCT02337062|75596128|FG000|NOT COMPLETED|Overall Study||17||
59503771|NCT02337062|75596129|FG001|NOT COMPLETED|Overall Study||19||
59503772|NCT00681473|75596137|FG000|STARTED|Overall Study|20 patients with WHO Grade 2 Glioma were enrolled.|20||
59503773|NCT00681473|75596137|FG000|COMPLETED|Overall Study|All 20 patients completed RT and tolerated treatment well.|20||
59503774|NCT00681473|75596137|FG000|NOT COMPLETED|Overall Study||0||
59503775|NCT00634283|75596141|FG000|STARTED|Overall Study||6||
59503776|NCT00634283|75596141|FG000|COMPLETED|Overall Study||6||
59503777|NCT00634283|75596141|FG000|NOT COMPLETED|Overall Study||0||
59503778|NCT00682565|75596150|FG000|STARTED|Overall Study||31||
59503779|NCT00682565|75596151|FG001|STARTED|Overall Study||35||
59503780|NCT00682565|75596152|FG002|STARTED|Overall Study||29||
59503781|NCT00682565|75596150|FG000|COMPLETED|Overall Study||30||
59503782|NCT00682565|75596151|FG001|COMPLETED|Overall Study||32||
59503783|NCT00682565|75596152|FG002|COMPLETED|Overall Study||29||
59503784|NCT00682565|75596150|FG000|NOT COMPLETED|Overall Study||1||
59503785|NCT00682565|75596151|FG001|NOT COMPLETED|Overall Study||3||
59503786|NCT00682565|75596152|FG002|NOT COMPLETED|Overall Study||0||
59503787|NCT00756613|75596163|FG000|STARTED|Overall Study||512||
59503788|NCT00756613|75596164|FG001|STARTED|Overall Study||532||
59503789|NCT00756613|75596163|FG000|COMPLETED|Overall Study||426||
59607718|NCT03742973|75718446|FG000|NOT COMPLETED|Overall Study||0||
59503790|NCT00756613|75596164|FG001|COMPLETED|Overall Study||462||
59503791|NCT00756613|75596163|FG000|NOT COMPLETED|Overall Study||86||
59503792|NCT00756613|75596164|FG001|NOT COMPLETED|Overall Study||70||
59503793|NCT00635453|75596173|FG000|STARTED|Overall Study||360|Pregnant woman|
59503794|NCT00635453|75596174|FG001|STARTED|Overall Study||355|Pregnant woman|
59503795|NCT00635453|75596173|FG000|6 Months Assessment|Overall Study||322|Mother-Child Pairs|
59503796|NCT00635453|75596174|FG001|6 Months Assessment|Overall Study||311|Mother-Child Pairs|
59503797|NCT00635453|75596173|FG000|12 Months Assessment|Overall Study||285|Mother-Child Pairs|
59503798|NCT00635453|75596174|FG001|12 Months Assessment|Overall Study||260|Mother-Child Pairs|
59503799|NCT00635453|75596173|FG000|3 Years Assessment|Overall Study||246||
59503800|NCT00635453|75596174|FG001|3 Years Assessment|Overall Study||204||
59503801|NCT00635453|75596173|FG000|COMPLETED|Overall Study||206|6 years assessment Mother-Child Pairs|
59503802|NCT00635453|75596174|FG001|COMPLETED|Overall Study||181|6 years assessment Mother-Child Pairs|
59607719|NCT03742973|75718447|FG001|NOT COMPLETED|Overall Study||0||
59607720|NCT03742427|75718453|FG000|STARTED|Overall Study||50||
59503803|NCT00635453|75596173|FG000|NOT COMPLETED|Overall Study||154||
59503804|NCT00635453|75596174|FG001|NOT COMPLETED|Overall Study||174||
59503805|NCT02135861|75596183|FG000|STARTED|Overall Study||21||
59503806|NCT02135861|75596184|FG001|STARTED|Overall Study||12||
59503807|NCT02135861|75596185|FG002|STARTED|Overall Study||3||
59503808|NCT02135861|75596183|FG000|COMPLETED|Overall Study||21||
59503809|NCT02135861|75596184|FG001|COMPLETED|Overall Study||12||
59503810|NCT02135861|75596185|FG002|COMPLETED|Overall Study||3||
59503811|NCT02135861|75596183|FG000|NOT COMPLETED|Overall Study||0||
59503812|NCT02135861|75596184|FG001|NOT COMPLETED|Overall Study||0||
59503813|NCT02135861|75596185|FG002|NOT COMPLETED|Overall Study||0||
59503814|NCT00635609|75596197|FG000|STARTED|Overall Study||48||
59503815|NCT00635609|75596198|FG001|STARTED|Overall Study||45||
59503816|NCT00635609|75596197|FG000|COMPLETED|Overall Study||41||
59503817|NCT00635609|75596198|FG001|COMPLETED|Overall Study||42||
59503818|NCT00635609|75596197|FG000|NOT COMPLETED|Overall Study||7||
59503819|NCT00635609|75596198|FG001|NOT COMPLETED|Overall Study||3||
59503820|NCT02137499|75596208|FG000|STARTED|Overall Study||10||
59503821|NCT02137499|75596209|FG001|STARTED|Overall Study||10||
59503822|NCT02137499|75596210|FG002|STARTED|Overall Study||10||
59503823|NCT02137499|75596211|FG003|STARTED|Overall Study||10||
59503824|NCT02137499|75596208|FG000|COMPLETED|Overall Study||10||
59503825|NCT02137499|75596209|FG001|COMPLETED|Overall Study||10||
59503826|NCT02137499|75596210|FG002|COMPLETED|Overall Study||10||
59503827|NCT02137499|75596211|FG003|COMPLETED|Overall Study||10||
59503828|NCT02137499|75596208|FG000|NOT COMPLETED|Overall Study||0||
59503829|NCT02137499|75596209|FG001|NOT COMPLETED|Overall Study||0||
59503830|NCT02137499|75596210|FG002|NOT COMPLETED|Overall Study||0||
59503831|NCT02137499|75596211|FG003|NOT COMPLETED|Overall Study||0||
59503832|NCT00684047|75596224|FG000|STARTED|Overall Study||72||
59503833|NCT00684047|75596225|FG001|STARTED|Overall Study||110||
59607721|NCT03742427|75718453|FG000|COMPLETED|Overall Study||50||
59886347|NCT00092495|76009081|FG003|STARTED|Base Study Follow-up Period|Protocol amended to extend follow-up for 10-15 year old subjects to Month 12 (6 months Postdose 3)|460||
59886348|NCT00092495|76009082|FG004|STARTED|Base Study Follow-up Period||0||
59886349|NCT00092495|76009078|FG000|COMPLETED|Base Study Follow-up Period||112||
59886350|NCT00092495|76009079|FG001|COMPLETED|Base Study Follow-up Period||122||
59886351|NCT00092495|76009080|FG002|COMPLETED|Base Study Follow-up Period||126||
59886352|NCT00092495|76009081|FG003|COMPLETED|Base Study Follow-up Period||446||
59886353|NCT00092495|76009082|FG004|COMPLETED|Base Study Follow-up Period||0||
59886354|NCT00092495|76009078|FG000|NOT COMPLETED|Base Study Follow-up Period||3||
59886355|NCT00092495|76009079|FG001|NOT COMPLETED|Base Study Follow-up Period||3||
59886356|NCT00092495|76009080|FG002|NOT COMPLETED|Base Study Follow-up Period||4||
59886357|NCT00092495|76009081|FG003|NOT COMPLETED|Base Study Follow-up Period||14||
59886358|NCT00092495|76009082|FG004|NOT COMPLETED|Base Study Follow-up Period||0||
59886359|NCT00092495|76009078|FG000|STARTED|Extension Study||0||
59886360|NCT00092495|76009079|FG001|STARTED|Extension Study||0||
59886361|NCT00092495|76009080|FG002|STARTED|Extension Study||0||
59886362|NCT00092495|76009081|FG003|STARTED|Extension Study||0||
59886363|NCT00092495|76009082|FG004|STARTED|Extension Study||12||
59503834|NCT00684047|75596226|FG002|STARTED|Overall Study||57||
59607722|NCT03742427|75718453|FG000|NOT COMPLETED|Overall Study||0||
59886364|NCT00092495|76009078|FG000|COMPLETED|Extension Study||0||
59886365|NCT00092495|76009079|FG001|COMPLETED|Extension Study||0||
59886366|NCT00092495|76009080|FG002|COMPLETED|Extension Study||0||
59886367|NCT00092495|76009081|FG003|COMPLETED|Extension Study||0||
59886368|NCT00092495|76009082|FG004|COMPLETED|Extension Study||12||
59886369|NCT00092495|76009078|FG000|NOT COMPLETED|Extension Study||0||
59886370|NCT00092495|76009079|FG001|NOT COMPLETED|Extension Study||0||
59886371|NCT00092495|76009080|FG002|NOT COMPLETED|Extension Study||0||
59886372|NCT00092495|76009081|FG003|NOT COMPLETED|Extension Study||0||
59886373|NCT00092495|76009082|FG004|NOT COMPLETED|Extension Study||0||
59886374|NCT00092417|76009097|FG000|STARTED|Overall Study|Started Period Group 1|464||
59886375|NCT00092417|76009098|FG001|STARTED|Overall Study|Started Period Group 2|234||
59886376|NCT00092417|76009097|FG000|Vaccinated|Overall Study|3 participants were allocated,not vaccinated; they are not reported in the Baseline Characteristics|461||
59886377|NCT00092417|76009098|FG001|Vaccinated|Overall Study||234||
59886378|NCT00092417|76009097|FG000|COMPLETED|Overall Study|Received the higher potency zoster vaccine & completed 42 days of safety follow-up post vaccination|459||
59886379|NCT00092417|76009098|FG001|COMPLETED|Overall Study|Received the lower potency zoster vaccine & completed 42 days of safety follow-up post vaccination|233||
59886380|NCT00092417|76009097|FG000|NOT COMPLETED|Overall Study||5||
59886381|NCT00092417|76009098|FG001|NOT COMPLETED|Overall Study||1||
59886382|NCT00091949|76009106|FG000|STARTED|Overall Study||1939||
59503835|NCT00684047|75596224|FG000|COMPLETED|Overall Study||59||
59503836|NCT00684047|75596225|FG001|COMPLETED|Overall Study||94||
59503837|NCT00684047|75596226|FG002|COMPLETED|Overall Study||52||
59503838|NCT00684047|75596224|FG000|NOT COMPLETED|Overall Study||13||
59503839|NCT00684047|75596225|FG001|NOT COMPLETED|Overall Study||16||
59607723|NCT03741725|75718460|FG000|STARTED|Overall Study||101||10
59886383|NCT00091949|76009107|FG001|STARTED|Overall Study||1937||
59886384|NCT00091949|76009106|FG000|COMPLETED|Overall Study||1764||
59886385|NCT00091949|76009107|FG001|COMPLETED|Overall Study||1786||
59886386|NCT00091949|76009106|FG000|NOT COMPLETED|Overall Study||175||
59503840|NCT00684047|75596226|FG002|NOT COMPLETED|Overall Study||5||
59503841|NCT00636077|75596234|FG000|STARTED|Week 1||3||
59503842|NCT00636077|75596235|FG001|STARTED|Week 1||3||
59503843|NCT00636077|75596236|FG002|STARTED|Week 1||3||
59503844|NCT00636077|75596237|FG003|STARTED|Week 1||3||
59503845|NCT00636077|75596234|FG000|COMPLETED|Week 1||3||
59503846|NCT00636077|75596235|FG001|COMPLETED|Week 1||3||
59503847|NCT00636077|75596236|FG002|COMPLETED|Week 1||3||
59503848|NCT00636077|75596237|FG003|COMPLETED|Week 1||3||
59503849|NCT00636077|75596234|FG000|NOT COMPLETED|Week 1||0||
59503850|NCT00636077|75596235|FG001|NOT COMPLETED|Week 1||0||
59503851|NCT00636077|75596236|FG002|NOT COMPLETED|Week 1||0||
59503852|NCT00636077|75596237|FG003|NOT COMPLETED|Week 1||0||
59503853|NCT00636077|75596234|FG000|STARTED|Week 2||3||
59503854|NCT00636077|75596235|FG001|STARTED|Week 2||3||
59503855|NCT00636077|75596236|FG002|STARTED|Week 2||3||
59503856|NCT00636077|75596237|FG003|STARTED|Week 2||3||
59503857|NCT00636077|75596234|FG000|COMPLETED|Week 2||3||
59503858|NCT00636077|75596235|FG001|COMPLETED|Week 2||3||
59503859|NCT00636077|75596236|FG002|COMPLETED|Week 2||3||
59503860|NCT00636077|75596237|FG003|COMPLETED|Week 2||3||
59503861|NCT00636077|75596234|FG000|NOT COMPLETED|Week 2||0||
59503862|NCT00636077|75596235|FG001|NOT COMPLETED|Week 2||0||
59503863|NCT00636077|75596236|FG002|NOT COMPLETED|Week 2||0||
59503864|NCT00636077|75596237|FG003|NOT COMPLETED|Week 2||0||
59503865|NCT00636077|75596234|FG000|STARTED|Week 3||3||
59503866|NCT00636077|75596235|FG001|STARTED|Week 3||3||
59503867|NCT00636077|75596236|FG002|STARTED|Week 3||3||
59503868|NCT00636077|75596237|FG003|STARTED|Week 3||3||
59503869|NCT00636077|75596234|FG000|COMPLETED|Week 3||3||
59503870|NCT00636077|75596235|FG001|COMPLETED|Week 3||3||
59503871|NCT00636077|75596236|FG002|COMPLETED|Week 3||3||
59503872|NCT00636077|75596237|FG003|COMPLETED|Week 3||3||
59503873|NCT00636077|75596234|FG000|NOT COMPLETED|Week 3||0||
59503874|NCT00636077|75596235|FG001|NOT COMPLETED|Week 3||0||
59503875|NCT00636077|75596236|FG002|NOT COMPLETED|Week 3||0||
59503876|NCT00636077|75596237|FG003|NOT COMPLETED|Week 3||0||
59503877|NCT00636077|75596234|FG000|STARTED|Week 4||3||
59503878|NCT00636077|75596235|FG001|STARTED|Week 4||3||
59503879|NCT00636077|75596236|FG002|STARTED|Week 4||3||
59503880|NCT00636077|75596237|FG003|STARTED|Week 4||3||
59503881|NCT00636077|75596234|FG000|COMPLETED|Week 4||3||
59503882|NCT00636077|75596235|FG001|COMPLETED|Week 4||3||
59503883|NCT00636077|75596236|FG002|COMPLETED|Week 4||3||
59503884|NCT00636077|75596237|FG003|COMPLETED|Week 4||3||
59503885|NCT00636077|75596234|FG000|NOT COMPLETED|Week 4||0||
59503886|NCT00636077|75596235|FG001|NOT COMPLETED|Week 4||0||
59503887|NCT00636077|75596236|FG002|NOT COMPLETED|Week 4||0||
59503888|NCT00636077|75596237|FG003|NOT COMPLETED|Week 4||0||
59503889|NCT00636389|75596247|FG000|STARTED|Period 1 - 1 Week||7||
59503890|NCT00636389|75596248|FG001|STARTED|Period 1 - 1 Week||5||
59503891|NCT00636389|75596247|FG000|COMPLETED|Period 1 - 1 Week||7||
59503892|NCT00636389|75596248|FG001|COMPLETED|Period 1 - 1 Week||5||
59503893|NCT00636389|75596247|FG000|NOT COMPLETED|Period 1 - 1 Week||0||
59503894|NCT00636389|75596248|FG001|NOT COMPLETED|Period 1 - 1 Week||0||
59886387|NCT00091949|76009107|FG001|NOT COMPLETED|Overall Study||151||
59886388|NCT02258542|76009117|FG000|STARTED|Overall Study||953||
59886389|NCT02258542|76009118|FG001|STARTED|Overall Study||973||
59886390|NCT02258542|76009119|FG002|STARTED|Overall Study||100||
59886391|NCT02258542|76009120|FG003|STARTED|Overall Study||97||
59503895|NCT00636389|75596247|FG000|STARTED|Period 2 - 1 Week||7||
59503896|NCT00636389|75596248|FG001|STARTED|Period 2 - 1 Week||5||
59607724|NCT03741725|75718461|FG001|STARTED|Overall Study||100||10
59886392|NCT02258542|76009117|FG000|Treated|Overall Study||953||
59503897|NCT00636389|75596247|FG000|COMPLETED|Period 2 - 1 Week||7||
59503898|NCT00636389|75596248|FG001|COMPLETED|Period 2 - 1 Week||5||
59503899|NCT00636389|75596247|FG000|NOT COMPLETED|Period 2 - 1 Week||0||
59503900|NCT00636389|75596248|FG001|NOT COMPLETED|Period 2 - 1 Week||0||
59503901|NCT04747977|75596257|FG000|STARTED|Overall Study||57||
59503902|NCT04747977|75596258|FG001|STARTED|Overall Study||57||
59503903|NCT04747977|75596259|FG002|STARTED|Overall Study||58||
59503904|NCT04747977|75596257|FG000|COMPLETED|Overall Study||54||
59503905|NCT04747977|75596258|FG001|COMPLETED|Overall Study||56||
59503906|NCT04747977|75596259|FG002|COMPLETED|Overall Study||55||
59503907|NCT04747977|75596257|FG000|NOT COMPLETED|Overall Study||3||
59503908|NCT04747977|75596258|FG001|NOT COMPLETED|Overall Study||1||
59503909|NCT04747977|75596259|FG002|NOT COMPLETED|Overall Study||3||
59503910|NCT00636701|75596269|FG000|STARTED|Overall Study||2||
59503911|NCT00636701|75596270|FG001|STARTED|Overall Study||2||
59503912|NCT00636701|75596269|FG000|COMPLETED|Overall Study||2||
59503913|NCT00636701|75596270|FG001|COMPLETED|Overall Study||2||
59503914|NCT00636701|75596269|FG000|NOT COMPLETED|Overall Study||0||
59886393|NCT02258542|76009118|FG001|Treated|Overall Study||971||
59886394|NCT02258542|76009119|FG002|Treated|Overall Study||100||
59503915|NCT00636701|75596270|FG001|NOT COMPLETED|Overall Study||0||
59503916|NCT00637247|75596278|FG000|STARTED|Overall Study||72||
59503917|NCT00637247|75596279|FG001|STARTED|Overall Study||70||
59503918|NCT00637247|75596278|FG000|COMPLETED|Overall Study||72||
59503919|NCT00637247|75596279|FG001|COMPLETED|Overall Study||70||
59503920|NCT00637247|75596278|FG000|NOT COMPLETED|Overall Study||0||
59503921|NCT00637247|75596279|FG001|NOT COMPLETED|Overall Study||0||
59503922|NCT00684749|75596287|FG000|STARTED|Overall Study||142||
59503923|NCT00684749|75596287|FG000|COMPLETED|Overall Study||142||
59503924|NCT00684749|75596287|FG000|NOT COMPLETED|Overall Study||0||
59886395|NCT02258542|76009120|FG003|Treated|Overall Study||97||
59886396|NCT02258542|76009117|FG000|Adolescents Only|Overall Study||25||
59886397|NCT02258542|76009118|FG001|Adolescents Only|Overall Study||61||
59886398|NCT02258542|76009119|FG002|Adolescents Only|Overall Study||0||
59886399|NCT02258542|76009120|FG003|Adolescents Only|Overall Study||0||
59886400|NCT02258542|76009117|FG000|COMPLETED|Overall Study|170 enrolled into study MELTEMI|911|Include patients enrolled into study MELTEMI (study 37)|
59886401|NCT02258542|76009118|FG001|COMPLETED|Overall Study|178 enrolled into study MELTEMI|924|Include patients enrolled into study MELTEMI (study 37)|
59886402|NCT02258542|76009119|FG002|COMPLETED|Overall Study|51 enrolled into study MELTEMI|92|Include patients enrolled into study MELTEMI (study 37)|
59886403|NCT02258542|76009120|FG003|COMPLETED|Overall Study|48 enrolled into study MELTEMI|92|Include patients enrolled into study MELTEMI (study 37)|
59886404|NCT02258542|76009117|FG000|NOT COMPLETED|Overall Study||42||
59886405|NCT02258542|76009118|FG001|NOT COMPLETED|Overall Study||49||
59886406|NCT02258542|76009119|FG002|NOT COMPLETED|Overall Study||8||
59886407|NCT02258542|76009120|FG003|NOT COMPLETED|Overall Study||5||
59886408|NCT00091793|76009150|FG000|STARTED|Overall Study||166||
59886409|NCT00091793|76009151|FG001|STARTED|Overall Study||166||
59886410|NCT00091793|76009150|FG000|COMPLETED|Overall Study||142||
59886411|NCT00091793|76009151|FG001|COMPLETED|Overall Study||144||
59886412|NCT00091793|76009150|FG000|NOT COMPLETED|Overall Study||24||
59886413|NCT00091793|76009151|FG001|NOT COMPLETED|Overall Study||22||
59886414|NCT00098813|76009157|FG000|STARTED|Overall Study||20||
59886415|NCT00098813|76009157|FG000|COMPLETED|Overall Study||1||
59886416|NCT00098813|76009157|FG000|NOT COMPLETED|Overall Study||19||
59886417|NCT00090857|76009163|FG000|STARTED|Overall Study||33||
59886418|NCT00090857|76009164|FG001|STARTED|Overall Study||16||
59886419|NCT00090857|76009163|FG000|COMPLETED|Overall Study||29||
59886420|NCT00090857|76009164|FG001|COMPLETED|Overall Study||13||
59886421|NCT00090857|76009163|FG000|NOT COMPLETED|Overall Study||4||
59886422|NCT00090857|76009164|FG001|NOT COMPLETED|Overall Study||3||
59886423|NCT04259086|76009170|FG000|STARTED|Overall Study||48||
59886424|NCT04259086|76009170|FG000|COMPLETED|Overall Study||45||
59886425|NCT04259086|76009170|FG000|NOT COMPLETED|Overall Study||3||
59886426|NCT00090779|76009176|FG000|STARTED|Step 1||66||
59886427|NCT00090779|76009177|FG001|STARTED|Step 1||64||
59886428|NCT00090779|76009176|FG000|COMPLETED|Step 1|Results are based on the database frozen on July 2, 2009 per DSMB recommendation of study closure.|55||
59886429|NCT00090779|76009177|FG001|COMPLETED|Step 1|Results are based on the database frozen on July 2, 2009 per DSMB recommendation of study closure.|49||
59886430|NCT00090779|76009176|FG000|NOT COMPLETED|Step 1||11||
59886431|NCT00090779|76009177|FG001|NOT COMPLETED|Step 1||15||
59886432|NCT00090779|76009176|FG000|STARTED|Step 2|One subject who had two consecutive CD4<350cells/mm^3 did not enter step 2.|6||
59886433|NCT00090779|76009177|FG001|STARTED|Step 2|Three with two consecutive CD4<350cells/mm^3 and one with CDC category B event didn't enter step 2.|19||
59886434|NCT00090779|76009176|FG000|COMPLETED|Step 2||0||
59886435|NCT00090779|76009177|FG001|COMPLETED|Step 2||1||
59886436|NCT00090779|76009176|FG000|NOT COMPLETED|Step 2||6||
59886437|NCT00090779|76009177|FG001|NOT COMPLETED|Step 2||18||
59886438|NCT00090779|76009176|FG000|STARTED|Step 3||7||
59886439|NCT00090779|76009177|FG001|STARTED|Step 3||5||
59886440|NCT00090779|76009176|FG000|COMPLETED|Step 3||0||
59886441|NCT00090779|76009177|FG001|COMPLETED|Step 3||0||
59886442|NCT00090779|76009176|FG000|NOT COMPLETED|Step 3||7||
59886443|NCT00090779|76009177|FG001|NOT COMPLETED|Step 3||5||
59886444|NCT00098345|76009183|FG000|STARTED|Overall Study||30||
59886445|NCT00098345|76009183|FG000|COMPLETED|Overall Study|ongoing study treatment at data cut-off|17||
59886446|NCT00098345|76009183|FG000|NOT COMPLETED|Overall Study||13||
59607725|NCT03741725|75718462|FG002|STARTED|Overall Study||100||10
59607726|NCT03741725|75718460|FG000|COMPLETED|Overall Study||101||10
59607727|NCT03741725|75718461|FG001|COMPLETED|Overall Study||100||10
59607728|NCT03741725|75718462|FG002|COMPLETED|Overall Study||100||10
59607729|NCT03741725|75718460|FG000|NOT COMPLETED|Overall Study||0||0
59607730|NCT03741725|75718461|FG001|NOT COMPLETED|Overall Study||0||0
59607731|NCT03741725|75718462|FG002|NOT COMPLETED|Overall Study||0||0
59607732|NCT00825227|75718475|FG000|STARTED|Overall Study||6||
59607733|NCT00825227|75718476|FG001|STARTED|Overall Study||4||
59607734|NCT00825227|75718475|FG000|COMPLETED|Overall Study||6||
59607735|NCT00825227|75718476|FG001|COMPLETED|Overall Study||4||
59607736|NCT00825227|75718475|FG000|NOT COMPLETED|Overall Study||0||
59607737|NCT00825227|75718476|FG001|NOT COMPLETED|Overall Study||0||
59607738|NCT01978535|75718486|FG000|STARTED|Overall Study||1||
59607739|NCT01978535|75718487|FG001|STARTED|Overall Study||2||
59607740|NCT01978535|75718486|FG000|COMPLETED|Overall Study||1||
59607741|NCT01978535|75718487|FG001|COMPLETED|Overall Study||2||
59886447|NCT02224456|76009187|FG000|STARTED|Overall Study||197||
59886448|NCT02224456|76009187|FG000|COMPLETED|Overall Study||161||
59503925|NCT02980731|75596291|FG000|STARTED|Overall Study||210||
59503926|NCT02980731|75596291|FG000|COMPLETED|Overall Study||0||
59503927|NCT02980731|75596291|FG000|NOT COMPLETED|Overall Study||210||
59503928|NCT02294253|75596295|FG000|STARTED|Overall Study||30||
59503929|NCT02294253|75596295|FG000|COMPLETED|Overall Study||15||
59503930|NCT02294253|75596295|FG000|NOT COMPLETED|Overall Study||15||
59503931|NCT02295735|75596301|FG000|STARTED|Overall Study||238||
59503932|NCT02295735|75596302|FG001|STARTED|Overall Study||237||
59503933|NCT02295735|75596301|FG000|COMPLETED|Overall Study||212||
59503934|NCT02295735|75596302|FG001|COMPLETED|Overall Study||210||
59503935|NCT02295735|75596301|FG000|NOT COMPLETED|Overall Study||26||
59886449|NCT02224456|76009187|FG000|NOT COMPLETED|Overall Study||36||
59886450|NCT00097721|76009193|FG000|STARTED|Overall Study|The number started is all enrolled subjects.BL Characteristics consists of Safety Population.|71||
59886451|NCT00097721|76009194|FG001|STARTED|Overall Study||33||
59886452|NCT00097721|76009193|FG000|COMPLETED|Overall Study||0||
59886453|NCT00097721|76009194|FG001|COMPLETED|Overall Study||0||
59886454|NCT00097721|76009193|FG000|NOT COMPLETED|Overall Study||71||
59886455|NCT00097721|76009194|FG001|NOT COMPLETED|Overall Study||33||
59886456|NCT03553498|76009202|FG000|STARTED|Overall Study||81||
59886457|NCT03553498|76009203|FG001|STARTED|Overall Study||81||
59886458|NCT03553498|76009202|FG000|COMPLETED|Overall Study||80||
59886459|NCT03553498|76009203|FG001|COMPLETED|Overall Study||79||
59886460|NCT03553498|76009202|FG000|NOT COMPLETED|Overall Study||1||
59886461|NCT03553498|76009203|FG001|NOT COMPLETED|Overall Study||2||
59886462|NCT00096941|76009209|FG000|STARTED|Overall Study||3||
59886463|NCT00096941|76009209|FG000|COMPLETED|Overall Study||0||
59886464|NCT00096941|76009209|FG000|NOT COMPLETED|Overall Study||3||
59886465|NCT00096785|76009215|FG000|STARTED|Overall Study|1 participant randomized to ADV, treated with ETV. (As randomized= 35; as treated=36)|35||
59886466|NCT00096785|76009216|FG001|STARTED|Overall Study|1 participant randomized to ADV, treated with ETV. (As randomized= 34; as treated=33)|34||
59886467|NCT00096785|76009215|FG000|As-Randomized Population|Overall Study||35||
59886468|NCT00096785|76009216|FG001|As-Randomized Population|Overall Study||34||
59886469|NCT00096785|76009215|FG000|As-Treated Population|Overall Study||36||
59886470|NCT00096785|76009216|FG001|As-Treated Population|Overall Study||33||
59886471|NCT00096785|76009215|FG000|COMPLETED|Overall Study|As randomized cohort|33||
59886472|NCT00096785|76009216|FG001|COMPLETED|Overall Study|As randomized cohort|33||
59886473|NCT00096785|76009215|FG000|NOT COMPLETED|Overall Study||2||
59886474|NCT00096785|76009216|FG001|NOT COMPLETED|Overall Study||1||
59886475|NCT03515044|76009227|FG000|STARTED|Double-Blind Period||15||
59886476|NCT03515044|76009228|FG001|STARTED|Double-Blind Period||15||
59886477|NCT03515044|76009229|FG002|STARTED|Double-Blind Period||14||
59886478|NCT03515044|76009230|FG003|STARTED|Double-Blind Period||13||
59886479|NCT03515044|76009231|FG004|STARTED|Double-Blind Period||14||
59886480|NCT03515044|76009232|FG005|STARTED|Double-Blind Period||0||
59886481|NCT03515044|76009227|FG000|COMPLETED|Double-Blind Period||13||
59503936|NCT02295735|75596302|FG001|NOT COMPLETED|Overall Study||27||
59886482|NCT03515044|76009228|FG001|COMPLETED|Double-Blind Period||13||
59886483|NCT03515044|76009229|FG002|COMPLETED|Double-Blind Period||8||
59886484|NCT03515044|76009230|FG003|COMPLETED|Double-Blind Period||11||
59886485|NCT03515044|76009231|FG004|COMPLETED|Double-Blind Period||8||
59886486|NCT03515044|76009232|FG005|COMPLETED|Double-Blind Period||0||
59886487|NCT03515044|76009227|FG000|NOT COMPLETED|Double-Blind Period||2||
59886488|NCT03515044|76009228|FG001|NOT COMPLETED|Double-Blind Period||2||
59886489|NCT03515044|76009229|FG002|NOT COMPLETED|Double-Blind Period||6||
59886490|NCT03515044|76009230|FG003|NOT COMPLETED|Double-Blind Period||2||
59886491|NCT03515044|76009231|FG004|NOT COMPLETED|Double-Blind Period||6||
59886492|NCT03515044|76009232|FG005|NOT COMPLETED|Double-Blind Period||0||
59886493|NCT03515044|76009227|FG000|STARTED|Open-label Extension Period||0||
59886494|NCT03515044|76009228|FG001|STARTED|Open-label Extension Period||0||
59886495|NCT03515044|76009229|FG002|STARTED|Open-label Extension Period||0||
59886496|NCT03515044|76009230|FG003|STARTED|Open-label Extension Period||0||
60013535|NCT02482935|76129450|FG001|Received Abemaciclib|Period 1||15||
59503937|NCT00684983|75596310|FG000|STARTED|Overall Study||19||
59503938|NCT00684983|75596311|FG001|STARTED|Overall Study||45||
59503939|NCT00684983|75596310|FG000|COMPLETED|Overall Study||19||
59886497|NCT03515044|76009231|FG004|STARTED|Open-label Extension Period||0||
59886498|NCT03515044|76009232|FG005|STARTED|Open-label Extension Period||53||
59886499|NCT03515044|76009227|FG000|COMPLETED|Open-label Extension Period||0||
59886500|NCT03515044|76009228|FG001|COMPLETED|Open-label Extension Period||0||
59503940|NCT00684983|75596311|FG001|COMPLETED|Overall Study|One major violation patient in Arm B is included in the primary analysis per protocol.|45||
59503941|NCT00684983|75596310|FG000|NOT COMPLETED|Overall Study||0||
59503942|NCT00684983|75596311|FG001|NOT COMPLETED|Overall Study||0||
59503943|NCT02337218|75596321|FG000|STARTED|Overall Study||17||
59503944|NCT02337218|75596322|FG001|STARTED|Overall Study||11||
59503945|NCT02337218|75596321|FG000|COMPLETED|Overall Study||17||
59503946|NCT02337218|75596322|FG001|COMPLETED|Overall Study||11||
59503947|NCT02337218|75596321|FG000|NOT COMPLETED|Overall Study||0||
59503948|NCT02337218|75596322|FG001|NOT COMPLETED|Overall Study||0||
59503949|NCT02641587|75596331|FG000|STARTED|Confinement Period||80||
59503950|NCT02641587|75596332|FG001|STARTED|Confinement Period||40||
59503951|NCT02641587|75596331|FG000|COMPLETED|Confinement Period||77||
59503952|NCT02641587|75596332|FG001|COMPLETED|Confinement Period||39||
59503953|NCT02641587|75596331|FG000|NOT COMPLETED|Confinement Period||3||
59503954|NCT02641587|75596332|FG001|NOT COMPLETED|Confinement Period||1||
59503955|NCT02641587|75596331|FG000|STARTED|Ambulatory Period||77||
59503956|NCT02641587|75596332|FG001|STARTED|Ambulatory Period||39||
59503957|NCT02641587|75596331|FG000|COMPLETED|Ambulatory Period||76||
59503958|NCT02641587|75596332|FG001|COMPLETED|Ambulatory Period||39||
59503959|NCT02641587|75596331|FG000|NOT COMPLETED|Ambulatory Period||1||
59503960|NCT02641587|75596332|FG001|NOT COMPLETED|Ambulatory Period||0||
59503961|NCT00638651|75596345|FG000|STARTED|Overall Study||3||
59503962|NCT00638651|75596345|FG000|COMPLETED|Overall Study||3||
59503963|NCT00638651|75596345|FG000|NOT COMPLETED|Overall Study||0||
59503964|NCT00685139|75596350|FG000|STARTED|First Intervention||17||
59503965|NCT00685139|75596351|FG001|STARTED|First Intervention||17||
59503966|NCT00685139|75596350|FG000|COMPLETED|First Intervention||17||
59503967|NCT00685139|75596351|FG001|COMPLETED|First Intervention||17||
59503968|NCT00685139|75596350|FG000|NOT COMPLETED|First Intervention||0||
59503969|NCT00685139|75596351|FG001|NOT COMPLETED|First Intervention||0||
59503970|NCT00685139|75596350|FG000|STARTED|Washout Period of 28 Days||17||
59503971|NCT00685139|75596351|FG001|STARTED|Washout Period of 28 Days||17||
59503972|NCT00685139|75596350|FG000|COMPLETED|Washout Period of 28 Days||17||
59503973|NCT00685139|75596351|FG001|COMPLETED|Washout Period of 28 Days||17||
59503974|NCT00685139|75596350|FG000|NOT COMPLETED|Washout Period of 28 Days||0||
59503975|NCT00685139|75596351|FG001|NOT COMPLETED|Washout Period of 28 Days||0||
59503976|NCT00685139|75596350|FG000|STARTED|Second Intervention||17||
59503977|NCT00685139|75596351|FG001|STARTED|Second Intervention||17||
59503978|NCT00685139|75596350|FG000|COMPLETED|Second Intervention||17||
59503979|NCT00685139|75596351|FG001|COMPLETED|Second Intervention||17||
59503980|NCT00685139|75596350|FG000|NOT COMPLETED|Second Intervention||0||
59503981|NCT00685139|75596351|FG001|NOT COMPLETED|Second Intervention||0||
59503982|NCT03338036|75596361|FG000|STARTED|Overall Study||0||
59503983|NCT03338036|75596362|FG001|STARTED|Overall Study||11||
59503984|NCT03338036|75596363|FG002|STARTED|Overall Study||12||
59503985|NCT03338036|75596364|FG003|STARTED|Overall Study||8||
59503986|NCT03338036|75596361|FG000|COMPLETED|Overall Study||0||
59503987|NCT03338036|75596362|FG001|COMPLETED|Overall Study||7||
59503988|NCT03338036|75596363|FG002|COMPLETED|Overall Study||9||
59503989|NCT03338036|75596364|FG003|COMPLETED|Overall Study||8||
59503990|NCT03338036|75596361|FG000|NOT COMPLETED|Overall Study||0||
59503991|NCT03338036|75596362|FG001|NOT COMPLETED|Overall Study||4||
59503992|NCT03338036|75596363|FG002|NOT COMPLETED|Overall Study||3||
59503993|NCT03338036|75596364|FG003|NOT COMPLETED|Overall Study||0||
59503994|NCT00685295|75596374|FG000|STARTED|Overall Study||30||
59503995|NCT00685295|75596375|FG001|STARTED|Overall Study||30||
59503996|NCT00685295|75596374|FG000|COMPLETED|Overall Study||30||
59503997|NCT00685295|75596375|FG001|COMPLETED|Overall Study||30||
59503998|NCT00685295|75596374|FG000|NOT COMPLETED|Overall Study||0||
59503999|NCT00685295|75596375|FG001|NOT COMPLETED|Overall Study||0||
59504000|NCT00686231|75596383|FG000|STARTED|Dose Test - Visit 1||12||
59504001|NCT00686231|75596384|FG001|STARTED|Dose Test - Visit 1||7||
59504002|NCT00686231|75596385|FG002|STARTED|Dose Test - Visit 1||0||
59504003|NCT00686231|75596386|FG003|STARTED|Dose Test - Visit 1||0||
59504004|NCT00686231|75596383|FG000|COMPLETED|Dose Test - Visit 1||12||
59504005|NCT00686231|75596384|FG001|COMPLETED|Dose Test - Visit 1||7||
59504006|NCT00686231|75596385|FG002|COMPLETED|Dose Test - Visit 1||0||
59504007|NCT00686231|75596386|FG003|COMPLETED|Dose Test - Visit 1||0||
59504008|NCT00686231|75596383|FG000|NOT COMPLETED|Dose Test - Visit 1||0||
59504009|NCT00686231|75596384|FG001|NOT COMPLETED|Dose Test - Visit 1||0||
59504010|NCT00686231|75596385|FG002|NOT COMPLETED|Dose Test - Visit 1||0||
59504011|NCT00686231|75596386|FG003|NOT COMPLETED|Dose Test - Visit 1||0||
59504012|NCT00686231|75596383|FG000|STARTED|Combination Test - Visit 2||0||
59504013|NCT00686231|75596384|FG001|STARTED|Combination Test - Visit 2||0||
59504014|NCT00686231|75596385|FG002|STARTED|Combination Test - Visit 2||10||
59504015|NCT00686231|75596386|FG003|STARTED|Combination Test - Visit 2||9||
59504016|NCT00686231|75596383|FG000|COMPLETED|Combination Test - Visit 2||0||
59504017|NCT00686231|75596384|FG001|COMPLETED|Combination Test - Visit 2||0||
59504018|NCT00686231|75596385|FG002|COMPLETED|Combination Test - Visit 2||10||
59504019|NCT00686231|75596386|FG003|COMPLETED|Combination Test - Visit 2||9||
59504020|NCT00686231|75596383|FG000|NOT COMPLETED|Combination Test - Visit 2||0||
59504021|NCT00686231|75596384|FG001|NOT COMPLETED|Combination Test - Visit 2||0||
59504022|NCT00686231|75596385|FG002|NOT COMPLETED|Combination Test - Visit 2||0||
59504023|NCT00686231|75596386|FG003|NOT COMPLETED|Combination Test - Visit 2||0||
59504024|NCT00638885|75596396|FG000|STARTED|Overall Study||142||
59504025|NCT00638885|75596396|FG000|COMPLETED|Overall Study||142||
59504026|NCT00638885|75596396|FG000|NOT COMPLETED|Overall Study||0||
59504027|NCT03335774|75596402|FG000|STARTED|Overall Study||51||
59950963|NCT01668004|76069883|FG000|STARTED|Overall Study||101||
59504028|NCT03335774|75596403|FG001|STARTED|Overall Study||52||
59504029|NCT03335774|75596402|FG000|COMPLETED|Overall Study||50||
59504030|NCT03335774|75596403|FG001|COMPLETED|Overall Study||51||
59504031|NCT03335774|75596402|FG000|NOT COMPLETED|Overall Study||1||
59504032|NCT03335774|75596403|FG001|NOT COMPLETED|Overall Study||1||
59504033|NCT00643097|75596412|FG000|STARTED|Overall Study||18||
59504034|NCT00643097|75596413|FG001|STARTED|Overall Study||12||
59504035|NCT00643097|75596414|FG002|STARTED|Overall Study||10||
59504036|NCT00643097|75596412|FG000|COMPLETED|Overall Study||18||
59504037|NCT00643097|75596413|FG001|COMPLETED|Overall Study||12||
59504038|NCT00643097|75596414|FG002|COMPLETED|Overall Study||10||
59504039|NCT00643097|75596412|FG000|NOT COMPLETED|Overall Study||0||
59504040|NCT00643097|75596413|FG001|NOT COMPLETED|Overall Study||0||
59504041|NCT00643097|75596414|FG002|NOT COMPLETED|Overall Study||0||
59504042|NCT02302365|75596422|FG000|STARTED|0-2 Hour Period|Data were collected from 58 WBCD procedures performed in 43 subjects - Full and Safety Analysis Sets|43||
59504043|NCT02302365|75596422|FG000|COMPLETED|0-2 Hour Period|The Per-protocol Analysis Set comprised 54 procedures performed in 41 subjects|41||
59504044|NCT02302365|75596422|FG000|NOT COMPLETED|0-2 Hour Period||2||
59504045|NCT02302365|75596422|FG000|STARTED|0-24 Hour Period|2 of 3 study sites collected additional safety data; 32 pts. 0-24 hour data, 43 pts. 0-2 hour data|32||
59504046|NCT02302365|75596422|FG000|COMPLETED|0-24 Hour Period||32||
59504047|NCT02302365|75596422|FG000|NOT COMPLETED|0-24 Hour Period||0||
59504048|NCT03793439|75596430|FG000|STARTED|Overall Study||5||
59504049|NCT03793439|75596430|FG000|COMPLETED|Overall Study||3||
59504050|NCT03793439|75596430|FG000|NOT COMPLETED|Overall Study||2||
59504051|NCT04672083|75596439|FG000|STARTED|Overall Study||6||
59504052|NCT04672083|75596440|FG001|STARTED|Overall Study||6||
59504053|NCT04672083|75596441|FG002|STARTED|Overall Study||6||
59607742|NCT01978535|75718486|FG000|NOT COMPLETED|Overall Study||0||
59607743|NCT01978535|75718487|FG001|NOT COMPLETED|Overall Study||0||
59607744|NCT00808769|75718493|FG000|STARTED|First Intervention||15||
59607745|NCT00808769|75718494|FG001|STARTED|First Intervention||15||
59504054|NCT04672083|75596442|FG003|STARTED|Overall Study||6||
59504055|NCT04672083|75596443|FG004|STARTED|Overall Study||8||
59504056|NCT04672083|75596439|FG000|COMPLETED|Overall Study||5||
59504057|NCT04672083|75596440|FG001|COMPLETED|Overall Study||6||
59504058|NCT04672083|75596441|FG002|COMPLETED|Overall Study||6||
59504059|NCT04672083|75596442|FG003|COMPLETED|Overall Study||6||
59504060|NCT04672083|75596443|FG004|COMPLETED|Overall Study||8||
59504061|NCT04672083|75596439|FG000|NOT COMPLETED|Overall Study||1||
59504062|NCT04672083|75596440|FG001|NOT COMPLETED|Overall Study||0||
59504063|NCT04672083|75596441|FG002|NOT COMPLETED|Overall Study||0||
59607746|NCT00808769|75718493|FG000|COMPLETED|First Intervention||15||
59504064|NCT04672083|75596442|FG003|NOT COMPLETED|Overall Study||0||
59504065|NCT04672083|75596443|FG004|NOT COMPLETED|Overall Study||0||
59504066|NCT00687167|75596456|FG000|STARTED|First Intervention||17||
59504067|NCT00687167|75596457|FG001|STARTED|First Intervention||17||
59504068|NCT00687167|75596456|FG000|COMPLETED|First Intervention||17||
59504069|NCT00687167|75596457|FG001|COMPLETED|First Intervention||17||
59504070|NCT00687167|75596456|FG000|NOT COMPLETED|First Intervention||0||
59504071|NCT00687167|75596457|FG001|NOT COMPLETED|First Intervention||0||
59504072|NCT00687167|75596456|FG000|STARTED|Washout Period of 28 Days||17||
59504073|NCT00687167|75596457|FG001|STARTED|Washout Period of 28 Days||17||
59504074|NCT00687167|75596456|FG000|COMPLETED|Washout Period of 28 Days||17||
59504075|NCT00687167|75596457|FG001|COMPLETED|Washout Period of 28 Days||17||
59504076|NCT00687167|75596456|FG000|NOT COMPLETED|Washout Period of 28 Days||0||
59504077|NCT00687167|75596457|FG001|NOT COMPLETED|Washout Period of 28 Days||0||
59504078|NCT00687167|75596456|FG000|STARTED|Second Intervention||17||
59504079|NCT00687167|75596457|FG001|STARTED|Second Intervention||17||
59504080|NCT00687167|75596456|FG000|COMPLETED|Second Intervention||17||
59504081|NCT00687167|75596457|FG001|COMPLETED|Second Intervention||17||
59504082|NCT00687167|75596456|FG000|NOT COMPLETED|Second Intervention||0||
59504083|NCT00687167|75596457|FG001|NOT COMPLETED|Second Intervention||0||
59504084|NCT00687713|75596465|FG000|STARTED|Overall Study||100||
59504085|NCT00687713|75596466|FG001|STARTED|Overall Study||104||
59504086|NCT00687713|75596465|FG000|COMPLETED|Overall Study||68||
59504087|NCT00687713|75596466|FG001|COMPLETED|Overall Study||64||
59504088|NCT00687713|75596465|FG000|NOT COMPLETED|Overall Study||32||
59504089|NCT00687713|75596466|FG001|NOT COMPLETED|Overall Study||40||
59504090|NCT02304159|75596476|FG000|STARTED|Overall Study||21||
59504091|NCT02304159|75596477|FG001|STARTED|Overall Study||18||
59504092|NCT02304159|75596476|FG000|COMPLETED|Overall Study||19||
59504093|NCT02304159|75596477|FG001|COMPLETED|Overall Study||16||
59504094|NCT02304159|75596476|FG000|NOT COMPLETED|Overall Study||2||
59504095|NCT02304159|75596477|FG001|NOT COMPLETED|Overall Study||2||
59504096|NCT02143973|75596483|FG000|STARTED|Overall Study||167||
59504097|NCT02143973|75596483|FG000|COMPLETED|Overall Study||101||
59504098|NCT02143973|75596483|FG000|NOT COMPLETED|Overall Study||66||
59504099|NCT00689819|75596489|FG000|STARTED|Overall Study||65||
59504100|NCT00689819|75596490|FG001|STARTED|Overall Study||58||
59504101|NCT00689819|75596489|FG000|COMPLETED|Overall Study||45||
59504102|NCT00689819|75596490|FG001|COMPLETED|Overall Study||43||
59504103|NCT00689819|75596489|FG000|NOT COMPLETED|Overall Study||20||
59504104|NCT00689819|75596490|FG001|NOT COMPLETED|Overall Study||15||
59504105|NCT00690833|75596496|FG000|STARTED|Overall Study||41||
59504106|NCT00690833|75596496|FG000|COMPLETED|Overall Study||39||
59504107|NCT00690833|75596496|FG000|NOT COMPLETED|Overall Study||2||
59504108|NCT00644657|75596500|FG000|STARTED|Overall Study||27||
59504109|NCT00644657|75596500|FG000|COMPLETED|Overall Study||27||
59504110|NCT00644657|75596500|FG000|NOT COMPLETED|Overall Study||0||
59504111|NCT00645047|75596506|FG000|STARTED|Overall Study||103||
59504112|NCT00645047|75596507|FG001|STARTED|Overall Study||104||
59504113|NCT00645047|75596506|FG000|Post|Overall Study||74||
59504114|NCT00645047|75596507|FG001|Post|Overall Study||80||
59504115|NCT00645047|75596506|FG000|COMPLETED|Overall Study|6 month follow up|60||
59504116|NCT00645047|75596507|FG001|COMPLETED|Overall Study||65||
59504117|NCT00645047|75596506|FG000|NOT COMPLETED|Overall Study||43||
59504118|NCT00645047|75596507|FG001|NOT COMPLETED|Overall Study||39||
59504119|NCT00645827|75596515|FG000|STARTED|Overall Study||14||
59504120|NCT00645827|75596516|FG001|STARTED|Overall Study||17||
59504121|NCT00645827|75596515|FG000|COMPLETED|Overall Study||14||
59504122|NCT00645827|75596516|FG001|COMPLETED|Overall Study||17||
59504123|NCT00645827|75596515|FG000|NOT COMPLETED|Overall Study||0||
59504124|NCT00645827|75596516|FG001|NOT COMPLETED|Overall Study||0||
59504125|NCT02144519|75596524|FG000|STARTED|Year 1||895||10
59504126|NCT02144519|75596525|FG001|STARTED|Year 1||870||10
59607747|NCT00808769|75718494|FG001|COMPLETED|First Intervention||15||
59607748|NCT00808769|75718493|FG000|NOT COMPLETED|First Intervention||0||
59607749|NCT00808769|75718494|FG001|NOT COMPLETED|First Intervention||0||
59607750|NCT00808769|75718493|FG000|STARTED|Second Intervention||15||
59607751|NCT00808769|75718494|FG001|STARTED|Second Intervention||15||
59504127|NCT02144519|75596524|FG000|COMPLETED|Year 1||895||10
59504128|NCT02144519|75596525|FG001|COMPLETED|Year 1||870||10
59504129|NCT02144519|75596524|FG000|NOT COMPLETED|Year 1||0||0
59607752|NCT00808769|75718493|FG000|COMPLETED|Second Intervention||15||
59607753|NCT00808769|75718494|FG001|COMPLETED|Second Intervention||15||
59755703|NCT02937116|75874804|FG003|STARTED|Overall Study||3||
59504130|NCT02144519|75596525|FG001|NOT COMPLETED|Year 1||0||0
59504131|NCT02144519|75596524|FG000|STARTED|Year 2||763||10
59504132|NCT02144519|75596525|FG001|STARTED|Year 2||864||10
59504133|NCT02144519|75596524|FG000|COMPLETED|Year 2||763||10
59504134|NCT02144519|75596525|FG001|COMPLETED|Year 2||864||10
59504135|NCT02144519|75596524|FG000|NOT COMPLETED|Year 2||0||0
59504136|NCT02144519|75596525|FG001|NOT COMPLETED|Year 2||0||0
59504137|NCT02144519|75596524|FG000|STARTED|Year 3||894||10
59504138|NCT02144519|75596525|FG001|STARTED|Year 3||760||10
59504139|NCT02144519|75596524|FG000|COMPLETED|Year 3||894||10
59607754|NCT00808769|75718493|FG000|NOT COMPLETED|Second Intervention||0||
59607755|NCT00808769|75718494|FG001|NOT COMPLETED|Second Intervention||0||
59607756|NCT01974635|75718500|FG000|STARTED|Overall Study||2||
59504140|NCT02144519|75596525|FG001|COMPLETED|Year 3||760||10
59504141|NCT02144519|75596524|FG000|NOT COMPLETED|Year 3||0||0
59504142|NCT02144519|75596525|FG001|NOT COMPLETED|Year 3||0||0
59504143|NCT00646763|75596533|FG000|STARTED|Overall Study||18||
59504144|NCT00646763|75596534|FG001|STARTED|Overall Study||17||
59504145|NCT00646763|75596533|FG000|COMPLETED|Overall Study||18||
59504146|NCT00646763|75596534|FG001|COMPLETED|Overall Study||17||
59504147|NCT00646763|75596533|FG000|NOT COMPLETED|Overall Study||0||
59504148|NCT00646763|75596534|FG001|NOT COMPLETED|Overall Study||0||
59504149|NCT00649961|75596540|FG000|STARTED|Overall Study||18||
59504150|NCT00649961|75596540|FG000|COMPLETED|Overall Study||18||
59504151|NCT00649961|75596540|FG000|NOT COMPLETED|Overall Study||0||
59504152|NCT01781637|75596546|FG000|STARTED|Overall Study||28||
59504153|NCT01781637|75596547|FG001|STARTED|Overall Study||8||
59504154|NCT01781637|75596546|FG000|COMPLETED|Overall Study||24||
59504155|NCT01781637|75596547|FG001|COMPLETED|Overall Study||2||
59504156|NCT01781637|75596546|FG000|NOT COMPLETED|Overall Study||4||
59504157|NCT01781637|75596547|FG001|NOT COMPLETED|Overall Study||6||
59504158|NCT00652145|75596555|FG000|STARTED|Overall Study||26||
59504159|NCT00652145|75596556|FG001|STARTED|Overall Study||26||
59504160|NCT00652145|75596555|FG000|COMPLETED|Overall Study||26||
59504161|NCT00652145|75596556|FG001|COMPLETED|Overall Study||26||
59504162|NCT00652145|75596555|FG000|NOT COMPLETED|Overall Study||0||
59504163|NCT00652145|75596556|FG001|NOT COMPLETED|Overall Study||0||
59504164|NCT03241589|75596566|FG000|STARTED|Overall Study||109||
59504165|NCT03241589|75596567|FG001|STARTED|Overall Study||357||
59504166|NCT03241589|75596566|FG000|COMPLETED|Overall Study||109||
59504167|NCT03241589|75596567|FG001|COMPLETED|Overall Study||357||
59504168|NCT03241589|75596566|FG000|NOT COMPLETED|Overall Study||0||
59504169|NCT03241589|75596567|FG001|NOT COMPLETED|Overall Study||0||
59504170|NCT02298933|75596575|FG000|STARTED|Overall Study||10||
59504171|NCT02298933|75596575|FG000|COMPLETED|Overall Study||10||
59504172|NCT02298933|75596575|FG000|NOT COMPLETED|Overall Study||0||
59504173|NCT02959775|75596582|FG000|STARTED|Overall Study||160||
59504174|NCT02959775|75596583|FG001|STARTED|Overall Study||160||
59504175|NCT02959775|75596584|FG002|STARTED|Overall Study||160||
59504176|NCT02959775|75596582|FG000|COMPLETED|Overall Study||133||
59504177|NCT02959775|75596583|FG001|COMPLETED|Overall Study||133||
59504178|NCT02959775|75596584|FG002|COMPLETED|Overall Study||124||
59504179|NCT02959775|75596582|FG000|NOT COMPLETED|Overall Study||27||
59504180|NCT02959775|75596583|FG001|NOT COMPLETED|Overall Study||27||
59504181|NCT02959775|75596584|FG002|NOT COMPLETED|Overall Study||36||
59504182|NCT02334267|75596595|FG000|STARTED|Overall Study||6||
59504183|NCT02334267|75596596|FG001|STARTED|Overall Study||5||
59504184|NCT02334267|75596595|FG000|COMPLETED|Overall Study||5||
59504185|NCT02334267|75596596|FG001|COMPLETED|Overall Study||5||
59504186|NCT02334267|75596595|FG000|NOT COMPLETED|Overall Study||1||
59504187|NCT02334267|75596596|FG001|NOT COMPLETED|Overall Study||0||
59504188|NCT00693485|75596611|FG000|STARTED|Overall Study||25||
59504189|NCT00693485|75596612|FG001|STARTED|Overall Study||21||
59504190|NCT00693485|75596613|FG002|STARTED|Overall Study||24||
59504191|NCT00693485|75596611|FG000|COMPLETED|Overall Study||25||
59504192|NCT00693485|75596612|FG001|COMPLETED|Overall Study||19||
59504193|NCT00693485|75596613|FG002|COMPLETED|Overall Study||24||
59504194|NCT00693485|75596611|FG000|NOT COMPLETED|Overall Study||0||
59504195|NCT00693485|75596612|FG001|NOT COMPLETED|Overall Study||2||
59504196|NCT00693485|75596613|FG002|NOT COMPLETED|Overall Study||0||
59504197|NCT00693719|75596621|FG000|STARTED|Overall Study||31||
59504198|NCT00693719|75596621|FG000|COMPLETED|Overall Study||31||
59504199|NCT00693719|75596621|FG000|NOT COMPLETED|Overall Study||0||
59504200|NCT00653861|75596625|FG000|STARTED|Overall Study||72||
59504201|NCT00653861|75596625|FG000|COMPLETED|Overall Study||72||
59504202|NCT00653861|75596625|FG000|NOT COMPLETED|Overall Study||0||
59504203|NCT00654329|75596638|FG000|STARTED|Overall Study||23||
59504204|NCT00654329|75596639|FG001|STARTED|Overall Study||28||
59504205|NCT00654329|75596640|FG002|STARTED|Overall Study||23||
59504206|NCT00654329|75596641|FG003|STARTED|Overall Study||27||
59504207|NCT00654329|75596638|FG000|COMPLETED|Overall Study||23||
59504208|NCT00654329|75596639|FG001|COMPLETED|Overall Study||28||
59504209|NCT00654329|75596640|FG002|COMPLETED|Overall Study||23||
59504210|NCT00654329|75596641|FG003|COMPLETED|Overall Study||27||
59504211|NCT00654329|75596638|FG000|NOT COMPLETED|Overall Study||0||
59504212|NCT00654329|75596639|FG001|NOT COMPLETED|Overall Study||0||
59504213|NCT00654329|75596640|FG002|NOT COMPLETED|Overall Study||0||
59504214|NCT00654329|75596641|FG003|NOT COMPLETED|Overall Study||0||
59504215|NCT00695435|75596651|FG000|STARTED|Overall Study||7||
59886501|NCT03515044|76009229|FG002|COMPLETED|Open-label Extension Period||0||
59886502|NCT03515044|76009230|FG003|COMPLETED|Open-label Extension Period||0||
59886503|NCT03515044|76009231|FG004|COMPLETED|Open-label Extension Period||0||
59886504|NCT03515044|76009232|FG005|COMPLETED|Open-label Extension Period||31||
59886505|NCT03515044|76009227|FG000|NOT COMPLETED|Open-label Extension Period||0||
59886506|NCT03515044|76009228|FG001|NOT COMPLETED|Open-label Extension Period||0||
59886507|NCT03515044|76009229|FG002|NOT COMPLETED|Open-label Extension Period||0||
59886508|NCT03515044|76009230|FG003|NOT COMPLETED|Open-label Extension Period||0||
59886509|NCT03515044|76009231|FG004|NOT COMPLETED|Open-label Extension Period||0||
59886510|NCT03515044|76009232|FG005|NOT COMPLETED|Open-label Extension Period||22||
59886511|NCT03285178|76009251|FG000|STARTED|Single-Blind Run-In Period||88||
59886512|NCT03285178|76009252|FG001|STARTED|Single-Blind Run-In Period||0||
59886513|NCT03285178|76009253|FG002|STARTED|Single-Blind Run-In Period||0||
59886514|NCT03285178|76009254|FG003|STARTED|Single-Blind Run-In Period||0||
59886515|NCT03285178|76009255|FG004|STARTED|Single-Blind Run-In Period||0||
59886516|NCT03285178|76009256|FG005|STARTED|Single-Blind Run-In Period||0||
59886517|NCT03285178|76009257|FG006|STARTED|Single-Blind Run-In Period||0||
59886518|NCT03285178|76009251|FG000|COMPLETED|Single-Blind Run-In Period||70||
59886519|NCT03285178|76009252|FG001|COMPLETED|Single-Blind Run-In Period||0||
59886520|NCT03285178|76009253|FG002|COMPLETED|Single-Blind Run-In Period||0||
59886521|NCT03285178|76009254|FG003|COMPLETED|Single-Blind Run-In Period||0||
59886522|NCT03285178|76009255|FG004|COMPLETED|Single-Blind Run-In Period||0||
59886523|NCT03285178|76009256|FG005|COMPLETED|Single-Blind Run-In Period||0||
59886524|NCT03285178|76009257|FG006|COMPLETED|Single-Blind Run-In Period||0||
59886525|NCT03285178|76009251|FG000|NOT COMPLETED|Single-Blind Run-In Period||18||
59886526|NCT03285178|76009252|FG001|NOT COMPLETED|Single-Blind Run-In Period||0||
59886527|NCT03285178|76009253|FG002|NOT COMPLETED|Single-Blind Run-In Period||0||
59886528|NCT03285178|76009254|FG003|NOT COMPLETED|Single-Blind Run-In Period||0||
59886529|NCT03285178|76009255|FG004|NOT COMPLETED|Single-Blind Run-In Period||0||
59886530|NCT03285178|76009256|FG005|NOT COMPLETED|Single-Blind Run-In Period||0||
59886531|NCT03285178|76009257|FG006|NOT COMPLETED|Single-Blind Run-In Period||0||
59886532|NCT03285178|76009251|FG000|STARTED|Double-Blind Treatment Period||0||
59886533|NCT03285178|76009252|FG001|STARTED|Double-Blind Treatment Period||10||
59886534|NCT03285178|76009253|FG002|STARTED|Double-Blind Treatment Period||9||
59886535|NCT03285178|76009254|FG003|STARTED|Double-Blind Treatment Period||8||
59886536|NCT03285178|76009255|FG004|STARTED|Double-Blind Treatment Period||8||
59886537|NCT03285178|76009256|FG005|STARTED|Double-Blind Treatment Period||11||
59886538|NCT03285178|76009257|FG006|STARTED|Double-Blind Treatment Period||24||
59886539|NCT03285178|76009251|FG000|COMPLETED|Double-Blind Treatment Period||0||
59886540|NCT03285178|76009252|FG001|COMPLETED|Double-Blind Treatment Period||8||
59886541|NCT03285178|76009253|FG002|COMPLETED|Double-Blind Treatment Period||6||
59886542|NCT03285178|76009254|FG003|COMPLETED|Double-Blind Treatment Period||7||
59886543|NCT03285178|76009255|FG004|COMPLETED|Double-Blind Treatment Period||6||
59886544|NCT03285178|76009256|FG005|COMPLETED|Double-Blind Treatment Period||9||
59886545|NCT03285178|76009257|FG006|COMPLETED|Double-Blind Treatment Period||21||
59886546|NCT03285178|76009251|FG000|NOT COMPLETED|Double-Blind Treatment Period||0||
59886547|NCT03285178|76009252|FG001|NOT COMPLETED|Double-Blind Treatment Period||2||
59886548|NCT03285178|76009253|FG002|NOT COMPLETED|Double-Blind Treatment Period||3||
59886549|NCT03285178|76009254|FG003|NOT COMPLETED|Double-Blind Treatment Period||1||
59886550|NCT03285178|76009255|FG004|NOT COMPLETED|Double-Blind Treatment Period||2||
59886551|NCT03285178|76009256|FG005|NOT COMPLETED|Double-Blind Treatment Period||2||
59886552|NCT03285178|76009257|FG006|NOT COMPLETED|Double-Blind Treatment Period||3||
59886553|NCT00090545|76009281|FG000|STARTED|Overall Study||22||
59886554|NCT00090545|76009282|FG001|STARTED|Overall Study||24||
59886555|NCT00090545|76009281|FG000|COMPLETED|Overall Study||0||
59886556|NCT00090545|76009282|FG001|COMPLETED|Overall Study||0||
59886557|NCT00090545|76009281|FG000|NOT COMPLETED|Overall Study||22||
59886558|NCT00090545|76009282|FG001|NOT COMPLETED|Overall Study||24||
59886559|NCT03249376|76009292|FG000|STARTED|Overall Study|191 patients were randomized but only 188 patients received study drug. The number completed and discontinued is based on the 188 patients that received study drug.|188||
59886560|NCT03249376|76009293|FG001|STARTED|Overall Study|190 patients were randomized but only 189 patients received study drug. The number completed and discontinued is based on the 189 patients that received study drug.|189||
59886561|NCT03249376|76009292|FG000|COMPLETED|Overall Study||167||
59886562|NCT03249376|76009293|FG001|COMPLETED|Overall Study||166||
59886563|NCT03249376|76009292|FG000|NOT COMPLETED|Overall Study||21||
59886564|NCT03249376|76009293|FG001|NOT COMPLETED|Overall Study||23||
59886565|NCT00070109|76009304|FG000|STARTED|Overall Study||8||
59886566|NCT00070109|76009305|FG001|STARTED|Overall Study||6||
59886567|NCT00070109|76009306|FG002|STARTED|Overall Study||8||
59504216|NCT00695435|75596652|FG001|STARTED|Overall Study||7||
59504217|NCT00695435|75596653|FG002|STARTED|Overall Study||7||
59504218|NCT00695435|75596651|FG000|COMPLETED|Overall Study||7||
59504219|NCT00695435|75596652|FG001|COMPLETED|Overall Study||7||
59504220|NCT00695435|75596653|FG002|COMPLETED|Overall Study||7||
59504221|NCT00695435|75596651|FG000|NOT COMPLETED|Overall Study||0||
59504222|NCT00695435|75596652|FG001|NOT COMPLETED|Overall Study||0||
59504223|NCT00695435|75596653|FG002|NOT COMPLETED|Overall Study||0||
59504224|NCT00654953|75596664|FG000|STARTED|Overall Study||36||
59504225|NCT00654953|75596665|FG001|STARTED|Overall Study||36||
59504226|NCT00654953|75596666|FG002|STARTED|Overall Study||30||
59504227|NCT00654953|75596664|FG000|COMPLETED|Overall Study||6||
59504228|NCT00654953|75596665|FG001|COMPLETED|Overall Study||8||
59504229|NCT00654953|75596666|FG002|COMPLETED|Overall Study||8||
59504230|NCT00654953|75596664|FG000|NOT COMPLETED|Overall Study||30||
59504231|NCT00654953|75596665|FG001|NOT COMPLETED|Overall Study||28||
59504232|NCT00654953|75596666|FG002|NOT COMPLETED|Overall Study||22||
59504233|NCT02299089|75596678|FG000|STARTED|Overall Study||3||
59504234|NCT02299089|75596679|FG001|STARTED|Overall Study||4||
59504235|NCT02299089|75596680|FG002|STARTED|Overall Study||1||
59504236|NCT02299089|75596681|FG003|STARTED|Overall Study||4||
59504237|NCT02299089|75596678|FG000|COMPLETED|Overall Study||3||
59504238|NCT02299089|75596679|FG001|COMPLETED|Overall Study||4||
59504239|NCT02299089|75596680|FG002|COMPLETED|Overall Study||1||
59504240|NCT02299089|75596681|FG003|COMPLETED|Overall Study||4||
59504241|NCT02299089|75596678|FG000|NOT COMPLETED|Overall Study||0||
59504242|NCT02299089|75596679|FG001|NOT COMPLETED|Overall Study||0||
59504243|NCT02299089|75596680|FG002|NOT COMPLETED|Overall Study||0||
59504244|NCT02299089|75596681|FG003|NOT COMPLETED|Overall Study||0||
59504245|NCT00655811|75596701|FG000|STARTED|Overall Study||40||
59504246|NCT00655811|75596701|FG000|COMPLETED|Overall Study||40||
59504247|NCT00655811|75596701|FG000|NOT COMPLETED|Overall Study||0||
59504248|NCT00696293|75596711|FG000|STARTED|Overall Study||30||
59504249|NCT00696293|75596711|FG000|COMPLETED|Overall Study||28||
59504250|NCT00696293|75596711|FG000|NOT COMPLETED|Overall Study||2||
59504251|NCT00696449|75596720|FG000|STARTED|Overall Study||15||
59504252|NCT00696449|75596721|FG001|STARTED|Overall Study||15||
59504253|NCT00696449|75596722|FG002|STARTED|Overall Study||15||
59504254|NCT00696449|75596723|FG003|STARTED|Overall Study||16||
59504255|NCT00696449|75596720|FG000|COMPLETED|Overall Study||12||
59504256|NCT00696449|75596721|FG001|COMPLETED|Overall Study||9||
59504257|NCT00696449|75596722|FG002|COMPLETED|Overall Study||14||
59504258|NCT00696449|75596723|FG003|COMPLETED|Overall Study||13||
59886568|NCT00070109|76009307|FG003|STARTED|Overall Study||20||
59886569|NCT00070109|76009308|FG004|STARTED|Overall Study||8||
59886570|NCT00070109|76009304|FG000|COMPLETED|Overall Study||0||
59886571|NCT00070109|76009305|FG001|COMPLETED|Overall Study||0||
59886572|NCT00070109|76009306|FG002|COMPLETED|Overall Study||0||
59886573|NCT00070109|76009307|FG003|COMPLETED|Overall Study||0||
59886574|NCT00070109|76009308|FG004|COMPLETED|Overall Study||0||
59886575|NCT00070109|76009304|FG000|NOT COMPLETED|Overall Study||8||
59886576|NCT00070109|76009305|FG001|NOT COMPLETED|Overall Study||6||
59886577|NCT00070109|76009306|FG002|NOT COMPLETED|Overall Study||8||
59886578|NCT00070109|76009307|FG003|NOT COMPLETED|Overall Study||20||
59504259|NCT00696449|75596720|FG000|NOT COMPLETED|Overall Study||3||
59886579|NCT00070109|76009308|FG004|NOT COMPLETED|Overall Study||8||
59886580|NCT00090233|76009329|FG000|STARTED|Overall Study|Evaluated by data safety monitoring board (DSMB) when they recommended stopping enrollment|34644||
59886581|NCT00090233|76009330|FG001|STARTED|Overall Study|Evaluated by data safety monitoring board when they recommended stopping enrollment|34630||
59886582|NCT00090233|76009329|FG000|Vaccinated at Visit 1|Overall Study|Randomized Not vaccinated 609|34035||
59886583|NCT00090233|76009330|FG001|Vaccinated at Visit 1|Overall Study|Randomized Not vaccinated 627|34003||
59886584|NCT00090233|76009329|FG000|Vaccinated at Visit 2|Overall Study||31052||
59504260|NCT00696449|75596721|FG001|NOT COMPLETED|Overall Study||6||
59504261|NCT00696449|75596722|FG002|NOT COMPLETED|Overall Study||1||
59504262|NCT00696449|75596723|FG003|NOT COMPLETED|Overall Study||3||
59504263|NCT00696761|75596737|FG000|STARTED|Overall Study||61||
59607757|NCT01974635|75718500|FG000|COMPLETED|Overall Study||2||
59886585|NCT00090233|76009330|FG001|Vaccinated at Visit 2|Overall Study||31066||
59886586|NCT00090233|76009329|FG000|Vaccinated at Visit 3|Overall Study||29667||
59886587|NCT00090233|76009330|FG001|Vaccinated at Visit 3|Overall Study||29598||
59886588|NCT00090233|76009329|FG000|COMPLETED|Overall Study|Does not include participants who discontinued prior to the 42 day safety follow-up|29645||
59886589|NCT00090233|76009330|FG001|COMPLETED|Overall Study|Does not include participants who discontinued prior to the 42 day safety follow-up|29565||
59886590|NCT00090233|76009329|FG000|NOT COMPLETED|Overall Study||4999||
59886591|NCT00090233|76009330|FG001|NOT COMPLETED|Overall Study||5065||
59504264|NCT00696761|75596738|FG001|STARTED|Overall Study||76||
59607758|NCT01974635|75718500|FG000|NOT COMPLETED|Overall Study||0||
59607759|NCT01937507|75718505|FG000|STARTED|Overall Study||2||
59607760|NCT01937507|75718505|FG000|COMPLETED|Overall Study||0||
59886592|NCT00069953|76009340|FG000|STARTED|Overall Study||43||
59950964|NCT01668004|76069883|FG000|Treated|Overall Study||101||
59504265|NCT00696761|75596739|FG002|STARTED|Overall Study||41||
59504266|NCT00696761|75596740|FG003|STARTED|Overall Study||54||
59504267|NCT00696761|75596737|FG000|COMPLETED|Overall Study||41||
59504268|NCT00696761|75596738|FG001|COMPLETED|Overall Study||50||
59504269|NCT00696761|75596739|FG002|COMPLETED|Overall Study||30||
59504270|NCT00696761|75596740|FG003|COMPLETED|Overall Study||44||
59504271|NCT00696761|75596737|FG000|NOT COMPLETED|Overall Study||20||
59607761|NCT01937507|75718505|FG000|NOT COMPLETED|Overall Study||2||
59607762|NCT01938833|75718509|FG000|STARTED|Overall Study||9||
59607763|NCT01938833|75718509|FG000|COMPLETED|Overall Study||9||
59607764|NCT01938833|75718509|FG000|NOT COMPLETED|Overall Study||0||
59607765|NCT01893359|75718516|FG000|STARTED|Overall Study||0||
60013536|NCT02482935|76129449|FG000|Washout|Period 1||15||
60013537|NCT02482935|76129450|FG001|Washout|Period 1||15||
60013538|NCT02482935|76129449|FG000|COMPLETED|Period 1||14||
60013539|NCT02482935|76129450|FG001|COMPLETED|Period 1||15||
60013540|NCT02482935|76129449|FG000|NOT COMPLETED|Period 1||1||
60013541|NCT02482935|76129450|FG001|NOT COMPLETED|Period 1||0||
60013542|NCT02482935|76129449|FG000|STARTED|Period 2||14||
60013543|NCT02482935|76129450|FG001|STARTED|Period 2||15||
60013544|NCT02482935|76129449|FG000|Received Abemaciclib|Period 2||14||
60013545|NCT02482935|76129450|FG001|Received Abemaciclib|Period 2||15||
60013546|NCT02482935|76129449|FG000|Follow-up|Period 2||14||
60013547|NCT02482935|76129450|FG001|Follow-up|Period 2||15||
60013548|NCT02482935|76129449|FG000|COMPLETED|Period 2||14||
60013549|NCT02482935|76129450|FG001|COMPLETED|Period 2||15||
60013550|NCT02482935|76129449|FG000|NOT COMPLETED|Period 2||0||
60013551|NCT02482935|76129450|FG001|NOT COMPLETED|Period 2||0||
60013552|NCT02513823|76129456|FG000|STARTED|Overall Study||27||
60013553|NCT02513823|76129456|FG000|COMPLETED|Overall Study||22||
60013554|NCT02513823|76129456|FG000|NOT COMPLETED|Overall Study||5||
60013555|NCT02513745|76129462|FG000|STARTED|Overall Study||42|Contralateral eye study. 42 subjects/84 eyes. Each subject had 1 eye (randomized) in each group.|42
60013556|NCT02513745|76129463|FG001|STARTED|Overall Study||42|Contralateral eye study. 42 subjects/84 eyes. Each subject had 1 eye (randomized) in each group.|42
60013557|NCT02513745|76129462|FG000|COMPLETED|Overall Study||39|Contralateral eye study. 39 subjects/78 eyes. Each subject had 1 eye (randomized) in each group.|39
60013558|NCT02513745|76129463|FG001|COMPLETED|Overall Study||39|Contralateral eye study. 39 subjects/78 eyes. Each subject had 1 eye (randomized) in each group.|39
60013559|NCT02513745|76129462|FG000|NOT COMPLETED|Overall Study||3||3
60013560|NCT02513745|76129463|FG001|NOT COMPLETED|Overall Study||3||3
60013561|NCT02477553|76129471|FG000|STARTED|Overall Study||364||
60013562|NCT02477553|76129472|FG001|STARTED|Overall Study||364||
60013563|NCT02477553|76129471|FG000|COMPLETED|Overall Study||344||
60013564|NCT02477553|76129472|FG001|COMPLETED|Overall Study||344||
60013565|NCT02477553|76129471|FG000|NOT COMPLETED|Overall Study||20||
60013566|NCT02477553|76129472|FG001|NOT COMPLETED|Overall Study||20||
60013567|NCT01665911|76129478|FG000|STARTED|Overall Study||28||
59607766|NCT01893359|75718517|FG001|STARTED|Overall Study||2||
60013568|NCT01665911|76129478|FG000|0 mg Fluoride in 200 ml Milk|Overall Study||22||
60013569|NCT01665911|76129478|FG000|1.5 mg Sodium Fluoride in 100 ml Milk|Overall Study||23||
60013570|NCT01665911|76129478|FG000|1.5 mg Sodium Fluoride in 200 ml Milk|Overall Study||25||
60013571|NCT01665911|76129478|FG000|3.0 mg Sodium Fluoride in 100 ml Milk|Overall Study||22||
60013572|NCT01665911|76129478|FG000|3.0 mg Sodium Fluoride in 200 ml Milk|Overall Study||22||
60013573|NCT01665911|76129478|FG000|COMPLETED|Overall Study||22||
60013574|NCT01665911|76129478|FG000|NOT COMPLETED|Overall Study||6||
59607767|NCT01893359|75718518|FG002|STARTED|Overall Study||0||
59504272|NCT00696761|75596738|FG001|NOT COMPLETED|Overall Study||26||
59886593|NCT00069953|76009340|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study|41||
59886594|NCT00069953|76009340|FG000|NOT COMPLETED|Overall Study||2||
59886595|NCT02750800|76009350|FG000|STARTED|Overall Study||412||
59886596|NCT02750800|76009350|FG000|COMPLETED|Overall Study||314||
59886597|NCT02750800|76009350|FG000|NOT COMPLETED|Overall Study||98||
59886598|NCT01329562|76009370|FG000|STARTED|Overall Study||20||
59886599|NCT01329562|76009371|FG001|STARTED|Overall Study||21||
59886600|NCT01329562|76009370|FG000|COMPLETED|Overall Study||11||
59886601|NCT01329562|76009371|FG001|COMPLETED|Overall Study||14||
59886602|NCT01329562|76009370|FG000|NOT COMPLETED|Overall Study||9||
59886603|NCT01329562|76009371|FG001|NOT COMPLETED|Overall Study||7||
59886604|NCT00069641|76009382|FG000|STARTED|Overall Study||32||
59886605|NCT00069641|76009383|FG001|STARTED|Overall Study||32||
59886606|NCT00069641|76009384|FG002|STARTED|Overall Study||32||
59886607|NCT00069641|76009382|FG000|COMPLETED|Overall Study||31||
59886608|NCT00069641|76009383|FG001|COMPLETED|Overall Study||32||
59886609|NCT00069641|76009384|FG002|COMPLETED|Overall Study||31||
59886610|NCT00069641|76009382|FG000|NOT COMPLETED|Overall Study||1||
59886611|NCT00069641|76009383|FG001|NOT COMPLETED|Overall Study||0||
59886612|NCT00069641|76009384|FG002|NOT COMPLETED|Overall Study||1||
59886613|NCT03653026|76009395|FG000|STARTED|Part 1: Placebo-controlled Period||345||
59886614|NCT03653026|76009396|FG001|STARTED|Part 1: Placebo-controlled Period||177||
59886615|NCT03653026|76009397|FG002|STARTED|Part 1: Placebo-controlled Period||0||
59886616|NCT03653026|76009398|FG003|STARTED|Part 1: Placebo-controlled Period||0||
59886617|NCT03653026|76009395|FG000|Received Treatment|Part 1: Placebo-controlled Period||344||
59755704|NCT02937116|75874805|FG004|STARTED|Overall Study||22||
59755705|NCT02937116|75874806|FG005|STARTED|Overall Study||87||
59755706|NCT02937116|75874807|FG006|STARTED|Overall Study||37||
59755707|NCT02937116|75874808|FG007|STARTED|Overall Study||21||
59755708|NCT02937116|75874809|FG008|STARTED|Overall Study||20||
59755709|NCT02937116|75874810|FG009|STARTED|Overall Study||20||
59755710|NCT02937116|75874811|FG010|STARTED|Overall Study||7||
59755711|NCT02937116|75874812|FG011|STARTED|Overall Study||7||
59755712|NCT02937116|75874801|FG000|COMPLETED|Overall Study||0||
59755713|NCT02937116|75874802|FG001|COMPLETED|Overall Study||0||
59755714|NCT02937116|75874803|FG002|COMPLETED|Overall Study||0||
59755715|NCT02937116|75874804|FG003|COMPLETED|Overall Study||0||
59755716|NCT02937116|75874805|FG004|COMPLETED|Overall Study||0||
59755717|NCT02937116|75874806|FG005|COMPLETED|Overall Study||0||
59755718|NCT02937116|75874807|FG006|COMPLETED|Overall Study||0||
59755719|NCT02937116|75874808|FG007|COMPLETED|Overall Study||0||
59755720|NCT02937116|75874809|FG008|COMPLETED|Overall Study||0||
59755721|NCT02937116|75874810|FG009|COMPLETED|Overall Study||0||
59755722|NCT02937116|75874811|FG010|COMPLETED|Overall Study||0||
59755723|NCT02937116|75874812|FG011|COMPLETED|Overall Study||0||
59886618|NCT03653026|76009396|FG001|Received Treatment|Part 1: Placebo-controlled Period||177||
59886619|NCT03653026|76009397|FG002|Received Treatment|Part 1: Placebo-controlled Period||0||
59886620|NCT03653026|76009398|FG003|Received Treatment|Part 1: Placebo-controlled Period||0||
59886621|NCT03653026|76009395|FG000|COMPLETED|Part 1: Placebo-controlled Period||334||
59886622|NCT03653026|76009396|FG001|COMPLETED|Part 1: Placebo-controlled Period||164||
59886623|NCT03653026|76009397|FG002|COMPLETED|Part 1: Placebo-controlled Period||0||
59886624|NCT03653026|76009398|FG003|COMPLETED|Part 1: Placebo-controlled Period||0||
59886625|NCT03653026|76009395|FG000|NOT COMPLETED|Part 1: Placebo-controlled Period||11||
59886626|NCT03653026|76009396|FG001|NOT COMPLETED|Part 1: Placebo-controlled Period||13||
59886627|NCT03653026|76009397|FG002|NOT COMPLETED|Part 1: Placebo-controlled Period||0||
59886628|NCT03653026|76009398|FG003|NOT COMPLETED|Part 1: Placebo-controlled Period||0||
59886629|NCT03653026|76009395|FG000|STARTED|Part 2: Open-label Extension||0|Part 2 was an extended treatment period for participants who did not achieve clinical response per Adapted Mayo score at Week 8 in Part 1.|
59886630|NCT03653026|76009396|FG001|STARTED|Part 2: Open-label Extension||0|Part 2 was an extended treatment period for participants who did not achieve clinical response per Adapted Mayo score at Week 8 in Part 1.|
59886631|NCT03653026|76009397|FG002|STARTED|Part 2: Open-label Extension||68|Part 2 was an extended treatment period for participants who did not achieve clinical response per Adapted Mayo score at Week 8 in Part 1.|
59886632|NCT03653026|76009398|FG003|STARTED|Part 2: Open-label Extension||116|Part 2 was an extended treatment period for participants who did not achieve clinical response per Adapted Mayo score at Week 8 in Part 1.|
59886633|NCT03653026|76009395|FG000|COMPLETED|Part 2: Open-label Extension||0||
59886634|NCT03653026|76009396|FG001|COMPLETED|Part 2: Open-label Extension||0||
59886635|NCT03653026|76009397|FG002|COMPLETED|Part 2: Open-label Extension||65||
59755724|NCT02937116|75874801|FG000|NOT COMPLETED|Overall Study||3||
59886636|NCT03653026|76009398|FG003|COMPLETED|Part 2: Open-label Extension||111||
59886637|NCT03653026|76009395|FG000|NOT COMPLETED|Part 2: Open-label Extension||0||
59886638|NCT03653026|76009396|FG001|NOT COMPLETED|Part 2: Open-label Extension||0||
59755725|NCT02937116|75874802|FG001|NOT COMPLETED|Overall Study||3||
59755726|NCT02937116|75874803|FG002|NOT COMPLETED|Overall Study||3||
59755727|NCT02937116|75874804|FG003|NOT COMPLETED|Overall Study||3||
59755728|NCT02937116|75874805|FG004|NOT COMPLETED|Overall Study||22||
59886639|NCT03653026|76009397|FG002|NOT COMPLETED|Part 2: Open-label Extension||3||
59504273|NCT00696761|75596739|FG002|NOT COMPLETED|Overall Study||11||
59504274|NCT00696761|75596740|FG003|NOT COMPLETED|Overall Study||10||
59504275|NCT00656201|75596760|FG000|STARTED|Overall Study||235||
59504276|NCT00656201|75596761|FG001|STARTED|Overall Study||233||
59504277|NCT00656201|75596760|FG000|COMPLETED|Overall Study||206||
59504278|NCT00656201|75596761|FG001|COMPLETED|Overall Study||201||
59504279|NCT00656201|75596760|FG000|NOT COMPLETED|Overall Study||29||
59504280|NCT00656201|75596761|FG001|NOT COMPLETED|Overall Study||32||
59504281|NCT00759291|75596769|FG000|STARTED|First Treatment Period||17||
59504282|NCT00759291|75596770|FG001|STARTED|First Treatment Period||23||
59504283|NCT00759291|75596769|FG000|COMPLETED|First Treatment Period||17||
59504284|NCT00759291|75596770|FG001|COMPLETED|First Treatment Period||23||
59504285|NCT00759291|75596769|FG000|NOT COMPLETED|First Treatment Period||0||
59504286|NCT00759291|75596770|FG001|NOT COMPLETED|First Treatment Period||0||
59504287|NCT00759291|75596769|FG000|STARTED|Crossover|All subjects received acipicmox in the first period then received placebo in the second.|17||
59504288|NCT00759291|75596770|FG001|STARTED|Crossover|All subjects who received placebo in the first period received acipimox in the second period.|23||
59504289|NCT00759291|75596769|FG000|COMPLETED|Crossover||17||
59504290|NCT00759291|75596770|FG001|COMPLETED|Crossover||23||
59504291|NCT00759291|75596769|FG000|NOT COMPLETED|Crossover||0||
59504292|NCT00759291|75596770|FG001|NOT COMPLETED|Crossover||0||
59504293|NCT00657605|75596776|FG000|STARTED|Overall Study||3||
59504294|NCT00657605|75596776|FG000|COMPLETED|Overall Study||3||
59504295|NCT00657605|75596776|FG000|NOT COMPLETED|Overall Study||0||
59504296|NCT00697541|75596782|FG000|STARTED|Overall Study||10||
59504297|NCT00697541|75596783|FG001|STARTED|Overall Study||10||
59504298|NCT00697541|75596782|FG000|COMPLETED|Overall Study||8||
59504299|NCT00697541|75596783|FG001|COMPLETED|Overall Study||9||
59504300|NCT00697541|75596782|FG000|NOT COMPLETED|Overall Study||2||
59504301|NCT00697541|75596783|FG001|NOT COMPLETED|Overall Study||1||
59504302|NCT00697697|75596792|FG000|STARTED|Overall Study||94||
59504303|NCT00697697|75596793|FG001|STARTED|Overall Study||98||
59504304|NCT00697697|75596792|FG000|COMPLETED|Overall Study||45||
59504305|NCT00697697|75596793|FG001|COMPLETED|Overall Study||44||
59504306|NCT00697697|75596792|FG000|NOT COMPLETED|Overall Study||49||
59504307|NCT00697697|75596793|FG001|NOT COMPLETED|Overall Study||54||
59504308|NCT00698867|75596799|FG000|STARTED|Overall Study||118||118
59504309|NCT00698867|75596799|FG000|Subjects With 1 Year Data|Overall Study||68||68
59504310|NCT00698867|75596799|FG000|Subjects With 2 Year Data|Overall Study||55||55
59504311|NCT00698867|75596799|FG000|Subjects With 3 Year Data|Overall Study||35||35
59504312|NCT00698867|75596799|FG000|Subjects With 4 Year Data|Overall Study||34||34
59504313|NCT00698867|75596799|FG000|COMPLETED|Overall Study||27||27
59504314|NCT00698867|75596799|FG000|NOT COMPLETED|Overall Study||91||91
59504315|NCT00657917|75596803|FG000|STARTED|Overall Study||1||
59504316|NCT00657917|75596803|FG000|COMPLETED|Overall Study||1||
59504317|NCT00657917|75596803|FG000|NOT COMPLETED|Overall Study||0||
59504318|NCT01959945|75596811|FG000|STARTED|Overall Study||80||
59504319|NCT01959945|75596812|FG001|STARTED|Overall Study||78||
59504320|NCT01959945|75596813|FG002|STARTED|Overall Study||28||
59504321|NCT01959945|75596814|FG003|STARTED|Overall Study||31||
59504322|NCT01959945|75596811|FG000|COMPLETED|Overall Study||76||
59504323|NCT01959945|75596812|FG001|COMPLETED|Overall Study||75||
59504324|NCT01959945|75596813|FG002|COMPLETED|Overall Study||9||
59504325|NCT01959945|75596814|FG003|COMPLETED|Overall Study||15||
59504326|NCT01959945|75596811|FG000|NOT COMPLETED|Overall Study||4||
59504327|NCT01959945|75596812|FG001|NOT COMPLETED|Overall Study||3||
59504328|NCT01959945|75596813|FG002|NOT COMPLETED|Overall Study||19||
59504329|NCT01959945|75596814|FG003|NOT COMPLETED|Overall Study||16||
59504330|NCT00658385|75596826|FG000|STARTED|Overall Study||5||
59504331|NCT00658385|75596826|FG000|COMPLETED|Overall Study||5||
59504332|NCT00658385|75596826|FG000|NOT COMPLETED|Overall Study||0||
59504333|NCT01961271|75596830|FG000|STARTED|Overall Study||114||
59504334|NCT01961271|75596830|FG000|COMPLETED|Overall Study||64||
59504335|NCT01961271|75596830|FG000|NOT COMPLETED|Overall Study||50||
59504336|NCT01963143|75596837|FG000|STARTED|Overall Study||14||
59607768|NCT01893359|75718516|FG000|COMPLETED|Overall Study||0||
59504337|NCT01963143|75596838|FG001|STARTED|Overall Study||19||
59504338|NCT01963143|75596839|FG002|STARTED|Overall Study||15||
59504339|NCT01963143|75596837|FG000|COMPLETED|Overall Study||14||
59504340|NCT01963143|75596838|FG001|COMPLETED|Overall Study||18||
59504341|NCT01963143|75596839|FG002|COMPLETED|Overall Study||14||
59504342|NCT01963143|75596837|FG000|NOT COMPLETED|Overall Study||0||
59504343|NCT01963143|75596838|FG001|NOT COMPLETED|Overall Study||1||
59504344|NCT01963143|75596839|FG002|NOT COMPLETED|Overall Study||1||
59504345|NCT01963845|75596847|FG000|STARTED|Overall Study||25||
59504346|NCT01963845|75596848|FG001|STARTED|Overall Study||25||
59504347|NCT01963845|75596847|FG000|COMPLETED|Overall Study||25||
59504348|NCT01963845|75596848|FG001|COMPLETED|Overall Study||25||
59504349|NCT01963845|75596847|FG000|NOT COMPLETED|Overall Study||0||
59504350|NCT01963845|75596848|FG001|NOT COMPLETED|Overall Study||0||
59504351|NCT02332863|75596856|FG000|STARTED|Overall Study||22||
59504352|NCT02332863|75596857|FG001|STARTED|Overall Study||22||
59504353|NCT02332863|75596856|FG000|COMPLETED|Overall Study||22||
59607769|NCT01893359|75718517|FG001|COMPLETED|Overall Study||2||
59504354|NCT02332863|75596857|FG001|COMPLETED|Overall Study||22||
59504355|NCT02332863|75596856|FG000|NOT COMPLETED|Overall Study||0||
59504356|NCT02332863|75596857|FG001|NOT COMPLETED|Overall Study||0||
59504357|NCT01963923|75596865|FG000|STARTED|3 Weeks Post-surgery||20||
59504358|NCT01963923|75596866|FG001|STARTED|3 Weeks Post-surgery||20||
59504359|NCT01963923|75596865|FG000|COMPLETED|3 Weeks Post-surgery||12||
59504360|NCT01963923|75596866|FG001|COMPLETED|3 Weeks Post-surgery||10||
59504361|NCT01963923|75596865|FG000|NOT COMPLETED|3 Weeks Post-surgery||8||
59504362|NCT01963923|75596866|FG001|NOT COMPLETED|3 Weeks Post-surgery||10||
59504363|NCT01963923|75596865|FG000|STARTED|3 Months Post-surgery||12||
59504364|NCT01963923|75596866|FG001|STARTED|3 Months Post-surgery||10||
59504365|NCT01963923|75596865|FG000|COMPLETED|3 Months Post-surgery||10||
59504366|NCT01963923|75596866|FG001|COMPLETED|3 Months Post-surgery||9||
59504367|NCT01963923|75596865|FG000|NOT COMPLETED|3 Months Post-surgery||2||
59504368|NCT01963923|75596866|FG001|NOT COMPLETED|3 Months Post-surgery||1||
59504369|NCT01965561|75596879|FG000|STARTED|Overall Study||10||
59504370|NCT01965561|75596879|FG000|COMPLETED|Overall Study||10||
59504371|NCT01965561|75596879|FG000|NOT COMPLETED|Overall Study||0||
59504372|NCT00658619|75596891|FG000|STARTED|Overall Study||3||
59504373|NCT00658619|75596892|FG001|STARTED|Overall Study||3||
59504374|NCT00658619|75596893|FG002|STARTED|Overall Study||41||
59504375|NCT00658619|75596894|FG003|STARTED|Overall Study||49||
59504376|NCT00658619|75596895|FG004|STARTED|Overall Study||23||
59504377|NCT00658619|75596891|FG000|COMPLETED|Overall Study||3||
59504378|NCT00658619|75596892|FG001|COMPLETED|Overall Study||2||
59504379|NCT00658619|75596893|FG002|COMPLETED|Overall Study||31||
59504380|NCT00658619|75596894|FG003|COMPLETED|Overall Study||37||
59504381|NCT00658619|75596895|FG004|COMPLETED|Overall Study||21||
59504382|NCT00658619|75596891|FG000|NOT COMPLETED|Overall Study||0||
59504383|NCT00658619|75596892|FG001|NOT COMPLETED|Overall Study||1||
59504384|NCT00658619|75596893|FG002|NOT COMPLETED|Overall Study||10||
59504385|NCT00658619|75596894|FG003|NOT COMPLETED|Overall Study||12||
59504386|NCT00658619|75596895|FG004|NOT COMPLETED|Overall Study||2||
59504387|NCT01966419|75596906|FG000|STARTED|Overall Study||115||
59504388|NCT01966419|75596907|FG001|STARTED|Overall Study||116||
59504389|NCT01966419|75596906|FG000|Intent to Treat Population (ITT)T)115|Overall Study||115||
59504390|NCT01966419|75596907|FG001|Intent to Treat Population (ITT)T)115|Overall Study||116||
59504391|NCT01966419|75596906|FG000|Safety Analysis Set (SAS)|Overall Study||112||
59504392|NCT01966419|75596907|FG001|Safety Analysis Set (SAS)|Overall Study||114||
59504393|NCT01966419|75596906|FG000|COMPLETED|Overall Study||74||
59504394|NCT01966419|75596907|FG001|COMPLETED|Overall Study||80||
59504395|NCT01966419|75596906|FG000|NOT COMPLETED|Overall Study||41||
59504396|NCT01966419|75596907|FG001|NOT COMPLETED|Overall Study||36||
59504397|NCT01966809|75596913|FG000|STARTED|Overall Study||1||
59504398|NCT01966809|75596913|FG000|COMPLETED|Overall Study||1||
59504399|NCT01966809|75596913|FG000|NOT COMPLETED|Overall Study||0||
59504400|NCT01967121|75596920|FG000|STARTED|Overall Study||25||
59504401|NCT01967121|75596921|FG001|STARTED|Overall Study||25||
59504402|NCT01967121|75596922|FG002|STARTED|Overall Study||25||
59504403|NCT01967121|75596920|FG000|COMPLETED|Overall Study||25||
59504404|NCT01967121|75596921|FG001|COMPLETED|Overall Study||25||
59504405|NCT01967121|75596922|FG002|COMPLETED|Overall Study||25||
59504406|NCT01967121|75596920|FG000|NOT COMPLETED|Overall Study||0||
59504407|NCT01967121|75596921|FG001|NOT COMPLETED|Overall Study||0||
59504408|NCT01967121|75596922|FG002|NOT COMPLETED|Overall Study||0||
59504409|NCT04575584|75596936|FG000|STARTED|Overall Study||75||
59504410|NCT04575584|75596937|FG001|STARTED|Overall Study||75||
59504411|NCT04575584|75596938|FG002|STARTED|Overall Study||76||
59504412|NCT04575584|75596939|FG003|STARTED|Overall Study||78||
59504413|NCT04575584|75596940|FG004|STARTED|Overall Study|Study terminated prior to initiating Part 2|0||
59504414|NCT04575584|75596941|FG005|STARTED|Overall Study|Study terminated prior to initiating Part 2|0||
59504415|NCT04575584|75596936|FG000|Treated|Overall Study||73||
59504416|NCT04575584|75596937|FG001|Treated|Overall Study||73||
59504417|NCT04575584|75596938|FG002|Treated|Overall Study||72||
59504418|NCT04575584|75596939|FG003|Treated|Overall Study||75||
59504419|NCT04575584|75596940|FG004|Treated|Overall Study||0||
59504420|NCT04575584|75596941|FG005|Treated|Overall Study||0||
59504421|NCT04575584|75596936|FG000|COMPLETED|Overall Study||61||
59504422|NCT04575584|75596937|FG001|COMPLETED|Overall Study||60||
59504423|NCT04575584|75596938|FG002|COMPLETED|Overall Study||63||
59504424|NCT04575584|75596939|FG003|COMPLETED|Overall Study||70||
59504425|NCT04575584|75596940|FG004|COMPLETED|Overall Study||0||
59504426|NCT04575584|75596941|FG005|COMPLETED|Overall Study||0||
59504427|NCT04575584|75596936|FG000|NOT COMPLETED|Overall Study||14||
59504428|NCT04575584|75596937|FG001|NOT COMPLETED|Overall Study||15||
59504429|NCT04575584|75596938|FG002|NOT COMPLETED|Overall Study||13||
59504430|NCT04575584|75596939|FG003|NOT COMPLETED|Overall Study||8||
59504431|NCT04575584|75596940|FG004|NOT COMPLETED|Overall Study||0||
59504432|NCT04575584|75596941|FG005|NOT COMPLETED|Overall Study||0||
59504433|NCT00699491|75596961|FG000|STARTED|Overall Study||3||
59504434|NCT00699491|75596962|FG001|STARTED|Overall Study||2||
59504435|NCT00699491|75596963|FG002|STARTED|Overall Study||7||
59504436|NCT00699491|75596964|FG003|STARTED|Overall Study||6||
59886640|NCT03653026|76009398|FG003|NOT COMPLETED|Part 2: Open-label Extension||5||
59886641|NCT01329328|76009409|FG000|STARTED|Overall Study||15||
59886642|NCT01329328|76009410|FG001|STARTED|Overall Study||17||
59886643|NCT01329328|76009411|FG002|STARTED|Overall Study||18||
59886644|NCT01329328|76009409|FG000|COMPLETED|Overall Study||13||
59886645|NCT01329328|76009410|FG001|COMPLETED|Overall Study||13||
59886646|NCT01329328|76009411|FG002|COMPLETED|Overall Study||15||
59886647|NCT01329328|76009409|FG000|NOT COMPLETED|Overall Study||2||
59886648|NCT01329328|76009410|FG001|NOT COMPLETED|Overall Study||4||
59886649|NCT01329328|76009411|FG002|NOT COMPLETED|Overall Study||3||
59886650|NCT01337986|76009421|FG000|STARTED|Overall Study||23||
59886651|NCT01337986|76009422|FG001|STARTED|Overall Study||23||
59886652|NCT01337986|76009421|FG000|COMPLETED|Overall Study||20||
59886653|NCT01337986|76009422|FG001|COMPLETED|Overall Study||18||
59886654|NCT01337986|76009421|FG000|NOT COMPLETED|Overall Study||3||
59886655|NCT01337986|76009422|FG001|NOT COMPLETED|Overall Study||5||
59886656|NCT01337674|76009446|FG000|STARTED|Treatment Period 1||6||
59886657|NCT01337674|76009447|FG001|STARTED|Treatment Period 1|The discontinued participant was replaced|7||
59886658|NCT01337674|76009448|FG002|STARTED|Treatment Period 1||6||
59886659|NCT01337674|76009449|FG003|STARTED|Treatment Period 1|The discontinued participant was replaced|7||
59886660|NCT01337674|76009446|FG000|COMPLETED|Treatment Period 1||6||
59886661|NCT01337674|76009447|FG001|COMPLETED|Treatment Period 1||6||
59886662|NCT01337674|76009448|FG002|COMPLETED|Treatment Period 1||6||
59886663|NCT01337674|76009449|FG003|COMPLETED|Treatment Period 1||6||
59886664|NCT01337674|76009446|FG000|NOT COMPLETED|Treatment Period 1||0||
59886665|NCT01337674|76009447|FG001|NOT COMPLETED|Treatment Period 1||1||
59886666|NCT01337674|76009448|FG002|NOT COMPLETED|Treatment Period 1||0||
59886667|NCT01337674|76009449|FG003|NOT COMPLETED|Treatment Period 1||1||
59886668|NCT01337674|76009446|FG000|STARTED|Two-week Washout Period||6||
59886669|NCT01337674|76009447|FG001|STARTED|Two-week Washout Period||6||
59886670|NCT01337674|76009448|FG002|STARTED|Two-week Washout Period||6||
59886671|NCT01337674|76009449|FG003|STARTED|Two-week Washout Period||6||
59886672|NCT01337674|76009446|FG000|COMPLETED|Two-week Washout Period||6||
59886673|NCT01337674|76009447|FG001|COMPLETED|Two-week Washout Period||6||
59886674|NCT01337674|76009448|FG002|COMPLETED|Two-week Washout Period||6||
59886675|NCT01337674|76009449|FG003|COMPLETED|Two-week Washout Period||6||
59886676|NCT01337674|76009446|FG000|NOT COMPLETED|Two-week Washout Period||0||
59886677|NCT01337674|76009447|FG001|NOT COMPLETED|Two-week Washout Period||0||
59886678|NCT01337674|76009448|FG002|NOT COMPLETED|Two-week Washout Period||0||
59886679|NCT01337674|76009449|FG003|NOT COMPLETED|Two-week Washout Period||0||
59886680|NCT01337674|76009446|FG000|STARTED|Treatment Period 2||6||
59886681|NCT01337674|76009447|FG001|STARTED|Treatment Period 2||6||
59886682|NCT01337674|76009448|FG002|STARTED|Treatment Period 2||6||
59886683|NCT01337674|76009449|FG003|STARTED|Treatment Period 2||6||
59886684|NCT01337674|76009446|FG000|COMPLETED|Treatment Period 2||6||
59886685|NCT01337674|76009447|FG001|COMPLETED|Treatment Period 2||6||
59886686|NCT01337674|76009448|FG002|COMPLETED|Treatment Period 2||5||
59886687|NCT01337674|76009449|FG003|COMPLETED|Treatment Period 2||6||
59886688|NCT01337674|76009446|FG000|NOT COMPLETED|Treatment Period 2||0||
59886689|NCT01337674|76009447|FG001|NOT COMPLETED|Treatment Period 2||0||
59886690|NCT01337674|76009448|FG002|NOT COMPLETED|Treatment Period 2||1||
59886691|NCT01337674|76009449|FG003|NOT COMPLETED|Treatment Period 2||0||
59886692|NCT02750410|76009464|FG000|STARTED|Double-Blind Treatment Period||39||
59886693|NCT02750410|76009465|FG001|STARTED|Double-Blind Treatment Period||120||
59886694|NCT02750410|76009464|FG000|Received at Least One Dose of Study Drug|Double-Blind Treatment Period||39||
59886695|NCT02750410|76009465|FG001|Received at Least One Dose of Study Drug|Double-Blind Treatment Period||120||
59886696|NCT02750410|76009464|FG000|COMPLETED|Double-Blind Treatment Period||37||
59886697|NCT02750410|76009465|FG001|COMPLETED|Double-Blind Treatment Period||117||
59886698|NCT02750410|76009464|FG000|NOT COMPLETED|Double-Blind Treatment Period||2||
59950965|NCT01668004|76069883|FG000|COMPLETED|Overall Study||76||
59950966|NCT01668004|76069883|FG000|NOT COMPLETED|Overall Study||25||
59950967|NCT01667926|76069891|FG000|STARTED|Overall Study||13||
59950968|NCT01667926|76069892|FG001|STARTED|Overall Study||13||
59950969|NCT01667926|76069893|FG002|STARTED|Overall Study||11||
59950970|NCT01667926|76069891|FG000|COMPLETED|Overall Study||8||
59950971|NCT01667926|76069892|FG001|COMPLETED|Overall Study||9||
59950972|NCT01667926|76069893|FG002|COMPLETED|Overall Study|Participants in the screen fail group were not randomized in the study.|0||
59950973|NCT01667926|76069891|FG000|NOT COMPLETED|Overall Study||5||
59950974|NCT01667926|76069892|FG001|NOT COMPLETED|Overall Study||4||
59950975|NCT01667926|76069893|FG002|NOT COMPLETED|Overall Study||11||
59950976|NCT02604160|76069901|FG000|STARTED|Overall Study||2||
59950977|NCT02604160|76069902|FG001|STARTED|Overall Study||5||
59950978|NCT02604160|76069901|FG000|Received at Least One Dose of Study Drug|Overall Study||2||
59950979|NCT02604160|76069902|FG001|Received at Least One Dose of Study Drug|Overall Study||5||
59504437|NCT00699491|75596965|FG004|STARTED|Overall Study||8||
59504438|NCT00699491|75596966|FG005|STARTED|Overall Study||22||
59504439|NCT00699491|75596961|FG000|COMPLETED|Overall Study||3||
59504440|NCT00699491|75596962|FG001|COMPLETED|Overall Study||2||
59504441|NCT00699491|75596963|FG002|COMPLETED|Overall Study||7||
59504442|NCT00699491|75596964|FG003|COMPLETED|Overall Study||6||
59504443|NCT00699491|75596965|FG004|COMPLETED|Overall Study||8||
59504444|NCT00699491|75596966|FG005|COMPLETED|Overall Study||22||
59504445|NCT00699491|75596961|FG000|NOT COMPLETED|Overall Study||0||
59504446|NCT00699491|75596962|FG001|NOT COMPLETED|Overall Study||0||
59504447|NCT00699491|75596963|FG002|NOT COMPLETED|Overall Study||0||
59504448|NCT00699491|75596964|FG003|NOT COMPLETED|Overall Study||0||
59504449|NCT00699491|75596965|FG004|NOT COMPLETED|Overall Study||0||
59504450|NCT00699491|75596966|FG005|NOT COMPLETED|Overall Study||0||
59504451|NCT03721965|75596980|FG000|STARTED|Overall Study||2||
59504452|NCT03721965|75596980|FG000|COMPLETED|Overall Study||0||
59504453|NCT03721965|75596980|FG000|NOT COMPLETED|Overall Study||2||
59504454|NCT00699803|75596986|FG000|STARTED|Overall Study||32||
59504455|NCT00699803|75596987|FG001|STARTED|Overall Study||32||
59504456|NCT00699803|75596986|FG000|COMPLETED|Overall Study||30||
59504457|NCT00699803|75596987|FG001|COMPLETED|Overall Study||26||
59504458|NCT00699803|75596986|FG000|NOT COMPLETED|Overall Study||2||
59504459|NCT00699803|75596987|FG001|NOT COMPLETED|Overall Study||6||
59504460|NCT01967433|75596995|FG000|STARTED|Overall Study||61||
59504461|NCT01967433|75596996|FG001|STARTED|Overall Study||59||
59504462|NCT01967433|75596995|FG000|COMPLETED|Overall Study||61||
59504463|NCT01967433|75596996|FG001|COMPLETED|Overall Study||58||
59504464|NCT01967433|75596995|FG000|NOT COMPLETED|Overall Study||0||
59504465|NCT01967433|75596996|FG001|NOT COMPLETED|Overall Study||1||
59504466|NCT02299479|75597008|FG000|STARTED|Overall Study||20||
59504467|NCT02299479|75597008|FG000|COMPLETED|Overall Study||18||
59504468|NCT02299479|75597008|FG000|NOT COMPLETED|Overall Study||2||
59504469|NCT01968057|75597012|FG000|STARTED|Period 1 (Day 1 to Predosing Day 4)||18||
59504470|NCT01968057|75597012|FG000|Received Baricitinib|Period 1 (Day 1 to Predosing Day 4)||18||
59504471|NCT01968057|75597012|FG000|COMPLETED|Period 1 (Day 1 to Predosing Day 4)||18||
59504472|NCT01968057|75597012|FG000|NOT COMPLETED|Period 1 (Day 1 to Predosing Day 4)||0||
59504473|NCT01968057|75597012|FG000|STARTED|Period 2 (At Dosing Day 4 to Day 7)||18||
59504474|NCT01968057|75597012|FG000|Received Baricitinib + Ciclosporin|Period 2 (At Dosing Day 4 to Day 7)||18||
59504475|NCT01968057|75597012|FG000|COMPLETED|Period 2 (At Dosing Day 4 to Day 7)||18||
59504476|NCT01968057|75597012|FG000|NOT COMPLETED|Period 2 (At Dosing Day 4 to Day 7)||0||
59504477|NCT01968135|75597020|FG000|STARTED|Overall Study||16||
59504478|NCT01968135|75597021|FG001|STARTED|Overall Study||16||
59504479|NCT01968135|75597020|FG000|COMPLETED|Overall Study||16||
59504480|NCT01968135|75597021|FG001|COMPLETED|Overall Study||16||
59504481|NCT01968135|75597020|FG000|NOT COMPLETED|Overall Study||0||
59504482|NCT01968135|75597021|FG001|NOT COMPLETED|Overall Study||0||
59504483|NCT00658697|75597027|FG000|STARTED|Overall Study||41||
59504484|NCT00658697|75597027|FG000|COMPLETED|Overall Study||41||
59504485|NCT00658697|75597027|FG000|NOT COMPLETED|Overall Study||0||
59504486|NCT03873116|75597036|FG000|STARTED|Overall Study||6||
59504487|NCT03873116|75597037|FG001|STARTED|Overall Study||7||
59504488|NCT03873116|75597038|FG002|STARTED|Overall Study||6||
59504489|NCT03873116|75597036|FG000|COMPLETED|Overall Study||6||
59504490|NCT03873116|75597037|FG001|COMPLETED|Overall Study||7||
59504491|NCT03873116|75597038|FG002|COMPLETED|Overall Study||5||
59755729|NCT02937116|75874806|FG005|NOT COMPLETED|Overall Study||87||
59755730|NCT02937116|75874807|FG006|NOT COMPLETED|Overall Study||37||
59755731|NCT02937116|75874808|FG007|NOT COMPLETED|Overall Study||21||
59755732|NCT02937116|75874809|FG008|NOT COMPLETED|Overall Study||20||
59886699|NCT02750410|76009465|FG001|NOT COMPLETED|Double-Blind Treatment Period||3||
59886700|NCT02750410|76009464|FG000|STARTED|Open-Label Extension Period||37||
59504492|NCT03873116|75597036|FG000|NOT COMPLETED|Overall Study||0||
59504493|NCT03873116|75597037|FG001|NOT COMPLETED|Overall Study||0||
59504494|NCT03873116|75597038|FG002|NOT COMPLETED|Overall Study||1||
59504495|NCT01968447|75597048|FG000|STARTED|Overall Study||20||
59504496|NCT01968447|75597049|FG001|STARTED|Overall Study||20||
59504497|NCT01968447|75597048|FG000|COMPLETED|Overall Study||20||
59886701|NCT02750410|76009465|FG001|STARTED|Open-Label Extension Period||117||
59886702|NCT02750410|76009464|FG000|COMPLETED|Open-Label Extension Period||31||
59886703|NCT02750410|76009465|FG001|COMPLETED|Open-Label Extension Period||111||
59886704|NCT02750410|76009464|FG000|NOT COMPLETED|Open-Label Extension Period||6||
59504498|NCT01968447|75597049|FG001|COMPLETED|Overall Study||20||
59504499|NCT01968447|75597048|FG000|NOT COMPLETED|Overall Study||0||
59504500|NCT01968447|75597049|FG001|NOT COMPLETED|Overall Study||0||
59504501|NCT00659165|75597057|FG000|STARTED|Overall Study||5||
59504502|NCT00659165|75597058|FG001|STARTED|Overall Study||5||
59504503|NCT00659165|75597057|FG000|COMPLETED|Overall Study||5||
59504504|NCT00659165|75597058|FG001|COMPLETED|Overall Study||5||
59504505|NCT00659165|75597057|FG000|NOT COMPLETED|Overall Study||0||
59504506|NCT00659165|75597058|FG001|NOT COMPLETED|Overall Study||0||
59504507|NCT02299791|75597066|FG000|STARTED|Overall Study||2053||6
59886705|NCT02750410|76009465|FG001|NOT COMPLETED|Open-Label Extension Period||6||
59504508|NCT02299791|75597067|FG001|STARTED|Overall Study||2803||5
59504509|NCT02299791|75597066|FG000|COMPLETED|Overall Study||2053||6
59504510|NCT02299791|75597067|FG001|COMPLETED|Overall Study||2803||5
59886706|NCT02750332|76009475|FG000|STARTED|Treatment Period 1||10||
59886707|NCT02750332|76009476|FG001|STARTED|Treatment Period 1||10||
59886708|NCT02750332|76009475|FG000|COMPLETED|Treatment Period 1||10||
59886709|NCT02750332|76009476|FG001|COMPLETED|Treatment Period 1||9||
59886710|NCT02750332|76009475|FG000|NOT COMPLETED|Treatment Period 1||0||
59886711|NCT02750332|76009476|FG001|NOT COMPLETED|Treatment Period 1||1||
59886712|NCT02750332|76009475|FG000|STARTED|Treatment Period 2||10||
59886713|NCT02750332|76009476|FG001|STARTED|Treatment Period 2||9||
59886714|NCT02750332|76009475|FG000|COMPLETED|Treatment Period 2||10||
59886715|NCT02750332|76009476|FG001|COMPLETED|Treatment Period 2||9||
59886716|NCT02750332|76009475|FG000|NOT COMPLETED|Treatment Period 2||0||
59886717|NCT02750332|76009476|FG001|NOT COMPLETED|Treatment Period 2||0||
59886718|NCT01337596|76009491|FG000|STARTED|Overall Study||7||
59886719|NCT01337596|76009492|FG001|STARTED|Overall Study||7||
59886720|NCT01337596|76009493|FG002|STARTED|Overall Study||7||
59886721|NCT01337596|76009494|FG003|STARTED|Overall Study||7||
59886722|NCT01337596|76009495|FG004|STARTED|Overall Study||7||
59886723|NCT01337596|76009496|FG005|STARTED|Overall Study||7||
59886724|NCT01337596|76009497|FG006|STARTED|Overall Study||12||
59886725|NCT01337596|76009498|FG007|STARTED|Overall Study||2||
59886726|NCT01337596|76009499|FG008|STARTED|Overall Study||7||
59886727|NCT01337596|76009491|FG000|Safety Population|Overall Study||7||
59886728|NCT01337596|76009492|FG001|Safety Population|Overall Study||7||
59886729|NCT01337596|76009493|FG002|Safety Population|Overall Study||7||
59886730|NCT01337596|76009494|FG003|Safety Population|Overall Study||7||
59886731|NCT01337596|76009495|FG004|Safety Population|Overall Study||7||
59886732|NCT01337596|76009496|FG005|Safety Population|Overall Study||7||
59886733|NCT01337596|76009497|FG006|Safety Population|Overall Study||12||
59886734|NCT01337596|76009498|FG007|Safety Population|Overall Study||2||
59886735|NCT01337596|76009499|FG008|Safety Population|Overall Study||7||
59886736|NCT01337596|76009491|FG000|COMPLETED|Overall Study||7||
59886737|NCT01337596|76009492|FG001|COMPLETED|Overall Study||7||
59886738|NCT01337596|76009493|FG002|COMPLETED|Overall Study||7||
59886739|NCT01337596|76009494|FG003|COMPLETED|Overall Study||7||
59886740|NCT01337596|76009495|FG004|COMPLETED|Overall Study||5||
59886741|NCT01337596|76009496|FG005|COMPLETED|Overall Study||7||
59886742|NCT01337596|76009497|FG006|COMPLETED|Overall Study||12||
59886743|NCT01337596|76009498|FG007|COMPLETED|Overall Study||2||
59886744|NCT01337596|76009499|FG008|COMPLETED|Overall Study||7||
59886745|NCT01337596|76009491|FG000|NOT COMPLETED|Overall Study||0||
59886746|NCT01337596|76009492|FG001|NOT COMPLETED|Overall Study||0||
59886747|NCT01337596|76009493|FG002|NOT COMPLETED|Overall Study||0||
59886748|NCT01337596|76009494|FG003|NOT COMPLETED|Overall Study||0||
59886749|NCT01337596|76009495|FG004|NOT COMPLETED|Overall Study||2||
59886750|NCT01337596|76009496|FG005|NOT COMPLETED|Overall Study||0||
59886751|NCT01337596|76009497|FG006|NOT COMPLETED|Overall Study||0||
59886752|NCT01337596|76009498|FG007|NOT COMPLETED|Overall Study||0||
59886753|NCT01337596|76009499|FG008|NOT COMPLETED|Overall Study||0||
59504511|NCT02299791|75597066|FG000|NOT COMPLETED|Overall Study||0||0
59504512|NCT02299791|75597067|FG001|NOT COMPLETED|Overall Study||0||0
59886754|NCT00069095|76009528|FG000|STARTED|Primary Treatment Phase||317||
59504513|NCT00700973|75597075|FG000|STARTED|Overall Study||71||
59504514|NCT00700973|75597076|FG001|STARTED|Overall Study||70||
59886755|NCT00069095|76009529|FG001|STARTED|Primary Treatment Phase||317||
59886756|NCT00069095|76009530|FG002|STARTED|Primary Treatment Phase||350||
59886757|NCT00069095|76009531|FG003|STARTED|Primary Treatment Phase||351||
59886758|NCT00069095|76009532|FG004|STARTED|Primary Treatment Phase||350||
59886759|NCT00069095|76009533|FG005|STARTED|Primary Treatment Phase||349||
59886760|NCT00069095|76009528|FG000|COMPLETED|Primary Treatment Phase||22||
59886761|NCT00069095|76009529|FG001|COMPLETED|Primary Treatment Phase||15||
59886762|NCT00069095|76009530|FG002|COMPLETED|Primary Treatment Phase||36||
59886763|NCT00069095|76009531|FG003|COMPLETED|Primary Treatment Phase||31||
59886764|NCT00069095|76009532|FG004|COMPLETED|Primary Treatment Phase||48||
59886765|NCT00069095|76009533|FG005|COMPLETED|Primary Treatment Phase||48||
59886766|NCT00069095|76009528|FG000|NOT COMPLETED|Primary Treatment Phase||295||
59886767|NCT00069095|76009529|FG001|NOT COMPLETED|Primary Treatment Phase||302||
59504515|NCT00700973|75597075|FG000|COMPLETED|Overall Study||63||
59504516|NCT00700973|75597076|FG001|COMPLETED|Overall Study||63||
59504517|NCT00700973|75597075|FG000|NOT COMPLETED|Overall Study||8||
59504518|NCT00700973|75597076|FG001|NOT COMPLETED|Overall Study||7||
59504519|NCT02299869|75597086|FG000|STARTED|Overall Study||10||
59504520|NCT02299869|75597087|FG001|STARTED|Overall Study||10||
59504521|NCT02299869|75597088|FG002|STARTED|Overall Study||10||
59886768|NCT00069095|76009530|FG002|NOT COMPLETED|Primary Treatment Phase||314||
59886769|NCT00069095|76009531|FG003|NOT COMPLETED|Primary Treatment Phase||320||
59886770|NCT00069095|76009532|FG004|NOT COMPLETED|Primary Treatment Phase||302||
59886771|NCT00069095|76009533|FG005|NOT COMPLETED|Primary Treatment Phase||301||
59886772|NCT00069095|76009528|FG000|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|8||
59886773|NCT00069095|76009529|FG001|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|13||
59886774|NCT00069095|76009530|FG002|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|21||
59886775|NCT00069095|76009531|FG003|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|17||
59886776|NCT00069095|76009532|FG004|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|36||
59886777|NCT00069095|76009533|FG005|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|29||
59886778|NCT00069095|76009528|FG000|COMPLETED|Post-study Treatment Phase||0||
59886779|NCT00069095|76009529|FG001|COMPLETED|Post-study Treatment Phase||0||
59886780|NCT00069095|76009530|FG002|COMPLETED|Post-study Treatment Phase||0||
59886781|NCT00069095|76009531|FG003|COMPLETED|Post-study Treatment Phase||0||
59886782|NCT00069095|76009532|FG004|COMPLETED|Post-study Treatment Phase||0||
59886783|NCT00069095|76009533|FG005|COMPLETED|Post-study Treatment Phase||0||
59886784|NCT00069095|76009528|FG000|NOT COMPLETED|Post-study Treatment Phase||8||
59504522|NCT02299869|75597089|FG003|STARTED|Overall Study||10||
59504523|NCT02299869|75597086|FG000|COMPLETED|Overall Study||10||
59504524|NCT02299869|75597087|FG001|COMPLETED|Overall Study||10||
59886785|NCT00069095|76009529|FG001|NOT COMPLETED|Post-study Treatment Phase||13||
59886786|NCT00069095|76009530|FG002|NOT COMPLETED|Post-study Treatment Phase||21||
59886787|NCT00069095|76009531|FG003|NOT COMPLETED|Post-study Treatment Phase||17||
59886788|NCT00069095|76009532|FG004|NOT COMPLETED|Post-study Treatment Phase||36||
59886789|NCT00069095|76009533|FG005|NOT COMPLETED|Post-study Treatment Phase||29||
59886790|NCT00069095|76009528|FG000|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|284||
59886791|NCT00069095|76009529|FG001|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|299||
59886792|NCT00069095|76009530|FG002|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|298||
59886793|NCT00069095|76009531|FG003|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|299||
59886794|NCT00069095|76009532|FG004|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|278||
59886795|NCT00069095|76009533|FG005|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|272||
59886796|NCT00069095|76009528|FG000|COMPLETED|Follow-up Phase||110||
59886797|NCT00069095|76009529|FG001|COMPLETED|Follow-up Phase||93||
59886798|NCT00069095|76009530|FG002|COMPLETED|Follow-up Phase||178||
59886799|NCT00069095|76009531|FG003|COMPLETED|Follow-up Phase||187||
59886800|NCT00069095|76009532|FG004|COMPLETED|Follow-up Phase||186||
59886801|NCT00069095|76009533|FG005|COMPLETED|Follow-up Phase||171||
59886802|NCT00069095|76009528|FG000|NOT COMPLETED|Follow-up Phase||174||
59886803|NCT00069095|76009529|FG001|NOT COMPLETED|Follow-up Phase||206||
59886804|NCT00069095|76009530|FG002|NOT COMPLETED|Follow-up Phase||120||
59886805|NCT00069095|76009531|FG003|NOT COMPLETED|Follow-up Phase||112||
59886806|NCT00069095|76009532|FG004|NOT COMPLETED|Follow-up Phase||92||
59886807|NCT00069095|76009533|FG005|NOT COMPLETED|Follow-up Phase||101||
59886808|NCT00086411|76009549|FG000|STARTED|Overall Study||70||
59886809|NCT00086411|76009550|FG001|STARTED|Overall Study||63||
59886810|NCT00086411|76009551|FG002|STARTED|Overall Study||62||
59886811|NCT00086411|76009552|FG003|STARTED|Overall Study||65||
59886812|NCT00086411|76009549|FG000|COMPLETED|Overall Study||59||
59886813|NCT00086411|76009550|FG001|COMPLETED|Overall Study||52||
59504525|NCT02299869|75597088|FG002|COMPLETED|Overall Study||10||
59886814|NCT00086411|76009551|FG002|COMPLETED|Overall Study||49||
59886815|NCT00086411|76009552|FG003|COMPLETED|Overall Study||53||
59886816|NCT00086411|76009549|FG000|NOT COMPLETED|Overall Study||11||
59886817|NCT00086411|76009550|FG001|NOT COMPLETED|Overall Study||11||
59886818|NCT00086411|76009551|FG002|NOT COMPLETED|Overall Study||13||
59886819|NCT00086411|76009552|FG003|NOT COMPLETED|Overall Study||12||
59886820|NCT00068237|76009563|FG000|STARTED|Overall Study||49||
59504526|NCT02299869|75597089|FG003|COMPLETED|Overall Study||10||
59504527|NCT02299869|75597086|FG000|NOT COMPLETED|Overall Study||0||
59504528|NCT02299869|75597087|FG001|NOT COMPLETED|Overall Study||0||
59607770|NCT01893359|75718518|FG002|COMPLETED|Overall Study||0||
59504529|NCT02299869|75597088|FG002|NOT COMPLETED|Overall Study||0||
59504530|NCT02299869|75597089|FG003|NOT COMPLETED|Overall Study||0||
59755733|NCT02937116|75874810|FG009|NOT COMPLETED|Overall Study||20||
59755734|NCT02937116|75874811|FG010|NOT COMPLETED|Overall Study||7||
59755735|NCT02937116|75874812|FG011|NOT COMPLETED|Overall Study||7||
59755736|NCT03927105|75874838|FG000|STARTED|Overall Study||4||
59755737|NCT03927105|75874838|FG000|Began Treatment|Overall Study||3||
59755738|NCT03927105|75874838|FG000|Follow-up|Overall Study||3||
59886821|NCT00068237|76009563|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|44||
59886822|NCT00068237|76009563|FG000|NOT COMPLETED|Overall Study||5||
59886823|NCT00055601|76009569|FG000|STARTED|Overall Study||48||
59886824|NCT00055601|76009570|FG001|STARTED|Overall Study||49||
59886825|NCT00055601|76009569|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|46||
59755739|NCT03927105|75874838|FG000|COMPLETED|Overall Study||0|completed through primary outcome measure collection; two participants are still in observation for secondary outcome measure assessments (not yet completed).|
59755740|NCT03927105|75874838|FG000|NOT COMPLETED|Overall Study||4||
59755741|NCT00613327|75874842|FG000|STARTED|Overall Study||345||
59755742|NCT00613327|75874842|FG000|COMPLETED|Overall Study||244||
59504531|NCT00659633|75597096|FG000|STARTED|Overall Study||10||
59504532|NCT00659633|75597096|FG000|COMPLETED|Overall Study||10||
59504533|NCT00659633|75597096|FG000|NOT COMPLETED|Overall Study||0||
59504534|NCT02300025|75597104|FG000|STARTED|Overall Study||10||
59504535|NCT02300025|75597105|FG001|STARTED|Overall Study||6||
59504536|NCT02300025|75597106|FG002|STARTED|Overall Study||6||
59504537|NCT02300025|75597107|FG003|STARTED|Overall Study||6||
59755743|NCT00613327|75874842|FG000|NOT COMPLETED|Overall Study||101||
59755744|NCT00954941|75874848|FG000|STARTED|Overall Study||50||
59755745|NCT00954941|75874849|FG001|STARTED|Overall Study||48||
59755746|NCT00954941|75874848|FG000|COMPLETED|Overall Study||42||
59504538|NCT02300025|75597104|FG000|COMPLETED|Overall Study||10||
59504539|NCT02300025|75597105|FG001|COMPLETED|Overall Study||6||
59504540|NCT02300025|75597106|FG002|COMPLETED|Overall Study||6||
59504541|NCT02300025|75597107|FG003|COMPLETED|Overall Study||6||
59504542|NCT02300025|75597104|FG000|NOT COMPLETED|Overall Study||0||
59504543|NCT02300025|75597105|FG001|NOT COMPLETED|Overall Study||0||
59504544|NCT02300025|75597106|FG002|NOT COMPLETED|Overall Study||0||
59504545|NCT02300025|75597107|FG003|NOT COMPLETED|Overall Study||0||
59504546|NCT00701675|75597121|FG000|STARTED|Overall Study||14||
59504547|NCT00701675|75597122|FG001|STARTED|Overall Study||14||
59504548|NCT00701675|75597123|FG002|STARTED|Overall Study||14||
59504549|NCT00701675|75597121|FG000|COMPLETED|Overall Study||10||
59504550|NCT00701675|75597122|FG001|COMPLETED|Overall Study||6||
59504551|NCT00701675|75597123|FG002|COMPLETED|Overall Study||7||
59504552|NCT00701675|75597121|FG000|NOT COMPLETED|Overall Study||4||
59504553|NCT00701675|75597122|FG001|NOT COMPLETED|Overall Study||8||
59504554|NCT00701675|75597123|FG002|NOT COMPLETED|Overall Study||7||
59504555|NCT01987089|75597133|FG000|STARTED|Overall Study||31||
59504556|NCT01987089|75597134|FG001|STARTED|Overall Study||32||
59755747|NCT00954941|75874849|FG001|COMPLETED|Overall Study||41||
59886826|NCT00055601|76009570|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|47||
59886827|NCT00055601|76009569|FG000|NOT COMPLETED|Overall Study||2||
59886828|NCT00055601|76009570|FG001|NOT COMPLETED|Overall Study||2||
59755748|NCT00954941|75874848|FG000|NOT COMPLETED|Overall Study||8||
59755749|NCT00954941|75874849|FG001|NOT COMPLETED|Overall Study||7||
59755750|NCT00954707|75874855|FG000|STARTED|Overall Study||2509||
59755751|NCT00954707|75874855|FG000|COMPLETED|Overall Study|2342 Subjects completed 12-month Phase 1 follow-up; 167 subjects didn't complete the Phase 1.|2342||
59755752|NCT00954707|75874855|FG000|NOT COMPLETED|Overall Study||167||
59755753|NCT00589797|75874861|FG000|STARTED|Overall Study||264||
59886829|NCT03806231|76009578|FG000|STARTED|Overall Study||4||
59886830|NCT03806231|76009579|FG001|STARTED|Overall Study||4||
59886831|NCT03806231|76009578|FG000|COMPLETED|Overall Study||2||
59886832|NCT03806231|76009579|FG001|COMPLETED|Overall Study||4||
59886833|NCT03806231|76009578|FG000|NOT COMPLETED|Overall Study||2||
59886834|NCT03806231|76009579|FG001|NOT COMPLETED|Overall Study||0||
59886835|NCT00054275|76009585|FG000|STARTED|Overall Study||39||
59886836|NCT00054275|76009585|FG000|COMPLETED|Overall Study||28||
59886837|NCT00054275|76009585|FG000|NOT COMPLETED|Overall Study||11||
59886838|NCT00053417|76009593|FG000|STARTED|Overall Study||47||
59886839|NCT00053417|76009594|FG001|STARTED|Overall Study||52||
59886840|NCT00053417|76009595|FG002|STARTED|Overall Study||50||
59886841|NCT00053417|76009596|FG003|STARTED|Overall Study||57||
59886842|NCT00053417|76009593|FG000|COMPLETED|Overall Study||45||
59886843|NCT00053417|76009594|FG001|COMPLETED|Overall Study||50||
59886844|NCT00053417|76009595|FG002|COMPLETED|Overall Study||49||
59886845|NCT00053417|76009596|FG003|COMPLETED|Overall Study||51||
59886846|NCT00053417|76009593|FG000|NOT COMPLETED|Overall Study||2||
59886847|NCT00053417|76009594|FG001|NOT COMPLETED|Overall Study||2||
59886848|NCT00053417|76009595|FG002|NOT COMPLETED|Overall Study||1||
59886849|NCT00053417|76009596|FG003|NOT COMPLETED|Overall Study||6||
59504557|NCT01987089|75597133|FG000|COMPLETED|Overall Study||30||
59504558|NCT01987089|75597134|FG001|COMPLETED|Overall Study||28||
59504559|NCT01987089|75597133|FG000|NOT COMPLETED|Overall Study||1||
59504560|NCT01987089|75597134|FG001|NOT COMPLETED|Overall Study||4||
59504561|NCT01987401|75597143|FG000|STARTED|Overall Study||591||
59504562|NCT01987401|75597144|FG001|STARTED|Overall Study||591||
59504563|NCT01987401|75597145|FG002|STARTED|Overall Study||60||
59755754|NCT00589797|75874862|FG001|STARTED|Overall Study||112||
59755755|NCT00589797|75874861|FG000|Baseline|Overall Study||218||
59886850|NCT00052715|76009606|FG000|STARTED|Overall Study||31||
59886851|NCT00052715|76009606|FG000|COMPLETED|Overall Study||30||
59886852|NCT00052715|76009606|FG000|NOT COMPLETED|Overall Study||1||
59886853|NCT00051311|76009612|FG000|STARTED|Overall Study||31||
59886854|NCT00051311|76009613|FG001|STARTED|Overall Study||31||
59504564|NCT01987401|75597143|FG000|COMPLETED|Overall Study||137||
59504565|NCT01987401|75597144|FG001|COMPLETED|Overall Study||121||
59504566|NCT01987401|75597145|FG002|COMPLETED|Overall Study||16||
59504567|NCT01987401|75597143|FG000|NOT COMPLETED|Overall Study||454||
59504568|NCT01987401|75597144|FG001|NOT COMPLETED|Overall Study||470||
59504569|NCT01987401|75597145|FG002|NOT COMPLETED|Overall Study||44||
59504570|NCT01969539|75597153|FG000|STARTED|Overall Study||11||
59504571|NCT01969539|75597153|FG000|COMPLETED|Overall Study||11||
59504572|NCT01969539|75597153|FG000|NOT COMPLETED|Overall Study||0||
59504573|NCT00659789|75597159|FG000|STARTED|Overall Study||93||
59886855|NCT00051311|76009612|FG000|COMPLETED|Overall Study||19||
59504574|NCT00659789|75597160|FG001|STARTED|Overall Study||43||
59504575|NCT00659789|75597159|FG000|COMPLETED|Overall Study||86||
59504576|NCT00659789|75597160|FG001|COMPLETED|Overall Study||36||
59504577|NCT00659789|75597159|FG000|NOT COMPLETED|Overall Study||7||
59504578|NCT00659789|75597160|FG001|NOT COMPLETED|Overall Study||7||
59504579|NCT02300727|75597172|FG000|STARTED|Overall Study||0||
59504580|NCT02300727|75597173|FG001|STARTED|Overall Study||0||
59504581|NCT02300727|75597174|FG002|STARTED|Overall Study||3||
59504582|NCT02300727|75597175|FG003|STARTED|Overall Study||3||
59504583|NCT02300727|75597176|FG004|STARTED|Overall Study||0||
59504584|NCT02300727|75597177|FG005|STARTED|Overall Study||0||
59504585|NCT02300727|75597172|FG000|COMPLETED|Overall Study||0||
59504586|NCT02300727|75597173|FG001|COMPLETED|Overall Study||0||
59504587|NCT02300727|75597174|FG002|COMPLETED|Overall Study||3||
59504588|NCT02300727|75597175|FG003|COMPLETED|Overall Study||2||
59504589|NCT02300727|75597176|FG004|COMPLETED|Overall Study||0||
59504590|NCT02300727|75597177|FG005|COMPLETED|Overall Study||0||
59504591|NCT02300727|75597172|FG000|NOT COMPLETED|Overall Study||0||
59504592|NCT02300727|75597173|FG001|NOT COMPLETED|Overall Study||0||
59504593|NCT02300727|75597174|FG002|NOT COMPLETED|Overall Study||0||
59504594|NCT02300727|75597175|FG003|NOT COMPLETED|Overall Study||1||
59504595|NCT02300727|75597176|FG004|NOT COMPLETED|Overall Study||0||
59504596|NCT02300727|75597177|FG005|NOT COMPLETED|Overall Study||0||
59755756|NCT00589797|75874862|FG001|Baseline|Overall Study||106||
59755757|NCT00589797|75874861|FG000|24 Months|Overall Study||191||
59755758|NCT00589797|75874862|FG001|24 Months|Overall Study||89||
59755759|NCT00589797|75874861|FG000|COMPLETED|Overall Study||191||
59755760|NCT00589797|75874862|FG001|COMPLETED|Overall Study||89||
59755761|NCT00589797|75874861|FG000|NOT COMPLETED|Overall Study||73||
59755762|NCT00589797|75874862|FG001|NOT COMPLETED|Overall Study||23||
59755763|NCT00613171|75874868|FG000|STARTED|Overall Study||27||
59886856|NCT00051311|76009613|FG001|COMPLETED|Overall Study||17||
59886857|NCT00051311|76009612|FG000|NOT COMPLETED|Overall Study||12||
59886858|NCT00051311|76009613|FG001|NOT COMPLETED|Overall Study||14||
59504597|NCT03836612|75597193|FG000|STARTED|Overall Study||19011||
59504598|NCT03836612|75597194|FG001|STARTED|Overall Study||76044||
59504599|NCT03836612|75597193|FG000|COMPLETED|Overall Study||19011||
59504600|NCT03836612|75597194|FG001|COMPLETED|Overall Study||76044||
59504601|NCT03836612|75597193|FG000|NOT COMPLETED|Overall Study||0||
59504602|NCT03836612|75597194|FG001|NOT COMPLETED|Overall Study||0||
59504603|NCT00659945|75597213|FG000|STARTED|Overall Study||75||
59504604|NCT00659945|75597214|FG001|STARTED|Overall Study||75||
59504605|NCT00659945|75597213|FG000|COMPLETED|Overall Study||75||
59755764|NCT00613171|75874868|FG000|COMPLETED|Overall Study||13||
59755765|NCT00613171|75874868|FG000|NOT COMPLETED|Overall Study||14||
59755766|NCT00896480|75874873|FG000|STARTED|Overall Study||24||
59755767|NCT00896480|75874873|FG000|COMPLETED|Overall Study||3||
59755768|NCT00896480|75874873|FG000|NOT COMPLETED|Overall Study||21||
59755769|NCT00953225|75874882|FG000|STARTED|Overall Study||46||
59886859|NCT00049673|76009619|FG000|STARTED|Overall Study||166||
59504606|NCT00659945|75597214|FG001|COMPLETED|Overall Study||75||
59504607|NCT00659945|75597213|FG000|NOT COMPLETED|Overall Study||0||
59504608|NCT00659945|75597214|FG001|NOT COMPLETED|Overall Study||0||
59504609|NCT02141555|75597222|FG000|STARTED|Overall Study||2||
59504610|NCT02141555|75597223|FG001|STARTED|Overall Study||2||
59504611|NCT02141555|75597222|FG000|COMPLETED|Overall Study||2||
59504612|NCT02141555|75597223|FG001|COMPLETED|Overall Study||2||
59504613|NCT02141555|75597222|FG000|NOT COMPLETED|Overall Study||0||
59504614|NCT02141555|75597223|FG001|NOT COMPLETED|Overall Study||0||
59504615|NCT02141867|75597229|FG000|STARTED|Overall Study||4021||
59504616|NCT02141867|75597229|FG000|COMPLETED|Overall Study||3927||
59504617|NCT02141867|75597229|FG000|NOT COMPLETED|Overall Study||94||
59504618|NCT02320175|75597235|FG000|STARTED|Overall Study|Patients (n=1574); Parents (n=1222); Physicians (n=478); Nurses (n=264).|3538||
59504619|NCT02320175|75597236|FG001|STARTED|Overall Study|Patients (n=1532); Parents (n=926); Physicians (n=311); Nurses (n=171).|2940||
59886860|NCT00049673|76009620|FG001|STARTED|Overall Study||166||
59504620|NCT02320175|75597235|FG000|COMPLETED|Overall Study|Patients (n=1574); Parents (n=1222); Physicians (n=478); Nurses (n=264).|3538||
59504621|NCT02320175|75597236|FG001|COMPLETED|Overall Study|Patients (n=1532); Parents (n=926); Physicians (n=311); Nurses (n=171).|2940||
59886861|NCT00049673|76009619|FG000|COMPLETED|Overall Study||165||
59886862|NCT00049673|76009620|FG001|COMPLETED|Overall Study||163||
59886863|NCT00049673|76009619|FG000|NOT COMPLETED|Overall Study||1||
59886864|NCT00049673|76009620|FG001|NOT COMPLETED|Overall Study||3||
59886865|NCT00049127|76009631|FG000|STARTED|Overall Study||12||
59886866|NCT00049127|76009632|FG001|STARTED|Overall Study||0||
59886867|NCT00049127|76009633|FG002|STARTED|Overall Study||40||
59886868|NCT00049127|76009634|FG003|STARTED|Overall Study||0||
59886869|NCT00049127|76009635|FG004|STARTED|Overall Study||12||
59886870|NCT00049127|76009631|FG000|COMPLETED|Overall Study||12||
59886871|NCT00049127|76009632|FG001|COMPLETED|Overall Study||0||
59886872|NCT00049127|76009633|FG002|COMPLETED|Overall Study||39||
59886873|NCT00049127|76009634|FG003|COMPLETED|Overall Study||0||
59886874|NCT00049127|76009635|FG004|COMPLETED|Overall Study||12||
59886875|NCT00049127|76009631|FG000|NOT COMPLETED|Overall Study||0||
59886876|NCT00049127|76009632|FG001|NOT COMPLETED|Overall Study||0||
59886877|NCT00049127|76009633|FG002|NOT COMPLETED|Overall Study||1||
59886878|NCT00049127|76009634|FG003|NOT COMPLETED|Overall Study||0||
59886879|NCT00049127|76009635|FG004|NOT COMPLETED|Overall Study||0||
59886880|NCT00066365|76009649|FG000|STARTED|Overall Study||31||
59886881|NCT00066365|76009650|FG001|STARTED|Overall Study||18||
59886882|NCT00066365|76009649|FG000|COMPLETED|Overall Study||8||
59886883|NCT00066365|76009650|FG001|COMPLETED|Overall Study||4||
59886884|NCT00066365|76009649|FG000|NOT COMPLETED|Overall Study||23||
59886885|NCT00066365|76009650|FG001|NOT COMPLETED|Overall Study||14||
59886886|NCT00048581|76009660|FG000|STARTED|Double-Blind Period||258||
59886887|NCT00048581|76009661|FG001|STARTED|Double-Blind Period||133||
59886888|NCT00048581|76009662|FG002|STARTED|Double-Blind Period||0||
59886889|NCT00048581|76009660|FG000|COMPLETED|Double-Blind Period||223||
59886890|NCT00048581|76009661|FG001|COMPLETED|Double-Blind Period||99||
59504622|NCT02320175|75597235|FG000|NOT COMPLETED|Overall Study||0||
59504623|NCT02320175|75597236|FG001|NOT COMPLETED|Overall Study||0||
59504624|NCT00661037|75597247|FG000|STARTED|Overall Study||836||
59504625|NCT00661037|75597248|FG001|STARTED|Overall Study||1284||
59504626|NCT00661037|75597247|FG000|Witdrawn|Overall Study||47||
59504627|NCT00661037|75597248|FG001|Witdrawn|Overall Study||68||
59504628|NCT00661037|75597247|FG000|Deaths|Overall Study||108||
59504629|NCT00661037|75597248|FG001|Deaths|Overall Study||188||
59504630|NCT00661037|75597247|FG000|COMPLETED|Overall Study||682||
59504631|NCT00661037|75597248|FG001|COMPLETED|Overall Study||1027||
59504632|NCT00661037|75597247|FG000|NOT COMPLETED|Overall Study||154||
59504633|NCT00661037|75597248|FG001|NOT COMPLETED|Overall Study||257||
59504634|NCT00588809|75597256|FG000|STARTED|Overall Study||47||
59504635|NCT00588809|75597256|FG000|COMPLETED|Overall Study||47||
59504636|NCT00588809|75597256|FG000|NOT COMPLETED|Overall Study||0||
59886891|NCT00048581|76009662|FG002|COMPLETED|Double-Blind Period||0||
59886892|NCT00048581|76009660|FG000|NOT COMPLETED|Double-Blind Period||35||
59886893|NCT00048581|76009661|FG001|NOT COMPLETED|Double-Blind Period||34||
59886894|NCT00048581|76009662|FG002|NOT COMPLETED|Double-Blind Period||0||
59886895|NCT00048581|76009660|FG000|STARTED|Open-Label Period||0||
59886896|NCT00048581|76009661|FG001|STARTED|Open-Label Period||0||
59886897|NCT00048581|76009662|FG002|STARTED|Open-Label Period||317||
59504637|NCT00588965|75597260|FG000|STARTED|Overall Study||35||
59886898|NCT00048581|76009660|FG000|COMPLETED|Open-Label Period||0||
59886899|NCT00048581|76009661|FG001|COMPLETED|Open-Label Period||0||
59886900|NCT00048581|76009662|FG002|COMPLETED|Open-Label Period||150||
59886901|NCT00048581|76009660|FG000|NOT COMPLETED|Open-Label Period||0||
59886902|NCT00048581|76009661|FG001|NOT COMPLETED|Open-Label Period||0||
59886903|NCT00048581|76009662|FG002|NOT COMPLETED|Open-Label Period||167||
59886904|NCT00048347|76009675|FG000|STARTED|Overall Study||18||
59886905|NCT00048347|76009675|FG000|COMPLETED|Overall Study||16||
59886906|NCT00048347|76009675|FG000|NOT COMPLETED|Overall Study||2||
59886907|NCT00065507|76009681|FG000|STARTED|Overall Study|101 participants were randomized; 1 never treated.|100||
59886908|NCT00065507|76009682|FG001|STARTED|Overall Study|94 participants were randomized; 3 never treated.|91||
59504638|NCT00588965|75597260|FG000|COMPLETED|Overall Study||35||
59504639|NCT00588965|75597260|FG000|NOT COMPLETED|Overall Study||0||
59504640|NCT00589277|75597268|FG000|STARTED|Overall Study||1222||
59504641|NCT00589277|75597269|FG001|STARTED|Overall Study||810||
59504642|NCT00589277|75597268|FG000|Completed 2 Week Follow Up|Overall Study||603||
59504643|NCT00589277|75597269|FG001|Completed 2 Week Follow Up|Overall Study||424||
59504644|NCT00589277|75597268|FG000|Completed 3 Month Follow Up|Overall Study||762||
59504645|NCT00589277|75597269|FG001|Completed 3 Month Follow Up|Overall Study||524||
59504646|NCT00589277|75597268|FG000|COMPLETED|Overall Study||762||
59504647|NCT00589277|75597269|FG001|COMPLETED|Overall Study||524||
59504648|NCT00589277|75597268|FG000|NOT COMPLETED|Overall Study||460||
59504649|NCT00589277|75597269|FG001|NOT COMPLETED|Overall Study||286||
59504650|NCT00702299|75597275|FG000|STARTED|Overall Study||15||
59504651|NCT00702299|75597275|FG000|COMPLETED|Overall Study||15||
60013575|NCT02452359|76129483|FG000|STARTED|Overall Study||54||
59607771|NCT01893359|75718516|FG000|NOT COMPLETED|Overall Study||0||
59607772|NCT01893359|75718517|FG001|NOT COMPLETED|Overall Study||0||
59607773|NCT01893359|75718518|FG002|NOT COMPLETED|Overall Study||0||
59607774|NCT00795665|75718526|FG000|STARTED|Overall Study||7||
59607775|NCT00795665|75718526|FG000|COMPLETED|Overall Study||7||
59607776|NCT00795665|75718526|FG000|NOT COMPLETED|Overall Study||0||
59607777|NCT00791843|75718530|FG000|STARTED|Overall Study|Data unavailable for the study|0||
59607778|NCT00791843|75718530|FG000|COMPLETED|Overall Study|Data unavailable for the study|0||
59607779|NCT00791843|75718530|FG000|NOT COMPLETED|Overall Study||0||
59607780|NCT01836809|75718538|FG000|STARTED|Overall Study||0||
59607781|NCT01836809|75718539|FG001|STARTED|Overall Study||0||
59607782|NCT01836809|75718540|FG002|STARTED|Overall Study||0||
59607783|NCT01836809|75718541|FG003|STARTED|Overall Study||2||
59607784|NCT01836809|75718538|FG000|COMPLETED|Overall Study||0||
59607785|NCT01836809|75718539|FG001|COMPLETED|Overall Study||0||
59607786|NCT01836809|75718540|FG002|COMPLETED|Overall Study||0||
59607787|NCT01836809|75718541|FG003|COMPLETED|Overall Study||0||
59607788|NCT01836809|75718538|FG000|NOT COMPLETED|Overall Study||0||
59504652|NCT00702299|75597275|FG000|NOT COMPLETED|Overall Study||0||
59504653|NCT00702377|75597284|FG000|STARTED|Overall Study||53||
59504654|NCT00702377|75597285|FG001|STARTED|Overall Study||56||
59504655|NCT00702377|75597284|FG000|COMPLETED|Overall Study||52||
59504656|NCT00702377|75597285|FG001|COMPLETED|Overall Study||53||
59504657|NCT00702377|75597284|FG000|NOT COMPLETED|Overall Study||1||
59607789|NCT01836809|75718539|FG001|NOT COMPLETED|Overall Study||0||
59607790|NCT01836809|75718540|FG002|NOT COMPLETED|Overall Study||0||
59607791|NCT01836809|75718541|FG003|NOT COMPLETED|Overall Study||2||
59607792|NCT00780455|75718557|FG000|STARTED|Overall Study||2||
59607793|NCT00780455|75718558|FG001|STARTED|Overall Study||2||
59504658|NCT00702377|75597285|FG001|NOT COMPLETED|Overall Study||3||
59607794|NCT00780455|75718557|FG000|COMPLETED|Overall Study||2||
59607795|NCT00780455|75718558|FG001|COMPLETED|Overall Study||2||
59607796|NCT00780455|75718557|FG000|NOT COMPLETED|Overall Study||0||
59607797|NCT00780455|75718558|FG001|NOT COMPLETED|Overall Study||0||
59607798|NCT00755261|75718564|FG000|STARTED|Overall Study||6||
59607799|NCT00755261|75718564|FG000|COMPLETED|Overall Study||4||
59607800|NCT00755261|75718564|FG000|NOT COMPLETED|Overall Study||2||
59607801|NCT00748085|75718568|FG000|STARTED|Overall Study||5||
59607802|NCT00748085|75718568|FG000|COMPLETED|Overall Study|No analysis -study terminated for business reasons.|5||
59607803|NCT00748085|75718568|FG000|NOT COMPLETED|Overall Study||0||
59607804|NCT03725033|75718574|FG000|STARTED|Overall Study||105||
59607805|NCT03725033|75718575|FG001|STARTED|Overall Study||97||
59504659|NCT00703391|75597293|FG000|STARTED|Overall Study||12||
59607806|NCT03725033|75718574|FG000|COMPLETED|Overall Study||105||
59607807|NCT03725033|75718575|FG001|COMPLETED|Overall Study||97||
59607808|NCT03725033|75718574|FG000|NOT COMPLETED|Overall Study||0||
59607809|NCT03725033|75718575|FG001|NOT COMPLETED|Overall Study||0||
59607810|NCT03724877|75718585|FG000|STARTED|Overall Study||6921|Started are Initiators|
59607811|NCT03724877|75718586|FG001|STARTED|Overall Study||1932|Started are Initiators|
59607812|NCT03724877|75718585|FG000|COMPLETED|Overall Study||6921||
59607813|NCT03724877|75718586|FG001|COMPLETED|Overall Study||1932||
59607814|NCT03724877|75718585|FG000|NOT COMPLETED|Overall Study||0||
59607815|NCT03724877|75718586|FG001|NOT COMPLETED|Overall Study||0||
59607816|NCT03724253|75718597|FG000|STARTED|Overall Study||5|Full Analysis Set (FAS) = all subjects who enter the study and receive the [68Ga]-NeoBOMB1 dose|
59607817|NCT03724253|75718598|FG001|STARTED|Overall Study||5|Full Analysis Set (FAS) = all subjects who enter the study and receive the [68Ga]-NeoBOMB1 dose|
59607818|NCT03724253|75718599|FG002|STARTED|Overall Study||5|Full Analysis Set (FAS) = all subjects who enter the study and receive the [68Ga]-NeoBOMB1 dose|
59886909|NCT00065507|76009681|FG000|Treated (As-Randomized Population)|Overall Study|As-randomized population was used in efficacy analyses, unless otherwise noted.|100||
59886910|NCT00065507|76009682|FG001|Treated (As-Randomized Population)|Overall Study|As-randomized population was used in efficacy analyses, unless otherwise noted.|91||
59886911|NCT00065507|76009681|FG000|Treated (As-Treated Population)|Overall Study|2 subjects randomized to ADV were treated with ETV for the entire dosing period and included in ETV.|102||
59886912|NCT00065507|76009682|FG001|Treated (As-Treated Population)|Overall Study|2 subjects randomized to ADV were treated with ETV for the entire dosing period and included in ETV.|89||
59886913|NCT00065507|76009681|FG000|Treated, Wk 48 (As-Treated Population)|Overall Study|2 subjects randomized to ADV were treated with ETV for the entire dosing period and included in ETV.|102||
59886914|NCT00065507|76009682|FG001|Treated, Wk 48 (As-Treated Population)|Overall Study|2 subjects randomized to ADV were treated with ETV for the entire dosing period and included in ETV.|89||
59886915|NCT00065507|76009681|FG000|Treated, 24-Week Follow-Up Population|Overall Study||25||
59886916|NCT00065507|76009682|FG001|Treated, 24-Week Follow-Up Population|Overall Study||28||
59886917|NCT00065507|76009681|FG000|COMPLETED|Overall Study|Completed first 48 weeks of treatment|71||
59886918|NCT00065507|76009682|FG001|COMPLETED|Overall Study|Completed first 48 weeks of treatment|62||
59886919|NCT00065507|76009681|FG000|NOT COMPLETED|Overall Study||29||
59886920|NCT00065507|76009682|FG001|NOT COMPLETED|Overall Study||29||
59886921|NCT00065429|76009699|FG000|STARTED|Phase I - May 2001 - Oct 2002||4||
59886922|NCT00065429|76009700|FG001|STARTED|Phase I - May 2001 - Oct 2002||3||
59886923|NCT00065429|76009701|FG002|STARTED|Phase I - May 2001 - Oct 2002||4||
59886924|NCT00065429|76009702|FG003|STARTED|Phase I - May 2001 - Oct 2002||4||
59886925|NCT00065429|76009703|FG004|STARTED|Phase I - May 2001 - Oct 2002||9||
59886926|NCT00065429|76009704|FG005|STARTED|Phase I - May 2001 - Oct 2002||4||
59886927|NCT00065429|76009705|FG006|STARTED|Phase I - May 2001 - Oct 2002||4||
59886928|NCT00065429|76009699|FG000|COMPLETED|Phase I - May 2001 - Oct 2002||3||
59886929|NCT00065429|76009700|FG001|COMPLETED|Phase I - May 2001 - Oct 2002||3||
59886930|NCT00065429|76009701|FG002|COMPLETED|Phase I - May 2001 - Oct 2002||3||
59886931|NCT00065429|76009702|FG003|COMPLETED|Phase I - May 2001 - Oct 2002||3||
59886932|NCT00065429|76009703|FG004|COMPLETED|Phase I - May 2001 - Oct 2002||8||
59886933|NCT00065429|76009704|FG005|COMPLETED|Phase I - May 2001 - Oct 2002||2||
59886934|NCT00065429|76009705|FG006|COMPLETED|Phase I - May 2001 - Oct 2002||2||
59886935|NCT00065429|76009699|FG000|NOT COMPLETED|Phase I - May 2001 - Oct 2002||1||
59886936|NCT00065429|76009700|FG001|NOT COMPLETED|Phase I - May 2001 - Oct 2002||0||
59886937|NCT00065429|76009701|FG002|NOT COMPLETED|Phase I - May 2001 - Oct 2002||1||
59886938|NCT00065429|76009702|FG003|NOT COMPLETED|Phase I - May 2001 - Oct 2002||1||
59886939|NCT00065429|76009703|FG004|NOT COMPLETED|Phase I - May 2001 - Oct 2002||1||
59886940|NCT00065429|76009704|FG005|NOT COMPLETED|Phase I - May 2001 - Oct 2002||2||
59886941|NCT00065429|76009705|FG006|NOT COMPLETED|Phase I - May 2001 - Oct 2002||2||
59886942|NCT00065429|76009699|FG000|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0||
59886943|NCT00065429|76009700|FG001|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0||
59886944|NCT00065429|76009701|FG002|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0||
59886945|NCT00065429|76009702|FG003|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0||
59886946|NCT00065429|76009703|FG004|STARTED|Phase II - Apr 2003 - Aug 2008|All 32 patients enrolled in Phase 2 were at 60 mg/m2.|32||
59886947|NCT00065429|76009704|FG005|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0||
59886948|NCT00065429|76009705|FG006|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0||
59886949|NCT00065429|76009699|FG000|COMPLETED|Phase II - Apr 2003 - Aug 2008||0||
59886950|NCT00065429|76009700|FG001|COMPLETED|Phase II - Apr 2003 - Aug 2008||0||
59886951|NCT00065429|76009701|FG002|COMPLETED|Phase II - Apr 2003 - Aug 2008||0||
59886952|NCT00065429|76009702|FG003|COMPLETED|Phase II - Apr 2003 - Aug 2008||0||
59886953|NCT00065429|76009703|FG004|COMPLETED|Phase II - Apr 2003 - Aug 2008||26||
59886954|NCT00065429|76009704|FG005|COMPLETED|Phase II - Apr 2003 - Aug 2008||0||
59886955|NCT00065429|76009705|FG006|COMPLETED|Phase II - Apr 2003 - Aug 2008||0||
59886956|NCT00065429|76009699|FG000|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0||
59886957|NCT00065429|76009700|FG001|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0||
59886958|NCT00065429|76009701|FG002|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0||
59886959|NCT00065429|76009702|FG003|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0||
59886960|NCT00065429|76009703|FG004|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||6||
59886961|NCT00065429|76009704|FG005|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0||
59886962|NCT00065429|76009705|FG006|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0||
59886963|NCT00048035|76009722|FG000|STARTED|Core Period||15||
59886964|NCT00048035|76009723|FG001|STARTED|Core Period||15||
59886965|NCT00048035|76009724|FG002|STARTED|Core Period||15||
59886966|NCT00048035|76009725|FG003|STARTED|Core Period||15||
59886967|NCT00048035|76009726|FG004|STARTED|Core Period||16||
59886968|NCT00048035|76009727|FG005|STARTED|Core Period||15||
59886969|NCT00048035|76009728|FG006|STARTED|Core Period||0||
59886970|NCT00048035|76009729|FG007|STARTED|Core Period||0||
59886971|NCT00048035|76009722|FG000|COMPLETED|Core Period||11||
59886972|NCT00048035|76009723|FG001|COMPLETED|Core Period||13||
59886973|NCT00048035|76009724|FG002|COMPLETED|Core Period||14||
59886974|NCT00048035|76009725|FG003|COMPLETED|Core Period||14||
59607819|NCT03724253|75718600|FG003|STARTED|Overall Study||3|Full Analysis Set (FAS) = all subjects who enter the study and receive the [68Ga]-NeoBOMB1 dose|
59607820|NCT03724253|75718601|FG004|STARTED|Overall Study||1|Full Analysis Set (FAS) = all subjects who enter the study and receive the [68Ga]-NeoBOMB1 dose|
59607821|NCT03724253|75718597|FG000|COMPLETED|Overall Study||5||
59607822|NCT03724253|75718598|FG001|COMPLETED|Overall Study||5||
59607823|NCT03724253|75718599|FG002|COMPLETED|Overall Study||5||
59607824|NCT03724253|75718600|FG003|COMPLETED|Overall Study||3||
59607825|NCT03724253|75718601|FG004|COMPLETED|Overall Study||1||
59607826|NCT03724253|75718597|FG000|NOT COMPLETED|Overall Study||0||
59607827|NCT03724253|75718598|FG001|NOT COMPLETED|Overall Study||0||
59607828|NCT03724253|75718599|FG002|NOT COMPLETED|Overall Study||0||
59607829|NCT03724253|75718600|FG003|NOT COMPLETED|Overall Study||0||
59607830|NCT03724253|75718601|FG004|NOT COMPLETED|Overall Study||0||
59607831|NCT01809899|75718615|FG000|STARTED|Overall Study||8||
59607832|NCT01809899|75718616|FG001|STARTED|Overall Study||4||
59607833|NCT01809899|75718615|FG000|COMPLETED|Overall Study||8||
59607834|NCT01809899|75718616|FG001|COMPLETED|Overall Study||4||
59607835|NCT01809899|75718615|FG000|NOT COMPLETED|Overall Study||0||
59607836|NCT01809899|75718616|FG001|NOT COMPLETED|Overall Study||0||
59607837|NCT00746603|75718623|FG000|STARTED|Overall Study||3||
59607838|NCT00746603|75718623|FG000|COMPLETED|Overall Study||3||
59607839|NCT00746603|75718623|FG000|NOT COMPLETED|Overall Study||0||
59607840|NCT00716807|75718631|FG000|STARTED|Overall Study||8||
59607841|NCT00716807|75718632|FG001|STARTED|Overall Study||5||
59607842|NCT00716807|75718633|FG002|STARTED|Overall Study||18||
59607843|NCT00716807|75718634|FG003|STARTED|Overall Study||15||
59607844|NCT00716807|75718631|FG000|COMPLETED|Overall Study||8||
59607845|NCT00716807|75718632|FG001|COMPLETED|Overall Study||5||
59607846|NCT00716807|75718633|FG002|COMPLETED|Overall Study||18||
59607847|NCT00716807|75718634|FG003|COMPLETED|Overall Study||15||
59607848|NCT00716807|75718631|FG000|NOT COMPLETED|Overall Study||0||
59607849|NCT00716807|75718632|FG001|NOT COMPLETED|Overall Study||0||
59607850|NCT00716807|75718633|FG002|NOT COMPLETED|Overall Study||0||
59607851|NCT00716807|75718634|FG003|NOT COMPLETED|Overall Study||0||
59607852|NCT03461705|75718644|FG000|STARTED|Overall Study||5||
59504660|NCT00703391|75597294|FG001|STARTED|Overall Study||6||
59504661|NCT00703391|75597293|FG000|COMPLETED|Overall Study||12||
59504662|NCT00703391|75597294|FG001|COMPLETED|Overall Study||6||
59504663|NCT00703391|75597293|FG000|NOT COMPLETED|Overall Study||0||
59504664|NCT00703391|75597294|FG001|NOT COMPLETED|Overall Study||0||
59504665|NCT00661583|75597303|FG000|STARTED|Overall Study||10||
59504666|NCT00661583|75597304|FG001|STARTED|Overall Study||10||
59504667|NCT00661583|75597305|FG002|STARTED|Overall Study||10||
59504668|NCT00661583|75597303|FG000|COMPLETED|Overall Study||10||
59504669|NCT00661583|75597304|FG001|COMPLETED|Overall Study||10||
59504670|NCT00661583|75597305|FG002|COMPLETED|Overall Study||10||
59504671|NCT00661583|75597303|FG000|NOT COMPLETED|Overall Study||0||
59504672|NCT00661583|75597304|FG001|NOT COMPLETED|Overall Study||0||
59504673|NCT00661583|75597305|FG002|NOT COMPLETED|Overall Study||0||
59504674|NCT00661895|75597315|FG000|STARTED|Overall Study||49||
59504675|NCT00661895|75597316|FG001|STARTED|Overall Study||50||
59504676|NCT00661895|75597315|FG000|COMPLETED|Overall Study||49||
59504677|NCT00661895|75597316|FG001|COMPLETED|Overall Study||50||
59504678|NCT00661895|75597315|FG000|NOT COMPLETED|Overall Study||0||
59504679|NCT00661895|75597316|FG001|NOT COMPLETED|Overall Study||0||
59504680|NCT00590369|75597324|FG000|STARTED|Overall Study||6||
59504681|NCT00590369|75597325|FG001|STARTED|Overall Study||5||
59504682|NCT00590369|75597324|FG000|COMPLETED|Overall Study|Study stopped early due to difficulty recruiting subjects|6||
59504683|NCT00590369|75597325|FG001|COMPLETED|Overall Study||5||
59504684|NCT00590369|75597324|FG000|NOT COMPLETED|Overall Study||0||
59504685|NCT00590369|75597325|FG001|NOT COMPLETED|Overall Study||0||
59504686|NCT00703937|75597333|FG000|STARTED|Overall Study||343||
59504687|NCT00703937|75597334|FG001|STARTED|Overall Study||360||
59504688|NCT00703937|75597333|FG000|COMPLETED|Overall Study||278||
59504689|NCT00703937|75597334|FG001|COMPLETED|Overall Study||267||
59504690|NCT00703937|75597333|FG000|NOT COMPLETED|Overall Study||65||
59504691|NCT00703937|75597334|FG001|NOT COMPLETED|Overall Study||93||
59504692|NCT00662207|75597340|FG000|STARTED|Overall Study||3||
59504693|NCT00662207|75597340|FG000|COMPLETED|Overall Study||3||
59504694|NCT00662207|75597340|FG000|NOT COMPLETED|Overall Study||0||
59504695|NCT02301039|75597347|FG000|STARTED|Overall Study||42||
59504696|NCT02301039|75597348|FG001|STARTED|Overall Study||42||
59504697|NCT02301039|75597349|FG002|STARTED|Overall Study||60||
59504698|NCT02301039|75597347|FG000|COMPLETED|Overall Study||42||
59504699|NCT02301039|75597348|FG001|COMPLETED|Overall Study||42||
59607853|NCT03461705|75718644|FG000|COMPLETED|Overall Study||5||
59607854|NCT03461705|75718644|FG000|NOT COMPLETED|Overall Study||0||
59504700|NCT02301039|75597349|FG002|COMPLETED|Overall Study||60||
59504701|NCT02301039|75597347|FG000|NOT COMPLETED|Overall Study||0||
59504702|NCT02301039|75597348|FG001|NOT COMPLETED|Overall Study||0||
59607855|NCT03426137|75718651|FG000|STARTED|Overall Study||0||
59504703|NCT02301039|75597349|FG002|NOT COMPLETED|Overall Study||0||
59607856|NCT03426137|75718652|FG001|STARTED|Overall Study||0||
59607857|NCT03426137|75718653|FG002|STARTED|Overall Study||0||
59886975|NCT00048035|76009726|FG004|COMPLETED|Core Period||15||
59886976|NCT00048035|76009727|FG005|COMPLETED|Core Period||14||
59886977|NCT00048035|76009728|FG006|COMPLETED|Core Period||0||
59886978|NCT00048035|76009729|FG007|COMPLETED|Core Period||0||
59886979|NCT00048035|76009722|FG000|NOT COMPLETED|Core Period||4||
59886980|NCT00048035|76009723|FG001|NOT COMPLETED|Core Period||2||
59886981|NCT00048035|76009724|FG002|NOT COMPLETED|Core Period||1||
59504704|NCT00662675|75597359|FG000|STARTED|Overall Study||20||
59504705|NCT00662675|75597360|FG001|STARTED|Overall Study||20||
59504706|NCT00662675|75597359|FG000|COMPLETED|Overall Study||20||
59504707|NCT00662675|75597360|FG001|COMPLETED|Overall Study||20||
59504708|NCT00662675|75597359|FG000|NOT COMPLETED|Overall Study||0||
59504709|NCT00662675|75597360|FG001|NOT COMPLETED|Overall Study||0||
59504710|NCT01970787|75597366|FG000|STARTED|Overall Study||22||
59504711|NCT01970787|75597366|FG000|COMPLETED|Overall Study||21||
59504712|NCT01970787|75597366|FG000|NOT COMPLETED|Overall Study||1||
59504713|NCT00591305|75597372|FG000|STARTED|Overall Study||1||
59504714|NCT00591305|75597373|FG001|STARTED|Overall Study||0||
59504715|NCT00591305|75597372|FG000|1st Follow-up in 2 Wks After Surgery|Overall Study||1||
59504716|NCT00591305|75597373|FG001|1st Follow-up in 2 Wks After Surgery|Overall Study||0||
59504717|NCT00591305|75597372|FG000|COMPLETED|Overall Study||1||
59886982|NCT00048035|76009725|FG003|NOT COMPLETED|Core Period||1||
59886983|NCT00048035|76009726|FG004|NOT COMPLETED|Core Period||1||
59886984|NCT00048035|76009727|FG005|NOT COMPLETED|Core Period||1||
59886985|NCT00048035|76009728|FG006|NOT COMPLETED|Core Period||0||
59886986|NCT00048035|76009729|FG007|NOT COMPLETED|Core Period||0||
59886987|NCT00048035|76009722|FG000|STARTED|Extension Year 1||0||
59504718|NCT00591305|75597373|FG001|COMPLETED|Overall Study||0||
59504719|NCT00591305|75597372|FG000|NOT COMPLETED|Overall Study||0||
59504720|NCT00591305|75597373|FG001|NOT COMPLETED|Overall Study||0||
59504721|NCT01988415|75597380|FG000|STARTED|Overall Study|52 eyes of 26 subjects (paired-eyes: commercial and investigational software)|26||
59504722|NCT01988415|75597380|FG000|COMPLETED|Overall Study||26||
59504723|NCT01988415|75597380|FG000|NOT COMPLETED|Overall Study||0||
59504724|NCT01970943|75597386|FG000|STARTED|Overall Study||11||
59504725|NCT01970943|75597387|FG001|STARTED|Overall Study||12||
59504726|NCT01970943|75597386|FG000|COMPLETED|Overall Study||8||
59504727|NCT01970943|75597387|FG001|COMPLETED|Overall Study||11||
59504728|NCT01970943|75597386|FG000|NOT COMPLETED|Overall Study||3||
59504729|NCT01970943|75597387|FG001|NOT COMPLETED|Overall Study||1||
59504730|NCT00666029|75597395|FG000|STARTED|Overall Study||20||
59504731|NCT00666029|75597396|FG001|STARTED|Overall Study||20||
59504732|NCT00666029|75597395|FG000|COMPLETED|Overall Study||19||
59504733|NCT00666029|75597396|FG001|COMPLETED|Overall Study||20||
59504734|NCT00666029|75597395|FG000|NOT COMPLETED|Overall Study||1||
59504735|NCT00666029|75597396|FG001|NOT COMPLETED|Overall Study||0||
59504736|NCT01971255|75597405|FG000|STARTED|Overall Study||32||
59504737|NCT01971255|75597406|FG001|STARTED|Overall Study||42||
59504738|NCT01971255|75597405|FG000|COMPLETED|Overall Study||31||
59504739|NCT01971255|75597406|FG001|COMPLETED|Overall Study||40||
59504740|NCT01971255|75597405|FG000|NOT COMPLETED|Overall Study||1||
59755770|NCT00953225|75874883|FG001|STARTED|Overall Study||37||
59755771|NCT00953225|75874882|FG000|COMPLETED|Overall Study||44||
59755772|NCT00953225|75874883|FG001|COMPLETED|Overall Study||37||
59755773|NCT00953225|75874882|FG000|NOT COMPLETED|Overall Study||2||
59755774|NCT00953225|75874883|FG001|NOT COMPLETED|Overall Study||0||
59755775|NCT00613015|75874895|FG000|STARTED|Overall Study||13||
59755776|NCT00613015|75874896|FG001|STARTED|Overall Study||12||
59886988|NCT00048035|76009723|FG001|STARTED|Extension Year 1||0||
59504741|NCT01971255|75597406|FG001|NOT COMPLETED|Overall Study||2||
59504742|NCT00592475|75597415|FG000|STARTED|Overall Study||6||
59504743|NCT00592475|75597416|FG001|STARTED|Overall Study||9||
59504744|NCT00592475|75597417|FG002|STARTED|Overall Study||5||
59504745|NCT00592475|75597415|FG000|COMPLETED|Overall Study||6||
59504746|NCT00592475|75597416|FG001|COMPLETED|Overall Study||9||
59504747|NCT00592475|75597417|FG002|COMPLETED|Overall Study||5||
59504748|NCT00592475|75597415|FG000|NOT COMPLETED|Overall Study||0||
59504749|NCT00592475|75597416|FG001|NOT COMPLETED|Overall Study||0||
59504750|NCT00592475|75597417|FG002|NOT COMPLETED|Overall Study||0||
59504751|NCT01989195|75597425|FG000|STARTED|Overall Study||6||
59504752|NCT01989195|75597425|FG000|COMPLETED|Overall Study||6||
59504753|NCT01989195|75597425|FG000|NOT COMPLETED|Overall Study||0||
59504754|NCT00592943|75597434|FG000|STARTED|Overall Study||6||
59886989|NCT00048035|76009724|FG002|STARTED|Extension Year 1||0||
59504755|NCT00592943|75597435|FG001|STARTED|Overall Study||6||
59504756|NCT00592943|75597434|FG000|COMPLETED|Overall Study||6||
59504757|NCT00592943|75597435|FG001|COMPLETED|Overall Study||6||
59504758|NCT00592943|75597434|FG000|NOT COMPLETED|Overall Study||0||
59504759|NCT00592943|75597435|FG001|NOT COMPLETED|Overall Study||0||
59504760|NCT01973205|75597443|FG000|STARTED|Overall Study||453||
59755777|NCT00613015|75874897|FG002|STARTED|Overall Study||26||
59755778|NCT00613015|75874898|FG003|STARTED|Overall Study||24||
59755779|NCT00613015|75874899|FG004|STARTED|Overall Study||15||
59886990|NCT00048035|76009725|FG003|STARTED|Extension Year 1||0||
59886991|NCT00048035|76009726|FG004|STARTED|Extension Year 1||0||
59886992|NCT00048035|76009727|FG005|STARTED|Extension Year 1||0||
59504761|NCT01973205|75597444|FG001|STARTED|Overall Study||447||
59504762|NCT01973205|75597443|FG000|COMPLETED|Overall Study||423||
59504763|NCT01973205|75597444|FG001|COMPLETED|Overall Study||425||
59504764|NCT01973205|75597443|FG000|NOT COMPLETED|Overall Study||30||
59504765|NCT01973205|75597444|FG001|NOT COMPLETED|Overall Study||22||
59504766|NCT01989975|75597450|FG000|STARTED|Overall Study||40||
59504767|NCT01989975|75597450|FG000|COMPLETED|Overall Study||40||
59504768|NCT01989975|75597450|FG000|NOT COMPLETED|Overall Study||0||
59504769|NCT01990677|75597456|FG000|STARTED|Overall Study||12||
59504770|NCT01990677|75597457|FG001|STARTED|Overall Study||6||
59504771|NCT01990677|75597456|FG000|COMPLETED|Overall Study||10||
59504772|NCT01990677|75597457|FG001|COMPLETED|Overall Study||5||
59504773|NCT01990677|75597456|FG000|NOT COMPLETED|Overall Study||2||
59504774|NCT01990677|75597457|FG001|NOT COMPLETED|Overall Study||1||
59504775|NCT00593645|75597463|FG000|STARTED|Overall Study||7||
59504776|NCT00593645|75597463|FG000|COMPLETED|Overall Study||7||
59504777|NCT00593645|75597463|FG000|NOT COMPLETED|Overall Study||0||
59504778|NCT00704717|75597467|FG000|STARTED|Overall Study||185||
59504779|NCT00704717|75597467|FG000|COMPLETED|Overall Study||185||
59504780|NCT00704717|75597467|FG000|NOT COMPLETED|Overall Study||0||
59504781|NCT00594425|75597474|FG000|STARTED|Overall Study||50||
59504782|NCT00594425|75597475|FG001|STARTED|Overall Study||48||
59504783|NCT00594425|75597476|FG002|STARTED|Overall Study||52||
59504784|NCT00594425|75597474|FG000|COMPLETED|Overall Study||43||
59504785|NCT00594425|75597475|FG001|COMPLETED|Overall Study||34||
59504786|NCT00594425|75597476|FG002|COMPLETED|Overall Study||42||
59504787|NCT00594425|75597474|FG000|NOT COMPLETED|Overall Study||7||
59504788|NCT00594425|75597475|FG001|NOT COMPLETED|Overall Study||14||
59504789|NCT00594425|75597476|FG002|NOT COMPLETED|Overall Study||10||
59504790|NCT03686384|75597486|FG000|STARTED|Overall Study||82||
59504791|NCT03686384|75597487|FG001|STARTED|Overall Study||36||
59504792|NCT03686384|75597486|FG000|COMPLETED|Overall Study||75||
59504793|NCT03686384|75597487|FG001|COMPLETED|Overall Study||21||
59504794|NCT03686384|75597486|FG000|NOT COMPLETED|Overall Study||7||
59504795|NCT03686384|75597487|FG001|NOT COMPLETED|Overall Study||15||
59504796|NCT00667511|75597493|FG000|STARTED|Intervention 1: Home DHD||58||
59504797|NCT00667511|75597493|FG000|COMPLETED|Intervention 1: Home DHD||51||
59504798|NCT00667511|75597493|FG000|NOT COMPLETED|Intervention 1: Home DHD||7||
59504799|NCT00667511|75597493|FG000|STARTED|Training/Transition Period||51||
59504800|NCT00667511|75597493|FG000|COMPLETED|Training/Transition Period||43||
59504801|NCT00667511|75597493|FG000|NOT COMPLETED|Training/Transition Period||8||
59504802|NCT00667511|75597493|FG000|STARTED|Intervention 2: Home NHD||43||
59504803|NCT00667511|75597493|FG000|COMPLETED|Intervention 2: Home NHD||39||
59504804|NCT00667511|75597493|FG000|NOT COMPLETED|Intervention 2: Home NHD||4||
59504805|NCT00667589|75597503|FG000|STARTED|Overall Study||1||
59504806|NCT00667589|75597504|FG001|STARTED|Overall Study||0||
59504807|NCT00667589|75597505|FG002|STARTED|Overall Study||3||
59504808|NCT00667589|75597506|FG003|STARTED|Overall Study||2||
59504809|NCT00667589|75597503|FG000|COMPLETED|Overall Study||0||
59504810|NCT00667589|75597504|FG001|COMPLETED|Overall Study||0||
59504811|NCT00667589|75597505|FG002|COMPLETED|Overall Study||0||
59504812|NCT00667589|75597506|FG003|COMPLETED|Overall Study||1||
59504813|NCT00667589|75597503|FG000|NOT COMPLETED|Overall Study||1||
59504814|NCT00667589|75597504|FG001|NOT COMPLETED|Overall Study||0||
59504815|NCT00667589|75597505|FG002|NOT COMPLETED|Overall Study||3||
59504816|NCT00667589|75597506|FG003|NOT COMPLETED|Overall Study||1||
59504817|NCT00667745|75597518|FG000|STARTED|Overall Study||141||
59504818|NCT00667745|75597519|FG001|STARTED|Overall Study||142||
59504819|NCT00667745|75597518|FG000|COMPLETED|Overall Study||116||
59504820|NCT00667745|75597519|FG001|COMPLETED|Overall Study||121||
59504821|NCT00667745|75597518|FG000|NOT COMPLETED|Overall Study||25||
59504822|NCT00667745|75597519|FG001|NOT COMPLETED|Overall Study||21||
59504823|NCT00595361|75597528|FG000|STARTED|Overall Study||12||
59504824|NCT00595361|75597529|FG001|STARTED|Overall Study||18||
59755780|NCT00613015|75874900|FG005|STARTED|Overall Study||19||
59504825|NCT00595361|75597528|FG000|COMPLETED|Overall Study||12||
59504826|NCT00595361|75597529|FG001|COMPLETED|Overall Study||18||
59504827|NCT00595361|75597528|FG000|NOT COMPLETED|Overall Study||0||
59504828|NCT00595361|75597529|FG001|NOT COMPLETED|Overall Study||0||
59504829|NCT00596453|75597537|FG000|STARTED|Overall Study||13||
59504830|NCT00596453|75597538|FG001|STARTED|Overall Study||15||
59504831|NCT00596453|75597537|FG000|COMPLETED|Overall Study||12||
59504832|NCT00596453|75597538|FG001|COMPLETED|Overall Study||12||
59504833|NCT00596453|75597537|FG000|NOT COMPLETED|Overall Study||1||
59504834|NCT00596453|75597538|FG001|NOT COMPLETED|Overall Study||3||
59504835|NCT00597545|75597546|FG000|STARTED|Overall Study||4||
59504836|NCT00597545|75597547|FG001|STARTED|Overall Study||6||
59504837|NCT00597545|75597546|FG000|COMPLETED|Overall Study||4||
59504838|NCT00597545|75597547|FG001|COMPLETED|Overall Study||6||
59504839|NCT00597545|75597546|FG000|NOT COMPLETED|Overall Study||0||
59504840|NCT00597545|75597547|FG001|NOT COMPLETED|Overall Study||0||
59504841|NCT00705107|75597553|FG000|STARTED|Overall Study||267||
59504842|NCT00705107|75597553|FG000|COMPLETED|Overall Study||218||
59504843|NCT00705107|75597553|FG000|NOT COMPLETED|Overall Study||49||
59755781|NCT00613015|75874895|FG000|COMPLETED|Overall Study||13||
59504844|NCT00240331|75597559|FG000|STARTED|Overall Study|Two patients were incorrectly randomised and not included in the analyses.|1389||
59504845|NCT00240331|75597560|FG001|STARTED|Overall Study|One patient was incorrectly randomised and not included in the analyses|1384||
59755782|NCT00613015|75874896|FG001|COMPLETED|Overall Study|One participant did not complete the one-week follow-up visit.|11||
59755783|NCT00613015|75874897|FG002|COMPLETED|Overall Study|Three participants did not complete one-week follow-up visit.|23||
59755784|NCT00613015|75874898|FG003|COMPLETED|Overall Study|Three participants did not complete one-week follow-up visit.|21||
59755785|NCT00613015|75874899|FG004|COMPLETED|Overall Study|Two participants did not complete one-week follow-up visit.|13||
59755786|NCT00613015|75874900|FG005|COMPLETED|Overall Study|Three participants did not complete one-week follow-up visit.|16||
59755787|NCT00613015|75874895|FG000|NOT COMPLETED|Overall Study||0||
59755788|NCT00613015|75874896|FG001|NOT COMPLETED|Overall Study||1||
59755789|NCT00613015|75874897|FG002|NOT COMPLETED|Overall Study||3||
59755790|NCT00613015|75874898|FG003|NOT COMPLETED|Overall Study||3||
59755791|NCT00613015|75874899|FG004|NOT COMPLETED|Overall Study||2||
59755792|NCT00613015|75874900|FG005|NOT COMPLETED|Overall Study||3||
59755793|NCT00803595|75874917|FG000|STARTED|Overall Study||337||
59755794|NCT00803595|75874918|FG001|STARTED|Overall Study||327||
59755795|NCT00803595|75874919|FG002|STARTED|Overall Study||338||
59755796|NCT00803595|75874917|FG000|COMPLETED|Overall Study||322||
59755797|NCT00803595|75874918|FG001|COMPLETED|Overall Study||319||
59755798|NCT00803595|75874919|FG002|COMPLETED|Overall Study||322||
59755799|NCT00803595|75874917|FG000|NOT COMPLETED|Overall Study||15||
59755800|NCT00803595|75874918|FG001|NOT COMPLETED|Overall Study||8||
59755801|NCT00803595|75874919|FG002|NOT COMPLETED|Overall Study||16||
59755802|NCT00953927|75874929|FG000|STARTED|Overall Study||1399||
59755803|NCT00953927|75874930|FG001|STARTED|Overall Study||1398||
59755804|NCT00953927|75874929|FG000|COMPLETED|Overall Study||1294||
59755805|NCT00953927|75874930|FG001|COMPLETED|Overall Study||1303||
59755806|NCT00953927|75874929|FG000|NOT COMPLETED|Overall Study||105||
59755807|NCT00953927|75874930|FG001|NOT COMPLETED|Overall Study||95||
59755808|NCT00611767|75874938|FG000|STARTED|Overall Study||49||
59755809|NCT00611767|75874939|FG001|STARTED|Overall Study||24||
59755810|NCT00611767|75874938|FG000|Thiopental Test Day|Overall Study||3||
59755811|NCT00611767|75874939|FG001|Thiopental Test Day|Overall Study||1||
59755812|NCT00611767|75874938|FG000|Placebo Test Day|Overall Study||6||
59755813|NCT00611767|75874939|FG001|Placebo Test Day|Overall Study||1||
59755814|NCT00611767|75874938|FG000|COMPLETED|Overall Study||40||
59755815|NCT00611767|75874939|FG001|COMPLETED|Overall Study||22||
59755816|NCT00611767|75874938|FG000|NOT COMPLETED|Overall Study||9||
59755817|NCT00611767|75874939|FG001|NOT COMPLETED|Overall Study||2||
59755818|NCT00803361|75874947|FG000|STARTED|Overall Study||108||
59755819|NCT00803361|75874948|FG001|STARTED|Overall Study||102||
59755820|NCT00803361|75874947|FG000|COMPLETED|Overall Study||82||
59755821|NCT00803361|75874948|FG001|COMPLETED|Overall Study||74||
59504846|NCT00240331|75597559|FG000|COMPLETED|Overall Study|Vital status was obtained for all randomised patients at the end of the study|1263||
59755822|NCT00803361|75874947|FG000|NOT COMPLETED|Overall Study||26||
59755823|NCT00803361|75874948|FG001|NOT COMPLETED|Overall Study||28||
59755824|NCT00611533|75874954|FG000|STARTED|First Intervention (6 Weeks)||8||
59755825|NCT00611533|75874955|FG001|STARTED|First Intervention (6 Weeks)||8||
59755826|NCT00611533|75874954|FG000|COMPLETED|First Intervention (6 Weeks)||8||
59755827|NCT00611533|75874955|FG001|COMPLETED|First Intervention (6 Weeks)||6||
59755828|NCT00611533|75874954|FG000|NOT COMPLETED|First Intervention (6 Weeks)||0||
59755829|NCT00611533|75874955|FG001|NOT COMPLETED|First Intervention (6 Weeks)||2||
59755830|NCT00611533|75874954|FG000|STARTED|Second Intervention (6 Weeks)||8||
59755831|NCT00611533|75874955|FG001|STARTED|Second Intervention (6 Weeks)||6||
59755832|NCT00611533|75874954|FG000|COMPLETED|Second Intervention (6 Weeks)||8||
59755833|NCT00611533|75874955|FG001|COMPLETED|Second Intervention (6 Weeks)||4||
59755834|NCT00611533|75874954|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0||
59755835|NCT00611533|75874955|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||2||
59755836|NCT02420990|75874964|FG000|STARTED|Baseline||53||
59755837|NCT02420990|75874965|FG001|STARTED|Baseline||92||
59755838|NCT02420990|75874964|FG000|COMPLETED|Baseline||53||
59755839|NCT02420990|75874965|FG001|COMPLETED|Baseline||92||
59755840|NCT02420990|75874964|FG000|NOT COMPLETED|Baseline||0||
59755841|NCT02420990|75874965|FG001|NOT COMPLETED|Baseline||0||
59504847|NCT00240331|75597560|FG001|COMPLETED|Overall Study|Vital status was obtained for all randomised patients at the end of the study|1250||
59504848|NCT00240331|75597559|FG000|NOT COMPLETED|Overall Study||126||
59504849|NCT00240331|75597560|FG001|NOT COMPLETED|Overall Study||134||
59755842|NCT02420990|75874964|FG000|STARTED|3-Month Follow-up||53||
59755843|NCT02420990|75874965|FG001|STARTED|3-Month Follow-up||92||
59755844|NCT02420990|75874964|FG000|COMPLETED|3-Month Follow-up||53||
59755845|NCT02420990|75874965|FG001|COMPLETED|3-Month Follow-up||92||
59755846|NCT02420990|75874964|FG000|NOT COMPLETED|3-Month Follow-up||0||
59755847|NCT02420990|75874965|FG001|NOT COMPLETED|3-Month Follow-up||0||
59755848|NCT02420990|75874964|FG000|STARTED|6-Month Follow-up||53||
59755849|NCT02420990|75874965|FG001|STARTED|6-Month Follow-up||92||
59755850|NCT02420990|75874964|FG000|COMPLETED|6-Month Follow-up||53||
59755851|NCT02420990|75874965|FG001|COMPLETED|6-Month Follow-up||92||
59755852|NCT02420990|75874964|FG000|NOT COMPLETED|6-Month Follow-up||0||
59504850|NCT00240097|75597566|FG000|STARTED|Part I||30||
59504851|NCT00240097|75597566|FG000|COMPLETED|Part I||26||
59504852|NCT00240097|75597566|FG000|NOT COMPLETED|Part I||4||
59504853|NCT00240097|75597566|FG000|STARTED|Part II||26||
59504854|NCT00240097|75597566|FG000|COMPLETED|Part II||3||
59504855|NCT00240097|75597566|FG000|NOT COMPLETED|Part II||23||
59504856|NCT00597935|75597578|FG000|STARTED|Randomized to Surgical and BPMT Arms||95||
59504857|NCT00597935|75597579|FG001|STARTED|Randomized to Surgical and BPMT Arms||91||
59504858|NCT00597935|75597580|FG002|STARTED|Randomized to Surgical and BPMT Arms||91||
59504859|NCT00597935|75597581|FG003|STARTED|Randomized to Surgical and BPMT Arms||97||
59504860|NCT00597935|75597578|FG000|COMPLETED|Randomized to Surgical and BPMT Arms||95||
59504861|NCT00597935|75597579|FG001|COMPLETED|Randomized to Surgical and BPMT Arms||91||
59504862|NCT00597935|75597580|FG002|COMPLETED|Randomized to Surgical and BPMT Arms||91||
59504863|NCT00597935|75597581|FG003|COMPLETED|Randomized to Surgical and BPMT Arms||97||
59504864|NCT00597935|75597578|FG000|NOT COMPLETED|Randomized to Surgical and BPMT Arms||0||
59504865|NCT00597935|75597579|FG001|NOT COMPLETED|Randomized to Surgical and BPMT Arms||0||
59504866|NCT00597935|75597580|FG002|NOT COMPLETED|Randomized to Surgical and BPMT Arms||0||
59504867|NCT00597935|75597581|FG003|NOT COMPLETED|Randomized to Surgical and BPMT Arms||0||
59504868|NCT00597935|75597578|FG000|STARTED|Baseline to 6-Months||95||
59504869|NCT00597935|75597579|FG001|STARTED|Baseline to 6-Months||91||
59504870|NCT00597935|75597580|FG002|STARTED|Baseline to 6-Months||91||
59504871|NCT00597935|75597581|FG003|STARTED|Baseline to 6-Months||97||
59504872|NCT00597935|75597578|FG000|COMPLETED|Baseline to 6-Months||93||
59504873|NCT00597935|75597579|FG001|COMPLETED|Baseline to 6-Months||87||
59504874|NCT00597935|75597580|FG002|COMPLETED|Baseline to 6-Months||87||
59504875|NCT00597935|75597581|FG003|COMPLETED|Baseline to 6-Months||93||
59504876|NCT00597935|75597578|FG000|NOT COMPLETED|Baseline to 6-Months||2||
59504877|NCT00597935|75597579|FG001|NOT COMPLETED|Baseline to 6-Months||4||
59504878|NCT00597935|75597580|FG002|NOT COMPLETED|Baseline to 6-Months||4||
59504879|NCT00597935|75597581|FG003|NOT COMPLETED|Baseline to 6-Months||4||
59504880|NCT00597935|75597578|FG000|STARTED|6-Months to 24-Months||93||
59504881|NCT00597935|75597579|FG001|STARTED|6-Months to 24-Months||87||
59504882|NCT00597935|75597580|FG002|STARTED|6-Months to 24-Months||87||
59504883|NCT00597935|75597581|FG003|STARTED|6-Months to 24-Months||93||
59504884|NCT00597935|75597578|FG000|COMPLETED|6-Months to 24-Months||76||
59504885|NCT00597935|75597579|FG001|COMPLETED|6-Months to 24-Months||79||
59504886|NCT00597935|75597580|FG002|COMPLETED|6-Months to 24-Months||77||
59504887|NCT00597935|75597581|FG003|COMPLETED|6-Months to 24-Months||85||
59504888|NCT00597935|75597578|FG000|NOT COMPLETED|6-Months to 24-Months||17||
59504889|NCT00597935|75597579|FG001|NOT COMPLETED|6-Months to 24-Months||8||
59504890|NCT00597935|75597580|FG002|NOT COMPLETED|6-Months to 24-Months||10||
59504891|NCT00597935|75597581|FG003|NOT COMPLETED|6-Months to 24-Months||8||
59504892|NCT00739765|75597594|FG000|STARTED|Overall Study||40||
59504893|NCT00739765|75597595|FG001|STARTED|Overall Study||38||
59504894|NCT00739765|75597596|FG002|STARTED|Overall Study||32||
59504895|NCT00739765|75597594|FG000|COMPLETED|Overall Study||34||
59504896|NCT00739765|75597595|FG001|COMPLETED|Overall Study||27||
59504897|NCT00739765|75597596|FG002|COMPLETED|Overall Study||21||
59504898|NCT00739765|75597594|FG000|NOT COMPLETED|Overall Study||6||
59504899|NCT00739765|75597595|FG001|NOT COMPLETED|Overall Study||11||
59504900|NCT00739765|75597596|FG002|NOT COMPLETED|Overall Study||11||
59504901|NCT00705653|75597604|FG000|STARTED|Overall Study||46||
59504902|NCT00705653|75597604|FG000|COMPLETED|Overall Study||46||
59504903|NCT00705653|75597604|FG000|NOT COMPLETED|Overall Study||0||
59504904|NCT00739999|75597610|FG000|STARTED|Overall Study||15||
59504905|NCT00739999|75597611|FG001|STARTED|Overall Study||24||
59504906|NCT00739999|75597610|FG000|COMPLETED|Overall Study||15||
59504907|NCT00739999|75597611|FG001|COMPLETED|Overall Study||24||
59504908|NCT00739999|75597610|FG000|NOT COMPLETED|Overall Study||0||
59504909|NCT00739999|75597611|FG001|NOT COMPLETED|Overall Study||0||
59504910|NCT00600743|75597626|FG000|STARTED|Overall Study||4||
59504911|NCT00600743|75597627|FG001|STARTED|Overall Study||4||
59504912|NCT00600743|75597628|FG002|STARTED|Overall Study||8||
59504913|NCT00600743|75597629|FG003|STARTED|Overall Study||7||
59504914|NCT00600743|75597626|FG000|COMPLETED|Overall Study||4||
59504915|NCT00600743|75597627|FG001|COMPLETED|Overall Study||4||
59504916|NCT00600743|75597628|FG002|COMPLETED|Overall Study||8||
59504917|NCT00600743|75597629|FG003|COMPLETED|Overall Study||7||
59504918|NCT00600743|75597626|FG000|NOT COMPLETED|Overall Study||0||
59504919|NCT00600743|75597627|FG001|NOT COMPLETED|Overall Study||0||
59504920|NCT00600743|75597628|FG002|NOT COMPLETED|Overall Study||0||
59607858|NCT03426137|75718651|FG000|COMPLETED|Overall Study||0||
59504921|NCT00600743|75597629|FG003|NOT COMPLETED|Overall Study||0||
59504922|NCT00601367|75597648|FG000|STARTED|Overall Study||480||
59504923|NCT00601367|75597648|FG000|COMPLETED|Overall Study||293||
59504924|NCT00601367|75597648|FG000|NOT COMPLETED|Overall Study||187||
59504925|NCT03620162|75597657|FG000|STARTED|Overall Study||179||
59504926|NCT03620162|75597658|FG001|STARTED|Overall Study||181||
59504927|NCT03620162|75597659|FG002|STARTED|Overall Study||180||
59504928|NCT03620162|75597660|FG003|STARTED|Overall Study||180||
59504929|NCT03620162|75597661|FG004|STARTED|Overall Study||180||
59504930|NCT03620162|75597657|FG000|Vaccination 1 (V114 or Prevnar 13™)|Overall Study||179||
59504931|NCT03620162|75597658|FG001|Vaccination 1 (V114 or Prevnar 13™)|Overall Study||181||
59504932|NCT03620162|75597659|FG002|Vaccination 1 (V114 or Prevnar 13™)|Overall Study||178||
59755853|NCT02420990|75874965|FG001|NOT COMPLETED|6-Month Follow-up||0||
59755854|NCT02420990|75874964|FG000|STARTED|12-Month Follow-up||53||
59755855|NCT02420990|75874965|FG001|STARTED|12-Month Follow-up||92||
59504933|NCT03620162|75597660|FG003|Vaccination 1 (V114 or Prevnar 13™)|Overall Study||179||
59504934|NCT03620162|75597661|FG004|Vaccination 1 (V114 or Prevnar 13™)|Overall Study||179||
59755856|NCT02420990|75874964|FG000|COMPLETED|12-Month Follow-up||53||
59755857|NCT02420990|75874965|FG001|COMPLETED|12-Month Follow-up||92||
59755858|NCT02420990|75874964|FG000|NOT COMPLETED|12-Month Follow-up||0||
59755859|NCT02420990|75874965|FG001|NOT COMPLETED|12-Month Follow-up||0||
59755860|NCT00953147|75874974|FG000|STARTED|Overall Study||298||
59755861|NCT00953147|75874975|FG001|STARTED|Overall Study||505||
59755862|NCT00953147|75874976|FG002|STARTED|Overall Study||307||
59755863|NCT00953147|75874974|FG000|COMPLETED|Overall Study||261||
59755864|NCT00953147|75874975|FG001|COMPLETED|Overall Study||439||
59755865|NCT00953147|75874976|FG002|COMPLETED|Overall Study||265||
59755866|NCT00953147|75874974|FG000|NOT COMPLETED|Overall Study||37||
59755867|NCT00953147|75874975|FG001|NOT COMPLETED|Overall Study||66||
59755868|NCT00953147|75874976|FG002|NOT COMPLETED|Overall Study||42||
59755869|NCT00803205|75874986|FG000|STARTED|Overall Study||120||
59755870|NCT00803205|75874987|FG001|STARTED|Overall Study||118||
59755871|NCT00803205|75874986|FG000|Completed Week 16|Overall Study||107||
59755872|NCT00803205|75874987|FG001|Completed Week 16|Overall Study||113||
59755873|NCT00803205|75874986|FG000|Completed Week 24|Overall Study||103||
59755874|NCT00803205|75874987|FG001|Completed Week 24|Overall Study||110||
59755875|NCT00803205|75874986|FG000|As-Treated Population*|Overall Study||120|"Randomized participants who received at least 1 dose of study drug~*assessed for safety"|
59755876|NCT00803205|75874987|FG001|As-Treated Population*|Overall Study||118|"Randomized participants who received at least 1 dose of study drug~*assessed for safety"|
59755877|NCT00803205|75874986|FG000|ITT Population|Overall Study||116|Randomized participants with FEV1 data at Baseline and 1 post-Baseline assessment by Week 8|
59755878|NCT00803205|75874987|FG001|ITT Population|Overall Study||116|Randomized participants with FEV1 data at Baseline and 1 post-Baseline assessment by Week 8|
59755879|NCT00803205|75874986|FG000|Per Protocol Population|Overall Study||100|Randomized participants who completed study treatment and had FEV1 data at Week 48|
59755880|NCT00803205|75874987|FG001|Per Protocol Population|Overall Study||103|Randomized participants who completed study treatment and had FEV1 data at Week 48|
59755881|NCT00803205|75874986|FG000|COMPLETED|Overall Study||100||
59755882|NCT00803205|75874987|FG001|COMPLETED|Overall Study||104||
59755883|NCT00803205|75874986|FG000|NOT COMPLETED|Overall Study||20||
59755884|NCT00803205|75874987|FG001|NOT COMPLETED|Overall Study||14||
59755885|NCT00952523|75874993|FG000|STARTED|Overall Study||162||
59755886|NCT00952523|75874993|FG000|COMPLETED|Overall Study||155||
59755887|NCT00952523|75874993|FG000|NOT COMPLETED|Overall Study||7||
59755888|NCT02232737|75875002|FG000|STARTED|Overall Study||254||
59755889|NCT02232737|75875003|FG001|STARTED|Overall Study||235||
59755890|NCT02232737|75875004|FG002|STARTED|Overall Study||286||
59755891|NCT02232737|75875002|FG000|COMPLETED|Overall Study||218||
59755892|NCT02232737|75875003|FG001|COMPLETED|Overall Study||190||
59755893|NCT02232737|75875004|FG002|COMPLETED|Overall Study||224||
59755894|NCT02232737|75875002|FG000|NOT COMPLETED|Overall Study||36||
59755895|NCT02232737|75875003|FG001|NOT COMPLETED|Overall Study||45||
59755896|NCT02232737|75875004|FG002|NOT COMPLETED|Overall Study||62||
59755897|NCT00952367|75875012|FG000|STARTED|Overall Study||3641||
59755898|NCT00952367|75875012|FG000|COMPLETED|Overall Study||3635||
59755899|NCT00952367|75875012|FG000|NOT COMPLETED|Overall Study||6||
59755900|NCT00948857|75875018|FG000|STARTED|Overall Study||3||
59755901|NCT00948857|75875019|FG001|STARTED|Overall Study||2||
59755902|NCT00948857|75875018|FG000|COMPLETED|Overall Study|3 completed and 1 dropped out.|2||
59755903|NCT00948857|75875019|FG001|COMPLETED|Overall Study||2||
59755904|NCT00948857|75875018|FG000|NOT COMPLETED|Overall Study||1||
59755905|NCT00948857|75875019|FG001|NOT COMPLETED|Overall Study||0||
59755906|NCT01778946|75875025|FG000|STARTED|Overall Study||7||
59755907|NCT01778946|75875025|FG000|COMPLETED|Overall Study||4||
59755908|NCT01778946|75875025|FG000|NOT COMPLETED|Overall Study||3||
59755909|NCT00948389|75875034|FG000|STARTED|Overall Study||6||
59755910|NCT00948389|75875035|FG001|STARTED|Overall Study||3||
59755911|NCT00948389|75875036|FG002|STARTED|Overall Study||7||
59755912|NCT00948389|75875037|FG003|STARTED|Overall Study||9||
59755913|NCT00948389|75875038|FG004|STARTED|Overall Study||1||
59755914|NCT00948389|75875034|FG000|COMPLETED|Overall Study||0||
59755915|NCT00948389|75875035|FG001|COMPLETED|Overall Study||0||
59755916|NCT00948389|75875036|FG002|COMPLETED|Overall Study||0||
59755917|NCT00948389|75875037|FG003|COMPLETED|Overall Study||0||
59755918|NCT00948389|75875038|FG004|COMPLETED|Overall Study||0||
59755919|NCT00948389|75875034|FG000|NOT COMPLETED|Overall Study||6||
59755920|NCT00948389|75875035|FG001|NOT COMPLETED|Overall Study||3||
59755921|NCT00948389|75875036|FG002|NOT COMPLETED|Overall Study||7||
59755922|NCT00948389|75875037|FG003|NOT COMPLETED|Overall Study||9||
59755923|NCT00948389|75875038|FG004|NOT COMPLETED|Overall Study||1||
59755924|NCT00948155|75875054|FG000|STARTED|First Intervention 21 Days||14||
59504935|NCT03620162|75597657|FG000|Vaccination 2 (V114 or Prevnar 13™)|Overall Study||176||
59504936|NCT03620162|75597658|FG001|Vaccination 2 (V114 or Prevnar 13™)|Overall Study||175||
59504937|NCT03620162|75597659|FG002|Vaccination 2 (V114 or Prevnar 13™)|Overall Study||166||
59504938|NCT03620162|75597660|FG003|Vaccination 2 (V114 or Prevnar 13™)|Overall Study||169||
59504939|NCT03620162|75597661|FG004|Vaccination 2 (V114 or Prevnar 13™)|Overall Study||173||
59504940|NCT03620162|75597657|FG000|Vaccination 3 (V114 or Prevnar 13™)|Overall Study||175||
59504941|NCT03620162|75597658|FG001|Vaccination 3 (V114 or Prevnar 13™)|Overall Study||174||
59504942|NCT03620162|75597659|FG002|Vaccination 3 (V114 or Prevnar 13™)|Overall Study||161||
59504943|NCT03620162|75597660|FG003|Vaccination 3 (V114 or Prevnar 13™)|Overall Study||167||
59504944|NCT03620162|75597661|FG004|Vaccination 3 (V114 or Prevnar 13™)|Overall Study||173||
59504945|NCT03620162|75597657|FG000|Vaccination 4 (V114 or Prevnar 13™)|Overall Study||165||
59504946|NCT03620162|75597658|FG001|Vaccination 4 (V114 or Prevnar 13™)|Overall Study||168||
59504947|NCT03620162|75597659|FG002|Vaccination 4 (V114 or Prevnar 13™)|Overall Study||150||
59504948|NCT03620162|75597660|FG003|Vaccination 4 (V114 or Prevnar 13™)|Overall Study||162||
59504949|NCT03620162|75597661|FG004|Vaccination 4 (V114 or Prevnar 13™)|Overall Study||168||
59504950|NCT03620162|75597657|FG000|COMPLETED|Overall Study||164||
59504951|NCT03620162|75597658|FG001|COMPLETED|Overall Study||167||
59504952|NCT03620162|75597659|FG002|COMPLETED|Overall Study||147||
59504953|NCT03620162|75597660|FG003|COMPLETED|Overall Study||160||
59504954|NCT03620162|75597661|FG004|COMPLETED|Overall Study||167||
59504955|NCT03620162|75597657|FG000|NOT COMPLETED|Overall Study||15||
59504956|NCT03620162|75597658|FG001|NOT COMPLETED|Overall Study||14||
59504957|NCT03620162|75597659|FG002|NOT COMPLETED|Overall Study||33||
59504958|NCT03620162|75597660|FG003|NOT COMPLETED|Overall Study||20||
59504959|NCT03620162|75597661|FG004|NOT COMPLETED|Overall Study||13||
59504960|NCT00742573|75597677|FG000|STARTED|Overall Study||83||
59504961|NCT00742573|75597678|FG001|STARTED|Overall Study||87||
59504962|NCT00742573|75597677|FG000|Week 12|Overall Study||46||
59504963|NCT00742573|75597678|FG001|Week 12|Overall Study||51||
59504964|NCT00742573|75597677|FG000|Week 24|Overall Study||39||
59504965|NCT00742573|75597678|FG001|Week 24|Overall Study||37||
59504966|NCT00742573|75597677|FG000|Week 52|Overall Study||26||
59504967|NCT00742573|75597678|FG001|Week 52|Overall Study||25||
59504968|NCT00742573|75597677|FG000|COMPLETED|Overall Study||26||
59504969|NCT00742573|75597678|FG001|COMPLETED|Overall Study||25||
59504970|NCT00742573|75597677|FG000|NOT COMPLETED|Overall Study||57||
59504971|NCT00742573|75597678|FG001|NOT COMPLETED|Overall Study||62||
59504972|NCT02321111|75597684|FG000|STARTED|Infusion1||1||
59504973|NCT02321111|75597685|FG001|STARTED|Infusion1||4||
59504974|NCT02321111|75597686|FG002|STARTED|Infusion1||4||
59504975|NCT02321111|75597687|FG003|STARTED|Infusion1||1||
59504976|NCT02321111|75597688|FG004|STARTED|Infusion1||0||
59504977|NCT02321111|75597689|FG005|STARTED|Infusion1||0||
59504978|NCT02321111|75597684|FG000|COMPLETED|Infusion1||1||
59504979|NCT02321111|75597685|FG001|COMPLETED|Infusion1||4||
59504980|NCT02321111|75597686|FG002|COMPLETED|Infusion1||4||
59504981|NCT02321111|75597687|FG003|COMPLETED|Infusion1||1||
59504982|NCT02321111|75597688|FG004|COMPLETED|Infusion1||0||
59504983|NCT02321111|75597689|FG005|COMPLETED|Infusion1||0||
59504984|NCT02321111|75597684|FG000|NOT COMPLETED|Infusion1||0||
59504985|NCT02321111|75597685|FG001|NOT COMPLETED|Infusion1||0||
59504986|NCT02321111|75597686|FG002|NOT COMPLETED|Infusion1||0||
59504987|NCT02321111|75597687|FG003|NOT COMPLETED|Infusion1||0||
59504988|NCT02321111|75597688|FG004|NOT COMPLETED|Infusion1||0||
59607859|NCT03426137|75718652|FG001|COMPLETED|Overall Study||0||
59607860|NCT03426137|75718653|FG002|COMPLETED|Overall Study||0||
59607861|NCT03426137|75718651|FG000|NOT COMPLETED|Overall Study||0||
59607862|NCT03426137|75718652|FG001|NOT COMPLETED|Overall Study||0||
59607863|NCT03426137|75718653|FG002|NOT COMPLETED|Overall Study||0||
59607864|NCT01760993|75718661|FG000|STARTED|Overall Study||0||
59607865|NCT01760993|75718661|FG000|COMPLETED|Overall Study||0||
59607866|NCT01760993|75718661|FG000|NOT COMPLETED|Overall Study||0||
59607867|NCT00669461|75718665|FG000|STARTED|Overall Study||1||
59607868|NCT00669461|75718665|FG000|COMPLETED|Overall Study||1||
59607869|NCT00669461|75718665|FG000|NOT COMPLETED|Overall Study||0||
59607870|NCT00673595|75718672|FG000|STARTED|Overall Study||8||
59607871|NCT00673595|75718673|FG001|STARTED|Overall Study||11||
59607872|NCT00673595|75718672|FG000|COMPLETED|Overall Study||8||
59607873|NCT00673595|75718673|FG001|COMPLETED|Overall Study||11||
59504989|NCT02321111|75597689|FG005|NOT COMPLETED|Infusion1||0||
59504990|NCT02321111|75597684|FG000|STARTED|Washout1 (3-4weeks Between Infusions)||1||
59504991|NCT02321111|75597685|FG001|STARTED|Washout1 (3-4weeks Between Infusions)||4||
59504992|NCT02321111|75597686|FG002|STARTED|Washout1 (3-4weeks Between Infusions)||4||
59504993|NCT02321111|75597687|FG003|STARTED|Washout1 (3-4weeks Between Infusions)||1||
59504994|NCT02321111|75597688|FG004|STARTED|Washout1 (3-4weeks Between Infusions)||0||
59504995|NCT02321111|75597689|FG005|STARTED|Washout1 (3-4weeks Between Infusions)||0||
59607874|NCT00673595|75718672|FG000|NOT COMPLETED|Overall Study||0||
59607875|NCT00673595|75718673|FG001|NOT COMPLETED|Overall Study||0||
59607876|NCT00670631|75718679|FG000|STARTED|Overall Study||0||
59607877|NCT00670631|75718679|FG000|COMPLETED|Overall Study||0||
59607878|NCT00670631|75718679|FG000|NOT COMPLETED|Overall Study||0||
59607879|NCT03248141|75718686|FG000|STARTED|Overall Study||11||
59607880|NCT03248141|75718687|FG001|STARTED|Overall Study|No enrollment occurred in this arm prior to study termination.|0||
59607881|NCT03248141|75718686|FG000|COMPLETED|Overall Study|Participants who were present in the study till termination were considered as completed.|11||
59607882|NCT03248141|75718687|FG001|COMPLETED|Overall Study||0||
59607883|NCT03248141|75718686|FG000|NOT COMPLETED|Overall Study||0||
59607884|NCT03248141|75718687|FG001|NOT COMPLETED|Overall Study||0||
59607885|NCT01754987|75718695|FG000|STARTED|Overall Study||5||
59607886|NCT01754987|75718696|FG001|STARTED|Overall Study||0||
59607887|NCT01754987|75718695|FG000|COMPLETED|Overall Study||5||
59607888|NCT01754987|75718696|FG001|COMPLETED|Overall Study||0||
59607889|NCT01754987|75718695|FG000|NOT COMPLETED|Overall Study||0||
59607890|NCT01754987|75718696|FG001|NOT COMPLETED|Overall Study||0||
59607891|NCT01732211|75718702|FG000|STARTED|Overall Study||1||
59607892|NCT01732211|75718702|FG000|COMPLETED|Overall Study||1||
59607893|NCT01732211|75718702|FG000|NOT COMPLETED|Overall Study||0||
59607894|NCT00652457|75718706|FG000|STARTED|Overall Study||23||
59607895|NCT00652457|75718707|FG001|STARTED|Overall Study||27||
59607896|NCT00652457|75718706|FG000|COMPLETED|Overall Study||23||
59607897|NCT00652457|75718707|FG001|COMPLETED|Overall Study||27||
59607898|NCT00652457|75718706|FG000|NOT COMPLETED|Overall Study||0||
59607899|NCT00652457|75718707|FG001|NOT COMPLETED|Overall Study||0||
59607900|NCT00645359|75718713|FG000|STARTED|Overall Study||9||
59607901|NCT00645359|75718713|FG000|COMPLETED|Overall Study||9||
59886993|NCT00048035|76009728|FG006|STARTED|Extension Year 1|Participants (Cohorts 1, 3, and 5) who completed core, entered extension period (entry optional).|27||
59886994|NCT00048035|76009729|FG007|STARTED|Extension Year 1|Participants (Cohorts 2, 4 and 6) who completed core, entered extension period (entry optional).|26||
59886995|NCT00048035|76009722|FG000|COMPLETED|Extension Year 1||0||
59886996|NCT00048035|76009723|FG001|COMPLETED|Extension Year 1||0||
59886997|NCT00048035|76009724|FG002|COMPLETED|Extension Year 1||0||
59886998|NCT00048035|76009725|FG003|COMPLETED|Extension Year 1||0||
59886999|NCT00048035|76009726|FG004|COMPLETED|Extension Year 1||0||
59887000|NCT00048035|76009727|FG005|COMPLETED|Extension Year 1||0||
59887001|NCT00048035|76009728|FG006|COMPLETED|Extension Year 1||16||
59887002|NCT00048035|76009729|FG007|COMPLETED|Extension Year 1||15||
59887003|NCT00048035|76009722|FG000|NOT COMPLETED|Extension Year 1||0||
59887004|NCT00048035|76009723|FG001|NOT COMPLETED|Extension Year 1||0||
59607902|NCT00645359|75718713|FG000|NOT COMPLETED|Overall Study||0||
59607903|NCT01681589|75718720|FG000|STARTED|Overall Study||0||
59607904|NCT01681589|75718721|FG001|STARTED|Overall Study||0||
59607905|NCT01681589|75718722|FG002|STARTED|Overall Study||0||
59607906|NCT01681589|75718720|FG000|COMPLETED|Overall Study||0||
59607907|NCT01681589|75718721|FG001|COMPLETED|Overall Study||0||
59607908|NCT01681589|75718722|FG002|COMPLETED|Overall Study||0||
59607909|NCT01681589|75718720|FG000|NOT COMPLETED|Overall Study||0||
59607910|NCT01681589|75718721|FG001|NOT COMPLETED|Overall Study||0||
59607911|NCT01681589|75718722|FG002|NOT COMPLETED|Overall Study||0||
59607912|NCT00625703|75718730|FG000|STARTED|Overall Study||0||
59607913|NCT00625703|75718730|FG000|COMPLETED|Overall Study||0||
59607914|NCT00625703|75718730|FG000|NOT COMPLETED|Overall Study||0||
59607915|NCT00616577|75718737|FG000|STARTED|Overall Study||6||
59607916|NCT00616577|75718738|FG001|STARTED|Overall Study||9||
59607917|NCT00616577|75718739|FG002|STARTED|Overall Study||7||
59607918|NCT00616577|75718737|FG000|COMPLETED|Overall Study||6||
59607919|NCT00616577|75718738|FG001|COMPLETED|Overall Study||9||
59607920|NCT00616577|75718739|FG002|COMPLETED|Overall Study||7||
59607921|NCT00616577|75718737|FG000|NOT COMPLETED|Overall Study||0||
59887005|NCT00048035|76009724|FG002|NOT COMPLETED|Extension Year 1||0||
59887006|NCT00048035|76009725|FG003|NOT COMPLETED|Extension Year 1||0||
59607922|NCT00616577|75718738|FG001|NOT COMPLETED|Overall Study||0||
59607923|NCT00616577|75718739|FG002|NOT COMPLETED|Overall Study||0||
59607924|NCT00616343|75718747|FG000|STARTED|Overall Study||9||
59755925|NCT00948155|75875055|FG001|STARTED|First Intervention 21 Days||15||
59755926|NCT00948155|75875054|FG000|COMPLETED|First Intervention 21 Days||12||
59755927|NCT00948155|75875055|FG001|COMPLETED|First Intervention 21 Days||13||
59755928|NCT00948155|75875054|FG000|NOT COMPLETED|First Intervention 21 Days||2||
59755929|NCT00948155|75875055|FG001|NOT COMPLETED|First Intervention 21 Days||2||
59755930|NCT00948155|75875054|FG000|STARTED|Washout 14 Days||12||
59755931|NCT00948155|75875055|FG001|STARTED|Washout 14 Days||13||
59755932|NCT00948155|75875054|FG000|COMPLETED|Washout 14 Days||11||
59755933|NCT00948155|75875055|FG001|COMPLETED|Washout 14 Days||11||
59755934|NCT00948155|75875054|FG000|NOT COMPLETED|Washout 14 Days||1||
59755935|NCT00948155|75875055|FG001|NOT COMPLETED|Washout 14 Days||2||
59607925|NCT00616343|75718747|FG000|COMPLETED|Overall Study||9||
59607926|NCT00616343|75718747|FG000|NOT COMPLETED|Overall Study||0||
59607927|NCT01645709|75718753|FG000|STARTED|Overall Study|Study was terminated; not made unblind|0||
59607928|NCT01645709|75718754|FG001|STARTED|Overall Study|Study was terminated; not made unblind|0||
59607929|NCT01645709|75718753|FG000|COMPLETED|Overall Study|Study was terminated; not made unblind|0||
59607930|NCT01645709|75718754|FG001|COMPLETED|Overall Study|Study was terminated; not made unblind|0||
59607931|NCT01645709|75718753|FG000|NOT COMPLETED|Overall Study||0||
59607932|NCT01645709|75718754|FG001|NOT COMPLETED|Overall Study||0||
59607933|NCT00608465|75718760|FG000|STARTED|Overall Study||4||
59607934|NCT00608465|75718760|FG000|COMPLETED|Overall Study||4||
59607935|NCT00608465|75718760|FG000|NOT COMPLETED|Overall Study||0||
59607936|NCT00608777|75718764|FG000|STARTED|Overall Study||6||
59607937|NCT00608777|75718764|FG000|COMPLETED|Overall Study||6||
59607938|NCT00608777|75718764|FG000|NOT COMPLETED|Overall Study||0||
59607939|NCT01643525|75718768|FG000|STARTED|Overall Study||29||
59607940|NCT01643525|75718768|FG000|COMPLETED|Overall Study||29||
59607941|NCT01643525|75718768|FG000|NOT COMPLETED|Overall Study||0||
59607942|NCT01629329|75718774|FG000|STARTED|Overall Study||0||
59607943|NCT01629329|75718775|FG001|STARTED|Overall Study||0||
59607944|NCT01629329|75718774|FG000|COMPLETED|Overall Study||0||
59607945|NCT01629329|75718775|FG001|COMPLETED|Overall Study||0||
59607946|NCT01629329|75718774|FG000|NOT COMPLETED|Overall Study||0||
59607947|NCT01629329|75718775|FG001|NOT COMPLETED|Overall Study||0||
59607948|NCT01606709|75718783|FG000|STARTED|Overall Study||4||
59607949|NCT01606709|75718784|FG001|STARTED|Overall Study||3||
59607950|NCT01606709|75718783|FG000|COMPLETED|Overall Study||4||
59607951|NCT01606709|75718784|FG001|COMPLETED|Overall Study||3||
59607952|NCT01606709|75718783|FG000|NOT COMPLETED|Overall Study||0||
59607953|NCT01606709|75718784|FG001|NOT COMPLETED|Overall Study||0||
59607954|NCT00585611|75718792|FG000|STARTED|Overall Study||0||
59607955|NCT00585611|75718793|FG001|STARTED|Overall Study||0||
59607956|NCT00585611|75718792|FG000|COMPLETED|Overall Study||0||
59607957|NCT00585611|75718793|FG001|COMPLETED|Overall Study||0||
59607958|NCT00585611|75718792|FG000|NOT COMPLETED|Overall Study||0||
59607959|NCT00585611|75718793|FG001|NOT COMPLETED|Overall Study||0||
59607960|NCT01557881|75718799|FG000|STARTED|Overall Study||98||
59607961|NCT01557881|75718799|FG000|COMPLETED|Overall Study||98||
59607962|NCT01557881|75718799|FG000|NOT COMPLETED|Overall Study||0||
59607963|NCT01556009|75718805|FG000|STARTED|Overall Study||0||
59607964|NCT01556009|75718806|FG001|STARTED|Overall Study||0||
59607965|NCT01556009|75718805|FG000|COMPLETED|Overall Study||0||
59607966|NCT01556009|75718806|FG001|COMPLETED|Overall Study||0||
59607967|NCT01556009|75718805|FG000|NOT COMPLETED|Overall Study||0||
59607968|NCT01556009|75718806|FG001|NOT COMPLETED|Overall Study||0||
59607969|NCT01521143|75718816|FG000|STARTED|Overall Study||40||
59607970|NCT01521143|75718817|FG001|STARTED|Overall Study||36||
59755936|NCT00948155|75875054|FG000|STARTED|Second Intervention 21 Days||11||
59755937|NCT00948155|75875055|FG001|STARTED|Second Intervention 21 Days||11||
59755938|NCT00948155|75875054|FG000|COMPLETED|Second Intervention 21 Days||9||
59755939|NCT00948155|75875055|FG001|COMPLETED|Second Intervention 21 Days||8||
59755940|NCT00948155|75875054|FG000|NOT COMPLETED|Second Intervention 21 Days||2||
59755941|NCT00948155|75875055|FG001|NOT COMPLETED|Second Intervention 21 Days||3||
59755942|NCT00958217|75875065|FG000|STARTED|Overall Study||61||
59755943|NCT00958217|75875066|FG001|STARTED|Overall Study||62||
59762577|NCT03888391|75882385|FG000|COMPLETED|Overall Study||3||
59607971|NCT01521143|75718818|FG002|STARTED|Overall Study||8||
59607972|NCT01521143|75718819|FG003|STARTED|Overall Study||7||
59607973|NCT01521143|75718816|FG000|Received Treatment|Overall Study||20||
59607974|NCT01521143|75718817|FG001|Received Treatment|Overall Study||20||
59607975|NCT01521143|75718818|FG002|Received Treatment|Overall Study||3||
59607976|NCT01521143|75718819|FG003|Received Treatment|Overall Study||4||
59607977|NCT01521143|75718816|FG000|COMPLETED|Overall Study||11||
59607978|NCT01521143|75718817|FG001|COMPLETED|Overall Study||10||
59607979|NCT01521143|75718818|FG002|COMPLETED|Overall Study||0||
59607980|NCT01521143|75718819|FG003|COMPLETED|Overall Study||0||
59607981|NCT01521143|75718816|FG000|NOT COMPLETED|Overall Study||29||
59607982|NCT01521143|75718817|FG001|NOT COMPLETED|Overall Study||26||
59607983|NCT01521143|75718818|FG002|NOT COMPLETED|Overall Study||8||
59607984|NCT01521143|75718819|FG003|NOT COMPLETED|Overall Study||7||
59607985|NCT00546455|75718831|FG000|STARTED|Overall Study||0||
59607986|NCT00546455|75718832|FG001|STARTED|Overall Study||0||
59607987|NCT00546455|75718831|FG000|COMPLETED|Overall Study||0||
59607988|NCT00546455|75718832|FG001|COMPLETED|Overall Study||0||
59607989|NCT00546455|75718831|FG000|NOT COMPLETED|Overall Study||0||
59607990|NCT00546455|75718832|FG001|NOT COMPLETED|Overall Study||0||
59607991|NCT01525745|75718840|FG000|STARTED|Overall Study||4||
59607992|NCT01525745|75718841|FG001|STARTED|Overall Study||2||
59607993|NCT01525745|75718840|FG000|COMPLETED|Overall Study||3||
59607994|NCT01525745|75718841|FG001|COMPLETED|Overall Study||1||
59607995|NCT01525745|75718840|FG000|NOT COMPLETED|Overall Study||1||
59607996|NCT01525745|75718841|FG001|NOT COMPLETED|Overall Study||1||
59607997|NCT00533351|75718851|FG000|STARTED|Period 1||7||
59607998|NCT00533351|75718852|FG001|STARTED|Period 1||2||
59607999|NCT00533351|75718851|FG000|COMPLETED|Period 1||5||
59608000|NCT00533351|75718852|FG001|COMPLETED|Period 1||1||
59608001|NCT00533351|75718851|FG000|NOT COMPLETED|Period 1||2||
59608002|NCT00533351|75718852|FG001|NOT COMPLETED|Period 1||1||
59887007|NCT00048035|76009726|FG004|NOT COMPLETED|Extension Year 1||0||
59887008|NCT00048035|76009727|FG005|NOT COMPLETED|Extension Year 1||0||
59887009|NCT00048035|76009728|FG006|NOT COMPLETED|Extension Year 1||11||
59887010|NCT00048035|76009729|FG007|NOT COMPLETED|Extension Year 1||11||
59887011|NCT00048035|76009722|FG000|STARTED|Extension Year 2||0||
59887012|NCT00048035|76009723|FG001|STARTED|Extension Year 2||0||
59887013|NCT00048035|76009724|FG002|STARTED|Extension Year 2||0||
59887014|NCT00048035|76009725|FG003|STARTED|Extension Year 2||0||
59887015|NCT00048035|76009726|FG004|STARTED|Extension Year 2||0||
59887016|NCT00048035|76009727|FG005|STARTED|Extension Year 2||0||
59887017|NCT00048035|76009728|FG006|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|14||
59887018|NCT00048035|76009729|FG007|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|13||
59887019|NCT00048035|76009722|FG000|COMPLETED|Extension Year 2||0||
59887020|NCT00048035|76009723|FG001|COMPLETED|Extension Year 2||0||
59887021|NCT00048035|76009724|FG002|COMPLETED|Extension Year 2||0||
59887022|NCT00048035|76009725|FG003|COMPLETED|Extension Year 2||0||
59887023|NCT00048035|76009726|FG004|COMPLETED|Extension Year 2||0||
59887024|NCT00048035|76009727|FG005|COMPLETED|Extension Year 2||0||
59887025|NCT00048035|76009728|FG006|COMPLETED|Extension Year 2||11||
59887026|NCT00048035|76009729|FG007|COMPLETED|Extension Year 2||10||
59887027|NCT00048035|76009722|FG000|NOT COMPLETED|Extension Year 2||0||
59887028|NCT00048035|76009723|FG001|NOT COMPLETED|Extension Year 2||0||
59504996|NCT02321111|75597684|FG000|COMPLETED|Washout1 (3-4weeks Between Infusions)||1||
59504997|NCT02321111|75597685|FG001|COMPLETED|Washout1 (3-4weeks Between Infusions)||4||
59504998|NCT02321111|75597686|FG002|COMPLETED|Washout1 (3-4weeks Between Infusions)||4||
59504999|NCT02321111|75597687|FG003|COMPLETED|Washout1 (3-4weeks Between Infusions)||1||
59505000|NCT02321111|75597688|FG004|COMPLETED|Washout1 (3-4weeks Between Infusions)||0||
59505001|NCT02321111|75597689|FG005|COMPLETED|Washout1 (3-4weeks Between Infusions)||0||
59505002|NCT02321111|75597684|FG000|NOT COMPLETED|Washout1 (3-4weeks Between Infusions)||0||
59505003|NCT02321111|75597685|FG001|NOT COMPLETED|Washout1 (3-4weeks Between Infusions)||0||
59505004|NCT02321111|75597686|FG002|NOT COMPLETED|Washout1 (3-4weeks Between Infusions)||0||
59505005|NCT02321111|75597687|FG003|NOT COMPLETED|Washout1 (3-4weeks Between Infusions)||0||
59505006|NCT02321111|75597688|FG004|NOT COMPLETED|Washout1 (3-4weeks Between Infusions)||0||
59505007|NCT02321111|75597689|FG005|NOT COMPLETED|Washout1 (3-4weeks Between Infusions)||0||
59505008|NCT02321111|75597684|FG000|STARTED|Infusion2||1||
59505009|NCT02321111|75597685|FG001|STARTED|Infusion2||4||
59505010|NCT02321111|75597686|FG002|STARTED|Infusion2||4||
59505011|NCT02321111|75597687|FG003|STARTED|Infusion2||1||
59505012|NCT02321111|75597688|FG004|STARTED|Infusion2||0||
59505013|NCT02321111|75597689|FG005|STARTED|Infusion2||0||
59505014|NCT02321111|75597684|FG000|COMPLETED|Infusion2||1||
59505015|NCT02321111|75597685|FG001|COMPLETED|Infusion2||4||
59505016|NCT02321111|75597686|FG002|COMPLETED|Infusion2||4||
59505017|NCT02321111|75597687|FG003|COMPLETED|Infusion2||1||
59505018|NCT02321111|75597688|FG004|COMPLETED|Infusion2||0||
59505019|NCT02321111|75597689|FG005|COMPLETED|Infusion2||0||
59505020|NCT02321111|75597684|FG000|NOT COMPLETED|Infusion2||0||
59505021|NCT02321111|75597685|FG001|NOT COMPLETED|Infusion2||0||
59505022|NCT02321111|75597686|FG002|NOT COMPLETED|Infusion2||0||
59608003|NCT00533351|75718851|FG000|STARTED|Period 2||5||
59505023|NCT02321111|75597687|FG003|NOT COMPLETED|Infusion2||0||
59887029|NCT00048035|76009724|FG002|NOT COMPLETED|Extension Year 2||0||
59887030|NCT00048035|76009725|FG003|NOT COMPLETED|Extension Year 2||0||
59887031|NCT00048035|76009726|FG004|NOT COMPLETED|Extension Year 2||0||
59887032|NCT00048035|76009727|FG005|NOT COMPLETED|Extension Year 2||0||
59887033|NCT00048035|76009728|FG006|NOT COMPLETED|Extension Year 2||3||
59505024|NCT02321111|75597688|FG004|NOT COMPLETED|Infusion2||0||
59505025|NCT02321111|75597689|FG005|NOT COMPLETED|Infusion2||0||
59505026|NCT02321111|75597684|FG000|STARTED|Washout2 (3-4weeks Between Infusions)||1||
59608004|NCT00533351|75718852|FG001|STARTED|Period 2||1||
59608005|NCT00533351|75718851|FG000|COMPLETED|Period 2||5||
59887034|NCT00048035|76009729|FG007|NOT COMPLETED|Extension Year 2||3||
59608006|NCT00533351|75718852|FG001|COMPLETED|Period 2||1||
59608007|NCT00533351|75718851|FG000|NOT COMPLETED|Period 2||0||
59608008|NCT00533351|75718852|FG001|NOT COMPLETED|Period 2||0||
59608009|NCT00533351|75718851|FG000|STARTED|Period 3|Three out of the five patients who completed Period 2 continued to Period 3|3||
59608010|NCT00533351|75718852|FG001|STARTED|Period 3|No patients continued to Period 3|0||
59608011|NCT00533351|75718851|FG000|COMPLETED|Period 3||3||
59608012|NCT00533351|75718852|FG001|COMPLETED|Period 3||0||
59608013|NCT00533351|75718851|FG000|NOT COMPLETED|Period 3||0||
59608014|NCT00533351|75718852|FG001|NOT COMPLETED|Period 3||0||
59608015|NCT00528437|75718858|FG000|STARTED|Overall Study||46||
59608016|NCT00528437|75718858|FG000|COMPLETED|Overall Study||46||
59608017|NCT00528437|75718858|FG000|NOT COMPLETED|Overall Study||0||
59608018|NCT00506909|75718862|FG000|STARTED|Overall Study||0||
59608019|NCT00506909|75718862|FG000|COMPLETED|Overall Study||0||
59608020|NCT00506909|75718862|FG000|NOT COMPLETED|Overall Study||0||
59608021|NCT00500045|75718866|FG000|STARTED|Overall Study||0||
59608022|NCT00500045|75718866|FG000|COMPLETED|Overall Study||0||
59608023|NCT00500045|75718866|FG000|NOT COMPLETED|Overall Study||0||
59608024|NCT00456989|75718870|FG000|STARTED|Overall Study||39||
59887035|NCT00047879|76009746|FG000|STARTED|Overall Study||4||
59887036|NCT00047879|76009747|FG001|STARTED|Overall Study||3||
59887037|NCT00047879|76009746|FG000|COMPLETED|Overall Study||0||
59887038|NCT00047879|76009747|FG001|COMPLETED|Overall Study||0||
59887039|NCT00047879|76009746|FG000|NOT COMPLETED|Overall Study||4||
59887040|NCT00047879|76009747|FG001|NOT COMPLETED|Overall Study||3||
59887041|NCT00064337|76009753|FG000|STARTED|PBSCC or Induction/PBSCC|104 patients were registered, 93 of whom were eligible and analyzable.|93||
59887042|NCT00064337|76009753|FG000|COMPLETED|PBSCC or Induction/PBSCC||73||
59608025|NCT00456989|75718870|FG000|COMPLETED|Overall Study||39||
59608026|NCT00456989|75718870|FG000|NOT COMPLETED|Overall Study||0||
59608027|NCT00428207|75718875|FG000|STARTED|Overall Study||2||
59608028|NCT00428207|75718876|FG001|STARTED|Overall Study||2||
59608029|NCT00428207|75718875|FG000|COMPLETED|Overall Study||2||
59608030|NCT00428207|75718876|FG001|COMPLETED|Overall Study||2||
59608031|NCT00428207|75718875|FG000|NOT COMPLETED|Overall Study||0||
59608032|NCT00428207|75718876|FG001|NOT COMPLETED|Overall Study||0||
59608033|NCT00374543|75718884|FG000|STARTED|Overall Study||2||
59608034|NCT00374543|75718885|FG001|STARTED|Overall Study||1||
59608035|NCT00374543|75718884|FG000|COMPLETED|Overall Study||2||
59608036|NCT00374543|75718885|FG001|COMPLETED|Overall Study||1||
59608037|NCT00374543|75718884|FG000|NOT COMPLETED|Overall Study||0||
59608038|NCT00374543|75718885|FG001|NOT COMPLETED|Overall Study||0||
59608039|NCT00314093|75718891|FG000|STARTED|Overall Study||0||
59608040|NCT00314093|75718891|FG000|COMPLETED|Overall Study||0||
59608041|NCT00314093|75718891|FG000|NOT COMPLETED|Overall Study||0||
59608042|NCT00299195|75718897|FG000|STARTED|Overall Study||30||
59608043|NCT00299195|75718898|FG001|STARTED|Overall Study||33||
59608044|NCT00299195|75718897|FG000|COMPLETED|Overall Study||30||
59608045|NCT00299195|75718898|FG001|COMPLETED|Overall Study||33||
59608046|NCT00299195|75718897|FG000|NOT COMPLETED|Overall Study||0||
59608047|NCT00299195|75718898|FG001|NOT COMPLETED|Overall Study||0||
59608048|NCT01351415|75718906|FG000|STARTED|Overall Study||245||
59608049|NCT01351415|75718907|FG001|STARTED|Overall Study||240||
59608050|NCT01351415|75718906|FG000|Treated Participants|Overall Study||243||
59608051|NCT01351415|75718907|FG001|Treated Participants|Overall Study||232||
59887043|NCT00064337|76009753|FG000|NOT COMPLETED|PBSCC or Induction/PBSCC||20||
59950980|NCT02604160|76069901|FG000|COMPLETED|Overall Study||2||
59608052|NCT01351415|75718906|FG000|COMPLETED|Overall Study||0||
59608053|NCT01351415|75718907|FG001|COMPLETED|Overall Study||0||
59608054|NCT01351415|75718906|FG000|NOT COMPLETED|Overall Study||245||
59608055|NCT01351415|75718907|FG001|NOT COMPLETED|Overall Study||240||
59608056|NCT00281879|75718921|FG000|STARTED|Overall Study||128||
59608057|NCT00281879|75718922|FG001|STARTED|Overall Study||36||
59608058|NCT00281879|75718923|FG002|STARTED|Overall Study||20||
59608059|NCT00281879|75718924|FG003|STARTED|Overall Study||0||
59608060|NCT00281879|75718925|FG004|STARTED|Overall Study||6||
59608061|NCT00281879|75718926|FG005|STARTED|Overall Study||9||
59608062|NCT00281879|75718927|FG006|STARTED|Overall Study||0||
59608063|NCT00281879|75718928|FG007|STARTED|Overall Study||1||
59608064|NCT00281879|75718921|FG000|COMPLETED|Overall Study||0||
59608065|NCT00281879|75718922|FG001|COMPLETED|Overall Study||0||
59608066|NCT00281879|75718923|FG002|COMPLETED|Overall Study||0||
59608067|NCT00281879|75718924|FG003|COMPLETED|Overall Study||0||
59608068|NCT00281879|75718925|FG004|COMPLETED|Overall Study||0||
59608069|NCT00281879|75718926|FG005|COMPLETED|Overall Study||0||
59608070|NCT00281879|75718927|FG006|COMPLETED|Overall Study||0||
59608071|NCT00281879|75718928|FG007|COMPLETED|Overall Study||0||
59608072|NCT00281879|75718921|FG000|NOT COMPLETED|Overall Study||128||
59608073|NCT00281879|75718922|FG001|NOT COMPLETED|Overall Study||36||
59608074|NCT00281879|75718923|FG002|NOT COMPLETED|Overall Study||20||
59608075|NCT00281879|75718924|FG003|NOT COMPLETED|Overall Study||0||
59608076|NCT00281879|75718925|FG004|NOT COMPLETED|Overall Study||6||
59608077|NCT00281879|75718926|FG005|NOT COMPLETED|Overall Study||9||
59608078|NCT00281879|75718927|FG006|NOT COMPLETED|Overall Study||0||
59608079|NCT00281879|75718928|FG007|NOT COMPLETED|Overall Study||1||
59608080|NCT00240227|75718946|FG000|STARTED|Overall Study||8||
59608081|NCT00240227|75718946|FG000|COMPLETED|Overall Study||8||
59608082|NCT00240227|75718946|FG000|NOT COMPLETED|Overall Study||0||
59608083|NCT00205049|75718955|FG000|STARTED|Overall Study||0||
59608084|NCT00205049|75718956|FG001|STARTED|Overall Study||0||
59608085|NCT00205049|75718955|FG000|COMPLETED|Overall Study||0||
59608086|NCT00205049|75718956|FG001|COMPLETED|Overall Study||0||
59608087|NCT00205049|75718955|FG000|NOT COMPLETED|Overall Study||0||
59608088|NCT00205049|75718956|FG001|NOT COMPLETED|Overall Study||0||
59608089|NCT00176501|75718962|FG000|STARTED|Overall Study||3||
59608090|NCT00176501|75718962|FG000|COMPLETED|Overall Study||3||
59608091|NCT00176501|75718962|FG000|NOT COMPLETED|Overall Study||0||
59608092|NCT00133679|75718968|FG000|STARTED|Overall Study||0||
59608093|NCT00133679|75718969|FG001|STARTED|Overall Study||0||
59608094|NCT00133679|75718968|FG000|COMPLETED|Overall Study||0||
59608095|NCT00133679|75718969|FG001|COMPLETED|Overall Study||0||
59608096|NCT00133679|75718968|FG000|NOT COMPLETED|Overall Study||0||
59608097|NCT00133679|75718969|FG001|NOT COMPLETED|Overall Study||0||
59608098|NCT00002975|75718975|FG000|STARTED|Overall Study||180||
59608099|NCT00002975|75718975|FG000|Treated With Study Therapy|Overall Study||175||
59608100|NCT00002975|75718975|FG000|COMPLETED|Overall Study||175||
59608101|NCT00002975|75718975|FG000|NOT COMPLETED|Overall Study||5||
59608102|NCT02221817|75718981|FG000|STARTED|Overall Study||0||
59608103|NCT02221817|75718982|FG001|STARTED|Overall Study||0||
59608104|NCT02221817|75718981|FG000|COMPLETED|Overall Study||0||
59608105|NCT02221817|75718982|FG001|COMPLETED|Overall Study||0||
59608106|NCT02221817|75718981|FG000|NOT COMPLETED|Overall Study||0||
59608107|NCT02221817|75718982|FG001|NOT COMPLETED|Overall Study||0||
59608108|NCT00521885|75718990|FG000|STARTED|Overall Study||0||
59608109|NCT00521885|75718991|FG001|STARTED|Overall Study||0||
59608110|NCT00521885|75718990|FG000|COMPLETED|Overall Study||0||
59608111|NCT00521885|75718991|FG001|COMPLETED|Overall Study||0||
59608112|NCT00521885|75718990|FG000|NOT COMPLETED|Overall Study||0||
59608113|NCT00521885|75718991|FG001|NOT COMPLETED|Overall Study||0||
59608114|NCT04018001|75718999|FG000|STARTED|Overall Study||678||
59608115|NCT04018001|75719000|FG001|STARTED|Overall Study||379||
59608116|NCT04018001|75718999|FG000|COMPLETED|Overall Study||678||
59608117|NCT04018001|75719000|FG001|COMPLETED|Overall Study||379||
59887044|NCT00064337|76009753|FG000|STARTED|Transplant|6 patients who completed PBSCC or Induction/PBSCC did not begin Transplant|67||
59608118|NCT04018001|75718999|FG000|NOT COMPLETED|Overall Study||0||
59887045|NCT00064337|76009753|FG000|COMPLETED|Transplant||46||
59887046|NCT00064337|76009753|FG000|NOT COMPLETED|Transplant||21||
59608119|NCT04018001|75719000|FG001|NOT COMPLETED|Overall Study||0||
59608120|NCT03979079|75719006|FG000|STARTED|Overall Study||2384||
59608121|NCT03979079|75719006|FG000|COMPLETED|Overall Study||2384||
59608122|NCT03979079|75719006|FG000|NOT COMPLETED|Overall Study||0||
59608123|NCT04811339|75719015|FG000|STARTED|Overall Study|19 patients were given BSS.|19|19 patients received some BSS. 10 completed and 9 did not complete|
59608124|NCT04811339|75719016|FG001|STARTED|Overall Study|No drug given|25|19 patients received some BSS. 10 completed and 9 did not complete|
59608125|NCT04811339|75719017|FG002|STARTED|Overall Study||0|19 patients received some BSS. 10 completed and 9 did not complete|
59887047|NCT00064337|76009753|FG000|STARTED|Maintenance|Only patients with High Risk MM or AL + MM were allowed to enroll to Maintenance treatment.|13||
59608126|NCT04811339|75719015|FG000|Complete 3 Days of BSS|Overall Study||10|To complete BSS therapy, patients also needed to provide 3 days of saliva for SARS-CoV2 testing, record three days of bowel movements and record and score (between 0-3) 5 symptoms : cough, headache, fatigue, shortness of breath and anosmia ( loss of smell)|
59613499|NCT01684722|75724629|FG002|STARTED|Overall Study||320||
59613500|NCT01684722|75724630|FG003|STARTED|Overall Study||370||
59608127|NCT04811339|75719016|FG001|Complete 3 Days of BSS|Overall Study||0|To complete BSS therapy, patients also needed to provide 3 days of saliva for SARS-CoV2 testing, record three days of bowel movements and record and score (between 0-3) 5 symptoms : cough, headache, fatigue, shortness of breath and anosmia ( loss of smell)|
59608128|NCT04811339|75719017|FG002|Complete 3 Days of BSS|Overall Study||0|To complete BSS therapy, patients also needed to provide 3 days of saliva for SARS-CoV2 testing, record three days of bowel movements and record and score (between 0-3) 5 symptoms : cough, headache, fatigue, shortness of breath and anosmia ( loss of smell)|
59608129|NCT04811339|75719015|FG000|COMPLETED|Overall Study|10 persons did complete all requirements of taking BSS and providing all samples and answering all questions|10||
59608130|NCT04811339|75719016|FG001|COMPLETED|Overall Study||0||
59608131|NCT04811339|75719017|FG002|COMPLETED|Overall Study||0||
59608132|NCT04811339|75719015|FG000|NOT COMPLETED|Overall Study||9||
59608133|NCT04811339|75719016|FG001|NOT COMPLETED|Overall Study||25||
59608134|NCT04811339|75719017|FG002|NOT COMPLETED|Overall Study||0||
59608135|NCT04332107|75719029|FG000|STARTED|Day 3||171||
59608136|NCT04332107|75719030|FG001|STARTED|Day 3||92||
59608137|NCT04332107|75719029|FG000|COMPLETED|Day 3||145||
59608138|NCT04332107|75719030|FG001|COMPLETED|Day 3||72||
59608139|NCT04332107|75719029|FG000|NOT COMPLETED|Day 3||26||
59608140|NCT04332107|75719030|FG001|NOT COMPLETED|Day 3||20||
59608141|NCT04332107|75719029|FG000|STARTED|Day 14|Those who had missing measurements at Day 3 but were not completely lost-to-followup were allowed to continue with the trial.|148||
59608142|NCT04332107|75719030|FG001|STARTED|Day 14|Those who had missing measurements at Day 3 but were not completely lost-to-followup were allowed to continue with the trial.|78||
59608143|NCT04332107|75719029|FG000|COMPLETED|Day 14||131||
59608144|NCT04332107|75719030|FG001|COMPLETED|Day 14||70||
59505027|NCT02321111|75597685|FG001|STARTED|Washout2 (3-4weeks Between Infusions)||4||
59505028|NCT02321111|75597686|FG002|STARTED|Washout2 (3-4weeks Between Infusions)||4||
59505029|NCT02321111|75597687|FG003|STARTED|Washout2 (3-4weeks Between Infusions)||1||
59505030|NCT02321111|75597688|FG004|STARTED|Washout2 (3-4weeks Between Infusions)||0||
59505031|NCT02321111|75597689|FG005|STARTED|Washout2 (3-4weeks Between Infusions)||0||
59505032|NCT02321111|75597684|FG000|COMPLETED|Washout2 (3-4weeks Between Infusions)||1||
59505033|NCT02321111|75597685|FG001|COMPLETED|Washout2 (3-4weeks Between Infusions)||4||
59505034|NCT02321111|75597686|FG002|COMPLETED|Washout2 (3-4weeks Between Infusions)||4||
59505035|NCT02321111|75597687|FG003|COMPLETED|Washout2 (3-4weeks Between Infusions)||1||
59505036|NCT02321111|75597688|FG004|COMPLETED|Washout2 (3-4weeks Between Infusions)||0||
59505037|NCT02321111|75597689|FG005|COMPLETED|Washout2 (3-4weeks Between Infusions)||0||
59608145|NCT04332107|75719029|FG000|NOT COMPLETED|Day 14||17||
59608146|NCT04332107|75719030|FG001|NOT COMPLETED|Day 14||8||
59608147|NCT04332107|75719029|FG000|STARTED|Day 21|Those who had missing measurements at Day 14 but were not completely lost-to-followup were allowed to continue with the trial.|135||
59608148|NCT04332107|75719030|FG001|STARTED|Day 21|Those who had missing measurements at Day 14 but were not completely lost-to-followup were allowed to continue with the trial.|74||
59608149|NCT04332107|75719029|FG000|COMPLETED|Day 21||125||
59608150|NCT04332107|75719030|FG001|COMPLETED|Day 21||72||
59608151|NCT04332107|75719029|FG000|NOT COMPLETED|Day 21||10||
59608152|NCT04332107|75719030|FG001|NOT COMPLETED|Day 21||2||
59608153|NCT04159025|75719036|FG000|STARTED|Overall Study||20||
59608154|NCT04159025|75719036|FG000|COMPLETED|Overall Study||20||
59608155|NCT04159025|75719036|FG000|NOT COMPLETED|Overall Study||0||
59608156|NCT03375203|75719045|FG000|STARTED|Overall Study||75||
59608157|NCT03375203|75719046|FG001|STARTED|Overall Study||72||
59608158|NCT03375203|75719047|FG002|STARTED|Overall Study||74||
59608159|NCT03375203|75719048|FG003|STARTED|Overall Study||71||
59608160|NCT03375203|75719049|FG004|STARTED|Overall Study||73||
59505038|NCT02321111|75597684|FG000|NOT COMPLETED|Washout2 (3-4weeks Between Infusions)||0||
59505039|NCT02321111|75597685|FG001|NOT COMPLETED|Washout2 (3-4weeks Between Infusions)||0||
59505040|NCT02321111|75597686|FG002|NOT COMPLETED|Washout2 (3-4weeks Between Infusions)||0||
59505041|NCT02321111|75597687|FG003|NOT COMPLETED|Washout2 (3-4weeks Between Infusions)||0||
59608161|NCT03375203|75719045|FG000|COMPLETED|Overall Study||69||
59608162|NCT03375203|75719046|FG001|COMPLETED|Overall Study||68||
59608163|NCT03375203|75719047|FG002|COMPLETED|Overall Study||72||
59608164|NCT03375203|75719048|FG003|COMPLETED|Overall Study||69||
59608165|NCT03375203|75719049|FG004|COMPLETED|Overall Study||69||
59608166|NCT03375203|75719045|FG000|NOT COMPLETED|Overall Study||6||
59887048|NCT00064337|76009753|FG000|COMPLETED|Maintenance||3||
59887049|NCT00064337|76009753|FG000|NOT COMPLETED|Maintenance||10||
59887050|NCT00064259|76009760|FG000|STARTED|Overall Study||4||
59887051|NCT00064259|76009761|FG001|STARTED|Overall Study||4||
59887052|NCT00064259|76009762|FG002|STARTED|Overall Study||6||
59887053|NCT00064259|76009763|FG003|STARTED|Overall Study||1||
59887054|NCT00064259|76009760|FG000|COMPLETED|Overall Study||3||
59887055|NCT00064259|76009761|FG001|COMPLETED|Overall Study||4||
59887056|NCT00064259|76009762|FG002|COMPLETED|Overall Study||6||
59887057|NCT00064259|76009763|FG003|COMPLETED|Overall Study||0||
59887058|NCT00064259|76009760|FG000|NOT COMPLETED|Overall Study||1||
59887059|NCT00064259|76009761|FG001|NOT COMPLETED|Overall Study||0||
59887060|NCT00064259|76009762|FG002|NOT COMPLETED|Overall Study||0||
59887061|NCT00064259|76009763|FG003|NOT COMPLETED|Overall Study||1||
59887062|NCT00044213|76009772|FG000|STARTED|Overall Study||421||
59887063|NCT00044213|76009773|FG001|STARTED|Overall Study||418||
59887064|NCT00044213|76009774|FG002|STARTED|Overall Study||432||
59887065|NCT00044213|76009775|FG003|STARTED|Overall Study||437||
59887066|NCT00044213|76009772|FG000|COMPLETED|Overall Study||321||
59887067|NCT00044213|76009773|FG001|COMPLETED|Overall Study||306||
59887068|NCT00044213|76009774|FG002|COMPLETED|Overall Study||294||
59887069|NCT00044213|76009775|FG003|COMPLETED|Overall Study||301||
59887070|NCT00044213|76009772|FG000|NOT COMPLETED|Overall Study||100||
59887071|NCT00044213|76009773|FG001|NOT COMPLETED|Overall Study||112||
59887072|NCT00044213|76009774|FG002|NOT COMPLETED|Overall Study||138||
59887073|NCT00044213|76009775|FG003|NOT COMPLETED|Overall Study||136||
59887074|NCT00064025|76009785|FG000|STARTED|Overall Study||75||
59887075|NCT00064025|76009785|FG000|COMPLETED|Overall Study||68||
59887076|NCT00064025|76009785|FG000|NOT COMPLETED|Overall Study||7||
59887077|NCT00043979|76009793|FG000|STARTED|Period 1||30||
59887078|NCT00043979|76009794|FG001|STARTED|Period 1||17||
59887079|NCT00043979|76009795|FG002|STARTED|Period 1||13||
59887080|NCT00043979|76009793|FG000|COMPLETED|Period 1||23||
59887081|NCT00043979|76009794|FG001|COMPLETED|Period 1||13||
59887082|NCT00043979|76009795|FG002|COMPLETED|Period 1||10||
59887083|NCT00043979|76009793|FG000|NOT COMPLETED|Period 1||7||
59887084|NCT00043979|76009794|FG001|NOT COMPLETED|Period 1||4||
59887085|NCT00043979|76009795|FG002|NOT COMPLETED|Period 1||3||
59887086|NCT00043979|76009793|FG000|STARTED|Period 2||0||
59887087|NCT00043979|76009794|FG001|STARTED|Period 2||13||
59887088|NCT00043979|76009795|FG002|STARTED|Period 2||10||
59887089|NCT00043979|76009793|FG000|COMPLETED|Period 2||0||
59887090|NCT00043979|76009794|FG001|COMPLETED|Period 2||13||
59887091|NCT00043979|76009795|FG002|COMPLETED|Period 2||10||
59887092|NCT00043979|76009793|FG000|NOT COMPLETED|Period 2||0||
59887093|NCT00043979|76009794|FG001|NOT COMPLETED|Period 2||0||
59887094|NCT00043979|76009795|FG002|NOT COMPLETED|Period 2||0||
59887095|NCT01397968|76009803|FG000|STARTED|Double-blind Period of Study YKP3089C013||113||
59887096|NCT01397968|76009804|FG001|STARTED|Double-blind Period of Study YKP3089C013||109||
59887097|NCT01397968|76009803|FG000|COMPLETED|Double-blind Period of Study YKP3089C013||102||
59887098|NCT01397968|76009804|FG001|COMPLETED|Double-blind Period of Study YKP3089C013||99||
59887099|NCT01397968|76009803|FG000|NOT COMPLETED|Double-blind Period of Study YKP3089C013||11||
59887100|NCT01397968|76009804|FG001|NOT COMPLETED|Double-blind Period of Study YKP3089C013||10||
59887101|NCT01397968|76009803|FG000|STARTED|Open-label Extension Study YKP3089C013|Not all subjects from double-blind rolled over to open-label.|76|Not all subjects moved from double-blind to open-label extension.|
59887102|NCT01397968|76009804|FG001|STARTED|Open-label Extension Study YKP3089C013|Not all subjects from double-blind rolled over to open-label.|73|Not all subjects moved from double-blind to open-label extension.|
59887103|NCT01397968|76009803|FG000|COMPLETED|Open-label Extension Study YKP3089C013||40||
59887104|NCT01397968|76009804|FG001|COMPLETED|Open-label Extension Study YKP3089C013||37||
59887105|NCT01397968|76009803|FG000|NOT COMPLETED|Open-label Extension Study YKP3089C013||36||
59505042|NCT02321111|75597688|FG004|NOT COMPLETED|Washout2 (3-4weeks Between Infusions)||0||
59505043|NCT02321111|75597689|FG005|NOT COMPLETED|Washout2 (3-4weeks Between Infusions)||0||
59505044|NCT02321111|75597684|FG000|STARTED|Infusion3||1||
59505045|NCT02321111|75597685|FG001|STARTED|Infusion3||4||
59505046|NCT02321111|75597686|FG002|STARTED|Infusion3||4||
59505047|NCT02321111|75597687|FG003|STARTED|Infusion3||1||
59505048|NCT02321111|75597688|FG004|STARTED|Infusion3||0||
59608167|NCT03375203|75719046|FG001|NOT COMPLETED|Overall Study||4||
59887106|NCT01397968|76009804|FG001|NOT COMPLETED|Open-label Extension Study YKP3089C013||36||
59887107|NCT00039377|76009812|FG000|STARTED|Initial Registration||57||
59887108|NCT00039377|76009813|FG001|STARTED|Initial Registration||0||
59887109|NCT00039377|76009814|FG002|STARTED|Initial Registration||0||
59887110|NCT00039377|76009815|FG003|STARTED|Initial Registration||0||
59887111|NCT00039377|76009812|FG000|COMPLETED|Initial Registration||35||
59887112|NCT00039377|76009813|FG001|COMPLETED|Initial Registration||0||
59887113|NCT00039377|76009814|FG002|COMPLETED|Initial Registration||0||
59887114|NCT00039377|76009815|FG003|COMPLETED|Initial Registration||0||
59505049|NCT02321111|75597689|FG005|STARTED|Infusion3||0||
59608168|NCT03375203|75719047|FG002|NOT COMPLETED|Overall Study||2||
59505050|NCT02321111|75597684|FG000|COMPLETED|Infusion3||1||
59608169|NCT03375203|75719048|FG003|NOT COMPLETED|Overall Study||2||
59608170|NCT03375203|75719049|FG004|NOT COMPLETED|Overall Study||4||
59608171|NCT03151967|75719064|FG000|STARTED|Overall Study||14||
59608172|NCT03151967|75719065|FG001|STARTED|Overall Study||13||
59608173|NCT03151967|75719064|FG000|COMPLETED|Overall Study||12||
59608174|NCT03151967|75719065|FG001|COMPLETED|Overall Study||12||
59608175|NCT03151967|75719064|FG000|NOT COMPLETED|Overall Study||2||
59608176|NCT03151967|75719065|FG001|NOT COMPLETED|Overall Study||1||
59608177|NCT03075839|75719071|FG000|STARTED|Overall Study||33||
59608178|NCT03075839|75719071|FG000|COMPLETED|Overall Study||29||
59608179|NCT03075839|75719071|FG000|NOT COMPLETED|Overall Study||4||
59608180|NCT02919683|75719077|FG000|STARTED|Pre-Surgery Intervention||15||
59762578|NCT03888391|75882385|FG000|NOT COMPLETED|Overall Study||15||
60013576|NCT02452359|76129483|FG000|COMPLETED|Overall Study||33||
60013577|NCT02452359|76129483|FG000|NOT COMPLETED|Overall Study||21||
60013578|NCT02476617|76129487|FG000|STARTED|Overall Study||25||
60013579|NCT02476617|76129487|FG000|COMPLETED|Overall Study||23||
60013580|NCT02476617|76129487|FG000|NOT COMPLETED|Overall Study||2||
60013581|NCT03813199|76129494|FG000|STARTED|Overall Study||21||
60013582|NCT03813199|76129495|FG001|STARTED|Overall Study||19||
60013583|NCT03813199|76129496|FG002|STARTED|Overall Study||20||
60013584|NCT03813199|76129494|FG000|COMPLETED|Overall Study||18||
60013585|NCT03813199|76129495|FG001|COMPLETED|Overall Study||6||
60013586|NCT03813199|76129496|FG002|COMPLETED|Overall Study||19||
59505051|NCT02321111|75597685|FG001|COMPLETED|Infusion3||4||
59505052|NCT02321111|75597686|FG002|COMPLETED|Infusion3||4||
59505053|NCT02321111|75597687|FG003|COMPLETED|Infusion3||1||
59505054|NCT02321111|75597688|FG004|COMPLETED|Infusion3||0||
59505055|NCT02321111|75597689|FG005|COMPLETED|Infusion3||0||
59505056|NCT02321111|75597684|FG000|NOT COMPLETED|Infusion3||0||
59505057|NCT02321111|75597685|FG001|NOT COMPLETED|Infusion3||0||
59505058|NCT02321111|75597686|FG002|NOT COMPLETED|Infusion3||0||
59505059|NCT02321111|75597687|FG003|NOT COMPLETED|Infusion3||0||
59505060|NCT02321111|75597688|FG004|NOT COMPLETED|Infusion3||0||
59608181|NCT02919683|75719078|FG001|STARTED|Pre-Surgery Intervention||15||
60013587|NCT03813199|76129494|FG000|NOT COMPLETED|Overall Study||3||
60013588|NCT03813199|76129495|FG001|NOT COMPLETED|Overall Study||13||
60013589|NCT03813199|76129496|FG002|NOT COMPLETED|Overall Study||1||
60013590|NCT01665599|76129504|FG000|STARTED|Overall Study||180||
60013591|NCT01665599|76129504|FG000|COMPLETED|Overall Study||172||
60013592|NCT01665599|76129504|FG000|NOT COMPLETED|Overall Study||8||
60013593|NCT01671085|76129510|FG000|STARTED|Overall Study|1 participant who dropped out was replaced.|11||
60013594|NCT01671085|76129511|FG001|STARTED|Overall Study||2||
60013595|NCT01671085|76129510|FG000|Received at Least 1 Dose of Study Drug|Overall Study||11||
60013596|NCT01671085|76129511|FG001|Received at Least 1 Dose of Study Drug|Overall Study||2||
60013597|NCT01671085|76129510|FG000|COMPLETED|Overall Study||10||
60013598|NCT01671085|76129511|FG001|COMPLETED|Overall Study||2||
60013599|NCT01671085|76129510|FG000|NOT COMPLETED|Overall Study||1||
60013600|NCT01671085|76129511|FG001|NOT COMPLETED|Overall Study||0||
60013601|NCT02510001|76129526|FG000|STARTED|Overall Study||6||
60013602|NCT02510001|76129527|FG001|STARTED|Overall Study||5||
60013603|NCT02510001|76129528|FG002|STARTED|Overall Study||6||
60013604|NCT02510001|76129529|FG003|STARTED|Overall Study||8||
60013605|NCT02510001|76129530|FG004|STARTED|Overall Study||8||
60013606|NCT02510001|76129531|FG005|STARTED|Overall Study||7||
60013607|NCT02510001|76129532|FG006|STARTED|Overall Study||5||
60013608|NCT02510001|76129533|FG007|STARTED|Overall Study||37||
60013609|NCT02510001|76129526|FG000|COMPLETED|Overall Study||6||
60013610|NCT02510001|76129527|FG001|COMPLETED|Overall Study||5||
59505061|NCT02321111|75597689|FG005|NOT COMPLETED|Infusion3||0||
60013611|NCT02510001|76129528|FG002|COMPLETED|Overall Study||6||
60013612|NCT02510001|76129529|FG003|COMPLETED|Overall Study||6||
60013613|NCT02510001|76129530|FG004|COMPLETED|Overall Study||4||
59608182|NCT02919683|75719077|FG000|COMPLETED|Pre-Surgery Intervention||15||
59608183|NCT02919683|75719078|FG001|COMPLETED|Pre-Surgery Intervention||15||
59608184|NCT02919683|75719077|FG000|NOT COMPLETED|Pre-Surgery Intervention||0||
60013614|NCT02510001|76129531|FG005|COMPLETED|Overall Study||5||
60013615|NCT02510001|76129532|FG006|COMPLETED|Overall Study||3||
59887115|NCT00039377|76009812|FG000|NOT COMPLETED|Initial Registration||22||
59887116|NCT00039377|76009813|FG001|NOT COMPLETED|Initial Registration||0||
59887117|NCT00039377|76009814|FG002|NOT COMPLETED|Initial Registration||0||
59887118|NCT00039377|76009815|FG003|NOT COMPLETED|Initial Registration||0||
59887119|NCT00039377|76009812|FG000|STARTED|Course 5 (Transplant Assignments)|After Course I-IV, participants were grouped into autologous, allogeneic or no transplant arms.|0||
59887120|NCT00039377|76009813|FG001|STARTED|Course 5 (Transplant Assignments)||15||
59887121|NCT00039377|76009814|FG002|STARTED|Course 5 (Transplant Assignments)||19||
59887122|NCT00039377|76009815|FG003|STARTED|Course 5 (Transplant Assignments)||1||
59887123|NCT00039377|76009812|FG000|COMPLETED|Course 5 (Transplant Assignments)||0||
59887124|NCT00039377|76009813|FG001|COMPLETED|Course 5 (Transplant Assignments)||15||
59887125|NCT00039377|76009814|FG002|COMPLETED|Course 5 (Transplant Assignments)||19||
59887126|NCT00039377|76009815|FG003|COMPLETED|Course 5 (Transplant Assignments)||1||
59887127|NCT00039377|76009812|FG000|NOT COMPLETED|Course 5 (Transplant Assignments)||0||
59887128|NCT00039377|76009813|FG001|NOT COMPLETED|Course 5 (Transplant Assignments)||0||
59887129|NCT00039377|76009814|FG002|NOT COMPLETED|Course 5 (Transplant Assignments)||0||
59887130|NCT00039377|76009815|FG003|NOT COMPLETED|Course 5 (Transplant Assignments)||0||
59887131|NCT00154102|76009825|FG000|STARTED|Overall Study|Randomized and treated subjects; 1 additional subject was treated but not randomised|599||
59887132|NCT00154102|76009826|FG001|STARTED|Overall Study|Randomized and treated subjects; 3 additional subjects were treated but not randomised|599||
59887133|NCT00154102|76009825|FG000|COMPLETED|Overall Study||592||
59887134|NCT00154102|76009826|FG001|COMPLETED|Overall Study||597||
59887135|NCT00154102|76009825|FG000|NOT COMPLETED|Overall Study||7||
59887136|NCT00154102|76009826|FG001|NOT COMPLETED|Overall Study||2||
59887137|NCT03758404|76009835|FG000|STARTED|Overall Study||3||
59887138|NCT03758404|76009836|FG001|STARTED|Overall Study||3||
59887139|NCT03758404|76009837|FG002|STARTED|Overall Study||5||
59887140|NCT03758404|76009835|FG000|COMPLETED|Overall Study||3||
59887141|NCT03758404|76009836|FG001|COMPLETED|Overall Study||3||
59887142|NCT03758404|76009837|FG002|COMPLETED|Overall Study||5||
59887143|NCT03758404|76009835|FG000|NOT COMPLETED|Overall Study||0||
59887144|NCT03758404|76009836|FG001|NOT COMPLETED|Overall Study||0||
59887145|NCT03758404|76009837|FG002|NOT COMPLETED|Overall Study||0||
59887146|NCT03687502|76009849|FG000|STARTED|Overall Study||37||
59887147|NCT03687502|76009849|FG000|COMPLETED|Overall Study||35||
59887148|NCT03687502|76009849|FG000|NOT COMPLETED|Overall Study||2||
59887149|NCT03654976|76009857|FG000|STARTED|Overall Study||270||
59887150|NCT03654976|76009858|FG001|STARTED|Overall Study||263||
59887151|NCT03654976|76009857|FG000|Completed IMP|Overall Study||239||
59887152|NCT03654976|76009858|FG001|Completed IMP|Overall Study||242||
59887153|NCT03654976|76009857|FG000|Full Analysis Set|Overall Study||264||
59887154|NCT03654976|76009858|FG001|Full Analysis Set|Overall Study||260||
59887155|NCT03654976|76009857|FG000|Safety Analysis Set|Overall Study||270||
59887156|NCT03654976|76009858|FG001|Safety Analysis Set|Overall Study||263||
59887157|NCT03654976|76009857|FG000|COMPLETED|Overall Study||241|Completed trial|
59887158|NCT03654976|76009858|FG001|COMPLETED|Overall Study||245|Completed trial|
59887159|NCT03654976|76009857|FG000|NOT COMPLETED|Overall Study||29||
59887160|NCT03654976|76009858|FG001|NOT COMPLETED|Overall Study||18||
59887161|NCT00035555|76009867|FG000|STARTED|Overall Study|Randomized patients|74||
59887162|NCT00035555|76009868|FG001|STARTED|Overall Study|Randomized patients|71||
59887163|NCT00035555|76009869|FG002|STARTED|Overall Study|Randomized patients|73||
59887164|NCT00035555|76009867|FG000|Number Who Had Undergone Transplantation|Overall Study||74||
59887165|NCT00035555|76009868|FG001|Number Who Had Undergone Transplantation|Overall Study||71||
59887166|NCT00035555|76009869|FG002|Number Who Had Undergone Transplantation|Overall Study||73||
59887167|NCT00035555|76009867|FG000|Number Who Received Study Drug|Overall Study||74||
59887168|NCT00035555|76009868|FG001|Number Who Received Study Drug|Overall Study||71||
59887169|NCT00035555|76009869|FG002|Number Who Received Study Drug|Overall Study||71||
59887170|NCT00035555|76009867|FG000|COMPLETED|Overall Study||58||
59887171|NCT00035555|76009868|FG001|COMPLETED|Overall Study||55||
59887172|NCT00035555|76009869|FG002|COMPLETED|Overall Study||51||
59887173|NCT00035555|76009867|FG000|NOT COMPLETED|Overall Study||16||
59887174|NCT00035555|76009868|FG001|NOT COMPLETED|Overall Study||16||
59887175|NCT00035555|76009869|FG002|NOT COMPLETED|Overall Study||22||
59887176|NCT03894046|76009881|FG000|STARTED|Overall Study||92||
59887177|NCT03894046|76009882|FG001|STARTED|Overall Study||89||
59887178|NCT03894046|76009883|FG002|STARTED|Overall Study||26||
59887179|NCT03894046|76009881|FG000|COMPLETED|Overall Study||69||
59887180|NCT03894046|76009882|FG001|COMPLETED|Overall Study||61||
59887181|NCT03894046|76009883|FG002|COMPLETED|Overall Study||20||
59887182|NCT03894046|76009881|FG000|NOT COMPLETED|Overall Study||23||
59887183|NCT03894046|76009882|FG001|NOT COMPLETED|Overall Study||28||
59887184|NCT03894046|76009883|FG002|NOT COMPLETED|Overall Study||6||
59887185|NCT00033371|76009892|FG000|STARTED|Overall Study||55||
59887186|NCT00033371|76009893|FG001|STARTED|Overall Study||57||
59887187|NCT00033371|76009892|FG000|COMPLETED|Overall Study||49||
59887188|NCT00033371|76009893|FG001|COMPLETED|Overall Study||47||
59887189|NCT00033371|76009892|FG000|NOT COMPLETED|Overall Study||6||
59887190|NCT00033371|76009893|FG001|NOT COMPLETED|Overall Study||10||
59887191|NCT00081731|76009905|FG000|STARTED|Overall Study||480||
60013616|NCT02510001|76129533|FG007|COMPLETED|Overall Study||30||
59608185|NCT02919683|75719078|FG001|NOT COMPLETED|Pre-Surgery Intervention||0||
59608186|NCT02919683|75719077|FG000|STARTED|Post-Surgery Follow-Up||15||
59608187|NCT02919683|75719078|FG001|STARTED|Post-Surgery Follow-Up||15||
59608188|NCT02919683|75719077|FG000|COMPLETED|Post-Surgery Follow-Up||12||
59608189|NCT02919683|75719078|FG001|COMPLETED|Post-Surgery Follow-Up||13||
59608190|NCT02919683|75719077|FG000|NOT COMPLETED|Post-Surgery Follow-Up||3||
59608191|NCT02919683|75719078|FG001|NOT COMPLETED|Post-Surgery Follow-Up||2||
59608192|NCT01928082|75719085|FG000|STARTED|Overall Study||1||
59608193|NCT01928082|75719085|FG000|COMPLETED|Overall Study||0||
59608194|NCT01928082|75719085|FG000|NOT COMPLETED|Overall Study||1||
59608195|NCT01972776|75719095|FG000|STARTED|Part 1||6||
59608196|NCT01972776|75719096|FG001|STARTED|Part 1||6||
59608197|NCT01972776|75719097|FG002|STARTED|Part 1||8||
59608198|NCT01972776|75719098|FG003|STARTED|Part 1||7||
59608199|NCT01972776|75719099|FG004|STARTED|Part 1||0||
59608200|NCT01972776|75719100|FG005|STARTED|Part 1||0||
59608201|NCT01972776|75719095|FG000|COMPLETED|Part 1||6||
59608202|NCT01972776|75719096|FG001|COMPLETED|Part 1||6||
59608203|NCT01972776|75719097|FG002|COMPLETED|Part 1||6||
59608204|NCT01972776|75719098|FG003|COMPLETED|Part 1||6||
59608205|NCT01972776|75719099|FG004|COMPLETED|Part 1||0||
59608206|NCT01972776|75719100|FG005|COMPLETED|Part 1||0||
59608207|NCT01972776|75719095|FG000|NOT COMPLETED|Part 1||0||
59608208|NCT01972776|75719096|FG001|NOT COMPLETED|Part 1||0||
59608209|NCT01972776|75719097|FG002|NOT COMPLETED|Part 1||2||
59608210|NCT01972776|75719098|FG003|NOT COMPLETED|Part 1||1||
59608211|NCT01972776|75719099|FG004|NOT COMPLETED|Part 1||0||
59608212|NCT01972776|75719100|FG005|NOT COMPLETED|Part 1||0||
59608213|NCT01972776|75719095|FG000|STARTED|Part 2||0||
59887192|NCT00081731|76009906|FG001|STARTED|Overall Study||467||
59887193|NCT00081731|76009905|FG000|COMPLETED|Overall Study||472||
59887194|NCT00081731|76009906|FG001|COMPLETED|Overall Study||459||
59887195|NCT00081731|76009905|FG000|NOT COMPLETED|Overall Study||8||
59887196|NCT00081731|76009906|FG001|NOT COMPLETED|Overall Study||8||
59887197|NCT00079937|76009914|FG000|STARTED|Overall Study||421||
59608214|NCT01972776|75719096|FG001|STARTED|Part 2||0||
59608215|NCT01972776|75719097|FG002|STARTED|Part 2||0||
59608216|NCT01972776|75719098|FG003|STARTED|Part 2||0||
59608217|NCT01972776|75719099|FG004|STARTED|Part 2||14||
59608218|NCT01972776|75719100|FG005|STARTED|Part 2||7||
59608219|NCT01972776|75719095|FG000|COMPLETED|Part 2||0||
59608220|NCT01972776|75719096|FG001|COMPLETED|Part 2||0||
59608221|NCT01972776|75719097|FG002|COMPLETED|Part 2||0||
59608222|NCT01972776|75719098|FG003|COMPLETED|Part 2||0||
59608223|NCT01972776|75719099|FG004|COMPLETED|Part 2||1||
59608224|NCT01972776|75719100|FG005|COMPLETED|Part 2||0||
59608225|NCT01972776|75719095|FG000|NOT COMPLETED|Part 2||0||
59608226|NCT01972776|75719096|FG001|NOT COMPLETED|Part 2||0||
59608227|NCT01972776|75719097|FG002|NOT COMPLETED|Part 2||0||
59608228|NCT01972776|75719098|FG003|NOT COMPLETED|Part 2||0||
59608229|NCT01972776|75719099|FG004|NOT COMPLETED|Part 2||13||
59608230|NCT01972776|75719100|FG005|NOT COMPLETED|Part 2||7||
59608231|NCT03763331|75719116|FG000|STARTED|Overall Study||16||
59608232|NCT03763331|75719117|FG001|STARTED|Overall Study||18||
59608233|NCT03763331|75719116|FG000|COMPLETED|Overall Study||14||
59608234|NCT03763331|75719117|FG001|COMPLETED|Overall Study||15||
59608235|NCT03763331|75719116|FG000|NOT COMPLETED|Overall Study||2||
59608236|NCT03763331|75719117|FG001|NOT COMPLETED|Overall Study||3||
59608237|NCT01545557|75719123|FG000|STARTED|Overall Study||60||
59608238|NCT01545557|75719123|FG000|COMPLETED|Overall Study||60||
59608239|NCT01545557|75719123|FG000|NOT COMPLETED|Overall Study||0||
59608240|NCT00330551|75719133|FG000|STARTED|Overall Study||40||
59608241|NCT00330551|75719134|FG001|STARTED|Overall Study||43||
59608242|NCT00330551|75719133|FG000|COMPLETED|Overall Study||30||
59608243|NCT00330551|75719134|FG001|COMPLETED|Overall Study||27||
59608244|NCT00330551|75719133|FG000|NOT COMPLETED|Overall Study||10||
59608245|NCT00330551|75719134|FG001|NOT COMPLETED|Overall Study||16||
59608246|NCT00001259|75719144|FG000|STARTED|Study 1||10||
59887198|NCT00079937|76009915|FG001|STARTED|Overall Study||207||
60013617|NCT02510001|76129526|FG000|NOT COMPLETED|Overall Study||0||
59608247|NCT00001259|75719145|FG001|STARTED|Study 1||10||
59887199|NCT00079937|76009914|FG000|COMPLETED|Overall Study||352||
59608248|NCT00001259|75719146|FG002|STARTED|Study 1||0||
59887200|NCT00079937|76009915|FG001|COMPLETED|Overall Study||175||
59608249|NCT00001259|75719147|FG003|STARTED|Study 1||0||
59608250|NCT00001259|75719148|FG004|STARTED|Study 1||0||
59608251|NCT00001259|75719149|FG005|STARTED|Study 1||0||
59608252|NCT00001259|75719150|FG006|STARTED|Study 1||0||
59608253|NCT00001259|75719144|FG000|Completed Phase 1|Study 1||10||
59608254|NCT00001259|75719145|FG001|Completed Phase 1|Study 1||10||
59608255|NCT00001259|75719146|FG002|Completed Phase 1|Study 1||0||
59608256|NCT00001259|75719147|FG003|Completed Phase 1|Study 1||0||
59608257|NCT00001259|75719148|FG004|Completed Phase 1|Study 1||0||
59887201|NCT00079937|76009914|FG000|NOT COMPLETED|Overall Study||69||
59608258|NCT00001259|75719149|FG005|Completed Phase 1|Study 1||0||
59608259|NCT00001259|75719150|FG006|Completed Phase 1|Study 1||0||
59608260|NCT00001259|75719144|FG000|Started Phase 2|Study 1||0||
59608261|NCT00001259|75719145|FG001|Started Phase 2|Study 1||0||
59608262|NCT00001259|75719146|FG002|Started Phase 2|Study 1|4 of 10 participants from Study 1, Phase 1, Assignment 2 - GnRH agonist injections (Lupron-L only) were randomized to this arm|4||
59608263|NCT00001259|75719147|FG003|Started Phase 2|Study 1|6 of 10 participants from Study 1, Phase 1, Assignment 2 - GnRH agonist injections (Lupron-L only) were randomized to this arm|6||
59608264|NCT00001259|75719148|FG004|Started Phase 2|Study 1||0||
59608265|NCT00001259|75719149|FG005|Started Phase 2|Study 1||0||
59608266|NCT00001259|75719150|FG006|Started Phase 2|Study 1||0||
59608267|NCT00001259|75719144|FG000|Completed Phase 2|Study 1||0||
59608268|NCT00001259|75719145|FG001|Completed Phase 2|Study 1||0||
59608269|NCT00001259|75719146|FG002|Completed Phase 2|Study 1||4||
59608270|NCT00001259|75719147|FG003|Completed Phase 2|Study 1|one participant dropped off due to adverse reaction|5||
59608271|NCT00001259|75719148|FG004|Completed Phase 2|Study 1||0||
59608272|NCT00001259|75719149|FG005|Completed Phase 2|Study 1||0||
59608273|NCT00001259|75719150|FG006|Completed Phase 2|Study 1||0||
59608274|NCT00001259|75719144|FG000|Started Phase 2 - Crossover Arm|Study 1||0||
59608275|NCT00001259|75719145|FG001|Started Phase 2 - Crossover Arm|Study 1||0||
59608276|NCT00001259|75719146|FG002|Started Phase 2 - Crossover Arm|Study 1||4||
59608277|NCT00001259|75719147|FG003|Started Phase 2 - Crossover Arm|Study 1||5||
59608278|NCT00001259|75719148|FG004|Started Phase 2 - Crossover Arm|Study 1||0||
59608279|NCT00001259|75719149|FG005|Started Phase 2 - Crossover Arm|Study 1||0||
59608280|NCT00001259|75719150|FG006|Started Phase 2 - Crossover Arm|Study 1||0||
59608281|NCT00001259|75719144|FG000|Completed Phase 2 - Crossover Arm|Study 1||0||
59608282|NCT00001259|75719145|FG001|Completed Phase 2 - Crossover Arm|Study 1||0||
59608283|NCT00001259|75719146|FG002|Completed Phase 2 - Crossover Arm|Study 1||4||
59608284|NCT00001259|75719147|FG003|Completed Phase 2 - Crossover Arm|Study 1||5||
59608285|NCT00001259|75719148|FG004|Completed Phase 2 - Crossover Arm|Study 1||0||
59608286|NCT00001259|75719149|FG005|Completed Phase 2 - Crossover Arm|Study 1||0||
59608287|NCT00001259|75719150|FG006|Completed Phase 2 - Crossover Arm|Study 1||0||
59608288|NCT00001259|75719144|FG000|COMPLETED|Study 1||10||
59608289|NCT00001259|75719145|FG001|COMPLETED|Study 1||10||
59608290|NCT00001259|75719146|FG002|COMPLETED|Study 1||0||
59608291|NCT00001259|75719147|FG003|COMPLETED|Study 1||0||
59608292|NCT00001259|75719148|FG004|COMPLETED|Study 1||0||
59608293|NCT00001259|75719149|FG005|COMPLETED|Study 1||0||
59608294|NCT00001259|75719150|FG006|COMPLETED|Study 1||0||
59608295|NCT00001259|75719144|FG000|NOT COMPLETED|Study 1||0||
59608296|NCT00001259|75719145|FG001|NOT COMPLETED|Study 1||0||
59608297|NCT00001259|75719146|FG002|NOT COMPLETED|Study 1||0||
59608298|NCT00001259|75719147|FG003|NOT COMPLETED|Study 1||0||
59608299|NCT00001259|75719148|FG004|NOT COMPLETED|Study 1||0||
59608300|NCT00001259|75719149|FG005|NOT COMPLETED|Study 1||0||
59608301|NCT00001259|75719150|FG006|NOT COMPLETED|Study 1||0||
59608302|NCT00001259|75719144|FG000|STARTED|Study 2||0||
59608303|NCT00001259|75719145|FG001|STARTED|Study 2||0||
59608304|NCT00001259|75719146|FG002|STARTED|Study 2||0||
59608305|NCT00001259|75719147|FG003|STARTED|Study 2||0||
59608306|NCT00001259|75719148|FG004|STARTED|Study 2|Include 9 subjects from Study 1, Phase 1, Assignment 1 - Placebo|48||
59608307|NCT00001259|75719149|FG005|STARTED|Study 2||0||
59608308|NCT00001259|75719150|FG006|STARTED|Study 2||0||
59608309|NCT00001259|75719144|FG000|Completed Phase 1|Study 2||0||
59608310|NCT00001259|75719145|FG001|Completed Phase 1|Study 2||0||
59608311|NCT00001259|75719146|FG002|Completed Phase 1|Study 2||0||
59608312|NCT00001259|75719147|FG003|Completed Phase 1|Study 2||0||
59608313|NCT00001259|75719148|FG004|Completed Phase 1|Study 2||46||
59608314|NCT00001259|75719149|FG005|Completed Phase 1|Study 2||0||
59608315|NCT00001259|75719150|FG006|Completed Phase 1|Study 2||0||
59608316|NCT00001259|75719144|FG000|Started Phase 2|Study 2||0||
59608317|NCT00001259|75719145|FG001|Started Phase 2|Study 2||0||
59755944|NCT00958217|75875065|FG000|End of Treatment|Overall Study|Participants had a maximum of 16 weeks to complete 12 individual psychotherapy sessions|56||
59755945|NCT00958217|75875066|FG001|End of Treatment|Overall Study|Participants had a maximum of 16 weeks to complete 12 individual psychotherapy sessions|57||
59755946|NCT00958217|75875065|FG000|COMPLETED|Overall Study|Participants were assessed quarterly for one year following end of treatment|37||
59755947|NCT00958217|75875066|FG001|COMPLETED|Overall Study|Participants were assessed quarterly for one year following end of treatment|37||
59755948|NCT00958217|75875065|FG000|NOT COMPLETED|Overall Study||24||
59755949|NCT00958217|75875066|FG001|NOT COMPLETED|Overall Study||25||
59755950|NCT00891020|75875076|FG000|STARTED|24 Week Treatment Period||163||
59755951|NCT00891020|75875077|FG001|STARTED|24 Week Treatment Period||363||
59755952|NCT00891020|75875078|FG002|STARTED|24 Week Treatment Period||360||
59755953|NCT00891020|75875076|FG000|Intent-to-Treat (ITT)|24 Week Treatment Period||163||
59755954|NCT00891020|75875077|FG001|Intent-to-Treat (ITT)|24 Week Treatment Period||362||
59608318|NCT00001259|75719146|FG002|Started Phase 2|Study 2||0||
59608319|NCT00001259|75719147|FG003|Started Phase 2|Study 2||0||
59608320|NCT00001259|75719148|FG004|Started Phase 2|Study 2||0||
59608321|NCT00001259|75719149|FG005|Started Phase 2|Study 2||21||
59608322|NCT00001259|75719150|FG006|Started Phase 2|Study 2||17||
59608323|NCT00001259|75719144|FG000|Completed Phase 2|Study 2||0||
59608324|NCT00001259|75719145|FG001|Completed Phase 2|Study 2||0||
59608325|NCT00001259|75719146|FG002|Completed Phase 2|Study 2||0||
59608326|NCT00001259|75719147|FG003|Completed Phase 2|Study 2||0||
59608327|NCT00001259|75719148|FG004|Completed Phase 2|Study 2||0||
59608328|NCT00001259|75719149|FG005|Completed Phase 2|Study 2||21||
59608329|NCT00001259|75719150|FG006|Completed Phase 2|Study 2||17||
59608330|NCT00001259|75719144|FG000|Started Phase 2 - Crossover Arm|Study 2||0||
59608331|NCT00001259|75719145|FG001|Started Phase 2 - Crossover Arm|Study 2||0||
59608332|NCT00001259|75719146|FG002|Started Phase 2 - Crossover Arm|Study 2||0||
59608333|NCT00001259|75719147|FG003|Started Phase 2 - Crossover Arm|Study 2||0||
59608334|NCT00001259|75719148|FG004|Started Phase 2 - Crossover Arm|Study 2||0||
59608335|NCT00001259|75719149|FG005|Started Phase 2 - Crossover Arm|Study 2||21||
59608336|NCT00001259|75719150|FG006|Started Phase 2 - Crossover Arm|Study 2||17||
59608337|NCT00001259|75719144|FG000|Completed Phase 2 - Crossover Arm|Study 2||0||
59608338|NCT00001259|75719145|FG001|Completed Phase 2 - Crossover Arm|Study 2||0||
59608339|NCT00001259|75719146|FG002|Completed Phase 2 - Crossover Arm|Study 2||0||
59608340|NCT00001259|75719147|FG003|Completed Phase 2 - Crossover Arm|Study 2||0||
59608341|NCT00001259|75719148|FG004|Completed Phase 2 - Crossover Arm|Study 2||0||
59608342|NCT00001259|75719149|FG005|Completed Phase 2 - Crossover Arm|Study 2||21||
59608343|NCT00001259|75719150|FG006|Completed Phase 2 - Crossover Arm|Study 2||17||
59608344|NCT00001259|75719144|FG000|COMPLETED|Study 2||0||
59608345|NCT00001259|75719145|FG001|COMPLETED|Study 2||0||
59608346|NCT00001259|75719146|FG002|COMPLETED|Study 2||0||
59608347|NCT00001259|75719147|FG003|COMPLETED|Study 2||0||
59608348|NCT00001259|75719148|FG004|COMPLETED|Study 2||46||
59608349|NCT00001259|75719149|FG005|COMPLETED|Study 2||0||
59608350|NCT00001259|75719150|FG006|COMPLETED|Study 2||0||
59608351|NCT00001259|75719144|FG000|NOT COMPLETED|Study 2||0||
59608352|NCT00001259|75719145|FG001|NOT COMPLETED|Study 2||0||
59608353|NCT00001259|75719146|FG002|NOT COMPLETED|Study 2||0||
59608354|NCT00001259|75719147|FG003|NOT COMPLETED|Study 2||0||
59608355|NCT00001259|75719148|FG004|NOT COMPLETED|Study 2||2||
59608356|NCT00001259|75719149|FG005|NOT COMPLETED|Study 2||0||
59608357|NCT00001259|75719150|FG006|NOT COMPLETED|Study 2||0||
59608358|NCT01926444|75719164|FG000|STARTED|Overall Study||56||
59608359|NCT01926444|75719165|FG001|STARTED|Overall Study||52||
59608360|NCT01926444|75719166|FG002|STARTED|Overall Study||57||
59608361|NCT01926444|75719167|FG003|STARTED|Overall Study||103||
59608362|NCT01926444|75719164|FG000|COMPLETED|Overall Study||56||
59608363|NCT01926444|75719165|FG001|COMPLETED|Overall Study||52||
59608364|NCT01926444|75719166|FG002|COMPLETED|Overall Study||53||
59608365|NCT01926444|75719167|FG003|COMPLETED|Overall Study||101||
59608366|NCT01926444|75719164|FG000|NOT COMPLETED|Overall Study||0||
59608367|NCT01926444|75719165|FG001|NOT COMPLETED|Overall Study||0||
59608368|NCT01926444|75719166|FG002|NOT COMPLETED|Overall Study||4||
59608369|NCT01926444|75719167|FG003|NOT COMPLETED|Overall Study||2||
59608370|NCT05003167|75719177|FG000|STARTED|Overall Study||13||
59608371|NCT05003167|75719177|FG000|COMPLETED|Overall Study||12||
59608372|NCT05003167|75719177|FG000|NOT COMPLETED|Overall Study||1||
59608373|NCT04988035|75719183|FG000|STARTED|Overall Study||98||
59608374|NCT04988035|75719184|FG001|STARTED|Overall Study||103||
59608375|NCT04988035|75719183|FG000|COMPLETED|Overall Study||63||
59608376|NCT04988035|75719184|FG001|COMPLETED|Overall Study||77||
59608377|NCT04988035|75719183|FG000|NOT COMPLETED|Overall Study||35||
59608378|NCT04988035|75719184|FG001|NOT COMPLETED|Overall Study||26||
59608379|NCT04864249|75719192|FG000|STARTED|Overall Study||54||
59608380|NCT04864249|75719193|FG001|STARTED|Overall Study||56||
59608381|NCT04864249|75719192|FG000|COMPLETED|Overall Study||45||
59608382|NCT04864249|75719193|FG001|COMPLETED|Overall Study||31||
59608383|NCT04864249|75719192|FG000|NOT COMPLETED|Overall Study||9||
59608384|NCT04864249|75719193|FG001|NOT COMPLETED|Overall Study||25||
59887202|NCT00079937|76009915|FG001|NOT COMPLETED|Overall Study||32||
59608385|NCT04847674|75719202|FG000|STARTED|Overall Study||32||
59755955|NCT00891020|75875078|FG002|Intent-to-Treat (ITT)|24 Week Treatment Period||358||
59755956|NCT00891020|75875076|FG000|Safety Set|24 Week Treatment Period|4 patients from 8 mg/kg +DMARD arm did not receive DMARD, included in Monotherapy arm for safety.|138||
59755957|NCT00891020|75875077|FG001|Safety Set|24 Week Treatment Period|1 patient from Monotherapy arm and 1 from 8 mg/kg +DMARD, included in 4 mg/kg +DMARD arm for safety.|364||
59608386|NCT04847674|75719203|FG001|STARTED|Overall Study||33||
59608387|NCT04847674|75719204|FG002|STARTED|Overall Study||32||
59608388|NCT04847674|75719202|FG000|Received at Least 1 Dose of Study Drug as Randomized|Overall Study||31||
59887203|NCT00909610|76009923|FG000|STARTED|Period: First Intervention||40||
59608389|NCT04847674|75719203|FG001|Received at Least 1 Dose of Study Drug as Randomized|Overall Study||33||
59755958|NCT00891020|75875078|FG002|Safety Set|24 Week Treatment Period|28 patients from Monotherapy arm received DMARD, included in 8 mg/kg +DMARD arm for safety.|381||
59755959|NCT00891020|75875076|FG000|COMPLETED|24 Week Treatment Period||126||
59887204|NCT00909610|76009924|FG001|STARTED|Period: First Intervention||40||
59887205|NCT00909610|76009923|FG000|COMPLETED|Period: First Intervention||40||
59608390|NCT04847674|75719204|FG002|Received at Least 1 Dose of Study Drug as Randomized|Overall Study||32||
59608391|NCT04847674|75719202|FG000|Modified Intent-to-treat (mITT) Analysis Set|Overall Study||31|All randomized participants who received at least a partial dose of study drug.|
59608392|NCT04847674|75719203|FG001|Modified Intent-to-treat (mITT) Analysis Set|Overall Study||33|All randomized participants who received at least a partial dose of study drug.|
59608393|NCT04847674|75719204|FG002|Modified Intent-to-treat (mITT) Analysis Set|Overall Study||32|All randomized participants who received at least a partial dose of study drug.|
59613501|NCT01684722|75724627|FG000|COMPLETED|Overall Study||236||
59613502|NCT01684722|75724628|FG001|COMPLETED|Overall Study||212||
59608394|NCT04847674|75719202|FG000|Safety Analysis Set|Overall Study||31|All randomized participants who received at least 1 dose of study drug. In this set, data were summarized based upon the treatment actually received regardless of the assigned treatment.|
59608395|NCT04847674|75719203|FG001|Safety Analysis Set|Overall Study|One participant was randomized to TEV-53275 Dose B but received TEV-53275 Dose A. Therefore, the participant was included in the TEV-53275 Dose A arm for the Safety Analysis Set.|34|All randomized participants who received at least 1 dose of study drug. In this set, data were summarized based upon the treatment actually received regardless of the assigned treatment.|
59608396|NCT04847674|75719204|FG002|Safety Analysis Set|Overall Study||31|All randomized participants who received at least 1 dose of study drug. In this set, data were summarized based upon the treatment actually received regardless of the assigned treatment.|
59608397|NCT04847674|75719202|FG000|COMPLETED|Overall Study||11||
59608398|NCT04847674|75719203|FG001|COMPLETED|Overall Study||12||
59608399|NCT04847674|75719204|FG002|COMPLETED|Overall Study||10||
59608400|NCT04847674|75719202|FG000|NOT COMPLETED|Overall Study||21||
59608401|NCT04847674|75719203|FG001|NOT COMPLETED|Overall Study||21||
59608402|NCT04847674|75719204|FG002|NOT COMPLETED|Overall Study||22||
59608403|NCT04649060|75719216|FG000|STARTED|Arm A/Arm B Treatment||27||
59608404|NCT04649060|75719217|FG001|STARTED|Arm A/Arm B Treatment||27||
59608405|NCT04649060|75719216|FG000|Treated|Arm A/Arm B Treatment||22|There were 6 randomized patients (5 in Arm A and 1 in Arm B) who never received treatment due to failure to meet treatment initiation criteria and/or consent withdrawal.|
59608406|NCT04649060|75719217|FG001|Treated|Arm A/Arm B Treatment||26|There were 6 randomized patients (5 in Arm A and 1 in Arm B) who never received treatment due to failure to meet treatment initiation criteria and/or consent withdrawal.|
59608407|NCT04649060|75719216|FG000|COMPLETED|Arm A/Arm B Treatment||0||
59608408|NCT04649060|75719217|FG001|COMPLETED|Arm A/Arm B Treatment||0||
59608409|NCT04649060|75719216|FG000|NOT COMPLETED|Arm A/Arm B Treatment||27||
59608410|NCT04649060|75719217|FG001|NOT COMPLETED|Arm A/Arm B Treatment||27||
59608411|NCT04649060|75719216|FG000|STARTED|Crossover (Arm B)||0||
59608412|NCT04649060|75719217|FG001|STARTED|Crossover (Arm B)|There were 2 patients in Arm B who crossed over and received Melflufen+Dexamethasone+Daratumumab after a confirmed disease progression and received at least one dose of treatment.|2||
59608413|NCT04649060|75719216|FG000|Treated|Crossover (Arm B)||0||
59608414|NCT04649060|75719217|FG001|Treated|Crossover (Arm B)||2||
59608415|NCT04649060|75719216|FG000|COMPLETED|Crossover (Arm B)||0||
59608416|NCT04649060|75719217|FG001|COMPLETED|Crossover (Arm B)||0||
59608417|NCT04649060|75719216|FG000|NOT COMPLETED|Crossover (Arm B)||0||
59608418|NCT04649060|75719217|FG001|NOT COMPLETED|Crossover (Arm B)||2||
59608419|NCT04640272|75719224|FG000|STARTED|Overall Study||22||
59608420|NCT04640272|75719224|FG000|COMPLETED|Overall Study||21||
59608421|NCT04640272|75719224|FG000|NOT COMPLETED|Overall Study||1||
59755960|NCT00891020|75875077|FG001|COMPLETED|24 Week Treatment Period||303||
59755961|NCT00891020|75875078|FG002|COMPLETED|24 Week Treatment Period||302||
59755962|NCT00891020|75875076|FG000|NOT COMPLETED|24 Week Treatment Period||37||
59755963|NCT00891020|75875077|FG001|NOT COMPLETED|24 Week Treatment Period||60||
59755964|NCT00891020|75875078|FG002|NOT COMPLETED|24 Week Treatment Period||58||
59755965|NCT00891020|75875076|FG000|STARTED|Long-term Extension Period||55||
59755966|NCT00891020|75875077|FG001|STARTED|Long-term Extension Period||196||
59755967|NCT00891020|75875078|FG002|STARTED|Long-term Extension Period||193||
59755968|NCT00891020|75875076|FG000|COMPLETED|Long-term Extension Period||49||
59887206|NCT00909610|76009924|FG001|COMPLETED|Period: First Intervention||39||
59608422|NCT04511650|75719231|FG000|STARTED|Overall Study||10||
59608423|NCT04511650|75719232|FG001|STARTED|Overall Study||10||
59608424|NCT04511650|75719233|FG002|STARTED|Overall Study||11||
59608425|NCT04511650|75719231|FG000|Subjects Treated|Overall Study||9||
59755969|NCT00891020|75875077|FG001|COMPLETED|Long-term Extension Period||172||
59755970|NCT00891020|75875078|FG002|COMPLETED|Long-term Extension Period||170||
59755971|NCT00891020|75875076|FG000|NOT COMPLETED|Long-term Extension Period||6||
59755972|NCT00891020|75875077|FG001|NOT COMPLETED|Long-term Extension Period||24||
59755973|NCT00891020|75875078|FG002|NOT COMPLETED|Long-term Extension Period||23||
59755974|NCT00611455|75875090|FG000|STARTED|DB Treatment Period (24 Weeks)||134||
59755975|NCT00611455|75875091|FG001|STARTED|DB Treatment Period (24 Weeks)||131||
59755976|NCT00611455|75875092|FG002|STARTED|DB Treatment Period (24 Weeks)||0||
59755977|NCT00611455|75875090|FG000|COMPLETED|DB Treatment Period (24 Weeks)||121||
59755978|NCT00611455|75875091|FG001|COMPLETED|DB Treatment Period (24 Weeks)||117||
59755979|NCT00611455|75875092|FG002|COMPLETED|DB Treatment Period (24 Weeks)||0||
59755980|NCT00611455|75875090|FG000|NOT COMPLETED|DB Treatment Period (24 Weeks)||13||
59608426|NCT04511650|75719232|FG001|Subjects Treated|Overall Study||10||
59608427|NCT04511650|75719233|FG002|Subjects Treated|Overall Study||10||
59608428|NCT04511650|75719231|FG000|Subjects Randomized But Not Treated|Overall Study||1||
59755981|NCT00611455|75875091|FG001|NOT COMPLETED|DB Treatment Period (24 Weeks)||14||
59755982|NCT00611455|75875092|FG002|NOT COMPLETED|DB Treatment Period (24 Weeks)||0||
59755983|NCT00611455|75875090|FG000|STARTED|OL Treatment Period (120 Weeks)||0||
59755984|NCT00611455|75875091|FG001|STARTED|OL Treatment Period (120 Weeks)|118 participants received OFA during the DB Period; 113 received placebo during the DB Period.|231||
59755985|NCT00611455|75875092|FG002|STARTED|OL Treatment Period (120 Weeks)||0||
59755986|NCT00611455|75875090|FG000|COMPLETED|OL Treatment Period (120 Weeks)||0||
59755987|NCT00611455|75875091|FG001|COMPLETED|OL Treatment Period (120 Weeks)||52||
59887207|NCT00909610|76009923|FG000|NOT COMPLETED|Period: First Intervention||0||
59608429|NCT04511650|75719232|FG001|Subjects Randomized But Not Treated|Overall Study||0||
59608430|NCT04511650|75719233|FG002|Subjects Randomized But Not Treated|Overall Study||1||
59608431|NCT04511650|75719231|FG000|COMPLETED|Overall Study||7||
59608432|NCT04511650|75719232|FG001|COMPLETED|Overall Study||9||
59608433|NCT04511650|75719233|FG002|COMPLETED|Overall Study||9||
59608434|NCT04511650|75719231|FG000|NOT COMPLETED|Overall Study||3||
59608435|NCT04511650|75719232|FG001|NOT COMPLETED|Overall Study||1||
59608436|NCT04511650|75719233|FG002|NOT COMPLETED|Overall Study||2||
59608437|NCT04463693|75719246|FG000|STARTED|Overall Study||5||
59608438|NCT04463693|75719246|FG000|COMPLETED|Overall Study||5||
59608439|NCT04463693|75719246|FG000|NOT COMPLETED|Overall Study||0||
59608440|NCT04285580|75719252|FG000|STARTED|Overall Study||31||
59608441|NCT04285580|75719253|FG001|STARTED|Overall Study||6||
59608442|NCT04285580|75719252|FG000|COMPLETED|Overall Study||31||
59608443|NCT04285580|75719253|FG001|COMPLETED|Overall Study||5||
59608444|NCT04285580|75719252|FG000|NOT COMPLETED|Overall Study||0||
59608445|NCT04285580|75719253|FG001|NOT COMPLETED|Overall Study||1||
59608446|NCT04259905|75719261|FG000|STARTED|Overall Study||10||
59608447|NCT04259905|75719262|FG001|STARTED|Overall Study||10||
59608448|NCT04259905|75719261|FG000|COMPLETED|Overall Study||10||
59608449|NCT04259905|75719262|FG001|COMPLETED|Overall Study||8||
59608450|NCT04259905|75719261|FG000|NOT COMPLETED|Overall Study||0||
59608451|NCT04259905|75719262|FG001|NOT COMPLETED|Overall Study||2||
59608452|NCT04200248|75719271|FG000|STARTED|Overall Study||32||
59608453|NCT04200248|75719272|FG001|STARTED|Overall Study||31||
59608454|NCT04200248|75719273|FG002|STARTED|Overall Study||31||
59608455|NCT04200248|75719271|FG000|COMPLETED|Overall Study||29||
59608456|NCT04200248|75719272|FG001|COMPLETED|Overall Study||28||
59608457|NCT04200248|75719273|FG002|COMPLETED|Overall Study||28||
59608458|NCT04200248|75719271|FG000|NOT COMPLETED|Overall Study||3||
59608459|NCT04200248|75719272|FG001|NOT COMPLETED|Overall Study||3||
59608460|NCT04200248|75719273|FG002|NOT COMPLETED|Overall Study||3||
59608461|NCT04137887|75719283|FG000|STARTED|Overall Study||16549||
59608462|NCT04137887|75719284|FG001|STARTED|Overall Study||16546||
59608463|NCT04137887|75719283|FG000|Vaccinated|Overall Study||16549||
59608464|NCT04137887|75719284|FG001|Vaccinated|Overall Study||16544||
59608465|NCT04137887|75719283|FG000|COMPLETED|Overall Study||16445||
59608466|NCT04137887|75719284|FG001|COMPLETED|Overall Study||16450||
59608467|NCT04137887|75719283|FG000|NOT COMPLETED|Overall Study||104||
59608468|NCT04137887|75719284|FG001|NOT COMPLETED|Overall Study||96||
59608469|NCT04074590|75719292|FG000|STARTED|Overall Study||16||
59608470|NCT04074590|75719293|FG001|STARTED|Overall Study||7||
59608471|NCT04074590|75719292|FG000|COMPLETED|Overall Study||12||
59608472|NCT04074590|75719293|FG001|COMPLETED|Overall Study||7||
59608473|NCT04074590|75719292|FG000|NOT COMPLETED|Overall Study||4||
59608474|NCT04074590|75719293|FG001|NOT COMPLETED|Overall Study||0||
59608475|NCT03935932|75719302|FG000|STARTED|Overall Study||6||
59608476|NCT03935932|75719303|FG001|STARTED|Overall Study||6||
59608477|NCT03935932|75719302|FG000|COMPLETED|Overall Study||6||
59608478|NCT03935932|75719303|FG001|COMPLETED|Overall Study||6||
59608479|NCT03935932|75719302|FG000|NOT COMPLETED|Overall Study||0||
59608480|NCT03935932|75719303|FG001|NOT COMPLETED|Overall Study||0||
59608481|NCT03557684|75719315|FG000|STARTED|Overall Study||23||
59608482|NCT03557684|75719316|FG001|STARTED|Overall Study||18||
59608483|NCT03557684|75719317|FG002|STARTED|Overall Study||8||
59608484|NCT03557684|75719318|FG003|STARTED|Overall Study||10||
59608485|NCT03557684|75719315|FG000|COMPLETED|Overall Study||23||
59608486|NCT03557684|75719316|FG001|COMPLETED|Overall Study||18||
59608487|NCT03557684|75719317|FG002|COMPLETED|Overall Study||8||
59608488|NCT03557684|75719318|FG003|COMPLETED|Overall Study||10||
59608489|NCT03557684|75719315|FG000|NOT COMPLETED|Overall Study||0||
59608490|NCT03557684|75719316|FG001|NOT COMPLETED|Overall Study||0||
59608491|NCT03557684|75719317|FG002|NOT COMPLETED|Overall Study||0||
59608492|NCT03557684|75719318|FG003|NOT COMPLETED|Overall Study||0||
59608493|NCT03557008|75719330|FG000|STARTED|Overall Study||19||
59608494|NCT03557008|75719331|FG001|STARTED|Overall Study||18||
59608495|NCT03557008|75719330|FG000|COMPLETED|Overall Study||14|Completed the Day 28 assessment|
59608496|NCT03557008|75719331|FG001|COMPLETED|Overall Study||15|Completed the Day 28 assessment|
59608497|NCT03557008|75719330|FG000|NOT COMPLETED|Overall Study||5||
59608498|NCT03557008|75719331|FG001|NOT COMPLETED|Overall Study||3||
59608499|NCT03040999|75719339|FG000|STARTED|Overall Study||402|Randomized|
59608500|NCT03040999|75719340|FG001|STARTED|Overall Study||402|Randomized|
59608501|NCT03040999|75719339|FG000|Treated|Overall Study||398||
59608502|NCT03040999|75719340|FG001|Treated|Overall Study||398||
59608503|NCT03040999|75719339|FG000|COMPLETED|Overall Study||0||
59608504|NCT03040999|75719340|FG001|COMPLETED|Overall Study||0||
59608505|NCT03040999|75719339|FG000|NOT COMPLETED|Overall Study||402||
59608506|NCT03040999|75719340|FG001|NOT COMPLETED|Overall Study||402||
59608507|NCT02366728|75719349|FG000|STARTED|Overall Study||27||
59608508|NCT02366728|75719350|FG001|STARTED|Overall Study||28||
59608509|NCT02366728|75719351|FG002|STARTED|Overall Study||9||
59608510|NCT02366728|75719349|FG000|Received at Least One ppp65 Vaccine|Overall Study||25||
59608511|NCT02366728|75719350|FG001|Received at Least One ppp65 Vaccine|Overall Study||27||
59608512|NCT02366728|75719351|FG002|Received at Least One ppp65 Vaccine|Overall Study||8||
59608513|NCT02366728|75719349|FG000|COMPLETED|Overall Study||23||
59608514|NCT02366728|75719350|FG001|COMPLETED|Overall Study||27||
59608515|NCT02366728|75719351|FG002|COMPLETED|Overall Study||8||
59608516|NCT02366728|75719349|FG000|NOT COMPLETED|Overall Study||4||
59608517|NCT02366728|75719350|FG001|NOT COMPLETED|Overall Study||1||
59608518|NCT02366728|75719351|FG002|NOT COMPLETED|Overall Study||1||
59608519|NCT02355002|75719361|FG000|STARTED|Period 1: Phase 1, Randomized-Controlled||15||
59608520|NCT02355002|75719362|FG001|STARTED|Period 1: Phase 1, Randomized-Controlled||11||
59608521|NCT02355002|75719361|FG000|COMPLETED|Period 1: Phase 1, Randomized-Controlled||12||
59608522|NCT02355002|75719362|FG001|COMPLETED|Period 1: Phase 1, Randomized-Controlled||10||
59608523|NCT02355002|75719361|FG000|NOT COMPLETED|Period 1: Phase 1, Randomized-Controlled||3||
59608524|NCT02355002|75719362|FG001|NOT COMPLETED|Period 1: Phase 1, Randomized-Controlled||1||
59608525|NCT02355002|75719361|FG000|STARTED|Period 2: Phase 2 Open-Label||16|Six participants from the phase I RCT (2 active TMS, 4 sham) showed sufficient symptom improvement and were not invited to participate in the phase II open-label treatment. All other phase I completers were invited to receive open-label, active TMS in phase II (there were no sham participants in phase II).|
59608526|NCT02355002|75719362|FG001|STARTED|Period 2: Phase 2 Open-Label||0|Six participants from the phase I RCT (2 active TMS, 4 sham) showed sufficient symptom improvement and were not invited to participate in the phase II open-label treatment. All other phase I completers were invited to receive open-label, active TMS in phase II (there were no sham participants in phase II).|
59608527|NCT02355002|75719361|FG000|COMPLETED|Period 2: Phase 2 Open-Label||12||
59608528|NCT02355002|75719362|FG001|COMPLETED|Period 2: Phase 2 Open-Label||0||
59608529|NCT02355002|75719361|FG000|NOT COMPLETED|Period 2: Phase 2 Open-Label||4||
59608530|NCT02355002|75719362|FG001|NOT COMPLETED|Period 2: Phase 2 Open-Label||0||
59608531|NCT02246920|75719372|FG000|STARTED|Overall Study||484||
59608532|NCT02246920|75719373|FG001|STARTED|Overall Study||460||
59608533|NCT02246920|75719374|FG002|STARTED|Overall Study||234||
59608534|NCT02246920|75719372|FG000|COMPLETED|Overall Study||477||
59608535|NCT02246920|75719373|FG001|COMPLETED|Overall Study||453||
59608536|NCT02246920|75719374|FG002|COMPLETED|Overall Study||231||
59608537|NCT02246920|75719372|FG000|NOT COMPLETED|Overall Study||7||
59608538|NCT02246920|75719373|FG001|NOT COMPLETED|Overall Study||7||
59608539|NCT02246920|75719374|FG002|NOT COMPLETED|Overall Study||3||
59608540|NCT01832402|75719384|FG000|STARTED|Overall Study||19||
59608541|NCT01832402|75719385|FG001|STARTED|Overall Study||16||
59608542|NCT01832402|75719384|FG000|Received Allocated Medication|Overall Study||12||
59608543|NCT01832402|75719385|FG001|Received Allocated Medication|Overall Study||12||
59608544|NCT01832402|75719384|FG000|Completed Study With Correct Dose|Overall Study||10||
59608545|NCT01832402|75719385|FG001|Completed Study With Correct Dose|Overall Study||9||
59608546|NCT01832402|75719384|FG000|Completed Study With Incorrect Dose|Overall Study||2||
59608547|NCT01832402|75719385|FG001|Completed Study With Incorrect Dose|Overall Study||3||
59608548|NCT01832402|75719384|FG000|COMPLETED|Overall Study||12||
59608549|NCT01832402|75719385|FG001|COMPLETED|Overall Study||12||
59608550|NCT01832402|75719384|FG000|NOT COMPLETED|Overall Study||7||
59608551|NCT01832402|75719385|FG001|NOT COMPLETED|Overall Study||4||
59608552|NCT01619488|75719395|FG000|STARTED|Overall Study||57||
59608553|NCT01619488|75719395|FG000|COMPLETED|Overall Study||57||
59608554|NCT01619488|75719395|FG000|NOT COMPLETED|Overall Study||0||
59608555|NCT00667628|75719402|FG000|STARTED|Overall Study||25||
59608556|NCT00667628|75719403|FG001|STARTED|Overall Study||27||
59608557|NCT00667628|75719402|FG000|COMPLETED|Overall Study||0||
59755988|NCT00611455|75875092|FG002|COMPLETED|OL Treatment Period (120 Weeks)||0||
60013618|NCT02510001|76129527|FG001|NOT COMPLETED|Overall Study||0||
59608558|NCT00667628|75719403|FG001|COMPLETED|Overall Study||0||
59608559|NCT00667628|75719402|FG000|NOT COMPLETED|Overall Study||25||
59608560|NCT00667628|75719403|FG001|NOT COMPLETED|Overall Study||27||
59608561|NCT04563767|75719409|FG000|STARTED|Overall Study||4||
59608562|NCT04563767|75719409|FG000|COMPLETED|Overall Study||4||
59608563|NCT04563767|75719409|FG000|NOT COMPLETED|Overall Study||0||
59755989|NCT00611455|75875090|FG000|NOT COMPLETED|OL Treatment Period (120 Weeks)||0||
59755990|NCT00611455|75875091|FG001|NOT COMPLETED|OL Treatment Period (120 Weeks)||179||
60013619|NCT02510001|76129528|FG002|NOT COMPLETED|Overall Study||0||
60013620|NCT02510001|76129529|FG003|NOT COMPLETED|Overall Study||2||
60013621|NCT02510001|76129530|FG004|NOT COMPLETED|Overall Study||4||
60013622|NCT02510001|76129531|FG005|NOT COMPLETED|Overall Study||2||
60013623|NCT02510001|76129532|FG006|NOT COMPLETED|Overall Study||2||
60013624|NCT02510001|76129533|FG007|NOT COMPLETED|Overall Study||7||
60013625|NCT02452047|76129572|FG000|STARTED|Overall Study||31||
60013626|NCT02452047|76129573|FG001|STARTED|Overall Study||16||
60013627|NCT02452047|76129574|FG002|STARTED|Overall Study||3||
59608564|NCT01597908|75719415|FG000|STARTED|Randomized Phase||352|All randomized patients included into Intent-to-Treat (ITT) population.|
59608565|NCT01597908|75719416|FG001|STARTED|Randomized Phase||352|All randomized patients included into Intent-to-Treat (ITT) population.|
59608566|NCT01597908|75719417|FG002|STARTED|Randomized Phase||0|All randomized patients included into Intent-to-Treat (ITT) population.|
60013628|NCT02452047|76129572|FG000|COMPLETED|Overall Study||27||
59608567|NCT01597908|75719415|FG000|Safety Set|Randomized Phase||350|All patients who received at least one dose of study treatment|
59505062|NCT00719329|75597700|FG000|STARTED|Overall Study||705||
59608568|NCT01597908|75719416|FG001|Safety Set|Randomized Phase||349|All patients who received at least one dose of study treatment|
59608569|NCT01597908|75719417|FG002|Safety Set|Randomized Phase||0|All patients who received at least one dose of study treatment|
59608570|NCT01597908|75719415|FG000|COMPLETED|Randomized Phase||1|ongoing status (incomplete end-of-study data and never received study treatment)|
59608571|NCT01597908|75719416|FG001|COMPLETED|Randomized Phase||0|ongoing status (incomplete end-of-study data and never received study treatment)|
59608572|NCT01597908|75719417|FG002|COMPLETED|Randomized Phase||0|ongoing status (incomplete end-of-study data and never received study treatment)|
59608573|NCT01597908|75719415|FG000|NOT COMPLETED|Randomized Phase||351||
59608574|NCT01597908|75719416|FG001|NOT COMPLETED|Randomized Phase||352||
59608575|NCT01597908|75719417|FG002|NOT COMPLETED|Randomized Phase||0||
59608576|NCT01597908|75719415|FG000|STARTED|Crossover Phase||0|All crossover randomized patients included into ITT & Safety Sets|
59608577|NCT01597908|75719416|FG001|STARTED|Crossover Phase||0|All crossover randomized patients included into ITT & Safety Sets|
59608578|NCT01597908|75719417|FG002|STARTED|Crossover Phase||34|All crossover randomized patients included into ITT & Safety Sets|
59608579|NCT01597908|75719415|FG000|COMPLETED|Crossover Phase||0||
59608580|NCT01597908|75719416|FG001|COMPLETED|Crossover Phase||0||
59608581|NCT01597908|75719417|FG002|COMPLETED|Crossover Phase||0||
59608582|NCT01597908|75719415|FG000|NOT COMPLETED|Crossover Phase||0||
59608583|NCT01597908|75719416|FG001|NOT COMPLETED|Crossover Phase||0||
59608584|NCT01597908|75719417|FG002|NOT COMPLETED|Crossover Phase||34||
59608585|NCT01951170|75719426|FG000|STARTED|Overall Study||52||
59608586|NCT01951170|75719426|FG000|COMPLETED|Overall Study||51||
59608587|NCT01951170|75719426|FG000|NOT COMPLETED|Overall Study||1||
59608588|NCT01951092|75719430|FG000|STARTED|Overall Study||32||
59887208|NCT00909610|76009924|FG001|NOT COMPLETED|Period: First Intervention||1||
59887209|NCT00909610|76009923|FG000|STARTED|Period: Washout of 28 Days||40||
59887210|NCT00909610|76009924|FG001|STARTED|Period: Washout of 28 Days||39||
59887211|NCT00909610|76009923|FG000|COMPLETED|Period: Washout of 28 Days||37||
59887212|NCT00909610|76009924|FG001|COMPLETED|Period: Washout of 28 Days||33||
59887213|NCT00909610|76009923|FG000|NOT COMPLETED|Period: Washout of 28 Days||3||
59887214|NCT00909610|76009924|FG001|NOT COMPLETED|Period: Washout of 28 Days||6||
59887215|NCT00909610|76009923|FG000|STARTED|Period: Second Intervention||37||
59505063|NCT00719329|75597701|FG001|STARTED|Overall Study||571||
59505064|NCT00719329|75597702|FG002|STARTED|Overall Study||647||
59505065|NCT00719329|75597700|FG000|Day 1 Swab|Overall Study||705||
59505066|NCT00719329|75597701|FG001|Day 1 Swab|Overall Study||569||
59505067|NCT00719329|75597702|FG002|Day 1 Swab|Overall Study||646||
59505068|NCT00719329|75597700|FG000|Day 3 Swab|Overall Study||614||
59505069|NCT00719329|75597701|FG001|Day 3 Swab|Overall Study||501||
59505070|NCT00719329|75597702|FG002|Day 3 Swab|Overall Study||578||
59505071|NCT00719329|75597700|FG000|Day 7 Swab|Overall Study||593||
59505072|NCT00719329|75597701|FG001|Day 7 Swab|Overall Study||467||
59505073|NCT00719329|75597702|FG002|Day 7 Swab|Overall Study||561||
59505074|NCT00719329|75597700|FG000|COMPLETED|Overall Study||705||
59505075|NCT00719329|75597701|FG001|COMPLETED|Overall Study||569||
59505076|NCT00719329|75597702|FG002|COMPLETED|Overall Study||646||
59505077|NCT00719329|75597700|FG000|NOT COMPLETED|Overall Study||0||
59505078|NCT00719329|75597701|FG001|NOT COMPLETED|Overall Study||2||
59505079|NCT00719329|75597702|FG002|NOT COMPLETED|Overall Study||1||
59505080|NCT00602225|75597713|FG000|STARTED|Overall Study||50||
59505081|NCT00602225|75597713|FG000|COMPLETED|Overall Study||50||
59887216|NCT00909610|76009924|FG001|STARTED|Period: Second Intervention||33||
59887217|NCT00909610|76009923|FG000|COMPLETED|Period: Second Intervention||36||
59887218|NCT00909610|76009924|FG001|COMPLETED|Period: Second Intervention||33||
59887219|NCT00909610|76009923|FG000|NOT COMPLETED|Period: Second Intervention||1||
59887220|NCT00909610|76009924|FG001|NOT COMPLETED|Period: Second Intervention||0||
59887221|NCT03126110|76009946|FG000|STARTED|Phase 1||4||
59887222|NCT03126110|76009947|FG001|STARTED|Phase 1||4||
59887223|NCT03126110|76009948|FG002|STARTED|Phase 1||5||
59887224|NCT03126110|76009949|FG003|STARTED|Phase 1||4||
59505082|NCT00602225|75597713|FG000|NOT COMPLETED|Overall Study||0||
59505083|NCT00602771|75597720|FG000|STARTED|Overall Study||63||
59505084|NCT00602771|75597721|FG001|STARTED|Overall Study||21||
59505085|NCT00602771|75597720|FG000|COMPLETED|Overall Study||62||
59505086|NCT00602771|75597721|FG001|COMPLETED|Overall Study||21||
59505087|NCT00602771|75597720|FG000|NOT COMPLETED|Overall Study||1||
59505088|NCT00602771|75597721|FG001|NOT COMPLETED|Overall Study||0||
59608589|NCT01951092|75719430|FG000|COMPLETED|Overall Study||20||
59608590|NCT01951092|75719430|FG000|NOT COMPLETED|Overall Study||12||
59608591|NCT01949532|75719436|FG000|STARTED|Overall Study||15||
59608592|NCT01949532|75719437|FG001|STARTED|Overall Study||11||
59608593|NCT01949532|75719436|FG000|COMPLETED|Overall Study||12||
59608594|NCT01949532|75719437|FG001|COMPLETED|Overall Study||8||
59608595|NCT01949532|75719436|FG000|NOT COMPLETED|Overall Study||3||
59608596|NCT01949532|75719437|FG001|NOT COMPLETED|Overall Study||3||
59608597|NCT01949142|75719445|FG000|STARTED|Overall Study||179||
59608598|NCT01949142|75719446|FG001|STARTED|Overall Study||87||
59608599|NCT01949142|75719445|FG000|COMPLETED|Overall Study||176||
59608600|NCT01949142|75719446|FG001|COMPLETED|Overall Study||86||
59608601|NCT01949142|75719445|FG000|NOT COMPLETED|Overall Study||3||
59608602|NCT01949142|75719446|FG001|NOT COMPLETED|Overall Study||1||
59608603|NCT01948908|75719456|FG000|STARTED|Overall Study||33||
59608604|NCT01948908|75719457|FG001|STARTED|Overall Study||33||
59608605|NCT01948908|75719458|FG002|STARTED|Overall Study||33||
59608606|NCT01948908|75719456|FG000|COMPLETED|Overall Study||32||
59608607|NCT01948908|75719457|FG001|COMPLETED|Overall Study||33||
59608608|NCT01948908|75719458|FG002|COMPLETED|Overall Study||31||
59608609|NCT01948908|75719456|FG000|NOT COMPLETED|Overall Study||1||
59608610|NCT01948908|75719457|FG001|NOT COMPLETED|Overall Study||0||
59608611|NCT01948908|75719458|FG002|NOT COMPLETED|Overall Study||2||
59608612|NCT01925274|75719469|FG000|STARTED|Overall Study||7||
59608613|NCT01925274|75719470|FG001|STARTED|Overall Study||6||
59608614|NCT01925274|75719471|FG002|STARTED|Overall Study||6||
59608615|NCT01925274|75719469|FG000|COMPLETED|Overall Study||0||
59608616|NCT01925274|75719470|FG001|COMPLETED|Overall Study||0||
59608617|NCT01925274|75719471|FG002|COMPLETED|Overall Study||0||
59608618|NCT01925274|75719469|FG000|NOT COMPLETED|Overall Study||7||
59608619|NCT01925274|75719470|FG001|NOT COMPLETED|Overall Study||6||
59608620|NCT01925274|75719471|FG002|NOT COMPLETED|Overall Study||6||
59608621|NCT01948830|75719483|FG000|STARTED|Overall Study||323||
59608622|NCT01948830|75719484|FG001|STARTED|Overall Study||327||
59608623|NCT01948830|75719483|FG000|Safety Set|Overall Study||323||
59608624|NCT01948830|75719484|FG001|Safety Set|Overall Study||326||
59608625|NCT01948830|75719483|FG000|COMPLETED|Overall Study||290||
59608626|NCT01948830|75719484|FG001|COMPLETED|Overall Study||295||
59608627|NCT01948830|75719483|FG000|NOT COMPLETED|Overall Study||33||
59608628|NCT01948830|75719484|FG001|NOT COMPLETED|Overall Study||32||
59608629|NCT01972464|75719492|FG000|STARTED|Treatment Period (Week 1 Through Week 8)||19||
59608630|NCT01972464|75719493|FG001|STARTED|Treatment Period (Week 1 Through Week 8)||22||
59608631|NCT01972464|75719492|FG000|COMPLETED|Treatment Period (Week 1 Through Week 8)||16||
59608632|NCT01972464|75719493|FG001|COMPLETED|Treatment Period (Week 1 Through Week 8)||18||
59608633|NCT01972464|75719492|FG000|NOT COMPLETED|Treatment Period (Week 1 Through Week 8)||3||
59608634|NCT01972464|75719493|FG001|NOT COMPLETED|Treatment Period (Week 1 Through Week 8)||4||
59608635|NCT01972464|75719492|FG000|STARTED|3-Month Follow-Up (Week 20)||16||
59608636|NCT01972464|75719493|FG001|STARTED|3-Month Follow-Up (Week 20)||18||
59608637|NCT01972464|75719492|FG000|COMPLETED|3-Month Follow-Up (Week 20)||15||
59608638|NCT01972464|75719493|FG001|COMPLETED|3-Month Follow-Up (Week 20)||17||
59608639|NCT01972464|75719492|FG000|NOT COMPLETED|3-Month Follow-Up (Week 20)||1||
59608640|NCT01972464|75719493|FG001|NOT COMPLETED|3-Month Follow-Up (Week 20)||1||
59608641|NCT01948050|75719502|FG000|STARTED|Overall Study||16||
59608642|NCT01948050|75719503|FG001|STARTED|Overall Study||8||
59608643|NCT01948050|75719502|FG000|COMPLETED|Overall Study||16||
59608644|NCT01948050|75719503|FG001|COMPLETED|Overall Study||7||
59608645|NCT01948050|75719502|FG000|NOT COMPLETED|Overall Study||0||
59608646|NCT01948050|75719503|FG001|NOT COMPLETED|Overall Study||1||
59608647|NCT01947894|75719512|FG000|STARTED|Overall Study||247||
59608648|NCT01947894|75719513|FG001|STARTED|Overall Study||42||
59608649|NCT01947894|75719514|FG002|STARTED|Overall Study||88||
59608650|NCT01947894|75719512|FG000|Treated|Overall Study||246||
59608651|NCT01947894|75719513|FG001|Treated|Overall Study||41||
59608652|NCT01947894|75719514|FG002|Treated|Overall Study||87||
59608653|NCT01947894|75719512|FG000|COMPLETED|Overall Study||160||
59608654|NCT01947894|75719513|FG001|COMPLETED|Overall Study||24||
59608655|NCT01947894|75719514|FG002|COMPLETED|Overall Study||61||
59608656|NCT01947894|75719512|FG000|NOT COMPLETED|Overall Study||87||
59608657|NCT01947894|75719513|FG001|NOT COMPLETED|Overall Study||18||
59608658|NCT01947894|75719514|FG002|NOT COMPLETED|Overall Study||27||
59608659|NCT01947582|75719522|FG000|STARTED|Overall Study||2||
59608660|NCT01947582|75719522|FG000|COMPLETED|Overall Study||1||
59608661|NCT01947582|75719522|FG000|NOT COMPLETED|Overall Study||1||
59608662|NCT01924806|75719528|FG000|STARTED|Overall Study||5||5
59608663|NCT01924806|75719529|FG001|STARTED|Overall Study||4||4
59608664|NCT01924806|75719528|FG000|COMPLETED|Overall Study||3||3
59608665|NCT01924806|75719529|FG001|COMPLETED|Overall Study||3||3
59608666|NCT01924806|75719528|FG000|NOT COMPLETED|Overall Study||2||2
59608667|NCT01924806|75719529|FG001|NOT COMPLETED|Overall Study||1||1
59608668|NCT01924182|75719537|FG000|STARTED|Overall Study||3||
59608669|NCT01924182|75719538|FG001|STARTED|Overall Study||0||
59608670|NCT01924182|75719537|FG000|COMPLETED|Overall Study||2||
59608671|NCT01924182|75719538|FG001|COMPLETED|Overall Study||0||
59608672|NCT01924182|75719537|FG000|NOT COMPLETED|Overall Study||1||
59608673|NCT01924182|75719538|FG001|NOT COMPLETED|Overall Study||0||
59608674|NCT01972308|75719546|FG000|STARTED|Overall Study||156||
59608675|NCT01972308|75719547|FG001|STARTED|Overall Study||156||
59608676|NCT01972308|75719546|FG000|COMPLETED|Overall Study||148||
59608677|NCT01972308|75719547|FG001|COMPLETED|Overall Study||148||
59608678|NCT01972308|75719546|FG000|NOT COMPLETED|Overall Study||8||
59608679|NCT01972308|75719547|FG001|NOT COMPLETED|Overall Study||8||
59608680|NCT01946880|75719557|FG000|STARTED|Overall Study||50||
59608681|NCT01946880|75719558|FG001|STARTED|Overall Study||52||
59608682|NCT01946880|75719557|FG000|COMPLETED|Overall Study||43||
59608683|NCT01946880|75719558|FG001|COMPLETED|Overall Study||49||
59608684|NCT01946880|75719557|FG000|NOT COMPLETED|Overall Study||7||
59608685|NCT01946880|75719558|FG001|NOT COMPLETED|Overall Study||3||
59608686|NCT01972152|75719564|FG000|STARTED|First Treatment Visit||5||
59608687|NCT01972152|75719565|FG001|STARTED|First Treatment Visit||5||
59608688|NCT01972152|75719566|FG002|STARTED|First Treatment Visit||5||
59608689|NCT01972152|75719567|FG003|STARTED|First Treatment Visit||5||
59608690|NCT01972152|75719568|FG004|STARTED|First Treatment Visit||5||
59608691|NCT01972152|75719569|FG005|STARTED|First Treatment Visit||5||
59608692|NCT01972152|75719564|FG000|COMPLETED|First Treatment Visit||5||
59608693|NCT01972152|75719565|FG001|COMPLETED|First Treatment Visit||4||
59608694|NCT01972152|75719566|FG002|COMPLETED|First Treatment Visit||5||
59608695|NCT01972152|75719567|FG003|COMPLETED|First Treatment Visit||5||
59608696|NCT01972152|75719568|FG004|COMPLETED|First Treatment Visit||5||
59608697|NCT01972152|75719569|FG005|COMPLETED|First Treatment Visit||5||
59608698|NCT01972152|75719564|FG000|NOT COMPLETED|First Treatment Visit||0||
59608699|NCT01972152|75719565|FG001|NOT COMPLETED|First Treatment Visit||1||
59608700|NCT01972152|75719566|FG002|NOT COMPLETED|First Treatment Visit||0||
59505089|NCT00742963|75597727|FG000|STARTED|Overall Study||101||
59505090|NCT00742963|75597727|FG000|Completed All Treatment Cycles|Overall Study||68||
59505091|NCT00742963|75597727|FG000|COMPLETED|Overall Study||68||
59505092|NCT00742963|75597727|FG000|NOT COMPLETED|Overall Study||33||
59505093|NCT00744211|75597734|FG000|STARTED|Baseline||10||
59608701|NCT01972152|75719567|FG003|NOT COMPLETED|First Treatment Visit||0||
59608702|NCT01972152|75719568|FG004|NOT COMPLETED|First Treatment Visit||0||
59608703|NCT01972152|75719569|FG005|NOT COMPLETED|First Treatment Visit||0||
59608704|NCT01972152|75719564|FG000|STARTED|Second Treatment Visit||5||
59608705|NCT01972152|75719565|FG001|STARTED|Second Treatment Visit||4||
59608706|NCT01972152|75719566|FG002|STARTED|Second Treatment Visit||5||
59608707|NCT01972152|75719567|FG003|STARTED|Second Treatment Visit||5||
59608708|NCT01972152|75719568|FG004|STARTED|Second Treatment Visit||5||
59608709|NCT01972152|75719569|FG005|STARTED|Second Treatment Visit||5||
59608710|NCT01972152|75719564|FG000|COMPLETED|Second Treatment Visit||5||
59608711|NCT01972152|75719565|FG001|COMPLETED|Second Treatment Visit||3||
59608712|NCT01972152|75719566|FG002|COMPLETED|Second Treatment Visit||5||
59608713|NCT01972152|75719567|FG003|COMPLETED|Second Treatment Visit||5||
59608714|NCT01972152|75719568|FG004|COMPLETED|Second Treatment Visit||5||
59608715|NCT01972152|75719569|FG005|COMPLETED|Second Treatment Visit||5||
59608716|NCT01972152|75719564|FG000|NOT COMPLETED|Second Treatment Visit||0||
59608717|NCT01972152|75719565|FG001|NOT COMPLETED|Second Treatment Visit||1||
59608718|NCT01972152|75719566|FG002|NOT COMPLETED|Second Treatment Visit||0||
59608719|NCT01972152|75719567|FG003|NOT COMPLETED|Second Treatment Visit||0||
59608720|NCT01972152|75719568|FG004|NOT COMPLETED|Second Treatment Visit||0||
59608721|NCT01972152|75719569|FG005|NOT COMPLETED|Second Treatment Visit||0||
59608722|NCT01972152|75719564|FG000|STARTED|Third Treatment Visit||5||
59608723|NCT01972152|75719565|FG001|STARTED|Third Treatment Visit||3||
59608724|NCT01972152|75719566|FG002|STARTED|Third Treatment Visit||5||
59608725|NCT01972152|75719567|FG003|STARTED|Third Treatment Visit||5||
59608726|NCT01972152|75719568|FG004|STARTED|Third Treatment Visit||5||
59505094|NCT00744211|75597735|FG001|STARTED|Baseline||9||
59505095|NCT00744211|75597736|FG002|STARTED|Baseline||10||
59505096|NCT00744211|75597734|FG000|COMPLETED|Baseline||10||
59505097|NCT00744211|75597735|FG001|COMPLETED|Baseline||9||
59505098|NCT00744211|75597736|FG002|COMPLETED|Baseline||10||
59505099|NCT00744211|75597734|FG000|NOT COMPLETED|Baseline||0||
59505100|NCT00744211|75597735|FG001|NOT COMPLETED|Baseline||0||
59608727|NCT01972152|75719569|FG005|STARTED|Third Treatment Visit||5||
59608728|NCT01972152|75719564|FG000|COMPLETED|Third Treatment Visit||5||
59608729|NCT01972152|75719565|FG001|COMPLETED|Third Treatment Visit||3||
59608730|NCT01972152|75719566|FG002|COMPLETED|Third Treatment Visit||5||
59608731|NCT01972152|75719567|FG003|COMPLETED|Third Treatment Visit||5||
59608732|NCT01972152|75719568|FG004|COMPLETED|Third Treatment Visit||5||
59608733|NCT01972152|75719569|FG005|COMPLETED|Third Treatment Visit||5||
59608734|NCT01972152|75719564|FG000|NOT COMPLETED|Third Treatment Visit||0||
59608735|NCT01972152|75719565|FG001|NOT COMPLETED|Third Treatment Visit||0||
59608736|NCT01972152|75719566|FG002|NOT COMPLETED|Third Treatment Visit||0||
59505101|NCT00744211|75597736|FG002|NOT COMPLETED|Baseline||0||
59505102|NCT00744211|75597734|FG000|STARTED|0.5 Hours After Cardiopulmonary Bypass||10||
59608737|NCT01972152|75719567|FG003|NOT COMPLETED|Third Treatment Visit||0||
59608738|NCT01972152|75719568|FG004|NOT COMPLETED|Third Treatment Visit||0||
59608739|NCT01972152|75719569|FG005|NOT COMPLETED|Third Treatment Visit||0||
59608740|NCT01972074|75719583|FG000|STARTED|Overall Study||22||
59608741|NCT01972074|75719584|FG001|STARTED|Overall Study||21||
59608742|NCT01972074|75719585|FG002|STARTED|Overall Study||18||
59608743|NCT01972074|75719583|FG000|COMPLETED|Overall Study||16||
59608744|NCT01972074|75719584|FG001|COMPLETED|Overall Study||17||
59608745|NCT01972074|75719585|FG002|COMPLETED|Overall Study||15||
59608746|NCT01972074|75719583|FG000|NOT COMPLETED|Overall Study||6||
59608747|NCT01972074|75719584|FG001|NOT COMPLETED|Overall Study||4||
59608748|NCT01972074|75719585|FG002|NOT COMPLETED|Overall Study||3||
59608749|NCT01970982|75719595|FG000|STARTED|Overall Study||80||
59608750|NCT01970982|75719596|FG001|STARTED|Overall Study||40||
59608751|NCT01970982|75719597|FG002|STARTED|Overall Study||40||
59608752|NCT01970982|75719595|FG000|COMPLETED|Overall Study||80||
59608753|NCT01970982|75719596|FG001|COMPLETED|Overall Study||40||
59608754|NCT01970982|75719597|FG002|COMPLETED|Overall Study||38||
59608755|NCT01970982|75719595|FG000|NOT COMPLETED|Overall Study||0||
59608756|NCT01970982|75719596|FG001|NOT COMPLETED|Overall Study||0||
59608757|NCT01970982|75719597|FG002|NOT COMPLETED|Overall Study||2||
59608758|NCT01946802|75719606|FG000|STARTED|Overall Study||44||
59608759|NCT01946802|75719606|FG000|COMPLETED|Overall Study||39||
59608760|NCT01946802|75719606|FG000|NOT COMPLETED|Overall Study||5||
59608761|NCT01618266|75719610|FG000|STARTED|Overall Study||375||
59608762|NCT01618266|75719610|FG000|COMPLETED|Overall Study||279||
59608763|NCT01618266|75719610|FG000|NOT COMPLETED|Overall Study||96||
59608764|NCT01919112|75719617|FG000|STARTED|Primary Analysis-day 5 of Intervention||14||
59608765|NCT01919112|75719618|FG001|STARTED|Primary Analysis-day 5 of Intervention||13||
59608766|NCT01919112|75719619|FG002|STARTED|Primary Analysis-day 5 of Intervention||15||
59608767|NCT01919112|75719617|FG000|COMPLETED|Primary Analysis-day 5 of Intervention||14||
59608768|NCT01919112|75719618|FG001|COMPLETED|Primary Analysis-day 5 of Intervention||13||
59608769|NCT01919112|75719619|FG002|COMPLETED|Primary Analysis-day 5 of Intervention||15||
59608770|NCT01919112|75719617|FG000|NOT COMPLETED|Primary Analysis-day 5 of Intervention||0||
59608771|NCT01919112|75719618|FG001|NOT COMPLETED|Primary Analysis-day 5 of Intervention||0||
59608772|NCT01919112|75719619|FG002|NOT COMPLETED|Primary Analysis-day 5 of Intervention||0||
59608773|NCT01919112|75719617|FG000|STARTED|Secondary Analysis-day 30||14||
59608774|NCT01919112|75719618|FG001|STARTED|Secondary Analysis-day 30||13||
59608775|NCT01919112|75719619|FG002|STARTED|Secondary Analysis-day 30||15||
59608776|NCT01919112|75719617|FG000|COMPLETED|Secondary Analysis-day 30||12||
59608777|NCT01919112|75719618|FG001|COMPLETED|Secondary Analysis-day 30||12||
59608778|NCT01919112|75719619|FG002|COMPLETED|Secondary Analysis-day 30||14||
59608779|NCT01919112|75719617|FG000|NOT COMPLETED|Secondary Analysis-day 30||2||
59608780|NCT01919112|75719618|FG001|NOT COMPLETED|Secondary Analysis-day 30||1||
59608781|NCT01919112|75719619|FG002|NOT COMPLETED|Secondary Analysis-day 30||1||
59608782|NCT01918332|75719631|FG000|STARTED|Overall Study||43||
59608783|NCT01918332|75719632|FG001|STARTED|Overall Study||41||
59608784|NCT01918332|75719633|FG002|STARTED|Overall Study||39||
59608785|NCT01918332|75719634|FG003|STARTED|Overall Study||45||
59608786|NCT01918332|75719631|FG000|COMPLETED|Overall Study||35||
59608787|NCT01918332|75719632|FG001|COMPLETED|Overall Study||36||
59608788|NCT01918332|75719633|FG002|COMPLETED|Overall Study||30||
59608789|NCT01918332|75719634|FG003|COMPLETED|Overall Study||38||
59608790|NCT01918332|75719631|FG000|NOT COMPLETED|Overall Study||8||
59608791|NCT01918332|75719632|FG001|NOT COMPLETED|Overall Study||5||
59608792|NCT01918332|75719633|FG002|NOT COMPLETED|Overall Study||9||
59608793|NCT01918332|75719634|FG003|NOT COMPLETED|Overall Study||7||
59608794|NCT01922934|75719646|FG000|STARTED|Eligible Patients||428||
59608795|NCT01922934|75719647|FG001|STARTED|Eligible Patients||4302||
59608796|NCT01922934|75719646|FG000|COMPLETED|Eligible Patients|375 patients determined eligible after original random selection from DHHA data warehouse.|375||
59608797|NCT01922934|75719647|FG001|COMPLETED|Eligible Patients|81 patients did not meet inclusion criteria as they were 80 years or older. 7 patients had died.|4214||
59608798|NCT01922934|75719646|FG000|NOT COMPLETED|Eligible Patients||53||
59608799|NCT01922934|75719647|FG001|NOT COMPLETED|Eligible Patients||88||
59608800|NCT01922934|75719646|FG000|STARTED|Visit 0 - Patient Contacted & Consented||375||
59608801|NCT01922934|75719647|FG001|STARTED|Visit 0 - Patient Contacted & Consented|Control group patients were not contacted or offered intervention|4214||
60013629|NCT02452047|76129573|FG001|COMPLETED|Overall Study||11||
59608802|NCT01922934|75719646|FG000|COMPLETED|Visit 0 - Patient Contacted & Consented|reflects number of patients that were contacted and agreed to attend Visit 0|140||
59608803|NCT01922934|75719647|FG001|COMPLETED|Visit 0 - Patient Contacted & Consented||4214||
59608804|NCT01922934|75719646|FG000|NOT COMPLETED|Visit 0 - Patient Contacted & Consented||235||
59608805|NCT01922934|75719647|FG001|NOT COMPLETED|Visit 0 - Patient Contacted & Consented||0||
59608806|NCT01922934|75719646|FG000|STARTED|Visit 1- Weight Measured|21 patients did not return for Visit 1 to receive tool or have weight measured.|140||
59608807|NCT01922934|75719647|FG001|STARTED|Visit 1- Weight Measured||4214||
59608808|NCT01922934|75719646|FG000|COMPLETED|Visit 1- Weight Measured|Patients first received tool and were weighed at Visit 1|119||
59608809|NCT01922934|75719647|FG001|COMPLETED|Visit 1- Weight Measured|1284 patients did not have any weights recorded in EMR during study timeframe|2930||
59608810|NCT01922934|75719646|FG000|NOT COMPLETED|Visit 1- Weight Measured||21||
59608811|NCT01922934|75719647|FG001|NOT COMPLETED|Visit 1- Weight Measured||1284||
59608812|NCT01922934|75719646|FG000|STARTED|Visit 12 / Final Visits||119||
59608813|NCT01922934|75719647|FG001|STARTED|Visit 12 / Final Visits||2930||
59608814|NCT01922934|75719646|FG000|COMPLETED|Visit 12 / Final Visits|6 patients did not return for final visit and weight measure|113||
59608815|NCT01922934|75719647|FG001|COMPLETED|Visit 12 / Final Visits|290 patients did not have a second weight recorded at one year (+/- 6months) of first weight|2640||
59608816|NCT01922934|75719646|FG000|NOT COMPLETED|Visit 12 / Final Visits||6||
59608817|NCT01922934|75719647|FG001|NOT COMPLETED|Visit 12 / Final Visits||290||
59608818|NCT01970592|75719655|FG000|STARTED|Overall Study|Completed all training sessions|56||
59608819|NCT01970592|75719655|FG000|COMPLETED|Overall Study||50|Completed all training sessions|
59608820|NCT01970592|75719655|FG000|NOT COMPLETED|Overall Study||6||
59608821|NCT01920594|75719661|FG000|STARTED|Overall Study||27||
59608822|NCT01920594|75719662|FG001|STARTED|Overall Study||28||
59608823|NCT01920594|75719661|FG000|COMPLETED|Overall Study||20||
59608824|NCT01920594|75719662|FG001|COMPLETED|Overall Study||25||
59608825|NCT01920594|75719661|FG000|NOT COMPLETED|Overall Study||7||
59608826|NCT01920594|75719662|FG001|NOT COMPLETED|Overall Study||3||
59608827|NCT01917084|75719668|FG000|STARTED|Overall Study||20||
59608828|NCT01917084|75719668|FG000|COMPLETED|Overall Study||19||
59608829|NCT01917084|75719668|FG000|NOT COMPLETED|Overall Study||1||
59608830|NCT01917006|75719679|FG000|STARTED|Randomized-treatment Period||5||
59608831|NCT01917006|75719680|FG001|STARTED|Randomized-treatment Period||7||
59608832|NCT01917006|75719681|FG002|STARTED|Randomized-treatment Period||8||
59608833|NCT01917006|75719682|FG003|STARTED|Randomized-treatment Period||8||
59608834|NCT01917006|75719683|FG004|STARTED|Randomized-treatment Period||8||
59608835|NCT01917006|75719684|FG005|STARTED|Randomized-treatment Period||8||
59608836|NCT01917006|75719685|FG006|STARTED|Randomized-treatment Period||15||
59608837|NCT01917006|75719686|FG007|STARTED|Randomized-treatment Period||0||
59608838|NCT01917006|75719679|FG000|COMPLETED|Randomized-treatment Period||3||
59608839|NCT01917006|75719680|FG001|COMPLETED|Randomized-treatment Period||7||
59608840|NCT01917006|75719681|FG002|COMPLETED|Randomized-treatment Period||8||
59608841|NCT01917006|75719682|FG003|COMPLETED|Randomized-treatment Period||7||
59608842|NCT01917006|75719683|FG004|COMPLETED|Randomized-treatment Period||8||
59608843|NCT01917006|75719684|FG005|COMPLETED|Randomized-treatment Period||7||
59608844|NCT01917006|75719685|FG006|COMPLETED|Randomized-treatment Period||14||
59608845|NCT01917006|75719686|FG007|COMPLETED|Randomized-treatment Period||0||
59608846|NCT01917006|75719679|FG000|NOT COMPLETED|Randomized-treatment Period||2||
59608847|NCT01917006|75719680|FG001|NOT COMPLETED|Randomized-treatment Period||0||
59608848|NCT01917006|75719681|FG002|NOT COMPLETED|Randomized-treatment Period||0||
59608849|NCT01917006|75719682|FG003|NOT COMPLETED|Randomized-treatment Period||1||
59505103|NCT00744211|75597735|FG001|STARTED|0.5 Hours After Cardiopulmonary Bypass||9||
59505104|NCT00744211|75597736|FG002|STARTED|0.5 Hours After Cardiopulmonary Bypass||10||
59505105|NCT00744211|75597734|FG000|COMPLETED|0.5 Hours After Cardiopulmonary Bypass||10||
59505106|NCT00744211|75597735|FG001|COMPLETED|0.5 Hours After Cardiopulmonary Bypass||9||
59505107|NCT00744211|75597736|FG002|COMPLETED|0.5 Hours After Cardiopulmonary Bypass||10||
59505108|NCT00744211|75597734|FG000|NOT COMPLETED|0.5 Hours After Cardiopulmonary Bypass||0||
59505109|NCT00744211|75597735|FG001|NOT COMPLETED|0.5 Hours After Cardiopulmonary Bypass||0||
59505110|NCT00744211|75597736|FG002|NOT COMPLETED|0.5 Hours After Cardiopulmonary Bypass||0||
59505111|NCT00744211|75597734|FG000|STARTED|6 Hours After Cardiopulmonary Bypass||10||
59505112|NCT00744211|75597735|FG001|STARTED|6 Hours After Cardiopulmonary Bypass||9||
59505113|NCT00744211|75597736|FG002|STARTED|6 Hours After Cardiopulmonary Bypass||10||
59505114|NCT00744211|75597734|FG000|COMPLETED|6 Hours After Cardiopulmonary Bypass||10||
59505115|NCT00744211|75597735|FG001|COMPLETED|6 Hours After Cardiopulmonary Bypass||9||
59505116|NCT00744211|75597736|FG002|COMPLETED|6 Hours After Cardiopulmonary Bypass||10||
59505117|NCT00744211|75597734|FG000|NOT COMPLETED|6 Hours After Cardiopulmonary Bypass||0||
59505118|NCT00744211|75597735|FG001|NOT COMPLETED|6 Hours After Cardiopulmonary Bypass||0||
59505119|NCT00744211|75597736|FG002|NOT COMPLETED|6 Hours After Cardiopulmonary Bypass||0||
59505120|NCT00744211|75597734|FG000|STARTED|12 Hours After Cardiopulmonary Bypass||10||
59505121|NCT00744211|75597735|FG001|STARTED|12 Hours After Cardiopulmonary Bypass||9||
59608850|NCT01917006|75719683|FG004|NOT COMPLETED|Randomized-treatment Period||0||
59608851|NCT01917006|75719684|FG005|NOT COMPLETED|Randomized-treatment Period||1||
59608852|NCT01917006|75719685|FG006|NOT COMPLETED|Randomized-treatment Period||1||
59608853|NCT01917006|75719686|FG007|NOT COMPLETED|Randomized-treatment Period||0||
59608854|NCT01917006|75719679|FG000|STARTED|Open-label Period||0||
59608855|NCT01917006|75719680|FG001|STARTED|Open-label Period||0||
59608856|NCT01917006|75719681|FG002|STARTED|Open-label Period||0||
59608857|NCT01917006|75719682|FG003|STARTED|Open-label Period||0||
59608858|NCT01917006|75719683|FG004|STARTED|Open-label Period||0||
59608859|NCT01917006|75719684|FG005|STARTED|Open-label Period||0||
59608860|NCT01917006|75719685|FG006|STARTED|Open-label Period||0||
59608861|NCT01917006|75719686|FG007|STARTED|Open-label Period||8||
59608862|NCT01917006|75719679|FG000|COMPLETED|Open-label Period||0||
59608863|NCT01917006|75719680|FG001|COMPLETED|Open-label Period||0||
59608864|NCT01917006|75719681|FG002|COMPLETED|Open-label Period||0||
59608865|NCT01917006|75719682|FG003|COMPLETED|Open-label Period||0||
59608866|NCT01917006|75719683|FG004|COMPLETED|Open-label Period||0||
59608867|NCT01917006|75719684|FG005|COMPLETED|Open-label Period||0||
59608868|NCT01917006|75719685|FG006|COMPLETED|Open-label Period||0||
59608869|NCT01917006|75719686|FG007|COMPLETED|Open-label Period||6||
59608870|NCT01917006|75719679|FG000|NOT COMPLETED|Open-label Period||0||
59608871|NCT01917006|75719680|FG001|NOT COMPLETED|Open-label Period||0||
59608872|NCT01917006|75719681|FG002|NOT COMPLETED|Open-label Period||0||
59608873|NCT01917006|75719682|FG003|NOT COMPLETED|Open-label Period||0||
59608874|NCT01917006|75719683|FG004|NOT COMPLETED|Open-label Period||0||
59608875|NCT01917006|75719684|FG005|NOT COMPLETED|Open-label Period||0||
59608876|NCT01917006|75719685|FG006|NOT COMPLETED|Open-label Period||0||
59608877|NCT01917006|75719686|FG007|NOT COMPLETED|Open-label Period||2||
59608878|NCT01916304|75719703|FG000|STARTED|Overall Study||101||
59608879|NCT01916304|75719703|FG000|Safety Set|Overall Study||101||
59608880|NCT01916304|75719703|FG000|Intent-to-Treat Set|Overall Study||84||
59608881|NCT01916304|75719703|FG000|COMPLETED|Overall Study||84||
59608882|NCT01916304|75719703|FG000|NOT COMPLETED|Overall Study||17||
59608883|NCT01916226|75719711|FG000|STARTED|Overall Study||170||
59608884|NCT01916226|75719712|FG001|STARTED|Overall Study||170||
59608885|NCT01916226|75719713|FG002|STARTED|Overall Study||171||
59608886|NCT01916226|75719714|FG003|STARTED|Overall Study||171||
59608887|NCT01916226|75719711|FG000|COMPLETED|Overall Study||169||
59608888|NCT01916226|75719712|FG001|COMPLETED|Overall Study||169||
59608889|NCT01916226|75719713|FG002|COMPLETED|Overall Study||168||
59608890|NCT01916226|75719714|FG003|COMPLETED|Overall Study||167||
59608891|NCT01916226|75719711|FG000|NOT COMPLETED|Overall Study||1||
59608892|NCT01916226|75719712|FG001|NOT COMPLETED|Overall Study||1||
59608893|NCT01916226|75719713|FG002|NOT COMPLETED|Overall Study||3||
59608894|NCT01916226|75719714|FG003|NOT COMPLETED|Overall Study||4||
59608895|NCT01969500|75719727|FG000|STARTED|Overall Study||25||
59608896|NCT01969500|75719728|FG001|STARTED|Overall Study||26||
59608897|NCT01969500|75719727|FG000|COMPLETED|Overall Study||24||
59608898|NCT01969500|75719728|FG001|COMPLETED|Overall Study||24||
59608899|NCT01969500|75719727|FG000|NOT COMPLETED|Overall Study||1||
59608900|NCT01969500|75719728|FG001|NOT COMPLETED|Overall Study||2||
59608901|NCT01915914|75719734|FG000|STARTED|Acute Phase||123||
59608902|NCT01915914|75719735|FG001|STARTED|Acute Phase||0||
59608903|NCT01915914|75719736|FG002|STARTED|Acute Phase||0||
59608904|NCT01915914|75719737|FG003|STARTED|Acute Phase||0||
59608905|NCT01915914|75719734|FG000|Completed-Not Entered Maintenance Phase|Acute Phase||4||
59608906|NCT01915914|75719735|FG001|Completed-Not Entered Maintenance Phase|Acute Phase||0||
59608907|NCT01915914|75719736|FG002|Completed-Not Entered Maintenance Phase|Acute Phase||0||
59608908|NCT01915914|75719737|FG003|Completed-Not Entered Maintenance Phase|Acute Phase||0||
59608909|NCT01915914|75719734|FG000|COMPLETED|Acute Phase||111||
59608910|NCT01915914|75719735|FG001|COMPLETED|Acute Phase||0||
59608911|NCT01915914|75719736|FG002|COMPLETED|Acute Phase||0||
59608912|NCT01915914|75719737|FG003|COMPLETED|Acute Phase||0||
59608913|NCT01915914|75719734|FG000|NOT COMPLETED|Acute Phase||12||
59608914|NCT01915914|75719735|FG001|NOT COMPLETED|Acute Phase||0||
59608915|NCT01915914|75719736|FG002|NOT COMPLETED|Acute Phase||0||
59608916|NCT01915914|75719737|FG003|NOT COMPLETED|Acute Phase||0||
59608917|NCT01915914|75719734|FG000|STARTED|Maintenance Phase||0||
59608918|NCT01915914|75719735|FG001|STARTED|Maintenance Phase||54||
59608919|NCT01915914|75719736|FG002|STARTED|Maintenance Phase||53||
59608920|NCT01915914|75719737|FG003|STARTED|Maintenance Phase||0||
59608921|NCT01915914|75719734|FG000|COMPLETED|Maintenance Phase||0||
59762579|NCT00594204|75882391|FG000|STARTED|Overall Study||394||
60013630|NCT02452047|76129574|FG002|COMPLETED|Overall Study||1||
60013631|NCT02452047|76129572|FG000|NOT COMPLETED|Overall Study||4||
59608922|NCT01915914|75719735|FG001|COMPLETED|Maintenance Phase||48||
59608923|NCT01915914|75719736|FG002|COMPLETED|Maintenance Phase||51||
59608924|NCT01915914|75719737|FG003|COMPLETED|Maintenance Phase||0||
59608925|NCT01915914|75719734|FG000|NOT COMPLETED|Maintenance Phase||0||
59608926|NCT01915914|75719735|FG001|NOT COMPLETED|Maintenance Phase||6||
59608927|NCT01915914|75719736|FG002|NOT COMPLETED|Maintenance Phase||2||
59608928|NCT01915914|75719737|FG003|NOT COMPLETED|Maintenance Phase||0||
59608929|NCT01915914|75719734|FG000|STARTED|Follow-up Phase||0||
59608930|NCT01915914|75719735|FG001|STARTED|Follow-up Phase||0||
59608931|NCT01915914|75719736|FG002|STARTED|Follow-up Phase||0||
59608932|NCT01915914|75719737|FG003|STARTED|Follow-up Phase||66||
59608933|NCT01915914|75719734|FG000|COMPLETED|Follow-up Phase||0||
59608934|NCT01915914|75719735|FG001|COMPLETED|Follow-up Phase||0||
59608935|NCT01915914|75719736|FG002|COMPLETED|Follow-up Phase||0||
60013632|NCT02452047|76129573|FG001|NOT COMPLETED|Overall Study||5||
59608936|NCT01915914|75719737|FG003|COMPLETED|Follow-up Phase||64||
59608937|NCT01915914|75719734|FG000|NOT COMPLETED|Follow-up Phase||0||
59608938|NCT01915914|75719735|FG001|NOT COMPLETED|Follow-up Phase||0||
59608939|NCT01915914|75719736|FG002|NOT COMPLETED|Follow-up Phase||0||
59608940|NCT01915914|75719737|FG003|NOT COMPLETED|Follow-up Phase||2||
59608941|NCT01919970|75719757|FG000|STARTED|Overall Study||14||
59608942|NCT01919970|75719758|FG001|STARTED|Overall Study||18||
59608943|NCT01919970|75719757|FG000|COMPLETED|Overall Study||11||
59608944|NCT01919970|75719758|FG001|COMPLETED|Overall Study||18||
59608945|NCT01919970|75719757|FG000|NOT COMPLETED|Overall Study||3||
59608946|NCT01919970|75719758|FG001|NOT COMPLETED|Overall Study||0||
59608947|NCT01919814|75719764|FG000|STARTED|Overall Study||30||
59608948|NCT01919814|75719765|FG001|STARTED|Overall Study||30||
59608949|NCT01919814|75719764|FG000|COMPLETED|Overall Study||27||
59608950|NCT01919814|75719765|FG001|COMPLETED|Overall Study||30||
59608951|NCT01919814|75719764|FG000|NOT COMPLETED|Overall Study||3||
59608952|NCT01919814|75719765|FG001|NOT COMPLETED|Overall Study||0||
59608953|NCT01968954|75719773|FG000|STARTED|Overall Study||354||
59608954|NCT01968954|75719774|FG001|STARTED|Overall Study||357||
59608955|NCT01968954|75719773|FG000|Treated|Overall Study||353||
59608956|NCT01968954|75719774|FG001|Treated|Overall Study||356||
59608957|NCT01968954|75719773|FG000|COMPLETED|Overall Study||314||
59608958|NCT01968954|75719774|FG001|COMPLETED|Overall Study||314||
59608959|NCT01968954|75719773|FG000|NOT COMPLETED|Overall Study||40||
59608960|NCT01968954|75719774|FG001|NOT COMPLETED|Overall Study||43||
59608961|NCT01919190|75719783|FG000|STARTED|Overall Study|Met eligibility criteria|33||
59608962|NCT01919190|75719784|FG001|STARTED|Overall Study|Met eligibility criteria|34||
59608963|NCT01919190|75719783|FG000|COMPLETED|Overall Study||30||
59608964|NCT01919190|75719784|FG001|COMPLETED|Overall Study||34||
59608965|NCT01919190|75719783|FG000|NOT COMPLETED|Overall Study||3||
59608966|NCT01919190|75719784|FG001|NOT COMPLETED|Overall Study||0||
59608967|NCT01620060|75719791|FG000|STARTED|Overall Study||105||
59608968|NCT01620060|75719791|FG000|COMPLETED|Overall Study||90||
59608969|NCT01620060|75719791|FG000|NOT COMPLETED|Overall Study||15||
59608970|NCT01914666|75719798|FG000|STARTED|Treatment Period||68||
59608971|NCT01914666|75719799|FG001|STARTED|Treatment Period||42||
59608972|NCT01914666|75719800|FG002|STARTED|Treatment Period||41||
59608973|NCT01914666|75719798|FG000|Received at Least 1 Dose of Study Drug|Treatment Period||68||
59608974|NCT01914666|75719799|FG001|Received at Least 1 Dose of Study Drug|Treatment Period||42||
59608975|NCT01914666|75719800|FG002|Received at Least 1 Dose of Study Drug|Treatment Period||41||
59608976|NCT01914666|75719798|FG000|COMPLETED|Treatment Period||55||
59608977|NCT01914666|75719799|FG001|COMPLETED|Treatment Period||36||
59608978|NCT01914666|75719800|FG002|COMPLETED|Treatment Period||33||
59608979|NCT01914666|75719798|FG000|NOT COMPLETED|Treatment Period||13||
59608980|NCT01914666|75719799|FG001|NOT COMPLETED|Treatment Period||6||
59608981|NCT01914666|75719800|FG002|NOT COMPLETED|Treatment Period||8||
59608982|NCT01914666|75719798|FG000|STARTED|Tapering Period|4 Pts who discontinued, and 55 Pts who completed Treatment Period entered Tapering Period.|59||
59608983|NCT01914666|75719799|FG001|STARTED|Tapering Period|3 Pts who discontinued, and 36 Pts who completed Treatment Period entered Tapering Period.|39||
59608984|NCT01914666|75719800|FG002|STARTED|Tapering Period|7 Pts who discontinued, and 33 Pts who completed Treatment Period entered Tapering Period.|40||
59608985|NCT01914666|75719798|FG000|COMPLETED|Tapering Period||59||
59608986|NCT01914666|75719799|FG001|COMPLETED|Tapering Period||39||
59608987|NCT01914666|75719800|FG002|COMPLETED|Tapering Period||40||
59608988|NCT01914666|75719798|FG000|NOT COMPLETED|Tapering Period||0||
59608989|NCT01914666|75719799|FG001|NOT COMPLETED|Tapering Period||0||
59608990|NCT01914666|75719800|FG002|NOT COMPLETED|Tapering Period||0||
59608991|NCT01913340|75719808|FG000|STARTED|Overall Study|22 (92%) received all 5 doses, 1 (4%) received 4 doses, and 1 (4%) only received 1 dose.|24||
59608992|NCT01913340|75719809|FG001|STARTED|Overall Study||26||
59608993|NCT01913340|75719808|FG000|COMPLETED|Overall Study||21||
59608994|NCT01913340|75719809|FG001|COMPLETED|Overall Study||20||
59608995|NCT01913340|75719808|FG000|NOT COMPLETED|Overall Study||3||
59608996|NCT01913340|75719809|FG001|NOT COMPLETED|Overall Study||6||
59608997|NCT01864200|75719817|FG000|STARTED|Overall Study||45||
59608998|NCT01864200|75719818|FG001|STARTED|Overall Study||29||
59887225|NCT03126110|76009950|FG004|STARTED|Phase 1||5||
59608999|NCT01864200|75719817|FG000|COMPLETED|Overall Study||43||
59609000|NCT01864200|75719818|FG001|COMPLETED|Overall Study||26||
59609001|NCT01864200|75719817|FG000|NOT COMPLETED|Overall Study||2||
59609002|NCT01864200|75719818|FG001|NOT COMPLETED|Overall Study||3||
59609003|NCT01912872|75719828|FG000|STARTED|Overall Study||16||
59609004|NCT01912872|75719829|FG001|STARTED|Overall Study||17||
59609005|NCT01912872|75719830|FG002|STARTED|Overall Study||40||
59609006|NCT01912872|75719831|FG003|STARTED|Overall Study||39||
59609007|NCT01912872|75719828|FG000|Completed Study Treatment at Month 12|Overall Study||11||
59609008|NCT01912872|75719829|FG001|Completed Study Treatment at Month 12|Overall Study||13||
59609009|NCT01912872|75719830|FG002|Completed Study Treatment at Month 12|Overall Study||30||
59609010|NCT01912872|75719831|FG003|Completed Study Treatment at Month 12|Overall Study||27||
59887226|NCT03126110|76009951|FG005|STARTED|Phase 1||4||
59887227|NCT03126110|76009952|FG006|STARTED|Phase 1||4||
59887228|NCT03126110|76009953|FG007|STARTED|Phase 1||4||
59609011|NCT01912872|75719828|FG000|Discontinued Treatment Prior to Month 12|Overall Study||5||
59609012|NCT01912872|75719829|FG001|Discontinued Treatment Prior to Month 12|Overall Study||4||
59609013|NCT01912872|75719830|FG002|Discontinued Treatment Prior to Month 12|Overall Study||10||
59609014|NCT01912872|75719831|FG003|Discontinued Treatment Prior to Month 12|Overall Study||11||
59609015|NCT01912872|75719828|FG000|COMPLETED|Overall Study||11||
59609016|NCT01912872|75719829|FG001|COMPLETED|Overall Study||13||
59609017|NCT01912872|75719830|FG002|COMPLETED|Overall Study||30||
59609018|NCT01912872|75719831|FG003|COMPLETED|Overall Study||27||
59609019|NCT01912872|75719828|FG000|NOT COMPLETED|Overall Study||5||
59609020|NCT01912872|75719829|FG001|NOT COMPLETED|Overall Study||4||
59609021|NCT01912872|75719830|FG002|NOT COMPLETED|Overall Study||10||
59609022|NCT01912872|75719831|FG003|NOT COMPLETED|Overall Study||12||
59609023|NCT01912404|75719844|FG000|STARTED|Overall Study||3||
59609024|NCT01912404|75719845|FG001|STARTED|Overall Study||2||
59609025|NCT01912404|75719844|FG000|COMPLETED|Overall Study||2||
59609026|NCT01912404|75719845|FG001|COMPLETED|Overall Study||2||
59609027|NCT01912404|75719844|FG000|NOT COMPLETED|Overall Study||1||
59609028|NCT01912404|75719845|FG001|NOT COMPLETED|Overall Study||0||
59609029|NCT01911780|75719853|FG000|STARTED|Double-blind Period (8 Weeks)||68||
59609030|NCT01911780|75719854|FG001|STARTED|Double-blind Period (8 Weeks)||64||
59609031|NCT01911780|75719853|FG000|COMPLETED|Double-blind Period (8 Weeks)||65||
59609032|NCT01911780|75719854|FG001|COMPLETED|Double-blind Period (8 Weeks)||61||
59609033|NCT01911780|75719853|FG000|NOT COMPLETED|Double-blind Period (8 Weeks)||3||
59609034|NCT01911780|75719854|FG001|NOT COMPLETED|Double-blind Period (8 Weeks)||3||
59609035|NCT01911780|75719853|FG000|STARTED|Extension Period (52 Weeks)||65||
59609036|NCT01911780|75719854|FG001|STARTED|Extension Period (52 Weeks)||61||
59609037|NCT01911780|75719853|FG000|COMPLETED|Extension Period (52 Weeks)||61||
59609038|NCT01911780|75719854|FG001|COMPLETED|Extension Period (52 Weeks)||58||
59609039|NCT01911780|75719853|FG000|NOT COMPLETED|Extension Period (52 Weeks)||4||
59609040|NCT01911780|75719854|FG001|NOT COMPLETED|Extension Period (52 Weeks)||3||
59609041|NCT01911546|75719864|FG000|STARTED|Overall Study||20||
59609042|NCT01911546|75719864|FG000|COMPLETED|Overall Study||14||
59609043|NCT01911546|75719864|FG000|NOT COMPLETED|Overall Study||6||
59609044|NCT01910298|75719870|FG000|STARTED|Overall Study||76||
59609045|NCT01910298|75719871|FG001|STARTED|Overall Study||55||
59609046|NCT01910298|75719870|FG000|Safety Set|Overall Study||76||
59609047|NCT01910298|75719871|FG001|Safety Set|Overall Study|4 participants did not have first surgery date and were not included in Safety Set.|51||
59609048|NCT01910298|75719870|FG000|COMPLETED|Overall Study||71||
59609049|NCT01910298|75719871|FG001|COMPLETED|Overall Study||23||
59609050|NCT01910298|75719870|FG000|NOT COMPLETED|Overall Study||5||
59609051|NCT01910298|75719871|FG001|NOT COMPLETED|Overall Study||32||
59609052|NCT01909674|75719879|FG000|STARTED|Overall Study||12||
59609053|NCT01909674|75719880|FG001|STARTED|Overall Study||9||
59609054|NCT01909674|75719879|FG000|COMPLETED|Overall Study||7||
59609055|NCT01909674|75719880|FG001|COMPLETED|Overall Study||7||
59609056|NCT01909674|75719879|FG000|NOT COMPLETED|Overall Study||5||
59609057|NCT01909674|75719880|FG001|NOT COMPLETED|Overall Study||2||
59609058|NCT01908816|75719890|FG000|STARTED|Overall Study||93||
59609059|NCT01908816|75719891|FG001|STARTED|Overall Study||84||
59609060|NCT01908816|75719892|FG002|STARTED|Overall Study||58||
59609061|NCT01908816|75719893|FG003|STARTED|Overall Study||35||
59609062|NCT01908816|75719890|FG000|COMPLETED|Overall Study||0||
59609063|NCT01908816|75719891|FG001|COMPLETED|Overall Study||0||
59609064|NCT01908816|75719892|FG002|COMPLETED|Overall Study||0||
59609065|NCT01908816|75719893|FG003|COMPLETED|Overall Study||0||
59609066|NCT01908816|75719890|FG000|NOT COMPLETED|Overall Study||93||
59609067|NCT01908816|75719891|FG001|NOT COMPLETED|Overall Study||84||
59609068|NCT01908816|75719892|FG002|NOT COMPLETED|Overall Study||58||
59609069|NCT01908816|75719893|FG003|NOT COMPLETED|Overall Study||35||
59609070|NCT01908582|75719906|FG000|STARTED|Period 1||26||
59609071|NCT01908582|75719906|FG000|Received at Least One Dose of Study Drug|Period 1||26||
59609072|NCT01908582|75719906|FG000|COMPLETED|Period 1||26||
59609073|NCT01908582|75719906|FG000|NOT COMPLETED|Period 1||0||
59609074|NCT01908582|75719906|FG000|STARTED|Period 2||26||
59609075|NCT01908582|75719906|FG000|COMPLETED|Period 2||24||
59609076|NCT01908582|75719906|FG000|NOT COMPLETED|Period 2||2||
59609077|NCT01908426|75719915|FG000|STARTED|Overall Study||470||
59609078|NCT01908426|75719916|FG001|STARTED|Overall Study||237||
59762580|NCT00594204|75882392|FG001|STARTED|Overall Study||199||
59609079|NCT01908426|75719915|FG000|COMPLETED|Overall Study||73||
59609080|NCT01908426|75719916|FG001|COMPLETED|Overall Study||26||
59609081|NCT01908426|75719915|FG000|NOT COMPLETED|Overall Study||397||
59609082|NCT01908426|75719916|FG001|NOT COMPLETED|Overall Study||211||
59609083|NCT01907100|75719926|FG000|STARTED|Overall Study||43||
59609084|NCT01907100|75719927|FG001|STARTED|Overall Study||44||
59609085|NCT01907100|75719928|FG002|STARTED|Overall Study||229||
59609086|NCT01907100|75719929|FG003|STARTED|Overall Study||229||
59609087|NCT01907100|75719926|FG000|Treated Patients|Overall Study||41||
59609088|NCT01907100|75719927|FG001|Treated Patients|Overall Study||44||
59609089|NCT01907100|75719928|FG002|Treated Patients|Overall Study||228||
59609090|NCT01907100|75719929|FG003|Treated Patients|Overall Study||227||
59613503|NCT01684722|75724629|FG002|COMPLETED|Overall Study||226||
59609091|NCT01907100|75719926|FG000|COMPLETED|Overall Study||1|On treatment or completed according to protocol at the time of analysis|
59609092|NCT01907100|75719927|FG001|COMPLETED|Overall Study||4|On treatment or completed according to protocol at the time of analysis|
59609093|NCT01907100|75719928|FG002|COMPLETED|Overall Study||82|On treatment or completed according to protocol at the time of analysis|
59609094|NCT01907100|75719929|FG003|COMPLETED|Overall Study||83|On treatment or completed according to protocol at the time of analysis|
59609095|NCT01907100|75719926|FG000|NOT COMPLETED|Overall Study||42||
59609096|NCT01907100|75719927|FG001|NOT COMPLETED|Overall Study||40||
59609097|NCT01907100|75719928|FG002|NOT COMPLETED|Overall Study||147||
59609098|NCT01907100|75719929|FG003|NOT COMPLETED|Overall Study||146||
59609099|NCT01889862|75719937|FG000|STARTED|Part 1 (Up to 13 Weeks)||86|51 subjects out of 215 entered Part 4 directly, as they didn't receive target dose in study 165-301.|
59609100|NCT01889862|75719938|FG001|STARTED|Part 1 (Up to 13 Weeks)||0|51 subjects out of 215 entered Part 4 directly, as they didn't receive target dose in study 165-301.|
59609101|NCT01889862|75719939|FG002|STARTED|Part 1 (Up to 13 Weeks)||78|51 subjects out of 215 entered Part 4 directly, as they didn't receive target dose in study 165-301.|
59609102|NCT01889862|75719940|FG003|STARTED|Part 1 (Up to 13 Weeks)||0|51 subjects out of 215 entered Part 4 directly, as they didn't receive target dose in study 165-301.|
59609103|NCT01889862|75719941|FG004|STARTED|Part 1 (Up to 13 Weeks)||0|51 subjects out of 215 entered Part 4 directly, as they didn't receive target dose in study 165-301.|
59609104|NCT01889862|75719937|FG000|COMPLETED|Part 1 (Up to 13 Weeks)|Out of 164, total 12 subjects have not completed Part 1.|74|57 Subjects out of 164 didn't meet Part 2 eligibility criterion, so transitioned directly to Part 4|
59609105|NCT01889862|75719938|FG001|COMPLETED|Part 1 (Up to 13 Weeks)||0|57 Subjects out of 164 didn't meet Part 2 eligibility criterion, so transitioned directly to Part 4|
59609106|NCT01889862|75719939|FG002|COMPLETED|Part 1 (Up to 13 Weeks)||78|57 Subjects out of 164 didn't meet Part 2 eligibility criterion, so transitioned directly to Part 4|
59609107|NCT01889862|75719940|FG003|COMPLETED|Part 1 (Up to 13 Weeks)||0|57 Subjects out of 164 didn't meet Part 2 eligibility criterion, so transitioned directly to Part 4|
59609108|NCT01889862|75719941|FG004|COMPLETED|Part 1 (Up to 13 Weeks)||0|57 Subjects out of 164 didn't meet Part 2 eligibility criterion, so transitioned directly to Part 4|
59609109|NCT01889862|75719937|FG000|NOT COMPLETED|Part 1 (Up to 13 Weeks)||12||
59609110|NCT01889862|75719938|FG001|NOT COMPLETED|Part 1 (Up to 13 Weeks)||0||
59609111|NCT01889862|75719939|FG002|NOT COMPLETED|Part 1 (Up to 13 Weeks)||0||
59609112|NCT01889862|75719940|FG003|NOT COMPLETED|Part 1 (Up to 13 Weeks)||0||
59609113|NCT01889862|75719941|FG004|NOT COMPLETED|Part 1 (Up to 13 Weeks)||0||
59609114|NCT01889862|75719937|FG000|STARTED|Part 2 (8 Weeks)|Subjects ≥20% reduction in blood Phe from naïve baseline levels are randomized in Part 2.|34||
59609115|NCT01889862|75719938|FG001|STARTED|Part 2 (8 Weeks)|Subjects ≥20% reduction in blood Phe from naïve baseline levels are randomized in Part 2.|15||
59609116|NCT01889862|75719939|FG002|STARTED|Part 2 (8 Weeks)|Subjects ≥20% reduction in blood Phe from naïve baseline levels are randomized in Part 2.|32||
59609117|NCT01889862|75719940|FG003|STARTED|Part 2 (8 Weeks)|Subjects ≥20% reduction in blood Phe from naïve baseline levels are randomized in Part 2.|14||
59609118|NCT01889862|75719941|FG004|STARTED|Part 2 (8 Weeks)||0||
59609119|NCT01889862|75719937|FG000|Per Amendment #2 of the Protocol|Part 2 (8 Weeks)||29|Subjects not included in mITT, if the last two consecutive blood Phe reduction of ≥ 20% in Part 1.|
59609120|NCT01889862|75719938|FG001|Per Amendment #2 of the Protocol|Part 2 (8 Weeks)||14|Subjects not included in mITT, if the last two consecutive blood Phe reduction of ≥ 20% in Part 1.|
59609121|NCT01889862|75719939|FG002|Per Amendment #2 of the Protocol|Part 2 (8 Weeks)||29|Subjects not included in mITT, if the last two consecutive blood Phe reduction of ≥ 20% in Part 1.|
59609122|NCT01889862|75719940|FG003|Per Amendment #2 of the Protocol|Part 2 (8 Weeks)||14|Subjects not included in mITT, if the last two consecutive blood Phe reduction of ≥ 20% in Part 1.|
59609123|NCT01889862|75719941|FG004|Per Amendment #2 of the Protocol|Part 2 (8 Weeks)||0|Subjects not included in mITT, if the last two consecutive blood Phe reduction of ≥ 20% in Part 1.|
59609124|NCT01889862|75719937|FG000|COMPLETED|Part 2 (8 Weeks)||34|5 subjects unable to complete Part 2 due to an Adverse Event transitioned directly into Part 4.|
59609125|NCT01889862|75719938|FG001|COMPLETED|Part 2 (8 Weeks)||15|5 subjects unable to complete Part 2 due to an Adverse Event transitioned directly into Part 4.|
59609126|NCT01889862|75719939|FG002|COMPLETED|Part 2 (8 Weeks)||31|5 subjects unable to complete Part 2 due to an Adverse Event transitioned directly into Part 4.|
59609127|NCT01889862|75719940|FG003|COMPLETED|Part 2 (8 Weeks)||14|5 subjects unable to complete Part 2 due to an Adverse Event transitioned directly into Part 4.|
59609128|NCT01889862|75719941|FG004|COMPLETED|Part 2 (8 Weeks)||0|5 subjects unable to complete Part 2 due to an Adverse Event transitioned directly into Part 4.|
59609129|NCT01889862|75719937|FG000|NOT COMPLETED|Part 2 (8 Weeks)||0||
59609130|NCT01889862|75719938|FG001|NOT COMPLETED|Part 2 (8 Weeks)||0||
59609131|NCT01889862|75719939|FG002|NOT COMPLETED|Part 2 (8 Weeks)||1||
59609132|NCT01889862|75719940|FG003|NOT COMPLETED|Part 2 (8 Weeks)||0||
59609133|NCT01889862|75719941|FG004|NOT COMPLETED|Part 2 (8 Weeks)||0||
59609134|NCT01889862|75719937|FG000|STARTED|Part 3A/B (6 Week)|Subjects switch from placebo to active 20mg/kg.|48||
59613504|NCT01684722|75724630|FG003|COMPLETED|Overall Study||260||
59755991|NCT00611455|75875092|FG002|NOT COMPLETED|OL Treatment Period (120 Weeks)||0||
59755992|NCT00611455|75875090|FG000|STARTED|Follow-up Period (Approximately 2 Years)||0||
59755993|NCT00611455|75875091|FG001|STARTED|Follow-up Period (Approximately 2 Years)||0||
59755994|NCT00611455|75875092|FG002|STARTED|Follow-up Period (Approximately 2 Years)|These participants received at least one infusion of placebo or ofatumumab.|260||
59755995|NCT00611455|75875090|FG000|COMPLETED|Follow-up Period (Approximately 2 Years)||0||
59755996|NCT00611455|75875091|FG001|COMPLETED|Follow-up Period (Approximately 2 Years)||0||
59609135|NCT01889862|75719938|FG001|STARTED|Part 3A/B (6 Week)|Subjects switch from placebo to active 20mg/kg.|0||
59609136|NCT01889862|75719939|FG002|STARTED|Part 3A/B (6 Week)|Subjects switch from placebo to active 40mg/kg.|41||
59609137|NCT01889862|75719940|FG003|STARTED|Part 3A/B (6 Week)|Subjects switch from placebo to active 40mg/kg.|0||
59609138|NCT01889862|75719941|FG004|STARTED|Part 3A/B (6 Week)||0||
59609139|NCT01889862|75719937|FG000|Per Amendment #2 of the Protocol|Part 3A/B (6 Week)||34|58 of 89 subjects enrolled under Amendment #2 were included in the PK/PD analyses.|
59609140|NCT01889862|75719938|FG001|Per Amendment #2 of the Protocol|Part 3A/B (6 Week)||0|58 of 89 subjects enrolled under Amendment #2 were included in the PK/PD analyses.|
59609141|NCT01889862|75719939|FG002|Per Amendment #2 of the Protocol|Part 3A/B (6 Week)||26|58 of 89 subjects enrolled under Amendment #2 were included in the PK/PD analyses.|
59609142|NCT01889862|75719940|FG003|Per Amendment #2 of the Protocol|Part 3A/B (6 Week)||0|58 of 89 subjects enrolled under Amendment #2 were included in the PK/PD analyses.|
59609143|NCT01889862|75719941|FG004|Per Amendment #2 of the Protocol|Part 3A/B (6 Week)||0|58 of 89 subjects enrolled under Amendment #2 were included in the PK/PD analyses.|
59887229|NCT03126110|76009954|FG008|STARTED|Phase 1||8||
59887230|NCT03126110|76009955|FG009|STARTED|Phase 1||3||
59887231|NCT03126110|76009956|FG010|STARTED|Phase 1||6||
59887232|NCT03126110|76009957|FG011|STARTED|Phase 1||0||
59887233|NCT03126110|76009958|FG012|STARTED|Phase 1||0||
59887234|NCT03126110|76009959|FG013|STARTED|Phase 1||0||
59887235|NCT03126110|76009960|FG014|STARTED|Phase 1||0||
59887236|NCT03126110|76009961|FG015|STARTED|Phase 1||0||
59887237|NCT03126110|76009962|FG016|STARTED|Phase 1||0||
59609144|NCT01889862|75719937|FG000|COMPLETED|Part 3A/B (6 Week)||48||
59609145|NCT01889862|75719938|FG001|COMPLETED|Part 3A/B (6 Week)||0||
59609146|NCT01889862|75719939|FG002|COMPLETED|Part 3A/B (6 Week)||41||
59609147|NCT01889862|75719940|FG003|COMPLETED|Part 3A/B (6 Week)||0||
59609148|NCT01889862|75719941|FG004|COMPLETED|Part 3A/B (6 Week)||0||
59609149|NCT01889862|75719937|FG000|NOT COMPLETED|Part 3A/B (6 Week)||0||
59609150|NCT01889862|75719938|FG001|NOT COMPLETED|Part 3A/B (6 Week)||0||
59609151|NCT01889862|75719939|FG002|NOT COMPLETED|Part 3A/B (6 Week)||0||
59609152|NCT01889862|75719940|FG003|NOT COMPLETED|Part 3A/B (6 Week)||0||
59609153|NCT01889862|75719941|FG004|NOT COMPLETED|Part 3A/B (6 Week)||0||
59609154|NCT01889862|75719937|FG000|STARTED|Part 4 (Up to 274 Weeks)|51, 57, 5 and 89 subjects from 165-301, 165-302 Part 1, 2 & 3 entered 165-302 Part 4 respectively.|0||
59609155|NCT01889862|75719938|FG001|STARTED|Part 4 (Up to 274 Weeks)||0||
59609156|NCT01889862|75719939|FG002|STARTED|Part 4 (Up to 274 Weeks)|51, 57, 5 and 89 subjects from 165-301, 165-302 Part 1, 2 & 3 entered 165-302 Part 4 respectively.|0||
59609157|NCT01889862|75719940|FG003|STARTED|Part 4 (Up to 274 Weeks)||0||
59609158|NCT01889862|75719941|FG004|STARTED|Part 4 (Up to 274 Weeks)|Total of 202 subjects from 165-301, Part 1, 2, 3 entered Part 4 to receive dose of up to 60mg/kg.|202||
59609159|NCT01889862|75719937|FG000|COMPLETED|Part 4 (Up to 274 Weeks)||0||
59609160|NCT01889862|75719938|FG001|COMPLETED|Part 4 (Up to 274 Weeks)||0||
59609161|NCT01889862|75719939|FG002|COMPLETED|Part 4 (Up to 274 Weeks)||0||
59609162|NCT01889862|75719940|FG003|COMPLETED|Part 4 (Up to 274 Weeks)||0||
59609163|NCT01889862|75719941|FG004|COMPLETED|Part 4 (Up to 274 Weeks)||172||
59609164|NCT01889862|75719937|FG000|NOT COMPLETED|Part 4 (Up to 274 Weeks)||0||
59609165|NCT01889862|75719938|FG001|NOT COMPLETED|Part 4 (Up to 274 Weeks)||0||
59609166|NCT01889862|75719939|FG002|NOT COMPLETED|Part 4 (Up to 274 Weeks)||0||
59609167|NCT01889862|75719940|FG003|NOT COMPLETED|Part 4 (Up to 274 Weeks)||0||
59609168|NCT01889862|75719941|FG004|NOT COMPLETED|Part 4 (Up to 274 Weeks)||30||
59609169|NCT01887912|75719968|FG000|STARTED|Overall Study||6201||
59609170|NCT01887912|75719969|FG001|STARTED|Overall Study||3101||
59609171|NCT01887912|75719968|FG000|Safety Population|Overall Study||6113|Participants who had received the study or control vaccine, analyzed according to vaccine received|
59609172|NCT01887912|75719969|FG001|Safety Population|Overall Study||3057|Participants who had received the study or control vaccine, analyzed according to vaccine received|
59609173|NCT01887912|75719968|FG000|COMPLETED|Overall Study||4809||
59609174|NCT01887912|75719969|FG001|COMPLETED|Overall Study||2370||
59609175|NCT01887912|75719968|FG000|NOT COMPLETED|Overall Study||1392||
59609176|NCT01887912|75719969|FG001|NOT COMPLETED|Overall Study||731||
59609177|NCT01887678|75719977|FG000|STARTED|Overall Study||119||
59609178|NCT01887678|75719978|FG001|STARTED|Overall Study||113||
59609179|NCT01887678|75719977|FG000|COMPLETED|Overall Study||102||
59609180|NCT01887678|75719978|FG001|COMPLETED|Overall Study||85||
59609181|NCT01887678|75719977|FG000|NOT COMPLETED|Overall Study||17||
59609182|NCT01887678|75719978|FG001|NOT COMPLETED|Overall Study||28||
59609183|NCT01887600|75719986|FG000|STARTED|Overall Study||391||
59609184|NCT01887600|75719987|FG001|STARTED|Overall Study||203||
59609185|NCT01887600|75719986|FG000|Treatment Received|Overall Study||391||
59609186|NCT01887600|75719987|FG001|Treatment Received|Overall Study||203||
59609187|NCT01887600|75719986|FG000|COMPLETED|Overall Study||245||
59609188|NCT01887600|75719987|FG001|COMPLETED|Overall Study||89||
59609189|NCT01887600|75719986|FG000|NOT COMPLETED|Overall Study||146||
59609190|NCT01887600|75719987|FG001|NOT COMPLETED|Overall Study||114||
59887238|NCT03126110|76009946|FG000|COMPLETED|Phase 1||0||
59887239|NCT03126110|76009947|FG001|COMPLETED|Phase 1||1||
59887240|NCT03126110|76009948|FG002|COMPLETED|Phase 1||0||
59887241|NCT03126110|76009949|FG003|COMPLETED|Phase 1||0||
59887242|NCT03126110|76009950|FG004|COMPLETED|Phase 1||0||
59887243|NCT03126110|76009951|FG005|COMPLETED|Phase 1||0||
59887244|NCT03126110|76009952|FG006|COMPLETED|Phase 1||1||
59755997|NCT00611455|75875092|FG002|COMPLETED|Follow-up Period (Approximately 2 Years)||49||
59505122|NCT00744211|75597736|FG002|STARTED|12 Hours After Cardiopulmonary Bypass||10||
59505123|NCT00744211|75597734|FG000|COMPLETED|12 Hours After Cardiopulmonary Bypass||10||
59505124|NCT00744211|75597735|FG001|COMPLETED|12 Hours After Cardiopulmonary Bypass||9||
59505125|NCT00744211|75597736|FG002|COMPLETED|12 Hours After Cardiopulmonary Bypass||10||
59505126|NCT00744211|75597734|FG000|NOT COMPLETED|12 Hours After Cardiopulmonary Bypass||0||
59505127|NCT00744211|75597735|FG001|NOT COMPLETED|12 Hours After Cardiopulmonary Bypass||0||
59609191|NCT01887288|75719994|FG000|STARTED|Overall Study||16||
59609192|NCT01887288|75719994|FG000|COMPLETED|Overall Study||0||
59609193|NCT01887288|75719994|FG000|NOT COMPLETED|Overall Study||16||
59505128|NCT00744211|75597736|FG002|NOT COMPLETED|12 Hours After Cardiopulmonary Bypass||0||
59505129|NCT00744211|75597734|FG000|STARTED|24 Hours After Cardiopulmonary Bypass||10||
59505130|NCT00744211|75597735|FG001|STARTED|24 Hours After Cardiopulmonary Bypass||9||
59505131|NCT00744211|75597736|FG002|STARTED|24 Hours After Cardiopulmonary Bypass||10||
59505132|NCT00744211|75597734|FG000|COMPLETED|24 Hours After Cardiopulmonary Bypass||10||
59505133|NCT00744211|75597735|FG001|COMPLETED|24 Hours After Cardiopulmonary Bypass||9||
59505134|NCT00744211|75597736|FG002|COMPLETED|24 Hours After Cardiopulmonary Bypass||10||
59505135|NCT00744211|75597734|FG000|NOT COMPLETED|24 Hours After Cardiopulmonary Bypass||0||
59505136|NCT00744211|75597735|FG001|NOT COMPLETED|24 Hours After Cardiopulmonary Bypass||0||
59505137|NCT00744211|75597736|FG002|NOT COMPLETED|24 Hours After Cardiopulmonary Bypass||0||
59505138|NCT00714233|75597751|FG000|STARTED|Overall Study||10||
59505139|NCT00714233|75597752|FG001|STARTED|Overall Study||11||
59505140|NCT00714233|75597753|FG002|STARTED|Overall Study||11||
59505141|NCT00714233|75597754|FG003|STARTED|Overall Study||10||
59505142|NCT00714233|75597751|FG000|COMPLETED|Overall Study||6||
59505143|NCT00714233|75597752|FG001|COMPLETED|Overall Study||10||
59505144|NCT00714233|75597753|FG002|COMPLETED|Overall Study||10||
59505145|NCT00714233|75597754|FG003|COMPLETED|Overall Study||6||
59505146|NCT00714233|75597751|FG000|NOT COMPLETED|Overall Study||4||
59505147|NCT00714233|75597752|FG001|NOT COMPLETED|Overall Study||1||
59505148|NCT00714233|75597753|FG002|NOT COMPLETED|Overall Study||1||
59505149|NCT00714233|75597754|FG003|NOT COMPLETED|Overall Study||4||
59505150|NCT00721357|75597771|FG000|STARTED|Overall Study||15||
59505151|NCT00721357|75597772|FG001|STARTED|Overall Study||15||
59505152|NCT00721357|75597771|FG000|COMPLETED|Overall Study||15||
59505153|NCT00721357|75597772|FG001|COMPLETED|Overall Study||15||
59505154|NCT00721357|75597771|FG000|NOT COMPLETED|Overall Study||0||
59505155|NCT00721357|75597772|FG001|NOT COMPLETED|Overall Study||0||
59505156|NCT00714311|75597782|FG000|STARTED|Overall Study||52||
59505157|NCT00714311|75597783|FG001|STARTED|Overall Study||52||
59505158|NCT00714311|75597782|FG000|COMPLETED|Overall Study||39||
59505159|NCT00714311|75597783|FG001|COMPLETED|Overall Study||30||
59505160|NCT00714311|75597782|FG000|NOT COMPLETED|Overall Study||13||
59505161|NCT00714311|75597783|FG001|NOT COMPLETED|Overall Study||22||
59505162|NCT00746395|75597791|FG000|STARTED|Overall Study||20||
59505163|NCT00746395|75597792|FG001|STARTED|Overall Study||20||
59505164|NCT00746395|75597791|FG000|COMPLETED|Overall Study||20||
59505165|NCT00746395|75597792|FG001|COMPLETED|Overall Study||20||
59505166|NCT00746395|75597791|FG000|NOT COMPLETED|Overall Study||0||
59505167|NCT00746395|75597792|FG001|NOT COMPLETED|Overall Study||0||
59505168|NCT00714389|75597798|FG000|STARTED|Overall Study||12||
59505169|NCT00714389|75597798|FG000|COMPLETED|Overall Study||12||
59505170|NCT00714389|75597798|FG000|NOT COMPLETED|Overall Study||0||
59505171|NCT03084302|75597802|FG000|STARTED|Overall Study||120||
59505172|NCT03084302|75597802|FG000|COMPLETED|Overall Study||105||
59505173|NCT03084302|75597802|FG000|NOT COMPLETED|Overall Study||15||
59505174|NCT00721513|75597807|FG000|STARTED|Overall Study||20||
59505175|NCT00721513|75597807|FG000|COMPLETED|Overall Study||20||
59505176|NCT00721513|75597807|FG000|NOT COMPLETED|Overall Study||0||
59505177|NCT00706121|75597815|FG000|STARTED|Overall Study||2039||
59505178|NCT00706121|75597816|FG001|STARTED|Overall Study||2096||
59505179|NCT00706121|75597817|FG002|STARTED|Overall Study||2030||
59505180|NCT00706121|75597818|FG003|STARTED|Overall Study||1929||
59505181|NCT00706121|75597815|FG000|COMPLETED|Overall Study||1643||
59505182|NCT00706121|75597816|FG001|COMPLETED|Overall Study||1700||
59505183|NCT00706121|75597817|FG002|COMPLETED|Overall Study||1626||
59755998|NCT00611455|75875090|FG000|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||0||
59755999|NCT00611455|75875091|FG001|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||0||
59505184|NCT00706121|75597818|FG003|COMPLETED|Overall Study||1577||
59505185|NCT00706121|75597815|FG000|NOT COMPLETED|Overall Study||396||
59505186|NCT00706121|75597816|FG001|NOT COMPLETED|Overall Study||396||
59505187|NCT00706121|75597817|FG002|NOT COMPLETED|Overall Study||404||
59505188|NCT00706121|75597818|FG003|NOT COMPLETED|Overall Study||352||
59505189|NCT00746863|75597838|FG000|STARTED|Overall Study||21||
59505190|NCT00746863|75597839|FG001|STARTED|Overall Study||21||
59505191|NCT00746863|75597838|FG000|COMPLETED|Overall Study||21||
59505192|NCT00746863|75597839|FG001|COMPLETED|Overall Study||21||
59505193|NCT00746863|75597838|FG000|NOT COMPLETED|Overall Study||0||
59505194|NCT00746863|75597839|FG001|NOT COMPLETED|Overall Study||0||
59505195|NCT03082898|75597847|FG000|STARTED|Overall Study||27||
59609194|NCT01887210|75720000|FG000|STARTED|Overall Study||33||
59609195|NCT01887210|75720001|FG001|STARTED|Overall Study||33||
59609196|NCT01887210|75720000|FG000|COMPLETED|Overall Study||32||
59609197|NCT01887210|75720001|FG001|COMPLETED|Overall Study||29||
59609198|NCT01887210|75720000|FG000|NOT COMPLETED|Overall Study||1||
59609199|NCT01887210|75720001|FG001|NOT COMPLETED|Overall Study||4||
59609200|NCT03405714|75720011|FG000|STARTED|Overall Study||12||
59609201|NCT03405714|75720012|FG001|STARTED|Overall Study||12||
59609202|NCT03405714|75720013|FG002|STARTED|Overall Study||13||
59609203|NCT03405714|75720014|FG003|STARTED|Overall Study||13||
59609204|NCT03405714|75720011|FG000|COMPLETED|Overall Study||12||
59609205|NCT03405714|75720012|FG001|COMPLETED|Overall Study||12||
59609206|NCT03405714|75720013|FG002|COMPLETED|Overall Study||13||
59609207|NCT03405714|75720014|FG003|COMPLETED|Overall Study||13||
59609208|NCT03405714|75720011|FG000|NOT COMPLETED|Overall Study||0||
59505196|NCT03082898|75597848|FG001|STARTED|Overall Study||12||
59505197|NCT03082898|75597847|FG000|COMPLETED|Overall Study||24||
59505198|NCT03082898|75597848|FG001|COMPLETED|Overall Study||11||
59609209|NCT03405714|75720012|FG001|NOT COMPLETED|Overall Study||0||
59609210|NCT03405714|75720013|FG002|NOT COMPLETED|Overall Study||0||
59609211|NCT03405714|75720014|FG003|NOT COMPLETED|Overall Study||0||
59609212|NCT01885182|75720032|FG000|STARTED|Overall Study||117||
59609213|NCT01885182|75720033|FG001|STARTED|Overall Study||115||
59609214|NCT01885182|75720032|FG000|Safety Population|Overall Study||114||
59609215|NCT01885182|75720033|FG001|Safety Population|Overall Study||111||
59609216|NCT01885182|75720032|FG000|FAP Population|Overall Study||107||
59609217|NCT01885182|75720033|FG001|FAP Population|Overall Study||106||
59609218|NCT01885182|75720032|FG000|COMPLETED|Overall Study||83||
59609219|NCT01885182|75720033|FG001|COMPLETED|Overall Study||93||
59609220|NCT01885182|75720032|FG000|NOT COMPLETED|Overall Study||34||
59609221|NCT01885182|75720033|FG001|NOT COMPLETED|Overall Study||22||
59609222|NCT01885104|75720043|FG000|STARTED|Overall Study||31||
59609223|NCT01885104|75720044|FG001|STARTED|Overall Study||34||
59609224|NCT01885104|75720043|FG000|COMPLETED|Overall Study||29||
59609225|NCT01885104|75720044|FG001|COMPLETED|Overall Study||33||
59609226|NCT01885104|75720043|FG000|NOT COMPLETED|Overall Study||2||
59609227|NCT01885104|75720044|FG001|NOT COMPLETED|Overall Study||1||
59609228|NCT01881750|75720052|FG000|STARTED|Overall Study||27||
59887245|NCT03126110|76009953|FG007|COMPLETED|Phase 1||0||
59505199|NCT03082898|75597847|FG000|NOT COMPLETED|Overall Study||3||
59505200|NCT03082898|75597848|FG001|NOT COMPLETED|Overall Study||1||
59505201|NCT00726713|75597856|FG000|STARTED|Overall Study||106||
59505202|NCT00726713|75597857|FG001|STARTED|Overall Study||108||
59505203|NCT00726713|75597856|FG000|COMPLETED|Overall Study||99||
59505204|NCT00726713|75597857|FG001|COMPLETED|Overall Study||101||
59505205|NCT00726713|75597856|FG000|NOT COMPLETED|Overall Study||7||
59505206|NCT00726713|75597857|FG001|NOT COMPLETED|Overall Study||7||
59505207|NCT00759187|75597867|FG000|STARTED|Overall Study||8||
59505208|NCT00759187|75597868|FG001|STARTED|Overall Study||8||
59505209|NCT00759187|75597869|FG002|STARTED|Overall Study||9||
59609229|NCT01881750|75720053|FG001|STARTED|Overall Study||26||
59609230|NCT01881750|75720052|FG000|COMPLETED|Overall Study||25||
59609231|NCT01881750|75720053|FG001|COMPLETED|Overall Study||22||
59609232|NCT01881750|75720052|FG000|NOT COMPLETED|Overall Study||2||
59609233|NCT01881750|75720053|FG001|NOT COMPLETED|Overall Study||4||
59609234|NCT01906008|75720063|FG000|STARTED|Overall Study||59||
59609235|NCT01906008|75720064|FG001|STARTED|Overall Study||61||
59609236|NCT01906008|75720063|FG000|COMPLETED|Overall Study||32||
59609237|NCT01906008|75720064|FG001|COMPLETED|Overall Study||34||
59609238|NCT01906008|75720063|FG000|NOT COMPLETED|Overall Study||27||
59609239|NCT01906008|75720064|FG001|NOT COMPLETED|Overall Study||27||
59609240|NCT01863732|75720074|FG000|STARTED|Overall Study||100||
59609241|NCT01863732|75720075|FG001|STARTED|Overall Study||87||
59609242|NCT01863732|75720076|FG002|STARTED|Overall Study||46||
59609243|NCT01863732|75720077|FG003|STARTED|Overall Study||41||
59609244|NCT01863732|75720074|FG000|COMPLETED|Overall Study||87||
59609245|NCT01863732|75720075|FG001|COMPLETED|Overall Study||75||
59609246|NCT01863732|75720076|FG002|COMPLETED|Overall Study||35||
59609247|NCT01863732|75720077|FG003|COMPLETED|Overall Study||33||
59887246|NCT03126110|76009954|FG008|COMPLETED|Phase 1||0||
59505210|NCT00759187|75597867|FG000|COMPLETED|Overall Study||8||
59505211|NCT00759187|75597868|FG001|COMPLETED|Overall Study||8||
59505212|NCT00759187|75597869|FG002|COMPLETED|Overall Study||9||
59609248|NCT01863732|75720074|FG000|NOT COMPLETED|Overall Study||13||
59609249|NCT01863732|75720075|FG001|NOT COMPLETED|Overall Study||12||
59609250|NCT01863732|75720076|FG002|NOT COMPLETED|Overall Study||11||
59609251|NCT01863732|75720077|FG003|NOT COMPLETED|Overall Study||8||
59609252|NCT01905540|75720090|FG000|STARTED|Period 1||7||
59609253|NCT01905540|75720091|FG001|STARTED|Period 1||7||
59609254|NCT01905540|75720092|FG002|STARTED|Period 1||7||
59609255|NCT01905540|75720093|FG003|STARTED|Period 1||7||
59609256|NCT01905540|75720090|FG000|COMPLETED|Period 1||7||
59609257|NCT01905540|75720091|FG001|COMPLETED|Period 1||7||
59609258|NCT01905540|75720092|FG002|COMPLETED|Period 1||7||
59609259|NCT01905540|75720093|FG003|COMPLETED|Period 1||7||
59609260|NCT01905540|75720090|FG000|NOT COMPLETED|Period 1||0||
59609261|NCT01905540|75720091|FG001|NOT COMPLETED|Period 1||0||
59887247|NCT03126110|76009955|FG009|COMPLETED|Phase 1||0||
59756000|NCT00611455|75875092|FG002|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||211||
59756001|NCT00952289|75875104|FG000|STARTED|All Participants||155||
59756002|NCT00952289|75875105|FG001|STARTED|All Participants||154||
59756003|NCT00952289|75875104|FG000|Safety Population|All Participants||155||
60013633|NCT02452047|76129574|FG002|NOT COMPLETED|Overall Study||2||
59756004|NCT00952289|75875105|FG001|Safety Population|All Participants|Randomized patients who are documented to have received at least 1 dose of study medication.|151||
59756005|NCT00952289|75875104|FG000|COMPLETED|All Participants|Represents the number of patients who were still in the study as of 02 November 2010|134||
59756006|NCT00952289|75875105|FG001|COMPLETED|All Participants|Includes patients in the study as of 2 November 2010 (78) + those who crossed over to Ruxolitinib.|114||
59756007|NCT00952289|75875104|FG000|NOT COMPLETED|All Participants||21||
59756008|NCT00952289|75875105|FG001|NOT COMPLETED|All Participants||40||
59756009|NCT00952289|75875104|FG000|STARTED|Patients Who Crossed Over to Ruxolitinib||0||
59756010|NCT00952289|75875105|FG001|STARTED|Patients Who Crossed Over to Ruxolitinib||111||
59756011|NCT00952289|75875104|FG000|COMPLETED|Patients Who Crossed Over to Ruxolitinib||0||
59756012|NCT00952289|75875105|FG001|COMPLETED|Patients Who Crossed Over to Ruxolitinib|Number of cross over subjects who were still in the study as of 25 JAN 2013|57||
59756013|NCT00952289|75875104|FG000|NOT COMPLETED|Patients Who Crossed Over to Ruxolitinib||0||
59756014|NCT00952289|75875105|FG001|NOT COMPLETED|Patients Who Crossed Over to Ruxolitinib||54||
59756015|NCT00612313|75875113|FG000|STARTED|Overall Study||69||
59756016|NCT00612313|75875114|FG001|STARTED|Overall Study||75||
59756017|NCT00612313|75875113|FG000|COMPLETED|Overall Study||52||
59756018|NCT00612313|75875114|FG001|COMPLETED|Overall Study||62||
59756019|NCT00612313|75875113|FG000|NOT COMPLETED|Overall Study||17||
59756020|NCT00612313|75875114|FG001|NOT COMPLETED|Overall Study||13||
59756021|NCT00890552|75875126|FG000|STARTED|Enrollment and Pre-treatment||25||
59756022|NCT00890552|75875126|FG000|COMPLETED|Enrollment and Pre-treatment||24||
59756023|NCT00890552|75875126|FG000|NOT COMPLETED|Enrollment and Pre-treatment||1||
59756024|NCT00890552|75875126|FG000|STARTED|On-treatment||24||
59756025|NCT00890552|75875126|FG000|COMPLETED|On-treatment||14||
59756026|NCT00890552|75875126|FG000|NOT COMPLETED|On-treatment||10||
59756027|NCT00946985|75875130|FG000|STARTED|Stabilization Phase (25 Weeks)||162||
59756028|NCT00946985|75875130|FG000|COMPLETED|Stabilization Phase (25 Weeks)||2||
59756029|NCT00946985|75875130|FG000|NOT COMPLETED|Stabilization Phase (25 Weeks)||160||
59756030|NCT00946985|75875130|FG000|STARTED|Relapse Prevention Phase (24 Months)|Both randomized patients were discontinued when the sponsor terminated the trial early.|2||
59756031|NCT00946985|75875130|FG000|COMPLETED|Relapse Prevention Phase (24 Months)||0||
59756032|NCT00946985|75875130|FG000|NOT COMPLETED|Relapse Prevention Phase (24 Months)||2||
59756033|NCT00611923|75875136|FG000|STARTED|Overall Study||12||
59756034|NCT00611923|75875137|FG001|STARTED|Overall Study||13||
59756035|NCT00611923|75875136|FG000|COMPLETED|Overall Study||10||
59756036|NCT00611923|75875137|FG001|COMPLETED|Overall Study||11||
59756037|NCT00611923|75875136|FG000|NOT COMPLETED|Overall Study||2||
59756038|NCT00611923|75875137|FG001|NOT COMPLETED|Overall Study||2||
59756039|NCT00609973|75875147|FG000|STARTED|Overall Study||17||
59756040|NCT00609973|75875148|FG001|STARTED|Overall Study||16||
59756041|NCT00609973|75875147|FG000|COMPLETED|Overall Study||9||
59756042|NCT00609973|75875148|FG001|COMPLETED|Overall Study||10||
59756043|NCT00609973|75875147|FG000|NOT COMPLETED|Overall Study||8||
59756044|NCT00609973|75875148|FG001|NOT COMPLETED|Overall Study||6||
59756045|NCT00803049|75875158|FG000|STARTED|Overall Study|Randomized in extension study|129||
59756046|NCT00803049|75875159|FG001|STARTED|Overall Study|Randomized in extension study|252||
59756047|NCT00803049|75875160|FG002|STARTED|Overall Study|Randomized in extension study|108||
59756048|NCT00803049|75875161|FG003|STARTED|Overall Study|Randomized in extension study|253||
59756049|NCT00803049|75875158|FG000|Treated|Overall Study||129||
59756050|NCT00803049|75875159|FG001|Treated|Overall Study||252||
59756051|NCT00803049|75875160|FG002|Treated|Overall Study||108||
59756052|NCT00803049|75875161|FG003|Treated|Overall Study||251||
59756053|NCT00803049|75875158|FG000|Safety Population|Overall Study||129||
59756054|NCT00803049|75875159|FG001|Safety Population|Overall Study|Included 1 participant from Placebo/Teriflunomide 14 mg and 1 from Teriflunomide14 mg/14 mg arm|254||
59756055|NCT00803049|75875160|FG002|Safety Population|Overall Study|1 participant received Teriflunomide 7 mg and analysed in Teriflunomide 7 mg/7 mg arm|107||
59756056|NCT00803049|75875161|FG003|Safety Population|Overall Study|1 participant received Teriflunomide 7 mg and analysed in Teriflunomide 7 mg/7 mg arm|250||
59756057|NCT00803049|75875158|FG000|COMPLETED|Overall Study||68||
59756058|NCT00803049|75875159|FG001|COMPLETED|Overall Study||134||
59756059|NCT00803049|75875160|FG002|COMPLETED|Overall Study||64||
59756060|NCT00803049|75875161|FG003|COMPLETED|Overall Study||151||
59756061|NCT00803049|75875158|FG000|NOT COMPLETED|Overall Study||61||
59756062|NCT00803049|75875159|FG001|NOT COMPLETED|Overall Study||118||
59756063|NCT00803049|75875160|FG002|NOT COMPLETED|Overall Study||44||
60013634|NCT02475369|76129582|FG000|STARTED|Run-in Washout Period #1 (7 Days)||10||
59756064|NCT00803049|75875161|FG003|NOT COMPLETED|Overall Study||102||
59756065|NCT00890084|75875171|FG000|STARTED|Overall Study||2913||
59756066|NCT00890084|75875171|FG000|COMPLETED|Overall Study||2771||
59756067|NCT00890084|75875171|FG000|NOT COMPLETED|Overall Study||142||
59756068|NCT02046135|75875177|FG000|STARTED|Overall Study||26||
59756069|NCT02046135|75875178|FG001|STARTED|Overall Study||25||
59756070|NCT02046135|75875177|FG000|COMPLETED|Overall Study||26||
59609262|NCT01905540|75720092|FG002|NOT COMPLETED|Period 1||0||
59609263|NCT01905540|75720093|FG003|NOT COMPLETED|Period 1||0||
59609264|NCT01905540|75720090|FG000|STARTED|Period 2||7||
59609265|NCT01905540|75720091|FG001|STARTED|Period 2||7||
59609266|NCT01905540|75720092|FG002|STARTED|Period 2||7||
59609267|NCT01905540|75720093|FG003|STARTED|Period 2||7||
59609268|NCT01905540|75720090|FG000|COMPLETED|Period 2||7||
59609269|NCT01905540|75720091|FG001|COMPLETED|Period 2||7||
59609270|NCT01905540|75720092|FG002|COMPLETED|Period 2||7||
59609271|NCT01905540|75720093|FG003|COMPLETED|Period 2||7||
59609272|NCT01905540|75720090|FG000|NOT COMPLETED|Period 2||0||
59609273|NCT01905540|75720091|FG001|NOT COMPLETED|Period 2||0||
59609274|NCT01905540|75720092|FG002|NOT COMPLETED|Period 2||0||
59609275|NCT01905540|75720093|FG003|NOT COMPLETED|Period 2||0||
59609276|NCT01905540|75720090|FG000|STARTED|Period 3||7||
59609277|NCT01905540|75720091|FG001|STARTED|Period 3||7||
59609278|NCT01905540|75720092|FG002|STARTED|Period 3||7||
59609279|NCT01905540|75720093|FG003|STARTED|Period 3||7||
59609280|NCT01905540|75720090|FG000|COMPLETED|Period 3||6||
59609281|NCT01905540|75720091|FG001|COMPLETED|Period 3||7||
59609282|NCT01905540|75720092|FG002|COMPLETED|Period 3||6||
59609283|NCT01905540|75720093|FG003|COMPLETED|Period 3||6||
59609284|NCT01905540|75720090|FG000|NOT COMPLETED|Period 3||1||
59609285|NCT01905540|75720091|FG001|NOT COMPLETED|Period 3||0||
59609286|NCT01905540|75720092|FG002|NOT COMPLETED|Period 3||1||
59609287|NCT01905540|75720093|FG003|NOT COMPLETED|Period 3||1||
59609288|NCT01904760|75720105|FG000|STARTED|Overall Study||40||
59609289|NCT01904760|75720106|FG001|STARTED|Overall Study||40||
59609290|NCT01904760|75720105|FG000|COMPLETED|Overall Study||39||
59609291|NCT01904760|75720106|FG001|COMPLETED|Overall Study||40||
59609292|NCT01904760|75720105|FG000|NOT COMPLETED|Overall Study||1||
59609293|NCT01904760|75720106|FG001|NOT COMPLETED|Overall Study||0||
59609294|NCT01904604|75720115|FG000|STARTED|Overall Study||25||
59609295|NCT01904604|75720116|FG001|STARTED|Overall Study||25||
59609296|NCT01904604|75720117|FG002|STARTED|Overall Study||25||
59609297|NCT01904604|75720115|FG000|Completed Week 52 OFC|Overall Study||22|Completion of the Week 52 OFC was required to assess the primary endpoint of the study.|
59609298|NCT01904604|75720116|FG001|Completed Week 52 OFC|Overall Study||21|Completion of the Week 52 OFC was required to assess the primary endpoint of the study.|
59609299|NCT01904604|75720117|FG002|Completed Week 52 OFC|Overall Study||25|Completion of the Week 52 OFC was required to assess the primary endpoint of the study.|
59609300|NCT01904604|75720115|FG000|Began Crossover Treatment|Overall Study|2 participants who completed the Week 52 OFC did not crossover; 1 passed the OFC and 1 relocated.|20||
59609301|NCT01904604|75720116|FG001|Began Crossover Treatment|Overall Study||21||
59609302|NCT01904604|75720117|FG002|Began Crossover Treatment|Overall Study|Per protocol, this treatment group did not crossover.|0||
59609303|NCT01904604|75720115|FG000|Completed Week 130 OFC|Overall Study||18||
59609304|NCT01904604|75720116|FG001|Completed Week 130 OFC|Overall Study||18||
59609305|NCT01904604|75720117|FG002|Completed Week 130 OFC|Overall Study||23||
59609306|NCT01904604|75720115|FG000|COMPLETED|Overall Study|COMPLETED: Completed the Week 130 Oral Food Challenge (OFC).|18||
60013635|NCT02475369|76129583|FG001|STARTED|Run-in Washout Period #1 (7 Days)||11||
60013636|NCT02475369|76129582|FG000|COMPLETED|Run-in Washout Period #1 (7 Days)||3||
59609307|NCT01904604|75720116|FG001|COMPLETED|Overall Study|COMPLETED: Completed the Week 130 Oral Food Challenge (OFC).|18||
59609308|NCT01904604|75720117|FG002|COMPLETED|Overall Study|COMPLETED: Completed the Week 130 Oral Food Challenge (OFC).|23||
59609309|NCT01904604|75720115|FG000|NOT COMPLETED|Overall Study||7||
59609310|NCT01904604|75720116|FG001|NOT COMPLETED|Overall Study||7||
59609311|NCT01904604|75720117|FG002|NOT COMPLETED|Overall Study||2||
59609312|NCT01904058|75720132|FG000|STARTED|Overall Study||21||
59609313|NCT01904058|75720133|FG001|STARTED|Overall Study||21||
59609314|NCT01904058|75720134|FG002|STARTED|Overall Study||11||
59609315|NCT01904058|75720135|FG003|STARTED|Overall Study||13||
59609316|NCT01904058|75720132|FG000|COMPLETED|Overall Study||18||
59609317|NCT01904058|75720133|FG001|COMPLETED|Overall Study||21||
59609318|NCT01904058|75720134|FG002|COMPLETED|Overall Study||10||
59609319|NCT01904058|75720135|FG003|COMPLETED|Overall Study||12||
59609320|NCT01904058|75720132|FG000|NOT COMPLETED|Overall Study||3||
59609321|NCT01904058|75720133|FG001|NOT COMPLETED|Overall Study||0||
59609322|NCT01904058|75720134|FG002|NOT COMPLETED|Overall Study||1||
59609323|NCT01904058|75720135|FG003|NOT COMPLETED|Overall Study||1||
59609324|NCT01881126|75720153|FG000|STARTED|Overall Study||47||
59609325|NCT01881126|75720154|FG001|STARTED|Overall Study||46||
59609326|NCT01881126|75720153|FG000|COMPLETED|Overall Study||46||
59609327|NCT01881126|75720154|FG001|COMPLETED|Overall Study||44||
59609328|NCT01881126|75720153|FG000|NOT COMPLETED|Overall Study||1||
59609329|NCT01881126|75720154|FG001|NOT COMPLETED|Overall Study||2||
59609330|NCT01614600|75720160|FG000|STARTED|Overall Study||88||
59609331|NCT01614600|75720160|FG000|COMPLETED|Overall Study||84||
59609332|NCT01614600|75720160|FG000|NOT COMPLETED|Overall Study||4||
59609333|NCT01880736|75720168|FG000|STARTED|Overall Study||114||
59609334|NCT01880736|75720169|FG001|STARTED|Overall Study||115||
59887248|NCT03126110|76009956|FG010|COMPLETED|Phase 1||0||
59887249|NCT03126110|76009957|FG011|COMPLETED|Phase 1||0||
59887250|NCT03126110|76009958|FG012|COMPLETED|Phase 1||0||
59887251|NCT03126110|76009959|FG013|COMPLETED|Phase 1||0||
59887252|NCT03126110|76009960|FG014|COMPLETED|Phase 1||0||
59887253|NCT03126110|76009961|FG015|COMPLETED|Phase 1||0||
59887254|NCT03126110|76009962|FG016|COMPLETED|Phase 1||0||
59887255|NCT03126110|76009946|FG000|NOT COMPLETED|Phase 1||4||
59887256|NCT03126110|76009947|FG001|NOT COMPLETED|Phase 1||3||
59887257|NCT03126110|76009948|FG002|NOT COMPLETED|Phase 1||5||
59887258|NCT03126110|76009949|FG003|NOT COMPLETED|Phase 1||4||
59887259|NCT03126110|76009950|FG004|NOT COMPLETED|Phase 1||5||
59887260|NCT03126110|76009951|FG005|NOT COMPLETED|Phase 1||4||
59887261|NCT03126110|76009952|FG006|NOT COMPLETED|Phase 1||3||
59887262|NCT03126110|76009953|FG007|NOT COMPLETED|Phase 1||4||
59887263|NCT03126110|76009954|FG008|NOT COMPLETED|Phase 1||8||
59887264|NCT03126110|76009955|FG009|NOT COMPLETED|Phase 1||3||
59887265|NCT03126110|76009956|FG010|NOT COMPLETED|Phase 1||6||
59887266|NCT03126110|76009957|FG011|NOT COMPLETED|Phase 1||0||
59887267|NCT03126110|76009958|FG012|NOT COMPLETED|Phase 1||0||
59887268|NCT03126110|76009959|FG013|NOT COMPLETED|Phase 1||0||
59887269|NCT03126110|76009960|FG014|NOT COMPLETED|Phase 1||0||
59887270|NCT03126110|76009961|FG015|NOT COMPLETED|Phase 1||0||
59887271|NCT03126110|76009962|FG016|NOT COMPLETED|Phase 1||0||
59887272|NCT03126110|76009946|FG000|STARTED|Phase 2||0||
59887273|NCT03126110|76009947|FG001|STARTED|Phase 2||0||
59887274|NCT03126110|76009948|FG002|STARTED|Phase 2||0||
59887275|NCT03126110|76009949|FG003|STARTED|Phase 2||0||
59887276|NCT03126110|76009950|FG004|STARTED|Phase 2||0||
59887277|NCT03126110|76009951|FG005|STARTED|Phase 2||0||
59887278|NCT03126110|76009952|FG006|STARTED|Phase 2||0||
59887279|NCT03126110|76009953|FG007|STARTED|Phase 2||0||
59887280|NCT03126110|76009954|FG008|STARTED|Phase 2||0||
59887281|NCT03126110|76009955|FG009|STARTED|Phase 2||0||
59505213|NCT00759187|75597867|FG000|NOT COMPLETED|Overall Study||0||
59505214|NCT00759187|75597868|FG001|NOT COMPLETED|Overall Study||0||
59505215|NCT00759187|75597869|FG002|NOT COMPLETED|Overall Study||0||
59505216|NCT00727337|75597881|FG000|STARTED|Overall Study||68||
59505217|NCT00727337|75597882|FG001|STARTED|Overall Study||65||
59505218|NCT00727337|75597883|FG002|STARTED|Overall Study||73||
59505219|NCT00727337|75597884|FG003|STARTED|Overall Study||73||
59505220|NCT00727337|75597881|FG000|COMPLETED|Overall Study||61||
59505221|NCT00727337|75597882|FG001|COMPLETED|Overall Study||55||
59505222|NCT00727337|75597883|FG002|COMPLETED|Overall Study||63||
59505223|NCT00727337|75597884|FG003|COMPLETED|Overall Study||64||
59505224|NCT00727337|75597881|FG000|NOT COMPLETED|Overall Study||7||
59505225|NCT00727337|75597882|FG001|NOT COMPLETED|Overall Study||10||
59505226|NCT00727337|75597883|FG002|NOT COMPLETED|Overall Study||10||
59505227|NCT00727337|75597884|FG003|NOT COMPLETED|Overall Study||9||
59505228|NCT00759811|75597901|FG000|STARTED|Overall Study||25||
59505229|NCT00759811|75597902|FG001|STARTED|Overall Study||25||
59505230|NCT00759811|75597901|FG000|COMPLETED|Overall Study||23||
59505231|NCT00759811|75597902|FG001|COMPLETED|Overall Study||24||
59505232|NCT00759811|75597901|FG000|NOT COMPLETED|Overall Study||2||
59505233|NCT00759811|75597902|FG001|NOT COMPLETED|Overall Study||1||
59505234|NCT00694577|75597911|FG000|STARTED|Overall Study||99||
59505235|NCT00694577|75597912|FG001|STARTED|Overall Study||101||
59505236|NCT00694577|75597913|FG002|STARTED|Overall Study||124||
59505237|NCT00694577|75597911|FG000|COMPLETED|Overall Study||98||
59505238|NCT00694577|75597912|FG001|COMPLETED|Overall Study||101||
59609335|NCT01880736|75720170|FG002|STARTED|Overall Study||115||
59609336|NCT01880736|75720171|FG003|STARTED|Overall Study||114||
59756071|NCT02046135|75875178|FG001|COMPLETED|Overall Study||25||
59756072|NCT02046135|75875177|FG000|NOT COMPLETED|Overall Study||0||
59756073|NCT02046135|75875178|FG001|NOT COMPLETED|Overall Study||0||
59756074|NCT00802893|75875184|FG000|STARTED|Overall Study||3||
59756075|NCT00802893|75875184|FG000|COMPLETED|Overall Study||0||
59756076|NCT00802893|75875184|FG000|NOT COMPLETED|Overall Study||3||
59756077|NCT04300010|75875191|FG000|STARTED|Overall Study||20||20
59756078|NCT04300010|75875192|FG001|STARTED|Overall Study||20||20
59756079|NCT04300010|75875193|FG002|STARTED|Overall Study||20||20
59756080|NCT04300010|75875194|FG003|STARTED|Overall Study||60||60
59756081|NCT04300010|75875191|FG000|COMPLETED|Overall Study||20||20
59756082|NCT04300010|75875192|FG001|COMPLETED|Overall Study||20||20
59756083|NCT04300010|75875193|FG002|COMPLETED|Overall Study||20||20
59887282|NCT03126110|76009956|FG010|STARTED|Phase 2||0||
59887283|NCT03126110|76009957|FG011|STARTED|Phase 2||8||
59887284|NCT03126110|76009958|FG012|STARTED|Phase 2||16||
59887285|NCT03126110|76009959|FG013|STARTED|Phase 2||46||
59887286|NCT03126110|76009960|FG014|STARTED|Phase 2||18||
59887287|NCT03126110|76009961|FG015|STARTED|Phase 2||4||
59887288|NCT03126110|76009962|FG016|STARTED|Phase 2||2||
59887289|NCT03126110|76009946|FG000|COMPLETED|Phase 2||0||
59887290|NCT03126110|76009947|FG001|COMPLETED|Phase 2||0||
59887291|NCT03126110|76009948|FG002|COMPLETED|Phase 2||0||
59887292|NCT03126110|76009949|FG003|COMPLETED|Phase 2||0||
59887293|NCT03126110|76009950|FG004|COMPLETED|Phase 2||0||
59887294|NCT03126110|76009951|FG005|COMPLETED|Phase 2||0||
59887295|NCT03126110|76009952|FG006|COMPLETED|Phase 2||0||
59505239|NCT00694577|75597913|FG002|COMPLETED|Overall Study||124||
59505240|NCT00694577|75597911|FG000|NOT COMPLETED|Overall Study||1||
59505241|NCT00694577|75597912|FG001|NOT COMPLETED|Overall Study||0||
59505242|NCT00694577|75597913|FG002|NOT COMPLETED|Overall Study||0||
59505243|NCT02996981|75597926|FG000|STARTED|Overall Study||96||
59505244|NCT02996981|75597927|FG001|STARTED|Overall Study||71||
59505245|NCT02996981|75597926|FG000|COMPLETED|Overall Study||96||
59505246|NCT02996981|75597927|FG001|COMPLETED|Overall Study||71||
59505247|NCT02996981|75597926|FG000|NOT COMPLETED|Overall Study||0||
59505248|NCT02996981|75597927|FG001|NOT COMPLETED|Overall Study||0||
59505249|NCT00706589|75597935|FG000|STARTED|Overall Study||32||
59505250|NCT00706589|75597936|FG001|STARTED|Overall Study||29||
59505251|NCT00706589|75597935|FG000|COMPLETED|Overall Study||29||
59505252|NCT00706589|75597936|FG001|COMPLETED|Overall Study||25||
59505253|NCT00706589|75597935|FG000|NOT COMPLETED|Overall Study||3||
59505254|NCT00706589|75597936|FG001|NOT COMPLETED|Overall Study||4||
59505255|NCT01279681|75597944|FG000|STARTED|Overall Study||15||
59505256|NCT01279681|75597945|FG001|STARTED|Overall Study||17||
59505257|NCT01279681|75597944|FG000|COMPLETED|Overall Study||0||
59505258|NCT01279681|75597945|FG001|COMPLETED|Overall Study||0||
59505259|NCT01279681|75597944|FG000|NOT COMPLETED|Overall Study||15||
59505260|NCT01279681|75597945|FG001|NOT COMPLETED|Overall Study||17||
59505261|NCT00728507|75597953|FG000|STARTED|Overall Study||62||
59505262|NCT00728507|75597954|FG001|STARTED|Overall Study||59||
59505263|NCT00728507|75597953|FG000|COMPLETED|Overall Study||60||
59505264|NCT00728507|75597954|FG001|COMPLETED|Overall Study||51||
59505265|NCT00728507|75597953|FG000|NOT COMPLETED|Overall Study||2||
59505266|NCT00728507|75597954|FG001|NOT COMPLETED|Overall Study||8||
59505267|NCT01279057|75597963|FG000|STARTED|Overall Study||288||
59505268|NCT01279057|75597964|FG001|STARTED|Overall Study||292||
59505269|NCT01279057|75597965|FG002|STARTED|Overall Study||147||
59505270|NCT01279057|75597963|FG000|Per-Protocol (PPP) Population|Overall Study||257|All participants who satisfied the criteria set forth in the protocol in terms of dosing compliance, number of available post-randomization evaluations and absence of significant protocol violations.|
59505271|NCT01279057|75597964|FG001|Per-Protocol (PPP) Population|Overall Study||245|All participants who satisfied the criteria set forth in the protocol in terms of dosing compliance, number of available post-randomization evaluations and absence of significant protocol violations.|
59505272|NCT01279057|75597965|FG002|Per-Protocol (PPP) Population|Overall Study||126|All participants who satisfied the criteria set forth in the protocol in terms of dosing compliance, number of available post-randomization evaluations and absence of significant protocol violations.|
59505273|NCT01279057|75597963|FG000|Intent-to-Treat (ITT) Population|Overall Study||284|All participants in the PPP as well as all participants who administered at least one dose of randomized study drug and had at least one post-randomization evaluation.|
59505274|NCT01279057|75597964|FG001|Intent-to-Treat (ITT) Population|Overall Study||285|All participants in the PPP as well as all participants who administered at least one dose of randomized study drug and had at least one post-randomization evaluation.|
59505275|NCT01279057|75597965|FG002|Intent-to-Treat (ITT) Population|Overall Study||144|All participants in the PPP as well as all participants who administered at least one dose of randomized study drug and had at least one post-randomization evaluation.|
59505276|NCT01279057|75597963|FG000|COMPLETED|Overall Study||282||
59505277|NCT01279057|75597964|FG001|COMPLETED|Overall Study||287||
59505278|NCT01279057|75597965|FG002|COMPLETED|Overall Study||144||
59505279|NCT01279057|75597963|FG000|NOT COMPLETED|Overall Study||6||
59505280|NCT01279057|75597964|FG001|NOT COMPLETED|Overall Study||5||
59505281|NCT01279057|75597965|FG002|NOT COMPLETED|Overall Study||3||
59505282|NCT02999633|75597973|FG000|STARTED|Overall Study||14||
59505283|NCT02999633|75597973|FG000|COMPLETED|Overall Study||0||
59505284|NCT02999633|75597973|FG000|NOT COMPLETED|Overall Study||14||
59505285|NCT02991599|75597979|FG000|STARTED|Overall Study||98||
59505286|NCT02991599|75597980|FG001|STARTED|Overall Study||98||
59505287|NCT02991599|75597979|FG000|COMPLETED|Overall Study||60||
59505288|NCT02991599|75597980|FG001|COMPLETED|Overall Study||61||
59505289|NCT02991599|75597979|FG000|NOT COMPLETED|Overall Study||38||
59505290|NCT02991599|75597980|FG001|NOT COMPLETED|Overall Study||37||
59505291|NCT00706823|75597988|FG000|STARTED|Overall Study||25||
59505292|NCT00706823|75597989|FG001|STARTED|Overall Study||25||
59505293|NCT00706823|75597988|FG000|COMPLETED|Overall Study||25||
59505294|NCT00706823|75597989|FG001|COMPLETED|Overall Study||25||
59505295|NCT00706823|75597988|FG000|NOT COMPLETED|Overall Study||0||
59505296|NCT00706823|75597989|FG001|NOT COMPLETED|Overall Study||0||
59505297|NCT00728819|75597997|FG000|STARTED|Overall Study||171||
59505298|NCT00728819|75597998|FG001|STARTED|Overall Study||168||
59505299|NCT00728819|75597997|FG000|COMPLETED|Overall Study||135||
59505300|NCT00728819|75597998|FG001|COMPLETED|Overall Study||139||
59505301|NCT00728819|75597997|FG000|NOT COMPLETED|Overall Study||36||
59505302|NCT00728819|75597998|FG001|NOT COMPLETED|Overall Study||29||
59505303|NCT00729053|75598008|FG000|STARTED|Overall Study||23||
59505304|NCT00729053|75598009|FG001|STARTED|Overall Study||23||
59505305|NCT00729053|75598010|FG002|STARTED|Overall Study||23||
59505306|NCT00729053|75598011|FG003|STARTED|Overall Study||23||
59505307|NCT00729053|75598008|FG000|COMPLETED|Overall Study||23||
59505308|NCT00729053|75598009|FG001|COMPLETED|Overall Study||23||
59505309|NCT00729053|75598010|FG002|COMPLETED|Overall Study||23||
59505310|NCT00729053|75598011|FG003|COMPLETED|Overall Study||23||
59505311|NCT00729053|75598008|FG000|NOT COMPLETED|Overall Study||0||
59609337|NCT01880736|75720168|FG000|COMPLETED|Overall Study||113||
59609338|NCT01880736|75720169|FG001|COMPLETED|Overall Study||113||
59609339|NCT01880736|75720170|FG002|COMPLETED|Overall Study||114||
59609340|NCT01880736|75720171|FG003|COMPLETED|Overall Study||108||
59609341|NCT01880736|75720168|FG000|NOT COMPLETED|Overall Study||1||
59609342|NCT01880736|75720169|FG001|NOT COMPLETED|Overall Study||2||
59609343|NCT01880736|75720170|FG002|NOT COMPLETED|Overall Study||1||
59609344|NCT01880736|75720171|FG003|NOT COMPLETED|Overall Study||6||
59609345|NCT01880424|75720183|FG000|STARTED|Overall Study||417||
59609346|NCT01880424|75720184|FG001|STARTED|Overall Study||422||
59609347|NCT01880424|75720183|FG000|COMPLETED|Overall Study||384||
59609348|NCT01880424|75720184|FG001|COMPLETED|Overall Study||367||
59609349|NCT01880424|75720183|FG000|NOT COMPLETED|Overall Study||33||
59609350|NCT01880424|75720184|FG001|NOT COMPLETED|Overall Study||55||
59609351|NCT01862874|75720192|FG000|STARTED|Overall Study|Randomized participants|562||
59609352|NCT01862874|75720193|FG001|STARTED|Overall Study|Randomized participants|562||
59609353|NCT01862874|75720192|FG000|Vaccination 1|Overall Study||561||
59609354|NCT01862874|75720193|FG001|Vaccination 1|Overall Study||562||
59609355|NCT01862874|75720192|FG000|Vaccination 2|Overall Study||539||
59609356|NCT01862874|75720193|FG001|Vaccination 2|Overall Study||542||
59609357|NCT01862874|75720192|FG000|Vaccination 3|Overall Study||530||
59609358|NCT01862874|75720193|FG001|Vaccination 3|Overall Study||532||
59609359|NCT01862874|75720192|FG000|COMPLETED|Overall Study||483||
59609360|NCT01862874|75720193|FG001|COMPLETED|Overall Study||485||
59609361|NCT01862874|75720192|FG000|NOT COMPLETED|Overall Study||79||
59609362|NCT01862874|75720193|FG001|NOT COMPLETED|Overall Study||77||
59609363|NCT01879722|75720209|FG000|STARTED|Overall Study||7||
59609364|NCT01879722|75720210|FG001|STARTED|Overall Study||8||
59609365|NCT01879722|75720211|FG002|STARTED|Overall Study||7||
59609366|NCT01879722|75720212|FG003|STARTED|Overall Study||8||
59609367|NCT01879722|75720213|FG004|STARTED|Overall Study||8||
59609368|NCT01879722|75720214|FG005|STARTED|Overall Study||9||
59609369|NCT01879722|75720215|FG006|STARTED|Overall Study||8||
59609370|NCT01879722|75720216|FG007|STARTED|Overall Study||8||
59609371|NCT01879722|75720217|FG008|STARTED|Overall Study||8||
59609372|NCT01879722|75720218|FG009|STARTED|Overall Study||6||
59609373|NCT01879722|75720209|FG000|COMPLETED|Overall Study||7||
59609374|NCT01879722|75720210|FG001|COMPLETED|Overall Study||7||
59609375|NCT01879722|75720211|FG002|COMPLETED|Overall Study||7||
59609376|NCT01879722|75720212|FG003|COMPLETED|Overall Study||7||
59887296|NCT03126110|76009953|FG007|COMPLETED|Phase 2||0||
59887297|NCT03126110|76009954|FG008|COMPLETED|Phase 2||0||
59887298|NCT03126110|76009955|FG009|COMPLETED|Phase 2||0||
59887299|NCT03126110|76009956|FG010|COMPLETED|Phase 2||0||
59887300|NCT03126110|76009957|FG011|COMPLETED|Phase 2||0||
59887301|NCT03126110|76009958|FG012|COMPLETED|Phase 2||0||
59887302|NCT03126110|76009959|FG013|COMPLETED|Phase 2||12||
59609377|NCT01879722|75720213|FG004|COMPLETED|Overall Study||7||
59609378|NCT01879722|75720214|FG005|COMPLETED|Overall Study||9||
59609379|NCT01879722|75720215|FG006|COMPLETED|Overall Study||8||
59609380|NCT01879722|75720216|FG007|COMPLETED|Overall Study||7||
59609381|NCT01879722|75720217|FG008|COMPLETED|Overall Study||6||
59609382|NCT01879722|75720218|FG009|COMPLETED|Overall Study||6||
59609383|NCT01879722|75720209|FG000|NOT COMPLETED|Overall Study||0||
59609384|NCT01879722|75720210|FG001|NOT COMPLETED|Overall Study||1||
59609385|NCT01879722|75720211|FG002|NOT COMPLETED|Overall Study||0||
59609386|NCT01879722|75720212|FG003|NOT COMPLETED|Overall Study||1||
59609387|NCT01879722|75720213|FG004|NOT COMPLETED|Overall Study||1||
59609388|NCT01879722|75720214|FG005|NOT COMPLETED|Overall Study||0||
59609389|NCT01879722|75720215|FG006|NOT COMPLETED|Overall Study||0||
59609390|NCT01879722|75720216|FG007|NOT COMPLETED|Overall Study||1||
59609391|NCT01879722|75720217|FG008|NOT COMPLETED|Overall Study||2||
59609392|NCT01879722|75720218|FG009|NOT COMPLETED|Overall Study||0||
59609393|NCT01879410|75720245|FG000|STARTED|Overall Study||350||
59609394|NCT01879410|75720246|FG001|STARTED|Overall Study||350||
59609395|NCT01879410|75720245|FG000|Intent-to-Treat Population|Overall Study||349||
59609396|NCT01879410|75720246|FG001|Intent-to-Treat Population|Overall Study||348||
59609397|NCT01879410|75720245|FG000|COMPLETED|Overall Study||326||
59609398|NCT01879410|75720246|FG001|COMPLETED|Overall Study||312||
59609399|NCT01879410|75720245|FG000|NOT COMPLETED|Overall Study||24||
59609400|NCT01879410|75720246|FG001|NOT COMPLETED|Overall Study||38||
59609401|NCT01903434|75720252|FG000|STARTED|Treatment Period 1||30||
59887303|NCT03126110|76009960|FG014|COMPLETED|Phase 2||2||
59887304|NCT03126110|76009961|FG015|COMPLETED|Phase 2||0||
59887305|NCT03126110|76009962|FG016|COMPLETED|Phase 2||0||
59609402|NCT01903434|75720253|FG001|STARTED|Treatment Period 1||30||
59887306|NCT03126110|76009946|FG000|NOT COMPLETED|Phase 2||0||
59887307|NCT03126110|76009947|FG001|NOT COMPLETED|Phase 2||0||
59609403|NCT01903434|75720252|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 1||30||
59613505|NCT01684722|75724627|FG000|NOT COMPLETED|Overall Study||97||
59887308|NCT03126110|76009948|FG002|NOT COMPLETED|Phase 2||0||
59887309|NCT03126110|76009949|FG003|NOT COMPLETED|Phase 2||0||
59887310|NCT03126110|76009950|FG004|NOT COMPLETED|Phase 2||0||
59887311|NCT03126110|76009951|FG005|NOT COMPLETED|Phase 2||0||
59609404|NCT01903434|75720253|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 1||30||
59609405|NCT01903434|75720252|FG000|COMPLETED|Treatment Period 1||30||
59609406|NCT01903434|75720253|FG001|COMPLETED|Treatment Period 1||30||
59609407|NCT01903434|75720252|FG000|NOT COMPLETED|Treatment Period 1||0||
59609408|NCT01903434|75720253|FG001|NOT COMPLETED|Treatment Period 1||0||
59609409|NCT01903434|75720252|FG000|STARTED|Washout Period 1 (at Least 14 Days)||30||
59609410|NCT01903434|75720253|FG001|STARTED|Washout Period 1 (at Least 14 Days)||30||
59609411|NCT01903434|75720252|FG000|COMPLETED|Washout Period 1 (at Least 14 Days)||29||
59609412|NCT01903434|75720253|FG001|COMPLETED|Washout Period 1 (at Least 14 Days)||28||
59609413|NCT01903434|75720252|FG000|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||1||
59609414|NCT01903434|75720253|FG001|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||2||
59609415|NCT01903434|75720252|FG000|STARTED|Treatment Period 2||29||
59609416|NCT01903434|75720253|FG001|STARTED|Treatment Period 2||28||
59609417|NCT01903434|75720252|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 2||29||
59609418|NCT01903434|75720253|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 2||28||
59609419|NCT01903434|75720252|FG000|COMPLETED|Treatment Period 2||29||
59609420|NCT01903434|75720253|FG001|COMPLETED|Treatment Period 2||28||
59609421|NCT01903434|75720252|FG000|NOT COMPLETED|Treatment Period 2||0||
59609422|NCT01903434|75720253|FG001|NOT COMPLETED|Treatment Period 2||0||
59609423|NCT01903434|75720252|FG000|STARTED|Washout Period 1 (at Least 14 Days)||29||
59609424|NCT01903434|75720253|FG001|STARTED|Washout Period 1 (at Least 14 Days)||28||
59609425|NCT01903434|75720252|FG000|COMPLETED|Washout Period 1 (at Least 14 Days)||29||
59609426|NCT01903434|75720253|FG001|COMPLETED|Washout Period 1 (at Least 14 Days)||28||
59609427|NCT01903434|75720252|FG000|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0||
59609428|NCT01903434|75720253|FG001|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0||
59609429|NCT01903434|75720252|FG000|STARTED|Treatment Period 3||29||
59609430|NCT01903434|75720253|FG001|STARTED|Treatment Period 3||28||
59609431|NCT01903434|75720252|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 3||29||
59609432|NCT01903434|75720253|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 3||28||
59609433|NCT01903434|75720252|FG000|COMPLETED|Treatment Period 3||29||
59609434|NCT01903434|75720253|FG001|COMPLETED|Treatment Period 3||28||
59609435|NCT01903434|75720252|FG000|NOT COMPLETED|Treatment Period 3||0||
59609436|NCT01903434|75720253|FG001|NOT COMPLETED|Treatment Period 3||0||
59609437|NCT01903356|75720259|FG000|STARTED|Overall Study||724||
59609438|NCT01903356|75720259|FG000|COMPLETED|Overall Study||709||
59609439|NCT01903356|75720259|FG000|NOT COMPLETED|Overall Study||15||
59609440|NCT01862796|75720266|FG000|STARTED|Overall Study||19||
59609441|NCT01862796|75720267|FG001|STARTED|Overall Study||18||
59609442|NCT01862796|75720268|FG002|STARTED|Overall Study||24||
59609443|NCT01862796|75720266|FG000|COMPLETED|Overall Study||19||
59609444|NCT01862796|75720267|FG001|COMPLETED|Overall Study||18||
59609445|NCT01862796|75720268|FG002|COMPLETED|Overall Study||23||
59609446|NCT01862796|75720266|FG000|NOT COMPLETED|Overall Study||0||
59609447|NCT01862796|75720267|FG001|NOT COMPLETED|Overall Study||0||
59609448|NCT01862796|75720268|FG002|NOT COMPLETED|Overall Study||1||
59609449|NCT01878084|75720276|FG000|STARTED|Overall Study||9||18
59609450|NCT01878084|75720276|FG000|Test(Received TAMP Bioglass) s|Overall Study||7||7
59609451|NCT01878084|75720276|FG000|Control (Sockets Were Left Empty)|Overall Study||7||7
59609452|NCT01878084|75720276|FG000|COMPLETED|Overall Study||7||14
59609453|NCT01878084|75720276|FG000|NOT COMPLETED|Overall Study||2||4
59609454|NCT01862640|75720285|FG000|STARTED|Overall Study||20||
59609455|NCT01862640|75720286|FG001|STARTED|Overall Study||137||
59609456|NCT01862640|75720287|FG002|STARTED|Overall Study||140||
59609457|NCT01862640|75720288|FG003|STARTED|Overall Study||136||
59609458|NCT01862640|75720285|FG000|COMPLETED|Overall Study||13||
59609459|NCT01862640|75720286|FG001|COMPLETED|Overall Study||121||
59756084|NCT04300010|75875194|FG003|COMPLETED|Overall Study||60||60
59756085|NCT04300010|75875191|FG000|NOT COMPLETED|Overall Study||0||0
59609460|NCT01862640|75720287|FG002|COMPLETED|Overall Study||122||
59609461|NCT01862640|75720288|FG003|COMPLETED|Overall Study||121||
59609462|NCT01862640|75720285|FG000|NOT COMPLETED|Overall Study||7||
59609463|NCT01862640|75720286|FG001|NOT COMPLETED|Overall Study||16||
59609464|NCT01862640|75720287|FG002|NOT COMPLETED|Overall Study||18||
59609465|NCT01862640|75720288|FG003|NOT COMPLETED|Overall Study||15||
59609466|NCT01902966|75720297|FG000|STARTED|Overall Study||5||
59756086|NCT04300010|75875192|FG001|NOT COMPLETED|Overall Study||0||0
59756087|NCT04300010|75875193|FG002|NOT COMPLETED|Overall Study||0||0
59756088|NCT04300010|75875194|FG003|NOT COMPLETED|Overall Study||0||0
59756089|NCT00608569|75875205|FG000|STARTED|Overall Study||129||
59609467|NCT01902966|75720297|FG000|COMPLETED|Overall Study||2||
59609468|NCT01902966|75720297|FG000|NOT COMPLETED|Overall Study||3||
59609469|NCT01862484|75720303|FG000|STARTED|Overall Study||15||
59609470|NCT01862484|75720304|FG001|STARTED|Overall Study||14||
59756090|NCT00608569|75875206|FG001|STARTED|Overall Study||128||
59609471|NCT01862484|75720303|FG000|COMPLETED|Overall Study||13||
59609472|NCT01862484|75720304|FG001|COMPLETED|Overall Study||6||
59609473|NCT01862484|75720303|FG000|NOT COMPLETED|Overall Study||2||
59609474|NCT01862484|75720304|FG001|NOT COMPLETED|Overall Study||8||
59609475|NCT01902888|75720310|FG000|STARTED|Overall Study||3||
59756091|NCT00608569|75875205|FG000|COMPLETED|Overall Study||119||
59609476|NCT01902888|75720310|FG000|COMPLETED|Overall Study||0||
59609477|NCT01902888|75720310|FG000|NOT COMPLETED|Overall Study||3||
59609478|NCT01862328|75720321|FG000|STARTED|Overall Study||4||
59609479|NCT01862328|75720322|FG001|STARTED|Overall Study||18||
59609480|NCT01862328|75720323|FG002|STARTED|Overall Study||6||
59609481|NCT01862328|75720324|FG003|STARTED|Overall Study||7||
59609482|NCT01862328|75720325|FG004|STARTED|Overall Study||12||
59609483|NCT01862328|75720326|FG005|STARTED|Overall Study||7||
59609484|NCT01862328|75720327|FG006|STARTED|Overall Study||10||
59609485|NCT01862328|75720321|FG000|COMPLETED|Overall Study||0||
59609486|NCT01862328|75720322|FG001|COMPLETED|Overall Study||0||
59609487|NCT01862328|75720323|FG002|COMPLETED|Overall Study||0||
59609488|NCT01862328|75720324|FG003|COMPLETED|Overall Study||0||
59609489|NCT01862328|75720325|FG004|COMPLETED|Overall Study||0||
59609490|NCT01862328|75720326|FG005|COMPLETED|Overall Study||0||
59609491|NCT01862328|75720327|FG006|COMPLETED|Overall Study||0||
59609492|NCT01862328|75720321|FG000|NOT COMPLETED|Overall Study||4||
59609493|NCT01862328|75720322|FG001|NOT COMPLETED|Overall Study||18||
59609494|NCT01862328|75720323|FG002|NOT COMPLETED|Overall Study||6||
59609495|NCT01862328|75720324|FG003|NOT COMPLETED|Overall Study||7||
59609496|NCT01862328|75720325|FG004|NOT COMPLETED|Overall Study||12||
59609497|NCT01862328|75720326|FG005|NOT COMPLETED|Overall Study||7||
59609498|NCT01862328|75720327|FG006|NOT COMPLETED|Overall Study||10||
59609499|NCT01862250|75720349|FG000|STARTED|Overall Study||12||
59609500|NCT01862250|75720349|FG000|COMPLETED|Overall Study||8||
59609501|NCT01862250|75720349|FG000|NOT COMPLETED|Overall Study||4||
59609502|NCT01860846|75720353|FG000|STARTED|Overall Study||106||
59609503|NCT01860846|75720353|FG000|Month 1|Overall Study||97||
59609504|NCT01860846|75720353|FG000|Month 2|Overall Study||83||
59609505|NCT01860846|75720353|FG000|Month 4|Overall Study||82||
59609506|NCT01860846|75720353|FG000|Month 6|Overall Study||85||
59609507|NCT01860846|75720353|FG000|Month 12|Overall Study||73||
59609508|NCT01860846|75720353|FG000|COMPLETED|Overall Study||73||
59609509|NCT01860846|75720353|FG000|NOT COMPLETED|Overall Study||33||
59609510|NCT01901874|75720357|FG000|STARTED|Procedure||312||
59609511|NCT01901874|75720357|FG000|COMPLETED|Procedure||312||
59756092|NCT00608569|75875206|FG001|COMPLETED|Overall Study||119||
59756093|NCT00608569|75875205|FG000|NOT COMPLETED|Overall Study||10||
59756094|NCT00608569|75875206|FG001|NOT COMPLETED|Overall Study||9||
59756095|NCT00610675|75875212|FG000|STARTED|Overall Study||346||
59505312|NCT00729053|75598009|FG001|NOT COMPLETED|Overall Study||0||
59505313|NCT00729053|75598010|FG002|NOT COMPLETED|Overall Study||0||
59505314|NCT00729053|75598011|FG003|NOT COMPLETED|Overall Study||0||
59756096|NCT00610675|75875212|FG000|Treated|Overall Study||342||
59756097|NCT00610675|75875212|FG000|COMPLETED|Overall Study||126||
59505315|NCT00706979|75598023|FG000|STARTED|Overall Study||426||
59505316|NCT00706979|75598024|FG001|STARTED|Overall Study||423||
59505317|NCT00706979|75598023|FG000|COMPLETED|Overall Study||426||
59505318|NCT00706979|75598024|FG001|COMPLETED|Overall Study||423||
59505319|NCT00706979|75598023|FG000|NOT COMPLETED|Overall Study||0||
59505320|NCT00706979|75598024|FG001|NOT COMPLETED|Overall Study||0||
59505321|NCT00729521|75598033|FG000|STARTED|Overall Study|10 communities in Control with average annual population of 12,494 residents over 65 years old.|12494||
59505322|NCT00729521|75598034|FG001|STARTED|Overall Study|Five communities with average annual population of 14,842 residents over 65 years old.|14842||
59505323|NCT00729521|75598035|FG002|STARTED|Overall Study|5 communities in Facilitative System with average annual pop. of 7,701 residents over 65 years.|7701||
59609512|NCT01901874|75720357|FG000|NOT COMPLETED|Procedure||0||
59609513|NCT01901874|75720357|FG000|STARTED|Screening Committee Retrospective Review||312||
59756098|NCT00610675|75875212|FG000|NOT COMPLETED|Overall Study||220||
59609514|NCT01901874|75720357|FG000|COMPLETED|Screening Committee Retrospective Review||265||
59609515|NCT01901874|75720357|FG000|NOT COMPLETED|Screening Committee Retrospective Review||47||
59756099|NCT00888134|75875216|FG000|STARTED|Treatment With Study Drug||28||
59756100|NCT00888134|75875216|FG000|COMPLETED|Treatment With Study Drug|21 had progressive disease; 5 had unacceptable toxicity; 1 finished treatment|27||
59756101|NCT00888134|75875216|FG000|NOT COMPLETED|Treatment With Study Drug||1||
59609516|NCT01901874|75720357|FG000|STARTED|30-Day MAE Evaluation||265||
59609517|NCT01901874|75720357|FG000|COMPLETED|30-Day MAE Evaluation||264||
59609518|NCT01901874|75720357|FG000|NOT COMPLETED|30-Day MAE Evaluation||1||
59609519|NCT01901874|75720357|FG000|STARTED|1-Year (365-Day) MAE Evaluation||264||
59609520|NCT01901874|75720357|FG000|COMPLETED|1-Year (365-Day) MAE Evaluation||244||
59609521|NCT01901874|75720357|FG000|NOT COMPLETED|1-Year (365-Day) MAE Evaluation||20||
59609522|NCT01860534|75720363|FG000|STARTED|ROP #1||14||
59609523|NCT01860534|75720364|FG001|STARTED|ROP #1||14||
59756102|NCT00888134|75875216|FG000|STARTED|Follow-up||27||
59756103|NCT00888134|75875216|FG000|COMPLETED|Follow-up|23 died; 3 were lost-to-follow-up|26||
59505324|NCT00729521|75598033|FG000|COMPLETED|Overall Study|Average annual population over 65 years old.|12494||
59505325|NCT00729521|75598034|FG001|COMPLETED|Overall Study|Average annual population over 65 years old.|14842||
59609524|NCT01860534|75720363|FG000|COMPLETED|ROP #1||14||
59609525|NCT01860534|75720364|FG001|COMPLETED|ROP #1||13||
59609526|NCT01860534|75720363|FG000|NOT COMPLETED|ROP #1||0||
59609527|NCT01860534|75720364|FG001|NOT COMPLETED|ROP #1||1||
59609528|NCT01860534|75720363|FG000|STARTED|ROP #2||14||
59609529|NCT01860534|75720364|FG001|STARTED|ROP #2||13||
59756104|NCT00888134|75875216|FG000|NOT COMPLETED|Follow-up||1||
59756105|NCT00573157|75875223|FG000|STARTED|Overall Study||4||
59756106|NCT00573157|75875224|FG001|STARTED|Overall Study||2||
59756107|NCT00573157|75875223|FG000|COMPLETED|Overall Study||0||
59756108|NCT00573157|75875224|FG001|COMPLETED|Overall Study||0||
59756109|NCT00573157|75875223|FG000|NOT COMPLETED|Overall Study||4||
59609530|NCT01860534|75720363|FG000|COMPLETED|ROP #2||13||
59609531|NCT01860534|75720364|FG001|COMPLETED|ROP #2||13||
59609532|NCT01860534|75720363|FG000|NOT COMPLETED|ROP #2||1||
59609533|NCT01860534|75720364|FG001|NOT COMPLETED|ROP #2||0||
59609534|NCT01901328|75720374|FG000|STARTED|Overall Study||26||
59609535|NCT01901328|75720375|FG001|STARTED|Overall Study||23||
59609536|NCT01901328|75720374|FG000|Received at Least 1 Dose of Study Drug|Overall Study||26||
59609537|NCT01901328|75720375|FG001|Received at Least 1 Dose of Study Drug|Overall Study||23||
59609538|NCT01901328|75720374|FG000|COMPLETED|Overall Study||4||
59609539|NCT01901328|75720375|FG001|COMPLETED|Overall Study||2||
59609540|NCT01901328|75720374|FG000|NOT COMPLETED|Overall Study||22||
59609541|NCT01901328|75720375|FG001|NOT COMPLETED|Overall Study||21||
59609542|NCT01859988|75720388|FG000|STARTED|Overall Study||63||
59609543|NCT01859988|75720389|FG001|STARTED|Overall Study||64||
59609544|NCT01859988|75720390|FG002|STARTED|Overall Study||62||
59609545|NCT01859988|75720391|FG003|STARTED|Overall Study||65||
59609546|NCT01859988|75720392|FG004|STARTED|Overall Study||65||
59609547|NCT01859988|75720393|FG005|STARTED|Overall Study||61||
59609548|NCT01859988|75720388|FG000|Treated|Overall Study||63||
59609549|NCT01859988|75720389|FG001|Treated|Overall Study||64||
59609550|NCT01859988|75720390|FG002|Treated|Overall Study||61||
59609551|NCT01859988|75720391|FG003|Treated|Overall Study||65||
59609552|NCT01859988|75720392|FG004|Treated|Overall Study||65||
59609553|NCT01859988|75720393|FG005|Treated|Overall Study||61||
59609554|NCT01859988|75720388|FG000|COMPLETED|Overall Study||52||
59609555|NCT01859988|75720389|FG001|COMPLETED|Overall Study||52||
59609556|NCT01859988|75720390|FG002|COMPLETED|Overall Study||34||
59609557|NCT01859988|75720391|FG003|COMPLETED|Overall Study||55||
59609558|NCT01859988|75720392|FG004|COMPLETED|Overall Study||42||
59609559|NCT01859988|75720393|FG005|COMPLETED|Overall Study||42||
59609560|NCT01859988|75720388|FG000|NOT COMPLETED|Overall Study||11||
59609561|NCT01859988|75720389|FG001|NOT COMPLETED|Overall Study||12||
59609562|NCT01859988|75720390|FG002|NOT COMPLETED|Overall Study||28||
59609563|NCT01859988|75720391|FG003|NOT COMPLETED|Overall Study||10||
59609564|NCT01859988|75720392|FG004|NOT COMPLETED|Overall Study||23||
59609565|NCT01859988|75720393|FG005|NOT COMPLETED|Overall Study||19||
59609566|NCT01859598|75720407|FG000|STARTED|Visit 2 at 3 Months|At visit 1, patients remained at baseline, N=18995|18995||
59609567|NCT01859598|75720407|FG000|COMPLETED|Visit 2 at 3 Months||17253||
59609568|NCT01859598|75720407|FG000|NOT COMPLETED|Visit 2 at 3 Months||1742||
59609569|NCT01859598|75720407|FG000|STARTED|Visit 3 at 6 Months||17253||
59609570|NCT01859598|75720407|FG000|COMPLETED|Visit 3 at 6 Months|Loss to follow-up, N=1517; Come back at visit 3, N=605;|16341||
59609571|NCT01859598|75720407|FG000|NOT COMPLETED|Visit 3 at 6 Months||912||
59609572|NCT01876446|75720415|FG000|STARTED|Overall Study||20||
59609573|NCT01876446|75720416|FG001|STARTED|Overall Study||18||
59609574|NCT01876446|75720415|FG000|COMPLETED|Overall Study||18||
59609575|NCT01876446|75720416|FG001|COMPLETED|Overall Study||12||
59609576|NCT01876446|75720415|FG000|NOT COMPLETED|Overall Study||2||
59609577|NCT01876446|75720416|FG001|NOT COMPLETED|Overall Study||6||
59609578|NCT01900626|75720424|FG000|STARTED|Overall Study||1||
59609579|NCT01900626|75720425|FG001|STARTED|Overall Study||1||
59609580|NCT01900626|75720424|FG000|COMPLETED|Overall Study||0||
59609581|NCT01900626|75720425|FG001|COMPLETED|Overall Study||0||
59609582|NCT01900626|75720424|FG000|NOT COMPLETED|Overall Study||1||
59609583|NCT01900626|75720425|FG001|NOT COMPLETED|Overall Study||1||
59609584|NCT01900314|75720435|FG000|STARTED|Overall Study||20||
59756110|NCT00573157|75875224|FG001|NOT COMPLETED|Overall Study||2||
59756111|NCT00802737|75875233|FG000|STARTED|Overall Study||17||
59756112|NCT00802737|75875234|FG001|STARTED|Overall Study||11||
59609585|NCT01900314|75720436|FG001|STARTED|Overall Study||20||
59609586|NCT01900314|75720435|FG000|Completed MRI#1|Overall Study|2 withdrew consent prior to MRI, 1 had MRI technical failure|17|MRI required BEFORE first treatment|
59609587|NCT01900314|75720436|FG001|Completed MRI#1|Overall Study|2 withdrew consent, 1 patient was unable to tolerate MRI|17|MRI required BEFORE first treatment|
59609588|NCT01900314|75720435|FG000|COMPLETED|Overall Study|1 patient had MRI, then moved away after 5 TMS treatments|16||
59609589|NCT01900314|75720436|FG001|COMPLETED|Overall Study|1 patient had 4 TMS Tx, but missed too many for protocol requirements,|16||
59609590|NCT01900314|75720435|FG000|NOT COMPLETED|Overall Study||4||
59609591|NCT01900314|75720436|FG001|NOT COMPLETED|Overall Study||4||
59609592|NCT01899768|75720443|FG000|STARTED|Part A||16||
59609593|NCT01899768|75720443|FG000|COMPLETED|Part A||13||
59609594|NCT01899768|75720443|FG000|NOT COMPLETED|Part A||3||
59609595|NCT01899768|75720443|FG000|STARTED|Part B||13||
59609596|NCT01899768|75720443|FG000|COMPLETED|Part B||11||
59609597|NCT01899768|75720443|FG000|NOT COMPLETED|Part B||2||
59609598|NCT01899768|75720443|FG000|STARTED|Part C||11||
59609599|NCT01899768|75720443|FG000|COMPLETED|Part C||11||
59609600|NCT01899768|75720443|FG000|NOT COMPLETED|Part C||0||
59609601|NCT01898598|75720453|FG000|STARTED|Overall Study||12||
59609602|NCT01898598|75720454|FG001|STARTED|Overall Study||6||
59609603|NCT01898598|75720453|FG000|Treated|Overall Study||11||
59609604|NCT01898598|75720454|FG001|Treated|Overall Study||5||
59609605|NCT01898598|75720453|FG000|COMPLETED|Overall Study||8||
59609606|NCT01898598|75720454|FG001|COMPLETED|Overall Study||4||
59756113|NCT00802737|75875235|FG002|STARTED|Overall Study||1||
59609607|NCT01898598|75720453|FG000|NOT COMPLETED|Overall Study||4||
59756114|NCT00802737|75875233|FG000|COMPLETED|Overall Study||0||
59756115|NCT00802737|75875234|FG001|COMPLETED|Overall Study||0||
59505326|NCT00729521|75598035|FG002|COMPLETED|Overall Study|Average annual population over 65 years old.|7701||
59505327|NCT00729521|75598033|FG000|NOT COMPLETED|Overall Study||0||
59756116|NCT00802737|75875235|FG002|COMPLETED|Overall Study||0||
59756117|NCT00802737|75875233|FG000|NOT COMPLETED|Overall Study||17||
59756118|NCT00802737|75875234|FG001|NOT COMPLETED|Overall Study||11||
59756119|NCT00802737|75875235|FG002|NOT COMPLETED|Overall Study||1||
59756120|NCT00588861|75875246|FG000|STARTED|Pre-Operative|202 Patients were enrolled, however only 107 contributed preop data.|202||
59756121|NCT00588861|75875247|FG001|STARTED|Pre-Operative|200 patients were enrolled, however only 114 contributed preop data.|200||
59756122|NCT00588861|75875246|FG000|COMPLETED|Pre-Operative||107||
59756123|NCT00588861|75875247|FG001|COMPLETED|Pre-Operative||114||
59756124|NCT00588861|75875246|FG000|NOT COMPLETED|Pre-Operative||95||
59756125|NCT00588861|75875247|FG001|NOT COMPLETED|Pre-Operative||86||
59756126|NCT00588861|75875246|FG000|STARTED|6 Months|107 cases were due at 6 Months, however only 9 returned for follow-up.|107||
59756127|NCT00588861|75875247|FG001|STARTED|6 Months|114 cases were due at 6 Months, however only 41 returned for follow-up.|114||
59756128|NCT00588861|75875246|FG000|COMPLETED|6 Months||9||
59756129|NCT00588861|75875247|FG001|COMPLETED|6 Months||41||
59756130|NCT00588861|75875246|FG000|NOT COMPLETED|6 Months||98||
59756131|NCT00588861|75875247|FG001|NOT COMPLETED|6 Months||73||
59756132|NCT00588861|75875246|FG000|STARTED|1 Year|107 cases were due at 1 Year, however only 18 returned for follow-up.|107||
59756133|NCT00588861|75875247|FG001|STARTED|1 Year|114 cases were due at 1 Year, however only 32 returned for follow-up.|114||
59756134|NCT00588861|75875246|FG000|COMPLETED|1 Year||18||
59756135|NCT00588861|75875247|FG001|COMPLETED|1 Year||32||
59756136|NCT00588861|75875246|FG000|NOT COMPLETED|1 Year||89||
59756137|NCT00588861|75875247|FG001|NOT COMPLETED|1 Year||82||
59756138|NCT00588861|75875246|FG000|STARTED|2 Years|107 cases were due at 2 Years, however only 15 returned for follow-up.|107||
59756139|NCT00588861|75875247|FG001|STARTED|2 Years|114 cases were due at 2 Years, however only 27 returned for follow-up.|114||
59756140|NCT00588861|75875246|FG000|COMPLETED|2 Years||15||
59756141|NCT00588861|75875247|FG001|COMPLETED|2 Years||27||
59756142|NCT00588861|75875246|FG000|NOT COMPLETED|2 Years||92||
59756143|NCT00588861|75875247|FG001|NOT COMPLETED|2 Years||87||
59756144|NCT00588861|75875246|FG000|STARTED|4 Years|107 cases were due at 4 Years, however only 16 returned for follow-up.|107||
59756145|NCT00588861|75875247|FG001|STARTED|4 Years|114 cases were due at 4 Years, however only 11 returned for follow-up.|114||
59756146|NCT00588861|75875246|FG000|COMPLETED|4 Years||16||
59756147|NCT00588861|75875247|FG001|COMPLETED|4 Years||11||
59756148|NCT00588861|75875246|FG000|NOT COMPLETED|4 Years||91||
59756149|NCT00588861|75875247|FG001|NOT COMPLETED|4 Years||103||
59756150|NCT00588861|75875246|FG000|STARTED|6 Years|107 cases were due at 6 Years, however only 3 returned for follow-up.|107||
59756151|NCT00588861|75875247|FG001|STARTED|6 Years|114 cases were due at 6 Years, however only 5 returned for follow-up.|114||
59756152|NCT00588861|75875246|FG000|COMPLETED|6 Years||3||
59756153|NCT00588861|75875247|FG001|COMPLETED|6 Years||5||
59756154|NCT00588861|75875246|FG000|NOT COMPLETED|6 Years||104||
59756155|NCT00588861|75875247|FG001|NOT COMPLETED|6 Years||109||
59756156|NCT00588861|75875246|FG000|STARTED|8 Years|107 cases were due at 8 Years, however only 2 returned for follow-up.|107||
59756157|NCT00588861|75875247|FG001|STARTED|8 Years|114 cases were due at 8 Years, however no patients returned for follow-up.|114||
59756158|NCT00588861|75875246|FG000|COMPLETED|8 Years||2||
59756159|NCT00588861|75875247|FG001|COMPLETED|8 Years||0||
59756160|NCT00588861|75875246|FG000|NOT COMPLETED|8 Years||105||
59756161|NCT00588861|75875247|FG001|NOT COMPLETED|8 Years||114||
59756162|NCT00588861|75875246|FG000|STARTED|10 Years|107 cases were due at 10 Years, however no patients returned for follow-up.|107||
59756163|NCT00588861|75875247|FG001|STARTED|10 Years|114 cases were due at 10 Years, however no patients returned for follow-up.|114||
59756164|NCT00588861|75875246|FG000|COMPLETED|10 Years||0||
59756165|NCT00588861|75875247|FG001|COMPLETED|10 Years||0||
59756166|NCT00588861|75875246|FG000|NOT COMPLETED|10 Years||107||
59756167|NCT00588861|75875247|FG001|NOT COMPLETED|10 Years||114||
59756168|NCT00887978|75875255|FG000|STARTED|Overall Study||157||
59887312|NCT03126110|76009952|FG006|NOT COMPLETED|Phase 2||0||
59505328|NCT00729521|75598034|FG001|NOT COMPLETED|Overall Study||0||
59505329|NCT00729521|75598035|FG002|NOT COMPLETED|Overall Study||0||
59609608|NCT01898598|75720454|FG001|NOT COMPLETED|Overall Study||2||
59609609|NCT01898442|75720463|FG000|STARTED|Overall Study||17||
59609610|NCT01898442|75720464|FG001|STARTED|Overall Study||17||
59609611|NCT01898442|75720465|FG002|STARTED|Overall Study||18||
59609612|NCT01898442|75720463|FG000|COMPLETED|Overall Study||16||
59609613|NCT01898442|75720464|FG001|COMPLETED|Overall Study||15||
59609614|NCT01898442|75720465|FG002|COMPLETED|Overall Study||15||
59609615|NCT01898442|75720463|FG000|NOT COMPLETED|Overall Study||1||
59609616|NCT01898442|75720464|FG001|NOT COMPLETED|Overall Study||2||
59609617|NCT01898442|75720465|FG002|NOT COMPLETED|Overall Study||3||
59609618|NCT01898286|75720473|FG000|STARTED|Overall Study||38||
59609619|NCT01898286|75720473|FG000|COMPLETED|Overall Study|"For this study completed is defined as completing the Early Termination visit"|35||
59609620|NCT01898286|75720473|FG000|NOT COMPLETED|Overall Study||3||
59609621|NCT01898208|75720480|FG000|STARTED|Overall Study||247||
59609622|NCT01898208|75720481|FG001|STARTED|Overall Study||247||
59609623|NCT01898208|75720482|FG002|STARTED|Overall Study||249||
59609624|NCT01898208|75720480|FG000|COMPLETED|Overall Study||207||
59609625|NCT01898208|75720481|FG001|COMPLETED|Overall Study||198||
59609626|NCT01898208|75720482|FG002|COMPLETED|Overall Study||212||
59609627|NCT01898208|75720480|FG000|NOT COMPLETED|Overall Study||40||
59609628|NCT01898208|75720481|FG001|NOT COMPLETED|Overall Study||49||
59609629|NCT01898208|75720482|FG002|NOT COMPLETED|Overall Study||37||
59609630|NCT01898130|75720490|FG000|STARTED|Treatment||27||
59609631|NCT01898130|75720490|FG000|Reached 1st Response/2 Cycles|Treatment||24||
59609632|NCT01898130|75720490|FG000|Went on to Start Cycle 3|Treatment||21||
59609633|NCT01898130|75720490|FG000|COMPLETED|Treatment||21||
59609634|NCT01898130|75720490|FG000|NOT COMPLETED|Treatment||6||
59609635|NCT01898130|75720490|FG000|STARTED|Follow up Until PD or Death|All patients treated on study go into follow up period for survival data.|27||
59609636|NCT01898130|75720490|FG000|COMPLETED|Follow up Until PD or Death||26||
59609637|NCT01898130|75720490|FG000|NOT COMPLETED|Follow up Until PD or Death||1||
59609638|NCT01876368|75720496|FG000|STARTED|Overall Study||188||
59609639|NCT01876368|75720497|FG001|STARTED|Overall Study||188||
59609640|NCT01876368|75720496|FG000|Full Analysis Set (FAS)|Overall Study||188||
59609641|NCT01876368|75720497|FG001|Full Analysis Set (FAS)|Overall Study|One patient was not included in the SAF and FAS due to mis-randomization.|187||
59609642|NCT01876368|75720496|FG000|Safety Set (SAF)|Overall Study||188||
59609643|NCT01876368|75720497|FG001|Safety Set (SAF)|Overall Study||187||
59609644|NCT01876368|75720496|FG000|COMPLETED|Overall Study||179||
59609645|NCT01876368|75720497|FG001|COMPLETED|Overall Study||175||
59609646|NCT01876368|75720496|FG000|NOT COMPLETED|Overall Study||9||
59609647|NCT01876368|75720497|FG001|NOT COMPLETED|Overall Study||13||
59609648|NCT01874340|75720507|FG000|STARTED|Overall Study||6||
59609649|NCT01874340|75720508|FG001|STARTED|Overall Study||8||
59609650|NCT01874340|75720509|FG002|STARTED|Overall Study||8||
59609651|NCT01874340|75720510|FG003|STARTED|Overall Study||6||
59609652|NCT01874340|75720507|FG000|COMPLETED|Overall Study||0||
59609653|NCT01874340|75720508|FG001|COMPLETED|Overall Study||0||
59609654|NCT01874340|75720509|FG002|COMPLETED|Overall Study||0||
59756169|NCT00887978|75875256|FG001|STARTED|Overall Study||153||
59756170|NCT00887978|75875255|FG000|COMPLETED|Overall Study||132||
59756171|NCT00887978|75875256|FG001|COMPLETED|Overall Study||138||
59756172|NCT00887978|75875255|FG000|NOT COMPLETED|Overall Study||25||
59756173|NCT00887978|75875256|FG001|NOT COMPLETED|Overall Study||15||
59756174|NCT00608023|75875265|FG000|STARTED|Overall Study||92||
59756175|NCT00608023|75875266|FG001|STARTED|Overall Study||85||
59887313|NCT03126110|76009953|FG007|NOT COMPLETED|Phase 2||0||
59887314|NCT03126110|76009954|FG008|NOT COMPLETED|Phase 2||0||
59609655|NCT01874340|75720510|FG003|COMPLETED|Overall Study||1||
59609656|NCT01874340|75720507|FG000|NOT COMPLETED|Overall Study||6||
59609657|NCT01874340|75720508|FG001|NOT COMPLETED|Overall Study||8||
59609658|NCT01874340|75720509|FG002|NOT COMPLETED|Overall Study||8||
59609659|NCT01874340|75720510|FG003|NOT COMPLETED|Overall Study||5||
59609660|NCT01897896|75720522|FG000|STARTED|Overall Study||82||
59609661|NCT01897896|75720523|FG001|STARTED|Overall Study||37||
59609662|NCT01897896|75720522|FG000|COMPLETED|Overall Study||56||
59609663|NCT01897896|75720523|FG001|COMPLETED|Overall Study||25||
59609664|NCT01897896|75720522|FG000|NOT COMPLETED|Overall Study||26||
59609665|NCT01897896|75720523|FG001|NOT COMPLETED|Overall Study||12||
59609666|NCT01858194|75720533|FG000|STARTED|Overall Study||8||
59609667|NCT01858194|75720534|FG001|STARTED|Overall Study||9||
59609668|NCT01858194|75720533|FG000|COMPLETED|Overall Study|All patients in Control arm completed.|8||
59609669|NCT01858194|75720534|FG001|COMPLETED|Overall Study||7||
59609670|NCT01858194|75720533|FG000|NOT COMPLETED|Overall Study||0||
59756176|NCT00608023|75875267|FG002|STARTED|Overall Study||86||
59887315|NCT03126110|76009955|FG009|NOT COMPLETED|Phase 2||0||
59887316|NCT03126110|76009956|FG010|NOT COMPLETED|Phase 2||0||
59887317|NCT03126110|76009957|FG011|NOT COMPLETED|Phase 2||8||
59887318|NCT03126110|76009958|FG012|NOT COMPLETED|Phase 2||16||
59887319|NCT03126110|76009959|FG013|NOT COMPLETED|Phase 2||34||
59756177|NCT00608023|75875265|FG000|COMPLETED|Overall Study||80||
59756178|NCT00608023|75875266|FG001|COMPLETED|Overall Study||63||
59756179|NCT00608023|75875267|FG002|COMPLETED|Overall Study||72||
59887320|NCT03126110|76009960|FG014|NOT COMPLETED|Phase 2||16||
59609671|NCT01858194|75720534|FG001|NOT COMPLETED|Overall Study||2||
59609672|NCT01873950|75720542|FG000|STARTED|Period 1||5||
59609673|NCT01873950|75720543|FG001|STARTED|Period 1||4||
59609674|NCT01873950|75720544|FG002|STARTED|Period 1||5||
59609675|NCT01873950|75720545|FG003|STARTED|Period 1||4||
59609676|NCT01873950|75720546|FG004|STARTED|Period 1||4||
59609677|NCT01873950|75720542|FG000|COMPLETED|Period 1||5||
59609678|NCT01873950|75720543|FG001|COMPLETED|Period 1||4||
59609679|NCT01873950|75720544|FG002|COMPLETED|Period 1||5||
59609680|NCT01873950|75720545|FG003|COMPLETED|Period 1||4||
59609681|NCT01873950|75720546|FG004|COMPLETED|Period 1||4||
59609682|NCT01873950|75720542|FG000|NOT COMPLETED|Period 1||0||
59609683|NCT01873950|75720543|FG001|NOT COMPLETED|Period 1||0||
59609684|NCT01873950|75720544|FG002|NOT COMPLETED|Period 1||0||
59609685|NCT01873950|75720545|FG003|NOT COMPLETED|Period 1||0||
59609686|NCT01873950|75720546|FG004|NOT COMPLETED|Period 1||0||
59756180|NCT00608023|75875265|FG000|NOT COMPLETED|Overall Study||12||
59756181|NCT00608023|75875266|FG001|NOT COMPLETED|Overall Study||22||
59756182|NCT00608023|75875267|FG002|NOT COMPLETED|Overall Study||14||
59756183|NCT00802659|75875282|FG000|STARTED|Overall Study||0||
59756184|NCT00802659|75875283|FG001|STARTED|Overall Study||2||
59756185|NCT00802659|75875284|FG002|STARTED|Overall Study||0||
59887321|NCT03126110|76009961|FG015|NOT COMPLETED|Phase 2||4||
59887322|NCT03126110|76009962|FG016|NOT COMPLETED|Phase 2||2||
59887323|NCT00908128|76010005|FG000|STARTED|Period 1||20||
59887324|NCT00908128|76010006|FG001|STARTED|Period 1||20||
59887325|NCT00908128|76010005|FG000|COMPLETED|Period 1||20||
59887326|NCT00908128|76010006|FG001|COMPLETED|Period 1||20||
59887327|NCT00908128|76010005|FG000|NOT COMPLETED|Period 1||0||
59887328|NCT00908128|76010006|FG001|NOT COMPLETED|Period 1||0||
59887329|NCT00908128|76010005|FG000|STARTED|Period 2||20||
59887330|NCT00908128|76010006|FG001|STARTED|Period 2||20||
59887331|NCT00908128|76010005|FG000|COMPLETED|Period 2||20||
59887332|NCT00908128|76010006|FG001|COMPLETED|Period 2||20||
59887333|NCT00908128|76010005|FG000|NOT COMPLETED|Period 2||0||
59887334|NCT00908128|76010006|FG001|NOT COMPLETED|Period 2||0||
59887335|NCT00908128|76010005|FG000|STARTED|Period 3||20||
59887336|NCT00908128|76010006|FG001|STARTED|Period 3||20||
59887337|NCT00908128|76010005|FG000|COMPLETED|Period 3||20||
59887338|NCT00908128|76010006|FG001|COMPLETED|Period 3||20||
59609687|NCT01873950|75720542|FG000|STARTED|Period 2||5||
59609688|NCT01873950|75720543|FG001|STARTED|Period 2||4||
59609689|NCT01873950|75720544|FG002|STARTED|Period 2||4||
59609690|NCT01873950|75720545|FG003|STARTED|Period 2||4||
59609691|NCT01873950|75720546|FG004|STARTED|Period 2||5||
59756186|NCT00802659|75875285|FG003|STARTED|Overall Study||0||
59756187|NCT00802659|75875282|FG000|COMPLETED|Overall Study||0||
59756188|NCT00802659|75875283|FG001|COMPLETED|Overall Study||1||
59756189|NCT00802659|75875284|FG002|COMPLETED|Overall Study||0||
59756190|NCT00802659|75875285|FG003|COMPLETED|Overall Study||0||
59756191|NCT00802659|75875282|FG000|NOT COMPLETED|Overall Study||0||
59756192|NCT00802659|75875283|FG001|NOT COMPLETED|Overall Study||1||
59887339|NCT00908128|76010005|FG000|NOT COMPLETED|Period 3||0||
59887340|NCT00908128|76010006|FG001|NOT COMPLETED|Period 3||0||
59887341|NCT00908128|76010005|FG000|STARTED|Period 4||20||
59887342|NCT00908128|76010006|FG001|STARTED|Period 4|One subject withdrew prior to Period 4 dosing due to adverse events|19||
59887343|NCT00908128|76010005|FG000|COMPLETED|Period 4||20||
59887344|NCT00908128|76010006|FG001|COMPLETED|Period 4||19||
59609692|NCT01873950|75720542|FG000|COMPLETED|Period 2||5||
59609693|NCT01873950|75720543|FG001|COMPLETED|Period 2||4||
59609694|NCT01873950|75720544|FG002|COMPLETED|Period 2||4||
59609695|NCT01873950|75720545|FG003|COMPLETED|Period 2||4||
59609696|NCT01873950|75720546|FG004|COMPLETED|Period 2||5||
59609697|NCT01873950|75720542|FG000|NOT COMPLETED|Period 2||0||
59609698|NCT01873950|75720543|FG001|NOT COMPLETED|Period 2||0||
59609699|NCT01873950|75720544|FG002|NOT COMPLETED|Period 2||0||
59609700|NCT01873950|75720545|FG003|NOT COMPLETED|Period 2||0||
59609701|NCT01873950|75720546|FG004|NOT COMPLETED|Period 2||0||
59609702|NCT01873950|75720542|FG000|STARTED|Period 3||4||
59609703|NCT01873950|75720543|FG001|STARTED|Period 3||4||
59756193|NCT00802659|75875284|FG002|NOT COMPLETED|Overall Study||0||
59756194|NCT00802659|75875285|FG003|NOT COMPLETED|Overall Study||0||
59756195|NCT00607789|75875297|FG000|STARTED|Overall Study|20 participants were randomized in each group|20||
59756196|NCT00607789|75875298|FG001|STARTED|Overall Study||20||
59756197|NCT00607789|75875297|FG000|COMPLETED|Overall Study||13||
59887345|NCT00908128|76010005|FG000|NOT COMPLETED|Period 4||0||
59887346|NCT00908128|76010006|FG001|NOT COMPLETED|Period 4||0||
59887347|NCT00905164|76010012|FG000|STARTED|Period 1||12||
59887348|NCT00905164|76010013|FG001|STARTED|Period 1||12||
59887349|NCT00905164|76010012|FG000|COMPLETED|Period 1||12||
59887350|NCT00905164|76010013|FG001|COMPLETED|Period 1||11||
59887351|NCT00905164|76010012|FG000|NOT COMPLETED|Period 1||0||
59887352|NCT00905164|76010013|FG001|NOT COMPLETED|Period 1||1||
59887353|NCT00905164|76010012|FG000|STARTED|Period 2||12||
59887354|NCT00905164|76010013|FG001|STARTED|Period 2||11||
59887355|NCT00905164|76010012|FG000|COMPLETED|Period 2||12||
59887356|NCT00905164|76010013|FG001|COMPLETED|Period 2||11||
59887357|NCT00905164|76010012|FG000|NOT COMPLETED|Period 2||0||
59887358|NCT00905164|76010013|FG001|NOT COMPLETED|Period 2||0||
59887359|NCT03181958|76010020|FG000|STARTED|Overall Study||497||
59887360|NCT03181958|76010021|FG001|STARTED|Overall Study||501||
59887361|NCT03181958|76010022|FG002|STARTED|Overall Study||495||
59887362|NCT03181958|76010020|FG000|COMPLETED|Overall Study||480||
59887363|NCT03181958|76010021|FG001|COMPLETED|Overall Study||480||
59609704|NCT01873950|75720544|FG002|STARTED|Period 3||5||
59609705|NCT01873950|75720545|FG003|STARTED|Period 3||5||
59609706|NCT01873950|75720546|FG004|STARTED|Period 3||4||
59609707|NCT01873950|75720542|FG000|COMPLETED|Period 3||4||
59609708|NCT01873950|75720543|FG001|COMPLETED|Period 3||4||
59609709|NCT01873950|75720544|FG002|COMPLETED|Period 3||5||
59609710|NCT01873950|75720545|FG003|COMPLETED|Period 3||5||
59609711|NCT01873950|75720546|FG004|COMPLETED|Period 3||4||
59609712|NCT01873950|75720542|FG000|NOT COMPLETED|Period 3||0||
59609713|NCT01873950|75720543|FG001|NOT COMPLETED|Period 3||0||
59609714|NCT01873950|75720544|FG002|NOT COMPLETED|Period 3||0||
59609715|NCT01873950|75720545|FG003|NOT COMPLETED|Period 3||0||
59609716|NCT01873950|75720546|FG004|NOT COMPLETED|Period 3||0||
59609717|NCT01873950|75720542|FG000|STARTED|Period 4||4||
59609718|NCT01873950|75720543|FG001|STARTED|Period 4||5||
59609719|NCT01873950|75720544|FG002|STARTED|Period 4||4||
59609720|NCT01873950|75720545|FG003|STARTED|Period 4||4||
59609721|NCT01873950|75720546|FG004|STARTED|Period 4||5||
59609722|NCT01873950|75720542|FG000|COMPLETED|Period 4||4||
59609723|NCT01873950|75720543|FG001|COMPLETED|Period 4||5||
59609724|NCT01873950|75720544|FG002|COMPLETED|Period 4||4||
59609725|NCT01873950|75720545|FG003|COMPLETED|Period 4||4||
59609726|NCT01873950|75720546|FG004|COMPLETED|Period 4||5||
59609727|NCT01873950|75720542|FG000|NOT COMPLETED|Period 4||0||
59609728|NCT01873950|75720543|FG001|NOT COMPLETED|Period 4||0||
59609729|NCT01873950|75720544|FG002|NOT COMPLETED|Period 4||0||
59609730|NCT01873950|75720545|FG003|NOT COMPLETED|Period 4||0||
59609731|NCT01873950|75720546|FG004|NOT COMPLETED|Period 4||0||
59609732|NCT01873950|75720542|FG000|STARTED|Period 5||4||
59609733|NCT01873950|75720543|FG001|STARTED|Period 5||5||
59609734|NCT01873950|75720544|FG002|STARTED|Period 5||4||
59609735|NCT01873950|75720545|FG003|STARTED|Period 5||4||
59609736|NCT01873950|75720546|FG004|STARTED|Period 5||4||
59609737|NCT01873950|75720542|FG000|COMPLETED|Period 5||4||
59609738|NCT01873950|75720543|FG001|COMPLETED|Period 5||5||
59609739|NCT01873950|75720544|FG002|COMPLETED|Period 5||4||
59609740|NCT01873950|75720545|FG003|COMPLETED|Period 5||3||
59609741|NCT01873950|75720546|FG004|COMPLETED|Period 5||4||
59887364|NCT03181958|76010022|FG002|COMPLETED|Overall Study||480||
59887365|NCT03181958|76010020|FG000|NOT COMPLETED|Overall Study||17||
59887366|NCT03181958|76010021|FG001|NOT COMPLETED|Overall Study||21||
59887367|NCT03181958|76010022|FG002|NOT COMPLETED|Overall Study||15||
59887368|NCT03165110|76010030|FG000|STARTED|Overall Study||47||
59887369|NCT03165110|76010030|FG000|COMPLETED|Overall Study||46||
59887370|NCT03165110|76010030|FG000|NOT COMPLETED|Overall Study||1||
59887371|NCT00079781|76010037|FG000|STARTED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|45||
59887372|NCT00079781|76010038|FG001|STARTED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|10||
59887373|NCT00079781|76010039|FG002|STARTED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|15||
59887374|NCT00079781|76010037|FG000|COMPLETED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|42||
59887375|NCT00079781|76010038|FG001|COMPLETED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|9||
59887376|NCT00079781|76010039|FG002|COMPLETED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|14||
59887377|NCT00079781|76010037|FG000|NOT COMPLETED|Pre-implant Period||3||
59887378|NCT00079781|76010038|FG001|NOT COMPLETED|Pre-implant Period||1||
59609742|NCT01873950|75720542|FG000|NOT COMPLETED|Period 5||0||
59609743|NCT01873950|75720543|FG001|NOT COMPLETED|Period 5||0||
59887379|NCT00079781|76010039|FG002|NOT COMPLETED|Pre-implant Period||1||
59887380|NCT00079781|76010037|FG000|STARTED|Evaluation Period||42||
59887381|NCT00079781|76010038|FG001|STARTED|Evaluation Period||9||
59887382|NCT00079781|76010039|FG002|STARTED|Evaluation Period||14||
59887383|NCT00079781|76010037|FG000|COMPLETED|Evaluation Period||42||
59609744|NCT01873950|75720544|FG002|NOT COMPLETED|Period 5||0||
59609745|NCT01873950|75720545|FG003|NOT COMPLETED|Period 5||1||
59609746|NCT01873950|75720546|FG004|NOT COMPLETED|Period 5||0||
59609747|NCT01857102|75720560|FG000|STARTED|Period 1||58||
59609748|NCT01857102|75720561|FG001|STARTED|Period 1||56||
59609749|NCT01857102|75720560|FG000|Habitual Users|Period 1||51||
59887384|NCT00079781|76010038|FG001|COMPLETED|Evaluation Period||9||
60013637|NCT02475369|76129583|FG001|COMPLETED|Run-in Washout Period #1 (7 Days)||9||
59609750|NCT01857102|75720561|FG001|Habitual Users|Period 1||52||
59609751|NCT01857102|75720560|FG000|Neophtyes|Period 1||7||
59609752|NCT01857102|75720561|FG001|Neophtyes|Period 1||4||
59609753|NCT01857102|75720560|FG000|COMPLETED|Period 1||55||
59609754|NCT01857102|75720561|FG001|COMPLETED|Period 1||51||
59609755|NCT01857102|75720560|FG000|NOT COMPLETED|Period 1||3||
59609756|NCT01857102|75720561|FG001|NOT COMPLETED|Period 1||5||
59609757|NCT01857102|75720560|FG000|STARTED|Period 2||55||
59609758|NCT01857102|75720561|FG001|STARTED|Period 2||51||
59609759|NCT01857102|75720560|FG000|Habitual Users|Period 2||48||
59609760|NCT01857102|75720561|FG001|Habitual Users|Period 2||47||
59609761|NCT01857102|75720560|FG000|Neophytes|Period 2||7||
59609762|NCT01857102|75720561|FG001|Neophytes|Period 2||4||
59609763|NCT01857102|75720560|FG000|COMPLETED|Period 2||53||
59609764|NCT01857102|75720561|FG001|COMPLETED|Period 2||51||
59609765|NCT01857102|75720560|FG000|NOT COMPLETED|Period 2||2||
59609766|NCT01857102|75720561|FG001|NOT COMPLETED|Period 2||0||
59609767|NCT01872078|75720573|FG000|STARTED|Overall Study||16||
59609768|NCT01872078|75720574|FG001|STARTED|Overall Study||15||
59609769|NCT01872078|75720575|FG002|STARTED|Overall Study||17||
59609770|NCT01872078|75720576|FG003|STARTED|Overall Study||17||
59609771|NCT01872078|75720573|FG000|COMPLETED|Overall Study||16||
59609772|NCT01872078|75720574|FG001|COMPLETED|Overall Study||15||
59609773|NCT01872078|75720575|FG002|COMPLETED|Overall Study||14||
59609774|NCT01872078|75720576|FG003|COMPLETED|Overall Study||15||
59609775|NCT01872078|75720573|FG000|NOT COMPLETED|Overall Study||0||
59609776|NCT01872078|75720574|FG001|NOT COMPLETED|Overall Study||0||
59609777|NCT01872078|75720575|FG002|NOT COMPLETED|Overall Study||3||
59887385|NCT00079781|76010039|FG002|COMPLETED|Evaluation Period||14||
59887386|NCT00079781|76010037|FG000|NOT COMPLETED|Evaluation Period||0||
59887387|NCT00079781|76010038|FG001|NOT COMPLETED|Evaluation Period||0||
59887388|NCT00079781|76010039|FG002|NOT COMPLETED|Evaluation Period||0||
59887389|NCT00079781|76010037|FG000|STARTED|Follow-up Period||42||
59887390|NCT00079781|76010038|FG001|STARTED|Follow-up Period||9||
59887391|NCT00079781|76010039|FG002|STARTED|Follow-up Period||14||
59887392|NCT00079781|76010037|FG000|COMPLETED|Follow-up Period||38||
59887393|NCT00079781|76010038|FG001|COMPLETED|Follow-up Period||9||
59887394|NCT00079781|76010039|FG002|COMPLETED|Follow-up Period||12||
59887395|NCT00079781|76010037|FG000|NOT COMPLETED|Follow-up Period||4||
59887396|NCT00079781|76010038|FG001|NOT COMPLETED|Follow-up Period||0||
59887397|NCT00079781|76010039|FG002|NOT COMPLETED|Follow-up Period||2||
59887398|NCT03176966|76010047|FG000|STARTED|Baseline to 3 Months (1st Intervention)||14||
59887399|NCT03176966|76010048|FG001|STARTED|Baseline to 3 Months (1st Intervention)||16||
59887400|NCT03176966|76010047|FG000|COMPLETED|Baseline to 3 Months (1st Intervention)||10||
59887401|NCT03176966|76010048|FG001|COMPLETED|Baseline to 3 Months (1st Intervention)||9||
59887402|NCT03176966|76010047|FG000|NOT COMPLETED|Baseline to 3 Months (1st Intervention)||4||
59887403|NCT03176966|76010048|FG001|NOT COMPLETED|Baseline to 3 Months (1st Intervention)||7||
59887404|NCT03176966|76010047|FG000|STARTED|3 Month to 6 Months (2nd Intervention)||10||
59887405|NCT03176966|76010048|FG001|STARTED|3 Month to 6 Months (2nd Intervention)||9||
59887406|NCT03176966|76010047|FG000|COMPLETED|3 Month to 6 Months (2nd Intervention)||4||
59887407|NCT03176966|76010048|FG001|COMPLETED|3 Month to 6 Months (2nd Intervention)||4||
59887408|NCT03176966|76010047|FG000|NOT COMPLETED|3 Month to 6 Months (2nd Intervention)||6||
59887409|NCT03176966|76010048|FG001|NOT COMPLETED|3 Month to 6 Months (2nd Intervention)||5||
59887410|NCT03175562|76010054|FG000|STARTED|Overall Study||240||
59887411|NCT03175562|76010054|FG000|Test Product|Overall Study||240|All participants received both the study treatments in a single semi-occlusive patch.|
59887412|NCT03175562|76010054|FG000|Negative Control|Overall Study||240|All participants received both the study treatments in a single semi-occlusive patch.|
59887413|NCT03175562|76010054|FG000|COMPLETED|Overall Study||224||
59887414|NCT03175562|76010054|FG000|NOT COMPLETED|Overall Study||16||
59887415|NCT00079391|76010061|FG000|STARTED|Overall Study|1 of these withdrew after consent.|50||
59887416|NCT00079391|76010061|FG000|COMPLETED|Overall Study||49||
59887417|NCT00079391|76010061|FG000|NOT COMPLETED|Overall Study||1||
59887418|NCT03209570|76010069|FG000|STARTED|Overall Study||24||
59887419|NCT03209570|76010070|FG001|STARTED|Overall Study||25||
59609778|NCT01872078|75720576|FG003|NOT COMPLETED|Overall Study||2||
59609779|NCT01896726|75720586|FG000|STARTED|Treatment Period 1 (Days 1-22)||20||
59756198|NCT00607789|75875298|FG001|COMPLETED|Overall Study||14||
59756199|NCT00607789|75875297|FG000|NOT COMPLETED|Overall Study||7||
59756200|NCT00607789|75875298|FG001|NOT COMPLETED|Overall Study||6||
59756201|NCT00887822|75875306|FG000|STARTED|Overall Study||100||
59887420|NCT03209570|76010069|FG000|COMPLETED|Overall Study||14||
59887421|NCT03209570|76010070|FG001|COMPLETED|Overall Study||12||
59609780|NCT01896726|75720586|FG000|Received Microgynon|Treatment Period 1 (Days 1-22)||20||
59609781|NCT01896726|75720586|FG000|COMPLETED|Treatment Period 1 (Days 1-22)||20||
59609782|NCT01896726|75720586|FG000|NOT COMPLETED|Treatment Period 1 (Days 1-22)||0||
59609783|NCT01896726|75720586|FG000|STARTED|Treatment Period 2 (Days 23-31)||20||
59609784|NCT01896726|75720586|FG000|Received at Least 1 Dose of Baricitinib|Treatment Period 2 (Days 23-31)||20||
59756202|NCT00887822|75875307|FG001|STARTED|Overall Study||102||
59756203|NCT00887822|75875306|FG000|Treated (Safety Population)|Overall Study||100||
59756204|NCT00887822|75875307|FG001|Treated (Safety Population)|Overall Study||101||
59756205|NCT00887822|75875306|FG000|COMPLETED|Overall Study||3||
59756206|NCT00887822|75875307|FG001|COMPLETED|Overall Study||0||
59756207|NCT00887822|75875306|FG000|NOT COMPLETED|Overall Study||97||
59609785|NCT01896726|75720586|FG000|Received Microgynon|Treatment Period 2 (Days 23-31)||18||
59887422|NCT03209570|76010069|FG000|NOT COMPLETED|Overall Study||10||
59609786|NCT01896726|75720586|FG000|COMPLETED|Treatment Period 2 (Days 23-31)||18||
59609787|NCT01896726|75720586|FG000|NOT COMPLETED|Treatment Period 2 (Days 23-31)||2||
59609788|NCT01856790|75720593|FG000|STARTED|Closed Loop Control||15||
59609789|NCT01856790|75720593|FG000|COMPLETED|Closed Loop Control||13||
59609790|NCT01856790|75720593|FG000|NOT COMPLETED|Closed Loop Control||2||
59609791|NCT01856790|75720593|FG000|STARTED|Closed Loop Control + Liraglutide||13||
59609792|NCT01856790|75720593|FG000|COMPLETED|Closed Loop Control + Liraglutide||11||
59609793|NCT01856790|75720593|FG000|NOT COMPLETED|Closed Loop Control + Liraglutide||2||
59609794|NCT01856322|75720607|FG000|STARTED|Overall Study||0||
59609795|NCT01856322|75720608|FG001|STARTED|Overall Study||0||
59609796|NCT01856322|75720609|FG002|STARTED|Overall Study||3||
59609797|NCT01856322|75720607|FG000|COMPLETED|Overall Study||0||
59609798|NCT01856322|75720608|FG001|COMPLETED|Overall Study||0||
59609799|NCT01856322|75720609|FG002|COMPLETED|Overall Study||0||
59609800|NCT01856322|75720607|FG000|NOT COMPLETED|Overall Study||0||
59609801|NCT01856322|75720608|FG001|NOT COMPLETED|Overall Study||0||
59609802|NCT01856322|75720609|FG002|NOT COMPLETED|Overall Study||3||
59609803|NCT01896102|75720616|FG000|STARTED|Overall Study||32||
59609804|NCT01896102|75720616|FG000|COMPLETED|Overall Study||29||
59609805|NCT01896102|75720616|FG000|NOT COMPLETED|Overall Study||3||
59609806|NCT01871532|75720623|FG000|STARTED|Overall Study||12||
59609807|NCT01871532|75720624|FG001|STARTED|Overall Study||12||
59609808|NCT01871532|75720623|FG000|Subjects Received hCG Treatment|Overall Study||11||
59609809|NCT01871532|75720624|FG001|Subjects Received hCG Treatment|Overall Study||9||
59609810|NCT01871532|75720623|FG000|COMPLETED|Overall Study||11||
59609811|NCT01871532|75720624|FG001|COMPLETED|Overall Study||10||
59609812|NCT01871532|75720623|FG000|NOT COMPLETED|Overall Study||1||
59609813|NCT01871532|75720624|FG001|NOT COMPLETED|Overall Study||2||
59609814|NCT01855074|75720630|FG000|STARTED|Overall Study||80||
59609815|NCT01855074|75720630|FG000|Treated|Overall Study||79||
59609816|NCT01855074|75720630|FG000|COMPLETED|Overall Study||66||
59609817|NCT01855074|75720630|FG000|NOT COMPLETED|Overall Study||14||
59609818|NCT01871142|75720634|FG000|STARTED|Overall Study||12||
59609819|NCT01871142|75720634|FG000|Received Placebo + Normoixa|Overall Study||11||
59609820|NCT01871142|75720634|FG000|Received Placebo + Hypoxia|Overall Study||12||
59609821|NCT01871142|75720634|FG000|Received 1000mg Aes 103+ Hypoxia|Overall Study||11||
59609822|NCT01871142|75720634|FG000|Received 3000mg Aes-103 + Hypoxia|Overall Study||12||
59609823|NCT01871142|75720634|FG000|COMPLETED|Overall Study||11||
59609824|NCT01871142|75720634|FG000|NOT COMPLETED|Overall Study||1||
59756208|NCT00887822|75875307|FG001|NOT COMPLETED|Overall Study||102||
59756209|NCT00951665|75875319|FG000|STARTED|Phase 1b||29||
59756210|NCT00951665|75875320|FG001|STARTED|Phase 1b||10||
59756211|NCT00951665|75875321|FG002|STARTED|Phase 1b||21||
59756212|NCT00951665|75875322|FG003|STARTED|Phase 1b||3||
59756213|NCT00951665|75875323|FG004|STARTED|Phase 1b||0||
59756214|NCT00951665|75875324|FG005|STARTED|Phase 1b||0||
59756215|NCT00951665|75875319|FG000|Started Treatment|Phase 1b||26||
59756216|NCT00951665|75875320|FG001|Started Treatment|Phase 1b||10||
59756217|NCT00951665|75875321|FG002|Started Treatment|Phase 1b||21||
59756218|NCT00951665|75875322|FG003|Started Treatment|Phase 1b||3||
59756219|NCT00951665|75875323|FG004|Started Treatment|Phase 1b||0||
59756220|NCT00951665|75875324|FG005|Started Treatment|Phase 1b||0||
59756221|NCT00951665|75875319|FG000|COMPLETED|Phase 1b||7||
59756222|NCT00951665|75875320|FG001|COMPLETED|Phase 1b||6||
59756223|NCT00951665|75875321|FG002|COMPLETED|Phase 1b||4||
59756224|NCT00951665|75875322|FG003|COMPLETED|Phase 1b||2||
59756225|NCT00951665|75875323|FG004|COMPLETED|Phase 1b||0||
59756226|NCT00951665|75875324|FG005|COMPLETED|Phase 1b||0||
59756227|NCT00951665|75875319|FG000|NOT COMPLETED|Phase 1b||22||
59756228|NCT00951665|75875320|FG001|NOT COMPLETED|Phase 1b||4||
59756229|NCT00951665|75875321|FG002|NOT COMPLETED|Phase 1b||17||
59756230|NCT00951665|75875322|FG003|NOT COMPLETED|Phase 1b||1||
59756231|NCT00951665|75875323|FG004|NOT COMPLETED|Phase 1b||0||
59756232|NCT00951665|75875324|FG005|NOT COMPLETED|Phase 1b||0||
59609825|NCT01895322|75720648|FG000|STARTED|Overall Study||20||
59609826|NCT01895322|75720648|FG000|COMPLETED|Overall Study||7||
59609827|NCT01895322|75720648|FG000|NOT COMPLETED|Overall Study||13||
59609828|NCT01894776|75720653|FG000|STARTED|Overall Study||15||
59609829|NCT01894776|75720653|FG000|COMPLETED|Overall Study||14||
59609830|NCT01894776|75720653|FG000|NOT COMPLETED|Overall Study||1||
59756233|NCT00951665|75875319|FG000|STARTED|Phase 2a||0||
59756234|NCT00951665|75875320|FG001|STARTED|Phase 2a||0||
59756235|NCT00951665|75875321|FG002|STARTED|Phase 2a||0||
59609831|NCT01894620|75720659|FG000|STARTED|Overall Study||6||
59609832|NCT01894620|75720660|FG001|STARTED|Overall Study||5||
59609833|NCT01894620|75720659|FG000|COMPLETED|Overall Study||6||
59756236|NCT00951665|75875322|FG003|STARTED|Phase 2a||0||
59756237|NCT00951665|75875323|FG004|STARTED|Phase 2a||22||
59756238|NCT00951665|75875324|FG005|STARTED|Phase 2a||22||
59756239|NCT00951665|75875319|FG000|COMPLETED|Phase 2a||0||
59609834|NCT01894620|75720660|FG001|COMPLETED|Overall Study||4||
59609835|NCT01894620|75720659|FG000|NOT COMPLETED|Overall Study||0||
59609836|NCT01894620|75720660|FG001|NOT COMPLETED|Overall Study||1||
59609837|NCT01854918|75720670|FG000|STARTED|SOC-controlled Period (Year 1)||1227||
59756240|NCT00951665|75875320|FG001|COMPLETED|Phase 2a||0||
59756241|NCT00951665|75875321|FG002|COMPLETED|Phase 2a||0||
59887423|NCT03209570|76010070|FG001|NOT COMPLETED|Overall Study||13||
59887424|NCT03209492|76010076|FG000|STARTED|Overall Study||333||
59887425|NCT03209492|76010076|FG000|COMPLETED|Overall Study||328||
59887426|NCT03209492|76010076|FG000|NOT COMPLETED|Overall Study||5||
59887427|NCT03208244|76010080|FG000|STARTED|Overall Study||33||
59887428|NCT03208244|76010080|FG000|COMPLETED|Overall Study||32||
59887429|NCT03208244|76010080|FG000|NOT COMPLETED|Overall Study||1||
59887430|NCT03175172|76010084|FG000|STARTED|Overall Study||10||
59887431|NCT03175172|76010084|FG000|COMPLETED|Overall Study||0||
59887432|NCT03175172|76010084|FG000|NOT COMPLETED|Overall Study||10||
59887433|NCT03172364|76010090|FG000|STARTED|Overall Study||55||
59887434|NCT03172364|76010091|FG001|STARTED|Overall Study||58||
59887435|NCT03172364|76010090|FG000|COMPLETED|Overall Study||53||
59887436|NCT03172364|76010091|FG001|COMPLETED|Overall Study||57||
59887437|NCT03172364|76010090|FG000|NOT COMPLETED|Overall Study||2||
59887438|NCT03172364|76010091|FG001|NOT COMPLETED|Overall Study||1||
59887439|NCT00078767|76010099|FG000|STARTED|Overall Study||12||
59887440|NCT00078767|76010100|FG001|STARTED|Overall Study||12||
59887441|NCT00078767|76010099|FG000|COMPLETED|Overall Study||11||
59887442|NCT00078767|76010100|FG001|COMPLETED|Overall Study||11||
59887443|NCT00078767|76010099|FG000|NOT COMPLETED|Overall Study||1||
59887444|NCT00078767|76010100|FG001|NOT COMPLETED|Overall Study||1||
59887445|NCT03208088|76010106|FG000|STARTED|Period 1||10||
59887446|NCT03208088|76010107|FG001|STARTED|Period 1||9||
59887447|NCT03208088|76010108|FG002|STARTED|Period 1||10||
59887448|NCT03208088|76010109|FG003|STARTED|Period 1||9||
59887449|NCT03208088|76010110|FG004|STARTED|Period 1||9||
59887450|NCT03208088|76010111|FG005|STARTED|Period 1||9||
59887451|NCT03208088|76010112|FG006|STARTED|Period 1||8||
59887452|NCT03208088|76010113|FG007|STARTED|Period 1||10||
59887453|NCT03208088|76010114|FG008|STARTED|Period 1||8||
59887454|NCT03208088|76010115|FG009|STARTED|Period 1||9||
59887455|NCT03208088|76010106|FG000|COMPLETED|Period 1||10||
59887456|NCT03208088|76010107|FG001|COMPLETED|Period 1||9||
59887457|NCT03208088|76010108|FG002|COMPLETED|Period 1||10||
59887458|NCT03208088|76010109|FG003|COMPLETED|Period 1||9||
59887459|NCT03208088|76010110|FG004|COMPLETED|Period 1||9||
59887460|NCT03208088|76010111|FG005|COMPLETED|Period 1||9||
59887461|NCT03208088|76010112|FG006|COMPLETED|Period 1||8||
59887462|NCT03208088|76010113|FG007|COMPLETED|Period 1||10||
59887463|NCT03208088|76010114|FG008|COMPLETED|Period 1||8||
59887464|NCT03208088|76010115|FG009|COMPLETED|Period 1||9||
59887465|NCT03208088|76010106|FG000|NOT COMPLETED|Period 1||0||
59887466|NCT03208088|76010107|FG001|NOT COMPLETED|Period 1||0||
59887467|NCT03208088|76010108|FG002|NOT COMPLETED|Period 1||0||
59887468|NCT03208088|76010109|FG003|NOT COMPLETED|Period 1||0||
59505330|NCT00729677|75598043|FG000|STARTED|Overall Study||64||
59505331|NCT00729677|75598043|FG000|COMPLETED|Overall Study||64||
59505332|NCT00729677|75598043|FG000|NOT COMPLETED|Overall Study||0||
59505333|NCT00716963|75598054|FG000|STARTED|Overall Study||2||
59505334|NCT00716963|75598055|FG001|STARTED|Overall Study||1||
59505335|NCT00716963|75598056|FG002|STARTED|Overall Study||1||
59505336|NCT00716963|75598057|FG003|STARTED|Overall Study||1||
59505337|NCT00716963|75598058|FG004|STARTED|Overall Study||1||
59887469|NCT03208088|76010110|FG004|NOT COMPLETED|Period 1||0||
59887470|NCT03208088|76010111|FG005|NOT COMPLETED|Period 1||0||
59887471|NCT03208088|76010112|FG006|NOT COMPLETED|Period 1||0||
59887472|NCT03208088|76010113|FG007|NOT COMPLETED|Period 1||0||
59887473|NCT03208088|76010114|FG008|NOT COMPLETED|Period 1||0||
59887474|NCT03208088|76010115|FG009|NOT COMPLETED|Period 1||0||
59887475|NCT03208088|76010106|FG000|STARTED|Period 2||10||
59887476|NCT03208088|76010107|FG001|STARTED|Period 2||9||
59887477|NCT03208088|76010108|FG002|STARTED|Period 2||10||
59887478|NCT03208088|76010109|FG003|STARTED|Period 2||9||
59887479|NCT03208088|76010110|FG004|STARTED|Period 2||9||
59887480|NCT03208088|76010111|FG005|STARTED|Period 2||9||
59887481|NCT03208088|76010112|FG006|STARTED|Period 2||8||
59887482|NCT03208088|76010113|FG007|STARTED|Period 2||10||
59887483|NCT03208088|76010114|FG008|STARTED|Period 2||8||
59505338|NCT00716963|75598059|FG005|STARTED|Overall Study||1||
59505339|NCT00716963|75598054|FG000|COMPLETED|Overall Study||1||
59505340|NCT00716963|75598055|FG001|COMPLETED|Overall Study||1||
59505341|NCT00716963|75598056|FG002|COMPLETED|Overall Study||1||
59505342|NCT00716963|75598057|FG003|COMPLETED|Overall Study||1||
59505343|NCT00716963|75598058|FG004|COMPLETED|Overall Study||1||
59505344|NCT00716963|75598059|FG005|COMPLETED|Overall Study||1||
59505345|NCT00716963|75598054|FG000|NOT COMPLETED|Overall Study||1||
59887484|NCT03208088|76010115|FG009|STARTED|Period 2||9||
59887485|NCT03208088|76010106|FG000|COMPLETED|Period 2||10||
59887486|NCT03208088|76010107|FG001|COMPLETED|Period 2||9||
59887487|NCT03208088|76010108|FG002|COMPLETED|Period 2||10||
59887488|NCT03208088|76010109|FG003|COMPLETED|Period 2||9||
59887489|NCT03208088|76010110|FG004|COMPLETED|Period 2||9||
59887490|NCT03208088|76010111|FG005|COMPLETED|Period 2||9||
59887491|NCT03208088|76010112|FG006|COMPLETED|Period 2||8||
59887492|NCT03208088|76010113|FG007|COMPLETED|Period 2||10||
59887493|NCT03208088|76010114|FG008|COMPLETED|Period 2||7||
59887494|NCT03208088|76010115|FG009|COMPLETED|Period 2||9||
59887495|NCT03208088|76010106|FG000|NOT COMPLETED|Period 2||0||
59609838|NCT01854918|75720671|FG001|STARTED|SOC-controlled Period (Year 1)||2454||
59609839|NCT01854918|75720670|FG000|Received Evolocumab|SOC-controlled Period (Year 1)|5 participants received evolocumab in error|5||
59609840|NCT01854918|75720671|FG001|Received Evolocumab|SOC-controlled Period (Year 1)||2452||
59609841|NCT01854918|75720670|FG000|COMPLETED|SOC-controlled Period (Year 1)||1197||
59609842|NCT01854918|75720671|FG001|COMPLETED|SOC-controlled Period (Year 1)||2391||
59609843|NCT01854918|75720670|FG000|NOT COMPLETED|SOC-controlled Period (Year 1)||30||
59609844|NCT01854918|75720671|FG001|NOT COMPLETED|SOC-controlled Period (Year 1)||63||
59609845|NCT01854918|75720670|FG000|STARTED|All-IP Period (Years 2 and 3)||1197||
59609846|NCT01854918|75720671|FG001|STARTED|All-IP Period (Years 2 and 3)||2391||
59609847|NCT01854918|75720670|FG000|Received Evolocumab|All-IP Period (Years 2 and 3)||1152||
59609848|NCT01854918|75720671|FG001|Received Evolocumab|All-IP Period (Years 2 and 3)||2291||
59609849|NCT01854918|75720670|FG000|COMPLETED|All-IP Period (Years 2 and 3)||1079||
59609850|NCT01854918|75720671|FG001|COMPLETED|All-IP Period (Years 2 and 3)||2196||
59609851|NCT01854918|75720670|FG000|NOT COMPLETED|All-IP Period (Years 2 and 3)||118||
59609852|NCT01854918|75720671|FG001|NOT COMPLETED|All-IP Period (Years 2 and 3)||195||
59609853|NCT01894230|75720686|FG000|STARTED|Overall Study||83||
59609854|NCT01894230|75720687|FG001|STARTED|Overall Study||76||
59609855|NCT01894230|75720686|FG000|COMPLETED|Overall Study||76||
59609856|NCT01894230|75720687|FG001|COMPLETED|Overall Study||69||
59609857|NCT01894230|75720686|FG000|NOT COMPLETED|Overall Study||7||
59609858|NCT01894230|75720687|FG001|NOT COMPLETED|Overall Study||7||
59609859|NCT01894152|75720693|FG000|STARTED|Overall Study||2002||
59609860|NCT01894152|75720693|FG000|COMPLETED|Overall Study||1851||
59609861|NCT01894152|75720693|FG000|NOT COMPLETED|Overall Study||151||
59609862|NCT01854528|75720699|FG000|STARTED|Overall Study||101||
59609863|NCT01854528|75720700|FG001|STARTED|Overall Study||47||
59609864|NCT01854528|75720699|FG000|COMPLETED|Overall Study||101||
59609865|NCT01854528|75720700|FG001|COMPLETED|Overall Study||32||
59609866|NCT01854528|75720699|FG000|NOT COMPLETED|Overall Study||0||
59609867|NCT01854528|75720700|FG001|NOT COMPLETED|Overall Study||15||
59609868|NCT01853982|75720708|FG000|STARTED|Overall Study||2||
59609869|NCT01853982|75720709|FG001|STARTED|Overall Study||2||
59756242|NCT00951665|75875322|FG003|COMPLETED|Phase 2a||0||
59756243|NCT00951665|75875323|FG004|COMPLETED|Phase 2a||10||
59756244|NCT00951665|75875324|FG005|COMPLETED|Phase 2a||15||
59756245|NCT00951665|75875319|FG000|NOT COMPLETED|Phase 2a||0||
60013638|NCT02475369|76129582|FG000|NOT COMPLETED|Run-in Washout Period #1 (7 Days)||7||
60013639|NCT02475369|76129583|FG001|NOT COMPLETED|Run-in Washout Period #1 (7 Days)||2||
60013640|NCT02475369|76129582|FG000|STARTED|Treatment Period #1 (10 Days)||3||
60013641|NCT02475369|76129583|FG001|STARTED|Treatment Period #1 (10 Days)||9||
60013642|NCT02475369|76129582|FG000|COMPLETED|Treatment Period #1 (10 Days)||3||
60013643|NCT02475369|76129583|FG001|COMPLETED|Treatment Period #1 (10 Days)||9||
60013644|NCT02475369|76129582|FG000|NOT COMPLETED|Treatment Period #1 (10 Days)||0||
60013645|NCT02475369|76129583|FG001|NOT COMPLETED|Treatment Period #1 (10 Days)||0||
59505346|NCT00716963|75598055|FG001|NOT COMPLETED|Overall Study||0||
59505347|NCT00716963|75598056|FG002|NOT COMPLETED|Overall Study||0||
59505348|NCT00716963|75598057|FG003|NOT COMPLETED|Overall Study||0||
59505349|NCT00716963|75598058|FG004|NOT COMPLETED|Overall Study||0||
59505350|NCT00716963|75598059|FG005|NOT COMPLETED|Overall Study||0||
59505351|NCT00717041|75598067|FG000|STARTED|Overall Study||1206||
59505352|NCT00717041|75598067|FG000|COMPLETED|Overall Study||1206||
59505353|NCT00717041|75598067|FG000|NOT COMPLETED|Overall Study||0||
59505354|NCT01278745|75598075|FG000|STARTED|Overall Study||89||
59505355|NCT01278745|75598076|FG001|STARTED|Overall Study||74||
59505356|NCT01278745|75598077|FG002|STARTED|Overall Study||121||
59505357|NCT01278745|75598078|FG003|STARTED|Overall Study||78||
59505358|NCT01278745|75598075|FG000|COMPLETED|Overall Study||84||
59505359|NCT01278745|75598076|FG001|COMPLETED|Overall Study||68||
59505360|NCT01278745|75598077|FG002|COMPLETED|Overall Study||0||
59505361|NCT01278745|75598078|FG003|COMPLETED|Overall Study||0||
59505362|NCT01278745|75598075|FG000|NOT COMPLETED|Overall Study||5||
59505363|NCT01278745|75598076|FG001|NOT COMPLETED|Overall Study||6||
59505364|NCT01278745|75598077|FG002|NOT COMPLETED|Overall Study||121||
59505365|NCT01278745|75598078|FG003|NOT COMPLETED|Overall Study||78||
59505366|NCT00748657|75598086|FG000|STARTED|Overall Study||36||
59505367|NCT00748657|75598086|FG000|COMPLETED|Overall Study||36||
59609870|NCT01853982|75720708|FG000|Received at Least 1 Dose of Study Drug|Overall Study||2||
59609871|NCT01853982|75720709|FG001|Received at Least 1 Dose of Study Drug|Overall Study||2||
59609872|NCT01853982|75720708|FG000|COMPLETED|Overall Study||0||
59756246|NCT00951665|75875320|FG001|NOT COMPLETED|Phase 2a||0||
59756247|NCT00951665|75875321|FG002|NOT COMPLETED|Phase 2a||0||
59756248|NCT00951665|75875322|FG003|NOT COMPLETED|Phase 2a||0||
59756249|NCT00951665|75875323|FG004|NOT COMPLETED|Phase 2a||12||
59756250|NCT00951665|75875324|FG005|NOT COMPLETED|Phase 2a||7||
59609873|NCT01853982|75720709|FG001|COMPLETED|Overall Study||1||
59609874|NCT01853982|75720708|FG000|NOT COMPLETED|Overall Study||2||
59609875|NCT01853982|75720709|FG001|NOT COMPLETED|Overall Study||1||
59609876|NCT01853280|75720717|FG000|STARTED|Overall Study||22||
59609877|NCT01853280|75720718|FG001|STARTED|Overall Study||22||
59609878|NCT01853280|75720717|FG000|COMPLETED|Overall Study||20||
59609879|NCT01853280|75720718|FG001|COMPLETED|Overall Study||16||
59609880|NCT01853280|75720717|FG000|NOT COMPLETED|Overall Study||2||
59609881|NCT01853280|75720718|FG001|NOT COMPLETED|Overall Study||6||
59609882|NCT01892436|75720728|FG000|STARTED|Overall Study||147||
59609883|NCT01892436|75720729|FG001|STARTED|Overall Study||161||
59609884|NCT01892436|75720730|FG002|STARTED|Overall Study||74||
59609885|NCT01892436|75720731|FG003|STARTED|Overall Study||75||
59609886|NCT01892436|75720728|FG000|COMPLETED|Overall Study||124||
59609887|NCT01892436|75720729|FG001|COMPLETED|Overall Study||132||
59609888|NCT01892436|75720730|FG002|COMPLETED|Overall Study||63||
59609889|NCT01892436|75720731|FG003|COMPLETED|Overall Study||61||
59609890|NCT01892436|75720728|FG000|NOT COMPLETED|Overall Study||23||
60013646|NCT02475369|76129582|FG000|STARTED|Run-in Washout Period #2 (7 Days)||3||
60013647|NCT02475369|76129583|FG001|STARTED|Run-in Washout Period #2 (7 Days)||9||
60013648|NCT02475369|76129582|FG000|COMPLETED|Run-in Washout Period #2 (7 Days)||3||
60013649|NCT02475369|76129583|FG001|COMPLETED|Run-in Washout Period #2 (7 Days)||9||
60013650|NCT02475369|76129582|FG000|NOT COMPLETED|Run-in Washout Period #2 (7 Days)||0||
60013651|NCT02475369|76129583|FG001|NOT COMPLETED|Run-in Washout Period #2 (7 Days)||0||
59609891|NCT01892436|75720729|FG001|NOT COMPLETED|Overall Study||29||
59609892|NCT01892436|75720730|FG002|NOT COMPLETED|Overall Study||11||
59609893|NCT01892436|75720731|FG003|NOT COMPLETED|Overall Study||14||
59609894|NCT01853046|75720743|FG000|STARTED|Overall Study||18||
59609895|NCT01853046|75720744|FG001|STARTED|Overall Study||6||
59609896|NCT01853046|75720743|FG000|Received Treatment|Overall Study||18||
59609897|NCT01853046|75720744|FG001|Received Treatment|Overall Study||6||
59609898|NCT01853046|75720743|FG000|COMPLETED|Overall Study||0||
59609899|NCT01853046|75720744|FG001|COMPLETED|Overall Study||0||
59609900|NCT01853046|75720743|FG000|NOT COMPLETED|Overall Study||18||
59609901|NCT01853046|75720744|FG001|NOT COMPLETED|Overall Study||6||
59609902|NCT01891890|75720754|FG000|STARTED|Overall Study||24||
59609903|NCT01891890|75720755|FG001|STARTED|Overall Study||27||
59609904|NCT01891890|75720756|FG002|STARTED|Overall Study||21||
59609905|NCT01891890|75720754|FG000|COMPLETED|Overall Study||17||
59609906|NCT01891890|75720755|FG001|COMPLETED|Overall Study||24||
59609907|NCT01891890|75720756|FG002|COMPLETED|Overall Study||14||
59609908|NCT01891890|75720754|FG000|NOT COMPLETED|Overall Study||7||
59609909|NCT01891890|75720755|FG001|NOT COMPLETED|Overall Study||3||
59609910|NCT01891890|75720756|FG002|NOT COMPLETED|Overall Study||7||
59609911|NCT01852812|75720767|FG000|STARTED|Overall Study||51||
59609912|NCT01852812|75720768|FG001|STARTED|Overall Study||18||
59609913|NCT01852812|75720769|FG002|STARTED|Overall Study||18||
59609914|NCT01852812|75720767|FG000|COMPLETED|Overall Study||51||
59609915|NCT01852812|75720768|FG001|COMPLETED|Overall Study||17||
59609916|NCT01852812|75720769|FG002|COMPLETED|Overall Study||17||
59609917|NCT01852812|75720767|FG000|NOT COMPLETED|Overall Study||0||
59609918|NCT01852812|75720768|FG001|NOT COMPLETED|Overall Study||1||
59609919|NCT01852812|75720769|FG002|NOT COMPLETED|Overall Study||1||
59609920|NCT01869348|75720779|FG000|STARTED|Overall Study||20||
59609921|NCT01869348|75720780|FG001|STARTED|Overall Study||20||
59609922|NCT01869348|75720779|FG000|COMPLETED|Overall Study||19||
59609923|NCT01869348|75720780|FG001|COMPLETED|Overall Study||19||
59609924|NCT01869348|75720779|FG000|NOT COMPLETED|Overall Study||1||
59609925|NCT01869348|75720780|FG001|NOT COMPLETED|Overall Study||1||
59609926|NCT01869192|75720788|FG000|STARTED|Preoperative Chemotherapy to Surgery||37||
59609927|NCT01869192|75720789|FG001|STARTED|Preoperative Chemotherapy to Surgery||35||
59609928|NCT01869192|75720788|FG000|COMPLETED|Preoperative Chemotherapy to Surgery||35|2 did not go to surgery|
59609929|NCT01869192|75720789|FG001|COMPLETED|Preoperative Chemotherapy to Surgery|one never got treatment on study|34|2 did not go to surgery|
59609930|NCT01869192|75720788|FG000|NOT COMPLETED|Preoperative Chemotherapy to Surgery||2||
59609931|NCT01869192|75720789|FG001|NOT COMPLETED|Preoperative Chemotherapy to Surgery||1||
59609932|NCT01869192|75720788|FG000|STARTED|Postoperative Chemotherapy|3 did not start postop chemotherapy|32||
59609933|NCT01869192|75720789|FG001|STARTED|Postoperative Chemotherapy||33||
59609934|NCT01869192|75720788|FG000|COMPLETED|Postoperative Chemotherapy||32||
59609935|NCT01869192|75720789|FG001|COMPLETED|Postoperative Chemotherapy||31||
59609936|NCT01869192|75720788|FG000|NOT COMPLETED|Postoperative Chemotherapy||0||
60013652|NCT02475369|76129582|FG000|STARTED|Treatment Period #2 (10 Days)||3||
59609937|NCT01869192|75720789|FG001|NOT COMPLETED|Postoperative Chemotherapy||2||
59609938|NCT01868646|75720797|FG000|STARTED|Overall Study||76||
59609939|NCT01868646|75720798|FG001|STARTED|Overall Study||72||
60013653|NCT02475369|76129583|FG001|STARTED|Treatment Period #2 (10 Days)||9||
59609940|NCT01868646|75720797|FG000|COMPLETED|Overall Study||73||
59609941|NCT01868646|75720798|FG001|COMPLETED|Overall Study||67||
59609942|NCT01868646|75720797|FG000|NOT COMPLETED|Overall Study||3||
59609943|NCT01868646|75720798|FG001|NOT COMPLETED|Overall Study||5||
59609944|NCT01852110|75720806|FG000|STARTED|Overall Study||120||
59609945|NCT01852110|75720807|FG001|STARTED|Overall Study||120||
59609946|NCT01852110|75720808|FG002|STARTED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0||
59609947|NCT01852110|75720809|FG003|STARTED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0||
59609948|NCT01852110|75720810|FG004|STARTED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0||
59609949|NCT01852110|75720811|FG005|STARTED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0||
59609950|NCT01852110|75720806|FG000|Treated|Overall Study||119||
59609951|NCT01852110|75720807|FG001|Treated|Overall Study||120||
59609952|NCT01852110|75720808|FG002|Treated|Overall Study||0||
59609953|NCT01852110|75720809|FG003|Treated|Overall Study||0||
59609954|NCT01852110|75720810|FG004|Treated|Overall Study||0||
59609955|NCT01852110|75720811|FG005|Treated|Overall Study||0||
59609956|NCT01852110|75720806|FG000|COMPLETED|Overall Study||70||
59609957|NCT01852110|75720807|FG001|COMPLETED|Overall Study||74||
59609958|NCT01852110|75720808|FG002|COMPLETED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0||
59609959|NCT01852110|75720809|FG003|COMPLETED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0||
59609960|NCT01852110|75720810|FG004|COMPLETED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0||
59609961|NCT01852110|75720811|FG005|COMPLETED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0||
59609962|NCT01852110|75720806|FG000|NOT COMPLETED|Overall Study||50||
59609963|NCT01852110|75720807|FG001|NOT COMPLETED|Overall Study||46||
59609964|NCT01852110|75720808|FG002|NOT COMPLETED|Overall Study||0||
59609965|NCT01852110|75720809|FG003|NOT COMPLETED|Overall Study||0||
59609966|NCT01852110|75720810|FG004|NOT COMPLETED|Overall Study||0||
59609967|NCT01852110|75720811|FG005|NOT COMPLETED|Overall Study||0||
59609968|NCT01851720|75720827|FG000|STARTED|Overall Study||0||
59609969|NCT01851720|75720828|FG001|STARTED|Overall Study||1||
59609970|NCT01851720|75720827|FG000|COMPLETED|Overall Study||0||
59609971|NCT01851720|75720828|FG001|COMPLETED|Overall Study||0||
59609972|NCT01851720|75720827|FG000|NOT COMPLETED|Overall Study||0||
59609973|NCT01851720|75720828|FG001|NOT COMPLETED|Overall Study||1||
59609974|NCT01851330|75720837|FG000|STARTED|Overall Study||215||
59609975|NCT01851330|75720838|FG001|STARTED|Overall Study||216||
59609976|NCT01851330|75720839|FG002|STARTED|Overall Study||216||
59609977|NCT01851330|75720837|FG000|COMPLETED|Overall Study||202||
59609978|NCT01851330|75720838|FG001|COMPLETED|Overall Study||200||
59609979|NCT01851330|75720839|FG002|COMPLETED|Overall Study||204||
59609980|NCT01851330|75720837|FG000|NOT COMPLETED|Overall Study||13||
59609981|NCT01851330|75720838|FG001|NOT COMPLETED|Overall Study||16||
59609982|NCT01851330|75720839|FG002|NOT COMPLETED|Overall Study||12||
59609983|NCT01868022|75720856|FG000|STARTED|Overall Study||3||
59609984|NCT01868022|75720857|FG001|STARTED|Overall Study||3||
59609985|NCT01868022|75720858|FG002|STARTED|Overall Study||14||
59609986|NCT01868022|75720859|FG003|STARTED|Overall Study||3||
59609987|NCT01868022|75720860|FG004|STARTED|Overall Study||3||
59609988|NCT01868022|75720861|FG005|STARTED|Overall Study||3||
59609989|NCT01868022|75720862|FG006|STARTED|Overall Study||3||
59609990|NCT01868022|75720863|FG007|STARTED|Overall Study||25||
59609991|NCT01868022|75720864|FG008|STARTED|Overall Study||8||
59609992|NCT01868022|75720856|FG000|COMPLETED|Overall Study||3||
59609993|NCT01868022|75720857|FG001|COMPLETED|Overall Study||3||
59609994|NCT01868022|75720858|FG002|COMPLETED|Overall Study||13||
59609995|NCT01868022|75720859|FG003|COMPLETED|Overall Study||2||
59609996|NCT01868022|75720860|FG004|COMPLETED|Overall Study||1||
59609997|NCT01868022|75720861|FG005|COMPLETED|Overall Study||2||
59609998|NCT01868022|75720862|FG006|COMPLETED|Overall Study||3||
59609999|NCT01868022|75720863|FG007|COMPLETED|Overall Study||16||
59610000|NCT01868022|75720864|FG008|COMPLETED|Overall Study||6||
59610001|NCT01868022|75720856|FG000|NOT COMPLETED|Overall Study||0||
59610002|NCT01868022|75720857|FG001|NOT COMPLETED|Overall Study||0||
59610003|NCT01868022|75720858|FG002|NOT COMPLETED|Overall Study||1||
59610004|NCT01868022|75720859|FG003|NOT COMPLETED|Overall Study||1||
59610005|NCT01868022|75720860|FG004|NOT COMPLETED|Overall Study||2||
59756251|NCT00801099|75875358|FG000|STARTED|Overall Study||276||
59756252|NCT00801099|75875358|FG000|COMPLETED|Overall Study||175||
59756253|NCT00801099|75875358|FG000|NOT COMPLETED|Overall Study||101||
59756254|NCT00887744|75875362|FG000|STARTED|Overall Study|162 patients signed an informed consent but only 157 patients were treated with the Aperius.|162||
59756255|NCT00887744|75875362|FG000|COMPLETED|Overall Study||128||
59756256|NCT00887744|75875362|FG000|NOT COMPLETED|Overall Study||34||
59756257|NCT00951509|75875366|FG000|STARTED|Overall Study||31||
59887496|NCT03208088|76010107|FG001|NOT COMPLETED|Period 2||0||
59610006|NCT01868022|75720861|FG005|NOT COMPLETED|Overall Study||1||
59610007|NCT01868022|75720862|FG006|NOT COMPLETED|Overall Study||0||
59610008|NCT01868022|75720863|FG007|NOT COMPLETED|Overall Study||9||
59610009|NCT01868022|75720864|FG008|NOT COMPLETED|Overall Study||2||
59610010|NCT01850004|75720890|FG000|STARTED|Overall Study||84||
59610011|NCT01850004|75720890|FG000|Restart Treatment|Overall Study||47|Restarted treatment due to failure to maintain MMR levels of BCL-ABL|
59610012|NCT01850004|75720890|FG000|Discontinued Study Treatment After Restart|Overall Study||47||
59610013|NCT01850004|75720890|FG000|COMPLETED|Overall Study||60|Completed study|
59610014|NCT01850004|75720890|FG000|NOT COMPLETED|Overall Study||24||
59610015|NCT01867710|75720898|FG000|STARTED|Overall Study||41||
59610016|NCT01867710|75720899|FG001|STARTED|Overall Study||41||
59610017|NCT01867710|75720900|FG002|STARTED|Overall Study||40||
59610018|NCT01867710|75720901|FG003|STARTED|Overall Study||42||
59610019|NCT01867710|75720898|FG000|Treated|Overall Study||41||
59610020|NCT01867710|75720899|FG001|Treated|Overall Study||41||
59610021|NCT01867710|75720900|FG002|Treated|Overall Study||39||
59610022|NCT01867710|75720901|FG003|Treated|Overall Study||42||
59610023|NCT01867710|75720898|FG000|COMPLETED|Overall Study||0||
59610024|NCT01867710|75720899|FG001|COMPLETED|Overall Study||0||
59610025|NCT01867710|75720900|FG002|COMPLETED|Overall Study||0||
59610026|NCT01867710|75720901|FG003|COMPLETED|Overall Study||0||
59610027|NCT01867710|75720898|FG000|NOT COMPLETED|Overall Study||41||
59610028|NCT01867710|75720899|FG001|NOT COMPLETED|Overall Study||41||
59610029|NCT01867710|75720900|FG002|NOT COMPLETED|Overall Study||40||
59610030|NCT01867710|75720901|FG003|NOT COMPLETED|Overall Study||42||
59610031|NCT01849848|75720911|FG000|STARTED|Overall Study||17||
59610032|NCT01849848|75720911|FG000|COMPLETED|Overall Study||13||
59610033|NCT01849848|75720911|FG000|NOT COMPLETED|Overall Study||4||
59610034|NCT01849458|75720915|FG000|STARTED|Overall Study||50||50
59610035|NCT01849458|75720915|FG000|6 Months Follow-up|Overall Study||50||50
59610036|NCT01849458|75720915|FG000|COMPLETED|Overall Study||46||46
59610037|NCT01849458|75720915|FG000|NOT COMPLETED|Overall Study||4||4
59610038|NCT01832766|75720919|FG000|STARTED|First Intervention||7||
59610039|NCT01832766|75720920|FG001|STARTED|First Intervention||6||
59610040|NCT01832766|75720919|FG000|COMPLETED|First Intervention||7||
59610041|NCT01832766|75720920|FG001|COMPLETED|First Intervention|one participant did not return for cross over visit|6||
59610042|NCT01832766|75720919|FG000|NOT COMPLETED|First Intervention||0||
59610043|NCT01832766|75720920|FG001|NOT COMPLETED|First Intervention||0||
59610044|NCT01832766|75720919|FG000|STARTED|Washout||7||
59610045|NCT01832766|75720920|FG001|STARTED|Washout||6||
59610046|NCT01832766|75720919|FG000|COMPLETED|Washout||7||
59610047|NCT01832766|75720920|FG001|COMPLETED|Washout||5||
59610048|NCT01832766|75720919|FG000|NOT COMPLETED|Washout||0||
59887497|NCT03208088|76010108|FG002|NOT COMPLETED|Period 2||0||
59887498|NCT03208088|76010109|FG003|NOT COMPLETED|Period 2||0||
59887499|NCT03208088|76010110|FG004|NOT COMPLETED|Period 2||0||
59610049|NCT01832766|75720920|FG001|NOT COMPLETED|Washout||1||
59610050|NCT01832766|75720919|FG000|STARTED|Second Intervention||7||
59610051|NCT01832766|75720920|FG001|STARTED|Second Intervention||5||
59610052|NCT01832766|75720919|FG000|COMPLETED|Second Intervention||7||
59610053|NCT01832766|75720920|FG001|COMPLETED|Second Intervention||5||
59610054|NCT01832766|75720919|FG000|NOT COMPLETED|Second Intervention||0||
59610055|NCT01832766|75720920|FG001|NOT COMPLETED|Second Intervention||0||
59610056|NCT01832532|75720928|FG000|STARTED|Overall Study||23||
59610057|NCT01832532|75720929|FG001|STARTED|Overall Study||11||
59610058|NCT01832532|75720928|FG000|COMPLETED|Overall Study||18||
59610059|NCT01832532|75720929|FG001|COMPLETED|Overall Study||9||
59610060|NCT01832532|75720928|FG000|NOT COMPLETED|Overall Study||5||
59610061|NCT01832532|75720929|FG001|NOT COMPLETED|Overall Study||2||
59610062|NCT01848990|75720938|FG000|STARTED|Overall Study||227||
59610063|NCT01848990|75720939|FG001|STARTED|Overall Study||115||
59610064|NCT01848990|75720940|FG002|STARTED|Overall Study|One participant was randomized and withdrew consent before start of study treatment.|114||
59610065|NCT01848990|75720938|FG000|Received at Least 1 Dose of Study Drug|Overall Study||227||
59610066|NCT01848990|75720939|FG001|Received at Least 1 Dose of Study Drug|Overall Study||115||
59756258|NCT00951509|75875366|FG000|Driving Condition 1|Overall Study||29||
59610067|NCT01848990|75720940|FG002|Received at Least 1 Dose of Study Drug|Overall Study||113||
59756259|NCT00951509|75875366|FG000|Driving Condition 2|Overall Study||29||
59756260|NCT00951509|75875366|FG000|Driving Condition 3|Overall Study||25||
59756261|NCT00951509|75875366|FG000|Driving Condition 4|Overall Study||28||
59756262|NCT00951509|75875366|FG000|Driving Condition 5|Overall Study||30||
59756263|NCT00951509|75875366|FG000|COMPLETED|Overall Study||29||
59756264|NCT00951509|75875366|FG000|NOT COMPLETED|Overall Study||2||
59756265|NCT00610441|75875378|FG000|STARTED|Treatment Period 1 - 3 Weeks||15||
59756266|NCT00610441|75875379|FG001|STARTED|Treatment Period 1 - 3 Weeks||16||
59756267|NCT00610441|75875380|FG002|STARTED|Treatment Period 1 - 3 Weeks||18||
59756268|NCT00610441|75875381|FG003|STARTED|Treatment Period 1 - 3 Weeks||18||
59756269|NCT00610441|75875378|FG000|COMPLETED|Treatment Period 1 - 3 Weeks||12||
59756270|NCT00610441|75875379|FG001|COMPLETED|Treatment Period 1 - 3 Weeks||14||
59756271|NCT00610441|75875380|FG002|COMPLETED|Treatment Period 1 - 3 Weeks||11||
59756272|NCT00610441|75875381|FG003|COMPLETED|Treatment Period 1 - 3 Weeks||16||
59756273|NCT00610441|75875378|FG000|NOT COMPLETED|Treatment Period 1 - 3 Weeks||3||
59887500|NCT03208088|76010111|FG005|NOT COMPLETED|Period 2||0||
59887501|NCT03208088|76010112|FG006|NOT COMPLETED|Period 2||0||
59610068|NCT01848990|75720938|FG000|Completed Month 6|Overall Study||194||
59610069|NCT01848990|75720939|FG001|Completed Month 6|Overall Study||106||
59610070|NCT01848990|75720940|FG002|Completed Month 6|Overall Study||103||
59610071|NCT01848990|75720938|FG000|COMPLETED|Overall Study||181||
59610072|NCT01848990|75720939|FG001|COMPLETED|Overall Study||95||
59610073|NCT01848990|75720940|FG002|COMPLETED|Overall Study||98||
59756274|NCT00610441|75875379|FG001|NOT COMPLETED|Treatment Period 1 - 3 Weeks||2||
59610074|NCT01848990|75720938|FG000|NOT COMPLETED|Overall Study||46||
59610075|NCT01848990|75720939|FG001|NOT COMPLETED|Overall Study||20||
59610076|NCT01848990|75720940|FG002|NOT COMPLETED|Overall Study||16||
59887502|NCT03208088|76010113|FG007|NOT COMPLETED|Period 2||0||
59887503|NCT03208088|76010114|FG008|NOT COMPLETED|Period 2||1||
59887504|NCT03208088|76010115|FG009|NOT COMPLETED|Period 2||0||
59887505|NCT03208088|76010106|FG000|STARTED|Period 3||10||
59887506|NCT03208088|76010107|FG001|STARTED|Period 3||9||
59887507|NCT03208088|76010108|FG002|STARTED|Period 3||10||
59887508|NCT03208088|76010109|FG003|STARTED|Period 3||9||
59887509|NCT03208088|76010110|FG004|STARTED|Period 3||9||
59887510|NCT03208088|76010111|FG005|STARTED|Period 3||9||
59887511|NCT03208088|76010112|FG006|STARTED|Period 3||8||
59887512|NCT03208088|76010113|FG007|STARTED|Period 3||10||
59887513|NCT03208088|76010114|FG008|STARTED|Period 3||7||
59887514|NCT03208088|76010115|FG009|STARTED|Period 3||9||
59887515|NCT03208088|76010106|FG000|COMPLETED|Period 3||10||
59887516|NCT03208088|76010107|FG001|COMPLETED|Period 3||9||
59887517|NCT03208088|76010108|FG002|COMPLETED|Period 3||10||
59887518|NCT03208088|76010109|FG003|COMPLETED|Period 3||8||
59887519|NCT03208088|76010110|FG004|COMPLETED|Period 3||9||
59887520|NCT03208088|76010111|FG005|COMPLETED|Period 3||9||
59887521|NCT03208088|76010112|FG006|COMPLETED|Period 3||8||
59887522|NCT03208088|76010113|FG007|COMPLETED|Period 3||10||
59887523|NCT03208088|76010114|FG008|COMPLETED|Period 3||7||
59887524|NCT03208088|76010115|FG009|COMPLETED|Period 3||9||
59887525|NCT03208088|76010106|FG000|NOT COMPLETED|Period 3||0||
59887526|NCT03208088|76010107|FG001|NOT COMPLETED|Period 3||0||
59887527|NCT03208088|76010108|FG002|NOT COMPLETED|Period 3||0||
59887528|NCT03208088|76010109|FG003|NOT COMPLETED|Period 3||1||
59887529|NCT03208088|76010110|FG004|NOT COMPLETED|Period 3||0||
59887530|NCT03208088|76010111|FG005|NOT COMPLETED|Period 3||0||
59887531|NCT03208088|76010112|FG006|NOT COMPLETED|Period 3||0||
59887532|NCT03208088|76010113|FG007|NOT COMPLETED|Period 3||0||
59887533|NCT03208088|76010114|FG008|NOT COMPLETED|Period 3||0||
59887534|NCT03208088|76010115|FG009|NOT COMPLETED|Period 3||0||
59887535|NCT03208088|76010106|FG000|STARTED|Period 4||10||
59887536|NCT03208088|76010107|FG001|STARTED|Period 4||9||
59887537|NCT03208088|76010108|FG002|STARTED|Period 4||10||
59887538|NCT03208088|76010109|FG003|STARTED|Period 4||8||
59887539|NCT03208088|76010110|FG004|STARTED|Period 4||9||
59887540|NCT03208088|76010111|FG005|STARTED|Period 4||9||
59887541|NCT03208088|76010112|FG006|STARTED|Period 4||8||
59887542|NCT03208088|76010113|FG007|STARTED|Period 4||10||
59887543|NCT03208088|76010114|FG008|STARTED|Period 4||7||
59887544|NCT03208088|76010115|FG009|STARTED|Period 4||9||
59887545|NCT03208088|76010106|FG000|COMPLETED|Period 4||10||
59887546|NCT03208088|76010107|FG001|COMPLETED|Period 4||9||
59887547|NCT03208088|76010108|FG002|COMPLETED|Period 4||10||
59887548|NCT03208088|76010109|FG003|COMPLETED|Period 4||7||
59887549|NCT03208088|76010110|FG004|COMPLETED|Period 4||9||
59887550|NCT03208088|76010111|FG005|COMPLETED|Period 4||9||
59887551|NCT03208088|76010112|FG006|COMPLETED|Period 4||8||
59887552|NCT03208088|76010113|FG007|COMPLETED|Period 4||10||
59887553|NCT03208088|76010114|FG008|COMPLETED|Period 4||7||
59887554|NCT03208088|76010115|FG009|COMPLETED|Period 4||9||
59887555|NCT03208088|76010106|FG000|NOT COMPLETED|Period 4||0||
59887556|NCT03208088|76010107|FG001|NOT COMPLETED|Period 4||0||
59887557|NCT03208088|76010108|FG002|NOT COMPLETED|Period 4||0||
59887558|NCT03208088|76010109|FG003|NOT COMPLETED|Period 4||1||
59610077|NCT01867086|75720952|FG000|STARTED|Overall Study||1||
59610078|NCT01867086|75720952|FG000|COMPLETED|Overall Study|"Completed means subject had been given all manufactured doses."|0||
59610079|NCT01867086|75720952|FG000|NOT COMPLETED|Overall Study||1||
59610080|NCT01831596|75720956|FG000|STARTED|Overall Study||59||
59610081|NCT01831596|75720956|FG000|COMPLETED|Overall Study||51||
59887559|NCT03208088|76010110|FG004|NOT COMPLETED|Period 4||0||
59887560|NCT03208088|76010111|FG005|NOT COMPLETED|Period 4||0||
59887561|NCT03208088|76010112|FG006|NOT COMPLETED|Period 4||0||
59887562|NCT03208088|76010113|FG007|NOT COMPLETED|Period 4||0||
59887563|NCT03208088|76010114|FG008|NOT COMPLETED|Period 4||0||
59887564|NCT03208088|76010115|FG009|NOT COMPLETED|Period 4||0||
59887565|NCT03208088|76010106|FG000|STARTED|Period 5||10||
59887566|NCT03208088|76010107|FG001|STARTED|Period 5||9||
59887567|NCT03208088|76010108|FG002|STARTED|Period 5||10||
59887568|NCT03208088|76010109|FG003|STARTED|Period 5||7||
59887569|NCT03208088|76010110|FG004|STARTED|Period 5||9||
59887570|NCT03208088|76010111|FG005|STARTED|Period 5||9||
59887571|NCT03208088|76010112|FG006|STARTED|Period 5||8||
59887572|NCT03208088|76010113|FG007|STARTED|Period 5||10||
59887573|NCT03208088|76010114|FG008|STARTED|Period 5||7||
59887574|NCT03208088|76010115|FG009|STARTED|Period 5||9||
59887575|NCT03208088|76010106|FG000|COMPLETED|Period 5||10||
59887576|NCT03208088|76010107|FG001|COMPLETED|Period 5||9||
59887577|NCT03208088|76010108|FG002|COMPLETED|Period 5||10||
59887578|NCT03208088|76010109|FG003|COMPLETED|Period 5||7||
59887579|NCT03208088|76010110|FG004|COMPLETED|Period 5||9||
59887580|NCT03208088|76010111|FG005|COMPLETED|Period 5||9||
59887581|NCT03208088|76010112|FG006|COMPLETED|Period 5||8||
59887582|NCT03208088|76010113|FG007|COMPLETED|Period 5||10||
59887583|NCT03208088|76010114|FG008|COMPLETED|Period 5||7||
59887584|NCT03208088|76010115|FG009|COMPLETED|Period 5||9||
59887585|NCT03208088|76010106|FG000|NOT COMPLETED|Period 5||0||
59887586|NCT03208088|76010107|FG001|NOT COMPLETED|Period 5||0||
59887587|NCT03208088|76010108|FG002|NOT COMPLETED|Period 5||0||
59887588|NCT03208088|76010109|FG003|NOT COMPLETED|Period 5||0||
59887589|NCT03208088|76010110|FG004|NOT COMPLETED|Period 5||0||
59887590|NCT03208088|76010111|FG005|NOT COMPLETED|Period 5||0||
59887591|NCT03208088|76010112|FG006|NOT COMPLETED|Period 5||0||
59887592|NCT03208088|76010113|FG007|NOT COMPLETED|Period 5||0||
59887593|NCT03208088|76010114|FG008|NOT COMPLETED|Period 5||0||
59887594|NCT03208088|76010115|FG009|NOT COMPLETED|Period 5||0||
59887595|NCT00078377|76010130|FG000|STARTED|Overall Study||67||
59610082|NCT01831596|75720956|FG000|NOT COMPLETED|Overall Study||8||
59610083|NCT01848834|75720965|FG000|STARTED|Overall Study||32||
59887596|NCT00078377|76010131|FG001|STARTED|Overall Study||65||
59887597|NCT00078377|76010132|FG002|STARTED|Overall Study||64||
59887598|NCT00078377|76010130|FG000|COMPLETED|Overall Study||56||
59887599|NCT00078377|76010131|FG001|COMPLETED|Overall Study||49||
59887600|NCT00078377|76010132|FG002|COMPLETED|Overall Study||55||
59887601|NCT00078377|76010130|FG000|NOT COMPLETED|Overall Study||11||
59887602|NCT00078377|76010131|FG001|NOT COMPLETED|Overall Study||16||
59887603|NCT00078377|76010132|FG002|NOT COMPLETED|Overall Study||9||
59887604|NCT00886600|76010145|FG000|STARTED|Double-blind Monotherapy||32||
59887605|NCT00886600|76010146|FG001|STARTED|Double-blind Monotherapy||29||
59887606|NCT00886600|76010147|FG002|STARTED|Double-blind Monotherapy||30||
59887607|NCT00886600|76010148|FG003|STARTED|Double-blind Monotherapy||31||
59887608|NCT00886600|76010145|FG000|COMPLETED|Double-blind Monotherapy||30||
59887609|NCT00886600|76010146|FG001|COMPLETED|Double-blind Monotherapy|1 pt discontinued after Wk 4 due to AE starting in placebo baseline and continuing into double-blind|28||
59887610|NCT00886600|76010147|FG002|COMPLETED|Double-blind Monotherapy||29||
59887611|NCT00886600|76010148|FG003|COMPLETED|Double-blind Monotherapy||29||
59887612|NCT00886600|76010145|FG000|NOT COMPLETED|Double-blind Monotherapy||2||
59887613|NCT00886600|76010146|FG001|NOT COMPLETED|Double-blind Monotherapy||1||
59887614|NCT00886600|76010147|FG002|NOT COMPLETED|Double-blind Monotherapy||1||
59887615|NCT00886600|76010148|FG003|NOT COMPLETED|Double-blind Monotherapy||2||
59887616|NCT00886600|76010145|FG000|STARTED|Combination Therapy Period|Patients did not continue from monotherapy period : 2-(Sitting Diastolic Blood Pressure (SiDBP) <85)|28||
59505368|NCT00748657|75598086|FG000|NOT COMPLETED|Overall Study||0||
59887617|NCT00886600|76010146|FG001|STARTED|Combination Therapy Period|Patients did not continue from monotherapy period : 4-(SiDBP <85); 3-(SiDBP ≥85)|21||
59887618|NCT00886600|76010147|FG002|STARTED|Combination Therapy Period|Patients did not continue from monotherapy period : 7-(SiDBP <85); 1-(SiDBP ≥85)|21||
59887619|NCT00886600|76010148|FG003|STARTED|Combination Therapy Period|Patients did not continue from monotherapy period : 5-(SiDBP <85); 1-(SiDBP ≥85)|23||
59887620|NCT00886600|76010145|FG000|COMPLETED|Combination Therapy Period||28||
59887621|NCT00886600|76010146|FG001|COMPLETED|Combination Therapy Period||21||
59887622|NCT00886600|76010147|FG002|COMPLETED|Combination Therapy Period||19||
59887623|NCT00886600|76010148|FG003|COMPLETED|Combination Therapy Period||23||
59887624|NCT00886600|76010145|FG000|NOT COMPLETED|Combination Therapy Period||0||
59887625|NCT00886600|76010146|FG001|NOT COMPLETED|Combination Therapy Period||0||
59887626|NCT00886600|76010147|FG002|NOT COMPLETED|Combination Therapy Period||2||
59887627|NCT00886600|76010148|FG003|NOT COMPLETED|Combination Therapy Period||0||
59887628|NCT03172130|76010156|FG000|STARTED|Overall Study||12||
59887629|NCT03172130|76010157|FG001|STARTED|Overall Study||10||
59887630|NCT03172130|76010156|FG000|COMPLETED|Overall Study||9||
59887631|NCT03172130|76010157|FG001|COMPLETED|Overall Study||9||
59887632|NCT03172130|76010156|FG000|NOT COMPLETED|Overall Study||3||
59887633|NCT03172130|76010157|FG001|NOT COMPLETED|Overall Study||1||
59505369|NCT00717977|75598096|FG000|STARTED|Overall Study||74||
59505370|NCT00717977|75598096|FG000|COMPLETED|Overall Study||74||
59505371|NCT00717977|75598096|FG000|NOT COMPLETED|Overall Study||0||
59505372|NCT00759967|75598100|FG000|STARTED|First Intervention||10||
59505373|NCT00759967|75598101|FG001|STARTED|First Intervention||9||
59505374|NCT00759967|75598100|FG000|COMPLETED|First Intervention||10||
59505375|NCT00759967|75598101|FG001|COMPLETED|First Intervention||9||
59505376|NCT00759967|75598100|FG000|NOT COMPLETED|First Intervention||0||
59505377|NCT00759967|75598101|FG001|NOT COMPLETED|First Intervention||0||
59505378|NCT00759967|75598100|FG000|STARTED|Second Intervention||10||
59505379|NCT00759967|75598101|FG001|STARTED|Second Intervention||9||
59887634|NCT00947518|76010166|FG000|STARTED|Overall Study||20||
59887635|NCT00947518|76010167|FG001|STARTED|Overall Study||20||
59887636|NCT00947518|76010168|FG002|STARTED|Overall Study||20||
59610084|NCT01848834|75720966|FG001|STARTED|Overall Study||61||
59887637|NCT00947518|76010166|FG000|COMPLETED|Overall Study||20||
59887638|NCT00947518|76010167|FG001|COMPLETED|Overall Study||20||
59887639|NCT00947518|76010168|FG002|COMPLETED|Overall Study||20||
59887640|NCT00947518|76010166|FG000|NOT COMPLETED|Overall Study||0||
59887641|NCT00947518|76010167|FG001|NOT COMPLETED|Overall Study||0||
59887642|NCT00947518|76010168|FG002|NOT COMPLETED|Overall Study||0||
59887643|NCT00870688|76010173|FG000|STARTED|Overall Study||82||
59887644|NCT00870688|76010173|FG000|COMPLETED|Overall Study||78||
59887645|NCT00870688|76010173|FG000|NOT COMPLETED|Overall Study||4||
59887646|NCT00869128|76010176|FG000|STARTED|Overall Study||18||
59887647|NCT00869128|76010177|FG001|STARTED|Overall Study||18||
59887648|NCT00869128|76010176|FG000|COMPLETED|Overall Study||12||
59887649|NCT00869128|76010177|FG001|COMPLETED|Overall Study||12||
59887650|NCT00869128|76010176|FG000|NOT COMPLETED|Overall Study||6||
59887651|NCT00869128|76010177|FG001|NOT COMPLETED|Overall Study||6||
59887652|NCT00077675|76010183|FG000|STARTED|Overall Study||103||
59887653|NCT00077675|76010184|FG001|STARTED|Overall Study||98||
59887654|NCT00077675|76010183|FG000|COMPLETED|Overall Study||92||
59887655|NCT00077675|76010184|FG001|COMPLETED|Overall Study||89||
59887656|NCT00077675|76010183|FG000|NOT COMPLETED|Overall Study||11||
59887657|NCT00077675|76010184|FG001|NOT COMPLETED|Overall Study||9||
59887658|NCT00934180|76010192|FG000|STARTED|First Intervention||12||
59887659|NCT00934180|76010193|FG001|STARTED|First Intervention||12||
59887660|NCT00934180|76010192|FG000|COMPLETED|First Intervention||12||
59887661|NCT00934180|76010193|FG001|COMPLETED|First Intervention||12||
59887662|NCT00934180|76010192|FG000|NOT COMPLETED|First Intervention||0||
59887663|NCT00934180|76010193|FG001|NOT COMPLETED|First Intervention||0||
59887664|NCT00934180|76010192|FG000|STARTED|Second Intervention||12||
59887665|NCT00934180|76010193|FG001|STARTED|Second Intervention||12||
59887666|NCT00934180|76010192|FG000|COMPLETED|Second Intervention||12||
59887667|NCT00934180|76010193|FG001|COMPLETED|Second Intervention||12||
59887668|NCT00934180|76010192|FG000|NOT COMPLETED|Second Intervention||0||
59887669|NCT00934180|76010193|FG001|NOT COMPLETED|Second Intervention||0||
59887670|NCT02576444|76010201|FG000|STARTED|Overall Study||26||
59887671|NCT02576444|76010202|FG001|STARTED|Overall Study||16||
59887672|NCT02576444|76010203|FG002|STARTED|Overall Study||25||
59887673|NCT02576444|76010204|FG003|STARTED|Overall Study||0||
59887674|NCT02576444|76010201|FG000|COMPLETED|Overall Study||25||
59887675|NCT02576444|76010202|FG001|COMPLETED|Overall Study||15||
59887676|NCT02576444|76010203|FG002|COMPLETED|Overall Study||21||
59887677|NCT02576444|76010204|FG003|COMPLETED|Overall Study||0||
59887678|NCT02576444|76010201|FG000|NOT COMPLETED|Overall Study||1||
59887679|NCT02576444|76010202|FG001|NOT COMPLETED|Overall Study||1||
59887680|NCT02576444|76010203|FG002|NOT COMPLETED|Overall Study||4||
59887681|NCT02576444|76010204|FG003|NOT COMPLETED|Overall Study||0||
59887682|NCT00850174|76010215|FG000|STARTED|First Intervention||30||
59887683|NCT00850174|76010216|FG001|STARTED|First Intervention||30||
59887684|NCT00850174|76010215|FG000|COMPLETED|First Intervention||30||
59887685|NCT00850174|76010216|FG001|COMPLETED|First Intervention||30||
59887686|NCT00850174|76010215|FG000|NOT COMPLETED|First Intervention||0||
59887687|NCT00850174|76010216|FG001|NOT COMPLETED|First Intervention||0||
59887688|NCT00850174|76010215|FG000|STARTED|Washout: One Week||30||
59887689|NCT00850174|76010216|FG001|STARTED|Washout: One Week||30||
59887690|NCT00850174|76010215|FG000|COMPLETED|Washout: One Week||30||
59887691|NCT00850174|76010216|FG001|COMPLETED|Washout: One Week||28||
59610085|NCT01848834|75720967|FG002|STARTED|Overall Study||33||
59610086|NCT01848834|75720968|FG003|STARTED|Overall Study||39||
59610087|NCT01848834|75720969|FG004|STARTED|Overall Study||132||
59610088|NCT01848834|75720965|FG000|Treated|Overall Study||32||
59610089|NCT01848834|75720966|FG001|Treated|Overall Study||60||
59610090|NCT01848834|75720967|FG002|Treated|Overall Study||33||
59610091|NCT01848834|75720968|FG003|Treated|Overall Study||39||
59610092|NCT01848834|75720969|FG004|Treated|Overall Study||132||
59887692|NCT00850174|76010215|FG000|NOT COMPLETED|Washout: One Week||0||
59887693|NCT00850174|76010216|FG001|NOT COMPLETED|Washout: One Week||2||
59610093|NCT01848834|75720965|FG000|COMPLETED|Overall Study|Completed means two-year treatment completed|13||
59610094|NCT01848834|75720966|FG001|COMPLETED|Overall Study|Completed means two-year treatment completed|13||
59610095|NCT01848834|75720967|FG002|COMPLETED|Overall Study|Completed means two-year treatment completed|9||
59610096|NCT01848834|75720968|FG003|COMPLETED|Overall Study|Completed means two-year treatment completed|13||
59610097|NCT01848834|75720969|FG004|COMPLETED|Overall Study|Completed means two-year treatment completed|38||
59887694|NCT00850174|76010215|FG000|STARTED|Second Intervention||30||
59887695|NCT00850174|76010216|FG001|STARTED|Second Intervention||28||
59887696|NCT00850174|76010215|FG000|COMPLETED|Second Intervention||29||
59887697|NCT00850174|76010216|FG001|COMPLETED|Second Intervention||28||
59887698|NCT00850174|76010215|FG000|NOT COMPLETED|Second Intervention||1||
59887699|NCT00850174|76010216|FG001|NOT COMPLETED|Second Intervention||0||
59887700|NCT00849862|76010222|FG000|STARTED|First Intervention||11||
59887701|NCT00849862|76010223|FG001|STARTED|First Intervention||11||
59887702|NCT00849862|76010222|FG000|COMPLETED|First Intervention||11||
59887703|NCT00849862|76010223|FG001|COMPLETED|First Intervention||11||
59887704|NCT00849862|76010222|FG000|NOT COMPLETED|First Intervention||0||
59887705|NCT00849862|76010223|FG001|NOT COMPLETED|First Intervention||0||
59887706|NCT00849862|76010222|FG000|STARTED|Washout: 7 Days||11||
59887707|NCT00849862|76010223|FG001|STARTED|Washout: 7 Days||11||
59887708|NCT00849862|76010222|FG000|COMPLETED|Washout: 7 Days||11||
59887709|NCT00849862|76010223|FG001|COMPLETED|Washout: 7 Days||11||
59887710|NCT00849862|76010222|FG000|NOT COMPLETED|Washout: 7 Days||0||
59887711|NCT00849862|76010223|FG001|NOT COMPLETED|Washout: 7 Days||0||
59887712|NCT00849862|76010222|FG000|STARTED|Second Intervention||11||
59887713|NCT00849862|76010223|FG001|STARTED|Second Intervention||11||
59887714|NCT00849862|76010222|FG000|COMPLETED|Second Intervention||11||
59887715|NCT00849862|76010223|FG001|COMPLETED|Second Intervention||11||
59887716|NCT00849862|76010222|FG000|NOT COMPLETED|Second Intervention||0||
59610098|NCT01848834|75720965|FG000|NOT COMPLETED|Overall Study||19||
59610099|NCT01848834|75720966|FG001|NOT COMPLETED|Overall Study||48||
59610100|NCT01848834|75720967|FG002|NOT COMPLETED|Overall Study||24||
59887717|NCT00849862|76010223|FG001|NOT COMPLETED|Second Intervention||0||
59887718|NCT00077207|76010227|FG000|STARTED|Overall Study||66||
59887719|NCT00077207|76010227|FG000|COMPLETED|Overall Study||36||
59887720|NCT00077207|76010227|FG000|NOT COMPLETED|Overall Study||30||
59887721|NCT03206918|76010232|FG000|STARTED|Overall Study||91||
59887722|NCT03206918|76010232|FG000|COMPLETED|Overall Study||0||
59887723|NCT03206918|76010232|FG000|NOT COMPLETED|Overall Study||91||
59887724|NCT03206216|76010239|FG000|STARTED|Overall Study||0||
59887725|NCT03206216|76010240|FG001|STARTED|Overall Study||1||
59887726|NCT03206216|76010239|FG000|COMPLETED|Overall Study||0||
59887727|NCT03206216|76010240|FG001|COMPLETED|Overall Study||0||
59887728|NCT03206216|76010239|FG000|NOT COMPLETED|Overall Study||0||
59887729|NCT03206216|76010240|FG001|NOT COMPLETED|Overall Study||1||
59887730|NCT03169244|76010248|FG000|STARTED|Overall Study||22||
59887731|NCT03169244|76010249|FG001|STARTED|Overall Study||20||
59887732|NCT03169244|76010248|FG000|Randomly Assigned|Overall Study||22||
59887733|NCT03169244|76010249|FG001|Randomly Assigned|Overall Study||20||
59887734|NCT03169244|76010248|FG000|Received Intervention|Overall Study||22||
59887735|NCT03169244|76010249|FG001|Received Intervention|Overall Study||18||
59887736|NCT03169244|76010248|FG000|COMPLETED|Overall Study||17||
59887737|NCT03169244|76010249|FG001|COMPLETED|Overall Study||16||
59887738|NCT03169244|76010248|FG000|NOT COMPLETED|Overall Study||5||
59887739|NCT03169244|76010249|FG001|NOT COMPLETED|Overall Study||4||
59887740|NCT02486042|76010257|FG000|STARTED|Overall Study||20||
59887741|NCT02486042|76010258|FG001|STARTED|Overall Study||21||
59887742|NCT02486042|76010257|FG000|COMPLETED|Overall Study||17||
59887743|NCT02486042|76010258|FG001|COMPLETED|Overall Study||10||
59887744|NCT02486042|76010257|FG000|NOT COMPLETED|Overall Study||3||
59887745|NCT02486042|76010258|FG001|NOT COMPLETED|Overall Study||11||
59887746|NCT00057941|76010266|FG000|STARTED|Overall Study||74||
59887747|NCT00057941|76010267|FG001|STARTED|Overall Study||74||
59887748|NCT00057941|76010266|FG000|Treated|Overall Study||74||
59610101|NCT01848834|75720968|FG003|NOT COMPLETED|Overall Study||26||
59756275|NCT00610441|75875380|FG002|NOT COMPLETED|Treatment Period 1 - 3 Weeks||7||
59756276|NCT00610441|75875381|FG003|NOT COMPLETED|Treatment Period 1 - 3 Weeks||2||
59887749|NCT00057941|76010267|FG001|Treated|Overall Study||74||
59887750|NCT00057941|76010266|FG000|Eligible|Overall Study||72||
59887751|NCT00057941|76010267|FG001|Eligible|Overall Study||69||
59756277|NCT00610441|75875378|FG000|STARTED|Placebo Washout Period - 2 Weeks||12||
59756278|NCT00610441|75875379|FG001|STARTED|Placebo Washout Period - 2 Weeks||14||
59756279|NCT00610441|75875380|FG002|STARTED|Placebo Washout Period - 2 Weeks||11||
59756280|NCT00610441|75875381|FG003|STARTED|Placebo Washout Period - 2 Weeks||16||
59756281|NCT00610441|75875378|FG000|COMPLETED|Placebo Washout Period - 2 Weeks||12||
59756282|NCT00610441|75875379|FG001|COMPLETED|Placebo Washout Period - 2 Weeks||13||
59756283|NCT00610441|75875380|FG002|COMPLETED|Placebo Washout Period - 2 Weeks||9||
59756284|NCT00610441|75875381|FG003|COMPLETED|Placebo Washout Period - 2 Weeks||16||
59756285|NCT00610441|75875378|FG000|NOT COMPLETED|Placebo Washout Period - 2 Weeks||0||
59756286|NCT00610441|75875379|FG001|NOT COMPLETED|Placebo Washout Period - 2 Weeks||1||
59887752|NCT00057941|76010266|FG000|COMPLETED|Overall Study||0||
59887753|NCT00057941|76010267|FG001|COMPLETED|Overall Study||0||
59887754|NCT00057941|76010266|FG000|NOT COMPLETED|Overall Study||74||
59887755|NCT00057941|76010267|FG001|NOT COMPLETED|Overall Study||74||
59887756|NCT03005522|76010275|FG000|STARTED|Overall Study||36||
59887757|NCT03005522|76010276|FG001|STARTED|Overall Study||37||
59887758|NCT03005522|76010275|FG000|COMPLETED|Overall Study||25||
59887759|NCT03005522|76010276|FG001|COMPLETED|Overall Study||27||
59887760|NCT03005522|76010275|FG000|NOT COMPLETED|Overall Study||11||
59887761|NCT03005522|76010276|FG001|NOT COMPLETED|Overall Study||10||
59887762|NCT00075881|76010282|FG000|STARTED|Overall Study||44||
59887763|NCT00075881|76010282|FG000|Eligible|Overall Study||43||
59610102|NCT01848834|75720969|FG004|NOT COMPLETED|Overall Study||94||
59610103|NCT01867008|75720985|FG000|STARTED|Overall Study||55||
59610104|NCT01867008|75720985|FG000|COMPLETED|Overall Study||54||
59887764|NCT00075881|76010282|FG000|Treated|Overall Study||42||
59887765|NCT00075881|76010282|FG000|Induction Treatment|Overall Study||42||
59887766|NCT00075881|76010282|FG000|Maintenance Treatment|Overall Study||15||
59887767|NCT00075881|76010282|FG000|Reinduction Treatment|Overall Study||7||
59887768|NCT00075881|76010282|FG000|COMPLETED|Overall Study||1||
59887769|NCT00075881|76010282|FG000|NOT COMPLETED|Overall Study||43||
59887770|NCT00838630|76010290|FG000|STARTED|First Intervention||18||
59887771|NCT00838630|76010291|FG001|STARTED|First Intervention||18||
59887772|NCT00838630|76010290|FG000|COMPLETED|First Intervention||17||
59887773|NCT00838630|76010291|FG001|COMPLETED|First Intervention||18||
59887774|NCT00838630|76010290|FG000|NOT COMPLETED|First Intervention||1||
59887775|NCT00838630|76010291|FG001|NOT COMPLETED|First Intervention||0||
59887776|NCT00838630|76010290|FG000|STARTED|Washout: 7 Days||17||
59887777|NCT00838630|76010291|FG001|STARTED|Washout: 7 Days||18||
59887778|NCT00838630|76010290|FG000|COMPLETED|Washout: 7 Days||16||
59887779|NCT00838630|76010291|FG001|COMPLETED|Washout: 7 Days||18||
59887780|NCT00838630|76010290|FG000|NOT COMPLETED|Washout: 7 Days||1||
59887781|NCT00838630|76010291|FG001|NOT COMPLETED|Washout: 7 Days||0||
59887782|NCT00838630|76010290|FG000|STARTED|Second Intervention||16||
59887783|NCT00838630|76010291|FG001|STARTED|Second Intervention||18||
59887784|NCT00838630|76010290|FG000|COMPLETED|Second Intervention||16||
59887785|NCT00838630|76010291|FG001|COMPLETED|Second Intervention||18||
59887786|NCT00838630|76010290|FG000|NOT COMPLETED|Second Intervention||0||
59887787|NCT00838630|76010291|FG001|NOT COMPLETED|Second Intervention||0||
59887788|NCT02996474|76010295|FG000|STARTED|Overall Study||10||
59887789|NCT02996474|76010295|FG000|COMPLETED|Overall Study||5||
59887790|NCT02996474|76010295|FG000|NOT COMPLETED|Overall Study||5||
59887791|NCT03667924|76010302|FG000|STARTED|Baseline Completed||7||
59887792|NCT03667924|76010303|FG001|STARTED|Baseline Completed||33||
59887793|NCT03667924|76010304|FG002|STARTED|Baseline Completed||4||
59887794|NCT03667924|76010302|FG000|COMPLETED|Baseline Completed||7||
59887795|NCT03667924|76010303|FG001|COMPLETED|Baseline Completed||31||
59887796|NCT03667924|76010304|FG002|COMPLETED|Baseline Completed||4||
59887797|NCT03667924|76010302|FG000|NOT COMPLETED|Baseline Completed||0||
59505380|NCT00759967|75598100|FG000|COMPLETED|Second Intervention||8||
59505381|NCT00759967|75598101|FG001|COMPLETED|Second Intervention||9||
59505382|NCT00759967|75598100|FG000|NOT COMPLETED|Second Intervention||2||
59505383|NCT00759967|75598101|FG001|NOT COMPLETED|Second Intervention||0||
59505384|NCT00719615|75598114|FG000|STARTED|Overall Study||42||
59887798|NCT03667924|76010303|FG001|NOT COMPLETED|Baseline Completed||2||
59887799|NCT03667924|76010304|FG002|NOT COMPLETED|Baseline Completed||0||
59887800|NCT03667924|76010302|FG000|STARTED|1-month Completed/Training (Volunteers)||7||
59887801|NCT03667924|76010303|FG001|STARTED|1-month Completed/Training (Volunteers)||31||
59887802|NCT03667924|76010304|FG002|STARTED|1-month Completed/Training (Volunteers)||4||
59887803|NCT03667924|76010302|FG000|COMPLETED|1-month Completed/Training (Volunteers)||6|"Please note: volunteers did not complete 1-month surveys as did clients and caregivers; instead, the numbers entered here reflect the milestone training completed"|
59887804|NCT03667924|76010303|FG001|COMPLETED|1-month Completed/Training (Volunteers)||15|"Please note: volunteers did not complete 1-month surveys as did clients and caregivers; instead, the numbers entered here reflect the milestone training completed"|
59887805|NCT03667924|76010304|FG002|COMPLETED|1-month Completed/Training (Volunteers)||3|"Please note: volunteers did not complete 1-month surveys as did clients and caregivers; instead, the numbers entered here reflect the milestone training completed"|
59887806|NCT03667924|76010302|FG000|NOT COMPLETED|1-month Completed/Training (Volunteers)||1||
59887807|NCT03667924|76010303|FG001|NOT COMPLETED|1-month Completed/Training (Volunteers)||16||
59887808|NCT03667924|76010304|FG002|NOT COMPLETED|1-month Completed/Training (Volunteers)||1||
59887809|NCT03667924|76010302|FG000|STARTED|3-month/Volunteers Who Enrolled Clients||6||
59887810|NCT03667924|76010303|FG001|STARTED|3-month/Volunteers Who Enrolled Clients||15||
59887811|NCT03667924|76010304|FG002|STARTED|3-month/Volunteers Who Enrolled Clients||3||
59887812|NCT03667924|76010302|FG000|COMPLETED|3-month/Volunteers Who Enrolled Clients||5||
59887813|NCT03667924|76010303|FG001|COMPLETED|3-month/Volunteers Who Enrolled Clients||5||
59887814|NCT03667924|76010304|FG002|COMPLETED|3-month/Volunteers Who Enrolled Clients||3||
59505385|NCT00719615|75598115|FG001|STARTED|Overall Study||45||
59505386|NCT00719615|75598116|FG002|STARTED|Overall Study||24||
59887815|NCT03667924|76010302|FG000|NOT COMPLETED|3-month/Volunteers Who Enrolled Clients||1||
59887816|NCT03667924|76010303|FG001|NOT COMPLETED|3-month/Volunteers Who Enrolled Clients||10||
59887817|NCT03667924|76010304|FG002|NOT COMPLETED|3-month/Volunteers Who Enrolled Clients||0||
59887818|NCT03667924|76010302|FG000|STARTED|Post-study Interview Completed||5||
59887819|NCT03667924|76010303|FG001|STARTED|Post-study Interview Completed||5||
59887820|NCT03667924|76010304|FG002|STARTED|Post-study Interview Completed||3||
59887821|NCT03667924|76010302|FG000|COMPLETED|Post-study Interview Completed||5||
59887822|NCT03667924|76010303|FG001|COMPLETED|Post-study Interview Completed||4||
59887823|NCT03667924|76010304|FG002|COMPLETED|Post-study Interview Completed||3||
59887824|NCT03667924|76010302|FG000|NOT COMPLETED|Post-study Interview Completed||0||
59887825|NCT03667924|76010303|FG001|NOT COMPLETED|Post-study Interview Completed||1||
59887826|NCT03667924|76010304|FG002|NOT COMPLETED|Post-study Interview Completed||0||
59887827|NCT03205046|76010316|FG000|STARTED|Overall Study||13||
59887828|NCT03205046|76010317|FG001|STARTED|Overall Study||12||
59887829|NCT03205046|76010316|FG000|COMPLETED|Overall Study||0||
59887830|NCT03205046|76010317|FG001|COMPLETED|Overall Study||2||
59505387|NCT00719615|75598114|FG000|COMPLETED|Overall Study||42||
59505388|NCT00719615|75598115|FG001|COMPLETED|Overall Study||45||
59505389|NCT00719615|75598116|FG002|COMPLETED|Overall Study||24||
59887831|NCT03205046|76010316|FG000|NOT COMPLETED|Overall Study||13||
59887832|NCT03205046|76010317|FG001|NOT COMPLETED|Overall Study||10||
59887833|NCT02339090|76010325|FG000|STARTED|Overall Study||104||
59887834|NCT02339090|76010326|FG001|STARTED|Overall Study||34||
59887835|NCT02339090|76010325|FG000|Received a Least 1 Dose of Study Drug|Overall Study||104||
59610105|NCT01867008|75720985|FG000|NOT COMPLETED|Overall Study||1||
59610106|NCT01848756|75720989|FG000|STARTED|Overall Study||15||
59610107|NCT01848756|75720989|FG000|COMPLETED|Overall Study|Cycle 1|12||
59610108|NCT01848756|75720989|FG000|NOT COMPLETED|Overall Study||3||
59610109|NCT01830972|75720996|FG000|STARTED|Part I||46||
59610110|NCT01830972|75720997|FG001|STARTED|Part I|Not applicable; participants in this arm entered during Part 2.|0||
59610111|NCT01830972|75720996|FG000|COMPLETED|Part I||46||
59610112|NCT01830972|75720997|FG001|COMPLETED|Part I|Not applicable; participants in this arm entered during Part 2.|0||
59610113|NCT01830972|75720996|FG000|NOT COMPLETED|Part I||0||
59610114|NCT01830972|75720997|FG001|NOT COMPLETED|Part I||0||
59610115|NCT01830972|75720996|FG000|STARTED|Part II||46||
59610116|NCT01830972|75720997|FG001|STARTED|Part II|Entered study at Part 2|13||
59610117|NCT01830972|75720996|FG000|COMPLETED|Part II||44||
59610118|NCT01830972|75720997|FG001|COMPLETED|Part II||11||
59610119|NCT01830972|75720996|FG000|NOT COMPLETED|Part II||2||
59610120|NCT01830972|75720997|FG001|NOT COMPLETED|Part II||2||
59610121|NCT01830972|75720996|FG000|STARTED|Part III|2 participants withdrew consent and did not enter Part 3|44||
59610122|NCT01830972|75720997|FG001|STARTED|Part III||11||
59610123|NCT01830972|75720996|FG000|COMPLETED|Part III||42||
59610124|NCT01830972|75720997|FG001|COMPLETED|Part III||11||
59610125|NCT01830972|75720996|FG000|NOT COMPLETED|Part III||2||
59610126|NCT01830972|75720997|FG001|NOT COMPLETED|Part III||0||
59610127|NCT01830972|75720996|FG000|STARTED|Part IV||42||
59610128|NCT01830972|75720997|FG001|STARTED|Part IV||11||
59610129|NCT01830972|75720996|FG000|COMPLETED|Part IV||39||
59610130|NCT01830972|75720997|FG001|COMPLETED|Part IV||10||
59756287|NCT00610441|75875380|FG002|NOT COMPLETED|Placebo Washout Period - 2 Weeks||2||
59756288|NCT00610441|75875381|FG003|NOT COMPLETED|Placebo Washout Period - 2 Weeks||0||
59756289|NCT00610441|75875378|FG000|STARTED|Treatment Period 2 - 3 Weeks||12||
59610131|NCT01830972|75720996|FG000|NOT COMPLETED|Part IV||3||
59610132|NCT01830972|75720997|FG001|NOT COMPLETED|Part IV||1||
59610133|NCT01848288|75721013|FG000|STARTED|Overall Study||100||
59610134|NCT01848288|75721013|FG000|COMPLETED|Overall Study|Two subjects were discontinued prior to undergoing surgery.|97||
59610135|NCT01848288|75721013|FG000|NOT COMPLETED|Overall Study||3||
59610136|NCT01848210|75721020|FG000|STARTED|Overall Study||411||
59610137|NCT01848210|75721021|FG001|STARTED|Overall Study||418||
59610138|NCT01848210|75721020|FG000|Safety Population-Received Study Drug|Overall Study||394||
59610139|NCT01848210|75721021|FG001|Safety Population-Received Study Drug|Overall Study||398||
59610140|NCT01848210|75721020|FG000|Intent-to-Treat (ITT) Population|Overall Study||383||
59610141|NCT01848210|75721021|FG001|Intent-to-Treat (ITT) Population|Overall Study||388||
59610142|NCT01848210|75721020|FG000|Per Protocol Population|Overall Study||222||
59610143|NCT01848210|75721021|FG001|Per Protocol Population|Overall Study||245||
59610144|NCT01848210|75721020|FG000|COMPLETED|Overall Study||323||
59610145|NCT01848210|75721021|FG001|COMPLETED|Overall Study||340||
59610146|NCT01848210|75721020|FG000|NOT COMPLETED|Overall Study||88||
59610147|NCT01848210|75721021|FG001|NOT COMPLETED|Overall Study||78||
59610148|NCT01830816|75721030|FG000|STARTED|Overall Study||20||
59610149|NCT01830816|75721031|FG001|STARTED|Overall Study||14||
59756290|NCT00610441|75875379|FG001|STARTED|Treatment Period 2 - 3 Weeks||13||
59756291|NCT00610441|75875380|FG002|STARTED|Treatment Period 2 - 3 Weeks||9||
59756292|NCT00610441|75875381|FG003|STARTED|Treatment Period 2 - 3 Weeks||16||
59756293|NCT00610441|75875378|FG000|COMPLETED|Treatment Period 2 - 3 Weeks||10||
59756294|NCT00610441|75875379|FG001|COMPLETED|Treatment Period 2 - 3 Weeks||12||
59887836|NCT02339090|76010326|FG001|Received a Least 1 Dose of Study Drug|Overall Study||32||
59610150|NCT01830816|75721032|FG002|STARTED|Overall Study||7||
59610151|NCT01830816|75721030|FG000|Pharmacokinetic-Evaluable Population|Overall Study|Participants are considered to have completed study treatment if they are PK evaluable.|18||
59610152|NCT01830816|75721031|FG001|Pharmacokinetic-Evaluable Population|Overall Study||14||
59610153|NCT01830816|75721032|FG002|Pharmacokinetic-Evaluable Population|Overall Study||6||
59756295|NCT00610441|75875380|FG002|COMPLETED|Treatment Period 2 - 3 Weeks||9||
59887837|NCT02339090|76010325|FG000|COMPLETED|Overall Study||98||
59887838|NCT02339090|76010326|FG001|COMPLETED|Overall Study||29||
59887839|NCT02339090|76010325|FG000|NOT COMPLETED|Overall Study||6||
59610154|NCT01830816|75721030|FG000|COMPLETED|Overall Study||0||
59610155|NCT01830816|75721031|FG001|COMPLETED|Overall Study||0||
59610156|NCT01830816|75721032|FG002|COMPLETED|Overall Study||0||
59610157|NCT01830816|75721030|FG000|NOT COMPLETED|Overall Study||20||
59610158|NCT01830816|75721031|FG001|NOT COMPLETED|Overall Study||14||
59610159|NCT01830816|75721032|FG002|NOT COMPLETED|Overall Study||7||
59610160|NCT01846416|75721046|FG000|STARTED|Treatment Phase||31||
59610161|NCT01846416|75721047|FG001|STARTED|Treatment Phase||93||
59610162|NCT01846416|75721048|FG002|STARTED|Treatment Phase||13||
59610163|NCT01846416|75721046|FG000|COMPLETED|Treatment Phase||0||
59610164|NCT01846416|75721047|FG001|COMPLETED|Treatment Phase||0||
59610165|NCT01846416|75721048|FG002|COMPLETED|Treatment Phase||0||
59610166|NCT01846416|75721046|FG000|NOT COMPLETED|Treatment Phase||31||
59610167|NCT01846416|75721047|FG001|NOT COMPLETED|Treatment Phase||93||
59610168|NCT01846416|75721048|FG002|NOT COMPLETED|Treatment Phase||13||
59610169|NCT01846416|75721046|FG000|STARTED|Survival Follow-up||28||
59610170|NCT01846416|75721047|FG001|STARTED|Survival Follow-up||80||
59610171|NCT01846416|75721048|FG002|STARTED|Survival Follow-up||12||
59610172|NCT01846416|75721046|FG000|COMPLETED|Survival Follow-up||0||
59756296|NCT00610441|75875381|FG003|COMPLETED|Treatment Period 2 - 3 Weeks||14||
59610173|NCT01846416|75721047|FG001|COMPLETED|Survival Follow-up||0||
59610174|NCT01846416|75721048|FG002|COMPLETED|Survival Follow-up||0||
59610175|NCT01846416|75721046|FG000|NOT COMPLETED|Survival Follow-up||28||
59610176|NCT01846416|75721047|FG001|NOT COMPLETED|Survival Follow-up||80||
59610177|NCT01846416|75721048|FG002|NOT COMPLETED|Survival Follow-up||12||
59610178|NCT01865448|75721059|FG000|STARTED|Overall Study||17||
59610179|NCT01865448|75721060|FG001|STARTED|Overall Study||17||
59610180|NCT01865448|75721059|FG000|COMPLETED|Overall Study||15||
59610181|NCT01865448|75721060|FG001|COMPLETED|Overall Study||14||
59610182|NCT01865448|75721059|FG000|NOT COMPLETED|Overall Study||2||
59610183|NCT01865448|75721060|FG001|NOT COMPLETED|Overall Study||3||
59610184|NCT01804140|75721067|FG000|STARTED|Overall Study|This includes all the participants who were enrolled for this study.|662||
59610185|NCT01804140|75721067|FG000|COMPLETED|Overall Study|This includes all the participants with mutation results from the sampling or biopsy procedures.|548||
59610186|NCT01804140|75721067|FG000|NOT COMPLETED|Overall Study||114||
59610187|NCT01846104|75721071|FG000|STARTED|Overall Study||4||
59610188|NCT01846104|75721071|FG000|COMPLETED|Overall Study||3||
59756297|NCT00610441|75875378|FG000|NOT COMPLETED|Treatment Period 2 - 3 Weeks||2||
59756298|NCT00610441|75875379|FG001|NOT COMPLETED|Treatment Period 2 - 3 Weeks||1||
59756299|NCT00610441|75875380|FG002|NOT COMPLETED|Treatment Period 2 - 3 Weeks||0||
59756300|NCT00610441|75875381|FG003|NOT COMPLETED|Treatment Period 2 - 3 Weeks||2||
59756301|NCT00799617|75875395|FG000|STARTED|Main Testosterone Trial||395||
59756302|NCT00799617|75875396|FG001|STARTED|Main Testosterone Trial||395||
59756303|NCT00799617|75875395|FG000|COMPLETED|Main Testosterone Trial|Participants qualified for 1 of the 3 main trials (sexual function, physical function, vitality).|376|The Testosterone Trials are a coordinated set of 7 trials.|
59756304|NCT00799617|75875396|FG001|COMPLETED|Main Testosterone Trial||374|The Testosterone Trials are a coordinated set of 7 trials.|
59756305|NCT00799617|75875395|FG000|NOT COMPLETED|Main Testosterone Trial||19||
59756306|NCT00799617|75875396|FG001|NOT COMPLETED|Main Testosterone Trial||21||
59756307|NCT00799617|75875395|FG000|STARTED|Sexual Funtion Trial||234||
59756308|NCT00799617|75875396|FG001|STARTED|Sexual Funtion Trial||236||
59756309|NCT00799617|75875395|FG000|COMPLETED|Sexual Funtion Trial||218||
59756310|NCT00799617|75875396|FG001|COMPLETED|Sexual Funtion Trial||215||
59756311|NCT00799617|75875395|FG000|NOT COMPLETED|Sexual Funtion Trial||16||
59756312|NCT00799617|75875396|FG001|NOT COMPLETED|Sexual Funtion Trial||21||
59756313|NCT00799617|75875395|FG000|STARTED|Physical Function Trial||191||
59756314|NCT00799617|75875396|FG001|STARTED|Physical Function Trial||196||
59756315|NCT00799617|75875395|FG000|COMPLETED|Physical Function Trial||185||
59756316|NCT00799617|75875396|FG001|COMPLETED|Physical Function Trial||185||
59756317|NCT00799617|75875395|FG000|NOT COMPLETED|Physical Function Trial||6||
59756318|NCT00799617|75875396|FG001|NOT COMPLETED|Physical Function Trial||11||
59756319|NCT00799617|75875395|FG000|STARTED|Vitality Trial||236||
59756320|NCT00799617|75875396|FG001|STARTED|Vitality Trial||238||
59756321|NCT00799617|75875395|FG000|COMPLETED|Vitality Trial||229||
59887840|NCT02339090|76010326|FG001|NOT COMPLETED|Overall Study||5||
59887841|NCT02947646|76010334|FG000|STARTED|Overall Study||10||
59887842|NCT02947646|76010335|FG001|STARTED|Overall Study||10||
59887843|NCT02947646|76010334|FG000|COMPLETED|Overall Study||10||
59887844|NCT02947646|76010335|FG001|COMPLETED|Overall Study||9||
59887845|NCT02947646|76010334|FG000|NOT COMPLETED|Overall Study||0||
59887846|NCT02947646|76010335|FG001|NOT COMPLETED|Overall Study||1||
59887847|NCT03331562|76010345|FG000|STARTED|Overall Study||12|Randomized to study arm, received allocated study treatment|
59887848|NCT03331562|76010346|FG001|STARTED|Overall Study||12|Randomized to study arm, received allocated study treatment|
59887849|NCT03331562|76010345|FG000|COMPLETED|Overall Study||9|Patients continued on study treatment until disease progression|
59887850|NCT03331562|76010346|FG001|COMPLETED|Overall Study||12|Patients continued on study treatment until disease progression|
59887851|NCT03331562|76010345|FG000|NOT COMPLETED|Overall Study||3||
59887852|NCT03331562|76010346|FG001|NOT COMPLETED|Overall Study||0||
59887853|NCT02038634|76010358|FG000|STARTED|Overall Study||3||
59887854|NCT02038634|76010359|FG001|STARTED|Overall Study||13||
59887855|NCT02038634|76010358|FG000|COMPLETED|Overall Study||3||
59887856|NCT02038634|76010359|FG001|COMPLETED|Overall Study||12||
59887857|NCT02038634|76010358|FG000|NOT COMPLETED|Overall Study||0||
59887858|NCT02038634|76010359|FG001|NOT COMPLETED|Overall Study||1||
59887859|NCT00836056|76010367|FG000|STARTED|First Intervention||12||
59610189|NCT01846104|75721071|FG000|NOT COMPLETED|Overall Study||1||
59610190|NCT01803282|75721087|FG000|STARTED|Overall Study||4||
59610191|NCT01803282|75721088|FG001|STARTED|Overall Study||3||
59610192|NCT01803282|75721089|FG002|STARTED|Overall Study||6||
59610193|NCT01803282|75721090|FG003|STARTED|Overall Study||36||
59610194|NCT01803282|75721091|FG004|STARTED|Overall Study||11||
59610195|NCT01803282|75721092|FG005|STARTED|Overall Study||10||
59610196|NCT01803282|75721093|FG006|STARTED|Overall Study||41||
59610197|NCT01803282|75721094|FG007|STARTED|Overall Study||46||
59610198|NCT01803282|75721095|FG008|STARTED|Overall Study||11||
59887860|NCT00836056|76010368|FG001|STARTED|First Intervention||12||
59887861|NCT00836056|76010367|FG000|COMPLETED|First Intervention||11||
59887862|NCT00836056|76010368|FG001|COMPLETED|First Intervention||12||
59887863|NCT00836056|76010367|FG000|NOT COMPLETED|First Intervention||1||
59887864|NCT00836056|76010368|FG001|NOT COMPLETED|First Intervention||0||
59887865|NCT00836056|76010367|FG000|STARTED|Washout: 7 Days||11||
59610199|NCT01803282|75721096|FG009|STARTED|Overall Study||45||
59610200|NCT01803282|75721097|FG010|STARTED|Overall Study||8||
59610201|NCT01803282|75721098|FG011|STARTED|Overall Study||15||
59887866|NCT00836056|76010368|FG001|STARTED|Washout: 7 Days||12||
59887867|NCT00836056|76010367|FG000|COMPLETED|Washout: 7 Days||11||
59887868|NCT00836056|76010368|FG001|COMPLETED|Washout: 7 Days||12||
59887869|NCT00836056|76010367|FG000|NOT COMPLETED|Washout: 7 Days||0||
59887870|NCT00836056|76010368|FG001|NOT COMPLETED|Washout: 7 Days||0||
59887871|NCT00836056|76010367|FG000|STARTED|Second Intervention||11||
59887872|NCT00836056|76010368|FG001|STARTED|Second Intervention||12||
59887873|NCT00836056|76010367|FG000|COMPLETED|Second Intervention||11||
59610202|NCT01803282|75721087|FG000|COMPLETED|Overall Study||0||
59610203|NCT01803282|75721088|FG001|COMPLETED|Overall Study||0||
59610204|NCT01803282|75721089|FG002|COMPLETED|Overall Study||0||
59610205|NCT01803282|75721090|FG003|COMPLETED|Overall Study||0||
59610206|NCT01803282|75721091|FG004|COMPLETED|Overall Study||0||
59610207|NCT01803282|75721092|FG005|COMPLETED|Overall Study||0||
59610208|NCT01803282|75721093|FG006|COMPLETED|Overall Study||0||
59610209|NCT01803282|75721094|FG007|COMPLETED|Overall Study||0||
59610210|NCT01803282|75721095|FG008|COMPLETED|Overall Study||0||
59610211|NCT01803282|75721096|FG009|COMPLETED|Overall Study||0||
59610212|NCT01803282|75721097|FG010|COMPLETED|Overall Study||0||
59610213|NCT01803282|75721098|FG011|COMPLETED|Overall Study||0||
59887874|NCT00836056|76010368|FG001|COMPLETED|Second Intervention||12||
59887875|NCT00836056|76010367|FG000|NOT COMPLETED|Second Intervention||0||
59887876|NCT00836056|76010368|FG001|NOT COMPLETED|Second Intervention||0||
59887877|NCT03200912|76010375|FG000|STARTED|Overall Study||170||
59887878|NCT03200912|76010376|FG001|STARTED|Overall Study||169||
59887879|NCT03200912|76010377|FG002|STARTED|Overall Study||168||
59887880|NCT03200912|76010375|FG000|COMPLETED|Overall Study||166||
59887881|NCT03200912|76010376|FG001|COMPLETED|Overall Study||166||
59887882|NCT03200912|76010377|FG002|COMPLETED|Overall Study||164||
59887883|NCT03200912|76010375|FG000|NOT COMPLETED|Overall Study||4||
59887884|NCT03200912|76010376|FG001|NOT COMPLETED|Overall Study||3||
59887885|NCT03200912|76010377|FG002|NOT COMPLETED|Overall Study||4||
59887886|NCT00835666|76010387|FG000|STARTED|First Intervention||16||
59887887|NCT00835666|76010388|FG001|STARTED|First Intervention||16||
59887888|NCT00835666|76010387|FG000|COMPLETED|First Intervention||16||
59887889|NCT00835666|76010388|FG001|COMPLETED|First Intervention||16||
59887890|NCT00835666|76010387|FG000|NOT COMPLETED|First Intervention||0||
59887891|NCT00835666|76010388|FG001|NOT COMPLETED|First Intervention||0||
59887892|NCT00835666|76010387|FG000|STARTED|Washout||16||
59887893|NCT00835666|76010388|FG001|STARTED|Washout||16||
59887894|NCT00835666|76010387|FG000|COMPLETED|Washout||14||
59887895|NCT00835666|76010388|FG001|COMPLETED|Washout||16||
59887896|NCT00835666|76010387|FG000|NOT COMPLETED|Washout||2||
59887897|NCT00835666|76010388|FG001|NOT COMPLETED|Washout||0||
59887898|NCT00835666|76010387|FG000|STARTED|Second Intervention||14||
59887899|NCT00835666|76010388|FG001|STARTED|Second Intervention||16||
59887900|NCT00835666|76010387|FG000|COMPLETED|Second Intervention||14||
59887901|NCT00835666|76010388|FG001|COMPLETED|Second Intervention||16||
59887902|NCT00835666|76010387|FG000|NOT COMPLETED|Second Intervention||0||
59887903|NCT00835666|76010388|FG001|NOT COMPLETED|Second Intervention||0||
59887904|NCT00835588|76010394|FG000|STARTED|First Intervention||50||
59887905|NCT00835588|76010395|FG001|STARTED|First Intervention||50||
59887906|NCT00835588|76010394|FG000|COMPLETED|First Intervention||50||
59610214|NCT01803282|75721087|FG000|NOT COMPLETED|Overall Study||4||
59610215|NCT01803282|75721088|FG001|NOT COMPLETED|Overall Study||3||
59610216|NCT01803282|75721089|FG002|NOT COMPLETED|Overall Study||6||
59610217|NCT01803282|75721090|FG003|NOT COMPLETED|Overall Study||36||
59610218|NCT01803282|75721091|FG004|NOT COMPLETED|Overall Study||11||
59610219|NCT01803282|75721092|FG005|NOT COMPLETED|Overall Study||10||
59610220|NCT01803282|75721093|FG006|NOT COMPLETED|Overall Study||41||
59610221|NCT01803282|75721094|FG007|NOT COMPLETED|Overall Study||46||
59610222|NCT01803282|75721095|FG008|NOT COMPLETED|Overall Study||11||
59610223|NCT01803282|75721096|FG009|NOT COMPLETED|Overall Study||45||
59610224|NCT01803282|75721097|FG010|NOT COMPLETED|Overall Study||8||
59610225|NCT01803282|75721098|FG011|NOT COMPLETED|Overall Study||15||
59610226|NCT01844778|75721127|FG000|STARTED|Overall Study||14||
59610227|NCT01844778|75721128|FG001|STARTED|Overall Study||28||
59887907|NCT00835588|76010395|FG001|COMPLETED|First Intervention||50||
59887908|NCT00835588|76010394|FG000|NOT COMPLETED|First Intervention||0||
59610228|NCT01844778|75721129|FG002|STARTED|Overall Study||18||
59610229|NCT01844778|75721127|FG000|Safety Set 1 (at Least 1 Dose, Cycle 1)|Overall Study||14||
59887909|NCT00835588|76010395|FG001|NOT COMPLETED|First Intervention||0||
59610230|NCT01844778|75721128|FG001|Safety Set 1 (at Least 1 Dose, Cycle 1)|Overall Study||28||
59610231|NCT01844778|75721129|FG002|Safety Set 1 (at Least 1 Dose, Cycle 1)|Overall Study||18||
59610232|NCT01844778|75721127|FG000|Safety Set 2 (at Least 1 Dose, Cycle 2)|Overall Study||12||
59610233|NCT01844778|75721128|FG001|Safety Set 2 (at Least 1 Dose, Cycle 2)|Overall Study||25||
59610234|NCT01844778|75721129|FG002|Safety Set 2 (at Least 1 Dose, Cycle 2)|Overall Study||15||
59610235|NCT01844778|75721127|FG000|COMPLETED|Overall Study||12||
59610236|NCT01844778|75721128|FG001|COMPLETED|Overall Study||25||
59610237|NCT01844778|75721129|FG002|COMPLETED|Overall Study||14||
59610238|NCT01844778|75721127|FG000|NOT COMPLETED|Overall Study||2||
59610239|NCT01844778|75721128|FG001|NOT COMPLETED|Overall Study||3||
59610240|NCT01844778|75721129|FG002|NOT COMPLETED|Overall Study||4||
59610241|NCT01802580|75721143|FG000|STARTED|Overall Study||20||
59610242|NCT01802580|75721144|FG001|STARTED|Overall Study||20||
59610243|NCT01802580|75721143|FG000|COMPLETED|Overall Study||11||
59610244|NCT01802580|75721144|FG001|COMPLETED|Overall Study||9||
59610245|NCT01802580|75721143|FG000|NOT COMPLETED|Overall Study||9||
59610246|NCT01802580|75721144|FG001|NOT COMPLETED|Overall Study||11||
59610247|NCT01611090|75721152|FG000|STARTED|Randomized Period||289||
59610248|NCT01611090|75721153|FG001|STARTED|Randomized Period||289||
59610249|NCT01611090|75721154|FG002|STARTED|Randomized Period||0||
59610250|NCT01611090|75721152|FG000|Treated|Randomized Period||287||
59610251|NCT01611090|75721153|FG001|Treated|Randomized Period||287||
59610252|NCT01611090|75721154|FG002|Treated|Randomized Period||0||
59610253|NCT01611090|75721152|FG000|COMPLETED|Randomized Period||259||
59610254|NCT01611090|75721153|FG001|COMPLETED|Randomized Period||260||
59610255|NCT01611090|75721154|FG002|COMPLETED|Randomized Period||0||
59610256|NCT01611090|75721152|FG000|NOT COMPLETED|Randomized Period||30||
59610257|NCT01611090|75721153|FG001|NOT COMPLETED|Randomized Period||29||
59610258|NCT01611090|75721154|FG002|NOT COMPLETED|Randomized Period||0||
59610259|NCT01611090|75721152|FG000|STARTED|Cross Over (Placebo to Ibrutinib)||0||
59610260|NCT01611090|75721153|FG001|STARTED|Cross Over (Placebo to Ibrutinib)||0||
59610261|NCT01611090|75721154|FG002|STARTED|Cross Over (Placebo to Ibrutinib)||183||
59610262|NCT01611090|75721152|FG000|Treated|Cross Over (Placebo to Ibrutinib)||0||
60013654|NCT02475369|76129582|FG000|COMPLETED|Treatment Period #2 (10 Days)||3||
60013655|NCT02475369|76129583|FG001|COMPLETED|Treatment Period #2 (10 Days)||9||
60013656|NCT02475369|76129582|FG000|NOT COMPLETED|Treatment Period #2 (10 Days)||0||
59610263|NCT01611090|75721153|FG001|Treated|Cross Over (Placebo to Ibrutinib)||0||
59756322|NCT00799617|75875396|FG001|COMPLETED|Vitality Trial||216||
59756323|NCT00799617|75875395|FG000|NOT COMPLETED|Vitality Trial||7||
59756324|NCT00799617|75875396|FG001|NOT COMPLETED|Vitality Trial||22||
59756325|NCT00799617|75875395|FG000|STARTED|Cardiovascular Trial||88||
59756326|NCT00799617|75875396|FG001|STARTED|Cardiovascular Trial||82||
59756327|NCT00799617|75875395|FG000|COMPLETED|Cardiovascular Trial||73||
59756328|NCT00799617|75875396|FG001|COMPLETED|Cardiovascular Trial||65||
59756329|NCT00799617|75875395|FG000|NOT COMPLETED|Cardiovascular Trial||15||
59756330|NCT00799617|75875396|FG001|NOT COMPLETED|Cardiovascular Trial||17||
59756331|NCT00799617|75875395|FG000|STARTED|Bone Trial||110||
59756332|NCT00799617|75875396|FG001|STARTED|Bone Trial||101||
59756333|NCT00799617|75875395|FG000|COMPLETED|Bone Trial||104||
59756334|NCT00799617|75875396|FG001|COMPLETED|Bone Trial||85||
59756335|NCT00799617|75875395|FG000|NOT COMPLETED|Bone Trial||6||
59756336|NCT00799617|75875396|FG001|NOT COMPLETED|Bone Trial||16||
59756337|NCT00799617|75875395|FG000|STARTED|Cognitive Function Trial||247||
59756338|NCT00799617|75875396|FG001|STARTED|Cognitive Function Trial||246||
59756339|NCT00799617|75875395|FG000|COMPLETED|Cognitive Function Trial||247||
59756340|NCT00799617|75875396|FG001|COMPLETED|Cognitive Function Trial||245||
59756341|NCT00799617|75875395|FG000|NOT COMPLETED|Cognitive Function Trial||0||
59756342|NCT00799617|75875396|FG001|NOT COMPLETED|Cognitive Function Trial||1||
59756343|NCT00799617|75875395|FG000|STARTED|Anemia Trial||27||
59756344|NCT00799617|75875396|FG001|STARTED|Anemia Trial||35||
59756345|NCT00799617|75875395|FG000|COMPLETED|Anemia Trial||24||
59756346|NCT00799617|75875396|FG001|COMPLETED|Anemia Trial||32||
59756347|NCT00799617|75875395|FG000|NOT COMPLETED|Anemia Trial||3||
59756348|NCT00799617|75875396|FG001|NOT COMPLETED|Anemia Trial||3||
59756349|NCT00607087|75875405|FG000|STARTED|Overall Study||99||
59610264|NCT01611090|75721154|FG002|Treated|Cross Over (Placebo to Ibrutinib)||183||
59610265|NCT01611090|75721152|FG000|COMPLETED|Cross Over (Placebo to Ibrutinib)||0||
59610266|NCT01611090|75721153|FG001|COMPLETED|Cross Over (Placebo to Ibrutinib)||0||
59610267|NCT01611090|75721154|FG002|COMPLETED|Cross Over (Placebo to Ibrutinib)||178||
59610268|NCT01611090|75721152|FG000|NOT COMPLETED|Cross Over (Placebo to Ibrutinib)||0||
59610269|NCT01611090|75721153|FG001|NOT COMPLETED|Cross Over (Placebo to Ibrutinib)||0||
59610270|NCT01611090|75721154|FG002|NOT COMPLETED|Cross Over (Placebo to Ibrutinib)||5||
59610271|NCT01844700|75721163|FG000|STARTED|Overall Study||4||
59610272|NCT01844700|75721164|FG001|STARTED|Overall Study||3||
59610273|NCT01844700|75721163|FG000|COMPLETED|Overall Study||1||
59610274|NCT01844700|75721164|FG001|COMPLETED|Overall Study||2||
59756350|NCT00607087|75875406|FG001|STARTED|Overall Study||95||
59756351|NCT00607087|75875407|FG002|STARTED|Overall Study||94||
59756352|NCT00607087|75875405|FG000|COMPLETED|Overall Study||84||
59756353|NCT00607087|75875406|FG001|COMPLETED|Overall Study||84||
59610275|NCT01844700|75721163|FG000|NOT COMPLETED|Overall Study||3||
59887910|NCT00835588|76010394|FG000|STARTED|Washout: 5 Days||50||
59887911|NCT00835588|76010395|FG001|STARTED|Washout: 5 Days||50||
59887912|NCT00835588|76010394|FG000|COMPLETED|Washout: 5 Days||50||
59887913|NCT00835588|76010395|FG001|COMPLETED|Washout: 5 Days||50||
59887914|NCT00835588|76010394|FG000|NOT COMPLETED|Washout: 5 Days||0||
59887915|NCT00835588|76010395|FG001|NOT COMPLETED|Washout: 5 Days||0||
59887916|NCT00835588|76010394|FG000|STARTED|Second Intervention||50||
59887917|NCT00835588|76010395|FG001|STARTED|Second Intervention||50||
59887918|NCT00835588|76010394|FG000|COMPLETED|Second Intervention||50||
59887919|NCT00835588|76010395|FG001|COMPLETED|Second Intervention||50||
59887920|NCT00835588|76010394|FG000|NOT COMPLETED|Second Intervention||0||
59887921|NCT00835588|76010395|FG001|NOT COMPLETED|Second Intervention||0||
59887922|NCT03200366|76010402|FG000|STARTED|Baseline Interview With Randomization||123||
59887923|NCT03200366|76010403|FG001|STARTED|Baseline Interview With Randomization||120||
59887924|NCT03200366|76010404|FG002|STARTED|Baseline Interview With Randomization||128||
59887925|NCT03200366|76010402|FG000|COMPLETED|Baseline Interview With Randomization||123||
59887926|NCT03200366|76010403|FG001|COMPLETED|Baseline Interview With Randomization||120||
59887927|NCT03200366|76010404|FG002|COMPLETED|Baseline Interview With Randomization||128||
59887928|NCT03200366|76010402|FG000|NOT COMPLETED|Baseline Interview With Randomization||0||
59887929|NCT03200366|76010403|FG001|NOT COMPLETED|Baseline Interview With Randomization||0||
59887930|NCT03200366|76010404|FG002|NOT COMPLETED|Baseline Interview With Randomization||0||
59887931|NCT03200366|76010402|FG000|STARTED|Tailored DVD Intervention Given||123||
59887932|NCT03200366|76010403|FG001|STARTED|Tailored DVD Intervention Given||120||
59887933|NCT03200366|76010404|FG002|STARTED|Tailored DVD Intervention Given||0||
59887934|NCT03200366|76010402|FG000|COMPLETED|Tailored DVD Intervention Given||123|Tailored DVD mailed 1-2 days post-randomization to participants in the 2 intervention arms: Tailored DVD and Tailored DVD + Patient Navigation. DVD was NOT mailed to participants in Usual Care arm.|
59887935|NCT03200366|76010403|FG001|COMPLETED|Tailored DVD Intervention Given||120|Tailored DVD mailed 1-2 days post-randomization to participants in the 2 intervention arms: Tailored DVD and Tailored DVD + Patient Navigation. DVD was NOT mailed to participants in Usual Care arm.|
59887936|NCT03200366|76010404|FG002|COMPLETED|Tailored DVD Intervention Given||0|Tailored DVD mailed 1-2 days post-randomization to participants in the 2 intervention arms: Tailored DVD and Tailored DVD + Patient Navigation. DVD was NOT mailed to participants in Usual Care arm.|
59887937|NCT03200366|76010402|FG000|NOT COMPLETED|Tailored DVD Intervention Given||0||
59887938|NCT03200366|76010403|FG001|NOT COMPLETED|Tailored DVD Intervention Given||0||
59887939|NCT03200366|76010404|FG002|NOT COMPLETED|Tailored DVD Intervention Given||0||
59887940|NCT03200366|76010402|FG000|STARTED|Patient Navigation Intervention Given||0|Patient Navigation delivered from 2 weeks post-randomization up to 6 months post-randomization to only participants in Tailored DVD + Patient Navigation arm.|
59887941|NCT03200366|76010403|FG001|STARTED|Patient Navigation Intervention Given||120|Patient Navigation delivered from 2 weeks post-randomization up to 6 months post-randomization to only participants in Tailored DVD + Patient Navigation arm.|
59887942|NCT03200366|76010404|FG002|STARTED|Patient Navigation Intervention Given||0|Patient Navigation delivered from 2 weeks post-randomization up to 6 months post-randomization to only participants in Tailored DVD + Patient Navigation arm.|
59887943|NCT03200366|76010402|FG000|COMPLETED|Patient Navigation Intervention Given||0||
59887944|NCT03200366|76010403|FG001|COMPLETED|Patient Navigation Intervention Given||89||
59887945|NCT03200366|76010404|FG002|COMPLETED|Patient Navigation Intervention Given||0||
59887946|NCT03200366|76010402|FG000|NOT COMPLETED|Patient Navigation Intervention Given||0||
59887947|NCT03200366|76010403|FG001|NOT COMPLETED|Patient Navigation Intervention Given||31||
59887948|NCT03200366|76010404|FG002|NOT COMPLETED|Patient Navigation Intervention Given||0||
59887949|NCT03200366|76010402|FG000|STARTED|6 Month Post-Baseline Interview||123|"Started number excludes 2 participants in Tailored DVD +Patient Navigation arm that were deceased before 6 month post-baseline timepoint."|
59887950|NCT03200366|76010403|FG001|STARTED|6 Month Post-Baseline Interview||118|"Started number excludes 2 participants in Tailored DVD +Patient Navigation arm that were deceased before 6 month post-baseline timepoint."|
59887951|NCT03200366|76010404|FG002|STARTED|6 Month Post-Baseline Interview||128|"Started number excludes 2 participants in Tailored DVD +Patient Navigation arm that were deceased before 6 month post-baseline timepoint."|
59887952|NCT03200366|76010402|FG000|COMPLETED|6 Month Post-Baseline Interview||93||
59887953|NCT03200366|76010403|FG001|COMPLETED|6 Month Post-Baseline Interview||95||
59887954|NCT03200366|76010404|FG002|COMPLETED|6 Month Post-Baseline Interview||109||
59887955|NCT03200366|76010402|FG000|NOT COMPLETED|6 Month Post-Baseline Interview||30||
59887956|NCT03200366|76010403|FG001|NOT COMPLETED|6 Month Post-Baseline Interview||23||
59887957|NCT03200366|76010404|FG002|NOT COMPLETED|6 Month Post-Baseline Interview||19||
59887958|NCT03200366|76010402|FG000|STARTED|9 Month Post-Baseline Interview||121|"Started number excludes participants that were deceased or withdrawn before 9 month post-baseline timepoint: Tailored DVD arm n=2; Tailored DVD + Patient Navigation arm n=4; and Usual Care arm n=1."|
59887959|NCT03200366|76010403|FG001|STARTED|9 Month Post-Baseline Interview||116|"Started number excludes participants that were deceased or withdrawn before 9 month post-baseline timepoint: Tailored DVD arm n=2; Tailored DVD + Patient Navigation arm n=4; and Usual Care arm n=1."|
60013657|NCT02475369|76129583|FG001|NOT COMPLETED|Treatment Period #2 (10 Days)||0||
60013658|NCT02474589|76129596|FG000|STARTED|Overall Study||359||
60013659|NCT02474589|76129597|FG001|STARTED|Overall Study||90||
60013660|NCT02474589|76129596|FG000|COMPLETED|Overall Study||334||
60013661|NCT02474589|76129597|FG001|COMPLETED|Overall Study||85||
60013662|NCT02474589|76129596|FG000|NOT COMPLETED|Overall Study||25||
59610276|NCT01844700|75721164|FG001|NOT COMPLETED|Overall Study||1||
59610277|NCT01844076|75721174|FG000|STARTED|Overall Study||3||
59610278|NCT01844076|75721175|FG001|STARTED|Overall Study||6||
59610279|NCT01844076|75721176|FG002|STARTED|Overall Study||3||
59610280|NCT01844076|75721177|FG003|STARTED|Overall Study||7||
59610281|NCT01844076|75721174|FG000|COMPLETED|Overall Study||1||
59610282|NCT01844076|75721175|FG001|COMPLETED|Overall Study||6||
59610283|NCT01844076|75721176|FG002|COMPLETED|Overall Study||3||
59610284|NCT01844076|75721177|FG003|COMPLETED|Overall Study||7||
59610285|NCT01844076|75721174|FG000|NOT COMPLETED|Overall Study||2||
59610286|NCT01844076|75721175|FG001|NOT COMPLETED|Overall Study||0||
59610287|NCT01844076|75721176|FG002|NOT COMPLETED|Overall Study||0||
59610288|NCT01844076|75721177|FG003|NOT COMPLETED|Overall Study||0||
59610289|NCT01826604|75721189|FG000|STARTED|Overall Study||144||
59756354|NCT00607087|75875407|FG002|COMPLETED|Overall Study||84||
59756355|NCT00607087|75875405|FG000|NOT COMPLETED|Overall Study||15||
59756356|NCT00607087|75875406|FG001|NOT COMPLETED|Overall Study||11||
59756357|NCT00607087|75875407|FG002|NOT COMPLETED|Overall Study||10||
59756358|NCT00607087|75875405|FG000|STARTED|Period 1||99||
59756359|NCT00607087|75875406|FG001|STARTED|Period 1||95||
59756360|NCT00607087|75875407|FG002|STARTED|Period 1||94||
59756361|NCT00607087|75875405|FG000|COMPLETED|Period 1||87||
59756362|NCT00607087|75875406|FG001|COMPLETED|Period 1||89||
59756363|NCT00607087|75875407|FG002|COMPLETED|Period 1||89||
59756364|NCT00607087|75875405|FG000|NOT COMPLETED|Period 1||12||
59756365|NCT00607087|75875406|FG001|NOT COMPLETED|Period 1||6||
59756366|NCT00607087|75875407|FG002|NOT COMPLETED|Period 1||5||
59756367|NCT00607087|75875405|FG000|STARTED|Period 2||87||
59756368|NCT00607087|75875406|FG001|STARTED|Period 2||89||
59756369|NCT00607087|75875407|FG002|STARTED|Period 2||89||
59756370|NCT00607087|75875405|FG000|COMPLETED|Period 2||86||
59756371|NCT00607087|75875406|FG001|COMPLETED|Period 2||86||
59756372|NCT00607087|75875407|FG002|COMPLETED|Period 2||84||
59756373|NCT00607087|75875405|FG000|NOT COMPLETED|Period 2||1||
59756374|NCT00607087|75875406|FG001|NOT COMPLETED|Period 2||3||
59756375|NCT00607087|75875407|FG002|NOT COMPLETED|Period 2||5||
59756376|NCT00607087|75875405|FG000|STARTED|Period 3||86||
59756377|NCT00607087|75875406|FG001|STARTED|Period 3||86||
59756378|NCT00607087|75875407|FG002|STARTED|Period 3||84||
59756379|NCT00607087|75875405|FG000|COMPLETED|Period 3||84||
59756380|NCT00607087|75875406|FG001|COMPLETED|Period 3||84||
59756381|NCT00607087|75875407|FG002|COMPLETED|Period 3||84||
59756382|NCT00607087|75875405|FG000|NOT COMPLETED|Period 3||2||
59756383|NCT00607087|75875406|FG001|NOT COMPLETED|Period 3||2||
59756384|NCT00607087|75875407|FG002|NOT COMPLETED|Period 3||0||
59756385|NCT00610363|75875417|FG000|STARTED|Overall Study||42||
59756386|NCT00610363|75875418|FG001|STARTED|Overall Study||41||
59756387|NCT00610363|75875417|FG000|COMPLETED|Overall Study||31||
59756388|NCT00610363|75875418|FG001|COMPLETED|Overall Study||38||
59756389|NCT00610363|75875417|FG000|NOT COMPLETED|Overall Study||11||
59756390|NCT00610363|75875418|FG001|NOT COMPLETED|Overall Study||3||
59756391|NCT00887588|75875427|FG000|STARTED|Core Period||149||
59756392|NCT00887588|75875428|FG001|STARTED|Core Period||152||
59756393|NCT00887588|75875427|FG000|Extension Efficacy Set|Core Period||127||
59756394|NCT00887588|75875428|FG001|Extension Efficacy Set|Core Period||125||
59756395|NCT00887588|75875427|FG000|Full Analysis Set|Core Period||148||
59756396|NCT00887588|75875428|FG001|Full Analysis Set|Core Period||146||
59756397|NCT00887588|75875427|FG000|Arterial Stiffness Set|Core Period||86||
59756398|NCT00887588|75875428|FG001|Arterial Stiffness Set|Core Period||94||
59756399|NCT00887588|75875427|FG000|COMPLETED|Core Period||130||
59756400|NCT00887588|75875428|FG001|COMPLETED|Core Period||131||
59756401|NCT00887588|75875427|FG000|NOT COMPLETED|Core Period||19||
59756402|NCT00887588|75875428|FG001|NOT COMPLETED|Core Period||21||
59756403|NCT00887588|75875427|FG000|STARTED|Extension Period||127||
59756404|NCT00887588|75875428|FG001|STARTED|Extension Period||125||
59756405|NCT00887588|75875427|FG000|Arterial Stiffness Set|Extension Period||86||
59756406|NCT00887588|75875428|FG001|Arterial Stiffness Set|Extension Period||94||
59756407|NCT00887588|75875427|FG000|COMPLETED|Extension Period||121||
59756408|NCT00887588|75875428|FG001|COMPLETED|Extension Period||120||
59756409|NCT00887588|75875427|FG000|NOT COMPLETED|Extension Period||6||
59756410|NCT00887588|75875428|FG001|NOT COMPLETED|Extension Period||5||
59756411|NCT00945893|75875436|FG000|STARTED|Overall Study||60||
59756412|NCT00945893|75875437|FG001|STARTED|Overall Study||240||
59756413|NCT00945893|75875436|FG000|Day 15 Post Dose 1|Overall Study||60||
59756414|NCT00945893|75875437|FG001|Day 15 Post Dose 1|Overall Study||238||
59756415|NCT00945893|75875436|FG000|Day 15 Post Dose 2|Overall Study||54||
59756416|NCT00945893|75875437|FG001|Day 15 Post Dose 2|Overall Study||226||
59756417|NCT00945893|75875436|FG000|COMPLETED|Overall Study||57||
59756418|NCT00945893|75875437|FG001|COMPLETED|Overall Study||230||
59756419|NCT00945893|75875436|FG000|NOT COMPLETED|Overall Study||3||
59756420|NCT00945893|75875437|FG001|NOT COMPLETED|Overall Study||10||
59756421|NCT00799383|75875449|FG000|STARTED|Overall Study||23||
59756422|NCT00799383|75875450|FG001|STARTED|Overall Study||24||
59756423|NCT00799383|75875449|FG000|COMPLETED|Overall Study||20||
59887960|NCT03200366|76010404|FG002|STARTED|9 Month Post-Baseline Interview||127|"Started number excludes participants that were deceased or withdrawn before 9 month post-baseline timepoint: Tailored DVD arm n=2; Tailored DVD + Patient Navigation arm n=4; and Usual Care arm n=1."|
59887961|NCT03200366|76010402|FG000|COMPLETED|9 Month Post-Baseline Interview||97||
59887962|NCT03200366|76010403|FG001|COMPLETED|9 Month Post-Baseline Interview||95||
59887963|NCT03200366|76010404|FG002|COMPLETED|9 Month Post-Baseline Interview||116||
59887964|NCT03200366|76010402|FG000|NOT COMPLETED|9 Month Post-Baseline Interview||24||
59887965|NCT03200366|76010403|FG001|NOT COMPLETED|9 Month Post-Baseline Interview||21||
59887966|NCT03200366|76010404|FG002|NOT COMPLETED|9 Month Post-Baseline Interview||11||
59887967|NCT00835354|76010416|FG000|STARTED|First Intervention||13||
59887968|NCT00835354|76010417|FG001|STARTED|First Intervention||13||
59887969|NCT00835354|76010416|FG000|COMPLETED|First Intervention||13||
59887970|NCT00835354|76010417|FG001|COMPLETED|First Intervention||12||
59887971|NCT00835354|76010416|FG000|NOT COMPLETED|First Intervention||0||
59887972|NCT00835354|76010417|FG001|NOT COMPLETED|First Intervention||1||
59887973|NCT00835354|76010416|FG000|STARTED|Washout of 7 Days||13||
59887974|NCT00835354|76010417|FG001|STARTED|Washout of 7 Days||12||
59887975|NCT00835354|76010416|FG000|COMPLETED|Washout of 7 Days||13||
59887976|NCT00835354|76010417|FG001|COMPLETED|Washout of 7 Days||12||
59887977|NCT00835354|76010416|FG000|NOT COMPLETED|Washout of 7 Days||0||
59887978|NCT00835354|76010417|FG001|NOT COMPLETED|Washout of 7 Days||0||
59887979|NCT00835354|76010416|FG000|STARTED|Second Intervention||13||
59887980|NCT00835354|76010417|FG001|STARTED|Second Intervention||12||
59887981|NCT00835354|76010416|FG000|COMPLETED|Second Intervention||13||
59887982|NCT00835354|76010417|FG001|COMPLETED|Second Intervention||12||
59887983|NCT00835354|76010416|FG000|NOT COMPLETED|Second Intervention||0||
59887984|NCT00835354|76010417|FG001|NOT COMPLETED|Second Intervention||0||
59887985|NCT00835276|76010423|FG000|STARTED|First Intervention||24||
59887986|NCT00835276|76010424|FG001|STARTED|First Intervention||24||
59887987|NCT00835276|76010423|FG000|COMPLETED|First Intervention||24||
59887988|NCT00835276|76010424|FG001|COMPLETED|First Intervention||24||
59887989|NCT00835276|76010423|FG000|NOT COMPLETED|First Intervention||0||
59887990|NCT00835276|76010424|FG001|NOT COMPLETED|First Intervention||0||
59887991|NCT00835276|76010423|FG000|STARTED|Washout of 7 Days||24||
59887992|NCT00835276|76010424|FG001|STARTED|Washout of 7 Days||24||
59887993|NCT00835276|76010423|FG000|COMPLETED|Washout of 7 Days||24||
59887994|NCT00835276|76010424|FG001|COMPLETED|Washout of 7 Days||24||
59887995|NCT00835276|76010423|FG000|NOT COMPLETED|Washout of 7 Days||0||
59887996|NCT00835276|76010424|FG001|NOT COMPLETED|Washout of 7 Days||0||
59887997|NCT00835276|76010423|FG000|STARTED|Second Intervention||24||
59887998|NCT00835276|76010424|FG001|STARTED|Second Intervention||24||
59887999|NCT00835276|76010423|FG000|COMPLETED|Second Intervention||24||
59888000|NCT00835276|76010424|FG001|COMPLETED|Second Intervention||24||
59888001|NCT00835276|76010423|FG000|NOT COMPLETED|Second Intervention||0||
59888002|NCT00835276|76010424|FG001|NOT COMPLETED|Second Intervention||0||
59888003|NCT03344536|76010430|FG000|STARTED|Overall Study||10||
59888004|NCT03344536|76010431|FG001|STARTED|Overall Study||0||
59888005|NCT03344536|76010430|FG000|COMPLETED|Overall Study||10||
59888006|NCT03344536|76010431|FG001|COMPLETED|Overall Study||0||
59888007|NCT03344536|76010430|FG000|NOT COMPLETED|Overall Study||0||
59888008|NCT03344536|76010431|FG001|NOT COMPLETED|Overall Study||0||
59888009|NCT03299062|76010439|FG000|STARTED|Overall Study||4||
59888010|NCT03299062|76010440|FG001|STARTED|Overall Study||5||
59888011|NCT03299062|76010439|FG000|COMPLETED|Overall Study||4||
59888012|NCT03299062|76010440|FG001|COMPLETED|Overall Study||5||
59888013|NCT03299062|76010439|FG000|NOT COMPLETED|Overall Study||0||
59888014|NCT03299062|76010440|FG001|NOT COMPLETED|Overall Study||0||
59888015|NCT00835042|76010448|FG000|STARTED|First Intervention||30||
59888016|NCT00835042|76010449|FG001|STARTED|First Intervention||28||
59888017|NCT00835042|76010448|FG000|COMPLETED|First Intervention||26||
59888018|NCT00835042|76010449|FG001|COMPLETED|First Intervention||26||
59888019|NCT00835042|76010448|FG000|NOT COMPLETED|First Intervention||4||
59888020|NCT00835042|76010449|FG001|NOT COMPLETED|First Intervention||2||
59888021|NCT00835042|76010448|FG000|STARTED|Washout of 21 Days||26||
59888022|NCT00835042|76010449|FG001|STARTED|Washout of 21 Days||26||
59888023|NCT00835042|76010448|FG000|COMPLETED|Washout of 21 Days||26||
59888024|NCT00835042|76010449|FG001|COMPLETED|Washout of 21 Days||24||
59888025|NCT00835042|76010448|FG000|NOT COMPLETED|Washout of 21 Days||0||
59888026|NCT00835042|76010449|FG001|NOT COMPLETED|Washout of 21 Days||2||
59888027|NCT00835042|76010448|FG000|STARTED|Second Intervention||26||
59888028|NCT00835042|76010449|FG001|STARTED|Second Intervention||24||
59888029|NCT00835042|76010448|FG000|COMPLETED|Second Intervention||26||
59888030|NCT00835042|76010449|FG001|COMPLETED|Second Intervention||24||
59888031|NCT00835042|76010448|FG000|NOT COMPLETED|Second Intervention||0||
59888032|NCT00835042|76010449|FG001|NOT COMPLETED|Second Intervention||0||
59888033|NCT03290248|76010456|FG000|STARTED|Study Part 1||8||
59888034|NCT03290248|76010457|FG001|STARTED|Study Part 1||8||
59888035|NCT03290248|76010458|FG002|STARTED|Study Part 1||8||
59888036|NCT03290248|76010456|FG000|COMPLETED|Study Part 1||8||
59888037|NCT03290248|76010457|FG001|COMPLETED|Study Part 1||8||
59888038|NCT03290248|76010458|FG002|COMPLETED|Study Part 1||8||
59888039|NCT03290248|76010456|FG000|NOT COMPLETED|Study Part 1||0||
59888040|NCT03290248|76010457|FG001|NOT COMPLETED|Study Part 1||0||
59888041|NCT03290248|76010458|FG002|NOT COMPLETED|Study Part 1||0||
59888042|NCT03290248|76010456|FG000|STARTED|Study Part 2||15||
59888043|NCT03290248|76010457|FG001|STARTED|Study Part 2||16||
59888044|NCT03290248|76010458|FG002|STARTED|Study Part 2||16||
59888045|NCT03290248|76010456|FG000|COMPLETED|Study Part 2||15||
59888046|NCT03290248|76010457|FG001|COMPLETED|Study Part 2||16||
59888047|NCT03290248|76010458|FG002|COMPLETED|Study Part 2||16||
59888048|NCT03290248|76010456|FG000|NOT COMPLETED|Study Part 2||0||
59888049|NCT03290248|76010457|FG001|NOT COMPLETED|Study Part 2||0||
59888050|NCT03290248|76010458|FG002|NOT COMPLETED|Study Part 2||0||
59888051|NCT00834964|76010472|FG000|STARTED|First Intervention||15||
59888052|NCT00834964|76010473|FG001|STARTED|First Intervention||15||
59888053|NCT00834964|76010472|FG000|COMPLETED|First Intervention||15||
59888054|NCT00834964|76010473|FG001|COMPLETED|First Intervention||15||
59888055|NCT00834964|76010472|FG000|NOT COMPLETED|First Intervention||0||
59888056|NCT00834964|76010473|FG001|NOT COMPLETED|First Intervention||0||
59888057|NCT00834964|76010472|FG000|STARTED|Washout: 7 Days||15||
59888058|NCT00834964|76010473|FG001|STARTED|Washout: 7 Days||15||
59888059|NCT00834964|76010472|FG000|COMPLETED|Washout: 7 Days||15||
59888060|NCT00834964|76010473|FG001|COMPLETED|Washout: 7 Days||15||
59888061|NCT00834964|76010472|FG000|NOT COMPLETED|Washout: 7 Days||0||
59888062|NCT00834964|76010473|FG001|NOT COMPLETED|Washout: 7 Days||0||
59888063|NCT00834964|76010472|FG000|STARTED|Second Intervention||15||
59888064|NCT00834964|76010473|FG001|STARTED|Second Intervention||15||
59888065|NCT00834964|76010472|FG000|COMPLETED|Second Intervention||15||
59888066|NCT00834964|76010473|FG001|COMPLETED|Second Intervention||15||
59888067|NCT00834964|76010472|FG000|NOT COMPLETED|Second Intervention||0||
59888068|NCT00834964|76010473|FG001|NOT COMPLETED|Second Intervention||0||
59888069|NCT00834574|76010479|FG000|STARTED|First Intervention||16||
59888070|NCT00834574|76010480|FG001|STARTED|First Intervention||16||
59888071|NCT00834574|76010479|FG000|COMPLETED|First Intervention||16||
59888072|NCT00834574|76010480|FG001|COMPLETED|First Intervention||16||
59888073|NCT00834574|76010479|FG000|NOT COMPLETED|First Intervention||0||
59888074|NCT00834574|76010480|FG001|NOT COMPLETED|First Intervention||0||
60013663|NCT02474589|76129597|FG001|NOT COMPLETED|Overall Study||5||
59505390|NCT00719615|75598114|FG000|NOT COMPLETED|Overall Study||0||
59610290|NCT01826604|75721190|FG001|STARTED|Overall Study||157||
59610291|NCT01826604|75721189|FG000|COMPLETED|Overall Study||136||
59610292|NCT01826604|75721190|FG001|COMPLETED|Overall Study||148||
59610293|NCT01826604|75721189|FG000|NOT COMPLETED|Overall Study||8||
59610294|NCT01826604|75721190|FG001|NOT COMPLETED|Overall Study||9||
59610295|NCT01843842|75721198|FG000|STARTED|Overall Study||154||
59610296|NCT01843842|75721199|FG001|STARTED|Overall Study||152||
59610297|NCT01843842|75721198|FG000|COMPLETED|Overall Study||153||
59610298|NCT01843842|75721199|FG001|COMPLETED|Overall Study||151||
59610299|NCT01843842|75721198|FG000|NOT COMPLETED|Overall Study||1||
59610300|NCT01843842|75721199|FG001|NOT COMPLETED|Overall Study||1||
59610301|NCT01826448|75721207|FG000|STARTED|Overall Study||4||
59610302|NCT01826448|75721208|FG001|STARTED|Overall Study||9||
59610303|NCT01826448|75721207|FG000|COMPLETED|Overall Study||0||
59610304|NCT01826448|75721208|FG001|COMPLETED|Overall Study||0||
59610305|NCT01826448|75721207|FG000|NOT COMPLETED|Overall Study||4||
59505391|NCT00719615|75598115|FG001|NOT COMPLETED|Overall Study||0||
59505392|NCT00719615|75598116|FG002|NOT COMPLETED|Overall Study||0||
59505393|NCT02394548|75598124|FG000|STARTED|Overall Study||26||
59505394|NCT02394548|75598124|FG000|COMPLETED|Overall Study||25||
59505395|NCT02394548|75598124|FG000|NOT COMPLETED|Overall Study||1||
59505396|NCT00720473|75598130|FG000|STARTED|Overall Study||45||
59505397|NCT00720473|75598131|FG001|STARTED|Overall Study||24||
59505398|NCT00720473|75598130|FG000|COMPLETED|Overall Study||15||
59505399|NCT00720473|75598131|FG001|COMPLETED|Overall Study||16||
59505400|NCT00720473|75598130|FG000|NOT COMPLETED|Overall Study||30||
59505401|NCT00720473|75598131|FG001|NOT COMPLETED|Overall Study||8||
59505402|NCT01277887|75598140|FG000|STARTED|Pre-Quit Treatment Phase||9||
59505403|NCT01277887|75598141|FG001|STARTED|Pre-Quit Treatment Phase||10||
59505404|NCT01277887|75598140|FG000|Entered Study|Pre-Quit Treatment Phase||7||
59505405|NCT01277887|75598141|FG001|Entered Study|Pre-Quit Treatment Phase||10||
59505406|NCT01277887|75598140|FG000|COMPLETED|Pre-Quit Treatment Phase||6||
59505407|NCT01277887|75598141|FG001|COMPLETED|Pre-Quit Treatment Phase||10||
59505408|NCT01277887|75598140|FG000|NOT COMPLETED|Pre-Quit Treatment Phase||3||
59505409|NCT01277887|75598141|FG001|NOT COMPLETED|Pre-Quit Treatment Phase||0||
59610306|NCT01826448|75721208|FG001|NOT COMPLETED|Overall Study||9||
59610307|NCT01826370|75721214|FG000|STARTED|Overall Study||678||
59610308|NCT01826370|75721214|FG000|COMPLETED|Overall Study||658||
59610309|NCT01826370|75721214|FG000|NOT COMPLETED|Overall Study||20||
59888075|NCT00834574|76010479|FG000|STARTED|Washout of 7 Days||16||
59888076|NCT00834574|76010480|FG001|STARTED|Washout of 7 Days||16||
59888077|NCT00834574|76010479|FG000|COMPLETED|Washout of 7 Days||16||
59505410|NCT01277887|75598140|FG000|STARTED|Post-Quit Treatment Phase||6||
59505411|NCT01277887|75598141|FG001|STARTED|Post-Quit Treatment Phase||10||
59610310|NCT01826214|75721220|FG000|STARTED|Overall Study||35||
59888078|NCT00834574|76010480|FG001|COMPLETED|Washout of 7 Days||16||
59505412|NCT01277887|75598140|FG000|COMPLETED|Post-Quit Treatment Phase||3||
59505413|NCT01277887|75598141|FG001|COMPLETED|Post-Quit Treatment Phase||5||
59505414|NCT01277887|75598140|FG000|NOT COMPLETED|Post-Quit Treatment Phase||3||
59505415|NCT01277887|75598141|FG001|NOT COMPLETED|Post-Quit Treatment Phase||5||
59505416|NCT00720629|75598147|FG000|STARTED|Overall Study||8||
59505417|NCT00720629|75598147|FG000|COMPLETED|Overall Study||8||
59505418|NCT00720629|75598147|FG000|NOT COMPLETED|Overall Study||0||
59505419|NCT01276327|75598155|FG000|STARTED|Overall Study||32||
59505420|NCT01276327|75598156|FG001|STARTED|Overall Study||32||
59505421|NCT01276327|75598155|FG000|COMPLETED|Overall Study||30||
59505422|NCT01276327|75598156|FG001|COMPLETED|Overall Study||29||
59505423|NCT01276327|75598155|FG000|NOT COMPLETED|Overall Study||2||
59505424|NCT01276327|75598156|FG001|NOT COMPLETED|Overall Study||3||
59505425|NCT00721175|75598164|FG000|STARTED|Overall Study||54||
59505426|NCT00721175|75598165|FG001|STARTED|Overall Study||54||
59505427|NCT00721175|75598164|FG000|COMPLETED|Overall Study||54||
59505428|NCT00721175|75598165|FG001|COMPLETED|Overall Study||54||
59505429|NCT00721175|75598164|FG000|NOT COMPLETED|Overall Study||0||
59888079|NCT00834574|76010479|FG000|NOT COMPLETED|Washout of 7 Days||0||
59888080|NCT00834574|76010480|FG001|NOT COMPLETED|Washout of 7 Days||0||
59505430|NCT00721175|75598165|FG001|NOT COMPLETED|Overall Study||0||
59505431|NCT00760435|75598173|FG000|STARTED|Overall Study||98||
59505432|NCT00760435|75598174|FG001|STARTED|Overall Study||98||
59505433|NCT00760435|75598173|FG000|COMPLETED|Overall Study||94||
59505434|NCT00760435|75598174|FG001|COMPLETED|Overall Study||93||
59505435|NCT00760435|75598173|FG000|NOT COMPLETED|Overall Study||4||
59756424|NCT00799383|75875450|FG001|COMPLETED|Overall Study||18||
59756425|NCT00799383|75875449|FG000|NOT COMPLETED|Overall Study||3||
59756426|NCT00799383|75875450|FG001|NOT COMPLETED|Overall Study||6||
59756427|NCT00610207|75875456|FG000|STARTED|Overall Study||21||
59756428|NCT00610207|75875456|FG000|COMPLETED|Overall Study||18||
59756429|NCT00610207|75875456|FG000|NOT COMPLETED|Overall Study||3||
59505436|NCT00760435|75598174|FG001|NOT COMPLETED|Overall Study||5||
59505437|NCT02144597|75598183|FG000|STARTED|Overall Study||10||
59505438|NCT02144597|75598184|FG001|STARTED|Overall Study||10||
59505439|NCT02144597|75598185|FG002|STARTED|Overall Study||10||
59505440|NCT02144597|75598183|FG000|COMPLETED|Overall Study||4||
59505441|NCT02144597|75598184|FG001|COMPLETED|Overall Study||6||
59505442|NCT02144597|75598185|FG002|COMPLETED|Overall Study||6||
59505443|NCT02144597|75598183|FG000|NOT COMPLETED|Overall Study||6||
59756430|NCT00798759|75875462|FG000|STARTED|Overall Study||117||
59756431|NCT00798759|75875463|FG001|STARTED|Overall Study||119||
59756432|NCT00798759|75875462|FG000|COMPLETED|Overall Study||109||
59756433|NCT00798759|75875463|FG001|COMPLETED|Overall Study||106||
59756434|NCT00798759|75875462|FG000|NOT COMPLETED|Overall Study||8||
59756435|NCT00798759|75875463|FG001|NOT COMPLETED|Overall Study||13||
59756436|NCT00887432|75875471|FG000|STARTED|Overall Study||58||
59756437|NCT00887432|75875472|FG001|STARTED|Overall Study||74||
59756438|NCT00887432|75875471|FG000|COMPLETED|Overall Study||43||
59756439|NCT00887432|75875472|FG001|COMPLETED|Overall Study||60||
59756440|NCT00887432|75875471|FG000|NOT COMPLETED|Overall Study||15||
59756441|NCT00887432|75875472|FG001|NOT COMPLETED|Overall Study||14||
59756442|NCT00951275|75875478|FG000|STARTED|Overall Study||105||
59756443|NCT00951275|75875478|FG000|COMPLETED|Overall Study||92||
59756444|NCT00951275|75875478|FG000|NOT COMPLETED|Overall Study||13||
59756445|NCT00798603|75875482|FG000|STARTED|Overall Study||62||
59613506|NCT01684722|75724628|FG001|NOT COMPLETED|Overall Study||77||
59756446|NCT00798603|75875482|FG000|COMPLETED|Overall Study||27||
59756447|NCT00798603|75875482|FG000|NOT COMPLETED|Overall Study||35||
59756448|NCT00887354|75875488|FG000|STARTED|Treatment Phase (Week 0 to Week 26)||111||
59756449|NCT00887354|75875489|FG001|STARTED|Treatment Phase (Week 0 to Week 26)||113||
59756450|NCT00887354|75875488|FG000|Received at Least 1 Dose of Study Drug|Treatment Phase (Week 0 to Week 26)||106||
59756451|NCT00887354|75875489|FG001|Received at Least 1 Dose of Study Drug|Treatment Phase (Week 0 to Week 26)||110||
59756452|NCT00887354|75875488|FG000|Included in Full Analysis Set|Treatment Phase (Week 0 to Week 26)||86||
59756453|NCT00887354|75875489|FG001|Included in Full Analysis Set|Treatment Phase (Week 0 to Week 26)||85||
59756454|NCT00887354|75875488|FG000|COMPLETED|Treatment Phase (Week 0 to Week 26)||60||
59756455|NCT00887354|75875489|FG001|COMPLETED|Treatment Phase (Week 0 to Week 26)||65||
59756456|NCT00887354|75875488|FG000|NOT COMPLETED|Treatment Phase (Week 0 to Week 26)||51||
59756457|NCT00887354|75875489|FG001|NOT COMPLETED|Treatment Phase (Week 0 to Week 26)||48||
59756458|NCT00887354|75875488|FG000|STARTED|Open Label Phase (Week 26 to Week 78)||60||
59756459|NCT00887354|75875489|FG001|STARTED|Open Label Phase (Week 26 to Week 78)||65||
59756460|NCT00887354|75875488|FG000|COMPLETED|Open Label Phase (Week 26 to Week 78)||57||
59756461|NCT00887354|75875489|FG001|COMPLETED|Open Label Phase (Week 26 to Week 78)||59||
59756462|NCT00887354|75875488|FG000|NOT COMPLETED|Open Label Phase (Week 26 to Week 78)||3||
59756463|NCT00887354|75875489|FG001|NOT COMPLETED|Open Label Phase (Week 26 to Week 78)||6||
59505444|NCT02144597|75598184|FG001|NOT COMPLETED|Overall Study||4||
59505445|NCT02144597|75598185|FG002|NOT COMPLETED|Overall Study||4||
59505446|NCT00749125|75598195|FG000|STARTED|Overall Study||47||
59505447|NCT00749125|75598196|FG001|STARTED|Overall Study||52||
59505448|NCT00749125|75598195|FG000|COMPLETED|Overall Study||36||
59756464|NCT00951041|75875498|FG000|STARTED|Overall Study||64||
59756465|NCT00951041|75875499|FG001|STARTED|Overall Study||66||
59756466|NCT00951041|75875498|FG000|COMPLETED|Overall Study||59||
59756467|NCT00951041|75875499|FG001|COMPLETED|Overall Study||65||
59756468|NCT00951041|75875498|FG000|NOT COMPLETED|Overall Study||5||
59756469|NCT00951041|75875499|FG001|NOT COMPLETED|Overall Study||1||
59756470|NCT02763462|75875506|FG000|STARTED|Overall Study||1492||
59756471|NCT02763462|75875506|FG000|COMPLETED|Overall Study||1486||
59610311|NCT01826214|75721221|FG001|STARTED|Overall Study|35 patients were randomized but only 34 patients received at least one dose of study drug|34||
59610312|NCT01826214|75721220|FG000|Untreated|Overall Study|Untreated = did not receive study drug|0||
59610313|NCT01826214|75721221|FG001|Untreated|Overall Study|Untreated = did not receive study drug|1||
59610314|NCT01826214|75721220|FG000|Treated|Overall Study|Treated = received at least one dose of study drug|35||
59610315|NCT01826214|75721221|FG001|Treated|Overall Study|Treated = received at least one dose of study drug|34||
59610316|NCT01826214|75721220|FG000|COMPLETED|Overall Study||0||
59610317|NCT01826214|75721221|FG001|COMPLETED|Overall Study||0||
59610318|NCT01826214|75721220|FG000|NOT COMPLETED|Overall Study||35||
59610319|NCT01826214|75721221|FG001|NOT COMPLETED|Overall Study||34||
59610320|NCT01843062|75721229|FG000|STARTED|Overall Study||155||
59756472|NCT02763462|75875506|FG000|NOT COMPLETED|Overall Study||6||
59756473|NCT00610129|75875520|FG000|STARTED|Overall Study||28||
59756474|NCT00610129|75875520|FG000|COMPLETED|Overall Study||25||
59756475|NCT00610129|75875520|FG000|NOT COMPLETED|Overall Study||3||
59756476|NCT00945815|75875524|FG000|STARTED|Overall Study||35||
59756477|NCT00945815|75875524|FG000|Eligible|Overall Study||32||
59756478|NCT00945815|75875524|FG000|Eligible and Began Protocol Therapy|Overall Study||31||
59756479|NCT00945815|75875524|FG000|COMPLETED|Overall Study||27||
59756480|NCT00945815|75875524|FG000|NOT COMPLETED|Overall Study||8||
59756481|NCT00606307|75875528|FG000|STARTED|Overall Study||29||
59756482|NCT00606307|75875528|FG000|COMPLETED|Overall Study||18||
59756483|NCT00606307|75875528|FG000|NOT COMPLETED|Overall Study||11||
59756484|NCT00798369|75875538|FG000|STARTED|Overall Study||28||
59756485|NCT00798369|75875539|FG001|STARTED|Overall Study||29||
59756486|NCT00798369|75875540|FG002|STARTED|Overall Study||29||
59756487|NCT00798369|75875541|FG003|STARTED|Overall Study||29||
59756488|NCT00798369|75875542|FG004|STARTED|Overall Study||28||
59756489|NCT00798369|75875543|FG005|STARTED|Overall Study||57||
59756490|NCT00798369|75875538|FG000|COMPLETED|Overall Study||27||
59756491|NCT00798369|75875539|FG001|COMPLETED|Overall Study||28||
59756492|NCT00798369|75875540|FG002|COMPLETED|Overall Study||27||
59756493|NCT00798369|75875541|FG003|COMPLETED|Overall Study||28||
59756494|NCT00798369|75875542|FG004|COMPLETED|Overall Study||27||
59756495|NCT00798369|75875543|FG005|COMPLETED|Overall Study||54||
59756496|NCT00798369|75875538|FG000|NOT COMPLETED|Overall Study||1||
59756497|NCT00798369|75875539|FG001|NOT COMPLETED|Overall Study||1||
59756498|NCT00798369|75875540|FG002|NOT COMPLETED|Overall Study||2||
59756499|NCT00798369|75875541|FG003|NOT COMPLETED|Overall Study||1||
59756500|NCT00798369|75875542|FG004|NOT COMPLETED|Overall Study||1||
59756501|NCT00798369|75875543|FG005|NOT COMPLETED|Overall Study||3||
59756502|NCT00950963|75875560|FG000|STARTED|Overall Study|Patients were randomized from a diabetes registry and were followed as intent to treat|381||
59756503|NCT00950963|75875561|FG001|STARTED|Overall Study|Patients were randomized from a diabetes registry and were followed as intent to treat|381||
59756504|NCT00950963|75875560|FG000|COMPLETED|Overall Study||352||
59756505|NCT00950963|75875561|FG001|COMPLETED|Overall Study||357||
59756506|NCT00950963|75875560|FG000|NOT COMPLETED|Overall Study||29||
59756507|NCT00950963|75875561|FG001|NOT COMPLETED|Overall Study||24||
59756508|NCT00608959|75875569|FG000|STARTED|Part 1|25 subjects each participated in Parts 1 and 2 .A total of 20 subjects participated in both parts.|25||
59756509|NCT00608959|75875569|FG000|COMPLETED|Part 1||24||
59756510|NCT00608959|75875569|FG000|NOT COMPLETED|Part 1||1||
59756511|NCT00608959|75875569|FG000|STARTED|Part 2|20 Part 1 subjects also participated in Part 2.Five more subjects were enrolled for a total of 25.|25||
59756512|NCT00608959|75875569|FG000|COMPLETED|Part 2||25||
59756513|NCT00608959|75875569|FG000|NOT COMPLETED|Part 2||0||
59756514|NCT00945659|75875582|FG000|STARTED|Overall Study||39||
59610321|NCT01843062|75721230|FG001|STARTED|Overall Study||78||
59610322|NCT01843062|75721229|FG000|Intention to Treat (ITT) Analysis Set|Overall Study||155||
59610323|NCT01843062|75721230|FG001|Intention to Treat (ITT) Analysis Set|Overall Study||78||
59756515|NCT00945659|75875583|FG001|STARTED|Overall Study||40||
59756516|NCT00945659|75875584|FG002|STARTED|Overall Study||37||
59756517|NCT00945659|75875582|FG000|Baseline|Overall Study||39||
59756518|NCT00945659|75875583|FG001|Baseline|Overall Study||40||
59756519|NCT00945659|75875584|FG002|Baseline|Overall Study||37||
59756520|NCT00945659|75875582|FG000|3-Months|Overall Study||38||
59756521|NCT00945659|75875583|FG001|3-Months|Overall Study||39||
59756522|NCT00945659|75875584|FG002|3-Months|Overall Study||35||
59756523|NCT00945659|75875582|FG000|6-Months|Overall Study||31||
59756524|NCT00945659|75875583|FG001|6-Months|Overall Study||29||
59756525|NCT00945659|75875584|FG002|6-Months|Overall Study||25||
59756526|NCT00945659|75875582|FG000|9-Months|Overall Study||32||
59756527|NCT00945659|75875583|FG001|9-Months|Overall Study||20||
59756528|NCT00945659|75875584|FG002|9-Months|Overall Study||20||
59756529|NCT00945659|75875582|FG000|12-Months|Overall Study||32||
59888081|NCT00834574|76010479|FG000|STARTED|Second Intervention||16||
59888082|NCT00834574|76010480|FG001|STARTED|Second Intervention||16||
59888083|NCT00834574|76010479|FG000|COMPLETED|Second Intervention||16||
59888084|NCT00834574|76010480|FG001|COMPLETED|Second Intervention||16||
59888085|NCT00834574|76010479|FG000|NOT COMPLETED|Second Intervention||0||
59888086|NCT00834574|76010480|FG001|NOT COMPLETED|Second Intervention||0||
59888087|NCT00834418|76010486|FG000|STARTED|Overall Study||42||
59888088|NCT00834418|76010487|FG001|STARTED|Overall Study||42||
59888089|NCT00834418|76010486|FG000|COMPLETED|Overall Study||42||
59888090|NCT00834418|76010487|FG001|COMPLETED|Overall Study||40||
59888091|NCT00834418|76010486|FG000|NOT COMPLETED|Overall Study||0||
59888092|NCT00834418|76010487|FG001|NOT COMPLETED|Overall Study||2||
59888093|NCT00834340|76010493|FG000|STARTED|First Intervention||16||
59888094|NCT00834340|76010494|FG001|STARTED|First Intervention||16||
59888095|NCT00834340|76010493|FG000|COMPLETED|First Intervention||16||
59888096|NCT00834340|76010494|FG001|COMPLETED|First Intervention||16||
59888097|NCT00834340|76010493|FG000|NOT COMPLETED|First Intervention||0||
59888098|NCT00834340|76010494|FG001|NOT COMPLETED|First Intervention||0||
59888099|NCT00834340|76010493|FG000|STARTED|Washout||16||
59888100|NCT00834340|76010494|FG001|STARTED|Washout||16||
59888101|NCT00834340|76010493|FG000|COMPLETED|Washout||14||
59888102|NCT00834340|76010494|FG001|COMPLETED|Washout||16||
59888103|NCT00834340|76010493|FG000|NOT COMPLETED|Washout||2||
59888104|NCT00834340|76010494|FG001|NOT COMPLETED|Washout||0||
59888105|NCT00834340|76010493|FG000|STARTED|Second Intervention||14||
59888106|NCT00834340|76010494|FG001|STARTED|Second Intervention||16||
59888107|NCT00834340|76010493|FG000|COMPLETED|Second Intervention||14||
59888108|NCT00834340|76010494|FG001|COMPLETED|Second Intervention||16||
59888109|NCT00834340|76010493|FG000|NOT COMPLETED|Second Intervention||0||
59888110|NCT00834340|76010494|FG001|NOT COMPLETED|Second Intervention||0||
59888111|NCT00151996|76010500|FG000|STARTED|Overall Study||42||
59888112|NCT00151996|76010501|FG001|STARTED|Overall Study||33||
59888113|NCT00151996|76010500|FG000|COMPLETED|Overall Study||37||
59888114|NCT00151996|76010501|FG001|COMPLETED|Overall Study||26||
59888115|NCT00151996|76010500|FG000|NOT COMPLETED|Overall Study||5||
59888116|NCT00151996|76010501|FG001|NOT COMPLETED|Overall Study||7||
59888117|NCT00830206|76010509|FG000|STARTED|First Intervention||40||
59888118|NCT00830206|76010510|FG001|STARTED|First Intervention||40||
59888119|NCT00830206|76010509|FG000|COMPLETED|First Intervention||40||
59888120|NCT00830206|76010510|FG001|COMPLETED|First Intervention||40||
59888121|NCT00830206|76010509|FG000|NOT COMPLETED|First Intervention||0||
59888122|NCT00830206|76010510|FG001|NOT COMPLETED|First Intervention||0||
59888123|NCT00830206|76010509|FG000|STARTED|Washout: 21 Days||40||
59888124|NCT00830206|76010510|FG001|STARTED|Washout: 21 Days||40||
59888125|NCT00830206|76010509|FG000|COMPLETED|Washout: 21 Days||39||
59888126|NCT00830206|76010510|FG001|COMPLETED|Washout: 21 Days||39||
59888127|NCT00830206|76010509|FG000|NOT COMPLETED|Washout: 21 Days||1||
59888128|NCT00830206|76010510|FG001|NOT COMPLETED|Washout: 21 Days||1||
59888129|NCT00830206|76010509|FG000|STARTED|Second Intervention||39||
59888130|NCT00830206|76010510|FG001|STARTED|Second Intervention||39||
59888131|NCT00830206|76010509|FG000|COMPLETED|Second Intervention||39||
59888132|NCT00830206|76010510|FG001|COMPLETED|Second Intervention||39||
59888133|NCT00830206|76010509|FG000|NOT COMPLETED|Second Intervention||0||
59888134|NCT00830206|76010510|FG001|NOT COMPLETED|Second Intervention||0||
59888135|NCT00829504|76010516|FG000|STARTED|First Intervention||22||
59888136|NCT00829504|76010517|FG001|STARTED|First Intervention||22||
59888137|NCT00829504|76010516|FG000|COMPLETED|First Intervention||21||
59888138|NCT00829504|76010517|FG001|COMPLETED|First Intervention||22||
59888139|NCT00829504|76010516|FG000|NOT COMPLETED|First Intervention||1||
59888140|NCT00829504|76010517|FG001|NOT COMPLETED|First Intervention||0||
59888141|NCT00829504|76010516|FG000|STARTED|Washout of 7 Days||21||
59888142|NCT00829504|76010517|FG001|STARTED|Washout of 7 Days||22||
59888143|NCT00829504|76010516|FG000|COMPLETED|Washout of 7 Days||20||
59888144|NCT00829504|76010517|FG001|COMPLETED|Washout of 7 Days||22||
59888145|NCT00829504|76010516|FG000|NOT COMPLETED|Washout of 7 Days||1||
59888146|NCT00829504|76010517|FG001|NOT COMPLETED|Washout of 7 Days||0||
59888147|NCT00829504|76010516|FG000|STARTED|Second Intervention||20||
59888148|NCT00829504|76010517|FG001|STARTED|Second Intervention||22||
59888149|NCT00829504|76010516|FG000|COMPLETED|Second Intervention||19||
59888150|NCT00829504|76010517|FG001|COMPLETED|Second Intervention||22||
59888151|NCT00829504|76010516|FG000|NOT COMPLETED|Second Intervention||1||
59888152|NCT00829504|76010517|FG001|NOT COMPLETED|Second Intervention||0||
59888153|NCT00829426|76010523|FG000|STARTED|First Intervention||16||
59888154|NCT00829426|76010524|FG001|STARTED|First Intervention||16||
59888155|NCT00829426|76010523|FG000|COMPLETED|First Intervention||16||
59888156|NCT00829426|76010524|FG001|COMPLETED|First Intervention||16||
59888157|NCT00829426|76010523|FG000|NOT COMPLETED|First Intervention||0||
59888158|NCT00829426|76010524|FG001|NOT COMPLETED|First Intervention||0||
59888159|NCT00829426|76010523|FG000|STARTED|Washout: 7 Days||16||
59888160|NCT00829426|76010524|FG001|STARTED|Washout: 7 Days||16||
59888161|NCT00829426|76010523|FG000|COMPLETED|Washout: 7 Days||15||
59888162|NCT00829426|76010524|FG001|COMPLETED|Washout: 7 Days||16||
59888163|NCT00829426|76010523|FG000|NOT COMPLETED|Washout: 7 Days||1||
59888164|NCT00829426|76010524|FG001|NOT COMPLETED|Washout: 7 Days||0||
59888165|NCT00829426|76010523|FG000|STARTED|Second Intervention||15||
59888166|NCT00829426|76010524|FG001|STARTED|Second Intervention||16||
59888167|NCT00829426|76010523|FG000|COMPLETED|Second Intervention||15||
59888168|NCT00829426|76010524|FG001|COMPLETED|Second Intervention||16||
59888169|NCT00829426|76010523|FG000|NOT COMPLETED|Second Intervention||0||
59888170|NCT00829426|76010524|FG001|NOT COMPLETED|Second Intervention||0||
59888171|NCT00152464|76010530|FG000|STARTED|Overall Study||255||
59888172|NCT00152464|76010531|FG001|STARTED|Overall Study||255||
59888173|NCT00152464|76010530|FG000|COMPLETED|Overall Study||215||
59888174|NCT00152464|76010531|FG001|COMPLETED|Overall Study||219||
59888175|NCT00152464|76010530|FG000|NOT COMPLETED|Overall Study||40||
59888176|NCT00152464|76010531|FG001|NOT COMPLETED|Overall Study||36||
59888177|NCT00674440|76010537|FG000|STARTED|Overall Study||106||
59610324|NCT01843062|75721229|FG000|Safety Analysis Set|Overall Study||154||
59610325|NCT01843062|75721230|FG001|Safety Analysis Set|Overall Study||77||
59610326|NCT01843062|75721229|FG000|BRAF/NRAS Mutation Positive Analysis Set|Overall Study||91|BRAF/NRAS positive = mutations in BRAF/NRAS oncogenes had been detected|
59610327|NCT01843062|75721230|FG001|BRAF/NRAS Mutation Positive Analysis Set|Overall Study||51|BRAF/NRAS positive = mutations in BRAF/NRAS oncogenes had been detected|
59610328|NCT01843062|75721229|FG000|Ongoing at Primary Analysis Data Cut-off|Overall Study||134||
59610329|NCT01843062|75721230|FG001|Ongoing at Primary Analysis Data Cut-off|Overall Study||71||
59610330|NCT01843062|75721229|FG000|COMPLETED|Overall Study||133|Completed the end of study visit or end of study phone call|
59610331|NCT01843062|75721230|FG001|COMPLETED|Overall Study||69|Completed the end of study visit or end of study phone call|
59610332|NCT01843062|75721229|FG000|NOT COMPLETED|Overall Study||22||
59888178|NCT00674440|76010537|FG000|COMPLETED|Overall Study|Subjects who had PET and surgery and were evaluable|95||
59888179|NCT00674440|76010537|FG000|NOT COMPLETED|Overall Study||11||
59888180|NCT02742766|76010561|FG000|STARTED|Part 1 (Up to 8 Days)||20||
59610333|NCT01843062|75721230|FG001|NOT COMPLETED|Overall Study||9||
59610334|NCT01842438|75721238|FG000|STARTED|T1: Immediately After the Intervention||42||
59610335|NCT01842438|75721239|FG001|STARTED|T1: Immediately After the Intervention||44||
59610336|NCT01842438|75721238|FG000|COMPLETED|T1: Immediately After the Intervention||36||
59610337|NCT01842438|75721239|FG001|COMPLETED|T1: Immediately After the Intervention||36||
59610338|NCT01842438|75721238|FG000|NOT COMPLETED|T1: Immediately After the Intervention||6||
59610339|NCT01842438|75721239|FG001|NOT COMPLETED|T1: Immediately After the Intervention||8||
59610340|NCT01842438|75721238|FG000|STARTED|T2: 6month Follow-up||36||
59610341|NCT01842438|75721239|FG001|STARTED|T2: 6month Follow-up||36||
59610342|NCT01842438|75721238|FG000|COMPLETED|T2: 6month Follow-up||32||
59610343|NCT01842438|75721239|FG001|COMPLETED|T2: 6month Follow-up||32||
59888181|NCT02742766|76010562|FG001|STARTED|Part 1 (Up to 8 Days)||6||
59888182|NCT02742766|76010563|FG002|STARTED|Part 1 (Up to 8 Days)||6||
59888183|NCT02742766|76010564|FG003|STARTED|Part 1 (Up to 8 Days)||6||
59888184|NCT02742766|76010565|FG004|STARTED|Part 1 (Up to 8 Days)||6||
59888185|NCT02742766|76010566|FG005|STARTED|Part 1 (Up to 8 Days)||6||
59888186|NCT02742766|76010567|FG006|STARTED|Part 1 (Up to 8 Days)||6||
59888187|NCT02742766|76010568|FG007|STARTED|Part 1 (Up to 8 Days)||6||
59888188|NCT02742766|76010569|FG008|STARTED|Part 1 (Up to 8 Days)||6||
59888189|NCT02742766|76010570|FG009|STARTED|Part 1 (Up to 8 Days)||0||
59888190|NCT02742766|76010571|FG010|STARTED|Part 1 (Up to 8 Days)||6||
59888191|NCT02742766|76010572|FG011|STARTED|Part 1 (Up to 8 Days)||6||
59888192|NCT02742766|76010573|FG012|STARTED|Part 1 (Up to 8 Days)||0||
59888193|NCT02742766|76010574|FG013|STARTED|Part 1 (Up to 8 Days)||0||
59888194|NCT02742766|76010575|FG014|STARTED|Part 1 (Up to 8 Days)||0||
59888195|NCT02742766|76010576|FG015|STARTED|Part 1 (Up to 8 Days)||0||
59888196|NCT02742766|76010577|FG016|STARTED|Part 1 (Up to 8 Days)||0||
59888197|NCT02742766|76010578|FG017|STARTED|Part 1 (Up to 8 Days)||0||
59610344|NCT01842438|75721238|FG000|NOT COMPLETED|T2: 6month Follow-up||4||
59610345|NCT01842438|75721239|FG001|NOT COMPLETED|T2: 6month Follow-up||4||
59888198|NCT02742766|76010579|FG018|STARTED|Part 1 (Up to 8 Days)||0||
59888199|NCT02742766|76010561|FG000|COMPLETED|Part 1 (Up to 8 Days)||20||
59888200|NCT02742766|76010562|FG001|COMPLETED|Part 1 (Up to 8 Days)||6||
59888201|NCT02742766|76010563|FG002|COMPLETED|Part 1 (Up to 8 Days)||6||
59888202|NCT02742766|76010564|FG003|COMPLETED|Part 1 (Up to 8 Days)||6||
59888203|NCT02742766|76010565|FG004|COMPLETED|Part 1 (Up to 8 Days)||6||
59888204|NCT02742766|76010566|FG005|COMPLETED|Part 1 (Up to 8 Days)||6||
59888205|NCT02742766|76010567|FG006|COMPLETED|Part 1 (Up to 8 Days)||6||
59888206|NCT02742766|76010568|FG007|COMPLETED|Part 1 (Up to 8 Days)||6||
59888207|NCT02742766|76010569|FG008|COMPLETED|Part 1 (Up to 8 Days)||6||
59610346|NCT01799226|75721251|FG000|STARTED|Overall Study||16||
59610347|NCT01799226|75721252|FG001|STARTED|Overall Study||16||
59610348|NCT01799226|75721251|FG000|Right Stent Side|Overall Study||8||
59610349|NCT01799226|75721252|FG001|Right Stent Side|Overall Study||8||
59610350|NCT01799226|75721251|FG000|Left Stent Side|Overall Study||8||
59610351|NCT01799226|75721252|FG001|Left Stent Side|Overall Study||8||
59610352|NCT01799226|75721251|FG000|COMPLETED|Overall Study||14||
59610353|NCT01799226|75721252|FG001|COMPLETED|Overall Study||16||
59610354|NCT01799226|75721251|FG000|NOT COMPLETED|Overall Study||2||
59610355|NCT01799226|75721252|FG001|NOT COMPLETED|Overall Study||0||
59610356|NCT01825200|75721260|FG000|STARTED|Overall Study||1319||
59610357|NCT01825200|75721261|FG001|STARTED|Overall Study||1321||
59610358|NCT01825200|75721260|FG000|COMPLETED|Overall Study||1314||
59610359|NCT01825200|75721261|FG001|COMPLETED|Overall Study||1314||
59610360|NCT01825200|75721260|FG000|NOT COMPLETED|Overall Study||5||
59610361|NCT01825200|75721261|FG001|NOT COMPLETED|Overall Study||7||
59610362|NCT01824576|75721267|FG000|STARTED|Overall Study||9||
59610363|NCT01824576|75721267|FG000|COMPLETED|Overall Study||7||
59610364|NCT01824576|75721267|FG000|NOT COMPLETED|Overall Study||2||
59610365|NCT01824498|75721277|FG000|STARTED|1st Intervention (8 Weeks)||5||
59610366|NCT01824498|75721278|FG001|STARTED|1st Intervention (8 Weeks)||2||
59610367|NCT01824498|75721279|FG002|STARTED|1st Intervention (8 Weeks)||6||
59610368|NCT01824498|75721280|FG003|STARTED|1st Intervention (8 Weeks)||3||
59610369|NCT01824498|75721281|FG004|STARTED|1st Intervention (8 Weeks)||4||
59610370|NCT01824498|75721282|FG005|STARTED|1st Intervention (8 Weeks)||4||
59610371|NCT01824498|75721277|FG000|COMPLETED|1st Intervention (8 Weeks)||5||
59610372|NCT01824498|75721278|FG001|COMPLETED|1st Intervention (8 Weeks)||2||
59610373|NCT01824498|75721279|FG002|COMPLETED|1st Intervention (8 Weeks)||6||
59610374|NCT01824498|75721280|FG003|COMPLETED|1st Intervention (8 Weeks)||3||
59610375|NCT01824498|75721281|FG004|COMPLETED|1st Intervention (8 Weeks)||4||
59756530|NCT00945659|75875583|FG001|12-Months|Overall Study||20||
59610376|NCT01824498|75721282|FG005|COMPLETED|1st Intervention (8 Weeks)||4||
59610377|NCT01824498|75721277|FG000|NOT COMPLETED|1st Intervention (8 Weeks)||0||
59610378|NCT01824498|75721278|FG001|NOT COMPLETED|1st Intervention (8 Weeks)||0||
59610379|NCT01824498|75721279|FG002|NOT COMPLETED|1st Intervention (8 Weeks)||0||
59610380|NCT01824498|75721280|FG003|NOT COMPLETED|1st Intervention (8 Weeks)||0||
59610381|NCT01824498|75721281|FG004|NOT COMPLETED|1st Intervention (8 Weeks)||0||
59610382|NCT01824498|75721282|FG005|NOT COMPLETED|1st Intervention (8 Weeks)||0||
59610383|NCT01824498|75721277|FG000|STARTED|Washout (8 Weeks)|2 dropped out|5||
59756531|NCT00945659|75875584|FG002|12-Months|Overall Study||20||
59756532|NCT00945659|75875582|FG000|COMPLETED|Overall Study||32||
59756533|NCT00945659|75875583|FG001|COMPLETED|Overall Study||20||
59756534|NCT00945659|75875584|FG002|COMPLETED|Overall Study||20||
59756535|NCT00945659|75875582|FG000|NOT COMPLETED|Overall Study||7||
59756536|NCT00945659|75875583|FG001|NOT COMPLETED|Overall Study||20||
59756537|NCT00945659|75875584|FG002|NOT COMPLETED|Overall Study||17||
59756538|NCT00941603|75875598|FG000|STARTED|Overall Study||104||
59756539|NCT00941603|75875599|FG001|STARTED|Overall Study||105||
59756540|NCT00941603|75875600|FG002|STARTED|Overall Study||104||
59756541|NCT00941603|75875601|FG003|STARTED|Overall Study||104||
59756542|NCT00941603|75875602|FG004|STARTED|Overall Study||105||
59756543|NCT00941603|75875603|FG005|STARTED|Overall Study||97||
59756544|NCT00941603|75875598|FG000|COMPLETED|Overall Study||93||
59756545|NCT00941603|75875599|FG001|COMPLETED|Overall Study||89||
59756546|NCT00941603|75875600|FG002|COMPLETED|Overall Study||99||
59756547|NCT00941603|75875601|FG003|COMPLETED|Overall Study||100||
59756548|NCT00941603|75875602|FG004|COMPLETED|Overall Study||101||
59756549|NCT00941603|75875603|FG005|COMPLETED|Overall Study||94||
59610384|NCT01824498|75721278|FG001|STARTED|Washout (8 Weeks)||2||
59610385|NCT01824498|75721279|FG002|STARTED|Washout (8 Weeks)|2 dropped out|6||
59610386|NCT01824498|75721280|FG003|STARTED|Washout (8 Weeks)|1 dropped out|3||
59610387|NCT01824498|75721281|FG004|STARTED|Washout (8 Weeks)|1 dropped out|4||
59610388|NCT01824498|75721282|FG005|STARTED|Washout (8 Weeks)||4||
59610389|NCT01824498|75721277|FG000|COMPLETED|Washout (8 Weeks)||3||
59756550|NCT00941603|75875598|FG000|NOT COMPLETED|Overall Study||11||
59756551|NCT00941603|75875599|FG001|NOT COMPLETED|Overall Study||16||
59756552|NCT00941603|75875600|FG002|NOT COMPLETED|Overall Study||5||
59756553|NCT00941603|75875601|FG003|NOT COMPLETED|Overall Study||4||
59756554|NCT00941603|75875602|FG004|NOT COMPLETED|Overall Study||4||
59888208|NCT02742766|76010570|FG009|COMPLETED|Part 1 (Up to 8 Days)||0||
59888209|NCT02742766|76010571|FG010|COMPLETED|Part 1 (Up to 8 Days)||6||
59610390|NCT01824498|75721278|FG001|COMPLETED|Washout (8 Weeks)||2||
59610391|NCT01824498|75721279|FG002|COMPLETED|Washout (8 Weeks)||4||
59610392|NCT01824498|75721280|FG003|COMPLETED|Washout (8 Weeks)||2||
59610393|NCT01824498|75721281|FG004|COMPLETED|Washout (8 Weeks)||3||
59610394|NCT01824498|75721282|FG005|COMPLETED|Washout (8 Weeks)||4||
59610395|NCT01824498|75721277|FG000|NOT COMPLETED|Washout (8 Weeks)||2||
59610396|NCT01824498|75721278|FG001|NOT COMPLETED|Washout (8 Weeks)||0||
59610397|NCT01824498|75721279|FG002|NOT COMPLETED|Washout (8 Weeks)||2||
59756555|NCT00941603|75875603|FG005|NOT COMPLETED|Overall Study||3||
59756556|NCT00797823|75875620|FG000|STARTED|Pilot Studies|Not involved in pilot studies|0||
59888210|NCT02742766|76010572|FG011|COMPLETED|Part 1 (Up to 8 Days)||6||
59888211|NCT02742766|76010573|FG012|COMPLETED|Part 1 (Up to 8 Days)||0||
59888212|NCT02742766|76010574|FG013|COMPLETED|Part 1 (Up to 8 Days)||0||
59888213|NCT02742766|76010575|FG014|COMPLETED|Part 1 (Up to 8 Days)||0||
59888214|NCT02742766|76010576|FG015|COMPLETED|Part 1 (Up to 8 Days)||0||
59888215|NCT02742766|76010577|FG016|COMPLETED|Part 1 (Up to 8 Days)||0||
59610398|NCT01824498|75721280|FG003|NOT COMPLETED|Washout (8 Weeks)||1||
59610399|NCT01824498|75721281|FG004|NOT COMPLETED|Washout (8 Weeks)||1||
59610400|NCT01824498|75721282|FG005|NOT COMPLETED|Washout (8 Weeks)||0||
59610401|NCT01824498|75721277|FG000|STARTED|2nd Intervention (8 Weeks)||3||
59610402|NCT01824498|75721278|FG001|STARTED|2nd Intervention (8 Weeks)||2||
59610403|NCT01824498|75721279|FG002|STARTED|2nd Intervention (8 Weeks)||4||
59610404|NCT01824498|75721280|FG003|STARTED|2nd Intervention (8 Weeks)||2||
59610405|NCT01824498|75721281|FG004|STARTED|2nd Intervention (8 Weeks)||3||
59610406|NCT01824498|75721282|FG005|STARTED|2nd Intervention (8 Weeks)||4||
59610407|NCT01824498|75721277|FG000|COMPLETED|2nd Intervention (8 Weeks)||3||
59610408|NCT01824498|75721278|FG001|COMPLETED|2nd Intervention (8 Weeks)||2||
59610409|NCT01824498|75721279|FG002|COMPLETED|2nd Intervention (8 Weeks)||4||
59756557|NCT00797823|75875621|FG001|STARTED|Pilot Studies|Not involved in pilot studies|0||
59756558|NCT00797823|75875622|FG002|STARTED|Pilot Studies||6||
59756559|NCT00797823|75875620|FG000|COMPLETED|Pilot Studies||0||
59756560|NCT00797823|75875621|FG001|COMPLETED|Pilot Studies||0||
59756561|NCT00797823|75875622|FG002|COMPLETED|Pilot Studies||6||
59756562|NCT00797823|75875620|FG000|NOT COMPLETED|Pilot Studies||0||
59756563|NCT00797823|75875621|FG001|NOT COMPLETED|Pilot Studies||0||
59756564|NCT00797823|75875622|FG002|NOT COMPLETED|Pilot Studies||0||
59756565|NCT00797823|75875620|FG000|STARTED|First Period (Initial Randomization)||4||
59756566|NCT00797823|75875621|FG001|STARTED|First Period (Initial Randomization)||4||
59756567|NCT00797823|75875622|FG002|STARTED|First Period (Initial Randomization)|Pilot studies only performed during initial period.|0||
59756568|NCT00797823|75875620|FG000|COMPLETED|First Period (Initial Randomization)||3||
59756569|NCT00797823|75875621|FG001|COMPLETED|First Period (Initial Randomization)||4||
59756570|NCT00797823|75875622|FG002|COMPLETED|First Period (Initial Randomization)||0||
59756571|NCT00797823|75875620|FG000|NOT COMPLETED|First Period (Initial Randomization)||1||
59756572|NCT00797823|75875621|FG001|NOT COMPLETED|First Period (Initial Randomization)||0||
59756573|NCT00797823|75875622|FG002|NOT COMPLETED|First Period (Initial Randomization)||0||
59756574|NCT00797823|75875620|FG000|STARTED|Second Period (Crossover)||3||
59756575|NCT00797823|75875621|FG001|STARTED|Second Period (Crossover)||4||
59756576|NCT00797823|75875622|FG002|STARTED|Second Period (Crossover)||0||
59756577|NCT00797823|75875620|FG000|COMPLETED|Second Period (Crossover)||3||
59756578|NCT00797823|75875621|FG001|COMPLETED|Second Period (Crossover)||4||
59756579|NCT00797823|75875622|FG002|COMPLETED|Second Period (Crossover)||0||
59756580|NCT00797823|75875620|FG000|NOT COMPLETED|Second Period (Crossover)||0||
59756581|NCT00797823|75875621|FG001|NOT COMPLETED|Second Period (Crossover)||0||
59756582|NCT00797823|75875622|FG002|NOT COMPLETED|Second Period (Crossover)||0||
59756583|NCT00797667|75875632|FG000|STARTED|Overall Study||265||
59756584|NCT00797667|75875633|FG001|STARTED|Overall Study||264||
59756585|NCT00797667|75875634|FG002|STARTED|Overall Study||131||
59756586|NCT00797667|75875632|FG000|Treated|Overall Study||263||
59756587|NCT00797667|75875633|FG001|Treated|Overall Study||263||
59610410|NCT01824498|75721280|FG003|COMPLETED|2nd Intervention (8 Weeks)||2||
59756588|NCT00797667|75875634|FG002|Treated|Overall Study||130||
59756589|NCT00797667|75875632|FG000|COMPLETED|Overall Study||5||
59756590|NCT00797667|75875633|FG001|COMPLETED|Overall Study||5||
59756591|NCT00797667|75875634|FG002|COMPLETED|Overall Study||4||
59888216|NCT02742766|76010578|FG017|COMPLETED|Part 1 (Up to 8 Days)||0||
59888217|NCT02742766|76010579|FG018|COMPLETED|Part 1 (Up to 8 Days)||0||
59888218|NCT02742766|76010561|FG000|NOT COMPLETED|Part 1 (Up to 8 Days)||0||
59888219|NCT02742766|76010562|FG001|NOT COMPLETED|Part 1 (Up to 8 Days)||0||
59888220|NCT02742766|76010563|FG002|NOT COMPLETED|Part 1 (Up to 8 Days)||0||
59888221|NCT02742766|76010564|FG003|NOT COMPLETED|Part 1 (Up to 8 Days)||0||
59888222|NCT02742766|76010565|FG004|NOT COMPLETED|Part 1 (Up to 8 Days)||0||
59888223|NCT02742766|76010566|FG005|NOT COMPLETED|Part 1 (Up to 8 Days)||0||
59888224|NCT02742766|76010567|FG006|NOT COMPLETED|Part 1 (Up to 8 Days)||0||
59888225|NCT02742766|76010568|FG007|NOT COMPLETED|Part 1 (Up to 8 Days)||0||
59888226|NCT02742766|76010569|FG008|NOT COMPLETED|Part 1 (Up to 8 Days)||0||
59888227|NCT02742766|76010570|FG009|NOT COMPLETED|Part 1 (Up to 8 Days)||0||
59888228|NCT02742766|76010571|FG010|NOT COMPLETED|Part 1 (Up to 8 Days)||0||
59610411|NCT01824498|75721281|FG004|COMPLETED|2nd Intervention (8 Weeks)||3||
59610412|NCT01824498|75721282|FG005|COMPLETED|2nd Intervention (8 Weeks)||4||
59610413|NCT01824498|75721277|FG000|NOT COMPLETED|2nd Intervention (8 Weeks)||0||
59610414|NCT01824498|75721278|FG001|NOT COMPLETED|2nd Intervention (8 Weeks)||0||
59610415|NCT01824498|75721279|FG002|NOT COMPLETED|2nd Intervention (8 Weeks)||0||
59610416|NCT01824498|75721280|FG003|NOT COMPLETED|2nd Intervention (8 Weeks)||0||
59610417|NCT01824498|75721281|FG004|NOT COMPLETED|2nd Intervention (8 Weeks)||0||
59610418|NCT01824498|75721282|FG005|NOT COMPLETED|2nd Intervention (8 Weeks)||0||
59610419|NCT01824498|75721277|FG000|STARTED|Washout (8 Weeks)||3||
59610420|NCT01824498|75721278|FG001|STARTED|Washout (8 Weeks)||2||
59610421|NCT01824498|75721279|FG002|STARTED|Washout (8 Weeks)||4||
59610422|NCT01824498|75721280|FG003|STARTED|Washout (8 Weeks)||2||
59610423|NCT01824498|75721281|FG004|STARTED|Washout (8 Weeks)||3||
59610424|NCT01824498|75721282|FG005|STARTED|Washout (8 Weeks)||4||
59610425|NCT01824498|75721277|FG000|COMPLETED|Washout (8 Weeks)||3||
59610426|NCT01824498|75721278|FG001|COMPLETED|Washout (8 Weeks)||2||
59610427|NCT01824498|75721279|FG002|COMPLETED|Washout (8 Weeks)||4||
59610428|NCT01824498|75721280|FG003|COMPLETED|Washout (8 Weeks)||2||
59756592|NCT00797667|75875632|FG000|NOT COMPLETED|Overall Study||260||
59756593|NCT00797667|75875633|FG001|NOT COMPLETED|Overall Study||259||
59888229|NCT02742766|76010572|FG011|NOT COMPLETED|Part 1 (Up to 8 Days)||0||
59888230|NCT02742766|76010573|FG012|NOT COMPLETED|Part 1 (Up to 8 Days)||0||
59888231|NCT02742766|76010574|FG013|NOT COMPLETED|Part 1 (Up to 8 Days)||0||
59888232|NCT02742766|76010575|FG014|NOT COMPLETED|Part 1 (Up to 8 Days)||0||
59888233|NCT02742766|76010576|FG015|NOT COMPLETED|Part 1 (Up to 8 Days)||0||
59888234|NCT02742766|76010577|FG016|NOT COMPLETED|Part 1 (Up to 8 Days)||0||
59888235|NCT02742766|76010578|FG017|NOT COMPLETED|Part 1 (Up to 8 Days)||0||
59888236|NCT02742766|76010579|FG018|NOT COMPLETED|Part 1 (Up to 8 Days)||0||
59888237|NCT02742766|76010561|FG000|STARTED|Part 2 (Up to 22 Days)||0||
59888238|NCT02742766|76010562|FG001|STARTED|Part 2 (Up to 22 Days)||0||
59888239|NCT02742766|76010563|FG002|STARTED|Part 2 (Up to 22 Days)||0||
59888240|NCT02742766|76010564|FG003|STARTED|Part 2 (Up to 22 Days)||0||
59888241|NCT02742766|76010565|FG004|STARTED|Part 2 (Up to 22 Days)||0||
59888242|NCT02742766|76010566|FG005|STARTED|Part 2 (Up to 22 Days)||0||
59888243|NCT02742766|76010567|FG006|STARTED|Part 2 (Up to 22 Days)||0||
59888244|NCT02742766|76010568|FG007|STARTED|Part 2 (Up to 22 Days)||0||
59610429|NCT01824498|75721281|FG004|COMPLETED|Washout (8 Weeks)||3||
59610430|NCT01824498|75721282|FG005|COMPLETED|Washout (8 Weeks)||4||
59610431|NCT01824498|75721277|FG000|NOT COMPLETED|Washout (8 Weeks)||0||
59610432|NCT01824498|75721278|FG001|NOT COMPLETED|Washout (8 Weeks)||0||
59756594|NCT00797667|75875634|FG002|NOT COMPLETED|Overall Study||127||
59756595|NCT00950807|75875642|FG000|STARTED|Treatment Period 1||59||
59756596|NCT00950807|75875643|FG001|STARTED|Treatment Period 1||13||
59756597|NCT00950807|75875644|FG002|STARTED|Treatment Period 1||14||
59756598|NCT00950807|75875645|FG003|STARTED|Treatment Period 1||12||
59756599|NCT00950807|75875646|FG004|STARTED|Treatment Period 1||13||
59756600|NCT00950807|75875647|FG005|STARTED|Treatment Period 1||13||
59756601|NCT00950807|75875648|FG006|STARTED|Treatment Period 1||12||
59756602|NCT00950807|75875649|FG007|STARTED|Treatment Period 1||14||
59756603|NCT00950807|75875650|FG008|STARTED|Treatment Period 1||13||
59756604|NCT00950807|75875651|FG009|STARTED|Treatment Period 1||13||
59756605|NCT00950807|75875642|FG000|COMPLETED|Treatment Period 1||56||
59756606|NCT00950807|75875643|FG001|COMPLETED|Treatment Period 1||13||
59756607|NCT00950807|75875644|FG002|COMPLETED|Treatment Period 1||13||
59756608|NCT00950807|75875645|FG003|COMPLETED|Treatment Period 1||12||
59756609|NCT00950807|75875646|FG004|COMPLETED|Treatment Period 1||12||
59756610|NCT00950807|75875647|FG005|COMPLETED|Treatment Period 1||11||
59756611|NCT00950807|75875648|FG006|COMPLETED|Treatment Period 1||12||
59756612|NCT00950807|75875649|FG007|COMPLETED|Treatment Period 1||14||
59756613|NCT00950807|75875650|FG008|COMPLETED|Treatment Period 1||12||
59888245|NCT02742766|76010569|FG008|STARTED|Part 2 (Up to 22 Days)||0||
59888246|NCT02742766|76010570|FG009|STARTED|Part 2 (Up to 22 Days)||0||
59888247|NCT02742766|76010571|FG010|STARTED|Part 2 (Up to 22 Days)||0||
59888248|NCT02742766|76010572|FG011|STARTED|Part 2 (Up to 22 Days)||0||
59888249|NCT02742766|76010573|FG012|STARTED|Part 2 (Up to 22 Days)||6||
59888250|NCT02742766|76010574|FG013|STARTED|Part 2 (Up to 22 Days)||6||
59888251|NCT02742766|76010575|FG014|STARTED|Part 2 (Up to 22 Days)||6||
59888252|NCT02742766|76010576|FG015|STARTED|Part 2 (Up to 22 Days)||6||
59888253|NCT02742766|76010577|FG016|STARTED|Part 2 (Up to 22 Days)||0||
59888254|NCT02742766|76010578|FG017|STARTED|Part 2 (Up to 22 Days)||0||
59888255|NCT02742766|76010579|FG018|STARTED|Part 2 (Up to 22 Days)||0||
59888256|NCT02742766|76010561|FG000|COMPLETED|Part 2 (Up to 22 Days)||0||
59888257|NCT02742766|76010562|FG001|COMPLETED|Part 2 (Up to 22 Days)||0||
59888258|NCT02742766|76010563|FG002|COMPLETED|Part 2 (Up to 22 Days)||0||
59888259|NCT02742766|76010564|FG003|COMPLETED|Part 2 (Up to 22 Days)||0||
59888260|NCT02742766|76010565|FG004|COMPLETED|Part 2 (Up to 22 Days)||0||
59888261|NCT02742766|76010566|FG005|COMPLETED|Part 2 (Up to 22 Days)||0||
59888262|NCT02742766|76010567|FG006|COMPLETED|Part 2 (Up to 22 Days)||0||
59888263|NCT02742766|76010568|FG007|COMPLETED|Part 2 (Up to 22 Days)||0||
59888264|NCT02742766|76010569|FG008|COMPLETED|Part 2 (Up to 22 Days)||0||
59888265|NCT02742766|76010570|FG009|COMPLETED|Part 2 (Up to 22 Days)||0||
59888266|NCT02742766|76010571|FG010|COMPLETED|Part 2 (Up to 22 Days)||0||
59888267|NCT02742766|76010572|FG011|COMPLETED|Part 2 (Up to 22 Days)||0||
59888268|NCT02742766|76010573|FG012|COMPLETED|Part 2 (Up to 22 Days)||4||
59888269|NCT02742766|76010574|FG013|COMPLETED|Part 2 (Up to 22 Days)||0||
59610433|NCT01824498|75721279|FG002|NOT COMPLETED|Washout (8 Weeks)||0||
59610434|NCT01824498|75721280|FG003|NOT COMPLETED|Washout (8 Weeks)||0||
59756614|NCT00950807|75875651|FG009|COMPLETED|Treatment Period 1||13||
59756615|NCT00950807|75875642|FG000|NOT COMPLETED|Treatment Period 1||3||
59888270|NCT02742766|76010575|FG014|COMPLETED|Part 2 (Up to 22 Days)||6||
59610435|NCT01824498|75721281|FG004|NOT COMPLETED|Washout (8 Weeks)||0||
59610436|NCT01824498|75721282|FG005|NOT COMPLETED|Washout (8 Weeks)||0||
59610437|NCT01824498|75721277|FG000|STARTED|3rd Intervention (8 Weeks)||3||
59610438|NCT01824498|75721278|FG001|STARTED|3rd Intervention (8 Weeks)||2||
59610439|NCT01824498|75721279|FG002|STARTED|3rd Intervention (8 Weeks)||4||
59756616|NCT00950807|75875643|FG001|NOT COMPLETED|Treatment Period 1||0||
59756617|NCT00950807|75875644|FG002|NOT COMPLETED|Treatment Period 1||1||
59756618|NCT00950807|75875645|FG003|NOT COMPLETED|Treatment Period 1||0||
59756619|NCT00950807|75875646|FG004|NOT COMPLETED|Treatment Period 1||1||
59756620|NCT00950807|75875647|FG005|NOT COMPLETED|Treatment Period 1||2||
59756621|NCT00950807|75875648|FG006|NOT COMPLETED|Treatment Period 1||0||
59756622|NCT00950807|75875649|FG007|NOT COMPLETED|Treatment Period 1||0||
59756623|NCT00950807|75875650|FG008|NOT COMPLETED|Treatment Period 1||1||
59756624|NCT00950807|75875651|FG009|NOT COMPLETED|Treatment Period 1||0||
59756625|NCT00950807|75875642|FG000|STARTED|Washout Period 1||56||
59756626|NCT00950807|75875643|FG001|STARTED|Washout Period 1||13||
59756627|NCT00950807|75875644|FG002|STARTED|Washout Period 1||13||
59756628|NCT00950807|75875645|FG003|STARTED|Washout Period 1||12||
59610440|NCT01824498|75721280|FG003|STARTED|3rd Intervention (8 Weeks)||2||
59610441|NCT01824498|75721281|FG004|STARTED|3rd Intervention (8 Weeks)||3||
59610442|NCT01824498|75721282|FG005|STARTED|3rd Intervention (8 Weeks)||4||
59610443|NCT01824498|75721277|FG000|COMPLETED|3rd Intervention (8 Weeks)||3||
59610444|NCT01824498|75721278|FG001|COMPLETED|3rd Intervention (8 Weeks)||2||
59610445|NCT01824498|75721279|FG002|COMPLETED|3rd Intervention (8 Weeks)||4||
59756629|NCT00950807|75875646|FG004|STARTED|Washout Period 1||12||
59756630|NCT00950807|75875647|FG005|STARTED|Washout Period 1||11||
59756631|NCT00950807|75875648|FG006|STARTED|Washout Period 1||12||
59756632|NCT00950807|75875649|FG007|STARTED|Washout Period 1||14||
59756633|NCT00950807|75875650|FG008|STARTED|Washout Period 1||12||
59756634|NCT00950807|75875651|FG009|STARTED|Washout Period 1||13||
59756635|NCT00950807|75875642|FG000|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|51||
59756636|NCT00950807|75875643|FG001|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|13||
59756637|NCT00950807|75875644|FG002|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|13||
59756638|NCT00950807|75875645|FG003|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|11||
59756639|NCT00950807|75875646|FG004|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|11||
59762581|NCT00594204|75882391|FG000|Received Treatment|Overall Study||390||
59505449|NCT00749125|75598196|FG001|COMPLETED|Overall Study||34||
59505450|NCT00749125|75598195|FG000|NOT COMPLETED|Overall Study||11||
59505451|NCT00749125|75598196|FG001|NOT COMPLETED|Overall Study||18||
59505452|NCT02144675|75598204|FG000|STARTED|Overall Study||13||
59505453|NCT02144675|75598205|FG001|STARTED|Overall Study||14||
59505454|NCT02144675|75598204|FG000|COMPLETED|Overall Study||13||
59505455|NCT02144675|75598205|FG001|COMPLETED|Overall Study||14||
59505456|NCT02144675|75598204|FG000|NOT COMPLETED|Overall Study||0||
59505457|NCT02144675|75598205|FG001|NOT COMPLETED|Overall Study||0||
59505458|NCT00721253|75598213|FG000|STARTED|Overall Study||20||
59505459|NCT00721253|75598214|FG001|STARTED|Overall Study||22||
59505460|NCT00721253|75598215|FG002|STARTED|Overall Study|There were no subjects that were implanted with the Tecnis lens.|0||
59505461|NCT00721253|75598213|FG000|COMPLETED|Overall Study||20||
59505462|NCT00721253|75598214|FG001|COMPLETED|Overall Study||22||
59505463|NCT00721253|75598215|FG002|COMPLETED|Overall Study||0||
59756640|NCT00950807|75875647|FG005|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|11||
59756641|NCT00950807|75875648|FG006|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|10||
59756642|NCT00950807|75875649|FG007|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|13||
59756643|NCT00950807|75875650|FG008|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|11||
59756644|NCT00950807|75875651|FG009|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|13||
59756645|NCT00950807|75875642|FG000|NOT COMPLETED|Washout Period 1||5||
59756646|NCT00950807|75875643|FG001|NOT COMPLETED|Washout Period 1||0||
59756647|NCT00950807|75875644|FG002|NOT COMPLETED|Washout Period 1||0||
59756648|NCT00950807|75875645|FG003|NOT COMPLETED|Washout Period 1||1||
59756649|NCT00950807|75875646|FG004|NOT COMPLETED|Washout Period 1||1||
59756650|NCT00950807|75875647|FG005|NOT COMPLETED|Washout Period 1||0||
59756651|NCT00950807|75875648|FG006|NOT COMPLETED|Washout Period 1||2||
59756652|NCT00950807|75875649|FG007|NOT COMPLETED|Washout Period 1||1||
59756653|NCT00950807|75875650|FG008|NOT COMPLETED|Washout Period 1||1||
59756654|NCT00950807|75875651|FG009|NOT COMPLETED|Washout Period 1||0||
59756655|NCT00950807|75875642|FG000|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|53||
59756656|NCT00950807|75875643|FG001|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|13||
59756657|NCT00950807|75875644|FG002|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|10||
59756658|NCT00950807|75875645|FG003|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|13||
59756659|NCT00950807|75875646|FG004|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|13||
59756660|NCT00950807|75875647|FG005|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|10||
59756661|NCT00950807|75875648|FG006|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|10||
59756662|NCT00950807|75875649|FG007|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|13||
59756663|NCT00950807|75875650|FG008|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|11||
59756664|NCT00950807|75875651|FG009|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|11||
59888271|NCT02742766|76010576|FG015|COMPLETED|Part 2 (Up to 22 Days)|Day 4 study medication interrupted due to an AE and eventually withdrew from study on Day 5.|5||
59888272|NCT02742766|76010577|FG016|COMPLETED|Part 2 (Up to 22 Days)||0||
59888273|NCT02742766|76010578|FG017|COMPLETED|Part 2 (Up to 22 Days)||0||
59888274|NCT02742766|76010579|FG018|COMPLETED|Part 2 (Up to 22 Days)||0||
59888275|NCT02742766|76010561|FG000|NOT COMPLETED|Part 2 (Up to 22 Days)||0||
59888276|NCT02742766|76010562|FG001|NOT COMPLETED|Part 2 (Up to 22 Days)||0||
59888277|NCT02742766|76010563|FG002|NOT COMPLETED|Part 2 (Up to 22 Days)||0||
59888278|NCT02742766|76010564|FG003|NOT COMPLETED|Part 2 (Up to 22 Days)||0||
59888279|NCT02742766|76010565|FG004|NOT COMPLETED|Part 2 (Up to 22 Days)||0||
59888280|NCT02742766|76010566|FG005|NOT COMPLETED|Part 2 (Up to 22 Days)||0||
59888281|NCT02742766|76010567|FG006|NOT COMPLETED|Part 2 (Up to 22 Days)||0||
59888282|NCT02742766|76010568|FG007|NOT COMPLETED|Part 2 (Up to 22 Days)||0||
59888283|NCT02742766|76010569|FG008|NOT COMPLETED|Part 2 (Up to 22 Days)||0||
59888284|NCT02742766|76010570|FG009|NOT COMPLETED|Part 2 (Up to 22 Days)||0||
59888285|NCT02742766|76010571|FG010|NOT COMPLETED|Part 2 (Up to 22 Days)||0||
59888286|NCT02742766|76010572|FG011|NOT COMPLETED|Part 2 (Up to 22 Days)||0||
59888287|NCT02742766|76010573|FG012|NOT COMPLETED|Part 2 (Up to 22 Days)||2||
59888288|NCT02742766|76010574|FG013|NOT COMPLETED|Part 2 (Up to 22 Days)||6||
59888289|NCT02742766|76010575|FG014|NOT COMPLETED|Part 2 (Up to 22 Days)||0||
59888290|NCT02742766|76010576|FG015|NOT COMPLETED|Part 2 (Up to 22 Days)||1||
59888291|NCT02742766|76010577|FG016|NOT COMPLETED|Part 2 (Up to 22 Days)||0||
59888292|NCT02742766|76010578|FG017|NOT COMPLETED|Part 2 (Up to 22 Days)||0||
59888293|NCT02742766|76010579|FG018|NOT COMPLETED|Part 2 (Up to 22 Days)||0||
59888294|NCT02742766|76010561|FG000|STARTED|Part 3 (Up to 36 Days)||0||
59888295|NCT02742766|76010562|FG001|STARTED|Part 3 (Up to 36 Days)||0||
59888296|NCT02742766|76010563|FG002|STARTED|Part 3 (Up to 36 Days)||0||
59888297|NCT02742766|76010564|FG003|STARTED|Part 3 (Up to 36 Days)||0||
59888298|NCT02742766|76010565|FG004|STARTED|Part 3 (Up to 36 Days)||0||
59888299|NCT02742766|76010566|FG005|STARTED|Part 3 (Up to 36 Days)||0||
59888300|NCT02742766|76010567|FG006|STARTED|Part 3 (Up to 36 Days)||0||
59888301|NCT02742766|76010568|FG007|STARTED|Part 3 (Up to 36 Days)||0||
59888302|NCT02742766|76010569|FG008|STARTED|Part 3 (Up to 36 Days)||0||
59888303|NCT02742766|76010570|FG009|STARTED|Part 3 (Up to 36 Days)||0||
59888304|NCT02742766|76010571|FG010|STARTED|Part 3 (Up to 36 Days)||0||
59888305|NCT02742766|76010572|FG011|STARTED|Part 3 (Up to 36 Days)||0||
59888306|NCT02742766|76010573|FG012|STARTED|Part 3 (Up to 36 Days)||0||
59888307|NCT02742766|76010574|FG013|STARTED|Part 3 (Up to 36 Days)||0||
59888308|NCT02742766|76010575|FG014|STARTED|Part 3 (Up to 36 Days)||0||
59888309|NCT02742766|76010576|FG015|STARTED|Part 3 (Up to 36 Days)||0||
59888310|NCT02742766|76010577|FG016|STARTED|Part 3 (Up to 36 Days)||0||
59888311|NCT02742766|76010578|FG017|STARTED|Part 3 (Up to 36 Days)||0||
59888312|NCT02742766|76010579|FG018|STARTED|Part 3 (Up to 36 Days)||0||
59888313|NCT02742766|76010561|FG000|COMPLETED|Part 3 (Up to 36 Days)||0||
59888314|NCT02742766|76010562|FG001|COMPLETED|Part 3 (Up to 36 Days)||0||
59888315|NCT02742766|76010563|FG002|COMPLETED|Part 3 (Up to 36 Days)||0||
59888316|NCT02742766|76010564|FG003|COMPLETED|Part 3 (Up to 36 Days)||0||
59888317|NCT02742766|76010565|FG004|COMPLETED|Part 3 (Up to 36 Days)||0||
59888318|NCT02742766|76010566|FG005|COMPLETED|Part 3 (Up to 36 Days)||0||
59888319|NCT02742766|76010567|FG006|COMPLETED|Part 3 (Up to 36 Days)||0||
59888320|NCT02742766|76010568|FG007|COMPLETED|Part 3 (Up to 36 Days)||0||
59888321|NCT02742766|76010569|FG008|COMPLETED|Part 3 (Up to 36 Days)||0||
59888322|NCT02742766|76010570|FG009|COMPLETED|Part 3 (Up to 36 Days)||0||
59888323|NCT02742766|76010571|FG010|COMPLETED|Part 3 (Up to 36 Days)||0||
59888324|NCT02742766|76010572|FG011|COMPLETED|Part 3 (Up to 36 Days)||0||
59888325|NCT02742766|76010573|FG012|COMPLETED|Part 3 (Up to 36 Days)||0||
59888326|NCT02742766|76010574|FG013|COMPLETED|Part 3 (Up to 36 Days)||0||
59888327|NCT02742766|76010575|FG014|COMPLETED|Part 3 (Up to 36 Days)||0||
59888328|NCT02742766|76010576|FG015|COMPLETED|Part 3 (Up to 36 Days)||0||
59888329|NCT02742766|76010577|FG016|COMPLETED|Part 3 (Up to 36 Days)||0||
59888330|NCT02742766|76010578|FG017|COMPLETED|Part 3 (Up to 36 Days)||0||
59888331|NCT02742766|76010579|FG018|COMPLETED|Part 3 (Up to 36 Days)||0||
59888332|NCT02742766|76010561|FG000|NOT COMPLETED|Part 3 (Up to 36 Days)||0||
59888333|NCT02742766|76010562|FG001|NOT COMPLETED|Part 3 (Up to 36 Days)||0||
59888334|NCT02742766|76010563|FG002|NOT COMPLETED|Part 3 (Up to 36 Days)||0||
59888335|NCT02742766|76010564|FG003|NOT COMPLETED|Part 3 (Up to 36 Days)||0||
59888336|NCT02742766|76010565|FG004|NOT COMPLETED|Part 3 (Up to 36 Days)||0||
59888337|NCT02742766|76010566|FG005|NOT COMPLETED|Part 3 (Up to 36 Days)||0||
59888338|NCT02742766|76010567|FG006|NOT COMPLETED|Part 3 (Up to 36 Days)||0||
59888339|NCT02742766|76010568|FG007|NOT COMPLETED|Part 3 (Up to 36 Days)||0||
59888340|NCT02742766|76010569|FG008|NOT COMPLETED|Part 3 (Up to 36 Days)||0||
59888341|NCT02742766|76010570|FG009|NOT COMPLETED|Part 3 (Up to 36 Days)||0||
59888342|NCT02742766|76010571|FG010|NOT COMPLETED|Part 3 (Up to 36 Days)||0||
59888343|NCT02742766|76010572|FG011|NOT COMPLETED|Part 3 (Up to 36 Days)||0||
59888344|NCT02742766|76010573|FG012|NOT COMPLETED|Part 3 (Up to 36 Days)||0||
59888345|NCT02742766|76010574|FG013|NOT COMPLETED|Part 3 (Up to 36 Days)||0||
59888346|NCT02742766|76010575|FG014|NOT COMPLETED|Part 3 (Up to 36 Days)||0||
59888347|NCT02742766|76010576|FG015|NOT COMPLETED|Part 3 (Up to 36 Days)||0||
59888348|NCT02742766|76010577|FG016|NOT COMPLETED|Part 3 (Up to 36 Days)||0||
59888349|NCT02742766|76010578|FG017|NOT COMPLETED|Part 3 (Up to 36 Days)||0||
59888350|NCT02742766|76010579|FG018|NOT COMPLETED|Part 3 (Up to 36 Days)||0||
59888351|NCT01858948|76010641|FG000|STARTED|Overall Study||9||
59888352|NCT01858948|76010642|FG001|STARTED|Overall Study||10||
59888353|NCT01858948|76010641|FG000|COMPLETED|Overall Study|Completed week 24|5||
59888354|NCT01858948|76010642|FG001|COMPLETED|Overall Study|Completed week 24|4||
59888355|NCT01858948|76010641|FG000|NOT COMPLETED|Overall Study||4||
59888356|NCT01858948|76010642|FG001|NOT COMPLETED|Overall Study||6||
59888357|NCT01468922|76010657|FG000|STARTED|Overall Study||3||
59888358|NCT01468922|76010658|FG001|STARTED|Overall Study||3||
59888359|NCT01468922|76010659|FG002|STARTED|Overall Study||2||
59888360|NCT01468922|76010660|FG003|STARTED|Overall Study||1||
59888361|NCT01468922|76010661|FG004|STARTED|Overall Study||4||
59888362|NCT01468922|76010662|FG005|STARTED|Overall Study||1||
59888363|NCT01468922|76010663|FG006|STARTED|Overall Study||1||
59888364|NCT01468922|76010664|FG007|STARTED|Overall Study||16||
59888365|NCT01468922|76010665|FG008|STARTED|Overall Study||1||
59888366|NCT01468922|76010657|FG000|COMPLETED|Overall Study||1||
59888367|NCT01468922|76010658|FG001|COMPLETED|Overall Study||3||
59888368|NCT01468922|76010659|FG002|COMPLETED|Overall Study||2||
59756665|NCT00950807|75875642|FG000|COMPLETED|Treatment Period 2||51||
59888369|NCT01468922|76010660|FG003|COMPLETED|Overall Study||1||
59610446|NCT01824498|75721280|FG003|COMPLETED|3rd Intervention (8 Weeks)||2||
59610447|NCT01824498|75721281|FG004|COMPLETED|3rd Intervention (8 Weeks)||3||
59756666|NCT00950807|75875643|FG001|COMPLETED|Treatment Period 2||12||
59756667|NCT00950807|75875644|FG002|COMPLETED|Treatment Period 2||10||
59888370|NCT01468922|76010661|FG004|COMPLETED|Overall Study||2||
59888371|NCT01468922|76010662|FG005|COMPLETED|Overall Study||1||
59888372|NCT01468922|76010663|FG006|COMPLETED|Overall Study||1||
59888373|NCT01468922|76010664|FG007|COMPLETED|Overall Study||12||
59888374|NCT01468922|76010665|FG008|COMPLETED|Overall Study||0||
59888375|NCT01468922|76010657|FG000|NOT COMPLETED|Overall Study||2||
59888376|NCT01468922|76010658|FG001|NOT COMPLETED|Overall Study||0||
59888377|NCT01468922|76010659|FG002|NOT COMPLETED|Overall Study||0||
59888378|NCT01468922|76010660|FG003|NOT COMPLETED|Overall Study||0||
59888379|NCT01468922|76010661|FG004|NOT COMPLETED|Overall Study||2||
59505464|NCT00721253|75598213|FG000|NOT COMPLETED|Overall Study||0||
59505465|NCT00721253|75598214|FG001|NOT COMPLETED|Overall Study||0||
59505466|NCT00721253|75598215|FG002|NOT COMPLETED|Overall Study||0||
59505467|NCT00749515|75598223|FG000|STARTED|Overall Study||10||
59505468|NCT00749515|75598224|FG001|STARTED|Overall Study||5||
59505469|NCT00749515|75598223|FG000|COMPLETED|Overall Study||10||
59505470|NCT00749515|75598224|FG001|COMPLETED|Overall Study||5||
59505471|NCT00749515|75598223|FG000|NOT COMPLETED|Overall Study||0||
59505472|NCT00749515|75598224|FG001|NOT COMPLETED|Overall Study||0||
59505473|NCT00707447|75598232|FG000|STARTED|Overall Study||89||
59505474|NCT00707447|75598233|FG001|STARTED|Overall Study||93||
59505475|NCT00707447|75598232|FG000|COMPLETED|Overall Study||81||
59505476|NCT00707447|75598233|FG001|COMPLETED|Overall Study||85||
59505477|NCT00707447|75598232|FG000|NOT COMPLETED|Overall Study||8||
59610448|NCT01824498|75721282|FG005|COMPLETED|3rd Intervention (8 Weeks)||4||
59756668|NCT00950807|75875645|FG003|COMPLETED|Treatment Period 2||12||
59756669|NCT00950807|75875646|FG004|COMPLETED|Treatment Period 2||13||
59756670|NCT00950807|75875647|FG005|COMPLETED|Treatment Period 2||9||
59756671|NCT00950807|75875648|FG006|COMPLETED|Treatment Period 2||9||
59756672|NCT00950807|75875649|FG007|COMPLETED|Treatment Period 2||10||
59756673|NCT00950807|75875650|FG008|COMPLETED|Treatment Period 2||11||
59756674|NCT00950807|75875651|FG009|COMPLETED|Treatment Period 2||11||
59756675|NCT00950807|75875642|FG000|NOT COMPLETED|Treatment Period 2||2||
59505478|NCT00707447|75598233|FG001|NOT COMPLETED|Overall Study||8||
59505479|NCT00749671|75598241|FG000|STARTED|Overall Study||11||
59610449|NCT01824498|75721277|FG000|NOT COMPLETED|3rd Intervention (8 Weeks)||0||
59610450|NCT01824498|75721278|FG001|NOT COMPLETED|3rd Intervention (8 Weeks)||0||
59756676|NCT00950807|75875643|FG001|NOT COMPLETED|Treatment Period 2||1||
59756677|NCT00950807|75875644|FG002|NOT COMPLETED|Treatment Period 2||0||
59756678|NCT00950807|75875645|FG003|NOT COMPLETED|Treatment Period 2||1||
59756679|NCT00950807|75875646|FG004|NOT COMPLETED|Treatment Period 2||0||
59756680|NCT00950807|75875647|FG005|NOT COMPLETED|Treatment Period 2||1||
59756681|NCT00950807|75875648|FG006|NOT COMPLETED|Treatment Period 2||1||
59756682|NCT00950807|75875649|FG007|NOT COMPLETED|Treatment Period 2||3||
59756683|NCT00950807|75875650|FG008|NOT COMPLETED|Treatment Period 2||0||
59756684|NCT00950807|75875651|FG009|NOT COMPLETED|Treatment Period 2||0||
59756685|NCT00950807|75875642|FG000|STARTED|Washout Period 2||51||
59756686|NCT00950807|75875643|FG001|STARTED|Washout Period 2||12||
59756687|NCT00950807|75875644|FG002|STARTED|Washout Period 2||10||
59756688|NCT00950807|75875645|FG003|STARTED|Washout Period 2||12||
59756689|NCT00950807|75875646|FG004|STARTED|Washout Period 2||13||
59888380|NCT01468922|76010662|FG005|NOT COMPLETED|Overall Study||0||
59888381|NCT01468922|76010663|FG006|NOT COMPLETED|Overall Study||0||
59888382|NCT01468922|76010664|FG007|NOT COMPLETED|Overall Study||4||
59888383|NCT01468922|76010665|FG008|NOT COMPLETED|Overall Study||1||
59888384|NCT01381094|76010688|FG000|STARTED|Overall Study||18||
59888385|NCT01381094|76010689|FG001|STARTED|Overall Study||18||
59888386|NCT01381094|76010690|FG002|STARTED|Overall Study||17||
59888387|NCT01381094|76010691|FG003|STARTED|Overall Study||19||
59888388|NCT01381094|76010692|FG004|STARTED|Overall Study||19||
59888389|NCT01381094|76010688|FG000|COMPLETED|Overall Study||16||
59888390|NCT01381094|76010689|FG001|COMPLETED|Overall Study||15||
59888391|NCT01381094|76010690|FG002|COMPLETED|Overall Study||17||
59888392|NCT01381094|76010691|FG003|COMPLETED|Overall Study||18||
59888393|NCT01381094|76010692|FG004|COMPLETED|Overall Study||18||
59888394|NCT01381094|76010688|FG000|NOT COMPLETED|Overall Study||2||
59888395|NCT01381094|76010689|FG001|NOT COMPLETED|Overall Study||3||
59888396|NCT01381094|76010690|FG002|NOT COMPLETED|Overall Study||0||
59888397|NCT01381094|76010691|FG003|NOT COMPLETED|Overall Study||1||
59888398|NCT01381094|76010692|FG004|NOT COMPLETED|Overall Study||1||
59888399|NCT03197558|76010704|FG000|STARTED|Overall Study||30||
59888400|NCT03197558|76010704|FG000|COMPLETED|Overall Study||29|Participants undergoing iontophoresis with adequate anesthesia for tube placement.|
59888401|NCT03197558|76010704|FG000|NOT COMPLETED|Overall Study||1||
59888402|NCT03197324|76010710|FG000|STARTED|Overall Study||10||
59888403|NCT03197324|76010711|FG001|STARTED|Overall Study||10||
59888404|NCT03197324|76010710|FG000|COMPLETED|Overall Study||10||
59888405|NCT03197324|76010711|FG001|COMPLETED|Overall Study||9||
59888406|NCT03197324|76010710|FG000|NOT COMPLETED|Overall Study||0||
59888407|NCT03197324|76010711|FG001|NOT COMPLETED|Overall Study||1||
59888408|NCT03162614|76010723|FG000|STARTED|Overall Study||26||
59888409|NCT03162614|76010724|FG001|STARTED|Overall Study||26||
59888410|NCT03162614|76010725|FG002|STARTED|Overall Study||26||
59888411|NCT03162614|76010726|FG003|STARTED|Overall Study||26||
59888412|NCT03162614|76010727|FG004|STARTED|Overall Study||26||
59888413|NCT03162614|76010728|FG005|STARTED|Overall Study||24||
59888414|NCT03162614|76010723|FG000|COMPLETED|Overall Study||20||
59888415|NCT03162614|76010724|FG001|COMPLETED|Overall Study||21||
59888416|NCT03162614|76010725|FG002|COMPLETED|Overall Study||22||
59888417|NCT03162614|76010726|FG003|COMPLETED|Overall Study||19||
59888418|NCT03162614|76010727|FG004|COMPLETED|Overall Study||21||
59888419|NCT03162614|76010728|FG005|COMPLETED|Overall Study||24||
59888420|NCT03162614|76010723|FG000|NOT COMPLETED|Overall Study||6||
59888421|NCT03162614|76010724|FG001|NOT COMPLETED|Overall Study||5||
59888422|NCT03162614|76010725|FG002|NOT COMPLETED|Overall Study||4||
59888423|NCT03162614|76010726|FG003|NOT COMPLETED|Overall Study||7||
59888424|NCT03162614|76010727|FG004|NOT COMPLETED|Overall Study||5||
59888425|NCT03162614|76010728|FG005|NOT COMPLETED|Overall Study||0||
59888426|NCT03160898|76010746|FG000|STARTED|Overall Study||115||
59888427|NCT03160898|76010747|FG001|STARTED|Overall Study|1 patient withdrew consent before study drug dosing and was therefore excluded from safety analysis|113||
59888428|NCT03160898|76010748|FG002|STARTED|Overall Study||113||
59888429|NCT03160898|76010749|FG003|STARTED|Overall Study||117||
59888430|NCT03160898|76010746|FG000|COMPLETED|Overall Study||95||
59888431|NCT03160898|76010747|FG001|COMPLETED|Overall Study||100||
59888432|NCT03160898|76010748|FG002|COMPLETED|Overall Study||97||
59888433|NCT03160898|76010749|FG003|COMPLETED|Overall Study||98||
59888434|NCT03160898|76010746|FG000|NOT COMPLETED|Overall Study||20||
59888435|NCT03160898|76010747|FG001|NOT COMPLETED|Overall Study||13||
59888436|NCT03160898|76010748|FG002|NOT COMPLETED|Overall Study||16||
59888437|NCT03160898|76010749|FG003|NOT COMPLETED|Overall Study||19||
59888438|NCT03193736|76010760|FG000|STARTED|Overall Study||26||
59888439|NCT03193736|76010760|FG000|Received Implant|Overall Study||25||
59888440|NCT03193736|76010760|FG000|COMPLETED|Overall Study||21||
59888441|NCT03193736|76010760|FG000|NOT COMPLETED|Overall Study||5||
59888442|NCT01235936|76010764|FG000|STARTED|Overall Study||10||
59888443|NCT01235936|76010764|FG000|COMPLETED|Overall Study||10||
59888444|NCT01235936|76010764|FG000|NOT COMPLETED|Overall Study||0||
59888445|NCT03192488|76010768|FG000|STARTED|First Intervention (d1)||1||
59888446|NCT03192488|76010769|FG001|STARTED|First Intervention (d1)||5||
59888447|NCT03192488|76010770|FG002|STARTED|First Intervention (d1)||2||
59888448|NCT03192488|76010771|FG003|STARTED|First Intervention (d1)||1||
59888449|NCT03192488|76010772|FG004|STARTED|First Intervention (d1)||1||
59888450|NCT03192488|76010773|FG005|STARTED|First Intervention (d1)||1||
59888451|NCT03192488|76010768|FG000|COMPLETED|First Intervention (d1)||1||
59888452|NCT03192488|76010769|FG001|COMPLETED|First Intervention (d1)||5||
59888453|NCT03192488|76010770|FG002|COMPLETED|First Intervention (d1)||2||
59888454|NCT03192488|76010771|FG003|COMPLETED|First Intervention (d1)||1||
59888455|NCT03192488|76010772|FG004|COMPLETED|First Intervention (d1)||1||
59888456|NCT03192488|76010773|FG005|COMPLETED|First Intervention (d1)||1||
59888457|NCT03192488|76010768|FG000|NOT COMPLETED|First Intervention (d1)||0||
59888458|NCT03192488|76010769|FG001|NOT COMPLETED|First Intervention (d1)||0||
59888459|NCT03192488|76010770|FG002|NOT COMPLETED|First Intervention (d1)||0||
59888460|NCT03192488|76010771|FG003|NOT COMPLETED|First Intervention (d1)||0||
59888461|NCT03192488|76010772|FG004|NOT COMPLETED|First Intervention (d1)||0||
59888462|NCT03192488|76010773|FG005|NOT COMPLETED|First Intervention (d1)||0||
59888463|NCT03192488|76010768|FG000|STARTED|First Washout (>6d)||1||
59888464|NCT03192488|76010769|FG001|STARTED|First Washout (>6d)||5||
59888465|NCT03192488|76010770|FG002|STARTED|First Washout (>6d)||2||
59888466|NCT03192488|76010771|FG003|STARTED|First Washout (>6d)||1||
59888467|NCT03192488|76010772|FG004|STARTED|First Washout (>6d)||1||
59888468|NCT03192488|76010773|FG005|STARTED|First Washout (>6d)||1||
59888469|NCT03192488|76010768|FG000|COMPLETED|First Washout (>6d)||1||
59888470|NCT03192488|76010769|FG001|COMPLETED|First Washout (>6d)||5||
59888471|NCT03192488|76010770|FG002|COMPLETED|First Washout (>6d)||1||
59888472|NCT03192488|76010771|FG003|COMPLETED|First Washout (>6d)||1||
59888473|NCT03192488|76010772|FG004|COMPLETED|First Washout (>6d)||1||
59888474|NCT03192488|76010773|FG005|COMPLETED|First Washout (>6d)||0||
59888475|NCT03192488|76010768|FG000|NOT COMPLETED|First Washout (>6d)||0||
59888476|NCT03192488|76010769|FG001|NOT COMPLETED|First Washout (>6d)||0||
59888477|NCT03192488|76010770|FG002|NOT COMPLETED|First Washout (>6d)||1||
59888478|NCT03192488|76010771|FG003|NOT COMPLETED|First Washout (>6d)||0||
59888479|NCT03192488|76010772|FG004|NOT COMPLETED|First Washout (>6d)||0||
59505480|NCT00749671|75598242|FG001|STARTED|Overall Study||9||
59505481|NCT00749671|75598241|FG000|COMPLETED|Overall Study||11||
59505482|NCT00749671|75598242|FG001|COMPLETED|Overall Study||9||
59505483|NCT00749671|75598241|FG000|NOT COMPLETED|Overall Study||0||
59505484|NCT00749671|75598242|FG001|NOT COMPLETED|Overall Study||0||
59505485|NCT00762307|75598254|FG000|STARTED|Overall Study||28||
59505486|NCT00762307|75598255|FG001|STARTED|Overall Study||11||
59505487|NCT00762307|75598256|FG002|STARTED|Overall Study||11||
59505488|NCT00762307|75598257|FG003|STARTED|Overall Study||10||
59505489|NCT00762307|75598254|FG000|COMPLETED|Overall Study||26||
59505490|NCT00762307|75598255|FG001|COMPLETED|Overall Study||11||
59888480|NCT03192488|76010773|FG005|NOT COMPLETED|First Washout (>6d)||1||
59888481|NCT03192488|76010768|FG000|STARTED|Second Intervention (d1)||1||
59888482|NCT03192488|76010769|FG001|STARTED|Second Intervention (d1)||5||
59888483|NCT03192488|76010770|FG002|STARTED|Second Intervention (d1)||1||
59888484|NCT03192488|76010771|FG003|STARTED|Second Intervention (d1)||1||
59888485|NCT03192488|76010772|FG004|STARTED|Second Intervention (d1)||1||
59888486|NCT03192488|76010773|FG005|STARTED|Second Intervention (d1)||0||
59888487|NCT03192488|76010768|FG000|COMPLETED|Second Intervention (d1)||1||
59888488|NCT03192488|76010769|FG001|COMPLETED|Second Intervention (d1)||5||
59888489|NCT03192488|76010770|FG002|COMPLETED|Second Intervention (d1)||1||
59888490|NCT03192488|76010771|FG003|COMPLETED|Second Intervention (d1)||1||
59888491|NCT03192488|76010772|FG004|COMPLETED|Second Intervention (d1)||1||
59888492|NCT03192488|76010773|FG005|COMPLETED|Second Intervention (d1)||0||
59888493|NCT03192488|76010768|FG000|NOT COMPLETED|Second Intervention (d1)||0||
59888494|NCT03192488|76010769|FG001|NOT COMPLETED|Second Intervention (d1)||0||
59888495|NCT03192488|76010770|FG002|NOT COMPLETED|Second Intervention (d1)||0||
59888496|NCT03192488|76010771|FG003|NOT COMPLETED|Second Intervention (d1)||0||
59888497|NCT03192488|76010772|FG004|NOT COMPLETED|Second Intervention (d1)||0||
59888498|NCT03192488|76010773|FG005|NOT COMPLETED|Second Intervention (d1)||0||
59888499|NCT03192488|76010768|FG000|STARTED|Second Washout (>6d)||1||
59888500|NCT03192488|76010769|FG001|STARTED|Second Washout (>6d)||5||
59888501|NCT03192488|76010770|FG002|STARTED|Second Washout (>6d)||1||
59505491|NCT00762307|75598256|FG002|COMPLETED|Overall Study||11||
59505492|NCT00762307|75598257|FG003|COMPLETED|Overall Study||9||
59888502|NCT03192488|76010771|FG003|STARTED|Second Washout (>6d)||1||
59888503|NCT03192488|76010772|FG004|STARTED|Second Washout (>6d)||1||
59888504|NCT03192488|76010773|FG005|STARTED|Second Washout (>6d)||0||
59888505|NCT03192488|76010768|FG000|COMPLETED|Second Washout (>6d)||1||
59888506|NCT03192488|76010769|FG001|COMPLETED|Second Washout (>6d)||5||
59888507|NCT03192488|76010770|FG002|COMPLETED|Second Washout (>6d)||1||
59888508|NCT03192488|76010771|FG003|COMPLETED|Second Washout (>6d)||1||
59888509|NCT03192488|76010772|FG004|COMPLETED|Second Washout (>6d)||1||
59888510|NCT03192488|76010773|FG005|COMPLETED|Second Washout (>6d)||0||
59888511|NCT03192488|76010768|FG000|NOT COMPLETED|Second Washout (>6d)||0||
59888512|NCT03192488|76010769|FG001|NOT COMPLETED|Second Washout (>6d)||0||
59888513|NCT03192488|76010770|FG002|NOT COMPLETED|Second Washout (>6d)||0||
59888514|NCT03192488|76010771|FG003|NOT COMPLETED|Second Washout (>6d)||0||
59888515|NCT03192488|76010772|FG004|NOT COMPLETED|Second Washout (>6d)||0||
59888516|NCT03192488|76010773|FG005|NOT COMPLETED|Second Washout (>6d)||0||
59888517|NCT03192488|76010768|FG000|STARTED|Third Intervention (d1)||1||
59888518|NCT03192488|76010769|FG001|STARTED|Third Intervention (d1)||5||
59888519|NCT03192488|76010770|FG002|STARTED|Third Intervention (d1)||1||
59888520|NCT03192488|76010771|FG003|STARTED|Third Intervention (d1)||1||
59888521|NCT03192488|76010772|FG004|STARTED|Third Intervention (d1)||1||
59888522|NCT03192488|76010773|FG005|STARTED|Third Intervention (d1)||0||
59888523|NCT03192488|76010768|FG000|COMPLETED|Third Intervention (d1)||1||
59888524|NCT03192488|76010769|FG001|COMPLETED|Third Intervention (d1)||5||
59888525|NCT03192488|76010770|FG002|COMPLETED|Third Intervention (d1)||1||
59888526|NCT03192488|76010771|FG003|COMPLETED|Third Intervention (d1)||1||
59888527|NCT03192488|76010772|FG004|COMPLETED|Third Intervention (d1)||0||
59888528|NCT03192488|76010773|FG005|COMPLETED|Third Intervention (d1)||0||
59888529|NCT03192488|76010768|FG000|NOT COMPLETED|Third Intervention (d1)||0||
59888530|NCT03192488|76010769|FG001|NOT COMPLETED|Third Intervention (d1)||0||
59888531|NCT03192488|76010770|FG002|NOT COMPLETED|Third Intervention (d1)||0||
59888532|NCT03192488|76010771|FG003|NOT COMPLETED|Third Intervention (d1)||0||
59888533|NCT03192488|76010772|FG004|NOT COMPLETED|Third Intervention (d1)||1||
59888534|NCT03192488|76010773|FG005|NOT COMPLETED|Third Intervention (d1)||0||
59888535|NCT01642004|76010789|FG000|STARTED|Randomization||135|Started=Randomized|
59888536|NCT01642004|76010790|FG001|STARTED|Randomization||137|Started=Randomized|
59888537|NCT01642004|76010789|FG000|COMPLETED|Randomization||131|Completed= participants that received treatment|
59888538|NCT01642004|76010790|FG001|COMPLETED|Randomization||129|Completed= participants that received treatment|
59888539|NCT01642004|76010789|FG000|NOT COMPLETED|Randomization||4||
59888540|NCT01642004|76010790|FG001|NOT COMPLETED|Randomization||8||
59888541|NCT01642004|76010789|FG000|STARTED|Treatment||131||
59888542|NCT01642004|76010790|FG001|STARTED|Treatment||129||
59888543|NCT01642004|76010789|FG000|Participants Transitioned to Nivolumab|Treatment||0||
59888544|NCT01642004|76010790|FG001|Participants Transitioned to Nivolumab|Treatment||6||
59888545|NCT01642004|76010789|FG000|COMPLETED|Treatment||0|Completed = continue in the treatment period|
59888546|NCT01642004|76010790|FG001|COMPLETED|Treatment||0|Completed = continue in the treatment period|
59888547|NCT01642004|76010789|FG000|NOT COMPLETED|Treatment||131||
59888548|NCT01642004|76010790|FG001|NOT COMPLETED|Treatment||129||
59888549|NCT00042289|76010846|FG000|STARTED|Overall Study||26||
59888550|NCT00042289|76010847|FG001|STARTED|Overall Study||30||
59888551|NCT00042289|76010848|FG002|STARTED|Overall Study||27||
59888552|NCT00042289|76010849|FG003|STARTED|Overall Study||33||
59888553|NCT00042289|76010850|FG004|STARTED|Overall Study||29||
59888554|NCT00042289|76010851|FG005|STARTED|Overall Study||31||
59888555|NCT00042289|76010852|FG006|STARTED|Overall Study||28||
59888556|NCT00042289|76010853|FG007|STARTED|Overall Study||12||
59505493|NCT00762307|75598254|FG000|NOT COMPLETED|Overall Study||2||
59505494|NCT00762307|75598255|FG001|NOT COMPLETED|Overall Study||0||
59505495|NCT00762307|75598256|FG002|NOT COMPLETED|Overall Study||0||
59505496|NCT00762307|75598257|FG003|NOT COMPLETED|Overall Study||1||
59505497|NCT00639002|75598278|FG000|STARTED|Overall Study||13||
59505498|NCT00639002|75598278|FG000|Received Ruxolitinib|Overall Study||13||
59505499|NCT00639002|75598278|FG000|Received Ruxolitinib + Dexamethasone|Overall Study||7||
59505500|NCT00639002|75598278|FG000|COMPLETED|Overall Study||0||
59505501|NCT00639002|75598278|FG000|NOT COMPLETED|Overall Study||13||
59505502|NCT00761137|75598283|FG000|STARTED|Overall Study||19||
59505503|NCT00761137|75598283|FG000|Placebo|Overall Study||19||
59505504|NCT00761137|75598283|FG000|0.3 mg Tropicamide|Overall Study||19||
59505505|NCT00761137|75598283|FG000|1 mg Tropicamide|Overall Study||19||
59888557|NCT00042289|76010854|FG008|STARTED|Overall Study||27||
59888558|NCT00042289|76010855|FG009|STARTED|Overall Study||24||
59888559|NCT00042289|76010856|FG010|STARTED|Overall Study||2||
59888560|NCT00042289|76010857|FG011|STARTED|Overall Study||27||
59505506|NCT00761137|75598283|FG000|3 mg Tropicamide|Overall Study||19||
59505507|NCT00761137|75598283|FG000|COMPLETED|Overall Study||19||
59505508|NCT00761137|75598283|FG000|NOT COMPLETED|Overall Study||0||
59505509|NCT02575118|75598290|FG000|STARTED|Overall Study||20||
59610451|NCT01824498|75721279|FG002|NOT COMPLETED|3rd Intervention (8 Weeks)||0||
59610452|NCT01824498|75721280|FG003|NOT COMPLETED|3rd Intervention (8 Weeks)||0||
59888561|NCT00042289|76010858|FG012|STARTED|Overall Study||13||
59888562|NCT00042289|76010859|FG013|STARTED|Overall Study||2||
59888563|NCT00042289|76010860|FG014|STARTED|Overall Study||6||
59888564|NCT00042289|76010861|FG015|STARTED|Overall Study||29||
59888565|NCT00042289|76010862|FG016|STARTED|Overall Study||28||
59888566|NCT00042289|76010863|FG017|STARTED|Overall Study||12||
59888567|NCT00042289|76010864|FG018|STARTED|Overall Study||26||
59888568|NCT00042289|76010865|FG019|STARTED|Overall Study||17||
59888569|NCT00042289|76010866|FG020|STARTED|Overall Study||1||
59888570|NCT00042289|76010867|FG021|STARTED|Overall Study||30||
59888571|NCT00042289|76010868|FG022|STARTED|Overall Study||29||
59888572|NCT00042289|76010869|FG023|STARTED|Overall Study||22||
59888573|NCT00042289|76010870|FG024|STARTED|Overall Study||18||
59888574|NCT00042289|76010871|FG025|STARTED|Overall Study||21||
59888575|NCT00042289|76010872|FG026|STARTED|Overall Study||28||
59888576|NCT00042289|76010873|FG027|STARTED|Overall Study||25||
59888577|NCT00042289|76010874|FG028|STARTED|Overall Study||29||
59888578|NCT00042289|76010875|FG029|STARTED|Overall Study||25||
59888579|NCT00042289|76010876|FG030|STARTED|Overall Study||1||
59888580|NCT00042289|76010877|FG031|STARTED|Overall Study||35||
59888581|NCT00042289|76010878|FG032|STARTED|Overall Study||43||
59888582|NCT00042289|76010879|FG033|STARTED|Overall Study||16||
59888583|NCT00042289|76010880|FG034|STARTED|Overall Study||12||
59888584|NCT00042289|76010881|FG035|STARTED|Overall Study||32||
59888585|NCT00042289|76010882|FG036|STARTED|Overall Study||36||
59888586|NCT00042289|76010883|FG037|STARTED|Overall Study||38||
59888587|NCT00042289|76010884|FG038|STARTED|Overall Study||35||
59888588|NCT00042289|76010885|FG039|STARTED|Overall Study||18||
59888589|NCT00042289|76010886|FG040|STARTED|Overall Study||26||
59888590|NCT00042289|76010887|FG041|STARTED|Overall Study||25||
59888591|NCT00042289|76010888|FG042|STARTED|Overall Study||32||
59888592|NCT00042289|76010889|FG043|STARTED|Overall Study||25||
59888593|NCT00042289|76010890|FG044|STARTED|Overall Study||27||
59888594|NCT00042289|76010891|FG045|STARTED|Overall Study||27||
59888595|NCT00042289|76010892|FG046|STARTED|Overall Study||28||
59888596|NCT00042289|76010846|FG000|Infant Started|Overall Study||25||
59888597|NCT00042289|76010847|FG001|Infant Started|Overall Study||30||
59888598|NCT00042289|76010848|FG002|Infant Started|Overall Study||27||
59888599|NCT00042289|76010849|FG003|Infant Started|Overall Study||32||
59888600|NCT00042289|76010850|FG004|Infant Started|Overall Study||28||
59888601|NCT00042289|76010851|FG005|Infant Started|Overall Study||31||
59888602|NCT00042289|76010852|FG006|Infant Started|Overall Study||27||
59888603|NCT00042289|76010853|FG007|Infant Started|Overall Study||12||
59888604|NCT00042289|76010854|FG008|Infant Started|Overall Study||26||
59888605|NCT00042289|76010855|FG009|Infant Started|Overall Study||23||
59888606|NCT00042289|76010856|FG010|Infant Started|Overall Study||2||
59888607|NCT00042289|76010857|FG011|Infant Started|Overall Study||27||
59888608|NCT00042289|76010858|FG012|Infant Started|Overall Study||14||
59888609|NCT00042289|76010859|FG013|Infant Started|Overall Study||0||
59888610|NCT00042289|76010860|FG014|Infant Started|Overall Study||0||
59888611|NCT00042289|76010861|FG015|Infant Started|Overall Study||0||
59888612|NCT00042289|76010862|FG016|Infant Started|Overall Study||0||
59888613|NCT00042289|76010863|FG017|Infant Started|Overall Study||0||
59888614|NCT00042289|76010864|FG018|Infant Started|Overall Study||0||
59888615|NCT00042289|76010865|FG019|Infant Started|Overall Study||0||
59888616|NCT00042289|76010866|FG020|Infant Started|Overall Study||0||
59888617|NCT00042289|76010867|FG021|Infant Started|Overall Study||9||
59888618|NCT00042289|76010868|FG022|Infant Started|Overall Study||0||
59888619|NCT00042289|76010869|FG023|Infant Started|Overall Study||22||
59888620|NCT00042289|76010870|FG024|Infant Started|Overall Study||4||
59888621|NCT00042289|76010871|FG025|Infant Started|Overall Study||5||
59888622|NCT00042289|76010872|FG026|Infant Started|Overall Study||0||
59888623|NCT00042289|76010873|FG027|Infant Started|Overall Study||21||
59888624|NCT00042289|76010874|FG028|Infant Started|Overall Study||0||
59888625|NCT00042289|76010875|FG029|Infant Started|Overall Study||21||
59888626|NCT00042289|76010876|FG030|Infant Started|Overall Study||0||
59888627|NCT00042289|76010877|FG031|Infant Started|Overall Study||0||
59888628|NCT00042289|76010878|FG032|Infant Started|Overall Study||6||
59888629|NCT00042289|76010879|FG033|Infant Started|Overall Study||6||
59888630|NCT00042289|76010880|FG034|Infant Started|Overall Study||4||
59888631|NCT00042289|76010881|FG035|Infant Started|Overall Study||0||
59888632|NCT00042289|76010882|FG036|Infant Started|Overall Study||9||
59888633|NCT00042289|76010883|FG037|Infant Started|Overall Study||38||
59888634|NCT00042289|76010884|FG038|Infant Started|Overall Study||35||
59888635|NCT00042289|76010885|FG039|Infant Started|Overall Study||0||
59888636|NCT00042289|76010886|FG040|Infant Started|Overall Study||26||
59888637|NCT00042289|76010887|FG041|Infant Started|Overall Study||25||
59888638|NCT00042289|76010888|FG042|Infant Started|Overall Study||30||
59888639|NCT00042289|76010889|FG043|Infant Started|Overall Study||0||
59888640|NCT00042289|76010890|FG044|Infant Started|Overall Study||0||
59888641|NCT00042289|76010891|FG045|Infant Started|Overall Study||0||
59888642|NCT00042289|76010892|FG046|Infant Started|Overall Study||0||
59888643|NCT00042289|76010846|FG000|Infant Completed|Overall Study||21||
59888644|NCT00042289|76010847|FG001|Infant Completed|Overall Study||28||
59888645|NCT00042289|76010848|FG002|Infant Completed|Overall Study||27||
59888646|NCT00042289|76010849|FG003|Infant Completed|Overall Study||29||
59888647|NCT00042289|76010850|FG004|Infant Completed|Overall Study||26||
59888648|NCT00042289|76010851|FG005|Infant Completed|Overall Study||25||
59888649|NCT00042289|76010852|FG006|Infant Completed|Overall Study||26||
59888650|NCT00042289|76010853|FG007|Infant Completed|Overall Study||10||
59888651|NCT00042289|76010854|FG008|Infant Completed|Overall Study||25||
59888652|NCT00042289|76010855|FG009|Infant Completed|Overall Study||20||
59888653|NCT00042289|76010856|FG010|Infant Completed|Overall Study||2||
59888654|NCT00042289|76010857|FG011|Infant Completed|Overall Study||24||
59888655|NCT00042289|76010858|FG012|Infant Completed|Overall Study||11||
59888656|NCT00042289|76010859|FG013|Infant Completed|Overall Study||0||
59888657|NCT00042289|76010860|FG014|Infant Completed|Overall Study||0||
59888658|NCT00042289|76010861|FG015|Infant Completed|Overall Study||0||
59888659|NCT00042289|76010862|FG016|Infant Completed|Overall Study||0||
59888660|NCT00042289|76010863|FG017|Infant Completed|Overall Study||0||
59888661|NCT00042289|76010864|FG018|Infant Completed|Overall Study||0||
59888662|NCT00042289|76010865|FG019|Infant Completed|Overall Study||0||
59888663|NCT00042289|76010866|FG020|Infant Completed|Overall Study||0||
59888664|NCT00042289|76010867|FG021|Infant Completed|Overall Study||9||
59888665|NCT00042289|76010868|FG022|Infant Completed|Overall Study||0||
59888666|NCT00042289|76010869|FG023|Infant Completed|Overall Study||20||
59888667|NCT00042289|76010870|FG024|Infant Completed|Overall Study||3||
59888668|NCT00042289|76010871|FG025|Infant Completed|Overall Study||5||
59888669|NCT00042289|76010872|FG026|Infant Completed|Overall Study||0||
59888670|NCT00042289|76010873|FG027|Infant Completed|Overall Study||20||
59888671|NCT00042289|76010874|FG028|Infant Completed|Overall Study||0||
59888672|NCT00042289|76010875|FG029|Infant Completed|Overall Study||21||
59888673|NCT00042289|76010876|FG030|Infant Completed|Overall Study||0||
59888674|NCT00042289|76010877|FG031|Infant Completed|Overall Study||0||
59888675|NCT00042289|76010878|FG032|Infant Completed|Overall Study||6||
59888676|NCT00042289|76010879|FG033|Infant Completed|Overall Study||4||
59888677|NCT00042289|76010880|FG034|Infant Completed|Overall Study||4||
59888678|NCT00042289|76010881|FG035|Infant Completed|Overall Study||0||
59888679|NCT00042289|76010882|FG036|Infant Completed|Overall Study||8||
59888680|NCT00042289|76010883|FG037|Infant Completed|Overall Study||35||
59888681|NCT00042289|76010884|FG038|Infant Completed|Overall Study||34||
59888682|NCT00042289|76010885|FG039|Infant Completed|Overall Study||0||
59888683|NCT00042289|76010886|FG040|Infant Completed|Overall Study||26||
59888684|NCT00042289|76010887|FG041|Infant Completed|Overall Study||21||
59888685|NCT00042289|76010888|FG042|Infant Completed|Overall Study||27||
59888686|NCT00042289|76010889|FG043|Infant Completed|Overall Study||0||
59888687|NCT00042289|76010890|FG044|Infant Completed|Overall Study||0||
59888688|NCT00042289|76010891|FG045|Infant Completed|Overall Study||0||
59888689|NCT00042289|76010892|FG046|Infant Completed|Overall Study||0||
59888690|NCT00042289|76010846|FG000|COMPLETED|Overall Study||19||
59888691|NCT00042289|76010847|FG001|COMPLETED|Overall Study||29||
59888692|NCT00042289|76010848|FG002|COMPLETED|Overall Study||27||
59888693|NCT00042289|76010849|FG003|COMPLETED|Overall Study||25||
59888694|NCT00042289|76010850|FG004|COMPLETED|Overall Study||26||
59888695|NCT00042289|76010851|FG005|COMPLETED|Overall Study||25||
59888696|NCT00042289|76010852|FG006|COMPLETED|Overall Study||22||
59888697|NCT00042289|76010853|FG007|COMPLETED|Overall Study||10||
59888698|NCT00042289|76010854|FG008|COMPLETED|Overall Study||26||
59888699|NCT00042289|76010855|FG009|COMPLETED|Overall Study||23||
59888700|NCT00042289|76010856|FG010|COMPLETED|Overall Study||2||
59888701|NCT00042289|76010857|FG011|COMPLETED|Overall Study||27||
59888702|NCT00042289|76010858|FG012|COMPLETED|Overall Study||11||
59888703|NCT00042289|76010859|FG013|COMPLETED|Overall Study||2||
59888704|NCT00042289|76010860|FG014|COMPLETED|Overall Study||6||
59888705|NCT00042289|76010861|FG015|COMPLETED|Overall Study||28||
59888706|NCT00042289|76010862|FG016|COMPLETED|Overall Study||27||
59888707|NCT00042289|76010863|FG017|COMPLETED|Overall Study||12||
59888708|NCT00042289|76010864|FG018|COMPLETED|Overall Study||18||
59888709|NCT00042289|76010865|FG019|COMPLETED|Overall Study||13||
59888710|NCT00042289|76010866|FG020|COMPLETED|Overall Study||1||
59888711|NCT00042289|76010867|FG021|COMPLETED|Overall Study||26||
59888712|NCT00042289|76010868|FG022|COMPLETED|Overall Study||27||
59888713|NCT00042289|76010869|FG023|COMPLETED|Overall Study||17||
59888714|NCT00042289|76010870|FG024|COMPLETED|Overall Study||17||
59888715|NCT00042289|76010871|FG025|COMPLETED|Overall Study||20||
59888716|NCT00042289|76010872|FG026|COMPLETED|Overall Study||20||
59888717|NCT00042289|76010873|FG027|COMPLETED|Overall Study||22||
59888718|NCT00042289|76010874|FG028|COMPLETED|Overall Study||21||
59888719|NCT00042289|76010875|FG029|COMPLETED|Overall Study||25||
59888720|NCT00042289|76010876|FG030|COMPLETED|Overall Study||0||
59888721|NCT00042289|76010877|FG031|COMPLETED|Overall Study||26||
59888722|NCT00042289|76010878|FG032|COMPLETED|Overall Study||38||
59888723|NCT00042289|76010879|FG033|COMPLETED|Overall Study||10||
59888724|NCT00042289|76010880|FG034|COMPLETED|Overall Study||10||
59888725|NCT00042289|76010881|FG035|COMPLETED|Overall Study||27||
59888726|NCT00042289|76010882|FG036|COMPLETED|Overall Study||32||
59888727|NCT00042289|76010883|FG037|COMPLETED|Overall Study||36||
59888728|NCT00042289|76010884|FG038|COMPLETED|Overall Study||33||
59888729|NCT00042289|76010885|FG039|COMPLETED|Overall Study||13||
59888730|NCT00042289|76010886|FG040|COMPLETED|Overall Study||26||
59888731|NCT00042289|76010887|FG041|COMPLETED|Overall Study||22||
59888732|NCT00042289|76010888|FG042|COMPLETED|Overall Study||25||
59888733|NCT00042289|76010889|FG043|COMPLETED|Overall Study||22||
59888734|NCT00042289|76010890|FG044|COMPLETED|Overall Study||27||
59888735|NCT00042289|76010891|FG045|COMPLETED|Overall Study||26||
59888736|NCT00042289|76010892|FG046|COMPLETED|Overall Study||27||
59888737|NCT00042289|76010846|FG000|NOT COMPLETED|Overall Study||7||
59888738|NCT00042289|76010847|FG001|NOT COMPLETED|Overall Study||1||
59888739|NCT00042289|76010848|FG002|NOT COMPLETED|Overall Study||0||
59888740|NCT00042289|76010849|FG003|NOT COMPLETED|Overall Study||8||
59888741|NCT00042289|76010850|FG004|NOT COMPLETED|Overall Study||3||
59888742|NCT00042289|76010851|FG005|NOT COMPLETED|Overall Study||6||
59888743|NCT00042289|76010852|FG006|NOT COMPLETED|Overall Study||6||
59888744|NCT00042289|76010853|FG007|NOT COMPLETED|Overall Study||2||
59888745|NCT00042289|76010854|FG008|NOT COMPLETED|Overall Study||1||
59888746|NCT00042289|76010855|FG009|NOT COMPLETED|Overall Study||1||
59888747|NCT00042289|76010856|FG010|NOT COMPLETED|Overall Study||0||
59888748|NCT00042289|76010857|FG011|NOT COMPLETED|Overall Study||0||
59888749|NCT00042289|76010858|FG012|NOT COMPLETED|Overall Study||2||
59888750|NCT00042289|76010859|FG013|NOT COMPLETED|Overall Study||0||
59888751|NCT00042289|76010860|FG014|NOT COMPLETED|Overall Study||0||
59888752|NCT00042289|76010861|FG015|NOT COMPLETED|Overall Study||1||
59888753|NCT00042289|76010862|FG016|NOT COMPLETED|Overall Study||1||
59888754|NCT00042289|76010863|FG017|NOT COMPLETED|Overall Study||0||
59888755|NCT00042289|76010864|FG018|NOT COMPLETED|Overall Study||8||
59888756|NCT00042289|76010865|FG019|NOT COMPLETED|Overall Study||4||
59888757|NCT00042289|76010866|FG020|NOT COMPLETED|Overall Study||0||
59888758|NCT00042289|76010867|FG021|NOT COMPLETED|Overall Study||4||
59888759|NCT00042289|76010868|FG022|NOT COMPLETED|Overall Study||2||
59888760|NCT00042289|76010869|FG023|NOT COMPLETED|Overall Study||5||
59888761|NCT00042289|76010870|FG024|NOT COMPLETED|Overall Study||1||
59888762|NCT00042289|76010871|FG025|NOT COMPLETED|Overall Study||1||
59888763|NCT00042289|76010872|FG026|NOT COMPLETED|Overall Study||8||
59888764|NCT00042289|76010873|FG027|NOT COMPLETED|Overall Study||3||
59888765|NCT00042289|76010874|FG028|NOT COMPLETED|Overall Study||8||
59888766|NCT00042289|76010875|FG029|NOT COMPLETED|Overall Study||0||
59888767|NCT00042289|76010876|FG030|NOT COMPLETED|Overall Study||1||
59888768|NCT00042289|76010877|FG031|NOT COMPLETED|Overall Study||9||
59888769|NCT00042289|76010878|FG032|NOT COMPLETED|Overall Study||5||
59888770|NCT00042289|76010879|FG033|NOT COMPLETED|Overall Study||6||
59888771|NCT00042289|76010880|FG034|NOT COMPLETED|Overall Study||2||
59888772|NCT00042289|76010881|FG035|NOT COMPLETED|Overall Study||5||
59888773|NCT00042289|76010882|FG036|NOT COMPLETED|Overall Study||4||
59888774|NCT00042289|76010883|FG037|NOT COMPLETED|Overall Study||2||
59888775|NCT00042289|76010884|FG038|NOT COMPLETED|Overall Study||2||
59888776|NCT00042289|76010885|FG039|NOT COMPLETED|Overall Study||5||
59888777|NCT00042289|76010886|FG040|NOT COMPLETED|Overall Study||0||
59888778|NCT00042289|76010887|FG041|NOT COMPLETED|Overall Study||3||
59888779|NCT00042289|76010888|FG042|NOT COMPLETED|Overall Study||7||
59888780|NCT00042289|76010889|FG043|NOT COMPLETED|Overall Study||3||
59888781|NCT00042289|76010890|FG044|NOT COMPLETED|Overall Study||0||
59888782|NCT00042289|76010891|FG045|NOT COMPLETED|Overall Study||1||
59888783|NCT00042289|76010892|FG046|NOT COMPLETED|Overall Study||1||
59888784|NCT02886728|76011064|FG000|STARTED|Overall Study||417||
59888785|NCT02886728|76011065|FG001|STARTED|Overall Study||207||
59888786|NCT02886728|76011066|FG002|STARTED|Overall Study||210||
59888787|NCT02886728|76011067|FG003|STARTED|Overall Study||418||
59888788|NCT02886728|76011064|FG000|COMPLETED|Overall Study||345||
59888789|NCT02886728|76011065|FG001|COMPLETED|Overall Study||175||
59888790|NCT02886728|76011066|FG002|COMPLETED|Overall Study||174||
59888791|NCT02886728|76011067|FG003|COMPLETED|Overall Study||331||
59888792|NCT02886728|76011064|FG000|NOT COMPLETED|Overall Study||72||
59888793|NCT02886728|76011065|FG001|NOT COMPLETED|Overall Study||32||
59888794|NCT02886728|76011066|FG002|NOT COMPLETED|Overall Study||36||
59888795|NCT02886728|76011067|FG003|NOT COMPLETED|Overall Study||87||
59888796|NCT00039871|76011077|FG000|STARTED|Overall Study|Enrolled 2333; 21 subjects excluded due to GCP non-compliance|2312||
59888797|NCT00039871|76011077|FG000|COMPLETED|Overall Study||928||
59888798|NCT00039871|76011077|FG000|NOT COMPLETED|Overall Study||1384||
59888799|NCT00015457|76011081|FG000|STARTED|First Intervention||8||
59888800|NCT00015457|76011082|FG001|STARTED|First Intervention||8||
59888801|NCT00015457|76011081|FG000|COMPLETED|First Intervention||8||
59888802|NCT00015457|76011082|FG001|COMPLETED|First Intervention||5||
59888803|NCT00015457|76011081|FG000|NOT COMPLETED|First Intervention||0||
59888804|NCT00015457|76011082|FG001|NOT COMPLETED|First Intervention||3||
59888805|NCT00015457|76011081|FG000|STARTED|Second Intervention||8||
59888806|NCT00015457|76011082|FG001|STARTED|Second Intervention||5||
59888807|NCT00015457|76011081|FG000|COMPLETED|Second Intervention||7||
59888808|NCT00015457|76011082|FG001|COMPLETED|Second Intervention||5||
59888809|NCT00015457|76011081|FG000|NOT COMPLETED|Second Intervention||1||
59888810|NCT00015457|76011082|FG001|NOT COMPLETED|Second Intervention||0||
59888811|NCT01574144|76011088|FG000|STARTED|Overall Study||70||
59888812|NCT01574144|76011088|FG000|COMPLETED|Overall Study||70||
59888813|NCT01574144|76011088|FG000|NOT COMPLETED|Overall Study||0||
59888814|NCT03191630|76011095|FG000|STARTED|Overall Study||30||
59888815|NCT03191630|76011096|FG001|STARTED|Overall Study||30||
59888816|NCT03191630|76011095|FG000|COMPLETED|Overall Study||23||
59888817|NCT03191630|76011096|FG001|COMPLETED|Overall Study||23||
59888818|NCT03191630|76011095|FG000|NOT COMPLETED|Overall Study||7||
59888819|NCT03191630|76011096|FG001|NOT COMPLETED|Overall Study||7||
59888820|NCT03191552|76011107|FG000|STARTED|Overall Study||9||
59888821|NCT03191552|76011108|FG001|STARTED|Overall Study||9||
59888822|NCT03191552|76011109|FG002|STARTED|Overall Study||8||
59888823|NCT03191552|76011107|FG000|COMPLETED|Overall Study||8||
59888824|NCT03191552|76011108|FG001|COMPLETED|Overall Study||8||
59888825|NCT03191552|76011109|FG002|COMPLETED|Overall Study||8||
60013664|NCT02586233|76129610|FG000|STARTED|Overall Study||7||
59888826|NCT03191552|76011107|FG000|NOT COMPLETED|Overall Study||1||
59888827|NCT03191552|76011108|FG001|NOT COMPLETED|Overall Study||1||
59888828|NCT03191552|76011109|FG002|NOT COMPLETED|Overall Study||0||
59888829|NCT03191396|76011123|FG000|STARTED|Overall Study||290||
59888830|NCT03191396|76011124|FG001|STARTED|Overall Study||287||
59888831|NCT03191396|76011123|FG000|COMPLETED|Overall Study||287||
59888832|NCT03191396|76011124|FG001|COMPLETED|Overall Study||282||
59888833|NCT03191396|76011123|FG000|NOT COMPLETED|Overall Study||3||
59888834|NCT03191396|76011124|FG001|NOT COMPLETED|Overall Study||5||
59888835|NCT00007345|76011132|FG000|STARTED|Overall Study||47||
59888836|NCT00007345|76011133|FG001|STARTED|Overall Study||84||
59888837|NCT00007345|76011132|FG000|COMPLETED|Overall Study||45||
59888838|NCT00007345|76011133|FG001|COMPLETED|Overall Study||73||
59888839|NCT00007345|76011132|FG000|NOT COMPLETED|Overall Study||2||
59888840|NCT00007345|76011133|FG001|NOT COMPLETED|Overall Study||11||
59888841|NCT03405662|76011141|FG000|STARTED|Overall Study||7||
59888842|NCT03405662|76011142|FG001|STARTED|Overall Study||7||
59888843|NCT03405662|76011141|FG000|COMPLETED|Overall Study||6||
59888844|NCT03405662|76011142|FG001|COMPLETED|Overall Study||4||
59888845|NCT03405662|76011141|FG000|NOT COMPLETED|Overall Study||1||
59888846|NCT03405662|76011142|FG001|NOT COMPLETED|Overall Study||3||
60013665|NCT02586233|76129611|FG001|STARTED|Overall Study||7||
59505510|NCT02575118|75598290|FG000|COMPLETED|Overall Study||20||
59505511|NCT02575118|75598290|FG000|NOT COMPLETED|Overall Study||0||
59505512|NCT02145247|75598296|FG000|STARTED|Overall Study||20||
59505513|NCT02145247|75598297|FG001|STARTED|Overall Study||19||
59505514|NCT02145247|75598296|FG000|COMPLETED|Overall Study||20||
59505515|NCT02145247|75598297|FG001|COMPLETED|Overall Study||19||
59505516|NCT02145247|75598296|FG000|NOT COMPLETED|Overall Study||0||
59505517|NCT02145247|75598297|FG001|NOT COMPLETED|Overall Study||0||
59505518|NCT00722111|75598305|FG000|STARTED|Overall Study||11||
59505519|NCT00722111|75598306|FG001|STARTED|Overall Study||72||
59505520|NCT00722111|75598305|FG000|COMPLETED|Overall Study||11||
59505521|NCT00722111|75598306|FG001|COMPLETED|Overall Study||72||
59756690|NCT00950807|75875647|FG005|STARTED|Washout Period 2||9||
59756691|NCT00950807|75875648|FG006|STARTED|Washout Period 2||9||
59756692|NCT00950807|75875649|FG007|STARTED|Washout Period 2||10||
59756693|NCT00950807|75875650|FG008|STARTED|Washout Period 2||11||
59756694|NCT00950807|75875651|FG009|STARTED|Washout Period 2||11||
59756695|NCT00950807|75875642|FG000|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|47||
59756696|NCT00950807|75875643|FG001|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|11||
59756697|NCT00950807|75875644|FG002|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|10||
59888847|NCT00031447|76011150|FG000|STARTED|Overall Study||14||
59888848|NCT00031447|76011151|FG001|STARTED|Overall Study||15||
59888849|NCT00031447|76011150|FG000|COMPLETED|Overall Study||4||
59888850|NCT00031447|76011151|FG001|COMPLETED|Overall Study||8||
59888851|NCT00031447|76011150|FG000|NOT COMPLETED|Overall Study||10||
59888852|NCT00031447|76011151|FG001|NOT COMPLETED|Overall Study||7||
59888853|NCT00006409|76011163|FG000|STARTED|Baseline||865||
59888854|NCT00006409|76011164|FG001|STARTED|Baseline||856||
59888855|NCT00006409|76011165|FG002|STARTED|Baseline||0||
59888856|NCT00006409|76011166|FG003|STARTED|Baseline||0||
59888857|NCT00006409|76011167|FG004|STARTED|Baseline||0||
59888858|NCT00006409|76011168|FG005|STARTED|Baseline||0||
59888859|NCT00006409|76011163|FG000|COMPLETED|Baseline||817||
59888860|NCT00006409|76011164|FG001|COMPLETED|Baseline||786||
60013666|NCT02586233|76129612|FG002|STARTED|Overall Study||13||
60013667|NCT02586233|76129613|FG003|STARTED|Overall Study||17||
60013668|NCT02586233|76129614|FG004|STARTED|Overall Study||18||
59505522|NCT00722111|75598305|FG000|NOT COMPLETED|Overall Study||0||
59888861|NCT00006409|76011165|FG002|COMPLETED|Baseline||0||
59888862|NCT00006409|76011166|FG003|COMPLETED|Baseline||0||
59888863|NCT00006409|76011167|FG004|COMPLETED|Baseline||0||
59888864|NCT00006409|76011168|FG005|COMPLETED|Baseline||0||
59888865|NCT00006409|76011163|FG000|NOT COMPLETED|Baseline||48||
59888866|NCT00006409|76011164|FG001|NOT COMPLETED|Baseline||70||
59888867|NCT00006409|76011165|FG002|NOT COMPLETED|Baseline||0||
59888868|NCT00006409|76011166|FG003|NOT COMPLETED|Baseline||0||
59888869|NCT00006409|76011167|FG004|NOT COMPLETED|Baseline||0||
59888870|NCT00006409|76011168|FG005|NOT COMPLETED|Baseline||0||
59888871|NCT00006409|76011163|FG000|STARTED|Post-2 Year Intervention|6th grade/2003 sample was not followed over time|0||
59888872|NCT00006409|76011164|FG001|STARTED|Post-2 Year Intervention|6th grade/2003 sample was not followed over time|0||
59888873|NCT00006409|76011165|FG002|STARTED|Post-2 Year Intervention|Sample is independent of 6th-grade/2003 sample that was measured at baseline|1791||
59888874|NCT00006409|76011166|FG003|STARTED|Post-2 Year Intervention|Sample is independent of 6th-grade/2003 sample that was measured at baseline|1713||
59888875|NCT00006409|76011167|FG004|STARTED|Post-2 Year Intervention||0||
59888876|NCT00006409|76011168|FG005|STARTED|Post-2 Year Intervention||0||
59888877|NCT00006409|76011163|FG000|COMPLETED|Post-2 Year Intervention||0||
59888878|NCT00006409|76011164|FG001|COMPLETED|Post-2 Year Intervention||0||
59888879|NCT00006409|76011165|FG002|COMPLETED|Post-2 Year Intervention||1540||
59888880|NCT00006409|76011166|FG003|COMPLETED|Post-2 Year Intervention||1545||
59505523|NCT00722111|75598306|FG001|NOT COMPLETED|Overall Study||0||
59505524|NCT00638846|75598314|FG000|STARTED|Overall Study||137||
59505525|NCT00638846|75598315|FG001|STARTED|Overall Study||139||
59505526|NCT00638846|75598314|FG000|COMPLETED|Overall Study||133||
59505527|NCT00638846|75598315|FG001|COMPLETED|Overall Study||133||
59505528|NCT00638846|75598314|FG000|NOT COMPLETED|Overall Study||4||
59505529|NCT00638846|75598315|FG001|NOT COMPLETED|Overall Study||6||
59505530|NCT00638456|75598323|FG000|STARTED|Overall Study||21||
59505531|NCT00638456|75598324|FG001|STARTED|Overall Study||11||
59505532|NCT00638456|75598323|FG000|COMPLETED|Overall Study||15||
59888881|NCT00006409|76011167|FG004|COMPLETED|Post-2 Year Intervention||0||
59888882|NCT00006409|76011168|FG005|COMPLETED|Post-2 Year Intervention||0||
59888883|NCT00006409|76011163|FG000|NOT COMPLETED|Post-2 Year Intervention||0||
60013669|NCT02586233|76129615|FG005|STARTED|Overall Study||18||
60013670|NCT02586233|76129616|FG006|STARTED|Overall Study||26||
59505533|NCT00638456|75598324|FG001|COMPLETED|Overall Study||9||
59505534|NCT00638456|75598323|FG000|NOT COMPLETED|Overall Study||6||
60013671|NCT02586233|76129610|FG000|COMPLETED|Overall Study||7||
59505535|NCT00638456|75598324|FG001|NOT COMPLETED|Overall Study||2||
59505536|NCT02147899|75598333|FG000|STARTED|Overall Study||71||
59505537|NCT02147899|75598334|FG001|STARTED|Overall Study||72||
59505538|NCT02147899|75598335|FG002|STARTED|Overall Study||72||
59505539|NCT02147899|75598333|FG000|COMPLETED|Overall Study||71||
59505540|NCT02147899|75598334|FG001|COMPLETED|Overall Study||72||
59505541|NCT02147899|75598335|FG002|COMPLETED|Overall Study||72||
59505542|NCT02147899|75598333|FG000|NOT COMPLETED|Overall Study||0||
59505543|NCT02147899|75598334|FG001|NOT COMPLETED|Overall Study||0||
59505544|NCT02147899|75598335|FG002|NOT COMPLETED|Overall Study||0||
59505545|NCT00733343|75598345|FG000|STARTED|Overall Study||666||
59505546|NCT00733343|75598346|FG001|STARTED|Overall Study||659||
59505547|NCT00733343|75598345|FG000|COMPLETED|Overall Study||583||
59505548|NCT00733343|75598346|FG001|COMPLETED|Overall Study||578||
59505549|NCT00733343|75598345|FG000|NOT COMPLETED|Overall Study||83||
59505550|NCT00733343|75598346|FG001|NOT COMPLETED|Overall Study||81||
59505551|NCT00638378|75598353|FG000|STARTED|Overall Study||22||
59505552|NCT00638378|75598353|FG000|COMPLETED|Overall Study||0||
59505553|NCT00638378|75598353|FG000|NOT COMPLETED|Overall Study||22||
59505554|NCT00762619|75598359|FG000|STARTED|Overall Study||55||
59505555|NCT00762619|75598360|FG001|STARTED|Overall Study||50||
59888884|NCT00006409|76011164|FG001|NOT COMPLETED|Post-2 Year Intervention||0||
59505556|NCT00762619|75598359|FG000|COMPLETED|Overall Study||55||
59756698|NCT00950807|75875645|FG003|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|11||
59756699|NCT00950807|75875646|FG004|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|12||
59756700|NCT00950807|75875647|FG005|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|9||
59756701|NCT00950807|75875648|FG006|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|8||
59756702|NCT00950807|75875649|FG007|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|9||
59756703|NCT00950807|75875650|FG008|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|11||
59756704|NCT00950807|75875651|FG009|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|11||
59756705|NCT00950807|75875642|FG000|NOT COMPLETED|Washout Period 2||4||
59756706|NCT00950807|75875643|FG001|NOT COMPLETED|Washout Period 2||1||
59756707|NCT00950807|75875644|FG002|NOT COMPLETED|Washout Period 2||0||
59756708|NCT00950807|75875645|FG003|NOT COMPLETED|Washout Period 2||1||
59756709|NCT00950807|75875646|FG004|NOT COMPLETED|Washout Period 2||1||
59888885|NCT00006409|76011165|FG002|NOT COMPLETED|Post-2 Year Intervention||251||
59888886|NCT00006409|76011166|FG003|NOT COMPLETED|Post-2 Year Intervention||168||
59888887|NCT00006409|76011167|FG004|NOT COMPLETED|Post-2 Year Intervention||0||
59888888|NCT00006409|76011168|FG005|NOT COMPLETED|Post-2 Year Intervention||0||
59888889|NCT00006409|76011163|FG000|STARTED|Post-3 Year Intervention||0||
59505557|NCT00762619|75598360|FG001|COMPLETED|Overall Study||50||
59888890|NCT00006409|76011164|FG001|STARTED|Post-3 Year Intervention||0||
59888891|NCT00006409|76011165|FG002|STARTED|Post-3 Year Intervention|8th-grade/2005 sample was not followed over time|0||
59888892|NCT00006409|76011166|FG003|STARTED|Post-3 Year Intervention|8th-grade/2005 sample was not followed over time|0||
59888893|NCT00006409|76011167|FG004|STARTED|Post-3 Year Intervention|Sample is independent of 8th-grade/2005 sample that was measured post-2 year intervention|1726||
59888894|NCT00006409|76011168|FG005|STARTED|Post-3 Year Intervention|Sample is independent of 8th-grade/2005 sample that was measured post-2 year intervention|1776||
59888895|NCT00006409|76011163|FG000|COMPLETED|Post-3 Year Intervention||0||
59888896|NCT00006409|76011164|FG001|COMPLETED|Post-3 Year Intervention||0||
59888897|NCT00006409|76011165|FG002|COMPLETED|Post-3 Year Intervention||0||
59888898|NCT00006409|76011166|FG003|COMPLETED|Post-3 Year Intervention||0||
59888899|NCT00006409|76011167|FG004|COMPLETED|Post-3 Year Intervention||1664||
59888900|NCT00006409|76011168|FG005|COMPLETED|Post-3 Year Intervention||1714||
59888901|NCT00006409|76011163|FG000|NOT COMPLETED|Post-3 Year Intervention||0||
59888902|NCT00006409|76011164|FG001|NOT COMPLETED|Post-3 Year Intervention||0||
59888903|NCT00006409|76011165|FG002|NOT COMPLETED|Post-3 Year Intervention||0||
59888904|NCT00006409|76011166|FG003|NOT COMPLETED|Post-3 Year Intervention||0||
59888905|NCT00006409|76011167|FG004|NOT COMPLETED|Post-3 Year Intervention||62||
59888906|NCT00006409|76011168|FG005|NOT COMPLETED|Post-3 Year Intervention||62||
59888907|NCT00006289|76011184|FG000|STARTED|First Intervention (5 Weeks)||11||
59888908|NCT00006289|76011185|FG001|STARTED|First Intervention (5 Weeks)||10||
59888909|NCT00006289|76011184|FG000|COMPLETED|First Intervention (5 Weeks)||10||
59888910|NCT00006289|76011185|FG001|COMPLETED|First Intervention (5 Weeks)||10||
59888911|NCT00006289|76011184|FG000|NOT COMPLETED|First Intervention (5 Weeks)||1||
59888912|NCT00006289|76011185|FG001|NOT COMPLETED|First Intervention (5 Weeks)||0||
59888913|NCT00006289|76011184|FG000|STARTED|Washout (>= 1 Week)||10||
59888914|NCT00006289|76011185|FG001|STARTED|Washout (>= 1 Week)||10||
59888915|NCT00006289|76011184|FG000|COMPLETED|Washout (>= 1 Week)||10||
59888916|NCT00006289|76011185|FG001|COMPLETED|Washout (>= 1 Week)||10||
59888917|NCT00006289|76011184|FG000|NOT COMPLETED|Washout (>= 1 Week)||0||
59888918|NCT00006289|76011185|FG001|NOT COMPLETED|Washout (>= 1 Week)||0||
59888919|NCT00006289|76011184|FG000|STARTED|Second Intervention (5 Weeks)||10||
59888920|NCT00006289|76011185|FG001|STARTED|Second Intervention (5 Weeks)||10||
59888921|NCT00006289|76011184|FG000|COMPLETED|Second Intervention (5 Weeks)||9||
59505558|NCT00762619|75598359|FG000|NOT COMPLETED|Overall Study||0||
59505559|NCT00762619|75598360|FG001|NOT COMPLETED|Overall Study||0||
59888922|NCT00006289|76011185|FG001|COMPLETED|Second Intervention (5 Weeks)||9||
59888923|NCT00006289|76011184|FG000|NOT COMPLETED|Second Intervention (5 Weeks)||1||
59888924|NCT00006289|76011185|FG001|NOT COMPLETED|Second Intervention (5 Weeks)||1||
59888925|NCT00005947|76011203|FG000|STARTED|Overall Study||82||
59888926|NCT00005947|76011204|FG001|STARTED|Overall Study||45||
59888927|NCT00005947|76011203|FG000|COMPLETED|Overall Study||25||
59888928|NCT00005947|76011204|FG001|COMPLETED|Overall Study||4||
59888929|NCT00005947|76011203|FG000|NOT COMPLETED|Overall Study||57||
59888930|NCT00005947|76011204|FG001|NOT COMPLETED|Overall Study||41||
59888931|NCT00005047|76011216|FG000|STARTED|Overall Study||58||
59888932|NCT00005047|76011217|FG001|STARTED|Overall Study||56||
60013672|NCT02586233|76129611|FG001|COMPLETED|Overall Study||5||
60013673|NCT02586233|76129612|FG002|COMPLETED|Overall Study||13||
60013674|NCT02586233|76129613|FG003|COMPLETED|Overall Study||17||
60013675|NCT02586233|76129614|FG004|COMPLETED|Overall Study||16||
60013676|NCT02586233|76129615|FG005|COMPLETED|Overall Study||16||
60013677|NCT02586233|76129616|FG006|COMPLETED|Overall Study||24||
60013678|NCT02586233|76129610|FG000|NOT COMPLETED|Overall Study||0||
60013679|NCT02586233|76129611|FG001|NOT COMPLETED|Overall Study||2||
60013680|NCT02586233|76129612|FG002|NOT COMPLETED|Overall Study||0||
60013681|NCT02586233|76129613|FG003|NOT COMPLETED|Overall Study||0||
60013682|NCT02586233|76129614|FG004|NOT COMPLETED|Overall Study||2||
60013683|NCT02586233|76129615|FG005|NOT COMPLETED|Overall Study||2||
60013684|NCT02586233|76129616|FG006|NOT COMPLETED|Overall Study||2||
60013685|NCT02474355|76129636|FG000|STARTED|Overall Study||3014||
60013686|NCT02474355|76129636|FG000|COMPLETED|Overall Study||1386|Participants who withdrew from the study owing to study closure in their country. The participants received the study drug at time of study closure and continued treatment with reimbursed commercial drug or in a local patient support program, those who had discontinued study drug at study closure had their survival follow-up stopped.|
60013687|NCT02474355|76129636|FG000|NOT COMPLETED|Overall Study||1628||
60013688|NCT02474199|76129642|FG000|STARTED|Overall Study||5||
60013689|NCT02474199|76129643|FG001|STARTED|Overall Study|Insufficient numbers of darTregs for infusion (4 of these 5 participants)|5||
60013690|NCT02474199|76129644|FG002|STARTED|Overall Study||2||
60013691|NCT02474199|76129645|FG003|STARTED|Overall Study||3||
60013692|NCT02474199|76129642|FG000|COMPLETED|Overall Study||3||
60013693|NCT02474199|76129643|FG001|COMPLETED|Overall Study||2||
59888933|NCT00005047|76011218|FG002|STARTED|Overall Study||227||
59888934|NCT00005047|76011219|FG003|STARTED|Overall Study||158||
59888935|NCT00005047|76011216|FG000|COMPLETED|Overall Study||39||
59888936|NCT00005047|76011217|FG001|COMPLETED|Overall Study||56||
60013694|NCT02474199|76129644|FG002|COMPLETED|Overall Study||0||
60013695|NCT02474199|76129645|FG003|COMPLETED|Overall Study||0||
60013696|NCT02474199|76129642|FG000|NOT COMPLETED|Overall Study||2||
59888937|NCT00005047|76011218|FG002|COMPLETED|Overall Study||227||
59888938|NCT00005047|76011219|FG003|COMPLETED|Overall Study||158||
59888939|NCT00005047|76011216|FG000|NOT COMPLETED|Overall Study||19||
59888940|NCT00005047|76011217|FG001|NOT COMPLETED|Overall Study||0||
59888941|NCT00005047|76011218|FG002|NOT COMPLETED|Overall Study||0||
59888942|NCT00005047|76011219|FG003|NOT COMPLETED|Overall Study||0||
59888943|NCT00003901|76011229|FG000|STARTED|Overall Study||1047||
59888944|NCT00003901|76011229|FG000|COMPLETED|Overall Study||1030||
59888945|NCT00003901|76011229|FG000|NOT COMPLETED|Overall Study||17||
59888946|NCT00003895|76011238|FG000|STARTED|Overall Study||18||
59888947|NCT00003895|76011239|FG001|STARTED|Overall Study||18||
59888948|NCT00003895|76011238|FG000|COMPLETED|Overall Study||11||
59888949|NCT00003895|76011239|FG001|COMPLETED|Overall Study||14||
59888950|NCT00003895|76011238|FG000|NOT COMPLETED|Overall Study||7||
59888951|NCT00003895|76011239|FG001|NOT COMPLETED|Overall Study||4||
59888952|NCT03800173|76011250|FG000|STARTED|Overall Study||8||
59888953|NCT03800173|76011251|FG001|STARTED|Overall Study||6||
59888954|NCT03800173|76011252|FG002|STARTED|Overall Study||6||
59888955|NCT03800173|76011253|FG003|STARTED|Overall Study||6||
59888956|NCT03800173|76011254|FG004|STARTED|Overall Study||6||
59888957|NCT03800173|76011250|FG000|Safety Population|Overall Study||8|Safety Population includes all subjects who received study drug.|
59888958|NCT03800173|76011251|FG001|Safety Population|Overall Study||6|Safety Population includes all subjects who received study drug.|
59888959|NCT03800173|76011252|FG002|Safety Population|Overall Study||6|Safety Population includes all subjects who received study drug.|
59888960|NCT03800173|76011253|FG003|Safety Population|Overall Study||6|Safety Population includes all subjects who received study drug.|
59888961|NCT03800173|76011254|FG004|Safety Population|Overall Study||6|Safety Population includes all subjects who received study drug.|
59888962|NCT03800173|76011250|FG000|PK Population|Overall Study||0|PK population included all subjects from whom at least 1 galidesivir PK parameter was estimated.|
59888963|NCT03800173|76011251|FG001|PK Population|Overall Study||6|PK population included all subjects from whom at least 1 galidesivir PK parameter was estimated.|
59888964|NCT03800173|76011252|FG002|PK Population|Overall Study||6|PK population included all subjects from whom at least 1 galidesivir PK parameter was estimated.|
59888965|NCT03800173|76011253|FG003|PK Population|Overall Study||6|PK population included all subjects from whom at least 1 galidesivir PK parameter was estimated.|
59888966|NCT03800173|76011254|FG004|PK Population|Overall Study||6|PK population included all subjects from whom at least 1 galidesivir PK parameter was estimated.|
59888967|NCT03800173|76011250|FG000|COMPLETED|Overall Study||8||
59888968|NCT03800173|76011251|FG001|COMPLETED|Overall Study||6||
59888969|NCT03800173|76011252|FG002|COMPLETED|Overall Study||6||
59888970|NCT03800173|76011253|FG003|COMPLETED|Overall Study||6||
59888971|NCT03800173|76011254|FG004|COMPLETED|Overall Study||5||
59888972|NCT03800173|76011250|FG000|NOT COMPLETED|Overall Study||0||
59888973|NCT03800173|76011251|FG001|NOT COMPLETED|Overall Study||0||
59888974|NCT03800173|76011252|FG002|NOT COMPLETED|Overall Study||0||
59888975|NCT03800173|76011253|FG003|NOT COMPLETED|Overall Study||0||
59888976|NCT03800173|76011254|FG004|NOT COMPLETED|Overall Study||1||
59888977|NCT00003631|76011273|FG000|STARTED|Overall Study||50||
59888978|NCT00003631|76011274|FG001|STARTED|Overall Study||44||
59888979|NCT00003631|76011275|FG002|STARTED|Overall Study||24||
59888980|NCT00003631|76011273|FG000|COMPLETED|Overall Study||47||
59888981|NCT00003631|76011274|FG001|COMPLETED|Overall Study||43||
59888982|NCT00003631|76011275|FG002|COMPLETED|Overall Study||15||
59888983|NCT00003631|76011273|FG000|NOT COMPLETED|Overall Study||3||
59888984|NCT00003631|76011274|FG001|NOT COMPLETED|Overall Study||1||
59888985|NCT00003631|76011275|FG002|NOT COMPLETED|Overall Study||9||
59888986|NCT00003535|76011283|FG000|STARTED|Overall Study||9||
59888987|NCT00003535|76011283|FG000|COMPLETED|Overall Study||4||
59888988|NCT00003535|76011283|FG000|NOT COMPLETED|Overall Study||5||
59888989|NCT00003511|76011287|FG000|STARTED|Overall Study||5||
59888990|NCT00003511|76011287|FG000|COMPLETED|Overall Study||1||
59888991|NCT00003511|76011287|FG000|NOT COMPLETED|Overall Study||4||
59888992|NCT00003499|76011291|FG000|STARTED|Overall Study||31||
59888993|NCT00003499|76011291|FG000|COMPLETED|Overall Study||23||
59888994|NCT00003499|76011291|FG000|NOT COMPLETED|Overall Study||8||
59888995|NCT00003487|76011295|FG000|STARTED|Overall Study||8||
59888996|NCT00003487|76011295|FG000|COMPLETED|Overall Study||6||
59888997|NCT00003487|76011295|FG000|NOT COMPLETED|Overall Study||2||
59888998|NCT00003475|76011299|FG000|STARTED|Overall Study||40||
59888999|NCT00003475|76011299|FG000|COMPLETED|Overall Study||27||
59889000|NCT00003475|76011299|FG000|NOT COMPLETED|Overall Study||13||
59889001|NCT00003457|76011304|FG000|STARTED|Overall Study||40||
59889002|NCT00003457|76011304|FG000|COMPLETED|Overall Study||31||
59889003|NCT00003457|76011304|FG000|NOT COMPLETED|Overall Study||9||
59889004|NCT00030901|76011310|FG000|STARTED|Initial Registration||619||
59889005|NCT00030901|76011311|FG001|STARTED|Initial Registration||0||
59889006|NCT00030901|76011312|FG002|STARTED|Initial Registration||0||
59889007|NCT00030901|76011310|FG000|COMPLETED|Initial Registration||452||
59889008|NCT00030901|76011311|FG001|COMPLETED|Initial Registration||0||
59889009|NCT00030901|76011312|FG002|COMPLETED|Initial Registration||0||
59889010|NCT00030901|76011310|FG000|NOT COMPLETED|Initial Registration||167||
59889011|NCT00030901|76011311|FG001|NOT COMPLETED|Initial Registration||0||
59889012|NCT00030901|76011312|FG002|NOT COMPLETED|Initial Registration||0||
59889013|NCT00030901|76011310|FG000|STARTED|Randomization||0||
59889014|NCT00030901|76011311|FG001|STARTED|Randomization||227||
59889015|NCT00030901|76011312|FG002|STARTED|Randomization||225||
59889016|NCT00030901|76011310|FG000|Eligible|Randomization||0||
59889017|NCT00030901|76011311|FG001|Eligible|Randomization||212||
59889018|NCT00030901|76011312|FG002|Eligible|Randomization||211||
59889019|NCT00030901|76011310|FG000|COMPLETED|Randomization||0||
59889020|NCT00030901|76011311|FG001|COMPLETED|Randomization||126||
59889021|NCT00030901|76011312|FG002|COMPLETED|Randomization||137||
59889022|NCT00030901|76011310|FG000|NOT COMPLETED|Randomization||0||
59889023|NCT00030901|76011311|FG001|NOT COMPLETED|Randomization||101||
59889024|NCT00030901|76011312|FG002|NOT COMPLETED|Randomization||88||
59889025|NCT00003199|76011318|FG000|STARTED|Overall Study||50||
59889026|NCT00003199|76011318|FG000|COMPLETED|Overall Study||28||
59889027|NCT00003199|76011318|FG000|NOT COMPLETED|Overall Study||22||
59889028|NCT00030823|76011322|FG000|STARTED|Overall Study||14||
59889029|NCT00030823|76011322|FG000|COMPLETED|Overall Study||13||
59889030|NCT00030823|76011322|FG000|NOT COMPLETED|Overall Study||1||
59889031|NCT00001849|76011326|FG000|STARTED|Overall Study||68||68
59889032|NCT00001849|76011326|FG000|COMPLETED|Overall Study|Patients completed when an ectopic ACTH-secreting tumor was identified|54||54
59889033|NCT00001849|76011326|FG000|NOT COMPLETED|Overall Study||14||14
59889034|NCT01342952|76011343|FG000|STARTED|Overall Study||9||
59889035|NCT01342952|76011344|FG001|STARTED|Overall Study||19||
59889036|NCT01342952|76011345|FG002|STARTED|Overall Study||5||
59889037|NCT01342952|76011346|FG003|STARTED|Overall Study||5||
59889038|NCT01342952|76011343|FG000|Intent-to-Treat Population|Overall Study||9|The Intention-to-Treat (ITT) Population consisted of all participants who received at least 1 dose of study drug. Participants were considered as belonging to ITT population at the start of study AMB114588|
59889039|NCT01342952|76011344|FG001|Intent-to-Treat Population|Overall Study||19|The Intention-to-Treat (ITT) Population consisted of all participants who received at least 1 dose of study drug. Participants were considered as belonging to ITT population at the start of study AMB114588|
59889040|NCT01342952|76011345|FG002|Intent-to-Treat Population|Overall Study||5|The Intention-to-Treat (ITT) Population consisted of all participants who received at least 1 dose of study drug. Participants were considered as belonging to ITT population at the start of study AMB114588|
59889041|NCT01342952|76011346|FG003|Intent-to-Treat Population|Overall Study||5|The Intention-to-Treat (ITT) Population consisted of all participants who received at least 1 dose of study drug. Participants were considered as belonging to ITT population at the start of study AMB114588|
59889042|NCT01342952|76011343|FG000|Safety Population|Overall Study||4|The Safety Population is defined as all participants who received at least 1 dose of study drug. Participants were considered as belonging to the treatment group according to the highest dose received|
59889043|NCT01342952|76011344|FG001|Safety Population|Overall Study||16|The Safety Population is defined as all participants who received at least 1 dose of study drug. Participants were considered as belonging to the treatment group according to the highest dose received|
59889044|NCT01342952|76011345|FG002|Safety Population|Overall Study||6|The Safety Population is defined as all participants who received at least 1 dose of study drug. Participants were considered as belonging to the treatment group according to the highest dose received|
59889045|NCT01342952|76011346|FG003|Safety Population|Overall Study||12|The Safety Population is defined as all participants who received at least 1 dose of study drug. Participants were considered as belonging to the treatment group according to the highest dose received|
59889046|NCT01342952|76011343|FG000|COMPLETED|Overall Study||5||
59889047|NCT01342952|76011344|FG001|COMPLETED|Overall Study||8||
59889048|NCT01342952|76011345|FG002|COMPLETED|Overall Study||3||
59889049|NCT01342952|76011346|FG003|COMPLETED|Overall Study||5||
59889050|NCT01342952|76011343|FG000|NOT COMPLETED|Overall Study||4||
59889051|NCT01342952|76011344|FG001|NOT COMPLETED|Overall Study||11||
59889052|NCT01342952|76011345|FG002|NOT COMPLETED|Overall Study||2||
59889053|NCT01342952|76011346|FG003|NOT COMPLETED|Overall Study||0||
59889054|NCT01341080|76011362|FG000|STARTED|Overall Study|Subjects were randomly assigned to Varenicline|18||
59889055|NCT01341080|76011363|FG001|STARTED|Overall Study|Subjects were randomly assigned to placebo|18||
59889056|NCT01341080|76011362|FG000|COMPLETED|Overall Study|Completed|15||
59505560|NCT00734903|75598370|FG000|STARTED|Overall Study||33||
59505561|NCT00734903|75598371|FG001|STARTED|Overall Study||33||
59889057|NCT01341080|76011363|FG001|COMPLETED|Overall Study|Completed|17||
59889058|NCT01341080|76011362|FG000|NOT COMPLETED|Overall Study||3||
59889059|NCT01341080|76011363|FG001|NOT COMPLETED|Overall Study||1||
59889060|NCT02886884|76011373|FG000|STARTED|Treatment||3||
59889061|NCT02886884|76011374|FG001|STARTED|Treatment||3||
59889062|NCT02886884|76011375|FG002|STARTED|Treatment||5||
59889063|NCT02886884|76011376|FG003|STARTED|Treatment||5||
59889064|NCT02886884|76011373|FG000|COMPLETED|Treatment||3||
59889065|NCT02886884|76011374|FG001|COMPLETED|Treatment||3||
59889066|NCT02886884|76011375|FG002|COMPLETED|Treatment||5||
59889067|NCT02886884|76011376|FG003|COMPLETED|Treatment||5||
59889068|NCT02886884|76011373|FG000|NOT COMPLETED|Treatment||0||
59889069|NCT02886884|76011374|FG001|NOT COMPLETED|Treatment||0||
59889070|NCT02886884|76011375|FG002|NOT COMPLETED|Treatment||0||
59889071|NCT02886884|76011376|FG003|NOT COMPLETED|Treatment||0||
59889072|NCT02886884|76011373|FG000|STARTED|Follow-up||3||
59889073|NCT02886884|76011374|FG001|STARTED|Follow-up||3||
59889074|NCT02886884|76011375|FG002|STARTED|Follow-up||5||
59889075|NCT02886884|76011376|FG003|STARTED|Follow-up||5||
59889076|NCT02886884|76011373|FG000|COMPLETED|Follow-up||3||
59889077|NCT02886884|76011374|FG001|COMPLETED|Follow-up||3||
59889078|NCT02886884|76011375|FG002|COMPLETED|Follow-up||5||
59889079|NCT02886884|76011376|FG003|COMPLETED|Follow-up||4||
59889080|NCT02886884|76011373|FG000|NOT COMPLETED|Follow-up||0||
59889081|NCT02886884|76011374|FG001|NOT COMPLETED|Follow-up||0||
59889082|NCT02886884|76011375|FG002|NOT COMPLETED|Follow-up||0||
59889083|NCT02886884|76011376|FG003|NOT COMPLETED|Follow-up||1||
59889084|NCT04253834|76011388|FG000|STARTED|Overall Study||10||
59889085|NCT04253834|76011389|FG001|STARTED|Overall Study||10||
59889086|NCT04253834|76011388|FG000|COMPLETED|Overall Study||10||
59889087|NCT04253834|76011389|FG001|COMPLETED|Overall Study||10||
59889088|NCT04253834|76011388|FG000|NOT COMPLETED|Overall Study||0||
59889089|NCT04253834|76011389|FG001|NOT COMPLETED|Overall Study||0||
59889090|NCT01240694|76011395|FG000|STARTED|Overall Study||136||
59889091|NCT01240694|76011395|FG000|Received at Least 1 Dose of Study Drug|Overall Study||136||
59889092|NCT01240694|76011395|FG000|COMPLETED|Overall Study||1||
59889093|NCT01240694|76011395|FG000|NOT COMPLETED|Overall Study||135||
59889094|NCT03162224|76011402|FG000|STARTED|Overall Study||15||
59889095|NCT03162224|76011403|FG001|STARTED|Overall Study||9||
59889096|NCT03162224|76011404|FG002|STARTED|Overall Study||11||
59889097|NCT03162224|76011402|FG000|COMPLETED|Overall Study||4||
59889098|NCT03162224|76011403|FG001|COMPLETED|Overall Study||1||
59889099|NCT03162224|76011404|FG002|COMPLETED|Overall Study||1||
59889100|NCT03162224|76011402|FG000|NOT COMPLETED|Overall Study||11||
59889101|NCT03162224|76011403|FG001|NOT COMPLETED|Overall Study||8||
59889102|NCT03162224|76011404|FG002|NOT COMPLETED|Overall Study||10||
59889103|NCT01524536|76011412|FG000|STARTED|Overall Study||23||
59889104|NCT01524536|76011412|FG000|COMPLETED|Overall Study||23||
59889105|NCT01524536|76011412|FG000|NOT COMPLETED|Overall Study||0||
59889106|NCT00537134|76011424|FG000|STARTED|Overall Study||42||
59889107|NCT00537134|76011425|FG001|STARTED|Overall Study||38||
59889108|NCT00537134|76011424|FG000|COMPLETED|Overall Study||42||
59889109|NCT00537134|76011425|FG001|COMPLETED|Overall Study||38||
59889110|NCT00537134|76011424|FG000|NOT COMPLETED|Overall Study||0||
59889111|NCT00537134|76011425|FG001|NOT COMPLETED|Overall Study||0||
59889112|NCT00533468|76011435|FG000|STARTED|Overall Study||35||
59889113|NCT00533468|76011436|FG001|STARTED|Overall Study||35||
59889114|NCT00533468|76011435|FG000|COMPLETED|Overall Study||28||
59889115|NCT00533468|76011436|FG001|COMPLETED|Overall Study||24||
59889116|NCT00533468|76011435|FG000|NOT COMPLETED|Overall Study||7||
59889117|NCT00533468|76011436|FG001|NOT COMPLETED|Overall Study||11||
59505562|NCT00734903|75598370|FG000|Completed End of Treatment Assessment|Overall Study||21||
59505563|NCT00734903|75598371|FG001|Completed End of Treatment Assessment|Overall Study||23||
59505564|NCT00734903|75598370|FG000|Completed 3-month Followup|Overall Study||14||
59505565|NCT00734903|75598371|FG001|Completed 3-month Followup|Overall Study||15||
59889118|NCT02886338|76011443|FG000|STARTED|Overall Study||10||
59889119|NCT02886338|76011443|FG000|COMPLETED|Overall Study||9||
59889120|NCT02886338|76011443|FG000|NOT COMPLETED|Overall Study||1||
59889121|NCT00004124|76011449|FG000|STARTED|Overall Study||481|Eligible Patients Enrolled & Randomized to Study|
59889122|NCT00004124|76011450|FG001|STARTED|Overall Study||480|Eligible Patients Enrolled & Randomized to Study|
59889123|NCT00004124|76011449|FG000|COMPLETED|Overall Study||469|Received Any Protocol Treatment -- population assessable for adverse events.|
59889124|NCT00004124|76011450|FG001|COMPLETED|Overall Study||460|Received Any Protocol Treatment -- population assessable for adverse events.|
59889125|NCT00004124|76011449|FG000|NOT COMPLETED|Overall Study||12||
59889126|NCT00004124|76011450|FG001|NOT COMPLETED|Overall Study||20||
59889127|NCT00383552|76011460|FG000|STARTED|Overall Study||182||
59889128|NCT00383552|76011461|FG001|STARTED|Overall Study||188||
59889129|NCT00383552|76011462|FG002|STARTED|Overall Study||188||
59889130|NCT00383552|76011463|FG003|STARTED|Overall Study||188||
59889131|NCT00383552|76011460|FG000|COMPLETED|Overall Study||146||
59889132|NCT00383552|76011461|FG001|COMPLETED|Overall Study||147||
59889133|NCT00383552|76011462|FG002|COMPLETED|Overall Study||127||
59889134|NCT00383552|76011463|FG003|COMPLETED|Overall Study||116||
59889135|NCT00383552|76011460|FG000|NOT COMPLETED|Overall Study||36||
59889136|NCT00383552|76011461|FG001|NOT COMPLETED|Overall Study||41||
59889137|NCT00383552|76011462|FG002|NOT COMPLETED|Overall Study||61||
59889138|NCT00383552|76011463|FG003|NOT COMPLETED|Overall Study||72||
59889139|NCT03158012|76011480|FG000|STARTED|Overall Study||8||
59889140|NCT03158012|76011481|FG001|STARTED|Overall Study||7||
59889141|NCT03158012|76011480|FG000|COMPLETED|Overall Study||8||
59889142|NCT03158012|76011481|FG001|COMPLETED|Overall Study||6||
59889143|NCT03158012|76011480|FG000|NOT COMPLETED|Overall Study||0||
59889144|NCT03158012|76011481|FG001|NOT COMPLETED|Overall Study||1||
59889145|NCT01776424|76011490|FG000|STARTED|Antithrombotic Part (Double Blind)||9152|Randomized to antithrombotic treatment; intention-to-treat analysis set (ITT)|
59889146|NCT01776424|76011491|FG001|STARTED|Antithrombotic Part (Double Blind)||9117|Randomized to antithrombotic treatment; intention-to-treat analysis set (ITT)|
59889147|NCT01776424|76011492|FG002|STARTED|Antithrombotic Part (Double Blind)||9126|Randomized to antithrombotic treatment; intention-to-treat analysis set (ITT)|
59889148|NCT01776424|76011490|FG000|Treated With Antithrombotic Treatment|Antithrombotic Part (Double Blind)||9134|Safety analysis set (SAF); Antithrombotic treatment: rivaroxaban/placebo and/or study aspirin/placebo|
59889149|NCT01776424|76011491|FG001|Treated With Antithrombotic Treatment|Antithrombotic Part (Double Blind)||9109|Safety analysis set (SAF); Antithrombotic treatment: rivaroxaban/placebo and/or study aspirin/placebo|
59889150|NCT01776424|76011492|FG002|Treated With Antithrombotic Treatment|Antithrombotic Part (Double Blind)||9107|Safety analysis set (SAF); Antithrombotic treatment: rivaroxaban/placebo and/or study aspirin/placebo|
59889151|NCT01776424|76011490|FG000|Randomized to Study Pantoprazole/Placebo|Antithrombotic Part (Double Blind)||5878||
59889152|NCT01776424|76011491|FG001|Randomized to Study Pantoprazole/Placebo|Antithrombotic Part (Double Blind)||5859||
59889153|NCT01776424|76011492|FG002|Randomized to Study Pantoprazole/Placebo|Antithrombotic Part (Double Blind)||5861||
59889154|NCT01776424|76011490|FG000|COMPLETED|Antithrombotic Part (Double Blind)||9132||
59889155|NCT01776424|76011491|FG001|COMPLETED|Antithrombotic Part (Double Blind)||9098||
59889156|NCT01776424|76011492|FG002|COMPLETED|Antithrombotic Part (Double Blind)||9102||
59889157|NCT01776424|76011490|FG000|NOT COMPLETED|Antithrombotic Part (Double Blind)||20||
59889158|NCT01776424|76011491|FG001|NOT COMPLETED|Antithrombotic Part (Double Blind)||19||
59889159|NCT01776424|76011492|FG002|NOT COMPLETED|Antithrombotic Part (Double Blind)||24||
59889160|NCT01776424|76011490|FG000|STARTED|LTOLE Part (Open Label)||4399|LTOLE ITT; All participants were assigned to Rivaroxaban 2.5mg + Aspirin 100mg in LTOLE part; the original arms from Antithrombotic part do not fit any more|
59889161|NCT01776424|76011491|FG001|STARTED|LTOLE Part (Open Label)||4292|LTOLE ITT; All participants were assigned to Rivaroxaban 2.5mg + Aspirin 100mg in LTOLE part; the original arms from Antithrombotic part do not fit any more|
59889162|NCT01776424|76011492|FG002|STARTED|LTOLE Part (Open Label)||4273|LTOLE ITT; All participants were assigned to Rivaroxaban 2.5mg + Aspirin 100mg in LTOLE part; the original arms from Antithrombotic part do not fit any more|
59889163|NCT01776424|76011490|FG000|Treated in LTOLE Part|LTOLE Part (Open Label)||4379|LTOLE SAF|
59889164|NCT01776424|76011491|FG001|Treated in LTOLE Part|LTOLE Part (Open Label)||4274|LTOLE SAF|
59889165|NCT01776424|76011492|FG002|Treated in LTOLE Part|LTOLE Part (Open Label)||4250|LTOLE SAF|
59889166|NCT01776424|76011490|FG000|COMPLETED|LTOLE Part (Open Label)||4320|LTOLE part follow-up completed, including death during LTOLE part|
59889167|NCT01776424|76011491|FG001|COMPLETED|LTOLE Part (Open Label)||4230|LTOLE part follow-up completed, including death during LTOLE part|
59889168|NCT01776424|76011492|FG002|COMPLETED|LTOLE Part (Open Label)||4195|LTOLE part follow-up completed, including death during LTOLE part|
59889169|NCT01776424|76011490|FG000|NOT COMPLETED|LTOLE Part (Open Label)||79||
59889170|NCT01776424|76011491|FG001|NOT COMPLETED|LTOLE Part (Open Label)||62||
59889171|NCT01776424|76011492|FG002|NOT COMPLETED|LTOLE Part (Open Label)||78||
59889172|NCT00758290|76011504|FG000|STARTED|Overall Study||11||
59889173|NCT00758290|76011505|FG001|STARTED|Overall Study||12||
59889174|NCT00758290|76011504|FG000|COMPLETED|Overall Study||11||
59889175|NCT00758290|76011505|FG001|COMPLETED|Overall Study||12||
59889176|NCT00758290|76011504|FG000|NOT COMPLETED|Overall Study||0||
59889177|NCT00758290|76011505|FG001|NOT COMPLETED|Overall Study||0||
59889178|NCT03799627|76011518|FG000|STARTED|Overall Study||35||
59889179|NCT03799627|76011519|FG001|STARTED|Overall Study||34||
59889180|NCT03799627|76011520|FG002|STARTED|Overall Study||23||
59889181|NCT03799627|76011521|FG003|STARTED|Overall Study||18||
59889182|NCT03799627|76011522|FG004|STARTED|Overall Study||21||
59889183|NCT03799627|76011523|FG005|STARTED|Overall Study||21||
59889184|NCT03799627|76011524|FG006|STARTED|Overall Study||13||
59889185|NCT03799627|76011525|FG007|STARTED|Overall Study||5||
59889186|NCT03799627|76011526|FG008|STARTED|Overall Study||5||
59889187|NCT03799627|76011518|FG000|COMPLETED|Overall Study||27||
59889188|NCT03799627|76011519|FG001|COMPLETED|Overall Study||23||
59889189|NCT03799627|76011520|FG002|COMPLETED|Overall Study||22||
59889190|NCT03799627|76011521|FG003|COMPLETED|Overall Study||8||
59889191|NCT03799627|76011522|FG004|COMPLETED|Overall Study||12||
59889192|NCT03799627|76011523|FG005|COMPLETED|Overall Study||8||
59889193|NCT03799627|76011524|FG006|COMPLETED|Overall Study||10||
59889194|NCT03799627|76011525|FG007|COMPLETED|Overall Study||3||
59889195|NCT03799627|76011526|FG008|COMPLETED|Overall Study||2||
59889196|NCT03799627|76011518|FG000|NOT COMPLETED|Overall Study||8||
59889197|NCT03799627|76011519|FG001|NOT COMPLETED|Overall Study||11||
59889198|NCT03799627|76011520|FG002|NOT COMPLETED|Overall Study||1||
59889199|NCT03799627|76011521|FG003|NOT COMPLETED|Overall Study||10||
59889200|NCT03799627|76011522|FG004|NOT COMPLETED|Overall Study||9||
59889201|NCT03799627|76011523|FG005|NOT COMPLETED|Overall Study||13||
59889202|NCT03799627|76011524|FG006|NOT COMPLETED|Overall Study||3||
59889203|NCT03799627|76011525|FG007|NOT COMPLETED|Overall Study||2||
59889204|NCT03799627|76011526|FG008|NOT COMPLETED|Overall Study||3||
59889205|NCT00756574|76011567|FG000|STARTED|Overall Study||225||
59889206|NCT00756574|76011568|FG001|STARTED|Overall Study||221||
59889207|NCT00756574|76011567|FG000|COMPLETED|Overall Study||212||
59889208|NCT00756574|76011568|FG001|COMPLETED|Overall Study||210||
59889209|NCT00756574|76011567|FG000|NOT COMPLETED|Overall Study||13||
59889210|NCT00756574|76011568|FG001|NOT COMPLETED|Overall Study||11||
59889211|NCT02743780|76011577|FG000|STARTED|Part 1 (3 Days)||6||
59889212|NCT02743780|76011578|FG001|STARTED|Part 1 (3 Days)||6||
59889213|NCT02743780|76011579|FG002|STARTED|Part 1 (3 Days)||6||
59889214|NCT02743780|76011580|FG003|STARTED|Part 1 (3 Days)||6||
59889215|NCT02743780|76011581|FG004|STARTED|Part 1 (3 Days)||8||
59889216|NCT02743780|76011577|FG000|COMPLETED|Part 1 (3 Days)||6||
59889217|NCT02743780|76011578|FG001|COMPLETED|Part 1 (3 Days)||6||
59889218|NCT02743780|76011579|FG002|COMPLETED|Part 1 (3 Days)||6||
59889219|NCT02743780|76011580|FG003|COMPLETED|Part 1 (3 Days)||6||
59889220|NCT02743780|76011581|FG004|COMPLETED|Part 1 (3 Days)||8||
59889221|NCT02743780|76011577|FG000|NOT COMPLETED|Part 1 (3 Days)||0||
59889222|NCT02743780|76011578|FG001|NOT COMPLETED|Part 1 (3 Days)||0||
59889223|NCT02743780|76011579|FG002|NOT COMPLETED|Part 1 (3 Days)||0||
59889224|NCT02743780|76011580|FG003|NOT COMPLETED|Part 1 (3 Days)||0||
59889225|NCT02743780|76011581|FG004|NOT COMPLETED|Part 1 (3 Days)||0||
59889226|NCT02743780|76011577|FG000|STARTED|Part 2 (8 Days)||0||
59889227|NCT02743780|76011578|FG001|STARTED|Part 2 (8 Days)||6||
59889228|NCT02743780|76011579|FG002|STARTED|Part 2 (8 Days)||6||
59889229|NCT02743780|76011580|FG003|STARTED|Part 2 (8 Days)||0||
59889230|NCT02743780|76011581|FG004|STARTED|Part 2 (8 Days)||4||
59889231|NCT02743780|76011577|FG000|COMPLETED|Part 2 (8 Days)||0||
59889232|NCT02743780|76011578|FG001|COMPLETED|Part 2 (8 Days)||6||
59889233|NCT02743780|76011579|FG002|COMPLETED|Part 2 (8 Days)||6||
59889234|NCT02743780|76011580|FG003|COMPLETED|Part 2 (8 Days)||0||
59889235|NCT02743780|76011581|FG004|COMPLETED|Part 2 (8 Days)||4||
59889236|NCT02743780|76011577|FG000|NOT COMPLETED|Part 2 (8 Days)||0||
59889237|NCT02743780|76011578|FG001|NOT COMPLETED|Part 2 (8 Days)||0||
59889238|NCT02743780|76011579|FG002|NOT COMPLETED|Part 2 (8 Days)||0||
59889239|NCT02743780|76011580|FG003|NOT COMPLETED|Part 2 (8 Days)||0||
59889240|NCT02743780|76011581|FG004|NOT COMPLETED|Part 2 (8 Days)||0||
59889241|NCT02743780|76011577|FG000|STARTED|Part 3 (7 Days)||0||
59889242|NCT02743780|76011578|FG001|STARTED|Part 3 (7 Days)||0||
59889243|NCT02743780|76011579|FG002|STARTED|Part 3 (7 Days)||25||
59889244|NCT02743780|76011580|FG003|STARTED|Part 3 (7 Days)||0||
59889245|NCT02743780|76011581|FG004|STARTED|Part 3 (7 Days)||25||
59889246|NCT02743780|76011577|FG000|COMPLETED|Part 3 (7 Days)||0||
59889247|NCT02743780|76011578|FG001|COMPLETED|Part 3 (7 Days)||0||
59889248|NCT02743780|76011579|FG002|COMPLETED|Part 3 (7 Days)||24||
59889249|NCT02743780|76011580|FG003|COMPLETED|Part 3 (7 Days)||0||
59889250|NCT02743780|76011581|FG004|COMPLETED|Part 3 (7 Days)||25||
59889251|NCT02743780|76011577|FG000|NOT COMPLETED|Part 3 (7 Days)||0||
59889252|NCT02743780|76011578|FG001|NOT COMPLETED|Part 3 (7 Days)||0||
59889253|NCT02743780|76011579|FG002|NOT COMPLETED|Part 3 (7 Days)||1||
59889254|NCT02743780|76011580|FG003|NOT COMPLETED|Part 3 (7 Days)||0||
59889255|NCT02743780|76011581|FG004|NOT COMPLETED|Part 3 (7 Days)||0||
59889256|NCT02880956|76011605|FG000|STARTED|Overall Study||116||
59889257|NCT02880956|76011606|FG001|STARTED|Overall Study||108||
59889258|NCT02880956|76011607|FG002|STARTED|Overall Study||116||
59889259|NCT02880956|76011608|FG003|STARTED|Overall Study||113||
59889260|NCT02880956|76011605|FG000|COMPLETED|Overall Study||99||
59889261|NCT02880956|76011606|FG001|COMPLETED|Overall Study||93||
59889262|NCT02880956|76011607|FG002|COMPLETED|Overall Study||105||
59889263|NCT02880956|76011608|FG003|COMPLETED|Overall Study||95||
59889264|NCT02880956|76011605|FG000|NOT COMPLETED|Overall Study||17||
59889265|NCT02880956|76011606|FG001|NOT COMPLETED|Overall Study||15||
59889266|NCT02880956|76011607|FG002|NOT COMPLETED|Overall Study||11||
59889267|NCT02880956|76011608|FG003|NOT COMPLETED|Overall Study||18||
59889268|NCT01352416|76011625|FG000|STARTED|Overall Study||4||
59889269|NCT01352416|76011626|FG001|STARTED|Overall Study||7||
59889270|NCT01352416|76011627|FG002|STARTED|Overall Study||2||
59889271|NCT01352416|76011628|FG003|STARTED|Overall Study||2||
59889272|NCT01352416|76011625|FG000|COMPLETED|Overall Study||3||
59889273|NCT01352416|76011626|FG001|COMPLETED|Overall Study||5||
59889274|NCT01352416|76011627|FG002|COMPLETED|Overall Study||0||
59889275|NCT01352416|76011628|FG003|COMPLETED|Overall Study||1||
59889276|NCT01352416|76011625|FG000|NOT COMPLETED|Overall Study||1||
59889277|NCT01352416|76011626|FG001|NOT COMPLETED|Overall Study||2||
59889278|NCT01352416|76011627|FG002|NOT COMPLETED|Overall Study||2||
59889279|NCT01352416|76011628|FG003|NOT COMPLETED|Overall Study||1||
59889280|NCT00439738|76011640|FG000|STARTED|Overall Study||206||
59889281|NCT00439738|76011641|FG001|STARTED|Overall Study||206||
59889282|NCT00439738|76011640|FG000|COMPLETED|Overall Study||170||
59889283|NCT00439738|76011641|FG001|COMPLETED|Overall Study||178||
59889284|NCT00439738|76011640|FG000|NOT COMPLETED|Overall Study||36||
59889285|NCT00439738|76011641|FG001|NOT COMPLETED|Overall Study||28||
59889286|NCT00338104|76011648|FG000|STARTED|Overall Study||25||
59889287|NCT00338104|76011649|FG001|STARTED|Overall Study||25||
59889288|NCT00338104|76011650|FG002|STARTED|Overall Study||25||
59889289|NCT00338104|76011648|FG000|COMPLETED|Overall Study||23||
59889290|NCT00338104|76011649|FG001|COMPLETED|Overall Study||24||
59889291|NCT00338104|76011650|FG002|COMPLETED|Overall Study||22||
59889292|NCT00338104|76011648|FG000|NOT COMPLETED|Overall Study||2||
59889293|NCT00338104|76011649|FG001|NOT COMPLETED|Overall Study||1||
59889294|NCT00338104|76011650|FG002|NOT COMPLETED|Overall Study||3||
59889295|NCT05593913|76011655|FG000|STARTED|Overall Study||986||
59889296|NCT05593913|76011655|FG000|COMPLETED|Overall Study||947||
59889297|NCT05593913|76011655|FG000|NOT COMPLETED|Overall Study||39||
59889298|NCT05396742|76011664|FG000|STARTED|Overall Study||7||
59889299|NCT05396742|76011665|FG001|STARTED|Overall Study||12||
59889300|NCT05396742|76011666|FG002|STARTED|Overall Study||12||
59889301|NCT05396742|76011667|FG003|STARTED|Overall Study||12||
59889302|NCT05396742|76011668|FG004|STARTED|Overall Study||6||
59889303|NCT05396742|76011664|FG000|Received at Least 1 Dose of Study Drug|Overall Study||7||
59889304|NCT05396742|76011665|FG001|Received at Least 1 Dose of Study Drug|Overall Study||12||
59889305|NCT05396742|76011666|FG002|Received at Least 1 Dose of Study Drug|Overall Study||12||
59889306|NCT05396742|76011667|FG003|Received at Least 1 Dose of Study Drug|Overall Study||12||
59889307|NCT05396742|76011668|FG004|Received at Least 1 Dose of Study Drug|Overall Study||6||
59889308|NCT05396742|76011664|FG000|COMPLETED|Overall Study||7||
59889309|NCT05396742|76011665|FG001|COMPLETED|Overall Study||12||
59889310|NCT05396742|76011666|FG002|COMPLETED|Overall Study||12||
59889311|NCT05396742|76011667|FG003|COMPLETED|Overall Study||12||
59889312|NCT05396742|76011668|FG004|COMPLETED|Overall Study||6||
59889313|NCT05396742|76011664|FG000|NOT COMPLETED|Overall Study||0||
59889314|NCT05396742|76011665|FG001|NOT COMPLETED|Overall Study||0||
59889315|NCT05396742|76011666|FG002|NOT COMPLETED|Overall Study||0||
59889316|NCT05396742|76011667|FG003|NOT COMPLETED|Overall Study||0||
59889317|NCT05396742|76011668|FG004|NOT COMPLETED|Overall Study||0||
59889318|NCT05166603|76011685|FG000|STARTED|Overall Study||73||
59889319|NCT05166603|76011686|FG001|STARTED|Overall Study||38||
59889320|NCT05166603|76011685|FG000|COMPLETED|Overall Study||5||
59889321|NCT05166603|76011686|FG001|COMPLETED|Overall Study||38||
59889322|NCT05166603|76011685|FG000|NOT COMPLETED|Overall Study||68||
59889323|NCT05166603|76011686|FG001|NOT COMPLETED|Overall Study||0||
59889324|NCT05049122|76011692|FG000|STARTED|Overall Study||25|Enrolled|
59889325|NCT05049122|76011692|FG000|Participants Who Completed the Week 24 Study Treatment Period as Per Protocol|Overall Study||23||
59889326|NCT05049122|76011692|FG000|Participants Who Were Considered Stable Condition at Week 24|Overall Study||3||
59889327|NCT05049122|76011692|FG000|q4w Regimen Participants (Stable Condition)Who Completed Week 52 Study Treatment Period Per Protocol|Overall Study||3||
59889328|NCT05049122|76011692|FG000|Participants Who Continued the q2w Regimen|Overall Study||20||
59889329|NCT05049122|76011692|FG000|The q2w Regimen Participants Who Completed the Week 52 Treatment Period as Per Protocol|Overall Study||19||
59889330|NCT05049122|76011692|FG000|COMPLETED|Overall Study||22|Participants who completed the Week 52 treatment period as per protocol|
59889331|NCT05049122|76011692|FG000|NOT COMPLETED|Overall Study||3||
59889332|NCT04987931|76011696|FG000|STARTED|Overall Study||84||
59889333|NCT04987931|76011696|FG000|COMPLETED|Overall Study||84||
59889334|NCT04987931|76011696|FG000|NOT COMPLETED|Overall Study||0||
59889335|NCT04969263|76011700|FG000|STARTED|Overall Study||81||
59889336|NCT04969263|76011700|FG000|COMPLETED|Overall Study||72||
59889337|NCT04969263|76011700|FG000|NOT COMPLETED|Overall Study||9||
59610453|NCT01824498|75721281|FG004|NOT COMPLETED|3rd Intervention (8 Weeks)||0||
59610454|NCT01824498|75721282|FG005|NOT COMPLETED|3rd Intervention (8 Weeks)||0||
59610455|NCT01798134|75721290|FG000|STARTED|Overall Study||25||
59889338|NCT04964063|76011704|FG000|STARTED|Overall Study||655||
59889339|NCT04964063|76011704|FG000|COMPLETED|Overall Study||557||
59889340|NCT04964063|76011704|FG000|NOT COMPLETED|Overall Study||98||
59889341|NCT04744831|76011711|FG000|STARTED|Overall Study||40|This analysis population is based on the Full Analysis Set, which included 1 participant who was randomized/registered to T-DXd 6.4 mg/kg Q3W but actually received T-DXd 5.4 mg/kg Q3W.|
59889342|NCT04744831|76011712|FG001|STARTED|Overall Study||42|This analysis population is based on the Full Analysis Set, which included 1 participant who was randomized/registered to T-DXd 6.4 mg/kg Q3W but actually received T-DXd 5.4 mg/kg Q3W.|
59889343|NCT04744831|76011713|FG002|STARTED|Overall Study||40|This analysis population is based on the Full Analysis Set, which included 1 participant who was randomized/registered to T-DXd 6.4 mg/kg Q3W but actually received T-DXd 5.4 mg/kg Q3W.|
59889344|NCT04744831|76011711|FG000|COMPLETED|Overall Study||3|Completed = Participants who are on-going study treatment as of 01 November 2022, Not Completed = Participants who discontinued treatment and participants randomized/registered.|
59889345|NCT04744831|76011712|FG001|COMPLETED|Overall Study||6|Completed = Participants who are on-going study treatment as of 01 November 2022, Not Completed = Participants who discontinued treatment and participants randomized/registered.|
59889346|NCT04744831|76011713|FG002|COMPLETED|Overall Study||5|Completed = Participants who are on-going study treatment as of 01 November 2022, Not Completed = Participants who discontinued treatment and participants randomized/registered.|
59889347|NCT04744831|76011711|FG000|NOT COMPLETED|Overall Study||37||
59889348|NCT04744831|76011712|FG001|NOT COMPLETED|Overall Study||36||
59610456|NCT01798134|75721290|FG000|COMPLETED|Overall Study||9||
59889349|NCT04744831|76011713|FG002|NOT COMPLETED|Overall Study||35||
59889350|NCT04642079|76011724|FG000|STARTED|Overall Study||210||
59889351|NCT04642079|76011725|FG001|STARTED|Overall Study||219||
59889352|NCT04642079|76011726|FG002|STARTED|Overall Study||203||
59889353|NCT04642079|76011727|FG003|STARTED|Overall Study||207||
59889354|NCT04642079|76011724|FG000|Vaccinated|Overall Study||209||
59889355|NCT04642079|76011725|FG001|Vaccinated|Overall Study||216||
59889356|NCT04642079|76011726|FG002|Vaccinated|Overall Study||201||
59889357|NCT04642079|76011727|FG003|Vaccinated|Overall Study||205||
59889358|NCT04642079|76011724|FG000|COMPLETED|Overall Study||207||
59889359|NCT04642079|76011725|FG001|COMPLETED|Overall Study||210||
59889360|NCT04642079|76011726|FG002|COMPLETED|Overall Study||199||
59889361|NCT04642079|76011727|FG003|COMPLETED|Overall Study||203||
59889362|NCT04642079|76011724|FG000|NOT COMPLETED|Overall Study||3||
59889363|NCT04642079|76011725|FG001|NOT COMPLETED|Overall Study||9||
59889364|NCT04642079|76011726|FG002|NOT COMPLETED|Overall Study||4||
59889365|NCT04642079|76011727|FG003|NOT COMPLETED|Overall Study||4||
59889366|NCT04446182|76011742|FG000|STARTED|Overall Study||3||
59889367|NCT04446182|76011742|FG000|COMPLETED|Overall Study||3||
59889368|NCT04446182|76011742|FG000|NOT COMPLETED|Overall Study||0||
59889369|NCT04420195|76011748|FG000|STARTED|Overall Study||40||
59889370|NCT04420195|76011749|FG001|STARTED|Overall Study||24||
59889371|NCT04420195|76011748|FG000|COMPLETED|Overall Study||40||
59889372|NCT04420195|76011749|FG001|COMPLETED|Overall Study||24||
59889373|NCT04420195|76011748|FG000|NOT COMPLETED|Overall Study||0||
59889374|NCT04420195|76011749|FG001|NOT COMPLETED|Overall Study||0||
59889375|NCT04260464|76011759|FG000|STARTED|Overall Study||8||
59889376|NCT04260464|76011760|FG001|STARTED|Overall Study||7||
59889377|NCT04260464|76011761|FG002|STARTED|Overall Study||7||
59889378|NCT04260464|76011762|FG003|STARTED|Overall Study||8||
59889379|NCT04260464|76011759|FG000|COMPLETED|Overall Study||8||
59889380|NCT04260464|76011760|FG001|COMPLETED|Overall Study||7||
59889381|NCT04260464|76011761|FG002|COMPLETED|Overall Study||7||
59889382|NCT04260464|76011762|FG003|COMPLETED|Overall Study||8||
59889383|NCT04260464|76011759|FG000|NOT COMPLETED|Overall Study||0||
59889384|NCT04260464|76011760|FG001|NOT COMPLETED|Overall Study||0||
59889385|NCT04260464|76011761|FG002|NOT COMPLETED|Overall Study||0||
59889386|NCT04260464|76011762|FG003|NOT COMPLETED|Overall Study||0||
59889387|NCT04232124|76011772|FG000|STARTED|Overall Study||30||
59889388|NCT04232124|76011772|FG000|COMPLETED|Overall Study||27||
59889389|NCT04232124|76011772|FG000|NOT COMPLETED|Overall Study||3||
59889390|NCT03771157|76011776|FG000|STARTED|Overall Study||32||
59889391|NCT03771157|76011776|FG000|COMPLETED|Overall Study||31||
59889392|NCT03771157|76011776|FG000|NOT COMPLETED|Overall Study||1||
59889393|NCT03657069|76011780|FG000|STARTED|Overall Study||11||22
59889394|NCT03657069|76011780|FG000|COMPLETED|Overall Study||11||22
59889395|NCT03657069|76011780|FG000|NOT COMPLETED|Overall Study||0||0
59889396|NCT03529110|76011786|FG000|STARTED|Overall Study||261||
59889397|NCT03529110|76011787|FG001|STARTED|Overall Study||263||
59889398|NCT03529110|76011786|FG000|COMPLETED|Overall Study||136||
59889399|NCT03529110|76011787|FG001|COMPLETED|Overall Study||49||
59889400|NCT03529110|76011786|FG000|NOT COMPLETED|Overall Study||125||
59889401|NCT03529110|76011787|FG001|NOT COMPLETED|Overall Study||214||
59889402|NCT03524092|76011797|FG000|STARTED|Blinded Maintenance Period (Wk 0-40)||192||
59889403|NCT03524092|76011798|FG001|STARTED|Blinded Maintenance Period (Wk 0-40)||389||
59889404|NCT03524092|76011799|FG002|STARTED|Blinded Maintenance Period (Wk 0-40)||135||
59889405|NCT03524092|76011800|FG003|STARTED|Blinded Maintenance Period (Wk 0-40)||0||
59889406|NCT03524092|76011801|FG004|STARTED|Blinded Maintenance Period (Wk 0-40)||0||
59889407|NCT03524092|76011802|FG005|STARTED|Blinded Maintenance Period (Wk 0-40)||0||
59889408|NCT03524092|76011797|FG000|Received at Least One Dose of Study Drug|Blinded Maintenance Period (Wk 0-40)||192||
59889409|NCT03524092|76011798|FG001|Received at Least One Dose of Study Drug|Blinded Maintenance Period (Wk 0-40)||389||
59889410|NCT03524092|76011799|FG002|Received at Least One Dose of Study Drug|Blinded Maintenance Period (Wk 0-40)||135||
59889411|NCT03524092|76011800|FG003|Received at Least One Dose of Study Drug|Blinded Maintenance Period (Wk 0-40)||0||
59889412|NCT03524092|76011801|FG004|Received at Least One Dose of Study Drug|Blinded Maintenance Period (Wk 0-40)||0||
59889413|NCT03524092|76011802|FG005|Received at Least One Dose of Study Drug|Blinded Maintenance Period (Wk 0-40)||0||
59889414|NCT03524092|76011797|FG000|COMPLETED|Blinded Maintenance Period (Wk 0-40)||119||
59889415|NCT03524092|76011798|FG001|COMPLETED|Blinded Maintenance Period (Wk 0-40)||347||
59889416|NCT03524092|76011799|FG002|COMPLETED|Blinded Maintenance Period (Wk 0-40)||90||
59889417|NCT03524092|76011800|FG003|COMPLETED|Blinded Maintenance Period (Wk 0-40)||0||
59889418|NCT03524092|76011801|FG004|COMPLETED|Blinded Maintenance Period (Wk 0-40)||0||
59889419|NCT03524092|76011802|FG005|COMPLETED|Blinded Maintenance Period (Wk 0-40)||0||
59889420|NCT03524092|76011797|FG000|NOT COMPLETED|Blinded Maintenance Period (Wk 0-40)||73||
59889421|NCT03524092|76011798|FG001|NOT COMPLETED|Blinded Maintenance Period (Wk 0-40)||42||
59889422|NCT03524092|76011799|FG002|NOT COMPLETED|Blinded Maintenance Period (Wk 0-40)||45||
59950981|NCT02604160|76069902|FG001|COMPLETED|Overall Study||3||
59950982|NCT02604160|76069901|FG000|NOT COMPLETED|Overall Study||0||
59950983|NCT02604160|76069902|FG001|NOT COMPLETED|Overall Study||2||
59950984|NCT01359904|76069912|FG000|STARTED|Overall Study||15||
59950985|NCT01359904|76069913|FG001|STARTED|Overall Study||19||
59889423|NCT03524092|76011800|FG003|NOT COMPLETED|Blinded Maintenance Period (Wk 0-40)||0||
59889424|NCT03524092|76011801|FG004|NOT COMPLETED|Blinded Maintenance Period (Wk 0-40)||0||
59889425|NCT03524092|76011802|FG005|NOT COMPLETED|Blinded Maintenance Period (Wk 0-40)||0||
59889426|NCT03524092|76011797|FG000|STARTED|Loss of Response Rescue Period|Participants were assigned to this arm only after at least 12 weeks of blinded maintenance period.|0||
59889427|NCT03524092|76011798|FG001|STARTED|Loss of Response Rescue Period|Participants were assigned to this arm only after at least 12 weeks of blinded maintenance period.|0||
59889428|NCT03524092|76011799|FG002|STARTED|Loss of Response Rescue Period|Participants were assigned to this arm only after at least 12 weeks of blinded maintenance period.|0||
59889429|NCT03524092|76011800|FG003|STARTED|Loss of Response Rescue Period|Included only participants who experienced loss of response and were eligible for loss of response rescue induction.|90||
59889430|NCT03524092|76011801|FG004|STARTED|Loss of Response Rescue Period||0||
59889431|NCT03524092|76011802|FG005|STARTED|Loss of Response Rescue Period||0||
59889432|NCT03524092|76011797|FG000|COMPLETED|Loss of Response Rescue Period||0||
59889433|NCT03524092|76011798|FG001|COMPLETED|Loss of Response Rescue Period||0||
59889434|NCT03524092|76011799|FG002|COMPLETED|Loss of Response Rescue Period||0||
59889435|NCT03524092|76011800|FG003|COMPLETED|Loss of Response Rescue Period||81||
59889436|NCT03524092|76011801|FG004|COMPLETED|Loss of Response Rescue Period||0||
59889437|NCT03524092|76011802|FG005|COMPLETED|Loss of Response Rescue Period||0||
59889438|NCT03524092|76011797|FG000|NOT COMPLETED|Loss of Response Rescue Period||0||
59889439|NCT03524092|76011798|FG001|NOT COMPLETED|Loss of Response Rescue Period||0||
59889440|NCT03524092|76011799|FG002|NOT COMPLETED|Loss of Response Rescue Period||0||
59889441|NCT03524092|76011800|FG003|NOT COMPLETED|Loss of Response Rescue Period||9||
59889442|NCT03524092|76011801|FG004|NOT COMPLETED|Loss of Response Rescue Period||0||
59889443|NCT03524092|76011802|FG005|NOT COMPLETED|Loss of Response Rescue Period||0||
59889444|NCT03524092|76011797|FG000|STARTED|Open Label Extended Induction (Wk 0-12)||0||
59889445|NCT03524092|76011798|FG001|STARTED|Open Label Extended Induction (Wk 0-12)||0||
59889446|NCT03524092|76011799|FG002|STARTED|Open Label Extended Induction (Wk 0-12)||0||
59889447|NCT03524092|76011800|FG003|STARTED|Open Label Extended Induction (Wk 0-12)|Participants were assigned to this arm only during loss of response rescue period.|0||
59889448|NCT03524092|76011801|FG004|STARTED|Open Label Extended Induction (Wk 0-12)|Included only participants who entered open label extended induction period.|461||
59889449|NCT03524092|76011802|FG005|STARTED|Open Label Extended Induction (Wk 0-12)||0||
59889450|NCT03524092|76011797|FG000|COMPLETED|Open Label Extended Induction (Wk 0-12)||0||
59889451|NCT03524092|76011798|FG001|COMPLETED|Open Label Extended Induction (Wk 0-12)||0||
59889452|NCT03524092|76011799|FG002|COMPLETED|Open Label Extended Induction (Wk 0-12)||0||
59889453|NCT03524092|76011800|FG003|COMPLETED|Open Label Extended Induction (Wk 0-12)||0||
59889454|NCT03524092|76011801|FG004|COMPLETED|Open Label Extended Induction (Wk 0-12)||271||
59889455|NCT03524092|76011802|FG005|COMPLETED|Open Label Extended Induction (Wk 0-12)||0||
59889456|NCT03524092|76011797|FG000|NOT COMPLETED|Open Label Extended Induction (Wk 0-12)||0||
59889457|NCT03524092|76011798|FG001|NOT COMPLETED|Open Label Extended Induction (Wk 0-12)||0||
59889458|NCT03524092|76011799|FG002|NOT COMPLETED|Open Label Extended Induction (Wk 0-12)||0||
59889459|NCT03524092|76011800|FG003|NOT COMPLETED|Open Label Extended Induction (Wk 0-12)||0||
59889460|NCT03524092|76011801|FG004|NOT COMPLETED|Open Label Extended Induction (Wk 0-12)||190||
59889461|NCT03524092|76011802|FG005|NOT COMPLETED|Open Label Extended Induction (Wk 0-12)||0||
59889462|NCT03524092|76011797|FG000|STARTED|Open Label Maintenance Period (Wk 12-40)||0||
59889463|NCT03524092|76011798|FG001|STARTED|Open Label Maintenance Period (Wk 12-40)||0||
59889464|NCT03524092|76011799|FG002|STARTED|Open Label Maintenance Period (Wk 12-40)||0||
59889465|NCT03524092|76011800|FG003|STARTED|Open Label Maintenance Period (Wk 12-40)||0||
59889466|NCT03524092|76011801|FG004|STARTED|Open Label Maintenance Period (Wk 12-40)|Participants were assigned to this arm only during open label extended induction period.|0||
59889467|NCT03524092|76011802|FG005|STARTED|Open Label Maintenance Period (Wk 12-40)|Included only participants who entered open label maintenance period.|271||
59889468|NCT03524092|76011797|FG000|COMPLETED|Open Label Maintenance Period (Wk 12-40)||0||
59889469|NCT03524092|76011798|FG001|COMPLETED|Open Label Maintenance Period (Wk 12-40)||0||
59889470|NCT03524092|76011799|FG002|COMPLETED|Open Label Maintenance Period (Wk 12-40)||0||
59889471|NCT03524092|76011800|FG003|COMPLETED|Open Label Maintenance Period (Wk 12-40)||0||
59889472|NCT03524092|76011801|FG004|COMPLETED|Open Label Maintenance Period (Wk 12-40)||0||
59889473|NCT03524092|76011802|FG005|COMPLETED|Open Label Maintenance Period (Wk 12-40)||256||
59889474|NCT03524092|76011797|FG000|NOT COMPLETED|Open Label Maintenance Period (Wk 12-40)||0||
59889475|NCT03524092|76011798|FG001|NOT COMPLETED|Open Label Maintenance Period (Wk 12-40)||0||
59889476|NCT03524092|76011799|FG002|NOT COMPLETED|Open Label Maintenance Period (Wk 12-40)||0||
60013697|NCT02474199|76129643|FG001|NOT COMPLETED|Overall Study||3||
59889477|NCT03524092|76011800|FG003|NOT COMPLETED|Open Label Maintenance Period (Wk 12-40)||0||
59889478|NCT03524092|76011801|FG004|NOT COMPLETED|Open Label Maintenance Period (Wk 12-40)||0||
59889479|NCT03524092|76011802|FG005|NOT COMPLETED|Open Label Maintenance Period (Wk 12-40)||15||
60013698|NCT02474199|76129644|FG002|NOT COMPLETED|Overall Study||2||
60013699|NCT02474199|76129645|FG003|NOT COMPLETED|Overall Study||3||
60013700|NCT02450487|76129652|FG000|STARTED|Overall Study||105||
60013701|NCT02450487|76129652|FG000|COMPLETED|Overall Study||102||
60013702|NCT02450487|76129652|FG000|NOT COMPLETED|Overall Study||3||
60013703|NCT02473965|76129659|FG000|STARTED|Overall Study||30||
59889480|NCT03518086|76011815|FG000|STARTED|Overall Study||322||
59889481|NCT03518086|76011816|FG001|STARTED|Overall Study||959||
59889482|NCT03518086|76011817|FG002|STARTED|Overall Study||0||
59889483|NCT03518086|76011818|FG003|STARTED|Overall Study||0||
59889484|NCT03518086|76011815|FG000|Received at Least One Dose of Study Drug|Overall Study||321||
59889485|NCT03518086|76011816|FG001|Received at Least One Dose of Study Drug|Overall Study||958||
59889486|NCT03518086|76011817|FG002|Received at Least One Dose of Study Drug|Overall Study||0||
59889487|NCT03518086|76011818|FG003|Received at Least One Dose of Study Drug|Overall Study||0||
59889488|NCT03518086|76011815|FG000|COMPLETED|Overall Study||285||
59889489|NCT03518086|76011816|FG001|COMPLETED|Overall Study||920||
59889490|NCT03518086|76011817|FG002|COMPLETED|Overall Study||0||
59889491|NCT03518086|76011818|FG003|COMPLETED|Overall Study||0||
59889492|NCT03518086|76011815|FG000|NOT COMPLETED|Overall Study||37||
59889493|NCT03518086|76011816|FG001|NOT COMPLETED|Overall Study||39||
59889494|NCT03518086|76011817|FG002|NOT COMPLETED|Overall Study||0||
59889495|NCT03518086|76011818|FG003|NOT COMPLETED|Overall Study||0||
59889496|NCT03358472|76011828|FG000|STARTED|Overall Study||35||
59889497|NCT03358472|76011829|FG001|STARTED|Overall Study||19||
59889498|NCT03358472|76011830|FG002|STARTED|Overall Study||35||
59889499|NCT03358472|76011828|FG000|Intention-to-Treat (ITT)|Overall Study||35||
59889500|NCT03358472|76011829|FG001|Intention-to-Treat (ITT)|Overall Study||19||
59889501|NCT03358472|76011830|FG002|Intention-to-Treat (ITT)|Overall Study||35||
59889502|NCT03358472|76011828|FG000|All Participants as Treated (APaT)|Overall Study||34||
59889503|NCT03358472|76011829|FG001|All Participants as Treated (APaT)|Overall Study||19||
59889504|NCT03358472|76011830|FG002|All Participants as Treated (APaT)|Overall Study||34||
59889505|NCT03358472|76011828|FG000|COMPLETED|Overall Study||20||
59889506|NCT03358472|76011829|FG001|COMPLETED|Overall Study||9||
59889507|NCT03358472|76011830|FG002|COMPLETED|Overall Study||19||
59889508|NCT03358472|76011828|FG000|NOT COMPLETED|Overall Study||15||
59889509|NCT03358472|76011829|FG001|NOT COMPLETED|Overall Study||10||
59889510|NCT03358472|76011830|FG002|NOT COMPLETED|Overall Study||16||
59889511|NCT03276546|76011838|FG000|STARTED|Overall Study||23||
59889512|NCT03276546|76011838|FG000|COMPLETED|Overall Study||20||
59889513|NCT03276546|76011838|FG000|NOT COMPLETED|Overall Study||3||
59889514|NCT03104543|76011846|FG000|STARTED|Overall Study||175||
59889515|NCT03104543|76011847|FG001|STARTED|Overall Study||172||
59889516|NCT03104543|76011846|FG000|COMPLETED|Overall Study||126||
59889517|NCT03104543|76011847|FG001|COMPLETED|Overall Study||138||
59889518|NCT03104543|76011846|FG000|NOT COMPLETED|Overall Study||49||
59889519|NCT03104543|76011847|FG001|NOT COMPLETED|Overall Study||34||
59889520|NCT03099382|76011855|FG000|STARTED|Overall Study||228||
59889521|NCT03099382|76011856|FG001|STARTED|Overall Study||220||
59889522|NCT03099382|76011855|FG000|COMPLETED|Overall Study||226||
59889523|NCT03099382|76011856|FG001|COMPLETED|Overall Study||217||
59889524|NCT03099382|76011855|FG000|NOT COMPLETED|Overall Study||2||
59889525|NCT03099382|76011856|FG001|NOT COMPLETED|Overall Study||3||
59889526|NCT02939287|76011865|FG000|STARTED|Overall Study||18||
59889527|NCT02939287|76011866|FG001|STARTED|Overall Study||25||
59889528|NCT02939287|76011867|FG002|STARTED|Overall Study||9||
59889529|NCT02939287|76011865|FG000|COMPLETED|Overall Study||14||
59889530|NCT02939287|76011866|FG001|COMPLETED|Overall Study||21||
59889531|NCT02939287|76011867|FG002|COMPLETED|Overall Study||8||
59889532|NCT02939287|76011865|FG000|NOT COMPLETED|Overall Study||4||
59889533|NCT02939287|76011866|FG001|NOT COMPLETED|Overall Study||4||
59889534|NCT02939287|76011867|FG002|NOT COMPLETED|Overall Study||1||
59889535|NCT02802241|76011879|FG000|STARTED|Overall Study||89|intention to treat|
59889536|NCT02802241|76011880|FG001|STARTED|Overall Study||87|intention to treat|
59889537|NCT02802241|76011881|FG002|STARTED|Overall Study||46|intention to treat|
59889538|NCT02802241|76011882|FG003|STARTED|Overall Study||86|intention to treat|
59889539|NCT02802241|76011879|FG000|Planned Analysis|Overall Study||89||
59889540|NCT02802241|76011880|FG001|Planned Analysis|Overall Study||87||
59889541|NCT02802241|76011881|FG002|Planned Analysis|Overall Study|Not included in primary analysis|46||
59889542|NCT02802241|76011882|FG003|Planned Analysis|Overall Study||86||
59889543|NCT02802241|76011879|FG000|COMPLETED|Overall Study||68||
59889544|NCT02802241|76011880|FG001|COMPLETED|Overall Study||71||
59889545|NCT02802241|76011881|FG002|COMPLETED|Overall Study|Not included in primary analysis|30||
59889546|NCT02802241|76011882|FG003|COMPLETED|Overall Study||72||
60013704|NCT02473965|76129660|FG001|STARTED|Overall Study||30||
59889547|NCT02802241|76011879|FG000|NOT COMPLETED|Overall Study||21||
59889548|NCT02802241|76011880|FG001|NOT COMPLETED|Overall Study||16||
59889549|NCT02802241|76011881|FG002|NOT COMPLETED|Overall Study||16||
59889550|NCT02802241|76011882|FG003|NOT COMPLETED|Overall Study||14||
60013705|NCT02473965|76129659|FG000|COMPLETED|Overall Study||18|Completed up to Week 45|
60013706|NCT02473965|76129660|FG001|COMPLETED|Overall Study||20|Completed up to Week 45|
60013707|NCT02473965|76129659|FG000|NOT COMPLETED|Overall Study||12||
59889551|NCT02771275|76011892|FG000|STARTED|Overall Study||13|Received the Harpoon Medical Device.|
59889552|NCT02771275|76011892|FG000|COMPLETED|Overall Study||9||
59889553|NCT02771275|76011892|FG000|NOT COMPLETED|Overall Study||4||
59889554|NCT02587936|76011898|FG000|STARTED|Overall Study||9730||71
60013708|NCT02473965|76129660|FG001|NOT COMPLETED|Overall Study||10||
59889555|NCT02587936|76011899|FG001|STARTED|Overall Study||8538||70
59889556|NCT02587936|76011898|FG000|COMPLETED|Overall Study||5508||71
59889557|NCT02587936|76011899|FG001|COMPLETED|Overall Study||5492||70
59889558|NCT02587936|76011898|FG000|NOT COMPLETED|Overall Study||4222||0
59889559|NCT02587936|76011899|FG001|NOT COMPLETED|Overall Study||3046||0
59889560|NCT02564900|76011920|FG000|STARTED|Dose Escalation||3||
59889561|NCT02564900|76011921|FG001|STARTED|Dose Escalation||3||
59889562|NCT02564900|76011922|FG002|STARTED|Dose Escalation||3||
59889563|NCT02564900|76011923|FG003|STARTED|Dose Escalation||6||
59889564|NCT02564900|76011924|FG004|STARTED|Dose Escalation||6||
59889565|NCT02564900|76011925|FG005|STARTED|Dose Escalation||6||
59889566|NCT02564900|76011926|FG006|STARTED|Dose Escalation||0||
59889567|NCT02564900|76011927|FG007|STARTED|Dose Escalation||0||
59889568|NCT02564900|76011928|FG008|STARTED|Dose Escalation||0||
59889569|NCT02564900|76011929|FG009|STARTED|Dose Escalation||0||
59889570|NCT02564900|76011930|FG010|STARTED|Dose Escalation||0||
59889571|NCT02564900|76011931|FG011|STARTED|Dose Escalation||0||
59889572|NCT02564900|76011932|FG012|STARTED|Dose Escalation||0||
59889573|NCT02564900|76011933|FG013|STARTED|Dose Escalation||0||
59889574|NCT02564900|76011934|FG014|STARTED|Dose Escalation||0||
59889575|NCT02564900|76011920|FG000|COMPLETED|Dose Escalation||0|Data from Ongoing and Discontinued participants are presented as of data cutoff on 01 February 2019|
59889576|NCT02564900|76011921|FG001|COMPLETED|Dose Escalation||0|Data from Ongoing and Discontinued participants are presented as of data cutoff on 01 February 2019|
59889577|NCT02564900|76011922|FG002|COMPLETED|Dose Escalation||0|Data from Ongoing and Discontinued participants are presented as of data cutoff on 01 February 2019|
59889578|NCT02564900|76011923|FG003|COMPLETED|Dose Escalation||0|Data from Ongoing and Discontinued participants are presented as of data cutoff on 01 February 2019|
59889579|NCT02564900|76011924|FG004|COMPLETED|Dose Escalation||0|Data from Ongoing and Discontinued participants are presented as of data cutoff on 01 February 2019|
59889580|NCT02564900|76011925|FG005|COMPLETED|Dose Escalation||0|Data from Ongoing and Discontinued participants are presented as of data cutoff on 01 February 2019|
59889581|NCT02564900|76011926|FG006|COMPLETED|Dose Escalation||0|Data from Ongoing and Discontinued participants are presented as of data cutoff on 01 February 2019|
59889582|NCT02564900|76011927|FG007|COMPLETED|Dose Escalation||0|Data from Ongoing and Discontinued participants are presented as of data cutoff on 01 February 2019|
59889583|NCT02564900|76011928|FG008|COMPLETED|Dose Escalation||0|Data from Ongoing and Discontinued participants are presented as of data cutoff on 01 February 2019|
59889584|NCT02564900|76011929|FG009|COMPLETED|Dose Escalation||0|Data from Ongoing and Discontinued participants are presented as of data cutoff on 01 February 2019|
59889585|NCT02564900|76011930|FG010|COMPLETED|Dose Escalation||0|Data from Ongoing and Discontinued participants are presented as of data cutoff on 01 February 2019|
59889586|NCT02564900|76011931|FG011|COMPLETED|Dose Escalation||0|Data from Ongoing and Discontinued participants are presented as of data cutoff on 01 February 2019|
59889587|NCT02564900|76011932|FG012|COMPLETED|Dose Escalation||0|Data from Ongoing and Discontinued participants are presented as of data cutoff on 01 February 2019|
59889588|NCT02564900|76011933|FG013|COMPLETED|Dose Escalation||0|Data from Ongoing and Discontinued participants are presented as of data cutoff on 01 February 2019|
59889589|NCT02564900|76011934|FG014|COMPLETED|Dose Escalation||0|Data from Ongoing and Discontinued participants are presented as of data cutoff on 01 February 2019|
59889590|NCT02564900|76011920|FG000|NOT COMPLETED|Dose Escalation||3||
59889591|NCT02564900|76011921|FG001|NOT COMPLETED|Dose Escalation||3||
59889592|NCT02564900|76011922|FG002|NOT COMPLETED|Dose Escalation||3||
59889593|NCT02564900|76011923|FG003|NOT COMPLETED|Dose Escalation||6||
59889594|NCT02564900|76011924|FG004|NOT COMPLETED|Dose Escalation||6||
59889595|NCT02564900|76011925|FG005|NOT COMPLETED|Dose Escalation||6||
59889596|NCT02564900|76011926|FG006|NOT COMPLETED|Dose Escalation||0||
59889597|NCT02564900|76011927|FG007|NOT COMPLETED|Dose Escalation||0||
59889598|NCT02564900|76011928|FG008|NOT COMPLETED|Dose Escalation||0||
59889599|NCT02564900|76011929|FG009|NOT COMPLETED|Dose Escalation||0||
59889600|NCT02564900|76011930|FG010|NOT COMPLETED|Dose Escalation||0||
59889601|NCT02564900|76011931|FG011|NOT COMPLETED|Dose Escalation||0||
59889602|NCT02564900|76011932|FG012|NOT COMPLETED|Dose Escalation||0||
59889603|NCT02564900|76011933|FG013|NOT COMPLETED|Dose Escalation||0||
59889604|NCT02564900|76011934|FG014|NOT COMPLETED|Dose Escalation||0||
59889605|NCT02564900|76011920|FG000|STARTED|Dose Expansion||0|Only the Dose Expansion Phase is being presented.|
59889606|NCT02564900|76011921|FG001|STARTED|Dose Expansion||0|Only the Dose Expansion Phase is being presented.|
59889607|NCT02564900|76011922|FG002|STARTED|Dose Expansion||0|Only the Dose Expansion Phase is being presented.|
59889608|NCT02564900|76011923|FG003|STARTED|Dose Expansion||0|Only the Dose Expansion Phase is being presented.|
60013709|NCT02472795|76129671|FG000|STARTED|Overall Study||12||
60013710|NCT02472795|76129672|FG001|STARTED|Overall Study||12||
59756710|NCT00950807|75875647|FG005|NOT COMPLETED|Washout Period 2||0||
59756711|NCT00950807|75875648|FG006|NOT COMPLETED|Washout Period 2||1||
59756712|NCT00950807|75875649|FG007|NOT COMPLETED|Washout Period 2||1||
59756713|NCT00950807|75875650|FG008|NOT COMPLETED|Washout Period 2||0||
59756714|NCT00950807|75875651|FG009|NOT COMPLETED|Washout Period 2||0||
59756715|NCT00950807|75875642|FG000|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|46||
59756716|NCT00950807|75875643|FG001|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|9||
59756717|NCT00950807|75875644|FG002|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|10||
59889609|NCT02564900|76011924|FG004|STARTED|Dose Expansion||0|Only the Dose Expansion Phase is being presented.|
59889610|NCT02564900|76011925|FG005|STARTED|Dose Expansion||0|Only the Dose Expansion Phase is being presented.|
59889611|NCT02564900|76011926|FG006|STARTED|Dose Expansion||49|Only the Dose Expansion Phase is being presented.|
59889612|NCT02564900|76011927|FG007|STARTED|Dose Expansion||62|Only the Dose Expansion Phase is being presented.|
59889613|NCT02564900|76011928|FG008|STARTED|Dose Expansion||20|Only the Dose Expansion Phase is being presented.|
59889614|NCT02564900|76011929|FG009|STARTED|Dose Expansion||33|Only the Dose Expansion Phase is being presented.|
59889615|NCT02564900|76011930|FG010|STARTED|Dose Expansion||17|Only the Dose Expansion Phase is being presented.|
59889616|NCT02564900|76011931|FG011|STARTED|Dose Expansion||24|Only the Dose Expansion Phase is being presented.|
59889617|NCT02564900|76011932|FG012|STARTED|Dose Expansion||18|Only the Dose Expansion Phase is being presented.|
59889618|NCT02564900|76011933|FG013|STARTED|Dose Expansion||20|Only the Dose Expansion Phase is being presented.|
59889619|NCT02564900|76011934|FG014|STARTED|Dose Expansion||22|Only the Dose Expansion Phase is being presented.|
59889620|NCT02564900|76011920|FG000|Enrolled, But Not Dosed|Dose Expansion||0||
59889621|NCT02564900|76011921|FG001|Enrolled, But Not Dosed|Dose Expansion||0||
59889622|NCT02564900|76011922|FG002|Enrolled, But Not Dosed|Dose Expansion||0||
59889623|NCT02564900|76011923|FG003|Enrolled, But Not Dosed|Dose Expansion||0||
59889624|NCT02564900|76011924|FG004|Enrolled, But Not Dosed|Dose Expansion||0||
59889625|NCT02564900|76011925|FG005|Enrolled, But Not Dosed|Dose Expansion||0||
59889626|NCT02564900|76011926|FG006|Enrolled, But Not Dosed|Dose Expansion||1||
59889627|NCT02564900|76011927|FG007|Enrolled, But Not Dosed|Dose Expansion||1||
59889628|NCT02564900|76011928|FG008|Enrolled, But Not Dosed|Dose Expansion||0||
59889629|NCT02564900|76011929|FG009|Enrolled, But Not Dosed|Dose Expansion||0||
59889630|NCT02564900|76011930|FG010|Enrolled, But Not Dosed|Dose Expansion||0||
59889631|NCT02564900|76011931|FG011|Enrolled, But Not Dosed|Dose Expansion||0||
59889632|NCT02564900|76011932|FG012|Enrolled, But Not Dosed|Dose Expansion||0||
59889633|NCT02564900|76011933|FG013|Enrolled, But Not Dosed|Dose Expansion||0||
59889634|NCT02564900|76011934|FG014|Enrolled, But Not Dosed|Dose Expansion||1||
59889635|NCT02564900|76011920|FG000|COMPLETED|Dose Expansion||0|Data from Ongoing and Discontinued participants are presented as of data cutoff on 01 February 2019.|
59889636|NCT02564900|76011921|FG001|COMPLETED|Dose Expansion||0|Data from Ongoing and Discontinued participants are presented as of data cutoff on 01 February 2019.|
59889637|NCT02564900|76011922|FG002|COMPLETED|Dose Expansion||0|Data from Ongoing and Discontinued participants are presented as of data cutoff on 01 February 2019.|
59889638|NCT02564900|76011923|FG003|COMPLETED|Dose Expansion||0|Data from Ongoing and Discontinued participants are presented as of data cutoff on 01 February 2019.|
59889639|NCT02564900|76011924|FG004|COMPLETED|Dose Expansion||0|Data from Ongoing and Discontinued participants are presented as of data cutoff on 01 February 2019.|
59889640|NCT02564900|76011925|FG005|COMPLETED|Dose Expansion||0|Data from Ongoing and Discontinued participants are presented as of data cutoff on 01 February 2019.|
59889641|NCT02564900|76011926|FG006|COMPLETED|Dose Expansion||0|Data from Ongoing and Discontinued participants are presented as of data cutoff on 01 February 2019.|
59889642|NCT02564900|76011927|FG007|COMPLETED|Dose Expansion||0|Data from Ongoing and Discontinued participants are presented as of data cutoff on 01 February 2019.|
59889643|NCT02564900|76011928|FG008|COMPLETED|Dose Expansion||0|Data from Ongoing and Discontinued participants are presented as of data cutoff on 01 February 2019.|
59889644|NCT02564900|76011929|FG009|COMPLETED|Dose Expansion||0|Data from Ongoing and Discontinued participants are presented as of data cutoff on 01 February 2019.|
59889645|NCT02564900|76011930|FG010|COMPLETED|Dose Expansion||0|Data from Ongoing and Discontinued participants are presented as of data cutoff on 01 February 2019.|
59889646|NCT02564900|76011931|FG011|COMPLETED|Dose Expansion||0|Data from Ongoing and Discontinued participants are presented as of data cutoff on 01 February 2019.|
59889647|NCT02564900|76011932|FG012|COMPLETED|Dose Expansion||0|Data from Ongoing and Discontinued participants are presented as of data cutoff on 01 February 2019.|
59889648|NCT02564900|76011933|FG013|COMPLETED|Dose Expansion||0|Data from Ongoing and Discontinued participants are presented as of data cutoff on 01 February 2019.|
59889649|NCT02564900|76011934|FG014|COMPLETED|Dose Expansion||0|Data from Ongoing and Discontinued participants are presented as of data cutoff on 01 February 2019.|
59889650|NCT02564900|76011920|FG000|NOT COMPLETED|Dose Expansion||0||
59889651|NCT02564900|76011921|FG001|NOT COMPLETED|Dose Expansion||0||
59889652|NCT02564900|76011922|FG002|NOT COMPLETED|Dose Expansion||0||
59889653|NCT02564900|76011923|FG003|NOT COMPLETED|Dose Expansion||0||
59889654|NCT02564900|76011924|FG004|NOT COMPLETED|Dose Expansion||0||
59889655|NCT02564900|76011925|FG005|NOT COMPLETED|Dose Expansion||0||
59889656|NCT02564900|76011926|FG006|NOT COMPLETED|Dose Expansion||49||
59889657|NCT02564900|76011927|FG007|NOT COMPLETED|Dose Expansion||62||
59889658|NCT02564900|76011928|FG008|NOT COMPLETED|Dose Expansion||20||
59889659|NCT02564900|76011929|FG009|NOT COMPLETED|Dose Expansion||33||
59889660|NCT02564900|76011930|FG010|NOT COMPLETED|Dose Expansion||17||
59889661|NCT02564900|76011931|FG011|NOT COMPLETED|Dose Expansion||24||
59889662|NCT02564900|76011932|FG012|NOT COMPLETED|Dose Expansion||18||
59889663|NCT02564900|76011933|FG013|NOT COMPLETED|Dose Expansion||20||
59889664|NCT02564900|76011934|FG014|NOT COMPLETED|Dose Expansion||22||
59889665|NCT02470091|76011977|FG000|STARTED|Overall Study||16||
59889666|NCT02470091|76011978|FG001|STARTED|Overall Study||40||
59889667|NCT02470091|76011977|FG000|Follow-up Report|Overall Study||1||
60013711|NCT02472795|76129673|FG002|STARTED|Overall Study||13||
60013712|NCT02472795|76129674|FG003|STARTED|Overall Study||13||
59889668|NCT02470091|76011978|FG001|Follow-up Report|Overall Study||10||
59889669|NCT02470091|76011977|FG000|COMPLETED|Overall Study||15||
59889670|NCT02470091|76011978|FG001|COMPLETED|Overall Study||38||
59889671|NCT02470091|76011977|FG000|NOT COMPLETED|Overall Study||1||
59889672|NCT02470091|76011978|FG001|NOT COMPLETED|Overall Study||2||
59889673|NCT02451943|76011988|FG000|STARTED|Overall Study||258||
59889674|NCT02451943|76011989|FG001|STARTED|Overall Study||251||
59889675|NCT02451943|76011988|FG000|Received at Least One Dose of Study Drug|Overall Study||257||
59889676|NCT02451943|76011989|FG001|Received at Least One Dose of Study Drug|Overall Study||249||
59889677|NCT02451943|76011988|FG000|Leiomyosarcoma (LMS) Population|Overall Study||119||
59889678|NCT02451943|76011989|FG001|Leiomyosarcoma (LMS) Population|Overall Study||115||
59889679|NCT02451943|76011988|FG000|COMPLETED|Overall Study||238||
59889680|NCT02451943|76011989|FG001|COMPLETED|Overall Study||227||
59889681|NCT02451943|76011988|FG000|NOT COMPLETED|Overall Study||20||
59889682|NCT02451943|76011989|FG001|NOT COMPLETED|Overall Study||24||
59889683|NCT02432196|76011995|FG000|STARTED|Overall Study||26|Enrolled in Study|
59889684|NCT02432196|76011995|FG000|COMPLETED|Overall Study||20||
59889685|NCT02432196|76011995|FG000|NOT COMPLETED|Overall Study||6||
59889686|NCT02329860|76012001|FG000|STARTED|Overall Study||267||
59889687|NCT02329860|76012002|FG001|STARTED|Overall Study||133||
59889688|NCT02329860|76012001|FG000|Treated|Overall Study||261||
59889689|NCT02329860|76012002|FG001|Treated|Overall Study||132||
59889690|NCT02329860|76012001|FG000|COMPLETED|Overall Study||161||
59889691|NCT02329860|76012002|FG001|COMPLETED|Overall Study||107||
59889692|NCT02329860|76012001|FG000|NOT COMPLETED|Overall Study||106||
59889693|NCT02329860|76012002|FG001|NOT COMPLETED|Overall Study||26||
59889694|NCT02269332|76012008|FG000|STARTED|Overall Study||298||
59889695|NCT02269332|76012008|FG000|COMPLETED|Overall Study|number analyzed|228||
59889696|NCT02269332|76012008|FG000|NOT COMPLETED|Overall Study||70||
59889697|NCT02163733|76012014|FG000|STARTED|Part A: Day 1-9 (1st Intervention)||18||
59889698|NCT02163733|76012015|FG001|STARTED|Part A: Day 1-9 (1st Intervention)||20||
59889699|NCT02163733|76012016|FG002|STARTED|Part A: Day 1-9 (1st Intervention)||0||
59889700|NCT02163733|76012014|FG000|COMPLETED|Part A: Day 1-9 (1st Intervention)||18||
59889701|NCT02163733|76012015|FG001|COMPLETED|Part A: Day 1-9 (1st Intervention)||20||
59889702|NCT02163733|76012016|FG002|COMPLETED|Part A: Day 1-9 (1st Intervention)||0||
59889703|NCT02163733|76012014|FG000|NOT COMPLETED|Part A: Day 1-9 (1st Intervention)||0||
59889704|NCT02163733|76012015|FG001|NOT COMPLETED|Part A: Day 1-9 (1st Intervention)||0||
59889705|NCT02163733|76012016|FG002|NOT COMPLETED|Part A: Day 1-9 (1st Intervention)||0||
59889706|NCT02163733|76012014|FG000|STARTED|Part A: Day 10-15 (2nd Intervention)||18||
59889707|NCT02163733|76012015|FG001|STARTED|Part A: Day 10-15 (2nd Intervention)||20||
59889708|NCT02163733|76012016|FG002|STARTED|Part A: Day 10-15 (2nd Intervention)||0||
59889709|NCT02163733|76012014|FG000|COMPLETED|Part A: Day 10-15 (2nd Intervention)||18||
59889710|NCT02163733|76012015|FG001|COMPLETED|Part A: Day 10-15 (2nd Intervention)||20||
59889711|NCT02163733|76012016|FG002|COMPLETED|Part A: Day 10-15 (2nd Intervention)||0||
59889712|NCT02163733|76012014|FG000|NOT COMPLETED|Part A: Day 10-15 (2nd Intervention)||0||
59889713|NCT02163733|76012015|FG001|NOT COMPLETED|Part A: Day 10-15 (2nd Intervention)||0||
59889714|NCT02163733|76012016|FG002|NOT COMPLETED|Part A: Day 10-15 (2nd Intervention)||0||
59889715|NCT02163733|76012014|FG000|STARTED|Part B: Day 15 to End Part B (AZD9291)|Only the AZD9291 once daily (Part B) arm is applicable for this period.|0||
59889716|NCT02163733|76012015|FG001|STARTED|Part B: Day 15 to End Part B (AZD9291)|Only the AZD9291 once daily (Part B) arm is applicable for this period.|0||
59889717|NCT02163733|76012016|FG002|STARTED|Part B: Day 15 to End Part B (AZD9291)|No patients completed previous period as relates to Part A and arm is applicable only for Part B.|38||
59889718|NCT02163733|76012014|FG000|COMPLETED|Part B: Day 15 to End Part B (AZD9291)||0||
59889719|NCT02163733|76012015|FG001|COMPLETED|Part B: Day 15 to End Part B (AZD9291)||0||
59889720|NCT02163733|76012016|FG002|COMPLETED|Part B: Day 15 to End Part B (AZD9291)||14||
59889721|NCT02163733|76012014|FG000|NOT COMPLETED|Part B: Day 15 to End Part B (AZD9291)||0||
59889722|NCT02163733|76012015|FG001|NOT COMPLETED|Part B: Day 15 to End Part B (AZD9291)||0||
59889723|NCT02163733|76012016|FG002|NOT COMPLETED|Part B: Day 15 to End Part B (AZD9291)||24||
59889724|NCT02062593|76012025|FG000|STARTED|Overall Study||105||
59889725|NCT02062593|76012026|FG001|STARTED|Overall Study||95||
59889726|NCT02062593|76012025|FG000|COMPLETED|Overall Study||105||
59889727|NCT02062593|76012026|FG001|COMPLETED|Overall Study||91||
59889728|NCT02062593|76012025|FG000|NOT COMPLETED|Overall Study||0||
59889729|NCT02062593|76012026|FG001|NOT COMPLETED|Overall Study||4||
59889730|NCT01391832|76012034|FG000|STARTED|Overall Study||49||
59889731|NCT01391832|76012035|FG001|STARTED|Overall Study||54||
59889732|NCT01391832|76012034|FG000|1 Month Follow-Up|Overall Study||30||
59889733|NCT01391832|76012035|FG001|1 Month Follow-Up|Overall Study||31||
59889734|NCT01391832|76012034|FG000|3 Month Follow-Up|Overall Study||28||
59889735|NCT01391832|76012035|FG001|3 Month Follow-Up|Overall Study||29||
60013713|NCT02472795|76129675|FG004|STARTED|Overall Study||17||
59889736|NCT01391832|76012034|FG000|COMPLETED|Overall Study||28||
59889737|NCT01391832|76012035|FG001|COMPLETED|Overall Study||31||
59889738|NCT01391832|76012034|FG000|NOT COMPLETED|Overall Study||21||
59889739|NCT01391832|76012035|FG001|NOT COMPLETED|Overall Study||23||
59889740|NCT05590000|76012041|FG000|STARTED|Overall Study||25||
59889741|NCT05590000|76012041|FG000|COMPLETED|Overall Study||24||
59889742|NCT05590000|76012041|FG000|NOT COMPLETED|Overall Study||1||
59889743|NCT05562583|76012045|FG000|STARTED|Overall Study||15||
59889744|NCT05562583|76012045|FG000|COMPLETED|Overall Study||10||
59889745|NCT05562583|76012045|FG000|NOT COMPLETED|Overall Study||5||
59889746|NCT05333965|76012049|FG000|STARTED|First Intervention||13||
59889747|NCT05333965|76012050|FG001|STARTED|First Intervention||13||
59889748|NCT05333965|76012049|FG000|COMPLETED|First Intervention||13||
59889749|NCT05333965|76012050|FG001|COMPLETED|First Intervention||11||
59889750|NCT05333965|76012049|FG000|NOT COMPLETED|First Intervention||0||
59889751|NCT05333965|76012050|FG001|NOT COMPLETED|First Intervention||2||
59889752|NCT05333965|76012049|FG000|STARTED|Second Intervention||13||
59889753|NCT05333965|76012050|FG001|STARTED|Second Intervention||11||
59889754|NCT05333965|76012049|FG000|COMPLETED|Second Intervention||13||
59889755|NCT05333965|76012050|FG001|COMPLETED|Second Intervention||11||
59889756|NCT05333965|76012049|FG000|NOT COMPLETED|Second Intervention||0||
59889757|NCT05333965|76012050|FG001|NOT COMPLETED|Second Intervention||0||
59889758|NCT05113901|76012058|FG000|STARTED|Overall Study||4||
59889759|NCT05113901|76012059|FG001|STARTED|Overall Study||0||
59889760|NCT05113901|76012058|FG000|COMPLETED|Overall Study||3||
59889761|NCT05113901|76012059|FG001|COMPLETED|Overall Study||0||
59889762|NCT05113901|76012058|FG000|NOT COMPLETED|Overall Study||1||
59889763|NCT05113901|76012059|FG001|NOT COMPLETED|Overall Study||0||
59889764|NCT05109702|76012067|FG000|STARTED|Placebo Run-in Period (14 Days)||260||
59889765|NCT05109702|76012068|FG001|STARTED|Placebo Run-in Period (14 Days)||0||
59889766|NCT05109702|76012069|FG002|STARTED|Placebo Run-in Period (14 Days)||0||
59889767|NCT05109702|76012067|FG000|COMPLETED|Placebo Run-in Period (14 Days)||260||
59889768|NCT05109702|76012068|FG001|COMPLETED|Placebo Run-in Period (14 Days)||0||
59889769|NCT05109702|76012069|FG002|COMPLETED|Placebo Run-in Period (14 Days)||0||
59889770|NCT05109702|76012067|FG000|NOT COMPLETED|Placebo Run-in Period (14 Days)||0||
59889771|NCT05109702|76012068|FG001|NOT COMPLETED|Placebo Run-in Period (14 Days)||0||
59889772|NCT05109702|76012069|FG002|NOT COMPLETED|Placebo Run-in Period (14 Days)||0||
59889773|NCT05109702|76012067|FG000|STARTED|Treatment Period (8 Weeks)||0||
59889774|NCT05109702|76012068|FG001|STARTED|Treatment Period (8 Weeks)||130||
59889775|NCT05109702|76012069|FG002|STARTED|Treatment Period (8 Weeks)||130||
59889776|NCT05109702|76012067|FG000|COMPLETED|Treatment Period (8 Weeks)||0||
59889777|NCT05109702|76012068|FG001|COMPLETED|Treatment Period (8 Weeks)||116||
59889778|NCT05109702|76012069|FG002|COMPLETED|Treatment Period (8 Weeks)||122||
59889779|NCT05109702|76012067|FG000|NOT COMPLETED|Treatment Period (8 Weeks)||0||
59889780|NCT05109702|76012068|FG001|NOT COMPLETED|Treatment Period (8 Weeks)||14||
59889781|NCT05109702|76012069|FG002|NOT COMPLETED|Treatment Period (8 Weeks)||8||
59889782|NCT04846322|76012076|FG000|STARTED|Overall Study||100||
59889783|NCT04846322|76012076|FG000|COMPLETED|Overall Study||100||
59889784|NCT04846322|76012076|FG000|NOT COMPLETED|Overall Study||0||
59889785|NCT04699461|76012082|FG000|STARTED|Overall Study||4||
59889786|NCT04699461|76012083|FG001|STARTED|Overall Study||2||
59889787|NCT04699461|76012082|FG000|COMPLETED|Overall Study||0||
59889788|NCT04699461|76012083|FG001|COMPLETED|Overall Study||0||
59889789|NCT04699461|76012082|FG000|NOT COMPLETED|Overall Study||4||
59889790|NCT04699461|76012083|FG001|NOT COMPLETED|Overall Study||2||
59889791|NCT04399551|76012089|FG000|STARTED|Overall Study||430|Participants who received study treatment.|
59889792|NCT04399551|76012089|FG000|COMPLETED|Overall Study||402||
59889793|NCT04399551|76012089|FG000|NOT COMPLETED|Overall Study||28||
59889794|NCT04395222|76012105|FG000|STARTED|Overall Study||10||
59889795|NCT04395222|76012106|FG001|STARTED|Overall Study||10||
59889796|NCT04395222|76012107|FG002|STARTED|Overall Study||1||
59889797|NCT04395222|76012108|FG003|STARTED|Overall Study||0||
59889798|NCT04395222|76012105|FG000|COMPLETED|Overall Study||10||
59889799|NCT04395222|76012106|FG001|COMPLETED|Overall Study||10||
59889800|NCT04395222|76012107|FG002|COMPLETED|Overall Study||1||
59889801|NCT04395222|76012108|FG003|COMPLETED|Overall Study||0||
59889802|NCT04395222|76012105|FG000|NOT COMPLETED|Overall Study||0||
59889803|NCT04395222|76012106|FG001|NOT COMPLETED|Overall Study||0||
59889804|NCT04395222|76012107|FG002|NOT COMPLETED|Overall Study||0||
59889805|NCT04395222|76012108|FG003|NOT COMPLETED|Overall Study||0||
59889806|NCT04343235|76012120|FG000|STARTED|Overall Study||6||
59889807|NCT04343235|76012121|FG001|STARTED|Overall Study||7||
59889808|NCT04343235|76012120|FG000|COMPLETED|Overall Study||3||
59889809|NCT04343235|76012121|FG001|COMPLETED|Overall Study||5||
59889810|NCT04343235|76012120|FG000|NOT COMPLETED|Overall Study||3||
59889811|NCT04343235|76012121|FG001|NOT COMPLETED|Overall Study||2||
59889812|NCT04338321|76012129|FG000|STARTED|Overall Study||336||
59889813|NCT04338321|76012130|FG001|STARTED|Overall Study||340||
59889814|NCT04338321|76012129|FG000|Treated (Safety Analysis Set)|Overall Study||334||
59889815|NCT04338321|76012130|FG001|Treated (Safety Analysis Set)|Overall Study||336||
59889816|NCT04338321|76012129|FG000|Completed Treatment|Overall Study||258||
59889817|NCT04338321|76012130|FG001|Completed Treatment|Overall Study||203||
59889818|NCT04338321|76012129|FG000|COMPLETED|Overall Study||274||
59889819|NCT04338321|76012130|FG001|COMPLETED|Overall Study||232||
59889820|NCT04338321|76012129|FG000|NOT COMPLETED|Overall Study||62||
59889821|NCT04338321|76012130|FG001|NOT COMPLETED|Overall Study||108||
59889822|NCT04303780|76012138|FG000|STARTED|Overall Study||171||
59889823|NCT04303780|76012139|FG001|STARTED|Overall Study||174||
59889824|NCT04303780|76012138|FG000|Switched From Docetaxel to AMG 510|Overall Study||0||
59889825|NCT04303780|76012139|FG001|Switched From Docetaxel to AMG 510|Overall Study||46||
59889826|NCT04303780|76012138|FG000|COMPLETED|Overall Study||0|Number of participants who have completed the study as of the primary analysis completion date (02 August 2022).|
59889827|NCT04303780|76012139|FG001|COMPLETED|Overall Study||3|Number of participants who have completed the study as of the primary analysis completion date (02 August 2022).|
59889828|NCT04303780|76012138|FG000|NOT COMPLETED|Overall Study||171||
59889829|NCT04303780|76012139|FG001|NOT COMPLETED|Overall Study||171||
59889830|NCT04068181|76012150|FG000|STARTED|Overall Study||27||
59889831|NCT04068181|76012151|FG001|STARTED|Overall Study||15||
59889832|NCT04068181|76012152|FG002|STARTED|Overall Study||15||
59889833|NCT04068181|76012153|FG003|STARTED|Overall Study||15||
59889834|NCT04068181|76012150|FG000|Received Talimogene Laherparepvec|Overall Study||26||
59889835|NCT04068181|76012151|FG001|Received Talimogene Laherparepvec|Overall Study||15||
59889836|NCT04068181|76012152|FG002|Received Talimogene Laherparepvec|Overall Study||15||
59889837|NCT04068181|76012153|FG003|Received Talimogene Laherparepvec|Overall Study||15||
59889838|NCT04068181|76012150|FG000|Received Pembrolizumab|Overall Study||26||
59889839|NCT04068181|76012151|FG001|Received Pembrolizumab|Overall Study||15||
59889840|NCT04068181|76012152|FG002|Received Pembrolizumab|Overall Study||15||
59889841|NCT04068181|76012153|FG003|Received Pembrolizumab|Overall Study||15||
59889842|NCT04068181|76012150|FG000|COMPLETED|Overall Study||0||
59889843|NCT04068181|76012151|FG001|COMPLETED|Overall Study||0||
59889844|NCT04068181|76012152|FG002|COMPLETED|Overall Study||0||
59889845|NCT04068181|76012153|FG003|COMPLETED|Overall Study||0||
59889846|NCT04068181|76012150|FG000|NOT COMPLETED|Overall Study||27||
59889847|NCT04068181|76012151|FG001|NOT COMPLETED|Overall Study||15||
59889848|NCT04068181|76012152|FG002|NOT COMPLETED|Overall Study||15||
59889849|NCT04068181|76012153|FG003|NOT COMPLETED|Overall Study||15||
59889850|NCT03945019|76012165|FG000|STARTED|Induction Phase||396||
59889851|NCT03945019|76012166|FG001|STARTED|Induction Phase||0||
59889852|NCT03945019|76012167|FG002|STARTED|Induction Phase||0||
59889853|NCT03945019|76012165|FG000|COMPLETED|Induction Phase||343||
59889854|NCT03945019|76012166|FG001|COMPLETED|Induction Phase||0||
59889855|NCT03945019|76012167|FG002|COMPLETED|Induction Phase||0||
59889856|NCT03945019|76012165|FG000|NOT COMPLETED|Induction Phase||53||
59889857|NCT03945019|76012166|FG001|NOT COMPLETED|Induction Phase||0||
59889858|NCT03945019|76012167|FG002|NOT COMPLETED|Induction Phase||0||
59889859|NCT03945019|76012165|FG000|STARTED|Maintenance Phase||0||
59889860|NCT03945019|76012166|FG001|STARTED|Maintenance Phase||231||
59889861|NCT03945019|76012167|FG002|STARTED|Maintenance Phase||112||
59889862|NCT03945019|76012165|FG000|COMPLETED|Maintenance Phase||0||
59889863|NCT03945019|76012166|FG001|COMPLETED|Maintenance Phase||196||
59889864|NCT03945019|76012167|FG002|COMPLETED|Maintenance Phase||87||
59889865|NCT03945019|76012165|FG000|NOT COMPLETED|Maintenance Phase||0||
59889866|NCT03945019|76012166|FG001|NOT COMPLETED|Maintenance Phase||35||
59889867|NCT03945019|76012167|FG002|NOT COMPLETED|Maintenance Phase||25||
59889868|NCT03910673|76012182|FG000|STARTED|Overall Study||7||
59889869|NCT03910673|76012183|FG001|STARTED|Overall Study||6||
59889870|NCT03910673|76012184|FG002|STARTED|Overall Study||7||
59889871|NCT03910673|76012185|FG003|STARTED|Overall Study||13||
59889872|NCT03910673|76012186|FG004|STARTED|Overall Study||6||
59889873|NCT03910673|76012182|FG000|Enrolled and Randomized|Overall Study||6||
59889874|NCT03910673|76012183|FG001|Enrolled and Randomized|Overall Study||6||
59889875|NCT03910673|76012184|FG002|Enrolled and Randomized|Overall Study||6||
59889876|NCT03910673|76012185|FG003|Enrolled and Randomized|Overall Study||6||
59889877|NCT03910673|76012186|FG004|Enrolled and Randomized|Overall Study||6||
59889878|NCT03910673|76012182|FG000|Enrolled as Replacement|Overall Study||1||
59889879|NCT03910673|76012183|FG001|Enrolled as Replacement|Overall Study||0||
59889880|NCT03910673|76012184|FG002|Enrolled as Replacement|Overall Study||1||
59889881|NCT03910673|76012185|FG003|Enrolled as Replacement|Overall Study||7||
59889882|NCT03910673|76012186|FG004|Enrolled as Replacement|Overall Study||0||
59889883|NCT03910673|76012182|FG000|Began Infusion of Dose 1|Overall Study||7||
59889884|NCT03910673|76012183|FG001|Began Infusion of Dose 1|Overall Study||6||
59889885|NCT03910673|76012184|FG002|Began Infusion of Dose 1|Overall Study||7||
59889886|NCT03910673|76012185|FG003|Began Infusion of Dose 1|Overall Study||13||
59889887|NCT03910673|76012186|FG004|Began Infusion of Dose 1|Overall Study||6||
59889888|NCT03910673|76012182|FG000|Completed Dose 1|Overall Study||7||
59889889|NCT03910673|76012183|FG001|Completed Dose 1|Overall Study||6||
59889890|NCT03910673|76012184|FG002|Completed Dose 1|Overall Study||7||
59889891|NCT03910673|76012185|FG003|Completed Dose 1|Overall Study||13||
59889892|NCT03910673|76012186|FG004|Completed Dose 1|Overall Study||6||
59889893|NCT03910673|76012182|FG000|Completed Dose 2|Overall Study||7||
59889894|NCT03910673|76012183|FG001|Completed Dose 2|Overall Study||6||
59889895|NCT03910673|76012184|FG002|Completed Dose 2|Overall Study||7||
59889896|NCT03910673|76012185|FG003|Completed Dose 2|Overall Study||13||
59889897|NCT03910673|76012186|FG004|Completed Dose 2|Overall Study||6||
59889898|NCT03910673|76012182|FG000|Completed Dose 3|Overall Study||6||
59889899|NCT03910673|76012183|FG001|Completed Dose 3|Overall Study||6||
59889900|NCT03910673|76012184|FG002|Completed Dose 3|Overall Study||7||
59889901|NCT03910673|76012185|FG003|Completed Dose 3|Overall Study||12||
59889902|NCT03910673|76012186|FG004|Completed Dose 3|Overall Study||6||
59889903|NCT03910673|76012182|FG000|Completed All Scheduled Treatment|Overall Study||6||
59889904|NCT03910673|76012183|FG001|Completed All Scheduled Treatment|Overall Study||6||
59889905|NCT03910673|76012184|FG002|Completed All Scheduled Treatment|Overall Study||7||
59889906|NCT03910673|76012185|FG003|Completed All Scheduled Treatment|Overall Study||12||
59889907|NCT03910673|76012186|FG004|Completed All Scheduled Treatment|Overall Study||6||
59889908|NCT03910673|76012182|FG000|Completed All PK Blood Draws|Overall Study||6||
59889909|NCT03910673|76012183|FG001|Completed All PK Blood Draws|Overall Study||6||
59889910|NCT03910673|76012184|FG002|Completed All PK Blood Draws|Overall Study||6||
59889911|NCT03910673|76012185|FG003|Completed All PK Blood Draws|Overall Study||6||
59889912|NCT03910673|76012186|FG004|Completed All PK Blood Draws|Overall Study||6||
59889913|NCT03910673|76012182|FG000|Completed Bronchoscopy With BAL|Overall Study||6||
59889914|NCT03910673|76012183|FG001|Completed Bronchoscopy With BAL|Overall Study||6||
59889915|NCT03910673|76012184|FG002|Completed Bronchoscopy With BAL|Overall Study||6||
59889916|NCT03910673|76012185|FG003|Completed Bronchoscopy With BAL|Overall Study||6||
59505566|NCT00734903|75598370|FG000|COMPLETED|Overall Study||30|Completion was defined, a priori, as completing at least 2 study assessments|
59505567|NCT00734903|75598371|FG001|COMPLETED|Overall Study||32|Completion was defined, a priori, as completing at least 2 study assessments|
59889917|NCT03910673|76012186|FG004|Completed Bronchoscopy With BAL|Overall Study||6||
59889918|NCT03910673|76012182|FG000|Completed All Plasma Urea Samples|Overall Study||6||
59889919|NCT03910673|76012183|FG001|Completed All Plasma Urea Samples|Overall Study||6||
59889920|NCT03910673|76012184|FG002|Completed All Plasma Urea Samples|Overall Study||6||
59889921|NCT03910673|76012185|FG003|Completed All Plasma Urea Samples|Overall Study||6||
59889922|NCT03910673|76012186|FG004|Completed All Plasma Urea Samples|Overall Study||6||
59889923|NCT03910673|76012182|FG000|At Least One PK Blood Draw Concurrent With BAL Timepoint|Overall Study||6||
59889924|NCT03910673|76012183|FG001|At Least One PK Blood Draw Concurrent With BAL Timepoint|Overall Study||6||
59889925|NCT03910673|76012184|FG002|At Least One PK Blood Draw Concurrent With BAL Timepoint|Overall Study||6||
59889926|NCT03910673|76012185|FG003|At Least One PK Blood Draw Concurrent With BAL Timepoint|Overall Study||6||
59889927|NCT03910673|76012186|FG004|At Least One PK Blood Draw Concurrent With BAL Timepoint|Overall Study||6||
59889928|NCT03910673|76012182|FG000|COMPLETED|Overall Study||7||
59889929|NCT03910673|76012183|FG001|COMPLETED|Overall Study||6||
59889930|NCT03910673|76012184|FG002|COMPLETED|Overall Study||7||
59889931|NCT03910673|76012185|FG003|COMPLETED|Overall Study||11||
59889932|NCT03910673|76012186|FG004|COMPLETED|Overall Study||6||
59889933|NCT03910673|76012182|FG000|NOT COMPLETED|Overall Study||0||
59889934|NCT03910673|76012183|FG001|NOT COMPLETED|Overall Study||0||
59889935|NCT03910673|76012184|FG002|NOT COMPLETED|Overall Study||0||
59889936|NCT03910673|76012185|FG003|NOT COMPLETED|Overall Study||2||
59889937|NCT03910673|76012186|FG004|NOT COMPLETED|Overall Study||0||
59889938|NCT03829514|76012190|FG000|STARTED|Overall Study||10||
59889939|NCT03829514|76012190|FG000|COMPLETED|Overall Study||10||
59889940|NCT03829514|76012190|FG000|NOT COMPLETED|Overall Study||0||
59889941|NCT03781167|76012196|FG000|STARTED|Overall Study||131||
59889942|NCT03781167|76012197|FG001|STARTED|Overall Study||113||
59505568|NCT00734903|75598370|FG000|NOT COMPLETED|Overall Study||3||
59505569|NCT00734903|75598371|FG001|NOT COMPLETED|Overall Study||1||
59505570|NCT00735449|75598379|FG000|STARTED|Overall Study||102||
59505571|NCT00735449|75598380|FG001|STARTED|Overall Study||102||
59889943|NCT03781167|76012196|FG000|COMPLETED|Overall Study||84||
59889944|NCT03781167|76012197|FG001|COMPLETED|Overall Study||65||
59889945|NCT03781167|76012196|FG000|NOT COMPLETED|Overall Study||47||
59889946|NCT03781167|76012197|FG001|NOT COMPLETED|Overall Study||48||
59889947|NCT03727802|76012215|FG000|STARTED|Overall Study||3||
59889948|NCT03727802|76012216|FG001|STARTED|Overall Study||3||
59889949|NCT03727802|76012217|FG002|STARTED|Overall Study||3||
59889950|NCT03727802|76012218|FG003|STARTED|Overall Study||3||
59889951|NCT03727802|76012219|FG004|STARTED|Overall Study||4||
59889952|NCT03727802|76012220|FG005|STARTED|Overall Study||4||
59889953|NCT03727802|76012221|FG006|STARTED|Overall Study||4||
59889954|NCT03727802|76012222|FG007|STARTED|Overall Study||4||
59889955|NCT03727802|76012223|FG008|STARTED|Overall Study||6||
59889956|NCT03727802|76012215|FG000|COMPLETED|Overall Study||3||
59889957|NCT03727802|76012216|FG001|COMPLETED|Overall Study||3||
59889958|NCT03727802|76012217|FG002|COMPLETED|Overall Study||3||
59889959|NCT03727802|76012218|FG003|COMPLETED|Overall Study||3||
59889960|NCT03727802|76012219|FG004|COMPLETED|Overall Study||4||
59889961|NCT03727802|76012220|FG005|COMPLETED|Overall Study||4||
59889962|NCT03727802|76012221|FG006|COMPLETED|Overall Study||4||
59889963|NCT03727802|76012222|FG007|COMPLETED|Overall Study||3||
59889964|NCT03727802|76012223|FG008|COMPLETED|Overall Study||5||
59889965|NCT03727802|76012215|FG000|NOT COMPLETED|Overall Study||0||
59889966|NCT03727802|76012216|FG001|NOT COMPLETED|Overall Study||0||
59889967|NCT03727802|76012217|FG002|NOT COMPLETED|Overall Study||0||
59889968|NCT03727802|76012218|FG003|NOT COMPLETED|Overall Study||0||
59889969|NCT03727802|76012219|FG004|NOT COMPLETED|Overall Study||0||
59889970|NCT03727802|76012220|FG005|NOT COMPLETED|Overall Study||0||
59889971|NCT03727802|76012221|FG006|NOT COMPLETED|Overall Study||0||
59889972|NCT03727802|76012222|FG007|NOT COMPLETED|Overall Study||1||
59889973|NCT03727802|76012223|FG008|NOT COMPLETED|Overall Study||1||
59889974|NCT03689712|76012245|FG000|STARTED|Overall Study||270||
59889975|NCT03689712|76012246|FG001|STARTED|Overall Study||185||
59889976|NCT03689712|76012245|FG000|Intent to Treat Population|Overall Study||241|Intent-to-Treat (ITT) population includes all randomized subjects who received at least one dose of GC4419/Placebo, with the exception of the 28 subjects whose treatment course was discontinued during the Sponsor's voluntary suspension of dosing.|
59889977|NCT03689712|76012246|FG001|Intent to Treat Population|Overall Study||166|Intent-to-Treat (ITT) population includes all randomized subjects who received at least one dose of GC4419/Placebo, with the exception of the 28 subjects whose treatment course was discontinued during the Sponsor's voluntary suspension of dosing.|
59889978|NCT03689712|76012245|FG000|COMPLETED|Overall Study||105||
59889979|NCT03689712|76012246|FG001|COMPLETED|Overall Study||74||
59889980|NCT03689712|76012245|FG000|NOT COMPLETED|Overall Study||165||
59889981|NCT03689712|76012246|FG001|NOT COMPLETED|Overall Study||111||
59889982|NCT03679624|76012254|FG000|STARTED|Overall Study||1||
59889983|NCT03679624|76012255|FG001|STARTED|Overall Study||0||
59889984|NCT03679624|76012254|FG000|COMPLETED|Overall Study||0||
59889985|NCT03679624|76012255|FG001|COMPLETED|Overall Study||0||
59889986|NCT03679624|76012254|FG000|NOT COMPLETED|Overall Study||1||
59889987|NCT03679624|76012255|FG001|NOT COMPLETED|Overall Study||0||
59889988|NCT03602586|76012261|FG000|STARTED|Overall Study||14||
59889989|NCT03602586|76012261|FG000|COMPLETED|Overall Study||11||
59889990|NCT03602586|76012261|FG000|NOT COMPLETED|Overall Study||3||
59889991|NCT03539900|76012267|FG000|STARTED|Overall Study||43||
59889992|NCT03539900|76012268|FG001|STARTED|Overall Study||46||
59889993|NCT03539900|76012267|FG000|COMPLETED|Overall Study||38||
59889994|NCT03539900|76012268|FG001|COMPLETED|Overall Study||44||
59889995|NCT03539900|76012267|FG000|NOT COMPLETED|Overall Study||5||
59889996|NCT03539900|76012268|FG001|NOT COMPLETED|Overall Study||2||
59889997|NCT03399552|76012274|FG000|STARTED|Overall Study||15||
59889998|NCT03399552|76012274|FG000|COMPLETED|Overall Study||13||
59889999|NCT03399552|76012274|FG000|NOT COMPLETED|Overall Study||2||
59890000|NCT03370276|76012281|FG000|STARTED|Overall Study||3||
59890001|NCT03370276|76012282|FG001|STARTED|Overall Study||44||
59890002|NCT03370276|76012283|FG002|STARTED|Overall Study||48||
59505572|NCT00735449|75598379|FG000|COMPLETED|Overall Study||95||
59890003|NCT03370276|76012281|FG000|COMPLETED|Overall Study||3||
59890004|NCT03370276|76012282|FG001|COMPLETED|Overall Study||42||
59890005|NCT03370276|76012283|FG002|COMPLETED|Overall Study||43||
59505573|NCT00735449|75598380|FG001|COMPLETED|Overall Study||96||
59505574|NCT00735449|75598379|FG000|NOT COMPLETED|Overall Study||7||
59505575|NCT00735449|75598380|FG001|NOT COMPLETED|Overall Study||6||
59505576|NCT00735839|75598388|FG000|STARTED|Overall Study||30||
59505577|NCT00735839|75598389|FG001|STARTED|Overall Study||10||
59505578|NCT00735839|75598388|FG000|COMPLETED|Overall Study||30||
59890006|NCT03370276|76012281|FG000|NOT COMPLETED|Overall Study||0||
59890007|NCT03370276|76012282|FG001|NOT COMPLETED|Overall Study||2||
59890008|NCT03370276|76012283|FG002|NOT COMPLETED|Overall Study||5||
59890009|NCT03359902|76012293|FG000|STARTED|Overall Study||41||
59890010|NCT03359902|76012294|FG001|STARTED|Overall Study||18||
59890011|NCT03359902|76012293|FG000|COMPLETED|Overall Study||41||
59890012|NCT03359902|76012294|FG001|COMPLETED|Overall Study||18||
59890013|NCT03359902|76012293|FG000|NOT COMPLETED|Overall Study||0||
59890014|NCT03359902|76012294|FG001|NOT COMPLETED|Overall Study||0||
59890015|NCT03328507|76012304|FG000|STARTED|Overall Study||21||
59890016|NCT03328507|76012305|FG001|STARTED|Overall Study||40||
59890017|NCT03328507|76012306|FG002|STARTED|Overall Study||41||
59890018|NCT03328507|76012307|FG003|STARTED|Overall Study||19||
59890019|NCT03328507|76012304|FG000|COMPLETED|Overall Study||21||
59890020|NCT03328507|76012305|FG001|COMPLETED|Overall Study||40||
59890021|NCT03328507|76012306|FG002|COMPLETED|Overall Study||40||
59890022|NCT03328507|76012307|FG003|COMPLETED|Overall Study||19||
59890023|NCT03328507|76012304|FG000|NOT COMPLETED|Overall Study||0||
59890024|NCT03328507|76012305|FG001|NOT COMPLETED|Overall Study||0||
59890025|NCT03328507|76012306|FG002|NOT COMPLETED|Overall Study||1||
59890026|NCT03328507|76012307|FG003|NOT COMPLETED|Overall Study||0||
59890027|NCT03312231|76012322|FG000|STARTED|Overall Study||184|One subject allocated to Group 4 and received Group 5 treatment due to error was analyzed as Group 5|
59890028|NCT03312231|76012323|FG001|STARTED|Overall Study||176|One subject allocated to Group 4 and received Group 5 treatment due to error was analyzed as Group 5|
59890029|NCT03312231|76012324|FG002|STARTED|Overall Study||181|One subject allocated to Group 4 and received Group 5 treatment due to error was analyzed as Group 5|
59890030|NCT03312231|76012325|FG003|STARTED|Overall Study||89|One subject allocated to Group 4 and received Group 5 treatment due to error was analyzed as Group 5|
59890031|NCT03312231|76012326|FG004|STARTED|Overall Study||90|One subject allocated to Group 4 and received Group 5 treatment due to error was analyzed as Group 5|
59890032|NCT03312231|76012322|FG000|COMPLETED|Overall Study||181||
59890033|NCT03312231|76012323|FG001|COMPLETED|Overall Study||165||
59890034|NCT03312231|76012324|FG002|COMPLETED|Overall Study||177||
59890035|NCT03312231|76012325|FG003|COMPLETED|Overall Study||86||
59890036|NCT03312231|76012326|FG004|COMPLETED|Overall Study||89||
59890037|NCT03312231|76012322|FG000|NOT COMPLETED|Overall Study||3||
59505579|NCT00735839|75598389|FG001|COMPLETED|Overall Study||10||
59505580|NCT00735839|75598388|FG000|NOT COMPLETED|Overall Study||0||
59890038|NCT03312231|76012323|FG001|NOT COMPLETED|Overall Study||11||
59890039|NCT03312231|76012324|FG002|NOT COMPLETED|Overall Study||4||
59890040|NCT03312231|76012325|FG003|NOT COMPLETED|Overall Study||3||
59890041|NCT03312231|76012326|FG004|NOT COMPLETED|Overall Study||1||
59890042|NCT03294590|76012340|FG000|STARTED|Overall Study||377|Number of parent/caregiver-child dyads randomized|
59890043|NCT03294590|76012341|FG001|STARTED|Overall Study||377|Number of parent/caregiver-child dyads randomized|
59890044|NCT03294590|76012340|FG000|Number of Parent/Caregiver Participants|Overall Study||377||
59890045|NCT03294590|76012341|FG001|Number of Parent/Caregiver Participants|Overall Study||377||
59890046|NCT03294590|76012340|FG000|Number of Children Participants|Overall Study||377||
59890047|NCT03294590|76012341|FG001|Number of Children Participants|Overall Study||377||
59890048|NCT03294590|76012340|FG000|4-month Time Point (Survey)|Overall Study|Number of parents/caregivers completing the 4-month questionnaire assessment|290||
59890049|NCT03294590|76012341|FG001|4-month Time Point (Survey)|Overall Study|Number of parents/caregivers completing the 4-month questionnaire assessment|288||
59890050|NCT03294590|76012340|FG000|12-month Time Point (Survey)|Overall Study|Number of parents/caregivers completing the 12-month questionnaire assessment|282||
59890051|NCT03294590|76012341|FG001|12-month Time Point (Survey)|Overall Study|Number of parents/caregivers completing the 12-month questionnaire assessment|290||
59890052|NCT03294590|76012340|FG000|12-month Time Point (Oral Exam)|Overall Study|Number of children completing the 12-month oral health exam|206||
59890053|NCT03294590|76012341|FG001|12-month Time Point (Oral Exam)|Overall Study|Number of children completing the 12-month oral health exam|185||
59890054|NCT03294590|76012340|FG000|24-month Time Point (Survey)|Overall Study|Number of parents/caregivers completing the 24-month questionnaire assessment|272||
59890055|NCT03294590|76012341|FG001|24-month Time Point (Survey)|Overall Study|Number of parents/caregivers completing the 24-month questionnaire assessment|270||
59890056|NCT03294590|76012340|FG000|24-month Time Point (Oral Exam)|Overall Study|Number of children completing the 24-month oral health exam|160||
59890057|NCT03294590|76012341|FG001|24-month Time Point (Oral Exam)|Overall Study|Number of children completing the 24-month oral health exam|156||
59890058|NCT03294590|76012340|FG000|COMPLETED|Overall Study||272|542 parent/caregiver participants completed at least the questionnaire assessment of the final study visit (24-month time point)|
59890059|NCT03294590|76012341|FG001|COMPLETED|Overall Study||270|542 parent/caregiver participants completed at least the questionnaire assessment of the final study visit (24-month time point)|
59890060|NCT03294590|76012340|FG000|NOT COMPLETED|Overall Study||105||
59890061|NCT03294590|76012341|FG001|NOT COMPLETED|Overall Study||107||
59890062|NCT03292731|76012352|FG000|STARTED|Overall Study||67||
59890063|NCT03292731|76012353|FG001|STARTED|Overall Study||76||
59890064|NCT03292731|76012354|FG002|STARTED|Overall Study||16||
59890065|NCT03292731|76012352|FG000|COMPLETED|Overall Study||63||
59890066|NCT03292731|76012353|FG001|COMPLETED|Overall Study||65||
59890067|NCT03292731|76012354|FG002|COMPLETED|Overall Study||15||
59890068|NCT03292731|76012352|FG000|NOT COMPLETED|Overall Study||4||
59890069|NCT03292731|76012353|FG001|NOT COMPLETED|Overall Study||11||
59890070|NCT03292731|76012354|FG002|NOT COMPLETED|Overall Study||1||
59890071|NCT03277313|76012379|FG000|STARTED|Epoch 1 (Six-week Ramp-up Period)||44||
59890072|NCT03277313|76012380|FG001|STARTED|Epoch 1 (Six-week Ramp-up Period)||0||
59890073|NCT03277313|76012379|FG000|COMPLETED|Epoch 1 (Six-week Ramp-up Period)||43||
59890074|NCT03277313|76012380|FG001|COMPLETED|Epoch 1 (Six-week Ramp-up Period)||0||
59890075|NCT03277313|76012379|FG000|NOT COMPLETED|Epoch 1 (Six-week Ramp-up Period)||1||
59890076|NCT03277313|76012380|FG001|NOT COMPLETED|Epoch 1 (Six-week Ramp-up Period)||0||
59890077|NCT03277313|76012379|FG000|STARTED|Epoch 2 (36 Months After Epoch 1)||0||
59890078|NCT03277313|76012380|FG001|STARTED|Epoch 2 (36 Months After Epoch 1)||43||
59890079|NCT03277313|76012379|FG000|COMPLETED|Epoch 2 (36 Months After Epoch 1)||0||
59890080|NCT03277313|76012380|FG001|COMPLETED|Epoch 2 (36 Months After Epoch 1)||34||
59890081|NCT03277313|76012379|FG000|NOT COMPLETED|Epoch 2 (36 Months After Epoch 1)||0||
59890082|NCT03277313|76012380|FG001|NOT COMPLETED|Epoch 2 (36 Months After Epoch 1)||9||
59890083|NCT03206073|76012392|FG000|STARTED|Overall Study||4||
59890084|NCT03206073|76012393|FG001|STARTED|Overall Study||12||
59890085|NCT03206073|76012394|FG002|STARTED|Overall Study||4||
59890086|NCT03206073|76012395|FG003|STARTED|Overall Study||14||
59890087|NCT03206073|76012392|FG000|COMPLETED|Overall Study||3||
59890088|NCT03206073|76012393|FG001|COMPLETED|Overall Study||11||
59890089|NCT03206073|76012394|FG002|COMPLETED|Overall Study||0||
59890090|NCT03206073|76012395|FG003|COMPLETED|Overall Study||14||
59890091|NCT03206073|76012392|FG000|NOT COMPLETED|Overall Study||1||
59890092|NCT03206073|76012393|FG001|NOT COMPLETED|Overall Study||1||
59890093|NCT03206073|76012394|FG002|NOT COMPLETED|Overall Study||4||
59890094|NCT03206073|76012395|FG003|NOT COMPLETED|Overall Study||0||
59890095|NCT03193801|76012405|FG000|STARTED|Overall Study||53||
59890096|NCT03193801|76012405|FG000|COMPLETED|Overall Study||50||
59890097|NCT03193801|76012405|FG000|NOT COMPLETED|Overall Study||3||
59890098|NCT02973997|76012411|FG000|STARTED|Overall Study||30||
59890099|NCT02973997|76012412|FG001|STARTED|Overall Study||25||
59890100|NCT02973997|76012411|FG000|COMPLETED|Overall Study||8||
59890101|NCT02973997|76012412|FG001|COMPLETED|Overall Study||2||
59890102|NCT02973997|76012411|FG000|NOT COMPLETED|Overall Study||22||
59890103|NCT02973997|76012412|FG001|NOT COMPLETED|Overall Study||23||
59890104|NCT02941926|76012420|FG000|STARTED|Core Phase||3246||
59890105|NCT02941926|76012420|FG000|Canadian Sub-study|Core Phase||88|Participants who participated in the Canadian sub-study|
59890106|NCT02941926|76012420|FG000|COMPLETED|Core Phase||1301||
59890107|NCT02941926|76012420|FG000|NOT COMPLETED|Core Phase||1945||
59890108|NCT02941926|76012420|FG000|STARTED|Extension Phase||413|Subjects from countries where ribociclib was not yet approved and reimbursed who were still deriving benefit at the end of the Core Phase|
59890109|NCT02941926|76012420|FG000|COMPLETED|Extension Phase||112||
59890110|NCT02941926|76012420|FG000|NOT COMPLETED|Extension Phase||301||
59890111|NCT02846415|76012431|FG000|STARTED|Overall Study||18||
59890112|NCT02846415|76012432|FG001|STARTED|Overall Study||12||
59890113|NCT02846415|76012431|FG000|COMPLETED|Overall Study||15||
59890114|NCT02846415|76012432|FG001|COMPLETED|Overall Study||11||
59890115|NCT02846415|76012431|FG000|NOT COMPLETED|Overall Study||3||
59890116|NCT02846415|76012432|FG001|NOT COMPLETED|Overall Study||1||
59890117|NCT02688868|76012438|FG000|STARTED|Overall Study||38||
59890118|NCT02688868|76012438|FG000|COMPLETED|Overall Study||34||
59890119|NCT02688868|76012438|FG000|NOT COMPLETED|Overall Study||4||
59890120|NCT02688842|76012442|FG000|STARTED|Overall Study||38||
59890121|NCT02688842|76012442|FG000|COMPLETED|Overall Study||38||
59890122|NCT02688842|76012442|FG000|NOT COMPLETED|Overall Study||0||
59890123|NCT02671435|76012461|FG000|STARTED|Overall Study||3||
59890124|NCT02671435|76012462|FG001|STARTED|Overall Study||3||
59890125|NCT02671435|76012463|FG002|STARTED|Overall Study||3||
59890126|NCT02671435|76012464|FG003|STARTED|Overall Study||18||
59890127|NCT02671435|76012465|FG004|STARTED|Overall Study||18||
59890128|NCT02671435|76012466|FG005|STARTED|Overall Study||40||
59890129|NCT02671435|76012467|FG006|STARTED|Overall Study||40||
59890130|NCT02671435|76012468|FG007|STARTED|Overall Study||40||
59890131|NCT02671435|76012469|FG008|STARTED|Overall Study||20||
59890132|NCT02671435|76012470|FG009|STARTED|Overall Study||18||
59890133|NCT02671435|76012471|FG010|STARTED|Overall Study||18||
59890134|NCT02671435|76012472|FG011|STARTED|Overall Study||40||
59890135|NCT02671435|76012473|FG012|STARTED|Overall Study||41||
59890136|NCT02671435|76012474|FG013|STARTED|Overall Study||44||
59890137|NCT02671435|76012475|FG014|STARTED|Overall Study||37||
59890138|NCT02671435|76012461|FG000|Treated|Overall Study||3||
59890139|NCT02671435|76012462|FG001|Treated|Overall Study||3||
59890140|NCT02671435|76012463|FG002|Treated|Overall Study||3||
59890141|NCT02671435|76012464|FG003|Treated|Overall Study||18||
59890142|NCT02671435|76012465|FG004|Treated|Overall Study||18||
59890143|NCT02671435|76012466|FG005|Treated|Overall Study||40||
59890144|NCT02671435|76012467|FG006|Treated|Overall Study||40||
59890145|NCT02671435|76012468|FG007|Treated|Overall Study||40||
59890146|NCT02671435|76012469|FG008|Treated|Overall Study||20||
59890147|NCT02671435|76012470|FG009|Treated|Overall Study||18||
59890148|NCT02671435|76012471|FG010|Treated|Overall Study||18||
59890149|NCT02671435|76012472|FG011|Treated|Overall Study||39||
59890150|NCT02671435|76012473|FG012|Treated|Overall Study||41||
59890151|NCT02671435|76012474|FG013|Treated|Overall Study||44||
59890152|NCT02671435|76012475|FG014|Treated|Overall Study||37||
59890153|NCT02671435|76012461|FG000|COMPLETED|Overall Study||0||
59890154|NCT02671435|76012462|FG001|COMPLETED|Overall Study||0||
59890155|NCT02671435|76012463|FG002|COMPLETED|Overall Study||0||
59890156|NCT02671435|76012464|FG003|COMPLETED|Overall Study||0||
59890157|NCT02671435|76012465|FG004|COMPLETED|Overall Study||0||
59890158|NCT02671435|76012466|FG005|COMPLETED|Overall Study||0||
59890159|NCT02671435|76012467|FG006|COMPLETED|Overall Study||0||
59890160|NCT02671435|76012468|FG007|COMPLETED|Overall Study||0||
59890161|NCT02671435|76012469|FG008|COMPLETED|Overall Study||0||
59890162|NCT02671435|76012470|FG009|COMPLETED|Overall Study||0||
59890163|NCT02671435|76012471|FG010|COMPLETED|Overall Study||0||
59890164|NCT02671435|76012472|FG011|COMPLETED|Overall Study||0||
59890165|NCT02671435|76012473|FG012|COMPLETED|Overall Study||0||
59890166|NCT02671435|76012474|FG013|COMPLETED|Overall Study||0||
59890167|NCT02671435|76012475|FG014|COMPLETED|Overall Study||0||
59890168|NCT02671435|76012461|FG000|NOT COMPLETED|Overall Study||3||
60013714|NCT02472795|76129671|FG000|Pharmacodynamic Set|Overall Study||12||
60013715|NCT02472795|76129672|FG001|Pharmacodynamic Set|Overall Study||10||
60013716|NCT02472795|76129673|FG002|Pharmacodynamic Set|Overall Study||13||
60013717|NCT02472795|76129674|FG003|Pharmacodynamic Set|Overall Study||13||
60013718|NCT02472795|76129675|FG004|Pharmacodynamic Set|Overall Study||16||
59890169|NCT02671435|76012462|FG001|NOT COMPLETED|Overall Study||3||
59890170|NCT02671435|76012463|FG002|NOT COMPLETED|Overall Study||3||
59890171|NCT02671435|76012464|FG003|NOT COMPLETED|Overall Study||18||
59890172|NCT02671435|76012465|FG004|NOT COMPLETED|Overall Study||18||
59890173|NCT02671435|76012466|FG005|NOT COMPLETED|Overall Study||40||
59890174|NCT02671435|76012467|FG006|NOT COMPLETED|Overall Study||40||
59890175|NCT02671435|76012468|FG007|NOT COMPLETED|Overall Study||40||
59890176|NCT02671435|76012469|FG008|NOT COMPLETED|Overall Study||20||
59890177|NCT02671435|76012470|FG009|NOT COMPLETED|Overall Study||18||
59890178|NCT02671435|76012471|FG010|NOT COMPLETED|Overall Study||18||
59890179|NCT02671435|76012472|FG011|NOT COMPLETED|Overall Study||40||
59890180|NCT02671435|76012473|FG012|NOT COMPLETED|Overall Study||41||
59890181|NCT02671435|76012474|FG013|NOT COMPLETED|Overall Study||44||
59890182|NCT02671435|76012475|FG014|NOT COMPLETED|Overall Study||37||
59890183|NCT02519348|76012537|FG000|STARTED|Overall Study||40||
59890184|NCT02519348|76012538|FG001|STARTED|Overall Study||104||
59890185|NCT02519348|76012539|FG002|STARTED|Overall Study||75||
59890186|NCT02519348|76012540|FG003|STARTED|Overall Study||69||
59890187|NCT02519348|76012541|FG004|STARTED|Overall Study||84||
59890188|NCT02519348|76012542|FG005|STARTED|Overall Study||47||
59890189|NCT02519348|76012543|FG006|STARTED|Overall Study||3||
59890190|NCT02519348|76012544|FG007|STARTED|Overall Study||5||
59890191|NCT02519348|76012545|FG008|STARTED|Overall Study||6||
59890192|NCT02519348|76012537|FG000|Treated|Overall Study||40||
59890193|NCT02519348|76012538|FG001|Treated|Overall Study||101||
59890194|NCT02519348|76012539|FG002|Treated|Overall Study||74||
59890195|NCT02519348|76012540|FG003|Treated|Overall Study||69||
59890196|NCT02519348|76012541|FG004|Treated|Overall Study||82||
59890197|NCT02519348|76012542|FG005|Treated|Overall Study||47||
59890198|NCT02519348|76012543|FG006|Treated|Overall Study||3||
59890199|NCT02519348|76012544|FG007|Treated|Overall Study||5||
59890200|NCT02519348|76012545|FG008|Treated|Overall Study||5||
59890201|NCT02519348|76012537|FG000|COMPLETED|Overall Study||0||
59890202|NCT02519348|76012538|FG001|COMPLETED|Overall Study||0||
59890203|NCT02519348|76012539|FG002|COMPLETED|Overall Study||0||
59890204|NCT02519348|76012540|FG003|COMPLETED|Overall Study||0||
59890205|NCT02519348|76012541|FG004|COMPLETED|Overall Study||0||
59890206|NCT02519348|76012542|FG005|COMPLETED|Overall Study||0||
59890207|NCT02519348|76012543|FG006|COMPLETED|Overall Study||0||
59890208|NCT02519348|76012544|FG007|COMPLETED|Overall Study||0||
59890209|NCT02519348|76012545|FG008|COMPLETED|Overall Study||0||
59890210|NCT02519348|76012537|FG000|NOT COMPLETED|Overall Study||40||
59890211|NCT02519348|76012538|FG001|NOT COMPLETED|Overall Study||104||
59890212|NCT02519348|76012539|FG002|NOT COMPLETED|Overall Study||75||
59890213|NCT02519348|76012540|FG003|NOT COMPLETED|Overall Study||69||
59890214|NCT02519348|76012541|FG004|NOT COMPLETED|Overall Study||84||
59890215|NCT02519348|76012542|FG005|NOT COMPLETED|Overall Study||47||
59890216|NCT02519348|76012543|FG006|NOT COMPLETED|Overall Study||3||
59890217|NCT02519348|76012544|FG007|NOT COMPLETED|Overall Study||5||
59890218|NCT02519348|76012545|FG008|NOT COMPLETED|Overall Study||6||
59890219|NCT02485639|76012566|FG000|STARTED|Overall Study||27||
59890220|NCT02485639|76012566|FG000|COMPLETED|Overall Study||11||
59890221|NCT02485639|76012566|FG000|NOT COMPLETED|Overall Study||16||
59890222|NCT02418949|76012574|FG000|STARTED|Overall Study||23||
59890223|NCT02418949|76012575|FG001|STARTED|Overall Study||22||
59890224|NCT02418949|76012576|FG002|STARTED|Overall Study||26||
59890225|NCT02418949|76012577|FG003|STARTED|Overall Study||25||
59890226|NCT02418949|76012574|FG000|COMPLETED|Overall Study||20||
59890227|NCT02418949|76012575|FG001|COMPLETED|Overall Study||21||
59890228|NCT02418949|76012576|FG002|COMPLETED|Overall Study||23||
59890229|NCT02418949|76012577|FG003|COMPLETED|Overall Study||24||
59890230|NCT02418949|76012574|FG000|NOT COMPLETED|Overall Study||3||
59890231|NCT02418949|76012575|FG001|NOT COMPLETED|Overall Study||1||
59890232|NCT02418949|76012576|FG002|NOT COMPLETED|Overall Study||3||
59890233|NCT02418949|76012577|FG003|NOT COMPLETED|Overall Study||1||
59890234|NCT02383433|76012587|FG000|STARTED|Overall Study||2||
59890235|NCT02383433|76012587|FG000|COMPLETED|Overall Study||0||
59890236|NCT02383433|76012587|FG000|NOT COMPLETED|Overall Study||2||
59890237|NCT02373774|76012593|FG000|STARTED|Overall Study||40||
59890238|NCT02373774|76012594|FG001|STARTED|Overall Study||41||
59890239|NCT02373774|76012593|FG000|COMPLETED|Overall Study||40||
59890240|NCT02373774|76012594|FG001|COMPLETED|Overall Study||38||
59890241|NCT02373774|76012593|FG000|NOT COMPLETED|Overall Study||0||
59890242|NCT02373774|76012594|FG001|NOT COMPLETED|Overall Study||3||
59890243|NCT02336074|76012602|FG000|STARTED|Overall Study||30||
59890244|NCT02336074|76012603|FG001|STARTED|Overall Study||30||
59890245|NCT02336074|76012602|FG000|COMPLETED|Overall Study||30||
59890246|NCT02336074|76012603|FG001|COMPLETED|Overall Study||28||
59756718|NCT00950807|75875645|FG003|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|11||
59756719|NCT00950807|75875646|FG004|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|12||
59756720|NCT00950807|75875647|FG005|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|9||
59756721|NCT00950807|75875648|FG006|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|12||
59756722|NCT00950807|75875649|FG007|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|10||
59756723|NCT00950807|75875650|FG008|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|9||
59756724|NCT00950807|75875651|FG009|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|11||
59756725|NCT00950807|75875642|FG000|COMPLETED|Treatment Period 3||45||
59890247|NCT02336074|76012602|FG000|NOT COMPLETED|Overall Study||0||
59890248|NCT02336074|76012603|FG001|NOT COMPLETED|Overall Study||2||
59890249|NCT02313272|76012617|FG000|STARTED|Overall Study||3||
59890250|NCT02313272|76012618|FG001|STARTED|Overall Study||16||
59890251|NCT02313272|76012619|FG002|STARTED|Overall Study||13||
59890252|NCT02313272|76012617|FG000|COMPLETED|Overall Study||3||
59890253|NCT02313272|76012618|FG001|COMPLETED|Overall Study||16||
59890254|NCT02313272|76012619|FG002|COMPLETED|Overall Study||13||
59890255|NCT02313272|76012617|FG000|NOT COMPLETED|Overall Study||0||
59890256|NCT02313272|76012618|FG001|NOT COMPLETED|Overall Study||0||
59890257|NCT02313272|76012619|FG002|NOT COMPLETED|Overall Study||0||
59890258|NCT02255435|76012638|FG000|STARTED|Overall Study||6||
59890259|NCT02255435|76012639|FG001|STARTED|Overall Study||6||
59890260|NCT02255435|76012640|FG002|STARTED|Overall Study||6||
59890261|NCT02255435|76012641|FG003|STARTED|Overall Study||6||
59890262|NCT02255435|76012642|FG004|STARTED|Overall Study||6||
59890263|NCT02255435|76012643|FG005|STARTED|Overall Study||12||
59890264|NCT02255435|76012644|FG006|STARTED|Overall Study||10||
59890265|NCT02255435|76012645|FG007|STARTED|Overall Study||17||
59890266|NCT02255435|76012646|FG008|STARTED|Overall Study||52||
59890267|NCT02255435|76012647|FG009|STARTED|Overall Study||51||
59890268|NCT02255435|76012638|FG000|Number of Participants With Pes Cavus|Overall Study||2||
59890269|NCT02255435|76012639|FG001|Number of Participants With Pes Cavus|Overall Study||2||
59890270|NCT02255435|76012640|FG002|Number of Participants With Pes Cavus|Overall Study||3||
59890271|NCT02255435|76012641|FG003|Number of Participants With Pes Cavus|Overall Study||2||
59890272|NCT02255435|76012642|FG004|Number of Participants With Pes Cavus|Overall Study||2||
59890273|NCT02255435|76012643|FG005|Number of Participants With Pes Cavus|Overall Study||8||
59890274|NCT02255435|76012644|FG006|Number of Participants With Pes Cavus|Overall Study||3||
59890275|NCT02255435|76012645|FG007|Number of Participants With Pes Cavus|Overall Study||10||
59890276|NCT02255435|76012646|FG008|Number of Participants With Pes Cavus|Overall Study||10||
59890277|NCT02255435|76012647|FG009|Number of Participants With Pes Cavus|Overall Study||10||
59890278|NCT02255435|76012638|FG000|COMPLETED|Overall Study||6||
59890279|NCT02255435|76012639|FG001|COMPLETED|Overall Study||6||
59890280|NCT02255435|76012640|FG002|COMPLETED|Overall Study||6||
59890281|NCT02255435|76012641|FG003|COMPLETED|Overall Study||6||
59890282|NCT02255435|76012642|FG004|COMPLETED|Overall Study||6||
59890283|NCT02255435|76012643|FG005|COMPLETED|Overall Study||12||
59890284|NCT02255435|76012644|FG006|COMPLETED|Overall Study||10||
59890285|NCT02255435|76012645|FG007|COMPLETED|Overall Study||16||
59890286|NCT02255435|76012646|FG008|COMPLETED|Overall Study||51||
59890287|NCT02255435|76012647|FG009|COMPLETED|Overall Study||45||
59890288|NCT02255435|76012638|FG000|NOT COMPLETED|Overall Study||0||
59890289|NCT02255435|76012639|FG001|NOT COMPLETED|Overall Study||0||
59890290|NCT02255435|76012640|FG002|NOT COMPLETED|Overall Study||0||
59890291|NCT02255435|76012641|FG003|NOT COMPLETED|Overall Study||0||
59890292|NCT02255435|76012642|FG004|NOT COMPLETED|Overall Study||0||
59890293|NCT02255435|76012643|FG005|NOT COMPLETED|Overall Study||0||
59890294|NCT02255435|76012644|FG006|NOT COMPLETED|Overall Study||0||
59890295|NCT02255435|76012645|FG007|NOT COMPLETED|Overall Study||1||
59890296|NCT02255435|76012646|FG008|NOT COMPLETED|Overall Study||1||
59890297|NCT02255435|76012647|FG009|NOT COMPLETED|Overall Study||6||
59890298|NCT02229825|76012671|FG000|STARTED|Overall Study||167||
59890299|NCT02229825|76012672|FG001|STARTED|Overall Study||172||
59890300|NCT02229825|76012671|FG000|Treated|Overall Study||167||
59890301|NCT02229825|76012672|FG001|Treated|Overall Study||171||
59890302|NCT02229825|76012671|FG000|COMPLETED|Overall Study||143||
59890303|NCT02229825|76012672|FG001|COMPLETED|Overall Study||142||
59890304|NCT02229825|76012671|FG000|NOT COMPLETED|Overall Study||24||
59890305|NCT02229825|76012672|FG001|NOT COMPLETED|Overall Study||30||
59890306|NCT02112916|76012693|FG000|STARTED|Overall Study||312||
59890307|NCT02112916|76012694|FG001|STARTED|Overall Study||315||
59890308|NCT02112916|76012695|FG002|STARTED|Overall Study||111||
59890309|NCT02112916|76012696|FG003|STARTED|Overall Study||109||
59890310|NCT02112916|76012693|FG000|COMPLETED|Overall Study||108||
59890311|NCT02112916|76012694|FG001|COMPLETED|Overall Study||123||
59890312|NCT02112916|76012695|FG002|COMPLETED|Overall Study||52||
59890313|NCT02112916|76012696|FG003|COMPLETED|Overall Study||62||
59890314|NCT02112916|76012693|FG000|NOT COMPLETED|Overall Study||204||
59890315|NCT02112916|76012694|FG001|NOT COMPLETED|Overall Study||192||
59890316|NCT02112916|76012695|FG002|NOT COMPLETED|Overall Study||59||
59890317|NCT02112916|76012696|FG003|NOT COMPLETED|Overall Study||47||
59890318|NCT02057718|76012713|FG000|STARTED|Completed Study Treatment Through Wk. 72||8||
59890319|NCT02057718|76012714|FG001|STARTED|Completed Study Treatment Through Wk. 72||25||
59890320|NCT02057718|76012713|FG000|Completed Study Treatment Through Week 72|Completed Study Treatment Through Wk. 72||6||
59890321|NCT02057718|76012714|FG001|Completed Study Treatment Through Week 72|Completed Study Treatment Through Wk. 72||16||
59890322|NCT02057718|76012713|FG000|COMPLETED|Completed Study Treatment Through Wk. 72||6||
59890323|NCT02057718|76012714|FG001|COMPLETED|Completed Study Treatment Through Wk. 72||16||
59890324|NCT02057718|76012713|FG000|NOT COMPLETED|Completed Study Treatment Through Wk. 72||2||
59890325|NCT02057718|76012714|FG001|NOT COMPLETED|Completed Study Treatment Through Wk. 72||9||
59890326|NCT02057718|76012713|FG000|STARTED|Optional Follow-up Treatment Period||6||
59890327|NCT02057718|76012714|FG001|STARTED|Optional Follow-up Treatment Period||16||
59890328|NCT02057718|76012713|FG000|COMPLETED|Optional Follow-up Treatment Period||4||
59890329|NCT02057718|76012714|FG001|COMPLETED|Optional Follow-up Treatment Period||8||
59890330|NCT02057718|76012713|FG000|NOT COMPLETED|Optional Follow-up Treatment Period||2||
59890331|NCT02057718|76012714|FG001|NOT COMPLETED|Optional Follow-up Treatment Period||8||
59890332|NCT01981551|76012720|FG000|STARTED|Overall Study||17||
59890333|NCT01981551|76012720|FG000|COMPLETED|Overall Study||8||
59890334|NCT01981551|76012720|FG000|NOT COMPLETED|Overall Study||9||
59890335|NCT01750281|76012727|FG000|STARTED|Overall Study||43||
59890336|NCT01750281|76012728|FG001|STARTED|Overall Study||85||
59890337|NCT01750281|76012729|FG002|STARTED|Overall Study||84||
59890338|NCT01750281|76012727|FG000|Received Treatment|Overall Study||43||
59890339|NCT01750281|76012728|FG001|Received Treatment|Overall Study||84||
59890340|NCT01750281|76012729|FG002|Received Treatment|Overall Study||84||
59890341|NCT01750281|76012727|FG000|Did Not Receive Treatment|Overall Study||0||
59890342|NCT01750281|76012728|FG001|Did Not Receive Treatment|Overall Study||1||
59890343|NCT01750281|76012729|FG002|Did Not Receive Treatment|Overall Study||0||
59890344|NCT01750281|76012727|FG000|COMPLETED|Overall Study||0||
59890345|NCT01750281|76012728|FG001|COMPLETED|Overall Study||0||
59890346|NCT01750281|76012729|FG002|COMPLETED|Overall Study||0||
59890347|NCT01750281|76012727|FG000|NOT COMPLETED|Overall Study||43||
59890348|NCT01750281|76012728|FG001|NOT COMPLETED|Overall Study||85||
59890349|NCT01750281|76012729|FG002|NOT COMPLETED|Overall Study||84||
59890350|NCT01205061|76012739|FG000|STARTED|Overall Study||162||
59890351|NCT01205061|76012739|FG000|Emervel Deep Lidocaine in Left NLF Followed by Juvederm Ultra in Right NLF|Overall Study||80||
59890352|NCT01205061|76012739|FG000|Juvederm Ultra in Left NLF Followed by Emervel Deep Lidocaine in Right NLF|Overall Study||82||
59890353|NCT01205061|76012739|FG000|COMPLETED|Overall Study||136||
59890354|NCT01205061|76012739|FG000|NOT COMPLETED|Overall Study||26||
59890355|NCT01108237|76012747|FG000|STARTED|Overall Study|78 subjects were consented with intent to treat, however, 73 had surgery.|73||
59890356|NCT01108237|76012748|FG001|STARTED|Overall Study||101||
59890357|NCT01108237|76012747|FG000|COMPLETED|Overall Study|66 subjects underwent surgery per the protocol, however, only 64 met the primary end point.|64||
59890358|NCT01108237|76012748|FG001|COMPLETED|Overall Study||86||
59890359|NCT01108237|76012747|FG000|NOT COMPLETED|Overall Study||9||
59890360|NCT01108237|76012748|FG001|NOT COMPLETED|Overall Study||15||
59890361|NCT00888459|76012770|FG000|STARTED|Overall Study||30||
59890362|NCT00888459|76012771|FG001|STARTED|Overall Study||30||
59890363|NCT00888459|76012770|FG000|COMPLETED|Overall Study||30||
59890364|NCT00888459|76012771|FG001|COMPLETED|Overall Study||30||
59890365|NCT00888459|76012770|FG000|NOT COMPLETED|Overall Study||0||
59890366|NCT00888459|76012771|FG001|NOT COMPLETED|Overall Study||0||
59890367|NCT00736450|76012777|FG000|STARTED|Overall Study||37||
59890368|NCT00736450|76012777|FG000|COMPLETED|Overall Study||12||
59890369|NCT00736450|76012777|FG000|NOT COMPLETED|Overall Study||25||
59890370|NCT00611351|76012781|FG000|STARTED|Overall Study||5||
59890371|NCT00611351|76012781|FG000|COMPLETED|Overall Study||3||
59890372|NCT00611351|76012781|FG000|NOT COMPLETED|Overall Study||2||
59890373|NCT00572936|76012785|FG000|STARTED|First Intervention||4||
59890374|NCT00572936|76012786|FG001|STARTED|First Intervention||4||
59890375|NCT00572936|76012787|FG002|STARTED|First Intervention||5||
59890376|NCT00572936|76012788|FG003|STARTED|First Intervention||5||
59890377|NCT00572936|76012789|FG004|STARTED|First Intervention||5||
59890378|NCT00572936|76012790|FG005|STARTED|First Intervention||5||
59890379|NCT00572936|76012785|FG000|COMPLETED|First Intervention||4||
59890380|NCT00572936|76012786|FG001|COMPLETED|First Intervention||4||
59890381|NCT00572936|76012787|FG002|COMPLETED|First Intervention||5||
59890382|NCT00572936|76012788|FG003|COMPLETED|First Intervention||5||
59890383|NCT00572936|76012789|FG004|COMPLETED|First Intervention||5||
59890384|NCT00572936|76012790|FG005|COMPLETED|First Intervention||5||
59890385|NCT00572936|76012785|FG000|NOT COMPLETED|First Intervention||0||
59890386|NCT00572936|76012786|FG001|NOT COMPLETED|First Intervention||0||
59890387|NCT00572936|76012787|FG002|NOT COMPLETED|First Intervention||0||
59890388|NCT00572936|76012788|FG003|NOT COMPLETED|First Intervention||0||
59890389|NCT00572936|76012789|FG004|NOT COMPLETED|First Intervention||0||
59890390|NCT00572936|76012790|FG005|NOT COMPLETED|First Intervention||0||
59890391|NCT00572936|76012785|FG000|STARTED|Second Intervention||4||
59890392|NCT00572936|76012786|FG001|STARTED|Second Intervention|1 participant dropped out between the first and second intervention due to car accident|3||
59890393|NCT00572936|76012787|FG002|STARTED|Second Intervention|1 participant dropped out between first intervention and second intervention due to increased IOP|4||
59890394|NCT00572936|76012788|FG003|STARTED|Second Intervention||5||
59890395|NCT00572936|76012789|FG004|STARTED|Second Intervention|1 participant dropped out between first intervention and second intervention due to increased IOP|4||
59890396|NCT00572936|76012790|FG005|STARTED|Second Intervention||5||
59890397|NCT00572936|76012785|FG000|COMPLETED|Second Intervention||4||
59890398|NCT00572936|76012786|FG001|COMPLETED|Second Intervention||3||
59890399|NCT00572936|76012787|FG002|COMPLETED|Second Intervention||4||
59890400|NCT00572936|76012788|FG003|COMPLETED|Second Intervention||5||
59890401|NCT00572936|76012789|FG004|COMPLETED|Second Intervention||4||
59890402|NCT00572936|76012790|FG005|COMPLETED|Second Intervention||5||
59890403|NCT00572936|76012785|FG000|NOT COMPLETED|Second Intervention||0||
59890404|NCT00572936|76012786|FG001|NOT COMPLETED|Second Intervention||0||
59890405|NCT00572936|76012787|FG002|NOT COMPLETED|Second Intervention||0||
59890406|NCT00572936|76012788|FG003|NOT COMPLETED|Second Intervention||0||
59890407|NCT00572936|76012789|FG004|NOT COMPLETED|Second Intervention||0||
59890408|NCT00572936|76012790|FG005|NOT COMPLETED|Second Intervention||0||
59890409|NCT00572936|76012785|FG000|STARTED|Third Intervention||4||
59890410|NCT00572936|76012786|FG001|STARTED|Third Intervention||3||
59890411|NCT00572936|76012787|FG002|STARTED|Third Intervention||4||
59890412|NCT00572936|76012788|FG003|STARTED|Third Intervention||5||
59890413|NCT00572936|76012789|FG004|STARTED|Third Intervention|1 participant dropped out between second intervention and third intervention due to increased IOP|3||
59890414|NCT00572936|76012790|FG005|STARTED|Third Intervention||5||
59890415|NCT00572936|76012785|FG000|COMPLETED|Third Intervention||4||
59890416|NCT00572936|76012786|FG001|COMPLETED|Third Intervention||3||
59890417|NCT00572936|76012787|FG002|COMPLETED|Third Intervention||4||
59890418|NCT00572936|76012788|FG003|COMPLETED|Third Intervention||5||
59890419|NCT00572936|76012789|FG004|COMPLETED|Third Intervention||3||
59890420|NCT00572936|76012790|FG005|COMPLETED|Third Intervention||5||
59890421|NCT00572936|76012785|FG000|NOT COMPLETED|Third Intervention||0||
59890422|NCT00572936|76012786|FG001|NOT COMPLETED|Third Intervention||0||
59890423|NCT00572936|76012787|FG002|NOT COMPLETED|Third Intervention||0||
59890424|NCT00572936|76012788|FG003|NOT COMPLETED|Third Intervention||0||
59890425|NCT00572936|76012789|FG004|NOT COMPLETED|Third Intervention||0||
59890426|NCT00572936|76012790|FG005|NOT COMPLETED|Third Intervention||0||
59890427|NCT00571662|76012798|FG000|STARTED|Overall Study||76||
59890428|NCT00571662|76012798|FG000|COMPLETED|Overall Study||68||
59890429|NCT00571662|76012798|FG000|NOT COMPLETED|Overall Study||8||
59890430|NCT00310765|76012806|FG000|STARTED|Placebo Controlled Double Blind||11||
59890431|NCT00310765|76012807|FG001|STARTED|Placebo Controlled Double Blind||7||
59890432|NCT00310765|76012806|FG000|COMPLETED|Placebo Controlled Double Blind||8||
59890433|NCT00310765|76012807|FG001|COMPLETED|Placebo Controlled Double Blind||5||
59890434|NCT00310765|76012806|FG000|NOT COMPLETED|Placebo Controlled Double Blind||3||
59890435|NCT00310765|76012807|FG001|NOT COMPLETED|Placebo Controlled Double Blind||2||
59890436|NCT00310765|76012806|FG000|STARTED|Open Label||8||
60013719|NCT02472795|76129671|FG000|Modified Pharmacodynamic Analysis Set|Overall Study||12||
60013720|NCT02472795|76129672|FG001|Modified Pharmacodynamic Analysis Set|Overall Study||10||
59610457|NCT01798134|75721290|FG000|NOT COMPLETED|Overall Study||16||
59756726|NCT00950807|75875643|FG001|COMPLETED|Treatment Period 3||9||
59756727|NCT00950807|75875644|FG002|COMPLETED|Treatment Period 3||10||
59756728|NCT00950807|75875645|FG003|COMPLETED|Treatment Period 3||11||
59756729|NCT00950807|75875646|FG004|COMPLETED|Treatment Period 3||12||
59756730|NCT00950807|75875647|FG005|COMPLETED|Treatment Period 3||9||
59756731|NCT00950807|75875648|FG006|COMPLETED|Treatment Period 3||11||
59756732|NCT00950807|75875649|FG007|COMPLETED|Treatment Period 3||9||
59756733|NCT00950807|75875650|FG008|COMPLETED|Treatment Period 3||9||
59756734|NCT00950807|75875651|FG009|COMPLETED|Treatment Period 3||10||
59756735|NCT00950807|75875642|FG000|NOT COMPLETED|Treatment Period 3||1||
59890437|NCT00310765|76012807|FG001|STARTED|Open Label||5||
59890438|NCT00310765|76012806|FG000|COMPLETED|Open Label||7||
59890439|NCT00310765|76012807|FG001|COMPLETED|Open Label||3||
59890440|NCT00310765|76012806|FG000|NOT COMPLETED|Open Label||1||
59890441|NCT00310765|76012807|FG001|NOT COMPLETED|Open Label||2||
59890442|NCT05038904|76012817|FG000|STARTED|Overall Study||10||
59890443|NCT05038904|76012817|FG000|COMPLETED|Overall Study||10||
59890444|NCT05038904|76012817|FG000|NOT COMPLETED|Overall Study||0||
59890445|NCT04500769|76012821|FG000|STARTED|Overall Study||38||
59890446|NCT04500769|76012821|FG000|COMPLETED|Overall Study||33||
59890447|NCT04500769|76012821|FG000|NOT COMPLETED|Overall Study||5||
59890448|NCT04446377|76012827|FG000|STARTED|Overall Study||71||
59890449|NCT04446377|76012828|FG001|STARTED|Overall Study||71||
59890450|NCT04446377|76012827|FG000|COMPLETED|Overall Study||64||
59890451|NCT04446377|76012828|FG001|COMPLETED|Overall Study||66||
59890452|NCT04446377|76012827|FG000|NOT COMPLETED|Overall Study||7||
59890453|NCT04446377|76012828|FG001|NOT COMPLETED|Overall Study||5||
59890454|NCT04398368|76012838|FG000|STARTED|Overall Study||25||
59890455|NCT04398368|76012838|FG000|COMPLETED|Overall Study||23||
59890456|NCT04398368|76012838|FG000|NOT COMPLETED|Overall Study||2||
59890457|NCT04275297|76012844|FG000|STARTED|Overall Study||52||
59890458|NCT04275297|76012845|FG001|STARTED|Overall Study||26||
59890459|NCT04275297|76012844|FG000|Completed Optional In-person Assessment Including Quantitative Sensory Testing|Overall Study||29||
59890460|NCT04275297|76012845|FG001|Completed Optional In-person Assessment Including Quantitative Sensory Testing|Overall Study||11||
59890461|NCT04275297|76012844|FG000|COMPLETED|Overall Study||51||
59890462|NCT04275297|76012845|FG001|COMPLETED|Overall Study||25||
59610458|NCT01798056|75721296|FG000|STARTED|Overall Study||117||
59610459|NCT01798056|75721297|FG001|STARTED|Overall Study||115||
59610460|NCT01798056|75721296|FG000|COMPLETED|Overall Study||90||
59610461|NCT01798056|75721297|FG001|COMPLETED|Overall Study||90||
59610462|NCT01798056|75721296|FG000|NOT COMPLETED|Overall Study||27||
59610463|NCT01798056|75721297|FG001|NOT COMPLETED|Overall Study||25||
59610464|NCT01824342|75721307|FG000|STARTED|Overall Study||11||
59610465|NCT01824342|75721308|FG001|STARTED|Overall Study||7||
59610466|NCT01824342|75721307|FG000|COMPLETED|Overall Study||2||
59610467|NCT01824342|75721308|FG001|COMPLETED|Overall Study||2||
59610468|NCT01824342|75721307|FG000|NOT COMPLETED|Overall Study||9||
59610469|NCT01824342|75721308|FG001|NOT COMPLETED|Overall Study||5||
59890463|NCT04275297|76012844|FG000|NOT COMPLETED|Overall Study||1||
59890464|NCT04275297|76012845|FG001|NOT COMPLETED|Overall Study||1||
59890465|NCT04247282|76012855|FG000|STARTED|Overall Study||14||
59890466|NCT04247282|76012856|FG001|STARTED|Overall Study||6||
59890467|NCT04247282|76012857|FG002|STARTED|Overall Study||0||
59890468|NCT04247282|76012858|FG003|STARTED|Overall Study||1||
59890469|NCT04247282|76012855|FG000|COMPLETED|Overall Study||14||
59890470|NCT04247282|76012856|FG001|COMPLETED|Overall Study||5||
59890471|NCT04247282|76012857|FG002|COMPLETED|Overall Study||0||
59890472|NCT04247282|76012858|FG003|COMPLETED|Overall Study||0||
59890473|NCT04247282|76012855|FG000|NOT COMPLETED|Overall Study||0||
59890474|NCT04247282|76012856|FG001|NOT COMPLETED|Overall Study||1||
59890475|NCT04247282|76012857|FG002|NOT COMPLETED|Overall Study||0||
59890476|NCT04247282|76012858|FG003|NOT COMPLETED|Overall Study||1||
59890477|NCT04224688|76012869|FG000|STARTED|Overall Study||10||
59890478|NCT04224688|76012870|FG001|STARTED|Overall Study||20||
59890479|NCT04224688|76012869|FG000|COMPLETED|Overall Study||8||
59890480|NCT04224688|76012870|FG001|COMPLETED|Overall Study||13||
59890481|NCT04224688|76012869|FG000|NOT COMPLETED|Overall Study||2||
59890482|NCT04224688|76012870|FG001|NOT COMPLETED|Overall Study||7||
59890483|NCT04200456|76012878|FG000|STARTED|Overall Study||12||
59890484|NCT04200456|76012879|FG001|STARTED|Overall Study||21||
59890485|NCT04200456|76012878|FG000|COMPLETED|Overall Study||9||
59890486|NCT04200456|76012879|FG001|COMPLETED|Overall Study||15||
59890487|NCT04200456|76012878|FG000|NOT COMPLETED|Overall Study||3||
59890488|NCT04200456|76012879|FG001|NOT COMPLETED|Overall Study||6||
59890489|NCT03766685|76012889|FG000|STARTED|Overall Study||66||
59890490|NCT03766685|76012890|FG001|STARTED|Overall Study||68||
59890491|NCT03766685|76012891|FG002|STARTED|Overall Study||19||
59890492|NCT03766685|76012892|FG003|STARTED|Overall Study||19||
59890493|NCT03766685|76012889|FG000|COMPLETED|Overall Study||65||
59890494|NCT03766685|76012890|FG001|COMPLETED|Overall Study||61||
59890495|NCT03766685|76012891|FG002|COMPLETED|Overall Study||19||
59890496|NCT03766685|76012892|FG003|COMPLETED|Overall Study||18||
59890497|NCT03766685|76012889|FG000|NOT COMPLETED|Overall Study||1||
59890498|NCT03766685|76012890|FG001|NOT COMPLETED|Overall Study||7||
59890499|NCT03766685|76012891|FG002|NOT COMPLETED|Overall Study||0||
59890500|NCT03766685|76012892|FG003|NOT COMPLETED|Overall Study||1||
59890501|NCT03654274|76012906|FG000|STARTED|Overall Study||278||
59890502|NCT03654274|76012907|FG001|STARTED|Overall Study||247||
59890503|NCT03654274|76012908|FG002|STARTED|Overall Study||277||
59890504|NCT03654274|76012906|FG000|Received at Least 1 Dose of Study Drug|Overall Study||277||
59890505|NCT03654274|76012907|FG001|Received at Least 1 Dose of Study Drug|Overall Study||247||
59890506|NCT03654274|76012908|FG002|Received at Least 1 Dose of Study Drug|Overall Study||275||
60013721|NCT02472795|76129673|FG002|Modified Pharmacodynamic Analysis Set|Overall Study||13||
60013722|NCT02472795|76129674|FG003|Modified Pharmacodynamic Analysis Set|Overall Study||9||
60013723|NCT02472795|76129675|FG004|Modified Pharmacodynamic Analysis Set|Overall Study||16||
60013724|NCT02472795|76129671|FG000|COMPLETED|Overall Study||12||
60013725|NCT02472795|76129672|FG001|COMPLETED|Overall Study||11||
59890507|NCT03654274|76012906|FG000|COMPLETED|Overall Study||172||
59890508|NCT03654274|76012907|FG001|COMPLETED|Overall Study||155||
59890509|NCT03654274|76012908|FG002|COMPLETED|Overall Study||174||
59890510|NCT03654274|76012906|FG000|NOT COMPLETED|Overall Study||106||
59890511|NCT03654274|76012907|FG001|NOT COMPLETED|Overall Study||92||
59890512|NCT03654274|76012908|FG002|NOT COMPLETED|Overall Study||103||
59890513|NCT03533686|76012926|FG000|STARTED|Overall Study||9||
59890514|NCT03533686|76012927|FG001|STARTED|Overall Study||3||
59890515|NCT03533686|76012928|FG002|STARTED|Overall Study||18||
59890516|NCT03533686|76012929|FG003|STARTED|Overall Study|One child did not sign consent.|15||
59890517|NCT03533686|76012930|FG004|STARTED|Overall Study|Two parents consented for one child.|17||
59890518|NCT03533686|76012931|FG005|STARTED|Overall Study||4||
59890519|NCT03533686|76012926|FG000|Received Intervention|Overall Study|Withdrew consent prior to receiving intervention.|8||
59890520|NCT03533686|76012927|FG001|Received Intervention|Overall Study||3||
59890521|NCT03533686|76012928|FG002|Received Intervention|Overall Study||18||
59890522|NCT03533686|76012929|FG003|Received Intervention|Overall Study|One parent child dyad screen failed. One parent consented while child did not consent, therefore, dyad screen failed.|12||
59890523|NCT03533686|76012930|FG004|Received Intervention|Overall Study|One of two parents of a single child participant withdrew consent. And one parent child dyad withdrew consent prior to receiving intervention.|14||
59890524|NCT03533686|76012931|FG005|Received Intervention|Overall Study||4||
59890525|NCT03533686|76012926|FG000|COMPLETED|Overall Study||8||
59890526|NCT03533686|76012927|FG001|COMPLETED|Overall Study||2||
59890527|NCT03533686|76012928|FG002|COMPLETED|Overall Study||18||
60013726|NCT02472795|76129673|FG002|COMPLETED|Overall Study||13||
60013727|NCT02472795|76129674|FG003|COMPLETED|Overall Study||13||
59890528|NCT03533686|76012929|FG003|COMPLETED|Overall Study||10||
59890529|NCT03533686|76012930|FG004|COMPLETED|Overall Study||10||
59890530|NCT03533686|76012931|FG005|COMPLETED|Overall Study||3||
59890531|NCT03533686|76012926|FG000|NOT COMPLETED|Overall Study||1||
59890532|NCT03533686|76012927|FG001|NOT COMPLETED|Overall Study||1||
59890533|NCT03533686|76012928|FG002|NOT COMPLETED|Overall Study||0||
59890534|NCT03533686|76012929|FG003|NOT COMPLETED|Overall Study||5||
59890535|NCT03533686|76012930|FG004|NOT COMPLETED|Overall Study||7||
59890536|NCT03533686|76012931|FG005|NOT COMPLETED|Overall Study||1||
59890537|NCT03363581|76012964|FG000|STARTED|Overall Study||14||
59890538|NCT03363581|76012965|FG001|STARTED|Overall Study||20||
59890539|NCT03363581|76012964|FG000|COMPLETED|Overall Study||14||
59890540|NCT03363581|76012965|FG001|COMPLETED|Overall Study||20||
59890541|NCT03363581|76012964|FG000|NOT COMPLETED|Overall Study||0||
59890542|NCT03363581|76012965|FG001|NOT COMPLETED|Overall Study||0||
59890543|NCT03330457|76012976|FG000|STARTED|Overall Study||6||
59890544|NCT03330457|76012977|FG001|STARTED|Overall Study||3||
59890545|NCT03330457|76012978|FG002|STARTED|Overall Study||6||
59890546|NCT03330457|76012979|FG003|STARTED|Overall Study||3||
59890547|NCT03330457|76012976|FG000|COMPLETED|Overall Study||6||
59890548|NCT03330457|76012977|FG001|COMPLETED|Overall Study||3||
59890549|NCT03330457|76012978|FG002|COMPLETED|Overall Study||6||
59890550|NCT03330457|76012979|FG003|COMPLETED|Overall Study||3||
59890551|NCT03330457|76012976|FG000|NOT COMPLETED|Overall Study||0||
59890552|NCT03330457|76012977|FG001|NOT COMPLETED|Overall Study||0||
59890553|NCT03330457|76012978|FG002|NOT COMPLETED|Overall Study||0||
59890554|NCT03330457|76012979|FG003|NOT COMPLETED|Overall Study||0||
59890555|NCT03154359|76012989|FG000|STARTED|Overall Study||42||
59890556|NCT03154359|76012989|FG000|6 Weeks|Overall Study||29||
59890557|NCT03154359|76012989|FG000|18 Weeks|Overall Study||20||
59890558|NCT03154359|76012989|FG000|COMPLETED|Overall Study||20||
59890559|NCT03154359|76012989|FG000|NOT COMPLETED|Overall Study||22||
59890560|NCT03148379|76012997|FG000|STARTED|Overall Study||21||
59890561|NCT03148379|76012998|FG001|STARTED|Overall Study||11||
59890562|NCT03148379|76012997|FG000|COMPLETED|Overall Study||20||
59890563|NCT03148379|76012998|FG001|COMPLETED|Overall Study||11||
59890564|NCT03148379|76012997|FG000|NOT COMPLETED|Overall Study||1||
59890565|NCT03148379|76012998|FG001|NOT COMPLETED|Overall Study||0||
59890566|NCT03135834|76013008|FG000|STARTED|Stage 1||272||
59890567|NCT03135834|76013009|FG001|STARTED|Stage 1||537||
59890568|NCT03135834|76013010|FG002|STARTED|Stage 1||272||
59890569|NCT03135834|76013011|FG003|STARTED|Stage 1||529||
59890570|NCT03135834|76013008|FG000|Vaccination 1 at Month 0|Stage 1||272||
59890571|NCT03135834|76013009|FG001|Vaccination 1 at Month 0|Stage 1||534||
59890572|NCT03135834|76013010|FG002|Vaccination 1 at Month 0|Stage 1||271||
59890573|NCT03135834|76013011|FG003|Vaccination 1 at Month 0|Stage 1||523||
59890574|NCT03135834|76013008|FG000|Vaccination 2 at Month 6|Stage 1||242||
59890575|NCT03135834|76013009|FG001|Vaccination 2 at Month 6|Stage 1||469||
59890576|NCT03135834|76013010|FG002|Vaccination 2 at Month 6|Stage 1||244||
59890577|NCT03135834|76013011|FG003|Vaccination 2 at Month 6|Stage 1||477||
59890578|NCT03135834|76013008|FG000|COMPLETED|Stage 1|Completed Vaccination|233||
59890579|NCT03135834|76013009|FG001|COMPLETED|Stage 1|Completed Vaccination|462||
59890580|NCT03135834|76013010|FG002|COMPLETED|Stage 1|Completed Vaccination|232||
59890581|NCT03135834|76013011|FG003|COMPLETED|Stage 1|Completed Vaccination|463||
59890582|NCT03135834|76013008|FG000|NOT COMPLETED|Stage 1||39||
59890583|NCT03135834|76013009|FG001|NOT COMPLETED|Stage 1||75||
59890584|NCT03135834|76013010|FG002|NOT COMPLETED|Stage 1||40||
59890585|NCT03135834|76013011|FG003|NOT COMPLETED|Stage 1||66||
59890586|NCT03135834|76013008|FG000|STARTED|Stage 2|Eligible participants entered Stage 2.|114||
59890587|NCT03135834|76013009|FG001|STARTED|Stage 2|Eligible participants entered Stage 2.|65||
59890588|NCT03135834|76013010|FG002|STARTED|Stage 2|Eligible participants entered Stage 2.|101||
59890589|NCT03135834|76013011|FG003|STARTED|Stage 2|Eligible participants entered Stage 2.|73||
59890590|NCT03135834|76013008|FG000|Antibody Persistence: Blood Draw Month18|Stage 2||114||
59890591|NCT03135834|76013009|FG001|Antibody Persistence: Blood Draw Month18|Stage 2||63||
59890592|NCT03135834|76013010|FG002|Antibody Persistence: Blood Draw Month18|Stage 2||53||
59890593|NCT03135834|76013011|FG003|Antibody Persistence: Blood Draw Month18|Stage 2||23||
59890594|NCT03135834|76013008|FG000|Antibody Persistence: Blood Draw Month 30|Stage 2||104||
59890595|NCT03135834|76013009|FG001|Antibody Persistence: Blood Draw Month 30|Stage 2||61||
59890596|NCT03135834|76013010|FG002|Antibody Persistence: Blood Draw Month 30|Stage 2||96||
59890597|NCT03135834|76013011|FG003|Antibody Persistence: Blood Draw Month 30|Stage 2||71||
59890598|NCT03135834|76013008|FG000|Antibody Persistence: Blood Draw Month 42|Stage 2||97||
59890599|NCT03135834|76013009|FG001|Antibody Persistence: Blood Draw Month 42|Stage 2||55||
59890600|NCT03135834|76013010|FG002|Antibody Persistence: Blood Draw Month 42|Stage 2||97||
59890601|NCT03135834|76013011|FG003|Antibody Persistence: Blood Draw Month 42|Stage 2||68||
59890602|NCT03135834|76013008|FG000|Received Booster Vaccination|Stage 2||67||
59890603|NCT03135834|76013009|FG001|Received Booster Vaccination|Stage 2||40||
59890604|NCT03135834|76013010|FG002|Received Booster Vaccination|Stage 2||77||
59890605|NCT03135834|76013011|FG003|Received Booster Vaccination|Stage 2|Two participants were not included in summary of demographics (safety population) for stage 2 since they were of mixed regimen (received MenABCWY at the booster vaccination instead of bivalent rLP2086 + MenACWY-CRM as randomized).|58||
59890606|NCT03135834|76013008|FG000|COMPLETED|Stage 2|Completed Stage 2|67|Completed Stage 2|
59890607|NCT03135834|76013009|FG001|COMPLETED|Stage 2|Completed Stage 2|38|Completed Stage 2|
59890608|NCT03135834|76013010|FG002|COMPLETED|Stage 2|Completed Stage 2|77|Completed Stage 2|
59890609|NCT03135834|76013011|FG003|COMPLETED|Stage 2|Completed Stage 2|58|Completed Stage 2|
59890610|NCT03135834|76013008|FG000|NOT COMPLETED|Stage 2||47||
59890611|NCT03135834|76013009|FG001|NOT COMPLETED|Stage 2||27||
59890612|NCT03135834|76013010|FG002|NOT COMPLETED|Stage 2||24||
59890613|NCT03135834|76013011|FG003|NOT COMPLETED|Stage 2||15||
59890614|NCT03130777|76013044|FG000|STARTED|Overall Study||61||
59890615|NCT03130777|76013045|FG001|STARTED|Overall Study||25||
59890616|NCT03130777|76013044|FG000|COMPLETED|Overall Study||60||
59890617|NCT03130777|76013045|FG001|COMPLETED|Overall Study||24||
59890618|NCT03130777|76013044|FG000|NOT COMPLETED|Overall Study||1||
59890619|NCT03130777|76013045|FG001|NOT COMPLETED|Overall Study||1||
59890620|NCT03010358|76013054|FG000|STARTED|Stage 1 - Dose Escalation||6||
59890621|NCT03010358|76013055|FG001|STARTED|Stage 1 - Dose Escalation||3||
59890622|NCT03010358|76013056|FG002|STARTED|Stage 1 - Dose Escalation||0||
59890623|NCT03010358|76013054|FG000|COMPLETED|Stage 1 - Dose Escalation||6||
59890624|NCT03010358|76013055|FG001|COMPLETED|Stage 1 - Dose Escalation||3||
59890625|NCT03010358|76013056|FG002|COMPLETED|Stage 1 - Dose Escalation||0||
59890626|NCT03010358|76013054|FG000|NOT COMPLETED|Stage 1 - Dose Escalation||0||
59890627|NCT03010358|76013055|FG001|NOT COMPLETED|Stage 1 - Dose Escalation||0||
59890628|NCT03010358|76013056|FG002|NOT COMPLETED|Stage 1 - Dose Escalation||0||
59890629|NCT03010358|76013054|FG000|STARTED|Stage 2 - Dose Expansion||0||
59890630|NCT03010358|76013055|FG001|STARTED|Stage 2 - Dose Expansion||0||
59890631|NCT03010358|76013056|FG002|STARTED|Stage 2 - Dose Expansion||15||
59890632|NCT03010358|76013054|FG000|COMPLETED|Stage 2 - Dose Expansion||0||
59890633|NCT03010358|76013055|FG001|COMPLETED|Stage 2 - Dose Expansion||0||
59890634|NCT03010358|76013056|FG002|COMPLETED|Stage 2 - Dose Expansion||14||
59890635|NCT03010358|76013054|FG000|NOT COMPLETED|Stage 2 - Dose Expansion||0||
59890636|NCT03010358|76013055|FG001|NOT COMPLETED|Stage 2 - Dose Expansion||0||
59890637|NCT03010358|76013056|FG002|NOT COMPLETED|Stage 2 - Dose Expansion||1||
59890638|NCT02657577|76013066|FG000|STARTED|Overall Study||201||
59890639|NCT02657577|76013067|FG001|STARTED|Overall Study||427||
59890640|NCT02657577|76013066|FG000|COMPLETED|Overall Study||164||
59890641|NCT02657577|76013067|FG001|COMPLETED|Overall Study||383||
59890642|NCT02657577|76013066|FG000|NOT COMPLETED|Overall Study||37||
59890643|NCT02657577|76013067|FG001|NOT COMPLETED|Overall Study||44||
59890644|NCT02621476|76013075|FG000|STARTED|Overall Study||31493||
59890645|NCT02621476|76013076|FG001|STARTED|Overall Study||31519||
59890646|NCT02621476|76013075|FG000|COMPLETED|Overall Study||26342||
59890647|NCT02621476|76013076|FG001|COMPLETED|Overall Study||26404||
59890648|NCT02621476|76013075|FG000|NOT COMPLETED|Overall Study||5151||
59890649|NCT02621476|76013076|FG001|NOT COMPLETED|Overall Study||5115||
59890650|NCT02207725|76013086|FG000|STARTED|Overall Study||9||
59890651|NCT02207725|76013087|FG001|STARTED|Overall Study||25||
59890652|NCT02207725|76013088|FG002|STARTED|Overall Study||9||
59890653|NCT02207725|76013089|FG003|STARTED|Overall Study||25||
59890654|NCT02207725|76013086|FG000|COMPLETED|Overall Study||9||
59890655|NCT02207725|76013087|FG001|COMPLETED|Overall Study||24||
59890656|NCT02207725|76013088|FG002|COMPLETED|Overall Study||8||
59890657|NCT02207725|76013089|FG003|COMPLETED|Overall Study||24||
59890658|NCT02207725|76013086|FG000|NOT COMPLETED|Overall Study||0||
59890659|NCT02207725|76013087|FG001|NOT COMPLETED|Overall Study||1||
59890660|NCT02207725|76013088|FG002|NOT COMPLETED|Overall Study||1||
59890661|NCT02207725|76013089|FG003|NOT COMPLETED|Overall Study||1||
59890662|NCT01872949|76013101|FG000|STARTED|Overall Study||15||
59890663|NCT01872949|76013101|FG000|COMPLETED|Overall Study||4||
59890664|NCT01872949|76013101|FG000|NOT COMPLETED|Overall Study||11||
59890665|NCT01782352|76013110|FG000|STARTED|Overall Study||6463||
59890666|NCT01782352|76013111|FG001|STARTED|Overall Study||6464||
59890667|NCT01782352|76013112|FG002|STARTED|Overall Study||6470||
59890668|NCT01782352|76013113|FG003|STARTED|Overall Study||6474||
59890669|NCT01782352|76013110|FG000|COMPLETED|Overall Study||6463||
59890670|NCT01782352|76013111|FG001|COMPLETED|Overall Study||6464||
59890671|NCT01782352|76013112|FG002|COMPLETED|Overall Study||6470||
59890672|NCT01782352|76013113|FG003|COMPLETED|Overall Study||6474||
59890673|NCT01782352|76013110|FG000|NOT COMPLETED|Overall Study||0||
59890674|NCT01782352|76013111|FG001|NOT COMPLETED|Overall Study||0||
59890675|NCT01782352|76013112|FG002|NOT COMPLETED|Overall Study||0||
59890676|NCT01782352|76013113|FG003|NOT COMPLETED|Overall Study||0||
59890677|NCT00968799|76013123|FG000|STARTED|Overall Study||6||
59890678|NCT00968799|76013123|FG000|COMPLETED|Overall Study||4||
59890679|NCT00968799|76013123|FG000|NOT COMPLETED|Overall Study||2||
59890680|NCT02883452|76013133|FG000|STARTED|Overall Study|This cohort is only for Part 1.|13||
59890681|NCT02883452|76013134|FG001|STARTED|Overall Study|This cohort is only for Part 1.|11||
59890682|NCT02883452|76013135|FG002|STARTED|Overall Study|This cohort is only for Part 1.|12||
59890683|NCT02883452|76013136|FG003|STARTED|Overall Study|This cohort is only for Part 1.|8||
59890684|NCT02883452|76013137|FG004|STARTED|Overall Study|This arm is for Part 2. All of the patients in Part 2 were screened only for Part 2.|66||
59890685|NCT02883452|76013138|FG005|STARTED|Overall Study|This arm is for Part 2. All of the patients in Part 2 were screened only for Part 2.|65||
59890686|NCT02883452|76013133|FG000|COMPLETED|Overall Study||8||
59890687|NCT02883452|76013134|FG001|COMPLETED|Overall Study||9||
59890688|NCT02883452|76013135|FG002|COMPLETED|Overall Study||7||
59890689|NCT02883452|76013136|FG003|COMPLETED|Overall Study||6||
59890690|NCT02883452|76013137|FG004|COMPLETED|Overall Study||55||
59890691|NCT02883452|76013138|FG005|COMPLETED|Overall Study||50||
59890692|NCT02883452|76013133|FG000|NOT COMPLETED|Overall Study||5||
59890693|NCT02883452|76013134|FG001|NOT COMPLETED|Overall Study||2||
59890694|NCT02883452|76013135|FG002|NOT COMPLETED|Overall Study||5||
59890695|NCT02883452|76013136|FG003|NOT COMPLETED|Overall Study||2||
59890696|NCT02883452|76013137|FG004|NOT COMPLETED|Overall Study||11||
59890697|NCT02883452|76013138|FG005|NOT COMPLETED|Overall Study||15||
59890698|NCT00151372|76013155|FG000|STARTED|Overall Study||67||
59890699|NCT00151372|76013156|FG001|STARTED|Overall Study||74||
59890700|NCT00151372|76013155|FG000|COMPLETED|Overall Study||38||
59890701|NCT00151372|76013156|FG001|COMPLETED|Overall Study||45||
59890702|NCT00151372|76013155|FG000|NOT COMPLETED|Overall Study||29||
59890703|NCT00151372|76013156|FG001|NOT COMPLETED|Overall Study||29||
59890704|NCT02603809|76013168|FG000|STARTED|Overall Study||82||
59890705|NCT02603809|76013169|FG001|STARTED|Overall Study||82||
59890706|NCT02603809|76013170|FG002|STARTED|Overall Study||82||
59890707|NCT02603809|76013171|FG003|STARTED|Overall Study||82||
59890708|NCT02603809|76013172|FG004|STARTED|Overall Study||81||
59890709|NCT02603809|76013173|FG005|STARTED|Overall Study||81||
59890710|NCT02603809|76013168|FG000|Per-protocol Set|Overall Study||67||
59890711|NCT02603809|76013169|FG001|Per-protocol Set|Overall Study||68||
59890712|NCT02603809|76013170|FG002|Per-protocol Set|Overall Study||71||
59890713|NCT02603809|76013171|FG003|Per-protocol Set|Overall Study||67||
59890714|NCT02603809|76013172|FG004|Per-protocol Set|Overall Study||68||
59890715|NCT02603809|76013173|FG005|Per-protocol Set|Overall Study||69||
59890716|NCT02603809|76013168|FG000|Modified Per-Protocol Set|Overall Study|One participant had out of analysis window blood pressure measurements.|66||
59890717|NCT02603809|76013169|FG001|Modified Per-Protocol Set|Overall Study||68||
59890718|NCT02603809|76013170|FG002|Modified Per-Protocol Set|Overall Study||71||
59890719|NCT02603809|76013171|FG003|Modified Per-Protocol Set|Overall Study||67||
59890720|NCT02603809|76013172|FG004|Modified Per-Protocol Set|Overall Study||68||
59890721|NCT02603809|76013173|FG005|Modified Per-Protocol Set|Overall Study||69||
59890722|NCT02603809|76013168|FG000|Completed Study|Overall Study||75|Participants that completed the 30-day follow-up telephone call / visit (i.e., End-of-Study).|
59890723|NCT02603809|76013169|FG001|Completed Study|Overall Study||79|Participants that completed the 30-day follow-up telephone call / visit (i.e., End-of-Study).|
59890724|NCT02603809|76013170|FG002|Completed Study|Overall Study||79|Participants that completed the 30-day follow-up telephone call / visit (i.e., End-of-Study).|
59890725|NCT02603809|76013171|FG003|Completed Study|Overall Study||76|Participants that completed the 30-day follow-up telephone call / visit (i.e., End-of-Study).|
59890726|NCT02603809|76013172|FG004|Completed Study|Overall Study||78|Participants that completed the 30-day follow-up telephone call / visit (i.e., End-of-Study).|
59890727|NCT02603809|76013173|FG005|Completed Study|Overall Study||75|Participants that completed the 30-day follow-up telephone call / visit (i.e., End-of-Study).|
59890728|NCT02603809|76013168|FG000|COMPLETED|Overall Study||70|Participants that completed the 8-week treatment period.|
59890729|NCT02603809|76013169|FG001|COMPLETED|Overall Study||74|Participants that completed the 8-week treatment period.|
59890730|NCT02603809|76013170|FG002|COMPLETED|Overall Study||75|Participants that completed the 8-week treatment period.|
59890731|NCT02603809|76013171|FG003|COMPLETED|Overall Study||70|Participants that completed the 8-week treatment period.|
59890732|NCT02603809|76013172|FG004|COMPLETED|Overall Study||70|Participants that completed the 8-week treatment period.|
59890733|NCT02603809|76013173|FG005|COMPLETED|Overall Study||71|Participants that completed the 8-week treatment period.|
59890734|NCT02603809|76013168|FG000|NOT COMPLETED|Overall Study||12||
59890735|NCT02603809|76013169|FG001|NOT COMPLETED|Overall Study||8||
59890736|NCT02603809|76013170|FG002|NOT COMPLETED|Overall Study||7||
59890737|NCT02603809|76013171|FG003|NOT COMPLETED|Overall Study||12||
59890738|NCT02603809|76013172|FG004|NOT COMPLETED|Overall Study||11||
59890739|NCT02603809|76013173|FG005|NOT COMPLETED|Overall Study||10||
59890740|NCT04469998|76013192|FG000|STARTED|Full Analysis Set (ITT Population)|One subject was randomized to AXR-270 Low Dose but received Vehicle instead|43||
59890741|NCT04469998|76013193|FG001|STARTED|Full Analysis Set (ITT Population)||44||
59890742|NCT04469998|76013194|FG002|STARTED|Full Analysis Set (ITT Population)|One subject was randomized to AXR-270 Low Dose but received Vehicle instead|42||
59890743|NCT04469998|76013192|FG000|COMPLETED|Full Analysis Set (ITT Population)||42||
59890744|NCT04469998|76013193|FG001|COMPLETED|Full Analysis Set (ITT Population)||43||
59890745|NCT04469998|76013194|FG002|COMPLETED|Full Analysis Set (ITT Population)||42||
59890746|NCT04469998|76013192|FG000|NOT COMPLETED|Full Analysis Set (ITT Population)||1||
59890747|NCT04469998|76013193|FG001|NOT COMPLETED|Full Analysis Set (ITT Population)||1||
59890748|NCT04469998|76013194|FG002|NOT COMPLETED|Full Analysis Set (ITT Population)||0||
59890749|NCT04469998|76013192|FG000|STARTED|Safety Set (as Treated)|One subject was randomized to AXR-270 Low Dose but received Vehicle instead|42||
59890750|NCT04469998|76013193|FG001|STARTED|Safety Set (as Treated)|One subject withdrew consent and was withdrawn from the study prior to dosing with the assigned treatment because the subject was not able to comply with the visit schedule|43||
59890751|NCT04469998|76013194|FG002|STARTED|Safety Set (as Treated)|One subject was randomized to AXR-270 Low Dose but received Vehicle instead|43||
59890752|NCT04469998|76013192|FG000|COMPLETED|Safety Set (as Treated)||41||
59890753|NCT04469998|76013193|FG001|COMPLETED|Safety Set (as Treated)||42||
59890754|NCT04469998|76013194|FG002|COMPLETED|Safety Set (as Treated)||43||
59890755|NCT04469998|76013192|FG000|NOT COMPLETED|Safety Set (as Treated)||1||
59890756|NCT04469998|76013193|FG001|NOT COMPLETED|Safety Set (as Treated)||1||
59890757|NCT04469998|76013194|FG002|NOT COMPLETED|Safety Set (as Treated)||0||
59890758|NCT02741596|76013204|FG000|STARTED|Overall Study||109||
59890759|NCT02741596|76013205|FG001|STARTED|Overall Study||103||
59890760|NCT02741596|76013204|FG000|COMPLETED|Overall Study||31||
59890761|NCT02741596|76013205|FG001|COMPLETED|Overall Study||25||
59890762|NCT02741596|76013204|FG000|NOT COMPLETED|Overall Study||78||
59890763|NCT02741596|76013205|FG001|NOT COMPLETED|Overall Study||78||
59890764|NCT03147248|76013217|FG000|STARTED|Overall Study|This cohort is only for Part 1.|13||
59890765|NCT03147248|76013218|FG001|STARTED|Overall Study|This cohort is only for Part 1.|11||
59890766|NCT03147248|76013219|FG002|STARTED|Overall Study|This cohort is only for Part 1.|12||
59890767|NCT03147248|76013220|FG003|STARTED|Overall Study|This cohort is only for Part 1.|12||
59890768|NCT03147248|76013221|FG004|STARTED|Overall Study|This arm is for Part 2. All of the participants in Part 2 were screened only for Part 2.|167||
59890769|NCT03147248|76013222|FG005|STARTED|Overall Study|This arm is for Part 2. All of the participants in Part 2 were screened only for Part 2.|176||
59890770|NCT03147248|76013217|FG000|COMPLETED|Overall Study||12||
59890771|NCT03147248|76013218|FG001|COMPLETED|Overall Study||9||
59890772|NCT03147248|76013219|FG002|COMPLETED|Overall Study||10||
59890773|NCT03147248|76013220|FG003|COMPLETED|Overall Study||10||
59890774|NCT03147248|76013221|FG004|COMPLETED|Overall Study||141||
59890775|NCT03147248|76013222|FG005|COMPLETED|Overall Study||145||
59890776|NCT03147248|76013217|FG000|NOT COMPLETED|Overall Study||1||
59890777|NCT03147248|76013218|FG001|NOT COMPLETED|Overall Study||2||
59890778|NCT03147248|76013219|FG002|NOT COMPLETED|Overall Study||2||
59890779|NCT03147248|76013220|FG003|NOT COMPLETED|Overall Study||2||
59890780|NCT03147248|76013221|FG004|NOT COMPLETED|Overall Study||26||
59890781|NCT03147248|76013222|FG005|NOT COMPLETED|Overall Study||31||
59890782|NCT03796039|76013238|FG000|STARTED|Overall Study||50||
59890783|NCT03796039|76013239|FG001|STARTED|Overall Study||47||
59890784|NCT03796039|76013238|FG000|COMPLETED|Overall Study||41||
59890785|NCT03796039|76013239|FG001|COMPLETED|Overall Study||42||
59890786|NCT03796039|76013238|FG000|NOT COMPLETED|Overall Study||9||
59890787|NCT03796039|76013239|FG001|NOT COMPLETED|Overall Study||5||
59890788|NCT03151304|76013245|FG000|STARTED|Overall Study||64||
59890789|NCT03151304|76013245|FG000|COMPLETED|Overall Study||0||
59890790|NCT03151304|76013245|FG000|NOT COMPLETED|Overall Study||64||
59890791|NCT03152552|76013254|FG000|STARTED|Treatment Period 1 (12 Weeks)||15|Randomized Set (RAN): all randomized patients|
59890792|NCT03152552|76013255|FG001|STARTED|Treatment Period 1 (12 Weeks)||16|Randomized Set (RAN): all randomized patients|
59890793|NCT03152552|76013256|FG002|STARTED|Treatment Period 1 (12 Weeks)||31|Randomized Set (RAN): all randomized patients|
59890794|NCT03152552|76013257|FG003|STARTED|Treatment Period 1 (12 Weeks)||30|Randomized Set (RAN): all randomized patients|
59890795|NCT03152552|76013258|FG004|STARTED|Treatment Period 1 (12 Weeks)||33|Randomized Set (RAN): all randomized patients|
59890796|NCT03152552|76013254|FG000|Full Analysis Set (FAS)|Treatment Period 1 (12 Weeks)||15|All patients in RAN who were not mis-randomized|
59890797|NCT03152552|76013255|FG001|Full Analysis Set (FAS)|Treatment Period 1 (12 Weeks)||16|All patients in RAN who were not mis-randomized|
59890798|NCT03152552|76013256|FG002|Full Analysis Set (FAS)|Treatment Period 1 (12 Weeks)||30|All patients in RAN who were not mis-randomized|
59890799|NCT03152552|76013257|FG003|Full Analysis Set (FAS)|Treatment Period 1 (12 Weeks)||30|All patients in RAN who were not mis-randomized|
59890800|NCT03152552|76013258|FG004|Full Analysis Set (FAS)|Treatment Period 1 (12 Weeks)||33|All patients in RAN who were not mis-randomized|
59890801|NCT03152552|76013254|FG000|COMPLETED|Treatment Period 1 (12 Weeks)||7|Completed EPOCH 3 (double-blind period 1)|
59890802|NCT03152552|76013255|FG001|COMPLETED|Treatment Period 1 (12 Weeks)||5|Completed EPOCH 3 (double-blind period 1)|
59890803|NCT03152552|76013256|FG002|COMPLETED|Treatment Period 1 (12 Weeks)||10|Completed EPOCH 3 (double-blind period 1)|
59890804|NCT03152552|76013257|FG003|COMPLETED|Treatment Period 1 (12 Weeks)||10|Completed EPOCH 3 (double-blind period 1)|
59890805|NCT03152552|76013258|FG004|COMPLETED|Treatment Period 1 (12 Weeks)||12|Completed EPOCH 3 (double-blind period 1)|
59890806|NCT03152552|76013254|FG000|NOT COMPLETED|Treatment Period 1 (12 Weeks)||8||
59890807|NCT03152552|76013255|FG001|NOT COMPLETED|Treatment Period 1 (12 Weeks)||11||
59890808|NCT03152552|76013256|FG002|NOT COMPLETED|Treatment Period 1 (12 Weeks)||21||
59890809|NCT03152552|76013257|FG003|NOT COMPLETED|Treatment Period 1 (12 Weeks)||20||
59890810|NCT03152552|76013258|FG004|NOT COMPLETED|Treatment Period 1 (12 Weeks)||21||
59890811|NCT03152552|76013254|FG000|STARTED|Treatment Period 2 (24 Weeks)||7||
59890812|NCT03152552|76013255|FG001|STARTED|Treatment Period 2 (24 Weeks)||5||
59890813|NCT03152552|76013256|FG002|STARTED|Treatment Period 2 (24 Weeks)|All patients who entered Treatment Period 2 (EPOCH 4)|9||
59890814|NCT03152552|76013257|FG003|STARTED|Treatment Period 2 (24 Weeks)|All patients who entered Treatment Period 2 (EPOCH 4)|9||
59950986|NCT01359904|76069912|FG000|COMPLETED|Overall Study||14||
59890815|NCT03152552|76013258|FG004|STARTED|Treatment Period 2 (24 Weeks)|All patients who entered Treatment Period 2 (EPOCH 4)|11||
59890816|NCT03152552|76013254|FG000|COMPLETED|Treatment Period 2 (24 Weeks)||1|Completed EPOCH 4 (double-blind period 2)|
59890817|NCT03152552|76013255|FG001|COMPLETED|Treatment Period 2 (24 Weeks)||0|Completed EPOCH 4 (double-blind period 2)|
59890818|NCT03152552|76013256|FG002|COMPLETED|Treatment Period 2 (24 Weeks)||0|Completed EPOCH 4 (double-blind period 2)|
59890819|NCT03152552|76013257|FG003|COMPLETED|Treatment Period 2 (24 Weeks)||0|Completed EPOCH 4 (double-blind period 2)|
59890820|NCT03152552|76013258|FG004|COMPLETED|Treatment Period 2 (24 Weeks)||0|Completed EPOCH 4 (double-blind period 2)|
59890821|NCT03152552|76013254|FG000|NOT COMPLETED|Treatment Period 2 (24 Weeks)||6||
59890822|NCT03152552|76013255|FG001|NOT COMPLETED|Treatment Period 2 (24 Weeks)||5||
59890823|NCT03152552|76013256|FG002|NOT COMPLETED|Treatment Period 2 (24 Weeks)||9||
59890824|NCT03152552|76013257|FG003|NOT COMPLETED|Treatment Period 2 (24 Weeks)||9||
59890825|NCT03152552|76013258|FG004|NOT COMPLETED|Treatment Period 2 (24 Weeks)||11||
59890826|NCT03151226|76013271|FG000|STARTED|Overall Study||3||
59890827|NCT03151226|76013271|FG000|COMPLETED|Overall Study||0||
59890828|NCT03151226|76013271|FG000|NOT COMPLETED|Overall Study||3||
59890829|NCT03151148|76013277|FG000|STARTED|Overall Study||36||
59890830|NCT03151148|76013278|FG001|STARTED|Overall Study||18||
59890831|NCT03151148|76013277|FG000|COMPLETED|Overall Study||34||
59890832|NCT03151148|76013278|FG001|COMPLETED|Overall Study||18||
59890833|NCT03151148|76013277|FG000|NOT COMPLETED|Overall Study||2||
59890834|NCT03151148|76013278|FG001|NOT COMPLETED|Overall Study||0||
59890835|NCT02741518|76013287|FG000|STARTED|Overall Study||11||
59890836|NCT02741518|76013288|FG001|STARTED|Overall Study||11||
59890837|NCT02741518|76013287|FG000|COMPLETED|Overall Study||10||
59890838|NCT02741518|76013288|FG001|COMPLETED|Overall Study||10||
59890839|NCT02741518|76013287|FG000|NOT COMPLETED|Overall Study||1||
59890840|NCT02741518|76013288|FG001|NOT COMPLETED|Overall Study||1||
59890841|NCT03145766|76013299|FG000|STARTED|Active Vaccination Phase (Day 0-Day 56)||80|Randomized.|
59890842|NCT03145766|76013300|FG001|STARTED|Active Vaccination Phase (Day 0-Day 56)||80|Randomized.|
59890843|NCT03145766|76013301|FG002|STARTED|Active Vaccination Phase (Day 0-Day 56)||80|Randomized.|
59890844|NCT03145766|76013302|FG003|STARTED|Active Vaccination Phase (Day 0-Day 56)||40|Randomized.|
59890845|NCT03145766|76013303|FG004|STARTED|Active Vaccination Phase (Day 0-Day 56)||40|Randomized.|
59890846|NCT03145766|76013299|FG000|Vaccination 1|Active Vaccination Phase (Day 0-Day 56)||80||
59890847|NCT03145766|76013300|FG001|Vaccination 1|Active Vaccination Phase (Day 0-Day 56)||80||
59890848|NCT03145766|76013301|FG002|Vaccination 1|Active Vaccination Phase (Day 0-Day 56)||80||
59890849|NCT03145766|76013302|FG003|Vaccination 1|Active Vaccination Phase (Day 0-Day 56)|1 participant of this arm received Imovax Rabies, and counted in Group 5 for safety analysis.|39||
59890850|NCT03145766|76013303|FG004|Vaccination 1|Active Vaccination Phase (Day 0-Day 56)|1 participant of Group 4 received Imovax Rabies, and counted in Group 5 for safety analysis.|41||
59890851|NCT03145766|76013299|FG000|Vaccination 2|Active Vaccination Phase (Day 0-Day 56)|1 participant received Group 2 vaccine: counted in Group 2 for post-vaccination 2 safety analysis.|77||
59890852|NCT03145766|76013300|FG001|Vaccination 2|Active Vaccination Phase (Day 0-Day 56)|1 participant of Group 1 received Group 2 vaccine: counted in Group 2 for post-vaccination 2 safety.|81||
59890853|NCT03145766|76013301|FG002|Vaccination 2|Active Vaccination Phase (Day 0-Day 56)||80||
59890854|NCT03145766|76013302|FG003|Vaccination 2|Active Vaccination Phase (Day 0-Day 56)||39||
59890855|NCT03145766|76013303|FG004|Vaccination 2|Active Vaccination Phase (Day 0-Day 56)||39||
59890856|NCT03145766|76013299|FG000|Vaccination 3|Active Vaccination Phase (Day 0-Day 56)||78||
59890857|NCT03145766|76013300|FG001|Vaccination 3|Active Vaccination Phase (Day 0-Day 56)||79||
59890858|NCT03145766|76013301|FG002|Vaccination 3|Active Vaccination Phase (Day 0-Day 56)||80||
59890859|NCT03145766|76013302|FG003|Vaccination 3|Active Vaccination Phase (Day 0-Day 56)||39||
59890860|NCT03145766|76013303|FG004|Vaccination 3|Active Vaccination Phase (Day 0-Day 56)||38||
59890861|NCT03145766|76013299|FG000|Vaccination 4|Active Vaccination Phase (Day 0-Day 56)||78||
59890862|NCT03145766|76013300|FG001|Vaccination 4|Active Vaccination Phase (Day 0-Day 56)||79||
59890863|NCT03145766|76013301|FG002|Vaccination 4|Active Vaccination Phase (Day 0-Day 56)||80||
59890864|NCT03145766|76013302|FG003|Vaccination 4|Active Vaccination Phase (Day 0-Day 56)||38||
59890865|NCT03145766|76013303|FG004|Vaccination 4|Active Vaccination Phase (Day 0-Day 56)||38||
59890866|NCT03145766|76013299|FG000|Vaccination 5|Active Vaccination Phase (Day 0-Day 56)||75||
59890867|NCT03145766|76013300|FG001|Vaccination 5|Active Vaccination Phase (Day 0-Day 56)||78||
59890868|NCT03145766|76013301|FG002|Vaccination 5|Active Vaccination Phase (Day 0-Day 56)||79||
59890869|NCT03145766|76013302|FG003|Vaccination 5|Active Vaccination Phase (Day 0-Day 56)||34||
59890870|NCT03145766|76013303|FG004|Vaccination 5|Active Vaccination Phase (Day 0-Day 56)||37||
59890871|NCT03145766|76013299|FG000|COMPLETED|Active Vaccination Phase (Day 0-Day 56)||74||
59890872|NCT03145766|76013300|FG001|COMPLETED|Active Vaccination Phase (Day 0-Day 56)||77||
59890873|NCT03145766|76013301|FG002|COMPLETED|Active Vaccination Phase (Day 0-Day 56)||78||
59890874|NCT03145766|76013302|FG003|COMPLETED|Active Vaccination Phase (Day 0-Day 56)||33||
59890875|NCT03145766|76013303|FG004|COMPLETED|Active Vaccination Phase (Day 0-Day 56)||37||
59890876|NCT03145766|76013299|FG000|NOT COMPLETED|Active Vaccination Phase (Day 0-Day 56)||6||
59890877|NCT03145766|76013300|FG001|NOT COMPLETED|Active Vaccination Phase (Day 0-Day 56)||3||
59890878|NCT03145766|76013301|FG002|NOT COMPLETED|Active Vaccination Phase (Day 0-Day 56)||2||
59950987|NCT01359904|76069913|FG001|COMPLETED|Overall Study||19||
59890879|NCT03145766|76013302|FG003|NOT COMPLETED|Active Vaccination Phase (Day 0-Day 56)||7||
59890880|NCT03145766|76013303|FG004|NOT COMPLETED|Active Vaccination Phase (Day 0-Day 56)||3||
59890881|NCT03145766|76013299|FG000|STARTED|Follow-up Phase (Day 56 Till Month 7)||74||
59890882|NCT03145766|76013300|FG001|STARTED|Follow-up Phase (Day 56 Till Month 7)||77||
59890883|NCT03145766|76013301|FG002|STARTED|Follow-up Phase (Day 56 Till Month 7)||78||
59890884|NCT03145766|76013302|FG003|STARTED|Follow-up Phase (Day 56 Till Month 7)||33||
59890885|NCT03145766|76013303|FG004|STARTED|Follow-up Phase (Day 56 Till Month 7)||37||
59890886|NCT03145766|76013299|FG000|COMPLETED|Follow-up Phase (Day 56 Till Month 7)||67||
59890887|NCT03145766|76013300|FG001|COMPLETED|Follow-up Phase (Day 56 Till Month 7)||75||
59890888|NCT03145766|76013301|FG002|COMPLETED|Follow-up Phase (Day 56 Till Month 7)||73||
59890889|NCT03145766|76013302|FG003|COMPLETED|Follow-up Phase (Day 56 Till Month 7)||30||
59890890|NCT03145766|76013303|FG004|COMPLETED|Follow-up Phase (Day 56 Till Month 7)||34||
59890891|NCT03145766|76013299|FG000|NOT COMPLETED|Follow-up Phase (Day 56 Till Month 7)||7||
59890892|NCT03145766|76013300|FG001|NOT COMPLETED|Follow-up Phase (Day 56 Till Month 7)||2||
59890893|NCT03145766|76013301|FG002|NOT COMPLETED|Follow-up Phase (Day 56 Till Month 7)||5||
59756736|NCT00950807|75875643|FG001|NOT COMPLETED|Treatment Period 3||0||
59756737|NCT00950807|75875644|FG002|NOT COMPLETED|Treatment Period 3||0||
59756738|NCT00950807|75875645|FG003|NOT COMPLETED|Treatment Period 3||0||
59756739|NCT00950807|75875646|FG004|NOT COMPLETED|Treatment Period 3||0||
59756740|NCT00950807|75875647|FG005|NOT COMPLETED|Treatment Period 3||0||
59756741|NCT00950807|75875648|FG006|NOT COMPLETED|Treatment Period 3||1||
59756742|NCT00950807|75875649|FG007|NOT COMPLETED|Treatment Period 3||1||
59756743|NCT00950807|75875650|FG008|NOT COMPLETED|Treatment Period 3||0||
59756744|NCT00950807|75875651|FG009|NOT COMPLETED|Treatment Period 3||1||
59756745|NCT00797511|75875673|FG000|STARTED|Overall Study||132||
59756746|NCT00797511|75875673|FG000|COMPLETED|Overall Study||131||
59756747|NCT00797511|75875673|FG000|NOT COMPLETED|Overall Study||1||
59756748|NCT00608881|75875680|FG000|STARTED|Overall Study||303||
59756749|NCT00608881|75875681|FG001|STARTED|Overall Study||306||
59756750|NCT00608881|75875680|FG000|COMPLETED|Overall Study||224||
59756751|NCT00608881|75875681|FG001|COMPLETED|Overall Study||240||
59756752|NCT00608881|75875680|FG000|NOT COMPLETED|Overall Study||79||
59756753|NCT00608881|75875681|FG001|NOT COMPLETED|Overall Study||66||
59756754|NCT00945191|75875687|FG000|STARTED|Overall Study||24||
59756755|NCT00945191|75875687|FG000|COMPLETED|Overall Study||0||
59756756|NCT00945191|75875687|FG000|NOT COMPLETED|Overall Study||24||
59756757|NCT00606931|75875691|FG000|STARTED|Overall Study||22||
59756758|NCT00606931|75875691|FG000|COMPLETED|Overall Study||19||
59756759|NCT00606931|75875691|FG000|NOT COMPLETED|Overall Study||3||
59756760|NCT00792909|75875698|FG000|STARTED|Overall Study||51||
59756761|NCT00792909|75875699|FG001|STARTED|Overall Study||59||
59756762|NCT00792909|75875700|FG002|STARTED|Overall Study||62||
59756763|NCT00792909|75875698|FG000|COMPLETED|Overall Study||51||
59756764|NCT00792909|75875699|FG001|COMPLETED|Overall Study||58||
59756765|NCT00792909|75875700|FG002|COMPLETED|Overall Study||62||
59756766|NCT00792909|75875698|FG000|NOT COMPLETED|Overall Study||0||
59756767|NCT00792909|75875699|FG001|NOT COMPLETED|Overall Study||1||
59756768|NCT00792909|75875700|FG002|NOT COMPLETED|Overall Study||0||
59756769|NCT00944645|75875711|FG000|STARTED|Period 1||94||
59756770|NCT00944645|75875712|FG001|STARTED|Period 1||94||
59756771|NCT00944645|75875711|FG000|COMPLETED|Period 1||94||
59756772|NCT00944645|75875712|FG001|COMPLETED|Period 1||94||
59756773|NCT00944645|75875711|FG000|NOT COMPLETED|Period 1||0||
59756774|NCT00944645|75875712|FG001|NOT COMPLETED|Period 1||0||
59756775|NCT00944645|75875711|FG000|STARTED|Period 2||94||
59756776|NCT00944645|75875712|FG001|STARTED|Period 2||94||
59756777|NCT00944645|75875711|FG000|COMPLETED|Period 2||86||
59756778|NCT00944645|75875712|FG001|COMPLETED|Period 2||85||
59756779|NCT00944645|75875711|FG000|NOT COMPLETED|Period 2||8||
59756780|NCT00944645|75875712|FG001|NOT COMPLETED|Period 2||9||
59756781|NCT00606229|75875718|FG000|STARTED|Overall Study||41||
59756782|NCT00606229|75875718|FG000|COMPLETED|Overall Study||19||
59756783|NCT00606229|75875718|FG000|NOT COMPLETED|Overall Study||22||
59756784|NCT00950651|75875724|FG000|STARTED|Overall Study||215||
59756785|NCT00950651|75875725|FG001|STARTED|Overall Study|216 patients randomized but one never took study medication|216||
59756786|NCT00950651|75875724|FG000|COMPLETED|Overall Study||184||
59756787|NCT00950651|75875725|FG001|COMPLETED|Overall Study||181||
59756788|NCT00950651|75875724|FG000|NOT COMPLETED|Overall Study||31||
59756789|NCT00950651|75875725|FG001|NOT COMPLETED|Overall Study||35||
59756790|NCT00605293|75875733|FG000|STARTED|Overall Study||65||
59756791|NCT00605293|75875734|FG001|STARTED|Overall Study||36||
59756792|NCT00605293|75875733|FG000|COMPLETED|Overall Study||48||
59756793|NCT00605293|75875734|FG001|COMPLETED|Overall Study||31||
59756794|NCT00605293|75875733|FG000|NOT COMPLETED|Overall Study||17||
59756795|NCT00605293|75875734|FG001|NOT COMPLETED|Overall Study||5||
59756796|NCT00572533|75875742|FG000|STARTED|Overall Study||31||
59756797|NCT00572533|75875743|FG001|STARTED|Overall Study||31||
59890894|NCT03145766|76013302|FG003|NOT COMPLETED|Follow-up Phase (Day 56 Till Month 7)||3||
59756798|NCT00572533|75875742|FG000|COMPLETED|Overall Study||24||
59890895|NCT03145766|76013303|FG004|NOT COMPLETED|Follow-up Phase (Day 56 Till Month 7)||3||
59890896|NCT03145064|76013316|FG000|STARTED|Overall Study||41||
59890897|NCT03145064|76013316|FG000|Received At Least 1 Dose of Study Drug|Overall Study||41||
59890898|NCT03145064|76013316|FG000|COMPLETED|Overall Study||0||
59890899|NCT03145064|76013316|FG000|NOT COMPLETED|Overall Study||41||
59890900|NCT05072470|76013321|FG000|STARTED|Overall Study||10||
59890901|NCT05072470|76013321|FG000|COMPLETED|Overall Study||10||
59890902|NCT05072470|76013321|FG000|NOT COMPLETED|Overall Study||0||
59890903|NCT03198988|76013325|FG000|STARTED|Overall Study||10||
59890904|NCT03198988|76013325|FG000|COMPLETED|Overall Study||10||
59890905|NCT03198988|76013325|FG000|NOT COMPLETED|Overall Study||0||
59890906|NCT04391036|76013332|FG000|STARTED|Overall Study||15||
59890907|NCT04391036|76013333|FG001|STARTED|Overall Study||15||
59890908|NCT04391036|76013332|FG000|COMPLETED|Overall Study||15||
59890909|NCT04391036|76013333|FG001|COMPLETED|Overall Study||15||
59890910|NCT04391036|76013332|FG000|NOT COMPLETED|Overall Study||0||
59890911|NCT04391036|76013333|FG001|NOT COMPLETED|Overall Study||0||
59890912|NCT03787615|76013341|FG000|STARTED|Overall Study||31||
59890913|NCT03787615|76013341|FG000|COMPLETED|Overall Study||27||
59890914|NCT03787615|76013341|FG000|NOT COMPLETED|Overall Study||4||
59890915|NCT03784963|76013350|FG000|STARTED|Overall Study||12||
59890916|NCT03784963|76013351|FG001|STARTED|Overall Study||10||
59890917|NCT03784963|76013352|FG002|STARTED|Overall Study||1||
59890918|NCT03784963|76013353|FG003|STARTED|Overall Study||0||
59890919|NCT03784963|76013350|FG000|COMPLETED|Overall Study||0||
59890920|NCT03784963|76013351|FG001|COMPLETED|Overall Study||0||
59890921|NCT03784963|76013352|FG002|COMPLETED|Overall Study||0||
59890922|NCT03784963|76013353|FG003|COMPLETED|Overall Study||0||
59890923|NCT03784963|76013350|FG000|NOT COMPLETED|Overall Study||12||
59890924|NCT03784963|76013351|FG001|NOT COMPLETED|Overall Study||10||
59890925|NCT03784963|76013352|FG002|NOT COMPLETED|Overall Study||1||
59890926|NCT03784963|76013353|FG003|NOT COMPLETED|Overall Study||0||
59890927|NCT03787303|76013363|FG000|STARTED|Overall Study||7||
59890928|NCT03787303|76013363|FG000|COMPLETED|Overall Study||5||
59890929|NCT03787303|76013363|FG000|NOT COMPLETED|Overall Study||2||
59890930|NCT04170296|76013369|FG000|STARTED|Overall Study||81||
59890931|NCT04170296|76013370|FG001|STARTED|Overall Study||72||
59890932|NCT04170296|76013369|FG000|COMPLETED|Overall Study||73||
59890933|NCT04170296|76013370|FG001|COMPLETED|Overall Study||68||
59890934|NCT04170296|76013369|FG000|NOT COMPLETED|Overall Study||8||
59890935|NCT04170296|76013370|FG001|NOT COMPLETED|Overall Study||4||
59890936|NCT05128058|76013384|FG000|STARTED|Overall Study||8||
59890937|NCT05128058|76013385|FG001|STARTED|Overall Study||8||
59890938|NCT05128058|76013384|FG000|COMPLETED|Overall Study||8||
59505581|NCT00735839|75598389|FG001|NOT COMPLETED|Overall Study||0||
59505582|NCT00723073|75598397|FG000|STARTED|Overall Study||149||
59890939|NCT05128058|76013385|FG001|COMPLETED|Overall Study||8||
59890940|NCT05128058|76013384|FG000|NOT COMPLETED|Overall Study||0||
59890941|NCT05128058|76013385|FG001|NOT COMPLETED|Overall Study||0||
59890942|NCT03143816|76013393|FG000|STARTED|Overall Study||26||
59890943|NCT03143816|76013394|FG001|STARTED|Overall Study||34||
59890944|NCT03143816|76013393|FG000|COMPLETED|Overall Study||22||
59890945|NCT03143816|76013394|FG001|COMPLETED|Overall Study||34||
59890946|NCT03143816|76013393|FG000|NOT COMPLETED|Overall Study||4||
59890947|NCT03143816|76013394|FG001|NOT COMPLETED|Overall Study||0||
59890948|NCT03141788|76013406|FG000|STARTED|Overall Study||52||
59890949|NCT03141788|76013406|FG000|COMPLETED|Overall Study||44||
59890950|NCT03141788|76013406|FG000|NOT COMPLETED|Overall Study||8||
59890951|NCT03781375|76013415|FG000|STARTED|Double-blind Phase||12||
59890952|NCT03781375|76013416|FG001|STARTED|Double-blind Phase||13||
59890953|NCT03781375|76013415|FG000|Received Study Drug|Double-blind Phase||12||
59890954|NCT03781375|76013416|FG001|Received Study Drug|Double-blind Phase||13||
59890955|NCT03781375|76013415|FG000|COMPLETED|Double-blind Phase||5||
59890956|NCT03781375|76013416|FG001|COMPLETED|Double-blind Phase||7||
59505583|NCT00723073|75598398|FG001|STARTED|Overall Study||174||
59505584|NCT00723073|75598397|FG000|COMPLETED|Overall Study||149||
59890957|NCT03781375|76013415|FG000|NOT COMPLETED|Double-blind Phase||7||
59890958|NCT03781375|76013416|FG001|NOT COMPLETED|Double-blind Phase||6||
59890959|NCT03781375|76013415|FG000|STARTED|Open-label Phase||11|Participants who completed blinded treatment or who withdrew early due to flare or lack of response|
59890960|NCT03781375|76013416|FG001|STARTED|Open-label Phase||9|Participants who completed blinded treatment or who withdrew early due to flare or lack of response|
59890961|NCT03781375|76013415|FG000|Received Study Drug|Open-label Phase||10||
59890962|NCT03781375|76013416|FG001|Received Study Drug|Open-label Phase||9||
59890963|NCT03781375|76013415|FG000|COMPLETED|Open-label Phase||8||
59890964|NCT03781375|76013416|FG001|COMPLETED|Open-label Phase||6||
59890965|NCT03781375|76013415|FG000|NOT COMPLETED|Open-label Phase||3||
59890966|NCT03781375|76013416|FG001|NOT COMPLETED|Open-label Phase||3||
59890967|NCT03779503|76013423|FG000|STARTED|First Intervention||28||
59890968|NCT03779503|76013424|FG001|STARTED|First Intervention||27||
59890969|NCT03779503|76013423|FG000|COMPLETED|First Intervention||27||
59890970|NCT03779503|76013424|FG001|COMPLETED|First Intervention||26||
59505585|NCT00723073|75598398|FG001|COMPLETED|Overall Study||174||
59505586|NCT00723073|75598397|FG000|NOT COMPLETED|Overall Study||0||
59890971|NCT03779503|76013423|FG000|NOT COMPLETED|First Intervention||1||
59890972|NCT03779503|76013424|FG001|NOT COMPLETED|First Intervention||1||
59890973|NCT03779503|76013423|FG000|STARTED|Second Intervention||27||
59890974|NCT03779503|76013424|FG001|STARTED|Second Intervention||26||
59890975|NCT03779503|76013423|FG000|COMPLETED|Second Intervention||27||
59890976|NCT03779503|76013424|FG001|COMPLETED|Second Intervention||26||
59890977|NCT03779503|76013423|FG000|NOT COMPLETED|Second Intervention||0||
59890978|NCT03779503|76013424|FG001|NOT COMPLETED|Second Intervention||0||
59890979|NCT03150056|76013436|FG000|STARTED|Overall Study||10||
59890980|NCT03150056|76013437|FG001|STARTED|Overall Study||6||
59890981|NCT03150056|76013438|FG002|STARTED|Overall Study||4||
59890982|NCT03150056|76013439|FG003|STARTED|Overall Study||10||
59890983|NCT03150056|76013440|FG004|STARTED|Overall Study||22||
59890984|NCT03150056|76013441|FG005|STARTED|Overall Study||21||
59890985|NCT03150056|76013436|FG000|COMPLETED|Overall Study||0||
59890986|NCT03150056|76013437|FG001|COMPLETED|Overall Study||1||
59890987|NCT03150056|76013438|FG002|COMPLETED|Overall Study||1||
59890988|NCT03150056|76013439|FG003|COMPLETED|Overall Study||2||
59890989|NCT03150056|76013440|FG004|COMPLETED|Overall Study||9||
59890990|NCT03150056|76013441|FG005|COMPLETED|Overall Study||3||
59890991|NCT03150056|76013436|FG000|NOT COMPLETED|Overall Study||10||
59890992|NCT03150056|76013437|FG001|NOT COMPLETED|Overall Study||5||
59890993|NCT03150056|76013438|FG002|NOT COMPLETED|Overall Study||3||
59890994|NCT03150056|76013439|FG003|NOT COMPLETED|Overall Study||8||
59890995|NCT03150056|76013440|FG004|NOT COMPLETED|Overall Study||13||
59890996|NCT03150056|76013441|FG005|NOT COMPLETED|Overall Study||18||
59890997|NCT02640664|76013461|FG000|STARTED|Epoch 1||61||
59890998|NCT02640664|76013462|FG001|STARTED|Epoch 1||65||
59890999|NCT02640664|76013463|FG002|STARTED|Epoch 1||54||
59891000|NCT02640664|76013461|FG000|COMPLETED|Epoch 1||60|Number of subjects who completed post-treatment follow-up 1 (Epoch 1)|
59891001|NCT02640664|76013462|FG001|COMPLETED|Epoch 1||65|Number of subjects who completed post-treatment follow-up 1 (Epoch 1)|
59891002|NCT02640664|76013463|FG002|COMPLETED|Epoch 1||53|Number of subjects who completed post-treatment follow-up 1 (Epoch 1)|
59891003|NCT02640664|76013461|FG000|NOT COMPLETED|Epoch 1||1||
59891004|NCT02640664|76013462|FG001|NOT COMPLETED|Epoch 1||0||
59891005|NCT02640664|76013463|FG002|NOT COMPLETED|Epoch 1||1||
59891006|NCT02640664|76013461|FG000|STARTED|Epoch 2||60||
59891007|NCT02640664|76013462|FG001|STARTED|Epoch 2||65||
59891008|NCT02640664|76013463|FG002|STARTED|Epoch 2||53||
59891009|NCT02640664|76013461|FG000|COMPLETED|Epoch 2||54|Number of subjects who completed post-treatment follow-up 2|
59891010|NCT02640664|76013462|FG001|COMPLETED|Epoch 2||55|Number of subjects who completed post-treatment follow-up 2|
59891011|NCT02640664|76013463|FG002|COMPLETED|Epoch 2||47|Number of subjects who completed post-treatment follow-up 2|
59891012|NCT02640664|76013461|FG000|NOT COMPLETED|Epoch 2||6||
59891013|NCT02640664|76013462|FG001|NOT COMPLETED|Epoch 2||10||
59891014|NCT02640664|76013463|FG002|NOT COMPLETED|Epoch 2||6||
59891015|NCT00812006|76013475|FG000|STARTED|Overall Study||36||
59891016|NCT00812006|76013476|FG001|STARTED|Overall Study||36||
59891017|NCT00812006|76013477|FG002|STARTED|Overall Study||36||
59891018|NCT00812006|76013475|FG000|COMPLETED|Overall Study||30||
59891019|NCT00812006|76013476|FG001|COMPLETED|Overall Study||33||
59891020|NCT00812006|76013477|FG002|COMPLETED|Overall Study||30||
59891021|NCT00812006|76013475|FG000|NOT COMPLETED|Overall Study||6||
59891022|NCT00812006|76013476|FG001|NOT COMPLETED|Overall Study||3||
59891023|NCT00812006|76013477|FG002|NOT COMPLETED|Overall Study||6||
59891024|NCT04625062|76013483|FG000|STARTED|Overall Study||7||10
59891025|NCT04625062|76013484|FG001|STARTED|Overall Study||7||10
59891026|NCT04625062|76013483|FG000|COMPLETED|Overall Study||7||10
59891027|NCT04625062|76013484|FG001|COMPLETED|Overall Study||7||10
59891028|NCT04625062|76013483|FG000|NOT COMPLETED|Overall Study||0||0
59891029|NCT04625062|76013484|FG001|NOT COMPLETED|Overall Study||0||0
59891030|NCT05197257|76013490|FG000|STARTED|Overall Study||39||
59891031|NCT05197257|76013490|FG000|COMPLETED|Overall Study||39||
59891032|NCT05197257|76013490|FG000|NOT COMPLETED|Overall Study||0||
59891033|NCT05127304|76013501|FG000|STARTED|Overall Study||5658|Overall post matched|
59891034|NCT05127304|76013502|FG001|STARTED|Overall Study||5658|Overall post matched|
59891035|NCT05127304|76013501|FG000|COMPLETED|Overall Study||5658||
59891036|NCT05127304|76013502|FG001|COMPLETED|Overall Study||5658||
59891037|NCT05127304|76013501|FG000|NOT COMPLETED|Overall Study||0||
59891038|NCT05127304|76013502|FG001|NOT COMPLETED|Overall Study||0||
59891039|NCT04988308|76013511|FG000|STARTED|Placebo Controlled Period (Weeks 0-16)||50||
59891040|NCT04988308|76013512|FG001|STARTED|Placebo Controlled Period (Weeks 0-16)||51||
59891041|NCT04988308|76013513|FG002|STARTED|Placebo Controlled Period (Weeks 0-16)||50||
59891042|NCT04988308|76013514|FG003|STARTED|Placebo Controlled Period (Weeks 0-16)||0||
59891043|NCT04988308|76013515|FG004|STARTED|Placebo Controlled Period (Weeks 0-16)||0||
59891044|NCT04988308|76013516|FG005|STARTED|Placebo Controlled Period (Weeks 0-16)||0||
59891045|NCT04988308|76013511|FG000|Full- Analysis Set (FAS)|Placebo Controlled Period (Weeks 0-16)||35||
59891046|NCT04988308|76013512|FG001|Full- Analysis Set (FAS)|Placebo Controlled Period (Weeks 0-16)||35||
59891047|NCT04988308|76013513|FG002|Full- Analysis Set (FAS)|Placebo Controlled Period (Weeks 0-16)||35||
59891048|NCT04988308|76013514|FG003|Full- Analysis Set (FAS)|Placebo Controlled Period (Weeks 0-16)||0||
59891049|NCT04988308|76013515|FG004|Full- Analysis Set (FAS)|Placebo Controlled Period (Weeks 0-16)||0||
59891050|NCT04988308|76013516|FG005|Full- Analysis Set (FAS)|Placebo Controlled Period (Weeks 0-16)||0||
59891051|NCT04988308|76013511|FG000|COMPLETED|Placebo Controlled Period (Weeks 0-16)||28||
59891052|NCT04988308|76013512|FG001|COMPLETED|Placebo Controlled Period (Weeks 0-16)||30||
59891053|NCT04988308|76013513|FG002|COMPLETED|Placebo Controlled Period (Weeks 0-16)||28||
59891054|NCT04988308|76013514|FG003|COMPLETED|Placebo Controlled Period (Weeks 0-16)||0||
59891055|NCT04988308|76013515|FG004|COMPLETED|Placebo Controlled Period (Weeks 0-16)||0||
59891056|NCT04988308|76013516|FG005|COMPLETED|Placebo Controlled Period (Weeks 0-16)||0||
59891057|NCT04988308|76013511|FG000|NOT COMPLETED|Placebo Controlled Period (Weeks 0-16)||22||
59891058|NCT04988308|76013512|FG001|NOT COMPLETED|Placebo Controlled Period (Weeks 0-16)||21||
59891059|NCT04988308|76013513|FG002|NOT COMPLETED|Placebo Controlled Period (Weeks 0-16)||22||
59891060|NCT04988308|76013514|FG003|NOT COMPLETED|Placebo Controlled Period (Weeks 0-16)||0||
59891061|NCT04988308|76013515|FG004|NOT COMPLETED|Placebo Controlled Period (Weeks 0-16)||0||
59891062|NCT04988308|76013516|FG005|NOT COMPLETED|Placebo Controlled Period (Weeks 0-16)||0||
59891063|NCT04988308|76013511|FG000|STARTED|Active Treatment+Safety F-U (Week 17-36)||0||
59891064|NCT04988308|76013512|FG001|STARTED|Active Treatment+Safety F-U (Week 17-36)||0||
59891065|NCT04988308|76013513|FG002|STARTED|Active Treatment+Safety F-U (Week 17-36)||0||
59891066|NCT04988308|76013514|FG003|STARTED|Active Treatment+Safety F-U (Week 17-36)|All participants who completed placebo-controlled period entered in active treatment + safety follow-up period.|28||
59891067|NCT04988308|76013515|FG004|STARTED|Active Treatment+Safety F-U (Week 17-36)|All participants who completed placebo-controlled period entered in active treatment + safety follow-up period.|30||
59891068|NCT04988308|76013516|FG005|STARTED|Active Treatment+Safety F-U (Week 17-36)|All participants who completed placebo-controlled period entered in active treatment + safety follow-up period.|28||
59891069|NCT04988308|76013511|FG000|COMPLETED|Active Treatment+Safety F-U (Week 17-36)||0||
59891070|NCT04988308|76013512|FG001|COMPLETED|Active Treatment+Safety F-U (Week 17-36)||0||
59891071|NCT04988308|76013513|FG002|COMPLETED|Active Treatment+Safety F-U (Week 17-36)||0||
59891072|NCT04988308|76013514|FG003|COMPLETED|Active Treatment+Safety F-U (Week 17-36)||7||
59891073|NCT04988308|76013515|FG004|COMPLETED|Active Treatment+Safety F-U (Week 17-36)||9||
59891074|NCT04988308|76013516|FG005|COMPLETED|Active Treatment+Safety F-U (Week 17-36)||10||
59891075|NCT04988308|76013511|FG000|NOT COMPLETED|Active Treatment+Safety F-U (Week 17-36)||0||
59891076|NCT04988308|76013512|FG001|NOT COMPLETED|Active Treatment+Safety F-U (Week 17-36)||0||
59891077|NCT04988308|76013513|FG002|NOT COMPLETED|Active Treatment+Safety F-U (Week 17-36)||0||
59891078|NCT04988308|76013514|FG003|NOT COMPLETED|Active Treatment+Safety F-U (Week 17-36)||21||
59891079|NCT04988308|76013515|FG004|NOT COMPLETED|Active Treatment+Safety F-U (Week 17-36)||21||
59891080|NCT04988308|76013516|FG005|NOT COMPLETED|Active Treatment+Safety F-U (Week 17-36)||18||
59891081|NCT04737109|76013529|FG000|STARTED|Study Treatment||6||
59891082|NCT04737109|76013530|FG001|STARTED|Study Treatment|No subjects were enrolled at this level.|0||
59891083|NCT04737109|76013531|FG002|STARTED|Study Treatment|No subjects were enrolled at this level.|0||
59891084|NCT04737109|76013532|FG003|STARTED|Study Treatment|Study was terminated before subjects were enrolled at Phase II due to Funder's Decision.|0||
59891085|NCT04737109|76013529|FG000|COMPLETED|Study Treatment||0||
59891086|NCT04737109|76013530|FG001|COMPLETED|Study Treatment||0||
59891087|NCT04737109|76013531|FG002|COMPLETED|Study Treatment||0||
59891088|NCT04737109|76013532|FG003|COMPLETED|Study Treatment||0||
59891089|NCT04737109|76013529|FG000|NOT COMPLETED|Study Treatment||6||
59891090|NCT04737109|76013530|FG001|NOT COMPLETED|Study Treatment||0||
59891091|NCT04737109|76013531|FG002|NOT COMPLETED|Study Treatment||0||
59891092|NCT04737109|76013532|FG003|NOT COMPLETED|Study Treatment||0||
59891093|NCT04737109|76013529|FG000|STARTED|Follow up|One subject died on treatment.|5|Treatment and Follow up both are at different time period. Therefore, the number of subjects to start follow up is not equal to the number of subjects who have completed treatment.|
59891094|NCT04737109|76013530|FG001|STARTED|Follow up|No subjects were enrolled at this level.|0|Treatment and Follow up both are at different time period. Therefore, the number of subjects to start follow up is not equal to the number of subjects who have completed treatment.|
59891095|NCT04737109|76013531|FG002|STARTED|Follow up|No subjects were enrolled at this level.|0|Treatment and Follow up both are at different time period. Therefore, the number of subjects to start follow up is not equal to the number of subjects who have completed treatment.|
59891096|NCT04737109|76013532|FG003|STARTED|Follow up|Study was terminated before subjects were enrolled at Phase II due to Funder's Decision.|0|Treatment and Follow up both are at different time period. Therefore, the number of subjects to start follow up is not equal to the number of subjects who have completed treatment.|
59891097|NCT04737109|76013529|FG000|COMPLETED|Follow up||5||
60013728|NCT02472795|76129675|FG004|COMPLETED|Overall Study||14||
59756799|NCT00572533|75875743|FG001|COMPLETED|Overall Study||28||
59756800|NCT00572533|75875742|FG000|NOT COMPLETED|Overall Study||7||
59756801|NCT00572533|75875743|FG001|NOT COMPLETED|Overall Study||3||
59756802|NCT00949715|75875751|FG000|STARTED|Overall Study||32||
59756803|NCT00949715|75875752|FG001|STARTED|Overall Study||33||
59756804|NCT00949715|75875751|FG000|COMPLETED|Overall Study||28||
59756805|NCT00949715|75875752|FG001|COMPLETED|Overall Study||33||
59756806|NCT00949715|75875751|FG000|NOT COMPLETED|Overall Study||4||
59756807|NCT00949715|75875752|FG001|NOT COMPLETED|Overall Study||0||
59756808|NCT00791661|75875760|FG000|STARTED|Period 1||8||
59756809|NCT00791661|75875761|FG001|STARTED|Period 1||8||
59756810|NCT00791661|75875762|FG002|STARTED|Period 1||8||
59891098|NCT04737109|76013530|FG001|COMPLETED|Follow up||0||
59891099|NCT04737109|76013531|FG002|COMPLETED|Follow up||0||
59891100|NCT04737109|76013532|FG003|COMPLETED|Follow up||0||
59891101|NCT04737109|76013529|FG000|NOT COMPLETED|Follow up||0||
59891102|NCT04737109|76013530|FG001|NOT COMPLETED|Follow up||0||
59891103|NCT04737109|76013531|FG002|NOT COMPLETED|Follow up||0||
59891104|NCT04737109|76013532|FG003|NOT COMPLETED|Follow up||0||
59505587|NCT00723073|75598398|FG001|NOT COMPLETED|Overall Study||0||
59505588|NCT00735917|75598404|FG000|STARTED|Overall Study||19||
59505589|NCT00735917|75598404|FG000|COMPLETED|Overall Study||19||
59505590|NCT00735917|75598404|FG000|NOT COMPLETED|Overall Study||0||
59505591|NCT00779155|75598410|FG000|STARTED|Overall Study||6||
59505592|NCT00779155|75598411|FG001|STARTED|Overall Study||6||
59505593|NCT00779155|75598410|FG000|COMPLETED|Overall Study||6||
59505594|NCT00779155|75598411|FG001|COMPLETED|Overall Study||6||
59505595|NCT00779155|75598410|FG000|NOT COMPLETED|Overall Study||0||
59505596|NCT00779155|75598411|FG001|NOT COMPLETED|Overall Study||0||
59505597|NCT00736073|75598419|FG000|STARTED|Overall Study||34||
59505598|NCT00736073|75598420|FG001|STARTED|Overall Study||39||
59505599|NCT00736073|75598419|FG000|COMPLETED|Overall Study||34||
59505600|NCT00736073|75598420|FG001|COMPLETED|Overall Study||39||
59505601|NCT00736073|75598419|FG000|NOT COMPLETED|Overall Study||0||
59505602|NCT00736073|75598420|FG001|NOT COMPLETED|Overall Study||0||
59505603|NCT00736229|75598430|FG000|STARTED|Overall Study|Actively Enrolled|40||
59505604|NCT00736229|75598431|FG001|STARTED|Overall Study|Historic control|71||
59505605|NCT00736229|75598432|FG002|STARTED|Overall Study|Historic Control|84||
59505606|NCT00736229|75598430|FG000|COMPLETED|Overall Study|All patients received bolus and fixed infusion of study drug, thus completed the study|40||
59891105|NCT04662801|76013539|FG000|STARTED|Overall Study||12||
59891106|NCT04662801|76013540|FG001|STARTED|Overall Study||10||
59891107|NCT04662801|76013539|FG000|COMPLETED|Overall Study||9||
59505607|NCT00736229|75598431|FG001|COMPLETED|Overall Study||71||
59505608|NCT00736229|75598432|FG002|COMPLETED|Overall Study||84||
59891108|NCT04662801|76013540|FG001|COMPLETED|Overall Study||7||
59891109|NCT04662801|76013539|FG000|NOT COMPLETED|Overall Study||3||
59891110|NCT04662801|76013540|FG001|NOT COMPLETED|Overall Study||3||
59891111|NCT04582669|76013550|FG000|STARTED|Overall Study||3||
59891112|NCT04582669|76013551|FG001|STARTED|Overall Study||3||
59891113|NCT04582669|76013552|FG002|STARTED|Overall Study||2||
59891114|NCT04582669|76013553|FG003|STARTED|Overall Study||3||
59891115|NCT04582669|76013550|FG000|COMPLETED|Overall Study||2||
59891116|NCT04582669|76013551|FG001|COMPLETED|Overall Study||2||
59891117|NCT04582669|76013552|FG002|COMPLETED|Overall Study||0||
59891118|NCT04582669|76013553|FG003|COMPLETED|Overall Study||1||
59891119|NCT04582669|76013550|FG000|NOT COMPLETED|Overall Study||1||
59891120|NCT04582669|76013551|FG001|NOT COMPLETED|Overall Study||1||
59891121|NCT04582669|76013552|FG002|NOT COMPLETED|Overall Study||2||
59891122|NCT04582669|76013553|FG003|NOT COMPLETED|Overall Study||2||
59891123|NCT04560309|76013565|FG000|STARTED|Overall Study||30||
59891124|NCT04560309|76013566|FG001|STARTED|Overall Study||30||
59891125|NCT04560309|76013565|FG000|COMPLETED|Overall Study||29||
59891126|NCT04560309|76013566|FG001|COMPLETED|Overall Study||29||
59891127|NCT04560309|76013565|FG000|NOT COMPLETED|Overall Study||1||
59891128|NCT04560309|76013566|FG001|NOT COMPLETED|Overall Study||1||
59891129|NCT04535986|76013574|FG000|STARTED|Overall Study||479||
59891130|NCT04535986|76013575|FG001|STARTED|Overall Study||284||
59891131|NCT04535986|76013574|FG000|Received Treatment|Overall Study||477||
59891132|NCT04535986|76013575|FG001|Received Treatment|Overall Study||283||
59891133|NCT04535986|76013574|FG000|COMPLETED|Overall Study||400||
59891134|NCT04535986|76013575|FG001|COMPLETED|Overall Study||245||
59891135|NCT04535986|76013574|FG000|NOT COMPLETED|Overall Study||79||
59891136|NCT04535986|76013575|FG001|NOT COMPLETED|Overall Study||39||
59891137|NCT04187196|76013585|FG000|STARTED|Overall Study||35||
59891138|NCT04187196|76013586|FG001|STARTED|Overall Study||38||
59891139|NCT04187196|76013585|FG000|COMPLETED|Overall Study||33||
59891140|NCT04187196|76013586|FG001|COMPLETED|Overall Study||38||
59891141|NCT04187196|76013585|FG000|NOT COMPLETED|Overall Study||2||
59891142|NCT04187196|76013586|FG001|NOT COMPLETED|Overall Study||0||
59891143|NCT04091971|76013592|FG000|STARTED|Overall Study||9||
59891144|NCT04091971|76013592|FG000|COMPLETED|Overall Study||5||
59891145|NCT04091971|76013592|FG000|NOT COMPLETED|Overall Study||4||
59891146|NCT04021238|76013596|FG000|STARTED|Overall Study||24||
59891147|NCT04021238|76013596|FG000|COMPLETED|Overall Study||24||
59891148|NCT04021238|76013596|FG000|NOT COMPLETED|Overall Study||0||
59891149|NCT03902613|76013621|FG000|STARTED|Overall Study||1||
59891150|NCT03902613|76013621|FG000|COMPLETED|Overall Study||0||
59891151|NCT03902613|76013621|FG000|NOT COMPLETED|Overall Study||1||
59891152|NCT03845894|76013627|FG000|STARTED|Overall Study||12||
59891153|NCT03845894|76013628|FG001|STARTED|Overall Study||13||
59891154|NCT03845894|76013627|FG000|COMPLETED|Overall Study||12||
59891155|NCT03845894|76013628|FG001|COMPLETED|Overall Study||13||
59891156|NCT03845894|76013627|FG000|NOT COMPLETED|Overall Study||0||
59891157|NCT03845894|76013628|FG001|NOT COMPLETED|Overall Study||0||
59891158|NCT03658954|76013637|FG000|STARTED|Overall Study||30||
59891159|NCT03658954|76013638|FG001|STARTED|Overall Study||30||
59891160|NCT03658954|76013639|FG002|STARTED|Overall Study||60||
59891161|NCT03658954|76013637|FG000|Completed 2 Week Treatment|Overall Study||28||
59891162|NCT03658954|76013638|FG001|Completed 2 Week Treatment|Overall Study||30||
59891163|NCT03658954|76013639|FG002|Completed 2 Week Treatment|Overall Study||60||
59891164|NCT03658954|76013637|FG000|Completed 12 Week Follow-up|Overall Study||27||
59891165|NCT03658954|76013638|FG001|Completed 12 Week Follow-up|Overall Study||30||
59891166|NCT03658954|76013639|FG002|Completed 12 Week Follow-up|Overall Study||57||
59891167|NCT03658954|76013637|FG000|COMPLETED|Overall Study||28||
59891168|NCT03658954|76013638|FG001|COMPLETED|Overall Study||30||
59891169|NCT03658954|76013639|FG002|COMPLETED|Overall Study||60||
59891170|NCT03658954|76013637|FG000|NOT COMPLETED|Overall Study||2||
59891171|NCT03658954|76013638|FG001|NOT COMPLETED|Overall Study||0||
59891172|NCT03658954|76013639|FG002|NOT COMPLETED|Overall Study||0||
59891173|NCT03508908|76013651|FG000|STARTED|Month 0-3||249||2
59891174|NCT03508908|76013652|FG001|STARTED|Month 0-3||0||0
59891175|NCT03508908|76013653|FG002|STARTED|Month 0-3||0||0
59891176|NCT03508908|76013654|FG003|STARTED|Month 0-3||0||0
59891177|NCT03508908|76013651|FG000|COMPLETED|Month 0-3||249||2
59891178|NCT03508908|76013652|FG001|COMPLETED|Month 0-3||0||0
59891179|NCT03508908|76013653|FG002|COMPLETED|Month 0-3||0||0
59891180|NCT03508908|76013654|FG003|COMPLETED|Month 0-3||0||0
59891181|NCT03508908|76013651|FG000|NOT COMPLETED|Month 0-3||0||0
59891182|NCT03508908|76013652|FG001|NOT COMPLETED|Month 0-3||0||0
59891183|NCT03508908|76013653|FG002|NOT COMPLETED|Month 0-3||0||0
59891184|NCT03508908|76013654|FG003|NOT COMPLETED|Month 0-3||0||0
59891185|NCT03508908|76013651|FG000|STARTED|Month 4-6||250||2
59891186|NCT03508908|76013652|FG001|STARTED|Month 4-6||125||1
59891187|NCT03508908|76013653|FG002|STARTED|Month 4-6||1||1
59891188|NCT03508908|76013654|FG003|STARTED|Month 4-6||1||1
59891189|NCT03508908|76013651|FG000|COMPLETED|Month 4-6||250||2
59891190|NCT03508908|76013652|FG001|COMPLETED|Month 4-6||125||1
59891191|NCT03508908|76013653|FG002|COMPLETED|Month 4-6||1||1
59891192|NCT03508908|76013654|FG003|COMPLETED|Month 4-6||1||1
59891193|NCT03508908|76013651|FG000|NOT COMPLETED|Month 4-6||0||0
59891194|NCT03508908|76013652|FG001|NOT COMPLETED|Month 4-6||0||0
59891195|NCT03508908|76013653|FG002|NOT COMPLETED|Month 4-6||0||0
59756811|NCT00791661|75875760|FG000|Received MK-1006|Period 1||6||
59756812|NCT00791661|75875761|FG001|Received MK-1006|Period 1||6||
59756813|NCT00791661|75875762|FG002|Received MK-1006|Period 1||6||
59756814|NCT00791661|75875760|FG000|Received Matching Placebo to MK-1006|Period 1||2||
59756815|NCT00791661|75875761|FG001|Received Matching Placebo to MK-1006|Period 1||2||
59756816|NCT00791661|75875762|FG002|Received Matching Placebo to MK-1006|Period 1||2||
59891196|NCT03508908|76013654|FG003|NOT COMPLETED|Month 4-6||0||0
59891197|NCT03508908|76013651|FG000|STARTED|Month 7-9||250||2
59891198|NCT03508908|76013652|FG001|STARTED|Month 7-9||250||2
59891199|NCT03508908|76013653|FG002|STARTED|Month 7-9||1||1
59891200|NCT03508908|76013654|FG003|STARTED|Month 7-9||1||1
59891201|NCT03508908|76013651|FG000|COMPLETED|Month 7-9||250||2
59891202|NCT03508908|76013652|FG001|COMPLETED|Month 7-9||250||2
59891203|NCT03508908|76013653|FG002|COMPLETED|Month 7-9||1||1
59891204|NCT03508908|76013654|FG003|COMPLETED|Month 7-9||1||1
59891205|NCT03508908|76013651|FG000|NOT COMPLETED|Month 7-9||0||0
59891206|NCT03508908|76013652|FG001|NOT COMPLETED|Month 7-9||0||0
59891207|NCT03508908|76013653|FG002|NOT COMPLETED|Month 7-9||0||0
59891208|NCT03508908|76013654|FG003|NOT COMPLETED|Month 7-9||0||0
59891209|NCT03508908|76013651|FG000|STARTED|Month 10-12||250||2
59891210|NCT03508908|76013652|FG001|STARTED|Month 10-12||250||2
59891211|NCT03508908|76013653|FG002|STARTED|Month 10-12||0||0
59891212|NCT03508908|76013654|FG003|STARTED|Month 10-12||2||2
59891213|NCT03508908|76013651|FG000|COMPLETED|Month 10-12||250||2
59891214|NCT03508908|76013652|FG001|COMPLETED|Month 10-12||250||2
59891215|NCT03508908|76013653|FG002|COMPLETED|Month 10-12||0||0
59891216|NCT03508908|76013654|FG003|COMPLETED|Month 10-12||2||2
59891217|NCT03508908|76013651|FG000|NOT COMPLETED|Month 10-12||0||0
59891218|NCT03508908|76013652|FG001|NOT COMPLETED|Month 10-12||0||0
59891219|NCT03508908|76013653|FG002|NOT COMPLETED|Month 10-12||0||0
59891220|NCT03508908|76013654|FG003|NOT COMPLETED|Month 10-12||0||0
59891221|NCT03508908|76013651|FG000|STARTED|Month 13-15||250||2
59891222|NCT03508908|76013652|FG001|STARTED|Month 13-15||250||2
59891223|NCT03508908|76013653|FG002|STARTED|Month 13-15||0||0
59891224|NCT03508908|76013654|FG003|STARTED|Month 13-15||2||2
59891225|NCT03508908|76013651|FG000|COMPLETED|Month 13-15||250||2
59891226|NCT03508908|76013652|FG001|COMPLETED|Month 13-15||250||2
59505609|NCT00736229|75598430|FG000|NOT COMPLETED|Overall Study||0||
59505610|NCT00736229|75598431|FG001|NOT COMPLETED|Overall Study||0||
59505611|NCT00736229|75598432|FG002|NOT COMPLETED|Overall Study||0||
59505612|NCT00737243|75598441|FG000|STARTED|Overall Study||289||
59891227|NCT03508908|76013653|FG002|COMPLETED|Month 13-15||0||0
59891228|NCT03508908|76013654|FG003|COMPLETED|Month 13-15||2||2
59891229|NCT03508908|76013651|FG000|NOT COMPLETED|Month 13-15||0||0
59891230|NCT03508908|76013652|FG001|NOT COMPLETED|Month 13-15||0||0
59891231|NCT03508908|76013653|FG002|NOT COMPLETED|Month 13-15||0||0
59891232|NCT03508908|76013654|FG003|NOT COMPLETED|Month 13-15||0||0
59891233|NCT03508908|76013651|FG000|STARTED|Month 16-18||125||1
59891234|NCT03508908|76013652|FG001|STARTED|Month 16-18||250||2
59891235|NCT03508908|76013653|FG002|STARTED|Month 16-18||1||1
59891236|NCT03508908|76013654|FG003|STARTED|Month 16-18||1||1
59891237|NCT03508908|76013651|FG000|COMPLETED|Month 16-18||125||1
59891238|NCT03508908|76013652|FG001|COMPLETED|Month 16-18||250||2
59891239|NCT03508908|76013653|FG002|COMPLETED|Month 16-18||1||1
59505613|NCT00737243|75598441|FG000|Successful Assay Performed|Overall Study||252||
59505614|NCT00737243|75598441|FG000|Insufficient Tissue for Assay, Withdrawn|Overall Study||37||
59505615|NCT00737243|75598441|FG000|Treated|Overall Study||223||
59518986|NCT03587428|75612871|FG001|COMPLETED|Period 1||2||
59756817|NCT00791661|75875760|FG000|COMPLETED|Period 1||8||
59756818|NCT00791661|75875761|FG001|COMPLETED|Period 1||8||
59756819|NCT00791661|75875762|FG002|COMPLETED|Period 1||8||
59756820|NCT00791661|75875760|FG000|NOT COMPLETED|Period 1||0||
59756821|NCT00791661|75875761|FG001|NOT COMPLETED|Period 1||0||
59756822|NCT00791661|75875762|FG002|NOT COMPLETED|Period 1||0||
59756823|NCT00791661|75875760|FG000|STARTED|7 Day Wash-out||8||
59756824|NCT00791661|75875761|FG001|STARTED|7 Day Wash-out||8||
59756825|NCT00791661|75875762|FG002|STARTED|7 Day Wash-out||8||
59756826|NCT00791661|75875760|FG000|COMPLETED|7 Day Wash-out||8||
59756827|NCT00791661|75875761|FG001|COMPLETED|7 Day Wash-out||8||
59756828|NCT00791661|75875762|FG002|COMPLETED|7 Day Wash-out||6||
59756829|NCT00791661|75875760|FG000|NOT COMPLETED|7 Day Wash-out||0||
59756830|NCT00791661|75875761|FG001|NOT COMPLETED|7 Day Wash-out||0||
59756831|NCT00791661|75875762|FG002|NOT COMPLETED|7 Day Wash-out||2||
59756832|NCT00791661|75875760|FG000|STARTED|Period 2||8||
59756833|NCT00791661|75875761|FG001|STARTED|Period 2||8||
59891240|NCT03508908|76013654|FG003|COMPLETED|Month 16-18||1||1
59891241|NCT03508908|76013651|FG000|NOT COMPLETED|Month 16-18||0||0
59891242|NCT03508908|76013652|FG001|NOT COMPLETED|Month 16-18||0||0
59891243|NCT03508908|76013653|FG002|NOT COMPLETED|Month 16-18||0||0
59891244|NCT03508908|76013654|FG003|NOT COMPLETED|Month 16-18||0||0
59891245|NCT03508908|76013651|FG000|STARTED|Month 19-21||0||0
59891246|NCT03508908|76013652|FG001|STARTED|Month 19-21||250||2
59891247|NCT03508908|76013653|FG002|STARTED|Month 19-21||0||0
59891248|NCT03508908|76013654|FG003|STARTED|Month 19-21||3||2
59891249|NCT03508908|76013651|FG000|COMPLETED|Month 19-21||0||0
59505616|NCT00737243|75598441|FG000|Not Treated|Overall Study|16 pts no longer met eligibility criteria; 13 came off study due to physician or pt preference.|29||
59505617|NCT00737243|75598441|FG000|Site Specific Therapy More Responsive|Overall Study||115||
59505618|NCT00737243|75598441|FG000|Site Specific Therapy Less Responsive|Overall Study||79||
59505619|NCT00737243|75598441|FG000|Empiric CUP Therapy|Overall Study||29||
59505620|NCT00737243|75598441|FG000|COMPLETED|Overall Study||194||
59505621|NCT00737243|75598441|FG000|NOT COMPLETED|Overall Study||95||
59505622|NCT00707759|75598449|FG000|STARTED|Overall Study||14||
59505623|NCT00707759|75598450|FG001|STARTED|Overall Study||14||
59756834|NCT00791661|75875762|FG002|STARTED|Period 2||6||
59756835|NCT00791661|75875760|FG000|Received MK-1006|Period 2||6||
59756836|NCT00791661|75875761|FG001|Received MK-1006|Period 2||6||
59756837|NCT00791661|75875762|FG002|Received MK-1006|Period 2||4||
59756838|NCT00791661|75875760|FG000|Received Matching Placebo to MK-1006|Period 2||2||
59756839|NCT00791661|75875761|FG001|Received Matching Placebo to MK-1006|Period 2||2||
59756840|NCT00791661|75875762|FG002|Received Matching Placebo to MK-1006|Period 2||2||
59756841|NCT00791661|75875760|FG000|COMPLETED|Period 2||8||
59891250|NCT03508908|76013652|FG001|COMPLETED|Month 19-21||250||2
59891251|NCT03508908|76013653|FG002|COMPLETED|Month 19-21||0||0
59505624|NCT00707759|75598449|FG000|COMPLETED|Overall Study||12||
59505625|NCT00707759|75598450|FG001|COMPLETED|Overall Study||12||
59756842|NCT00791661|75875761|FG001|COMPLETED|Period 2||8||
59756843|NCT00791661|75875762|FG002|COMPLETED|Period 2||6||
59756844|NCT00791661|75875760|FG000|NOT COMPLETED|Period 2||0||
59756845|NCT00791661|75875761|FG001|NOT COMPLETED|Period 2||0||
59756846|NCT00791661|75875762|FG002|NOT COMPLETED|Period 2||0||
59756847|NCT00791661|75875760|FG000|STARTED|7 Day Wash-out||8||
59756848|NCT00791661|75875761|FG001|STARTED|7 Day Wash-out||8||
59756849|NCT00791661|75875762|FG002|STARTED|7 Day Wash-out||6||
59756850|NCT00791661|75875760|FG000|COMPLETED|7 Day Wash-out||8||
59756851|NCT00791661|75875761|FG001|COMPLETED|7 Day Wash-out||8||
59756852|NCT00791661|75875762|FG002|COMPLETED|7 Day Wash-out||6||
59756853|NCT00791661|75875760|FG000|NOT COMPLETED|7 Day Wash-out||0||
59756854|NCT00791661|75875761|FG001|NOT COMPLETED|7 Day Wash-out||0||
59756855|NCT00791661|75875762|FG002|NOT COMPLETED|7 Day Wash-out||0||
59756856|NCT00791661|75875760|FG000|STARTED|Period 3||8||
59756857|NCT00791661|75875761|FG001|STARTED|Period 3||8||
59756858|NCT00791661|75875762|FG002|STARTED|Period 3||6||
59756859|NCT00791661|75875760|FG000|Received MK-1006|Period 3||6||
59756860|NCT00791661|75875761|FG001|Received MK-1006|Period 3||6||
59756861|NCT00791661|75875762|FG002|Received MK-1006|Period 3||5||
59756862|NCT00791661|75875760|FG000|Received Matching Placebo to MK-1006|Period 3||2||
59756863|NCT00791661|75875761|FG001|Received Matching Placebo to MK-1006|Period 3||2||
59756864|NCT00791661|75875762|FG002|Received Matching Placebo to MK-1006|Period 3||1||
59756865|NCT00791661|75875760|FG000|COMPLETED|Period 3||8||
59756866|NCT00791661|75875761|FG001|COMPLETED|Period 3||8||
59756867|NCT00791661|75875762|FG002|COMPLETED|Period 3||6||
59756868|NCT00791661|75875760|FG000|NOT COMPLETED|Period 3||0||
59756869|NCT00791661|75875761|FG001|NOT COMPLETED|Period 3||0||
59756870|NCT00791661|75875762|FG002|NOT COMPLETED|Period 3||0||
59756871|NCT00943787|75875786|FG000|STARTED|Overall Study||41||
59756872|NCT00943787|75875786|FG000|COMPLETED|Overall Study||34||
59756873|NCT00943787|75875786|FG000|NOT COMPLETED|Overall Study||7||
59756874|NCT00949325|75875790|FG000|STARTED|Overall Study||3||
59505626|NCT00707759|75598449|FG000|NOT COMPLETED|Overall Study||2||
59505627|NCT00707759|75598450|FG001|NOT COMPLETED|Overall Study||2||
59505628|NCT00707915|75598456|FG000|STARTED|Overall Study||30||
59505629|NCT00707915|75598456|FG000|Effects of Discontinuing Benzodiazepine|Overall Study||30||
59505630|NCT00707915|75598456|FG000|COMPLETED|Overall Study||30||
59505631|NCT00707915|75598456|FG000|NOT COMPLETED|Overall Study||0||
59505632|NCT00708071|75598460|FG000|STARTED|Overall Study|Randomized and treated|45||
59505633|NCT00708071|75598460|FG000|COMPLETED|Overall Study||45||
59505634|NCT00708071|75598460|FG000|NOT COMPLETED|Overall Study||0||
59505635|NCT00723749|75598494|FG000|STARTED|Overall Study|384 patients were enrolled, 36 non-eligible datasets were excluded from analysis|345||
59756875|NCT00949325|75875791|FG001|STARTED|Overall Study||18||
59756876|NCT00949325|75875792|FG002|STARTED|Overall Study||3||
59756877|NCT00949325|75875790|FG000|COMPLETED|Overall Study||3||
59756878|NCT00949325|75875791|FG001|COMPLETED|Overall Study||16||
59756879|NCT00949325|75875792|FG002|COMPLETED|Overall Study||3||
59756880|NCT00949325|75875790|FG000|NOT COMPLETED|Overall Study||0||
59756881|NCT00949325|75875791|FG001|NOT COMPLETED|Overall Study||2||
59756882|NCT00949325|75875792|FG002|NOT COMPLETED|Overall Study||0||
59756883|NCT00943319|75875808|FG000|STARTED|Overall Study||50||
59756884|NCT00943319|75875808|FG000|COMPLETED|Overall Study||49||
59756885|NCT00943319|75875808|FG000|NOT COMPLETED|Overall Study||1||
59756886|NCT00790647|75875812|FG000|STARTED|Overall Study||10||
59756887|NCT00790647|75875812|FG000|COMPLETED|Overall Study||9||
59756888|NCT00790647|75875812|FG000|NOT COMPLETED|Overall Study||1||
59756889|NCT00790569|75875821|FG000|STARTED|End of Treatment (6 Month Interview)||137||
59756890|NCT00790569|75875822|FG001|STARTED|End of Treatment (6 Month Interview)||45||
59756891|NCT00790569|75875823|FG002|STARTED|End of Treatment (6 Month Interview)||133||
59756892|NCT00790569|75875821|FG000|COMPLETED|End of Treatment (6 Month Interview)||115||
59891252|NCT03508908|76013654|FG003|COMPLETED|Month 19-21||3||2
59891253|NCT03508908|76013651|FG000|NOT COMPLETED|Month 19-21||0||0
59891254|NCT03508908|76013652|FG001|NOT COMPLETED|Month 19-21||0||0
59891255|NCT03508908|76013653|FG002|NOT COMPLETED|Month 19-21||0||0
59891256|NCT03508908|76013654|FG003|NOT COMPLETED|Month 19-21||0||0
59891257|NCT03508908|76013651|FG000|STARTED|Month 22-24||0||0
59891258|NCT03508908|76013652|FG001|STARTED|Month 22-24||125||1
59891259|NCT03508908|76013653|FG002|STARTED|Month 22-24||0||0
59891260|NCT03508908|76013654|FG003|STARTED|Month 22-24||0||0
59891261|NCT03508908|76013651|FG000|COMPLETED|Month 22-24||0||0
59891262|NCT03508908|76013652|FG001|COMPLETED|Month 22-24||125||1
59891263|NCT03508908|76013653|FG002|COMPLETED|Month 22-24||0||0
59891264|NCT03508908|76013654|FG003|COMPLETED|Month 22-24||0||0
59891265|NCT03508908|76013651|FG000|NOT COMPLETED|Month 22-24||0||0
59891266|NCT03508908|76013652|FG001|NOT COMPLETED|Month 22-24||0||0
59891267|NCT03508908|76013653|FG002|NOT COMPLETED|Month 22-24||0||0
59891268|NCT03508908|76013654|FG003|NOT COMPLETED|Month 22-24||0||0
59891269|NCT03299842|76013669|FG000|STARTED|Overall Study||5||
59891270|NCT03299842|76013669|FG000|COMPLETED|Overall Study||0||
59891271|NCT03299842|76013669|FG000|NOT COMPLETED|Overall Study||5||
59891272|NCT03237611|76013673|FG000|STARTED|Overall Study||15||
59891273|NCT03237611|76013673|FG000|COMPLETED|Overall Study||13||
59610470|NCT01841970|75721314|FG000|STARTED|Overall Study||20||
59610471|NCT01841970|75721314|FG000|COMPLETED|Overall Study||9||
59610472|NCT01841970|75721314|FG000|NOT COMPLETED|Overall Study||11||
59610473|NCT01823328|75721323|FG000|STARTED|Overall Study||70||
59610474|NCT01823328|75721324|FG001|STARTED|Overall Study||73||
59891274|NCT03237611|76013673|FG000|NOT COMPLETED|Overall Study||2||
59891275|NCT03104374|76013680|FG000|STARTED|Overall Study||106||
59891276|NCT03104374|76013681|FG001|STARTED|Overall Study||106||
59891277|NCT03104374|76013682|FG002|STARTED|Overall Study||211||
59891278|NCT03104374|76013683|FG003|STARTED|Overall Study||219||
59891279|NCT03104374|76013680|FG000|Received Study Drug|Overall Study||106||
59891280|NCT03104374|76013681|FG001|Received Study Drug|Overall Study||106||
59891281|NCT03104374|76013682|FG002|Received Study Drug|Overall Study||211||
59891282|NCT03104374|76013683|FG003|Received Study Drug|Overall Study||218||
59891283|NCT03104374|76013680|FG000|Completed Week 24|Overall Study||81||
59891284|NCT03104374|76013681|FG001|Completed Week 24|Overall Study||92||
59891285|NCT03104374|76013682|FG002|Completed Week 24|Overall Study||192||
59891286|NCT03104374|76013683|FG003|Completed Week 24|Overall Study||195||
59891287|NCT03104374|76013680|FG000|COMPLETED|Overall Study||69|Completed Week 56 (Period 1)|
59891288|NCT03104374|76013681|FG001|COMPLETED|Overall Study||77|Completed Week 56 (Period 1)|
59891289|NCT03104374|76013682|FG002|COMPLETED|Overall Study||167|Completed Week 56 (Period 1)|
59891290|NCT03104374|76013683|FG003|COMPLETED|Overall Study||166|Completed Week 56 (Period 1)|
59891291|NCT03104374|76013680|FG000|NOT COMPLETED|Overall Study||37||
59891292|NCT03104374|76013681|FG001|NOT COMPLETED|Overall Study||29||
59891293|NCT03104374|76013682|FG002|NOT COMPLETED|Overall Study||44||
59891294|NCT03104374|76013683|FG003|NOT COMPLETED|Overall Study||53||
59891295|NCT03098641|76013693|FG000|STARTED|Overall Study||272||
59891296|NCT03098641|76013693|FG000|COMPLETED|Overall Study||220||
59891297|NCT03098641|76013693|FG000|NOT COMPLETED|Overall Study||52||
59891298|NCT03054363|76013699|FG000|STARTED|Overall Study||20||
59891299|NCT03054363|76013700|FG001|STARTED|Overall Study||22||
59891300|NCT03054363|76013699|FG000|COMPLETED|Overall Study||20||
59891301|NCT03054363|76013700|FG001|COMPLETED|Overall Study||22||
59891302|NCT03054363|76013699|FG000|NOT COMPLETED|Overall Study||0||
59891303|NCT03054363|76013700|FG001|NOT COMPLETED|Overall Study||0||
59891304|NCT03043313|76013716|FG000|STARTED|Overall Study||45||
59891305|NCT03043313|76013717|FG001|STARTED|Overall Study||41||
59610475|NCT01823328|75721323|FG000|COMPLETED|Overall Study||62|The number of completions is lower than the number started because of withdrawal by patients.|
59610476|NCT01823328|75721324|FG001|COMPLETED|Overall Study||67|The number of completions is lower than the number started because of withdrawal by patients.|
59756893|NCT00790569|75875822|FG001|COMPLETED|End of Treatment (6 Month Interview)||35||
59756894|NCT00790569|75875823|FG002|COMPLETED|End of Treatment (6 Month Interview)||107||
59756895|NCT00790569|75875821|FG000|NOT COMPLETED|End of Treatment (6 Month Interview)||22||
59756896|NCT00790569|75875822|FG001|NOT COMPLETED|End of Treatment (6 Month Interview)||10||
59756897|NCT00790569|75875823|FG002|NOT COMPLETED|End of Treatment (6 Month Interview)||26||
59756898|NCT00790569|75875821|FG000|STARTED|End of Study (12 Month Interview)||137||
59756899|NCT00790569|75875822|FG001|STARTED|End of Study (12 Month Interview)||45||
59891306|NCT03043313|76013718|FG002|STARTED|Overall Study||31||
59891307|NCT03043313|76013716|FG000|COMPLETED|Overall Study||0||
59891308|NCT03043313|76013717|FG001|COMPLETED|Overall Study||0||
59891309|NCT03043313|76013718|FG002|COMPLETED|Overall Study||0||
59891310|NCT03043313|76013716|FG000|NOT COMPLETED|Overall Study||45||
59891311|NCT03043313|76013717|FG001|NOT COMPLETED|Overall Study||41||
59891312|NCT03043313|76013718|FG002|NOT COMPLETED|Overall Study||31||
59891313|NCT02834780|76013738|FG000|STARTED|Overall Study||3||
59891314|NCT02834780|76013739|FG001|STARTED|Overall Study||3||
59891315|NCT02834780|76013740|FG002|STARTED|Overall Study||4||
59891316|NCT02834780|76013741|FG003|STARTED|Overall Study||10||
59891317|NCT02834780|76013742|FG004|STARTED|Overall Study||3||
59891318|NCT02834780|76013743|FG005|STARTED|Overall Study||7||
59891319|NCT02834780|76013744|FG006|STARTED|Overall Study||4||
59891320|NCT02834780|76013745|FG007|STARTED|Overall Study||7||
59891321|NCT02834780|76013746|FG008|STARTED|Overall Study||3||
59891322|NCT02834780|76013747|FG009|STARTED|Overall Study||10||
59891323|NCT02834780|76013748|FG010|STARTED|Overall Study||5||
59891324|NCT02834780|76013749|FG011|STARTED|Overall Study||29||
59891325|NCT02834780|76013750|FG012|STARTED|Overall Study||40||
59891326|NCT02834780|76013738|FG000|COMPLETED|Overall Study||0||
59891327|NCT02834780|76013739|FG001|COMPLETED|Overall Study||0||
59891328|NCT02834780|76013740|FG002|COMPLETED|Overall Study||0||
59891329|NCT02834780|76013741|FG003|COMPLETED|Overall Study||0||
59891330|NCT02834780|76013742|FG004|COMPLETED|Overall Study||0||
59891331|NCT02834780|76013743|FG005|COMPLETED|Overall Study||0||
59891332|NCT02834780|76013744|FG006|COMPLETED|Overall Study||0||
59891333|NCT02834780|76013745|FG007|COMPLETED|Overall Study||0||
59891334|NCT02834780|76013746|FG008|COMPLETED|Overall Study||0||
59891335|NCT02834780|76013747|FG009|COMPLETED|Overall Study||0||
59891336|NCT02834780|76013748|FG010|COMPLETED|Overall Study||0||
59891337|NCT02834780|76013749|FG011|COMPLETED|Overall Study||0||
59891338|NCT02834780|76013750|FG012|COMPLETED|Overall Study||0||
59891339|NCT02834780|76013738|FG000|NOT COMPLETED|Overall Study||3||
59891340|NCT02834780|76013739|FG001|NOT COMPLETED|Overall Study||3||
59891341|NCT02834780|76013740|FG002|NOT COMPLETED|Overall Study||4||
59891342|NCT02834780|76013741|FG003|NOT COMPLETED|Overall Study||10||
59891343|NCT02834780|76013742|FG004|NOT COMPLETED|Overall Study||3||
59891344|NCT02834780|76013743|FG005|NOT COMPLETED|Overall Study||7||
59891345|NCT02834780|76013744|FG006|NOT COMPLETED|Overall Study||4||
59891346|NCT02834780|76013745|FG007|NOT COMPLETED|Overall Study||7||
59891347|NCT02834780|76013746|FG008|NOT COMPLETED|Overall Study||3||
59891348|NCT02834780|76013747|FG009|NOT COMPLETED|Overall Study||10||
59891349|NCT02834780|76013748|FG010|NOT COMPLETED|Overall Study||5||
59891350|NCT02834780|76013749|FG011|NOT COMPLETED|Overall Study||29||
59891351|NCT02834780|76013750|FG012|NOT COMPLETED|Overall Study||40||
59891352|NCT02829957|76013786|FG000|STARTED|Overall Study||8||
59891353|NCT02829957|76013787|FG001|STARTED|Overall Study||11||
59891354|NCT02829957|76013786|FG000|COMPLETED|Overall Study||6||
59891355|NCT02829957|76013787|FG001|COMPLETED|Overall Study||10||
59891356|NCT02829957|76013786|FG000|NOT COMPLETED|Overall Study||2||
59891357|NCT02829957|76013787|FG001|NOT COMPLETED|Overall Study||1||
59891358|NCT02022436|76013795|FG000|STARTED|Overall Study||59||
59891359|NCT02022436|76013796|FG001|STARTED|Overall Study||7||
59891360|NCT02022436|76013795|FG000|COMPLETED|Overall Study||59||
59891361|NCT02022436|76013796|FG001|COMPLETED|Overall Study||7||
59891362|NCT02022436|76013795|FG000|NOT COMPLETED|Overall Study||0||
59891363|NCT02022436|76013796|FG001|NOT COMPLETED|Overall Study||0||
59891364|NCT01984346|76013806|FG000|STARTED|Overall Study|Date of full approval was 8/22/13. Date of first treated patient was 01/08/14|115|FDA full approval|
59891365|NCT01984346|76013807|FG001|STARTED|Overall Study||55|FDA full approval|
59891366|NCT01984346|76013806|FG000|Treated|Overall Study||102||
59891367|NCT01984346|76013807|FG001|Treated|Overall Study||51||
59891368|NCT01984346|76013806|FG000|COMPLETED|Overall Study||98|enrollment complete 153 treated|
59891369|NCT01984346|76013807|FG001|COMPLETED|Overall Study||50|enrollment complete 153 treated|
59891370|NCT01984346|76013806|FG000|NOT COMPLETED|Overall Study||17||
59891371|NCT01984346|76013807|FG001|NOT COMPLETED|Overall Study||5||
59891372|NCT01442363|76013816|FG000|STARTED|Overall Study||2||
59891373|NCT01442363|76013817|FG001|STARTED|Overall Study||2||
59891374|NCT01442363|76013818|FG002|STARTED|Overall Study||0||
59891375|NCT01442363|76013816|FG000|COMPLETED|Overall Study||2||
59891376|NCT01442363|76013817|FG001|COMPLETED|Overall Study||1||
59891377|NCT01442363|76013818|FG002|COMPLETED|Overall Study||0||
59891378|NCT01442363|76013816|FG000|NOT COMPLETED|Overall Study||0||
59891379|NCT01442363|76013817|FG001|NOT COMPLETED|Overall Study||1||
59891380|NCT01442363|76013818|FG002|NOT COMPLETED|Overall Study||0||
59891381|NCT01393171|76013829|FG000|STARTED|Overall Study||36|Oct 2005|
59891382|NCT01393171|76013830|FG001|STARTED|Overall Study||32|Oct 2005|
59891383|NCT01393171|76013831|FG002|STARTED|Overall Study||31|Oct 2005|
59891384|NCT01393171|76013829|FG000|COMPLETED|Overall Study||28||
59891385|NCT01393171|76013830|FG001|COMPLETED|Overall Study||24||
59891386|NCT01393171|76013831|FG002|COMPLETED|Overall Study||26||
59891387|NCT01393171|76013829|FG000|NOT COMPLETED|Overall Study||8||
59891388|NCT01393171|76013830|FG001|NOT COMPLETED|Overall Study||8||
59891389|NCT01393171|76013831|FG002|NOT COMPLETED|Overall Study||5||
59891390|NCT01186198|76013839|FG000|STARTED|Overall Study||71||
59891391|NCT01186198|76013839|FG000|COMPLETED|Overall Study||71||
59891392|NCT01186198|76013839|FG000|NOT COMPLETED|Overall Study||0||
59891393|NCT03772327|76013845|FG000|STARTED|Overall Study||30|Eligible participants were randomized at the end of a screening visit|
59891394|NCT03772327|76013846|FG001|STARTED|Overall Study||33|Eligible participants were randomized at the end of a screening visit|
59891395|NCT03772327|76013845|FG000|Week 0 Visit|Overall Study|2 participants were lost to follow up after randomization prior to any study interventions.|28||
59891396|NCT03772327|76013846|FG001|Week 0 Visit|Overall Study||33||
59891397|NCT03772327|76013845|FG000|COMPLETED|Overall Study||25||
59891398|NCT03772327|76013846|FG001|COMPLETED|Overall Study||26||
59891399|NCT03772327|76013845|FG000|NOT COMPLETED|Overall Study||5||
59891400|NCT03772327|76013846|FG001|NOT COMPLETED|Overall Study||7||
59891401|NCT03109262|76013852|FG000|STARTED|Overall Study||42||
59610477|NCT01823328|75721323|FG000|NOT COMPLETED|Overall Study||8||
59610478|NCT01823328|75721324|FG001|NOT COMPLETED|Overall Study||6||
59610479|NCT01840410|75721332|FG000|STARTED|Overall Study||119||
59610480|NCT01840410|75721333|FG001|STARTED|Overall Study||59||
59756900|NCT00790569|75875823|FG002|STARTED|End of Study (12 Month Interview)||133||
59756901|NCT00790569|75875821|FG000|COMPLETED|End of Study (12 Month Interview)||71||
59756902|NCT00790569|75875822|FG001|COMPLETED|End of Study (12 Month Interview)||26||
59756903|NCT00790569|75875823|FG002|COMPLETED|End of Study (12 Month Interview)||83||
59756904|NCT00790569|75875821|FG000|NOT COMPLETED|End of Study (12 Month Interview)||66||
59756905|NCT00790569|75875822|FG001|NOT COMPLETED|End of Study (12 Month Interview)||19||
59756906|NCT00790569|75875823|FG002|NOT COMPLETED|End of Study (12 Month Interview)||50||
59756907|NCT00939029|75875833|FG000|STARTED|Overall Study||25||
59756908|NCT00939029|75875834|FG001|STARTED|Overall Study||27||
59756909|NCT00939029|75875833|FG000|COMPLETED|Overall Study||19||
59756910|NCT00939029|75875834|FG001|COMPLETED|Overall Study||15||
59756911|NCT00939029|75875833|FG000|NOT COMPLETED|Overall Study||6||
59756912|NCT00939029|75875834|FG001|NOT COMPLETED|Overall Study||12||
59756913|NCT00587847|75875840|FG000|STARTED|Overall Study||12||
59756914|NCT00587847|75875840|FG000|COMPLETED|Overall Study||5||
59756915|NCT00587847|75875840|FG000|NOT COMPLETED|Overall Study||7||
59756916|NCT00784563|75875848|FG000|STARTED|Years 1 & 2||21||
59756917|NCT00784563|75875849|FG001|STARTED|Years 1 & 2||22||
59756918|NCT00784563|75875850|FG002|STARTED|Years 1 & 2||0||
59756919|NCT00784563|75875848|FG000|COMPLETED|Years 1 & 2||18||
59756920|NCT00784563|75875849|FG001|COMPLETED|Years 1 & 2||17||
59756921|NCT00784563|75875850|FG002|COMPLETED|Years 1 & 2||0||
59756922|NCT00784563|75875848|FG000|NOT COMPLETED|Years 1 & 2||3||
59756923|NCT00784563|75875849|FG001|NOT COMPLETED|Years 1 & 2||5||
59756924|NCT00784563|75875850|FG002|NOT COMPLETED|Years 1 & 2||0||
59756925|NCT00784563|75875848|FG000|STARTED|Year 3||0||
59756926|NCT00784563|75875849|FG001|STARTED|Year 3||0||
59756927|NCT00784563|75875850|FG002|STARTED|Year 3||17||
59756928|NCT00784563|75875848|FG000|COMPLETED|Year 3||0||
59756929|NCT00784563|75875849|FG001|COMPLETED|Year 3||0||
59756930|NCT00784563|75875850|FG002|COMPLETED|Year 3||14||
59756931|NCT00784563|75875848|FG000|NOT COMPLETED|Year 3||0||
59756932|NCT00784563|75875849|FG001|NOT COMPLETED|Year 3||0||
59756933|NCT00784563|75875850|FG002|NOT COMPLETED|Year 3||3||
59756934|NCT00938717|75875858|FG000|STARTED|Overall Study||403||
59756935|NCT00938717|75875859|FG001|STARTED|Overall Study||402||
59756936|NCT00938717|75875858|FG000|COMPLETED|Overall Study||305||
59756937|NCT00938717|75875859|FG001|COMPLETED|Overall Study||294||
59756938|NCT00938717|75875858|FG000|NOT COMPLETED|Overall Study||98||
59756939|NCT00938717|75875859|FG001|NOT COMPLETED|Overall Study||108||
59756940|NCT00587223|75875865|FG000|STARTED|Overall Study|Study design was within-subject control. Only 1 subject was enrolled in the study.|1||
59756941|NCT00587223|75875865|FG000|COMPLETED|Overall Study|Subject withdrawn from study at Day 7.|0||
59756942|NCT00587223|75875865|FG000|NOT COMPLETED|Overall Study||1||
59756943|NCT00938639|75875874|FG000|STARTED|Overall Study||120||
59756944|NCT00938639|75875875|FG001|STARTED|Overall Study||120||
59756945|NCT00938639|75875874|FG000|COMPLETED|Overall Study||117||
59610481|NCT01840410|75721332|FG000|Safety Set|Overall Study||119||
59610482|NCT01840410|75721333|FG001|Safety Set|Overall Study|52 received ranibizumab at or after Month 2;7 did not receive ranibizumab any time during the study|59||
59610483|NCT01840410|75721332|FG000|Full Analysis Set|Overall Study||119||
59610484|NCT01840410|75721333|FG001|Full Analysis Set|Overall Study||59||
59610485|NCT01840410|75721332|FG000|COMPLETED|Overall Study||112||
59610486|NCT01840410|75721333|FG001|COMPLETED|Overall Study||55||
59610487|NCT01840410|75721332|FG000|NOT COMPLETED|Overall Study||7||
59610488|NCT01840410|75721333|FG001|NOT COMPLETED|Overall Study||4||
59610489|NCT01797432|75721341|FG000|STARTED|Overall Study||14||
59610490|NCT01797432|75721341|FG000|COMPLETED|Overall Study||10||
59610491|NCT01797432|75721341|FG000|NOT COMPLETED|Overall Study||4||
59610492|NCT01797120|75721347|FG000|STARTED|Overall Study||66||
59610493|NCT01797120|75721348|FG001|STARTED|Overall Study||65||
59610494|NCT01797120|75721347|FG000|COMPLETED|Overall Study||0||
59610495|NCT01797120|75721348|FG001|COMPLETED|Overall Study||0||
59610496|NCT01797120|75721347|FG000|NOT COMPLETED|Overall Study||66||
59756946|NCT00938639|75875875|FG001|COMPLETED|Overall Study||116||
59610497|NCT01797120|75721348|FG001|NOT COMPLETED|Overall Study||65||
59610498|NCT01796964|75721356|FG000|STARTED|Overall Study||44||
59610499|NCT01796964|75721357|FG001|STARTED|Overall Study||45||
59610500|NCT01796964|75721356|FG000|COMPLETED|Overall Study||41||
59610501|NCT01796964|75721357|FG001|COMPLETED|Overall Study||42||
59756947|NCT00938639|75875874|FG000|NOT COMPLETED|Overall Study||3||
59756948|NCT00938639|75875875|FG001|NOT COMPLETED|Overall Study||4||
59756949|NCT00783705|75875887|FG000|STARTED|Overall Study||44||
59756950|NCT00783705|75875888|FG001|STARTED|Overall Study||41||
59891402|NCT03109262|76013852|FG000|COMPLETED|Overall Study||42||
59891403|NCT03109262|76013852|FG000|NOT COMPLETED|Overall Study||0||
59891404|NCT03072134|76013861|FG000|STARTED|Cohort 1: 0.5x10^8/NSCs/6.25x10^10 vp||3||
59891405|NCT03072134|76013861|FG000|COMPLETED|Cohort 1: 0.5x10^8/NSCs/6.25x10^10 vp||3||
59891406|NCT03072134|76013861|FG000|NOT COMPLETED|Cohort 1: 0.5x10^8/NSCs/6.25x10^10 vp||0||
59891407|NCT03072134|76013861|FG000|STARTED|Cohort 2: 1.0x10^8 NSCs/1.25x10^10 vp||3||
59891408|NCT03072134|76013861|FG000|COMPLETED|Cohort 2: 1.0x10^8 NSCs/1.25x10^10 vp||3||
59891409|NCT03072134|76013861|FG000|NOT COMPLETED|Cohort 2: 1.0x10^8 NSCs/1.25x10^10 vp||0||
59891410|NCT03072134|76013861|FG000|STARTED|Cohort 3: 1.5x10^8 NSCs/1.875x10^10 vp||6|An additional 3 subjects were added as one subject at this dose level experienced a DLT.|
59891411|NCT03072134|76013861|FG000|COMPLETED|Cohort 3: 1.5x10^8 NSCs/1.875x10^10 vp||6||
59891412|NCT03072134|76013861|FG000|NOT COMPLETED|Cohort 3: 1.5x10^8 NSCs/1.875x10^10 vp||0||
59891413|NCT05022602|76013870|FG000|STARTED|Overall Study||38||
59891414|NCT05022602|76013870|FG000|COMPLETED|Overall Study||38||
59891415|NCT05022602|76013870|FG000|NOT COMPLETED|Overall Study||0||
59891416|NCT04549597|76013877|FG000|STARTED|Overall Study||151||
59891417|NCT04549597|76013878|FG001|STARTED|Overall Study||152||
59891418|NCT04549597|76013879|FG002|STARTED|Overall Study||30||
59891419|NCT04549597|76013877|FG000|COMPLETED|Overall Study||127||
59891420|NCT04549597|76013878|FG001|COMPLETED|Overall Study||133||
59891421|NCT04549597|76013879|FG002|COMPLETED|Overall Study||25||
59891422|NCT04549597|76013877|FG000|NOT COMPLETED|Overall Study||24||
59891423|NCT04549597|76013878|FG001|NOT COMPLETED|Overall Study||19||
59891424|NCT04549597|76013879|FG002|NOT COMPLETED|Overall Study||5||
59891425|NCT04364763|76013889|FG000|STARTED|Overall Study||28||
59891426|NCT04364763|76013890|FG001|STARTED|Overall Study||14||
59891427|NCT04364763|76013889|FG000|COMPLETED|Overall Study||26|Day 56 Study Visit|
59891428|NCT04364763|76013890|FG001|COMPLETED|Overall Study||12|Day 56 Study Visit|
59891429|NCT04364763|76013889|FG000|NOT COMPLETED|Overall Study||2||
59891430|NCT04364763|76013890|FG001|NOT COMPLETED|Overall Study||2||
59891431|NCT04249778|76013898|FG000|STARTED|Overall Study||50||
59891432|NCT04249778|76013899|FG001|STARTED|Overall Study||55||
59891433|NCT04249778|76013898|FG000|COMPLETED|Overall Study||16||
59891434|NCT04249778|76013899|FG001|COMPLETED|Overall Study||24||
59891435|NCT04249778|76013898|FG000|NOT COMPLETED|Overall Study||34||
59891436|NCT04249778|76013899|FG001|NOT COMPLETED|Overall Study||31||
59891437|NCT04247815|76013907|FG000|STARTED|Overall Study||16||
59891438|NCT04247815|76013908|FG001|STARTED|Overall Study||3||
59891439|NCT04247815|76013907|FG000|COMPLETED|Overall Study||14||
59891440|NCT04247815|76013908|FG001|COMPLETED|Overall Study||2||
59891441|NCT04247815|76013907|FG000|NOT COMPLETED|Overall Study||2||
59891442|NCT04247815|76013908|FG001|NOT COMPLETED|Overall Study||1||
59891443|NCT03988920|76013916|FG000|STARTED|Overall Study||111||
59891444|NCT03988920|76013917|FG001|STARTED|Overall Study||61||
59891445|NCT03988920|76013916|FG000|COMPLETED|Overall Study||89||
59891446|NCT03988920|76013917|FG001|COMPLETED|Overall Study||35||
59891447|NCT03988920|76013916|FG000|NOT COMPLETED|Overall Study||22||
59891448|NCT03988920|76013917|FG001|NOT COMPLETED|Overall Study||26||
59891449|NCT03664752|76013925|FG000|STARTED|Overall Study||293||
59891450|NCT03664752|76013926|FG001|STARTED|Overall Study||292||
59891451|NCT03664752|76013925|FG000|COMPLETED|Overall Study||244||
59891452|NCT03664752|76013926|FG001|COMPLETED|Overall Study||241||
59891453|NCT03664752|76013925|FG000|NOT COMPLETED|Overall Study||49||
59891454|NCT03664752|76013926|FG001|NOT COMPLETED|Overall Study||51||
59891455|NCT03664739|76013934|FG000|STARTED|Overall Study||306||
59891456|NCT03664739|76013935|FG001|STARTED|Overall Study||302||
59891457|NCT03664739|76013934|FG000|COMPLETED|Overall Study||256||
59891458|NCT03664739|76013935|FG001|COMPLETED|Overall Study||270||
59891459|NCT03664739|76013934|FG000|NOT COMPLETED|Overall Study||50||
59891460|NCT03664739|76013935|FG001|NOT COMPLETED|Overall Study||32||
59891461|NCT03432819|76013943|FG000|STARTED|Overall Study||38||
59891462|NCT03432819|76013944|FG001|STARTED|Overall Study||38||
59891463|NCT03432819|76013943|FG000|COMPLETED|Overall Study||31||
59891464|NCT03432819|76013944|FG001|COMPLETED|Overall Study||33||
59891465|NCT03432819|76013943|FG000|NOT COMPLETED|Overall Study||7||
59891466|NCT03432819|76013944|FG001|NOT COMPLETED|Overall Study||5||
60013729|NCT02472795|76129671|FG000|NOT COMPLETED|Overall Study||0||
59891467|NCT03411031|76013952|FG000|STARTED|Overall Study||9||
59891468|NCT03411031|76013953|FG001|STARTED|Overall Study||9||
59891469|NCT03411031|76013952|FG000|COMPLETED|Overall Study||9||
59891470|NCT03411031|76013953|FG001|COMPLETED|Overall Study||9||
59891471|NCT03411031|76013952|FG000|NOT COMPLETED|Overall Study||0||
59891472|NCT03411031|76013953|FG001|NOT COMPLETED|Overall Study||0||
59891473|NCT03289351|76013961|FG000|STARTED|Overall Study||80||
59891474|NCT03289351|76013962|FG001|STARTED|Overall Study||82||
59891475|NCT03289351|76013961|FG000|COMPLETED|Overall Study||80||
59891476|NCT03289351|76013962|FG001|COMPLETED|Overall Study||82||
59891477|NCT03289351|76013961|FG000|NOT COMPLETED|Overall Study||0||
59891478|NCT03289351|76013962|FG001|NOT COMPLETED|Overall Study||0||
60013730|NCT02472795|76129672|FG001|NOT COMPLETED|Overall Study||1||
59891479|NCT03272347|76013972|FG000|STARTED|Overall Study||31||
59891480|NCT03272347|76013973|FG001|STARTED|Overall Study||30||
59891481|NCT03272347|76013974|FG002|STARTED|Overall Study||31||
59891482|NCT03272347|76013975|FG003|STARTED|Overall Study||31||
59891483|NCT03272347|76013972|FG000|Treated|Overall Study||29||
59891484|NCT03272347|76013973|FG001|Treated|Overall Study||30||
59891485|NCT03272347|76013974|FG002|Treated|Overall Study||31||
59891486|NCT03272347|76013975|FG003|Treated|Overall Study||31||
59891487|NCT03272347|76013972|FG000|COMPLETED|Overall Study||20||
59891488|NCT03272347|76013973|FG001|COMPLETED|Overall Study||24||
59891489|NCT03272347|76013974|FG002|COMPLETED|Overall Study||19||
59891490|NCT03272347|76013975|FG003|COMPLETED|Overall Study||24||
59891491|NCT03272347|76013972|FG000|NOT COMPLETED|Overall Study||11||
59891492|NCT03272347|76013973|FG001|NOT COMPLETED|Overall Study||6||
59891493|NCT03272347|76013974|FG002|NOT COMPLETED|Overall Study||12||
59891494|NCT03272347|76013975|FG003|NOT COMPLETED|Overall Study||7||
59891495|NCT03259568|76013997|FG000|STARTED|Overall Study||27||
59891496|NCT03259568|76013997|FG000|COMPLETED|Overall Study||24||
59891497|NCT03259568|76013997|FG000|NOT COMPLETED|Overall Study||3||
59891498|NCT03239470|76014007|FG000|STARTED|Blood Donation||5||
59891499|NCT03239470|76014008|FG001|STARTED|Blood Donation||0||
59891500|NCT03239470|76014007|FG000|COMPLETED|Blood Donation||5||
59891501|NCT03239470|76014008|FG001|COMPLETED|Blood Donation||0||
59891502|NCT03239470|76014007|FG000|NOT COMPLETED|Blood Donation||0||
59891503|NCT03239470|76014008|FG001|NOT COMPLETED|Blood Donation||0||
59891504|NCT03239470|76014007|FG000|STARTED|Polyclonal Treg Infusion|Started includes all participants who completed the pre-infusion checklist at the infusion visit.|5||
59891505|NCT03239470|76014008|FG001|STARTED|Polyclonal Treg Infusion||0||
59891506|NCT03239470|76014007|FG000|COMPLETED|Polyclonal Treg Infusion|Participants who did not meet eligibility, per the pre-infusion checklist, did not complete study infusion.|4||
59891507|NCT03239470|76014008|FG001|COMPLETED|Polyclonal Treg Infusion||0||
59891508|NCT03239470|76014007|FG000|NOT COMPLETED|Polyclonal Treg Infusion||1||
59891509|NCT03239470|76014008|FG001|NOT COMPLETED|Polyclonal Treg Infusion||0||
59891510|NCT03167723|76014014|FG000|STARTED|Overall Study||55||
59891511|NCT03167723|76014015|FG001|STARTED|Overall Study||54||
59891512|NCT03167723|76014014|FG000|COMPLETED|Overall Study||51||
59891513|NCT03167723|76014015|FG001|COMPLETED|Overall Study||48||
59891514|NCT03167723|76014014|FG000|NOT COMPLETED|Overall Study||4||
59891515|NCT03167723|76014015|FG001|NOT COMPLETED|Overall Study||6||
59891516|NCT03103152|76014027|FG000|STARTED|Overall Study||17||
59891517|NCT03103152|76014028|FG001|STARTED|Overall Study||16||
59891518|NCT03103152|76014029|FG002|STARTED|Overall Study||19||
59891519|NCT03103152|76014030|FG003|STARTED|Overall Study||18||
59891520|NCT03103152|76014031|FG004|STARTED|Overall Study||16||
59891521|NCT03103152|76014032|FG005|STARTED|Overall Study||18||
59891522|NCT03103152|76014027|FG000|COMPLETED|Overall Study||7||
59891523|NCT03103152|76014028|FG001|COMPLETED|Overall Study||10||
59891524|NCT03103152|76014029|FG002|COMPLETED|Overall Study||8||
59891525|NCT03103152|76014030|FG003|COMPLETED|Overall Study||9||
59891526|NCT03103152|76014031|FG004|COMPLETED|Overall Study||10||
60013731|NCT02472795|76129673|FG002|NOT COMPLETED|Overall Study||0||
60013732|NCT02472795|76129674|FG003|NOT COMPLETED|Overall Study||0||
60013733|NCT02472795|76129675|FG004|NOT COMPLETED|Overall Study||3||
60013734|NCT02507349|76129689|FG000|STARTED|Overall Study||1232||
60013735|NCT02507349|76129690|FG001|STARTED|Overall Study||1211||
60013736|NCT02507349|76129689|FG000|COMPLETED|Overall Study||1045||
60013737|NCT02507349|76129690|FG001|COMPLETED|Overall Study||1050||
60013738|NCT02507349|76129689|FG000|NOT COMPLETED|Overall Study||187||
60013739|NCT02507349|76129690|FG001|NOT COMPLETED|Overall Study||161||
60013740|NCT02506881|76129700|FG000|STARTED|First Intervention (Day 1)||13||
60013741|NCT02506881|76129701|FG001|STARTED|First Intervention (Day 1)||12||
60013742|NCT02506881|76129702|FG002|STARTED|First Intervention (Day 1)||25||
60013743|NCT02506881|76129703|FG003|STARTED|First Intervention (Day 1)||24||
60013744|NCT02506881|76129700|FG000|COMPLETED|First Intervention (Day 1)||12||
60013745|NCT02506881|76129701|FG001|COMPLETED|First Intervention (Day 1)||12||
60013746|NCT02506881|76129702|FG002|COMPLETED|First Intervention (Day 1)||12||
59891527|NCT03103152|76014032|FG005|COMPLETED|Overall Study||9||
59891528|NCT03103152|76014027|FG000|NOT COMPLETED|Overall Study||10||
60013747|NCT02506881|76129703|FG003|COMPLETED|First Intervention (Day 1)||12||
60013748|NCT02506881|76129700|FG000|NOT COMPLETED|First Intervention (Day 1)||1||
59891529|NCT03103152|76014028|FG001|NOT COMPLETED|Overall Study||6||
59891530|NCT03103152|76014029|FG002|NOT COMPLETED|Overall Study||11||
59891531|NCT03103152|76014030|FG003|NOT COMPLETED|Overall Study||9||
59891532|NCT03103152|76014031|FG004|NOT COMPLETED|Overall Study||6||
60013749|NCT02506881|76129701|FG001|NOT COMPLETED|First Intervention (Day 1)||0||
59891533|NCT03103152|76014032|FG005|NOT COMPLETED|Overall Study||9||
59891534|NCT03033901|76014046|FG000|STARTED|Overall Study||345||
59891535|NCT03033901|76014046|FG000|COMPLETED|Overall Study||248||
59891536|NCT03033901|76014046|FG000|NOT COMPLETED|Overall Study||97||
59891537|NCT02878785|76014050|FG000|STARTED|Overall Study||3||
59891538|NCT02878785|76014051|FG001|STARTED|Overall Study||0||
59891539|NCT02878785|76014052|FG002|STARTED|Overall Study||0||
59891540|NCT02878785|76014053|FG003|STARTED|Overall Study||0||
59891541|NCT02878785|76014054|FG004|STARTED|Overall Study||0||
59891542|NCT02878785|76014055|FG005|STARTED|Overall Study||0||
59891543|NCT02878785|76014056|FG006|STARTED|Overall Study||0||
59891544|NCT02878785|76014057|FG007|STARTED|Overall Study||0||
59891545|NCT02878785|76014058|FG008|STARTED|Overall Study||3||
59891546|NCT02878785|76014059|FG009|STARTED|Overall Study||7||
59891547|NCT02878785|76014060|FG010|STARTED|Overall Study||3||
59891548|NCT02878785|76014061|FG011|STARTED|Overall Study||3||
59891549|NCT02878785|76014062|FG012|STARTED|Overall Study||3||
59891550|NCT02878785|76014063|FG013|STARTED|Overall Study||3||
59891551|NCT02878785|76014050|FG000|COMPLETED|Overall Study||3||
59891552|NCT02878785|76014051|FG001|COMPLETED|Overall Study||0||
59891553|NCT02878785|76014052|FG002|COMPLETED|Overall Study||0||
59891554|NCT02878785|76014053|FG003|COMPLETED|Overall Study||0||
59891555|NCT02878785|76014054|FG004|COMPLETED|Overall Study||0||
59891556|NCT02878785|76014055|FG005|COMPLETED|Overall Study||0||
59891557|NCT02878785|76014056|FG006|COMPLETED|Overall Study||0||
59891558|NCT02878785|76014057|FG007|COMPLETED|Overall Study||0||
59891559|NCT02878785|76014058|FG008|COMPLETED|Overall Study||3||
59891560|NCT02878785|76014059|FG009|COMPLETED|Overall Study||7||
59891561|NCT02878785|76014060|FG010|COMPLETED|Overall Study||3||
59891562|NCT02878785|76014061|FG011|COMPLETED|Overall Study||3||
59891563|NCT02878785|76014062|FG012|COMPLETED|Overall Study||3||
59891564|NCT02878785|76014063|FG013|COMPLETED|Overall Study||3||
59891565|NCT02878785|76014050|FG000|NOT COMPLETED|Overall Study||0||
59891566|NCT02878785|76014051|FG001|NOT COMPLETED|Overall Study||0||
59891567|NCT02878785|76014052|FG002|NOT COMPLETED|Overall Study||0||
59891568|NCT02878785|76014053|FG003|NOT COMPLETED|Overall Study||0||
59891569|NCT02878785|76014054|FG004|NOT COMPLETED|Overall Study||0||
59891570|NCT02878785|76014055|FG005|NOT COMPLETED|Overall Study||0||
59891571|NCT02878785|76014056|FG006|NOT COMPLETED|Overall Study||0||
59891572|NCT02878785|76014057|FG007|NOT COMPLETED|Overall Study||0||
60013750|NCT02506881|76129702|FG002|NOT COMPLETED|First Intervention (Day 1)||13||
60013751|NCT02506881|76129703|FG003|NOT COMPLETED|First Intervention (Day 1)||12||
60013752|NCT02506881|76129700|FG000|STARTED|Washout (at Least 25 Days)||12||
60013753|NCT02506881|76129701|FG001|STARTED|Washout (at Least 25 Days)||12||
60013754|NCT02506881|76129702|FG002|STARTED|Washout (at Least 25 Days)||12||
60013755|NCT02506881|76129703|FG003|STARTED|Washout (at Least 25 Days)||12||
60013756|NCT02506881|76129700|FG000|COMPLETED|Washout (at Least 25 Days)||12||
60013757|NCT02506881|76129701|FG001|COMPLETED|Washout (at Least 25 Days)||12||
60013758|NCT02506881|76129702|FG002|COMPLETED|Washout (at Least 25 Days)||12||
60013759|NCT02506881|76129703|FG003|COMPLETED|Washout (at Least 25 Days)||12||
59891573|NCT02878785|76014058|FG008|NOT COMPLETED|Overall Study||0||
59891574|NCT02878785|76014059|FG009|NOT COMPLETED|Overall Study||0||
59891575|NCT02878785|76014060|FG010|NOT COMPLETED|Overall Study||0||
59891576|NCT02878785|76014061|FG011|NOT COMPLETED|Overall Study||0||
59891577|NCT02878785|76014062|FG012|NOT COMPLETED|Overall Study||0||
59891578|NCT02878785|76014063|FG013|NOT COMPLETED|Overall Study||0||
59891579|NCT02771990|76014082|FG000|STARTED|Overall Study||11||
59891580|NCT02771990|76014083|FG001|STARTED|Overall Study||10||
59891581|NCT02771990|76014082|FG000|COMPLETED|Overall Study||11||
59891582|NCT02771990|76014083|FG001|COMPLETED|Overall Study||10||
59891583|NCT02771990|76014082|FG000|NOT COMPLETED|Overall Study||0||
59891584|NCT02771990|76014083|FG001|NOT COMPLETED|Overall Study||0||
60013760|NCT02506881|76129700|FG000|NOT COMPLETED|Washout (at Least 25 Days)||0||
60013761|NCT02506881|76129701|FG001|NOT COMPLETED|Washout (at Least 25 Days)||0||
59891585|NCT02315196|76014089|FG000|STARTED|Overall Study||62||
59891586|NCT02315196|76014089|FG000|COMPLETED|Overall Study||53||
59891587|NCT02315196|76014089|FG000|NOT COMPLETED|Overall Study||9||
59891588|NCT02059005|76014095|FG000|STARTED|Overall Study||49||
59891589|NCT02059005|76014096|FG001|STARTED|Overall Study||48||
59891590|NCT02059005|76014095|FG000|3 Month Assessment|Overall Study||37||
59891591|NCT02059005|76014096|FG001|3 Month Assessment|Overall Study||33||
59891592|NCT02059005|76014095|FG000|6 Month Assessment|Overall Study||29||
59891593|NCT02059005|76014096|FG001|6 Month Assessment|Overall Study||24||
59891594|NCT02059005|76014095|FG000|COMPLETED|Overall Study||29||
59891595|NCT02059005|76014096|FG001|COMPLETED|Overall Study||24||
59891596|NCT02059005|76014095|FG000|NOT COMPLETED|Overall Study||20||
59891597|NCT02059005|76014096|FG001|NOT COMPLETED|Overall Study||24||
59891598|NCT01393821|76014106|FG000|STARTED|Overall Study||14|eligible participants|
59891599|NCT01393821|76014107|FG001|STARTED|Overall Study||13|eligible participants|
59891600|NCT01393821|76014106|FG000|COMPLETED|Overall Study||9|evaluable for primary endpoint|
59891601|NCT01393821|76014107|FG001|COMPLETED|Overall Study||10|evaluable for primary endpoint|
59891602|NCT01393821|76014106|FG000|NOT COMPLETED|Overall Study||5||
59891603|NCT01393821|76014107|FG001|NOT COMPLETED|Overall Study||3||
59891604|NCT00804713|76014113|FG000|STARTED|Overall Study||1978||
59891605|NCT00804713|76014113|FG000|COMPLETED|Overall Study||1978||
59891606|NCT00804713|76014113|FG000|NOT COMPLETED|Overall Study||0||
59891607|NCT00496873|76014119|FG000|STARTED|Overall Study||85||
59891608|NCT00496873|76014119|FG000|COMPLETED|Overall Study||78||
59891609|NCT00496873|76014119|FG000|NOT COMPLETED|Overall Study||7||
59891610|NCT00492778|76014125|FG000|STARTED|Overall Study||82||
59891611|NCT00492778|76014126|FG001|STARTED|Overall Study||83||
59891612|NCT00492778|76014125|FG000|COMPLETED|Overall Study||74||
59891613|NCT00492778|76014126|FG001|COMPLETED|Overall Study||82||
59891614|NCT00492778|76014125|FG000|NOT COMPLETED|Overall Study||8||
59891615|NCT00492778|76014126|FG001|NOT COMPLETED|Overall Study||1||
59891616|NCT00359216|76014140|FG000|STARTED|Overall Study||20||
59891617|NCT00359216|76014141|FG001|STARTED|Overall Study||10||
59891618|NCT00359216|76014140|FG000|COMPLETED|Overall Study||20||
59891619|NCT00359216|76014141|FG001|COMPLETED|Overall Study|Completed treatment but simultaneously partaking in other study,final study procedures not performed|9||
59891620|NCT00359216|76014140|FG000|NOT COMPLETED|Overall Study||0||
59891621|NCT00359216|76014141|FG001|NOT COMPLETED|Overall Study||1||
59891622|NCT03721328|76014147|FG000|STARTED|Overall Study||15||
59891623|NCT03721328|76014147|FG000|COMPLETED|Overall Study||15||
59891624|NCT03721328|76014147|FG000|NOT COMPLETED|Overall Study||0||
59891625|NCT04495166|76014153|FG000|STARTED|Overall Study||37||
59891626|NCT04495166|76014154|FG001|STARTED|Overall Study||44||
59891627|NCT04495166|76014153|FG000|COMPLETED|Overall Study||30||
59891628|NCT04495166|76014154|FG001|COMPLETED|Overall Study||41||
59891629|NCT04495166|76014153|FG000|NOT COMPLETED|Overall Study||7||
59891630|NCT04495166|76014154|FG001|NOT COMPLETED|Overall Study||3||
59891631|NCT03775681|76014160|FG000|STARTED|Overall Study||33||
59891632|NCT03775681|76014160|FG000|COMPLETED|Overall Study||30||
59891633|NCT03775681|76014160|FG000|NOT COMPLETED|Overall Study||3||
59891634|NCT03774823|76014166|FG000|STARTED|Overall Study||5||
59891635|NCT03774823|76014167|FG001|STARTED|Overall Study||5||
59891636|NCT03774823|76014166|FG000|COMPLETED|Overall Study||4||
59891637|NCT03774823|76014167|FG001|COMPLETED|Overall Study||4||
59891638|NCT03774823|76014166|FG000|NOT COMPLETED|Overall Study||1||
59891639|NCT03774823|76014167|FG001|NOT COMPLETED|Overall Study||1||
59891640|NCT03149042|76014173|FG000|STARTED|Overall Study||75||
59891641|NCT03149042|76014173|FG000|COMPLETED|Overall Study||52||
59891642|NCT03149042|76014173|FG000|NOT COMPLETED|Overall Study||23||
59891643|NCT03496012|76014181|FG000|STARTED|Overall Study||66||
59891644|NCT03496012|76014182|FG001|STARTED|Overall Study||34||
59891645|NCT03496012|76014183|FG002|STARTED|Overall Study||69||
59891646|NCT03496012|76014181|FG000|COMPLETED|Overall Study||62||
59891647|NCT03496012|76014182|FG001|COMPLETED|Overall Study||34||
59891648|NCT03496012|76014183|FG002|COMPLETED|Overall Study||65||
59891649|NCT03496012|76014181|FG000|NOT COMPLETED|Overall Study||4||
59891650|NCT03496012|76014182|FG001|NOT COMPLETED|Overall Study||0||
59891651|NCT03496012|76014183|FG002|NOT COMPLETED|Overall Study||4||
59891652|NCT03774433|76014191|FG000|STARTED|Overall Study||114||
59891653|NCT03774433|76014191|FG000|COMPLETED|Overall Study|Participants who completed at least 12 EMAs for inclusion in data analysis|100||
59891654|NCT03774433|76014191|FG000|NOT COMPLETED|Overall Study||14||
59891655|NCT05583903|76014197|FG000|STARTED|Overall Study||15||
59891656|NCT05583903|76014198|FG001|STARTED|Overall Study||15||
59891657|NCT05583903|76014197|FG000|COMPLETED|Overall Study||15||
59891658|NCT05583903|76014198|FG001|COMPLETED|Overall Study||15||
59891659|NCT05583903|76014197|FG000|NOT COMPLETED|Overall Study||0||
59891660|NCT05583903|76014198|FG001|NOT COMPLETED|Overall Study||0||
59891661|NCT05061992|76014206|FG000|STARTED|Overall Study||28||
59891662|NCT05061992|76014207|FG001|STARTED|Overall Study||28||
59891663|NCT05061992|76014206|FG000|COMPLETED|Overall Study||25||
59891664|NCT05061992|76014207|FG001|COMPLETED|Overall Study||27||
59891665|NCT05061992|76014206|FG000|NOT COMPLETED|Overall Study||3||
59891666|NCT05061992|76014207|FG001|NOT COMPLETED|Overall Study||1||
59891667|NCT04992052|76014215|FG000|STARTED|Overall Study||29||
59891668|NCT04992052|76014216|FG001|STARTED|Overall Study||23||
59891669|NCT04992052|76014215|FG000|COMPLETED|Overall Study||29||
59891670|NCT04992052|76014216|FG001|COMPLETED|Overall Study||23||
59891671|NCT04992052|76014215|FG000|NOT COMPLETED|Overall Study||0||
59891672|NCT04992052|76014216|FG001|NOT COMPLETED|Overall Study||0||
59891673|NCT04814823|76014222|FG000|STARTED|Overall Study||13||
59891674|NCT04814823|76014222|FG000|COMPLETED|Overall Study||11||
59891675|NCT04814823|76014222|FG000|NOT COMPLETED|Overall Study||2||
59891676|NCT04814342|76014226|FG000|STARTED|Overall Study||5||
59891677|NCT04814342|76014226|FG000|COMPLETED|Overall Study||5||
59891678|NCT04814342|76014226|FG000|NOT COMPLETED|Overall Study||0||
59891679|NCT04776928|76014232|FG000|STARTED|Overall Study||95||
59891680|NCT04776928|76014233|FG001|STARTED|Overall Study||122||
59891681|NCT04776928|76014232|FG000|COMPLETED|Overall Study||95||
59891682|NCT04776928|76014233|FG001|COMPLETED|Overall Study||122||
59891683|NCT04776928|76014232|FG000|NOT COMPLETED|Overall Study||0||
59891684|NCT04776928|76014233|FG001|NOT COMPLETED|Overall Study||0||
59891685|NCT04762160|76014239|FG000|STARTED|Overall Study||5||
59891686|NCT04762160|76014239|FG000|COMPLETED|Overall Study||0||
59891687|NCT04762160|76014239|FG000|NOT COMPLETED|Overall Study||5||
59891688|NCT04625972|76014245|FG000|STARTED|Overall Study||756||
59891689|NCT04625972|76014246|FG001|STARTED|Overall Study||375||
59505636|NCT00723749|75598494|FG000|COMPLETED|Overall Study||182||
59505637|NCT00723749|75598494|FG000|NOT COMPLETED|Overall Study||163||
59891690|NCT04625972|76014245|FG000|Dosed (Full Analysis Set)|Overall Study||749||
59891691|NCT04625972|76014246|FG001|Dosed (Full Analysis Set)|Overall Study||372||
59891692|NCT04625972|76014245|FG000|COMPLETED|Overall Study||624||
59891693|NCT04625972|76014246|FG001|COMPLETED|Overall Study||304||
59891694|NCT04625972|76014245|FG000|NOT COMPLETED|Overall Study||132||
59891695|NCT04625972|76014246|FG001|NOT COMPLETED|Overall Study||71||
59891696|NCT04482647|76014252|FG000|STARTED|Overall Study||100||
59891697|NCT04482647|76014252|FG000|COMPLETED|Overall Study||88||
59891698|NCT04482647|76014252|FG000|NOT COMPLETED|Overall Study||12||
59891699|NCT04429503|76014259|FG000|STARTED|Overall Study||167|Randomized|
59891700|NCT04429503|76014260|FG001|STARTED|Overall Study||329|Randomized|
59891701|NCT04429503|76014261|FG002|STARTED|Overall Study||164|Randomized|
59891702|NCT04429503|76014259|FG000|Treated|Overall Study||167|All randomized participants who received at least 1 dose of study drug (Full Analysis Set)|
59891703|NCT04429503|76014260|FG001|Treated|Overall Study||328|All randomized participants who received at least 1 dose of study drug (Full Analysis Set)|
59891704|NCT04429503|76014261|FG002|Treated|Overall Study||163|All randomized participants who received at least 1 dose of study drug (Full Analysis Set)|
59891705|NCT04429503|76014259|FG000|Completed Week 48|Overall Study||157||
59891706|NCT04429503|76014260|FG001|Completed Week 48|Overall Study||300||
59891707|NCT04429503|76014261|FG002|Completed Week 48|Overall Study||156||
59891708|NCT04429503|76014259|FG000|COMPLETED|Overall Study||155|Completed Week 60|
59891709|NCT04429503|76014260|FG001|COMPLETED|Overall Study||289|Completed Week 60|
59891710|NCT04429503|76014261|FG002|COMPLETED|Overall Study||152|Completed Week 60|
59891711|NCT04429503|76014259|FG000|NOT COMPLETED|Overall Study||12||
59891712|NCT04429503|76014260|FG001|NOT COMPLETED|Overall Study||40||
59891713|NCT04429503|76014261|FG002|NOT COMPLETED|Overall Study||12||
59891714|NCT04408924|76014269|FG000|STARTED|Overall Study||44||
59891715|NCT04408924|76014269|FG000|Received at Least One Dose of Study Drug|Overall Study||44||
59891716|NCT04408924|76014269|FG000|COMPLETED|Overall Study||19||
59891717|NCT04408924|76014269|FG000|NOT COMPLETED|Overall Study||25||
59891718|NCT04400487|76014273|FG000|STARTED|Screening Period (28 Days)||25||
59891719|NCT04400487|76014273|FG000|COMPLETED|Screening Period (28 Days)||25||
59891720|NCT04400487|76014273|FG000|NOT COMPLETED|Screening Period (28 Days)||0||
59891721|NCT04400487|76014273|FG000|STARTED|Run-in Period (14 Days)||25||
59891722|NCT04400487|76014273|FG000|COMPLETED|Run-in Period (14 Days)||25||
59891723|NCT04400487|76014273|FG000|NOT COMPLETED|Run-in Period (14 Days)||0||
59891724|NCT04400487|76014273|FG000|STARTED|Treatment Period (24 Weeks)||25||
59891725|NCT04400487|76014273|FG000|Treated (With at Least 1 Dose of Study Treatment)|Treatment Period (24 Weeks)||25||
59891726|NCT04400487|76014273|FG000|COMPLETED|Treatment Period (24 Weeks)||23||
59891727|NCT04400487|76014273|FG000|NOT COMPLETED|Treatment Period (24 Weeks)||2||
59891728|NCT04400487|76014273|FG000|STARTED|Follow-up Period (28 Days)||23||
59891729|NCT04400487|76014273|FG000|COMPLETED|Follow-up Period (28 Days)||21||
59891730|NCT04400487|76014273|FG000|NOT COMPLETED|Follow-up Period (28 Days)||2||
59505638|NCT00723827|75598498|FG000|STARTED|Overall Study||682||
59505639|NCT00723827|75598498|FG000|COMPLETED|Overall Study||682||
59891731|NCT04258254|76014281|FG000|STARTED|Overall Study||15||
59891732|NCT04258254|76014282|FG001|STARTED|Overall Study||16||
59891733|NCT04258254|76014283|FG002|STARTED|Overall Study||15||
59891734|NCT04258254|76014281|FG000|COMPLETED|Overall Study||15||
59891735|NCT04258254|76014282|FG001|COMPLETED|Overall Study||15||
59891736|NCT04258254|76014283|FG002|COMPLETED|Overall Study||15||
59891737|NCT04258254|76014281|FG000|NOT COMPLETED|Overall Study||0||
59891738|NCT04258254|76014282|FG001|NOT COMPLETED|Overall Study||1||
59891739|NCT04258254|76014283|FG002|NOT COMPLETED|Overall Study||0||
59891740|NCT04247594|76014291|FG000|STARTED|Overall Study||6||
59891741|NCT04247594|76014291|FG000|COMPLETED|Overall Study||2||
59891742|NCT04247594|76014291|FG000|NOT COMPLETED|Overall Study||4||
59891743|NCT04127331|76014305|FG000|STARTED|Overall Study||41||
59891744|NCT04127331|76014306|FG001|STARTED|Overall Study||32||
59891745|NCT04127331|76014307|FG002|STARTED|Overall Study||27||
59891746|NCT04127331|76014305|FG000|COMPLETED|Overall Study||41||
59891747|NCT04127331|76014306|FG001|COMPLETED|Overall Study||32||
59891748|NCT04127331|76014307|FG002|COMPLETED|Overall Study||27||
59891749|NCT04127331|76014305|FG000|NOT COMPLETED|Overall Study||0||
59891750|NCT04127331|76014306|FG001|NOT COMPLETED|Overall Study||0||
59891751|NCT04127331|76014307|FG002|NOT COMPLETED|Overall Study||0||
59891752|NCT04118595|76014321|FG000|STARTED|Overall Study||112||
59891753|NCT04118595|76014322|FG001|STARTED|Overall Study||107||
59891754|NCT04118595|76014323|FG002|STARTED|Overall Study||111||
59891755|NCT04118595|76014321|FG000|Completed Week 1 Within 7-day Window|Overall Study||107||
59891756|NCT04118595|76014322|FG001|Completed Week 1 Within 7-day Window|Overall Study||97||
59891757|NCT04118595|76014323|FG002|Completed Week 1 Within 7-day Window|Overall Study||108||
59891758|NCT04118595|76014321|FG000|Completed Month 1 Within 7-day Window|Overall Study||108||
59891759|NCT04118595|76014322|FG001|Completed Month 1 Within 7-day Window|Overall Study||100||
59891760|NCT04118595|76014323|FG002|Completed Month 1 Within 7-day Window|Overall Study||106||
59891761|NCT04118595|76014321|FG000|Completed Month 3 Within 7-day Window|Overall Study||103||
59891762|NCT04118595|76014322|FG001|Completed Month 3 Within 7-day Window|Overall Study||99||
59610502|NCT01796964|75721356|FG000|NOT COMPLETED|Overall Study||3||
59610503|NCT01796964|75721357|FG001|NOT COMPLETED|Overall Study||3||
59610504|NCT01838694|75721366|FG000|STARTED|Overall Study||8||
59610505|NCT01838694|75721367|FG001|STARTED|Overall Study||22||
59610506|NCT01838694|75721366|FG000|COMPLETED|Overall Study||8||
59610507|NCT01838694|75721367|FG001|COMPLETED|Overall Study||21||
59891763|NCT04118595|76014323|FG002|Completed Month 3 Within 7-day Window|Overall Study||102||
59891764|NCT04118595|76014321|FG000|Completed Month 6 Within 7-day Window|Overall Study||104||
59891765|NCT04118595|76014322|FG001|Completed Month 6 Within 7-day Window|Overall Study||96||
59891766|NCT04118595|76014323|FG002|Completed Month 6 Within 7-day Window|Overall Study||102||
59891767|NCT04118595|76014321|FG000|Completed Month 12 Within 7-day Window|Overall Study||101||
59891768|NCT04118595|76014322|FG001|Completed Month 12 Within 7-day Window|Overall Study||88||
59891769|NCT04118595|76014323|FG002|Completed Month 12 Within 7-day Window|Overall Study||96||
59891770|NCT04118595|76014321|FG000|COMPLETED|Overall Study||101||
59891771|NCT04118595|76014322|FG001|COMPLETED|Overall Study||88||
59891772|NCT04118595|76014323|FG002|COMPLETED|Overall Study||96||
59891773|NCT04118595|76014321|FG000|NOT COMPLETED|Overall Study||11||
59891774|NCT04118595|76014322|FG001|NOT COMPLETED|Overall Study||19||
59891775|NCT04118595|76014323|FG002|NOT COMPLETED|Overall Study||15||
59891776|NCT03995225|76014331|FG000|STARTED|Overall Study|Enrolled in the study and provided demographics data. Considered intent to treat.|155|Completed Zoom onboarding|
59891777|NCT03995225|76014331|FG000|Baseline Survey Completed|Overall Study||154||
59891778|NCT03995225|76014331|FG000|Smartband Worn for at Least 1 Day|Overall Study||115||
59891779|NCT03995225|76014331|FG000|Confirmed/Denied Smoking on Smartband|Overall Study|Participants who wore the smartband for at least one day, and additionally confirmed/denied smoking events detected by the smartband, allowing measurement of correct detection of smoking events and false alarms.|111||
59891780|NCT03995225|76014331|FG000|Received Mindful Smoking Exercise Triggered by Smoking|Overall Study|"Participants had smoking events during the mindful smoking part of the study and therefore received mindful smoking exercises triggered by smartband-detected smoking.~All participants who wore the smartband for at least one day (N=115) were able to receive mindful smoking triggered by the smartband, even if they never confirmed/denied smoking."|114||
59891781|NCT03995225|76014331|FG000|21-day Survey Completed|Overall Study||112||
59891782|NCT03995225|76014331|FG000|28-day Survey Completed|Overall Study||101||
59891783|NCT03995225|76014331|FG000|Primary Smoking Outcomes Reported at End of Treatment|Overall Study|Participants who reported primary outcomes measuring smoking but did not complete the full end of treatment survey.|96||
59891784|NCT03995225|76014331|FG000|End of Treatment Survey Completed|Overall Study||95||
59891785|NCT03995225|76014331|FG000|COMPLETED|Overall Study||115|Total number analyzed had to wear smartband for at least one day|
59891786|NCT03995225|76014331|FG000|NOT COMPLETED|Overall Study||40||
59891787|NCT03954704|76014342|FG000|STARTED|Overall Study||1||
59891788|NCT03954704|76014343|FG001|STARTED|Overall Study||1||
59891789|NCT03954704|76014344|FG002|STARTED|Overall Study||3||
59891790|NCT03954704|76014345|FG003|STARTED|Overall Study||3||
59891791|NCT03954704|76014346|FG004|STARTED|Overall Study||3||
59891792|NCT03954704|76014347|FG005|STARTED|Overall Study||8||
59891793|NCT03954704|76014348|FG006|STARTED|Overall Study||3||
59891794|NCT03954704|76014342|FG000|COMPLETED|Overall Study||0||
59891795|NCT03954704|76014343|FG001|COMPLETED|Overall Study||0||
59891796|NCT03954704|76014344|FG002|COMPLETED|Overall Study||0||
59891797|NCT03954704|76014345|FG003|COMPLETED|Overall Study||0||
59891798|NCT03954704|76014346|FG004|COMPLETED|Overall Study||0||
59891799|NCT03954704|76014347|FG005|COMPLETED|Overall Study||0||
59891800|NCT03954704|76014348|FG006|COMPLETED|Overall Study||0||
59891801|NCT03954704|76014342|FG000|NOT COMPLETED|Overall Study||1||
59891802|NCT03954704|76014343|FG001|NOT COMPLETED|Overall Study||1||
59891803|NCT03954704|76014344|FG002|NOT COMPLETED|Overall Study||3||
59891804|NCT03954704|76014345|FG003|NOT COMPLETED|Overall Study||3||
60013762|NCT02506881|76129702|FG002|NOT COMPLETED|Washout (at Least 25 Days)||0||
59891805|NCT03954704|76014346|FG004|NOT COMPLETED|Overall Study||3||
59891806|NCT03954704|76014347|FG005|NOT COMPLETED|Overall Study||8||
59891807|NCT03954704|76014348|FG006|NOT COMPLETED|Overall Study||3||
59891808|NCT03904264|76014367|FG000|STARTED|Overall Study||11||
59891809|NCT03904264|76014368|FG001|STARTED|Overall Study||54||
59891810|NCT03904264|76014367|FG000|COMPLETED|Overall Study||3||
59891811|NCT03904264|76014368|FG001|COMPLETED|Overall Study||17||
59891812|NCT03904264|76014367|FG000|NOT COMPLETED|Overall Study||8||
59891813|NCT03904264|76014368|FG001|NOT COMPLETED|Overall Study||37||
59891814|NCT03825380|76014375|FG000|STARTED|Overall Study||236||
59891815|NCT03825380|76014376|FG001|STARTED|Overall Study||249||
59891816|NCT03825380|76014375|FG000|COMPLETED|Overall Study||218||
59891817|NCT03825380|76014376|FG001|COMPLETED|Overall Study||227||
59891818|NCT03825380|76014375|FG000|NOT COMPLETED|Overall Study||18||
59891819|NCT03825380|76014376|FG001|NOT COMPLETED|Overall Study||22||
59891820|NCT03761732|76014382|FG000|STARTED|Overall Study||26||
59891821|NCT03761732|76014382|FG000|COMPLETED|Overall Study||26||
59891822|NCT03761732|76014382|FG000|NOT COMPLETED|Overall Study||0||
59891823|NCT03653390|76014389|FG000|STARTED|Overall Study||183||
59891824|NCT03653390|76014390|FG001|STARTED|Overall Study||159||
59891825|NCT03653390|76014391|FG002|STARTED|Overall Study||163||
59891826|NCT03653390|76014389|FG000|3 Month Survey|Overall Study||165||
59891827|NCT03653390|76014390|FG001|3 Month Survey|Overall Study||152||
59891828|NCT03653390|76014391|FG002|3 Month Survey|Overall Study||159||
59891829|NCT03653390|76014389|FG000|7 Month Survey|Overall Study||165||
59891830|NCT03653390|76014390|FG001|7 Month Survey|Overall Study||150||
59891831|NCT03653390|76014391|FG002|7 Month Survey|Overall Study||156||
59891832|NCT03653390|76014389|FG000|COMPLETED|Overall Study||163||
59891833|NCT03653390|76014390|FG001|COMPLETED|Overall Study||150||
59891834|NCT03653390|76014391|FG002|COMPLETED|Overall Study||155||
59891835|NCT03653390|76014389|FG000|NOT COMPLETED|Overall Study||20||
59891836|NCT03653390|76014390|FG001|NOT COMPLETED|Overall Study||9||
59891837|NCT03653390|76014391|FG002|NOT COMPLETED|Overall Study||8||
60013763|NCT02506881|76129703|FG003|NOT COMPLETED|Washout (at Least 25 Days)||0||
60013764|NCT02506881|76129700|FG000|STARTED|Second Intervention (Day 1)||12||
60013765|NCT02506881|76129701|FG001|STARTED|Second Intervention (Day 1)||12||
59505640|NCT00723827|75598498|FG000|NOT COMPLETED|Overall Study||0||
60013766|NCT02506881|76129702|FG002|STARTED|Second Intervention (Day 1)||12||
60013767|NCT02506881|76129703|FG003|STARTED|Second Intervention (Day 1)||12||
60013768|NCT02506881|76129700|FG000|COMPLETED|Second Intervention (Day 1)||12||
60013769|NCT02506881|76129701|FG001|COMPLETED|Second Intervention (Day 1)||12||
60013770|NCT02506881|76129702|FG002|COMPLETED|Second Intervention (Day 1)||12||
60013771|NCT02506881|76129703|FG003|COMPLETED|Second Intervention (Day 1)||12||
60013772|NCT02506881|76129700|FG000|NOT COMPLETED|Second Intervention (Day 1)||0||
60013773|NCT02506881|76129701|FG001|NOT COMPLETED|Second Intervention (Day 1)||0||
60013774|NCT02506881|76129702|FG002|NOT COMPLETED|Second Intervention (Day 1)||0||
60013775|NCT02506881|76129703|FG003|NOT COMPLETED|Second Intervention (Day 1)||0||
60013776|NCT02506257|76129727|FG000|STARTED|Overall Study||26||
60013777|NCT02506257|76129728|FG001|STARTED|Overall Study||28||
60013778|NCT02506257|76129729|FG002|STARTED|Overall Study||27||
60013779|NCT02506257|76129730|FG003|STARTED|Overall Study||9||
60013780|NCT02506257|76129727|FG000|COMPLETED|Overall Study||26||
60013781|NCT02506257|76129728|FG001|COMPLETED|Overall Study||26||
60013782|NCT02506257|76129729|FG002|COMPLETED|Overall Study||23||
59518987|NCT03587428|75612872|FG002|COMPLETED|Period 1||3||
60013783|NCT02506257|76129730|FG003|COMPLETED|Overall Study||9||
60013784|NCT02506257|76129727|FG000|NOT COMPLETED|Overall Study||0||
60013785|NCT02506257|76129728|FG001|NOT COMPLETED|Overall Study||2||
59891862|NCT03366844|76014436|FG000|STARTED|Overall Study||66||
59891863|NCT03366844|76014436|FG000|Phase 1b|Overall Study|Phase 1b began with 10 TNBC subjects enrolled.|10||
59891864|NCT03366844|76014436|FG000|Phase II|Overall Study|Phase II proceeded with 50 subjects enrolled into the TNBC Cohort and 10 subjects into the HR+ Cohort.|50||
59891865|NCT03366844|76014436|FG000|COMPLETED|Overall Study||60||
59891866|NCT03366844|76014436|FG000|NOT COMPLETED|Overall Study||6||
59891867|NCT03258554|76014445|FG000|STARTED|Lead-in Component||10||
59891868|NCT03258554|76014446|FG001|STARTED|Lead-in Component||0||
59610508|NCT01838694|75721366|FG000|NOT COMPLETED|Overall Study||0||
59610509|NCT01838694|75721367|FG001|NOT COMPLETED|Overall Study||1||
59610510|NCT01795638|75721378|FG000|STARTED|Overall Study||27||
59610511|NCT01795638|75721379|FG001|STARTED|Overall Study||26||
59610512|NCT01795638|75721378|FG000|COMPLETED|Overall Study||14||
59610513|NCT01795638|75721379|FG001|COMPLETED|Overall Study||15||
59610514|NCT01795638|75721378|FG000|NOT COMPLETED|Overall Study||13||
59610515|NCT01795638|75721379|FG001|NOT COMPLETED|Overall Study||11||
59610516|NCT01794780|75721393|FG000|STARTED|Overall Study||32||
59610517|NCT01794780|75721394|FG001|STARTED|Overall Study||276||
59756951|NCT00783705|75875887|FG000|COMPLETED|Overall Study||38||
59891869|NCT03258554|76014447|FG002|STARTED|Lead-in Component||0||
59891870|NCT03258554|76014445|FG000|Started Treatment|Lead-in Component||10||
59891871|NCT03258554|76014446|FG001|Started Treatment|Lead-in Component||0||
59891872|NCT03258554|76014447|FG002|Started Treatment|Lead-in Component||0||
59891873|NCT03258554|76014445|FG000|COMPLETED|Lead-in Component||10||
59891874|NCT03258554|76014446|FG001|COMPLETED|Lead-in Component||0||
59891875|NCT03258554|76014447|FG002|COMPLETED|Lead-in Component||0||
59891876|NCT03258554|76014445|FG000|NOT COMPLETED|Lead-in Component||0||
59891877|NCT03258554|76014446|FG001|NOT COMPLETED|Lead-in Component||0||
59891878|NCT03258554|76014447|FG002|NOT COMPLETED|Lead-in Component||0||
59891879|NCT03258554|76014445|FG000|STARTED|Randomized Component||0||
59891880|NCT03258554|76014446|FG001|STARTED|Randomized Component||63||
59891881|NCT03258554|76014447|FG002|STARTED|Randomized Component||123||
59891882|NCT03258554|76014445|FG000|Started Treatment|Randomized Component||0||
59891883|NCT03258554|76014446|FG001|Started Treatment|Randomized Component||61||
59891884|NCT03258554|76014447|FG002|Started Treatment|Randomized Component||119||
59891885|NCT03258554|76014445|FG000|COMPLETED|Randomized Component||0||
59891886|NCT03258554|76014446|FG001|COMPLETED|Randomized Component||63||
59891887|NCT03258554|76014447|FG002|COMPLETED|Randomized Component||123||
59891888|NCT03258554|76014445|FG000|NOT COMPLETED|Randomized Component||0||
59891889|NCT03258554|76014446|FG001|NOT COMPLETED|Randomized Component||0||
59891890|NCT03258554|76014447|FG002|NOT COMPLETED|Randomized Component||0||
59891891|NCT03238248|76014456|FG000|STARTED|Overall Study||71||
59891892|NCT03238248|76014456|FG000|COMPLETED|Overall Study||4||
59891893|NCT03238248|76014456|FG000|NOT COMPLETED|Overall Study||67||
59891894|NCT03196180|76014460|FG000|STARTED|Overall Study||13||
59891895|NCT03196180|76014460|FG000|COMPLETED|Overall Study||11||
59610518|NCT01794780|75721395|FG002|STARTED|Overall Study||813||
59610519|NCT01794780|75721396|FG003|STARTED|Overall Study||283||
59610520|NCT01794780|75721397|FG004|STARTED|Overall Study||9||
59610521|NCT01794780|75721398|FG005|STARTED|Overall Study||632||
59610522|NCT01794780|75721399|FG006|STARTED|Overall Study||154||
59610523|NCT01794780|75721400|FG007|STARTED|Overall Study||30||
59756952|NCT00783705|75875888|FG001|COMPLETED|Overall Study||36||
59756953|NCT00783705|75875887|FG000|NOT COMPLETED|Overall Study||6||
59891896|NCT03196180|76014460|FG000|NOT COMPLETED|Overall Study||2||
59891897|NCT02919072|76014466|FG000|STARTED|Overall Study||8||
59891898|NCT02919072|76014467|FG001|STARTED|Overall Study||8||
59891899|NCT02919072|76014466|FG000|COMPLETED|Overall Study||8||
59891900|NCT02919072|76014467|FG001|COMPLETED|Overall Study||8||
59891901|NCT02919072|76014466|FG000|NOT COMPLETED|Overall Study||0||
59891902|NCT02919072|76014467|FG001|NOT COMPLETED|Overall Study||0||
59891903|NCT02874014|76014473|FG000|STARTED|Overall Study||56||
59756954|NCT00783705|75875888|FG001|NOT COMPLETED|Overall Study||5||
59756955|NCT00604669|75875894|FG000|STARTED|Overall Study||170||
59756956|NCT00604669|75875894|FG000|COMPLETED|Overall Study||163||
59756957|NCT00604669|75875894|FG000|NOT COMPLETED|Overall Study||7||
59891904|NCT02874014|76014473|FG000|COMPLETED|Overall Study||54||
59891905|NCT02874014|76014473|FG000|NOT COMPLETED|Overall Study||2||
59891906|NCT02739035|76014480|FG000|STARTED|6 Weeks Post-MUA||59||
59891907|NCT02739035|76014481|FG001|STARTED|6 Weeks Post-MUA||71||
59891908|NCT02739035|76014480|FG000|COMPLETED|6 Weeks Post-MUA||56||
59891909|NCT02739035|76014481|FG001|COMPLETED|6 Weeks Post-MUA||61||
59891910|NCT02739035|76014480|FG000|NOT COMPLETED|6 Weeks Post-MUA||3||
59891911|NCT02739035|76014481|FG001|NOT COMPLETED|6 Weeks Post-MUA||10||
59891912|NCT02739035|76014480|FG000|STARTED|1 Year Post-MUA||56||
59891913|NCT02739035|76014481|FG001|STARTED|1 Year Post-MUA||61||
59891914|NCT02739035|76014480|FG000|COMPLETED|1 Year Post-MUA||46||
59610524|NCT01794780|75721393|FG000|COMPLETED|Overall Study||15||
59756958|NCT00938327|75875898|FG000|STARTED|Overall Study||332||
59756959|NCT00938327|75875898|FG000|COMPLETED|Overall Study||272||
59756960|NCT00938327|75875898|FG000|NOT COMPLETED|Overall Study||60||
59756961|NCT00887198|75875904|FG000|STARTED|Randomized Period||546||
59756962|NCT00887198|75875905|FG001|STARTED|Randomized Period||542||
59756963|NCT00887198|75875906|FG002|STARTED|Randomized Period||0||
59756964|NCT00887198|75875904|FG000|Treated|Randomized Period||542||
59756965|NCT00887198|75875905|FG001|Treated|Randomized Period||540||
59610525|NCT01794780|75721394|FG001|COMPLETED|Overall Study||180||
59610526|NCT01794780|75721395|FG002|COMPLETED|Overall Study||571||
59610527|NCT01794780|75721396|FG003|COMPLETED|Overall Study||200||
59610528|NCT01794780|75721397|FG004|COMPLETED|Overall Study||6||
59610529|NCT01794780|75721398|FG005|COMPLETED|Overall Study||452||
59756966|NCT00887198|75875906|FG002|Treated|Randomized Period||0||
59891915|NCT02739035|76014481|FG001|COMPLETED|1 Year Post-MUA||50||
59891916|NCT02739035|76014480|FG000|NOT COMPLETED|1 Year Post-MUA||10||
59891917|NCT02739035|76014481|FG001|NOT COMPLETED|1 Year Post-MUA||11||
59891918|NCT02663934|76014489|FG000|STARTED|Overall Study||45||
59891919|NCT02663934|76014490|FG001|STARTED|Overall Study||20||
59891920|NCT02663934|76014489|FG000|COMPLETED|Overall Study||33||
59891921|NCT02663934|76014490|FG001|COMPLETED|Overall Study||14||
59891922|NCT02663934|76014489|FG000|NOT COMPLETED|Overall Study||12||
59891923|NCT02663934|76014490|FG001|NOT COMPLETED|Overall Study||6||
59891924|NCT02657434|76014501|FG000|STARTED|Overall Study||286||
59891925|NCT02657434|76014502|FG001|STARTED|Overall Study||292||
59891926|NCT02657434|76014501|FG000|COMPLETED|Overall Study||0||
59891927|NCT02657434|76014502|FG001|COMPLETED|Overall Study||0||
59891928|NCT02657434|76014501|FG000|NOT COMPLETED|Overall Study||286||
59891929|NCT02657434|76014502|FG001|NOT COMPLETED|Overall Study||292||
59891930|NCT02656290|76014509|FG000|STARTED|Overall Study||26||
59891931|NCT02656290|76014509|FG000|Discharge|Overall Study||26||
59891932|NCT02656290|76014509|FG000|30 Days|Overall Study||26||
59891933|NCT02656290|76014509|FG000|3-6 Months|Overall Study||25||
59891934|NCT02656290|76014509|FG000|1 Year|Overall Study||25||
59891935|NCT02656290|76014509|FG000|2 Years|Overall Study||24||
59891936|NCT02656290|76014509|FG000|3 Years|Overall Study||24||
59891937|NCT02656290|76014509|FG000|4 Years|Overall Study||19||
59891938|NCT02656290|76014509|FG000|5 Years|Overall Study||22||
59891939|NCT02656290|76014509|FG000|COMPLETED|Overall Study||22||
59891940|NCT02656290|76014509|FG000|NOT COMPLETED|Overall Study||4||
59891941|NCT02255149|76014521|FG000|STARTED|Overall Study||10||
59891942|NCT02255149|76014521|FG000|COMPLETED|Overall Study||5||
59891943|NCT02255149|76014521|FG000|NOT COMPLETED|Overall Study||5||
59891944|NCT02180867|76014532|FG000|STARTED|Overall Study||10||
59891945|NCT02180867|76014533|FG001|STARTED|Overall Study||11||
59891946|NCT02180867|76014534|FG002|STARTED|Overall Study||10||
59891947|NCT02180867|76014535|FG003|STARTED|Overall Study||49||
59891948|NCT02180867|76014536|FG004|STARTED|Overall Study||48||
59891949|NCT02180867|76014537|FG005|STARTED|Overall Study||6||
59891950|NCT02180867|76014538|FG006|STARTED|Overall Study||6||
59891951|NCT02180867|76014532|FG000|Pediatric Patients|Overall Study||6||
59891952|NCT02180867|76014533|FG001|Pediatric Patients|Overall Study||4||
59891953|NCT02180867|76014534|FG002|Pediatric Patients|Overall Study||3||
59891954|NCT02180867|76014535|FG003|Pediatric Patients|Overall Study||18||
59891955|NCT02180867|76014536|FG004|Pediatric Patients|Overall Study||19||
59891956|NCT02180867|76014537|FG005|Pediatric Patients|Overall Study||1||
59891957|NCT02180867|76014538|FG006|Pediatric Patients|Overall Study||0||
59891958|NCT02180867|76014532|FG000|Adult Patients|Overall Study||4||
59891959|NCT02180867|76014533|FG001|Adult Patients|Overall Study||7||
59891960|NCT02180867|76014534|FG002|Adult Patients|Overall Study||7||
59891961|NCT02180867|76014535|FG003|Adult Patients|Overall Study||31||
59891962|NCT02180867|76014536|FG004|Adult Patients|Overall Study||29||
59891963|NCT02180867|76014537|FG005|Adult Patients|Overall Study||5||
59891964|NCT02180867|76014538|FG006|Adult Patients|Overall Study||6||
59891965|NCT02180867|76014532|FG000|COMPLETED|Overall Study||4||
59891966|NCT02180867|76014533|FG001|COMPLETED|Overall Study||0||
59891967|NCT02180867|76014534|FG002|COMPLETED|Overall Study||6||
59891968|NCT02180867|76014535|FG003|COMPLETED|Overall Study||23||
59891969|NCT02180867|76014536|FG004|COMPLETED|Overall Study||21||
59891970|NCT02180867|76014537|FG005|COMPLETED|Overall Study||3||
59891971|NCT02180867|76014538|FG006|COMPLETED|Overall Study||1||
59891972|NCT02180867|76014532|FG000|NOT COMPLETED|Overall Study||6||
59891973|NCT02180867|76014533|FG001|NOT COMPLETED|Overall Study||11||
59891974|NCT02180867|76014534|FG002|NOT COMPLETED|Overall Study||4||
59891975|NCT02180867|76014535|FG003|NOT COMPLETED|Overall Study||26||
59891976|NCT02180867|76014536|FG004|NOT COMPLETED|Overall Study||27||
59891977|NCT02180867|76014537|FG005|NOT COMPLETED|Overall Study||3||
59891978|NCT02180867|76014538|FG006|NOT COMPLETED|Overall Study||5||
59891979|NCT02127567|76014566|FG000|STARTED|Overall Study|41 participants completed 246 domains, 3 domains were completed with the tool per participant|41||
59891980|NCT02127567|76014566|FG000|COMPLETED|Overall Study||41||
59891981|NCT02127567|76014566|FG000|NOT COMPLETED|Overall Study||0||
59891982|NCT02101853|76014574|FG000|STARTED|Block 1 Induction||669||
59891983|NCT02101853|76014575|FG001|STARTED|Block 1 Induction||0||
59891984|NCT02101853|76014576|FG002|STARTED|Block 1 Induction||0||
59891985|NCT02101853|76014577|FG003|STARTED|Block 1 Induction||0||
59891986|NCT02101853|76014578|FG004|STARTED|Block 1 Induction||0||
59891987|NCT02101853|76014579|FG005|STARTED|Block 1 Induction||0||
59891988|NCT02101853|76014574|FG000|COMPLETED|Block 1 Induction||494||
59891989|NCT02101853|76014575|FG001|COMPLETED|Block 1 Induction||0||
59891990|NCT02101853|76014576|FG002|COMPLETED|Block 1 Induction||0||
59891991|NCT02101853|76014577|FG003|COMPLETED|Block 1 Induction||0||
59891992|NCT02101853|76014578|FG004|COMPLETED|Block 1 Induction||0||
59891993|NCT02101853|76014579|FG005|COMPLETED|Block 1 Induction||0||
59891994|NCT02101853|76014574|FG000|NOT COMPLETED|Block 1 Induction||175||
59891995|NCT02101853|76014575|FG001|NOT COMPLETED|Block 1 Induction||0||
59891996|NCT02101853|76014576|FG002|NOT COMPLETED|Block 1 Induction||0||
59891997|NCT02101853|76014577|FG003|NOT COMPLETED|Block 1 Induction||0||
59891998|NCT02101853|76014578|FG004|NOT COMPLETED|Block 1 Induction||0||
59891999|NCT02101853|76014579|FG005|NOT COMPLETED|Block 1 Induction||0||
59892000|NCT02101853|76014574|FG000|STARTED|Post Induction Randomization||0||
59892001|NCT02101853|76014575|FG001|STARTED|Post Induction Randomization||109||
59892002|NCT02101853|76014576|FG002|STARTED|Post Induction Randomization||107||
59892003|NCT02101853|76014577|FG003|STARTED|Post Induction Randomization||129||
59892004|NCT02101853|76014578|FG004|STARTED|Post Induction Randomization||127||
59892005|NCT02101853|76014579|FG005|STARTED|Post Induction Randomization||0||
59892006|NCT02101853|76014574|FG000|COMPLETED|Post Induction Randomization||0||
59892007|NCT02101853|76014575|FG001|COMPLETED|Post Induction Randomization||14||
59892008|NCT02101853|76014576|FG002|COMPLETED|Post Induction Randomization||31||
59892009|NCT02101853|76014577|FG003|COMPLETED|Post Induction Randomization||78||
59892010|NCT02101853|76014578|FG004|COMPLETED|Post Induction Randomization||79||
59892011|NCT02101853|76014579|FG005|COMPLETED|Post Induction Randomization||0||
59892012|NCT02101853|76014574|FG000|NOT COMPLETED|Post Induction Randomization||0||
59892013|NCT02101853|76014575|FG001|NOT COMPLETED|Post Induction Randomization||95||
59892014|NCT02101853|76014576|FG002|NOT COMPLETED|Post Induction Randomization||76||
59892015|NCT02101853|76014577|FG003|NOT COMPLETED|Post Induction Randomization||51||
59892016|NCT02101853|76014578|FG004|NOT COMPLETED|Post Induction Randomization||48||
59892017|NCT02101853|76014579|FG005|NOT COMPLETED|Post Induction Randomization||0||
59892018|NCT02101853|76014574|FG000|STARTED|Blinatumomab Salvage Therapy||0||
59892019|NCT02101853|76014575|FG001|STARTED|Blinatumomab Salvage Therapy||0||
59892020|NCT02101853|76014576|FG002|STARTED|Blinatumomab Salvage Therapy||0||
59892021|NCT02101853|76014577|FG003|STARTED|Blinatumomab Salvage Therapy||0||
59892022|NCT02101853|76014578|FG004|STARTED|Blinatumomab Salvage Therapy||0||
59892023|NCT02101853|76014579|FG005|STARTED|Blinatumomab Salvage Therapy||27||
59892024|NCT02101853|76014574|FG000|COMPLETED|Blinatumomab Salvage Therapy||0||
59892025|NCT02101853|76014575|FG001|COMPLETED|Blinatumomab Salvage Therapy||0||
59892026|NCT02101853|76014576|FG002|COMPLETED|Blinatumomab Salvage Therapy||0||
59892027|NCT02101853|76014577|FG003|COMPLETED|Blinatumomab Salvage Therapy||0||
59892028|NCT02101853|76014578|FG004|COMPLETED|Blinatumomab Salvage Therapy||0||
59892029|NCT02101853|76014579|FG005|COMPLETED|Blinatumomab Salvage Therapy||2||
59892030|NCT02101853|76014574|FG000|NOT COMPLETED|Blinatumomab Salvage Therapy||0||
59892031|NCT02101853|76014575|FG001|NOT COMPLETED|Blinatumomab Salvage Therapy||0||
59892032|NCT02101853|76014576|FG002|NOT COMPLETED|Blinatumomab Salvage Therapy||0||
59892033|NCT02101853|76014577|FG003|NOT COMPLETED|Blinatumomab Salvage Therapy||0||
59892034|NCT02101853|76014578|FG004|NOT COMPLETED|Blinatumomab Salvage Therapy||0||
59892035|NCT02101853|76014579|FG005|NOT COMPLETED|Blinatumomab Salvage Therapy||25||
59892036|NCT01990352|76014591|FG000|STARTED|Overall Study||24||
59892037|NCT01990352|76014591|FG000|COMPLETED|Overall Study||24||
59892038|NCT01990352|76014591|FG000|NOT COMPLETED|Overall Study||0||
59892039|NCT01236560|76014601|FG000|STARTED|Overall Study||6||
59892040|NCT01236560|76014602|FG001|STARTED|Overall Study||32||
59892041|NCT01236560|76014603|FG002|STARTED|Overall Study||31||
59892042|NCT01236560|76014604|FG003|STARTED|Overall Study||32||
59892043|NCT01236560|76014605|FG004|STARTED|Overall Study||0||
59892044|NCT01236560|76014606|FG005|STARTED|Overall Study||0||
59892045|NCT01236560|76014601|FG000|COMPLETED|Overall Study||1||
59892046|NCT01236560|76014602|FG001|COMPLETED|Overall Study||8||
59892047|NCT01236560|76014603|FG002|COMPLETED|Overall Study||11||
59892048|NCT01236560|76014604|FG003|COMPLETED|Overall Study||10||
59892049|NCT01236560|76014605|FG004|COMPLETED|Overall Study||0||
59892050|NCT01236560|76014606|FG005|COMPLETED|Overall Study||0||
59892051|NCT01236560|76014601|FG000|NOT COMPLETED|Overall Study||5||
59892052|NCT01236560|76014602|FG001|NOT COMPLETED|Overall Study||24||
59892053|NCT01236560|76014603|FG002|NOT COMPLETED|Overall Study||20||
59892054|NCT01236560|76014604|FG003|NOT COMPLETED|Overall Study||22||
59892055|NCT01236560|76014605|FG004|NOT COMPLETED|Overall Study||0||
59892056|NCT01236560|76014606|FG005|NOT COMPLETED|Overall Study||0||
59892057|NCT01193842|76014621|FG000|STARTED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||3||
59892058|NCT01193842|76014622|FG001|STARTED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0||
59892059|NCT01193842|76014623|FG002|STARTED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0||
59892060|NCT01193842|76014624|FG003|STARTED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0||
59892061|NCT01193842|76014625|FG004|STARTED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0||
59892062|NCT01193842|76014621|FG000|COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||3||
59892063|NCT01193842|76014622|FG001|COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0||
59892064|NCT01193842|76014623|FG002|COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0||
59892065|NCT01193842|76014624|FG003|COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0||
59892066|NCT01193842|76014625|FG004|COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0||
59892067|NCT01193842|76014621|FG000|NOT COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0||
59892068|NCT01193842|76014622|FG001|NOT COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0||
59892069|NCT01193842|76014623|FG002|NOT COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0||
59892070|NCT01193842|76014624|FG003|NOT COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0||
59892071|NCT01193842|76014625|FG004|NOT COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0||
59892072|NCT01193842|76014621|FG000|STARTED|Phase I: VR-DA-EPOCH, DL 2||0||
59892073|NCT01193842|76014622|FG001|STARTED|Phase I: VR-DA-EPOCH, DL 2||7||
59892074|NCT01193842|76014623|FG002|STARTED|Phase I: VR-DA-EPOCH, DL 2||0||
59892075|NCT01193842|76014624|FG003|STARTED|Phase I: VR-DA-EPOCH, DL 2||0||
59892076|NCT01193842|76014625|FG004|STARTED|Phase I: VR-DA-EPOCH, DL 2||0||
59892077|NCT01193842|76014621|FG000|COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0||
59892078|NCT01193842|76014622|FG001|COMPLETED|Phase I: VR-DA-EPOCH, DL 2||6||
59892079|NCT01193842|76014623|FG002|COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0||
59892080|NCT01193842|76014624|FG003|COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0||
59892081|NCT01193842|76014625|FG004|COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0||
59892082|NCT01193842|76014621|FG000|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0||
59892083|NCT01193842|76014622|FG001|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 2||1||
59892084|NCT01193842|76014623|FG002|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0||
59892085|NCT01193842|76014624|FG003|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0||
59892086|NCT01193842|76014625|FG004|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0||
59892087|NCT01193842|76014621|FG000|STARTED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||4||
59892088|NCT01193842|76014622|FG001|STARTED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0||
59892089|NCT01193842|76014623|FG002|STARTED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0||
59892090|NCT01193842|76014624|FG003|STARTED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0||
59892091|NCT01193842|76014625|FG004|STARTED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0||
59892092|NCT01193842|76014621|FG000|COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||3||
59892093|NCT01193842|76014622|FG001|COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0||
59892094|NCT01193842|76014623|FG002|COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0||
59892095|NCT01193842|76014624|FG003|COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0||
59892096|NCT01193842|76014625|FG004|COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0||
59892097|NCT01193842|76014621|FG000|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||1||
59892098|NCT01193842|76014622|FG001|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0||
59892099|NCT01193842|76014623|FG002|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0||
59892100|NCT01193842|76014624|FG003|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0||
59892101|NCT01193842|76014625|FG004|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0||
59892102|NCT01193842|76014621|FG000|STARTED|Phase I: VR-CHOP, DL 1||0||
59892103|NCT01193842|76014622|FG001|STARTED|Phase I: VR-CHOP, DL 1||0||
59892104|NCT01193842|76014623|FG002|STARTED|Phase I: VR-CHOP, DL 1||2||
59892105|NCT01193842|76014624|FG003|STARTED|Phase I: VR-CHOP, DL 1||0||
59892106|NCT01193842|76014625|FG004|STARTED|Phase I: VR-CHOP, DL 1||0||
59892107|NCT01193842|76014621|FG000|COMPLETED|Phase I: VR-CHOP, DL 1||0||
59892108|NCT01193842|76014622|FG001|COMPLETED|Phase I: VR-CHOP, DL 1||0||
59892109|NCT01193842|76014623|FG002|COMPLETED|Phase I: VR-CHOP, DL 1||1||
59892110|NCT01193842|76014624|FG003|COMPLETED|Phase I: VR-CHOP, DL 1||0||
59892111|NCT01193842|76014625|FG004|COMPLETED|Phase I: VR-CHOP, DL 1||0||
59892112|NCT01193842|76014621|FG000|NOT COMPLETED|Phase I: VR-CHOP, DL 1||0||
59892113|NCT01193842|76014622|FG001|NOT COMPLETED|Phase I: VR-CHOP, DL 1||0||
59892114|NCT01193842|76014623|FG002|NOT COMPLETED|Phase I: VR-CHOP, DL 1||1||
59892115|NCT01193842|76014624|FG003|NOT COMPLETED|Phase I: VR-CHOP, DL 1||0||
59892116|NCT01193842|76014625|FG004|NOT COMPLETED|Phase I: VR-CHOP, DL 1||0||
59892117|NCT01193842|76014621|FG000|STARTED|Phase II: Randomized Groups||0||
59892118|NCT01193842|76014622|FG001|STARTED|Phase II: Randomized Groups||0||
59892119|NCT01193842|76014623|FG002|STARTED|Phase II: Randomized Groups||0||
59892120|NCT01193842|76014624|FG003|STARTED|Phase II: Randomized Groups||45||
59892121|NCT01193842|76014625|FG004|STARTED|Phase II: Randomized Groups||46||
59892122|NCT01193842|76014621|FG000|COMPLETED|Phase II: Randomized Groups||0||
59892123|NCT01193842|76014622|FG001|COMPLETED|Phase II: Randomized Groups||0||
59892124|NCT01193842|76014623|FG002|COMPLETED|Phase II: Randomized Groups||0||
59892125|NCT01193842|76014624|FG003|COMPLETED|Phase II: Randomized Groups||33||
59892126|NCT01193842|76014625|FG004|COMPLETED|Phase II: Randomized Groups||36||
59892127|NCT01193842|76014621|FG000|NOT COMPLETED|Phase II: Randomized Groups||0||
59892128|NCT01193842|76014622|FG001|NOT COMPLETED|Phase II: Randomized Groups||0||
59892129|NCT01193842|76014623|FG002|NOT COMPLETED|Phase II: Randomized Groups||0||
59892130|NCT01193842|76014624|FG003|NOT COMPLETED|Phase II: Randomized Groups||12||
59892131|NCT01193842|76014625|FG004|NOT COMPLETED|Phase II: Randomized Groups||10||
59892132|NCT00855465|76014649|FG000|STARTED|Treatment Period||174||
59892133|NCT00855465|76014650|FG001|STARTED|Treatment Period||88||
59892134|NCT00855465|76014649|FG000|Participants Received Treatment|Treatment Period|1 subject randomized but not treated|173||
59892135|NCT00855465|76014650|FG001|Participants Received Treatment|Treatment Period||88||
59892136|NCT00855465|76014649|FG000|COMPLETED|Treatment Period||160||
59892137|NCT00855465|76014650|FG001|COMPLETED|Treatment Period||83||
59892138|NCT00855465|76014649|FG000|NOT COMPLETED|Treatment Period||14||
59892139|NCT00855465|76014650|FG001|NOT COMPLETED|Treatment Period||5||
59892140|NCT00855465|76014649|FG000|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|17||
59892141|NCT00855465|76014650|FG001|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|4||
59892142|NCT00855465|76014649|FG000|COMPLETED|Follow-up Period (FUP)||9||
59892143|NCT00855465|76014650|FG001|COMPLETED|Follow-up Period (FUP)||2||
59892144|NCT00855465|76014649|FG000|NOT COMPLETED|Follow-up Period (FUP)||8||
59892145|NCT00855465|76014650|FG001|NOT COMPLETED|Follow-up Period (FUP)||2||
59892146|NCT00770809|76014659|FG000|STARTED|Overall Study||118||
59892147|NCT00770809|76014660|FG001|STARTED|Overall Study||120||
59892148|NCT00770809|76014661|FG002|STARTED|Overall Study||67||
59892149|NCT00770809|76014659|FG000|COMPLETED|Overall Study||101||
59892150|NCT00770809|76014660|FG001|COMPLETED|Overall Study||110||
59892151|NCT00770809|76014661|FG002|COMPLETED|Overall Study||44||
59892152|NCT00770809|76014659|FG000|NOT COMPLETED|Overall Study||17||
59892153|NCT00770809|76014660|FG001|NOT COMPLETED|Overall Study||10||
59892154|NCT00770809|76014661|FG002|NOT COMPLETED|Overall Study||23||
59892155|NCT00602641|76014671|FG000|STARTED|Overall Study||154||
59892156|NCT00602641|76014672|FG001|STARTED|Overall Study||152||
59892157|NCT00602641|76014671|FG000|Started Protocol Therapy|Overall Study||148||
59892158|NCT00602641|76014672|FG001|Started Protocol Therapy|Overall Study||150||
59892159|NCT00602641|76014671|FG000|COMPLETED|Overall Study|Treatment continued until progression of disease, unacceptable toxicity or patient withdrawal.|0||
59892160|NCT00602641|76014672|FG001|COMPLETED|Overall Study|Treatment continued until progression of disease, unacceptable toxicity or patient withdrawal.|0||
59892161|NCT00602641|76014671|FG000|NOT COMPLETED|Overall Study||154||
59892162|NCT00602641|76014672|FG001|NOT COMPLETED|Overall Study||152||
59892163|NCT00569127|76014680|FG000|STARTED|Overall Study||214||
59892164|NCT00569127|76014681|FG001|STARTED|Overall Study||213||
59892165|NCT00569127|76014680|FG000|Eligible|Overall Study||200||
59892166|NCT00569127|76014681|FG001|Eligible|Overall Study||202||
59892167|NCT00569127|76014680|FG000|COMPLETED|Overall Study||0||
59892168|NCT00569127|76014681|FG001|COMPLETED|Overall Study||0||
59892169|NCT00569127|76014680|FG000|NOT COMPLETED|Overall Study||214||
59892170|NCT00569127|76014681|FG001|NOT COMPLETED|Overall Study||213||
59892171|NCT00114101|76014689|FG000|STARTED|Overall Study||231||
59892172|NCT00114101|76014690|FG001|STARTED|Overall Study||229||
59892173|NCT00114101|76014689|FG000|COMPLETED|Overall Study||231||
59892174|NCT00114101|76014690|FG001|COMPLETED|Overall Study||229||
59892175|NCT00114101|76014689|FG000|NOT COMPLETED|Overall Study||0||
59892176|NCT00114101|76014690|FG001|NOT COMPLETED|Overall Study||0||
59892177|NCT00098475|76014700|FG000|STARTED|Step 1||223||
59892178|NCT00098475|76014701|FG001|STARTED|Step 1||222||
59892179|NCT00098475|76014702|FG002|STARTED|Step 1||4||
59892180|NCT00098475|76014703|FG003|STARTED|Step 1||3||
59892181|NCT00098475|76014700|FG000|Treated|Step 1||223||
59892182|NCT00098475|76014701|FG001|Treated|Step 1||220||
59892183|NCT00098475|76014702|FG002|Treated|Step 1||4||
59892184|NCT00098475|76014703|FG003|Treated|Step 1||3||
59892185|NCT00098475|76014700|FG000|Eligible|Step 1|Some patients were considered eligible at registration but found ineligible in the analysis.|214||
59892186|NCT00098475|76014701|FG001|Eligible|Step 1|Some patients were considered eligible at registration but found ineligible in the analysis.|208||
59892187|NCT00098475|76014702|FG002|Eligible|Step 1||4||
59892188|NCT00098475|76014703|FG003|Eligible|Step 1||3||
59892189|NCT00098475|76014700|FG000|COMPLETED|Step 1||52||
59892190|NCT00098475|76014701|FG001|COMPLETED|Step 1||49||
59892191|NCT00098475|76014702|FG002|COMPLETED|Step 1||0||
59892192|NCT00098475|76014703|FG003|COMPLETED|Step 1||0||
59892193|NCT00098475|76014700|FG000|NOT COMPLETED|Step 1||171||
59892194|NCT00098475|76014701|FG001|NOT COMPLETED|Step 1||173||
59892195|NCT00098475|76014702|FG002|NOT COMPLETED|Step 1||4||
59892196|NCT00098475|76014703|FG003|NOT COMPLETED|Step 1||3||
59892197|NCT00098475|76014700|FG000|STARTED|Step 2|Step 2 treatment was an option but not required for patients who ended step 1 treatment.|5||
59892198|NCT00098475|76014701|FG001|STARTED|Step 2|Step 2 treatment was an option but not required for patients who ended step 1 treatment.|15||
59892199|NCT00098475|76014702|FG002|STARTED|Step 2||0||
59892200|NCT00098475|76014703|FG003|STARTED|Step 2||0||
59892201|NCT00098475|76014700|FG000|Treated|Step 2||4||
59892202|NCT00098475|76014701|FG001|Treated|Step 2||14||
59892203|NCT00098475|76014702|FG002|Treated|Step 2||0||
59892204|NCT00098475|76014703|FG003|Treated|Step 2||0||
59892205|NCT00098475|76014700|FG000|Eligible|Step 2|Some patients were considered eligible at registration but found ineligible in the analysis.|2||
59892206|NCT00098475|76014701|FG001|Eligible|Step 2|Some patients were considered eligible at registration but found ineligible in the analysis.|9||
59892207|NCT00098475|76014702|FG002|Eligible|Step 2||0||
59892208|NCT00098475|76014703|FG003|Eligible|Step 2||0||
59892209|NCT00098475|76014700|FG000|COMPLETED|Step 2||0||
59892210|NCT00098475|76014701|FG001|COMPLETED|Step 2||5||
59892211|NCT00098475|76014702|FG002|COMPLETED|Step 2||0||
59892212|NCT00098475|76014703|FG003|COMPLETED|Step 2||0||
59892213|NCT00098475|76014700|FG000|NOT COMPLETED|Step 2||5||
59892214|NCT00098475|76014701|FG001|NOT COMPLETED|Step 2||10||
59892215|NCT00098475|76014702|FG002|NOT COMPLETED|Step 2||0||
59892216|NCT00098475|76014703|FG003|NOT COMPLETED|Step 2||0||
59892217|NCT00003468|76014713|FG000|STARTED|Overall Study||11||
59892218|NCT00003468|76014713|FG000|COMPLETED|Overall Study|Two patients were not evaluable.|9||
59892219|NCT00003468|76014713|FG000|NOT COMPLETED|Overall Study||2||
59892220|NCT03136484|76014719|FG000|STARTED|Overall Study||394||
59892221|NCT03136484|76014720|FG001|STARTED|Overall Study||394||
59892222|NCT03136484|76014719|FG000|Exposed|Overall Study||392||
59892223|NCT03136484|76014720|FG001|Exposed|Overall Study||394||
59892224|NCT03136484|76014719|FG000|COMPLETED|Overall Study||367||
59892225|NCT03136484|76014720|FG001|COMPLETED|Overall Study||372||
59892226|NCT03136484|76014719|FG000|NOT COMPLETED|Overall Study||27||
59892227|NCT03136484|76014720|FG001|NOT COMPLETED|Overall Study||22||
59892228|NCT03922711|76014729|FG000|STARTED|Overall Study||7||
59892229|NCT03922711|76014730|FG001|STARTED|Overall Study||8||
59892230|NCT03922711|76014731|FG002|STARTED|Overall Study||8||
59892231|NCT03922711|76014729|FG000|Treatment Group Based on Maximal Possible Highest Dose Received (Used for Analysis)|Overall Study||12|A total of 8 patients were randomized to pridopidine 150 mg BID. Of these, 5 patients discontinued study drug during titration, i.e. did not reach the full maintenance dose. Therefore, they were analyzed under the 100 mg BID group. The 100 mg BID group included patients who received any dose between 75 mg QD and 100 mg BID.|
59892232|NCT03922711|76014730|FG001|Treatment Group Based on Maximal Possible Highest Dose Received (Used for Analysis)|Overall Study||3|A total of 8 patients were randomized to pridopidine 150 mg BID. Of these, 5 patients discontinued study drug during titration, i.e. did not reach the full maintenance dose. Therefore, they were analyzed under the 100 mg BID group. The 100 mg BID group included patients who received any dose between 75 mg QD and 100 mg BID.|
59892233|NCT03922711|76014731|FG002|Treatment Group Based on Maximal Possible Highest Dose Received (Used for Analysis)|Overall Study||8|A total of 8 patients were randomized to pridopidine 150 mg BID. Of these, 5 patients discontinued study drug during titration, i.e. did not reach the full maintenance dose. Therefore, they were analyzed under the 100 mg BID group. The 100 mg BID group included patients who received any dose between 75 mg QD and 100 mg BID.|
59892234|NCT03922711|76014729|FG000|COMPLETED|Overall Study||3||
59892235|NCT03922711|76014730|FG001|COMPLETED|Overall Study||3||
59892236|NCT03922711|76014731|FG002|COMPLETED|Overall Study||4||
59892237|NCT03922711|76014729|FG000|NOT COMPLETED|Overall Study||4||
59892238|NCT03922711|76014730|FG001|NOT COMPLETED|Overall Study||5||
59892239|NCT03922711|76014731|FG002|NOT COMPLETED|Overall Study||4||
59892240|NCT02877680|76014740|FG000|STARTED|Overall Study||55||
59892241|NCT02877680|76014741|FG001|STARTED|Overall Study||25||
59892242|NCT02877680|76014740|FG000|COMPLETED|Overall Study||54||
59892243|NCT02877680|76014741|FG001|COMPLETED|Overall Study||24||
59892244|NCT02877680|76014740|FG000|NOT COMPLETED|Overall Study||1||
59892245|NCT02877680|76014741|FG001|NOT COMPLETED|Overall Study||1||
59892246|NCT03141086|76014753|FG000|STARTED|Overall Study||7||
59892247|NCT03141086|76014754|FG001|STARTED|Overall Study||17||
59892248|NCT03141086|76014753|FG000|COMPLETED|Overall Study||6||
59892249|NCT03141086|76014754|FG001|COMPLETED|Overall Study||12||
59892250|NCT03141086|76014753|FG000|NOT COMPLETED|Overall Study||1||
59892251|NCT03141086|76014754|FG001|NOT COMPLETED|Overall Study||5||
59892252|NCT03135548|76014763|FG000|STARTED|Overall Study||19|Started are randomised/treated|
59892253|NCT03135548|76014764|FG001|STARTED|Overall Study||19|Started are randomised/treated|
59892254|NCT03135548|76014765|FG002|STARTED|Overall Study||21|Started are randomised/treated|
59892255|NCT03135548|76014763|FG000|COMPLETED|Overall Study||14||
59892256|NCT03135548|76014764|FG001|COMPLETED|Overall Study||15||
59892257|NCT03135548|76014765|FG002|COMPLETED|Overall Study||18||
59892258|NCT03135548|76014763|FG000|NOT COMPLETED|Overall Study||5||
59892259|NCT03135548|76014764|FG001|NOT COMPLETED|Overall Study||4||
59892260|NCT03135548|76014765|FG002|NOT COMPLETED|Overall Study||3||
59892261|NCT03134222|76014776|FG000|STARTED|Treatment Period (Up to Week 12)||19||
59892262|NCT03134222|76014777|FG001|STARTED|Treatment Period (Up to Week 12)||18||
59892263|NCT03134222|76014778|FG002|STARTED|Treatment Period (Up to Week 12)||10||
59892264|NCT03134222|76014779|FG003|STARTED|Treatment Period (Up to Week 12)||0||
59892265|NCT03134222|76014780|FG004|STARTED|Treatment Period (Up to Week 12)||0||
59892266|NCT03134222|76014776|FG000|COMPLETED|Treatment Period (Up to Week 12)||14||
59892267|NCT03134222|76014777|FG001|COMPLETED|Treatment Period (Up to Week 12)||14||
59892268|NCT03134222|76014778|FG002|COMPLETED|Treatment Period (Up to Week 12)||8||
59892269|NCT03134222|76014779|FG003|COMPLETED|Treatment Period (Up to Week 12)||0||
59892270|NCT03134222|76014780|FG004|COMPLETED|Treatment Period (Up to Week 12)||0||
59892271|NCT03134222|76014776|FG000|NOT COMPLETED|Treatment Period (Up to Week 12)||5||
59892272|NCT03134222|76014777|FG001|NOT COMPLETED|Treatment Period (Up to Week 12)||4||
59892273|NCT03134222|76014778|FG002|NOT COMPLETED|Treatment Period (Up to Week 12)||2||
59892274|NCT03134222|76014779|FG003|NOT COMPLETED|Treatment Period (Up to Week 12)||0||
59892275|NCT03134222|76014780|FG004|NOT COMPLETED|Treatment Period (Up to Week 12)||0||
59892276|NCT03134222|76014776|FG000|STARTED|Treatment Period (Week 12 to 48)||14||
59892277|NCT03134222|76014777|FG001|STARTED|Treatment Period (Week 12 to 48)||14||
59892278|NCT03134222|76014778|FG002|STARTED|Treatment Period (Week 12 to 48)|Participants were rerandomized 1:1 to either Placebo to Lanraplenib or Placebo to Filgotinib arm.|0||
59892279|NCT03134222|76014779|FG003|STARTED|Treatment Period (Week 12 to 48)|Participants were rerandomized from the Placebo arm.|4||
59892280|NCT03134222|76014780|FG004|STARTED|Treatment Period (Week 12 to 48)|Participants were rerandomized from the Placebo arm.|4||
59892281|NCT03134222|76014776|FG000|COMPLETED|Treatment Period (Week 12 to 48)||12||
59892282|NCT03134222|76014777|FG001|COMPLETED|Treatment Period (Week 12 to 48)||11||
59892283|NCT03134222|76014778|FG002|COMPLETED|Treatment Period (Week 12 to 48)||0||
59892284|NCT03134222|76014779|FG003|COMPLETED|Treatment Period (Week 12 to 48)||3||
59892285|NCT03134222|76014780|FG004|COMPLETED|Treatment Period (Week 12 to 48)||3||
59950988|NCT01359904|76069912|FG000|NOT COMPLETED|Overall Study||1||
59950989|NCT01359904|76069913|FG001|NOT COMPLETED|Overall Study||0||
59950990|NCT04789382|76069923|FG000|STARTED|First Wear Period (2 Hours)||9||
59950991|NCT04789382|76069924|FG001|STARTED|First Wear Period (2 Hours)||9||
59950992|NCT04789382|76069925|FG002|STARTED|First Wear Period (2 Hours)||9||
59950993|NCT04789382|76069926|FG003|STARTED|First Wear Period (2 Hours)||9||
59892286|NCT03134222|76014776|FG000|NOT COMPLETED|Treatment Period (Week 12 to 48)||2||
59892287|NCT03134222|76014777|FG001|NOT COMPLETED|Treatment Period (Week 12 to 48)||3||
59892288|NCT03134222|76014778|FG002|NOT COMPLETED|Treatment Period (Week 12 to 48)||0||
59892289|NCT03134222|76014779|FG003|NOT COMPLETED|Treatment Period (Week 12 to 48)||1||
59892290|NCT03134222|76014780|FG004|NOT COMPLETED|Treatment Period (Week 12 to 48)||1||
59892291|NCT03769753|76014790|FG000|STARTED|Overall Study||8||
59892292|NCT03769753|76014790|FG000|COMPLETED|Overall Study||1||
59892293|NCT03769753|76014790|FG000|NOT COMPLETED|Overall Study||7||
59892294|NCT01235065|76014796|FG000|STARTED|Overall Study||320||
59892295|NCT01235065|76014797|FG001|STARTED|Overall Study||303||
59892296|NCT01235065|76014796|FG000|COMPLETED|Overall Study||320||
59892297|NCT01235065|76014797|FG001|COMPLETED|Overall Study||303||
59892298|NCT01235065|76014796|FG000|NOT COMPLETED|Overall Study||0||
59892299|NCT01235065|76014797|FG001|NOT COMPLETED|Overall Study||0||
59892300|NCT03263923|76014805|FG000|STARTED|Overall Study||174|Enrolled, consented, Participants who were sent the baseline questionnaire.|
59892301|NCT03263923|76014806|FG001|STARTED|Overall Study||172|Enrolled, consented, Participants who were sent the baseline questionnaire.|
59892302|NCT03263923|76014805|FG000|Completed Enrolled Participants Who Completed the Baseline Questionnaire|Overall Study||173||
59892303|NCT03263923|76014806|FG001|Completed Enrolled Participants Who Completed the Baseline Questionnaire|Overall Study||169||
59892304|NCT03263923|76014805|FG000|Completed Intervention and T2 Questionnaire|Overall Study||149||
59892305|NCT03263923|76014806|FG001|Completed Intervention and T2 Questionnaire|Overall Study||151||
59892306|NCT03263923|76014805|FG000|COMPLETED|Overall Study||149||
59892307|NCT03263923|76014806|FG001|COMPLETED|Overall Study||151||
59892308|NCT03263923|76014805|FG000|NOT COMPLETED|Overall Study||25||
59892309|NCT03263923|76014806|FG001|NOT COMPLETED|Overall Study||21||
59892310|NCT03139604|76014816|FG000|STARTED|Overall Study||219||
59892311|NCT03139604|76014817|FG001|STARTED|Overall Study||220||
59892312|NCT03139604|76014816|FG000|COMPLETED|Overall Study|Participants were considered to have completed the study if they dies or discontinued study treatment for any reason|0||
59892313|NCT03139604|76014817|FG001|COMPLETED|Overall Study|Participants were considered to have completed the study if they dies or discontinued study treatment for any reason|0||
59892314|NCT03139604|76014816|FG000|NOT COMPLETED|Overall Study||219||
59892315|NCT03139604|76014817|FG001|NOT COMPLETED|Overall Study||220||
59892316|NCT03139448|76014826|FG000|STARTED|Overall Study||85|All participants randomized|
59892317|NCT03139448|76014827|FG001|STARTED|Overall Study||89|All participants randomized|
59892318|NCT03139448|76014826|FG000|Intervention Started|Overall Study||79|All participants that received partial or full intervention|
59892319|NCT03139448|76014827|FG001|Intervention Started|Overall Study||70|All participants that received partial or full intervention|
59892320|NCT03139448|76014826|FG000|COMPLETED|Overall Study||73|Participants that received a full intervention|
59892321|NCT03139448|76014827|FG001|COMPLETED|Overall Study||63|Participants that received a full intervention|
59892322|NCT03139448|76014826|FG000|NOT COMPLETED|Overall Study||12||
59892323|NCT03139448|76014827|FG001|NOT COMPLETED|Overall Study||26||
59892324|NCT02875340|76014833|FG000|STARTED|Overall Study||8||
59892325|NCT02875340|76014833|FG000|COMPLETED|Overall Study|No patients completed 6 months of continuous treatment|0||
59892326|NCT02875340|76014833|FG000|NOT COMPLETED|Overall Study||8||
59892327|NCT03237325|76014845|FG000|STARTED|Overall Study||127||
59892328|NCT03237325|76014846|FG001|STARTED|Overall Study||139||
59892329|NCT03237325|76014845|FG000|COMPLETED|Overall Study||112||
59892330|NCT03237325|76014846|FG001|COMPLETED|Overall Study||114||
59892331|NCT03237325|76014845|FG000|NOT COMPLETED|Overall Study||15||
59892332|NCT03237325|76014846|FG001|NOT COMPLETED|Overall Study||25||
59892333|NCT03113383|76014852|FG000|STARTED|Overall Study||4||
59892334|NCT03113383|76014853|FG001|STARTED|Overall Study||0||
59892335|NCT03113383|76014852|FG000|COMPLETED|Overall Study||0||
59892336|NCT03113383|76014853|FG001|COMPLETED|Overall Study||0||
59892337|NCT03113383|76014852|FG000|NOT COMPLETED|Overall Study||4||
59892338|NCT03113383|76014853|FG001|NOT COMPLETED|Overall Study||0||
59892339|NCT03433040|76014862|FG000|STARTED|Overall Study||19||
59892340|NCT03433040|76014863|FG001|STARTED|Overall Study||16||
59892341|NCT03433040|76014864|FG002|STARTED|Overall Study||9||
59892342|NCT03433040|76014862|FG000|COMPLETED|Overall Study||17||
59892343|NCT03433040|76014863|FG001|COMPLETED|Overall Study||8||
59892344|NCT03433040|76014864|FG002|COMPLETED|Overall Study||5||
59892345|NCT03433040|76014862|FG000|NOT COMPLETED|Overall Study||2||
59892346|NCT03433040|76014863|FG001|NOT COMPLETED|Overall Study||8||
59892347|NCT03433040|76014864|FG002|NOT COMPLETED|Overall Study||4||
59892348|NCT03131960|76014874|FG000|STARTED|Overall Study|1 participant missed the day one visit (V5) but remained in the study and returned for the day 90 assessment (V7).|53||
59892349|NCT03131960|76014875|FG001|STARTED|Overall Study|1 discontinued treatment due to adverse event and inability to tolerate rehabilitation.|55||
59892350|NCT03131960|76014874|FG000|COMPLETED|Overall Study||53||
59892351|NCT03131960|76014875|FG001|COMPLETED|Overall Study||54||
59892352|NCT03131960|76014874|FG000|NOT COMPLETED|Overall Study||0||
59892353|NCT03131960|76014875|FG001|NOT COMPLETED|Overall Study||1||
59892354|NCT03225170|76014884|FG000|STARTED|Overall Study||23||
59892355|NCT03225170|76014885|FG001|STARTED|Overall Study||22||
59892356|NCT03225170|76014886|FG002|STARTED|Overall Study||2||
59892357|NCT03225170|76014884|FG000|COMPLETED|Overall Study||19||
59892358|NCT03225170|76014885|FG001|COMPLETED|Overall Study||17||
59892359|NCT03225170|76014886|FG002|COMPLETED|Overall Study||2||
59892360|NCT03225170|76014884|FG000|NOT COMPLETED|Overall Study||4||
59892361|NCT03225170|76014885|FG001|NOT COMPLETED|Overall Study||5||
59892362|NCT03225170|76014886|FG002|NOT COMPLETED|Overall Study||0||
59892363|NCT02115139|76014892|FG000|STARTED|Overall Study||58||
59892364|NCT02115139|76014892|FG000|COMPLETED|Overall Study||51||
59892365|NCT02115139|76014892|FG000|NOT COMPLETED|Overall Study||7||
59892366|NCT02047981|76014898|FG000|STARTED|MORDOR Stage I Year 1-2||97047||
59892367|NCT02047981|76014899|FG001|STARTED|MORDOR Stage I Year 1-2||93191||
59892368|NCT02047981|76014898|FG000|COMPLETED|MORDOR Stage I Year 1-2||87650||
59892369|NCT02047981|76014899|FG001|COMPLETED|MORDOR Stage I Year 1-2||84474||
59892370|NCT02047981|76014898|FG000|NOT COMPLETED|MORDOR Stage I Year 1-2||9397||
59892371|NCT02047981|76014899|FG001|NOT COMPLETED|MORDOR Stage I Year 1-2||8717||
59892372|NCT02047981|76014898|FG000|STARTED|MORDOR Stage II Year 3||37497||
59892373|NCT02047981|76014899|FG001|STARTED|MORDOR Stage II Year 3||33294||
59892374|NCT02047981|76014898|FG000|COMPLETED|MORDOR Stage II Year 3||34611||
59892375|NCT02047981|76014899|FG001|COMPLETED|MORDOR Stage II Year 3||30931||
59892376|NCT02047981|76014898|FG000|NOT COMPLETED|MORDOR Stage II Year 3||2886||
59892377|NCT02047981|76014899|FG001|NOT COMPLETED|MORDOR Stage II Year 3||2363||
59892378|NCT03947788|76014907|FG000|STARTED|Overall Study||69||
59892379|NCT03947788|76014908|FG001|STARTED|Overall Study||74||
59892380|NCT03947788|76014907|FG000|COMPLETED|Overall Study||69||
59892381|NCT03947788|76014908|FG001|COMPLETED|Overall Study||74||
59892382|NCT03947788|76014907|FG000|NOT COMPLETED|Overall Study||0||
59892383|NCT03947788|76014908|FG001|NOT COMPLETED|Overall Study||0||
59892384|NCT03646162|76014922|FG000|STARTED|Overall Study||31||
59892385|NCT03646162|76014923|FG001|STARTED|Overall Study||31||
59892386|NCT03646162|76014924|FG002|STARTED|Overall Study||31||
59892387|NCT03646162|76014922|FG000|COMPLETED|Overall Study||26||
59892388|NCT03646162|76014923|FG001|COMPLETED|Overall Study||27||
59892389|NCT03646162|76014924|FG002|COMPLETED|Overall Study||30||
59892390|NCT03646162|76014922|FG000|NOT COMPLETED|Overall Study||5||
59892391|NCT03646162|76014923|FG001|NOT COMPLETED|Overall Study||4||
59892392|NCT03646162|76014924|FG002|NOT COMPLETED|Overall Study||1||
59892393|NCT01763827|76014940|FG000|STARTED|Overall Study||77||
59892394|NCT01763827|76014941|FG001|STARTED|Overall Study||78||
59892395|NCT01763827|76014942|FG002|STARTED|Overall Study||77||
59892396|NCT01763827|76014943|FG003|STARTED|Overall Study||77||
59892397|NCT01763827|76014944|FG004|STARTED|Overall Study||153||
59892398|NCT01763827|76014945|FG005|STARTED|Overall Study||153||
59892399|NCT01763827|76014940|FG000|Received at Least 1 Dose of Study Drug|Overall Study||76||
59892400|NCT01763827|76014941|FG001|Received at Least 1 Dose of Study Drug|Overall Study||78||
59892401|NCT01763827|76014942|FG002|Received at Least 1 Dose of Study Drug|Overall Study||77||
59892402|NCT01763827|76014943|FG003|Received at Least 1 Dose of Study Drug|Overall Study||77||
59892403|NCT01763827|76014944|FG004|Received at Least 1 Dose of Study Drug|Overall Study||153||
59892404|NCT01763827|76014945|FG005|Received at Least 1 Dose of Study Drug|Overall Study||153||
59518988|NCT03587428|75612873|FG003|COMPLETED|Period 1||3||
59892405|NCT01763827|76014940|FG000|COMPLETED|Overall Study||74||
59892406|NCT01763827|76014941|FG001|COMPLETED|Overall Study||77||
59892407|NCT01763827|76014942|FG002|COMPLETED|Overall Study||73||
59892408|NCT01763827|76014943|FG003|COMPLETED|Overall Study||76||
59892409|NCT01763827|76014944|FG004|COMPLETED|Overall Study||147||
59892410|NCT01763827|76014945|FG005|COMPLETED|Overall Study||151||
59892411|NCT01763827|76014940|FG000|NOT COMPLETED|Overall Study||3||
59892412|NCT01763827|76014941|FG001|NOT COMPLETED|Overall Study||1||
59892413|NCT01763827|76014942|FG002|NOT COMPLETED|Overall Study||4||
59892414|NCT01763827|76014943|FG003|NOT COMPLETED|Overall Study||1||
59892415|NCT01763827|76014944|FG004|NOT COMPLETED|Overall Study||6||
59892416|NCT01763827|76014945|FG005|NOT COMPLETED|Overall Study||2||
59892417|NCT03348514|76014967|FG000|STARTED|Overall Study||1||
59892418|NCT03348514|76014968|FG001|STARTED|Overall Study||1||
59892419|NCT03348514|76014969|FG002|STARTED|Overall Study||1||
59892420|NCT03348514|76014970|FG003|STARTED|Overall Study||1||
59892421|NCT03348514|76014971|FG004|STARTED|Overall Study||3||
59892422|NCT03348514|76014972|FG005|STARTED|Overall Study||4||
59892423|NCT03348514|76014973|FG006|STARTED|Overall Study||6||
59892424|NCT03348514|76014974|FG007|STARTED|Overall Study||2||
59892425|NCT03348514|76014967|FG000|COMPLETED|Overall Study||1||
59892426|NCT03348514|76014968|FG001|COMPLETED|Overall Study||1||
59892427|NCT03348514|76014969|FG002|COMPLETED|Overall Study||1||
59892428|NCT03348514|76014970|FG003|COMPLETED|Overall Study||1||
59892429|NCT03348514|76014971|FG004|COMPLETED|Overall Study||3||
59892430|NCT03348514|76014972|FG005|COMPLETED|Overall Study||4||
59892431|NCT03348514|76014973|FG006|COMPLETED|Overall Study||6||
59892432|NCT03348514|76014974|FG007|COMPLETED|Overall Study||2||
59892433|NCT03348514|76014967|FG000|NOT COMPLETED|Overall Study||0||
59892434|NCT03348514|76014968|FG001|NOT COMPLETED|Overall Study||0||
59892435|NCT03348514|76014969|FG002|NOT COMPLETED|Overall Study||0||
59892436|NCT03348514|76014970|FG003|NOT COMPLETED|Overall Study||0||
59892437|NCT03348514|76014971|FG004|NOT COMPLETED|Overall Study||0||
59892438|NCT03348514|76014972|FG005|NOT COMPLETED|Overall Study||0||
59892439|NCT03348514|76014973|FG006|NOT COMPLETED|Overall Study||0||
59892440|NCT03348514|76014974|FG007|NOT COMPLETED|Overall Study||0||
59892441|NCT01732783|76014998|FG000|STARTED|Overall Study||164||
59892442|NCT01732783|76014999|FG001|STARTED|Overall Study||37||
59892443|NCT01732783|76015000|FG002|STARTED|Overall Study||12||
59892444|NCT01732783|76014998|FG000|COMPLETED|Overall Study|Completed 12-month observation period.|29||
59892445|NCT01732783|76014999|FG001|COMPLETED|Overall Study|Completed 12-month observation period.|5||
59892446|NCT01732783|76015000|FG002|COMPLETED|Overall Study|Completed 12-month observation period.|2||
59892447|NCT01732783|76014998|FG000|NOT COMPLETED|Overall Study||135||
59892448|NCT01732783|76014999|FG001|NOT COMPLETED|Overall Study||32||
59892449|NCT01732783|76015000|FG002|NOT COMPLETED|Overall Study||10||
59892450|NCT03777007|76015008|FG000|STARTED|Overall Study||40||
59892451|NCT03777007|76015008|FG000|COMPLETED|Overall Study||40||
59892452|NCT03777007|76015008|FG000|NOT COMPLETED|Overall Study||0||
59892453|NCT04355728|76015014|FG000|STARTED|Overall Study||12||
59892454|NCT04355728|76015015|FG001|STARTED|Overall Study||12||
59892455|NCT04355728|76015014|FG000|COMPLETED|Overall Study||12||
59892456|NCT04355728|76015015|FG001|COMPLETED|Overall Study||12||
59892457|NCT04355728|76015014|FG000|NOT COMPLETED|Overall Study||0||
59892458|NCT04355728|76015015|FG001|NOT COMPLETED|Overall Study||0||
59892459|NCT01693783|76015021|FG000|STARTED|Overall Study||42||
59892460|NCT01693783|76015021|FG000|COMPLETED|Overall Study||42||
59892461|NCT01693783|76015021|FG000|NOT COMPLETED|Overall Study||0||
59892462|NCT02787850|76015027|FG000|STARTED|Overall Study||10||
59892463|NCT02787850|76015028|FG001|STARTED|Overall Study||10||
59892464|NCT02787850|76015027|FG000|COMPLETED|Overall Study||10||
59892465|NCT02787850|76015028|FG001|COMPLETED|Overall Study||9||
59892466|NCT02787850|76015027|FG000|NOT COMPLETED|Overall Study||0||
59892467|NCT02787850|76015028|FG001|NOT COMPLETED|Overall Study||1||
59892468|NCT01375777|76015052|FG000|STARTED|Overall Study||46||
59892469|NCT01375777|76015053|FG001|STARTED|Overall Study||45||
59892470|NCT01375777|76015054|FG002|STARTED|Overall Study||46||
59892471|NCT01375777|76015055|FG003|STARTED|Overall Study||45||
59892472|NCT01375777|76015056|FG004|STARTED|Overall Study||46||
59892473|NCT01375777|76015057|FG005|STARTED|Overall Study||45||
59892474|NCT01375777|76015058|FG006|STARTED|Overall Study||46||
59892475|NCT01375777|76015059|FG007|STARTED|Overall Study||46||
59892476|NCT01375777|76015060|FG008|STARTED|Overall Study||46||
59892477|NCT01375777|76015052|FG000|Received Treatment|Overall Study||45||
59892478|NCT01375777|76015053|FG001|Received Treatment|Overall Study||45||
59892479|NCT01375777|76015054|FG002|Received Treatment|Overall Study||45||
59892480|NCT01375777|76015055|FG003|Received Treatment|Overall Study||45||
59892481|NCT01375777|76015056|FG004|Received Treatment|Overall Study||46||
59892482|NCT01375777|76015057|FG005|Received Treatment|Overall Study||45||
59892483|NCT01375777|76015058|FG006|Received Treatment|Overall Study||45||
59892484|NCT01375777|76015059|FG007|Received Treatment|Overall Study||45||
59892485|NCT01375777|76015060|FG008|Received Treatment|Overall Study||45||
59892486|NCT01375777|76015052|FG000|COMPLETED|Overall Study||44||
59892487|NCT01375777|76015053|FG001|COMPLETED|Overall Study||42||
59892488|NCT01375777|76015054|FG002|COMPLETED|Overall Study||45||
59892489|NCT01375777|76015055|FG003|COMPLETED|Overall Study||45||
59892490|NCT01375777|76015056|FG004|COMPLETED|Overall Study||45||
59892491|NCT01375777|76015057|FG005|COMPLETED|Overall Study||44||
59892492|NCT01375777|76015058|FG006|COMPLETED|Overall Study||44||
59892493|NCT01375777|76015059|FG007|COMPLETED|Overall Study||44||
59892494|NCT01375777|76015060|FG008|COMPLETED|Overall Study||44||
59892495|NCT01375777|76015052|FG000|NOT COMPLETED|Overall Study||2||
59892496|NCT01375777|76015053|FG001|NOT COMPLETED|Overall Study||3||
59892497|NCT01375777|76015054|FG002|NOT COMPLETED|Overall Study||1||
59892498|NCT01375777|76015055|FG003|NOT COMPLETED|Overall Study||0||
59892499|NCT01375777|76015056|FG004|NOT COMPLETED|Overall Study||1||
59892500|NCT01375777|76015057|FG005|NOT COMPLETED|Overall Study||1||
59892501|NCT01375777|76015058|FG006|NOT COMPLETED|Overall Study||2||
59892502|NCT01375777|76015059|FG007|NOT COMPLETED|Overall Study||2||
59892503|NCT01375777|76015060|FG008|NOT COMPLETED|Overall Study||2||
59892504|NCT02431702|76015080|FG000|STARTED|Part 1: 2-Month Oral Run-in Phase||273||
59892505|NCT02431702|76015081|FG001|STARTED|Part 1: 2-Month Oral Run-in Phase||0||
59892506|NCT02431702|76015082|FG002|STARTED|Part 1: 2-Month Oral Run-in Phase||0||
59892507|NCT02431702|76015083|FG003|STARTED|Part 1: 2-Month Oral Run-in Phase||0||
59892508|NCT02431702|76015084|FG004|STARTED|Part 1: 2-Month Oral Run-in Phase||0||
59892509|NCT02431702|76015085|FG005|STARTED|Part 1: 2-Month Oral Run-in Phase||0||
59892510|NCT02431702|76015086|FG006|STARTED|Part 1: 2-Month Oral Run-in Phase||64||
59892511|NCT02431702|76015080|FG000|COMPLETED|Part 1: 2-Month Oral Run-in Phase||239||
59892512|NCT02431702|76015081|FG001|COMPLETED|Part 1: 2-Month Oral Run-in Phase||0||
59892513|NCT02431702|76015082|FG002|COMPLETED|Part 1: 2-Month Oral Run-in Phase||0||
59892514|NCT02431702|76015083|FG003|COMPLETED|Part 1: 2-Month Oral Run-in Phase||0||
59892515|NCT02431702|76015084|FG004|COMPLETED|Part 1: 2-Month Oral Run-in Phase||0||
59892516|NCT02431702|76015085|FG005|COMPLETED|Part 1: 2-Month Oral Run-in Phase||0||
59892517|NCT02431702|76015086|FG006|COMPLETED|Part 1: 2-Month Oral Run-in Phase||32||
59892518|NCT02431702|76015080|FG000|NOT COMPLETED|Part 1: 2-Month Oral Run-in Phase||34||
59892519|NCT02431702|76015081|FG001|NOT COMPLETED|Part 1: 2-Month Oral Run-in Phase||0||
59892520|NCT02431702|76015082|FG002|NOT COMPLETED|Part 1: 2-Month Oral Run-in Phase||0||
59892521|NCT02431702|76015083|FG003|NOT COMPLETED|Part 1: 2-Month Oral Run-in Phase||0||
59892522|NCT02431702|76015084|FG004|NOT COMPLETED|Part 1: 2-Month Oral Run-in Phase||0||
59892523|NCT02431702|76015085|FG005|NOT COMPLETED|Part 1: 2-Month Oral Run-in Phase||0||
59892524|NCT02431702|76015086|FG006|NOT COMPLETED|Part 1: 2-Month Oral Run-in Phase||32||
59892525|NCT02431702|76015080|FG000|STARTED|Part 2: 9Month Disease Progression Phase||0||
59892526|NCT02431702|76015081|FG001|STARTED|Part 2: 9Month Disease Progression Phase|Participants who completed Part 1 and were eligible to be randomized in this group.|78||
59892527|NCT02431702|76015082|FG002|STARTED|Part 2: 9Month Disease Progression Phase|Participants who completed Part 1 and were eligible to be randomized in this group.|157||
59892528|NCT02431702|76015083|FG003|STARTED|Part 2: 9Month Disease Progression Phase||0||
59892529|NCT02431702|76015084|FG004|STARTED|Part 2: 9Month Disease Progression Phase||0||
59892530|NCT02431702|76015085|FG005|STARTED|Part 2: 9Month Disease Progression Phase||0||
59892531|NCT02431702|76015086|FG006|STARTED|Part 2: 9Month Disease Progression Phase||0||
59892532|NCT02431702|76015080|FG000|COMPLETED|Part 2: 9Month Disease Progression Phase||0||
59892533|NCT02431702|76015081|FG001|COMPLETED|Part 2: 9Month Disease Progression Phase||52||
59892534|NCT02431702|76015082|FG002|COMPLETED|Part 2: 9Month Disease Progression Phase||128||
59892535|NCT02431702|76015083|FG003|COMPLETED|Part 2: 9Month Disease Progression Phase||0||
59892536|NCT02431702|76015084|FG004|COMPLETED|Part 2: 9Month Disease Progression Phase||0||
59892537|NCT02431702|76015085|FG005|COMPLETED|Part 2: 9Month Disease Progression Phase||0||
59892538|NCT02431702|76015086|FG006|COMPLETED|Part 2: 9Month Disease Progression Phase||0||
59892539|NCT02431702|76015080|FG000|NOT COMPLETED|Part 2: 9Month Disease Progression Phase||0||
59892540|NCT02431702|76015081|FG001|NOT COMPLETED|Part 2: 9Month Disease Progression Phase||26||
59756967|NCT00887198|75875904|FG000|COMPLETED|Randomized Period||0||
59756968|NCT00887198|75875905|FG001|COMPLETED|Randomized Period||0||
59756969|NCT00887198|75875906|FG002|COMPLETED|Randomized Period||0||
59756970|NCT00887198|75875904|FG000|NOT COMPLETED|Randomized Period||546||
59756971|NCT00887198|75875905|FG001|NOT COMPLETED|Randomized Period||542||
59756972|NCT00887198|75875906|FG002|NOT COMPLETED|Randomized Period||0||
59756973|NCT00887198|75875904|FG000|STARTED|Cross Over (Placebo to AA)||0||
59756974|NCT00887198|75875905|FG001|STARTED|Cross Over (Placebo to AA)||0||
59756975|NCT00887198|75875906|FG002|STARTED|Cross Over (Placebo to AA)|93= 51 participants(crossed over under amendment 3)+42 participants (crossed over under amendment 4)|93||
59756976|NCT00887198|75875904|FG000|COMPLETED|Cross Over (Placebo to AA)||0||
59892541|NCT02431702|76015082|FG002|NOT COMPLETED|Part 2: 9Month Disease Progression Phase||29||
59892542|NCT02431702|76015083|FG003|NOT COMPLETED|Part 2: 9Month Disease Progression Phase||0||
59892543|NCT02431702|76015084|FG004|NOT COMPLETED|Part 2: 9Month Disease Progression Phase||0||
59892544|NCT02431702|76015085|FG005|NOT COMPLETED|Part 2: 9Month Disease Progression Phase||0||
59892545|NCT02431702|76015086|FG006|NOT COMPLETED|Part 2: 9Month Disease Progression Phase||0||
59892546|NCT02431702|76015080|FG000|STARTED|Part 3: 9 Month of Additional Treatment||0||
59892547|NCT02431702|76015081|FG001|STARTED|Part 3: 9 Month of Additional Treatment||0||
59892548|NCT02431702|76015082|FG002|STARTED|Part 3: 9 Month of Additional Treatment||0||
59892549|NCT02431702|76015083|FG003|STARTED|Part 3: 9 Month of Additional Treatment|Participants who completed Part 2 and were eligible to continue treatment in this group.|49||
59892550|NCT02431702|76015084|FG004|STARTED|Part 3: 9 Month of Additional Treatment|Participants who completed Part 2 and were eligible to be re-randomized in this group.|57||
59892551|NCT02431702|76015085|FG005|STARTED|Part 3: 9 Month of Additional Treatment|Participants who completed Part 2 and were eligible to be re-randomized in this group.|63||
59892552|NCT02431702|76015086|FG006|STARTED|Part 3: 9 Month of Additional Treatment||0||
59892553|NCT02431702|76015080|FG000|COMPLETED|Part 3: 9 Month of Additional Treatment||0||
59892554|NCT02431702|76015081|FG001|COMPLETED|Part 3: 9 Month of Additional Treatment||0||
59892555|NCT02431702|76015082|FG002|COMPLETED|Part 3: 9 Month of Additional Treatment||0||
59892556|NCT02431702|76015083|FG003|COMPLETED|Part 3: 9 Month of Additional Treatment||40||
59892557|NCT02431702|76015084|FG004|COMPLETED|Part 3: 9 Month of Additional Treatment||47||
59892558|NCT02431702|76015085|FG005|COMPLETED|Part 3: 9 Month of Additional Treatment||46||
59892559|NCT02431702|76015086|FG006|COMPLETED|Part 3: 9 Month of Additional Treatment||0||
59892560|NCT02431702|76015080|FG000|NOT COMPLETED|Part 3: 9 Month of Additional Treatment||0||
59892561|NCT02431702|76015081|FG001|NOT COMPLETED|Part 3: 9 Month of Additional Treatment||0||
59892562|NCT02431702|76015082|FG002|NOT COMPLETED|Part 3: 9 Month of Additional Treatment||0||
59892563|NCT02431702|76015083|FG003|NOT COMPLETED|Part 3: 9 Month of Additional Treatment||9||
59892564|NCT02431702|76015084|FG004|NOT COMPLETED|Part 3: 9 Month of Additional Treatment||10||
59892565|NCT02431702|76015085|FG005|NOT COMPLETED|Part 3: 9 Month of Additional Treatment||17||
59892566|NCT02431702|76015086|FG006|NOT COMPLETED|Part 3: 9 Month of Additional Treatment||0||
59892567|NCT02086552|76015102|FG000|STARTED|Overall Study||28||
59892568|NCT02086552|76015102|FG000|COMPLETED|Overall Study||27||
59892569|NCT02086552|76015102|FG000|NOT COMPLETED|Overall Study||1||
59892570|NCT00924326|76015115|FG000|STARTED|Dose Administration||8||
59892571|NCT00924326|76015116|FG001|STARTED|Dose Administration||2||
59892572|NCT00924326|76015117|FG002|STARTED|Dose Administration||5||
59892573|NCT00924326|76015118|FG003|STARTED|Dose Administration||6||
59892574|NCT00924326|76015119|FG004|STARTED|Dose Administration||7||
59892575|NCT00924326|76015120|FG005|STARTED|Dose Administration||10||
59892576|NCT00924326|76015121|FG006|STARTED|Dose Administration||1||
59892577|NCT00924326|76015122|FG007|STARTED|Dose Administration||2||
59892578|NCT00924326|76015123|FG008|STARTED|Dose Administration||2||
59892579|NCT00924326|76015115|FG000|COMPLETED|Dose Administration||8||
59892580|NCT00924326|76015116|FG001|COMPLETED|Dose Administration||2||
59892581|NCT00924326|76015117|FG002|COMPLETED|Dose Administration||5||
59892582|NCT00924326|76015118|FG003|COMPLETED|Dose Administration||6||
59892583|NCT00924326|76015119|FG004|COMPLETED|Dose Administration||7||
59892584|NCT00924326|76015120|FG005|COMPLETED|Dose Administration||10||
59892585|NCT00924326|76015121|FG006|COMPLETED|Dose Administration||1||
59892586|NCT00924326|76015122|FG007|COMPLETED|Dose Administration||2||
59892587|NCT00924326|76015123|FG008|COMPLETED|Dose Administration||2||
59892588|NCT00924326|76015115|FG000|NOT COMPLETED|Dose Administration||0||
59892589|NCT00924326|76015116|FG001|NOT COMPLETED|Dose Administration||0||
59892590|NCT00924326|76015117|FG002|NOT COMPLETED|Dose Administration||0||
59892591|NCT00924326|76015118|FG003|NOT COMPLETED|Dose Administration||0||
59892592|NCT00924326|76015119|FG004|NOT COMPLETED|Dose Administration||0||
59892593|NCT00924326|76015120|FG005|NOT COMPLETED|Dose Administration||0||
59892594|NCT00924326|76015121|FG006|NOT COMPLETED|Dose Administration||0||
59892595|NCT00924326|76015122|FG007|NOT COMPLETED|Dose Administration||0||
59892596|NCT00924326|76015123|FG008|NOT COMPLETED|Dose Administration||0||
59892597|NCT00924326|76015115|FG000|STARTED|1x10^9-1x10^10 + High Dose Retreat||3||
59892598|NCT00924326|76015116|FG001|STARTED|1x10^9-1x10^10 + High Dose Retreat||0||
59892599|NCT00924326|76015117|FG002|STARTED|1x10^9-1x10^10 + High Dose Retreat||0||
59892600|NCT00924326|76015118|FG003|STARTED|1x10^9-1x10^10 + High Dose Retreat||0||
59892601|NCT00924326|76015119|FG004|STARTED|1x10^9-1x10^10 + High Dose Retreat||0||
59892602|NCT00924326|76015120|FG005|STARTED|1x10^9-1x10^10 + High Dose Retreat||0||
59892603|NCT00924326|76015121|FG006|STARTED|1x10^9-1x10^10 + High Dose Retreat||0||
59892604|NCT00924326|76015122|FG007|STARTED|1x10^9-1x10^10 + High Dose Retreat||0||
59892605|NCT00924326|76015123|FG008|STARTED|1x10^9-1x10^10 + High Dose Retreat||0||
59892606|NCT00924326|76015115|FG000|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||3||
59892607|NCT00924326|76015116|FG001|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0||
59892608|NCT00924326|76015117|FG002|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0||
59892609|NCT00924326|76015118|FG003|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0||
59892610|NCT00924326|76015119|FG004|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0||
59892611|NCT00924326|76015120|FG005|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0||
59892612|NCT00924326|76015121|FG006|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0||
59892613|NCT00924326|76015122|FG007|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0||
59892614|NCT00924326|76015123|FG008|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0||
59892615|NCT00924326|76015115|FG000|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0||
59892616|NCT00924326|76015116|FG001|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0||
59892617|NCT00924326|76015117|FG002|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0||
59892618|NCT00924326|76015118|FG003|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0||
59892619|NCT00924326|76015119|FG004|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0||
59892620|NCT00924326|76015120|FG005|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0||
59892621|NCT00924326|76015121|FG006|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0||
59892622|NCT00924326|76015122|FG007|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0||
59892623|NCT00924326|76015123|FG008|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0||
59892624|NCT03131570|76015147|FG000|STARTED|Overall Study||12||
59892625|NCT03131570|76015148|FG001|STARTED|Overall Study||11||
59892626|NCT03131570|76015147|FG000|COMPLETED|Overall Study||11||
59892627|NCT03131570|76015148|FG001|COMPLETED|Overall Study||11||
59892628|NCT03131570|76015147|FG000|NOT COMPLETED|Overall Study||1||
59892629|NCT03131570|76015148|FG001|NOT COMPLETED|Overall Study||0||
59892630|NCT02930018|76015158|FG000|STARTED|Overall Study||556||
59892631|NCT02930018|76015159|FG001|STARTED|Overall Study||549||
59892632|NCT02930018|76015158|FG000|COMPLETED|Overall Study||550||
59892633|NCT02930018|76015159|FG001|COMPLETED|Overall Study||546||
59892634|NCT02930018|76015158|FG000|NOT COMPLETED|Overall Study||6||
59892635|NCT02930018|76015159|FG001|NOT COMPLETED|Overall Study||3||
59892636|NCT02875028|76015167|FG000|STARTED|First Intervention (24 Hours)||8|One subject did not participate in the second study period, therefore only 15 started vorapaxar|
59892637|NCT02875028|76015168|FG001|STARTED|First Intervention (24 Hours)||8|One subject did not participate in the second study period, therefore only 15 started vorapaxar|
59892638|NCT02875028|76015167|FG000|COMPLETED|First Intervention (24 Hours)||8||
59892639|NCT02875028|76015168|FG001|COMPLETED|First Intervention (24 Hours)||8||
59892640|NCT02875028|76015167|FG000|NOT COMPLETED|First Intervention (24 Hours)||0||
59892641|NCT02875028|76015168|FG001|NOT COMPLETED|First Intervention (24 Hours)||0||
59892642|NCT02875028|76015167|FG000|STARTED|Washout Period||8||
59892643|NCT02875028|76015168|FG001|STARTED|Washout Period||8||
59892644|NCT02875028|76015167|FG000|COMPLETED|Washout Period||8||
59892645|NCT02875028|76015168|FG001|COMPLETED|Washout Period||7||
59892646|NCT02875028|76015167|FG000|NOT COMPLETED|Washout Period||0||
59892647|NCT02875028|76015168|FG001|NOT COMPLETED|Washout Period||1||
59892648|NCT02875028|76015167|FG000|STARTED|Second Intervention (24 Hours)||8||
59892649|NCT02875028|76015168|FG001|STARTED|Second Intervention (24 Hours)||7||
59892650|NCT02875028|76015167|FG000|COMPLETED|Second Intervention (24 Hours)||8||
59892651|NCT02875028|76015168|FG001|COMPLETED|Second Intervention (24 Hours)||7||
59892652|NCT02875028|76015167|FG000|NOT COMPLETED|Second Intervention (24 Hours)||0||
59892653|NCT02875028|76015168|FG001|NOT COMPLETED|Second Intervention (24 Hours)||0||
59892654|NCT00943618|76015179|FG000|STARTED|Overall Study||163||
59892655|NCT00943618|76015180|FG001|STARTED|Overall Study||166||
59892656|NCT00943618|76015181|FG002|STARTED|Overall Study||56||
59892657|NCT00943618|76015179|FG000|COMPLETED|Overall Study||108||
59892658|NCT00943618|76015180|FG001|COMPLETED|Overall Study||89||
59892659|NCT00943618|76015181|FG002|COMPLETED|Overall Study||25||
59505641|NCT00779311|75598507|FG000|STARTED|Overall Study|2 of 6 patients were not evaluable for DLT assessment and were replaced for a total of 8 enrolled.|8||
59505642|NCT00779311|75598508|FG001|STARTED|Overall Study||0||
59505643|NCT00779311|75598509|FG002|STARTED|Overall Study||0||
59505644|NCT00779311|75598510|FG003|STARTED|Overall Study||0||
59505645|NCT00779311|75598511|FG004|STARTED|Overall Study||0||
59505646|NCT00779311|75598507|FG000|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||6||
59505647|NCT00779311|75598508|FG001|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||0||
59505648|NCT00779311|75598509|FG002|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||0||
59505649|NCT00779311|75598510|FG003|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||0||
59505650|NCT00779311|75598511|FG004|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||0||
59505651|NCT00779311|75598507|FG000|COMPLETED|Overall Study||8||
59892660|NCT00943618|76015179|FG000|NOT COMPLETED|Overall Study||55||
59892661|NCT00943618|76015180|FG001|NOT COMPLETED|Overall Study||77||
59892662|NCT00943618|76015181|FG002|NOT COMPLETED|Overall Study||31||
59892663|NCT02710084|76015191|FG000|STARTED|First Phase - 12 Weeks||10||
59892664|NCT02710084|76015192|FG001|STARTED|First Phase - 12 Weeks||8||
59892665|NCT02710084|76015191|FG000|COMPLETED|First Phase - 12 Weeks||7||
59892666|NCT02710084|76015192|FG001|COMPLETED|First Phase - 12 Weeks||7||
59892667|NCT02710084|76015191|FG000|NOT COMPLETED|First Phase - 12 Weeks||3||
59892668|NCT02710084|76015192|FG001|NOT COMPLETED|First Phase - 12 Weeks||1||
59892669|NCT02710084|76015191|FG000|STARTED|Open Label Phase: Week 12 to 24||7||
59505652|NCT00779311|75598508|FG001|COMPLETED|Overall Study||0||
59505653|NCT00779311|75598509|FG002|COMPLETED|Overall Study||0||
59505654|NCT00779311|75598510|FG003|COMPLETED|Overall Study||0||
59505655|NCT00779311|75598511|FG004|COMPLETED|Overall Study||0||
59505656|NCT00779311|75598507|FG000|NOT COMPLETED|Overall Study||0||
59892670|NCT02710084|76015192|FG001|STARTED|Open Label Phase: Week 12 to 24||7||
59505657|NCT00779311|75598508|FG001|NOT COMPLETED|Overall Study||0||
59505658|NCT00779311|75598509|FG002|NOT COMPLETED|Overall Study||0||
59505659|NCT00779311|75598510|FG003|NOT COMPLETED|Overall Study||0||
59505660|NCT00779311|75598511|FG004|NOT COMPLETED|Overall Study||0||
59505661|NCT00725153|75598523|FG000|STARTED|Period One, 10 Hours of Wear||27||
59505662|NCT00725153|75598524|FG001|STARTED|Period One, 10 Hours of Wear||28||
59892671|NCT02710084|76015191|FG000|COMPLETED|Open Label Phase: Week 12 to 24||7||
59892672|NCT02710084|76015192|FG001|COMPLETED|Open Label Phase: Week 12 to 24||7||
59892673|NCT02710084|76015191|FG000|NOT COMPLETED|Open Label Phase: Week 12 to 24||0||
59892674|NCT02710084|76015192|FG001|NOT COMPLETED|Open Label Phase: Week 12 to 24||0||
59892675|NCT02849990|76015199|FG000|STARTED|Overall Study||22||
59892676|NCT02849990|76015199|FG000|COMPLETED|Overall Study||20||
59892677|NCT02849990|76015199|FG000|NOT COMPLETED|Overall Study||2||
59892678|NCT02017964|76015203|FG000|STARTED|Overall Study||26||
59892679|NCT02017964|76015203|FG000|COMPLETED|Overall Study||25||
59892680|NCT02017964|76015203|FG000|NOT COMPLETED|Overall Study||1||
59892681|NCT01956110|76015209|FG000|STARTED|Overall Study||665||
59892682|NCT01956110|76015210|FG001|STARTED|Overall Study||661||
59892683|NCT01956110|76015209|FG000|COMPLETED|Overall Study||630||
59892684|NCT01956110|76015210|FG001|COMPLETED|Overall Study||639||
59892685|NCT01956110|76015209|FG000|NOT COMPLETED|Overall Study||35||
59892686|NCT01956110|76015210|FG001|NOT COMPLETED|Overall Study||22||
59892687|NCT00535990|76015217|FG000|STARTED|Overall Study||250||
59892688|NCT00535990|76015217|FG000|COMPLETED|Overall Study||250||
59892689|NCT00535990|76015217|FG000|NOT COMPLETED|Overall Study||0||
59892690|NCT04373746|76015223|FG000|STARTED|Overall Study||31||
59892691|NCT04373746|76015224|FG001|STARTED|Overall Study||51||
59892692|NCT04373746|76015223|FG000|COMPLETED|Overall Study||24||
59892693|NCT04373746|76015224|FG001|COMPLETED|Overall Study||44||
59892694|NCT04373746|76015223|FG000|NOT COMPLETED|Overall Study||7||
59892695|NCT04373746|76015224|FG001|NOT COMPLETED|Overall Study||7||
59892696|NCT02893514|76015232|FG000|STARTED|Overall Study||42||
59892697|NCT02893514|76015233|FG001|STARTED|Overall Study||37||
59892698|NCT02893514|76015232|FG000|COMPLETED|Overall Study||42||
59892699|NCT02893514|76015233|FG001|COMPLETED|Overall Study||37||
59892700|NCT02893514|76015232|FG000|NOT COMPLETED|Overall Study||0||
59892701|NCT02893514|76015233|FG001|NOT COMPLETED|Overall Study||0||
59892702|NCT03116828|76015241|FG000|STARTED|Overall Study||44||
59892703|NCT03116828|76015242|FG001|STARTED|Overall Study||58||
59892704|NCT03116828|76015241|FG000|COMPLETED|Overall Study||36||
59892705|NCT03116828|76015242|FG001|COMPLETED|Overall Study||37||
59892706|NCT03116828|76015241|FG000|NOT COMPLETED|Overall Study||8||
59892707|NCT03116828|76015242|FG001|NOT COMPLETED|Overall Study||21||
59892708|NCT03938272|76015250|FG000|STARTED|Overall Study||11||
59892709|NCT03938272|76015251|FG001|STARTED|Overall Study||11||
59892710|NCT03938272|76015250|FG000|COMPLETED|Overall Study||0||
59892711|NCT03938272|76015251|FG001|COMPLETED|Overall Study||1||
59892712|NCT03938272|76015250|FG000|NOT COMPLETED|Overall Study||11||
59892713|NCT03938272|76015251|FG001|NOT COMPLETED|Overall Study||10||
59892714|NCT03165916|76015259|FG000|STARTED|Overall Study||58||
59892715|NCT03165916|76015260|FG001|STARTED|Overall Study||57||
59892716|NCT03165916|76015259|FG000|Reconstruction Interventions|Overall Study||59||
59892717|NCT03165916|76015260|FG001|Reconstruction Interventions|Overall Study||57||
59892718|NCT03165916|76015259|FG000|COMPLETED|Overall Study||58||
59892719|NCT03165916|76015260|FG001|COMPLETED|Overall Study||57||
59892720|NCT03165916|76015259|FG000|NOT COMPLETED|Overall Study||0||
59892721|NCT03165916|76015260|FG001|NOT COMPLETED|Overall Study||0||
59892722|NCT03126344|76015269|FG000|STARTED|Overall Study||33||
59892723|NCT03126344|76015270|FG001|STARTED|Overall Study||33||
59505663|NCT00725153|75598523|FG000|COMPLETED|Period One, 10 Hours of Wear||27||
59505664|NCT00725153|75598524|FG001|COMPLETED|Period One, 10 Hours of Wear||28||
59892724|NCT03126344|76015271|FG002|STARTED|Overall Study||33||
59892725|NCT03126344|76015269|FG000|COMPLETED|Overall Study||33||
59892726|NCT03126344|76015270|FG001|COMPLETED|Overall Study||33||
59892727|NCT03126344|76015271|FG002|COMPLETED|Overall Study||28||
59892728|NCT03126344|76015269|FG000|NOT COMPLETED|Overall Study||0||
59892729|NCT03126344|76015270|FG001|NOT COMPLETED|Overall Study||0||
60013786|NCT02506257|76129729|FG002|NOT COMPLETED|Overall Study||4||
60013787|NCT02506257|76129730|FG003|NOT COMPLETED|Overall Study||0||
59892730|NCT03126344|76015271|FG002|NOT COMPLETED|Overall Study||5||
59892731|NCT00349466|76015281|FG000|STARTED|Overall Study||42||
59892732|NCT00349466|76015282|FG001|STARTED|Overall Study||38||
59892733|NCT00349466|76015281|FG000|COMPLETED|Overall Study||33||
59892734|NCT00349466|76015282|FG001|COMPLETED|Overall Study||35||
59892735|NCT00349466|76015281|FG000|NOT COMPLETED|Overall Study||9||
59892736|NCT00349466|76015282|FG001|NOT COMPLETED|Overall Study||3||
59892737|NCT03115112|76015292|FG000|STARTED|Overall Study||192||
59892738|NCT03115112|76015293|FG001|STARTED|Overall Study||194||
59892739|NCT03115112|76015292|FG000|Intention-to-treat|Overall Study||191|One randomized subject in each group was excluded in the ITT and the safety populations due to site closure for GCP violation.|
59892740|NCT03115112|76015293|FG001|Intention-to-treat|Overall Study||193|One randomized subject in each group was excluded in the ITT and the safety populations due to site closure for GCP violation.|
59892741|NCT03115112|76015292|FG000|COMPLETED|Overall Study||180||
59892742|NCT03115112|76015293|FG001|COMPLETED|Overall Study||189||
59892743|NCT03115112|76015292|FG000|NOT COMPLETED|Overall Study||12||
59892744|NCT03115112|76015293|FG001|NOT COMPLETED|Overall Study||5||
59892745|NCT03690284|76015303|FG000|STARTED|Overall Study||25||
59892746|NCT03690284|76015304|FG001|STARTED|Overall Study||25||
59892747|NCT03690284|76015303|FG000|COMPLETED|Overall Study||25||
59892748|NCT03690284|76015304|FG001|COMPLETED|Overall Study||25||
59892749|NCT03690284|76015303|FG000|NOT COMPLETED|Overall Study||0||
59892750|NCT03690284|76015304|FG001|NOT COMPLETED|Overall Study||0||
59892751|NCT03556358|76015312|FG000|STARTED|Overall Study||404||
59892752|NCT03556358|76015313|FG001|STARTED|Overall Study||405||
59892753|NCT03556358|76015312|FG000|Subjects Treated|Overall Study||401|Treated: Subjects treated with epirubicin and /or cyclophosphamide in cycle 1.|
59892754|NCT03556358|76015313|FG001|Subjects Treated|Overall Study||405|Treated: Subjects treated with epirubicin and /or cyclophosphamide in cycle 1.|
59892755|NCT03556358|76015312|FG000|Subjects Receiving TX05 or Herceptin|Overall Study||394|TX05 or Herceptin was received at Cycle 5|
59892756|NCT03556358|76015313|FG001|Subjects Receiving TX05 or Herceptin|Overall Study||400|TX05 or Herceptin was received at Cycle 5|
59892757|NCT03556358|76015312|FG000|COMPLETED|Overall Study||393||
59892758|NCT03556358|76015313|FG001|COMPLETED|Overall Study||393||
59892759|NCT03556358|76015312|FG000|NOT COMPLETED|Overall Study||11||
59892760|NCT03556358|76015313|FG001|NOT COMPLETED|Overall Study||12||
59892761|NCT03077204|76015319|FG000|STARTED|Overall Study||20||
59892762|NCT03077204|76015319|FG000|COMPLETED|Overall Study||20||
59892763|NCT03077204|76015319|FG000|NOT COMPLETED|Overall Study||0||
59892764|NCT02891798|76015326|FG000|STARTED|Overall Study||62||
59892765|NCT02891798|76015327|FG001|STARTED|Overall Study||16||
59892766|NCT02891798|76015326|FG000|COMPLETED|Overall Study||62||
59892767|NCT02891798|76015327|FG001|COMPLETED|Overall Study||16||
59892768|NCT02891798|76015326|FG000|NOT COMPLETED|Overall Study||0||
59892769|NCT02891798|76015327|FG001|NOT COMPLETED|Overall Study||0||
59892770|NCT02507960|76015333|FG000|STARTED|Overall Study||17||
59892771|NCT02507960|76015333|FG000|COMPLETED|Overall Study||17||
59892772|NCT02507960|76015333|FG000|NOT COMPLETED|Overall Study||0||
59892773|NCT03118934|76015340|FG000|STARTED|Overall Study||34|Randomized and trial fit, as randomized|
59892774|NCT03118934|76015341|FG001|STARTED|Overall Study||31|Randomized and trial fit, as randomized|
59892775|NCT03118934|76015342|FG002|STARTED|Overall Study||34|Randomized and trial fit, as randomized|
59892776|NCT03118934|76015343|FG003|STARTED|Overall Study||29|Randomized and trial fit, as randomized|
59892777|NCT03118934|76015344|FG004|STARTED|Overall Study||29|Randomized and trial fit, as randomized|
59892778|NCT03118934|76015345|FG005|STARTED|Overall Study||25|Randomized and trial fit, as randomized|
59892779|NCT03118934|76015340|FG000|Safety Analysis Set|Overall Study||34|All subjects/eyes exposed to study lenses, except those used for trial fit at Visit 1, as exposed|
59892780|NCT03118934|76015341|FG001|Safety Analysis Set|Overall Study||29|All subjects/eyes exposed to study lenses, except those used for trial fit at Visit 1, as exposed|
59892781|NCT03118934|76015342|FG002|Safety Analysis Set|Overall Study||34|All subjects/eyes exposed to study lenses, except those used for trial fit at Visit 1, as exposed|
59892782|NCT03118934|76015343|FG003|Safety Analysis Set|Overall Study||29|All subjects/eyes exposed to study lenses, except those used for trial fit at Visit 1, as exposed|
59892783|NCT03118934|76015344|FG004|Safety Analysis Set|Overall Study||26|All subjects/eyes exposed to study lenses, except those used for trial fit at Visit 1, as exposed|
59892784|NCT03118934|76015345|FG005|Safety Analysis Set|Overall Study||25|All subjects/eyes exposed to study lenses, except those used for trial fit at Visit 1, as exposed|
59892785|NCT03118934|76015340|FG000|COMPLETED|Overall Study||34|Completed, as randomized|
59892786|NCT03118934|76015341|FG001|COMPLETED|Overall Study||30|Completed, as randomized|
59892787|NCT03118934|76015342|FG002|COMPLETED|Overall Study||33|Completed, as randomized|
59892788|NCT03118934|76015343|FG003|COMPLETED|Overall Study||28|Completed, as randomized|
59892789|NCT03118934|76015344|FG004|COMPLETED|Overall Study||27|Completed, as randomized|
59892790|NCT03118934|76015345|FG005|COMPLETED|Overall Study||23|Completed, as randomized|
59892791|NCT03118934|76015340|FG000|NOT COMPLETED|Overall Study||0||
59892792|NCT03118934|76015341|FG001|NOT COMPLETED|Overall Study||1||
59892793|NCT03118934|76015342|FG002|NOT COMPLETED|Overall Study||1||
59892794|NCT03118934|76015343|FG003|NOT COMPLETED|Overall Study||1||
59892795|NCT03118934|76015344|FG004|NOT COMPLETED|Overall Study||2||
59892796|NCT03118934|76015345|FG005|NOT COMPLETED|Overall Study||2||
59892797|NCT03114488|76015355|FG000|STARTED|Time Period 1||19||
59892798|NCT03114488|76015356|FG001|STARTED|Time Period 1||22||
59892799|NCT03114488|76015355|FG000|COMPLETED|Time Period 1||19||
59892800|NCT03114488|76015356|FG001|COMPLETED|Time Period 1||22||
59892801|NCT03114488|76015355|FG000|NOT COMPLETED|Time Period 1||0||
59892802|NCT03114488|76015356|FG001|NOT COMPLETED|Time Period 1||0||
59892803|NCT03114488|76015355|FG000|STARTED|Time Period 2||19||
59892804|NCT03114488|76015356|FG001|STARTED|Time Period 2||22||
59892805|NCT03114488|76015355|FG000|COMPLETED|Time Period 2||18||
59892806|NCT03114488|76015356|FG001|COMPLETED|Time Period 2||19||
59892807|NCT03114488|76015355|FG000|NOT COMPLETED|Time Period 2||1||
59892808|NCT03114488|76015356|FG001|NOT COMPLETED|Time Period 2||3||
59892809|NCT03631472|76015366|FG000|STARTED|Overall Study||21||
59892810|NCT03631472|76015366|FG000|COMPLETED|Overall Study||21||
59892811|NCT03631472|76015366|FG000|NOT COMPLETED|Overall Study||0||
59892812|NCT03135262|76015375|FG000|STARTED|Overall Study||9||
59892813|NCT03135262|76015376|FG001|STARTED|Overall Study||6||
59892814|NCT03135262|76015377|FG002|STARTED|Overall Study||7||
59892815|NCT03135262|76015378|FG003|STARTED|Overall Study||6||
59892816|NCT03135262|76015379|FG004|STARTED|Overall Study||1||
59892817|NCT03135262|76015375|FG000|COMPLETED|Overall Study|The study was terminated after escalation phase. The planned expansion phase did not take place due to the early termination.|0||
59505665|NCT00725153|75598523|FG000|NOT COMPLETED|Period One, 10 Hours of Wear||0||
59505666|NCT00725153|75598524|FG001|NOT COMPLETED|Period One, 10 Hours of Wear||0||
59505667|NCT00725153|75598523|FG000|STARTED|Period Two, 10 Hours of Wear||27||
59892818|NCT03135262|76015376|FG001|COMPLETED|Overall Study|The study was terminated after escalation phase. The planned expansion phase did not take place due to the early termination.|0||
59892819|NCT03135262|76015377|FG002|COMPLETED|Overall Study|The study was terminated after escalation phase. The planned expansion phase did not take place due to the early termination.|0||
59892820|NCT03135262|76015378|FG003|COMPLETED|Overall Study|The study was terminated after escalation phase. The planned expansion phase did not take place due to the early termination.|0||
59892821|NCT03135262|76015379|FG004|COMPLETED|Overall Study|The study was terminated after escalation phase. The planned expansion phase did not take place due to the early termination.|0||
59892822|NCT03135262|76015375|FG000|NOT COMPLETED|Overall Study||9||
59892823|NCT03135262|76015376|FG001|NOT COMPLETED|Overall Study||6||
59892824|NCT03135262|76015377|FG002|NOT COMPLETED|Overall Study||7||
59892825|NCT03135262|76015378|FG003|NOT COMPLETED|Overall Study||6||
59892826|NCT03135262|76015379|FG004|NOT COMPLETED|Overall Study||1||
59892827|NCT03535194|76015414|FG000|STARTED|Induction Period||454||
59892828|NCT03535194|76015415|FG001|STARTED|Induction Period||451||
59892829|NCT03535194|76015416|FG002|STARTED|Induction Period||112||
59892830|NCT03535194|76015417|FG003|STARTED|Induction Period||448||
59892831|NCT03535194|76015418|FG004|STARTED|Induction Period|A plaque psoriasis participant was misrandomized by the site.|19||
59892832|NCT03535194|76015414|FG000|Received at Least One Dose of Study Drug|Induction Period||454||
59892833|NCT03535194|76015415|FG001|Received at Least One Dose of Study Drug|Induction Period||450||
59892834|NCT03535194|76015416|FG002|Received at Least One Dose of Study Drug|Induction Period||112||
59892835|NCT03535194|76015417|FG003|Received at Least One Dose of Study Drug|Induction Period||448||
59892836|NCT03535194|76015418|FG004|Received at Least One Dose of Study Drug|Induction Period||19||
59892837|NCT03535194|76015414|FG000|COMPLETED|Induction Period||443||
59892838|NCT03535194|76015415|FG001|COMPLETED|Induction Period||434||
59892839|NCT03535194|76015416|FG002|COMPLETED|Induction Period||104||
59892840|NCT03535194|76015417|FG003|COMPLETED|Induction Period||437||
59892841|NCT03535194|76015418|FG004|COMPLETED|Induction Period||19||
59892842|NCT03535194|76015414|FG000|NOT COMPLETED|Induction Period||11||
59892843|NCT03535194|76015415|FG001|NOT COMPLETED|Induction Period||17||
59892844|NCT03535194|76015416|FG002|NOT COMPLETED|Induction Period||8||
59892845|NCT03535194|76015417|FG003|NOT COMPLETED|Induction Period||11||
59892846|NCT03535194|76015418|FG004|NOT COMPLETED|Induction Period||0||
59892847|NCT03535194|76015414|FG000|STARTED|Maintenance Period||443||
59892848|NCT03535194|76015415|FG001|STARTED|Maintenance Period||434||
59892849|NCT03535194|76015416|FG002|STARTED|Maintenance Period||104||
59892850|NCT03535194|76015417|FG003|STARTED|Maintenance Period||437||
59892851|NCT03535194|76015418|FG004|STARTED|Maintenance Period||19||
59892852|NCT03535194|76015414|FG000|COMPLETED|Maintenance Period||421||
59892853|NCT03535194|76015415|FG001|COMPLETED|Maintenance Period||418||
59892854|NCT03535194|76015416|FG002|COMPLETED|Maintenance Period||96||
59892855|NCT03535194|76015417|FG003|COMPLETED|Maintenance Period||400||
59892856|NCT03535194|76015418|FG004|COMPLETED|Maintenance Period||13||
59892857|NCT03535194|76015414|FG000|NOT COMPLETED|Maintenance Period||22||
59892858|NCT03535194|76015415|FG001|NOT COMPLETED|Maintenance Period||16||
59892859|NCT03535194|76015416|FG002|NOT COMPLETED|Maintenance Period||8||
59892860|NCT03535194|76015417|FG003|NOT COMPLETED|Maintenance Period||37||
59892861|NCT03535194|76015418|FG004|NOT COMPLETED|Maintenance Period||6||
59892862|NCT03535194|76015414|FG000|STARTED|Post-Treatment Followup Period|Participants who discontinued/completed Induction/Maintenance had option to enter post-treatment|38||
59892863|NCT03535194|76015415|FG001|STARTED|Post-Treatment Followup Period|Participants who discontinued/completed Induction/Maintenance had option to enter post-treatment|35||
59892864|NCT03535194|76015416|FG002|STARTED|Post-Treatment Followup Period|Participants who discontinued/completed Induction/Maintenance had option to enter post-treatment|18||
59892865|NCT03535194|76015417|FG003|STARTED|Post-Treatment Followup Period|Participants who discontinued/completed Induction/Maintenance had option to enter post-treatment|47||
59892866|NCT03535194|76015418|FG004|STARTED|Post-Treatment Followup Period|Participants who discontinued/completed Induction/Maintenance had option to enter post-treatment|8||
59505668|NCT00725153|75598524|FG001|STARTED|Period Two, 10 Hours of Wear||28||
59892867|NCT03535194|76015414|FG000|COMPLETED|Post-Treatment Followup Period||27||
59892868|NCT03535194|76015415|FG001|COMPLETED|Post-Treatment Followup Period||21||
59892869|NCT03535194|76015416|FG002|COMPLETED|Post-Treatment Followup Period||7||
59892870|NCT03535194|76015417|FG003|COMPLETED|Post-Treatment Followup Period||23||
59892871|NCT03535194|76015418|FG004|COMPLETED|Post-Treatment Followup Period||8||
59892872|NCT03535194|76015414|FG000|NOT COMPLETED|Post-Treatment Followup Period||11||
59892873|NCT03535194|76015415|FG001|NOT COMPLETED|Post-Treatment Followup Period||14||
59892874|NCT03535194|76015416|FG002|NOT COMPLETED|Post-Treatment Followup Period||11||
59892875|NCT03535194|76015417|FG003|NOT COMPLETED|Post-Treatment Followup Period||24||
59892876|NCT03535194|76015418|FG004|NOT COMPLETED|Post-Treatment Followup Period||0||
59892877|NCT03559530|76015442|FG000|STARTED|Overall Study||197||
59892878|NCT03559530|76015443|FG001|STARTED|Overall Study||65||
59892879|NCT03559530|76015442|FG000|COMPLETED|Overall Study||106||
59892880|NCT03559530|76015443|FG001|COMPLETED|Overall Study||65||
59892881|NCT03559530|76015442|FG000|NOT COMPLETED|Overall Study||91||
59892882|NCT03559530|76015443|FG001|NOT COMPLETED|Overall Study||0||
59892883|NCT02740972|76015450|FG000|STARTED|4-week Double-blinded Placebo-controlled||5||
59892884|NCT02740972|76015451|FG001|STARTED|4-week Double-blinded Placebo-controlled||6||
59892885|NCT02740972|76015452|FG002|STARTED|4-week Double-blinded Placebo-controlled||5||
59892886|NCT02740972|76015453|FG003|STARTED|4-week Double-blinded Placebo-controlled||0||
59892887|NCT02740972|76015454|FG004|STARTED|4-week Double-blinded Placebo-controlled||0||
59892888|NCT02740972|76015450|FG000|COMPLETED|4-week Double-blinded Placebo-controlled||5||
59892889|NCT02740972|76015451|FG001|COMPLETED|4-week Double-blinded Placebo-controlled||6||
59892890|NCT02740972|76015452|FG002|COMPLETED|4-week Double-blinded Placebo-controlled||5||
59892891|NCT02740972|76015453|FG003|COMPLETED|4-week Double-blinded Placebo-controlled||0||
59892892|NCT02740972|76015454|FG004|COMPLETED|4-week Double-blinded Placebo-controlled||0||
59892893|NCT02740972|76015450|FG000|NOT COMPLETED|4-week Double-blinded Placebo-controlled||0||
59892894|NCT02740972|76015451|FG001|NOT COMPLETED|4-week Double-blinded Placebo-controlled||0||
59892895|NCT02740972|76015452|FG002|NOT COMPLETED|4-week Double-blinded Placebo-controlled||0||
59892896|NCT02740972|76015453|FG003|NOT COMPLETED|4-week Double-blinded Placebo-controlled||0||
59892897|NCT02740972|76015454|FG004|NOT COMPLETED|4-week Double-blinded Placebo-controlled||0||
59892898|NCT02740972|76015450|FG000|STARTED|20-week Open Label Treatment Period||0||
59892899|NCT02740972|76015451|FG001|STARTED|20-week Open Label Treatment Period||0||
59892900|NCT02740972|76015452|FG002|STARTED|20-week Open Label Treatment Period||0||
59892901|NCT02740972|76015453|FG003|STARTED|20-week Open Label Treatment Period||8||
59892902|NCT02740972|76015454|FG004|STARTED|20-week Open Label Treatment Period||8||
59892903|NCT02740972|76015450|FG000|COMPLETED|20-week Open Label Treatment Period||0||
59892904|NCT02740972|76015451|FG001|COMPLETED|20-week Open Label Treatment Period||0||
59892905|NCT02740972|76015452|FG002|COMPLETED|20-week Open Label Treatment Period||0||
59892906|NCT02740972|76015453|FG003|COMPLETED|20-week Open Label Treatment Period||8||
59892907|NCT02740972|76015454|FG004|COMPLETED|20-week Open Label Treatment Period||8||
59505669|NCT00725153|75598523|FG000|COMPLETED|Period Two, 10 Hours of Wear||27||
59518989|NCT03587428|75612874|FG004|COMPLETED|Period 1||2||
59892908|NCT02740972|76015450|FG000|NOT COMPLETED|20-week Open Label Treatment Period||0||
59892909|NCT02740972|76015451|FG001|NOT COMPLETED|20-week Open Label Treatment Period||0||
59892910|NCT02740972|76015452|FG002|NOT COMPLETED|20-week Open Label Treatment Period||0||
59892911|NCT02740972|76015453|FG003|NOT COMPLETED|20-week Open Label Treatment Period||0||
59892912|NCT02740972|76015454|FG004|NOT COMPLETED|20-week Open Label Treatment Period||0||
59892913|NCT03124784|76015471|FG000|STARTED|Overall Study||27||
59892914|NCT03124784|76015471|FG000|COMPLETED|Overall Study||25||
59892915|NCT03124784|76015471|FG000|NOT COMPLETED|Overall Study||2||
59892916|NCT03531840|76015479|FG000|STARTED|Overall Study||5||
59892917|NCT03531840|76015480|FG001|STARTED|Overall Study||6||
59892918|NCT03531840|76015481|FG002|STARTED|Overall Study||8||
59892919|NCT03531840|76015482|FG003|STARTED|Overall Study||4||
59892920|NCT03531840|76015479|FG000|COMPLETED|Overall Study||0||
59892921|NCT03531840|76015480|FG001|COMPLETED|Overall Study||1||
59892922|NCT03531840|76015481|FG002|COMPLETED|Overall Study||3||
59892923|NCT03531840|76015482|FG003|COMPLETED|Overall Study||1||
59892924|NCT03531840|76015479|FG000|NOT COMPLETED|Overall Study||5||
59892925|NCT03531840|76015480|FG001|NOT COMPLETED|Overall Study||5||
59892926|NCT03531840|76015481|FG002|NOT COMPLETED|Overall Study||5||
59892927|NCT03531840|76015482|FG003|NOT COMPLETED|Overall Study||3||
59892928|NCT03110900|76015499|FG000|STARTED|Overall Study||1||
59892929|NCT03110900|76015500|FG001|STARTED|Overall Study||1||
59892930|NCT03110900|76015499|FG000|COMPLETED|Overall Study||0||
59892931|NCT03110900|76015500|FG001|COMPLETED|Overall Study||0||
59892932|NCT03110900|76015499|FG000|NOT COMPLETED|Overall Study||1||
59892933|NCT03110900|76015500|FG001|NOT COMPLETED|Overall Study||1||
59892934|NCT03867734|76015506|FG000|STARTED|Overall Study||32||
59892935|NCT03867734|76015506|FG000|COMPLETED|Overall Study||30||
59892936|NCT03867734|76015506|FG000|NOT COMPLETED|Overall Study||2||
59892937|NCT03446456|76015516|FG000|STARTED|Overall Study||20||
59892938|NCT03446456|76015517|FG001|STARTED|Overall Study||20||
59892939|NCT03446456|76015516|FG000|COMPLETED|Overall Study||16||
59892940|NCT03446456|76015517|FG001|COMPLETED|Overall Study||16||
59892941|NCT03446456|76015516|FG000|NOT COMPLETED|Overall Study||4||
59892942|NCT03446456|76015517|FG001|NOT COMPLETED|Overall Study||4||
59892943|NCT03495102|76015526|FG000|STARTED|Overall Study||612||
59892944|NCT03495102|76015527|FG001|STARTED|Overall Study||616||
59892945|NCT03495102|76015528|FG002|STARTED|Overall Study||614||
59892946|NCT03495102|76015526|FG000|Received at Least One Dose of Study Drug|Overall Study||612||
59892947|NCT03495102|76015527|FG001|Received at Least One Dose of Study Drug|Overall Study||616||
59892948|NCT03495102|76015528|FG002|Received at Least One Dose of Study Drug|Overall Study||614||
59892949|NCT03495102|76015526|FG000|COMPLETED|Overall Study||556||
59892950|NCT03495102|76015527|FG001|COMPLETED|Overall Study||549||
59892951|NCT03495102|76015528|FG002|COMPLETED|Overall Study||560||
59892952|NCT03495102|76015526|FG000|NOT COMPLETED|Overall Study||56||
59892953|NCT03495102|76015527|FG001|NOT COMPLETED|Overall Study||67||
59892954|NCT03495102|76015528|FG002|NOT COMPLETED|Overall Study||54||
59892955|NCT03105362|76015536|FG000|STARTED|Overall Study||4||
59892956|NCT03105362|76015536|FG000|Completed 1 Week of Study|Overall Study||4||
59892957|NCT03105362|76015536|FG000|Completed 2 Weeks of Study|Overall Study||3||
59892958|NCT03105362|76015536|FG000|Completed 2 Week Questionaire|Overall Study||2||
59505670|NCT00725153|75598524|FG001|COMPLETED|Period Two, 10 Hours of Wear||28||
59892959|NCT03105362|76015536|FG000|COMPLETED|Overall Study||2||
59892960|NCT03105362|76015536|FG000|NOT COMPLETED|Overall Study||2||
59892961|NCT03559218|76015545|FG000|STARTED|Overall Study||12||
59505671|NCT00725153|75598523|FG000|NOT COMPLETED|Period Two, 10 Hours of Wear||0||
59892962|NCT03559218|76015546|FG001|STARTED|Overall Study||13||
59892963|NCT03559218|76015545|FG000|COMPLETED|Overall Study||11||
59892964|NCT03559218|76015546|FG001|COMPLETED|Overall Study||13||
59892965|NCT03559218|76015545|FG000|NOT COMPLETED|Overall Study||1||
59892966|NCT03559218|76015546|FG001|NOT COMPLETED|Overall Study||0||
59892967|NCT03104816|76015555|FG000|STARTED|Overall Study||11||
59892968|NCT03104816|76015556|FG001|STARTED|Overall Study||11||
59892969|NCT03104816|76015557|FG002|STARTED|Overall Study||6||
59892970|NCT03104816|76015555|FG000|COMPLETED|Overall Study||9||
59892971|NCT03104816|76015556|FG001|COMPLETED|Overall Study||9||
59892972|NCT03104816|76015557|FG002|COMPLETED|Overall Study||4||
59892973|NCT03104816|76015555|FG000|NOT COMPLETED|Overall Study||2||
59892974|NCT03104816|76015556|FG001|NOT COMPLETED|Overall Study||2||
59892975|NCT03104816|76015557|FG002|NOT COMPLETED|Overall Study||2||
59892976|NCT03559062|76015568|FG000|STARTED|Overall Study||10||
59892977|NCT03559062|76015569|FG001|STARTED|Overall Study||54||
59892978|NCT03559062|76015570|FG002|STARTED|Overall Study||3||
59892979|NCT03559062|76015568|FG000|COMPLETED|Overall Study||10||
59892980|NCT03559062|76015569|FG001|COMPLETED|Overall Study||53||
59892981|NCT03559062|76015570|FG002|COMPLETED|Overall Study||3||
59892982|NCT03559062|76015568|FG000|NOT COMPLETED|Overall Study||0||
59892983|NCT03559062|76015569|FG001|NOT COMPLETED|Overall Study||1||
59892984|NCT03559062|76015570|FG002|NOT COMPLETED|Overall Study||0||
59892985|NCT00089791|76015581|FG000|STARTED|Overall Study||3906||
59892986|NCT00089791|76015582|FG001|STARTED|Overall Study||3902||
59892987|NCT00089791|76015581|FG000|Received Study Medication|Overall Study||3883||
59892988|NCT00089791|76015582|FG001|Received Study Medication|Overall Study||3879||
59892989|NCT00089791|76015581|FG000|Safety Analysis Set|Overall Study|7 participants in the placebo arm received ≥1 dose of denosumab & were analyzed in the denosumab arm|3876||
59892990|NCT00089791|76015582|FG001|Safety Analysis Set|Overall Study||3886||
59892991|NCT00089791|76015581|FG000|COMPLETED|Overall Study||3206||
59892992|NCT00089791|76015582|FG001|COMPLETED|Overall Study||3272||
59892993|NCT00089791|76015581|FG000|NOT COMPLETED|Overall Study||700||
59892994|NCT00089791|76015582|FG001|NOT COMPLETED|Overall Study||630||
59892995|NCT03558672|76015588|FG000|STARTED|Overall Study||18||
59892996|NCT03558672|76015588|FG000|COMPLETED|Overall Study||8||
59892997|NCT03558672|76015588|FG000|NOT COMPLETED|Overall Study||10||
59892998|NCT03558516|76015594|FG000|STARTED|Overall Study||40||
59892999|NCT03558516|76015595|FG001|STARTED|Overall Study||40||
59893000|NCT03558516|76015594|FG000|COMPLETED|Overall Study||38||
59893001|NCT03558516|76015595|FG001|COMPLETED|Overall Study||38||
59893002|NCT03558516|76015594|FG000|NOT COMPLETED|Overall Study||2||
59893003|NCT03558516|76015595|FG001|NOT COMPLETED|Overall Study||2||
59893004|NCT03557970|76015603|FG000|STARTED|Overall Study||1||
59893005|NCT03557970|76015604|FG001|STARTED|Overall Study||2||
59893006|NCT03557970|76015603|FG000|COMPLETED|Overall Study||0||
59893007|NCT03557970|76015604|FG001|COMPLETED|Overall Study||0||
59893008|NCT03557970|76015603|FG000|NOT COMPLETED|Overall Study||1||
59893009|NCT03557970|76015604|FG001|NOT COMPLETED|Overall Study||2||
59893010|NCT02815280|76015612|FG000|STARTED|Double-Blind Phase||333||
59893011|NCT02815280|76015613|FG001|STARTED|Double-Blind Phase||162||
59893012|NCT02815280|76015612|FG000|COMPLETED|Double-Blind Phase||297||
59893013|NCT02815280|76015613|FG001|COMPLETED|Double-Blind Phase||137||
59893014|NCT02815280|76015612|FG000|NOT COMPLETED|Double-Blind Phase||36||
59893015|NCT02815280|76015613|FG001|NOT COMPLETED|Double-Blind Phase||25||
59893016|NCT02815280|76015612|FG000|STARTED|Open-Label Phase||256||
59893017|NCT02815280|76015613|FG001|STARTED|Open-Label Phase||117||
59893018|NCT02815280|76015612|FG000|COMPLETED|Open-Label Phase||169||
59893019|NCT02815280|76015613|FG001|COMPLETED|Open-Label Phase||73||
59893020|NCT02815280|76015612|FG000|NOT COMPLETED|Open-Label Phase||87||
59893021|NCT02815280|76015613|FG001|NOT COMPLETED|Open-Label Phase||44||
59893022|NCT02737930|76015625|FG000|STARTED|Overall Study||5||
59893023|NCT02737930|76015626|FG001|STARTED|Overall Study||7||
59893024|NCT02737930|76015625|FG000|COMPLETED|Overall Study||5||
59893025|NCT02737930|76015626|FG001|COMPLETED|Overall Study||6||
59893026|NCT02737930|76015625|FG000|NOT COMPLETED|Overall Study||0||
59893027|NCT02737930|76015626|FG001|NOT COMPLETED|Overall Study||1||
59893028|NCT03493698|76015632|FG000|STARTED|Treatment Period A||17||
59893029|NCT03493698|76015632|FG000|COMPLETED|Treatment Period A||17||
59893030|NCT03493698|76015632|FG000|NOT COMPLETED|Treatment Period A||0||
59893031|NCT03493698|76015632|FG000|STARTED|Treatment Period B||17||
59893032|NCT03493698|76015632|FG000|COMPLETED|Treatment Period B||17||
59893033|NCT03493698|76015632|FG000|NOT COMPLETED|Treatment Period B||0||
59893034|NCT03493698|76015632|FG000|STARTED|Treatment Period C||17||
59893035|NCT03493698|76015632|FG000|COMPLETED|Treatment Period C||15|One subject withdrawn from the study on Day 9 and was replaced|
59893036|NCT03493698|76015632|FG000|NOT COMPLETED|Treatment Period C||2||
59893037|NCT03493698|76015632|FG000|STARTED|Treatment Period D||15||
59893038|NCT03493698|76015632|FG000|COMPLETED|Treatment Period D||15||
59893039|NCT03493698|76015632|FG000|NOT COMPLETED|Treatment Period D||0||
59893040|NCT02737852|76015646|FG000|STARTED|Overall Study||32||
59893041|NCT02737852|76015646|FG000|COMPLETED|Overall Study||30||
59893042|NCT02737852|76015646|FG000|NOT COMPLETED|Overall Study||2||
59893043|NCT03528174|76015650|FG000|STARTED|Overall Study||10||
59893044|NCT03528174|76015650|FG000|COMPLETED|Overall Study||8||
59893045|NCT03528174|76015650|FG000|NOT COMPLETED|Overall Study||2||
59893046|NCT01883804|76015654|FG000|STARTED|Overall Study||25||
59893047|NCT01883804|76015654|FG000|COMPLETED|Overall Study||20||
59893048|NCT01883804|76015654|FG000|NOT COMPLETED|Overall Study||5||
59893049|NCT03109184|76015660|FG000|STARTED|Overall Study||60||
59893050|NCT03109184|76015661|FG001|STARTED|Overall Study||59||
59893051|NCT03109184|76015660|FG000|COMPLETED|Overall Study||53||
59893052|NCT03109184|76015661|FG001|COMPLETED|Overall Study||52||
59893053|NCT03109184|76015660|FG000|NOT COMPLETED|Overall Study||7||
59893054|NCT03109184|76015661|FG001|NOT COMPLETED|Overall Study||7||
59893055|NCT02348203|76015669|FG000|STARTED|Overall Study||31||
59893056|NCT02348203|76015670|FG001|STARTED|Overall Study||32||
59893057|NCT02348203|76015669|FG000|COMPLETED|Overall Study||21||
59893058|NCT02348203|76015670|FG001|COMPLETED|Overall Study||22||
59893059|NCT02348203|76015669|FG000|NOT COMPLETED|Overall Study||10||
59893060|NCT02348203|76015670|FG001|NOT COMPLETED|Overall Study||10||
59893061|NCT03493386|76015679|FG000|STARTED|Part 1, Intervention Period 1 (2 Days)||26||
59893062|NCT03493386|76015680|FG001|STARTED|Part 1, Intervention Period 1 (2 Days)||26||
59893063|NCT03493386|76015681|FG002|STARTED|Part 1, Intervention Period 1 (2 Days)||0||
59893064|NCT03493386|76015682|FG003|STARTED|Part 1, Intervention Period 1 (2 Days)||0||
59893065|NCT03493386|76015679|FG000|COMPLETED|Part 1, Intervention Period 1 (2 Days)||26||
59893066|NCT03493386|76015680|FG001|COMPLETED|Part 1, Intervention Period 1 (2 Days)||26||
59893067|NCT03493386|76015681|FG002|COMPLETED|Part 1, Intervention Period 1 (2 Days)||0||
59893068|NCT03493386|76015682|FG003|COMPLETED|Part 1, Intervention Period 1 (2 Days)||0||
59893069|NCT03493386|76015679|FG000|NOT COMPLETED|Part 1, Intervention Period 1 (2 Days)||0||
59893070|NCT03493386|76015680|FG001|NOT COMPLETED|Part 1, Intervention Period 1 (2 Days)||0||
59893071|NCT03493386|76015681|FG002|NOT COMPLETED|Part 1, Intervention Period 1 (2 Days)||0||
59893072|NCT03493386|76015682|FG003|NOT COMPLETED|Part 1, Intervention Period 1 (2 Days)||0||
59893073|NCT03493386|76015679|FG000|STARTED|Part 1, Washout Period (at Least 5 Days)||26||
59893074|NCT03493386|76015680|FG001|STARTED|Part 1, Washout Period (at Least 5 Days)||26||
59893075|NCT03493386|76015681|FG002|STARTED|Part 1, Washout Period (at Least 5 Days)||0||
59893076|NCT03493386|76015682|FG003|STARTED|Part 1, Washout Period (at Least 5 Days)||0||
59893077|NCT03493386|76015679|FG000|COMPLETED|Part 1, Washout Period (at Least 5 Days)||26||
59893078|NCT03493386|76015680|FG001|COMPLETED|Part 1, Washout Period (at Least 5 Days)||25||
59893079|NCT03493386|76015681|FG002|COMPLETED|Part 1, Washout Period (at Least 5 Days)||0||
59893080|NCT03493386|76015682|FG003|COMPLETED|Part 1, Washout Period (at Least 5 Days)||0||
59893081|NCT03493386|76015679|FG000|NOT COMPLETED|Part 1, Washout Period (at Least 5 Days)||0||
59893082|NCT03493386|76015680|FG001|NOT COMPLETED|Part 1, Washout Period (at Least 5 Days)||1||
59893083|NCT03493386|76015681|FG002|NOT COMPLETED|Part 1, Washout Period (at Least 5 Days)||0||
59893084|NCT03493386|76015682|FG003|NOT COMPLETED|Part 1, Washout Period (at Least 5 Days)||0||
59893085|NCT03493386|76015679|FG000|STARTED|Part 1, Intervention Period 2 (2 Days)||26||
59893086|NCT03493386|76015680|FG001|STARTED|Part 1, Intervention Period 2 (2 Days)||25||
59893087|NCT03493386|76015681|FG002|STARTED|Part 1, Intervention Period 2 (2 Days)||0||
59893088|NCT03493386|76015682|FG003|STARTED|Part 1, Intervention Period 2 (2 Days)||0||
59893089|NCT03493386|76015679|FG000|COMPLETED|Part 1, Intervention Period 2 (2 Days)||26||
59893090|NCT03493386|76015680|FG001|COMPLETED|Part 1, Intervention Period 2 (2 Days)||25||
59893091|NCT03493386|76015681|FG002|COMPLETED|Part 1, Intervention Period 2 (2 Days)||0||
59893092|NCT03493386|76015682|FG003|COMPLETED|Part 1, Intervention Period 2 (2 Days)||0||
59893093|NCT03493386|76015679|FG000|NOT COMPLETED|Part 1, Intervention Period 2 (2 Days)||0||
59893094|NCT03493386|76015680|FG001|NOT COMPLETED|Part 1, Intervention Period 2 (2 Days)||0||
59893095|NCT03493386|76015681|FG002|NOT COMPLETED|Part 1, Intervention Period 2 (2 Days)||0||
59893096|NCT03493386|76015682|FG003|NOT COMPLETED|Part 1, Intervention Period 2 (2 Days)||0||
59893097|NCT03493386|76015679|FG000|STARTED|Part 2, Intervention Period 1 (2 Days)||0||
59893098|NCT03493386|76015680|FG001|STARTED|Part 2, Intervention Period 1 (2 Days)||0||
59893099|NCT03493386|76015681|FG002|STARTED|Part 2, Intervention Period 1 (2 Days)||6||
59893100|NCT03493386|76015682|FG003|STARTED|Part 2, Intervention Period 1 (2 Days)||6||
59893101|NCT03493386|76015679|FG000|COMPLETED|Part 2, Intervention Period 1 (2 Days)||0||
59893102|NCT03493386|76015680|FG001|COMPLETED|Part 2, Intervention Period 1 (2 Days)||0||
59505672|NCT00725153|75598524|FG001|NOT COMPLETED|Period Two, 10 Hours of Wear||0||
59893103|NCT03493386|76015681|FG002|COMPLETED|Part 2, Intervention Period 1 (2 Days)||6||
59893104|NCT03493386|76015682|FG003|COMPLETED|Part 2, Intervention Period 1 (2 Days)||6||
59893105|NCT03493386|76015679|FG000|NOT COMPLETED|Part 2, Intervention Period 1 (2 Days)||0||
59893106|NCT03493386|76015680|FG001|NOT COMPLETED|Part 2, Intervention Period 1 (2 Days)||0||
59893107|NCT03493386|76015681|FG002|NOT COMPLETED|Part 2, Intervention Period 1 (2 Days)||0||
59893108|NCT03493386|76015682|FG003|NOT COMPLETED|Part 2, Intervention Period 1 (2 Days)||0||
59893109|NCT03493386|76015679|FG000|STARTED|Part 2, Washout Period (at Least 5 Days)||0||
59893110|NCT03493386|76015680|FG001|STARTED|Part 2, Washout Period (at Least 5 Days)||0||
59893111|NCT03493386|76015681|FG002|STARTED|Part 2, Washout Period (at Least 5 Days)||6||
59893112|NCT03493386|76015682|FG003|STARTED|Part 2, Washout Period (at Least 5 Days)||6||
59893113|NCT03493386|76015679|FG000|COMPLETED|Part 2, Washout Period (at Least 5 Days)||0||
59893114|NCT03493386|76015680|FG001|COMPLETED|Part 2, Washout Period (at Least 5 Days)||0||
59893115|NCT03493386|76015681|FG002|COMPLETED|Part 2, Washout Period (at Least 5 Days)||6||
59893116|NCT03493386|76015682|FG003|COMPLETED|Part 2, Washout Period (at Least 5 Days)||6||
59893117|NCT03493386|76015679|FG000|NOT COMPLETED|Part 2, Washout Period (at Least 5 Days)||0||
59893118|NCT03493386|76015680|FG001|NOT COMPLETED|Part 2, Washout Period (at Least 5 Days)||0||
59893119|NCT03493386|76015681|FG002|NOT COMPLETED|Part 2, Washout Period (at Least 5 Days)||0||
59893120|NCT03493386|76015682|FG003|NOT COMPLETED|Part 2, Washout Period (at Least 5 Days)||0||
59893121|NCT03493386|76015679|FG000|STARTED|Part 2, Intervention Period 2 (2 Days)||0||
59893122|NCT03493386|76015680|FG001|STARTED|Part 2, Intervention Period 2 (2 Days)||0||
59893123|NCT03493386|76015681|FG002|STARTED|Part 2, Intervention Period 2 (2 Days)||6||
59951257|NCT03743415|76070178|FG003|NOT COMPLETED|Overall Study||10||
59951258|NCT03743415|76070179|FG004|NOT COMPLETED|Overall Study||6||
59505673|NCT03807349|75598530|FG000|STARTED|Overall Study||12||
59893124|NCT03493386|76015682|FG003|STARTED|Part 2, Intervention Period 2 (2 Days)||6||
59893125|NCT03493386|76015679|FG000|COMPLETED|Part 2, Intervention Period 2 (2 Days)||0||
59893126|NCT03493386|76015680|FG001|COMPLETED|Part 2, Intervention Period 2 (2 Days)||0||
59893127|NCT03493386|76015681|FG002|COMPLETED|Part 2, Intervention Period 2 (2 Days)||6||
59893128|NCT03493386|76015682|FG003|COMPLETED|Part 2, Intervention Period 2 (2 Days)||6||
59893129|NCT03493386|76015679|FG000|NOT COMPLETED|Part 2, Intervention Period 2 (2 Days)||0||
59893130|NCT03493386|76015680|FG001|NOT COMPLETED|Part 2, Intervention Period 2 (2 Days)||0||
59893131|NCT03493386|76015681|FG002|NOT COMPLETED|Part 2, Intervention Period 2 (2 Days)||0||
59893132|NCT03493386|76015682|FG003|NOT COMPLETED|Part 2, Intervention Period 2 (2 Days)||0||
59893133|NCT03478644|76015701|FG000|STARTED|Phase 1|In Phase 1, only the wipe treatment was administered to eligible participants.|31||
59893134|NCT03478644|76015702|FG001|STARTED|Phase 1||0||
59893135|NCT03478644|76015701|FG000|COMPLETED|Phase 1|In Phase 1, only the wipe treatment was administered to eligible participants.|31||
59893136|NCT03478644|76015702|FG001|COMPLETED|Phase 1||0||
59893137|NCT03478644|76015701|FG000|NOT COMPLETED|Phase 1||0||
59893138|NCT03478644|76015702|FG001|NOT COMPLETED|Phase 1||0||
59893139|NCT03478644|76015701|FG000|STARTED|Phase 2||76||
59893140|NCT03478644|76015702|FG001|STARTED|Phase 2||76||
59893141|NCT03478644|76015701|FG000|COMPLETED|Phase 2||73||
59893142|NCT03478644|76015702|FG001|COMPLETED|Phase 2||75||
59893143|NCT03478644|76015701|FG000|NOT COMPLETED|Phase 2||3||
59893144|NCT03478644|76015702|FG001|NOT COMPLETED|Phase 2||1||
59893145|NCT03527550|76015710|FG000|STARTED|Overall Study||24||
59893146|NCT03527550|76015711|FG001|STARTED|Overall Study||22||
59893147|NCT03527550|76015710|FG000|COMPLETED|Overall Study||15||
59893148|NCT03527550|76015711|FG001|COMPLETED|Overall Study||19||
59893149|NCT03527550|76015710|FG000|NOT COMPLETED|Overall Study||9||
59893150|NCT03527550|76015711|FG001|NOT COMPLETED|Overall Study||3||
59893151|NCT03475056|76015721|FG000|STARTED|Overall Study||20||
59893152|NCT03475056|76015722|FG001|STARTED|Overall Study||20||
59893153|NCT03475056|76015721|FG000|Received Product Administration|Overall Study||20||
59893154|NCT03475056|76015722|FG001|Received Product Administration|Overall Study||20||
59610530|NCT01794780|75721399|FG006|COMPLETED|Overall Study||112||
59610531|NCT01794780|75721400|FG007|COMPLETED|Overall Study||21||
59610532|NCT01794780|75721393|FG000|NOT COMPLETED|Overall Study||17||
59610533|NCT01794780|75721394|FG001|NOT COMPLETED|Overall Study||96||
59610534|NCT01794780|75721395|FG002|NOT COMPLETED|Overall Study||242||
59610535|NCT01794780|75721396|FG003|NOT COMPLETED|Overall Study||83||
59610536|NCT01794780|75721397|FG004|NOT COMPLETED|Overall Study||3||
59610537|NCT01794780|75721398|FG005|NOT COMPLETED|Overall Study||180||
59610538|NCT01794780|75721399|FG006|NOT COMPLETED|Overall Study||42||
59893155|NCT03475056|76015721|FG000|COMPLETED|Overall Study||20||
59893156|NCT03475056|76015722|FG001|COMPLETED|Overall Study||17||
59893157|NCT03475056|76015721|FG000|NOT COMPLETED|Overall Study||0||
59893158|NCT03475056|76015722|FG001|NOT COMPLETED|Overall Study||3||
59893159|NCT00938912|76015729|FG000|STARTED|Overall Study||365||
59893160|NCT00938912|76015729|FG000|COMPLETED|Overall Study||254||
59893161|NCT00938912|76015729|FG000|NOT COMPLETED|Overall Study||111||
59893162|NCT03473808|76015736|FG000|STARTED|Overall Study||5||
59893163|NCT03473808|76015736|FG000|COMPLETED|Overall Study||4||
59893164|NCT03473808|76015736|FG000|NOT COMPLETED|Overall Study||1||
59893165|NCT03473340|76015742|FG000|STARTED|Overall Study||13||
59893166|NCT03473340|76015743|FG001|STARTED|Overall Study||11||
59893167|NCT03473340|76015742|FG000|COMPLETED|Overall Study||8||
59893168|NCT03473340|76015743|FG001|COMPLETED|Overall Study||9||
59893169|NCT03473340|76015742|FG000|NOT COMPLETED|Overall Study||5||
59893170|NCT03473340|76015743|FG001|NOT COMPLETED|Overall Study||2||
59893171|NCT03490032|76015752|FG000|STARTED|Overall Study||6|All enrolled patients were included in the Full Analysis Set (FAS)|
59893172|NCT03490032|76015753|FG001|STARTED|Overall Study||12|All enrolled patients were included in the Full Analysis Set (FAS)|
59893173|NCT03490032|76015754|FG002|STARTED|Overall Study||12|All enrolled patients were included in the Full Analysis Set (FAS)|
59893174|NCT03490032|76015752|FG000|COMPLETED|Overall Study||5||
59893175|NCT03490032|76015753|FG001|COMPLETED|Overall Study||12||
59893176|NCT03490032|76015754|FG002|COMPLETED|Overall Study||12||
59893177|NCT03490032|76015752|FG000|NOT COMPLETED|Overall Study||1||
59893178|NCT03490032|76015753|FG001|NOT COMPLETED|Overall Study||0||
59893179|NCT03490032|76015754|FG002|NOT COMPLETED|Overall Study||0||
59893180|NCT03722472|76015765|FG000|STARTED|Overall Study||23||
59893181|NCT03722472|76015766|FG001|STARTED|Overall Study||25||
59893182|NCT03722472|76015765|FG000|COMPLETED|Overall Study||23||
59893183|NCT03722472|76015766|FG001|COMPLETED|Overall Study||22||
59893184|NCT03722472|76015765|FG000|NOT COMPLETED|Overall Study||0||
59893185|NCT03722472|76015766|FG001|NOT COMPLETED|Overall Study||3||
59610539|NCT01794780|75721400|FG007|NOT COMPLETED|Overall Study||9||
59610540|NCT01838616|75721427|FG000|STARTED|Titration Period||130||
59610541|NCT01838616|75721428|FG001|STARTED|Titration Period||128||
59893186|NCT03489720|76015774|FG000|STARTED|Overall Study||24||
59893187|NCT03489720|76015775|FG001|STARTED|Overall Study||22||
59893188|NCT03489720|76015774|FG000|COMPLETED|Overall Study||22||
59893189|NCT03489720|76015775|FG001|COMPLETED|Overall Study||22||
59893190|NCT03489720|76015774|FG000|NOT COMPLETED|Overall Study||2||
59893191|NCT03489720|76015775|FG001|NOT COMPLETED|Overall Study||0||
59610542|NCT01838616|75721427|FG000|No Post Baseline Pain Intensity Values|Titration Period||0||
59610543|NCT01838616|75721428|FG001|No Post Baseline Pain Intensity Values|Titration Period||2||
59610544|NCT01838616|75721427|FG000|Major Protocol Deviations|Titration Period||13||
59893192|NCT03527160|76015787|FG000|STARTED|Overall Study||134||
59893193|NCT03527160|76015787|FG000|COMPLETED|Overall Study||113||
59893194|NCT03527160|76015787|FG000|NOT COMPLETED|Overall Study||21||
59893195|NCT03739138|76015797|FG000|STARTED|Overall Study||0||
59893196|NCT03739138|76015798|FG001|STARTED|Overall Study||7||
59893197|NCT03739138|76015799|FG002|STARTED|Overall Study||5||
59893198|NCT03739138|76015800|FG003|STARTED|Overall Study||18||
59893199|NCT03739138|76015801|FG004|STARTED|Overall Study||0||
59893200|NCT03739138|76015797|FG000|COMPLETED|Overall Study||0||
59893201|NCT03739138|76015798|FG001|COMPLETED|Overall Study||0||
59893202|NCT03739138|76015799|FG002|COMPLETED|Overall Study||0||
59893203|NCT03739138|76015800|FG003|COMPLETED|Overall Study||0||
59893204|NCT03739138|76015801|FG004|COMPLETED|Overall Study||0||
59893205|NCT03739138|76015797|FG000|NOT COMPLETED|Overall Study||0||
59893206|NCT03739138|76015798|FG001|NOT COMPLETED|Overall Study||7||
59893207|NCT03739138|76015799|FG002|NOT COMPLETED|Overall Study||5||
59893208|NCT03739138|76015800|FG003|NOT COMPLETED|Overall Study||18||
59893209|NCT03739138|76015801|FG004|NOT COMPLETED|Overall Study||0||
59893210|NCT03472326|76015811|FG000|STARTED|Part 1: GS-9131 Functional Monotherapy||11||
59893211|NCT03472326|76015812|FG001|STARTED|Part 1: GS-9131 Functional Monotherapy||10||
59893212|NCT03472326|76015813|FG002|STARTED|Part 1: GS-9131 Functional Monotherapy||0||
59893213|NCT03472326|76015814|FG003|STARTED|Part 1: GS-9131 Functional Monotherapy||0||
59893214|NCT03472326|76015811|FG000|COMPLETED|Part 1: GS-9131 Functional Monotherapy||11||
59893215|NCT03472326|76015812|FG001|COMPLETED|Part 1: GS-9131 Functional Monotherapy||10||
59893216|NCT03472326|76015813|FG002|COMPLETED|Part 1: GS-9131 Functional Monotherapy||0||
59893217|NCT03472326|76015814|FG003|COMPLETED|Part 1: GS-9131 Functional Monotherapy||0||
59893218|NCT03472326|76015811|FG000|NOT COMPLETED|Part 1: GS-9131 Functional Monotherapy||0||
59893219|NCT03472326|76015812|FG001|NOT COMPLETED|Part 1: GS-9131 Functional Monotherapy||0||
59893220|NCT03472326|76015813|FG002|NOT COMPLETED|Part 1: GS-9131 Functional Monotherapy||0||
59893221|NCT03472326|76015814|FG003|NOT COMPLETED|Part 1: GS-9131 Functional Monotherapy||0||
59893222|NCT03472326|76015811|FG000|STARTED|Part 2: Combination Therapy||0||
59893223|NCT03472326|76015812|FG001|STARTED|Part 2: Combination Therapy||0||
59893224|NCT03472326|76015813|FG002|STARTED|Part 2: Combination Therapy|Of the participants who completed Part 1, only 1 participant entered in Part 2.|1||
59893225|NCT03472326|76015814|FG003|STARTED|Part 2: Combination Therapy|Of the participants who completed Part 1, only 3 participants entered in Part 2.|3||
59893226|NCT03472326|76015811|FG000|COMPLETED|Part 2: Combination Therapy||0||
59610545|NCT01838616|75721428|FG001|Major Protocol Deviations|Titration Period||16||
59610546|NCT01838616|75721427|FG000|Switched to Pick-up Arm|Titration Period||0||
59610547|NCT01838616|75721428|FG001|Switched to Pick-up Arm|Titration Period||43||
59610548|NCT01838616|75721427|FG000|Full Analysis Set|Titration Period||130||
59893227|NCT03472326|76015812|FG001|COMPLETED|Part 2: Combination Therapy||0||
59893228|NCT03472326|76015813|FG002|COMPLETED|Part 2: Combination Therapy||0||
59893229|NCT03472326|76015814|FG003|COMPLETED|Part 2: Combination Therapy||0||
59893230|NCT03472326|76015811|FG000|NOT COMPLETED|Part 2: Combination Therapy||0||
59893231|NCT03472326|76015812|FG001|NOT COMPLETED|Part 2: Combination Therapy||0||
59893232|NCT03472326|76015813|FG002|NOT COMPLETED|Part 2: Combination Therapy||1||
59893233|NCT03472326|76015814|FG003|NOT COMPLETED|Part 2: Combination Therapy||3||
59893234|NCT02737618|76015823|FG000|STARTED|Overall Study||43||
59893235|NCT02737618|76015823|FG000|COMPLETED|Overall Study||34||
59893236|NCT02737618|76015823|FG000|NOT COMPLETED|Overall Study||9||
59893237|NCT03472014|76015827|FG000|STARTED|Overall Study||22||
59893238|NCT03472014|76015827|FG000|COMPLETED|Overall Study||18|active trial phase|
59893239|NCT03472014|76015827|FG000|NOT COMPLETED|Overall Study||4||
59893240|NCT03526458|76015833|FG000|STARTED|Overall Study||20||
59893241|NCT03526458|76015834|FG001|STARTED|Overall Study||20||
59893242|NCT03526458|76015833|FG000|COMPLETED|Overall Study||12||
59893243|NCT03526458|76015834|FG001|COMPLETED|Overall Study||15||
59893244|NCT03526458|76015833|FG000|NOT COMPLETED|Overall Study||8||
59893245|NCT03526458|76015834|FG001|NOT COMPLETED|Overall Study||5||
59893246|NCT03488238|76015840|FG000|STARTED|Overall Study||31||
59893247|NCT03488238|76015840|FG000|COMPLETED|Overall Study||29||
59893248|NCT03488238|76015840|FG000|NOT COMPLETED|Overall Study||2||
59893249|NCT03525834|76015844|FG000|STARTED|Overall Study||40||
59893250|NCT03525834|76015844|FG000|COMPLETED|Overall Study||39||
59893251|NCT03525834|76015844|FG000|NOT COMPLETED|Overall Study||1||
59893252|NCT00925652|76015852|FG000|STARTED|Overall Study||13||
59893253|NCT00925652|76015853|FG001|STARTED|Overall Study||13||
59893254|NCT00925652|76015854|FG002|STARTED|Overall Study||11||
59893255|NCT00925652|76015855|FG003|STARTED|Overall Study||13||
59893256|NCT00925652|76015852|FG000|Withdraw|Overall Study||6||
59893257|NCT00925652|76015853|FG001|Withdraw|Overall Study||5||
59893258|NCT00925652|76015854|FG002|Withdraw|Overall Study||3||
59893259|NCT00925652|76015855|FG003|Withdraw|Overall Study||1||
59893260|NCT00925652|76015852|FG000|Off Treatment Because of Other Complicating Disease|Overall Study||0||
59610549|NCT01838616|75721428|FG001|Full Analysis Set|Titration Period||128||
59893261|NCT00925652|76015853|FG001|Off Treatment Because of Other Complicating Disease|Overall Study||0||
59893262|NCT00925652|76015854|FG002|Off Treatment Because of Other Complicating Disease|Overall Study||2||
59893263|NCT00925652|76015855|FG003|Off Treatment Because of Other Complicating Disease|Overall Study||3||
59893264|NCT00925652|76015852|FG000|Off Treatment Because of Disease Recurrence|Overall Study||1||
59893265|NCT00925652|76015853|FG001|Off Treatment Because of Disease Recurrence|Overall Study||3||
59893266|NCT00925652|76015854|FG002|Off Treatment Because of Disease Recurrence|Overall Study||0||
59893267|NCT00925652|76015855|FG003|Off Treatment Because of Disease Recurrence|Overall Study||0||
59893268|NCT00925652|76015852|FG000|Lost of Follow-up|Overall Study||0||
59893269|NCT00925652|76015853|FG001|Lost of Follow-up|Overall Study||1||
59893270|NCT00925652|76015854|FG002|Lost of Follow-up|Overall Study||0||
59893271|NCT00925652|76015855|FG003|Lost of Follow-up|Overall Study||0||
59893272|NCT00925652|76015852|FG000|Death|Overall Study||0||
59893273|NCT00925652|76015853|FG001|Death|Overall Study||0||
59893274|NCT00925652|76015854|FG002|Death|Overall Study||0||
59893275|NCT00925652|76015855|FG003|Death|Overall Study||3||
59893276|NCT00925652|76015852|FG000|COMPLETED|Overall Study||6||
59893277|NCT00925652|76015853|FG001|COMPLETED|Overall Study||4||
59893278|NCT00925652|76015854|FG002|COMPLETED|Overall Study||6||
59893279|NCT00925652|76015855|FG003|COMPLETED|Overall Study||6||
59893280|NCT00925652|76015852|FG000|NOT COMPLETED|Overall Study||7||
59893281|NCT00925652|76015853|FG001|NOT COMPLETED|Overall Study||9||
59893282|NCT00925652|76015854|FG002|NOT COMPLETED|Overall Study||5||
59893283|NCT00925652|76015855|FG003|NOT COMPLETED|Overall Study||7||
59893284|NCT03954106|76015875|FG000|STARTED|Part 1: Safety Lead In Phase||4||
59893285|NCT03954106|76015876|FG001|STARTED|Part 1: Safety Lead In Phase||0||
59893286|NCT03954106|76015875|FG000|COMPLETED|Part 1: Safety Lead In Phase||4||
59893287|NCT03954106|76015876|FG001|COMPLETED|Part 1: Safety Lead In Phase||0||
59893288|NCT03954106|76015875|FG000|NOT COMPLETED|Part 1: Safety Lead In Phase||0||
59893289|NCT03954106|76015876|FG001|NOT COMPLETED|Part 1: Safety Lead In Phase||0||
59893290|NCT03954106|76015875|FG000|STARTED|Phase 2: Treatment at RP2D||0||
59893291|NCT03954106|76015876|FG001|STARTED|Phase 2: Treatment at RP2D||21||
59893292|NCT03954106|76015875|FG000|COMPLETED|Phase 2: Treatment at RP2D||0||
59893293|NCT03954106|76015876|FG001|COMPLETED|Phase 2: Treatment at RP2D||21||
59893294|NCT03954106|76015875|FG000|NOT COMPLETED|Phase 2: Treatment at RP2D||0||
59893295|NCT03954106|76015876|FG001|NOT COMPLETED|Phase 2: Treatment at RP2D||0||
59893296|NCT03525444|76015886|FG000|STARTED|Overall Study||203||
59893297|NCT03525444|76015887|FG001|STARTED|Overall Study||200||
59893298|NCT03525444|76015886|FG000|Safety Set|Overall Study||201|Based on actual treatment received.|
59893299|NCT03525444|76015887|FG001|Safety Set|Overall Study||202|Based on actual treatment received.|
59893300|NCT03525444|76015886|FG000|COMPLETED|Overall Study||203||
59893301|NCT03525444|76015887|FG001|COMPLETED|Overall Study||197||
59893302|NCT03525444|76015886|FG000|NOT COMPLETED|Overall Study||0||
59893303|NCT03525444|76015887|FG001|NOT COMPLETED|Overall Study||3||
59893304|NCT03487848|76015894|FG000|STARTED|Overall Study||5||
59893305|NCT03487848|76015894|FG000|COMPLETED|Overall Study||4||
59893306|NCT03487848|76015894|FG000|NOT COMPLETED|Overall Study||1||
59893307|NCT03524664|76015900|FG000|STARTED|Overall Study||33||
59893308|NCT03524664|76015901|FG001|STARTED|Overall Study||54||
59893309|NCT03524664|76015900|FG000|Completed Allocated Condition|Overall Study||33||
59893310|NCT03524664|76015901|FG001|Completed Allocated Condition|Overall Study|Completing 5 or more of the 8 sessions was defined as completion of the intervention program. A total of 7 participants started but discontinued intervention program. Ten did not start the program|37||
59893311|NCT03524664|76015900|FG000|Immediate Post-Intervention Follow-up Assessments (T2)|Overall Study||32||
59893312|NCT03524664|76015901|FG001|Immediate Post-Intervention Follow-up Assessments (T2)|Overall Study||45||
59893313|NCT03524664|76015900|FG000|3-month Post-Intervention Follow-up Assessments (T3)|Overall Study||28||
59893314|NCT03524664|76015901|FG001|3-month Post-Intervention Follow-up Assessments (T3)|Overall Study||39||
59893315|NCT03524664|76015900|FG000|COMPLETED|Overall Study||28||
59893316|NCT03524664|76015901|FG001|COMPLETED|Overall Study|Completing 5 or more of the 8 sessions was defined as completion of the program|39||
59893317|NCT03524664|76015900|FG000|NOT COMPLETED|Overall Study||5||
59893318|NCT03524664|76015901|FG001|NOT COMPLETED|Overall Study||15||
59893319|NCT04377620|76015910|FG000|STARTED|Overall Study||77||
59893320|NCT04377620|76015911|FG001|STARTED|Overall Study||87||
59893321|NCT04377620|76015912|FG002|STARTED|Overall Study||47||
59893322|NCT04377620|76015910|FG000|COMPLETED|Overall Study||35||
59893323|NCT04377620|76015911|FG001|COMPLETED|Overall Study||37||
59893324|NCT04377620|76015912|FG002|COMPLETED|Overall Study||11||
59893325|NCT04377620|76015910|FG000|NOT COMPLETED|Overall Study||42||
59893326|NCT04377620|76015911|FG001|NOT COMPLETED|Overall Study||50||
59893327|NCT04377620|76015912|FG002|NOT COMPLETED|Overall Study||36||
59893328|NCT03522948|76015921|FG000|STARTED|Overall Study||8||
59893329|NCT03522948|76015921|FG000|COMPLETED|Overall Study||7||
59893330|NCT03522948|76015921|FG000|NOT COMPLETED|Overall Study||1||
59893331|NCT03406078|76015927|FG000|STARTED|Overall Study||74||
59893332|NCT03406078|76015928|FG001|STARTED|Overall Study||76||
59893333|NCT03406078|76015927|FG000|COMPLETED|Overall Study||68||
59893334|NCT03406078|76015928|FG001|COMPLETED|Overall Study||73||
59893335|NCT03406078|76015927|FG000|NOT COMPLETED|Overall Study||6||
59893336|NCT03406078|76015928|FG001|NOT COMPLETED|Overall Study||3||
59893337|NCT03634033|76015941|FG000|STARTED|Overall Study||3497||9
59893338|NCT03634033|76015942|FG001|STARTED|Overall Study||3533||9
59893339|NCT03634033|76015943|FG002|STARTED|Overall Study||282||9
59893340|NCT03634033|76015944|FG003|STARTED|Overall Study||257||9
59893341|NCT03634033|76015945|FG004|STARTED|Overall Study||106||3
59893342|NCT03634033|76015946|FG005|STARTED|Overall Study||50||3
59893343|NCT03634033|76015947|FG006|STARTED|Overall Study||52||3
59893344|NCT03634033|76015941|FG000|COMPLETED|Overall Study||3113||9
59893345|NCT03634033|76015942|FG001|COMPLETED|Overall Study||3242||9
59893346|NCT03634033|76015943|FG002|COMPLETED|Overall Study||168||9
59893347|NCT03634033|76015944|FG003|COMPLETED|Overall Study||96||9
59893348|NCT03634033|76015945|FG004|COMPLETED|Overall Study||101||3
59893349|NCT03634033|76015946|FG005|COMPLETED|Overall Study||37||3
59893350|NCT03634033|76015947|FG006|COMPLETED|Overall Study||37||3
59893351|NCT03634033|76015941|FG000|NOT COMPLETED|Overall Study||384||0
59893352|NCT03634033|76015942|FG001|NOT COMPLETED|Overall Study||291||0
59893353|NCT03634033|76015943|FG002|NOT COMPLETED|Overall Study||114||0
59893354|NCT03634033|76015944|FG003|NOT COMPLETED|Overall Study||161||0
59893355|NCT03634033|76015945|FG004|NOT COMPLETED|Overall Study||5||0
59893356|NCT03634033|76015946|FG005|NOT COMPLETED|Overall Study||13||0
59893357|NCT03634033|76015947|FG006|NOT COMPLETED|Overall Study||15||0
59893358|NCT03103100|76015981|FG000|STARTED|Overall Study||25||
59893359|NCT03103100|76015982|FG001|STARTED|Overall Study||25||
59893360|NCT03103100|76015983|FG002|STARTED|Overall Study||25||
59893361|NCT03103100|76015981|FG000|COMPLETED|Overall Study||23||
59893362|NCT03103100|76015982|FG001|COMPLETED|Overall Study||25||
59893363|NCT03103100|76015983|FG002|COMPLETED|Overall Study||23||
59893364|NCT03103100|76015981|FG000|NOT COMPLETED|Overall Study||2||
59893365|NCT03103100|76015982|FG001|NOT COMPLETED|Overall Study||0||
59893366|NCT03103100|76015983|FG002|NOT COMPLETED|Overall Study||2||
59893367|NCT03438006|76015991|FG000|STARTED|Overall Study||3013||
59893368|NCT03438006|76015991|FG000|COMPLETED|Overall Study||2895||
59893369|NCT03438006|76015991|FG000|NOT COMPLETED|Overall Study||118||
59893370|NCT04206020|76015997|FG000|STARTED|Overall Study||306||
59893371|NCT04206020|76015998|FG001|STARTED|Overall Study||304||
59893372|NCT04206020|76015997|FG000|COMPLETED|Overall Study||298||
59893373|NCT04206020|76015998|FG001|COMPLETED|Overall Study||297||
59893374|NCT04206020|76015997|FG000|NOT COMPLETED|Overall Study||8||
59893375|NCT04206020|76015998|FG001|NOT COMPLETED|Overall Study||7||
59893376|NCT03466086|76016004|FG000|STARTED|Period 1||28||
59893377|NCT03466086|76016005|FG001|STARTED|Period 1||27||
59893378|NCT03466086|76016004|FG000|COMPLETED|Period 1||26||
59893379|NCT03466086|76016005|FG001|COMPLETED|Period 1||27||
59893380|NCT03466086|76016004|FG000|NOT COMPLETED|Period 1||2||
59893381|NCT03466086|76016005|FG001|NOT COMPLETED|Period 1||0||
59893382|NCT03466086|76016004|FG000|STARTED|Period 2||26||
59893383|NCT03466086|76016005|FG001|STARTED|Period 2||27||
59893384|NCT03466086|76016004|FG000|COMPLETED|Period 2||26||
59893385|NCT03466086|76016005|FG001|COMPLETED|Period 2||27||
59893386|NCT03466086|76016004|FG000|NOT COMPLETED|Period 2||0||
59893387|NCT03466086|76016005|FG001|NOT COMPLETED|Period 2||0||
59893388|NCT03101462|76016013|FG000|STARTED|Overall Study||19||
59893389|NCT03101462|76016014|FG001|STARTED|Overall Study||19||
59893390|NCT03101462|76016013|FG000|COMPLETED|Overall Study||18||
59893391|NCT03101462|76016014|FG001|COMPLETED|Overall Study||18||
59893392|NCT03101462|76016013|FG000|NOT COMPLETED|Overall Study||1||
59893393|NCT03101462|76016014|FG001|NOT COMPLETED|Overall Study||1||
59893394|NCT02873936|76016023|FG000|STARTED|Overall Study||148||
59893395|NCT02873936|76016024|FG001|STARTED|Overall Study||153||
59893396|NCT02873936|76016025|FG002|STARTED|Overall Study||148||
59893397|NCT02873936|76016023|FG000|COMPLETED|Overall Study||135||
59893398|NCT02873936|76016024|FG001|COMPLETED|Overall Study||130||
59893399|NCT02873936|76016025|FG002|COMPLETED|Overall Study||116||
59893400|NCT02873936|76016023|FG000|NOT COMPLETED|Overall Study||13||
59893401|NCT02873936|76016024|FG001|NOT COMPLETED|Overall Study||23||
59893402|NCT02873936|76016025|FG002|NOT COMPLETED|Overall Study||32||
59893403|NCT02874794|76016035|FG000|STARTED|Overall Study||233||
59893404|NCT02874794|76016036|FG001|STARTED|Overall Study||232||
59893405|NCT02874794|76016035|FG000|COMPLETED|Overall Study||226||
59893406|NCT02874794|76016036|FG001|COMPLETED|Overall Study||221||
59893407|NCT02874794|76016035|FG000|NOT COMPLETED|Overall Study||7||
59893408|NCT02874794|76016036|FG001|NOT COMPLETED|Overall Study||11||
59893409|NCT03102710|76016048|FG000|STARTED|Overall Study||28||
59893410|NCT03102710|76016049|FG001|STARTED|Overall Study||30||
59893411|NCT03102710|76016050|FG002|STARTED|Overall Study||27||
59893412|NCT03102710|76016048|FG000|COMPLETED|Overall Study||27||
59893413|NCT03102710|76016049|FG001|COMPLETED|Overall Study||27||
59893414|NCT03102710|76016050|FG002|COMPLETED|Overall Study||27||
59893415|NCT03102710|76016048|FG000|NOT COMPLETED|Overall Study||1||
59893416|NCT03102710|76016049|FG001|NOT COMPLETED|Overall Study||3||
59893417|NCT03102710|76016050|FG002|NOT COMPLETED|Overall Study||0||
59893418|NCT03101150|76016060|FG000|STARTED|Overall Study||86||
59893419|NCT03101150|76016061|FG001|STARTED|Overall Study||93||
59893420|NCT03101150|76016060|FG000|COMPLETED|Overall Study||81||
59893421|NCT03101150|76016061|FG001|COMPLETED|Overall Study||83||
59893422|NCT03101150|76016060|FG000|NOT COMPLETED|Overall Study||5||
59893423|NCT03101150|76016061|FG001|NOT COMPLETED|Overall Study||10||
59893424|NCT03101930|76016070|FG000|STARTED|Overall Study||46||
59893425|NCT03101930|76016071|FG001|STARTED|Overall Study||23||
59893426|NCT03101930|76016072|FG002|STARTED|Overall Study||24||
59893427|NCT03101930|76016070|FG000|COMPLETED|Overall Study||44||
59893428|NCT03101930|76016071|FG001|COMPLETED|Overall Study||22||
59893429|NCT03101930|76016072|FG002|COMPLETED|Overall Study||22||
59893430|NCT03101930|76016070|FG000|NOT COMPLETED|Overall Study||2||
59893431|NCT03101930|76016071|FG001|NOT COMPLETED|Overall Study||1||
59893432|NCT03101930|76016072|FG002|NOT COMPLETED|Overall Study||2||
59893433|NCT02928848|76016082|FG000|STARTED|Arm 1||9||
59893434|NCT02928848|76016083|FG001|STARTED|Arm 1||7||
59893435|NCT02928848|76016082|FG000|COMPLETED|Arm 1||9||
59893436|NCT02928848|76016083|FG001|COMPLETED|Arm 1||6||
59893437|NCT02928848|76016082|FG000|NOT COMPLETED|Arm 1||0||
59893438|NCT02928848|76016083|FG001|NOT COMPLETED|Arm 1||1||
59893439|NCT02928848|76016082|FG000|STARTED|Arm 2||9||
59893440|NCT02928848|76016083|FG001|STARTED|Arm 2||6||
59893441|NCT02928848|76016082|FG000|COMPLETED|Arm 2||8||
59893442|NCT02928848|76016083|FG001|COMPLETED|Arm 2||6||
59893443|NCT02928848|76016082|FG000|NOT COMPLETED|Arm 2||1||
59893444|NCT02928848|76016083|FG001|NOT COMPLETED|Arm 2||0||
59893445|NCT02928770|76016091|FG000|STARTED|Overall Study||32||
59893446|NCT02928770|76016091|FG000|COMPLETED|Overall Study||30||
59893447|NCT02928770|76016091|FG000|NOT COMPLETED|Overall Study||2||
59893448|NCT03100838|76016095|FG000|STARTED|Overall Study||16||
59893449|NCT03100838|76016096|FG001|STARTED|Overall Study||16||
59893450|NCT03100838|76016097|FG002|STARTED|Overall Study||16||
59893451|NCT03100838|76016098|FG003|STARTED|Overall Study||16||
59893452|NCT03100838|76016095|FG000|COMPLETED|Overall Study||14||
59893453|NCT03100838|76016096|FG001|COMPLETED|Overall Study||14||
59893454|NCT03100838|76016097|FG002|COMPLETED|Overall Study||14||
59893455|NCT03100838|76016098|FG003|COMPLETED|Overall Study||15||
59893456|NCT03100838|76016095|FG000|NOT COMPLETED|Overall Study||2||
59893457|NCT03100838|76016096|FG001|NOT COMPLETED|Overall Study||2||
59893458|NCT03100838|76016097|FG002|NOT COMPLETED|Overall Study||2||
59893459|NCT03100838|76016098|FG003|NOT COMPLETED|Overall Study||1||
59893460|NCT03480750|76016114|FG000|STARTED|Overall Study||3||
59893461|NCT03480750|76016115|FG001|STARTED|Overall Study||4||
59893462|NCT03480750|76016116|FG002|STARTED|Overall Study||3||
59893463|NCT03480750|76016117|FG003|STARTED|Overall Study||3||
59893464|NCT03480750|76016118|FG004|STARTED|Overall Study||3||
59893465|NCT03480750|76016119|FG005|STARTED|Overall Study||2||
59893466|NCT03480750|76016114|FG000|COMPLETED|Overall Study||3||
59893467|NCT03480750|76016115|FG001|COMPLETED|Overall Study||3||
59893468|NCT03480750|76016116|FG002|COMPLETED|Overall Study||3||
59893469|NCT03480750|76016117|FG003|COMPLETED|Overall Study||3||
59893470|NCT03480750|76016118|FG004|COMPLETED|Overall Study||3||
59893471|NCT03480750|76016119|FG005|COMPLETED|Overall Study||1||
59893472|NCT03480750|76016114|FG000|NOT COMPLETED|Overall Study||0||
59893473|NCT03480750|76016115|FG001|NOT COMPLETED|Overall Study||1||
59893474|NCT03480750|76016116|FG002|NOT COMPLETED|Overall Study||0||
59893475|NCT03480750|76016117|FG003|NOT COMPLETED|Overall Study||0||
59893476|NCT03480750|76016118|FG004|NOT COMPLETED|Overall Study||0||
60013788|NCT02506101|76129742|FG000|STARTED|Overall Study||2||
59893477|NCT03480750|76016119|FG005|NOT COMPLETED|Overall Study||1||
59893478|NCT03412734|76016144|FG000|STARTED|Overall Study||47||
59893479|NCT03412734|76016145|FG001|STARTED|Overall Study||41||
60013789|NCT02506101|76129743|FG001|STARTED|Overall Study||0||
60013790|NCT02506101|76129742|FG000|COMPLETED|Overall Study||0||
59893480|NCT03412734|76016144|FG000|COMPLETED|Overall Study||44||
59893481|NCT03412734|76016145|FG001|COMPLETED|Overall Study||41||
59893482|NCT03412734|76016144|FG000|NOT COMPLETED|Overall Study||3||
59893483|NCT03412734|76016145|FG001|NOT COMPLETED|Overall Study||0||
59893484|NCT02374814|76016157|FG000|STARTED|Overall Study||12||
59893485|NCT02374814|76016158|FG001|STARTED|Overall Study||12||
59893486|NCT02374814|76016159|FG002|STARTED|Overall Study||12||
59893487|NCT02374814|76016160|FG003|STARTED|Overall Study||11||
59893488|NCT02374814|76016161|FG004|STARTED|Overall Study||6||
59893489|NCT02374814|76016162|FG005|STARTED|Overall Study||6||
59893490|NCT02374814|76016157|FG000|COMPLETED|Overall Study||11||
59893491|NCT02374814|76016158|FG001|COMPLETED|Overall Study||11||
59893492|NCT02374814|76016159|FG002|COMPLETED|Overall Study||11||
59893493|NCT02374814|76016160|FG003|COMPLETED|Overall Study||9||
59893494|NCT02374814|76016161|FG004|COMPLETED|Overall Study||6||
59893495|NCT02374814|76016162|FG005|COMPLETED|Overall Study||6||
59893496|NCT02374814|76016157|FG000|NOT COMPLETED|Overall Study||1||
59893497|NCT02374814|76016158|FG001|NOT COMPLETED|Overall Study||1||
59893498|NCT02374814|76016159|FG002|NOT COMPLETED|Overall Study||1||
59893499|NCT02374814|76016160|FG003|NOT COMPLETED|Overall Study||2||
60013791|NCT02506101|76129743|FG001|COMPLETED|Overall Study||0||
59893500|NCT02374814|76016161|FG004|NOT COMPLETED|Overall Study||0||
59893501|NCT02374814|76016162|FG005|NOT COMPLETED|Overall Study||0||
59893502|NCT04608344|76016186|FG000|STARTED|Period 1 (AB: 3 Days, BA: 11 Days)||14||
59893503|NCT04608344|76016187|FG001|STARTED|Period 1 (AB: 3 Days, BA: 11 Days)||13||
59893504|NCT04608344|76016186|FG000|COMPLETED|Period 1 (AB: 3 Days, BA: 11 Days)||13||
59893505|NCT04608344|76016187|FG001|COMPLETED|Period 1 (AB: 3 Days, BA: 11 Days)||12||
59893506|NCT04608344|76016186|FG000|NOT COMPLETED|Period 1 (AB: 3 Days, BA: 11 Days)||1||
59893507|NCT04608344|76016187|FG001|NOT COMPLETED|Period 1 (AB: 3 Days, BA: 11 Days)||1||
59893508|NCT04608344|76016186|FG000|STARTED|Period 2 (AB: 11 Days, BA: 3 Days)||13||
59893509|NCT04608344|76016187|FG001|STARTED|Period 2 (AB: 11 Days, BA: 3 Days)||12||
59893510|NCT04608344|76016186|FG000|COMPLETED|Period 2 (AB: 11 Days, BA: 3 Days)||13||
59893511|NCT04608344|76016187|FG001|COMPLETED|Period 2 (AB: 11 Days, BA: 3 Days)||12||
59893512|NCT04608344|76016186|FG000|NOT COMPLETED|Period 2 (AB: 11 Days, BA: 3 Days)||0||
59893513|NCT04608344|76016187|FG001|NOT COMPLETED|Period 2 (AB: 11 Days, BA: 3 Days)||0||
59893514|NCT03433482|76016205|FG000|STARTED|Overall Study||420||
59893515|NCT03433482|76016206|FG001|STARTED|Overall Study||424||
59893516|NCT03433482|76016207|FG002|STARTED|Overall Study||427||
59893517|NCT03433482|76016208|FG003|STARTED|Overall Study||419||
59893518|NCT03433482|76016205|FG000|COMPLETED|Overall Study||419||
59893519|NCT03433482|76016206|FG001|COMPLETED|Overall Study||424||
59893520|NCT03433482|76016207|FG002|COMPLETED|Overall Study||423||
59893521|NCT03433482|76016208|FG003|COMPLETED|Overall Study||418||
59893522|NCT03433482|76016205|FG000|NOT COMPLETED|Overall Study||1||
59893523|NCT03433482|76016206|FG001|NOT COMPLETED|Overall Study||0||
59893524|NCT03433482|76016207|FG002|NOT COMPLETED|Overall Study||4||
59893525|NCT03433482|76016208|FG003|NOT COMPLETED|Overall Study||1||
59893526|NCT03432858|76016221|FG000|STARTED|Overall Study||12||
59893527|NCT03432858|76016222|FG001|STARTED|Overall Study||83||
59893528|NCT03432858|76016223|FG002|STARTED|Overall Study||89||
59893529|NCT03432858|76016221|FG000|COMPLETED|Overall Study||10||
59893530|NCT03432858|76016222|FG001|COMPLETED|Overall Study||72||
59893531|NCT03432858|76016223|FG002|COMPLETED|Overall Study||72||
59893532|NCT03432858|76016221|FG000|NOT COMPLETED|Overall Study||2||
59893533|NCT03432858|76016222|FG001|NOT COMPLETED|Overall Study||11||
59893534|NCT03432858|76016223|FG002|NOT COMPLETED|Overall Study||17||
59893535|NCT03432390|76016233|FG000|STARTED|Apnea Period||36||
59893536|NCT03432390|76016234|FG001|STARTED|Apnea Period||36||
59893537|NCT03432390|76016233|FG000|COMPLETED|Apnea Period||34||
59893538|NCT03432390|76016234|FG001|COMPLETED|Apnea Period||34||
59893539|NCT03432390|76016233|FG000|NOT COMPLETED|Apnea Period||2||
59893540|NCT03432390|76016234|FG001|NOT COMPLETED|Apnea Period||2||
59893541|NCT03432390|76016233|FG000|STARTED|Recovery Period||34||
59893542|NCT03432390|76016234|FG001|STARTED|Recovery Period||34||
59893543|NCT03432390|76016233|FG000|COMPLETED|Recovery Period||34||
59893544|NCT03432390|76016234|FG001|COMPLETED|Recovery Period||34||
59893545|NCT03432390|76016233|FG000|NOT COMPLETED|Recovery Period||0||
59893546|NCT03432390|76016234|FG001|NOT COMPLETED|Recovery Period||0||
59893547|NCT03456960|76016246|FG000|STARTED|Period 1 (1 Day)||12||
59893548|NCT03456960|76016247|FG001|STARTED|Period 1 (1 Day)||12||
59893549|NCT03456960|76016248|FG002|STARTED|Period 1 (1 Day)||120||
59893550|NCT03456960|76016249|FG003|STARTED|Period 1 (1 Day)||120||
59893551|NCT03456960|76016250|FG004|STARTED|Period 1 (1 Day)||6||
59893552|NCT03456960|76016251|FG005|STARTED|Period 1 (1 Day)||6||
59893553|NCT03456960|76016246|FG000|COMPLETED|Period 1 (1 Day)||12||
59893554|NCT03456960|76016247|FG001|COMPLETED|Period 1 (1 Day)||12||
59893555|NCT03456960|76016248|FG002|COMPLETED|Period 1 (1 Day)||120||
59893556|NCT03456960|76016249|FG003|COMPLETED|Period 1 (1 Day)||120||
59893557|NCT03456960|76016250|FG004|COMPLETED|Period 1 (1 Day)||6||
59893558|NCT03456960|76016251|FG005|COMPLETED|Period 1 (1 Day)||6||
59893559|NCT03456960|76016246|FG000|NOT COMPLETED|Period 1 (1 Day)||0||
59893560|NCT03456960|76016247|FG001|NOT COMPLETED|Period 1 (1 Day)||0||
59893561|NCT03456960|76016248|FG002|NOT COMPLETED|Period 1 (1 Day)||0||
59893562|NCT03456960|76016249|FG003|NOT COMPLETED|Period 1 (1 Day)||0||
59893563|NCT03456960|76016250|FG004|NOT COMPLETED|Period 1 (1 Day)||0||
59893564|NCT03456960|76016251|FG005|NOT COMPLETED|Period 1 (1 Day)||0||
59893565|NCT03456960|76016246|FG000|STARTED|Washout Period (at Least 14 Days)||12||
59893566|NCT03456960|76016247|FG001|STARTED|Washout Period (at Least 14 Days)||12||
59893567|NCT03456960|76016248|FG002|STARTED|Washout Period (at Least 14 Days)||120||
59893568|NCT03456960|76016249|FG003|STARTED|Washout Period (at Least 14 Days)||120||
59893569|NCT03456960|76016250|FG004|STARTED|Washout Period (at Least 14 Days)||6||
59893570|NCT03456960|76016251|FG005|STARTED|Washout Period (at Least 14 Days)||6||
59893571|NCT03456960|76016246|FG000|COMPLETED|Washout Period (at Least 14 Days)||12||
59893572|NCT03456960|76016247|FG001|COMPLETED|Washout Period (at Least 14 Days)||12||
59893573|NCT03456960|76016248|FG002|COMPLETED|Washout Period (at Least 14 Days)||119||
59893574|NCT03456960|76016249|FG003|COMPLETED|Washout Period (at Least 14 Days)||118||
59893575|NCT03456960|76016250|FG004|COMPLETED|Washout Period (at Least 14 Days)||6||
59893576|NCT03456960|76016251|FG005|COMPLETED|Washout Period (at Least 14 Days)||6||
59893577|NCT03456960|76016246|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0||
59893578|NCT03456960|76016247|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0||
59893579|NCT03456960|76016248|FG002|NOT COMPLETED|Washout Period (at Least 14 Days)||1||
59893580|NCT03456960|76016249|FG003|NOT COMPLETED|Washout Period (at Least 14 Days)||2||
59893581|NCT03456960|76016250|FG004|NOT COMPLETED|Washout Period (at Least 14 Days)||0||
59893582|NCT03456960|76016251|FG005|NOT COMPLETED|Washout Period (at Least 14 Days)||0||
59893583|NCT03456960|76016246|FG000|STARTED|Period 2 (1 Day)||12||
59893584|NCT03456960|76016247|FG001|STARTED|Period 2 (1 Day)||12||
59893585|NCT03456960|76016248|FG002|STARTED|Period 2 (1 Day)||119||
59893586|NCT03456960|76016249|FG003|STARTED|Period 2 (1 Day)||118||
59893587|NCT03456960|76016250|FG004|STARTED|Period 2 (1 Day)||6||
59893588|NCT03456960|76016251|FG005|STARTED|Period 2 (1 Day)||6||
59893589|NCT03456960|76016246|FG000|COMPLETED|Period 2 (1 Day)||11||
59893590|NCT03456960|76016247|FG001|COMPLETED|Period 2 (1 Day)||12||
59893591|NCT03456960|76016248|FG002|COMPLETED|Period 2 (1 Day)||119||
59893592|NCT03456960|76016249|FG003|COMPLETED|Period 2 (1 Day)||117||
59893593|NCT03456960|76016250|FG004|COMPLETED|Period 2 (1 Day)||6||
59893594|NCT03456960|76016251|FG005|COMPLETED|Period 2 (1 Day)||6||
59893595|NCT03456960|76016246|FG000|NOT COMPLETED|Period 2 (1 Day)||1||
59893596|NCT03456960|76016247|FG001|NOT COMPLETED|Period 2 (1 Day)||0||
59893597|NCT03456960|76016248|FG002|NOT COMPLETED|Period 2 (1 Day)||0||
59893598|NCT03456960|76016249|FG003|NOT COMPLETED|Period 2 (1 Day)||1||
59893599|NCT03456960|76016250|FG004|NOT COMPLETED|Period 2 (1 Day)||0||
59893600|NCT03456960|76016251|FG005|NOT COMPLETED|Period 2 (1 Day)||0||
59893601|NCT03430986|76016269|FG000|STARTED|24-week Control Period||42||
59893602|NCT03430986|76016270|FG001|STARTED|24-week Control Period||122||
59893603|NCT03430986|76016269|FG000|Treated as Randomized|24-week Control Period||42||
59893604|NCT03430986|76016270|FG001|Treated as Randomized|24-week Control Period||120||
59893605|NCT03430986|76016269|FG000|COMPLETED|24-week Control Period||34||
59893606|NCT03430986|76016270|FG001|COMPLETED|24-week Control Period||118||
59893607|NCT03430986|76016269|FG000|NOT COMPLETED|24-week Control Period||8||
59893608|NCT03430986|76016270|FG001|NOT COMPLETED|24-week Control Period||4||
59893609|NCT03430986|76016269|FG000|STARTED|24-week Post-Control Period|Not all participants received the Optional Treatment.|31||
59893610|NCT03430986|76016270|FG001|STARTED|24-week Post-Control Period||118||
59893611|NCT03430986|76016269|FG000|COMPLETED|24-week Post-Control Period||30||
59893612|NCT03430986|76016270|FG001|COMPLETED|24-week Post-Control Period||116||
59893613|NCT03430986|76016269|FG000|NOT COMPLETED|24-week Post-Control Period||1||
59893614|NCT03430986|76016270|FG001|NOT COMPLETED|24-week Post-Control Period||2||
59893615|NCT03448536|76016281|FG000|STARTED|Overall Study||100||
59893616|NCT03448536|76016282|FG001|STARTED|Overall Study||101||
59893617|NCT03448536|76016281|FG000|Completed First Intervention|Overall Study||83|Per Protocol (PP) population|
59893618|NCT03448536|76016282|FG001|Completed First Intervention|Overall Study||78|Per Protocol (PP) population|
59893619|NCT03448536|76016281|FG000|Completed First Intervention|Overall Study||95|Safety population|
59893620|NCT03448536|76016282|FG001|Completed First Intervention|Overall Study||97|Safety population|
59893621|NCT03448536|76016281|FG000|Completed Second Intervention|Overall Study||82|Per Protocol (PP) population|
59893622|NCT03448536|76016282|FG001|Completed Second Intervention|Overall Study||87|Per Protocol (PP) population|
59893623|NCT03448536|76016281|FG000|COMPLETED|Overall Study||88|Completed second intervention in Safety population|
59893624|NCT03448536|76016282|FG001|COMPLETED|Overall Study||97|Completed second intervention in Safety population|
59893625|NCT03448536|76016281|FG000|NOT COMPLETED|Overall Study||12||
59893626|NCT03448536|76016282|FG001|NOT COMPLETED|Overall Study||4||
59893627|NCT03448224|76016290|FG000|STARTED|Overall Study||28||
59893628|NCT03448224|76016291|FG001|STARTED|Overall Study||26||
59893629|NCT03448224|76016290|FG000|COMPLETED|Overall Study||27||
59893630|NCT03448224|76016291|FG001|COMPLETED|Overall Study||26||
59893631|NCT03448224|76016290|FG000|NOT COMPLETED|Overall Study||1||
59893632|NCT03448224|76016291|FG001|NOT COMPLETED|Overall Study||0||
59893633|NCT03424044|76016297|FG000|STARTED|Dexcom Training Visit (1 Week)||4||
59893634|NCT03424044|76016298|FG001|STARTED|Dexcom Training Visit (1 Week)||3||
59893635|NCT03424044|76016299|FG002|STARTED|Dexcom Training Visit (1 Week)||3||
59893636|NCT03424044|76016300|FG003|STARTED|Dexcom Training Visit (1 Week)||3||
59893637|NCT03424044|76016301|FG004|STARTED|Dexcom Training Visit (1 Week)||3||
59893638|NCT03424044|76016302|FG005|STARTED|Dexcom Training Visit (1 Week)||4||
59893639|NCT03424044|76016303|FG006|STARTED|Dexcom Training Visit (1 Week)||1||
59893640|NCT03424044|76016304|FG007|STARTED|Dexcom Training Visit (1 Week)||1||
59893641|NCT03424044|76016305|FG008|STARTED|Dexcom Training Visit (1 Week)||1||
59893642|NCT03424044|76016297|FG000|COMPLETED|Dexcom Training Visit (1 Week)||4||
59893643|NCT03424044|76016298|FG001|COMPLETED|Dexcom Training Visit (1 Week)||3||
60013792|NCT02506101|76129742|FG000|NOT COMPLETED|Overall Study||2||
60013793|NCT02506101|76129743|FG001|NOT COMPLETED|Overall Study||0||
59893644|NCT03424044|76016299|FG002|COMPLETED|Dexcom Training Visit (1 Week)||3||
59893645|NCT03424044|76016300|FG003|COMPLETED|Dexcom Training Visit (1 Week)||3||
59893646|NCT03424044|76016301|FG004|COMPLETED|Dexcom Training Visit (1 Week)||3||
59893647|NCT03424044|76016302|FG005|COMPLETED|Dexcom Training Visit (1 Week)||4||
59893648|NCT03424044|76016303|FG006|COMPLETED|Dexcom Training Visit (1 Week)||1||
60013794|NCT01671007|76129758|FG000|STARTED|Overall Study||2089||
60013795|NCT01671007|76129759|FG001|STARTED|Overall Study||2834||
59893649|NCT03424044|76016304|FG007|COMPLETED|Dexcom Training Visit (1 Week)||1||
60013796|NCT01671007|76129760|FG002|STARTED|Overall Study||2033||
60013797|NCT01671007|76129761|FG003|STARTED|Overall Study||2214||
59893650|NCT03424044|76016305|FG008|COMPLETED|Dexcom Training Visit (1 Week)||1||
59893651|NCT03424044|76016297|FG000|NOT COMPLETED|Dexcom Training Visit (1 Week)||0||
59893652|NCT03424044|76016298|FG001|NOT COMPLETED|Dexcom Training Visit (1 Week)||0||
59893653|NCT03424044|76016299|FG002|NOT COMPLETED|Dexcom Training Visit (1 Week)||0||
59893654|NCT03424044|76016300|FG003|NOT COMPLETED|Dexcom Training Visit (1 Week)||0||
59893655|NCT03424044|76016301|FG004|NOT COMPLETED|Dexcom Training Visit (1 Week)||0||
59893656|NCT03424044|76016302|FG005|NOT COMPLETED|Dexcom Training Visit (1 Week)||0||
59893657|NCT03424044|76016303|FG006|NOT COMPLETED|Dexcom Training Visit (1 Week)||0||
59893658|NCT03424044|76016304|FG007|NOT COMPLETED|Dexcom Training Visit (1 Week)||0||
59893659|NCT03424044|76016305|FG008|NOT COMPLETED|Dexcom Training Visit (1 Week)||0||
59893660|NCT03424044|76016297|FG000|STARTED|First Rest Period (1-12 Weeks)||4||
59893661|NCT03424044|76016298|FG001|STARTED|First Rest Period (1-12 Weeks)||3||
59893662|NCT03424044|76016299|FG002|STARTED|First Rest Period (1-12 Weeks)||3||
59893663|NCT03424044|76016300|FG003|STARTED|First Rest Period (1-12 Weeks)||3||
59893664|NCT03424044|76016301|FG004|STARTED|First Rest Period (1-12 Weeks)||3||
59893665|NCT03424044|76016302|FG005|STARTED|First Rest Period (1-12 Weeks)||4||
59893666|NCT03424044|76016303|FG006|STARTED|First Rest Period (1-12 Weeks)||1||
59893667|NCT03424044|76016304|FG007|STARTED|First Rest Period (1-12 Weeks)||1||
59893668|NCT03424044|76016305|FG008|STARTED|First Rest Period (1-12 Weeks)||1||
59893669|NCT03424044|76016297|FG000|COMPLETED|First Rest Period (1-12 Weeks)||4||
59893670|NCT03424044|76016298|FG001|COMPLETED|First Rest Period (1-12 Weeks)||3||
59893671|NCT03424044|76016299|FG002|COMPLETED|First Rest Period (1-12 Weeks)||2||
59893672|NCT03424044|76016300|FG003|COMPLETED|First Rest Period (1-12 Weeks)||3||
59893673|NCT03424044|76016301|FG004|COMPLETED|First Rest Period (1-12 Weeks)||3||
59893674|NCT03424044|76016302|FG005|COMPLETED|First Rest Period (1-12 Weeks)||4||
59893675|NCT03424044|76016303|FG006|COMPLETED|First Rest Period (1-12 Weeks)||1||
59893676|NCT03424044|76016304|FG007|COMPLETED|First Rest Period (1-12 Weeks)||1||
59893677|NCT03424044|76016305|FG008|COMPLETED|First Rest Period (1-12 Weeks)||1||
59893678|NCT03424044|76016297|FG000|NOT COMPLETED|First Rest Period (1-12 Weeks)||0||
59893679|NCT03424044|76016298|FG001|NOT COMPLETED|First Rest Period (1-12 Weeks)||0||
59893680|NCT03424044|76016299|FG002|NOT COMPLETED|First Rest Period (1-12 Weeks)||1||
59893681|NCT03424044|76016300|FG003|NOT COMPLETED|First Rest Period (1-12 Weeks)||0||
59893682|NCT03424044|76016301|FG004|NOT COMPLETED|First Rest Period (1-12 Weeks)||0||
59893683|NCT03424044|76016302|FG005|NOT COMPLETED|First Rest Period (1-12 Weeks)||0||
59893684|NCT03424044|76016303|FG006|NOT COMPLETED|First Rest Period (1-12 Weeks)||0||
59893685|NCT03424044|76016304|FG007|NOT COMPLETED|First Rest Period (1-12 Weeks)||0||
59893686|NCT03424044|76016305|FG008|NOT COMPLETED|First Rest Period (1-12 Weeks)||0||
59893687|NCT03424044|76016297|FG000|STARTED|First Intervention (76 Hours)||4||
59893688|NCT03424044|76016298|FG001|STARTED|First Intervention (76 Hours)||3||
59893689|NCT03424044|76016299|FG002|STARTED|First Intervention (76 Hours)||2||
59893690|NCT03424044|76016300|FG003|STARTED|First Intervention (76 Hours)||3||
59893691|NCT03424044|76016301|FG004|STARTED|First Intervention (76 Hours)||3||
59893692|NCT03424044|76016302|FG005|STARTED|First Intervention (76 Hours)||4||
59893693|NCT03424044|76016303|FG006|STARTED|First Intervention (76 Hours)||1||
59893694|NCT03424044|76016304|FG007|STARTED|First Intervention (76 Hours)||1||
59893695|NCT03424044|76016305|FG008|STARTED|First Intervention (76 Hours)||1||
59893696|NCT03424044|76016297|FG000|COMPLETED|First Intervention (76 Hours)||4||
59893697|NCT03424044|76016298|FG001|COMPLETED|First Intervention (76 Hours)||3||
59893698|NCT03424044|76016299|FG002|COMPLETED|First Intervention (76 Hours)||2||
59893699|NCT03424044|76016300|FG003|COMPLETED|First Intervention (76 Hours)||3||
59893700|NCT03424044|76016301|FG004|COMPLETED|First Intervention (76 Hours)||2||
59893701|NCT03424044|76016302|FG005|COMPLETED|First Intervention (76 Hours)||4||
59893702|NCT03424044|76016303|FG006|COMPLETED|First Intervention (76 Hours)||0||
59893703|NCT03424044|76016304|FG007|COMPLETED|First Intervention (76 Hours)||0||
59893704|NCT03424044|76016305|FG008|COMPLETED|First Intervention (76 Hours)||0||
59893705|NCT03424044|76016297|FG000|NOT COMPLETED|First Intervention (76 Hours)||0||
59893706|NCT03424044|76016298|FG001|NOT COMPLETED|First Intervention (76 Hours)||0||
59893707|NCT03424044|76016299|FG002|NOT COMPLETED|First Intervention (76 Hours)||0||
59893708|NCT03424044|76016300|FG003|NOT COMPLETED|First Intervention (76 Hours)||0||
59893709|NCT03424044|76016301|FG004|NOT COMPLETED|First Intervention (76 Hours)||1||
59893710|NCT03424044|76016302|FG005|NOT COMPLETED|First Intervention (76 Hours)||0||
59893711|NCT03424044|76016303|FG006|NOT COMPLETED|First Intervention (76 Hours)||1||
59893712|NCT03424044|76016304|FG007|NOT COMPLETED|First Intervention (76 Hours)||1||
59893713|NCT03424044|76016305|FG008|NOT COMPLETED|First Intervention (76 Hours)||1||
59893714|NCT03424044|76016297|FG000|STARTED|Second Rest Period (7-45 Days)||4||
59893715|NCT03424044|76016298|FG001|STARTED|Second Rest Period (7-45 Days)||3||
59893716|NCT03424044|76016299|FG002|STARTED|Second Rest Period (7-45 Days)||2||
59893717|NCT03424044|76016300|FG003|STARTED|Second Rest Period (7-45 Days)||3||
59893718|NCT03424044|76016301|FG004|STARTED|Second Rest Period (7-45 Days)||2||
59893719|NCT03424044|76016302|FG005|STARTED|Second Rest Period (7-45 Days)||4||
59893720|NCT03424044|76016303|FG006|STARTED|Second Rest Period (7-45 Days)||1||
59893721|NCT03424044|76016304|FG007|STARTED|Second Rest Period (7-45 Days)||1||
59893722|NCT03424044|76016305|FG008|STARTED|Second Rest Period (7-45 Days)||1||
59893723|NCT03424044|76016297|FG000|COMPLETED|Second Rest Period (7-45 Days)||4||
59893724|NCT03424044|76016298|FG001|COMPLETED|Second Rest Period (7-45 Days)||3||
59893725|NCT03424044|76016299|FG002|COMPLETED|Second Rest Period (7-45 Days)||2||
59893726|NCT03424044|76016300|FG003|COMPLETED|Second Rest Period (7-45 Days)||3||
59893727|NCT03424044|76016301|FG004|COMPLETED|Second Rest Period (7-45 Days)||2||
59893728|NCT03424044|76016302|FG005|COMPLETED|Second Rest Period (7-45 Days)||4||
59893729|NCT03424044|76016303|FG006|COMPLETED|Second Rest Period (7-45 Days)||1||
59893730|NCT03424044|76016304|FG007|COMPLETED|Second Rest Period (7-45 Days)||1||
59893731|NCT03424044|76016305|FG008|COMPLETED|Second Rest Period (7-45 Days)||1||
59893732|NCT03424044|76016297|FG000|NOT COMPLETED|Second Rest Period (7-45 Days)||0||
59893733|NCT03424044|76016298|FG001|NOT COMPLETED|Second Rest Period (7-45 Days)||0||
59893734|NCT03424044|76016299|FG002|NOT COMPLETED|Second Rest Period (7-45 Days)||0||
59893735|NCT03424044|76016300|FG003|NOT COMPLETED|Second Rest Period (7-45 Days)||0||
59893736|NCT03424044|76016301|FG004|NOT COMPLETED|Second Rest Period (7-45 Days)||0||
59893737|NCT03424044|76016302|FG005|NOT COMPLETED|Second Rest Period (7-45 Days)||0||
59893738|NCT03424044|76016303|FG006|NOT COMPLETED|Second Rest Period (7-45 Days)||0||
59893739|NCT03424044|76016304|FG007|NOT COMPLETED|Second Rest Period (7-45 Days)||0||
59893740|NCT03424044|76016305|FG008|NOT COMPLETED|Second Rest Period (7-45 Days)||0||
59893741|NCT03424044|76016297|FG000|STARTED|Second Intervention (76 Hours)||4||
59893742|NCT03424044|76016298|FG001|STARTED|Second Intervention (76 Hours)||3||
59893743|NCT03424044|76016299|FG002|STARTED|Second Intervention (76 Hours)||2||
59893744|NCT03424044|76016300|FG003|STARTED|Second Intervention (76 Hours)||3||
59893745|NCT03424044|76016301|FG004|STARTED|Second Intervention (76 Hours)||2||
59893746|NCT03424044|76016302|FG005|STARTED|Second Intervention (76 Hours)||4||
59893747|NCT03424044|76016303|FG006|STARTED|Second Intervention (76 Hours)||1||
59893748|NCT03424044|76016304|FG007|STARTED|Second Intervention (76 Hours)||1||
59893749|NCT03424044|76016305|FG008|STARTED|Second Intervention (76 Hours)||1||
59893750|NCT03424044|76016297|FG000|COMPLETED|Second Intervention (76 Hours)||4||
59893751|NCT03424044|76016298|FG001|COMPLETED|Second Intervention (76 Hours)||3||
59893752|NCT03424044|76016299|FG002|COMPLETED|Second Intervention (76 Hours)||2||
59893753|NCT03424044|76016300|FG003|COMPLETED|Second Intervention (76 Hours)||3||
59893754|NCT03424044|76016301|FG004|COMPLETED|Second Intervention (76 Hours)||2||
59893755|NCT03424044|76016302|FG005|COMPLETED|Second Intervention (76 Hours)||4||
59893756|NCT03424044|76016303|FG006|COMPLETED|Second Intervention (76 Hours)||1||
59893757|NCT03424044|76016304|FG007|COMPLETED|Second Intervention (76 Hours)||1||
59893758|NCT03424044|76016305|FG008|COMPLETED|Second Intervention (76 Hours)||1||
59893759|NCT03424044|76016297|FG000|NOT COMPLETED|Second Intervention (76 Hours)||0||
59893760|NCT03424044|76016298|FG001|NOT COMPLETED|Second Intervention (76 Hours)||0||
59893761|NCT03424044|76016299|FG002|NOT COMPLETED|Second Intervention (76 Hours)||0||
59893762|NCT03424044|76016300|FG003|NOT COMPLETED|Second Intervention (76 Hours)||0||
59893763|NCT03424044|76016301|FG004|NOT COMPLETED|Second Intervention (76 Hours)||0||
59893764|NCT03424044|76016302|FG005|NOT COMPLETED|Second Intervention (76 Hours)||0||
59893765|NCT03424044|76016303|FG006|NOT COMPLETED|Second Intervention (76 Hours)||0||
59893766|NCT03424044|76016304|FG007|NOT COMPLETED|Second Intervention (76 Hours)||0||
59893767|NCT03424044|76016305|FG008|NOT COMPLETED|Second Intervention (76 Hours)||0||
59893768|NCT03424044|76016297|FG000|STARTED|Third Rest Period (7-45 Days)||4||
59893769|NCT03424044|76016298|FG001|STARTED|Third Rest Period (7-45 Days)||3||
59893770|NCT03424044|76016299|FG002|STARTED|Third Rest Period (7-45 Days)||2||
59893771|NCT03424044|76016300|FG003|STARTED|Third Rest Period (7-45 Days)||3||
59893772|NCT03424044|76016301|FG004|STARTED|Third Rest Period (7-45 Days)||2||
59893773|NCT03424044|76016302|FG005|STARTED|Third Rest Period (7-45 Days)||4||
59893774|NCT03424044|76016303|FG006|STARTED|Third Rest Period (7-45 Days)||1||
59893775|NCT03424044|76016304|FG007|STARTED|Third Rest Period (7-45 Days)||1||
59893776|NCT03424044|76016305|FG008|STARTED|Third Rest Period (7-45 Days)||1||
59893777|NCT03424044|76016297|FG000|COMPLETED|Third Rest Period (7-45 Days)||4||
59893778|NCT03424044|76016298|FG001|COMPLETED|Third Rest Period (7-45 Days)||3||
59893779|NCT03424044|76016299|FG002|COMPLETED|Third Rest Period (7-45 Days)||2||
59893780|NCT03424044|76016300|FG003|COMPLETED|Third Rest Period (7-45 Days)||3||
59893781|NCT03424044|76016301|FG004|COMPLETED|Third Rest Period (7-45 Days)||2||
59893782|NCT03424044|76016302|FG005|COMPLETED|Third Rest Period (7-45 Days)||4||
59893783|NCT03424044|76016303|FG006|COMPLETED|Third Rest Period (7-45 Days)||1||
59893784|NCT03424044|76016304|FG007|COMPLETED|Third Rest Period (7-45 Days)||1||
59893785|NCT03424044|76016305|FG008|COMPLETED|Third Rest Period (7-45 Days)||1||
59893786|NCT03424044|76016297|FG000|NOT COMPLETED|Third Rest Period (7-45 Days)||0||
59893787|NCT03424044|76016298|FG001|NOT COMPLETED|Third Rest Period (7-45 Days)||0||
59893788|NCT03424044|76016299|FG002|NOT COMPLETED|Third Rest Period (7-45 Days)||0||
59893789|NCT03424044|76016300|FG003|NOT COMPLETED|Third Rest Period (7-45 Days)||0||
59893790|NCT03424044|76016301|FG004|NOT COMPLETED|Third Rest Period (7-45 Days)||0||
59893791|NCT03424044|76016302|FG005|NOT COMPLETED|Third Rest Period (7-45 Days)||0||
59893792|NCT03424044|76016303|FG006|NOT COMPLETED|Third Rest Period (7-45 Days)||0||
59893793|NCT03424044|76016304|FG007|NOT COMPLETED|Third Rest Period (7-45 Days)||0||
59893794|NCT03424044|76016305|FG008|NOT COMPLETED|Third Rest Period (7-45 Days)||0||
59893795|NCT03424044|76016297|FG000|STARTED|Third Intervention (76 Hours)||4||
59756977|NCT00887198|75875905|FG001|COMPLETED|Cross Over (Placebo to AA)||0||
59756978|NCT00887198|75875906|FG002|COMPLETED|Cross Over (Placebo to AA)||0||
59756979|NCT00887198|75875904|FG000|NOT COMPLETED|Cross Over (Placebo to AA)||0||
59756980|NCT00887198|75875905|FG001|NOT COMPLETED|Cross Over (Placebo to AA)||0||
59756981|NCT00887198|75875906|FG002|NOT COMPLETED|Cross Over (Placebo to AA)||93||
59756982|NCT00782067|75875914|FG000|STARTED|Overall Study||116|All patients to whom study treatment had been assigned (FAS)|
59756983|NCT00782067|75875914|FG000|Safety Set (SS)|Overall Study||116|All patients who received at least one dose of study drug|
59756984|NCT00782067|75875914|FG000|Primary Efficacy Population (PEP)|Overall Study||89|FAS patients meeting diagnostic criteria for ASM/MCL presenting at least one measurable C-finding|
59756985|NCT00782067|75875914|FG000|COMPLETED|Overall Study||0||
59756986|NCT00782067|75875914|FG000|NOT COMPLETED|Overall Study||116||
59756987|NCT00886340|75875920|FG000|STARTED|Overall Study||27||
59756988|NCT00886340|75875921|FG001|STARTED|Overall Study||31||
59756989|NCT00886340|75875920|FG000|COMPLETED|Overall Study||27||
59756990|NCT00886340|75875921|FG001|COMPLETED|Overall Study||24||
59756991|NCT00886340|75875920|FG000|NOT COMPLETED|Overall Study||0||
59756992|NCT00886340|75875921|FG001|NOT COMPLETED|Overall Study||7||
59756993|NCT00605215|75875930|FG000|STARTED|Overall Study||450||
59756994|NCT00605215|75875931|FG001|STARTED|Overall Study||434||
59756995|NCT00605215|75875932|FG002|STARTED|Overall Study||447||
59756996|NCT00605215|75875930|FG000|Received at Least 1 Dose of Study Drug|Overall Study||449||
59756997|NCT00605215|75875931|FG001|Received at Least 1 Dose of Study Drug|Overall Study||433||
59756998|NCT00605215|75875932|FG002|Received at Least 1 Dose of Study Drug|Overall Study||442||
59756999|NCT00605215|75875930|FG000|COMPLETED|Overall Study||359||
59757000|NCT00605215|75875931|FG001|COMPLETED|Overall Study||353||
59757001|NCT00605215|75875932|FG002|COMPLETED|Overall Study||378||
59757002|NCT00605215|75875930|FG000|NOT COMPLETED|Overall Study||91||
59757003|NCT00605215|75875931|FG001|NOT COMPLETED|Overall Study||81||
59757004|NCT00605215|75875932|FG002|NOT COMPLETED|Overall Study||69||
59757005|NCT00604279|75875942|FG000|STARTED|Overall Study||229||
59757006|NCT00604279|75875943|FG001|STARTED|Overall Study||223||
59757007|NCT00604279|75875942|FG000|COMPLETED|Overall Study||165||
59757008|NCT00604279|75875943|FG001|COMPLETED|Overall Study||185||
59757009|NCT00604279|75875942|FG000|NOT COMPLETED|Overall Study||64||
59757010|NCT00604279|75875943|FG001|NOT COMPLETED|Overall Study||38||
59757011|NCT00938015|75875949|FG000|STARTED|Overall Study||303||
59757012|NCT00938015|75875949|FG000|COMPLETED|Overall Study||156||
59757013|NCT00938015|75875949|FG000|NOT COMPLETED|Overall Study||147||
59757014|NCT00781911|75875955|FG000|STARTED|Overall Study||31||
59757015|NCT00781911|75875956|FG001|STARTED|Overall Study||12||
59757016|NCT00781911|75875955|FG000|Received at Least 1 Dose of Study Drug|Overall Study||31||
59757017|NCT00781911|75875956|FG001|Received at Least 1 Dose of Study Drug|Overall Study||12||
59757018|NCT00781911|75875955|FG000|COMPLETED|Overall Study||25||
59757019|NCT00781911|75875956|FG001|COMPLETED|Overall Study||4||
59757020|NCT00781911|75875955|FG000|NOT COMPLETED|Overall Study||6||
59757021|NCT00781911|75875956|FG001|NOT COMPLETED|Overall Study||8||
59757022|NCT00605917|75875964|FG000|STARTED|Overall Study||987||
59757023|NCT00605917|75875964|FG000|COMPLETED|Overall Study||908||
59757024|NCT00605917|75875964|FG000|NOT COMPLETED|Overall Study||79||
59757025|NCT00781599|75876001|FG000|STARTED|Overall Study||36||
59757026|NCT00781599|75876002|FG001|STARTED|Overall Study||36||
59757027|NCT00781599|75876001|FG000|COMPLETED|Overall Study||29||
59757028|NCT00781599|75876002|FG001|COMPLETED|Overall Study||32||
59757029|NCT00781599|75876001|FG000|NOT COMPLETED|Overall Study||7||
59757030|NCT00781599|75876002|FG001|NOT COMPLETED|Overall Study||4||
59757031|NCT04468074|75876010|FG000|STARTED|Overall Study||31||
59757032|NCT04468074|75876011|FG001|STARTED|Overall Study||30||
59757033|NCT04468074|75876010|FG000|COMPLETED|Overall Study||30||
59757034|NCT04468074|75876011|FG001|COMPLETED|Overall Study||30||
59757035|NCT04468074|75876010|FG000|NOT COMPLETED|Overall Study||1||
59757036|NCT04468074|75876011|FG001|NOT COMPLETED|Overall Study||0||
59893796|NCT03424044|76016298|FG001|STARTED|Third Intervention (76 Hours)||3||
59893797|NCT03424044|76016299|FG002|STARTED|Third Intervention (76 Hours)||2||
59893798|NCT03424044|76016300|FG003|STARTED|Third Intervention (76 Hours)||3||
59893799|NCT03424044|76016301|FG004|STARTED|Third Intervention (76 Hours)||2||
59893800|NCT03424044|76016302|FG005|STARTED|Third Intervention (76 Hours)||4||
59893801|NCT03424044|76016303|FG006|STARTED|Third Intervention (76 Hours)||1||
59893802|NCT03424044|76016304|FG007|STARTED|Third Intervention (76 Hours)||1||
59893803|NCT03424044|76016305|FG008|STARTED|Third Intervention (76 Hours)||1||
59893804|NCT03424044|76016297|FG000|COMPLETED|Third Intervention (76 Hours)||3||
59893805|NCT03424044|76016298|FG001|COMPLETED|Third Intervention (76 Hours)||3||
59893806|NCT03424044|76016299|FG002|COMPLETED|Third Intervention (76 Hours)||2||
59893807|NCT03424044|76016300|FG003|COMPLETED|Third Intervention (76 Hours)||2||
59893808|NCT03424044|76016301|FG004|COMPLETED|Third Intervention (76 Hours)||2||
59893809|NCT03424044|76016302|FG005|COMPLETED|Third Intervention (76 Hours)||4||
59893810|NCT03424044|76016303|FG006|COMPLETED|Third Intervention (76 Hours)||0||
59893811|NCT03424044|76016304|FG007|COMPLETED|Third Intervention (76 Hours)||1||
59893812|NCT03424044|76016305|FG008|COMPLETED|Third Intervention (76 Hours)||1||
59893813|NCT03424044|76016297|FG000|NOT COMPLETED|Third Intervention (76 Hours)||1||
59893814|NCT03424044|76016298|FG001|NOT COMPLETED|Third Intervention (76 Hours)||0||
59893815|NCT03424044|76016299|FG002|NOT COMPLETED|Third Intervention (76 Hours)||0||
59893816|NCT03424044|76016300|FG003|NOT COMPLETED|Third Intervention (76 Hours)||1||
59893817|NCT03424044|76016301|FG004|NOT COMPLETED|Third Intervention (76 Hours)||0||
59893818|NCT03424044|76016302|FG005|NOT COMPLETED|Third Intervention (76 Hours)||0||
59893819|NCT03424044|76016303|FG006|NOT COMPLETED|Third Intervention (76 Hours)||1||
59893820|NCT03424044|76016304|FG007|NOT COMPLETED|Third Intervention (76 Hours)||0||
59893821|NCT03424044|76016305|FG008|NOT COMPLETED|Third Intervention (76 Hours)||0||
59893822|NCT03424044|76016297|FG000|STARTED|Optional Fourth Rest Period (7-45 Days)||0||
59893823|NCT03424044|76016298|FG001|STARTED|Optional Fourth Rest Period (7-45 Days)||0||
59893824|NCT03424044|76016299|FG002|STARTED|Optional Fourth Rest Period (7-45 Days)||0||
59893825|NCT03424044|76016300|FG003|STARTED|Optional Fourth Rest Period (7-45 Days)||0||
59893826|NCT03424044|76016301|FG004|STARTED|Optional Fourth Rest Period (7-45 Days)||0||
59893827|NCT03424044|76016302|FG005|STARTED|Optional Fourth Rest Period (7-45 Days)||0||
59893828|NCT03424044|76016303|FG006|STARTED|Optional Fourth Rest Period (7-45 Days)||0||
59893829|NCT03424044|76016304|FG007|STARTED|Optional Fourth Rest Period (7-45 Days)||1||
59893830|NCT03424044|76016305|FG008|STARTED|Optional Fourth Rest Period (7-45 Days)||1||
59893831|NCT03424044|76016297|FG000|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0||
59893832|NCT03424044|76016298|FG001|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0||
59893833|NCT03424044|76016299|FG002|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0||
59893834|NCT03424044|76016300|FG003|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0||
59893835|NCT03424044|76016301|FG004|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0||
59893836|NCT03424044|76016302|FG005|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0||
59893837|NCT03424044|76016303|FG006|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0||
59893838|NCT03424044|76016304|FG007|COMPLETED|Optional Fourth Rest Period (7-45 Days)||1||
59893839|NCT03424044|76016305|FG008|COMPLETED|Optional Fourth Rest Period (7-45 Days)||1||
59893840|NCT03424044|76016297|FG000|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0||
59893841|NCT03424044|76016298|FG001|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0||
59893842|NCT03424044|76016299|FG002|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0||
59893843|NCT03424044|76016300|FG003|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0||
59893844|NCT03424044|76016301|FG004|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0||
59893845|NCT03424044|76016302|FG005|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0||
59893846|NCT03424044|76016303|FG006|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0||
59893847|NCT03424044|76016304|FG007|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0||
59893848|NCT03424044|76016305|FG008|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0||
59893849|NCT03424044|76016297|FG000|STARTED|Fourth Intervention Repeat Visit (76 hr)||0||
59893850|NCT03424044|76016298|FG001|STARTED|Fourth Intervention Repeat Visit (76 hr)||0||
59893851|NCT03424044|76016299|FG002|STARTED|Fourth Intervention Repeat Visit (76 hr)||0||
59893852|NCT03424044|76016300|FG003|STARTED|Fourth Intervention Repeat Visit (76 hr)||0||
59893853|NCT03424044|76016301|FG004|STARTED|Fourth Intervention Repeat Visit (76 hr)||0||
59893854|NCT03424044|76016302|FG005|STARTED|Fourth Intervention Repeat Visit (76 hr)||0||
59893855|NCT03424044|76016303|FG006|STARTED|Fourth Intervention Repeat Visit (76 hr)||0||
59893856|NCT03424044|76016304|FG007|STARTED|Fourth Intervention Repeat Visit (76 hr)||1||
59893857|NCT03424044|76016305|FG008|STARTED|Fourth Intervention Repeat Visit (76 hr)||1||
59893858|NCT03424044|76016297|FG000|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0||
59893859|NCT03424044|76016298|FG001|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0||
59893860|NCT03424044|76016299|FG002|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0||
59893861|NCT03424044|76016300|FG003|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0||
59893862|NCT03424044|76016301|FG004|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0||
59893863|NCT03424044|76016302|FG005|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0||
59893864|NCT03424044|76016303|FG006|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0||
59893865|NCT03424044|76016304|FG007|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||1||
59893866|NCT03424044|76016305|FG008|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||1||
59893867|NCT03424044|76016297|FG000|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0||
59893868|NCT03424044|76016298|FG001|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0||
59893869|NCT03424044|76016299|FG002|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0||
59893870|NCT03424044|76016300|FG003|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0||
59893871|NCT03424044|76016301|FG004|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0||
59893872|NCT03424044|76016302|FG005|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0||
59893873|NCT03424044|76016303|FG006|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0||
59893874|NCT03424044|76016304|FG007|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0||
59893875|NCT03424044|76016305|FG008|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0||
59893876|NCT03422250|76016319|FG000|STARTED|Intervention||11||
59893877|NCT03422250|76016320|FG001|STARTED|Intervention||11||
59893878|NCT03422250|76016321|FG002|STARTED|Intervention||12||
59893879|NCT03422250|76016322|FG003|STARTED|Intervention||11||
59893880|NCT03422250|76016319|FG000|COMPLETED|Intervention||10||
59893881|NCT03422250|76016320|FG001|COMPLETED|Intervention||10||
59893882|NCT03422250|76016321|FG002|COMPLETED|Intervention||10||
59893883|NCT03422250|76016322|FG003|COMPLETED|Intervention||10||
59893884|NCT03422250|76016319|FG000|NOT COMPLETED|Intervention||1||
59893885|NCT03422250|76016320|FG001|NOT COMPLETED|Intervention||1||
59893886|NCT03422250|76016321|FG002|NOT COMPLETED|Intervention||2||
59893887|NCT03422250|76016322|FG003|NOT COMPLETED|Intervention||1||
59893888|NCT03422250|76016319|FG000|STARTED|Follow-up||10||
59893889|NCT03422250|76016320|FG001|STARTED|Follow-up||10||
59893890|NCT03422250|76016321|FG002|STARTED|Follow-up||10||
59893891|NCT03422250|76016322|FG003|STARTED|Follow-up||10||
59893892|NCT03422250|76016319|FG000|COMPLETED|Follow-up||10||
59893893|NCT03422250|76016320|FG001|COMPLETED|Follow-up||10||
59893894|NCT03422250|76016321|FG002|COMPLETED|Follow-up||10||
59893895|NCT03422250|76016322|FG003|COMPLETED|Follow-up||8||
59893896|NCT03422250|76016319|FG000|NOT COMPLETED|Follow-up||0||
59893897|NCT03422250|76016320|FG001|NOT COMPLETED|Follow-up||0||
59893898|NCT03422250|76016321|FG002|NOT COMPLETED|Follow-up||0||
59893899|NCT03422250|76016322|FG003|NOT COMPLETED|Follow-up||2||
59893900|NCT01266031|76016337|FG000|STARTED|Overall Study||6||
59893901|NCT01266031|76016338|FG001|STARTED|Overall Study||41||
59893902|NCT01266031|76016339|FG002|STARTED|Overall Study||49||
59893903|NCT01266031|76016337|FG000|COMPLETED|Overall Study||6||
59893904|NCT01266031|76016338|FG001|COMPLETED|Overall Study||38||
59893905|NCT01266031|76016339|FG002|COMPLETED|Overall Study||47||
59893906|NCT01266031|76016337|FG000|NOT COMPLETED|Overall Study||0||
59893907|NCT01266031|76016338|FG001|NOT COMPLETED|Overall Study||3||
59893908|NCT01266031|76016339|FG002|NOT COMPLETED|Overall Study||2||
59893909|NCT00075725|76016370|FG000|STARTED|Overall Study||246||
59893910|NCT00075725|76016371|FG001|STARTED|Overall Study||106||
59893911|NCT00075725|76016372|FG002|STARTED|Overall Study||296||
59893912|NCT00075725|76016373|FG003|STARTED|Overall Study||246||
59893913|NCT00075725|76016374|FG004|STARTED|Overall Study||232||
59893914|NCT00075725|76016375|FG005|STARTED|Overall Study||710||
59893915|NCT00075725|76016376|FG006|STARTED|Overall Study||246||
59893916|NCT00075725|76016377|FG007|STARTED|Overall Study||696||
59893917|NCT00075725|76016378|FG008|STARTED|Overall Study||302||
59893918|NCT00075725|76016379|FG009|STARTED|Overall Study||34||
59893919|NCT00075725|76016380|FG010|STARTED|Overall Study||12||
59893920|NCT00075725|76016381|FG011|STARTED|Overall Study||28||
59893921|NCT00075725|76016370|FG000|COMPLETED|Overall Study||172||
59893922|NCT00075725|76016371|FG001|COMPLETED|Overall Study||57||
59893923|NCT00075725|76016372|FG002|COMPLETED|Overall Study||175||
59893924|NCT00075725|76016373|FG003|COMPLETED|Overall Study||168||
59893925|NCT00075725|76016374|FG004|COMPLETED|Overall Study||166||
59893926|NCT00075725|76016375|FG005|COMPLETED|Overall Study||397||
59893927|NCT00075725|76016376|FG006|COMPLETED|Overall Study||171||
59893928|NCT00075725|76016377|FG007|COMPLETED|Overall Study||401||
59893929|NCT00075725|76016378|FG008|COMPLETED|Overall Study||185||
59893930|NCT00075725|76016379|FG009|COMPLETED|Overall Study||16||
59893931|NCT00075725|76016380|FG010|COMPLETED|Overall Study||3||
59893932|NCT00075725|76016381|FG011|COMPLETED|Overall Study||10||
59893933|NCT00075725|76016370|FG000|NOT COMPLETED|Overall Study||74||
60013798|NCT01671007|76129762|FG004|STARTED|Overall Study||180||
59893934|NCT00075725|76016371|FG001|NOT COMPLETED|Overall Study||49||
59893935|NCT00075725|76016372|FG002|NOT COMPLETED|Overall Study||121||
59893936|NCT00075725|76016373|FG003|NOT COMPLETED|Overall Study||78||
59893937|NCT00075725|76016374|FG004|NOT COMPLETED|Overall Study||66||
59893938|NCT00075725|76016375|FG005|NOT COMPLETED|Overall Study||313||
59893939|NCT00075725|76016376|FG006|NOT COMPLETED|Overall Study||75||
59893940|NCT00075725|76016377|FG007|NOT COMPLETED|Overall Study||295||
59893941|NCT00075725|76016378|FG008|NOT COMPLETED|Overall Study||117||
59893942|NCT00075725|76016379|FG009|NOT COMPLETED|Overall Study||18||
59893943|NCT00075725|76016380|FG010|NOT COMPLETED|Overall Study||9||
59893944|NCT00075725|76016381|FG011|NOT COMPLETED|Overall Study||18||
59893945|NCT02953782|76016420|FG000|STARTED|Phase 1b (Maximum Duration: 14.3 Months)||6||
59893946|NCT02953782|76016421|FG001|STARTED|Phase 1b (Maximum Duration: 14.3 Months)||3||
59893947|NCT02953782|76016422|FG002|STARTED|Phase 1b (Maximum Duration: 14.3 Months)||9||
59893948|NCT02953782|76016423|FG003|STARTED|Phase 1b (Maximum Duration: 14.3 Months)||8||
59893949|NCT02953782|76016424|FG004|STARTED|Phase 1b (Maximum Duration: 14.3 Months)||6||
59893950|NCT02953782|76016425|FG005|STARTED|Phase 1b (Maximum Duration: 14.3 Months)||0||
59893951|NCT02953782|76016426|FG006|STARTED|Phase 1b (Maximum Duration: 14.3 Months)||0||
59893952|NCT02953782|76016427|FG007|STARTED|Phase 1b (Maximum Duration: 14.3 Months)||0||
59893953|NCT02953782|76016420|FG000|COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0||
59893954|NCT02953782|76016421|FG001|COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0||
59893955|NCT02953782|76016422|FG002|COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0||
59893956|NCT02953782|76016423|FG003|COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0||
59893957|NCT02953782|76016424|FG004|COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0||
59893958|NCT02953782|76016425|FG005|COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0||
59893959|NCT02953782|76016426|FG006|COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0||
59893960|NCT02953782|76016427|FG007|COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0||
59893961|NCT02953782|76016420|FG000|NOT COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||6||
59893962|NCT02953782|76016421|FG001|NOT COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||3||
59893963|NCT02953782|76016422|FG002|NOT COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||9||
59893964|NCT02953782|76016423|FG003|NOT COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||8||
59893965|NCT02953782|76016424|FG004|NOT COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||6||
59893966|NCT02953782|76016425|FG005|NOT COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0||
59893967|NCT02953782|76016426|FG006|NOT COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0||
59893968|NCT02953782|76016427|FG007|NOT COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0||
59893969|NCT02953782|76016420|FG000|STARTED|Phase 2 (Maximum Duration: 11.1 Months)||0||
59893970|NCT02953782|76016421|FG001|STARTED|Phase 2 (Maximum Duration: 11.1 Months)||0||
59893971|NCT02953782|76016422|FG002|STARTED|Phase 2 (Maximum Duration: 11.1 Months)||0||
59893972|NCT02953782|76016423|FG003|STARTED|Phase 2 (Maximum Duration: 11.1 Months)||0||
59893973|NCT02953782|76016424|FG004|STARTED|Phase 2 (Maximum Duration: 11.1 Months)||0||
59893974|NCT02953782|76016425|FG005|STARTED|Phase 2 (Maximum Duration: 11.1 Months)|11 participants were included in safety run-in to evaluate DLT. 9 out of 11 were evaluable for DLT.|16||
59893975|NCT02953782|76016426|FG006|STARTED|Phase 2 (Maximum Duration: 11.1 Months)||15||
59893976|NCT02953782|76016427|FG007|STARTED|Phase 2 (Maximum Duration: 11.1 Months)||15||
59893977|NCT02953782|76016420|FG000|COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0||
59893978|NCT02953782|76016421|FG001|COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0||
59893979|NCT02953782|76016422|FG002|COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0||
59893980|NCT02953782|76016423|FG003|COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0||
59893981|NCT02953782|76016424|FG004|COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0||
59893982|NCT02953782|76016425|FG005|COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0||
59893983|NCT02953782|76016426|FG006|COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0||
59893984|NCT02953782|76016427|FG007|COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0||
59893985|NCT02953782|76016420|FG000|NOT COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0||
59893986|NCT02953782|76016421|FG001|NOT COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0||
59893987|NCT02953782|76016422|FG002|NOT COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0||
59893988|NCT02953782|76016423|FG003|NOT COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0||
59893989|NCT02953782|76016424|FG004|NOT COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0||
59893990|NCT02953782|76016425|FG005|NOT COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||16||
59893991|NCT02953782|76016426|FG006|NOT COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||15||
59893992|NCT02953782|76016427|FG007|NOT COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||15||
59893993|NCT03760081|76016450|FG000|STARTED|Overall Study||6||
59893994|NCT03760081|76016451|FG001|STARTED|Overall Study||13||
59893995|NCT03760081|76016450|FG000|COMPLETED|Overall Study||0||
59893996|NCT03760081|76016451|FG001|COMPLETED|Overall Study||1||
59893997|NCT03760081|76016450|FG000|NOT COMPLETED|Overall Study||6||
59893998|NCT03760081|76016451|FG001|NOT COMPLETED|Overall Study||12||
59893999|NCT03422172|76016459|FG000|STARTED|Oral lead-in Phase (4 Weeks)||48||
59894000|NCT03422172|76016459|FG000|COMPLETED|Oral lead-in Phase (4 Weeks)||47||
59894001|NCT03422172|76016459|FG000|NOT COMPLETED|Oral lead-in Phase (4 Weeks)||1||
59894002|NCT03422172|76016459|FG000|STARTED|Washout (7 Days)||47||
59894003|NCT03422172|76016459|FG000|COMPLETED|Washout (7 Days)||47||
59894004|NCT03422172|76016459|FG000|NOT COMPLETED|Washout (7 Days)||0||
59894005|NCT03422172|76016459|FG000|STARTED|Injection Phase (Week 5 to Week 41)||47||
59894006|NCT03422172|76016459|FG000|COMPLETED|Injection Phase (Week 5 to Week 41)||43||
59894007|NCT03422172|76016459|FG000|NOT COMPLETED|Injection Phase (Week 5 to Week 41)||4||
59894008|NCT03422172|76016459|FG000|STARTED|Long Term Follow-up Phase(Upto Week 89)||43||
59894009|NCT03422172|76016459|FG000|COMPLETED|Long Term Follow-up Phase(Upto Week 89)||43||
59894010|NCT03422172|76016459|FG000|NOT COMPLETED|Long Term Follow-up Phase(Upto Week 89)||0||
59894011|NCT00057863|76016468|FG000|STARTED|Overall Study||35||
59894012|NCT00057863|76016468|FG000|COMPLETED|Overall Study||32||
59894013|NCT00057863|76016468|FG000|NOT COMPLETED|Overall Study||3||
60013799|NCT01671007|76129763|FG005|STARTED|Overall Study||513||
59894014|NCT00075023|76016474|FG000|STARTED|Pilot Study||5||
59894015|NCT00075023|76016475|FG001|STARTED|Pilot Study||5||
59894016|NCT00075023|76016474|FG000|COMPLETED|Pilot Study||3||
59894017|NCT00075023|76016475|FG001|COMPLETED|Pilot Study||3||
59894018|NCT00075023|76016474|FG000|NOT COMPLETED|Pilot Study||2||
59894019|NCT00075023|76016475|FG001|NOT COMPLETED|Pilot Study||2||
59894020|NCT00075023|76016474|FG000|STARTED|Part Two|Study was terminated after the pilot study. No participants entered Part Two.|0||
59894021|NCT00075023|76016475|FG001|STARTED|Part Two|Study was terminated after the pilot study. No participants entered Part Two.|0||
59894022|NCT00075023|76016474|FG000|COMPLETED|Part Two||0||
59894023|NCT00075023|76016475|FG001|COMPLETED|Part Two||0||
59894024|NCT00075023|76016474|FG000|NOT COMPLETED|Part Two||0||
59894025|NCT00075023|76016475|FG001|NOT COMPLETED|Part Two||0||
59894026|NCT00074711|76016484|FG000|STARTED|Overall Study||120||
59894027|NCT00074711|76016485|FG001|STARTED|Overall Study||121||
59894028|NCT00074711|76016484|FG000|COMPLETED|Overall Study||105||
59894029|NCT00074711|76016485|FG001|COMPLETED|Overall Study||106||
59894030|NCT00074711|76016484|FG000|NOT COMPLETED|Overall Study||15||
59894031|NCT00074711|76016485|FG001|NOT COMPLETED|Overall Study||15||
59894032|NCT03420300|76016491|FG000|STARTED|Overall Study||40||
59894033|NCT03420300|76016491|FG000|COMPLETED|Overall Study||38||
59894034|NCT03420300|76016491|FG000|NOT COMPLETED|Overall Study||2||
59894035|NCT03419598|76016495|FG000|STARTED|Overall Study||30|Since this is a virtual trial, the virtual patients were duplicated and enrolled into both arms|
59894036|NCT03419598|76016495|FG000|Subject Specific Tibia Models Created and Virtual Osteotomy Performed|Overall Study||28||
59894037|NCT03419598|76016495|FG000|Virtual Cohort Duplicated Into A. Personalised and B. Generic Copies|Overall Study||28||
59894038|NCT03419598|76016495|FG000|Finite Element (FE) Model Created for Cohort Copy Stabilised by Personalised HTO Plate|Overall Study||28||
59894039|NCT03419598|76016495|FG000|FE Models Created for Cohort Copy Stabilised by Generic HTO Plate|Overall Study||28||
59894040|NCT03419598|76016495|FG000|FE Models Solved for Personalised HTO Plate Stabilised Cohort Copy|Overall Study||28||
59894041|NCT03419598|76016495|FG000|FE Models Solved for Generic HTO Plate Stabilised Cohort Copy|Overall Study||28||
59894042|NCT03419598|76016495|FG000|COMPLETED|Overall Study||28||
59894043|NCT03419598|76016495|FG000|NOT COMPLETED|Overall Study||2||
59894044|NCT03407430|76016503|FG000|STARTED|First Intervention||5||
59894045|NCT03407430|76016504|FG001|STARTED|First Intervention||3||
59894046|NCT03407430|76016503|FG000|COMPLETED|First Intervention||5||
59894047|NCT03407430|76016504|FG001|COMPLETED|First Intervention||3||
59894048|NCT03407430|76016503|FG000|NOT COMPLETED|First Intervention||0||
59894049|NCT03407430|76016504|FG001|NOT COMPLETED|First Intervention||0||
59894050|NCT03407430|76016503|FG000|STARTED|Washout||5||
59894051|NCT03407430|76016504|FG001|STARTED|Washout||3||
59894052|NCT03407430|76016503|FG000|COMPLETED|Washout||4||
59894053|NCT03407430|76016504|FG001|COMPLETED|Washout||3||
59505674|NCT03807349|75598530|FG000|COMPLETED|Overall Study||3||
59505675|NCT03807349|75598530|FG000|NOT COMPLETED|Overall Study||9||
59505676|NCT00779701|75598534|FG000|STARTED|Overall Study||27||
59505677|NCT00779701|75598534|FG000|COMPLETED|Overall Study||27||
59505678|NCT00779701|75598534|FG000|NOT COMPLETED|Overall Study||0||
59894054|NCT03407430|76016503|FG000|NOT COMPLETED|Washout||1||
59894055|NCT03407430|76016504|FG001|NOT COMPLETED|Washout||0||
59894056|NCT03407430|76016503|FG000|STARTED|Second Intervention||4||
59894057|NCT03407430|76016504|FG001|STARTED|Second Intervention||3||
59894058|NCT03407430|76016503|FG000|COMPLETED|Second Intervention||4||
59894059|NCT03407430|76016504|FG001|COMPLETED|Second Intervention||3||
59894060|NCT03407430|76016503|FG000|NOT COMPLETED|Second Intervention||0||
59894061|NCT03407430|76016504|FG001|NOT COMPLETED|Second Intervention||0||
59894062|NCT03407118|76016517|FG000|STARTED|Period 1||14||
59894063|NCT03407118|76016518|FG001|STARTED|Period 1||17||
59894064|NCT03407118|76016517|FG000|Received at Least 1 Dose of Study Drug|Period 1||14||
59894065|NCT03407118|76016518|FG001|Received at Least 1 Dose of Study Drug|Period 1||17||
59894066|NCT03407118|76016517|FG000|COMPLETED|Period 1||14||
59894067|NCT03407118|76016518|FG001|COMPLETED|Period 1||17||
59894068|NCT03407118|76016517|FG000|NOT COMPLETED|Period 1||0||
59894069|NCT03407118|76016518|FG001|NOT COMPLETED|Period 1||0||
59894070|NCT03407118|76016517|FG000|STARTED|Period 2||14||
59894071|NCT03407118|76016518|FG001|STARTED|Period 2||17||
59894072|NCT03407118|76016517|FG000|Received at Least 1 Dose of Study Drug|Period 2||13||
59894073|NCT03407118|76016518|FG001|Received at Least 1 Dose of Study Drug|Period 2||17||
59894074|NCT03407118|76016517|FG000|COMPLETED|Period 2||13||
59894075|NCT03407118|76016518|FG001|COMPLETED|Period 2||17||
59894076|NCT03407118|76016517|FG000|NOT COMPLETED|Period 2||1||
59894077|NCT03407118|76016518|FG001|NOT COMPLETED|Period 2||0||
59894078|NCT03406962|76016524|FG000|STARTED|Overall Study||8||
59894079|NCT03406962|76016524|FG000|COMPLETED|Overall Study||5||
59894080|NCT03406962|76016524|FG000|NOT COMPLETED|Overall Study||3||
59894081|NCT03406260|76016535|FG000|STARTED|Period 1||6||
59894082|NCT03406260|76016536|FG001|STARTED|Period 1||6||
59894083|NCT03406260|76016537|FG002|STARTED|Period 1||6||
59894084|NCT03406260|76016538|FG003|STARTED|Period 1||6||
59894085|NCT03406260|76016539|FG004|STARTED|Period 1||6||
59894086|NCT03406260|76016540|FG005|STARTED|Period 1||6||
59894087|NCT03406260|76016535|FG000|Received at Least 1 Dose of Study Drug|Period 1||6||
59894088|NCT03406260|76016536|FG001|Received at Least 1 Dose of Study Drug|Period 1||6||
59894089|NCT03406260|76016537|FG002|Received at Least 1 Dose of Study Drug|Period 1||6||
59505679|NCT03802825|75598540|FG000|STARTED|Overall Study||54||
59505680|NCT03802825|75598541|FG001|STARTED|Overall Study||56||
59757037|NCT00605839|75876020|FG000|STARTED|Overall Study||40||
59757038|NCT00605839|75876021|FG001|STARTED|Overall Study||37||
59757039|NCT00605839|75876022|FG002|STARTED|Overall Study||28||
59757040|NCT00605839|75876020|FG000|COMPLETED|Overall Study|One patient would not keep to the text messaging constraints and had to be removed.|39||
59757041|NCT00605839|75876021|FG001|COMPLETED|Overall Study||37||
59757042|NCT00605839|75876022|FG002|COMPLETED|Overall Study||28||
59757043|NCT00605839|75876020|FG000|NOT COMPLETED|Overall Study||1||
59757044|NCT00605839|75876021|FG001|NOT COMPLETED|Overall Study||0||
59757045|NCT00605839|75876022|FG002|NOT COMPLETED|Overall Study||0||
59757046|NCT00781365|75876032|FG000|STARTED|Overall Study||228||
59757047|NCT00781365|75876033|FG001|STARTED|Overall Study||222||
59757048|NCT00781365|75876032|FG000|COMPLETED|Overall Study|completed both 6 and 12 month follow up|194||
59757049|NCT00781365|75876033|FG001|COMPLETED|Overall Study|completed both 6 and 12 month follow up|186||
59757050|NCT00781365|75876032|FG000|NOT COMPLETED|Overall Study||34||
59757051|NCT00781365|75876033|FG001|NOT COMPLETED|Overall Study||36||
59757052|NCT00937547|75876042|FG000|STARTED|Overall Study||96||
59757053|NCT00937547|75876043|FG001|STARTED|Overall Study||84||
59757054|NCT00937547|75876044|FG002|STARTED|Overall Study||149||
59757055|NCT00937547|75876042|FG000|Histological Samples|Overall Study||95||
59757056|NCT00937547|75876043|FG001|Histological Samples|Overall Study||78||
59757057|NCT00937547|75876044|FG002|Histological Samples|Overall Study||142||
59757058|NCT00937547|75876042|FG000|COMPLETED|Overall Study||95||
59757059|NCT00937547|75876043|FG001|COMPLETED|Overall Study||78||
59757060|NCT00937547|75876044|FG002|COMPLETED|Overall Study||142||
59757061|NCT00937547|75876042|FG000|NOT COMPLETED|Overall Study||1||
59757062|NCT00937547|75876043|FG001|NOT COMPLETED|Overall Study||6||
59757063|NCT00937547|75876044|FG002|NOT COMPLETED|Overall Study||7||
59757064|NCT00780975|75876052|FG000|STARTED|Overall Study||8||
59757065|NCT00780975|75876052|FG000|COMPLETED|Overall Study||0||
59757066|NCT00780975|75876052|FG000|NOT COMPLETED|Overall Study||8||
59757067|NCT00780273|75876056|FG000|STARTED|Overall Study||19||
59757068|NCT00780273|75876056|FG000|COMPLETED|Overall Study||17||
59757069|NCT00780273|75876056|FG000|NOT COMPLETED|Overall Study||2||
59757070|NCT00779259|75876061|FG000|STARTED|Theophylline Alone||24||
59757071|NCT00779259|75876061|FG000|COMPLETED|Theophylline Alone||24||
59757072|NCT00779259|75876061|FG000|NOT COMPLETED|Theophylline Alone||0||
59757073|NCT00779259|75876061|FG000|STARTED|4 Day Washout Period||24||
59757074|NCT00779259|75876061|FG000|COMPLETED|4 Day Washout Period||24||
59757075|NCT00779259|75876061|FG000|NOT COMPLETED|4 Day Washout Period||0||
59757076|NCT00779259|75876061|FG000|STARTED|Quinine Alone||24||
59757077|NCT00779259|75876061|FG000|COMPLETED|Quinine Alone||22||
59757078|NCT00779259|75876061|FG000|NOT COMPLETED|Quinine Alone||2||
59757079|NCT00779259|75876061|FG000|STARTED|Theophylline With Quinine||22||
59757080|NCT00779259|75876061|FG000|COMPLETED|Theophylline With Quinine||22||
59757081|NCT00779259|75876061|FG000|NOT COMPLETED|Theophylline With Quinine||0||
59757082|NCT00779025|75876079|FG000|STARTED|Overall Study||82||
59757083|NCT00779025|75876079|FG000|COMPLETED|Overall Study||81||
59757084|NCT00779025|75876079|FG000|NOT COMPLETED|Overall Study||1||
59757085|NCT00936065|75876087|FG000|STARTED|Overall Study||21||
59757086|NCT00936065|75876088|FG001|STARTED|Overall Study||20||
59757087|NCT00936065|75876089|FG002|STARTED|Overall Study||19||
59757088|NCT00936065|75876087|FG000|Received Treatment|Overall Study||21||
59757089|NCT00936065|75876088|FG001|Received Treatment|Overall Study||20||
59757090|NCT00936065|75876089|FG002|Received Treatment|Overall Study||18||
59757091|NCT00936065|75876087|FG000|Study Assessments Performed|Overall Study||21||
59757092|NCT00936065|75876088|FG001|Study Assessments Performed|Overall Study||19||
59757093|NCT00936065|75876089|FG002|Study Assessments Performed|Overall Study||18||
59757094|NCT00936065|75876087|FG000|COMPLETED|Overall Study||17||
59757095|NCT00936065|75876088|FG001|COMPLETED|Overall Study||16||
59757096|NCT00936065|75876089|FG002|COMPLETED|Overall Study||12||
59757097|NCT00936065|75876087|FG000|NOT COMPLETED|Overall Study||4||
59757098|NCT00936065|75876088|FG001|NOT COMPLETED|Overall Study||4||
59757099|NCT00936065|75876089|FG002|NOT COMPLETED|Overall Study||7||
59894090|NCT03406260|76016538|FG003|Received at Least 1 Dose of Study Drug|Period 1||6||
59894091|NCT03406260|76016539|FG004|Received at Least 1 Dose of Study Drug|Period 1||6||
59894092|NCT03406260|76016540|FG005|Received at Least 1 Dose of Study Drug|Period 1||6||
59757100|NCT04441788|75876100|FG000|STARTED|Overall Study||20||
59757101|NCT04441788|75876101|FG001|STARTED|Overall Study||21||
59757102|NCT04441788|75876102|FG002|STARTED|Overall Study||19||
59757103|NCT04441788|75876100|FG000|COMPLETED|Overall Study||3||
59757104|NCT04441788|75876101|FG001|COMPLETED|Overall Study||4||
59757105|NCT04441788|75876102|FG002|COMPLETED|Overall Study||3||
59757106|NCT04441788|75876100|FG000|NOT COMPLETED|Overall Study||17||
59757107|NCT04441788|75876101|FG001|NOT COMPLETED|Overall Study||17||
59757108|NCT04441788|75876102|FG002|NOT COMPLETED|Overall Study||16||
59757109|NCT00604825|75876118|FG000|STARTED|Overall Study||90||
59757110|NCT00604825|75876119|FG001|STARTED|Overall Study||87||
59757111|NCT00604825|75876120|FG002|STARTED|Overall Study||89||
59757112|NCT00604825|75876121|FG003|STARTED|Overall Study||90||
59757113|NCT00604825|75876118|FG000|COMPLETED|Overall Study||81||
59757114|NCT00604825|75876119|FG001|COMPLETED|Overall Study||72||
59757115|NCT00604825|75876120|FG002|COMPLETED|Overall Study||73||
59894093|NCT03406260|76016535|FG000|COMPLETED|Period 1||6||
59894094|NCT03406260|76016536|FG001|COMPLETED|Period 1||6||
59894095|NCT03406260|76016537|FG002|COMPLETED|Period 1||6||
59894096|NCT03406260|76016538|FG003|COMPLETED|Period 1||6||
59894097|NCT03406260|76016539|FG004|COMPLETED|Period 1||5||
59894098|NCT03406260|76016540|FG005|COMPLETED|Period 1||6||
59894099|NCT03406260|76016535|FG000|NOT COMPLETED|Period 1||0||
59894100|NCT03406260|76016536|FG001|NOT COMPLETED|Period 1||0||
59894101|NCT03406260|76016537|FG002|NOT COMPLETED|Period 1||0||
59894102|NCT03406260|76016538|FG003|NOT COMPLETED|Period 1||0||
59894103|NCT03406260|76016539|FG004|NOT COMPLETED|Period 1||1||
59894104|NCT03406260|76016540|FG005|NOT COMPLETED|Period 1||0||
59894105|NCT03406260|76016535|FG000|STARTED|Period 2||6||
59894106|NCT03406260|76016536|FG001|STARTED|Period 2||6||
59894107|NCT03406260|76016537|FG002|STARTED|Period 2||6||
59894108|NCT03406260|76016538|FG003|STARTED|Period 2||6||
59894109|NCT03406260|76016539|FG004|STARTED|Period 2||5||
59894110|NCT03406260|76016540|FG005|STARTED|Period 2||6||
60013800|NCT01671007|76129764|FG006|STARTED|Overall Study||80||
59610550|NCT01838616|75721427|FG000|Per Protocol Set|Titration Period||117||
59757116|NCT00604825|75876121|FG003|COMPLETED|Overall Study||79||
59757117|NCT00604825|75876118|FG000|NOT COMPLETED|Overall Study||9||
59757118|NCT00604825|75876119|FG001|NOT COMPLETED|Overall Study||15||
59757119|NCT00604825|75876120|FG002|NOT COMPLETED|Overall Study||16||
59757120|NCT00604825|75876121|FG003|NOT COMPLETED|Overall Study||11||
59757121|NCT00937391|75876133|FG000|STARTED|Stage 1||20||
59757122|NCT00937391|75876133|FG000|Treated|Stage 1|Valid for Full Analysis Set (FAS); includes all participants administered Magnevist Injection|20||
59757123|NCT00937391|75876133|FG000|COMPLETED|Stage 1||20||
59757124|NCT00937391|75876133|FG000|NOT COMPLETED|Stage 1||0||
59757125|NCT00937391|75876133|FG000|STARTED|Stage 2|Stage 1 and Stage 2 are independent each enrolling a different set of participants|34||
59757126|NCT00937391|75876133|FG000|Treated|Stage 2|Valid for Full Analysis Set; participants administered correct Magnevist dose based on body weight|34||
59757127|NCT00937391|75876133|FG000|COMPLETED|Stage 2|The number completed includes participants within the FAS and Per Protocol Set (PPS)|33||
59757128|NCT00937391|75876133|FG000|NOT COMPLETED|Stage 2||1||
59757129|NCT00937157|75876150|FG000|STARTED|Overall Study||12||
59757130|NCT00937157|75876150|FG000|COMPLETED|Overall Study||8||
59757131|NCT00937157|75876150|FG000|NOT COMPLETED|Overall Study||4||
59757132|NCT00777153|75876157|FG000|STARTED|Overall Study||131||
59757133|NCT00777153|75876158|FG001|STARTED|Overall Study||129||
59757134|NCT00777153|75876159|FG002|STARTED|Overall Study||65||
59757135|NCT00777153|75876157|FG000|COMPLETED|Overall Study||41||
59757136|NCT00777153|75876158|FG001|COMPLETED|Overall Study||46||
59757137|NCT00777153|75876159|FG002|COMPLETED|Overall Study||28||
59757138|NCT00777153|75876157|FG000|NOT COMPLETED|Overall Study||90||
59757139|NCT00777153|75876158|FG001|NOT COMPLETED|Overall Study||83||
59757140|NCT00777153|75876159|FG002|NOT COMPLETED|Overall Study||37||
59757141|NCT00567541|75876173|FG000|STARTED|Overall Study||7||
59757142|NCT00567541|75876174|FG001|STARTED|Overall Study||9||
59757143|NCT00567541|75876173|FG000|COMPLETED|Overall Study||7||
59757144|NCT00567541|75876174|FG001|COMPLETED|Overall Study||8||
59757145|NCT00567541|75876173|FG000|NOT COMPLETED|Overall Study||0||
59757146|NCT00567541|75876174|FG001|NOT COMPLETED|Overall Study||1||
59757147|NCT00776997|75876180|FG000|STARTED|Overall Study||100||
59757148|NCT00776997|75876180|FG000|COMPLETED|Overall Study|98 subjects evaluated at 12-months. Endpoint analysis based on all subjects treated (n=100)|98||
59757149|NCT00776997|75876180|FG000|NOT COMPLETED|Overall Study||2||
59757150|NCT00940823|75876186|FG000|STARTED|Overall Study||124||
59757151|NCT00940823|75876187|FG001|STARTED|Overall Study||114||
59894111|NCT03406260|76016535|FG000|COMPLETED|Period 2||6||
59894112|NCT03406260|76016536|FG001|COMPLETED|Period 2||6||
59894113|NCT03406260|76016537|FG002|COMPLETED|Period 2||6||
59894114|NCT03406260|76016538|FG003|COMPLETED|Period 2||6||
59894115|NCT03406260|76016539|FG004|COMPLETED|Period 2||5||
59894116|NCT03406260|76016540|FG005|COMPLETED|Period 2||6||
59894117|NCT03406260|76016535|FG000|NOT COMPLETED|Period 2||0||
59894118|NCT03406260|76016536|FG001|NOT COMPLETED|Period 2||0||
59894119|NCT03406260|76016537|FG002|NOT COMPLETED|Period 2||0||
59894120|NCT03406260|76016538|FG003|NOT COMPLETED|Period 2||0||
59894121|NCT03406260|76016539|FG004|NOT COMPLETED|Period 2||0||
59894122|NCT03406260|76016540|FG005|NOT COMPLETED|Period 2||0||
59894123|NCT03406260|76016535|FG000|STARTED|Period 3||6||
59894124|NCT03406260|76016536|FG001|STARTED|Period 3||6||
59894125|NCT03406260|76016537|FG002|STARTED|Period 3||6||
59894126|NCT03406260|76016538|FG003|STARTED|Period 3||6||
59894127|NCT03406260|76016539|FG004|STARTED|Period 3||5||
59894128|NCT03406260|76016540|FG005|STARTED|Period 3||6||
59894129|NCT03406260|76016535|FG000|COMPLETED|Period 3||6||
59894130|NCT03406260|76016536|FG001|COMPLETED|Period 3||6||
59894131|NCT03406260|76016537|FG002|COMPLETED|Period 3||6||
59894132|NCT03406260|76016538|FG003|COMPLETED|Period 3||6||
59894133|NCT03406260|76016539|FG004|COMPLETED|Period 3||5||
59894134|NCT03406260|76016540|FG005|COMPLETED|Period 3||6||
59894135|NCT03406260|76016535|FG000|NOT COMPLETED|Period 3||0||
59894136|NCT03406260|76016536|FG001|NOT COMPLETED|Period 3||0||
59894137|NCT03406260|76016537|FG002|NOT COMPLETED|Period 3||0||
59894138|NCT03406260|76016538|FG003|NOT COMPLETED|Period 3||0||
59894139|NCT03406260|76016539|FG004|NOT COMPLETED|Period 3||0||
59894140|NCT03406260|76016540|FG005|NOT COMPLETED|Period 3||0||
59894141|NCT03419364|76016553|FG000|STARTED|Overall Study||11||
59894142|NCT03419364|76016554|FG001|STARTED|Overall Study||6||
59894143|NCT03419364|76016555|FG002|STARTED|Overall Study||6||
59894144|NCT03419364|76016553|FG000|Signed Consent|Overall Study||11||
59894145|NCT03419364|76016554|FG001|Signed Consent|Overall Study||6||
59894146|NCT03419364|76016555|FG002|Signed Consent|Overall Study||6||
59894147|NCT03419364|76016553|FG000|Received Intervention|Overall Study||9||
59894148|NCT03419364|76016554|FG001|Received Intervention|Overall Study||6||
59894149|NCT03419364|76016555|FG002|Received Intervention|Overall Study||6||
59894150|NCT03419364|76016553|FG000|COMPLETED|Overall Study||9||
59894151|NCT03419364|76016554|FG001|COMPLETED|Overall Study||6||
59894152|NCT03419364|76016555|FG002|COMPLETED|Overall Study||6||
59894153|NCT03419364|76016553|FG000|NOT COMPLETED|Overall Study||2||
59894154|NCT03419364|76016554|FG001|NOT COMPLETED|Overall Study||0||
59894155|NCT03419364|76016555|FG002|NOT COMPLETED|Overall Study||0||
59894156|NCT02954172|76016565|FG000|STARTED|Overall Study||226||
59894157|NCT02954172|76016566|FG001|STARTED|Overall Study||224||
59894158|NCT02954172|76016565|FG000|COMPLETED|Overall Study||220||
59894159|NCT02954172|76016566|FG001|COMPLETED|Overall Study||221||
59894160|NCT02954172|76016565|FG000|NOT COMPLETED|Overall Study||6||
59894161|NCT02954172|76016566|FG001|NOT COMPLETED|Overall Study||3||
59894162|NCT02953938|76016575|FG000|STARTED|Overall Study||29||
59894163|NCT02953938|76016576|FG001|STARTED|Overall Study||30||
59894164|NCT02953938|76016575|FG000|COMPLETED|Overall Study||28|Completed Study Prior to 12 Months|
59894165|NCT02953938|76016576|FG001|COMPLETED|Overall Study||28|Completed Study Prior to 12 Months|
59894166|NCT02953938|76016575|FG000|NOT COMPLETED|Overall Study||1||
59894167|NCT02953938|76016576|FG001|NOT COMPLETED|Overall Study||2||
59894168|NCT03758443|76016587|FG000|STARTED|Induction Period||61||
59894169|NCT03758443|76016588|FG001|STARTED|Induction Period||61||
59894170|NCT03758443|76016589|FG002|STARTED|Induction Period||59||
59894171|NCT03758443|76016590|FG003|STARTED|Induction Period||58||
59894172|NCT03758443|76016587|FG000|COMPLETED|Induction Period||55||
59894173|NCT03758443|76016588|FG001|COMPLETED|Induction Period||54||
59894174|NCT03758443|76016589|FG002|COMPLETED|Induction Period||52||
59894175|NCT03758443|76016590|FG003|COMPLETED|Induction Period||50||
59894176|NCT03758443|76016587|FG000|NOT COMPLETED|Induction Period||6||
59894177|NCT03758443|76016588|FG001|NOT COMPLETED|Induction Period||7||
59894178|NCT03758443|76016589|FG002|NOT COMPLETED|Induction Period||7||
59894179|NCT03758443|76016590|FG003|NOT COMPLETED|Induction Period||8||
59894180|NCT03758443|76016587|FG000|STARTED|Extended Induction Period|Included only participants who did not achieve clinical response at Week 8.|42||
59894181|NCT03758443|76016588|FG001|STARTED|Extended Induction Period|Included only participants who did not achieve clinical response at Week 8.|32||
59894182|NCT03758443|76016589|FG002|STARTED|Extended Induction Period|Included only participants who did not achieve clinical response at Week 8.|32||
59894183|NCT03758443|76016590|FG003|STARTED|Extended Induction Period|Included only participants who did not achieve clinical response at Week 8.|29||
59894184|NCT03758443|76016587|FG000|COMPLETED|Extended Induction Period||29||
59894185|NCT03758443|76016588|FG001|COMPLETED|Extended Induction Period||29||
59894186|NCT03758443|76016589|FG002|COMPLETED|Extended Induction Period||23||
59894187|NCT03758443|76016590|FG003|COMPLETED|Extended Induction Period||22||
59894188|NCT03758443|76016587|FG000|NOT COMPLETED|Extended Induction Period||13||
59894189|NCT03758443|76016588|FG001|NOT COMPLETED|Extended Induction Period||3||
59894190|NCT03758443|76016589|FG002|NOT COMPLETED|Extended Induction Period||9||
59894191|NCT03758443|76016590|FG003|NOT COMPLETED|Extended Induction Period||7||
59894192|NCT03758443|76016587|FG000|STARTED|Maintenance Period|Included only participants who achieved clinical response at Week 8 or Week 16.|29||
59894193|NCT03758443|76016588|FG001|STARTED|Maintenance Period|Included only participants who achieved clinical response at Week 8 or Week 16.|31||
59894194|NCT03758443|76016589|FG002|STARTED|Maintenance Period|Included only participants who achieved clinical response at Week 8 or Week 16.|25||
59894195|NCT03758443|76016590|FG003|STARTED|Maintenance Period|Included only participants who achieved clinical response at Week 8 or Week 16.|22||
59894196|NCT03758443|76016587|FG000|COMPLETED|Maintenance Period||13||
59894197|NCT03758443|76016588|FG001|COMPLETED|Maintenance Period||11||
59894198|NCT03758443|76016589|FG002|COMPLETED|Maintenance Period||12||
59894199|NCT03758443|76016590|FG003|COMPLETED|Maintenance Period||9||
59894200|NCT03758443|76016587|FG000|NOT COMPLETED|Maintenance Period||16||
59894201|NCT03758443|76016588|FG001|NOT COMPLETED|Maintenance Period||20||
59894202|NCT03758443|76016589|FG002|NOT COMPLETED|Maintenance Period||13||
59894203|NCT03758443|76016590|FG003|NOT COMPLETED|Maintenance Period||13||
59894204|NCT03442764|76016612|FG000|STARTED|Overall Study||19||
59894205|NCT03442764|76016613|FG001|STARTED|Overall Study||21||
59894206|NCT03442764|76016614|FG002|STARTED|Overall Study||19||
59894207|NCT03442764|76016612|FG000|COMPLETED|Overall Study||18||
59894208|NCT03442764|76016613|FG001|COMPLETED|Overall Study||21||
59894209|NCT03442764|76016614|FG002|COMPLETED|Overall Study||19||
59894210|NCT03442764|76016612|FG000|NOT COMPLETED|Overall Study||1||
59894211|NCT03442764|76016613|FG001|NOT COMPLETED|Overall Study||0||
59894212|NCT03442764|76016614|FG002|NOT COMPLETED|Overall Study||0||
59894213|NCT03442296|76016625|FG000|STARTED|3 Month Follow-up||78||
59894214|NCT03442296|76016626|FG001|STARTED|3 Month Follow-up||73||
59894215|NCT03442296|76016625|FG000|COMPLETED|3 Month Follow-up||73||
59894216|NCT03442296|76016626|FG001|COMPLETED|3 Month Follow-up||70||
59894217|NCT03442296|76016625|FG000|NOT COMPLETED|3 Month Follow-up||5||
59894218|NCT03442296|76016626|FG001|NOT COMPLETED|3 Month Follow-up||3||
59894219|NCT03442296|76016625|FG000|STARTED|12 Month Follow-up|15 participants in the immediate group did not start the 12month visit due to: death unrelated to study (3), loss to follow up (8), or withdrew consent (4)|58||
59894220|NCT03442296|76016626|FG001|STARTED|12 Month Follow-up|18 participants in the delayed group did not start the 12month visit due to: death unrelated to study (3), loss to follow up (5), or withdrew consent (10)|52||
59894221|NCT03442296|76016625|FG000|COMPLETED|12 Month Follow-up||57||
59894222|NCT03442296|76016626|FG001|COMPLETED|12 Month Follow-up||51||
59894223|NCT03442296|76016625|FG000|NOT COMPLETED|12 Month Follow-up||1||
59894224|NCT03442296|76016626|FG001|NOT COMPLETED|12 Month Follow-up||1||
59894225|NCT03441984|76016634|FG000|STARTED|Part 1: Period 1 (Up to Day 4)||3||
59894226|NCT03441984|76016635|FG001|STARTED|Part 1: Period 1 (Up to Day 4)||3||
59894227|NCT03441984|76016636|FG002|STARTED|Part 1: Period 1 (Up to Day 4)||3||
59894228|NCT03441984|76016637|FG003|STARTED|Part 1: Period 1 (Up to Day 4)||3||
59894229|NCT03441984|76016638|FG004|STARTED|Part 1: Period 1 (Up to Day 4)||3||
59894230|NCT03441984|76016639|FG005|STARTED|Part 1: Period 1 (Up to Day 4)||3||
59894231|NCT03441984|76016640|FG006|STARTED|Part 1: Period 1 (Up to Day 4)||0||
59894232|NCT03441984|76016641|FG007|STARTED|Part 1: Period 1 (Up to Day 4)||0||
59894233|NCT03441984|76016642|FG008|STARTED|Part 1: Period 1 (Up to Day 4)||0||
59894234|NCT03441984|76016643|FG009|STARTED|Part 1: Period 1 (Up to Day 4)||0||
59894235|NCT03441984|76016644|FG010|STARTED|Part 1: Period 1 (Up to Day 4)||0||
59894236|NCT03441984|76016645|FG011|STARTED|Part 1: Period 1 (Up to Day 4)||0||
59894237|NCT03441984|76016634|FG000|COMPLETED|Part 1: Period 1 (Up to Day 4)||3||
59894238|NCT03441984|76016635|FG001|COMPLETED|Part 1: Period 1 (Up to Day 4)||3||
59894239|NCT03441984|76016636|FG002|COMPLETED|Part 1: Period 1 (Up to Day 4)||3||
59894240|NCT03441984|76016637|FG003|COMPLETED|Part 1: Period 1 (Up to Day 4)||3||
59894241|NCT03441984|76016638|FG004|COMPLETED|Part 1: Period 1 (Up to Day 4)||3||
59894242|NCT03441984|76016639|FG005|COMPLETED|Part 1: Period 1 (Up to Day 4)||3||
59894243|NCT03441984|76016640|FG006|COMPLETED|Part 1: Period 1 (Up to Day 4)||0||
59894244|NCT03441984|76016641|FG007|COMPLETED|Part 1: Period 1 (Up to Day 4)||0||
59894245|NCT03441984|76016642|FG008|COMPLETED|Part 1: Period 1 (Up to Day 4)||0||
59894246|NCT03441984|76016643|FG009|COMPLETED|Part 1: Period 1 (Up to Day 4)||0||
59894247|NCT03441984|76016644|FG010|COMPLETED|Part 1: Period 1 (Up to Day 4)||0||
59894248|NCT03441984|76016645|FG011|COMPLETED|Part 1: Period 1 (Up to Day 4)||0||
59894249|NCT03441984|76016634|FG000|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0||
59894250|NCT03441984|76016635|FG001|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0||
59894251|NCT03441984|76016636|FG002|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0||
59894252|NCT03441984|76016637|FG003|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0||
59894253|NCT03441984|76016638|FG004|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0||
59894254|NCT03441984|76016639|FG005|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0||
59894255|NCT03441984|76016640|FG006|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0||
59894256|NCT03441984|76016641|FG007|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0||
59894257|NCT03441984|76016642|FG008|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0||
59894258|NCT03441984|76016643|FG009|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0||
59894259|NCT03441984|76016644|FG010|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0||
59894260|NCT03441984|76016645|FG011|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0||
59894261|NCT03441984|76016634|FG000|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||3||
59894262|NCT03441984|76016635|FG001|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||3||
59894263|NCT03441984|76016636|FG002|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||3||
59894264|NCT03441984|76016637|FG003|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||3||
59894265|NCT03441984|76016638|FG004|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||3||
59894266|NCT03441984|76016639|FG005|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||3||
59894267|NCT03441984|76016640|FG006|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||0||
59894268|NCT03441984|76016641|FG007|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||0||
59894269|NCT03441984|76016642|FG008|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||0||
59894270|NCT03441984|76016643|FG009|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||0||
59894271|NCT03441984|76016644|FG010|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||0||
59894272|NCT03441984|76016645|FG011|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||0||
59894273|NCT03441984|76016634|FG000|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||3||
59894274|NCT03441984|76016635|FG001|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||3||
59894275|NCT03441984|76016636|FG002|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||3||
59894276|NCT03441984|76016637|FG003|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||3||
59894277|NCT03441984|76016638|FG004|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||3||
59894278|NCT03441984|76016639|FG005|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||3||
59894279|NCT03441984|76016640|FG006|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0||
59894280|NCT03441984|76016641|FG007|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0||
59894281|NCT03441984|76016642|FG008|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0||
59894282|NCT03441984|76016643|FG009|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0||
59894283|NCT03441984|76016644|FG010|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0||
59894284|NCT03441984|76016645|FG011|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0||
59894285|NCT03441984|76016634|FG000|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0||
59894286|NCT03441984|76016635|FG001|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0||
59894287|NCT03441984|76016636|FG002|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0||
59894288|NCT03441984|76016637|FG003|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0||
59894289|NCT03441984|76016638|FG004|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0||
59894290|NCT03441984|76016639|FG005|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0||
59894291|NCT03441984|76016640|FG006|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0||
59894292|NCT03441984|76016641|FG007|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0||
59894293|NCT03441984|76016642|FG008|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0||
59894294|NCT03441984|76016643|FG009|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0||
59894295|NCT03441984|76016644|FG010|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0||
59894296|NCT03441984|76016645|FG011|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0||
59894297|NCT03441984|76016634|FG000|STARTED|Part 1: Period 2 (Up to Day 4 )||3||
59894298|NCT03441984|76016635|FG001|STARTED|Part 1: Period 2 (Up to Day 4 )||3||
59894299|NCT03441984|76016636|FG002|STARTED|Part 1: Period 2 (Up to Day 4 )||3||
59894300|NCT03441984|76016637|FG003|STARTED|Part 1: Period 2 (Up to Day 4 )||3||
59894301|NCT03441984|76016638|FG004|STARTED|Part 1: Period 2 (Up to Day 4 )||3||
59894302|NCT03441984|76016639|FG005|STARTED|Part 1: Period 2 (Up to Day 4 )||3||
59894303|NCT03441984|76016640|FG006|STARTED|Part 1: Period 2 (Up to Day 4 )||0||
59894304|NCT03441984|76016641|FG007|STARTED|Part 1: Period 2 (Up to Day 4 )||0||
59894305|NCT03441984|76016642|FG008|STARTED|Part 1: Period 2 (Up to Day 4 )||0||
59894306|NCT03441984|76016643|FG009|STARTED|Part 1: Period 2 (Up to Day 4 )||0||
59894307|NCT03441984|76016644|FG010|STARTED|Part 1: Period 2 (Up to Day 4 )||0||
59894308|NCT03441984|76016645|FG011|STARTED|Part 1: Period 2 (Up to Day 4 )||0||
59894309|NCT03441984|76016634|FG000|COMPLETED|Part 1: Period 2 (Up to Day 4 )||3||
59894310|NCT03441984|76016635|FG001|COMPLETED|Part 1: Period 2 (Up to Day 4 )||3||
59894311|NCT03441984|76016636|FG002|COMPLETED|Part 1: Period 2 (Up to Day 4 )||2||
59894312|NCT03441984|76016637|FG003|COMPLETED|Part 1: Period 2 (Up to Day 4 )||3||
59894313|NCT03441984|76016638|FG004|COMPLETED|Part 1: Period 2 (Up to Day 4 )||3||
59894314|NCT03441984|76016639|FG005|COMPLETED|Part 1: Period 2 (Up to Day 4 )||3||
59894315|NCT03441984|76016640|FG006|COMPLETED|Part 1: Period 2 (Up to Day 4 )||0||
59894316|NCT03441984|76016641|FG007|COMPLETED|Part 1: Period 2 (Up to Day 4 )||0||
59894317|NCT03441984|76016642|FG008|COMPLETED|Part 1: Period 2 (Up to Day 4 )||0||
59894318|NCT03441984|76016643|FG009|COMPLETED|Part 1: Period 2 (Up to Day 4 )||0||
59894319|NCT03441984|76016644|FG010|COMPLETED|Part 1: Period 2 (Up to Day 4 )||0||
59894320|NCT03441984|76016645|FG011|COMPLETED|Part 1: Period 2 (Up to Day 4 )||0||
59894321|NCT03441984|76016634|FG000|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0||
59894322|NCT03441984|76016635|FG001|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0||
59894323|NCT03441984|76016636|FG002|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||1||
59894324|NCT03441984|76016637|FG003|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0||
59894325|NCT03441984|76016638|FG004|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0||
59894326|NCT03441984|76016639|FG005|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0||
59894327|NCT03441984|76016640|FG006|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0||
59894328|NCT03441984|76016641|FG007|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0||
59894329|NCT03441984|76016642|FG008|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0||
59894330|NCT03441984|76016643|FG009|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0||
59894331|NCT03441984|76016644|FG010|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0||
59894332|NCT03441984|76016645|FG011|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0||
59894333|NCT03441984|76016634|FG000|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||3||
59894334|NCT03441984|76016635|FG001|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||3||
59894335|NCT03441984|76016636|FG002|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||2||
59894336|NCT03441984|76016637|FG003|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||3||
59894337|NCT03441984|76016638|FG004|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||3||
59894338|NCT03441984|76016639|FG005|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||3||
59894339|NCT03441984|76016640|FG006|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||0||
59894340|NCT03441984|76016641|FG007|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||0||
59894341|NCT03441984|76016642|FG008|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||0||
59894342|NCT03441984|76016643|FG009|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||0||
59894343|NCT03441984|76016644|FG010|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||0||
59894344|NCT03441984|76016645|FG011|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||0||
59894345|NCT03441984|76016634|FG000|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||3||
59894346|NCT03441984|76016635|FG001|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||3||
59894347|NCT03441984|76016636|FG002|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||2||
59894348|NCT03441984|76016637|FG003|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||3||
59894349|NCT03441984|76016638|FG004|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||3||
59894350|NCT03441984|76016639|FG005|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||3||
59894351|NCT03441984|76016640|FG006|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0||
59894352|NCT03441984|76016641|FG007|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0||
59894353|NCT03441984|76016642|FG008|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0||
59894354|NCT03441984|76016643|FG009|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0||
59894355|NCT03441984|76016644|FG010|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0||
59894356|NCT03441984|76016645|FG011|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0||
59894357|NCT03441984|76016634|FG000|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0||
59894358|NCT03441984|76016635|FG001|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0||
59894359|NCT03441984|76016636|FG002|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0||
59894360|NCT03441984|76016637|FG003|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0||
59894361|NCT03441984|76016638|FG004|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0||
59894362|NCT03441984|76016639|FG005|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0||
59894363|NCT03441984|76016640|FG006|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0||
59894364|NCT03441984|76016641|FG007|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0||
59894365|NCT03441984|76016642|FG008|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0||
59894366|NCT03441984|76016643|FG009|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0||
59894367|NCT03441984|76016644|FG010|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0||
59894368|NCT03441984|76016645|FG011|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0||
59894369|NCT03441984|76016634|FG000|STARTED|Part 1: Period 3 (Up to Day 4 )||3||
59894370|NCT03441984|76016635|FG001|STARTED|Part 1: Period 3 (Up to Day 4 )||3||
59894371|NCT03441984|76016636|FG002|STARTED|Part 1: Period 3 (Up to Day 4 )||2||
59894372|NCT03441984|76016637|FG003|STARTED|Part 1: Period 3 (Up to Day 4 )||3||
59894373|NCT03441984|76016638|FG004|STARTED|Part 1: Period 3 (Up to Day 4 )||3||
59894374|NCT03441984|76016639|FG005|STARTED|Part 1: Period 3 (Up to Day 4 )||3||
59894375|NCT03441984|76016640|FG006|STARTED|Part 1: Period 3 (Up to Day 4 )||0||
59894376|NCT03441984|76016641|FG007|STARTED|Part 1: Period 3 (Up to Day 4 )||0||
59894377|NCT03441984|76016642|FG008|STARTED|Part 1: Period 3 (Up to Day 4 )||0||
59894378|NCT03441984|76016643|FG009|STARTED|Part 1: Period 3 (Up to Day 4 )||0||
59505681|NCT03802825|75598540|FG000|COMPLETED|Overall Study||42||
59505682|NCT03802825|75598541|FG001|COMPLETED|Overall Study||40||
59894379|NCT03441984|76016644|FG010|STARTED|Part 1: Period 3 (Up to Day 4 )||0||
59894380|NCT03441984|76016645|FG011|STARTED|Part 1: Period 3 (Up to Day 4 )||0||
59894381|NCT03441984|76016634|FG000|COMPLETED|Part 1: Period 3 (Up to Day 4 )||3||
59894382|NCT03441984|76016635|FG001|COMPLETED|Part 1: Period 3 (Up to Day 4 )||3||
59894383|NCT03441984|76016636|FG002|COMPLETED|Part 1: Period 3 (Up to Day 4 )||2||
59894384|NCT03441984|76016637|FG003|COMPLETED|Part 1: Period 3 (Up to Day 4 )||3||
59894385|NCT03441984|76016638|FG004|COMPLETED|Part 1: Period 3 (Up to Day 4 )||3||
59894386|NCT03441984|76016639|FG005|COMPLETED|Part 1: Period 3 (Up to Day 4 )||3||
59894387|NCT03441984|76016640|FG006|COMPLETED|Part 1: Period 3 (Up to Day 4 )||0||
59505683|NCT03802825|75598540|FG000|NOT COMPLETED|Overall Study||12||
59894388|NCT03441984|76016641|FG007|COMPLETED|Part 1: Period 3 (Up to Day 4 )||0||
59894389|NCT03441984|76016642|FG008|COMPLETED|Part 1: Period 3 (Up to Day 4 )||0||
59894390|NCT03441984|76016643|FG009|COMPLETED|Part 1: Period 3 (Up to Day 4 )||0||
59894391|NCT03441984|76016644|FG010|COMPLETED|Part 1: Period 3 (Up to Day 4 )||0||
59894392|NCT03441984|76016645|FG011|COMPLETED|Part 1: Period 3 (Up to Day 4 )||0||
59894393|NCT03441984|76016634|FG000|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0||
59894394|NCT03441984|76016635|FG001|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0||
59894395|NCT03441984|76016636|FG002|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0||
59894396|NCT03441984|76016637|FG003|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0||
59505684|NCT03802825|75598541|FG001|NOT COMPLETED|Overall Study||16||
59505685|NCT00738023|75598550|FG000|STARTED|Intralipid Infusion||19||
59505686|NCT00738023|75598551|FG001|STARTED|Intralipid Infusion||13||
59894397|NCT03441984|76016638|FG004|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0||
59894398|NCT03441984|76016639|FG005|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0||
59894399|NCT03441984|76016640|FG006|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0||
59894400|NCT03441984|76016641|FG007|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0||
59894401|NCT03441984|76016642|FG008|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0||
59894402|NCT03441984|76016643|FG009|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0||
59894403|NCT03441984|76016644|FG010|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0||
59894404|NCT03441984|76016645|FG011|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0||
59894405|NCT03441984|76016634|FG000|STARTED|Part 2: Period 1(Up to Day 4)||0||
59894406|NCT03441984|76016635|FG001|STARTED|Part 2: Period 1(Up to Day 4)||0||
59894407|NCT03441984|76016636|FG002|STARTED|Part 2: Period 1(Up to Day 4)||0||
59894408|NCT03441984|76016637|FG003|STARTED|Part 2: Period 1(Up to Day 4)||0||
59894409|NCT03441984|76016638|FG004|STARTED|Part 2: Period 1(Up to Day 4)||0||
59894410|NCT03441984|76016639|FG005|STARTED|Part 2: Period 1(Up to Day 4)||0||
59894411|NCT03441984|76016640|FG006|STARTED|Part 2: Period 1(Up to Day 4)||3||
59894412|NCT03441984|76016641|FG007|STARTED|Part 2: Period 1(Up to Day 4)||3||
59894413|NCT03441984|76016642|FG008|STARTED|Part 2: Period 1(Up to Day 4)||3||
59894414|NCT03441984|76016643|FG009|STARTED|Part 2: Period 1(Up to Day 4)||3||
59894415|NCT03441984|76016644|FG010|STARTED|Part 2: Period 1(Up to Day 4)||3||
59894416|NCT03441984|76016645|FG011|STARTED|Part 2: Period 1(Up to Day 4)||3||
59894417|NCT03441984|76016634|FG000|COMPLETED|Part 2: Period 1(Up to Day 4)||0||
59894418|NCT03441984|76016635|FG001|COMPLETED|Part 2: Period 1(Up to Day 4)||0||
59894419|NCT03441984|76016636|FG002|COMPLETED|Part 2: Period 1(Up to Day 4)||0||
59894420|NCT03441984|76016637|FG003|COMPLETED|Part 2: Period 1(Up to Day 4)||0||
59894421|NCT03441984|76016638|FG004|COMPLETED|Part 2: Period 1(Up to Day 4)||0||
59894422|NCT03441984|76016639|FG005|COMPLETED|Part 2: Period 1(Up to Day 4)||0||
59894423|NCT03441984|76016640|FG006|COMPLETED|Part 2: Period 1(Up to Day 4)||3||
59894424|NCT03441984|76016641|FG007|COMPLETED|Part 2: Period 1(Up to Day 4)||3||
59894425|NCT03441984|76016642|FG008|COMPLETED|Part 2: Period 1(Up to Day 4)||3||
59894426|NCT03441984|76016643|FG009|COMPLETED|Part 2: Period 1(Up to Day 4)||3||
59894427|NCT03441984|76016644|FG010|COMPLETED|Part 2: Period 1(Up to Day 4)||3||
59894428|NCT03441984|76016645|FG011|COMPLETED|Part 2: Period 1(Up to Day 4)||3||
59894429|NCT03441984|76016634|FG000|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0||
59894430|NCT03441984|76016635|FG001|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0||
59894431|NCT03441984|76016636|FG002|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0||
59894432|NCT03441984|76016637|FG003|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0||
59894433|NCT03441984|76016638|FG004|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0||
59894434|NCT03441984|76016639|FG005|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0||
59894435|NCT03441984|76016640|FG006|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0||
59894436|NCT03441984|76016641|FG007|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0||
59894437|NCT03441984|76016642|FG008|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0||
59894438|NCT03441984|76016643|FG009|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0||
59894439|NCT03441984|76016644|FG010|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0||
59894440|NCT03441984|76016645|FG011|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0||
59894441|NCT03441984|76016634|FG000|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||0||
59894442|NCT03441984|76016635|FG001|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||0||
59894443|NCT03441984|76016636|FG002|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||0||
59894444|NCT03441984|76016637|FG003|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||0||
59894445|NCT03441984|76016638|FG004|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||0||
59894446|NCT03441984|76016639|FG005|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||0||
59894447|NCT03441984|76016640|FG006|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||3||
59894448|NCT03441984|76016641|FG007|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||3||
59894449|NCT03441984|76016642|FG008|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||3||
59894450|NCT03441984|76016643|FG009|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||3||
59894451|NCT03441984|76016644|FG010|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||3||
59894452|NCT03441984|76016645|FG011|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||3||
59894453|NCT03441984|76016634|FG000|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0||
59894454|NCT03441984|76016635|FG001|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0||
59894455|NCT03441984|76016636|FG002|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0||
59894456|NCT03441984|76016637|FG003|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0||
59894457|NCT03441984|76016638|FG004|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0||
59894458|NCT03441984|76016639|FG005|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0||
59894459|NCT03441984|76016640|FG006|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||3||
59894460|NCT03441984|76016641|FG007|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||3||
59894461|NCT03441984|76016642|FG008|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||3||
59894462|NCT03441984|76016643|FG009|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||3||
59894463|NCT03441984|76016644|FG010|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||3||
59894464|NCT03441984|76016645|FG011|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||3||
59894465|NCT03441984|76016634|FG000|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0||
59894466|NCT03441984|76016635|FG001|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0||
59894467|NCT03441984|76016636|FG002|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0||
59894468|NCT03441984|76016637|FG003|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0||
59894469|NCT03441984|76016638|FG004|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0||
59894470|NCT03441984|76016639|FG005|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0||
59894471|NCT03441984|76016640|FG006|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0||
59894472|NCT03441984|76016641|FG007|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0||
59894473|NCT03441984|76016642|FG008|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0||
59894474|NCT03441984|76016643|FG009|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0||
59894475|NCT03441984|76016644|FG010|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0||
59894476|NCT03441984|76016645|FG011|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0||
59894477|NCT03441984|76016634|FG000|STARTED|Part 2: Period 2 (Up to Day 4)||0||
59894478|NCT03441984|76016635|FG001|STARTED|Part 2: Period 2 (Up to Day 4)||0||
59894479|NCT03441984|76016636|FG002|STARTED|Part 2: Period 2 (Up to Day 4)||0||
59894480|NCT03441984|76016637|FG003|STARTED|Part 2: Period 2 (Up to Day 4)||0||
59894481|NCT03441984|76016638|FG004|STARTED|Part 2: Period 2 (Up to Day 4)||0||
59894482|NCT03441984|76016639|FG005|STARTED|Part 2: Period 2 (Up to Day 4)||0||
59894483|NCT03441984|76016640|FG006|STARTED|Part 2: Period 2 (Up to Day 4)||3||
59894484|NCT03441984|76016641|FG007|STARTED|Part 2: Period 2 (Up to Day 4)||3||
59894485|NCT03441984|76016642|FG008|STARTED|Part 2: Period 2 (Up to Day 4)||3||
59894486|NCT03441984|76016643|FG009|STARTED|Part 2: Period 2 (Up to Day 4)||3||
59894487|NCT03441984|76016644|FG010|STARTED|Part 2: Period 2 (Up to Day 4)||3||
59894488|NCT03441984|76016645|FG011|STARTED|Part 2: Period 2 (Up to Day 4)||3||
59894489|NCT03441984|76016634|FG000|COMPLETED|Part 2: Period 2 (Up to Day 4)||0||
59894490|NCT03441984|76016635|FG001|COMPLETED|Part 2: Period 2 (Up to Day 4)||0||
59894491|NCT03441984|76016636|FG002|COMPLETED|Part 2: Period 2 (Up to Day 4)||0||
59894492|NCT03441984|76016637|FG003|COMPLETED|Part 2: Period 2 (Up to Day 4)||0||
59894493|NCT03441984|76016638|FG004|COMPLETED|Part 2: Period 2 (Up to Day 4)||0||
59894494|NCT03441984|76016639|FG005|COMPLETED|Part 2: Period 2 (Up to Day 4)||0||
59894495|NCT03441984|76016640|FG006|COMPLETED|Part 2: Period 2 (Up to Day 4)||3||
59894496|NCT03441984|76016641|FG007|COMPLETED|Part 2: Period 2 (Up to Day 4)||3||
59894497|NCT03441984|76016642|FG008|COMPLETED|Part 2: Period 2 (Up to Day 4)||3||
59894498|NCT03441984|76016643|FG009|COMPLETED|Part 2: Period 2 (Up to Day 4)||3||
59894499|NCT03441984|76016644|FG010|COMPLETED|Part 2: Period 2 (Up to Day 4)||3||
59894500|NCT03441984|76016645|FG011|COMPLETED|Part 2: Period 2 (Up to Day 4)||3||
59894501|NCT03441984|76016634|FG000|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0||
59894502|NCT03441984|76016635|FG001|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0||
59894503|NCT03441984|76016636|FG002|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0||
59894504|NCT03441984|76016637|FG003|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0||
59894505|NCT03441984|76016638|FG004|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0||
59894506|NCT03441984|76016639|FG005|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0||
59894507|NCT03441984|76016640|FG006|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0||
59894508|NCT03441984|76016641|FG007|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0||
59894509|NCT03441984|76016642|FG008|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0||
59894510|NCT03441984|76016643|FG009|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0||
59894511|NCT03441984|76016644|FG010|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0||
59894512|NCT03441984|76016645|FG011|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0||
59894513|NCT03441984|76016634|FG000|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||0||
59894514|NCT03441984|76016635|FG001|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||0||
59894515|NCT03441984|76016636|FG002|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||0||
59894516|NCT03441984|76016637|FG003|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||0||
59894517|NCT03441984|76016638|FG004|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||0||
59894518|NCT03441984|76016639|FG005|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||0||
59894519|NCT03441984|76016640|FG006|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||3||
59894520|NCT03441984|76016641|FG007|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||3||
59894521|NCT03441984|76016642|FG008|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||3||
59894522|NCT03441984|76016643|FG009|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||3||
59894523|NCT03441984|76016644|FG010|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||3||
59894524|NCT03441984|76016645|FG011|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||3||
59894525|NCT03441984|76016634|FG000|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0||
59894526|NCT03441984|76016635|FG001|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0||
59894527|NCT03441984|76016636|FG002|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0||
59894528|NCT03441984|76016637|FG003|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0||
59894529|NCT03441984|76016638|FG004|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0||
59894530|NCT03441984|76016639|FG005|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0||
59894531|NCT03441984|76016640|FG006|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||3||
59894532|NCT03441984|76016641|FG007|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||3||
59894533|NCT03441984|76016642|FG008|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||3||
59894534|NCT03441984|76016643|FG009|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||3||
59894535|NCT03441984|76016644|FG010|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||3||
59894536|NCT03441984|76016645|FG011|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||3||
59894537|NCT03441984|76016634|FG000|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0||
59894538|NCT03441984|76016635|FG001|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0||
59894539|NCT03441984|76016636|FG002|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0||
59894540|NCT03441984|76016637|FG003|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0||
59894541|NCT03441984|76016638|FG004|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0||
59894542|NCT03441984|76016639|FG005|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0||
59894543|NCT03441984|76016640|FG006|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0||
59894544|NCT03441984|76016641|FG007|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0||
59894545|NCT03441984|76016642|FG008|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0||
59894546|NCT03441984|76016643|FG009|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0||
59951259|NCT03743415|76070180|FG005|NOT COMPLETED|Overall Study||2||
59757152|NCT00940823|75876186|FG000|COMPLETED|Overall Study||89||
59757153|NCT00940823|75876187|FG001|COMPLETED|Overall Study||82||
59757154|NCT00940823|75876186|FG000|NOT COMPLETED|Overall Study||35||
59757155|NCT00940823|75876187|FG001|NOT COMPLETED|Overall Study||32||
59757156|NCT00936611|75876195|FG000|STARTED|Overall Study||39||
59757157|NCT00936611|75876195|FG000|Treated|Overall Study||36|3 patients deemed ineligible|
59757158|NCT00936611|75876195|FG000|Starting Dose Reduction: 30 mg to 25 mg|Overall Study||12|Protocol Amendment 6/15/2010. Study drug starting dose reduced.|
59757159|NCT00936611|75876195|FG000|COMPLETED|Overall Study||0|Since treatment was not of fixed duration, all participants were considered as 'Not Completed' and reason off-treatment is provided.|
59757160|NCT00936611|75876195|FG000|NOT COMPLETED|Overall Study||39||
59757161|NCT03123822|75876202|FG000|STARTED|Overall Study||1||
59757162|NCT03123822|75876203|FG001|STARTED|Overall Study||1||
59757163|NCT03123822|75876204|FG002|STARTED|Overall Study||3||
59757164|NCT03123822|75876202|FG000|COMPLETED|Overall Study||1||
59757165|NCT03123822|75876203|FG001|COMPLETED|Overall Study||1||
59757166|NCT03123822|75876204|FG002|COMPLETED|Overall Study||3||
59757167|NCT03123822|75876202|FG000|NOT COMPLETED|Overall Study||0||
59757168|NCT03123822|75876203|FG001|NOT COMPLETED|Overall Study||0||
59757169|NCT03123822|75876204|FG002|NOT COMPLETED|Overall Study||0||
59757170|NCT02920476|75876212|FG000|STARTED|Overall Study||4||
59757171|NCT02920476|75876212|FG000|COMPLETED|Overall Study||3||
59757172|NCT02920476|75876212|FG000|NOT COMPLETED|Overall Study||1||
59757173|NCT00936221|75876218|FG000|STARTED|Overall Study||45||
59757174|NCT00936221|75876219|FG001|STARTED|Overall Study||46||
59757175|NCT00936221|75876218|FG000|Received Treatment|Overall Study||44||
59757176|NCT00936221|75876219|FG001|Received Treatment|Overall Study||45||
59757177|NCT00936221|75876218|FG000|COMPLETED|Overall Study|13 patients ongoing cutoff + 31 patients who had died.|44||
59757178|NCT00936221|75876219|FG001|COMPLETED|Overall Study|10 patients ongoing at data cutoff + 35 patients who had died.|45||
59757179|NCT00936221|75876218|FG000|NOT COMPLETED|Overall Study||1||
59757180|NCT00936221|75876219|FG001|NOT COMPLETED|Overall Study||1||
59757181|NCT00776919|75876229|FG000|STARTED|Overall Study||327||
59757182|NCT00776919|75876230|FG001|STARTED|Overall Study||328||
59757183|NCT00776919|75876231|FG002|STARTED|Overall Study||328||
59757184|NCT00776919|75876232|FG003|STARTED|Overall Study||332||
59757185|NCT00776919|75876229|FG000|COMPLETED|Overall Study||300||
59757186|NCT00776919|75876230|FG001|COMPLETED|Overall Study||295||
59757187|NCT00776919|75876231|FG002|COMPLETED|Overall Study||296||
59757188|NCT00776919|75876232|FG003|COMPLETED|Overall Study||293||
59757189|NCT00776919|75876229|FG000|NOT COMPLETED|Overall Study||27||
59757190|NCT00776919|75876230|FG001|NOT COMPLETED|Overall Study||33||
59757191|NCT00776919|75876231|FG002|NOT COMPLETED|Overall Study||32||
59757192|NCT00776919|75876232|FG003|NOT COMPLETED|Overall Study||39||
59757193|NCT00247728|75876245|FG000|STARTED|Overall Study||58||
59757194|NCT00247728|75876246|FG001|STARTED|Overall Study||57||
59757195|NCT00247728|75876247|FG002|STARTED|Overall Study||57||
59757196|NCT00247728|75876245|FG000|COMPLETED|Overall Study||55||
59757197|NCT00247728|75876246|FG001|COMPLETED|Overall Study||51||
59757198|NCT00247728|75876247|FG002|COMPLETED|Overall Study||43||
59757199|NCT00247728|75876245|FG000|NOT COMPLETED|Overall Study||3||
59757200|NCT00247728|75876246|FG001|NOT COMPLETED|Overall Study||6||
59757201|NCT00247728|75876247|FG002|NOT COMPLETED|Overall Study||14||
59757202|NCT00775983|75876259|FG000|STARTED|Overall Study||36||
59757203|NCT00775983|75876260|FG001|STARTED|Overall Study||36||
59757204|NCT00775983|75876259|FG000|COMPLETED|Overall Study||35||
59757205|NCT00775983|75876260|FG001|COMPLETED|Overall Study||34||
59757206|NCT00775983|75876259|FG000|NOT COMPLETED|Overall Study||1||
59757207|NCT00775983|75876260|FG001|NOT COMPLETED|Overall Study||2||
59757208|NCT00775593|75876266|FG000|STARTED|Overall Study||60||
59757209|NCT00775593|75876266|FG000|COMPLETED|Overall Study||53||
59757210|NCT00775593|75876266|FG000|NOT COMPLETED|Overall Study||7||
59757211|NCT00939809|75876270|FG000|STARTED|Overall Study||31||
59757212|NCT00939809|75876270|FG000|COMPLETED|Overall Study|Patients treated until disease progression; completed defined as off treatment due to progression.|28||
59757213|NCT00939809|75876270|FG000|NOT COMPLETED|Overall Study||3||
59757214|NCT00934661|75876276|FG000|STARTED|Overall Study||20||
59757215|NCT00934661|75876277|FG001|STARTED|Overall Study||20||
59757216|NCT00934661|75876276|FG000|COMPLETED|Overall Study||19||
59757217|NCT00934661|75876277|FG001|COMPLETED|Overall Study||20||
59757218|NCT00934661|75876276|FG000|NOT COMPLETED|Overall Study||1||
59757219|NCT00934661|75876277|FG001|NOT COMPLETED|Overall Study||0||
59894547|NCT03441984|76016644|FG010|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0||
59894548|NCT03441984|76016645|FG011|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0||
59894549|NCT03441984|76016634|FG000|STARTED|Part 2: Period 3 (Up to Day 4)||0||
59894550|NCT03441984|76016635|FG001|STARTED|Part 2: Period 3 (Up to Day 4)||0||
59894551|NCT03441984|76016636|FG002|STARTED|Part 2: Period 3 (Up to Day 4)||0||
59894552|NCT03441984|76016637|FG003|STARTED|Part 2: Period 3 (Up to Day 4)||0||
59894553|NCT03441984|76016638|FG004|STARTED|Part 2: Period 3 (Up to Day 4)||0||
59894554|NCT03441984|76016639|FG005|STARTED|Part 2: Period 3 (Up to Day 4)||0||
59894555|NCT03441984|76016640|FG006|STARTED|Part 2: Period 3 (Up to Day 4)||3||
59894556|NCT03441984|76016641|FG007|STARTED|Part 2: Period 3 (Up to Day 4)||3||
59894557|NCT03441984|76016642|FG008|STARTED|Part 2: Period 3 (Up to Day 4)||3||
59894558|NCT03441984|76016643|FG009|STARTED|Part 2: Period 3 (Up to Day 4)||3||
59894559|NCT03441984|76016644|FG010|STARTED|Part 2: Period 3 (Up to Day 4)||3||
59894560|NCT03441984|76016645|FG011|STARTED|Part 2: Period 3 (Up to Day 4)||3||
59894561|NCT03441984|76016634|FG000|COMPLETED|Part 2: Period 3 (Up to Day 4)||0||
59894562|NCT03441984|76016635|FG001|COMPLETED|Part 2: Period 3 (Up to Day 4)||0||
59894563|NCT03441984|76016636|FG002|COMPLETED|Part 2: Period 3 (Up to Day 4)||0||
59894564|NCT03441984|76016637|FG003|COMPLETED|Part 2: Period 3 (Up to Day 4)||0||
59894565|NCT03441984|76016638|FG004|COMPLETED|Part 2: Period 3 (Up to Day 4)||0||
59894566|NCT03441984|76016639|FG005|COMPLETED|Part 2: Period 3 (Up to Day 4)||0||
59894567|NCT03441984|76016640|FG006|COMPLETED|Part 2: Period 3 (Up to Day 4)||3||
59894568|NCT03441984|76016641|FG007|COMPLETED|Part 2: Period 3 (Up to Day 4)||3||
59894569|NCT03441984|76016642|FG008|COMPLETED|Part 2: Period 3 (Up to Day 4)||3||
59894570|NCT03441984|76016643|FG009|COMPLETED|Part 2: Period 3 (Up to Day 4)||3||
59894571|NCT03441984|76016644|FG010|COMPLETED|Part 2: Period 3 (Up to Day 4)||3||
59894572|NCT03441984|76016645|FG011|COMPLETED|Part 2: Period 3 (Up to Day 4)||3||
59894573|NCT03441984|76016634|FG000|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0||
59894574|NCT03441984|76016635|FG001|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0||
59894575|NCT03441984|76016636|FG002|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0||
59894576|NCT03441984|76016637|FG003|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0||
59894577|NCT03441984|76016638|FG004|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0||
59894578|NCT03441984|76016639|FG005|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0||
59894579|NCT03441984|76016640|FG006|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0||
59894580|NCT03441984|76016641|FG007|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0||
59894581|NCT03441984|76016642|FG008|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0||
59894582|NCT03441984|76016643|FG009|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0||
59894583|NCT03441984|76016644|FG010|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0||
59894584|NCT03441984|76016645|FG011|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0||
59894585|NCT03441360|76016663|FG000|STARTED|Overall Study||8||
59894586|NCT03441360|76016664|FG001|STARTED|Overall Study||8||
59894587|NCT03441360|76016665|FG002|STARTED|Overall Study||5||
59894588|NCT03441360|76016663|FG000|COMPLETED|Overall Study||0||
59894589|NCT03441360|76016664|FG001|COMPLETED|Overall Study||0||
59894590|NCT03441360|76016665|FG002|COMPLETED|Overall Study||0||
59894591|NCT03441360|76016663|FG000|NOT COMPLETED|Overall Study||8||
59894592|NCT03441360|76016664|FG001|NOT COMPLETED|Overall Study||8||
59894593|NCT03441360|76016665|FG002|NOT COMPLETED|Overall Study||5||
59894594|NCT01347840|76016673|FG000|STARTED|Overall Study|1 subject enrolled but withdrew consent|1||
59894595|NCT01347840|76016673|FG000|COMPLETED|Overall Study||0||
59894596|NCT01347840|76016673|FG000|NOT COMPLETED|Overall Study||1||
59894597|NCT01347762|76016681|FG000|STARTED|Overall Study||10||
59894598|NCT01347762|76016682|FG001|STARTED|Overall Study||8||
59894599|NCT01347762|76016683|FG002|STARTED|Overall Study||16||
59894600|NCT01347762|76016684|FG003|STARTED|Overall Study||18||
59894601|NCT01347762|76016681|FG000|COMPLETED|Overall Study||6||
59894602|NCT01347762|76016682|FG001|COMPLETED|Overall Study||6||
59894603|NCT01347762|76016683|FG002|COMPLETED|Overall Study||7||
59894604|NCT01347762|76016684|FG003|COMPLETED|Overall Study||10||
59894605|NCT01347762|76016681|FG000|NOT COMPLETED|Overall Study||4||
59894606|NCT01347762|76016682|FG001|NOT COMPLETED|Overall Study||2||
59894607|NCT01347762|76016683|FG002|NOT COMPLETED|Overall Study||9||
59894608|NCT01347762|76016684|FG003|NOT COMPLETED|Overall Study||8||
59894609|NCT03438396|76016694|FG000|STARTED|Overall Study||102||
59894610|NCT03438396|76016694|FG000|Treated|Overall Study||101||
59894611|NCT03438396|76016694|FG000|COMPLETED|Overall Study||0||
59894612|NCT03438396|76016694|FG000|NOT COMPLETED|Overall Study||102||
59894613|NCT00073307|76016700|FG000|STARTED|Double-Blind (DB, as of ~31May2005)||451||
59894614|NCT00073307|76016701|FG001|STARTED|Double-Blind (DB, as of ~31May2005)||452||
59894615|NCT00073307|76016702|FG002|STARTED|Double-Blind (DB, as of ~31May2005)||0||
59894616|NCT00073307|76016700|FG000|Participants Received Treatment|Double-Blind (DB, as of ~31May2005)||451||
59894617|NCT00073307|76016701|FG001|Participants Received Treatment|Double-Blind (DB, as of ~31May2005)||451||
59894618|NCT00073307|76016702|FG002|Participants Received Treatment|Double-Blind (DB, as of ~31May2005)||0||
59894619|NCT00073307|76016700|FG000|COMPLETED|Double-Blind (DB, as of ~31May2005)||254||
59894620|NCT00073307|76016701|FG001|COMPLETED|Double-Blind (DB, as of ~31May2005)||299||
59894621|NCT00073307|76016702|FG002|COMPLETED|Double-Blind (DB, as of ~31May2005)||0||
59894622|NCT00073307|76016700|FG000|NOT COMPLETED|Double-Blind (DB, as of ~31May2005)||197||
59894623|NCT00073307|76016701|FG001|NOT COMPLETED|Double-Blind (DB, as of ~31May2005)||153||
59894624|NCT00073307|76016702|FG002|NOT COMPLETED|Double-Blind (DB, as of ~31May2005)||0||
59894625|NCT00073307|76016700|FG000|STARTED|Open Label-Sorafenib Only [30Jun2008]||254||
59894626|NCT00073307|76016701|FG001|STARTED|Open Label-Sorafenib Only [30Jun2008]|Placebo treatment ended ~ 31May2005. Those who continued, switched to receive Sorafenib.|0||
59894627|NCT00073307|76016702|FG002|STARTED|Open Label-Sorafenib Only [30Jun2008]||299||
59894628|NCT00073307|76016700|FG000|Entered OL With Sorafenib Only Phase|Open Label-Sorafenib Only [30Jun2008]||219||
59894629|NCT00073307|76016701|FG001|Entered OL With Sorafenib Only Phase|Open Label-Sorafenib Only [30Jun2008]||0||
59894630|NCT00073307|76016702|FG002|Entered OL With Sorafenib Only Phase|Open Label-Sorafenib Only [30Jun2008]||216||
59894631|NCT00073307|76016700|FG000|COMPLETED|Open Label-Sorafenib Only [30Jun2008]||120||
59894632|NCT00073307|76016701|FG001|COMPLETED|Open Label-Sorafenib Only [30Jun2008]||0||
59894633|NCT00073307|76016702|FG002|COMPLETED|Open Label-Sorafenib Only [30Jun2008]||143||
59894634|NCT00073307|76016700|FG000|NOT COMPLETED|Open Label-Sorafenib Only [30Jun2008]||134||
59894635|NCT00073307|76016701|FG001|NOT COMPLETED|Open Label-Sorafenib Only [30Jun2008]||0||
59894636|NCT00073307|76016702|FG002|NOT COMPLETED|Open Label-Sorafenib Only [30Jun2008]||156||
59894637|NCT03388164|76016713|FG000|STARTED|Overall Study||10||
59894638|NCT03388164|76016714|FG001|STARTED|Overall Study||10||
59894639|NCT03388164|76016713|FG000|COMPLETED|Overall Study||7||
59894640|NCT03388164|76016714|FG001|COMPLETED|Overall Study||9||
59894641|NCT03388164|76016713|FG000|NOT COMPLETED|Overall Study||3||
59894642|NCT03388164|76016714|FG001|NOT COMPLETED|Overall Study||1||
59894643|NCT03403374|76016720|FG000|STARTED|Overall Study||30||
59894644|NCT03403374|76016720|FG000|COMPLETED|Overall Study||29||
59894645|NCT03403374|76016720|FG000|NOT COMPLETED|Overall Study||1||
59894646|NCT03387462|76016724|FG000|STARTED|Overall Study||20||
59894647|NCT03387462|76016724|FG000|4 Weeks|Overall Study||20||
59894648|NCT03387462|76016724|FG000|8 Weeks|Overall Study||19||
59894649|NCT03387462|76016724|FG000|COMPLETED|Overall Study||19||
59894650|NCT03387462|76016724|FG000|NOT COMPLETED|Overall Study||1||
59894651|NCT03756883|76016731|FG000|STARTED|Overall Study||485||
59894652|NCT03756883|76016732|FG001|STARTED|Overall Study||413||
59894653|NCT03756883|76016733|FG002|STARTED|Overall Study||101||
59894654|NCT03756883|76016731|FG000|COMPLETED|Overall Study||472||
59894655|NCT03756883|76016732|FG001|COMPLETED|Overall Study||402||
59894656|NCT03756883|76016733|FG002|COMPLETED|Overall Study||94||
59894657|NCT03756883|76016731|FG000|NOT COMPLETED|Overall Study||13||
59894658|NCT03756883|76016732|FG001|NOT COMPLETED|Overall Study||11||
59894659|NCT03756883|76016733|FG002|NOT COMPLETED|Overall Study||7||
59894660|NCT03386994|76016744|FG000|STARTED|Overall Study||204|At inclusion visit (T0)|
59894661|NCT03386994|76016744|FG000|COMPLETED|Overall Study||166|At 12 month visit (T12)|
59894662|NCT03386994|76016744|FG000|NOT COMPLETED|Overall Study||38||
59894663|NCT03756571|76016761|FG000|STARTED|Overall Study||10||
59894664|NCT03756571|76016762|FG001|STARTED|Overall Study||11||
59894665|NCT03756571|76016761|FG000|COMPLETED|Overall Study||9||
59894666|NCT03756571|76016762|FG001|COMPLETED|Overall Study||10||
59894667|NCT03756571|76016761|FG000|NOT COMPLETED|Overall Study||1||
59894668|NCT03756571|76016762|FG001|NOT COMPLETED|Overall Study||1||
59894669|NCT03386448|76016770|FG000|STARTED|Overall Study||6||
59894670|NCT03386448|76016771|FG001|STARTED|Overall Study||8||
59894671|NCT03386448|76016770|FG000|COMPLETED|Overall Study||6||
59894672|NCT03386448|76016771|FG001|COMPLETED|Overall Study||6||
59894673|NCT03386448|76016770|FG000|NOT COMPLETED|Overall Study||0||
59894674|NCT03386448|76016771|FG001|NOT COMPLETED|Overall Study||2||
59894675|NCT02951988|76016780|FG000|STARTED|Open-Label Treatment Period||1304||
59894676|NCT02951988|76016781|FG001|STARTED|Open-Label Treatment Period||0||
59894677|NCT02951988|76016782|FG002|STARTED|Open-Label Treatment Period||0||
59894678|NCT02951988|76016783|FG003|STARTED|Open-Label Treatment Period||0||
59894679|NCT02951988|76016780|FG000|COMPLETED|Open-Label Treatment Period||1056||
59894680|NCT02951988|76016781|FG001|COMPLETED|Open-Label Treatment Period||0||
59894681|NCT02951988|76016782|FG002|COMPLETED|Open-Label Treatment Period||0||
59894682|NCT02951988|76016783|FG003|COMPLETED|Open-Label Treatment Period||0||
59894683|NCT02951988|76016780|FG000|NOT COMPLETED|Open-Label Treatment Period||248||
59894684|NCT02951988|76016781|FG001|NOT COMPLETED|Open-Label Treatment Period||0||
59894685|NCT02951988|76016782|FG002|NOT COMPLETED|Open-Label Treatment Period||0||
59894686|NCT02951988|76016783|FG003|NOT COMPLETED|Open-Label Treatment Period||0||
59894687|NCT02951988|76016780|FG000|STARTED|Double-Blind Treatment Period||0||
59894688|NCT02951988|76016781|FG001|STARTED|Double-Blind Treatment Period||202||
59894689|NCT02951988|76016782|FG002|STARTED|Double-Blind Treatment Period||202||
59894690|NCT02951988|76016783|FG003|STARTED|Double-Blind Treatment Period||200||
59894691|NCT02951988|76016780|FG000|COMPLETED|Double-Blind Treatment Period||0||
59894692|NCT02951988|76016781|FG001|COMPLETED|Double-Blind Treatment Period||101||
59894693|NCT02951988|76016782|FG002|COMPLETED|Double-Blind Treatment Period||101||
59894694|NCT02951988|76016783|FG003|COMPLETED|Double-Blind Treatment Period||85||
59894695|NCT02951988|76016780|FG000|NOT COMPLETED|Double-Blind Treatment Period||0||
59894696|NCT02951988|76016781|FG001|NOT COMPLETED|Double-Blind Treatment Period||101||
59894697|NCT02951988|76016782|FG002|NOT COMPLETED|Double-Blind Treatment Period||101||
59894698|NCT02951988|76016783|FG003|NOT COMPLETED|Double-Blind Treatment Period||115||
59894699|NCT00009737|76016795|FG000|STARTED|Overall Study||1004||
59894700|NCT00009737|76016796|FG001|STARTED|Overall Study||983||
59894701|NCT00009737|76016795|FG000|COMPLETED|Overall Study||834||
59894702|NCT00009737|76016796|FG001|COMPLETED|Overall Study||860||
59894703|NCT00009737|76016795|FG000|NOT COMPLETED|Overall Study||170||
59894704|NCT00009737|76016796|FG001|NOT COMPLETED|Overall Study||123||
59894705|NCT03417102|76016804|FG000|STARTED|Overall Study||19||
59894706|NCT03417102|76016805|FG001|STARTED|Overall Study||38||
59894707|NCT03417102|76016804|FG000|Safety Analysis Set|Overall Study||19|Participants received at least 1 dose of study drug or randomized to on-demand arm, analyzed per treatment received.|
59894708|NCT03417102|76016805|FG001|Safety Analysis Set|Overall Study|3 participants were non-randomized but treated with Fitusiran considered in this arm for safety.|41|Participants received at least 1 dose of study drug or randomized to on-demand arm, analyzed per treatment received.|
59894709|NCT03417102|76016804|FG000|COMPLETED|Overall Study||19||
59894710|NCT03417102|76016805|FG001|COMPLETED|Overall Study||33||
59894711|NCT03417102|76016804|FG000|NOT COMPLETED|Overall Study||0||
59894712|NCT03417102|76016805|FG001|NOT COMPLETED|Overall Study||5||
59894713|NCT03417024|76016811|FG000|STARTED|Overall Study||13||
59894714|NCT03417024|76016811|FG000|COMPLETED|Overall Study||0||
59894715|NCT03417024|76016811|FG000|NOT COMPLETED|Overall Study||13||
59894716|NCT00028769|76016815|FG000|STARTED|Overall Study||41||
59894717|NCT00028769|76016815|FG000|Eligible|Overall Study||36||
59894718|NCT00028769|76016815|FG000|Eligible and Began Protocol Therapy|Overall Study|One patient refused all protocol treatment and was not evaluable for the present analysis|35||
59894719|NCT00028769|76016815|FG000|COMPLETED|Overall Study|Patients receive protocol treatments until evidence of disease progression|0||
59894720|NCT00028769|76016815|FG000|NOT COMPLETED|Overall Study||41||
59894721|NCT02953314|76016821|FG000|STARTED|Overall Study||13||
59894722|NCT02953314|76016822|FG001|STARTED|Overall Study||70||
59894723|NCT02953314|76016821|FG000|COMPLETED|Overall Study||13||
59894724|NCT02953314|76016822|FG001|COMPLETED|Overall Study||67||
59894725|NCT02953314|76016821|FG000|NOT COMPLETED|Overall Study||0||
59894726|NCT02953314|76016822|FG001|NOT COMPLETED|Overall Study||3||
59894727|NCT03402750|76016830|FG000|STARTED|Overall Study||20||
59894728|NCT03402750|76016831|FG001|STARTED|Overall Study||20||
59894729|NCT03402750|76016830|FG000|COMPLETED|Overall Study||18||
59894730|NCT03402750|76016831|FG001|COMPLETED|Overall Study||19||
59894731|NCT03402750|76016830|FG000|NOT COMPLETED|Overall Study||2||
59894732|NCT03402750|76016831|FG001|NOT COMPLETED|Overall Study||1||
59894733|NCT00007475|76016840|FG000|STARTED|Overall Study|[ arm reflects un-assayed participants' disposition ]|12||
59894734|NCT00007475|76016841|FG001|STARTED|Overall Study|[ arm reflects eventual participant disposition ]|1||
59894735|NCT00007475|76016842|FG002|STARTED|Overall Study|[ arm reflects eventual participant disposition ]|2||
59894736|NCT00007475|76016843|FG003|STARTED|Overall Study||0||
59894737|NCT00007475|76016840|FG000|FSGS Permeability Factor (FPF) Assayed|Overall Study|FSGS Permeability Factor's provisional assay only applied to minority of early enrollees, by design.|0||
59894738|NCT00007475|76016841|FG001|FSGS Permeability Factor (FPF) Assayed|Overall Study||1||
59894739|NCT00007475|76016842|FG002|FSGS Permeability Factor (FPF) Assayed|Overall Study||2||
59894740|NCT00007475|76016843|FG003|FSGS Permeability Factor (FPF) Assayed|Overall Study||0||
59894741|NCT00007475|76016840|FG000|Initial Transplant|Overall Study||12||
59894742|NCT00007475|76016841|FG001|Initial Transplant|Overall Study||1||
59894743|NCT00007475|76016842|FG002|Initial Transplant|Overall Study||2||
59894744|NCT00007475|76016843|FG003|Initial Transplant|Overall Study||0||
59894745|NCT00007475|76016840|FG000|Post-initial Transplant Proteinuria|Overall Study||12||
59894746|NCT00007475|76016841|FG001|Post-initial Transplant Proteinuria|Overall Study||1||
59894747|NCT00007475|76016842|FG002|Post-initial Transplant Proteinuria|Overall Study||2||
59894748|NCT00007475|76016843|FG003|Post-initial Transplant Proteinuria|Overall Study||0||
59894749|NCT00007475|76016840|FG000|Initial Plasma Exchange|Overall Study||12||
59894750|NCT00007475|76016841|FG001|Initial Plasma Exchange|Overall Study||1||
59894751|NCT00007475|76016842|FG002|Initial Plasma Exchange|Overall Study||2||
59894752|NCT00007475|76016843|FG003|Initial Plasma Exchange|Overall Study||0||
59894753|NCT00007475|76016840|FG000|Initiate Cyclophosphamide|Overall Study||12||
59894754|NCT00007475|76016841|FG001|Initiate Cyclophosphamide|Overall Study||1||
59894755|NCT00007475|76016842|FG002|Initiate Cyclophosphamide|Overall Study||2||
59894756|NCT00007475|76016843|FG003|Initiate Cyclophosphamide|Overall Study||0||
59894757|NCT00007475|76016840|FG000|COMPLETED|Overall Study||8||
59894758|NCT00007475|76016841|FG001|COMPLETED|Overall Study||1||
59894759|NCT00007475|76016842|FG002|COMPLETED|Overall Study||2||
59894760|NCT00007475|76016843|FG003|COMPLETED|Overall Study||0||
59894761|NCT00007475|76016840|FG000|NOT COMPLETED|Overall Study||4||
59894762|NCT00007475|76016841|FG001|NOT COMPLETED|Overall Study||0||
59894763|NCT00007475|76016842|FG002|NOT COMPLETED|Overall Study||0||
59894764|NCT00007475|76016843|FG003|NOT COMPLETED|Overall Study||0||
59894765|NCT00025883|76016855|FG000|STARTED|Overall Study||103||
59894766|NCT00025883|76016855|FG000|Generalized Lipodystrophy|Overall Study||63||
59894767|NCT00025883|76016855|FG000|Partial Lipodystrophy|Overall Study||40||
59894768|NCT00025883|76016855|FG000|COMPLETED|Overall Study||86||
59894769|NCT00025883|76016855|FG000|NOT COMPLETED|Overall Study||17||
59894770|NCT00072293|76016862|FG000|STARTED|Overall Study||465||
59894771|NCT00072293|76016863|FG001|STARTED|Overall Study||469||
59894772|NCT00072293|76016862|FG000|COMPLETED|Overall Study||464||
59894773|NCT00072293|76016863|FG001|COMPLETED|Overall Study||467||
59894774|NCT00072293|76016862|FG000|NOT COMPLETED|Overall Study||1||
59894775|NCT00072293|76016863|FG001|NOT COMPLETED|Overall Study||2||
59894776|NCT03753763|76016871|FG000|STARTED|Overall Study||32||
59894777|NCT03753763|76016872|FG001|STARTED|Overall Study||17||
59894778|NCT03753763|76016871|FG000|COMPLETED|Overall Study||26|Completed the study (at week 14)|
59894779|NCT03753763|76016872|FG001|COMPLETED|Overall Study||16|Completed the study (at week 14)|
59894780|NCT03753763|76016871|FG000|NOT COMPLETED|Overall Study||6||
59894781|NCT03753763|76016872|FG001|NOT COMPLETED|Overall Study||1||
59894782|NCT03384966|76016881|FG000|STARTED|Randomized at End of Screening Period||115||
59894783|NCT03384966|76016882|FG001|STARTED|Randomized at End of Screening Period||115||
59894784|NCT03384966|76016883|FG002|STARTED|Randomized at End of Screening Period||116||
59894785|NCT03384966|76016881|FG000|COMPLETED|Randomized at End of Screening Period||114||
59894786|NCT03384966|76016882|FG001|COMPLETED|Randomized at End of Screening Period||115||
59894787|NCT03384966|76016883|FG002|COMPLETED|Randomized at End of Screening Period||116||
59894788|NCT03384966|76016881|FG000|NOT COMPLETED|Randomized at End of Screening Period||1||
59894789|NCT03384966|76016882|FG001|NOT COMPLETED|Randomized at End of Screening Period||0||
59894790|NCT03384966|76016883|FG002|NOT COMPLETED|Randomized at End of Screening Period||0||
59894791|NCT03384966|76016881|FG000|STARTED|Treatment Period||114||
59894792|NCT03384966|76016882|FG001|STARTED|Treatment Period||115||
59894793|NCT03384966|76016883|FG002|STARTED|Treatment Period||116||
59894794|NCT03384966|76016881|FG000|Thigh Administration|Treatment Period||57||
59894795|NCT03384966|76016882|FG001|Thigh Administration|Treatment Period||57||
59894796|NCT03384966|76016883|FG002|Thigh Administration|Treatment Period||58||
59894797|NCT03384966|76016881|FG000|Abdomen Administration|Treatment Period||57||
59894798|NCT03384966|76016882|FG001|Abdomen Administration|Treatment Period||58||
59894799|NCT03384966|76016883|FG002|Abdomen Administration|Treatment Period||58||
59894800|NCT03384966|76016881|FG000|Per-protocol Analysis Set|Treatment Period||96|The per-protocol set includes all participants who complied with the protocol sufficiently to allow adequate estimation of the treatment effect (including availability of primary pharmacodynamic endpoint assessment and absence of protocol deviations that impact on the treatment effect).|
59894801|NCT03384966|76016882|FG001|Per-protocol Analysis Set|Treatment Period||90|The per-protocol set includes all participants who complied with the protocol sufficiently to allow adequate estimation of the treatment effect (including availability of primary pharmacodynamic endpoint assessment and absence of protocol deviations that impact on the treatment effect).|
59894802|NCT03384966|76016883|FG002|Per-protocol Analysis Set|Treatment Period||93|The per-protocol set includes all participants who complied with the protocol sufficiently to allow adequate estimation of the treatment effect (including availability of primary pharmacodynamic endpoint assessment and absence of protocol deviations that impact on the treatment effect).|
59894803|NCT03384966|76016881|FG000|Safety Analysis Set|Treatment Period||114|The safety analysis set (SAF) includes all participants who received at least one dose of study treatment. Participants were evaluated according to the actual treatment they received.|
59894804|NCT03384966|76016882|FG001|Safety Analysis Set|Treatment Period||115|The safety analysis set (SAF) includes all participants who received at least one dose of study treatment. Participants were evaluated according to the actual treatment they received.|
59894805|NCT03384966|76016883|FG002|Safety Analysis Set|Treatment Period||116|The safety analysis set (SAF) includes all participants who received at least one dose of study treatment. Participants were evaluated according to the actual treatment they received.|
59894806|NCT03384966|76016881|FG000|Pharmacokinetic Analysis Set|Treatment Period||111|The PK analysis set includes all participants from the SAF who have at least one plasma concentration measurement after administration of study treatment. Participants in the PK set were evaluated according to the actual treatment they received.|
59894807|NCT03384966|76016882|FG001|Pharmacokinetic Analysis Set|Treatment Period||115|The PK analysis set includes all participants from the SAF who have at least one plasma concentration measurement after administration of study treatment. Participants in the PK set were evaluated according to the actual treatment they received.|
59951260|NCT03743415|76070181|FG006|NOT COMPLETED|Overall Study||3||
59951261|NCT03743415|76070182|FG007|NOT COMPLETED|Overall Study||9||
59894808|NCT03384966|76016883|FG002|Pharmacokinetic Analysis Set|Treatment Period||0|The PK analysis set includes all participants from the SAF who have at least one plasma concentration measurement after administration of study treatment. Participants in the PK set were evaluated according to the actual treatment they received.|
59894809|NCT03384966|76016881|FG000|COMPLETED|Treatment Period||114||
59894810|NCT03384966|76016882|FG001|COMPLETED|Treatment Period||115||
59894811|NCT03384966|76016883|FG002|COMPLETED|Treatment Period||116||
59894812|NCT03384966|76016881|FG000|NOT COMPLETED|Treatment Period||0||
59894813|NCT03384966|76016882|FG001|NOT COMPLETED|Treatment Period||0||
59894814|NCT03384966|76016883|FG002|NOT COMPLETED|Treatment Period||0||
59894815|NCT03384966|76016881|FG000|STARTED|Follow-up Period||114||
59894816|NCT03384966|76016882|FG001|STARTED|Follow-up Period||115||
59894817|NCT03384966|76016883|FG002|STARTED|Follow-up Period||116||
59894818|NCT03384966|76016881|FG000|COMPLETED|Follow-up Period||113||
59894819|NCT03384966|76016882|FG001|COMPLETED|Follow-up Period||115||
59894820|NCT03384966|76016883|FG002|COMPLETED|Follow-up Period||116||
59894821|NCT03384966|76016881|FG000|NOT COMPLETED|Follow-up Period||1||
59894822|NCT03384966|76016882|FG001|NOT COMPLETED|Follow-up Period||0||
59894823|NCT03384966|76016883|FG002|NOT COMPLETED|Follow-up Period||0||
59894824|NCT03402126|76016900|FG000|STARTED|Overall Study||138||
59894825|NCT03402126|76016900|FG000|COMPLETED|Overall Study||76||
59894826|NCT03402126|76016900|FG000|NOT COMPLETED|Overall Study||62||
59894827|NCT03355326|76016906|FG000|STARTED|Overall Study||9||
59894828|NCT03355326|76016907|FG001|STARTED|Overall Study||7||
59894829|NCT03355326|76016906|FG000|COMPLETED|Overall Study||6||
59894830|NCT03355326|76016907|FG001|COMPLETED|Overall Study||4||
59894831|NCT03355326|76016906|FG000|NOT COMPLETED|Overall Study||3||
59894832|NCT03355326|76016907|FG001|NOT COMPLETED|Overall Study||3||
59894833|NCT03353220|76016913|FG000|STARTED|First Intervention (7 Days) - Phase 1||14||
59894834|NCT03353220|76016914|FG001|STARTED|First Intervention (7 Days) - Phase 1||16||
59894835|NCT03353220|76016913|FG000|COMPLETED|First Intervention (7 Days) - Phase 1||14||
59894836|NCT03353220|76016914|FG001|COMPLETED|First Intervention (7 Days) - Phase 1||16||
59894837|NCT03353220|76016913|FG000|NOT COMPLETED|First Intervention (7 Days) - Phase 1||0||
59894838|NCT03353220|76016914|FG001|NOT COMPLETED|First Intervention (7 Days) - Phase 1||0||
59894839|NCT03353220|76016913|FG000|STARTED|Washout (3 Weeks) - Phase 1||14||
59894840|NCT03353220|76016914|FG001|STARTED|Washout (3 Weeks) - Phase 1||16||
59894841|NCT03353220|76016913|FG000|COMPLETED|Washout (3 Weeks) - Phase 1||14||
59894842|NCT03353220|76016914|FG001|COMPLETED|Washout (3 Weeks) - Phase 1||16||
59894843|NCT03353220|76016913|FG000|NOT COMPLETED|Washout (3 Weeks) - Phase 1||0||
59894844|NCT03353220|76016914|FG001|NOT COMPLETED|Washout (3 Weeks) - Phase 1||0||
59894845|NCT03353220|76016913|FG000|STARTED|Second Intervention (7 Days) - Phase 1||14||
59894846|NCT03353220|76016914|FG001|STARTED|Second Intervention (7 Days) - Phase 1||16||
59894847|NCT03353220|76016913|FG000|COMPLETED|Second Intervention (7 Days) - Phase 1||14||
59894848|NCT03353220|76016914|FG001|COMPLETED|Second Intervention (7 Days) - Phase 1||16||
59894849|NCT03353220|76016913|FG000|NOT COMPLETED|Second Intervention (7 Days) - Phase 1||0||
59894850|NCT03353220|76016914|FG001|NOT COMPLETED|Second Intervention (7 Days) - Phase 1||0||
59894851|NCT03353220|76016913|FG000|STARTED|Third Intervention (6 Months) - Phase 2||14||
59894852|NCT03353220|76016914|FG001|STARTED|Third Intervention (6 Months) - Phase 2||16||
59894853|NCT03353220|76016913|FG000|COMPLETED|Third Intervention (6 Months) - Phase 2||10||
59894854|NCT03353220|76016914|FG001|COMPLETED|Third Intervention (6 Months) - Phase 2||9||
59894855|NCT03353220|76016913|FG000|NOT COMPLETED|Third Intervention (6 Months) - Phase 2||4||
59894856|NCT03353220|76016914|FG001|NOT COMPLETED|Third Intervention (6 Months) - Phase 2||7||
59894857|NCT03751657|76016922|FG000|STARTED|Overall Study||125||
59894858|NCT03751657|76016923|FG001|STARTED|Overall Study||122||
59894859|NCT03751657|76016922|FG000|COMPLETED|Overall Study||122||
59894860|NCT03751657|76016923|FG001|COMPLETED|Overall Study||119||
59894861|NCT03751657|76016922|FG000|NOT COMPLETED|Overall Study||3||
59894862|NCT03751657|76016923|FG001|NOT COMPLETED|Overall Study||3||
59894863|NCT00025259|76016936|FG000|STARTED|Overall Study||52||
59894864|NCT00025259|76016937|FG001|STARTED|Overall Study||381||
59894865|NCT00025259|76016938|FG002|STARTED|Overall Study||382||
59894866|NCT00025259|76016939|FG003|STARTED|Overall Study||571||
59894867|NCT00025259|76016940|FG004|STARTED|Overall Study||42||
59894868|NCT00025259|76016941|FG005|STARTED|Overall Study||153||
59894869|NCT00025259|76016942|FG006|STARTED|Overall Study||153||
59894870|NCT00025259|76016936|FG000|COMPLETED|Overall Study||7||
59894871|NCT00025259|76016937|FG001|COMPLETED|Overall Study||292||
59894872|NCT00025259|76016938|FG002|COMPLETED|Overall Study||301||
59894873|NCT00025259|76016939|FG003|COMPLETED|Overall Study||457||
59894874|NCT00025259|76016940|FG004|COMPLETED|Overall Study||6||
59894875|NCT00025259|76016941|FG005|COMPLETED|Overall Study||101||
59894876|NCT00025259|76016942|FG006|COMPLETED|Overall Study||102||
59894877|NCT00025259|76016936|FG000|NOT COMPLETED|Overall Study||45||
59894878|NCT00025259|76016937|FG001|NOT COMPLETED|Overall Study||89||
59894879|NCT00025259|76016938|FG002|NOT COMPLETED|Overall Study||81||
59894880|NCT00025259|76016939|FG003|NOT COMPLETED|Overall Study||114||
59894881|NCT00025259|76016940|FG004|NOT COMPLETED|Overall Study||36||
59894882|NCT00025259|76016941|FG005|NOT COMPLETED|Overall Study||52||
59894883|NCT00025259|76016942|FG006|NOT COMPLETED|Overall Study||51||
59894884|NCT03351738|76016967|FG000|STARTED|Overall Study||23||
59894885|NCT03351738|76016968|FG001|STARTED|Overall Study||20||
59894886|NCT03351738|76016969|FG002|STARTED|Overall Study||24||
59894887|NCT03351738|76016970|FG003|STARTED|Overall Study||22||
59894888|NCT03351738|76016971|FG004|STARTED|Overall Study||21||
59894889|NCT03351738|76016972|FG005|STARTED|Overall Study||22||
59894890|NCT03351738|76016967|FG000|COMPLETED|Overall Study||23||
59894891|NCT03351738|76016968|FG001|COMPLETED|Overall Study||19||
59894892|NCT03351738|76016969|FG002|COMPLETED|Overall Study||24||
59894893|NCT03351738|76016970|FG003|COMPLETED|Overall Study||21||
59894894|NCT03351738|76016971|FG004|COMPLETED|Overall Study||21||
59894895|NCT03351738|76016972|FG005|COMPLETED|Overall Study||22||
59894896|NCT03351738|76016967|FG000|NOT COMPLETED|Overall Study||0||
59894897|NCT03351738|76016968|FG001|NOT COMPLETED|Overall Study||1||
59894898|NCT03351738|76016969|FG002|NOT COMPLETED|Overall Study||0||
59894899|NCT03351738|76016970|FG003|NOT COMPLETED|Overall Study||1||
59894900|NCT03351738|76016971|FG004|NOT COMPLETED|Overall Study||0||
59894901|NCT03351738|76016972|FG005|NOT COMPLETED|Overall Study||0||
59894902|NCT03351114|76016991|FG000|STARTED|Overall Study||8||
59894903|NCT03351114|76016991|FG000|COMPLETED|Overall Study||7||
59894904|NCT03351114|76016991|FG000|NOT COMPLETED|Overall Study||1||
59894905|NCT03350256|76016995|FG000|STARTED|Overall Study||60||
59894906|NCT03350256|76016995|FG000|Spinal Cord Stimulation Trial|Overall Study|Subject that underwent SCS trial|50||
59894907|NCT03350256|76016995|FG000|Permanent Implant|Overall Study|subjects that underwent permanent SCS implant|35||
59894908|NCT03350256|76016995|FG000|1 Month Follow up|Overall Study||30||
59894909|NCT03350256|76016995|FG000|3 Month Follow up|Overall Study||27||
59894910|NCT03350256|76016995|FG000|6 Month Follow up|Overall Study||24||
59894911|NCT03350256|76016995|FG000|COMPLETED|Overall Study||24||
59894912|NCT03350256|76016995|FG000|NOT COMPLETED|Overall Study||36||
59894913|NCT00024167|76017002|FG000|STARTED|Overall Study||65||
59894914|NCT00024167|76017003|FG001|STARTED|Overall Study||62||
59894915|NCT00024167|76017002|FG000|Induction Treatment Option 1 Completed|Overall Study||22||
59894916|NCT00024167|76017003|FG001|Induction Treatment Option 1 Completed|Overall Study||21||
59894917|NCT00024167|76017002|FG000|Induction Treatment Option 2 Completed|Overall Study||43||
59894918|NCT00024167|76017003|FG001|Induction Treatment Option 2 Completed|Overall Study||41||
59894919|NCT00024167|76017002|FG000|COMPLETED|Overall Study||12||
59894920|NCT00024167|76017003|FG001|COMPLETED|Overall Study||15||
59894921|NCT00024167|76017002|FG000|NOT COMPLETED|Overall Study||53||
59894922|NCT00024167|76017003|FG001|NOT COMPLETED|Overall Study||47||
59894923|NCT00022763|76017012|FG000|STARTED|Overall Study||24||
59894924|NCT00022763|76017013|FG001|STARTED|Overall Study||28||
59894925|NCT00022763|76017012|FG000|COMPLETED|Overall Study||15||
59894926|NCT00022763|76017013|FG001|COMPLETED|Overall Study||11||
59894927|NCT00022763|76017012|FG000|NOT COMPLETED|Overall Study||9||
59894928|NCT00022763|76017013|FG001|NOT COMPLETED|Overall Study||17||
59894929|NCT00071513|76017020|FG000|STARTED|Intervention Component||241||
59894930|NCT00071513|76017021|FG001|STARTED|Intervention Component||256||
59894931|NCT00071513|76017020|FG000|COMPLETED|Intervention Component||239||
59894932|NCT00071513|76017021|FG001|COMPLETED|Intervention Component||253||
59894933|NCT00071513|76017020|FG000|NOT COMPLETED|Intervention Component||2||
59894934|NCT00071513|76017021|FG001|NOT COMPLETED|Intervention Component||3||
59894935|NCT00071513|76017020|FG000|STARTED|Follow-up Assessment||239||
59894936|NCT00071513|76017021|FG001|STARTED|Follow-up Assessment||253||
59894937|NCT00071513|76017020|FG000|COMPLETED|Follow-up Assessment||233||
59894938|NCT00071513|76017021|FG001|COMPLETED|Follow-up Assessment||247||
59894939|NCT00071513|76017020|FG000|NOT COMPLETED|Follow-up Assessment||6||
59894940|NCT00071513|76017021|FG001|NOT COMPLETED|Follow-up Assessment||6||
59894941|NCT00006389|76017029|FG000|STARTED|Overall Study||12||
59894942|NCT00006389|76017029|FG000|COMPLETED|Overall Study||11||
59894943|NCT00006389|76017029|FG000|NOT COMPLETED|Overall Study||1||
59894944|NCT00006305|76017038|FG000|STARTED|Overall Study||592||
59894945|NCT00006305|76017039|FG001|STARTED|Overall Study||584||
59894946|NCT00006305|76017040|FG002|STARTED|Overall Study||593||
59894947|NCT00006305|76017041|FG003|STARTED|Overall Study||599||
60013801|NCT01671007|76129765|FG007|STARTED|Overall Study||526||
60013802|NCT01671007|76129766|FG008|STARTED|Overall Study||2||
59894948|NCT00006305|76017038|FG000|COMPLETED|Overall Study||575||
59894949|NCT00006305|76017039|FG001|COMPLETED|Overall Study||574||
59894950|NCT00006305|76017040|FG002|COMPLETED|Overall Study||578||
59894951|NCT00006305|76017041|FG003|COMPLETED|Overall Study||585||
59894952|NCT00006305|76017038|FG000|NOT COMPLETED|Overall Study||17||
59894953|NCT00006305|76017039|FG001|NOT COMPLETED|Overall Study||10||
59894954|NCT00006305|76017040|FG002|NOT COMPLETED|Overall Study||15||
59894955|NCT00006305|76017041|FG003|NOT COMPLETED|Overall Study||14||
59894956|NCT03529773|76017091|FG000|STARTED|Overall Study||12||
59894957|NCT03529773|76017092|FG001|STARTED|Overall Study||12||
59894958|NCT03529773|76017093|FG002|STARTED|Overall Study||12||
59894959|NCT03529773|76017094|FG003|STARTED|Overall Study||12||
59894960|NCT03529773|76017095|FG004|STARTED|Overall Study||12||
59894961|NCT03529773|76017096|FG005|STARTED|Overall Study||12||
59894962|NCT03529773|76017097|FG006|STARTED|Overall Study||12||
59894963|NCT03529773|76017098|FG007|STARTED|Overall Study||12||
59894964|NCT03529773|76017099|FG008|STARTED|Overall Study||12||
59894965|NCT03529773|76017100|FG009|STARTED|Overall Study||12||
59894966|NCT03529773|76017101|FG010|STARTED|Overall Study||12||
59894967|NCT03529773|76017102|FG011|STARTED|Overall Study||12||
59894968|NCT03529773|76017103|FG012|STARTED|Overall Study||12||
59894969|NCT03529773|76017104|FG013|STARTED|Overall Study||12||
59894970|NCT03529773|76017105|FG014|STARTED|Overall Study||41||
59894971|NCT03529773|76017106|FG015|STARTED|Overall Study||42||
59894972|NCT03529773|76017107|FG016|STARTED|Overall Study||41||
59894973|NCT03529773|76017108|FG017|STARTED|Overall Study||41||
59894974|NCT03529773|76017109|FG018|STARTED|Overall Study||41||
59894975|NCT03529773|76017110|FG019|STARTED|Overall Study||41||
59894976|NCT03529773|76017111|FG020|STARTED|Overall Study||41||
59894977|NCT03529773|76017112|FG021|STARTED|Overall Study||41||
59894978|NCT03529773|76017113|FG022|STARTED|Overall Study||41||
59894979|NCT03529773|76017114|FG023|STARTED|Overall Study||41||
59894980|NCT03529773|76017115|FG024|STARTED|Overall Study||41||
59894981|NCT03529773|76017116|FG025|STARTED|Overall Study||41||
59894982|NCT03529773|76017117|FG026|STARTED|Overall Study||41||
59894983|NCT03529773|76017118|FG027|STARTED|Overall Study||41||
59894984|NCT03529773|76017119|FG028|STARTED|Overall Study||41||
59894985|NCT03529773|76017120|FG029|STARTED|Overall Study||40||
59894986|NCT03529773|76017121|FG030|STARTED|Overall Study||42||
59894987|NCT03529773|76017122|FG031|STARTED|Overall Study||40||
59894988|NCT03529773|76017123|FG032|STARTED|Overall Study||40||
59894989|NCT03529773|76017124|FG033|STARTED|Overall Study||41||
59894990|NCT03529773|76017125|FG034|STARTED|Overall Study||41||
59894991|NCT03529773|76017126|FG035|STARTED|Overall Study||40||
59894992|NCT03529773|76017127|FG036|STARTED|Overall Study||41||
59894993|NCT03529773|76017128|FG037|STARTED|Overall Study||42||
59894994|NCT03529773|76017129|FG038|STARTED|Overall Study||43||
59894995|NCT03529773|76017130|FG039|STARTED|Overall Study||41||
59894996|NCT03529773|76017091|FG000|COMPLETED|Overall Study||12||
59894997|NCT03529773|76017092|FG001|COMPLETED|Overall Study||12||
59894998|NCT03529773|76017093|FG002|COMPLETED|Overall Study||11||
59894999|NCT03529773|76017094|FG003|COMPLETED|Overall Study||12||
59895000|NCT03529773|76017095|FG004|COMPLETED|Overall Study||11||
59895001|NCT03529773|76017096|FG005|COMPLETED|Overall Study||11||
59895002|NCT03529773|76017097|FG006|COMPLETED|Overall Study||12||
59895003|NCT03529773|76017098|FG007|COMPLETED|Overall Study||11||
59895004|NCT03529773|76017099|FG008|COMPLETED|Overall Study||12||
59895005|NCT03529773|76017100|FG009|COMPLETED|Overall Study||11||
59895006|NCT03529773|76017101|FG010|COMPLETED|Overall Study||11||
59895007|NCT03529773|76017102|FG011|COMPLETED|Overall Study||12||
59895008|NCT03529773|76017103|FG012|COMPLETED|Overall Study||10||
59895009|NCT03529773|76017104|FG013|COMPLETED|Overall Study||11||
59895010|NCT03529773|76017105|FG014|COMPLETED|Overall Study||35||
59895011|NCT03529773|76017106|FG015|COMPLETED|Overall Study||38||
59895012|NCT03529773|76017107|FG016|COMPLETED|Overall Study||40||
59895013|NCT03529773|76017108|FG017|COMPLETED|Overall Study||35||
59895014|NCT03529773|76017109|FG018|COMPLETED|Overall Study||37||
59895015|NCT03529773|76017110|FG019|COMPLETED|Overall Study||37||
59895016|NCT03529773|76017111|FG020|COMPLETED|Overall Study||34||
59895017|NCT03529773|76017112|FG021|COMPLETED|Overall Study||36||
59895018|NCT03529773|76017113|FG022|COMPLETED|Overall Study||34||
59895019|NCT03529773|76017114|FG023|COMPLETED|Overall Study||35||
59895020|NCT03529773|76017115|FG024|COMPLETED|Overall Study||33||
59895021|NCT03529773|76017116|FG025|COMPLETED|Overall Study||30||
59895022|NCT03529773|76017117|FG026|COMPLETED|Overall Study||32||
59895023|NCT03529773|76017118|FG027|COMPLETED|Overall Study||39||
59895024|NCT03529773|76017119|FG028|COMPLETED|Overall Study||40||
59895025|NCT03529773|76017120|FG029|COMPLETED|Overall Study||40||
59895026|NCT03529773|76017121|FG030|COMPLETED|Overall Study||39||
59895027|NCT03529773|76017122|FG031|COMPLETED|Overall Study||40||
59895028|NCT03529773|76017123|FG032|COMPLETED|Overall Study||40||
59895029|NCT03529773|76017124|FG033|COMPLETED|Overall Study||39||
59895030|NCT03529773|76017125|FG034|COMPLETED|Overall Study||37||
59895031|NCT03529773|76017126|FG035|COMPLETED|Overall Study||36||
59895032|NCT03529773|76017127|FG036|COMPLETED|Overall Study||39||
59895033|NCT03529773|76017128|FG037|COMPLETED|Overall Study||36||
59895034|NCT03529773|76017129|FG038|COMPLETED|Overall Study||39||
59895035|NCT03529773|76017130|FG039|COMPLETED|Overall Study||37||
59895036|NCT03529773|76017091|FG000|NOT COMPLETED|Overall Study||0||
59895037|NCT03529773|76017092|FG001|NOT COMPLETED|Overall Study||0||
59895038|NCT03529773|76017093|FG002|NOT COMPLETED|Overall Study||1||
59895039|NCT03529773|76017094|FG003|NOT COMPLETED|Overall Study||0||
59895040|NCT03529773|76017095|FG004|NOT COMPLETED|Overall Study||1||
59895041|NCT03529773|76017096|FG005|NOT COMPLETED|Overall Study||1||
59895042|NCT03529773|76017097|FG006|NOT COMPLETED|Overall Study||0||
59895043|NCT03529773|76017098|FG007|NOT COMPLETED|Overall Study||1||
59895044|NCT03529773|76017099|FG008|NOT COMPLETED|Overall Study||0||
59895045|NCT03529773|76017100|FG009|NOT COMPLETED|Overall Study||1||
59895046|NCT03529773|76017101|FG010|NOT COMPLETED|Overall Study||1||
59895047|NCT03529773|76017102|FG011|NOT COMPLETED|Overall Study||0||
59895048|NCT03529773|76017103|FG012|NOT COMPLETED|Overall Study||2||
59895049|NCT03529773|76017104|FG013|NOT COMPLETED|Overall Study||1||
59895050|NCT03529773|76017105|FG014|NOT COMPLETED|Overall Study||6||
59895051|NCT03529773|76017106|FG015|NOT COMPLETED|Overall Study||4||
59895052|NCT03529773|76017107|FG016|NOT COMPLETED|Overall Study||1||
59895053|NCT03529773|76017108|FG017|NOT COMPLETED|Overall Study||6||
59895054|NCT03529773|76017109|FG018|NOT COMPLETED|Overall Study||4||
59895055|NCT03529773|76017110|FG019|NOT COMPLETED|Overall Study||4||
59895056|NCT03529773|76017111|FG020|NOT COMPLETED|Overall Study||7||
59895057|NCT03529773|76017112|FG021|NOT COMPLETED|Overall Study||5||
59895058|NCT03529773|76017113|FG022|NOT COMPLETED|Overall Study||7||
59895059|NCT03529773|76017114|FG023|NOT COMPLETED|Overall Study||6||
59895060|NCT03529773|76017115|FG024|NOT COMPLETED|Overall Study||8||
59895061|NCT03529773|76017116|FG025|NOT COMPLETED|Overall Study||11||
59895062|NCT03529773|76017117|FG026|NOT COMPLETED|Overall Study||9||
59895063|NCT03529773|76017118|FG027|NOT COMPLETED|Overall Study||2||
59895064|NCT03529773|76017119|FG028|NOT COMPLETED|Overall Study||1||
59895065|NCT03529773|76017120|FG029|NOT COMPLETED|Overall Study||0||
59895066|NCT03529773|76017121|FG030|NOT COMPLETED|Overall Study||3||
59895067|NCT03529773|76017122|FG031|NOT COMPLETED|Overall Study||0||
59895068|NCT03529773|76017123|FG032|NOT COMPLETED|Overall Study||0||
59895069|NCT03529773|76017124|FG033|NOT COMPLETED|Overall Study||2||
59895070|NCT03529773|76017125|FG034|NOT COMPLETED|Overall Study||4||
59895071|NCT03529773|76017126|FG035|NOT COMPLETED|Overall Study||4||
59895072|NCT03529773|76017127|FG036|NOT COMPLETED|Overall Study||2||
59895073|NCT03529773|76017128|FG037|NOT COMPLETED|Overall Study||6||
59895074|NCT03529773|76017129|FG038|NOT COMPLETED|Overall Study||4||
59895075|NCT03529773|76017130|FG039|NOT COMPLETED|Overall Study||4||
59895076|NCT03799211|76017235|FG000|STARTED|Overall Study||36||
59895077|NCT03799211|76017236|FG001|STARTED|Overall Study||40||
59895078|NCT03799211|76017235|FG000|COMPLETED|Overall Study||32||
59895079|NCT03799211|76017236|FG001|COMPLETED|Overall Study||27||
59895080|NCT03799211|76017235|FG000|NOT COMPLETED|Overall Study||4||
59895081|NCT03799211|76017236|FG001|NOT COMPLETED|Overall Study||13||
59895082|NCT03349710|76017248|FG000|STARTED|Randomized||12|= Participants Randomized|
59895083|NCT03349710|76017249|FG001|STARTED|Randomized||10|= Participants Randomized|
59895084|NCT03349710|76017250|FG002|STARTED|Randomized||27|= Participants Randomized|
59895085|NCT03349710|76017251|FG003|STARTED|Randomized||25|= Participants Randomized|
59895086|NCT03349710|76017248|FG000|COMPLETED|Randomized||12|= Participants Treated|
59895087|NCT03349710|76017249|FG001|COMPLETED|Randomized||10|= Participants Treated|
59895088|NCT03349710|76017250|FG002|COMPLETED|Randomized||27|= Participants Treated|
59895089|NCT03349710|76017251|FG003|COMPLETED|Randomized||24|= Participants Treated|
59895090|NCT03349710|76017248|FG000|NOT COMPLETED|Randomized||0||
59895091|NCT03349710|76017249|FG001|NOT COMPLETED|Randomized||0||
59895092|NCT03349710|76017250|FG002|NOT COMPLETED|Randomized||0||
59895093|NCT03349710|76017251|FG003|NOT COMPLETED|Randomized||1||
59895094|NCT03349710|76017248|FG000|STARTED|Treatment Period||12|= Participants Treated|
59895095|NCT03349710|76017249|FG001|STARTED|Treatment Period||10|= Participants Treated|
59895096|NCT03349710|76017250|FG002|STARTED|Treatment Period||27|= Participants Treated|
59895097|NCT03349710|76017251|FG003|STARTED|Treatment Period||24|= Participants Treated|
59895098|NCT03349710|76017248|FG000|COMPLETED|Treatment Period||0|= Continuing Treatment|
59895099|NCT03349710|76017249|FG001|COMPLETED|Treatment Period||0|= Continuing Treatment|
59895100|NCT03349710|76017250|FG002|COMPLETED|Treatment Period||0|= Continuing Treatment|
59895101|NCT03349710|76017251|FG003|COMPLETED|Treatment Period||0|= Continuing Treatment|
59895102|NCT03349710|76017248|FG000|NOT COMPLETED|Treatment Period||12||
59895103|NCT03349710|76017249|FG001|NOT COMPLETED|Treatment Period||10||
59895104|NCT03349710|76017250|FG002|NOT COMPLETED|Treatment Period||27||
59895105|NCT03349710|76017251|FG003|NOT COMPLETED|Treatment Period||24||
59895106|NCT03511053|76017261|FG000|STARTED|Overall Study||11||
59895107|NCT03511053|76017261|FG000|COMPLETED|Overall Study||10||
59895108|NCT03511053|76017261|FG000|NOT COMPLETED|Overall Study||1||
59895109|NCT03377634|76017267|FG000|STARTED|Intervention Usability Testing Period||5||
59895110|NCT03377634|76017268|FG001|STARTED|Intervention Usability Testing Period||0||
59895111|NCT03377634|76017267|FG000|COMPLETED|Intervention Usability Testing Period||5||
59951262|NCT03743415|76070183|FG008|NOT COMPLETED|Overall Study||23||
59895112|NCT03377634|76017268|FG001|COMPLETED|Intervention Usability Testing Period||0||
59895113|NCT03377634|76017267|FG000|NOT COMPLETED|Intervention Usability Testing Period||0||
59895114|NCT03377634|76017268|FG001|NOT COMPLETED|Intervention Usability Testing Period||0||
59895115|NCT03377634|76017267|FG000|STARTED|Study Period||15|Data from this period does not include the 5 subjects from the usability period because outcome measure information was not collected from those five subjects.|
59895116|NCT03377634|76017268|FG001|STARTED|Study Period||13|Data from this period does not include the 5 subjects from the usability period because outcome measure information was not collected from those five subjects.|
59895117|NCT03377634|76017267|FG000|COMPLETED|Study Period||13||
59895118|NCT03377634|76017268|FG001|COMPLETED|Study Period||13||
59895119|NCT03377634|76017267|FG000|NOT COMPLETED|Study Period||2||
59895120|NCT03377634|76017268|FG001|NOT COMPLETED|Study Period||0||
59895121|NCT03528369|76017277|FG000|STARTED|Overall Study||40||
59895122|NCT03528369|76017278|FG001|STARTED|Overall Study||42||
59895123|NCT03528369|76017279|FG002|STARTED|Overall Study||40||
59895124|NCT03528369|76017277|FG000|COMPLETED|Overall Study||37||
59895125|NCT03528369|76017278|FG001|COMPLETED|Overall Study||41||
59895126|NCT03528369|76017279|FG002|COMPLETED|Overall Study||40||
59895127|NCT03528369|76017277|FG000|NOT COMPLETED|Overall Study||3||
59895128|NCT03528369|76017278|FG001|NOT COMPLETED|Overall Study||1||
59895129|NCT03528369|76017279|FG002|NOT COMPLETED|Overall Study||0||
59895130|NCT00006011|76017290|FG000|STARTED|Overall Study|total number of participants enrolled, that received random treatment assignment to Arm 1 of study.|288||
59895131|NCT00006011|76017291|FG001|STARTED|Overall Study|total number of participants enrolled, that received random treatment assignment to Arm 2 of study.|298||
59895132|NCT00006011|76017292|FG002|STARTED|Overall Study|total number of participants enrolled, that only received radiation treatment.|73||
59895133|NCT00006011|76017290|FG000|COMPLETED|Overall Study|total number of partipants that completed 6 cycles of chemotherapy.|223||
59895134|NCT00006011|76017291|FG001|COMPLETED|Overall Study|total number of partipants that completed 6 cycles of chemotherapy.|221||
59895135|NCT00006011|76017292|FG002|COMPLETED|Overall Study|total number of partipants that completed 6 cycles of chemotherapy.|0||
59895136|NCT00006011|76017290|FG000|NOT COMPLETED|Overall Study||65||
59895137|NCT00006011|76017291|FG001|NOT COMPLETED|Overall Study||77||
59895138|NCT00006011|76017292|FG002|NOT COMPLETED|Overall Study||73||
59895139|NCT03377556|76017298|FG000|STARTED|Overall Study||47||
59895140|NCT03377556|76017298|FG000|Primary Analysis Population (HRRD-positive Per MDVN Criteria)|Overall Study||24||
59895141|NCT03377556|76017298|FG000|COMPLETED|Overall Study||0||
59895142|NCT03377556|76017298|FG000|NOT COMPLETED|Overall Study||47||
59895143|NCT03750955|76017304|FG000|STARTED|Hygiene Phase of 2 Weeks|No intervention during the hygiene phase.|16||16
59895144|NCT03750955|76017305|FG001|STARTED|Hygiene Phase of 2 Weeks|No intervention during the hygiene phase.|16||16
59895145|NCT03750955|76017304|FG000|COMPLETED|Hygiene Phase of 2 Weeks||13||13
59895146|NCT03750955|76017305|FG001|COMPLETED|Hygiene Phase of 2 Weeks||13||13
59895147|NCT03750955|76017304|FG000|NOT COMPLETED|Hygiene Phase of 2 Weeks||3||3
59895148|NCT03750955|76017305|FG001|NOT COMPLETED|Hygiene Phase of 2 Weeks||3||3
59895149|NCT03750955|76017304|FG000|STARTED|Gingivitis Induction Phase of 2 Weeks||13||13
59895150|NCT03750955|76017305|FG001|STARTED|Gingivitis Induction Phase of 2 Weeks||13||13
59895151|NCT03750955|76017304|FG000|COMPLETED|Gingivitis Induction Phase of 2 Weeks|6 participants randomized to L maxillary sextant SIBO; 7 randomized to R maxillary sextant SIBO.|13||13
59895152|NCT03750955|76017305|FG001|COMPLETED|Gingivitis Induction Phase of 2 Weeks|6 randomized to R max. sextant oral hygiene maintenance (OHM); 7 randomized to L max. sextant OHM.|13||13
59895153|NCT03750955|76017304|FG000|NOT COMPLETED|Gingivitis Induction Phase of 2 Weeks||0||0
59895154|NCT03750955|76017305|FG001|NOT COMPLETED|Gingivitis Induction Phase of 2 Weeks||0||0
59895155|NCT03750955|76017304|FG000|STARTED|Resolution Phase of 2 Weeks|No stent in use; oral hygiene resumed.|13||13
59895156|NCT03750955|76017305|FG001|STARTED|Resolution Phase of 2 Weeks|Oral hygiene maintenance continued.|13||13
59895157|NCT03750955|76017304|FG000|COMPLETED|Resolution Phase of 2 Weeks||13||13
59895158|NCT03750955|76017305|FG001|COMPLETED|Resolution Phase of 2 Weeks||13||13
59895159|NCT03750955|76017304|FG000|NOT COMPLETED|Resolution Phase of 2 Weeks||0||0
59895160|NCT03750955|76017305|FG001|NOT COMPLETED|Resolution Phase of 2 Weeks||0||0
59895161|NCT00005879|76017315|FG000|STARTED|Overall Study||101||
59895162|NCT00005879|76017316|FG001|STARTED|Overall Study||98||
59895163|NCT00005879|76017315|FG000|COMPLETED|Overall Study||93||
59895164|NCT00005879|76017316|FG001|COMPLETED|Overall Study||88||
59895165|NCT00005879|76017315|FG000|NOT COMPLETED|Overall Study||8||
59895166|NCT00005879|76017316|FG001|NOT COMPLETED|Overall Study||10||
59895167|NCT03510663|76017330|FG000|STARTED|Overall Study||6||
59895168|NCT03510663|76017331|FG001|STARTED|Overall Study||6||
59895169|NCT03510663|76017332|FG002|STARTED|Overall Study||6||
59895170|NCT03510663|76017333|FG003|STARTED|Overall Study||6||
59895171|NCT03510663|76017334|FG004|STARTED|Overall Study||6||
59895172|NCT03510663|76017335|FG005|STARTED|Overall Study||6||
59895173|NCT03510663|76017336|FG006|STARTED|Overall Study||6||
59895174|NCT03510663|76017337|FG007|STARTED|Overall Study||6||
59895175|NCT03510663|76017330|FG000|COMPLETED|Overall Study||6||
59895176|NCT03510663|76017331|FG001|COMPLETED|Overall Study||5||
59895177|NCT03510663|76017332|FG002|COMPLETED|Overall Study||6||
59895178|NCT03510663|76017333|FG003|COMPLETED|Overall Study||6||
59895179|NCT03510663|76017334|FG004|COMPLETED|Overall Study||6||
59895180|NCT03510663|76017335|FG005|COMPLETED|Overall Study||6||
59895181|NCT03510663|76017336|FG006|COMPLETED|Overall Study||6||
59895182|NCT03510663|76017337|FG007|COMPLETED|Overall Study||6||
59895183|NCT03510663|76017330|FG000|NOT COMPLETED|Overall Study||0||
59895184|NCT03510663|76017331|FG001|NOT COMPLETED|Overall Study||1||
59895185|NCT03510663|76017332|FG002|NOT COMPLETED|Overall Study||0||
59895186|NCT03510663|76017333|FG003|NOT COMPLETED|Overall Study||0||
59895187|NCT03510663|76017334|FG004|NOT COMPLETED|Overall Study||0||
59895188|NCT03510663|76017335|FG005|NOT COMPLETED|Overall Study||0||
59895189|NCT03510663|76017336|FG006|NOT COMPLETED|Overall Study||0||
59895190|NCT03510663|76017337|FG007|NOT COMPLETED|Overall Study||0||
59895191|NCT03510273|76017347|FG000|STARTED|Overall Study||319||
59895192|NCT03510273|76017347|FG000|Treated With Thermal Coagulation|Overall Study||319||
59895193|NCT03510273|76017347|FG000|Completed 1-mth Follow-up Visit & Exited|Overall Study||192|Completed one-month follow-up visit and exited study per protocol|
59895194|NCT03510273|76017347|FG000|Completed 1-mth Follow-up Visit & Cont'd|Overall Study||126|Completed one-month follow-up visit and continued in study for secondary outcomes|
59895195|NCT03510273|76017347|FG000|Completed All One-year Follow up Visits|Overall Study||118||
59895196|NCT03510273|76017347|FG000|COMPLETED|Overall Study||310||
59895197|NCT03510273|76017347|FG000|NOT COMPLETED|Overall Study||9||
59895198|NCT03582813|76017357|FG000|STARTED|Overall Study||114||
59895199|NCT03582813|76017358|FG001|STARTED|Overall Study||102||
59895200|NCT03582813|76017357|FG000|COMPLETED|Overall Study||95||
59895201|NCT03582813|76017358|FG001|COMPLETED|Overall Study||81||
59895202|NCT03582813|76017357|FG000|NOT COMPLETED|Overall Study||19||
59895203|NCT03582813|76017358|FG001|NOT COMPLETED|Overall Study||21||
59895204|NCT03480009|76017368|FG000|STARTED|Overall Study||62||
59895205|NCT03480009|76017369|FG001|STARTED|Overall Study||62||
59895206|NCT03480009|76017370|FG002|STARTED|Overall Study||16||
59895207|NCT03480009|76017371|FG003|STARTED|Overall Study||16||
59895208|NCT03480009|76017368|FG000|COMPLETED|Overall Study||58||
59895209|NCT03480009|76017369|FG001|COMPLETED|Overall Study||57||
59895210|NCT03480009|76017370|FG002|COMPLETED|Overall Study||12||
59895211|NCT03480009|76017371|FG003|COMPLETED|Overall Study||16||
59895212|NCT03480009|76017368|FG000|NOT COMPLETED|Overall Study||4||
59895213|NCT03480009|76017369|FG001|NOT COMPLETED|Overall Study||5||
59895214|NCT03480009|76017370|FG002|NOT COMPLETED|Overall Study||4||
59895215|NCT03480009|76017371|FG003|NOT COMPLETED|Overall Study||0||
59895216|NCT03399786|76017386|FG000|STARTED|Double-blind Treatment Period (DBTP)||22||
59895217|NCT03399786|76017387|FG001|STARTED|Double-blind Treatment Period (DBTP)||43||
59895218|NCT03399786|76017388|FG002|STARTED|Double-blind Treatment Period (DBTP)||0||
59895219|NCT03399786|76017389|FG003|STARTED|Double-blind Treatment Period (DBTP)||0||
59895220|NCT03399786|76017386|FG000|COMPLETED|Double-blind Treatment Period (DBTP)||21||
59895221|NCT03399786|76017387|FG001|COMPLETED|Double-blind Treatment Period (DBTP)||43||
59895222|NCT03399786|76017388|FG002|COMPLETED|Double-blind Treatment Period (DBTP)||0||
59757220|NCT00775437|75876283|FG000|STARTED|Overall Study||32||
59757221|NCT00775437|75876283|FG000|COMPLETED|Overall Study||26||
59757222|NCT00775437|75876283|FG000|NOT COMPLETED|Overall Study||6||
59757223|NCT00775203|75876289|FG000|STARTED|Overall Study||206||
59757224|NCT00775203|75876290|FG001|STARTED|Overall Study||206||
59757225|NCT00775203|75876289|FG000|Received Study Medication|Overall Study||202||
59757226|NCT00775203|75876290|FG001|Received Study Medication|Overall Study||204||
59757227|NCT00775203|75876289|FG000|COMPLETED|Overall Study||144||
59757228|NCT00775203|75876290|FG001|COMPLETED|Overall Study||163||
59757229|NCT00775203|75876289|FG000|NOT COMPLETED|Overall Study||62||
59757230|NCT00775203|75876290|FG001|NOT COMPLETED|Overall Study||43||
59757231|NCT00568321|75876299|FG000|STARTED|Overall Study||33||
59757232|NCT00568321|75876300|FG001|STARTED|Overall Study||33||
59895223|NCT03399786|76017389|FG003|COMPLETED|Double-blind Treatment Period (DBTP)||0||
59895224|NCT03399786|76017386|FG000|NOT COMPLETED|Double-blind Treatment Period (DBTP)||1||
59895225|NCT03399786|76017387|FG001|NOT COMPLETED|Double-blind Treatment Period (DBTP)||0||
59757233|NCT00568321|75876301|FG002|STARTED|Overall Study||33||
59757234|NCT00568321|75876299|FG000|Treated|Overall Study||31||
59757235|NCT00568321|75876300|FG001|Treated|Overall Study||33||
59757236|NCT00568321|75876301|FG002|Treated|Overall Study||32||
59757237|NCT00568321|75876299|FG000|COMPLETED|Overall Study||20||
59757238|NCT00568321|75876300|FG001|COMPLETED|Overall Study||28||
59757239|NCT00568321|75876301|FG002|COMPLETED|Overall Study||24||
59895226|NCT03399786|76017388|FG002|NOT COMPLETED|Double-blind Treatment Period (DBTP)||0||
59757240|NCT00568321|75876299|FG000|NOT COMPLETED|Overall Study||13||
59757241|NCT00568321|75876300|FG001|NOT COMPLETED|Overall Study||5||
59757242|NCT00568321|75876301|FG002|NOT COMPLETED|Overall Study||9||
59895227|NCT03399786|76017389|FG003|NOT COMPLETED|Double-blind Treatment Period (DBTP)||0||
59895228|NCT03399786|76017386|FG000|STARTED|Open-label Treatment Period (OLTP)||0||
59895229|NCT03399786|76017387|FG001|STARTED|Open-label Treatment Period (OLTP)||0||
59951263|NCT03743415|76070184|FG009|NOT COMPLETED|Overall Study||23||
59895230|NCT03399786|76017388|FG002|STARTED|Open-label Treatment Period (OLTP)|One participant from the placebo group received evinacumab during the DBTP|20||
59895231|NCT03399786|76017389|FG003|STARTED|Open-label Treatment Period (OLTP)||44||
59895232|NCT03399786|76017386|FG000|COMPLETED|Open-label Treatment Period (OLTP)||0||
59895233|NCT03399786|76017387|FG001|COMPLETED|Open-label Treatment Period (OLTP)||0||
59895234|NCT03399786|76017388|FG002|COMPLETED|Open-label Treatment Period (OLTP)||19||
59895235|NCT03399786|76017389|FG003|COMPLETED|Open-label Treatment Period (OLTP)||43||
59895236|NCT03399786|76017386|FG000|NOT COMPLETED|Open-label Treatment Period (OLTP)||0||
59895237|NCT03399786|76017387|FG001|NOT COMPLETED|Open-label Treatment Period (OLTP)||0||
59895238|NCT03399786|76017388|FG002|NOT COMPLETED|Open-label Treatment Period (OLTP)||1||
59895239|NCT03399786|76017389|FG003|NOT COMPLETED|Open-label Treatment Period (OLTP)||1||
59895240|NCT03505593|76017397|FG000|STARTED|Overall Study||48||
59895241|NCT03505593|76017397|FG000|COMPLETED|Overall Study||43||
59895242|NCT03505593|76017397|FG000|NOT COMPLETED|Overall Study||5||
59895243|NCT03504189|76017401|FG000|STARTED|Overall Study||151||
59895244|NCT03504189|76017401|FG000|COMPLETED|Overall Study||147||
59895245|NCT03504189|76017401|FG000|NOT COMPLETED|Overall Study||4||
59895246|NCT03374358|76017412|FG000|STARTED|Overall Study||24||
59895247|NCT03374358|76017413|FG001|STARTED|Overall Study||21||
59895248|NCT03374358|76017412|FG000|COMPLETED|Overall Study||24||
59895249|NCT03374358|76017413|FG001|COMPLETED|Overall Study||19||
59895250|NCT03374358|76017412|FG000|NOT COMPLETED|Overall Study||0||
59895251|NCT03374358|76017413|FG001|NOT COMPLETED|Overall Study||2||
59895252|NCT03372096|76017419|FG000|STARTED|Overall Study||18||
59895253|NCT03372096|76017419|FG000|Received Intervention|Overall Study||10||
59895254|NCT03372096|76017419|FG000|COMPLETED|Overall Study||10||
59895255|NCT03372096|76017419|FG000|NOT COMPLETED|Overall Study||8||
59895256|NCT00004859|76017428|FG000|STARTED|Overall Study||295||
59895257|NCT00004859|76017429|FG001|STARTED|Overall Study||294||
59895258|NCT00004859|76017428|FG000|Eligible|Overall Study||275||
59895259|NCT00004859|76017429|FG001|Eligible|Overall Study||271||
59505687|NCT00738023|75598550|FG000|COMPLETED|Intralipid Infusion||19||
59505688|NCT00738023|75598551|FG001|COMPLETED|Intralipid Infusion||13||
59505689|NCT00738023|75598550|FG000|NOT COMPLETED|Intralipid Infusion||0||
59895260|NCT00004859|76017428|FG000|Treated|Overall Study||289||
59895261|NCT00004859|76017429|FG001|Treated|Overall Study||289||
59895262|NCT00004859|76017428|FG000|Treated and Having Toxicity Data|Overall Study||289||
59895263|NCT00004859|76017429|FG001|Treated and Having Toxicity Data|Overall Study|1 patient had missing record for toxicity|288||
59895264|NCT00004859|76017428|FG000|COMPLETED|Overall Study||177||
59895265|NCT00004859|76017429|FG001|COMPLETED|Overall Study||12||
59895266|NCT00004859|76017428|FG000|NOT COMPLETED|Overall Study||118||
59895267|NCT00004859|76017429|FG001|NOT COMPLETED|Overall Study||282||
59895268|NCT03500679|76017439|FG000|STARTED|Overall Study||75||
59895269|NCT03500679|76017440|FG001|STARTED|Overall Study||25||
59895270|NCT03500679|76017439|FG000|COMPLETED|Overall Study||66||
59895271|NCT03500679|76017440|FG001|COMPLETED|Overall Study||22||
59895272|NCT03500679|76017439|FG000|NOT COMPLETED|Overall Study||9||
59895273|NCT03500679|76017440|FG001|NOT COMPLETED|Overall Study||3||
59895274|NCT03348930|76017446|FG000|STARTED|First Intervention (2 Weeks)||10||
59895275|NCT03348930|76017447|FG001|STARTED|First Intervention (2 Weeks)||10||
59895276|NCT03348930|76017446|FG000|COMPLETED|First Intervention (2 Weeks)||10||
59895277|NCT03348930|76017447|FG001|COMPLETED|First Intervention (2 Weeks)||10||
59895278|NCT03348930|76017446|FG000|NOT COMPLETED|First Intervention (2 Weeks)||0||
59895279|NCT03348930|76017447|FG001|NOT COMPLETED|First Intervention (2 Weeks)||0||
59895280|NCT03348930|76017446|FG000|STARTED|Washout (1 Week)||10||
59895281|NCT03348930|76017447|FG001|STARTED|Washout (1 Week)||10||
59895282|NCT03348930|76017446|FG000|COMPLETED|Washout (1 Week)||9||
59895283|NCT03348930|76017447|FG001|COMPLETED|Washout (1 Week)||9||
59895284|NCT03348930|76017446|FG000|NOT COMPLETED|Washout (1 Week)||1||
59895285|NCT03348930|76017447|FG001|NOT COMPLETED|Washout (1 Week)||1||
59895286|NCT03348930|76017446|FG000|STARTED|Second Intervention (2 Weeks)||9||
59895287|NCT03348930|76017447|FG001|STARTED|Second Intervention (2 Weeks)||9||
59505690|NCT00738023|75598551|FG001|NOT COMPLETED|Intralipid Infusion||0||
59505691|NCT00738023|75598550|FG000|STARTED|Saline Infusion||19||
59505692|NCT00738023|75598551|FG001|STARTED|Saline Infusion||0||
59895288|NCT03348930|76017446|FG000|COMPLETED|Second Intervention (2 Weeks)||9||
59895289|NCT03348930|76017447|FG001|COMPLETED|Second Intervention (2 Weeks)||9||
59895290|NCT03348930|76017446|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||0||
59895291|NCT03348930|76017447|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||0||
59895292|NCT03500211|76017455|FG000|STARTED|Overall Study||25||
59895293|NCT03500211|76017456|FG001|STARTED|Overall Study||25||
59505693|NCT00738023|75598550|FG000|COMPLETED|Saline Infusion||19||
59505694|NCT00738023|75598551|FG001|COMPLETED|Saline Infusion||0||
59895294|NCT03500211|76017455|FG000|COMPLETED|Overall Study||24||
59895295|NCT03500211|76017456|FG001|COMPLETED|Overall Study||24||
59895296|NCT03500211|76017455|FG000|NOT COMPLETED|Overall Study||1||
59895297|NCT03500211|76017456|FG001|NOT COMPLETED|Overall Study||1||
59895298|NCT03478683|76017464|FG000|STARTED|Overall Study||363||
59895299|NCT03478683|76017465|FG001|STARTED|Overall Study||365||
59895300|NCT03478683|76017464|FG000|COMPLETED|Overall Study||350||
59895301|NCT03478683|76017465|FG001|COMPLETED|Overall Study||347||
59895302|NCT03478683|76017464|FG000|NOT COMPLETED|Overall Study||13||
59895303|NCT03478683|76017465|FG001|NOT COMPLETED|Overall Study||18||
59895304|NCT03478371|76017471|FG000|STARTED|Overall Study||94||
59895305|NCT03478371|76017471|FG000|Received Tampon D|Overall Study||91||
59895306|NCT03478371|76017471|FG000|Received Tampon M|Overall Study||92||
59895307|NCT03478371|76017471|FG000|Recived Tampon T|Overall Study||90||
59895308|NCT03478371|76017471|FG000|Received Tampon V|Overall Study||91||
59895309|NCT03478371|76017471|FG000|COMPLETED|Overall Study||89||
59895310|NCT03478371|76017471|FG000|NOT COMPLETED|Overall Study||5||
59895311|NCT03477903|76017481|FG000|STARTED|Overall Study||1||
59895312|NCT03477903|76017481|FG000|COMPLETED|Overall Study||0||
59895313|NCT03477903|76017481|FG000|NOT COMPLETED|Overall Study||1||
59895314|NCT03475875|76017485|FG000|STARTED|Period 1||46||
59895315|NCT03475875|76017486|FG001|STARTED|Period 1||45||
59895316|NCT03475875|76017485|FG000|COMPLETED|Period 1||43||
59757243|NCT00774345|75876313|FG000|STARTED|Pre-treatment||160|Started = Randomized|
59757244|NCT00774345|75876314|FG001|STARTED|Pre-treatment||157|Started = Randomized|
59757245|NCT00774345|75876313|FG000|COMPLETED|Pre-treatment||158|Completed = Treated|
59757246|NCT00774345|75876314|FG001|COMPLETED|Pre-treatment||157|Completed = Treated|
59757247|NCT00774345|75876313|FG000|NOT COMPLETED|Pre-treatment||2||
59757248|NCT00774345|75876314|FG001|NOT COMPLETED|Pre-treatment||0||
59895317|NCT03475875|76017486|FG001|COMPLETED|Period 1||44||
59895318|NCT03475875|76017485|FG000|NOT COMPLETED|Period 1||3||
59895319|NCT03475875|76017486|FG001|NOT COMPLETED|Period 1||1||
59895320|NCT03475875|76017485|FG000|STARTED|Period 2||43||
59895321|NCT03475875|76017486|FG001|STARTED|Period 2||44||
59895322|NCT03475875|76017485|FG000|COMPLETED|Period 2||40||
59895323|NCT03475875|76017486|FG001|COMPLETED|Period 2||43||
59895324|NCT03475875|76017485|FG000|NOT COMPLETED|Period 2||3||
59895325|NCT03475875|76017486|FG001|NOT COMPLETED|Period 2||1||
59895326|NCT03475875|76017485|FG000|STARTED|Period 3||40||
59895327|NCT03475875|76017486|FG001|STARTED|Period 3||43||
59895328|NCT03475875|76017485|FG000|COMPLETED|Period 3||40||
59895329|NCT03475875|76017486|FG001|COMPLETED|Period 3||43||
59895330|NCT03475875|76017485|FG000|NOT COMPLETED|Period 3||0||
59895331|NCT03475875|76017486|FG001|NOT COMPLETED|Period 3||0||
59895332|NCT03474081|76017494|FG000|STARTED|Overall Study||400||
59895333|NCT03474081|76017495|FG001|STARTED|Overall Study||400||
59895334|NCT03474081|76017494|FG000|Received Study Treatment|Overall Study||400||
59895335|NCT03474081|76017495|FG001|Received Study Treatment|Overall Study|One randomized participant withdrew consent and never received study treatment.|399||
59895336|NCT03474081|76017494|FG000|COMPLETED|Overall Study||383||
59895337|NCT03474081|76017495|FG001|COMPLETED|Overall Study||387||
59895338|NCT03474081|76017494|FG000|NOT COMPLETED|Overall Study||17||
59895339|NCT03474081|76017495|FG001|NOT COMPLETED|Overall Study||13||
59895340|NCT03346434|76017507|FG000|STARTED|Overall Study||10||
59895341|NCT03346434|76017508|FG001|STARTED|Overall Study||10||
59895342|NCT03346434|76017509|FG002|STARTED|Overall Study||10||
59895343|NCT03346434|76017510|FG003|STARTED|Overall Study||10||
59895344|NCT03346434|76017511|FG004|STARTED|Overall Study||79||
59895345|NCT03346434|76017512|FG005|STARTED|Overall Study||83||
59895346|NCT03346434|76017507|FG000|Completed Part A|Overall Study||10||
59895347|NCT03346434|76017508|FG001|Completed Part A|Overall Study||10||
59757249|NCT00774345|75876313|FG000|STARTED|Treatment||158||
59757250|NCT00774345|75876314|FG001|STARTED|Treatment||157||
59757251|NCT00774345|75876313|FG000|Participants Escalated to 5mg|Treatment||129||
59757252|NCT00774345|75876314|FG001|Participants Escalated to 5mg|Treatment||149||
59757253|NCT00774345|75876313|FG000|Participants Escalated to 10mg|Treatment||68||
59757254|NCT00774345|75876314|FG001|Participants Escalated to 10mg|Treatment||88||
59757255|NCT00774345|75876313|FG000|COMPLETED|Treatment||0||
59757256|NCT00774345|75876314|FG001|COMPLETED|Treatment||0||
59757257|NCT00774345|75876313|FG000|NOT COMPLETED|Treatment||158||
59757258|NCT00774345|75876314|FG001|NOT COMPLETED|Treatment||157||
59757259|NCT04314414|75876320|FG000|STARTED|3 Months||31||
59757260|NCT04314414|75876320|FG000|COMPLETED|3 Months||31||
59757261|NCT04314414|75876320|FG000|NOT COMPLETED|3 Months||0||
59757262|NCT04314414|75876320|FG000|STARTED|6 Months||31||
59757263|NCT04314414|75876320|FG000|COMPLETED|6 Months||29||
59895348|NCT03346434|76017509|FG002|Completed Part A|Overall Study||9||
59895349|NCT03346434|76017510|FG003|Completed Part A|Overall Study||10||
59895350|NCT03346434|76017511|FG004|Completed Part A|Overall Study||0||
59895351|NCT03346434|76017512|FG005|Completed Part A|Overall Study||0||
59895352|NCT03346434|76017507|FG000|Completed Part B (Week 16)|Overall Study||0||
59757264|NCT04314414|75876320|FG000|NOT COMPLETED|6 Months||2||
59757265|NCT00773253|75876326|FG000|STARTED|First Intervention (Week 0-24)||5||
59757266|NCT00773253|75876327|FG001|STARTED|First Intervention (Week 0-24)||5||
59757267|NCT00773253|75876326|FG000|COMPLETED|First Intervention (Week 0-24)||5||
59757268|NCT00773253|75876327|FG001|COMPLETED|First Intervention (Week 0-24)||4||
59895353|NCT03346434|76017508|FG001|Completed Part B (Week 16)|Overall Study||0||
59895354|NCT03346434|76017509|FG002|Completed Part B (Week 16)|Overall Study||0||
59895355|NCT03346434|76017510|FG003|Completed Part B (Week 16)|Overall Study||0||
59895356|NCT03346434|76017511|FG004|Completed Part B (Week 16)|Overall Study||76||
59895357|NCT03346434|76017512|FG005|Completed Part B (Week 16)|Overall Study||83||
59895358|NCT03346434|76017507|FG000|Completed Part B (Week 28)|Overall Study||0|End of Study|
59895359|NCT03346434|76017508|FG001|Completed Part B (Week 28)|Overall Study||0|End of Study|
59895360|NCT03346434|76017509|FG002|Completed Part B (Week 28)|Overall Study||0|End of Study|
59895361|NCT03346434|76017510|FG003|Completed Part B (Week 28)|Overall Study||0|End of Study|
59895362|NCT03346434|76017511|FG004|Completed Part B (Week 28)|Overall Study||1|End of Study|
59895363|NCT03346434|76017512|FG005|Completed Part B (Week 28)|Overall Study||1|End of Study|
59895364|NCT03346434|76017507|FG000|COMPLETED|Overall Study||10||
59895365|NCT03346434|76017508|FG001|COMPLETED|Overall Study||10||
59895366|NCT03346434|76017509|FG002|COMPLETED|Overall Study||9||
59895367|NCT03346434|76017510|FG003|COMPLETED|Overall Study||10||
59895368|NCT03346434|76017511|FG004|COMPLETED|Overall Study||1||
59895369|NCT03346434|76017512|FG005|COMPLETED|Overall Study||1||
59895370|NCT03346434|76017507|FG000|NOT COMPLETED|Overall Study||0||
59895371|NCT03346434|76017508|FG001|NOT COMPLETED|Overall Study||0||
59895372|NCT03346434|76017509|FG002|NOT COMPLETED|Overall Study||1||
59895373|NCT03346434|76017510|FG003|NOT COMPLETED|Overall Study||0||
59895374|NCT03346434|76017511|FG004|NOT COMPLETED|Overall Study||78||
59895375|NCT03346434|76017512|FG005|NOT COMPLETED|Overall Study||82||
59895376|NCT03393000|76017530|FG000|STARTED|Overall Study|23 subjects screened|19||
59895377|NCT03393000|76017530|FG000|COMPLETED|Overall Study|19 subjects treated|5||
59895378|NCT03393000|76017530|FG000|NOT COMPLETED|Overall Study||14||
59895379|NCT03370770|76017534|FG000|STARTED|Overall Study||204||
59895380|NCT03370770|76017534|FG000|COMPLETED|Overall Study||98||
59895381|NCT03370770|76017534|FG000|NOT COMPLETED|Overall Study||106||
59895382|NCT03473301|76017541|FG000|STARTED|Overall Study||31||
59895383|NCT03473301|76017542|FG001|STARTED|Overall Study||29||
59757269|NCT00773253|75876326|FG000|NOT COMPLETED|First Intervention (Week 0-24)||0||
59757270|NCT00773253|75876327|FG001|NOT COMPLETED|First Intervention (Week 0-24)||1||
59757271|NCT00773253|75876326|FG000|STARTED|Second Intervention (Week 24-48)||5||
59757272|NCT00773253|75876327|FG001|STARTED|Second Intervention (Week 24-48)||4||
59757273|NCT00773253|75876326|FG000|COMPLETED|Second Intervention (Week 24-48)||5||
59757274|NCT00773253|75876327|FG001|COMPLETED|Second Intervention (Week 24-48)||4||
59757275|NCT00773253|75876326|FG000|NOT COMPLETED|Second Intervention (Week 24-48)||0||
59757276|NCT00773253|75876327|FG001|NOT COMPLETED|Second Intervention (Week 24-48)||0||
59895384|NCT03473301|76017543|FG002|STARTED|Overall Study||31||
59895385|NCT03473301|76017541|FG000|COMPLETED|Overall Study||20||
59895386|NCT03473301|76017542|FG001|COMPLETED|Overall Study||23||
59895387|NCT03473301|76017543|FG002|COMPLETED|Overall Study||25||
59895388|NCT03473301|76017541|FG000|NOT COMPLETED|Overall Study||11||
59895389|NCT03473301|76017542|FG001|NOT COMPLETED|Overall Study||6||
59895390|NCT03473301|76017543|FG002|NOT COMPLETED|Overall Study||6||
59895391|NCT03390426|76017555|FG000|STARTED|Overall Study||15||
59895392|NCT03390426|76017556|FG001|STARTED|Overall Study||16||
59895393|NCT03390426|76017555|FG000|COMPLETED|Overall Study||15||
59895394|NCT03390426|76017556|FG001|COMPLETED|Overall Study||15||
59895395|NCT03390426|76017555|FG000|NOT COMPLETED|Overall Study||0||
59895396|NCT03390426|76017556|FG001|NOT COMPLETED|Overall Study||1||
59895397|NCT03472521|76017564|FG000|STARTED|Overall Study||41||
59895398|NCT03472521|76017565|FG001|STARTED|Overall Study||37||
59895399|NCT03472521|76017564|FG000|Received Allocated Intervention|Overall Study||41||
59895400|NCT03472521|76017565|FG001|Received Allocated Intervention|Overall Study||37||
59895401|NCT03472521|76017564|FG000|COMPLETED|Overall Study||35||
59895402|NCT03472521|76017565|FG001|COMPLETED|Overall Study||34||
59895403|NCT03472521|76017564|FG000|NOT COMPLETED|Overall Study||6||
59895404|NCT03472521|76017565|FG001|NOT COMPLETED|Overall Study||3||
59895405|NCT02906020|76017581|FG000|STARTED|Part 1: Dose Escalation Period||4||
59895406|NCT02906020|76017582|FG001|STARTED|Part 1: Dose Escalation Period||4||
59895407|NCT02906020|76017583|FG002|STARTED|Part 1: Dose Escalation Period||5||
59757277|NCT00773175|75876337|FG000|STARTED|Overall Study||73||
59757278|NCT00773175|75876338|FG001|STARTED|Overall Study||75||
59757279|NCT00773175|75876337|FG000|Initial Fluids Via Randomized Route|Overall Study||73||
59757280|NCT00773175|75876338|FG001|Initial Fluids Via Randomized Route|Overall Study||59||
59757281|NCT00773175|75876337|FG000|Initial Fluids Via Subcutaneous Rescue|Overall Study||0|Subcutaneous fluid administration by hylenex-facilitated infusion was given as rescue.|
59757282|NCT00773175|75876338|FG001|Initial Fluids Via Subcutaneous Rescue|Overall Study||15|Subcutaneous fluid administration by hylenex-facilitated infusion was given as rescue.|
59757283|NCT00773175|75876337|FG000|No Fluids Received|Overall Study||0||
59895408|NCT02906020|76017584|FG003|STARTED|Part 1: Dose Escalation Period||4||
59895409|NCT02906020|76017585|FG004|STARTED|Part 1: Dose Escalation Period||3||
59895410|NCT02906020|76017586|FG005|STARTED|Part 1: Dose Escalation Period||3||
59895411|NCT02906020|76017587|FG006|STARTED|Part 1: Dose Escalation Period||3||
59895412|NCT02906020|76017588|FG007|STARTED|Part 1: Dose Escalation Period||3||
59895413|NCT02906020|76017589|FG008|STARTED|Part 1: Dose Escalation Period||0||
59895414|NCT02906020|76017590|FG009|STARTED|Part 1: Dose Escalation Period||0||
59895415|NCT02906020|76017591|FG010|STARTED|Part 1: Dose Escalation Period||0||
59895416|NCT02906020|76017592|FG011|STARTED|Part 1: Dose Escalation Period||0||
59895417|NCT02906020|76017593|FG012|STARTED|Part 1: Dose Escalation Period||0||
59895418|NCT02906020|76017594|FG013|STARTED|Part 1: Dose Escalation Period||0||
59895419|NCT02906020|76017595|FG014|STARTED|Part 1: Dose Escalation Period||0||
59895420|NCT02906020|76017596|FG015|STARTED|Part 1: Dose Escalation Period||0||
59895421|NCT02906020|76017581|FG000|Treated|Part 1: Dose Escalation Period||4||
59895422|NCT02906020|76017582|FG001|Treated|Part 1: Dose Escalation Period||4||
59895423|NCT02906020|76017583|FG002|Treated|Part 1: Dose Escalation Period||5||
59895424|NCT02906020|76017584|FG003|Treated|Part 1: Dose Escalation Period||4||
59895425|NCT02906020|76017585|FG004|Treated|Part 1: Dose Escalation Period||3||
59895426|NCT02906020|76017586|FG005|Treated|Part 1: Dose Escalation Period||3||
59895427|NCT02906020|76017587|FG006|Treated|Part 1: Dose Escalation Period||3||
59895428|NCT02906020|76017588|FG007|Treated|Part 1: Dose Escalation Period||3||
59895429|NCT02906020|76017589|FG008|Treated|Part 1: Dose Escalation Period||0||
59895430|NCT02906020|76017590|FG009|Treated|Part 1: Dose Escalation Period||0||
59895431|NCT02906020|76017591|FG010|Treated|Part 1: Dose Escalation Period||0||
59895432|NCT02906020|76017592|FG011|Treated|Part 1: Dose Escalation Period||0||
59895433|NCT02906020|76017593|FG012|Treated|Part 1: Dose Escalation Period||0||
59895434|NCT02906020|76017594|FG013|Treated|Part 1: Dose Escalation Period||0||
59895435|NCT02906020|76017595|FG014|Treated|Part 1: Dose Escalation Period||0||
59895436|NCT02906020|76017596|FG015|Treated|Part 1: Dose Escalation Period||0||
59895437|NCT02906020|76017581|FG000|COMPLETED|Part 1: Dose Escalation Period||4||
59895438|NCT02906020|76017582|FG001|COMPLETED|Part 1: Dose Escalation Period||3||
59895439|NCT02906020|76017583|FG002|COMPLETED|Part 1: Dose Escalation Period||5||
59895440|NCT02906020|76017584|FG003|COMPLETED|Part 1: Dose Escalation Period||3||
59895441|NCT02906020|76017585|FG004|COMPLETED|Part 1: Dose Escalation Period||3||
59895442|NCT02906020|76017586|FG005|COMPLETED|Part 1: Dose Escalation Period||3||
59895443|NCT02906020|76017587|FG006|COMPLETED|Part 1: Dose Escalation Period||3||
59895444|NCT02906020|76017588|FG007|COMPLETED|Part 1: Dose Escalation Period||3||
59895445|NCT02906020|76017589|FG008|COMPLETED|Part 1: Dose Escalation Period||0||
59895446|NCT02906020|76017590|FG009|COMPLETED|Part 1: Dose Escalation Period||0||
59895447|NCT02906020|76017591|FG010|COMPLETED|Part 1: Dose Escalation Period||0||
59895448|NCT02906020|76017592|FG011|COMPLETED|Part 1: Dose Escalation Period||0||
59895449|NCT02906020|76017593|FG012|COMPLETED|Part 1: Dose Escalation Period||0||
59895450|NCT02906020|76017594|FG013|COMPLETED|Part 1: Dose Escalation Period||0||
59895451|NCT02906020|76017595|FG014|COMPLETED|Part 1: Dose Escalation Period||0||
59895452|NCT02906020|76017596|FG015|COMPLETED|Part 1: Dose Escalation Period||0||
59895453|NCT02906020|76017581|FG000|NOT COMPLETED|Part 1: Dose Escalation Period||0||
59895454|NCT02906020|76017582|FG001|NOT COMPLETED|Part 1: Dose Escalation Period||1||
59895455|NCT02906020|76017583|FG002|NOT COMPLETED|Part 1: Dose Escalation Period||0||
59895456|NCT02906020|76017584|FG003|NOT COMPLETED|Part 1: Dose Escalation Period||1||
59895457|NCT02906020|76017585|FG004|NOT COMPLETED|Part 1: Dose Escalation Period||0||
59895458|NCT02906020|76017586|FG005|NOT COMPLETED|Part 1: Dose Escalation Period||0||
59895459|NCT02906020|76017587|FG006|NOT COMPLETED|Part 1: Dose Escalation Period||0||
59895460|NCT02906020|76017588|FG007|NOT COMPLETED|Part 1: Dose Escalation Period||0||
59895461|NCT02906020|76017589|FG008|NOT COMPLETED|Part 1: Dose Escalation Period||0||
59895462|NCT02906020|76017590|FG009|NOT COMPLETED|Part 1: Dose Escalation Period||0||
59895463|NCT02906020|76017591|FG010|NOT COMPLETED|Part 1: Dose Escalation Period||0||
59895464|NCT02906020|76017592|FG011|NOT COMPLETED|Part 1: Dose Escalation Period||0||
59895465|NCT02906020|76017593|FG012|NOT COMPLETED|Part 1: Dose Escalation Period||0||
59895466|NCT02906020|76017594|FG013|NOT COMPLETED|Part 1: Dose Escalation Period||0||
59895467|NCT02906020|76017595|FG014|NOT COMPLETED|Part 1: Dose Escalation Period||0||
59895468|NCT02906020|76017596|FG015|NOT COMPLETED|Part 1: Dose Escalation Period||0||
59895469|NCT02906020|76017581|FG000|STARTED|Part 2: Double-blind Treatment Period||0||
59895470|NCT02906020|76017582|FG001|STARTED|Part 2: Double-blind Treatment Period||0||
59895471|NCT02906020|76017583|FG002|STARTED|Part 2: Double-blind Treatment Period||0||
59895472|NCT02906020|76017584|FG003|STARTED|Part 2: Double-blind Treatment Period||0||
59895473|NCT02906020|76017585|FG004|STARTED|Part 2: Double-blind Treatment Period||0||
59895474|NCT02906020|76017586|FG005|STARTED|Part 2: Double-blind Treatment Period||0||
59895475|NCT02906020|76017587|FG006|STARTED|Part 2: Double-blind Treatment Period||0||
59895476|NCT02906020|76017588|FG007|STARTED|Part 2: Double-blind Treatment Period||0||
59895477|NCT02906020|76017589|FG008|STARTED|Part 2: Double-blind Treatment Period||111||
59895478|NCT02906020|76017590|FG009|STARTED|Part 2: Double-blind Treatment Period||110||
59895479|NCT02906020|76017591|FG010|STARTED|Part 2: Double-blind Treatment Period||10||
59895480|NCT02906020|76017592|FG011|STARTED|Part 2: Double-blind Treatment Period||13||
59895481|NCT02906020|76017593|FG012|STARTED|Part 2: Double-blind Treatment Period||0||
59895482|NCT02906020|76017594|FG013|STARTED|Part 2: Double-blind Treatment Period||0||
59895483|NCT02906020|76017595|FG014|STARTED|Part 2: Double-blind Treatment Period||0||
59895484|NCT02906020|76017596|FG015|STARTED|Part 2: Double-blind Treatment Period||0||
59895485|NCT02906020|76017581|FG000|Treated|Part 2: Double-blind Treatment Period||0||
59895486|NCT02906020|76017582|FG001|Treated|Part 2: Double-blind Treatment Period||0||
59895487|NCT02906020|76017583|FG002|Treated|Part 2: Double-blind Treatment Period||0||
59895488|NCT02906020|76017584|FG003|Treated|Part 2: Double-blind Treatment Period||0||
59895489|NCT02906020|76017585|FG004|Treated|Part 2: Double-blind Treatment Period||0||
59895490|NCT02906020|76017586|FG005|Treated|Part 2: Double-blind Treatment Period||0||
59895491|NCT02906020|76017587|FG006|Treated|Part 2: Double-blind Treatment Period||0||
59895492|NCT02906020|76017588|FG007|Treated|Part 2: Double-blind Treatment Period||0||
59895493|NCT02906020|76017589|FG008|Treated|Part 2: Double-blind Treatment Period||111||
59895494|NCT02906020|76017590|FG009|Treated|Part 2: Double-blind Treatment Period||110||
59895495|NCT02906020|76017591|FG010|Treated|Part 2: Double-blind Treatment Period||10||
59895496|NCT02906020|76017592|FG011|Treated|Part 2: Double-blind Treatment Period||13||
59895497|NCT02906020|76017593|FG012|Treated|Part 2: Double-blind Treatment Period||0||
59895498|NCT02906020|76017594|FG013|Treated|Part 2: Double-blind Treatment Period||0||
59895499|NCT02906020|76017595|FG014|Treated|Part 2: Double-blind Treatment Period||0||
59895500|NCT02906020|76017596|FG015|Treated|Part 2: Double-blind Treatment Period||0||
59895501|NCT02906020|76017581|FG000|COMPLETED|Part 2: Double-blind Treatment Period||0||
59895502|NCT02906020|76017582|FG001|COMPLETED|Part 2: Double-blind Treatment Period||0||
59895503|NCT02906020|76017583|FG002|COMPLETED|Part 2: Double-blind Treatment Period||0||
59895504|NCT02906020|76017584|FG003|COMPLETED|Part 2: Double-blind Treatment Period||0||
59895505|NCT02906020|76017585|FG004|COMPLETED|Part 2: Double-blind Treatment Period||0||
59895506|NCT02906020|76017586|FG005|COMPLETED|Part 2: Double-blind Treatment Period||0||
59895507|NCT02906020|76017587|FG006|COMPLETED|Part 2: Double-blind Treatment Period||0||
59895508|NCT02906020|76017588|FG007|COMPLETED|Part 2: Double-blind Treatment Period||0||
59895509|NCT02906020|76017589|FG008|COMPLETED|Part 2: Double-blind Treatment Period||99||
59895510|NCT02906020|76017590|FG009|COMPLETED|Part 2: Double-blind Treatment Period||85||
59895511|NCT02906020|76017591|FG010|COMPLETED|Part 2: Double-blind Treatment Period||10||
59895512|NCT02906020|76017592|FG011|COMPLETED|Part 2: Double-blind Treatment Period||13||
59895513|NCT02906020|76017593|FG012|COMPLETED|Part 2: Double-blind Treatment Period||0||
59895514|NCT02906020|76017594|FG013|COMPLETED|Part 2: Double-blind Treatment Period||0||
59895515|NCT02906020|76017595|FG014|COMPLETED|Part 2: Double-blind Treatment Period||0||
59895516|NCT02906020|76017596|FG015|COMPLETED|Part 2: Double-blind Treatment Period||0||
59895517|NCT02906020|76017581|FG000|NOT COMPLETED|Part 2: Double-blind Treatment Period||0||
59895518|NCT02906020|76017582|FG001|NOT COMPLETED|Part 2: Double-blind Treatment Period||0||
59895519|NCT02906020|76017583|FG002|NOT COMPLETED|Part 2: Double-blind Treatment Period||0||
59895520|NCT02906020|76017584|FG003|NOT COMPLETED|Part 2: Double-blind Treatment Period||0||
59895521|NCT02906020|76017585|FG004|NOT COMPLETED|Part 2: Double-blind Treatment Period||0||
59895522|NCT02906020|76017586|FG005|NOT COMPLETED|Part 2: Double-blind Treatment Period||0||
59895523|NCT02906020|76017587|FG006|NOT COMPLETED|Part 2: Double-blind Treatment Period||0||
59895524|NCT02906020|76017588|FG007|NOT COMPLETED|Part 2: Double-blind Treatment Period||0||
59895525|NCT02906020|76017589|FG008|NOT COMPLETED|Part 2: Double-blind Treatment Period||12||
59895526|NCT02906020|76017590|FG009|NOT COMPLETED|Part 2: Double-blind Treatment Period||25||
59895527|NCT02906020|76017591|FG010|NOT COMPLETED|Part 2: Double-blind Treatment Period||0||
59895528|NCT02906020|76017592|FG011|NOT COMPLETED|Part 2: Double-blind Treatment Period||0||
59895529|NCT02906020|76017593|FG012|NOT COMPLETED|Part 2: Double-blind Treatment Period||0||
59895530|NCT02906020|76017594|FG013|NOT COMPLETED|Part 2: Double-blind Treatment Period||0||
59895531|NCT02906020|76017595|FG014|NOT COMPLETED|Part 2: Double-blind Treatment Period||0||
59895532|NCT02906020|76017596|FG015|NOT COMPLETED|Part 2: Double-blind Treatment Period||0||
59895533|NCT02906020|76017581|FG000|STARTED|Part 2: Long-term Follow-up Period||0||
59895534|NCT02906020|76017582|FG001|STARTED|Part 2: Long-term Follow-up Period||0||
59895535|NCT02906020|76017583|FG002|STARTED|Part 2: Long-term Follow-up Period||0||
59895536|NCT02906020|76017584|FG003|STARTED|Part 2: Long-term Follow-up Period||0||
59895537|NCT02906020|76017585|FG004|STARTED|Part 2: Long-term Follow-up Period||0||
59895538|NCT02906020|76017586|FG005|STARTED|Part 2: Long-term Follow-up Period||0||
59895539|NCT02906020|76017587|FG006|STARTED|Part 2: Long-term Follow-up Period||0||
59895540|NCT02906020|76017588|FG007|STARTED|Part 2: Long-term Follow-up Period||0||
59895541|NCT02906020|76017589|FG008|STARTED|Part 2: Long-term Follow-up Period||0||
59895542|NCT02906020|76017590|FG009|STARTED|Part 2: Long-term Follow-up Period||0||
59895543|NCT02906020|76017591|FG010|STARTED|Part 2: Long-term Follow-up Period||0||
59895544|NCT02906020|76017592|FG011|STARTED|Part 2: Long-term Follow-up Period||0||
59895545|NCT02906020|76017593|FG012|STARTED|Part 2: Long-term Follow-up Period||99||
59895546|NCT02906020|76017594|FG013|STARTED|Part 2: Long-term Follow-up Period||85||
59895547|NCT02906020|76017595|FG014|STARTED|Part 2: Long-term Follow-up Period||10||
59895548|NCT02906020|76017596|FG015|STARTED|Part 2: Long-term Follow-up Period|Out of 13 completed participants in the previous part 2 DB period-arm, 2 didn't enter LTFU period.|11||
59895549|NCT02906020|76017581|FG000|Treated|Part 2: Long-term Follow-up Period||0||
59895550|NCT02906020|76017582|FG001|Treated|Part 2: Long-term Follow-up Period||0||
59895551|NCT02906020|76017583|FG002|Treated|Part 2: Long-term Follow-up Period||0||
59895552|NCT02906020|76017584|FG003|Treated|Part 2: Long-term Follow-up Period||0||
59895553|NCT02906020|76017585|FG004|Treated|Part 2: Long-term Follow-up Period||0||
59895554|NCT02906020|76017586|FG005|Treated|Part 2: Long-term Follow-up Period||0||
59895555|NCT02906020|76017587|FG006|Treated|Part 2: Long-term Follow-up Period||0||
59895556|NCT02906020|76017588|FG007|Treated|Part 2: Long-term Follow-up Period||0||
59895557|NCT02906020|76017589|FG008|Treated|Part 2: Long-term Follow-up Period||0||
59895558|NCT02906020|76017590|FG009|Treated|Part 2: Long-term Follow-up Period||0||
59895559|NCT02906020|76017591|FG010|Treated|Part 2: Long-term Follow-up Period||0||
59895560|NCT02906020|76017592|FG011|Treated|Part 2: Long-term Follow-up Period||0||
59895561|NCT02906020|76017593|FG012|Treated|Part 2: Long-term Follow-up Period||87||
59895562|NCT02906020|76017594|FG013|Treated|Part 2: Long-term Follow-up Period||75||
59895563|NCT02906020|76017595|FG014|Treated|Part 2: Long-term Follow-up Period||10||
59895564|NCT02906020|76017596|FG015|Treated|Part 2: Long-term Follow-up Period||11||
59895565|NCT02906020|76017581|FG000|COMPLETED|Part 2: Long-term Follow-up Period||0||
59895566|NCT02906020|76017582|FG001|COMPLETED|Part 2: Long-term Follow-up Period||0||
59895567|NCT02906020|76017583|FG002|COMPLETED|Part 2: Long-term Follow-up Period||0||
59895568|NCT02906020|76017584|FG003|COMPLETED|Part 2: Long-term Follow-up Period||0||
59895569|NCT02906020|76017585|FG004|COMPLETED|Part 2: Long-term Follow-up Period||0||
59895570|NCT02906020|76017586|FG005|COMPLETED|Part 2: Long-term Follow-up Period||0||
59895571|NCT02906020|76017587|FG006|COMPLETED|Part 2: Long-term Follow-up Period||0||
59895572|NCT02906020|76017588|FG007|COMPLETED|Part 2: Long-term Follow-up Period||0||
59895573|NCT02906020|76017589|FG008|COMPLETED|Part 2: Long-term Follow-up Period||0||
59895574|NCT02906020|76017590|FG009|COMPLETED|Part 2: Long-term Follow-up Period||0||
59895575|NCT02906020|76017591|FG010|COMPLETED|Part 2: Long-term Follow-up Period||0||
59895576|NCT02906020|76017592|FG011|COMPLETED|Part 2: Long-term Follow-up Period||0||
59895577|NCT02906020|76017593|FG012|COMPLETED|Part 2: Long-term Follow-up Period||0||
59895578|NCT02906020|76017594|FG013|COMPLETED|Part 2: Long-term Follow-up Period||0||
59895579|NCT02906020|76017595|FG014|COMPLETED|Part 2: Long-term Follow-up Period||0||
59505695|NCT00738023|75598550|FG000|NOT COMPLETED|Saline Infusion||0||
59505696|NCT00738023|75598551|FG001|NOT COMPLETED|Saline Infusion||0||
59505697|NCT00738023|75598550|FG000|STARTED|Intralipid Infusion (Post 6 Wks of Drug)||19||
59505698|NCT00738023|75598551|FG001|STARTED|Intralipid Infusion (Post 6 Wks of Drug)||0||
59505699|NCT00738023|75598550|FG000|COMPLETED|Intralipid Infusion (Post 6 Wks of Drug)||19||
59505700|NCT00738023|75598551|FG001|COMPLETED|Intralipid Infusion (Post 6 Wks of Drug)||0||
59505701|NCT00738023|75598550|FG000|NOT COMPLETED|Intralipid Infusion (Post 6 Wks of Drug)||0||
59505702|NCT00738023|75598551|FG001|NOT COMPLETED|Intralipid Infusion (Post 6 Wks of Drug)||0||
59505703|NCT03808909|75598560|FG000|STARTED|Overall Study||12||
59505704|NCT03808909|75598561|FG001|STARTED|Overall Study||1||
59505705|NCT03808909|75598560|FG000|COMPLETED|Overall Study||9||
59505706|NCT03808909|75598561|FG001|COMPLETED|Overall Study||1||
59505707|NCT03808909|75598560|FG000|NOT COMPLETED|Overall Study||3||
59505708|NCT03808909|75598561|FG001|NOT COMPLETED|Overall Study||0||
59505709|NCT00708851|75598567|FG000|STARTED|Overall Study||12||
59505710|NCT00708851|75598567|FG000|COMPLETED|Overall Study||12||
59505711|NCT00708851|75598567|FG000|NOT COMPLETED|Overall Study||0||
59505712|NCT00739583|75598575|FG000|STARTED|Overall Study||10||
59505713|NCT00739583|75598576|FG001|STARTED|Overall Study||10||
59505714|NCT00739583|75598575|FG000|COMPLETED|Overall Study||10||
59505715|NCT00739583|75598576|FG001|COMPLETED|Overall Study||10||
59505716|NCT00739583|75598575|FG000|NOT COMPLETED|Overall Study||0||
59505717|NCT00739583|75598576|FG001|NOT COMPLETED|Overall Study||0||
59505718|NCT03802513|75598582|FG000|STARTED|Overall Study||10||
59610551|NCT01838616|75721428|FG001|Per Protocol Set|Titration Period||112||
59895580|NCT02906020|76017596|FG015|COMPLETED|Part 2: Long-term Follow-up Period||0||
59895581|NCT02906020|76017581|FG000|NOT COMPLETED|Part 2: Long-term Follow-up Period||0||
59895582|NCT02906020|76017582|FG001|NOT COMPLETED|Part 2: Long-term Follow-up Period||0||
59895583|NCT02906020|76017583|FG002|NOT COMPLETED|Part 2: Long-term Follow-up Period||0||
59895584|NCT02906020|76017584|FG003|NOT COMPLETED|Part 2: Long-term Follow-up Period||0||
59895585|NCT02906020|76017585|FG004|NOT COMPLETED|Part 2: Long-term Follow-up Period||0||
59895586|NCT02906020|76017586|FG005|NOT COMPLETED|Part 2: Long-term Follow-up Period||0||
59895587|NCT02906020|76017587|FG006|NOT COMPLETED|Part 2: Long-term Follow-up Period||0||
59895588|NCT02906020|76017588|FG007|NOT COMPLETED|Part 2: Long-term Follow-up Period||0||
59895589|NCT02906020|76017589|FG008|NOT COMPLETED|Part 2: Long-term Follow-up Period||0||
59895590|NCT02906020|76017590|FG009|NOT COMPLETED|Part 2: Long-term Follow-up Period||0||
59895591|NCT02906020|76017591|FG010|NOT COMPLETED|Part 2: Long-term Follow-up Period||0||
59895592|NCT02906020|76017592|FG011|NOT COMPLETED|Part 2: Long-term Follow-up Period||0||
59895593|NCT02906020|76017593|FG012|NOT COMPLETED|Part 2: Long-term Follow-up Period||99||
59895594|NCT02906020|76017594|FG013|NOT COMPLETED|Part 2: Long-term Follow-up Period||85||
59895595|NCT02906020|76017595|FG014|NOT COMPLETED|Part 2: Long-term Follow-up Period||10||
59895596|NCT02906020|76017596|FG015|NOT COMPLETED|Part 2: Long-term Follow-up Period||11||
59895597|NCT03499353|76017624|FG000|STARTED|Treatment||61||
59895598|NCT03499353|76017624|FG000|COMPLETED|Treatment||45||
59895599|NCT03499353|76017624|FG000|NOT COMPLETED|Treatment||16||
59895600|NCT03499353|76017624|FG000|STARTED|Safety Follow-up||49||
59895601|NCT03499353|76017624|FG000|Received Treatment|Safety Follow-up||0||
59505719|NCT03802513|75598582|FG000|COMPLETED|Overall Study||9||
59505720|NCT03802513|75598582|FG000|NOT COMPLETED|Overall Study||1||
59505721|NCT00723931|75598586|FG000|STARTED|Overall Study||1267||
59505722|NCT00723931|75598586|FG000|COMPLETED|Overall Study||1267||
59610552|NCT01838616|75721427|FG000|COMPLETED|Titration Period||100||
59757284|NCT00773175|75876338|FG001|No Fluids Received|Overall Study||1||
59895602|NCT03499353|76017624|FG000|COMPLETED|Safety Follow-up||49||
59895603|NCT03499353|76017624|FG000|NOT COMPLETED|Safety Follow-up||0||
59895604|NCT03499353|76017624|FG000|STARTED|Long-Term Follow-up||58||
59895605|NCT03499353|76017624|FG000|Received Treatment|Long-Term Follow-up||0||
59895606|NCT03499353|76017624|FG000|COMPLETED|Long-Term Follow-up||0||
59895607|NCT03499353|76017624|FG000|NOT COMPLETED|Long-Term Follow-up||58||
59895608|NCT00004259|76017632|FG000|STARTED|Overall Study||98||
59895609|NCT00004259|76017633|FG001|STARTED|Overall Study||103||
59895610|NCT00004259|76017634|FG002|STARTED|Overall Study||15||
59610553|NCT01838616|75721428|FG001|COMPLETED|Titration Period||62||
59610554|NCT01838616|75721427|FG000|NOT COMPLETED|Titration Period||30||
59610555|NCT01838616|75721428|FG001|NOT COMPLETED|Titration Period||66||
59610556|NCT01838616|75721427|FG000|STARTED|Continuation Period||100||
59610557|NCT01838616|75721428|FG001|STARTED|Continuation Period||62||
59610558|NCT01838616|75721427|FG000|Switched to Pick-up Arm|Continuation Period||0||
59610559|NCT01838616|75721428|FG001|Switched to Pick-up Arm|Continuation Period||7||
59610560|NCT01838616|75721427|FG000|COMPLETED|Continuation Period||86||
59610561|NCT01838616|75721428|FG001|COMPLETED|Continuation Period||48||
59610562|NCT01838616|75721427|FG000|NOT COMPLETED|Continuation Period||14||
59610563|NCT01838616|75721428|FG001|NOT COMPLETED|Continuation Period||14||
59610564|NCT01838616|75721427|FG000|STARTED|Pick-up Arm|Switch to Tapentadol (PR) after Oxycodone/Naloxone (PR) treatment discontinuation.|50||
59895611|NCT00004259|76017635|FG003|STARTED|Overall Study||14||
59895612|NCT00004259|76017632|FG000|COMPLETED|Overall Study||97||
59895613|NCT00004259|76017633|FG001|COMPLETED|Overall Study||99||
59895614|NCT00004259|76017634|FG002|COMPLETED|Overall Study||15||
59895615|NCT00004259|76017635|FG003|COMPLETED|Overall Study||14||
59895616|NCT00004259|76017632|FG000|NOT COMPLETED|Overall Study||1||
59895617|NCT00004259|76017633|FG001|NOT COMPLETED|Overall Study||4||
59895618|NCT00004259|76017634|FG002|NOT COMPLETED|Overall Study||0||
59895619|NCT00004259|76017635|FG003|NOT COMPLETED|Overall Study||0||
59895620|NCT02819050|76017650|FG000|STARTED|Overall Study||40||
59895621|NCT02819050|76017651|FG001|STARTED|Overall Study||40||
59895622|NCT02819050|76017650|FG000|COMPLETED|Overall Study||40||
59895623|NCT02819050|76017651|FG001|COMPLETED|Overall Study||40||
59895624|NCT02819050|76017650|FG000|NOT COMPLETED|Overall Study||0||
59895625|NCT02819050|76017651|FG001|NOT COMPLETED|Overall Study||0||
59895626|NCT03365934|76017659|FG000|STARTED|Overall Study||35||
59895627|NCT03365934|76017659|FG000|COMPLETED|Overall Study||33||
59895628|NCT03365934|76017659|FG000|NOT COMPLETED|Overall Study||2||
59895629|NCT03468855|76017668|FG000|STARTED|Overall Study||34||
59895630|NCT03468855|76017668|FG000|COMPLETED|Overall Study||23||
59895631|NCT03468855|76017668|FG000|NOT COMPLETED|Overall Study||11||
59895632|NCT03738865|76017674|FG000|STARTED|Overall Study||66||
59895633|NCT03738865|76017675|FG001|STARTED|Overall Study||66||
59895634|NCT03738865|76017674|FG000|COMPLETED|Overall Study||61||
59895635|NCT03738865|76017675|FG001|COMPLETED|Overall Study||62||
59895636|NCT03738865|76017674|FG000|NOT COMPLETED|Overall Study||5||
59895637|NCT03738865|76017675|FG001|NOT COMPLETED|Overall Study||4||
59895638|NCT03524157|76017684|FG000|STARTED|Overall Study||10||
59895639|NCT03524157|76017685|FG001|STARTED|Overall Study||10||
59895640|NCT03524157|76017686|FG002|STARTED|Overall Study||10||
59895641|NCT03524157|76017684|FG000|COMPLETED|Overall Study||10||
59895642|NCT03524157|76017685|FG001|COMPLETED|Overall Study||10||
59895643|NCT03524157|76017686|FG002|COMPLETED|Overall Study||9||
59895644|NCT03524157|76017684|FG000|NOT COMPLETED|Overall Study||0||
59895645|NCT03524157|76017685|FG001|NOT COMPLETED|Overall Study||0||
59895646|NCT03524157|76017686|FG002|NOT COMPLETED|Overall Study||1||
59895647|NCT02750215|76017694|FG000|STARTED|Overall Study||20||
59895648|NCT02750215|76017694|FG000|COMPLETED|Overall Study||20||
59895649|NCT02750215|76017694|FG000|NOT COMPLETED|Overall Study||0||
59895650|NCT03437733|76017700|FG000|STARTED|Overall Study||8||
59505723|NCT00723931|75598586|FG000|NOT COMPLETED|Overall Study||0||
59505724|NCT00740129|75598590|FG000|STARTED|Overall Study||6||
59505725|NCT00740129|75598590|FG000|COMPLETED|Overall Study||6||
59505726|NCT00740129|75598590|FG000|NOT COMPLETED|Overall Study||0||
59505727|NCT00762853|75598597|FG000|STARTED|First Treatment Period||10||
59505728|NCT00762853|75598598|FG001|STARTED|First Treatment Period||10||
59505729|NCT00762853|75598597|FG000|COMPLETED|First Treatment Period||10||
59505730|NCT00762853|75598598|FG001|COMPLETED|First Treatment Period||10||
59505731|NCT00762853|75598597|FG000|NOT COMPLETED|First Treatment Period||0||
59610565|NCT01838616|75721428|FG001|STARTED|Pick-up Arm||0||
59610566|NCT01838616|75721427|FG000|Full Analysis Set|Pick-up Arm||49||
59895651|NCT03437733|76017701|FG001|STARTED|Overall Study||90||
59505732|NCT00762853|75598598|FG001|NOT COMPLETED|First Treatment Period||0||
59895652|NCT03437733|76017700|FG000|Safety|Overall Study||8||
59895653|NCT03437733|76017701|FG001|Safety|Overall Study||87||
59895654|NCT03437733|76017700|FG000|COMPLETED|Overall Study||8||
59895655|NCT03437733|76017701|FG001|COMPLETED|Overall Study||87||
59895656|NCT03437733|76017700|FG000|NOT COMPLETED|Overall Study||0||
59895657|NCT03437733|76017701|FG001|NOT COMPLETED|Overall Study||3||
59895658|NCT03468543|76017709|FG000|STARTED|Overall Study||3||
59895659|NCT03468543|76017709|FG000|COMPLETED|Overall Study||0||
59895660|NCT03468543|76017709|FG000|NOT COMPLETED|Overall Study||3||
59895661|NCT03467763|76017713|FG000|STARTED|Overall Study||13||
59895662|NCT03467763|76017713|FG000|Weeks 1-2|Overall Study||13||
59895663|NCT03467763|76017713|FG000|Weeks 3-4|Overall Study||10||
59895664|NCT03467763|76017713|FG000|Weeks 5-6|Overall Study||8||
59895665|NCT03467763|76017713|FG000|Weeks 7-8|Overall Study||7||
59895666|NCT03467763|76017713|FG000|Weeks 9 - 10|Overall Study||6||
59895667|NCT03467763|76017713|FG000|Week 11-12|Overall Study||6||
59895668|NCT03467763|76017713|FG000|Weeks 13-14|Overall Study||2||
59895669|NCT03467763|76017713|FG000|Weeks 15-16|Overall Study||2||
59895670|NCT03467763|76017713|FG000|COMPLETED|Overall Study||10|Subjects who stopped medication after completing a period are considered to have completed the study|
59895671|NCT03467763|76017713|FG000|NOT COMPLETED|Overall Study||3||
59895672|NCT00004031|76017721|FG000|STARTED|Overall Study||128||
59895673|NCT00004031|76017722|FG001|STARTED|Overall Study||125||
59895674|NCT00004031|76017721|FG000|Assessed for Adverse Events|Overall Study||123||
59895675|NCT00004031|76017722|FG001|Assessed for Adverse Events|Overall Study||113||
59895676|NCT00004031|76017721|FG000|COMPLETED|Overall Study||103||
59895677|NCT00004031|76017722|FG001|COMPLETED|Overall Study||104||
59895678|NCT00004031|76017721|FG000|NOT COMPLETED|Overall Study||25||
59895679|NCT00004031|76017722|FG001|NOT COMPLETED|Overall Study||21||
59895680|NCT03467217|76017732|FG000|STARTED|Overall Study||43||
59895681|NCT03467217|76017733|FG001|STARTED|Overall Study||40||
59895682|NCT03467217|76017732|FG000|COMPLETED|Overall Study||33||
59895683|NCT03467217|76017733|FG001|COMPLETED|Overall Study||34||
59895684|NCT03467217|76017732|FG000|NOT COMPLETED|Overall Study||10||
59895685|NCT03467217|76017733|FG001|NOT COMPLETED|Overall Study||6||
59895686|NCT00003875|76017739|FG000|STARTED|Overall Study||30||
59895687|NCT00003875|76017739|FG000|COMPLETED|Overall Study||29||
59895688|NCT00003875|76017739|FG000|NOT COMPLETED|Overall Study||1||
59895689|NCT03364686|76017743|FG000|STARTED|Overall Study||6||
59895690|NCT03364686|76017743|FG000|COMPLETED|Overall Study||4||
59895691|NCT03364686|76017743|FG000|NOT COMPLETED|Overall Study||2||
59895692|NCT03437577|76017750|FG000|STARTED|Pre-Randomization||0||
59895693|NCT03437577|76017751|FG001|STARTED|Pre-Randomization||0||
59895694|NCT03437577|76017752|FG002|STARTED|Pre-Randomization||10||
59895695|NCT03437577|76017750|FG000|COMPLETED|Pre-Randomization||0||
59895696|NCT03437577|76017751|FG001|COMPLETED|Pre-Randomization||0||
59895697|NCT03437577|76017752|FG002|COMPLETED|Pre-Randomization||0||
59895698|NCT03437577|76017750|FG000|NOT COMPLETED|Pre-Randomization||0||
59895699|NCT03437577|76017751|FG001|NOT COMPLETED|Pre-Randomization||0||
59895700|NCT03437577|76017752|FG002|NOT COMPLETED|Pre-Randomization||10||
59895701|NCT03437577|76017750|FG000|STARTED|Post-Randomization||3||
59895702|NCT03437577|76017751|FG001|STARTED|Post-Randomization||5||
59895703|NCT03437577|76017752|FG002|STARTED|Post-Randomization||0||
59895704|NCT03437577|76017750|FG000|COMPLETED|Post-Randomization||3||
59895705|NCT03437577|76017751|FG001|COMPLETED|Post-Randomization||3||
59895706|NCT03437577|76017752|FG002|COMPLETED|Post-Randomization||0||
59895707|NCT03437577|76017750|FG000|NOT COMPLETED|Post-Randomization||0||
59895708|NCT03437577|76017751|FG001|NOT COMPLETED|Post-Randomization||2||
59895709|NCT03437577|76017752|FG002|NOT COMPLETED|Post-Randomization||0||
59895710|NCT03336528|76017760|FG000|STARTED|Overall Study||92||
59895711|NCT03336528|76017761|FG001|STARTED|Overall Study||88||
59895712|NCT03336528|76017760|FG000|Participated in Optional Outpatient Study|Overall Study||72||
59895713|NCT03336528|76017761|FG001|Participated in Optional Outpatient Study|Overall Study||59||
59895714|NCT03336528|76017760|FG000|COMPLETED|Overall Study||82|Completed inpatient portion of the study|
59895715|NCT03336528|76017761|FG001|COMPLETED|Overall Study||79|Completed inpatient portion of the study|
59895716|NCT03336528|76017760|FG000|NOT COMPLETED|Overall Study||10||
59895717|NCT03336528|76017761|FG001|NOT COMPLETED|Overall Study||9||
59895718|NCT03364608|76017769|FG000|STARTED|Overall Study||86|ITT Analysis Set|
59895719|NCT03364608|76017769|FG000|Placebo MDI|Overall Study||82|(2 actuations)|
59895720|NCT03364608|76017769|FG000|AS MDI 90 µg|Overall Study||81|(2 actuations of 45 µg/actuation)|
59895721|NCT03364608|76017769|FG000|AS MDI 180 µg|Overall Study||81|(2 actuations of 90 µg/actuation)|
59895722|NCT03364608|76017769|FG000|Proventil 90 µg|Overall Study||82|(1 actuation of 90 µg/actuation)|
59895723|NCT03364608|76017769|FG000|Proventil 180 µg|Overall Study||79|(2 actuations of 90 µg/actuation)|
59895724|NCT03364608|76017769|FG000|COMPLETED|Overall Study||78||
59895725|NCT03364608|76017769|FG000|NOT COMPLETED|Overall Study||8||
59895726|NCT00003869|76017783|FG000|STARTED|Overall Study||94||
59895727|NCT00003869|76017784|FG001|STARTED|Overall Study||92||
59895728|NCT00003869|76017783|FG000|COMPLETED|Overall Study||53||
59895729|NCT00003869|76017784|FG001|COMPLETED|Overall Study||80||
59895730|NCT00003869|76017783|FG000|NOT COMPLETED|Overall Study||41||
59895731|NCT00003869|76017784|FG001|NOT COMPLETED|Overall Study||12||
59895732|NCT03344640|76017792|FG000|STARTED|Overall Study||49||
59895733|NCT03344640|76017793|FG001|STARTED|Overall Study||47||
59895734|NCT03344640|76017792|FG000|COMPLETED|Overall Study||46||
59895735|NCT03344640|76017793|FG001|COMPLETED|Overall Study||44||
59895736|NCT03344640|76017792|FG000|NOT COMPLETED|Overall Study||3||
59895737|NCT03344640|76017793|FG001|NOT COMPLETED|Overall Study||3||
59895738|NCT03344640|76017792|FG000|STARTED|Follow-up Epoch||46||
59895739|NCT03344640|76017793|FG001|STARTED|Follow-up Epoch||44||
59895740|NCT03344640|76017792|FG000|COMPLETED|Follow-up Epoch||46||
59895741|NCT03344640|76017793|FG001|COMPLETED|Follow-up Epoch||42||
59895742|NCT03344640|76017792|FG000|NOT COMPLETED|Follow-up Epoch||0||
59895743|NCT03344640|76017793|FG001|NOT COMPLETED|Follow-up Epoch||2||
59895744|NCT03344562|76017801|FG000|STARTED|Overall Study||10||
59895745|NCT03344562|76017802|FG001|STARTED|Overall Study||9||
59895746|NCT03344562|76017801|FG000|COMPLETED|Overall Study||8||
59895747|NCT03344562|76017802|FG001|COMPLETED|Overall Study||9||
59895748|NCT03344562|76017801|FG000|NOT COMPLETED|Overall Study||2||
59895749|NCT03344562|76017802|FG001|NOT COMPLETED|Overall Study||0||
59895750|NCT00003659|76017808|FG000|STARTED|Overall Study||39||
59895751|NCT00003659|76017808|FG000|COMPLETED|Overall Study||36||
59895752|NCT00003659|76017808|FG000|NOT COMPLETED|Overall Study||3||
59895753|NCT03494985|76017816|FG000|STARTED|Overall Study||101||
59895754|NCT03494985|76017817|FG001|STARTED|Overall Study||98||
59895755|NCT03494985|76017818|FG002|STARTED|Overall Study||98||
59895756|NCT03494985|76017819|FG003|STARTED|Overall Study||99||
59895757|NCT03494985|76017816|FG000|COMPLETED|Overall Study||96||
59895758|NCT03494985|76017817|FG001|COMPLETED|Overall Study||92||
59895759|NCT03494985|76017818|FG002|COMPLETED|Overall Study||92||
59895760|NCT03494985|76017819|FG003|COMPLETED|Overall Study||94||
59895761|NCT03494985|76017816|FG000|NOT COMPLETED|Overall Study||5||
59895762|NCT03494985|76017817|FG001|NOT COMPLETED|Overall Study||6||
59895763|NCT03494985|76017818|FG002|NOT COMPLETED|Overall Study||6||
59895764|NCT03494985|76017819|FG003|NOT COMPLETED|Overall Study||5||
59895765|NCT00003509|76017829|FG000|STARTED|Overall Study||13||
59895766|NCT00003509|76017829|FG000|COMPLETED|Overall Study||8||
59895767|NCT00003509|76017829|FG000|NOT COMPLETED|Overall Study||5||
59895768|NCT03344172|76017835|FG000|STARTED|Overall Study||16||
59895769|NCT03344172|76017836|FG001|STARTED|Overall Study||16||
59895770|NCT03344172|76017835|FG000|COMPLETED|Overall Study||15||
59895771|NCT03344172|76017836|FG001|COMPLETED|Overall Study||16||
59895772|NCT03344172|76017835|FG000|NOT COMPLETED|Overall Study||1||
59895773|NCT03344172|76017836|FG001|NOT COMPLETED|Overall Study||0||
59895774|NCT03465891|76017844|FG000|STARTED|Overall Study||1||
59895775|NCT03465891|76017845|FG001|STARTED|Overall Study||1||
59895776|NCT03465891|76017844|FG000|COMPLETED|Overall Study||0||
59895777|NCT03465891|76017845|FG001|COMPLETED|Overall Study||0||
59895778|NCT03465891|76017844|FG000|NOT COMPLETED|Overall Study||1||
59895779|NCT03465891|76017845|FG001|NOT COMPLETED|Overall Study||1||
59895780|NCT03363906|76017851|FG000|STARTED|Period 1 (Reference or Test)||15||
59895781|NCT03363906|76017852|FG001|STARTED|Period 1 (Reference or Test)||12||
59895782|NCT03363906|76017851|FG000|Received at Least One Dose of Study Drug|Period 1 (Reference or Test)||15||
59895783|NCT03363906|76017852|FG001|Received at Least One Dose of Study Drug|Period 1 (Reference or Test)||11||
59895784|NCT03363906|76017851|FG000|COMPLETED|Period 1 (Reference or Test)||14||
59895785|NCT03363906|76017852|FG001|COMPLETED|Period 1 (Reference or Test)||10||
59895786|NCT03363906|76017851|FG000|NOT COMPLETED|Period 1 (Reference or Test)||1||
59895787|NCT03363906|76017852|FG001|NOT COMPLETED|Period 1 (Reference or Test)||2||
59895788|NCT03363906|76017851|FG000|STARTED|Period 2 (Test or Reference)||14||
59505733|NCT00762853|75598597|FG000|STARTED|1 Week Washout After Treatment 1||10||
59505734|NCT00762853|75598598|FG001|STARTED|1 Week Washout After Treatment 1||10||
59505735|NCT00762853|75598597|FG000|COMPLETED|1 Week Washout After Treatment 1||10||
59505736|NCT00762853|75598598|FG001|COMPLETED|1 Week Washout After Treatment 1||10||
59505737|NCT00762853|75598597|FG000|NOT COMPLETED|1 Week Washout After Treatment 1||0||
59505738|NCT00762853|75598598|FG001|NOT COMPLETED|1 Week Washout After Treatment 1||0||
59505739|NCT00762853|75598597|FG000|STARTED|Second Treatment Period||10||
59505740|NCT00762853|75598598|FG001|STARTED|Second Treatment Period||10||
59505741|NCT00762853|75598597|FG000|COMPLETED|Second Treatment Period||10||
59505742|NCT00762853|75598598|FG001|COMPLETED|Second Treatment Period||10||
59505743|NCT00762853|75598597|FG000|NOT COMPLETED|Second Treatment Period||0||
59505744|NCT00762853|75598598|FG001|NOT COMPLETED|Second Treatment Period||0||
59895789|NCT03363906|76017852|FG001|STARTED|Period 2 (Test or Reference)||10||
59895790|NCT03363906|76017851|FG000|Received at Least One Dose of Study Drug|Period 2 (Test or Reference)||12||
59895791|NCT03363906|76017852|FG001|Received at Least One Dose of Study Drug|Period 2 (Test or Reference)||9||
59895792|NCT03363906|76017851|FG000|COMPLETED|Period 2 (Test or Reference)||10||
59505745|NCT00740207|75598606|FG000|STARTED|Overall Study||17||
59505746|NCT00740207|75598607|FG001|STARTED|Overall Study||16||
59895793|NCT03363906|76017852|FG001|COMPLETED|Period 2 (Test or Reference)||9||
60013803|NCT01671007|76129758|FG000|All Eligible|Overall Study||2066||
59505747|NCT00740207|75598606|FG000|COMPLETED|Overall Study||17||
59895794|NCT03363906|76017851|FG000|NOT COMPLETED|Period 2 (Test or Reference)||4||
59895795|NCT03363906|76017852|FG001|NOT COMPLETED|Period 2 (Test or Reference)||1||
59895796|NCT00003473|76017858|FG000|STARTED|Overall Study||20||
59895797|NCT00003473|76017858|FG000|COMPLETED|Overall Study||17||
59895798|NCT00003473|76017858|FG000|NOT COMPLETED|Overall Study||3||
59895799|NCT03343626|76017870|FG000|STARTED|Overall Study||31||
59895800|NCT03343626|76017871|FG001|STARTED|Overall Study||31||
59895801|NCT03343626|76017872|FG002|STARTED|Overall Study||31||
59895802|NCT03343626|76017873|FG003|STARTED|Overall Study||32||
59895803|NCT03343626|76017874|FG004|STARTED|Overall Study||36||
59895804|NCT03343626|76017875|FG005|STARTED|Overall Study||37||
59895805|NCT03343626|76017876|FG006|STARTED|Overall Study||37||
59895806|NCT03343626|76017877|FG007|STARTED|Overall Study||36||
59895807|NCT03343626|76017870|FG000|Safety Analysis Set|Overall Study||31|Safety Analysis Set included all participants who received at least one (1) dose of PIZV or placebo.|
59895808|NCT03343626|76017871|FG001|Safety Analysis Set|Overall Study||31|Safety Analysis Set included all participants who received at least one (1) dose of PIZV or placebo.|
59895809|NCT03343626|76017872|FG002|Safety Analysis Set|Overall Study||31|Safety Analysis Set included all participants who received at least one (1) dose of PIZV or placebo.|
59895810|NCT03343626|76017873|FG003|Safety Analysis Set|Overall Study||32|Safety Analysis Set included all participants who received at least one (1) dose of PIZV or placebo.|
59895811|NCT03343626|76017874|FG004|Safety Analysis Set|Overall Study||36|Safety Analysis Set included all participants who received at least one (1) dose of PIZV or placebo.|
59895812|NCT03343626|76017875|FG005|Safety Analysis Set|Overall Study||37|Safety Analysis Set included all participants who received at least one (1) dose of PIZV or placebo.|
59895813|NCT03343626|76017876|FG006|Safety Analysis Set|Overall Study||37|Safety Analysis Set included all participants who received at least one (1) dose of PIZV or placebo.|
59895814|NCT03343626|76017877|FG007|Safety Analysis Set|Overall Study||36|Safety Analysis Set included all participants who received at least one (1) dose of PIZV or placebo.|
59895815|NCT03343626|76017870|FG000|Full Analysis Set|Overall Study||30|Full Analysis Set (FAS) included all randomized participants who had received at least one dose of the investigational vaccine/placebo and had provided valid Baseline and at least one post-vaccination serology result.|
59895816|NCT03343626|76017871|FG001|Full Analysis Set|Overall Study||28|Full Analysis Set (FAS) included all randomized participants who had received at least one dose of the investigational vaccine/placebo and had provided valid Baseline and at least one post-vaccination serology result.|
59895817|NCT03343626|76017872|FG002|Full Analysis Set|Overall Study||31|Full Analysis Set (FAS) included all randomized participants who had received at least one dose of the investigational vaccine/placebo and had provided valid Baseline and at least one post-vaccination serology result.|
59895818|NCT03343626|76017873|FG003|Full Analysis Set|Overall Study||30|Full Analysis Set (FAS) included all randomized participants who had received at least one dose of the investigational vaccine/placebo and had provided valid Baseline and at least one post-vaccination serology result.|
59895819|NCT03343626|76017874|FG004|Full Analysis Set|Overall Study||34|Full Analysis Set (FAS) included all randomized participants who had received at least one dose of the investigational vaccine/placebo and had provided valid Baseline and at least one post-vaccination serology result.|
59895820|NCT03343626|76017875|FG005|Full Analysis Set|Overall Study||34|Full Analysis Set (FAS) included all randomized participants who had received at least one dose of the investigational vaccine/placebo and had provided valid Baseline and at least one post-vaccination serology result.|
59895821|NCT03343626|76017876|FG006|Full Analysis Set|Overall Study||34|Full Analysis Set (FAS) included all randomized participants who had received at least one dose of the investigational vaccine/placebo and had provided valid Baseline and at least one post-vaccination serology result.|
59895822|NCT03343626|76017877|FG007|Full Analysis Set|Overall Study||34|Full Analysis Set (FAS) included all randomized participants who had received at least one dose of the investigational vaccine/placebo and had provided valid Baseline and at least one post-vaccination serology result.|
59895823|NCT03343626|76017870|FG000|Per Protocol Set|Overall Study||28|Per-Protocol Set (PPS) included participants in the FAS who had no major protocol violations (relevant for the analysis, primary immunogenicity assessment or persistence assessment).|
59895824|NCT03343626|76017871|FG001|Per Protocol Set|Overall Study||25|Per-Protocol Set (PPS) included participants in the FAS who had no major protocol violations (relevant for the analysis, primary immunogenicity assessment or persistence assessment).|
59895825|NCT03343626|76017872|FG002|Per Protocol Set|Overall Study||29|Per-Protocol Set (PPS) included participants in the FAS who had no major protocol violations (relevant for the analysis, primary immunogenicity assessment or persistence assessment).|
59895826|NCT03343626|76017873|FG003|Per Protocol Set|Overall Study||30|Per-Protocol Set (PPS) included participants in the FAS who had no major protocol violations (relevant for the analysis, primary immunogenicity assessment or persistence assessment).|
59895827|NCT03343626|76017874|FG004|Per Protocol Set|Overall Study||34|Per-Protocol Set (PPS) included participants in the FAS who had no major protocol violations (relevant for the analysis, primary immunogenicity assessment or persistence assessment).|
59895828|NCT03343626|76017875|FG005|Per Protocol Set|Overall Study||33|Per-Protocol Set (PPS) included participants in the FAS who had no major protocol violations (relevant for the analysis, primary immunogenicity assessment or persistence assessment).|
59895829|NCT03343626|76017876|FG006|Per Protocol Set|Overall Study||34|Per-Protocol Set (PPS) included participants in the FAS who had no major protocol violations (relevant for the analysis, primary immunogenicity assessment or persistence assessment).|
59895830|NCT03343626|76017877|FG007|Per Protocol Set|Overall Study||33|Per-Protocol Set (PPS) included participants in the FAS who had no major protocol violations (relevant for the analysis, primary immunogenicity assessment or persistence assessment).|
59895831|NCT03343626|76017870|FG000|COMPLETED|Overall Study||25||
59895832|NCT03343626|76017871|FG001|COMPLETED|Overall Study||26||
59895833|NCT03343626|76017872|FG002|COMPLETED|Overall Study||29||
59895834|NCT03343626|76017873|FG003|COMPLETED|Overall Study||24||
59895835|NCT03343626|76017874|FG004|COMPLETED|Overall Study||29||
59895836|NCT03343626|76017875|FG005|COMPLETED|Overall Study||32||
59895837|NCT03343626|76017876|FG006|COMPLETED|Overall Study||32||
59895838|NCT03343626|76017877|FG007|COMPLETED|Overall Study||25||
59895839|NCT03343626|76017870|FG000|NOT COMPLETED|Overall Study||6||
59895840|NCT03343626|76017871|FG001|NOT COMPLETED|Overall Study||5||
59895841|NCT03343626|76017872|FG002|NOT COMPLETED|Overall Study||2||
59895842|NCT03343626|76017873|FG003|NOT COMPLETED|Overall Study||8||
59895843|NCT03343626|76017874|FG004|NOT COMPLETED|Overall Study||7||
59895844|NCT03343626|76017875|FG005|NOT COMPLETED|Overall Study||5||
59895845|NCT03343626|76017876|FG006|NOT COMPLETED|Overall Study||5||
59895846|NCT03343626|76017877|FG007|NOT COMPLETED|Overall Study||11||
59895847|NCT03334422|76017902|FG000|STARTED|Overall Study||244||
59895848|NCT03334422|76017903|FG001|STARTED|Overall Study||125||
59895849|NCT03334422|76017904|FG002|STARTED|Overall Study||123||
59895850|NCT03334422|76017905|FG003|STARTED|Overall Study||123||
59895851|NCT03334422|76017902|FG000|Received at Least One Dose of Study Drug|Overall Study||244||
59895852|NCT03334422|76017903|FG001|Received at Least One Dose of Study Drug|Overall Study||124||
59895853|NCT03334422|76017904|FG002|Received at Least One Dose of Study Drug|Overall Study||123||
59895854|NCT03334422|76017905|FG003|Received at Least One Dose of Study Drug|Overall Study||123||
59895855|NCT03334422|76017902|FG000|COMPLETED|Overall Study||225||
59895856|NCT03334422|76017903|FG001|COMPLETED|Overall Study||115||
59895857|NCT03334422|76017904|FG002|COMPLETED|Overall Study||113||
59895858|NCT03334422|76017905|FG003|COMPLETED|Overall Study||117||
59895859|NCT03334422|76017902|FG000|NOT COMPLETED|Overall Study||19||
59895860|NCT03334422|76017903|FG001|NOT COMPLETED|Overall Study||10||
59895861|NCT03334422|76017904|FG002|NOT COMPLETED|Overall Study||10||
59895862|NCT03334422|76017905|FG003|NOT COMPLETED|Overall Study||6||
59895863|NCT03362190|76017924|FG000|STARTED|Overall Study||10||
59895864|NCT03362190|76017925|FG001|STARTED|Overall Study||10||
59895865|NCT03362190|76017926|FG002|STARTED|Overall Study||22||
59895866|NCT03362190|76017927|FG003|STARTED|Overall Study||22||
59895867|NCT03362190|76017924|FG000|COMPLETED|Overall Study||10||
59895868|NCT03362190|76017925|FG001|COMPLETED|Overall Study||10||
59895869|NCT03362190|76017926|FG002|COMPLETED|Overall Study||22||
59895870|NCT03362190|76017927|FG003|COMPLETED|Overall Study||20||
59895871|NCT03362190|76017924|FG000|NOT COMPLETED|Overall Study||0||
59895872|NCT03362190|76017925|FG001|NOT COMPLETED|Overall Study||0||
59895873|NCT03362190|76017926|FG002|NOT COMPLETED|Overall Study||0||
59895874|NCT03362190|76017927|FG003|NOT COMPLETED|Overall Study||2||
59895875|NCT02323126|76017943|FG000|STARTED|Overall Study||18||
59895876|NCT02323126|76017944|FG001|STARTED|Overall Study||16||
59895877|NCT02323126|76017945|FG002|STARTED|Overall Study||30||
59895878|NCT02323126|76017943|FG000|COMPLETED|Overall Study||0||
59895879|NCT02323126|76017944|FG001|COMPLETED|Overall Study||0||
59895880|NCT02323126|76017945|FG002|COMPLETED|Overall Study||0||
59895881|NCT02323126|76017943|FG000|NOT COMPLETED|Overall Study||18||
59895882|NCT02323126|76017944|FG001|NOT COMPLETED|Overall Study||16||
59895883|NCT02323126|76017945|FG002|NOT COMPLETED|Overall Study||30||
59895884|NCT03491553|76017962|FG000|STARTED|Main Study (Up to Week 48)||9||
59895885|NCT03491553|76017963|FG001|STARTED|Main Study (Up to Week 48)||10||
59895886|NCT03491553|76017964|FG002|STARTED|Main Study (Up to Week 48)||10||
59895887|NCT03491553|76017965|FG003|STARTED|Main Study (Up to Week 48)||10||
59895888|NCT03491553|76017966|FG004|STARTED|Main Study (Up to Week 48)||5||
59895889|NCT03491553|76017967|FG005|STARTED|Main Study (Up to Week 48)||4||
59895890|NCT03491553|76017962|FG000|COMPLETED|Main Study (Up to Week 48)||8||
59895891|NCT03491553|76017963|FG001|COMPLETED|Main Study (Up to Week 48)||9||
59895892|NCT03491553|76017964|FG002|COMPLETED|Main Study (Up to Week 48)||10||
59895893|NCT03491553|76017965|FG003|COMPLETED|Main Study (Up to Week 48)||9||
59895894|NCT03491553|76017966|FG004|COMPLETED|Main Study (Up to Week 48)||5||
59895895|NCT03491553|76017967|FG005|COMPLETED|Main Study (Up to Week 48)||4||
59895896|NCT03491553|76017962|FG000|NOT COMPLETED|Main Study (Up to Week 48)||1||
59895897|NCT03491553|76017963|FG001|NOT COMPLETED|Main Study (Up to Week 48)||1||
59895898|NCT03491553|76017964|FG002|NOT COMPLETED|Main Study (Up to Week 48)||0||
59895899|NCT03491553|76017965|FG003|NOT COMPLETED|Main Study (Up to Week 48)||1||
59895900|NCT03491553|76017966|FG004|NOT COMPLETED|Main Study (Up to Week 48)||0||
59895901|NCT03491553|76017967|FG005|NOT COMPLETED|Main Study (Up to Week 48)||0||
59895902|NCT03491553|76017962|FG000|STARTED|TFFU (Week 49 up to Additional 48 Weeks)|8 participants completed the study period up to Week 48 but did not continue in the TFFU phase.|0||
59895903|NCT03491553|76017963|FG001|STARTED|TFFU (Week 49 up to Additional 48 Weeks)|9 participants completed the study period up to Week 48 but only 1 participant continued in the TFFU phase.|1||
59895904|NCT03491553|76017964|FG002|STARTED|TFFU (Week 49 up to Additional 48 Weeks)|10 participants completed the study period up to Week 48 but did not continue in the TFFU phase.|0||
59895905|NCT03491553|76017965|FG003|STARTED|TFFU (Week 49 up to Additional 48 Weeks)|9 participants completed the study period up to Week 48 but did not continue in the TFFU phase.|0||
59895906|NCT03491553|76017966|FG004|STARTED|TFFU (Week 49 up to Additional 48 Weeks)|5 participants completed the study period up to Week 48 but did not continue in the TFFU phase.|0||
59895907|NCT03491553|76017967|FG005|STARTED|TFFU (Week 49 up to Additional 48 Weeks)|4 participants completed the study period up to Week 48 but did not continue in the TFFU phase.|0||
59895908|NCT03491553|76017962|FG000|COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0||
59895909|NCT03491553|76017963|FG001|COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||1||
59895910|NCT03491553|76017964|FG002|COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0||
59895911|NCT03491553|76017965|FG003|COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0||
59757285|NCT00773175|75876337|FG000|COMPLETED|Overall Study||71||
59757286|NCT00773175|75876338|FG001|COMPLETED|Overall Study||73||
59757287|NCT00773175|75876337|FG000|NOT COMPLETED|Overall Study||2||
59757288|NCT00773175|75876338|FG001|NOT COMPLETED|Overall Study||2||
59757289|NCT00566527|75876352|FG000|STARTED|Overall Study|Number randomized.|541||
59757290|NCT00566527|75876353|FG001|STARTED|Overall Study|Number randomized.|540||
59895912|NCT03491553|76017966|FG004|COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0||
59895913|NCT03491553|76017967|FG005|COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0||
59895914|NCT03491553|76017962|FG000|NOT COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0||
59895915|NCT03491553|76017963|FG001|NOT COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0||
59895916|NCT03491553|76017964|FG002|NOT COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0||
59895917|NCT03491553|76017965|FG003|NOT COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0||
59895918|NCT03491553|76017966|FG004|NOT COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0||
59895919|NCT03491553|76017967|FG005|NOT COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0||
59895920|NCT00003377|76017988|FG000|STARTED|Period I||3||
59895921|NCT00003377|76017989|FG001|STARTED|Period I||3||
59895922|NCT00003377|76017990|FG002|STARTED|Period I||3||
59895923|NCT00003377|76017991|FG003|STARTED|Period I||3||
59895924|NCT00003377|76017992|FG004|STARTED|Period I||0||
59895925|NCT00003377|76017988|FG000|COMPLETED|Period I||3||
59895926|NCT00003377|76017989|FG001|COMPLETED|Period I||3||
59895927|NCT00003377|76017990|FG002|COMPLETED|Period I||2||
59757291|NCT00566527|75876354|FG002|STARTED|Overall Study|Number randomized.|539||
59757292|NCT00566527|75876352|FG000|Received ProQuad® Dose 1|Overall Study||529||
59757293|NCT00566527|75876353|FG001|Received ProQuad® Dose 1|Overall Study||484||
59757294|NCT00566527|75876354|FG002|Received ProQuad® Dose 1|Overall Study||470||
59757295|NCT00566527|75876352|FG000|Received ProQuad® Dose 2|Overall Study||525||
59757296|NCT00566527|75876353|FG001|Received ProQuad® Dose 2|Overall Study||478||
59757297|NCT00566527|75876354|FG002|Received ProQuad® Dose 2|Overall Study||462||
59757298|NCT00566527|75876352|FG000|COMPLETED|Overall Study||524||
59757299|NCT00566527|75876353|FG001|COMPLETED|Overall Study||474||
59757300|NCT00566527|75876354|FG002|COMPLETED|Overall Study||461||
59757301|NCT00566527|75876352|FG000|NOT COMPLETED|Overall Study||17||
59757302|NCT00566527|75876353|FG001|NOT COMPLETED|Overall Study||66||
59757303|NCT00566527|75876354|FG002|NOT COMPLETED|Overall Study||78||
59757304|NCT00773097|75876364|FG000|STARTED|Overall Study||46||
59757305|NCT00773097|75876364|FG000|COMPLETED|Overall Study||39||
59757306|NCT00773097|75876364|FG000|NOT COMPLETED|Overall Study||7||
59757307|NCT00933335|75876370|FG000|STARTED|Overall Study||2||
59762582|NCT00594204|75882392|FG001|Received Treatment|Overall Study||198||
59762583|NCT00594204|75882391|FG000|COMPLETED|Overall Study||336||
59762584|NCT00594204|75882392|FG001|COMPLETED|Overall Study||154||
59762585|NCT00594204|75882391|FG000|NOT COMPLETED|Overall Study||58||
59762586|NCT00594204|75882392|FG001|NOT COMPLETED|Overall Study||45||
59762587|NCT02704156|75882400|FG000|STARTED|Overall Study||85||
59762588|NCT02704156|75882401|FG001|STARTED|Overall Study||85||
59762589|NCT02704156|75882400|FG000|COMPLETED|Overall Study||85||
59762590|NCT02704156|75882401|FG001|COMPLETED|Overall Study||85||
59762591|NCT02704156|75882400|FG000|NOT COMPLETED|Overall Study||0||
59895928|NCT00003377|76017991|FG003|COMPLETED|Period I||2||
59895929|NCT00003377|76017992|FG004|COMPLETED|Period I||0||
59895930|NCT00003377|76017988|FG000|NOT COMPLETED|Period I||0||
59895931|NCT00003377|76017989|FG001|NOT COMPLETED|Period I||0||
59895932|NCT00003377|76017990|FG002|NOT COMPLETED|Period I||1||
59895933|NCT00003377|76017991|FG003|NOT COMPLETED|Period I||1||
59895934|NCT00003377|76017992|FG004|NOT COMPLETED|Period I||0||
59895935|NCT00003377|76017988|FG000|STARTED|Period II|Patients participated at this dose level only in Period I.|0||
59895936|NCT00003377|76017989|FG001|STARTED|Period II|Patients participated at this dose level only in Period I.|0||
59895937|NCT00003377|76017990|FG002|STARTED|Period II|Patients participated at this dose level only in Period I.|0||
59895938|NCT00003377|76017991|FG003|STARTED|Period II|Patients participated at this dose level only in Period I.|0||
59895939|NCT00003377|76017992|FG004|STARTED|Period II|All pts enrolled on Per II received cisplatin 40 mg/m2 & paclitaxel 40 mg/m2 concurrent w/ radiation|17||
59895940|NCT00003377|76017988|FG000|COMPLETED|Period II||0||
59895941|NCT00003377|76017989|FG001|COMPLETED|Period II||0||
59895942|NCT00003377|76017990|FG002|COMPLETED|Period II||0||
59895943|NCT00003377|76017991|FG003|COMPLETED|Period II||0||
59895944|NCT00003377|76017992|FG004|COMPLETED|Period II||16||
59895945|NCT00003377|76017988|FG000|NOT COMPLETED|Period II||0||
59895946|NCT00003377|76017989|FG001|NOT COMPLETED|Period II||0||
59895947|NCT00003377|76017990|FG002|NOT COMPLETED|Period II||0||
59895948|NCT00003377|76017991|FG003|NOT COMPLETED|Period II||0||
59895949|NCT00003377|76017992|FG004|NOT COMPLETED|Period II||1||
59895950|NCT00651742|76018005|FG000|STARTED|Overall Study||28|Enrolled|
59895951|NCT00651742|76018005|FG000|Treated|Overall Study||27||
59895952|NCT00651742|76018005|FG000|Efficacy Analysis Per Investigator|Overall Study||21||
59895953|NCT00651742|76018005|FG000|Efficacy Analysis Per Independent Reader|Overall Study||25||
59895954|NCT00651742|76018005|FG000|COMPLETED|Overall Study||0||
59895955|NCT00651742|76018005|FG000|NOT COMPLETED|Overall Study||28||
59895956|NCT00002651|76018011|FG000|STARTED|Induction||3040||
59895957|NCT00002651|76018012|FG001|STARTED|Induction||0||
59895958|NCT00002651|76018013|FG002|STARTED|Induction||0||
59895959|NCT00002651|76018011|FG000|Eligible|Induction||2950||
59895960|NCT00002651|76018012|FG001|Eligible|Induction||0||
59895961|NCT00002651|76018013|FG002|Eligible|Induction||0||
59895962|NCT00002651|76018011|FG000|Eligible and Began Protocol Therapy|Induction||2950||
59895963|NCT00002651|76018012|FG001|Eligible and Began Protocol Therapy|Induction||0||
59895964|NCT00002651|76018013|FG002|Eligible and Began Protocol Therapy|Induction||0||
59895965|NCT00002651|76018011|FG000|COMPLETED|Induction||1697||
59895966|NCT00002651|76018012|FG001|COMPLETED|Induction||0||
59895967|NCT00002651|76018013|FG002|COMPLETED|Induction||0||
59895968|NCT00002651|76018011|FG000|NOT COMPLETED|Induction||1343||
59895969|NCT00002651|76018012|FG001|NOT COMPLETED|Induction||0||
59895970|NCT00002651|76018013|FG002|NOT COMPLETED|Induction||0||
59895971|NCT00002651|76018011|FG000|STARTED|Consolidation and Randomization||0||
59895972|NCT00002651|76018012|FG001|STARTED|Consolidation and Randomization|After induction,patients with stable or declining PSA (≤ 4.0 ng/mL) were eligible for randomization|867||
59895973|NCT00002651|76018013|FG002|STARTED|Consolidation and Randomization|After induction,patients with stable or declining PSA (≤ 4.0 ng/mL) were eligible for randomization|882||
59895974|NCT00002651|76018011|FG000|Eligible|Consolidation and Randomization||0||
59895975|NCT00002651|76018012|FG001|Eligible|Consolidation and Randomization||765||
59895976|NCT00002651|76018013|FG002|Eligible|Consolidation and Randomization||770||
59895977|NCT00002651|76018011|FG000|Assessable for Toxicity|Consolidation and Randomization||0|Patients with no AE evaluations, received wrong protocol arm, or received non-protocol trt excluded|
59895978|NCT00002651|76018012|FG001|Assessable for Toxicity|Consolidation and Randomization||732|Patients with no AE evaluations, received wrong protocol arm, or received non-protocol trt excluded|
59895979|NCT00002651|76018013|FG002|Assessable for Toxicity|Consolidation and Randomization||702|Patients with no AE evaluations, received wrong protocol arm, or received non-protocol trt excluded|
59895980|NCT00002651|76018011|FG000|COMPLETED|Consolidation and Randomization||0||
59895981|NCT00002651|76018012|FG001|COMPLETED|Consolidation and Randomization||29||
59895982|NCT00002651|76018013|FG002|COMPLETED|Consolidation and Randomization||22||
59895983|NCT00002651|76018011|FG000|NOT COMPLETED|Consolidation and Randomization||0||
59895984|NCT00002651|76018012|FG001|NOT COMPLETED|Consolidation and Randomization||838||
59895985|NCT00002651|76018013|FG002|NOT COMPLETED|Consolidation and Randomization||860||
59895986|NCT00002597|76018023|FG000|STARTED|Overall Study||1013||
59895987|NCT00002597|76018024|FG001|STARTED|Overall Study||1015||
59895988|NCT00002597|76018023|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|987||
59895989|NCT00002597|76018024|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|992||
59895990|NCT00002597|76018023|FG000|NOT COMPLETED|Overall Study||26||
59895991|NCT00002597|76018024|FG001|NOT COMPLETED|Overall Study||23||
59895992|NCT03435081|76018033|FG000|STARTED|Week 0 to Week 16||147||
59895993|NCT03435081|76018034|FG001|STARTED|Week 0 to Week 16||147||
59895994|NCT03435081|76018035|FG002|STARTED|Week 0 to Week 16||146||
59895995|NCT03435081|76018033|FG000|Received at Least One Dose of Study Drug|Week 0 to Week 16||147||
59895996|NCT03435081|76018034|FG001|Received at Least One Dose of Study Drug|Week 0 to Week 16||147||
59895997|NCT03435081|76018035|FG002|Received at Least One Dose of Study Drug|Week 0 to Week 16||146||
60013804|NCT01671007|76129759|FG001|All Eligible|Overall Study||2758||
59895998|NCT03435081|76018033|FG000|Completed Week 16 and Entered JAIX Study|Week 0 to Week 16||111||
59895999|NCT03435081|76018034|FG001|Completed Week 16 and Entered JAIX Study|Week 0 to Week 16||112||
59896000|NCT03435081|76018035|FG002|Completed Week 16 and Entered JAIX Study|Week 0 to Week 16||96||
59896001|NCT03435081|76018033|FG000|COMPLETED|Week 0 to Week 16||126||
59896002|NCT03435081|76018034|FG001|COMPLETED|Week 0 to Week 16||131||
59896003|NCT03435081|76018035|FG002|COMPLETED|Week 0 to Week 16||127||
59896004|NCT03435081|76018033|FG000|NOT COMPLETED|Week 0 to Week 16||21||
59896005|NCT03435081|76018034|FG001|NOT COMPLETED|Week 0 to Week 16||16||
59896006|NCT03435081|76018035|FG002|NOT COMPLETED|Week 0 to Week 16||19||
59896007|NCT03435081|76018033|FG000|STARTED|Week 16 to Week 104|Participants who met IGA 0 or 1 and did not require rescue therapy before Week 16 were allowed to continue in the study beyond 16 weeks.|8||
59896008|NCT03435081|76018034|FG001|STARTED|Week 16 to Week 104|Participants who met IGA 0 or 1 and did not require rescue therapy before Week 16 were allowed to continue in the study beyond 16 weeks.|19||
59896009|NCT03435081|76018035|FG002|STARTED|Week 16 to Week 104|Participants who met IGA 0 or 1 and did not require rescue therapy before Week 16 were allowed to continue in the study beyond 16 weeks.|35||
59896010|NCT03435081|76018033|FG000|Rolled Over Into the Open-Label Extension Study JAIX.|Week 16 to Week 104|Participants who completed Week 104 and participants who experienced a loss of benefit (IGA score of ≥3) after Week 16, if eligible, had the option to roll over into the Open-Label Extension study JAIX.|6||
59896011|NCT03435081|76018034|FG001|Rolled Over Into the Open-Label Extension Study JAIX.|Week 16 to Week 104|Participants who completed Week 104 and participants who experienced a loss of benefit (IGA score of ≥3) after Week 16, if eligible, had the option to roll over into the Open-Label Extension study JAIX.|14||
59896012|NCT03435081|76018035|FG002|Rolled Over Into the Open-Label Extension Study JAIX.|Week 16 to Week 104|Participants who completed Week 104 and participants who experienced a loss of benefit (IGA score of ≥3) after Week 16, if eligible, had the option to roll over into the Open-Label Extension study JAIX.|19||
59896013|NCT03435081|76018033|FG000|COMPLETED|Week 16 to Week 104||5||
59896014|NCT03435081|76018034|FG001|COMPLETED|Week 16 to Week 104||6||
59896015|NCT03435081|76018035|FG002|COMPLETED|Week 16 to Week 104||16||
59896016|NCT03435081|76018033|FG000|NOT COMPLETED|Week 16 to Week 104||3||
59896017|NCT03435081|76018034|FG001|NOT COMPLETED|Week 16 to Week 104||13||
59896018|NCT03435081|76018035|FG002|NOT COMPLETED|Week 16 to Week 104||19||
59896019|NCT02738008|76018050|FG000|STARTED|Overall Study||1||
59896020|NCT02738008|76018051|FG001|STARTED|Overall Study||6||
59896021|NCT02738008|76018052|FG002|STARTED|Overall Study||5||
59896022|NCT02738008|76018050|FG000|COMPLETED|Overall Study||0||
59896023|NCT02738008|76018051|FG001|COMPLETED|Overall Study||0||
59896024|NCT02738008|76018052|FG002|COMPLETED|Overall Study||0||
59896025|NCT02738008|76018050|FG000|NOT COMPLETED|Overall Study||1||
59896026|NCT02738008|76018051|FG001|NOT COMPLETED|Overall Study||6||
59896027|NCT02738008|76018052|FG002|NOT COMPLETED|Overall Study||5||
59896028|NCT03489369|76018064|FG000|STARTED|Overall Study||3||
59896029|NCT03489369|76018065|FG001|STARTED|Overall Study||3||
59896030|NCT03489369|76018066|FG002|STARTED|Overall Study||3||
59896031|NCT03489369|76018067|FG003|STARTED|Overall Study||6||
59896032|NCT03489369|76018064|FG000|COMPLETED|Overall Study||0||
59896033|NCT03489369|76018065|FG001|COMPLETED|Overall Study||0||
59896034|NCT03489369|76018066|FG002|COMPLETED|Overall Study||0||
59896035|NCT03489369|76018067|FG003|COMPLETED|Overall Study||0||
59896036|NCT03489369|76018064|FG000|NOT COMPLETED|Overall Study||3||
59896037|NCT03489369|76018065|FG001|NOT COMPLETED|Overall Study||3||
59896038|NCT03489369|76018066|FG002|NOT COMPLETED|Overall Study||3||
59896039|NCT03489369|76018067|FG003|NOT COMPLETED|Overall Study||6||
59896040|NCT03257254|76018077|FG000|STARTED|Overall Study||76||
59896041|NCT03257254|76018077|FG000|COMPLETED|Overall Study||55||
59896042|NCT03257254|76018077|FG000|NOT COMPLETED|Overall Study||21||
59896043|NCT03738475|76018083|FG000|STARTED|Overall Study||16||
59896044|NCT03738475|76018084|FG001|STARTED|Overall Study||18||
59896045|NCT03738475|76018083|FG000|COMPLETED|Overall Study||15||
59896046|NCT03738475|76018084|FG001|COMPLETED|Overall Study||18||
59896047|NCT03738475|76018083|FG000|NOT COMPLETED|Overall Study||1||
59896048|NCT03738475|76018084|FG001|NOT COMPLETED|Overall Study||0||
59896049|NCT03084718|76018095|FG000|STARTED|Overall Study||120||
59896050|NCT03084718|76018096|FG001|STARTED|Overall Study||120||
59896051|NCT03084718|76018097|FG002|STARTED|Overall Study||122||
59896052|NCT03084718|76018098|FG003|STARTED|Overall Study||124||
59896053|NCT03084718|76018099|FG004|STARTED|Overall Study||124||
59896054|NCT03084718|76018095|FG000|COMPLETED|Overall Study||109||
59896055|NCT03084718|76018096|FG001|COMPLETED|Overall Study||110||
59896056|NCT03084718|76018097|FG002|COMPLETED|Overall Study||110||
59896057|NCT03084718|76018098|FG003|COMPLETED|Overall Study||110||
59896058|NCT03084718|76018099|FG004|COMPLETED|Overall Study||120||
59896059|NCT03084718|76018095|FG000|NOT COMPLETED|Overall Study||11||
60013805|NCT01671007|76129760|FG002|All Eligible|Overall Study||2008||
59896060|NCT03084718|76018096|FG001|NOT COMPLETED|Overall Study||10||
59896061|NCT03084718|76018097|FG002|NOT COMPLETED|Overall Study||12||
59896062|NCT03084718|76018098|FG003|NOT COMPLETED|Overall Study||14||
59896063|NCT03084718|76018099|FG004|NOT COMPLETED|Overall Study||4||
59950994|NCT04789382|76069923|FG000|COMPLETED|First Wear Period (2 Hours)||9||
59950995|NCT04789382|76069924|FG001|COMPLETED|First Wear Period (2 Hours)||9||
59950996|NCT04789382|76069925|FG002|COMPLETED|First Wear Period (2 Hours)||9||
59950997|NCT04789382|76069926|FG003|COMPLETED|First Wear Period (2 Hours)||9||
59896064|NCT04321252|76018123|FG000|STARTED|Overall Study||6|All enrolled participants were included in the Randomized Set and in the Safety Analysis Set|
59896065|NCT04321252|76018124|FG001|STARTED|Overall Study||6|All enrolled participants were included in the Randomized Set and in the Safety Analysis Set|
59896066|NCT04321252|76018125|FG002|STARTED|Overall Study||6|All enrolled participants were included in the Randomized Set and in the Safety Analysis Set|
59896067|NCT04321252|76018126|FG003|STARTED|Overall Study||6|All enrolled participants were included in the Randomized Set and in the Safety Analysis Set|
59896068|NCT04321252|76018127|FG004|STARTED|Overall Study||6|All enrolled participants were included in the Randomized Set and in the Safety Analysis Set|
59896069|NCT04321252|76018128|FG005|STARTED|Overall Study||9|All enrolled participants were included in the Randomized Set and in the Safety Analysis Set|
59896070|NCT04321252|76018129|FG006|STARTED|Overall Study||6|All enrolled participants were included in the Randomized Set and in the Safety Analysis Set|
59896071|NCT04321252|76018130|FG007|STARTED|Overall Study||6|All enrolled participants were included in the Randomized Set and in the Safety Analysis Set|
59896072|NCT04321252|76018131|FG008|STARTED|Overall Study||6|All enrolled participants were included in the Randomized Set and in the Safety Analysis Set|
59896073|NCT04321252|76018123|FG000|PK Analysis Set|Overall Study||6|All KAE609-treated participants were included in the PK analysis set|
59896074|NCT04321252|76018124|FG001|PK Analysis Set|Overall Study||6|All KAE609-treated participants were included in the PK analysis set|
59896075|NCT04321252|76018125|FG002|PK Analysis Set|Overall Study||6|All KAE609-treated participants were included in the PK analysis set|
59896076|NCT04321252|76018126|FG003|PK Analysis Set|Overall Study||6|All KAE609-treated participants were included in the PK analysis set|
59896077|NCT04321252|76018127|FG004|PK Analysis Set|Overall Study||6|All KAE609-treated participants were included in the PK analysis set|
59896078|NCT04321252|76018128|FG005|PK Analysis Set|Overall Study||0|All KAE609-treated participants were included in the PK analysis set|
59896079|NCT04321252|76018129|FG006|PK Analysis Set|Overall Study||6|All KAE609-treated participants were included in the PK analysis set|
59896080|NCT04321252|76018130|FG007|PK Analysis Set|Overall Study||6|All KAE609-treated participants were included in the PK analysis set|
59896081|NCT04321252|76018131|FG008|PK Analysis Set|Overall Study||0|All KAE609-treated participants were included in the PK analysis set|
59896082|NCT04321252|76018123|FG000|COMPLETED|Overall Study||6||
59896083|NCT04321252|76018124|FG001|COMPLETED|Overall Study||6||
59896084|NCT04321252|76018125|FG002|COMPLETED|Overall Study||6||
59896085|NCT04321252|76018126|FG003|COMPLETED|Overall Study||6||
59505748|NCT00740207|75598607|FG001|COMPLETED|Overall Study||16||
59505749|NCT00740207|75598606|FG000|NOT COMPLETED|Overall Study||0||
59505750|NCT00740207|75598607|FG001|NOT COMPLETED|Overall Study||0||
59505751|NCT00724009|75598617|FG000|STARTED|Overall Study||29||
59505752|NCT00724009|75598617|FG000|COMPLETED|Overall Study|One patient underwent conditioning but died 1 day before stem cell infusion due to sepsis.|29||
59505753|NCT00724009|75598617|FG000|NOT COMPLETED|Overall Study||0||
59505754|NCT00762931|75598621|FG000|STARTED|Overall Study||25||
59505755|NCT00762931|75598621|FG000|COMPLETED|Overall Study||23||
59505756|NCT00762931|75598621|FG000|NOT COMPLETED|Overall Study||2||
59896086|NCT04321252|76018127|FG004|COMPLETED|Overall Study||6||
59896087|NCT04321252|76018128|FG005|COMPLETED|Overall Study||8||
59896088|NCT04321252|76018129|FG006|COMPLETED|Overall Study||6||
59896089|NCT04321252|76018130|FG007|COMPLETED|Overall Study||6||
59896090|NCT04321252|76018131|FG008|COMPLETED|Overall Study||6||
59896091|NCT04321252|76018123|FG000|NOT COMPLETED|Overall Study||0||
59896092|NCT04321252|76018124|FG001|NOT COMPLETED|Overall Study||0||
59896093|NCT04321252|76018125|FG002|NOT COMPLETED|Overall Study||0||
59896094|NCT04321252|76018126|FG003|NOT COMPLETED|Overall Study||0||
59896095|NCT04321252|76018127|FG004|NOT COMPLETED|Overall Study||0||
59896096|NCT04321252|76018128|FG005|NOT COMPLETED|Overall Study||1||
59896097|NCT04321252|76018129|FG006|NOT COMPLETED|Overall Study||0||
59896098|NCT04321252|76018130|FG007|NOT COMPLETED|Overall Study||0||
59896099|NCT04321252|76018131|FG008|NOT COMPLETED|Overall Study||0||
59896100|NCT04285684|76018157|FG000|STARTED|Overall Study||4||
59896101|NCT04285684|76018157|FG000|COMPLETED|Overall Study||4||
59896102|NCT04285684|76018157|FG000|NOT COMPLETED|Overall Study||0||
59896103|NCT03433677|76018163|FG000|STARTED|Period 1||24||
59896104|NCT03433677|76018164|FG001|STARTED|Period 1||25||
59896105|NCT03433677|76018163|FG000|Received at Least 1 Dose of Study Drug|Period 1||24||
59896106|NCT03433677|76018164|FG001|Received at Least 1 Dose of Study Drug|Period 1||25||
59896107|NCT03433677|76018163|FG000|COMPLETED|Period 1||23||
59896108|NCT03433677|76018164|FG001|COMPLETED|Period 1||25||
59896109|NCT03433677|76018163|FG000|NOT COMPLETED|Period 1||1||
59896110|NCT03433677|76018164|FG001|NOT COMPLETED|Period 1||0||
59896111|NCT03433677|76018163|FG000|STARTED|Period 2||23||
59896112|NCT03433677|76018164|FG001|STARTED|Period 2||25||
60013806|NCT01671007|76129761|FG003|All Eligible|Overall Study||2197||
60013807|NCT01671007|76129762|FG004|All Eligible|Overall Study||180||
60013808|NCT01671007|76129763|FG005|All Eligible|Overall Study||507||
60013809|NCT01671007|76129764|FG006|All Eligible|Overall Study||79||
60013810|NCT01671007|76129765|FG007|All Eligible|Overall Study||507||
60013811|NCT01671007|76129766|FG008|All Eligible|Overall Study||2||
60013812|NCT01671007|76129758|FG000|COMPLETED|Overall Study||1768||
60013813|NCT01671007|76129759|FG001|COMPLETED|Overall Study||2183||
59505757|NCT00780715|75598629|FG000|STARTED|Overall Study||6||
59505758|NCT00780715|75598630|FG001|STARTED|Overall Study||6||
59896113|NCT03433677|76018163|FG000|Received at Least 1 Dose of Study Drug|Period 2||23||
59896114|NCT03433677|76018164|FG001|Received at Least 1 Dose of Study Drug|Period 2||25||
59896115|NCT03433677|76018163|FG000|COMPLETED|Period 2||22||
59896116|NCT03433677|76018164|FG001|COMPLETED|Period 2||24||
59896117|NCT03433677|76018163|FG000|NOT COMPLETED|Period 2||1||
59896118|NCT03433677|76018164|FG001|NOT COMPLETED|Period 2||1||
59896119|NCT02492711|76018174|FG000|STARTED|Overall Study||266||
59896120|NCT02492711|76018175|FG001|STARTED|Overall Study||270||
59896121|NCT02492711|76018176|FG002|STARTED|Overall Study||88||
59896122|NCT02492711|76018174|FG000|Intent-to-treat (ITT) Population|Overall Study||266||
59896123|NCT02492711|76018175|FG001|Intent-to-treat (ITT) Population|Overall Study||270||
59896124|NCT02492711|76018176|FG002|Intent-to-treat (ITT) Population|Overall Study||88||
59896125|NCT02492711|76018174|FG000|Safety Population|Overall Study||264||
59896126|NCT02492711|76018175|FG001|Safety Population|Overall Study||266||
59896127|NCT02492711|76018176|FG002|Safety Population|Overall Study||88||
59896128|NCT02492711|76018174|FG000|COMPLETED|Overall Study||230||
59896129|NCT02492711|76018175|FG001|COMPLETED|Overall Study||230||
59896130|NCT02492711|76018176|FG002|COMPLETED|Overall Study||75||
59896131|NCT02492711|76018174|FG000|NOT COMPLETED|Overall Study||36||
59896132|NCT02492711|76018175|FG001|NOT COMPLETED|Overall Study||40||
59896133|NCT02492711|76018176|FG002|NOT COMPLETED|Overall Study||13||
59896134|NCT01147822|76018191|FG000|STARTED|Overall Study||188||
59896135|NCT01147822|76018192|FG001|STARTED|Overall Study||179||
59896136|NCT01147822|76018191|FG000|Not Completed/Ongoing|Overall Study||111||
59896137|NCT01147822|76018192|FG001|Not Completed/Ongoing|Overall Study||102||
59896138|NCT01147822|76018191|FG000|COMPLETED|Overall Study||0||
59896139|NCT01147822|76018192|FG001|COMPLETED|Overall Study||0||
59896140|NCT01147822|76018191|FG000|NOT COMPLETED|Overall Study||188||
59896141|NCT01147822|76018192|FG001|NOT COMPLETED|Overall Study||179||
59896142|NCT03431337|76018200|FG000|STARTED|Overall Study||78||
59896143|NCT03431337|76018201|FG001|STARTED|Overall Study||79||
59896144|NCT03431337|76018200|FG000|COMPLETED|Overall Study||49||
59896145|NCT03431337|76018201|FG001|COMPLETED|Overall Study||57||
59896146|NCT03431337|76018200|FG000|NOT COMPLETED|Overall Study||29||
59896147|NCT03431337|76018201|FG001|NOT COMPLETED|Overall Study||22||
59896148|NCT03738241|76018221|FG000|STARTED|Overall Study||38||
59896149|NCT03738241|76018222|FG001|STARTED|Overall Study||40||
59896150|NCT03738241|76018223|FG002|STARTED|Overall Study||24||
59896151|NCT03738241|76018224|FG003|STARTED|Overall Study||18||
59896152|NCT03738241|76018225|FG004|STARTED|Overall Study||40||
59896153|NCT03738241|76018226|FG005|STARTED|Overall Study||44||
59896154|NCT03738241|76018227|FG006|STARTED|Overall Study||20||
59896155|NCT03738241|76018228|FG007|STARTED|Overall Study||16||
59896156|NCT03738241|76018229|FG008|STARTED|Overall Study||29||
59896157|NCT03738241|76018230|FG009|STARTED|Overall Study||35||
59896158|NCT03738241|76018221|FG000|COMPLETED|Overall Study||37||
59896159|NCT03738241|76018222|FG001|COMPLETED|Overall Study||40||
59896160|NCT03738241|76018223|FG002|COMPLETED|Overall Study||24||
59896161|NCT03738241|76018224|FG003|COMPLETED|Overall Study||18||
59896162|NCT03738241|76018225|FG004|COMPLETED|Overall Study||40||
59896163|NCT03738241|76018226|FG005|COMPLETED|Overall Study||44||
59896164|NCT03738241|76018227|FG006|COMPLETED|Overall Study||20||
59896165|NCT03738241|76018228|FG007|COMPLETED|Overall Study||16||
59896166|NCT03738241|76018229|FG008|COMPLETED|Overall Study||28||
59896167|NCT03738241|76018230|FG009|COMPLETED|Overall Study||34||
59896168|NCT03738241|76018221|FG000|NOT COMPLETED|Overall Study||1||
59896169|NCT03738241|76018222|FG001|NOT COMPLETED|Overall Study||0||
59896170|NCT03738241|76018223|FG002|NOT COMPLETED|Overall Study||0||
59896171|NCT03738241|76018224|FG003|NOT COMPLETED|Overall Study||0||
59896172|NCT03738241|76018225|FG004|NOT COMPLETED|Overall Study||0||
59896173|NCT03738241|76018226|FG005|NOT COMPLETED|Overall Study||0||
60013814|NCT01671007|76129760|FG002|COMPLETED|Overall Study||1667||
59896174|NCT03738241|76018227|FG006|NOT COMPLETED|Overall Study||0||
59896175|NCT03738241|76018228|FG007|NOT COMPLETED|Overall Study||0||
59896176|NCT03738241|76018229|FG008|NOT COMPLETED|Overall Study||1||
59896177|NCT03738241|76018230|FG009|NOT COMPLETED|Overall Study||1||
59896178|NCT03430245|76018252|FG000|STARTED|Overall Study||16||
59896179|NCT03430245|76018252|FG000|COMPLETED|Overall Study|6 subjects withdrew from study due to lengthy treatment. Treatment protocol amended.|9||
59896180|NCT03430245|76018252|FG000|NOT COMPLETED|Overall Study||7||
59896181|NCT03461289|76018256|FG000|STARTED|Overall Study||33||
59896182|NCT03461289|76018256|FG000|COMPLETED|Overall Study||32||
59896183|NCT03461289|76018256|FG000|NOT COMPLETED|Overall Study||1||
59896184|NCT03452943|76018262|FG000|STARTED|Titration Period (7 Weeks)||59|Intent-to-treat (ITT) analysis set: all randomized participants|
59896185|NCT03452943|76018263|FG001|STARTED|Titration Period (7 Weeks)||60|Intent-to-treat (ITT) analysis set: all randomized participants|
59896186|NCT03452943|76018262|FG000|Safety Analysis Set|Titration Period (7 Weeks)||58|Received at least 1 dose of study drug|
59896187|NCT03452943|76018263|FG001|Safety Analysis Set|Titration Period (7 Weeks)||59|Received at least 1 dose of study drug|
59896188|NCT03452943|76018262|FG000|Modified ITT (mITT) Analysis Set|Titration Period (7 Weeks)||58|Received at least 1 dose of study drug; had both baseline & at least 1 postbaseline YGTSS assessment|
59610567|NCT01838616|75721428|FG001|Full Analysis Set|Pick-up Arm||0||
59610568|NCT01838616|75721427|FG000|COMPLETED|Pick-up Arm|Participants completed the tapentadol pick-up arm after initially on oxycodone/naloxone PR treatment|35||
59610569|NCT01838616|75721428|FG001|COMPLETED|Pick-up Arm||0||
59610570|NCT01838616|75721427|FG000|NOT COMPLETED|Pick-up Arm||15||
59610571|NCT01838616|75721428|FG001|NOT COMPLETED|Pick-up Arm||0||
59610572|NCT01611792|75721441|FG000|STARTED|Initial Period: Time 0||29||
59610573|NCT01611792|75721442|FG001|STARTED|Initial Period: Time 0||29||
59610574|NCT01611792|75721441|FG000|COMPLETED|Initial Period: Time 0||17||
59610575|NCT01611792|75721442|FG001|COMPLETED|Initial Period: Time 0||20||
59610576|NCT01611792|75721441|FG000|NOT COMPLETED|Initial Period: Time 0||12||
59610577|NCT01611792|75721442|FG001|NOT COMPLETED|Initial Period: Time 0||9||
59610578|NCT01611792|75721441|FG000|STARTED|Follow-up: at 11 Weeks||17||
59610579|NCT01611792|75721442|FG001|STARTED|Follow-up: at 11 Weeks||20||
59610580|NCT01611792|75721441|FG000|COMPLETED|Follow-up: at 11 Weeks||17||
59610581|NCT01611792|75721442|FG001|COMPLETED|Follow-up: at 11 Weeks||20||
59610582|NCT01611792|75721441|FG000|NOT COMPLETED|Follow-up: at 11 Weeks||0||
59610583|NCT01611792|75721442|FG001|NOT COMPLETED|Follow-up: at 11 Weeks||0||
59610584|NCT01611792|75721441|FG000|STARTED|Followup: at 6 Months||17||
59610585|NCT01611792|75721442|FG001|STARTED|Followup: at 6 Months||20||
59610586|NCT01611792|75721441|FG000|COMPLETED|Followup: at 6 Months||11||
59610587|NCT01611792|75721442|FG001|COMPLETED|Followup: at 6 Months||7||
59610588|NCT01611792|75721441|FG000|NOT COMPLETED|Followup: at 6 Months||6||
59610589|NCT01611792|75721442|FG001|NOT COMPLETED|Followup: at 6 Months||13||
59610590|NCT01820364|75721449|FG000|STARTED|Part I: LGX818||15||
59610591|NCT01820364|75721450|FG001|STARTED|Part I: LGX818||0||
59610592|NCT01820364|75721449|FG000|COMPLETED|Part I: LGX818||1||
59610593|NCT01820364|75721450|FG001|COMPLETED|Part I: LGX818||0||
59610594|NCT01820364|75721449|FG000|NOT COMPLETED|Part I: LGX818||14||
59505759|NCT00780715|75598631|FG002|STARTED|Overall Study||6||
59610595|NCT01820364|75721450|FG001|NOT COMPLETED|Part I: LGX818||0||
59610596|NCT01820364|75721449|FG000|STARTED|Part II: LGX818 + MEK162||0||
59610597|NCT01820364|75721450|FG001|STARTED|Part II: LGX818 + MEK162||1||
59610598|NCT01820364|75721449|FG000|COMPLETED|Part II: LGX818 + MEK162||0||
59610599|NCT01820364|75721450|FG001|COMPLETED|Part II: LGX818 + MEK162||0||
59610600|NCT01820364|75721449|FG000|NOT COMPLETED|Part II: LGX818 + MEK162||0||
59610601|NCT01820364|75721450|FG001|NOT COMPLETED|Part II: LGX818 + MEK162||1||
59610602|NCT01819506|75721458|FG000|STARTED|Overall Study||51||
59610603|NCT01819506|75721459|FG001|STARTED|Overall Study||52||
59610604|NCT01819506|75721458|FG000|COMPLETED|Overall Study||43||
59610605|NCT01819506|75721459|FG001|COMPLETED|Overall Study||47||
59610606|NCT01819506|75721458|FG000|NOT COMPLETED|Overall Study||8||
59610607|NCT01819506|75721459|FG001|NOT COMPLETED|Overall Study||5||
59610608|NCT01794000|75721467|FG000|STARTED|Double-Blind Phase (DBP)||171||
59610609|NCT01794000|75721468|FG001|STARTED|Double-Blind Phase (DBP)||170||
59610610|NCT01794000|75721467|FG000|Received at Least One Dose of Drug|Double-Blind Phase (DBP)||170||
59610611|NCT01794000|75721468|FG001|Received at Least One Dose of Drug|Double-Blind Phase (DBP)||170||
59610612|NCT01794000|75721467|FG000|Discontinued During Double Blind Phase|Double-Blind Phase (DBP)||169||
59610613|NCT01794000|75721468|FG001|Discontinued During Double Blind Phase|Double-Blind Phase (DBP)||166||
59610614|NCT01794000|75721467|FG000|COMPLETED|Double-Blind Phase (DBP)||2||
59610615|NCT01794000|75721468|FG001|COMPLETED|Double-Blind Phase (DBP)||4||
59505760|NCT00780715|75598632|FG003|STARTED|Overall Study||11||
59505761|NCT00780715|75598629|FG000|COMPLETED|Overall Study||6||
59505762|NCT00780715|75598630|FG001|COMPLETED|Overall Study||6||
59505763|NCT00780715|75598631|FG002|COMPLETED|Overall Study||6||
59505764|NCT00780715|75598632|FG003|COMPLETED|Overall Study||11||
59505765|NCT00780715|75598629|FG000|NOT COMPLETED|Overall Study||0||
59505766|NCT00780715|75598630|FG001|NOT COMPLETED|Overall Study||0||
59505767|NCT00780715|75598631|FG002|NOT COMPLETED|Overall Study||0||
59505768|NCT00780715|75598632|FG003|NOT COMPLETED|Overall Study||0||
59505769|NCT00740831|75598645|FG000|STARTED|Overall Study|Safety population|97||
59505770|NCT00740831|75598646|FG001|STARTED|Overall Study|Safety population|103||
59505771|NCT00740831|75598647|FG002|STARTED|Overall Study|Safety population|101||
59505772|NCT00740831|75598645|FG000|COMPLETED|Overall Study|Patients who completed part A (visit 6)|93||
59505773|NCT00740831|75598646|FG001|COMPLETED|Overall Study|Patients who completed part A (visit 6)|100||
59610616|NCT01794000|75721467|FG000|NOT COMPLETED|Double-Blind Phase (DBP)||169||
59610617|NCT01794000|75721468|FG001|NOT COMPLETED|Double-Blind Phase (DBP)||166||
59613507|NCT01684722|75724629|FG002|NOT COMPLETED|Overall Study||94||
59505774|NCT00740831|75598647|FG002|COMPLETED|Overall Study|Patients who completed part A (visit 6)|95||
59505775|NCT00740831|75598645|FG000|NOT COMPLETED|Overall Study||4||
59610618|NCT01794000|75721467|FG000|STARTED|Open-Label Extension Phase (OLE)|Pts. who had not permanently discontinued study drug and concluded DBP were eligible to enter OLE|3||
59610619|NCT01794000|75721468|FG001|STARTED|Open-Label Extension Phase (OLE)|Placebo arm was not applicable to Open-Label Extension Phase|0||
59610620|NCT01794000|75721467|FG000|COMPLETED|Open-Label Extension Phase (OLE)||0||
59610621|NCT01794000|75721468|FG001|COMPLETED|Open-Label Extension Phase (OLE)||0||
59610622|NCT01794000|75721467|FG000|NOT COMPLETED|Open-Label Extension Phase (OLE)||3||
59610623|NCT01794000|75721468|FG001|NOT COMPLETED|Open-Label Extension Phase (OLE)||0||
59610624|NCT01609296|75721475|FG000|STARTED|Overall Study||1406||
59610625|NCT01609296|75721475|FG000|COMPLETED|Overall Study||918||
59610626|NCT01609296|75721475|FG000|NOT COMPLETED|Overall Study||488||
59610627|NCT01609218|75721483|FG000|STARTED|Period 1||13||
59610628|NCT01609218|75721484|FG001|STARTED|Period 1||14||
59610629|NCT01609218|75721483|FG000|Received LY2140023|Period 1||13||
59610630|NCT01609218|75721484|FG001|Received LY2140023|Period 1||14||
59610631|NCT01609218|75721483|FG000|Received Activated Charcoal|Period 1|Participants in this treatment sequence did not receive activated charcoal during Period 1.|0||
60013815|NCT01671007|76129761|FG003|COMPLETED|Overall Study||1846||
60013816|NCT01671007|76129762|FG004|COMPLETED|Overall Study||155||
60013817|NCT01671007|76129763|FG005|COMPLETED|Overall Study||401||
59505776|NCT00740831|75598646|FG001|NOT COMPLETED|Overall Study||3||
59505777|NCT00740831|75598647|FG002|NOT COMPLETED|Overall Study||6||
59505778|NCT00741455|75598655|FG000|STARTED|Overall Study||18||
59505779|NCT00741455|75598655|FG000|COMPLETED|Overall Study||17||
59505780|NCT00741455|75598655|FG000|NOT COMPLETED|Overall Study||1||
59505781|NCT00742313|75598661|FG000|STARTED|Overall Study||25||
59505782|NCT00742313|75598662|FG001|STARTED|Overall Study||19||
59505783|NCT00742313|75598661|FG000|COMPLETED|Overall Study||24||
59505784|NCT00742313|75598662|FG001|COMPLETED|Overall Study||19||
59610632|NCT01609218|75721484|FG001|Received Activated Charcoal|Period 1|Two participants discontinued after receiving LY2140023 but prior to receiving activated charcoal.|12||
59610633|NCT01609218|75721483|FG000|COMPLETED|Period 1||10||
59610634|NCT01609218|75721484|FG001|COMPLETED|Period 1||8||
59610635|NCT01609218|75721483|FG000|NOT COMPLETED|Period 1||3||
59610636|NCT01609218|75721484|FG001|NOT COMPLETED|Period 1||6||
59610637|NCT01609218|75721483|FG000|STARTED|Period 2||10||
59610638|NCT01609218|75721484|FG001|STARTED|Period 2|One participant did not complete Period 1 but did continue onto Period 2.|9||
59610639|NCT01609218|75721483|FG000|Received LY2140023|Period 2||10||
59610640|NCT01609218|75721484|FG001|Received LY2140023|Period 2||9||
59610641|NCT01609218|75721483|FG000|Received Activated Charcoal|Period 2||9||
59610642|NCT01609218|75721484|FG001|Received Activated Charcoal|Period 2|Participants in this treatment sequence did not receive activated charcoal during Period 2.|0||
59610643|NCT01609218|75721483|FG000|COMPLETED|Period 2||9||
59610644|NCT01609218|75721484|FG001|COMPLETED|Period 2||9||
59610645|NCT01609218|75721483|FG000|NOT COMPLETED|Period 2||1||
59610646|NCT01609218|75721484|FG001|NOT COMPLETED|Period 2||0||
59610647|NCT01609062|75721492|FG000|STARTED|Primary Phase||15||
59610648|NCT01609062|75721493|FG001|STARTED|Primary Phase||10||
59610649|NCT01609062|75721492|FG000|COMPLETED|Primary Phase||15||
59610650|NCT01609062|75721493|FG001|COMPLETED|Primary Phase||10||
59610651|NCT01609062|75721492|FG000|NOT COMPLETED|Primary Phase||0||
59610652|NCT01609062|75721493|FG001|NOT COMPLETED|Primary Phase||0||
59610653|NCT01609062|75721492|FG000|STARTED|Extension Phase||15||
59610654|NCT01609062|75721493|FG001|STARTED|Extension Phase||10||
60013818|NCT01671007|76129764|FG006|COMPLETED|Overall Study||59||
60013819|NCT01671007|76129765|FG007|COMPLETED|Overall Study||394||
60013820|NCT01671007|76129766|FG008|COMPLETED|Overall Study||2||
60013821|NCT01671007|76129758|FG000|NOT COMPLETED|Overall Study||321||
60013822|NCT01671007|76129759|FG001|NOT COMPLETED|Overall Study||651||
60013823|NCT01671007|76129760|FG002|NOT COMPLETED|Overall Study||366||
60013824|NCT01671007|76129761|FG003|NOT COMPLETED|Overall Study||368||
60013825|NCT01671007|76129762|FG004|NOT COMPLETED|Overall Study||25||
60013826|NCT01671007|76129763|FG005|NOT COMPLETED|Overall Study||112||
60013827|NCT01671007|76129764|FG006|NOT COMPLETED|Overall Study||21||
60013828|NCT01671007|76129765|FG007|NOT COMPLETED|Overall Study||132||
60013829|NCT01671007|76129766|FG008|NOT COMPLETED|Overall Study||0||
59610655|NCT01609062|75721492|FG000|COMPLETED|Extension Phase||0||
59610656|NCT01609062|75721493|FG001|COMPLETED|Extension Phase|EAP = Expanded Access Program|0||
59610657|NCT01609062|75721492|FG000|NOT COMPLETED|Extension Phase||15||
59610658|NCT01609062|75721493|FG001|NOT COMPLETED|Extension Phase||10||
59610659|NCT01819272|75721506|FG000|STARTED|Overall Study||41||
59610660|NCT01819272|75721507|FG001|STARTED|Overall Study||39||
59610661|NCT01819272|75721508|FG002|STARTED|Overall Study||40||
59610662|NCT01819272|75721509|FG003|STARTED|Overall Study||40||
59610663|NCT01819272|75721510|FG004|STARTED|Overall Study||40||
60013830|NCT02505945|76129779|FG000|STARTED|Overall Study||102||
60013831|NCT02505945|76129780|FG001|STARTED|Overall Study||50||
60013832|NCT02505945|76129779|FG000|COMPLETED|Overall Study||80||
59505785|NCT00742313|75598661|FG000|NOT COMPLETED|Overall Study||1||
59505786|NCT00742313|75598662|FG001|NOT COMPLETED|Overall Study||0||
59505787|NCT00742469|75598670|FG000|STARTED|Overall Study||106||
59505788|NCT00742469|75598671|FG001|STARTED|Overall Study||104||
59505789|NCT00742469|75598670|FG000|COMPLETED|Overall Study||88||
59610664|NCT01819272|75721511|FG005|STARTED|Overall Study||40||
59610665|NCT01819272|75721506|FG000|COMPLETED|Overall Study||35||
59610666|NCT01819272|75721507|FG001|COMPLETED|Overall Study||36||
59610667|NCT01819272|75721508|FG002|COMPLETED|Overall Study||37||
59610668|NCT01819272|75721509|FG003|COMPLETED|Overall Study||35||
59610669|NCT01819272|75721510|FG004|COMPLETED|Overall Study||36||
59610670|NCT01819272|75721511|FG005|COMPLETED|Overall Study||33||
59610671|NCT01819272|75721506|FG000|NOT COMPLETED|Overall Study||6||
59610672|NCT01819272|75721507|FG001|NOT COMPLETED|Overall Study||3||
59610673|NCT01819272|75721508|FG002|NOT COMPLETED|Overall Study||3||
59610674|NCT01819272|75721509|FG003|NOT COMPLETED|Overall Study||5||
59610675|NCT01819272|75721510|FG004|NOT COMPLETED|Overall Study||4||
59610676|NCT01819272|75721511|FG005|NOT COMPLETED|Overall Study||7||
59610677|NCT01819194|75721525|FG000|STARTED|Overall Study||62||
59610678|NCT01819194|75721525|FG000|COMPLETED|Overall Study||60||
59610679|NCT01819194|75721525|FG000|NOT COMPLETED|Overall Study||2||
59610680|NCT01611558|75721529|FG000|STARTED|Induction Phase||40||
59610681|NCT01611558|75721529|FG000|COMPLETED|Induction Phase||2||
59610682|NCT01611558|75721529|FG000|NOT COMPLETED|Induction Phase||38||
59610683|NCT01611558|75721529|FG000|STARTED|Maintenance Phase||2||
59610684|NCT01611558|75721529|FG000|COMPLETED|Maintenance Phase||0||
59610685|NCT01611558|75721529|FG000|NOT COMPLETED|Maintenance Phase||2||
59610686|NCT01818726|75721536|FG000|STARTED|Overall Study||10||
59610687|NCT01818726|75721537|FG001|STARTED|Overall Study||5||
59610688|NCT01818726|75721536|FG000|COMPLETED|Overall Study||4||
59610689|NCT01818726|75721537|FG001|COMPLETED|Overall Study||3||
59610690|NCT01818726|75721536|FG000|NOT COMPLETED|Overall Study||6||
59610691|NCT01818726|75721537|FG001|NOT COMPLETED|Overall Study||2||
59610692|NCT01818336|75721543|FG000|STARTED|Overall Study||391||
59610693|NCT01818336|75721544|FG001|STARTED|Overall Study||59||
59610694|NCT01818336|75721543|FG000|COMPLETED|Overall Study||391||
59610695|NCT01818336|75721544|FG001|COMPLETED|Overall Study||47||
59610696|NCT01818336|75721543|FG000|NOT COMPLETED|Overall Study||0||
59610697|NCT01818336|75721544|FG001|NOT COMPLETED|Overall Study||12||
59610698|NCT01818258|75721552|FG000|STARTED|Overall Study||25||
59610699|NCT01818258|75721553|FG001|STARTED|Overall Study||27||
59610700|NCT01818258|75721552|FG000|COMPLETED|Overall Study||22||
59610701|NCT01818258|75721553|FG001|COMPLETED|Overall Study||24||
59610702|NCT01818258|75721552|FG000|NOT COMPLETED|Overall Study||3||
59610703|NCT01818258|75721553|FG001|NOT COMPLETED|Overall Study||3||
59610704|NCT01817790|75721562|FG000|STARTED|Overall Study||314||
59610705|NCT01817790|75721563|FG001|STARTED|Overall Study||312||
59610706|NCT01817790|75721562|FG000|COMPLETED|Overall Study||310||
59610707|NCT01817790|75721563|FG001|COMPLETED|Overall Study||304||
59610708|NCT01817790|75721562|FG000|NOT COMPLETED|Overall Study||4||
59610709|NCT01817790|75721563|FG001|NOT COMPLETED|Overall Study||8||
59610710|NCT01793688|75721571|FG000|STARTED|Overall Study||982||
59610711|NCT01793688|75721571|FG000|COMPLETED|Overall Study||980||
59610712|NCT01793688|75721571|FG000|NOT COMPLETED|Overall Study||2||
59610713|NCT01793142|75721575|FG000|STARTED|Overall Study||3430||
59610714|NCT01793142|75721575|FG000|Treated|Overall Study||3423||
59610715|NCT01793142|75721575|FG000|COMPLETED|Overall Study||3423||
59610716|NCT01793142|75721575|FG000|NOT COMPLETED|Overall Study||7||
59610717|NCT01792830|75721590|FG000|STARTED|Overall Study||84||
59610718|NCT01792830|75721591|FG001|STARTED|Overall Study||3||
59610719|NCT01792830|75721592|FG002|STARTED|Overall Study||4||
59610720|NCT01792830|75721593|FG003|STARTED|Overall Study||21||
59610721|NCT01792830|75721594|FG004|STARTED|Overall Study||2||
59610722|NCT01792830|75721595|FG005|STARTED|Overall Study||4||
59610723|NCT01792830|75721596|FG006|STARTED|Overall Study||14||
59610724|NCT01792830|75721597|FG007|STARTED|Overall Study||7||
59610725|NCT01792830|75721598|FG008|STARTED|Overall Study||20||
59610726|NCT01792830|75721599|FG009|STARTED|Overall Study||4||
59610727|NCT01792830|75721600|FG010|STARTED|Overall Study||12||
59610728|NCT01792830|75721590|FG000|COMPLETED|Overall Study||59|Participants who died in the hospital, before follow-up, are considered as not completing the study.|
59610729|NCT01792830|75721591|FG001|COMPLETED|Overall Study||3|Participants who died in the hospital, before follow-up, are considered as not completing the study.|
59610730|NCT01792830|75721592|FG002|COMPLETED|Overall Study||4|Participants who died in the hospital, before follow-up, are considered as not completing the study.|
59610731|NCT01792830|75721593|FG003|COMPLETED|Overall Study||18|Participants who died in the hospital, before follow-up, are considered as not completing the study.|
59610732|NCT01792830|75721594|FG004|COMPLETED|Overall Study||1|Participants who died in the hospital, before follow-up, are considered as not completing the study.|
59610733|NCT01792830|75721595|FG005|COMPLETED|Overall Study||3|Participants who died in the hospital, before follow-up, are considered as not completing the study.|
59610734|NCT01792830|75721596|FG006|COMPLETED|Overall Study||12|Participants who died in the hospital, before follow-up, are considered as not completing the study.|
59610735|NCT01792830|75721597|FG007|COMPLETED|Overall Study||6|Participants who died in the hospital, before follow-up, are considered as not completing the study.|
59610736|NCT01792830|75721598|FG008|COMPLETED|Overall Study||11|Participants who died in the hospital, before follow-up, are considered as not completing the study.|
59610737|NCT01792830|75721599|FG009|COMPLETED|Overall Study||4|Participants who died in the hospital, before follow-up, are considered as not completing the study.|
59610738|NCT01792830|75721600|FG010|COMPLETED|Overall Study||9|Participants who died in the hospital, before follow-up, are considered as not completing the study.|
59610739|NCT01792830|75721590|FG000|NOT COMPLETED|Overall Study||25||
59610740|NCT01792830|75721591|FG001|NOT COMPLETED|Overall Study||0||
59610741|NCT01792830|75721592|FG002|NOT COMPLETED|Overall Study||0||
59610742|NCT01792830|75721593|FG003|NOT COMPLETED|Overall Study||3||
59610743|NCT01792830|75721594|FG004|NOT COMPLETED|Overall Study||1||
59610744|NCT01792830|75721595|FG005|NOT COMPLETED|Overall Study||1||
59610745|NCT01792830|75721596|FG006|NOT COMPLETED|Overall Study||2||
59610746|NCT01792830|75721597|FG007|NOT COMPLETED|Overall Study||1||
59610747|NCT01792830|75721598|FG008|NOT COMPLETED|Overall Study||9||
59610748|NCT01792830|75721599|FG009|NOT COMPLETED|Overall Study||0||
59610749|NCT01792830|75721600|FG010|NOT COMPLETED|Overall Study||3||
59610750|NCT01792518|75721632|FG000|STARTED|Overall Study||178||
59610751|NCT01792518|75721633|FG001|STARTED|Overall Study||182||
59610752|NCT01792518|75721632|FG000|COMPLETED|Overall Study||170||
59610753|NCT01792518|75721633|FG001|COMPLETED|Overall Study||175||
59610754|NCT01792518|75721632|FG000|NOT COMPLETED|Overall Study||8||
59610755|NCT01792518|75721633|FG001|NOT COMPLETED|Overall Study||7||
59610756|NCT01792284|75721639|FG000|STARTED|Lead-in Period||212||
59610757|NCT01792284|75721640|FG001|STARTED|Lead-in Period||0||
59610758|NCT01792284|75721641|FG002|STARTED|Lead-in Period||0||
59610759|NCT01792284|75721639|FG000|COMPLETED|Lead-in Period|Participants that completed the Lead-in Period were randomized and entered Randomization Period 1.|182||
59610760|NCT01792284|75721640|FG001|COMPLETED|Lead-in Period||0||
59610761|NCT01792284|75721641|FG002|COMPLETED|Lead-in Period||0||
59610762|NCT01792284|75721639|FG000|NOT COMPLETED|Lead-in Period||30||
59610763|NCT01792284|75721640|FG001|NOT COMPLETED|Lead-in Period||0||
59610764|NCT01792284|75721641|FG002|NOT COMPLETED|Lead-in Period||0||
59610765|NCT01792284|75721639|FG000|STARTED|Randomization Period 1||0||
59610766|NCT01792284|75721640|FG001|STARTED|Randomization Period 1||92||
59610767|NCT01792284|75721641|FG002|STARTED|Randomization Period 1||90||
59610768|NCT01792284|75721639|FG000|Received at Least 1 Dose of Study Drug|Randomization Period 1||0||
59610769|NCT01792284|75721640|FG001|Received at Least 1 Dose of Study Drug|Randomization Period 1||92||
59610770|NCT01792284|75721641|FG002|Received at Least 1 Dose of Study Drug|Randomization Period 1||90||
59610771|NCT01792284|75721639|FG000|COMPLETED|Randomization Period 1||0||
59610772|NCT01792284|75721640|FG001|COMPLETED|Randomization Period 1||90||
59610773|NCT01792284|75721641|FG002|COMPLETED|Randomization Period 1||85||
59610774|NCT01792284|75721639|FG000|NOT COMPLETED|Randomization Period 1||0||
59610775|NCT01792284|75721640|FG001|NOT COMPLETED|Randomization Period 1||2||
59610776|NCT01792284|75721641|FG002|NOT COMPLETED|Randomization Period 1||5||
59610777|NCT01792284|75721639|FG000|STARTED|Randomization Period 2||0||
59610778|NCT01792284|75721640|FG001|STARTED|Randomization Period 2||90||
59610779|NCT01792284|75721641|FG002|STARTED|Randomization Period 2||85||
59610780|NCT01792284|75721639|FG000|Received at Least 1 Dose of Study Drug|Randomization Period 2||0||
59610781|NCT01792284|75721640|FG001|Received at Least 1 Dose of Study Drug|Randomization Period 2||90||
59610782|NCT01792284|75721641|FG002|Received at Least 1 Dose of Study Drug|Randomization Period 2||85||
59610783|NCT01792284|75721639|FG000|COMPLETED|Randomization Period 2||0||
59610784|NCT01792284|75721640|FG001|COMPLETED|Randomization Period 2||87||
59610785|NCT01792284|75721641|FG002|COMPLETED|Randomization Period 2||85||
59610786|NCT01792284|75721639|FG000|NOT COMPLETED|Randomization Period 2||0||
59610787|NCT01792284|75721640|FG001|NOT COMPLETED|Randomization Period 2||3||
59610788|NCT01792284|75721641|FG002|NOT COMPLETED|Randomization Period 2||0||
59610789|NCT01791894|75721649|FG000|STARTED|Overall Study||5||
59610790|NCT01791894|75721649|FG000|COMPLETED|Overall Study||4||
59610791|NCT01791894|75721649|FG000|NOT COMPLETED|Overall Study||1||
59610792|NCT01837680|75721656|FG000|STARTED|Overall Study||52||
59610793|NCT01837680|75721657|FG001|STARTED|Overall Study||53||
59610794|NCT01837680|75721656|FG000|COMPLETED|Overall Study||42||
59610795|NCT01837680|75721657|FG001|COMPLETED|Overall Study||45||
59610796|NCT01837680|75721656|FG000|NOT COMPLETED|Overall Study||10||
59610797|NCT01837680|75721657|FG001|NOT COMPLETED|Overall Study||8||
59610798|NCT01836276|75721665|FG000|STARTED|Overall Study||224||
59610799|NCT01836276|75721666|FG001|STARTED|Overall Study||225||
59610800|NCT01836276|75721665|FG000|Week 4|Overall Study||198||
59610801|NCT01836276|75721666|FG001|Week 4|Overall Study||186||
59610802|NCT01836276|75721665|FG000|Week 12|Overall Study||183||
59610803|NCT01836276|75721666|FG001|Week 12|Overall Study||165||
59610804|NCT01836276|75721665|FG000|COMPLETED|Overall Study||196||
59610805|NCT01836276|75721666|FG001|COMPLETED|Overall Study||174||
59610806|NCT01836276|75721665|FG000|NOT COMPLETED|Overall Study||28||
59610807|NCT01836276|75721666|FG001|NOT COMPLETED|Overall Study||51||
59610808|NCT01790568|75721672|FG000|STARTED|Overall Study||12||
59610809|NCT01790568|75721673|FG001|STARTED|Overall Study||26||
59610810|NCT01790568|75721672|FG000|COMPLETED|Overall Study||12||
59610811|NCT01790568|75721673|FG001|COMPLETED|Overall Study||25||
59610812|NCT01790568|75721672|FG000|NOT COMPLETED|Overall Study||0||
59610813|NCT01790568|75721673|FG001|NOT COMPLETED|Overall Study||1||
59610814|NCT01610076|75721679|FG000|STARTED|Overall Study||103||
59610815|NCT01610076|75721680|FG001|STARTED|Overall Study||105||
59610816|NCT01610076|75721679|FG000|COMPLETED|Overall Study||100||
59610817|NCT01610076|75721680|FG001|COMPLETED|Overall Study||100||
59610818|NCT01610076|75721679|FG000|NOT COMPLETED|Overall Study||3||
59610819|NCT01610076|75721680|FG001|NOT COMPLETED|Overall Study||5||
59610820|NCT01836198|75721689|FG000|STARTED|Part A, Period 1||15||
59610821|NCT01836198|75721690|FG001|STARTED|Part A, Period 1||15||
59610822|NCT01836198|75721691|FG002|STARTED|Part A, Period 1||0||
59610823|NCT01836198|75721689|FG000|Received at Least 1 Dose of Study Drug|Part A, Period 1||15||
59610824|NCT01836198|75721690|FG001|Received at Least 1 Dose of Study Drug|Part A, Period 1||15||
59610825|NCT01836198|75721691|FG002|Received at Least 1 Dose of Study Drug|Part A, Period 1||0||
59610826|NCT01836198|75721689|FG000|COMPLETED|Part A, Period 1||15||
59610827|NCT01836198|75721690|FG001|COMPLETED|Part A, Period 1||15||
59610828|NCT01836198|75721691|FG002|COMPLETED|Part A, Period 1||0||
59610829|NCT01836198|75721689|FG000|NOT COMPLETED|Part A, Period 1||0||
59610830|NCT01836198|75721690|FG001|NOT COMPLETED|Part A, Period 1||0||
59610831|NCT01836198|75721691|FG002|NOT COMPLETED|Part A, Period 1||0||
59610832|NCT01836198|75721689|FG000|STARTED|Part A, Period 2||15||
59610833|NCT01836198|75721690|FG001|STARTED|Part A, Period 2||15||
59610834|NCT01836198|75721691|FG002|STARTED|Part A, Period 2||0||
59610835|NCT01836198|75721689|FG000|Completed Part A, Entered Part B|Part A, Period 2||6||
59610836|NCT01836198|75721690|FG001|Completed Part A, Entered Part B|Part A, Period 2||6||
59610837|NCT01836198|75721691|FG002|Completed Part A, Entered Part B|Part A, Period 2||0||
59610838|NCT01836198|75721689|FG000|COMPLETED|Part A, Period 2||15||
59610839|NCT01836198|75721690|FG001|COMPLETED|Part A, Period 2||14||
59610840|NCT01836198|75721691|FG002|COMPLETED|Part A, Period 2||0||
59610841|NCT01836198|75721689|FG000|NOT COMPLETED|Part A, Period 2||0||
59610842|NCT01836198|75721690|FG001|NOT COMPLETED|Part A, Period 2||1||
59610843|NCT01836198|75721691|FG002|NOT COMPLETED|Part A, Period 2||0||
59610844|NCT01836198|75721689|FG000|STARTED|Part B||0||
59610845|NCT01836198|75721690|FG001|STARTED|Part B||0||
59610846|NCT01836198|75721691|FG002|STARTED|Part B||12||
59610847|NCT01836198|75721689|FG000|Received at Least 1 Dose of Study Drug|Part B||0||
59610848|NCT01836198|75721690|FG001|Received at Least 1 Dose of Study Drug|Part B||0||
59610849|NCT01836198|75721691|FG002|Received at Least 1 Dose of Study Drug|Part B||12||
59610850|NCT01836198|75721689|FG000|COMPLETED|Part B||0||
59610851|NCT01836198|75721690|FG001|COMPLETED|Part B||0||
59610852|NCT01836198|75721691|FG002|COMPLETED|Part B||12||
59610853|NCT01836198|75721689|FG000|NOT COMPLETED|Part B||0||
59610854|NCT01836198|75721690|FG001|NOT COMPLETED|Part B||0||
59610855|NCT01836198|75721691|FG002|NOT COMPLETED|Part B||0||
59610856|NCT01816074|75721711|FG000|STARTED|Phase 1||11||
59610857|NCT01816074|75721712|FG001|STARTED|Phase 1||9||
59610858|NCT01816074|75721713|FG002|STARTED|Phase 1||11||
59610859|NCT01816074|75721714|FG003|STARTED|Phase 1||10||
59610860|NCT01816074|75721711|FG000|COMPLETED|Phase 1||11||
59610861|NCT01816074|75721712|FG001|COMPLETED|Phase 1||9||
59610862|NCT01816074|75721713|FG002|COMPLETED|Phase 1||10||
59610863|NCT01816074|75721714|FG003|COMPLETED|Phase 1||10||
59610864|NCT01816074|75721711|FG000|NOT COMPLETED|Phase 1||0||
59610865|NCT01816074|75721712|FG001|NOT COMPLETED|Phase 1||0||
59610866|NCT01816074|75721713|FG002|NOT COMPLETED|Phase 1||1||
59610867|NCT01816074|75721714|FG003|NOT COMPLETED|Phase 1||0||
59610868|NCT01816074|75721711|FG000|STARTED|Phase 2||11||
59610869|NCT01816074|75721712|FG001|STARTED|Phase 2||9||
59610870|NCT01816074|75721713|FG002|STARTED|Phase 2||10||
59610871|NCT01816074|75721714|FG003|STARTED|Phase 2||10||
59610872|NCT01816074|75721711|FG000|COMPLETED|Phase 2||9||
59610873|NCT01816074|75721712|FG001|COMPLETED|Phase 2||7||
59610874|NCT01816074|75721713|FG002|COMPLETED|Phase 2||10||
59610875|NCT01816074|75721714|FG003|COMPLETED|Phase 2||9||
59610876|NCT01816074|75721711|FG000|NOT COMPLETED|Phase 2||2||
59610877|NCT01816074|75721712|FG001|NOT COMPLETED|Phase 2||2||
59610878|NCT01816074|75721713|FG002|NOT COMPLETED|Phase 2||0||
59610879|NCT01816074|75721714|FG003|NOT COMPLETED|Phase 2||1||
59610880|NCT01815918|75721740|FG000|STARTED|Overall Study||30||
59610881|NCT01815918|75721741|FG001|STARTED|Overall Study||30||
59610882|NCT01815918|75721740|FG000|COMPLETED|Overall Study||12||
59610883|NCT01815918|75721741|FG001|COMPLETED|Overall Study||11||
59610884|NCT01815918|75721740|FG000|NOT COMPLETED|Overall Study||18||
59610885|NCT01815918|75721741|FG001|NOT COMPLETED|Overall Study||19||
59610886|NCT01789476|75721753|FG000|STARTED|Overall Study||34||
59610887|NCT01789476|75721754|FG001|STARTED|Overall Study||17||
59610888|NCT01789476|75721753|FG000|COMPLETED|Overall Study||26||
59610889|NCT01789476|75721754|FG001|COMPLETED|Overall Study||15||
59610890|NCT01789476|75721753|FG000|NOT COMPLETED|Overall Study||8||
59610891|NCT01789476|75721754|FG001|NOT COMPLETED|Overall Study||2||
59610892|NCT01789320|75721760|FG000|STARTED|Overall Study||11||
59610893|NCT01789320|75721760|FG000|COMPLETED|Overall Study||9||
59610894|NCT01789320|75721760|FG000|NOT COMPLETED|Overall Study||2||
59610895|NCT01815840|75721766|FG000|STARTED|Overall Study||116||
59610896|NCT01815840|75721767|FG001|STARTED|Overall Study||113||
59610897|NCT01815840|75721766|FG000|COMPLETED|Overall Study||57||
59610898|NCT01815840|75721767|FG001|COMPLETED|Overall Study||50||
59610899|NCT01815840|75721766|FG000|NOT COMPLETED|Overall Study||59||
59610900|NCT01815840|75721767|FG001|NOT COMPLETED|Overall Study||63||
59610901|NCT01774110|75721773|FG000|STARTED|Overall Study||12||
59610902|NCT01774110|75721773|FG000|COMPLETED|Overall Study||5||
59610903|NCT01774110|75721773|FG000|NOT COMPLETED|Overall Study||7||
59610904|NCT01788228|75721780|FG000|STARTED|Overall Study||49||
59610905|NCT01788228|75721781|FG001|STARTED|Overall Study||1||
59610906|NCT01788228|75721780|FG000|COMPLETED|Overall Study||48||
59610907|NCT01788228|75721781|FG001|COMPLETED|Overall Study||1||
59610908|NCT01788228|75721780|FG000|NOT COMPLETED|Overall Study||1||
59610909|NCT01788228|75721781|FG001|NOT COMPLETED|Overall Study||0||
59610910|NCT01607346|75721790|FG000|STARTED|Overall Study||10||
59610911|NCT01607346|75721790|FG000|COMPLETED|Overall Study||7||
59610912|NCT01607346|75721790|FG000|NOT COMPLETED|Overall Study||3||
59610913|NCT01787838|75721794|FG000|STARTED|Overall Study|This is the number who met Centers for Disease Control and Prevention guidelines for vaccine.|2509||
59610914|NCT01787838|75721794|FG000|COMPLETED|Overall Study|This is the number of patients successfully immunized in a one year period.|1096||
59610915|NCT01787838|75721794|FG000|NOT COMPLETED|Overall Study||1413||
59610916|NCT01787760|75721801|FG000|STARTED|Overall Study||51||
59610917|NCT01787760|75721802|FG001|STARTED|Overall Study||50||
59610918|NCT01787760|75721803|FG002|STARTED|Overall Study||51||
59610919|NCT01787760|75721801|FG000|COMPLETED|Overall Study||25||
59610920|NCT01787760|75721802|FG001|COMPLETED|Overall Study||34||
59610921|NCT01787760|75721803|FG002|COMPLETED|Overall Study||46||
59610922|NCT01787760|75721801|FG000|NOT COMPLETED|Overall Study||26||
59610923|NCT01787760|75721802|FG001|NOT COMPLETED|Overall Study||16||
59610924|NCT01787760|75721803|FG002|NOT COMPLETED|Overall Study||5||
59610925|NCT01815138|75721814|FG000|STARTED|Overall Study||34||
59610926|NCT01815138|75721815|FG001|STARTED|Overall Study||37||
59610927|NCT01815138|75721814|FG000|COMPLETED|Overall Study||26||
59610928|NCT01815138|75721815|FG001|COMPLETED|Overall Study||31||
59610929|NCT01815138|75721814|FG000|NOT COMPLETED|Overall Study||8||
59610930|NCT01815138|75721815|FG001|NOT COMPLETED|Overall Study||6||
59610931|NCT01606800|75721823|FG000|STARTED|Overall Study||22||
59610932|NCT01606800|75721824|FG001|STARTED|Overall Study||23||
59610933|NCT01606800|75721823|FG000|Treated|Overall Study||22||
59610934|NCT01606800|75721824|FG001|Treated|Overall Study||23||
59610935|NCT01606800|75721823|FG000|COMPLETED|Overall Study||17||
59610936|NCT01606800|75721824|FG001|COMPLETED|Overall Study||21||
59610937|NCT01606800|75721823|FG000|NOT COMPLETED|Overall Study||5||
59610938|NCT01606800|75721824|FG001|NOT COMPLETED|Overall Study||2||
59610939|NCT01772550|75721833|FG000|STARTED|Overall Study||102||
59610940|NCT01772550|75721834|FG001|STARTED|Overall Study||103||
59610941|NCT01772550|75721835|FG002|STARTED|Overall Study||33||
59610942|NCT01772550|75721833|FG000|CT Pancreas|Overall Study||40||
59610943|NCT01772550|75721834|FG001|CT Pancreas|Overall Study||36||
59610944|NCT01772550|75721835|FG002|CT Pancreas|Overall Study||8||
59610945|NCT01772550|75721833|FG000|CT Angiogram|Overall Study||24||
59610946|NCT01772550|75721834|FG001|CT Angiogram|Overall Study||25||
59610947|NCT01772550|75721835|FG002|CT Angiogram|Overall Study||4||
59610948|NCT01772550|75721833|FG000|CT Liver|Overall Study||18||
59610949|NCT01772550|75721834|FG001|CT Liver|Overall Study||14||
59610950|NCT01772550|75721835|FG002|CT Liver|Overall Study||8||
59610951|NCT01772550|75721833|FG000|CT Kidney|Overall Study||12||
59610952|NCT01772550|75721834|FG001|CT Kidney|Overall Study||19||
59610953|NCT01772550|75721835|FG002|CT Kidney|Overall Study||6||
59610954|NCT01772550|75721833|FG000|CT Cardiac|Overall Study||7||
59610955|NCT01772550|75721834|FG001|CT Cardiac|Overall Study||7||
59610956|NCT01772550|75721835|FG002|CT Cardiac|Overall Study||1||
59610957|NCT01772550|75721833|FG000|COMPLETED|Overall Study||101||
59610958|NCT01772550|75721834|FG001|COMPLETED|Overall Study||102||
59610959|NCT01772550|75721835|FG002|COMPLETED|Overall Study||27||
59610960|NCT01772550|75721833|FG000|NOT COMPLETED|Overall Study||1||
59610961|NCT01772550|75721834|FG001|NOT COMPLETED|Overall Study||1||
59610962|NCT01772550|75721835|FG002|NOT COMPLETED|Overall Study||6||
59610963|NCT01787292|75721843|FG000|STARTED|Crossover Exercise Interventions|Participants in this group performed aerobic training prior to cross-over to balance training.|17||
59610964|NCT01787292|75721844|FG001|STARTED|Crossover Exercise Interventions|Participants in this group performed balance training prior to cross-over to aerobic training.|16||
59610965|NCT01787292|75721843|FG000|COMPLETED|Crossover Exercise Interventions|Participants completed the 12-week in-house program and cross-over into the balance program.|15||
59610966|NCT01787292|75721844|FG001|COMPLETED|Crossover Exercise Interventions|These participants completed the 12-week in-house program and cross-over into the balance program.|14||
59610967|NCT01787292|75721843|FG000|NOT COMPLETED|Crossover Exercise Interventions||2||
59610968|NCT01787292|75721844|FG001|NOT COMPLETED|Crossover Exercise Interventions||2||
59610969|NCT01787292|75721843|FG000|STARTED|Home Based Exercise Program||15||
59610970|NCT01787292|75721844|FG001|STARTED|Home Based Exercise Program||14||
59610971|NCT01787292|75721843|FG000|COMPLETED|Home Based Exercise Program||12||
59610972|NCT01787292|75721844|FG001|COMPLETED|Home Based Exercise Program||13||
59610973|NCT01787292|75721843|FG000|NOT COMPLETED|Home Based Exercise Program||3||
59610974|NCT01787292|75721844|FG001|NOT COMPLETED|Home Based Exercise Program||1||
59610975|NCT01814748|75721857|FG000|STARTED|Overall Study||102||
59610976|NCT01814748|75721858|FG001|STARTED|Overall Study||101||
59610977|NCT01814748|75721857|FG000|COMPLETED|Overall Study||94||
59610978|NCT01814748|75721858|FG001|COMPLETED|Overall Study||94||
59610979|NCT01814748|75721857|FG000|NOT COMPLETED|Overall Study||8||
59610980|NCT01814748|75721858|FG001|NOT COMPLETED|Overall Study||7||
59610981|NCT01814670|75721864|FG000|STARTED|Overall Study||185||
59610982|NCT01814670|75721864|FG000|COMPLETED|Overall Study||173||
59610983|NCT01814670|75721864|FG000|NOT COMPLETED|Overall Study||12||
59610984|NCT01814046|75721870|FG000|STARTED|Drug Administration||22||
59610985|NCT01814046|75721871|FG001|STARTED|Drug Administration||2||
59610986|NCT01814046|75721872|FG002|STARTED|Drug Administration||0||
59610987|NCT01814046|75721870|FG000|COMPLETED|Drug Administration||21||
59610988|NCT01814046|75721871|FG001|COMPLETED|Drug Administration||2||
59610989|NCT01814046|75721872|FG002|COMPLETED|Drug Administration||0||
59610990|NCT01814046|75721870|FG000|NOT COMPLETED|Drug Administration||1||
59610991|NCT01814046|75721871|FG001|NOT COMPLETED|Drug Administration||0||
59610992|NCT01814046|75721872|FG002|NOT COMPLETED|Drug Administration||0||
59610993|NCT01814046|75721870|FG000|STARTED|Retreatment||0||
59610994|NCT01814046|75721871|FG001|STARTED|Retreatment||0||
59610995|NCT01814046|75721872|FG002|STARTED|Retreatment||3||
59610996|NCT01814046|75721870|FG000|COMPLETED|Retreatment||0||
59610997|NCT01814046|75721871|FG001|COMPLETED|Retreatment||0||
59610998|NCT01814046|75721872|FG002|COMPLETED|Retreatment||3||
59610999|NCT01814046|75721870|FG000|NOT COMPLETED|Retreatment||0||
59611000|NCT01814046|75721871|FG001|NOT COMPLETED|Retreatment||0||
59611001|NCT01814046|75721872|FG002|NOT COMPLETED|Retreatment||0||
59611002|NCT01813890|75721882|FG000|STARTED|Overall Study||20||
59611003|NCT01813890|75721883|FG001|STARTED|Overall Study||21||
59611004|NCT01813890|75721884|FG002|STARTED|Overall Study||19||
59611005|NCT01813890|75721882|FG000|COMPLETED|Overall Study||11||
59611006|NCT01813890|75721883|FG001|COMPLETED|Overall Study||17||
59611007|NCT01813890|75721884|FG002|COMPLETED|Overall Study||13||
59611008|NCT01813890|75721882|FG000|NOT COMPLETED|Overall Study||9||
59611009|NCT01813890|75721883|FG001|NOT COMPLETED|Overall Study||4||
59611010|NCT01813890|75721884|FG002|NOT COMPLETED|Overall Study||6||
59611011|NCT01772316|75721892|FG000|STARTED|Overall Study||47||
59611012|NCT01772316|75721892|FG000|COMPLETED|Overall Study||40||
59611013|NCT01772316|75721892|FG000|NOT COMPLETED|Overall Study||7||
59611014|NCT01813422|75721898|FG000|STARTED|Overall Study||486||
59611015|NCT01813422|75721899|FG001|STARTED|Overall Study||484||
59611016|NCT01813422|75721898|FG000|Received Treatment|Overall Study||484||
59611017|NCT01813422|75721899|FG001|Received Treatment|Overall Study||484||
59611018|NCT01813422|75721898|FG000|COMPLETED|Overall Study||466||
59611019|NCT01813422|75721899|FG001|COMPLETED|Overall Study||468||
59611020|NCT01813422|75721898|FG000|NOT COMPLETED|Overall Study||20||
59611021|NCT01813422|75721899|FG001|NOT COMPLETED|Overall Study||16||
59611022|NCT01786668|75721909|FG000|STARTED|Overall Study||52||
59611023|NCT01786668|75721910|FG001|STARTED|Overall Study||52||
59611024|NCT01786668|75721911|FG002|STARTED|Overall Study||52||
59611025|NCT01786668|75721912|FG003|STARTED|Overall Study||51||
59611026|NCT01786668|75721909|FG000|COMPLETED|Overall Study||51||
59611027|NCT01786668|75721910|FG001|COMPLETED|Overall Study||51||
59611028|NCT01786668|75721911|FG002|COMPLETED|Overall Study||47||
59611029|NCT01786668|75721912|FG003|COMPLETED|Overall Study||47||
59611030|NCT01786668|75721909|FG000|NOT COMPLETED|Overall Study||1||
59611031|NCT01786668|75721910|FG001|NOT COMPLETED|Overall Study||1||
59611032|NCT01786668|75721911|FG002|NOT COMPLETED|Overall Study||5||
59611033|NCT01786668|75721912|FG003|NOT COMPLETED|Overall Study||4||
59611034|NCT01786512|75721933|FG000|STARTED|Overall Study||11||
59611035|NCT01786512|75721934|FG001|STARTED|Overall Study||11||
59611036|NCT01786512|75721935|FG002|STARTED|Overall Study||14||
59611037|NCT01786512|75721936|FG003|STARTED|Overall Study||13||
59611038|NCT01786512|75721937|FG004|STARTED|Overall Study||10||
59611039|NCT01786512|75721938|FG005|STARTED|Overall Study||11||
59611040|NCT01786512|75721939|FG006|STARTED|Overall Study||12||
59611041|NCT01786512|75721940|FG007|STARTED|Overall Study||14||
59611042|NCT01786512|75721941|FG008|STARTED|Overall Study||149||
59611043|NCT01786512|75721942|FG009|STARTED|Overall Study||150||
59611044|NCT01786512|75721943|FG010|STARTED|Overall Study||149||
59611045|NCT01786512|75721933|FG000|Received Study Treatment|Overall Study||11||
59611046|NCT01786512|75721934|FG001|Received Study Treatment|Overall Study||10||
59611047|NCT01786512|75721935|FG002|Received Study Treatment|Overall Study||14||
59611048|NCT01786512|75721936|FG003|Received Study Treatment|Overall Study||13||
59611049|NCT01786512|75721937|FG004|Received Study Treatment|Overall Study||10||
59611050|NCT01786512|75721938|FG005|Received Study Treatment|Overall Study||11||
59611051|NCT01786512|75721939|FG006|Received Study Treatment|Overall Study||11||
59611052|NCT01786512|75721940|FG007|Received Study Treatment|Overall Study||14||
59611053|NCT01786512|75721941|FG008|Received Study Treatment|Overall Study||149||
59611054|NCT01786512|75721942|FG009|Received Study Treatment|Overall Study||150||
59611055|NCT01786512|75721943|FG010|Received Study Treatment|Overall Study||146||
59611056|NCT01786512|75721933|FG000|COMPLETED|Overall Study||11||
59611057|NCT01786512|75721934|FG001|COMPLETED|Overall Study||10||
59611058|NCT01786512|75721935|FG002|COMPLETED|Overall Study||14||
59611059|NCT01786512|75721936|FG003|COMPLETED|Overall Study||13||
59611060|NCT01786512|75721937|FG004|COMPLETED|Overall Study||10||
59611061|NCT01786512|75721938|FG005|COMPLETED|Overall Study||11||
59611062|NCT01786512|75721939|FG006|COMPLETED|Overall Study||11||
59611063|NCT01786512|75721940|FG007|COMPLETED|Overall Study||14||
59611064|NCT01786512|75721941|FG008|COMPLETED|Overall Study||145||
59611065|NCT01786512|75721942|FG009|COMPLETED|Overall Study||145||
59611066|NCT01786512|75721943|FG010|COMPLETED|Overall Study||137||
59611067|NCT01786512|75721933|FG000|NOT COMPLETED|Overall Study||0||
59611068|NCT01786512|75721934|FG001|NOT COMPLETED|Overall Study||1||
59611069|NCT01786512|75721935|FG002|NOT COMPLETED|Overall Study||0||
59611070|NCT01786512|75721936|FG003|NOT COMPLETED|Overall Study||0||
59611071|NCT01786512|75721937|FG004|NOT COMPLETED|Overall Study||0||
59611072|NCT01786512|75721938|FG005|NOT COMPLETED|Overall Study||0||
59611073|NCT01786512|75721939|FG006|NOT COMPLETED|Overall Study||1||
59611074|NCT01786512|75721940|FG007|NOT COMPLETED|Overall Study||0||
59611075|NCT01786512|75721941|FG008|NOT COMPLETED|Overall Study||4||
59611076|NCT01786512|75721942|FG009|NOT COMPLETED|Overall Study||5||
59611077|NCT01786512|75721943|FG010|NOT COMPLETED|Overall Study||12||
59611078|NCT01772160|75721975|FG000|STARTED|Overall Study||394||
59611079|NCT01772160|75721975|FG000|COMPLETED|Overall Study||346||
59611080|NCT01772160|75721975|FG000|NOT COMPLETED|Overall Study||48||
59611081|NCT01770912|75721981|FG000|STARTED|Overall Study||12||
59611082|NCT01770912|75721982|FG001|STARTED|Overall Study||12||
59611083|NCT01770912|75721981|FG000|COMPLETED|Overall Study||10||
59611084|NCT01770912|75721982|FG001|COMPLETED|Overall Study||12||
59611085|NCT01770912|75721981|FG000|NOT COMPLETED|Overall Study||2||
59611086|NCT01770912|75721982|FG001|NOT COMPLETED|Overall Study||0||
59611087|NCT01811706|75721988|FG000|STARTED|First Intervention ( 4 Weeks)||10||
59611088|NCT01811706|75721989|FG001|STARTED|First Intervention ( 4 Weeks)||10||
59611089|NCT01811706|75721988|FG000|COMPLETED|First Intervention ( 4 Weeks)||9||
59611090|NCT01811706|75721989|FG001|COMPLETED|First Intervention ( 4 Weeks)||10||
59611091|NCT01811706|75721988|FG000|NOT COMPLETED|First Intervention ( 4 Weeks)||1||
59611092|NCT01811706|75721989|FG001|NOT COMPLETED|First Intervention ( 4 Weeks)||0||
59611093|NCT01811706|75721988|FG000|STARTED|Washout ( 2 Weeks)||9||
59611094|NCT01811706|75721989|FG001|STARTED|Washout ( 2 Weeks)||10||
59611095|NCT01811706|75721988|FG000|COMPLETED|Washout ( 2 Weeks)||9||
59611096|NCT01811706|75721989|FG001|COMPLETED|Washout ( 2 Weeks)||10||
59611097|NCT01811706|75721988|FG000|NOT COMPLETED|Washout ( 2 Weeks)||0||
59611098|NCT01811706|75721989|FG001|NOT COMPLETED|Washout ( 2 Weeks)||0||
59611099|NCT01811706|75721988|FG000|STARTED|Second Intervention (4 Weeks)||9||
59611100|NCT01811706|75721989|FG001|STARTED|Second Intervention (4 Weeks)||10||
59611101|NCT01811706|75721988|FG000|COMPLETED|Second Intervention (4 Weeks)||9||
59611102|NCT01811706|75721989|FG001|COMPLETED|Second Intervention (4 Weeks)||10||
59611103|NCT01811706|75721988|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0||
59611104|NCT01811706|75721989|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||0||
59611105|NCT01811472|75722000|FG000|STARTED|Overall Study||20||
59611106|NCT01811472|75722001|FG001|STARTED|Overall Study||11||
59611107|NCT01811472|75722002|FG002|STARTED|Overall Study||21||
59611108|NCT01811472|75722000|FG000|COMPLETED|Overall Study||18||
59611109|NCT01811472|75722001|FG001|COMPLETED|Overall Study||11||
59611110|NCT01811472|75722002|FG002|COMPLETED|Overall Study||16||
59611111|NCT01811472|75722000|FG000|NOT COMPLETED|Overall Study||2||
59611112|NCT01811472|75722001|FG001|NOT COMPLETED|Overall Study||0||
59611113|NCT01811472|75722002|FG002|NOT COMPLETED|Overall Study||5||
59611114|NCT01811238|75722011|FG000|STARTED|Overall Study|First patient was recruited on 26 Sep. 2012.|240||
59611115|NCT01811238|75722011|FG000|Safety Set|Overall Study|20 subjects excluded from the safety set due to study drug not administered.|220||
59611116|NCT01811238|75722011|FG000|ITT Set|Overall Study|11 subjects excluded from ITT set due to no primary efficacy assessment(5) and IC/EC violation(6).|209||
59611117|NCT01811238|75722011|FG000|PP Set|Overall Study|89 subjects excluded from PP set due to various reasons.|120||
59611118|NCT01811238|75722011|FG000|COMPLETED|Overall Study|159 subjects regardless PP set completed study visit.|159||
59611119|NCT01811238|75722011|FG000|NOT COMPLETED|Overall Study||81||
59611120|NCT01769508|75722016|FG000|STARTED|Overall Study||12||
59611121|NCT01769508|75722016|FG000|COMPLETED|Overall Study||6||
59611122|NCT01769508|75722016|FG000|NOT COMPLETED|Overall Study||6||
59611123|NCT01810380|75722023|FG000|STARTED|Overall Study||163||
59611124|NCT01810380|75722024|FG001|STARTED|Overall Study||151||
59611125|NCT01810380|75722025|FG002|STARTED|Overall Study||154||
59611126|NCT01810380|75722023|FG000|Treated|Overall Study||161||
59611127|NCT01810380|75722024|FG001|Treated|Overall Study||150||
59611128|NCT01810380|75722025|FG002|Treated|Overall Study||153||
59611129|NCT01810380|75722023|FG000|COMPLETED|Overall Study||108||
59611130|NCT01810380|75722024|FG001|COMPLETED|Overall Study||113||
59611131|NCT01810380|75722025|FG002|COMPLETED|Overall Study||122||
59611132|NCT01810380|75722023|FG000|NOT COMPLETED|Overall Study||55||
59611133|NCT01810380|75722024|FG001|NOT COMPLETED|Overall Study||38||
59611134|NCT01810380|75722025|FG002|NOT COMPLETED|Overall Study||32||
59611135|NCT01769196|75722035|FG000|STARTED|Overall Study||272||
59611136|NCT01769196|75722036|FG001|STARTED|Overall Study||272||
59611137|NCT01769196|75722035|FG000|COMPLETED|Overall Study||0||
59611138|NCT01769196|75722036|FG001|COMPLETED|Overall Study||0||
59611139|NCT01769196|75722035|FG000|NOT COMPLETED|Overall Study||272||
59611140|NCT01769196|75722036|FG001|NOT COMPLETED|Overall Study||272||
59611141|NCT01810302|75722044|FG000|STARTED|Overall Study||1||
59611142|NCT01810302|75722045|FG001|STARTED|Overall Study||1||
59611143|NCT01810302|75722044|FG000|COMPLETED|Overall Study||0||
59611144|NCT01810302|75722045|FG001|COMPLETED|Overall Study||0||
59611145|NCT01810302|75722044|FG000|NOT COMPLETED|Overall Study||1||
59611146|NCT01810302|75722045|FG001|NOT COMPLETED|Overall Study||1||
59611147|NCT01783938|75722053|FG000|STARTED|Overall Study||68||
59611148|NCT01783938|75722054|FG001|STARTED|Overall Study||70||
59611149|NCT01783938|75722053|FG000|COMPLETED|Overall Study||11||
59611150|NCT01783938|75722054|FG001|COMPLETED|Overall Study||9||
59611151|NCT01783938|75722053|FG000|NOT COMPLETED|Overall Study||57||
59611152|NCT01783938|75722054|FG001|NOT COMPLETED|Overall Study||61||
59611153|NCT01768572|75722063|FG000|STARTED|Overall Study||49||
59611154|NCT01768572|75722064|FG001|STARTED|Overall Study||51||
59611155|NCT01768572|75722065|FG002|STARTED|Overall Study||102||
59611156|NCT01768572|75722063|FG000|COMPLETED|Overall Study||40||
59611157|NCT01768572|75722064|FG001|COMPLETED|Overall Study||39||
59611158|NCT01768572|75722065|FG002|COMPLETED|Overall Study||96||
59611159|NCT01768572|75722063|FG000|NOT COMPLETED|Overall Study||9||
59611160|NCT01768572|75722064|FG001|NOT COMPLETED|Overall Study||12||
59611161|NCT01768572|75722065|FG002|NOT COMPLETED|Overall Study||6||
59611162|NCT01783548|75722075|FG000|STARTED|Overall Study|Randomized|362||
59611163|NCT01783548|75722076|FG001|STARTED|Overall Study|Randomized|185||
59611164|NCT01783548|75722075|FG000|Full Analysis Set (FAS)|Overall Study||358||
59611165|NCT01783548|75722076|FG001|Full Analysis Set (FAS)|Overall Study||184||
59611166|NCT01783548|75722075|FG000|COMPLETED|Overall Study||328||
59611167|NCT01783548|75722076|FG001|COMPLETED|Overall Study||167||
59611168|NCT01783548|75722075|FG000|NOT COMPLETED|Overall Study||34||
59611169|NCT01783548|75722076|FG001|NOT COMPLETED|Overall Study||18||
59611170|NCT01809210|75722089|FG000|STARTED|Overall Study||3||
59611171|NCT01809210|75722090|FG001|STARTED|Overall Study||9||
59611172|NCT01809210|75722091|FG002|STARTED|Overall Study||7||
59611173|NCT01809210|75722092|FG003|STARTED|Overall Study||3||
59611174|NCT01809210|75722093|FG004|STARTED|Overall Study||6||
59611175|NCT01809210|75722094|FG005|STARTED|Overall Study||15||
59611176|NCT01809210|75722095|FG006|STARTED|Overall Study||12||
59611177|NCT01809210|75722089|FG000|COMPLETED|Overall Study||2||
59611178|NCT01809210|75722090|FG001|COMPLETED|Overall Study||8||
59611179|NCT01809210|75722091|FG002|COMPLETED|Overall Study||4||
59611180|NCT01809210|75722092|FG003|COMPLETED|Overall Study||2||
59611181|NCT01809210|75722093|FG004|COMPLETED|Overall Study||4||
59611182|NCT01809210|75722094|FG005|COMPLETED|Overall Study||12||
59611183|NCT01809210|75722095|FG006|COMPLETED|Overall Study||7||
59611184|NCT01809210|75722089|FG000|NOT COMPLETED|Overall Study||1||
59611185|NCT01809210|75722090|FG001|NOT COMPLETED|Overall Study||1||
59611186|NCT01809210|75722091|FG002|NOT COMPLETED|Overall Study||3||
59611187|NCT01809210|75722092|FG003|NOT COMPLETED|Overall Study||1||
59611188|NCT01809210|75722093|FG004|NOT COMPLETED|Overall Study||2||
59611189|NCT01809210|75722094|FG005|NOT COMPLETED|Overall Study||3||
59611190|NCT01809210|75722095|FG006|NOT COMPLETED|Overall Study||5||
59611191|NCT01809132|75722114|FG000|STARTED|Overall Study||53||
59611192|NCT01809132|75722115|FG001|STARTED|Overall Study||50||
59611193|NCT01809132|75722116|FG002|STARTED|Overall Study|Subject was consented but withdrew prior to randomization and initiation of treatment.|1||
59611194|NCT01809132|75722114|FG000|COMPLETED|Overall Study||53||
59611195|NCT01809132|75722115|FG001|COMPLETED|Overall Study||50||
59611196|NCT01809132|75722116|FG002|COMPLETED|Overall Study||0||
59611197|NCT01809132|75722114|FG000|NOT COMPLETED|Overall Study||0||
59611198|NCT01809132|75722115|FG001|NOT COMPLETED|Overall Study||0||
59611199|NCT01809132|75722116|FG002|NOT COMPLETED|Overall Study||1||
59611200|NCT01808508|75722127|FG000|STARTED|Overall Study||11||
59611201|NCT01808508|75722128|FG001|STARTED|Overall Study||9||
59611202|NCT01808508|75722129|FG002|STARTED|Overall Study||3||
59611203|NCT01808508|75722127|FG000|COMPLETED|Overall Study||10||
59611204|NCT01808508|75722128|FG001|COMPLETED|Overall Study||9||
59611205|NCT01808508|75722129|FG002|COMPLETED|Overall Study||3||
59611206|NCT01808508|75722127|FG000|NOT COMPLETED|Overall Study||1||
59611207|NCT01808508|75722128|FG001|NOT COMPLETED|Overall Study||0||
59611208|NCT01808508|75722129|FG002|NOT COMPLETED|Overall Study||0||
59611209|NCT01766778|75722139|FG000|STARTED|Overall Study|Intent to treat population|56||
59611210|NCT01766778|75722140|FG001|STARTED|Overall Study||61||
59611211|NCT01766778|75722139|FG000|COMPLETED|Overall Study||51||
59611212|NCT01766778|75722140|FG001|COMPLETED|Overall Study||57||
59611213|NCT01766778|75722139|FG000|NOT COMPLETED|Overall Study||5||
59611214|NCT01766778|75722140|FG001|NOT COMPLETED|Overall Study||4||
59611215|NCT01808196|75722146|FG000|STARTED|Overall Study||6||
59611216|NCT01808196|75722146|FG000|COMPLETED|Overall Study||5||
59611217|NCT01808196|75722146|FG000|NOT COMPLETED|Overall Study||1||
59611218|NCT01808118|75722150|FG000|STARTED|Period 1||673||
59611219|NCT01808118|75722151|FG001|STARTED|Period 1||0||
59611220|NCT01808118|75722152|FG002|STARTED|Period 1||0||
59611221|NCT01808118|75722150|FG000|COMPLETED|Period 1||305||
59611222|NCT01808118|75722151|FG001|COMPLETED|Period 1||0||
59611223|NCT01808118|75722152|FG002|COMPLETED|Period 1||0||
59611224|NCT01808118|75722150|FG000|NOT COMPLETED|Period 1||368||
59611225|NCT01808118|75722151|FG001|NOT COMPLETED|Period 1||0||
59611226|NCT01808118|75722152|FG002|NOT COMPLETED|Period 1||0||
59611227|NCT01808118|75722150|FG000|STARTED|Period 2||0||
59611228|NCT01808118|75722151|FG001|STARTED|Period 2||153||
59611229|NCT01808118|75722152|FG002|STARTED|Period 2||152||
59611230|NCT01808118|75722150|FG000|COMPLETED|Period 2||0||
59611231|NCT01808118|75722151|FG001|COMPLETED|Period 2||140||
59611232|NCT01808118|75722152|FG002|COMPLETED|Period 2||144||
59611233|NCT01808118|75722150|FG000|NOT COMPLETED|Period 2||0||
59611234|NCT01808118|75722151|FG001|NOT COMPLETED|Period 2||13||
59611235|NCT01808118|75722152|FG002|NOT COMPLETED|Period 2||8||
59611236|NCT01807650|75722166|FG000|STARTED|Overall Study||112||112
59611237|NCT01807650|75722166|FG000|COMPLETED|Overall Study||92||92
59611238|NCT01807650|75722166|FG000|NOT COMPLETED|Overall Study||20||20
59611239|NCT01782690|75722207|FG000|STARTED|Overall Study||338||
59611240|NCT01782690|75722207|FG000|COMPLETED|Overall Study||39||
59611241|NCT01782690|75722207|FG000|NOT COMPLETED|Overall Study||299||
59611242|NCT01782378|75722213|FG000|STARTED|First Series||32||
59611243|NCT01782378|75722214|FG001|STARTED|First Series||31||
59611244|NCT01782378|75722213|FG000|COMPLETED|First Series||25||
59611245|NCT01782378|75722214|FG001|COMPLETED|First Series||23||
59611246|NCT01782378|75722213|FG000|NOT COMPLETED|First Series||7||
59611247|NCT01782378|75722214|FG001|NOT COMPLETED|First Series||8||
59611248|NCT01782378|75722213|FG000|STARTED|Second Series||31||
59611249|NCT01782378|75722214|FG001|STARTED|Second Series||32||
59611250|NCT01782378|75722213|FG000|COMPLETED|Second Series||5||
59611251|NCT01782378|75722214|FG001|COMPLETED|Second Series||0||
59611252|NCT01782378|75722213|FG000|NOT COMPLETED|Second Series||26||
59611253|NCT01782378|75722214|FG001|NOT COMPLETED|Second Series||32||
59611254|NCT01766310|75722222|FG000|STARTED|Overall Study||24||
59611255|NCT01766310|75722223|FG001|STARTED|Overall Study||26||
59611256|NCT01766310|75722222|FG000|COMPLETED|Overall Study||23||
59896189|NCT03452943|76018263|FG001|Modified ITT (mITT) Analysis Set|Titration Period (7 Weeks)||59|Received at least 1 dose of study drug; had both baseline & at least 1 postbaseline YGTSS assessment|
59896190|NCT03452943|76018262|FG000|COMPLETED|Titration Period (7 Weeks)||54||
59896191|NCT03452943|76018263|FG001|COMPLETED|Titration Period (7 Weeks)||56||
59896192|NCT03452943|76018262|FG000|NOT COMPLETED|Titration Period (7 Weeks)||5||
59896193|NCT03452943|76018263|FG001|NOT COMPLETED|Titration Period (7 Weeks)||4||
59896194|NCT03452943|76018262|FG000|STARTED|Maintenance Period (5 Weeks)||54||
59896195|NCT03452943|76018263|FG001|STARTED|Maintenance Period (5 Weeks)||56||
59896196|NCT03452943|76018262|FG000|COMPLETED|Maintenance Period (5 Weeks)||51||
59896197|NCT03452943|76018263|FG001|COMPLETED|Maintenance Period (5 Weeks)||56||
59896198|NCT03452943|76018262|FG000|NOT COMPLETED|Maintenance Period (5 Weeks)||3||
59896199|NCT03452943|76018263|FG001|NOT COMPLETED|Maintenance Period (5 Weeks)||0||
59896200|NCT03481725|76018271|FG000|STARTED|Overall Study||31||
59896201|NCT03481725|76018272|FG001|STARTED|Overall Study||34||
59896202|NCT03481725|76018271|FG000|COMPLETED|Overall Study||30||
59896203|NCT03481725|76018272|FG001|COMPLETED|Overall Study||34||
59896204|NCT03481725|76018271|FG000|NOT COMPLETED|Overall Study||1||
59896205|NCT03481725|76018272|FG001|NOT COMPLETED|Overall Study||0||
59896206|NCT03480243|76018280|FG000|STARTED|Padsevonil (Period 1)||28||
59896207|NCT03480243|76018280|FG000|COMPLETED|Padsevonil (Period 1)||28||
59896208|NCT03480243|76018280|FG000|NOT COMPLETED|Padsevonil (Period 1)||0||
59896209|NCT03480243|76018280|FG000|STARTED|Padsevonil (Period 2)||28||
59896210|NCT03480243|76018280|FG000|COMPLETED|Padsevonil (Period 2)||27||
59896211|NCT03480243|76018280|FG000|NOT COMPLETED|Padsevonil (Period 2)||1||
59896212|NCT03480243|76018280|FG000|STARTED|Erythromycin (Period 3a)||27||
59896213|NCT03480243|76018280|FG000|COMPLETED|Erythromycin (Period 3a)||27||
59896214|NCT03480243|76018280|FG000|NOT COMPLETED|Erythromycin (Period 3a)||0||
60013833|NCT02505945|76129780|FG001|COMPLETED|Overall Study||46||
60013834|NCT02505945|76129779|FG000|NOT COMPLETED|Overall Study||22||
59611257|NCT01766310|75722223|FG001|COMPLETED|Overall Study||23||
59611258|NCT01766310|75722222|FG000|NOT COMPLETED|Overall Study||1||
59611259|NCT01766310|75722223|FG001|NOT COMPLETED|Overall Study||3||
59611260|NCT01765920|75722231|FG000|STARTED|Overall Study||169||
59611261|NCT01765920|75722232|FG001|STARTED|Overall Study||173||
59611262|NCT01765920|75722231|FG000|COMPLETED|Overall Study||167||
59611263|NCT01765920|75722232|FG001|COMPLETED|Overall Study||167||
59611264|NCT01765920|75722231|FG000|NOT COMPLETED|Overall Study||2||
59896215|NCT03480243|76018280|FG000|STARTED|Padsevonil and Erythromycin (Period 3b)||27||
59896216|NCT03480243|76018280|FG000|COMPLETED|Padsevonil and Erythromycin (Period 3b)||26||
59896217|NCT03480243|76018280|FG000|NOT COMPLETED|Padsevonil and Erythromycin (Period 3b)||1||
59896218|NCT03480243|76018280|FG000|STARTED|Erythromycin (Period 3c)||26||
59896219|NCT03480243|76018280|FG000|COMPLETED|Erythromycin (Period 3c)||26||
59896220|NCT03480243|76018280|FG000|NOT COMPLETED|Erythromycin (Period 3c)||0||
59896221|NCT03426345|76018295|FG000|STARTED|Overall Study||155||
59896222|NCT03426345|76018296|FG001|STARTED|Overall Study||156||
59896223|NCT03426345|76018295|FG000|Safety Population|Overall Study||152|The Safety Population included all participants who received ≥1 administration of double-blind study treatment.|
59896224|NCT03426345|76018296|FG001|Safety Population|Overall Study||155|The Safety Population included all participants who received ≥1 administration of double-blind study treatment.|
59896225|NCT03426345|76018295|FG000|COMPLETED|Overall Study||137||
59896226|NCT03426345|76018296|FG001|COMPLETED|Overall Study||139||
59896227|NCT03426345|76018295|FG000|NOT COMPLETED|Overall Study||18||
59896228|NCT03426345|76018296|FG001|NOT COMPLETED|Overall Study||17||
59896229|NCT03426267|76018305|FG000|STARTED|Overall Study||163||
59896230|NCT03426267|76018306|FG001|STARTED|Overall Study||162||
59896231|NCT03426267|76018305|FG000|Modified Intent-to-Treat Population|Overall Study||154||
59896232|NCT03426267|76018306|FG001|Modified Intent-to-Treat Population|Overall Study||144||
59896233|NCT03426267|76018305|FG000|COMPLETED|Overall Study||142||
59896234|NCT03426267|76018306|FG001|COMPLETED|Overall Study||90||
59896235|NCT03426267|76018305|FG000|NOT COMPLETED|Overall Study||21||
59896236|NCT03426267|76018306|FG001|NOT COMPLETED|Overall Study||72||
59896237|NCT03412929|76018312|FG000|STARTED|Overall Study||8||
59896238|NCT03412929|76018312|FG000|COMPLETED|Overall Study||5||
59896239|NCT03412929|76018312|FG000|NOT COMPLETED|Overall Study||3||
59896240|NCT03451773|76018318|FG000|STARTED|Overall Study||1||
59896241|NCT03451773|76018319|FG001|STARTED|Overall Study||6||
59896242|NCT03451773|76018318|FG000|COMPLETED|Overall Study||0||
59896243|NCT03451773|76018319|FG001|COMPLETED|Overall Study||0||
59896244|NCT03451773|76018318|FG000|NOT COMPLETED|Overall Study||1||
59896245|NCT03451773|76018319|FG001|NOT COMPLETED|Overall Study||6||
59896246|NCT03425253|76018326|FG000|STARTED|Overall Study||58||
59896247|NCT03425253|76018326|FG000|Safety Analysis Set|Overall Study||53|Safety Analysis Set included participants who are defined as Full Analysis Set (FAS) participants and those participants who underwent biopsy procedure but did not receive the BELKYRA® treatment.|
59896248|NCT03425253|76018326|FG000|FAS|Overall Study||53|FAS population included all participants who received BELKYRA®.|
59896249|NCT03425253|76018326|FG000|Evaluable Set (ES)|Overall Study||42|ES population included all participants who received BELKYRA® plus VOLUMA™.|
59896250|NCT03425253|76018326|FG000|COMPLETED|Overall Study||42||
59896251|NCT03425253|76018326|FG000|NOT COMPLETED|Overall Study||16||
59896252|NCT03424239|76018331|FG000|STARTED|Overall Study||6||
59896253|NCT03424239|76018331|FG000|Baseline/Zoledronic Acid Administration|Overall Study||4||
59896254|NCT03424239|76018331|FG000|2 Week Post-op|Overall Study||4||
59896255|NCT03424239|76018331|FG000|12 Week Post-op|Overall Study||4||
59896256|NCT03424239|76018331|FG000|24 Week Post-op|Overall Study||4||
59896257|NCT03424239|76018331|FG000|COMPLETED|Overall Study||4||
59896258|NCT03424239|76018331|FG000|NOT COMPLETED|Overall Study||2||
59896259|NCT03451071|76018335|FG000|STARTED|First Vaccine||56||
59896260|NCT03451071|76018335|FG000|COMPLETED|First Vaccine||55||
59896261|NCT03451071|76018335|FG000|NOT COMPLETED|First Vaccine||1||
59896262|NCT03451071|76018335|FG000|STARTED|Second Vaccine||55||
59896263|NCT03451071|76018335|FG000|COMPLETED|Second Vaccine||36||
59896264|NCT03451071|76018335|FG000|NOT COMPLETED|Second Vaccine||19||
59896265|NCT03451071|76018335|FG000|STARTED|Third Vaccine||36||
59896266|NCT03451071|76018335|FG000|COMPLETED|Third Vaccine||14||
59896267|NCT03451071|76018335|FG000|NOT COMPLETED|Third Vaccine||22||
59896268|NCT03451071|76018335|FG000|STARTED|Final Questionnaire and Blood Draw||14||
59896269|NCT03451071|76018335|FG000|COMPLETED|Final Questionnaire and Blood Draw||10||
59896270|NCT03451071|76018335|FG000|NOT COMPLETED|Final Questionnaire and Blood Draw||4||
59896271|NCT03449979|76018343|FG000|STARTED|Overall Study||21||
59896272|NCT03449979|76018344|FG001|STARTED|Overall Study||20||
59896273|NCT03449979|76018345|FG002|STARTED|Overall Study||21||
59896274|NCT03449979|76018346|FG003|STARTED|Overall Study||22||
60013835|NCT02505945|76129780|FG001|NOT COMPLETED|Overall Study||4||
60013836|NCT02505867|76129788|FG000|STARTED|Overall Study||6||
59896275|NCT03449979|76018343|FG000|COMPLETED|Overall Study||21||
59896276|NCT03449979|76018344|FG001|COMPLETED|Overall Study||20||
59896277|NCT03449979|76018345|FG002|COMPLETED|Overall Study||21||
60013837|NCT02505867|76129789|FG001|STARTED|Overall Study||6||
60013838|NCT02505867|76129788|FG000|COMPLETED|Overall Study||0||
60013839|NCT02505867|76129789|FG001|COMPLETED|Overall Study||0||
59896278|NCT03449979|76018346|FG003|COMPLETED|Overall Study||21||
59896279|NCT03449979|76018343|FG000|NOT COMPLETED|Overall Study||0||
59896280|NCT03449979|76018344|FG001|NOT COMPLETED|Overall Study||0||
59896281|NCT03449979|76018345|FG002|NOT COMPLETED|Overall Study||0||
59896282|NCT03449979|76018346|FG003|NOT COMPLETED|Overall Study||1||
59896283|NCT03449199|76018359|FG000|STARTED|Overall Study||42||
59896284|NCT03449199|76018360|FG001|STARTED|Overall Study||44||
60013840|NCT02505867|76129788|FG000|NOT COMPLETED|Overall Study||6||
60013841|NCT02505867|76129789|FG001|NOT COMPLETED|Overall Study||6||
59896285|NCT03449199|76018361|FG002|STARTED|Overall Study||44||
59896286|NCT03449199|76018359|FG000|COMPLETED|Overall Study||41||
59896287|NCT03449199|76018360|FG001|COMPLETED|Overall Study||43||
59896288|NCT03449199|76018361|FG002|COMPLETED|Overall Study||42||
59896289|NCT03449199|76018359|FG000|NOT COMPLETED|Overall Study||1||
59896290|NCT03449199|76018360|FG001|NOT COMPLETED|Overall Study||1||
59896291|NCT03449199|76018361|FG002|NOT COMPLETED|Overall Study||2||
59896292|NCT03421431|76018375|FG000|STARTED|Overall Study||24||
59896293|NCT03421431|76018376|FG001|STARTED|Overall Study||55||
59896294|NCT03421431|76018377|FG002|STARTED|Overall Study||53||
59896295|NCT03421431|76018375|FG000|COMPLETED|Overall Study||18||
59896296|NCT03421431|76018376|FG001|COMPLETED|Overall Study||49||
59896297|NCT03421431|76018377|FG002|COMPLETED|Overall Study||39||
59896298|NCT03421431|76018375|FG000|NOT COMPLETED|Overall Study||6||
59896299|NCT03421431|76018376|FG001|NOT COMPLETED|Overall Study||6||
59896300|NCT03421431|76018377|FG002|NOT COMPLETED|Overall Study||14||
59896301|NCT03448419|76018389|FG000|STARTED|Overall Study||156||
59896302|NCT03448419|76018390|FG001|STARTED|Overall Study||156||
59896303|NCT03448419|76018389|FG000|Treated|Overall Study||156||
59896304|NCT03448419|76018390|FG001|Treated|Overall Study||155||
59896305|NCT03448419|76018389|FG000|COMPLETED|Overall Study||143||
59896306|NCT03448419|76018390|FG001|COMPLETED|Overall Study||140||
59896307|NCT03448419|76018389|FG000|NOT COMPLETED|Overall Study||13||
59896308|NCT03448419|76018390|FG001|NOT COMPLETED|Overall Study||16||
59896309|NCT04897841|76018400|FG000|STARTED|Overall Study||29||
59896310|NCT04897841|76018401|FG001|STARTED|Overall Study||31||
59896311|NCT04897841|76018400|FG000|COMPLETED|Overall Study||29||
59896312|NCT04897841|76018401|FG001|COMPLETED|Overall Study||31||
59896313|NCT04897841|76018400|FG000|NOT COMPLETED|Overall Study||0||
59896314|NCT04897841|76018401|FG001|NOT COMPLETED|Overall Study||0||
59896315|NCT04816214|76018407|FG000|STARTED|Overall Study||6||
59896316|NCT04816214|76018408|FG001|STARTED|Overall Study||0||
59896317|NCT04816214|76018409|FG002|STARTED|Overall Study||0||
59896318|NCT04816214|76018407|FG000|Full Analysis Set (FAS)|Overall Study||6|FAS included all participants who received any component of the study treatment.|
59896319|NCT04816214|76018408|FG001|Full Analysis Set (FAS)|Overall Study||0|FAS included all participants who received any component of the study treatment.|
59896320|NCT04816214|76018409|FG002|Full Analysis Set (FAS)|Overall Study||0|FAS included all participants who received any component of the study treatment.|
59896321|NCT04816214|76018407|FG000|Safety Set|Overall Study||6|Safety set included all participants who received at least one dose of study treatment.|
59896322|NCT04816214|76018408|FG001|Safety Set|Overall Study||0|Safety set included all participants who received at least one dose of study treatment.|
59896323|NCT04816214|76018409|FG002|Safety Set|Overall Study||0|Safety set included all participants who received at least one dose of study treatment.|
59896324|NCT04816214|76018407|FG000|Pharmacokinetic (PK) Analysis Set|Overall Study||6|PK analysis set included all participants who provided at least one evaluable PK concentration.|
59896325|NCT04816214|76018408|FG001|Pharmacokinetic (PK) Analysis Set|Overall Study||0|PK analysis set included all participants who provided at least one evaluable PK concentration.|
59896326|NCT04816214|76018409|FG002|Pharmacokinetic (PK) Analysis Set|Overall Study||0|PK analysis set included all participants who provided at least one evaluable PK concentration.|
59896327|NCT04816214|76018407|FG000|COMPLETED|Overall Study||0||
59896328|NCT04816214|76018408|FG001|COMPLETED|Overall Study||0||
59896329|NCT04816214|76018409|FG002|COMPLETED|Overall Study||0||
59896330|NCT04816214|76018407|FG000|NOT COMPLETED|Overall Study||6||
59896331|NCT04816214|76018408|FG001|NOT COMPLETED|Overall Study||0||
59896332|NCT04816214|76018409|FG002|NOT COMPLETED|Overall Study||0||
59896333|NCT04686279|76018415|FG000|STARTED|Overall Study||8||
59896334|NCT04686279|76018415|FG000|COMPLETED|Overall Study||8||
59896335|NCT04686279|76018415|FG000|NOT COMPLETED|Overall Study||0||
59896336|NCT04671615|76018420|FG000|STARTED|Overall Study||559||
59896337|NCT04671615|76018420|FG000|COMPLETED|Overall Study||559||
59896338|NCT04671615|76018420|FG000|NOT COMPLETED|Overall Study||0||
59896339|NCT04643808|76018426|FG000|STARTED|Overall Study||14||
59896340|NCT04643808|76018427|FG001|STARTED|Overall Study||21||
59896341|NCT04643808|76018426|FG000|COMPLETED|Overall Study||14||
59896342|NCT04643808|76018427|FG001|COMPLETED|Overall Study||21||
59896343|NCT04643808|76018426|FG000|NOT COMPLETED|Overall Study||0||
59896344|NCT04643808|76018427|FG001|NOT COMPLETED|Overall Study||0||
59896345|NCT04520321|76018439|FG000|STARTED|Overall Study||5||
59896346|NCT04520321|76018440|FG001|STARTED|Overall Study||7||
59896347|NCT04520321|76018441|FG002|STARTED|Overall Study||3||
59896348|NCT04520321|76018442|FG003|STARTED|Overall Study||7||
59896349|NCT04520321|76018439|FG000|COMPLETED|Overall Study||5||
59896350|NCT04520321|76018440|FG001|COMPLETED|Overall Study||7||
59896351|NCT04520321|76018441|FG002|COMPLETED|Overall Study||3||
59896352|NCT04520321|76018442|FG003|COMPLETED|Overall Study||7||
59896353|NCT04520321|76018439|FG000|NOT COMPLETED|Overall Study||0||
59896354|NCT04520321|76018440|FG001|NOT COMPLETED|Overall Study||0||
59896355|NCT04520321|76018441|FG002|NOT COMPLETED|Overall Study||0||
59896356|NCT04520321|76018442|FG003|NOT COMPLETED|Overall Study||0||
59896357|NCT04350827|76018454|FG000|STARTED|Overall Study||6||
59896358|NCT04350827|76018455|FG001|STARTED|Overall Study||8||
59896359|NCT04350827|76018454|FG000|6 Months|Overall Study||5||
59896360|NCT04350827|76018455|FG001|6 Months|Overall Study||6||
59896361|NCT04350827|76018454|FG000|COMPLETED|Overall Study||5||
59896362|NCT04350827|76018455|FG001|COMPLETED|Overall Study||6||
59896363|NCT04350827|76018454|FG000|NOT COMPLETED|Overall Study||1||
59896364|NCT04350827|76018455|FG001|NOT COMPLETED|Overall Study||2||
59896365|NCT04303000|76018463|FG000|STARTED|Opioid Use Questionnaire||319||
59896366|NCT04303000|76018464|FG001|STARTED|Opioid Use Questionnaire|Participants were randomized to group after the first study period.|0||
59896367|NCT04303000|76018465|FG002|STARTED|Opioid Use Questionnaire|Participants were randomized to group after the first study period.|0||
59896368|NCT04303000|76018463|FG000|COMPLETED|Opioid Use Questionnaire||304||
59896369|NCT04303000|76018464|FG001|COMPLETED|Opioid Use Questionnaire|The total number of participants who completed this period of the study is 304. Participants were randomized to groups after this study period.|0||
59896370|NCT04303000|76018465|FG002|COMPLETED|Opioid Use Questionnaire|The total number of participants who completed this period of the study is 304. Participants were randomized to groups after this study period.|0||
59896371|NCT04303000|76018463|FG000|NOT COMPLETED|Opioid Use Questionnaire||15||
59896372|NCT04303000|76018464|FG001|NOT COMPLETED|Opioid Use Questionnaire||0||
59896373|NCT04303000|76018465|FG002|NOT COMPLETED|Opioid Use Questionnaire||0||
59896374|NCT04303000|76018463|FG000|STARTED|Training Portion||0||
59896375|NCT04303000|76018464|FG001|STARTED|Training Portion||55||
59896376|NCT04303000|76018465|FG002|STARTED|Training Portion||56||
59896377|NCT04303000|76018463|FG000|Month 1 Follow-Up|Training Portion||0||
59896378|NCT04303000|76018464|FG001|Month 1 Follow-Up|Training Portion||48||
59896379|NCT04303000|76018465|FG002|Month 1 Follow-Up|Training Portion||50||
59896380|NCT04303000|76018463|FG000|Month 2 Follow-Up|Training Portion||0||
59896381|NCT04303000|76018464|FG001|Month 2 Follow-Up|Training Portion||48||
59896382|NCT04303000|76018465|FG002|Month 2 Follow-Up|Training Portion||50||
59896383|NCT04303000|76018463|FG000|Month 3 Follow-Up|Training Portion||0||
59896384|NCT04303000|76018464|FG001|Month 3 Follow-Up|Training Portion||47||
59896385|NCT04303000|76018465|FG002|Month 3 Follow-Up|Training Portion||48||
59896386|NCT04303000|76018463|FG000|COMPLETED|Training Portion||0||
59896387|NCT04303000|76018464|FG001|COMPLETED|Training Portion||45||
59896388|NCT04303000|76018465|FG002|COMPLETED|Training Portion||47||
59896389|NCT04303000|76018463|FG000|NOT COMPLETED|Training Portion||0||
59896390|NCT04303000|76018464|FG001|NOT COMPLETED|Training Portion||10||
59896391|NCT04303000|76018465|FG002|NOT COMPLETED|Training Portion||9||
59896392|NCT04259749|76018474|FG000|STARTED|Overall Study||89||
59896393|NCT04259749|76018475|FG001|STARTED|Overall Study||91||
59896394|NCT04259749|76018476|FG002|STARTED|Overall Study||87||
59896395|NCT04259749|76018474|FG000|COMPLETED|Overall Study||89||
59896396|NCT04259749|76018475|FG001|COMPLETED|Overall Study||91||
59896397|NCT04259749|76018476|FG002|COMPLETED|Overall Study||87||
59896398|NCT04259749|76018474|FG000|NOT COMPLETED|Overall Study||0||
59896399|NCT04259749|76018475|FG001|NOT COMPLETED|Overall Study||0||
59896400|NCT04259749|76018476|FG002|NOT COMPLETED|Overall Study||0||
59896401|NCT04212650|76018486|FG000|STARTED|Overall Study||1||
59896402|NCT04212650|76018487|FG001|STARTED|Overall Study||0||
59896403|NCT04212650|76018486|FG000|COMPLETED|Overall Study||0||
59896404|NCT04212650|76018487|FG001|COMPLETED|Overall Study||0||
59896405|NCT04212650|76018486|FG000|NOT COMPLETED|Overall Study||1||
59896406|NCT04212650|76018487|FG001|NOT COMPLETED|Overall Study||0||
59896407|NCT04196101|76018495|FG000|STARTED|Overall Study||41||
59896408|NCT04196101|76018496|FG001|STARTED|Overall Study||41||
59896409|NCT04196101|76018495|FG000|COMPLETED|Overall Study||31||
59896410|NCT04196101|76018496|FG001|COMPLETED|Overall Study||30||
59896411|NCT04196101|76018495|FG000|NOT COMPLETED|Overall Study||10||
60013842|NCT02472639|76129797|FG000|STARTED|Overall Study||4||
59896412|NCT04196101|76018496|FG001|NOT COMPLETED|Overall Study||11||
59896413|NCT03995667|76018502|FG000|STARTED|Overall Study||3||
59896414|NCT03995667|76018502|FG000|COMPLETED|Overall Study||1||
59896415|NCT03995667|76018502|FG000|NOT COMPLETED|Overall Study||2||
59896416|NCT03992196|76018508|FG000|STARTED|Enrollment||1||
59896417|NCT03992196|76018509|FG001|STARTED|Enrollment||2||
59896418|NCT03992196|76018510|FG002|STARTED|Enrollment||7||
59896419|NCT03992196|76018508|FG000|COMPLETED|Enrollment||0||
60013843|NCT02472639|76129798|FG001|STARTED|Overall Study||3||
60013844|NCT02472639|76129797|FG000|COMPLETED|Overall Study||0||
60013845|NCT02472639|76129798|FG001|COMPLETED|Overall Study||0||
60013846|NCT02472639|76129797|FG000|NOT COMPLETED|Overall Study||4||
60013847|NCT02472639|76129798|FG001|NOT COMPLETED|Overall Study||3||
60013848|NCT02472405|76129804|FG000|STARTED|Overall Study||18||
59896420|NCT03992196|76018509|FG001|COMPLETED|Enrollment||2||
59896421|NCT03992196|76018510|FG002|COMPLETED|Enrollment||7||
59896422|NCT03992196|76018508|FG000|NOT COMPLETED|Enrollment||1||
59896423|NCT03992196|76018509|FG001|NOT COMPLETED|Enrollment||0||
59896424|NCT03992196|76018510|FG002|NOT COMPLETED|Enrollment||0||
59896425|NCT03992196|76018508|FG000|STARTED|Treatment||0||
59896426|NCT03992196|76018509|FG001|STARTED|Treatment||2||
59896427|NCT03992196|76018510|FG002|STARTED|Treatment||7||
59896428|NCT03992196|76018508|FG000|COMPLETED|Treatment||0||
59896429|NCT03992196|76018509|FG001|COMPLETED|Treatment||2||
59896430|NCT03992196|76018510|FG002|COMPLETED|Treatment||1||
59896431|NCT03992196|76018508|FG000|NOT COMPLETED|Treatment||0||
59896432|NCT03992196|76018509|FG001|NOT COMPLETED|Treatment||0||
59896433|NCT03992196|76018510|FG002|NOT COMPLETED|Treatment||6||
59896434|NCT03970200|76018519|FG000|STARTED|Overall Study||5||
59896435|NCT03970200|76018520|FG001|STARTED|Overall Study||4||
59896436|NCT03970200|76018521|FG002|STARTED|Overall Study||6||
59896437|NCT03970200|76018519|FG000|COMPLETED|Overall Study||3||
59896438|NCT03970200|76018520|FG001|COMPLETED|Overall Study||2||
59896439|NCT03970200|76018521|FG002|COMPLETED|Overall Study||4||
59896440|NCT03970200|76018519|FG000|NOT COMPLETED|Overall Study||2||
59896441|NCT03970200|76018520|FG001|NOT COMPLETED|Overall Study||2||
59896442|NCT03970200|76018521|FG002|NOT COMPLETED|Overall Study||2||
59896443|NCT03840200|76018533|FG000|STARTED|Overall Study||8||
59896444|NCT03840200|76018534|FG001|STARTED|Overall Study||6||
59896445|NCT03840200|76018535|FG002|STARTED|Overall Study||7||
59896446|NCT03840200|76018536|FG003|STARTED|Overall Study||30||
59896447|NCT03840200|76018533|FG000|COMPLETED|Overall Study||0||
59896448|NCT03840200|76018534|FG001|COMPLETED|Overall Study||0||
59896449|NCT03840200|76018535|FG002|COMPLETED|Overall Study||0||
59896450|NCT03840200|76018536|FG003|COMPLETED|Overall Study||0||
59896451|NCT03840200|76018533|FG000|NOT COMPLETED|Overall Study||8||
59896452|NCT03840200|76018534|FG001|NOT COMPLETED|Overall Study||6||
59896453|NCT03840200|76018535|FG002|NOT COMPLETED|Overall Study||7||
59896454|NCT03840200|76018536|FG003|NOT COMPLETED|Overall Study||30||
59896455|NCT03334851|76018569|FG000|STARTED|Overall Study||8||
59896456|NCT03334851|76018570|FG001|STARTED|Overall Study||3||
59896457|NCT03334851|76018571|FG002|STARTED|Overall Study||3||
59896458|NCT03334851|76018572|FG003|STARTED|Overall Study||3||
59896459|NCT03334851|76018573|FG004|STARTED|Overall Study||3||
59896460|NCT03334851|76018574|FG005|STARTED|Overall Study||6||
59896461|NCT03334851|76018575|FG006|STARTED|Overall Study||5||
59896462|NCT03334851|76018576|FG007|STARTED|Overall Study||11||
59896463|NCT03334851|76018577|FG008|STARTED|Overall Study||6||
59896464|NCT03334851|76018578|FG009|STARTED|Overall Study||6||
59896465|NCT03334851|76018579|FG010|STARTED|Overall Study||7||
59896466|NCT03334851|76018580|FG011|STARTED|Overall Study||6||
59896467|NCT03334851|76018581|FG012|STARTED|Overall Study||6||
59896468|NCT03334851|76018569|FG000|COMPLETED|Overall Study||8||
59896469|NCT03334851|76018570|FG001|COMPLETED|Overall Study||3||
59896470|NCT03334851|76018571|FG002|COMPLETED|Overall Study||3||
59896471|NCT03334851|76018572|FG003|COMPLETED|Overall Study||3||
59896472|NCT03334851|76018573|FG004|COMPLETED|Overall Study||3||
59896473|NCT03334851|76018574|FG005|COMPLETED|Overall Study||6||
59896474|NCT03334851|76018575|FG006|COMPLETED|Overall Study||5||
59896475|NCT03334851|76018576|FG007|COMPLETED|Overall Study||9||
59896476|NCT03334851|76018577|FG008|COMPLETED|Overall Study||6||
59896477|NCT03334851|76018578|FG009|COMPLETED|Overall Study||6||
59896478|NCT03334851|76018579|FG010|COMPLETED|Overall Study||4||
59896479|NCT03334851|76018580|FG011|COMPLETED|Overall Study||5||
59896480|NCT03334851|76018581|FG012|COMPLETED|Overall Study||5||
59896481|NCT03334851|76018569|FG000|NOT COMPLETED|Overall Study||0||
59896482|NCT03334851|76018570|FG001|NOT COMPLETED|Overall Study||0||
59896483|NCT03334851|76018571|FG002|NOT COMPLETED|Overall Study||0||
59896484|NCT03334851|76018572|FG003|NOT COMPLETED|Overall Study||0||
59896485|NCT03334851|76018573|FG004|NOT COMPLETED|Overall Study||0||
59896486|NCT03334851|76018574|FG005|NOT COMPLETED|Overall Study||0||
59896487|NCT03334851|76018575|FG006|NOT COMPLETED|Overall Study||0||
59896488|NCT03334851|76018576|FG007|NOT COMPLETED|Overall Study||2||
59896489|NCT03334851|76018577|FG008|NOT COMPLETED|Overall Study||0||
59896490|NCT03334851|76018578|FG009|NOT COMPLETED|Overall Study||0||
59896491|NCT03334851|76018579|FG010|NOT COMPLETED|Overall Study||3||
59896492|NCT03334851|76018580|FG011|NOT COMPLETED|Overall Study||1||
59896493|NCT03334851|76018581|FG012|NOT COMPLETED|Overall Study||1||
59896494|NCT02885311|76018628|FG000|STARTED|Overall Study||6||
59896495|NCT02885311|76018629|FG001|STARTED|Overall Study||10||
59896496|NCT02885311|76018630|FG002|STARTED|Overall Study||9||
59896497|NCT02885311|76018631|FG003|STARTED|Overall Study||2||
59896498|NCT02885311|76018628|FG000|COMPLETED|Overall Study||6||
59896499|NCT02885311|76018629|FG001|COMPLETED|Overall Study||9||
59896500|NCT02885311|76018630|FG002|COMPLETED|Overall Study||8||
59896501|NCT02885311|76018631|FG003|COMPLETED|Overall Study||2||
59896502|NCT02885311|76018628|FG000|NOT COMPLETED|Overall Study||0||
59896503|NCT02885311|76018629|FG001|NOT COMPLETED|Overall Study||1||
59896504|NCT02885311|76018630|FG002|NOT COMPLETED|Overall Study||1||
59896505|NCT02885311|76018631|FG003|NOT COMPLETED|Overall Study||0||
59896506|NCT02744612|76018643|FG000|STARTED|Overall Study||3||
59896507|NCT02744612|76018644|FG001|STARTED|Overall Study||36||
59896508|NCT02744612|76018643|FG000|COMPLETED|Overall Study||3||
59896509|NCT02744612|76018644|FG001|COMPLETED|Overall Study||34||
59896510|NCT02744612|76018643|FG000|NOT COMPLETED|Overall Study||0||
59896511|NCT02744612|76018644|FG001|NOT COMPLETED|Overall Study||2||
59896512|NCT02717507|76018652|FG000|STARTED|Overall Study||89||
59896513|NCT02717507|76018653|FG001|STARTED|Overall Study||93||
59896514|NCT02717507|76018652|FG000|2nd Timepoint Assessment of Echocardiology Required to be Analyzable|Overall Study||75|31 participants who did not have a second timepoint assessment of echocardiography were excluded, resulting in 151 analyzable participants.|
59896515|NCT02717507|76018653|FG001|2nd Timepoint Assessment of Echocardiology Required to be Analyzable|Overall Study||76|31 participants who did not have a second timepoint assessment of echocardiography were excluded, resulting in 151 analyzable participants.|
59896516|NCT02717507|76018652|FG000|COMPLETED|Overall Study||58||
59896517|NCT02717507|76018653|FG001|COMPLETED|Overall Study||55||
59896518|NCT02717507|76018652|FG000|NOT COMPLETED|Overall Study||31||
59896519|NCT02717507|76018653|FG001|NOT COMPLETED|Overall Study||38||
59896520|NCT02596906|76018662|FG000|STARTED|Overall Study||12|The units assigned is indeed the participants|
59896521|NCT02596906|76018663|FG001|STARTED|Overall Study||10|The units assigned is indeed the participants|
59896522|NCT02596906|76018662|FG000|COMPLETED|Overall Study||8|3-month follow-up|
59896523|NCT02596906|76018663|FG001|COMPLETED|Overall Study||7|3-month follow-up|
59896524|NCT02596906|76018662|FG000|NOT COMPLETED|Overall Study||4||
59896525|NCT02596906|76018663|FG001|NOT COMPLETED|Overall Study||3||
59896526|NCT02547662|76018669|FG000|STARTED|Overall Study||17||
59896527|NCT02547662|76018669|FG000|COMPLETED|Overall Study||17||
59896528|NCT02547662|76018669|FG000|NOT COMPLETED|Overall Study||0||
59896529|NCT02470585|76018676|FG000|STARTED|Overall Study||375|Started indicates the number of participants randomized.|
59896530|NCT02470585|76018677|FG001|STARTED|Overall Study||383|Started indicates the number of participants randomized.|
59896531|NCT02470585|76018678|FG002|STARTED|Overall Study||382|Started indicates the number of participants randomized.|
59896532|NCT02470585|76018676|FG000|Received Study Drug|Overall Study||371||
59896533|NCT02470585|76018677|FG001|Received Study Drug|Overall Study||376||
59896534|NCT02470585|76018678|FG002|Received Study Drug|Overall Study||377||
59896535|NCT02470585|76018676|FG000|COMPLETED|Overall Study||268|Completed indicates participants remaining on study.|
59896536|NCT02470585|76018677|FG001|COMPLETED|Overall Study||266|Completed indicates participants remaining on study.|
59896537|NCT02470585|76018678|FG002|COMPLETED|Overall Study||257|Completed indicates participants remaining on study.|
59896538|NCT02470585|76018676|FG000|NOT COMPLETED|Overall Study||107||
59896539|NCT02470585|76018677|FG001|NOT COMPLETED|Overall Study||117||
59896540|NCT02470585|76018678|FG002|NOT COMPLETED|Overall Study||125||
59896541|NCT02425306|76018690|FG000|STARTED|Overall Study||3||
59896542|NCT02425306|76018691|FG001|STARTED|Overall Study||7||
59896543|NCT02425306|76018692|FG002|STARTED|Overall Study||6||
59896544|NCT02425306|76018693|FG003|STARTED|Overall Study||32||
59896545|NCT02425306|76018690|FG000|COMPLETED|Overall Study||3||
59896546|NCT02425306|76018691|FG001|COMPLETED|Overall Study||6||
59896547|NCT02425306|76018692|FG002|COMPLETED|Overall Study||5||
59896548|NCT02425306|76018693|FG003|COMPLETED|Overall Study||18||
59896549|NCT02425306|76018690|FG000|NOT COMPLETED|Overall Study||0||
59896550|NCT02425306|76018691|FG001|NOT COMPLETED|Overall Study||1||
59896551|NCT02425306|76018692|FG002|NOT COMPLETED|Overall Study||1||
59896552|NCT02425306|76018693|FG003|NOT COMPLETED|Overall Study||14||
59896553|NCT02293954|76018703|FG000|STARTED|Overall Study||20||
59896554|NCT02293954|76018703|FG000|COMPLETED|Overall Study||20||
59896555|NCT02293954|76018703|FG000|NOT COMPLETED|Overall Study||0||
59896556|NCT02199080|76018707|FG000|STARTED|Overall Study||2506||
59896557|NCT02199080|76018707|FG000|COMPLETED|Overall Study||2494||
59896558|NCT02199080|76018707|FG000|NOT COMPLETED|Overall Study||12||
59896559|NCT02173379|76018715|FG000|STARTED|Overall Study||1296||
59896560|NCT02173379|76018716|FG001|STARTED|Overall Study||1308||
59896561|NCT02173379|76018715|FG000|COMPLETED|Overall Study||1099||
59896562|NCT02173379|76018716|FG001|COMPLETED|Overall Study||1118||
59896563|NCT02173379|76018715|FG000|NOT COMPLETED|Overall Study||197||
59896564|NCT02173379|76018716|FG001|NOT COMPLETED|Overall Study||190||
59896565|NCT02134925|76018727|FG000|STARTED|Overall Study||54||
59896566|NCT02134925|76018728|FG001|STARTED|Overall Study||56||
59896567|NCT02134925|76018727|FG000|Received at Least One Dose of Treatment|Overall Study||53|Received at least one dose of treatment and assessed for AEs|
59896568|NCT02134925|76018728|FG001|Received at Least One Dose of Treatment|Overall Study||50|Received at least one dose of treatment and assessed for AEs|
59896569|NCT02134925|76018727|FG000|COMPLETED|Overall Study||52||
59896570|NCT02134925|76018728|FG001|COMPLETED|Overall Study||50||
59896571|NCT02134925|76018727|FG000|NOT COMPLETED|Overall Study||2||
59896572|NCT02134925|76018728|FG001|NOT COMPLETED|Overall Study||6||
60013849|NCT02472405|76129804|FG000|COMPLETED|Overall Study||8||
60013850|NCT02472405|76129804|FG000|NOT COMPLETED|Overall Study||10||
60013851|NCT02448771|76129810|FG000|STARTED|Overall Study||36||
60013852|NCT02448771|76129810|FG000|COMPLETED|Overall Study||0||
60013853|NCT02448771|76129810|FG000|NOT COMPLETED|Overall Study||36||
60013854|NCT02504541|76129815|FG000|STARTED|Overall Study||133||
59896579|NCT01849874|76018745|FG000|STARTED|Overall Study||228||
59896580|NCT01849874|76018746|FG001|STARTED|Overall Study||113||
59896581|NCT01849874|76018745|FG000|Treated|Overall Study||227||
59896582|NCT01849874|76018746|FG001|Treated|Overall Study||106||
59896583|NCT01849874|76018745|FG000|Safety Population|Overall Study|"The safety population number reported as At risk in AE section."|227|Safety population consisted of all participants who received at any dose of study intervention (MEK162 or physician's choice chemotherapy).|
59896584|NCT01849874|76018746|FG001|Safety Population|Overall Study|"The safety population number reported as At risk in AE section."|106|Safety population consisted of all participants who received at any dose of study intervention (MEK162 or physician's choice chemotherapy).|
59896585|NCT01849874|76018745|FG000|Crossover Period|Overall Study||0|After failure of physician's choice chemotherapy in the randomized period, participants entered into the crossover period to receive MEK162 treatment 45 mg orally twice daily with water irrespective of food, continuously, starting on Day 1 of the crossover period. Crossover from physician's choice chemotherapy treatment to MEK162 treatment was no longer permitted after enrollment was early discontinued.|
59896586|NCT01849874|76018746|FG001|Crossover Period|Overall Study|No data, safety or efficacy, were collected for crossover set, as the crossover period was stopped early.|18|After failure of physician's choice chemotherapy in the randomized period, participants entered into the crossover period to receive MEK162 treatment 45 mg orally twice daily with water irrespective of food, continuously, starting on Day 1 of the crossover period. Crossover from physician's choice chemotherapy treatment to MEK162 treatment was no longer permitted after enrollment was early discontinued.|
59611265|NCT01765920|75722232|FG001|NOT COMPLETED|Overall Study||6||
59896587|NCT01849874|76018745|FG000|COMPLETED|Overall Study||0||
59896588|NCT01849874|76018746|FG001|COMPLETED|Overall Study||0||
59896589|NCT01849874|76018745|FG000|NOT COMPLETED|Overall Study||228||
59896590|NCT01849874|76018746|FG001|NOT COMPLETED|Overall Study||113||
59896591|NCT01849263|76018753|FG000|STARTED|Overall Study||40||
59896592|NCT01849263|76018753|FG000|COMPLETED|Overall Study||40||
59896593|NCT01849263|76018753|FG000|NOT COMPLETED|Overall Study||0||
59896594|NCT01771107|76018759|FG000|STARTED|Overall Study||6||
59896595|NCT01771107|76018760|FG001|STARTED|Overall Study||35||
59896596|NCT01771107|76018759|FG000|COMPLETED|Overall Study||5||
59896597|NCT01771107|76018760|FG001|COMPLETED|Overall Study||27||
59896598|NCT01771107|76018759|FG000|NOT COMPLETED|Overall Study||1||
59896599|NCT01771107|76018760|FG001|NOT COMPLETED|Overall Study||8||
59896600|NCT01375114|76018771|FG000|STARTED|Overall Study||30||
59896601|NCT01375114|76018772|FG001|STARTED|Overall Study||63||
59896602|NCT01375114|76018773|FG002|STARTED|Overall Study||64||
59896603|NCT01375114|76018771|FG000|COMPLETED|Overall Study||24||
59896604|NCT01375114|76018772|FG001|COMPLETED|Overall Study||56||
59896605|NCT01375114|76018773|FG002|COMPLETED|Overall Study||56||
59611266|NCT01782222|75722241|FG000|STARTED|Overall Study||40||
59611267|NCT01782222|75722242|FG001|STARTED|Overall Study||41||
59611268|NCT01782222|75722243|FG002|STARTED|Overall Study||41||
59896606|NCT01375114|76018771|FG000|NOT COMPLETED|Overall Study||6||
59896607|NCT01375114|76018772|FG001|NOT COMPLETED|Overall Study||7||
59896608|NCT01375114|76018773|FG002|NOT COMPLETED|Overall Study||8||
59896609|NCT01009645|76018787|FG000|STARTED|Overall Study||31||
59896610|NCT01009645|76018788|FG001|STARTED|Overall Study||31||
59896611|NCT01009645|76018789|FG002|STARTED|Overall Study||32||
59896612|NCT01009645|76018790|FG003|STARTED|Overall Study||31||
59896613|NCT01009645|76018787|FG000|COMPLETED|Overall Study||29||
59896614|NCT01009645|76018788|FG001|COMPLETED|Overall Study||23||
59896615|NCT01009645|76018789|FG002|COMPLETED|Overall Study||28||
59896616|NCT01009645|76018790|FG003|COMPLETED|Overall Study||26||
59896617|NCT01009645|76018787|FG000|NOT COMPLETED|Overall Study||2||
59896618|NCT01009645|76018788|FG001|NOT COMPLETED|Overall Study||8||
59896619|NCT01009645|76018789|FG002|NOT COMPLETED|Overall Study||4||
59896620|NCT01009645|76018790|FG003|NOT COMPLETED|Overall Study||5||
59896621|NCT00950846|76018800|FG000|STARTED|Overall Study||40||
59896622|NCT00950846|76018800|FG000|COMPLETED|Overall Study||30||
59896623|NCT00950846|76018800|FG000|NOT COMPLETED|Overall Study||10||
59896624|NCT00577278|76018804|FG000|STARTED|Overall Study||41||
59896625|NCT00577278|76018804|FG000|COMPLETED|Overall Study||41||
59896626|NCT00577278|76018804|FG000|NOT COMPLETED|Overall Study||0||
59896627|NCT03419403|76018811|FG000|STARTED|Overall Study||14||
59896628|NCT03419403|76018812|FG001|STARTED|Overall Study||12||
59896629|NCT03419403|76018813|FG002|STARTED|Overall Study||12||
59896630|NCT03419403|76018814|FG003|STARTED|Overall Study||2||
59896631|NCT03419403|76018811|FG000|COMPLETED|Overall Study||2||
59896632|NCT03419403|76018812|FG001|COMPLETED|Overall Study||3||
59896633|NCT03419403|76018813|FG002|COMPLETED|Overall Study||0||
59896634|NCT03419403|76018814|FG003|COMPLETED|Overall Study||0||
59896635|NCT03419403|76018811|FG000|NOT COMPLETED|Overall Study||12||
59896636|NCT03419403|76018812|FG001|NOT COMPLETED|Overall Study||9||
59896637|NCT03419403|76018813|FG002|NOT COMPLETED|Overall Study||12||
59896638|NCT03419403|76018814|FG003|NOT COMPLETED|Overall Study||2||
59896639|NCT03447249|76018824|FG000|STARTED|Overall Study||190||
59896640|NCT03447249|76018825|FG001|STARTED|Overall Study||192||
59896641|NCT03447249|76018824|FG000|Safety Set|Overall Study||189|Based on actual treatment received.|
59896642|NCT03447249|76018825|FG001|Safety Set|Overall Study||193|Based on actual treatment received.|
59896643|NCT03447249|76018824|FG000|COMPLETED|Overall Study||185||
59896644|NCT03447249|76018825|FG001|COMPLETED|Overall Study||192||
59896645|NCT03447249|76018824|FG000|NOT COMPLETED|Overall Study||5||
59896646|NCT03447249|76018825|FG001|NOT COMPLETED|Overall Study||0||
59896647|NCT03418545|76018835|FG000|STARTED|Overall Study||35||
59896648|NCT03418545|76018836|FG001|STARTED|Overall Study||105||
59896649|NCT03418545|76018835|FG000|Safety Population|Overall Study||34|Safety Population included participants who were randomized to study treatment (JUVÉDERM® VOLBELLA™ XC treatment group) and received at least 1 study device treatment and participants who were randomized to the control group.|
59896650|NCT03418545|76018836|FG001|Safety Population|Overall Study||105|Safety Population included participants who were randomized to study treatment (JUVÉDERM® VOLBELLA™ XC treatment group) and received at least 1 study device treatment and participants who were randomized to the control group.|
59896651|NCT03418545|76018835|FG000|Received Optional or Repeat Treatment|Overall Study||29|Participants randomized to the No-treatment Control group who received optional treatment with JUVÉDERM® VOLBELLA™ XC injectable gel after Month 3 and participants randomized to the JUVÉDERM® VOLBELLA™ XC arm who received repeat treatment with JUVÉDERM® VOLBELLA™ XC injectable gel 12 months after the initial treatment.|
59896652|NCT03418545|76018836|FG001|Received Optional or Repeat Treatment|Overall Study||37|Participants randomized to the No-treatment Control group who received optional treatment with JUVÉDERM® VOLBELLA™ XC injectable gel after Month 3 and participants randomized to the JUVÉDERM® VOLBELLA™ XC arm who received repeat treatment with JUVÉDERM® VOLBELLA™ XC injectable gel 12 months after the initial treatment.|
59896653|NCT03418545|76018835|FG000|COMPLETED|Overall Study||30||
59896654|NCT03418545|76018836|FG001|COMPLETED|Overall Study||94||
59896655|NCT03418545|76018835|FG000|NOT COMPLETED|Overall Study||5||
59896656|NCT03418545|76018836|FG001|NOT COMPLETED|Overall Study||11||
59896657|NCT03446781|76018847|FG000|STARTED|Overall Study||214||
59896658|NCT03446781|76018848|FG001|STARTED|Overall Study||208||
59896659|NCT03446781|76018847|FG000|COMPLETED|Overall Study||186||
59896660|NCT03446781|76018848|FG001|COMPLETED|Overall Study||191||
59896661|NCT03446781|76018847|FG000|NOT COMPLETED|Overall Study||28||
59896662|NCT03446781|76018848|FG001|NOT COMPLETED|Overall Study||17||
59896663|NCT03445065|76018880|FG000|STARTED|Overall Study||97||
59896664|NCT03445065|76018881|FG001|STARTED|Overall Study||52||
59896665|NCT03445065|76018882|FG002|STARTED|Overall Study||62||
59896666|NCT03445065|76018883|FG003|STARTED|Overall Study||28||
59896667|NCT03445065|76018880|FG000|COMPLETED|Overall Study||90||
59896668|NCT03445065|76018881|FG001|COMPLETED|Overall Study||43||
59896669|NCT03445065|76018882|FG002|COMPLETED|Overall Study||57||
59896670|NCT03445065|76018883|FG003|COMPLETED|Overall Study||25||
59896671|NCT03445065|76018880|FG000|NOT COMPLETED|Overall Study||7||
59896672|NCT03445065|76018881|FG001|NOT COMPLETED|Overall Study||9||
59896673|NCT03445065|76018882|FG002|NOT COMPLETED|Overall Study||5||
59896674|NCT03445065|76018883|FG003|NOT COMPLETED|Overall Study||3||
59896675|NCT01224106|76018908|FG000|STARTED|Double-Blind Treatment Phase||266||
59896676|NCT01224106|76018909|FG001|STARTED|Double-Blind Treatment Phase||271||
59896677|NCT01224106|76018910|FG002|STARTED|Double-Blind Treatment Phase||260||
59896678|NCT01224106|76018911|FG003|STARTED|Double-Blind Treatment Phase||0||
59896679|NCT01224106|76018912|FG004|STARTED|Double-Blind Treatment Phase||0||
59896680|NCT01224106|76018908|FG000|COMPLETED|Double-Blind Treatment Phase||187||
59896681|NCT01224106|76018909|FG001|COMPLETED|Double-Blind Treatment Phase||185||
59896682|NCT01224106|76018910|FG002|COMPLETED|Double-Blind Treatment Phase||180||
59896683|NCT01224106|76018911|FG003|COMPLETED|Double-Blind Treatment Phase||0||
59896684|NCT01224106|76018912|FG004|COMPLETED|Double-Blind Treatment Phase||0||
59896685|NCT01224106|76018908|FG000|NOT COMPLETED|Double-Blind Treatment Phase||79||
59896686|NCT01224106|76018909|FG001|NOT COMPLETED|Double-Blind Treatment Phase||86||
59896687|NCT01224106|76018910|FG002|NOT COMPLETED|Double-Blind Treatment Phase||80||
59896688|NCT01224106|76018911|FG003|NOT COMPLETED|Double-Blind Treatment Phase||0||
59896689|NCT01224106|76018912|FG004|NOT COMPLETED|Double-Blind Treatment Phase||0||
59896690|NCT01224106|76018908|FG000|STARTED|Open-Label Extension (OLE) Phase||0||
59896691|NCT01224106|76018909|FG001|STARTED|Open-Label Extension (OLE) Phase||0||
59896692|NCT01224106|76018910|FG002|STARTED|Open-Label Extension (OLE) Phase||0||
59896693|NCT01224106|76018911|FG003|STARTED|Open-Label Extension (OLE) Phase||49||
59896694|NCT01224106|76018912|FG004|STARTED|Open-Label Extension (OLE) Phase||105||
59896695|NCT01224106|76018908|FG000|COMPLETED|Open-Label Extension (OLE) Phase||0||
59896696|NCT01224106|76018909|FG001|COMPLETED|Open-Label Extension (OLE) Phase||0||
59896697|NCT01224106|76018910|FG002|COMPLETED|Open-Label Extension (OLE) Phase||0||
59896698|NCT01224106|76018911|FG003|COMPLETED|Open-Label Extension (OLE) Phase||33||
59896699|NCT01224106|76018912|FG004|COMPLETED|Open-Label Extension (OLE) Phase||71||
59896700|NCT01224106|76018908|FG000|NOT COMPLETED|Open-Label Extension (OLE) Phase||0||
59896701|NCT01224106|76018909|FG001|NOT COMPLETED|Open-Label Extension (OLE) Phase||0||
59896702|NCT01224106|76018910|FG002|NOT COMPLETED|Open-Label Extension (OLE) Phase||0||
59896703|NCT01224106|76018911|FG003|NOT COMPLETED|Open-Label Extension (OLE) Phase||16||
59896704|NCT01224106|76018912|FG004|NOT COMPLETED|Open-Label Extension (OLE) Phase||34||
59896705|NCT03409107|76018932|FG000|STARTED|Overall Study||307||
59896706|NCT03409107|76018933|FG001|STARTED|Overall Study||307||
59896707|NCT03409107|76018932|FG000|COMPLETED|Overall Study||290||
59896708|NCT03409107|76018933|FG001|COMPLETED|Overall Study||300||
59896709|NCT03409107|76018932|FG000|NOT COMPLETED|Overall Study||17||
59896710|NCT03409107|76018933|FG001|NOT COMPLETED|Overall Study||7||
59896711|NCT03921073|76018939|FG000|STARTED|Overall Study||5||
59896712|NCT03921073|76018939|FG000|COMPLETED|Overall Study||5||
59896713|NCT03921073|76018939|FG000|NOT COMPLETED|Overall Study||0||
59896714|NCT03294304|76018943|FG000|STARTED|Overall Study||43||
59896715|NCT03294304|76018943|FG000|COMPLETED|Overall Study||43||
59896716|NCT03294304|76018943|FG000|NOT COMPLETED|Overall Study||0||
59896717|NCT03408873|76018947|FG000|STARTED|Visit 1 Assessment (Baseline)||30||
59896718|NCT03408873|76018947|FG000|COMPLETED|Visit 1 Assessment (Baseline)||27||
59896719|NCT03408873|76018947|FG000|NOT COMPLETED|Visit 1 Assessment (Baseline)||3||
59896720|NCT03408873|76018947|FG000|STARTED|Visit 2 Assessment||27||
59896721|NCT03408873|76018947|FG000|COMPLETED|Visit 2 Assessment||26||
59896722|NCT03408873|76018947|FG000|NOT COMPLETED|Visit 2 Assessment||1||
59896723|NCT03408873|76018947|FG000|STARTED|Visit 3 Assessment||26||
59896724|NCT03408873|76018947|FG000|COMPLETED|Visit 3 Assessment||25||
59896725|NCT03408873|76018947|FG000|NOT COMPLETED|Visit 3 Assessment||1||
59896726|NCT03408873|76018947|FG000|STARTED|Visit 4 Assessment||25||
59896727|NCT03408873|76018947|FG000|COMPLETED|Visit 4 Assessment||23||
59896728|NCT03408873|76018947|FG000|NOT COMPLETED|Visit 4 Assessment||2||
59896729|NCT03408873|76018947|FG000|STARTED|Visit 5 Assessment||23||
59896730|NCT03408873|76018947|FG000|COMPLETED|Visit 5 Assessment||22||
59896731|NCT03408873|76018947|FG000|NOT COMPLETED|Visit 5 Assessment||1||
59896732|NCT03408873|76018947|FG000|STARTED|Visit 6 Assessment||22||
59896733|NCT03408873|76018947|FG000|COMPLETED|Visit 6 Assessment||21||
59896734|NCT03408873|76018947|FG000|NOT COMPLETED|Visit 6 Assessment||1||
59896735|NCT03408873|76018947|FG000|STARTED|Visit 7 Assessment||21||
59896736|NCT03408873|76018947|FG000|COMPLETED|Visit 7 Assessment||21||
59896737|NCT03408873|76018947|FG000|NOT COMPLETED|Visit 7 Assessment||0||
59896738|NCT03780959|76018954|FG000|STARTED|Part 1||69||
59896739|NCT03780959|76018955|FG001|STARTED|Part 1||0||
59896740|NCT03780959|76018956|FG002|STARTED|Part 1||0||
59896741|NCT03780959|76018954|FG000|COMPLETED|Part 1||64||
59896742|NCT03780959|76018955|FG001|COMPLETED|Part 1||0||
59896743|NCT03780959|76018956|FG002|COMPLETED|Part 1||0||
59505790|NCT00742469|75598671|FG001|COMPLETED|Overall Study||69||
59896744|NCT03780959|76018954|FG000|NOT COMPLETED|Part 1||5||
59896745|NCT03780959|76018955|FG001|NOT COMPLETED|Part 1||0||
59896746|NCT03780959|76018956|FG002|NOT COMPLETED|Part 1||0||
59896747|NCT03780959|76018954|FG000|STARTED|Part 2||0|Participants who met response criteria at day 90|
59896748|NCT03780959|76018955|FG001|STARTED|Part 2||26|Participants who met response criteria at day 90|
59896749|NCT03780959|76018956|FG002|STARTED|Part 2||25|Participants who met response criteria at day 90|
59896750|NCT03780959|76018954|FG000|COMPLETED|Part 2||0||
59896751|NCT03780959|76018955|FG001|COMPLETED|Part 2||7||
59896752|NCT03780959|76018956|FG002|COMPLETED|Part 2||19||
59896753|NCT03780959|76018954|FG000|NOT COMPLETED|Part 2||0||
59896754|NCT03780959|76018955|FG001|NOT COMPLETED|Part 2||19||
59896755|NCT03780959|76018956|FG002|NOT COMPLETED|Part 2||6||
59896756|NCT03408639|76018968|FG000|STARTED|Overall Study||78||
59896757|NCT03408639|76018969|FG001|STARTED|Overall Study||78||
59896758|NCT03408639|76018968|FG000|COMPLETED|Overall Study||67||
59896759|NCT03408639|76018969|FG001|COMPLETED|Overall Study||56||
59896760|NCT03408639|76018968|FG000|NOT COMPLETED|Overall Study||11||
59896761|NCT03408639|76018969|FG001|NOT COMPLETED|Overall Study||22||
59896762|NCT03810235|76018977|FG000|STARTED|Overall Study||32||
59896763|NCT03810235|76018978|FG001|STARTED|Overall Study||31||
59896764|NCT03810235|76018977|FG000|Participant Data Analyzed|Overall Study||30||
59896765|NCT03810235|76018978|FG001|Participant Data Analyzed|Overall Study||31||
59896766|NCT03810235|76018977|FG000|COMPLETED|Overall Study||30||
59896767|NCT03810235|76018978|FG001|COMPLETED|Overall Study||31||
59896768|NCT03810235|76018977|FG000|NOT COMPLETED|Overall Study||2||
59896769|NCT03810235|76018978|FG001|NOT COMPLETED|Overall Study||0||
59896770|NCT03408483|76018987|FG000|STARTED|Overall Study||42||
59896771|NCT03408483|76018988|FG001|STARTED|Overall Study||38||
59896772|NCT03408483|76018987|FG000|COMPLETED|Overall Study||36||
59896773|NCT03408483|76018988|FG001|COMPLETED|Overall Study||35||
59896774|NCT03408483|76018987|FG000|NOT COMPLETED|Overall Study||6||
59896775|NCT03408483|76018988|FG001|NOT COMPLETED|Overall Study||3||
59896776|NCT03777059|76018998|FG000|STARTED|DB Treatment Period (Up to Week 12)||223||
59896777|NCT03777059|76018999|FG001|STARTED|DB Treatment Period (Up to Week 12)||222||
59896778|NCT03777059|76019000|FG002|STARTED|DB Treatment Period (Up to Week 12)||230||
59896779|NCT03777059|76019001|FG003|STARTED|DB Treatment Period (Up to Week 12)||235||
59896780|NCT03777059|76018998|FG000|Treated: Safety Population|DB Treatment Period (Up to Week 12)||222|Safety Population included all participants who received at least 1 dose of study intervention.|
59896781|NCT03777059|76018999|FG001|Treated: Safety Population|DB Treatment Period (Up to Week 12)||221|Safety Population included all participants who received at least 1 dose of study intervention.|
59896782|NCT03777059|76019000|FG002|Treated: Safety Population|DB Treatment Period (Up to Week 12)||228|Safety Population included all participants who received at least 1 dose of study intervention.|
59896783|NCT03777059|76019001|FG003|Treated: Safety Population|DB Treatment Period (Up to Week 12)||231|Safety Population included all participants who received at least 1 dose of study intervention.|
59896784|NCT03777059|76018998|FG000|COMPLETED|DB Treatment Period (Up to Week 12)||201|Out of 805 participants who completed DB Treatment Period, 683 participants did not complete follow-up since they rolled into study 3101-309-002 (NCT03939312), 183 entered Follow-Up Period.|
59896785|NCT03777059|76018999|FG001|COMPLETED|DB Treatment Period (Up to Week 12)||193|Out of 805 participants who completed DB Treatment Period, 683 participants did not complete follow-up since they rolled into study 3101-309-002 (NCT03939312), 183 entered Follow-Up Period.|
59896786|NCT03777059|76019000|FG002|COMPLETED|DB Treatment Period (Up to Week 12)||207|Out of 805 participants who completed DB Treatment Period, 683 participants did not complete follow-up since they rolled into study 3101-309-002 (NCT03939312), 183 entered Follow-Up Period.|
59896787|NCT03777059|76019001|FG003|COMPLETED|DB Treatment Period (Up to Week 12)||204|Out of 805 participants who completed DB Treatment Period, 683 participants did not complete follow-up since they rolled into study 3101-309-002 (NCT03939312), 183 entered Follow-Up Period.|
59896788|NCT03777059|76018998|FG000|NOT COMPLETED|DB Treatment Period (Up to Week 12)||22||
59896789|NCT03777059|76018999|FG001|NOT COMPLETED|DB Treatment Period (Up to Week 12)||29||
60013855|NCT02504541|76129815|FG000|COMPLETED|Overall Study||113||
60013856|NCT02504541|76129815|FG000|NOT COMPLETED|Overall Study||20||
60013857|NCT02448537|76129822|FG000|STARTED|Overall Study||20||
60013858|NCT02448537|76129823|FG001|STARTED|Overall Study||10||
60013859|NCT02448537|76129824|FG002|STARTED|Overall Study||12||
60013860|NCT02448537|76129822|FG000|COMPLETED|Overall Study||19||
60013861|NCT02448537|76129823|FG001|COMPLETED|Overall Study||9||
60013862|NCT02448537|76129824|FG002|COMPLETED|Overall Study||11||
60013863|NCT02448537|76129822|FG000|NOT COMPLETED|Overall Study||1||
60013864|NCT02448537|76129823|FG001|NOT COMPLETED|Overall Study||1||
60013865|NCT02448537|76129824|FG002|NOT COMPLETED|Overall Study||1||
60013866|NCT04836247|76129834|FG000|STARTED|Overall Study||25||
60013867|NCT04836247|76129835|FG001|STARTED|Overall Study||25||
60013868|NCT04836247|76129834|FG000|COMPLETED|Overall Study|25 participants responded to primary outcome measures, 24-25 responded to secondary outcome measures|25||
60013869|NCT04836247|76129835|FG001|COMPLETED|Overall Study|25 participants responded to primary outcome measures, 24-25 responded to secondary outcome measures. 1 participant was excluded from secondary outcome analyses (due to missing data)|25||
60013870|NCT04836247|76129834|FG000|NOT COMPLETED|Overall Study||0||
60013871|NCT04836247|76129835|FG001|NOT COMPLETED|Overall Study||0||
59505791|NCT00742469|75598670|FG000|NOT COMPLETED|Overall Study||18||
59896790|NCT03777059|76019000|FG002|NOT COMPLETED|DB Treatment Period (Up to Week 12)||23||
59896791|NCT03777059|76019001|FG003|NOT COMPLETED|DB Treatment Period (Up to Week 12)||31||
59896792|NCT03777059|76018998|FG000|STARTED|Follow-Up Period (Weeks 12 to 16)||46||
59896793|NCT03777059|76018999|FG001|STARTED|Follow-Up Period (Weeks 12 to 16)||54||
59896794|NCT03777059|76019000|FG002|STARTED|Follow-Up Period (Weeks 12 to 16)||38||
59896795|NCT03777059|76019001|FG003|STARTED|Follow-Up Period (Weeks 12 to 16)||45||
59896796|NCT03777059|76018998|FG000|COMPLETED|Follow-Up Period (Weeks 12 to 16)||41||
59896797|NCT03777059|76018999|FG001|COMPLETED|Follow-Up Period (Weeks 12 to 16)||49||
59896798|NCT03777059|76019000|FG002|COMPLETED|Follow-Up Period (Weeks 12 to 16)||32||
59896799|NCT03777059|76019001|FG003|COMPLETED|Follow-Up Period (Weeks 12 to 16)||36||
59896800|NCT03777059|76018998|FG000|NOT COMPLETED|Follow-Up Period (Weeks 12 to 16)||5||
59896801|NCT03777059|76018999|FG001|NOT COMPLETED|Follow-Up Period (Weeks 12 to 16)||5||
59896802|NCT03777059|76019000|FG002|NOT COMPLETED|Follow-Up Period (Weeks 12 to 16)||6||
59896803|NCT03777059|76019001|FG003|NOT COMPLETED|Follow-Up Period (Weeks 12 to 16)||9||
59896804|NCT03100058|76019020|FG000|STARTED|Epoch 3 (24 Weeks of Treatment)||38||
59896805|NCT03100058|76019021|FG001|STARTED|Epoch 3 (24 Weeks of Treatment)||38||
59896806|NCT03100058|76019022|FG002|STARTED|Epoch 3 (24 Weeks of Treatment)||38||
59896807|NCT03100058|76019023|FG003|STARTED|Epoch 3 (24 Weeks of Treatment)||77||
59896808|NCT03100058|76019024|FG004|STARTED|Epoch 3 (24 Weeks of Treatment)||38||
59896809|NCT03100058|76019025|FG005|STARTED|Epoch 3 (24 Weeks of Treatment)||39||
59896810|NCT03100058|76019026|FG006|STARTED|Epoch 3 (24 Weeks of Treatment)||38||
59896811|NCT03100058|76019027|FG007|STARTED|Epoch 3 (24 Weeks of Treatment)||76||
59896812|NCT03100058|76019028|FG008|STARTED|Epoch 3 (24 Weeks of Treatment)||78||
59896813|NCT03100058|76019029|FG009|STARTED|Epoch 3 (24 Weeks of Treatment)||0||
59896814|NCT03100058|76019030|FG010|STARTED|Epoch 3 (24 Weeks of Treatment)||0||
59896815|NCT03100058|76019031|FG011|STARTED|Epoch 3 (24 Weeks of Treatment)||0||
59896816|NCT03100058|76019032|FG012|STARTED|Epoch 3 (24 Weeks of Treatment)||0||
59896817|NCT03100058|76019020|FG000|COMPLETED|Epoch 3 (24 Weeks of Treatment)||35||
59896818|NCT03100058|76019021|FG001|COMPLETED|Epoch 3 (24 Weeks of Treatment)||31||
59896819|NCT03100058|76019022|FG002|COMPLETED|Epoch 3 (24 Weeks of Treatment)||29||
59896820|NCT03100058|76019023|FG003|COMPLETED|Epoch 3 (24 Weeks of Treatment)||63||
59896821|NCT03100058|76019024|FG004|COMPLETED|Epoch 3 (24 Weeks of Treatment)||36||
59896822|NCT03100058|76019025|FG005|COMPLETED|Epoch 3 (24 Weeks of Treatment)||37||
59896823|NCT03100058|76019026|FG006|COMPLETED|Epoch 3 (24 Weeks of Treatment)||30||
59896824|NCT03100058|76019027|FG007|COMPLETED|Epoch 3 (24 Weeks of Treatment)||60||
59896825|NCT03100058|76019028|FG008|COMPLETED|Epoch 3 (24 Weeks of Treatment)||73||
59896826|NCT03100058|76019029|FG009|COMPLETED|Epoch 3 (24 Weeks of Treatment)||0||
59611269|NCT01782222|75722241|FG000|COMPLETED|Overall Study||32||
59896827|NCT03100058|76019030|FG010|COMPLETED|Epoch 3 (24 Weeks of Treatment)||0||
59896828|NCT03100058|76019031|FG011|COMPLETED|Epoch 3 (24 Weeks of Treatment)||0||
59896829|NCT03100058|76019032|FG012|COMPLETED|Epoch 3 (24 Weeks of Treatment)||0||
59896830|NCT03100058|76019020|FG000|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||3||
59896831|NCT03100058|76019021|FG001|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||7||
59896832|NCT03100058|76019022|FG002|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||9||
59611270|NCT01782222|75722242|FG001|COMPLETED|Overall Study||30||
59896833|NCT03100058|76019023|FG003|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||14||
59896834|NCT03100058|76019024|FG004|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||2||
59757308|NCT00933335|75876371|FG001|STARTED|Overall Study|35/36 participants who received 3 cycles of fludarabine later received a DD and TD of TST/I 131 TST.|36||
59896835|NCT03100058|76019025|FG005|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||2||
59896836|NCT03100058|76019026|FG006|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||8||
59896837|NCT03100058|76019027|FG007|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||16||
59896838|NCT03100058|76019028|FG008|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||5||
59896839|NCT03100058|76019029|FG009|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||0||
59896840|NCT03100058|76019030|FG010|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||0||
59896841|NCT03100058|76019031|FG011|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||0||
59896842|NCT03100058|76019032|FG012|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||0||
59896843|NCT03100058|76019020|FG000|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0||
59896844|NCT03100058|76019021|FG001|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0||
59896845|NCT03100058|76019022|FG002|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0||
59896846|NCT03100058|76019023|FG003|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0||
59896847|NCT03100058|76019024|FG004|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0||
59896848|NCT03100058|76019025|FG005|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0||
59896849|NCT03100058|76019026|FG006|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0||
59896850|NCT03100058|76019027|FG007|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0||
59896851|NCT03100058|76019028|FG008|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0||
59896852|NCT03100058|76019029|FG009|STARTED|Epoch 4 (Last 24 Weeks of the Study)||158||
59896853|NCT03100058|76019030|FG010|STARTED|Epoch 4 (Last 24 Weeks of the Study)||163||
59896854|NCT03100058|76019031|FG011|STARTED|Epoch 4 (Last 24 Weeks of the Study)||39||
59896855|NCT03100058|76019032|FG012|STARTED|Epoch 4 (Last 24 Weeks of the Study)||34||
59896856|NCT03100058|76019020|FG000|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0||
59896857|NCT03100058|76019021|FG001|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0||
59896858|NCT03100058|76019022|FG002|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0||
59896859|NCT03100058|76019023|FG003|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0||
59896860|NCT03100058|76019024|FG004|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0||
59896861|NCT03100058|76019025|FG005|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0||
59896862|NCT03100058|76019026|FG006|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0||
59896863|NCT03100058|76019027|FG007|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0||
59896864|NCT03100058|76019028|FG008|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0||
59896865|NCT03100058|76019029|FG009|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||153||
59896866|NCT03100058|76019030|FG010|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||148||
59896867|NCT03100058|76019031|FG011|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||36||
59896868|NCT03100058|76019032|FG012|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||30||
59896869|NCT03100058|76019020|FG000|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0||
59896870|NCT03100058|76019021|FG001|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0||
59896871|NCT03100058|76019022|FG002|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0||
59896872|NCT03100058|76019023|FG003|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0||
59896873|NCT03100058|76019024|FG004|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0||
59896874|NCT03100058|76019025|FG005|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0||
59896875|NCT03100058|76019026|FG006|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0||
59896876|NCT03100058|76019027|FG007|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0||
59896877|NCT03100058|76019028|FG008|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0||
59896878|NCT03100058|76019029|FG009|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||5||
59896879|NCT03100058|76019030|FG010|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||15||
59896880|NCT03100058|76019031|FG011|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||3||
59896881|NCT03100058|76019032|FG012|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||4||
59896882|NCT02866279|76019064|FG000|STARTED|Overall Study||51||
59896883|NCT02866279|76019065|FG001|STARTED|Overall Study||52||
59896884|NCT02866279|76019066|FG002|STARTED|Overall Study||52||
60013872|NCT02504151|76129843|FG000|STARTED|First Intervention (4 Weeks)||8||
59757309|NCT00933335|75876370|FG000|COMPLETED|Overall Study||0||
59757310|NCT00933335|75876371|FG001|COMPLETED|Overall Study||20||
59896885|NCT02866279|76019064|FG000|COMPLETED|Overall Study||51||
59896886|NCT02866279|76019065|FG001|COMPLETED|Overall Study||52||
59896887|NCT02866279|76019066|FG002|COMPLETED|Overall Study||52||
59896888|NCT02866279|76019064|FG000|NOT COMPLETED|Overall Study||0||
59896889|NCT02866279|76019065|FG001|NOT COMPLETED|Overall Study||0||
59896890|NCT02866279|76019066|FG002|NOT COMPLETED|Overall Study||0||
59896891|NCT02871778|76019078|FG000|STARTED|Part A: Treatment Period 1||43||
59896892|NCT02871778|76019079|FG001|STARTED|Part A: Treatment Period 1||41||
59896893|NCT02871778|76019080|FG002|STARTED|Part A: Treatment Period 1||21||
59896894|NCT02871778|76019081|FG003|STARTED|Part A: Treatment Period 1||18||
59896895|NCT02871778|76019082|FG004|STARTED|Part A: Treatment Period 1||0||
59896896|NCT02871778|76019083|FG005|STARTED|Part A: Treatment Period 1||0||
59896897|NCT02871778|76019084|FG006|STARTED|Part A: Treatment Period 1||0||
59896898|NCT02871778|76019085|FG007|STARTED|Part A: Treatment Period 1||0||
59896899|NCT02871778|76019078|FG000|Safety Analysis Set|Part A: Treatment Period 1|1 participant was randomized to receive HS in Period 1, but instead received VX-371 in HS in Period 1.|44||
59896900|NCT02871778|76019079|FG001|Safety Analysis Set|Part A: Treatment Period 1||40||
59896901|NCT02871778|76019080|FG002|Safety Analysis Set|Part A: Treatment Period 1||21||
59896902|NCT02871778|76019081|FG003|Safety Analysis Set|Part A: Treatment Period 1||18||
59896903|NCT02871778|76019082|FG004|Safety Analysis Set|Part A: Treatment Period 1||0||
59896904|NCT02871778|76019083|FG005|Safety Analysis Set|Part A: Treatment Period 1||0||
59896905|NCT02871778|76019084|FG006|Safety Analysis Set|Part A: Treatment Period 1||0||
59896906|NCT02871778|76019085|FG007|Safety Analysis Set|Part A: Treatment Period 1||0||
59896907|NCT02871778|76019078|FG000|COMPLETED|Part A: Treatment Period 1||40||
59896908|NCT02871778|76019079|FG001|COMPLETED|Part A: Treatment Period 1||37||
59896909|NCT02871778|76019080|FG002|COMPLETED|Part A: Treatment Period 1||18||
59896910|NCT02871778|76019081|FG003|COMPLETED|Part A: Treatment Period 1||16||
59896911|NCT02871778|76019082|FG004|COMPLETED|Part A: Treatment Period 1||0||
59896912|NCT02871778|76019083|FG005|COMPLETED|Part A: Treatment Period 1||0||
59896913|NCT02871778|76019084|FG006|COMPLETED|Part A: Treatment Period 1||0||
59896914|NCT02871778|76019085|FG007|COMPLETED|Part A: Treatment Period 1||0||
59896915|NCT02871778|76019078|FG000|NOT COMPLETED|Part A: Treatment Period 1||3||
59896916|NCT02871778|76019079|FG001|NOT COMPLETED|Part A: Treatment Period 1||4||
59896917|NCT02871778|76019080|FG002|NOT COMPLETED|Part A: Treatment Period 1||3||
59896918|NCT02871778|76019081|FG003|NOT COMPLETED|Part A: Treatment Period 1||2||
59896919|NCT02871778|76019082|FG004|NOT COMPLETED|Part A: Treatment Period 1||0||
59896920|NCT02871778|76019083|FG005|NOT COMPLETED|Part A: Treatment Period 1||0||
59896921|NCT02871778|76019084|FG006|NOT COMPLETED|Part A: Treatment Period 1||0||
59896922|NCT02871778|76019085|FG007|NOT COMPLETED|Part A: Treatment Period 1||0||
59896923|NCT02871778|76019078|FG000|STARTED|Part A: Treatment Period 2||40||
59896924|NCT02871778|76019079|FG001|STARTED|Part A: Treatment Period 2||37||
59896925|NCT02871778|76019080|FG002|STARTED|Part A: Treatment Period 2||18||
59896926|NCT02871778|76019081|FG003|STARTED|Part A: Treatment Period 2||16||
59896927|NCT02871778|76019082|FG004|STARTED|Part A: Treatment Period 2||0||
59896928|NCT02871778|76019083|FG005|STARTED|Part A: Treatment Period 2||0||
59896929|NCT02871778|76019084|FG006|STARTED|Part A: Treatment Period 2||0||
59896930|NCT02871778|76019085|FG007|STARTED|Part A: Treatment Period 2||0||
59896931|NCT02871778|76019078|FG000|Safety Analysis Set|Part A: Treatment Period 2||40||
59896932|NCT02871778|76019079|FG001|Safety Analysis Set|Part A: Treatment Period 2||37||
59896933|NCT02871778|76019080|FG002|Safety Analysis Set|Part A: Treatment Period 2||18||
59896934|NCT02871778|76019081|FG003|Safety Analysis Set|Part A: Treatment Period 2||16||
59896935|NCT02871778|76019082|FG004|Safety Analysis Set|Part A: Treatment Period 2||0||
59896936|NCT02871778|76019083|FG005|Safety Analysis Set|Part A: Treatment Period 2||0||
59896937|NCT02871778|76019084|FG006|Safety Analysis Set|Part A: Treatment Period 2||0||
59896938|NCT02871778|76019085|FG007|Safety Analysis Set|Part A: Treatment Period 2||0||
59896939|NCT02871778|76019078|FG000|COMPLETED|Part A: Treatment Period 2||37||
59896940|NCT02871778|76019079|FG001|COMPLETED|Part A: Treatment Period 2||35||
59896941|NCT02871778|76019080|FG002|COMPLETED|Part A: Treatment Period 2||17||
59896942|NCT02871778|76019081|FG003|COMPLETED|Part A: Treatment Period 2||15||
59896943|NCT02871778|76019082|FG004|COMPLETED|Part A: Treatment Period 2||0||
59896944|NCT02871778|76019083|FG005|COMPLETED|Part A: Treatment Period 2||0||
59896945|NCT02871778|76019084|FG006|COMPLETED|Part A: Treatment Period 2||0||
59896946|NCT02871778|76019085|FG007|COMPLETED|Part A: Treatment Period 2||0||
59896947|NCT02871778|76019078|FG000|NOT COMPLETED|Part A: Treatment Period 2||3||
59896948|NCT02871778|76019079|FG001|NOT COMPLETED|Part A: Treatment Period 2||2||
59896949|NCT02871778|76019080|FG002|NOT COMPLETED|Part A: Treatment Period 2||1||
59896950|NCT02871778|76019081|FG003|NOT COMPLETED|Part A: Treatment Period 2||1||
59896951|NCT02871778|76019082|FG004|NOT COMPLETED|Part A: Treatment Period 2||0||
59896952|NCT02871778|76019083|FG005|NOT COMPLETED|Part A: Treatment Period 2||0||
59896953|NCT02871778|76019084|FG006|NOT COMPLETED|Part A: Treatment Period 2||0||
59896954|NCT02871778|76019085|FG007|NOT COMPLETED|Part A: Treatment Period 2||0||
59896955|NCT02871778|76019078|FG000|STARTED|Part B: Treatment Period 3||0||
59896956|NCT02871778|76019079|FG001|STARTED|Part B: Treatment Period 3||0||
59896957|NCT02871778|76019080|FG002|STARTED|Part B: Treatment Period 3||0||
59896958|NCT02871778|76019081|FG003|STARTED|Part B: Treatment Period 3||0||
59896959|NCT02871778|76019082|FG004|STARTED|Part B: Treatment Period 3|Out of 35 participants who were on VX-371 in HS in Treatment period 2 and completed Part A, 11 participants rolled-over to Part B.|11||
59896960|NCT02871778|76019083|FG005|STARTED|Part B: Treatment Period 3|Out of 37 participants who were on HS in Treatment period 2 and completed Part A, 27 participants rolled-over to Part B.|27||
59896961|NCT02871778|76019084|FG006|STARTED|Part B: Treatment Period 3|Out of 15 participants who were on VX-371 in Treatment period 2 and completed Part A, 7 participants rolled-over to Part B.|7||
59896962|NCT02871778|76019085|FG007|STARTED|Part B: Treatment Period 3|Out of 17 participants who were on Placebo in Treatment period 2 and completed Part A, 12 participants rolled-over to Part B.|12||
59896963|NCT02871778|76019078|FG000|Safety Analysis Set|Part B: Treatment Period 3||0||
59896964|NCT02871778|76019079|FG001|Safety Analysis Set|Part B: Treatment Period 3||0||
59896965|NCT02871778|76019080|FG002|Safety Analysis Set|Part B: Treatment Period 3||0||
59896966|NCT02871778|76019081|FG003|Safety Analysis Set|Part B: Treatment Period 3||0||
59896967|NCT02871778|76019082|FG004|Safety Analysis Set|Part B: Treatment Period 3||11||
59896968|NCT02871778|76019083|FG005|Safety Analysis Set|Part B: Treatment Period 3||27||
59896969|NCT02871778|76019084|FG006|Safety Analysis Set|Part B: Treatment Period 3||7||
59896970|NCT02871778|76019085|FG007|Safety Analysis Set|Part B: Treatment Period 3||12||
59896971|NCT02871778|76019078|FG000|COMPLETED|Part B: Treatment Period 3||0||
59896972|NCT02871778|76019079|FG001|COMPLETED|Part B: Treatment Period 3||0||
59896973|NCT02871778|76019080|FG002|COMPLETED|Part B: Treatment Period 3||0||
59896974|NCT02871778|76019081|FG003|COMPLETED|Part B: Treatment Period 3||0||
59896975|NCT02871778|76019082|FG004|COMPLETED|Part B: Treatment Period 3||10||
59896976|NCT02871778|76019083|FG005|COMPLETED|Part B: Treatment Period 3||26||
59896977|NCT02871778|76019084|FG006|COMPLETED|Part B: Treatment Period 3||6||
59896978|NCT02871778|76019085|FG007|COMPLETED|Part B: Treatment Period 3||12||
59896979|NCT02871778|76019078|FG000|NOT COMPLETED|Part B: Treatment Period 3||0||
59896980|NCT02871778|76019079|FG001|NOT COMPLETED|Part B: Treatment Period 3||0||
59896981|NCT02871778|76019080|FG002|NOT COMPLETED|Part B: Treatment Period 3||0||
59896982|NCT02871778|76019081|FG003|NOT COMPLETED|Part B: Treatment Period 3||0||
59896983|NCT02871778|76019082|FG004|NOT COMPLETED|Part B: Treatment Period 3||1||
59896984|NCT02871778|76019083|FG005|NOT COMPLETED|Part B: Treatment Period 3||1||
59896985|NCT02871778|76019084|FG006|NOT COMPLETED|Part B: Treatment Period 3||1||
59896986|NCT02871778|76019085|FG007|NOT COMPLETED|Part B: Treatment Period 3||0||
59896987|NCT02735473|76019109|FG000|STARTED|Overall Study||23||
59896988|NCT02735473|76019110|FG001|STARTED|Overall Study||23||
59896989|NCT02735473|76019109|FG000|COMPLETED|Overall Study||17||
59896990|NCT02735473|76019110|FG001|COMPLETED|Overall Study||16||
59896991|NCT02735473|76019109|FG000|NOT COMPLETED|Overall Study||6||
59896992|NCT02735473|76019110|FG001|NOT COMPLETED|Overall Study||7||
59896993|NCT01471444|76019118|FG000|STARTED|Overall Study||133||
59896994|NCT01471444|76019119|FG001|STARTED|Overall Study||123||
59896995|NCT01471444|76019118|FG000|COMPLETED|Overall Study||130||
59896996|NCT01471444|76019119|FG001|COMPLETED|Overall Study||120||
59896997|NCT01471444|76019118|FG000|NOT COMPLETED|Overall Study||3||
59896998|NCT01471444|76019119|FG001|NOT COMPLETED|Overall Study||3||
59896999|NCT02644135|76019128|FG000|STARTED|Overall Study||50||
59897000|NCT02644135|76019129|FG001|STARTED|Overall Study||44||
59897001|NCT02644135|76019128|FG000|COMPLETED|Overall Study||50||
59897002|NCT02644135|76019129|FG001|COMPLETED|Overall Study||44||
59897003|NCT02644135|76019128|FG000|NOT COMPLETED|Overall Study||0||
59897004|NCT02644135|76019129|FG001|NOT COMPLETED|Overall Study||0||
59897005|NCT03443427|76019137|FG000|STARTED|Overall Study||100||
59897006|NCT03443427|76019138|FG001|STARTED|Overall Study||100||
59897007|NCT03443427|76019137|FG000|COMPLETED|Overall Study||88||
59897008|NCT03443427|76019138|FG001|COMPLETED|Overall Study||89||
59897009|NCT03443427|76019137|FG000|NOT COMPLETED|Overall Study||12||
59897010|NCT03443427|76019138|FG001|NOT COMPLETED|Overall Study||11||
59897011|NCT03417219|76019146|FG000|STARTED|Overall Study||8||
59897012|NCT03417219|76019147|FG001|STARTED|Overall Study||8||
59897013|NCT03417219|76019146|FG000|COMPLETED|Overall Study||8||
59897014|NCT03417219|76019147|FG001|COMPLETED|Overall Study||5||
59897015|NCT03417219|76019146|FG000|NOT COMPLETED|Overall Study||0||
59897016|NCT03417219|76019147|FG001|NOT COMPLETED|Overall Study||3||
59897017|NCT02953821|76019155|FG000|STARTED|Overall Study||86||
59897018|NCT02953821|76019156|FG001|STARTED|Overall Study||86||
59897019|NCT02953821|76019155|FG000|Safety Population|Overall Study||86||
59897020|NCT02953821|76019156|FG001|Safety Population|Overall Study||86||
59897021|NCT02953821|76019155|FG000|Modified Intent to Treat (mITT) Populati|Overall Study||85||
59897022|NCT02953821|76019156|FG001|Modified Intent to Treat (mITT) Populati|Overall Study||84||
59897023|NCT02953821|76019155|FG000|Per Protocol (PP) Population|Overall Study||72||
59897024|NCT02953821|76019156|FG001|Per Protocol (PP) Population|Overall Study||75||
59897025|NCT02953821|76019155|FG000|Completed Week 16 Visit|Overall Study||76||
59897026|NCT02953821|76019156|FG001|Completed Week 16 Visit|Overall Study||77||
59897027|NCT02953821|76019155|FG000|Completed Study Treatment (Week 24)|Overall Study||73||
59897028|NCT02953821|76019156|FG001|Completed Study Treatment (Week 24)|Overall Study||76||
59897029|NCT02953821|76019155|FG000|COMPLETED|Overall Study||71|including follow-up|
59897030|NCT02953821|76019156|FG001|COMPLETED|Overall Study||73|including follow-up|
59897031|NCT02953821|76019155|FG000|NOT COMPLETED|Overall Study||15||
59897032|NCT02953821|76019156|FG001|NOT COMPLETED|Overall Study||13||
59897033|NCT03783923|76019166|FG000|STARTED|Placebo-Controlled Period (26 Weeks)||5||
59897034|NCT03783923|76019167|FG001|STARTED|Placebo-Controlled Period (26 Weeks)||6||
59897035|NCT03783923|76019166|FG000|Safety Population|Placebo-Controlled Period (26 Weeks)||5|Safety population included all enrolled participants who received at least 1 dose of deflazacort.|
59897036|NCT03783923|76019167|FG001|Safety Population|Placebo-Controlled Period (26 Weeks)|2 participants who received placebo in placebo-controlled period transitioned to receive deflazacort in open-label extension.|2|Safety population included all enrolled participants who received at least 1 dose of deflazacort.|
59897037|NCT03783923|76019166|FG000|COMPLETED|Placebo-Controlled Period (26 Weeks)||1|Open-label transition|
59897038|NCT03783923|76019167|FG001|COMPLETED|Placebo-Controlled Period (26 Weeks)||2|Open-label transition|
59897039|NCT03783923|76019166|FG000|NOT COMPLETED|Placebo-Controlled Period (26 Weeks)||4||
59897040|NCT03783923|76019167|FG001|NOT COMPLETED|Placebo-Controlled Period (26 Weeks)||4||
59897041|NCT03783923|76019166|FG000|STARTED|Open-Label Extension (26 Weeks)||1|Transited to Protocol V4 and Dosed under Open-Label|
59897042|NCT03783923|76019167|FG001|STARTED|Open-Label Extension (26 Weeks)||2|Transited to Protocol V4 and Dosed under Open-Label|
59897043|NCT03783923|76019166|FG000|COMPLETED|Open-Label Extension (26 Weeks)||0||
59897044|NCT03783923|76019167|FG001|COMPLETED|Open-Label Extension (26 Weeks)||0||
59897045|NCT03783923|76019166|FG000|NOT COMPLETED|Open-Label Extension (26 Weeks)||1||
59897046|NCT03783923|76019167|FG001|NOT COMPLETED|Open-Label Extension (26 Weeks)||2||
59897047|NCT03417141|76019171|FG000|STARTED|Overall Study||12||
59897048|NCT03417141|76019171|FG000|COMPLETED|Overall Study||8||
59897049|NCT03417141|76019171|FG000|NOT COMPLETED|Overall Study||4||
59897050|NCT02453113|76019175|FG000|STARTED|Overall Study||10||
59897051|NCT02453113|76019175|FG000|COMPLETED|Overall Study||10||
59897052|NCT02453113|76019175|FG000|NOT COMPLETED|Overall Study||0||
59897053|NCT03724981|76019179|FG000|STARTED|First Device||156||
59757311|NCT00933335|75876370|FG000|NOT COMPLETED|Overall Study||2||
59757312|NCT00933335|75876371|FG001|NOT COMPLETED|Overall Study||16||
59757313|NCT00772941|75876383|FG000|STARTED|Overall Study||3939||
59897054|NCT03724981|76019180|FG001|STARTED|First Device||156||
59897055|NCT03724981|76019179|FG000|COMPLETED|First Device||155||
59897056|NCT03724981|76019180|FG001|COMPLETED|First Device||155||
59897057|NCT03724981|76019179|FG000|NOT COMPLETED|First Device||1||
59897058|NCT03724981|76019180|FG001|NOT COMPLETED|First Device||1||
59897059|NCT03724981|76019179|FG000|STARTED|Second Device||155||
59897060|NCT03724981|76019180|FG001|STARTED|Second Device||155||
59897061|NCT03724981|76019179|FG000|COMPLETED|Second Device||155||
59897062|NCT03724981|76019180|FG001|COMPLETED|Second Device||155||
59897063|NCT03724981|76019179|FG000|NOT COMPLETED|Second Device||0||
59897064|NCT03724981|76019180|FG001|NOT COMPLETED|Second Device||0||
59897065|NCT01347879|76019190|FG000|STARTED|Overall Study||53||
59897066|NCT01347879|76019191|FG001|STARTED|Overall Study||100||
59897067|NCT01347879|76019190|FG000|COMPLETED|Overall Study||46||
59897068|NCT01347879|76019191|FG001|COMPLETED|Overall Study||83||
59897069|NCT01347879|76019190|FG000|NOT COMPLETED|Overall Study||7||
59897070|NCT01347879|76019191|FG001|NOT COMPLETED|Overall Study||17||
59897071|NCT04249310|76019199|FG000|STARTED|Overall Study||1436|Unmatched cohort|
59897072|NCT04249310|76019200|FG001|STARTED|Overall Study||5352|Unmatched cohort|
59757314|NCT00772941|75876383|FG000|COMPLETED|Overall Study||3257||
59897073|NCT04249310|76019199|FG000|PS-matched Cohort|Overall Study||1412||
59897074|NCT04249310|76019200|FG001|PS-matched Cohort|Overall Study||1412||
59897075|NCT04249310|76019199|FG000|hdPS-matched Cohort|Overall Study||1302||
59897076|NCT04249310|76019200|FG001|hdPS-matched Cohort|Overall Study||1302||
59897077|NCT04249310|76019199|FG000|COMPLETED|Overall Study||1436||
59897078|NCT04249310|76019200|FG001|COMPLETED|Overall Study||5352||
59897079|NCT04249310|76019199|FG000|NOT COMPLETED|Overall Study||0||
59897080|NCT04249310|76019200|FG001|NOT COMPLETED|Overall Study||0||
59897081|NCT03441789|76019208|FG000|STARTED|Overall Study||14||
59897082|NCT03441789|76019209|FG001|STARTED|Overall Study||14||
59897083|NCT03441789|76019208|FG000|COMPLETED|Overall Study||13||
59897084|NCT03441789|76019209|FG001|COMPLETED|Overall Study||10||
59897085|NCT03441789|76019208|FG000|NOT COMPLETED|Overall Study||1||
59897086|NCT03441789|76019209|FG001|NOT COMPLETED|Overall Study||4||
59897087|NCT03287050|76019215|FG000|STARTED|Overall Study||6||
59897088|NCT03287050|76019215|FG000|COMPLETED|Overall Study||6||
59897089|NCT03287050|76019215|FG000|NOT COMPLETED|Overall Study||0||
59897090|NCT03387735|76019221|FG000|STARTED|Overall Study||168||
59757315|NCT00772941|75876383|FG000|NOT COMPLETED|Overall Study||682||
59757316|NCT00772707|75876410|FG000|STARTED|Overall Study||114||
59897091|NCT03387735|76019222|FG001|STARTED|Overall Study||176||
59897092|NCT03387735|76019221|FG000|COMPLETED|Overall Study||160||
59897093|NCT03387735|76019222|FG001|COMPLETED|Overall Study||160||
59897094|NCT03387735|76019221|FG000|NOT COMPLETED|Overall Study||8||
59897095|NCT03387735|76019222|FG001|NOT COMPLETED|Overall Study||16||
59950998|NCT04789382|76069923|FG000|NOT COMPLETED|First Wear Period (2 Hours)||0||
59950999|NCT04789382|76069924|FG001|NOT COMPLETED|First Wear Period (2 Hours)||0||
59951000|NCT04789382|76069925|FG002|NOT COMPLETED|First Wear Period (2 Hours)||0||
59951001|NCT04789382|76069926|FG003|NOT COMPLETED|First Wear Period (2 Hours)||0||
59951002|NCT04789382|76069923|FG000|STARTED|Washout (Day of & Day Prior to Visit 3)||9||
59951003|NCT04789382|76069924|FG001|STARTED|Washout (Day of & Day Prior to Visit 3)||9||
59757317|NCT00772707|75876410|FG000|COMPLETED|Overall Study||111||
59897096|NCT04055090|76019230|FG000|STARTED|Overall Study||65|Treatment assignments (Engensis or Placebo) for this study, VMDN-003b, are based on the treatment groups in the prior study, VMDN-003|
59897097|NCT04055090|76019231|FG001|STARTED|Overall Study||36|Treatment assignments (Engensis or Placebo) for this study, VMDN-003b, are based on the treatment groups in the prior study, VMDN-003|
59897098|NCT04055090|76019230|FG000|COMPLETED|Overall Study||63||
59897099|NCT04055090|76019231|FG001|COMPLETED|Overall Study||36||
59897100|NCT04055090|76019230|FG000|NOT COMPLETED|Overall Study||2||
59897101|NCT04055090|76019231|FG001|NOT COMPLETED|Overall Study||0||
59897102|NCT03531112|76019243|FG000|STARTED|Overall Study||20||
59897103|NCT03531112|76019244|FG001|STARTED|Overall Study||0||
59897104|NCT03531112|76019243|FG000|Month 4|Overall Study||17||
59897105|NCT03531112|76019244|FG001|Month 4|Overall Study||0||
59897106|NCT03531112|76019243|FG000|Month 6 (Follow-Up)|Overall Study||13||
59897107|NCT03531112|76019244|FG001|Month 6 (Follow-Up)|Overall Study||0||
59897108|NCT03531112|76019243|FG000|COMPLETED|Overall Study||13||
59897109|NCT03531112|76019244|FG001|COMPLETED|Overall Study||0||
59897110|NCT03531112|76019243|FG000|NOT COMPLETED|Overall Study||7||
59897111|NCT03531112|76019244|FG001|NOT COMPLETED|Overall Study||0||
59897112|NCT00890617|76019250|FG000|STARTED|Overall Study||9||
59897113|NCT00890617|76019250|FG000|COMPLETED|Overall Study||9||
59897114|NCT00890617|76019250|FG000|NOT COMPLETED|Overall Study||0||
59897115|NCT03403413|76019254|FG000|STARTED|Overall Study||5|Case series of 3 subjects with multiple sclerosis.|
59897116|NCT03403413|76019254|FG000|COMPLETED|Overall Study||3||
59897117|NCT03403413|76019254|FG000|NOT COMPLETED|Overall Study||2||
59897118|NCT03181828|76019262|FG000|STARTED|Overall Study||2||
59897119|NCT03181828|76019263|FG001|STARTED|Overall Study||2||
59897120|NCT03181828|76019262|FG000|COMPLETED|Overall Study||2||
59897121|NCT03181828|76019263|FG001|COMPLETED|Overall Study||2||
59897122|NCT03181828|76019262|FG000|NOT COMPLETED|Overall Study||0||
59897123|NCT03181828|76019263|FG001|NOT COMPLETED|Overall Study||0||
59897124|NCT03721705|76019271|FG000|STARTED|Overall Study||95||
59897125|NCT03721705|76019272|FG001|STARTED|Overall Study||95||
59897126|NCT03721705|76019271|FG000|COMPLETED|Overall Study||85||
59897127|NCT03721705|76019272|FG001|COMPLETED|Overall Study||77||
59897128|NCT03721705|76019271|FG000|NOT COMPLETED|Overall Study||10||
59897129|NCT03721705|76019272|FG001|NOT COMPLETED|Overall Study||18||
59897130|NCT03720847|76019278|FG000|STARTED|Condition 1||15||
59897131|NCT03720847|76019279|FG001|STARTED|Condition 1||15||
59897132|NCT03720847|76019278|FG000|COMPLETED|Condition 1||15||
59897133|NCT03720847|76019279|FG001|COMPLETED|Condition 1||15||
59897134|NCT03720847|76019278|FG000|NOT COMPLETED|Condition 1||0||
59897135|NCT03720847|76019279|FG001|NOT COMPLETED|Condition 1||0||
59897136|NCT03720847|76019278|FG000|STARTED|Washout||15||
59897137|NCT03720847|76019279|FG001|STARTED|Washout||15||
59897138|NCT03720847|76019278|FG000|COMPLETED|Washout||14||
59897139|NCT03720847|76019279|FG001|COMPLETED|Washout||13||
59897140|NCT03720847|76019278|FG000|NOT COMPLETED|Washout||1||
59897141|NCT03720847|76019279|FG001|NOT COMPLETED|Washout||2||
59897142|NCT03720847|76019278|FG000|STARTED|Condition 2||14||
59897143|NCT03720847|76019279|FG001|STARTED|Condition 2||13||
59611271|NCT01782222|75722243|FG002|COMPLETED|Overall Study||37||
59611272|NCT01782222|75722241|FG000|NOT COMPLETED|Overall Study||8||
59611273|NCT01782222|75722242|FG001|NOT COMPLETED|Overall Study||11||
59611274|NCT01782222|75722243|FG002|NOT COMPLETED|Overall Study||4||
59611275|NCT01781832|75722251|FG000|STARTED|Overall Study||26||
59611276|NCT01781832|75722251|FG000|COMPLETED|Overall Study||25||
59611277|NCT01781832|75722251|FG000|NOT COMPLETED|Overall Study||1||
59897144|NCT03720847|76019278|FG000|COMPLETED|Condition 2||14||
59897145|NCT03720847|76019279|FG001|COMPLETED|Condition 2||13||
59897146|NCT03720847|76019278|FG000|NOT COMPLETED|Condition 2||0||
59897147|NCT03720847|76019279|FG001|NOT COMPLETED|Condition 2||0||
59897148|NCT02631070|76019288|FG000|STARTED|Overall Study||153||
59897149|NCT02631070|76019289|FG001|STARTED|Overall Study||76||
59897150|NCT02631070|76019288|FG000|COMPLETED|Overall Study||4||
59611278|NCT01807182|75722255|FG000|STARTED|Overall Study||10||
59611279|NCT01807182|75722255|FG000|COMPLETED|Overall Study||7||
59611280|NCT01807182|75722255|FG000|NOT COMPLETED|Overall Study||3||
59897151|NCT02631070|76019289|FG001|COMPLETED|Overall Study||12||
59897152|NCT02631070|76019288|FG000|NOT COMPLETED|Overall Study||149||
59897153|NCT02631070|76019289|FG001|NOT COMPLETED|Overall Study||64||
59611281|NCT01806714|75722261|FG000|STARTED|Overall Study||2093||
59611282|NCT01806714|75722262|FG001|STARTED|Overall Study||2089||
59611283|NCT01806714|75722261|FG000|COMPLETED|Overall Study||1893||
59611284|NCT01806714|75722262|FG001|COMPLETED|Overall Study||1919||
59897154|NCT00741988|76019297|FG000|STARTED|Overall Study||42||
59897155|NCT00741988|76019298|FG001|STARTED|Overall Study||40||
59897156|NCT00741988|76019297|FG000|COMPLETED|Overall Study||38||
59897157|NCT00741988|76019298|FG001|COMPLETED|Overall Study||36||
59897158|NCT00741988|76019297|FG000|NOT COMPLETED|Overall Study||4||
59897159|NCT00741988|76019298|FG001|NOT COMPLETED|Overall Study||4||
59897160|NCT03354429|76019306|FG000|STARTED|Overall Study||5523||
59897161|NCT03354429|76019307|FG001|STARTED|Overall Study||5493||
59611285|NCT01806714|75722261|FG000|NOT COMPLETED|Overall Study||200||
59611286|NCT01806714|75722262|FG001|NOT COMPLETED|Overall Study||170||
59897162|NCT03354429|76019306|FG000|COMPLETED|Overall Study||5514||
59611287|NCT01765764|75722271|FG000|STARTED|Treatment Period||118||
59611288|NCT01765764|75722272|FG001|STARTED|Treatment Period||118||
59611289|NCT01765764|75722273|FG002|STARTED|Treatment Period||121||
59611290|NCT01765764|75722271|FG000|COMPLETED|Treatment Period||115||
59611291|NCT01765764|75722272|FG001|COMPLETED|Treatment Period||109||
59611292|NCT01765764|75722273|FG002|COMPLETED|Treatment Period||115||
59611293|NCT01765764|75722271|FG000|NOT COMPLETED|Treatment Period||3||
59611294|NCT01765764|75722272|FG001|NOT COMPLETED|Treatment Period||9||
59611295|NCT01765764|75722273|FG002|NOT COMPLETED|Treatment Period||6||
59611296|NCT01765764|75722271|FG000|STARTED|Post-treatment Period|1 participant did not enter the Post-treatment Period. [Personal Reasons]|114||
59611297|NCT01765764|75722272|FG001|STARTED|Post-treatment Period|2 participants did not enter the Post-treatment Period [2 Lost-to-Follow-up (LFU)]|107||
59611298|NCT01765764|75722273|FG002|STARTED|Post-treatment Period|3 participants did not enter the Post-treatment Period [1 Personal Reasons,2 LFU].|112||
59611299|NCT01765764|75722271|FG000|COMPLETED|Post-treatment Period||114||
59611300|NCT01765764|75722272|FG001|COMPLETED|Post-treatment Period||107||
59611301|NCT01765764|75722273|FG002|COMPLETED|Post-treatment Period||112||
59611302|NCT01765764|75722271|FG000|NOT COMPLETED|Post-treatment Period||0||
59897163|NCT03354429|76019307|FG001|COMPLETED|Overall Study||5486||
59897164|NCT03354429|76019306|FG000|NOT COMPLETED|Overall Study||9||
59897165|NCT03354429|76019307|FG001|NOT COMPLETED|Overall Study||7||
59897166|NCT03352713|76019313|FG000|STARTED|Overall Study||185||
59897167|NCT03352713|76019313|FG000|COMPLETED|Overall Study|Participants who completed at least 1 EMA for inclusion in data analysis|159||
59897168|NCT03352713|76019313|FG000|NOT COMPLETED|Overall Study||26||
59897169|NCT03901144|76019317|FG000|STARTED|Overall Study||50|Each participant used all three creams and had one area untreated, i.e. 4 treatment areas per subject. Total number of subjects was 50|50
59897170|NCT03901144|76019318|FG001|STARTED|Overall Study||50|Each participant used all three creams and had one area untreated, i.e. 4 treatment areas per subject. Total number of subjects was 50|50
59897171|NCT03901144|76019319|FG002|STARTED|Overall Study||50|Each participant used all three creams and had one area untreated, i.e. 4 treatment areas per subject. Total number of subjects was 50|50
59897172|NCT03901144|76019320|FG003|STARTED|Overall Study||50|Each participant used all three creams and had one area untreated, i.e. 4 treatment areas per subject. Total number of subjects was 50|50
59897173|NCT03901144|76019317|FG000|COMPLETED|Overall Study||49|Each participant used all three creams and had one area untreated, i.e. 4 treatment areas per subject. Total number of completed subjects was 49|49
59897174|NCT03901144|76019318|FG001|COMPLETED|Overall Study||49|Each participant used all three creams and had one area untreated, i.e. 4 treatment areas per subject. Total number of completed subjects was 49|49
59897175|NCT03901144|76019319|FG002|COMPLETED|Overall Study||49|Each participant used all three creams and had one area untreated, i.e. 4 treatment areas per subject. Total number of completed subjects was 49|49
59897176|NCT03901144|76019320|FG003|COMPLETED|Overall Study||49|Each participant used all three creams and had one area untreated, i.e. 4 treatment areas per subject. Total number of completed subjects was 49|49
59897177|NCT03901144|76019317|FG000|NOT COMPLETED|Overall Study||1||1
59897178|NCT03901144|76019318|FG001|NOT COMPLETED|Overall Study||1||1
59897179|NCT03901144|76019319|FG002|NOT COMPLETED|Overall Study||1||1
59897180|NCT03901144|76019320|FG003|NOT COMPLETED|Overall Study||1||1
59897181|NCT02952261|76019332|FG000|STARTED|Overall Study||100||
59897182|NCT02952261|76019333|FG001|STARTED|Overall Study||100||
59897183|NCT02952261|76019332|FG000|COMPLETED|Overall Study||95||
59897184|NCT02952261|76019333|FG001|COMPLETED|Overall Study||95||
59897185|NCT02952261|76019332|FG000|NOT COMPLETED|Overall Study||5||
59897186|NCT02952261|76019333|FG001|NOT COMPLETED|Overall Study||5||
59897187|NCT03384693|76019339|FG000|STARTED|Overall Study||25||
59897188|NCT03384693|76019339|FG000|COMPLETED|Overall Study||22||
59897189|NCT03384693|76019339|FG000|NOT COMPLETED|Overall Study||3||
59897190|NCT03525808|76019343|FG000|STARTED|Overall Study||40||
59897191|NCT03525808|76019343|FG000|COMPLETED|Overall Study||34||
59897192|NCT03525808|76019343|FG000|NOT COMPLETED|Overall Study||6||
59897193|NCT03718429|76019351|FG000|STARTED|Baseline Treatment||20||
59897194|NCT03718429|76019352|FG001|STARTED|Baseline Treatment||21||
59611303|NCT01765764|75722272|FG001|NOT COMPLETED|Post-treatment Period||0||
59757318|NCT00772707|75876410|FG000|NOT COMPLETED|Overall Study||3||
59897195|NCT03718429|76019353|FG002|STARTED|Baseline Treatment||21||
59897196|NCT03718429|76019354|FG003|STARTED|Baseline Treatment||20||
59897197|NCT03718429|76019351|FG000|COMPLETED|Baseline Treatment||20||
59897198|NCT03718429|76019352|FG001|COMPLETED|Baseline Treatment||21||
59897199|NCT03718429|76019353|FG002|COMPLETED|Baseline Treatment||21||
59897200|NCT03718429|76019354|FG003|COMPLETED|Baseline Treatment||20||
59897201|NCT03718429|76019351|FG000|NOT COMPLETED|Baseline Treatment||0||
59897202|NCT03718429|76019352|FG001|NOT COMPLETED|Baseline Treatment||0||
59897203|NCT03718429|76019353|FG002|NOT COMPLETED|Baseline Treatment||0||
59897204|NCT03718429|76019354|FG003|NOT COMPLETED|Baseline Treatment||0||
59897205|NCT03718429|76019351|FG000|STARTED|Adjunctive Rivaroxaban 2.5 mg||20||
59897206|NCT03718429|76019352|FG001|STARTED|Adjunctive Rivaroxaban 2.5 mg||21||
59611304|NCT01765764|75722273|FG002|NOT COMPLETED|Post-treatment Period||0||
59611305|NCT01806168|75722284|FG000|STARTED|Overall Study||11||
59757319|NCT00772629|75876416|FG000|STARTED|Overall Study||17||
59611306|NCT01806168|75722285|FG001|STARTED|Overall Study||10||
59611307|NCT01806168|75722286|FG002|STARTED|Overall Study||10||
59897207|NCT03718429|76019353|FG002|STARTED|Adjunctive Rivaroxaban 2.5 mg||21||
59897208|NCT03718429|76019354|FG003|STARTED|Adjunctive Rivaroxaban 2.5 mg||0||
59897209|NCT03718429|76019351|FG000|COMPLETED|Adjunctive Rivaroxaban 2.5 mg||20||
59897210|NCT03718429|76019352|FG001|COMPLETED|Adjunctive Rivaroxaban 2.5 mg||20||
59897211|NCT03718429|76019353|FG002|COMPLETED|Adjunctive Rivaroxaban 2.5 mg||20||
59897212|NCT03718429|76019354|FG003|COMPLETED|Adjunctive Rivaroxaban 2.5 mg||0||
59897213|NCT03718429|76019351|FG000|NOT COMPLETED|Adjunctive Rivaroxaban 2.5 mg||0||
59897214|NCT03718429|76019352|FG001|NOT COMPLETED|Adjunctive Rivaroxaban 2.5 mg||1||
59611308|NCT01806168|75722284|FG000|Received Allocated Intervention|Overall Study||11||
59897215|NCT03718429|76019353|FG002|NOT COMPLETED|Adjunctive Rivaroxaban 2.5 mg||1||
59897216|NCT03718429|76019354|FG003|NOT COMPLETED|Adjunctive Rivaroxaban 2.5 mg||0||
59897217|NCT03718429|76019351|FG000|STARTED|Stopping Aspirin||20||
59897218|NCT03718429|76019352|FG001|STARTED|Stopping Aspirin||20||
59897219|NCT03718429|76019353|FG002|STARTED|Stopping Aspirin||20||
59897220|NCT03718429|76019354|FG003|STARTED|Stopping Aspirin||0||
59897221|NCT03718429|76019351|FG000|COMPLETED|Stopping Aspirin||20||
59897222|NCT03718429|76019352|FG001|COMPLETED|Stopping Aspirin||20||
59897223|NCT03718429|76019353|FG002|COMPLETED|Stopping Aspirin||20||
59897224|NCT03718429|76019354|FG003|COMPLETED|Stopping Aspirin||0||
59897225|NCT03718429|76019351|FG000|NOT COMPLETED|Stopping Aspirin||0||
59897226|NCT03718429|76019352|FG001|NOT COMPLETED|Stopping Aspirin||0||
59897227|NCT03718429|76019353|FG002|NOT COMPLETED|Stopping Aspirin||0||
59897228|NCT03718429|76019354|FG003|NOT COMPLETED|Stopping Aspirin||0||
59897229|NCT01285102|76019374|FG000|STARTED|Overall Study||4||
59897230|NCT01285102|76019374|FG000|COMPLETED|Overall Study||0||
59897231|NCT01285102|76019374|FG000|NOT COMPLETED|Overall Study||4||
59897232|NCT00677560|76019383|FG000|STARTED|Overall Study||20||
59897233|NCT00677560|76019384|FG001|STARTED|Overall Study||23||
59897234|NCT00677560|76019385|FG002|STARTED|Overall Study||29||
59897235|NCT00677560|76019386|FG003|STARTED|Overall Study||20||
59897236|NCT00677560|76019387|FG004|STARTED|Overall Study||34||
59897237|NCT00677560|76019383|FG000|COMPLETED|Overall Study||5||
59897238|NCT00677560|76019384|FG001|COMPLETED|Overall Study||13||
59897239|NCT00677560|76019385|FG002|COMPLETED|Overall Study||6||
59897240|NCT00677560|76019386|FG003|COMPLETED|Overall Study||3||
59757320|NCT00772629|75876417|FG001|STARTED|Overall Study||1||
59757321|NCT00772629|75876416|FG000|COMPLETED|Overall Study||16||
59757322|NCT00772629|75876417|FG001|COMPLETED|Overall Study||1||
59757323|NCT00772629|75876416|FG000|NOT COMPLETED|Overall Study||1||
59757324|NCT00772629|75876417|FG001|NOT COMPLETED|Overall Study||0||
59757325|NCT00939341|75876423|FG000|STARTED|Overall Study|1022 participants were enrolled. There were 160 screen failures, 862 proceeded to treatment period.|862||
59757326|NCT00939341|75876423|FG000|COMPLETED|Overall Study|862 participants entered into the 12-week treatment,66 discontinued, 796 completed the treatment.|796||
59757327|NCT00939341|75876423|FG000|NOT COMPLETED|Overall Study||66||
59757328|NCT04557215|75876430|FG000|STARTED|Overall Study||15||
59757329|NCT04557215|75876431|FG001|STARTED|Overall Study||15||
59757330|NCT04557215|75876432|FG002|STARTED|Overall Study||15||
59757331|NCT04557215|75876430|FG000|COMPLETED|Overall Study||15||
59757332|NCT04557215|75876431|FG001|COMPLETED|Overall Study||15||
59757333|NCT04557215|75876432|FG002|COMPLETED|Overall Study||15||
59757334|NCT04557215|75876430|FG000|NOT COMPLETED|Overall Study||0||
59757335|NCT04557215|75876431|FG001|NOT COMPLETED|Overall Study||0||
59757336|NCT04557215|75876432|FG002|NOT COMPLETED|Overall Study||0||
59757337|NCT04496414|75876446|FG000|STARTED|Overall Study||50||
59757338|NCT04496414|75876446|FG000|COMPLETED|Overall Study||50||
59897241|NCT00677560|76019387|FG004|COMPLETED|Overall Study||21||
59897242|NCT00677560|76019383|FG000|NOT COMPLETED|Overall Study||15||
59897243|NCT00677560|76019384|FG001|NOT COMPLETED|Overall Study||10||
59897244|NCT00677560|76019385|FG002|NOT COMPLETED|Overall Study||23||
59897245|NCT00677560|76019386|FG003|NOT COMPLETED|Overall Study||17||
59897246|NCT00677560|76019387|FG004|NOT COMPLETED|Overall Study||13||
59897247|NCT03382899|76019408|FG000|STARTED|Overall Study||51||
59897248|NCT03382899|76019409|FG001|STARTED|Overall Study||50||
59897249|NCT03382899|76019408|FG000|Received at Least 1 Dose of Study Drug|Overall Study||50||
59897250|NCT03382899|76019409|FG001|Received at Least 1 Dose of Study Drug|Overall Study||48||
59897251|NCT03382899|76019408|FG000|COMPLETED|Overall Study||20||
59897252|NCT03382899|76019409|FG001|COMPLETED|Overall Study||15||
59897253|NCT03382899|76019408|FG000|NOT COMPLETED|Overall Study||31||
59897254|NCT03382899|76019409|FG001|NOT COMPLETED|Overall Study||35||
59897255|NCT00709852|76019415|FG000|STARTED|Period 1||228||
59897256|NCT00709852|76019416|FG001|STARTED|Period 1||174||
59897257|NCT00709852|76019415|FG000|COMPLETED|Period 1||220||
59897258|NCT00709852|76019416|FG001|COMPLETED|Period 1||171||
59897259|NCT00709852|76019415|FG000|NOT COMPLETED|Period 1||8||
59897260|NCT00709852|76019416|FG001|NOT COMPLETED|Period 1||3||
59897261|NCT00709852|76019415|FG000|STARTED|Period 2||220||
59897262|NCT00709852|76019416|FG001|STARTED|Period 2||171||
59897263|NCT00709852|76019415|FG000|COMPLETED|Period 2||211||
59897264|NCT00709852|76019416|FG001|COMPLETED|Period 2||169||
59897265|NCT00709852|76019415|FG000|NOT COMPLETED|Period 2||9||
59897266|NCT00709852|76019416|FG001|NOT COMPLETED|Period 2||2||
59897267|NCT03382041|76019433|FG000|STARTED|Overall Study||7||
59897268|NCT03382041|76019434|FG001|STARTED|Overall Study||13||
59897269|NCT03382041|76019433|FG000|COMPLETED|Overall Study||3||
59897270|NCT03382041|76019434|FG001|COMPLETED|Overall Study||4||
59897271|NCT03382041|76019433|FG000|NOT COMPLETED|Overall Study||4||
59897272|NCT03382041|76019434|FG001|NOT COMPLETED|Overall Study||9||
59897273|NCT03351231|76019440|FG000|STARTED|Combination Therapy Period|Started = initiated and completed monotherapy, then initiated combination therapy|5||
59897274|NCT03351231|76019440|FG000|COMPLETED|Combination Therapy Period|Completed = finished combination therapy|0||
59897275|NCT03351231|76019440|FG000|NOT COMPLETED|Combination Therapy Period||5||
59897276|NCT03351231|76019440|FG000|STARTED|Safety Follow-Up Period|Started = Initiated Safety Follow-up|3||
59897277|NCT03351231|76019440|FG000|COMPLETED|Safety Follow-Up Period|Completed = Finishing safety follow-up and continuing in study|0||
59897278|NCT03351231|76019440|FG000|NOT COMPLETED|Safety Follow-Up Period||3||
59897279|NCT03381339|76019446|FG000|STARTED|Overall Study||27||
59897280|NCT03381339|76019447|FG001|STARTED|Overall Study||28||
59897281|NCT03381339|76019446|FG000|COMPLETED|Overall Study||23|Subjects who completed all 12 weeks|
59897282|NCT03381339|76019447|FG001|COMPLETED|Overall Study||24|Subjects who completed all 12 weeks|
59897283|NCT03381339|76019446|FG000|NOT COMPLETED|Overall Study||4||
59897284|NCT03381339|76019447|FG001|NOT COMPLETED|Overall Study||4||
59897285|NCT03401229|76019455|FG000|STARTED|Overall Study||207||
59897286|NCT03401229|76019456|FG001|STARTED|Overall Study||203||
59897287|NCT03401229|76019455|FG000|COMPLETED|Overall Study||167||
59897288|NCT03401229|76019456|FG001|COMPLETED|Overall Study||166||
59897289|NCT03401229|76019455|FG000|NOT COMPLETED|Overall Study||40||
59897290|NCT03401229|76019456|FG001|NOT COMPLETED|Overall Study||37||
59897291|NCT03349515|76019464|FG000|STARTED|Overall Study||55||
59897292|NCT03349515|76019465|FG001|STARTED|Overall Study||51||
59897293|NCT03349515|76019464|FG000|COMPLETED|Overall Study||50||
59897294|NCT03349515|76019465|FG001|COMPLETED|Overall Study||50||
59897295|NCT03349515|76019464|FG000|NOT COMPLETED|Overall Study||5||
59897296|NCT03349515|76019465|FG001|NOT COMPLETED|Overall Study||1||
59897297|NCT03349437|76019471|FG000|STARTED|Screening||25||
59897298|NCT03349437|76019472|FG001|STARTED|Screening||0||
59897299|NCT03349437|76019473|FG002|STARTED|Screening||0||
59897300|NCT03349437|76019471|FG000|COMPLETED|Screening||20||
59897301|NCT03349437|76019472|FG001|COMPLETED|Screening||0||
59897302|NCT03349437|76019473|FG002|COMPLETED|Screening||0||
59897303|NCT03349437|76019471|FG000|NOT COMPLETED|Screening||5||
59897304|NCT03349437|76019472|FG001|NOT COMPLETED|Screening||0||
59897305|NCT03349437|76019473|FG002|NOT COMPLETED|Screening||0||
59897306|NCT03349437|76019471|FG000|STARTED|Intervention||0||
59897307|NCT03349437|76019472|FG001|STARTED|Intervention||10||
59897308|NCT03349437|76019473|FG002|STARTED|Intervention||10||
59897309|NCT03349437|76019471|FG000|COMPLETED|Intervention||0||
59897310|NCT03349437|76019472|FG001|COMPLETED|Intervention||10||
59897311|NCT03349437|76019473|FG002|COMPLETED|Intervention||10||
59897312|NCT03349437|76019471|FG000|NOT COMPLETED|Intervention||0||
59897313|NCT03349437|76019472|FG001|NOT COMPLETED|Intervention||0||
59897314|NCT03349437|76019473|FG002|NOT COMPLETED|Intervention||0||
59897315|NCT03380091|76019482|FG000|STARTED|Overall Study||3||
59897316|NCT03380091|76019483|FG001|STARTED|Overall Study||2||
59897317|NCT03380091|76019482|FG000|Began Arm Treatment|Overall Study|1 participant withdrew after completing baseline measures and another withdrew just after enrolling.|1||
59897318|NCT03380091|76019483|FG001|Began Arm Treatment|Overall Study|1 of the 2 participant assigned to Metformin withdrew from the study just after enrolling.|1||
59897319|NCT03380091|76019482|FG000|COMPLETED|Overall Study||1||
59897320|NCT03380091|76019483|FG001|COMPLETED|Overall Study||1||
59897321|NCT03380091|76019482|FG000|NOT COMPLETED|Overall Study||2||
59897322|NCT03380091|76019483|FG001|NOT COMPLETED|Overall Study||1||
59897323|NCT03379233|76019493|FG000|STARTED|Overall Study||1||
59897324|NCT03379233|76019494|FG001|STARTED|Overall Study||6||
59897325|NCT03379233|76019493|FG000|COMPLETED|Overall Study||0||
59897326|NCT03379233|76019494|FG001|COMPLETED|Overall Study||0||
59897327|NCT03379233|76019493|FG000|NOT COMPLETED|Overall Study||1||
59897328|NCT03379233|76019494|FG001|NOT COMPLETED|Overall Study||6||
59897329|NCT01377922|76019502|FG000|STARTED|Overall Study||22||
59897330|NCT01377922|76019503|FG001|STARTED|Overall Study||16||
59897331|NCT01377922|76019502|FG000|COMPLETED|Overall Study||21||
59897332|NCT01377922|76019503|FG001|COMPLETED|Overall Study||16||
59897333|NCT01377922|76019502|FG000|NOT COMPLETED|Overall Study||1||
59897334|NCT01377922|76019503|FG001|NOT COMPLETED|Overall Study||0||
59897335|NCT03372603|76019509|FG000|STARTED|Treatment Period 1 (Up to 7 Days)||9||
59897336|NCT03372603|76019510|FG001|STARTED|Treatment Period 1 (Up to 7 Days)||8||
59897337|NCT03372603|76019509|FG000|COMPLETED|Treatment Period 1 (Up to 7 Days)||9||
59897338|NCT03372603|76019510|FG001|COMPLETED|Treatment Period 1 (Up to 7 Days)||8||
59897339|NCT03372603|76019509|FG000|NOT COMPLETED|Treatment Period 1 (Up to 7 Days)||0||
59897340|NCT03372603|76019510|FG001|NOT COMPLETED|Treatment Period 1 (Up to 7 Days)||0||
59897341|NCT03372603|76019509|FG000|STARTED|Wash-out Period (14-21 Days)||9||
59897342|NCT03372603|76019510|FG001|STARTED|Wash-out Period (14-21 Days)||8||
59897343|NCT03372603|76019509|FG000|COMPLETED|Wash-out Period (14-21 Days)||8||
59897344|NCT03372603|76019510|FG001|COMPLETED|Wash-out Period (14-21 Days)||8||
59897345|NCT03372603|76019509|FG000|NOT COMPLETED|Wash-out Period (14-21 Days)||1||
59897346|NCT03372603|76019510|FG001|NOT COMPLETED|Wash-out Period (14-21 Days)||0||
59897347|NCT03372603|76019509|FG000|STARTED|Treatment Period 2 (Up to 7 Days)||8||
59897348|NCT03372603|76019510|FG001|STARTED|Treatment Period 2 (Up to 7 Days)||8||
59897349|NCT03372603|76019509|FG000|COMPLETED|Treatment Period 2 (Up to 7 Days)||7||
59897350|NCT03372603|76019510|FG001|COMPLETED|Treatment Period 2 (Up to 7 Days)||8||
59897351|NCT03372603|76019509|FG000|NOT COMPLETED|Treatment Period 2 (Up to 7 Days)||1||
59897352|NCT03372603|76019510|FG001|NOT COMPLETED|Treatment Period 2 (Up to 7 Days)||0||
59897353|NCT01377844|76019518|FG000|STARTED|Overall Study||145||
59897354|NCT01377844|76019519|FG001|STARTED|Overall Study||143||
59897355|NCT01377844|76019518|FG000|Safety Population|Overall Study||145|Two subjects did not meet the eligibility criteria and were not dosed. They were excluded from the safety population.|
59897356|NCT01377844|76019519|FG001|Safety Population|Overall Study||141|Two subjects did not meet the eligibility criteria and were not dosed. They were excluded from the safety population.|
59897357|NCT01377844|76019518|FG000|COMPLETED|Overall Study||109||
59897358|NCT01377844|76019519|FG001|COMPLETED|Overall Study||108||
59897359|NCT01377844|76019518|FG000|NOT COMPLETED|Overall Study||36||
59897360|NCT01377844|76019519|FG001|NOT COMPLETED|Overall Study||35||
59897361|NCT03372369|76019528|FG000|STARTED|Qualification Period||495||
59897362|NCT03372369|76019529|FG001|STARTED|Qualification Period||495||
59897363|NCT03372369|76019528|FG000|COMPLETED|Qualification Period||469||
59897364|NCT03372369|76019529|FG001|COMPLETED|Qualification Period||473||
59897365|NCT03372369|76019528|FG000|NOT COMPLETED|Qualification Period||26||
59897366|NCT03372369|76019529|FG001|NOT COMPLETED|Qualification Period||22||
59897367|NCT03372369|76019528|FG000|STARTED|Intervention and Follow-Up Period||469||
59897368|NCT03372369|76019529|FG001|STARTED|Intervention and Follow-Up Period||473||
59897369|NCT03372369|76019528|FG000|COMPLETED|Intervention and Follow-Up Period||466||
59897370|NCT03372369|76019529|FG001|COMPLETED|Intervention and Follow-Up Period||470||
59897371|NCT03372369|76019528|FG000|NOT COMPLETED|Intervention and Follow-Up Period||3||
59897372|NCT03372369|76019529|FG001|NOT COMPLETED|Intervention and Follow-Up Period||3||
59897373|NCT03371355|76019539|FG000|STARTED|Overall Study||27||
59897374|NCT03371355|76019540|FG001|STARTED|Overall Study||26||
59897375|NCT03371355|76019541|FG002|STARTED|Overall Study||26||
59897376|NCT03371355|76019542|FG003|STARTED|Overall Study||26||
59897377|NCT03371355|76019539|FG000|COMPLETED|Overall Study||26|Completed here refers to participants who completed study treatment.|
59897378|NCT03371355|76019540|FG001|COMPLETED|Overall Study||24|Completed here refers to participants who completed study treatment.|
59897379|NCT03371355|76019541|FG002|COMPLETED|Overall Study||22|Completed here refers to participants who completed study treatment.|
59897380|NCT03371355|76019542|FG003|COMPLETED|Overall Study||19|Completed here refers to participants who completed study treatment.|
59897381|NCT03371355|76019539|FG000|NOT COMPLETED|Overall Study||1||
59897382|NCT03371355|76019540|FG001|NOT COMPLETED|Overall Study||2||
59897383|NCT03371355|76019541|FG002|NOT COMPLETED|Overall Study||4||
59897384|NCT03371355|76019542|FG003|NOT COMPLETED|Overall Study||7||
59897385|NCT03370419|76019556|FG000|STARTED|Overall Study||40||
59897386|NCT03370419|76019556|FG000|COMPLETED|Overall Study||24||
59897387|NCT03370419|76019556|FG000|NOT COMPLETED|Overall Study||16||
59897388|NCT03373006|76019560|FG000|STARTED|Overall Study||20||
59897389|NCT03373006|76019560|FG000|COMPLETED|Overall Study||20||
59897390|NCT03373006|76019560|FG000|NOT COMPLETED|Overall Study||0||
59897391|NCT03369951|76019564|FG000|STARTED|Overall Study||58||
59897392|NCT03369951|76019564|FG000|Received Study Drug|Overall Study||57||
59897393|NCT03369951|76019564|FG000|COMPLETED|Overall Study||52||
59897394|NCT03369951|76019564|FG000|NOT COMPLETED|Overall Study||6||
59897395|NCT04040192|76019568|FG000|STARTED|Open Label Run-in Period (up to 8 Weeks)||497||
59897396|NCT04040192|76019569|FG001|STARTED|Open Label Run-in Period (up to 8 Weeks)||0||
59897397|NCT04040192|76019570|FG002|STARTED|Open Label Run-in Period (up to 8 Weeks)||0||
59897398|NCT04040192|76019568|FG000|COMPLETED|Open Label Run-in Period (up to 8 Weeks)|Participants were randomized to DB period.|270||
59897399|NCT04040192|76019569|FG001|COMPLETED|Open Label Run-in Period (up to 8 Weeks)||0||
59897400|NCT04040192|76019570|FG002|COMPLETED|Open Label Run-in Period (up to 8 Weeks)||0||
59897401|NCT04040192|76019568|FG000|NOT COMPLETED|Open Label Run-in Period (up to 8 Weeks)||227||
59897402|NCT04040192|76019569|FG001|NOT COMPLETED|Open Label Run-in Period (up to 8 Weeks)||0||
59897403|NCT04040192|76019570|FG002|NOT COMPLETED|Open Label Run-in Period (up to 8 Weeks)||0||
59951004|NCT04789382|76069925|FG002|STARTED|Washout (Day of & Day Prior to Visit 3)||9||
59897404|NCT04040192|76019568|FG000|STARTED|Double Blind Period (up to 52 Weeks)|In DB period, participants were randomized to receive Vehicle QD and Crisaborole 2% QD.|0||
59897405|NCT04040192|76019569|FG001|STARTED|Double Blind Period (up to 52 Weeks)|Crisaborole responders in OL period were randomized to Vehicle QD arm.|135||
59897406|NCT04040192|76019570|FG002|STARTED|Double Blind Period (up to 52 Weeks)|Crisaborole responders in OL period were randomized to Crisaborole 2% QD arm.|135||
59897407|NCT04040192|76019568|FG000|COMPLETED|Double Blind Period (up to 52 Weeks)||0||
59897408|NCT04040192|76019569|FG001|COMPLETED|Double Blind Period (up to 52 Weeks)||78||
59897409|NCT04040192|76019570|FG002|COMPLETED|Double Blind Period (up to 52 Weeks)||78||
59897410|NCT04040192|76019568|FG000|NOT COMPLETED|Double Blind Period (up to 52 Weeks)||0||
59897411|NCT04040192|76019569|FG001|NOT COMPLETED|Double Blind Period (up to 52 Weeks)||57||
59897412|NCT04040192|76019570|FG002|NOT COMPLETED|Double Blind Period (up to 52 Weeks)||57||
59897413|NCT03369249|76019585|FG000|STARTED|Overall Study||152||
59897414|NCT03369249|76019586|FG001|STARTED|Overall Study||155||
59897415|NCT03369249|76019585|FG000|COMPLETED|Overall Study||135||
59897416|NCT03369249|76019586|FG001|COMPLETED|Overall Study||139||
59897417|NCT03369249|76019585|FG000|NOT COMPLETED|Overall Study||17||
59897418|NCT03369249|76019586|FG001|NOT COMPLETED|Overall Study||16||
59897419|NCT03368859|76019594|FG000|STARTED|Overall Study||36||
59897420|NCT03368859|76019595|FG001|STARTED|Overall Study||34||
59897421|NCT03368859|76019594|FG000|COMPLETED|Overall Study||0||
59897422|NCT03368859|76019595|FG001|COMPLETED|Overall Study||0||
59897423|NCT03368859|76019594|FG000|NOT COMPLETED|Overall Study||36||
59897424|NCT03368859|76019595|FG001|NOT COMPLETED|Overall Study||34||
59897425|NCT04100590|76019601|FG000|STARTED|Overall Study||1||
59897426|NCT04100590|76019601|FG000|COMPLETED|Overall Study||1||
59897427|NCT04100590|76019601|FG000|NOT COMPLETED|Overall Study||0||
59897428|NCT03096314|76019609|FG000|STARTED|Screened Vitamin D Deficient||690||
59897429|NCT03096314|76019610|FG001|STARTED|Screened Vitamin D Deficient|2 randomized but not included in analysis; 1 treated but inadequate consent and 1 withdrew.|668||
59897430|NCT03096314|76019609|FG000|COMPLETED|Screened Vitamin D Deficient||681||
59897431|NCT03096314|76019610|FG001|COMPLETED|Screened Vitamin D Deficient||656||
59897432|NCT03096314|76019609|FG000|NOT COMPLETED|Screened Vitamin D Deficient||9||
59897433|NCT03096314|76019610|FG001|NOT COMPLETED|Screened Vitamin D Deficient||12||
59897434|NCT03096314|76019609|FG000|STARTED|Confirmed Vitamin D Deficient|Confirmed deficient (a prior primary analysis subgroup) is a subgroup of the screened deficient.|538||
59897435|NCT03096314|76019610|FG001|STARTED|Confirmed Vitamin D Deficient|Confirmed deficient (a prior primary analysis subgroup) is a subgroup of the screened deficient.|540||
59897436|NCT03096314|76019609|FG000|COMPLETED|Confirmed Vitamin D Deficient||531||
59897437|NCT03096314|76019610|FG001|COMPLETED|Confirmed Vitamin D Deficient||528||
59897438|NCT03096314|76019609|FG000|NOT COMPLETED|Confirmed Vitamin D Deficient||7||
59897439|NCT03096314|76019610|FG001|NOT COMPLETED|Confirmed Vitamin D Deficient||12||
59611309|NCT01806168|75722285|FG001|Received Allocated Intervention|Overall Study||9||
59897440|NCT03335163|76019616|FG000|STARTED|Overall Study||48||
59897441|NCT03335163|76019616|FG000|Completed Visit 2|Overall Study||32||
59897442|NCT03335163|76019616|FG000|Completed Visit 3|Overall Study||31||
59897443|NCT03335163|76019616|FG000|COMPLETED|Overall Study||27|Visit 4 completed|
59897444|NCT03335163|76019616|FG000|NOT COMPLETED|Overall Study||21||
59897445|NCT03711500|76019624|FG000|STARTED|Overall Study||12||
59897446|NCT03711500|76019625|FG001|STARTED|Overall Study||12||
59897447|NCT03711500|76019626|FG002|STARTED|Overall Study||12||
59897448|NCT03711500|76019627|FG003|STARTED|Overall Study||9||
59897449|NCT03711500|76019624|FG000|COMPLETED|Overall Study||12||
59897450|NCT03711500|76019625|FG001|COMPLETED|Overall Study|One subject completed 2 of three treatment sessions, with LOCF carried forward for analysis|11||
59897451|NCT03711500|76019626|FG002|COMPLETED|Overall Study||12||
59897452|NCT03711500|76019627|FG003|COMPLETED|Overall Study||9||
59897453|NCT03711500|76019624|FG000|NOT COMPLETED|Overall Study||0||
59897454|NCT03711500|76019625|FG001|NOT COMPLETED|Overall Study||1||
59897455|NCT03711500|76019626|FG002|NOT COMPLETED|Overall Study||0||
59897456|NCT03711500|76019627|FG003|NOT COMPLETED|Overall Study||0||
59897457|NCT03364335|76019642|FG000|STARTED|Overall Study||52||
59897458|NCT03364335|76019643|FG001|STARTED|Overall Study||51||
59897459|NCT03364335|76019644|FG002|STARTED|Overall Study||53||
59897460|NCT03364335|76019645|FG003|STARTED|Overall Study||50||
59897461|NCT03364335|76019646|FG004|STARTED|Overall Study||52||
59897462|NCT03364335|76019642|FG000|COMPLETED|Overall Study||42||
59897463|NCT03364335|76019643|FG001|COMPLETED|Overall Study||40||
59897464|NCT03364335|76019644|FG002|COMPLETED|Overall Study||42||
59897465|NCT03364335|76019645|FG003|COMPLETED|Overall Study||37||
59897466|NCT03364335|76019646|FG004|COMPLETED|Overall Study||41||
59897467|NCT03364335|76019642|FG000|NOT COMPLETED|Overall Study||10||
59897468|NCT03364335|76019643|FG001|NOT COMPLETED|Overall Study||11||
59897469|NCT03364335|76019644|FG002|NOT COMPLETED|Overall Study||11||
59897470|NCT03364335|76019645|FG003|NOT COMPLETED|Overall Study||13||
59897471|NCT03364335|76019646|FG004|NOT COMPLETED|Overall Study||11||
59897472|NCT03630770|76019660|FG000|STARTED|Overall Study||4||
59897473|NCT03630770|76019661|FG001|STARTED|Overall Study||8||
59897474|NCT03630770|76019660|FG000|COMPLETED|Overall Study||4||
59897475|NCT03630770|76019661|FG001|COMPLETED|Overall Study||8||
59897476|NCT03630770|76019660|FG000|NOT COMPLETED|Overall Study||0||
59897477|NCT03630770|76019661|FG001|NOT COMPLETED|Overall Study||0||
59897478|NCT03334695|76019669|FG000|STARTED|Overall Study||31||
59897479|NCT03334695|76019670|FG001|STARTED|Overall Study||32||
59897480|NCT03334695|76019669|FG000|COMPLETED|Overall Study||27||
59897481|NCT03334695|76019670|FG001|COMPLETED|Overall Study||26||
59897482|NCT03334695|76019669|FG000|NOT COMPLETED|Overall Study||4||
59897483|NCT03334695|76019670|FG001|NOT COMPLETED|Overall Study||6||
59897484|NCT03364023|76019678|FG000|STARTED|Overall Study||183||
59897485|NCT03364023|76019678|FG000|COMPLETED|Overall Study||166||
59897486|NCT03364023|76019678|FG000|NOT COMPLETED|Overall Study||17||
59897487|NCT01649947|76019684|FG000|STARTED|Overall Study||12||
59897488|NCT01649947|76019685|FG001|STARTED|Overall Study||20||
59897489|NCT01649947|76019684|FG000|COMPLETED|Overall Study||0||
59897490|NCT01649947|76019685|FG001|COMPLETED|Overall Study||2||
59505792|NCT00742469|75598671|FG001|NOT COMPLETED|Overall Study||35||
59505793|NCT00763243|75598677|FG000|STARTED|Waiting Period||9||
59505794|NCT00763243|75598677|FG000|COMPLETED|Waiting Period||9||
59505795|NCT00763243|75598677|FG000|NOT COMPLETED|Waiting Period||0||
59505796|NCT00763243|75598677|FG000|STARTED|Training Period||9||
59505797|NCT00763243|75598677|FG000|COMPLETED|Training Period||9||
59611310|NCT01806168|75722286|FG002|Received Allocated Intervention|Overall Study||9||
59611311|NCT01806168|75722284|FG000|COMPLETED|Overall Study||10||
59611312|NCT01806168|75722285|FG001|COMPLETED|Overall Study||9||
59611313|NCT01806168|75722286|FG002|COMPLETED|Overall Study||7||
59611314|NCT01806168|75722284|FG000|NOT COMPLETED|Overall Study||1||
59611315|NCT01806168|75722285|FG001|NOT COMPLETED|Overall Study||1||
59611316|NCT01806168|75722286|FG002|NOT COMPLETED|Overall Study||3||
59611317|NCT01804842|75722300|FG000|STARTED|Overall Study||9||
59897491|NCT01649947|76019684|FG000|NOT COMPLETED|Overall Study||12||
59611318|NCT01804842|75722301|FG001|STARTED|Overall Study||8||
59611319|NCT01804842|75722302|FG002|STARTED|Overall Study||9||
59611320|NCT01804842|75722300|FG000|Completed Treatment A|Overall Study||9||
59611321|NCT01804842|75722301|FG001|Completed Treatment A|Overall Study||6||
59611322|NCT01804842|75722302|FG002|Completed Treatment A|Overall Study||8||
59611323|NCT01804842|75722300|FG000|Completed Treatment B|Overall Study||8||
59611324|NCT01804842|75722301|FG001|Completed Treatment B|Overall Study||8||
59611325|NCT01804842|75722302|FG002|Completed Treatment B|Overall Study||8||
59897492|NCT01649947|76019685|FG001|NOT COMPLETED|Overall Study||18||
59897493|NCT03382574|76019692|FG000|STARTED|Overall Study||0||
59897494|NCT03382574|76019692|FG000|COMPLETED|Overall Study||0||
59897495|NCT03382574|76019692|FG000|NOT COMPLETED|Overall Study||0||
59897496|NCT03764813|76019702|FG000|STARTED|From Enrollment to the Age of 32 Weeks|Patients receiving no transfusions before the age of 32 weeks|14||127
59897497|NCT03764813|76019703|FG001|STARTED|From Enrollment to the Age of 32 Weeks|Patients receiving only cord-RBC transfusions before the age of 32 weeks|3||27
59897498|NCT03764813|76019704|FG002|STARTED|From Enrollment to the Age of 32 Weeks|Patients receiving only adult-RBC transfusions before the age of 32 weeks|4||38
59897499|NCT03764813|76019705|FG003|STARTED|From Enrollment to the Age of 32 Weeks|Patients receiving both adult-RBC and cord-RBCs before the age of 32 weeks|4||85
59897500|NCT03764813|76019702|FG000|COMPLETED|From Enrollment to the Age of 32 Weeks||14||127
59897501|NCT03764813|76019703|FG001|COMPLETED|From Enrollment to the Age of 32 Weeks||2||19
59897502|NCT03764813|76019704|FG002|COMPLETED|From Enrollment to the Age of 32 Weeks||3||33
59897503|NCT03764813|76019705|FG003|COMPLETED|From Enrollment to the Age of 32 Weeks||4||85
59897504|NCT03764813|76019702|FG000|NOT COMPLETED|From Enrollment to the Age of 32 Weeks||0||0
59897505|NCT03764813|76019703|FG001|NOT COMPLETED|From Enrollment to the Age of 32 Weeks||1||8
59897506|NCT03764813|76019704|FG002|NOT COMPLETED|From Enrollment to the Age of 32 Weeks||1||5
59897507|NCT03764813|76019705|FG003|NOT COMPLETED|From Enrollment to the Age of 32 Weeks||0||0
59897508|NCT03764813|76019702|FG000|STARTED|From Enrollment to the Last HbF Test|Patients receiving no transfusions before last HbF test (occurring at 36 weeks,discharge or death)|13||224
59505798|NCT00763243|75598677|FG000|NOT COMPLETED|Training Period||0||
59505799|NCT00763243|75598677|FG000|STARTED|1-Month Follow-Up Period||9||
59505800|NCT00763243|75598677|FG000|COMPLETED|1-Month Follow-Up Period||9||
59505801|NCT00763243|75598677|FG000|NOT COMPLETED|1-Month Follow-Up Period||0||
59611326|NCT01804842|75722300|FG000|Completed Treatment C|Overall Study||7||
59897509|NCT03764813|76019703|FG001|STARTED|From Enrollment to the Last HbF Test|Patients receiving only cord-RBCs before last HbF test (occurring at 36 wks,discharge or death)|3||46
59897510|NCT03764813|76019704|FG002|STARTED|From Enrollment to the Last HbF Test|Patients receiving only adult-RBC before last HbF test (occurring at 36 wks,discharge or death)|4||68
59897511|NCT03764813|76019705|FG003|STARTED|From Enrollment to the Last HbF Test|Patients receiving both cord and adult-RBCs before the last HbFtest(age of 36 wk,discharge or death)|5||140
59897512|NCT03764813|76019702|FG000|COMPLETED|From Enrollment to the Last HbF Test||13||224
59897513|NCT03764813|76019703|FG001|COMPLETED|From Enrollment to the Last HbF Test||3||46
59897514|NCT03764813|76019704|FG002|COMPLETED|From Enrollment to the Last HbF Test||4||68
59897515|NCT03764813|76019705|FG003|COMPLETED|From Enrollment to the Last HbF Test||5||140
59897516|NCT03764813|76019702|FG000|NOT COMPLETED|From Enrollment to the Last HbF Test||0||0
59897517|NCT03764813|76019703|FG001|NOT COMPLETED|From Enrollment to the Last HbF Test||0||0
59897518|NCT03764813|76019704|FG002|NOT COMPLETED|From Enrollment to the Last HbF Test||0||0
59897519|NCT03764813|76019705|FG003|NOT COMPLETED|From Enrollment to the Last HbF Test||0||0
59897520|NCT03363321|76019726|FG000|STARTED|Overall Study||5||
59897521|NCT03363321|76019727|FG001|STARTED|Overall Study||4||
59897522|NCT03363321|76019728|FG002|STARTED|Overall Study||4||
59897523|NCT03363321|76019729|FG003|STARTED|Overall Study||5||
59897524|NCT03363321|76019730|FG004|STARTED|Overall Study||2||
59897525|NCT03363321|76019726|FG000|COMPLETED|Overall Study||5||
59897526|NCT03363321|76019727|FG001|COMPLETED|Overall Study||3||
59897527|NCT03363321|76019728|FG002|COMPLETED|Overall Study||4||
59897528|NCT03363321|76019729|FG003|COMPLETED|Overall Study||4||
59897529|NCT03363321|76019730|FG004|COMPLETED|Overall Study||2||
59897530|NCT03363321|76019726|FG000|NOT COMPLETED|Overall Study||0||
59897531|NCT03363321|76019727|FG001|NOT COMPLETED|Overall Study||1||
59897532|NCT03363321|76019728|FG002|NOT COMPLETED|Overall Study||0||
59897533|NCT03363321|76019729|FG003|NOT COMPLETED|Overall Study||1||
59897534|NCT03363321|76019730|FG004|NOT COMPLETED|Overall Study||0||
59897535|NCT03361605|76019743|FG000|STARTED|Overall Study||29||
59897536|NCT03361605|76019743|FG000|COMPLETED|Overall Study||26||
59897537|NCT03361605|76019743|FG000|NOT COMPLETED|Overall Study||3||
59897538|NCT03829046|76019749|FG000|STARTED|Overall Study||20||
59897539|NCT03829046|76019750|FG001|STARTED|Overall Study||21||
59897540|NCT03829046|76019749|FG000|COMPLETED|Overall Study||19||
59897541|NCT03829046|76019750|FG001|COMPLETED|Overall Study||21||
59897542|NCT03829046|76019749|FG000|NOT COMPLETED|Overall Study||1||
59897543|NCT03829046|76019750|FG001|NOT COMPLETED|Overall Study||0||
59897544|NCT03361293|76019758|FG000|STARTED|Overall Study||20||
59897545|NCT03361293|76019759|FG001|STARTED|Overall Study||24||
59897546|NCT03361293|76019758|FG000|COMPLETED|Overall Study||19||
59897547|NCT03361293|76019759|FG001|COMPLETED|Overall Study||19||
59897548|NCT03361293|76019758|FG000|NOT COMPLETED|Overall Study||1||
59897549|NCT03361293|76019759|FG001|NOT COMPLETED|Overall Study||5||
59897550|NCT03361137|76019770|FG000|STARTED|Overall Study||1||
59897551|NCT03361137|76019771|FG001|STARTED|Overall Study||9||
59897552|NCT03361137|76019772|FG002|STARTED|Overall Study||1||
59897553|NCT03361137|76019773|FG003|STARTED|Overall Study||2||
59897554|NCT03361137|76019774|FG004|STARTED|Overall Study||1||
59897555|NCT03361137|76019770|FG000|COMPLETED|Overall Study||0||
59897556|NCT03361137|76019771|FG001|COMPLETED|Overall Study||9||
59897557|NCT03361137|76019772|FG002|COMPLETED|Overall Study||1||
59897558|NCT03361137|76019773|FG003|COMPLETED|Overall Study||2||
59897559|NCT03361137|76019774|FG004|COMPLETED|Overall Study||1||
59897560|NCT03361137|76019770|FG000|NOT COMPLETED|Overall Study||1||
59897561|NCT03361137|76019771|FG001|NOT COMPLETED|Overall Study||0||
59897562|NCT03361137|76019772|FG002|NOT COMPLETED|Overall Study||0||
59897563|NCT03361137|76019773|FG003|NOT COMPLETED|Overall Study||0||
59897564|NCT03361137|76019774|FG004|NOT COMPLETED|Overall Study||0||
59897565|NCT03360747|76019788|FG000|STARTED|Overall Study||3||
59897566|NCT03360747|76019788|FG000|COMPLETED|Overall Study||2||
59897567|NCT03360747|76019788|FG000|NOT COMPLETED|Overall Study||1||
59897568|NCT03359811|76019794|FG000|STARTED|Overall Study||35||
59897569|NCT03359811|76019795|FG001|STARTED|Overall Study||35||
59897570|NCT03359811|76019794|FG000|COMPLETED|Overall Study||33||
59897571|NCT03359811|76019795|FG001|COMPLETED|Overall Study||35||
59897572|NCT03359811|76019794|FG000|NOT COMPLETED|Overall Study||2||
59897573|NCT03359811|76019795|FG001|NOT COMPLETED|Overall Study||0||
59897574|NCT03728426|76019802|FG000|STARTED|Overall Study||10||
59897575|NCT03728426|76019802|FG000|COMPLETED|Overall Study||7||
59897576|NCT03728426|76019802|FG000|NOT COMPLETED|Overall Study||3||
59897577|NCT02095678|76019808|FG000|STARTED|Overall Study||34||
59897578|NCT02095678|76019809|FG001|STARTED|Overall Study||18||
59897579|NCT02095678|76019808|FG000|COMPLETED|Overall Study||17||
59897580|NCT02095678|76019809|FG001|COMPLETED|Overall Study||0||
59757339|NCT04496414|75876446|FG000|NOT COMPLETED|Overall Study||0||
59897581|NCT02095678|76019808|FG000|NOT COMPLETED|Overall Study||17||
59897582|NCT02095678|76019809|FG001|NOT COMPLETED|Overall Study||18||
59897583|NCT03763877|76019822|FG000|STARTED|Overall Study||31|Randomized|
59897584|NCT03763877|76019823|FG001|STARTED|Overall Study||30|Randomized|
59897585|NCT03763877|76019824|FG002|STARTED|Overall Study||31|Randomized|
59897586|NCT03763877|76019825|FG003|STARTED|Overall Study||29|Randomized|
59757340|NCT04292470|75876452|FG000|STARTED|Overall Study||2||
59757341|NCT04292470|75876453|FG001|STARTED|Overall Study||5||
59757342|NCT04292470|75876452|FG000|COMPLETED|Overall Study||2||
59757343|NCT04292470|75876453|FG001|COMPLETED|Overall Study||4||
59757344|NCT04292470|75876452|FG000|NOT COMPLETED|Overall Study||0||
59897587|NCT03763877|76019822|FG000|Received at Least 1 Dose of Double-blind Study Treatment|Overall Study||31||
59897588|NCT03763877|76019823|FG001|Received at Least 1 Dose of Double-blind Study Treatment|Overall Study||30||
59897589|NCT03763877|76019824|FG002|Received at Least 1 Dose of Double-blind Study Treatment|Overall Study||30||
59897590|NCT03763877|76019825|FG003|Received at Least 1 Dose of Double-blind Study Treatment|Overall Study||29||
59897591|NCT03763877|76019822|FG000|Completed the Double-blind Period|Overall Study||27||
59897592|NCT03763877|76019823|FG001|Completed the Double-blind Period|Overall Study||26||
59897593|NCT03763877|76019824|FG002|Completed the Double-blind Period|Overall Study||25||
59897594|NCT03763877|76019825|FG003|Completed the Double-blind Period|Overall Study||24||
59897595|NCT03763877|76019822|FG000|COMPLETED|Overall Study||26|Completed the follow-up period|
59897596|NCT03763877|76019823|FG001|COMPLETED|Overall Study||26|Completed the follow-up period|
59897597|NCT03763877|76019824|FG002|COMPLETED|Overall Study||24|Completed the follow-up period|
59897598|NCT03763877|76019825|FG003|COMPLETED|Overall Study||24|Completed the follow-up period|
59897599|NCT03763877|76019822|FG000|NOT COMPLETED|Overall Study||5||
59897600|NCT03763877|76019823|FG001|NOT COMPLETED|Overall Study||4||
59897601|NCT03763877|76019824|FG002|NOT COMPLETED|Overall Study||7||
59897602|NCT03763877|76019825|FG003|NOT COMPLETED|Overall Study||5||
59897603|NCT03578965|76019841|FG000|STARTED|Overall Study||24||
59897604|NCT03578965|76019842|FG001|STARTED|Overall Study||26||
59897605|NCT03578965|76019841|FG000|COMPLETED|Overall Study||24||
59897606|NCT03578965|76019842|FG001|COMPLETED|Overall Study||26||
59897607|NCT03578965|76019841|FG000|NOT COMPLETED|Overall Study||0||
59897608|NCT03578965|76019842|FG001|NOT COMPLETED|Overall Study||0||
59897609|NCT03358407|76019858|FG000|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||2|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59897610|NCT03358407|76019859|FG001|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||2|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59897611|NCT03358407|76019860|FG002|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||2|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59897612|NCT03358407|76019861|FG003|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||2|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59897613|NCT03358407|76019862|FG004|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||2|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59897614|NCT03358407|76019863|FG005|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||0|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59897615|NCT03358407|76019864|FG006|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||0|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59897616|NCT03358407|76019865|FG007|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||0|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59897617|NCT03358407|76019866|FG008|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||0|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59897618|NCT03358407|76019867|FG009|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||0|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59897619|NCT03358407|76019858|FG000|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||2||
59897620|NCT03358407|76019859|FG001|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||2||
59897621|NCT03358407|76019860|FG002|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||2||
59897622|NCT03358407|76019861|FG003|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||2||
59897623|NCT03358407|76019862|FG004|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||2||
59897624|NCT03358407|76019863|FG005|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0||
59897625|NCT03358407|76019864|FG006|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0||
59897626|NCT03358407|76019865|FG007|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0||
59897627|NCT03358407|76019866|FG008|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0||
59897628|NCT03358407|76019867|FG009|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0||
59897629|NCT03358407|76019858|FG000|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0||
59897630|NCT03358407|76019859|FG001|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0||
59897631|NCT03358407|76019860|FG002|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0||
59897632|NCT03358407|76019861|FG003|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0||
59897633|NCT03358407|76019862|FG004|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0||
60013873|NCT02504151|76129844|FG001|STARTED|First Intervention (4 Weeks)||10||
60013874|NCT02504151|76129843|FG000|COMPLETED|First Intervention (4 Weeks)||7||
60013875|NCT02504151|76129844|FG001|COMPLETED|First Intervention (4 Weeks)||9||
60013876|NCT02504151|76129843|FG000|NOT COMPLETED|First Intervention (4 Weeks)||1||
60013877|NCT02504151|76129844|FG001|NOT COMPLETED|First Intervention (4 Weeks)||1||
59505802|NCT00763243|75598677|FG000|STARTED|6-Month Follow-Up Period||9||
59757345|NCT04292470|75876453|FG001|NOT COMPLETED|Overall Study||1||
59757346|NCT04217590|75876461|FG000|STARTED|Overall Study||67||
59757347|NCT04217590|75876462|FG001|STARTED|Overall Study||67||
59757348|NCT04217590|75876461|FG000|COMPLETED|Overall Study||63||
59897634|NCT03358407|76019863|FG005|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0||
59897635|NCT03358407|76019864|FG006|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0||
59897636|NCT03358407|76019865|FG007|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0||
59897637|NCT03358407|76019866|FG008|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0||
59897638|NCT03358407|76019867|FG009|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0||
59897639|NCT03358407|76019858|FG000|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||2|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59897640|NCT03358407|76019859|FG001|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||2|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59897641|NCT03358407|76019860|FG002|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||2|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59897642|NCT03358407|76019861|FG003|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||2|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59897643|NCT03358407|76019862|FG004|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||2|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59897644|NCT03358407|76019863|FG005|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||0|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59897645|NCT03358407|76019864|FG006|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||0|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59897646|NCT03358407|76019865|FG007|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||0|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59897647|NCT03358407|76019866|FG008|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||0|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59897648|NCT03358407|76019867|FG009|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||0|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59897649|NCT03358407|76019858|FG000|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||2||
59897650|NCT03358407|76019859|FG001|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||2||
59897651|NCT03358407|76019860|FG002|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||1||
59897652|NCT03358407|76019861|FG003|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||2||
59897653|NCT03358407|76019862|FG004|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||2||
59897654|NCT03358407|76019863|FG005|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0||
59897655|NCT03358407|76019864|FG006|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0||
59897656|NCT03358407|76019865|FG007|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0||
59897657|NCT03358407|76019866|FG008|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0||
59897658|NCT03358407|76019867|FG009|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0||
59897659|NCT03358407|76019858|FG000|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0||
59897660|NCT03358407|76019859|FG001|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0||
59897661|NCT03358407|76019860|FG002|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||1||
59897662|NCT03358407|76019861|FG003|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0||
59897663|NCT03358407|76019862|FG004|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0||
59897664|NCT03358407|76019863|FG005|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0||
59897665|NCT03358407|76019864|FG006|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0||
59897666|NCT03358407|76019865|FG007|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0||
59897667|NCT03358407|76019866|FG008|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0||
59897668|NCT03358407|76019867|FG009|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0||
59897669|NCT03358407|76019858|FG000|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||2|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59897670|NCT03358407|76019859|FG001|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||2|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59897671|NCT03358407|76019860|FG002|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)|1 participant was added to Part A-Cohort 1: GSK 2mg/GSK 4mg/Placebo/GSK 30mg/GSK 100mg arm|2|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59897672|NCT03358407|76019861|FG003|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||2|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59897673|NCT03358407|76019862|FG004|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||2|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59897674|NCT03358407|76019863|FG005|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||0|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59897675|NCT03358407|76019864|FG006|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||0|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59897676|NCT03358407|76019865|FG007|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||0|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59897677|NCT03358407|76019866|FG008|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||0|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59951005|NCT04789382|76069926|FG003|STARTED|Washout (Day of & Day Prior to Visit 3)||9||
59897678|NCT03358407|76019867|FG009|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||0|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59897679|NCT03358407|76019858|FG000|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||2||
59897680|NCT03358407|76019859|FG001|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||2||
59897681|NCT03358407|76019860|FG002|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||2||
59897682|NCT03358407|76019861|FG003|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||2||
59897683|NCT03358407|76019862|FG004|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||2||
59897684|NCT03358407|76019863|FG005|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0||
59897685|NCT03358407|76019864|FG006|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0||
59897686|NCT03358407|76019865|FG007|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0||
59897687|NCT03358407|76019866|FG008|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0||
59897688|NCT03358407|76019867|FG009|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0||
59897689|NCT03358407|76019858|FG000|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0||
59897690|NCT03358407|76019859|FG001|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0||
59897691|NCT03358407|76019860|FG002|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0||
59897692|NCT03358407|76019861|FG003|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0||
59897693|NCT03358407|76019862|FG004|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0||
59897694|NCT03358407|76019863|FG005|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0||
59897695|NCT03358407|76019864|FG006|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0||
59897696|NCT03358407|76019865|FG007|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0||
59897697|NCT03358407|76019866|FG008|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0||
59897698|NCT03358407|76019867|FG009|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0||
59897699|NCT03358407|76019858|FG000|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||2|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59897700|NCT03358407|76019859|FG001|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||2|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59897701|NCT03358407|76019860|FG002|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||2|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59897702|NCT03358407|76019861|FG003|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||2|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59951006|NCT04789382|76069923|FG000|COMPLETED|Washout (Day of & Day Prior to Visit 3)||9||
59951007|NCT04789382|76069924|FG001|COMPLETED|Washout (Day of & Day Prior to Visit 3)||9||
59951008|NCT04789382|76069925|FG002|COMPLETED|Washout (Day of & Day Prior to Visit 3)||9||
59611327|NCT01804842|75722301|FG001|Completed Treatment C|Overall Study||7||
59951009|NCT04789382|76069926|FG003|COMPLETED|Washout (Day of & Day Prior to Visit 3)||9||
59951010|NCT04789382|76069923|FG000|NOT COMPLETED|Washout (Day of & Day Prior to Visit 3)||0||
59951011|NCT04789382|76069924|FG001|NOT COMPLETED|Washout (Day of & Day Prior to Visit 3)||0||
59951012|NCT04789382|76069925|FG002|NOT COMPLETED|Washout (Day of & Day Prior to Visit 3)||0||
59951013|NCT04789382|76069926|FG003|NOT COMPLETED|Washout (Day of & Day Prior to Visit 3)||0||
59951014|NCT04789382|76069923|FG000|STARTED|Second Wear Period (2 Hours)||9||
59951015|NCT04789382|76069924|FG001|STARTED|Second Wear Period (2 Hours)||9||
59951016|NCT04789382|76069925|FG002|STARTED|Second Wear Period (2 Hours)||9||
59951017|NCT04789382|76069926|FG003|STARTED|Second Wear Period (2 Hours)||9||
59951018|NCT04789382|76069923|FG000|COMPLETED|Second Wear Period (2 Hours)||9||
59951019|NCT04789382|76069924|FG001|COMPLETED|Second Wear Period (2 Hours)||9||
59951020|NCT04789382|76069925|FG002|COMPLETED|Second Wear Period (2 Hours)||9||
59951021|NCT04789382|76069926|FG003|COMPLETED|Second Wear Period (2 Hours)||9||
59951022|NCT04789382|76069923|FG000|NOT COMPLETED|Second Wear Period (2 Hours)||0||
59951023|NCT04789382|76069924|FG001|NOT COMPLETED|Second Wear Period (2 Hours)||0||
59951024|NCT04789382|76069925|FG002|NOT COMPLETED|Second Wear Period (2 Hours)||0||
59951025|NCT04789382|76069926|FG003|NOT COMPLETED|Second Wear Period (2 Hours)||0||
59951026|NCT05784103|76069938|FG000|STARTED|Overall Study||20||
59951027|NCT05784103|76069938|FG000|COMPLETED|Overall Study||20||
59951028|NCT05784103|76069938|FG000|NOT COMPLETED|Overall Study||0||
59951029|NCT05418777|76069956|FG000|STARTED|Overall Study||1||
59951030|NCT05418777|76069957|FG001|STARTED|Overall Study||0||
59951031|NCT05418777|76069956|FG000|COMPLETED|Overall Study||1||
59951032|NCT05418777|76069957|FG001|COMPLETED|Overall Study||0||
59951033|NCT05418777|76069956|FG000|NOT COMPLETED|Overall Study||0||
59951034|NCT05418777|76069957|FG001|NOT COMPLETED|Overall Study||0||
59951035|NCT05388617|76069965|FG000|STARTED|Overall Study||16||
59951036|NCT05388617|76069966|FG001|STARTED|Overall Study||0||
59951037|NCT05388617|76069965|FG000|COMPLETED|Overall Study||16||
59951038|NCT05388617|76069966|FG001|COMPLETED|Overall Study||0||
59951039|NCT05388617|76069965|FG000|NOT COMPLETED|Overall Study||0||
59951040|NCT05388617|76069966|FG001|NOT COMPLETED|Overall Study||0||
59951041|NCT05289869|76069974|FG000|STARTED|Overall Study||10||
59951042|NCT05289869|76069975|FG001|STARTED|Overall Study||10||
59951043|NCT05289869|76069974|FG000|COMPLETED|Overall Study||10||
59951044|NCT05289869|76069975|FG001|COMPLETED|Overall Study||10||
59951045|NCT05289869|76069974|FG000|NOT COMPLETED|Overall Study||0||
59951046|NCT05289869|76069975|FG001|NOT COMPLETED|Overall Study||0||
59897703|NCT03358407|76019862|FG004|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||2|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59897704|NCT03358407|76019863|FG005|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||0|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59897705|NCT03358407|76019864|FG006|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||0|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59897706|NCT03358407|76019865|FG007|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||0|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59897707|NCT03358407|76019866|FG008|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||0|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59897708|NCT03358407|76019867|FG009|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||0|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59897709|NCT03358407|76019858|FG000|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||2||
60013878|NCT02504151|76129843|FG000|STARTED|Washout (2 Weeks)||7||
60013879|NCT02504151|76129844|FG001|STARTED|Washout (2 Weeks)||9||
60013880|NCT02504151|76129843|FG000|COMPLETED|Washout (2 Weeks)||6||
60013881|NCT02504151|76129844|FG001|COMPLETED|Washout (2 Weeks)||9||
60013882|NCT02504151|76129843|FG000|NOT COMPLETED|Washout (2 Weeks)||1||
60013883|NCT02504151|76129844|FG001|NOT COMPLETED|Washout (2 Weeks)||0||
60013884|NCT02504151|76129843|FG000|STARTED|Second Intervention (4 Weeks)||6||
60013885|NCT02504151|76129844|FG001|STARTED|Second Intervention (4 Weeks)||9||
60013886|NCT02504151|76129843|FG000|COMPLETED|Second Intervention (4 Weeks)||4||
60013887|NCT02504151|76129844|FG001|COMPLETED|Second Intervention (4 Weeks)||7||
60013888|NCT02504151|76129843|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||2||
60013889|NCT02504151|76129844|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||2||
60013890|NCT02448381|76129852|FG000|STARTED|Overall Study||118||
60013891|NCT02448381|76129853|FG001|STARTED|Overall Study||51||
60013892|NCT02448381|76129852|FG000|Randomized, Not Treated|Overall Study||2||
60013893|NCT02448381|76129853|FG001|Randomized, Not Treated|Overall Study||1||
60013894|NCT02448381|76129852|FG000|Cycle 1|Overall Study||116||
60013895|NCT02448381|76129853|FG001|Cycle 1|Overall Study||50||
60013896|NCT02448381|76129852|FG000|Cycle 2|Overall Study||110||
60013897|NCT02448381|76129853|FG001|Cycle 2|Overall Study||45||
60013898|NCT02448381|76129852|FG000|Cycle 3|Overall Study||78||
60013899|NCT02448381|76129853|FG001|Cycle 3|Overall Study||32||
60013900|NCT02448381|76129852|FG000|Follow-up Period|Overall Study||98||
60013901|NCT02448381|76129853|FG001|Follow-up Period|Overall Study||39||
60013902|NCT02448381|76129852|FG000|COMPLETED|Overall Study||83||
60013903|NCT02448381|76129853|FG001|COMPLETED|Overall Study||32||
60013904|NCT02448381|76129852|FG000|NOT COMPLETED|Overall Study||35||
60013905|NCT02448381|76129853|FG001|NOT COMPLETED|Overall Study||19||
60013906|NCT02448225|76129865|FG000|STARTED|Overall Study||46||
60013907|NCT02448225|76129865|FG000|COMPLETED|Overall Study||26||
60013908|NCT02448225|76129865|FG000|NOT COMPLETED|Overall Study||20||
60013909|NCT02503215|76129872|FG000|STARTED|Overall Study||17||
60013910|NCT02503215|76129872|FG000|COMPLETED|Overall Study||14||
60013911|NCT02503215|76129872|FG000|NOT COMPLETED|Overall Study||3||
60013912|NCT02447991|76129878|FG000|STARTED|Overall Study||45||
60013913|NCT02447991|76129879|FG001|STARTED|Overall Study||89||
60013914|NCT02447991|76129878|FG000|COMPLETED|Overall Study||35||
60013915|NCT02447991|76129879|FG001|COMPLETED|Overall Study||59||
60013916|NCT02447991|76129878|FG000|NOT COMPLETED|Overall Study||10||
60013917|NCT02447991|76129879|FG001|NOT COMPLETED|Overall Study||30||
60013918|NCT02586155|76129891|FG000|STARTED|Overall Study||1215||
60013919|NCT02586155|76129892|FG001|STARTED|Overall Study||1210||
59897710|NCT03358407|76019859|FG001|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||2||
59897711|NCT03358407|76019860|FG002|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||2||
59897712|NCT03358407|76019861|FG003|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||2||
59897713|NCT03358407|76019862|FG004|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||1||
59897714|NCT03358407|76019863|FG005|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0||
59897715|NCT03358407|76019864|FG006|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0||
60013920|NCT02586155|76129891|FG000|Final Number Randomized|Overall Study||1212||
60013921|NCT02586155|76129892|FG001|Final Number Randomized|Overall Study||1206||
60013922|NCT02586155|76129891|FG000|COMPLETED|Overall Study||1088||
60013923|NCT02586155|76129892|FG001|COMPLETED|Overall Study||1083||
60013924|NCT02586155|76129891|FG000|NOT COMPLETED|Overall Study||127||
60013925|NCT02586155|76129892|FG001|NOT COMPLETED|Overall Study||127||
60013926|NCT02446743|76129900|FG000|STARTED|Overall Study||276||
60013927|NCT02446743|76129901|FG001|STARTED|Overall Study||255||
60013928|NCT02446743|76129900|FG000|COMPLETED|Overall Study||271||
60013929|NCT02446743|76129901|FG001|COMPLETED|Overall Study||250||
60013930|NCT02446743|76129900|FG000|NOT COMPLETED|Overall Study||5||
60013931|NCT02446743|76129901|FG001|NOT COMPLETED|Overall Study||5||
60013932|NCT02586077|76129916|FG000|STARTED|Overall Study||36||
60013933|NCT02586077|76129916|FG000|COMPLETED|Overall Study||28||
60013934|NCT02586077|76129916|FG000|NOT COMPLETED|Overall Study||8||
60013935|NCT02583425|76129921|FG000|STARTED|Screening||27||
60013936|NCT02583425|76129921|FG000|COMPLETED|Screening||15||
60013937|NCT02583425|76129921|FG000|NOT COMPLETED|Screening||12||
60013938|NCT02583425|76129921|FG000|STARTED|Baseline||15||
59897716|NCT03358407|76019865|FG007|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0||
59897717|NCT03358407|76019866|FG008|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0||
59897718|NCT03358407|76019867|FG009|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0||
59897719|NCT03358407|76019858|FG000|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0||
59897720|NCT03358407|76019859|FG001|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0||
59897721|NCT03358407|76019860|FG002|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0||
59897722|NCT03358407|76019861|FG003|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0||
59897723|NCT03358407|76019862|FG004|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||1||
59897724|NCT03358407|76019863|FG005|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0||
59897725|NCT03358407|76019864|FG006|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0||
59897726|NCT03358407|76019865|FG007|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0||
59897727|NCT03358407|76019866|FG008|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0||
59897728|NCT03358407|76019867|FG009|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0||
59897729|NCT03358407|76019858|FG000|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||2|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59897730|NCT03358407|76019859|FG001|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||2|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59897731|NCT03358407|76019860|FG002|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||2|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59897732|NCT03358407|76019861|FG003|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||2|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59897733|NCT03358407|76019862|FG004|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)|1 participant was added to Part A-Cohort 1: GSK 2mg/GSK 4mg/GSK 10mg/GSK 30mg/Placebo arm|2|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59897734|NCT03358407|76019863|FG005|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||0|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59897735|NCT03358407|76019864|FG006|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||0|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59897736|NCT03358407|76019865|FG007|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||0|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59897737|NCT03358407|76019866|FG008|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||0|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59897738|NCT03358407|76019867|FG009|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||0|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
60013939|NCT02583425|76129921|FG000|COMPLETED|Baseline||10||
60013940|NCT02583425|76129921|FG000|NOT COMPLETED|Baseline||5||
60013941|NCT02583425|76129921|FG000|STARTED|Treatment Period||10||
60013942|NCT02583425|76129921|FG000|COMPLETED|Treatment Period||9||
60013943|NCT02583425|76129921|FG000|NOT COMPLETED|Treatment Period||1||
60013944|NCT02581163|76129926|FG000|STARTED|Overall Study||311||
60013945|NCT02581163|76129926|FG000|COMPLETED|Overall Study||282||
60013946|NCT02581163|76129926|FG000|NOT COMPLETED|Overall Study||29||
60013947|NCT02627677|76129936|FG000|STARTED|Overall Study||11||
60013948|NCT02627677|76129937|FG001|STARTED|Overall Study||21||
60013949|NCT02627677|76129938|FG002|STARTED|Overall Study||12||
60013950|NCT02627677|76129936|FG000|COMPLETED|Overall Study||0||
60013951|NCT02627677|76129937|FG001|COMPLETED|Overall Study||0||
60013952|NCT02627677|76129938|FG002|COMPLETED|Overall Study||0||
60013953|NCT02627677|76129936|FG000|NOT COMPLETED|Overall Study||11||
60013954|NCT02627677|76129937|FG001|NOT COMPLETED|Overall Study||21||
60013955|NCT02627677|76129938|FG002|NOT COMPLETED|Overall Study||12||
60013956|NCT02501811|76129951|FG000|STARTED|Overall Study||33||
60013957|NCT02501811|76129952|FG001|STARTED|Overall Study||29||
60013958|NCT02501811|76129953|FG002|STARTED|Overall Study||31||
60013959|NCT02501811|76129954|FG003|STARTED|Overall Study||32||
60013960|NCT02501811|76129951|FG000|COMPLETED|Overall Study|includes 1 participant who completed final study visit but died within 30 days after final visit.|29||
59897739|NCT03358407|76019858|FG000|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||2||
59897740|NCT03358407|76019859|FG001|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||2||
59897741|NCT03358407|76019860|FG002|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||2||
59897742|NCT03358407|76019861|FG003|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||2||
60013961|NCT02501811|76129952|FG001|COMPLETED|Overall Study||23||
60013962|NCT02501811|76129953|FG002|COMPLETED|Overall Study||25||
60013963|NCT02501811|76129954|FG003|COMPLETED|Overall Study|includes 1 participant who completed final study visit but died within 30 days after final visit.|25||
60013964|NCT02501811|76129951|FG000|NOT COMPLETED|Overall Study||4||
60013965|NCT02501811|76129952|FG001|NOT COMPLETED|Overall Study||6||
60013966|NCT02501811|76129953|FG002|NOT COMPLETED|Overall Study||6||
60013967|NCT02501811|76129954|FG003|NOT COMPLETED|Overall Study||7||
59897743|NCT03358407|76019862|FG004|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||2||
59897744|NCT03358407|76019863|FG005|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0||
59897745|NCT03358407|76019864|FG006|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0||
59897746|NCT03358407|76019865|FG007|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0||
59897747|NCT03358407|76019866|FG008|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0||
59897748|NCT03358407|76019867|FG009|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0||
59897749|NCT03358407|76019858|FG000|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0||
59897750|NCT03358407|76019859|FG001|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0||
59897751|NCT03358407|76019860|FG002|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0||
59897752|NCT03358407|76019861|FG003|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0||
59897753|NCT03358407|76019862|FG004|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0||
59897754|NCT03358407|76019863|FG005|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0||
59897755|NCT03358407|76019864|FG006|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0||
59897756|NCT03358407|76019865|FG007|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0||
59897757|NCT03358407|76019866|FG008|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0||
59897758|NCT03358407|76019867|FG009|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0||
59897759|NCT03358407|76019858|FG000|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59897760|NCT03358407|76019859|FG001|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59897761|NCT03358407|76019860|FG002|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59897762|NCT03358407|76019861|FG003|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59897763|NCT03358407|76019862|FG004|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59897764|NCT03358407|76019863|FG005|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||3|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59897765|NCT03358407|76019864|FG006|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||3|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59897766|NCT03358407|76019865|FG007|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||6|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59897767|NCT03358407|76019866|FG008|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59897768|NCT03358407|76019867|FG009|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59897769|NCT03358407|76019858|FG000|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0||
59897770|NCT03358407|76019859|FG001|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0||
59897771|NCT03358407|76019860|FG002|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0||
59897772|NCT03358407|76019861|FG003|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0||
59897773|NCT03358407|76019862|FG004|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0||
59897774|NCT03358407|76019863|FG005|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0||
59897775|NCT03358407|76019864|FG006|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||2||
59897776|NCT03358407|76019865|FG007|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||3||
59897777|NCT03358407|76019866|FG008|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0||
59897778|NCT03358407|76019867|FG009|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0||
59897779|NCT03358407|76019858|FG000|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0||
59897780|NCT03358407|76019859|FG001|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0||
59897781|NCT03358407|76019860|FG002|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0||
59897782|NCT03358407|76019861|FG003|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0||
59897783|NCT03358407|76019862|FG004|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0||
59897784|NCT03358407|76019863|FG005|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||3||
59897785|NCT03358407|76019864|FG006|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||1||
59897786|NCT03358407|76019865|FG007|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||3||
59897787|NCT03358407|76019866|FG008|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0||
59897788|NCT03358407|76019867|FG009|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0||
59897789|NCT03358407|76019858|FG000|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59897790|NCT03358407|76019859|FG001|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59897791|NCT03358407|76019860|FG002|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59897792|NCT03358407|76019861|FG003|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
60013968|NCT02585999|76129964|FG000|STARTED|Overall Study||28||
60013969|NCT02585999|76129964|FG000|COMPLETED|Overall Study|28 participants enrolled; 2 withdrew prior to starting, leaving 26 to complete study activity.|26||
60013970|NCT02585999|76129964|FG000|NOT COMPLETED|Overall Study||2||
60013971|NCT02582255|76129971|FG000|STARTED|Overall Study||50||
60013972|NCT02582255|76129972|FG001|STARTED|Overall Study||50||
59897793|NCT03358407|76019862|FG004|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59897794|NCT03358407|76019863|FG005|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)|3 participants were added to Part A-Cohort 2: Placebo/GSK 400mg arm|3|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59897795|NCT03358407|76019864|FG006|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)|1 participant was added to Part A-Cohort 2: GSK 200mg/ Placebo arm|3|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59897796|NCT03358407|76019865|FG007|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)|3 participants were added to Part A-Cohort 2: GSK 200mg/GSK 400mg arm|6|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59897797|NCT03358407|76019866|FG008|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59897798|NCT03358407|76019867|FG009|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59897799|NCT03358407|76019858|FG000|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0||
59897800|NCT03358407|76019859|FG001|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0||
59897801|NCT03358407|76019860|FG002|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0||
59897802|NCT03358407|76019861|FG003|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0||
59897803|NCT03358407|76019862|FG004|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0||
60013973|NCT02582255|76129971|FG000|COMPLETED|Overall Study||50||
60013974|NCT02582255|76129972|FG001|COMPLETED|Overall Study||47||
60013975|NCT02582255|76129971|FG000|NOT COMPLETED|Overall Study||0||
60013976|NCT02582255|76129972|FG001|NOT COMPLETED|Overall Study||3||
60013977|NCT02500719|76129981|FG000|STARTED|Overall Study||14||
60013978|NCT02500719|76129982|FG001|STARTED|Overall Study||16||
60013979|NCT02500719|76129981|FG000|COMPLETED|Overall Study||11||
60013980|NCT02500719|76129982|FG001|COMPLETED|Overall Study||9||
60013981|NCT02500719|76129981|FG000|NOT COMPLETED|Overall Study||3||
60013982|NCT02500719|76129982|FG001|NOT COMPLETED|Overall Study||7||
60013983|NCT02500641|76129990|FG000|STARTED|Overall Study||98||
59897804|NCT03358407|76019863|FG005|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0||
59897805|NCT03358407|76019864|FG006|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0||
60013984|NCT02500641|76129991|FG001|STARTED|Overall Study||98||
60013985|NCT02500641|76129990|FG000|COMPLETED|Overall Study||88||
60013986|NCT02500641|76129991|FG001|COMPLETED|Overall Study||86||
60013987|NCT02500641|76129990|FG000|NOT COMPLETED|Overall Study||10||
60013988|NCT02500641|76129991|FG001|NOT COMPLETED|Overall Study||12||
60013989|NCT02499783|76129999|FG000|STARTED|DB Period/Placebo-Controlled: Weeks 0-4||102||
60013990|NCT02499783|76130000|FG001|STARTED|DB Period/Placebo-Controlled: Weeks 0-4||103||
60013991|NCT02499783|76130001|FG002|STARTED|DB Period/Placebo-Controlled: Weeks 0-4||0||
60013992|NCT02499783|76129999|FG000|COMPLETED|DB Period/Placebo-Controlled: Weeks 0-4||98||
60013993|NCT02499783|76130000|FG001|COMPLETED|DB Period/Placebo-Controlled: Weeks 0-4||98||
60013994|NCT02499783|76130001|FG002|COMPLETED|DB Period/Placebo-Controlled: Weeks 0-4||0||
60013995|NCT02499783|76129999|FG000|NOT COMPLETED|DB Period/Placebo-Controlled: Weeks 0-4||4||
60013996|NCT02499783|76130000|FG001|NOT COMPLETED|DB Period/Placebo-Controlled: Weeks 0-4||5||
60013997|NCT02499783|76130001|FG002|NOT COMPLETED|DB Period/Placebo-Controlled: Weeks 0-4||0||
60013998|NCT02499783|76129999|FG000|STARTED|DB Period: Weeks 0-8||102||
60013999|NCT02499783|76130000|FG001|STARTED|DB Period: Weeks 0-8||103||
60014000|NCT02499783|76130001|FG002|STARTED|DB Period: Weeks 0-8||0||
60014001|NCT02499783|76129999|FG000|COMPLETED|DB Period: Weeks 0-8||92||
60014002|NCT02499783|76130000|FG001|COMPLETED|DB Period: Weeks 0-8||96||
60014003|NCT02499783|76130001|FG002|COMPLETED|DB Period: Weeks 0-8||0||
60014004|NCT02499783|76129999|FG000|NOT COMPLETED|DB Period: Weeks 0-8||10||
60014005|NCT02499783|76130000|FG001|NOT COMPLETED|DB Period: Weeks 0-8||7||
60014006|NCT02499783|76130001|FG002|NOT COMPLETED|DB Period: Weeks 0-8||0||
60014007|NCT02499783|76129999|FG000|STARTED|Open Label Period: Weeks 8 to 26||0||
60014008|NCT02499783|76130000|FG001|STARTED|Open Label Period: Weeks 8 to 26||0||
60014009|NCT02499783|76130001|FG002|STARTED|Open Label Period: Weeks 8 to 26||188||
60014010|NCT02499783|76129999|FG000|COMPLETED|Open Label Period: Weeks 8 to 26||0||
60014011|NCT02499783|76130000|FG001|COMPLETED|Open Label Period: Weeks 8 to 26||0||
60014012|NCT02499783|76130001|FG002|COMPLETED|Open Label Period: Weeks 8 to 26||159||
60014013|NCT02499783|76129999|FG000|NOT COMPLETED|Open Label Period: Weeks 8 to 26||0||
60014014|NCT02499783|76130000|FG001|NOT COMPLETED|Open Label Period: Weeks 8 to 26||0||
60014015|NCT02499783|76130001|FG002|NOT COMPLETED|Open Label Period: Weeks 8 to 26||29||
60014016|NCT02468193|76130011|FG000|STARTED|Overall Study||9||
60014017|NCT02468193|76130011|FG000|Completed Week-12 (Study Period I)|Overall Study||7||
60014018|NCT02468193|76130011|FG000|Discontinued at or Prior to Week-12|Overall Study||2||
60014019|NCT02468193|76130011|FG000|Completed Week-12, Did Not Enter Per. II|Overall Study||3||
60014020|NCT02468193|76130011|FG000|Completed Week-12, Entered Study Per. II|Overall Study||4||
60014021|NCT02468193|76130011|FG000|Completed Week-48 (Study Period II)|Overall Study||2||
60014022|NCT02468193|76130011|FG000|Discontinued at or Prior to Week48|Overall Study||2||
60014023|NCT02468193|76130011|FG000|Compl. Wk-48, Didn't Enter Opt. Ext. Per|Overall Study||0||
60014024|NCT02468193|76130011|FG000|Compl. Wk-48, Entered Opt. Ext. Period|Overall Study||2||
60014025|NCT02468193|76130011|FG000|Completed Optional Extension Period|Overall Study||0||
59897806|NCT03358407|76019865|FG007|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0||
59897807|NCT03358407|76019866|FG008|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0||
59897808|NCT03358407|76019867|FG009|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0||
59897809|NCT03358407|76019858|FG000|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0||
59897810|NCT03358407|76019859|FG001|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0||
59897811|NCT03358407|76019860|FG002|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0||
59897812|NCT03358407|76019861|FG003|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0||
59897813|NCT03358407|76019862|FG004|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0||
59897814|NCT03358407|76019863|FG005|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||3||
59897815|NCT03358407|76019864|FG006|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||3||
59897816|NCT03358407|76019865|FG007|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||6||
59897817|NCT03358407|76019866|FG008|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0||
59897818|NCT03358407|76019867|FG009|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0||
59897819|NCT03358407|76019858|FG000|STARTED|Part B: Overall Period (11 Weeks)||0|No participants were enrolled in Part B as the study was terminated during Part A.|
59897820|NCT03358407|76019859|FG001|STARTED|Part B: Overall Period (11 Weeks)||0|No participants were enrolled in Part B as the study was terminated during Part A.|
59897821|NCT03358407|76019860|FG002|STARTED|Part B: Overall Period (11 Weeks)||0|No participants were enrolled in Part B as the study was terminated during Part A.|
59897822|NCT03358407|76019861|FG003|STARTED|Part B: Overall Period (11 Weeks)||0|No participants were enrolled in Part B as the study was terminated during Part A.|
59897823|NCT03358407|76019862|FG004|STARTED|Part B: Overall Period (11 Weeks)||0|No participants were enrolled in Part B as the study was terminated during Part A.|
59897824|NCT03358407|76019863|FG005|STARTED|Part B: Overall Period (11 Weeks)||0|No participants were enrolled in Part B as the study was terminated during Part A.|
59897825|NCT03358407|76019864|FG006|STARTED|Part B: Overall Period (11 Weeks)||0|No participants were enrolled in Part B as the study was terminated during Part A.|
59897826|NCT03358407|76019865|FG007|STARTED|Part B: Overall Period (11 Weeks)||0|No participants were enrolled in Part B as the study was terminated during Part A.|
59897827|NCT03358407|76019866|FG008|STARTED|Part B: Overall Period (11 Weeks)||0|No participants were enrolled in Part B as the study was terminated during Part A.|
59897828|NCT03358407|76019867|FG009|STARTED|Part B: Overall Period (11 Weeks)||0|No participants were enrolled in Part B as the study was terminated during Part A.|
59897829|NCT03358407|76019858|FG000|COMPLETED|Part B: Overall Period (11 Weeks)||0||
59897830|NCT03358407|76019859|FG001|COMPLETED|Part B: Overall Period (11 Weeks)||0||
59897831|NCT03358407|76019860|FG002|COMPLETED|Part B: Overall Period (11 Weeks)||0||
59897832|NCT03358407|76019861|FG003|COMPLETED|Part B: Overall Period (11 Weeks)||0||
59897833|NCT03358407|76019862|FG004|COMPLETED|Part B: Overall Period (11 Weeks)||0||
59897834|NCT03358407|76019863|FG005|COMPLETED|Part B: Overall Period (11 Weeks)||0||
59897835|NCT03358407|76019864|FG006|COMPLETED|Part B: Overall Period (11 Weeks)||0||
59897836|NCT03358407|76019865|FG007|COMPLETED|Part B: Overall Period (11 Weeks)||0||
59897837|NCT03358407|76019866|FG008|COMPLETED|Part B: Overall Period (11 Weeks)||0||
59897838|NCT03358407|76019867|FG009|COMPLETED|Part B: Overall Period (11 Weeks)||0||
59897839|NCT03358407|76019858|FG000|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0||
59897840|NCT03358407|76019859|FG001|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0||
59897841|NCT03358407|76019860|FG002|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0||
59897842|NCT03358407|76019861|FG003|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0||
59897843|NCT03358407|76019862|FG004|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0||
59897844|NCT03358407|76019863|FG005|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0||
59897845|NCT03358407|76019864|FG006|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0||
59897846|NCT03358407|76019865|FG007|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0||
59897847|NCT03358407|76019866|FG008|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0||
59897848|NCT03358407|76019867|FG009|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0||
59897849|NCT02014051|76019895|FG000|STARTED|Overall Study||3||
59897850|NCT02014051|76019896|FG001|STARTED|Overall Study||6||
59897851|NCT02014051|76019895|FG000|COMPLETED|Overall Study||2||
59897852|NCT02014051|76019896|FG001|COMPLETED|Overall Study||5||
59897853|NCT02014051|76019895|FG000|NOT COMPLETED|Overall Study||1||
59897854|NCT02014051|76019896|FG001|NOT COMPLETED|Overall Study||1||
59897855|NCT02950545|76019909|FG000|STARTED|Session 1 (70 Minutes)||9||
59897856|NCT02950545|76019910|FG001|STARTED|Session 1 (70 Minutes)||9||
59897857|NCT02950545|76019911|FG002|STARTED|Session 1 (70 Minutes)||7||
59897858|NCT02950545|76019912|FG003|STARTED|Session 1 (70 Minutes)||8||
59897859|NCT02950545|76019913|FG004|STARTED|Session 1 (70 Minutes)||8||
59897860|NCT02950545|76019914|FG005|STARTED|Session 1 (70 Minutes)||10||
59897861|NCT02950545|76019909|FG000|COMPLETED|Session 1 (70 Minutes)||9||
59897862|NCT02950545|76019910|FG001|COMPLETED|Session 1 (70 Minutes)||9||
59897863|NCT02950545|76019911|FG002|COMPLETED|Session 1 (70 Minutes)||7||
59897864|NCT02950545|76019912|FG003|COMPLETED|Session 1 (70 Minutes)||8||
59897865|NCT02950545|76019913|FG004|COMPLETED|Session 1 (70 Minutes)||8||
59897866|NCT02950545|76019914|FG005|COMPLETED|Session 1 (70 Minutes)||9||
59897867|NCT02950545|76019909|FG000|NOT COMPLETED|Session 1 (70 Minutes)||0||
59897868|NCT02950545|76019910|FG001|NOT COMPLETED|Session 1 (70 Minutes)||0||
59897869|NCT02950545|76019911|FG002|NOT COMPLETED|Session 1 (70 Minutes)||0||
59897870|NCT02950545|76019912|FG003|NOT COMPLETED|Session 1 (70 Minutes)||0||
59897871|NCT02950545|76019913|FG004|NOT COMPLETED|Session 1 (70 Minutes)||0||
59897872|NCT02950545|76019914|FG005|NOT COMPLETED|Session 1 (70 Minutes)||1||
59897873|NCT02950545|76019909|FG000|STARTED|Washout 1 (5 Minutes)||9||
59897874|NCT02950545|76019910|FG001|STARTED|Washout 1 (5 Minutes)||9||
59897875|NCT02950545|76019911|FG002|STARTED|Washout 1 (5 Minutes)||7||
59897876|NCT02950545|76019912|FG003|STARTED|Washout 1 (5 Minutes)||8||
59897877|NCT02950545|76019913|FG004|STARTED|Washout 1 (5 Minutes)||8||
59897878|NCT02950545|76019914|FG005|STARTED|Washout 1 (5 Minutes)||9||
59897879|NCT02950545|76019909|FG000|COMPLETED|Washout 1 (5 Minutes)||8||
59897880|NCT02950545|76019910|FG001|COMPLETED|Washout 1 (5 Minutes)||9||
59897881|NCT02950545|76019911|FG002|COMPLETED|Washout 1 (5 Minutes)||7||
59897882|NCT02950545|76019912|FG003|COMPLETED|Washout 1 (5 Minutes)||7||
59897883|NCT02950545|76019913|FG004|COMPLETED|Washout 1 (5 Minutes)||8||
59897884|NCT02950545|76019914|FG005|COMPLETED|Washout 1 (5 Minutes)||8||
59897885|NCT02950545|76019909|FG000|NOT COMPLETED|Washout 1 (5 Minutes)||1||
59897886|NCT02950545|76019910|FG001|NOT COMPLETED|Washout 1 (5 Minutes)||0||
59897887|NCT02950545|76019911|FG002|NOT COMPLETED|Washout 1 (5 Minutes)||0||
59897888|NCT02950545|76019912|FG003|NOT COMPLETED|Washout 1 (5 Minutes)||1||
59611328|NCT01804842|75722302|FG002|Completed Treatment C|Overall Study||9||
59611329|NCT01804842|75722300|FG000|COMPLETED|Overall Study||6||
59611330|NCT01804842|75722301|FG001|COMPLETED|Overall Study||6||
59611331|NCT01804842|75722302|FG002|COMPLETED|Overall Study||8||
59897889|NCT02950545|76019913|FG004|NOT COMPLETED|Washout 1 (5 Minutes)||0||
59897890|NCT02950545|76019914|FG005|NOT COMPLETED|Washout 1 (5 Minutes)||1||
59897891|NCT02950545|76019909|FG000|STARTED|Session 2 (70 Minutes)||8||
59897892|NCT02950545|76019910|FG001|STARTED|Session 2 (70 Minutes)||9||
59897893|NCT02950545|76019911|FG002|STARTED|Session 2 (70 Minutes)||7||
59897894|NCT02950545|76019912|FG003|STARTED|Session 2 (70 Minutes)||7||
59897895|NCT02950545|76019913|FG004|STARTED|Session 2 (70 Minutes)||8||
59897896|NCT02950545|76019914|FG005|STARTED|Session 2 (70 Minutes)||8||
59897897|NCT02950545|76019909|FG000|COMPLETED|Session 2 (70 Minutes)||8||
59897898|NCT02950545|76019910|FG001|COMPLETED|Session 2 (70 Minutes)||9||
59897899|NCT02950545|76019911|FG002|COMPLETED|Session 2 (70 Minutes)||7||
59897900|NCT02950545|76019912|FG003|COMPLETED|Session 2 (70 Minutes)||7||
59897901|NCT02950545|76019913|FG004|COMPLETED|Session 2 (70 Minutes)||7||
59897902|NCT02950545|76019914|FG005|COMPLETED|Session 2 (70 Minutes)||8||
59897903|NCT02950545|76019909|FG000|NOT COMPLETED|Session 2 (70 Minutes)||0||
59897904|NCT02950545|76019910|FG001|NOT COMPLETED|Session 2 (70 Minutes)||0||
59897905|NCT02950545|76019911|FG002|NOT COMPLETED|Session 2 (70 Minutes)||0||
59897906|NCT02950545|76019912|FG003|NOT COMPLETED|Session 2 (70 Minutes)||0||
59897907|NCT02950545|76019913|FG004|NOT COMPLETED|Session 2 (70 Minutes)||1||
59897908|NCT02950545|76019914|FG005|NOT COMPLETED|Session 2 (70 Minutes)||0||
59897909|NCT02950545|76019909|FG000|STARTED|Washout 2 (5 Minutes)||8||
59897910|NCT02950545|76019910|FG001|STARTED|Washout 2 (5 Minutes)||9||
59897911|NCT02950545|76019911|FG002|STARTED|Washout 2 (5 Minutes)||7||
59897912|NCT02950545|76019912|FG003|STARTED|Washout 2 (5 Minutes)||7||
59897913|NCT02950545|76019913|FG004|STARTED|Washout 2 (5 Minutes)||7||
59897914|NCT02950545|76019914|FG005|STARTED|Washout 2 (5 Minutes)||8||
59897915|NCT02950545|76019909|FG000|COMPLETED|Washout 2 (5 Minutes)||7||
59897916|NCT02950545|76019910|FG001|COMPLETED|Washout 2 (5 Minutes)||9||
59897917|NCT02950545|76019911|FG002|COMPLETED|Washout 2 (5 Minutes)||7||
59897918|NCT02950545|76019912|FG003|COMPLETED|Washout 2 (5 Minutes)||7||
59897919|NCT02950545|76019913|FG004|COMPLETED|Washout 2 (5 Minutes)||7||
59897920|NCT02950545|76019914|FG005|COMPLETED|Washout 2 (5 Minutes)||8||
59897921|NCT02950545|76019909|FG000|NOT COMPLETED|Washout 2 (5 Minutes)||1||
59897922|NCT02950545|76019910|FG001|NOT COMPLETED|Washout 2 (5 Minutes)||0||
59897923|NCT02950545|76019911|FG002|NOT COMPLETED|Washout 2 (5 Minutes)||0||
59611332|NCT01804842|75722300|FG000|NOT COMPLETED|Overall Study||3||
59611333|NCT01804842|75722301|FG001|NOT COMPLETED|Overall Study||2||
59611334|NCT01804842|75722302|FG002|NOT COMPLETED|Overall Study||1||
59897924|NCT02950545|76019912|FG003|NOT COMPLETED|Washout 2 (5 Minutes)||0||
59897925|NCT02950545|76019913|FG004|NOT COMPLETED|Washout 2 (5 Minutes)||0||
59897926|NCT02950545|76019914|FG005|NOT COMPLETED|Washout 2 (5 Minutes)||0||
59897927|NCT02950545|76019909|FG000|STARTED|Session 3 (70 Minutes)||7||
59897928|NCT02950545|76019910|FG001|STARTED|Session 3 (70 Minutes)||9||
59897929|NCT02950545|76019911|FG002|STARTED|Session 3 (70 Minutes)||7||
59897930|NCT02950545|76019912|FG003|STARTED|Session 3 (70 Minutes)||7||
59897931|NCT02950545|76019913|FG004|STARTED|Session 3 (70 Minutes)||7||
59897932|NCT02950545|76019914|FG005|STARTED|Session 3 (70 Minutes)||8||
59897933|NCT02950545|76019909|FG000|COMPLETED|Session 3 (70 Minutes)||7||
59897934|NCT02950545|76019910|FG001|COMPLETED|Session 3 (70 Minutes)||9||
59897935|NCT02950545|76019911|FG002|COMPLETED|Session 3 (70 Minutes)||7||
59611335|NCT01781286|75722310|FG000|STARTED|Overall Study||7||
59611336|NCT01781286|75722311|FG001|STARTED|Overall Study||4||
59897936|NCT02950545|76019912|FG003|COMPLETED|Session 3 (70 Minutes)||7||
59897937|NCT02950545|76019913|FG004|COMPLETED|Session 3 (70 Minutes)||7||
59897938|NCT02950545|76019914|FG005|COMPLETED|Session 3 (70 Minutes)||7||
59897939|NCT02950545|76019909|FG000|NOT COMPLETED|Session 3 (70 Minutes)||0||
59897940|NCT02950545|76019910|FG001|NOT COMPLETED|Session 3 (70 Minutes)||0||
59897941|NCT02950545|76019911|FG002|NOT COMPLETED|Session 3 (70 Minutes)||0||
59897942|NCT02950545|76019912|FG003|NOT COMPLETED|Session 3 (70 Minutes)||0||
59897943|NCT02950545|76019913|FG004|NOT COMPLETED|Session 3 (70 Minutes)||0||
59897944|NCT02950545|76019914|FG005|NOT COMPLETED|Session 3 (70 Minutes)||1||
59897945|NCT03358329|76019920|FG000|STARTED|Overall Study||50||
59897946|NCT03358329|76019920|FG000|COMPLETED|Overall Study||46||
59897947|NCT03358329|76019920|FG000|NOT COMPLETED|Overall Study||4||
59897948|NCT01700335|76019926|FG000|STARTED|Overall Study||3||
59897949|NCT01700335|76019927|FG001|STARTED|Overall Study||6||
59897950|NCT01700335|76019926|FG000|COMPLETED|Overall Study||2||
59897951|NCT01700335|76019927|FG001|COMPLETED|Overall Study||2||
59897952|NCT01700335|76019926|FG000|NOT COMPLETED|Overall Study||1||
59897953|NCT01700335|76019927|FG001|NOT COMPLETED|Overall Study||4||
59897954|NCT03357471|76019936|FG000|STARTED|Overall Study||35||
59897955|NCT03357471|76019937|FG001|STARTED|Overall Study||32||
59897956|NCT03357471|76019936|FG000|COMPLETED|Overall Study||33||
59897957|NCT03357471|76019937|FG001|COMPLETED|Overall Study||32||
59897958|NCT03357471|76019936|FG000|NOT COMPLETED|Overall Study||2||
59897959|NCT03357471|76019937|FG001|NOT COMPLETED|Overall Study||0||
59897960|NCT03342963|76019947|FG000|STARTED|Overall Study||27||
59897961|NCT03342963|76019948|FG001|STARTED|Overall Study||27||
59897962|NCT03342963|76019949|FG002|STARTED|Overall Study||10||
59897963|NCT03342963|76019950|FG003|STARTED|Overall Study||10||
59897964|NCT03342963|76019947|FG000|COMPLETED|Overall Study||25||
59897965|NCT03342963|76019948|FG001|COMPLETED|Overall Study||25||
59897966|NCT03342963|76019949|FG002|COMPLETED|Overall Study||10||
59897967|NCT03342963|76019950|FG003|COMPLETED|Overall Study||10||
59897968|NCT03342963|76019947|FG000|NOT COMPLETED|Overall Study||2||
59897969|NCT03342963|76019948|FG001|NOT COMPLETED|Overall Study||2||
59897970|NCT03342963|76019949|FG002|NOT COMPLETED|Overall Study||0||
59897971|NCT03342963|76019950|FG003|NOT COMPLETED|Overall Study||0||
59897972|NCT03361956|76019965|FG000|STARTED|Overall Study||43||
59897973|NCT03361956|76019966|FG001|STARTED|Overall Study||28||
59897974|NCT03361956|76019967|FG002|STARTED|Overall Study||66||
59897975|NCT03361956|76019968|FG003|STARTED|Overall Study||32||
59897976|NCT03361956|76019969|FG004|STARTED|Overall Study||63||
59897977|NCT03361956|76019965|FG000|Currently Not Treated|Overall Study||22||
59897978|NCT03361956|76019966|FG001|Currently Not Treated|Overall Study||28||
59897979|NCT03361956|76019967|FG002|Currently Not Treated|Overall Study||33||
59897980|NCT03361956|76019968|FG003|Currently Not Treated|Overall Study||32||
59897981|NCT03361956|76019969|FG004|Currently Not Treated|Overall Study||33||
59897982|NCT03361956|76019965|FG000|Virologically Suppressed|Overall Study||21||
59897983|NCT03361956|76019966|FG001|Virologically Suppressed|Overall Study||0||
59897984|NCT03361956|76019967|FG002|Virologically Suppressed|Overall Study||33||
59897985|NCT03361956|76019968|FG003|Virologically Suppressed|Overall Study||0||
59897986|NCT03361956|76019969|FG004|Virologically Suppressed|Overall Study||30||
59897987|NCT03361956|76019965|FG000|COMPLETED|Overall Study||40||
59897988|NCT03361956|76019966|FG001|COMPLETED|Overall Study||24||
59897989|NCT03361956|76019967|FG002|COMPLETED|Overall Study||61||
59897990|NCT03361956|76019968|FG003|COMPLETED|Overall Study||28||
59897991|NCT03361956|76019969|FG004|COMPLETED|Overall Study||58||
59897992|NCT03361956|76019965|FG000|NOT COMPLETED|Overall Study||3||
59897993|NCT03361956|76019966|FG001|NOT COMPLETED|Overall Study||4||
59897994|NCT03361956|76019967|FG002|NOT COMPLETED|Overall Study||5||
59897995|NCT03361956|76019968|FG003|NOT COMPLETED|Overall Study||4||
59897996|NCT03361956|76019969|FG004|NOT COMPLETED|Overall Study||5||
59897997|NCT04749459|76020027|FG000|STARTED|Overall Study||14||
59897998|NCT04749459|76020027|FG000|CSM Classic|Overall Study||12||
59897999|NCT04749459|76020027|FG000|CSM Strawberry Flavor|Overall Study||10||
59898000|NCT04749459|76020027|FG000|P2 Control Standard|Overall Study||14||
59898001|NCT04749459|76020027|FG000|COMPLETED|Overall Study||14||
59898002|NCT04749459|76020027|FG000|NOT COMPLETED|Overall Study||0||
59898003|NCT03361176|76020040|FG000|STARTED|Overall Study||10||
59898004|NCT03361176|76020041|FG001|STARTED|Overall Study||20||
59898005|NCT03361176|76020040|FG000|COMPLETED|Overall Study||9||
59898006|NCT03361176|76020041|FG001|COMPLETED|Overall Study||15||
59898007|NCT03361176|76020040|FG000|NOT COMPLETED|Overall Study||1||
59898008|NCT03361176|76020041|FG001|NOT COMPLETED|Overall Study||5||
59898009|NCT05283499|76020049|FG000|STARTED|Overall Study||26||
59898010|NCT05283499|76020050|FG001|STARTED|Overall Study||27||
59898011|NCT05283499|76020049|FG000|COMPLETED|Overall Study||25||
59898012|NCT05283499|76020050|FG001|COMPLETED|Overall Study||25||
59898013|NCT05283499|76020049|FG000|NOT COMPLETED|Overall Study||1||
59898014|NCT05283499|76020050|FG001|NOT COMPLETED|Overall Study||2||
59898015|NCT05271175|76020059|FG000|STARTED|Treatment||34||
59898016|NCT05271175|76020060|FG001|STARTED|Treatment||33||
59898017|NCT05271175|76020061|FG002|STARTED|Treatment||37||
59898018|NCT05271175|76020059|FG000|COMPLETED|Treatment||29||
59898019|NCT05271175|76020060|FG001|COMPLETED|Treatment||30||
59898020|NCT05271175|76020061|FG002|COMPLETED|Treatment||30||
59898021|NCT05271175|76020059|FG000|NOT COMPLETED|Treatment||5||
59898022|NCT05271175|76020060|FG001|NOT COMPLETED|Treatment||3||
59898023|NCT05271175|76020061|FG002|NOT COMPLETED|Treatment||7||
59898024|NCT05271175|76020059|FG000|STARTED|One Week Follow up||29||
59898025|NCT05271175|76020060|FG001|STARTED|One Week Follow up||30||
59898026|NCT05271175|76020061|FG002|STARTED|One Week Follow up||30||
59898027|NCT05271175|76020059|FG000|COMPLETED|One Week Follow up||19||
59898028|NCT05271175|76020060|FG001|COMPLETED|One Week Follow up||23||
59898029|NCT05271175|76020061|FG002|COMPLETED|One Week Follow up||25||
59898030|NCT05271175|76020059|FG000|NOT COMPLETED|One Week Follow up||10||
59898031|NCT05271175|76020060|FG001|NOT COMPLETED|One Week Follow up||7||
59898032|NCT05271175|76020061|FG002|NOT COMPLETED|One Week Follow up||5||
59898033|NCT05271175|76020059|FG000|STARTED|One Month Follow up||29|Αll participants who completed the study (n=89) were asked to complete the one-month follow-up, regardless of whether they completed the one-week follow-up.|
59898034|NCT05271175|76020060|FG001|STARTED|One Month Follow up||30|Αll participants who completed the study (n=89) were asked to complete the one-month follow-up, regardless of whether they completed the one-week follow-up.|
59898035|NCT05271175|76020061|FG002|STARTED|One Month Follow up||30|Αll participants who completed the study (n=89) were asked to complete the one-month follow-up, regardless of whether they completed the one-week follow-up.|
59898036|NCT05271175|76020059|FG000|COMPLETED|One Month Follow up||17||
59898037|NCT05271175|76020060|FG001|COMPLETED|One Month Follow up||23||
59898038|NCT05271175|76020061|FG002|COMPLETED|One Month Follow up||21||
59898039|NCT05271175|76020059|FG000|NOT COMPLETED|One Month Follow up||12||
59898040|NCT05271175|76020060|FG001|NOT COMPLETED|One Month Follow up||7||
59898041|NCT05271175|76020061|FG002|NOT COMPLETED|One Month Follow up||9||
59898042|NCT05271175|76020059|FG000|STARTED|Six Months Follow up||29|Αll participants who completed the study (n=89) were asked to complete the six-months follow-up, regardless of whether they completed the one-month follow-up.|
59898043|NCT05271175|76020060|FG001|STARTED|Six Months Follow up||30|Αll participants who completed the study (n=89) were asked to complete the six-months follow-up, regardless of whether they completed the one-month follow-up.|
59898044|NCT05271175|76020061|FG002|STARTED|Six Months Follow up||30|Αll participants who completed the study (n=89) were asked to complete the six-months follow-up, regardless of whether they completed the one-month follow-up.|
59898045|NCT05271175|76020059|FG000|COMPLETED|Six Months Follow up||21||
59898046|NCT05271175|76020060|FG001|COMPLETED|Six Months Follow up||28||
59898047|NCT05271175|76020061|FG002|COMPLETED|Six Months Follow up||28||
59898048|NCT05271175|76020059|FG000|NOT COMPLETED|Six Months Follow up||8||
59898049|NCT05271175|76020060|FG001|NOT COMPLETED|Six Months Follow up||2||
59898050|NCT05271175|76020061|FG002|NOT COMPLETED|Six Months Follow up||2||
59898051|NCT03098030|76020073|FG000|STARTED|Overall Study||12||
59898052|NCT03098030|76020074|FG001|STARTED|Overall Study||187||
59898053|NCT03098030|76020075|FG002|STARTED|Overall Study||190||
59898054|NCT03098030|76020076|FG003|STARTED|Overall Study||94||
59898055|NCT03098030|76020073|FG000|COMPLETED|Overall Study|Represents number of subjects that had not discontinued the study at time of data lock.|2||
59898056|NCT03098030|76020074|FG001|COMPLETED|Overall Study|Represents number of subjects that had not discontinued the study at time of data lock.|24||
59898057|NCT03098030|76020075|FG002|COMPLETED|Overall Study|Represents number of subjects that had not discontinued the study at time of data lock.|24||
59898058|NCT03098030|76020076|FG003|COMPLETED|Overall Study|Represents number of subjects that had not discontinued the study at time of data lock.|9||
59898059|NCT03098030|76020073|FG000|NOT COMPLETED|Overall Study||10||
59898060|NCT03098030|76020074|FG001|NOT COMPLETED|Overall Study||163||
59898061|NCT03098030|76020075|FG002|NOT COMPLETED|Overall Study||166||
59898062|NCT03098030|76020076|FG003|NOT COMPLETED|Overall Study||85||
59898063|NCT03341637|76020087|FG000|STARTED|Overall Study||100||
59898064|NCT03341637|76020088|FG001|STARTED|Overall Study||300||
59898065|NCT03341637|76020087|FG000|COMPLETED|Overall Study||95||
59898066|NCT03341637|76020088|FG001|COMPLETED|Overall Study||296||
59898067|NCT03341637|76020087|FG000|NOT COMPLETED|Overall Study||5||
59898068|NCT03341637|76020088|FG001|NOT COMPLETED|Overall Study||4||
59898069|NCT01378858|76020096|FG000|STARTED|Overall Study||50||
59898070|NCT01378858|76020097|FG001|STARTED|Overall Study||50||
59898071|NCT01378858|76020096|FG000|COMPLETED|Overall Study||46||
59898072|NCT01378858|76020097|FG001|COMPLETED|Overall Study||46||
59898073|NCT01378858|76020096|FG000|NOT COMPLETED|Overall Study||4||
59898074|NCT01378858|76020097|FG001|NOT COMPLETED|Overall Study||4||
59898075|NCT02891850|76020105|FG000|STARTED|Overall Study||111|Treated|
59898076|NCT02891850|76020106|FG001|STARTED|Overall Study||114|Treated|
59898077|NCT02891850|76020105|FG000|COMPLETED|Overall Study||104||
59898078|NCT02891850|76020106|FG001|COMPLETED|Overall Study||107||
59898079|NCT02891850|76020105|FG000|NOT COMPLETED|Overall Study||7||
59898080|NCT02891850|76020106|FG001|NOT COMPLETED|Overall Study||7||
59898081|NCT05594173|76020112|FG000|STARTED|Overall Study||20||
59898082|NCT05594173|76020112|FG000|COMPLETED|Overall Study||17||
59611337|NCT01781286|75722312|FG002|STARTED|Overall Study||9||
59611338|NCT01781286|75722313|FG003|STARTED|Overall Study||8||
59611339|NCT01781286|75722314|FG004|STARTED|Overall Study||6||
59611340|NCT01781286|75722315|FG005|STARTED|Overall Study||3||
59611341|NCT01781286|75722310|FG000|Started 1st Intervention|Overall Study||6||
59611342|NCT01781286|75722311|FG001|Started 1st Intervention|Overall Study||4||
59898083|NCT05594173|76020112|FG000|NOT COMPLETED|Overall Study||3||
59898084|NCT03339999|76020125|FG000|STARTED|Overall Study||7||
59898085|NCT03339999|76020126|FG001|STARTED|Overall Study||6||
59898086|NCT03339999|76020127|FG002|STARTED|Overall Study||6||
59898087|NCT03339999|76020128|FG003|STARTED|Overall Study||5||
59898088|NCT03339999|76020125|FG000|Modified Intent-to-Treat Population|Overall Study||7||
59898089|NCT03339999|76020126|FG001|Modified Intent-to-Treat Population|Overall Study||6||
59898090|NCT03339999|76020127|FG002|Modified Intent-to-Treat Population|Overall Study||5||
59898091|NCT03339999|76020128|FG003|Modified Intent-to-Treat Population|Overall Study||4||
59898092|NCT03339999|76020125|FG000|Safety Population: Received Treatment|Overall Study||7||
59898093|NCT03339999|76020126|FG001|Safety Population: Received Treatment|Overall Study||6||
59898094|NCT03339999|76020127|FG002|Safety Population: Received Treatment|Overall Study||6||
59898095|NCT03339999|76020128|FG003|Safety Population: Received Treatment|Overall Study||4||
59898096|NCT03339999|76020125|FG000|COMPLETED|Overall Study||0||
59898097|NCT03339999|76020126|FG001|COMPLETED|Overall Study||0||
59898098|NCT03339999|76020127|FG002|COMPLETED|Overall Study||0||
59898099|NCT03339999|76020128|FG003|COMPLETED|Overall Study||0||
59898100|NCT03339999|76020125|FG000|NOT COMPLETED|Overall Study||7||
59898101|NCT03339999|76020126|FG001|NOT COMPLETED|Overall Study||6||
59898102|NCT03339999|76020127|FG002|NOT COMPLETED|Overall Study||6||
59898103|NCT03339999|76020128|FG003|NOT COMPLETED|Overall Study||5||
59898104|NCT03339453|76020141|FG000|STARTED|First Visit of Glucagon Treatment||35||
59898105|NCT03339453|76020142|FG001|STARTED|First Visit of Glucagon Treatment||35||
59898106|NCT03339453|76020141|FG000|Received at Least 1 Dose of Study Drug|First Visit of Glucagon Treatment||35||
59898107|NCT03339453|76020142|FG001|Received at Least 1 Dose of Study Drug|First Visit of Glucagon Treatment||35||
59898108|NCT03339453|76020141|FG000|COMPLETED|First Visit of Glucagon Treatment||35||
59898109|NCT03339453|76020142|FG001|COMPLETED|First Visit of Glucagon Treatment||34||
59898110|NCT03339453|76020141|FG000|NOT COMPLETED|First Visit of Glucagon Treatment||0||
59898111|NCT03339453|76020142|FG001|NOT COMPLETED|First Visit of Glucagon Treatment||1||
59898112|NCT03339453|76020141|FG000|STARTED|Second Visit for Alternate Glucagon||35||
59898113|NCT03339453|76020142|FG001|STARTED|Second Visit for Alternate Glucagon||34||
59898114|NCT03339453|76020141|FG000|COMPLETED|Second Visit for Alternate Glucagon||35|Completed both inpatient study visits.|
59898115|NCT03339453|76020142|FG001|COMPLETED|Second Visit for Alternate Glucagon||34|Completed both inpatient study visits.|
59898116|NCT03339453|76020141|FG000|NOT COMPLETED|Second Visit for Alternate Glucagon||0||
59898117|NCT03339453|76020142|FG001|NOT COMPLETED|Second Visit for Alternate Glucagon||0||
59898118|NCT03045068|76020150|FG000|STARTED|Overall Study||23||
59898119|NCT03045068|76020151|FG001|STARTED|Overall Study||23||
59898120|NCT03045068|76020150|FG000|Received Intervention|Overall Study||23||
59898121|NCT03045068|76020151|FG001|Received Intervention|Overall Study||23||
59898122|NCT03045068|76020150|FG000|COMPLETED|Overall Study||21||
59898123|NCT03045068|76020151|FG001|COMPLETED|Overall Study||21||
59898124|NCT03045068|76020150|FG000|NOT COMPLETED|Overall Study||2||
59898125|NCT03045068|76020151|FG001|NOT COMPLETED|Overall Study||2||
59898126|NCT02318264|76020159|FG000|STARTED|Overall Study||8||
59898127|NCT02318264|76020160|FG001|STARTED|Overall Study||7||
59898128|NCT02318264|76020159|FG000|COMPLETED|Overall Study||8||
59898129|NCT02318264|76020160|FG001|COMPLETED|Overall Study||7||
59898130|NCT02318264|76020159|FG000|NOT COMPLETED|Overall Study||0||
59898131|NCT02318264|76020160|FG001|NOT COMPLETED|Overall Study||0||
59898132|NCT00602576|76020171|FG000|STARTED|Overall Study||38||
59898133|NCT00602576|76020172|FG001|STARTED|Overall Study||40||
59898134|NCT00602576|76020173|FG002|STARTED|Overall Study||38||
59898135|NCT00602576|76020174|FG003|STARTED|Overall Study||53||
59898136|NCT00602576|76020171|FG000|COMPLETED|Overall Study||38||
59898137|NCT00602576|76020172|FG001|COMPLETED|Overall Study||40||
59898138|NCT00602576|76020173|FG002|COMPLETED|Overall Study||38||
59898139|NCT00602576|76020174|FG003|COMPLETED|Overall Study||53||
59898140|NCT00602576|76020171|FG000|NOT COMPLETED|Overall Study||0||
59898141|NCT00602576|76020172|FG001|NOT COMPLETED|Overall Study||0||
59898142|NCT00602576|76020173|FG002|NOT COMPLETED|Overall Study||0||
59898143|NCT00602576|76020174|FG003|NOT COMPLETED|Overall Study||0||
59898144|NCT03359850|76020186|FG000|STARTED|PK Phase (Up to Day 8)||9||
59898145|NCT03359850|76020187|FG001|STARTED|PK Phase (Up to Day 8)||8||
59898146|NCT03359850|76020186|FG000|COMPLETED|PK Phase (Up to Day 8)||8||
59898147|NCT03359850|76020187|FG001|COMPLETED|PK Phase (Up to Day 8)||7||
59898148|NCT03359850|76020186|FG000|NOT COMPLETED|PK Phase (Up to Day 8)||1||
59898149|NCT03359850|76020187|FG001|NOT COMPLETED|PK Phase (Up to Day 8)||1||
59898150|NCT03359850|76020186|FG000|STARTED|Extension Phase (Up to 28 Months)||8||
59898151|NCT03359850|76020187|FG001|STARTED|Extension Phase (Up to 28 Months)||7||
60014026|NCT02468193|76130011|FG000|Discontinued Study in Optional Ext. Per.|Overall Study||2||
60014027|NCT02468193|76130011|FG000|COMPLETED|Overall Study||3||
60014028|NCT02468193|76130011|FG000|NOT COMPLETED|Overall Study||6||
60014029|NCT02466555|76130031|FG000|STARTED|Overall Study||30||
60014030|NCT02466555|76130031|FG000|COMPLETED|Overall Study||28||
60014031|NCT02466555|76130031|FG000|NOT COMPLETED|Overall Study||2||
60014032|NCT02466399|76130038|FG000|STARTED|Overall Study||53||
60014033|NCT02466399|76130039|FG001|STARTED|Overall Study||27||
60014034|NCT02466399|76130038|FG000|COMPLETED|Overall Study||51||
60014035|NCT02466399|76130039|FG001|COMPLETED|Overall Study||27||
59898152|NCT03359850|76020186|FG000|COMPLETED|Extension Phase (Up to 28 Months)||0||
59898153|NCT03359850|76020187|FG001|COMPLETED|Extension Phase (Up to 28 Months)||1||
59898154|NCT03359850|76020186|FG000|NOT COMPLETED|Extension Phase (Up to 28 Months)||8||
59898155|NCT03359850|76020187|FG001|NOT COMPLETED|Extension Phase (Up to 28 Months)||6||
59898156|NCT04644328|76020197|FG000|STARTED|Thanksgiving Period|"Two separate, sequential experiments were run within the study using the same counties (with differences in exclusion criteria explained in the pre-assignment details).~Thanksgiving experiment: 410 counties were assigned to high-intensity treatment. A total of 3,545 ZCTAs (of which 2,702 were in high-intensity counties) were treated.~Counties randomized to intervention, data collected at the population level, actual number of participants unknown."|||410
59898157|NCT04644328|76020198|FG001|STARTED|Thanksgiving Period|"Two separate, sequential experiments were run within the study using the same counties (with differences in exclusion criteria explained in the pre-assignment details).~Thanksgiving experiment: 410 counties were assigned to low-intensity treatment. A total of 3,453 ZCTAs (of which 2,549 were in low-intensity counties) were not treated.~Counties randomized to intervention, data collected at the population level, actual number of participants unknown."|||410
60014036|NCT02466399|76130038|FG000|NOT COMPLETED|Overall Study||2||
59898158|NCT04644328|76020197|FG000|COMPLETED|Thanksgiving Period|Counties randomized to intervention, data collected at the population level, actual number of participants unknown.|||410
59898159|NCT04644328|76020198|FG001|COMPLETED|Thanksgiving Period|Counties randomized to intervention, data collected at the population level, actual number of participants unknown.|||410
59898160|NCT04644328|76020197|FG000|NOT COMPLETED|Thanksgiving Period||||0
59898161|NCT04644328|76020198|FG001|NOT COMPLETED|Thanksgiving Period||||0
59898162|NCT04644328|76020197|FG000|STARTED|Christmas Period|"Two separate, sequential experiments were run within the study using the same counties (with differences in exclusion criteria explained in the pre-assignment details).~Christmas experiment: 386 counties were assigned to high-intensity treatment. A total of 5,077 ZCTAs (of which 3,818 were in high-intensity counties) were treated.~Counties randomized to intervention, data collected at the population level, actual number of participants unknown."|||386
59898163|NCT04644328|76020198|FG001|STARTED|Christmas Period|"Two separate, sequential experiments were run within the study using the same counties (with differences in exclusion criteria explained in the pre-assignment details).~Christmas experiment: 381 counties were assigned to low-intensity treatment. A total of 5,102 ZCTAs (of which 3,833 were in low-intensity counties) were not treated.~Counties randomized to intervention, data collected at the population level, actual number of participants unknown."|||381
59898164|NCT04644328|76020197|FG000|COMPLETED|Christmas Period|Counties randomized to intervention, data collected at the population level, actual number of participants unknown.|||386
59898165|NCT04644328|76020198|FG001|COMPLETED|Christmas Period|Counties randomized to intervention, data collected at the population level, actual number of participants unknown.|||381
59898166|NCT04644328|76020197|FG000|NOT COMPLETED|Christmas Period||||0
59898167|NCT04644328|76020198|FG001|NOT COMPLETED|Christmas Period||||0
59898168|NCT00114140|76020206|FG000|STARTED|Overall Study||136||
59898169|NCT00114140|76020206|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|129||
59898170|NCT00114140|76020206|FG000|NOT COMPLETED|Overall Study||7||
59898171|NCT03712345|76020220|FG000|STARTED|Overall Study||6||
59898172|NCT03712345|76020221|FG001|STARTED|Overall Study||7||
59898173|NCT03712345|76020222|FG002|STARTED|Overall Study|One participant was mistakenly randomized, but never treated because the participant was a screening failure.|7||
59898174|NCT03712345|76020220|FG000|COMPLETED|Overall Study||6||
59898175|NCT03712345|76020221|FG001|COMPLETED|Overall Study||7||
59898176|NCT03712345|76020222|FG002|COMPLETED|Overall Study||6||
59898177|NCT03712345|76020220|FG000|NOT COMPLETED|Overall Study||0||
59898178|NCT03712345|76020221|FG001|NOT COMPLETED|Overall Study||0||
59898179|NCT03712345|76020222|FG002|NOT COMPLETED|Overall Study||1||
60014037|NCT02466399|76130039|FG001|NOT COMPLETED|Overall Study||0||
60014038|NCT02465931|76130047|FG000|STARTED|Overall Study||55||
60014039|NCT02465931|76130048|FG001|STARTED|Overall Study||56||
60014040|NCT02465931|76130047|FG000|COMPLETED|Overall Study||44||
60014041|NCT02465931|76130048|FG001|COMPLETED|Overall Study||45||
60014042|NCT02465931|76130047|FG000|NOT COMPLETED|Overall Study||11||
60014043|NCT02465931|76130048|FG001|NOT COMPLETED|Overall Study||11||
60014044|NCT02465463|76130056|FG000|STARTED|Overall Study||8||
59757349|NCT04217590|75876462|FG001|COMPLETED|Overall Study||64||
59757350|NCT04217590|75876461|FG000|NOT COMPLETED|Overall Study||4||
59757351|NCT04217590|75876462|FG001|NOT COMPLETED|Overall Study||3||
59757352|NCT03963232|75876470|FG000|STARTED|Double-Blind Treatment Phase||259||
59757353|NCT03963232|75876471|FG001|STARTED|Double-Blind Treatment Phase||261||
59757354|NCT03963232|75876470|FG000|Received at Least One Dose of Study Drug|Double-Blind Treatment Phase||259||
59757355|NCT03963232|75876471|FG001|Received at Least One Dose of Study Drug|Double-Blind Treatment Phase||261||
59757356|NCT03963232|75876470|FG000|COMPLETED|Double-Blind Treatment Phase||242||
59757357|NCT03963232|75876471|FG001|COMPLETED|Double-Blind Treatment Phase||245||
60014045|NCT02465463|76130057|FG001|STARTED|Overall Study||5||
60014046|NCT02465463|76130056|FG000|COMPLETED|Overall Study||4||
60014047|NCT02465463|76130057|FG001|COMPLETED|Overall Study||4||
60014048|NCT02465463|76130056|FG000|NOT COMPLETED|Overall Study||4||
60014049|NCT02465463|76130057|FG001|NOT COMPLETED|Overall Study||1||
60014050|NCT02464059|76130064|FG000|STARTED|Overall Study||23||
60014051|NCT02464059|76130064|FG000|COMPLETED|Overall Study||17||
60014052|NCT02464059|76130064|FG000|NOT COMPLETED|Overall Study||6||
60014053|NCT02463357|76130073|FG000|STARTED|Overall Study||20||
60014054|NCT02463357|76130074|FG001|STARTED|Overall Study||20||
60014055|NCT02463357|76130075|FG002|STARTED|Overall Study||20||
60014056|NCT02463357|76130076|FG003|STARTED|Overall Study||19||
60014057|NCT02463357|76130077|FG004|STARTED|Overall Study||20||
60014058|NCT02463357|76130073|FG000|COMPLETED|Overall Study||19||
60014059|NCT02463357|76130074|FG001|COMPLETED|Overall Study||20||
60014060|NCT02463357|76130075|FG002|COMPLETED|Overall Study||20||
60014061|NCT02463357|76130076|FG003|COMPLETED|Overall Study||19||
60014062|NCT02463357|76130077|FG004|COMPLETED|Overall Study||19||
60014063|NCT02463357|76130073|FG000|NOT COMPLETED|Overall Study||1||
60014064|NCT02463357|76130074|FG001|NOT COMPLETED|Overall Study||0||
60014065|NCT02463357|76130075|FG002|NOT COMPLETED|Overall Study||0||
60014066|NCT02463357|76130076|FG003|NOT COMPLETED|Overall Study||0||
60014067|NCT02463357|76130077|FG004|NOT COMPLETED|Overall Study||1||
60014068|NCT02579759|76130092|FG000|STARTED|Overall Study||109||
60014069|NCT02579759|76130093|FG001|STARTED|Overall Study||113||
60014070|NCT02579759|76130094|FG002|STARTED|Overall Study||101||
59898180|NCT03358290|76020235|FG000|STARTED|Overall Study||2||
59898181|NCT03358290|76020236|FG001|STARTED|Overall Study||3||
59898182|NCT03358290|76020237|FG002|STARTED|Overall Study||3||
59898183|NCT03358290|76020238|FG003|STARTED|Overall Study||3||
59898184|NCT03358290|76020239|FG004|STARTED|Overall Study||2||
59898185|NCT03358290|76020235|FG000|COMPLETED|Overall Study||2||
60014071|NCT02579759|76130092|FG000|COMPLETED|Overall Study||85|Completed at 12 months|
60014072|NCT02579759|76130093|FG001|COMPLETED|Overall Study||49|Completed at 12 months|
60014073|NCT02579759|76130094|FG002|COMPLETED|Overall Study||80|Completed at 12 months|
60014074|NCT02579759|76130092|FG000|NOT COMPLETED|Overall Study||24||
60014075|NCT02579759|76130093|FG001|NOT COMPLETED|Overall Study||64||
60014076|NCT02579759|76130094|FG002|NOT COMPLETED|Overall Study||21||
60014077|NCT02445963|76130108|FG000|STARTED|Overall Study||9||
60014078|NCT02445963|76130109|FG001|STARTED|Overall Study||9||
60014079|NCT02445963|76130110|FG002|STARTED|Overall Study||10||
60014080|NCT02445963|76130111|FG003|STARTED|Overall Study||10||
60014081|NCT02445963|76130108|FG000|COMPLETED|Overall Study||7||
60014082|NCT02445963|76130109|FG001|COMPLETED|Overall Study||9||
60014083|NCT02445963|76130110|FG002|COMPLETED|Overall Study||9||
60014084|NCT02445963|76130111|FG003|COMPLETED|Overall Study||10||
60014085|NCT02445963|76130108|FG000|NOT COMPLETED|Overall Study||2||
60014086|NCT02445963|76130109|FG001|NOT COMPLETED|Overall Study||0||
60014087|NCT02445963|76130110|FG002|NOT COMPLETED|Overall Study||1||
60014088|NCT02445963|76130111|FG003|NOT COMPLETED|Overall Study||0||
60014089|NCT02499159|76130125|FG000|STARTED|Randomization||50||
60014090|NCT02499159|76130126|FG001|STARTED|Randomization||50||
59611343|NCT01781286|75722312|FG002|Started 1st Intervention|Overall Study||9||
59898186|NCT03358290|76020236|FG001|COMPLETED|Overall Study||2||
59898187|NCT03358290|76020237|FG002|COMPLETED|Overall Study||1||
59898188|NCT03358290|76020238|FG003|COMPLETED|Overall Study||1||
59898189|NCT03358290|76020239|FG004|COMPLETED|Overall Study||1||
60014091|NCT02499159|76130125|FG000|COMPLETED|Randomization||49||
60014092|NCT02499159|76130126|FG001|COMPLETED|Randomization||49||
59898190|NCT03358290|76020235|FG000|NOT COMPLETED|Overall Study||0||
59898191|NCT03358290|76020236|FG001|NOT COMPLETED|Overall Study||1||
59898192|NCT03358290|76020237|FG002|NOT COMPLETED|Overall Study||2||
60014093|NCT02499159|76130125|FG000|NOT COMPLETED|Randomization||1||
60014094|NCT02499159|76130126|FG001|NOT COMPLETED|Randomization||1||
60014095|NCT02499159|76130125|FG000|STARTED|30-Day Follow-Up Phone Call||49||
60014096|NCT02499159|76130126|FG001|STARTED|30-Day Follow-Up Phone Call||49||
60014097|NCT02499159|76130125|FG000|COMPLETED|30-Day Follow-Up Phone Call||42||
60014098|NCT02499159|76130126|FG001|COMPLETED|30-Day Follow-Up Phone Call||47||
60014099|NCT02499159|76130125|FG000|NOT COMPLETED|30-Day Follow-Up Phone Call||7||
60014100|NCT02499159|76130126|FG001|NOT COMPLETED|30-Day Follow-Up Phone Call||2||
60014101|NCT01664039|76130134|FG000|STARTED|Overall Study||52||
60014102|NCT01664039|76130135|FG001|STARTED|Overall Study||52||
60014103|NCT01664039|76130134|FG000|COMPLETED|Overall Study||46||
60014104|NCT01664039|76130135|FG001|COMPLETED|Overall Study||43||
59898193|NCT03358290|76020238|FG003|NOT COMPLETED|Overall Study||2||
60014105|NCT01664039|76130134|FG000|NOT COMPLETED|Overall Study||6||
60014106|NCT01664039|76130135|FG001|NOT COMPLETED|Overall Study||9||
60014107|NCT02445573|76130143|FG000|STARTED|Overall Study||40||
60014108|NCT02445573|76130144|FG001|STARTED|Overall Study||40||
60014109|NCT02445573|76130143|FG000|COMPLETED|Overall Study||39||
60014110|NCT02445573|76130144|FG001|COMPLETED|Overall Study||38||
60014111|NCT02445573|76130143|FG000|NOT COMPLETED|Overall Study||1||
60014112|NCT02445573|76130144|FG001|NOT COMPLETED|Overall Study||2||
59898194|NCT03358290|76020239|FG004|NOT COMPLETED|Overall Study||1||
59898195|NCT03089216|76020255|FG000|STARTED|Overall Study||27||
59898196|NCT03089216|76020256|FG001|STARTED|Overall Study||27||
59898197|NCT03089216|76020257|FG002|STARTED|Overall Study||27||
59898198|NCT03089216|76020258|FG003|STARTED|Overall Study||27||
59898199|NCT03089216|76020255|FG000|COMPLETED|Overall Study||27||
59898200|NCT03089216|76020256|FG001|COMPLETED|Overall Study||27||
59898201|NCT03089216|76020257|FG002|COMPLETED|Overall Study||27||
59898202|NCT03089216|76020258|FG003|COMPLETED|Overall Study||26||
59898203|NCT03089216|76020255|FG000|NOT COMPLETED|Overall Study||0||
59898204|NCT03089216|76020256|FG001|NOT COMPLETED|Overall Study||0||
59898205|NCT03089216|76020257|FG002|NOT COMPLETED|Overall Study||0||
59898206|NCT03089216|76020258|FG003|NOT COMPLETED|Overall Study||1||
59898207|NCT03339726|76020275|FG000|STARTED|Overall Study||64||
59898208|NCT03339726|76020276|FG001|STARTED|Overall Study||66||
59898209|NCT03339726|76020277|FG002|STARTED|Overall Study||63||
59898210|NCT03339726|76020275|FG000|COMPLETED|Overall Study||63||
59898211|NCT03339726|76020276|FG001|COMPLETED|Overall Study||65||
59898212|NCT03339726|76020277|FG002|COMPLETED|Overall Study||63||
59898213|NCT03339726|76020275|FG000|NOT COMPLETED|Overall Study||1||
59898214|NCT03339726|76020276|FG001|NOT COMPLETED|Overall Study||1||
59898215|NCT03339726|76020277|FG002|NOT COMPLETED|Overall Study||0||
59898216|NCT03339297|76020287|FG000|STARTED|Overall Study||79||
59898217|NCT03339297|76020288|FG001|STARTED|Overall Study||73||
59898218|NCT03339297|76020287|FG000|COMPLETED|Overall Study||56||
59898219|NCT03339297|76020288|FG001|COMPLETED|Overall Study||59||
59898220|NCT03339297|76020287|FG000|NOT COMPLETED|Overall Study||23||
59898221|NCT03339297|76020288|FG001|NOT COMPLETED|Overall Study||14||
59898222|NCT03001310|76020300|FG000|STARTED|Overall Study||3||
59898223|NCT03001310|76020301|FG001|STARTED|Overall Study||12||
59898224|NCT03001310|76020302|FG002|STARTED|Overall Study||3||
59898225|NCT03001310|76020303|FG003|STARTED|Overall Study||5||
59898226|NCT03001310|76020300|FG000|COMPLETED|Overall Study||3||
59898227|NCT03001310|76020301|FG001|COMPLETED|Overall Study||12||
59898228|NCT03001310|76020302|FG002|COMPLETED|Overall Study||3||
59898229|NCT03001310|76020303|FG003|COMPLETED|Overall Study||5||
59898230|NCT03001310|76020300|FG000|NOT COMPLETED|Overall Study||0||
59898231|NCT03001310|76020301|FG001|NOT COMPLETED|Overall Study||0||
59898232|NCT03001310|76020302|FG002|NOT COMPLETED|Overall Study||0||
59898233|NCT03001310|76020303|FG003|NOT COMPLETED|Overall Study||0||
59898234|NCT03713281|76020314|FG000|STARTED|Overall Study||28||
59898235|NCT03713281|76020314|FG000|COMPLETED|Overall Study||25||
59898236|NCT03713281|76020314|FG000|NOT COMPLETED|Overall Study||3||
59898237|NCT03339219|76020318|FG000|STARTED|Overall Study||35||
59898238|NCT03339219|76020318|FG000|COMPLETED|Overall Study||0||
59898239|NCT03339219|76020318|FG000|NOT COMPLETED|Overall Study||35||
59898240|NCT03338673|76020324|FG000|STARTED|Overall Study||6||
59898241|NCT03338673|76020325|FG001|STARTED|Overall Study||6||
59898242|NCT03338673|76020324|FG000|COMPLETED|Overall Study||5||
59898243|NCT03338673|76020325|FG001|COMPLETED|Overall Study||5||
59898244|NCT03338673|76020324|FG000|NOT COMPLETED|Overall Study||1||
59898245|NCT03338673|76020325|FG001|NOT COMPLETED|Overall Study||1||
59898246|NCT02949024|76020333|FG000|STARTED|Overall Study||10||
59898247|NCT02949024|76020334|FG001|STARTED|Overall Study||10||
59898248|NCT02949024|76020333|FG000|COMPLETED|Overall Study||10||
59898249|NCT02949024|76020334|FG001|COMPLETED|Overall Study||9||
59898250|NCT02949024|76020333|FG000|NOT COMPLETED|Overall Study||0||
59898251|NCT02949024|76020334|FG001|NOT COMPLETED|Overall Study||1||
59898252|NCT03093428|76020344|FG000|STARTED|Overall Study||31||
59898253|NCT03093428|76020345|FG001|STARTED|Overall Study||14||
59898254|NCT03093428|76020344|FG000|COMPLETED|Overall Study||12||
59898255|NCT03093428|76020345|FG001|COMPLETED|Overall Study||8||
59898256|NCT03093428|76020344|FG000|NOT COMPLETED|Overall Study||19||
59898257|NCT03093428|76020345|FG001|NOT COMPLETED|Overall Study||6||
59898258|NCT02735980|76020354|FG000|STARTED|Overall Study||58||
59898259|NCT02735980|76020355|FG001|STARTED|Overall Study||60||
59898260|NCT02735980|76020356|FG002|STARTED|Overall Study||15||
59898261|NCT02735980|76020354|FG000|Received at Least 1 Dose of Study Drug|Overall Study||56||
59898262|NCT02735980|76020355|FG001|Received at Least 1 Dose of Study Drug|Overall Study||60||
59898263|NCT02735980|76020356|FG002|Received at Least 1 Dose of Study Drug|Overall Study||15||
59898264|NCT02735980|76020354|FG000|COMPLETED|Overall Study||48||
59898265|NCT02735980|76020355|FG001|COMPLETED|Overall Study||49||
59898266|NCT02735980|76020356|FG002|COMPLETED|Overall Study||14||
59898267|NCT02735980|76020354|FG000|NOT COMPLETED|Overall Study||10||
59898268|NCT02735980|76020355|FG001|NOT COMPLETED|Overall Study||11||
59898269|NCT02735980|76020356|FG002|NOT COMPLETED|Overall Study||1||
59898270|NCT03338400|76020371|FG000|STARTED|Overall Study||25||
59898271|NCT03338400|76020372|FG001|STARTED|Overall Study||26||
59898272|NCT03338400|76020371|FG000|COMPLETED|Overall Study||24||
59898273|NCT03338400|76020372|FG001|COMPLETED|Overall Study||24||
59898274|NCT03338400|76020371|FG000|NOT COMPLETED|Overall Study||1||
59898275|NCT03338400|76020372|FG001|NOT COMPLETED|Overall Study||2||
59898276|NCT03337113|76020390|FG000|STARTED|Overall Study||13||
59898277|NCT03337113|76020391|FG001|STARTED|Overall Study||12||
59898278|NCT03337113|76020392|FG002|STARTED|Overall Study||12||
59898279|NCT03337113|76020393|FG003|STARTED|Overall Study||13||
59898280|NCT03337113|76020390|FG000|COMPLETED|Overall Study||12||
59898281|NCT03337113|76020391|FG001|COMPLETED|Overall Study||9||
59898282|NCT03337113|76020392|FG002|COMPLETED|Overall Study||11||
59898283|NCT03337113|76020393|FG003|COMPLETED|Overall Study||11||
59898284|NCT03337113|76020390|FG000|NOT COMPLETED|Overall Study||1||
59898285|NCT03337113|76020391|FG001|NOT COMPLETED|Overall Study||3||
59898286|NCT03337113|76020392|FG002|NOT COMPLETED|Overall Study||1||
59898287|NCT03337113|76020393|FG003|NOT COMPLETED|Overall Study||2||
59898288|NCT03092726|76020405|FG000|STARTED|Overall Study||88||
59898289|NCT03092726|76020406|FG001|STARTED|Overall Study||95||
59898290|NCT03092726|76020405|FG000|Treated|Overall Study||88||
59898291|NCT03092726|76020406|FG001|Treated|Overall Study||95||
59898292|NCT03092726|76020405|FG000|COMPLETED|Overall Study||79|Completed the treatment period.|
59898293|NCT03092726|76020406|FG001|COMPLETED|Overall Study||81|Completed the treatment period.|
59898294|NCT03092726|76020405|FG000|NOT COMPLETED|Overall Study||9||
59898295|NCT03092726|76020406|FG001|NOT COMPLETED|Overall Study||14||
59898296|NCT03338010|76020414|FG000|STARTED|Overall Study||359||
59898297|NCT03338010|76020415|FG001|STARTED|Overall Study||177||
59898298|NCT03338010|76020414|FG000|Received at Least One Dose of Study Drug|Overall Study||359||
59898299|NCT03338010|76020415|FG001|Received at Least One Dose of Study Drug|Overall Study||177||
59898300|NCT03338010|76020414|FG000|COMPLETED|Overall Study||336||
59898301|NCT03338010|76020415|FG001|COMPLETED|Overall Study||159||
59898302|NCT03338010|76020414|FG000|NOT COMPLETED|Overall Study||23||
59898303|NCT03338010|76020415|FG001|NOT COMPLETED|Overall Study||18||
59898304|NCT03337542|76020421|FG000|STARTED|Overall Study||243||
59898305|NCT03337542|76020421|FG000|Safety Population|Overall Study||242||
59898306|NCT03337542|76020421|FG000|COMPLETED|Overall Study||222||
59898307|NCT03337542|76020421|FG000|NOT COMPLETED|Overall Study||21||
59898308|NCT01328548|76020428|FG000|STARTED|Overall Study||191||
59898309|NCT01328548|76020429|FG001|STARTED|Overall Study||50||
59898310|NCT01328548|76020428|FG000|COMPLETED|Overall Study||187||
59898311|NCT01328548|76020429|FG001|COMPLETED|Overall Study||50||
59898312|NCT01328548|76020428|FG000|NOT COMPLETED|Overall Study||4||
59898313|NCT01328548|76020429|FG001|NOT COMPLETED|Overall Study||0||
59898314|NCT04411082|76020441|FG000|STARTED|Overall Study||29||
59898315|NCT04411082|76020442|FG001|STARTED|Overall Study||25||
59898316|NCT04411082|76020443|FG002|STARTED|Overall Study||20||
59898317|NCT04411082|76020444|FG003|STARTED|Overall Study||24||
59898318|NCT04411082|76020445|FG004|STARTED|Overall Study||12||
59898319|NCT04411082|76020446|FG005|STARTED|Overall Study||12||
59898320|NCT04411082|76020441|FG000|COMPLETED|Overall Study||18||
59898321|NCT04411082|76020442|FG001|COMPLETED|Overall Study||16||
59898322|NCT04411082|76020443|FG002|COMPLETED|Overall Study||16||
59898323|NCT04411082|76020444|FG003|COMPLETED|Overall Study||10||
59898324|NCT04411082|76020445|FG004|COMPLETED|Overall Study||8||
59898325|NCT04411082|76020446|FG005|COMPLETED|Overall Study||6||
59898326|NCT04411082|76020441|FG000|NOT COMPLETED|Overall Study||11||
59898327|NCT04411082|76020442|FG001|NOT COMPLETED|Overall Study||9||
59898328|NCT04411082|76020443|FG002|NOT COMPLETED|Overall Study||4||
59898329|NCT04411082|76020444|FG003|NOT COMPLETED|Overall Study||14||
59898330|NCT04411082|76020445|FG004|NOT COMPLETED|Overall Study||4||
59898331|NCT04411082|76020446|FG005|NOT COMPLETED|Overall Study||6||
59898332|NCT03337308|76020467|FG000|STARTED|Overall Study||108||
59898333|NCT03337308|76020468|FG001|STARTED|Overall Study||110||
59898334|NCT03337308|76020469|FG002|STARTED|Overall Study||109||
59898335|NCT03337308|76020470|FG003|STARTED|Overall Study||55||
59898336|NCT03337308|76020467|FG000|COMPLETED|Overall Study||103||
59898337|NCT03337308|76020468|FG001|COMPLETED|Overall Study||103||
59898338|NCT03337308|76020469|FG002|COMPLETED|Overall Study||104||
59898339|NCT03337308|76020470|FG003|COMPLETED|Overall Study||53||
59898340|NCT03337308|76020467|FG000|NOT COMPLETED|Overall Study||5||
59898341|NCT03337308|76020468|FG001|NOT COMPLETED|Overall Study||7||
59898342|NCT03337308|76020469|FG002|NOT COMPLETED|Overall Study||5||
59898343|NCT03337308|76020470|FG003|NOT COMPLETED|Overall Study||2||
59898344|NCT03337152|76020482|FG000|STARTED|Overall Study||24||
59898345|NCT03337152|76020483|FG001|STARTED|Overall Study||24||
59898346|NCT03337152|76020482|FG000|COMPLETED|Overall Study||13||
59898347|NCT03337152|76020483|FG001|COMPLETED|Overall Study||13||
59898348|NCT03337152|76020482|FG000|NOT COMPLETED|Overall Study||11||
59898349|NCT03337152|76020483|FG001|NOT COMPLETED|Overall Study||11||
59898350|NCT02725580|76020491|FG000|STARTED|Overall Study||13||
59898351|NCT02725580|76020491|FG000|Received at Least 1 Dose of Study Drug|Overall Study||13||
59898352|NCT02725580|76020491|FG000|COMPLETED|Overall Study||13||
59898353|NCT02725580|76020491|FG000|NOT COMPLETED|Overall Study||0||
59898354|NCT03091400|76020497|FG000|STARTED|Phase 1 - 6 Weeks||5||
59898355|NCT03091400|76020498|FG001|STARTED|Phase 1 - 6 Weeks||6||
59898356|NCT03091400|76020497|FG000|COMPLETED|Phase 1 - 6 Weeks||5||
59898357|NCT03091400|76020498|FG001|COMPLETED|Phase 1 - 6 Weeks||6||
59898358|NCT03091400|76020497|FG000|NOT COMPLETED|Phase 1 - 6 Weeks||0||
59898359|NCT03091400|76020498|FG001|NOT COMPLETED|Phase 1 - 6 Weeks||0||
59898360|NCT03091400|76020497|FG000|STARTED|Washout - 2 Weeks||5||
59898361|NCT03091400|76020498|FG001|STARTED|Washout - 2 Weeks||6||
59898362|NCT03091400|76020497|FG000|COMPLETED|Washout - 2 Weeks||4||
59505803|NCT00763243|75598677|FG000|COMPLETED|6-Month Follow-Up Period||9||
59898363|NCT03091400|76020498|FG001|COMPLETED|Washout - 2 Weeks||6||
59898364|NCT03091400|76020497|FG000|NOT COMPLETED|Washout - 2 Weeks||1||
59898365|NCT03091400|76020498|FG001|NOT COMPLETED|Washout - 2 Weeks||0||
59898366|NCT03091400|76020497|FG000|STARTED|Phase 2 - 6 Weeks||4||
59898367|NCT03091400|76020498|FG001|STARTED|Phase 2 - 6 Weeks||6||
59898368|NCT03091400|76020497|FG000|COMPLETED|Phase 2 - 6 Weeks||4||
59898369|NCT03091400|76020498|FG001|COMPLETED|Phase 2 - 6 Weeks||6||
59898370|NCT03091400|76020497|FG000|NOT COMPLETED|Phase 2 - 6 Weeks||0||
59898371|NCT03091400|76020498|FG001|NOT COMPLETED|Phase 2 - 6 Weeks||0||
59898372|NCT01318993|76020504|FG000|STARTED|Overall Study||398||
59898373|NCT01318993|76020504|FG000|COMPLETED|Overall Study||0||
59898374|NCT01318993|76020504|FG000|NOT COMPLETED|Overall Study||398||
59898375|NCT03090152|76020511|FG000|STARTED|Overall Study||60||
59898376|NCT03090152|76020512|FG001|STARTED|Overall Study||60||
59898377|NCT03090152|76020513|FG002|STARTED|Overall Study||60||
59898378|NCT03090152|76020511|FG000|COMPLETED|Overall Study||59||
59898379|NCT03090152|76020512|FG001|COMPLETED|Overall Study||56||
59898380|NCT03090152|76020513|FG002|COMPLETED|Overall Study||59||
59898381|NCT03090152|76020511|FG000|NOT COMPLETED|Overall Study||1||
59898382|NCT03090152|76020512|FG001|NOT COMPLETED|Overall Study||4||
59898383|NCT03090152|76020513|FG002|NOT COMPLETED|Overall Study||1||
59898384|NCT04252287|76020523|FG000|STARTED|Overall Study||238||
59898385|NCT04252287|76020524|FG001|STARTED|Overall Study||238||
59898386|NCT04252287|76020523|FG000|Treated (Safety Analysis Set)|Overall Study||231|Safety analysis set included all randomized participants who received at least 1 dose of study intervention.|
59898387|NCT04252287|76020524|FG001|Treated (Safety Analysis Set)|Overall Study||224|Safety analysis set included all randomized participants who received at least 1 dose of study intervention.|
59898388|NCT04252287|76020523|FG000|COMPLETED|Overall Study||207||
59898389|NCT04252287|76020524|FG001|COMPLETED|Overall Study||209||
59898390|NCT04252287|76020523|FG000|NOT COMPLETED|Overall Study||31||
59898391|NCT04252287|76020524|FG001|NOT COMPLETED|Overall Study||29||
59898392|NCT04195958|76020530|FG000|STARTED|Overall Study||3||
59898393|NCT04195958|76020530|FG000|COMPLETED|Overall Study||1||
59898394|NCT04195958|76020530|FG000|NOT COMPLETED|Overall Study||2||
59898395|NCT02735200|76020536|FG000|STARTED|Overall Study||200||
59898396|NCT02735200|76020537|FG001|STARTED|Overall Study||350||
59898397|NCT02735200|76020536|FG000|COMPLETED|Overall Study||192||
59898398|NCT02735200|76020537|FG001|COMPLETED|Overall Study||345||
59898399|NCT02735200|76020536|FG000|NOT COMPLETED|Overall Study||8||
59898400|NCT02735200|76020537|FG001|NOT COMPLETED|Overall Study||5||
59898401|NCT02946918|76020545|FG000|STARTED|Overall Study||6||
59898402|NCT02946918|76020546|FG001|STARTED|Overall Study||8||
59898403|NCT02946918|76020545|FG000|COMPLETED|Overall Study||5||
59898404|NCT02946918|76020546|FG001|COMPLETED|Overall Study||5||
59898405|NCT02946918|76020545|FG000|NOT COMPLETED|Overall Study||1||
59898406|NCT02946918|76020546|FG001|NOT COMPLETED|Overall Study||3||
59898407|NCT03011450|76020554|FG000|STARTED|12-week Efficacy||311|One participant was randomized but not assigned to a treatment group per physician decision.|
59898408|NCT03011450|76020555|FG001|STARTED|12-week Efficacy||159|One participant was randomized but not assigned to a treatment group per physician decision.|
59898409|NCT03011450|76020554|FG000|COMPLETED|12-week Efficacy||299||
59898410|NCT03011450|76020555|FG001|COMPLETED|12-week Efficacy||159||
59898411|NCT03011450|76020554|FG000|NOT COMPLETED|12-week Efficacy||12||
59898412|NCT03011450|76020555|FG001|NOT COMPLETED|12-week Efficacy||0||
59898413|NCT03011450|76020554|FG000|STARTED|40-week Extension||292|Note that 12 participants (7 participants in the K-877 group and 5 participants in the placebo/fenofibrate group) withdrew after completing the 12-week Efficacy Period and did not start the 40-week Extension Period.|
59898414|NCT03011450|76020555|FG001|STARTED|40-week Extension||154|Note that 12 participants (7 participants in the K-877 group and 5 participants in the placebo/fenofibrate group) withdrew after completing the 12-week Efficacy Period and did not start the 40-week Extension Period.|
59898415|NCT03011450|76020554|FG000|COMPLETED|40-week Extension||275||
59898416|NCT03011450|76020555|FG001|COMPLETED|40-week Extension||146||
59898417|NCT03011450|76020554|FG000|NOT COMPLETED|40-week Extension||17||
59898418|NCT03011450|76020555|FG001|NOT COMPLETED|40-week Extension||8||
59898419|NCT02734810|76020567|FG000|STARTED|Overall Study||15||
59898420|NCT02734810|76020568|FG001|STARTED|Overall Study||0||
59898421|NCT02734810|76020567|FG000|COMPLETED|Overall Study||13||
59898422|NCT02734810|76020568|FG001|COMPLETED|Overall Study||0||
59505804|NCT00763243|75598677|FG000|NOT COMPLETED|6-Month Follow-Up Period||0||
59505805|NCT00782821|75598693|FG000|STARTED|Overall Study||10||
59505806|NCT00782821|75598694|FG001|STARTED|Overall Study||10||
59505807|NCT00782821|75598695|FG002|STARTED|Overall Study||10||
59505808|NCT00782821|75598696|FG003|STARTED|Overall Study||10||
59611344|NCT01781286|75722313|FG003|Started 1st Intervention|Overall Study||8||
59898423|NCT02734810|76020567|FG000|NOT COMPLETED|Overall Study||2||
59898424|NCT02734810|76020568|FG001|NOT COMPLETED|Overall Study||0||
59898425|NCT02251106|76020577|FG000|STARTED|Overall Study||19||
59898426|NCT02251106|76020578|FG001|STARTED|Overall Study||18||
59898427|NCT02251106|76020579|FG002|STARTED|Overall Study||17||
59898428|NCT02251106|76020577|FG000|COMPLETED|Overall Study||19||
59898429|NCT02251106|76020578|FG001|COMPLETED|Overall Study||18||
59898430|NCT02251106|76020579|FG002|COMPLETED|Overall Study||17||
59898431|NCT02251106|76020577|FG000|NOT COMPLETED|Overall Study||0||
59898432|NCT02251106|76020578|FG001|NOT COMPLETED|Overall Study||0||
59898433|NCT02251106|76020579|FG002|NOT COMPLETED|Overall Study||0||
59898434|NCT03656068|76020593|FG000|STARTED|Overall Study||21||
59898435|NCT03656068|76020593|FG000|COMPLETED|Overall Study||16||
59898436|NCT03656068|76020593|FG000|NOT COMPLETED|Overall Study||5||
59898437|NCT02944383|76020600|FG000|STARTED|Overall Study||30||
59898438|NCT02944383|76020601|FG001|STARTED|Overall Study||30||
59898439|NCT02944383|76020602|FG002|STARTED|Overall Study||31||
59898440|NCT02944383|76020600|FG000|COMPLETED|Overall Study||29||
59898441|NCT02944383|76020601|FG001|COMPLETED|Overall Study||30||
59898442|NCT02944383|76020602|FG002|COMPLETED|Overall Study||30||
59898443|NCT02944383|76020600|FG000|NOT COMPLETED|Overall Study||1||
59898444|NCT02944383|76020601|FG001|NOT COMPLETED|Overall Study||0||
59898445|NCT02944383|76020602|FG002|NOT COMPLETED|Overall Study||1||
59898446|NCT03768089|76020630|FG000|STARTED|Part A||8||
59898447|NCT03768089|76020631|FG001|STARTED|Part A||5||
59898448|NCT03768089|76020632|FG002|STARTED|Part A||6||
59898449|NCT03768089|76020633|FG003|STARTED|Part A||6||
59898450|NCT03768089|76020634|FG004|STARTED|Part A||6||
59898451|NCT03768089|76020635|FG005|STARTED|Part A||6||
59898452|NCT03768089|76020636|FG006|STARTED|Part A||8||
59898453|NCT03768089|76020637|FG007|STARTED|Part A||0||
59898454|NCT03768089|76020638|FG008|STARTED|Part A||0||
59898455|NCT03768089|76020639|FG009|STARTED|Part A||0||
59898456|NCT03768089|76020640|FG010|STARTED|Part A||0||
59898457|NCT03768089|76020641|FG011|STARTED|Part A||0||
59898458|NCT03768089|76020642|FG012|STARTED|Part A||0||
59898459|NCT03768089|76020643|FG013|STARTED|Part A||0||
59898460|NCT03768089|76020644|FG014|STARTED|Part A||0||
59898461|NCT03768089|76020645|FG015|STARTED|Part A||0||
59898462|NCT03768089|76020646|FG016|STARTED|Part A||0||
59898463|NCT03768089|76020647|FG017|STARTED|Part A||0||
59898464|NCT03768089|76020630|FG000|Safety Set|Part A||8|Received at least 1 dose of study drug.|
59898465|NCT03768089|76020631|FG001|Safety Set|Part A||5|Received at least 1 dose of study drug.|
59898466|NCT03768089|76020632|FG002|Safety Set|Part A||6|Received at least 1 dose of study drug.|
59898467|NCT03768089|76020633|FG003|Safety Set|Part A||6|Received at least 1 dose of study drug.|
59898468|NCT03768089|76020634|FG004|Safety Set|Part A||6|Received at least 1 dose of study drug.|
59898469|NCT03768089|76020635|FG005|Safety Set|Part A||6|Received at least 1 dose of study drug.|
59898470|NCT03768089|76020636|FG006|Safety Set|Part A||8|Received at least 1 dose of study drug.|
59898471|NCT03768089|76020637|FG007|Safety Set|Part A||0|Received at least 1 dose of study drug.|
59898472|NCT03768089|76020638|FG008|Safety Set|Part A||0|Received at least 1 dose of study drug.|
59898473|NCT03768089|76020639|FG009|Safety Set|Part A||0|Received at least 1 dose of study drug.|
59898474|NCT03768089|76020640|FG010|Safety Set|Part A||0|Received at least 1 dose of study drug.|
59898475|NCT03768089|76020641|FG011|Safety Set|Part A||0|Received at least 1 dose of study drug.|
59898476|NCT03768089|76020642|FG012|Safety Set|Part A||0|Received at least 1 dose of study drug.|
59898477|NCT03768089|76020643|FG013|Safety Set|Part A||0|Received at least 1 dose of study drug.|
59898478|NCT03768089|76020644|FG014|Safety Set|Part A||0|Received at least 1 dose of study drug.|
59898479|NCT03768089|76020645|FG015|Safety Set|Part A||0|Received at least 1 dose of study drug.|
59898480|NCT03768089|76020646|FG016|Safety Set|Part A||0|Received at least 1 dose of study drug.|
59898481|NCT03768089|76020647|FG017|Safety Set|Part A||0|Received at least 1 dose of study drug.|
59898482|NCT03768089|76020630|FG000|COMPLETED|Part A||8||
59898483|NCT03768089|76020631|FG001|COMPLETED|Part A||5||
59898484|NCT03768089|76020632|FG002|COMPLETED|Part A||6||
59898485|NCT03768089|76020633|FG003|COMPLETED|Part A||6||
59898486|NCT03768089|76020634|FG004|COMPLETED|Part A||5||
59898487|NCT03768089|76020635|FG005|COMPLETED|Part A||6||
59898488|NCT03768089|76020636|FG006|COMPLETED|Part A||8||
59898489|NCT03768089|76020637|FG007|COMPLETED|Part A||0||
59898490|NCT03768089|76020638|FG008|COMPLETED|Part A||0||
59898491|NCT03768089|76020639|FG009|COMPLETED|Part A||0||
59898492|NCT03768089|76020640|FG010|COMPLETED|Part A||0||
59898493|NCT03768089|76020641|FG011|COMPLETED|Part A||0||
59898494|NCT03768089|76020642|FG012|COMPLETED|Part A||0||
59898495|NCT03768089|76020643|FG013|COMPLETED|Part A||0||
59898496|NCT03768089|76020644|FG014|COMPLETED|Part A||0||
59898497|NCT03768089|76020645|FG015|COMPLETED|Part A||0||
59898498|NCT03768089|76020646|FG016|COMPLETED|Part A||0||
59898499|NCT03768089|76020647|FG017|COMPLETED|Part A||0||
59898500|NCT03768089|76020630|FG000|NOT COMPLETED|Part A||0||
59898501|NCT03768089|76020631|FG001|NOT COMPLETED|Part A||0||
59898502|NCT03768089|76020632|FG002|NOT COMPLETED|Part A||0||
59898503|NCT03768089|76020633|FG003|NOT COMPLETED|Part A||0||
59898504|NCT03768089|76020634|FG004|NOT COMPLETED|Part A||1||
59898505|NCT03768089|76020635|FG005|NOT COMPLETED|Part A||0||
59898506|NCT03768089|76020636|FG006|NOT COMPLETED|Part A||0||
59898507|NCT03768089|76020637|FG007|NOT COMPLETED|Part A||0||
59898508|NCT03768089|76020638|FG008|NOT COMPLETED|Part A||0||
59898509|NCT03768089|76020639|FG009|NOT COMPLETED|Part A||0||
59898510|NCT03768089|76020640|FG010|NOT COMPLETED|Part A||0||
59898511|NCT03768089|76020641|FG011|NOT COMPLETED|Part A||0||
59898512|NCT03768089|76020642|FG012|NOT COMPLETED|Part A||0||
59898513|NCT03768089|76020643|FG013|NOT COMPLETED|Part A||0||
59898514|NCT03768089|76020644|FG014|NOT COMPLETED|Part A||0||
59898515|NCT03768089|76020645|FG015|NOT COMPLETED|Part A||0||
59898516|NCT03768089|76020646|FG016|NOT COMPLETED|Part A||0||
59898517|NCT03768089|76020647|FG017|NOT COMPLETED|Part A||0||
59898518|NCT03768089|76020630|FG000|STARTED|Part B||0||
59898519|NCT03768089|76020631|FG001|STARTED|Part B||0||
59898520|NCT03768089|76020632|FG002|STARTED|Part B||0||
59898521|NCT03768089|76020633|FG003|STARTED|Part B||0||
59898522|NCT03768089|76020634|FG004|STARTED|Part B||0||
59898523|NCT03768089|76020635|FG005|STARTED|Part B||0||
59898524|NCT03768089|76020636|FG006|STARTED|Part B||0||
59898525|NCT03768089|76020637|FG007|STARTED|Part B||9||
59898526|NCT03768089|76020638|FG008|STARTED|Part B||6||
59898527|NCT03768089|76020639|FG009|STARTED|Part B||6||
59898528|NCT03768089|76020640|FG010|STARTED|Part B|One participant who participated in A2 also participated in B3.|6||
59898529|NCT03768089|76020641|FG011|STARTED|Part B||6||
59898530|NCT03768089|76020642|FG012|STARTED|Part B||0||
59898531|NCT03768089|76020643|FG013|STARTED|Part B||0||
59898532|NCT03768089|76020644|FG014|STARTED|Part B||0||
59898533|NCT03768089|76020645|FG015|STARTED|Part B||0||
59898534|NCT03768089|76020646|FG016|STARTED|Part B||0||
59898535|NCT03768089|76020647|FG017|STARTED|Part B||0||
59898536|NCT03768089|76020630|FG000|Safety Set|Part B||0|Received at least 1 dose of study drug.|
59898537|NCT03768089|76020631|FG001|Safety Set|Part B||0|Received at least 1 dose of study drug.|
59898538|NCT03768089|76020632|FG002|Safety Set|Part B||0|Received at least 1 dose of study drug.|
59898539|NCT03768089|76020633|FG003|Safety Set|Part B||0|Received at least 1 dose of study drug.|
59898540|NCT03768089|76020634|FG004|Safety Set|Part B||0|Received at least 1 dose of study drug.|
59898541|NCT03768089|76020635|FG005|Safety Set|Part B||0|Received at least 1 dose of study drug.|
59898542|NCT03768089|76020636|FG006|Safety Set|Part B||0|Received at least 1 dose of study drug.|
59898543|NCT03768089|76020637|FG007|Safety Set|Part B||9|Received at least 1 dose of study drug.|
59898544|NCT03768089|76020638|FG008|Safety Set|Part B||6|Received at least 1 dose of study drug.|
59898545|NCT03768089|76020639|FG009|Safety Set|Part B||6|Received at least 1 dose of study drug.|
59898546|NCT03768089|76020640|FG010|Safety Set|Part B||6|Received at least 1 dose of study drug.|
59898547|NCT03768089|76020641|FG011|Safety Set|Part B||6|Received at least 1 dose of study drug.|
59898548|NCT03768089|76020642|FG012|Safety Set|Part B||0|Received at least 1 dose of study drug.|
59898549|NCT03768089|76020643|FG013|Safety Set|Part B||0|Received at least 1 dose of study drug.|
59898550|NCT03768089|76020644|FG014|Safety Set|Part B||0|Received at least 1 dose of study drug.|
59898551|NCT03768089|76020645|FG015|Safety Set|Part B||0|Received at least 1 dose of study drug.|
59898552|NCT03768089|76020646|FG016|Safety Set|Part B||0|Received at least 1 dose of study drug.|
59898553|NCT03768089|76020647|FG017|Safety Set|Part B||0|Received at least 1 dose of study drug.|
59898554|NCT03768089|76020630|FG000|COMPLETED|Part B||0||
59898555|NCT03768089|76020631|FG001|COMPLETED|Part B||0||
59898556|NCT03768089|76020632|FG002|COMPLETED|Part B||0||
59898557|NCT03768089|76020633|FG003|COMPLETED|Part B||0||
59898558|NCT03768089|76020634|FG004|COMPLETED|Part B||0||
59898559|NCT03768089|76020635|FG005|COMPLETED|Part B||0||
59898560|NCT03768089|76020636|FG006|COMPLETED|Part B||0||
59898561|NCT03768089|76020637|FG007|COMPLETED|Part B||9||
59898562|NCT03768089|76020638|FG008|COMPLETED|Part B||6||
59898563|NCT03768089|76020639|FG009|COMPLETED|Part B||6||
59898564|NCT03768089|76020640|FG010|COMPLETED|Part B||6||
59898565|NCT03768089|76020641|FG011|COMPLETED|Part B||6||
59898566|NCT03768089|76020642|FG012|COMPLETED|Part B||0||
59898567|NCT03768089|76020643|FG013|COMPLETED|Part B||0||
59898568|NCT03768089|76020644|FG014|COMPLETED|Part B||0||
59898569|NCT03768089|76020645|FG015|COMPLETED|Part B||0||
59898570|NCT03768089|76020646|FG016|COMPLETED|Part B||0||
59898571|NCT03768089|76020647|FG017|COMPLETED|Part B||0||
59898572|NCT03768089|76020630|FG000|NOT COMPLETED|Part B||0||
59898573|NCT03768089|76020631|FG001|NOT COMPLETED|Part B||0||
59898574|NCT03768089|76020632|FG002|NOT COMPLETED|Part B||0||
59898575|NCT03768089|76020633|FG003|NOT COMPLETED|Part B||0||
59898576|NCT03768089|76020634|FG004|NOT COMPLETED|Part B||0||
59898577|NCT03768089|76020635|FG005|NOT COMPLETED|Part B||0||
59898578|NCT03768089|76020636|FG006|NOT COMPLETED|Part B||0||
59898579|NCT03768089|76020637|FG007|NOT COMPLETED|Part B||0||
59898580|NCT03768089|76020638|FG008|NOT COMPLETED|Part B||0||
59898581|NCT03768089|76020639|FG009|NOT COMPLETED|Part B||0||
59898582|NCT03768089|76020640|FG010|NOT COMPLETED|Part B||0||
59898583|NCT03768089|76020641|FG011|NOT COMPLETED|Part B||0||
59898584|NCT03768089|76020642|FG012|NOT COMPLETED|Part B||0||
59898585|NCT03768089|76020643|FG013|NOT COMPLETED|Part B||0||
59898586|NCT03768089|76020644|FG014|NOT COMPLETED|Part B||0||
59898587|NCT03768089|76020645|FG015|NOT COMPLETED|Part B||0||
59898588|NCT03768089|76020646|FG016|NOT COMPLETED|Part B||0||
59898589|NCT03768089|76020647|FG017|NOT COMPLETED|Part B||0||
59898590|NCT03768089|76020630|FG000|STARTED|Part C||0||
59898591|NCT03768089|76020631|FG001|STARTED|Part C||0||
59898592|NCT03768089|76020632|FG002|STARTED|Part C||0||
59898593|NCT03768089|76020633|FG003|STARTED|Part C||0||
59898594|NCT03768089|76020634|FG004|STARTED|Part C||0||
59898595|NCT03768089|76020635|FG005|STARTED|Part C||0||
59898596|NCT03768089|76020636|FG006|STARTED|Part C||0||
59898597|NCT03768089|76020637|FG007|STARTED|Part C||0||
59898598|NCT03768089|76020638|FG008|STARTED|Part C||0||
59898599|NCT03768089|76020639|FG009|STARTED|Part C||0||
59898600|NCT03768089|76020640|FG010|STARTED|Part C||0||
59898601|NCT03768089|76020641|FG011|STARTED|Part C||0||
59898602|NCT03768089|76020642|FG012|STARTED|Part C||6||
59898603|NCT03768089|76020643|FG013|STARTED|Part C||6||
59898604|NCT03768089|76020644|FG014|STARTED|Part C||8||
59898605|NCT03768089|76020645|FG015|STARTED|Part C||6||
59898606|NCT03768089|76020646|FG016|STARTED|Part C||0||
59898607|NCT03768089|76020647|FG017|STARTED|Part C||0||
59898608|NCT03768089|76020630|FG000|Safety Set|Part C||0|Received at least 1 dose of study drug.|
59898609|NCT03768089|76020631|FG001|Safety Set|Part C||0|Received at least 1 dose of study drug.|
59898610|NCT03768089|76020632|FG002|Safety Set|Part C||0|Received at least 1 dose of study drug.|
59898611|NCT03768089|76020633|FG003|Safety Set|Part C||0|Received at least 1 dose of study drug.|
59898612|NCT03768089|76020634|FG004|Safety Set|Part C||0|Received at least 1 dose of study drug.|
59898613|NCT03768089|76020635|FG005|Safety Set|Part C||0|Received at least 1 dose of study drug.|
59898614|NCT03768089|76020636|FG006|Safety Set|Part C||0|Received at least 1 dose of study drug.|
59898615|NCT03768089|76020637|FG007|Safety Set|Part C||0|Received at least 1 dose of study drug.|
59898616|NCT03768089|76020638|FG008|Safety Set|Part C||0|Received at least 1 dose of study drug.|
59898617|NCT03768089|76020639|FG009|Safety Set|Part C||0|Received at least 1 dose of study drug.|
59898618|NCT03768089|76020640|FG010|Safety Set|Part C||0|Received at least 1 dose of study drug.|
59898619|NCT03768089|76020641|FG011|Safety Set|Part C||0|Received at least 1 dose of study drug.|
59898620|NCT03768089|76020642|FG012|Safety Set|Part C||6|Received at least 1 dose of study drug.|
59898621|NCT03768089|76020643|FG013|Safety Set|Part C||6|Received at least 1 dose of study drug.|
59898622|NCT03768089|76020644|FG014|Safety Set|Part C||7|Received at least 1 dose of study drug.|
59898623|NCT03768089|76020645|FG015|Safety Set|Part C||6|Received at least 1 dose of study drug.|
59898624|NCT03768089|76020646|FG016|Safety Set|Part C||0|Received at least 1 dose of study drug.|
59898625|NCT03768089|76020647|FG017|Safety Set|Part C||0|Received at least 1 dose of study drug.|
59898626|NCT03768089|76020630|FG000|COMPLETED|Part C||0||
59898627|NCT03768089|76020631|FG001|COMPLETED|Part C||0||
59898628|NCT03768089|76020632|FG002|COMPLETED|Part C||0||
59898629|NCT03768089|76020633|FG003|COMPLETED|Part C||0||
59898630|NCT03768089|76020634|FG004|COMPLETED|Part C||0||
59898631|NCT03768089|76020635|FG005|COMPLETED|Part C||0||
59898632|NCT03768089|76020636|FG006|COMPLETED|Part C||0||
60014113|NCT02445339|76130152|FG000|STARTED|Overall Study||25||
60014114|NCT02445339|76130153|FG001|STARTED|Overall Study||25||
60014115|NCT02445339|76130152|FG000|COMPLETED|Overall Study||13||
60014116|NCT02445339|76130153|FG001|COMPLETED|Overall Study||10||
60014117|NCT02445339|76130152|FG000|NOT COMPLETED|Overall Study||12||
60014118|NCT02445339|76130153|FG001|NOT COMPLETED|Overall Study||15||
60014119|NCT02579603|76130161|FG000|STARTED|Overall Study|Started are the randomised patients|52||
60014120|NCT02579603|76130162|FG001|STARTED|Overall Study|Started are the randomised patients|53||
60014121|NCT02579603|76130161|FG000|Number of Patients Treated|Overall Study||51||
60014122|NCT02579603|76130162|FG001|Number of Patients Treated|Overall Study||53||
59898633|NCT03768089|76020637|FG007|COMPLETED|Part C||0||
59898634|NCT03768089|76020638|FG008|COMPLETED|Part C||0||
59898635|NCT03768089|76020639|FG009|COMPLETED|Part C||0||
59898636|NCT03768089|76020640|FG010|COMPLETED|Part C||0||
59898637|NCT03768089|76020641|FG011|COMPLETED|Part C||0||
60014123|NCT02579603|76130161|FG000|COMPLETED|Overall Study||48||
60014124|NCT02579603|76130162|FG001|COMPLETED|Overall Study||51||
60014125|NCT02579603|76130161|FG000|NOT COMPLETED|Overall Study||4||
60014126|NCT02579603|76130162|FG001|NOT COMPLETED|Overall Study||2||
60014127|NCT02625259|76130174|FG000|STARTED|First Intervention (Day 1)||11||
60014128|NCT02625259|76130175|FG001|STARTED|First Intervention (Day 1)||9||
60014129|NCT02625259|76130176|FG002|STARTED|First Intervention (Day 1)||8||
60014130|NCT02625259|76130177|FG003|STARTED|First Intervention (Day 1)||10||
60014131|NCT02625259|76130178|FG004|STARTED|First Intervention (Day 1)||16||
60014132|NCT02625259|76130174|FG000|COMPLETED|First Intervention (Day 1)||9||
60014133|NCT02625259|76130175|FG001|COMPLETED|First Intervention (Day 1)||8||
60014134|NCT02625259|76130176|FG002|COMPLETED|First Intervention (Day 1)||7||
60014135|NCT02625259|76130177|FG003|COMPLETED|First Intervention (Day 1)||9||
59898638|NCT03768089|76020642|FG012|COMPLETED|Part C||6||
59898639|NCT03768089|76020643|FG013|COMPLETED|Part C||6||
59898640|NCT03768089|76020644|FG014|COMPLETED|Part C||7||
59898641|NCT03768089|76020645|FG015|COMPLETED|Part C||6||
59898642|NCT03768089|76020646|FG016|COMPLETED|Part C||0||
59898643|NCT03768089|76020647|FG017|COMPLETED|Part C||0||
59898644|NCT03768089|76020630|FG000|NOT COMPLETED|Part C||0||
59898645|NCT03768089|76020631|FG001|NOT COMPLETED|Part C||0||
59898646|NCT03768089|76020632|FG002|NOT COMPLETED|Part C||0||
59898647|NCT03768089|76020633|FG003|NOT COMPLETED|Part C||0||
59898648|NCT03768089|76020634|FG004|NOT COMPLETED|Part C||0||
59898649|NCT03768089|76020635|FG005|NOT COMPLETED|Part C||0||
59898650|NCT03768089|76020636|FG006|NOT COMPLETED|Part C||0||
59898651|NCT03768089|76020637|FG007|NOT COMPLETED|Part C||0||
59898652|NCT03768089|76020638|FG008|NOT COMPLETED|Part C||0||
59898653|NCT03768089|76020639|FG009|NOT COMPLETED|Part C||0||
60014136|NCT02625259|76130178|FG004|COMPLETED|First Intervention (Day 1)||16||
60014137|NCT02625259|76130174|FG000|NOT COMPLETED|First Intervention (Day 1)||2||
60014138|NCT02625259|76130175|FG001|NOT COMPLETED|First Intervention (Day 1)||1||
60014139|NCT02625259|76130176|FG002|NOT COMPLETED|First Intervention (Day 1)||1||
59898654|NCT03768089|76020640|FG010|NOT COMPLETED|Part C||0||
59898655|NCT03768089|76020641|FG011|NOT COMPLETED|Part C||0||
59898656|NCT03768089|76020642|FG012|NOT COMPLETED|Part C||0||
59898657|NCT03768089|76020643|FG013|NOT COMPLETED|Part C||0||
59898658|NCT03768089|76020644|FG014|NOT COMPLETED|Part C||1||
59898659|NCT03768089|76020645|FG015|NOT COMPLETED|Part C||0||
59898660|NCT03768089|76020646|FG016|NOT COMPLETED|Part C||0||
59898661|NCT03768089|76020647|FG017|NOT COMPLETED|Part C||0||
59898662|NCT03768089|76020630|FG000|STARTED|Part D||0||
59898663|NCT03768089|76020631|FG001|STARTED|Part D||0||
59898664|NCT03768089|76020632|FG002|STARTED|Part D||0||
59898665|NCT03768089|76020633|FG003|STARTED|Part D||0||
59898666|NCT03768089|76020634|FG004|STARTED|Part D||0||
59898667|NCT03768089|76020635|FG005|STARTED|Part D||0||
59898668|NCT03768089|76020636|FG006|STARTED|Part D||0||
59898669|NCT03768089|76020637|FG007|STARTED|Part D||0||
59898670|NCT03768089|76020638|FG008|STARTED|Part D||0||
59898671|NCT03768089|76020639|FG009|STARTED|Part D||0||
59898672|NCT03768089|76020640|FG010|STARTED|Part D||0||
59898673|NCT03768089|76020641|FG011|STARTED|Part D||0||
59898674|NCT03768089|76020642|FG012|STARTED|Part D||0||
59898675|NCT03768089|76020643|FG013|STARTED|Part D||0||
59898676|NCT03768089|76020644|FG014|STARTED|Part D||0||
59898677|NCT03768089|76020645|FG015|STARTED|Part D||0||
59898678|NCT03768089|76020646|FG016|STARTED|Part D||3||
59898679|NCT03768089|76020647|FG017|STARTED|Part D||9||
59898680|NCT03768089|76020630|FG000|Safety Set|Part D||0|Received at least 1 dose of study drug.|
59898681|NCT03768089|76020631|FG001|Safety Set|Part D||0|Received at least 1 dose of study drug.|
59898682|NCT03768089|76020632|FG002|Safety Set|Part D||0|Received at least 1 dose of study drug.|
59898683|NCT03768089|76020633|FG003|Safety Set|Part D||0|Received at least 1 dose of study drug.|
59898684|NCT03768089|76020634|FG004|Safety Set|Part D||0|Received at least 1 dose of study drug.|
59898685|NCT03768089|76020635|FG005|Safety Set|Part D||0|Received at least 1 dose of study drug.|
59898686|NCT03768089|76020636|FG006|Safety Set|Part D||0|Received at least 1 dose of study drug.|
59898687|NCT03768089|76020637|FG007|Safety Set|Part D||0|Received at least 1 dose of study drug.|
59898688|NCT03768089|76020638|FG008|Safety Set|Part D||0|Received at least 1 dose of study drug.|
59898689|NCT03768089|76020639|FG009|Safety Set|Part D||0|Received at least 1 dose of study drug.|
59898690|NCT03768089|76020640|FG010|Safety Set|Part D||0|Received at least 1 dose of study drug.|
59898691|NCT03768089|76020641|FG011|Safety Set|Part D||0|Received at least 1 dose of study drug.|
59898692|NCT03768089|76020642|FG012|Safety Set|Part D||0|Received at least 1 dose of study drug.|
59898693|NCT03768089|76020643|FG013|Safety Set|Part D||0|Received at least 1 dose of study drug.|
59898694|NCT03768089|76020644|FG014|Safety Set|Part D||0|Received at least 1 dose of study drug.|
59898695|NCT03768089|76020645|FG015|Safety Set|Part D||0|Received at least 1 dose of study drug.|
59898696|NCT03768089|76020646|FG016|Safety Set|Part D||3|Received at least 1 dose of study drug.|
59898697|NCT03768089|76020647|FG017|Safety Set|Part D||9|Received at least 1 dose of study drug.|
59898698|NCT03768089|76020630|FG000|COMPLETED|Part D||0||
59898699|NCT03768089|76020631|FG001|COMPLETED|Part D||0||
59898700|NCT03768089|76020632|FG002|COMPLETED|Part D||0||
59898701|NCT03768089|76020633|FG003|COMPLETED|Part D||0||
59898702|NCT03768089|76020634|FG004|COMPLETED|Part D||0||
59898703|NCT03768089|76020635|FG005|COMPLETED|Part D||0||
59898704|NCT03768089|76020636|FG006|COMPLETED|Part D||0||
59898705|NCT03768089|76020637|FG007|COMPLETED|Part D||0||
59898706|NCT03768089|76020638|FG008|COMPLETED|Part D||0||
59898707|NCT03768089|76020639|FG009|COMPLETED|Part D||0||
59898708|NCT03768089|76020640|FG010|COMPLETED|Part D||0||
59898709|NCT03768089|76020641|FG011|COMPLETED|Part D||0||
59898710|NCT03768089|76020642|FG012|COMPLETED|Part D||0||
59898711|NCT03768089|76020643|FG013|COMPLETED|Part D||0||
59898712|NCT03768089|76020644|FG014|COMPLETED|Part D||0||
59898713|NCT03768089|76020645|FG015|COMPLETED|Part D||0||
59898714|NCT03768089|76020646|FG016|COMPLETED|Part D||3||
59898715|NCT03768089|76020647|FG017|COMPLETED|Part D||9||
59505809|NCT00782821|75598693|FG000|COMPLETED|Overall Study||10||
59898716|NCT03768089|76020630|FG000|NOT COMPLETED|Part D||0||
59898717|NCT03768089|76020631|FG001|NOT COMPLETED|Part D||0||
59898718|NCT03768089|76020632|FG002|NOT COMPLETED|Part D||0||
59898719|NCT03768089|76020633|FG003|NOT COMPLETED|Part D||0||
59898720|NCT03768089|76020634|FG004|NOT COMPLETED|Part D||0||
59898721|NCT03768089|76020635|FG005|NOT COMPLETED|Part D||0||
59898722|NCT03768089|76020636|FG006|NOT COMPLETED|Part D||0||
59898723|NCT03768089|76020637|FG007|NOT COMPLETED|Part D||0||
59898724|NCT03768089|76020638|FG008|NOT COMPLETED|Part D||0||
59898725|NCT03768089|76020639|FG009|NOT COMPLETED|Part D||0||
59898726|NCT03768089|76020640|FG010|NOT COMPLETED|Part D||0||
59898727|NCT03768089|76020641|FG011|NOT COMPLETED|Part D||0||
59898728|NCT03768089|76020642|FG012|NOT COMPLETED|Part D||0||
59898729|NCT03768089|76020643|FG013|NOT COMPLETED|Part D||0||
59898730|NCT03768089|76020644|FG014|NOT COMPLETED|Part D||0||
59898731|NCT03768089|76020645|FG015|NOT COMPLETED|Part D||0||
59898732|NCT03768089|76020646|FG016|NOT COMPLETED|Part D||0||
59898733|NCT03768089|76020647|FG017|NOT COMPLETED|Part D||0||
59898734|NCT03548584|76020705|FG000|STARTED|Overall Study||75||
59898735|NCT03548584|76020706|FG001|STARTED|Overall Study||153||
59898736|NCT03548584|76020707|FG002|STARTED|Overall Study||117||
59898737|NCT03548584|76020705|FG000|Intent-to-treat Population|Overall Study||73|Intent-to-treat (ITT) Population consisted of all participants in the randomized sample, who took at least 1 dose of investigational medical product (IMP) and had a baseline and at least one post-baseline evaluation for the Cohen-Mansfield Agitation Inventory (CMAI) total score.|
59898738|NCT03548584|76020706|FG001|Intent-to-treat Population|Overall Study||153|Intent-to-treat (ITT) Population consisted of all participants in the randomized sample, who took at least 1 dose of investigational medical product (IMP) and had a baseline and at least one post-baseline evaluation for the Cohen-Mansfield Agitation Inventory (CMAI) total score.|
59898739|NCT03548584|76020707|FG002|Intent-to-treat Population|Overall Study||116|Intent-to-treat (ITT) Population consisted of all participants in the randomized sample, who took at least 1 dose of investigational medical product (IMP) and had a baseline and at least one post-baseline evaluation for the Cohen-Mansfield Agitation Inventory (CMAI) total score.|
59898740|NCT03548584|76020705|FG000|COMPLETED|Overall Study||68||
59898741|NCT03548584|76020706|FG001|COMPLETED|Overall Study||130||
59898742|NCT03548584|76020707|FG002|COMPLETED|Overall Study||104||
59898743|NCT03548584|76020705|FG000|NOT COMPLETED|Overall Study||7||
59898744|NCT03548584|76020706|FG001|NOT COMPLETED|Overall Study||23||
59898745|NCT03548584|76020707|FG002|NOT COMPLETED|Overall Study||13||
60014140|NCT02625259|76130177|FG003|NOT COMPLETED|First Intervention (Day 1)||1||
60014141|NCT02625259|76130178|FG004|NOT COMPLETED|First Intervention (Day 1)||0||
60014142|NCT02625259|76130174|FG000|STARTED|Washout (Day 2 to Day 14)||9||
60014143|NCT02625259|76130175|FG001|STARTED|Washout (Day 2 to Day 14)||8||
60014144|NCT02625259|76130176|FG002|STARTED|Washout (Day 2 to Day 14)||7||
60014145|NCT02625259|76130177|FG003|STARTED|Washout (Day 2 to Day 14)||9||
60014146|NCT02625259|76130178|FG004|STARTED|Washout (Day 2 to Day 14)||0||
60014147|NCT02625259|76130174|FG000|COMPLETED|Washout (Day 2 to Day 14)||9||
60014148|NCT02625259|76130175|FG001|COMPLETED|Washout (Day 2 to Day 14)||8||
60014149|NCT02625259|76130176|FG002|COMPLETED|Washout (Day 2 to Day 14)||7||
60014150|NCT02625259|76130177|FG003|COMPLETED|Washout (Day 2 to Day 14)||9||
59505810|NCT00782821|75598694|FG001|COMPLETED|Overall Study||10||
59898746|NCT01491620|76020714|FG000|STARTED|Overall Study||24||
59898747|NCT01491620|76020714|FG000|COMPLETED|Overall Study||24||
59898748|NCT01491620|76020714|FG000|NOT COMPLETED|Overall Study||0||
59898749|NCT03086330|76020720|FG000|STARTED|Overall Study||151||
59898750|NCT03086330|76020721|FG001|STARTED|Overall Study||151||
59898751|NCT03086330|76020720|FG000|Exposed|Overall Study||150||
59898752|NCT03086330|76020721|FG001|Exposed|Overall Study||151||
59898753|NCT03086330|76020720|FG000|COMPLETED|Overall Study||147||
59898754|NCT03086330|76020721|FG001|COMPLETED|Overall Study||147||
59898755|NCT03086330|76020720|FG000|NOT COMPLETED|Overall Study||4||
60014151|NCT02625259|76130178|FG004|COMPLETED|Washout (Day 2 to Day 14)||0||
59505811|NCT00782821|75598695|FG002|COMPLETED|Overall Study||9||
59505812|NCT00782821|75598696|FG003|COMPLETED|Overall Study||8||
59757358|NCT03963232|75876470|FG000|NOT COMPLETED|Double-Blind Treatment Phase||17||
59757359|NCT03963232|75876471|FG001|NOT COMPLETED|Double-Blind Treatment Phase||16||
59757360|NCT03963232|75876470|FG000|STARTED|Open-Label Treatment Phase|Participants from double-blind treatment phase had the option to enter the open-label treatment phase or proceed directly to the follow-up phase.|241||
60014152|NCT02625259|76130174|FG000|NOT COMPLETED|Washout (Day 2 to Day 14)||0||
59757361|NCT03963232|75876471|FG001|STARTED|Open-Label Treatment Phase|Participants from double-blind treatment phase had the option to enter the open-label treatment phase or proceed directly to the follow-up phase.|243||
59757362|NCT03963232|75876470|FG000|COMPLETED|Open-Label Treatment Phase||234||
59757363|NCT03963232|75876471|FG001|COMPLETED|Open-Label Treatment Phase||232||
59757364|NCT03963232|75876470|FG000|NOT COMPLETED|Open-Label Treatment Phase||7||
59762592|NCT02704156|75882401|FG001|NOT COMPLETED|Overall Study||0||
60014153|NCT02625259|76130175|FG001|NOT COMPLETED|Washout (Day 2 to Day 14)||0||
60014154|NCT02625259|76130176|FG002|NOT COMPLETED|Washout (Day 2 to Day 14)||0||
60014155|NCT02625259|76130177|FG003|NOT COMPLETED|Washout (Day 2 to Day 14)||0||
60014156|NCT02625259|76130178|FG004|NOT COMPLETED|Washout (Day 2 to Day 14)||0||
60014157|NCT02625259|76130174|FG000|STARTED|Second Intervention (Day 15)||9||
60014158|NCT02625259|76130175|FG001|STARTED|Second Intervention (Day 15)||8||
60014159|NCT02625259|76130176|FG002|STARTED|Second Intervention (Day 15)||7||
59505813|NCT00782821|75598693|FG000|NOT COMPLETED|Overall Study||0||
59505814|NCT00782821|75598694|FG001|NOT COMPLETED|Overall Study||0||
59898756|NCT03086330|76020721|FG001|NOT COMPLETED|Overall Study||4||
59898757|NCT03233217|76020732|FG000|STARTED|Overall Study||5|Randomized and vaccinated.|
59898758|NCT03233217|76020733|FG001|STARTED|Overall Study||5|Randomized and vaccinated.|
59898759|NCT03233217|76020734|FG002|STARTED|Overall Study||55|Randomized and vaccinated.|
59898760|NCT03233217|76020735|FG003|STARTED|Overall Study||55|Randomized and vaccinated.|
59898761|NCT03233217|76020736|FG004|STARTED|Overall Study||55|Randomized and vaccinated.|
59898762|NCT03233217|76020732|FG000|Safety Analysis Set (SafAS)|Overall Study||5||
59898763|NCT03233217|76020733|FG001|Safety Analysis Set (SafAS)|Overall Study||5||
59898764|NCT03233217|76020734|FG002|Safety Analysis Set (SafAS)|Overall Study||55||
59898765|NCT03233217|76020735|FG003|Safety Analysis Set (SafAS)|Overall Study||55||
59898766|NCT03233217|76020736|FG004|Safety Analysis Set (SafAS)|Overall Study||55||
59898767|NCT03233217|76020732|FG000|Per-protocol Analysis Set (PPAS)|Overall Study||5|Cohort 1 = 10 participants, and Cohort 2 = 164 participants|
59898768|NCT03233217|76020733|FG001|Per-protocol Analysis Set (PPAS)|Overall Study||5|Cohort 1 = 10 participants, and Cohort 2 = 164 participants|
59898769|NCT03233217|76020734|FG002|Per-protocol Analysis Set (PPAS)|Overall Study||55|Cohort 1 = 10 participants, and Cohort 2 = 164 participants|
59898770|NCT03233217|76020735|FG003|Per-protocol Analysis Set (PPAS)|Overall Study||55|Cohort 1 = 10 participants, and Cohort 2 = 164 participants|
59898771|NCT03233217|76020736|FG004|Per-protocol Analysis Set (PPAS)|Overall Study||54|Cohort 1 = 10 participants, and Cohort 2 = 164 participants|
59898772|NCT03233217|76020732|FG000|COMPLETED|Overall Study||5||
59898773|NCT03233217|76020733|FG001|COMPLETED|Overall Study||5||
59898774|NCT03233217|76020734|FG002|COMPLETED|Overall Study||55||
59898775|NCT03233217|76020735|FG003|COMPLETED|Overall Study||55||
59898776|NCT03233217|76020736|FG004|COMPLETED|Overall Study||55||
59898777|NCT03233217|76020732|FG000|NOT COMPLETED|Overall Study||0||
59898778|NCT03233217|76020733|FG001|NOT COMPLETED|Overall Study||0||
59898779|NCT03233217|76020734|FG002|NOT COMPLETED|Overall Study||0||
59898780|NCT03233217|76020735|FG003|NOT COMPLETED|Overall Study||0||
59898781|NCT03233217|76020736|FG004|NOT COMPLETED|Overall Study||0||
59898782|NCT02681614|76020748|FG000|STARTED|Overall Study||5||
59898783|NCT02681614|76020748|FG000|COMPLETED|Overall Study||5||
59898784|NCT02681614|76020748|FG000|NOT COMPLETED|Overall Study||0||
59898785|NCT02943993|76020753|FG000|STARTED|Overall Study|Disposition data are based on Baseline Analysis Set (BAS) defined as All-Documented Patient Set participants with any documentation at the Baseline data collection point who fulfil the BAS criteria.|2655||
59898786|NCT02943993|76020753|FG000|COMPLETED|Overall Study||2325||
59898787|NCT02943993|76020753|FG000|NOT COMPLETED|Overall Study||330||
59898788|NCT03961256|76020759|FG000|STARTED|Overall Study||6||
59898789|NCT03961256|76020760|FG001|STARTED|Overall Study||3||
59898790|NCT03961256|76020759|FG000|COMPLETED|Overall Study||6||
59898791|NCT03961256|76020760|FG001|COMPLETED|Overall Study||3||
59898792|NCT03961256|76020759|FG000|NOT COMPLETED|Overall Study||0||
59898793|NCT03961256|76020760|FG001|NOT COMPLETED|Overall Study||0||
59898794|NCT03747497|76020767|FG000|STARTED|Overall Study||131||
59898795|NCT03747497|76020768|FG001|STARTED|Overall Study||65||
59898796|NCT03747497|76020767|FG000|COMPLETED|Overall Study||106||
59898797|NCT03747497|76020768|FG001|COMPLETED|Overall Study||55||
59898798|NCT03747497|76020767|FG000|NOT COMPLETED|Overall Study||25||
59898799|NCT03747497|76020768|FG001|NOT COMPLETED|Overall Study||10||
59898800|NCT02943447|76020777|FG000|STARTED|Blinded Study Phase||28||
59898801|NCT02943447|76020778|FG001|STARTED|Blinded Study Phase||30||
59898802|NCT02943447|76020779|FG002|STARTED|Blinded Study Phase||13||
59898803|NCT02943447|76020777|FG000|COMPLETED|Blinded Study Phase||23||
59898804|NCT02943447|76020778|FG001|COMPLETED|Blinded Study Phase||28||
59898805|NCT02943447|76020779|FG002|COMPLETED|Blinded Study Phase||12||
59898806|NCT02943447|76020777|FG000|NOT COMPLETED|Blinded Study Phase||5||
59898807|NCT02943447|76020778|FG001|NOT COMPLETED|Blinded Study Phase||2||
59898808|NCT02943447|76020779|FG002|NOT COMPLETED|Blinded Study Phase||1||
59898809|NCT02943447|76020777|FG000|STARTED|Open-Label Extension Phase||23||
59898810|NCT02943447|76020778|FG001|STARTED|Open-Label Extension Phase||28||
59898811|NCT02943447|76020779|FG002|STARTED|Open-Label Extension Phase||12||
59898812|NCT02943447|76020777|FG000|COMPLETED|Open-Label Extension Phase||5||
59898813|NCT02943447|76020778|FG001|COMPLETED|Open-Label Extension Phase||3||
59898814|NCT02943447|76020779|FG002|COMPLETED|Open-Label Extension Phase||2||
59898815|NCT02943447|76020777|FG000|NOT COMPLETED|Open-Label Extension Phase||18||
59898816|NCT02943447|76020778|FG001|NOT COMPLETED|Open-Label Extension Phase||25||
59898817|NCT02943447|76020779|FG002|NOT COMPLETED|Open-Label Extension Phase||10||
59898818|NCT03679013|76020798|FG000|STARTED|Overall Study||8||
59898819|NCT03679013|76020799|FG001|STARTED|Overall Study||11||
59898820|NCT03679013|76020798|FG000|COMPLETED|Overall Study||8||
59898821|NCT03679013|76020799|FG001|COMPLETED|Overall Study||7||
59898822|NCT03679013|76020798|FG000|NOT COMPLETED|Overall Study||0||
59898823|NCT03679013|76020799|FG001|NOT COMPLETED|Overall Study||4||
59898824|NCT02844777|76020808|FG000|STARTED|Overall Study||29||
59898825|NCT02844777|76020809|FG001|STARTED|Overall Study||32||
59898826|NCT02844777|76020810|FG002|STARTED|Overall Study||32||
59898827|NCT02844777|76020808|FG000|COMPLETED|Overall Study||27||
59898828|NCT02844777|76020809|FG001|COMPLETED|Overall Study||32||
59898829|NCT02844777|76020810|FG002|COMPLETED|Overall Study||32||
59898830|NCT02844777|76020808|FG000|NOT COMPLETED|Overall Study||2||
59898831|NCT02844777|76020809|FG001|NOT COMPLETED|Overall Study||0||
59898832|NCT02844777|76020810|FG002|NOT COMPLETED|Overall Study||0||
59898833|NCT02612337|76020820|FG000|STARTED|Overall Study||83||
59898834|NCT02612337|76020821|FG001|STARTED|Overall Study||83||
59898835|NCT02612337|76020820|FG000|Received Study Drug|Overall Study||83||
59898836|NCT02612337|76020821|FG001|Received Study Drug|Overall Study||82||
59898837|NCT02612337|76020820|FG000|COMPLETED|Overall Study||80||
59898838|NCT02612337|76020821|FG001|COMPLETED|Overall Study||80||
59898839|NCT02612337|76020820|FG000|NOT COMPLETED|Overall Study||3||
59898840|NCT02612337|76020821|FG001|NOT COMPLETED|Overall Study||3||
59898841|NCT03641937|76020829|FG000|STARTED|Overall Study||10||
59898842|NCT03641937|76020829|FG000|COMPLETED|Overall Study||10||
59898843|NCT03641937|76020829|FG000|NOT COMPLETED|Overall Study||0||
59898844|NCT03532451|76020835|FG000|STARTED|Overall Study||13||
59898845|NCT03532451|76020836|FG001|STARTED|Overall Study||30||
59898846|NCT03532451|76020835|FG000|COMPLETED|Overall Study||12||
59898847|NCT03532451|76020836|FG001|COMPLETED|Overall Study||29||
59898848|NCT03532451|76020835|FG000|NOT COMPLETED|Overall Study||1||
59898849|NCT03532451|76020836|FG001|NOT COMPLETED|Overall Study||1||
59898850|NCT03085238|76020842|FG000|STARTED|Overall Study||23||
59898851|NCT03085238|76020842|FG000|1 Month|Overall Study||23||
59898852|NCT03085238|76020842|FG000|3 Months|Overall Study||22||
59898853|NCT03085238|76020842|FG000|6 Months|Overall Study||19||
59898854|NCT03085238|76020842|FG000|9 Months|Overall Study||16||
59898855|NCT03085238|76020842|FG000|12 Months|Overall Study||14||
59898856|NCT03085238|76020842|FG000|15 Months|Overall Study||11||
59898857|NCT03085238|76020842|FG000|18 Months|Overall Study||7||
59898858|NCT03085238|76020842|FG000|COMPLETED|Overall Study||19||
59898859|NCT03085238|76020842|FG000|NOT COMPLETED|Overall Study||4||
59898860|NCT03383666|76020855|FG000|STARTED|Overall Study||21||
59898861|NCT03383666|76020855|FG000|Implanted With Pulse Rider|Overall Study||18||
59898862|NCT03383666|76020855|FG000|Attempted But Unsuccessful Implantation|Overall Study||3||
59898863|NCT03383666|76020855|FG000|COMPLETED|Overall Study||17||
59898864|NCT03383666|76020855|FG000|NOT COMPLETED|Overall Study||4||
59898865|NCT03086018|76020859|FG000|STARTED|Field Testing||30||
59898866|NCT03086018|76020859|FG000|COMPLETED|Field Testing||30||
59898867|NCT03086018|76020859|FG000|NOT COMPLETED|Field Testing||0||
59898868|NCT03086018|76020859|FG000|STARTED|Final Testing for End of Trial||30||
59898869|NCT03086018|76020859|FG000|COMPLETED|Final Testing for End of Trial||28||
59898870|NCT03086018|76020859|FG000|NOT COMPLETED|Final Testing for End of Trial||2||
59898871|NCT03319953|76020869|FG000|STARTED|Period 1 (Day 1 to 14)||3||
59898872|NCT03319953|76020870|FG001|STARTED|Period 1 (Day 1 to 14)||4||
59898873|NCT03319953|76020871|FG002|STARTED|Period 1 (Day 1 to 14)||9||
59898874|NCT03319953|76020872|FG003|STARTED|Period 1 (Day 1 to 14)||7||
59898875|NCT03319953|76020869|FG000|COMPLETED|Period 1 (Day 1 to 14)||3|Completed = Participants who completed study treatment.|
59898876|NCT03319953|76020870|FG001|COMPLETED|Period 1 (Day 1 to 14)||4|Completed = Participants who completed study treatment.|
59898877|NCT03319953|76020871|FG002|COMPLETED|Period 1 (Day 1 to 14)||9|Completed = Participants who completed study treatment.|
59898878|NCT03319953|76020872|FG003|COMPLETED|Period 1 (Day 1 to 14)||7|Completed = Participants who completed study treatment.|
59898879|NCT03319953|76020869|FG000|NOT COMPLETED|Period 1 (Day 1 to 14)||0||
59898880|NCT03319953|76020870|FG001|NOT COMPLETED|Period 1 (Day 1 to 14)||0||
59898881|NCT03319953|76020871|FG002|NOT COMPLETED|Period 1 (Day 1 to 14)||0||
59898882|NCT03319953|76020872|FG003|NOT COMPLETED|Period 1 (Day 1 to 14)||0||
59898883|NCT03319953|76020869|FG000|STARTED|Washout Period (Day 15 to 49)||3||
59898884|NCT03319953|76020870|FG001|STARTED|Washout Period (Day 15 to 49)||4||
59898885|NCT03319953|76020871|FG002|STARTED|Washout Period (Day 15 to 49)||9||
59898886|NCT03319953|76020872|FG003|STARTED|Washout Period (Day 15 to 49)||7||
59898887|NCT03319953|76020869|FG000|COMPLETED|Washout Period (Day 15 to 49)||3||
59898888|NCT03319953|76020870|FG001|COMPLETED|Washout Period (Day 15 to 49)||4||
59898889|NCT03319953|76020871|FG002|COMPLETED|Washout Period (Day 15 to 49)||9||
59898890|NCT03319953|76020872|FG003|COMPLETED|Washout Period (Day 15 to 49)||7||
59898891|NCT03319953|76020869|FG000|NOT COMPLETED|Washout Period (Day 15 to 49)||0||
59898892|NCT03319953|76020870|FG001|NOT COMPLETED|Washout Period (Day 15 to 49)||0||
59898893|NCT03319953|76020871|FG002|NOT COMPLETED|Washout Period (Day 15 to 49)||0||
59898894|NCT03319953|76020872|FG003|NOT COMPLETED|Washout Period (Day 15 to 49)||0||
59898895|NCT03319953|76020869|FG000|STARTED|Period 2 (Day 49 to 154)||3||
59898896|NCT03319953|76020870|FG001|STARTED|Period 2 (Day 49 to 154)||4||
59898897|NCT03319953|76020871|FG002|STARTED|Period 2 (Day 49 to 154)||9||
59898898|NCT03319953|76020872|FG003|STARTED|Period 2 (Day 49 to 154)||7||
59898899|NCT03319953|76020869|FG000|Treated|Period 2 (Day 49 to 154)||2|3 participants discontinued before receiving their respective treatment, per sequence, in Period 2.|
59898900|NCT03319953|76020870|FG001|Treated|Period 2 (Day 49 to 154)||4|3 participants discontinued before receiving their respective treatment, per sequence, in Period 2.|
59898901|NCT03319953|76020871|FG002|Treated|Period 2 (Day 49 to 154)||8|3 participants discontinued before receiving their respective treatment, per sequence, in Period 2.|
59951047|NCT05120115|76069981|FG000|STARTED|Overall Study||21||
59951048|NCT05120115|76069981|FG000|no Weight|Overall Study||21||
59951049|NCT05120115|76069981|FG000|4kg and Bilateral Weight Distribution|Overall Study||21||
59951050|NCT05120115|76069981|FG000|6kg and Bilateral Weight Distriubtion|Overall Study||21||
59898902|NCT03319953|76020872|FG003|Treated|Period 2 (Day 49 to 154)||6|3 participants discontinued before receiving their respective treatment, per sequence, in Period 2.|
59898903|NCT03319953|76020869|FG000|COMPLETED|Period 2 (Day 49 to 154)||2|Completed = Participants who completed study treatment.|
59898904|NCT03319953|76020870|FG001|COMPLETED|Period 2 (Day 49 to 154)||4|Completed = Participants who completed study treatment.|
59898905|NCT03319953|76020871|FG002|COMPLETED|Period 2 (Day 49 to 154)||8|Completed = Participants who completed study treatment.|
59898906|NCT03319953|76020872|FG003|COMPLETED|Period 2 (Day 49 to 154)||6|Completed = Participants who completed study treatment.|
59898907|NCT03319953|76020869|FG000|NOT COMPLETED|Period 2 (Day 49 to 154)||1||
59898908|NCT03319953|76020870|FG001|NOT COMPLETED|Period 2 (Day 49 to 154)||0||
59898909|NCT03319953|76020871|FG002|NOT COMPLETED|Period 2 (Day 49 to 154)||1||
59898910|NCT03319953|76020872|FG003|NOT COMPLETED|Period 2 (Day 49 to 154)||1||
59898911|NCT02927834|76020883|FG000|STARTED|Overall Study||8||
59898912|NCT02927834|76020884|FG001|STARTED|Overall Study||8||
59898913|NCT02927834|76020885|FG002|STARTED|Overall Study||8||
59898914|NCT02927834|76020883|FG000|COMPLETED|Overall Study||7||
59898915|NCT02927834|76020884|FG001|COMPLETED|Overall Study||6||
59898916|NCT02927834|76020885|FG002|COMPLETED|Overall Study||6||
59898917|NCT02927834|76020883|FG000|NOT COMPLETED|Overall Study||1||
59898918|NCT02927834|76020884|FG001|NOT COMPLETED|Overall Study||2||
59898919|NCT02927834|76020885|FG002|NOT COMPLETED|Overall Study||2||
59898920|NCT03318497|76020893|FG000|STARTED|Overall Study||6||
59898921|NCT03318497|76020893|FG000|COMPLETED|Overall Study||2||
59898922|NCT03318497|76020893|FG000|NOT COMPLETED|Overall Study||4||
59898923|NCT01964547|76020899|FG000|STARTED|Overall Study||62||
59898924|NCT01964547|76020900|FG001|STARTED|Overall Study||59||
59898925|NCT01964547|76020899|FG000|COMPLETED|Overall Study||50||
59898926|NCT01964547|76020900|FG001|COMPLETED|Overall Study||48||
59898927|NCT01964547|76020899|FG000|NOT COMPLETED|Overall Study||12||
59898928|NCT01964547|76020900|FG001|NOT COMPLETED|Overall Study||11||
59898929|NCT03319719|76020906|FG000|STARTED|Overall Study||52||
59898930|NCT03319719|76020906|FG000|COMPLETED|Overall Study||51||
59898931|NCT03319719|76020906|FG000|NOT COMPLETED|Overall Study||1||
59898932|NCT03318783|76020914|FG000|STARTED|Overall Study||10||
59898933|NCT03318783|76020915|FG001|STARTED|Overall Study||10||
59898934|NCT03318783|76020914|FG000|COMPLETED|Overall Study||10||
59898935|NCT03318783|76020915|FG001|COMPLETED|Overall Study||8||
59898936|NCT03318783|76020914|FG000|NOT COMPLETED|Overall Study||0||
59898937|NCT03318783|76020915|FG001|NOT COMPLETED|Overall Study||2||
59898938|NCT01313689|76020926|FG000|STARTED|24-Week Randomization 1||79||
59898939|NCT01313689|76020927|FG001|STARTED|24-Week Randomization 1|Of the 43 participants in the PC arm, 22 entered the OFA Salvage arm.|43||
59898940|NCT01313689|76020928|FG002|STARTED|24-Week Randomization 1||0||
59898941|NCT01313689|76020929|FG003|STARTED|24-Week Randomization 1||0||
59898942|NCT01313689|76020930|FG004|STARTED|24-Week Randomization 1||0||
59898943|NCT01313689|76020926|FG000|COMPLETED|24-Week Randomization 1|Par. not entering Randomization 2 continued visits for Follow-up and overall survival assessment|60||
59898944|NCT01313689|76020927|FG001|COMPLETED|24-Week Randomization 1|Par. that did not receive OFA salvage continued visits for Follow-up and overall survival assessment|33||
59898945|NCT01313689|76020928|FG002|COMPLETED|24-Week Randomization 1||0||
59898946|NCT01313689|76020929|FG003|COMPLETED|24-Week Randomization 1||0||
59898947|NCT01313689|76020930|FG004|COMPLETED|24-Week Randomization 1||0||
59898948|NCT01313689|76020926|FG000|NOT COMPLETED|24-Week Randomization 1||19||
59898949|NCT01313689|76020927|FG001|NOT COMPLETED|24-Week Randomization 1||10||
59898950|NCT01313689|76020928|FG002|NOT COMPLETED|24-Week Randomization 1||0||
59898951|NCT01313689|76020929|FG003|NOT COMPLETED|24-Week Randomization 1||0||
59898952|NCT01313689|76020930|FG004|NOT COMPLETED|24-Week Randomization 1||0||
59898953|NCT01313689|76020926|FG000|STARTED|24-Week Randomization 2||0||
59898954|NCT01313689|76020927|FG001|STARTED|24-Week Randomization 2||0||
59898955|NCT01313689|76020928|FG002|STARTED|24-Week Randomization 2|Not all participants from Randomization 1 continued to Randomization 2.|24||
59898956|NCT01313689|76020929|FG003|STARTED|24-Week Randomization 2|Not all participants from Randomization 1 continued to Randomization 2.|13||
59898957|NCT01313689|76020930|FG004|STARTED|24-Week Randomization 2|OFA Participants who did not enter Randomization 2.|42||
59898958|NCT01313689|76020926|FG000|COMPLETED|24-Week Randomization 2||0||
59898959|NCT01313689|76020927|FG001|COMPLETED|24-Week Randomization 2||0||
59898960|NCT01313689|76020928|FG002|COMPLETED|24-Week Randomization 2||21||
60014160|NCT02625259|76130177|FG003|STARTED|Second Intervention (Day 15)||9||
59898961|NCT01313689|76020929|FG003|COMPLETED|24-Week Randomization 2||12||
59898962|NCT01313689|76020930|FG004|COMPLETED|24-Week Randomization 2||27||
59898963|NCT01313689|76020926|FG000|NOT COMPLETED|24-Week Randomization 2||0||
59898964|NCT01313689|76020927|FG001|NOT COMPLETED|24-Week Randomization 2||0||
59898965|NCT01313689|76020928|FG002|NOT COMPLETED|24-Week Randomization 2||3||
59898966|NCT01313689|76020929|FG003|NOT COMPLETED|24-Week Randomization 2||1||
59898967|NCT01313689|76020930|FG004|NOT COMPLETED|24-Week Randomization 2||15||
59898968|NCT03318315|76020952|FG000|STARTED|Overall Study||62||
59898969|NCT03318315|76020953|FG001|STARTED|Overall Study||53||
59898970|NCT03318315|76020954|FG002|STARTED|Overall Study||34||
59898971|NCT03318315|76020952|FG000|Received First Vaccination|Overall Study||62||
60014161|NCT02625259|76130178|FG004|STARTED|Second Intervention (Day 15)||0||
60014162|NCT02625259|76130174|FG000|COMPLETED|Second Intervention (Day 15)||9||
59898972|NCT03318315|76020953|FG001|Received First Vaccination|Overall Study||53||
59898973|NCT03318315|76020954|FG002|Received First Vaccination|Overall Study||34||
59898974|NCT03318315|76020952|FG000|Received Second Vaccination|Overall Study||59||
59898975|NCT03318315|76020953|FG001|Received Second Vaccination|Overall Study||48||
59898976|NCT03318315|76020954|FG002|Received Second Vaccination|Overall Study||0||
59898977|NCT03318315|76020952|FG000|Received Third Vaccination|Overall Study||0||
59898978|NCT03318315|76020953|FG001|Received Third Vaccination|Overall Study||46||
59898979|NCT03318315|76020954|FG002|Received Third Vaccination|Overall Study||0||
59898980|NCT03318315|76020952|FG000|COMPLETED|Overall Study||58||
59898981|NCT03318315|76020953|FG001|COMPLETED|Overall Study||50||
59898982|NCT03318315|76020954|FG002|COMPLETED|Overall Study||30||
59898983|NCT03318315|76020952|FG000|NOT COMPLETED|Overall Study||4||
59898984|NCT03318315|76020953|FG001|NOT COMPLETED|Overall Study||3||
59898985|NCT03318315|76020954|FG002|NOT COMPLETED|Overall Study||4||
59898986|NCT04460183|76020965|FG000|STARTED|Overall Study||14||
59898987|NCT04460183|76020966|FG001|STARTED|Overall Study||5||
59898988|NCT04460183|76020965|FG000|COMPLETED|Overall Study||10||
59898989|NCT04460183|76020966|FG001|COMPLETED|Overall Study||4||
59898990|NCT04460183|76020965|FG000|NOT COMPLETED|Overall Study||4||
59898991|NCT04460183|76020966|FG001|NOT COMPLETED|Overall Study||1||
59898992|NCT03710083|76020972|FG000|STARTED|Overall Study||66||
59898993|NCT03710083|76020972|FG000|COMPLETED|Overall Study||63||
59898994|NCT03710083|76020972|FG000|NOT COMPLETED|Overall Study||3||
59898995|NCT03318003|76020978|FG000|STARTED|Overall Study||21||
59898996|NCT03318003|76020979|FG001|STARTED|Overall Study||22||
59898997|NCT03318003|76020978|FG000|COMPLETED|Overall Study|completed means the presence of 3rd trimester ultrasound and delivery information.|20||
59898998|NCT03318003|76020979|FG001|COMPLETED|Overall Study||20||
59898999|NCT03318003|76020978|FG000|NOT COMPLETED|Overall Study||1||
59899000|NCT03318003|76020979|FG001|NOT COMPLETED|Overall Study||2||
59899001|NCT03317379|76020988|FG000|STARTED|Overall Study||20||
59899002|NCT03317379|76020989|FG001|STARTED|Overall Study||18||
59899003|NCT03317379|76020990|FG002|STARTED|Overall Study||22||
59899004|NCT03317379|76020988|FG000|Completed Intervention|Overall Study||16|Completed intervention defined as participated in intervention for at least 20 weeks (out of 6 months)|
59899005|NCT03317379|76020989|FG001|Completed Intervention|Overall Study||6|Completed intervention defined as participated in intervention for at least 20 weeks (out of 6 months)|
59899006|NCT03317379|76020990|FG002|Completed Intervention|Overall Study||0|Completed intervention defined as participated in intervention for at least 20 weeks (out of 6 months)|
59899007|NCT03317379|76020988|FG000|COMPLETED|Overall Study||20|Completion defined as completion of at least one follow-up study interval|
60014163|NCT02625259|76130175|FG001|COMPLETED|Second Intervention (Day 15)||8||
60014164|NCT02625259|76130176|FG002|COMPLETED|Second Intervention (Day 15)||7||
60014165|NCT02625259|76130177|FG003|COMPLETED|Second Intervention (Day 15)||9||
60014166|NCT02625259|76130178|FG004|COMPLETED|Second Intervention (Day 15)||0||
60014167|NCT02625259|76130174|FG000|NOT COMPLETED|Second Intervention (Day 15)||0||
60014168|NCT02625259|76130175|FG001|NOT COMPLETED|Second Intervention (Day 15)||0||
60014169|NCT02625259|76130176|FG002|NOT COMPLETED|Second Intervention (Day 15)||0||
60014170|NCT02625259|76130177|FG003|NOT COMPLETED|Second Intervention (Day 15)||0||
60014171|NCT02625259|76130178|FG004|NOT COMPLETED|Second Intervention (Day 15)||0||
60014172|NCT02577107|76130195|FG000|STARTED|Overall Study||6||
60014173|NCT02577107|76130196|FG001|STARTED|Overall Study||6||
60014174|NCT02577107|76130195|FG000|COMPLETED|Overall Study||6||
60014175|NCT02577107|76130196|FG001|COMPLETED|Overall Study||5||
60014176|NCT02577107|76130195|FG000|NOT COMPLETED|Overall Study||0||
60014177|NCT02577107|76130196|FG001|NOT COMPLETED|Overall Study||1||
59899008|NCT03317379|76020989|FG001|COMPLETED|Overall Study||15|Completion defined as completion of at least one follow-up study interval|
59899009|NCT03317379|76020990|FG002|COMPLETED|Overall Study||20|Completion defined as completion of at least one follow-up study interval|
59899010|NCT03317379|76020988|FG000|NOT COMPLETED|Overall Study||0||
59899011|NCT03317379|76020989|FG001|NOT COMPLETED|Overall Study||3||
59899012|NCT03317379|76020990|FG002|NOT COMPLETED|Overall Study||2||
59899013|NCT03316911|76021000|FG000|STARTED|Overall Study|2 did not complete baseline survey|122||
59899014|NCT03316911|76021001|FG001|STARTED|Overall Study|3 did not complete baseline survey|139||
59899015|NCT03316911|76021000|FG000|3-Month Follow-up Survey|Overall Study||93||
59899016|NCT03316911|76021001|FG001|3-Month Follow-up Survey|Overall Study||112||
59899017|NCT03316911|76021000|FG000|5-Month Follow-up Survey|Overall Study||89||
60014178|NCT02444793|76130206|FG000|STARTED|Overall Study||11||
60014179|NCT02444793|76130207|FG001|STARTED|Overall Study||6||
60014180|NCT02444793|76130208|FG002|STARTED|Overall Study||4||
60014181|NCT02444793|76130209|FG003|STARTED|Overall Study||3||
60014182|NCT02444793|76130206|FG000|COMPLETED|Overall Study||0||
60014183|NCT02444793|76130207|FG001|COMPLETED|Overall Study||0||
60014184|NCT02444793|76130208|FG002|COMPLETED|Overall Study||0||
60014185|NCT02444793|76130209|FG003|COMPLETED|Overall Study||0||
60014186|NCT02444793|76130206|FG000|NOT COMPLETED|Overall Study||11||
60014187|NCT02444793|76130207|FG001|NOT COMPLETED|Overall Study||6||
60014188|NCT02444793|76130208|FG002|NOT COMPLETED|Overall Study||4||
60014189|NCT02444793|76130209|FG003|NOT COMPLETED|Overall Study||3||
60014190|NCT02624713|76130222|FG000|STARTED|Overall Study||78||
60014191|NCT02624713|76130223|FG001|STARTED|Overall Study||81||
59757365|NCT03963232|75876471|FG001|NOT COMPLETED|Open-Label Treatment Phase||11||
59757366|NCT03963232|75876470|FG000|STARTED|Follow-up Phase|Participants from double-blind or open-label treatment phases entered the follow-up phase.|243||
59757367|NCT03963232|75876471|FG001|STARTED|Follow-up Phase|Participants from double-blind or open-label treatment phases entered the follow-up phase.|247||
59757368|NCT03963232|75876470|FG000|Entered From Double-blind Treatment Phase|Follow-up Phase||7||
59757369|NCT03963232|75876471|FG001|Entered From Double-blind Treatment Phase|Follow-up Phase||11||
59899018|NCT03316911|76021001|FG001|5-Month Follow-up Survey|Overall Study||110||
59899019|NCT03316911|76021000|FG000|COMPLETED|Overall Study||89||
59899020|NCT03316911|76021001|FG001|COMPLETED|Overall Study||110||
59899021|NCT03316911|76021000|FG000|NOT COMPLETED|Overall Study||33||
59899022|NCT03316911|76021001|FG001|NOT COMPLETED|Overall Study||29||
59899023|NCT01106391|76021007|FG000|STARTED|Overall Study||60||
59899024|NCT01106391|76021007|FG000|COMPLETED|Overall Study||41|Completed is defined as subjects completed 5 years follow up.|
59899025|NCT01106391|76021007|FG000|NOT COMPLETED|Overall Study||19||
59899026|NCT03316131|76021011|FG000|STARTED|Treatment Period 1||18||
59899027|NCT03316131|76021012|FG001|STARTED|Treatment Period 1||18||
59899028|NCT03316131|76021011|FG000|COMPLETED|Treatment Period 1||18||
59899029|NCT03316131|76021012|FG001|COMPLETED|Treatment Period 1||18||
59899030|NCT03316131|76021011|FG000|NOT COMPLETED|Treatment Period 1||0||
59899031|NCT03316131|76021012|FG001|NOT COMPLETED|Treatment Period 1||0||
59899032|NCT03316131|76021011|FG000|STARTED|Treatment Period 2||18||
59899033|NCT03316131|76021012|FG001|STARTED|Treatment Period 2||18||
59899034|NCT03316131|76021011|FG000|COMPLETED|Treatment Period 2||17||
59899035|NCT03316131|76021012|FG001|COMPLETED|Treatment Period 2||18||
59899036|NCT03316131|76021011|FG000|NOT COMPLETED|Treatment Period 2||1||
59899037|NCT03316131|76021012|FG001|NOT COMPLETED|Treatment Period 2||0||
59899038|NCT03301415|76021018|FG000|STARTED|Overall Study||7||
59899039|NCT03301415|76021018|FG000|COMPLETED|Overall Study||3||
59899040|NCT03301415|76021018|FG000|NOT COMPLETED|Overall Study||4||
59899041|NCT02732938|76021024|FG000|STARTED|Overall Study||4||
59899042|NCT02732938|76021025|FG001|STARTED|Overall Study||18||
59899043|NCT02732938|76021026|FG002|STARTED|Overall Study||0||
59899044|NCT02732938|76021024|FG000|Received Treatment|Overall Study||4||
59757370|NCT03963232|75876470|FG000|Entered From Open-Label Treatment Phase|Follow-up Phase||236||
59899045|NCT02732938|76021025|FG001|Received Treatment|Overall Study||17||
59899046|NCT02732938|76021026|FG002|Received Treatment|Overall Study||0||
59899047|NCT02732938|76021024|FG000|COMPLETED|Overall Study||0||
59899048|NCT02732938|76021025|FG001|COMPLETED|Overall Study||0||
59899049|NCT02732938|76021026|FG002|COMPLETED|Overall Study||0||
59899050|NCT02732938|76021024|FG000|NOT COMPLETED|Overall Study||4||
59899051|NCT02732938|76021025|FG001|NOT COMPLETED|Overall Study||18||
59899052|NCT02732938|76021026|FG002|NOT COMPLETED|Overall Study||0||
59899053|NCT04647721|76021034|FG000|STARTED|Overall Study||61||122
59899054|NCT04647721|76021035|FG001|STARTED|Overall Study||60||120
59899055|NCT04647721|76021034|FG000|Safety Population|Overall Study||61|1 subject randomized to Left side Restylane® / RIght side Radiesse® did not receive any treatment and was excluded from the safety population.|122
59899056|NCT04647721|76021035|FG001|Safety Population|Overall Study||59|1 subject randomized to Left side Restylane® / RIght side Radiesse® did not receive any treatment and was excluded from the safety population.|118
59899057|NCT04647721|76021034|FG000|COMPLETED|Overall Study||59||118
59899058|NCT04647721|76021035|FG001|COMPLETED|Overall Study||58||116
59899059|NCT04647721|76021034|FG000|NOT COMPLETED|Overall Study||2||4
59899060|NCT04647721|76021035|FG001|NOT COMPLETED|Overall Study||2||4
59899061|NCT04267276|76021043|FG000|STARTED|Overall Study||7||
59899062|NCT04267276|76021043|FG000|Treated|Overall Study||7||
59899063|NCT04267276|76021043|FG000|COMPLETED|Overall Study||7||
59899064|NCT04267276|76021043|FG000|NOT COMPLETED|Overall Study||0||
59899065|NCT03750292|76021047|FG000|STARTED|First Intervention (Baseline to 8 Weeks)||5||
59899066|NCT03750292|76021048|FG001|STARTED|First Intervention (Baseline to 8 Weeks)||4||
59899067|NCT03750292|76021047|FG000|COMPLETED|First Intervention (Baseline to 8 Weeks)||5||
59899068|NCT03750292|76021048|FG001|COMPLETED|First Intervention (Baseline to 8 Weeks)||4||
59899069|NCT03750292|76021047|FG000|NOT COMPLETED|First Intervention (Baseline to 8 Weeks)||0||
60014192|NCT02624713|76130222|FG000|COMPLETED|Overall Study||64||
60014193|NCT02624713|76130223|FG001|COMPLETED|Overall Study||81||
60014194|NCT02624713|76130222|FG000|NOT COMPLETED|Overall Study||14||
60014195|NCT02624713|76130223|FG001|NOT COMPLETED|Overall Study||0||
60014196|NCT02624791|76130230|FG000|STARTED|Overall Study||2||
60014197|NCT02624791|76130231|FG001|STARTED|Overall Study||1||
60014198|NCT02624791|76130232|FG002|STARTED|Overall Study||2||
60014199|NCT02624791|76130233|FG003|STARTED|Overall Study||2||
60014200|NCT02624791|76130234|FG004|STARTED|Overall Study||2||
60014201|NCT02624791|76130235|FG005|STARTED|Overall Study||2||
60014202|NCT02624791|76130230|FG000|COMPLETED|Overall Study||0||
60014203|NCT02624791|76130231|FG001|COMPLETED|Overall Study||1||
59899070|NCT03750292|76021048|FG001|NOT COMPLETED|First Intervention (Baseline to 8 Weeks)||0||
59899071|NCT03750292|76021047|FG000|STARTED|Washout (3 Weeks)||5||
59899072|NCT03750292|76021048|FG001|STARTED|Washout (3 Weeks)||4||
59899073|NCT03750292|76021047|FG000|COMPLETED|Washout (3 Weeks)||5||
59899074|NCT03750292|76021048|FG001|COMPLETED|Washout (3 Weeks)||4||
59899075|NCT03750292|76021047|FG000|NOT COMPLETED|Washout (3 Weeks)||0||
59899076|NCT03750292|76021048|FG001|NOT COMPLETED|Washout (3 Weeks)||0||
59899077|NCT03750292|76021047|FG000|STARTED|Second Intervention (11 to 19 Weeks)||5||
59899078|NCT03750292|76021048|FG001|STARTED|Second Intervention (11 to 19 Weeks)||4||
59899079|NCT03750292|76021047|FG000|COMPLETED|Second Intervention (11 to 19 Weeks)||5||
59899080|NCT03750292|76021048|FG001|COMPLETED|Second Intervention (11 to 19 Weeks)||4||
59899081|NCT03750292|76021047|FG000|NOT COMPLETED|Second Intervention (11 to 19 Weeks)||0||
60014204|NCT02624791|76130232|FG002|COMPLETED|Overall Study||2||
60014205|NCT02624791|76130233|FG003|COMPLETED|Overall Study||2||
60014206|NCT02624791|76130234|FG004|COMPLETED|Overall Study||2||
60014207|NCT02624791|76130235|FG005|COMPLETED|Overall Study||2||
60014208|NCT02624791|76130230|FG000|NOT COMPLETED|Overall Study||2||
60014209|NCT02624791|76130231|FG001|NOT COMPLETED|Overall Study||0||
60014210|NCT02624791|76130232|FG002|NOT COMPLETED|Overall Study||0||
60014211|NCT02624791|76130233|FG003|NOT COMPLETED|Overall Study||0||
60014212|NCT02624791|76130234|FG004|NOT COMPLETED|Overall Study||0||
60014213|NCT02624791|76130235|FG005|NOT COMPLETED|Overall Study||0||
60014214|NCT02577029|76130247|FG000|STARTED|Overall Study||10||
59505815|NCT00782821|75598695|FG002|NOT COMPLETED|Overall Study||1||
59899082|NCT03750292|76021048|FG001|NOT COMPLETED|Second Intervention (11 to 19 Weeks)||0||
59899083|NCT03718000|76021056|FG000|STARTED|Overall Study||55||
59899084|NCT03718000|76021057|FG001|STARTED|Overall Study||56||
59899085|NCT03718000|76021056|FG000|COMPLETED|Overall Study||53||
59899086|NCT03718000|76021057|FG001|COMPLETED|Overall Study||51||
59899087|NCT03718000|76021056|FG000|NOT COMPLETED|Overall Study||2||
59899088|NCT03718000|76021057|FG001|NOT COMPLETED|Overall Study||5||
59899089|NCT03063203|76021064|FG000|STARTED|Overall Study||17||
59899090|NCT03063203|76021064|FG000|COMPLETED|Overall Study||3||
59899091|NCT03063203|76021064|FG000|NOT COMPLETED|Overall Study||14||
59899092|NCT04854031|76021075|FG000|STARTED|Overall Study||8||
59899093|NCT04854031|76021075|FG000|COMPLETED|Overall Study||8||
59505816|NCT00782821|75598696|FG003|NOT COMPLETED|Overall Study||2||
59899094|NCT04854031|76021075|FG000|NOT COMPLETED|Overall Study||0||
59899095|NCT02891226|76021083|FG000|STARTED|Period 1 (Weeks 0 to 12)||64||
59899096|NCT02891226|76021084|FG001|STARTED|Period 1 (Weeks 0 to 12)||31||
59899097|NCT02891226|76021085|FG002|STARTED|Period 1 (Weeks 0 to 12)||32||
59899098|NCT02891226|76021086|FG003|STARTED|Period 1 (Weeks 0 to 12)||64||
59899099|NCT02891226|76021087|FG004|STARTED|Period 1 (Weeks 0 to 12)||0||
59899100|NCT02891226|76021088|FG005|STARTED|Period 1 (Weeks 0 to 12)||0||
59899101|NCT02891226|76021089|FG006|STARTED|Period 1 (Weeks 0 to 12)||0||
59899102|NCT02891226|76021090|FG007|STARTED|Period 1 (Weeks 0 to 12)||0||
60014215|NCT02577029|76130248|FG001|STARTED|Overall Study||2||
60014216|NCT02577029|76130249|FG002|STARTED|Overall Study||7||
60014217|NCT02577029|76130250|FG003|STARTED|Overall Study||12||
60014218|NCT02577029|76130251|FG004|STARTED|Overall Study||11||
60014219|NCT02577029|76130252|FG005|STARTED|Overall Study||13||
60014220|NCT02577029|76130253|FG006|STARTED|Overall Study||12||
60014221|NCT02577029|76130254|FG007|STARTED|Overall Study||12||
59899103|NCT02891226|76021091|FG008|STARTED|Period 1 (Weeks 0 to 12)||0||
59899104|NCT02891226|76021092|FG009|STARTED|Period 1 (Weeks 0 to 12)||0||
59899105|NCT02891226|76021093|FG010|STARTED|Period 1 (Weeks 0 to 12)||0||
59899106|NCT02891226|76021094|FG011|STARTED|Period 1 (Weeks 0 to 12)||0||
60014222|NCT02577029|76130247|FG000|COMPLETED|Overall Study||0||
60014223|NCT02577029|76130248|FG001|COMPLETED|Overall Study||0||
60014224|NCT02577029|76130249|FG002|COMPLETED|Overall Study||0||
60014225|NCT02577029|76130250|FG003|COMPLETED|Overall Study||0||
59899107|NCT02891226|76021095|FG012|STARTED|Period 1 (Weeks 0 to 12)||0||
59899108|NCT02891226|76021096|FG013|STARTED|Period 1 (Weeks 0 to 12)||0||
59899109|NCT02891226|76021097|FG014|STARTED|Period 1 (Weeks 0 to 12)||0||
59899110|NCT02891226|76021098|FG015|STARTED|Period 1 (Weeks 0 to 12)||0||
59899111|NCT02891226|76021083|FG000|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||64||
59899112|NCT02891226|76021084|FG001|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||31||
59899113|NCT02891226|76021085|FG002|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||32||
59899114|NCT02891226|76021086|FG003|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||64||
59899115|NCT02891226|76021087|FG004|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||0||
59505817|NCT00743093|75598715|FG000|STARTED|Base Study Period||224||
59899116|NCT02891226|76021088|FG005|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||0||
59899117|NCT02891226|76021089|FG006|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||0||
59899118|NCT02891226|76021090|FG007|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||0||
59899119|NCT02891226|76021091|FG008|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||0||
59899120|NCT02891226|76021092|FG009|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||0||
59899121|NCT02891226|76021093|FG010|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||0||
59899122|NCT02891226|76021094|FG011|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||0||
59899123|NCT02891226|76021095|FG012|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||0||
59899124|NCT02891226|76021096|FG013|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||0||
59899125|NCT02891226|76021097|FG014|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||0||
59899126|NCT02891226|76021098|FG015|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||0||
59899127|NCT02891226|76021083|FG000|COMPLETED|Period 1 (Weeks 0 to 12)||59||
59899128|NCT02891226|76021084|FG001|COMPLETED|Period 1 (Weeks 0 to 12)||29||
59899129|NCT02891226|76021085|FG002|COMPLETED|Period 1 (Weeks 0 to 12)||28||
59899130|NCT02891226|76021086|FG003|COMPLETED|Period 1 (Weeks 0 to 12)||60||
59899131|NCT02891226|76021087|FG004|COMPLETED|Period 1 (Weeks 0 to 12)||0||
59899132|NCT02891226|76021088|FG005|COMPLETED|Period 1 (Weeks 0 to 12)||0||
59899133|NCT02891226|76021089|FG006|COMPLETED|Period 1 (Weeks 0 to 12)||0||
59899134|NCT02891226|76021090|FG007|COMPLETED|Period 1 (Weeks 0 to 12)||0||
59899135|NCT02891226|76021091|FG008|COMPLETED|Period 1 (Weeks 0 to 12)||0||
59899136|NCT02891226|76021092|FG009|COMPLETED|Period 1 (Weeks 0 to 12)||0||
59899137|NCT02891226|76021093|FG010|COMPLETED|Period 1 (Weeks 0 to 12)||0||
59899138|NCT02891226|76021094|FG011|COMPLETED|Period 1 (Weeks 0 to 12)||0||
59899139|NCT02891226|76021095|FG012|COMPLETED|Period 1 (Weeks 0 to 12)||0||
59899140|NCT02891226|76021096|FG013|COMPLETED|Period 1 (Weeks 0 to 12)||0||
59899141|NCT02891226|76021097|FG014|COMPLETED|Period 1 (Weeks 0 to 12)||0||
59899142|NCT02891226|76021098|FG015|COMPLETED|Period 1 (Weeks 0 to 12)||0||
59899143|NCT02891226|76021083|FG000|NOT COMPLETED|Period 1 (Weeks 0 to 12)||5||
59899144|NCT02891226|76021084|FG001|NOT COMPLETED|Period 1 (Weeks 0 to 12)||2||
59899145|NCT02891226|76021085|FG002|NOT COMPLETED|Period 1 (Weeks 0 to 12)||4||
59899146|NCT02891226|76021086|FG003|NOT COMPLETED|Period 1 (Weeks 0 to 12)||4||
59899147|NCT02891226|76021087|FG004|NOT COMPLETED|Period 1 (Weeks 0 to 12)||0||
59899148|NCT02891226|76021088|FG005|NOT COMPLETED|Period 1 (Weeks 0 to 12)||0||
59899149|NCT02891226|76021089|FG006|NOT COMPLETED|Period 1 (Weeks 0 to 12)||0||
59899150|NCT02891226|76021090|FG007|NOT COMPLETED|Period 1 (Weeks 0 to 12)||0||
59899151|NCT02891226|76021091|FG008|NOT COMPLETED|Period 1 (Weeks 0 to 12)||0||
59899152|NCT02891226|76021092|FG009|NOT COMPLETED|Period 1 (Weeks 0 to 12)||0||
59899153|NCT02891226|76021093|FG010|NOT COMPLETED|Period 1 (Weeks 0 to 12)||0||
59899154|NCT02891226|76021094|FG011|NOT COMPLETED|Period 1 (Weeks 0 to 12)||0||
59899155|NCT02891226|76021095|FG012|NOT COMPLETED|Period 1 (Weeks 0 to 12)||0||
59899156|NCT02891226|76021096|FG013|NOT COMPLETED|Period 1 (Weeks 0 to 12)||0||
59899157|NCT02891226|76021097|FG014|NOT COMPLETED|Period 1 (Weeks 0 to 12)||0||
59899158|NCT02891226|76021098|FG015|NOT COMPLETED|Period 1 (Weeks 0 to 12)||0||
59899159|NCT02891226|76021083|FG000|STARTED|Period 2 (Weeks 12 to 52)|Participants were assigned to this arm during period 1.|0||
59899160|NCT02891226|76021084|FG001|STARTED|Period 2 (Weeks 12 to 52)|Participants were assigned to this arm during period 1.|0||
59899161|NCT02891226|76021085|FG002|STARTED|Period 2 (Weeks 12 to 52)|Participants were assigned to this arm during period 1.|0||
59899162|NCT02891226|76021086|FG003|STARTED|Period 2 (Weeks 12 to 52)|Participants were assigned to this arm during period 1.|0||
59899163|NCT02891226|76021087|FG004|STARTED|Period 2 (Weeks 12 to 52)|Participants were assigned to this arm during period 2.|9||
59899164|NCT02891226|76021088|FG005|STARTED|Period 2 (Weeks 12 to 52)|Participants were assigned to this arm during period 2.|9||
59899165|NCT02891226|76021089|FG006|STARTED|Period 2 (Weeks 12 to 52)|Participants were assigned to this arm during period 2.|23||
59899166|NCT02891226|76021090|FG007|STARTED|Period 2 (Weeks 12 to 52)|Participants were assigned to this arm during period 2.|46||
59899167|NCT02891226|76021091|FG008|STARTED|Period 2 (Weeks 12 to 52)|Participants were assigned to this arm during period 2.|30||
59899168|NCT02891226|76021092|FG009|STARTED|Period 2 (Weeks 12 to 52)|Participants were assigned to this arm during period 2.|59||
59899169|NCT02891226|76021093|FG010|STARTED|Period 2 (Weeks 12 to 52)||0||
59899170|NCT02891226|76021094|FG011|STARTED|Period 2 (Weeks 12 to 52)||0||
59899171|NCT02891226|76021095|FG012|STARTED|Period 2 (Weeks 12 to 52)||0||
59505818|NCT00743093|75598716|FG001|STARTED|Base Study Period||52||
59899172|NCT02891226|76021096|FG013|STARTED|Period 2 (Weeks 12 to 52)||0||
59505819|NCT00743093|75598715|FG000|COMPLETED|Base Study Period||205||
59757371|NCT03963232|75876471|FG001|Entered From Open-Label Treatment Phase|Follow-up Phase||236||
59899173|NCT02891226|76021097|FG014|STARTED|Period 2 (Weeks 12 to 52)||0||
59899174|NCT02891226|76021098|FG015|STARTED|Period 2 (Weeks 12 to 52)||0||
59899175|NCT02891226|76021083|FG000|COMPLETED|Period 2 (Weeks 12 to 52)||0||
59899176|NCT02891226|76021084|FG001|COMPLETED|Period 2 (Weeks 12 to 52)||0||
59899177|NCT02891226|76021085|FG002|COMPLETED|Period 2 (Weeks 12 to 52)||0||
59899178|NCT02891226|76021086|FG003|COMPLETED|Period 2 (Weeks 12 to 52)||0||
59899179|NCT02891226|76021087|FG004|COMPLETED|Period 2 (Weeks 12 to 52)||8||
59899180|NCT02891226|76021088|FG005|COMPLETED|Period 2 (Weeks 12 to 52)||8||
59899181|NCT02891226|76021089|FG006|COMPLETED|Period 2 (Weeks 12 to 52)||20||
59899182|NCT02891226|76021090|FG007|COMPLETED|Period 2 (Weeks 12 to 52)||41||
59899183|NCT02891226|76021091|FG008|COMPLETED|Period 2 (Weeks 12 to 52)||24||
59899184|NCT02891226|76021092|FG009|COMPLETED|Period 2 (Weeks 12 to 52)||42||
59899185|NCT02891226|76021093|FG010|COMPLETED|Period 2 (Weeks 12 to 52)||0||
59899186|NCT02891226|76021094|FG011|COMPLETED|Period 2 (Weeks 12 to 52)||0||
59899187|NCT02891226|76021095|FG012|COMPLETED|Period 2 (Weeks 12 to 52)||0||
59899188|NCT02891226|76021096|FG013|COMPLETED|Period 2 (Weeks 12 to 52)||0||
59899189|NCT02891226|76021097|FG014|COMPLETED|Period 2 (Weeks 12 to 52)||0||
59899190|NCT02891226|76021098|FG015|COMPLETED|Period 2 (Weeks 12 to 52)||0||
59899191|NCT02891226|76021083|FG000|NOT COMPLETED|Period 2 (Weeks 12 to 52)||0||
59899192|NCT02891226|76021084|FG001|NOT COMPLETED|Period 2 (Weeks 12 to 52)||0||
59899193|NCT02891226|76021085|FG002|NOT COMPLETED|Period 2 (Weeks 12 to 52)||0||
59899194|NCT02891226|76021086|FG003|NOT COMPLETED|Period 2 (Weeks 12 to 52)||0||
59899195|NCT02891226|76021087|FG004|NOT COMPLETED|Period 2 (Weeks 12 to 52)||1||
59899196|NCT02891226|76021088|FG005|NOT COMPLETED|Period 2 (Weeks 12 to 52)||1||
59899197|NCT02891226|76021089|FG006|NOT COMPLETED|Period 2 (Weeks 12 to 52)||3||
59899198|NCT02891226|76021090|FG007|NOT COMPLETED|Period 2 (Weeks 12 to 52)||5||
59899199|NCT02891226|76021091|FG008|NOT COMPLETED|Period 2 (Weeks 12 to 52)||6||
59899200|NCT02891226|76021092|FG009|NOT COMPLETED|Period 2 (Weeks 12 to 52)||17||
59899201|NCT02891226|76021093|FG010|NOT COMPLETED|Period 2 (Weeks 12 to 52)||0||
59899202|NCT02891226|76021094|FG011|NOT COMPLETED|Period 2 (Weeks 12 to 52)||0||
59899203|NCT02891226|76021095|FG012|NOT COMPLETED|Period 2 (Weeks 12 to 52)||0||
59899204|NCT02891226|76021096|FG013|NOT COMPLETED|Period 2 (Weeks 12 to 52)||0||
59899205|NCT02891226|76021097|FG014|NOT COMPLETED|Period 2 (Weeks 12 to 52)||0||
59899206|NCT02891226|76021098|FG015|NOT COMPLETED|Period 2 (Weeks 12 to 52)||0||
59899207|NCT02891226|76021083|FG000|STARTED|Period 3 (Weeks 52 to 208)||0||
59899208|NCT02891226|76021084|FG001|STARTED|Period 3 (Weeks 52 to 208)||0||
59899209|NCT02891226|76021085|FG002|STARTED|Period 3 (Weeks 52 to 208)||0||
59899210|NCT02891226|76021086|FG003|STARTED|Period 3 (Weeks 52 to 208)||0||
59899211|NCT02891226|76021087|FG004|STARTED|Period 3 (Weeks 52 to 208)|Participants were assigned to this arm during period 2.|0||
59899212|NCT02891226|76021088|FG005|STARTED|Period 3 (Weeks 52 to 208)|Participants were assigned to this arm during period 2.|0||
59899213|NCT02891226|76021089|FG006|STARTED|Period 3 (Weeks 52 to 208)|Participants were assigned to this arm during period 2.|0||
59899214|NCT02891226|76021090|FG007|STARTED|Period 3 (Weeks 52 to 208)|Participants were assigned to this arm during period 2.|0||
59899215|NCT02891226|76021091|FG008|STARTED|Period 3 (Weeks 52 to 208)|Participants were assigned to this arm during period 2.|0||
59899216|NCT02891226|76021092|FG009|STARTED|Period 3 (Weeks 52 to 208)|Participants were assigned to this arm during period 2.|0||
59899217|NCT02891226|76021093|FG010|STARTED|Period 3 (Weeks 52 to 208)|Participants were assigned to this arm during period 3.|137||
59899218|NCT02891226|76021094|FG011|STARTED|Period 3 (Weeks 52 to 208)||0||
59899219|NCT02891226|76021095|FG012|STARTED|Period 3 (Weeks 52 to 208)||0||
59899220|NCT02891226|76021096|FG013|STARTED|Period 3 (Weeks 52 to 208)||0||
59899221|NCT02891226|76021097|FG014|STARTED|Period 3 (Weeks 52 to 208)||0||
59899222|NCT02891226|76021098|FG015|STARTED|Period 3 (Weeks 52 to 208)||0||
59899223|NCT02891226|76021083|FG000|COMPLETED|Period 3 (Weeks 52 to 208)||0||
59899224|NCT02891226|76021084|FG001|COMPLETED|Period 3 (Weeks 52 to 208)||0||
59505820|NCT00743093|75598716|FG001|COMPLETED|Base Study Period||47||
59505821|NCT00743093|75598715|FG000|NOT COMPLETED|Base Study Period||19||
59505822|NCT00743093|75598716|FG001|NOT COMPLETED|Base Study Period||5||
59505823|NCT00743093|75598715|FG000|STARTED|Extended Dosing Period|Subjects not meeting stopping criteria after base continued into the extended dosing.|51||
59757372|NCT03963232|75876470|FG000|COMPLETED|Follow-up Phase||236||
59757373|NCT03963232|75876471|FG001|COMPLETED|Follow-up Phase||238||
59757374|NCT03963232|75876470|FG000|NOT COMPLETED|Follow-up Phase||7||
59757375|NCT03963232|75876471|FG001|NOT COMPLETED|Follow-up Phase||9||
59757376|NCT03954392|75876486|FG000|STARTED|Overall Study||23||
59757377|NCT03954392|75876487|FG001|STARTED|Overall Study||22||
59757378|NCT03954392|75876486|FG000|COMPLETED|Overall Study||23||
59757379|NCT03954392|75876487|FG001|COMPLETED|Overall Study||22||
59757380|NCT03954392|75876486|FG000|NOT COMPLETED|Overall Study||0||
59757381|NCT03954392|75876487|FG001|NOT COMPLETED|Overall Study||0||
59757382|NCT03856593|75876495|FG000|STARTED|Overall Study||284||
59757383|NCT03856593|75876496|FG001|STARTED|Overall Study||257||
59757384|NCT03856593|75876495|FG000|COMPLETED|Overall Study||269||
59757385|NCT03856593|75876496|FG001|COMPLETED|Overall Study||241||
59757386|NCT03856593|75876495|FG000|NOT COMPLETED|Overall Study||15||
59899225|NCT02891226|76021085|FG002|COMPLETED|Period 3 (Weeks 52 to 208)||0||
59899226|NCT02891226|76021086|FG003|COMPLETED|Period 3 (Weeks 52 to 208)||0||
59899227|NCT02891226|76021087|FG004|COMPLETED|Period 3 (Weeks 52 to 208)||0||
59899228|NCT02891226|76021088|FG005|COMPLETED|Period 3 (Weeks 52 to 208)||0||
59899229|NCT02891226|76021089|FG006|COMPLETED|Period 3 (Weeks 52 to 208)||0||
59899230|NCT02891226|76021090|FG007|COMPLETED|Period 3 (Weeks 52 to 208)||0||
59899231|NCT02891226|76021091|FG008|COMPLETED|Period 3 (Weeks 52 to 208)||0||
59899232|NCT02891226|76021092|FG009|COMPLETED|Period 3 (Weeks 52 to 208)||0||
59899233|NCT02891226|76021093|FG010|COMPLETED|Period 3 (Weeks 52 to 208)||0||
59899234|NCT02891226|76021094|FG011|COMPLETED|Period 3 (Weeks 52 to 208)||0||
59899235|NCT02891226|76021095|FG012|COMPLETED|Period 3 (Weeks 52 to 208)||0||
59899236|NCT02891226|76021096|FG013|COMPLETED|Period 3 (Weeks 52 to 208)||0||
59899237|NCT02891226|76021097|FG014|COMPLETED|Period 3 (Weeks 52 to 208)||0||
59899238|NCT02891226|76021098|FG015|COMPLETED|Period 3 (Weeks 52 to 208)||0||
59899239|NCT02891226|76021083|FG000|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0||
59899240|NCT02891226|76021084|FG001|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0||
59899241|NCT02891226|76021085|FG002|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0||
59899242|NCT02891226|76021086|FG003|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0||
59899243|NCT02891226|76021087|FG004|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0||
59899244|NCT02891226|76021088|FG005|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0||
59899245|NCT02891226|76021089|FG006|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0||
59899246|NCT02891226|76021090|FG007|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0||
59899247|NCT02891226|76021091|FG008|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0||
59899248|NCT02891226|76021092|FG009|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0||
59899249|NCT02891226|76021093|FG010|NOT COMPLETED|Period 3 (Weeks 52 to 208)||137||
59899250|NCT02891226|76021094|FG011|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0||
59899251|NCT02891226|76021095|FG012|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0||
59899252|NCT02891226|76021096|FG013|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0||
59899253|NCT02891226|76021097|FG014|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0||
59899254|NCT02891226|76021098|FG015|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0||
59899255|NCT02891226|76021083|FG000|STARTED|Follow-up Period||0||
59899256|NCT02891226|76021084|FG001|STARTED|Follow-up Period||0||
59899257|NCT02891226|76021085|FG002|STARTED|Follow-up Period||0||
59899258|NCT02891226|76021086|FG003|STARTED|Follow-up Period||0||
59899259|NCT02891226|76021087|FG004|STARTED|Follow-up Period||0||
59899260|NCT02891226|76021088|FG005|STARTED|Follow-up Period||0||
59899261|NCT02891226|76021089|FG006|STARTED|Follow-up Period||0||
59899262|NCT02891226|76021090|FG007|STARTED|Follow-up Period||0||
59899263|NCT02891226|76021091|FG008|STARTED|Follow-up Period||0||
59899264|NCT02891226|76021092|FG009|STARTED|Follow-up Period||0||
59899265|NCT02891226|76021093|FG010|STARTED|Follow-up Period||0||
59899266|NCT02891226|76021094|FG011|STARTED|Follow-up Period|Participants were assigned to this arm during follow-up period.|1||
59899267|NCT02891226|76021095|FG012|STARTED|Follow-up Period|Participants were assigned to this arm during follow-up period.|2||
59899268|NCT02891226|76021096|FG013|STARTED|Follow-up Period|Participants were assigned to this arm during follow-up period.|1||
59899269|NCT02891226|76021097|FG014|STARTED|Follow-up Period|Participants were assigned to this arm during follow-up period.|1||
59899270|NCT02891226|76021098|FG015|STARTED|Follow-up Period|Participants were assigned to this arm during follow-up period.|3||
59899271|NCT02891226|76021083|FG000|COMPLETED|Follow-up Period||0||
59899272|NCT02891226|76021084|FG001|COMPLETED|Follow-up Period||0||
59899273|NCT02891226|76021085|FG002|COMPLETED|Follow-up Period||0||
59899274|NCT02891226|76021086|FG003|COMPLETED|Follow-up Period||0||
59899275|NCT02891226|76021087|FG004|COMPLETED|Follow-up Period||0||
59899276|NCT02891226|76021088|FG005|COMPLETED|Follow-up Period||0||
59899277|NCT02891226|76021089|FG006|COMPLETED|Follow-up Period||0||
59899278|NCT02891226|76021090|FG007|COMPLETED|Follow-up Period||0||
59899279|NCT02891226|76021091|FG008|COMPLETED|Follow-up Period||0||
59899280|NCT02891226|76021092|FG009|COMPLETED|Follow-up Period||0||
59899281|NCT02891226|76021093|FG010|COMPLETED|Follow-up Period||0||
59899282|NCT02891226|76021094|FG011|COMPLETED|Follow-up Period||0||
59899283|NCT02891226|76021095|FG012|COMPLETED|Follow-up Period||2||
59899284|NCT02891226|76021096|FG013|COMPLETED|Follow-up Period||1||
59899285|NCT02891226|76021097|FG014|COMPLETED|Follow-up Period||0||
59899286|NCT02891226|76021098|FG015|COMPLETED|Follow-up Period||2||
59899287|NCT02891226|76021083|FG000|NOT COMPLETED|Follow-up Period||0||
59899288|NCT02891226|76021084|FG001|NOT COMPLETED|Follow-up Period||0||
59899289|NCT02891226|76021085|FG002|NOT COMPLETED|Follow-up Period||0||
59899290|NCT02891226|76021086|FG003|NOT COMPLETED|Follow-up Period||0||
59899291|NCT02891226|76021087|FG004|NOT COMPLETED|Follow-up Period||0||
59899292|NCT02891226|76021088|FG005|NOT COMPLETED|Follow-up Period||0||
59899293|NCT02891226|76021089|FG006|NOT COMPLETED|Follow-up Period||0||
59899294|NCT02891226|76021090|FG007|NOT COMPLETED|Follow-up Period||0||
59899295|NCT02891226|76021091|FG008|NOT COMPLETED|Follow-up Period||0||
59899296|NCT02891226|76021092|FG009|NOT COMPLETED|Follow-up Period||0||
59899297|NCT02891226|76021093|FG010|NOT COMPLETED|Follow-up Period||0||
59899298|NCT02891226|76021094|FG011|NOT COMPLETED|Follow-up Period||1||
59899299|NCT02891226|76021095|FG012|NOT COMPLETED|Follow-up Period||0||
59899300|NCT02891226|76021096|FG013|NOT COMPLETED|Follow-up Period||0||
59899301|NCT02891226|76021097|FG014|NOT COMPLETED|Follow-up Period||1||
59899302|NCT02891226|76021098|FG015|NOT COMPLETED|Follow-up Period||1||
59899303|NCT03612856|76021125|FG000|STARTED|Pre-dose Period||8||
59899304|NCT03612856|76021126|FG001|STARTED|Pre-dose Period||10||
59899305|NCT03612856|76021127|FG002|STARTED|Pre-dose Period||9||
59899306|NCT03612856|76021125|FG000|COMPLETED|Pre-dose Period||8||
59899307|NCT03612856|76021126|FG001|COMPLETED|Pre-dose Period||8||
59899308|NCT03612856|76021127|FG002|COMPLETED|Pre-dose Period||8||
59899309|NCT03612856|76021125|FG000|NOT COMPLETED|Pre-dose Period||0||
59899310|NCT03612856|76021126|FG001|NOT COMPLETED|Pre-dose Period||2||
59899311|NCT03612856|76021127|FG002|NOT COMPLETED|Pre-dose Period||1||
59899312|NCT03612856|76021125|FG000|STARTED|Post-dose Period||8||
59899313|NCT03612856|76021126|FG001|STARTED|Post-dose Period||8||
59899314|NCT03612856|76021127|FG002|STARTED|Post-dose Period||8||
59899315|NCT03612856|76021125|FG000|COMPLETED|Post-dose Period||8||
59899316|NCT03612856|76021126|FG001|COMPLETED|Post-dose Period||8||
59899317|NCT03612856|76021127|FG002|COMPLETED|Post-dose Period||8||
59899318|NCT03612856|76021125|FG000|NOT COMPLETED|Post-dose Period||0||
59899319|NCT03612856|76021126|FG001|NOT COMPLETED|Post-dose Period||0||
59899320|NCT03612856|76021127|FG002|NOT COMPLETED|Post-dose Period||0||
59899321|NCT03333837|76021140|FG000|STARTED|Overall Study||24|Shows number of dyads who signed consent. Total number of participants is double the number of dyads. e.g., 20 dyads noted here = 40 participants|
59899322|NCT03333837|76021141|FG001|STARTED|Overall Study||25|Shows number of dyads who signed consent. Total number of participants is double the number of dyads. e.g., 20 dyads noted here = 40 participants|
59899323|NCT03333837|76021142|FG002|STARTED|Overall Study||27|Shows number of dyads who signed consent. Total number of participants is double the number of dyads. e.g., 20 dyads noted here = 40 participants|
59899324|NCT03333837|76021143|FG003|STARTED|Overall Study||25|Shows number of dyads who signed consent. Total number of participants is double the number of dyads. e.g., 20 dyads noted here = 40 participants|
59899325|NCT03333837|76021144|FG004|STARTED|Overall Study||3|Shows number of dyads who signed consent. Total number of participants is double the number of dyads. e.g., 20 dyads noted here = 40 participants|
59899326|NCT03333837|76021140|FG000|COMPLETED|Overall Study||22|Shows number of dyads. Total number of participants is double the number of dyads. e.g., 20 dyads noted here = 40 participants|
59899327|NCT03333837|76021141|FG001|COMPLETED|Overall Study||22|Shows number of dyads. Total number of participants is double the number of dyads. e.g., 20 dyads noted here = 40 participants|
59899328|NCT03333837|76021142|FG002|COMPLETED|Overall Study||22|Shows number of dyads. Total number of participants is double the number of dyads. e.g., 20 dyads noted here = 40 participants|
59899329|NCT03333837|76021143|FG003|COMPLETED|Overall Study||23|Shows number of dyads. Total number of participants is double the number of dyads. e.g., 20 dyads noted here = 40 participants|
59899330|NCT03333837|76021144|FG004|COMPLETED|Overall Study||0|Shows number of dyads. Total number of participants is double the number of dyads. e.g., 20 dyads noted here = 40 participants|
59899331|NCT03333837|76021140|FG000|NOT COMPLETED|Overall Study||2||
59899332|NCT03333837|76021141|FG001|NOT COMPLETED|Overall Study||3||
59899333|NCT03333837|76021142|FG002|NOT COMPLETED|Overall Study||5||
59611345|NCT01781286|75722314|FG004|Started 1st Intervention|Overall Study||6||
59611346|NCT01781286|75722315|FG005|Started 1st Intervention|Overall Study||2||
59611347|NCT01781286|75722310|FG000|Started 2nd Intervention|Overall Study||5||
59611348|NCT01781286|75722311|FG001|Started 2nd Intervention|Overall Study||4||
59611349|NCT01781286|75722312|FG002|Started 2nd Intervention|Overall Study||9||
59611350|NCT01781286|75722313|FG003|Started 2nd Intervention|Overall Study||8||
59899334|NCT03333837|76021143|FG003|NOT COMPLETED|Overall Study||2||
59899335|NCT03333837|76021144|FG004|NOT COMPLETED|Overall Study||3||
59899336|NCT03708211|76021162|FG000|STARTED|Overall Study||12||
59899337|NCT03708211|76021163|FG001|STARTED|Overall Study||8||
59899338|NCT03708211|76021162|FG000|COMPLETED|Overall Study||0||
59899339|NCT03708211|76021163|FG001|COMPLETED|Overall Study||0||
59899340|NCT03708211|76021162|FG000|NOT COMPLETED|Overall Study||12||
59899341|NCT03708211|76021163|FG001|NOT COMPLETED|Overall Study||8||
59899342|NCT02948634|76021173|FG000|STARTED|Overall Study||17||
59899343|NCT02948634|76021174|FG001|STARTED|Overall Study||11||
59899344|NCT02948634|76021173|FG000|COMPLETED|Overall Study||7||
59899345|NCT02948634|76021174|FG001|COMPLETED|Overall Study||9||
59899346|NCT02948634|76021173|FG000|NOT COMPLETED|Overall Study||10||
59899347|NCT02948634|76021174|FG001|NOT COMPLETED|Overall Study||2||
59899348|NCT02945046|76021183|FG000|STARTED|Overall Study||59|Intent-to-treat (ITT) analysis set: all randomized participants.|
59899349|NCT02945046|76021184|FG001|STARTED|Overall Study||55|Intent-to-treat (ITT) analysis set: all randomized participants.|
59899350|NCT02945046|76021185|FG002|STARTED|Overall Study||55|Intent-to-treat (ITT) analysis set: all randomized participants.|
59899351|NCT02945046|76021183|FG000|Safety Analysis Set|Overall Study||59|All randomized participants who received at least 1 dose of investigational medicinal product (IMP).|
59899352|NCT02945046|76021184|FG001|Safety Analysis Set|Overall Study||55|All randomized participants who received at least 1 dose of investigational medicinal product (IMP).|
59899353|NCT02945046|76021185|FG002|Safety Analysis Set|Overall Study||55|All randomized participants who received at least 1 dose of investigational medicinal product (IMP).|
59899354|NCT02945046|76021183|FG000|Full Analysis Set|Overall Study||57|Received ≥1 dose of IMP; had ≥10 days of postbaseline efficacy assessment on primary endpoint.|
59611351|NCT01781286|75722314|FG004|Started 2nd Intervention|Overall Study||6||
59611352|NCT01781286|75722315|FG005|Started 2nd Intervention|Overall Study||2||
59611353|NCT01781286|75722310|FG000|Started 3rd Intervention|Overall Study||5||
59899355|NCT02945046|76021184|FG001|Full Analysis Set|Overall Study||53|Received ≥1 dose of IMP; had ≥10 days of postbaseline efficacy assessment on primary endpoint.|
59899356|NCT02945046|76021185|FG002|Full Analysis Set|Overall Study||55|Received ≥1 dose of IMP; had ≥10 days of postbaseline efficacy assessment on primary endpoint.|
59899357|NCT02945046|76021183|FG000|COMPLETED|Overall Study||46||
59899358|NCT02945046|76021184|FG001|COMPLETED|Overall Study||42||
59899359|NCT02945046|76021185|FG002|COMPLETED|Overall Study||40||
59899360|NCT02945046|76021183|FG000|NOT COMPLETED|Overall Study||13||
59899361|NCT02945046|76021184|FG001|NOT COMPLETED|Overall Study||13||
59899362|NCT02945046|76021185|FG002|NOT COMPLETED|Overall Study||15||
59899363|NCT03705793|76021195|FG000|STARTED|Overall Study||27||
59899364|NCT03705793|76021196|FG001|STARTED|Overall Study||26||
59899365|NCT03705793|76021195|FG000|COMPLETED|Overall Study||22||
59899366|NCT03705793|76021196|FG001|COMPLETED|Overall Study||21||
59899367|NCT03705793|76021195|FG000|NOT COMPLETED|Overall Study||5||
59899368|NCT03705793|76021196|FG001|NOT COMPLETED|Overall Study||5||
59899369|NCT03333057|76021205|FG000|STARTED|Overall Study||111||
59899370|NCT03333057|76021206|FG001|STARTED|Overall Study||114||
59899371|NCT03333057|76021207|FG002|STARTED|Overall Study||111||
59899372|NCT03333057|76021205|FG000|COMPLETED|Overall Study||105||
59899373|NCT03333057|76021206|FG001|COMPLETED|Overall Study||110||
59899374|NCT03333057|76021207|FG002|COMPLETED|Overall Study||108||
59899375|NCT03333057|76021205|FG000|NOT COMPLETED|Overall Study||6||
59899376|NCT03333057|76021206|FG001|NOT COMPLETED|Overall Study||4||
59899377|NCT03333057|76021207|FG002|NOT COMPLETED|Overall Study||3||
59899378|NCT02944968|76021215|FG000|STARTED|Overall Study||51|Enrolled subjects (under protocol v1.0 and v2.0).|
59899379|NCT02944968|76021215|FG000|COMPLETED|Overall Study||48|Evaluable subjects (under protocol v1.0 and v2.0) who completed the study.|
59899380|NCT02944968|76021215|FG000|NOT COMPLETED|Overall Study||3||
59899381|NCT03761797|76021219|FG000|STARTED|Overall Study||1164||
59899382|NCT03761797|76021219|FG000|Safety Set|Overall Study||1146||
59899383|NCT03761797|76021219|FG000|COMPLETED|Overall Study||1025||
59899384|NCT03761797|76021219|FG000|NOT COMPLETED|Overall Study||139||
59611354|NCT01781286|75722311|FG001|Started 3rd Intervention|Overall Study||4||
59899385|NCT02944656|76021225|FG000|STARTED|Overall Study||57||
60014226|NCT02577029|76130251|FG004|COMPLETED|Overall Study||0||
59899386|NCT02944656|76021226|FG001|STARTED|Overall Study||57||
59899387|NCT02944656|76021225|FG000|Completed Procedure Day|Overall Study||54||
59899388|NCT02944656|76021226|FG001|Completed Procedure Day|Overall Study||57||
59899389|NCT02944656|76021225|FG000|Completed Day 1 Follow up|Overall Study||47||
59899390|NCT02944656|76021226|FG001|Completed Day 1 Follow up|Overall Study||47||
59899391|NCT02944656|76021225|FG000|COMPLETED|Overall Study||47||
59899392|NCT02944656|76021226|FG001|COMPLETED|Overall Study||47||
59899393|NCT02944656|76021225|FG000|NOT COMPLETED|Overall Study||10||
59899394|NCT02944656|76021226|FG001|NOT COMPLETED|Overall Study||10||
59899395|NCT02713529|76021239|FG000|STARTED|Overall Study||8||
59899396|NCT02713529|76021240|FG001|STARTED|Overall Study||7||
59899397|NCT02713529|76021241|FG002|STARTED|Overall Study||42||
59899398|NCT02713529|76021242|FG003|STARTED|Overall Study||31||
59899399|NCT02713529|76021243|FG004|STARTED|Overall Study||4||
59899400|NCT02713529|76021244|FG005|STARTED|Overall Study||19||
59899401|NCT02713529|76021245|FG006|STARTED|Overall Study||6||
59899402|NCT02713529|76021239|FG000|COMPLETED|Overall Study||1||
59899403|NCT02713529|76021240|FG001|COMPLETED|Overall Study||3||
59899404|NCT02713529|76021241|FG002|COMPLETED|Overall Study||11||
59899405|NCT02713529|76021242|FG003|COMPLETED|Overall Study||2||
59899406|NCT02713529|76021243|FG004|COMPLETED|Overall Study||1||
59899407|NCT02713529|76021244|FG005|COMPLETED|Overall Study||5||
59899408|NCT02713529|76021245|FG006|COMPLETED|Overall Study||2||
59899409|NCT02713529|76021239|FG000|NOT COMPLETED|Overall Study||7||
59899410|NCT02713529|76021240|FG001|NOT COMPLETED|Overall Study||4||
59899411|NCT02713529|76021241|FG002|NOT COMPLETED|Overall Study||31||
59899412|NCT02713529|76021242|FG003|NOT COMPLETED|Overall Study||29||
59611355|NCT01781286|75722312|FG002|Started 3rd Intervention|Overall Study||7||
59611356|NCT01781286|75722313|FG003|Started 3rd Intervention|Overall Study||7||
59757387|NCT03856593|75876496|FG001|NOT COMPLETED|Overall Study||16||
59757388|NCT03785925|75876504|FG000|STARTED|Overall Study||188||
59757389|NCT03785925|75876504|FG000|COMPLETED|Overall Study||172||
59757390|NCT03785925|75876504|FG000|NOT COMPLETED|Overall Study||16||
59757391|NCT03427411|75876515|FG000|STARTED|Overall Study||30||
59899413|NCT02713529|76021243|FG004|NOT COMPLETED|Overall Study||3||
59899414|NCT02713529|76021244|FG005|NOT COMPLETED|Overall Study||14||
59899415|NCT02713529|76021245|FG006|NOT COMPLETED|Overall Study||4||
59899416|NCT04800627|76021265|FG000|STARTED|Overall Study||2||
59899417|NCT04800627|76021265|FG000|COMPLETED|Overall Study||0||
59899418|NCT04800627|76021265|FG000|NOT COMPLETED|Overall Study||2||
59757392|NCT03427411|75876516|FG001|STARTED|Overall Study||27||
59899419|NCT03707821|76021271|FG000|STARTED|Overall Study||125||
59899420|NCT03707821|76021272|FG001|STARTED|Overall Study||126||
59899421|NCT03707821|76021271|FG000|COMPLETED|Overall Study||123||
59899422|NCT03707821|76021272|FG001|COMPLETED|Overall Study||125||
59899423|NCT03707821|76021271|FG000|NOT COMPLETED|Overall Study||2||
59899424|NCT03707821|76021272|FG001|NOT COMPLETED|Overall Study||1||
60014227|NCT02577029|76130252|FG005|COMPLETED|Overall Study||0||
59899425|NCT04546581|76021280|FG000|STARTED|Overall Study||301||
59899426|NCT04546581|76021281|FG001|STARTED|Overall Study||292||
59899427|NCT04546581|76021280|FG000|COMPLETED|Overall Study||288||
59899428|NCT04546581|76021281|FG001|COMPLETED|Overall Study||279||
59899429|NCT04546581|76021280|FG000|NOT COMPLETED|Overall Study||13||
59899430|NCT04546581|76021281|FG001|NOT COMPLETED|Overall Study||13||
59899431|NCT03707587|76021289|FG000|STARTED|Overall Study||7||
59899432|NCT03707587|76021290|FG001|STARTED|Overall Study||2||
59899433|NCT03707587|76021289|FG000|COMPLETED|Overall Study||7||
59899434|NCT03707587|76021290|FG001|COMPLETED|Overall Study||1||
59899435|NCT03707587|76021289|FG000|NOT COMPLETED|Overall Study||0||
59899436|NCT03707587|76021290|FG001|NOT COMPLETED|Overall Study||1||
59899437|NCT03416920|76021296|FG000|STARTED|Overall Study||167||
59899438|NCT03416920|76021296|FG000|COMPLETED|Overall Study||118||
59899439|NCT03416920|76021296|FG000|NOT COMPLETED|Overall Study||49||
59899440|NCT03312933|76021300|FG000|STARTED|Overall Study||100||
59899441|NCT03312933|76021300|FG000|COMPLETED|Overall Study||46||
59899442|NCT03312933|76021300|FG000|NOT COMPLETED|Overall Study||54||
59899443|NCT03312543|76021306|FG000|STARTED|Before Treatment (Screening to Baseline)||61||
59899444|NCT03312543|76021307|FG001|STARTED|Before Treatment (Screening to Baseline)||63||
59899445|NCT03312543|76021306|FG000|COMPLETED|Before Treatment (Screening to Baseline)||60||
59899446|NCT03312543|76021307|FG001|COMPLETED|Before Treatment (Screening to Baseline)||59||
59899447|NCT03312543|76021306|FG000|NOT COMPLETED|Before Treatment (Screening to Baseline)||1||
59899448|NCT03312543|76021307|FG001|NOT COMPLETED|Before Treatment (Screening to Baseline)||4||
59899449|NCT03312543|76021306|FG000|STARTED|Treatment (Baseline to Week 12)||60||
59899450|NCT03312543|76021307|FG001|STARTED|Treatment (Baseline to Week 12)||59||
59899451|NCT03312543|76021306|FG000|COMPLETED|Treatment (Baseline to Week 12)||56||
59899452|NCT03312543|76021307|FG001|COMPLETED|Treatment (Baseline to Week 12)||54||
59899453|NCT03312543|76021306|FG000|NOT COMPLETED|Treatment (Baseline to Week 12)||4||
59899454|NCT03312543|76021307|FG001|NOT COMPLETED|Treatment (Baseline to Week 12)||5||
59899455|NCT03312543|76021306|FG000|STARTED|Regression (Week 12 to Week 24)||56||
59899456|NCT03312543|76021307|FG001|STARTED|Regression (Week 12 to Week 24)||54||
59899457|NCT03312543|76021306|FG000|COMPLETED|Regression (Week 12 to Week 24)||55||
59899458|NCT03312543|76021307|FG001|COMPLETED|Regression (Week 12 to Week 24)||52||
59899459|NCT03312543|76021306|FG000|NOT COMPLETED|Regression (Week 12 to Week 24)||1||
59899460|NCT03312543|76021307|FG001|NOT COMPLETED|Regression (Week 12 to Week 24)||2||
59899461|NCT04756128|76021317|FG000|STARTED|Overall Study||35||
59899462|NCT04756128|76021318|FG001|STARTED|Overall Study||35||
59899463|NCT04756128|76021319|FG002|STARTED|Overall Study||36||
59899464|NCT04756128|76021320|FG003|STARTED|Overall Study||36||
59899465|NCT04756128|76021317|FG000|COMPLETED|Overall Study||34||
59899466|NCT04756128|76021318|FG001|COMPLETED|Overall Study||33||
59899467|NCT04756128|76021319|FG002|COMPLETED|Overall Study||35||
59899468|NCT04756128|76021320|FG003|COMPLETED|Overall Study||35||
59899469|NCT04756128|76021317|FG000|NOT COMPLETED|Overall Study||1||
59899470|NCT04756128|76021318|FG001|NOT COMPLETED|Overall Study||2||
59899471|NCT04756128|76021319|FG002|NOT COMPLETED|Overall Study||1||
59899472|NCT04756128|76021320|FG003|NOT COMPLETED|Overall Study||1||
59899473|NCT02392559|76021336|FG000|STARTED|Overall Study||53|Randomized|
59899474|NCT02392559|76021337|FG001|STARTED|Overall Study||105|Randomized|
59899475|NCT02392559|76021336|FG000|Randomized and Dosed|Overall Study||53||
59899476|NCT02392559|76021337|FG001|Randomized and Dosed|Overall Study||104||
59899477|NCT02392559|76021336|FG000|COMPLETED|Overall Study||53||
59899478|NCT02392559|76021337|FG001|COMPLETED|Overall Study||104||
59899479|NCT02392559|76021336|FG000|NOT COMPLETED|Overall Study||0||
59899480|NCT02392559|76021337|FG001|NOT COMPLETED|Overall Study||1||
59899481|NCT04919070|76021344|FG000|STARTED|Overall Study||5||
59899482|NCT04919070|76021344|FG000|COMPLETED|Overall Study||5||
59899483|NCT04919070|76021344|FG000|NOT COMPLETED|Overall Study||0||
59899484|NCT03332589|76021351|FG000|STARTED|Overall Study||4||
59899485|NCT03332589|76021352|FG001|STARTED|Overall Study||0||
59899486|NCT03332589|76021353|FG002|STARTED|Overall Study||0||
59899487|NCT03332589|76021351|FG000|COMPLETED|Overall Study||0||
59899488|NCT03332589|76021352|FG001|COMPLETED|Overall Study||0||
59899489|NCT03332589|76021353|FG002|COMPLETED|Overall Study||0||
59899490|NCT03332589|76021351|FG000|NOT COMPLETED|Overall Study||4||
59899491|NCT03332589|76021352|FG001|NOT COMPLETED|Overall Study||0||
59899492|NCT03332589|76021353|FG002|NOT COMPLETED|Overall Study||0||
59899493|NCT00458003|76021363|FG000|STARTED|Overall Study||55||
59899494|NCT00458003|76021364|FG001|STARTED|Overall Study||55||
59899495|NCT00458003|76021363|FG000|COMPLETED|Overall Study||54||
59899496|NCT00458003|76021364|FG001|COMPLETED|Overall Study||54||
59899497|NCT00458003|76021363|FG000|NOT COMPLETED|Overall Study||1||
59899498|NCT00458003|76021364|FG001|NOT COMPLETED|Overall Study||1||
59899499|NCT02061293|76021374|FG000|STARTED|Overall Study||49||
59899500|NCT02061293|76021375|FG001|STARTED|Overall Study||46||
59899501|NCT02061293|76021374|FG000|COMPLETED|Overall Study||48||
59899502|NCT02061293|76021375|FG001|COMPLETED|Overall Study||45||
59899503|NCT02061293|76021374|FG000|NOT COMPLETED|Overall Study||1||
59899504|NCT02061293|76021375|FG001|NOT COMPLETED|Overall Study||1||
59899505|NCT02913612|76021385|FG000|STARTED|Overall Study||44||
59899506|NCT02913612|76021386|FG001|STARTED|Overall Study||51||
59899507|NCT02913612|76021387|FG002|STARTED|Overall Study||10||
59899508|NCT02913612|76021388|FG003|STARTED|Overall Study||36||
59899509|NCT02913612|76021385|FG000|COMPLETED|Overall Study||32||
59899510|NCT02913612|76021386|FG001|COMPLETED|Overall Study||33||
59899511|NCT02913612|76021387|FG002|COMPLETED|Overall Study||7||
59899512|NCT02913612|76021388|FG003|COMPLETED|Overall Study||36||
59899513|NCT02913612|76021385|FG000|NOT COMPLETED|Overall Study||12||
59899514|NCT02913612|76021386|FG001|NOT COMPLETED|Overall Study||18||
59899515|NCT02913612|76021387|FG002|NOT COMPLETED|Overall Study||3||
59899516|NCT02913612|76021388|FG003|NOT COMPLETED|Overall Study||0||
59899517|NCT03323736|76021400|FG000|STARTED|Overall Study||241||
59899518|NCT03323736|76021401|FG001|STARTED|Overall Study||59||
59899519|NCT03323736|76021402|FG002|STARTED|Overall Study||70||
59899520|NCT03323736|76021400|FG000|Treated|Overall Study||222||
59899521|NCT03323736|76021401|FG001|Treated|Overall Study||47||
59899522|NCT03323736|76021402|FG002|Treated|Overall Study||68||
59899523|NCT03323736|76021400|FG000|COMPLETED|Overall Study||222||
59899524|NCT03323736|76021401|FG001|COMPLETED|Overall Study||47||
59899525|NCT03323736|76021402|FG002|COMPLETED|Overall Study||68||
59899526|NCT03323736|76021400|FG000|NOT COMPLETED|Overall Study||19||
59899527|NCT03323736|76021401|FG001|NOT COMPLETED|Overall Study||12||
59899528|NCT03323736|76021402|FG002|NOT COMPLETED|Overall Study||2||
59899529|NCT03311841|76021417|FG000|STARTED|Period 1||6||
59899530|NCT03311841|76021418|FG001|STARTED|Period 1||7||
59899531|NCT03311841|76021419|FG002|STARTED|Period 1||6||
59899532|NCT03311841|76021420|FG003|STARTED|Period 1||7||
59899533|NCT03311841|76021421|FG004|STARTED|Period 1||6||
59899534|NCT03311841|76021417|FG000|COMPLETED|Period 1||6||
59899535|NCT03311841|76021418|FG001|COMPLETED|Period 1||7||
59899536|NCT03311841|76021419|FG002|COMPLETED|Period 1||6||
59899537|NCT03311841|76021420|FG003|COMPLETED|Period 1||7||
59899538|NCT03311841|76021421|FG004|COMPLETED|Period 1||6||
59899539|NCT03311841|76021417|FG000|NOT COMPLETED|Period 1||0||
59899540|NCT03311841|76021418|FG001|NOT COMPLETED|Period 1||0||
59899541|NCT03311841|76021419|FG002|NOT COMPLETED|Period 1||0||
59899542|NCT03311841|76021420|FG003|NOT COMPLETED|Period 1||0||
59899543|NCT03311841|76021421|FG004|NOT COMPLETED|Period 1||0||
59899544|NCT03311841|76021417|FG000|STARTED|14-day Wash-out||6||
59899545|NCT03311841|76021418|FG001|STARTED|14-day Wash-out||7||
59899546|NCT03311841|76021419|FG002|STARTED|14-day Wash-out||6||
59899547|NCT03311841|76021420|FG003|STARTED|14-day Wash-out||7||
59899548|NCT03311841|76021421|FG004|STARTED|14-day Wash-out||6||
59899549|NCT03311841|76021417|FG000|COMPLETED|14-day Wash-out||6||
59899550|NCT03311841|76021418|FG001|COMPLETED|14-day Wash-out||6||
59899551|NCT03311841|76021419|FG002|COMPLETED|14-day Wash-out||6||
59899552|NCT03311841|76021420|FG003|COMPLETED|14-day Wash-out||6||
59899553|NCT03311841|76021421|FG004|COMPLETED|14-day Wash-out||6||
59899554|NCT03311841|76021417|FG000|NOT COMPLETED|14-day Wash-out||0||
59899555|NCT03311841|76021418|FG001|NOT COMPLETED|14-day Wash-out||1||
59899556|NCT03311841|76021419|FG002|NOT COMPLETED|14-day Wash-out||0||
59899557|NCT03311841|76021420|FG003|NOT COMPLETED|14-day Wash-out||1||
59899558|NCT03311841|76021421|FG004|NOT COMPLETED|14-day Wash-out||0||
59899559|NCT03311841|76021417|FG000|STARTED|Period 2||6||
59899560|NCT03311841|76021418|FG001|STARTED|Period 2||6||
59899561|NCT03311841|76021419|FG002|STARTED|Period 2||6||
59899562|NCT03311841|76021420|FG003|STARTED|Period 2||6||
59899563|NCT03311841|76021421|FG004|STARTED|Period 2||6||
59899564|NCT03311841|76021417|FG000|COMPLETED|Period 2||6||
59899565|NCT03311841|76021418|FG001|COMPLETED|Period 2||6||
59899566|NCT03311841|76021419|FG002|COMPLETED|Period 2||6||
59899567|NCT03311841|76021420|FG003|COMPLETED|Period 2||6||
59899568|NCT03311841|76021421|FG004|COMPLETED|Period 2||6||
59899569|NCT03311841|76021417|FG000|NOT COMPLETED|Period 2||0||
59899570|NCT03311841|76021418|FG001|NOT COMPLETED|Period 2||0||
59899571|NCT03311841|76021419|FG002|NOT COMPLETED|Period 2||0||
59899572|NCT03311841|76021420|FG003|NOT COMPLETED|Period 2||0||
59899573|NCT03311841|76021421|FG004|NOT COMPLETED|Period 2||0||
59899574|NCT05138783|76021444|FG000|STARTED|First Wear Period, 8 -0/+3 Days||62||124
59899575|NCT05138783|76021445|FG001|STARTED|First Wear Period, 8 -0/+3 Days||64||128
59899576|NCT05138783|76021444|FG000|COMPLETED|First Wear Period, 8 -0/+3 Days||62||124
59899577|NCT05138783|76021445|FG001|COMPLETED|First Wear Period, 8 -0/+3 Days||64||128
59899578|NCT05138783|76021444|FG000|NOT COMPLETED|First Wear Period, 8 -0/+3 Days||0||0
59899579|NCT05138783|76021445|FG001|NOT COMPLETED|First Wear Period, 8 -0/+3 Days||0||0
59899580|NCT05138783|76021444|FG000|STARTED|Second Wear Period, 8 -0/+3 Days||62||124
59899581|NCT05138783|76021445|FG001|STARTED|Second Wear Period, 8 -0/+3 Days||64||128
59899582|NCT05138783|76021444|FG000|COMPLETED|Second Wear Period, 8 -0/+3 Days||62||124
59899583|NCT05138783|76021445|FG001|COMPLETED|Second Wear Period, 8 -0/+3 Days||64||128
59899584|NCT05138783|76021444|FG000|NOT COMPLETED|Second Wear Period, 8 -0/+3 Days||0||0
59899585|NCT05138783|76021445|FG001|NOT COMPLETED|Second Wear Period, 8 -0/+3 Days||0||0
59899586|NCT03311373|76021454|FG000|STARTED|Overall Study||56||
59899587|NCT03311373|76021454|FG000|COMPLETED|Overall Study||47||
59899588|NCT03311373|76021454|FG000|NOT COMPLETED|Overall Study||9||
59899589|NCT01155375|76021466|FG000|STARTED|Overall Study||8|Data are for the combined AMAG-FER-CKD-251 and AMAG-FER-CKD-252 studies.|
59951051|NCT05120115|76069981|FG000|8 kg and Bilateral Weight Distriubtion|Overall Study||21||
59899590|NCT01155375|76021467|FG001|STARTED|Overall Study||6|Data are for the combined AMAG-FER-CKD-251 and AMAG-FER-CKD-252 studies.|
59899591|NCT01155375|76021466|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8||
59899592|NCT01155375|76021467|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6||
59899593|NCT01155375|76021466|FG000|COMPLETED|Overall Study||7||
59899594|NCT01155375|76021467|FG001|COMPLETED|Overall Study||6||
59899595|NCT01155375|76021466|FG000|NOT COMPLETED|Overall Study||1||
59899596|NCT01155375|76021467|FG001|NOT COMPLETED|Overall Study||0||
59899597|NCT03764059|76021476|FG000|STARTED|Overall Study||120||
59899598|NCT03764059|76021477|FG001|STARTED|Overall Study||120||
59899599|NCT03764059|76021476|FG000|COMPLETED|Overall Study||120||
59899600|NCT03764059|76021477|FG001|COMPLETED|Overall Study||120||
59899601|NCT03764059|76021476|FG000|NOT COMPLETED|Overall Study||0||
59899602|NCT03764059|76021477|FG001|NOT COMPLETED|Overall Study||0||
59899603|NCT00628095|76021485|FG000|STARTED|Overall Study||53||
59899604|NCT00628095|76021486|FG001|STARTED|Overall Study||47||
59899605|NCT00628095|76021485|FG000|COMPLETED|Overall Study||46||
59899606|NCT00628095|76021486|FG001|COMPLETED|Overall Study||40||
59899607|NCT00628095|76021485|FG000|NOT COMPLETED|Overall Study||7||
59899608|NCT00628095|76021486|FG001|NOT COMPLETED|Overall Study||7||
59899609|NCT02889861|76021494|FG000|STARTED|Overall Study||3||
59899610|NCT02889861|76021494|FG000|COMPLETED|Overall Study||1||
59899611|NCT02889861|76021494|FG000|NOT COMPLETED|Overall Study||2||
59899612|NCT03325881|76021505|FG000|STARTED|Overall Study||44||
59899613|NCT03325881|76021506|FG001|STARTED|Overall Study||45||
59899614|NCT03325881|76021505|FG000|Treated|Overall Study||43||
59899615|NCT03325881|76021506|FG001|Treated|Overall Study||45||
59899616|NCT03325881|76021505|FG000|COMPLETED|Overall Study||41||
59899617|NCT03325881|76021506|FG001|COMPLETED|Overall Study||42||
59899618|NCT03325881|76021505|FG000|NOT COMPLETED|Overall Study||3||
59899619|NCT03325881|76021506|FG001|NOT COMPLETED|Overall Study||3||
59899620|NCT02887989|76021516|FG000|STARTED|Overall Study||70||
59899621|NCT02887989|76021517|FG001|STARTED|Overall Study||70||
59899622|NCT02887989|76021516|FG000|COMPLETED|Overall Study||61||
59899623|NCT02887989|76021517|FG001|COMPLETED|Overall Study||59||
59899624|NCT02887989|76021516|FG000|NOT COMPLETED|Overall Study||9||
59899625|NCT02887989|76021517|FG001|NOT COMPLETED|Overall Study||11||
59899626|NCT02887521|76021525|FG000|STARTED|Overall Study||4||
59899627|NCT02887521|76021526|FG001|STARTED|Overall Study||5||
59899628|NCT02887521|76021525|FG000|COMPLETED|Overall Study||4||
59899629|NCT02887521|76021526|FG001|COMPLETED|Overall Study||2||
59899630|NCT02887521|76021525|FG000|NOT COMPLETED|Overall Study||0||
59899631|NCT02887521|76021526|FG001|NOT COMPLETED|Overall Study||3||
59899632|NCT03305055|76021534|FG000|STARTED|Overall Study||2||
59899633|NCT03305055|76021535|FG001|STARTED|Overall Study||2||
59899634|NCT03305055|76021534|FG000|COMPLETED|Overall Study||1||
59899635|NCT03305055|76021535|FG001|COMPLETED|Overall Study||0||
59899636|NCT03305055|76021534|FG000|NOT COMPLETED|Overall Study||1||
59899637|NCT03305055|76021535|FG001|NOT COMPLETED|Overall Study||2||
59899638|NCT02763189|76021543|FG000|STARTED|Overall Study||4||
59899639|NCT02763189|76021544|FG001|STARTED|Overall Study||4||
59757393|NCT03427411|75876515|FG000|COMPLETED|Overall Study||30||
59757394|NCT03427411|75876516|FG001|COMPLETED|Overall Study||26||
59757395|NCT03427411|75876515|FG000|NOT COMPLETED|Overall Study||0||
59757396|NCT03427411|75876516|FG001|NOT COMPLETED|Overall Study||1||
59757397|NCT03330106|75876524|FG000|STARTED|Part A||22||
59757398|NCT03330106|75876525|FG001|STARTED|Part A||22||
59899640|NCT02763189|76021543|FG000|COMPLETED|Overall Study||4||
59899641|NCT02763189|76021544|FG001|COMPLETED|Overall Study||2||
59899642|NCT02763189|76021543|FG000|NOT COMPLETED|Overall Study||0||
59899643|NCT02763189|76021544|FG001|NOT COMPLETED|Overall Study||2||
59899644|NCT03273387|76021552|FG000|STARTED|Overall Study||13||
59899645|NCT03273387|76021553|FG001|STARTED|Overall Study||13||
59899646|NCT03273387|76021552|FG000|COMPLETED|Overall Study||10||
59899647|NCT03273387|76021553|FG001|COMPLETED|Overall Study||10||
59899648|NCT03273387|76021552|FG000|NOT COMPLETED|Overall Study||3||
59899649|NCT03273387|76021553|FG001|NOT COMPLETED|Overall Study||3||
59899650|NCT01328080|76021559|FG000|STARTED|Overall Study|11 subjects consented; 1 withdrew consent before first UVB treatment|11||
59899651|NCT01328080|76021559|FG000|COMPLETED|Overall Study||6||
60014228|NCT02577029|76130253|FG006|COMPLETED|Overall Study||0||
59899652|NCT01328080|76021559|FG000|NOT COMPLETED|Overall Study||5||
59899653|NCT02790034|76021566|FG000|STARTED|Overall Study||33||
59899654|NCT02790034|76021567|FG001|STARTED|Overall Study||56||
59899655|NCT02790034|76021568|FG002|STARTED|Overall Study||40||
59899656|NCT02790034|76021566|FG000|COMPLETED|Overall Study||27||
59899657|NCT02790034|76021567|FG001|COMPLETED|Overall Study||46||
59899658|NCT02790034|76021568|FG002|COMPLETED|Overall Study||36||
59899659|NCT02790034|76021566|FG000|NOT COMPLETED|Overall Study||6||
59757399|NCT03330106|75876526|FG002|STARTED|Part A||0||
59899660|NCT02790034|76021567|FG001|NOT COMPLETED|Overall Study||10||
59899661|NCT02790034|76021568|FG002|NOT COMPLETED|Overall Study||4||
59899662|NCT02649946|76021578|FG000|STARTED|Overall Study||142||
59899663|NCT02649946|76021579|FG001|STARTED|Overall Study||138||
59899664|NCT02649946|76021578|FG000|COMPLETED|Overall Study||130||
60014229|NCT02577029|76130254|FG007|COMPLETED|Overall Study||0||
59899665|NCT02649946|76021579|FG001|COMPLETED|Overall Study||123||
59899666|NCT02649946|76021578|FG000|NOT COMPLETED|Overall Study||12||
59899667|NCT02649946|76021579|FG001|NOT COMPLETED|Overall Study||15||
59899668|NCT03273153|76021587|FG000|STARTED|Overall Study||224||
59899669|NCT03273153|76021588|FG001|STARTED|Overall Study||222||
59899670|NCT03273153|76021587|FG000|COMPLETED|Overall Study||0||
59899671|NCT03273153|76021588|FG001|COMPLETED|Overall Study||0||
59899672|NCT03273153|76021587|FG000|NOT COMPLETED|Overall Study||224||
59899673|NCT03273153|76021588|FG001|NOT COMPLETED|Overall Study||222||
59899674|NCT04410783|76021597|FG000|STARTED|Overall Study||876||
59899675|NCT04410783|76021598|FG001|STARTED|Overall Study||895||
59899676|NCT04410783|76021597|FG000|COMPLETED|Overall Study||196||
59899677|NCT04410783|76021598|FG001|COMPLETED|Overall Study||219||
59899678|NCT04410783|76021597|FG000|NOT COMPLETED|Overall Study||680||
59899679|NCT04410783|76021598|FG001|NOT COMPLETED|Overall Study||676||
59899680|NCT02749968|76021606|FG000|STARTED|Overall Study||50||
59899681|NCT02749968|76021607|FG001|STARTED|Overall Study||50||
59899682|NCT02749968|76021606|FG000|Interim Analysis|Overall Study||25|Interim safety and efficacy analysis was performed after 25 patients were recruited to each arm.|
59899683|NCT02749968|76021607|FG001|Interim Analysis|Overall Study||25|Interim safety and efficacy analysis was performed after 25 patients were recruited to each arm.|
59899684|NCT02749968|76021606|FG000|COMPLETED|Overall Study||50||
59899685|NCT02749968|76021607|FG001|COMPLETED|Overall Study||50||
59899686|NCT02749968|76021606|FG000|NOT COMPLETED|Overall Study||0||
59899687|NCT02749968|76021607|FG001|NOT COMPLETED|Overall Study||0||
59899688|NCT03270657|76021613|FG000|STARTED|Overall Study||5||
59899689|NCT03270657|76021613|FG000|COMPLETED|Overall Study||4||
59899690|NCT03270657|76021613|FG000|NOT COMPLETED|Overall Study||1||
59899691|NCT03303417|76021617|FG000|STARTED|Overall Study||8||
59899692|NCT03303417|76021618|FG001|STARTED|Overall Study||8||
59899693|NCT03303417|76021617|FG000|COMPLETED|Overall Study||7||
59899694|NCT03303417|76021618|FG001|COMPLETED|Overall Study||7||
59899695|NCT03303417|76021617|FG000|NOT COMPLETED|Overall Study||1||
59899696|NCT03303417|76021618|FG001|NOT COMPLETED|Overall Study||1||
59899697|NCT04908748|76021626|FG000|STARTED|Overall Study||98||
59899698|NCT04908748|76021627|FG001|STARTED|Overall Study||102||
59899699|NCT04908748|76021626|FG000|COMPLETED|Overall Study||98||
59899700|NCT04908748|76021627|FG001|COMPLETED|Overall Study||102||
59899701|NCT04908748|76021626|FG000|NOT COMPLETED|Overall Study||0||
59899702|NCT04908748|76021627|FG001|NOT COMPLETED|Overall Study||0||
59899703|NCT02943564|76021636|FG000|STARTED|Overall Study||217||
59899704|NCT02943564|76021637|FG001|STARTED|Overall Study||211||
59899705|NCT02943564|76021638|FG002|STARTED|Overall Study||210||
59899706|NCT02943564|76021636|FG000|Responder|Overall Study||83||
59899707|NCT02943564|76021637|FG001|Responder|Overall Study||77||
59899708|NCT02943564|76021638|FG002|Responder|Overall Study||77||
59899709|NCT02943564|76021636|FG000|Non-Responder|Overall Study||134||
59899710|NCT02943564|76021637|FG001|Non-Responder|Overall Study||134||
59899711|NCT02943564|76021638|FG002|Non-Responder|Overall Study||133||
59899712|NCT02943564|76021636|FG000|COMPLETED|Overall Study||207||
59899713|NCT02943564|76021637|FG001|COMPLETED|Overall Study||198||
59899714|NCT02943564|76021638|FG002|COMPLETED|Overall Study||201||
59899715|NCT02943564|76021636|FG000|NOT COMPLETED|Overall Study||10||
59899716|NCT02943564|76021637|FG001|NOT COMPLETED|Overall Study||13||
59899717|NCT02943564|76021638|FG002|NOT COMPLETED|Overall Study||9||
59899718|NCT03268941|76021650|FG000|STARTED|Part 1 (Days 1 to 9)||12||
59899719|NCT03268941|76021651|FG001|STARTED|Part 1 (Days 1 to 9)||14||
59899720|NCT03268941|76021652|FG002|STARTED|Part 1 (Days 1 to 9)||12||
59899721|NCT03268941|76021653|FG003|STARTED|Part 1 (Days 1 to 9)||13||
59899722|NCT03268941|76021654|FG004|STARTED|Part 1 (Days 1 to 9)||0||
59899723|NCT03268941|76021655|FG005|STARTED|Part 1 (Days 1 to 9)||0||
59899724|NCT03268941|76021656|FG006|STARTED|Part 1 (Days 1 to 9)||0||
59899725|NCT03268941|76021650|FG000|COMPLETED|Part 1 (Days 1 to 9)||11||
59899726|NCT03268941|76021651|FG001|COMPLETED|Part 1 (Days 1 to 9)||14||
59899727|NCT03268941|76021652|FG002|COMPLETED|Part 1 (Days 1 to 9)||12||
59899728|NCT03268941|76021653|FG003|COMPLETED|Part 1 (Days 1 to 9)||11||
59899729|NCT03268941|76021654|FG004|COMPLETED|Part 1 (Days 1 to 9)||0||
59899730|NCT03268941|76021655|FG005|COMPLETED|Part 1 (Days 1 to 9)||0||
59899731|NCT03268941|76021656|FG006|COMPLETED|Part 1 (Days 1 to 9)||0||
59899732|NCT03268941|76021650|FG000|NOT COMPLETED|Part 1 (Days 1 to 9)||1||
59899733|NCT03268941|76021651|FG001|NOT COMPLETED|Part 1 (Days 1 to 9)||0||
59899734|NCT03268941|76021652|FG002|NOT COMPLETED|Part 1 (Days 1 to 9)||0||
60014230|NCT02577029|76130247|FG000|NOT COMPLETED|Overall Study||10||
59899735|NCT03268941|76021653|FG003|NOT COMPLETED|Part 1 (Days 1 to 9)||2||
59899736|NCT03268941|76021654|FG004|NOT COMPLETED|Part 1 (Days 1 to 9)||0||
59899737|NCT03268941|76021655|FG005|NOT COMPLETED|Part 1 (Days 1 to 9)||0||
59899738|NCT03268941|76021656|FG006|NOT COMPLETED|Part 1 (Days 1 to 9)||0||
59899739|NCT03268941|76021650|FG000|STARTED|Part 2: Days 17 to 25||0||
59899740|NCT03268941|76021651|FG001|STARTED|Part 2: Days 17 to 25||0||
59899741|NCT03268941|76021652|FG002|STARTED|Part 2: Days 17 to 25||0||
59899742|NCT03268941|76021653|FG003|STARTED|Part 2: Days 17 to 25||0||
59899743|NCT03268941|76021654|FG004|STARTED|Part 2: Days 17 to 25||6||
59899744|NCT03268941|76021655|FG005|STARTED|Part 2: Days 17 to 25||0||
59899745|NCT03268941|76021656|FG006|STARTED|Part 2: Days 17 to 25||15||
59899746|NCT03268941|76021650|FG000|Treated|Part 2: Days 17 to 25||0||
59899747|NCT03268941|76021651|FG001|Treated|Part 2: Days 17 to 25||0||
59899748|NCT03268941|76021652|FG002|Treated|Part 2: Days 17 to 25||0||
59899749|NCT03268941|76021653|FG003|Treated|Part 2: Days 17 to 25||0||
59899750|NCT03268941|76021654|FG004|Treated|Part 2: Days 17 to 25||6||
59899751|NCT03268941|76021655|FG005|Treated|Part 2: Days 17 to 25||0||
59899752|NCT03268941|76021656|FG006|Treated|Part 2: Days 17 to 25||13||
59899753|NCT03268941|76021650|FG000|COMPLETED|Part 2: Days 17 to 25||0||
59899754|NCT03268941|76021651|FG001|COMPLETED|Part 2: Days 17 to 25||0||
59899755|NCT03268941|76021652|FG002|COMPLETED|Part 2: Days 17 to 25||0||
59899756|NCT03268941|76021653|FG003|COMPLETED|Part 2: Days 17 to 25||0||
59899757|NCT03268941|76021654|FG004|COMPLETED|Part 2: Days 17 to 25||6||
59899758|NCT03268941|76021655|FG005|COMPLETED|Part 2: Days 17 to 25||0||
59899759|NCT03268941|76021656|FG006|COMPLETED|Part 2: Days 17 to 25||13||
59899760|NCT03268941|76021650|FG000|NOT COMPLETED|Part 2: Days 17 to 25||0||
59899761|NCT03268941|76021651|FG001|NOT COMPLETED|Part 2: Days 17 to 25||0||
59899762|NCT03268941|76021652|FG002|NOT COMPLETED|Part 2: Days 17 to 25||0||
59899763|NCT03268941|76021653|FG003|NOT COMPLETED|Part 2: Days 17 to 25||0||
59899764|NCT03268941|76021654|FG004|NOT COMPLETED|Part 2: Days 17 to 25||0||
59899765|NCT03268941|76021655|FG005|NOT COMPLETED|Part 2: Days 17 to 25||0||
59899766|NCT03268941|76021656|FG006|NOT COMPLETED|Part 2: Days 17 to 25||2||
59899767|NCT03268941|76021650|FG000|STARTED|Part 2: Period 2: Fasted (Day 25)||0||
59899768|NCT03268941|76021651|FG001|STARTED|Part 2: Period 2: Fasted (Day 25)||0||
59899769|NCT03268941|76021652|FG002|STARTED|Part 2: Period 2: Fasted (Day 25)||0||
59899770|NCT03268941|76021653|FG003|STARTED|Part 2: Period 2: Fasted (Day 25)||0||
59899771|NCT03268941|76021654|FG004|STARTED|Part 2: Period 2: Fasted (Day 25)||0||
59899772|NCT03268941|76021655|FG005|STARTED|Part 2: Period 2: Fasted (Day 25)||6||
59899773|NCT03268941|76021656|FG006|STARTED|Part 2: Period 2: Fasted (Day 25)||0||
59899774|NCT03268941|76021650|FG000|COMPLETED|Part 2: Period 2: Fasted (Day 25)||0||
59899775|NCT03268941|76021651|FG001|COMPLETED|Part 2: Period 2: Fasted (Day 25)||0||
59899776|NCT03268941|76021652|FG002|COMPLETED|Part 2: Period 2: Fasted (Day 25)||0||
59899777|NCT03268941|76021653|FG003|COMPLETED|Part 2: Period 2: Fasted (Day 25)||0||
59899778|NCT03268941|76021654|FG004|COMPLETED|Part 2: Period 2: Fasted (Day 25)||0||
59899779|NCT03268941|76021655|FG005|COMPLETED|Part 2: Period 2: Fasted (Day 25)||6||
59899780|NCT03268941|76021656|FG006|COMPLETED|Part 2: Period 2: Fasted (Day 25)||0||
59899781|NCT03268941|76021650|FG000|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0||
59505824|NCT00743093|75598716|FG001|STARTED|Extended Dosing Period|Subjects not meeting stopping criteria after base continued into the extended dosing.|1||
59505825|NCT00743093|75598715|FG000|COMPLETED|Extended Dosing Period||48||
59899782|NCT03268941|76021651|FG001|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0||
59899783|NCT03268941|76021652|FG002|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0||
59899784|NCT03268941|76021653|FG003|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0||
59899785|NCT03268941|76021654|FG004|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0||
59899786|NCT03268941|76021655|FG005|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0||
59899787|NCT03268941|76021656|FG006|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0||
59899788|NCT03397264|76021680|FG000|STARTED|Overall Study||3||
59899789|NCT03397264|76021681|FG001|STARTED|Overall Study||3||
59899790|NCT03397264|76021682|FG002|STARTED|Overall Study||3||
59899791|NCT03397264|76021683|FG003|STARTED|Overall Study||96||
59899792|NCT03397264|76021684|FG004|STARTED|Overall Study||48||
59899793|NCT03397264|76021680|FG000|COMPLETED|Overall Study||3|Completed the Treatment Phase to Week 12|
59899794|NCT03397264|76021681|FG001|COMPLETED|Overall Study||3|Completed the Treatment Phase to Week 12|
59899795|NCT03397264|76021682|FG002|COMPLETED|Overall Study||3|Completed the Treatment Phase to Week 12|
59899796|NCT03397264|76021683|FG003|COMPLETED|Overall Study||89|Completed the Treatment Phase to Week 12|
59899797|NCT03397264|76021684|FG004|COMPLETED|Overall Study||47|Completed the Treatment Phase to Week 12|
59899798|NCT03397264|76021680|FG000|NOT COMPLETED|Overall Study||0||
59899799|NCT03397264|76021681|FG001|NOT COMPLETED|Overall Study||0||
59899800|NCT03397264|76021682|FG002|NOT COMPLETED|Overall Study||0||
59899801|NCT03397264|76021683|FG003|NOT COMPLETED|Overall Study||7||
59899802|NCT03397264|76021684|FG004|NOT COMPLETED|Overall Study||1||
59899803|NCT04632706|76021701|FG000|STARTED|Overall Study||6||
59899804|NCT04632706|76021702|FG001|STARTED|Overall Study||6||
59899805|NCT04632706|76021703|FG002|STARTED|Overall Study||6||
59899806|NCT04632706|76021704|FG003|STARTED|Overall Study||6||
59899807|NCT04632706|76021701|FG000|COMPLETED|Overall Study||6||
59899808|NCT04632706|76021702|FG001|COMPLETED|Overall Study||6||
59899809|NCT04632706|76021703|FG002|COMPLETED|Overall Study||5||
59899810|NCT04632706|76021704|FG003|COMPLETED|Overall Study||6||
59899811|NCT04632706|76021701|FG000|NOT COMPLETED|Overall Study||0||
59899812|NCT04632706|76021702|FG001|NOT COMPLETED|Overall Study||0||
59899813|NCT04632706|76021703|FG002|NOT COMPLETED|Overall Study||1||
59899814|NCT04632706|76021704|FG003|NOT COMPLETED|Overall Study||0||
59899815|NCT03245619|76021733|FG000|STARTED|Part A (Up to Day 22)||5||
59899816|NCT03245619|76021734|FG001|STARTED|Part A (Up to Day 22)||6||
59505826|NCT00743093|75598716|FG001|COMPLETED|Extended Dosing Period||1||
59505827|NCT00743093|75598715|FG000|NOT COMPLETED|Extended Dosing Period||3||
60014231|NCT02577029|76130248|FG001|NOT COMPLETED|Overall Study||2||
60014232|NCT02577029|76130249|FG002|NOT COMPLETED|Overall Study||7||
60014233|NCT02577029|76130250|FG003|NOT COMPLETED|Overall Study||12||
60014234|NCT02577029|76130251|FG004|NOT COMPLETED|Overall Study||11||
59757400|NCT03330106|75876527|FG003|STARTED|Part A||0||
59757401|NCT03330106|75876524|FG000|COMPLETED|Part A||18||
59757402|NCT03330106|75876525|FG001|COMPLETED|Part A||17||
59757403|NCT03330106|75876526|FG002|COMPLETED|Part A||0||
59757404|NCT03330106|75876527|FG003|COMPLETED|Part A||0||
59757405|NCT03330106|75876524|FG000|NOT COMPLETED|Part A||4||
59757406|NCT03330106|75876525|FG001|NOT COMPLETED|Part A||5||
60014235|NCT02577029|76130252|FG005|NOT COMPLETED|Overall Study||13||
60014236|NCT02577029|76130253|FG006|NOT COMPLETED|Overall Study||12||
60014237|NCT02577029|76130254|FG007|NOT COMPLETED|Overall Study||12||
60014238|NCT02577887|76130272|FG000|STARTED|Overall Study||2101||
60014239|NCT02577887|76130272|FG000|6 Month Follow-up|Overall Study||1938||
60014240|NCT02577887|76130272|FG000|COMPLETED|Overall Study||1803|The last follow-up was at 12 months post implant.|
60014241|NCT02577887|76130272|FG000|NOT COMPLETED|Overall Study||298||
60014242|NCT03597347|76130279|FG000|STARTED|Overall Study||7||
60014243|NCT03597347|76130280|FG001|STARTED|Overall Study||3||
60014244|NCT03597347|76130281|FG002|STARTED|Overall Study||4||
60014245|NCT03597347|76130279|FG000|COMPLETED|Overall Study||0||
60014246|NCT03597347|76130280|FG001|COMPLETED|Overall Study||0||
60014247|NCT03597347|76130281|FG002|COMPLETED|Overall Study||0||
60014248|NCT03597347|76130279|FG000|NOT COMPLETED|Overall Study||7||
60014249|NCT03597347|76130280|FG001|NOT COMPLETED|Overall Study||3||
60014250|NCT03597347|76130281|FG002|NOT COMPLETED|Overall Study||4||
60014251|NCT02576951|76130293|FG000|STARTED|Overall Study||15||
60014252|NCT02576951|76130294|FG001|STARTED|Overall Study||3||
60014253|NCT02576951|76130295|FG002|STARTED|Overall Study||80||
60014254|NCT02576951|76130296|FG003|STARTED|Overall Study||80||
60014255|NCT02576951|76130293|FG000|Received at Least One Dose of Study Drug|Overall Study||15||
60014256|NCT02576951|76130294|FG001|Received at Least One Dose of Study Drug|Overall Study||3||
60014257|NCT02576951|76130295|FG002|Received at Least One Dose of Study Drug|Overall Study||80||
60014258|NCT02576951|76130296|FG003|Received at Least One Dose of Study Drug|Overall Study||80||
60014259|NCT02576951|76130293|FG000|COMPLETED|Overall Study||14||
60014260|NCT02576951|76130294|FG001|COMPLETED|Overall Study||3||
60014261|NCT02576951|76130295|FG002|COMPLETED|Overall Study||78||
60014262|NCT02576951|76130296|FG003|COMPLETED|Overall Study||75||
60014263|NCT02576951|76130293|FG000|NOT COMPLETED|Overall Study||1||
60014264|NCT02576951|76130294|FG001|NOT COMPLETED|Overall Study||0||
59757407|NCT03330106|75876526|FG002|NOT COMPLETED|Part A||0||
59757408|NCT03330106|75876527|FG003|NOT COMPLETED|Part A||0||
59757409|NCT03330106|75876524|FG000|STARTED|Part B||0|Participants who completed Part A were randomized in Part B to receive pevonedistat in combination with standard of care agents, either docetaxel or carboplatin+paclitaxel, as recommended by the Investigator.|
59757410|NCT03330106|75876525|FG001|STARTED|Part B||0|Participants who completed Part A were randomized in Part B to receive pevonedistat in combination with standard of care agents, either docetaxel or carboplatin+paclitaxel, as recommended by the Investigator.|
59757411|NCT03330106|75876526|FG002|STARTED|Part B||23|Participants who completed Part A were randomized in Part B to receive pevonedistat in combination with standard of care agents, either docetaxel or carboplatin+paclitaxel, as recommended by the Investigator.|
59757412|NCT03330106|75876527|FG003|STARTED|Part B||12|Participants who completed Part A were randomized in Part B to receive pevonedistat in combination with standard of care agents, either docetaxel or carboplatin+paclitaxel, as recommended by the Investigator.|
59757413|NCT03330106|75876524|FG000|COMPLETED|Part B||0||
59757414|NCT03330106|75876525|FG001|COMPLETED|Part B||0||
59757415|NCT03330106|75876526|FG002|COMPLETED|Part B||5||
59757416|NCT03330106|75876527|FG003|COMPLETED|Part B||4||
59757417|NCT03330106|75876524|FG000|NOT COMPLETED|Part B||0||
59757418|NCT03330106|75876525|FG001|NOT COMPLETED|Part B||0||
59757419|NCT03330106|75876526|FG002|NOT COMPLETED|Part B||18||
59757420|NCT03330106|75876527|FG003|NOT COMPLETED|Part B||8||
59757421|NCT03164564|75876539|FG000|STARTED|Overall Study||1614||
59757422|NCT03164564|75876540|FG001|STARTED|Overall Study||1610||
59757423|NCT03164564|75876539|FG000|Ongoing|Overall Study||1586|Ongoing in the study indicates the participant has not terminated or completed the study.|
60014265|NCT02576951|76130295|FG002|NOT COMPLETED|Overall Study||2||
60014266|NCT02576951|76130296|FG003|NOT COMPLETED|Overall Study||5||
60014267|NCT04929613|76130308|FG000|STARTED|Overall Study||30||
60014268|NCT04929613|76130308|FG000|COMPLETED|Overall Study||18||
60014269|NCT04929613|76130308|FG000|NOT COMPLETED|Overall Study||12||
60014270|NCT02621047|76130315|FG000|STARTED|Overall Study||8||
60014271|NCT02621047|76130316|FG001|STARTED|Overall Study||8||
60014272|NCT02621047|76130317|FG002|STARTED|Overall Study||12||
60014273|NCT02621047|76130315|FG000|COMPLETED|Overall Study||8||
60014274|NCT02621047|76130316|FG001|COMPLETED|Overall Study||8||
60014275|NCT02621047|76130317|FG002|COMPLETED|Overall Study||11||
60014276|NCT02621047|76130315|FG000|NOT COMPLETED|Overall Study||0||
60014277|NCT02621047|76130316|FG001|NOT COMPLETED|Overall Study||0||
60014278|NCT02621047|76130317|FG002|NOT COMPLETED|Overall Study||1||
60014279|NCT02443155|76130330|FG000|STARTED|Overall Study||77||
60014280|NCT02443155|76130331|FG001|STARTED|Overall Study||77||
60014281|NCT02443155|76130332|FG002|STARTED|Overall Study||76||
60014282|NCT02443155|76130333|FG003|STARTED|Overall Study||77||
60014283|NCT02443155|76130330|FG000|Full Analysis Set|Overall Study||77||
60014284|NCT02443155|76130331|FG001|Full Analysis Set|Overall Study||77||
60014285|NCT02443155|76130332|FG002|Full Analysis Set|Overall Study||76||
60014286|NCT02443155|76130333|FG003|Full Analysis Set|Overall Study||77||
60014287|NCT02443155|76130330|FG000|PK Analysis Set|Overall Study||21||
60014288|NCT02443155|76130331|FG001|PK Analysis Set|Overall Study||21||
60014289|NCT02443155|76130332|FG002|PK Analysis Set|Overall Study||22||
60014290|NCT02443155|76130333|FG003|PK Analysis Set|Overall Study||20||
60014291|NCT02443155|76130330|FG000|Safety Analysis Set|Overall Study||77||
60014292|NCT02443155|76130331|FG001|Safety Analysis Set|Overall Study||77||
60014293|NCT02443155|76130332|FG002|Safety Analysis Set|Overall Study||76||
60014294|NCT02443155|76130333|FG003|Safety Analysis Set|Overall Study||77||
60014295|NCT02443155|76130330|FG000|COMPLETED|Overall Study||65||
60014296|NCT02443155|76130331|FG001|COMPLETED|Overall Study||63||
60014297|NCT02443155|76130332|FG002|COMPLETED|Overall Study||67||
60014298|NCT02443155|76130333|FG003|COMPLETED|Overall Study||61||
60014299|NCT02443155|76130330|FG000|NOT COMPLETED|Overall Study||12||
60014300|NCT02443155|76130331|FG001|NOT COMPLETED|Overall Study||14||
60014301|NCT02443155|76130332|FG002|NOT COMPLETED|Overall Study||9||
60014302|NCT02443155|76130333|FG003|NOT COMPLETED|Overall Study||16||
60014303|NCT02460159|76130346|FG000|STARTED|Overall Study||117||
60014304|NCT02460159|76130347|FG001|STARTED|Overall Study||18||
60014305|NCT02460159|76130346|FG000|COMPLETED|Overall Study||111||
60014306|NCT02460159|76130347|FG001|COMPLETED|Overall Study||17||
60014307|NCT02460159|76130346|FG000|NOT COMPLETED|Overall Study||6||
60014308|NCT02460159|76130347|FG001|NOT COMPLETED|Overall Study||1||
60014309|NCT02498067|76130353|FG000|STARTED|Overall Study||104||
60014310|NCT02498067|76130353|FG000|COMPLETED|Overall Study||71||
60014311|NCT02498067|76130353|FG000|NOT COMPLETED|Overall Study||33||
60014312|NCT02497755|76130361|FG000|STARTED|Overall Study||18||
60014313|NCT02497755|76130362|FG001|STARTED|Overall Study||1||
60014314|NCT02497755|76130361|FG000|COMPLETED|Overall Study||17||
60014315|NCT02497755|76130362|FG001|COMPLETED|Overall Study||1||
60014316|NCT02497755|76130361|FG000|NOT COMPLETED|Overall Study||1||
60014317|NCT02497755|76130362|FG001|NOT COMPLETED|Overall Study||0||
60014318|NCT02619175|76130371|FG000|STARTED|Overall Study||18||
60014319|NCT02619175|76130372|FG001|STARTED|Overall Study||16||
60014320|NCT02619175|76130371|FG000|COMPLETED|Overall Study||16||
60014321|NCT02619175|76130372|FG001|COMPLETED|Overall Study||16||
60014322|NCT02619175|76130371|FG000|NOT COMPLETED|Overall Study||2||
60014323|NCT02619175|76130372|FG001|NOT COMPLETED|Overall Study||0||
60014324|NCT03056443|76130382|FG000|STARTED|Overall Study||13||
60014325|NCT03056443|76130382|FG000|COMPLETED|Overall Study||13||
60014326|NCT03056443|76130382|FG000|NOT COMPLETED|Overall Study||0||
60014327|NCT01360021|76130389|FG000|STARTED|Overall Study|Patients randomized|71||
60014328|NCT01360021|76130390|FG001|STARTED|Overall Study|Patients randomized|71||
60014329|NCT01360021|76130391|FG002|STARTED|Overall Study|Patients randomized|72||
60014330|NCT01360021|76130389|FG000|COMPLETED|Overall Study|Patients who completed study|63||
60014331|NCT01360021|76130390|FG001|COMPLETED|Overall Study|Patients who completed study|67||
60014332|NCT01360021|76130391|FG002|COMPLETED|Overall Study|Patients who completed study|65||
60014333|NCT01360021|76130389|FG000|NOT COMPLETED|Overall Study||8||
60014334|NCT01360021|76130390|FG001|NOT COMPLETED|Overall Study||4||
60014335|NCT01360021|76130391|FG002|NOT COMPLETED|Overall Study||7||
60014336|NCT04912297|76130401|FG000|STARTED|Overall Study||99||
60014337|NCT04912297|76130402|FG001|STARTED|Overall Study||87||
60014338|NCT04912297|76130401|FG000|COMPLETED|Overall Study||68||
60014339|NCT04912297|76130402|FG001|COMPLETED|Overall Study||54||
60014340|NCT04912297|76130401|FG000|NOT COMPLETED|Overall Study||31||
60014341|NCT04912297|76130402|FG001|NOT COMPLETED|Overall Study||33||
60014342|NCT02497287|76130408|FG000|STARTED|Induction Phase (4 Weeks)|Included DE participants (691) and non-responders from TRD3005 (88).|779||
60014343|NCT02497287|76130408|FG000|COMPLETED|Induction Phase (4 Weeks)||580||
60014344|NCT02497287|76130408|FG000|NOT COMPLETED|Induction Phase (4 Weeks)||199||
60014345|NCT02497287|76130408|FG000|STARTED|Optimization/Maintenance (48 Weeks)|Included who completed IND phase (580) + responders from TRD3005 (23).|603||
60014346|NCT02497287|76130408|FG000|COMPLETED|Optimization/Maintenance (48 Weeks)||150||
60014347|NCT02497287|76130408|FG000|NOT COMPLETED|Optimization/Maintenance (48 Weeks)||453||
60014348|NCT02497287|76130408|FG000|STARTED|Follow-up Phase (4 Week)|Included non-responders (IND phase) or discontinued treatment phase or completed OP/MA phase.|357||
60014349|NCT02497287|76130408|FG000|COMPLETED|Follow-up Phase (4 Week)||326||
60014350|NCT02497287|76130408|FG000|NOT COMPLETED|Follow-up Phase (4 Week)||31||
60014351|NCT02458287|76130418|FG000|STARTED|Overall Study||50||
60014352|NCT02458287|76130419|FG001|STARTED|Overall Study||100||
60014353|NCT02458287|76130420|FG002|STARTED|Overall Study||49||
60014354|NCT02458287|76130421|FG003|STARTED|Overall Study||100||
60014355|NCT02458287|76130418|FG000|COMPLETED|Overall Study||50||
60014356|NCT02458287|76130419|FG001|COMPLETED|Overall Study||96||
60014357|NCT02458287|76130420|FG002|COMPLETED|Overall Study||46||
60014358|NCT02458287|76130421|FG003|COMPLETED|Overall Study||97||
60014359|NCT02458287|76130418|FG000|NOT COMPLETED|Overall Study||0||
60014360|NCT02458287|76130419|FG001|NOT COMPLETED|Overall Study||4||
60014361|NCT02458287|76130420|FG002|NOT COMPLETED|Overall Study||3||
60014362|NCT02458287|76130421|FG003|NOT COMPLETED|Overall Study||3||
60014363|NCT02441517|76130437|FG000|STARTED|Overall Study||4||
60014364|NCT02441517|76130437|FG000|Received Treatment|Overall Study||4||
60014365|NCT02441517|76130437|FG000|COMPLETED|Overall Study||0||
60014366|NCT02441517|76130437|FG000|NOT COMPLETED|Overall Study||4||
60014367|NCT02457819|76130441|FG000|STARTED|Overall Study||237||
59757424|NCT03164564|75876540|FG001|Ongoing|Overall Study||1586|Ongoing in the study indicates the participant has not terminated or completed the study.|
60014368|NCT02457819|76130441|FG000|Safety Population|Overall Study||236||
60014369|NCT02457819|76130441|FG000|COMPLETED|Overall Study||138||
60014370|NCT02457819|76130441|FG000|NOT COMPLETED|Overall Study||99||
60014371|NCT02496039|76130445|FG000|STARTED|Overall Study||5||
60014372|NCT02496039|76130445|FG000|COMPLETED|Overall Study||1||
60014373|NCT02496039|76130445|FG000|NOT COMPLETED|Overall Study||4||
60014374|NCT02441283|76130449|FG000|STARTED|Overall Study||377||
59757425|NCT03164564|75876539|FG000|Terminated From the Study|Overall Study||25|Excludes participants who completed the study.|
59757426|NCT03164564|75876540|FG001|Terminated From the Study|Overall Study||17|Excludes participants who completed the study.|
59757427|NCT03164564|75876539|FG000|COMPLETED|Overall Study||3|Any seroconverters (per Site results or EAC) in Step 1 and seroconverters in Step 2 who have completed 48 weeks of follow-up.|
59757428|NCT03164564|75876540|FG001|COMPLETED|Overall Study||7|Any seroconverters (per Site results or EAC) in Step 1 and seroconverters in Step 2 who have completed 48 weeks of follow-up.|
59757429|NCT03164564|75876539|FG000|NOT COMPLETED|Overall Study||1611||
59757430|NCT03164564|75876540|FG001|NOT COMPLETED|Overall Study||1603||
59757431|NCT02888691|75876546|FG000|STARTED|First Intervention Period||7||
59757432|NCT02888691|75876547|FG001|STARTED|First Intervention Period||7||
59757433|NCT02888691|75876546|FG000|COMPLETED|First Intervention Period||6||
59757434|NCT02888691|75876547|FG001|COMPLETED|First Intervention Period||7||
59757435|NCT02888691|75876546|FG000|NOT COMPLETED|First Intervention Period||1||
59757436|NCT02888691|75876547|FG001|NOT COMPLETED|First Intervention Period||0||
59757437|NCT02888691|75876546|FG000|STARTED|Second Intervention Period|This is a cross-over study. Therefore starters does not necessarily equal completers of period 1.|7||
59757438|NCT02888691|75876547|FG001|STARTED|Second Intervention Period||5||
59757439|NCT02888691|75876546|FG000|COMPLETED|Second Intervention Period||7||
59757440|NCT02888691|75876547|FG001|COMPLETED|Second Intervention Period||3||
59757441|NCT02888691|75876546|FG000|NOT COMPLETED|Second Intervention Period||0||
59757442|NCT02888691|75876547|FG001|NOT COMPLETED|Second Intervention Period||2||
59757443|NCT02821754|75876556|FG000|STARTED|Overall Study||36||
59757444|NCT02821754|75876557|FG001|STARTED|Overall Study||16||
59757445|NCT02821754|75876558|FG002|STARTED|Overall Study|No results data were collected for these participants.|2||
59757446|NCT02821754|75876556|FG000|COMPLETED|Overall Study||20||
59757447|NCT02821754|75876557|FG001|COMPLETED|Overall Study||4||
59757448|NCT02821754|75876558|FG002|COMPLETED|Overall Study||0||
59757449|NCT02821754|75876556|FG000|NOT COMPLETED|Overall Study||16||
59757450|NCT02821754|75876557|FG001|NOT COMPLETED|Overall Study||12||
59757451|NCT02821754|75876558|FG002|NOT COMPLETED|Overall Study||2||
59757452|NCT02708108|75876566|FG000|STARTED|Overall Study||40||
59757453|NCT02708108|75876567|FG001|STARTED|Overall Study||83||
59757454|NCT02708108|75876566|FG000|COMPLETED|Overall Study||38||
59757455|NCT02708108|75876567|FG001|COMPLETED|Overall Study||80||
59757456|NCT02708108|75876566|FG000|NOT COMPLETED|Overall Study||2||
59757457|NCT02708108|75876567|FG001|NOT COMPLETED|Overall Study||3||
60014375|NCT02441283|76130449|FG000|COMPLETED|Overall Study||287||
60014376|NCT02441283|76130449|FG000|NOT COMPLETED|Overall Study||90||
60014377|NCT02495883|76130455|FG000|STARTED|Overall Study||32||
60014378|NCT02495883|76130456|FG001|STARTED|Overall Study||24||
60014379|NCT02495883|76130455|FG000|COMPLETED|Overall Study||31||
60014380|NCT02495883|76130456|FG001|COMPLETED|Overall Study||24||
60014381|NCT02495883|76130455|FG000|NOT COMPLETED|Overall Study||1||
60014382|NCT02495883|76130456|FG001|NOT COMPLETED|Overall Study||0||
60014383|NCT02495025|76130463|FG000|STARTED|Overall Study||77||
60014384|NCT02495025|76130464|FG001|STARTED|Overall Study||75||
60014385|NCT02495025|76130463|FG000|COMPLETED|Overall Study||51||
60014386|NCT02495025|76130464|FG001|COMPLETED|Overall Study||61||
60014387|NCT02495025|76130463|FG000|NOT COMPLETED|Overall Study||26||
60014388|NCT02495025|76130464|FG001|NOT COMPLETED|Overall Study||14||
60014389|NCT02439957|76130472|FG000|STARTED|Overall Study||3||
60014390|NCT02439957|76130473|FG001|STARTED|Overall Study||3||
60014391|NCT02439957|76130472|FG000|Blinded Treatment Period|Overall Study||1|Ranged from 20 to 89 days|
60014392|NCT02439957|76130473|FG001|Blinded Treatment Period|Overall Study||2|Ranged from 20 to 89 days|
60014393|NCT02439957|76130472|FG000|COMPLETED|Overall Study||0||
60014394|NCT02439957|76130473|FG001|COMPLETED|Overall Study||0||
60014395|NCT02439957|76130472|FG000|NOT COMPLETED|Overall Study||3||
60014396|NCT02439957|76130473|FG001|NOT COMPLETED|Overall Study||3||
60014397|NCT02494401|76130481|FG000|STARTED|Overall Study||134||
60014398|NCT02494401|76130482|FG001|STARTED|Overall Study||133||
60014399|NCT02494401|76130481|FG000|Week 16|Overall Study||123||
60014400|NCT02494401|76130482|FG001|Week 16|Overall Study||124||
60014401|NCT02494401|76130481|FG000|6 Month Follow up|Overall Study||109||
60014402|NCT02494401|76130482|FG001|6 Month Follow up|Overall Study||106||
60014403|NCT02494401|76130481|FG000|COMPLETED|Overall Study||109||
60014404|NCT02494401|76130482|FG001|COMPLETED|Overall Study||106||
59899817|NCT03245619|76021735|FG002|STARTED|Part A (Up to Day 22)||6||
59899818|NCT03245619|76021736|FG003|STARTED|Part A (Up to Day 22)||1||
59899819|NCT03245619|76021737|FG004|STARTED|Part A (Up to Day 22)||0||
59899820|NCT03245619|76021738|FG005|STARTED|Part A (Up to Day 22)||0||
59899821|NCT03245619|76021739|FG006|STARTED|Part A (Up to Day 22)||0||
59899822|NCT03245619|76021740|FG007|STARTED|Part A (Up to Day 22)||0||
59899823|NCT03245619|76021741|FG008|STARTED|Part A (Up to Day 22)||0||
59899824|NCT03245619|76021742|FG009|STARTED|Part A (Up to Day 22)||0||
59899825|NCT03245619|76021743|FG010|STARTED|Part A (Up to Day 22)||0||
59899826|NCT03245619|76021744|FG011|STARTED|Part A (Up to Day 22)||0||
59899827|NCT03245619|76021745|FG012|STARTED|Part A (Up to Day 22)||0||
59899828|NCT03245619|76021746|FG013|STARTED|Part A (Up to Day 22)||0||
59899829|NCT03245619|76021747|FG014|STARTED|Part A (Up to Day 22)||0||
59899830|NCT03245619|76021748|FG015|STARTED|Part A (Up to Day 22)||0||
59899831|NCT03245619|76021749|FG016|STARTED|Part A (Up to Day 22)||0||
59899832|NCT03245619|76021733|FG000|COMPLETED|Part A (Up to Day 22)||1||
59899833|NCT03245619|76021734|FG001|COMPLETED|Part A (Up to Day 22)||0||
59899834|NCT03245619|76021735|FG002|COMPLETED|Part A (Up to Day 22)||0||
59899835|NCT03245619|76021736|FG003|COMPLETED|Part A (Up to Day 22)||1||
59899836|NCT03245619|76021737|FG004|COMPLETED|Part A (Up to Day 22)||0||
59899837|NCT03245619|76021738|FG005|COMPLETED|Part A (Up to Day 22)||0||
59899838|NCT03245619|76021739|FG006|COMPLETED|Part A (Up to Day 22)||0||
59899839|NCT03245619|76021740|FG007|COMPLETED|Part A (Up to Day 22)||0||
59899840|NCT03245619|76021741|FG008|COMPLETED|Part A (Up to Day 22)||0||
59899841|NCT03245619|76021742|FG009|COMPLETED|Part A (Up to Day 22)||0||
59899842|NCT03245619|76021743|FG010|COMPLETED|Part A (Up to Day 22)||0||
59899843|NCT03245619|76021744|FG011|COMPLETED|Part A (Up to Day 22)||0||
59899844|NCT03245619|76021745|FG012|COMPLETED|Part A (Up to Day 22)||0||
59899845|NCT03245619|76021746|FG013|COMPLETED|Part A (Up to Day 22)||0||
59899846|NCT03245619|76021747|FG014|COMPLETED|Part A (Up to Day 22)||0||
59899847|NCT03245619|76021748|FG015|COMPLETED|Part A (Up to Day 22)||0||
59899848|NCT03245619|76021749|FG016|COMPLETED|Part A (Up to Day 22)||0||
59899849|NCT03245619|76021733|FG000|NOT COMPLETED|Part A (Up to Day 22)||4||
59899850|NCT03245619|76021734|FG001|NOT COMPLETED|Part A (Up to Day 22)||6||
59899851|NCT03245619|76021735|FG002|NOT COMPLETED|Part A (Up to Day 22)||6||
59899852|NCT03245619|76021736|FG003|NOT COMPLETED|Part A (Up to Day 22)||0||
59899853|NCT03245619|76021737|FG004|NOT COMPLETED|Part A (Up to Day 22)||0||
59899854|NCT03245619|76021738|FG005|NOT COMPLETED|Part A (Up to Day 22)||0||
59899855|NCT03245619|76021739|FG006|NOT COMPLETED|Part A (Up to Day 22)||0||
59899856|NCT03245619|76021740|FG007|NOT COMPLETED|Part A (Up to Day 22)||0||
59899857|NCT03245619|76021741|FG008|NOT COMPLETED|Part A (Up to Day 22)||0||
59899858|NCT03245619|76021742|FG009|NOT COMPLETED|Part A (Up to Day 22)||0||
59899859|NCT03245619|76021743|FG010|NOT COMPLETED|Part A (Up to Day 22)||0||
59899860|NCT03245619|76021744|FG011|NOT COMPLETED|Part A (Up to Day 22)||0||
59899861|NCT03245619|76021745|FG012|NOT COMPLETED|Part A (Up to Day 22)||0||
59899862|NCT03245619|76021746|FG013|NOT COMPLETED|Part A (Up to Day 22)||0||
59899863|NCT03245619|76021747|FG014|NOT COMPLETED|Part A (Up to Day 22)||0||
59899864|NCT03245619|76021748|FG015|NOT COMPLETED|Part A (Up to Day 22)||0||
59899865|NCT03245619|76021749|FG016|NOT COMPLETED|Part A (Up to Day 22)||0||
59899866|NCT03245619|76021733|FG000|STARTED|Part B (Up to 34 Days)||0||
59899867|NCT03245619|76021734|FG001|STARTED|Part B (Up to 34 Days)||0||
59899868|NCT03245619|76021735|FG002|STARTED|Part B (Up to 34 Days)||0||
59899869|NCT03245619|76021736|FG003|STARTED|Part B (Up to 34 Days)||0||
59899870|NCT03245619|76021737|FG004|STARTED|Part B (Up to 34 Days)||0||
59899871|NCT03245619|76021738|FG005|STARTED|Part B (Up to 34 Days)||0||
59899872|NCT03245619|76021739|FG006|STARTED|Part B (Up to 34 Days)||0||
59899873|NCT03245619|76021740|FG007|STARTED|Part B (Up to 34 Days)||0||
59899874|NCT03245619|76021741|FG008|STARTED|Part B (Up to 34 Days)||0||
59899875|NCT03245619|76021742|FG009|STARTED|Part B (Up to 34 Days)||0||
59899876|NCT03245619|76021743|FG010|STARTED|Part B (Up to 34 Days)||0||
59899877|NCT03245619|76021744|FG011|STARTED|Part B (Up to 34 Days)||0||
59899878|NCT03245619|76021745|FG012|STARTED|Part B (Up to 34 Days)||0||
59899879|NCT03245619|76021746|FG013|STARTED|Part B (Up to 34 Days)||0||
59899880|NCT03245619|76021747|FG014|STARTED|Part B (Up to 34 Days)||0||
59899881|NCT03245619|76021748|FG015|STARTED|Part B (Up to 34 Days)||0||
59899882|NCT03245619|76021749|FG016|STARTED|Part B (Up to 34 Days)||0||
59899883|NCT03245619|76021733|FG000|COMPLETED|Part B (Up to 34 Days)||0||
59899884|NCT03245619|76021734|FG001|COMPLETED|Part B (Up to 34 Days)||0||
59899885|NCT03245619|76021735|FG002|COMPLETED|Part B (Up to 34 Days)||0||
59899886|NCT03245619|76021736|FG003|COMPLETED|Part B (Up to 34 Days)||0||
59899887|NCT03245619|76021737|FG004|COMPLETED|Part B (Up to 34 Days)||0||
59899888|NCT03245619|76021738|FG005|COMPLETED|Part B (Up to 34 Days)||0||
59899889|NCT03245619|76021739|FG006|COMPLETED|Part B (Up to 34 Days)||0||
59899890|NCT03245619|76021740|FG007|COMPLETED|Part B (Up to 34 Days)||0||
59899891|NCT03245619|76021741|FG008|COMPLETED|Part B (Up to 34 Days)||0||
59899892|NCT03245619|76021742|FG009|COMPLETED|Part B (Up to 34 Days)||0||
59899893|NCT03245619|76021743|FG010|COMPLETED|Part B (Up to 34 Days)||0||
59899894|NCT03245619|76021744|FG011|COMPLETED|Part B (Up to 34 Days)||0||
59899895|NCT03245619|76021745|FG012|COMPLETED|Part B (Up to 34 Days)||0||
59899896|NCT03245619|76021746|FG013|COMPLETED|Part B (Up to 34 Days)||0||
59899897|NCT03245619|76021747|FG014|COMPLETED|Part B (Up to 34 Days)||0||
59899898|NCT03245619|76021748|FG015|COMPLETED|Part B (Up to 34 Days)||0||
59899899|NCT03245619|76021749|FG016|COMPLETED|Part B (Up to 34 Days)||0||
59899900|NCT03245619|76021733|FG000|NOT COMPLETED|Part B (Up to 34 Days)||0||
59899901|NCT03245619|76021734|FG001|NOT COMPLETED|Part B (Up to 34 Days)||0||
59899902|NCT03245619|76021735|FG002|NOT COMPLETED|Part B (Up to 34 Days)||0||
59899903|NCT03245619|76021736|FG003|NOT COMPLETED|Part B (Up to 34 Days)||0||
59899904|NCT03245619|76021737|FG004|NOT COMPLETED|Part B (Up to 34 Days)||0||
59899905|NCT03245619|76021738|FG005|NOT COMPLETED|Part B (Up to 34 Days)||0||
59899906|NCT03245619|76021739|FG006|NOT COMPLETED|Part B (Up to 34 Days)||0||
59899907|NCT03245619|76021740|FG007|NOT COMPLETED|Part B (Up to 34 Days)||0||
59899908|NCT03245619|76021741|FG008|NOT COMPLETED|Part B (Up to 34 Days)||0||
59899909|NCT03245619|76021742|FG009|NOT COMPLETED|Part B (Up to 34 Days)||0||
59611357|NCT01781286|75722314|FG004|Started 3rd Intervention|Overall Study||6||
59611358|NCT01781286|75722315|FG005|Started 3rd Intervention|Overall Study||2||
59611359|NCT01781286|75722310|FG000|COMPLETED|Overall Study||5||
59611360|NCT01781286|75722311|FG001|COMPLETED|Overall Study||4||
59899910|NCT03245619|76021743|FG010|NOT COMPLETED|Part B (Up to 34 Days)||0||
59899911|NCT03245619|76021744|FG011|NOT COMPLETED|Part B (Up to 34 Days)||0||
59899912|NCT03245619|76021745|FG012|NOT COMPLETED|Part B (Up to 34 Days)||0||
59899913|NCT03245619|76021746|FG013|NOT COMPLETED|Part B (Up to 34 Days)||0||
59899914|NCT03245619|76021747|FG014|NOT COMPLETED|Part B (Up to 34 Days)||0||
59899915|NCT03245619|76021748|FG015|NOT COMPLETED|Part B (Up to 34 Days)||0||
59899916|NCT03245619|76021749|FG016|NOT COMPLETED|Part B (Up to 34 Days)||0||
59899917|NCT03245619|76021733|FG000|STARTED|Part C (Up to 34 Days)||0||
59899918|NCT03245619|76021734|FG001|STARTED|Part C (Up to 34 Days)||0||
59899919|NCT03245619|76021735|FG002|STARTED|Part C (Up to 34 Days)||0||
59899920|NCT03245619|76021736|FG003|STARTED|Part C (Up to 34 Days)||0||
59899921|NCT03245619|76021737|FG004|STARTED|Part C (Up to 34 Days)||0||
59899922|NCT03245619|76021738|FG005|STARTED|Part C (Up to 34 Days)||0||
59899923|NCT03245619|76021739|FG006|STARTED|Part C (Up to 34 Days)||0||
59899924|NCT03245619|76021740|FG007|STARTED|Part C (Up to 34 Days)||0||
59899925|NCT03245619|76021741|FG008|STARTED|Part C (Up to 34 Days)||0||
59899926|NCT03245619|76021742|FG009|STARTED|Part C (Up to 34 Days)||0||
59899927|NCT03245619|76021743|FG010|STARTED|Part C (Up to 34 Days)||0||
59899928|NCT03245619|76021744|FG011|STARTED|Part C (Up to 34 Days)||0||
59899929|NCT03245619|76021745|FG012|STARTED|Part C (Up to 34 Days)||0||
59899930|NCT03245619|76021746|FG013|STARTED|Part C (Up to 34 Days)||0||
59899931|NCT03245619|76021747|FG014|STARTED|Part C (Up to 34 Days)||0||
59899932|NCT03245619|76021748|FG015|STARTED|Part C (Up to 34 Days)||0||
59899933|NCT03245619|76021749|FG016|STARTED|Part C (Up to 34 Days)||0||
59899934|NCT03245619|76021733|FG000|COMPLETED|Part C (Up to 34 Days)||0||
59899935|NCT03245619|76021734|FG001|COMPLETED|Part C (Up to 34 Days)||0||
59899936|NCT03245619|76021735|FG002|COMPLETED|Part C (Up to 34 Days)||0||
59899937|NCT03245619|76021736|FG003|COMPLETED|Part C (Up to 34 Days)||0||
59899938|NCT03245619|76021737|FG004|COMPLETED|Part C (Up to 34 Days)||0||
59899939|NCT03245619|76021738|FG005|COMPLETED|Part C (Up to 34 Days)||0||
59899940|NCT03245619|76021739|FG006|COMPLETED|Part C (Up to 34 Days)||0||
59899941|NCT03245619|76021740|FG007|COMPLETED|Part C (Up to 34 Days)||0||
59899942|NCT03245619|76021741|FG008|COMPLETED|Part C (Up to 34 Days)||0||
59899943|NCT03245619|76021742|FG009|COMPLETED|Part C (Up to 34 Days)||0||
59899944|NCT03245619|76021743|FG010|COMPLETED|Part C (Up to 34 Days)||0||
59899945|NCT03245619|76021744|FG011|COMPLETED|Part C (Up to 34 Days)||0||
59899946|NCT03245619|76021745|FG012|COMPLETED|Part C (Up to 34 Days)||0||
59899947|NCT03245619|76021746|FG013|COMPLETED|Part C (Up to 34 Days)||0||
59899948|NCT03245619|76021747|FG014|COMPLETED|Part C (Up to 34 Days)||0||
59899949|NCT03245619|76021748|FG015|COMPLETED|Part C (Up to 34 Days)||0||
59899950|NCT03245619|76021749|FG016|COMPLETED|Part C (Up to 34 Days)||0||
59899951|NCT03245619|76021733|FG000|NOT COMPLETED|Part C (Up to 34 Days)||0||
59899952|NCT03245619|76021734|FG001|NOT COMPLETED|Part C (Up to 34 Days)||0||
59899953|NCT03245619|76021735|FG002|NOT COMPLETED|Part C (Up to 34 Days)||0||
59899954|NCT03245619|76021736|FG003|NOT COMPLETED|Part C (Up to 34 Days)||0||
59899955|NCT03245619|76021737|FG004|NOT COMPLETED|Part C (Up to 34 Days)||0||
59899956|NCT03245619|76021738|FG005|NOT COMPLETED|Part C (Up to 34 Days)||0||
59899957|NCT03245619|76021739|FG006|NOT COMPLETED|Part C (Up to 34 Days)||0||
59899958|NCT03245619|76021740|FG007|NOT COMPLETED|Part C (Up to 34 Days)||0||
59899959|NCT03245619|76021741|FG008|NOT COMPLETED|Part C (Up to 34 Days)||0||
59899960|NCT03245619|76021742|FG009|NOT COMPLETED|Part C (Up to 34 Days)||0||
59899961|NCT03245619|76021743|FG010|NOT COMPLETED|Part C (Up to 34 Days)||0||
59899962|NCT03245619|76021744|FG011|NOT COMPLETED|Part C (Up to 34 Days)||0||
59611361|NCT01781286|75722312|FG002|COMPLETED|Overall Study||7||
59611362|NCT01781286|75722313|FG003|COMPLETED|Overall Study||7||
59899963|NCT03245619|76021745|FG012|NOT COMPLETED|Part C (Up to 34 Days)||0||
59899964|NCT03245619|76021746|FG013|NOT COMPLETED|Part C (Up to 34 Days)||0||
59899965|NCT03245619|76021747|FG014|NOT COMPLETED|Part C (Up to 34 Days)||0||
59899966|NCT03245619|76021748|FG015|NOT COMPLETED|Part C (Up to 34 Days)||0||
59899967|NCT03245619|76021749|FG016|NOT COMPLETED|Part C (Up to 34 Days)||0||
59899968|NCT04472650|76021810|FG000|STARTED|Period 1 (Up to 15 Days)||13||
59899969|NCT04472650|76021811|FG001|STARTED|Period 1 (Up to 15 Days)||13||
59899970|NCT04472650|76021810|FG000|COMPLETED|Period 1 (Up to 15 Days)||13||
59899971|NCT04472650|76021811|FG001|COMPLETED|Period 1 (Up to 15 Days)||13||
59899972|NCT04472650|76021810|FG000|NOT COMPLETED|Period 1 (Up to 15 Days)||0||
59899973|NCT04472650|76021811|FG001|NOT COMPLETED|Period 1 (Up to 15 Days)||0||
59899974|NCT04472650|76021810|FG000|STARTED|Washout Period (Minimum 14 Days)||13||
59899975|NCT04472650|76021811|FG001|STARTED|Washout Period (Minimum 14 Days)||13||
59899976|NCT04472650|76021810|FG000|COMPLETED|Washout Period (Minimum 14 Days)||12||
59899977|NCT04472650|76021811|FG001|COMPLETED|Washout Period (Minimum 14 Days)||13||
59899978|NCT04472650|76021810|FG000|NOT COMPLETED|Washout Period (Minimum 14 Days)||1||
59899979|NCT04472650|76021811|FG001|NOT COMPLETED|Washout Period (Minimum 14 Days)||0||
59899980|NCT04472650|76021810|FG000|STARTED|Period 2 (Up to 15 Days)||12||
59899981|NCT04472650|76021811|FG001|STARTED|Period 2 (Up to 15 Days)||13||
59899982|NCT04472650|76021810|FG000|COMPLETED|Period 2 (Up to 15 Days)||12||
59899983|NCT04472650|76021811|FG001|COMPLETED|Period 2 (Up to 15 Days)||13||
59899984|NCT04472650|76021810|FG000|NOT COMPLETED|Period 2 (Up to 15 Days)||0||
59899985|NCT04472650|76021811|FG001|NOT COMPLETED|Period 2 (Up to 15 Days)||0||
59899986|NCT02606461|76021823|FG000|STARTED|Period 1: Double-blinded Period||27||
59757458|NCT02617589|75876576|FG000|STARTED|Randomization||280||
59757459|NCT02617589|75876577|FG001|STARTED|Randomization||280||
59757460|NCT02617589|75876576|FG000|COMPLETED|Randomization||278||
59757461|NCT02617589|75876577|FG001|COMPLETED|Randomization||275||
59899987|NCT02606461|76021824|FG001|STARTED|Period 1: Double-blinded Period||30||
59899988|NCT02606461|76021825|FG002|STARTED|Period 1: Double-blinded Period||188||
59899989|NCT02606461|76021826|FG003|STARTED|Period 1: Double-blinded Period||97||
59899990|NCT02606461|76021827|FG004|STARTED|Period 1: Double-blinded Period||0||
59899991|NCT02606461|76021828|FG005|STARTED|Period 1: Double-blinded Period||0||
59899992|NCT02606461|76021823|FG000|Treated|Period 1: Double-blinded Period||27||
59899993|NCT02606461|76021824|FG001|Treated|Period 1: Double-blinded Period||30||
59899994|NCT02606461|76021825|FG002|Treated|Period 1: Double-blinded Period||187||
59899995|NCT02606461|76021826|FG003|Treated|Period 1: Double-blinded Period||97||
59899996|NCT02606461|76021827|FG004|Treated|Period 1: Double-blinded Period||0||
59899997|NCT02606461|76021828|FG005|Treated|Period 1: Double-blinded Period||0||
59899998|NCT02606461|76021823|FG000|COMPLETED|Period 1: Double-blinded Period||27||
59899999|NCT02606461|76021824|FG001|COMPLETED|Period 1: Double-blinded Period||30||
59900000|NCT02606461|76021825|FG002|COMPLETED|Period 1: Double-blinded Period||187||
59900001|NCT02606461|76021826|FG003|COMPLETED|Period 1: Double-blinded Period||97||
59900002|NCT02606461|76021827|FG004|COMPLETED|Period 1: Double-blinded Period||0||
59900003|NCT02606461|76021828|FG005|COMPLETED|Period 1: Double-blinded Period||0||
59900004|NCT02606461|76021823|FG000|NOT COMPLETED|Period 1: Double-blinded Period||0||
59900005|NCT02606461|76021824|FG001|NOT COMPLETED|Period 1: Double-blinded Period||0||
59900006|NCT02606461|76021825|FG002|NOT COMPLETED|Period 1: Double-blinded Period||1||
59900007|NCT02606461|76021826|FG003|NOT COMPLETED|Period 1: Double-blinded Period||0||
59900008|NCT02606461|76021827|FG004|NOT COMPLETED|Period 1: Double-blinded Period||0||
59900009|NCT02606461|76021828|FG005|NOT COMPLETED|Period 1: Double-blinded Period||0||
59900010|NCT02606461|76021823|FG000|STARTED|Period 2: Open Label Period||0||
59900011|NCT02606461|76021824|FG001|STARTED|Period 2: Open Label Period||0||
59900012|NCT02606461|76021825|FG002|STARTED|Period 2: Open Label Period||0||
59900013|NCT02606461|76021826|FG003|STARTED|Period 2: Open Label Period||0||
59900014|NCT02606461|76021827|FG004|STARTED|Period 2: Open Label Period|Participants in the placebo group who had PD during the Phase 2 double-blinded treatment, switched to open-label selinexor.|24||
59900015|NCT02606461|76021828|FG005|STARTED|Period 2: Open Label Period|Participants in the placebo group who had PD during the Phase 3 double-blinded treatment, switched to open-label selinexor.|63||
59900016|NCT02606461|76021823|FG000|COMPLETED|Period 2: Open Label Period||0||
59900017|NCT02606461|76021824|FG001|COMPLETED|Period 2: Open Label Period||0||
59900018|NCT02606461|76021825|FG002|COMPLETED|Period 2: Open Label Period||0||
59757462|NCT02617589|75876576|FG000|NOT COMPLETED|Randomization||2||
59900019|NCT02606461|76021826|FG003|COMPLETED|Period 2: Open Label Period||0||
59900020|NCT02606461|76021827|FG004|COMPLETED|Period 2: Open Label Period||24||
59900021|NCT02606461|76021828|FG005|COMPLETED|Period 2: Open Label Period||63||
59900022|NCT02606461|76021823|FG000|NOT COMPLETED|Period 2: Open Label Period||0||
59900023|NCT02606461|76021824|FG001|NOT COMPLETED|Period 2: Open Label Period||0||
59900024|NCT02606461|76021825|FG002|NOT COMPLETED|Period 2: Open Label Period||0||
59900025|NCT02606461|76021826|FG003|NOT COMPLETED|Period 2: Open Label Period||0||
59757463|NCT02617589|75876577|FG001|NOT COMPLETED|Randomization||5||
59757464|NCT02617589|75876576|FG000|STARTED|Treatment||278||
59900026|NCT02606461|76021827|FG004|NOT COMPLETED|Period 2: Open Label Period||0||
59900027|NCT02606461|76021828|FG005|NOT COMPLETED|Period 2: Open Label Period||0||
59757465|NCT02617589|75876577|FG001|STARTED|Treatment||275||
59757466|NCT02617589|75876576|FG000|COMPLETED|Treatment||0||
59757467|NCT02617589|75876577|FG001|COMPLETED|Treatment||76||
59757468|NCT02617589|75876576|FG000|NOT COMPLETED|Treatment||278||
59757469|NCT02617589|75876577|FG001|NOT COMPLETED|Treatment||199||
59757470|NCT02471807|75876583|FG000|STARTED|Overall Study||34||
59757471|NCT02471807|75876583|FG000|COMPLETED|Overall Study||12||
59757472|NCT02471807|75876583|FG000|NOT COMPLETED|Overall Study||22||
59757473|NCT02340169|75876587|FG000|STARTED|Overall Study||129||
59900028|NCT03321396|76021843|FG000|STARTED|Overall Study||13||
59900029|NCT03321396|76021843|FG000|COMPLETED|Overall Study||12||
59900030|NCT03321396|76021843|FG000|NOT COMPLETED|Overall Study||1||
59900031|NCT03244917|76021849|FG000|STARTED|Overall Study||201||
59900032|NCT03244917|76021850|FG001|STARTED|Overall Study||229||
59900033|NCT03244917|76021849|FG000|COMPLETED|Overall Study||199||
59900034|NCT03244917|76021850|FG001|COMPLETED|Overall Study||227||
59900035|NCT03244917|76021849|FG000|NOT COMPLETED|Overall Study||2||
59900036|NCT03244917|76021850|FG001|NOT COMPLETED|Overall Study||2||
59900037|NCT03321006|76021858|FG000|STARTED|Overall Study||14||
59900038|NCT03321006|76021859|FG001|STARTED|Overall Study||11||
59900039|NCT03321006|76021858|FG000|COMPLETED|Overall Study||12||
59900040|NCT03321006|76021859|FG001|COMPLETED|Overall Study||11||
59900041|NCT03321006|76021858|FG000|NOT COMPLETED|Overall Study||2||
59900042|NCT03321006|76021859|FG001|NOT COMPLETED|Overall Study||0||
59900043|NCT03572244|76021867|FG000|STARTED|Overall Study||6||
59900044|NCT03572244|76021868|FG001|STARTED|Overall Study||6||
59900045|NCT03572244|76021867|FG000|COMPLETED|Overall Study||6||
59900046|NCT03572244|76021868|FG001|COMPLETED|Overall Study||6||
59900047|NCT03572244|76021867|FG000|NOT COMPLETED|Overall Study||0||
59900048|NCT03572244|76021868|FG001|NOT COMPLETED|Overall Study||0||
59900049|NCT02593123|76021876|FG000|STARTED|Overall Study||18||
59900050|NCT02593123|76021877|FG001|STARTED|Overall Study||13||
59900051|NCT02593123|76021876|FG000|COMPLETED|Overall Study||15||
59900052|NCT02593123|76021877|FG001|COMPLETED|Overall Study||11||
59900053|NCT02593123|76021876|FG000|NOT COMPLETED|Overall Study||3||
59900054|NCT02593123|76021877|FG001|NOT COMPLETED|Overall Study||2||
59900055|NCT03302559|76021885|FG000|STARTED|Overall Study||29||
59900056|NCT03302559|76021885|FG000|COMPLETED|Overall Study||23||
59900057|NCT03302559|76021885|FG000|NOT COMPLETED|Overall Study||6||
59900058|NCT03302247|76021889|FG000|STARTED|Overall Study||3||
59900059|NCT03302247|76021889|FG000|COMPLETED|Overall Study||0||
59611363|NCT01781286|75722314|FG004|COMPLETED|Overall Study||6||
59611364|NCT01781286|75722315|FG005|COMPLETED|Overall Study||2||
59900060|NCT03302247|76021889|FG000|NOT COMPLETED|Overall Study||3||
59900061|NCT04993339|76021895|FG000|STARTED|Overall Study||14||
59900062|NCT04993339|76021896|FG001|STARTED|Overall Study||12||
59900063|NCT04993339|76021895|FG000|COMPLETED|Overall Study||11||
59900064|NCT04993339|76021896|FG001|COMPLETED|Overall Study||10||
59900065|NCT04993339|76021895|FG000|NOT COMPLETED|Overall Study||3||
59900066|NCT04993339|76021896|FG001|NOT COMPLETED|Overall Study||2||
59900067|NCT04974697|76021904|FG000|STARTED|Overall Study||86||
59900068|NCT04974697|76021904|FG000|COMPLETED|Overall Study||84||
59900069|NCT04974697|76021904|FG000|NOT COMPLETED|Overall Study||2||
59900070|NCT03265119|76021912|FG000|STARTED|Overall Study||34||
59900071|NCT03265119|76021913|FG001|STARTED|Overall Study||35||
59900072|NCT03265119|76021912|FG000|COMPLETED|Overall Study||24||
59900073|NCT03265119|76021913|FG001|COMPLETED|Overall Study||28||
59900074|NCT03265119|76021912|FG000|NOT COMPLETED|Overall Study||10||
59900075|NCT03265119|76021913|FG001|NOT COMPLETED|Overall Study||7||
59900076|NCT04952701|76021919|FG000|STARTED|Control Lens||63||
59900077|NCT04952701|76021919|FG000|COMPLETED|Control Lens||59||
59900078|NCT04952701|76021919|FG000|NOT COMPLETED|Control Lens||4||
59900079|NCT04952701|76021919|FG000|STARTED|Test Lens||59||
59900080|NCT04952701|76021919|FG000|COMPLETED|Test Lens||58||
59900081|NCT04952701|76021919|FG000|NOT COMPLETED|Test Lens||1||
59900082|NCT04723173|76021925|FG000|STARTED|Measure of Detection Threshold (in dB)||10||
59900083|NCT04723173|76021925|FG000|Feature for Soft Sounds On|Measure of Detection Threshold (in dB)||10||
59900084|NCT04723173|76021925|FG000|Feature for Soft Sounds Off|Measure of Detection Threshold (in dB)||10||
59900085|NCT04723173|76021925|FG000|COMPLETED|Measure of Detection Threshold (in dB)||10||
59900086|NCT04723173|76021925|FG000|NOT COMPLETED|Measure of Detection Threshold (in dB)||0||
59900087|NCT04723173|76021925|FG000|STARTED|Subjective Listening Effort Scaling|The test in this test period is independent (also temporally) from the previous test period. That is the reason, why the number of participants, who started this test period is lesser than the number of participants, who completed the previous period.|9||
59900088|NCT04723173|76021925|FG000|DNC on|Subjective Listening Effort Scaling||9||
59900089|NCT04723173|76021925|FG000|DNC Off|Subjective Listening Effort Scaling||9||
59951052|NCT05120115|76069981|FG000|4 kg and Lumbar Weight Distriubtion|Overall Study||21||
59951053|NCT05120115|76069981|FG000|6kg and Lumbar Weight Distriubtion|Overall Study||21||
59951054|NCT05120115|76069981|FG000|8 kg and Lumbar Weight Distribution|Overall Study||21||
59951055|NCT05120115|76069981|FG000|4kg and Unilateral Weight Distribution|Overall Study||21||
59900090|NCT04723173|76021925|FG000|COMPLETED|Subjective Listening Effort Scaling||8|This test compared the activated and deactivated feature for noisy situations. It was done in a single appointment and each participant performed randomized the test with both conditions. The reason for the smaller sample size (10 started the study, just 9 this test period) is that 1 participant left the study prior to the test and 1 participant started the test, but was not able to perform the test as the study protocol required. Nevertheless this participant completed the rest of the study.|
59900091|NCT04723173|76021925|FG000|NOT COMPLETED|Subjective Listening Effort Scaling||1||
59900092|NCT04723173|76021925|FG000|STARTED|Subjective Ratings of Sound Samples|The test in this test period is independent (also temporal) from the previous test period. That is the reason, why the number of participants, who started this test period is greater than the number of participants, who completed the previous period.|9||
59900093|NCT04723173|76021925|FG000|DNC on|Subjective Ratings of Sound Samples||9||
59900094|NCT04723173|76021925|FG000|DNC Off|Subjective Ratings of Sound Samples||9||
59900095|NCT04723173|76021925|FG000|COMPLETED|Subjective Ratings of Sound Samples|"All participants completed this study period, but just the results of 8 participants could be used.~This was because technical issues limited the reliability of the measures made for one participant.~N.B. this test was independent from the other tests in the study. Therefore the results are not influenced by other test periods. The number of people included in the analysis described here relates only to this test."|9||
59900096|NCT04723173|76021925|FG000|NOT COMPLETED|Subjective Ratings of Sound Samples||0||
59900097|NCT04919161|76021939|FG000|STARTED|Overall Study||16||
59900098|NCT04919161|76021940|FG001|STARTED|Overall Study||16||
59900099|NCT04919161|76021939|FG000|COMPLETED|Overall Study||15||
59900100|NCT04919161|76021940|FG001|COMPLETED|Overall Study||14||
59900101|NCT04919161|76021939|FG000|NOT COMPLETED|Overall Study||1||
59900102|NCT04919161|76021940|FG001|NOT COMPLETED|Overall Study||2||
59900103|NCT03262389|76021968|FG000|STARTED|Overall Study||10||
59900104|NCT03262389|76021968|FG000|COMPLETED|Overall Study||7||
59900105|NCT03262389|76021968|FG000|NOT COMPLETED|Overall Study||3||
59900106|NCT03262233|76021976|FG000|STARTED|Overall Study||53||
59900107|NCT03262233|76021977|FG001|STARTED|Overall Study||53||
59900108|NCT03262233|76021978|FG002|STARTED|Overall Study||59||
59900109|NCT03262233|76021979|FG003|STARTED|Overall Study||61||
59900110|NCT03262233|76021976|FG000|COMPLETED|Overall Study||35||
59900111|NCT03262233|76021977|FG001|COMPLETED|Overall Study||32||
59900112|NCT03262233|76021978|FG002|COMPLETED|Overall Study||34||
59900113|NCT03262233|76021979|FG003|COMPLETED|Overall Study||32||
59900114|NCT03262233|76021976|FG000|NOT COMPLETED|Overall Study||18||
59900115|NCT03262233|76021977|FG001|NOT COMPLETED|Overall Study||21||
59900116|NCT03262233|76021978|FG002|NOT COMPLETED|Overall Study||25||
59900117|NCT03262233|76021979|FG003|NOT COMPLETED|Overall Study||29||
59900118|NCT03261531|76021990|FG000|STARTED|Overall Study||7||
59900119|NCT03261531|76021990|FG000|COMPLETED|Overall Study||3||
59900120|NCT03261531|76021990|FG000|NOT COMPLETED|Overall Study||4||
59900121|NCT04151290|76021994|FG000|STARTED|Overall Study||711||
59900122|NCT04151290|76021994|FG000|COMPLETED|Overall Study||425||
59900123|NCT04151290|76021994|FG000|NOT COMPLETED|Overall Study||286||
59900124|NCT04389333|76022000|FG000|STARTED|Overall Study|From March 26th to April 26th, 2020, 20 patients were enrolled and underwent non-contract MCE in Changhai hpospital and the first medical center of PLA general hospital.|20||
59900125|NCT04389333|76022001|FG001|STARTED|Overall Study|From March 26th to April 26th, 2020, 20 patients were enrolled and accept MCE in Changhai hpospital and the first medical center of PLA general hospital.|20||
59900126|NCT04389333|76022000|FG000|COMPLETED|Overall Study||20||
59900127|NCT04389333|76022001|FG001|COMPLETED|Overall Study||20||
59900128|NCT04389333|76022000|FG000|NOT COMPLETED|Overall Study||0||
59900129|NCT04389333|76022001|FG001|NOT COMPLETED|Overall Study||0||
59900130|NCT03260205|76022013|FG000|STARTED|Overall Study||46||
59900131|NCT03260205|76022014|FG001|STARTED|Overall Study||40||
59900132|NCT03260205|76022015|FG002|STARTED|Overall Study||37||
59900133|NCT03260205|76022016|FG003|STARTED|Overall Study||37||
59900134|NCT03260205|76022017|FG004|STARTED|Overall Study||39||
59900135|NCT03260205|76022013|FG000|Received Treatment|Overall Study||45||
59900136|NCT03260205|76022014|FG001|Received Treatment|Overall Study||39||
59900137|NCT03260205|76022015|FG002|Received Treatment|Overall Study||35||
59900138|NCT03260205|76022016|FG003|Received Treatment|Overall Study||34||
59900139|NCT03260205|76022017|FG004|Received Treatment|Overall Study||38||
59900140|NCT03260205|76022013|FG000|COMPLETED|Overall Study||37||
59900141|NCT03260205|76022014|FG001|COMPLETED|Overall Study||32||
59900142|NCT03260205|76022015|FG002|COMPLETED|Overall Study||26||
59900143|NCT03260205|76022016|FG003|COMPLETED|Overall Study||30||
59900144|NCT03260205|76022017|FG004|COMPLETED|Overall Study||25||
59900145|NCT03260205|76022013|FG000|NOT COMPLETED|Overall Study||9||
59900146|NCT03260205|76022014|FG001|NOT COMPLETED|Overall Study||8||
59900147|NCT03260205|76022015|FG002|NOT COMPLETED|Overall Study||11||
59900148|NCT03260205|76022016|FG003|NOT COMPLETED|Overall Study||7||
59900149|NCT03260205|76022017|FG004|NOT COMPLETED|Overall Study||14||
59900150|NCT04666441|76022042|FG000|STARTED|Overall Study||82|Started = Randomized and treated|
59900151|NCT04666441|76022043|FG001|STARTED|Overall Study||165|Started = Randomized and treated|
59900152|NCT04666441|76022044|FG002|STARTED|Overall Study||162|Started = Randomized and treated|
59900153|NCT04666441|76022045|FG003|STARTED|Overall Study||165|Started = Randomized and treated|
59900154|NCT04666441|76022046|FG004|STARTED|Overall Study||166|Started = Randomized and treated|
59900155|NCT04666441|76022047|FG005|STARTED|Overall Study||82|Started = Randomized and treated|
59900156|NCT04666441|76022048|FG006|STARTED|Overall Study||163|Started = Randomized and treated|
59900157|NCT04666441|76022049|FG007|STARTED|Overall Study||164|Started = Randomized and treated|
59900158|NCT04666441|76022042|FG000|COMPLETED|Overall Study||80||
59900159|NCT04666441|76022043|FG001|COMPLETED|Overall Study||160||
59900160|NCT04666441|76022044|FG002|COMPLETED|Overall Study||158||
59900161|NCT04666441|76022045|FG003|COMPLETED|Overall Study||161||
59900162|NCT04666441|76022046|FG004|COMPLETED|Overall Study||166||
59900163|NCT04666441|76022047|FG005|COMPLETED|Overall Study||79||
59900164|NCT04666441|76022048|FG006|COMPLETED|Overall Study||158||
59900165|NCT04666441|76022049|FG007|COMPLETED|Overall Study||160||
59900166|NCT04666441|76022042|FG000|NOT COMPLETED|Overall Study||2||
59900167|NCT04666441|76022043|FG001|NOT COMPLETED|Overall Study||5||
59900168|NCT04666441|76022044|FG002|NOT COMPLETED|Overall Study||4||
59900169|NCT04666441|76022045|FG003|NOT COMPLETED|Overall Study||4||
59900170|NCT04666441|76022046|FG004|NOT COMPLETED|Overall Study||0||
59900171|NCT04666441|76022047|FG005|NOT COMPLETED|Overall Study||3||
59900172|NCT04666441|76022048|FG006|NOT COMPLETED|Overall Study||5||
59900173|NCT04666441|76022049|FG007|NOT COMPLETED|Overall Study||4||
59900174|NCT03320850|76022086|FG000|STARTED|Overall Study||18||
59900175|NCT03320850|76022087|FG001|STARTED|Overall Study||12||
59900176|NCT03320850|76022088|FG002|STARTED|Overall Study||18||
59900177|NCT03320850|76022089|FG003|STARTED|Overall Study||22||
59900178|NCT03320850|76022090|FG004|STARTED|Overall Study||19||
59900179|NCT03320850|76022091|FG005|STARTED|Overall Study||58||
59900180|NCT03320850|76022092|FG006|STARTED|Overall Study||57||
59900181|NCT03320850|76022093|FG007|STARTED|Overall Study||60||
59900182|NCT03320850|76022094|FG008|STARTED|Overall Study||60||
59900183|NCT03320850|76022095|FG009|STARTED|Overall Study||59||
59900184|NCT03320850|76022086|FG000|Safety Population|Overall Study||18|Safety Population included all participants enrolled in this study who received the study treatment in Stage 1 and Stage 2.|
59900185|NCT03320850|76022087|FG001|Safety Population|Overall Study||12|Safety Population included all participants enrolled in this study who received the study treatment in Stage 1 and Stage 2.|
59900186|NCT03320850|76022088|FG002|Safety Population|Overall Study||18|Safety Population included all participants enrolled in this study who received the study treatment in Stage 1 and Stage 2.|
59900187|NCT03320850|76022089|FG003|Safety Population|Overall Study||22|Safety Population included all participants enrolled in this study who received the study treatment in Stage 1 and Stage 2.|
59900188|NCT03320850|76022090|FG004|Safety Population|Overall Study||19|Safety Population included all participants enrolled in this study who received the study treatment in Stage 1 and Stage 2.|
59900189|NCT03320850|76022091|FG005|Safety Population|Overall Study||57|Safety Population included all participants enrolled in this study who received the study treatment in Stage 1 and Stage 2.|
59900190|NCT03320850|76022092|FG006|Safety Population|Overall Study||57|Safety Population included all participants enrolled in this study who received the study treatment in Stage 1 and Stage 2.|
59900191|NCT03320850|76022093|FG007|Safety Population|Overall Study||60|Safety Population included all participants enrolled in this study who received the study treatment in Stage 1 and Stage 2.|
59900192|NCT03320850|76022094|FG008|Safety Population|Overall Study||60|Safety Population included all participants enrolled in this study who received the study treatment in Stage 1 and Stage 2.|
59900193|NCT03320850|76022095|FG009|Safety Population|Overall Study||58|Safety Population included all participants enrolled in this study who received the study treatment in Stage 1 and Stage 2.|
59900194|NCT03320850|76022086|FG000|COMPLETED|Overall Study||18||
59900195|NCT03320850|76022087|FG001|COMPLETED|Overall Study||12||
59900196|NCT03320850|76022088|FG002|COMPLETED|Overall Study||18||
59900197|NCT03320850|76022089|FG003|COMPLETED|Overall Study||21||
59900198|NCT03320850|76022090|FG004|COMPLETED|Overall Study||17||
59900199|NCT03320850|76022091|FG005|COMPLETED|Overall Study||49||
59900200|NCT03320850|76022092|FG006|COMPLETED|Overall Study||50||
59900201|NCT03320850|76022093|FG007|COMPLETED|Overall Study||53||
59900202|NCT03320850|76022094|FG008|COMPLETED|Overall Study||50||
59900203|NCT03320850|76022095|FG009|COMPLETED|Overall Study||50||
59900204|NCT03320850|76022086|FG000|NOT COMPLETED|Overall Study||0||
59900205|NCT03320850|76022087|FG001|NOT COMPLETED|Overall Study||0||
59900206|NCT03320850|76022088|FG002|NOT COMPLETED|Overall Study||0||
59900207|NCT03320850|76022089|FG003|NOT COMPLETED|Overall Study||1||
59900208|NCT03320850|76022090|FG004|NOT COMPLETED|Overall Study||2||
59900209|NCT03320850|76022091|FG005|NOT COMPLETED|Overall Study||9||
59900210|NCT03320850|76022092|FG006|NOT COMPLETED|Overall Study||7||
59900211|NCT03320850|76022093|FG007|NOT COMPLETED|Overall Study||7||
59900212|NCT03320850|76022094|FG008|NOT COMPLETED|Overall Study||10||
59900213|NCT03320850|76022095|FG009|NOT COMPLETED|Overall Study||9||
59900214|NCT03301623|76022124|FG000|STARTED|Overall Study||462||
59900215|NCT03301623|76022125|FG001|STARTED|Overall Study||521||
59900216|NCT03301623|76022124|FG000|COMPLETED|Overall Study||445||
59900217|NCT03301623|76022125|FG001|COMPLETED|Overall Study||506||
59900218|NCT03301623|76022124|FG000|NOT COMPLETED|Overall Study||17||
59900219|NCT03301623|76022125|FG001|NOT COMPLETED|Overall Study||15||
59900220|NCT03319212|76022133|FG000|STARTED|Overall Study||29||
59900221|NCT03319212|76022134|FG001|STARTED|Overall Study||52||
59900222|NCT03319212|76022133|FG000|COMPLETED|Overall Study||26||
59900223|NCT03319212|76022134|FG001|COMPLETED|Overall Study||47||
59900224|NCT03319212|76022133|FG000|NOT COMPLETED|Overall Study||3||
59900225|NCT03319212|76022134|FG001|NOT COMPLETED|Overall Study||5||
59900226|NCT04656691|76022139|FG000|STARTED|Overall Study||139||
59900227|NCT04656691|76022139|FG000|COMPLETED|Overall Study||138||
59900228|NCT04656691|76022139|FG000|NOT COMPLETED|Overall Study||1||
59900229|NCT03301155|76022145|FG000|STARTED|Overall Study||528||
59900230|NCT03301155|76022146|FG001|STARTED|Overall Study||508||
59900231|NCT03301155|76022145|FG000|COMPLETED|Overall Study||520||
59900232|NCT03301155|76022146|FG001|COMPLETED|Overall Study||501||
59900233|NCT03301155|76022145|FG000|NOT COMPLETED|Overall Study||8||
59900234|NCT03301155|76022146|FG001|NOT COMPLETED|Overall Study||7||
59900235|NCT01952730|76022152|FG000|STARTED|Overall Study||1||
59900236|NCT01952730|76022152|FG000|COMPLETED|Overall Study||0||
59900237|NCT01952730|76022152|FG000|NOT COMPLETED|Overall Study||1||
59900238|NCT03316170|76022158|FG000|STARTED|Overall Study||24||
59900239|NCT03316170|76022159|FG001|STARTED|Overall Study||25||
59900240|NCT03316170|76022158|FG000|COMPLETED|Overall Study||17||
59900241|NCT03316170|76022159|FG001|COMPLETED|Overall Study||18||
59900242|NCT03316170|76022158|FG000|NOT COMPLETED|Overall Study||7||
59900243|NCT03316170|76022159|FG001|NOT COMPLETED|Overall Study||7||
59900244|NCT03257865|76022168|FG000|STARTED|Overall Study||163||
59900245|NCT03257865|76022169|FG001|STARTED|Overall Study||170||
59900246|NCT03257865|76022168|FG000|Received at Least 1 Dose of Study Drug|Overall Study||162|Randomized participants who received at least 1 dose of study drug were analyzed for safety.|
59900247|NCT03257865|76022169|FG001|Received at Least 1 Dose of Study Drug|Overall Study||170|Randomized participants who received at least 1 dose of study drug were analyzed for safety.|
59900248|NCT03257865|76022168|FG000|COMPLETED|Overall Study||128||
59900249|NCT03257865|76022169|FG001|COMPLETED|Overall Study||135||
59900250|NCT03257865|76022168|FG000|NOT COMPLETED|Overall Study||35||
59900251|NCT03257865|76022169|FG001|NOT COMPLETED|Overall Study||35||
59900252|NCT04617847|76022177|FG000|STARTED|Overall Study||3||
59900253|NCT04617847|76022178|FG001|STARTED|Overall Study||24||
59900254|NCT04617847|76022177|FG000|Dose Modified to 16 mg WVE-120101|Overall Study||3||
59900255|NCT04617847|76022178|FG001|Dose Modified to 16 mg WVE-120101|Overall Study||1||
59900256|NCT04617847|76022177|FG000|Dose Modified to 32 mg WVE-120101|Overall Study||0||
59900257|NCT04617847|76022178|FG001|Dose Modified to 32 mg WVE-120101|Overall Study||5||
59900258|NCT04617847|76022177|FG000|COMPLETED|Overall Study||0||
59900259|NCT04617847|76022178|FG001|COMPLETED|Overall Study||0||
59900260|NCT04617847|76022177|FG000|NOT COMPLETED|Overall Study||3||
59900261|NCT04617847|76022178|FG001|NOT COMPLETED|Overall Study||24||
59900262|NCT04615507|76022188|FG000|STARTED|Period 1||34||
59900263|NCT04615507|76022189|FG001|STARTED|Period 1||34||
59900264|NCT04615507|76022188|FG000|COMPLETED|Period 1||32||
59900265|NCT04615507|76022189|FG001|COMPLETED|Period 1||33||
59900266|NCT04615507|76022188|FG000|NOT COMPLETED|Period 1||2||
59900267|NCT04615507|76022189|FG001|NOT COMPLETED|Period 1||1||
59900268|NCT04615507|76022188|FG000|STARTED|Period 2||32||
59900269|NCT04615507|76022189|FG001|STARTED|Period 2||33||
59900270|NCT04615507|76022188|FG000|COMPLETED|Period 2||30||
59900271|NCT04615507|76022189|FG001|COMPLETED|Period 2||31||
59900272|NCT04615507|76022188|FG000|NOT COMPLETED|Period 2||2||
59900273|NCT04615507|76022189|FG001|NOT COMPLETED|Period 2||2||
59900274|NCT04615507|76022188|FG000|STARTED|Period 3||30||
59900275|NCT04615507|76022189|FG001|STARTED|Period 3||31||
59900276|NCT04615507|76022188|FG000|COMPLETED|Period 3||30||
59900277|NCT04615507|76022189|FG001|COMPLETED|Period 3||30||
59900278|NCT04615507|76022188|FG000|NOT COMPLETED|Period 3||0||
59900279|NCT04615507|76022189|FG001|NOT COMPLETED|Period 3||1||
59900280|NCT04120233|76022201|FG000|STARTED|Overall Study||10||
59900281|NCT04120233|76022202|FG001|STARTED|Overall Study||6||
59900282|NCT04120233|76022203|FG002|STARTED|Overall Study||6||
59900283|NCT04120233|76022204|FG003|STARTED|Overall Study||6||
59900284|NCT04120233|76022205|FG004|STARTED|Overall Study||6||
59900285|NCT04120233|76022206|FG005|STARTED|Overall Study||6||
59900286|NCT04120233|76022201|FG000|COMPLETED|Overall Study||10||
59900287|NCT04120233|76022202|FG001|COMPLETED|Overall Study||6||
59900288|NCT04120233|76022203|FG002|COMPLETED|Overall Study||6||
59900289|NCT04120233|76022204|FG003|COMPLETED|Overall Study||6||
59900290|NCT04120233|76022205|FG004|COMPLETED|Overall Study||5||
59900291|NCT04120233|76022206|FG005|COMPLETED|Overall Study||6||
59900292|NCT04120233|76022201|FG000|NOT COMPLETED|Overall Study||0||
59900293|NCT04120233|76022202|FG001|NOT COMPLETED|Overall Study||0||
60014405|NCT02494401|76130481|FG000|NOT COMPLETED|Overall Study||25||
59900294|NCT04120233|76022203|FG002|NOT COMPLETED|Overall Study||0||
59900295|NCT04120233|76022204|FG003|NOT COMPLETED|Overall Study||0||
59900296|NCT04120233|76022205|FG004|NOT COMPLETED|Overall Study||1||
59900297|NCT04120233|76022206|FG005|NOT COMPLETED|Overall Study||0||
59900298|NCT01610700|76022222|FG000|STARTED|Overall Study||80||
59900299|NCT01610700|76022223|FG001|STARTED|Overall Study||80||
59900300|NCT01610700|76022222|FG000|COMPLETED|Overall Study||77||
59900301|NCT01610700|76022223|FG001|COMPLETED|Overall Study||77||
59900302|NCT01610700|76022222|FG000|NOT COMPLETED|Overall Study||3||
59900303|NCT01610700|76022223|FG001|NOT COMPLETED|Overall Study||3||
59900304|NCT03256851|76022232|FG000|STARTED|Overall Study||10||
59900305|NCT03256851|76022233|FG001|STARTED|Overall Study||10||
59900306|NCT03256851|76022232|FG000|COMPLETED|Overall Study||9||
59900307|NCT03256851|76022233|FG001|COMPLETED|Overall Study||10||
59900308|NCT03256851|76022232|FG000|NOT COMPLETED|Overall Study||1||
59900309|NCT03256851|76022233|FG001|NOT COMPLETED|Overall Study||0||
59900310|NCT04837807|76022239|FG000|STARTED|First Sequence (Week 1)||15|This was a crossover study, so all subject got both treatments.|
59900311|NCT04837807|76022240|FG001|STARTED|First Sequence (Week 1)||15|This was a crossover study, so all subject got both treatments.|
59900312|NCT04837807|76022239|FG000|Received Sequence|First Sequence (Week 1)||15||
59900313|NCT04837807|76022240|FG001|Received Sequence|First Sequence (Week 1)||15||
59900314|NCT04837807|76022239|FG000|COMPLETED|First Sequence (Week 1)||15||
59900315|NCT04837807|76022240|FG001|COMPLETED|First Sequence (Week 1)||14||
59900316|NCT04837807|76022239|FG000|NOT COMPLETED|First Sequence (Week 1)||0||
59900317|NCT04837807|76022240|FG001|NOT COMPLETED|First Sequence (Week 1)||1||
59900318|NCT04837807|76022239|FG000|STARTED|Washout 1 Day||15||
59900319|NCT04837807|76022240|FG001|STARTED|Washout 1 Day||14||
59900320|NCT04837807|76022239|FG000|COMPLETED|Washout 1 Day||14||
59900321|NCT04837807|76022240|FG001|COMPLETED|Washout 1 Day||14||
59900322|NCT04837807|76022239|FG000|NOT COMPLETED|Washout 1 Day||1||
59900323|NCT04837807|76022240|FG001|NOT COMPLETED|Washout 1 Day||0||
59900324|NCT04837807|76022239|FG000|STARTED|Second Sequence (Week 2)||14||
59900325|NCT04837807|76022240|FG001|STARTED|Second Sequence (Week 2)||14||
59900326|NCT04837807|76022239|FG000|COMPLETED|Second Sequence (Week 2)||14|Person dropped out prior to the crossover.|
59900327|NCT04837807|76022240|FG001|COMPLETED|Second Sequence (Week 2)||14|Person dropped out prior to the crossover.|
59900328|NCT04837807|76022239|FG000|NOT COMPLETED|Second Sequence (Week 2)||0||
59900329|NCT04837807|76022240|FG001|NOT COMPLETED|Second Sequence (Week 2)||0||
59900330|NCT03256695|76022246|FG000|STARTED|Overall Study||405||
59900331|NCT03256695|76022246|FG000|Used ABS eMDPI at Least Once|Overall Study||390||
59900332|NCT03256695|76022246|FG000|COMPLETED|Overall Study||366||
59900333|NCT03256695|76022246|FG000|NOT COMPLETED|Overall Study||39||
59900334|NCT03305016|76022250|FG000|STARTED|Overall Study||146||
59900335|NCT03305016|76022250|FG000|COMPLETED|Overall Study||144||
59900336|NCT03305016|76022250|FG000|NOT COMPLETED|Overall Study||2||
59900337|NCT03297021|76022257|FG000|STARTED|Overall Study||48||
59900338|NCT03297021|76022258|FG001|STARTED|Overall Study||46||
59900339|NCT03297021|76022259|FG002|STARTED|Overall Study||47||
59900340|NCT03297021|76022257|FG000|COMPLETED|Overall Study||43||
59900341|NCT03297021|76022258|FG001|COMPLETED|Overall Study||42||
59900342|NCT03297021|76022259|FG002|COMPLETED|Overall Study||43||
59900343|NCT03297021|76022257|FG000|NOT COMPLETED|Overall Study||5||
59900344|NCT03297021|76022258|FG001|NOT COMPLETED|Overall Study||4||
59900345|NCT03297021|76022259|FG002|NOT COMPLETED|Overall Study||4||
59900346|NCT04820491|76022269|FG000|STARTED|Overall Study||5||
59900347|NCT04820491|76022270|FG001|STARTED|Overall Study||4||
59900348|NCT04820491|76022269|FG000|COMPLETED|Overall Study||4||
59900349|NCT04820491|76022270|FG001|COMPLETED|Overall Study||4||
59900350|NCT04820491|76022269|FG000|NOT COMPLETED|Overall Study||1||
59900351|NCT04820491|76022270|FG001|NOT COMPLETED|Overall Study||0||
59900352|NCT01988571|76022278|FG000|STARTED|Overall Study||139||
59900353|NCT01988571|76022279|FG001|STARTED|Overall Study||140||
59900354|NCT01988571|76022278|FG000|Completed Baseline|Overall Study||136|Defined as having labs done at that time point.|
59900355|NCT01988571|76022279|FG001|Completed Baseline|Overall Study||139|Defined as having labs done at that time point.|
59900356|NCT01988571|76022278|FG000|Completed 6 Month Visit|Overall Study||122|Defined as having labs done at that time point.|
59900357|NCT01988571|76022279|FG001|Completed 6 Month Visit|Overall Study||126|Defined as having labs done at that time point.|
59900358|NCT01988571|76022278|FG000|COMPLETED|Overall Study||100|Defined as having labs done at that time point.|
59900359|NCT01988571|76022279|FG001|COMPLETED|Overall Study||105|Defined as having labs done at that time point.|
59900360|NCT01988571|76022278|FG000|NOT COMPLETED|Overall Study||39||
59900361|NCT01988571|76022279|FG001|NOT COMPLETED|Overall Study||35||
59900362|NCT04794751|76022285|FG000|STARTED|Period 1||38||
59900363|NCT04794751|76022286|FG001|STARTED|Period 1||37||
59900364|NCT04794751|76022285|FG000|COMPLETED|Period 1||36||
59900365|NCT04794751|76022286|FG001|COMPLETED|Period 1||32||
59900366|NCT04794751|76022285|FG000|NOT COMPLETED|Period 1||2||
59900367|NCT04794751|76022286|FG001|NOT COMPLETED|Period 1||5||
59900368|NCT04794751|76022285|FG000|STARTED|Period 2||36||
59900369|NCT04794751|76022286|FG001|STARTED|Period 2||32||
59900370|NCT04794751|76022285|FG000|COMPLETED|Period 2||35||
59900371|NCT04794751|76022286|FG001|COMPLETED|Period 2||29||
59900372|NCT04794751|76022285|FG000|NOT COMPLETED|Period 2||1||
59900373|NCT04794751|76022286|FG001|NOT COMPLETED|Period 2||3||
59900374|NCT04794751|76022285|FG000|STARTED|Period 3||35||
59900375|NCT04794751|76022286|FG001|STARTED|Period 3||29||
59900376|NCT04794751|76022285|FG000|COMPLETED|Period 3||35||
59900377|NCT04794751|76022286|FG001|COMPLETED|Period 3||29||
59900378|NCT04794751|76022285|FG000|NOT COMPLETED|Period 3||0||
59900379|NCT04794751|76022286|FG001|NOT COMPLETED|Period 3||0||
59900380|NCT04578457|76022292|FG000|STARTED|Hearing Aid Without NR Enabled (0)||19||
59900381|NCT04578457|76022292|FG000|COMPLETED|Hearing Aid Without NR Enabled (0)||17||
59900382|NCT04578457|76022292|FG000|NOT COMPLETED|Hearing Aid Without NR Enabled (0)||2||
59900383|NCT04578457|76022292|FG000|STARTED|Hearing Aid With NR (1)||19|"The discrepancy between the number of participants starting this period and finishing the previous period is simply due to the fact that the study 'periods' as reported are not chronological.~See 'Arm/Group Description' for details."|
59900384|NCT04578457|76022292|FG000|COMPLETED|Hearing Aid With NR (1)||17||
59900385|NCT04578457|76022292|FG000|NOT COMPLETED|Hearing Aid With NR (1)||2||
59900386|NCT04578457|76022292|FG000|STARTED|Hearing Aid With NR (2)||19|"The discrepancy between the number of participants starting this period and finishing the previous period is simply due to the fact that the study 'periods' as reported are not chronological.~See 'Arm/Group Description' for details."|
59900387|NCT04578457|76022292|FG000|COMPLETED|Hearing Aid With NR (2)||17||
59900388|NCT04578457|76022292|FG000|NOT COMPLETED|Hearing Aid With NR (2)||2||
59900389|NCT04578457|76022292|FG000|STARTED|Hearing Aid With NR (4)||19|"The discrepancy between the number of participants starting this period and finishing the previous period is simply due to the fact that the study 'periods' as reported are not chronological.~See 'Arm/Group Description' for details."|
59900390|NCT04578457|76022292|FG000|COMPLETED|Hearing Aid With NR (4)||17||
59900391|NCT04578457|76022292|FG000|NOT COMPLETED|Hearing Aid With NR (4)||2||
59900392|NCT03334188|76022302|FG000|STARTED|Overall Study||153||
59900393|NCT03334188|76022303|FG001|STARTED|Overall Study||153||
59900394|NCT03334188|76022302|FG000|COMPLETED|Overall Study||145||
59900395|NCT03334188|76022303|FG001|COMPLETED|Overall Study||145||
59900396|NCT03334188|76022302|FG000|NOT COMPLETED|Overall Study||8||
59900397|NCT03334188|76022303|FG001|NOT COMPLETED|Overall Study||8||
59900398|NCT03333876|76022312|FG000|STARTED|Screening Period||58||29
59900399|NCT03333876|76022312|FG000|COMPLETED|Screening Period||54||27
59900400|NCT03333876|76022312|FG000|NOT COMPLETED|Screening Period||4||2
59900401|NCT03333876|76022312|FG000|STARTED|Nasal Dilator||54||27
59900402|NCT03333876|76022312|FG000|COMPLETED|Nasal Dilator||48||24
59900403|NCT03333876|76022312|FG000|NOT COMPLETED|Nasal Dilator||6||3
59900404|NCT03333876|76022312|FG000|STARTED|Mandibular Advancement||54||27
59900405|NCT03333876|76022312|FG000|COMPLETED|Mandibular Advancement||50||25
59900406|NCT03333876|76022312|FG000|NOT COMPLETED|Mandibular Advancement||4||2
59900407|NCT03333876|76022312|FG000|STARTED|Positional Therapy||54||27
59900408|NCT03333876|76022312|FG000|COMPLETED|Positional Therapy||54||27
59900409|NCT03333876|76022312|FG000|NOT COMPLETED|Positional Therapy||0||0
59900410|NCT03294681|76022325|FG000|STARTED|Overall Study||153||
59900411|NCT03294681|76022325|FG000|COMPLETED|Overall Study||152||
59900412|NCT03294681|76022325|FG000|NOT COMPLETED|Overall Study||1||
59900413|NCT01140867|76022329|FG000|STARTED|Overall Study||121||
59900414|NCT01140867|76022329|FG000|COMPLETED|Overall Study||88||
59900415|NCT01140867|76022329|FG000|NOT COMPLETED|Overall Study||33||
59900416|NCT04572997|76022333|FG000|STARTED|Overall Study||21||
59900417|NCT04572997|76022333|FG000|COMPLETED|Overall Study||20||
59900418|NCT04572997|76022333|FG000|NOT COMPLETED|Overall Study||1||
59900419|NCT02943096|76022343|FG000|STARTED|Overall Study||3||
59900420|NCT02943096|76022344|FG001|STARTED|Overall Study||3||
59900421|NCT02943096|76022343|FG000|COMPLETED|Overall Study||3||
59900422|NCT02943096|76022344|FG001|COMPLETED|Overall Study||2||
59900423|NCT02943096|76022343|FG000|NOT COMPLETED|Overall Study||0||
59900424|NCT02943096|76022344|FG001|NOT COMPLETED|Overall Study||1||
59900425|NCT04571515|76022355|FG000|STARTED|Overall Study||22||
59900426|NCT04571515|76022356|FG001|STARTED|Overall Study||24||
59900427|NCT04571515|76022357|FG002|STARTED|Overall Study||23||
59900428|NCT04571515|76022358|FG003|STARTED|Overall Study||23||
59900429|NCT04571515|76022359|FG004|STARTED|Overall Study||22||
59900430|NCT04571515|76022355|FG000|COMPLETED|Overall Study||21||
59900431|NCT04571515|76022356|FG001|COMPLETED|Overall Study||24||
59900432|NCT04571515|76022357|FG002|COMPLETED|Overall Study||23||
59900433|NCT04571515|76022358|FG003|COMPLETED|Overall Study||23||
59900434|NCT04571515|76022359|FG004|COMPLETED|Overall Study||19||
59900435|NCT04571515|76022355|FG000|NOT COMPLETED|Overall Study||1||
59900436|NCT04571515|76022356|FG001|NOT COMPLETED|Overall Study||0||
59900437|NCT04571515|76022357|FG002|NOT COMPLETED|Overall Study||0||
59900438|NCT04571515|76022358|FG003|NOT COMPLETED|Overall Study||0||
59900439|NCT04571515|76022359|FG004|NOT COMPLETED|Overall Study||3||
60014406|NCT02494401|76130482|FG001|NOT COMPLETED|Overall Study||27||
60014407|NCT02457195|76130488|FG000|STARTED|Overall Study||50||
59900440|NCT03292653|76022374|FG000|STARTED|Overall Study||11||
59900441|NCT03292653|76022375|FG001|STARTED|Overall Study||10||
59900442|NCT03292653|76022376|FG002|STARTED|Overall Study||11||
59900443|NCT03292653|76022374|FG000|COMPLETED|Overall Study||10||
60014408|NCT02457195|76130488|FG000|COMPLETED|Overall Study||41||
60014409|NCT02457195|76130488|FG000|NOT COMPLETED|Overall Study||9||
59900444|NCT03292653|76022375|FG001|COMPLETED|Overall Study||10||
59900445|NCT03292653|76022376|FG002|COMPLETED|Overall Study||10||
59900446|NCT03292653|76022374|FG000|NOT COMPLETED|Overall Study||1||
59900447|NCT03292653|76022375|FG001|NOT COMPLETED|Overall Study||0||
59900448|NCT03292653|76022376|FG002|NOT COMPLETED|Overall Study||1||
59900449|NCT03858634|76022387|FG000|STARTED|Overall Study||39||
59900450|NCT03858634|76022388|FG001|STARTED|Overall Study||19||
59900451|NCT03858634|76022387|FG000|Participants With Chronic Idiopathic Urticaria (CIU)|Overall Study||4||
59900452|NCT03858634|76022388|FG001|Participants With Chronic Idiopathic Urticaria (CIU)|Overall Study||2||
59900453|NCT03858634|76022387|FG000|Participants With Chronic Idiopathic Pruritus (CIP)|Overall Study||14||
59900454|NCT03858634|76022388|FG001|Participants With Chronic Idiopathic Pruritus (CIP)|Overall Study||9||
59900455|NCT03858634|76022387|FG000|Participants With Lichen Planus (LP)|Overall Study||3||
59900456|NCT03858634|76022388|FG001|Participants With Lichen Planus (LP)|Overall Study||0||
59900457|NCT03858634|76022387|FG000|Participants With Lichen Simplex Chronicus (LSC)|Overall Study||4||
59900458|NCT03858634|76022388|FG001|Participants With Lichen Simplex Chronicus (LSC)|Overall Study||1||
59900459|NCT03858634|76022387|FG000|Participants With Plaque Psoriasis (PPs)|Overall Study||14||
59900460|NCT03858634|76022388|FG001|Participants With Plaque Psoriasis (PPs)|Overall Study||7||
59900461|NCT03858634|76022387|FG000|COMPLETED|Overall Study||36||
59900462|NCT03858634|76022388|FG001|COMPLETED|Overall Study||17||
59900463|NCT03858634|76022387|FG000|NOT COMPLETED|Overall Study||3||
59900464|NCT03858634|76022388|FG001|NOT COMPLETED|Overall Study||2||
59900465|NCT02891070|76022404|FG000|STARTED|Overall Study||110||
59900466|NCT02891070|76022405|FG001|STARTED|Overall Study||114||
59900467|NCT02891070|76022404|FG000|COMPLETED|Overall Study||100||
59900468|NCT02891070|76022405|FG001|COMPLETED|Overall Study||106||
59900469|NCT02891070|76022404|FG000|NOT COMPLETED|Overall Study||10||
59900470|NCT02891070|76022405|FG001|NOT COMPLETED|Overall Study||8||
59900471|NCT03255291|76022417|FG000|STARTED|Overall Study||93||
59900472|NCT03255291|76022418|FG001|STARTED|Overall Study||90||
59900473|NCT03255291|76022419|FG002|STARTED|Overall Study||91||
59900474|NCT03255291|76022420|FG003|STARTED|Overall Study||90||
59900475|NCT03255291|76022421|FG004|STARTED|Overall Study||95||
59900476|NCT03255291|76022422|FG005|STARTED|Overall Study||95||
59900477|NCT03255291|76022417|FG000|COMPLETED|Overall Study||80||
59900478|NCT03255291|76022418|FG001|COMPLETED|Overall Study||78||
59900479|NCT03255291|76022419|FG002|COMPLETED|Overall Study||85||
59900480|NCT03255291|76022420|FG003|COMPLETED|Overall Study||84||
59900481|NCT03255291|76022421|FG004|COMPLETED|Overall Study||88||
59900482|NCT03255291|76022422|FG005|COMPLETED|Overall Study||85||
59900483|NCT03255291|76022417|FG000|NOT COMPLETED|Overall Study||13||
59900484|NCT03255291|76022418|FG001|NOT COMPLETED|Overall Study||12||
59900485|NCT03255291|76022419|FG002|NOT COMPLETED|Overall Study||6||
59900486|NCT03255291|76022420|FG003|NOT COMPLETED|Overall Study||6||
59900487|NCT03255291|76022421|FG004|NOT COMPLETED|Overall Study||7||
59900488|NCT03255291|76022422|FG005|NOT COMPLETED|Overall Study||10||
59900489|NCT00381381|76022440|FG000|STARTED|Overall Study||199||
59900490|NCT00381381|76022440|FG000|COMPLETED|Overall Study||135||
59900491|NCT00381381|76022440|FG000|NOT COMPLETED|Overall Study||64||
59900492|NCT02939937|76022446|FG000|STARTED|Overall Study|5 patients had drug reaction and 1 patient excluded from study,|21||
59900493|NCT02939937|76022447|FG001|STARTED|Overall Study|3 patients excluded from study|50||
59900494|NCT02939937|76022446|FG000|COMPLETED|Overall Study||15||
59900495|NCT02939937|76022447|FG001|COMPLETED|Overall Study||47||
59900496|NCT02939937|76022446|FG000|NOT COMPLETED|Overall Study||6||
59900497|NCT02939937|76022447|FG001|NOT COMPLETED|Overall Study||3||
59900498|NCT02939079|76022455|FG000|STARTED|Overall Study||25||
59900499|NCT02939079|76022456|FG001|STARTED|Overall Study||25||
59900500|NCT02939079|76022455|FG000|COMPLETED|Overall Study||21||
59900501|NCT02939079|76022456|FG001|COMPLETED|Overall Study||20||
59900502|NCT02939079|76022455|FG000|NOT COMPLETED|Overall Study||4||
59900503|NCT02939079|76022456|FG001|NOT COMPLETED|Overall Study||5||
59900504|NCT04562155|76022466|FG000|STARTED|Overall Study||75||
59900505|NCT04562155|76022467|FG001|STARTED|Overall Study||78||
59900506|NCT04562155|76022468|FG002|STARTED|Overall Study||80||
59900507|NCT04562155|76022469|FG003|STARTED|Overall Study||77||
59900508|NCT04562155|76022466|FG000|COMPLETED|Overall Study||64||
59900509|NCT04562155|76022467|FG001|COMPLETED|Overall Study||69||
59900510|NCT04562155|76022468|FG002|COMPLETED|Overall Study||67||
59900511|NCT04562155|76022469|FG003|COMPLETED|Overall Study||71||
59900512|NCT04562155|76022466|FG000|NOT COMPLETED|Overall Study||11||
59900513|NCT04562155|76022467|FG001|NOT COMPLETED|Overall Study||9||
59900514|NCT04562155|76022468|FG002|NOT COMPLETED|Overall Study||13||
59900515|NCT04562155|76022469|FG003|NOT COMPLETED|Overall Study||6||
59900516|NCT03313050|76022483|FG000|STARTED|Stage 1: 6 Months||34||
59900517|NCT03313050|76022484|FG001|STARTED|Stage 1: 6 Months||32||
59900518|NCT03313050|76022485|FG002|STARTED|Stage 1: 6 Months||0||
59900519|NCT03313050|76022486|FG003|STARTED|Stage 1: 6 Months||0||
59900520|NCT03313050|76022483|FG000|Vaccinated|Stage 1: 6 Months||34||
59900521|NCT03313050|76022484|FG001|Vaccinated|Stage 1: 6 Months||32||
59900522|NCT03313050|76022485|FG002|Vaccinated|Stage 1: 6 Months||0||
59900523|NCT03313050|76022486|FG003|Vaccinated|Stage 1: 6 Months||0||
59900524|NCT03313050|76022483|FG000|COMPLETED|Stage 1: 6 Months||34||
59900525|NCT03313050|76022484|FG001|COMPLETED|Stage 1: 6 Months||32||
59900526|NCT03313050|76022485|FG002|COMPLETED|Stage 1: 6 Months||0||
59900527|NCT03313050|76022486|FG003|COMPLETED|Stage 1: 6 Months||0||
59900528|NCT03313050|76022483|FG000|NOT COMPLETED|Stage 1: 6 Months||0||
59900529|NCT03313050|76022484|FG001|NOT COMPLETED|Stage 1: 6 Months||0||
59900530|NCT03313050|76022485|FG002|NOT COMPLETED|Stage 1: 6 Months||0||
59900531|NCT03313050|76022486|FG003|NOT COMPLETED|Stage 1: 6 Months||0||
59900532|NCT03313050|76022483|FG000|STARTED|Stage 2: 12 Months|Stage 1 participants did not continue in Stage 2.|0||
59900533|NCT03313050|76022484|FG001|STARTED|Stage 2: 12 Months|Stage 1 participants did not continue in Stage 2.|0||
59900534|NCT03313050|76022485|FG002|STARTED|Stage 2: 12 Months|After Stage 1 safety was acceptable then Stage 2 followed with newer participants.|221||
59900535|NCT03313050|76022486|FG003|STARTED|Stage 2: 12 Months|After Stage 1 safety was acceptable then Stage 2 followed with newer participants.|224||
59900536|NCT03313050|76022483|FG000|Vaccinated|Stage 2: 12 Months||0||
59900537|NCT03313050|76022484|FG001|Vaccinated|Stage 2: 12 Months||0||
59900538|NCT03313050|76022485|FG002|Vaccinated|Stage 2: 12 Months||221||
59900539|NCT03313050|76022486|FG003|Vaccinated|Stage 2: 12 Months||223||
59900540|NCT03313050|76022483|FG000|COMPLETED|Stage 2: 12 Months||0||
59900541|NCT03313050|76022484|FG001|COMPLETED|Stage 2: 12 Months||0||
59900542|NCT03313050|76022485|FG002|COMPLETED|Stage 2: 12 Months||210||
59900543|NCT03313050|76022486|FG003|COMPLETED|Stage 2: 12 Months||204||
59900544|NCT03313050|76022483|FG000|NOT COMPLETED|Stage 2: 12 Months||0||
59900545|NCT03313050|76022484|FG001|NOT COMPLETED|Stage 2: 12 Months||0||
59900546|NCT03313050|76022485|FG002|NOT COMPLETED|Stage 2: 12 Months||11||
59900547|NCT03313050|76022486|FG003|NOT COMPLETED|Stage 2: 12 Months||20||
59900548|NCT02774265|76022498|FG000|STARTED|Overall Study||164||
59900549|NCT02774265|76022499|FG001|STARTED|Overall Study||165||
59900550|NCT02774265|76022498|FG000|COMPLETED|Overall Study||151||
59900551|NCT02774265|76022499|FG001|COMPLETED|Overall Study||159||
59900552|NCT02774265|76022498|FG000|NOT COMPLETED|Overall Study||13||
59900553|NCT02774265|76022499|FG001|NOT COMPLETED|Overall Study||6||
59900554|NCT04755595|76022505|FG000|STARTED|Overall Study||20||
59900555|NCT04755595|76022505|FG000|COMPLETED|Overall Study||19||
59900556|NCT04755595|76022505|FG000|NOT COMPLETED|Overall Study||1||
59900557|NCT04749745|76022510|FG000|STARTED|Overall Study||5||
59900558|NCT04749745|76022511|FG001|STARTED|Overall Study||6||
59900559|NCT04749745|76022510|FG000|First Intervention|Overall Study||4||
59900560|NCT04749745|76022511|FG001|First Intervention|Overall Study||6||
59900561|NCT04749745|76022510|FG000|Washout|Overall Study||4|72 hours at least|
59900562|NCT04749745|76022511|FG001|Washout|Overall Study||6|72 hours at least|
59900563|NCT04749745|76022510|FG000|Second Intervention|Overall Study||4||
59900564|NCT04749745|76022511|FG001|Second Intervention|Overall Study||6||
59900565|NCT04749745|76022510|FG000|COMPLETED|Overall Study||4||
59900566|NCT04749745|76022511|FG001|COMPLETED|Overall Study||6||
59900567|NCT04749745|76022510|FG000|NOT COMPLETED|Overall Study||1||
59900568|NCT04749745|76022511|FG001|NOT COMPLETED|Overall Study||0||
59900569|NCT03257436|76022517|FG000|STARTED|Overall Study||584||
59900570|NCT03257436|76022517|FG000|COMPLETED|Overall Study||489||
59900571|NCT03257436|76022517|FG000|NOT COMPLETED|Overall Study||95||
59900572|NCT04748341|76022523|FG000|STARTED|Overall Study||31||
59900573|NCT04748341|76022524|FG001|STARTED|Overall Study||31||
59900574|NCT04748341|76022523|FG000|COMPLETED|Overall Study||30||
59900575|NCT04748341|76022524|FG001|COMPLETED|Overall Study||30||
59900576|NCT04748341|76022523|FG000|NOT COMPLETED|Overall Study||1||
59900577|NCT04748341|76022524|FG001|NOT COMPLETED|Overall Study||1||
59900578|NCT01328002|76022530|FG000|STARTED|Open-Label Period||116||
59900579|NCT01328002|76022531|FG001|STARTED|Open-Label Period||0||
59900580|NCT01328002|76022530|FG000|COMPLETED|Open-Label Period||20||
59900581|NCT01328002|76022531|FG001|COMPLETED|Open-Label Period||0||
59900582|NCT01328002|76022530|FG000|NOT COMPLETED|Open-Label Period||96||
59900583|NCT01328002|76022531|FG001|NOT COMPLETED|Open-Label Period||0||
59900584|NCT01328002|76022530|FG000|STARTED|Double-Blind Period||14||
59900585|NCT01328002|76022531|FG001|STARTED|Double-Blind Period||6||
59900586|NCT01328002|76022530|FG000|COMPLETED|Double-Blind Period||12||
59900587|NCT01328002|76022531|FG001|COMPLETED|Double-Blind Period||6||
59900588|NCT01328002|76022530|FG000|NOT COMPLETED|Double-Blind Period||2||
59900589|NCT01328002|76022531|FG001|NOT COMPLETED|Double-Blind Period||0||
59900590|NCT02579265|76022540|FG000|STARTED|Overall Study||83||
59900591|NCT02579265|76022541|FG001|STARTED|Overall Study||78||
59900592|NCT02579265|76022540|FG000|COMPLETED|Overall Study||33||
59900593|NCT02579265|76022541|FG001|COMPLETED|Overall Study||33||
59900594|NCT02579265|76022540|FG000|NOT COMPLETED|Overall Study||50||
59900595|NCT02579265|76022541|FG001|NOT COMPLETED|Overall Study||45||
59900596|NCT03289533|76022547|FG000|STARTED|Overall Study||22||
59900597|NCT03289533|76022547|FG000|COMPLETED|Overall Study||0||
59900598|NCT03289533|76022547|FG000|NOT COMPLETED|Overall Study||22||
59900599|NCT04727749|76022553|FG000|STARTED|Overall Study||107||
59900600|NCT04727749|76022554|FG001|STARTED|Overall Study||104||
59900601|NCT04727749|76022553|FG000|COMPLETED|Overall Study||97||
59900602|NCT04727749|76022554|FG001|COMPLETED|Overall Study||101||
59900603|NCT04727749|76022553|FG000|NOT COMPLETED|Overall Study||10||
59900604|NCT04727749|76022554|FG001|NOT COMPLETED|Overall Study||3||
59900605|NCT04547023|76022564|FG000|STARTED|Overall Study||100||
59900606|NCT04547023|76022565|FG001|STARTED|Overall Study||100||
59900607|NCT04547023|76022564|FG000|COMPLETED|Overall Study||96||
59900608|NCT04547023|76022565|FG001|COMPLETED|Overall Study||97||
59900609|NCT04547023|76022564|FG000|NOT COMPLETED|Overall Study||4||
59900610|NCT04547023|76022565|FG001|NOT COMPLETED|Overall Study||3||
59900611|NCT03697993|76022575|FG000|STARTED|Overall Study||32||
59900612|NCT03697993|76022576|FG001|STARTED|Overall Study||30||
59900613|NCT03697993|76022575|FG000|Initiated Treatment|Overall Study||30||
59900614|NCT03697993|76022576|FG001|Initiated Treatment|Overall Study||28||
59900615|NCT03697993|76022575|FG000|Switched Treatment|Overall Study||0|All participants who switched treatment within a strategy switched before initiation of the original treatment.|
59900616|NCT03697993|76022576|FG001|Switched Treatment|Overall Study|Five (5) participants switched to Fosfomycin; 1 participant switched to Cefixime.|6|All participants who switched treatment within a strategy switched before initiation of the original treatment.|
59900617|NCT03697993|76022575|FG000|Treated With at Least Two Dose of Fosfomycin|Overall Study||27||
59900618|NCT03697993|76022576|FG001|Treated With at Least Two Dose of Fosfomycin|Overall Study||4||
59900619|NCT03697993|76022575|FG000|COMPLETED|Overall Study||22||
59900620|NCT03697993|76022576|FG001|COMPLETED|Overall Study||25||
59900621|NCT03697993|76022575|FG000|NOT COMPLETED|Overall Study||10||
59900622|NCT03697993|76022576|FG001|NOT COMPLETED|Overall Study||5||
59900623|NCT03289455|76022586|FG000|STARTED|Overall Study||4||
59900624|NCT03289455|76022587|FG001|STARTED|Overall Study||5||
59900625|NCT03289455|76022588|FG002|STARTED|Overall Study||6||
59900626|NCT03289455|76022586|FG000|COMPLETED|Overall Study|Completed = Received AUTO3 infusion and completed 24 months visit|0||
59900627|NCT03289455|76022587|FG001|COMPLETED|Overall Study|Completed = Received AUTO3 infusion and completed 24 months visit|0||
59900628|NCT03289455|76022588|FG002|COMPLETED|Overall Study|Completed = Received AUTO3 infusion and completed 24 months visit|0||
59900629|NCT03289455|76022586|FG000|NOT COMPLETED|Overall Study||4||
59900630|NCT03289455|76022587|FG001|NOT COMPLETED|Overall Study||5||
59900631|NCT03289455|76022588|FG002|NOT COMPLETED|Overall Study||6||
59900632|NCT04484857|76022597|FG000|STARTED|Overall Study||283||
59900633|NCT04484857|76022597|FG000|Received at Least 1 Dose of Study Drug|Overall Study||283||
59900634|NCT04484857|76022597|FG000|Full Analysis Set|Overall Study||282|All enrolled participants who provided baseline Hb data and data for at least 1 postbaseline Hb time point.|
59900635|NCT04484857|76022597|FG000|COMPLETED|Overall Study||36||
59900636|NCT04484857|76022597|FG000|NOT COMPLETED|Overall Study||247||
59900637|NCT04095793|76022601|FG000|STARTED|Overall Study||110||
59900638|NCT04095793|76022601|FG000|COMPLETED|Overall Study||0||
59900639|NCT04095793|76022601|FG000|NOT COMPLETED|Overall Study||110||
59900640|NCT04482439|76022605|FG000|STARTED|Overall Study||35||
59900641|NCT04482439|76022605|FG000|COMPLETED|Overall Study||33||
59900642|NCT04482439|76022605|FG000|NOT COMPLETED|Overall Study||2||
59900643|NCT04535947|76022612|FG000|STARTED|Overall Study||76||
59900644|NCT04535947|76022613|FG001|STARTED|Overall Study||77||
59900645|NCT04535947|76022612|FG000|COMPLETED|Overall Study||72||
59900646|NCT04535947|76022613|FG001|COMPLETED|Overall Study||72||
59900647|NCT04535947|76022612|FG000|NOT COMPLETED|Overall Study||4||
59900648|NCT04535947|76022613|FG001|NOT COMPLETED|Overall Study||5||
59900649|NCT04474405|76022625|FG000|STARTED|Overall Study||4||
59900650|NCT04474405|76022626|FG001|STARTED|Overall Study||3||
59900651|NCT04474405|76022627|FG002|STARTED|Overall Study||5||
59900652|NCT04474405|76022628|FG003|STARTED|Overall Study||4||
59900653|NCT04474405|76022629|FG004|STARTED|Overall Study||13||
59900654|NCT04474405|76022630|FG005|STARTED|Overall Study||7||
59900655|NCT04474405|76022625|FG000|Flortaucipir PET Scan|Overall Study||4||
59900656|NCT04474405|76022626|FG001|Flortaucipir PET Scan|Overall Study||3||
59900657|NCT04474405|76022627|FG002|Flortaucipir PET Scan|Overall Study||4||
59900658|NCT04474405|76022628|FG003|Flortaucipir PET Scan|Overall Study||4||
59900659|NCT04474405|76022629|FG004|Flortaucipir PET Scan|Overall Study||9||
59505828|NCT00743093|75598716|FG001|NOT COMPLETED|Extended Dosing Period||0||
59505829|NCT00743717|75598724|FG000|STARTED|Overall Study||2||
59900660|NCT04474405|76022630|FG005|Flortaucipir PET Scan|Overall Study||0||
59900661|NCT04474405|76022625|FG000|Florbetapir PET Scan|Overall Study||4||
59900662|NCT04474405|76022626|FG001|Florbetapir PET Scan|Overall Study||3||
59900663|NCT04474405|76022627|FG002|Florbetapir PET Scan|Overall Study||0||
59900664|NCT04474405|76022628|FG003|Florbetapir PET Scan|Overall Study||4||
59900665|NCT04474405|76022629|FG004|Florbetapir PET Scan|Overall Study||0||
59900666|NCT04474405|76022630|FG005|Florbetapir PET Scan|Overall Study||4||
59900667|NCT04474405|76022625|FG000|COMPLETED|Overall Study||4||
59900668|NCT04474405|76022626|FG001|COMPLETED|Overall Study||3||
59900669|NCT04474405|76022627|FG002|COMPLETED|Overall Study||4||
59900670|NCT04474405|76022628|FG003|COMPLETED|Overall Study||4||
59900671|NCT04474405|76022629|FG004|COMPLETED|Overall Study||9||
59505830|NCT00743717|75598725|FG001|STARTED|Overall Study||2||
59505831|NCT00743717|75598724|FG000|COMPLETED|Overall Study||2||
59900672|NCT04474405|76022630|FG005|COMPLETED|Overall Study||7||
59900673|NCT04474405|76022625|FG000|NOT COMPLETED|Overall Study||0||
59900674|NCT04474405|76022626|FG001|NOT COMPLETED|Overall Study||0||
59900675|NCT04474405|76022627|FG002|NOT COMPLETED|Overall Study||1||
59900676|NCT04474405|76022628|FG003|NOT COMPLETED|Overall Study||0||
59900677|NCT04474405|76022629|FG004|NOT COMPLETED|Overall Study||4||
59900678|NCT04474405|76022630|FG005|NOT COMPLETED|Overall Study||0||
59757474|NCT02340169|75876587|FG000|Cohort 1 12-17 Years of Age|Overall Study||84||
59900679|NCT04531813|76022644|FG000|STARTED|Overall Study||32||
59900680|NCT04531813|76022644|FG000|Treated|Overall Study||31||
59900681|NCT04531813|76022644|FG000|COMPLETED|Overall Study||30||
59900682|NCT04531813|76022644|FG000|NOT COMPLETED|Overall Study||2||
59900683|NCT03538444|76022650|FG000|STARTED|Overall Study||4||
59900684|NCT03538444|76022651|FG001|STARTED|Overall Study||3||
59900685|NCT03538444|76022650|FG000|COMPLETED|Overall Study||3||
59900686|NCT03538444|76022651|FG001|COMPLETED|Overall Study||3||
59900687|NCT03538444|76022650|FG000|NOT COMPLETED|Overall Study||1||
59900688|NCT03538444|76022651|FG001|NOT COMPLETED|Overall Study||0||
59900689|NCT01199302|76022661|FG000|STARTED|Overall Study||20||
59900690|NCT01199302|76022662|FG001|STARTED|Overall Study||16||
59900691|NCT01199302|76022663|FG002|STARTED|Overall Study||20||
59757475|NCT02340169|75876587|FG000|Cohort 2 6 to 11 Years of Age|Overall Study||35||
59900692|NCT01199302|76022664|FG003|STARTED|Overall Study||11||
59900693|NCT01199302|76022661|FG000|COMPLETED|Overall Study||0||
59900694|NCT01199302|76022662|FG001|COMPLETED|Overall Study||0||
59900695|NCT01199302|76022663|FG002|COMPLETED|Overall Study||0||
59900696|NCT01199302|76022664|FG003|COMPLETED|Overall Study||0||
59900697|NCT01199302|76022661|FG000|NOT COMPLETED|Overall Study||20||
59900698|NCT01199302|76022662|FG001|NOT COMPLETED|Overall Study||16||
59900699|NCT01199302|76022663|FG002|NOT COMPLETED|Overall Study||20||
59900700|NCT01199302|76022664|FG003|NOT COMPLETED|Overall Study||11||
59900701|NCT03332784|76022691|FG000|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2||
59900702|NCT03332784|76022692|FG001|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2||
59900703|NCT03332784|76022693|FG002|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2||
59900704|NCT03332784|76022694|FG003|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2||
59900705|NCT03332784|76022695|FG004|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2||
59900706|NCT03332784|76022696|FG005|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2||
59900707|NCT03332784|76022697|FG006|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2||
59900708|NCT03332784|76022698|FG007|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2||
59900709|NCT03332784|76022699|FG008|STARTED|Parts 1 and 2 - Period 1 (1 Day)||4||
59900710|NCT03332784|76022700|FG009|STARTED|Parts 1 and 2 - Period 1 (1 Day)||6||
59900711|NCT03332784|76022701|FG010|STARTED|Parts 1 and 2 - Period 1 (1 Day)||6||
59900712|NCT03332784|76022702|FG011|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2||
59900713|NCT03332784|76022703|FG012|STARTED|Parts 1 and 2 - Period 1 (1 Day)||6||
59900714|NCT03332784|76022704|FG013|STARTED|Parts 1 and 2 - Period 1 (1 Day)||4||
59900715|NCT03332784|76022705|FG014|STARTED|Parts 1 and 2 - Period 1 (1 Day)|A washout period of 7 days was required before the dosing on Day 1 for prior medications.|2||
59900716|NCT03332784|76022706|FG015|STARTED|Parts 1 and 2 - Period 1 (1 Day)|A washout period of 7 days was required before the dosing on Day 1 for prior medications.|2||
59900717|NCT03332784|76022707|FG016|STARTED|Parts 1 and 2 - Period 1 (1 Day)|A washout period of 7 days was required before the dosing on Day 1 for prior medications.|2||
59900718|NCT03332784|76022708|FG017|STARTED|Parts 1 and 2 - Period 1 (1 Day)|A washout period of 7 days was required before the dosing on Day 1 for prior medications.|2||
59900719|NCT03332784|76022709|FG018|STARTED|Parts 1 and 2 - Period 1 (1 Day)|A washout period of 7 days was required before the dosing on Day 1 for prior medications.|3||
59900720|NCT03332784|76022710|FG019|STARTED|Parts 1 and 2 - Period 1 (1 Day)|A washout period of 7 days was required before the dosing on Day 1 for prior medications.|3||
59900721|NCT03332784|76022691|FG000|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2||
59900722|NCT03332784|76022692|FG001|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||1||
59900723|NCT03332784|76022693|FG002|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2||
59900724|NCT03332784|76022694|FG003|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2||
59900725|NCT03332784|76022695|FG004|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2||
59900726|NCT03332784|76022696|FG005|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2||
59900727|NCT03332784|76022697|FG006|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2||
59900728|NCT03332784|76022698|FG007|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2||
59900729|NCT03332784|76022699|FG008|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||4||
59900730|NCT03332784|76022700|FG009|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||6||
59900731|NCT03332784|76022701|FG010|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||6||
59900732|NCT03332784|76022702|FG011|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2||
59900733|NCT03332784|76022703|FG012|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||6||
59900734|NCT03332784|76022704|FG013|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||4||
59900735|NCT03332784|76022705|FG014|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||1||
59900736|NCT03332784|76022706|FG015|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2||
59900737|NCT03332784|76022707|FG016|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2||
59900738|NCT03332784|76022708|FG017|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2||
59900739|NCT03332784|76022709|FG018|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||3||
59900740|NCT03332784|76022710|FG019|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||3||
59900741|NCT03332784|76022691|FG000|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0||
59900742|NCT03332784|76022692|FG001|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||1||
59900743|NCT03332784|76022693|FG002|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0||
59900744|NCT03332784|76022694|FG003|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0||
59900745|NCT03332784|76022695|FG004|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0||
59900746|NCT03332784|76022696|FG005|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0||
59900747|NCT03332784|76022697|FG006|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0||
59900748|NCT03332784|76022698|FG007|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0||
59900749|NCT03332784|76022699|FG008|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0||
59900750|NCT03332784|76022700|FG009|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0||
59900751|NCT03332784|76022701|FG010|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0||
59900752|NCT03332784|76022702|FG011|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0||
59900753|NCT03332784|76022703|FG012|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0||
59900754|NCT03332784|76022704|FG013|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0||
59900755|NCT03332784|76022705|FG014|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||1||
59900756|NCT03332784|76022706|FG015|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0||
59900757|NCT03332784|76022707|FG016|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0||
59900758|NCT03332784|76022708|FG017|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0||
59900759|NCT03332784|76022709|FG018|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0||
59900760|NCT03332784|76022710|FG019|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0||
59900761|NCT03332784|76022691|FG000|STARTED|Parts 1 and 2- Period 2 (1 Day)||2||
59900762|NCT03332784|76022692|FG001|STARTED|Parts 1 and 2- Period 2 (1 Day)||1||
59900763|NCT03332784|76022693|FG002|STARTED|Parts 1 and 2- Period 2 (1 Day)||2||
59900764|NCT03332784|76022694|FG003|STARTED|Parts 1 and 2- Period 2 (1 Day)||2||
59900765|NCT03332784|76022695|FG004|STARTED|Parts 1 and 2- Period 2 (1 Day)||2||
59900766|NCT03332784|76022696|FG005|STARTED|Parts 1 and 2- Period 2 (1 Day)||2||
59900767|NCT03332784|76022697|FG006|STARTED|Parts 1 and 2- Period 2 (1 Day)||2||
59900768|NCT03332784|76022698|FG007|STARTED|Parts 1 and 2- Period 2 (1 Day)||2||
59900769|NCT03332784|76022699|FG008|STARTED|Parts 1 and 2- Period 2 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0||
59900770|NCT03332784|76022700|FG009|STARTED|Parts 1 and 2- Period 2 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0||
59900771|NCT03332784|76022701|FG010|STARTED|Parts 1 and 2- Period 2 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0||
59900772|NCT03332784|76022702|FG011|STARTED|Parts 1 and 2- Period 2 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0||
59900773|NCT03332784|76022703|FG012|STARTED|Parts 1 and 2- Period 2 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0||
59900774|NCT03332784|76022704|FG013|STARTED|Parts 1 and 2- Period 2 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0||
59900775|NCT03332784|76022705|FG014|STARTED|Parts 1 and 2- Period 2 (1 Day)||1||
59900776|NCT03332784|76022706|FG015|STARTED|Parts 1 and 2- Period 2 (1 Day)||2||
59900777|NCT03332784|76022707|FG016|STARTED|Parts 1 and 2- Period 2 (1 Day)||2||
59900778|NCT03332784|76022708|FG017|STARTED|Parts 1 and 2- Period 2 (1 Day)||2||
59900779|NCT03332784|76022709|FG018|STARTED|Parts 1 and 2- Period 2 (1 Day)||3||
59900780|NCT03332784|76022710|FG019|STARTED|Parts 1 and 2- Period 2 (1 Day)||3||
59900781|NCT03332784|76022691|FG000|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2||
59900782|NCT03332784|76022692|FG001|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||1||
59900783|NCT03332784|76022693|FG002|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2||
59900784|NCT03332784|76022694|FG003|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2||
59900785|NCT03332784|76022695|FG004|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2||
59900786|NCT03332784|76022696|FG005|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2||
59900787|NCT03332784|76022697|FG006|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2||
59900788|NCT03332784|76022698|FG007|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2||
59900789|NCT03332784|76022699|FG008|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0||
59900790|NCT03332784|76022700|FG009|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0||
59900791|NCT03332784|76022701|FG010|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0||
59900792|NCT03332784|76022702|FG011|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0||
59900793|NCT03332784|76022703|FG012|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0||
59900794|NCT03332784|76022704|FG013|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0||
59900795|NCT03332784|76022705|FG014|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||1||
59900796|NCT03332784|76022706|FG015|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2||
59900797|NCT03332784|76022707|FG016|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2||
59900798|NCT03332784|76022708|FG017|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2||
59900799|NCT03332784|76022709|FG018|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||3||
59900800|NCT03332784|76022710|FG019|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||3||
59900801|NCT03332784|76022691|FG000|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0||
59900802|NCT03332784|76022692|FG001|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0||
59900803|NCT03332784|76022693|FG002|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0||
59900804|NCT03332784|76022694|FG003|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0||
59900805|NCT03332784|76022695|FG004|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0||
59900806|NCT03332784|76022696|FG005|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0||
59900807|NCT03332784|76022697|FG006|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0||
59900808|NCT03332784|76022698|FG007|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0||
59900809|NCT03332784|76022699|FG008|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0||
59900810|NCT03332784|76022700|FG009|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0||
59900811|NCT03332784|76022701|FG010|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0||
59900812|NCT03332784|76022702|FG011|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0||
59900813|NCT03332784|76022703|FG012|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0||
59900814|NCT03332784|76022704|FG013|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0||
59900815|NCT03332784|76022705|FG014|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0||
59900816|NCT03332784|76022706|FG015|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0||
59900817|NCT03332784|76022707|FG016|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0||
59900818|NCT03332784|76022708|FG017|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0||
59900819|NCT03332784|76022709|FG018|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0||
59900820|NCT03332784|76022710|FG019|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0||
59900821|NCT03332784|76022691|FG000|STARTED|Part 1- Period 3 (1 Day)||2||
59900822|NCT03332784|76022692|FG001|STARTED|Part 1- Period 3 (1 Day)||1||
59900823|NCT03332784|76022693|FG002|STARTED|Part 1- Period 3 (1 Day)||2||
59900824|NCT03332784|76022694|FG003|STARTED|Part 1- Period 3 (1 Day)||2||
59900825|NCT03332784|76022695|FG004|STARTED|Part 1- Period 3 (1 Day)||2||
59900826|NCT03332784|76022696|FG005|STARTED|Part 1- Period 3 (1 Day)||2||
59900827|NCT03332784|76022697|FG006|STARTED|Part 1- Period 3 (1 Day)||2||
59900828|NCT03332784|76022698|FG007|STARTED|Part 1- Period 3 (1 Day)||2||
59900829|NCT03332784|76022699|FG008|STARTED|Part 1- Period 3 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0||
59900830|NCT03332784|76022700|FG009|STARTED|Part 1- Period 3 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0||
59900831|NCT03332784|76022701|FG010|STARTED|Part 1- Period 3 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0||
59900832|NCT03332784|76022702|FG011|STARTED|Part 1- Period 3 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0||
59900833|NCT03332784|76022703|FG012|STARTED|Part 1- Period 3 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0||
59900834|NCT03332784|76022704|FG013|STARTED|Part 1- Period 3 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0||
59900835|NCT03332784|76022705|FG014|STARTED|Part 1- Period 3 (1 Day)|Part 2 participants did not continue in subsequent periods after Period 2.|0||
59900836|NCT03332784|76022706|FG015|STARTED|Part 1- Period 3 (1 Day)|Part 2 participants did not continue in subsequent periods after Period 2.|0||
59900837|NCT03332784|76022707|FG016|STARTED|Part 1- Period 3 (1 Day)|Part 2 participants did not continue in subsequent periods after Period 2.|0||
59900838|NCT03332784|76022708|FG017|STARTED|Part 1- Period 3 (1 Day)|Part 2 participants did not continue in subsequent periods after Period 2.|0||
59900839|NCT03332784|76022709|FG018|STARTED|Part 1- Period 3 (1 Day)|Part 2 participants did not continue in subsequent periods after Period 2.|0||
59900840|NCT03332784|76022710|FG019|STARTED|Part 1- Period 3 (1 Day)|Part 2 participants did not continue in subsequent periods after Period 2.|0||
59900841|NCT03332784|76022691|FG000|COMPLETED|Part 1- Period 3 (1 Day)||2||
59900842|NCT03332784|76022692|FG001|COMPLETED|Part 1- Period 3 (1 Day)||1||
59900843|NCT03332784|76022693|FG002|COMPLETED|Part 1- Period 3 (1 Day)||2||
59900844|NCT03332784|76022694|FG003|COMPLETED|Part 1- Period 3 (1 Day)||2||
59900845|NCT03332784|76022695|FG004|COMPLETED|Part 1- Period 3 (1 Day)||2||
59900846|NCT03332784|76022696|FG005|COMPLETED|Part 1- Period 3 (1 Day)||2||
59900847|NCT03332784|76022697|FG006|COMPLETED|Part 1- Period 3 (1 Day)||2||
59900848|NCT03332784|76022698|FG007|COMPLETED|Part 1- Period 3 (1 Day)||2||
59900849|NCT03332784|76022699|FG008|COMPLETED|Part 1- Period 3 (1 Day)||0||
59900850|NCT03332784|76022700|FG009|COMPLETED|Part 1- Period 3 (1 Day)||0||
59900851|NCT03332784|76022701|FG010|COMPLETED|Part 1- Period 3 (1 Day)||0||
59900852|NCT03332784|76022702|FG011|COMPLETED|Part 1- Period 3 (1 Day)||0||
59900853|NCT03332784|76022703|FG012|COMPLETED|Part 1- Period 3 (1 Day)||0||
59900854|NCT03332784|76022704|FG013|COMPLETED|Part 1- Period 3 (1 Day)||0||
59900855|NCT03332784|76022705|FG014|COMPLETED|Part 1- Period 3 (1 Day)||0||
59900856|NCT03332784|76022706|FG015|COMPLETED|Part 1- Period 3 (1 Day)||0||
59900857|NCT03332784|76022707|FG016|COMPLETED|Part 1- Period 3 (1 Day)||0||
59900858|NCT03332784|76022708|FG017|COMPLETED|Part 1- Period 3 (1 Day)||0||
59900859|NCT03332784|76022709|FG018|COMPLETED|Part 1- Period 3 (1 Day)||0||
59900860|NCT03332784|76022710|FG019|COMPLETED|Part 1- Period 3 (1 Day)||0||
59900861|NCT03332784|76022691|FG000|NOT COMPLETED|Part 1- Period 3 (1 Day)||0||
59900862|NCT03332784|76022692|FG001|NOT COMPLETED|Part 1- Period 3 (1 Day)||0||
59900863|NCT03332784|76022693|FG002|NOT COMPLETED|Part 1- Period 3 (1 Day)||0||
59900864|NCT03332784|76022694|FG003|NOT COMPLETED|Part 1- Period 3 (1 Day)||0||
59900865|NCT03332784|76022695|FG004|NOT COMPLETED|Part 1- Period 3 (1 Day)||0||
59900866|NCT03332784|76022696|FG005|NOT COMPLETED|Part 1- Period 3 (1 Day)||0||
59900867|NCT03332784|76022697|FG006|NOT COMPLETED|Part 1- Period 3 (1 Day)||0||
59900868|NCT03332784|76022698|FG007|NOT COMPLETED|Part 1- Period 3 (1 Day)||0||
59900869|NCT03332784|76022699|FG008|NOT COMPLETED|Part 1- Period 3 (1 Day)||0||
59900870|NCT03332784|76022700|FG009|NOT COMPLETED|Part 1- Period 3 (1 Day)||0||
59900871|NCT03332784|76022701|FG010|NOT COMPLETED|Part 1- Period 3 (1 Day)||0||
59900872|NCT03332784|76022702|FG011|NOT COMPLETED|Part 1- Period 3 (1 Day)||0||
59900873|NCT03332784|76022703|FG012|NOT COMPLETED|Part 1- Period 3 (1 Day)||0||
59900874|NCT03332784|76022704|FG013|NOT COMPLETED|Part 1- Period 3 (1 Day)||0||
59900875|NCT03332784|76022705|FG014|NOT COMPLETED|Part 1- Period 3 (1 Day)||0||
59900876|NCT03332784|76022706|FG015|NOT COMPLETED|Part 1- Period 3 (1 Day)||0||
59900877|NCT03332784|76022707|FG016|NOT COMPLETED|Part 1- Period 3 (1 Day)||0||
59900878|NCT03332784|76022708|FG017|NOT COMPLETED|Part 1- Period 3 (1 Day)||0||
59900879|NCT03332784|76022709|FG018|NOT COMPLETED|Part 1- Period 3 (1 Day)||0||
59900880|NCT03332784|76022710|FG019|NOT COMPLETED|Part 1- Period 3 (1 Day)||0||
59900881|NCT03171480|76022766|FG000|STARTED|Overall Study||89||
59900882|NCT03171480|76022767|FG001|STARTED|Overall Study||87||
59900883|NCT03171480|76022766|FG000|COMPLETED|Overall Study||89||
59900884|NCT03171480|76022767|FG001|COMPLETED|Overall Study||87||
59900885|NCT03171480|76022766|FG000|NOT COMPLETED|Overall Study||0||
59900886|NCT03171480|76022767|FG001|NOT COMPLETED|Overall Study||0||
59900887|NCT04465357|76022774|FG000|STARTED|Overall Study||55||
59900888|NCT04465357|76022774|FG000|COMPLETED|Overall Study||42||
59900889|NCT04465357|76022774|FG000|NOT COMPLETED|Overall Study||13||
59900890|NCT03332628|76022778|FG000|STARTED|Overall Study||113||
59900891|NCT03332628|76022778|FG000|COMPLETED|Overall Study||111||
59900892|NCT03332628|76022778|FG000|NOT COMPLETED|Overall Study||2||
59900893|NCT04516759|76022785|FG000|STARTED|Overall Study|excluding 2 subjects who were randomized but did not start treatment|80||
59900894|NCT04516759|76022786|FG001|STARTED|Overall Study|excluding 1 subject who was randomized but did not start treatment|73||
59900895|NCT04516759|76022785|FG000|COMPLETED|Overall Study||79||
59900896|NCT04516759|76022786|FG001|COMPLETED|Overall Study||71||
59900897|NCT04516759|76022785|FG000|NOT COMPLETED|Overall Study||1||
59900898|NCT04516759|76022786|FG001|NOT COMPLETED|Overall Study||2||
59900899|NCT03332160|76022794|FG000|STARTED|Overall Study||25||
59900900|NCT03332160|76022795|FG001|STARTED|Overall Study||24||
59900901|NCT03332160|76022794|FG000|COMPLETED|Overall Study||24||
59900902|NCT03332160|76022795|FG001|COMPLETED|Overall Study||19||
59900903|NCT03332160|76022794|FG000|NOT COMPLETED|Overall Study||1||
59900904|NCT03332160|76022795|FG001|NOT COMPLETED|Overall Study||5||
59900905|NCT03312114|76022802|FG000|STARTED|Overall Study||5||
59900906|NCT03312114|76022802|FG000|COMPLETED|Overall Study||0||
59900907|NCT03312114|76022802|FG000|NOT COMPLETED|Overall Study||5||
59900908|NCT03694327|76022809|FG000|STARTED|Overall Study||79||
59900909|NCT03694327|76022810|FG001|STARTED|Overall Study||79||
59900910|NCT03694327|76022809|FG000|COMPLETED|Overall Study||66||
59900911|NCT03694327|76022810|FG001|COMPLETED|Overall Study||56||
59900912|NCT03694327|76022809|FG000|NOT COMPLETED|Overall Study||13||
59900913|NCT03694327|76022810|FG001|NOT COMPLETED|Overall Study||23||
59900914|NCT03330288|76022818|FG000|STARTED|Overall Study|Enrolled|824||
59900915|NCT03330288|76022819|FG001|STARTED|Overall Study|Enrolled|278||
59900916|NCT03330288|76022818|FG000|COMPLETED|Overall Study||794||
59900917|NCT03330288|76022819|FG001|COMPLETED|Overall Study||270||
59900918|NCT03330288|76022818|FG000|NOT COMPLETED|Overall Study||30||
59900919|NCT03330288|76022819|FG001|NOT COMPLETED|Overall Study||8||
59900920|NCT03084536|76022828|FG000|STARTED|Overall Study||53||
59900921|NCT03084536|76022829|FG001|STARTED|Overall Study||54||
59900922|NCT03084536|76022830|FG002|STARTED|Overall Study||27||
59900923|NCT03084536|76022828|FG000|COMPLETED|Overall Study||53||
59900924|NCT03084536|76022829|FG001|COMPLETED|Overall Study||54||
59900925|NCT03084536|76022830|FG002|COMPLETED|Overall Study||0||
59900926|NCT03084536|76022828|FG000|NOT COMPLETED|Overall Study||0||
59900927|NCT03084536|76022829|FG001|NOT COMPLETED|Overall Study||0||
59900928|NCT03084536|76022830|FG002|NOT COMPLETED|Overall Study||27||
59900929|NCT05291936|76022837|FG000|STARTED|Period 1||36||
59900930|NCT05291936|76022838|FG001|STARTED|Period 1||37||
59900931|NCT05291936|76022837|FG000|COMPLETED|Period 1||35||
59900932|NCT05291936|76022838|FG001|COMPLETED|Period 1||36||
59900933|NCT05291936|76022837|FG000|NOT COMPLETED|Period 1||1||
59900934|NCT05291936|76022838|FG001|NOT COMPLETED|Period 1||1||
59900935|NCT05291936|76022837|FG000|STARTED|Period 2||35||
59505832|NCT00743717|75598725|FG001|COMPLETED|Overall Study||2||
59505833|NCT00743717|75598724|FG000|NOT COMPLETED|Overall Study||0||
59505834|NCT00743717|75598725|FG001|NOT COMPLETED|Overall Study||0||
59505835|NCT00744965|75598733|FG000|STARTED|Overall Study||197||
59505836|NCT00744965|75598734|FG001|STARTED|Overall Study||198||
59505837|NCT00744965|75598733|FG000|COMPLETED|Overall Study||186||
59505838|NCT00744965|75598734|FG001|COMPLETED|Overall Study||189||
59505839|NCT00744965|75598733|FG000|NOT COMPLETED|Overall Study||11||
59505840|NCT00744965|75598734|FG001|NOT COMPLETED|Overall Study||9||
59505841|NCT00763867|75598742|FG000|STARTED|Overall Study||103||
59505842|NCT00763867|75598743|FG001|STARTED|Overall Study||113||
59505843|NCT00763867|75598742|FG000|COMPLETED|Overall Study||98||
59900936|NCT05291936|76022838|FG001|STARTED|Period 2||36||
59900937|NCT05291936|76022837|FG000|COMPLETED|Period 2||34||
59900938|NCT05291936|76022838|FG001|COMPLETED|Period 2||35||
59900939|NCT05291936|76022837|FG000|NOT COMPLETED|Period 2||1||
59900940|NCT05291936|76022838|FG001|NOT COMPLETED|Period 2||1||
59900941|NCT03289143|76022848|FG000|STARTED|Overall Study||135||
59900942|NCT03289143|76022849|FG001|STARTED|Overall Study||94||
59900943|NCT03289143|76022850|FG002|STARTED|Overall Study||136||
59900944|NCT03289143|76022851|FG003|STARTED|Overall Study||92||
59900945|NCT03289143|76022848|FG000|COMPLETED|Overall Study||1||
59900946|NCT03289143|76022849|FG001|COMPLETED|Overall Study||0||
59900947|NCT03289143|76022850|FG002|COMPLETED|Overall Study||2||
59900948|NCT03289143|76022851|FG003|COMPLETED|Overall Study||0||
59900949|NCT03289143|76022848|FG000|NOT COMPLETED|Overall Study||134||
59900950|NCT03289143|76022849|FG001|NOT COMPLETED|Overall Study||94||
59900951|NCT03289143|76022850|FG002|NOT COMPLETED|Overall Study||134||
59900952|NCT03289143|76022851|FG003|NOT COMPLETED|Overall Study||92||
59900953|NCT03311724|76022870|FG000|STARTED|Overall Study||26||
59900954|NCT03311724|76022871|FG001|STARTED|Overall Study||29||
59900955|NCT03311724|76022872|FG002|STARTED|Overall Study||28||
59900956|NCT03311724|76022873|FG003|STARTED|Overall Study||28||
59900957|NCT03311724|76022870|FG000|Received At Least One Dose of Study Drug|Overall Study||26||
59900958|NCT03311724|76022871|FG001|Received At Least One Dose of Study Drug|Overall Study||29||
59900959|NCT03311724|76022872|FG002|Received At Least One Dose of Study Drug|Overall Study||28||
59900960|NCT03311724|76022873|FG003|Received At Least One Dose of Study Drug|Overall Study||28||
59900961|NCT03311724|76022870|FG000|Completed Treatment|Overall Study||20||
59900962|NCT03311724|76022871|FG001|Completed Treatment|Overall Study||27||
59900963|NCT03311724|76022872|FG002|Completed Treatment|Overall Study||22||
59900964|NCT03311724|76022873|FG003|Completed Treatment|Overall Study||26||
59900965|NCT03311724|76022870|FG000|COMPLETED|Overall Study||23||
59900966|NCT03311724|76022871|FG001|COMPLETED|Overall Study||28||
59900967|NCT03311724|76022872|FG002|COMPLETED|Overall Study||26||
59900968|NCT03311724|76022873|FG003|COMPLETED|Overall Study||27||
59900969|NCT03311724|76022870|FG000|NOT COMPLETED|Overall Study||3||
59900970|NCT03311724|76022871|FG001|NOT COMPLETED|Overall Study||1||
59900971|NCT03311724|76022872|FG002|NOT COMPLETED|Overall Study||2||
59900972|NCT03311724|76022873|FG003|NOT COMPLETED|Overall Study||1||
59505844|NCT00763867|75598743|FG001|COMPLETED|Overall Study||101||
59505845|NCT00763867|75598742|FG000|NOT COMPLETED|Overall Study||5||
59505846|NCT00763867|75598743|FG001|NOT COMPLETED|Overall Study||12||
59505847|NCT00749879|75598749|FG000|STARTED|Overall Study||12||
59505848|NCT00749879|75598749|FG000|COMPLETED|Overall Study||12||
59505849|NCT00749879|75598749|FG000|NOT COMPLETED|Overall Study||0||
59505850|NCT00711347|75598763|FG000|STARTED|Overall Study||14||
59505851|NCT00711347|75598764|FG001|STARTED|Overall Study||14||
59505852|NCT00711347|75598763|FG000|COMPLETED|Overall Study||14||
59505853|NCT00711347|75598764|FG001|COMPLETED|Overall Study||14||
59900973|NCT03846024|76022888|FG000|STARTED|Overall Study||12||
59900974|NCT03846024|76022889|FG001|STARTED|Overall Study||15||
59900975|NCT03846024|76022888|FG000|COMPLETED|Overall Study||11||
59900976|NCT03846024|76022889|FG001|COMPLETED|Overall Study||14||
59900977|NCT03846024|76022888|FG000|NOT COMPLETED|Overall Study||1||
59900978|NCT03846024|76022889|FG001|NOT COMPLETED|Overall Study||1||
59900979|NCT03311646|76022895|FG000|STARTED|Overall Study|Number who were eligible and consented.|31||
59900980|NCT03311646|76022895|FG000|COMPLETED|Overall Study|Completed VLNC Condition|16||
59900981|NCT03311646|76022895|FG000|NOT COMPLETED|Overall Study||15||
59900982|NCT01672892|76022902|FG000|STARTED|Overall Study||137||
59900983|NCT01672892|76022903|FG001|STARTED|Overall Study||152||
59900984|NCT01672892|76022902|FG000|Eligible Population|Overall Study||130||
59900985|NCT01672892|76022903|FG001|Eligible Population|Overall Study||149||
59900986|NCT01672892|76022902|FG000|Adverse Event Population|Overall Study||125|Eligible participants with adverse event data collected anytime during the study.|
59900987|NCT01672892|76022903|FG001|Adverse Event Population|Overall Study||144|Eligible participants with adverse event data collected anytime during the study.|
59900988|NCT01672892|76022902|FG000|COMPLETED|Overall Study||130|Participants contributing data to any results are considered to have completed the study.|
59900989|NCT01672892|76022903|FG001|COMPLETED|Overall Study||149|Participants contributing data to any results are considered to have completed the study.|
59900990|NCT01672892|76022902|FG000|NOT COMPLETED|Overall Study||7||
59900991|NCT01672892|76022903|FG001|NOT COMPLETED|Overall Study||3||
59900992|NCT03288987|76022914|FG000|STARTED|Overall Study||82||
59900993|NCT03288987|76022915|FG001|STARTED|Overall Study||44||
59900994|NCT03288987|76022914|FG000|Patients Receiving Medication|Overall Study||80||
59900995|NCT03288987|76022915|FG001|Patients Receiving Medication|Overall Study||44||
59900996|NCT03288987|76022914|FG000|COMPLETED|Overall Study|Per protocol population|72||
59900997|NCT03288987|76022915|FG001|COMPLETED|Overall Study|Per protocol population|40||
59900998|NCT03288987|76022914|FG000|NOT COMPLETED|Overall Study||10||
59900999|NCT03288987|76022915|FG001|NOT COMPLETED|Overall Study||4||
59901000|NCT02939781|76022921|FG000|STARTED|Overall Study||12||
59901001|NCT02939781|76022921|FG000|COMPLETED|Overall Study||3||
59901002|NCT02939781|76022921|FG000|NOT COMPLETED|Overall Study||9||
59901003|NCT03682224|76022928|FG000|STARTED|Overall Study||29||
59901004|NCT03682224|76022929|FG001|STARTED|Overall Study||28||
59901005|NCT03682224|76022928|FG000|COMPLETED|Overall Study||26||
59901006|NCT03682224|76022929|FG001|COMPLETED|Overall Study||24||
59901007|NCT03682224|76022928|FG000|NOT COMPLETED|Overall Study||3||
59901008|NCT03682224|76022929|FG001|NOT COMPLETED|Overall Study||4||
59901009|NCT03083990|76022937|FG000|STARTED|Overall Study||50||
59611365|NCT01781286|75722310|FG000|NOT COMPLETED|Overall Study||2||
59611366|NCT01781286|75722311|FG001|NOT COMPLETED|Overall Study||0||
59611367|NCT01781286|75722312|FG002|NOT COMPLETED|Overall Study||2||
59611368|NCT01781286|75722313|FG003|NOT COMPLETED|Overall Study||1||
59611369|NCT01781286|75722314|FG004|NOT COMPLETED|Overall Study||0||
59901010|NCT03083990|76022938|FG001|STARTED|Overall Study||50||
59901011|NCT03083990|76022937|FG000|COMPLETED|Overall Study||49||
59901012|NCT03083990|76022938|FG001|COMPLETED|Overall Study||50||
59901013|NCT03083990|76022937|FG000|NOT COMPLETED|Overall Study||1||
59901014|NCT03083990|76022938|FG001|NOT COMPLETED|Overall Study||0||
59901015|NCT04950998|76022946|FG000|STARTED|Overall Study||15||
59901016|NCT04950998|76022947|FG001|STARTED|Overall Study||6||
59901017|NCT04950998|76022946|FG000|COMPLETED|Overall Study||15||
59901018|NCT04950998|76022947|FG001|COMPLETED|Overall Study||6||
59901019|NCT04950998|76022946|FG000|NOT COMPLETED|Overall Study||0||
59901020|NCT04950998|76022947|FG001|NOT COMPLETED|Overall Study||0||
59901021|NCT03252015|76022956|FG000|STARTED|Overall Study||12||
59901022|NCT03252015|76022957|FG001|STARTED|Overall Study||28||
59901023|NCT03252015|76022958|FG002|STARTED|Overall Study||15||
59901024|NCT03252015|76022959|FG003|STARTED|Overall Study||15||
59901025|NCT03252015|76022956|FG000|Received at Least 1 Dose of Study Drug|Overall Study||12||
59901026|NCT03252015|76022957|FG001|Received at Least 1 Dose of Study Drug|Overall Study||28||
59901027|NCT03252015|76022958|FG002|Received at Least 1 Dose of Study Drug|Overall Study||15||
59901028|NCT03252015|76022959|FG003|Received at Least 1 Dose of Study Drug|Overall Study||15||
59901029|NCT03252015|76022956|FG000|COMPLETED|Overall Study||11||
59901030|NCT03252015|76022957|FG001|COMPLETED|Overall Study||27||
59901031|NCT03252015|76022958|FG002|COMPLETED|Overall Study||14||
59901032|NCT03252015|76022959|FG003|COMPLETED|Overall Study||14||
59901033|NCT03252015|76022956|FG000|NOT COMPLETED|Overall Study||1||
59901034|NCT03252015|76022957|FG001|NOT COMPLETED|Overall Study||1||
59901035|NCT03252015|76022958|FG002|NOT COMPLETED|Overall Study||1||
59901036|NCT03252015|76022959|FG003|NOT COMPLETED|Overall Study||1||
59901037|NCT03083132|76022985|FG000|STARTED|First 12 Weeks (Placebo vs Modafinil)||12||
59901038|NCT03083132|76022986|FG001|STARTED|First 12 Weeks (Placebo vs Modafinil)||9||
59611370|NCT01781286|75722315|FG005|NOT COMPLETED|Overall Study||1||
59611371|NCT01780974|75722327|FG000|STARTED|Overall Study||21||
59611372|NCT01780974|75722328|FG001|STARTED|Overall Study||21||
59611373|NCT01780974|75722327|FG000|COMPLETED|Overall Study||19||
59901039|NCT03083132|76022985|FG000|COMPLETED|First 12 Weeks (Placebo vs Modafinil)||12||
59901040|NCT03083132|76022986|FG001|COMPLETED|First 12 Weeks (Placebo vs Modafinil)||7||
59901041|NCT03083132|76022985|FG000|NOT COMPLETED|First 12 Weeks (Placebo vs Modafinil)||0||
59901042|NCT03083132|76022986|FG001|NOT COMPLETED|First 12 Weeks (Placebo vs Modafinil)||2||
59901043|NCT03083132|76022985|FG000|STARTED|Last 12 Weeks (Drug for All Subjects)||12||
59901044|NCT03083132|76022986|FG001|STARTED|Last 12 Weeks (Drug for All Subjects)||7||
59901045|NCT03083132|76022985|FG000|COMPLETED|Last 12 Weeks (Drug for All Subjects)||11||
59901046|NCT03083132|76022986|FG001|COMPLETED|Last 12 Weeks (Drug for All Subjects)||6||
59901047|NCT03083132|76022985|FG000|NOT COMPLETED|Last 12 Weeks (Drug for All Subjects)||1||
59901048|NCT03083132|76022986|FG001|NOT COMPLETED|Last 12 Weeks (Drug for All Subjects)||1||
59901049|NCT03683823|76022994|FG000|STARTED|Post-treatment Assessment||11||
59901050|NCT03683823|76022995|FG001|STARTED|Post-treatment Assessment||10||
59901051|NCT03683823|76022994|FG000|COMPLETED|Post-treatment Assessment||10||
59901052|NCT03683823|76022995|FG001|COMPLETED|Post-treatment Assessment||8||
59901053|NCT03683823|76022994|FG000|NOT COMPLETED|Post-treatment Assessment||1||
59901054|NCT03683823|76022995|FG001|NOT COMPLETED|Post-treatment Assessment||2||
59901055|NCT03683823|76022994|FG000|STARTED|1-week Follow-up||10||
59901056|NCT03683823|76022995|FG001|STARTED|1-week Follow-up||8||
59901057|NCT03683823|76022994|FG000|COMPLETED|1-week Follow-up||9||
59901058|NCT03683823|76022995|FG001|COMPLETED|1-week Follow-up||7||
59901059|NCT03683823|76022994|FG000|NOT COMPLETED|1-week Follow-up||1||
59901060|NCT03683823|76022995|FG001|NOT COMPLETED|1-week Follow-up||1||
59901061|NCT03285711|76023003|FG000|STARTED|Blinded Phase (Up to Week 16)||4||
59901062|NCT03285711|76023004|FG001|STARTED|Blinded Phase (Up to Week 16)||5||
59901063|NCT03285711|76023005|FG002|STARTED|Blinded Phase (Up to Week 16)||0||
59901064|NCT03285711|76023006|FG003|STARTED|Blinded Phase (Up to Week 16)||0||
59901065|NCT03285711|76023003|FG000|COMPLETED|Blinded Phase (Up to Week 16)||1||
59901066|NCT03285711|76023004|FG001|COMPLETED|Blinded Phase (Up to Week 16)||4||
59901067|NCT03285711|76023005|FG002|COMPLETED|Blinded Phase (Up to Week 16)||0||
59901068|NCT03285711|76023006|FG003|COMPLETED|Blinded Phase (Up to Week 16)||0||
59901069|NCT03285711|76023003|FG000|NOT COMPLETED|Blinded Phase (Up to Week 16)||3||
59901070|NCT03285711|76023004|FG001|NOT COMPLETED|Blinded Phase (Up to Week 16)||1||
59901071|NCT03285711|76023005|FG002|NOT COMPLETED|Blinded Phase (Up to Week 16)||0||
59901072|NCT03285711|76023006|FG003|NOT COMPLETED|Blinded Phase (Up to Week 16)||0||
59901073|NCT03285711|76023003|FG000|STARTED|Blinded Phase (Week 16 to 32)|1 participant switched treatment to filgotinib.|0||
59901074|NCT03285711|76023004|FG001|STARTED|Blinded Phase (Week 16 to 32)|1 participant switched treatment to lanraplenib.|3||
59901075|NCT03285711|76023005|FG002|STARTED|Blinded Phase (Week 16 to 32)|1 participant switched treatment from lanraplenib.|1||
59901076|NCT03285711|76023006|FG003|STARTED|Blinded Phase (Week 16 to 32)|1 participant switched treatment from filgotinib.|1||
59901077|NCT03285711|76023003|FG000|COMPLETED|Blinded Phase (Week 16 to 32)||0||
59901078|NCT03285711|76023004|FG001|COMPLETED|Blinded Phase (Week 16 to 32)||3||
59901079|NCT03285711|76023005|FG002|COMPLETED|Blinded Phase (Week 16 to 32)||0||
59901080|NCT03285711|76023006|FG003|COMPLETED|Blinded Phase (Week 16 to 32)||1||
59901081|NCT03285711|76023003|FG000|NOT COMPLETED|Blinded Phase (Week 16 to 32)||0||
59901082|NCT03285711|76023004|FG001|NOT COMPLETED|Blinded Phase (Week 16 to 32)||0||
59901083|NCT03285711|76023005|FG002|NOT COMPLETED|Blinded Phase (Week 16 to 32)||1||
59901084|NCT03285711|76023006|FG003|NOT COMPLETED|Blinded Phase (Week 16 to 32)||0||
59901085|NCT03285711|76023003|FG000|STARTED|Extended Blinded Phase (Week 32 to 52)||0||
59901086|NCT03285711|76023004|FG001|STARTED|Extended Blinded Phase (Week 32 to 52)||3||
59901087|NCT03285711|76023005|FG002|STARTED|Extended Blinded Phase (Week 32 to 52)||0||
59901088|NCT03285711|76023006|FG003|STARTED|Extended Blinded Phase (Week 32 to 52)||1||
59901089|NCT03285711|76023003|FG000|COMPLETED|Extended Blinded Phase (Week 32 to 52)||0||
59901090|NCT03285711|76023004|FG001|COMPLETED|Extended Blinded Phase (Week 32 to 52)||2||
59901091|NCT03285711|76023005|FG002|COMPLETED|Extended Blinded Phase (Week 32 to 52)||0||
59901092|NCT03285711|76023006|FG003|COMPLETED|Extended Blinded Phase (Week 32 to 52)||1||
59901093|NCT03285711|76023003|FG000|NOT COMPLETED|Extended Blinded Phase (Week 32 to 52)||0||
59901094|NCT03285711|76023004|FG001|NOT COMPLETED|Extended Blinded Phase (Week 32 to 52)||1||
59901095|NCT03285711|76023005|FG002|NOT COMPLETED|Extended Blinded Phase (Week 32 to 52)||0||
59901096|NCT03285711|76023006|FG003|NOT COMPLETED|Extended Blinded Phase (Week 32 to 52)||0||
59901097|NCT02927366|76023018|FG000|STARTED|Overall Study||6|All randomized patients were included in the Safety Analysis Set (SAF).|
59901098|NCT02927366|76023019|FG001|STARTED|Overall Study||2|All randomized patients were included in the Safety Analysis Set (SAF).|
59901099|NCT02927366|76023018|FG000|Pharmacodynamic (PD) Analysis Set|Overall Study||6|At least one dose of study drug and one evaluable PD assessment|
59901100|NCT02927366|76023019|FG001|Pharmacodynamic (PD) Analysis Set|Overall Study||2|At least one dose of study drug and one evaluable PD assessment|
59901101|NCT02927366|76023018|FG000|Pharmacokinetic (PK) Analysis Set|Overall Study||4|At least one dose of study drug and one evaluable PK concentration measurement|
59901102|NCT02927366|76023019|FG001|Pharmacokinetic (PK) Analysis Set|Overall Study||0|At least one dose of study drug and one evaluable PK concentration measurement|
59901103|NCT02927366|76023018|FG000|COMPLETED|Overall Study||4||
59901104|NCT02927366|76023019|FG001|COMPLETED|Overall Study||2||
59901105|NCT02927366|76023018|FG000|NOT COMPLETED|Overall Study||2||
59901106|NCT02927366|76023019|FG001|NOT COMPLETED|Overall Study||0||
59901107|NCT03249909|76023028|FG000|STARTED|Overall Study||78||
59901108|NCT03249909|76023029|FG001|STARTED|Overall Study||15||
59901109|NCT03249909|76023030|FG002|STARTED|Overall Study||16||
59901110|NCT03249909|76023028|FG000|COMPLETED|Overall Study||72||
59901111|NCT03249909|76023029|FG001|COMPLETED|Overall Study||14||
59901112|NCT03249909|76023030|FG002|COMPLETED|Overall Study||16||
59901113|NCT03249909|76023028|FG000|NOT COMPLETED|Overall Study||6||
59901114|NCT03249909|76023029|FG001|NOT COMPLETED|Overall Study||1||
59901115|NCT03249909|76023030|FG002|NOT COMPLETED|Overall Study||0||
59901116|NCT03081884|76023041|FG000|STARTED|Overall Study||61||
59901117|NCT03081884|76023041|FG000|COMPLETED|Overall Study||57||
59901118|NCT03081884|76023041|FG000|NOT COMPLETED|Overall Study||4||
59901119|NCT03077438|76023048|FG000|STARTED|Overall Study||499||
59901120|NCT03077438|76023049|FG001|STARTED|Overall Study||501||
59901121|NCT03077438|76023048|FG000|Safety Analysis Set (SafAS)|Overall Study||498|SafAS:participants who received at least 1 dose of study vaccine(s) & had any safety data available.|
59901122|NCT03077438|76023049|FG001|Safety Analysis Set (SafAS)|Overall Study||494|SafAS:participants who received at least 1 dose of study vaccine(s) & had any safety data available.|
59901123|NCT03077438|76023048|FG000|COMPLETED|Overall Study||487||
59901124|NCT03077438|76023049|FG001|COMPLETED|Overall Study||487||
59901125|NCT03077438|76023048|FG000|NOT COMPLETED|Overall Study||12||
59901126|NCT03077438|76023049|FG001|NOT COMPLETED|Overall Study||14||
59901127|NCT03076970|76023059|FG000|STARTED|Period 1||7||
59901128|NCT03076970|76023060|FG001|STARTED|Period 1||7||
59901129|NCT03076970|76023061|FG002|STARTED|Period 1||7||
59901130|NCT03076970|76023062|FG003|STARTED|Period 1||7||
59901131|NCT03076970|76023063|FG004|STARTED|Period 1||7||
59901132|NCT03076970|76023064|FG005|STARTED|Period 1||7||
59901133|NCT03076970|76023059|FG000|Received at Least 1 Dose of Study Drug|Period 1||7||
59901134|NCT03076970|76023060|FG001|Received at Least 1 Dose of Study Drug|Period 1||7||
59901135|NCT03076970|76023061|FG002|Received at Least 1 Dose of Study Drug|Period 1||7||
59901136|NCT03076970|76023062|FG003|Received at Least 1 Dose of Study Drug|Period 1||7||
59901137|NCT03076970|76023063|FG004|Received at Least 1 Dose of Study Drug|Period 1||7||
59901138|NCT03076970|76023064|FG005|Received at Least 1 Dose of Study Drug|Period 1||7||
59901139|NCT03076970|76023059|FG000|COMPLETED|Period 1||7||
59901140|NCT03076970|76023060|FG001|COMPLETED|Period 1||7||
59901141|NCT03076970|76023061|FG002|COMPLETED|Period 1||7||
59757476|NCT02340169|75876587|FG000|Cohort 3 2 to 5 Years of Age|Overall Study||10||
59901142|NCT03076970|76023062|FG003|COMPLETED|Period 1||7||
59901143|NCT03076970|76023063|FG004|COMPLETED|Period 1||7||
59901144|NCT03076970|76023064|FG005|COMPLETED|Period 1||7||
59901145|NCT03076970|76023059|FG000|NOT COMPLETED|Period 1||0||
59901146|NCT03076970|76023060|FG001|NOT COMPLETED|Period 1||0||
59901147|NCT03076970|76023061|FG002|NOT COMPLETED|Period 1||0||
59901148|NCT03076970|76023062|FG003|NOT COMPLETED|Period 1||0||
59901149|NCT03076970|76023063|FG004|NOT COMPLETED|Period 1||0||
59901150|NCT03076970|76023064|FG005|NOT COMPLETED|Period 1||0||
59901151|NCT03076970|76023059|FG000|STARTED|Washout Period 1||7||
59901152|NCT03076970|76023060|FG001|STARTED|Washout Period 1||7||
59901153|NCT03076970|76023061|FG002|STARTED|Washout Period 1||7||
59901154|NCT03076970|76023062|FG003|STARTED|Washout Period 1||7||
59901155|NCT03076970|76023063|FG004|STARTED|Washout Period 1||7||
59901156|NCT03076970|76023064|FG005|STARTED|Washout Period 1||7||
59901157|NCT03076970|76023059|FG000|COMPLETED|Washout Period 1||7||
59901158|NCT03076970|76023060|FG001|COMPLETED|Washout Period 1||7||
59901159|NCT03076970|76023061|FG002|COMPLETED|Washout Period 1||7||
59901160|NCT03076970|76023062|FG003|COMPLETED|Washout Period 1||7||
59901161|NCT03076970|76023063|FG004|COMPLETED|Washout Period 1||7||
59901162|NCT03076970|76023064|FG005|COMPLETED|Washout Period 1||7||
59901163|NCT03076970|76023059|FG000|NOT COMPLETED|Washout Period 1||0||
59901164|NCT03076970|76023060|FG001|NOT COMPLETED|Washout Period 1||0||
59901165|NCT03076970|76023061|FG002|NOT COMPLETED|Washout Period 1||0||
59901166|NCT03076970|76023062|FG003|NOT COMPLETED|Washout Period 1||0||
59901167|NCT03076970|76023063|FG004|NOT COMPLETED|Washout Period 1||0||
59901168|NCT03076970|76023064|FG005|NOT COMPLETED|Washout Period 1||0||
59901169|NCT03076970|76023059|FG000|STARTED|Period 2||7||
59901170|NCT03076970|76023060|FG001|STARTED|Period 2||7||
59901171|NCT03076970|76023061|FG002|STARTED|Period 2||7||
59901172|NCT03076970|76023062|FG003|STARTED|Period 2||7||
59901173|NCT03076970|76023063|FG004|STARTED|Period 2||7||
59901174|NCT03076970|76023064|FG005|STARTED|Period 2||7||
59901175|NCT03076970|76023059|FG000|COMPLETED|Period 2||7||
59901176|NCT03076970|76023060|FG001|COMPLETED|Period 2||7||
59901177|NCT03076970|76023061|FG002|COMPLETED|Period 2||7||
59901178|NCT03076970|76023062|FG003|COMPLETED|Period 2||7||
59901179|NCT03076970|76023063|FG004|COMPLETED|Period 2||7||
59901180|NCT03076970|76023064|FG005|COMPLETED|Period 2||7||
59901181|NCT03076970|76023059|FG000|NOT COMPLETED|Period 2||0||
59901182|NCT03076970|76023060|FG001|NOT COMPLETED|Period 2||0||
59901183|NCT03076970|76023061|FG002|NOT COMPLETED|Period 2||0||
59901184|NCT03076970|76023062|FG003|NOT COMPLETED|Period 2||0||
59901185|NCT03076970|76023063|FG004|NOT COMPLETED|Period 2||0||
59901186|NCT03076970|76023064|FG005|NOT COMPLETED|Period 2||0||
59901187|NCT03076970|76023059|FG000|STARTED|Washout Period 2||7||
59901188|NCT03076970|76023060|FG001|STARTED|Washout Period 2||7||
59901189|NCT03076970|76023061|FG002|STARTED|Washout Period 2||7||
59901190|NCT03076970|76023062|FG003|STARTED|Washout Period 2||7||
59901191|NCT03076970|76023063|FG004|STARTED|Washout Period 2||7||
59901192|NCT03076970|76023064|FG005|STARTED|Washout Period 2||7||
59901193|NCT03076970|76023059|FG000|COMPLETED|Washout Period 2||7||
59901194|NCT03076970|76023060|FG001|COMPLETED|Washout Period 2||7||
59757477|NCT02340169|75876587|FG000|COMPLETED|Overall Study||106||
59901195|NCT03076970|76023061|FG002|COMPLETED|Washout Period 2||7||
59901196|NCT03076970|76023062|FG003|COMPLETED|Washout Period 2||7||
59901197|NCT03076970|76023063|FG004|COMPLETED|Washout Period 2||6||
59901198|NCT03076970|76023064|FG005|COMPLETED|Washout Period 2||7||
59901199|NCT03076970|76023059|FG000|NOT COMPLETED|Washout Period 2||0||
59901200|NCT03076970|76023060|FG001|NOT COMPLETED|Washout Period 2||0||
59901201|NCT03076970|76023061|FG002|NOT COMPLETED|Washout Period 2||0||
59901202|NCT03076970|76023062|FG003|NOT COMPLETED|Washout Period 2||0||
59901203|NCT03076970|76023063|FG004|NOT COMPLETED|Washout Period 2||1||
59901204|NCT03076970|76023064|FG005|NOT COMPLETED|Washout Period 2||0||
59901205|NCT03076970|76023059|FG000|STARTED|Period 3||7||
59901206|NCT03076970|76023060|FG001|STARTED|Period 3||7||
59901207|NCT03076970|76023061|FG002|STARTED|Period 3||7||
59901208|NCT03076970|76023062|FG003|STARTED|Period 3||7||
59901209|NCT03076970|76023063|FG004|STARTED|Period 3||6||
59901210|NCT03076970|76023064|FG005|STARTED|Period 3||7||
59901211|NCT03076970|76023059|FG000|COMPLETED|Period 3||7||
59901212|NCT03076970|76023060|FG001|COMPLETED|Period 3||7||
59901213|NCT03076970|76023061|FG002|COMPLETED|Period 3||7||
59901214|NCT03076970|76023062|FG003|COMPLETED|Period 3||7||
59901215|NCT03076970|76023063|FG004|COMPLETED|Period 3||5||
59901216|NCT03076970|76023064|FG005|COMPLETED|Period 3||6||
59901217|NCT03076970|76023059|FG000|NOT COMPLETED|Period 3||0||
59901218|NCT03076970|76023060|FG001|NOT COMPLETED|Period 3||0||
59901219|NCT03076970|76023061|FG002|NOT COMPLETED|Period 3||0||
59901220|NCT03076970|76023062|FG003|NOT COMPLETED|Period 3||0||
59901221|NCT03076970|76023063|FG004|NOT COMPLETED|Period 3||1||
59901222|NCT03076970|76023064|FG005|NOT COMPLETED|Period 3||1||
59901223|NCT03076970|76023059|FG000|STARTED|Washout Period 3||7||
59901224|NCT03076970|76023060|FG001|STARTED|Washout Period 3||7||
59901225|NCT03076970|76023061|FG002|STARTED|Washout Period 3||7||
59901226|NCT03076970|76023062|FG003|STARTED|Washout Period 3||7||
59505854|NCT00711347|75598763|FG000|NOT COMPLETED|Overall Study||0||
59505855|NCT00711347|75598764|FG001|NOT COMPLETED|Overall Study||0||
59505856|NCT01276223|75598773|FG000|STARTED|Overall Study||78||
59901227|NCT03076970|76023063|FG004|STARTED|Washout Period 3||5||
59901228|NCT03076970|76023064|FG005|STARTED|Washout Period 3||6||
59901229|NCT03076970|76023059|FG000|COMPLETED|Washout Period 3||7||
59901230|NCT03076970|76023060|FG001|COMPLETED|Washout Period 3||7||
59901231|NCT03076970|76023061|FG002|COMPLETED|Washout Period 3||7||
59901232|NCT03076970|76023062|FG003|COMPLETED|Washout Period 3||7||
59901233|NCT03076970|76023063|FG004|COMPLETED|Washout Period 3||5||
59901234|NCT03076970|76023064|FG005|COMPLETED|Washout Period 3||6||
59901235|NCT03076970|76023059|FG000|NOT COMPLETED|Washout Period 3||0||
59901236|NCT03076970|76023060|FG001|NOT COMPLETED|Washout Period 3||0||
59901237|NCT03076970|76023061|FG002|NOT COMPLETED|Washout Period 3||0||
59901238|NCT03076970|76023062|FG003|NOT COMPLETED|Washout Period 3||0||
59901239|NCT03076970|76023063|FG004|NOT COMPLETED|Washout Period 3||0||
59901240|NCT03076970|76023064|FG005|NOT COMPLETED|Washout Period 3||0||
59901241|NCT00726596|76023077|FG000|STARTED|Overall Study||36||
59901242|NCT00726596|76023078|FG001|STARTED|Overall Study||28||
59901243|NCT00726596|76023077|FG000|COMPLETED|Overall Study||31||
59901244|NCT00726596|76023078|FG001|COMPLETED|Overall Study||24||
59901245|NCT00726596|76023077|FG000|NOT COMPLETED|Overall Study||5||
59901246|NCT00726596|76023078|FG001|NOT COMPLETED|Overall Study||4||
59901247|NCT04460690|76023086|FG000|STARTED|Overall Study||93||
59901248|NCT04460690|76023086|FG000|Community Participants|Overall Study||83||
59901249|NCT04460690|76023086|FG000|Investigator Participants|Overall Study||10||
59901250|NCT04460690|76023086|FG000|COMPLETED|Overall Study||93||
59901251|NCT04460690|76023086|FG000|NOT COMPLETED|Overall Study||0||
59901252|NCT02890992|76023101|FG000|STARTED|12 Weeks Open-Label Dose Finding Period||4||
59901253|NCT02890992|76023102|FG001|STARTED|12 Weeks Open-Label Dose Finding Period||6||
59901254|NCT02890992|76023103|FG002|STARTED|12 Weeks Open-Label Dose Finding Period||4||
59901255|NCT02890992|76023104|FG003|STARTED|12 Weeks Open-Label Dose Finding Period||6||
59901256|NCT02890992|76023105|FG004|STARTED|12 Weeks Open-Label Dose Finding Period||6||
59901257|NCT02890992|76023106|FG005|STARTED|12 Weeks Open-Label Dose Finding Period||5||
59901258|NCT02890992|76023107|FG006|STARTED|12 Weeks Open-Label Dose Finding Period||6||
59901259|NCT02890992|76023108|FG007|STARTED|12 Weeks Open-Label Dose Finding Period||5||
59901260|NCT02890992|76023101|FG000|Treated|12 Weeks Open-Label Dose Finding Period||4||
59901261|NCT02890992|76023102|FG001|Treated|12 Weeks Open-Label Dose Finding Period||6||
59505857|NCT01276223|75598774|FG001|STARTED|Overall Study||107||
59901262|NCT02890992|76023103|FG002|Treated|12 Weeks Open-Label Dose Finding Period||4||
59901263|NCT02890992|76023104|FG003|Treated|12 Weeks Open-Label Dose Finding Period||6||
59901264|NCT02890992|76023105|FG004|Treated|12 Weeks Open-Label Dose Finding Period||6||
59901265|NCT02890992|76023106|FG005|Treated|12 Weeks Open-Label Dose Finding Period||5||
59505858|NCT01276223|75598775|FG002|STARTED|Overall Study||104||
59505859|NCT01276223|75598773|FG000|COMPLETED|Overall Study||67||
59505860|NCT01276223|75598774|FG001|COMPLETED|Overall Study||103||
59901266|NCT02890992|76023107|FG006|Treated|12 Weeks Open-Label Dose Finding Period||6||
59901267|NCT02890992|76023108|FG007|Treated|12 Weeks Open-Label Dose Finding Period||5||
59901268|NCT02890992|76023101|FG000|COMPLETED|12 Weeks Open-Label Dose Finding Period|Out of 4 participants, 3 participants entered into the open-label extension (OLE) period.|4||
59901269|NCT02890992|76023102|FG001|COMPLETED|12 Weeks Open-Label Dose Finding Period||6||
59901270|NCT02890992|76023103|FG002|COMPLETED|12 Weeks Open-Label Dose Finding Period||4||
59901271|NCT02890992|76023104|FG003|COMPLETED|12 Weeks Open-Label Dose Finding Period||6||
59901272|NCT02890992|76023105|FG004|COMPLETED|12 Weeks Open-Label Dose Finding Period||6||
59901273|NCT02890992|76023106|FG005|COMPLETED|12 Weeks Open-Label Dose Finding Period||5||
59901274|NCT02890992|76023107|FG006|COMPLETED|12 Weeks Open-Label Dose Finding Period||6||
59901275|NCT02890992|76023108|FG007|COMPLETED|12 Weeks Open-Label Dose Finding Period||5||
59901276|NCT02890992|76023101|FG000|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0||
59901277|NCT02890992|76023102|FG001|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0||
59901278|NCT02890992|76023103|FG002|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0||
59901279|NCT02890992|76023104|FG003|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0||
59901280|NCT02890992|76023105|FG004|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0||
59901281|NCT02890992|76023106|FG005|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0||
59901282|NCT02890992|76023107|FG006|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0||
59901283|NCT02890992|76023108|FG007|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0||
59901284|NCT02890992|76023101|FG000|STARTED|130 Weeks Open-Label Extension Period|3 participants from Open-Label Dose Finding Period (OLDFI) entered in OLE period.|3||
59901285|NCT02890992|76023102|FG001|STARTED|130 Weeks Open-Label Extension Period||6||
59901286|NCT02890992|76023103|FG002|STARTED|130 Weeks Open-Label Extension Period||4||
59901287|NCT02890992|76023104|FG003|STARTED|130 Weeks Open-Label Extension Period||6||
59901288|NCT02890992|76023105|FG004|STARTED|130 Weeks Open-Label Extension Period||6||
59901289|NCT02890992|76023106|FG005|STARTED|130 Weeks Open-Label Extension Period||5||
59901290|NCT02890992|76023107|FG006|STARTED|130 Weeks Open-Label Extension Period||6||
59901291|NCT02890992|76023108|FG007|STARTED|130 Weeks Open-Label Extension Period||5||
59901292|NCT02890992|76023101|FG000|Treated|130 Weeks Open-Label Extension Period||3||
59901293|NCT02890992|76023102|FG001|Treated|130 Weeks Open-Label Extension Period||6||
59901294|NCT02890992|76023103|FG002|Treated|130 Weeks Open-Label Extension Period||4||
59901295|NCT02890992|76023104|FG003|Treated|130 Weeks Open-Label Extension Period||6||
59901296|NCT02890992|76023105|FG004|Treated|130 Weeks Open-Label Extension Period||6||
59901297|NCT02890992|76023106|FG005|Treated|130 Weeks Open-Label Extension Period||5||
59901298|NCT02890992|76023107|FG006|Treated|130 Weeks Open-Label Extension Period||5||
59901299|NCT02890992|76023108|FG007|Treated|130 Weeks Open-Label Extension Period||4||
59901300|NCT02890992|76023101|FG000|COMPLETED|130 Weeks Open-Label Extension Period||3||
59901301|NCT02890992|76023102|FG001|COMPLETED|130 Weeks Open-Label Extension Period||3||
59901302|NCT02890992|76023103|FG002|COMPLETED|130 Weeks Open-Label Extension Period||4||
59901303|NCT02890992|76023104|FG003|COMPLETED|130 Weeks Open-Label Extension Period||6||
59901304|NCT02890992|76023105|FG004|COMPLETED|130 Weeks Open-Label Extension Period||6||
59901305|NCT02890992|76023106|FG005|COMPLETED|130 Weeks Open-Label Extension Period||5||
59901306|NCT02890992|76023107|FG006|COMPLETED|130 Weeks Open-Label Extension Period||5||
59901307|NCT02890992|76023108|FG007|COMPLETED|130 Weeks Open-Label Extension Period||4||
59901308|NCT02890992|76023101|FG000|NOT COMPLETED|130 Weeks Open-Label Extension Period||0||
59901309|NCT02890992|76023102|FG001|NOT COMPLETED|130 Weeks Open-Label Extension Period||3||
59901310|NCT02890992|76023103|FG002|NOT COMPLETED|130 Weeks Open-Label Extension Period||0||
59901311|NCT02890992|76023104|FG003|NOT COMPLETED|130 Weeks Open-Label Extension Period||0||
59901312|NCT02890992|76023105|FG004|NOT COMPLETED|130 Weeks Open-Label Extension Period||0||
59901313|NCT02890992|76023106|FG005|NOT COMPLETED|130 Weeks Open-Label Extension Period||0||
59901314|NCT02890992|76023107|FG006|NOT COMPLETED|130 Weeks Open-Label Extension Period||1||
59901315|NCT02890992|76023108|FG007|NOT COMPLETED|130 Weeks Open-Label Extension Period||1||
59901316|NCT04357730|76023137|FG000|STARTED|Phase 1||17||
59901317|NCT04357730|76023138|FG001|STARTED|Phase 1||19||
59901318|NCT04357730|76023139|FG002|STARTED|Phase 1||0||
59901319|NCT04357730|76023137|FG000|COMPLETED|Phase 1||17||
59901320|NCT04357730|76023138|FG001|COMPLETED|Phase 1||19||
59901321|NCT04357730|76023139|FG002|COMPLETED|Phase 1||0||
59901322|NCT04357730|76023137|FG000|NOT COMPLETED|Phase 1||0||
59901323|NCT04357730|76023138|FG001|NOT COMPLETED|Phase 1||0||
59901324|NCT04357730|76023139|FG002|NOT COMPLETED|Phase 1||0||
59901325|NCT04357730|76023137|FG000|STARTED|Phase 2||8||
59901326|NCT04357730|76023138|FG001|STARTED|Phase 2||0||
59901327|NCT04357730|76023139|FG002|STARTED|Phase 2||6||
59901328|NCT04357730|76023137|FG000|COMPLETED|Phase 2||8||
59901329|NCT04357730|76023138|FG001|COMPLETED|Phase 2||0||
59901330|NCT04357730|76023139|FG002|COMPLETED|Phase 2||6||
59901331|NCT04357730|76023137|FG000|NOT COMPLETED|Phase 2||0||
59901332|NCT04357730|76023138|FG001|NOT COMPLETED|Phase 2||0||
59901333|NCT04357730|76023139|FG002|NOT COMPLETED|Phase 2||0||
59901334|NCT03076190|76023153|FG000|STARTED|Overall Study||50||
59901335|NCT03076190|76023154|FG001|STARTED|Overall Study||77||
59901336|NCT03076190|76023153|FG000|COMPLETED|Overall Study||32||
59901337|NCT03076190|76023154|FG001|COMPLETED|Overall Study||36||
59901338|NCT03076190|76023153|FG000|NOT COMPLETED|Overall Study||18||
59901339|NCT03076190|76023154|FG001|NOT COMPLETED|Overall Study||41||
59901340|NCT03328182|76023163|FG000|STARTED|Overall Study||34||
59901341|NCT03328182|76023163|FG000|COMPLETED|Overall Study||30||
59901342|NCT03328182|76023163|FG000|NOT COMPLETED|Overall Study||4||
59901343|NCT03327402|76023167|FG000|STARTED|Overall Study||24||
59901344|NCT03327402|76023167|FG000|Rich PK Sampling Group|Overall Study||12||
59901345|NCT03327402|76023167|FG000|Sparse PK Sampling Group|Overall Study||12||
59901346|NCT03327402|76023167|FG000|COMPLETED|Overall Study||22||
59901347|NCT03327402|76023167|FG000|NOT COMPLETED|Overall Study||2||
59901348|NCT03075878|76023171|FG000|STARTED|Overall Study||8||
59901349|NCT03075878|76023171|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8|Safety Population|
59901350|NCT03075878|76023171|FG000|COMPLETED|Overall Study||7||
59901351|NCT03075878|76023171|FG000|NOT COMPLETED|Overall Study||1||
59901352|NCT03326856|76023180|FG000|STARTED|Overall Study||13||
59901353|NCT03326856|76023181|FG001|STARTED|Overall Study||9||
59901354|NCT03326856|76023182|FG002|STARTED|Overall Study||9||
59901355|NCT03326856|76023183|FG003|STARTED|Overall Study||9||
59901356|NCT03326856|76023184|FG004|STARTED|Overall Study||8||
59901357|NCT03326856|76023180|FG000|COMPLETED|Overall Study||12||
59901358|NCT03326856|76023181|FG001|COMPLETED|Overall Study||8||
59901359|NCT03326856|76023182|FG002|COMPLETED|Overall Study||9||
59901360|NCT03326856|76023183|FG003|COMPLETED|Overall Study||9||
59901361|NCT03326856|76023184|FG004|COMPLETED|Overall Study||8||
59901362|NCT03326856|76023180|FG000|NOT COMPLETED|Overall Study||1||
59901363|NCT03326856|76023181|FG001|NOT COMPLETED|Overall Study||1||
59901364|NCT03326856|76023182|FG002|NOT COMPLETED|Overall Study||0||
59901365|NCT03326856|76023183|FG003|NOT COMPLETED|Overall Study||0||
59901366|NCT03326856|76023184|FG004|NOT COMPLETED|Overall Study||0||
59901367|NCT03309696|76023198|FG000|STARTED|Overall Study|All five subjects in this arm were randomize to all sham and active tDCS and rTMS interventions.|5||
59901368|NCT03309696|76023199|FG001|STARTED|Overall Study|All five subjects in this arm were randomize to all sham and active tDCS and rTMS interventions.|5||
59901369|NCT03309696|76023200|FG002|STARTED|Overall Study||0||
59901370|NCT03309696|76023201|FG003|STARTED|Overall Study||0||
59901371|NCT03309696|76023198|FG000|COMPLETED|Overall Study||5||
59901372|NCT03309696|76023199|FG001|COMPLETED|Overall Study||0||
59901373|NCT03309696|76023200|FG002|COMPLETED|Overall Study||0||
59901374|NCT03309696|76023201|FG003|COMPLETED|Overall Study||0||
59901375|NCT03309696|76023198|FG000|NOT COMPLETED|Overall Study||0||
59901376|NCT03309696|76023199|FG001|NOT COMPLETED|Overall Study||5||
59901377|NCT03309696|76023200|FG002|NOT COMPLETED|Overall Study||0||
59901378|NCT03309696|76023201|FG003|NOT COMPLETED|Overall Study||0||
59901379|NCT03294330|76023209|FG000|STARTED|Overall Study||35||
59901380|NCT03294330|76023209|FG000|COMPLETED|Overall Study||35||
59901381|NCT03294330|76023209|FG000|NOT COMPLETED|Overall Study||0||
59901382|NCT03075644|76023215|FG000|STARTED|Overall Study||16||
59901383|NCT03075644|76023216|FG001|STARTED|Overall Study||46||
59757478|NCT02340169|75876587|FG000|NOT COMPLETED|Overall Study||23||
59757479|NCT03481907|75876596|FG000|STARTED|Overall Study||8||16
59757480|NCT03481907|75876596|FG000|Two Biopsies One on Each Thigh at Day 0 With Photo IHC and Histopathological Processing|Overall Study||8||16
59757481|NCT03481907|75876596|FG000|One Biopsy Wound Managed With Primary Closure|Overall Study||8||8
59901384|NCT03075644|76023215|FG000|Full Analysis Set (FAS)|Overall Study||16||
59901385|NCT03075644|76023216|FG001|Full Analysis Set (FAS)|Overall Study||46||
59901386|NCT03075644|76023215|FG000|Safety Analysis Set (SAS)|Overall Study||16||
59901387|NCT03075644|76023216|FG001|Safety Analysis Set (SAS)|Overall Study||46||
59901388|NCT03075644|76023215|FG000|COMPLETED|Overall Study||15||
59901389|NCT03075644|76023216|FG001|COMPLETED|Overall Study||45||
59901390|NCT03075644|76023215|FG000|NOT COMPLETED|Overall Study||1||
59901391|NCT03075644|76023216|FG001|NOT COMPLETED|Overall Study||1||
59901392|NCT03075410|76023232|FG000|STARTED|Part A-Period 1 (14 Days)||2||
59901393|NCT03075410|76023233|FG001|STARTED|Part A-Period 1 (14 Days)||1||
59901394|NCT03075410|76023234|FG002|STARTED|Part A-Period 1 (14 Days)||2||
59901395|NCT03075410|76023235|FG003|STARTED|Part A-Period 1 (14 Days)||1||
59901396|NCT03075410|76023236|FG004|STARTED|Part A-Period 1 (14 Days)||2||
59901397|NCT03075410|76023237|FG005|STARTED|Part A-Period 1 (14 Days)||1||
59901398|NCT03075410|76023238|FG006|STARTED|Part A-Period 1 (14 Days)||0||
59901399|NCT03075410|76023239|FG007|STARTED|Part A-Period 1 (14 Days)||0||
59901400|NCT03075410|76023240|FG008|STARTED|Part A-Period 1 (14 Days)||0||
59901401|NCT03075410|76023232|FG000|COMPLETED|Part A-Period 1 (14 Days)||2||
59901402|NCT03075410|76023233|FG001|COMPLETED|Part A-Period 1 (14 Days)||1||
59901403|NCT03075410|76023234|FG002|COMPLETED|Part A-Period 1 (14 Days)||2||
59901404|NCT03075410|76023235|FG003|COMPLETED|Part A-Period 1 (14 Days)||1||
59901405|NCT03075410|76023236|FG004|COMPLETED|Part A-Period 1 (14 Days)||2||
59901406|NCT03075410|76023237|FG005|COMPLETED|Part A-Period 1 (14 Days)||1||
59901407|NCT03075410|76023238|FG006|COMPLETED|Part A-Period 1 (14 Days)||0||
59901408|NCT03075410|76023239|FG007|COMPLETED|Part A-Period 1 (14 Days)||0||
59901409|NCT03075410|76023240|FG008|COMPLETED|Part A-Period 1 (14 Days)||0||
59901410|NCT03075410|76023232|FG000|NOT COMPLETED|Part A-Period 1 (14 Days)||0||
59901411|NCT03075410|76023233|FG001|NOT COMPLETED|Part A-Period 1 (14 Days)||0||
59901412|NCT03075410|76023234|FG002|NOT COMPLETED|Part A-Period 1 (14 Days)||0||
59901413|NCT03075410|76023235|FG003|NOT COMPLETED|Part A-Period 1 (14 Days)||0||
59901414|NCT03075410|76023236|FG004|NOT COMPLETED|Part A-Period 1 (14 Days)||0||
59901415|NCT03075410|76023237|FG005|NOT COMPLETED|Part A-Period 1 (14 Days)||0||
59901416|NCT03075410|76023238|FG006|NOT COMPLETED|Part A-Period 1 (14 Days)||0||
59901417|NCT03075410|76023239|FG007|NOT COMPLETED|Part A-Period 1 (14 Days)||0||
59901418|NCT03075410|76023240|FG008|NOT COMPLETED|Part A-Period 1 (14 Days)||0||
59901419|NCT03075410|76023232|FG000|STARTED|Part A-Washout Period 1 (14 Days)||2||
59901420|NCT03075410|76023233|FG001|STARTED|Part A-Washout Period 1 (14 Days)||1||
59901421|NCT03075410|76023234|FG002|STARTED|Part A-Washout Period 1 (14 Days)||2||
59901422|NCT03075410|76023235|FG003|STARTED|Part A-Washout Period 1 (14 Days)||1||
59901423|NCT03075410|76023236|FG004|STARTED|Part A-Washout Period 1 (14 Days)||2||
59901424|NCT03075410|76023237|FG005|STARTED|Part A-Washout Period 1 (14 Days)||1||
59901425|NCT03075410|76023238|FG006|STARTED|Part A-Washout Period 1 (14 Days)||0||
59901426|NCT03075410|76023239|FG007|STARTED|Part A-Washout Period 1 (14 Days)||0||
59901427|NCT03075410|76023240|FG008|STARTED|Part A-Washout Period 1 (14 Days)||0||
59901428|NCT03075410|76023232|FG000|COMPLETED|Part A-Washout Period 1 (14 Days)||2||
59901429|NCT03075410|76023233|FG001|COMPLETED|Part A-Washout Period 1 (14 Days)||1||
59901430|NCT03075410|76023234|FG002|COMPLETED|Part A-Washout Period 1 (14 Days)||2||
59901431|NCT03075410|76023235|FG003|COMPLETED|Part A-Washout Period 1 (14 Days)||1||
59901432|NCT03075410|76023236|FG004|COMPLETED|Part A-Washout Period 1 (14 Days)||2||
59901433|NCT03075410|76023237|FG005|COMPLETED|Part A-Washout Period 1 (14 Days)||1||
59901434|NCT03075410|76023238|FG006|COMPLETED|Part A-Washout Period 1 (14 Days)||0||
59901435|NCT03075410|76023239|FG007|COMPLETED|Part A-Washout Period 1 (14 Days)||0||
59901436|NCT03075410|76023240|FG008|COMPLETED|Part A-Washout Period 1 (14 Days)||0||
59901437|NCT03075410|76023232|FG000|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0||
59901438|NCT03075410|76023233|FG001|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0||
59901439|NCT03075410|76023234|FG002|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0||
59901440|NCT03075410|76023235|FG003|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0||
59901441|NCT03075410|76023236|FG004|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0||
59901442|NCT03075410|76023237|FG005|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0||
59901443|NCT03075410|76023238|FG006|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0||
59901444|NCT03075410|76023239|FG007|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0||
59901445|NCT03075410|76023240|FG008|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0||
59901446|NCT03075410|76023232|FG000|STARTED|Part A-Period 2 (14 Days)||2||
59901447|NCT03075410|76023233|FG001|STARTED|Part A-Period 2 (14 Days)||1||
59901448|NCT03075410|76023234|FG002|STARTED|Part A-Period 2 (14 Days)||2||
59901449|NCT03075410|76023235|FG003|STARTED|Part A-Period 2 (14 Days)||1||
59901450|NCT03075410|76023236|FG004|STARTED|Part A-Period 2 (14 Days)||2||
59901451|NCT03075410|76023237|FG005|STARTED|Part A-Period 2 (14 Days)||1||
59901452|NCT03075410|76023238|FG006|STARTED|Part A-Period 2 (14 Days)||0||
59901453|NCT03075410|76023239|FG007|STARTED|Part A-Period 2 (14 Days)||0||
59901454|NCT03075410|76023240|FG008|STARTED|Part A-Period 2 (14 Days)||0||
59901455|NCT03075410|76023232|FG000|COMPLETED|Part A-Period 2 (14 Days)||1||
59901456|NCT03075410|76023233|FG001|COMPLETED|Part A-Period 2 (14 Days)||1||
59901457|NCT03075410|76023234|FG002|COMPLETED|Part A-Period 2 (14 Days)||1||
59901458|NCT03075410|76023235|FG003|COMPLETED|Part A-Period 2 (14 Days)||1||
59901459|NCT03075410|76023236|FG004|COMPLETED|Part A-Period 2 (14 Days)||2||
59901460|NCT03075410|76023237|FG005|COMPLETED|Part A-Period 2 (14 Days)||1||
59901461|NCT03075410|76023238|FG006|COMPLETED|Part A-Period 2 (14 Days)||0||
59901462|NCT03075410|76023239|FG007|COMPLETED|Part A-Period 2 (14 Days)||0||
59901463|NCT03075410|76023240|FG008|COMPLETED|Part A-Period 2 (14 Days)||0||
59901464|NCT03075410|76023232|FG000|NOT COMPLETED|Part A-Period 2 (14 Days)||1||
59901465|NCT03075410|76023233|FG001|NOT COMPLETED|Part A-Period 2 (14 Days)||0||
59901466|NCT03075410|76023234|FG002|NOT COMPLETED|Part A-Period 2 (14 Days)||1||
59901467|NCT03075410|76023235|FG003|NOT COMPLETED|Part A-Period 2 (14 Days)||0||
59901468|NCT03075410|76023236|FG004|NOT COMPLETED|Part A-Period 2 (14 Days)||0||
59901469|NCT03075410|76023237|FG005|NOT COMPLETED|Part A-Period 2 (14 Days)||0||
59901470|NCT03075410|76023238|FG006|NOT COMPLETED|Part A-Period 2 (14 Days)||0||
59901471|NCT03075410|76023239|FG007|NOT COMPLETED|Part A-Period 2 (14 Days)||0||
59901472|NCT03075410|76023240|FG008|NOT COMPLETED|Part A-Period 2 (14 Days)||0||
59901473|NCT03075410|76023232|FG000|STARTED|Part A-Washout Period 2 (14 Days)||1||
59901474|NCT03075410|76023233|FG001|STARTED|Part A-Washout Period 2 (14 Days)||1||
59901475|NCT03075410|76023234|FG002|STARTED|Part A-Washout Period 2 (14 Days)||1||
59901476|NCT03075410|76023235|FG003|STARTED|Part A-Washout Period 2 (14 Days)||1||
59901477|NCT03075410|76023236|FG004|STARTED|Part A-Washout Period 2 (14 Days)||2||
59901478|NCT03075410|76023237|FG005|STARTED|Part A-Washout Period 2 (14 Days)||1||
59901479|NCT03075410|76023238|FG006|STARTED|Part A-Washout Period 2 (14 Days)||0||
59901480|NCT03075410|76023239|FG007|STARTED|Part A-Washout Period 2 (14 Days)||0||
59901481|NCT03075410|76023240|FG008|STARTED|Part A-Washout Period 2 (14 Days)||0||
59901482|NCT03075410|76023232|FG000|COMPLETED|Part A-Washout Period 2 (14 Days)||1||
59901483|NCT03075410|76023233|FG001|COMPLETED|Part A-Washout Period 2 (14 Days)||1||
59901484|NCT03075410|76023234|FG002|COMPLETED|Part A-Washout Period 2 (14 Days)||1||
59901485|NCT03075410|76023235|FG003|COMPLETED|Part A-Washout Period 2 (14 Days)||1||
59901486|NCT03075410|76023236|FG004|COMPLETED|Part A-Washout Period 2 (14 Days)||2||
59901487|NCT03075410|76023237|FG005|COMPLETED|Part A-Washout Period 2 (14 Days)||1||
59901488|NCT03075410|76023238|FG006|COMPLETED|Part A-Washout Period 2 (14 Days)||0||
59901489|NCT03075410|76023239|FG007|COMPLETED|Part A-Washout Period 2 (14 Days)||0||
59901490|NCT03075410|76023240|FG008|COMPLETED|Part A-Washout Period 2 (14 Days)||0||
59901491|NCT03075410|76023232|FG000|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0||
59901492|NCT03075410|76023233|FG001|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0||
59901493|NCT03075410|76023234|FG002|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0||
59901494|NCT03075410|76023235|FG003|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0||
59901495|NCT03075410|76023236|FG004|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0||
59901496|NCT03075410|76023237|FG005|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0||
59901497|NCT03075410|76023238|FG006|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0||
59901498|NCT03075410|76023239|FG007|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0||
59901499|NCT03075410|76023240|FG008|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0||
59901500|NCT03075410|76023232|FG000|STARTED|Part A-Period 3 (14 Days)|Participants who withdrew in Period 2 were replaced (2 new participants entered Part A period 3).|2||
59901501|NCT03075410|76023233|FG001|STARTED|Part A-Period 3 (14 Days)||1||
59901502|NCT03075410|76023234|FG002|STARTED|Part A-Period 3 (14 Days)|Participants who withdrew in Period 2 were replaced (2 new participants entered Part A period 3).|2||
59901503|NCT03075410|76023235|FG003|STARTED|Part A-Period 3 (14 Days)||1||
59901504|NCT03075410|76023236|FG004|STARTED|Part A-Period 3 (14 Days)||2||
59901505|NCT03075410|76023237|FG005|STARTED|Part A-Period 3 (14 Days)||1||
59901506|NCT03075410|76023238|FG006|STARTED|Part A-Period 3 (14 Days)||0||
59901507|NCT03075410|76023239|FG007|STARTED|Part A-Period 3 (14 Days)||0||
59901508|NCT03075410|76023240|FG008|STARTED|Part A-Period 3 (14 Days)||0||
59901509|NCT03075410|76023232|FG000|COMPLETED|Part A-Period 3 (14 Days)||1||
59901510|NCT03075410|76023233|FG001|COMPLETED|Part A-Period 3 (14 Days)||1||
59901511|NCT03075410|76023234|FG002|COMPLETED|Part A-Period 3 (14 Days)||2||
59901512|NCT03075410|76023235|FG003|COMPLETED|Part A-Period 3 (14 Days)||1||
59901513|NCT03075410|76023236|FG004|COMPLETED|Part A-Period 3 (14 Days)||2||
59901514|NCT03075410|76023237|FG005|COMPLETED|Part A-Period 3 (14 Days)||1||
59901515|NCT03075410|76023238|FG006|COMPLETED|Part A-Period 3 (14 Days)||0||
59901516|NCT03075410|76023239|FG007|COMPLETED|Part A-Period 3 (14 Days)||0||
59901517|NCT03075410|76023240|FG008|COMPLETED|Part A-Period 3 (14 Days)||0||
59901518|NCT03075410|76023232|FG000|NOT COMPLETED|Part A-Period 3 (14 Days)||1||
59901519|NCT03075410|76023233|FG001|NOT COMPLETED|Part A-Period 3 (14 Days)||0||
59901520|NCT03075410|76023234|FG002|NOT COMPLETED|Part A-Period 3 (14 Days)||0||
59901521|NCT03075410|76023235|FG003|NOT COMPLETED|Part A-Period 3 (14 Days)||0||
59901522|NCT03075410|76023236|FG004|NOT COMPLETED|Part A-Period 3 (14 Days)||0||
59901523|NCT03075410|76023237|FG005|NOT COMPLETED|Part A-Period 3 (14 Days)||0||
59901524|NCT03075410|76023238|FG006|NOT COMPLETED|Part A-Period 3 (14 Days)||0||
59901525|NCT03075410|76023239|FG007|NOT COMPLETED|Part A-Period 3 (14 Days)||0||
59901526|NCT03075410|76023240|FG008|NOT COMPLETED|Part A-Period 3 (14 Days)||0||
59901527|NCT03075410|76023232|FG000|STARTED|Part A-Washout Period 3 (14 Days)||1||
59901528|NCT03075410|76023233|FG001|STARTED|Part A-Washout Period 3 (14 Days)||1||
59901529|NCT03075410|76023234|FG002|STARTED|Part A-Washout Period 3 (14 Days)||2||
59901530|NCT03075410|76023235|FG003|STARTED|Part A-Washout Period 3 (14 Days)||1||
59901531|NCT03075410|76023236|FG004|STARTED|Part A-Washout Period 3 (14 Days)||2||
59901532|NCT03075410|76023237|FG005|STARTED|Part A-Washout Period 3 (14 Days)||1||
59901533|NCT03075410|76023238|FG006|STARTED|Part A-Washout Period 3 (14 Days)||0||
59901534|NCT03075410|76023239|FG007|STARTED|Part A-Washout Period 3 (14 Days)||0||
59901535|NCT03075410|76023240|FG008|STARTED|Part A-Washout Period 3 (14 Days)||0||
59901536|NCT03075410|76023232|FG000|COMPLETED|Part A-Washout Period 3 (14 Days)||1||
59901537|NCT03075410|76023233|FG001|COMPLETED|Part A-Washout Period 3 (14 Days)||1||
59901538|NCT03075410|76023234|FG002|COMPLETED|Part A-Washout Period 3 (14 Days)||2||
59901539|NCT03075410|76023235|FG003|COMPLETED|Part A-Washout Period 3 (14 Days)||1||
59901540|NCT03075410|76023236|FG004|COMPLETED|Part A-Washout Period 3 (14 Days)||2||
59901541|NCT03075410|76023237|FG005|COMPLETED|Part A-Washout Period 3 (14 Days)||1||
59901542|NCT03075410|76023238|FG006|COMPLETED|Part A-Washout Period 3 (14 Days)||0||
59901543|NCT03075410|76023239|FG007|COMPLETED|Part A-Washout Period 3 (14 Days)||0||
59901544|NCT03075410|76023240|FG008|COMPLETED|Part A-Washout Period 3 (14 Days)||0||
59901545|NCT03075410|76023232|FG000|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0||
59901546|NCT03075410|76023233|FG001|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0||
59901547|NCT03075410|76023234|FG002|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0||
59901548|NCT03075410|76023235|FG003|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0||
59901549|NCT03075410|76023236|FG004|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0||
59901550|NCT03075410|76023237|FG005|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0||
59901551|NCT03075410|76023238|FG006|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0||
59901552|NCT03075410|76023239|FG007|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0||
59901553|NCT03075410|76023240|FG008|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0||
60067716|NCT01617187|76182894|FG003|NOT COMPLETED|Randomization Through Start Treatment||2||
59901554|NCT03075410|76023232|FG000|STARTED|Part A-Period 4 (14 Days)||1||
59901555|NCT03075410|76023233|FG001|STARTED|Part A-Period 4 (14 Days)||1||
59901556|NCT03075410|76023234|FG002|STARTED|Part A-Period 4 (14 Days)||2||
59901557|NCT03075410|76023235|FG003|STARTED|Part A-Period 4 (14 Days)||1||
59901558|NCT03075410|76023236|FG004|STARTED|Part A-Period 4 (14 Days)||2||
59901559|NCT03075410|76023237|FG005|STARTED|Part A-Period 4 (14 Days)||1||
59901560|NCT03075410|76023238|FG006|STARTED|Part A-Period 4 (14 Days)||0||
59901561|NCT03075410|76023239|FG007|STARTED|Part A-Period 4 (14 Days)||0||
59901562|NCT03075410|76023240|FG008|STARTED|Part A-Period 4 (14 Days)||0||
59901563|NCT03075410|76023232|FG000|COMPLETED|Part A-Period 4 (14 Days)||1||
59901564|NCT03075410|76023233|FG001|COMPLETED|Part A-Period 4 (14 Days)||1||
59901565|NCT03075410|76023234|FG002|COMPLETED|Part A-Period 4 (14 Days)||2||
59901566|NCT03075410|76023235|FG003|COMPLETED|Part A-Period 4 (14 Days)||1||
59901567|NCT03075410|76023236|FG004|COMPLETED|Part A-Period 4 (14 Days)||2||
59901568|NCT03075410|76023237|FG005|COMPLETED|Part A-Period 4 (14 Days)||1||
59901569|NCT03075410|76023238|FG006|COMPLETED|Part A-Period 4 (14 Days)||0||
59901570|NCT03075410|76023239|FG007|COMPLETED|Part A-Period 4 (14 Days)||0||
59901571|NCT03075410|76023240|FG008|COMPLETED|Part A-Period 4 (14 Days)||0||
59901572|NCT03075410|76023232|FG000|NOT COMPLETED|Part A-Period 4 (14 Days)||0||
59901573|NCT03075410|76023233|FG001|NOT COMPLETED|Part A-Period 4 (14 Days)||0||
59901574|NCT03075410|76023234|FG002|NOT COMPLETED|Part A-Period 4 (14 Days)||0||
59901575|NCT03075410|76023235|FG003|NOT COMPLETED|Part A-Period 4 (14 Days)||0||
59901576|NCT03075410|76023236|FG004|NOT COMPLETED|Part A-Period 4 (14 Days)||0||
59901577|NCT03075410|76023237|FG005|NOT COMPLETED|Part A-Period 4 (14 Days)||0||
59901578|NCT03075410|76023238|FG006|NOT COMPLETED|Part A-Period 4 (14 Days)||0||
59901579|NCT03075410|76023239|FG007|NOT COMPLETED|Part A-Period 4 (14 Days)||0||
59901580|NCT03075410|76023240|FG008|NOT COMPLETED|Part A-Period 4 (14 Days)||0||
59901581|NCT03075410|76023232|FG000|STARTED|Part B (up to 28 Days)||0||
59901582|NCT03075410|76023233|FG001|STARTED|Part B (up to 28 Days)||0||
59901583|NCT03075410|76023234|FG002|STARTED|Part B (up to 28 Days)||0||
59901584|NCT03075410|76023235|FG003|STARTED|Part B (up to 28 Days)||0||
59901585|NCT03075410|76023236|FG004|STARTED|Part B (up to 28 Days)||0||
59901586|NCT03075410|76023237|FG005|STARTED|Part B (up to 28 Days)||0||
59901587|NCT03075410|76023238|FG006|STARTED|Part B (up to 28 Days)||4||
59901588|NCT03075410|76023239|FG007|STARTED|Part B (up to 28 Days)||7||
59901589|NCT03075410|76023240|FG008|STARTED|Part B (up to 28 Days)||8||
59901590|NCT03075410|76023232|FG000|COMPLETED|Part B (up to 28 Days)||0||
59901591|NCT03075410|76023233|FG001|COMPLETED|Part B (up to 28 Days)||0||
59901592|NCT03075410|76023234|FG002|COMPLETED|Part B (up to 28 Days)||0||
59901593|NCT03075410|76023235|FG003|COMPLETED|Part B (up to 28 Days)||0||
59901594|NCT03075410|76023236|FG004|COMPLETED|Part B (up to 28 Days)||0||
59901595|NCT03075410|76023237|FG005|COMPLETED|Part B (up to 28 Days)||0||
59901596|NCT03075410|76023238|FG006|COMPLETED|Part B (up to 28 Days)||4||
59901597|NCT03075410|76023239|FG007|COMPLETED|Part B (up to 28 Days)||7||
59901598|NCT03075410|76023240|FG008|COMPLETED|Part B (up to 28 Days)||8||
59901599|NCT03075410|76023232|FG000|NOT COMPLETED|Part B (up to 28 Days)||0||
59901600|NCT03075410|76023233|FG001|NOT COMPLETED|Part B (up to 28 Days)||0||
59901601|NCT03075410|76023234|FG002|NOT COMPLETED|Part B (up to 28 Days)||0||
59901602|NCT03075410|76023235|FG003|NOT COMPLETED|Part B (up to 28 Days)||0||
59901603|NCT03075410|76023236|FG004|NOT COMPLETED|Part B (up to 28 Days)||0||
59901604|NCT03075410|76023237|FG005|NOT COMPLETED|Part B (up to 28 Days)||0||
59901605|NCT03075410|76023238|FG006|NOT COMPLETED|Part B (up to 28 Days)||0||
59901606|NCT03075410|76023239|FG007|NOT COMPLETED|Part B (up to 28 Days)||0||
59901607|NCT03075410|76023240|FG008|NOT COMPLETED|Part B (up to 28 Days)||0||
59901608|NCT00614432|76023266|FG000|STARTED|Overall Study||4||
59901609|NCT00614432|76023267|FG001|STARTED|Overall Study||6||
59901610|NCT00614432|76023266|FG000|COMPLETED|Overall Study||4||
59901611|NCT00614432|76023267|FG001|COMPLETED|Overall Study||6||
59901612|NCT00614432|76023266|FG000|NOT COMPLETED|Overall Study||0||
59901613|NCT00614432|76023267|FG001|NOT COMPLETED|Overall Study||0||
59901614|NCT02121158|76023275|FG000|STARTED|Overall Study||85||
59901615|NCT02121158|76023276|FG001|STARTED|Overall Study||82||
59901616|NCT02121158|76023275|FG000|COMPLETED|Overall Study||85||
59901617|NCT02121158|76023276|FG001|COMPLETED|Overall Study||82||
59901618|NCT02121158|76023275|FG000|NOT COMPLETED|Overall Study||0||
59901619|NCT02121158|76023276|FG001|NOT COMPLETED|Overall Study||0||
59901620|NCT03071276|76023282|FG000|STARTED|Overall Study||37||
59901621|NCT03071276|76023282|FG000|COMPLETED|Overall Study||22||
59901622|NCT03071276|76023282|FG000|NOT COMPLETED|Overall Study||15||
59901623|NCT03074162|76023292|FG000|STARTED|Period 1 Including Washout 1||8||
59901624|NCT03074162|76023293|FG001|STARTED|Period 1 Including Washout 1||8||
59901625|NCT03074162|76023294|FG002|STARTED|Period 1 Including Washout 1||8||
59901626|NCT03074162|76023295|FG003|STARTED|Period 1 Including Washout 1||8||
59901627|NCT03074162|76023296|FG004|STARTED|Period 1 Including Washout 1||8||
59901628|NCT03074162|76023297|FG005|STARTED|Period 1 Including Washout 1||8||
59901629|NCT03074162|76023292|FG000|COMPLETED|Period 1 Including Washout 1||8||
59901630|NCT03074162|76023293|FG001|COMPLETED|Period 1 Including Washout 1||8||
59901631|NCT03074162|76023294|FG002|COMPLETED|Period 1 Including Washout 1||7||
59901632|NCT03074162|76023295|FG003|COMPLETED|Period 1 Including Washout 1||8||
59901633|NCT03074162|76023296|FG004|COMPLETED|Period 1 Including Washout 1||8||
59901634|NCT03074162|76023297|FG005|COMPLETED|Period 1 Including Washout 1||8||
59901635|NCT03074162|76023292|FG000|NOT COMPLETED|Period 1 Including Washout 1||0||
59901636|NCT03074162|76023293|FG001|NOT COMPLETED|Period 1 Including Washout 1||0||
59901637|NCT03074162|76023294|FG002|NOT COMPLETED|Period 1 Including Washout 1||1||
59901638|NCT03074162|76023295|FG003|NOT COMPLETED|Period 1 Including Washout 1||0||
59901639|NCT03074162|76023296|FG004|NOT COMPLETED|Period 1 Including Washout 1||0||
59901640|NCT03074162|76023297|FG005|NOT COMPLETED|Period 1 Including Washout 1||0||
59901641|NCT03074162|76023292|FG000|STARTED|Period 2 Including Washout 2||8||
59901642|NCT03074162|76023293|FG001|STARTED|Period 2 Including Washout 2||8||
59901643|NCT03074162|76023294|FG002|STARTED|Period 2 Including Washout 2||7||
59901644|NCT03074162|76023295|FG003|STARTED|Period 2 Including Washout 2||8||
59901645|NCT03074162|76023296|FG004|STARTED|Period 2 Including Washout 2||8||
59901646|NCT03074162|76023297|FG005|STARTED|Period 2 Including Washout 2||8||
59901647|NCT03074162|76023292|FG000|COMPLETED|Period 2 Including Washout 2||8||
59901648|NCT03074162|76023293|FG001|COMPLETED|Period 2 Including Washout 2||8||
59901649|NCT03074162|76023294|FG002|COMPLETED|Period 2 Including Washout 2||6||
59901650|NCT03074162|76023295|FG003|COMPLETED|Period 2 Including Washout 2||8||
59901651|NCT03074162|76023296|FG004|COMPLETED|Period 2 Including Washout 2||8||
59901652|NCT03074162|76023297|FG005|COMPLETED|Period 2 Including Washout 2||7||
59901653|NCT03074162|76023292|FG000|NOT COMPLETED|Period 2 Including Washout 2||0||
59901654|NCT03074162|76023293|FG001|NOT COMPLETED|Period 2 Including Washout 2||0||
59901655|NCT03074162|76023294|FG002|NOT COMPLETED|Period 2 Including Washout 2||1||
59901656|NCT03074162|76023295|FG003|NOT COMPLETED|Period 2 Including Washout 2||0||
59901657|NCT03074162|76023296|FG004|NOT COMPLETED|Period 2 Including Washout 2||0||
59901658|NCT03074162|76023297|FG005|NOT COMPLETED|Period 2 Including Washout 2||1||
59901659|NCT03074162|76023292|FG000|STARTED|Period 3||8||
59901660|NCT03074162|76023293|FG001|STARTED|Period 3||8||
59901661|NCT03074162|76023294|FG002|STARTED|Period 3||6||
59901662|NCT03074162|76023295|FG003|STARTED|Period 3||8||
59901663|NCT03074162|76023296|FG004|STARTED|Period 3||8||
59901664|NCT03074162|76023297|FG005|STARTED|Period 3||7||
59901665|NCT03074162|76023292|FG000|COMPLETED|Period 3||7||
59901666|NCT03074162|76023293|FG001|COMPLETED|Period 3||8||
59901667|NCT03074162|76023294|FG002|COMPLETED|Period 3||6||
59901668|NCT03074162|76023295|FG003|COMPLETED|Period 3||8||
59901669|NCT03074162|76023296|FG004|COMPLETED|Period 3||7||
59901670|NCT03074162|76023297|FG005|COMPLETED|Period 3||7||
59901671|NCT03074162|76023292|FG000|NOT COMPLETED|Period 3||1||
59901672|NCT03074162|76023293|FG001|NOT COMPLETED|Period 3||0||
59901673|NCT03074162|76023294|FG002|NOT COMPLETED|Period 3||0||
59901674|NCT03074162|76023295|FG003|NOT COMPLETED|Period 3||0||
59901675|NCT03074162|76023296|FG004|NOT COMPLETED|Period 3||1||
60014410|NCT02456727|76130494|FG000|STARTED|Overall Study||389|Participants who were baselined and completed an oral consent.|
59901676|NCT03074162|76023297|FG005|NOT COMPLETED|Period 3||0||
59901677|NCT03070964|76023305|FG000|STARTED|Overall Study||14||
59901678|NCT03070964|76023305|FG000|COMPLETED|Overall Study||0||
59901679|NCT03070964|76023305|FG000|NOT COMPLETED|Overall Study||14||
59901680|NCT02888106|76023315|FG000|STARTED|Overall Study||15||
59901681|NCT02888106|76023316|FG001|STARTED|Overall Study||15||
59901682|NCT02888106|76023317|FG002|STARTED|Overall Study||15||
59901683|NCT02888106|76023318|FG003|STARTED|Overall Study||15||
59901684|NCT02888106|76023319|FG004|STARTED|Overall Study||15||
59901685|NCT02888106|76023320|FG005|STARTED|Overall Study||15||
59901686|NCT02888106|76023315|FG000|COMPLETED|Overall Study||10||
59901687|NCT02888106|76023316|FG001|COMPLETED|Overall Study||13||
59901688|NCT02888106|76023317|FG002|COMPLETED|Overall Study||15||
59901689|NCT02888106|76023318|FG003|COMPLETED|Overall Study||13||
59901690|NCT02888106|76023319|FG004|COMPLETED|Overall Study||14||
59901691|NCT02888106|76023320|FG005|COMPLETED|Overall Study||14||
59901692|NCT02888106|76023315|FG000|NOT COMPLETED|Overall Study||5||
59901693|NCT02888106|76023316|FG001|NOT COMPLETED|Overall Study||2||
59901694|NCT02888106|76023317|FG002|NOT COMPLETED|Overall Study||0||
59901695|NCT02888106|76023318|FG003|NOT COMPLETED|Overall Study||2||
59901696|NCT02888106|76023319|FG004|NOT COMPLETED|Overall Study||1||
59901697|NCT02888106|76023320|FG005|NOT COMPLETED|Overall Study||1||
59901698|NCT03304626|76023342|FG000|STARTED|Overall Study||20||
59901699|NCT03304626|76023343|FG001|STARTED|Overall Study||20||
59901700|NCT03304626|76023342|FG000|COMPLETED|Overall Study||18||
59901701|NCT03304626|76023343|FG001|COMPLETED|Overall Study||19||
59901702|NCT03304626|76023342|FG000|NOT COMPLETED|Overall Study||2||
59901703|NCT03304626|76023343|FG001|NOT COMPLETED|Overall Study||1||
59901704|NCT03274986|76023352|FG000|STARTED|Overall Study||107|All subjects with attempted implantation, as treated.|
59901705|NCT03274986|76023353|FG001|STARTED|Overall Study||113|All subjects with attempted implantation, as treated.|
59901706|NCT03274986|76023352|FG000|Successful Implantation, as Treated|Overall Study||107||
59901707|NCT03274986|76023353|FG001|Successful Implantation, as Treated|Overall Study||113||
59901708|NCT03274986|76023352|FG000|COMPLETED|Overall Study||107||
59901709|NCT03274986|76023353|FG001|COMPLETED|Overall Study||111||
59901710|NCT03274986|76023352|FG000|NOT COMPLETED|Overall Study||0||
59901711|NCT03274986|76023353|FG001|NOT COMPLETED|Overall Study||2||
59901712|NCT02919306|76023368|FG000|STARTED|Overall Study||18||
59901713|NCT02919306|76023369|FG001|STARTED|Overall Study||9||
59901714|NCT02919306|76023368|FG000|COMPLETED|Overall Study||16||
59901715|NCT02919306|76023369|FG001|COMPLETED|Overall Study||9||
59901716|NCT02919306|76023368|FG000|NOT COMPLETED|Overall Study||2||
59901717|NCT02919306|76023369|FG001|NOT COMPLETED|Overall Study||0||
60014411|NCT02456727|76130495|FG001|STARTED|Overall Study||390|Participants who were baselined and completed an oral consent.|
59901718|NCT03274440|76023375|FG000|STARTED|Overall Study||3||
59901719|NCT03274440|76023376|FG001|STARTED|Overall Study||2||
59901720|NCT03274440|76023377|FG002|STARTED|Overall Study||4||
59901721|NCT03274440|76023378|FG003|STARTED|Overall Study||1||
59901722|NCT03274440|76023379|FG004|STARTED|Overall Study||1||
59901723|NCT03274440|76023380|FG005|STARTED|Overall Study||3||
59901724|NCT03274440|76023375|FG000|COMPLETED|Overall Study||2||
59901725|NCT03274440|76023376|FG001|COMPLETED|Overall Study||2||
59901726|NCT03274440|76023377|FG002|COMPLETED|Overall Study||4||
59901727|NCT03274440|76023378|FG003|COMPLETED|Overall Study||0||
59901728|NCT03274440|76023379|FG004|COMPLETED|Overall Study||1||
59901729|NCT03274440|76023380|FG005|COMPLETED|Overall Study||3||
59901730|NCT03274440|76023375|FG000|NOT COMPLETED|Overall Study||1||
59901731|NCT03274440|76023376|FG001|NOT COMPLETED|Overall Study||0||
59901732|NCT03274440|76023377|FG002|NOT COMPLETED|Overall Study||0||
59901733|NCT03274440|76023378|FG003|NOT COMPLETED|Overall Study||1||
59901734|NCT03274440|76023379|FG004|NOT COMPLETED|Overall Study||0||
59901735|NCT03274440|76023380|FG005|NOT COMPLETED|Overall Study||0||
59901736|NCT03268746|76023388|FG000|STARTED|Overall Study||45|Attempted Implantation|
59901737|NCT03268746|76023388|FG000|COMPLETED|Overall Study||44||
59901738|NCT03268746|76023388|FG000|NOT COMPLETED|Overall Study||1||
59901739|NCT03268590|76023399|FG000|STARTED|Overall Study||33||
59757482|NCT03481907|75876596|FG000|Other One Biopsy Wound Managed With Topical Collagen Powder for 4 Weeks|Overall Study||8||8
59901740|NCT03268590|76023399|FG000|COMPLETED|Overall Study|One participant did not complete MRI due to a previously undiagnosed subdermal metal shard in scalp.|32||
59505861|NCT01276223|75598775|FG002|COMPLETED|Overall Study||101||
59901741|NCT03268590|76023399|FG000|NOT COMPLETED|Overall Study||1||
59901742|NCT03267576|76023408|FG000|STARTED|Period 1: Day 0 to 27||31||
59901743|NCT03267576|76023409|FG001|STARTED|Period 1: Day 0 to 27||32||
59901744|NCT03267576|76023408|FG000|COMPLETED|Period 1: Day 0 to 27||31||
59901745|NCT03267576|76023409|FG001|COMPLETED|Period 1: Day 0 to 27||32||
59901746|NCT03267576|76023408|FG000|NOT COMPLETED|Period 1: Day 0 to 27||0||
59505862|NCT01276223|75598773|FG000|NOT COMPLETED|Overall Study||11||
59901747|NCT03267576|76023409|FG001|NOT COMPLETED|Period 1: Day 0 to 27||0||
59901748|NCT03267576|76023408|FG000|STARTED|Washout Period: 16 Days||31||
59901749|NCT03267576|76023409|FG001|STARTED|Washout Period: 16 Days||32||
59901750|NCT03267576|76023408|FG000|COMPLETED|Washout Period: 16 Days||31||
59901751|NCT03267576|76023409|FG001|COMPLETED|Washout Period: 16 Days||32||
59901752|NCT03267576|76023408|FG000|NOT COMPLETED|Washout Period: 16 Days||0||
59901753|NCT03267576|76023409|FG001|NOT COMPLETED|Washout Period: 16 Days||0||
59901754|NCT03267576|76023408|FG000|STARTED|Period 2: Day 44 to 71||31||
59901755|NCT03267576|76023409|FG001|STARTED|Period 2: Day 44 to 71||32||
59901756|NCT03267576|76023408|FG000|COMPLETED|Period 2: Day 44 to 71||30||
59901757|NCT03267576|76023409|FG001|COMPLETED|Period 2: Day 44 to 71||30||
59901758|NCT03267576|76023408|FG000|NOT COMPLETED|Period 2: Day 44 to 71||1||
59901759|NCT03267576|76023409|FG001|NOT COMPLETED|Period 2: Day 44 to 71||2||
59901760|NCT03267264|76023419|FG000|STARTED|Overall Study||66||
59901761|NCT03267264|76023420|FG001|STARTED|Overall Study||49||
59901762|NCT03267264|76023421|FG002|STARTED|Overall Study||68||
59901763|NCT03267264|76023422|FG003|STARTED|Overall Study||65||
59901764|NCT03267264|76023419|FG000|Sequence A(Nucleus)|Overall Study||34||
59901765|NCT03267264|76023420|FG001|Sequence A(Nucleus)|Overall Study||25||
59901766|NCT03267264|76023421|FG002|Sequence A(Nucleus)|Overall Study||33||
59901767|NCT03267264|76023422|FG003|Sequence A(Nucleus)|Overall Study||33||
59901768|NCT03267264|76023419|FG000|Sequence B(Comparator)|Overall Study||32||
59901769|NCT03267264|76023420|FG001|Sequence B(Comparator)|Overall Study||24||
59901770|NCT03267264|76023421|FG002|Sequence B(Comparator)|Overall Study||33||
59901771|NCT03267264|76023422|FG003|Sequence B(Comparator)|Overall Study||32||
59901772|NCT03267264|76023419|FG000|COMPLETED|Overall Study||65||
59901773|NCT03267264|76023420|FG001|COMPLETED|Overall Study||49||
59901774|NCT03267264|76023421|FG002|COMPLETED|Overall Study||66||
59901775|NCT03267264|76023422|FG003|COMPLETED|Overall Study||61||
59901776|NCT03267264|76023419|FG000|NOT COMPLETED|Overall Study||1||
59901777|NCT03267264|76023420|FG001|NOT COMPLETED|Overall Study||0||
59901778|NCT03267264|76023421|FG002|NOT COMPLETED|Overall Study||2||
59901779|NCT03267264|76023422|FG003|NOT COMPLETED|Overall Study||4||
59901780|NCT03244800|76023439|FG000|STARTED|Overall Study||13||
59901781|NCT03244800|76023440|FG001|STARTED|Overall Study||26||
59901782|NCT03244800|76023441|FG002|STARTED|Overall Study||6||
59901783|NCT03244800|76023442|FG003|STARTED|Overall Study||20||
59901784|NCT03244800|76023439|FG000|COMPLETED|Overall Study||13||
59901785|NCT03244800|76023440|FG001|COMPLETED|Overall Study||25||
59901786|NCT03244800|76023441|FG002|COMPLETED|Overall Study||6||
59901787|NCT03244800|76023442|FG003|COMPLETED|Overall Study||18||
59901788|NCT03244800|76023439|FG000|NOT COMPLETED|Overall Study||0||
59901789|NCT03244800|76023440|FG001|NOT COMPLETED|Overall Study||1||
59901790|NCT03244800|76023441|FG002|NOT COMPLETED|Overall Study||0||
59901791|NCT03244800|76023442|FG003|NOT COMPLETED|Overall Study||2||
59901792|NCT04516291|76023463|FG000|STARTED|Treatment Period (24 Weeks)||44||
59901793|NCT04516291|76023464|FG001|STARTED|Treatment Period (24 Weeks)||23||
59901794|NCT04516291|76023465|FG002|STARTED|Treatment Period (24 Weeks)||24||
59901795|NCT04516291|76023466|FG003|STARTED|Treatment Period (24 Weeks)||23||
59901796|NCT04516291|76023467|FG004|STARTED|Treatment Period (24 Weeks)||45||
59901797|NCT04516291|76023468|FG005|STARTED|Treatment Period (24 Weeks)||45||
59901798|NCT04516291|76023469|FG006|STARTED|Treatment Period (24 Weeks)||46||
59901799|NCT04516291|76023470|FG007|STARTED|Treatment Period (24 Weeks)||36||
59901800|NCT04516291|76023463|FG000|COMPLETED|Treatment Period (24 Weeks)||42||
59901801|NCT04516291|76023464|FG001|COMPLETED|Treatment Period (24 Weeks)||18||
59901802|NCT04516291|76023465|FG002|COMPLETED|Treatment Period (24 Weeks)||20||
59901803|NCT04516291|76023466|FG003|COMPLETED|Treatment Period (24 Weeks)||17||
59901804|NCT04516291|76023467|FG004|COMPLETED|Treatment Period (24 Weeks)||33||
59901805|NCT04516291|76023468|FG005|COMPLETED|Treatment Period (24 Weeks)||37||
59901806|NCT04516291|76023469|FG006|COMPLETED|Treatment Period (24 Weeks)||37||
59901807|NCT04516291|76023470|FG007|COMPLETED|Treatment Period (24 Weeks)||22||
59901808|NCT04516291|76023463|FG000|NOT COMPLETED|Treatment Period (24 Weeks)||2||
59901809|NCT04516291|76023464|FG001|NOT COMPLETED|Treatment Period (24 Weeks)||5||
59901810|NCT04516291|76023465|FG002|NOT COMPLETED|Treatment Period (24 Weeks)||4||
59901811|NCT04516291|76023466|FG003|NOT COMPLETED|Treatment Period (24 Weeks)||6||
59901812|NCT04516291|76023467|FG004|NOT COMPLETED|Treatment Period (24 Weeks)||12||
59901813|NCT04516291|76023468|FG005|NOT COMPLETED|Treatment Period (24 Weeks)||8||
59901814|NCT04516291|76023469|FG006|NOT COMPLETED|Treatment Period (24 Weeks)||9||
59901815|NCT04516291|76023470|FG007|NOT COMPLETED|Treatment Period (24 Weeks)||14||
59901816|NCT04516291|76023463|FG000|STARTED|Follow-up Period (12 Weeks)|Number of participants to start this period may include participants that did not complete treatment period.|44||
59901817|NCT04516291|76023464|FG001|STARTED|Follow-up Period (12 Weeks)|Number of participants to start this period may include participants that did not complete treatment period.|23||
59901818|NCT04516291|76023465|FG002|STARTED|Follow-up Period (12 Weeks)|Number of participants to start this period may include participants that did not complete treatment period.|24||
59901819|NCT04516291|76023466|FG003|STARTED|Follow-up Period (12 Weeks)|Number of participants to start this period may include participants that did not complete treatment period.|23||
59901820|NCT04516291|76023467|FG004|STARTED|Follow-up Period (12 Weeks)|Number of participants to start this period may include participants that did not complete treatment period.|45||
59901821|NCT04516291|76023468|FG005|STARTED|Follow-up Period (12 Weeks)|Number of participants to start this period may include participants that did not complete treatment period.|45||
59901822|NCT04516291|76023469|FG006|STARTED|Follow-up Period (12 Weeks)|Number of participants to start this period may include participants that did not complete treatment period.|46||
59901823|NCT04516291|76023470|FG007|STARTED|Follow-up Period (12 Weeks)|Number of participants to start this period may include participants that did not complete treatment period.|36||
59901824|NCT04516291|76023463|FG000|COMPLETED|Follow-up Period (12 Weeks)||44||
59901825|NCT04516291|76023464|FG001|COMPLETED|Follow-up Period (12 Weeks)||22||
59901826|NCT04516291|76023465|FG002|COMPLETED|Follow-up Period (12 Weeks)||23||
59901827|NCT04516291|76023466|FG003|COMPLETED|Follow-up Period (12 Weeks)||21||
59901828|NCT04516291|76023467|FG004|COMPLETED|Follow-up Period (12 Weeks)||43||
59901829|NCT04516291|76023468|FG005|COMPLETED|Follow-up Period (12 Weeks)||45||
59901830|NCT04516291|76023469|FG006|COMPLETED|Follow-up Period (12 Weeks)||46||
59901831|NCT04516291|76023470|FG007|COMPLETED|Follow-up Period (12 Weeks)||36||
59901832|NCT04516291|76023463|FG000|NOT COMPLETED|Follow-up Period (12 Weeks)||0||
59901833|NCT04516291|76023464|FG001|NOT COMPLETED|Follow-up Period (12 Weeks)||1||
59901834|NCT04516291|76023465|FG002|NOT COMPLETED|Follow-up Period (12 Weeks)||1||
59901835|NCT04516291|76023466|FG003|NOT COMPLETED|Follow-up Period (12 Weeks)||2||
59901836|NCT04516291|76023467|FG004|NOT COMPLETED|Follow-up Period (12 Weeks)||2||
59901837|NCT04516291|76023468|FG005|NOT COMPLETED|Follow-up Period (12 Weeks)||0||
59901838|NCT04516291|76023469|FG006|NOT COMPLETED|Follow-up Period (12 Weeks)||0||
59901839|NCT04516291|76023470|FG007|NOT COMPLETED|Follow-up Period (12 Weeks)||0||
59901840|NCT03243630|76023488|FG000|STARTED|Overall Study||24||
59901841|NCT03243630|76023488|FG000|Menthol E-liquid Saline|Overall Study||22||
59757483|NCT03481907|75876596|FG000|Photos of Both Wounds Were Taken at Week 46 With a Ruler in the Frame for Size Calibration|Overall Study||8||16
59757484|NCT03481907|75876596|FG000|Immunohistochemistry Done at 4 Weeks to Determine Collagen Content by Performing a Second Biopsy|Overall Study||8||16
59901842|NCT03243630|76023488|FG000|Menthol E-liquid Higher|Overall Study||22||
59901843|NCT03243630|76023488|FG000|Menthol E-liquid Lower|Overall Study||22||
59901844|NCT03243630|76023488|FG000|Green Apple E-liquid Saline|Overall Study||20||
59901845|NCT03243630|76023488|FG000|Green Apple E-liquid Higher|Overall Study||20||
59901846|NCT03243630|76023488|FG000|Green Apple E-liquid Lower|Overall Study||20||
59901847|NCT03243630|76023488|FG000|Green Apple and Menthol E-liquid Saline|Overall Study||21||
59901848|NCT03243630|76023488|FG000|Green Apple and Menthol E-liquid Higher|Overall Study||21||
59901849|NCT03243630|76023488|FG000|Green Apple and Menthol E-liquid Lower|Overall Study||21||
59901850|NCT03243630|76023488|FG000|COMPLETED|Overall Study||22||
59901851|NCT03243630|76023488|FG000|NOT COMPLETED|Overall Study||2||
59901852|NCT04450381|76023496|FG000|STARTED|Overall Study||131||
59901853|NCT04450381|76023496|FG000|COMPLETED|Overall Study||125||
59901854|NCT04450381|76023496|FG000|NOT COMPLETED|Overall Study||6||
59901855|NCT03068468|76023502|FG000|STARTED|Placebo-Controlled Period||166||
59901856|NCT03068468|76023503|FG001|STARTED|Placebo-Controlled Period||324||
59901857|NCT03068468|76023504|FG002|STARTED|Placebo-Controlled Period||0||
59901858|NCT03068468|76023505|FG003|STARTED|Placebo-Controlled Period||0||
59901859|NCT03068468|76023502|FG000|Treated|Placebo-Controlled Period||165||
59901860|NCT03068468|76023503|FG001|Treated|Placebo-Controlled Period||321||
59901861|NCT03068468|76023504|FG002|Treated|Placebo-Controlled Period||0||
59901862|NCT03068468|76023505|FG003|Treated|Placebo-Controlled Period||0||
59901863|NCT03068468|76023502|FG000|COMPLETED|Placebo-Controlled Period||144|Participants who completed the study PC period|
59901864|NCT03068468|76023503|FG001|COMPLETED|Placebo-Controlled Period||279|Participants who completed the study PC period|
59505863|NCT01276223|75598774|FG001|NOT COMPLETED|Overall Study||4||
59505864|NCT01276223|75598775|FG002|NOT COMPLETED|Overall Study||3||
59505865|NCT01275833|75598784|FG000|STARTED|Overall Study||1||
59505866|NCT01275833|75598785|FG001|STARTED|Overall Study||1||
59505867|NCT01275833|75598784|FG000|COMPLETED|Overall Study||0||
59505868|NCT01275833|75598785|FG001|COMPLETED|Overall Study||0||
59505869|NCT01275833|75598784|FG000|NOT COMPLETED|Overall Study||1||
59505870|NCT01275833|75598785|FG001|NOT COMPLETED|Overall Study||1||
59505871|NCT01275755|75598793|FG000|STARTED|Run-in Placebo Period||41||
59611374|NCT01780974|75722328|FG001|COMPLETED|Overall Study||18||
59611375|NCT01780974|75722327|FG000|NOT COMPLETED|Overall Study||2||
59611376|NCT01780974|75722328|FG001|NOT COMPLETED|Overall Study||3||
59757485|NCT03481907|75876596|FG000|COMPLETED|Overall Study||8||16
59757486|NCT03481907|75876596|FG000|NOT COMPLETED|Overall Study||0||0
59901865|NCT03068468|76023504|FG002|COMPLETED|Placebo-Controlled Period||0|Participants who completed the study PC period|
59505872|NCT01275755|75598794|FG001|STARTED|Run-in Placebo Period||40||
59505873|NCT01275755|75598793|FG000|COMPLETED|Run-in Placebo Period||41||
59611377|NCT01780662|75722337|FG000|STARTED|Overall Study||3||
59611378|NCT01780662|75722338|FG001|STARTED|Overall Study||13||
59611379|NCT01780662|75722339|FG002|STARTED|Overall Study||30||
59901866|NCT03068468|76023505|FG003|COMPLETED|Placebo-Controlled Period||0|Participants who completed the study PC period|
59901867|NCT03068468|76023502|FG000|NOT COMPLETED|Placebo-Controlled Period||22||
59901868|NCT03068468|76023503|FG001|NOT COMPLETED|Placebo-Controlled Period||45||
59901869|NCT03068468|76023504|FG002|NOT COMPLETED|Placebo-Controlled Period||0||
59901870|NCT03068468|76023505|FG003|NOT COMPLETED|Placebo-Controlled Period||0||
59901871|NCT03068468|76023502|FG000|STARTED|Open-Label Extension Period||0||
59901872|NCT03068468|76023503|FG001|STARTED|Open-Label Extension Period||0||
59901873|NCT03068468|76023504|FG002|STARTED|Open-Label Extension Period|4 participants did not enter OLE period.|140||
59901874|NCT03068468|76023505|FG003|STARTED|Open-Label Extension Period|3 participants did not enter OLE period.|276||
59901875|NCT03068468|76023502|FG000|COMPLETED|Open-Label Extension Period||0||
59901876|NCT03068468|76023503|FG001|COMPLETED|Open-Label Extension Period||0||
59901877|NCT03068468|76023504|FG002|COMPLETED|Open-Label Extension Period||0||
59901878|NCT03068468|76023505|FG003|COMPLETED|Open-Label Extension Period||0||
59901879|NCT03068468|76023502|FG000|NOT COMPLETED|Open-Label Extension Period||0||
59901880|NCT03068468|76023503|FG001|NOT COMPLETED|Open-Label Extension Period||0||
59901881|NCT03068468|76023504|FG002|NOT COMPLETED|Open-Label Extension Period||140||
59901882|NCT03068468|76023505|FG003|NOT COMPLETED|Open-Label Extension Period||276||
59901883|NCT04512001|76023515|FG000|STARTED|Week 0 to Week 24||302||
59901884|NCT04512001|76023516|FG001|STARTED|Week 0 to Week 24||302||
59901885|NCT04512001|76023517|FG002|STARTED|Week 0 to Week 24||0||
59901886|NCT04512001|76023518|FG003|STARTED|Week 0 to Week 24||0||
59901887|NCT04512001|76023519|FG004|STARTED|Week 0 to Week 24||0||
59901888|NCT04512001|76023515|FG000|Received Treatment|Week 0 to Week 24||302||
59901889|NCT04512001|76023516|FG001|Received Treatment|Week 0 to Week 24||302||
59901890|NCT04512001|76023517|FG002|Received Treatment|Week 0 to Week 24||0||
59901891|NCT04512001|76023518|FG003|Received Treatment|Week 0 to Week 24||0||
59901892|NCT04512001|76023519|FG004|Received Treatment|Week 0 to Week 24||0||
59901893|NCT04512001|76023515|FG000|COMPLETED|Week 0 to Week 24||267|Re-randomized at Week 24|
59901894|NCT04512001|76023516|FG001|COMPLETED|Week 0 to Week 24||276|Re-randomized at Week 24|
59901895|NCT04512001|76023517|FG002|COMPLETED|Week 0 to Week 24||0|Re-randomized at Week 24|
59901896|NCT04512001|76023518|FG003|COMPLETED|Week 0 to Week 24||0|Re-randomized at Week 24|
59901897|NCT04512001|76023519|FG004|COMPLETED|Week 0 to Week 24||0|Re-randomized at Week 24|
59901898|NCT04512001|76023515|FG000|NOT COMPLETED|Week 0 to Week 24||35||
59901899|NCT04512001|76023516|FG001|NOT COMPLETED|Week 0 to Week 24||26||
59901900|NCT04512001|76023517|FG002|NOT COMPLETED|Week 0 to Week 24||0||
59901901|NCT04512001|76023518|FG003|NOT COMPLETED|Week 0 to Week 24||0||
59901902|NCT04512001|76023519|FG004|NOT COMPLETED|Week 0 to Week 24||0||
59901903|NCT04512001|76023515|FG000|STARTED|Week 24 to Week 63||0||
59901904|NCT04512001|76023516|FG001|STARTED|Week 24 to Week 63||0||
59901905|NCT04512001|76023517|FG002|STARTED|Week 24 to Week 63||267||
59901906|NCT04512001|76023518|FG003|STARTED|Week 24 to Week 63||139||
59901907|NCT04512001|76023519|FG004|STARTED|Week 24 to Week 63||137||
59901908|NCT04512001|76023515|FG000|Received Treatment|Week 24 to Week 63||0||
59901909|NCT04512001|76023516|FG001|Received Treatment|Week 24 to Week 63||0||
59901910|NCT04512001|76023517|FG002|Received Treatment|Week 24 to Week 63||266||
59901911|NCT04512001|76023518|FG003|Received Treatment|Week 24 to Week 63||139||
59901912|NCT04512001|76023519|FG004|Received Treatment|Week 24 to Week 63||136||
59901913|NCT04512001|76023515|FG000|COMPLETED|Week 24 to Week 63||0||
59901914|NCT04512001|76023516|FG001|COMPLETED|Week 24 to Week 63||0||
59901915|NCT04512001|76023517|FG002|COMPLETED|Week 24 to Week 63||244||
59901916|NCT04512001|76023518|FG003|COMPLETED|Week 24 to Week 63||123||
59901917|NCT04512001|76023519|FG004|COMPLETED|Week 24 to Week 63||122||
59901918|NCT04512001|76023515|FG000|NOT COMPLETED|Week 24 to Week 63||0||
59901919|NCT04512001|76023516|FG001|NOT COMPLETED|Week 24 to Week 63||0||
59901920|NCT04512001|76023517|FG002|NOT COMPLETED|Week 24 to Week 63||23||
59901921|NCT04512001|76023518|FG003|NOT COMPLETED|Week 24 to Week 63||16||
59901922|NCT04512001|76023519|FG004|NOT COMPLETED|Week 24 to Week 63||15||
59901923|NCT04447417|76023534|FG000|STARTED|Overall Study||26||
59901924|NCT04447417|76023535|FG001|STARTED|Overall Study||26||
59901925|NCT04447417|76023534|FG000|COMPLETED|Overall Study||23||
59901926|NCT04447417|76023535|FG001|COMPLETED|Overall Study||26||
59901927|NCT04447417|76023534|FG000|NOT COMPLETED|Overall Study||3||
59901928|NCT04447417|76023535|FG001|NOT COMPLETED|Overall Study||0||
59901929|NCT02787044|76023543|FG000|STARTED|Overall Study||2630|Total Randomized patients|
59901930|NCT02787044|76023544|FG001|STARTED|Overall Study||2630|Total Randomized patients|
59901931|NCT02787044|76023543|FG000|COMPLETED|Overall Study||2615||
59901932|NCT02787044|76023544|FG001|COMPLETED|Overall Study||2611||
59901933|NCT02787044|76023543|FG000|NOT COMPLETED|Overall Study||15||
59901934|NCT02787044|76023544|FG001|NOT COMPLETED|Overall Study||19||
59901935|NCT01345019|76023556|FG000|STARTED|Blinded Treatment Phase||859||
59901936|NCT01345019|76023557|FG001|STARTED|Blinded Treatment Phase||859||
59901937|NCT01345019|76023556|FG000|Received Treatment|Blinded Treatment Phase||852||
59901938|NCT01345019|76023557|FG001|Received Treatment|Blinded Treatment Phase||850||
59901939|NCT01345019|76023556|FG000|COMPLETED|Blinded Treatment Phase||541|Still on-study as of blinded treatment analysis cutoff date of 05 January 2017|
59901940|NCT01345019|76023557|FG001|COMPLETED|Blinded Treatment Phase||555|Still on-study as of blinded treatment analysis cutoff date of 05 January 2017|
59901941|NCT01345019|76023556|FG000|NOT COMPLETED|Blinded Treatment Phase||318||
59901942|NCT01345019|76023557|FG001|NOT COMPLETED|Blinded Treatment Phase||304||
59901943|NCT01345019|76023556|FG000|STARTED|Open Label Treatment Phase||418||
59901944|NCT01345019|76023557|FG001|STARTED|Open Label Treatment Phase||426||
59901945|NCT01345019|76023556|FG000|COMPLETED|Open Label Treatment Phase||227||
59901946|NCT01345019|76023557|FG001|COMPLETED|Open Label Treatment Phase||233||
59901947|NCT01345019|76023556|FG000|NOT COMPLETED|Open Label Treatment Phase||191||
59901948|NCT01345019|76023557|FG001|NOT COMPLETED|Open Label Treatment Phase||193||
59901949|NCT04507867|76023567|FG000|STARTED|Overall Study||40||
59901950|NCT04507867|76023568|FG001|STARTED|Overall Study||40||
59901951|NCT04507867|76023567|FG000|COMPLETED|Overall Study||33||
59901952|NCT04507867|76023568|FG001|COMPLETED|Overall Study||39||
59901953|NCT04507867|76023567|FG000|NOT COMPLETED|Overall Study||7||
59901954|NCT04507867|76023568|FG001|NOT COMPLETED|Overall Study||1||
59901955|NCT03069716|76023592|FG000|STARTED|Run-in Period (2 Weeks)||49||
59901956|NCT03069716|76023593|FG001|STARTED|Run-in Period (2 Weeks)||0||
59901957|NCT03069716|76023594|FG002|STARTED|Run-in Period (2 Weeks)||0||
59901958|NCT03069716|76023592|FG000|COMPLETED|Run-in Period (2 Weeks)||42||
59901959|NCT03069716|76023593|FG001|COMPLETED|Run-in Period (2 Weeks)||0||
59901960|NCT03069716|76023594|FG002|COMPLETED|Run-in Period (2 Weeks)||0||
59901961|NCT03069716|76023592|FG000|NOT COMPLETED|Run-in Period (2 Weeks)||7||
59901962|NCT03069716|76023593|FG001|NOT COMPLETED|Run-in Period (2 Weeks)||0||
59901963|NCT03069716|76023594|FG002|NOT COMPLETED|Run-in Period (2 Weeks)||0||
59901964|NCT03069716|76023592|FG000|STARTED|Randomized Treatment||0||
59901965|NCT03069716|76023593|FG001|STARTED|Randomized Treatment||20||
59901966|NCT03069716|76023594|FG002|STARTED|Randomized Treatment||22||
59901967|NCT03069716|76023592|FG000|COMPLETED|Randomized Treatment||0||
59901968|NCT03069716|76023593|FG001|COMPLETED|Randomized Treatment||18||
59901969|NCT03069716|76023594|FG002|COMPLETED|Randomized Treatment||22||
59901970|NCT03069716|76023592|FG000|NOT COMPLETED|Randomized Treatment||0||
59901971|NCT03069716|76023593|FG001|NOT COMPLETED|Randomized Treatment||2||
59901972|NCT03069716|76023594|FG002|NOT COMPLETED|Randomized Treatment||0||
59901973|NCT05167370|76023601|FG000|STARTED|Overall Study||2||
59901974|NCT05167370|76023601|FG000|COMPLETED|Overall Study||2||
59901975|NCT05167370|76023601|FG000|NOT COMPLETED|Overall Study||0||
59901976|NCT03693625|76023607|FG000|STARTED|Overall Study||23||
59901977|NCT03693625|76023608|FG001|STARTED|Overall Study||8||
59901978|NCT03693625|76023607|FG000|COMPLETED|Overall Study||0||
59901979|NCT03693625|76023608|FG001|COMPLETED|Overall Study||0||
59901980|NCT03693625|76023607|FG000|NOT COMPLETED|Overall Study||23||
59901981|NCT03693625|76023608|FG001|NOT COMPLETED|Overall Study||8||
59901982|NCT01265537|76023616|FG000|STARTED|Overall Study||15||
59901983|NCT01265537|76023617|FG001|STARTED|Overall Study||15||
59901984|NCT01265537|76023616|FG000|COMPLETED|Overall Study||13||
59901985|NCT01265537|76023617|FG001|COMPLETED|Overall Study||13||
59901986|NCT01265537|76023616|FG000|NOT COMPLETED|Overall Study||2||
59901987|NCT01265537|76023617|FG001|NOT COMPLETED|Overall Study||2||
59901988|NCT04396639|76023623|FG000|STARTED|Overall Study||50||
59901989|NCT04396639|76023623|FG000|Completed Follow up|Overall Study||48||
59901990|NCT04396639|76023623|FG000|COMPLETED|Overall Study||48||
59901991|NCT04396639|76023623|FG000|NOT COMPLETED|Overall Study||2||
59901992|NCT04432298|76023629|FG000|STARTED|Overall Study||11||
59901993|NCT04432298|76023630|FG001|STARTED|Overall Study||11||
59901994|NCT04432298|76023629|FG000|Intent-to-Treat (ITT) Population|Overall Study||11|All randomized participants|
60014412|NCT02456727|76130494|FG000|Initiated Treatment|Overall Study||346|Participants who signed the treatment consent form and attended at least one session of acupuncture.|
59757487|NCT01899326|75876603|FG000|STARTED|Overall Study||10||
59757488|NCT01899326|75876603|FG000|COMPLETED|Overall Study||6||
59757489|NCT01899326|75876603|FG000|NOT COMPLETED|Overall Study||4||
59757490|NCT01572480|75876608|FG000|STARTED|Participants Enrolled||55||
59757491|NCT01572480|75876608|FG000|COMPLETED|Participants Enrolled||54||
59901995|NCT04432298|76023630|FG001|Intent-to-Treat (ITT) Population|Overall Study||11|All randomized participants|
59901996|NCT04432298|76023629|FG000|Safety Population|Overall Study||9|Received at least 1 dose of study drug|
59901997|NCT04432298|76023630|FG001|Safety Population|Overall Study||11|Received at least 1 dose of study drug|
59901998|NCT04432298|76023629|FG000|COMPLETED|Overall Study||5||
59901999|NCT04432298|76023630|FG001|COMPLETED|Overall Study||8||
59902000|NCT04432298|76023629|FG000|NOT COMPLETED|Overall Study||6||
59902001|NCT04432298|76023630|FG001|NOT COMPLETED|Overall Study||3||
59902002|NCT04167085|76023638|FG000|STARTED|Baseline||13||
59902003|NCT04167085|76023639|FG001|STARTED|Baseline||13||
59902004|NCT04167085|76023638|FG000|Day 1|Baseline||12||
59902005|NCT04167085|76023639|FG001|Day 1|Baseline||12||
59902006|NCT04167085|76023638|FG000|COMPLETED|Baseline||11||
59902007|NCT04167085|76023639|FG001|COMPLETED|Baseline||12||
59902008|NCT04167085|76023638|FG000|NOT COMPLETED|Baseline||2||
59902009|NCT04167085|76023639|FG001|NOT COMPLETED|Baseline||1||
59902010|NCT04167085|76023638|FG000|STARTED|First Intervention (2 Months)||11||
59902011|NCT04167085|76023639|FG001|STARTED|First Intervention (2 Months)||12||
59757492|NCT01572480|75876608|FG000|NOT COMPLETED|Participants Enrolled||1||
59902012|NCT04167085|76023638|FG000|COMPLETED|First Intervention (2 Months)||11||
59902013|NCT04167085|76023639|FG001|COMPLETED|First Intervention (2 Months)||12||
59902014|NCT04167085|76023638|FG000|NOT COMPLETED|First Intervention (2 Months)||0||
59902015|NCT04167085|76023639|FG001|NOT COMPLETED|First Intervention (2 Months)||0||
59902016|NCT04167085|76023638|FG000|STARTED|Washout (1 Month)||11||
59902017|NCT04167085|76023639|FG001|STARTED|Washout (1 Month)||12||
59902018|NCT04167085|76023638|FG000|COMPLETED|Washout (1 Month)||10||
59902019|NCT04167085|76023639|FG001|COMPLETED|Washout (1 Month)||12||
59902020|NCT04167085|76023638|FG000|NOT COMPLETED|Washout (1 Month)||1||
59902021|NCT04167085|76023639|FG001|NOT COMPLETED|Washout (1 Month)||0||
59902022|NCT04167085|76023638|FG000|STARTED|Second Intervention (2 Months)||10||
59902023|NCT04167085|76023639|FG001|STARTED|Second Intervention (2 Months)||12||
59902024|NCT04167085|76023638|FG000|COMPLETED|Second Intervention (2 Months)||10||
59902025|NCT04167085|76023639|FG001|COMPLETED|Second Intervention (2 Months)||12||
59902026|NCT04167085|76023638|FG000|NOT COMPLETED|Second Intervention (2 Months)||0||
59902027|NCT04167085|76023639|FG001|NOT COMPLETED|Second Intervention (2 Months)||0||
59902028|NCT04167085|76023638|FG000|STARTED|Washout (1 Month)||10||
59902029|NCT04167085|76023639|FG001|STARTED|Washout (1 Month)||12||
59902030|NCT04167085|76023638|FG000|COMPLETED|Washout (1 Month)||10||
59902031|NCT04167085|76023639|FG001|COMPLETED|Washout (1 Month)||12||
59902032|NCT04167085|76023638|FG000|NOT COMPLETED|Washout (1 Month)||0||
59902033|NCT04167085|76023639|FG001|NOT COMPLETED|Washout (1 Month)||0||
59902034|NCT04162795|76023645|FG000|STARTED|Overall Study||468||
59902035|NCT04162795|76023645|FG000|COMPLETED|Overall Study||442||
59902036|NCT04162795|76023645|FG000|NOT COMPLETED|Overall Study||26||
59902037|NCT03069482|76023651|FG000|STARTED|Overall Study||34||
59902038|NCT03069482|76023652|FG001|STARTED|Overall Study||29||
59902039|NCT03069482|76023651|FG000|COMPLETED|Overall Study||33||
59902040|NCT03069482|76023652|FG001|COMPLETED|Overall Study||28||
59902041|NCT03069482|76023651|FG000|NOT COMPLETED|Overall Study||1||
59902042|NCT03069482|76023652|FG001|NOT COMPLETED|Overall Study||1||
59902043|NCT03266172|76023664|FG000|STARTED|Part A: Period 1(2 Days)||16||
59902044|NCT03266172|76023665|FG001|STARTED|Part A: Period 1(2 Days)||0||
59902045|NCT03266172|76023666|FG002|STARTED|Part A: Period 1(2 Days)||0||
59902046|NCT03266172|76023664|FG000|COMPLETED|Part A: Period 1(2 Days)||15||
59902047|NCT03266172|76023665|FG001|COMPLETED|Part A: Period 1(2 Days)||0||
59902048|NCT03266172|76023666|FG002|COMPLETED|Part A: Period 1(2 Days)||0||
59902049|NCT03266172|76023664|FG000|NOT COMPLETED|Part A: Period 1(2 Days)||1||
59902050|NCT03266172|76023665|FG001|NOT COMPLETED|Part A: Period 1(2 Days)||0||
59902051|NCT03266172|76023666|FG002|NOT COMPLETED|Part A: Period 1(2 Days)||0||
59902052|NCT03266172|76023664|FG000|STARTED|Part A: Washout Period (7 Days)||15||
59902053|NCT03266172|76023665|FG001|STARTED|Part A: Washout Period (7 Days)||0||
59902054|NCT03266172|76023666|FG002|STARTED|Part A: Washout Period (7 Days)||0||
59902055|NCT03266172|76023664|FG000|COMPLETED|Part A: Washout Period (7 Days)||13||
59902056|NCT03266172|76023665|FG001|COMPLETED|Part A: Washout Period (7 Days)||0||
59902057|NCT03266172|76023666|FG002|COMPLETED|Part A: Washout Period (7 Days)||0||
59902058|NCT03266172|76023664|FG000|NOT COMPLETED|Part A: Washout Period (7 Days)||2||
59902059|NCT03266172|76023665|FG001|NOT COMPLETED|Part A: Washout Period (7 Days)||0||
59902060|NCT03266172|76023666|FG002|NOT COMPLETED|Part A: Washout Period (7 Days)||0||
59902061|NCT03266172|76023664|FG000|STARTED|Part A: Period 2 (2 Days)||13||
59902062|NCT03266172|76023665|FG001|STARTED|Part A: Period 2 (2 Days)||0||
59902063|NCT03266172|76023666|FG002|STARTED|Part A: Period 2 (2 Days)||0||
59902064|NCT03266172|76023664|FG000|COMPLETED|Part A: Period 2 (2 Days)||13||
59902065|NCT03266172|76023665|FG001|COMPLETED|Part A: Period 2 (2 Days)||0||
59902066|NCT03266172|76023666|FG002|COMPLETED|Part A: Period 2 (2 Days)||0||
59902067|NCT03266172|76023664|FG000|NOT COMPLETED|Part A: Period 2 (2 Days)||0||
59902068|NCT03266172|76023665|FG001|NOT COMPLETED|Part A: Period 2 (2 Days)||0||
59902069|NCT03266172|76023666|FG002|NOT COMPLETED|Part A: Period 2 (2 Days)||0||
59902070|NCT03266172|76023664|FG000|STARTED|Part A: Washout (7 Days)||13||
59902071|NCT03266172|76023665|FG001|STARTED|Part A: Washout (7 Days)||0||
59902072|NCT03266172|76023666|FG002|STARTED|Part A: Washout (7 Days)||0||
59902073|NCT03266172|76023664|FG000|COMPLETED|Part A: Washout (7 Days)||13||
59902074|NCT03266172|76023665|FG001|COMPLETED|Part A: Washout (7 Days)||0||
59902075|NCT03266172|76023666|FG002|COMPLETED|Part A: Washout (7 Days)||0||
59902076|NCT03266172|76023664|FG000|NOT COMPLETED|Part A: Washout (7 Days)||0||
59902077|NCT03266172|76023665|FG001|NOT COMPLETED|Part A: Washout (7 Days)||0||
59902078|NCT03266172|76023666|FG002|NOT COMPLETED|Part A: Washout (7 Days)||0||
59902079|NCT03266172|76023664|FG000|STARTED|Part A: Period 3 (2 Days)|3 replacement participants were enrolled|16||
59902080|NCT03266172|76023665|FG001|STARTED|Part A: Period 3 (2 Days)||0||
59902081|NCT03266172|76023666|FG002|STARTED|Part A: Period 3 (2 Days)||0||
59902082|NCT03266172|76023664|FG000|COMPLETED|Part A: Period 3 (2 Days)||16||
59902083|NCT03266172|76023665|FG001|COMPLETED|Part A: Period 3 (2 Days)||0||
59902084|NCT03266172|76023666|FG002|COMPLETED|Part A: Period 3 (2 Days)||0||
59902085|NCT03266172|76023664|FG000|NOT COMPLETED|Part A: Period 3 (2 Days)||0||
59902086|NCT03266172|76023665|FG001|NOT COMPLETED|Part A: Period 3 (2 Days)||0||
59902087|NCT03266172|76023666|FG002|NOT COMPLETED|Part A: Period 3 (2 Days)||0||
59902088|NCT03266172|76023664|FG000|STARTED|Part A: Washout (7 Days)||16||
59902089|NCT03266172|76023665|FG001|STARTED|Part A: Washout (7 Days)||0||
59902090|NCT03266172|76023666|FG002|STARTED|Part A: Washout (7 Days)||0||
59902091|NCT03266172|76023664|FG000|COMPLETED|Part A: Washout (7 Days)||16||
59902092|NCT03266172|76023665|FG001|COMPLETED|Part A: Washout (7 Days)||0||
59902093|NCT03266172|76023666|FG002|COMPLETED|Part A: Washout (7 Days)||0||
59902094|NCT03266172|76023664|FG000|NOT COMPLETED|Part A: Washout (7 Days)||0||
59902095|NCT03266172|76023665|FG001|NOT COMPLETED|Part A: Washout (7 Days)||0||
59902096|NCT03266172|76023666|FG002|NOT COMPLETED|Part A: Washout (7 Days)||0||
59902097|NCT03266172|76023664|FG000|STARTED|Part A: Period 4 (2 Days)||16||
59902098|NCT03266172|76023665|FG001|STARTED|Part A: Period 4 (2 Days)||0||
59902099|NCT03266172|76023666|FG002|STARTED|Part A: Period 4 (2 Days)||0||
59902100|NCT03266172|76023664|FG000|COMPLETED|Part A: Period 4 (2 Days)||16||
59902101|NCT03266172|76023665|FG001|COMPLETED|Part A: Period 4 (2 Days)||0||
59902102|NCT03266172|76023666|FG002|COMPLETED|Part A: Period 4 (2 Days)||0||
59902103|NCT03266172|76023664|FG000|NOT COMPLETED|Part A: Period 4 (2 Days)||0||
59902104|NCT03266172|76023665|FG001|NOT COMPLETED|Part A: Period 4 (2 Days)||0||
59902105|NCT03266172|76023666|FG002|NOT COMPLETED|Part A: Period 4 (2 Days)||0||
59902106|NCT03266172|76023664|FG000|STARTED|Part B: Period 1 (4 Days)|Participants from Part A did not enter Part B|0||
59902107|NCT03266172|76023665|FG001|STARTED|Part B: Period 1 (4 Days)|New participants were enrolled in Part B of study|10||
59902108|NCT03266172|76023666|FG002|STARTED|Part B: Period 1 (4 Days)||0||
59902109|NCT03266172|76023664|FG000|COMPLETED|Part B: Period 1 (4 Days)||0||
59902110|NCT03266172|76023665|FG001|COMPLETED|Part B: Period 1 (4 Days)||10||
59902111|NCT03266172|76023666|FG002|COMPLETED|Part B: Period 1 (4 Days)||0||
59902112|NCT03266172|76023664|FG000|NOT COMPLETED|Part B: Period 1 (4 Days)||0||
59902113|NCT03266172|76023665|FG001|NOT COMPLETED|Part B: Period 1 (4 Days)||0||
59902114|NCT03266172|76023666|FG002|NOT COMPLETED|Part B: Period 1 (4 Days)||0||
59902115|NCT03266172|76023664|FG000|STARTED|Part B: Washout (7 Days)||0||
59902116|NCT03266172|76023665|FG001|STARTED|Part B: Washout (7 Days)||10||
59902117|NCT03266172|76023666|FG002|STARTED|Part B: Washout (7 Days)||0||
59902118|NCT03266172|76023664|FG000|COMPLETED|Part B: Washout (7 Days)||0||
59902119|NCT03266172|76023665|FG001|COMPLETED|Part B: Washout (7 Days)||10||
59902120|NCT03266172|76023666|FG002|COMPLETED|Part B: Washout (7 Days)||0||
59902121|NCT03266172|76023664|FG000|NOT COMPLETED|Part B: Washout (7 Days)||0||
59902122|NCT03266172|76023665|FG001|NOT COMPLETED|Part B: Washout (7 Days)||0||
59902123|NCT03266172|76023666|FG002|NOT COMPLETED|Part B: Washout (7 Days)||0||
59902124|NCT03266172|76023664|FG000|STARTED|Part B: Period 2 (4 Days)||0||
59902125|NCT03266172|76023665|FG001|STARTED|Part B: Period 2 (4 Days)||10||
59902126|NCT03266172|76023666|FG002|STARTED|Part B: Period 2 (4 Days)||0||
59902127|NCT03266172|76023664|FG000|COMPLETED|Part B: Period 2 (4 Days)||0||
59902128|NCT03266172|76023665|FG001|COMPLETED|Part B: Period 2 (4 Days)||10||
59902129|NCT03266172|76023666|FG002|COMPLETED|Part B: Period 2 (4 Days)||0||
59902130|NCT03266172|76023664|FG000|NOT COMPLETED|Part B: Period 2 (4 Days)||0||
59902131|NCT03266172|76023665|FG001|NOT COMPLETED|Part B: Period 2 (4 Days)||0||
59902132|NCT03266172|76023666|FG002|NOT COMPLETED|Part B: Period 2 (4 Days)||0||
59902133|NCT03266172|76023664|FG000|STARTED|Part B: Washout (7 Days)||0||
59902134|NCT03266172|76023665|FG001|STARTED|Part B: Washout (7 Days)||10||
59902135|NCT03266172|76023666|FG002|STARTED|Part B: Washout (7 Days)||0||
59902136|NCT03266172|76023664|FG000|COMPLETED|Part B: Washout (7 Days)||0||
59902137|NCT03266172|76023665|FG001|COMPLETED|Part B: Washout (7 Days)||8||
59902138|NCT03266172|76023666|FG002|COMPLETED|Part B: Washout (7 Days)||0||
59902139|NCT03266172|76023664|FG000|NOT COMPLETED|Part B: Washout (7 Days)||0||
59902140|NCT03266172|76023665|FG001|NOT COMPLETED|Part B: Washout (7 Days)||2||
59902141|NCT03266172|76023666|FG002|NOT COMPLETED|Part B: Washout (7 Days)||0||
59902142|NCT03266172|76023664|FG000|STARTED|Part B: Period 3 (4 Days)||0||
59902143|NCT03266172|76023665|FG001|STARTED|Part B: Period 3 (4 Days)|Two participants completed Washout Period but withdrew before the start of Period 3.|6||
59902144|NCT03266172|76023666|FG002|STARTED|Part B: Period 3 (4 Days)||0||
59902145|NCT03266172|76023664|FG000|COMPLETED|Part B: Period 3 (4 Days)||0||
59902146|NCT03266172|76023665|FG001|COMPLETED|Part B: Period 3 (4 Days)||6||
59902147|NCT03266172|76023666|FG002|COMPLETED|Part B: Period 3 (4 Days)||0||
59902148|NCT03266172|76023664|FG000|NOT COMPLETED|Part B: Period 3 (4 Days)||0||
59902149|NCT03266172|76023665|FG001|NOT COMPLETED|Part B: Period 3 (4 Days)||0||
59902150|NCT03266172|76023666|FG002|NOT COMPLETED|Part B: Period 3 (4 Days)||0||
59902151|NCT03266172|76023664|FG000|STARTED|Part C: Period 1(2 Days)||0||
59902152|NCT03266172|76023665|FG001|STARTED|Part C: Period 1(2 Days)|Participants from Part B did not enter Part C|0||
59902153|NCT03266172|76023666|FG002|STARTED|Part C: Period 1(2 Days)|New participants were enrolled in Part C of study|15||
59902154|NCT03266172|76023664|FG000|COMPLETED|Part C: Period 1(2 Days)||0||
59902155|NCT03266172|76023665|FG001|COMPLETED|Part C: Period 1(2 Days)||0||
59902156|NCT03266172|76023666|FG002|COMPLETED|Part C: Period 1(2 Days)||15||
59902157|NCT03266172|76023664|FG000|NOT COMPLETED|Part C: Period 1(2 Days)||0||
59902158|NCT03266172|76023665|FG001|NOT COMPLETED|Part C: Period 1(2 Days)||0||
59902159|NCT03266172|76023666|FG002|NOT COMPLETED|Part C: Period 1(2 Days)||0||
59902160|NCT03266172|76023664|FG000|STARTED|Part C Washout Period (7 Days)||0||
59902161|NCT03266172|76023665|FG001|STARTED|Part C Washout Period (7 Days)||0||
59902162|NCT03266172|76023666|FG002|STARTED|Part C Washout Period (7 Days)||15||
59902163|NCT03266172|76023664|FG000|COMPLETED|Part C Washout Period (7 Days)||0||
59902164|NCT03266172|76023665|FG001|COMPLETED|Part C Washout Period (7 Days)||0||
59902165|NCT03266172|76023666|FG002|COMPLETED|Part C Washout Period (7 Days)||15||
59902166|NCT03266172|76023664|FG000|NOT COMPLETED|Part C Washout Period (7 Days)||0||
59902167|NCT03266172|76023665|FG001|NOT COMPLETED|Part C Washout Period (7 Days)||0||
59902168|NCT03266172|76023666|FG002|NOT COMPLETED|Part C Washout Period (7 Days)||0||
59902169|NCT03266172|76023664|FG000|STARTED|Part C Period 2(2 Days)||0||
59902170|NCT03266172|76023665|FG001|STARTED|Part C Period 2(2 Days)||0||
59902171|NCT03266172|76023666|FG002|STARTED|Part C Period 2(2 Days)||15||
59902172|NCT03266172|76023664|FG000|COMPLETED|Part C Period 2(2 Days)||0||
59902173|NCT03266172|76023665|FG001|COMPLETED|Part C Period 2(2 Days)||0||
59902174|NCT03266172|76023666|FG002|COMPLETED|Part C Period 2(2 Days)||15||
59902175|NCT03266172|76023664|FG000|NOT COMPLETED|Part C Period 2(2 Days)||0||
59902176|NCT03266172|76023665|FG001|NOT COMPLETED|Part C Period 2(2 Days)||0||
59902177|NCT03266172|76023666|FG002|NOT COMPLETED|Part C Period 2(2 Days)||0||
59902178|NCT03266172|76023664|FG000|STARTED|Part C Washout Period (7 Days)||0||
59902179|NCT03266172|76023665|FG001|STARTED|Part C Washout Period (7 Days)||0||
59902180|NCT03266172|76023666|FG002|STARTED|Part C Washout Period (7 Days)||15||
60014413|NCT02456727|76130495|FG001|Initiated Treatment|Overall Study||360|Participants who signed the treatment consent form and attended at least one session of acupuncture.|
60014414|NCT02456727|76130494|FG000|6 Week|Overall Study||298|Patients who completed the week 6 follow up questionnaires.|
60014415|NCT02456727|76130495|FG001|6 Week|Overall Study||320|Patients who completed the week 6 follow up questionnaires.|
60014416|NCT02456727|76130494|FG000|12 Week|Overall Study||295|Patients who completed the week 12 follow up questionnaires.|
60014417|NCT02456727|76130495|FG001|12 Week|Overall Study||310|Patients who completed the week 12 follow up questionnaires.|
60014418|NCT02456727|76130494|FG000|24 Week|Overall Study||280|Patients who completed the week 24 follow up questionnaires.|
60014419|NCT02456727|76130495|FG001|24 Week|Overall Study||284|Patients who completed the week 24 follow up questionnaires.|
60014420|NCT02456727|76130494|FG000|COMPLETED|Overall Study||280||
60014421|NCT02456727|76130495|FG001|COMPLETED|Overall Study||284||
59505874|NCT01275755|75598794|FG001|COMPLETED|Run-in Placebo Period||40||
59505875|NCT01275755|75598793|FG000|NOT COMPLETED|Run-in Placebo Period||0||
59505876|NCT01275755|75598794|FG001|NOT COMPLETED|Run-in Placebo Period||0||
59505877|NCT01275755|75598793|FG000|STARTED|Double-blind Treatment Period||41||
59505878|NCT01275755|75598794|FG001|STARTED|Double-blind Treatment Period||40||
59505879|NCT01275755|75598793|FG000|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||41||
59505880|NCT01275755|75598794|FG001|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||40||
59757493|NCT01572480|75876608|FG000|STARTED|Drug Administration||54||
59757494|NCT01572480|75876608|FG000|COMPLETED|Drug Administration|2 participants discontinued drug administration early because of adverse events, thus 1 was taken off study and 1 proceeded to maintenance.|53||
59757495|NCT01572480|75876608|FG000|NOT COMPLETED|Drug Administration||1||
59757496|NCT01572480|75876608|FG000|STARTED|Initiated Maintenance Therapy||53||
59757497|NCT01572480|75876608|FG000|COMPLETED|Initiated Maintenance Therapy||50||
59757498|NCT01572480|75876608|FG000|NOT COMPLETED|Initiated Maintenance Therapy||3||
59757499|NCT01572480|75876608|FG000|STARTED|Completed Maintenance Therapy||50||
59757500|NCT01572480|75876608|FG000|COMPLETED|Completed Maintenance Therapy||30||
59757501|NCT01572480|75876608|FG000|NOT COMPLETED|Completed Maintenance Therapy||20||
59757502|NCT01126190|75876615|FG000|STARTED|Double-Blind Phase||151||
59757503|NCT01126190|75876616|FG001|STARTED|Double-Blind Phase||153||
59757504|NCT01126190|75876617|FG002|STARTED|Double-Blind Phase||0||
59757505|NCT01126190|75876615|FG000|Received at Least 1 Dose of Study Drug|Double-Blind Phase||150||
59757506|NCT01126190|75876616|FG001|Received at Least 1 Dose of Study Drug|Double-Blind Phase||153||
59757507|NCT01126190|75876617|FG002|Received at Least 1 Dose of Study Drug|Double-Blind Phase||0||
59757508|NCT01126190|75876615|FG000|Completed Without a Major Protocol Deviation|Double-Blind Phase||148||
59757509|NCT01126190|75876616|FG001|Completed Without a Major Protocol Deviation|Double-Blind Phase||150||
59757510|NCT01126190|75876617|FG002|Completed Without a Major Protocol Deviation|Double-Blind Phase||77||
59757511|NCT01126190|75876615|FG000|COMPLETED|Double-Blind Phase||145||
59757512|NCT01126190|75876616|FG001|COMPLETED|Double-Blind Phase||138||
59757513|NCT01126190|75876617|FG002|COMPLETED|Double-Blind Phase||0||
59757514|NCT01126190|75876615|FG000|NOT COMPLETED|Double-Blind Phase||6||
59757515|NCT01126190|75876616|FG001|NOT COMPLETED|Double-Blind Phase||15||
59757516|NCT01126190|75876617|FG002|NOT COMPLETED|Double-Blind Phase||0||
59757517|NCT01126190|75876615|FG000|STARTED|Open-Label Phase||0||
59757518|NCT01126190|75876616|FG001|STARTED|Open-Label Phase||0||
59757519|NCT01126190|75876617|FG002|STARTED|Open-Label Phase||77||
59757520|NCT01126190|75876615|FG000|Received at Least 1 Dose of Study Drug|Open-Label Phase||0||
59902181|NCT03266172|76023664|FG000|COMPLETED|Part C Washout Period (7 Days)||0||
59902182|NCT03266172|76023665|FG001|COMPLETED|Part C Washout Period (7 Days)||0||
59902183|NCT03266172|76023666|FG002|COMPLETED|Part C Washout Period (7 Days)||15||
59902184|NCT03266172|76023664|FG000|NOT COMPLETED|Part C Washout Period (7 Days)||0||
59902185|NCT03266172|76023665|FG001|NOT COMPLETED|Part C Washout Period (7 Days)||0||
59902186|NCT03266172|76023666|FG002|NOT COMPLETED|Part C Washout Period (7 Days)||0||
59902187|NCT03266172|76023664|FG000|STARTED|Part C Period 3(2 Days)||0||
59902188|NCT03266172|76023665|FG001|STARTED|Part C Period 3(2 Days)||0||
60014422|NCT02456727|76130494|FG000|NOT COMPLETED|Overall Study||109||
60014423|NCT02456727|76130495|FG001|NOT COMPLETED|Overall Study||106||
60014424|NCT02456103|76130517|FG000|STARTED|Overall Study||246||
60014425|NCT02456103|76130517|FG000|As-Treated Population|Overall Study||245|Participants who received at least 1 dose of ataluren.|
60014426|NCT02456103|76130517|FG000|Intent-to-treat (ITT) Population|Overall Study||244|Participants in the As-Treated Population with at least 1 postbaseline efficacy assessment.|
60014427|NCT02456103|76130517|FG000|COMPLETED|Overall Study||0||
60014428|NCT02456103|76130517|FG000|NOT COMPLETED|Overall Study||246||
60014429|NCT01653327|76130521|FG000|STARTED|Overall Study||11||
59902189|NCT03266172|76023666|FG002|STARTED|Part C Period 3(2 Days)|1 replacement participant enrolled|16||
59902190|NCT03266172|76023664|FG000|COMPLETED|Part C Period 3(2 Days)||0||
59902191|NCT03266172|76023665|FG001|COMPLETED|Part C Period 3(2 Days)||0||
59902192|NCT03266172|76023666|FG002|COMPLETED|Part C Period 3(2 Days)||16||
59902193|NCT03266172|76023664|FG000|NOT COMPLETED|Part C Period 3(2 Days)||0||
59902194|NCT03266172|76023665|FG001|NOT COMPLETED|Part C Period 3(2 Days)||0||
59902195|NCT03266172|76023666|FG002|NOT COMPLETED|Part C Period 3(2 Days)||0||
59902196|NCT03266172|76023664|FG000|STARTED|Part C Washout Period (7 Days)||0||
59902197|NCT03266172|76023665|FG001|STARTED|Part C Washout Period (7 Days)||0||
59902198|NCT03266172|76023666|FG002|STARTED|Part C Washout Period (7 Days)||16||
59902199|NCT03266172|76023664|FG000|COMPLETED|Part C Washout Period (7 Days)||0||
59902200|NCT03266172|76023665|FG001|COMPLETED|Part C Washout Period (7 Days)||0||
59902201|NCT03266172|76023666|FG002|COMPLETED|Part C Washout Period (7 Days)||16||
59902202|NCT03266172|76023664|FG000|NOT COMPLETED|Part C Washout Period (7 Days)||0||
59902203|NCT03266172|76023665|FG001|NOT COMPLETED|Part C Washout Period (7 Days)||0||
59902204|NCT03266172|76023666|FG002|NOT COMPLETED|Part C Washout Period (7 Days)||0||
59902205|NCT03266172|76023664|FG000|STARTED|Part C Period 4(2 Days)||0||
59902206|NCT03266172|76023665|FG001|STARTED|Part C Period 4(2 Days)||0||
59902207|NCT03266172|76023666|FG002|STARTED|Part C Period 4(2 Days)||16||
59902208|NCT03266172|76023664|FG000|COMPLETED|Part C Period 4(2 Days)||0||
59902209|NCT03266172|76023665|FG001|COMPLETED|Part C Period 4(2 Days)||0||
59902210|NCT03266172|76023666|FG002|COMPLETED|Part C Period 4(2 Days)||16||
59902211|NCT03266172|76023664|FG000|NOT COMPLETED|Part C Period 4(2 Days)||0||
59902212|NCT03266172|76023665|FG001|NOT COMPLETED|Part C Period 4(2 Days)||0||
59902213|NCT03266172|76023666|FG002|NOT COMPLETED|Part C Period 4(2 Days)||0||
59902214|NCT03266172|76023664|FG000|STARTED|Part C Washout Period (7 Days)||0||
59902215|NCT03266172|76023665|FG001|STARTED|Part C Washout Period (7 Days)||0||
59902216|NCT03266172|76023666|FG002|STARTED|Part C Washout Period (7 Days)||16||
59902217|NCT03266172|76023664|FG000|COMPLETED|Part C Washout Period (7 Days)||0||
59902218|NCT03266172|76023665|FG001|COMPLETED|Part C Washout Period (7 Days)||0||
59902219|NCT03266172|76023666|FG002|COMPLETED|Part C Washout Period (7 Days)||15||
59902220|NCT03266172|76023664|FG000|NOT COMPLETED|Part C Washout Period (7 Days)||0||
59902221|NCT03266172|76023665|FG001|NOT COMPLETED|Part C Washout Period (7 Days)||0||
59902222|NCT03266172|76023666|FG002|NOT COMPLETED|Part C Washout Period (7 Days)||1||
59902223|NCT03266172|76023664|FG000|STARTED|Part C Period 5(2 Days)||0||
59902224|NCT03266172|76023665|FG001|STARTED|Part C Period 5(2 Days)||0||
59902225|NCT03266172|76023666|FG002|STARTED|Part C Period 5(2 Days)||15||
59902226|NCT03266172|76023664|FG000|COMPLETED|Part C Period 5(2 Days)||0||
59902227|NCT03266172|76023665|FG001|COMPLETED|Part C Period 5(2 Days)||0||
59902228|NCT03266172|76023666|FG002|COMPLETED|Part C Period 5(2 Days)||15||
59902229|NCT03266172|76023664|FG000|NOT COMPLETED|Part C Period 5(2 Days)||0||
59902230|NCT03266172|76023665|FG001|NOT COMPLETED|Part C Period 5(2 Days)||0||
59902231|NCT03266172|76023666|FG002|NOT COMPLETED|Part C Period 5(2 Days)||0||
59902232|NCT03266172|76023664|FG000|STARTED|Part C Washout Period (7 Days)||0||
59902233|NCT03266172|76023665|FG001|STARTED|Part C Washout Period (7 Days)||0||
59902234|NCT03266172|76023666|FG002|STARTED|Part C Washout Period (7 Days)||15||
59902235|NCT03266172|76023664|FG000|COMPLETED|Part C Washout Period (7 Days)||0||
59902236|NCT03266172|76023665|FG001|COMPLETED|Part C Washout Period (7 Days)||0||
59902237|NCT03266172|76023666|FG002|COMPLETED|Part C Washout Period (7 Days)||14||
59902238|NCT03266172|76023664|FG000|NOT COMPLETED|Part C Washout Period (7 Days)||0||
59902239|NCT03266172|76023665|FG001|NOT COMPLETED|Part C Washout Period (7 Days)||0||
59902240|NCT03266172|76023666|FG002|NOT COMPLETED|Part C Washout Period (7 Days)||1||
59902241|NCT03266172|76023664|FG000|STARTED|Part C Period 6(2 Days)||0||
59902242|NCT03266172|76023665|FG001|STARTED|Part C Period 6(2 Days)||0||
59902243|NCT03266172|76023666|FG002|STARTED|Part C Period 6(2 Days)||14||
59902244|NCT03266172|76023664|FG000|COMPLETED|Part C Period 6(2 Days)||0||
59902245|NCT03266172|76023665|FG001|COMPLETED|Part C Period 6(2 Days)||0||
59902246|NCT03266172|76023666|FG002|COMPLETED|Part C Period 6(2 Days)||14||
59902247|NCT03266172|76023664|FG000|NOT COMPLETED|Part C Period 6(2 Days)||0||
59902248|NCT03266172|76023665|FG001|NOT COMPLETED|Part C Period 6(2 Days)||0||
60014430|NCT01653327|76130521|FG000|COMPLETED|Overall Study||10|8 participants received both Ketamine and Placebo; 1 received Ketamine only; 2 received Placebo only|
60014431|NCT01653327|76130521|FG000|NOT COMPLETED|Overall Study||1||
59902249|NCT03266172|76023666|FG002|NOT COMPLETED|Part C Period 6(2 Days)||0||
59902250|NCT04356937|76023718|FG000|STARTED|Randomization (Safety Population)||161||
59902251|NCT04356937|76023719|FG001|STARTED|Randomization (Safety Population)||82||
59902252|NCT04356937|76023718|FG000|COMPLETED|Randomization (Safety Population)||161||
59902253|NCT04356937|76023719|FG001|COMPLETED|Randomization (Safety Population)||82||
59902254|NCT04356937|76023718|FG000|NOT COMPLETED|Randomization (Safety Population)||0||
59902255|NCT04356937|76023719|FG001|NOT COMPLETED|Randomization (Safety Population)||0||
59902256|NCT04356937|76023718|FG000|STARTED|Treatment (mITT Population)||161||
59902257|NCT04356937|76023719|FG001|STARTED|Treatment (mITT Population)||82||
59902258|NCT04356937|76023718|FG000|COMPLETED|Treatment (mITT Population)||161||
59902259|NCT04356937|76023719|FG001|COMPLETED|Treatment (mITT Population)||81||
59902260|NCT04356937|76023718|FG000|NOT COMPLETED|Treatment (mITT Population)||0||
60014432|NCT02493855|76130530|FG000|STARTED|Overall Study||21||
59902261|NCT04356937|76023719|FG001|NOT COMPLETED|Treatment (mITT Population)||1||
59902262|NCT01125176|76023725|FG000|STARTED|Treatment Phase||14||
59902263|NCT01125176|76023725|FG000|COMPLETED|Treatment Phase||13||
59902264|NCT01125176|76023725|FG000|NOT COMPLETED|Treatment Phase||1||
59902265|NCT01125176|76023725|FG000|STARTED|Post-treatment Follow-up Phase||13||
59902266|NCT01125176|76023725|FG000|COMPLETED|Post-treatment Follow-up Phase||2||
59902267|NCT01125176|76023725|FG000|NOT COMPLETED|Post-treatment Follow-up Phase||11||
59902268|NCT03301740|76023731|FG000|STARTED|Phase 1 Intervention (3 Weeks)||18||
59902269|NCT03301740|76023732|FG001|STARTED|Phase 1 Intervention (3 Weeks)||16||
59902270|NCT03301740|76023731|FG000|COMPLETED|Phase 1 Intervention (3 Weeks)||18||
59902271|NCT03301740|76023732|FG001|COMPLETED|Phase 1 Intervention (3 Weeks)||16||
59902272|NCT03301740|76023731|FG000|NOT COMPLETED|Phase 1 Intervention (3 Weeks)||0||
59902273|NCT03301740|76023732|FG001|NOT COMPLETED|Phase 1 Intervention (3 Weeks)||0||
59902274|NCT03301740|76023731|FG000|STARTED|First Washout (1 Week)||18||
59902275|NCT03301740|76023732|FG001|STARTED|First Washout (1 Week)||16||
59902276|NCT03301740|76023731|FG000|COMPLETED|First Washout (1 Week)||18||
59902277|NCT03301740|76023732|FG001|COMPLETED|First Washout (1 Week)||16||
59902278|NCT03301740|76023731|FG000|NOT COMPLETED|First Washout (1 Week)||0||
59902279|NCT03301740|76023732|FG001|NOT COMPLETED|First Washout (1 Week)||0||
59902280|NCT03301740|76023731|FG000|STARTED|Phase 2 Intervention (3 Weeks)||18||
59902281|NCT03301740|76023732|FG001|STARTED|Phase 2 Intervention (3 Weeks)||16||
59902282|NCT03301740|76023731|FG000|COMPLETED|Phase 2 Intervention (3 Weeks)||17||
59902283|NCT03301740|76023732|FG001|COMPLETED|Phase 2 Intervention (3 Weeks)||16||
59902284|NCT03301740|76023731|FG000|NOT COMPLETED|Phase 2 Intervention (3 Weeks)||1||
59902285|NCT03301740|76023732|FG001|NOT COMPLETED|Phase 2 Intervention (3 Weeks)||0||
59902286|NCT03301740|76023731|FG000|STARTED|Second Washout (1 Week)||17||
59902287|NCT03301740|76023732|FG001|STARTED|Second Washout (1 Week)||16||
59902288|NCT03301740|76023731|FG000|COMPLETED|Second Washout (1 Week)||17||
59902289|NCT03301740|76023732|FG001|COMPLETED|Second Washout (1 Week)||16||
59902290|NCT03301740|76023731|FG000|NOT COMPLETED|Second Washout (1 Week)||0||
59902291|NCT03301740|76023732|FG001|NOT COMPLETED|Second Washout (1 Week)||0||
59902292|NCT03301740|76023731|FG000|STARTED|Phase 3 Intervention (3 Weeks)||17||
59902293|NCT03301740|76023732|FG001|STARTED|Phase 3 Intervention (3 Weeks)||16||
59902294|NCT03301740|76023731|FG000|COMPLETED|Phase 3 Intervention (3 Weeks)||17||
59902295|NCT03301740|76023732|FG001|COMPLETED|Phase 3 Intervention (3 Weeks)||16||
59902296|NCT03301740|76023731|FG000|NOT COMPLETED|Phase 3 Intervention (3 Weeks)||0||
59902297|NCT03301740|76023732|FG001|NOT COMPLETED|Phase 3 Intervention (3 Weeks)||0||
59902298|NCT03301740|76023731|FG000|STARTED|Third Washout (1 Week)||17||
59902299|NCT03301740|76023732|FG001|STARTED|Third Washout (1 Week)||16||
59902300|NCT03301740|76023731|FG000|COMPLETED|Third Washout (1 Week)||17||
59902301|NCT03301740|76023732|FG001|COMPLETED|Third Washout (1 Week)||16||
59902302|NCT03301740|76023731|FG000|NOT COMPLETED|Third Washout (1 Week)||0||
59902303|NCT03301740|76023732|FG001|NOT COMPLETED|Third Washout (1 Week)||0||
59902304|NCT03301740|76023731|FG000|STARTED|Phase 4 Intervention (3 Weeks)||17||
59902305|NCT03301740|76023732|FG001|STARTED|Phase 4 Intervention (3 Weeks)||16||
59902306|NCT03301740|76023731|FG000|COMPLETED|Phase 4 Intervention (3 Weeks)||16||
59902307|NCT03301740|76023732|FG001|COMPLETED|Phase 4 Intervention (3 Weeks)||16||
59902308|NCT03301740|76023731|FG000|NOT COMPLETED|Phase 4 Intervention (3 Weeks)||1||
59611380|NCT01780662|75722337|FG000|COMPLETED|Overall Study||2||
59902309|NCT03301740|76023732|FG001|NOT COMPLETED|Phase 4 Intervention (3 Weeks)||0||
59902310|NCT04355767|76023740|FG000|STARTED|Overall Study||257||
59902311|NCT04355767|76023741|FG001|STARTED|Overall Study||254||
59902312|NCT04355767|76023740|FG000|Intention-to-treat Population|Overall Study||257||
59902313|NCT04355767|76023741|FG001|Intention-to-treat Population|Overall Study||254||
59902314|NCT04355767|76023740|FG000|Had Data for 15-day Outcome|Overall Study||257||
59902315|NCT04355767|76023741|FG001|Had Data for 15-day Outcome|Overall Study||254||
59902316|NCT04355767|76023740|FG000|COMPLETED|Overall Study||250||
59902317|NCT04355767|76023741|FG001|COMPLETED|Overall Study||251||
59902318|NCT04355767|76023740|FG000|NOT COMPLETED|Overall Study||7||
59902319|NCT04355767|76023741|FG001|NOT COMPLETED|Overall Study||3||
59902320|NCT00882050|76023750|FG000|STARTED|Overall Study||32||
59902321|NCT00882050|76023751|FG001|STARTED|Overall Study||33||
59902322|NCT00882050|76023752|FG002|STARTED|Overall Study||39||
59902323|NCT00882050|76023750|FG000|COMPLETED|Overall Study||31||
59902324|NCT00882050|76023751|FG001|COMPLETED|Overall Study||33||
59902325|NCT00882050|76023752|FG002|COMPLETED|Overall Study||39||
59902326|NCT00882050|76023750|FG000|NOT COMPLETED|Overall Study||1||
59902327|NCT00882050|76023751|FG001|NOT COMPLETED|Overall Study||0||
59902328|NCT00882050|76023752|FG002|NOT COMPLETED|Overall Study||0||
59902329|NCT03266094|76023760|FG000|STARTED|Overall Study||60||
59902330|NCT03266094|76023760|FG000|COMPLETED|Overall Study||58||
59902331|NCT03266094|76023760|FG000|NOT COMPLETED|Overall Study||2||
59902332|NCT04161079|76023766|FG000|STARTED|Clinical Investigation 2010-040||12||
59902333|NCT04161079|76023766|FG000|COMPLETED|Clinical Investigation 2010-040||11||
59902334|NCT04161079|76023766|FG000|NOT COMPLETED|Clinical Investigation 2010-040||1||
59902335|NCT04161079|76023766|FG000|STARTED|2010-040FU5 >5 Years Follow-up|Of 11 subjects 3 refused to participate and 1 died.|7|It is follow-up group from the clinical investigation 2010-040.|
59902336|NCT04161079|76023766|FG000|COMPLETED|2010-040FU5 >5 Years Follow-up|Timepoint distribution for individual patients ranged approximately 6-8 yrs after MAR implantation.|7||
59902337|NCT04161079|76023766|FG000|NOT COMPLETED|2010-040FU5 >5 Years Follow-up||0||
59902338|NCT03243084|76023776|FG000|STARTED|Session 1||11||
59902339|NCT03243084|76023777|FG001|STARTED|Session 1||10||
59902340|NCT03243084|76023776|FG000|COMPLETED|Session 1||11||
59902341|NCT03243084|76023777|FG001|COMPLETED|Session 1||10||
59902342|NCT03243084|76023776|FG000|NOT COMPLETED|Session 1||0||
59902343|NCT03243084|76023777|FG001|NOT COMPLETED|Session 1||0||
59902344|NCT03243084|76023776|FG000|STARTED|Washout (1-3 Weeks)||11||
59902345|NCT03243084|76023777|FG001|STARTED|Washout (1-3 Weeks)||10||
59902346|NCT03243084|76023776|FG000|COMPLETED|Washout (1-3 Weeks)||10||
59902347|NCT03243084|76023777|FG001|COMPLETED|Washout (1-3 Weeks)||10||
59902348|NCT03243084|76023776|FG000|NOT COMPLETED|Washout (1-3 Weeks)||1||
59902349|NCT03243084|76023777|FG001|NOT COMPLETED|Washout (1-3 Weeks)||0||
59611381|NCT01780662|75722338|FG001|COMPLETED|Overall Study||7||
59902350|NCT03243084|76023776|FG000|STARTED|Session 2||10||
59902351|NCT03243084|76023777|FG001|STARTED|Session 2||10||
59902352|NCT03243084|76023776|FG000|COMPLETED|Session 2||10||
59902353|NCT03243084|76023777|FG001|COMPLETED|Session 2||10||
59902354|NCT03243084|76023776|FG000|NOT COMPLETED|Session 2||0||
59902355|NCT03243084|76023777|FG001|NOT COMPLETED|Session 2||0||
59902356|NCT04353817|76023786|FG000|STARTED|Overall Study||61||
59902357|NCT04353817|76023787|FG001|STARTED|Overall Study||60||
59902358|NCT04353817|76023786|FG000|COMPLETED|Overall Study||61||
59902359|NCT04353817|76023787|FG001|COMPLETED|Overall Study||59||
59902360|NCT04353817|76023786|FG000|NOT COMPLETED|Overall Study||0||
59902361|NCT04353817|76023787|FG001|NOT COMPLETED|Overall Study||1||
59902362|NCT00159588|76023796|FG000|STARTED|5 Month Follow-up||19||
59902363|NCT00159588|76023797|FG001|STARTED|5 Month Follow-up||22||
59902364|NCT00159588|76023798|FG002|STARTED|5 Month Follow-up||20||
59902365|NCT00159588|76023796|FG000|COMPLETED|5 Month Follow-up||17|Fulfilled the 5-month visit|
59902366|NCT00159588|76023797|FG001|COMPLETED|5 Month Follow-up||18|Fulfilled the 5-month visit|
59902367|NCT00159588|76023798|FG002|COMPLETED|5 Month Follow-up||18|Fulfilled the 5-month visit|
59902368|NCT00159588|76023796|FG000|NOT COMPLETED|5 Month Follow-up||2||
59902369|NCT00159588|76023797|FG001|NOT COMPLETED|5 Month Follow-up||4||
59902370|NCT00159588|76023798|FG002|NOT COMPLETED|5 Month Follow-up||2||
59902371|NCT00159588|76023796|FG000|STARTED|1-year Follow-up for Group 1 and 2||17||
59902372|NCT00159588|76023797|FG001|STARTED|1-year Follow-up for Group 1 and 2||18||
59902373|NCT00159588|76023798|FG002|STARTED|1-year Follow-up for Group 1 and 2||18||
59902374|NCT00159588|76023796|FG000|COMPLETED|1-year Follow-up for Group 1 and 2||16||
59902375|NCT00159588|76023797|FG001|COMPLETED|1-year Follow-up for Group 1 and 2||14||
59902376|NCT00159588|76023798|FG002|COMPLETED|1-year Follow-up for Group 1 and 2||18||
59902377|NCT00159588|76023796|FG000|NOT COMPLETED|1-year Follow-up for Group 1 and 2||1||
59902378|NCT00159588|76023797|FG001|NOT COMPLETED|1-year Follow-up for Group 1 and 2||4||
59902379|NCT00159588|76023798|FG002|NOT COMPLETED|1-year Follow-up for Group 1 and 2||0||
59902380|NCT03265938|76023809|FG000|STARTED|Overall Study||100||
59902381|NCT03265938|76023809|FG000|COMPLETED|Overall Study||92||
59902382|NCT03265938|76023809|FG000|NOT COMPLETED|Overall Study||8||
59902383|NCT04353037|76023818|FG000|STARTED|Overall Study||6||
59902384|NCT04353037|76023819|FG001|STARTED|Overall Study||3||
59902385|NCT04353037|76023820|FG002|STARTED|Overall Study||13||
59902386|NCT04353037|76023821|FG003|STARTED|Overall Study||17||
59902387|NCT04353037|76023818|FG000|COMPLETED|Overall Study||6||
59902388|NCT04353037|76023819|FG001|COMPLETED|Overall Study||0||
59902389|NCT04353037|76023820|FG002|COMPLETED|Overall Study||6||
59902390|NCT04353037|76023821|FG003|COMPLETED|Overall Study||7||
59902391|NCT04353037|76023818|FG000|NOT COMPLETED|Overall Study||0||
59902392|NCT04353037|76023819|FG001|NOT COMPLETED|Overall Study||3||
59902393|NCT04353037|76023820|FG002|NOT COMPLETED|Overall Study||7||
59902394|NCT04353037|76023821|FG003|NOT COMPLETED|Overall Study||10||
59902395|NCT04349917|76023835|FG000|STARTED|First Intervention (2-4 Hours)||19||
59902396|NCT04349917|76023836|FG001|STARTED|First Intervention (2-4 Hours)||18||
59902397|NCT04349917|76023835|FG000|Received Intervention|First Intervention (2-4 Hours)||19||
59902398|NCT04349917|76023836|FG001|Received Intervention|First Intervention (2-4 Hours)||17||
59902399|NCT04349917|76023835|FG000|COMPLETED|First Intervention (2-4 Hours)||19||
59902400|NCT04349917|76023836|FG001|COMPLETED|First Intervention (2-4 Hours)||16||
59902401|NCT04349917|76023835|FG000|NOT COMPLETED|First Intervention (2-4 Hours)||0||
59902402|NCT04349917|76023836|FG001|NOT COMPLETED|First Intervention (2-4 Hours)||2||
59902403|NCT04349917|76023835|FG000|STARTED|Washout Period (4-20 Days)||19||
59902404|NCT04349917|76023836|FG001|STARTED|Washout Period (4-20 Days)||16||
59902405|NCT04349917|76023835|FG000|COMPLETED|Washout Period (4-20 Days)||19||
59902406|NCT04349917|76023836|FG001|COMPLETED|Washout Period (4-20 Days)||16||
59505881|NCT01275755|75598793|FG000|COMPLETED|Double-blind Treatment Period||39||
59505882|NCT01275755|75598794|FG001|COMPLETED|Double-blind Treatment Period||37||
59505883|NCT01275755|75598793|FG000|NOT COMPLETED|Double-blind Treatment Period||2||
59505884|NCT01275755|75598794|FG001|NOT COMPLETED|Double-blind Treatment Period||3||
59505885|NCT01275755|75598793|FG000|STARTED|Run-out Placebo Period||39||
59505886|NCT01275755|75598794|FG001|STARTED|Run-out Placebo Period||37||
59902407|NCT04349917|76023835|FG000|NOT COMPLETED|Washout Period (4-20 Days)||0||
59902408|NCT04349917|76023836|FG001|NOT COMPLETED|Washout Period (4-20 Days)||0||
59902409|NCT04349917|76023835|FG000|STARTED|Second Intervention (2-4 Hours)||19||
59902410|NCT04349917|76023836|FG001|STARTED|Second Intervention (2-4 Hours)||16||
59902411|NCT04349917|76023835|FG000|Received Intervention|Second Intervention (2-4 Hours)||19||
59902412|NCT04349917|76023836|FG001|Received Intervention|Second Intervention (2-4 Hours)||16||
59902413|NCT04349917|76023835|FG000|COMPLETED|Second Intervention (2-4 Hours)||19||
59902414|NCT04349917|76023836|FG001|COMPLETED|Second Intervention (2-4 Hours)||16||
59902415|NCT04349917|76023835|FG000|NOT COMPLETED|Second Intervention (2-4 Hours)||0||
59902416|NCT04349917|76023836|FG001|NOT COMPLETED|Second Intervention (2-4 Hours)||0||
59902417|NCT04156399|76023843|FG000|STARTED|Overall Study||6||
59902418|NCT04156399|76023843|FG000|COMPLETED|Overall Study|Of the six participants who started the study, two completed all 10 acupuncture sessions, two completed 9 sessions, and one completed 8 sessions. The three who completed 8 or 9 sessions were unable to complete due to the COVID-19 lockdowns, however, we were able to collect post-test measures for them. Finally, one participant was hospitalized (unrelated to acupuncture) and could not complete the study nor provide post-test measures.|2||
59902419|NCT04156399|76023843|FG000|NOT COMPLETED|Overall Study||4||
59902420|NCT03300570|76023849|FG000|STARTED|Overall Study||13|Randomized|
59902421|NCT03300570|76023850|FG001|STARTED|Overall Study||14|Randomized|
59902422|NCT03300570|76023849|FG000|COMPLETED|Overall Study||11|Evaluable for the primary endpoint|
59902423|NCT03300570|76023850|FG001|COMPLETED|Overall Study||13|Evaluable for the primary endpoint|
59902424|NCT03300570|76023849|FG000|NOT COMPLETED|Overall Study||2||
59902425|NCT03300570|76023850|FG001|NOT COMPLETED|Overall Study||1||
59902426|NCT04154605|76023859|FG000|STARTED|Overall Study||68||
59902427|NCT04154605|76023860|FG001|STARTED|Overall Study||65||
59902428|NCT04154605|76023859|FG000|COMPLETED|Overall Study||65||
59902429|NCT04154605|76023860|FG001|COMPLETED|Overall Study||63||
59902430|NCT04154605|76023859|FG000|NOT COMPLETED|Overall Study||3||
59902431|NCT04154605|76023860|FG001|NOT COMPLETED|Overall Study||2||
59902432|NCT03264456|76023866|FG000|STARTED|Overall Study||18||
59902433|NCT03264456|76023866|FG000|COMPLETED|Overall Study||14||
59902434|NCT03264456|76023866|FG000|NOT COMPLETED|Overall Study||4||
59902435|NCT03853694|76023873|FG000|STARTED|Overall Study||56||
59902436|NCT03853694|76023874|FG001|STARTED|Overall Study||56||
59902437|NCT03853694|76023875|FG002|STARTED|Overall Study||55||
59902438|NCT03853694|76023873|FG000|COMPLETED|Overall Study||53||
59902439|NCT03853694|76023874|FG001|COMPLETED|Overall Study||47||
59902440|NCT03853694|76023875|FG002|COMPLETED|Overall Study||51||
59902441|NCT03853694|76023873|FG000|NOT COMPLETED|Overall Study||3||
59902442|NCT03853694|76023874|FG001|NOT COMPLETED|Overall Study||9||
59902443|NCT03853694|76023875|FG002|NOT COMPLETED|Overall Study||4||
59902444|NCT04154293|76023886|FG000|STARTED|Overall Study||12||
59902445|NCT04154293|76023887|FG001|STARTED|Overall Study||11||
59902446|NCT04154293|76023888|FG002|STARTED|Overall Study||11||
59902447|NCT04154293|76023886|FG000|Number Who Received at Least 1 Dose|Overall Study||12||
59902448|NCT04154293|76023887|FG001|Number Who Received at Least 1 Dose|Overall Study||11||
59902449|NCT04154293|76023888|FG002|Number Who Received at Least 1 Dose|Overall Study||10||
59902450|NCT04154293|76023886|FG000|COMPLETED|Overall Study||10||
59902451|NCT04154293|76023887|FG001|COMPLETED|Overall Study||8||
59902452|NCT04154293|76023888|FG002|COMPLETED|Overall Study||9||
59902453|NCT04154293|76023886|FG000|NOT COMPLETED|Overall Study||2||
59902454|NCT04154293|76023887|FG001|NOT COMPLETED|Overall Study||3||
59902455|NCT04154293|76023888|FG002|NOT COMPLETED|Overall Study||2||
59902456|NCT04342897|76023898|FG000|STARTED|Overall Study||47||
59902457|NCT04342897|76023899|FG001|STARTED|Overall Study||48||
59902458|NCT04342897|76023898|FG000|Received at Least One Dose of Study Drug|Overall Study||47||
59505887|NCT01275755|75598793|FG000|COMPLETED|Run-out Placebo Period||38||
59505888|NCT01275755|75598794|FG001|COMPLETED|Run-out Placebo Period||37||
59505889|NCT01275755|75598793|FG000|NOT COMPLETED|Run-out Placebo Period||1||
59902459|NCT04342897|76023899|FG001|Received at Least One Dose of Study Drug|Overall Study||48||
59902460|NCT04342897|76023898|FG000|COMPLETED|Overall Study||33||
59505890|NCT01275755|75598794|FG001|NOT COMPLETED|Run-out Placebo Period||0||
59505891|NCT00784225|75598804|FG000|STARTED|Overall Study||3375||
59505892|NCT00784225|75598805|FG001|STARTED|Overall Study||3357||
59505893|NCT00784225|75598806|FG002|STARTED|Overall Study||3369||
59505894|NCT00784225|75598807|FG003|STARTED|Overall Study||3374||
59505895|NCT00784225|75598804|FG000|COMPLETED|Overall Study||3375||
59505896|NCT00784225|75598805|FG001|COMPLETED|Overall Study||3357||
59902461|NCT04342897|76023899|FG001|COMPLETED|Overall Study||36||
59902462|NCT04342897|76023898|FG000|NOT COMPLETED|Overall Study||14||
59902463|NCT04342897|76023899|FG001|NOT COMPLETED|Overall Study||12||
59902464|NCT04340557|76023907|FG000|STARTED|Overall Study||16||
59902465|NCT04340557|76023908|FG001|STARTED|Overall Study||15||
59902466|NCT04340557|76023907|FG000|COMPLETED|Overall Study||15||
59902467|NCT04340557|76023908|FG001|COMPLETED|Overall Study||13||
59902468|NCT04340557|76023907|FG000|NOT COMPLETED|Overall Study||1||
59902469|NCT04340557|76023908|FG001|NOT COMPLETED|Overall Study||2||
59902470|NCT04382053|76023916|FG000|STARTED|Overall Study||71|All randomized Participants|
59902471|NCT04382053|76023917|FG001|STARTED|Overall Study||72|All randomized Participants|
59902472|NCT04382053|76023916|FG000|Safety Analysis Set|Overall Study|One participant that was randomized to the DFV890 + SoC arm did not attend any post-baseline visit|70|All randomized participants, who attended at least one post-baseline visit|
59902473|NCT04382053|76023917|FG001|Safety Analysis Set|Overall Study||72|All randomized participants, who attended at least one post-baseline visit|
59902474|NCT04382053|76023916|FG000|PD Analysis Set|Overall Study||62|All randomized participants with no protocol deviations with relevant impact on Pharmacodynamics (PD) data|
59902475|NCT04382053|76023917|FG001|PD Analysis Set|Overall Study||68|All randomized participants with no protocol deviations with relevant impact on Pharmacodynamics (PD) data|
59902476|NCT04382053|76023916|FG000|COMPLETED|Overall Study||62||
59902477|NCT04382053|76023917|FG001|COMPLETED|Overall Study||59||
59902478|NCT04382053|76023916|FG000|NOT COMPLETED|Overall Study||9||
59902479|NCT04382053|76023917|FG001|NOT COMPLETED|Overall Study||13||
59902480|NCT03066830|76023926|FG000|STARTED|Overall Study||254||
59902481|NCT03066830|76023927|FG001|STARTED|Overall Study||253||
59902482|NCT03066830|76023926|FG000|COMPLETED|Overall Study||221||
59902483|NCT03066830|76023927|FG001|COMPLETED|Overall Study||231||
59902484|NCT03066830|76023926|FG000|NOT COMPLETED|Overall Study||33||
59902485|NCT03066830|76023927|FG001|NOT COMPLETED|Overall Study||22||
59902486|NCT04380961|76023936|FG000|STARTED|Overall Study||140||
59902487|NCT04380961|76023937|FG001|STARTED|Overall Study||72||
59902488|NCT04380961|76023936|FG000|Treated|Overall Study||139||
59902489|NCT04380961|76023937|FG001|Treated|Overall Study||70||
59902490|NCT04380961|76023936|FG000|Participants Who Entered the Follow-up Phase|Overall Study||118||
59902491|NCT04380961|76023937|FG001|Participants Who Entered the Follow-up Phase|Overall Study||57||
59902492|NCT04380961|76023936|FG000|COMPLETED|Overall Study||96||
59902493|NCT04380961|76023937|FG001|COMPLETED|Overall Study||43||
59902494|NCT04380961|76023936|FG000|NOT COMPLETED|Overall Study||44||
59902495|NCT04380961|76023937|FG001|NOT COMPLETED|Overall Study||29||
59902496|NCT04331899|76023947|FG000|STARTED|Trial Period (28 Days)||60||
59902497|NCT04331899|76023948|FG001|STARTED|Trial Period (28 Days)||60||
59902498|NCT04331899|76023947|FG000|COMPLETED|Trial Period (28 Days)||58||
59902499|NCT04331899|76023948|FG001|COMPLETED|Trial Period (28 Days)||58||
59902500|NCT04331899|76023947|FG000|NOT COMPLETED|Trial Period (28 Days)||2||
59902501|NCT04331899|76023948|FG001|NOT COMPLETED|Trial Period (28 Days)||2||
59902502|NCT04331899|76023947|FG000|STARTED|Follow-up Period (10 Months)|16 participants who completed the trial period did not continue in the follow-up period.|42||
59902503|NCT04331899|76023948|FG001|STARTED|Follow-up Period (10 Months)|15 participants who completed the trial period did not continue in the follow-up period.|43||
59902504|NCT04331899|76023947|FG000|COMPLETED|Follow-up Period (10 Months)||42||
59902505|NCT04331899|76023948|FG001|COMPLETED|Follow-up Period (10 Months)||43||
59902506|NCT04331899|76023947|FG000|NOT COMPLETED|Follow-up Period (10 Months)||0||
59902507|NCT04331899|76023948|FG001|NOT COMPLETED|Follow-up Period (10 Months)||0||
59505897|NCT00784225|75598806|FG002|COMPLETED|Overall Study||3369||
59902508|NCT04328467|76023957|FG000|STARTED|Overall Study||494||
59902509|NCT04328467|76023958|FG001|STARTED|Overall Study||495||
59902510|NCT04328467|76023959|FG002|STARTED|Overall Study||494||
59902511|NCT04328467|76023957|FG000|COMPLETED|Overall Study||490||
59902512|NCT04328467|76023958|FG001|COMPLETED|Overall Study||493||
59902513|NCT04328467|76023959|FG002|COMPLETED|Overall Study||493||
59902514|NCT04328467|76023957|FG000|NOT COMPLETED|Overall Study||4||
60014433|NCT02493855|76130531|FG001|STARTED|Overall Study||19||
59902515|NCT04328467|76023958|FG001|NOT COMPLETED|Overall Study||2||
59902516|NCT04328467|76023959|FG002|NOT COMPLETED|Overall Study||1||
59902517|NCT04328077|76023971|FG000|STARTED|Overall Study||26||
59902518|NCT04328077|76023972|FG001|STARTED|Overall Study||25||
59902519|NCT04328077|76023973|FG002|STARTED|Overall Study||26||
59902520|NCT04328077|76023974|FG003|STARTED|Overall Study||24||
59505898|NCT00784225|75598807|FG003|COMPLETED|Overall Study||3374||
59505899|NCT00784225|75598804|FG000|NOT COMPLETED|Overall Study||0||
59505900|NCT00784225|75598805|FG001|NOT COMPLETED|Overall Study||0||
59505901|NCT00784225|75598806|FG002|NOT COMPLETED|Overall Study||0||
59902521|NCT04328077|76023971|FG000|COMPLETED|Overall Study||26||
59902522|NCT04328077|76023972|FG001|COMPLETED|Overall Study||23||
59902523|NCT04328077|76023973|FG002|COMPLETED|Overall Study||25||
59902524|NCT04328077|76023974|FG003|COMPLETED|Overall Study||21||
59902525|NCT04328077|76023971|FG000|NOT COMPLETED|Overall Study||0||
59902526|NCT04328077|76023972|FG001|NOT COMPLETED|Overall Study||2||
59757521|NCT01126190|75876616|FG001|Received at Least 1 Dose of Study Drug|Open-Label Phase||0||
59757522|NCT01126190|75876617|FG002|Received at Least 1 Dose of Study Drug|Open-Label Phase||77||
59757523|NCT01126190|75876615|FG000|COMPLETED|Open-Label Phase||0||
59757524|NCT01126190|75876616|FG001|COMPLETED|Open-Label Phase||0||
59757525|NCT01126190|75876617|FG002|COMPLETED|Open-Label Phase||66||
59757526|NCT01126190|75876615|FG000|NOT COMPLETED|Open-Label Phase||0||
59757527|NCT01126190|75876616|FG001|NOT COMPLETED|Open-Label Phase||0||
59757528|NCT01126190|75876617|FG002|NOT COMPLETED|Open-Label Phase||11||
59757529|NCT00323960|75876628|FG000|STARTED|Overall Study||47||
59757530|NCT00323960|75876629|FG001|STARTED|Overall Study||46||
59757531|NCT00323960|75876630|FG002|STARTED|Overall Study||46||
59757532|NCT00323960|75876628|FG000|COMPLETED|Overall Study||47||
59757533|NCT00323960|75876629|FG001|COMPLETED|Overall Study||46||
59757534|NCT00323960|75876630|FG002|COMPLETED|Overall Study||46||
59757535|NCT00323960|75876628|FG000|NOT COMPLETED|Overall Study||0||
59757536|NCT00323960|75876629|FG001|NOT COMPLETED|Overall Study||0||
59757537|NCT00323960|75876630|FG002|NOT COMPLETED|Overall Study||0||
59757538|NCT00323037|75876643|FG000|STARTED|Overall Study|Number randomized|165||
59757539|NCT00323037|75876644|FG001|STARTED|Overall Study|Number randomized|153||
59757540|NCT00323037|75876643|FG000|COMPLETED|Overall Study||132||
59757541|NCT00323037|75876644|FG001|COMPLETED|Overall Study||126||
59757542|NCT00323037|75876643|FG000|NOT COMPLETED|Overall Study||33||
59757543|NCT00323037|75876644|FG001|NOT COMPLETED|Overall Study||27||
59757544|NCT00939185|75876650|FG000|STARTED|Overall Study||400||
59757545|NCT00939185|75876650|FG000|Received Treatment|Overall Study||390||
59757546|NCT00939185|75876650|FG000|COMPLETED|Overall Study||375||
59757547|NCT00939185|75876650|FG000|NOT COMPLETED|Overall Study||25||
59757548|NCT03977155|75876657|FG000|STARTED|Overall Study||43||
59757549|NCT03977155|75876658|FG001|STARTED|Overall Study||48||
59757550|NCT03977155|75876659|FG002|STARTED|Overall Study||42||
59757551|NCT03977155|75876657|FG000|COMPLETED|Overall Study||38||
59757552|NCT03977155|75876658|FG001|COMPLETED|Overall Study||46||
59757553|NCT03977155|75876659|FG002|COMPLETED|Overall Study||40||
59757554|NCT03977155|75876657|FG000|NOT COMPLETED|Overall Study||5||
59757555|NCT03977155|75876658|FG001|NOT COMPLETED|Overall Study||2||
59757556|NCT03977155|75876659|FG002|NOT COMPLETED|Overall Study||2||
59902527|NCT04328077|76023973|FG002|NOT COMPLETED|Overall Study||1||
59902528|NCT04328077|76023974|FG003|NOT COMPLETED|Overall Study||3||
59902529|NCT03691831|76023992|FG000|STARTED|Overall Study||251||
59902530|NCT03691831|76023993|FG001|STARTED|Overall Study||251||
59902531|NCT03691831|76023992|FG000|COMPLETED|Overall Study||224||
59902532|NCT03691831|76023993|FG001|COMPLETED|Overall Study||220||
59902533|NCT03691831|76023992|FG000|NOT COMPLETED|Overall Study||27||
59902534|NCT03691831|76023993|FG001|NOT COMPLETED|Overall Study||31||
59902535|NCT03700970|76024001|FG000|STARTED|Overall Study||30||
59902536|NCT03700970|76024002|FG001|STARTED|Overall Study||30||
59902537|NCT03700970|76024001|FG000|COMPLETED|Overall Study||21||
59902538|NCT03700970|76024002|FG001|COMPLETED|Overall Study||19||
59902539|NCT03700970|76024001|FG000|NOT COMPLETED|Overall Study||9||
59902540|NCT03700970|76024002|FG001|NOT COMPLETED|Overall Study||11||
59902541|NCT04320745|76024010|FG000|STARTED|Overall Study||168||
59902542|NCT04320745|76024010|FG000|COMPLETED|Overall Study||121||
59902543|NCT04320745|76024010|FG000|NOT COMPLETED|Overall Study||47||
59902544|NCT03063086|76024014|FG000|STARTED|Overall Study||19||
59902545|NCT03063086|76024015|FG001|STARTED|Overall Study||20||
59902546|NCT03063086|76024016|FG002|STARTED|Overall Study||18||
59902547|NCT03063086|76024017|FG003|STARTED|Overall Study||20||
59902548|NCT03063086|76024018|FG004|STARTED|Overall Study||20||
59902549|NCT03063086|76024019|FG005|STARTED|Overall Study||19||
59902550|NCT03063086|76024014|FG000|COMPLETED|Overall Study||16||
59902551|NCT03063086|76024015|FG001|COMPLETED|Overall Study||19||
59902552|NCT03063086|76024016|FG002|COMPLETED|Overall Study||17||
59902553|NCT03063086|76024017|FG003|COMPLETED|Overall Study||17||
59902554|NCT03063086|76024018|FG004|COMPLETED|Overall Study||20||
59902555|NCT03063086|76024019|FG005|COMPLETED|Overall Study||18||
59902556|NCT03063086|76024014|FG000|NOT COMPLETED|Overall Study||3||
59902557|NCT03063086|76024015|FG001|NOT COMPLETED|Overall Study||1||
59757557|NCT04237272|75876672|FG000|STARTED|Overall Study||13||
59902558|NCT03063086|76024016|FG002|NOT COMPLETED|Overall Study||1||
59902559|NCT03063086|76024017|FG003|NOT COMPLETED|Overall Study||3||
59902560|NCT03063086|76024018|FG004|NOT COMPLETED|Overall Study||0||
59902561|NCT03063086|76024019|FG005|NOT COMPLETED|Overall Study||1||
59902562|NCT04128007|76024030|FG000|STARTED|Overall Study||200||
59902563|NCT04128007|76024031|FG001|STARTED|Overall Study||104||
59902564|NCT04128007|76024030|FG000|COMPLETED|Overall Study||177||
59902565|NCT04128007|76024031|FG001|COMPLETED|Overall Study||87||
59902566|NCT04128007|76024030|FG000|NOT COMPLETED|Overall Study||23||
59902567|NCT04128007|76024031|FG001|NOT COMPLETED|Overall Study||17||
59757558|NCT04237272|75876673|FG001|STARTED|Overall Study||12||
59757559|NCT04237272|75876674|FG002|STARTED|Overall Study||6||
59902568|NCT04318093|76024039|FG000|STARTED|Overall Study||13||
59902569|NCT04318093|76024040|FG001|STARTED|Overall Study||12||
59902570|NCT04318093|76024039|FG000|COMPLETED|Overall Study||10||
59902571|NCT04318093|76024040|FG001|COMPLETED|Overall Study||9||
59902572|NCT04318093|76024039|FG000|NOT COMPLETED|Overall Study||3||
59902573|NCT04318093|76024040|FG001|NOT COMPLETED|Overall Study||3||
59902574|NCT04123405|76024051|FG000|STARTED|Overall Study||235|Randomized|
59902575|NCT04123405|76024052|FG001|STARTED|Overall Study||238|Randomized|
59757560|NCT04237272|75876672|FG000|COMPLETED|Overall Study||13||
59757561|NCT04237272|75876673|FG001|COMPLETED|Overall Study||10||
59757562|NCT04237272|75876674|FG002|COMPLETED|Overall Study||3||
59757563|NCT04237272|75876672|FG000|NOT COMPLETED|Overall Study||0||
59757564|NCT04237272|75876673|FG001|NOT COMPLETED|Overall Study||2||
59757565|NCT04237272|75876674|FG002|NOT COMPLETED|Overall Study||3||
59757566|NCT00930059|75876684|FG000|STARTED|Overall Study||100||
59757567|NCT00930059|75876685|FG001|STARTED|Overall Study||91||
59757568|NCT00930059|75876684|FG000|COMPLETED|Overall Study||92||
59757569|NCT00930059|75876685|FG001|COMPLETED|Overall Study||79||
59757570|NCT00930059|75876684|FG000|NOT COMPLETED|Overall Study||8||
59757571|NCT00930059|75876685|FG001|NOT COMPLETED|Overall Study||12||
59757572|NCT04173962|75876693|FG000|STARTED|Overall Study||12||
59757573|NCT04173962|75876694|FG001|STARTED|Overall Study||12||
59757574|NCT04173962|75876693|FG000|COMPLETED|Overall Study||12||
59757575|NCT04173962|75876694|FG001|COMPLETED|Overall Study||12||
59757576|NCT04173962|75876693|FG000|NOT COMPLETED|Overall Study||0||
59902576|NCT04123405|76024053|FG002|STARTED|Overall Study||238|Randomized|
59902577|NCT04123405|76024054|FG003|STARTED|Overall Study||233|Randomized|
59951056|NCT05120115|76069981|FG000|6kg and Unilateral Weight Distribution|Overall Study||21||
59951057|NCT05120115|76069981|FG000|8kg and Unilateral Weight Distribution|Overall Study||21||
59757577|NCT04173962|75876694|FG001|NOT COMPLETED|Overall Study||0||
59951058|NCT05120115|76069981|FG000|COMPLETED|Overall Study||21||
59951059|NCT05120115|76069981|FG000|NOT COMPLETED|Overall Study||0||
59951060|NCT05044234|76069990|FG000|STARTED|Overall Study||39||
59951061|NCT05044234|76069991|FG001|STARTED|Overall Study||39||
59951062|NCT05044234|76069992|FG002|STARTED|Overall Study||39||
59951063|NCT05044234|76069993|FG003|STARTED|Overall Study||39||
59951064|NCT05044234|76069990|FG000|COMPLETED|Overall Study||10||
59951065|NCT05044234|76069991|FG001|COMPLETED|Overall Study||13||
59951066|NCT05044234|76069992|FG002|COMPLETED|Overall Study||12||
59951067|NCT05044234|76069993|FG003|COMPLETED|Overall Study||12||
59951068|NCT05044234|76069990|FG000|NOT COMPLETED|Overall Study||29||
59951069|NCT05044234|76069991|FG001|NOT COMPLETED|Overall Study||26||
59951070|NCT05044234|76069992|FG002|NOT COMPLETED|Overall Study||27||
59951071|NCT05044234|76069993|FG003|NOT COMPLETED|Overall Study||27||
59951072|NCT04862156|76070003|FG000|STARTED|Overall Study||19||
59951073|NCT04862156|76070003|FG000|COMPLETED|Overall Study||14||
59951074|NCT04862156|76070003|FG000|NOT COMPLETED|Overall Study||5||
59951075|NCT04844281|76070007|FG000|STARTED|Overall Study||30||
59951076|NCT04844281|76070007|FG000|COMPLETED|Overall Study||30||
59951077|NCT04844281|76070007|FG000|NOT COMPLETED|Overall Study||0||
59951078|NCT04725812|76070011|FG000|STARTED|Overall Study||2||
59951079|NCT04725812|76070011|FG000|COMPLETED|Overall Study||1||
59951080|NCT04725812|76070011|FG000|NOT COMPLETED|Overall Study||1||
59951081|NCT04612036|76070018|FG000|STARTED|Overall Study||25||
59951082|NCT04612036|76070019|FG001|STARTED|Overall Study||25||
59951083|NCT04612036|76070020|FG002|STARTED|Overall Study||10||
59951084|NCT04612036|76070018|FG000|COMPLETED|Overall Study||25||
59951085|NCT04612036|76070019|FG001|COMPLETED|Overall Study||25||
59951086|NCT04612036|76070020|FG002|COMPLETED|Overall Study||10||
59951087|NCT04612036|76070018|FG000|NOT COMPLETED|Overall Study||0||
59951088|NCT04612036|76070019|FG001|NOT COMPLETED|Overall Study||0||
59951089|NCT04612036|76070020|FG002|NOT COMPLETED|Overall Study||0||
59951090|NCT04281784|76070030|FG000|STARTED|Overall Study||1255||
59951091|NCT04281784|76070031|FG001|STARTED|Overall Study||1257||
59951092|NCT04281784|76070030|FG000|COMPLETED|Overall Study||1255||
59951093|NCT04281784|76070031|FG001|COMPLETED|Overall Study||1257||
59951094|NCT04281784|76070030|FG000|NOT COMPLETED|Overall Study||0||
59951095|NCT04281784|76070031|FG001|NOT COMPLETED|Overall Study||0||
59951096|NCT04147247|76070042|FG000|STARTED|Overall Study||3||
59951097|NCT04147247|76070043|FG001|STARTED|Overall Study||4||
59951098|NCT04147247|76070044|FG002|STARTED|Overall Study||5||
59951099|NCT04147247|76070045|FG003|STARTED|Overall Study||4||
59951100|NCT04147247|76070046|FG004|STARTED|Overall Study||5||
59951101|NCT04147247|76070042|FG000|COMPLETED|Overall Study||0||
59951102|NCT04147247|76070043|FG001|COMPLETED|Overall Study||0||
59951103|NCT04147247|76070044|FG002|COMPLETED|Overall Study||0||
59951104|NCT04147247|76070045|FG003|COMPLETED|Overall Study||0||
59951105|NCT04147247|76070046|FG004|COMPLETED|Overall Study||0||
59951106|NCT04147247|76070042|FG000|NOT COMPLETED|Overall Study||3||
59951107|NCT04147247|76070043|FG001|NOT COMPLETED|Overall Study||4||
59951108|NCT04147247|76070044|FG002|NOT COMPLETED|Overall Study||5||
59902578|NCT04123405|76024051|FG000|Full Analysis Set|Overall Study||235|all randomized patients who received at least one dose of the trial medication and who had at least one post-baseline assessment of MSS during the double-blind treatment period|
59902579|NCT04123405|76024052|FG001|Full Analysis Set|Overall Study||236|all randomized patients who received at least one dose of the trial medication and who had at least one post-baseline assessment of MSS during the double-blind treatment period|
59902580|NCT04123405|76024053|FG002|Full Analysis Set|Overall Study||238|all randomized patients who received at least one dose of the trial medication and who had at least one post-baseline assessment of MSS during the double-blind treatment period|
59902581|NCT04123405|76024054|FG003|Full Analysis Set|Overall Study||230|all randomized patients who received at least one dose of the trial medication and who had at least one post-baseline assessment of MSS during the double-blind treatment period|
59902582|NCT04123405|76024051|FG000|Per-protocol Set|Overall Study||213|all FAS-evaluable patients who completed the double-blind treatment period without major protocol violations that could affect the efficacy evaluation|
59902583|NCT04123405|76024052|FG001|Per-protocol Set|Overall Study||215|all FAS-evaluable patients who completed the double-blind treatment period without major protocol violations that could affect the efficacy evaluation|
59902584|NCT04123405|76024053|FG002|Per-protocol Set|Overall Study||212|all FAS-evaluable patients who completed the double-blind treatment period without major protocol violations that could affect the efficacy evaluation|
59902585|NCT04123405|76024054|FG003|Per-protocol Set|Overall Study||207|all FAS-evaluable patients who completed the double-blind treatment period without major protocol violations that could affect the efficacy evaluation|
59902586|NCT04123405|76024051|FG000|Safety Set|Overall Study||235|all randomized patients who received at least one dose of the trial medication|
59902587|NCT04123405|76024052|FG001|Safety Set|Overall Study||238|all randomized patients who received at least one dose of the trial medication|
59902588|NCT04123405|76024053|FG002|Safety Set|Overall Study||238|all randomized patients who received at least one dose of the trial medication|
59902589|NCT04123405|76024054|FG003|Safety Set|Overall Study||233|all randomized patients who received at least one dose of the trial medication|
59902590|NCT04123405|76024051|FG000|COMPLETED|Overall Study||231||
59902591|NCT04123405|76024052|FG001|COMPLETED|Overall Study||231||
59902592|NCT04123405|76024053|FG002|COMPLETED|Overall Study||235||
59902593|NCT04123405|76024054|FG003|COMPLETED|Overall Study||225||
59902594|NCT04123405|76024051|FG000|NOT COMPLETED|Overall Study||4||
59902595|NCT04123405|76024052|FG001|NOT COMPLETED|Overall Study||7||
59902596|NCT04123405|76024053|FG002|NOT COMPLETED|Overall Study||3||
59902597|NCT04123405|76024054|FG003|NOT COMPLETED|Overall Study||8||
59902598|NCT02519738|76024067|FG000|STARTED|Overall Study||20||
59902599|NCT02519738|76024068|FG001|STARTED|Overall Study||17||
59902600|NCT02519738|76024069|FG002|STARTED|Overall Study||15||
59902601|NCT02519738|76024067|FG000|COMPLETED|Overall Study||6||
59902602|NCT02519738|76024068|FG001|COMPLETED|Overall Study||4||
59902603|NCT02519738|76024069|FG002|COMPLETED|Overall Study||3||
59902604|NCT02519738|76024067|FG000|NOT COMPLETED|Overall Study||14||
59902605|NCT02519738|76024068|FG001|NOT COMPLETED|Overall Study||13||
59902606|NCT02519738|76024069|FG002|NOT COMPLETED|Overall Study||12||
59902607|NCT02343224|76024077|FG000|STARTED|Overall Study||9||
59902608|NCT02343224|76024077|FG000|COMPLETED|Overall Study||0||
59902609|NCT02343224|76024077|FG000|NOT COMPLETED|Overall Study||9||
59902610|NCT04314037|76024083|FG000|STARTED|Treatment Period 1||18||
59902611|NCT04314037|76024084|FG001|STARTED|Treatment Period 1||18||
59902612|NCT04314037|76024083|FG000|COMPLETED|Treatment Period 1||18||
59902613|NCT04314037|76024084|FG001|COMPLETED|Treatment Period 1||18||
59902614|NCT04314037|76024083|FG000|NOT COMPLETED|Treatment Period 1||0||
59902615|NCT04314037|76024084|FG001|NOT COMPLETED|Treatment Period 1||0||
59902616|NCT04314037|76024083|FG000|STARTED|Treatment Period 2||18||
59902617|NCT04314037|76024084|FG001|STARTED|Treatment Period 2||18||
59902618|NCT04314037|76024083|FG000|COMPLETED|Treatment Period 2||17||
59902619|NCT04314037|76024084|FG001|COMPLETED|Treatment Period 2||18||
59902620|NCT04314037|76024083|FG000|NOT COMPLETED|Treatment Period 2||1||
59902621|NCT04314037|76024084|FG001|NOT COMPLETED|Treatment Period 2||0||
59902622|NCT04314037|76024083|FG000|STARTED|Treatment Period 3||17||
59902623|NCT04314037|76024084|FG001|STARTED|Treatment Period 3||18||
59902624|NCT04314037|76024083|FG000|COMPLETED|Treatment Period 3||16||
59902625|NCT04314037|76024084|FG001|COMPLETED|Treatment Period 3||17||
59902626|NCT04314037|76024083|FG000|NOT COMPLETED|Treatment Period 3||1||
59902627|NCT04314037|76024084|FG001|NOT COMPLETED|Treatment Period 3||1||
59902628|NCT04314037|76024083|FG000|STARTED|Treatment Period 4||16||
59902629|NCT04314037|76024084|FG001|STARTED|Treatment Period 4||17||
59902630|NCT04314037|76024083|FG000|COMPLETED|Treatment Period 4||16||
59902631|NCT04314037|76024084|FG001|COMPLETED|Treatment Period 4||17||
59902632|NCT04314037|76024083|FG000|NOT COMPLETED|Treatment Period 4||0||
59902633|NCT04314037|76024084|FG001|NOT COMPLETED|Treatment Period 4||0||
59902634|NCT02248688|76024096|FG000|STARTED|Overall Study||5||
59902635|NCT02248688|76024096|FG000|COMPLETED|Overall Study||5||
59902636|NCT02248688|76024096|FG000|NOT COMPLETED|Overall Study||0||
59902637|NCT03056300|76024100|FG000|STARTED|Overall Study||50||
59902638|NCT03056300|76024100|FG000|COMPLETED|Overall Study||47||
59902639|NCT03056300|76024100|FG000|NOT COMPLETED|Overall Study||3||
59902640|NCT03061214|76024107|FG000|STARTED|Overall Study||288||
59902641|NCT03061214|76024108|FG001|STARTED|Overall Study||290||
59902642|NCT03061214|76024109|FG002|STARTED|Overall Study||290||
59902643|NCT03061214|76024107|FG000|Exposed|Overall Study||287||
59902644|NCT03061214|76024108|FG001|Exposed|Overall Study||290||
59902645|NCT03061214|76024109|FG002|Exposed|Overall Study||290||
59902646|NCT03061214|76024107|FG000|Full Analysis Set (FAS)|Overall Study||288||
59902647|NCT03061214|76024108|FG001|Full Analysis Set (FAS)|Overall Study||290||
59902648|NCT03061214|76024109|FG002|Full Analysis Set (FAS)|Overall Study||290||
59902649|NCT03061214|76024107|FG000|Safety Analysis Set (SAS)|Overall Study||287||
59902650|NCT03061214|76024108|FG001|Safety Analysis Set (SAS)|Overall Study||290||
59902651|NCT03061214|76024109|FG002|Safety Analysis Set (SAS)|Overall Study||290||
59902652|NCT03061214|76024107|FG000|COMPLETED|Overall Study||263||
59902653|NCT03061214|76024108|FG001|COMPLETED|Overall Study||262||
59902654|NCT03061214|76024109|FG002|COMPLETED|Overall Study||280||
59902655|NCT03061214|76024107|FG000|NOT COMPLETED|Overall Study||25||
59902656|NCT03061214|76024108|FG001|NOT COMPLETED|Overall Study||28||
59902657|NCT03061214|76024109|FG002|NOT COMPLETED|Overall Study||10||
59902658|NCT04115839|76024120|FG000|STARTED|Main Study (Up to 16 Weeks)||36||
59902659|NCT04115839|76024121|FG001|STARTED|Main Study (Up to 16 Weeks)||34||
59902660|NCT04115839|76024122|FG002|STARTED|Main Study (Up to 16 Weeks)||36||
59902661|NCT04115839|76024123|FG003|STARTED|Main Study (Up to 16 Weeks)||0||
59902662|NCT04115839|76024124|FG004|STARTED|Main Study (Up to 16 Weeks)||0||
59902663|NCT04115839|76024125|FG005|STARTED|Main Study (Up to 16 Weeks)||0||
59902664|NCT04115839|76024126|FG006|STARTED|Main Study (Up to 16 Weeks)||0||
59902665|NCT04115839|76024120|FG000|COMPLETED|Main Study (Up to 16 Weeks)||18||
59902666|NCT04115839|76024121|FG001|COMPLETED|Main Study (Up to 16 Weeks)||20||
59902667|NCT04115839|76024122|FG002|COMPLETED|Main Study (Up to 16 Weeks)||18||
59902668|NCT04115839|76024123|FG003|COMPLETED|Main Study (Up to 16 Weeks)||0||
59902669|NCT04115839|76024124|FG004|COMPLETED|Main Study (Up to 16 Weeks)||0||
59902670|NCT04115839|76024125|FG005|COMPLETED|Main Study (Up to 16 Weeks)||0||
59902671|NCT04115839|76024126|FG006|COMPLETED|Main Study (Up to 16 Weeks)||0||
59902672|NCT04115839|76024120|FG000|NOT COMPLETED|Main Study (Up to 16 Weeks)||18||
59902673|NCT04115839|76024121|FG001|NOT COMPLETED|Main Study (Up to 16 Weeks)||14||
59902674|NCT04115839|76024122|FG002|NOT COMPLETED|Main Study (Up to 16 Weeks)||18||
59902675|NCT04115839|76024123|FG003|NOT COMPLETED|Main Study (Up to 16 Weeks)||0||
59902676|NCT04115839|76024124|FG004|NOT COMPLETED|Main Study (Up to 16 Weeks)||0||
59902677|NCT04115839|76024125|FG005|NOT COMPLETED|Main Study (Up to 16 Weeks)||0||
59902678|NCT04115839|76024126|FG006|NOT COMPLETED|Main Study (Up to 16 Weeks)||0||
59902679|NCT04115839|76024120|FG000|STARTED|LTE Phase (After Week 16 to Week 63)|Participants who completed main study were randomised in LTE phase to receive filgotinib 200 mg or 100 mg.|0||
59902680|NCT04115839|76024121|FG001|STARTED|LTE Phase (After Week 16 to Week 63)|Participants who completed main study were randomised in LTE phase to receive filgotinib 200 mg or 100 mg.|0||
59902681|NCT04115839|76024122|FG002|STARTED|LTE Phase (After Week 16 to Week 63)|18 participants who completed main study did not enter LTE phase.|0||
59902682|NCT04115839|76024123|FG003|STARTED|LTE Phase (After Week 16 to Week 63)|Participants who completed main study were randomised in LTE phase to receive filgotinib 200 mg or 100 mg.|18||
59902683|NCT04115839|76024124|FG004|STARTED|LTE Phase (After Week 16 to Week 63)|Participants who completed main study were randomised in LTE phase to receive filgotinib 200 mg or 100 mg.|20||
59902684|NCT04115839|76024125|FG005|STARTED|LTE Phase (After Week 16 to Week 63)|10 participants who received placebo and completed main study were randomised in LTE phase to receive filgotinib 200 mg.|10||
59902685|NCT04115839|76024126|FG006|STARTED|LTE Phase (After Week 16 to Week 63)|8 participants who received placebo and completed main study were randomised in LTE phase to receive filgotinib 100 mg.|8||
59902686|NCT04115839|76024120|FG000|COMPLETED|LTE Phase (After Week 16 to Week 63)||0||
59902687|NCT04115839|76024121|FG001|COMPLETED|LTE Phase (After Week 16 to Week 63)||0||
59902688|NCT04115839|76024122|FG002|COMPLETED|LTE Phase (After Week 16 to Week 63)||0||
59902689|NCT04115839|76024123|FG003|COMPLETED|LTE Phase (After Week 16 to Week 63)||0||
59902690|NCT04115839|76024124|FG004|COMPLETED|LTE Phase (After Week 16 to Week 63)||0||
59902691|NCT04115839|76024125|FG005|COMPLETED|LTE Phase (After Week 16 to Week 63)||0||
59902692|NCT04115839|76024126|FG006|COMPLETED|LTE Phase (After Week 16 to Week 63)||0||
59902693|NCT04115839|76024120|FG000|NOT COMPLETED|LTE Phase (After Week 16 to Week 63)||0||
60014434|NCT02493855|76130532|FG002|STARTED|Overall Study||6||
60014435|NCT02493855|76130530|FG000|COMPLETED|Overall Study||19||
60014436|NCT02493855|76130531|FG001|COMPLETED|Overall Study||18||
60014437|NCT02493855|76130532|FG002|COMPLETED|Overall Study||6||
59902694|NCT04115839|76024121|FG001|NOT COMPLETED|LTE Phase (After Week 16 to Week 63)||0||
59902695|NCT04115839|76024122|FG002|NOT COMPLETED|LTE Phase (After Week 16 to Week 63)||0||
59902696|NCT04115839|76024123|FG003|NOT COMPLETED|LTE Phase (After Week 16 to Week 63)||18||
59902697|NCT04115839|76024124|FG004|NOT COMPLETED|LTE Phase (After Week 16 to Week 63)||20||
59902698|NCT04115839|76024125|FG005|NOT COMPLETED|LTE Phase (After Week 16 to Week 63)||10||
59902699|NCT04115839|76024126|FG006|NOT COMPLETED|LTE Phase (After Week 16 to Week 63)||8||
59902700|NCT01561430|76024155|FG000|STARTED|Overall Study||9||
59902701|NCT01561430|76024156|FG001|STARTED|Overall Study||23||
59902702|NCT01561430|76024157|FG002|STARTED|Overall Study||18||
59902703|NCT01561430|76024158|FG003|STARTED|Overall Study||20||
60014438|NCT02493855|76130530|FG000|NOT COMPLETED|Overall Study||2||
60014439|NCT02493855|76130531|FG001|NOT COMPLETED|Overall Study||1||
60014440|NCT02493855|76130532|FG002|NOT COMPLETED|Overall Study||0||
60014441|NCT02438787|76130543|FG000|STARTED|Overall Study||104||
60014442|NCT02438787|76130544|FG001|STARTED|Overall Study||106||
59902704|NCT01561430|76024155|FG000|Received at Least One Dose of Study Drug|Overall Study||9||
59902705|NCT01561430|76024156|FG001|Received at Least One Dose of Study Drug|Overall Study||23||
59902706|NCT01561430|76024157|FG002|Received at Least One Dose of Study Drug|Overall Study||18||
59902707|NCT01561430|76024158|FG003|Received at Least One Dose of Study Drug|Overall Study||20||
59902708|NCT01561430|76024155|FG000|COMPLETED|Overall Study||8||
59902709|NCT01561430|76024156|FG001|COMPLETED|Overall Study||8||
59902710|NCT01561430|76024157|FG002|COMPLETED|Overall Study||1||
59902711|NCT01561430|76024158|FG003|COMPLETED|Overall Study||7||
59902712|NCT01561430|76024155|FG000|NOT COMPLETED|Overall Study||1||
59902713|NCT01561430|76024156|FG001|NOT COMPLETED|Overall Study||15||
59902714|NCT01561430|76024157|FG002|NOT COMPLETED|Overall Study||17||
59902715|NCT01561430|76024158|FG003|NOT COMPLETED|Overall Study||13||
59902716|NCT03700658|76024169|FG000|STARTED|Overall Study||27||
59902717|NCT03700658|76024169|FG000|Received at Least 1 Dose of Study Drug|Overall Study||27||
59902718|NCT03700658|76024169|FG000|COMPLETED|Overall Study||27||
59902719|NCT03700658|76024169|FG000|NOT COMPLETED|Overall Study||0||
59902720|NCT01154933|76024184|FG000|STARTED|Exenatide 5 mcg||12||
59902721|NCT01154933|76024185|FG001|STARTED|Exenatide 5 mcg||12||
59902722|NCT01154933|76024184|FG000|COMPLETED|Exenatide 5 mcg||12||
59902723|NCT01154933|76024185|FG001|COMPLETED|Exenatide 5 mcg||12||
59902724|NCT01154933|76024184|FG000|NOT COMPLETED|Exenatide 5 mcg||0||
59902725|NCT01154933|76024185|FG001|NOT COMPLETED|Exenatide 5 mcg||0||
59902726|NCT01154933|76024184|FG000|STARTED|Exenatide 10 mcg||12||
59902727|NCT01154933|76024185|FG001|STARTED|Exenatide 10 mcg||12||
59902728|NCT01154933|76024184|FG000|COMPLETED|Exenatide 10 mcg||12||
59902729|NCT01154933|76024185|FG001|COMPLETED|Exenatide 10 mcg||12||
59902730|NCT01154933|76024184|FG000|NOT COMPLETED|Exenatide 10 mcg||0||
59902731|NCT01154933|76024185|FG001|NOT COMPLETED|Exenatide 10 mcg||0||
59902732|NCT03060512|76024193|FG000|STARTED|Overall Study||137||
59902733|NCT03060512|76024194|FG001|STARTED|Overall Study||139||
59902734|NCT03060512|76024193|FG000|Treated With Movantik|Overall Study||136||
59902735|NCT03060512|76024194|FG001|Treated With Movantik|Overall Study||135||
59902736|NCT03060512|76024193|FG000|Treated With PEG 3350|Overall Study||130||
59902737|NCT03060512|76024194|FG001|Treated With PEG 3350|Overall Study||138||
59902738|NCT03060512|76024193|FG000|COMPLETED|Overall Study||130||
59902739|NCT03060512|76024194|FG001|COMPLETED|Overall Study||130||
59902740|NCT03060512|76024193|FG000|NOT COMPLETED|Overall Study||7||
59902741|NCT03060512|76024194|FG001|NOT COMPLETED|Overall Study||9||
59902742|NCT03610334|76024216|FG000|STARTED|Period 1: 2.5mg (1 Day)||6||
59902743|NCT03610334|76024217|FG001|STARTED|Period 1: 2.5mg (1 Day)||2||
59902744|NCT03610334|76024218|FG002|STARTED|Period 1: 2.5mg (1 Day)||0||
59902745|NCT03610334|76024219|FG003|STARTED|Period 1: 2.5mg (1 Day)||0||
59902746|NCT03610334|76024220|FG004|STARTED|Period 1: 2.5mg (1 Day)||0||
59902747|NCT03610334|76024221|FG005|STARTED|Period 1: 2.5mg (1 Day)||0||
59902748|NCT03610334|76024222|FG006|STARTED|Period 1: 2.5mg (1 Day)||0||
59902749|NCT03610334|76024223|FG007|STARTED|Period 1: 2.5mg (1 Day)||0||
59902750|NCT03610334|76024224|FG008|STARTED|Period 1: 2.5mg (1 Day)||0||
59902751|NCT03610334|76024225|FG009|STARTED|Period 1: 2.5mg (1 Day)||0||
59902752|NCT03610334|76024226|FG010|STARTED|Period 1: 2.5mg (1 Day)||0||
59902753|NCT03610334|76024227|FG011|STARTED|Period 1: 2.5mg (1 Day)||0||
59902754|NCT03610334|76024228|FG012|STARTED|Period 1: 2.5mg (1 Day)||0||
59902755|NCT03610334|76024229|FG013|STARTED|Period 1: 2.5mg (1 Day)||0||
59902756|NCT03610334|76024230|FG014|STARTED|Period 1: 2.5mg (1 Day)||0||
59902757|NCT03610334|76024231|FG015|STARTED|Period 1: 2.5mg (1 Day)||0||
59902758|NCT03610334|76024232|FG016|STARTED|Period 1: 2.5mg (1 Day)||0||
59902759|NCT03610334|76024233|FG017|STARTED|Period 1: 2.5mg (1 Day)||0||
59902760|NCT03610334|76024216|FG000|COMPLETED|Period 1: 2.5mg (1 Day)||6||
59902761|NCT03610334|76024217|FG001|COMPLETED|Period 1: 2.5mg (1 Day)||2||
59902762|NCT03610334|76024218|FG002|COMPLETED|Period 1: 2.5mg (1 Day)||0||
59902763|NCT03610334|76024219|FG003|COMPLETED|Period 1: 2.5mg (1 Day)||0||
59902764|NCT03610334|76024220|FG004|COMPLETED|Period 1: 2.5mg (1 Day)||0||
59902765|NCT03610334|76024221|FG005|COMPLETED|Period 1: 2.5mg (1 Day)||0||
59902766|NCT03610334|76024222|FG006|COMPLETED|Period 1: 2.5mg (1 Day)||0||
59902767|NCT03610334|76024223|FG007|COMPLETED|Period 1: 2.5mg (1 Day)||0||
59902768|NCT03610334|76024224|FG008|COMPLETED|Period 1: 2.5mg (1 Day)||0||
59902769|NCT03610334|76024225|FG009|COMPLETED|Period 1: 2.5mg (1 Day)||0||
59902770|NCT03610334|76024226|FG010|COMPLETED|Period 1: 2.5mg (1 Day)||0||
59902771|NCT03610334|76024227|FG011|COMPLETED|Period 1: 2.5mg (1 Day)||0||
59902772|NCT03610334|76024228|FG012|COMPLETED|Period 1: 2.5mg (1 Day)||0||
59902773|NCT03610334|76024229|FG013|COMPLETED|Period 1: 2.5mg (1 Day)||0||
59902774|NCT03610334|76024230|FG014|COMPLETED|Period 1: 2.5mg (1 Day)||0||
59902775|NCT03610334|76024231|FG015|COMPLETED|Period 1: 2.5mg (1 Day)||0||
59902776|NCT03610334|76024232|FG016|COMPLETED|Period 1: 2.5mg (1 Day)||0||
59902777|NCT03610334|76024233|FG017|COMPLETED|Period 1: 2.5mg (1 Day)||0||
59902778|NCT03610334|76024216|FG000|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0||
59902779|NCT03610334|76024217|FG001|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0||
59902780|NCT03610334|76024218|FG002|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0||
59902781|NCT03610334|76024219|FG003|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0||
59902782|NCT03610334|76024220|FG004|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0||
59902783|NCT03610334|76024221|FG005|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0||
59902784|NCT03610334|76024222|FG006|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0||
59902785|NCT03610334|76024223|FG007|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0||
59902786|NCT03610334|76024224|FG008|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0||
59902787|NCT03610334|76024225|FG009|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0||
59902788|NCT03610334|76024226|FG010|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0||
59902789|NCT03610334|76024227|FG011|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0||
59902790|NCT03610334|76024228|FG012|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0||
59902791|NCT03610334|76024229|FG013|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0||
59902792|NCT03610334|76024230|FG014|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0||
59902793|NCT03610334|76024231|FG015|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0||
59902794|NCT03610334|76024232|FG016|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0||
59902795|NCT03610334|76024233|FG017|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0||
59902796|NCT03610334|76024216|FG000|STARTED|Period 2: 5.0mg (1 Day)||6||
59902797|NCT03610334|76024217|FG001|STARTED|Period 2: 5.0mg (1 Day)||2||
59902798|NCT03610334|76024218|FG002|STARTED|Period 2: 5.0mg (1 Day)||6||
59902799|NCT03610334|76024219|FG003|STARTED|Period 2: 5.0mg (1 Day)||2||
59902800|NCT03610334|76024220|FG004|STARTED|Period 2: 5.0mg (1 Day)||0||
59902801|NCT03610334|76024221|FG005|STARTED|Period 2: 5.0mg (1 Day)||0||
59902802|NCT03610334|76024222|FG006|STARTED|Period 2: 5.0mg (1 Day)||0||
59902803|NCT03610334|76024223|FG007|STARTED|Period 2: 5.0mg (1 Day)||0||
59902804|NCT03610334|76024224|FG008|STARTED|Period 2: 5.0mg (1 Day)||0||
59902805|NCT03610334|76024225|FG009|STARTED|Period 2: 5.0mg (1 Day)||0||
59902806|NCT03610334|76024226|FG010|STARTED|Period 2: 5.0mg (1 Day)||0||
59902807|NCT03610334|76024227|FG011|STARTED|Period 2: 5.0mg (1 Day)||0||
59902808|NCT03610334|76024228|FG012|STARTED|Period 2: 5.0mg (1 Day)||0||
59902809|NCT03610334|76024229|FG013|STARTED|Period 2: 5.0mg (1 Day)||0||
59902810|NCT03610334|76024230|FG014|STARTED|Period 2: 5.0mg (1 Day)||0||
59902811|NCT03610334|76024231|FG015|STARTED|Period 2: 5.0mg (1 Day)||0||
59902812|NCT03610334|76024232|FG016|STARTED|Period 2: 5.0mg (1 Day)||0||
59902813|NCT03610334|76024233|FG017|STARTED|Period 2: 5.0mg (1 Day)||0||
59902814|NCT03610334|76024216|FG000|COMPLETED|Period 2: 5.0mg (1 Day)||6||
59902815|NCT03610334|76024217|FG001|COMPLETED|Period 2: 5.0mg (1 Day)||2||
59902816|NCT03610334|76024218|FG002|COMPLETED|Period 2: 5.0mg (1 Day)||6||
59902817|NCT03610334|76024219|FG003|COMPLETED|Period 2: 5.0mg (1 Day)||2||
59902818|NCT03610334|76024220|FG004|COMPLETED|Period 2: 5.0mg (1 Day)||0||
59902819|NCT03610334|76024221|FG005|COMPLETED|Period 2: 5.0mg (1 Day)||0||
59902820|NCT03610334|76024222|FG006|COMPLETED|Period 2: 5.0mg (1 Day)||0||
59902821|NCT03610334|76024223|FG007|COMPLETED|Period 2: 5.0mg (1 Day)||0||
59902822|NCT03610334|76024224|FG008|COMPLETED|Period 2: 5.0mg (1 Day)||0||
59902823|NCT03610334|76024225|FG009|COMPLETED|Period 2: 5.0mg (1 Day)||0||
59902824|NCT03610334|76024226|FG010|COMPLETED|Period 2: 5.0mg (1 Day)||0||
59902825|NCT03610334|76024227|FG011|COMPLETED|Period 2: 5.0mg (1 Day)||0||
59902826|NCT03610334|76024228|FG012|COMPLETED|Period 2: 5.0mg (1 Day)||0||
59902827|NCT03610334|76024229|FG013|COMPLETED|Period 2: 5.0mg (1 Day)||0||
59902828|NCT03610334|76024230|FG014|COMPLETED|Period 2: 5.0mg (1 Day)||0||
59902829|NCT03610334|76024231|FG015|COMPLETED|Period 2: 5.0mg (1 Day)||0||
59902830|NCT03610334|76024232|FG016|COMPLETED|Period 2: 5.0mg (1 Day)||0||
59902831|NCT03610334|76024233|FG017|COMPLETED|Period 2: 5.0mg (1 Day)||0||
59902832|NCT03610334|76024216|FG000|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0||
59902833|NCT03610334|76024217|FG001|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0||
59902834|NCT03610334|76024218|FG002|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0||
59902835|NCT03610334|76024219|FG003|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0||
59902836|NCT03610334|76024220|FG004|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0||
59902837|NCT03610334|76024221|FG005|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0||
59902838|NCT03610334|76024222|FG006|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0||
59902839|NCT03610334|76024223|FG007|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0||
59902840|NCT03610334|76024224|FG008|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0||
59902841|NCT03610334|76024225|FG009|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0||
59902842|NCT03610334|76024226|FG010|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0||
59902843|NCT03610334|76024227|FG011|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0||
59902844|NCT03610334|76024228|FG012|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0||
59902845|NCT03610334|76024229|FG013|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0||
59902846|NCT03610334|76024230|FG014|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0||
59902847|NCT03610334|76024231|FG015|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0||
59902848|NCT03610334|76024232|FG016|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0||
59902849|NCT03610334|76024233|FG017|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0||
59902850|NCT03610334|76024216|FG000|STARTED|Period 3: 10.0mg (1 Day)||6||
59902851|NCT03610334|76024217|FG001|STARTED|Period 3: 10.0mg (1 Day)||2||
59902852|NCT03610334|76024218|FG002|STARTED|Period 3: 10.0mg (1 Day)||6||
59902853|NCT03610334|76024219|FG003|STARTED|Period 3: 10.0mg (1 Day)||2||
59902854|NCT03610334|76024220|FG004|STARTED|Period 3: 10.0mg (1 Day)||6||
59902855|NCT03610334|76024221|FG005|STARTED|Period 3: 10.0mg (1 Day)||2||
59902856|NCT03610334|76024222|FG006|STARTED|Period 3: 10.0mg (1 Day)||0||
59902857|NCT03610334|76024223|FG007|STARTED|Period 3: 10.0mg (1 Day)||0||
59902858|NCT03610334|76024224|FG008|STARTED|Period 3: 10.0mg (1 Day)||0||
59902859|NCT03610334|76024225|FG009|STARTED|Period 3: 10.0mg (1 Day)||0||
59902860|NCT03610334|76024226|FG010|STARTED|Period 3: 10.0mg (1 Day)||0||
59902861|NCT03610334|76024227|FG011|STARTED|Period 3: 10.0mg (1 Day)||0||
59902862|NCT03610334|76024228|FG012|STARTED|Period 3: 10.0mg (1 Day)||0||
59902863|NCT03610334|76024229|FG013|STARTED|Period 3: 10.0mg (1 Day)||0||
59902864|NCT03610334|76024230|FG014|STARTED|Period 3: 10.0mg (1 Day)||0||
59902865|NCT03610334|76024231|FG015|STARTED|Period 3: 10.0mg (1 Day)||0||
59902866|NCT03610334|76024232|FG016|STARTED|Period 3: 10.0mg (1 Day)||0||
59902867|NCT03610334|76024233|FG017|STARTED|Period 3: 10.0mg (1 Day)||0||
59902868|NCT03610334|76024216|FG000|COMPLETED|Period 3: 10.0mg (1 Day)||6||
59902869|NCT03610334|76024217|FG001|COMPLETED|Period 3: 10.0mg (1 Day)||2||
59902870|NCT03610334|76024218|FG002|COMPLETED|Period 3: 10.0mg (1 Day)||6||
59902871|NCT03610334|76024219|FG003|COMPLETED|Period 3: 10.0mg (1 Day)||2||
59902872|NCT03610334|76024220|FG004|COMPLETED|Period 3: 10.0mg (1 Day)||6||
59902873|NCT03610334|76024221|FG005|COMPLETED|Period 3: 10.0mg (1 Day)||2||
59902874|NCT03610334|76024222|FG006|COMPLETED|Period 3: 10.0mg (1 Day)||0||
59902875|NCT03610334|76024223|FG007|COMPLETED|Period 3: 10.0mg (1 Day)||0||
59902876|NCT03610334|76024224|FG008|COMPLETED|Period 3: 10.0mg (1 Day)||0||
59902877|NCT03610334|76024225|FG009|COMPLETED|Period 3: 10.0mg (1 Day)||0||
59902878|NCT03610334|76024226|FG010|COMPLETED|Period 3: 10.0mg (1 Day)||0||
59902879|NCT03610334|76024227|FG011|COMPLETED|Period 3: 10.0mg (1 Day)||0||
59902880|NCT03610334|76024228|FG012|COMPLETED|Period 3: 10.0mg (1 Day)||0||
59902881|NCT03610334|76024229|FG013|COMPLETED|Period 3: 10.0mg (1 Day)||0||
59902882|NCT03610334|76024230|FG014|COMPLETED|Period 3: 10.0mg (1 Day)||0||
59902883|NCT03610334|76024231|FG015|COMPLETED|Period 3: 10.0mg (1 Day)||0||
59902884|NCT03610334|76024232|FG016|COMPLETED|Period 3: 10.0mg (1 Day)||0||
59902885|NCT03610334|76024233|FG017|COMPLETED|Period 3: 10.0mg (1 Day)||0||
59902886|NCT03610334|76024216|FG000|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0||
59902887|NCT03610334|76024217|FG001|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0||
59902888|NCT03610334|76024218|FG002|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0||
59902889|NCT03610334|76024219|FG003|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0||
59902890|NCT03610334|76024220|FG004|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0||
59902891|NCT03610334|76024221|FG005|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0||
59902892|NCT03610334|76024222|FG006|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0||
59757578|NCT00772005|75876704|FG000|STARTED|Overall Study||71||
59757579|NCT00772005|75876705|FG001|STARTED|Overall Study|One patient withdrew before taking any study drug.|70||
59757580|NCT00772005|75876706|FG002|STARTED|Overall Study|One patient withdrew before taking any study drug.|72||
59757581|NCT00772005|75876707|FG003|STARTED|Overall Study|Two patients withdrew before taking any study drug.|72||
59757582|NCT00772005|75876704|FG000|COMPLETED|Overall Study||46||
59757583|NCT00772005|75876705|FG001|COMPLETED|Overall Study||40||
59757584|NCT00772005|75876706|FG002|COMPLETED|Overall Study||44||
59757585|NCT00772005|75876707|FG003|COMPLETED|Overall Study||46||
59757586|NCT00772005|75876704|FG000|NOT COMPLETED|Overall Study||25||
59757587|NCT00772005|75876705|FG001|NOT COMPLETED|Overall Study||30||
59757588|NCT00772005|75876706|FG002|NOT COMPLETED|Overall Study||28||
59757589|NCT00772005|75876707|FG003|NOT COMPLETED|Overall Study||26||
59757590|NCT00939107|75876719|FG000|STARTED|Overall Study||175||
59757591|NCT00939107|75876720|FG001|STARTED|Overall Study||175||
59757592|NCT00939107|75876719|FG000|12 Months Follow-up|Overall Study||161||
59757593|NCT00939107|75876720|FG001|12 Months Follow-up|Overall Study||163||
59757594|NCT00939107|75876719|FG000|COMPLETED|Overall Study||161||
59757595|NCT00939107|75876720|FG001|COMPLETED|Overall Study||163||
59757596|NCT00939107|75876719|FG000|NOT COMPLETED|Overall Study||14||
59757597|NCT00939107|75876720|FG001|NOT COMPLETED|Overall Study||12||
59757598|NCT00927485|75876728|FG000|STARTED|Overall Study||21||
59757599|NCT00927485|75876729|FG001|STARTED|Overall Study||23||
59757600|NCT00927485|75876728|FG000|COMPLETED|Overall Study||15||
59757601|NCT00927485|75876729|FG001|COMPLETED|Overall Study||19||
59757602|NCT00927485|75876728|FG000|NOT COMPLETED|Overall Study||6||
59757603|NCT00927485|75876729|FG001|NOT COMPLETED|Overall Study||4||
59757604|NCT00927251|75876735|FG000|STARTED|Overall Study||90||
59757605|NCT00927251|75876735|FG000|COMPLETED|Overall Study||82||
59757606|NCT00927251|75876735|FG000|NOT COMPLETED|Overall Study||8||
59757607|NCT00927095|75876742|FG000|STARTED|Overall Study||22||
59757608|NCT00927095|75876743|FG001|STARTED|Overall Study||21||
59757609|NCT00927095|75876744|FG002|STARTED|Overall Study||24||
59757610|NCT00927095|75876742|FG000|COMPLETED|Overall Study||16||
59757611|NCT00927095|75876743|FG001|COMPLETED|Overall Study||17||
59757612|NCT00927095|75876744|FG002|COMPLETED|Overall Study||22||
59757613|NCT00927095|75876742|FG000|NOT COMPLETED|Overall Study||6||
59757614|NCT00927095|75876743|FG001|NOT COMPLETED|Overall Study||4||
59757615|NCT00927095|75876744|FG002|NOT COMPLETED|Overall Study||2||
59757616|NCT00932165|75876752|FG000|STARTED|Overall Study||451||
59757617|NCT00932165|75876752|FG000|COMPLETED|Overall Study||450||
59757618|NCT00932165|75876752|FG000|NOT COMPLETED|Overall Study||1||
59757619|NCT04888494|75876759|FG000|STARTED|Overall Study||8||
59757620|NCT04888494|75876760|FG001|STARTED|Overall Study||8||
59757621|NCT04888494|75876759|FG000|First Intervention (5 Days)|Overall Study||5||
59757622|NCT04888494|75876760|FG001|First Intervention (5 Days)|Overall Study||5||
59757623|NCT04888494|75876759|FG000|Washout (14 Days)|Overall Study||5||
59757624|NCT04888494|75876760|FG001|Washout (14 Days)|Overall Study||5||
59757625|NCT04888494|75876759|FG000|Second Intervention (5 Days)|Overall Study||5||
59757626|NCT04888494|75876760|FG001|Second Intervention (5 Days)|Overall Study||5||
59757627|NCT04888494|75876759|FG000|COMPLETED|Overall Study||5||
60014443|NCT02438787|76130545|FG002|STARTED|Overall Study||105||
59611382|NCT01780662|75722339|FG002|COMPLETED|Overall Study||20||
59611383|NCT01780662|75722337|FG000|NOT COMPLETED|Overall Study||1||
59611384|NCT01780662|75722338|FG001|NOT COMPLETED|Overall Study||6||
59611385|NCT01780662|75722339|FG002|NOT COMPLETED|Overall Study||10||
59611386|NCT01780584|75722351|FG000|STARTED|Overall Study||15||
59611387|NCT01780584|75722352|FG001|STARTED|Overall Study||15||
59757628|NCT04888494|75876760|FG001|COMPLETED|Overall Study||5||
59757629|NCT04888494|75876759|FG000|NOT COMPLETED|Overall Study||3||
59757630|NCT04888494|75876760|FG001|NOT COMPLETED|Overall Study||3||
59757631|NCT04880070|75876768|FG000|STARTED|Overall Study||5||
59757632|NCT04880070|75876768|FG000|COMPLETED|Overall Study||5||
59757633|NCT04880070|75876768|FG000|NOT COMPLETED|Overall Study||0||
59757634|NCT04807205|75876772|FG000|STARTED|Overall Study||20||
59757635|NCT04807205|75876772|FG000|COMPLETED|Overall Study||20||
59757636|NCT04807205|75876772|FG000|NOT COMPLETED|Overall Study||0||
59757637|NCT04806100|75876782|FG000|STARTED|Overall Study||5||
59757638|NCT04806100|75876783|FG001|STARTED|Overall Study||5||
59757639|NCT04806100|75876784|FG002|STARTED|Overall Study||3||
59757640|NCT04806100|75876785|FG003|STARTED|Overall Study||2||
59757641|NCT04806100|75876786|FG004|STARTED|Overall Study||4||
59757642|NCT04806100|75876787|FG005|STARTED|Overall Study||1||
59757643|NCT04806100|75876782|FG000|COMPLETED|Overall Study||5||
59757644|NCT04806100|75876783|FG001|COMPLETED|Overall Study||5||
59757645|NCT04806100|75876784|FG002|COMPLETED|Overall Study||3||
59757646|NCT04806100|75876785|FG003|COMPLETED|Overall Study||2||
59757647|NCT04806100|75876786|FG004|COMPLETED|Overall Study||4||
59757648|NCT04806100|75876787|FG005|COMPLETED|Overall Study||1||
59757649|NCT04806100|75876782|FG000|NOT COMPLETED|Overall Study||0||
59757650|NCT04806100|75876783|FG001|NOT COMPLETED|Overall Study||0||
59757651|NCT04806100|75876784|FG002|NOT COMPLETED|Overall Study||0||
59757652|NCT04806100|75876785|FG003|NOT COMPLETED|Overall Study||0||
59757653|NCT04806100|75876786|FG004|NOT COMPLETED|Overall Study||0||
59757654|NCT04806100|75876787|FG005|NOT COMPLETED|Overall Study||0||
59757655|NCT04785794|75876803|FG000|STARTED|Overall Study||10||
59757656|NCT04785794|75876804|FG001|STARTED|Overall Study||5||
59757657|NCT04785794|75876805|FG002|STARTED|Overall Study||70||
59757658|NCT04785794|75876806|FG003|STARTED|Overall Study||37||
59757659|NCT04785794|75876803|FG000|COMPLETED|Overall Study||9||
59757660|NCT04785794|75876804|FG001|COMPLETED|Overall Study||5||
59757661|NCT04785794|75876805|FG002|COMPLETED|Overall Study||67||
59757662|NCT04785794|75876806|FG003|COMPLETED|Overall Study||37||
59757663|NCT04785794|75876803|FG000|NOT COMPLETED|Overall Study||1||
59757664|NCT04785794|75876804|FG001|NOT COMPLETED|Overall Study||0||
59757665|NCT04785794|75876805|FG002|NOT COMPLETED|Overall Study||3||
59757666|NCT04785794|75876806|FG003|NOT COMPLETED|Overall Study||0||
59757667|NCT04584099|75876816|FG000|STARTED|Overall Study||12||
59757668|NCT04584099|75876816|FG000|COMPLETED|Overall Study||0||
59757669|NCT04584099|75876816|FG000|NOT COMPLETED|Overall Study||12||
59757670|NCT04573972|75876822|FG000|STARTED|Overall Study||88||
59757671|NCT04573972|75876823|FG001|STARTED|Overall Study||84||
59757672|NCT04573972|75876822|FG000|COMPLETED|Overall Study||56||
59757673|NCT04573972|75876823|FG001|COMPLETED|Overall Study||70||
59757674|NCT04573972|75876822|FG000|NOT COMPLETED|Overall Study||32||
59757675|NCT04573972|75876823|FG001|NOT COMPLETED|Overall Study||14||
59757676|NCT04512040|75876831|FG000|STARTED|Overall Study||15||
59757677|NCT04512040|75876832|FG001|STARTED|Overall Study||15||
59757678|NCT04512040|75876831|FG000|COMPLETED|Overall Study||14||
59757679|NCT04512040|75876832|FG001|COMPLETED|Overall Study||14||
59757680|NCT04512040|75876831|FG000|NOT COMPLETED|Overall Study||1||
59757681|NCT04512040|75876832|FG001|NOT COMPLETED|Overall Study||1||
59757682|NCT04420949|75876842|FG000|STARTED|Overall Study||5||
59757683|NCT04420949|75876843|FG001|STARTED|Overall Study||5||
59757684|NCT04420949|75876842|FG000|COMPLETED|Overall Study||5||
59757685|NCT04420949|75876843|FG001|COMPLETED|Overall Study||5||
59757686|NCT04420949|75876842|FG000|NOT COMPLETED|Overall Study||0||
59757687|NCT04420949|75876843|FG001|NOT COMPLETED|Overall Study||0||
59757688|NCT04391309|75876851|FG000|STARTED|Overall Study||21||
59757689|NCT04391309|75876852|FG001|STARTED|Overall Study||20||
59757690|NCT04391309|75876851|FG000|Included in the Modified Intent to Treat Population (miTT)|Overall Study||20||
59757691|NCT04391309|75876852|FG001|Included in the Modified Intent to Treat Population (miTT)|Overall Study||20||
59757692|NCT04391309|75876851|FG000|COMPLETED|Overall Study||15||
59757693|NCT04391309|75876852|FG001|COMPLETED|Overall Study||15||
59757694|NCT04391309|75876851|FG000|NOT COMPLETED|Overall Study||6||
59757695|NCT04391309|75876852|FG001|NOT COMPLETED|Overall Study||5||
59757696|NCT04356690|75876860|FG000|STARTED|Overall Study||6||
59757697|NCT04356690|75876861|FG001|STARTED|Overall Study||2||
59757698|NCT04356690|75876860|FG000|COMPLETED|Overall Study||6||
59757699|NCT04356690|75876861|FG001|COMPLETED|Overall Study||2||
59757700|NCT04356690|75876860|FG000|NOT COMPLETED|Overall Study||0||
59757701|NCT04356690|75876861|FG001|NOT COMPLETED|Overall Study||0||
59757702|NCT04202965|75876867|FG000|STARTED|Overall Study||16||
59757703|NCT04202965|75876867|FG000|COMPLETED|Overall Study||12||
59757704|NCT04202965|75876867|FG000|NOT COMPLETED|Overall Study||4||
59902893|NCT03610334|76024223|FG007|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0||
59902894|NCT03610334|76024224|FG008|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0||
59902895|NCT03610334|76024225|FG009|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0||
59902896|NCT03610334|76024226|FG010|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0||
59902897|NCT03610334|76024227|FG011|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0||
59902898|NCT03610334|76024228|FG012|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0||
59902899|NCT03610334|76024229|FG013|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0||
59902900|NCT03610334|76024230|FG014|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0||
59902901|NCT03610334|76024231|FG015|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0||
59902902|NCT03610334|76024232|FG016|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0||
59902903|NCT03610334|76024233|FG017|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0||
59902904|NCT03610334|76024216|FG000|STARTED|Period 4: 20.0mg (1 Day)||6||
59902905|NCT03610334|76024217|FG001|STARTED|Period 4: 20.0mg (1 Day)||2||
59902906|NCT03610334|76024218|FG002|STARTED|Period 4: 20.0mg (1 Day)||6||
59902907|NCT03610334|76024219|FG003|STARTED|Period 4: 20.0mg (1 Day)||2||
59902908|NCT03610334|76024220|FG004|STARTED|Period 4: 20.0mg (1 Day)||6||
59902909|NCT03610334|76024221|FG005|STARTED|Period 4: 20.0mg (1 Day)||2||
59902910|NCT03610334|76024222|FG006|STARTED|Period 4: 20.0mg (1 Day)||6||
59902911|NCT03610334|76024223|FG007|STARTED|Period 4: 20.0mg (1 Day)||2||
59902912|NCT03610334|76024224|FG008|STARTED|Period 4: 20.0mg (1 Day)||0||
59902913|NCT03610334|76024225|FG009|STARTED|Period 4: 20.0mg (1 Day)||0||
59902914|NCT03610334|76024226|FG010|STARTED|Period 4: 20.0mg (1 Day)||0||
59902915|NCT03610334|76024227|FG011|STARTED|Period 4: 20.0mg (1 Day)||0||
59902916|NCT03610334|76024228|FG012|STARTED|Period 4: 20.0mg (1 Day)||0||
59902917|NCT03610334|76024229|FG013|STARTED|Period 4: 20.0mg (1 Day)||0||
59902918|NCT03610334|76024230|FG014|STARTED|Period 4: 20.0mg (1 Day)||0||
60014444|NCT02438787|76130543|FG000|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|21||
60014445|NCT02438787|76130544|FG001|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|21||
60014446|NCT02438787|76130545|FG002|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|20||
60014447|NCT02438787|76130543|FG000|Cross Over at Week 24|Overall Study|Out of 43: crossed over to Ustekinumab 45 mg (n=21) and Ustekinumab 90 mg (n=22)|43||
60014448|NCT02438787|76130544|FG001|Cross Over at Week 24|Overall Study||0||
60014449|NCT02438787|76130545|FG002|Cross Over at Week 24|Overall Study||0||
60014450|NCT02438787|76130543|FG000|COMPLETED|Overall Study||23||
60014451|NCT02438787|76130544|FG001|COMPLETED|Overall Study||23||
60014452|NCT02438787|76130545|FG002|COMPLETED|Overall Study||22||
60014453|NCT02438787|76130543|FG000|NOT COMPLETED|Overall Study||81||
60014454|NCT02438787|76130544|FG001|NOT COMPLETED|Overall Study||83||
60014455|NCT02438787|76130545|FG002|NOT COMPLETED|Overall Study||83||
60014456|NCT02493777|76130560|FG000|STARTED|Overall Study||65|Randomized safety population|
60014457|NCT02493777|76130561|FG001|STARTED|Overall Study||54|Randomized safety population|
60014458|NCT02493777|76130560|FG000|COMPLETED|Overall Study||65|Population completing 1-week randomized treatment|
60014459|NCT02493777|76130561|FG001|COMPLETED|Overall Study||53|Population completing 1-week randomized treatment|
60014460|NCT02493777|76130560|FG000|NOT COMPLETED|Overall Study||0||
60014461|NCT02493777|76130561|FG001|NOT COMPLETED|Overall Study||1||
60014462|NCT02616601|76130570|FG000|STARTED|Overall Study||140||
59902919|NCT03610334|76024231|FG015|STARTED|Period 4: 20.0mg (1 Day)||0||
59902920|NCT03610334|76024232|FG016|STARTED|Period 4: 20.0mg (1 Day)||0||
59902921|NCT03610334|76024233|FG017|STARTED|Period 4: 20.0mg (1 Day)||0||
59902922|NCT03610334|76024216|FG000|COMPLETED|Period 4: 20.0mg (1 Day)||6||
59902923|NCT03610334|76024217|FG001|COMPLETED|Period 4: 20.0mg (1 Day)||2||
59902924|NCT03610334|76024218|FG002|COMPLETED|Period 4: 20.0mg (1 Day)||6||
59902925|NCT03610334|76024219|FG003|COMPLETED|Period 4: 20.0mg (1 Day)||2||
59902926|NCT03610334|76024220|FG004|COMPLETED|Period 4: 20.0mg (1 Day)||6||
59902927|NCT03610334|76024221|FG005|COMPLETED|Period 4: 20.0mg (1 Day)||2||
59902928|NCT03610334|76024222|FG006|COMPLETED|Period 4: 20.0mg (1 Day)||6||
59902929|NCT03610334|76024223|FG007|COMPLETED|Period 4: 20.0mg (1 Day)||2||
60014463|NCT02616601|76130571|FG001|STARTED|Overall Study||140||
60014464|NCT02616601|76130572|FG002|STARTED|Overall Study||142||
60014465|NCT02616601|76130570|FG000|Safety Population|Overall Study||140|Randomized participants who received the study drug.|
60014466|NCT02616601|76130571|FG001|Safety Population|Overall Study||140|Randomized participants who received the study drug.|
60014467|NCT02616601|76130572|FG002|Safety Population|Overall Study||142|Randomized participants who received the study drug.|
60014468|NCT02616601|76130570|FG000|mITT Population|Overall Study||137|Randomized participants, applied ≥1 dose study drug, returned for ≥1 post-baseline evaluation visit|
60014469|NCT02616601|76130571|FG001|mITT Population|Overall Study||136|Randomized participants, applied ≥1 dose study drug, returned for ≥1 post-baseline evaluation visit|
60014470|NCT02616601|76130572|FG002|mITT Population|Overall Study||138|Randomized participants, applied ≥1 dose study drug, returned for ≥1 post-baseline evaluation visit|
59902930|NCT03610334|76024224|FG008|COMPLETED|Period 4: 20.0mg (1 Day)||0||
59902931|NCT03610334|76024225|FG009|COMPLETED|Period 4: 20.0mg (1 Day)||0||
59902932|NCT03610334|76024226|FG010|COMPLETED|Period 4: 20.0mg (1 Day)||0||
59902933|NCT03610334|76024227|FG011|COMPLETED|Period 4: 20.0mg (1 Day)||0||
60014471|NCT02616601|76130570|FG000|PP Population|Overall Study||112|mITT, >75-125% doses and >6 consecutive doses or discontinued for lack of treatment- completed ≥8wks|
59505902|NCT00784225|75598807|FG003|NOT COMPLETED|Overall Study||0||
59902934|NCT03610334|76024228|FG012|COMPLETED|Period 4: 20.0mg (1 Day)||0||
59902935|NCT03610334|76024229|FG013|COMPLETED|Period 4: 20.0mg (1 Day)||0||
59902936|NCT03610334|76024230|FG014|COMPLETED|Period 4: 20.0mg (1 Day)||0||
59902937|NCT03610334|76024231|FG015|COMPLETED|Period 4: 20.0mg (1 Day)||0||
59902938|NCT03610334|76024232|FG016|COMPLETED|Period 4: 20.0mg (1 Day)||0||
59902939|NCT03610334|76024233|FG017|COMPLETED|Period 4: 20.0mg (1 Day)||0||
59902940|NCT03610334|76024216|FG000|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0||
59902941|NCT03610334|76024217|FG001|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0||
59902942|NCT03610334|76024218|FG002|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0||
59902943|NCT03610334|76024219|FG003|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0||
59902944|NCT03610334|76024220|FG004|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0||
59902945|NCT03610334|76024221|FG005|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0||
60014472|NCT02616601|76130571|FG001|PP Population|Overall Study||121|mITT, >75-125% doses and >6 consecutive doses or discontinued for lack of treatment- completed ≥8wks|
60014473|NCT02616601|76130572|FG002|PP Population|Overall Study||123|mITT, >75-125% doses and >6 consecutive doses or discontinued for lack of treatment- completed ≥8wks|
60014474|NCT02616601|76130570|FG000|COMPLETED|Overall Study||131||
60014475|NCT02616601|76130571|FG001|COMPLETED|Overall Study||136||
60014476|NCT02616601|76130572|FG002|COMPLETED|Overall Study||135||
60014477|NCT02616601|76130570|FG000|NOT COMPLETED|Overall Study||9||
60014478|NCT02616601|76130571|FG001|NOT COMPLETED|Overall Study||4||
60014479|NCT02616601|76130572|FG002|NOT COMPLETED|Overall Study||7||
59505903|NCT01275131|75598825|FG000|STARTED|Period 1||11||
59505904|NCT01275131|75598826|FG001|STARTED|Period 1||9||
59505905|NCT01275131|75598827|FG002|STARTED|Period 1||13||
59505906|NCT01275131|75598828|FG003|STARTED|Period 1||12||
59505907|NCT01275131|75598825|FG000|Received at Least One Dose of Study Drug|Period 1||11||
59505908|NCT01275131|75598826|FG001|Received at Least One Dose of Study Drug|Period 1||9||
59505909|NCT01275131|75598827|FG002|Received at Least One Dose of Study Drug|Period 1||13||
59505910|NCT01275131|75598828|FG003|Received at Least One Dose of Study Drug|Period 1||12||
60014480|NCT02492997|76130582|FG000|STARTED|Overall Study||21||
60014481|NCT02492997|76130583|FG001|STARTED|Overall Study||21||
60014482|NCT02492997|76130582|FG000|COMPLETED|Overall Study||19||
60014483|NCT02492997|76130583|FG001|COMPLETED|Overall Study||20||
60014484|NCT02492997|76130582|FG000|NOT COMPLETED|Overall Study||2||
60014485|NCT02492997|76130583|FG001|NOT COMPLETED|Overall Study||1||
60014486|NCT02437305|76130591|FG000|STARTED|Overall Study||50||
60014487|NCT02437305|76130592|FG001|STARTED|Overall Study||50||
60014488|NCT02437305|76130591|FG000|COMPLETED|Overall Study||32||
60014489|NCT02437305|76130592|FG001|COMPLETED|Overall Study||38||
60014490|NCT02437305|76130591|FG000|NOT COMPLETED|Overall Study||18||
60014491|NCT02437305|76130592|FG001|NOT COMPLETED|Overall Study||12||
60014492|NCT02492841|76130601|FG000|STARTED|Overall Study||56||
60014493|NCT02492841|76130602|FG001|STARTED|Overall Study||53||
60014494|NCT02492841|76130603|FG002|STARTED|Overall Study||60||
60014495|NCT02492841|76130601|FG000|COMPLETED|Overall Study||22||
60014496|NCT02492841|76130602|FG001|COMPLETED|Overall Study||22||
59505911|NCT01275131|75598825|FG000|COMPLETED|Period 1||9||
59902946|NCT03610334|76024222|FG006|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0||
59902947|NCT03610334|76024223|FG007|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0||
59902948|NCT03610334|76024224|FG008|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0||
59902949|NCT03610334|76024225|FG009|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0||
59902950|NCT03610334|76024226|FG010|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0||
60014497|NCT02492841|76130603|FG002|COMPLETED|Overall Study||25||
60014498|NCT02492841|76130601|FG000|NOT COMPLETED|Overall Study||34||
60014499|NCT02492841|76130602|FG001|NOT COMPLETED|Overall Study||31||
60014500|NCT02492841|76130603|FG002|NOT COMPLETED|Overall Study||35||
60014501|NCT02436915|76130616|FG000|STARTED|Overall Study||9||
60014502|NCT02436915|76130617|FG001|STARTED|Overall Study||10||
60014503|NCT02436915|76130616|FG000|COMPLETED|Overall Study||9||
59902951|NCT03610334|76024227|FG011|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0||
59902952|NCT03610334|76024228|FG012|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0||
60014504|NCT02436915|76130617|FG001|COMPLETED|Overall Study||9||
60014505|NCT02436915|76130616|FG000|NOT COMPLETED|Overall Study||0||
60014506|NCT02436915|76130617|FG001|NOT COMPLETED|Overall Study||1||
60014507|NCT02492763|76130629|FG000|STARTED|Overall Study||46||
60014508|NCT02492763|76130630|FG001|STARTED|Overall Study||44||
60014509|NCT02492763|76130631|FG002|STARTED|Overall Study||43||
59902953|NCT03610334|76024229|FG013|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0||
59902954|NCT03610334|76024230|FG014|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0||
59902955|NCT03610334|76024231|FG015|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0||
59902956|NCT03610334|76024232|FG016|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0||
59902957|NCT03610334|76024233|FG017|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0||
59902958|NCT03610334|76024216|FG000|STARTED|Period 5: 40.0mg (1 Day)||6||
59902959|NCT03610334|76024217|FG001|STARTED|Period 5: 40.0mg (1 Day)||2||
59902960|NCT03610334|76024218|FG002|STARTED|Period 5: 40.0mg (1 Day)||6||
59902961|NCT03610334|76024219|FG003|STARTED|Period 5: 40.0mg (1 Day)||2||
59902962|NCT03610334|76024220|FG004|STARTED|Period 5: 40.0mg (1 Day)||6||
59902963|NCT03610334|76024221|FG005|STARTED|Period 5: 40.0mg (1 Day)||2||
59902964|NCT03610334|76024222|FG006|STARTED|Period 5: 40.0mg (1 Day)||6||
59902965|NCT03610334|76024223|FG007|STARTED|Period 5: 40.0mg (1 Day)||2||
59902966|NCT03610334|76024224|FG008|STARTED|Period 5: 40.0mg (1 Day)||6||
59902967|NCT03610334|76024225|FG009|STARTED|Period 5: 40.0mg (1 Day)||2||
59902968|NCT03610334|76024226|FG010|STARTED|Period 5: 40.0mg (1 Day)||0||
59902969|NCT03610334|76024227|FG011|STARTED|Period 5: 40.0mg (1 Day)||0||
59902970|NCT03610334|76024228|FG012|STARTED|Period 5: 40.0mg (1 Day)||0||
59902971|NCT03610334|76024229|FG013|STARTED|Period 5: 40.0mg (1 Day)||0||
59902972|NCT03610334|76024230|FG014|STARTED|Period 5: 40.0mg (1 Day)||0||
59902973|NCT03610334|76024231|FG015|STARTED|Period 5: 40.0mg (1 Day)||0||
59902974|NCT03610334|76024232|FG016|STARTED|Period 5: 40.0mg (1 Day)||0||
59902975|NCT03610334|76024233|FG017|STARTED|Period 5: 40.0mg (1 Day)||0||
59902976|NCT03610334|76024216|FG000|COMPLETED|Period 5: 40.0mg (1 Day)||6||
59902977|NCT03610334|76024217|FG001|COMPLETED|Period 5: 40.0mg (1 Day)||2||
59902978|NCT03610334|76024218|FG002|COMPLETED|Period 5: 40.0mg (1 Day)||6||
59902979|NCT03610334|76024219|FG003|COMPLETED|Period 5: 40.0mg (1 Day)||2||
59902980|NCT03610334|76024220|FG004|COMPLETED|Period 5: 40.0mg (1 Day)||6||
59902981|NCT03610334|76024221|FG005|COMPLETED|Period 5: 40.0mg (1 Day)||2||
59902982|NCT03610334|76024222|FG006|COMPLETED|Period 5: 40.0mg (1 Day)||6||
59902983|NCT03610334|76024223|FG007|COMPLETED|Period 5: 40.0mg (1 Day)||2||
59902984|NCT03610334|76024224|FG008|COMPLETED|Period 5: 40.0mg (1 Day)||6||
59902985|NCT03610334|76024225|FG009|COMPLETED|Period 5: 40.0mg (1 Day)||2||
59902986|NCT03610334|76024226|FG010|COMPLETED|Period 5: 40.0mg (1 Day)||0||
59902987|NCT03610334|76024227|FG011|COMPLETED|Period 5: 40.0mg (1 Day)||0||
59902988|NCT03610334|76024228|FG012|COMPLETED|Period 5: 40.0mg (1 Day)||0||
59902989|NCT03610334|76024229|FG013|COMPLETED|Period 5: 40.0mg (1 Day)||0||
59902990|NCT03610334|76024230|FG014|COMPLETED|Period 5: 40.0mg (1 Day)||0||
59902991|NCT03610334|76024231|FG015|COMPLETED|Period 5: 40.0mg (1 Day)||0||
59902992|NCT03610334|76024232|FG016|COMPLETED|Period 5: 40.0mg (1 Day)||0||
59902993|NCT03610334|76024233|FG017|COMPLETED|Period 5: 40.0mg (1 Day)||0||
59902994|NCT03610334|76024216|FG000|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0||
59902995|NCT03610334|76024217|FG001|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0||
59902996|NCT03610334|76024218|FG002|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0||
59902997|NCT03610334|76024219|FG003|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0||
59902998|NCT03610334|76024220|FG004|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0||
59902999|NCT03610334|76024221|FG005|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0||
59903000|NCT03610334|76024222|FG006|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0||
59903001|NCT03610334|76024223|FG007|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0||
60014510|NCT02492763|76130632|FG003|STARTED|Overall Study||43||
60014511|NCT02492763|76130629|FG000|Treated|Overall Study||46||
59903002|NCT03610334|76024224|FG008|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0||
59903003|NCT03610334|76024225|FG009|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0||
59903004|NCT03610334|76024226|FG010|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0||
59903005|NCT03610334|76024227|FG011|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0||
59903006|NCT03610334|76024228|FG012|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0||
59903007|NCT03610334|76024229|FG013|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0||
59903008|NCT03610334|76024230|FG014|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0||
59903009|NCT03610334|76024231|FG015|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0||
59903010|NCT03610334|76024232|FG016|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0||
59903011|NCT03610334|76024233|FG017|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0||
59903012|NCT03610334|76024216|FG000|STARTED|Period 6: 60.0mg (1 Day)||6||
59903013|NCT03610334|76024217|FG001|STARTED|Period 6: 60.0mg (1 Day)||2||
60014512|NCT02492763|76130630|FG001|Treated|Overall Study||44||
59903014|NCT03610334|76024218|FG002|STARTED|Period 6: 60.0mg (1 Day)||6||
59903015|NCT03610334|76024219|FG003|STARTED|Period 6: 60.0mg (1 Day)||2||
59903016|NCT03610334|76024220|FG004|STARTED|Period 6: 60.0mg (1 Day)||6||
60014513|NCT02492763|76130631|FG002|Treated|Overall Study||43||
59903017|NCT03610334|76024221|FG005|STARTED|Period 6: 60.0mg (1 Day)||2||
59903018|NCT03610334|76024222|FG006|STARTED|Period 6: 60.0mg (1 Day)||6||
59903019|NCT03610334|76024223|FG007|STARTED|Period 6: 60.0mg (1 Day)||2||
59903020|NCT03610334|76024224|FG008|STARTED|Period 6: 60.0mg (1 Day)||6||
59903021|NCT03610334|76024225|FG009|STARTED|Period 6: 60.0mg (1 Day)||2||
59903022|NCT03610334|76024226|FG010|STARTED|Period 6: 60.0mg (1 Day)||6||
59903023|NCT03610334|76024227|FG011|STARTED|Period 6: 60.0mg (1 Day)||2||
59903024|NCT03610334|76024228|FG012|STARTED|Period 6: 60.0mg (1 Day)||0||
59903025|NCT03610334|76024229|FG013|STARTED|Period 6: 60.0mg (1 Day)||0||
59903026|NCT03610334|76024230|FG014|STARTED|Period 6: 60.0mg (1 Day)||0||
59903027|NCT03610334|76024231|FG015|STARTED|Period 6: 60.0mg (1 Day)||0||
59903028|NCT03610334|76024232|FG016|STARTED|Period 6: 60.0mg (1 Day)||0||
59505912|NCT01275131|75598826|FG001|COMPLETED|Period 1||9||
59505913|NCT01275131|75598827|FG002|COMPLETED|Period 1||10||
59505914|NCT01275131|75598828|FG003|COMPLETED|Period 1||10||
59505915|NCT01275131|75598825|FG000|NOT COMPLETED|Period 1||2||
59505916|NCT01275131|75598826|FG001|NOT COMPLETED|Period 1||0||
59505917|NCT01275131|75598827|FG002|NOT COMPLETED|Period 1||3||
59505918|NCT01275131|75598828|FG003|NOT COMPLETED|Period 1||2||
59505919|NCT01275131|75598825|FG000|STARTED|5- to 14-Day Washout Period||9||
59505920|NCT01275131|75598826|FG001|STARTED|5- to 14-Day Washout Period||9||
59505921|NCT01275131|75598827|FG002|STARTED|5- to 14-Day Washout Period||10||
59505922|NCT01275131|75598828|FG003|STARTED|5- to 14-Day Washout Period||10||
59505923|NCT01275131|75598825|FG000|COMPLETED|5- to 14-Day Washout Period||9||
59757705|NCT04056624|75876875|FG000|STARTED|Overall Study||53||
59757706|NCT04056624|75876876|FG001|STARTED|Overall Study||56||
59757707|NCT04056624|75876877|FG002|STARTED|Overall Study||53||
59757708|NCT04056624|75876875|FG000|COMPLETED|Overall Study||52||
59757709|NCT04056624|75876876|FG001|COMPLETED|Overall Study||54||
59757710|NCT04056624|75876877|FG002|COMPLETED|Overall Study||52||
59757711|NCT04056624|75876875|FG000|NOT COMPLETED|Overall Study||1||
59757712|NCT04056624|75876876|FG001|NOT COMPLETED|Overall Study||2||
59757713|NCT04056624|75876877|FG002|NOT COMPLETED|Overall Study||1||
59757714|NCT03985098|75876887|FG000|STARTED|Overall Study||247||
59757715|NCT03985098|75876888|FG001|STARTED|Overall Study||480||
59757716|NCT03985098|75876887|FG000|COMPLETED|Overall Study||240||
59757717|NCT03985098|75876888|FG001|COMPLETED|Overall Study||480||
59757718|NCT03985098|75876887|FG000|NOT COMPLETED|Overall Study||7||
59757719|NCT03985098|75876888|FG001|NOT COMPLETED|Overall Study||0||
59757720|NCT03870763|75876897|FG000|STARTED|Overall Study||2||
59757721|NCT03870763|75876898|FG001|STARTED|Overall Study||6||
59757722|NCT03870763|75876899|FG002|STARTED|Overall Study||3||
59757723|NCT03870763|75876897|FG000|COMPLETED|Overall Study||2||
59757724|NCT03870763|75876898|FG001|COMPLETED|Overall Study||3||
59757725|NCT03870763|75876899|FG002|COMPLETED|Overall Study||2||
59757726|NCT03870763|75876897|FG000|NOT COMPLETED|Overall Study||0||
59757727|NCT03870763|75876898|FG001|NOT COMPLETED|Overall Study||3||
59757728|NCT03870763|75876899|FG002|NOT COMPLETED|Overall Study||1||
59757729|NCT03647501|75876909|FG000|STARTED|Overall Study||25||
59757730|NCT03647501|75876910|FG001|STARTED|Overall Study||28||
59757731|NCT03647501|75876909|FG000|COMPLETED|Overall Study||24||
59757732|NCT03647501|75876910|FG001|COMPLETED|Overall Study||26||
59757733|NCT03647501|75876909|FG000|NOT COMPLETED|Overall Study||1||
59757734|NCT03647501|75876910|FG001|NOT COMPLETED|Overall Study||2||
59757735|NCT03634228|75876919|FG000|STARTED|Overall Study||3||
59757736|NCT03634228|75876920|FG001|STARTED|Overall Study||6||
59757737|NCT03634228|75876921|FG002|STARTED|Overall Study||7||
59757738|NCT03634228|75876922|FG003|STARTED|Overall Study||0||
59757739|NCT03634228|75876919|FG000|COMPLETED|Overall Study||3||
59757740|NCT03634228|75876920|FG001|COMPLETED|Overall Study||6||
59757741|NCT03634228|75876921|FG002|COMPLETED|Overall Study||7||
59757742|NCT03634228|75876922|FG003|COMPLETED|Overall Study||0||
59757743|NCT03634228|75876919|FG000|NOT COMPLETED|Overall Study||0||
59757744|NCT03634228|75876920|FG001|NOT COMPLETED|Overall Study||0||
59757745|NCT03634228|75876921|FG002|NOT COMPLETED|Overall Study||0||
59757746|NCT03634228|75876922|FG003|NOT COMPLETED|Overall Study||0||
59903029|NCT03610334|76024233|FG017|STARTED|Period 6: 60.0mg (1 Day)||0||
59903030|NCT03610334|76024216|FG000|COMPLETED|Period 6: 60.0mg (1 Day)||6||
59903031|NCT03610334|76024217|FG001|COMPLETED|Period 6: 60.0mg (1 Day)||2||
59903032|NCT03610334|76024218|FG002|COMPLETED|Period 6: 60.0mg (1 Day)||6||
59903033|NCT03610334|76024219|FG003|COMPLETED|Period 6: 60.0mg (1 Day)||2||
59505924|NCT01275131|75598826|FG001|COMPLETED|5- to 14-Day Washout Period||9||
59505925|NCT01275131|75598827|FG002|COMPLETED|5- to 14-Day Washout Period||10||
59505926|NCT01275131|75598828|FG003|COMPLETED|5- to 14-Day Washout Period||10||
59505927|NCT01275131|75598825|FG000|NOT COMPLETED|5- to 14-Day Washout Period||0||
59505928|NCT01275131|75598826|FG001|NOT COMPLETED|5- to 14-Day Washout Period||0||
59757747|NCT03617783|75876933|FG000|STARTED|Overall Study||9||
59757748|NCT03617783|75876934|FG001|STARTED|Overall Study||13||
59757749|NCT03617783|75876933|FG000|COMPLETED|Overall Study||8||
59757750|NCT03617783|75876934|FG001|COMPLETED|Overall Study||12||
59757751|NCT03617783|75876933|FG000|NOT COMPLETED|Overall Study||1||
59757752|NCT03617783|75876934|FG001|NOT COMPLETED|Overall Study||1||
59757753|NCT03587142|75876942|FG000|STARTED|Overall Study||47||
59611388|NCT01780584|75722353|FG002|STARTED|Overall Study||15||
59903034|NCT03610334|76024220|FG004|COMPLETED|Period 6: 60.0mg (1 Day)||6||
59903035|NCT03610334|76024221|FG005|COMPLETED|Period 6: 60.0mg (1 Day)||2||
59903036|NCT03610334|76024222|FG006|COMPLETED|Period 6: 60.0mg (1 Day)||6||
59903037|NCT03610334|76024223|FG007|COMPLETED|Period 6: 60.0mg (1 Day)||2||
59903038|NCT03610334|76024224|FG008|COMPLETED|Period 6: 60.0mg (1 Day)||6||
59903039|NCT03610334|76024225|FG009|COMPLETED|Period 6: 60.0mg (1 Day)||2||
59903040|NCT03610334|76024226|FG010|COMPLETED|Period 6: 60.0mg (1 Day)||6||
59903041|NCT03610334|76024227|FG011|COMPLETED|Period 6: 60.0mg (1 Day)||2||
59903042|NCT03610334|76024228|FG012|COMPLETED|Period 6: 60.0mg (1 Day)||0||
59505929|NCT01275131|75598827|FG002|NOT COMPLETED|5- to 14-Day Washout Period||0||
59505930|NCT01275131|75598828|FG003|NOT COMPLETED|5- to 14-Day Washout Period||0||
59505931|NCT01275131|75598825|FG000|STARTED|Period 2 (Crossover)||9||
59505932|NCT01275131|75598826|FG001|STARTED|Period 2 (Crossover)||9||
59505933|NCT01275131|75598827|FG002|STARTED|Period 2 (Crossover)||10||
59505934|NCT01275131|75598828|FG003|STARTED|Period 2 (Crossover)||10||
59505935|NCT01275131|75598825|FG000|COMPLETED|Period 2 (Crossover)||8||
59505936|NCT01275131|75598826|FG001|COMPLETED|Period 2 (Crossover)||8||
59505937|NCT01275131|75598827|FG002|COMPLETED|Period 2 (Crossover)||9||
59903043|NCT03610334|76024229|FG013|COMPLETED|Period 6: 60.0mg (1 Day)||0||
59903044|NCT03610334|76024230|FG014|COMPLETED|Period 6: 60.0mg (1 Day)||0||
59903045|NCT03610334|76024231|FG015|COMPLETED|Period 6: 60.0mg (1 Day)||0||
59903046|NCT03610334|76024232|FG016|COMPLETED|Period 6: 60.0mg (1 Day)||0||
59903047|NCT03610334|76024233|FG017|COMPLETED|Period 6: 60.0mg (1 Day)||0||
59903048|NCT03610334|76024216|FG000|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0||
59903049|NCT03610334|76024217|FG001|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0||
59903050|NCT03610334|76024218|FG002|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0||
59903051|NCT03610334|76024219|FG003|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0||
59903052|NCT03610334|76024220|FG004|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0||
59903053|NCT03610334|76024221|FG005|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0||
59903054|NCT03610334|76024222|FG006|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0||
59903055|NCT03610334|76024223|FG007|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0||
59903056|NCT03610334|76024224|FG008|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0||
59903057|NCT03610334|76024225|FG009|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0||
59903058|NCT03610334|76024226|FG010|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0||
59903059|NCT03610334|76024227|FG011|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0||
59903060|NCT03610334|76024228|FG012|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0||
59903061|NCT03610334|76024229|FG013|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0||
59903062|NCT03610334|76024230|FG014|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0||
59903063|NCT03610334|76024231|FG015|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0||
59903064|NCT03610334|76024232|FG016|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0||
59505938|NCT01275131|75598828|FG003|COMPLETED|Period 2 (Crossover)||8||
59611389|NCT01780584|75722351|FG000|COMPLETED|Overall Study||14||
59611390|NCT01780584|75722352|FG001|COMPLETED|Overall Study||14||
60014514|NCT02492763|76130632|FG003|Treated|Overall Study||42||
60014515|NCT02492763|76130629|FG000|COMPLETED|Overall Study||30||
60014516|NCT02492763|76130630|FG001|COMPLETED|Overall Study||29||
59903065|NCT03610334|76024233|FG017|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0||
59903066|NCT03610334|76024216|FG000|STARTED|Period 7: 15.0mg (Day 1 to 14)||6||
59903067|NCT03610334|76024217|FG001|STARTED|Period 7: 15.0mg (Day 1 to 14)||2||
59903068|NCT03610334|76024218|FG002|STARTED|Period 7: 15.0mg (Day 1 to 14)||6||
59903069|NCT03610334|76024219|FG003|STARTED|Period 7: 15.0mg (Day 1 to 14)||2||
59903070|NCT03610334|76024220|FG004|STARTED|Period 7: 15.0mg (Day 1 to 14)||6||
59505939|NCT01275131|75598825|FG000|NOT COMPLETED|Period 2 (Crossover)||1||
59903071|NCT03610334|76024221|FG005|STARTED|Period 7: 15.0mg (Day 1 to 14)||2||
59903072|NCT03610334|76024222|FG006|STARTED|Period 7: 15.0mg (Day 1 to 14)||6||
59903073|NCT03610334|76024223|FG007|STARTED|Period 7: 15.0mg (Day 1 to 14)||2||
59903074|NCT03610334|76024224|FG008|STARTED|Period 7: 15.0mg (Day 1 to 14)||6||
59903075|NCT03610334|76024225|FG009|STARTED|Period 7: 15.0mg (Day 1 to 14)||2||
59903076|NCT03610334|76024226|FG010|STARTED|Period 7: 15.0mg (Day 1 to 14)||6||
59505940|NCT01275131|75598826|FG001|NOT COMPLETED|Period 2 (Crossover)||1||
59505941|NCT01275131|75598827|FG002|NOT COMPLETED|Period 2 (Crossover)||1||
59505942|NCT01275131|75598828|FG003|NOT COMPLETED|Period 2 (Crossover)||2||
59505943|NCT00749957|75598848|FG000|STARTED|Overall Study||6||
59611391|NCT01780584|75722353|FG002|COMPLETED|Overall Study||13||
59611392|NCT01780584|75722351|FG000|NOT COMPLETED|Overall Study||1||
59611393|NCT01780584|75722352|FG001|NOT COMPLETED|Overall Study||1||
59611394|NCT01780584|75722353|FG002|NOT COMPLETED|Overall Study||2||
59903077|NCT03610334|76024227|FG011|STARTED|Period 7: 15.0mg (Day 1 to 14)||2||
59903078|NCT03610334|76024228|FG012|STARTED|Period 7: 15.0mg (Day 1 to 14)||6||
59903079|NCT03610334|76024229|FG013|STARTED|Period 7: 15.0mg (Day 1 to 14)||2||
59903080|NCT03610334|76024230|FG014|STARTED|Period 7: 15.0mg (Day 1 to 14)||0||
59903081|NCT03610334|76024231|FG015|STARTED|Period 7: 15.0mg (Day 1 to 14)||0||
60014517|NCT02492763|76130631|FG002|COMPLETED|Overall Study||33||
59611395|NCT01780506|75722363|FG000|STARTED|Double-Blind Phase||438||
60014518|NCT02492763|76130632|FG003|COMPLETED|Overall Study||30||
60014519|NCT02492763|76130629|FG000|NOT COMPLETED|Overall Study||16||
60014520|NCT02492763|76130630|FG001|NOT COMPLETED|Overall Study||15||
60014521|NCT02492763|76130631|FG002|NOT COMPLETED|Overall Study||10||
60014522|NCT02492763|76130632|FG003|NOT COMPLETED|Overall Study||13||
60014523|NCT02491671|76130644|FG000|STARTED|Overall Study||129||
60014524|NCT02491671|76130645|FG001|STARTED|Overall Study||131||
60014525|NCT02491671|76130644|FG000|COMPLETED|Overall Study||118||
60014526|NCT02491671|76130645|FG001|COMPLETED|Overall Study||118||
60014527|NCT02491671|76130644|FG000|NOT COMPLETED|Overall Study||11||
60014528|NCT02491671|76130645|FG001|NOT COMPLETED|Overall Study||13||
59903082|NCT03610334|76024232|FG016|STARTED|Period 7: 15.0mg (Day 1 to 14)||0||
59903083|NCT03610334|76024233|FG017|STARTED|Period 7: 15.0mg (Day 1 to 14)||0||
59903084|NCT03610334|76024216|FG000|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||6||
59903085|NCT03610334|76024217|FG001|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||2||
59903086|NCT03610334|76024218|FG002|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||6||
59903087|NCT03610334|76024219|FG003|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||2||
60014529|NCT02453841|76130651|FG000|STARTED|Overall Study||30||
60014530|NCT02453841|76130651|FG000|COMPLETED|Overall Study||27||
60014531|NCT02453841|76130651|FG000|NOT COMPLETED|Overall Study||3||
60014532|NCT02453685|76130657|FG000|STARTED|Overall Study||168||
60014533|NCT02453685|76130658|FG001|STARTED|Overall Study||167||
60014534|NCT02453685|76130657|FG000|Exposed|Overall Study||166||
60014535|NCT02453685|76130658|FG001|Exposed|Overall Study||166||
60014536|NCT02453685|76130657|FG000|COMPLETED|Overall Study||149||
60014537|NCT02453685|76130658|FG001|COMPLETED|Overall Study||155||
60014538|NCT02453685|76130657|FG000|NOT COMPLETED|Overall Study||19||
60014539|NCT02453685|76130658|FG001|NOT COMPLETED|Overall Study||12||
60014540|NCT02436759|76130666|FG000|STARTED|Overall Study||94||
60014541|NCT02436759|76130667|FG001|STARTED|Overall Study||46||
60014542|NCT02436759|76130666|FG000|Subjects Randomized|Overall Study||94||
60014543|NCT02436759|76130667|FG001|Subjects Randomized|Overall Study||46||
59505944|NCT00749957|75598849|FG001|STARTED|Overall Study||6||
59505945|NCT00749957|75598848|FG000|COMPLETED|Overall Study||6||
59505946|NCT00749957|75598849|FG001|COMPLETED|Overall Study||6||
59505947|NCT00749957|75598848|FG000|NOT COMPLETED|Overall Study||0||
59505948|NCT00749957|75598849|FG001|NOT COMPLETED|Overall Study||0||
59505949|NCT01274429|75598857|FG000|STARTED|Overall Study||5||
59505950|NCT01274429|75598857|FG000|COMPLETED|Overall Study||0||
59903088|NCT03610334|76024220|FG004|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||6||
59903089|NCT03610334|76024221|FG005|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||2||
59903090|NCT03610334|76024222|FG006|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||6||
59903091|NCT03610334|76024223|FG007|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||2||
59903092|NCT03610334|76024224|FG008|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||6||
59903093|NCT03610334|76024225|FG009|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||2||
59903094|NCT03610334|76024226|FG010|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||6||
59903095|NCT03610334|76024227|FG011|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||2||
59903096|NCT03610334|76024228|FG012|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||6||
59903097|NCT03610334|76024229|FG013|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||2||
59903098|NCT03610334|76024230|FG014|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0||
59903099|NCT03610334|76024231|FG015|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0||
59903100|NCT03610334|76024232|FG016|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0||
59903101|NCT03610334|76024233|FG017|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0||
59903102|NCT03610334|76024216|FG000|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0||
59903103|NCT03610334|76024217|FG001|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0||
59903104|NCT03610334|76024218|FG002|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0||
59903105|NCT03610334|76024219|FG003|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0||
60014544|NCT02436759|76130666|FG000|Subjects Treated|Overall Study||94||
60014545|NCT02436759|76130667|FG001|Subjects Treated|Overall Study||46||
60014546|NCT02436759|76130666|FG000|COMPLETED|Overall Study||90||
60014547|NCT02436759|76130667|FG001|COMPLETED|Overall Study||45||
60014548|NCT02436759|76130666|FG000|NOT COMPLETED|Overall Study||4||
60014549|NCT02436759|76130667|FG001|NOT COMPLETED|Overall Study||1||
60014550|NCT02436681|76130673|FG000|STARTED|Overall Study||41||
60014551|NCT02436681|76130673|FG000|COMPLETED|Overall Study||27||
60014552|NCT02436681|76130673|FG000|NOT COMPLETED|Overall Study||14||
60014553|NCT02436135|76130679|FG000|STARTED|Overall Study||6||
60014554|NCT02436135|76130680|FG001|STARTED|Overall Study||4||
60014555|NCT02436135|76130679|FG000|COMPLETED|Overall Study||0||
60014556|NCT02436135|76130680|FG001|COMPLETED|Overall Study||0||
60014557|NCT02436135|76130679|FG000|NOT COMPLETED|Overall Study||6||
60014558|NCT02436135|76130680|FG001|NOT COMPLETED|Overall Study||4||
60014559|NCT02489799|76130688|FG000|STARTED|Overall Study||45||
60014560|NCT02489799|76130689|FG001|STARTED|Overall Study||47||
60014561|NCT02489799|76130688|FG000|Presurgical Consent Visit (V2)|Overall Study||40||
60014562|NCT02489799|76130689|FG001|Presurgical Consent Visit (V2)|Overall Study||39||
60014563|NCT02489799|76130688|FG000|Postsurgical One Week Visit (V3)|Overall Study||40||
59505951|NCT01274429|75598857|FG000|NOT COMPLETED|Overall Study||5||
59518990|NCT03587428|75612875|FG005|COMPLETED|Period 1||2||
60014564|NCT02489799|76130689|FG001|Postsurgical One Week Visit (V3)|Overall Study||39||
60014565|NCT02489799|76130688|FG000|COMPLETED|Overall Study||36||
60014566|NCT02489799|76130689|FG001|COMPLETED|Overall Study||38||
60014567|NCT02489799|76130688|FG000|NOT COMPLETED|Overall Study||9||
60014568|NCT02489799|76130689|FG001|NOT COMPLETED|Overall Study||9||
59903106|NCT03610334|76024220|FG004|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0||
59903107|NCT03610334|76024221|FG005|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0||
59903108|NCT03610334|76024222|FG006|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0||
59903109|NCT03610334|76024223|FG007|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0||
59903110|NCT03610334|76024224|FG008|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0||
59903111|NCT03610334|76024225|FG009|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0||
59903112|NCT03610334|76024226|FG010|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0||
59903113|NCT03610334|76024227|FG011|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0||
59903114|NCT03610334|76024228|FG012|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0||
59903115|NCT03610334|76024229|FG013|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0||
59903116|NCT03610334|76024230|FG014|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0||
59903117|NCT03610334|76024231|FG015|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0||
59903118|NCT03610334|76024232|FG016|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0||
59903119|NCT03610334|76024233|FG017|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0||
59903120|NCT03610334|76024216|FG000|STARTED|Period 8: 30.0mg (Day 1 to 14)||6||
59903121|NCT03610334|76024217|FG001|STARTED|Period 8: 30.0mg (Day 1 to 14)||2||
59903122|NCT03610334|76024218|FG002|STARTED|Period 8: 30.0mg (Day 1 to 14)||6||
59903123|NCT03610334|76024219|FG003|STARTED|Period 8: 30.0mg (Day 1 to 14)||2||
59903124|NCT03610334|76024220|FG004|STARTED|Period 8: 30.0mg (Day 1 to 14)||6||
59903125|NCT03610334|76024221|FG005|STARTED|Period 8: 30.0mg (Day 1 to 14)||2||
59903126|NCT03610334|76024222|FG006|STARTED|Period 8: 30.0mg (Day 1 to 14)||6||
59903127|NCT03610334|76024223|FG007|STARTED|Period 8: 30.0mg (Day 1 to 14)||2||
59903128|NCT03610334|76024224|FG008|STARTED|Period 8: 30.0mg (Day 1 to 14)||6||
59903129|NCT03610334|76024225|FG009|STARTED|Period 8: 30.0mg (Day 1 to 14)||2||
59903130|NCT03610334|76024226|FG010|STARTED|Period 8: 30.0mg (Day 1 to 14)||6||
59903131|NCT03610334|76024227|FG011|STARTED|Period 8: 30.0mg (Day 1 to 14)||2||
59903132|NCT03610334|76024228|FG012|STARTED|Period 8: 30.0mg (Day 1 to 14)||6||
59903133|NCT03610334|76024229|FG013|STARTED|Period 8: 30.0mg (Day 1 to 14)||2||
59903134|NCT03610334|76024230|FG014|STARTED|Period 8: 30.0mg (Day 1 to 14)||6||
59903135|NCT03610334|76024231|FG015|STARTED|Period 8: 30.0mg (Day 1 to 14)||2||
59903136|NCT03610334|76024232|FG016|STARTED|Period 8: 30.0mg (Day 1 to 14)||0||
59903137|NCT03610334|76024233|FG017|STARTED|Period 8: 30.0mg (Day 1 to 14)||0||
59903138|NCT03610334|76024216|FG000|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||6||
59903139|NCT03610334|76024217|FG001|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||2||
59903140|NCT03610334|76024218|FG002|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||6||
59903141|NCT03610334|76024219|FG003|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||2||
59903142|NCT03610334|76024220|FG004|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||6||
59903143|NCT03610334|76024221|FG005|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||2||
59903144|NCT03610334|76024222|FG006|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||6||
59903145|NCT03610334|76024223|FG007|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||2||
59903146|NCT03610334|76024224|FG008|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||6||
59903147|NCT03610334|76024225|FG009|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||2||
59903148|NCT03610334|76024226|FG010|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||6||
59903149|NCT03610334|76024227|FG011|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||2||
59903150|NCT03610334|76024228|FG012|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||6||
59903151|NCT03610334|76024229|FG013|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||2||
59903152|NCT03610334|76024230|FG014|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||6||
59903153|NCT03610334|76024231|FG015|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||2||
59903154|NCT03610334|76024232|FG016|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0||
59903155|NCT03610334|76024233|FG017|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0||
59903156|NCT03610334|76024216|FG000|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0||
59903157|NCT03610334|76024217|FG001|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0||
59903158|NCT03610334|76024218|FG002|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0||
59903159|NCT03610334|76024219|FG003|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0||
59903160|NCT03610334|76024220|FG004|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0||
59903161|NCT03610334|76024221|FG005|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0||
59903162|NCT03610334|76024222|FG006|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0||
59903163|NCT03610334|76024223|FG007|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0||
59903164|NCT03610334|76024224|FG008|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0||
59903165|NCT03610334|76024225|FG009|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0||
59903166|NCT03610334|76024226|FG010|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0||
59903167|NCT03610334|76024227|FG011|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0||
59903168|NCT03610334|76024228|FG012|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0||
59903169|NCT03610334|76024229|FG013|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0||
59903170|NCT03610334|76024230|FG014|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0||
59903171|NCT03610334|76024231|FG015|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0||
59903172|NCT03610334|76024232|FG016|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0||
59903173|NCT03610334|76024233|FG017|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0||
59903174|NCT03610334|76024216|FG000|STARTED|Period 9: 50.0mg (Day 1 to 14)||6||
59903175|NCT03610334|76024217|FG001|STARTED|Period 9: 50.0mg (Day 1 to 14)||2||
59903176|NCT03610334|76024218|FG002|STARTED|Period 9: 50.0mg (Day 1 to 14)||6||
59903177|NCT03610334|76024219|FG003|STARTED|Period 9: 50.0mg (Day 1 to 14)||2||
59903178|NCT03610334|76024220|FG004|STARTED|Period 9: 50.0mg (Day 1 to 14)||6||
59903179|NCT03610334|76024221|FG005|STARTED|Period 9: 50.0mg (Day 1 to 14)||2||
59903180|NCT03610334|76024222|FG006|STARTED|Period 9: 50.0mg (Day 1 to 14)||6||
59903181|NCT03610334|76024223|FG007|STARTED|Period 9: 50.0mg (Day 1 to 14)||2||
59903182|NCT03610334|76024224|FG008|STARTED|Period 9: 50.0mg (Day 1 to 14)||6||
59903183|NCT03610334|76024225|FG009|STARTED|Period 9: 50.0mg (Day 1 to 14)||2||
59903184|NCT03610334|76024226|FG010|STARTED|Period 9: 50.0mg (Day 1 to 14)||6||
59903185|NCT03610334|76024227|FG011|STARTED|Period 9: 50.0mg (Day 1 to 14)||2||
59903186|NCT03610334|76024228|FG012|STARTED|Period 9: 50.0mg (Day 1 to 14)||6||
59903187|NCT03610334|76024229|FG013|STARTED|Period 9: 50.0mg (Day 1 to 14)||2||
59903188|NCT03610334|76024230|FG014|STARTED|Period 9: 50.0mg (Day 1 to 14)||6||
59903189|NCT03610334|76024231|FG015|STARTED|Period 9: 50.0mg (Day 1 to 14)||2||
59903190|NCT03610334|76024232|FG016|STARTED|Period 9: 50.0mg (Day 1 to 14)||6||
59903191|NCT03610334|76024233|FG017|STARTED|Period 9: 50.0mg (Day 1 to 14)||2||
59903192|NCT03610334|76024216|FG000|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||6||
59903193|NCT03610334|76024217|FG001|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||2||
59903194|NCT03610334|76024218|FG002|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||6||
59903195|NCT03610334|76024219|FG003|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||2||
59903196|NCT03610334|76024220|FG004|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||6||
59903197|NCT03610334|76024221|FG005|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||2||
59903198|NCT03610334|76024222|FG006|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||6||
59903199|NCT03610334|76024223|FG007|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||2||
59903200|NCT03610334|76024224|FG008|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||6||
59903201|NCT03610334|76024225|FG009|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||2||
59903202|NCT03610334|76024226|FG010|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||6||
59903203|NCT03610334|76024227|FG011|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||2||
59903204|NCT03610334|76024228|FG012|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||6||
59903205|NCT03610334|76024229|FG013|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||2||
59903206|NCT03610334|76024230|FG014|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||6||
59903207|NCT03610334|76024231|FG015|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||2||
59903208|NCT03610334|76024232|FG016|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||6||
59903209|NCT03610334|76024233|FG017|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||2||
59903210|NCT03610334|76024216|FG000|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0||
59903211|NCT03610334|76024217|FG001|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0||
59903212|NCT03610334|76024218|FG002|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0||
59903213|NCT03610334|76024219|FG003|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0||
59903214|NCT03610334|76024220|FG004|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0||
59903215|NCT03610334|76024221|FG005|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0||
59903216|NCT03610334|76024222|FG006|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0||
59903217|NCT03610334|76024223|FG007|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0||
59903218|NCT03610334|76024224|FG008|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0||
59903219|NCT03610334|76024225|FG009|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0||
59903220|NCT03610334|76024226|FG010|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0||
59903221|NCT03610334|76024227|FG011|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0||
59903222|NCT03610334|76024228|FG012|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0||
59903223|NCT03610334|76024229|FG013|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0||
59903224|NCT03610334|76024230|FG014|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0||
59903225|NCT03610334|76024231|FG015|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0||
59903226|NCT03610334|76024232|FG016|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0||
59903227|NCT03610334|76024233|FG017|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0||
59903228|NCT02539160|76024282|FG000|STARTED|Phase 1 Pre-crossover||24||
59903229|NCT02539160|76024283|FG001|STARTED|Phase 1 Pre-crossover||24||
59903230|NCT02539160|76024284|FG002|STARTED|Phase 1 Pre-crossover||22||
59903231|NCT02539160|76024285|FG003|STARTED|Phase 1 Pre-crossover||22||
59903232|NCT02539160|76024282|FG000|COMPLETED|Phase 1 Pre-crossover||19||
59903233|NCT02539160|76024283|FG001|COMPLETED|Phase 1 Pre-crossover||20||
59903234|NCT02539160|76024284|FG002|COMPLETED|Phase 1 Pre-crossover||19||
59903235|NCT02539160|76024285|FG003|COMPLETED|Phase 1 Pre-crossover||19||
59903236|NCT02539160|76024282|FG000|NOT COMPLETED|Phase 1 Pre-crossover||5||
59903237|NCT02539160|76024283|FG001|NOT COMPLETED|Phase 1 Pre-crossover||4||
59903238|NCT02539160|76024284|FG002|NOT COMPLETED|Phase 1 Pre-crossover||3||
59903239|NCT02539160|76024285|FG003|NOT COMPLETED|Phase 1 Pre-crossover||3||
59903240|NCT02539160|76024282|FG000|STARTED|Phase 2 Post-crossover||19||
59903241|NCT02539160|76024283|FG001|STARTED|Phase 2 Post-crossover||20||
59903242|NCT02539160|76024284|FG002|STARTED|Phase 2 Post-crossover||19||
59903243|NCT02539160|76024285|FG003|STARTED|Phase 2 Post-crossover||19||
59903244|NCT02539160|76024282|FG000|COMPLETED|Phase 2 Post-crossover||19||
59903245|NCT02539160|76024283|FG001|COMPLETED|Phase 2 Post-crossover||20||
59903246|NCT02539160|76024284|FG002|COMPLETED|Phase 2 Post-crossover||19||
59903247|NCT02539160|76024285|FG003|COMPLETED|Phase 2 Post-crossover||19||
59903248|NCT02539160|76024282|FG000|NOT COMPLETED|Phase 2 Post-crossover||0||
59903249|NCT02539160|76024283|FG001|NOT COMPLETED|Phase 2 Post-crossover||0||
59903250|NCT02539160|76024284|FG002|NOT COMPLETED|Phase 2 Post-crossover||0||
59903251|NCT02539160|76024285|FG003|NOT COMPLETED|Phase 2 Post-crossover||0||
59903252|NCT04292899|76024299|FG000|STARTED|Overall Study||200||
59903253|NCT04292899|76024300|FG001|STARTED|Overall Study||197||
59903254|NCT04292899|76024301|FG002|STARTED|Overall Study||844||
59903255|NCT04292899|76024302|FG003|STARTED|Overall Study||3597||
59903256|NCT04292899|76024299|FG000|COMPLETED|Overall Study||168||
59903257|NCT04292899|76024300|FG001|COMPLETED|Overall Study||164||
59903258|NCT04292899|76024301|FG002|COMPLETED|Overall Study||621||
59903259|NCT04292899|76024302|FG003|COMPLETED|Overall Study||2952||
59903260|NCT04292899|76024299|FG000|NOT COMPLETED|Overall Study||32||
59903261|NCT04292899|76024300|FG001|NOT COMPLETED|Overall Study||33||
59903262|NCT04292899|76024301|FG002|NOT COMPLETED|Overall Study||223||
59903263|NCT04292899|76024302|FG003|NOT COMPLETED|Overall Study||645||
59903264|NCT03241173|76024321|FG000|STARTED|Overall Study||4||
59903265|NCT03241173|76024322|FG001|STARTED|Overall Study||4||
59903266|NCT03241173|76024323|FG002|STARTED|Overall Study||5||
59903267|NCT03241173|76024324|FG003|STARTED|Overall Study||5||
59903268|NCT03241173|76024325|FG004|STARTED|Overall Study||4||
59903269|NCT03241173|76024326|FG005|STARTED|Overall Study||5||
59903270|NCT03241173|76024327|FG006|STARTED|Overall Study||4||
59903271|NCT03241173|76024328|FG007|STARTED|Overall Study||3||
59903272|NCT03241173|76024329|FG008|STARTED|Overall Study|This treatment group did not open for enrollment.|0||
59903273|NCT03241173|76024330|FG009|STARTED|Overall Study||6||
59903274|NCT03241173|76024331|FG010|STARTED|Overall Study||6||
59903275|NCT03241173|76024332|FG011|STARTED|Overall Study||6||
59903276|NCT03241173|76024333|FG012|STARTED|Overall Study|This treatment group did not open for enrollment.|0||
59903277|NCT03241173|76024334|FG013|STARTED|Overall Study|Phase 2 of the study did not open for enrollment.|0||
59903278|NCT03241173|76024335|FG014|STARTED|Overall Study|Phase 2 of the study did not open for enrollment.|0||
59903279|NCT03241173|76024321|FG000|COMPLETED|Overall Study||0||
59903280|NCT03241173|76024322|FG001|COMPLETED|Overall Study||0||
59903281|NCT03241173|76024323|FG002|COMPLETED|Overall Study||0||
59903282|NCT03241173|76024324|FG003|COMPLETED|Overall Study||0||
59903283|NCT03241173|76024325|FG004|COMPLETED|Overall Study||0||
59903284|NCT03241173|76024326|FG005|COMPLETED|Overall Study||0||
59903285|NCT03241173|76024327|FG006|COMPLETED|Overall Study||0||
59903286|NCT03241173|76024328|FG007|COMPLETED|Overall Study||0||
59903287|NCT03241173|76024329|FG008|COMPLETED|Overall Study||0||
59903288|NCT03241173|76024330|FG009|COMPLETED|Overall Study||0||
59903289|NCT03241173|76024331|FG010|COMPLETED|Overall Study||0||
59903290|NCT03241173|76024332|FG011|COMPLETED|Overall Study||0||
59903291|NCT03241173|76024333|FG012|COMPLETED|Overall Study||0||
59903292|NCT03241173|76024334|FG013|COMPLETED|Overall Study||0||
59903293|NCT03241173|76024335|FG014|COMPLETED|Overall Study||0||
59903294|NCT03241173|76024321|FG000|NOT COMPLETED|Overall Study||4||
59903295|NCT03241173|76024322|FG001|NOT COMPLETED|Overall Study||4||
59903296|NCT03241173|76024323|FG002|NOT COMPLETED|Overall Study||5||
59903297|NCT03241173|76024324|FG003|NOT COMPLETED|Overall Study||5||
59903298|NCT03241173|76024325|FG004|NOT COMPLETED|Overall Study||4||
59903299|NCT03241173|76024326|FG005|NOT COMPLETED|Overall Study||5||
59903300|NCT03241173|76024327|FG006|NOT COMPLETED|Overall Study||4||
59903301|NCT03241173|76024328|FG007|NOT COMPLETED|Overall Study||3||
59903302|NCT03241173|76024329|FG008|NOT COMPLETED|Overall Study||0||
59903303|NCT03241173|76024330|FG009|NOT COMPLETED|Overall Study||6||
59903304|NCT03241173|76024331|FG010|NOT COMPLETED|Overall Study||6||
59903305|NCT03241173|76024332|FG011|NOT COMPLETED|Overall Study||6||
59903306|NCT03241173|76024333|FG012|NOT COMPLETED|Overall Study||0||
59903307|NCT03241173|76024334|FG013|NOT COMPLETED|Overall Study||0||
59903308|NCT03241173|76024335|FG014|NOT COMPLETED|Overall Study||0||
59903309|NCT03264066|76024369|FG000|STARTED|Overall Study||20||
59903310|NCT03264066|76024370|FG001|STARTED|Overall Study||20||
59903311|NCT03264066|76024371|FG002|STARTED|Overall Study||17||
59903312|NCT03264066|76024372|FG003|STARTED|Overall Study||20||
59903313|NCT03264066|76024373|FG004|STARTED|Overall Study||7||
59903314|NCT03264066|76024374|FG005|STARTED|Overall Study||3||
59903315|NCT03264066|76024369|FG000|COMPLETED|Overall Study||0||
59903316|NCT03264066|76024370|FG001|COMPLETED|Overall Study||0||
59903317|NCT03264066|76024371|FG002|COMPLETED|Overall Study||0||
59903318|NCT03264066|76024372|FG003|COMPLETED|Overall Study||0||
59903319|NCT03264066|76024373|FG004|COMPLETED|Overall Study||0||
59903320|NCT03264066|76024374|FG005|COMPLETED|Overall Study||0||
59903321|NCT03264066|76024369|FG000|NOT COMPLETED|Overall Study||20||
59903322|NCT03264066|76024370|FG001|NOT COMPLETED|Overall Study||20||
59903323|NCT03264066|76024371|FG002|NOT COMPLETED|Overall Study||17||
59903324|NCT03264066|76024372|FG003|NOT COMPLETED|Overall Study||20||
59903325|NCT03264066|76024373|FG004|NOT COMPLETED|Overall Study||7||
59903326|NCT03264066|76024374|FG005|NOT COMPLETED|Overall Study||3||
59903327|NCT03759041|76024392|FG000|STARTED|Overall Study||69||
59903328|NCT03759041|76024393|FG001|STARTED|Overall Study||68||
59903329|NCT03759041|76024394|FG002|STARTED|Overall Study||66||
59903330|NCT03759041|76024392|FG000|COMPLETED|Overall Study||42||
59903331|NCT03759041|76024393|FG001|COMPLETED|Overall Study||34||
59903332|NCT03759041|76024394|FG002|COMPLETED|Overall Study||38||
59903333|NCT03759041|76024392|FG000|NOT COMPLETED|Overall Study||27||
59903334|NCT03759041|76024393|FG001|NOT COMPLETED|Overall Study||34||
59903335|NCT03759041|76024394|FG002|NOT COMPLETED|Overall Study||28||
59903336|NCT04110145|76024407|FG000|STARTED|Double-Blind Treatment Period (4 Weeks)||7||
59903337|NCT04110145|76024408|FG001|STARTED|Double-Blind Treatment Period (4 Weeks)||7||
59903338|NCT04110145|76024409|FG002|STARTED|Double-Blind Treatment Period (4 Weeks)||6||
59903339|NCT04110145|76024410|FG003|STARTED|Double-Blind Treatment Period (4 Weeks)||7||
59903340|NCT04110145|76024411|FG004|STARTED|Double-Blind Treatment Period (4 Weeks)||8||
59903341|NCT04110145|76024407|FG000|COMPLETED|Double-Blind Treatment Period (4 Weeks)||7|Completed= Participants who completed the Double-Blind Treatment Period|
59903342|NCT04110145|76024408|FG001|COMPLETED|Double-Blind Treatment Period (4 Weeks)||7|Completed= Participants who completed the Double-Blind Treatment Period|
59903343|NCT04110145|76024409|FG002|COMPLETED|Double-Blind Treatment Period (4 Weeks)||6|Completed= Participants who completed the Double-Blind Treatment Period|
59903344|NCT04110145|76024410|FG003|COMPLETED|Double-Blind Treatment Period (4 Weeks)||6|Completed= Participants who completed the Double-Blind Treatment Period|
59903345|NCT04110145|76024411|FG004|COMPLETED|Double-Blind Treatment Period (4 Weeks)||8|Completed= Participants who completed the Double-Blind Treatment Period|
59903346|NCT04110145|76024407|FG000|NOT COMPLETED|Double-Blind Treatment Period (4 Weeks)||0||
59903347|NCT04110145|76024408|FG001|NOT COMPLETED|Double-Blind Treatment Period (4 Weeks)||0||
59903348|NCT04110145|76024409|FG002|NOT COMPLETED|Double-Blind Treatment Period (4 Weeks)||0||
59903349|NCT04110145|76024410|FG003|NOT COMPLETED|Double-Blind Treatment Period (4 Weeks)||1||
59903350|NCT04110145|76024411|FG004|NOT COMPLETED|Double-Blind Treatment Period (4 Weeks)||0||
59903351|NCT04110145|76024407|FG000|STARTED|Post-Treatment Period (1 Week)||7|Started=Participants who entered the Post-Treatment Period|
59903352|NCT04110145|76024408|FG001|STARTED|Post-Treatment Period (1 Week)||7|Started=Participants who entered the Post-Treatment Period|
59903353|NCT04110145|76024409|FG002|STARTED|Post-Treatment Period (1 Week)||5|Started=Participants who entered the Post-Treatment Period|
59903354|NCT04110145|76024410|FG003|STARTED|Post-Treatment Period (1 Week)||6|Started=Participants who entered the Post-Treatment Period|
59903355|NCT04110145|76024411|FG004|STARTED|Post-Treatment Period (1 Week)||8|Started=Participants who entered the Post-Treatment Period|
59903356|NCT04110145|76024407|FG000|COMPLETED|Post-Treatment Period (1 Week)||7||
59903357|NCT04110145|76024408|FG001|COMPLETED|Post-Treatment Period (1 Week)||7||
59903358|NCT04110145|76024409|FG002|COMPLETED|Post-Treatment Period (1 Week)||5||
59903359|NCT04110145|76024410|FG003|COMPLETED|Post-Treatment Period (1 Week)||6||
60014569|NCT02435277|76130699|FG000|STARTED|Overall Study||12||
60014570|NCT02435277|76130700|FG001|STARTED|Overall Study||16||
60014571|NCT02435277|76130701|FG002|STARTED|Overall Study||11||
60014572|NCT02435277|76130702|FG003|STARTED|Overall Study||11||
60014573|NCT02435277|76130699|FG000|COMPLETED|Overall Study||10||
60014574|NCT02435277|76130700|FG001|COMPLETED|Overall Study||15||
60014575|NCT02435277|76130701|FG002|COMPLETED|Overall Study||11||
60014576|NCT02435277|76130702|FG003|COMPLETED|Overall Study||11||
60014577|NCT02435277|76130699|FG000|NOT COMPLETED|Overall Study||2||
60014578|NCT02435277|76130700|FG001|NOT COMPLETED|Overall Study||1||
60014579|NCT02435277|76130701|FG002|NOT COMPLETED|Overall Study||0||
60014580|NCT02435277|76130702|FG003|NOT COMPLETED|Overall Study||0||
60014581|NCT02420223|76130714|FG000|STARTED|Overall Study||12||
60014582|NCT02420223|76130715|FG001|STARTED|Overall Study||13||
60014583|NCT02420223|76130714|FG000|COMPLETED|Overall Study||11||
60014584|NCT02420223|76130715|FG001|COMPLETED|Overall Study||11||
60014585|NCT02420223|76130714|FG000|NOT COMPLETED|Overall Study||1||
60014586|NCT02420223|76130715|FG001|NOT COMPLETED|Overall Study||2||
60014587|NCT02433483|76130721|FG000|STARTED|Overall Study||2||
60014588|NCT02433483|76130721|FG000|COMPLETED|Overall Study||0||
60014589|NCT02433483|76130721|FG000|NOT COMPLETED|Overall Study||2||
60014590|NCT02419755|76130727|FG000|STARTED|Overall Study||6||
60014591|NCT02419755|76130728|FG001|STARTED|Overall Study||6||
60014592|NCT02419755|76130727|FG000|COMPLETED|Overall Study||3||
60014593|NCT02419755|76130728|FG001|COMPLETED|Overall Study||2||
60014594|NCT02419755|76130727|FG000|NOT COMPLETED|Overall Study||3||
60014595|NCT02419755|76130728|FG001|NOT COMPLETED|Overall Study||4||
60014596|NCT02488551|76130738|FG000|STARTED|Overall Study||86||
60014597|NCT02488551|76130739|FG001|STARTED|Overall Study||49||
60014598|NCT02488551|76130740|FG002|STARTED|Overall Study||17||
60014599|NCT02488551|76130741|FG003|STARTED|Overall Study||15||
60014600|NCT02488551|76130738|FG000|COMPLETED|Overall Study||81||
60014601|NCT02488551|76130739|FG001|COMPLETED|Overall Study||41||
60014602|NCT02488551|76130740|FG002|COMPLETED|Overall Study||17||
60014603|NCT02488551|76130741|FG003|COMPLETED|Overall Study||15||
60014604|NCT02488551|76130738|FG000|NOT COMPLETED|Overall Study||5||
60014605|NCT02488551|76130739|FG001|NOT COMPLETED|Overall Study||8||
60014606|NCT02488551|76130740|FG002|NOT COMPLETED|Overall Study||0||
60014607|NCT02488551|76130741|FG003|NOT COMPLETED|Overall Study||0||
60014608|NCT02488239|76130751|FG000|STARTED|Overall Study||64||
60014609|NCT02488239|76130751|FG000|COMPLETED|Overall Study||54||
60014610|NCT02488239|76130751|FG000|NOT COMPLETED|Overall Study||10||
60014611|NCT02488005|76130756|FG000|STARTED|Overall Study||15||
60014612|NCT02488005|76130756|FG000|COMPLETED|Overall Study||13||
60014613|NCT02488005|76130756|FG000|NOT COMPLETED|Overall Study||2||
60014614|NCT02487771|76130762|FG000|STARTED|Overall Study||91||
60014615|NCT02487771|76130763|FG001|STARTED|Overall Study||99||
60014616|NCT02487771|76130762|FG000|COMPLETED|Overall Study||81||
60014617|NCT02487771|76130763|FG001|COMPLETED|Overall Study||85||
60014618|NCT02487771|76130762|FG000|NOT COMPLETED|Overall Study||10||
59903360|NCT04110145|76024411|FG004|COMPLETED|Post-Treatment Period (1 Week)||8||
59903361|NCT04110145|76024407|FG000|NOT COMPLETED|Post-Treatment Period (1 Week)||0||
59903362|NCT04110145|76024408|FG001|NOT COMPLETED|Post-Treatment Period (1 Week)||0||
59903363|NCT04110145|76024409|FG002|NOT COMPLETED|Post-Treatment Period (1 Week)||0||
59903364|NCT04110145|76024410|FG003|NOT COMPLETED|Post-Treatment Period (1 Week)||0||
59903365|NCT04110145|76024411|FG004|NOT COMPLETED|Post-Treatment Period (1 Week)||0||
59903366|NCT02477618|76024425|FG000|STARTED|Overall Study||65||
59903367|NCT02477618|76024426|FG001|STARTED|Overall Study||67||
59903368|NCT02477618|76024425|FG000|Intent-to-Treat Analysis Set|Overall Study||66||
59903369|NCT02477618|76024426|FG001|Intent-to-Treat Analysis Set|Overall Study||66||
59903370|NCT02477618|76024425|FG000|COMPLETED|Overall Study||50|Participants who completed both study drug and study visits.|
59903371|NCT02477618|76024426|FG001|COMPLETED|Overall Study||53|Participants who completed both study drug and study visits.|
59903372|NCT02477618|76024425|FG000|NOT COMPLETED|Overall Study||15||
59903373|NCT02477618|76024426|FG001|NOT COMPLETED|Overall Study||14||
59903374|NCT04102501|76024434|FG000|STARTED|Overall Study||33||
59903375|NCT04102501|76024435|FG001|STARTED|Overall Study||32||
59903376|NCT04102501|76024434|FG000|11 Month Visit|Overall Study||25||
59903377|NCT04102501|76024435|FG001|11 Month Visit|Overall Study||20||
59903378|NCT04102501|76024434|FG000|COMPLETED|Overall Study||25||
59903379|NCT04102501|76024435|FG001|COMPLETED|Overall Study||20||
59903380|NCT04102501|76024434|FG000|NOT COMPLETED|Overall Study||8||
59903381|NCT04102501|76024435|FG001|NOT COMPLETED|Overall Study||12||
59903382|NCT03285477|76024445|FG000|STARTED|Treatment and Response Assessment Period||176||
59903383|NCT03285477|76024446|FG001|STARTED|Treatment and Response Assessment Period||175||
59903384|NCT03285477|76024445|FG000|COMPLETED|Treatment and Response Assessment Period||174||
59903385|NCT03285477|76024446|FG001|COMPLETED|Treatment and Response Assessment Period||175||
59903386|NCT03285477|76024445|FG000|NOT COMPLETED|Treatment and Response Assessment Period||2||
59903387|NCT03285477|76024446|FG001|NOT COMPLETED|Treatment and Response Assessment Period||0||
59903388|NCT03285477|76024445|FG000|STARTED|Recurrence Follow-up Period||8|Number of participants who achieved 100% AK clearance at Day 57 visit and entered the recurrence follow-up period.|
59951109|NCT04147247|76070045|FG003|NOT COMPLETED|Overall Study||4||
59951110|NCT04147247|76070046|FG004|NOT COMPLETED|Overall Study||5||
59951111|NCT04080167|76070061|FG000|STARTED|Overall Study||136||2
59951112|NCT04080167|76070062|FG001|STARTED|Overall Study||99||2
59951113|NCT04080167|76070063|FG002|STARTED|Overall Study||147||3
59951114|NCT04080167|76070061|FG000|Patients-All Enrolled|Overall Study||94||2
59951115|NCT04080167|76070062|FG001|Patients-All Enrolled|Overall Study||88||2
59951116|NCT04080167|76070063|FG002|Patients-All Enrolled|Overall Study||111||3
59951117|NCT04080167|76070061|FG000|Providers-All Enrolled|Overall Study||42||2
59951118|NCT04080167|76070062|FG001|Providers-All Enrolled|Overall Study||11||2
59951119|NCT04080167|76070063|FG002|Providers-All Enrolled|Overall Study||36||3
59951120|NCT04080167|76070061|FG000|Patients-Completed|Overall Study||84||2
59951121|NCT04080167|76070062|FG001|Patients-Completed|Overall Study||67||2
59951122|NCT04080167|76070063|FG002|Patients-Completed|Overall Study||110||3
59951123|NCT04080167|76070061|FG000|Providers-Completed|Overall Study||40||2
59951124|NCT04080167|76070062|FG001|Providers-Completed|Overall Study||9||2
59951125|NCT04080167|76070063|FG002|Providers-Completed|Overall Study||32||3
59951126|NCT04080167|76070061|FG000|COMPLETED|Overall Study||124||2
59951127|NCT04080167|76070062|FG001|COMPLETED|Overall Study||76||2
59951128|NCT04080167|76070063|FG002|COMPLETED|Overall Study||142||3
59951129|NCT04080167|76070061|FG000|NOT COMPLETED|Overall Study||12||0
59951130|NCT04080167|76070062|FG001|NOT COMPLETED|Overall Study||23||0
59951131|NCT04080167|76070063|FG002|NOT COMPLETED|Overall Study||5||0
59951132|NCT04070378|76070070|FG000|STARTED|Overall Study||16||
59951133|NCT04070378|76070070|FG000|Subjects Who Received at Least One Dose of Study Drug.|Overall Study||9||
59951134|NCT04070378|76070070|FG000|COMPLETED|Overall Study||6||
59951135|NCT04070378|76070070|FG000|NOT COMPLETED|Overall Study||10||
59951136|NCT04007367|76070074|FG000|STARTED|Open-Label Phase (8-Weeks)||53||
59951137|NCT04007367|76070075|FG001|STARTED|Open-Label Phase (8-Weeks)||0||
59951138|NCT04007367|76070076|FG002|STARTED|Open-Label Phase (8-Weeks)||0||
59951139|NCT04007367|76070074|FG000|COMPLETED|Open-Label Phase (8-Weeks)||5||
59951140|NCT04007367|76070075|FG001|COMPLETED|Open-Label Phase (8-Weeks)||0||
59951141|NCT04007367|76070076|FG002|COMPLETED|Open-Label Phase (8-Weeks)||0||
59951142|NCT04007367|76070074|FG000|NOT COMPLETED|Open-Label Phase (8-Weeks)||48||
59951143|NCT04007367|76070075|FG001|NOT COMPLETED|Open-Label Phase (8-Weeks)||0||
59951144|NCT04007367|76070076|FG002|NOT COMPLETED|Open-Label Phase (8-Weeks)||0||
59951145|NCT04007367|76070074|FG000|STARTED|Double-Blind Phase (14-Weeks)||0|Of the five participants who completed the OL Phase, only those participants who meet the randomization criteria for the DB Phase entered it.|
59951146|NCT04007367|76070075|FG001|STARTED|Double-Blind Phase (14-Weeks)||0|Of the five participants who completed the OL Phase, only those participants who meet the randomization criteria for the DB Phase entered it.|
59951147|NCT04007367|76070076|FG002|STARTED|Double-Blind Phase (14-Weeks)||2|Of the five participants who completed the OL Phase, only those participants who meet the randomization criteria for the DB Phase entered it.|
59951148|NCT04007367|76070074|FG000|COMPLETED|Double-Blind Phase (14-Weeks)||0||
59903389|NCT03285477|76024446|FG001|STARTED|Recurrence Follow-up Period||77|Number of participants who achieved 100% AK clearance at Day 57 visit and entered the recurrence follow-up period.|
59903390|NCT03285477|76024445|FG000|COMPLETED|Recurrence Follow-up Period||2||
59903391|NCT03285477|76024446|FG001|COMPLETED|Recurrence Follow-up Period||22||
59903392|NCT03285477|76024445|FG000|NOT COMPLETED|Recurrence Follow-up Period||6||
59903393|NCT03285477|76024446|FG001|NOT COMPLETED|Recurrence Follow-up Period||55||
59903394|NCT02285504|76024453|FG000|STARTED|Overall Study||4||
59903395|NCT02285504|76024453|FG000|COMPLETED|Overall Study||4||
59903396|NCT02285504|76024453|FG000|NOT COMPLETED|Overall Study||0||
59903397|NCT04289623|76024463|FG000|STARTED|Wave 1 Emails||6782||
59903398|NCT04289623|76024464|FG001|STARTED|Wave 1 Emails||6764||
59903399|NCT04289623|76024465|FG002|STARTED|Wave 1 Emails|Participants who did not respond to the intervention in Wave 1 were randomly assigned to this intervention or the testimonial (rank-and-file) email in Wave 2.|0||
59903400|NCT04289623|76024466|FG003|STARTED|Wave 1 Emails|Participants who did not respond to the intervention in Wave 1 were randomly assigned to this intervention or the testimonial (medical expert) email in Wave 2.|0||
59903401|NCT04289623|76024467|FG004|STARTED|Wave 1 Emails|A planned Wave 3 of the study was not conducted due to COVID-19-related changes in the program being offered as part of the intervention.|0||
59903402|NCT04289623|76024468|FG005|STARTED|Wave 1 Emails|A planned Wave 3 of the study was not conducted due to COVID-19-related changes in the program being offered as part of the intervention.|0||
59903403|NCT04289623|76024463|FG000|COMPLETED|Wave 1 Emails||6514||
59903404|NCT04289623|76024464|FG001|COMPLETED|Wave 1 Emails||6507||
59903405|NCT04289623|76024465|FG002|COMPLETED|Wave 1 Emails||0||
59903406|NCT04289623|76024466|FG003|COMPLETED|Wave 1 Emails||0||
59903407|NCT04289623|76024467|FG004|COMPLETED|Wave 1 Emails||0||
59903408|NCT04289623|76024468|FG005|COMPLETED|Wave 1 Emails||0||
59903409|NCT04289623|76024463|FG000|NOT COMPLETED|Wave 1 Emails||268||
59903410|NCT04289623|76024464|FG001|NOT COMPLETED|Wave 1 Emails||257||
59903411|NCT04289623|76024465|FG002|NOT COMPLETED|Wave 1 Emails||0||
59903412|NCT04289623|76024466|FG003|NOT COMPLETED|Wave 1 Emails||0||
59903413|NCT04289623|76024467|FG004|NOT COMPLETED|Wave 1 Emails||0||
59903414|NCT04289623|76024468|FG005|NOT COMPLETED|Wave 1 Emails||0||
59903415|NCT04289623|76024463|FG000|STARTED|Wave 2 Emails|Participants were already sent this intervention or the loss frame email in Wave 1.|0|The participants who were sent the standard email and the loss frame email but did not respond to the intervention were pooled into one group and randomly assigned to either receive the testimonial (medical expert) email or the testimonial (rank-and-file) email.|
59903416|NCT04289623|76024464|FG001|STARTED|Wave 2 Emails|Participants were already sent this intervention or the standard email in Wave 1.|0|The participants who were sent the standard email and the loss frame email but did not respond to the intervention were pooled into one group and randomly assigned to either receive the testimonial (medical expert) email or the testimonial (rank-and-file) email.|
59903417|NCT04289623|76024465|FG002|STARTED|Wave 2 Emails|Participants who did not respond to the intervention in Wave 1 were randomly assigned to these groups in Wave 2.|6099|The participants who were sent the standard email and the loss frame email but did not respond to the intervention were pooled into one group and randomly assigned to either receive the testimonial (medical expert) email or the testimonial (rank-and-file) email.|
59903418|NCT04289623|76024466|FG003|STARTED|Wave 2 Emails|Participants who did not respond to the intervention in Wave 1 were randomly assigned to these groups in Wave 2.|6117|The participants who were sent the standard email and the loss frame email but did not respond to the intervention were pooled into one group and randomly assigned to either receive the testimonial (medical expert) email or the testimonial (rank-and-file) email.|
59903419|NCT04289623|76024467|FG004|STARTED|Wave 2 Emails|A planned Wave 3 of the study was not conducted due to COVID-19-related changes in the program being offered as part of the intervention.|0|The participants who were sent the standard email and the loss frame email but did not respond to the intervention were pooled into one group and randomly assigned to either receive the testimonial (medical expert) email or the testimonial (rank-and-file) email.|
59903420|NCT04289623|76024468|FG005|STARTED|Wave 2 Emails|A planned Wave 3 of the study was not conducted due to COVID-19-related changes in the program being offered as part of the intervention.|0|The participants who were sent the standard email and the loss frame email but did not respond to the intervention were pooled into one group and randomly assigned to either receive the testimonial (medical expert) email or the testimonial (rank-and-file) email.|
59903421|NCT04289623|76024463|FG000|COMPLETED|Wave 2 Emails||0||
59903422|NCT04289623|76024464|FG001|COMPLETED|Wave 2 Emails||0||
59903423|NCT04289623|76024465|FG002|COMPLETED|Wave 2 Emails||6099||
59903424|NCT04289623|76024466|FG003|COMPLETED|Wave 2 Emails||6117||
59903425|NCT04289623|76024467|FG004|COMPLETED|Wave 2 Emails||0||
59903426|NCT04289623|76024468|FG005|COMPLETED|Wave 2 Emails||0||
59903427|NCT04289623|76024463|FG000|NOT COMPLETED|Wave 2 Emails||0||
59903428|NCT04289623|76024464|FG001|NOT COMPLETED|Wave 2 Emails||0||
59903429|NCT04289623|76024465|FG002|NOT COMPLETED|Wave 2 Emails||0||
59903430|NCT04289623|76024466|FG003|NOT COMPLETED|Wave 2 Emails||0||
59903431|NCT04289623|76024467|FG004|NOT COMPLETED|Wave 2 Emails||0||
59903432|NCT04289623|76024468|FG005|NOT COMPLETED|Wave 2 Emails||0||
59903433|NCT03248037|76024484|FG000|STARTED|Overall Study|Fellow eyes could be enrolled and were automatically assigned to the opposite treatment arm.|95||95
59903434|NCT03248037|76024485|FG001|STARTED|Overall Study|Fellow eyes could be enrolled and were automatically assigned to the opposite treatment arm.|96||96
59505952|NCT01273883|75598861|FG000|STARTED|First Intervention|Received at least 1 dose of study drug.|19||
59505953|NCT01273883|75598862|FG001|STARTED|First Intervention|Received at least 1 dose of study drug.|19||
59505954|NCT01273883|75598861|FG000|COMPLETED|First Intervention||17||
59903435|NCT03248037|76024484|FG000|COMPLETED|Overall Study||74||74
59903436|NCT03248037|76024485|FG001|COMPLETED|Overall Study||87||87
59903437|NCT03248037|76024484|FG000|NOT COMPLETED|Overall Study||21||21
59903438|NCT03248037|76024485|FG001|NOT COMPLETED|Overall Study||9||9
59903439|NCT02227394|76024491|FG000|STARTED|Overall Study||10||
59903440|NCT02227394|76024492|FG001|STARTED|Overall Study||10||
59903441|NCT02227394|76024491|FG000|COMPLETED|Overall Study||10||
59903442|NCT02227394|76024492|FG001|COMPLETED|Overall Study||10||
60014619|NCT02487771|76130763|FG001|NOT COMPLETED|Overall Study||14||
59903443|NCT02227394|76024491|FG000|NOT COMPLETED|Overall Study||0||
59903444|NCT02227394|76024492|FG001|NOT COMPLETED|Overall Study||0||
59903445|NCT04287517|76024500|FG000|STARTED|Overall Study||19||
59903446|NCT04287517|76024501|FG001|STARTED|Overall Study||19||
59903447|NCT04287517|76024500|FG000|COMPLETED|Overall Study||18||
59903448|NCT04287517|76024501|FG001|COMPLETED|Overall Study||18||
59903449|NCT04287517|76024500|FG000|NOT COMPLETED|Overall Study||1||
59903450|NCT04287517|76024501|FG001|NOT COMPLETED|Overall Study||1||
59903451|NCT03284229|76024507|FG000|STARTED|Overall Study||28||
59903452|NCT03284229|76024507|FG000|COMPLETED|Overall Study||25||
59903453|NCT03284229|76024507|FG000|NOT COMPLETED|Overall Study||3||
59903454|NCT03242928|76024514|FG000|STARTED|Overall Study||31||
59903455|NCT03242928|76024515|FG001|STARTED|Overall Study||37||
59903456|NCT03242928|76024514|FG000|COMPLETED|Overall Study||22||
60014620|NCT01359943|76130772|FG000|STARTED|Double-blind (Weeks 0 - 16)||88||
60014621|NCT01359943|76130773|FG001|STARTED|Double-blind (Weeks 0 - 16)||89||
60014622|NCT01359943|76130774|FG002|STARTED|Double-blind (Weeks 0 - 16)||44||
60014623|NCT01359943|76130772|FG000|COMPLETED|Double-blind (Weeks 0 - 16)||86||
60014624|NCT01359943|76130773|FG001|COMPLETED|Double-blind (Weeks 0 - 16)||85||
60014625|NCT01359943|76130774|FG002|COMPLETED|Double-blind (Weeks 0 - 16)||44||
60014626|NCT01359943|76130772|FG000|NOT COMPLETED|Double-blind (Weeks 0 - 16)||2||
60014627|NCT01359943|76130773|FG001|NOT COMPLETED|Double-blind (Weeks 0 - 16)||4||
60014628|NCT01359943|76130774|FG002|NOT COMPLETED|Double-blind (Weeks 0 - 16)||0||
60014629|NCT01359943|76130772|FG000|STARTED|Open Label 150 mg s.c. (Weeks 16 - 52)||86||
60014630|NCT01359943|76130773|FG001|STARTED|Open Label 150 mg s.c. (Weeks 16 - 52)|One participant, who was continuing as of week 12, did not receive study drug at week 16.|84||
60014631|NCT01359943|76130774|FG002|STARTED|Open Label 150 mg s.c. (Weeks 16 - 52)||44||
60014632|NCT01359943|76130772|FG000|COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||78||
60014633|NCT01359943|76130773|FG001|COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||71||
60014634|NCT01359943|76130774|FG002|COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||36||
60014635|NCT01359943|76130772|FG000|NOT COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||8||
59903457|NCT03242928|76024515|FG001|COMPLETED|Overall Study||32||
59903458|NCT03242928|76024514|FG000|NOT COMPLETED|Overall Study||9||
59903459|NCT03242928|76024515|FG001|NOT COMPLETED|Overall Study||5||
59903460|NCT03300024|76024523|FG000|STARTED|Overall Study||4||
59903461|NCT03300024|76024524|FG001|STARTED|Overall Study||6||
60014636|NCT01359943|76130773|FG001|NOT COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||13||
60014637|NCT01359943|76130774|FG002|NOT COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||8||
60014638|NCT01359943|76130772|FG000|STARTED|Follow-up (Weeks 52 - 60)||86||
60014639|NCT01359943|76130773|FG001|STARTED|Follow-up (Weeks 52 - 60)||84||
60014640|NCT01359943|76130774|FG002|STARTED|Follow-up (Weeks 52 - 60)||44||
59903462|NCT03300024|76024523|FG000|COMPLETED|Overall Study||0||
59903463|NCT03300024|76024524|FG001|COMPLETED|Overall Study||0||
60014641|NCT01359943|76130772|FG000|COMPLETED|Follow-up (Weeks 52 - 60)||78||
60014642|NCT01359943|76130773|FG001|COMPLETED|Follow-up (Weeks 52 - 60)||69||
60014643|NCT01359943|76130774|FG002|COMPLETED|Follow-up (Weeks 52 - 60)||36||
60014644|NCT01359943|76130772|FG000|NOT COMPLETED|Follow-up (Weeks 52 - 60)||8||
60014645|NCT01359943|76130773|FG001|NOT COMPLETED|Follow-up (Weeks 52 - 60)||15||
60014646|NCT01359943|76130774|FG002|NOT COMPLETED|Follow-up (Weeks 52 - 60)||8||
60014647|NCT02432703|76130786|FG000|STARTED|Overall Study||75||
60014648|NCT02432703|76130787|FG001|STARTED|Overall Study||74||
60014649|NCT02432703|76130786|FG000|COMPLETED|Overall Study||53||
60014650|NCT02432703|76130787|FG001|COMPLETED|Overall Study||56||
60014651|NCT02432703|76130786|FG000|NOT COMPLETED|Overall Study||22||
60014652|NCT02432703|76130787|FG001|NOT COMPLETED|Overall Study||18||
59903464|NCT03300024|76024523|FG000|NOT COMPLETED|Overall Study||4||
59903465|NCT03300024|76024524|FG001|NOT COMPLETED|Overall Study||6||
59903466|NCT04276207|76024532|FG000|STARTED|Period 1||15||
60014653|NCT02486757|76130793|FG000|STARTED|Overall Study||6||
60014654|NCT02486757|76130793|FG000|COMPLETED|Overall Study||5||
60014655|NCT02486757|76130793|FG000|NOT COMPLETED|Overall Study||1||
59903467|NCT04276207|76024533|FG001|STARTED|Period 1||17||
59903468|NCT04276207|76024532|FG000|Received at Least One Dose of Study Drug|Period 1||15||
59903469|NCT04276207|76024533|FG001|Received at Least One Dose of Study Drug|Period 1||17||
59903470|NCT04276207|76024532|FG000|COMPLETED|Period 1||15||
59903471|NCT04276207|76024533|FG001|COMPLETED|Period 1||16||
59903472|NCT04276207|76024532|FG000|NOT COMPLETED|Period 1||0||
59903473|NCT04276207|76024533|FG001|NOT COMPLETED|Period 1||1||
59903474|NCT04276207|76024532|FG000|STARTED|Washout (3- 14 Days)||15||
59903475|NCT04276207|76024533|FG001|STARTED|Washout (3- 14 Days)||16||
59903476|NCT04276207|76024532|FG000|COMPLETED|Washout (3- 14 Days)||15||
59903477|NCT04276207|76024533|FG001|COMPLETED|Washout (3- 14 Days)||16||
59903478|NCT04276207|76024532|FG000|NOT COMPLETED|Washout (3- 14 Days)||0||
59903479|NCT04276207|76024533|FG001|NOT COMPLETED|Washout (3- 14 Days)||0||
59903480|NCT04276207|76024532|FG000|STARTED|Period 2||15||
59903481|NCT04276207|76024533|FG001|STARTED|Period 2||16||
59903482|NCT04276207|76024532|FG000|COMPLETED|Period 2||15||
59903483|NCT04276207|76024533|FG001|COMPLETED|Period 2||16||
59903484|NCT04276207|76024532|FG000|NOT COMPLETED|Period 2||0||
60014656|NCT02418819|76130801|FG000|STARTED|Overall Study||22||
60014657|NCT02418819|76130802|FG001|STARTED|Overall Study||16||
60014658|NCT02418819|76130803|FG002|STARTED|Overall Study||33||
59903485|NCT04276207|76024533|FG001|NOT COMPLETED|Period 2||0||
59903486|NCT03282357|76024539|FG000|STARTED|Overall Study||181||
59903487|NCT03282357|76024539|FG000|Safety Evaluation Set|Overall Study||176||
59903488|NCT03282357|76024539|FG000|COMPLETED|Overall Study||164||
59903489|NCT03282357|76024539|FG000|NOT COMPLETED|Overall Study||17||
59903490|NCT04272775|76024546|FG000|STARTED|Overall Study||7||
59903491|NCT04272775|76024547|FG001|STARTED|Overall Study||7||
59903492|NCT04272775|76024546|FG000|COMPLETED|Overall Study||0||
59903493|NCT04272775|76024547|FG001|COMPLETED|Overall Study||0||
59903494|NCT04272775|76024546|FG000|NOT COMPLETED|Overall Study||7||
59903495|NCT04272775|76024547|FG001|NOT COMPLETED|Overall Study||7||
59903496|NCT03232983|76024553|FG000|STARTED|Period 1||7||
59903497|NCT03232983|76024554|FG001|STARTED|Period 1||7||
60014659|NCT02418819|76130804|FG003|STARTED|Overall Study||29||
60014660|NCT02418819|76130801|FG000|COMPLETED|Overall Study||21||
60014661|NCT02418819|76130802|FG001|COMPLETED|Overall Study||16||
60014662|NCT02418819|76130803|FG002|COMPLETED|Overall Study||29||
60014663|NCT02418819|76130804|FG003|COMPLETED|Overall Study||28||
60014664|NCT02418819|76130801|FG000|NOT COMPLETED|Overall Study||1||
60014665|NCT02418819|76130802|FG001|NOT COMPLETED|Overall Study||0||
60014666|NCT02418819|76130803|FG002|NOT COMPLETED|Overall Study||4||
60014667|NCT02418819|76130804|FG003|NOT COMPLETED|Overall Study||1||
60014668|NCT02576639|76130819|FG000|STARTED|Overall Study||24||
60014669|NCT02576639|76130820|FG001|STARTED|Overall Study||25||
60014670|NCT02576639|76130821|FG002|STARTED|Overall Study||25||
60014671|NCT02576639|76130822|FG003|STARTED|Overall Study||26||
60014672|NCT02576639|76130823|FG004|STARTED|Overall Study||24||
60014673|NCT02576639|76130819|FG000|Pharmacodynamic Analysis Set|Overall Study||24||
60014674|NCT02576639|76130820|FG001|Pharmacodynamic Analysis Set|Overall Study||24||
60014675|NCT02576639|76130821|FG002|Pharmacodynamic Analysis Set|Overall Study||25||
60014676|NCT02576639|76130822|FG003|Pharmacodynamic Analysis Set|Overall Study||25||
59903498|NCT03232983|76024555|FG002|STARTED|Period 1||7||
59903499|NCT03232983|76024556|FG003|STARTED|Period 1||7||
59903500|NCT03232983|76024553|FG000|Received at Least One Dose of Study Drug|Period 1||7||
59903501|NCT03232983|76024554|FG001|Received at Least One Dose of Study Drug|Period 1||7||
59903502|NCT03232983|76024555|FG002|Received at Least One Dose of Study Drug|Period 1||7||
59903503|NCT03232983|76024556|FG003|Received at Least One Dose of Study Drug|Period 1||7||
59903504|NCT03232983|76024553|FG000|COMPLETED|Period 1||7||
59903505|NCT03232983|76024554|FG001|COMPLETED|Period 1||7||
59903506|NCT03232983|76024555|FG002|COMPLETED|Period 1||6||
59903507|NCT03232983|76024556|FG003|COMPLETED|Period 1||7||
59903508|NCT03232983|76024553|FG000|NOT COMPLETED|Period 1||0||
59903509|NCT03232983|76024554|FG001|NOT COMPLETED|Period 1||0||
59903510|NCT03232983|76024555|FG002|NOT COMPLETED|Period 1||1||
59903511|NCT03232983|76024556|FG003|NOT COMPLETED|Period 1||0||
59903512|NCT03232983|76024553|FG000|STARTED|Washout Period 1||7||
59903513|NCT03232983|76024554|FG001|STARTED|Washout Period 1||7||
59903514|NCT03232983|76024555|FG002|STARTED|Washout Period 1||6||
59903515|NCT03232983|76024556|FG003|STARTED|Washout Period 1||7||
60014677|NCT02576639|76130823|FG004|Pharmacodynamic Analysis Set|Overall Study||25||
60014678|NCT02576639|76130819|FG000|Pharmacokinetic Analysis Set|Overall Study||0||
60014679|NCT02576639|76130820|FG001|Pharmacokinetic Analysis Set|Overall Study||25||
60014680|NCT02576639|76130821|FG002|Pharmacokinetic Analysis Set|Overall Study||25||
60014681|NCT02576639|76130822|FG003|Pharmacokinetic Analysis Set|Overall Study||26||
59757754|NCT03587142|75876943|FG001|STARTED|Overall Study||49||
59757755|NCT03587142|75876942|FG000|COMPLETED|Overall Study||39||
59757756|NCT03587142|75876943|FG001|COMPLETED|Overall Study||39||
59757757|NCT03587142|75876942|FG000|NOT COMPLETED|Overall Study||8||
59757758|NCT03587142|75876943|FG001|NOT COMPLETED|Overall Study||10||
59757759|NCT03493854|75876951|FG000|STARTED|Neoadjuvant Treatment Phase (24 Weeks)|This includes all randomized participants.|252|Intent-to-Treat (ITT) Population|
59757760|NCT03493854|75876952|FG001|STARTED|Neoadjuvant Treatment Phase (24 Weeks)|This includes all randomized participants.|248|Intent-to-Treat (ITT) Population|
59757761|NCT03493854|75876951|FG000|Received at Least One Dose of Study Drug|Neoadjuvant Treatment Phase (24 Weeks)||252|Safety Population|
59757762|NCT03493854|75876952|FG001|Received at Least One Dose of Study Drug|Neoadjuvant Treatment Phase (24 Weeks)||248|Safety Population|
59757763|NCT03493854|75876951|FG000|COMPLETED|Neoadjuvant Treatment Phase (24 Weeks)||242||
59757764|NCT03493854|75876952|FG001|COMPLETED|Neoadjuvant Treatment Phase (24 Weeks)||234||
59757765|NCT03493854|75876951|FG000|NOT COMPLETED|Neoadjuvant Treatment Phase (24 Weeks)||10||
59757766|NCT03493854|75876952|FG001|NOT COMPLETED|Neoadjuvant Treatment Phase (24 Weeks)||14||
59757767|NCT03493854|75876951|FG000|STARTED|Surgery & Adjuvant Treatment (42 Weeks)||242|Completed Neoadjuvant Treatment Phase|
59757768|NCT03493854|75876952|FG001|STARTED|Surgery & Adjuvant Treatment (42 Weeks)||234|Completed Neoadjuvant Treatment Phase|
59757769|NCT03493854|75876951|FG000|Completed Surgery|Surgery & Adjuvant Treatment (42 Weeks)||239||
59757770|NCT03493854|75876952|FG001|Completed Surgery|Surgery & Adjuvant Treatment (42 Weeks)||234||
59757771|NCT03493854|75876951|FG000|COMPLETED|Surgery & Adjuvant Treatment (42 Weeks)||0||
59757772|NCT03493854|75876952|FG001|COMPLETED|Surgery & Adjuvant Treatment (42 Weeks)||0||
59757773|NCT03493854|75876951|FG000|NOT COMPLETED|Surgery & Adjuvant Treatment (42 Weeks)||242||
59757774|NCT03493854|75876952|FG001|NOT COMPLETED|Surgery & Adjuvant Treatment (42 Weeks)||234||
59757775|NCT03493854|75876951|FG000|STARTED|Treatment-Free Follow-Up (up to 3 Years)|Participants prematurely withdrew from treatment in other periods and entered the follow-up phase.|19||
59757776|NCT03493854|75876952|FG001|STARTED|Treatment-Free Follow-Up (up to 3 Years)|Participants prematurely withdrew from treatment in other periods and entered the follow-up phase.|17||
59757777|NCT03493854|75876951|FG000|COMPLETED|Treatment-Free Follow-Up (up to 3 Years)||0||
59757778|NCT03493854|75876952|FG001|COMPLETED|Treatment-Free Follow-Up (up to 3 Years)||0||
59757779|NCT03493854|75876951|FG000|NOT COMPLETED|Treatment-Free Follow-Up (up to 3 Years)||19||
59757780|NCT03493854|75876952|FG001|NOT COMPLETED|Treatment-Free Follow-Up (up to 3 Years)||17||
59757781|NCT03188705|75876958|FG000|STARTED|Clopidogrel Treatment||6||
59757782|NCT03188705|75876958|FG000|COMPLETED|Clopidogrel Treatment||5||
59757783|NCT03188705|75876958|FG000|NOT COMPLETED|Clopidogrel Treatment||1||
59757784|NCT03188705|75876958|FG000|STARTED|Clopidogrel Plus Aspirin Treatment||6||
59757785|NCT03188705|75876958|FG000|COMPLETED|Clopidogrel Plus Aspirin Treatment||5||
59757786|NCT03188705|75876958|FG000|NOT COMPLETED|Clopidogrel Plus Aspirin Treatment||1||
59757787|NCT03032484|75876963|FG000|STARTED|Overall Study Cycle 1 (C1)||13|After C1, all subjects were treated with a combination of TVB-2640 with Bevacizumab|
59757788|NCT03032484|75876964|FG001|STARTED|Overall Study Cycle 1 (C1)||12|After C1, all subjects were treated with a combination of TVB-2640 with Bevacizumab|
59757789|NCT03032484|75876963|FG000|COMPLETED|Overall Study Cycle 1 (C1)||12||
59757790|NCT03032484|75876964|FG001|COMPLETED|Overall Study Cycle 1 (C1)||12||
59757791|NCT03032484|75876963|FG000|NOT COMPLETED|Overall Study Cycle 1 (C1)||1||
59757792|NCT03032484|75876964|FG001|NOT COMPLETED|Overall Study Cycle 1 (C1)||0||
59757793|NCT03032484|75876963|FG000|STARTED|Start of Second Cycle (C2)|All subjects were treated with TVB-2640 and Bevacizumab following C1, there was no continuation of Bevacizumab treatment alone, and efficacy and safety data were assessed for the aggregated group.|24|All subjects were aggregated from Arms 1 and 2 into a single treatment group from cycle 2 onwards, and efficacy and safety data were assessed for the aggregated group.|
59757794|NCT03032484|75876964|FG001|STARTED|Start of Second Cycle (C2)|All subjects were treated with TVB-2640 and Bevacizumab following C1. No subject progressed to Bevacizumab treatment alone, all were treated with TVB/Bev combination.|0|All subjects were aggregated from Arms 1 and 2 into a single treatment group from cycle 2 onwards, and efficacy and safety data were assessed for the aggregated group.|
59757795|NCT03032484|75876963|FG000|COMPLETED|Start of Second Cycle (C2)||23||
59757796|NCT03032484|75876964|FG001|COMPLETED|Start of Second Cycle (C2)||0||
59757797|NCT03032484|75876963|FG000|NOT COMPLETED|Start of Second Cycle (C2)||1||
59757798|NCT03032484|75876964|FG001|NOT COMPLETED|Start of Second Cycle (C2)||0||
59757799|NCT02975349|75876973|FG000|STARTED|Active Treatment Period (24 Weeks)||54||
59757800|NCT02975349|75876974|FG001|STARTED|Active Treatment Period (24 Weeks)||0||
59757801|NCT02975349|75876975|FG002|STARTED|Active Treatment Period (24 Weeks)||52||
59757802|NCT02975349|75876976|FG003|STARTED|Active Treatment Period (24 Weeks)||53||
59757803|NCT02975349|75876977|FG004|STARTED|Active Treatment Period (24 Weeks)||54||
59757804|NCT02975349|75876978|FG005|STARTED|Active Treatment Period (24 Weeks)||54||
59757805|NCT02975349|75876973|FG000|COMPLETED|Active Treatment Period (24 Weeks)||49||
59757806|NCT02975349|75876974|FG001|COMPLETED|Active Treatment Period (24 Weeks)||0||
59757807|NCT02975349|75876975|FG002|COMPLETED|Active Treatment Period (24 Weeks)||47||
59757808|NCT02975349|75876976|FG003|COMPLETED|Active Treatment Period (24 Weeks)||48||
59757809|NCT02975349|75876977|FG004|COMPLETED|Active Treatment Period (24 Weeks)||48||
59903516|NCT03232983|76024553|FG000|COMPLETED|Washout Period 1||7||
59903517|NCT03232983|76024554|FG001|COMPLETED|Washout Period 1||7||
59903518|NCT03232983|76024555|FG002|COMPLETED|Washout Period 1||6||
59903519|NCT03232983|76024556|FG003|COMPLETED|Washout Period 1||7||
59903520|NCT03232983|76024553|FG000|NOT COMPLETED|Washout Period 1||0||
59903521|NCT03232983|76024554|FG001|NOT COMPLETED|Washout Period 1||0||
59903522|NCT03232983|76024555|FG002|NOT COMPLETED|Washout Period 1||0||
59903523|NCT03232983|76024556|FG003|NOT COMPLETED|Washout Period 1||0||
59903524|NCT03232983|76024553|FG000|STARTED|Period 2||7||
59903525|NCT03232983|76024554|FG001|STARTED|Period 2||7||
59903526|NCT03232983|76024555|FG002|STARTED|Period 2||6||
59903527|NCT03232983|76024556|FG003|STARTED|Period 2||7||
59903528|NCT03232983|76024553|FG000|COMPLETED|Period 2||7||
59903529|NCT03232983|76024554|FG001|COMPLETED|Period 2||7||
59903530|NCT03232983|76024555|FG002|COMPLETED|Period 2||6||
59903531|NCT03232983|76024556|FG003|COMPLETED|Period 2||7||
59903532|NCT03232983|76024553|FG000|NOT COMPLETED|Period 2||0||
59903533|NCT03232983|76024554|FG001|NOT COMPLETED|Period 2||0||
60014682|NCT02576639|76130823|FG004|Pharmacokinetic Analysis Set|Overall Study||24||
60014683|NCT02576639|76130819|FG000|Safety Analysis Set|Overall Study||24||
60014684|NCT02576639|76130820|FG001|Safety Analysis Set|Overall Study||25||
60014685|NCT02576639|76130821|FG002|Safety Analysis Set|Overall Study||25||
60014686|NCT02576639|76130822|FG003|Safety Analysis Set|Overall Study||26||
60014687|NCT02576639|76130823|FG004|Safety Analysis Set|Overall Study||24||
60014688|NCT02576639|76130819|FG000|COMPLETED|Overall Study||22||
60014689|NCT02576639|76130820|FG001|COMPLETED|Overall Study||23||
60014690|NCT02576639|76130821|FG002|COMPLETED|Overall Study||23||
60014691|NCT02576639|76130822|FG003|COMPLETED|Overall Study||25||
60014692|NCT02576639|76130823|FG004|COMPLETED|Overall Study||20||
60014693|NCT02576639|76130819|FG000|NOT COMPLETED|Overall Study||2||
60014694|NCT02576639|76130820|FG001|NOT COMPLETED|Overall Study||2||
60014695|NCT02576639|76130821|FG002|NOT COMPLETED|Overall Study||2||
60014696|NCT02576639|76130822|FG003|NOT COMPLETED|Overall Study||1||
60014697|NCT02576639|76130823|FG004|NOT COMPLETED|Overall Study||4||
60014698|NCT02418585|76130841|FG000|STARTED|Double Blind (DB) Phase (4 Weeks)||116||
60014699|NCT02418585|76130842|FG001|STARTED|Double Blind (DB) Phase (4 Weeks)||111||
60014700|NCT02418585|76130841|FG000|Safety Analysis Set|Double Blind (DB) Phase (4 Weeks)||115||
60014701|NCT02418585|76130842|FG001|Safety Analysis Set|Double Blind (DB) Phase (4 Weeks)||109||
60014702|NCT02418585|76130841|FG000|Full Analysis Set|Double Blind (DB) Phase (4 Weeks)||114||
60014703|NCT02418585|76130842|FG001|Full Analysis Set|Double Blind (DB) Phase (4 Weeks)||109||
60014704|NCT02418585|76130841|FG000|COMPLETED|Double Blind (DB) Phase (4 Weeks)||98||
60014705|NCT02418585|76130842|FG001|COMPLETED|Double Blind (DB) Phase (4 Weeks)||99||
60014706|NCT02418585|76130841|FG000|NOT COMPLETED|Double Blind (DB) Phase (4 Weeks)||18||
60014707|NCT02418585|76130842|FG001|NOT COMPLETED|Double Blind (DB) Phase (4 Weeks)||12||
60014708|NCT02418585|76130841|FG000|STARTED|Follow-up Phase (24 Weeks)||34||
60014709|NCT02418585|76130842|FG001|STARTED|Follow-up Phase (24 Weeks)||52||
60014710|NCT02418585|76130841|FG000|COMPLETED|Follow-up Phase (24 Weeks)||16||
60014711|NCT02418585|76130842|FG001|COMPLETED|Follow-up Phase (24 Weeks)||27||
60014712|NCT02418585|76130841|FG000|NOT COMPLETED|Follow-up Phase (24 Weeks)||18||
60014713|NCT02418585|76130842|FG001|NOT COMPLETED|Follow-up Phase (24 Weeks)||25||
60014714|NCT02417961|76130850|FG000|STARTED|Overall Study||116||
60014715|NCT02417961|76130850|FG000|COMPLETED|Overall Study||112||
60014716|NCT02417961|76130850|FG000|NOT COMPLETED|Overall Study||4||
60014717|NCT01596127|76130854|FG000|STARTED|Overall Study||4||
60014718|NCT01596127|76130854|FG000|COMPLETED|Overall Study||3||
60014719|NCT01596127|76130854|FG000|NOT COMPLETED|Overall Study||1||
60014720|NCT01595581|76130860|FG000|STARTED|Overall Study||7||
60014721|NCT01595581|76130861|FG001|STARTED|Overall Study||7||
60014722|NCT01595581|76130860|FG000|COMPLETED|Overall Study||6||
60014723|NCT01595581|76130861|FG001|COMPLETED|Overall Study||7||
59903534|NCT03232983|76024555|FG002|NOT COMPLETED|Period 2||0||
59903535|NCT03232983|76024556|FG003|NOT COMPLETED|Period 2||0||
59903536|NCT03232983|76024553|FG000|STARTED|Washout Period 2||7||
59903537|NCT03232983|76024554|FG001|STARTED|Washout Period 2||7||
59903538|NCT03232983|76024555|FG002|STARTED|Washout Period 2||6||
59903539|NCT03232983|76024556|FG003|STARTED|Washout Period 2||7||
59903540|NCT03232983|76024553|FG000|COMPLETED|Washout Period 2||7||
59903541|NCT03232983|76024554|FG001|COMPLETED|Washout Period 2||7||
59903542|NCT03232983|76024555|FG002|COMPLETED|Washout Period 2||5||
59903543|NCT03232983|76024556|FG003|COMPLETED|Washout Period 2||6||
59903544|NCT03232983|76024553|FG000|NOT COMPLETED|Washout Period 2||0||
59903545|NCT03232983|76024554|FG001|NOT COMPLETED|Washout Period 2||0||
59903546|NCT03232983|76024555|FG002|NOT COMPLETED|Washout Period 2||1||
59903547|NCT03232983|76024556|FG003|NOT COMPLETED|Washout Period 2||1||
59903548|NCT03232983|76024553|FG000|STARTED|Period 3||7||
60014724|NCT01595581|76130860|FG000|NOT COMPLETED|Overall Study||1||
60014725|NCT01595581|76130861|FG001|NOT COMPLETED|Overall Study||0||
60014726|NCT01610687|76130869|FG000|STARTED|Overall Study||137||
60014727|NCT01610687|76130869|FG000|COMPLETED|Overall Study||70||
60014728|NCT01610687|76130869|FG000|NOT COMPLETED|Overall Study||67||
60014729|NCT02615509|76130873|FG000|STARTED|Overall Study||347||
60014730|NCT02615509|76130873|FG000|COMPLETED|Overall Study||201||
59903549|NCT03232983|76024554|FG001|STARTED|Period 3||7||
59903550|NCT03232983|76024555|FG002|STARTED|Period 3||5||
59903551|NCT03232983|76024556|FG003|STARTED|Period 3||6||
59903552|NCT03232983|76024553|FG000|COMPLETED|Period 3||7||
59903553|NCT03232983|76024554|FG001|COMPLETED|Period 3||7||
59903554|NCT03232983|76024555|FG002|COMPLETED|Period 3||5||
59903555|NCT03232983|76024556|FG003|COMPLETED|Period 3||6||
59903556|NCT03232983|76024553|FG000|NOT COMPLETED|Period 3||0||
59903557|NCT03232983|76024554|FG001|NOT COMPLETED|Period 3||0||
59903558|NCT03232983|76024555|FG002|NOT COMPLETED|Period 3||0||
59903559|NCT03232983|76024556|FG003|NOT COMPLETED|Period 3||0||
59903560|NCT03232983|76024553|FG000|STARTED|Washout Period 3||7||
59903561|NCT03232983|76024554|FG001|STARTED|Washout Period 3||7||
59903562|NCT03232983|76024555|FG002|STARTED|Washout Period 3||5||
59903563|NCT03232983|76024556|FG003|STARTED|Washout Period 3||6||
59903564|NCT03232983|76024553|FG000|COMPLETED|Washout Period 3||7||
59903565|NCT03232983|76024554|FG001|COMPLETED|Washout Period 3||7||
59903566|NCT03232983|76024555|FG002|COMPLETED|Washout Period 3||5||
59903567|NCT03232983|76024556|FG003|COMPLETED|Washout Period 3||6||
59903568|NCT03232983|76024553|FG000|NOT COMPLETED|Washout Period 3||0||
59903569|NCT03232983|76024554|FG001|NOT COMPLETED|Washout Period 3||0||
59903570|NCT03232983|76024555|FG002|NOT COMPLETED|Washout Period 3||0||
59903571|NCT03232983|76024556|FG003|NOT COMPLETED|Washout Period 3||0||
59903572|NCT03232983|76024553|FG000|STARTED|Period 4||7||
59903573|NCT03232983|76024554|FG001|STARTED|Period 4||7||
59903574|NCT03232983|76024555|FG002|STARTED|Period 4||5||
59903575|NCT03232983|76024556|FG003|STARTED|Period 4||6||
59903576|NCT03232983|76024553|FG000|COMPLETED|Period 4||6||
59903577|NCT03232983|76024554|FG001|COMPLETED|Period 4||7||
59903578|NCT03232983|76024555|FG002|COMPLETED|Period 4||5||
59903579|NCT03232983|76024556|FG003|COMPLETED|Period 4||6||
59903580|NCT03232983|76024553|FG000|NOT COMPLETED|Period 4||1||
59903581|NCT03232983|76024554|FG001|NOT COMPLETED|Period 4||0||
59903582|NCT03232983|76024555|FG002|NOT COMPLETED|Period 4||0||
59903583|NCT03232983|76024556|FG003|NOT COMPLETED|Period 4||0||
59903584|NCT04102345|76024570|FG000|STARTED|Overall Study||26||
59903585|NCT04102345|76024571|FG001|STARTED|Overall Study||32||
59903586|NCT04102345|76024570|FG000|COMPLETED|Overall Study||25||
59903587|NCT04102345|76024571|FG001|COMPLETED|Overall Study||32||
59903588|NCT04102345|76024570|FG000|NOT COMPLETED|Overall Study||1||
59903589|NCT04102345|76024571|FG001|NOT COMPLETED|Overall Study||0||
59903590|NCT04271605|76024577|FG000|STARTED|Overall Study|Baseline questionnaire and examination were done after enrollment.|5|5 participants were enrolled and completed the baseline questionnaire and examination.|
59903591|NCT04271605|76024577|FG000|COMPLETED|Overall Study||0||
59903592|NCT04271605|76024577|FG000|NOT COMPLETED|Overall Study||5||
59903593|NCT03299244|76024583|FG000|STARTED|Overall Study||317||
59903594|NCT03299244|76024584|FG001|STARTED|Overall Study||320||
59903595|NCT03299244|76024583|FG000|Received Treatment|Overall Study||315||
59903596|NCT03299244|76024584|FG001|Received Treatment|Overall Study||318||
59903597|NCT03299244|76024583|FG000|COMPLETED|Overall Study||270||
59903598|NCT03299244|76024584|FG001|COMPLETED|Overall Study||282||
59903599|NCT03299244|76024583|FG000|NOT COMPLETED|Overall Study||47||
59903600|NCT03299244|76024584|FG001|NOT COMPLETED|Overall Study||38||
59903601|NCT03757715|76024593|FG000|STARTED|Overall Study||21||
59903602|NCT03757715|76024594|FG001|STARTED|Overall Study||25||
59903603|NCT03757715|76024593|FG000|COMPLETED|Overall Study||16||
59903604|NCT03757715|76024594|FG001|COMPLETED|Overall Study||15||
59903605|NCT03757715|76024593|FG000|NOT COMPLETED|Overall Study||5||
59903606|NCT03757715|76024594|FG001|NOT COMPLETED|Overall Study||10||
59903607|NCT03281577|76024604|FG000|STARTED|Overall Study||10||
59903608|NCT03281577|76024605|FG001|STARTED|Overall Study||10||
59903609|NCT03281577|76024606|FG002|STARTED|Overall Study||9||
59903610|NCT03281577|76024607|FG003|STARTED|Overall Study||7||
59903611|NCT03281577|76024604|FG000|COMPLETED|Overall Study||9||
59903612|NCT03281577|76024605|FG001|COMPLETED|Overall Study||10||
59903613|NCT03281577|76024606|FG002|COMPLETED|Overall Study||9||
59903614|NCT03281577|76024607|FG003|COMPLETED|Overall Study||6||
59903615|NCT03281577|76024604|FG000|NOT COMPLETED|Overall Study||1||
59903616|NCT03281577|76024605|FG001|NOT COMPLETED|Overall Study||0||
59903617|NCT03281577|76024606|FG002|NOT COMPLETED|Overall Study||0||
59903618|NCT03281577|76024607|FG003|NOT COMPLETED|Overall Study||1||
59903619|NCT04098367|76024623|FG000|STARTED|Overall Study||63||
59903620|NCT04098367|76024624|FG001|STARTED|Overall Study||65||
59903621|NCT04098367|76024625|FG002|STARTED|Overall Study||65||
59903622|NCT04098367|76024623|FG000|First Eye Implanted|Overall Study||63||
59903623|NCT04098367|76024624|FG001|First Eye Implanted|Overall Study||65||
59903624|NCT04098367|76024625|FG002|First Eye Implanted|Overall Study||65||
59903625|NCT04098367|76024623|FG000|Second Eye Implanted|Overall Study||63||
59903626|NCT04098367|76024624|FG001|Second Eye Implanted|Overall Study||65||
59903627|NCT04098367|76024625|FG002|Second Eye Implanted|Overall Study||63||
59903628|NCT04098367|76024623|FG000|COMPLETED|Overall Study||61||
59903629|NCT04098367|76024624|FG001|COMPLETED|Overall Study||60||
59903630|NCT04098367|76024625|FG002|COMPLETED|Overall Study||61||
59903631|NCT04098367|76024623|FG000|NOT COMPLETED|Overall Study||2||
59903632|NCT04098367|76024624|FG001|NOT COMPLETED|Overall Study||5||
59903633|NCT04098367|76024625|FG002|NOT COMPLETED|Overall Study||4||
59903634|NCT04091659|76024642|FG000|STARTED|Overall Study||40||
59903635|NCT04091659|76024643|FG001|STARTED|Overall Study||58||
59903636|NCT04091659|76024642|FG000|COMPLETED|Overall Study||37||
59903637|NCT04091659|76024643|FG001|COMPLETED|Overall Study||57||
59903638|NCT04091659|76024642|FG000|NOT COMPLETED|Overall Study||3||
59903639|NCT04091659|76024643|FG001|NOT COMPLETED|Overall Study||1||
59903640|NCT02814708|76024656|FG000|STARTED|Overall Study||20||
59903641|NCT02814708|76024657|FG001|STARTED|Overall Study||20||
59903642|NCT02814708|76024658|FG002|STARTED|Overall Study||20||
59903643|NCT02814708|76024659|FG003|STARTED|Overall Study||20||
59903644|NCT02814708|76024660|FG004|STARTED|Overall Study||20||
59903645|NCT02814708|76024661|FG005|STARTED|Overall Study||20||
59903646|NCT02814708|76024662|FG006|STARTED|Overall Study||20||
59903647|NCT02814708|76024656|FG000|COMPLETED|Overall Study||18||
59903648|NCT02814708|76024657|FG001|COMPLETED|Overall Study||17||
59903649|NCT02814708|76024658|FG002|COMPLETED|Overall Study||19||
59903650|NCT02814708|76024659|FG003|COMPLETED|Overall Study||20||
59903651|NCT02814708|76024660|FG004|COMPLETED|Overall Study||17||
59903652|NCT02814708|76024661|FG005|COMPLETED|Overall Study||16||
59903653|NCT02814708|76024662|FG006|COMPLETED|Overall Study||19||
59903654|NCT02814708|76024656|FG000|NOT COMPLETED|Overall Study||2||
59903655|NCT02814708|76024657|FG001|NOT COMPLETED|Overall Study||3||
59903656|NCT02814708|76024658|FG002|NOT COMPLETED|Overall Study||1||
59903657|NCT02814708|76024659|FG003|NOT COMPLETED|Overall Study||0||
59903658|NCT02814708|76024660|FG004|NOT COMPLETED|Overall Study||3||
59903659|NCT02814708|76024661|FG005|NOT COMPLETED|Overall Study||4||
59903660|NCT02814708|76024662|FG006|NOT COMPLETED|Overall Study||1||
59903661|NCT04256785|76024680|FG000|STARTED|Overall Study||54||
59903662|NCT04256785|76024681|FG001|STARTED|Overall Study||56||
59903663|NCT04256785|76024680|FG000|COMPLETED|Overall Study||26||
59903664|NCT04256785|76024681|FG001|COMPLETED|Overall Study||31||
59903665|NCT04256785|76024680|FG000|NOT COMPLETED|Overall Study||28||
59903666|NCT04256785|76024681|FG001|NOT COMPLETED|Overall Study||25||
59903667|NCT02959918|76024703|FG000|STARTED|Overall Study||3||
59903668|NCT02959918|76024704|FG001|STARTED|Overall Study||3||
59903669|NCT02959918|76024705|FG002|STARTED|Overall Study||9||
59903670|NCT02959918|76024706|FG003|STARTED|Overall Study||10||
59903671|NCT02959918|76024707|FG004|STARTED|Overall Study||6||
59903672|NCT02959918|76024708|FG005|STARTED|Overall Study||11||
59903673|NCT02959918|76024709|FG006|STARTED|Overall Study||11||
59903674|NCT02959918|76024710|FG007|STARTED|Overall Study||12||
59903675|NCT02959918|76024711|FG008|STARTED|Overall Study||14||
59903676|NCT02959918|76024712|FG009|STARTED|Overall Study||13||
59903677|NCT02959918|76024713|FG010|STARTED|Overall Study||14||
59903678|NCT02959918|76024714|FG011|STARTED|Overall Study||23||
59903679|NCT02959918|76024715|FG012|STARTED|Overall Study||11||
59903680|NCT02959918|76024716|FG013|STARTED|Overall Study||12||
59903681|NCT02959918|76024703|FG000|COMPLETED|Overall Study||0||
59903682|NCT02959918|76024704|FG001|COMPLETED|Overall Study||0||
59903683|NCT02959918|76024705|FG002|COMPLETED|Overall Study||1||
59903684|NCT02959918|76024706|FG003|COMPLETED|Overall Study||1||
59903685|NCT02959918|76024707|FG004|COMPLETED|Overall Study||1||
60014731|NCT02615509|76130873|FG000|NOT COMPLETED|Overall Study||146||
59903686|NCT02959918|76024708|FG005|COMPLETED|Overall Study||5||
59903687|NCT02959918|76024709|FG006|COMPLETED|Overall Study||6||
59903688|NCT02959918|76024710|FG007|COMPLETED|Overall Study||6||
59903689|NCT02959918|76024711|FG008|COMPLETED|Overall Study||7||
59903690|NCT02959918|76024712|FG009|COMPLETED|Overall Study||7||
59903691|NCT02959918|76024713|FG010|COMPLETED|Overall Study||8||
59903692|NCT02959918|76024714|FG011|COMPLETED|Overall Study||11||
59903693|NCT02959918|76024715|FG012|COMPLETED|Overall Study||4||
59903694|NCT02959918|76024716|FG013|COMPLETED|Overall Study||6||
59903695|NCT02959918|76024703|FG000|NOT COMPLETED|Overall Study||3||
59903696|NCT02959918|76024704|FG001|NOT COMPLETED|Overall Study||3||
59903697|NCT02959918|76024705|FG002|NOT COMPLETED|Overall Study||8||
59903698|NCT02959918|76024706|FG003|NOT COMPLETED|Overall Study||9||
59903699|NCT02959918|76024707|FG004|NOT COMPLETED|Overall Study||5||
59903700|NCT02959918|76024708|FG005|NOT COMPLETED|Overall Study||6||
59903701|NCT02959918|76024709|FG006|NOT COMPLETED|Overall Study||5||
59903702|NCT02959918|76024710|FG007|NOT COMPLETED|Overall Study||6||
59903703|NCT02959918|76024711|FG008|NOT COMPLETED|Overall Study||7||
59903704|NCT02959918|76024712|FG009|NOT COMPLETED|Overall Study||6||
59903705|NCT02959918|76024713|FG010|NOT COMPLETED|Overall Study||6||
59505955|NCT01273883|75598862|FG001|COMPLETED|First Intervention||18||
59505956|NCT01273883|75598861|FG000|NOT COMPLETED|First Intervention||2||
59505957|NCT01273883|75598862|FG001|NOT COMPLETED|First Intervention||1||
59505958|NCT01273883|75598861|FG000|STARTED|Washout Period of 2 Weeks||17||
59505959|NCT01273883|75598862|FG001|STARTED|Washout Period of 2 Weeks||18||
59505960|NCT01273883|75598861|FG000|COMPLETED|Washout Period of 2 Weeks||17||
59903706|NCT02959918|76024714|FG011|NOT COMPLETED|Overall Study||12||
59903707|NCT02959918|76024715|FG012|NOT COMPLETED|Overall Study||7||
59903708|NCT02959918|76024716|FG013|NOT COMPLETED|Overall Study||6||
59505961|NCT01273883|75598862|FG001|COMPLETED|Washout Period of 2 Weeks||18||
59505962|NCT01273883|75598861|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0||
59505963|NCT01273883|75598862|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0||
59505964|NCT01273883|75598861|FG000|STARTED|Second Intervention||17||
59505965|NCT01273883|75598862|FG001|STARTED|Second Intervention||18||
59505966|NCT01273883|75598861|FG000|COMPLETED|Second Intervention||15||
59505967|NCT01273883|75598862|FG001|COMPLETED|Second Intervention||17||
59505968|NCT01273883|75598861|FG000|NOT COMPLETED|Second Intervention||2||
59505969|NCT01273883|75598862|FG001|NOT COMPLETED|Second Intervention||1||
59903709|NCT03263442|76024751|FG000|STARTED|Inpatient Phase||30||
59903710|NCT03263442|76024752|FG001|STARTED|Inpatient Phase||34||
59903711|NCT03263442|76024751|FG000|COMPLETED|Inpatient Phase||28||
59903712|NCT03263442|76024752|FG001|COMPLETED|Inpatient Phase||33||
59903713|NCT03263442|76024751|FG000|NOT COMPLETED|Inpatient Phase||2||
59903714|NCT03263442|76024752|FG001|NOT COMPLETED|Inpatient Phase||1||
59903715|NCT03263442|76024751|FG000|STARTED|1-month Follow-Up||28||
59903716|NCT03263442|76024752|FG001|STARTED|1-month Follow-Up||33||
59903717|NCT03263442|76024751|FG000|COMPLETED|1-month Follow-Up||27||
59903718|NCT03263442|76024752|FG001|COMPLETED|1-month Follow-Up||33||
59903719|NCT03263442|76024751|FG000|NOT COMPLETED|1-month Follow-Up||1||
59903720|NCT03263442|76024752|FG001|NOT COMPLETED|1-month Follow-Up||0||
59903721|NCT03263442|76024751|FG000|STARTED|3-month Follow-Up||27||
59903722|NCT03263442|76024752|FG001|STARTED|3-month Follow-Up||33||
59903723|NCT03263442|76024751|FG000|COMPLETED|3-month Follow-Up||26||
59903724|NCT03263442|76024752|FG001|COMPLETED|3-month Follow-Up||30||
59903725|NCT03263442|76024751|FG000|NOT COMPLETED|3-month Follow-Up||1||
59903726|NCT03263442|76024752|FG001|NOT COMPLETED|3-month Follow-Up||3||
59903727|NCT03263442|76024751|FG000|STARTED|6-month Follow-Up||26||
59903728|NCT03263442|76024752|FG001|STARTED|6-month Follow-Up||30||
59903729|NCT03263442|76024751|FG000|COMPLETED|6-month Follow-Up||24||
59903730|NCT03263442|76024752|FG001|COMPLETED|6-month Follow-Up||28||
59903731|NCT03263442|76024751|FG000|NOT COMPLETED|6-month Follow-Up||2||
59903732|NCT03263442|76024752|FG001|NOT COMPLETED|6-month Follow-Up||2||
59903733|NCT04245709|76024760|FG000|STARTED|Overall Study||25||
59903734|NCT04245709|76024760|FG000|COMPLETED|Overall Study||11||
59903735|NCT04245709|76024760|FG000|NOT COMPLETED|Overall Study||14||
59903736|NCT04091581|76024766|FG000|STARTED|Overall Study||10||
59903737|NCT04091581|76024767|FG001|STARTED|Overall Study||11||
59903738|NCT04091581|76024766|FG000|COMPLETED|Overall Study||10||
59903739|NCT04091581|76024767|FG001|COMPLETED|Overall Study||10||
59903740|NCT04091581|76024766|FG000|NOT COMPLETED|Overall Study||0||
59505970|NCT01273805|75598870|FG000|STARTED|Overall Study||10||
59505971|NCT01273805|75598871|FG001|STARTED|Overall Study||10||
59903741|NCT04091581|76024767|FG001|NOT COMPLETED|Overall Study||1||
59903742|NCT02940522|76024775|FG000|STARTED|Overall Study||59||
59903743|NCT02940522|76024776|FG001|STARTED|Overall Study||61||
59903744|NCT02940522|76024775|FG000|COMPLETED|Overall Study||57||
59903745|NCT02940522|76024776|FG001|COMPLETED|Overall Study||59||
59903746|NCT02940522|76024775|FG000|NOT COMPLETED|Overall Study||2||
59903747|NCT02940522|76024776|FG001|NOT COMPLETED|Overall Study||2||
59903748|NCT03262038|76024784|FG000|STARTED|Overall Study||18||
59903749|NCT03262038|76024785|FG001|STARTED|Overall Study||28||
59903750|NCT03262038|76024784|FG000|COMPLETED|Overall Study||18||
59903751|NCT03262038|76024785|FG001|COMPLETED|Overall Study||27||
59903752|NCT03262038|76024784|FG000|NOT COMPLETED|Overall Study||0||
59903753|NCT03262038|76024785|FG001|NOT COMPLETED|Overall Study||1||
59505972|NCT01273805|75598870|FG000|COMPLETED|Overall Study||0||
59505973|NCT01273805|75598871|FG001|COMPLETED|Overall Study||0||
59505974|NCT01273805|75598870|FG000|NOT COMPLETED|Overall Study||10||
59505975|NCT01273805|75598871|FG001|NOT COMPLETED|Overall Study||10||
59505976|NCT01273181|75598881|FG000|STARTED|Phase I, Dose 1||3||
59505977|NCT01273181|75598882|FG001|STARTED|Phase I, Dose 1||0||
59903754|NCT02472964|76024793|FG000|STARTED|Part 1 (up to Week 24)||246|The disposition of the patients has been provided for the safety sample population.|
59903755|NCT02472964|76024794|FG001|STARTED|Part 1 (up to Week 24)||247|The disposition of the patients has been provided for the safety sample population.|
59903756|NCT02472964|76024793|FG000|COMPLETED|Part 1 (up to Week 24)||171||
59903757|NCT02472964|76024794|FG001|COMPLETED|Part 1 (up to Week 24)||185||
59903758|NCT02472964|76024793|FG000|NOT COMPLETED|Part 1 (up to Week 24)||75||
59903759|NCT02472964|76024794|FG001|NOT COMPLETED|Part 1 (up to Week 24)||62||
59903760|NCT02472964|76024793|FG000|STARTED|Part 2 (Week 24-week 48)||163|The disposition of the patients has been provided for the safety sample.|
59903761|NCT02472964|76024794|FG001|STARTED|Part 2 (Week 24-week 48)||179|The disposition of the patients has been provided for the safety sample.|
59903762|NCT02472964|76024793|FG000|COMPLETED|Part 2 (Week 24-week 48)||98||
59903763|NCT02472964|76024794|FG001|COMPLETED|Part 2 (Week 24-week 48)||116||
59903764|NCT02472964|76024793|FG000|NOT COMPLETED|Part 2 (Week 24-week 48)||65||
59903765|NCT02472964|76024794|FG001|NOT COMPLETED|Part 2 (Week 24-week 48)||63||
59903766|NCT01104922|76024800|FG000|STARTED|Overall Study||48||
59903767|NCT01104922|76024800|FG000|COMPLETED|Overall Study||48||
59903768|NCT01104922|76024800|FG000|NOT COMPLETED|Overall Study||0||
59903769|NCT04079803|76024807|FG000|STARTED|Overall Study||22||
59903770|NCT04079803|76024808|FG001|STARTED|Overall Study||21||
59903771|NCT04079803|76024809|FG002|STARTED|Overall Study||21||
59903772|NCT04079803|76024807|FG000|COMPLETED|Overall Study||22||
59903773|NCT04079803|76024808|FG001|COMPLETED|Overall Study||21||
59903774|NCT04079803|76024809|FG002|COMPLETED|Overall Study||20||
59903775|NCT04079803|76024807|FG000|NOT COMPLETED|Overall Study||0||
59903776|NCT04079803|76024808|FG001|NOT COMPLETED|Overall Study||0||
59903777|NCT04079803|76024809|FG002|NOT COMPLETED|Overall Study||1||
59903778|NCT00894244|76024831|FG000|STARTED|Overall Study||25||
59903779|NCT00894244|76024831|FG000|COMPLETED|Overall Study||24||
59903780|NCT00894244|76024831|FG000|NOT COMPLETED|Overall Study||1||
59903781|NCT03278613|76024837|FG000|STARTED|Overall Study||111||
59903782|NCT03278613|76024838|FG001|STARTED|Overall Study||55||
59903783|NCT03278613|76024837|FG000|COMPLETED|Overall Study||108||
59903784|NCT03278613|76024838|FG001|COMPLETED|Overall Study||54||
59903785|NCT03278613|76024837|FG000|NOT COMPLETED|Overall Study||3||
59903786|NCT03278613|76024838|FG001|NOT COMPLETED|Overall Study||1||
59903787|NCT03761147|76024846|FG000|STARTED|Overall Study||32||
59903788|NCT03761147|76024847|FG001|STARTED|Overall Study||32||
59903789|NCT03761147|76024846|FG000|COMPLETED|Overall Study||25||
59903790|NCT03761147|76024847|FG001|COMPLETED|Overall Study||28||
59903791|NCT03761147|76024846|FG000|NOT COMPLETED|Overall Study||7||
59903792|NCT03761147|76024847|FG001|NOT COMPLETED|Overall Study||4||
59903793|NCT04076917|76024853|FG000|STARTED|Overall Study||84||
59903794|NCT04076917|76024853|FG000|COMPLETED|Overall Study||15||
59903795|NCT04076917|76024853|FG000|NOT COMPLETED|Overall Study||69||
59903796|NCT04222699|76024857|FG000|STARTED|Overall Study||28||
59903797|NCT04222699|76024857|FG000|COMPLETED|Overall Study||26||
59903798|NCT04222699|76024857|FG000|NOT COMPLETED|Overall Study||2||
59903799|NCT03985813|76024863|FG000|STARTED|Overall Study||27||
59903800|NCT03985813|76024864|FG001|STARTED|Overall Study||26||
59903801|NCT03985813|76024863|FG000|COMPLETED|Overall Study||27||
59903802|NCT03985813|76024864|FG001|COMPLETED|Overall Study||26||
59903803|NCT03985813|76024863|FG000|NOT COMPLETED|Overall Study||0||
59903804|NCT03985813|76024864|FG001|NOT COMPLETED|Overall Study||0||
59903805|NCT02731690|76024870|FG000|STARTED|Overall Study||42||
59903806|NCT02731690|76024870|FG000|COMPLETED|Overall Study||12||
59903807|NCT02731690|76024870|FG000|NOT COMPLETED|Overall Study||30||
59903808|NCT04075513|76024876|FG000|STARTED|Overall Study||172||
59903809|NCT04075513|76024877|FG001|STARTED|Overall Study||171||
59903810|NCT04075513|76024876|FG000|COMPLETED|Overall Study||164||
60014732|NCT02575079|76130879|FG000|STARTED|Overall Study||48||
60014733|NCT02575079|76130880|FG001|STARTED|Overall Study||71||
60014734|NCT02575079|76130879|FG000|COMPLETED|Overall Study||42||
60014735|NCT02575079|76130880|FG001|COMPLETED|Overall Study||71||
59505978|NCT01273181|75598883|FG002|STARTED|Phase I, Dose 1||0||
59903811|NCT04075513|76024877|FG001|COMPLETED|Overall Study||167||
59903812|NCT04075513|76024876|FG000|NOT COMPLETED|Overall Study||8||
59903813|NCT04075513|76024877|FG001|NOT COMPLETED|Overall Study||4||
59903814|NCT04073407|76024885|FG000|STARTED|Part 1||6||
59903815|NCT04073407|76024886|FG001|STARTED|Part 1||3||
59903816|NCT04073407|76024885|FG000|COMPLETED|Part 1||1||
59903817|NCT04073407|76024886|FG001|COMPLETED|Part 1||2||
59903818|NCT04073407|76024885|FG000|NOT COMPLETED|Part 1||5||
59903819|NCT04073407|76024886|FG001|NOT COMPLETED|Part 1||1||
59903820|NCT04073407|76024885|FG000|STARTED|Part 2|Following Part 1, all subjects (including those randomly assigned to the placebo arm in Part 1) were given the option to continue in Part 2 to receive the study food product twice daily for an additional 12 weeks. If the subject chose to not take part in Part 2, the subject underwent a safety follow-up visit approximately 2 weeks after Week13 (Visit 6).|0||
59903821|NCT04073407|76024886|FG001|STARTED|Part 2|Following Part 1, all subjects (including those randomly assigned to the placebo arm in Part 1) were given the option to continue in Part 2 to receive the study food product twice daily for an additional 12 weeks. If the subject chose to not take part in Part 2, the subject underwent a safety follow-up visit approximately 2 weeks after Week13 (Visit 6).|1||
59903822|NCT04073407|76024885|FG000|COMPLETED|Part 2||0||
59903823|NCT04073407|76024886|FG001|COMPLETED|Part 2||0||
59903824|NCT04073407|76024885|FG000|NOT COMPLETED|Part 2||0||
59903825|NCT04073407|76024886|FG001|NOT COMPLETED|Part 2||1||
59903826|NCT02778204|76024896|FG000|STARTED|Overall Study||8||
59903827|NCT02778204|76024897|FG001|STARTED|Overall Study||7||
59903828|NCT02778204|76024898|FG002|STARTED|Overall Study||16||
59903829|NCT02778204|76024899|FG003|STARTED|Overall Study||16||
59903830|NCT02778204|76024896|FG000|COMPLETED|Overall Study||6||
60014736|NCT02575079|76130879|FG000|NOT COMPLETED|Overall Study||6||
60014737|NCT02575079|76130880|FG001|NOT COMPLETED|Overall Study||0||
59903831|NCT02778204|76024897|FG001|COMPLETED|Overall Study||7||
60014738|NCT02614183|76130888|FG000|STARTED|Double Blind Treatment Phase||434||
60014739|NCT02614183|76130889|FG001|STARTED|Double Blind Treatment Phase||214||
59903832|NCT02778204|76024898|FG002|COMPLETED|Overall Study||12||
59903833|NCT02778204|76024899|FG003|COMPLETED|Overall Study||12||
59903834|NCT02778204|76024896|FG000|NOT COMPLETED|Overall Study||2||
59903835|NCT02778204|76024897|FG001|NOT COMPLETED|Overall Study||0||
59903836|NCT02778204|76024898|FG002|NOT COMPLETED|Overall Study||4||
59903837|NCT02778204|76024899|FG003|NOT COMPLETED|Overall Study||4||
59903838|NCT04072159|76024913|FG000|STARTED|Overall Study||16||
59903839|NCT04072159|76024914|FG001|STARTED|Overall Study||17||
59903840|NCT04072159|76024913|FG000|COMPLETED|Overall Study||8||
59903841|NCT04072159|76024914|FG001|COMPLETED|Overall Study||11||
59903842|NCT04072159|76024913|FG000|NOT COMPLETED|Overall Study||8||
59903843|NCT04072159|76024914|FG001|NOT COMPLETED|Overall Study||6||
59903844|NCT03232281|76024924|FG000|STARTED|Overall Study||150||
59903845|NCT03232281|76024925|FG001|STARTED|Overall Study||150||
59903846|NCT03232281|76024924|FG000|Received Treatment|Overall Study||149||
59903847|NCT03232281|76024925|FG001|Received Treatment|Overall Study||150||
59903848|NCT03232281|76024924|FG000|Completed Week 12|Overall Study||143||
59903849|NCT03232281|76024925|FG001|Completed Week 12|Overall Study||148||
59903850|NCT03232281|76024924|FG000|Completed Week 24|Overall Study||143||
59903851|NCT03232281|76024925|FG001|Completed Week 24|Overall Study||144||
59903852|NCT03232281|76024924|FG000|COMPLETED|Overall Study||143||
59903853|NCT03232281|76024925|FG001|COMPLETED|Overall Study||144||
59903854|NCT03232281|76024924|FG000|NOT COMPLETED|Overall Study||7||
59903855|NCT03232281|76024925|FG001|NOT COMPLETED|Overall Study||6||
59903856|NCT04071301|76024931|FG000|STARTED|Overall Study||15||
59903857|NCT04071301|76024931|FG000|COMPLETED|Overall Study||8||
59903858|NCT04071301|76024931|FG000|NOT COMPLETED|Overall Study||7||
59903859|NCT03261336|76024935|FG000|STARTED|Overall Study||1||
59903860|NCT03261336|76024935|FG000|COMPLETED|Overall Study||0||
59903861|NCT03261336|76024935|FG000|NOT COMPLETED|Overall Study||1||
59903862|NCT00462748|76024942|FG000|STARTED|Overall Study||261||
59903863|NCT00462748|76024943|FG001|STARTED|Overall Study||263||
59903864|NCT00462748|76024944|FG002|STARTED|Overall Study||262||
59903865|NCT00462748|76024942|FG000|COMPLETED|Overall Study||249||
59903866|NCT00462748|76024943|FG001|COMPLETED|Overall Study||252||
59903867|NCT00462748|76024944|FG002|COMPLETED|Overall Study||251||
59903868|NCT00462748|76024942|FG000|NOT COMPLETED|Overall Study||12||
59903869|NCT00462748|76024943|FG001|NOT COMPLETED|Overall Study||11||
59903870|NCT00462748|76024944|FG002|NOT COMPLETED|Overall Study||11||
59903871|NCT04206085|76024955|FG000|STARTED|Overall Study||13||
59903872|NCT04206085|76024956|FG001|STARTED|Overall Study||13||
59903873|NCT04206085|76024957|FG002|STARTED|Overall Study||12||
59903874|NCT04206085|76024955|FG000|COMPLETED|Overall Study||13||
59903875|NCT04206085|76024956|FG001|COMPLETED|Overall Study||12||
59903876|NCT04206085|76024957|FG002|COMPLETED|Overall Study||11||
59903877|NCT04206085|76024955|FG000|NOT COMPLETED|Overall Study||0||
59903878|NCT04206085|76024956|FG001|NOT COMPLETED|Overall Study||1||
59903879|NCT04206085|76024957|FG002|NOT COMPLETED|Overall Study||1||
59903880|NCT04202497|76024965|FG000|STARTED|Baseline Scan (Day-1)||7||
59903881|NCT04202497|76024966|FG001|STARTED|Baseline Scan (Day-1)||0||
59903882|NCT04202497|76024967|FG002|STARTED|Baseline Scan (Day-1)||0||
60014740|NCT02614183|76130890|FG002|STARTED|Double Blind Treatment Phase||214||
59611396|NCT01780506|75722364|FG001|STARTED|Double-Blind Phase||434||
59903883|NCT04202497|76024968|FG003|STARTED|Baseline Scan (Day-1)||0||
60014741|NCT02614183|76130888|FG000|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||433||
60014742|NCT02614183|76130889|FG001|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||213||
60014743|NCT02614183|76130890|FG002|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||212||
59903884|NCT04202497|76024965|FG000|COMPLETED|Baseline Scan (Day-1)||6||
59903885|NCT04202497|76024966|FG001|COMPLETED|Baseline Scan (Day-1)||0||
59903886|NCT04202497|76024967|FG002|COMPLETED|Baseline Scan (Day-1)||0||
59903887|NCT04202497|76024968|FG003|COMPLETED|Baseline Scan (Day-1)||0||
60014744|NCT02614183|76130888|FG000|Safety Population|Double Blind Treatment Phase||432||
60014745|NCT02614183|76130889|FG001|Safety Population|Double Blind Treatment Phase|One pt randomized to placebo received galcanezumab 120mg due to dosing error moved to this group.|206||
60014746|NCT02614183|76130890|FG002|Safety Population|Double Blind Treatment Phase|Eight pts discontinued after loading dose of 240mg galcanezumab in 120mg group moved to this group.|220||
60014747|NCT02614183|76130888|FG000|COMPLETED|Double Blind Treatment Phase||351||
60014748|NCT02614183|76130889|FG001|COMPLETED|Double Blind Treatment Phase||177||
60014749|NCT02614183|76130890|FG002|COMPLETED|Double Blind Treatment Phase||175||
60014750|NCT02614183|76130888|FG000|NOT COMPLETED|Double Blind Treatment Phase||83||
60014751|NCT02614183|76130889|FG001|NOT COMPLETED|Double Blind Treatment Phase||37||
59903888|NCT04202497|76024965|FG000|NOT COMPLETED|Baseline Scan (Day-1)||1||
59903889|NCT04202497|76024966|FG001|NOT COMPLETED|Baseline Scan (Day-1)||0||
59903890|NCT04202497|76024967|FG002|NOT COMPLETED|Baseline Scan (Day-1)||0||
59903891|NCT04202497|76024968|FG003|NOT COMPLETED|Baseline Scan (Day-1)||0||
59903892|NCT04202497|76024965|FG000|STARTED|Treatment Period (Day 1 Through Day 2-3)||0||
59903893|NCT04202497|76024966|FG001|STARTED|Treatment Period (Day 1 Through Day 2-3)|Eligible participants from Baseline Period who received 10 mCi of [18F]MNI-1054 on Day -1.|2||
59903894|NCT04202497|76024967|FG002|STARTED|Treatment Period (Day 1 Through Day 2-3)|Eligible participants from Baseline Period who received 10 mCi of [18F]MNI-1054 on Day -1.|2||
59903895|NCT04202497|76024968|FG003|STARTED|Treatment Period (Day 1 Through Day 2-3)|Eligible participants from Baseline Period who received 10 mCi of [18F]MNI-1054 on Day -1.|2||
59903896|NCT04202497|76024965|FG000|COMPLETED|Treatment Period (Day 1 Through Day 2-3)||0||
59903897|NCT04202497|76024966|FG001|COMPLETED|Treatment Period (Day 1 Through Day 2-3)||2||
59903898|NCT04202497|76024967|FG002|COMPLETED|Treatment Period (Day 1 Through Day 2-3)||2||
59903899|NCT04202497|76024968|FG003|COMPLETED|Treatment Period (Day 1 Through Day 2-3)||2||
59903900|NCT04202497|76024965|FG000|NOT COMPLETED|Treatment Period (Day 1 Through Day 2-3)||0||
59903901|NCT04202497|76024966|FG001|NOT COMPLETED|Treatment Period (Day 1 Through Day 2-3)||0||
59903902|NCT04202497|76024967|FG002|NOT COMPLETED|Treatment Period (Day 1 Through Day 2-3)||0||
59903903|NCT04202497|76024968|FG003|NOT COMPLETED|Treatment Period (Day 1 Through Day 2-3)||0||
59903904|NCT03297294|76024984|FG000|STARTED|Double-Blind Treatment Period (DB)||70||
59903905|NCT03297294|76024985|FG001|STARTED|Double-Blind Treatment Period (DB)||67||
59903906|NCT03297294|76024986|FG002|STARTED|Double-Blind Treatment Period (DB)||0||
59903907|NCT03297294|76024987|FG003|STARTED|Double-Blind Treatment Period (DB)||0||
59903908|NCT03297294|76024988|FG004|STARTED|Double-Blind Treatment Period (DB)||0||
59903909|NCT03297294|76024984|FG000|COMPLETED|Double-Blind Treatment Period (DB)||32|Study completers completed the treatment phase regardless of completion of study treatment.|
59903910|NCT03297294|76024985|FG001|COMPLETED|Double-Blind Treatment Period (DB)||30|Study completers completed the treatment phase regardless of completion of study treatment.|
59903911|NCT03297294|76024986|FG002|COMPLETED|Double-Blind Treatment Period (DB)||0|Study completers completed the treatment phase regardless of completion of study treatment.|
59903912|NCT03297294|76024987|FG003|COMPLETED|Double-Blind Treatment Period (DB)||0|Study completers completed the treatment phase regardless of completion of study treatment.|
59903913|NCT03297294|76024988|FG004|COMPLETED|Double-Blind Treatment Period (DB)||0|Study completers completed the treatment phase regardless of completion of study treatment.|
59903914|NCT03297294|76024984|FG000|NOT COMPLETED|Double-Blind Treatment Period (DB)||38||
59903915|NCT03297294|76024985|FG001|NOT COMPLETED|Double-Blind Treatment Period (DB)||37||
59903916|NCT03297294|76024986|FG002|NOT COMPLETED|Double-Blind Treatment Period (DB)||0||
59903917|NCT03297294|76024987|FG003|NOT COMPLETED|Double-Blind Treatment Period (DB)||0||
59903918|NCT03297294|76024988|FG004|NOT COMPLETED|Double-Blind Treatment Period (DB)||0||
59903919|NCT03297294|76024984|FG000|STARTED|Treatment Withdrawal Period (TW)||0||
59903920|NCT03297294|76024985|FG001|STARTED|Treatment Withdrawal Period (TW)||0||
59903921|NCT03297294|76024986|FG002|STARTED|Treatment Withdrawal Period (TW)||14||
59903922|NCT03297294|76024987|FG003|STARTED|Treatment Withdrawal Period (TW)||12||
59903923|NCT03297294|76024988|FG004|STARTED|Treatment Withdrawal Period (TW)||27||
59903924|NCT03297294|76024984|FG000|COMPLETED|Treatment Withdrawal Period (TW)||0||
59903925|NCT03297294|76024985|FG001|COMPLETED|Treatment Withdrawal Period (TW)||0||
59903926|NCT03297294|76024986|FG002|COMPLETED|Treatment Withdrawal Period (TW)||14||
59903927|NCT03297294|76024987|FG003|COMPLETED|Treatment Withdrawal Period (TW)||11||
59903928|NCT03297294|76024988|FG004|COMPLETED|Treatment Withdrawal Period (TW)||27||
59903929|NCT03297294|76024984|FG000|NOT COMPLETED|Treatment Withdrawal Period (TW)||0||
59903930|NCT03297294|76024985|FG001|NOT COMPLETED|Treatment Withdrawal Period (TW)||0||
59903931|NCT03297294|76024986|FG002|NOT COMPLETED|Treatment Withdrawal Period (TW)||0||
59903932|NCT03297294|76024987|FG003|NOT COMPLETED|Treatment Withdrawal Period (TW)||1||
59903933|NCT03297294|76024988|FG004|NOT COMPLETED|Treatment Withdrawal Period (TW)||0||
59903934|NCT03238911|76025002|FG000|STARTED|Overall Study||62||
59903935|NCT03238911|76025003|FG001|STARTED|Overall Study||61||
59903936|NCT03238911|76025002|FG000|Safety Analysis Set|Overall Study|1 subject from ferric carboxymaltose group received iron isomaltoside/ferric derisomaltose in error.|63||
59903937|NCT03238911|76025003|FG001|Safety Analysis Set|Overall Study|1 subject from ferric carboxymaltose group received iron isomaltoside/ferric derisomaltose in error.|60||
59903938|NCT03238911|76025002|FG000|COMPLETED|Overall Study||59||
59903939|NCT03238911|76025003|FG001|COMPLETED|Overall Study||58||
59903940|NCT03238911|76025002|FG000|NOT COMPLETED|Overall Study||3||
59903941|NCT03238911|76025003|FG001|NOT COMPLETED|Overall Study||3||
59903942|NCT00418834|76025012|FG000|STARTED|Overall Study||526||
59903943|NCT00418834|76025013|FG001|STARTED|Overall Study||527||
59903944|NCT00418834|76025012|FG000|COMPLETED|Overall Study||503||
59903945|NCT00418834|76025013|FG001|COMPLETED|Overall Study||507||
59903946|NCT00418834|76025012|FG000|NOT COMPLETED|Overall Study||23||
59903947|NCT00418834|76025013|FG001|NOT COMPLETED|Overall Study||20||
59903948|NCT03276975|76025021|FG000|STARTED|Overall Study||8||
59903949|NCT03276975|76025022|FG001|STARTED|Overall Study||7||
59903950|NCT03276975|76025021|FG000|Crossover At 2 Months|Overall Study||0||
59903951|NCT03276975|76025022|FG001|Crossover At 2 Months|Overall Study||7||
59903952|NCT03276975|76025021|FG000|COMPLETED|Overall Study||7||
59903953|NCT03276975|76025022|FG001|COMPLETED|Overall Study||7||
59903954|NCT03276975|76025021|FG000|NOT COMPLETED|Overall Study||1||
59903955|NCT03276975|76025022|FG001|NOT COMPLETED|Overall Study||0||
59903956|NCT03297216|76025030|FG000|STARTED|Overall Study||399||
59903957|NCT03297216|76025031|FG001|STARTED|Overall Study||401||
59903958|NCT03297216|76025030|FG000|Discontinued Intervention|Overall Study||5||
59903959|NCT03297216|76025031|FG001|Discontinued Intervention|Overall Study||4||
59903960|NCT03297216|76025030|FG000|Infants Born During Study|Overall Study||399||
59903961|NCT03297216|76025031|FG001|Infants Born During Study|Overall Study||401||
59903962|NCT03297216|76025030|FG000|COMPLETED|Overall Study||396||
59903963|NCT03297216|76025031|FG001|COMPLETED|Overall Study||396||
59903964|NCT03297216|76025030|FG000|NOT COMPLETED|Overall Study||3||
59903965|NCT03297216|76025031|FG001|NOT COMPLETED|Overall Study||5||
59903966|NCT03260868|76025046|FG000|STARTED|Overall Study||8|Randomized population|
59903967|NCT03260868|76025047|FG001|STARTED|Overall Study||7|Randomized population|
59903968|NCT03260868|76025046|FG000|Safety Population|Overall Study||8|Treated|
59903969|NCT03260868|76025047|FG001|Safety Population|Overall Study||6|Treated|
59903970|NCT03260868|76025046|FG000|COMPLETED|Overall Study||5||
59903971|NCT03260868|76025047|FG001|COMPLETED|Overall Study||4||
59903972|NCT03260868|76025046|FG000|NOT COMPLETED|Overall Study||3||
59903973|NCT03260868|76025047|FG001|NOT COMPLETED|Overall Study||3||
59903974|NCT03293394|76025055|FG000|STARTED|First Intervention (2 Weeks)||20||
59903975|NCT03293394|76025056|FG001|STARTED|First Intervention (2 Weeks)||10||
59903976|NCT03293394|76025055|FG000|COMPLETED|First Intervention (2 Weeks)||20||
59903977|NCT03293394|76025056|FG001|COMPLETED|First Intervention (2 Weeks)||10||
59903978|NCT03293394|76025055|FG000|NOT COMPLETED|First Intervention (2 Weeks)||0||
59903979|NCT03293394|76025056|FG001|NOT COMPLETED|First Intervention (2 Weeks)||0||
59903980|NCT03293394|76025055|FG000|STARTED|Follow-up (6 Months)||20||
59903981|NCT03293394|76025056|FG001|STARTED|Follow-up (6 Months)||10||
59903982|NCT03293394|76025055|FG000|COMPLETED|Follow-up (6 Months)||16||
59903983|NCT03293394|76025056|FG001|COMPLETED|Follow-up (6 Months)||8||
59903984|NCT03293394|76025055|FG000|NOT COMPLETED|Follow-up (6 Months)||4||
59903985|NCT03293394|76025056|FG001|NOT COMPLETED|Follow-up (6 Months)||2||
59903986|NCT03259308|76025065|FG000|STARTED|Overall Study||56||
59903987|NCT03259308|76025066|FG001|STARTED|Overall Study||111||
59903988|NCT03259308|76025067|FG002|STARTED|Overall Study||112||
59903989|NCT03259308|76025065|FG000|COMPLETED|Overall Study||49||
59903990|NCT03259308|76025066|FG001|COMPLETED|Overall Study||103||
59903991|NCT03259308|76025067|FG002|COMPLETED|Overall Study||105||
59903992|NCT03259308|76025065|FG000|NOT COMPLETED|Overall Study||7||
59903993|NCT03259308|76025066|FG001|NOT COMPLETED|Overall Study||8||
59903994|NCT03259308|76025067|FG002|NOT COMPLETED|Overall Study||7||
59903995|NCT03258762|76025077|FG000|STARTED|Overall Study||7||
59903996|NCT03258762|76025078|FG001|STARTED|Overall Study||7||
59903997|NCT03258762|76025077|FG000|COMPLETED|Overall Study||7||
59903998|NCT03258762|76025078|FG001|COMPLETED|Overall Study||6||
59903999|NCT03258762|76025077|FG000|NOT COMPLETED|Overall Study||0||
59904000|NCT03258762|76025078|FG001|NOT COMPLETED|Overall Study||1||
59904001|NCT04502589|76025087|FG000|STARTED|Overall Study||2||
59505979|NCT01273181|75598884|FG003|STARTED|Phase I, Dose 1||0||
59505980|NCT01273181|75598881|FG000|COMPLETED|Phase I, Dose 1||2||
59505981|NCT01273181|75598882|FG001|COMPLETED|Phase I, Dose 1||0||
59505982|NCT01273181|75598883|FG002|COMPLETED|Phase I, Dose 1||0||
59505983|NCT01273181|75598884|FG003|COMPLETED|Phase I, Dose 1||0||
59505984|NCT01273181|75598881|FG000|NOT COMPLETED|Phase I, Dose 1||1||
59505985|NCT01273181|75598882|FG001|NOT COMPLETED|Phase I, Dose 1||0||
59505986|NCT01273181|75598883|FG002|NOT COMPLETED|Phase I, Dose 1||0||
59505987|NCT01273181|75598884|FG003|NOT COMPLETED|Phase I, Dose 1||0||
59505988|NCT01273181|75598881|FG000|STARTED|Phase I, Dose 2||0||
59505989|NCT01273181|75598882|FG001|STARTED|Phase I, Dose 2||3||
59505990|NCT01273181|75598883|FG002|STARTED|Phase I, Dose 2||0||
59505991|NCT01273181|75598884|FG003|STARTED|Phase I, Dose 2||0||
59505992|NCT01273181|75598881|FG000|COMPLETED|Phase I, Dose 2||0||
59505993|NCT01273181|75598882|FG001|COMPLETED|Phase I, Dose 2||2||
59505994|NCT01273181|75598883|FG002|COMPLETED|Phase I, Dose 2||0||
59505995|NCT01273181|75598884|FG003|COMPLETED|Phase I, Dose 2||0||
59505996|NCT01273181|75598881|FG000|NOT COMPLETED|Phase I, Dose 2||0||
59505997|NCT01273181|75598882|FG001|NOT COMPLETED|Phase I, Dose 2||1||
59505998|NCT01273181|75598883|FG002|NOT COMPLETED|Phase I, Dose 2||0||
59505999|NCT01273181|75598884|FG003|NOT COMPLETED|Phase I, Dose 2||0||
59506000|NCT01273181|75598881|FG000|STARTED|Phase 2, Dose 1||0||
59506001|NCT01273181|75598882|FG001|STARTED|Phase 2, Dose 1||0||
59611397|NCT01780506|75722363|FG000|COMPLETED|Double-Blind Phase||368||
59611398|NCT01780506|75722364|FG001|COMPLETED|Double-Blind Phase||356||
59904002|NCT04502589|76025088|FG001|STARTED|Overall Study||2||
59904003|NCT04502589|76025087|FG000|COMPLETED|Overall Study||1||
59904004|NCT04502589|76025088|FG001|COMPLETED|Overall Study||2||
59904005|NCT04502589|76025087|FG000|NOT COMPLETED|Overall Study||1||
59904006|NCT04502589|76025088|FG001|NOT COMPLETED|Overall Study||0||
59904007|NCT03291288|76025094|FG000|STARTED|Drug-drug Interaction Phase||32||
59904008|NCT03291288|76025095|FG001|STARTED|Drug-drug Interaction Phase||0||
60014752|NCT02614183|76130890|FG002|NOT COMPLETED|Double Blind Treatment Phase||39||
59904009|NCT03291288|76025094|FG000|COMPLETED|Drug-drug Interaction Phase||26||
59904010|NCT03291288|76025095|FG001|COMPLETED|Drug-drug Interaction Phase||0||
59904011|NCT03291288|76025094|FG000|NOT COMPLETED|Drug-drug Interaction Phase||6||
59506002|NCT01273181|75598883|FG002|STARTED|Phase 2, Dose 1||2||
59506003|NCT01273181|75598884|FG003|STARTED|Phase 2, Dose 1||0||
59506004|NCT01273181|75598881|FG000|COMPLETED|Phase 2, Dose 1||0||
59506005|NCT01273181|75598882|FG001|COMPLETED|Phase 2, Dose 1||0||
59506006|NCT01273181|75598883|FG002|COMPLETED|Phase 2, Dose 1||1||
59506007|NCT01273181|75598884|FG003|COMPLETED|Phase 2, Dose 1||0||
59506008|NCT01273181|75598881|FG000|NOT COMPLETED|Phase 2, Dose 1||0||
59506009|NCT01273181|75598882|FG001|NOT COMPLETED|Phase 2, Dose 1||0||
59506010|NCT01273181|75598883|FG002|NOT COMPLETED|Phase 2, Dose 1||1||
59506011|NCT01273181|75598884|FG003|NOT COMPLETED|Phase 2, Dose 1||0||
59506012|NCT01273181|75598881|FG000|STARTED|Phase 2, Dose 2||0||
59506013|NCT01273181|75598882|FG001|STARTED|Phase 2, Dose 2||0||
59506014|NCT01273181|75598883|FG002|STARTED|Phase 2, Dose 2||0||
59506015|NCT01273181|75598884|FG003|STARTED|Phase 2, Dose 2||1||
59506016|NCT01273181|75598881|FG000|COMPLETED|Phase 2, Dose 2||0||
59904012|NCT03291288|76025095|FG001|NOT COMPLETED|Drug-drug Interaction Phase||0||
59904013|NCT03291288|76025094|FG000|STARTED|Pexidartinib Only|This is a crossover trial; participants who completed Part 1 continued to Part 2.|0||
59904014|NCT03291288|76025095|FG001|STARTED|Pexidartinib Only||26||
59904015|NCT03291288|76025094|FG000|COMPLETED|Pexidartinib Only||0||
59904016|NCT03291288|76025095|FG001|COMPLETED|Pexidartinib Only||24||
59904017|NCT03291288|76025094|FG000|NOT COMPLETED|Pexidartinib Only||0||
59506017|NCT01273181|75598882|FG001|COMPLETED|Phase 2, Dose 2||0||
59506018|NCT01273181|75598883|FG002|COMPLETED|Phase 2, Dose 2||0||
59506019|NCT01273181|75598884|FG003|COMPLETED|Phase 2, Dose 2||0||
59506020|NCT01273181|75598881|FG000|NOT COMPLETED|Phase 2, Dose 2||0||
59506021|NCT01273181|75598882|FG001|NOT COMPLETED|Phase 2, Dose 2||0||
59506022|NCT01273181|75598883|FG002|NOT COMPLETED|Phase 2, Dose 2||0||
59506023|NCT01273181|75598884|FG003|NOT COMPLETED|Phase 2, Dose 2||1||
59506024|NCT01272947|75598900|FG000|STARTED|Overall Study||104||
59757810|NCT02975349|75876978|FG005|COMPLETED|Active Treatment Period (24 Weeks)||52||
59757811|NCT02975349|75876973|FG000|NOT COMPLETED|Active Treatment Period (24 Weeks)||5||
59904018|NCT03291288|76025095|FG001|NOT COMPLETED|Pexidartinib Only||2||
59904019|NCT03493126|76025111|FG000|STARTED|Overall Study||31||
59904020|NCT03493126|76025112|FG001|STARTED|Overall Study||28||
59904021|NCT03493126|76025111|FG000|COMPLETED|Overall Study||28||
59904022|NCT03493126|76025112|FG001|COMPLETED|Overall Study||28||
59904023|NCT03493126|76025111|FG000|NOT COMPLETED|Overall Study||3||
59904024|NCT03493126|76025112|FG001|NOT COMPLETED|Overall Study||0||
59904025|NCT03257358|76025120|FG000|STARTED|Overall Study||165||
59904026|NCT03257358|76025121|FG001|STARTED|Overall Study||217||
59904027|NCT03257358|76025120|FG000|Never Received Treatment|Overall Study||2||
59904028|NCT03257358|76025121|FG001|Never Received Treatment|Overall Study||0||
59904029|NCT03257358|76025120|FG000|COMPLETED|Overall Study||94||
59904030|NCT03257358|76025121|FG001|COMPLETED|Overall Study||183||
59904031|NCT03257358|76025120|FG000|NOT COMPLETED|Overall Study||71||
59904032|NCT03257358|76025121|FG001|NOT COMPLETED|Overall Study||34||
59904033|NCT02936037|76025129|FG000|STARTED|Double-Blind Treatment Period||316||
59904034|NCT02936037|76025130|FG001|STARTED|Double-Blind Treatment Period||326||
59904035|NCT02936037|76025129|FG000|COMPLETED|Double-Blind Treatment Period||267||
59904036|NCT02936037|76025130|FG001|COMPLETED|Double-Blind Treatment Period||261||
59506025|NCT01272947|75598901|FG001|STARTED|Overall Study||100||
59506026|NCT01272947|75598900|FG000|COMPLETED|Overall Study||102||
59506027|NCT01272947|75598901|FG001|COMPLETED|Overall Study||98||
59506028|NCT01272947|75598900|FG000|NOT COMPLETED|Overall Study||2||
59506029|NCT01272947|75598901|FG001|NOT COMPLETED|Overall Study||2||
59506030|NCT01279343|75598909|FG000|STARTED|Overall Study||59||
59506031|NCT01279343|75598910|FG001|STARTED|Overall Study||64||
59506032|NCT01279343|75598909|FG000|COMPLETED|Overall Study||57||
59506033|NCT01279343|75598910|FG001|COMPLETED|Overall Study||58||
59904037|NCT02936037|76025129|FG000|NOT COMPLETED|Double-Blind Treatment Period||49||
59904038|NCT02936037|76025130|FG001|NOT COMPLETED|Double-Blind Treatment Period||65||
59904039|NCT02936037|76025129|FG000|STARTED|Open Label Extension||0||
59904040|NCT02936037|76025130|FG001|STARTED|Open Label Extension||528||
59904041|NCT02936037|76025129|FG000|COMPLETED|Open Label Extension||0||
59904042|NCT02936037|76025130|FG001|COMPLETED|Open Label Extension||518||
59904043|NCT02936037|76025129|FG000|NOT COMPLETED|Open Label Extension||0||
59904044|NCT02936037|76025130|FG001|NOT COMPLETED|Open Label Extension||10||
59904045|NCT03288714|76025138|FG000|STARTED|Overall Study||59||
59506034|NCT01279343|75598909|FG000|NOT COMPLETED|Overall Study||2||
59506035|NCT01279343|75598910|FG001|NOT COMPLETED|Overall Study||6||
59506036|NCT01278797|75598916|FG000|STARTED|Period 1||14||
59904046|NCT03288714|76025139|FG001|STARTED|Overall Study||62||
59904047|NCT03288714|76025138|FG000|COMPLETED|Overall Study||49||
59904048|NCT03288714|76025139|FG001|COMPLETED|Overall Study||59||
59904049|NCT03288714|76025138|FG000|NOT COMPLETED|Overall Study||10||
59904050|NCT03288714|76025139|FG001|NOT COMPLETED|Overall Study||3||
59904051|NCT03256578|76025149|FG000|STARTED|Overall Study||204||
59904052|NCT03256578|76025150|FG001|STARTED|Overall Study||206||
59904053|NCT03256578|76025149|FG000|COMPLETED|Overall Study||138||
59904054|NCT03256578|76025150|FG001|COMPLETED|Overall Study||150||
59904055|NCT03256578|76025149|FG000|NOT COMPLETED|Overall Study||66||
59904056|NCT03256578|76025150|FG001|NOT COMPLETED|Overall Study||56||
59904057|NCT03227445|76025156|FG000|STARTED|Period 1 (28 Days)||60||
59904058|NCT03227445|76025157|FG001|STARTED|Period 1 (28 Days)||59||
59904059|NCT03227445|76025158|FG002|STARTED|Period 1 (28 Days)||60||
59904060|NCT03227445|76025159|FG003|STARTED|Period 1 (28 Days)||60||
59904061|NCT03227445|76025156|FG000|COMPLETED|Period 1 (28 Days)||58||
59904062|NCT03227445|76025157|FG001|COMPLETED|Period 1 (28 Days)||57||
59904063|NCT03227445|76025158|FG002|COMPLETED|Period 1 (28 Days)||59||
59904064|NCT03227445|76025159|FG003|COMPLETED|Period 1 (28 Days)||58||
59904065|NCT03227445|76025156|FG000|NOT COMPLETED|Period 1 (28 Days)||2||
59904066|NCT03227445|76025157|FG001|NOT COMPLETED|Period 1 (28 Days)||2||
59904067|NCT03227445|76025158|FG002|NOT COMPLETED|Period 1 (28 Days)||1||
59904068|NCT03227445|76025159|FG003|NOT COMPLETED|Period 1 (28 Days)||2||
59904069|NCT03227445|76025156|FG000|STARTED|Period 2 (28 Days)||58||
59904070|NCT03227445|76025157|FG001|STARTED|Period 2 (28 Days)||57||
59904071|NCT03227445|76025158|FG002|STARTED|Period 2 (28 Days)||59||
59904072|NCT03227445|76025159|FG003|STARTED|Period 2 (28 Days)||58||
59904073|NCT03227445|76025156|FG000|COMPLETED|Period 2 (28 Days)||57||
59904074|NCT03227445|76025157|FG001|COMPLETED|Period 2 (28 Days)||56||
59904075|NCT03227445|76025158|FG002|COMPLETED|Period 2 (28 Days)||57||
59904076|NCT03227445|76025159|FG003|COMPLETED|Period 2 (28 Days)||55||
59904077|NCT03227445|76025156|FG000|NOT COMPLETED|Period 2 (28 Days)||1||
59904078|NCT03227445|76025157|FG001|NOT COMPLETED|Period 2 (28 Days)||1||
59904079|NCT03227445|76025158|FG002|NOT COMPLETED|Period 2 (28 Days)||2||
59904080|NCT03227445|76025159|FG003|NOT COMPLETED|Period 2 (28 Days)||3||
59904081|NCT04067401|76025170|FG000|STARTED|Overall Study||748||
59904082|NCT04067401|76025171|FG001|STARTED|Overall Study||737||
59904083|NCT04067401|76025170|FG000|Baseline Survey Completion|Overall Study||746||
59904084|NCT04067401|76025171|FG001|Baseline Survey Completion|Overall Study||735||
59904085|NCT04067401|76025170|FG000|1 Month Survey Completion|Overall Study||697||
59904086|NCT04067401|76025171|FG001|1 Month Survey Completion|Overall Study||694||
59904087|NCT04067401|76025170|FG000|6 Month Survey Completion|Overall Study||629||
59904088|NCT04067401|76025171|FG001|6 Month Survey Completion|Overall Study||618||
59904089|NCT04067401|76025170|FG000|COMPLETED|Overall Study||740||
59904090|NCT04067401|76025171|FG001|COMPLETED|Overall Study||737||
59904091|NCT04067401|76025170|FG000|NOT COMPLETED|Overall Study||8||
59904092|NCT04067401|76025171|FG001|NOT COMPLETED|Overall Study||0||
59904093|NCT04194151|76025183|FG000|STARTED|Overall Study||32||
59904094|NCT04194151|76025184|FG001|STARTED|Overall Study||32||
59904095|NCT04194151|76025185|FG002|STARTED|Overall Study||32||
59904096|NCT04194151|76025186|FG003|STARTED|Overall Study||32||
59904097|NCT04194151|76025187|FG004|STARTED|Overall Study||32||
59904098|NCT04194151|76025188|FG005|STARTED|Overall Study||32||
59904099|NCT04194151|76025183|FG000|COMPLETED|Overall Study||31||
59904100|NCT04194151|76025184|FG001|COMPLETED|Overall Study||30||
59904101|NCT04194151|76025185|FG002|COMPLETED|Overall Study||31||
59904102|NCT04194151|76025186|FG003|COMPLETED|Overall Study||31||
59904103|NCT04194151|76025187|FG004|COMPLETED|Overall Study||32||
59904104|NCT04194151|76025188|FG005|COMPLETED|Overall Study||31||
59904105|NCT04194151|76025183|FG000|NOT COMPLETED|Overall Study||1||
59904106|NCT04194151|76025184|FG001|NOT COMPLETED|Overall Study||2||
59904107|NCT04194151|76025185|FG002|NOT COMPLETED|Overall Study||1||
59904108|NCT04194151|76025186|FG003|NOT COMPLETED|Overall Study||1||
59904109|NCT04194151|76025187|FG004|NOT COMPLETED|Overall Study||0||
59904110|NCT04194151|76025188|FG005|NOT COMPLETED|Overall Study||1||
59904111|NCT03820323|76025204|FG000|STARTED|Overall Study||355||
59904112|NCT03820323|76025205|FG001|STARTED|Overall Study||349||
59904113|NCT03820323|76025204|FG000|COMPLETED|Overall Study||315||
59904114|NCT03820323|76025205|FG001|COMPLETED|Overall Study||313||
59904115|NCT03820323|76025204|FG000|NOT COMPLETED|Overall Study||40||
59904116|NCT03820323|76025205|FG001|NOT COMPLETED|Overall Study||36||
59904117|NCT01580813|76025211|FG000|STARTED|Overall Study||4||
59904118|NCT01580813|76025212|FG001|STARTED|Overall Study||3||
59904119|NCT01580813|76025211|FG000|Completed First Intervention|Overall Study||4||
59904120|NCT01580813|76025212|FG001|Completed First Intervention|Overall Study||3||
59904121|NCT01580813|76025211|FG000|Completed 1 Week Washout|Overall Study||4||
59904122|NCT01580813|76025212|FG001|Completed 1 Week Washout|Overall Study||3||
59904123|NCT01580813|76025211|FG000|Started Second Intervention|Overall Study||4||
59904124|NCT01580813|76025212|FG001|Started Second Intervention|Overall Study||3||
59904125|NCT01580813|76025211|FG000|COMPLETED|Overall Study||4||
59904126|NCT01580813|76025212|FG001|COMPLETED|Overall Study||3||
59904127|NCT01580813|76025211|FG000|NOT COMPLETED|Overall Study||0||
59904128|NCT01580813|76025212|FG001|NOT COMPLETED|Overall Study||0||
59904129|NCT03287622|76025220|FG000|STARTED|Overall Study||356||
59904130|NCT03287622|76025221|FG001|STARTED|Overall Study||356||
59904131|NCT03287622|76025220|FG000|Sub-randomized to Nudge/NoNudge|Overall Study||253||
59904132|NCT03287622|76025221|FG001|Sub-randomized to Nudge/NoNudge|Overall Study||266||
59904133|NCT03287622|76025220|FG000|COMPLETED|Overall Study||298||
59904134|NCT03287622|76025221|FG001|COMPLETED|Overall Study||308||
59904135|NCT03287622|76025220|FG000|NOT COMPLETED|Overall Study||58||
59904136|NCT03287622|76025221|FG001|NOT COMPLETED|Overall Study||48||
59904137|NCT04063657|76025236|FG000|STARTED|Overall Study||1||
59904138|NCT04063657|76025237|FG001|STARTED|Overall Study||0||
59904139|NCT04063657|76025236|FG000|COMPLETED|Overall Study||0||
59904140|NCT04063657|76025237|FG001|COMPLETED|Overall Study||0||
59904141|NCT04063657|76025236|FG000|NOT COMPLETED|Overall Study||1||
59904142|NCT04063657|76025237|FG001|NOT COMPLETED|Overall Study||0||
59904143|NCT02970136|76025245|FG000|STARTED|Overall Study||377||
59904144|NCT02970136|76025246|FG001|STARTED|Overall Study||377||
59904145|NCT02970136|76025245|FG000|COMPLETED|Overall Study||297||
59904146|NCT02970136|76025246|FG001|COMPLETED|Overall Study||282||
59904147|NCT02970136|76025245|FG000|NOT COMPLETED|Overall Study||80||
59904148|NCT02970136|76025246|FG001|NOT COMPLETED|Overall Study||95||
59904149|NCT04058353|76025254|FG000|STARTED|Overall Study||126||
59904150|NCT04058353|76025255|FG001|STARTED|Overall Study||132||
59904151|NCT04058353|76025254|FG000|COMPLETED|Overall Study||122||
59904152|NCT04058353|76025255|FG001|COMPLETED|Overall Study||131||
59904153|NCT04058353|76025254|FG000|NOT COMPLETED|Overall Study||4||
59506037|NCT01278797|75598917|FG001|STARTED|Period 1||14||
59506038|NCT01278797|75598916|FG000|COMPLETED|Period 1||13||
59506039|NCT01278797|75598917|FG001|COMPLETED|Period 1||13||
59506040|NCT01278797|75598916|FG000|NOT COMPLETED|Period 1||1||
59904154|NCT04058353|76025255|FG001|NOT COMPLETED|Overall Study||1||
59904155|NCT03226353|76025262|FG000|STARTED|Overall Study||77||
59904156|NCT03226353|76025262|FG000|Habitual Wearers of Proclear 1 Day|Overall Study||2||
59904157|NCT03226353|76025262|FG000|Other Habitual Lens Types|Overall Study||75||
59506041|NCT01278797|75598917|FG001|NOT COMPLETED|Period 1||1||
59506042|NCT01278797|75598916|FG000|STARTED|Washout Period of 21 Days||13||
59506043|NCT01278797|75598917|FG001|STARTED|Washout Period of 21 Days||13||
59506044|NCT01278797|75598916|FG000|COMPLETED|Washout Period of 21 Days||13||
59506045|NCT01278797|75598917|FG001|COMPLETED|Washout Period of 21 Days||13||
59506046|NCT01278797|75598916|FG000|NOT COMPLETED|Washout Period of 21 Days||0||
59904158|NCT03226353|76025262|FG000|COMPLETED|Overall Study|Study participants completed includes the Omafilcon A habitual wearers.|71||
59904159|NCT03226353|76025262|FG000|NOT COMPLETED|Overall Study||6||
59904160|NCT02730598|76025271|FG000|STARTED|Overall Study||14||
59904161|NCT02730598|76025272|FG001|STARTED|Overall Study||14||
59904162|NCT02730598|76025271|FG000|COMPLETED|Overall Study||10||
59904163|NCT02730598|76025272|FG001|COMPLETED|Overall Study||10||
59904164|NCT02730598|76025271|FG000|NOT COMPLETED|Overall Study||4||
59904165|NCT02730598|76025272|FG001|NOT COMPLETED|Overall Study||4||
59506047|NCT01278797|75598917|FG001|NOT COMPLETED|Washout Period of 21 Days||0||
59506048|NCT01278797|75598916|FG000|STARTED|Period 2||13||
59506049|NCT01278797|75598917|FG001|STARTED|Period 2||13||
59506050|NCT01278797|75598916|FG000|COMPLETED|Period 2||13||
59506051|NCT01278797|75598917|FG001|COMPLETED|Period 2||13||
59506052|NCT01278797|75598916|FG000|NOT COMPLETED|Period 2||0||
59506053|NCT01278797|75598917|FG001|NOT COMPLETED|Period 2||0||
59506054|NCT01272869|75598925|FG000|STARTED|Period 1 (14 Days)||10||
59506055|NCT01272869|75598926|FG001|STARTED|Period 1 (14 Days)||10||
59506056|NCT01272869|75598925|FG000|COMPLETED|Period 1 (14 Days)||10||
59904166|NCT03226275|76025282|FG000|STARTED|Treatment Period 1 (8 Days)||8||
59904167|NCT03226275|76025283|FG001|STARTED|Treatment Period 1 (8 Days)||8||
59904168|NCT03226275|76025284|FG002|STARTED|Treatment Period 1 (8 Days)||8||
59904169|NCT03226275|76025285|FG003|STARTED|Treatment Period 1 (8 Days)||8||
59904170|NCT03226275|76025282|FG000|COMPLETED|Treatment Period 1 (8 Days)||8||
59904171|NCT03226275|76025283|FG001|COMPLETED|Treatment Period 1 (8 Days)||8||
59904172|NCT03226275|76025284|FG002|COMPLETED|Treatment Period 1 (8 Days)||7||
59904173|NCT03226275|76025285|FG003|COMPLETED|Treatment Period 1 (8 Days)||7||
59904174|NCT03226275|76025282|FG000|NOT COMPLETED|Treatment Period 1 (8 Days)||0||
59904175|NCT03226275|76025283|FG001|NOT COMPLETED|Treatment Period 1 (8 Days)||0||
59904176|NCT03226275|76025284|FG002|NOT COMPLETED|Treatment Period 1 (8 Days)||1||
59904177|NCT03226275|76025285|FG003|NOT COMPLETED|Treatment Period 1 (8 Days)||1||
59904178|NCT03226275|76025282|FG000|STARTED|Treatment Period 2 (8 Days)||8||
59506057|NCT01272869|75598926|FG001|COMPLETED|Period 1 (14 Days)||10||
59506058|NCT01272869|75598925|FG000|NOT COMPLETED|Period 1 (14 Days)||0||
59506059|NCT01272869|75598926|FG001|NOT COMPLETED|Period 1 (14 Days)||0||
59506060|NCT01272869|75598925|FG000|STARTED|Period 2 (14 Days)||10||
59506061|NCT01272869|75598926|FG001|STARTED|Period 2 (14 Days)||10||
59506062|NCT01272869|75598925|FG000|COMPLETED|Period 2 (14 Days)||9||
59506063|NCT01272869|75598926|FG001|COMPLETED|Period 2 (14 Days)||10||
59506064|NCT01272869|75598925|FG000|NOT COMPLETED|Period 2 (14 Days)||1||
59611399|NCT01780506|75722363|FG000|NOT COMPLETED|Double-Blind Phase||70||
59904179|NCT03226275|76025283|FG001|STARTED|Treatment Period 2 (8 Days)||8||
59904180|NCT03226275|76025284|FG002|STARTED|Treatment Period 2 (8 Days)||7||
59506065|NCT01272869|75598926|FG001|NOT COMPLETED|Period 2 (14 Days)||0||
59506066|NCT01272635|75598934|FG000|STARTED|Overall Study||153||
59506067|NCT01272635|75598935|FG001|STARTED|Overall Study||154||
59506068|NCT01272635|75598936|FG002|STARTED|Overall Study||148||
59506069|NCT01272635|75598937|FG003|STARTED|Overall Study||152||
59904181|NCT03226275|76025285|FG003|STARTED|Treatment Period 2 (8 Days)||7||
59904182|NCT03226275|76025282|FG000|COMPLETED|Treatment Period 2 (8 Days)||8||
59904183|NCT03226275|76025283|FG001|COMPLETED|Treatment Period 2 (8 Days)||8||
59904184|NCT03226275|76025284|FG002|COMPLETED|Treatment Period 2 (8 Days)||7||
59904185|NCT03226275|76025285|FG003|COMPLETED|Treatment Period 2 (8 Days)||7||
59904186|NCT03226275|76025282|FG000|NOT COMPLETED|Treatment Period 2 (8 Days)||0||
59904187|NCT03226275|76025283|FG001|NOT COMPLETED|Treatment Period 2 (8 Days)||0||
59904188|NCT03226275|76025284|FG002|NOT COMPLETED|Treatment Period 2 (8 Days)||0||
59904189|NCT03226275|76025285|FG003|NOT COMPLETED|Treatment Period 2 (8 Days)||0||
59904190|NCT04189081|76025298|FG000|STARTED|Overall Study||46||
59904191|NCT04189081|76025299|FG001|STARTED|Overall Study||45||
59904192|NCT04189081|76025300|FG002|STARTED|Overall Study||46||
59904193|NCT04189081|76025298|FG000|COMPLETED|Overall Study||45||
59904194|NCT04189081|76025299|FG001|COMPLETED|Overall Study||45||
59904195|NCT04189081|76025300|FG002|COMPLETED|Overall Study||45||
59904196|NCT04189081|76025298|FG000|NOT COMPLETED|Overall Study||1||
59904197|NCT04189081|76025299|FG001|NOT COMPLETED|Overall Study||0||
59904198|NCT04189081|76025300|FG002|NOT COMPLETED|Overall Study||1||
59506070|NCT01272635|75598934|FG000|COMPLETED|Overall Study||122||
59506071|NCT01272635|75598935|FG001|COMPLETED|Overall Study||134||
59506072|NCT01272635|75598936|FG002|COMPLETED|Overall Study||117||
59904199|NCT04187989|76025310|FG000|STARTED|Overall Study - 3-Month Follow-Up||76||
59904200|NCT04187989|76025311|FG001|STARTED|Overall Study - 3-Month Follow-Up||73||
59904201|NCT04187989|76025310|FG000|COMPLETED|Overall Study - 3-Month Follow-Up||70|Completed 3-Month Follow-Up|
59904202|NCT04187989|76025311|FG001|COMPLETED|Overall Study - 3-Month Follow-Up||65|Completed 3-Month Follow-Up|
59904203|NCT04187989|76025310|FG000|NOT COMPLETED|Overall Study - 3-Month Follow-Up||6||
59904204|NCT04187989|76025311|FG001|NOT COMPLETED|Overall Study - 3-Month Follow-Up||8||
59904205|NCT04187989|76025310|FG000|STARTED|Overall Study - 6-Month Follow-Up||76||
59904206|NCT04187989|76025311|FG001|STARTED|Overall Study - 6-Month Follow-Up||73||
59904207|NCT04187989|76025310|FG000|COMPLETED|Overall Study - 6-Month Follow-Up||68|Completed 6-Month Follow-Up|
59904208|NCT04187989|76025311|FG001|COMPLETED|Overall Study - 6-Month Follow-Up||65|Completed 6-Month Follow-Up|
59904209|NCT04187989|76025310|FG000|NOT COMPLETED|Overall Study - 6-Month Follow-Up||8||
59904210|NCT04187989|76025311|FG001|NOT COMPLETED|Overall Study - 6-Month Follow-Up||8||
59904211|NCT01150890|76025321|FG000|STARTED|Overall Study||32||
59904212|NCT01150890|76025322|FG001|STARTED|Overall Study||32||
59904213|NCT01150890|76025323|FG002|STARTED|Overall Study||33||
59904214|NCT01150890|76025324|FG003|STARTED|Overall Study||33||
59904215|NCT01150890|76025321|FG000|Received Study Drug|Overall Study||32||
59904216|NCT01150890|76025322|FG001|Received Study Drug|Overall Study||31||
59904217|NCT01150890|76025323|FG002|Received Study Drug|Overall Study||32||
59904218|NCT01150890|76025324|FG003|Received Study Drug|Overall Study||33||
59904219|NCT01150890|76025321|FG000|COMPLETED|Overall Study||28|Completing the study is defined as completing 12 weeks of study evaluations|
59904220|NCT01150890|76025322|FG001|COMPLETED|Overall Study||19|Completing the study is defined as completing 12 weeks of study evaluations|
59904221|NCT01150890|76025323|FG002|COMPLETED|Overall Study||21|Completing the study is defined as completing 12 weeks of study evaluations|
59904222|NCT01150890|76025324|FG003|COMPLETED|Overall Study||16|Completing the study is defined as completing 12 weeks of study evaluations|
59506073|NCT01272635|75598937|FG003|COMPLETED|Overall Study||129||
59506074|NCT01272635|75598934|FG000|NOT COMPLETED|Overall Study||31||
59506075|NCT01272635|75598935|FG001|NOT COMPLETED|Overall Study||20||
59506076|NCT01272635|75598936|FG002|NOT COMPLETED|Overall Study||31||
59506077|NCT01272635|75598937|FG003|NOT COMPLETED|Overall Study||23||
59506078|NCT01272011|75598948|FG000|STARTED|Overall Study||3||
59506079|NCT01272011|75598949|FG001|STARTED|Overall Study||10||
59506080|NCT01272011|75598950|FG002|STARTED|Overall Study||3||
59904223|NCT01150890|76025321|FG000|NOT COMPLETED|Overall Study||4||
59904224|NCT01150890|76025322|FG001|NOT COMPLETED|Overall Study||13||
59904225|NCT01150890|76025323|FG002|NOT COMPLETED|Overall Study||12||
59904226|NCT01150890|76025324|FG003|NOT COMPLETED|Overall Study||17||
59904227|NCT04057573|76025339|FG000|STARTED|24-Week Double-Blind Period||229||
59904228|NCT04057573|76025340|FG001|STARTED|24-Week Double-Blind Period||115||
59904229|NCT04057573|76025341|FG002|STARTED|24-Week Double-Blind Period||0||
59904230|NCT04057573|76025342|FG003|STARTED|24-Week Double-Blind Period||0||
59904231|NCT04057573|76025339|FG000|ITT Population|24-Week Double-Blind Period||229||
59904232|NCT04057573|76025340|FG001|ITT Population|24-Week Double-Blind Period||115||
59904233|NCT04057573|76025341|FG002|ITT Population|24-Week Double-Blind Period||0||
59904234|NCT04057573|76025342|FG003|ITT Population|24-Week Double-Blind Period||0||
59904235|NCT04057573|76025339|FG000|ITT Population, Excluding Non-compliant Site|24-Week Double-Blind Period||222||
59904236|NCT04057573|76025340|FG001|ITT Population, Excluding Non-compliant Site|24-Week Double-Blind Period||109||
59904237|NCT04057573|76025341|FG002|ITT Population, Excluding Non-compliant Site|24-Week Double-Blind Period||0||
59904238|NCT04057573|76025342|FG003|ITT Population, Excluding Non-compliant Site|24-Week Double-Blind Period||0||
59506081|NCT01272011|75598948|FG000|COMPLETED|Overall Study||3||
59506082|NCT01272011|75598949|FG001|COMPLETED|Overall Study||8||
59506083|NCT01272011|75598950|FG002|COMPLETED|Overall Study||3||
59904239|NCT04057573|76025339|FG000|COMPLETED|24-Week Double-Blind Period||199||
59904240|NCT04057573|76025340|FG001|COMPLETED|24-Week Double-Blind Period||98||
59904241|NCT04057573|76025341|FG002|COMPLETED|24-Week Double-Blind Period||0||
59904242|NCT04057573|76025342|FG003|COMPLETED|24-Week Double-Blind Period||0||
59904243|NCT04057573|76025339|FG000|NOT COMPLETED|24-Week Double-Blind Period||30||
59904244|NCT04057573|76025340|FG001|NOT COMPLETED|24-Week Double-Blind Period||17||
59904245|NCT04057573|76025341|FG002|NOT COMPLETED|24-Week Double-Blind Period||0||
59904246|NCT04057573|76025342|FG003|NOT COMPLETED|24-Week Double-Blind Period||0||
59904247|NCT04057573|76025339|FG000|STARTED|28-Week Treatment Extension Period||0||
59904248|NCT04057573|76025340|FG001|STARTED|28-Week Treatment Extension Period||0||
59904249|NCT04057573|76025341|FG002|STARTED|28-Week Treatment Extension Period|Treatment-Extension Evaluable Population: all participants who applied ruxolitinib cream at least once in the TE period|199||
59904250|NCT04057573|76025342|FG003|STARTED|28-Week Treatment Extension Period||98||
59904251|NCT04057573|76025339|FG000|COMPLETED|28-Week Treatment Extension Period||0||
59904252|NCT04057573|76025340|FG001|COMPLETED|28-Week Treatment Extension Period||0||
59904253|NCT04057573|76025341|FG002|COMPLETED|28-Week Treatment Extension Period||178||
59904254|NCT04057573|76025342|FG003|COMPLETED|28-Week Treatment Extension Period||79||
59904255|NCT04057573|76025339|FG000|NOT COMPLETED|28-Week Treatment Extension Period||0||
59904256|NCT04057573|76025340|FG001|NOT COMPLETED|28-Week Treatment Extension Period||0||
59904257|NCT04057573|76025341|FG002|NOT COMPLETED|28-Week Treatment Extension Period||21||
59904258|NCT04057573|76025342|FG003|NOT COMPLETED|28-Week Treatment Extension Period||19||
59904259|NCT04054765|76025355|FG000|STARTED|Baseline||155||
59904260|NCT04054765|76025356|FG001|STARTED|Baseline||132||
59904261|NCT04054765|76025355|FG000|COMPLETED|Baseline||150||
59904262|NCT04054765|76025356|FG001|COMPLETED|Baseline||129||
59904263|NCT04054765|76025355|FG000|NOT COMPLETED|Baseline||5||
59904264|NCT04054765|76025356|FG001|NOT COMPLETED|Baseline||3||
59904265|NCT04054765|76025355|FG000|STARTED|Post-Gameplay / 1-week Follow up||150||
59904266|NCT04054765|76025356|FG001|STARTED|Post-Gameplay / 1-week Follow up||129||
59904267|NCT04054765|76025355|FG000|COMPLETED|Post-Gameplay / 1-week Follow up||142||
59904268|NCT04054765|76025356|FG001|COMPLETED|Post-Gameplay / 1-week Follow up||126||
59904269|NCT04054765|76025355|FG000|NOT COMPLETED|Post-Gameplay / 1-week Follow up||8||
59904270|NCT04054765|76025356|FG001|NOT COMPLETED|Post-Gameplay / 1-week Follow up||3||
59904271|NCT04054765|76025355|FG000|STARTED|3-month Follow up||142||
59904272|NCT04054765|76025356|FG001|STARTED|3-month Follow up||126||
59904273|NCT04054765|76025355|FG000|COMPLETED|3-month Follow up||142||
59904274|NCT04054765|76025356|FG001|COMPLETED|3-month Follow up||123||
59904275|NCT04054765|76025355|FG000|NOT COMPLETED|3-month Follow up||0||
59904276|NCT04054765|76025356|FG001|NOT COMPLETED|3-month Follow up||3||
59904277|NCT04054765|76025355|FG000|STARTED|6-month Follow up||142||
59904278|NCT04054765|76025356|FG001|STARTED|6-month Follow up||123||
59904279|NCT04054765|76025355|FG000|COMPLETED|6-month Follow up||110||
59904280|NCT04054765|76025356|FG001|COMPLETED|6-month Follow up||91||
59904281|NCT04054765|76025355|FG000|NOT COMPLETED|6-month Follow up||32||
59904282|NCT04054765|76025356|FG001|NOT COMPLETED|6-month Follow up||32||
59904283|NCT04179721|76025364|FG000|STARTED|Overall Study||22|Enrolled|
59904284|NCT04179721|76025365|FG001|STARTED|Overall Study||32|Enrolled|
59904285|NCT04179721|76025364|FG000|T1 - Baseline|Overall Study||16||
59904286|NCT04179721|76025365|FG001|T1 - Baseline|Overall Study||24||
59506084|NCT01272011|75598948|FG000|NOT COMPLETED|Overall Study||0||
59506085|NCT01272011|75598949|FG001|NOT COMPLETED|Overall Study||2||
59904287|NCT04179721|76025364|FG000|T2 - Post-Training|Overall Study||16||
59904288|NCT04179721|76025365|FG001|T2 - Post-Training|Overall Study||21||
59904289|NCT04179721|76025364|FG000|T3 - End of Intervention|Overall Study||11||
59904290|NCT04179721|76025365|FG001|T3 - End of Intervention|Overall Study||18||
59904291|NCT04179721|76025364|FG000|COMPLETED|Overall Study||11||
59904292|NCT04179721|76025365|FG001|COMPLETED|Overall Study||18||
59904293|NCT04179721|76025364|FG000|NOT COMPLETED|Overall Study||11||
59904294|NCT04179721|76025365|FG001|NOT COMPLETED|Overall Study||14||
59904295|NCT03286218|76025371|FG000|STARTED|Qualification Phase Period 1||48||
59904296|NCT03286218|76025372|FG001|STARTED|Qualification Phase Period 1||48||
59904297|NCT03286218|76025373|FG002|STARTED|Qualification Phase Period 1||0||
59904298|NCT03286218|76025374|FG003|STARTED|Qualification Phase Period 1||0||
59904299|NCT03286218|76025375|FG004|STARTED|Qualification Phase Period 1||0||
59904300|NCT03286218|76025376|FG005|STARTED|Qualification Phase Period 1||0||
59904301|NCT03286218|76025377|FG006|STARTED|Qualification Phase Period 1||0||
59904302|NCT03286218|76025378|FG007|STARTED|Qualification Phase Period 1||0||
59506086|NCT01272011|75598950|FG002|NOT COMPLETED|Overall Study||0||
59904303|NCT03286218|76025379|FG008|STARTED|Qualification Phase Period 1||0||
59904304|NCT03286218|76025380|FG009|STARTED|Qualification Phase Period 1||0||
59904305|NCT03286218|76025381|FG010|STARTED|Qualification Phase Period 1||0||
59904306|NCT03286218|76025382|FG011|STARTED|Qualification Phase Period 1||0||
59904307|NCT03286218|76025371|FG000|Received at Least One Dose of Study Drug|Qualification Phase Period 1||47||
59904308|NCT03286218|76025372|FG001|Received at Least One Dose of Study Drug|Qualification Phase Period 1||47||
59904309|NCT03286218|76025373|FG002|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0||
59904310|NCT03286218|76025374|FG003|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0||
59904311|NCT03286218|76025375|FG004|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0||
59904312|NCT03286218|76025376|FG005|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0||
59904313|NCT03286218|76025377|FG006|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0||
59904314|NCT03286218|76025378|FG007|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0||
59904315|NCT03286218|76025379|FG008|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0||
59904316|NCT03286218|76025380|FG009|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0||
59904317|NCT03286218|76025381|FG010|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0||
59904318|NCT03286218|76025382|FG011|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0||
59904319|NCT03286218|76025371|FG000|COMPLETED|Qualification Phase Period 1||47||
59904320|NCT03286218|76025372|FG001|COMPLETED|Qualification Phase Period 1||47||
59904321|NCT03286218|76025373|FG002|COMPLETED|Qualification Phase Period 1||0||
59904322|NCT03286218|76025374|FG003|COMPLETED|Qualification Phase Period 1||0||
59904323|NCT03286218|76025375|FG004|COMPLETED|Qualification Phase Period 1||0||
59904324|NCT03286218|76025376|FG005|COMPLETED|Qualification Phase Period 1||0||
59904325|NCT03286218|76025377|FG006|COMPLETED|Qualification Phase Period 1||0||
59904326|NCT03286218|76025378|FG007|COMPLETED|Qualification Phase Period 1||0||
59904327|NCT03286218|76025379|FG008|COMPLETED|Qualification Phase Period 1||0||
59904328|NCT03286218|76025380|FG009|COMPLETED|Qualification Phase Period 1||0||
59904329|NCT03286218|76025381|FG010|COMPLETED|Qualification Phase Period 1||0||
59904330|NCT03286218|76025382|FG011|COMPLETED|Qualification Phase Period 1||0||
59904331|NCT03286218|76025371|FG000|NOT COMPLETED|Qualification Phase Period 1||1||
59904332|NCT03286218|76025372|FG001|NOT COMPLETED|Qualification Phase Period 1||1||
59904333|NCT03286218|76025373|FG002|NOT COMPLETED|Qualification Phase Period 1||0||
59904334|NCT03286218|76025374|FG003|NOT COMPLETED|Qualification Phase Period 1||0||
59904335|NCT03286218|76025375|FG004|NOT COMPLETED|Qualification Phase Period 1||0||
59904336|NCT03286218|76025376|FG005|NOT COMPLETED|Qualification Phase Period 1||0||
59904337|NCT03286218|76025377|FG006|NOT COMPLETED|Qualification Phase Period 1||0||
59904338|NCT03286218|76025378|FG007|NOT COMPLETED|Qualification Phase Period 1||0||
59904339|NCT03286218|76025379|FG008|NOT COMPLETED|Qualification Phase Period 1||0||
59904340|NCT03286218|76025380|FG009|NOT COMPLETED|Qualification Phase Period 1||0||
59904341|NCT03286218|76025381|FG010|NOT COMPLETED|Qualification Phase Period 1||0||
59904342|NCT03286218|76025382|FG011|NOT COMPLETED|Qualification Phase Period 1||0||
59904343|NCT03286218|76025371|FG000|STARTED|Qualification Phase Period 2||47||
59904344|NCT03286218|76025372|FG001|STARTED|Qualification Phase Period 2||47||
59904345|NCT03286218|76025373|FG002|STARTED|Qualification Phase Period 2||0||
59506087|NCT00750191|75598960|FG000|STARTED|Overall Study||27||
59506088|NCT00750191|75598961|FG001|STARTED|Overall Study||30||
59506089|NCT00750191|75598960|FG000|COMPLETED|Overall Study||22||
59506090|NCT00750191|75598961|FG001|COMPLETED|Overall Study||20||
59904346|NCT03286218|76025374|FG003|STARTED|Qualification Phase Period 2||0||
59904347|NCT03286218|76025375|FG004|STARTED|Qualification Phase Period 2||0||
59904348|NCT03286218|76025376|FG005|STARTED|Qualification Phase Period 2||0||
59904349|NCT03286218|76025377|FG006|STARTED|Qualification Phase Period 2||0||
59904350|NCT03286218|76025378|FG007|STARTED|Qualification Phase Period 2||0||
59904351|NCT03286218|76025379|FG008|STARTED|Qualification Phase Period 2||0||
59904352|NCT03286218|76025380|FG009|STARTED|Qualification Phase Period 2||0||
59904353|NCT03286218|76025381|FG010|STARTED|Qualification Phase Period 2||0||
59904354|NCT03286218|76025382|FG011|STARTED|Qualification Phase Period 2||0||
59506091|NCT00750191|75598960|FG000|NOT COMPLETED|Overall Study||5||
59506092|NCT00750191|75598961|FG001|NOT COMPLETED|Overall Study||10||
59506093|NCT01270841|75598971|FG000|STARTED|Overall Study||29||
59506094|NCT01270841|75598972|FG001|STARTED|Overall Study||33||
59506095|NCT01270841|75598973|FG002|STARTED|Overall Study||29||
59506096|NCT01270841|75598974|FG003|STARTED|Overall Study||33||
59506097|NCT01270841|75598971|FG000|COMPLETED|Overall Study||16||
59506098|NCT01270841|75598972|FG001|COMPLETED|Overall Study||19||
59904355|NCT03286218|76025371|FG000|COMPLETED|Qualification Phase Period 2||30||
59904356|NCT03286218|76025372|FG001|COMPLETED|Qualification Phase Period 2||28||
59904357|NCT03286218|76025373|FG002|COMPLETED|Qualification Phase Period 2||0||
59904358|NCT03286218|76025374|FG003|COMPLETED|Qualification Phase Period 2||0||
59904359|NCT03286218|76025375|FG004|COMPLETED|Qualification Phase Period 2||0||
59904360|NCT03286218|76025376|FG005|COMPLETED|Qualification Phase Period 2||0||
59904361|NCT03286218|76025377|FG006|COMPLETED|Qualification Phase Period 2||0||
59904362|NCT03286218|76025378|FG007|COMPLETED|Qualification Phase Period 2||0||
59506099|NCT01270841|75598973|FG002|COMPLETED|Overall Study||18||
59506100|NCT01270841|75598974|FG003|COMPLETED|Overall Study||20||
59506101|NCT01270841|75598971|FG000|NOT COMPLETED|Overall Study||13||
59506102|NCT01270841|75598972|FG001|NOT COMPLETED|Overall Study||14||
59506103|NCT01270841|75598973|FG002|NOT COMPLETED|Overall Study||11||
59506104|NCT01270841|75598974|FG003|NOT COMPLETED|Overall Study||13||
59506105|NCT01270139|75598987|FG000|STARTED|Overall Study|Intention-to-treat population|60||
59506106|NCT01270139|75598988|FG001|STARTED|Overall Study|Intention-to-treat population|60||
59506107|NCT01270139|75598989|FG002|STARTED|Overall Study|Intention-to-treat population|60||
59506108|NCT01270139|75598987|FG000|COMPLETED|Overall Study|Pre-treatment evaluable population|42||
59904363|NCT03286218|76025379|FG008|COMPLETED|Qualification Phase Period 2||0||
59904364|NCT03286218|76025380|FG009|COMPLETED|Qualification Phase Period 2||0||
59904365|NCT03286218|76025381|FG010|COMPLETED|Qualification Phase Period 2||0||
59904366|NCT03286218|76025382|FG011|COMPLETED|Qualification Phase Period 2||0||
59904367|NCT03286218|76025371|FG000|NOT COMPLETED|Qualification Phase Period 2||17||
59904368|NCT03286218|76025372|FG001|NOT COMPLETED|Qualification Phase Period 2||19||
59904369|NCT03286218|76025373|FG002|NOT COMPLETED|Qualification Phase Period 2||0||
59904370|NCT03286218|76025374|FG003|NOT COMPLETED|Qualification Phase Period 2||0||
59904371|NCT03286218|76025375|FG004|NOT COMPLETED|Qualification Phase Period 2||0||
59904372|NCT03286218|76025376|FG005|NOT COMPLETED|Qualification Phase Period 2||0||
59904373|NCT03286218|76025377|FG006|NOT COMPLETED|Qualification Phase Period 2||0||
59904374|NCT03286218|76025378|FG007|NOT COMPLETED|Qualification Phase Period 2||0||
59904375|NCT03286218|76025379|FG008|NOT COMPLETED|Qualification Phase Period 2||0||
59904376|NCT03286218|76025380|FG009|NOT COMPLETED|Qualification Phase Period 2||0||
59904377|NCT03286218|76025381|FG010|NOT COMPLETED|Qualification Phase Period 2||0||
59904378|NCT03286218|76025382|FG011|NOT COMPLETED|Qualification Phase Period 2||0||
59904379|NCT03286218|76025371|FG000|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase prior to entering the Treatment Phase.|0||
59904380|NCT03286218|76025372|FG001|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase prior to entering the Treatment Phase.|0||
59904381|NCT03286218|76025373|FG002|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6||
59904382|NCT03286218|76025374|FG003|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6||
59904383|NCT03286218|76025375|FG004|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|5||
59904384|NCT03286218|76025376|FG005|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6||
59904385|NCT03286218|76025377|FG006|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6||
59904386|NCT03286218|76025378|FG007|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6||
59904387|NCT03286218|76025379|FG008|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6||
59904388|NCT03286218|76025380|FG009|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6||
59904389|NCT03286218|76025381|FG010|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|5||
59904390|NCT03286218|76025382|FG011|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6||
59904391|NCT03286218|76025371|FG000|Received at Least One Dose of Study Drug|Treatment Phase Period 1||0||
59904392|NCT03286218|76025372|FG001|Received at Least One Dose of Study Drug|Treatment Phase Period 1||0||
59904393|NCT03286218|76025373|FG002|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6||
59904394|NCT03286218|76025374|FG003|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6||
59904395|NCT03286218|76025375|FG004|Received at Least One Dose of Study Drug|Treatment Phase Period 1||5||
59904396|NCT03286218|76025376|FG005|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6||
59904397|NCT03286218|76025377|FG006|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6||
59904398|NCT03286218|76025378|FG007|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6||
59904399|NCT03286218|76025379|FG008|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6||
59904400|NCT03286218|76025380|FG009|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6||
59506109|NCT01270139|75598988|FG001|COMPLETED|Overall Study|Pre-treatment evaluable population|34||
59506110|NCT01270139|75598989|FG002|COMPLETED|Overall Study|Pre-treatment evaluable population|40||
59506111|NCT01270139|75598987|FG000|NOT COMPLETED|Overall Study||18||
59904401|NCT03286218|76025381|FG010|Received at Least One Dose of Study Drug|Treatment Phase Period 1||5||
59904402|NCT03286218|76025382|FG011|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6||
59904403|NCT03286218|76025371|FG000|COMPLETED|Treatment Phase Period 1||0||
59904404|NCT03286218|76025372|FG001|COMPLETED|Treatment Phase Period 1||0||
59904405|NCT03286218|76025373|FG002|COMPLETED|Treatment Phase Period 1||5||
59904406|NCT03286218|76025374|FG003|COMPLETED|Treatment Phase Period 1||5||
59904407|NCT03286218|76025375|FG004|COMPLETED|Treatment Phase Period 1||5||
59904408|NCT03286218|76025376|FG005|COMPLETED|Treatment Phase Period 1||5||
59904409|NCT03286218|76025377|FG006|COMPLETED|Treatment Phase Period 1||6||
59904410|NCT03286218|76025378|FG007|COMPLETED|Treatment Phase Period 1||6||
59904411|NCT03286218|76025379|FG008|COMPLETED|Treatment Phase Period 1||6||
59904412|NCT03286218|76025380|FG009|COMPLETED|Treatment Phase Period 1||6||
59904413|NCT03286218|76025381|FG010|COMPLETED|Treatment Phase Period 1||5||
59904414|NCT03286218|76025382|FG011|COMPLETED|Treatment Phase Period 1||5||
59904415|NCT03286218|76025371|FG000|NOT COMPLETED|Treatment Phase Period 1||0||
59904416|NCT03286218|76025372|FG001|NOT COMPLETED|Treatment Phase Period 1||0||
59904417|NCT03286218|76025373|FG002|NOT COMPLETED|Treatment Phase Period 1||1||
59904418|NCT03286218|76025374|FG003|NOT COMPLETED|Treatment Phase Period 1||1||
59904419|NCT03286218|76025375|FG004|NOT COMPLETED|Treatment Phase Period 1||0||
59904420|NCT03286218|76025376|FG005|NOT COMPLETED|Treatment Phase Period 1||1||
59904421|NCT03286218|76025377|FG006|NOT COMPLETED|Treatment Phase Period 1||0||
59904422|NCT03286218|76025378|FG007|NOT COMPLETED|Treatment Phase Period 1||0||
59904423|NCT03286218|76025379|FG008|NOT COMPLETED|Treatment Phase Period 1||0||
59904424|NCT03286218|76025380|FG009|NOT COMPLETED|Treatment Phase Period 1||0||
59904425|NCT03286218|76025381|FG010|NOT COMPLETED|Treatment Phase Period 1||0||
59904426|NCT03286218|76025382|FG011|NOT COMPLETED|Treatment Phase Period 1||1||
59904427|NCT03286218|76025371|FG000|STARTED|Treatment Phase Period 2||0||
59904428|NCT03286218|76025372|FG001|STARTED|Treatment Phase Period 2||0||
59904429|NCT03286218|76025373|FG002|STARTED|Treatment Phase Period 2||5||
59904430|NCT03286218|76025374|FG003|STARTED|Treatment Phase Period 2||5||
59904431|NCT03286218|76025375|FG004|STARTED|Treatment Phase Period 2||5||
59904432|NCT03286218|76025376|FG005|STARTED|Treatment Phase Period 2||5||
59904433|NCT03286218|76025377|FG006|STARTED|Treatment Phase Period 2||6||
59904434|NCT03286218|76025378|FG007|STARTED|Treatment Phase Period 2||6||
59904435|NCT03286218|76025379|FG008|STARTED|Treatment Phase Period 2||6||
59904436|NCT03286218|76025380|FG009|STARTED|Treatment Phase Period 2||6||
59904437|NCT03286218|76025381|FG010|STARTED|Treatment Phase Period 2||5||
59904438|NCT03286218|76025382|FG011|STARTED|Treatment Phase Period 2||5||
59904439|NCT03286218|76025371|FG000|COMPLETED|Treatment Phase Period 2||0||
59904440|NCT03286218|76025372|FG001|COMPLETED|Treatment Phase Period 2||0||
59904441|NCT03286218|76025373|FG002|COMPLETED|Treatment Phase Period 2||5||
59506112|NCT01270139|75598988|FG001|NOT COMPLETED|Overall Study||26||
59506113|NCT01270139|75598989|FG002|NOT COMPLETED|Overall Study||20||
59506114|NCT01278407|75599007|FG000|STARTED|Confirmatory Phase||46||
59904442|NCT03286218|76025374|FG003|COMPLETED|Treatment Phase Period 2||5||
59904443|NCT03286218|76025375|FG004|COMPLETED|Treatment Phase Period 2||5||
59506115|NCT01278407|75599008|FG001|STARTED|Confirmatory Phase||47||
59904444|NCT03286218|76025376|FG005|COMPLETED|Treatment Phase Period 2||5||
59904445|NCT03286218|76025377|FG006|COMPLETED|Treatment Phase Period 2||6||
59904446|NCT03286218|76025378|FG007|COMPLETED|Treatment Phase Period 2||6||
59904447|NCT03286218|76025379|FG008|COMPLETED|Treatment Phase Period 2||6||
59904448|NCT03286218|76025380|FG009|COMPLETED|Treatment Phase Period 2||6||
59904449|NCT03286218|76025381|FG010|COMPLETED|Treatment Phase Period 2||5||
59904450|NCT03286218|76025382|FG011|COMPLETED|Treatment Phase Period 2||5||
59904451|NCT03286218|76025371|FG000|NOT COMPLETED|Treatment Phase Period 2||0||
59904452|NCT03286218|76025372|FG001|NOT COMPLETED|Treatment Phase Period 2||0||
59904453|NCT03286218|76025373|FG002|NOT COMPLETED|Treatment Phase Period 2||0||
59904454|NCT03286218|76025374|FG003|NOT COMPLETED|Treatment Phase Period 2||0||
59904455|NCT03286218|76025375|FG004|NOT COMPLETED|Treatment Phase Period 2||0||
59904456|NCT03286218|76025376|FG005|NOT COMPLETED|Treatment Phase Period 2||0||
59904457|NCT03286218|76025377|FG006|NOT COMPLETED|Treatment Phase Period 2||0||
59904458|NCT03286218|76025378|FG007|NOT COMPLETED|Treatment Phase Period 2||0||
59904459|NCT03286218|76025379|FG008|NOT COMPLETED|Treatment Phase Period 2||0||
59904460|NCT03286218|76025380|FG009|NOT COMPLETED|Treatment Phase Period 2||0||
59904461|NCT03286218|76025381|FG010|NOT COMPLETED|Treatment Phase Period 2||0||
59904462|NCT03286218|76025382|FG011|NOT COMPLETED|Treatment Phase Period 2||0||
59904463|NCT03286218|76025371|FG000|STARTED|Treatment Phase Period 3||0||
59904464|NCT03286218|76025372|FG001|STARTED|Treatment Phase Period 3||0||
59904465|NCT03286218|76025373|FG002|STARTED|Treatment Phase Period 3||5||
59904466|NCT03286218|76025374|FG003|STARTED|Treatment Phase Period 3||5||
59904467|NCT03286218|76025375|FG004|STARTED|Treatment Phase Period 3||5||
59506116|NCT01278407|75599009|FG002|STARTED|Confirmatory Phase||49||
59506117|NCT01278407|75599010|FG003|STARTED|Confirmatory Phase||0||
59904468|NCT03286218|76025376|FG005|STARTED|Treatment Phase Period 3||5||
59904469|NCT03286218|76025377|FG006|STARTED|Treatment Phase Period 3||6||
59904470|NCT03286218|76025378|FG007|STARTED|Treatment Phase Period 3||6||
59904471|NCT03286218|76025379|FG008|STARTED|Treatment Phase Period 3||6||
59904472|NCT03286218|76025380|FG009|STARTED|Treatment Phase Period 3||6||
59904473|NCT03286218|76025381|FG010|STARTED|Treatment Phase Period 3||5||
59904474|NCT03286218|76025382|FG011|STARTED|Treatment Phase Period 3||5||
59904475|NCT03286218|76025371|FG000|COMPLETED|Treatment Phase Period 3||0||
59904476|NCT03286218|76025372|FG001|COMPLETED|Treatment Phase Period 3||0||
59904477|NCT03286218|76025373|FG002|COMPLETED|Treatment Phase Period 3||5||
59904478|NCT03286218|76025374|FG003|COMPLETED|Treatment Phase Period 3||5||
59904479|NCT03286218|76025375|FG004|COMPLETED|Treatment Phase Period 3||5||
59904480|NCT03286218|76025376|FG005|COMPLETED|Treatment Phase Period 3||5||
59904481|NCT03286218|76025377|FG006|COMPLETED|Treatment Phase Period 3||6||
59904482|NCT03286218|76025378|FG007|COMPLETED|Treatment Phase Period 3||6||
59904483|NCT03286218|76025379|FG008|COMPLETED|Treatment Phase Period 3||6||
59904484|NCT03286218|76025380|FG009|COMPLETED|Treatment Phase Period 3||6||
59904485|NCT03286218|76025381|FG010|COMPLETED|Treatment Phase Period 3||5||
59904486|NCT03286218|76025382|FG011|COMPLETED|Treatment Phase Period 3||5||
59904487|NCT03286218|76025371|FG000|NOT COMPLETED|Treatment Phase Period 3||0||
59904488|NCT03286218|76025372|FG001|NOT COMPLETED|Treatment Phase Period 3||0||
59904489|NCT03286218|76025373|FG002|NOT COMPLETED|Treatment Phase Period 3||0||
59904490|NCT03286218|76025374|FG003|NOT COMPLETED|Treatment Phase Period 3||0||
59904491|NCT03286218|76025375|FG004|NOT COMPLETED|Treatment Phase Period 3||0||
59904492|NCT03286218|76025376|FG005|NOT COMPLETED|Treatment Phase Period 3||0||
59904493|NCT03286218|76025377|FG006|NOT COMPLETED|Treatment Phase Period 3||0||
59904494|NCT03286218|76025378|FG007|NOT COMPLETED|Treatment Phase Period 3||0||
59904495|NCT03286218|76025379|FG008|NOT COMPLETED|Treatment Phase Period 3||0||
59904496|NCT03286218|76025380|FG009|NOT COMPLETED|Treatment Phase Period 3||0||
59904497|NCT03286218|76025381|FG010|NOT COMPLETED|Treatment Phase Period 3||0||
59904498|NCT03286218|76025382|FG011|NOT COMPLETED|Treatment Phase Period 3||0||
59904499|NCT03286218|76025371|FG000|STARTED|Treatment Phase Period 4||0||
59904500|NCT03286218|76025372|FG001|STARTED|Treatment Phase Period 4||0||
59904501|NCT03286218|76025373|FG002|STARTED|Treatment Phase Period 4||5||
59904502|NCT03286218|76025374|FG003|STARTED|Treatment Phase Period 4||5||
59904503|NCT03286218|76025375|FG004|STARTED|Treatment Phase Period 4||5||
59904504|NCT03286218|76025376|FG005|STARTED|Treatment Phase Period 4||5||
59904505|NCT03286218|76025377|FG006|STARTED|Treatment Phase Period 4||6||
59904506|NCT03286218|76025378|FG007|STARTED|Treatment Phase Period 4||6||
59904507|NCT03286218|76025379|FG008|STARTED|Treatment Phase Period 4||6||
59904508|NCT03286218|76025380|FG009|STARTED|Treatment Phase Period 4||6||
59904509|NCT03286218|76025381|FG010|STARTED|Treatment Phase Period 4||5||
59904510|NCT03286218|76025382|FG011|STARTED|Treatment Phase Period 4||5||
59904511|NCT03286218|76025371|FG000|COMPLETED|Treatment Phase Period 4||0||
59904512|NCT03286218|76025372|FG001|COMPLETED|Treatment Phase Period 4||0||
59904513|NCT03286218|76025373|FG002|COMPLETED|Treatment Phase Period 4||5||
59904514|NCT03286218|76025374|FG003|COMPLETED|Treatment Phase Period 4||5||
59904515|NCT03286218|76025375|FG004|COMPLETED|Treatment Phase Period 4||5||
59904516|NCT03286218|76025376|FG005|COMPLETED|Treatment Phase Period 4||5||
59904517|NCT03286218|76025377|FG006|COMPLETED|Treatment Phase Period 4||6||
59904518|NCT03286218|76025378|FG007|COMPLETED|Treatment Phase Period 4||6||
59904519|NCT03286218|76025379|FG008|COMPLETED|Treatment Phase Period 4||6||
59904520|NCT03286218|76025380|FG009|COMPLETED|Treatment Phase Period 4||6||
59904521|NCT03286218|76025381|FG010|COMPLETED|Treatment Phase Period 4||5||
59904522|NCT03286218|76025382|FG011|COMPLETED|Treatment Phase Period 4||4||
59904523|NCT03286218|76025371|FG000|NOT COMPLETED|Treatment Phase Period 4||0||
59904524|NCT03286218|76025372|FG001|NOT COMPLETED|Treatment Phase Period 4||0||
59904525|NCT03286218|76025373|FG002|NOT COMPLETED|Treatment Phase Period 4||0||
59904526|NCT03286218|76025374|FG003|NOT COMPLETED|Treatment Phase Period 4||0||
59904527|NCT03286218|76025375|FG004|NOT COMPLETED|Treatment Phase Period 4||0||
59904528|NCT03286218|76025376|FG005|NOT COMPLETED|Treatment Phase Period 4||0||
59904529|NCT03286218|76025377|FG006|NOT COMPLETED|Treatment Phase Period 4||0||
59904530|NCT03286218|76025378|FG007|NOT COMPLETED|Treatment Phase Period 4||0||
59904531|NCT03286218|76025379|FG008|NOT COMPLETED|Treatment Phase Period 4||0||
59904532|NCT03286218|76025380|FG009|NOT COMPLETED|Treatment Phase Period 4||0||
59904533|NCT03286218|76025381|FG010|NOT COMPLETED|Treatment Phase Period 4||0||
59904534|NCT03286218|76025382|FG011|NOT COMPLETED|Treatment Phase Period 4||1||
60014753|NCT02614183|76130888|FG000|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post-treatment phase.|372||
60014754|NCT02614183|76130889|FG001|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post-treatment phase.|185||
60067717|NCT01617187|76182891|FG000|STARTED|Treatment Through Study Completion|Treated|97||
59904535|NCT03286218|76025371|FG000|STARTED|Treatment Phase Period 5||0||
59904536|NCT03286218|76025372|FG001|STARTED|Treatment Phase Period 5||0||
59904537|NCT03286218|76025373|FG002|STARTED|Treatment Phase Period 5||5||
59904538|NCT03286218|76025374|FG003|STARTED|Treatment Phase Period 5||5||
59904539|NCT03286218|76025375|FG004|STARTED|Treatment Phase Period 5||5||
59904540|NCT03286218|76025376|FG005|STARTED|Treatment Phase Period 5||5||
59904541|NCT03286218|76025377|FG006|STARTED|Treatment Phase Period 5||6||
59904542|NCT03286218|76025378|FG007|STARTED|Treatment Phase Period 5||6||
59904543|NCT03286218|76025379|FG008|STARTED|Treatment Phase Period 5||6||
59904544|NCT03286218|76025380|FG009|STARTED|Treatment Phase Period 5||6||
59904545|NCT03286218|76025381|FG010|STARTED|Treatment Phase Period 5||5||
59904546|NCT03286218|76025382|FG011|STARTED|Treatment Phase Period 5||4||
59904547|NCT03286218|76025371|FG000|COMPLETED|Treatment Phase Period 5||0||
59904548|NCT03286218|76025372|FG001|COMPLETED|Treatment Phase Period 5||0||
59904549|NCT03286218|76025373|FG002|COMPLETED|Treatment Phase Period 5||5||
59904550|NCT03286218|76025374|FG003|COMPLETED|Treatment Phase Period 5||5||
59904551|NCT03286218|76025375|FG004|COMPLETED|Treatment Phase Period 5||5||
59904552|NCT03286218|76025376|FG005|COMPLETED|Treatment Phase Period 5||5||
59904553|NCT03286218|76025377|FG006|COMPLETED|Treatment Phase Period 5||6||
59904554|NCT03286218|76025378|FG007|COMPLETED|Treatment Phase Period 5||6||
59904555|NCT03286218|76025379|FG008|COMPLETED|Treatment Phase Period 5||6||
59904556|NCT03286218|76025380|FG009|COMPLETED|Treatment Phase Period 5||6||
59904557|NCT03286218|76025381|FG010|COMPLETED|Treatment Phase Period 5||5||
59904558|NCT03286218|76025382|FG011|COMPLETED|Treatment Phase Period 5||4||
59904559|NCT03286218|76025371|FG000|NOT COMPLETED|Treatment Phase Period 5||0||
59904560|NCT03286218|76025372|FG001|NOT COMPLETED|Treatment Phase Period 5||0||
59904561|NCT03286218|76025373|FG002|NOT COMPLETED|Treatment Phase Period 5||0||
59904562|NCT03286218|76025374|FG003|NOT COMPLETED|Treatment Phase Period 5||0||
59904563|NCT03286218|76025375|FG004|NOT COMPLETED|Treatment Phase Period 5||0||
59904564|NCT03286218|76025376|FG005|NOT COMPLETED|Treatment Phase Period 5||0||
59904565|NCT03286218|76025377|FG006|NOT COMPLETED|Treatment Phase Period 5||0||
59904566|NCT03286218|76025378|FG007|NOT COMPLETED|Treatment Phase Period 5||0||
59904567|NCT03286218|76025379|FG008|NOT COMPLETED|Treatment Phase Period 5||0||
59904568|NCT03286218|76025380|FG009|NOT COMPLETED|Treatment Phase Period 5||0||
59904569|NCT03286218|76025381|FG010|NOT COMPLETED|Treatment Phase Period 5||0||
59904570|NCT03286218|76025382|FG011|NOT COMPLETED|Treatment Phase Period 5||0||
59904571|NCT03224325|76025416|FG000|STARTED|Overall Study||13||
59904572|NCT03224325|76025417|FG001|STARTED|Overall Study||6||
59904573|NCT03224325|76025418|FG002|STARTED|Overall Study||6||
59904574|NCT03224325|76025419|FG003|STARTED|Overall Study||6||
59904575|NCT03224325|76025420|FG004|STARTED|Overall Study||6||
59904576|NCT03224325|76025421|FG005|STARTED|Overall Study||6||
59904577|NCT03224325|76025422|FG006|STARTED|Overall Study||7||
59904578|NCT03224325|76025416|FG000|COMPLETED|Overall Study||12||
59904579|NCT03224325|76025417|FG001|COMPLETED|Overall Study||6||
59904580|NCT03224325|76025418|FG002|COMPLETED|Overall Study||6||
59904581|NCT03224325|76025419|FG003|COMPLETED|Overall Study||5||
59904582|NCT03224325|76025420|FG004|COMPLETED|Overall Study||6||
59904583|NCT03224325|76025421|FG005|COMPLETED|Overall Study||6||
59904584|NCT03224325|76025422|FG006|COMPLETED|Overall Study||6||
59904585|NCT03224325|76025416|FG000|NOT COMPLETED|Overall Study||1||
59904586|NCT03224325|76025417|FG001|NOT COMPLETED|Overall Study||0||
59904587|NCT03224325|76025418|FG002|NOT COMPLETED|Overall Study||0||
59904588|NCT03224325|76025419|FG003|NOT COMPLETED|Overall Study||1||
59904589|NCT03224325|76025420|FG004|NOT COMPLETED|Overall Study||0||
59904590|NCT03224325|76025421|FG005|NOT COMPLETED|Overall Study||0||
59904591|NCT03224325|76025422|FG006|NOT COMPLETED|Overall Study||1||
59904592|NCT04016779|76025446|FG000|STARTED|Overall Study||184|"Number of subjects started is based on the Randomized Population (defined as number of subjects who were randomized). Two subjects who were randomized, however, were not treated. Reason Not Completed section is summarized by Randomized Population."|
59904593|NCT04016779|76025447|FG001|STARTED|Overall Study||190|"Number of subjects started is based on the Randomized Population (defined as number of subjects who were randomized). Two subjects who were randomized, however, were not treated. Reason Not Completed section is summarized by Randomized Population."|
59904594|NCT04016779|76025446|FG000|Treated|Overall Study||183|Number of subjects treated is based on the Safety Population (defined as number of subjects who were randomized and took at least one dose of study medication)|
59904595|NCT04016779|76025447|FG001|Treated|Overall Study||189|Number of subjects treated is based on the Safety Population (defined as number of subjects who were randomized and took at least one dose of study medication)|
59904596|NCT04016779|76025446|FG000|COMPLETED|Overall Study||140|Number of subjects completed is based on the Randomized Population.|
59904597|NCT04016779|76025447|FG001|COMPLETED|Overall Study||127|Number of subjects completed is based on the Randomized Population.|
59904598|NCT04016779|76025446|FG000|NOT COMPLETED|Overall Study||44||
59904599|NCT04016779|76025447|FG001|NOT COMPLETED|Overall Study||63||
59904600|NCT02857426|76025457|FG000|STARTED|Overall Study||47|Started = received treatment|
59904601|NCT02857426|76025458|FG001|STARTED|Overall Study||19|Started = received treatment|
59904602|NCT02857426|76025457|FG000|COMPLETED|Overall Study||0|Completed = continuing in the treatment period|
59904603|NCT02857426|76025458|FG001|COMPLETED|Overall Study||0|Completed = continuing in the treatment period|
59904604|NCT02857426|76025457|FG000|NOT COMPLETED|Overall Study||47||
59904605|NCT02857426|76025458|FG001|NOT COMPLETED|Overall Study||19||
59904606|NCT01127256|76025466|FG000|STARTED|Overall Study||96||
59904607|NCT01127256|76025467|FG001|STARTED|Overall Study||104||
59904608|NCT01127256|76025466|FG000|COMPLETED|Overall Study||57||
59904609|NCT01127256|76025467|FG001|COMPLETED|Overall Study||65||
59904610|NCT01127256|76025466|FG000|NOT COMPLETED|Overall Study||39||
59904611|NCT01127256|76025467|FG001|NOT COMPLETED|Overall Study||39||
59904612|NCT04016311|76025475|FG000|STARTED|Overall Study||18||
59904613|NCT04016311|76025476|FG001|STARTED|Overall Study||20||
59904614|NCT04016311|76025475|FG000|COMPLETED|Overall Study||17||
59904615|NCT04016311|76025476|FG001|COMPLETED|Overall Study||20||
59904616|NCT04016311|76025475|FG000|NOT COMPLETED|Overall Study||1||
59904617|NCT04016311|76025476|FG001|NOT COMPLETED|Overall Study||0||
59904618|NCT04052425|76025486|FG000|STARTED|24-Week Double-blind Period||221||
59904619|NCT04052425|76025487|FG001|STARTED|24-Week Double-blind Period||109||
59904620|NCT04052425|76025488|FG002|STARTED|24-Week Double-blind Period||0||
59904621|NCT04052425|76025489|FG003|STARTED|24-Week Double-blind Period||0||
59904622|NCT04052425|76025486|FG000|COMPLETED|24-Week Double-blind Period||193||
59904623|NCT04052425|76025487|FG001|COMPLETED|24-Week Double-blind Period||90||
59904624|NCT04052425|76025488|FG002|COMPLETED|24-Week Double-blind Period||0||
59904625|NCT04052425|76025489|FG003|COMPLETED|24-Week Double-blind Period||0||
59904626|NCT04052425|76025486|FG000|NOT COMPLETED|24-Week Double-blind Period||28||
59904627|NCT04052425|76025487|FG001|NOT COMPLETED|24-Week Double-blind Period||19||
59904628|NCT04052425|76025488|FG002|NOT COMPLETED|24-Week Double-blind Period||0||
59904629|NCT04052425|76025489|FG003|NOT COMPLETED|24-Week Double-blind Period||0||
59904630|NCT04052425|76025486|FG000|STARTED|28-Week Treatment-Extension Period||0||
59506118|NCT01278407|75599011|FG004|STARTED|Confirmatory Phase||0||
59506119|NCT01278407|75599007|FG000|COMPLETED|Confirmatory Phase||37||
59506120|NCT01278407|75599008|FG001|COMPLETED|Confirmatory Phase||31||
59506121|NCT01278407|75599009|FG002|COMPLETED|Confirmatory Phase||43||
59506122|NCT01278407|75599010|FG003|COMPLETED|Confirmatory Phase||0||
59506123|NCT01278407|75599011|FG004|COMPLETED|Confirmatory Phase||0||
59904631|NCT04052425|76025487|FG001|STARTED|28-Week Treatment-Extension Period||0||
59904632|NCT04052425|76025488|FG002|STARTED|28-Week Treatment-Extension Period|Treatment-Extension Evaluable Population: all participants who applied ruxolitinib cream at least once in the TE period|193||
59904633|NCT04052425|76025489|FG003|STARTED|28-Week Treatment-Extension Period||90||
59904634|NCT04052425|76025486|FG000|COMPLETED|28-Week Treatment-Extension Period||0||
59904635|NCT04052425|76025487|FG001|COMPLETED|28-Week Treatment-Extension Period||0||
59904636|NCT04052425|76025488|FG002|COMPLETED|28-Week Treatment-Extension Period||174||
59506124|NCT01278407|75599007|FG000|NOT COMPLETED|Confirmatory Phase||9||
59506125|NCT01278407|75599008|FG001|NOT COMPLETED|Confirmatory Phase||16||
59506126|NCT01278407|75599009|FG002|NOT COMPLETED|Confirmatory Phase||6||
59506127|NCT01278407|75599010|FG003|NOT COMPLETED|Confirmatory Phase||0||
59506128|NCT01278407|75599011|FG004|NOT COMPLETED|Confirmatory Phase||0||
59506129|NCT01278407|75599007|FG000|STARTED|Extension Phase||0||
59506130|NCT01278407|75599008|FG001|STARTED|Extension Phase||0||
59506131|NCT01278407|75599009|FG002|STARTED|Extension Phase||0||
59904637|NCT04052425|76025489|FG003|COMPLETED|28-Week Treatment-Extension Period||80||
59904638|NCT04052425|76025486|FG000|NOT COMPLETED|28-Week Treatment-Extension Period||0||
59904639|NCT04052425|76025487|FG001|NOT COMPLETED|28-Week Treatment-Extension Period||0||
59904640|NCT04052425|76025488|FG002|NOT COMPLETED|28-Week Treatment-Extension Period||19||
59904641|NCT04052425|76025489|FG003|NOT COMPLETED|28-Week Treatment-Extension Period||10||
59904642|NCT03235089|76025499|FG000|STARTED|Overall Study||31||31
59904643|NCT03235089|76025500|FG001|STARTED|Overall Study||31||31
59904644|NCT03235089|76025499|FG000|COMPLETED|Overall Study||28||28
59904645|NCT03235089|76025500|FG001|COMPLETED|Overall Study||28||28
59904646|NCT03235089|76025499|FG000|NOT COMPLETED|Overall Study||3||3
59904647|NCT03235089|76025500|FG001|NOT COMPLETED|Overall Study||3||3
59904648|NCT04013191|76025509|FG000|STARTED|Overall Study||10||
59904649|NCT04013191|76025510|FG001|STARTED|Overall Study||18||
59904650|NCT04013191|76025509|FG000|Completed Period 1A (Single Dose)|Overall Study||10||
59904651|NCT04013191|76025510|FG001|Completed Period 1A (Single Dose)|Overall Study||18||
59904652|NCT04013191|76025509|FG000|Completed Period 1B (Multiple Dose)|Overall Study||9||
59904653|NCT04013191|76025510|FG001|Completed Period 1B (Multiple Dose)|Overall Study||18||
59904654|NCT04013191|76025509|FG000|COMPLETED|Overall Study||9||
59904655|NCT04013191|76025510|FG001|COMPLETED|Overall Study||18||
59904656|NCT04013191|76025509|FG000|NOT COMPLETED|Overall Study||1||
59904657|NCT04013191|76025510|FG001|NOT COMPLETED|Overall Study||0||
59904658|NCT03285594|76025523|FG000|STARTED|Overall Study||144||
59506132|NCT01278407|75599010|FG003|STARTED|Extension Phase||46||
59506133|NCT01278407|75599011|FG004|STARTED|Extension Phase||96||
59506134|NCT01278407|75599007|FG000|COMPLETED|Extension Phase||0||
59506135|NCT01278407|75599008|FG001|COMPLETED|Extension Phase||0||
59904659|NCT03285594|76025524|FG001|STARTED|Overall Study||141||
59904660|NCT03285594|76025525|FG002|STARTED|Overall Study||286||
59904661|NCT03285594|76025523|FG000|Treated|Overall Study||144||
59904662|NCT03285594|76025524|FG001|Treated|Overall Study||141||
59506136|NCT01278407|75599009|FG002|COMPLETED|Extension Phase||0||
59506137|NCT01278407|75599010|FG003|COMPLETED|Extension Phase||34||
59506138|NCT01278407|75599011|FG004|COMPLETED|Extension Phase||66||
59506139|NCT01278407|75599007|FG000|NOT COMPLETED|Extension Phase||0||
59904663|NCT03285594|76025525|FG002|Treated|Overall Study||285||
59904664|NCT03285594|76025523|FG000|COMPLETED|Overall Study||129||
59904665|NCT03285594|76025524|FG001|COMPLETED|Overall Study||130||
59506140|NCT01278407|75599008|FG001|NOT COMPLETED|Extension Phase||0||
59506141|NCT01278407|75599009|FG002|NOT COMPLETED|Extension Phase||0||
59506142|NCT01278407|75599010|FG003|NOT COMPLETED|Extension Phase||12||
59904666|NCT03285594|76025525|FG002|COMPLETED|Overall Study||249||
59904667|NCT03285594|76025523|FG000|NOT COMPLETED|Overall Study||15||
59904668|NCT03285594|76025524|FG001|NOT COMPLETED|Overall Study||11||
59904669|NCT03285594|76025525|FG002|NOT COMPLETED|Overall Study||37||
59904670|NCT03234465|76025536|FG000|STARTED|Overall Study||100||
59904671|NCT03234465|76025537|FG001|STARTED|Overall Study||100||
59904672|NCT03234465|76025536|FG000|COMPLETED|Overall Study||67||
59904673|NCT03234465|76025537|FG001|COMPLETED|Overall Study||60||
59904674|NCT03234465|76025536|FG000|NOT COMPLETED|Overall Study||33||
59904675|NCT03234465|76025537|FG001|NOT COMPLETED|Overall Study||40||
59904676|NCT03290131|76025546|FG000|STARTED|Overall Study||179||
59904677|NCT03290131|76025547|FG001|STARTED|Overall Study||179||
59904678|NCT03290131|76025548|FG002|STARTED|Overall Study||178||
59904679|NCT03290131|76025546|FG000|COMPLETED|Overall Study||137||
59904680|NCT03290131|76025547|FG001|COMPLETED|Overall Study||107||
59904681|NCT03290131|76025548|FG002|COMPLETED|Overall Study||159||
59904682|NCT03290131|76025546|FG000|NOT COMPLETED|Overall Study||42||
59904683|NCT03290131|76025547|FG001|NOT COMPLETED|Overall Study||72||
59904684|NCT03290131|76025548|FG002|NOT COMPLETED|Overall Study||19||
59904685|NCT04050865|76025559|FG000|STARTED|Overall Study||48||
59904686|NCT04050865|76025560|FG001|STARTED|Overall Study||48||
59904687|NCT04050865|76025559|FG000|COMPLETED|Overall Study||44||
59904688|NCT04050865|76025560|FG001|COMPLETED|Overall Study||43||
59904689|NCT04050865|76025559|FG000|NOT COMPLETED|Overall Study||4||
59904690|NCT04050865|76025560|FG001|NOT COMPLETED|Overall Study||5||
59904691|NCT03283566|76025568|FG000|STARTED|Overall Study||4||
59904692|NCT03283566|76025569|FG001|STARTED|Overall Study||5||
59904693|NCT03283566|76025568|FG000|COMPLETED|Overall Study||3||
59904694|NCT03283566|76025569|FG001|COMPLETED|Overall Study||3||
59904695|NCT03283566|76025568|FG000|NOT COMPLETED|Overall Study||1||
59904696|NCT03283566|76025569|FG001|NOT COMPLETED|Overall Study||2||
59904697|NCT03210519|76025577|FG000|STARTED|Overall Study||11||
59904698|NCT03210519|76025578|FG001|STARTED|Overall Study||10||
59904699|NCT03210519|76025577|FG000|COMPLETED|Overall Study||9||
59904700|NCT03210519|76025578|FG001|COMPLETED|Overall Study||10||
59904701|NCT03210519|76025577|FG000|NOT COMPLETED|Overall Study||2||
59904702|NCT03210519|76025578|FG001|NOT COMPLETED|Overall Study||0||
59904703|NCT04048681|76025584|FG000|STARTED|Overall Study||1||
59904704|NCT04048681|76025585|FG001|STARTED|Overall Study||1||
59904705|NCT04048681|76025586|FG002|STARTED|Overall Study||1||
59904706|NCT04048681|76025587|FG003|STARTED|Overall Study||1||
59904707|NCT04048681|76025588|FG004|STARTED|Overall Study||1||
59904708|NCT04048681|76025584|FG000|COMPLETED|Overall Study||1||
59904709|NCT04048681|76025585|FG001|COMPLETED|Overall Study||1||
59904710|NCT04048681|76025586|FG002|COMPLETED|Overall Study||1||
59904711|NCT04048681|76025587|FG003|COMPLETED|Overall Study||0||
59506143|NCT01278407|75599011|FG004|NOT COMPLETED|Extension Phase||30||
59506144|NCT01278173|75599021|FG000|STARTED|Overall Study||65||
59506145|NCT01278173|75599021|FG000|COMPLETED|Overall Study||38||
59506146|NCT01278173|75599021|FG000|NOT COMPLETED|Overall Study||27||
59904712|NCT04048681|76025588|FG004|COMPLETED|Overall Study||1||
59904713|NCT04048681|76025584|FG000|NOT COMPLETED|Overall Study||0||
59904714|NCT04048681|76025585|FG001|NOT COMPLETED|Overall Study||0||
59904715|NCT04048681|76025586|FG002|NOT COMPLETED|Overall Study||0||
59904716|NCT04048681|76025587|FG003|NOT COMPLETED|Overall Study||1||
59904717|NCT04048681|76025588|FG004|NOT COMPLETED|Overall Study||0||
59904718|NCT04007107|76025596|FG000|STARTED|Treatment Period 1 (Day 1)||26||
59904719|NCT04007107|76025597|FG001|STARTED|Treatment Period 1 (Day 1)||26||
59904720|NCT04007107|76025598|FG002|STARTED|Treatment Period 1 (Day 1)||25||
59904721|NCT04007107|76025599|FG003|STARTED|Treatment Period 1 (Day 1)||26||
59506147|NCT00784303|75599027|FG000|STARTED|Overall Study||58||
59506148|NCT00784303|75599028|FG001|STARTED|Overall Study||59||
59506149|NCT00784303|75599027|FG000|COMPLETED|Overall Study||58||
59904722|NCT04007107|76025596|FG000|Full Analysis Set (FAS)|Treatment Period 1 (Day 1)||26||
59904723|NCT04007107|76025597|FG001|Full Analysis Set (FAS)|Treatment Period 1 (Day 1)||26||
59904724|NCT04007107|76025598|FG002|Full Analysis Set (FAS)|Treatment Period 1 (Day 1)||25||
59904725|NCT04007107|76025599|FG003|Full Analysis Set (FAS)|Treatment Period 1 (Day 1)||26||
59904726|NCT04007107|76025596|FG000|Safety Analysis Set (SAS)|Treatment Period 1 (Day 1)||26||
59904727|NCT04007107|76025597|FG001|Safety Analysis Set (SAS)|Treatment Period 1 (Day 1)||26||
59904728|NCT04007107|76025598|FG002|Safety Analysis Set (SAS)|Treatment Period 1 (Day 1)||25||
59904729|NCT04007107|76025599|FG003|Safety Analysis Set (SAS)|Treatment Period 1 (Day 1)||26||
59506150|NCT00784303|75599028|FG001|COMPLETED|Overall Study||59||
59904730|NCT04007107|76025596|FG000|Per Protocol (PP) Set|Treatment Period 1 (Day 1)||26||
59904731|NCT04007107|76025597|FG001|Per Protocol (PP) Set|Treatment Period 1 (Day 1)||25||
59904732|NCT04007107|76025598|FG002|Per Protocol (PP) Set|Treatment Period 1 (Day 1)||25||
59904733|NCT04007107|76025599|FG003|Per Protocol (PP) Set|Treatment Period 1 (Day 1)||26||
59904734|NCT04007107|76025596|FG000|COMPLETED|Treatment Period 1 (Day 1)||26||
59904735|NCT04007107|76025597|FG001|COMPLETED|Treatment Period 1 (Day 1)||26||
59904736|NCT04007107|76025598|FG002|COMPLETED|Treatment Period 1 (Day 1)||25||
59904737|NCT04007107|76025599|FG003|COMPLETED|Treatment Period 1 (Day 1)||26||
59904738|NCT04007107|76025596|FG000|NOT COMPLETED|Treatment Period 1 (Day 1)||0||
59904739|NCT04007107|76025597|FG001|NOT COMPLETED|Treatment Period 1 (Day 1)||0||
59904740|NCT04007107|76025598|FG002|NOT COMPLETED|Treatment Period 1 (Day 1)||0||
59904741|NCT04007107|76025599|FG003|NOT COMPLETED|Treatment Period 1 (Day 1)||0||
59904742|NCT04007107|76025596|FG000|STARTED|Treatment Period 2 (Day 1)||26||
59904743|NCT04007107|76025597|FG001|STARTED|Treatment Period 2 (Day 1)||26||
59904744|NCT04007107|76025598|FG002|STARTED|Treatment Period 2 (Day 1)||25||
59904745|NCT04007107|76025599|FG003|STARTED|Treatment Period 2 (Day 1)||26||
59904746|NCT04007107|76025596|FG000|COMPLETED|Treatment Period 2 (Day 1)||26||
59904747|NCT04007107|76025597|FG001|COMPLETED|Treatment Period 2 (Day 1)||25||
59904748|NCT04007107|76025598|FG002|COMPLETED|Treatment Period 2 (Day 1)||25||
59904749|NCT04007107|76025599|FG003|COMPLETED|Treatment Period 2 (Day 1)||26||
59904750|NCT04007107|76025596|FG000|NOT COMPLETED|Treatment Period 2 (Day 1)||0||
59904751|NCT04007107|76025597|FG001|NOT COMPLETED|Treatment Period 2 (Day 1)||1||
59904752|NCT04007107|76025598|FG002|NOT COMPLETED|Treatment Period 2 (Day 1)||0||
59904753|NCT04007107|76025599|FG003|NOT COMPLETED|Treatment Period 2 (Day 1)||0||
59904754|NCT04046341|76025604|FG000|STARTED|Overall Study||15||
59904755|NCT04046341|76025604|FG000|COMPLETED|Overall Study||12||
59904756|NCT04046341|76025604|FG000|NOT COMPLETED|Overall Study||3||
59904757|NCT03233529|76025608|FG000|STARTED|Double-Blind Period (Day 1 to Day 15)||40||
59904758|NCT03233529|76025608|FG000|COMPLETED|Double-Blind Period (Day 1 to Day 15)||39||
59904759|NCT03233529|76025608|FG000|NOT COMPLETED|Double-Blind Period (Day 1 to Day 15)||1||
59904760|NCT03233529|76025608|FG000|STARTED|Open-Label Period (Day 15 to Day 71)||39||
59904761|NCT03233529|76025608|FG000|COMPLETED|Open-Label Period (Day 15 to Day 71)||38||
59904762|NCT03233529|76025608|FG000|NOT COMPLETED|Open-Label Period (Day 15 to Day 71)||1||
59904763|NCT04006171|76025618|FG000|STARTED|Overall Study||48||
59904764|NCT04006171|76025619|FG001|STARTED|Overall Study||42||
59904765|NCT04006171|76025618|FG000|COMPLETED|Overall Study||36||
59904766|NCT04006171|76025619|FG001|COMPLETED|Overall Study||30||
59904767|NCT04006171|76025618|FG000|NOT COMPLETED|Overall Study||12||
59904768|NCT04006171|76025619|FG001|NOT COMPLETED|Overall Study||12||
59904769|NCT02652468|76025626|FG000|STARTED|Overall Study||11||
59904770|NCT02652468|76025626|FG000|COMPLETED|Overall Study||11||
59904771|NCT02652468|76025626|FG000|NOT COMPLETED|Overall Study||0||
59904772|NCT04043143|76025632|FG000|STARTED|Overall Study||29||
59904773|NCT04043143|76025633|FG001|STARTED|Overall Study||27||
59904774|NCT04043143|76025632|FG000|COMPLETED|Overall Study||23||
59904775|NCT04043143|76025633|FG001|COMPLETED|Overall Study||22||
59904776|NCT04043143|76025632|FG000|NOT COMPLETED|Overall Study||6||
59904777|NCT04043143|76025633|FG001|NOT COMPLETED|Overall Study||5||
59904778|NCT03283098|76025641|FG000|STARTED|Overall Study||8||
59904779|NCT03283098|76025642|FG001|STARTED|Overall Study||25||
59904780|NCT03283098|76025641|FG000|COMPLETED|Overall Study||8||
59904781|NCT03283098|76025642|FG001|COMPLETED|Overall Study||24||
59904782|NCT03283098|76025641|FG000|NOT COMPLETED|Overall Study||0||
59904783|NCT03283098|76025642|FG001|NOT COMPLETED|Overall Study||1||
59904784|NCT03655951|76025650|FG000|STARTED|Overall Study||358|Randomized|
59904785|NCT03655951|76025651|FG001|STARTED|Overall Study||372|Randomized|
59904786|NCT03655951|76025650|FG000|Completed Pretest|Overall Study||344||
59904787|NCT03655951|76025651|FG001|Completed Pretest|Overall Study||366||
59904788|NCT03655951|76025650|FG000|COMPLETED|Overall Study||319|Completed posttest|
59904789|NCT03655951|76025651|FG001|COMPLETED|Overall Study||351|Completed posttest|
59904790|NCT03655951|76025650|FG000|NOT COMPLETED|Overall Study||39||
59904791|NCT03655951|76025651|FG001|NOT COMPLETED|Overall Study||21||
59904792|NCT02527798|76025663|FG000|STARTED|Overall Study||32||
59904793|NCT02527798|76025664|FG001|STARTED|Overall Study||10||
59904794|NCT02527798|76025665|FG002|STARTED|Overall Study||30||
59904795|NCT02527798|76025666|FG003|STARTED|Overall Study||10||
59904796|NCT02527798|76025667|FG004|STARTED|Overall Study||0||
59904797|NCT02527798|76025668|FG005|STARTED|Overall Study||0||
59904798|NCT02527798|76025663|FG000|Randomized, Not Dosed|Overall Study||31||
59904799|NCT02527798|76025664|FG001|Randomized, Not Dosed|Overall Study||9||
59904800|NCT02527798|76025665|FG002|Randomized, Not Dosed|Overall Study||30||
59904801|NCT02527798|76025666|FG003|Randomized, Not Dosed|Overall Study||10||
59904802|NCT02527798|76025667|FG004|Randomized, Not Dosed|Overall Study||0||
59904803|NCT02527798|76025668|FG005|Randomized, Not Dosed|Overall Study||0||
59904804|NCT02527798|76025663|FG000|Pharmacokinetic (PK) Population|Overall Study||20||
59904805|NCT02527798|76025664|FG001|Pharmacokinetic (PK) Population|Overall Study||0||
59904806|NCT02527798|76025665|FG002|Pharmacokinetic (PK) Population|Overall Study||19||
59904807|NCT02527798|76025666|FG003|Pharmacokinetic (PK) Population|Overall Study||0||
59904808|NCT02527798|76025667|FG004|Pharmacokinetic (PK) Population|Overall Study||0||
59904809|NCT02527798|76025668|FG005|Pharmacokinetic (PK) Population|Overall Study||0||
59904810|NCT02527798|76025663|FG000|COMPLETED|Overall Study||29||
59904811|NCT02527798|76025664|FG001|COMPLETED|Overall Study||8||
59904812|NCT02527798|76025665|FG002|COMPLETED|Overall Study||25||
59904813|NCT02527798|76025666|FG003|COMPLETED|Overall Study||9||
59904814|NCT02527798|76025667|FG004|COMPLETED|Overall Study||0||
59904815|NCT02527798|76025668|FG005|COMPLETED|Overall Study||0||
59904816|NCT02527798|76025663|FG000|NOT COMPLETED|Overall Study||3||
59904817|NCT02527798|76025664|FG001|NOT COMPLETED|Overall Study||2||
59904818|NCT02527798|76025665|FG002|NOT COMPLETED|Overall Study||5||
59904819|NCT02527798|76025666|FG003|NOT COMPLETED|Overall Study||1||
59904820|NCT02527798|76025667|FG004|NOT COMPLETED|Overall Study||0||
59904821|NCT02527798|76025668|FG005|NOT COMPLETED|Overall Study||0||
59904822|NCT03188991|76025699|FG000|STARTED|Overall Study||3||
59904823|NCT03188991|76025700|FG001|STARTED|Overall Study||3||
59904824|NCT03188991|76025701|FG002|STARTED|Overall Study||3||
59904825|NCT03188991|76025702|FG003|STARTED|Overall Study||11||
59904826|NCT03188991|76025699|FG000|COMPLETED|Overall Study||3||
59904827|NCT03188991|76025700|FG001|COMPLETED|Overall Study||3||
59904828|NCT03188991|76025701|FG002|COMPLETED|Overall Study||3||
59904829|NCT03188991|76025702|FG003|COMPLETED|Overall Study||10||
59904830|NCT03188991|76025699|FG000|NOT COMPLETED|Overall Study||0||
59904831|NCT03188991|76025700|FG001|NOT COMPLETED|Overall Study||0||
59904832|NCT03188991|76025701|FG002|NOT COMPLETED|Overall Study||0||
59904833|NCT03188991|76025702|FG003|NOT COMPLETED|Overall Study||1||
59904834|NCT03857542|76025714|FG000|STARTED|Overall Study||215||
59904835|NCT03857542|76025715|FG001|STARTED|Overall Study||212||
59904836|NCT03857542|76025714|FG000|COMPLETED|Overall Study||209||
59904837|NCT03857542|76025715|FG001|COMPLETED|Overall Study||207||
59904838|NCT03857542|76025714|FG000|NOT COMPLETED|Overall Study||6||
59904839|NCT03857542|76025715|FG001|NOT COMPLETED|Overall Study||5||
59904840|NCT03209973|76025722|FG000|STARTED|Overall Study||70||
59904841|NCT03209973|76025722|FG000|Completed Primary Outcome Period|Overall Study||66||
59904842|NCT03209973|76025722|FG000|COMPLETED|Overall Study||0||
59904843|NCT03209973|76025722|FG000|NOT COMPLETED|Overall Study||70||
59904844|NCT03751631|76025728|FG000|STARTED|Overall Study||10||20
59904845|NCT03751631|76025729|FG001|STARTED|Overall Study||11||22
59904846|NCT03751631|76025730|FG002|STARTED|Overall Study||11||22
59904847|NCT03751631|76025731|FG003|STARTED|Overall Study||11||22
59904848|NCT03751631|76025732|FG004|STARTED|Overall Study||10||20
59904849|NCT03751631|76025733|FG005|STARTED|Overall Study||11||22
59904850|NCT03751631|76025728|FG000|Received 1st Drug in Sequence|Overall Study||10||20
59904851|NCT03751631|76025729|FG001|Received 1st Drug in Sequence|Overall Study||11||22
59904852|NCT03751631|76025730|FG002|Received 1st Drug in Sequence|Overall Study||11||22
59904853|NCT03751631|76025731|FG003|Received 1st Drug in Sequence|Overall Study||11||22
59904854|NCT03751631|76025732|FG004|Received 1st Drug in Sequence|Overall Study||10||20
59904855|NCT03751631|76025733|FG005|Received 1st Drug in Sequence|Overall Study||11||22
59904856|NCT03751631|76025728|FG000|Received 2nd Drug in Sequence|Overall Study||10||20
59904857|NCT03751631|76025729|FG001|Received 2nd Drug in Sequence|Overall Study||11||22
59904858|NCT03751631|76025730|FG002|Received 2nd Drug in Sequence|Overall Study||10||20
59904859|NCT03751631|76025731|FG003|Received 2nd Drug in Sequence|Overall Study||10||20
59904860|NCT03751631|76025732|FG004|Received 2nd Drug in Sequence|Overall Study||10||20
59904861|NCT03751631|76025733|FG005|Received 2nd Drug in Sequence|Overall Study||11||22
59904862|NCT03751631|76025728|FG000|Received 3rd Drug in Sequence|Overall Study||10||20
59904863|NCT03751631|76025729|FG001|Received 3rd Drug in Sequence|Overall Study||11||22
59904864|NCT03751631|76025730|FG002|Received 3rd Drug in Sequence|Overall Study||10||20
59904865|NCT03751631|76025731|FG003|Received 3rd Drug in Sequence|Overall Study||10||20
59904866|NCT03751631|76025732|FG004|Received 3rd Drug in Sequence|Overall Study||10||20
59904867|NCT03751631|76025733|FG005|Received 3rd Drug in Sequence|Overall Study||11||22
59904868|NCT03751631|76025728|FG000|COMPLETED|Overall Study||10||20
59904869|NCT03751631|76025729|FG001|COMPLETED|Overall Study||11||22
59904870|NCT03751631|76025730|FG002|COMPLETED|Overall Study||10||20
59904871|NCT03751631|76025731|FG003|COMPLETED|Overall Study||10||20
59904872|NCT03751631|76025732|FG004|COMPLETED|Overall Study||10||20
59904873|NCT03751631|76025733|FG005|COMPLETED|Overall Study||11||22
59904874|NCT03751631|76025728|FG000|NOT COMPLETED|Overall Study||0||0
59904875|NCT03751631|76025729|FG001|NOT COMPLETED|Overall Study||0||0
59904876|NCT03751631|76025730|FG002|NOT COMPLETED|Overall Study||1||2
60067718|NCT01617187|76182892|FG001|STARTED|Treatment Through Study Completion|Treated|113||
59904877|NCT03751631|76025731|FG003|NOT COMPLETED|Overall Study||1||2
59904878|NCT03751631|76025732|FG004|NOT COMPLETED|Overall Study||0||0
59904879|NCT03751631|76025733|FG005|NOT COMPLETED|Overall Study||0||0
59904880|NCT03688711|76025746|FG000|STARTED|Overall Study||34|Randomized|
59904881|NCT03688711|76025747|FG001|STARTED|Overall Study||11|Randomized|
59904882|NCT03688711|76025746|FG000|COMPLETED|Overall Study||34||
59904883|NCT03688711|76025747|FG001|COMPLETED|Overall Study||10||
59904884|NCT03688711|76025746|FG000|NOT COMPLETED|Overall Study||0||
59904885|NCT03688711|76025747|FG001|NOT COMPLETED|Overall Study||1||
59904886|NCT03188055|76025755|FG000|STARTED|Overall Study||48||0
59904887|NCT03188055|76025756|FG001|STARTED|Overall Study|Family members consented (24/48 had patient enroll along with them as patient had DMC).|48||0
59904888|NCT03188055|76025757|FG002|STARTED|Overall Study||62||0
59904889|NCT03188055|76025758|FG003|STARTED|Overall Study|Family members consented (19/38 had patient enroll along with them as patient had DMC).|38||0
59904890|NCT03188055|76025759|FG004|STARTED|Overall Study||59||0
59904891|NCT03188055|76025760|FG005|STARTED|Overall Study|Anonymous survey, cannot ascertain if same participant completed it for both pre- and post-intervention.|||233
59904892|NCT03188055|76025755|FG000|Patients Who Provided Self-Consent|Overall Study||0|These participants count toward the total number of participants who 'started' the study.|0
59904893|NCT03188055|76025756|FG001|Patients Who Provided Self-Consent|Overall Study||24|These participants count toward the total number of participants who 'started' the study.|0
59904894|NCT03188055|76025757|FG002|Patients Who Provided Self-Consent|Overall Study||0|These participants count toward the total number of participants who 'started' the study.|0
59904895|NCT03188055|76025758|FG003|Patients Who Provided Self-Consent|Overall Study||19|These participants count toward the total number of participants who 'started' the study.|0
59904896|NCT03188055|76025759|FG004|Patients Who Provided Self-Consent|Overall Study||0|These participants count toward the total number of participants who 'started' the study.|0
59904897|NCT03188055|76025760|FG005|Patients Who Provided Self-Consent|Overall Study||0|These participants count toward the total number of participants who 'started' the study.|0
59904898|NCT03188055|76025755|FG000|MDS Pre-Intervention Survey Responses|Overall Study||0||0
59904899|NCT03188055|76025756|FG001|MDS Pre-Intervention Survey Responses|Overall Study||0||0
59904900|NCT03188055|76025757|FG002|MDS Pre-Intervention Survey Responses|Overall Study||0||0
59904901|NCT03188055|76025758|FG003|MDS Pre-Intervention Survey Responses|Overall Study||0||0
59904902|NCT03188055|76025759|FG004|MDS Pre-Intervention Survey Responses|Overall Study||0||0
59904903|NCT03188055|76025760|FG005|MDS Pre-Intervention Survey Responses|Overall Study||99||99
59904904|NCT03188055|76025755|FG000|MDS Post-Intervention Survey Responses|Overall Study||0||0
59904905|NCT03188055|76025756|FG001|MDS Post-Intervention Survey Responses|Overall Study||0||0
59904906|NCT03188055|76025757|FG002|MDS Post-Intervention Survey Responses|Overall Study||0||0
59904907|NCT03188055|76025758|FG003|MDS Post-Intervention Survey Responses|Overall Study||0||0
59904908|NCT03188055|76025759|FG004|MDS Post-Intervention Survey Responses|Overall Study||0||0
59904909|NCT03188055|76025760|FG005|MDS Post-Intervention Survey Responses|Overall Study||134||134
59904910|NCT03188055|76025755|FG000|Patient Survey 1|Overall Study||0||0
59904911|NCT03188055|76025756|FG001|Patient Survey 1|Overall Study||16||0
59904912|NCT03188055|76025757|FG002|Patient Survey 1|Overall Study||0||0
59904913|NCT03188055|76025758|FG003|Patient Survey 1|Overall Study||13||0
59611400|NCT01780506|75722364|FG001|NOT COMPLETED|Double-Blind Phase||78||
59611401|NCT01780506|75722363|FG000|STARTED|Open-Label Extension Phase|278 participants completed the Double-Blind Phase but did not enter the Open-Label Extension Phase|90||
59611402|NCT01780506|75722364|FG001|STARTED|Open-Label Extension Phase|261 participants completed the Double-Blind Phase but did not enter the Open-Label Extension Phase|95||
59611403|NCT01780506|75722363|FG000|COMPLETED|Open-Label Extension Phase||90||
59611404|NCT01780506|75722364|FG001|COMPLETED|Open-Label Extension Phase||94||
59611405|NCT01780506|75722363|FG000|NOT COMPLETED|Open-Label Extension Phase||0||
59611406|NCT01780506|75722364|FG001|NOT COMPLETED|Open-Label Extension Phase||1||
59904914|NCT03188055|76025759|FG004|Patient Survey 1|Overall Study||0||0
59904915|NCT03188055|76025760|FG005|Patient Survey 1|Overall Study||0||0
59904916|NCT03188055|76025755|FG000|Nurse Survey 1|Overall Study||0||0
59904917|NCT03188055|76025756|FG001|Nurse Survey 1|Overall Study||32||0
59904918|NCT03188055|76025757|FG002|Nurse Survey 1|Overall Study||0||0
59904919|NCT03188055|76025758|FG003|Nurse Survey 1|Overall Study||27||0
59904920|NCT03188055|76025759|FG004|Nurse Survey 1|Overall Study||0||0
59904921|NCT03188055|76025760|FG005|Nurse Survey 1|Overall Study||0||0
59904922|NCT03188055|76025755|FG000|Family Survey 1|Overall Study||0||0
59904923|NCT03188055|76025756|FG001|Family Survey 1|Overall Study||37||0
59904924|NCT03188055|76025757|FG002|Family Survey 1|Overall Study||0||0
59904925|NCT03188055|76025758|FG003|Family Survey 1|Overall Study||38||0
59904926|NCT03188055|76025759|FG004|Family Survey 1|Overall Study||0||0
59904927|NCT03188055|76025760|FG005|Family Survey 1|Overall Study||0||0
59904928|NCT03188055|76025755|FG000|Family Survey 2|Overall Study||0||0
59904929|NCT03188055|76025756|FG001|Family Survey 2|Overall Study||34||0
59904930|NCT03188055|76025757|FG002|Family Survey 2|Overall Study||0||0
59904931|NCT03188055|76025758|FG003|Family Survey 2|Overall Study||35||0
59904932|NCT03188055|76025759|FG004|Family Survey 2|Overall Study||0||0
59904933|NCT03188055|76025760|FG005|Family Survey 2|Overall Study||0||0
59904934|NCT03188055|76025755|FG000|Family Survey 3|Overall Study||0||0
59904935|NCT03188055|76025756|FG001|Family Survey 3|Overall Study||29||0
59904936|NCT03188055|76025757|FG002|Family Survey 3|Overall Study||0||0
59904937|NCT03188055|76025758|FG003|Family Survey 3|Overall Study||26||0
59904938|NCT03188055|76025759|FG004|Family Survey 3|Overall Study||0||0
59904939|NCT03188055|76025760|FG005|Family Survey 3|Overall Study||0||0
59904940|NCT03188055|76025755|FG000|COMPLETED|Overall Study||48||0
59904941|NCT03188055|76025756|FG001|COMPLETED|Overall Study||29||0
59904942|NCT03188055|76025757|FG002|COMPLETED|Overall Study||43||0
59904943|NCT03188055|76025758|FG003|COMPLETED|Overall Study||26||0
59904944|NCT03188055|76025759|FG004|COMPLETED|Overall Study||59||0
59904945|NCT03188055|76025760|FG005|COMPLETED|Overall Study|Anonymous survey, cannot ascertain if same participant completed it for both pre- and post-intervention.|||233
59904946|NCT03188055|76025755|FG000|NOT COMPLETED|Overall Study||0||0
59904947|NCT03188055|76025756|FG001|NOT COMPLETED|Overall Study||19||0
59904948|NCT03188055|76025757|FG002|NOT COMPLETED|Overall Study||19||0
59904949|NCT03188055|76025758|FG003|NOT COMPLETED|Overall Study||12||0
59904950|NCT03188055|76025759|FG004|NOT COMPLETED|Overall Study||0||0
59904951|NCT03188055|76025760|FG005|NOT COMPLETED|Overall Study||||0
59904952|NCT04035577|76025771|FG000|STARTED|Overall Study|One participant withdrew after signing the consent but before initiating any study activities.|21||
59904953|NCT04035577|76025771|FG000|COMPLETED|Overall Study||19||
59904954|NCT04035577|76025771|FG000|NOT COMPLETED|Overall Study||2||
59904955|NCT02416492|76025781|FG000|STARTED|Overall Study||15||
59904956|NCT02416492|76025782|FG001|STARTED|Overall Study||15||
59904957|NCT02416492|76025783|FG002|STARTED|Overall Study||16||
59904958|NCT02416492|76025784|FG003|STARTED|Overall Study||15||
59904959|NCT02416492|76025781|FG000|COMPLETED|Overall Study||15||
59904960|NCT02416492|76025782|FG001|COMPLETED|Overall Study||15||
59904961|NCT02416492|76025783|FG002|COMPLETED|Overall Study||16||
59904962|NCT02416492|76025784|FG003|COMPLETED|Overall Study||15||
60014755|NCT02614183|76130890|FG002|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post-treatment phase.|183||
59904963|NCT02416492|76025781|FG000|NOT COMPLETED|Overall Study||0||
59904964|NCT02416492|76025782|FG001|NOT COMPLETED|Overall Study||0||
59904965|NCT02416492|76025783|FG002|NOT COMPLETED|Overall Study||0||
59904966|NCT02416492|76025784|FG003|NOT COMPLETED|Overall Study||0||
59904967|NCT03655717|76025799|FG000|STARTED|Overall Study||70||
59904968|NCT03655717|76025800|FG001|STARTED|Overall Study||68||
59904969|NCT03655717|76025801|FG002|STARTED|Overall Study||2||
59904970|NCT03655717|76025802|FG003|STARTED|Overall Study||1||
59904971|NCT03655717|76025803|FG004|STARTED|Overall Study||0||
59904972|NCT03655717|76025804|FG005|STARTED|Overall Study||3||
59904973|NCT03655717|76025805|FG006|STARTED|Overall Study||3||
59904974|NCT03655717|76025806|FG007|STARTED|Overall Study||3||
59904975|NCT03655717|76025807|FG008|STARTED|Overall Study||2||
59904976|NCT03655717|76025808|FG009|STARTED|Overall Study||1||
59904977|NCT03655717|76025809|FG010|STARTED|Overall Study||1||
59904978|NCT03655717|76025810|FG011|STARTED|Overall Study||3||
59904979|NCT03655717|76025811|FG012|STARTED|Overall Study||2||
59904980|NCT03655717|76025812|FG013|STARTED|Overall Study||3||
59904981|NCT03655717|76025813|FG014|STARTED|Overall Study||2||
59904982|NCT03655717|76025814|FG015|STARTED|Overall Study||2||
59904983|NCT03655717|76025815|FG016|STARTED|Overall Study||2||
59904984|NCT03655717|76025816|FG017|STARTED|Overall Study||2||
59904985|NCT03655717|76025817|FG018|STARTED|Overall Study||3||
59904986|NCT03655717|76025818|FG019|STARTED|Overall Study||3||
60014756|NCT02614183|76130888|FG000|Safety Population|Post Treatment Follow-up Phase||372||
60014757|NCT02614183|76130889|FG001|Safety Population|Post Treatment Follow-up Phase||183||
59904987|NCT03655717|76025819|FG020|STARTED|Overall Study||2||
59904988|NCT03655717|76025820|FG021|STARTED|Overall Study||3||
59904989|NCT03655717|76025821|FG022|STARTED|Overall Study||2||
59904990|NCT03655717|76025822|FG023|STARTED|Overall Study||4||
59904991|NCT03655717|76025823|FG024|STARTED|Overall Study||1||
59904992|NCT03655717|76025824|FG025|STARTED|Overall Study||2||
59904993|NCT03655717|76025799|FG000|COMPLETED|Overall Study||60||
59904994|NCT03655717|76025800|FG001|COMPLETED|Overall Study||56||
59904995|NCT03655717|76025801|FG002|COMPLETED|Overall Study||1||
59904996|NCT03655717|76025802|FG003|COMPLETED|Overall Study||0||
59904997|NCT03655717|76025803|FG004|COMPLETED|Overall Study||0||
59904998|NCT03655717|76025804|FG005|COMPLETED|Overall Study||1||
59904999|NCT03655717|76025805|FG006|COMPLETED|Overall Study||0||
59905000|NCT03655717|76025806|FG007|COMPLETED|Overall Study||2||
59905001|NCT03655717|76025807|FG008|COMPLETED|Overall Study||0||
59905002|NCT03655717|76025808|FG009|COMPLETED|Overall Study||0||
59905003|NCT03655717|76025809|FG010|COMPLETED|Overall Study||1||
59905004|NCT03655717|76025810|FG011|COMPLETED|Overall Study||1||
59905005|NCT03655717|76025811|FG012|COMPLETED|Overall Study||2||
60014758|NCT02614183|76130890|FG002|Safety Population|Post Treatment Follow-up Phase|Two participants who received only 240mg loading dose prior to discontinuation moved to this group.|185||
60014759|NCT02614183|76130888|FG000|COMPLETED|Post Treatment Follow-up Phase||354||
59905006|NCT03655717|76025812|FG013|COMPLETED|Overall Study||0||
59905007|NCT03655717|76025813|FG014|COMPLETED|Overall Study||2||
59905008|NCT03655717|76025814|FG015|COMPLETED|Overall Study||1||
59905009|NCT03655717|76025815|FG016|COMPLETED|Overall Study||2||
59905010|NCT03655717|76025816|FG017|COMPLETED|Overall Study||2||
59905011|NCT03655717|76025817|FG018|COMPLETED|Overall Study||2||
59905012|NCT03655717|76025818|FG019|COMPLETED|Overall Study||2||
59905013|NCT03655717|76025819|FG020|COMPLETED|Overall Study||2||
59905014|NCT03655717|76025820|FG021|COMPLETED|Overall Study||2||
59905015|NCT03655717|76025821|FG022|COMPLETED|Overall Study||0||
59905016|NCT03655717|76025822|FG023|COMPLETED|Overall Study||2||
59905017|NCT03655717|76025823|FG024|COMPLETED|Overall Study||0||
59905018|NCT03655717|76025824|FG025|COMPLETED|Overall Study||2||
59905019|NCT03655717|76025799|FG000|NOT COMPLETED|Overall Study||10||
59905020|NCT03655717|76025800|FG001|NOT COMPLETED|Overall Study||12||
59905021|NCT03655717|76025801|FG002|NOT COMPLETED|Overall Study||1||
59905022|NCT03655717|76025802|FG003|NOT COMPLETED|Overall Study||1||
59905023|NCT03655717|76025803|FG004|NOT COMPLETED|Overall Study||0||
59905024|NCT03655717|76025804|FG005|NOT COMPLETED|Overall Study||2||
59905025|NCT03655717|76025805|FG006|NOT COMPLETED|Overall Study||3||
59905026|NCT03655717|76025806|FG007|NOT COMPLETED|Overall Study||1||
59905027|NCT03655717|76025807|FG008|NOT COMPLETED|Overall Study||2||
59905028|NCT03655717|76025808|FG009|NOT COMPLETED|Overall Study||1||
59905029|NCT03655717|76025809|FG010|NOT COMPLETED|Overall Study||0||
59905030|NCT03655717|76025810|FG011|NOT COMPLETED|Overall Study||2||
59905031|NCT03655717|76025811|FG012|NOT COMPLETED|Overall Study||0||
59905032|NCT03655717|76025812|FG013|NOT COMPLETED|Overall Study||3||
59905033|NCT03655717|76025813|FG014|NOT COMPLETED|Overall Study||0||
59905034|NCT03655717|76025814|FG015|NOT COMPLETED|Overall Study||1||
59905035|NCT03655717|76025815|FG016|NOT COMPLETED|Overall Study||0||
59905036|NCT03655717|76025816|FG017|NOT COMPLETED|Overall Study||0||
59905037|NCT03655717|76025817|FG018|NOT COMPLETED|Overall Study||1||
59905038|NCT03655717|76025818|FG019|NOT COMPLETED|Overall Study||1||
59905039|NCT03655717|76025819|FG020|NOT COMPLETED|Overall Study||0||
59905040|NCT03655717|76025820|FG021|NOT COMPLETED|Overall Study||1||
59905041|NCT03655717|76025821|FG022|NOT COMPLETED|Overall Study||2||
59905042|NCT03655717|76025822|FG023|NOT COMPLETED|Overall Study||2||
59905043|NCT03655717|76025823|FG024|NOT COMPLETED|Overall Study||1||
59905044|NCT03655717|76025824|FG025|NOT COMPLETED|Overall Study||0||
59905045|NCT04032613|76025840|FG000|STARTED|Overall Study||21||
59905046|NCT04032613|76025841|FG001|STARTED|Overall Study||25||
59905047|NCT04032613|76025840|FG000|COMPLETED|Overall Study||16||
59905048|NCT04032613|76025841|FG001|COMPLETED|Overall Study||23||
59905049|NCT04032613|76025840|FG000|NOT COMPLETED|Overall Study||5||
59905050|NCT04032613|76025841|FG001|NOT COMPLETED|Overall Study||2||
59905051|NCT04000165|76025847|FG000|STARTED|Overall Study||17||
59905052|NCT04000165|76025847|FG000|Completed Study at 50 mg Dose|Overall Study||7||
59905053|NCT04000165|76025847|FG000|Escalated to 100 mg|Overall Study||10||
59905054|NCT04000165|76025847|FG000|COMPLETED|Overall Study||15||
59905055|NCT04000165|76025847|FG000|NOT COMPLETED|Overall Study||2||
59905056|NCT03187197|76025854|FG000|STARTED|Overall Study||153|Started are Enrolled|
59905057|NCT03187197|76025855|FG001|STARTED|Overall Study||1097|Started are Enrolled|
59905058|NCT03187197|76025856|FG002|STARTED|Overall Study||55|Started are Enrolled|
59905059|NCT03187197|76025854|FG000|Started (Eligible Participants as FAS)|Overall Study||139||
59905060|NCT03187197|76025855|FG001|Started (Eligible Participants as FAS)|Overall Study||1052||
59905061|NCT03187197|76025856|FG002|Started (Eligible Participants as FAS)|Overall Study||54||
59905062|NCT03187197|76025854|FG000|COMPLETED|Overall Study||107||
59905063|NCT03187197|76025855|FG001|COMPLETED|Overall Study||704||
59905064|NCT03187197|76025856|FG002|COMPLETED|Overall Study||32||
59905065|NCT03187197|76025854|FG000|NOT COMPLETED|Overall Study||46||
59905066|NCT03187197|76025855|FG001|NOT COMPLETED|Overall Study||393||
59905067|NCT03187197|76025856|FG002|NOT COMPLETED|Overall Study||23||
59905068|NCT04000009|76025864|FG000|STARTED|Overall Study||235||
59905069|NCT04000009|76025864|FG000|COMPLETED|Overall Study||70||
59905070|NCT04000009|76025864|FG000|NOT COMPLETED|Overall Study||165||
59905071|NCT03282240|76025871|FG000|STARTED|Overall Study||1777||
59905072|NCT03282240|76025872|FG001|STARTED|Overall Study||443||
59905073|NCT03282240|76025873|FG002|STARTED|Overall Study||450||
59905074|NCT03282240|76025871|FG000|COMPLETED|Overall Study||1767||
59905075|NCT03282240|76025872|FG001|COMPLETED|Overall Study||440||
59905076|NCT03282240|76025873|FG002|COMPLETED|Overall Study||447||
59905077|NCT03282240|76025871|FG000|NOT COMPLETED|Overall Study||10||
59905078|NCT03282240|76025872|FG001|NOT COMPLETED|Overall Study||3||
59905079|NCT03282240|76025873|FG002|NOT COMPLETED|Overall Study||3||
59905080|NCT03185949|76025886|FG000|STARTED|ITT Analysis||22|Assessed for eligibility|
59905081|NCT03185949|76025887|FG001|STARTED|ITT Analysis||22|Assessed for eligibility|
59905082|NCT03185949|76025886|FG000|COMPLETED|ITT Analysis||18||
59905083|NCT03185949|76025887|FG001|COMPLETED|ITT Analysis||19||
59905084|NCT03185949|76025886|FG000|NOT COMPLETED|ITT Analysis||4||
59905085|NCT03185949|76025887|FG001|NOT COMPLETED|ITT Analysis||3||
59905086|NCT03185949|76025886|FG000|STARTED|PP Analysis||18|All participants who were part of the ITT Population|
59905087|NCT03185949|76025887|FG001|STARTED|PP Analysis||19|All participants who were part of the ITT Population|
59905088|NCT03185949|76025886|FG000|COMPLETED|PP Analysis||16||
59905089|NCT03185949|76025887|FG001|COMPLETED|PP Analysis||15||
59905090|NCT03185949|76025886|FG000|NOT COMPLETED|PP Analysis||2||
59905091|NCT03185949|76025887|FG001|NOT COMPLETED|PP Analysis||4||
59905092|NCT03185949|76025886|FG000|STARTED|Cross-over at 6 Months||16|At 6 months, study participants were unblinded and those in the sham control group were given the option to cross over.|
59905093|NCT03185949|76025887|FG001|STARTED|Cross-over at 6 Months||0|At 6 months, study participants were unblinded and those in the sham control group were given the option to cross over.|
59905094|NCT03185949|76025886|FG000|COMPLETED|Cross-over at 6 Months||15||
59905095|NCT03185949|76025887|FG001|COMPLETED|Cross-over at 6 Months||0||
59905096|NCT03185949|76025886|FG000|NOT COMPLETED|Cross-over at 6 Months||1||
59905097|NCT03185949|76025887|FG001|NOT COMPLETED|Cross-over at 6 Months||0||
59905098|NCT03655405|76025897|FG000|STARTED|Overall Study||32||
59905099|NCT03655405|76025898|FG001|STARTED|Overall Study||30||
59905100|NCT03655405|76025897|FG000|COMPLETED|Overall Study||27||
59905101|NCT03655405|76025898|FG001|COMPLETED|Overall Study||25||
59905102|NCT03655405|76025897|FG000|NOT COMPLETED|Overall Study||5||
60014760|NCT02614183|76130889|FG001|COMPLETED|Post Treatment Follow-up Phase||179||
60014761|NCT02614183|76130890|FG002|COMPLETED|Post Treatment Follow-up Phase||171||
60014762|NCT02614183|76130888|FG000|NOT COMPLETED|Post Treatment Follow-up Phase||18||
60014763|NCT02614183|76130889|FG001|NOT COMPLETED|Post Treatment Follow-up Phase||6||
60014764|NCT02614183|76130890|FG002|NOT COMPLETED|Post Treatment Follow-up Phase||12||
60014765|NCT02352103|76130906|FG000|STARTED|Overall Study||60||
60014766|NCT02352103|76130907|FG001|STARTED|Overall Study||60||
60014767|NCT02352103|76130906|FG000|COMPLETED|Overall Study||60||
60014768|NCT02352103|76130907|FG001|COMPLETED|Overall Study||59||
60014769|NCT02352103|76130906|FG000|NOT COMPLETED|Overall Study||0||
60014770|NCT02352103|76130907|FG001|NOT COMPLETED|Overall Study||1||
60014771|NCT02612155|76130915|FG000|STARTED|Overall Study||17||
60014772|NCT02612155|76130916|FG001|STARTED|Overall Study||18||
60014773|NCT02612155|76130915|FG000|COMPLETED|Overall Study||14||
60014774|NCT02612155|76130916|FG001|COMPLETED|Overall Study||15||
60014775|NCT02612155|76130915|FG000|NOT COMPLETED|Overall Study||3||
60014776|NCT02612155|76130916|FG001|NOT COMPLETED|Overall Study||3||
60014777|NCT02614729|76130924|FG000|STARTED|Overall Study||18||
60014778|NCT02614729|76130925|FG001|STARTED|Overall Study||17||
60014779|NCT02614729|76130924|FG000|COMPLETED|Overall Study||17||
60014780|NCT02614729|76130925|FG001|COMPLETED|Overall Study||17||
60014781|NCT02614729|76130924|FG000|NOT COMPLETED|Overall Study||1||
60014782|NCT02614729|76130925|FG001|NOT COMPLETED|Overall Study||0||
60014783|NCT02613871|76130933|FG000|STARTED|Overall Study||111||
60014784|NCT02613871|76130933|FG000|COMPLETED|Overall Study||108||
60014785|NCT02613871|76130933|FG000|NOT COMPLETED|Overall Study||3||
60014786|NCT05021081|76130939|FG000|STARTED|Phase 1||0||0
59905103|NCT03655405|76025898|FG001|NOT COMPLETED|Overall Study||5||
59905104|NCT03510598|76025904|FG000|STARTED|Overall Study||16||
59905105|NCT03510598|76025904|FG000|COMPLETED|Overall Study||15||
60014787|NCT05021081|76130940|FG001|STARTED|Phase 1||0||0
60014788|NCT05021081|76130941|FG002|STARTED|Phase 1||20||40
60014789|NCT05021081|76130939|FG000|COMPLETED|Phase 1||0||0
60014790|NCT05021081|76130940|FG001|COMPLETED|Phase 1||0||0
60014791|NCT05021081|76130941|FG002|COMPLETED|Phase 1||20||40
60014792|NCT05021081|76130939|FG000|NOT COMPLETED|Phase 1||0||0
60014793|NCT05021081|76130940|FG001|NOT COMPLETED|Phase 1||0||0
60014794|NCT05021081|76130941|FG002|NOT COMPLETED|Phase 1||0||0
60014795|NCT05021081|76130939|FG000|STARTED|Phase 2||31||62
60014796|NCT05021081|76130940|FG001|STARTED|Phase 2||31||62
60014797|NCT05021081|76130941|FG002|STARTED|Phase 2||0||0
60014798|NCT05021081|76130939|FG000|COMPLETED|Phase 2||30||60
60014799|NCT05021081|76130940|FG001|COMPLETED|Phase 2||30||60
60014800|NCT05021081|76130941|FG002|COMPLETED|Phase 2||0||0
60014801|NCT05021081|76130939|FG000|NOT COMPLETED|Phase 2||1||2
60014802|NCT05021081|76130940|FG001|NOT COMPLETED|Phase 2||1||2
60014803|NCT05021081|76130941|FG002|NOT COMPLETED|Phase 2||0||0
60014804|NCT02612077|76130957|FG000|STARTED|Overall Study||765||
60014805|NCT02612077|76130957|FG000|Did Not Receive Study Product|Overall Study||5||
60014806|NCT02612077|76130957|FG000|Safety Analysis Set|Overall Study||760||
60014807|NCT02612077|76130957|FG000|Efficacy Analysis Set|Overall Study||737||
60014808|NCT02612077|76130957|FG000|COMPLETED|Overall Study||299||
60014809|NCT02612077|76130957|FG000|NOT COMPLETED|Overall Study||466||
60014810|NCT02613481|76130964|FG000|STARTED|Overall Study||50||
59905106|NCT03510598|76025904|FG000|NOT COMPLETED|Overall Study||1||
59905107|NCT03222141|76025908|FG000|STARTED|Overall Study||583||
59905108|NCT03222141|76025908|FG000|COMPLETED|Overall Study||565|30-day Follow-up|
59905109|NCT03222141|76025908|FG000|NOT COMPLETED|Overall Study||18||
59905110|NCT04029961|76025915|FG000|STARTED|Overall Study||13||
59905111|NCT04029961|76025916|FG001|STARTED|Overall Study||13||
60014811|NCT02613481|76130964|FG000|COMPLETED|Overall Study||41||
60014812|NCT02613481|76130964|FG000|NOT COMPLETED|Overall Study||9||
60014813|NCT02613403|76130972|FG000|STARTED|Overall Study||36||
60014814|NCT02613403|76130973|FG001|STARTED|Overall Study||36||
60014815|NCT02613403|76130974|FG002|STARTED|Overall Study||9||
60014816|NCT02613403|76130975|FG003|STARTED|Overall Study||13||
60014817|NCT02613403|76130976|FG004|STARTED|Overall Study|Study terminated prior to participant recruitment for study Part B.|0||
60014818|NCT02613403|76130972|FG000|Treated|Overall Study||35||
60014819|NCT02613403|76130973|FG001|Treated|Overall Study||36||
60014820|NCT02613403|76130974|FG002|Treated|Overall Study||9||
60014821|NCT02613403|76130975|FG003|Treated|Overall Study||13||
60014822|NCT02613403|76130976|FG004|Treated|Overall Study|Study terminated prior to participant recruitment for study Part B.|0||
60014823|NCT02613403|76130972|FG000|COMPLETED|Overall Study||34||
60014824|NCT02613403|76130973|FG001|COMPLETED|Overall Study||35||
60014825|NCT02613403|76130974|FG002|COMPLETED|Overall Study||9||
59905112|NCT04029961|76025915|FG000|COMPLETED|Overall Study||12||
59905113|NCT04029961|76025916|FG001|COMPLETED|Overall Study||12||
59905114|NCT04029961|76025915|FG000|NOT COMPLETED|Overall Study||1||
60014826|NCT02613403|76130975|FG003|COMPLETED|Overall Study||13||
60014827|NCT02613403|76130976|FG004|COMPLETED|Overall Study|Study terminated prior to participant recruitment for study Part B.|0||
60014828|NCT02613403|76130972|FG000|NOT COMPLETED|Overall Study||2||
60014829|NCT02613403|76130973|FG001|NOT COMPLETED|Overall Study||1||
60014830|NCT02613403|76130974|FG002|NOT COMPLETED|Overall Study||0||
60014831|NCT02613403|76130975|FG003|NOT COMPLETED|Overall Study||0||
60014832|NCT02613403|76130976|FG004|NOT COMPLETED|Overall Study||0||
60014833|NCT02572817|76130988|FG000|STARTED|Overall Study||91||
60014834|NCT02572817|76130989|FG001|STARTED|Overall Study||47||
60014835|NCT02572817|76130988|FG000|COMPLETED|Overall Study||82||
60014836|NCT02572817|76130989|FG001|COMPLETED|Overall Study||41||
60014837|NCT02572817|76130988|FG000|NOT COMPLETED|Overall Study||9||
60014838|NCT02572817|76130989|FG001|NOT COMPLETED|Overall Study||6||
60014839|NCT02566109|76130995|FG000|STARTED|Overall Study||6||
60014840|NCT02566109|76130995|FG000|COMPLETED|Overall Study||5||
60014841|NCT02566109|76130995|FG000|NOT COMPLETED|Overall Study||1||
60014842|NCT02566031|76131001|FG000|STARTED|Overall Study||189||
60014843|NCT02566031|76131002|FG001|STARTED|Overall Study||190||
60014844|NCT02566031|76131001|FG000|COMPLETED|Overall Study||169||
60014845|NCT02566031|76131002|FG001|COMPLETED|Overall Study||178||
60014846|NCT02566031|76131001|FG000|NOT COMPLETED|Overall Study||20||
60014847|NCT02566031|76131002|FG001|NOT COMPLETED|Overall Study||12||
60014848|NCT02569853|76131011|FG000|STARTED|Overall Study||131||
60014849|NCT02569853|76131012|FG001|STARTED|Overall Study||137||
60014850|NCT02569853|76131011|FG000|COMPLETED|Overall Study||111||
60014851|NCT02569853|76131012|FG001|COMPLETED|Overall Study||123||
60014852|NCT02569853|76131011|FG000|NOT COMPLETED|Overall Study||20||
59905115|NCT04029961|76025916|FG001|NOT COMPLETED|Overall Study||1||
59905116|NCT03997825|76025922|FG000|STARTED|Overall Study||117||
59905117|NCT03997825|76025922|FG000|COMPLETED|Overall Study||100||
59905118|NCT03997825|76025922|FG000|NOT COMPLETED|Overall Study||17||
59905119|NCT04024891|76025928|FG000|STARTED|Overall Study||16||
59905120|NCT04024891|76025929|FG001|STARTED|Overall Study||16||
59905121|NCT04024891|76025928|FG000|COMPLETED|Overall Study||16||
59905122|NCT04024891|76025929|FG001|COMPLETED|Overall Study||15||
60014853|NCT02569853|76131012|FG001|NOT COMPLETED|Overall Study||14||
60014854|NCT02570711|76131022|FG000|STARTED|Overall Study||1||
60014855|NCT02570711|76131023|FG001|STARTED|Overall Study||2||
60014856|NCT02570711|76131022|FG000|COMPLETED|Overall Study||0||
60014857|NCT02570711|76131023|FG001|COMPLETED|Overall Study||0||
60014858|NCT02570711|76131022|FG000|NOT COMPLETED|Overall Study||1||
60014859|NCT02570711|76131023|FG001|NOT COMPLETED|Overall Study||2||
60014860|NCT02570165|76131036|FG000|STARTED|Overall Study||46||
60014861|NCT02570165|76131037|FG001|STARTED|Overall Study||46||
60014862|NCT02570165|76131038|FG002|STARTED|Overall Study||46||
60014863|NCT02570165|76131039|FG003|STARTED|Overall Study||45||
60014864|NCT02570165|76131040|FG004|STARTED|Overall Study||47||
60014865|NCT02570165|76131041|FG005|STARTED|Overall Study||46||
60014866|NCT02570165|76131042|FG006|STARTED|Overall Study||47||
60014867|NCT02570165|76131036|FG000|COMPLETED|Overall Study||44||
60014868|NCT02570165|76131037|FG001|COMPLETED|Overall Study||43||
60014869|NCT02570165|76131038|FG002|COMPLETED|Overall Study||41||
60014870|NCT02570165|76131039|FG003|COMPLETED|Overall Study||40||
60014871|NCT02570165|76131040|FG004|COMPLETED|Overall Study||41||
60014872|NCT02570165|76131041|FG005|COMPLETED|Overall Study||44||
60014873|NCT02570165|76131042|FG006|COMPLETED|Overall Study||47||
60014874|NCT02570165|76131036|FG000|NOT COMPLETED|Overall Study||2||
60014875|NCT02570165|76131037|FG001|NOT COMPLETED|Overall Study||3||
60014876|NCT02570165|76131038|FG002|NOT COMPLETED|Overall Study||5||
59757812|NCT02975349|75876974|FG001|NOT COMPLETED|Active Treatment Period (24 Weeks)||0||
59757813|NCT02975349|75876975|FG002|NOT COMPLETED|Active Treatment Period (24 Weeks)||5||
59757814|NCT02975349|75876976|FG003|NOT COMPLETED|Active Treatment Period (24 Weeks)||5||
60014877|NCT02570165|76131039|FG003|NOT COMPLETED|Overall Study||5||
60014878|NCT02570165|76131040|FG004|NOT COMPLETED|Overall Study||6||
59757815|NCT02975349|75876977|FG004|NOT COMPLETED|Active Treatment Period (24 Weeks)||6||
59757816|NCT02975349|75876978|FG005|NOT COMPLETED|Active Treatment Period (24 Weeks)||2||
59905123|NCT04024891|76025928|FG000|NOT COMPLETED|Overall Study||0||
59905124|NCT04024891|76025929|FG001|NOT COMPLETED|Overall Study||1||
59905125|NCT03250182|76025935|FG000|STARTED|Overall Study||30||
59905126|NCT03250182|76025935|FG000|COMPLETED|Overall Study||29||
60014879|NCT02570165|76131041|FG005|NOT COMPLETED|Overall Study||2||
59905127|NCT03250182|76025935|FG000|NOT COMPLETED|Overall Study||1||
60014880|NCT02570165|76131042|FG006|NOT COMPLETED|Overall Study||0||
60014881|NCT02564471|76131062|FG000|STARTED|Overall Study||25||
60014882|NCT02564471|76131063|FG001|STARTED|Overall Study||26||
60014883|NCT02564471|76131064|FG002|STARTED|Overall Study||27||
60014884|NCT02564471|76131065|FG003|STARTED|Overall Study||25||
60014885|NCT02564471|76131062|FG000|COMPLETED|Overall Study||22||
59905128|NCT03993379|76025943|FG000|STARTED|Overall Study||0||
59905129|NCT03993379|76025944|FG001|STARTED|Overall Study||3||
59905130|NCT03993379|76025945|FG002|STARTED|Overall Study||0||
59905131|NCT03993379|76025946|FG003|STARTED|Overall Study||0||
59905132|NCT03993379|76025943|FG000|COMPLETED|Overall Study|No subjects enrolled in this arm/group.|0||
59905133|NCT03993379|76025944|FG001|COMPLETED|Overall Study|Subjects did not complete due to early termination of the study due to business reasons.|0||
59905134|NCT03993379|76025945|FG002|COMPLETED|Overall Study|No subjects enrolled in this arm/group.|0||
59905135|NCT03993379|76025946|FG003|COMPLETED|Overall Study|No subjects enrolled in this arm/group.|0||
59905136|NCT03993379|76025943|FG000|NOT COMPLETED|Overall Study||0||
59905137|NCT03993379|76025944|FG001|NOT COMPLETED|Overall Study||3||
59905138|NCT03993379|76025945|FG002|NOT COMPLETED|Overall Study||0||
59905139|NCT03993379|76025946|FG003|NOT COMPLETED|Overall Study||0||
59905140|NCT03370120|76025956|FG000|STARTED|Overall Study||406||
59905141|NCT03370120|76025956|FG000|COMPLETED|Overall Study||0||
59905142|NCT03370120|76025956|FG000|NOT COMPLETED|Overall Study||406||
59905143|NCT03247686|76025964|FG000|STARTED|Overall Study||8||
59905144|NCT03247686|76025965|FG001|STARTED|Overall Study||20||
59905145|NCT03247686|76025964|FG000|COMPLETED|Overall Study||7||
59905146|NCT03247686|76025965|FG001|COMPLETED|Overall Study||18||
59905147|NCT03247686|76025964|FG000|NOT COMPLETED|Overall Study||1||
59905148|NCT03247686|76025965|FG001|NOT COMPLETED|Overall Study||2||
59905149|NCT03990649|76025976|FG000|STARTED|Part A: DB Treatment Period (15 Weeks)||9||
59905150|NCT03990649|76025977|FG001|STARTED|Part A: DB Treatment Period (15 Weeks)||15||
59905151|NCT03990649|76025978|FG002|STARTED|Part A: DB Treatment Period (15 Weeks)||0||
59905152|NCT03990649|76025976|FG000|COMPLETED|Part A: DB Treatment Period (15 Weeks)||6||
59905153|NCT03990649|76025977|FG001|COMPLETED|Part A: DB Treatment Period (15 Weeks)||12||
59905154|NCT03990649|76025978|FG002|COMPLETED|Part A: DB Treatment Period (15 Weeks)||0||
59905155|NCT03990649|76025976|FG000|NOT COMPLETED|Part A: DB Treatment Period (15 Weeks)||3||
59905156|NCT03990649|76025977|FG001|NOT COMPLETED|Part A: DB Treatment Period (15 Weeks)||3||
59905157|NCT03990649|76025978|FG002|NOT COMPLETED|Part A: DB Treatment Period (15 Weeks)||0||
59905158|NCT03990649|76025976|FG000|STARTED|Part B: OL Extension Period (14 Weeks)||0||
59905159|NCT03990649|76025977|FG001|STARTED|Part B: OL Extension Period (14 Weeks)||0||
59905160|NCT03990649|76025978|FG002|STARTED|Part B: OL Extension Period (14 Weeks)||18||
59905161|NCT03990649|76025976|FG000|COMPLETED|Part B: OL Extension Period (14 Weeks)||0||
59905162|NCT03990649|76025977|FG001|COMPLETED|Part B: OL Extension Period (14 Weeks)||0||
59905163|NCT03990649|76025978|FG002|COMPLETED|Part B: OL Extension Period (14 Weeks)||14||
59905164|NCT03990649|76025976|FG000|NOT COMPLETED|Part B: OL Extension Period (14 Weeks)||0||
59905165|NCT03990649|76025977|FG001|NOT COMPLETED|Part B: OL Extension Period (14 Weeks)||0||
59905166|NCT03990649|76025978|FG002|NOT COMPLETED|Part B: OL Extension Period (14 Weeks)||4||
59905167|NCT03185481|76025985|FG000|STARTED|Overall Study||5||
59905168|NCT03185481|76025985|FG000|COMPLETED|Overall Study||0||
59905169|NCT03185481|76025985|FG000|NOT COMPLETED|Overall Study||5||
59905170|NCT03652675|76025991|FG000|STARTED|Overall Study||16||
59905171|NCT03652675|76025992|FG001|STARTED|Overall Study||15||
59905172|NCT03652675|76025991|FG000|COMPLETED|Overall Study||12||
59905173|NCT03652675|76025992|FG001|COMPLETED|Overall Study||11||
59905174|NCT03652675|76025991|FG000|NOT COMPLETED|Overall Study||4||
59905175|NCT03652675|76025992|FG001|NOT COMPLETED|Overall Study||4||
59905176|NCT03241368|76025998|FG000|STARTED|Overall Study||158||
59905177|NCT03241368|76025998|FG000|COMPLETED|Overall Study||119||
59905178|NCT03241368|76025998|FG000|NOT COMPLETED|Overall Study||39||
59905179|NCT03220581|76026005|FG000|STARTED|Overall Study||28||
59905180|NCT03220581|76026006|FG001|STARTED|Overall Study||32||
59905181|NCT03220581|76026005|FG000|COMPLETED|Overall Study||25||
59905182|NCT03220581|76026006|FG001|COMPLETED|Overall Study||25||
59905183|NCT03220581|76026005|FG000|NOT COMPLETED|Overall Study||3||
59905184|NCT03220581|76026006|FG001|NOT COMPLETED|Overall Study||7||
59905185|NCT02954575|76026014|FG000|STARTED|Overall Study||57||
59905186|NCT02954575|76026014|FG000|Received Treatment|Overall Study||55||
59905187|NCT02954575|76026014|FG000|SAF Population|Overall Study||55|SAF population = study population of patients in safety analysis|
59905188|NCT02954575|76026014|FG000|FAS Population|Overall Study||55|FAS population = full analysis population|
59905189|NCT02954575|76026014|FG000|PP Population|Overall Study||52|PP population = per-protocol population|
59905190|NCT02954575|76026014|FG000|PK Population|Overall Study||21|PK population = study population of patients who underwent pharmacokinetic analysis|
59951149|NCT04007367|76070075|FG001|COMPLETED|Double-Blind Phase (14-Weeks)||0||
59951150|NCT04007367|76070076|FG002|COMPLETED|Double-Blind Phase (14-Weeks)||0||
59905191|NCT02954575|76026014|FG000|SURG Population|Overall Study||1|SURG population = study population of patients undergoing surgery treated with Wilate|
59905192|NCT02954575|76026014|FG000|COMPLETED|Overall Study||54||
59905193|NCT02954575|76026014|FG000|NOT COMPLETED|Overall Study||3||
59905194|NCT03184701|76026022|FG000|STARTED|Overall Study||45||
59905195|NCT03184701|76026022|FG000|COMPLETED|Overall Study||28||
59905196|NCT03184701|76026022|FG000|NOT COMPLETED|Overall Study||17||
59905197|NCT03247530|76026029|FG000|STARTED|Overall Study||159|Number of subjects is based on the Safety Population (defined as subjects who were randomized and took at least one dose of study medication)|
59905198|NCT03247530|76026030|FG001|STARTED|Overall Study||154|Number of subjects is based on the Safety Population (defined as subjects who were randomized and took at least one dose of study medication)|
59905199|NCT03247530|76026031|FG002|STARTED|Overall Study||161|Number of subjects is based on the Safety Population (defined as subjects who were randomized and took at least one dose of study medication)|
59905200|NCT03247530|76026029|FG000|COMPLETED|Overall Study||132||
59905201|NCT03247530|76026030|FG001|COMPLETED|Overall Study||126||
59905202|NCT03247530|76026031|FG002|COMPLETED|Overall Study||141||
59905203|NCT03247530|76026029|FG000|NOT COMPLETED|Overall Study||27||
59905204|NCT03247530|76026030|FG001|NOT COMPLETED|Overall Study||28||
59905205|NCT03247530|76026031|FG002|NOT COMPLETED|Overall Study||20||
60014886|NCT02564471|76131063|FG001|COMPLETED|Overall Study||23||
60014887|NCT02564471|76131064|FG002|COMPLETED|Overall Study||24||
60014888|NCT02564471|76131065|FG003|COMPLETED|Overall Study||25||
60014889|NCT02564471|76131062|FG000|NOT COMPLETED|Overall Study||3||
60014890|NCT02564471|76131063|FG001|NOT COMPLETED|Overall Study||3||
60014891|NCT02564471|76131064|FG002|NOT COMPLETED|Overall Study||3||
59905206|NCT03246672|76026042|FG000|STARTED|Overall Study||30||
59905207|NCT03246672|76026042|FG000|Completed First Phone Call|Overall Study||29||
59905208|NCT03246672|76026042|FG000|COMPLETED|Overall Study||28||
60014892|NCT02564471|76131065|FG003|NOT COMPLETED|Overall Study||0||
60014893|NCT02563067|76131078|FG000|STARTED|Overall Study||296||
60014894|NCT02563067|76131079|FG001|STARTED|Overall Study||294||
59905209|NCT03246672|76026042|FG000|NOT COMPLETED|Overall Study||2||
59905210|NCT03983317|76026046|FG000|STARTED|Overall Study||25||
59905211|NCT03983317|76026046|FG000|COMPLETED|Overall Study||20||
59905212|NCT03983317|76026046|FG000|NOT COMPLETED|Overall Study||5||
59905213|NCT03207243|76026052|FG000|STARTED|Overall Study||82||
59905214|NCT03207243|76026053|FG001|STARTED|Overall Study||83||
59905215|NCT03207243|76026052|FG000|COMPLETED|Overall Study||23||
59905216|NCT03207243|76026053|FG001|COMPLETED|Overall Study||39||
59905217|NCT03207243|76026052|FG000|NOT COMPLETED|Overall Study||59||
59905218|NCT03207243|76026053|FG001|NOT COMPLETED|Overall Study||44||
60014895|NCT02563067|76131080|FG002|STARTED|Overall Study||287||
60014896|NCT02563067|76131078|FG000|FAS/SAF: High Eosinophils Subpopulation|Overall Study||198|Full analysis set/safety set. All patients who received study drug and had high eosinophils count|
60014897|NCT02563067|76131079|FG001|FAS/SAF: High Eosinophils Subpopulation|Overall Study||196|Full analysis set/safety set. All patients who received study drug and had high eosinophils count|
60014898|NCT02563067|76131080|FG002|FAS/SAF: High Eosinophils Subpopulation|Overall Study||193|Full analysis set/safety set. All patients who received study drug and had high eosinophils count|
60014899|NCT02563067|76131078|FG000|FAS/SAF: Overall Population|Overall Study||296|Full analysis set/safety set. All patients who received study drug|
60014900|NCT02563067|76131079|FG001|FAS/SAF: Overall Population|Overall Study||293|Full analysis set/safety set. All patients who received study drug|
60014901|NCT02563067|76131080|FG002|FAS/SAF: Overall Population|Overall Study||287|Full analysis set/safety set. All patients who received study drug|
60014902|NCT02563067|76131078|FG000|COMPLETED|Overall Study||277||
60014903|NCT02563067|76131079|FG001|COMPLETED|Overall Study||268||
60014904|NCT02563067|76131080|FG002|COMPLETED|Overall Study||267||
60014905|NCT02563067|76131078|FG000|NOT COMPLETED|Overall Study||19||
60014906|NCT02563067|76131079|FG001|NOT COMPLETED|Overall Study||26||
60014907|NCT02563067|76131080|FG002|NOT COMPLETED|Overall Study||20||
60014908|NCT02568683|76131090|FG000|STARTED|Overall Study||6||
60014909|NCT02568683|76131091|FG001|STARTED|Overall Study||4||
60014910|NCT02568683|76131090|FG000|COMPLETED|Overall Study||0||
60014911|NCT02568683|76131091|FG001|COMPLETED|Overall Study||0||
60014912|NCT02568683|76131090|FG000|NOT COMPLETED|Overall Study||6||
60014913|NCT02568683|76131091|FG001|NOT COMPLETED|Overall Study||4||
59905219|NCT03982069|76026064|FG000|STARTED|Overall Study||108||
60014914|NCT02563925|76131097|FG000|STARTED|Overall Study||28||
60014915|NCT02563925|76131097|FG000|COMPLETED|Overall Study||26||
60014916|NCT02563925|76131097|FG000|NOT COMPLETED|Overall Study||2||
60014917|NCT01663727|76131104|FG000|STARTED|Overall Study||242||
60014918|NCT01663727|76131105|FG001|STARTED|Overall Study||239||
60014919|NCT01663727|76131104|FG000|COMPLETED|Overall Study||0||
60014920|NCT01663727|76131105|FG001|COMPLETED|Overall Study||1||
60014921|NCT01663727|76131104|FG000|NOT COMPLETED|Overall Study||242||
60014922|NCT01663727|76131105|FG001|NOT COMPLETED|Overall Study||238||
60014923|NCT02614261|76131114|FG000|STARTED|Double-Blind Treatment Phase||559||
60014924|NCT02614261|76131115|FG001|STARTED|Double-Blind Treatment Phase||279||
60014925|NCT02614261|76131116|FG002|STARTED|Double-Blind Treatment Phase||279||
59905220|NCT03982069|76026065|FG001|STARTED|Overall Study||110||
59905221|NCT03982069|76026066|FG002|STARTED|Overall Study||127||
60014926|NCT02614261|76131117|FG003|STARTED|Double-Blind Treatment Phase||0||
59905222|NCT03982069|76026067|FG003|STARTED|Overall Study||120||
60014927|NCT02614261|76131114|FG000|Received at Least One Dose of Study Drug|Double-Blind Treatment Phase||558||
60014928|NCT02614261|76131115|FG001|Received at Least One Dose of Study Drug|Double-Blind Treatment Phase||278||
59905223|NCT03982069|76026064|FG000|COMPLETED|Overall Study||98||
59905224|NCT03982069|76026065|FG001|COMPLETED|Overall Study||100||
59905225|NCT03982069|76026066|FG002|COMPLETED|Overall Study||118||
59905226|NCT03982069|76026067|FG003|COMPLETED|Overall Study||112||
59905227|NCT03982069|76026064|FG000|NOT COMPLETED|Overall Study||10||
59905228|NCT03982069|76026065|FG001|NOT COMPLETED|Overall Study||10||
60014929|NCT02614261|76131116|FG002|Received at Least One Dose of Study Drug|Double-Blind Treatment Phase||277||
60014930|NCT02614261|76131117|FG003|Received at Least One Dose of Study Drug|Double-Blind Treatment Phase||0||
60014931|NCT02614261|76131114|FG000|Safety Population|Double-Blind Treatment Phase||558||
60014932|NCT02614261|76131115|FG001|Safety Population|Double-Blind Treatment Phase|5 participants discontinued after receiving loading dose of 240mg. They were included under 240mg arm for safety analysis.|273||
60014933|NCT02614261|76131116|FG002|Safety Population|Double-Blind Treatment Phase||282||
60014934|NCT02614261|76131117|FG003|Safety Population|Double-Blind Treatment Phase||0||
60014935|NCT02614261|76131114|FG000|COMPLETED|Double-Blind Treatment Phase||509||
60014936|NCT02614261|76131115|FG001|COMPLETED|Double-Blind Treatment Phase||262||
60014937|NCT02614261|76131116|FG002|COMPLETED|Double-Blind Treatment Phase||266||
60014938|NCT02614261|76131117|FG003|COMPLETED|Double-Blind Treatment Phase||0||
60014939|NCT02614261|76131114|FG000|NOT COMPLETED|Double-Blind Treatment Phase||50||
60014940|NCT02614261|76131115|FG001|NOT COMPLETED|Double-Blind Treatment Phase||17||
60014941|NCT02614261|76131116|FG002|NOT COMPLETED|Double-Blind Treatment Phase||13||
60014942|NCT02614261|76131117|FG003|NOT COMPLETED|Double-Blind Treatment Phase||0||
60014943|NCT02614261|76131114|FG000|STARTED|Open-Label Extension Phase|Participants from double-blind treatment phase had the option to enter the open-label extension phase or proceed directly to the follow-up phase.|501||
60014944|NCT02614261|76131115|FG001|STARTED|Open-Label Extension Phase|Participants from double-blind treatment phase had the option to enter the open-label extension phase or proceed directly to the follow-up phase.|259||
60014945|NCT02614261|76131116|FG002|STARTED|Open-Label Extension Phase|Participants from double-blind treatment phase had the option to enter the open-label extension phase or proceed directly to the follow-up phase.|262||
60014946|NCT02614261|76131117|FG003|STARTED|Open-Label Extension Phase||0||
60014947|NCT02614261|76131114|FG000|Safety Population|Open-Label Extension Phase||501||
60014948|NCT02614261|76131115|FG001|Safety Population|Open-Label Extension Phase||259||
60014949|NCT02614261|76131116|FG002|Safety Population|Open-Label Extension Phase||262||
60014950|NCT02614261|76131117|FG003|Safety Population|Open-Label Extension Phase||0||
60014951|NCT02614261|76131114|FG000|COMPLETED|Open-Label Extension Phase||413||
60014952|NCT02614261|76131115|FG001|COMPLETED|Open-Label Extension Phase||204||
60014953|NCT02614261|76131116|FG002|COMPLETED|Open-Label Extension Phase||208||
60014954|NCT02614261|76131117|FG003|COMPLETED|Open-Label Extension Phase||0||
60014955|NCT02614261|76131114|FG000|NOT COMPLETED|Open-Label Extension Phase||88||
60014956|NCT02614261|76131115|FG001|NOT COMPLETED|Open-Label Extension Phase||55||
60014957|NCT02614261|76131116|FG002|NOT COMPLETED|Open-Label Extension Phase||54||
60014958|NCT02614261|76131117|FG003|NOT COMPLETED|Open-Label Extension Phase||0||
60014959|NCT02614261|76131114|FG000|STARTED|Follow-up Phase|Participants from double-blind treatment or open-label extension phases entered the follow-up phase.|453||
60014960|NCT02614261|76131115|FG001|STARTED|Follow-up Phase|Participants from double-blind treatment or open-label extension phases entered the follow-up phase.|228||
60014961|NCT02614261|76131116|FG002|STARTED|Follow-up Phase|Participants from double-blind treatment or open-label extension phases entered the follow-up phase.|231||
59905229|NCT03982069|76026066|FG002|NOT COMPLETED|Overall Study||9||
59905230|NCT03982069|76026067|FG003|NOT COMPLETED|Overall Study||8||
59905231|NCT02937870|76026075|FG000|STARTED|Overall Study||23||
60014962|NCT02614261|76131117|FG003|STARTED|Follow-up Phase||0||
60014963|NCT02614261|76131114|FG000|Entered From Double-blind Treatment Phase|Follow-up Phase||15||
60067719|NCT01617187|76182893|FG002|STARTED|Treatment Through Study Completion|Treated|46||
60067720|NCT01617187|76182894|FG003|STARTED|Treatment Through Study Completion|Treated|101||
60067721|NCT01617187|76182891|FG000|COMPLETED|Treatment Through Study Completion|Excludes the participant who did not receive study drug but completed study in database|86||
59905232|NCT02937870|76026075|FG000|Received Test Adhesive 1|Overall Study||21||
59905233|NCT02937870|76026075|FG000|Received Test Adhesive 2|Overall Study||22||
59905234|NCT02937870|76026075|FG000|Received Positive Control Adhesive|Overall Study||21||
59905235|NCT02937870|76026075|FG000|Received no Adhesive|Overall Study||20||
59905236|NCT02937870|76026075|FG000|COMPLETED|Overall Study||20||
59905237|NCT02937870|76026075|FG000|NOT COMPLETED|Overall Study||3||
59905238|NCT03629041|76026089|FG000|STARTED|Visit 1||4||
59905239|NCT03629041|76026090|FG001|STARTED|Visit 1||4||
59905240|NCT03629041|76026091|FG002|STARTED|Visit 1||4||
59905241|NCT03629041|76026092|FG003|STARTED|Visit 1||4||
59905242|NCT03629041|76026089|FG000|COMPLETED|Visit 1||4||
59905243|NCT03629041|76026090|FG001|COMPLETED|Visit 1||4||
59905244|NCT03629041|76026091|FG002|COMPLETED|Visit 1||4||
59905245|NCT03629041|76026092|FG003|COMPLETED|Visit 1||4||
59905246|NCT03629041|76026089|FG000|NOT COMPLETED|Visit 1||0||
59905247|NCT03629041|76026090|FG001|NOT COMPLETED|Visit 1||0||
60014964|NCT02614261|76131115|FG001|Entered From Double-blind Treatment Phase|Follow-up Phase|1 among these participants discontinued from double-blind treatment phase after receiving 240mg loading dose and entered Follow-up phase.|5||
60014965|NCT02614261|76131116|FG002|Entered From Double-blind Treatment Phase|Follow-up Phase||3||
60014966|NCT02614261|76131117|FG003|Entered From Double-blind Treatment Phase|Follow-up Phase||0||
60014967|NCT02614261|76131114|FG000|Safety Population (Entered From Double-blind Treatment Phase)|Follow-up Phase||15||
60014968|NCT02614261|76131115|FG001|Safety Population (Entered From Double-blind Treatment Phase)|Follow-up Phase|1 participant who discontinued from double-blind treatment phase after receiving 240mg loading dose and entered Follow-up phase was included under 240mg arm for safety analysis.|4||
60014969|NCT02614261|76131116|FG002|Safety Population (Entered From Double-blind Treatment Phase)|Follow-up Phase||4||
60014970|NCT02614261|76131117|FG003|Safety Population (Entered From Double-blind Treatment Phase)|Follow-up Phase||0||
60014971|NCT02614261|76131114|FG000|Entered From Open-label Extension Phase|Follow-up Phase||438||
60014972|NCT02614261|76131115|FG001|Entered From Open-label Extension Phase|Follow-up Phase||223||
60014973|NCT02614261|76131116|FG002|Entered From Open-label Extension Phase|Follow-up Phase||228||
60014974|NCT02614261|76131117|FG003|Entered From Open-label Extension Phase|Follow-up Phase||0||
60014975|NCT02614261|76131114|FG000|Safety Population (Entered From Open-label Extension Phase)|Follow-up Phase||438||
60014976|NCT02614261|76131115|FG001|Safety Population (Entered From Open-label Extension Phase)|Follow-up Phase||223||
60014977|NCT02614261|76131116|FG002|Safety Population (Entered From Open-label Extension Phase)|Follow-up Phase||228||
59905248|NCT03629041|76026091|FG002|NOT COMPLETED|Visit 1||0||
59905249|NCT03629041|76026092|FG003|NOT COMPLETED|Visit 1||0||
59905250|NCT03629041|76026089|FG000|STARTED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4||
59905251|NCT03629041|76026090|FG001|STARTED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4||
59905252|NCT03629041|76026091|FG002|STARTED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4||
59905253|NCT03629041|76026092|FG003|STARTED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4||
59905254|NCT03629041|76026089|FG000|COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4||
59905255|NCT03629041|76026090|FG001|COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||3||
59905256|NCT03629041|76026091|FG002|COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4||
60014978|NCT02614261|76131117|FG003|Safety Population (Entered From Open-label Extension Phase)|Follow-up Phase||0||
60014979|NCT02614261|76131114|FG000|COMPLETED|Follow-up Phase||421||
60014980|NCT02614261|76131115|FG001|COMPLETED|Follow-up Phase||217||
60014981|NCT02614261|76131116|FG002|COMPLETED|Follow-up Phase||217||
60014982|NCT02614261|76131117|FG003|COMPLETED|Follow-up Phase||0||
60014983|NCT02614261|76131114|FG000|NOT COMPLETED|Follow-up Phase||32||
59905257|NCT03629041|76026092|FG003|COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4||
59905258|NCT03629041|76026089|FG000|NOT COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||0||
59905259|NCT03629041|76026090|FG001|NOT COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||1||
59905260|NCT03629041|76026091|FG002|NOT COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||0||
59905261|NCT03629041|76026092|FG003|NOT COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||0||
59905262|NCT03219723|76026110|FG000|STARTED|Overall Study||560||
59905263|NCT03219723|76026110|FG000|COMPLETED|Overall Study||550||
59905264|NCT03219723|76026110|FG000|NOT COMPLETED|Overall Study||10||
59905265|NCT03628417|76026114|FG000|STARTED|Overall Study||7|If the patient has more than six metastases, then one to four metastases were used for biopsy.|24
59905266|NCT03628417|76026115|FG001|STARTED|Overall Study||7|If the patient has more than six metastases, then one to four metastases were used for biopsy.|20
59905267|NCT03628417|76026114|FG000|Day 0|Overall Study||7|The treatment of the previously removed metastases (before and after treatment) were known.|21
59905268|NCT03628417|76026115|FG001|Day 0|Overall Study||7|The treatment of the previously removed metastases (before and after treatment) were known.|17
59905269|NCT03628417|76026114|FG000|Day 7|Overall Study||7||18
59905270|NCT03628417|76026115|FG001|Day 7|Overall Study||7||15
59905271|NCT03628417|76026114|FG000|Day 15|Overall Study||7||18
59905272|NCT03628417|76026115|FG001|Day 15|Overall Study||7||15
59905273|NCT03628417|76026114|FG000|Day 30|Overall Study||7||18
59905274|NCT03628417|76026115|FG001|Day 30|Overall Study||7||15
59905275|NCT03628417|76026114|FG000|Day 60|Overall Study||7||18
59905276|NCT03628417|76026115|FG001|Day 60|Overall Study||7||15
59905277|NCT03628417|76026114|FG000|Day 90|Overall Study||7||18
59905278|NCT03628417|76026115|FG001|Day 90|Overall Study||7||15
59905279|NCT03628417|76026114|FG000|Day 180|Overall Study||7|The randomization code was revealed for each patient. Biopsies were taken from both arms.|12
59905280|NCT03628417|76026115|FG001|Day 180|Overall Study||7|The randomization code was revealed for each patient. Biopsies were taken from both arms.|9
60014984|NCT02614261|76131115|FG001|NOT COMPLETED|Follow-up Phase||11||
60014985|NCT02614261|76131116|FG002|NOT COMPLETED|Follow-up Phase||14||
60014986|NCT02614261|76131117|FG003|NOT COMPLETED|Follow-up Phase||0||
60014987|NCT02614261|76131114|FG000|STARTED|Israel Addendum|Main study arm.|0||
60014988|NCT02614261|76131115|FG001|STARTED|Israel Addendum|Main study arm.|0||
60014989|NCT02614261|76131116|FG002|STARTED|Israel Addendum|Main study arm.|0||
60014990|NCT02614261|76131117|FG003|STARTED|Israel Addendum|Eligible participants from main study enrolled in Israel addendum.|29||
60014991|NCT02614261|76131114|FG000|Safety Population|Israel Addendum||0||
60014992|NCT02614261|76131115|FG001|Safety Population|Israel Addendum||0||
60014993|NCT02614261|76131116|FG002|Safety Population|Israel Addendum||0||
60014994|NCT02614261|76131117|FG003|Safety Population|Israel Addendum||29||
60014995|NCT02614261|76131114|FG000|COMPLETED|Israel Addendum||0||
60014996|NCT02614261|76131115|FG001|COMPLETED|Israel Addendum||0||
60014997|NCT02614261|76131116|FG002|COMPLETED|Israel Addendum||0||
60014998|NCT02614261|76131117|FG003|COMPLETED|Israel Addendum||25||
60014999|NCT02614261|76131114|FG000|NOT COMPLETED|Israel Addendum||0||
60015000|NCT02614261|76131115|FG001|NOT COMPLETED|Israel Addendum||0||
60015001|NCT02614261|76131116|FG002|NOT COMPLETED|Israel Addendum||0||
60015002|NCT02614261|76131117|FG003|NOT COMPLETED|Israel Addendum||4||
60015003|NCT01594411|76131143|FG000|STARTED|Overall Study||251||
60015004|NCT01594411|76131143|FG000|COMPLETED|Overall Study||249||
60015005|NCT01594411|76131143|FG000|NOT COMPLETED|Overall Study||2||
60015006|NCT01594333|76131152|FG000|STARTED|Overall Study||2391||
60015007|NCT01594333|76131153|FG001|STARTED|Overall Study||2395||
59905281|NCT03628417|76026114|FG000|COMPLETED|Overall Study|One patient died and 3 more Ca electroporated lesions were removed before the one-year closing visit|6|The patients were followed a year after treatment.|7
59905282|NCT03628417|76026115|FG001|COMPLETED|Overall Study|One patient died before the one-year closing visit,this is why decreased the number of metastases|6|The patients were followed a year after treatment.|7
59905283|NCT03628417|76026114|FG000|NOT COMPLETED|Overall Study||1||17
59905284|NCT03628417|76026115|FG001|NOT COMPLETED|Overall Study||1||13
59905285|NCT03184077|76026127|FG000|STARTED|Overall Study||166||
59905286|NCT03184077|76026128|FG001|STARTED|Overall Study||152||
59905287|NCT03184077|76026127|FG000|COMPLETED|Overall Study||145||
59905288|NCT03184077|76026128|FG001|COMPLETED|Overall Study||131||
59905289|NCT03184077|76026127|FG000|NOT COMPLETED|Overall Study||21||
59905290|NCT03184077|76026128|FG001|NOT COMPLETED|Overall Study||21||
59905291|NCT03245736|76026134|FG000|STARTED|Overall Study||5||
59905292|NCT03245736|76026134|FG000|COMPLETED|Overall Study||0||
59905293|NCT03245736|76026134|FG000|NOT COMPLETED|Overall Study||5||
59905294|NCT02954887|76026138|FG000|STARTED|Overall Study||9||
59905295|NCT02954887|76026138|FG000|COMPLETED|Overall Study||2||
59905296|NCT02954887|76026138|FG000|NOT COMPLETED|Overall Study||7||
59905297|NCT03183063|76026145|FG000|STARTED|Overall Study||20||
59905298|NCT03183063|76026146|FG001|STARTED|Overall Study||4||
59905299|NCT03183063|76026147|FG002|STARTED|Overall Study||115||
59905300|NCT03183063|76026145|FG000|COMPLETED|Overall Study||15||
59905301|NCT03183063|76026146|FG001|COMPLETED|Overall Study||0||
59905302|NCT03183063|76026147|FG002|COMPLETED|Overall Study||111||
59905303|NCT03183063|76026145|FG000|NOT COMPLETED|Overall Study||5||
59905304|NCT03183063|76026146|FG001|NOT COMPLETED|Overall Study||4||
59905305|NCT03183063|76026147|FG002|NOT COMPLETED|Overall Study||4||
59905306|NCT03182829|76026163|FG000|STARTED|Overall Study||467||
59905307|NCT03182829|76026164|FG001|STARTED|Overall Study||444||
59905308|NCT03182829|76026163|FG000|COMPLETED|Overall Study||451||
59905309|NCT03182829|76026164|FG001|COMPLETED|Overall Study||429||
59905310|NCT03182829|76026163|FG000|NOT COMPLETED|Overall Study||16||
59905311|NCT03182829|76026164|FG001|NOT COMPLETED|Overall Study||15||
59905312|NCT03278028|76026172|FG000|STARTED|Overall Study||81||
59905313|NCT03278028|76026173|FG001|STARTED|Overall Study||78||
59905314|NCT03278028|76026172|FG000|COMPLETED|Overall Study||77||
59905315|NCT03278028|76026173|FG001|COMPLETED|Overall Study||76||
59905316|NCT03278028|76026172|FG000|NOT COMPLETED|Overall Study||4||
59905317|NCT03278028|76026173|FG001|NOT COMPLETED|Overall Study||2||
60015008|NCT01594333|76131152|FG000|COMPLETED|Overall Study||2230||
60015009|NCT01594333|76131153|FG001|COMPLETED|Overall Study||2244||
60015010|NCT01594333|76131152|FG000|NOT COMPLETED|Overall Study||161||
60015011|NCT01594333|76131153|FG001|NOT COMPLETED|Overall Study||151||
60015012|NCT02609659|76131159|FG000|STARTED|Overall Study||105||
60015013|NCT02609659|76131159|FG000|COMPLETED|Overall Study||97||
60015014|NCT02609659|76131159|FG000|NOT COMPLETED|Overall Study||8||
60015015|NCT02612779|76131165|FG000|STARTED|Overall Study||68||
60015016|NCT02612779|76131166|FG001|STARTED|Overall Study||6||
60015017|NCT02612779|76131165|FG000|COMPLETED|Overall Study||0||
59905318|NCT03181503|76026181|FG000|STARTED|Overall Study||36||
59905319|NCT03181503|76026182|FG001|STARTED|Overall Study||34||
59905320|NCT03181503|76026181|FG000|Treated|Overall Study||36||
59905321|NCT03181503|76026182|FG001|Treated|Overall Study||34||
59905322|NCT03181503|76026181|FG000|COMPLETED|Overall Study||29||
59905323|NCT03181503|76026182|FG001|COMPLETED|Overall Study||31||
59905324|NCT03181503|76026181|FG000|NOT COMPLETED|Overall Study||7||
59905325|NCT03181503|76026182|FG001|NOT COMPLETED|Overall Study||3||
59905326|NCT03277794|76026193|FG000|STARTED|Overall Study||31||
60015018|NCT02612779|76131166|FG001|COMPLETED|Overall Study||0||
60015019|NCT02612779|76131165|FG000|NOT COMPLETED|Overall Study||68||
60015020|NCT02612779|76131166|FG001|NOT COMPLETED|Overall Study||6||
59905327|NCT03277794|76026194|FG001|STARTED|Overall Study||34||
60015021|NCT02612623|76131177|FG000|STARTED|Overall Study||8|Randomized|
60015022|NCT02612623|76131178|FG001|STARTED|Overall Study||6|Randomized|
59905328|NCT03277794|76026193|FG000|COMPLETED|Overall Study||28||
60015023|NCT02612623|76131179|FG002|STARTED|Overall Study||6|Randomized|
60015024|NCT02612623|76131180|FG003|STARTED|Overall Study||4|Randomized|
59905329|NCT03277794|76026194|FG001|COMPLETED|Overall Study||30||
59905330|NCT03277794|76026193|FG000|NOT COMPLETED|Overall Study||3||
60015025|NCT02612623|76131177|FG000|Treated|Overall Study||8||
60015026|NCT02612623|76131178|FG001|Treated|Overall Study||5||
60015027|NCT02612623|76131179|FG002|Treated|Overall Study||6||
59905331|NCT03277794|76026194|FG001|NOT COMPLETED|Overall Study||4||
59905332|NCT03276078|76026201|FG000|STARTED|Overall Study||20||
59905333|NCT03276078|76026201|FG000|COMPLETED|Overall Study||19||
59905334|NCT03276078|76026201|FG000|NOT COMPLETED|Overall Study||1||
59905335|NCT03180801|76026208|FG000|STARTED|Overall Study||50||
59905336|NCT03180801|76026209|FG001|STARTED|Overall Study||52||
59905337|NCT03180801|76026210|FG002|STARTED|Overall Study||51||
59905338|NCT03180801|76026208|FG000|Safety Population|Overall Study||50|The safety population included all vaccinated subjects|
59905339|NCT03180801|76026209|FG001|Safety Population|Overall Study||52|The safety population included all vaccinated subjects|
59905340|NCT03180801|76026210|FG002|Safety Population|Overall Study||51|The safety population included all vaccinated subjects|
59905341|NCT03180801|76026208|FG000|Intention to Treat|Overall Study||42|ITT included all vaccinated and inoculated subjects|
59905342|NCT03180801|76026209|FG001|Intention to Treat|Overall Study||40|ITT included all vaccinated and inoculated subjects|
59905343|NCT03180801|76026210|FG002|Intention to Treat|Overall Study||41|ITT included all vaccinated and inoculated subjects|
59905344|NCT03180801|76026208|FG000|COMPLETED|Overall Study||42||
59905345|NCT03180801|76026209|FG001|COMPLETED|Overall Study||40||
59905346|NCT03180801|76026210|FG002|COMPLETED|Overall Study||41||
59905347|NCT03180801|76026208|FG000|NOT COMPLETED|Overall Study||8||
59905348|NCT03180801|76026209|FG001|NOT COMPLETED|Overall Study||12||
59905349|NCT03180801|76026210|FG002|NOT COMPLETED|Overall Study||10||
59905350|NCT03742271|76026221|FG000|STARTED|Overall Study||127||
59905351|NCT03742271|76026221|FG000|COMPLETED|Overall Study||115||
59905352|NCT03742271|76026221|FG000|NOT COMPLETED|Overall Study||12||
59905353|NCT03214224|76026225|FG000|STARTED|Overall Study|Subjects did both standard and remote assessments in the validation study. Total enrollment 49.|49||
59905354|NCT03214224|76026225|FG000|COMPLETED|Overall Study|3 therapists enrolled. 3 ctrls enrolled (not incl. in analysis). 3 pts enr. but not completed.|40||
59905355|NCT03214224|76026225|FG000|NOT COMPLETED|Overall Study||9||
59905356|NCT03180645|76026232|FG000|STARTED|Overall Study||24||
59905357|NCT03180645|76026233|FG001|STARTED|Overall Study||24||
59905358|NCT03180645|76026234|FG002|STARTED|Overall Study||24||
59905359|NCT03180645|76026232|FG000|COMPLETED|Overall Study||24||
59905360|NCT03180645|76026233|FG001|COMPLETED|Overall Study||23||
59905361|NCT03180645|76026234|FG002|COMPLETED|Overall Study||22||
59905362|NCT03180645|76026232|FG000|NOT COMPLETED|Overall Study||0||
59905363|NCT03180645|76026233|FG001|NOT COMPLETED|Overall Study||1||
59905364|NCT03180645|76026234|FG002|NOT COMPLETED|Overall Study||2||
59905365|NCT03750695|76026246|FG000|STARTED|Overall Study||8||
59905366|NCT03750695|76026247|FG001|STARTED|Overall Study||8||
59905367|NCT03750695|76026246|FG000|COMPLETED|Overall Study||8||
59905368|NCT03750695|76026247|FG001|COMPLETED|Overall Study||7||
59905369|NCT03750695|76026246|FG000|NOT COMPLETED|Overall Study||0||
59905370|NCT03750695|76026247|FG001|NOT COMPLETED|Overall Study||1||
59905371|NCT03231228|76026260|FG000|STARTED|Overall Study||33||
59905372|NCT03231228|76026261|FG001|STARTED|Overall Study||28||
59905373|NCT03231228|76026260|FG000|COMPLETED|Overall Study||30||
59905374|NCT03231228|76026261|FG001|COMPLETED|Overall Study||28||
59905375|NCT03231228|76026260|FG000|NOT COMPLETED|Overall Study||3||
59905376|NCT03231228|76026261|FG001|NOT COMPLETED|Overall Study||0||
59905377|NCT03213366|76026269|FG000|STARTED|Overall Study||81||7
59905378|NCT03213366|76026270|FG001|STARTED|Overall Study||71||5
59905379|NCT03213366|76026269|FG000|COMPLETED|Overall Study||72||5
59905380|NCT03213366|76026270|FG001|COMPLETED|Overall Study||67||5
59905381|NCT03213366|76026269|FG000|NOT COMPLETED|Overall Study||9||2
59905382|NCT03213366|76026270|FG001|NOT COMPLETED|Overall Study||4||0
59905383|NCT03213210|76026276|FG000|STARTED|Overall Study||5||
59905384|NCT03213210|76026276|FG000|6-month Follow-up|Overall Study||3||
59905385|NCT03213210|76026276|FG000|COMPLETED|Overall Study||0||
59905386|NCT03213210|76026276|FG000|NOT COMPLETED|Overall Study||5||
59506151|NCT00784303|75599027|FG000|NOT COMPLETED|Overall Study||0||
59905387|NCT02932878|76026282|FG000|STARTED|Overall Study||15||
59905388|NCT02932878|76026283|FG001|STARTED|Overall Study||1||
59905389|NCT02932878|76026282|FG000|COMPLETED|Overall Study||13||
59905390|NCT02932878|76026283|FG001|COMPLETED|Overall Study||0||
59506152|NCT00784303|75599028|FG001|NOT COMPLETED|Overall Study||0||
59905391|NCT02932878|76026282|FG000|NOT COMPLETED|Overall Study||2||
59905392|NCT02932878|76026283|FG001|NOT COMPLETED|Overall Study||1||
59905393|NCT03230292|76026289|FG000|STARTED|Overall Study||43||
59905394|NCT03230292|76026289|FG000|COMPLETED|Overall Study||37||
59905395|NCT03230292|76026289|FG000|NOT COMPLETED|Overall Study||6||
59905396|NCT03228420|76026297|FG000|STARTED|Overall Study||113||
59905397|NCT03228420|76026298|FG001|STARTED|Overall Study||103||
59905398|NCT03228420|76026297|FG000|Month-1|Overall Study||95||
59905399|NCT03228420|76026298|FG001|Month-1|Overall Study||101||
59905400|NCT03228420|76026297|FG000|Month-3|Overall Study||93||
59905401|NCT03228420|76026298|FG001|Month-3|Overall Study||98||
59905402|NCT03228420|76026297|FG000|COMPLETED|Overall Study||93||
59905403|NCT03228420|76026298|FG001|COMPLETED|Overall Study||98||
59905404|NCT03228420|76026297|FG000|NOT COMPLETED|Overall Study||20||
59905405|NCT03228420|76026298|FG001|NOT COMPLETED|Overall Study||5||
59905406|NCT03746483|76026306|FG000|STARTED|Overall Study||21||
59905407|NCT03746483|76026307|FG001|STARTED|Overall Study||20||
59905408|NCT03746483|76026306|FG000|COMPLETED|Overall Study||15||
59905409|NCT03746483|76026307|FG001|COMPLETED|Overall Study||17||
59905410|NCT03746483|76026306|FG000|NOT COMPLETED|Overall Study||6||
59905411|NCT03746483|76026307|FG001|NOT COMPLETED|Overall Study||3||
59905412|NCT03746405|76026317|FG000|STARTED|Overall Study||10|Seven subjects were excluded before the second visit (when rTMS occured) and therefore were not randomized in the active or the sham group|
59905413|NCT03746405|76026318|FG001|STARTED|Overall Study||8|Seven subjects were excluded before the second visit (when rTMS occured) and therefore were not randomized in the active or the sham group|
59905414|NCT03746405|76026317|FG000|COMPLETED|Overall Study||7||
59905415|NCT03746405|76026318|FG001|COMPLETED|Overall Study||6||
59905416|NCT03746405|76026317|FG000|NOT COMPLETED|Overall Study||3||
59905417|NCT03746405|76026318|FG001|NOT COMPLETED|Overall Study||2||
59905418|NCT03226392|76026326|FG000|STARTED|Overall Study||352||
59905419|NCT03226392|76026327|FG001|STARTED|Overall Study||352||
59905420|NCT03226392|76026326|FG000|FAS|Overall Study||352||
59905421|NCT03226392|76026327|FG001|FAS|Overall Study|"2 patients in the placebo were mis-randomized, not treated, not included due to technical problems"|350||
59905422|NCT03226392|76026326|FG000|COMPLETED|Overall Study||341||
59905423|NCT03226392|76026327|FG001|COMPLETED|Overall Study||344||
59905424|NCT03226392|76026326|FG000|NOT COMPLETED|Overall Study||11||
59905425|NCT03226392|76026327|FG001|NOT COMPLETED|Overall Study||8||
59905426|NCT03205371|76026345|FG000|STARTED|Overall Study||107||
59905427|NCT03205371|76026346|FG001|STARTED|Overall Study||53||
59905428|NCT03205371|76026347|FG002|STARTED|Overall Study||53||
59905429|NCT03205371|76026348|FG003|STARTED|Overall Study||86||
59905430|NCT03205371|76026349|FG004|STARTED|Overall Study||42||
59905431|NCT03205371|76026350|FG005|STARTED|Overall Study||42||
59905432|NCT03205371|76026351|FG006|STARTED|Overall Study||200||
59905433|NCT03205371|76026352|FG007|STARTED|Overall Study||100||
59905434|NCT03205371|76026353|FG008|STARTED|Overall Study||100||
59905435|NCT03205371|76026354|FG009|STARTED|Overall Study||200||
59905436|NCT03205371|76026355|FG010|STARTED|Overall Study||100||
59905437|NCT03205371|76026356|FG011|STARTED|Overall Study||100||
59905438|NCT03205371|76026345|FG000|Safety Analysis Set (SafAS)|Overall Study||103|SafAS: participants who received at least 1 dose of study vaccine(s) & had any safety data available|
59905439|NCT03205371|76026346|FG001|Safety Analysis Set (SafAS)|Overall Study||52|SafAS: participants who received at least 1 dose of study vaccine(s) & had any safety data available|
59905440|NCT03205371|76026347|FG002|Safety Analysis Set (SafAS)|Overall Study||53|SafAS: participants who received at least 1 dose of study vaccine(s) & had any safety data available|
59905441|NCT03205371|76026348|FG003|Safety Analysis Set (SafAS)|Overall Study||86|SafAS: participants who received at least 1 dose of study vaccine(s) & had any safety data available|
59905442|NCT03205371|76026349|FG004|Safety Analysis Set (SafAS)|Overall Study||42|SafAS: participants who received at least 1 dose of study vaccine(s) & had any safety data available|
59905443|NCT03205371|76026350|FG005|Safety Analysis Set (SafAS)|Overall Study||42|SafAS: participants who received at least 1 dose of study vaccine(s) & had any safety data available|
59905444|NCT03205371|76026351|FG006|Safety Analysis Set (SafAS)|Overall Study||200|SafAS: participants who received at least 1 dose of study vaccine(s) & had any safety data available|
59905445|NCT03205371|76026352|FG007|Safety Analysis Set (SafAS)|Overall Study||100|SafAS: participants who received at least 1 dose of study vaccine(s) & had any safety data available|
59905446|NCT03205371|76026353|FG008|Safety Analysis Set (SafAS)|Overall Study||100|SafAS: participants who received at least 1 dose of study vaccine(s) & had any safety data available|
59905447|NCT03205371|76026354|FG009|Safety Analysis Set (SafAS)|Overall Study||200|SafAS: participants who received at least 1 dose of study vaccine(s) & had any safety data available|
59905448|NCT03205371|76026355|FG010|Safety Analysis Set (SafAS)|Overall Study||100|SafAS: participants who received at least 1 dose of study vaccine(s) & had any safety data available|
59905449|NCT03205371|76026356|FG011|Safety Analysis Set (SafAS)|Overall Study||99|SafAS: participants who received at least 1 dose of study vaccine(s) & had any safety data available|
59905450|NCT03205371|76026345|FG000|Per-protocol Analysis Set (PPAS)|Overall Study||92|PPAS: participants who received at least 1 dose of study vaccine, and had no protocol deviations.|
59905451|NCT03205371|76026346|FG001|Per-protocol Analysis Set (PPAS)|Overall Study||45|PPAS: participants who received at least 1 dose of study vaccine, and had no protocol deviations.|
59905452|NCT03205371|76026347|FG002|Per-protocol Analysis Set (PPAS)|Overall Study||50|PPAS: participants who received at least 1 dose of study vaccine, and had no protocol deviations.|
59905453|NCT03205371|76026348|FG003|Per-protocol Analysis Set (PPAS)|Overall Study||85|PPAS: participants who received at least 1 dose of study vaccine, and had no protocol deviations.|
59905454|NCT03205371|76026349|FG004|Per-protocol Analysis Set (PPAS)|Overall Study||42|PPAS: participants who received at least 1 dose of study vaccine, and had no protocol deviations.|
59905455|NCT03205371|76026350|FG005|Per-protocol Analysis Set (PPAS)|Overall Study||42|PPAS: participants who received at least 1 dose of study vaccine, and had no protocol deviations.|
59905456|NCT03205371|76026351|FG006|Per-protocol Analysis Set (PPAS)|Overall Study||155|PPAS: participants who received at least 1 dose of study vaccine, and had no protocol deviations.|
59905457|NCT03205371|76026352|FG007|Per-protocol Analysis Set (PPAS)|Overall Study||79|PPAS: participants who received at least 1 dose of study vaccine, and had no protocol deviations.|
59905458|NCT03205371|76026353|FG008|Per-protocol Analysis Set (PPAS)|Overall Study||68|PPAS: participants who received at least 1 dose of study vaccine, and had no protocol deviations.|
59905459|NCT03205371|76026354|FG009|Per-protocol Analysis Set (PPAS)|Overall Study||196|PPAS: participants who received at least 1 dose of study vaccine, and had no protocol deviations.|
59951151|NCT04007367|76070074|FG000|NOT COMPLETED|Double-Blind Phase (14-Weeks)||0||
59951152|NCT04007367|76070075|FG001|NOT COMPLETED|Double-Blind Phase (14-Weeks)||0||
60015028|NCT02612623|76131180|FG003|Treated|Overall Study||4||
59905460|NCT03205371|76026355|FG010|Per-protocol Analysis Set (PPAS)|Overall Study||96|PPAS: participants who received at least 1 dose of study vaccine, and had no protocol deviations.|
59905461|NCT03205371|76026356|FG011|Per-protocol Analysis Set (PPAS)|Overall Study||92|PPAS: participants who received at least 1 dose of study vaccine, and had no protocol deviations.|
59905462|NCT03205371|76026345|FG000|COMPLETED|Overall Study||103||
59905463|NCT03205371|76026346|FG001|COMPLETED|Overall Study||52||
59905464|NCT03205371|76026347|FG002|COMPLETED|Overall Study||53||
59905465|NCT03205371|76026348|FG003|COMPLETED|Overall Study||86||
59905466|NCT03205371|76026349|FG004|COMPLETED|Overall Study||42||
59905467|NCT03205371|76026350|FG005|COMPLETED|Overall Study||42||
59905468|NCT03205371|76026351|FG006|COMPLETED|Overall Study||190||
59905469|NCT03205371|76026352|FG007|COMPLETED|Overall Study||97||
59905470|NCT03205371|76026353|FG008|COMPLETED|Overall Study||95||
59905471|NCT03205371|76026354|FG009|COMPLETED|Overall Study||200||
59905472|NCT03205371|76026355|FG010|COMPLETED|Overall Study||100||
59905473|NCT03205371|76026356|FG011|COMPLETED|Overall Study||99||
59905474|NCT03205371|76026345|FG000|NOT COMPLETED|Overall Study||4||
59905475|NCT03205371|76026346|FG001|NOT COMPLETED|Overall Study||1||
59905476|NCT03205371|76026347|FG002|NOT COMPLETED|Overall Study||0||
59905477|NCT03205371|76026348|FG003|NOT COMPLETED|Overall Study||0||
59905478|NCT03205371|76026349|FG004|NOT COMPLETED|Overall Study||0||
59905479|NCT03205371|76026350|FG005|NOT COMPLETED|Overall Study||0||
59905480|NCT03205371|76026351|FG006|NOT COMPLETED|Overall Study||10||
59905481|NCT03205371|76026352|FG007|NOT COMPLETED|Overall Study||3||
59905482|NCT03205371|76026353|FG008|NOT COMPLETED|Overall Study||5||
59905483|NCT03205371|76026354|FG009|NOT COMPLETED|Overall Study||0||
59905484|NCT03205371|76026355|FG010|NOT COMPLETED|Overall Study||0||
59905485|NCT03205371|76026356|FG011|NOT COMPLETED|Overall Study||1||
59905486|NCT03367858|76026404|FG000|STARTED|Intervention + Baseline Scan||101||
59905487|NCT03367858|76026405|FG001|STARTED|Intervention + Baseline Scan||103||
59905488|NCT03367858|76026404|FG000|COMPLETED|Intervention + Baseline Scan||97||
59905489|NCT03367858|76026405|FG001|COMPLETED|Intervention + Baseline Scan||101||
59905490|NCT03367858|76026404|FG000|NOT COMPLETED|Intervention + Baseline Scan||4||
59905491|NCT03367858|76026405|FG001|NOT COMPLETED|Intervention + Baseline Scan||2||
59905492|NCT03367858|76026404|FG000|STARTED|3 Month Follow Up|Participants must have completed baseline scan to be eligible for the 3 Month Follow Up scan|97||
59905493|NCT03367858|76026405|FG001|STARTED|3 Month Follow Up|Participants must have completed baseline scan to be eligible for the 3 Month Follow Up scan|101||
59905494|NCT03367858|76026404|FG000|COMPLETED|3 Month Follow Up||81||
59905495|NCT03367858|76026405|FG001|COMPLETED|3 Month Follow Up||87||
59905496|NCT03367858|76026404|FG000|NOT COMPLETED|3 Month Follow Up||16||
59905497|NCT03367858|76026405|FG001|NOT COMPLETED|3 Month Follow Up||14||
59905498|NCT03367858|76026404|FG000|STARTED|6 Month Follow Up|For analysis purposes, only participants with complete scan data (baseline + 3 Month) were followed|81||
59905499|NCT03367858|76026405|FG001|STARTED|6 Month Follow Up|For analysis purposes, only participants with complete scan data (baseline + 3 Month) were followed|87||
59905500|NCT03367858|76026404|FG000|COMPLETED|6 Month Follow Up||76||
59905501|NCT03367858|76026405|FG001|COMPLETED|6 Month Follow Up||84||
59905502|NCT03367858|76026404|FG000|NOT COMPLETED|6 Month Follow Up||5||
59905503|NCT03367858|76026405|FG001|NOT COMPLETED|6 Month Follow Up||3||
59905504|NCT03367858|76026404|FG000|STARTED|12 Month Follow Up|For analysis purposes, only participants with complete scan data (baseline + 3 Month) were followed|81||
59905505|NCT03367858|76026405|FG001|STARTED|12 Month Follow Up|For analysis purposes, only participants with complete scan data (baseline + 3 Month) were followed|87||
59905506|NCT03367858|76026404|FG000|COMPLETED|12 Month Follow Up||78||
59905507|NCT03367858|76026405|FG001|COMPLETED|12 Month Follow Up||83||
59905508|NCT03367858|76026404|FG000|NOT COMPLETED|12 Month Follow Up||3||
59905509|NCT03367858|76026405|FG001|NOT COMPLETED|12 Month Follow Up||4||
59905510|NCT03682705|76026417|FG000|STARTED|Overall Study||19||
59905511|NCT03682705|76026418|FG001|STARTED|Overall Study||62||
59905512|NCT03682705|76026419|FG002|STARTED|Overall Study||41||
59905513|NCT03682705|76026420|FG003|STARTED|Overall Study||39||
59905514|NCT03682705|76026421|FG004|STARTED|Overall Study||41||
59905515|NCT03682705|76026422|FG005|STARTED|Overall Study||40||
59905516|NCT03682705|76026417|FG000|COMPLETED|Overall Study||17||
59905517|NCT03682705|76026418|FG001|COMPLETED|Overall Study||58||
59905518|NCT03682705|76026419|FG002|COMPLETED|Overall Study||38||
59905519|NCT03682705|76026420|FG003|COMPLETED|Overall Study||34||
59905520|NCT03682705|76026421|FG004|COMPLETED|Overall Study||35||
59905521|NCT03682705|76026422|FG005|COMPLETED|Overall Study||38||
59905522|NCT03682705|76026417|FG000|NOT COMPLETED|Overall Study||2||
59905523|NCT03682705|76026418|FG001|NOT COMPLETED|Overall Study||4||
59905524|NCT03682705|76026419|FG002|NOT COMPLETED|Overall Study||3||
59905525|NCT03682705|76026420|FG003|NOT COMPLETED|Overall Study||5||
59905526|NCT03682705|76026421|FG004|NOT COMPLETED|Overall Study||6||
59905527|NCT03682705|76026422|FG005|NOT COMPLETED|Overall Study||2||
59905528|NCT03179787|76026436|FG000|STARTED|Overall Study||528||
59905529|NCT03179787|76026436|FG000|COMPLETED|Overall Study||510||
59905530|NCT03179787|76026436|FG000|NOT COMPLETED|Overall Study||18||
59905531|NCT03745937|76026444|FG000|STARTED|Overall Study||2||
59905532|NCT03745937|76026445|FG001|STARTED|Overall Study||6||
59905533|NCT03745937|76026446|FG002|STARTED|Overall Study||3||
59905534|NCT03745937|76026447|FG003|STARTED|Overall Study||9||
60015029|NCT02612623|76131177|FG000|COMPLETED|Overall Study||7||
59506153|NCT00750815|75599037|FG000|STARTED|Overall Study||12||
59506154|NCT00750815|75599038|FG001|STARTED|Overall Study||46||
59905535|NCT03745937|76026444|FG000|COMPLETED|Overall Study||2||
59905536|NCT03745937|76026445|FG001|COMPLETED|Overall Study||5||
59905537|NCT03745937|76026446|FG002|COMPLETED|Overall Study||3||
59905538|NCT03745937|76026447|FG003|COMPLETED|Overall Study||7||
59905539|NCT03745937|76026444|FG000|NOT COMPLETED|Overall Study||0||
59905540|NCT03745937|76026445|FG001|NOT COMPLETED|Overall Study||1||
59905541|NCT03745937|76026446|FG002|NOT COMPLETED|Overall Study||0||
59905542|NCT03745937|76026447|FG003|NOT COMPLETED|Overall Study||2||
59905543|NCT02956057|76026464|FG000|STARTED|Overall Study||174||
59905544|NCT02956057|76026465|FG001|STARTED|Overall Study||174||
59905545|NCT02956057|76026466|FG002|STARTED|Overall Study||174||
59905546|NCT02956057|76026467|FG003|STARTED|Overall Study||174||
59905547|NCT02956057|76026468|FG004|STARTED|Overall Study||174||
59905548|NCT02956057|76026469|FG005|STARTED|Overall Study||174||
59905549|NCT02956057|76026464|FG000|COMPLETED|Overall Study||160||
59905550|NCT02956057|76026465|FG001|COMPLETED|Overall Study||162||
59905551|NCT02956057|76026466|FG002|COMPLETED|Overall Study||166||
59905552|NCT02956057|76026467|FG003|COMPLETED|Overall Study||159||
59905553|NCT02956057|76026468|FG004|COMPLETED|Overall Study||169||
59905554|NCT02956057|76026469|FG005|COMPLETED|Overall Study||157||
59905555|NCT02956057|76026464|FG000|NOT COMPLETED|Overall Study||14||
59905556|NCT02956057|76026465|FG001|NOT COMPLETED|Overall Study||12||
59905557|NCT02956057|76026466|FG002|NOT COMPLETED|Overall Study||8||
59905558|NCT02956057|76026467|FG003|NOT COMPLETED|Overall Study||15||
59905559|NCT02956057|76026468|FG004|NOT COMPLETED|Overall Study||5||
59905560|NCT02956057|76026469|FG005|NOT COMPLETED|Overall Study||17||
59905561|NCT03179319|76026485|FG000|STARTED|Overall Study||40||
59905562|NCT03179319|76026486|FG001|STARTED|Overall Study||20||
59905563|NCT03179319|76026485|FG000|3 Month Visit|Overall Study||37||
59905564|NCT03179319|76026486|FG001|3 Month Visit|Overall Study||20||
59905565|NCT03179319|76026485|FG000|COMPLETED|Overall Study||34|6-month follow up|
59905566|NCT03179319|76026486|FG001|COMPLETED|Overall Study||20|6-month follow up|
59905567|NCT03179319|76026485|FG000|NOT COMPLETED|Overall Study||6||
59905568|NCT03179319|76026486|FG001|NOT COMPLETED|Overall Study||0||
59905569|NCT03627091|76026495|FG000|STARTED|Overall Study||19||
59905570|NCT03627091|76026496|FG001|STARTED|Overall Study||10||
59905571|NCT03627091|76026497|FG002|STARTED|Overall Study||11||
59905572|NCT03627091|76026495|FG000|COMPLETED|Overall Study||7||
59905573|NCT03627091|76026496|FG001|COMPLETED|Overall Study||4||
59905574|NCT03627091|76026497|FG002|COMPLETED|Overall Study||6||
59905575|NCT03627091|76026495|FG000|NOT COMPLETED|Overall Study||12||
59905576|NCT03627091|76026496|FG001|NOT COMPLETED|Overall Study||6||
59905577|NCT03627091|76026497|FG002|NOT COMPLETED|Overall Study||5||
59905578|NCT04237584|76026510|FG000|STARTED|R1- Lead-in ARB Treatment (12 Weeks)||5||
59905579|NCT04237584|76026511|FG001|STARTED|R1- Lead-in ARB Treatment (12 Weeks)||5||
59905580|NCT04237584|76026512|FG002|STARTED|R1- Lead-in ARB Treatment (12 Weeks)||6||
59905581|NCT04237584|76026513|FG003|STARTED|R1- Lead-in ARB Treatment (12 Weeks)||5||
59905582|NCT04237584|76026510|FG000|COMPLETED|R1- Lead-in ARB Treatment (12 Weeks)||4||
59905583|NCT04237584|76026511|FG001|COMPLETED|R1- Lead-in ARB Treatment (12 Weeks)||4||
59905584|NCT04237584|76026512|FG002|COMPLETED|R1- Lead-in ARB Treatment (12 Weeks)||3||
59905585|NCT04237584|76026513|FG003|COMPLETED|R1- Lead-in ARB Treatment (12 Weeks)||3||
59905586|NCT04237584|76026510|FG000|NOT COMPLETED|R1- Lead-in ARB Treatment (12 Weeks)||1||
59905587|NCT04237584|76026511|FG001|NOT COMPLETED|R1- Lead-in ARB Treatment (12 Weeks)||1||
59905588|NCT04237584|76026512|FG002|NOT COMPLETED|R1- Lead-in ARB Treatment (12 Weeks)||3||
59905589|NCT04237584|76026513|FG003|NOT COMPLETED|R1- Lead-in ARB Treatment (12 Weeks)||2||
59905590|NCT04237584|76026510|FG000|STARTED|R2- ARB Treatment With Ra-223 or Placebo||4||
59905591|NCT04237584|76026511|FG001|STARTED|R2- ARB Treatment With Ra-223 or Placebo||4||
59905592|NCT04237584|76026512|FG002|STARTED|R2- ARB Treatment With Ra-223 or Placebo||3||
59905593|NCT04237584|76026513|FG003|STARTED|R2- ARB Treatment With Ra-223 or Placebo||3||
59905594|NCT04237584|76026510|FG000|COMPLETED|R2- ARB Treatment With Ra-223 or Placebo||0||
59905595|NCT04237584|76026511|FG001|COMPLETED|R2- ARB Treatment With Ra-223 or Placebo||0||
59905596|NCT04237584|76026512|FG002|COMPLETED|R2- ARB Treatment With Ra-223 or Placebo||0||
59905597|NCT04237584|76026513|FG003|COMPLETED|R2- ARB Treatment With Ra-223 or Placebo||0||
59905598|NCT04237584|76026510|FG000|NOT COMPLETED|R2- ARB Treatment With Ra-223 or Placebo||4||
59905599|NCT04237584|76026511|FG001|NOT COMPLETED|R2- ARB Treatment With Ra-223 or Placebo||4||
59905600|NCT04237584|76026512|FG002|NOT COMPLETED|R2- ARB Treatment With Ra-223 or Placebo||3||
59905601|NCT04237584|76026513|FG003|NOT COMPLETED|R2- ARB Treatment With Ra-223 or Placebo||3||
59905602|NCT03224598|76026530|FG000|STARTED|Overall Study||9||
59905603|NCT03224598|76026531|FG001|STARTED|Overall Study||17||
60015030|NCT02612623|76131178|FG001|COMPLETED|Overall Study||5||
59905604|NCT03224598|76026532|FG002|STARTED|Overall Study||13||
60015031|NCT02612623|76131179|FG002|COMPLETED|Overall Study||5||
59506155|NCT00750815|75599037|FG000|COMPLETED|Overall Study||12||
59506156|NCT00750815|75599038|FG001|COMPLETED|Overall Study||46||
59905605|NCT03224598|76026530|FG000|COMPLETED|Overall Study||9||
59905606|NCT03224598|76026531|FG001|COMPLETED|Overall Study||14||
59905607|NCT03224598|76026532|FG002|COMPLETED|Overall Study||13||
59905608|NCT03224598|76026530|FG000|NOT COMPLETED|Overall Study||0||
59905609|NCT03224598|76026531|FG001|NOT COMPLETED|Overall Study||3||
59905610|NCT03224598|76026532|FG002|NOT COMPLETED|Overall Study||0||
59905611|NCT03681691|76026542|FG000|STARTED|Overall Study||8||
59905612|NCT03681691|76026543|FG001|STARTED|Overall Study||4||
59905613|NCT03681691|76026542|FG000|COMPLETED|Overall Study||6||
59905614|NCT03681691|76026543|FG001|COMPLETED|Overall Study||3||
59905615|NCT03681691|76026542|FG000|NOT COMPLETED|Overall Study||2||
59905616|NCT03681691|76026543|FG001|NOT COMPLETED|Overall Study||1||
59905617|NCT02935842|76026555|FG000|STARTED|Testing and Therapy Period 1||8||
59905618|NCT02935842|76026556|FG001|STARTED|Testing and Therapy Period 1||6||
59905619|NCT02935842|76026557|FG002|STARTED|Testing and Therapy Period 1||6||
59905620|NCT02935842|76026558|FG003|STARTED|Testing and Therapy Period 1|Due to limited staff capacity, HC have only been included in the final tranche.|0||
59905621|NCT02935842|76026555|FG000|COMPLETED|Testing and Therapy Period 1||8||
59905622|NCT02935842|76026556|FG001|COMPLETED|Testing and Therapy Period 1||6||
59905623|NCT02935842|76026557|FG002|COMPLETED|Testing and Therapy Period 1||6||
59905624|NCT02935842|76026558|FG003|COMPLETED|Testing and Therapy Period 1||0||
59905625|NCT02935842|76026555|FG000|NOT COMPLETED|Testing and Therapy Period 1||0||
59905626|NCT02935842|76026556|FG001|NOT COMPLETED|Testing and Therapy Period 1||0||
59905627|NCT02935842|76026557|FG002|NOT COMPLETED|Testing and Therapy Period 1||0||
59905628|NCT02935842|76026558|FG003|NOT COMPLETED|Testing and Therapy Period 1||0||
59905629|NCT02935842|76026555|FG000|STARTED|Testing and Therapy Period 2||8||
59905630|NCT02935842|76026556|FG001|STARTED|Testing and Therapy Period 2||6||
59905631|NCT02935842|76026557|FG002|STARTED|Testing and Therapy Period 2||6||
59905632|NCT02935842|76026558|FG003|STARTED|Testing and Therapy Period 2|Due to limited staff capacity, HC have only been included in the final tranche.|0||
59905633|NCT02935842|76026555|FG000|COMPLETED|Testing and Therapy Period 2||6||
59905634|NCT02935842|76026556|FG001|COMPLETED|Testing and Therapy Period 2||6||
59905635|NCT02935842|76026557|FG002|COMPLETED|Testing and Therapy Period 2||6||
59905636|NCT02935842|76026558|FG003|COMPLETED|Testing and Therapy Period 2||0||
59905637|NCT02935842|76026555|FG000|NOT COMPLETED|Testing and Therapy Period 2||2||
59905638|NCT02935842|76026556|FG001|NOT COMPLETED|Testing and Therapy Period 2||0||
59905639|NCT02935842|76026557|FG002|NOT COMPLETED|Testing and Therapy Period 2||0||
59905640|NCT02935842|76026558|FG003|NOT COMPLETED|Testing and Therapy Period 2||0||
59905641|NCT02935842|76026555|FG000|STARTED|Testing and Therapy Period 3||6||
59905642|NCT02935842|76026556|FG001|STARTED|Testing and Therapy Period 3||6||
59905643|NCT02935842|76026557|FG002|STARTED|Testing and Therapy Period 3||6||
59905644|NCT02935842|76026558|FG003|STARTED|Testing and Therapy Period 3|HC received no interventions. They have only been tested at BL, 4 Weeks and 6 Months.|18||
59905645|NCT02935842|76026555|FG000|COMPLETED|Testing and Therapy Period 3||3||
59905646|NCT02935842|76026556|FG001|COMPLETED|Testing and Therapy Period 3||2||
59905647|NCT02935842|76026557|FG002|COMPLETED|Testing and Therapy Period 3||1||
59905648|NCT02935842|76026558|FG003|COMPLETED|Testing and Therapy Period 3||17||
59905649|NCT02935842|76026555|FG000|NOT COMPLETED|Testing and Therapy Period 3||3||
60015032|NCT02612623|76131180|FG003|COMPLETED|Overall Study||4||
60015033|NCT02612623|76131177|FG000|NOT COMPLETED|Overall Study||1||
60015034|NCT02612623|76131178|FG001|NOT COMPLETED|Overall Study||1||
60015035|NCT02612623|76131179|FG002|NOT COMPLETED|Overall Study||1||
60015036|NCT02612623|76131180|FG003|NOT COMPLETED|Overall Study||0||
60015037|NCT02607865|76131194|FG000|STARTED|Overall Study||466||
60015038|NCT02607865|76131195|FG001|STARTED|Overall Study||466||
60015039|NCT02607865|76131196|FG002|STARTED|Overall Study||465||
60015040|NCT02607865|76131197|FG003|STARTED|Overall Study||467||
60015041|NCT02607865|76131194|FG000|Full Analysis Set (FAS)|Overall Study||466|One participant was excluded from the FAS as the participant was a confirmed screening failure.|
60015042|NCT02607865|76131195|FG001|Full Analysis Set (FAS)|Overall Study||465|One participant was excluded from the FAS as the participant was a confirmed screening failure.|
60015043|NCT02607865|76131196|FG002|Full Analysis Set (FAS)|Overall Study||465|One participant was excluded from the FAS as the participant was a confirmed screening failure.|
60015044|NCT02607865|76131197|FG003|Full Analysis Set (FAS)|Overall Study||467|One participant was excluded from the FAS as the participant was a confirmed screening failure.|
60015045|NCT02607865|76131194|FG000|Safety Analysis Set (SAS)|Overall Study||466||
60015046|NCT02607865|76131195|FG001|Safety Analysis Set (SAS)|Overall Study||464||
60015047|NCT02607865|76131196|FG002|Safety Analysis Set (SAS)|Overall Study||465||
60015048|NCT02607865|76131197|FG003|Safety Analysis Set (SAS)|Overall Study||466||
60015049|NCT02607865|76131194|FG000|COMPLETED|Overall Study||433||
60015050|NCT02607865|76131195|FG001|COMPLETED|Overall Study||436||
60015051|NCT02607865|76131196|FG002|COMPLETED|Overall Study||438||
60015052|NCT02607865|76131197|FG003|COMPLETED|Overall Study||451||
60015053|NCT02607865|76131194|FG000|NOT COMPLETED|Overall Study||33||
60015054|NCT02607865|76131195|FG001|NOT COMPLETED|Overall Study||30||
60015055|NCT02607865|76131196|FG002|NOT COMPLETED|Overall Study||27||
59905650|NCT02935842|76026556|FG001|NOT COMPLETED|Testing and Therapy Period 3||4||
59905651|NCT02935842|76026557|FG002|NOT COMPLETED|Testing and Therapy Period 3||5||
59905652|NCT02935842|76026558|FG003|NOT COMPLETED|Testing and Therapy Period 3||1||
59905653|NCT03680911|76026577|FG000|STARTED|Visit 1 (Baseline)||3||
59905654|NCT03680911|76026578|FG001|STARTED|Visit 1 (Baseline)||4||
59905655|NCT03680911|76026577|FG000|COMPLETED|Visit 1 (Baseline)||3||
59905656|NCT03680911|76026578|FG001|COMPLETED|Visit 1 (Baseline)||4||
59905657|NCT03680911|76026577|FG000|NOT COMPLETED|Visit 1 (Baseline)||0||
59905658|NCT03680911|76026578|FG001|NOT COMPLETED|Visit 1 (Baseline)||0||
59905659|NCT03680911|76026577|FG000|STARTED|At Home Treatment||3||
59905660|NCT03680911|76026578|FG001|STARTED|At Home Treatment||4||
59905661|NCT03680911|76026577|FG000|COMPLETED|At Home Treatment||0||
59905662|NCT03680911|76026578|FG001|COMPLETED|At Home Treatment||1||
59905663|NCT03680911|76026577|FG000|NOT COMPLETED|At Home Treatment||3||
59905664|NCT03680911|76026578|FG001|NOT COMPLETED|At Home Treatment||3||
59905665|NCT03680911|76026577|FG000|STARTED|Visit 2 (1 Month Follow up)||0||
59905666|NCT03680911|76026578|FG001|STARTED|Visit 2 (1 Month Follow up)||1||
59905667|NCT03680911|76026577|FG000|COMPLETED|Visit 2 (1 Month Follow up)||0||
59905668|NCT03680911|76026578|FG001|COMPLETED|Visit 2 (1 Month Follow up)||1||
59905669|NCT03680911|76026577|FG000|NOT COMPLETED|Visit 2 (1 Month Follow up)||0||
59905670|NCT03680911|76026578|FG001|NOT COMPLETED|Visit 2 (1 Month Follow up)||0||
59905671|NCT03680911|76026577|FG000|STARTED|Visit 3 (4 Month Follow up)||0||
59905672|NCT03680911|76026578|FG001|STARTED|Visit 3 (4 Month Follow up)||1||
59905673|NCT03680911|76026577|FG000|COMPLETED|Visit 3 (4 Month Follow up)||0||
59905674|NCT03680911|76026578|FG001|COMPLETED|Visit 3 (4 Month Follow up)||0||
59905675|NCT03680911|76026577|FG000|NOT COMPLETED|Visit 3 (4 Month Follow up)||0||
59905676|NCT03680911|76026578|FG001|NOT COMPLETED|Visit 3 (4 Month Follow up)||1||
59905677|NCT03224130|76026586|FG000|STARTED|Overall Study||483||
59905678|NCT03224130|76026587|FG001|STARTED|Overall Study||483||
59905679|NCT03224130|76026586|FG000|COMPLETED|Overall Study||483||
59905680|NCT03224130|76026587|FG001|COMPLETED|Overall Study||482||
59905681|NCT03224130|76026586|FG000|NOT COMPLETED|Overall Study||0||
59905682|NCT03224130|76026587|FG001|NOT COMPLETED|Overall Study||1||
59905683|NCT03679741|76026593|FG000|STARTED|Period 1||59||
59905684|NCT03679741|76026594|FG001|STARTED|Period 1||61||
59905685|NCT03679741|76026593|FG000|COMPLETED|Period 1||57||
59905686|NCT03679741|76026594|FG001|COMPLETED|Period 1||58||
59905687|NCT03679741|76026593|FG000|NOT COMPLETED|Period 1||2||
59905688|NCT03679741|76026594|FG001|NOT COMPLETED|Period 1||3||
59905689|NCT03679741|76026593|FG000|STARTED|Period 2||57||
59905690|NCT03679741|76026594|FG001|STARTED|Period 2||58||
59905691|NCT03679741|76026593|FG000|COMPLETED|Period 2||54||
59905692|NCT03679741|76026594|FG001|COMPLETED|Period 2||56||
59905693|NCT03679741|76026593|FG000|NOT COMPLETED|Period 2||3||
59905694|NCT03679741|76026594|FG001|NOT COMPLETED|Period 2||2||
59905695|NCT03679741|76026593|FG000|STARTED|Period 3||54||
59905696|NCT03679741|76026594|FG001|STARTED|Period 3||56||
59905697|NCT03679741|76026593|FG000|COMPLETED|Period 3||54||
59905698|NCT03679741|76026594|FG001|COMPLETED|Period 3||56||
59905699|NCT03679741|76026593|FG000|NOT COMPLETED|Period 3||0||
59905700|NCT03679741|76026594|FG001|NOT COMPLETED|Period 3||0||
59905701|NCT03678103|76026600|FG000|STARTED|Overall Study||30||
59905702|NCT03678103|76026600|FG000|COMPLETED|Overall Study||26||
59905703|NCT03678103|76026600|FG000|NOT COMPLETED|Overall Study||4||
59905704|NCT03649477|76026607|FG000|STARTED|Overall Study||44||
59905705|NCT03649477|76026608|FG001|STARTED|Overall Study||43||
59905706|NCT03649477|76026609|FG002|STARTED|Overall Study||43||
59905707|NCT03649477|76026607|FG000|COMPLETED|Overall Study||42||
59905708|NCT03649477|76026608|FG001|COMPLETED|Overall Study||43||
59905709|NCT03649477|76026609|FG002|COMPLETED|Overall Study||43||
59905710|NCT03649477|76026607|FG000|NOT COMPLETED|Overall Study||2||
59905711|NCT03649477|76026608|FG001|NOT COMPLETED|Overall Study||0||
59905712|NCT03649477|76026609|FG002|NOT COMPLETED|Overall Study||0||
59905713|NCT03677869|76026617|FG000|STARTED|Overall Study||35||
59905714|NCT03677869|76026617|FG000|COMPLETED|Overall Study||34||
59757817|NCT02975349|75876973|FG000|STARTED|Blinded Extension Period (24 Weeks)||0||
59757818|NCT02975349|75876974|FG001|STARTED|Blinded Extension Period (24 Weeks)||49||
59757819|NCT02975349|75876975|FG002|STARTED|Blinded Extension Period (24 Weeks)||47||
59905715|NCT03677869|76026617|FG000|NOT COMPLETED|Overall Study||1||
59905716|NCT03677401|76026623|FG000|STARTED|Overall Study||148||
59905717|NCT03677401|76026624|FG001|STARTED|Overall Study||147||
59905718|NCT03677401|76026623|FG000|COMPLETED|Overall Study||138||
59905719|NCT03677401|76026624|FG001|COMPLETED|Overall Study||129||
59905720|NCT03677401|76026623|FG000|NOT COMPLETED|Overall Study||10||
59757820|NCT02975349|75876976|FG003|STARTED|Blinded Extension Period (24 Weeks)||48||
59762678|NCT00857259|75882528|FG001|STARTED|Overall Study||1||
59905721|NCT03677401|76026624|FG001|NOT COMPLETED|Overall Study||18||
59905722|NCT03218787|76026630|FG000|STARTED|Overall Study||2047||
59905723|NCT03218787|76026630|FG000|COMPLETED|Overall Study||1841||
59905724|NCT03218787|76026630|FG000|NOT COMPLETED|Overall Study||206||
59905725|NCT01348087|76026634|FG000|STARTED|Overall Study||148||
59905726|NCT01348087|76026634|FG000|COMPLETED|Overall Study||0||
59905727|NCT01348087|76026634|FG000|NOT COMPLETED|Overall Study||148||
59905728|NCT01347931|76026648|FG000|STARTED|Standard Oxygen Therapy||30||
59905729|NCT01347931|76026648|FG000|COMPLETED|Standard Oxygen Therapy||29||
59905730|NCT01347931|76026648|FG000|NOT COMPLETED|Standard Oxygen Therapy||1||
59905731|NCT01347931|76026648|FG000|STARTED|NIOV System||29||
59905732|NCT01347931|76026648|FG000|COMPLETED|NIOV System||29||
59905733|NCT01347931|76026648|FG000|NOT COMPLETED|NIOV System||0||
59905734|NCT03645421|76026658|FG000|STARTED|Overall Study||16||
59905735|NCT03645421|76026659|FG001|STARTED|Overall Study||15||
59905736|NCT03645421|76026660|FG002|STARTED|Overall Study||15||
59905737|NCT03645421|76026661|FG003|STARTED|Overall Study||15||
59905738|NCT03645421|76026658|FG000|Received Investigational Product (IP)|Overall Study||16||
59905739|NCT03645421|76026659|FG001|Received Investigational Product (IP)|Overall Study||15||
59905740|NCT03645421|76026660|FG002|Received Investigational Product (IP)|Overall Study||15||
59905741|NCT03645421|76026661|FG003|Received Investigational Product (IP)|Overall Study||15||
59905742|NCT03645421|76026658|FG000|COMPLETED|Overall Study||16||
59905743|NCT03645421|76026659|FG001|COMPLETED|Overall Study||15||
59905744|NCT03645421|76026660|FG002|COMPLETED|Overall Study||10||
59905745|NCT03645421|76026661|FG003|COMPLETED|Overall Study||11||
59905746|NCT03645421|76026658|FG000|NOT COMPLETED|Overall Study||0||
59905747|NCT03645421|76026659|FG001|NOT COMPLETED|Overall Study||0||
59905748|NCT03645421|76026660|FG002|NOT COMPLETED|Overall Study||5||
59905749|NCT03645421|76026661|FG003|NOT COMPLETED|Overall Study||4||
59905750|NCT03207750|76026676|FG000|STARTED|Overall Study||632||
59905751|NCT03207750|76026677|FG001|STARTED|Overall Study||640||
59905752|NCT03207750|76026676|FG000|COMPLETED|Overall Study||574||
59905753|NCT03207750|76026677|FG001|COMPLETED|Overall Study||574||
59905754|NCT03207750|76026676|FG000|NOT COMPLETED|Overall Study||58||
59905755|NCT03207750|76026677|FG001|NOT COMPLETED|Overall Study||66||
59905756|NCT03674281|76026686|FG000|STARTED|Overall Study||18||
59905757|NCT03674281|76026687|FG001|STARTED|Overall Study||16||
59905758|NCT03674281|76026688|FG002|STARTED|Overall Study||16||
59905759|NCT03674281|76026686|FG000|COMPLETED|Overall Study||15||
59905760|NCT03674281|76026687|FG001|COMPLETED|Overall Study||13||
59905761|NCT03674281|76026688|FG002|COMPLETED|Overall Study||13||
59905762|NCT03674281|76026686|FG000|NOT COMPLETED|Overall Study||3||
59905763|NCT03674281|76026687|FG001|NOT COMPLETED|Overall Study||3||
59905764|NCT03674281|76026688|FG002|NOT COMPLETED|Overall Study||3||
59905765|NCT03673345|76026712|FG000|STARTED|Overall Study||5||
59905766|NCT03673345|76026713|FG001|STARTED|Overall Study||3||
59905767|NCT03673345|76026714|FG002|STARTED|Overall Study||57||
59905768|NCT03673345|76026715|FG003|STARTED|Overall Study||12||
59905769|NCT03673345|76026716|FG004|STARTED|Overall Study||21||
59905770|NCT03673345|76026717|FG005|STARTED|Overall Study||7||
59905771|NCT03673345|76026718|FG006|STARTED|Overall Study||20||
59905772|NCT03673345|76026719|FG007|STARTED|Overall Study||0||
59905773|NCT03673345|76026712|FG000|COMPLETED|Overall Study||3||
59905774|NCT03673345|76026713|FG001|COMPLETED|Overall Study||3||
59905775|NCT03673345|76026714|FG002|COMPLETED|Overall Study||48||
59905776|NCT03673345|76026715|FG003|COMPLETED|Overall Study||7||
59905777|NCT03673345|76026716|FG004|COMPLETED|Overall Study||19||
59905778|NCT03673345|76026717|FG005|COMPLETED|Overall Study||6||
59905779|NCT03673345|76026718|FG006|COMPLETED|Overall Study||20||
59905780|NCT03673345|76026719|FG007|COMPLETED|Overall Study||0||
59905781|NCT03673345|76026712|FG000|NOT COMPLETED|Overall Study||2||
59905782|NCT03673345|76026713|FG001|NOT COMPLETED|Overall Study||0||
59905783|NCT03673345|76026714|FG002|NOT COMPLETED|Overall Study||9||
59905784|NCT03673345|76026715|FG003|NOT COMPLETED|Overall Study||5||
59905785|NCT03673345|76026716|FG004|NOT COMPLETED|Overall Study||2||
59905786|NCT03673345|76026717|FG005|NOT COMPLETED|Overall Study||1||
59905787|NCT03673345|76026718|FG006|NOT COMPLETED|Overall Study||0||
59905788|NCT03673345|76026719|FG007|NOT COMPLETED|Overall Study||0||
59905789|NCT03223662|76026737|FG000|STARTED|Overall Study||2||
59905790|NCT03223662|76026737|FG000|COMPLETED|Overall Study||0||
59905791|NCT03223662|76026737|FG000|NOT COMPLETED|Overall Study||2||
59905792|NCT03672097|76026741|FG000|STARTED|Period 1||204||
59905793|NCT03672097|76026741|FG000|COMPLETED|Period 1||200||
59905794|NCT03672097|76026741|FG000|NOT COMPLETED|Period 1||4||
59905795|NCT03672097|76026741|FG000|STARTED|Period 2||200||
59905796|NCT03672097|76026741|FG000|COMPLETED|Period 2||196||
59905797|NCT03672097|76026741|FG000|NOT COMPLETED|Period 2||4||
59905798|NCT03847896|76026750|FG000|STARTED|Overall Study||197||
59506157|NCT00750815|75599037|FG000|NOT COMPLETED|Overall Study||0||
59506158|NCT00750815|75599038|FG001|NOT COMPLETED|Overall Study||0||
59905799|NCT03847896|76026751|FG001|STARTED|Overall Study||204||
59905800|NCT03847896|76026752|FG002|STARTED|Overall Study||200||
59905801|NCT03847896|76026753|FG003|STARTED|Overall Study||201||
59905802|NCT03847896|76026754|FG004|STARTED|Overall Study||199||
59905803|NCT03847896|76026750|FG000|COMPLETED|Overall Study||190||
59905804|NCT03847896|76026751|FG001|COMPLETED|Overall Study||188||
59905805|NCT03847896|76026752|FG002|COMPLETED|Overall Study||188||
59905806|NCT03847896|76026753|FG003|COMPLETED|Overall Study||184||
59905807|NCT03847896|76026754|FG004|COMPLETED|Overall Study||178||
59905808|NCT03847896|76026750|FG000|NOT COMPLETED|Overall Study||7||
59905809|NCT03847896|76026751|FG001|NOT COMPLETED|Overall Study||16||
59757821|NCT02975349|75876977|FG004|STARTED|Blinded Extension Period (24 Weeks)||48||
59757822|NCT02975349|75876978|FG005|STARTED|Blinded Extension Period (24 Weeks)||52||
59757823|NCT02975349|75876973|FG000|COMPLETED|Blinded Extension Period (24 Weeks)||0||
59757824|NCT02975349|75876974|FG001|COMPLETED|Blinded Extension Period (24 Weeks)||42||
59757825|NCT02975349|75876975|FG002|COMPLETED|Blinded Extension Period (24 Weeks)||43||
59757826|NCT02975349|75876976|FG003|COMPLETED|Blinded Extension Period (24 Weeks)||44||
59757827|NCT02975349|75876977|FG004|COMPLETED|Blinded Extension Period (24 Weeks)||46||
59757828|NCT02975349|75876978|FG005|COMPLETED|Blinded Extension Period (24 Weeks)||52||
59757829|NCT02975349|75876973|FG000|NOT COMPLETED|Blinded Extension Period (24 Weeks)||0||
59757830|NCT02975349|75876974|FG001|NOT COMPLETED|Blinded Extension Period (24 Weeks)||7||
59757831|NCT02975349|75876975|FG002|NOT COMPLETED|Blinded Extension Period (24 Weeks)||4||
59757832|NCT02975349|75876976|FG003|NOT COMPLETED|Blinded Extension Period (24 Weeks)||4||
59757833|NCT02975349|75876977|FG004|NOT COMPLETED|Blinded Extension Period (24 Weeks)||2||
59757834|NCT02975349|75876978|FG005|NOT COMPLETED|Blinded Extension Period (24 Weeks)||0||
59757835|NCT03645681|75876997|FG000|STARTED|Overall Study||26||
59757836|NCT03645681|75876997|FG000|Primary Endpoint Analyzed|Overall Study||12||
59757837|NCT03645681|75876997|FG000|Completed 24 Month|Overall Study||3||
59757838|NCT03645681|75876997|FG000|Not Completed|Overall Study||23||
59757839|NCT03645681|75876997|FG000|Entered Long Term Follow Up|Overall Study||3||
59757840|NCT03645681|75876997|FG000|COMPLETED|Overall Study||0|Completed long term follow up to date (Feb 2023)|
59757841|NCT03645681|75876997|FG000|NOT COMPLETED|Overall Study||26||
59757842|NCT02955394|75877003|FG000|STARTED|Overall Study||27||
59757843|NCT02955394|75877004|FG001|STARTED|Overall Study||34||
59757844|NCT02955394|75877003|FG000|COMPLETED|Overall Study||25||
59757845|NCT02955394|75877004|FG001|COMPLETED|Overall Study||32||
59757846|NCT02955394|75877003|FG000|NOT COMPLETED|Overall Study||2||
59757847|NCT02955394|75877004|FG001|NOT COMPLETED|Overall Study||2||
59757848|NCT02882321|75877014|FG000|STARTED|Overall Study||4||
59757849|NCT02882321|75877015|FG001|STARTED|Overall Study||3||
59757850|NCT02882321|75877016|FG002|STARTED|Overall Study||3||
59757851|NCT02882321|75877017|FG003|STARTED|Overall Study||7||
59757852|NCT02882321|75877014|FG000|COMPLETED|Overall Study||4||
59757853|NCT02882321|75877015|FG001|COMPLETED|Overall Study||3||
59757854|NCT02882321|75877016|FG002|COMPLETED|Overall Study||3||
59757855|NCT02882321|75877017|FG003|COMPLETED|Overall Study||7||
59757856|NCT02882321|75877014|FG000|NOT COMPLETED|Overall Study||0||
59757857|NCT02882321|75877015|FG001|NOT COMPLETED|Overall Study||0||
59757858|NCT02882321|75877016|FG002|NOT COMPLETED|Overall Study||0||
59757859|NCT02882321|75877017|FG003|NOT COMPLETED|Overall Study||0||
59757860|NCT02645019|75877033|FG000|STARTED|Overall Study||13||
59757861|NCT02645019|75877034|FG001|STARTED|Overall Study||15||
59757862|NCT02645019|75877035|FG002|STARTED|Overall Study||15||
59757863|NCT02645019|75877036|FG003|STARTED|Overall Study||33||
59757864|NCT02645019|75877037|FG004|STARTED|Overall Study||24||
59757865|NCT02645019|75877033|FG000|COMPLETED|Overall Study||13||
59757866|NCT02645019|75877034|FG001|COMPLETED|Overall Study||15||
59757867|NCT02645019|75877035|FG002|COMPLETED|Overall Study||15||
59757868|NCT02645019|75877036|FG003|COMPLETED|Overall Study||33||
59757869|NCT02645019|75877037|FG004|COMPLETED|Overall Study||24||
59757870|NCT02645019|75877033|FG000|NOT COMPLETED|Overall Study||0||
59757871|NCT02645019|75877034|FG001|NOT COMPLETED|Overall Study||0||
59757872|NCT02645019|75877035|FG002|NOT COMPLETED|Overall Study||0||
59757873|NCT02645019|75877036|FG003|NOT COMPLETED|Overall Study||0||
59757874|NCT02645019|75877037|FG004|NOT COMPLETED|Overall Study||0||
59757875|NCT02520141|75877049|FG000|STARTED|Overall Study||61||
59757876|NCT02520141|75877049|FG000|COMPLETED|Overall Study||60||
59757877|NCT02520141|75877049|FG000|NOT COMPLETED|Overall Study||1||
59757878|NCT02329847|75877061|FG000|STARTED|Overall Study||7||
59757879|NCT02329847|75877062|FG001|STARTED|Overall Study||7||
59757880|NCT02329847|75877063|FG002|STARTED|Overall Study||36||
59757881|NCT02329847|75877064|FG003|STARTED|Overall Study||35||
59757882|NCT02329847|75877065|FG004|STARTED|Overall Study||39||
59757883|NCT02329847|75877066|FG005|STARTED|Overall Study||20||
59757884|NCT02329847|75877061|FG000|Treated (Safety Analysis Set)|Overall Study||7||
59757885|NCT02329847|75877062|FG001|Treated (Safety Analysis Set)|Overall Study||7||
59757886|NCT02329847|75877063|FG002|Treated (Safety Analysis Set)|Overall Study||35||
59757887|NCT02329847|75877064|FG003|Treated (Safety Analysis Set)|Overall Study||35||
59757888|NCT02329847|75877065|FG004|Treated (Safety Analysis Set)|Overall Study||37||
59757889|NCT02329847|75877066|FG005|Treated (Safety Analysis Set)|Overall Study||20||
59757890|NCT02329847|75877061|FG000|COMPLETED|Overall Study||0||
59757891|NCT02329847|75877062|FG001|COMPLETED|Overall Study||0||
59757892|NCT02329847|75877063|FG002|COMPLETED|Overall Study||1||
59757893|NCT02329847|75877064|FG003|COMPLETED|Overall Study||0||
59757894|NCT02329847|75877065|FG004|COMPLETED|Overall Study||0||
59757895|NCT02329847|75877066|FG005|COMPLETED|Overall Study||0||
59757896|NCT02329847|75877061|FG000|NOT COMPLETED|Overall Study||7||
59757897|NCT02329847|75877062|FG001|NOT COMPLETED|Overall Study||7||
59757898|NCT02329847|75877063|FG002|NOT COMPLETED|Overall Study||35||
59757899|NCT02329847|75877064|FG003|NOT COMPLETED|Overall Study||35||
59757900|NCT02329847|75877065|FG004|NOT COMPLETED|Overall Study||39||
59905810|NCT03847896|76026752|FG002|NOT COMPLETED|Overall Study||12||
59905811|NCT03847896|76026753|FG003|NOT COMPLETED|Overall Study||17||
59905812|NCT03847896|76026754|FG004|NOT COMPLETED|Overall Study||21||
59905813|NCT03670537|76026766|FG000|STARTED|Overall Study||102||
59905814|NCT03670537|76026766|FG000|COMPLETED|Overall Study||101||
59905815|NCT03670537|76026766|FG000|NOT COMPLETED|Overall Study||1||
59905816|NCT03619837|76026770|FG000|STARTED|Screening||122||
59905817|NCT03619837|76026770|FG000|COMPLETED|Screening||24||
59905818|NCT03619837|76026770|FG000|NOT COMPLETED|Screening||98||
59905819|NCT03619837|76026770|FG000|STARTED|Main Study||24||
59905820|NCT03619837|76026770|FG000|COMPLETED|Main Study||24||
60015056|NCT02607865|76131197|FG003|NOT COMPLETED|Overall Study||16||
60015057|NCT01668667|76131211|FG000|STARTED|Overall Study||126||
60015058|NCT01668667|76131212|FG001|STARTED|Overall Study||125||
60015059|NCT01668667|76131213|FG002|STARTED|Overall Study||125||
60015060|NCT01668667|76131214|FG003|STARTED|Overall Study||125||
60015061|NCT01668667|76131211|FG000|COMPLETED|Overall Study||95||
60015062|NCT01668667|76131212|FG001|COMPLETED|Overall Study||99||
60015063|NCT01668667|76131213|FG002|COMPLETED|Overall Study||94||
60015064|NCT01668667|76131214|FG003|COMPLETED|Overall Study||102||
60015065|NCT01668667|76131211|FG000|NOT COMPLETED|Overall Study||31||
60015066|NCT01668667|76131212|FG001|NOT COMPLETED|Overall Study||26||
60015067|NCT01668667|76131213|FG002|NOT COMPLETED|Overall Study||31||
60015068|NCT01668667|76131214|FG003|NOT COMPLETED|Overall Study||23||
60015069|NCT02608879|76131227|FG000|STARTED|Overall Study||10||
60015070|NCT02608879|76131228|FG001|STARTED|Overall Study||6||
59506159|NCT00784849|75599048|FG000|STARTED|Overall Study||62||
59506160|NCT00784849|75599048|FG000|COMPLETED|Overall Study||62||
59506161|NCT00784849|75599048|FG000|NOT COMPLETED|Overall Study||0||
59506162|NCT01277861|75599054|FG000|STARTED|Overall Study||51||
59506163|NCT01277861|75599055|FG001|STARTED|Overall Study||49||
59506164|NCT01277861|75599054|FG000|COMPLETED|Overall Study||49||
59757901|NCT02329847|75877066|FG005|NOT COMPLETED|Overall Study||20||
59905821|NCT03619837|76026770|FG000|NOT COMPLETED|Main Study||0||
59905822|NCT03206970|76026774|FG000|STARTED|Overall Study||86||
59905823|NCT03206970|76026774|FG000|Received at Least 1 Dose of Study Drug|Overall Study||86|Safety Analysis Set|
59905824|NCT03206970|76026774|FG000|COMPLETED|Overall Study||0||
60015071|NCT02608879|76131229|FG002|STARTED|Overall Study||3||
60015072|NCT02608879|76131227|FG000|COMPLETED|Overall Study||9||
60015073|NCT02608879|76131228|FG001|COMPLETED|Overall Study||6||
60015074|NCT02608879|76131229|FG002|COMPLETED|Overall Study||0||
60015075|NCT02608879|76131227|FG000|NOT COMPLETED|Overall Study||1||
60015076|NCT02608879|76131228|FG001|NOT COMPLETED|Overall Study||0||
60015077|NCT02608879|76131229|FG002|NOT COMPLETED|Overall Study||3||
60015078|NCT02608099|76131239|FG000|STARTED|Overall Study||148|This number represents the intention-to-treat population.|
60015079|NCT02608099|76131240|FG001|STARTED|Overall Study||152|This number represents the intention-to-treat population.|
60015080|NCT02608099|76131239|FG000|Safety|Overall Study||149|This number represents the safety population (analyzed under the actual treatment received).|
60015081|NCT02608099|76131240|FG001|Safety|Overall Study||151|This number represents the safety population (analyzed under the actual treatment received).|
60015082|NCT02608099|76131239|FG000|COMPLETED|Overall Study||145|This represents the evaluable population (analyzed under assigned/randomized treatment).|
60015083|NCT02608099|76131240|FG001|COMPLETED|Overall Study||150|This represents the evaluable population (analyzed under assigned/randomized treatment).|
60015084|NCT02608099|76131239|FG000|NOT COMPLETED|Overall Study||3||
60015085|NCT02608099|76131240|FG001|NOT COMPLETED|Overall Study||2||
60015086|NCT01668589|76131250|FG000|STARTED|Overall Study||600||
60015087|NCT01668589|76131251|FG001|STARTED|Overall Study||300||
60015088|NCT01668589|76131252|FG002|STARTED|Overall Study||300||
59506165|NCT01277861|75599055|FG001|COMPLETED|Overall Study||47||
59506166|NCT01277861|75599054|FG000|NOT COMPLETED|Overall Study||2||
59506167|NCT01277861|75599055|FG001|NOT COMPLETED|Overall Study||2||
59506168|NCT00786487|75599067|FG000|STARTED|Overall Study||10||
59506169|NCT00786487|75599068|FG001|STARTED|Overall Study||7||
59506170|NCT00786487|75599069|FG002|STARTED|Overall Study||9||
59506171|NCT00786487|75599070|FG003|STARTED|Overall Study||7||
59506172|NCT00786487|75599067|FG000|COMPLETED|Overall Study||10||
59905825|NCT03206970|76026774|FG000|NOT COMPLETED|Overall Study||86||
59905826|NCT03644173|76026778|FG000|STARTED|Participants at Last Visit (Pre-surveys)||37||
59905827|NCT03644173|76026778|FG000|COMPLETED|Participants at Last Visit (Pre-surveys)||16||
59506173|NCT00786487|75599068|FG001|COMPLETED|Overall Study||7||
59506174|NCT00786487|75599069|FG002|COMPLETED|Overall Study||9||
59506175|NCT00786487|75599070|FG003|COMPLETED|Overall Study||7||
59506176|NCT00786487|75599067|FG000|NOT COMPLETED|Overall Study||0||
60015089|NCT01668589|76131253|FG003|STARTED|Overall Study||301||
60015090|NCT01668589|76131250|FG000|Received Denosumab|Overall Study||599||
60015091|NCT01668589|76131251|FG001|Received Denosumab|Overall Study||300||
60015092|NCT01668589|76131252|FG002|Received Denosumab|Overall Study||300||
60015093|NCT01668589|76131253|FG003|Received Denosumab|Overall Study||301||
60015094|NCT01668589|76131250|FG000|COMPLETED|Overall Study||461||
60015095|NCT01668589|76131251|FG001|COMPLETED|Overall Study||242||
60015096|NCT01668589|76131252|FG002|COMPLETED|Overall Study||265||
60015097|NCT01668589|76131253|FG003|COMPLETED|Overall Study||266||
60015098|NCT01668589|76131250|FG000|NOT COMPLETED|Overall Study||139||
60015099|NCT01668589|76131251|FG001|NOT COMPLETED|Overall Study||58||
60015100|NCT01668589|76131252|FG002|NOT COMPLETED|Overall Study||35||
60015101|NCT01668589|76131253|FG003|NOT COMPLETED|Overall Study||35||
60015102|NCT02432235|76131275|FG000|STARTED|Overall Study||2||
60015103|NCT02432235|76131276|FG001|STARTED|Overall Study||2||
60015104|NCT02432235|76131277|FG002|STARTED|Overall Study||2||
60015105|NCT02432235|76131278|FG003|STARTED|Overall Study||3||
60015106|NCT02432235|76131279|FG004|STARTED|Overall Study||2||
60015107|NCT02432235|76131280|FG005|STARTED|Overall Study||20||
60015108|NCT02432235|76131281|FG006|STARTED|Overall Study||41||
60015109|NCT02432235|76131282|FG007|STARTED|Overall Study||29||
60015110|NCT02432235|76131283|FG008|STARTED|Overall Study||26||
60015111|NCT02432235|76131284|FG009|STARTED|Overall Study||3||
60015112|NCT02432235|76131285|FG010|STARTED|Overall Study||2||
60015113|NCT02432235|76131286|FG011|STARTED|Overall Study||1||
60015114|NCT02432235|76131275|FG000|COMPLETED|Overall Study||1||
60015115|NCT02432235|76131276|FG001|COMPLETED|Overall Study||0||
60015116|NCT02432235|76131277|FG002|COMPLETED|Overall Study||0||
60015117|NCT02432235|76131278|FG003|COMPLETED|Overall Study||1||
60015118|NCT02432235|76131279|FG004|COMPLETED|Overall Study||0||
60015119|NCT02432235|76131280|FG005|COMPLETED|Overall Study||8||
60015120|NCT02432235|76131281|FG006|COMPLETED|Overall Study||23||
60015121|NCT02432235|76131282|FG007|COMPLETED|Overall Study||9||
60015122|NCT02432235|76131283|FG008|COMPLETED|Overall Study||5||
60015123|NCT02432235|76131284|FG009|COMPLETED|Overall Study||0||
60015124|NCT02432235|76131285|FG010|COMPLETED|Overall Study||1||
60015125|NCT02432235|76131286|FG011|COMPLETED|Overall Study||0||
60015126|NCT02432235|76131275|FG000|NOT COMPLETED|Overall Study||1||
60015127|NCT02432235|76131276|FG001|NOT COMPLETED|Overall Study||2||
60015128|NCT02432235|76131277|FG002|NOT COMPLETED|Overall Study||2||
60015129|NCT02432235|76131278|FG003|NOT COMPLETED|Overall Study||2||
60015130|NCT02432235|76131279|FG004|NOT COMPLETED|Overall Study||2||
60015131|NCT02432235|76131280|FG005|NOT COMPLETED|Overall Study||12||
60015132|NCT02432235|76131281|FG006|NOT COMPLETED|Overall Study||18||
60015133|NCT02432235|76131282|FG007|NOT COMPLETED|Overall Study||20||
60015134|NCT02432235|76131283|FG008|NOT COMPLETED|Overall Study||21||
60015135|NCT02432235|76131284|FG009|NOT COMPLETED|Overall Study||3||
60015136|NCT02432235|76131285|FG010|NOT COMPLETED|Overall Study||1||
60015137|NCT02432235|76131286|FG011|NOT COMPLETED|Overall Study||1||
60015138|NCT02431533|76131316|FG000|STARTED|Overall Study||25||
60015139|NCT02431533|76131317|FG001|STARTED|Overall Study||25||
60015140|NCT02431533|76131316|FG000|COMPLETED|Overall Study||23||
59506177|NCT00786487|75599068|FG001|NOT COMPLETED|Overall Study||0||
59506178|NCT00786487|75599069|FG002|NOT COMPLETED|Overall Study||0||
59506179|NCT00786487|75599070|FG003|NOT COMPLETED|Overall Study||0||
59506180|NCT01277549|75599082|FG000|STARTED|Overall Study||41||
59506181|NCT01277549|75599083|FG001|STARTED|Overall Study||29||
59506182|NCT01277549|75599082|FG000|COMPLETED|Overall Study||15||
59506183|NCT01277549|75599083|FG001|COMPLETED|Overall Study||15||
59506184|NCT01277549|75599082|FG000|NOT COMPLETED|Overall Study||26||
59506185|NCT01277549|75599083|FG001|NOT COMPLETED|Overall Study||14||
60015141|NCT02431533|76131317|FG001|COMPLETED|Overall Study||22||
60015142|NCT02431533|76131316|FG000|NOT COMPLETED|Overall Study||2||
60015143|NCT02431533|76131317|FG001|NOT COMPLETED|Overall Study||3||
60015144|NCT02416791|76131326|FG000|STARTED|6 Weeks||3||
60015145|NCT02416791|76131327|FG001|STARTED|6 Weeks||3||
60015146|NCT02416791|76131328|FG002|STARTED|6 Weeks||3||
59506186|NCT01276847|75599095|FG000|STARTED|Overall Study||10||
59506187|NCT01276847|75599096|FG001|STARTED|Overall Study||10||
59506188|NCT01276847|75599097|FG002|STARTED|Overall Study||20||
59506189|NCT01276847|75599095|FG000|COMPLETED|Overall Study||9||
59506190|NCT01276847|75599096|FG001|COMPLETED|Overall Study||10||
59506191|NCT01276847|75599097|FG002|COMPLETED|Overall Study||20||
59506192|NCT01276847|75599095|FG000|NOT COMPLETED|Overall Study||1||
60015147|NCT02416791|76131326|FG000|COMPLETED|6 Weeks||3||
60015148|NCT02416791|76131327|FG001|COMPLETED|6 Weeks||3||
60015149|NCT02416791|76131328|FG002|COMPLETED|6 Weeks||3||
60015150|NCT02416791|76131326|FG000|NOT COMPLETED|6 Weeks||0||
60015151|NCT02416791|76131327|FG001|NOT COMPLETED|6 Weeks||0||
60015152|NCT02416791|76131328|FG002|NOT COMPLETED|6 Weeks||0||
60015153|NCT02416791|76131326|FG000|STARTED|6 Months||3||
60015154|NCT02416791|76131327|FG001|STARTED|6 Months||3||
60015155|NCT02416791|76131328|FG002|STARTED|6 Months||3||
60015156|NCT02416791|76131326|FG000|COMPLETED|6 Months||3||
60015157|NCT02416791|76131327|FG001|COMPLETED|6 Months||3||
60015158|NCT02416791|76131328|FG002|COMPLETED|6 Months||2||
60015159|NCT02416791|76131326|FG000|NOT COMPLETED|6 Months||0||
60015160|NCT02416791|76131327|FG001|NOT COMPLETED|6 Months||0||
60015161|NCT02416791|76131328|FG002|NOT COMPLETED|6 Months||1||
60015162|NCT02414841|76131338|FG000|STARTED|Overall Study||405||
60015163|NCT02414841|76131339|FG001|STARTED|Overall Study||208||
59506193|NCT01276847|75599096|FG001|NOT COMPLETED|Overall Study||0||
59905828|NCT03644173|76026778|FG000|NOT COMPLETED|Participants at Last Visit (Pre-surveys)||21||
59905829|NCT03644173|76026778|FG000|STARTED|Participants at the 1-month Follow up||16||
59905830|NCT03644173|76026778|FG000|COMPLETED|Participants at the 1-month Follow up||12||
59905831|NCT03644173|76026778|FG000|NOT COMPLETED|Participants at the 1-month Follow up||4||
59905832|NCT03644173|76026778|FG000|STARTED|Participants at the 3-month Follow up||12||
59905833|NCT03644173|76026778|FG000|COMPLETED|Participants at the 3-month Follow up||10||
59905834|NCT03644173|76026778|FG000|NOT COMPLETED|Participants at the 3-month Follow up||2||
59905835|NCT03178851|76026786|FG000|STARTED|Overall Study||92||
59905836|NCT03178851|76026787|FG001|STARTED|Overall Study||11||
59905837|NCT03178851|76026788|FG002|STARTED|Overall Study||52||
59905838|NCT03178851|76026786|FG000|COMPLETED|Overall Study||0||
59905839|NCT03178851|76026787|FG001|COMPLETED|Overall Study||0||
59905840|NCT03178851|76026788|FG002|COMPLETED|Overall Study||0||
59905841|NCT03178851|76026786|FG000|NOT COMPLETED|Overall Study||92||
59905842|NCT03178851|76026787|FG001|NOT COMPLETED|Overall Study||11||
59905843|NCT03178851|76026788|FG002|NOT COMPLETED|Overall Study||52||
59905844|NCT03643159|76026799|FG000|STARTED|Overall Study||2||
59905845|NCT03643159|76026799|FG000|Received At Least 1 Dose Of Study Drug|Overall Study||2||
59905846|NCT03643159|76026799|FG000|COMPLETED|Overall Study||0||
59905847|NCT03643159|76026799|FG000|NOT COMPLETED|Overall Study||2||
59905848|NCT03205566|76026806|FG000|STARTED|Phase 1|One participant withdrawn and replaced. Data obtained from first participant still used in analysis|19||
59905849|NCT03205566|76026807|FG001|STARTED|Phase 1|One participant withdrawn and replaced. Data obtained from first participant still used in analysis|19||
59905850|NCT03205566|76026806|FG000|COMPLETED|Phase 1||18||
59905851|NCT03205566|76026807|FG001|COMPLETED|Phase 1||18||
59905852|NCT03205566|76026806|FG000|NOT COMPLETED|Phase 1||1||
59905853|NCT03205566|76026807|FG001|NOT COMPLETED|Phase 1||1||
59905854|NCT03205566|76026806|FG000|STARTED|Phase 2||18||
59905855|NCT03205566|76026807|FG001|STARTED|Phase 2||18||
59905856|NCT03205566|76026806|FG000|COMPLETED|Phase 2||18||
59905857|NCT03205566|76026807|FG001|COMPLETED|Phase 2||18||
59905858|NCT03205566|76026806|FG000|NOT COMPLETED|Phase 2||0||
59905859|NCT03205566|76026807|FG001|NOT COMPLETED|Phase 2||0||
59905860|NCT02935452|76026819|FG000|STARTED|Overall Study||30||
59905861|NCT02935452|76026820|FG001|STARTED|Overall Study||30||
59905862|NCT02935452|76026819|FG000|COMPLETED|Overall Study||27||
59905863|NCT02935452|76026820|FG001|COMPLETED|Overall Study||29||
59905864|NCT02935452|76026819|FG000|NOT COMPLETED|Overall Study||3||
59905865|NCT02935452|76026820|FG001|NOT COMPLETED|Overall Study||1||
59905866|NCT03178773|76026828|FG000|STARTED|Overall Study||86||
59905867|NCT03178773|76026829|FG001|STARTED|Overall Study||80||
59905868|NCT03178773|76026828|FG000|3month Phone Follow up|Overall Study||49||
59905869|NCT03178773|76026829|FG001|3month Phone Follow up|Overall Study||51||
59905870|NCT03178773|76026828|FG000|6month in Person Follow up|Overall Study||54||
59905871|NCT03178773|76026829|FG001|6month in Person Follow up|Overall Study||46||
59905872|NCT03178773|76026828|FG000|9month Follow up Phone|Overall Study||36||
59905873|NCT03178773|76026829|FG001|9month Follow up Phone|Overall Study||51||
59905874|NCT03178773|76026828|FG000|COMPLETED|Overall Study||47||
59905875|NCT03178773|76026829|FG001|COMPLETED|Overall Study||40||
59905876|NCT03178773|76026828|FG000|NOT COMPLETED|Overall Study||39||
59905877|NCT03178773|76026829|FG001|NOT COMPLETED|Overall Study||40||
59905878|NCT03713034|76026838|FG000|STARTED|Overall Study||150||
59905879|NCT03713034|76026839|FG001|STARTED|Overall Study||146||
59905880|NCT03713034|76026838|FG000|COMPLETED|Overall Study||145||
59905881|NCT03713034|76026839|FG001|COMPLETED|Overall Study||142||
59905882|NCT03713034|76026838|FG000|NOT COMPLETED|Overall Study||5||
59905883|NCT03713034|76026839|FG001|NOT COMPLETED|Overall Study||4||
59905884|NCT03218397|76026849|FG000|STARTED|Overall Study||249||
59905885|NCT03218397|76026850|FG001|STARTED|Overall Study||251||
60015164|NCT02414841|76131338|FG000|COMPLETED|Overall Study||349||
60015165|NCT02414841|76131339|FG001|COMPLETED|Overall Study||175||
60015166|NCT02414841|76131338|FG000|NOT COMPLETED|Overall Study||56||
59506194|NCT01276847|75599097|FG002|NOT COMPLETED|Overall Study||0||
59506195|NCT00765193|75599104|FG000|STARTED|Problem Area Examination||14381||
59905886|NCT03218397|76026849|FG000|COMPLETED|Overall Study||226||
59905887|NCT03218397|76026850|FG001|COMPLETED|Overall Study||222||
59905888|NCT03218397|76026849|FG000|NOT COMPLETED|Overall Study||23||
59905889|NCT03218397|76026850|FG001|NOT COMPLETED|Overall Study||29||
60015167|NCT02414841|76131339|FG001|NOT COMPLETED|Overall Study||33||
60015168|NCT02413593|76131347|FG000|STARTED|Overall Study||111||
59905890|NCT03618823|76026858|FG000|STARTED|Overall Study||132||
59905891|NCT03618823|76026859|FG001|STARTED|Overall Study||136||
59905892|NCT03618823|76026858|FG000|COMPLETED|Overall Study||69||
59905893|NCT03618823|76026859|FG001|COMPLETED|Overall Study||75||
59905894|NCT03618823|76026858|FG000|NOT COMPLETED|Overall Study||63||
59905895|NCT03618823|76026859|FG001|NOT COMPLETED|Overall Study||61||
59905896|NCT03640507|76026871|FG000|STARTED|Overall Study||10||
59905897|NCT03640507|76026872|FG001|STARTED|Overall Study||9||
59905898|NCT03640507|76026873|FG002|STARTED|Overall Study||11||
59905899|NCT03640507|76026871|FG000|COMPLETED|Overall Study||10||
59905900|NCT03640507|76026872|FG001|COMPLETED|Overall Study||9||
59905901|NCT03640507|76026873|FG002|COMPLETED|Overall Study||10||
59905902|NCT03640507|76026871|FG000|NOT COMPLETED|Overall Study||0||
59905903|NCT03640507|76026872|FG001|NOT COMPLETED|Overall Study||0||
59905904|NCT03640507|76026873|FG002|NOT COMPLETED|Overall Study||1||
59905905|NCT02937636|76026883|FG000|STARTED|Overall Study||63||
59905906|NCT02937636|76026884|FG001|STARTED|Overall Study||65||
59905907|NCT02937636|76026883|FG000|COMPLETED|Overall Study||60||
59905908|NCT02937636|76026884|FG001|COMPLETED|Overall Study||63||
59905909|NCT02937636|76026883|FG000|NOT COMPLETED|Overall Study||3||
59905910|NCT02937636|76026884|FG001|NOT COMPLETED|Overall Study||2||
59905911|NCT03638635|76026893|FG000|STARTED|Initial Hospitalization||39||
59905912|NCT03638635|76026894|FG001|STARTED|Initial Hospitalization||24||
59905913|NCT03638635|76026893|FG000|COMPLETED|Initial Hospitalization||39||
59905914|NCT03638635|76026894|FG001|COMPLETED|Initial Hospitalization||22||
59905915|NCT03638635|76026893|FG000|NOT COMPLETED|Initial Hospitalization||0||
59905916|NCT03638635|76026894|FG001|NOT COMPLETED|Initial Hospitalization||2||
59905917|NCT03638635|76026893|FG000|STARTED|Follow-Up (30 Days After Discharge)||39||
59905918|NCT03638635|76026894|FG001|STARTED|Follow-Up (30 Days After Discharge)||22||
59905919|NCT03638635|76026893|FG000|COMPLETED|Follow-Up (30 Days After Discharge)||0||
59905920|NCT03638635|76026894|FG001|COMPLETED|Follow-Up (30 Days After Discharge)||0||
59905921|NCT03638635|76026893|FG000|NOT COMPLETED|Follow-Up (30 Days After Discharge)||39||
59905922|NCT03638635|76026894|FG001|NOT COMPLETED|Follow-Up (30 Days After Discharge)||22||
59905923|NCT03204981|76026900|FG000|STARTED|Overall Study||52||
59905924|NCT03204981|76026900|FG000|COMPLETED|Overall Study||46||
59905925|NCT03204981|76026900|FG000|NOT COMPLETED|Overall Study||6||
59905926|NCT03205488|76026909|FG000|STARTED|Overall Study||25||
59905927|NCT03205488|76026910|FG001|STARTED|Overall Study||25||
59905928|NCT03205488|76026911|FG002|STARTED|Overall Study||26||
59905929|NCT03205488|76026909|FG000|COMPLETED|Overall Study||24||
59905930|NCT03205488|76026910|FG001|COMPLETED|Overall Study||23||
59905931|NCT03205488|76026911|FG002|COMPLETED|Overall Study||21||
59905932|NCT03205488|76026909|FG000|NOT COMPLETED|Overall Study||1||
59905933|NCT03205488|76026910|FG001|NOT COMPLETED|Overall Study||2||
59905934|NCT03205488|76026911|FG002|NOT COMPLETED|Overall Study||5||
59905935|NCT03204279|76026925|FG000|STARTED|Overall Study||34||
59905936|NCT03204279|76026926|FG001|STARTED|Overall Study||33||
59905937|NCT03204279|76026925|FG000|COMPLETED|Overall Study||34||
59905938|NCT03204279|76026926|FG001|COMPLETED|Overall Study||32||
59905939|NCT03204279|76026925|FG000|NOT COMPLETED|Overall Study||0||
59905940|NCT03204279|76026926|FG001|NOT COMPLETED|Overall Study||1||
59905941|NCT03173547|76026935|FG000|STARTED|Overall Study||40||
59905942|NCT03173547|76026936|FG001|STARTED|Overall Study||40||
59905943|NCT03173547|76026935|FG000|COMPLETED|Overall Study||36||
59905944|NCT03173547|76026936|FG001|COMPLETED|Overall Study||38||
59905945|NCT03173547|76026935|FG000|NOT COMPLETED|Overall Study||4||
59905946|NCT03173547|76026936|FG001|NOT COMPLETED|Overall Study||2||
59905947|NCT02954653|76026944|FG000|STARTED|Overall Study||4||
59905948|NCT02954653|76026945|FG001|STARTED|Overall Study||4||
59905949|NCT02954653|76026946|FG002|STARTED|Overall Study|No participants were enrolled in this arm.|0||
59905950|NCT02954653|76026947|FG003|STARTED|Overall Study|No participants were enrolled in this arm.|0||
59905951|NCT02954653|76026948|FG004|STARTED|Overall Study|No participants were enrolled in this arm.|0||
59905952|NCT02954653|76026949|FG005|STARTED|Overall Study|No participants were enrolled in this arm.|0||
59905953|NCT02954653|76026950|FG006|STARTED|Overall Study|No participants were enrolled in this arm.|0||
59905954|NCT02954653|76026951|FG007|STARTED|Overall Study|No participants were enrolled in this arm.|0||
59905955|NCT02954653|76026952|FG008|STARTED|Overall Study|No participants were enrolled in this arm.|0||
59905956|NCT02954653|76026944|FG000|Received Treatment|Overall Study||3||
59905957|NCT02954653|76026945|FG001|Received Treatment|Overall Study||4||
59905958|NCT02954653|76026946|FG002|Received Treatment|Overall Study||0||
59905959|NCT02954653|76026947|FG003|Received Treatment|Overall Study||0||
59905960|NCT02954653|76026948|FG004|Received Treatment|Overall Study||0||
59905961|NCT02954653|76026949|FG005|Received Treatment|Overall Study||0||
59905962|NCT02954653|76026950|FG006|Received Treatment|Overall Study||0||
59905963|NCT02954653|76026951|FG007|Received Treatment|Overall Study||0||
59905964|NCT02954653|76026952|FG008|Received Treatment|Overall Study||0||
59905965|NCT02954653|76026944|FG000|COMPLETED|Overall Study||0||
59905966|NCT02954653|76026945|FG001|COMPLETED|Overall Study||1||
59905967|NCT02954653|76026946|FG002|COMPLETED|Overall Study||0||
59905968|NCT02954653|76026947|FG003|COMPLETED|Overall Study||0||
59905969|NCT02954653|76026948|FG004|COMPLETED|Overall Study||0||
59905970|NCT02954653|76026949|FG005|COMPLETED|Overall Study||0||
59905971|NCT02954653|76026950|FG006|COMPLETED|Overall Study||0||
59905972|NCT02954653|76026951|FG007|COMPLETED|Overall Study||0||
59905973|NCT02954653|76026952|FG008|COMPLETED|Overall Study||0||
59905974|NCT02954653|76026944|FG000|NOT COMPLETED|Overall Study||4||
60015169|NCT02413593|76131347|FG000|COMPLETED|Overall Study||107||
60015170|NCT02413593|76131347|FG000|NOT COMPLETED|Overall Study||4||
60015171|NCT01652703|76131357|FG000|STARTED|Overall Study||52||
60015172|NCT01652703|76131358|FG001|STARTED|Overall Study||51||
60015173|NCT01652703|76131359|FG002|STARTED|Overall Study||50||
60015174|NCT01652703|76131360|FG003|STARTED|Overall Study||52||
60015175|NCT01652703|76131361|FG004|STARTED|Overall Study||52||
60015176|NCT01652703|76131362|FG005|STARTED|Overall Study||53||
60015177|NCT01652703|76131357|FG000|Received Treatment|Overall Study||52||
60015178|NCT01652703|76131358|FG001|Received Treatment|Overall Study||50||
59905975|NCT02954653|76026945|FG001|NOT COMPLETED|Overall Study||3||
59905976|NCT02954653|76026946|FG002|NOT COMPLETED|Overall Study||0||
59905977|NCT02954653|76026947|FG003|NOT COMPLETED|Overall Study||0||
59905978|NCT02954653|76026948|FG004|NOT COMPLETED|Overall Study||0||
59905979|NCT02954653|76026949|FG005|NOT COMPLETED|Overall Study||0||
59905980|NCT02954653|76026950|FG006|NOT COMPLETED|Overall Study||0||
59905981|NCT02954653|76026951|FG007|NOT COMPLETED|Overall Study||0||
59905982|NCT02954653|76026952|FG008|NOT COMPLETED|Overall Study||0||
59905983|NCT03173313|76026966|FG000|STARTED|Overall Study||58||
59905984|NCT03173313|76026967|FG001|STARTED|Overall Study||53||
60015179|NCT01652703|76131359|FG002|Received Treatment|Overall Study||49||
60015180|NCT01652703|76131360|FG003|Received Treatment|Overall Study||52||
60015181|NCT01652703|76131361|FG004|Received Treatment|Overall Study||51||
60015182|NCT01652703|76131362|FG005|Received Treatment|Overall Study||53||
60015183|NCT01652703|76131357|FG000|COMPLETED|Overall Study||52||
60015184|NCT01652703|76131358|FG001|COMPLETED|Overall Study||50||
60015185|NCT01652703|76131359|FG002|COMPLETED|Overall Study||47||
60015186|NCT01652703|76131360|FG003|COMPLETED|Overall Study||50||
60015187|NCT01652703|76131361|FG004|COMPLETED|Overall Study||51||
60015188|NCT01652703|76131362|FG005|COMPLETED|Overall Study||51||
60015189|NCT01652703|76131357|FG000|NOT COMPLETED|Overall Study||0||
60015190|NCT01652703|76131358|FG001|NOT COMPLETED|Overall Study||1||
60015191|NCT01652703|76131359|FG002|NOT COMPLETED|Overall Study||3||
60015192|NCT01652703|76131360|FG003|NOT COMPLETED|Overall Study||2||
60015193|NCT01652703|76131361|FG004|NOT COMPLETED|Overall Study||1||
60015194|NCT01652703|76131362|FG005|NOT COMPLETED|Overall Study||2||
60015195|NCT01652469|76131378|FG000|STARTED|Overall Study||38||
60015196|NCT01652469|76131379|FG001|STARTED|Overall Study||42||
60015197|NCT01652469|76131378|FG000|COMPLETED|Overall Study||37||
60015198|NCT01652469|76131379|FG001|COMPLETED|Overall Study||36||
60015199|NCT01652469|76131378|FG000|NOT COMPLETED|Overall Study||1||
60015200|NCT01652469|76131379|FG001|NOT COMPLETED|Overall Study||6||
60015201|NCT02429427|76131387|FG000|STARTED|Overall Study||1763||
60015202|NCT02429427|76131388|FG001|STARTED|Overall Study||876||
60015203|NCT02429427|76131387|FG000|COMPLETED|Overall Study||1392||
60015204|NCT02429427|76131388|FG001|COMPLETED|Overall Study||697||
60015205|NCT02429427|76131387|FG000|NOT COMPLETED|Overall Study||371||
60015206|NCT02429427|76131388|FG001|NOT COMPLETED|Overall Study||179||
60015207|NCT02412735|76131397|FG000|STARTED|Overall Study||143||
60015208|NCT02412735|76131398|FG001|STARTED|Overall Study||129||
60015209|NCT02412735|76131399|FG002|STARTED|Overall Study||132||
60015210|NCT02412735|76131397|FG000|Received Treatment|Overall Study||140||
60015211|NCT02412735|76131398|FG001|Received Treatment|Overall Study||128||
60015212|NCT02412735|76131399|FG002|Received Treatment|Overall Study||130||
60015213|NCT02412735|76131397|FG000|COMPLETED|Overall Study||97||
60015214|NCT02412735|76131398|FG001|COMPLETED|Overall Study||85||
60015215|NCT02412735|76131399|FG002|COMPLETED|Overall Study||86||
60015216|NCT02412735|76131397|FG000|NOT COMPLETED|Overall Study||46||
60015217|NCT02412735|76131398|FG001|NOT COMPLETED|Overall Study||44||
60015218|NCT02412735|76131399|FG002|NOT COMPLETED|Overall Study||46||
60015219|NCT02412657|76131410|FG000|STARTED|Overall Study||25||
60015220|NCT02412657|76131411|FG001|STARTED|Overall Study||25||
60015221|NCT02412657|76131412|FG002|STARTED|Overall Study||25||
60015222|NCT02412657|76131410|FG000|COMPLETED|Overall Study||24||
60015223|NCT02412657|76131411|FG001|COMPLETED|Overall Study||23||
60015224|NCT02412657|76131412|FG002|COMPLETED|Overall Study||22||
60015225|NCT02412657|76131410|FG000|NOT COMPLETED|Overall Study||1||
60015226|NCT02412657|76131411|FG001|NOT COMPLETED|Overall Study||2||
60015227|NCT02412657|76131412|FG002|NOT COMPLETED|Overall Study||3||
60015228|NCT02428413|76131422|FG000|STARTED|Overall Study||64||
60015229|NCT02428413|76131423|FG001|STARTED|Overall Study||61||
60015230|NCT02428413|76131422|FG000|COMPLETED|Overall Study||56||
60015231|NCT02428413|76131423|FG001|COMPLETED|Overall Study||52||
60015232|NCT02428413|76131422|FG000|NOT COMPLETED|Overall Study||8||
60015233|NCT02428413|76131423|FG001|NOT COMPLETED|Overall Study||9||
60015234|NCT02412111|76131431|FG000|STARTED|Ivacaftor Run-in Period (4 Weeks)||156||
60015235|NCT02412111|76131432|FG001|STARTED|Ivacaftor Run-in Period (4 Weeks)||0||
60015236|NCT02412111|76131433|FG002|STARTED|Ivacaftor Run-in Period (4 Weeks)||0||
60015237|NCT02412111|76131431|FG000|COMPLETED|Ivacaftor Run-in Period (4 Weeks)||153||
60015238|NCT02412111|76131432|FG001|COMPLETED|Ivacaftor Run-in Period (4 Weeks)||0||
60015239|NCT02412111|76131433|FG002|COMPLETED|Ivacaftor Run-in Period (4 Weeks)||0||
60015240|NCT02412111|76131431|FG000|NOT COMPLETED|Ivacaftor Run-in Period (4 Weeks)||3||
59905985|NCT03173313|76026966|FG000|Informed Consent Signed|Overall Study||58||
60015241|NCT02412111|76131432|FG001|NOT COMPLETED|Ivacaftor Run-in Period (4 Weeks)||0||
60015242|NCT02412111|76131433|FG002|NOT COMPLETED|Ivacaftor Run-in Period (4 Weeks)||0||
60015243|NCT02412111|76131431|FG000|STARTED|Active Comparator Period (8 Weeks)||0|Two participants who completed the Run-in period did not enter the active comparator period.|
60015244|NCT02412111|76131432|FG001|STARTED|Active Comparator Period (8 Weeks)||76|Two participants who completed the Run-in period did not enter the active comparator period.|
60015245|NCT02412111|76131433|FG002|STARTED|Active Comparator Period (8 Weeks)||75|Two participants who completed the Run-in period did not enter the active comparator period.|
60015246|NCT02412111|76131431|FG000|Full Analysis Set|Active Comparator Period (8 Weeks)||0||
60015247|NCT02412111|76131432|FG001|Full Analysis Set|Active Comparator Period (8 Weeks)||76||
60015248|NCT02412111|76131433|FG002|Full Analysis Set|Active Comparator Period (8 Weeks)||74||
60015249|NCT02412111|76131431|FG000|COMPLETED|Active Comparator Period (8 Weeks)||0||
60015250|NCT02412111|76131432|FG001|COMPLETED|Active Comparator Period (8 Weeks)||75||
60015251|NCT02412111|76131433|FG002|COMPLETED|Active Comparator Period (8 Weeks)||69||
60015252|NCT02412111|76131431|FG000|NOT COMPLETED|Active Comparator Period (8 Weeks)||0||
60015253|NCT02412111|76131432|FG001|NOT COMPLETED|Active Comparator Period (8 Weeks)||1||
60015254|NCT02412111|76131433|FG002|NOT COMPLETED|Active Comparator Period (8 Weeks)||6||
60015255|NCT02427477|76131445|FG000|STARTED|Period 1||60||
60015256|NCT02427477|76131446|FG001|STARTED|Period 1||60||
60015257|NCT02427477|76131445|FG000|COMPLETED|Period 1||59||
60015258|NCT02427477|76131446|FG001|COMPLETED|Period 1||60||
60015259|NCT02427477|76131445|FG000|NOT COMPLETED|Period 1||1||
60015260|NCT02427477|76131446|FG001|NOT COMPLETED|Period 1||0||
60015261|NCT02427477|76131445|FG000|STARTED|Period 2||59||
60015262|NCT02427477|76131446|FG001|STARTED|Period 2||60||
60015263|NCT02427477|76131445|FG000|COMPLETED|Period 2||59||
60015264|NCT02427477|76131446|FG001|COMPLETED|Period 2||60||
60015265|NCT02427477|76131445|FG000|NOT COMPLETED|Period 2||0||
60015266|NCT02427477|76131446|FG001|NOT COMPLETED|Period 2||0||
60015267|NCT02427477|76131445|FG000|STARTED|Period 3||59||
60015268|NCT02427477|76131446|FG001|STARTED|Period 3||60||
60015269|NCT02427477|76131445|FG000|COMPLETED|Period 3||59||
60015270|NCT02427477|76131446|FG001|COMPLETED|Period 3||60||
60015271|NCT02427477|76131445|FG000|NOT COMPLETED|Period 3||0||
60015272|NCT02427477|76131446|FG001|NOT COMPLETED|Period 3||0||
60015273|NCT02427399|76131457|FG000|STARTED|Overall Study||220||
60015274|NCT02427399|76131458|FG001|STARTED|Overall Study||220||
60015275|NCT02427399|76131459|FG002|STARTED|Overall Study||220||
60015276|NCT02427399|76131460|FG003|STARTED|Overall Study||220||
59611407|NCT01779648|75722374|FG000|STARTED|Overall Study||28||
59611408|NCT01779648|75722375|FG001|STARTED|Overall Study||27||
59611409|NCT01779648|75722374|FG000|COMPLETED|Overall Study||27||
59611410|NCT01779648|75722375|FG001|COMPLETED|Overall Study||27||
59611411|NCT01779648|75722374|FG000|NOT COMPLETED|Overall Study||1||
59611412|NCT01779648|75722375|FG001|NOT COMPLETED|Overall Study||0||
59611413|NCT01762800|75722383|FG000|STARTED|Overall Study||202||
59611414|NCT01762800|75722384|FG001|STARTED|Overall Study||204||
59611415|NCT01762800|75722383|FG000|COMPLETED|Overall Study||183||
59611416|NCT01762800|75722384|FG001|COMPLETED|Overall Study||183||
59611417|NCT01762800|75722383|FG000|NOT COMPLETED|Overall Study||19||
59611418|NCT01762800|75722384|FG001|NOT COMPLETED|Overall Study||21||
60015277|NCT02427399|76131461|FG004|STARTED|Overall Study||220||
60015278|NCT02427399|76131457|FG000|COMPLETED|Overall Study||206||
60015279|NCT02427399|76131458|FG001|COMPLETED|Overall Study||204||
60015280|NCT02427399|76131459|FG002|COMPLETED|Overall Study||208||
60015281|NCT02427399|76131460|FG003|COMPLETED|Overall Study||202||
60015282|NCT02427399|76131461|FG004|COMPLETED|Overall Study||205||
60015283|NCT02427399|76131457|FG000|NOT COMPLETED|Overall Study||14||
60015284|NCT02427399|76131458|FG001|NOT COMPLETED|Overall Study||16||
60015285|NCT02427399|76131459|FG002|NOT COMPLETED|Overall Study||12||
60015286|NCT02427399|76131460|FG003|NOT COMPLETED|Overall Study||18||
60015287|NCT02427399|76131461|FG004|NOT COMPLETED|Overall Study||15||
60015288|NCT02426541|76131475|FG000|STARTED|Overall Study||16||
60015289|NCT02426541|76131476|FG001|STARTED|Overall Study||16||
60015290|NCT02426541|76131475|FG000|COMPLETED|Overall Study||15||
60015291|NCT02426541|76131476|FG001|COMPLETED|Overall Study||16||
60015292|NCT02426541|76131475|FG000|NOT COMPLETED|Overall Study||1||
60015293|NCT02426541|76131476|FG001|NOT COMPLETED|Overall Study||0||
60015294|NCT02484651|76131484|FG000|STARTED|Overall Study|35 patients were randomized|35||
60015295|NCT02484651|76131485|FG001|STARTED|Overall Study|35 patients were randomized|35||
60015296|NCT02484651|76131484|FG000|End of Clinical Study|Overall Study||35|Patients that followed the protocol and finished the clinical study.|
60015297|NCT02484651|76131485|FG001|End of Clinical Study|Overall Study||35|Patients that followed the protocol and finished the clinical study.|
60015298|NCT02484651|76131484|FG000|Data Analysis|Overall Study||32|Patients with valid recorded data included in the data analysis|
60015299|NCT02484651|76131485|FG001|Data Analysis|Overall Study||31|Patients with valid recorded data included in the data analysis|
60015300|NCT02484651|76131484|FG000|COMPLETED|Overall Study||32||
60015301|NCT02484651|76131485|FG001|COMPLETED|Overall Study||31||
60015302|NCT02484651|76131484|FG000|NOT COMPLETED|Overall Study||3||
60015303|NCT02484651|76131485|FG001|NOT COMPLETED|Overall Study||4||
60015304|NCT02410551|76131492|FG000|STARTED|Overall Study||4||
60015305|NCT02410551|76131492|FG000|COMPLETED|Overall Study||0||
59905986|NCT03173313|76026967|FG001|Informed Consent Signed|Overall Study||53||
59905987|NCT03173313|76026966|FG000|Randomized|Overall Study||58||
59905988|NCT03173313|76026967|FG001|Randomized|Overall Study||53||
59905989|NCT03173313|76026966|FG000|Cooled|Overall Study||54||
59905990|NCT03173313|76026967|FG001|Cooled|Overall Study||0||
59905991|NCT03173313|76026966|FG000|4-6 Day Follow-up|Overall Study||57||
59905992|NCT03173313|76026967|FG001|4-6 Day Follow-up|Overall Study||53||
59905993|NCT03173313|76026966|FG000|30-day Follow-up|Overall Study||52||
59905994|NCT03173313|76026967|FG001|30-day Follow-up|Overall Study||51||
59905995|NCT03173313|76026966|FG000|12-month Follow-up|Overall Study||49||
59905996|NCT03173313|76026967|FG001|12-month Follow-up|Overall Study||48||
59905997|NCT03173313|76026966|FG000|COMPLETED|Overall Study||49||
59905998|NCT03173313|76026967|FG001|COMPLETED|Overall Study||48||
59905999|NCT03173313|76026966|FG000|NOT COMPLETED|Overall Study||9||
59906000|NCT03173313|76026967|FG001|NOT COMPLETED|Overall Study||5||
59906001|NCT03215667|76026973|FG000|STARTED|Overall Study||9||
59906002|NCT03215667|76026973|FG000|COMPLETED|Overall Study||5||
59906003|NCT03215667|76026973|FG000|NOT COMPLETED|Overall Study||4||
59906004|NCT03634579|76026977|FG000|STARTED|Overall Study||9||
59906005|NCT03634579|76026977|FG000|COMPLETED|Overall Study||0||
59906006|NCT03634579|76026977|FG000|NOT COMPLETED|Overall Study||9||
59906007|NCT02730208|76026983|FG000|STARTED|Overall Study||20||
59906008|NCT02730208|76026984|FG001|STARTED|Overall Study||21||
59906009|NCT02730208|76026983|FG000|COMPLETED|Overall Study||20||
59906010|NCT02730208|76026984|FG001|COMPLETED|Overall Study||20||
59906011|NCT02730208|76026983|FG000|NOT COMPLETED|Overall Study||0||
59906012|NCT02730208|76026984|FG001|NOT COMPLETED|Overall Study||1||
59906013|NCT01291511|76026992|FG000|STARTED|Cross-Titration and Stabilization Phase||635||
59906014|NCT01291511|76026993|FG001|STARTED|Cross-Titration and Stabilization Phase||0||
59906015|NCT01291511|76026992|FG000|COMPLETED|Cross-Titration and Stabilization Phase||309||
59906016|NCT01291511|76026993|FG001|COMPLETED|Cross-Titration and Stabilization Phase||0||
59906017|NCT01291511|76026992|FG000|NOT COMPLETED|Cross-Titration and Stabilization Phase||326||
59906018|NCT01291511|76026993|FG001|NOT COMPLETED|Cross-Titration and Stabilization Phase||0||
59906019|NCT01291511|76026992|FG000|STARTED|Double-blind Relapse Prevention Phase||153||
59906020|NCT01291511|76026993|FG001|STARTED|Double-blind Relapse Prevention Phase||150||
59906021|NCT01291511|76026992|FG000|COMPLETED|Double-blind Relapse Prevention Phase||76||
59906022|NCT01291511|76026993|FG001|COMPLETED|Double-blind Relapse Prevention Phase||102||
59906023|NCT01291511|76026992|FG000|NOT COMPLETED|Double-blind Relapse Prevention Phase||77||
59906024|NCT01291511|76026993|FG001|NOT COMPLETED|Double-blind Relapse Prevention Phase||48||
59906025|NCT03201900|76027000|FG000|STARTED|Treatment Phase (Up to 62 Weeks)||91||
59906026|NCT03201900|76027000|FG000|Treated|Treatment Phase (Up to 62 Weeks)||89||
59906027|NCT03201900|76027000|FG000|COMPLETED|Treatment Phase (Up to 62 Weeks)||54||
59906028|NCT03201900|76027000|FG000|NOT COMPLETED|Treatment Phase (Up to 62 Weeks)||37||
59906029|NCT03201900|76027000|FG000|STARTED|Extension Phase (From Week 63 to 156)|Eligible participants who completed Treatment Phase and agreed to continue in the Extension Phase.|46||
59906030|NCT03201900|76027000|FG000|COMPLETED|Extension Phase (From Week 63 to 156)||38||
59906031|NCT03201900|76027000|FG000|NOT COMPLETED|Extension Phase (From Week 63 to 156)||8||
59906032|NCT01572207|76027006|FG000|STARTED|Overall Study||14||
59906033|NCT01572207|76027007|FG001|STARTED|Overall Study||16||
59906034|NCT01572207|76027006|FG000|COMPLETED|Overall Study||12||
59906035|NCT01572207|76027007|FG001|COMPLETED|Overall Study||13||
59906036|NCT01572207|76027006|FG000|NOT COMPLETED|Overall Study||2||
59906037|NCT01572207|76027007|FG001|NOT COMPLETED|Overall Study||3||
59906038|NCT03170271|76027015|FG000|STARTED|Overall Study||431|Randomized|
59906039|NCT03170271|76027016|FG001|STARTED|Overall Study||229|Randomized|
59906040|NCT03170271|76027015|FG000|Received Treatment|Overall Study||427||
59906041|NCT03170271|76027016|FG001|Received Treatment|Overall Study||229||
59906042|NCT03170271|76027015|FG000|COMPLETED|Overall Study||398|Completed double-blind period of study|
59906043|NCT03170271|76027016|FG001|COMPLETED|Overall Study||218|Completed double-blind period of study|
59906044|NCT03170271|76027015|FG000|NOT COMPLETED|Overall Study||33||
59906045|NCT03170271|76027016|FG001|NOT COMPLETED|Overall Study||11||
59906046|NCT03613129|76027026|FG000|STARTED|Pre-treatment Assessment||3||
59906047|NCT03613129|76027027|FG001|STARTED|Pre-treatment Assessment||3||
59906048|NCT03613129|76027028|FG002|STARTED|Pre-treatment Assessment||7||
59906049|NCT03613129|76027029|FG003|STARTED|Pre-treatment Assessment||2||
59906050|NCT03613129|76027030|FG004|STARTED|Pre-treatment Assessment||2||
59906051|NCT03613129|76027026|FG000|COMPLETED|Pre-treatment Assessment||0||
59906052|NCT03613129|76027027|FG001|COMPLETED|Pre-treatment Assessment||3||
59906053|NCT03613129|76027028|FG002|COMPLETED|Pre-treatment Assessment||7||
59906054|NCT03613129|76027029|FG003|COMPLETED|Pre-treatment Assessment||2||
59906055|NCT03613129|76027030|FG004|COMPLETED|Pre-treatment Assessment||2||
59906056|NCT03613129|76027026|FG000|NOT COMPLETED|Pre-treatment Assessment||3||
59906057|NCT03613129|76027027|FG001|NOT COMPLETED|Pre-treatment Assessment||0||
59906058|NCT03613129|76027028|FG002|NOT COMPLETED|Pre-treatment Assessment||0||
59906059|NCT03613129|76027029|FG003|NOT COMPLETED|Pre-treatment Assessment||0||
59906060|NCT03613129|76027030|FG004|NOT COMPLETED|Pre-treatment Assessment||0||
59906061|NCT03613129|76027026|FG000|STARTED|Treatment||0||
59906062|NCT03613129|76027027|FG001|STARTED|Treatment||3||
59906063|NCT03613129|76027028|FG002|STARTED|Treatment||7||
59906064|NCT03613129|76027029|FG003|STARTED|Treatment||2||
59906065|NCT03613129|76027030|FG004|STARTED|Treatment||2||
59906066|NCT03613129|76027026|FG000|COMPLETED|Treatment||0||
59906067|NCT03613129|76027027|FG001|COMPLETED|Treatment|ID35 received only 1 infusion (due to symptom worsening)|3||
59906068|NCT03613129|76027028|FG002|COMPLETED|Treatment||7||
59906069|NCT03613129|76027029|FG003|COMPLETED|Treatment|ID34 did not receive 3rd infusion (for lack of venous access)|2||
59906070|NCT03613129|76027030|FG004|COMPLETED|Treatment||2||
59906071|NCT03613129|76027026|FG000|NOT COMPLETED|Treatment||0||
59906072|NCT03613129|76027027|FG001|NOT COMPLETED|Treatment||0||
59906073|NCT03613129|76027028|FG002|NOT COMPLETED|Treatment||0||
59906074|NCT03613129|76027029|FG003|NOT COMPLETED|Treatment||0||
59906075|NCT03613129|76027030|FG004|NOT COMPLETED|Treatment||0||
59906076|NCT03613129|76027026|FG000|STARTED|Post-treatment Assessment||0||
59906077|NCT03613129|76027027|FG001|STARTED|Post-treatment Assessment||3||
59906078|NCT03613129|76027028|FG002|STARTED|Post-treatment Assessment||7||
59906079|NCT03613129|76027029|FG003|STARTED|Post-treatment Assessment||2||
59906080|NCT03613129|76027030|FG004|STARTED|Post-treatment Assessment||2||
59906081|NCT03613129|76027026|FG000|COMPLETED|Post-treatment Assessment||0||
59906082|NCT03613129|76027027|FG001|COMPLETED|Post-treatment Assessment||3||
59906083|NCT03613129|76027028|FG002|COMPLETED|Post-treatment Assessment||7||
59906084|NCT03613129|76027029|FG003|COMPLETED|Post-treatment Assessment||2||
59906085|NCT03613129|76027030|FG004|COMPLETED|Post-treatment Assessment||2||
59906086|NCT03613129|76027026|FG000|NOT COMPLETED|Post-treatment Assessment||0||
59906087|NCT03613129|76027027|FG001|NOT COMPLETED|Post-treatment Assessment||0||
59906088|NCT03613129|76027028|FG002|NOT COMPLETED|Post-treatment Assessment||0||
59906089|NCT03613129|76027029|FG003|NOT COMPLETED|Post-treatment Assessment||0||
59906090|NCT03613129|76027030|FG004|NOT COMPLETED|Post-treatment Assessment||0||
59906091|NCT03235284|76027045|FG000|STARTED|Overall Study||15||
59906092|NCT03235284|76027046|FG001|STARTED|Overall Study||15||
59906093|NCT03235284|76027047|FG002|STARTED|Overall Study||15||
59906094|NCT03235284|76027045|FG000|COMPLETED|Overall Study||14||
59906095|NCT03235284|76027046|FG001|COMPLETED|Overall Study||13||
59906096|NCT03235284|76027047|FG002|COMPLETED|Overall Study||14||
59906097|NCT03235284|76027045|FG000|NOT COMPLETED|Overall Study||1||
59906098|NCT03235284|76027046|FG001|NOT COMPLETED|Overall Study||2||
59906099|NCT03235284|76027047|FG002|NOT COMPLETED|Overall Study||1||
59906100|NCT03170193|76027062|FG000|STARTED|Overall Study||12||
59906101|NCT03170193|76027063|FG001|STARTED|Overall Study||6||
59906102|NCT03170193|76027064|FG002|STARTED|Overall Study||6||
59906103|NCT03170193|76027065|FG003|STARTED|Overall Study||6||
59906104|NCT03170193|76027066|FG004|STARTED|Overall Study||6||
59906105|NCT03170193|76027067|FG005|STARTED|Overall Study||6||
59906106|NCT03170193|76027068|FG006|STARTED|Overall Study||6||
59906107|NCT03170193|76027062|FG000|COMPLETED|Overall Study||11||
59906108|NCT03170193|76027063|FG001|COMPLETED|Overall Study||5||
59906109|NCT03170193|76027064|FG002|COMPLETED|Overall Study||6||
59906110|NCT03170193|76027065|FG003|COMPLETED|Overall Study||5||
59906111|NCT03170193|76027066|FG004|COMPLETED|Overall Study||6||
59906112|NCT03170193|76027067|FG005|COMPLETED|Overall Study||6||
59906113|NCT03170193|76027068|FG006|COMPLETED|Overall Study||6||
59906114|NCT03170193|76027062|FG000|NOT COMPLETED|Overall Study||1||
59906115|NCT03170193|76027063|FG001|NOT COMPLETED|Overall Study||1||
59906116|NCT03170193|76027064|FG002|NOT COMPLETED|Overall Study||0||
59906117|NCT03170193|76027065|FG003|NOT COMPLETED|Overall Study||1||
59906118|NCT03170193|76027066|FG004|NOT COMPLETED|Overall Study||0||
59906119|NCT03170193|76027067|FG005|NOT COMPLETED|Overall Study||0||
59906120|NCT03170193|76027068|FG006|NOT COMPLETED|Overall Study||0||
59906121|NCT03633331|76027090|FG000|STARTED|Overall Study||93||
59906122|NCT03633331|76027090|FG000|COMPLETED|Overall Study||92||
59906123|NCT03633331|76027090|FG000|NOT COMPLETED|Overall Study||1||
59906124|NCT03201003|76027096|FG000|STARTED|Overall Study||132||
59906125|NCT03201003|76027097|FG001|STARTED|Overall Study||43||
59906126|NCT03201003|76027096|FG000|COMPLETED|Overall Study||106||
59906127|NCT03201003|76027097|FG001|COMPLETED|Overall Study||40||
59906128|NCT03201003|76027096|FG000|NOT COMPLETED|Overall Study||26||
59906129|NCT03201003|76027097|FG001|NOT COMPLETED|Overall Study||3||
59906130|NCT03166215|76027105|FG000|STARTED|Part 1 (Double-blind TP: Days 1 - 30)||4||
59906131|NCT03166215|76027106|FG001|STARTED|Part 1 (Double-blind TP: Days 1 - 30)||14||
59906132|NCT03166215|76027107|FG002|STARTED|Part 1 (Double-blind TP: Days 1 - 30)||0||
59906133|NCT03166215|76027105|FG000|COMPLETED|Part 1 (Double-blind TP: Days 1 - 30)||4||
59906134|NCT03166215|76027106|FG001|COMPLETED|Part 1 (Double-blind TP: Days 1 - 30)||12||
59906135|NCT03166215|76027107|FG002|COMPLETED|Part 1 (Double-blind TP: Days 1 - 30)||0||
59906136|NCT03166215|76027105|FG000|NOT COMPLETED|Part 1 (Double-blind TP: Days 1 - 30)||0||
59906137|NCT03166215|76027106|FG001|NOT COMPLETED|Part 1 (Double-blind TP: Days 1 - 30)||2||
59906138|NCT03166215|76027107|FG002|NOT COMPLETED|Part 1 (Double-blind TP: Days 1 - 30)||0||
59906139|NCT03166215|76027105|FG000|STARTED|Part 2 (Open-Label TP: Days 31 - 85)||0||
59906140|NCT03166215|76027106|FG001|STARTED|Part 2 (Open-Label TP: Days 31 - 85)||0||
59906141|NCT03166215|76027107|FG002|STARTED|Part 2 (Open-Label TP: Days 31 - 85)||16||
59906142|NCT03166215|76027105|FG000|COMPLETED|Part 2 (Open-Label TP: Days 31 - 85)||0||
60015306|NCT02410551|76131492|FG000|NOT COMPLETED|Overall Study||4||
60015307|NCT02424591|76131499|FG000|STARTED|Overall Study||22||
60015308|NCT02424591|76131500|FG001|STARTED|Overall Study||23||
60015309|NCT02424591|76131499|FG000|COMPLETED|Overall Study||20||
60015310|NCT02424591|76131500|FG001|COMPLETED|Overall Study||20||
60015311|NCT02424591|76131499|FG000|NOT COMPLETED|Overall Study||2||
60015312|NCT02424591|76131500|FG001|NOT COMPLETED|Overall Study||3||
60015313|NCT02408523|76131508|FG000|STARTED|Overall Study||121||
60015314|NCT02408523|76131509|FG001|STARTED|Overall Study||121||
60015315|NCT02408523|76131508|FG000|Completed Treatment Period|Overall Study||110||
60015316|NCT02408523|76131509|FG001|Completed Treatment Period|Overall Study||103||
60015317|NCT02408523|76131508|FG000|Enrolled Transition Period|Overall Study||108||
60015318|NCT02408523|76131509|FG001|Enrolled Transition Period|Overall Study||101||
60015319|NCT02408523|76131508|FG000|Enrolled Taper Period|Overall Study||7||
60015320|NCT02408523|76131509|FG001|Enrolled Taper Period|Overall Study||9||
60015321|NCT02408523|76131508|FG000|Enrolled Safety Folllow-up Period|Overall Study||10||
60015322|NCT02408523|76131509|FG001|Enrolled Safety Folllow-up Period|Overall Study||11||
60015323|NCT02408523|76131508|FG000|COMPLETED|Overall Study||110||
60015324|NCT02408523|76131509|FG001|COMPLETED|Overall Study||103||
60015325|NCT02408523|76131508|FG000|NOT COMPLETED|Overall Study||11||
60015326|NCT02408523|76131509|FG001|NOT COMPLETED|Overall Study||18||
60015327|NCT02603419|76131529|FG000|STARTED|Lead-in Phase:Maximum Exposure:123Weeks||6||
60015328|NCT02603419|76131530|FG001|STARTED|Lead-in Phase:Maximum Exposure:123Weeks||7||
60015329|NCT02603419|76131531|FG002|STARTED|Lead-in Phase:Maximum Exposure:123Weeks||6||
60015330|NCT02603419|76131532|FG003|STARTED|Lead-in Phase:Maximum Exposure:123Weeks||6||
60015331|NCT02603419|76131533|FG004|STARTED|Lead-in Phase:Maximum Exposure:123Weeks||6||
60015332|NCT02603419|76131534|FG005|STARTED|Lead-in Phase:Maximum Exposure:123Weeks||0||
60015333|NCT02603419|76131529|FG000|Treated|Lead-in Phase:Maximum Exposure:123Weeks||6||
60015334|NCT02603419|76131530|FG001|Treated|Lead-in Phase:Maximum Exposure:123Weeks||6||
60015335|NCT02603419|76131531|FG002|Treated|Lead-in Phase:Maximum Exposure:123Weeks||6||
60015336|NCT02603419|76131532|FG003|Treated|Lead-in Phase:Maximum Exposure:123Weeks||6||
60015337|NCT02603419|76131533|FG004|Treated|Lead-in Phase:Maximum Exposure:123Weeks||6||
60015338|NCT02603419|76131534|FG005|Treated|Lead-in Phase:Maximum Exposure:123Weeks||0||
60015339|NCT02603419|76131529|FG000|COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0||
60015340|NCT02603419|76131530|FG001|COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0||
60015341|NCT02603419|76131531|FG002|COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0||
60015342|NCT02603419|76131532|FG003|COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0||
60015343|NCT02603419|76131533|FG004|COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0||
60015344|NCT02603419|76131534|FG005|COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0||
60015345|NCT02603419|76131529|FG000|NOT COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||6||
60015346|NCT02603419|76131530|FG001|NOT COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||7||
59906143|NCT03166215|76027106|FG001|COMPLETED|Part 2 (Open-Label TP: Days 31 - 85)||0||
59906144|NCT03166215|76027107|FG002|COMPLETED|Part 2 (Open-Label TP: Days 31 - 85)||14||
59906145|NCT03166215|76027105|FG000|NOT COMPLETED|Part 2 (Open-Label TP: Days 31 - 85)||0||
59906146|NCT03166215|76027106|FG001|NOT COMPLETED|Part 2 (Open-Label TP: Days 31 - 85)||0||
59906147|NCT03166215|76027107|FG002|NOT COMPLETED|Part 2 (Open-Label TP: Days 31 - 85)||2||
59906148|NCT02752191|76027120|FG000|STARTED|Overall Study||14||
60015347|NCT02603419|76131531|FG002|NOT COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||6||
60015348|NCT02603419|76131532|FG003|NOT COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||6||
60015349|NCT02603419|76131533|FG004|NOT COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||6||
60015350|NCT02603419|76131534|FG005|NOT COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0||
60015351|NCT02603419|76131529|FG000|STARTED|Expansion Phase:Maximum Exposure:48Weeks||0||
60015352|NCT02603419|76131530|FG001|STARTED|Expansion Phase:Maximum Exposure:48Weeks||0||
60015353|NCT02603419|76131531|FG002|STARTED|Expansion Phase:Maximum Exposure:48Weeks||0||
60015354|NCT02603419|76131532|FG003|STARTED|Expansion Phase:Maximum Exposure:48Weeks||0||
60015355|NCT02603419|76131533|FG004|STARTED|Expansion Phase:Maximum Exposure:48Weeks||0||
60015356|NCT02603419|76131534|FG005|STARTED|Expansion Phase:Maximum Exposure:48Weeks|Participants started expansion phase while other few participants were completing lead-in phase.|3||
60015357|NCT02603419|76131529|FG000|COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0||
60015358|NCT02603419|76131530|FG001|COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0||
60015359|NCT02603419|76131531|FG002|COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0||
60015360|NCT02603419|76131532|FG003|COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0||
60015361|NCT02603419|76131533|FG004|COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0||
59906149|NCT02752191|76027121|FG001|STARTED|Overall Study||3||
59906150|NCT02752191|76027120|FG000|COMPLETED|Overall Study||14||
59906151|NCT02752191|76027121|FG001|COMPLETED|Overall Study||3||
60015362|NCT02603419|76131534|FG005|COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0||
60015363|NCT02603419|76131529|FG000|NOT COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0||
60015364|NCT02603419|76131530|FG001|NOT COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0||
60015365|NCT02603419|76131531|FG002|NOT COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0||
60015366|NCT02603419|76131532|FG003|NOT COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0||
60015367|NCT02603419|76131533|FG004|NOT COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0||
60015368|NCT02603419|76131534|FG005|NOT COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||3||
60015369|NCT01668355|76131551|FG000|STARTED|Overall Study||164||
59906152|NCT02752191|76027120|FG000|NOT COMPLETED|Overall Study||0||
59906153|NCT02752191|76027121|FG001|NOT COMPLETED|Overall Study||0||
59906154|NCT03168711|76027129|FG000|STARTED|Overall Study||14||
59906155|NCT03168711|76027130|FG001|STARTED|Overall Study||9||
59906156|NCT03168711|76027129|FG000|COMPLETED|Overall Study||12||
59906157|NCT03168711|76027130|FG001|COMPLETED|Overall Study||7||
59906158|NCT03168711|76027129|FG000|NOT COMPLETED|Overall Study||2||
59906159|NCT03168711|76027130|FG001|NOT COMPLETED|Overall Study||2||
59906160|NCT03738215|76027139|FG000|STARTED|Double-blind Treatment Period (6 Weeks)||253||
59906161|NCT03738215|76027140|FG001|STARTED|Double-blind Treatment Period (6 Weeks)||252||
59906162|NCT03738215|76027141|FG002|STARTED|Double-blind Treatment Period (6 Weeks)||252||
59906163|NCT03738215|76027139|FG000|COMPLETED|Double-blind Treatment Period (6 Weeks)||229||
59906164|NCT03738215|76027140|FG001|COMPLETED|Double-blind Treatment Period (6 Weeks)||231||
59906165|NCT03738215|76027141|FG002|COMPLETED|Double-blind Treatment Period (6 Weeks)||219||
60015370|NCT01668355|76131552|FG001|STARTED|Overall Study||167||
60015371|NCT01668355|76131551|FG000|COMPLETED|Overall Study||155||
60015372|NCT01668355|76131552|FG001|COMPLETED|Overall Study||165||
60015373|NCT01668355|76131551|FG000|NOT COMPLETED|Overall Study||9||
60015374|NCT01668355|76131552|FG001|NOT COMPLETED|Overall Study||2||
60015375|NCT01667731|76131564|FG000|STARTED|Overall Study||26||
60015376|NCT01667731|76131565|FG001|STARTED|Overall Study||42||
60015377|NCT01667731|76131566|FG002|STARTED|Overall Study||24||
60015378|NCT01667731|76131567|FG003|STARTED|Overall Study||17||
60015379|NCT01667731|76131568|FG004|STARTED|Overall Study||115||
59757902|NCT02314624|75877087|FG000|STARTED|Overall Study|43 provider participants and 37 patient participants were assigned to the WILLOW condition.|80||
59757903|NCT02314624|75877088|FG001|STARTED|Overall Study|33 provider participants and 29 patient participants were assigned to the TAU condition.|62||
59757904|NCT02314624|75877087|FG000|COMPLETED|Overall Study|18 provider participants and 31 patient participants in the WILLOW condition completed participation|49||
59906166|NCT03738215|76027139|FG000|NOT COMPLETED|Double-blind Treatment Period (6 Weeks)||24||
59906167|NCT03738215|76027140|FG001|NOT COMPLETED|Double-blind Treatment Period (6 Weeks)||21||
59906168|NCT03738215|76027141|FG002|NOT COMPLETED|Double-blind Treatment Period (6 Weeks)||33||
60015380|NCT01667731|76131564|FG000|COMPLETED|Overall Study||21||
60015381|NCT01667731|76131565|FG001|COMPLETED|Overall Study||26||
60015382|NCT01667731|76131566|FG002|COMPLETED|Overall Study||22||
60015383|NCT01667731|76131567|FG003|COMPLETED|Overall Study||15||
60015384|NCT01667731|76131568|FG004|COMPLETED|Overall Study||87||
60015385|NCT01667731|76131564|FG000|NOT COMPLETED|Overall Study||5||
60015386|NCT01667731|76131565|FG001|NOT COMPLETED|Overall Study||16||
60015387|NCT01667731|76131566|FG002|NOT COMPLETED|Overall Study||2||
60015388|NCT01667731|76131567|FG003|NOT COMPLETED|Overall Study||2||
60015389|NCT01667731|76131568|FG004|NOT COMPLETED|Overall Study||28||
60015390|NCT02605837|76131583|FG000|STARTED|Overall Study||105||
60015391|NCT02605837|76131584|FG001|STARTED|Overall Study||213||
60015392|NCT02605837|76131583|FG000|COMPLETED|Overall Study||94||
60015393|NCT02605837|76131584|FG001|COMPLETED|Overall Study||202||
60015394|NCT02605837|76131583|FG000|NOT COMPLETED|Overall Study||11||
60015395|NCT02605837|76131584|FG001|NOT COMPLETED|Overall Study||11||
60015396|NCT02423343|76131597|FG000|STARTED|Overall Study||3||
60015397|NCT02423343|76131598|FG001|STARTED|Overall Study||5||
60015398|NCT02423343|76131599|FG002|STARTED|Overall Study||3||
60015399|NCT02423343|76131600|FG003|STARTED|Overall Study||4||
60015400|NCT02423343|76131601|FG004|STARTED|Overall Study||25||
59906169|NCT03738215|76027139|FG000|STARTED|Safety Follow Up Period (4 Weeks)||240||
59906170|NCT03738215|76027140|FG001|STARTED|Safety Follow Up Period (4 Weeks)||239||
59906171|NCT03738215|76027141|FG002|STARTED|Safety Follow Up Period (4 Weeks)||238||
59906172|NCT03738215|76027139|FG000|COMPLETED|Safety Follow Up Period (4 Weeks)||237||
59906173|NCT03738215|76027140|FG001|COMPLETED|Safety Follow Up Period (4 Weeks)||234||
59906174|NCT03738215|76027141|FG002|COMPLETED|Safety Follow Up Period (4 Weeks)||230||
59906175|NCT03738215|76027139|FG000|NOT COMPLETED|Safety Follow Up Period (4 Weeks)||3||
59906176|NCT03738215|76027140|FG001|NOT COMPLETED|Safety Follow Up Period (4 Weeks)||5||
59906177|NCT03738215|76027141|FG002|NOT COMPLETED|Safety Follow Up Period (4 Weeks)||8||
59906178|NCT03199911|76027151|FG000|STARTED|Overall Study||208||
59906179|NCT03199911|76027152|FG001|STARTED|Overall Study||193||
60015401|NCT02423343|76131602|FG005|STARTED|Overall Study||1||
60015402|NCT02423343|76131597|FG000|Received at Least One Dose of Study Drug|Overall Study||3||
60015403|NCT02423343|76131598|FG001|Received at Least One Dose of Study Drug|Overall Study||5||
60015404|NCT02423343|76131599|FG002|Received at Least One Dose of Study Drug|Overall Study||3||
60015405|NCT02423343|76131600|FG003|Received at Least One Dose of Study Drug|Overall Study||4||
60015406|NCT02423343|76131601|FG004|Received at Least One Dose of Study Drug|Overall Study||25||
59518991|NCT03587428|75612870|FG000|NOT COMPLETED|Period 1||0||
59611419|NCT01597596|75722398|FG000|STARTED|Overall Study||1||
59906180|NCT03199911|76027151|FG000|Did Not Proceed With Surgery|Overall Study||2||
59906181|NCT03199911|76027152|FG001|Did Not Proceed With Surgery|Overall Study||1||
59906182|NCT03199911|76027151|FG000|Received Allocated Treatment|Overall Study||206||
59906183|NCT03199911|76027152|FG001|Received Allocated Treatment|Overall Study||192||
59906184|NCT03199911|76027151|FG000|Lost to Follow-up|Overall Study||5||
59906185|NCT03199911|76027152|FG001|Lost to Follow-up|Overall Study||5||
59906186|NCT03199911|76027151|FG000|Primary Outcome Analyzed|Overall Study||201||
59906187|NCT03199911|76027152|FG001|Primary Outcome Analyzed|Overall Study||187||
59906188|NCT03199911|76027151|FG000|COMPLETED|Overall Study||201||
59906189|NCT03199911|76027152|FG001|COMPLETED|Overall Study||187||
59906190|NCT03199911|76027151|FG000|NOT COMPLETED|Overall Study||7||
59906191|NCT03199911|76027152|FG001|NOT COMPLETED|Overall Study||6||
59906192|NCT03736967|76027162|FG000|STARTED|Overall Study||51||
59906193|NCT03736967|76027163|FG001|STARTED|Overall Study||52||
59906194|NCT03736967|76027164|FG002|STARTED|Overall Study||51||
59906195|NCT03736967|76027165|FG003|STARTED|Overall Study||52||
59906196|NCT03736967|76027162|FG000|Treated|Overall Study||50||
59906197|NCT03736967|76027163|FG001|Treated|Overall Study||52||
59906198|NCT03736967|76027164|FG002|Treated|Overall Study||51||
59906199|NCT03736967|76027165|FG003|Treated|Overall Study||52||
59906200|NCT03736967|76027162|FG000|COMPLETED|Overall Study||20||
59906201|NCT03736967|76027163|FG001|COMPLETED|Overall Study||24||
59906202|NCT03736967|76027164|FG002|COMPLETED|Overall Study||27||
59906203|NCT03736967|76027165|FG003|COMPLETED|Overall Study||22||
59906204|NCT03736967|76027162|FG000|NOT COMPLETED|Overall Study||31||
59906205|NCT03736967|76027163|FG001|NOT COMPLETED|Overall Study||28||
59906206|NCT03736967|76027164|FG002|NOT COMPLETED|Overall Study||24||
59906207|NCT03736967|76027165|FG003|NOT COMPLETED|Overall Study||30||
59906208|NCT03168555|76027178|FG000|STARTED|Visit 1 (Pro-operative)||23||
59906209|NCT03168555|76027178|FG000|COMPLETED|Visit 1 (Pro-operative)||22||
59906210|NCT03168555|76027178|FG000|NOT COMPLETED|Visit 1 (Pro-operative)||1||
59906211|NCT03168555|76027178|FG000|STARTED|Visit 2 (Post-operative)||22||
59906212|NCT03168555|76027178|FG000|COMPLETED|Visit 2 (Post-operative)||18||
59906213|NCT03168555|76027178|FG000|NOT COMPLETED|Visit 2 (Post-operative)||4||
59906214|NCT03235050|76027190|FG000|STARTED|Overall Study||112||
59906215|NCT03235050|76027191|FG001|STARTED|Overall Study||110||
59906216|NCT03235050|76027192|FG002|STARTED|Overall Study||100||
59906217|NCT03235050|76027193|FG003|STARTED|Overall Study||256||
59906218|NCT03235050|76027194|FG004|STARTED|Overall Study||256||
59906219|NCT03235050|76027190|FG000|COMPLETED|Overall Study||108||
59906220|NCT03235050|76027191|FG001|COMPLETED|Overall Study||105||
59906221|NCT03235050|76027192|FG002|COMPLETED|Overall Study||96||
59906222|NCT03235050|76027193|FG003|COMPLETED|Overall Study||242||
59906223|NCT03235050|76027194|FG004|COMPLETED|Overall Study||245||
59906224|NCT03235050|76027190|FG000|NOT COMPLETED|Overall Study||4||
59906225|NCT03235050|76027191|FG001|NOT COMPLETED|Overall Study||5||
59906226|NCT03235050|76027192|FG002|NOT COMPLETED|Overall Study||4||
59906227|NCT03235050|76027193|FG003|NOT COMPLETED|Overall Study||14||
59906228|NCT03235050|76027194|FG004|NOT COMPLETED|Overall Study||11||
59906229|NCT03004365|76027210|FG000|STARTED|Overall Study||8||
59906230|NCT03004365|76027211|FG001|STARTED|Overall Study||8||
59906231|NCT03004365|76027212|FG002|STARTED|Overall Study||8||
59906232|NCT03004365|76027213|FG003|STARTED|Overall Study||9||
59906233|NCT03004365|76027210|FG000|COMPLETED|Overall Study||8||
59906234|NCT03004365|76027211|FG001|COMPLETED|Overall Study||8||
59906235|NCT03004365|76027212|FG002|COMPLETED|Overall Study||8||
59906236|NCT03004365|76027213|FG003|COMPLETED|Overall Study||9||
59906237|NCT03004365|76027210|FG000|NOT COMPLETED|Overall Study||0||
59906238|NCT03004365|76027211|FG001|NOT COMPLETED|Overall Study||0||
59906239|NCT03004365|76027212|FG002|NOT COMPLETED|Overall Study||0||
59906240|NCT03004365|76027213|FG003|NOT COMPLETED|Overall Study||0||
59906241|NCT04502212|76027223|FG000|STARTED|Overall Study||16||
59906242|NCT04502212|76027223|FG000|COMPLETED|Overall Study||14||
59906243|NCT04502212|76027223|FG000|NOT COMPLETED|Overall Study||2||
59906244|NCT03167619|76027230|FG000|STARTED|Overall Study||23||
59906245|NCT03167619|76027231|FG001|STARTED|Overall Study||22||
59906246|NCT03167619|76027230|FG000|COMPLETED|Overall Study||11||
59906247|NCT03167619|76027231|FG001|COMPLETED|Overall Study||11||
59906248|NCT03167619|76027230|FG000|NOT COMPLETED|Overall Study||12||
59906249|NCT03167619|76027231|FG001|NOT COMPLETED|Overall Study||11||
59906250|NCT03578809|76027241|FG000|STARTED|Overall Study||94||
59906251|NCT03578809|76027242|FG001|STARTED|Overall Study||185||
59906252|NCT03578809|76027243|FG002|STARTED|Overall Study||112||
59906253|NCT03578809|76027244|FG003|STARTED|Overall Study||202||
59906254|NCT03578809|76027241|FG000|Treated|Overall Study||90||
59906255|NCT03578809|76027242|FG001|Treated|Overall Study||179||
59906256|NCT03578809|76027243|FG002|Treated|Overall Study||111||
59906257|NCT03578809|76027244|FG003|Treated|Overall Study||195||
59906258|NCT03578809|76027241|FG000|COMPLETED|Overall Study||88||
59906259|NCT03578809|76027242|FG001|COMPLETED|Overall Study||171||
59906260|NCT03578809|76027243|FG002|COMPLETED|Overall Study||108||
59906261|NCT03578809|76027244|FG003|COMPLETED|Overall Study||193||
59906262|NCT03578809|76027241|FG000|NOT COMPLETED|Overall Study||6||
60015407|NCT02423343|76131602|FG005|Received at Least One Dose of Study Drug|Overall Study||1||
60015408|NCT02423343|76131597|FG000|COMPLETED|Overall Study||3||
60015409|NCT02423343|76131598|FG001|COMPLETED|Overall Study||4||
60015410|NCT02423343|76131599|FG002|COMPLETED|Overall Study||3||
60015411|NCT02423343|76131600|FG003|COMPLETED|Overall Study||4||
60015412|NCT02423343|76131601|FG004|COMPLETED|Overall Study||20||
59906263|NCT03578809|76027242|FG001|NOT COMPLETED|Overall Study||14||
59906264|NCT03578809|76027243|FG002|NOT COMPLETED|Overall Study||4||
59906265|NCT03578809|76027244|FG003|NOT COMPLETED|Overall Study||9||
59906266|NCT03198507|76027259|FG000|STARTED|Overall Study||228||
59906267|NCT03198507|76027260|FG001|STARTED|Overall Study||227||
59906268|NCT03198507|76027259|FG000|COMPLETED|Overall Study||227||
59906269|NCT03198507|76027260|FG001|COMPLETED|Overall Study||227||
59906270|NCT03198507|76027259|FG000|NOT COMPLETED|Overall Study||1||
59906271|NCT03198507|76027260|FG001|NOT COMPLETED|Overall Study||0||
59906272|NCT03610165|76027268|FG000|STARTED|Overall Study||108||
59906273|NCT03610165|76027269|FG001|STARTED|Overall Study||106||
59906274|NCT03610165|76027268|FG000|COMPLETED|Overall Study||108||
59906275|NCT03610165|76027269|FG001|COMPLETED|Overall Study||105||
59906276|NCT03610165|76027268|FG000|NOT COMPLETED|Overall Study||0||
59906277|NCT03610165|76027269|FG001|NOT COMPLETED|Overall Study||1||
59906278|NCT03609619|76027277|FG000|STARTED|Overall Study||54||
59906279|NCT03609619|76027278|FG001|STARTED|Overall Study||55||
59906280|NCT03609619|76027277|FG000|COMPLETED|Overall Study||44||
59906281|NCT03609619|76027278|FG001|COMPLETED|Overall Study||49||
59906282|NCT03609619|76027277|FG000|NOT COMPLETED|Overall Study||10||
59906283|NCT03609619|76027278|FG001|NOT COMPLETED|Overall Study||6||
59906284|NCT03167151|76027287|FG000|STARTED|Overall Study||3||
59906285|NCT03167151|76027288|FG001|STARTED|Overall Study||3||
59906286|NCT03167151|76027289|FG002|STARTED|Overall Study||3||
59906287|NCT03167151|76027287|FG000|COMPLETED|Overall Study||2||
59906288|NCT03167151|76027288|FG001|COMPLETED|Overall Study||2||
59906289|NCT03167151|76027289|FG002|COMPLETED|Overall Study||2||
59906290|NCT03167151|76027287|FG000|NOT COMPLETED|Overall Study||1||
59906291|NCT03167151|76027288|FG001|NOT COMPLETED|Overall Study||1||
59906292|NCT03167151|76027289|FG002|NOT COMPLETED|Overall Study||1||
59906293|NCT03660943|76027299|FG000|STARTED|Overall Study||145||
59906294|NCT03660943|76027300|FG001|STARTED|Overall Study||187||
59906295|NCT03660943|76027299|FG000|Treated|Overall Study||140||
59906296|NCT03660943|76027300|FG001|Treated|Overall Study||184||
59906297|NCT03660943|76027299|FG000|COMPLETED|Overall Study||109||
59906298|NCT03660943|76027300|FG001|COMPLETED|Overall Study||134||
59906299|NCT03660943|76027299|FG000|NOT COMPLETED|Overall Study||36||
59906300|NCT03660943|76027300|FG001|NOT COMPLETED|Overall Study||53||
59906301|NCT03167073|76027308|FG000|STARTED|Overall Study||85||
59906302|NCT03167073|76027309|FG001|STARTED|Overall Study||85||
59906303|NCT03167073|76027308|FG000|COMPLETED|Overall Study||84||
59906304|NCT03167073|76027309|FG001|COMPLETED|Overall Study||85||
60015413|NCT02423343|76131602|FG005|COMPLETED|Overall Study||1||
60015414|NCT02423343|76131597|FG000|NOT COMPLETED|Overall Study||0||
59906305|NCT03167073|76027308|FG000|NOT COMPLETED|Overall Study||1||
59906306|NCT03167073|76027309|FG001|NOT COMPLETED|Overall Study||0||
59906307|NCT03657277|76027315|FG000|STARTED|Overall Study||46||
59906308|NCT03657277|76027315|FG000|COMPLETED|Overall Study||35||
59906309|NCT03657277|76027315|FG000|NOT COMPLETED|Overall Study||11||
59906310|NCT03197883|76027321|FG000|STARTED|Overall Study||50||
59906311|NCT03197883|76027322|FG001|STARTED|Overall Study||50||
59906312|NCT03197883|76027321|FG000|COMPLETED|Overall Study||47||
59906313|NCT03197883|76027322|FG001|COMPLETED|Overall Study||44||
59906314|NCT03197883|76027321|FG000|NOT COMPLETED|Overall Study||3||
60015415|NCT02423343|76131598|FG001|NOT COMPLETED|Overall Study||1||
60015416|NCT02423343|76131599|FG002|NOT COMPLETED|Overall Study||0||
60015417|NCT02423343|76131600|FG003|NOT COMPLETED|Overall Study||0||
60015418|NCT02423343|76131601|FG004|NOT COMPLETED|Overall Study||5||
60015419|NCT02423343|76131602|FG005|NOT COMPLETED|Overall Study||0||
59906315|NCT03197883|76027322|FG001|NOT COMPLETED|Overall Study||6||
59906316|NCT03234036|76027331|FG000|STARTED|Part 1: Treatment Period 1(Up to 7 Days)||8||
59906317|NCT03234036|76027332|FG001|STARTED|Part 1: Treatment Period 1(Up to 7 Days)||8||
59906318|NCT03234036|76027333|FG002|STARTED|Part 1: Treatment Period 1(Up to 7 Days)||0||
59906319|NCT03234036|76027334|FG003|STARTED|Part 1: Treatment Period 1(Up to 7 Days)||0||
59906320|NCT03234036|76027331|FG000|COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||8||
59906321|NCT03234036|76027332|FG001|COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||8||
60015420|NCT02605447|76131630|FG000|STARTED|Overall Study||1487||
59906322|NCT03234036|76027333|FG002|COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||0||
59906323|NCT03234036|76027334|FG003|COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||0||
59906324|NCT03234036|76027331|FG000|NOT COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||0||
59906325|NCT03234036|76027332|FG001|NOT COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||0||
59906326|NCT03234036|76027333|FG002|NOT COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||0||
59906327|NCT03234036|76027334|FG003|NOT COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||0||
59906328|NCT03234036|76027331|FG000|STARTED|Part 1:Washout Period 1 (Up to 10 Days)||8||
59906329|NCT03234036|76027332|FG001|STARTED|Part 1:Washout Period 1 (Up to 10 Days)||8||
59906330|NCT03234036|76027333|FG002|STARTED|Part 1:Washout Period 1 (Up to 10 Days)||0||
59906331|NCT03234036|76027334|FG003|STARTED|Part 1:Washout Period 1 (Up to 10 Days)||0||
59906332|NCT03234036|76027331|FG000|COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||7||
59906333|NCT03234036|76027332|FG001|COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||7||
59906334|NCT03234036|76027333|FG002|COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||0||
59906335|NCT03234036|76027334|FG003|COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||0||
59906336|NCT03234036|76027331|FG000|NOT COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||1||
59906337|NCT03234036|76027332|FG001|NOT COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||1||
59906338|NCT03234036|76027333|FG002|NOT COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||0||
59906339|NCT03234036|76027334|FG003|NOT COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||0||
59906340|NCT03234036|76027331|FG000|STARTED|Part 1: Treatment Period 2(Up to 7 Days)||7||
59906341|NCT03234036|76027332|FG001|STARTED|Part 1: Treatment Period 2(Up to 7 Days)||7||
59906342|NCT03234036|76027333|FG002|STARTED|Part 1: Treatment Period 2(Up to 7 Days)||0||
59906343|NCT03234036|76027334|FG003|STARTED|Part 1: Treatment Period 2(Up to 7 Days)||0||
59611420|NCT01597596|75722399|FG001|STARTED|Overall Study||3||
59611421|NCT01597596|75722398|FG000|COMPLETED|Overall Study||0||
59611422|NCT01597596|75722399|FG001|COMPLETED|Overall Study||2||
59611423|NCT01597596|75722398|FG000|NOT COMPLETED|Overall Study||1||
59611424|NCT01597596|75722399|FG001|NOT COMPLETED|Overall Study||1||
59611425|NCT01778556|75722407|FG000|STARTED|Intervention 1 (5 Days)||15||
59611426|NCT01778556|75722408|FG001|STARTED|Intervention 1 (5 Days)||10||
59611427|NCT01778556|75722407|FG000|COMPLETED|Intervention 1 (5 Days)||15||
59611428|NCT01778556|75722408|FG001|COMPLETED|Intervention 1 (5 Days)||8||
59611429|NCT01778556|75722407|FG000|NOT COMPLETED|Intervention 1 (5 Days)||0||
59611430|NCT01778556|75722408|FG001|NOT COMPLETED|Intervention 1 (5 Days)||2||
59611431|NCT01778556|75722407|FG000|STARTED|Intervention 2 (14 Days)||15||
59611432|NCT01778556|75722408|FG001|STARTED|Intervention 2 (14 Days)||8||
59611433|NCT01778556|75722407|FG000|COMPLETED|Intervention 2 (14 Days)||14||
59611434|NCT01778556|75722408|FG001|COMPLETED|Intervention 2 (14 Days)||8||
59762679|NCT00857259|75882529|FG002|STARTED|Overall Study||7||
59906344|NCT03234036|76027331|FG000|COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||7||
59906345|NCT03234036|76027332|FG001|COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||7||
59906346|NCT03234036|76027333|FG002|COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||0||
59906347|NCT03234036|76027334|FG003|COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||0||
59906348|NCT03234036|76027331|FG000|NOT COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||0||
59906349|NCT03234036|76027332|FG001|NOT COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||0||
59906350|NCT03234036|76027333|FG002|NOT COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||0||
59906351|NCT03234036|76027334|FG003|NOT COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||0||
59906352|NCT03234036|76027331|FG000|STARTED|Part 1:Washout Period 2 (Up to 15 Days)||7||
59906353|NCT03234036|76027332|FG001|STARTED|Part 1:Washout Period 2 (Up to 15 Days)||7||
59906354|NCT03234036|76027333|FG002|STARTED|Part 1:Washout Period 2 (Up to 15 Days)||0||
59906355|NCT03234036|76027334|FG003|STARTED|Part 1:Washout Period 2 (Up to 15 Days)||0||
59906356|NCT03234036|76027331|FG000|COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||7||
59906357|NCT03234036|76027332|FG001|COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||7||
59906358|NCT03234036|76027333|FG002|COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||0||
59906359|NCT03234036|76027334|FG003|COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||0||
59906360|NCT03234036|76027331|FG000|NOT COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||0||
59906361|NCT03234036|76027332|FG001|NOT COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||0||
59906362|NCT03234036|76027333|FG002|NOT COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||0||
59906363|NCT03234036|76027334|FG003|NOT COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||0||
59906364|NCT03234036|76027331|FG000|STARTED|Part 1:Treatment Period 3 (Up to 7 Days)||7||
59906365|NCT03234036|76027332|FG001|STARTED|Part 1:Treatment Period 3 (Up to 7 Days)||7||
59906366|NCT03234036|76027333|FG002|STARTED|Part 1:Treatment Period 3 (Up to 7 Days)||0||
59906367|NCT03234036|76027334|FG003|STARTED|Part 1:Treatment Period 3 (Up to 7 Days)||0||
59906368|NCT03234036|76027331|FG000|COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||7||
59906369|NCT03234036|76027332|FG001|COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||7||
59906370|NCT03234036|76027333|FG002|COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||0||
59906371|NCT03234036|76027334|FG003|COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||0||
59906372|NCT03234036|76027331|FG000|NOT COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||0||
59906373|NCT03234036|76027332|FG001|NOT COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||0||
59906374|NCT03234036|76027333|FG002|NOT COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||0||
59906375|NCT03234036|76027334|FG003|NOT COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||0||
59906376|NCT03234036|76027331|FG000|STARTED|Part 2 (Up to 25 Days)||0||
59906377|NCT03234036|76027332|FG001|STARTED|Part 2 (Up to 25 Days)||0||
59906378|NCT03234036|76027333|FG002|STARTED|Part 2 (Up to 25 Days)||3||
59906379|NCT03234036|76027334|FG003|STARTED|Part 2 (Up to 25 Days)||7||
59611435|NCT01778556|75722407|FG000|NOT COMPLETED|Intervention 2 (14 Days)||1||
59611436|NCT01778556|75722408|FG001|NOT COMPLETED|Intervention 2 (14 Days)||0||
59906380|NCT03234036|76027331|FG000|COMPLETED|Part 2 (Up to 25 Days)||0||
59906381|NCT03234036|76027332|FG001|COMPLETED|Part 2 (Up to 25 Days)||0||
59906382|NCT03234036|76027333|FG002|COMPLETED|Part 2 (Up to 25 Days)||3||
59611437|NCT01778556|75722407|FG000|STARTED|Long-term Follow-up||15||
59906383|NCT03234036|76027334|FG003|COMPLETED|Part 2 (Up to 25 Days)||7||
59906384|NCT03234036|76027331|FG000|NOT COMPLETED|Part 2 (Up to 25 Days)||0||
59906385|NCT03234036|76027332|FG001|NOT COMPLETED|Part 2 (Up to 25 Days)||0||
59906386|NCT03234036|76027333|FG002|NOT COMPLETED|Part 2 (Up to 25 Days)||0||
59906387|NCT03234036|76027334|FG003|NOT COMPLETED|Part 2 (Up to 25 Days)||0||
59906388|NCT03606109|76027352|FG000|STARTED|Overall Study||31||
59906389|NCT03606109|76027353|FG001|STARTED|Overall Study||27||
60015421|NCT02605447|76131630|FG000|COMPLETED|Overall Study||1385||
60015422|NCT02605447|76131630|FG000|NOT COMPLETED|Overall Study||102||
60015423|NCT02485899|76131637|FG000|STARTED|Overall Study||24||
60015424|NCT02485899|76131638|FG001|STARTED|Overall Study|The control group (NH comparator) used for determination of the primary efficacy outcomes of this study was comprised of data from 42 subjects with CLN2 disease from the DEM-CHILD database (NCT04613089).|42||
60015425|NCT02485899|76131637|FG000|COMPLETED|Overall Study||17||
60015426|NCT02485899|76131638|FG001|COMPLETED|Overall Study|The control group (NH comparator) used for determination of the primary efficacy outcomes of this study was comprised of data from 42 subjects with CLN2 disease from the DEM-CHILD database (NCT04613089).|42||
60015427|NCT02485899|76131637|FG000|NOT COMPLETED|Overall Study||7||
60015428|NCT02485899|76131638|FG001|NOT COMPLETED|Overall Study||0||
60015429|NCT02423109|76131644|FG000|STARTED|Lens 1||19||
60015430|NCT02423109|76131645|FG001|STARTED|Lens 1||14||
60015431|NCT02423109|76131644|FG000|COMPLETED|Lens 1||18||
60015432|NCT02423109|76131645|FG001|COMPLETED|Lens 1||14||
60015433|NCT02423109|76131644|FG000|NOT COMPLETED|Lens 1||1||
60015434|NCT02423109|76131645|FG001|NOT COMPLETED|Lens 1||0||
60015435|NCT02423109|76131644|FG000|STARTED|Lens 2||18||
60015436|NCT02423109|76131645|FG001|STARTED|Lens 2||14||
60015437|NCT02423109|76131644|FG000|COMPLETED|Lens 2||18||
59906390|NCT03606109|76027352|FG000|COMPLETED|Overall Study||29||
59906391|NCT03606109|76027353|FG001|COMPLETED|Overall Study||26||
59906392|NCT03606109|76027352|FG000|NOT COMPLETED|Overall Study||2||
59906393|NCT03606109|76027353|FG001|NOT COMPLETED|Overall Study||1||
59906394|NCT02729896|76027362|FG000|STARTED|Overall Study||3||
59906395|NCT02729896|76027363|FG001|STARTED|Overall Study||10||
59906396|NCT02729896|76027364|FG002|STARTED|Overall Study||23||
59906397|NCT02729896|76027362|FG000|COMPLETED|Overall Study||1||
59906398|NCT02729896|76027363|FG001|COMPLETED|Overall Study||1||
59906399|NCT02729896|76027364|FG002|COMPLETED|Overall Study||1||
59906400|NCT02729896|76027362|FG000|NOT COMPLETED|Overall Study||2||
59906401|NCT02729896|76027363|FG001|NOT COMPLETED|Overall Study||9||
60015438|NCT02423109|76131645|FG001|COMPLETED|Lens 2||14||
60015439|NCT02423109|76131644|FG000|NOT COMPLETED|Lens 2||0||
60015440|NCT02423109|76131645|FG001|NOT COMPLETED|Lens 2||0||
60015441|NCT02420691|76131653|FG000|STARTED|Overall Study||20||
60015442|NCT02420691|76131653|FG000|COMPLETED|Overall Study||14||
60015443|NCT02420691|76131653|FG000|NOT COMPLETED|Overall Study||6||
60015444|NCT02406651|76131657|FG000|STARTED|Overall Study||30||
60015445|NCT02406651|76131657|FG000|COMPLETED|Overall Study||27||
60015446|NCT02406651|76131657|FG000|NOT COMPLETED|Overall Study||3||
60015447|NCT02406261|76131664|FG000|STARTED|Period 1||50||
60015448|NCT02406261|76131665|FG001|STARTED|Period 1||32||
60015449|NCT02406261|76131664|FG000|Received at Least One Dose of Study Drug|Period 1||50||
60015450|NCT02406261|76131665|FG001|Received at Least One Dose of Study Drug|Period 1||32||
60015451|NCT02406261|76131664|FG000|COMPLETED|Period 1||47||
60015452|NCT02406261|76131665|FG001|COMPLETED|Period 1||32||
60015453|NCT02406261|76131664|FG000|NOT COMPLETED|Period 1||3||
60015454|NCT02406261|76131665|FG001|NOT COMPLETED|Period 1||0||
60015455|NCT02406261|76131664|FG000|STARTED|Period 2|Cohort A participated in Period 1 only|0||
60015456|NCT02406261|76131665|FG001|STARTED|Period 2||32||
60015457|NCT02406261|76131664|FG000|COMPLETED|Period 2||0||
60015458|NCT02406261|76131665|FG001|COMPLETED|Period 2||29||
60015459|NCT02406261|76131664|FG000|NOT COMPLETED|Period 2||0||
60015460|NCT02406261|76131665|FG001|NOT COMPLETED|Period 2||3||
60015461|NCT02405091|76131675|FG000|STARTED|Overall Study||49||
59906402|NCT02729896|76027364|FG002|NOT COMPLETED|Overall Study||22||
59906403|NCT03575065|76027375|FG000|STARTED|Overall Study||62||
59906404|NCT03575065|76027376|FG001|STARTED|Overall Study||26||
59906405|NCT03575065|76027375|FG000|COMPLETED|Overall Study||0||
59906406|NCT03575065|76027376|FG001|COMPLETED|Overall Study||0||
59906407|NCT03575065|76027375|FG000|NOT COMPLETED|Overall Study||62||
59906408|NCT03575065|76027376|FG001|NOT COMPLETED|Overall Study||26||
59906409|NCT03514134|76027385|FG000|STARTED|Overall Study||23||
59906410|NCT03514134|76027386|FG001|STARTED|Overall Study||48||
59906411|NCT03514134|76027385|FG000|COMPLETED|Overall Study||23||
59906412|NCT03514134|76027386|FG001|COMPLETED|Overall Study||47||
60015462|NCT02405091|76131676|FG001|STARTED|Overall Study||107||
60015463|NCT02405091|76131677|FG002|STARTED|Overall Study||11||
60015464|NCT02405091|76131675|FG000|COMPLETED|Overall Study||20||
60015465|NCT02405091|76131676|FG001|COMPLETED|Overall Study||74||
60015466|NCT02405091|76131677|FG002|COMPLETED|Overall Study||9||
60015467|NCT02405091|76131675|FG000|NOT COMPLETED|Overall Study||29||
60015468|NCT02405091|76131676|FG001|NOT COMPLETED|Overall Study||33||
59906413|NCT03514134|76027385|FG000|NOT COMPLETED|Overall Study||0||
59906414|NCT03514134|76027386|FG001|NOT COMPLETED|Overall Study||1||
59906415|NCT03188718|76027392|FG000|STARTED|Overall Study||45||
60015469|NCT02405091|76131677|FG002|NOT COMPLETED|Overall Study||2||
60015470|NCT02485353|76131688|FG000|STARTED|Overall Study||2||
60015471|NCT02485353|76131688|FG000|COMPLETED|Overall Study||0||
60015472|NCT02485353|76131688|FG000|NOT COMPLETED|Overall Study||2||
60015473|NCT02603107|76131694|FG000|STARTED|Randomized Phase||290||
60015474|NCT02603107|76131695|FG001|STARTED|Randomized Phase||287||
60015475|NCT02603107|76131694|FG000|COMPLETED|Randomized Phase||275||
60015476|NCT02603107|76131695|FG001|COMPLETED|Randomized Phase||266||
60015477|NCT02603107|76131694|FG000|NOT COMPLETED|Randomized Phase||15||
60015478|NCT02603107|76131695|FG001|NOT COMPLETED|Randomized Phase||21||
60015479|NCT02603107|76131694|FG000|STARTED|Optional Extension Phase|3 participants who completed the Randomized Phase did not continue in the Optional Extension Phase.|272||
59757905|NCT02314624|75877088|FG001|COMPLETED|Overall Study|11 provider participants and 25 patient participants in TAU condition completed study participation.|36||
59757906|NCT02314624|75877087|FG000|NOT COMPLETED|Overall Study||31||
59757907|NCT02314624|75877088|FG001|NOT COMPLETED|Overall Study||26||
59757908|NCT02119468|75877096|FG000|STARTED|Overall Study||7||
59757909|NCT02119468|75877097|FG001|STARTED|Overall Study||25||
59757910|NCT02119468|75877096|FG000|COMPLETED|Overall Study||7||
59757911|NCT02119468|75877097|FG001|COMPLETED|Overall Study||25||
59757912|NCT02119468|75877096|FG000|NOT COMPLETED|Overall Study||0||
59757913|NCT02119468|75877097|FG001|NOT COMPLETED|Overall Study||0||
59757914|NCT01976091|75877107|FG000|STARTED|Overall Study||1||
59757915|NCT01976091|75877108|FG001|STARTED|Overall Study||3||
59757916|NCT01976091|75877109|FG002|STARTED|Overall Study||2||
59757917|NCT01976091|75877107|FG000|Received at Least 1 Dose of Study Drug|Overall Study||1||
59757918|NCT01976091|75877108|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3||
59757919|NCT01976091|75877109|FG002|Received at Least 1 Dose of Study Drug|Overall Study||2||
59757920|NCT01976091|75877107|FG000|COMPLETED|Overall Study||1||
59757921|NCT01976091|75877108|FG001|COMPLETED|Overall Study||3||
59757922|NCT01976091|75877109|FG002|COMPLETED|Overall Study||2||
59757923|NCT01976091|75877107|FG000|NOT COMPLETED|Overall Study||0||
60015480|NCT02603107|76131695|FG001|STARTED|Optional Extension Phase|21 participants who completed the Randomized Phase did not continue in the Optional Extension Phase.|245||
60015481|NCT02603107|76131694|FG000|COMPLETED|Optional Extension Phase||263||
60015482|NCT02603107|76131695|FG001|COMPLETED|Optional Extension Phase||232||
60015483|NCT02603107|76131694|FG000|NOT COMPLETED|Optional Extension Phase||9||
60015484|NCT02603107|76131695|FG001|NOT COMPLETED|Optional Extension Phase||13||
60015485|NCT02484729|76131713|FG000|STARTED|Overall Study||16||
60015486|NCT02484729|76131714|FG001|STARTED|Overall Study||6||
60015487|NCT02484729|76131715|FG002|STARTED|Overall Study||6||
60015488|NCT02484729|76131716|FG003|STARTED|Overall Study||6||
60015489|NCT02484729|76131717|FG004|STARTED|Overall Study||5||
60015490|NCT02484729|76131718|FG005|STARTED|Overall Study||6||
60015491|NCT02484729|76131719|FG006|STARTED|Overall Study||5||
60015492|NCT02484729|76131720|FG007|STARTED|Overall Study||6||
60015493|NCT02484729|76131721|FG008|STARTED|Overall Study||6||
60015494|NCT02484729|76131722|FG009|STARTED|Overall Study||8||
60015495|NCT02484729|76131713|FG000|COMPLETED|Overall Study||16||
60015496|NCT02484729|76131714|FG001|COMPLETED|Overall Study||6||
60015497|NCT02484729|76131715|FG002|COMPLETED|Overall Study||6||
60015498|NCT02484729|76131716|FG003|COMPLETED|Overall Study||6||
60015499|NCT02484729|76131717|FG004|COMPLETED|Overall Study||5||
60015500|NCT02484729|76131718|FG005|COMPLETED|Overall Study||6||
60015501|NCT02484729|76131719|FG006|COMPLETED|Overall Study||5||
60015502|NCT02484729|76131720|FG007|COMPLETED|Overall Study||6||
59757924|NCT01976091|75877108|FG001|NOT COMPLETED|Overall Study||0||
59757925|NCT01976091|75877109|FG002|NOT COMPLETED|Overall Study||0||
59906416|NCT03188718|76027392|FG000|COMPLETED|Overall Study||37||
59906417|NCT03188718|76027392|FG000|NOT COMPLETED|Overall Study||8||
59906418|NCT03574753|76027396|FG000|STARTED|Overall Study||23||
59906419|NCT03574753|76027396|FG000|COMPLETED|Overall Study||0||
59906420|NCT03574753|76027396|FG000|NOT COMPLETED|Overall Study||23||
59906421|NCT03573505|76027403|FG000|STARTED|Overall Study||52|Started=Participants who received at least one dose of treatment.|
59906422|NCT03573505|76027404|FG001|STARTED|Overall Study||54|Started=Participants who received at least one dose of treatment.|
59906423|NCT03573505|76027403|FG000|COMPLETED|Overall Study||0||
59906424|NCT03573505|76027404|FG001|COMPLETED|Overall Study||0||
59906425|NCT03573505|76027403|FG000|NOT COMPLETED|Overall Study||52||
59906426|NCT03573505|76027404|FG001|NOT COMPLETED|Overall Study||54||
59906427|NCT01376908|76027413|FG000|STARTED|Overall Study||27||
59906428|NCT01376908|76027414|FG001|STARTED|Overall Study||29||
59906429|NCT01376908|76027413|FG000|COMPLETED|Overall Study||25||
59906430|NCT01376908|76027414|FG001|COMPLETED|Overall Study||26||
59906431|NCT01376908|76027413|FG000|NOT COMPLETED|Overall Study||2||
59906432|NCT01376908|76027414|FG001|NOT COMPLETED|Overall Study||3||
60015503|NCT02484729|76131721|FG008|COMPLETED|Overall Study||6||
60015504|NCT02484729|76131722|FG009|COMPLETED|Overall Study||7||
59757926|NCT01419080|75877117|FG000|STARTED|Overall Study||797||
60015505|NCT02484729|76131713|FG000|NOT COMPLETED|Overall Study||0||
60015506|NCT02484729|76131714|FG001|NOT COMPLETED|Overall Study||0||
60015507|NCT02484729|76131715|FG002|NOT COMPLETED|Overall Study||0||
60015508|NCT02484729|76131716|FG003|NOT COMPLETED|Overall Study||0||
60015509|NCT02484729|76131717|FG004|NOT COMPLETED|Overall Study||0||
59757927|NCT01419080|75877117|FG000|COMPLETED|Overall Study||666||
59757928|NCT01419080|75877117|FG000|NOT COMPLETED|Overall Study||131||
59757929|NCT01164228|75877125|FG000|STARTED|Overall Study||47||
59757930|NCT01164228|75877126|FG001|STARTED|Overall Study||40||
59757931|NCT01164228|75877125|FG000|Receipt of Protocol Therapy|Overall Study||46||
59757932|NCT01164228|75877126|FG001|Receipt of Protocol Therapy|Overall Study||37||
59757933|NCT01164228|75877125|FG000|Treated and Eligible Patients|Overall Study||45||
59757934|NCT01164228|75877126|FG001|Treated and Eligible Patients|Overall Study||37||
59757935|NCT01164228|75877125|FG000|COMPLETED|Overall Study||3||
59757936|NCT01164228|75877126|FG001|COMPLETED|Overall Study||2||
59757937|NCT01164228|75877125|FG000|NOT COMPLETED|Overall Study||44||
59757938|NCT01164228|75877126|FG001|NOT COMPLETED|Overall Study||38||
59757939|NCT00554515|75877132|FG000|STARTED|Overall Study||123||
59757940|NCT00554515|75877132|FG000|Treated|Overall Study||120|3 participants withdrew consent before starting treatment.|
59757941|NCT00554515|75877132|FG000|COMPLETED|Overall Study||5||
59757942|NCT00554515|75877132|FG000|NOT COMPLETED|Overall Study||118||
60015510|NCT02484729|76131718|FG005|NOT COMPLETED|Overall Study||0||
60015511|NCT02484729|76131719|FG006|NOT COMPLETED|Overall Study||0||
60015512|NCT02484729|76131720|FG007|NOT COMPLETED|Overall Study||0||
60015513|NCT02484729|76131721|FG008|NOT COMPLETED|Overall Study||0||
59757943|NCT00049517|75877159|FG000|STARTED|Induction||79||
59757944|NCT00049517|75877160|FG001|STARTED|Induction||90||
59757945|NCT00049517|75877161|FG002|STARTED|Induction||63||
59757946|NCT00049517|75877162|FG003|STARTED|Induction||75||
59757947|NCT00049517|75877163|FG004|STARTED|Induction||188||
59757948|NCT00049517|75877164|FG005|STARTED|Induction||162||
59757949|NCT00049517|75877159|FG000|Treated|Induction||79||
59757950|NCT00049517|75877160|FG001|Treated|Induction||90||
59757951|NCT00049517|75877161|FG002|Treated|Induction||63||
59757952|NCT00049517|75877162|FG003|Treated|Induction||75||
59757953|NCT00049517|75877163|FG004|Treated|Induction||186||
59757954|NCT00049517|75877164|FG005|Treated|Induction||160||
59757955|NCT00049517|75877159|FG000|COMPLETED|Induction||79||
59757956|NCT00049517|75877160|FG001|COMPLETED|Induction||90||
59757957|NCT00049517|75877161|FG002|COMPLETED|Induction||63||
59757958|NCT00049517|75877162|FG003|COMPLETED|Induction||75||
59757959|NCT00049517|75877163|FG004|COMPLETED|Induction||128||
59757960|NCT00049517|75877164|FG005|COMPLETED|Induction||108||
59757961|NCT00049517|75877159|FG000|NOT COMPLETED|Induction||0||
59757962|NCT00049517|75877160|FG001|NOT COMPLETED|Induction||0||
59757963|NCT00049517|75877161|FG002|NOT COMPLETED|Induction||0||
59757964|NCT00049517|75877162|FG003|NOT COMPLETED|Induction||0||
59757965|NCT00049517|75877163|FG004|NOT COMPLETED|Induction||60||
60015514|NCT02484729|76131722|FG009|NOT COMPLETED|Overall Study||1||
59757966|NCT00049517|75877164|FG005|NOT COMPLETED|Induction||54||
59757967|NCT00049517|75877159|FG000|STARTED|Conditioning/Transplant||79||
59757968|NCT00049517|75877160|FG001|STARTED|Conditioning/Transplant||90||
59757969|NCT00049517|75877161|FG002|STARTED|Conditioning/Transplant||63||
59757970|NCT00049517|75877162|FG003|STARTED|Conditioning/Transplant||75||
59757971|NCT00049517|75877163|FG004|STARTED|Conditioning/Transplant||21||
59757972|NCT00049517|75877164|FG005|STARTED|Conditioning/Transplant||24||
59757973|NCT00049517|75877159|FG000|Randomized to Autologous HCT +/- GO|Conditioning/Transplant|Additional 20 patients received Autologous HCT without randomization.|59||
59757974|NCT00049517|75877160|FG001|Randomized to Autologous HCT +/- GO|Conditioning/Transplant|Additional 17 patients received Autologous HCT without randomization.|73||
59757975|NCT00049517|75877161|FG002|Randomized to Autologous HCT +/- GO|Conditioning/Transplant||63||
59757976|NCT00049517|75877162|FG003|Randomized to Autologous HCT +/- GO|Conditioning/Transplant||75||
59757977|NCT00049517|75877163|FG004|Randomized to Autologous HCT +/- GO|Conditioning/Transplant|These 21 patients received Allogeneic HCT without randomization.|0||
59757978|NCT00049517|75877164|FG005|Randomized to Autologous HCT +/- GO|Conditioning/Transplant|These 24 patients received Allogeneic HCT without randomization.|0||
59757979|NCT00049517|75877159|FG000|COMPLETED|Conditioning/Transplant||27||
59757980|NCT00049517|75877160|FG001|COMPLETED|Conditioning/Transplant||40||
59757981|NCT00049517|75877161|FG002|COMPLETED|Conditioning/Transplant||25||
60015515|NCT02601625|76131760|FG000|STARTED|Overall Study||6|Participants|
60015516|NCT02601625|76131761|FG001|STARTED|Overall Study||6|Participants|
60015517|NCT02601625|76131762|FG002|STARTED|Overall Study||6|Participants|
60015518|NCT02601625|76131763|FG003|STARTED|Overall Study||12|Participants|
59757982|NCT00049517|75877162|FG003|COMPLETED|Conditioning/Transplant||32||
59757983|NCT00049517|75877163|FG004|COMPLETED|Conditioning/Transplant||15||
59757984|NCT00049517|75877164|FG005|COMPLETED|Conditioning/Transplant||18||
59757985|NCT00049517|75877159|FG000|NOT COMPLETED|Conditioning/Transplant||52||
59757986|NCT00049517|75877160|FG001|NOT COMPLETED|Conditioning/Transplant||50||
59757987|NCT00049517|75877161|FG002|NOT COMPLETED|Conditioning/Transplant||38||
59757988|NCT00049517|75877162|FG003|NOT COMPLETED|Conditioning/Transplant||43||
59757989|NCT00049517|75877163|FG004|NOT COMPLETED|Conditioning/Transplant||6||
59757990|NCT00049517|75877164|FG005|NOT COMPLETED|Conditioning/Transplant||6||
60015519|NCT02601625|76131760|FG000|COMPLETED|Overall Study||6|Participants|
60015520|NCT02601625|76131761|FG001|COMPLETED|Overall Study||6|Participants|
60015521|NCT02601625|76131762|FG002|COMPLETED|Overall Study||5|Participants|
60015522|NCT02601625|76131763|FG003|COMPLETED|Overall Study||11|Participants|
60015523|NCT02601625|76131760|FG000|NOT COMPLETED|Overall Study||0||
60015524|NCT02601625|76131761|FG001|NOT COMPLETED|Overall Study||0||
60015525|NCT02601625|76131762|FG002|NOT COMPLETED|Overall Study||1||
60015526|NCT02601625|76131763|FG003|NOT COMPLETED|Overall Study||1||
60015527|NCT02601469|76131789|FG000|STARTED|Overall Study||25||
60015528|NCT02601469|76131790|FG001|STARTED|Overall Study||1||
60015529|NCT02601469|76131789|FG000|COMPLETED|Overall Study||24||
60015530|NCT02601469|76131790|FG001|COMPLETED|Overall Study||1||
60015531|NCT02601469|76131789|FG000|NOT COMPLETED|Overall Study||1||
59906433|NCT03736031|76027429|FG000|STARTED|Overall Study||56||
59906434|NCT03736031|76027430|FG001|STARTED|Overall Study||46||
59906435|NCT03736031|76027429|FG000|COMPLETED|Overall Study||24||
59906436|NCT03736031|76027430|FG001|COMPLETED|Overall Study||40||
59906437|NCT03736031|76027429|FG000|NOT COMPLETED|Overall Study||32||
59906438|NCT03736031|76027430|FG001|NOT COMPLETED|Overall Study||6||
59906439|NCT03602053|76027439|FG000|STARTED|Overall Study||150||
59906440|NCT03602053|76027440|FG001|STARTED|Overall Study||150||
59906441|NCT03602053|76027441|FG002|STARTED|Overall Study||150||
59906442|NCT03602053|76027439|FG000|COMPLETED|Overall Study||131||
59906443|NCT03602053|76027440|FG001|COMPLETED|Overall Study||132||
59906444|NCT03602053|76027441|FG002|COMPLETED|Overall Study||139||
59906445|NCT03602053|76027439|FG000|NOT COMPLETED|Overall Study||19||
59906446|NCT03602053|76027440|FG001|NOT COMPLETED|Overall Study||18||
59906447|NCT03602053|76027441|FG002|NOT COMPLETED|Overall Study||11||
59906448|NCT04831515|76027453|FG000|STARTED|First Intervention||24||
59906449|NCT04831515|76027454|FG001|STARTED|First Intervention||24||
59906450|NCT04831515|76027453|FG000|COMPLETED|First Intervention||24||
59906451|NCT04831515|76027454|FG001|COMPLETED|First Intervention||23||
59906452|NCT04831515|76027453|FG000|NOT COMPLETED|First Intervention||0||
59906453|NCT04831515|76027454|FG001|NOT COMPLETED|First Intervention||1||
59906454|NCT04831515|76027453|FG000|STARTED|Second Intervention||24||
59906455|NCT04831515|76027454|FG001|STARTED|Second Intervention||23||
59906456|NCT04831515|76027453|FG000|COMPLETED|Second Intervention||24||
59906457|NCT04831515|76027454|FG001|COMPLETED|Second Intervention||23||
59906458|NCT04831515|76027453|FG000|NOT COMPLETED|Second Intervention||0||
59906459|NCT04831515|76027454|FG001|NOT COMPLETED|Second Intervention||0||
59906460|NCT03554629|76027460|FG000|STARTED|Overall Study|8 filterlines per participant for four scripted activities with supplemental oxygen|29||232
59906461|NCT03554629|76027460|FG000|COMPLETED|Overall Study|8 filterlines (CCSF) per participate for four scripted activities with supplemental oxygen.|23||184
59906462|NCT03554629|76027460|FG000|NOT COMPLETED|Overall Study||6||48
59906463|NCT03196791|76027490|FG000|STARTED|Overall Study||98||
59906464|NCT03196791|76027491|FG001|STARTED|Overall Study||98||
59906465|NCT03196791|76027490|FG000|COMPLETED|Overall Study||88||
60015532|NCT02601469|76131790|FG001|NOT COMPLETED|Overall Study||0||
60015533|NCT02604589|76131799|FG000|STARTED|Overall Study||3||
60015534|NCT02604589|76131800|FG001|STARTED|Overall Study||5||
60015535|NCT02604589|76131801|FG002|STARTED|Overall Study||2||
60015536|NCT02604589|76131799|FG000|COMPLETED|Overall Study||3||
60015537|NCT02604589|76131800|FG001|COMPLETED|Overall Study||5||
60015538|NCT02604589|76131801|FG002|COMPLETED|Overall Study||1||
60015539|NCT02604589|76131799|FG000|NOT COMPLETED|Overall Study||0||
60015540|NCT02604589|76131800|FG001|NOT COMPLETED|Overall Study||0||
60015541|NCT02604589|76131801|FG002|NOT COMPLETED|Overall Study||1||
60015542|NCT02601001|76131812|FG000|STARTED|Dosing Period 1||10||
59906466|NCT03196791|76027491|FG001|COMPLETED|Overall Study||93||
59906467|NCT03196791|76027490|FG000|NOT COMPLETED|Overall Study||10||
59906468|NCT03196791|76027491|FG001|NOT COMPLETED|Overall Study||5||
59906469|NCT03196635|76027497|FG000|STARTED|Overall Study||31||
59906470|NCT03196635|76027497|FG000|COMPLETED|Overall Study||30||
60015543|NCT02601001|76131813|FG001|STARTED|Dosing Period 1||20||
60015544|NCT02601001|76131814|FG002|STARTED|Dosing Period 1||20||
60015545|NCT02601001|76131815|FG003|STARTED|Dosing Period 1||0||
60015546|NCT02601001|76131816|FG004|STARTED|Dosing Period 1||0||
59906471|NCT03196635|76027497|FG000|NOT COMPLETED|Overall Study||1||
59906472|NCT03194217|76027519|FG000|STARTED|Overall Study||60||
60015547|NCT02601001|76131817|FG005|STARTED|Dosing Period 1||0||
60015548|NCT02601001|76131818|FG006|STARTED|Dosing Period 1||0||
60015549|NCT02601001|76131812|FG000|COMPLETED|Dosing Period 1||10|Completed dosing in period 1|
60015550|NCT02601001|76131813|FG001|COMPLETED|Dosing Period 1||20|Completed dosing in period 1|
60015551|NCT02601001|76131814|FG002|COMPLETED|Dosing Period 1||20|Completed dosing in period 1|
60015552|NCT02601001|76131815|FG003|COMPLETED|Dosing Period 1||0|Completed dosing in period 1|
60015553|NCT02601001|76131816|FG004|COMPLETED|Dosing Period 1||0|Completed dosing in period 1|
59906473|NCT03194217|76027520|FG001|STARTED|Overall Study||60||
59906474|NCT03194217|76027521|FG002|STARTED|Overall Study||60||
59906475|NCT03194217|76027522|FG003|STARTED|Overall Study||64||
59906476|NCT03194217|76027519|FG000|COMPLETED|Overall Study||60||
59906477|NCT03194217|76027520|FG001|COMPLETED|Overall Study||57||
59906478|NCT03194217|76027521|FG002|COMPLETED|Overall Study||56||
59906479|NCT03194217|76027522|FG003|COMPLETED|Overall Study||60||
59906480|NCT03194217|76027519|FG000|NOT COMPLETED|Overall Study||0||
59906481|NCT03194217|76027520|FG001|NOT COMPLETED|Overall Study||3||
59906482|NCT03194217|76027521|FG002|NOT COMPLETED|Overall Study||4||
59906483|NCT03194217|76027522|FG003|NOT COMPLETED|Overall Study||4||
59906484|NCT00709618|76027532|FG000|STARTED|Overall Study||44||
59906485|NCT00709618|76027532|FG000|COMPLETED|Overall Study||14||
59906486|NCT00709618|76027532|FG000|NOT COMPLETED|Overall Study||30||
59906487|NCT03193047|76027538|FG000|STARTED|Overall Study||31||
59906488|NCT03193047|76027539|FG001|STARTED|Overall Study||28||
59906489|NCT03193047|76027538|FG000|COMPLETED|Overall Study||29||
59906490|NCT03193047|76027539|FG001|COMPLETED|Overall Study||28||
59906491|NCT03193047|76027538|FG000|NOT COMPLETED|Overall Study||2||
59906492|NCT03193047|76027539|FG001|NOT COMPLETED|Overall Study||0||
59906493|NCT02918019|76027551|FG000|STARTED|Overall Study||127||
59906494|NCT02918019|76027552|FG001|STARTED|Overall Study||127||
59906495|NCT02918019|76027553|FG002|STARTED|Overall Study||126||
59906496|NCT02918019|76027554|FG003|STARTED|Overall Study||122||
59906497|NCT02918019|76027551|FG000|COMPLETED|Overall Study||121||
59906498|NCT02918019|76027552|FG001|COMPLETED|Overall Study||117||
59906499|NCT02918019|76027553|FG002|COMPLETED|Overall Study||117||
59906500|NCT02918019|76027554|FG003|COMPLETED|Overall Study||113||
59906501|NCT02918019|76027551|FG000|NOT COMPLETED|Overall Study||6||
59906502|NCT02918019|76027552|FG001|NOT COMPLETED|Overall Study||10||
59906503|NCT02918019|76027553|FG002|NOT COMPLETED|Overall Study||9||
59757991|NCT00926783|75877174|FG000|STARTED|Overall Study||42||
59757992|NCT00926783|75877175|FG001|STARTED|Overall Study||41||
59757993|NCT00926783|75877174|FG000|COMPLETED|Overall Study||39||
59757994|NCT00926783|75877175|FG001|COMPLETED|Overall Study||38||
59757995|NCT00926783|75877174|FG000|NOT COMPLETED|Overall Study||3||
59906504|NCT02918019|76027554|FG003|NOT COMPLETED|Overall Study||9||
59906505|NCT04842292|76027567|FG000|STARTED|Overall Study||2||
59906506|NCT04842292|76027567|FG000|COMPLETED|Overall Study||2||
59906507|NCT04842292|76027567|FG000|NOT COMPLETED|Overall Study||0||
59906508|NCT03055988|76027572|FG000|STARTED|Period 1||38||
59906509|NCT03055988|76027573|FG001|STARTED|Period 1||38||
59906510|NCT03055988|76027572|FG000|COMPLETED|Period 1||37||
59906511|NCT03055988|76027573|FG001|COMPLETED|Period 1||33||
59906512|NCT03055988|76027572|FG000|NOT COMPLETED|Period 1||1||
59906513|NCT03055988|76027573|FG001|NOT COMPLETED|Period 1||5||
59906514|NCT03055988|76027572|FG000|STARTED|Period 2||37||
59906515|NCT03055988|76027573|FG001|STARTED|Period 2||33||
59906516|NCT03055988|76027572|FG000|COMPLETED|Period 2||36||
59906517|NCT03055988|76027573|FG001|COMPLETED|Period 2||31||
59906518|NCT03055988|76027572|FG000|NOT COMPLETED|Period 2||1||
59906519|NCT03055988|76027573|FG001|NOT COMPLETED|Period 2||2||
59906520|NCT01250912|76027579|FG000|STARTED|Overall Study||20||
59906521|NCT01250912|76027579|FG000|COMPLETED|Overall Study||19||
59906522|NCT01250912|76027579|FG000|NOT COMPLETED|Overall Study||1||
59906523|NCT03733301|76027589|FG000|STARTED|Overall Study||109||
59906524|NCT03733301|76027590|FG001|STARTED|Overall Study||109||
59906525|NCT03733301|76027591|FG002|STARTED|Overall Study||111||
59906526|NCT03733301|76027589|FG000|Received One Dose of Study Drug|Overall Study||108||
59906527|NCT03733301|76027590|FG001|Received One Dose of Study Drug|Overall Study||109||
59906528|NCT03733301|76027591|FG002|Received One Dose of Study Drug|Overall Study||111||
59906529|NCT03733301|76027589|FG000|COMPLETED|Overall Study||102||
59906530|NCT03733301|76027590|FG001|COMPLETED|Overall Study||100||
59906531|NCT03733301|76027591|FG002|COMPLETED|Overall Study||107||
59906532|NCT03733301|76027589|FG000|NOT COMPLETED|Overall Study||7||
59906533|NCT03733301|76027590|FG001|NOT COMPLETED|Overall Study||9||
59906534|NCT03733301|76027591|FG002|NOT COMPLETED|Overall Study||4||
59906535|NCT02871297|76027600|FG000|STARTED|Overall Study||662||
59906536|NCT02871297|76027600|FG000|Received at Least 1 Dose of Study Drug|Overall Study||662||
59906537|NCT02871297|76027600|FG000|COMPLETED|Overall Study||526||
59906538|NCT02871297|76027600|FG000|NOT COMPLETED|Overall Study||136||
59906539|NCT03554005|76027610|FG000|STARTED|Overall Study||1||
59906540|NCT03554005|76027611|FG001|STARTED|Overall Study||2||
59757996|NCT00926783|75877175|FG001|NOT COMPLETED|Overall Study||3||
59757997|NCT00929669|75877181|FG000|STARTED|Overall Study||2||
59906541|NCT03554005|76027612|FG002|STARTED|Overall Study||2||
59906542|NCT03554005|76027613|FG003|STARTED|Overall Study||2||
59906543|NCT03554005|76027614|FG004|STARTED|Overall Study||11||
59906544|NCT03554005|76027615|FG005|STARTED|Overall Study||11||
59906545|NCT03554005|76027610|FG000|COMPLETED|Overall Study||0||
59906546|NCT03554005|76027611|FG001|COMPLETED|Overall Study||1||
59906547|NCT03554005|76027612|FG002|COMPLETED|Overall Study||1||
59906548|NCT03554005|76027613|FG003|COMPLETED|Overall Study||1||
59906549|NCT03554005|76027614|FG004|COMPLETED|Overall Study||5||
59906550|NCT03554005|76027615|FG005|COMPLETED|Overall Study||0||
59906551|NCT03554005|76027610|FG000|NOT COMPLETED|Overall Study||1||
60015554|NCT02601001|76131817|FG005|COMPLETED|Dosing Period 1||0|Completed dosing in period 1|
60015555|NCT02601001|76131818|FG006|COMPLETED|Dosing Period 1||0|Completed dosing in period 1|
60015556|NCT02601001|76131812|FG000|NOT COMPLETED|Dosing Period 1||0||
60015557|NCT02601001|76131813|FG001|NOT COMPLETED|Dosing Period 1||0||
60015558|NCT02601001|76131814|FG002|NOT COMPLETED|Dosing Period 1||0||
60015559|NCT02601001|76131815|FG003|NOT COMPLETED|Dosing Period 1||0||
59506196|NCT00765193|75599104|FG000|COMPLETED|Problem Area Examination||14381||
59757998|NCT00929669|75877181|FG000|COMPLETED|Overall Study||1||
59757999|NCT00929669|75877181|FG000|NOT COMPLETED|Overall Study||1||
59758000|NCT00566995|75877185|FG000|STARTED|Overall Study||37||
59758001|NCT00566995|75877185|FG000|COMPLETED|Overall Study||30||
59758002|NCT00566995|75877185|FG000|NOT COMPLETED|Overall Study||7||
59758003|NCT00926393|75877191|FG000|STARTED|Overall Study||69||
59758004|NCT00926393|75877192|FG001|STARTED|Overall Study||70||
59758005|NCT00926393|75877191|FG000|COMPLETED|Overall Study||67||
59758006|NCT00926393|75877192|FG001|COMPLETED|Overall Study||67||
59758007|NCT00926393|75877191|FG000|NOT COMPLETED|Overall Study||2||
59758008|NCT00926393|75877192|FG001|NOT COMPLETED|Overall Study||3||
59758009|NCT00926237|75877198|FG000|STARTED|Overall Study|Two subjects withdrew after receiving sham rTMS but before receiving active rTMS.|19||
59758010|NCT00926237|75877199|FG001|STARTED|Overall Study|One subjects withdrew after receiving sham rTMS but before receiving active rTMS.|20||
59758011|NCT00926237|75877198|FG000|COMPLETED|Overall Study||17||
59758012|NCT00926237|75877199|FG001|COMPLETED|Overall Study||19||
59758013|NCT00926237|75877198|FG000|NOT COMPLETED|Overall Study||2||
59758014|NCT00926237|75877199|FG001|NOT COMPLETED|Overall Study||1||
59758015|NCT00931463|75877211|FG000|STARTED|Overall Study||271||
59758016|NCT00931463|75877212|FG001|STARTED|Overall Study||270||
59758017|NCT00931463|75877211|FG000|COMPLETED|Overall Study||254||
59758018|NCT00931463|75877212|FG001|COMPLETED|Overall Study||265||
59758019|NCT00931463|75877211|FG000|NOT COMPLETED|Overall Study||17||
59758020|NCT00931463|75877212|FG001|NOT COMPLETED|Overall Study||5||
59758021|NCT00929201|75877218|FG000|STARTED|Period 1||30||
59758022|NCT00929201|75877219|FG001|STARTED|Period 1||31||
59758023|NCT00929201|75877218|FG000|COMPLETED|Period 1||30||
59758024|NCT00929201|75877219|FG001|COMPLETED|Period 1||30||
59758025|NCT00929201|75877218|FG000|NOT COMPLETED|Period 1||0||
59758026|NCT00929201|75877219|FG001|NOT COMPLETED|Period 1||1||
59758027|NCT00929201|75877218|FG000|STARTED|7-day Washout||30||
59758028|NCT00929201|75877219|FG001|STARTED|7-day Washout||30||
59758029|NCT00929201|75877218|FG000|COMPLETED|7-day Washout||30||
59758030|NCT00929201|75877219|FG001|COMPLETED|7-day Washout||30||
59758031|NCT00929201|75877218|FG000|NOT COMPLETED|7-day Washout||0||
59758032|NCT00929201|75877219|FG001|NOT COMPLETED|7-day Washout||0||
59758033|NCT00929201|75877218|FG000|STARTED|Period 2||30||
59758034|NCT00929201|75877219|FG001|STARTED|Period 2||30||
59758035|NCT00929201|75877218|FG000|COMPLETED|Period 2||30||
59758036|NCT00929201|75877219|FG001|COMPLETED|Period 2||30||
59758037|NCT00929201|75877218|FG000|NOT COMPLETED|Period 2||0||
59758038|NCT00929201|75877219|FG001|NOT COMPLETED|Period 2||0||
59758039|NCT00926003|75877229|FG000|STARTED|Baseline||53||
59758040|NCT00926003|75877230|FG001|STARTED|Baseline||54||
59758041|NCT00926003|75877231|FG002|STARTED|Baseline||52||
59758042|NCT00926003|75877229|FG000|COMPLETED|Baseline||53||
59758043|NCT00926003|75877230|FG001|COMPLETED|Baseline||54||
59758044|NCT00926003|75877231|FG002|COMPLETED|Baseline||52||
59758045|NCT00926003|75877229|FG000|NOT COMPLETED|Baseline||0||
59758046|NCT00926003|75877230|FG001|NOT COMPLETED|Baseline||0||
59758047|NCT00926003|75877231|FG002|NOT COMPLETED|Baseline||0||
59758048|NCT00926003|75877229|FG000|STARTED|Post-Training Evaluation||53||
59758049|NCT00926003|75877230|FG001|STARTED|Post-Training Evaluation||54||
59758050|NCT00926003|75877231|FG002|STARTED|Post-Training Evaluation||52||
59758051|NCT00926003|75877229|FG000|COMPLETED|Post-Training Evaluation||52||
59906552|NCT03554005|76027611|FG001|NOT COMPLETED|Overall Study||1||
59906553|NCT03554005|76027612|FG002|NOT COMPLETED|Overall Study||1||
59906554|NCT03554005|76027613|FG003|NOT COMPLETED|Overall Study||1||
59906555|NCT03554005|76027614|FG004|NOT COMPLETED|Overall Study||6||
59906556|NCT03554005|76027615|FG005|NOT COMPLETED|Overall Study||11||
59906557|NCT00709228|76027629|FG000|STARTED|Overall Study||496||
59906558|NCT00709228|76027629|FG000|COMPLETED|Overall Study|Number completed is defined as participants who completed the follow-up period.|164||
59906559|NCT00709228|76027629|FG000|NOT COMPLETED|Overall Study||332||
59906560|NCT03219372|76027635|FG000|STARTED|Overall Study||1||
59906561|NCT03219372|76027636|FG001|STARTED|Overall Study||0||
59906562|NCT03219372|76027635|FG000|COMPLETED|Overall Study||0||
59906563|NCT03219372|76027636|FG001|COMPLETED|Overall Study||0||
59906564|NCT03219372|76027635|FG000|NOT COMPLETED|Overall Study||1||
59906565|NCT03219372|76027636|FG001|NOT COMPLETED|Overall Study||0||
59906566|NCT02226796|76027642|FG000|STARTED|First Intervention Phase (Week 1)||2||
59906567|NCT02226796|76027643|FG001|STARTED|First Intervention Phase (Week 1)||1||
59906568|NCT02226796|76027642|FG000|Baseline Assessment|First Intervention Phase (Week 1)||2||
59906569|NCT02226796|76027643|FG001|Baseline Assessment|First Intervention Phase (Week 1)||1||
59906570|NCT02226796|76027642|FG000|Follow Up Assessment|First Intervention Phase (Week 1)||2||
60015560|NCT02601001|76131816|FG004|NOT COMPLETED|Dosing Period 1||0||
60015561|NCT02601001|76131817|FG005|NOT COMPLETED|Dosing Period 1||0||
59758052|NCT00926003|75877230|FG001|COMPLETED|Post-Training Evaluation||54||
59758053|NCT00926003|75877231|FG002|COMPLETED|Post-Training Evaluation||52||
59758054|NCT00926003|75877229|FG000|NOT COMPLETED|Post-Training Evaluation||1||
59758055|NCT00926003|75877230|FG001|NOT COMPLETED|Post-Training Evaluation||0||
59758056|NCT00926003|75877231|FG002|NOT COMPLETED|Post-Training Evaluation||0||
59758057|NCT00926003|75877229|FG000|STARTED|Post-Training 3-month Follow-up||52||
59758058|NCT00926003|75877230|FG001|STARTED|Post-Training 3-month Follow-up||54||
59758059|NCT00926003|75877231|FG002|STARTED|Post-Training 3-month Follow-up||52||
59758060|NCT00926003|75877229|FG000|COMPLETED|Post-Training 3-month Follow-up||51||
59758061|NCT00926003|75877230|FG001|COMPLETED|Post-Training 3-month Follow-up||54||
59758062|NCT00926003|75877231|FG002|COMPLETED|Post-Training 3-month Follow-up||52||
59906571|NCT02226796|76027643|FG001|Follow Up Assessment|First Intervention Phase (Week 1)||1||
59906572|NCT02226796|76027642|FG000|COMPLETED|First Intervention Phase (Week 1)||2||
59906573|NCT02226796|76027643|FG001|COMPLETED|First Intervention Phase (Week 1)||1||
59906574|NCT02226796|76027642|FG000|NOT COMPLETED|First Intervention Phase (Week 1)||0||
59906575|NCT02226796|76027643|FG001|NOT COMPLETED|First Intervention Phase (Week 1)||0||
59906576|NCT02226796|76027642|FG000|STARTED|Washout (Weeks 2-5)||2||
59906577|NCT02226796|76027643|FG001|STARTED|Washout (Weeks 2-5)||1||
59906578|NCT02226796|76027642|FG000|COMPLETED|Washout (Weeks 2-5)||2||
59906579|NCT02226796|76027643|FG001|COMPLETED|Washout (Weeks 2-5)||1||
59906580|NCT02226796|76027642|FG000|NOT COMPLETED|Washout (Weeks 2-5)||0||
59906581|NCT02226796|76027643|FG001|NOT COMPLETED|Washout (Weeks 2-5)||0||
59906582|NCT02226796|76027642|FG000|STARTED|Second Intervention Phase (Week 6)||2||
59906583|NCT02226796|76027643|FG001|STARTED|Second Intervention Phase (Week 6)||1||
59906584|NCT02226796|76027642|FG000|Baseline Assessment|Second Intervention Phase (Week 6)||2||
59906585|NCT02226796|76027643|FG001|Baseline Assessment|Second Intervention Phase (Week 6)||1||
59906586|NCT02226796|76027642|FG000|Follow Up Assessment|Second Intervention Phase (Week 6)||2||
59906587|NCT02226796|76027643|FG001|Follow Up Assessment|Second Intervention Phase (Week 6)||1||
59906588|NCT02226796|76027642|FG000|COMPLETED|Second Intervention Phase (Week 6)||2||
59906589|NCT02226796|76027643|FG001|COMPLETED|Second Intervention Phase (Week 6)||1||
59906590|NCT02226796|76027642|FG000|NOT COMPLETED|Second Intervention Phase (Week 6)||0||
59906591|NCT02226796|76027643|FG001|NOT COMPLETED|Second Intervention Phase (Week 6)||0||
59906592|NCT03056690|76027651|FG000|STARTED|Overall Study||95||
59906593|NCT03056690|76027652|FG001|STARTED|Overall Study||91||
59906594|NCT03056690|76027651|FG000|Treated|Overall Study||94||
59906595|NCT03056690|76027652|FG001|Treated|Overall Study||90||
59906596|NCT03056690|76027651|FG000|COMPLETED|Overall Study||81||
59906597|NCT03056690|76027652|FG001|COMPLETED|Overall Study||75||
59906598|NCT03056690|76027651|FG000|NOT COMPLETED|Overall Study||14||
59906599|NCT03056690|76027652|FG001|NOT COMPLETED|Overall Study||16||
59906600|NCT03191799|76027658|FG000|STARTED|Overall Study||195|Intent-to-Treat (ITT) Population|
59906601|NCT03191799|76027658|FG000|Received at Least One Dose of Emicizumab|Overall Study||193|Safety Population|
59906602|NCT03191799|76027658|FG000|Dose Up-Titrated to 3 mg/kg QW|Overall Study||2||
59906603|NCT03191799|76027658|FG000|COMPLETED|Overall Study||186||
59906604|NCT03191799|76027658|FG000|NOT COMPLETED|Overall Study||9||
59906605|NCT00708916|76027662|FG000|STARTED|Overall Study||12||
59906606|NCT00708916|76027662|FG000|COMPLETED|Overall Study||8||
59906607|NCT00708916|76027662|FG000|NOT COMPLETED|Overall Study||4||
59906608|NCT02352753|76027667|FG000|STARTED|6-Month Dosing Period||153||
59906609|NCT02352753|76027667|FG000|Received Investigational Product|6-Month Dosing Period||153||
59906610|NCT02352753|76027667|FG000|COMPLETED|6-Month Dosing Period||55||
59906611|NCT02352753|76027667|FG000|NOT COMPLETED|6-Month Dosing Period||98||
59906612|NCT02352753|76027667|FG000|STARTED|3-Month Dosing Period||60||
59906613|NCT02352753|76027667|FG000|Received Investigational Product|3-Month Dosing Period||60||
59906614|NCT02352753|76027667|FG000|COMPLETED|3-Month Dosing Period||40||
59906615|NCT02352753|76027667|FG000|NOT COMPLETED|3-Month Dosing Period||20||
59906616|NCT04532294|76027678|FG000|STARTED|Overall Study||4||
59906617|NCT04532294|76027679|FG001|STARTED|Overall Study||6||
59906618|NCT04532294|76027680|FG002|STARTED|Overall Study||8||
59906619|NCT04532294|76027678|FG000|COMPLETED|Overall Study||4||
59906620|NCT04532294|76027679|FG001|COMPLETED|Overall Study||6||
60015562|NCT02601001|76131818|FG006|NOT COMPLETED|Dosing Period 1||0||
59758063|NCT00926003|75877229|FG000|NOT COMPLETED|Post-Training 3-month Follow-up||1||
59906621|NCT04532294|76027680|FG002|COMPLETED|Overall Study||5||
59906622|NCT04532294|76027678|FG000|NOT COMPLETED|Overall Study||0||
59906623|NCT04532294|76027679|FG001|NOT COMPLETED|Overall Study||0||
59906624|NCT04532294|76027680|FG002|NOT COMPLETED|Overall Study||3||
59906625|NCT03197766|76027692|FG000|STARTED|Overall Study||60||
59906626|NCT03197766|76027693|FG001|STARTED|Overall Study||61||
59906627|NCT03197766|76027692|FG000|COMPLETED|Overall Study||58||
59906628|NCT03197766|76027693|FG001|COMPLETED|Overall Study||61||
59906629|NCT03197766|76027692|FG000|NOT COMPLETED|Overall Study||2||
59758064|NCT00926003|75877230|FG001|NOT COMPLETED|Post-Training 3-month Follow-up||0||
59758065|NCT00926003|75877231|FG002|NOT COMPLETED|Post-Training 3-month Follow-up||0||
59758066|NCT00928889|75877241|FG000|STARTED|Overall Study||80||
59758067|NCT00928889|75877242|FG001|STARTED|Overall Study||80||
59758068|NCT00928889|75877241|FG000|COMPLETED|Overall Study||75||
59906630|NCT03197766|76027693|FG001|NOT COMPLETED|Overall Study||0||
59906631|NCT03738332|76027699|FG000|STARTED|Overall Study||12||
59906632|NCT03738332|76027699|FG000|COMPLETED|Overall Study||11||
59906633|NCT03738332|76027699|FG000|NOT COMPLETED|Overall Study||1||
59906634|NCT03173456|76027709|FG000|STARTED|Baseline||120||
59906635|NCT03173456|76027710|FG001|STARTED|Baseline||120||
59906636|NCT03173456|76027711|FG002|STARTED|Baseline||120||
59906637|NCT03173456|76027712|FG003|STARTED|Baseline||120||
59906638|NCT03173456|76027713|FG004|STARTED|Baseline||120||
59906639|NCT03173456|76027709|FG000|COMPLETED|Baseline||120||
59906640|NCT03173456|76027710|FG001|COMPLETED|Baseline||119||
59906641|NCT03173456|76027711|FG002|COMPLETED|Baseline||120||
59906642|NCT03173456|76027712|FG003|COMPLETED|Baseline||120||
59906643|NCT03173456|76027713|FG004|COMPLETED|Baseline||118||
59906644|NCT03173456|76027709|FG000|NOT COMPLETED|Baseline||0||
59906645|NCT03173456|76027710|FG001|NOT COMPLETED|Baseline||1||
59906646|NCT03173456|76027711|FG002|NOT COMPLETED|Baseline||0||
59906647|NCT03173456|76027712|FG003|NOT COMPLETED|Baseline||0||
59906648|NCT03173456|76027713|FG004|NOT COMPLETED|Baseline||2||
59906649|NCT03173456|76027709|FG000|STARTED|2 Hour Follow-up||120||
59906650|NCT03173456|76027710|FG001|STARTED|2 Hour Follow-up||119||
59906651|NCT03173456|76027711|FG002|STARTED|2 Hour Follow-up||120||
59906652|NCT03173456|76027712|FG003|STARTED|2 Hour Follow-up||120||
59906653|NCT03173456|76027713|FG004|STARTED|2 Hour Follow-up||118||
59906654|NCT03173456|76027709|FG000|COMPLETED|2 Hour Follow-up||120||
59906655|NCT03173456|76027710|FG001|COMPLETED|2 Hour Follow-up||118||
59906656|NCT03173456|76027711|FG002|COMPLETED|2 Hour Follow-up||119||
59906657|NCT03173456|76027712|FG003|COMPLETED|2 Hour Follow-up||119||
59906658|NCT03173456|76027713|FG004|COMPLETED|2 Hour Follow-up||116||
59906659|NCT03173456|76027709|FG000|NOT COMPLETED|2 Hour Follow-up||0||
59906660|NCT03173456|76027710|FG001|NOT COMPLETED|2 Hour Follow-up||1||
59906661|NCT03173456|76027711|FG002|NOT COMPLETED|2 Hour Follow-up||1||
59906662|NCT03173456|76027712|FG003|NOT COMPLETED|2 Hour Follow-up||1||
59906663|NCT03173456|76027713|FG004|NOT COMPLETED|2 Hour Follow-up||2||
59906664|NCT02668874|76027725|FG000|STARTED|Overall Study||104||203
59906665|NCT02668874|76027726|FG001|STARTED|Overall Study||104||203
59906666|NCT02668874|76027725|FG000|6 Months After Placement|Overall Study||59||113
60015563|NCT02601001|76131812|FG000|STARTED|Dosing Period 2||10||
60015564|NCT02601001|76131813|FG001|STARTED|Dosing Period 2||0||
60015565|NCT02601001|76131814|FG002|STARTED|Dosing Period 2||0||
60015566|NCT02601001|76131815|FG003|STARTED|Dosing Period 2||7||
60015567|NCT02601001|76131816|FG004|STARTED|Dosing Period 2||13||
60015568|NCT02601001|76131817|FG005|STARTED|Dosing Period 2||7||
60015569|NCT02601001|76131818|FG006|STARTED|Dosing Period 2||13||
60015570|NCT02601001|76131812|FG000|COMPLETED|Dosing Period 2||10|Completed dosing in period 2|
60015571|NCT02601001|76131813|FG001|COMPLETED|Dosing Period 2||0|Completed dosing in period 2|
59906667|NCT02668874|76027726|FG001|6 Months After Placement|Overall Study||59||113
60015572|NCT02601001|76131814|FG002|COMPLETED|Dosing Period 2||0|Completed dosing in period 2|
60015573|NCT02601001|76131815|FG003|COMPLETED|Dosing Period 2||7|Completed dosing in period 2|
60015574|NCT02601001|76131816|FG004|COMPLETED|Dosing Period 2||13|Completed dosing in period 2|
60015575|NCT02601001|76131817|FG005|COMPLETED|Dosing Period 2||7|Completed dosing in period 2|
60015576|NCT02601001|76131818|FG006|COMPLETED|Dosing Period 2||12|Completed dosing in period 2|
60015577|NCT02601001|76131812|FG000|NOT COMPLETED|Dosing Period 2||0||
60015578|NCT02601001|76131813|FG001|NOT COMPLETED|Dosing Period 2||0||
60015579|NCT02601001|76131814|FG002|NOT COMPLETED|Dosing Period 2||0||
60015580|NCT02601001|76131815|FG003|NOT COMPLETED|Dosing Period 2||0||
60015581|NCT02601001|76131816|FG004|NOT COMPLETED|Dosing Period 2||0||
60015582|NCT02601001|76131817|FG005|NOT COMPLETED|Dosing Period 2||0||
60015583|NCT02601001|76131818|FG006|NOT COMPLETED|Dosing Period 2||1||
60015584|NCT02604199|76131843|FG000|STARTED|Overall Study||9||
60015585|NCT02604199|76131844|FG001|STARTED|Overall Study||11||
60015586|NCT02604199|76131845|FG002|STARTED|Overall Study||17||
59906668|NCT02668874|76027725|FG000|COMPLETED|Overall Study||47||82
59906669|NCT02668874|76027726|FG001|COMPLETED|Overall Study||47||82
59906670|NCT02668874|76027725|FG000|NOT COMPLETED|Overall Study||57||121
59906671|NCT02668874|76027726|FG001|NOT COMPLETED|Overall Study||57||121
59906672|NCT03197376|76027736|FG000|STARTED|Primary and Booster Phase||502||
59906673|NCT03197376|76027737|FG001|STARTED|Primary and Booster Phase||501||
59906674|NCT03197376|76027738|FG002|STARTED|Primary and Booster Phase||500||
59906675|NCT03197376|76027739|FG003|STARTED|Primary and Booster Phase||747||
59906676|NCT03197376|76027736|FG000|Vaccinated-Dose 1|Primary and Booster Phase||502||
59906677|NCT03197376|76027737|FG001|Vaccinated-Dose 1|Primary and Booster Phase||501||
59906678|NCT03197376|76027738|FG002|Vaccinated-Dose 1|Primary and Booster Phase||500||
59906679|NCT03197376|76027739|FG003|Vaccinated-Dose 1|Primary and Booster Phase||747||
59906680|NCT03197376|76027736|FG000|Vaccinated-Dose 2|Primary and Booster Phase||495||
60015587|NCT02604199|76131846|FG003|STARTED|Overall Study||21||
60015588|NCT02604199|76131843|FG000|COMPLETED|Overall Study||9||
60015589|NCT02604199|76131844|FG001|COMPLETED|Overall Study||8||
60015590|NCT02604199|76131845|FG002|COMPLETED|Overall Study||17||
59906681|NCT03197376|76027737|FG001|Vaccinated-Dose 2|Primary and Booster Phase||495||
59906682|NCT03197376|76027738|FG002|Vaccinated-Dose 2|Primary and Booster Phase||491||
59906683|NCT03197376|76027739|FG003|Vaccinated-Dose 2|Primary and Booster Phase||738||
59906684|NCT03197376|76027736|FG000|Vaccinated-Dose 3|Primary and Booster Phase||492||
59906685|NCT03197376|76027737|FG001|Vaccinated-Dose 3|Primary and Booster Phase||493||
59906686|NCT03197376|76027738|FG002|Vaccinated-Dose 3|Primary and Booster Phase||490||
59906687|NCT03197376|76027739|FG003|Vaccinated-Dose 3|Primary and Booster Phase||731||
59906688|NCT03197376|76027736|FG000|Primary Reactogenicity Cohort|Primary and Booster Phase||251||
59906689|NCT03197376|76027737|FG001|Primary Reactogenicity Cohort|Primary and Booster Phase||243||
59906690|NCT03197376|76027738|FG002|Primary Reactogenicity Cohort|Primary and Booster Phase||257||
59906691|NCT03197376|76027739|FG003|Primary Reactogenicity Cohort|Primary and Booster Phase||364||
59906692|NCT03197376|76027736|FG000|Booster Cohort|Primary and Booster Phase||150||
59906693|NCT03197376|76027737|FG001|Booster Cohort|Primary and Booster Phase||151||
59906694|NCT03197376|76027738|FG002|Booster Cohort|Primary and Booster Phase||150||
59906695|NCT03197376|76027739|FG003|Booster Cohort|Primary and Booster Phase||224||
59906696|NCT03197376|76027736|FG000|Received Booster Vaccine|Primary and Booster Phase||145||
59906697|NCT03197376|76027737|FG001|Received Booster Vaccine|Primary and Booster Phase||144||
59906698|NCT03197376|76027738|FG002|Received Booster Vaccine|Primary and Booster Phase||139||
59906699|NCT03197376|76027739|FG003|Received Booster Vaccine|Primary and Booster Phase||213||
59906700|NCT03197376|76027736|FG000|COMPLETED|Primary and Booster Phase||487|Completed main phase of study excluding immune persistence phase|
59906701|NCT03197376|76027737|FG001|COMPLETED|Primary and Booster Phase||488|Completed main phase of study excluding immune persistence phase|
59906702|NCT03197376|76027738|FG002|COMPLETED|Primary and Booster Phase||480|Completed main phase of study excluding immune persistence phase|
59906703|NCT03197376|76027739|FG003|COMPLETED|Primary and Booster Phase||722|Completed main phase of study excluding immune persistence phase|
59906704|NCT03197376|76027736|FG000|NOT COMPLETED|Primary and Booster Phase||15||
59906705|NCT03197376|76027737|FG001|NOT COMPLETED|Primary and Booster Phase||13||
59906706|NCT03197376|76027738|FG002|NOT COMPLETED|Primary and Booster Phase||20||
59906707|NCT03197376|76027739|FG003|NOT COMPLETED|Primary and Booster Phase||25||
59906708|NCT03197376|76027736|FG000|STARTED|Immune Persistence Phase||132||
59906709|NCT03197376|76027737|FG001|STARTED|Immune Persistence Phase||133||
59906710|NCT03197376|76027738|FG002|STARTED|Immune Persistence Phase||128||
59906711|NCT03197376|76027739|FG003|STARTED|Immune Persistence Phase||195||
59906712|NCT03197376|76027736|FG000|COMPLETED|Immune Persistence Phase||127||
59906713|NCT03197376|76027737|FG001|COMPLETED|Immune Persistence Phase||129||
59906714|NCT03197376|76027738|FG002|COMPLETED|Immune Persistence Phase||123||
59906715|NCT03197376|76027739|FG003|COMPLETED|Immune Persistence Phase||190||
59906716|NCT03197376|76027736|FG000|NOT COMPLETED|Immune Persistence Phase||5||
59906717|NCT03197376|76027737|FG001|NOT COMPLETED|Immune Persistence Phase||4||
59906718|NCT03197376|76027738|FG002|NOT COMPLETED|Immune Persistence Phase||5||
59906719|NCT03197376|76027739|FG003|NOT COMPLETED|Immune Persistence Phase||5||
59906720|NCT03600805|76027776|FG000|STARTED|Overall Study||28||
59906721|NCT03600805|76027777|FG001|STARTED|Overall Study||14||
59906722|NCT03600805|76027778|FG002|STARTED|Overall Study||14||
59906723|NCT03600805|76027779|FG003|STARTED|Overall Study||27||
59906724|NCT03600805|76027776|FG000|Week 52 Analysis Set Population|Overall Study||10|Randomized participants who had opportunity to complete the 52-week treatment period (randomized prior to October 16th, 2019).|
59906725|NCT03600805|76027777|FG001|Week 52 Analysis Set Population|Overall Study||6|Randomized participants who had opportunity to complete the 52-week treatment period (randomized prior to October 16th, 2019).|
59906726|NCT03600805|76027778|FG002|Week 52 Analysis Set Population|Overall Study||7|Randomized participants who had opportunity to complete the 52-week treatment period (randomized prior to October 16th, 2019).|
59906727|NCT03600805|76027779|FG003|Week 52 Analysis Set Population|Overall Study||13|Randomized participants who had opportunity to complete the 52-week treatment period (randomized prior to October 16th, 2019).|
59906728|NCT03600805|76027776|FG000|COMPLETED|Overall Study||9||
59906729|NCT03600805|76027777|FG001|COMPLETED|Overall Study||6||
59906730|NCT03600805|76027778|FG002|COMPLETED|Overall Study||6||
59906731|NCT03600805|76027779|FG003|COMPLETED|Overall Study||8||
59906732|NCT03600805|76027776|FG000|NOT COMPLETED|Overall Study||19||
59906733|NCT03600805|76027777|FG001|NOT COMPLETED|Overall Study||8||
59906734|NCT03600805|76027778|FG002|NOT COMPLETED|Overall Study||8||
59906735|NCT03600805|76027779|FG003|NOT COMPLETED|Overall Study||19||
59906736|NCT02729740|76027791|FG000|STARTED|Overall Study||995||
59906737|NCT02729740|76027791|FG000|COMPLETED|Overall Study||864||
59906738|NCT02729740|76027791|FG000|NOT COMPLETED|Overall Study||131||
59906739|NCT02942966|76027795|FG000|STARTED|Overall Study|Intent to Treat (ITT) population.|233||
59906740|NCT02942966|76027795|FG000|COMPLETED|Overall Study|Completed 6-month follow-up|205||
59906741|NCT02942966|76027795|FG000|NOT COMPLETED|Overall Study||28||
59906742|NCT03196284|76027801|FG000|STARTED|Main Part||17||
59906743|NCT03196284|76027802|FG001|STARTED|Main Part||9||
59906744|NCT03196284|76027803|FG002|STARTED|Main Part||0||
59906745|NCT03196284|76027801|FG000|Concizumab 0.15 mg/kg|Main Part||15|The last dose level the participants received in main part of the trial.|
60015591|NCT02604199|76131846|FG003|COMPLETED|Overall Study||18||
60015592|NCT02604199|76131843|FG000|NOT COMPLETED|Overall Study||0||
60015593|NCT02604199|76131844|FG001|NOT COMPLETED|Overall Study||3||
59906746|NCT03196284|76027802|FG001|Concizumab 0.15 mg/kg|Main Part||0|The last dose level the participants received in main part of the trial.|
59906747|NCT03196284|76027803|FG002|Concizumab 0.15 mg/kg|Main Part||0|The last dose level the participants received in main part of the trial.|
59906748|NCT03196284|76027801|FG000|Concizumab 0.20 mg/kg|Main Part||2|The last dose level the participants received in main part of the trial.|
59906749|NCT03196284|76027802|FG001|Concizumab 0.20 mg/kg|Main Part||0|The last dose level the participants received in main part of the trial.|
59906750|NCT03196284|76027803|FG002|Concizumab 0.20 mg/kg|Main Part||0|The last dose level the participants received in main part of the trial.|
59906751|NCT03196284|76027801|FG000|Concizumab 0.25 mg/kg|Main Part||0|The last dose level the participants received in main part of the trial.|
59906752|NCT03196284|76027802|FG001|Concizumab 0.25 mg/kg|Main Part||0|The last dose level the participants received in main part of the trial.|
59506197|NCT00765193|75599104|FG000|NOT COMPLETED|Problem Area Examination||0||
59506198|NCT00765193|75599104|FG000|STARTED|Full Body Examination||14381||
59506199|NCT00765193|75599104|FG000|COMPLETED|Full Body Examination||14381||
59506200|NCT00765193|75599104|FG000|NOT COMPLETED|Full Body Examination||0||
59506201|NCT00765661|75599111|FG000|STARTED|Overall Study||32||
59506202|NCT00765661|75599112|FG001|STARTED|Overall Study||31||
59506203|NCT00765661|75599111|FG000|COMPLETED|Overall Study||32||
59506204|NCT00765661|75599112|FG001|COMPLETED|Overall Study||31||
59906753|NCT03196284|76027803|FG002|Concizumab 0.25 mg/kg|Main Part||0|The last dose level the participants received in main part of the trial.|
59906754|NCT03196284|76027801|FG000|COMPLETED|Main Part||17||
59906755|NCT03196284|76027802|FG001|COMPLETED|Main Part||8||
59906756|NCT03196284|76027803|FG002|COMPLETED|Main Part||0||
59906757|NCT03196284|76027801|FG000|NOT COMPLETED|Main Part||0||
59906758|NCT03196284|76027802|FG001|NOT COMPLETED|Main Part||1||
59906759|NCT03196284|76027803|FG002|NOT COMPLETED|Main Part||0||
59906760|NCT03196284|76027801|FG000|STARTED|Extension Part|Participants who completed main part are presented in separate treatment arm.|0||
59906761|NCT03196284|76027802|FG001|STARTED|Extension Part|Participants switched to treatment with concizumab in the extension part of the study.|0||
59906762|NCT03196284|76027803|FG002|STARTED|Extension Part|Participants who completed the main part entered the extension part of the study.|25||
59906763|NCT03196284|76027801|FG000|Concizumab 0.15 mg/kg|Extension Part||0|The last dose level the participants received in extension part of the trial.|
59906764|NCT03196284|76027802|FG001|Concizumab 0.15 mg/kg|Extension Part||0|The last dose level the participants received in extension part of the trial.|
59906765|NCT03196284|76027803|FG002|Concizumab 0.15 mg/kg|Extension Part||12|The last dose level the participants received in extension part of the trial.|
59906766|NCT03196284|76027801|FG000|Concizumab 0.20 mg/kg|Extension Part||0|The last dose level the participants received in extension part of the trial.|
59906767|NCT03196284|76027802|FG001|Concizumab 0.20 mg/kg|Extension Part||0|The last dose level the participants received in extension part of the trial.|
59906768|NCT03196284|76027803|FG002|Concizumab 0.20 mg/kg|Extension Part||9|The last dose level the participants received in extension part of the trial.|
59906769|NCT03196284|76027801|FG000|Concizumab 0.25 mg/kg|Extension Part||0|The last dose level the participants received in extension part of the trial.|
59906770|NCT03196284|76027802|FG001|Concizumab 0.25 mg/kg|Extension Part||0|The last dose level the participants received in extension part of the trial.|
59906771|NCT03196284|76027803|FG002|Concizumab 0.25 mg/kg|Extension Part||4|The last dose level the participants received in extension part of the trial.|
59906772|NCT03196284|76027801|FG000|COMPLETED|Extension Part||0||
59906773|NCT03196284|76027802|FG001|COMPLETED|Extension Part||0||
59906774|NCT03196284|76027803|FG002|COMPLETED|Extension Part||22||
59906775|NCT03196284|76027801|FG000|NOT COMPLETED|Extension Part||0||
59906776|NCT03196284|76027802|FG001|NOT COMPLETED|Extension Part||0||
59906777|NCT03196284|76027803|FG002|NOT COMPLETED|Extension Part||3||
59906778|NCT03730961|76027825|FG000|STARTED|Overall Study||12|Started = Initiated Period 1 treatment|
59906779|NCT03730961|76027826|FG001|STARTED|Overall Study||11|Started = Initiated Period 1 treatment|
59906780|NCT03730961|76027825|FG000|Period 1 Completion|Overall Study||12||
59906781|NCT03730961|76027826|FG001|Period 1 Completion|Overall Study||11||
59906782|NCT03730961|76027825|FG000|Period 2 Completion|Overall Study|1 participant did not complete Period 2 due to hypotension but remained in the study|11||
59906783|NCT03730961|76027826|FG001|Period 2 Completion|Overall Study|1 participant discontinued study due to AE|10||
59906784|NCT03730961|76027825|FG000|COMPLETED|Overall Study||12|Completed study|
59906785|NCT03730961|76027826|FG001|COMPLETED|Overall Study||10|Completed study|
59906786|NCT03730961|76027825|FG000|NOT COMPLETED|Overall Study||0||
59906787|NCT03730961|76027826|FG001|NOT COMPLETED|Overall Study||1||
59906788|NCT01078454|76027834|FG000|STARTED|Overall Study||6||
59906789|NCT01078454|76027835|FG001|STARTED|Overall Study||5||
59906790|NCT01078454|76027834|FG000|COMPLETED|Overall Study||5||
59906791|NCT01078454|76027835|FG001|COMPLETED|Overall Study||3||
59906792|NCT01078454|76027834|FG000|NOT COMPLETED|Overall Study||1||
59906793|NCT01078454|76027835|FG001|NOT COMPLETED|Overall Study||2||
59906794|NCT02968602|76027843|FG000|STARTED|Overall Study||16||
59906795|NCT02968602|76027844|FG001|STARTED|Overall Study||16||
59906796|NCT02968602|76027843|FG000|COMPLETED|Overall Study||16||
59906797|NCT02968602|76027844|FG001|COMPLETED|Overall Study||16||
59906798|NCT02968602|76027843|FG000|NOT COMPLETED|Overall Study||0||
60015594|NCT02604199|76131845|FG002|NOT COMPLETED|Overall Study||0||
59506205|NCT00765661|75599111|FG000|NOT COMPLETED|Overall Study||0||
59506206|NCT00765661|75599112|FG001|NOT COMPLETED|Overall Study||0||
59906799|NCT02968602|76027844|FG001|NOT COMPLETED|Overall Study||0||
59906800|NCT03345004|76027852|FG000|STARTED|Overall Study||57||
59906801|NCT03345004|76027853|FG001|STARTED|Overall Study||52||
59906802|NCT03345004|76027852|FG000|Haplotype DR3-DQ2 Population Month 15|Overall Study||29||
59506207|NCT00765895|75599120|FG000|STARTED|Overall Study||65||
59506208|NCT00765895|75599121|FG001|STARTED|Overall Study||65||
59506209|NCT00765895|75599120|FG000|COMPLETED|Overall Study||65||
59506210|NCT00765895|75599121|FG001|COMPLETED|Overall Study||65||
59506211|NCT00765895|75599120|FG000|NOT COMPLETED|Overall Study||0||
59506212|NCT00765895|75599121|FG001|NOT COMPLETED|Overall Study||0||
59506213|NCT01276457|75599129|FG000|STARTED|Core Study||142||
59506214|NCT01276457|75599130|FG001|STARTED|Core Study||143||
59758069|NCT00928889|75877242|FG001|COMPLETED|Overall Study||78||
59758070|NCT00928889|75877241|FG000|NOT COMPLETED|Overall Study||5||
59758071|NCT00928889|75877242|FG001|NOT COMPLETED|Overall Study||2||
59758072|NCT03978091|75877254|FG000|STARTED|Overall Study||8||
59758073|NCT03978091|75877255|FG001|STARTED|Overall Study||8||
60015595|NCT02604199|76131846|FG003|NOT COMPLETED|Overall Study||3||
60015596|NCT02600845|76131859|FG000|STARTED|Overall Study||122||
60015597|NCT02600845|76131859|FG000|COMPLETED|Overall Study||104||
60015598|NCT02600845|76131859|FG000|NOT COMPLETED|Overall Study||18||
59758074|NCT03978091|75877256|FG002|STARTED|Overall Study||8||
59758075|NCT03978091|75877257|FG003|STARTED|Overall Study||8||
59906803|NCT03345004|76027853|FG001|Haplotype DR3-DQ2 Population Month 15|Overall Study||19||
59906804|NCT03345004|76027852|FG000|COMPLETED|Overall Study||56||
59906805|NCT03345004|76027853|FG001|COMPLETED|Overall Study||51||
59906806|NCT03345004|76027852|FG000|NOT COMPLETED|Overall Study||1||
59906807|NCT03345004|76027853|FG001|NOT COMPLETED|Overall Study||1||
59906808|NCT03552757|76027864|FG000|STARTED|Overall Study||403||
59906809|NCT03552757|76027865|FG001|STARTED|Overall Study||404||
59906810|NCT03552757|76027866|FG002|STARTED|Overall Study||403||
60015599|NCT02599129|76131865|FG000|STARTED|Overall Study||7||
60015600|NCT02599129|76131866|FG001|STARTED|Overall Study||4||
59506215|NCT01276457|75599129|FG000|COMPLETED|Core Study||129||
59506216|NCT01276457|75599130|FG001|COMPLETED|Core Study||123||
59506217|NCT01276457|75599129|FG000|NOT COMPLETED|Core Study||13||
59506218|NCT01276457|75599130|FG001|NOT COMPLETED|Core Study||20||
59506219|NCT01276457|75599129|FG000|STARTED|Extension Study||111||
59758076|NCT03978091|75877258|FG004|STARTED|Overall Study||8||
59758077|NCT03978091|75877259|FG005|STARTED|Overall Study||8||
59758078|NCT03978091|75877254|FG000|COMPLETED|Overall Study||8||
59906811|NCT03552757|76027864|FG000|Exposed|Overall Study||402||
59906812|NCT03552757|76027865|FG001|Exposed|Overall Study||403||
59906813|NCT03552757|76027866|FG002|Exposed|Overall Study||402||
59906814|NCT03552757|76027864|FG000|Full Analysis Set (FAS)|Overall Study||403||
59906815|NCT03552757|76027865|FG001|Full Analysis Set (FAS)|Overall Study||404||
59906816|NCT03552757|76027866|FG002|Full Analysis Set (FAS)|Overall Study||403||
60015601|NCT02599129|76131865|FG000|COMPLETED|Overall Study||2||
59906817|NCT03552757|76027864|FG000|Safety Analysis Set (SAS)|Overall Study||402||
59906818|NCT03552757|76027865|FG001|Safety Analysis Set (SAS)|Overall Study||403||
59906819|NCT03552757|76027866|FG002|Safety Analysis Set (SAS)|Overall Study||402||
59906820|NCT03552757|76027864|FG000|COMPLETED|Overall Study||390||
59906821|NCT03552757|76027865|FG001|COMPLETED|Overall Study||391||
59906822|NCT03552757|76027866|FG002|COMPLETED|Overall Study||383||
59906823|NCT03552757|76027864|FG000|NOT COMPLETED|Overall Study||13||
59906824|NCT03552757|76027865|FG001|NOT COMPLETED|Overall Study||13||
59906825|NCT03552757|76027866|FG002|NOT COMPLETED|Overall Study||20||
59906826|NCT03730103|76027879|FG000|STARTED|Overall Study||61||
59906827|NCT03730103|76027880|FG001|STARTED|Overall Study||52||
59906828|NCT03730103|76027879|FG000|COMPLETED|Overall Study||61||
59906829|NCT03730103|76027880|FG001|COMPLETED|Overall Study||47||
59906830|NCT03730103|76027879|FG000|NOT COMPLETED|Overall Study||0||
59906831|NCT03730103|76027880|FG001|NOT COMPLETED|Overall Study||5||
59906832|NCT03727841|76027888|FG000|STARTED|Overall Study||3||
59906833|NCT03727841|76027889|FG001|STARTED|Overall Study||1||
59906834|NCT03727841|76027888|FG000|COMPLETED|Overall Study||0||
59906835|NCT03727841|76027889|FG001|COMPLETED|Overall Study||0||
59906836|NCT03727841|76027888|FG000|NOT COMPLETED|Overall Study||3||
59906837|NCT03727841|76027889|FG001|NOT COMPLETED|Overall Study||1||
59906838|NCT03552523|76027895|FG000|STARTED|Overall Study||5||
59906839|NCT03552523|76027896|FG001|STARTED|Overall Study||2||
59906840|NCT03552523|76027895|FG000|COMPLETED|Overall Study||4||
59906841|NCT03552523|76027896|FG001|COMPLETED|Overall Study||1||
59906842|NCT03552523|76027895|FG000|NOT COMPLETED|Overall Study||1||
59906843|NCT03552523|76027896|FG001|NOT COMPLETED|Overall Study||1||
59906844|NCT03345550|76027904|FG000|STARTED|Overall Study||22||
59906845|NCT03345550|76027905|FG001|STARTED|Overall Study||22||
59906846|NCT03345550|76027904|FG000|First Received Drug|Overall Study||22||
59906847|NCT03345550|76027905|FG001|First Received Drug|Overall Study||22||
59906848|NCT03345550|76027904|FG000|COMPLETED|Overall Study||17||
59906849|NCT03345550|76027905|FG001|COMPLETED|Overall Study||17||
59906850|NCT03345550|76027904|FG000|NOT COMPLETED|Overall Study||5||
59906851|NCT03345550|76027905|FG001|NOT COMPLETED|Overall Study||5||
59906852|NCT03186378|76027913|FG000|STARTED|Overall Study||17||
59906853|NCT03186378|76027914|FG001|STARTED|Overall Study||16||
59906854|NCT03186378|76027913|FG000|COMPLETED|Overall Study||16||
59906855|NCT03186378|76027914|FG001|COMPLETED|Overall Study||16||
59906856|NCT03186378|76027913|FG000|NOT COMPLETED|Overall Study||1||
59906857|NCT03186378|76027914|FG001|NOT COMPLETED|Overall Study||0||
59906858|NCT00687596|76027922|FG000|STARTED|Overall Study||26||
59906859|NCT00687596|76027923|FG001|STARTED|Overall Study||26||
59906860|NCT00687596|76027922|FG000|COMPLETED|Overall Study||0||
59906861|NCT00687596|76027923|FG001|COMPLETED|Overall Study||0||
59906862|NCT00687596|76027922|FG000|NOT COMPLETED|Overall Study||26||
59906863|NCT00687596|76027923|FG001|NOT COMPLETED|Overall Study||26||
59906864|NCT02892409|76027931|FG000|STARTED|Overall Study||15||
59906865|NCT02892409|76027932|FG001|STARTED|Overall Study||15||
59906866|NCT02892409|76027931|FG000|COMPLETED|Overall Study||12||
59906867|NCT02892409|76027932|FG001|COMPLETED|Overall Study||14||
60015602|NCT02599129|76131866|FG001|COMPLETED|Overall Study||1||
60015603|NCT02599129|76131865|FG000|NOT COMPLETED|Overall Study||5||
60015604|NCT02599129|76131866|FG001|NOT COMPLETED|Overall Study||3||
60015605|NCT02596711|76131875|FG000|STARTED|Overall Study||9||
60015606|NCT02596711|76131876|FG001|STARTED|Overall Study||8||
60015607|NCT02596711|76131877|FG002|STARTED|Overall Study||8||
60015608|NCT02596711|76131875|FG000|Visit 2|Overall Study||9||
60015609|NCT02596711|76131876|FG001|Visit 2|Overall Study||7||
60015610|NCT02596711|76131877|FG002|Visit 2|Overall Study||6||
59906868|NCT02892409|76027931|FG000|NOT COMPLETED|Overall Study||3||
59906869|NCT02892409|76027932|FG001|NOT COMPLETED|Overall Study||1||
59906870|NCT03219216|76027940|FG000|STARTED|Overall Study||75||
59906871|NCT03219216|76027941|FG001|STARTED|Overall Study||25||
59906872|NCT03219216|76027940|FG000|COMPLETED|Overall Study||75||
59906873|NCT03219216|76027941|FG001|COMPLETED|Overall Study||24||
59906874|NCT03219216|76027940|FG000|NOT COMPLETED|Overall Study||0||
59906875|NCT03219216|76027941|FG001|NOT COMPLETED|Overall Study||1||
59906876|NCT02292758|76027948|FG000|STARTED|Overall Study||19||
59906877|NCT02292758|76027949|FG001|STARTED|Overall Study||17||
59906878|NCT02292758|76027948|FG000|COMPLETED|Overall Study||19||
59906879|NCT02292758|76027949|FG001|COMPLETED|Overall Study||17||
60015611|NCT02596711|76131875|FG000|Visit 3|Overall Study||7||
59506220|NCT01276457|75599130|FG001|STARTED|Extension Study||112||
59906880|NCT02292758|76027948|FG000|NOT COMPLETED|Overall Study||0||
59906881|NCT02292758|76027949|FG001|NOT COMPLETED|Overall Study||0||
59906882|NCT03195660|76027955|FG000|STARTED|Overall Study||2||
60015612|NCT02596711|76131876|FG001|Visit 3|Overall Study||8||
59906883|NCT03195660|76027955|FG000|COMPLETED|Overall Study||0||
59906884|NCT03195660|76027955|FG000|NOT COMPLETED|Overall Study||2||
59906885|NCT03194490|76027961|FG000|STARTED|Overall Study||20||
59906886|NCT03194490|76027962|FG001|STARTED|Overall Study||23||
59906887|NCT03194490|76027961|FG000|COMPLETED|Overall Study||18||
59906888|NCT03194490|76027962|FG001|COMPLETED|Overall Study||20||
59906889|NCT03194490|76027961|FG000|NOT COMPLETED|Overall Study||2||
59906890|NCT03194490|76027962|FG001|NOT COMPLETED|Overall Study||3||
59906891|NCT03217968|76027969|FG000|STARTED|Overall Study||59||
60015613|NCT02596711|76131877|FG002|Visit 3|Overall Study||6||
60015614|NCT02596711|76131875|FG000|3 Month Follow-up|Overall Study||8||
60015615|NCT02596711|76131876|FG001|3 Month Follow-up|Overall Study||6||
60015616|NCT02596711|76131877|FG002|3 Month Follow-up|Overall Study||6||
60015617|NCT02596711|76131875|FG000|6 Month Follow-up|Overall Study||8||
60015618|NCT02596711|76131876|FG001|6 Month Follow-up|Overall Study||6||
60015619|NCT02596711|76131877|FG002|6 Month Follow-up|Overall Study||5||
60015620|NCT02596711|76131875|FG000|COMPLETED|Overall Study||8||
60015621|NCT02596711|76131876|FG001|COMPLETED|Overall Study||6||
60015622|NCT02596711|76131877|FG002|COMPLETED|Overall Study||5||
60015623|NCT02596711|76131875|FG000|NOT COMPLETED|Overall Study||1||
59906892|NCT03217968|76027969|FG000|COMPLETED|Overall Study||48||
59906893|NCT03217968|76027969|FG000|NOT COMPLETED|Overall Study||11||
59906894|NCT03192306|76027975|FG000|STARTED|Overall Study||227||
59906895|NCT03192306|76027976|FG001|STARTED|Overall Study||224||
59906896|NCT03192306|76027975|FG000|Modified Intent to Treat (MITT)|Overall Study||76|MITT represents data collected from enrolled subjects who developed a cold sore and treated.|
59906897|NCT03192306|76027976|FG001|Modified Intent to Treat (MITT)|Overall Study||80|MITT represents data collected from enrolled subjects who developed a cold sore and treated.|
59906898|NCT03192306|76027975|FG000|COMPLETED|Overall Study||75||
59906899|NCT03192306|76027976|FG001|COMPLETED|Overall Study||79||
59906900|NCT03192306|76027975|FG000|NOT COMPLETED|Overall Study||152||
59906901|NCT03192306|76027976|FG001|NOT COMPLETED|Overall Study||145||
59906902|NCT04066829|76027986|FG000|STARTED|Overall Study||70||
59906903|NCT04066829|76027987|FG001|STARTED|Overall Study||61||
59906904|NCT04066829|76027988|FG002|STARTED|Overall Study||46||
59906905|NCT04066829|76027989|FG003|STARTED|Overall Study||60||
59906906|NCT04066829|76027986|FG000|Participants Who Completed the Post-operative Day 14 Survey Assessing Secondary Outcomes.|Overall Study||44||
59906907|NCT04066829|76027987|FG001|Participants Who Completed the Post-operative Day 14 Survey Assessing Secondary Outcomes.|Overall Study||40||
59906908|NCT04066829|76027988|FG002|Participants Who Completed the Post-operative Day 14 Survey Assessing Secondary Outcomes.|Overall Study||26||
59906909|NCT04066829|76027989|FG003|Participants Who Completed the Post-operative Day 14 Survey Assessing Secondary Outcomes.|Overall Study||40||
59906910|NCT04066829|76027986|FG000|COMPLETED|Overall Study||70||
59906911|NCT04066829|76027987|FG001|COMPLETED|Overall Study||61||
59906912|NCT04066829|76027988|FG002|COMPLETED|Overall Study||46||
59906913|NCT04066829|76027989|FG003|COMPLETED|Overall Study||60||
59906914|NCT04066829|76027986|FG000|NOT COMPLETED|Overall Study||0||
59906915|NCT04066829|76027987|FG001|NOT COMPLETED|Overall Study||0||
59906916|NCT04066829|76027988|FG002|NOT COMPLETED|Overall Study||0||
59906917|NCT04066829|76027989|FG003|NOT COMPLETED|Overall Study||0||
59906918|NCT03216954|76027999|FG000|STARTED|Overall Study||4||
59906919|NCT03216954|76028000|FG001|STARTED|Overall Study||3||
59906920|NCT03216954|76028001|FG002|STARTED|Overall Study||3||
59906921|NCT03216954|76028002|FG003|STARTED|Overall Study||3||
59906922|NCT03216954|76028003|FG004|STARTED|Overall Study||1||
59906923|NCT03216954|76027999|FG000|COMPLETED|Overall Study||2||
59906924|NCT03216954|76028000|FG001|COMPLETED|Overall Study||2||
59906925|NCT03216954|76028001|FG002|COMPLETED|Overall Study||2||
59906926|NCT03216954|76028002|FG003|COMPLETED|Overall Study||3||
59906927|NCT03216954|76028003|FG004|COMPLETED|Overall Study||0||
59906928|NCT03216954|76027999|FG000|NOT COMPLETED|Overall Study||2||
59906929|NCT03216954|76028000|FG001|NOT COMPLETED|Overall Study||1||
59906930|NCT03216954|76028001|FG002|NOT COMPLETED|Overall Study||1||
59906931|NCT03216954|76028002|FG003|NOT COMPLETED|Overall Study||0||
59906932|NCT03216954|76028003|FG004|NOT COMPLETED|Overall Study||1||
59906933|NCT03599089|76028015|FG000|STARTED|Overall Study||36||
59906934|NCT03599089|76028016|FG001|STARTED|Overall Study||36||
59906935|NCT03599089|76028017|FG002|STARTED|Overall Study||38||
59906936|NCT03599089|76028018|FG003|STARTED|Overall Study||37||
59906937|NCT03599089|76028015|FG000|COMPLETED|Overall Study||33||
59906938|NCT03599089|76028016|FG001|COMPLETED|Overall Study||35||
60015624|NCT02596711|76131876|FG001|NOT COMPLETED|Overall Study||2||
59906939|NCT03599089|76028017|FG002|COMPLETED|Overall Study||37||
59906940|NCT03599089|76028018|FG003|COMPLETED|Overall Study||35||
59906941|NCT03599089|76028015|FG000|NOT COMPLETED|Overall Study||3||
59906942|NCT03599089|76028016|FG001|NOT COMPLETED|Overall Study||1||
59906943|NCT03599089|76028017|FG002|NOT COMPLETED|Overall Study||1||
59906944|NCT03599089|76028018|FG003|NOT COMPLETED|Overall Study||2||
59906945|NCT03192150|76028030|FG000|STARTED|Overall Study||163||
59906946|NCT03192150|76028031|FG001|STARTED|Overall Study||83||
60015625|NCT02596711|76131877|FG002|NOT COMPLETED|Overall Study||3||
60015626|NCT02596009|76131885|FG000|STARTED|Overall Study||14||
60015627|NCT02596009|76131886|FG001|STARTED|Overall Study||16||
60015628|NCT02596009|76131887|FG002|STARTED|Overall Study||16||
59906947|NCT03192150|76028030|FG000|COMPLETED|Overall Study||108||
60015629|NCT02596009|76131888|FG003|STARTED|Overall Study||16||
60015630|NCT02596009|76131889|FG004|STARTED|Overall Study||18||
60015631|NCT02596009|76131890|FG005|STARTED|Overall Study||17||
60015632|NCT02596009|76131885|FG000|COMPLETED|Overall Study||14||
60015633|NCT02596009|76131886|FG001|COMPLETED|Overall Study||15||
60015634|NCT02596009|76131887|FG002|COMPLETED|Overall Study||16||
60015635|NCT02596009|76131888|FG003|COMPLETED|Overall Study||16||
60015636|NCT02596009|76131889|FG004|COMPLETED|Overall Study||18||
60015637|NCT02596009|76131890|FG005|COMPLETED|Overall Study||17||
60015638|NCT02596009|76131885|FG000|NOT COMPLETED|Overall Study||0||
60015639|NCT02596009|76131886|FG001|NOT COMPLETED|Overall Study||1||
60015640|NCT02596009|76131887|FG002|NOT COMPLETED|Overall Study||0||
59906948|NCT03192150|76028031|FG001|COMPLETED|Overall Study||29||
59906949|NCT03192150|76028030|FG000|NOT COMPLETED|Overall Study||55||
59906950|NCT03192150|76028031|FG001|NOT COMPLETED|Overall Study||54||
59906951|NCT03597529|76028039|FG000|STARTED|Overall Study||42||
59906952|NCT03597529|76028040|FG001|STARTED|Overall Study||42||
59906953|NCT03597529|76028039|FG000|Follow-up|Overall Study||22||
59906954|NCT03597529|76028040|FG001|Follow-up|Overall Study||24||
59906955|NCT03597529|76028039|FG000|COMPLETED|Overall Study||22||
59906956|NCT03597529|76028040|FG001|COMPLETED|Overall Study||24||
59906957|NCT03597529|76028039|FG000|NOT COMPLETED|Overall Study||20||
59906958|NCT03597529|76028040|FG001|NOT COMPLETED|Overall Study||18||
59906959|NCT03180528|76028046|FG000|STARTED|Overall Study||30||
59906960|NCT03180528|76028046|FG000|COMPLETED|Overall Study||27||
59906961|NCT03180528|76028046|FG000|NOT COMPLETED|Overall Study||3||
59906962|NCT03597295|76028050|FG000|STARTED|Overall Study||94||
59906963|NCT03597295|76028050|FG000|COMPLETED|Overall Study||17||
59906964|NCT03597295|76028050|FG000|NOT COMPLETED|Overall Study||77||
59906965|NCT03180138|76028057|FG000|STARTED|Overall Study||204||
59906966|NCT03180138|76028058|FG001|STARTED|Overall Study||201||
59906967|NCT03180138|76028059|FG002|STARTED|Overall Study||203||
59906968|NCT03180138|76028057|FG000|COMPLETED|Overall Study||182||
59906969|NCT03180138|76028058|FG001|COMPLETED|Overall Study||188||
59906970|NCT03180138|76028059|FG002|COMPLETED|Overall Study||179||
59906971|NCT03180138|76028057|FG000|NOT COMPLETED|Overall Study||22||
59906972|NCT03180138|76028058|FG001|NOT COMPLETED|Overall Study||13||
60015641|NCT02596009|76131888|FG003|NOT COMPLETED|Overall Study||0||
60015642|NCT02596009|76131889|FG004|NOT COMPLETED|Overall Study||0||
60015643|NCT02596009|76131890|FG005|NOT COMPLETED|Overall Study||0||
60015644|NCT02590939|76131898|FG000|STARTED|Overall Study||52||
60015645|NCT02590939|76131899|FG001|STARTED|Overall Study||54||
60015646|NCT02590939|76131898|FG000|COMPLETED|Overall Study||47||
60015647|NCT02590939|76131899|FG001|COMPLETED|Overall Study||52||
60015648|NCT02590939|76131898|FG000|NOT COMPLETED|Overall Study||5||
60015649|NCT02590939|76131899|FG001|NOT COMPLETED|Overall Study||2||
59906973|NCT03180138|76028059|FG002|NOT COMPLETED|Overall Study||24||
59906974|NCT03597139|76028069|FG000|STARTED|Overall Study||51||
60015650|NCT04351087|76131907|FG000|STARTED|Overall Study||36||
60015651|NCT04351087|76131908|FG001|STARTED|Overall Study||35||
60015652|NCT04351087|76131907|FG000|COMPLETED|Overall Study||23||
59906975|NCT03597139|76028070|FG001|STARTED|Overall Study||49||
59906976|NCT03597139|76028069|FG000|COMPLETED|Overall Study||47||
59906977|NCT03597139|76028070|FG001|COMPLETED|Overall Study||49||
59906978|NCT03597139|76028069|FG000|NOT COMPLETED|Overall Study||4||
59906979|NCT03597139|76028070|FG001|NOT COMPLETED|Overall Study||0||
59906980|NCT03179202|76028076|FG000|STARTED|Overall Study||166||
59906981|NCT03179202|76028076|FG000|Enrolled/Received Leads|Overall Study||99|Subjects who were consented, met eligibility criteria, and underwent Lead Placement. Also includes subjects participating in sub-studies with modified eligibility criteria allowing a history of prior radiofrequency ablation or prior lumbar surgery.|
59906982|NCT03179202|76028076|FG000|Protocol Population|Overall Study||91|Subjects who were consented, met eligibility criteria, underwent Lead Placement, and continued to meet eligibility criteria. Also includes subjects participating in sub-studies with modified eligibility criteria allowing a history of prior radiofrequency ablation or prior lumbar surgery.|
59906983|NCT03179202|76028076|FG000|COMPLETED|Overall Study||75||
59906984|NCT03179202|76028076|FG000|NOT COMPLETED|Overall Study||91||
60015653|NCT04351087|76131908|FG001|COMPLETED|Overall Study||26||
60015654|NCT04351087|76131907|FG000|NOT COMPLETED|Overall Study||13||
60015655|NCT04351087|76131908|FG001|NOT COMPLETED|Overall Study||9||
60015656|NCT02598193|76131914|FG000|STARTED|Overall Study||89||
60015657|NCT02598193|76131914|FG000|COMPLETED|Overall Study||73||
60015658|NCT02598193|76131914|FG000|NOT COMPLETED|Overall Study||16||
60015659|NCT02595073|76131920|FG000|STARTED|Overall Study||61||
59906985|NCT00708214|76028085|FG000|STARTED|Overall Study||7||
59906986|NCT00708214|76028086|FG001|STARTED|Overall Study||13||
59906987|NCT00708214|76028087|FG002|STARTED|Overall Study||8||
59906988|NCT00708214|76028085|FG000|COMPLETED|Overall Study|On treatment at analysis cut-off date (04 Jan 2010)|0||
60015660|NCT02595073|76131921|FG001|STARTED|Overall Study||63||
60015661|NCT02595073|76131920|FG000|COMPLETED|Overall Study||59||
60015662|NCT02595073|76131921|FG001|COMPLETED|Overall Study||62||
60015663|NCT02595073|76131920|FG000|NOT COMPLETED|Overall Study||2||
60015664|NCT02595073|76131921|FG001|NOT COMPLETED|Overall Study||1||
60015665|NCT02593825|76131929|FG000|STARTED|Intervention||67||
59906989|NCT00708214|76028086|FG001|COMPLETED|Overall Study|On treatment at analysis cut-off date (04 Jan 2010)|0||
59906990|NCT00708214|76028087|FG002|COMPLETED|Overall Study|On treatment at analysis cut-off date (04 Jan 2010)|0||
59906991|NCT00708214|76028085|FG000|NOT COMPLETED|Overall Study||7||
59906992|NCT00708214|76028086|FG001|NOT COMPLETED|Overall Study||13||
59906993|NCT00708214|76028087|FG002|NOT COMPLETED|Overall Study||8||
59906994|NCT03570697|76028102|FG000|STARTED|Overall Study||82||
59906995|NCT03570697|76028103|FG001|STARTED|Overall Study||82||
59906996|NCT03570697|76028102|FG000|Received at Least 1 Dose of Study Drug|Overall Study||81||
59906997|NCT03570697|76028103|FG001|Received at Least 1 Dose of Study Drug|Overall Study||80||
59906998|NCT03570697|76028102|FG000|COMPLETED|Overall Study||76||
59906999|NCT03570697|76028103|FG001|COMPLETED|Overall Study||79||
59907000|NCT03570697|76028102|FG000|NOT COMPLETED|Overall Study||6||
59907001|NCT03570697|76028103|FG001|NOT COMPLETED|Overall Study||3||
59907002|NCT01856270|76028111|FG000|STARTED|Overall Study||24||
59907003|NCT01856270|76028112|FG001|STARTED|Overall Study||26||
59907004|NCT01856270|76028111|FG000|COMPLETED|Overall Study||13|Completed the 180 day assessment|
59907005|NCT01856270|76028112|FG001|COMPLETED|Overall Study||14|Completed the 180 day assessment|
59907006|NCT01856270|76028111|FG000|NOT COMPLETED|Overall Study||11||
59907007|NCT01856270|76028112|FG001|NOT COMPLETED|Overall Study||12||
59907008|NCT03569371|76028120|FG000|STARTED|Overall Study||10||
59907009|NCT03569371|76028120|FG000|COMPLETED|Overall Study||7||
59907010|NCT03569371|76028120|FG000|NOT COMPLETED|Overall Study||3||
59907011|NCT01318070|76028127|FG000|STARTED|Overall Study||111||
59907012|NCT01318070|76028128|FG001|STARTED|Overall Study||113||
59907013|NCT01318070|76028129|FG002|STARTED|Overall Study||115||
59907014|NCT01318070|76028127|FG000|COMPLETED|Overall Study||109||
59907015|NCT01318070|76028128|FG001|COMPLETED|Overall Study||111||
59907016|NCT01318070|76028129|FG002|COMPLETED|Overall Study||108||
59907017|NCT01318070|76028127|FG000|NOT COMPLETED|Overall Study||2||
59907018|NCT01318070|76028128|FG001|NOT COMPLETED|Overall Study||2||
59907019|NCT01318070|76028129|FG002|NOT COMPLETED|Overall Study||7||
59907020|NCT02895295|76028140|FG000|STARTED|Overall Study||384||
59907021|NCT02895295|76028141|FG001|STARTED|Overall Study||410||
59907022|NCT02895295|76028142|FG002|STARTED|Overall Study||391||
59907023|NCT02895295|76028140|FG000|COMPLETED|Overall Study||313||
59907024|NCT02895295|76028141|FG001|COMPLETED|Overall Study||316||
59907025|NCT02895295|76028142|FG002|COMPLETED|Overall Study||299||
59907026|NCT02895295|76028140|FG000|NOT COMPLETED|Overall Study||71||
59907027|NCT02895295|76028141|FG001|NOT COMPLETED|Overall Study||94||
59907028|NCT02895295|76028142|FG002|NOT COMPLETED|Overall Study||92||
59907029|NCT00245960|76028152|FG000|STARTED|Period 1 (Double Blind): 1-12 Weeks||379||
59907030|NCT00245960|76028153|FG001|STARTED|Period 1 (Double Blind): 1-12 Weeks||373||
59907031|NCT00245960|76028152|FG000|COMPLETED|Period 1 (Double Blind): 1-12 Weeks||364||
59907032|NCT00245960|76028153|FG001|COMPLETED|Period 1 (Double Blind): 1-12 Weeks||362||
59907033|NCT00245960|76028152|FG000|NOT COMPLETED|Period 1 (Double Blind): 1-12 Weeks||15||
59907034|NCT00245960|76028153|FG001|NOT COMPLETED|Period 1 (Double Blind): 1-12 Weeks||11||
59907035|NCT00245960|76028152|FG000|STARTED|Period 2 (Open Label): 13-24 Weeks||364||
59907036|NCT00245960|76028153|FG001|STARTED|Period 2 (Open Label): 13-24 Weeks||362||
59907037|NCT00245960|76028152|FG000|COMPLETED|Period 2 (Open Label): 13-24 Weeks||350||
59907038|NCT00245960|76028153|FG001|COMPLETED|Period 2 (Open Label): 13-24 Weeks||344||
59907039|NCT00245960|76028152|FG000|NOT COMPLETED|Period 2 (Open Label): 13-24 Weeks||14||
59907040|NCT00245960|76028153|FG001|NOT COMPLETED|Period 2 (Open Label): 13-24 Weeks||18||
59907041|NCT02729194|76028159|FG000|STARTED|Overall Study||16||
59907042|NCT02729194|76028159|FG000|COMPLETED|Overall Study||13||
59907043|NCT02729194|76028159|FG000|NOT COMPLETED|Overall Study||3||
59907044|NCT03178266|76028165|FG000|STARTED|Overall Study||21||
59907045|NCT03178266|76028166|FG001|STARTED|Overall Study||20||
59907046|NCT03178266|76028165|FG000|COMPLETED|Overall Study||21||
59907047|NCT03178266|76028166|FG001|COMPLETED|Overall Study||16||
59907048|NCT03178266|76028165|FG000|NOT COMPLETED|Overall Study||0||
59907049|NCT03178266|76028166|FG001|NOT COMPLETED|Overall Study||4||
59907050|NCT03548935|76028174|FG000|STARTED|Overall Study||1306||
59907051|NCT03548935|76028175|FG001|STARTED|Overall Study||655||
59907052|NCT03548935|76028174|FG000|Full Analysis Set (FAS)|Overall Study||1306||
59907053|NCT03548935|76028175|FG001|Full Analysis Set (FAS)|Overall Study||655||
59907054|NCT03548935|76028174|FG000|Safety Analysis Set (SAS)|Overall Study||1306||
59907055|NCT03548935|76028175|FG001|Safety Analysis Set (SAS)|Overall Study||655||
59907056|NCT03548935|76028174|FG000|COMPLETED|Overall Study||1240||
59907057|NCT03548935|76028175|FG001|COMPLETED|Overall Study||609||
59907058|NCT03548935|76028174|FG000|NOT COMPLETED|Overall Study||66||
59907059|NCT03548935|76028175|FG001|NOT COMPLETED|Overall Study||46||
59907060|NCT03547687|76028181|FG000|STARTED|Overall Study||9||
59907061|NCT03547687|76028181|FG000|COMPLETED|Overall Study||7||
59907062|NCT03547687|76028181|FG000|NOT COMPLETED|Overall Study||2||
59907063|NCT03547531|76028187|FG000|STARTED|Overall Study||62||
59907064|NCT03547531|76028188|FG001|STARTED|Overall Study||62||
59907065|NCT03547531|76028187|FG000|COMPLETED|Overall Study||60||
59907066|NCT03547531|76028188|FG001|COMPLETED|Overall Study||58||
59907067|NCT03547531|76028187|FG000|NOT COMPLETED|Overall Study||2||
59907068|NCT03547531|76028188|FG001|NOT COMPLETED|Overall Study||4||
59758079|NCT03978091|75877255|FG001|COMPLETED|Overall Study||8||
59758080|NCT03978091|75877256|FG002|COMPLETED|Overall Study||7||
59758081|NCT03978091|75877257|FG003|COMPLETED|Overall Study||7||
59758082|NCT03978091|75877258|FG004|COMPLETED|Overall Study||7||
59758083|NCT03978091|75877259|FG005|COMPLETED|Overall Study||8||
59758084|NCT03978091|75877254|FG000|NOT COMPLETED|Overall Study||0||
59758085|NCT03978091|75877255|FG001|NOT COMPLETED|Overall Study||0||
59758086|NCT03978091|75877256|FG002|NOT COMPLETED|Overall Study||1||
59758087|NCT03978091|75877257|FG003|NOT COMPLETED|Overall Study||1||
59758088|NCT03978091|75877258|FG004|NOT COMPLETED|Overall Study||1||
59758089|NCT03978091|75877259|FG005|NOT COMPLETED|Overall Study||0||
59758090|NCT01969812|75877275|FG000|STARTED|Overall Study||12||
59758091|NCT01969812|75877276|FG001|STARTED|Overall Study||10||
59758092|NCT01969812|75877275|FG000|COMPLETED|Overall Study||12||
59758093|NCT01969812|75877276|FG001|COMPLETED|Overall Study||10||
59758094|NCT01969812|75877275|FG000|NOT COMPLETED|Overall Study||0||
59758095|NCT01969812|75877276|FG001|NOT COMPLETED|Overall Study||0||
59758096|NCT00564733|75877282|FG000|STARTED|Overall Study||55||
59758097|NCT00564733|75877282|FG000|COMPLETED|Overall Study||46||
59758098|NCT00564733|75877282|FG000|NOT COMPLETED|Overall Study||9||
59758099|NCT00931385|75877286|FG000|STARTED|Overall Study||25||
59758100|NCT00931385|75877287|FG001|STARTED|Overall Study||23||
59758101|NCT00931385|75877288|FG002|STARTED|Overall Study||25||
59758102|NCT00931385|75877289|FG003|STARTED|Overall Study||26||
59758103|NCT00931385|75877286|FG000|COMPLETED|Overall Study||23||
59758104|NCT00931385|75877287|FG001|COMPLETED|Overall Study||21||
59758105|NCT00931385|75877288|FG002|COMPLETED|Overall Study||24||
59758106|NCT00931385|75877289|FG003|COMPLETED|Overall Study||21||
59758107|NCT00931385|75877286|FG000|NOT COMPLETED|Overall Study||2||
59758108|NCT00931385|75877287|FG001|NOT COMPLETED|Overall Study||2||
59758109|NCT00931385|75877288|FG002|NOT COMPLETED|Overall Study||1||
59758110|NCT00931385|75877289|FG003|NOT COMPLETED|Overall Study||5||
59758111|NCT00565747|75877305|FG000|STARTED|Overall Study||654||
59758112|NCT00565747|75877306|FG001|STARTED|Overall Study||678||
59758113|NCT00565747|75877305|FG000|COMPLETED|Overall Study|Completed with an embryo transfer|587||
59758114|NCT00565747|75877306|FG001|COMPLETED|Overall Study|Completed with an embryo transfer|605||
59758115|NCT00565747|75877305|FG000|NOT COMPLETED|Overall Study||67||
59758116|NCT00565747|75877306|FG001|NOT COMPLETED|Overall Study||73||
59758117|NCT00563797|75877314|FG000|STARTED|Overall Study||11||
59758118|NCT00563797|75877315|FG001|STARTED|Overall Study||10||
59758119|NCT00563797|75877314|FG000|Received Allocated Intervention|Overall Study||11||
59758120|NCT00563797|75877315|FG001|Received Allocated Intervention|Overall Study||10||
59758121|NCT00563797|75877314|FG000|Follow-Up|Overall Study||11||
59758122|NCT00563797|75877315|FG001|Follow-Up|Overall Study||10||
59758123|NCT00563797|75877314|FG000|COMPLETED|Overall Study||4||
59758124|NCT00563797|75877315|FG001|COMPLETED|Overall Study||8||
59758125|NCT00563797|75877314|FG000|NOT COMPLETED|Overall Study||7||
59758126|NCT00563797|75877315|FG001|NOT COMPLETED|Overall Study||2||
59758127|NCT01192698|75877325|FG000|STARTED|Overall Study||10||
59758128|NCT01192698|75877326|FG001|STARTED|Overall Study||5||
59758129|NCT01192698|75877325|FG000|COMPLETED|Overall Study||10||
59758130|NCT01192698|75877326|FG001|COMPLETED|Overall Study||5||
59758131|NCT01192698|75877325|FG000|NOT COMPLETED|Overall Study||0||
59758132|NCT01192698|75877326|FG001|NOT COMPLETED|Overall Study||0||
59758133|NCT00771927|75877334|FG000|STARTED|Overall Study|Participant Flow and Baseline Characteristics refer to the Safety Set population.|511||
59758134|NCT00771927|75877335|FG001|STARTED|Overall Study|Participant Flow and Baseline Characteristics refer to the Safety Set population.|493||
59758135|NCT00771927|75877334|FG000|COMPLETED|Overall Study||256||
59758136|NCT00771927|75877335|FG001|COMPLETED|Overall Study||256||
59758137|NCT00771927|75877334|FG000|NOT COMPLETED|Overall Study||255||
59758138|NCT00771927|75877335|FG001|NOT COMPLETED|Overall Study||237||
59758139|NCT00771849|75877343|FG000|STARTED|Overall Study||52||
59758140|NCT00771849|75877344|FG001|STARTED|Overall Study|One subject was not vaccinated|51||
59758141|NCT00771849|75877343|FG000|COMPLETED|Overall Study||50||
59758142|NCT00771849|75877344|FG001|COMPLETED|Overall Study||47||
59758143|NCT00771849|75877343|FG000|NOT COMPLETED|Overall Study||2||
59758144|NCT00771849|75877344|FG001|NOT COMPLETED|Overall Study||4||
59758145|NCT00564889|75877350|FG000|STARTED|Overall Study||35||
59758146|NCT00564889|75877350|FG000|COMPLETED|Overall Study||6||
59758147|NCT00564889|75877350|FG000|NOT COMPLETED|Overall Study||29||
59758148|NCT04405999|75877356|FG000|STARTED|Overall Study||25||
59758149|NCT04405999|75877357|FG001|STARTED|Overall Study||25||
59758150|NCT04405999|75877356|FG000|COMPLETED|Overall Study||25||
59758151|NCT04405999|75877357|FG001|COMPLETED|Overall Study||25||
59758152|NCT04405999|75877356|FG000|NOT COMPLETED|Overall Study||0||
59758153|NCT04405999|75877357|FG001|NOT COMPLETED|Overall Study||0||
59907069|NCT03566485|76028196|FG000|STARTED|Overall Study||5||
59907070|NCT03566485|76028197|FG001|STARTED|Overall Study|Dose level 1 (Idasanutlin 100mg PO)|7||
59907071|NCT03566485|76028196|FG000|COMPLETED|Overall Study||0||
59907072|NCT03566485|76028197|FG001|COMPLETED|Overall Study||0||
59907073|NCT03566485|76028196|FG000|NOT COMPLETED|Overall Study||5||
59907074|NCT03566485|76028197|FG001|NOT COMPLETED|Overall Study||7||
59907075|NCT03176238|76028205|FG000|STARTED|Overall Study||199||
59907076|NCT03176238|76028206|FG001|STARTED|Overall Study||36||
59907077|NCT03176238|76028205|FG000|COMPLETED|Overall Study||0||
59907078|NCT03176238|76028206|FG001|COMPLETED|Overall Study||0||
59907079|NCT03176238|76028205|FG000|NOT COMPLETED|Overall Study||199||
59907080|NCT03176238|76028206|FG001|NOT COMPLETED|Overall Study||36||
59907081|NCT03565315|76028220|FG000|STARTED|Overall Study||3||
59907082|NCT03565315|76028221|FG001|STARTED|Overall Study||3||
60015666|NCT02593825|76131930|FG001|STARTED|Intervention||67||
60015667|NCT02593825|76131929|FG000|COMPLETED|Intervention||57||
60015668|NCT02593825|76131930|FG001|COMPLETED|Intervention||55||
60015669|NCT02593825|76131929|FG000|NOT COMPLETED|Intervention||10||
60015670|NCT02593825|76131930|FG001|NOT COMPLETED|Intervention||12||
60015671|NCT02593825|76131929|FG000|STARTED|Follow-up||57||
60015672|NCT02593825|76131930|FG001|STARTED|Follow-up||55||
60015673|NCT02593825|76131929|FG000|COMPLETED|Follow-up||57||
60015674|NCT02593825|76131930|FG001|COMPLETED|Follow-up||55||
60015675|NCT02593825|76131929|FG000|NOT COMPLETED|Follow-up||0||
60015676|NCT02593825|76131930|FG001|NOT COMPLETED|Follow-up||0||
60015677|NCT02388165|76131940|FG000|STARTED|Overall Study||1726||
60015678|NCT02388165|76131941|FG001|STARTED|Overall Study||1724||
60015679|NCT02388165|76131940|FG000|Vaccinated (Safety Population)|Overall Study||1708||
60015680|NCT02388165|76131941|FG001|Vaccinated (Safety Population)|Overall Study||1709||
60015681|NCT02388165|76131940|FG000|COMPLETED|Overall Study||1599||
60015682|NCT02388165|76131941|FG001|COMPLETED|Overall Study||1594||
60015683|NCT02388165|76131940|FG000|NOT COMPLETED|Overall Study||127||
60015684|NCT02388165|76131941|FG001|NOT COMPLETED|Overall Study||130||
60015685|NCT02404545|76131949|FG000|STARTED|Overall Study||6||
60015686|NCT02404545|76131950|FG001|STARTED|Overall Study||6||
60015687|NCT02404545|76131949|FG000|COMPLETED|Overall Study||0||
60015688|NCT02404545|76131950|FG001|COMPLETED|Overall Study||0||
60015689|NCT02404545|76131949|FG000|NOT COMPLETED|Overall Study||6||
60015690|NCT02404545|76131950|FG001|NOT COMPLETED|Overall Study||6||
60015691|NCT02420379|76131959|FG000|STARTED|Overall Study||26||
59758154|NCT00560833|75877368|FG000|STARTED|Overall Study||317||
59758155|NCT00560833|75877369|FG001|STARTED|Overall Study||155||
59907083|NCT03565315|76028222|FG002|STARTED|Overall Study||1||
59907084|NCT03565315|76028223|FG003|STARTED|Overall Study||2||
59907085|NCT03565315|76028220|FG000|Product Administration Completed|Overall Study||3||
59907086|NCT03565315|76028221|FG001|Product Administration Completed|Overall Study||0||
59907087|NCT03565315|76028222|FG002|Product Administration Completed|Overall Study||1||
59907088|NCT03565315|76028223|FG003|Product Administration Completed|Overall Study||0||
59907089|NCT03565315|76028220|FG000|Discontinued Product Administrations|Overall Study||0|All altered or discontinued product administration schedules were due to the IND Sponsor/PI decision to terminate the study.|
59907090|NCT03565315|76028221|FG001|Discontinued Product Administrations|Overall Study||3|All altered or discontinued product administration schedules were due to the IND Sponsor/PI decision to terminate the study.|
59907091|NCT03565315|76028222|FG002|Discontinued Product Administrations|Overall Study||0|All altered or discontinued product administration schedules were due to the IND Sponsor/PI decision to terminate the study.|
59907092|NCT03565315|76028223|FG003|Discontinued Product Administrations|Overall Study|One Group 4 participant enrolled but did not receive product due to IND/PI voluntary study pause.|2|All altered or discontinued product administration schedules were due to the IND Sponsor/PI decision to terminate the study.|
59907093|NCT03565315|76028220|FG000|COMPLETED|Overall Study||3||
59907094|NCT03565315|76028221|FG001|COMPLETED|Overall Study||3||
59907095|NCT03565315|76028222|FG002|COMPLETED|Overall Study||1||
59907096|NCT03565315|76028223|FG003|COMPLETED|Overall Study||1||
59907097|NCT03565315|76028220|FG000|NOT COMPLETED|Overall Study||0||
59907098|NCT03565315|76028221|FG001|NOT COMPLETED|Overall Study||0||
60015692|NCT02420379|76131960|FG001|STARTED|Overall Study||7||
60015693|NCT02420379|76131959|FG000|COMPLETED|Overall Study||25||
59907099|NCT03565315|76028222|FG002|NOT COMPLETED|Overall Study||0||
59907100|NCT03565315|76028223|FG003|NOT COMPLETED|Overall Study||1||
59907101|NCT03565237|76028246|FG000|STARTED|Overall Study||25||
59907102|NCT03565237|76028246|FG000|Safety Analysis Set (SAS)|Overall Study||25||
60015694|NCT02420379|76131960|FG001|COMPLETED|Overall Study||3||
60015695|NCT02420379|76131959|FG000|NOT COMPLETED|Overall Study||1||
60015696|NCT02420379|76131960|FG001|NOT COMPLETED|Overall Study||4||
60015697|NCT02347761|76131969|FG000|STARTED|All Collected||218||
60015698|NCT02347761|76131970|FG001|STARTED|All Collected||217||
60015699|NCT02347761|76131971|FG002|STARTED|All Collected||218||
59758156|NCT00560833|75877370|FG002|STARTED|Overall Study||160||
59758157|NCT00560833|75877371|FG003|STARTED|Overall Study||155||
60015700|NCT02347761|76131969|FG000|COMPLETED|All Collected||201||
59907103|NCT03565237|76028246|FG000|Effectiveness Full Analysis Set (EFAS)|Overall Study||25||
60015701|NCT02347761|76131970|FG001|COMPLETED|All Collected||203||
60015702|NCT02347761|76131971|FG002|COMPLETED|All Collected||191||
60015703|NCT02347761|76131969|FG000|NOT COMPLETED|All Collected||17||
60015704|NCT02347761|76131970|FG001|NOT COMPLETED|All Collected||14||
60015705|NCT02347761|76131971|FG002|NOT COMPLETED|All Collected||27||
60015706|NCT02347761|76131969|FG000|STARTED|On Study Treatment||218||
60015707|NCT02347761|76131970|FG001|STARTED|On Study Treatment||217||
60015708|NCT02347761|76131971|FG002|STARTED|On Study Treatment||218||
60015709|NCT02347761|76131969|FG000|COMPLETED|On Study Treatment||191||
60015710|NCT02347761|76131970|FG001|COMPLETED|On Study Treatment||194||
59758158|NCT00560833|75877372|FG004|STARTED|Overall Study||156||
59758159|NCT00560833|75877368|FG000|Treated|Overall Study|One participant was not randomized but was treated with placebo|317||
59907104|NCT03565237|76028246|FG000|COMPLETED|Overall Study||23||
59907105|NCT03565237|76028246|FG000|NOT COMPLETED|Overall Study||2||
59907106|NCT01345682|76028252|FG000|STARTED|Overall Study|Randomised|322||
59907107|NCT01345682|76028253|FG001|STARTED|Overall Study|Randomised|161||
59907108|NCT01345682|76028252|FG000|COMPLETED|Overall Study||0||
59907109|NCT01345682|76028253|FG001|COMPLETED|Overall Study||0||
59758160|NCT00560833|75877369|FG001|Treated|Overall Study|One participant was randomized but not treated|154||
59758161|NCT00560833|75877370|FG002|Treated|Overall Study||160||
59758162|NCT00560833|75877371|FG003|Treated|Overall Study||155||
59758163|NCT00560833|75877372|FG004|Treated|Overall Study|One participant was randomized but not treated|155||
59758164|NCT00560833|75877368|FG000|COMPLETED|Overall Study||273||
59758165|NCT00560833|75877369|FG001|COMPLETED|Overall Study||129||
59758166|NCT00560833|75877370|FG002|COMPLETED|Overall Study||121||
59758167|NCT00560833|75877371|FG003|COMPLETED|Overall Study||124||
59758168|NCT00560833|75877372|FG004|COMPLETED|Overall Study||114||
59758169|NCT00560833|75877368|FG000|NOT COMPLETED|Overall Study||44||
59758170|NCT00560833|75877369|FG001|NOT COMPLETED|Overall Study||26||
59758171|NCT00560833|75877370|FG002|NOT COMPLETED|Overall Study||39||
59907110|NCT01345682|76028252|FG000|NOT COMPLETED|Overall Study||322||
59907111|NCT01345682|76028253|FG001|NOT COMPLETED|Overall Study||161||
59907112|NCT03562117|76028262|FG000|STARTED|Part 1, Up to 3 Days||8||
59907113|NCT03562117|76028263|FG001|STARTED|Part 1, Up to 3 Days||8||
59907114|NCT03562117|76028264|FG002|STARTED|Part 1, Up to 3 Days||0||
59907115|NCT03562117|76028262|FG000|COMPLETED|Part 1, Up to 3 Days||7||
59758172|NCT00560833|75877371|FG003|NOT COMPLETED|Overall Study||31||
59758173|NCT00560833|75877372|FG004|NOT COMPLETED|Overall Study||42||
59758174|NCT00771615|75877393|FG000|STARTED|Overall Study||49||
59758175|NCT00771615|75877394|FG001|STARTED|Overall Study||72||
59758176|NCT00771615|75877395|FG002|STARTED|Overall Study||41||
59758177|NCT00771615|75877396|FG003|STARTED|Overall Study||60||
59758178|NCT00771615|75877397|FG004|STARTED|Overall Study||40||
59758179|NCT00771615|75877398|FG005|STARTED|Overall Study||61||
59758180|NCT00771615|75877399|FG006|STARTED|Overall Study||46||
59758181|NCT00771615|75877400|FG007|STARTED|Overall Study||59||
59758182|NCT00771615|75877401|FG008|STARTED|Overall Study||41||
59907116|NCT03562117|76028263|FG001|COMPLETED|Part 1, Up to 3 Days||8||
59907117|NCT03562117|76028264|FG002|COMPLETED|Part 1, Up to 3 Days||0||
60015711|NCT02347761|76131971|FG002|COMPLETED|On Study Treatment||176||
60015712|NCT02347761|76131969|FG000|NOT COMPLETED|On Study Treatment||27||
60015713|NCT02347761|76131970|FG001|NOT COMPLETED|On Study Treatment||23||
60015714|NCT02347761|76131971|FG002|NOT COMPLETED|On Study Treatment||42||
60015715|NCT02596945|76131979|FG000|STARTED|Overall Study||223||
60015716|NCT02596945|76131979|FG000|Treated|Overall Study||220||
60015717|NCT02596945|76131979|FG000|COMPLETED|Overall Study||167||
60015718|NCT02596945|76131979|FG000|NOT COMPLETED|Overall Study||56||
60015719|NCT04153435|76131985|FG000|STARTED|Overall Study||197||
60015720|NCT04153435|76131986|FG001|STARTED|Overall Study||200||
60015721|NCT04153435|76131985|FG000|COMPLETED|Overall Study||197||
59758183|NCT00771615|75877393|FG000|COMPLETED|Overall Study|Up to Day 364|48||
59758184|NCT00771615|75877394|FG001|COMPLETED|Overall Study|Up to Day 364|70||
59907118|NCT03562117|76028262|FG000|NOT COMPLETED|Part 1, Up to 3 Days||1||
59907119|NCT03562117|76028263|FG001|NOT COMPLETED|Part 1, Up to 3 Days||0||
60015722|NCT04153435|76131986|FG001|COMPLETED|Overall Study||200||
60015723|NCT04153435|76131985|FG000|NOT COMPLETED|Overall Study||0||
60015724|NCT04153435|76131986|FG001|NOT COMPLETED|Overall Study||0||
60015725|NCT02404389|76131997|FG000|STARTED|Overall Study||20||
60015726|NCT02404389|76131998|FG001|STARTED|Overall Study||20||
59758185|NCT00771615|75877395|FG002|COMPLETED|Overall Study|Up to Day 364|40||
59758186|NCT00771615|75877396|FG003|COMPLETED|Overall Study|Up to Day 364|59||
59758187|NCT00771615|75877397|FG004|COMPLETED|Overall Study|Up to Day 364|40||
59758188|NCT00771615|75877398|FG005|COMPLETED|Overall Study|Up to Day 364|60||
59758189|NCT00771615|75877399|FG006|COMPLETED|Overall Study|Up to Day 364|45||
60015727|NCT02404389|76131999|FG002|STARTED|Overall Study||11||
60015728|NCT02404389|76132000|FG003|STARTED|Overall Study||10||
60015729|NCT02404389|76132001|FG004|STARTED|Overall Study||21||
60015730|NCT02404389|76131997|FG000|COMPLETED|Overall Study||18||
59907120|NCT03562117|76028264|FG002|NOT COMPLETED|Part 1, Up to 3 Days||0||
60015731|NCT02404389|76131998|FG001|COMPLETED|Overall Study||20||
60015732|NCT02404389|76131999|FG002|COMPLETED|Overall Study||10||
59907121|NCT03562117|76028262|FG000|STARTED|Part 2, Up to 3 Days|Only 1 additional participant with normal hepatic function enrolled in Part 2 received dosing|8||
59907122|NCT03562117|76028263|FG001|STARTED|Part 2, Up to 3 Days||0||
59907123|NCT03562117|76028264|FG002|STARTED|Part 2, Up to 3 Days||8||
59907124|NCT03562117|76028262|FG000|COMPLETED|Part 2, Up to 3 Days||8||
59907125|NCT03562117|76028263|FG001|COMPLETED|Part 2, Up to 3 Days||0||
59758190|NCT00771615|75877400|FG007|COMPLETED|Overall Study|Up to Day 364|58||
59758191|NCT00771615|75877401|FG008|COMPLETED|Overall Study|Up to Day 364|41||
59758192|NCT00771615|75877393|FG000|NOT COMPLETED|Overall Study||1||
59758193|NCT00771615|75877394|FG001|NOT COMPLETED|Overall Study||2||
59758194|NCT00771615|75877395|FG002|NOT COMPLETED|Overall Study||1||
59758195|NCT00771615|75877396|FG003|NOT COMPLETED|Overall Study||1||
59758196|NCT00771615|75877397|FG004|NOT COMPLETED|Overall Study||0||
59758197|NCT00771615|75877398|FG005|NOT COMPLETED|Overall Study||1||
59758198|NCT00771615|75877399|FG006|NOT COMPLETED|Overall Study||1||
59758199|NCT00771615|75877400|FG007|NOT COMPLETED|Overall Study||1||
59758200|NCT00771615|75877401|FG008|NOT COMPLETED|Overall Study||0||
59758201|NCT02723604|75877430|FG000|STARTED|Overall Study||25||
59758202|NCT02723604|75877430|FG000|COMPLETED|Overall Study||23||
59758203|NCT02723604|75877430|FG000|NOT COMPLETED|Overall Study||2||
59758204|NCT00560755|75877434|FG000|STARTED|Overall Study|Vaccinated (at least one ProQuad® dose)|3388||
59758205|NCT00560755|75877434|FG000|ProQuad® Dose 1 and Dose 2|Overall Study||3346||
59907126|NCT03562117|76028264|FG002|COMPLETED|Part 2, Up to 3 Days||8||
59907127|NCT03562117|76028262|FG000|NOT COMPLETED|Part 2, Up to 3 Days||0||
59907128|NCT03562117|76028263|FG001|NOT COMPLETED|Part 2, Up to 3 Days||0||
59907129|NCT03562117|76028264|FG002|NOT COMPLETED|Part 2, Up to 3 Days||0||
59907130|NCT03561883|76028274|FG000|STARTED|Overall Study||305||
59907131|NCT03561883|76028275|FG001|STARTED|Overall Study||304||
59907132|NCT03561883|76028274|FG000|COMPLETED|Overall Study||259||
60015733|NCT02404389|76132000|FG003|COMPLETED|Overall Study||9||
60015734|NCT02404389|76132001|FG004|COMPLETED|Overall Study||18||
59758206|NCT00560755|75877434|FG000|COMPLETED|Overall Study||3328||
59758207|NCT00560755|75877434|FG000|NOT COMPLETED|Overall Study||60||
59758208|NCT00770991|75877441|FG000|STARTED|Overall Study|34 participants enrolled (signed informed consent). 24 subjects were eligible to be randomized.|12||
59758209|NCT00770991|75877442|FG001|STARTED|Overall Study|We anticipated 26-30 subjects with FAP 18 year or olders would need to be enrolled to randomize 18|12||
59758210|NCT00770991|75877441|FG000|COMPLETED|Overall Study|7 subjects completed 36 weeks (+/- 10 days)of treatment|7||
59758211|NCT00770991|75877442|FG001|COMPLETED|Overall Study|7 subjects completed 36 weeks (+/- 10 days)of treatment|7||
59758212|NCT00770991|75877441|FG000|NOT COMPLETED|Overall Study||5||
59758213|NCT00770991|75877442|FG001|NOT COMPLETED|Overall Study||5||
59758214|NCT00925769|75877453|FG000|STARTED|Overall Study||6||
59758215|NCT00925769|75877454|FG001|STARTED|Overall Study||6||
59758216|NCT00925769|75877455|FG002|STARTED|Overall Study||6||
59758217|NCT00925769|75877456|FG003|STARTED|Overall Study||6||
59758218|NCT00925769|75877457|FG004|STARTED|Overall Study||3||
59758219|NCT00925769|75877458|FG005|STARTED|Overall Study||3||
59758220|NCT00925769|75877453|FG000|COMPLETED|Overall Study||0||
59758221|NCT00925769|75877454|FG001|COMPLETED|Overall Study||0||
59758222|NCT00925769|75877455|FG002|COMPLETED|Overall Study||0||
59758223|NCT00925769|75877456|FG003|COMPLETED|Overall Study||0||
59907133|NCT03561883|76028275|FG001|COMPLETED|Overall Study||261||
59907134|NCT03561883|76028274|FG000|NOT COMPLETED|Overall Study||46||
59907135|NCT03561883|76028275|FG001|NOT COMPLETED|Overall Study||43||
59907136|NCT03546907|76028283|FG000|STARTED|Overall Study||171||
59907137|NCT03546907|76028284|FG001|STARTED|Overall Study||172||
59907138|NCT03546907|76028283|FG000|COMPLETED|Overall Study||154||
59907139|NCT03546907|76028284|FG001|COMPLETED|Overall Study||151||
59907140|NCT03546907|76028283|FG000|NOT COMPLETED|Overall Study||17||
59907141|NCT03546907|76028284|FG001|NOT COMPLETED|Overall Study||21||
59907142|NCT01318382|76028290|FG000|STARTED|Overall Study||302||
59907143|NCT01318382|76028290|FG000|COMPLETED|Overall Study||289||
59907144|NCT01318382|76028290|FG000|NOT COMPLETED|Overall Study||13||
59907145|NCT03001817|76028297|FG000|STARTED|12 Week Efficacy||368||
59907146|NCT03001817|76028298|FG001|STARTED|12 Week Efficacy||183||
59907147|NCT03001817|76028297|FG000|COMPLETED|12 Week Efficacy||356|Including 2 participants (one participant each group) who skipped Week 12 but did not discontinue study drug and entered the 40-week Extension Period.|
59758224|NCT00925769|75877457|FG004|COMPLETED|Overall Study||0||
59758225|NCT00925769|75877458|FG005|COMPLETED|Overall Study||0||
59758226|NCT00925769|75877453|FG000|NOT COMPLETED|Overall Study||6||
59758227|NCT00925769|75877454|FG001|NOT COMPLETED|Overall Study||6||
59758228|NCT00925769|75877455|FG002|NOT COMPLETED|Overall Study||6||
59758229|NCT00925769|75877456|FG003|NOT COMPLETED|Overall Study||6||
59758230|NCT00925769|75877457|FG004|NOT COMPLETED|Overall Study||3||
59758231|NCT00925769|75877458|FG005|NOT COMPLETED|Overall Study||3||
59907148|NCT03001817|76028298|FG001|COMPLETED|12 Week Efficacy||179|Including 2 participants (one participant each group) who skipped Week 12 but did not discontinue study drug and entered the 40-week Extension Period.|
59907149|NCT03001817|76028297|FG000|NOT COMPLETED|12 Week Efficacy||12||
59907150|NCT03001817|76028298|FG001|NOT COMPLETED|12 Week Efficacy||4||
59907151|NCT03001817|76028297|FG000|STARTED|40 Week Extension||350|Note that 8 participants (6 participants in the K-877 group and 2 participants in the placebo/fenofibrate 145 mg group) withdrew after completing the 12-week Efficacy Period and did not start the 40-week Extension Period.|
59907152|NCT03001817|76028298|FG001|STARTED|40 Week Extension||177|Note that 8 participants (6 participants in the K-877 group and 2 participants in the placebo/fenofibrate 145 mg group) withdrew after completing the 12-week Efficacy Period and did not start the 40-week Extension Period.|
59907153|NCT03001817|76028297|FG000|COMPLETED|40 Week Extension||335||
59907154|NCT03001817|76028298|FG001|COMPLETED|40 Week Extension||163||
59907155|NCT03001817|76028297|FG000|NOT COMPLETED|40 Week Extension||15||
59907156|NCT03001817|76028298|FG001|NOT COMPLETED|40 Week Extension||14||
59907157|NCT03053180|76028308|FG000|STARTED|Overall Study||60||
59907158|NCT03053180|76028308|FG000|COMPLETED|Overall Study||59||
59907159|NCT03053180|76028308|FG000|NOT COMPLETED|Overall Study||1||
59907160|NCT03560869|76028312|FG000|STARTED|Overall Study||14||
59907161|NCT03560869|76028313|FG001|STARTED|Overall Study||21||
59907162|NCT03560869|76028312|FG000|COMPLETED|Overall Study||7||
59907163|NCT03560869|76028313|FG001|COMPLETED|Overall Study||12||
59907164|NCT03560869|76028312|FG000|NOT COMPLETED|Overall Study||7||
59907165|NCT03560869|76028313|FG001|NOT COMPLETED|Overall Study||9||
59907166|NCT03590743|76028321|FG000|STARTED|Overall Study||2||
59907167|NCT03590743|76028322|FG001|STARTED|Overall Study||3||
59907168|NCT03590743|76028321|FG000|COMPLETED|Overall Study||2||
59907169|NCT03590743|76028322|FG001|COMPLETED|Overall Study||2||
59907170|NCT03590743|76028321|FG000|NOT COMPLETED|Overall Study||0||
59907171|NCT03590743|76028322|FG001|NOT COMPLETED|Overall Study||1||
59907172|NCT03053102|76028328|FG000|STARTED|Study Part 1: 28-Day Treatment||10||
59907173|NCT03053102|76028328|FG000|Received at Least 1 Dose of Study Drug|Study Part 1: 28-Day Treatment||10||
59907174|NCT03053102|76028328|FG000|COMPLETED|Study Part 1: 28-Day Treatment||10||
59907175|NCT03053102|76028328|FG000|NOT COMPLETED|Study Part 1: 28-Day Treatment||0||
59907176|NCT03053102|76028328|FG000|STARTED|Study Part 2: 84-Day Treatment||10||
59907177|NCT03053102|76028328|FG000|COMPLETED|Study Part 2: 84-Day Treatment||8||
59907178|NCT03053102|76028328|FG000|NOT COMPLETED|Study Part 2: 84-Day Treatment||2||
59907179|NCT03589885|76028336|FG000|STARTED|Treatment Period 1-Randomized Set||41||
59907180|NCT03589885|76028337|FG001|STARTED|Treatment Period 1-Randomized Set||41||
59907181|NCT03589885|76028338|FG002|STARTED|Treatment Period 1-Randomized Set||40||
59907182|NCT03589885|76028339|FG003|STARTED|Treatment Period 1-Randomized Set||0||
59907183|NCT03589885|76028340|FG004|STARTED|Treatment Period 1-Randomized Set||0||
59907184|NCT03589885|76028336|FG000|COMPLETED|Treatment Period 1-Randomized Set||41||
59907185|NCT03589885|76028337|FG001|COMPLETED|Treatment Period 1-Randomized Set||39||
59907186|NCT03589885|76028338|FG002|COMPLETED|Treatment Period 1-Randomized Set||37||
59907187|NCT03589885|76028339|FG003|COMPLETED|Treatment Period 1-Randomized Set||0||
59907188|NCT03589885|76028340|FG004|COMPLETED|Treatment Period 1-Randomized Set||0||
60015735|NCT02404389|76131997|FG000|NOT COMPLETED|Overall Study||2||
60015736|NCT02404389|76131998|FG001|NOT COMPLETED|Overall Study||0||
60015737|NCT02404389|76131999|FG002|NOT COMPLETED|Overall Study||1||
59758232|NCT00770913|75877477|FG000|STARTED|Overall Study||113||
59758233|NCT00770913|75877478|FG001|STARTED|Overall Study||111||
59758234|NCT00770913|75877479|FG002|STARTED|Overall Study||113||
59758235|NCT00770913|75877477|FG000|COMPLETED|Overall Study||102||
59758236|NCT00770913|75877478|FG001|COMPLETED|Overall Study||103||
59758237|NCT00770913|75877479|FG002|COMPLETED|Overall Study||100||
59758238|NCT00770913|75877477|FG000|NOT COMPLETED|Overall Study||11||
59758239|NCT00770913|75877478|FG001|NOT COMPLETED|Overall Study||8||
59758240|NCT00770913|75877479|FG002|NOT COMPLETED|Overall Study||13||
59758241|NCT00562861|75877489|FG000|STARTED|Overall Study||60||
59758242|NCT00562861|75877490|FG001|STARTED|Overall Study||59||
59758243|NCT00562861|75877489|FG000|COMPLETED|Overall Study||40||
59758244|NCT00562861|75877490|FG001|COMPLETED|Overall Study||48||
59758245|NCT00562861|75877489|FG000|NOT COMPLETED|Overall Study||20||
59758246|NCT00562861|75877490|FG001|NOT COMPLETED|Overall Study||11||
59758247|NCT00770679|75877496|FG000|STARTED|Overall Study||16||
59758248|NCT00770679|75877496|FG000|COMPLETED|Overall Study||10||
59758249|NCT00770679|75877496|FG000|NOT COMPLETED|Overall Study||6||
59758250|NCT00770601|75877500|FG000|STARTED|Overall Study||7||
59758251|NCT00770601|75877500|FG000|COMPLETED|Overall Study||6||
59758252|NCT00770601|75877500|FG000|NOT COMPLETED|Overall Study||1||
59758253|NCT00770367|75877506|FG000|STARTED|First Intervention||18||
59758254|NCT00770367|75877507|FG001|STARTED|First Intervention||18||
59758255|NCT00770367|75877506|FG000|COMPLETED|First Intervention||18||
59758256|NCT00770367|75877507|FG001|COMPLETED|First Intervention||16||
59758257|NCT00770367|75877506|FG000|NOT COMPLETED|First Intervention||0||
59758258|NCT00770367|75877507|FG001|NOT COMPLETED|First Intervention||2||
59758259|NCT00770367|75877506|FG000|STARTED|Washout Period of 4 Weeks||18||
59758260|NCT00770367|75877507|FG001|STARTED|Washout Period of 4 Weeks||16||
59758261|NCT00770367|75877506|FG000|COMPLETED|Washout Period of 4 Weeks||18||
59758262|NCT00770367|75877507|FG001|COMPLETED|Washout Period of 4 Weeks||15||
59758263|NCT00770367|75877506|FG000|NOT COMPLETED|Washout Period of 4 Weeks||0||
59758264|NCT00770367|75877507|FG001|NOT COMPLETED|Washout Period of 4 Weeks||1||
59758265|NCT00770367|75877506|FG000|STARTED|Second Intervention||18||
59758266|NCT00770367|75877507|FG001|STARTED|Second Intervention||15||
59758267|NCT00770367|75877506|FG000|COMPLETED|Second Intervention||16||
60015738|NCT02404389|76132000|FG003|NOT COMPLETED|Overall Study||1||
60015739|NCT02404389|76132001|FG004|NOT COMPLETED|Overall Study||3||
59907189|NCT03589885|76028336|FG000|NOT COMPLETED|Treatment Period 1-Randomized Set||0||
59907190|NCT03589885|76028337|FG001|NOT COMPLETED|Treatment Period 1-Randomized Set||2||
59907191|NCT03589885|76028338|FG002|NOT COMPLETED|Treatment Period 1-Randomized Set||3||
60015740|NCT01667419|76132019|FG000|STARTED|Overall Study||157||
60015741|NCT01667419|76132020|FG001|STARTED|Overall Study||157||
60015742|NCT01667419|76132021|FG002|STARTED|Overall Study||93||
59907192|NCT03589885|76028339|FG003|NOT COMPLETED|Treatment Period 1-Randomized Set||0||
59907193|NCT03589885|76028340|FG004|NOT COMPLETED|Treatment Period 1-Randomized Set||0||
59907194|NCT03589885|76028336|FG000|STARTED|Treatment Period 2-Randomized Set||41||
59907195|NCT03589885|76028337|FG001|STARTED|Treatment Period 2-Randomized Set||39||
59907196|NCT03589885|76028338|FG002|STARTED|Treatment Period 2-Randomized Set||4||
59907197|NCT03589885|76028339|FG003|STARTED|Treatment Period 2-Randomized Set||16||
59907198|NCT03589885|76028340|FG004|STARTED|Treatment Period 2-Randomized Set||17||
59907199|NCT03589885|76028336|FG000|COMPLETED|Treatment Period 2-Randomized Set||40||
59907200|NCT03589885|76028337|FG001|COMPLETED|Treatment Period 2-Randomized Set||34||
60015743|NCT01667419|76132022|FG003|STARTED|Overall Study||91||
59758268|NCT00770367|75877507|FG001|COMPLETED|Second Intervention||15||
59758269|NCT00770367|75877506|FG000|NOT COMPLETED|Second Intervention||2||
59758270|NCT00770367|75877507|FG001|NOT COMPLETED|Second Intervention||0||
59758271|NCT00931307|75877515|FG000|STARTED|Overall Study||22||
59758272|NCT00931307|75877515|FG000|COMPLETED|Overall Study||9||
59758273|NCT00931307|75877515|FG000|NOT COMPLETED|Overall Study||13||
59758274|NCT00930761|75877521|FG000|STARTED|Overall Study||50||
59758275|NCT00930761|75877522|FG001|STARTED|Overall Study||51||
59758276|NCT00930761|75877521|FG000|COMPLETED|Overall Study||46||
59758277|NCT00930761|75877522|FG001|COMPLETED|Overall Study||48||
59758278|NCT00930761|75877521|FG000|NOT COMPLETED|Overall Study||4||
59758279|NCT00930761|75877522|FG001|NOT COMPLETED|Overall Study||3||
59758280|NCT00770289|75877528|FG000|STARTED|Overall Study||851||
59758281|NCT00770289|75877528|FG000|COMPLETED|Overall Study||845||
59758282|NCT00770289|75877528|FG000|NOT COMPLETED|Overall Study||6||
60015744|NCT01667419|76132019|FG000|COMPLETED|Overall Study||114||
60015745|NCT01667419|76132020|FG001|COMPLETED|Overall Study||110||
60015746|NCT01667419|76132021|FG002|COMPLETED|Overall Study||57||
60015747|NCT01667419|76132022|FG003|COMPLETED|Overall Study||52||
60015748|NCT01667419|76132019|FG000|NOT COMPLETED|Overall Study||43||
60015749|NCT01667419|76132020|FG001|NOT COMPLETED|Overall Study||47||
60015750|NCT01667419|76132021|FG002|NOT COMPLETED|Overall Study||36||
60015751|NCT01667419|76132022|FG003|NOT COMPLETED|Overall Study||39||
60015752|NCT03529669|76132033|FG000|STARTED|Overall Study||41||
60015753|NCT03529669|76132033|FG000|COMPLETED|Overall Study||41||
60015754|NCT03529669|76132033|FG000|NOT COMPLETED|Overall Study||0||
60015755|NCT02588833|76132039|FG000|STARTED|Part 1|One subject was enrolled in both cohorts, this subject was enrolled twice.|3||
60015756|NCT02588833|76132040|FG001|STARTED|Part 1|One subject was enrolled in both cohorts, this subject was enrolled twice.|20||
60015757|NCT02588833|76132039|FG000|COMPLETED|Part 1||2||
60015758|NCT02588833|76132040|FG001|COMPLETED|Part 1||20||
59758283|NCT00770211|75877539|FG000|STARTED|Overall Study||182||
59758284|NCT00770211|75877540|FG001|STARTED|Overall Study||89||
59907201|NCT03589885|76028338|FG002|COMPLETED|Treatment Period 2-Randomized Set||3||
59907202|NCT03589885|76028339|FG003|COMPLETED|Treatment Period 2-Randomized Set||16||
59907203|NCT03589885|76028340|FG004|COMPLETED|Treatment Period 2-Randomized Set||16||
59907204|NCT03589885|76028336|FG000|NOT COMPLETED|Treatment Period 2-Randomized Set||1||
59907205|NCT03589885|76028337|FG001|NOT COMPLETED|Treatment Period 2-Randomized Set||5||
59907206|NCT03589885|76028338|FG002|NOT COMPLETED|Treatment Period 2-Randomized Set||1||
59907207|NCT03589885|76028339|FG003|NOT COMPLETED|Treatment Period 2-Randomized Set||0||
59907208|NCT03589885|76028340|FG004|NOT COMPLETED|Treatment Period 2-Randomized Set||1||
60015759|NCT02588833|76132039|FG000|NOT COMPLETED|Part 1||1||
59758285|NCT00770211|75877539|FG000|COMPLETED|Overall Study||181||
59758286|NCT00770211|75877540|FG001|COMPLETED|Overall Study||87||
59758287|NCT00770211|75877539|FG000|NOT COMPLETED|Overall Study||1||
59758288|NCT00770211|75877540|FG001|NOT COMPLETED|Overall Study||2||
59758289|NCT00928187|75877549|FG000|STARTED|Overall Study||152||
59758290|NCT00928187|75877550|FG001|STARTED|Overall Study||147||
59758291|NCT00928187|75877551|FG002|STARTED|Overall Study||155||
59758292|NCT00928187|75877549|FG000|Analysed|Overall Study||152||
59758293|NCT00928187|75877550|FG001|Analysed|Overall Study||145||
60015760|NCT02588833|76132040|FG001|NOT COMPLETED|Part 1||0||
60015761|NCT02588833|76132039|FG000|STARTED|Part 2A|Part 2A is not applicable since Cohort 1 subjects proceeded immediately to Part 3.|0||
60015762|NCT02588833|76132040|FG001|STARTED|Part 2A||20||
60015763|NCT02588833|76132039|FG000|COMPLETED|Part 2A||0||
60015764|NCT02588833|76132040|FG001|COMPLETED|Part 2A||18||
60015765|NCT02588833|76132039|FG000|NOT COMPLETED|Part 2A||0||
60015766|NCT02588833|76132040|FG001|NOT COMPLETED|Part 2A||2||
59758294|NCT00928187|75877551|FG002|Analysed|Overall Study||154||
59758295|NCT00928187|75877549|FG000|COMPLETED|Overall Study||150||
59758296|NCT00928187|75877550|FG001|COMPLETED|Overall Study||141||
59758297|NCT00928187|75877551|FG002|COMPLETED|Overall Study||150||
59758298|NCT00928187|75877549|FG000|NOT COMPLETED|Overall Study||2||
59758299|NCT00928187|75877550|FG001|NOT COMPLETED|Overall Study||6||
59758300|NCT00928187|75877551|FG002|NOT COMPLETED|Overall Study||5||
59758301|NCT00769119|75877561|FG000|STARTED|Overall Study||22||
59758302|NCT00769119|75877562|FG001|STARTED|Overall Study||16||
59758303|NCT00769119|75877561|FG000|COMPLETED|Overall Study||20||
59758304|NCT00769119|75877562|FG001|COMPLETED|Overall Study||13||
59758305|NCT00769119|75877561|FG000|NOT COMPLETED|Overall Study||2||
59758306|NCT00769119|75877562|FG001|NOT COMPLETED|Overall Study||3||
59758307|NCT00927953|75877570|FG000|STARTED|Overall Study||6||
59758308|NCT00927953|75877571|FG001|STARTED|Overall Study||7||
59758309|NCT00927953|75877570|FG000|COMPLETED|Overall Study||4||
59758310|NCT00927953|75877571|FG001|COMPLETED|Overall Study||6||
59758311|NCT00927953|75877570|FG000|NOT COMPLETED|Overall Study||2||
59758312|NCT00927953|75877571|FG001|NOT COMPLETED|Overall Study||1||
59758313|NCT00768651|75877578|FG000|STARTED|Overall Study||8||
59758314|NCT00768651|75877578|FG000|COMPLETED|Overall Study||7||
59758315|NCT00768651|75877578|FG000|NOT COMPLETED|Overall Study||1||
59758316|NCT00756717|75877583|FG000|STARTED|Overall Study||22||
59907209|NCT03545503|76028360|FG000|STARTED|Overall Study||208||
59907210|NCT03545503|76028361|FG001|STARTED|Overall Study||220||
59907211|NCT03545503|76028360|FG000|COMPLETED|Overall Study||194||
59907212|NCT03545503|76028361|FG001|COMPLETED|Overall Study||204||
59758317|NCT00756717|75877583|FG000|COMPLETED|Overall Study||20||
59758318|NCT00756717|75877583|FG000|NOT COMPLETED|Overall Study||2||
59758319|NCT05468918|75877587|FG000|STARTED|Overall Study||7||
59758320|NCT05468918|75877588|FG001|STARTED|Overall Study||7||
59758321|NCT05468918|75877587|FG000|COMPLETED|Overall Study||7||
59758322|NCT05468918|75877588|FG001|COMPLETED|Overall Study||7||
59758323|NCT05468918|75877587|FG000|NOT COMPLETED|Overall Study||0||
59758324|NCT05468918|75877588|FG001|NOT COMPLETED|Overall Study||0||
59758325|NCT04987762|75877593|FG000|STARTED|Overall Study||103||
59758326|NCT04987762|75877593|FG000|COMPLETED|Overall Study||0||
59758327|NCT04987762|75877593|FG000|NOT COMPLETED|Overall Study||103||
59758328|NCT04932655|75877601|FG000|STARTED|Period 1||6||
59907213|NCT03545503|76028360|FG000|NOT COMPLETED|Overall Study||14||
59907214|NCT03545503|76028361|FG001|NOT COMPLETED|Overall Study||16||
59907215|NCT03545113|76028369|FG000|STARTED|Overall Study||23||
59907216|NCT03545113|76028370|FG001|STARTED|Overall Study||21||
59907217|NCT03545113|76028369|FG000|COMPLETED|Overall Study||18||
59907218|NCT03545113|76028370|FG001|COMPLETED|Overall Study||21||
59907219|NCT03545113|76028369|FG000|NOT COMPLETED|Overall Study||5||
59907220|NCT03545113|76028370|FG001|NOT COMPLETED|Overall Study||0||
59907221|NCT03214380|76028382|FG000|STARTED|Lead-in||750||
59907222|NCT03214380|76028383|FG001|STARTED|Lead-in||0||
59907223|NCT03214380|76028384|FG002|STARTED|Lead-in||0||
59907224|NCT03214380|76028385|FG003|STARTED|Lead-in||183||
59907225|NCT03214380|76028386|FG004|STARTED|Lead-in||0||
59907226|NCT03214380|76028387|FG005|STARTED|Lead-in||0||
59907227|NCT03214380|76028382|FG000|Received at Least 1 Dose Lead-in Insulin|Lead-in||750||
59758329|NCT04932655|75877602|FG001|STARTED|Period 1||6||
59758330|NCT04932655|75877603|FG002|STARTED|Period 1||6||
59758331|NCT04932655|75877604|FG003|STARTED|Period 1||6||
59907228|NCT03214380|76028383|FG001|Received at Least 1 Dose Lead-in Insulin|Lead-in||0||
59907229|NCT03214380|76028384|FG002|Received at Least 1 Dose Lead-in Insulin|Lead-in||0||
59907230|NCT03214380|76028385|FG003|Received at Least 1 Dose Lead-in Insulin|Lead-in||183||
59758332|NCT04932655|75877601|FG000|COMPLETED|Period 1||6||
59758333|NCT04932655|75877602|FG001|COMPLETED|Period 1||6||
59758334|NCT04932655|75877603|FG002|COMPLETED|Period 1||6||
59758335|NCT04932655|75877604|FG003|COMPLETED|Period 1||6||
59758336|NCT04932655|75877601|FG000|NOT COMPLETED|Period 1||0||
59758337|NCT04932655|75877602|FG001|NOT COMPLETED|Period 1||0||
59907231|NCT03214380|76028386|FG004|Received at Least 1 Dose Lead-in Insulin|Lead-in||0||
59907232|NCT03214380|76028387|FG005|Received at Least 1 Dose Lead-in Insulin|Lead-in||0||
59907233|NCT03214380|76028382|FG000|COMPLETED|Lead-in||673||
59907234|NCT03214380|76028383|FG001|COMPLETED|Lead-in||0||
59907235|NCT03214380|76028384|FG002|COMPLETED|Lead-in||0||
59907236|NCT03214380|76028385|FG003|COMPLETED|Lead-in||164||
59907237|NCT03214380|76028386|FG004|COMPLETED|Lead-in||0||
59758338|NCT04932655|75877603|FG002|NOT COMPLETED|Period 1||0||
59758339|NCT04932655|75877604|FG003|NOT COMPLETED|Period 1||0||
59758340|NCT04932655|75877601|FG000|STARTED|Period 2||6||
59907238|NCT03214380|76028387|FG005|COMPLETED|Lead-in||0||
59907239|NCT03214380|76028382|FG000|NOT COMPLETED|Lead-in||77||
59907240|NCT03214380|76028383|FG001|NOT COMPLETED|Lead-in||0||
59758341|NCT04932655|75877602|FG001|STARTED|Period 2||6||
59758342|NCT04932655|75877603|FG002|STARTED|Period 2||6||
59758343|NCT04932655|75877604|FG003|STARTED|Period 2||6||
59758344|NCT04932655|75877601|FG000|COMPLETED|Period 2||6||
59758345|NCT04932655|75877602|FG001|COMPLETED|Period 2||6||
59758346|NCT04932655|75877603|FG002|COMPLETED|Period 2||6||
59907241|NCT03214380|76028384|FG002|NOT COMPLETED|Lead-in||0||
59907242|NCT03214380|76028385|FG003|NOT COMPLETED|Lead-in||19||
59907243|NCT03214380|76028386|FG004|NOT COMPLETED|Lead-in||0||
59907244|NCT03214380|76028387|FG005|NOT COMPLETED|Lead-in||0||
59758347|NCT04932655|75877604|FG003|COMPLETED|Period 2||6||
59758348|NCT04932655|75877601|FG000|NOT COMPLETED|Period 2||0||
59758349|NCT04932655|75877602|FG001|NOT COMPLETED|Period 2||0||
59758350|NCT04932655|75877603|FG002|NOT COMPLETED|Period 2||0||
59758351|NCT04932655|75877604|FG003|NOT COMPLETED|Period 2||0||
59758352|NCT04932655|75877601|FG000|STARTED|Period 3||6||
59758353|NCT04932655|75877602|FG001|STARTED|Period 3||6||
59758354|NCT04932655|75877603|FG002|STARTED|Period 3||6||
59758355|NCT04932655|75877604|FG003|STARTED|Period 3||6||
59758356|NCT04932655|75877601|FG000|COMPLETED|Period 3||6||
59758357|NCT04932655|75877602|FG001|COMPLETED|Period 3||6||
59758358|NCT04932655|75877603|FG002|COMPLETED|Period 3||6||
59758359|NCT04932655|75877604|FG003|COMPLETED|Period 3||6||
59758360|NCT04932655|75877601|FG000|NOT COMPLETED|Period 3||0||
59758361|NCT04932655|75877602|FG001|NOT COMPLETED|Period 3||0||
59758362|NCT04932655|75877603|FG002|NOT COMPLETED|Period 3||0||
59758363|NCT04932655|75877604|FG003|NOT COMPLETED|Period 3||0||
59758364|NCT04932655|75877601|FG000|STARTED|Period 4||6||
59758365|NCT04932655|75877602|FG001|STARTED|Period 4||6||
59907245|NCT03214380|76028382|FG000|STARTED|Treatment Period|Participants received Insulin Lispro during Lead-in Period.|0||
59907246|NCT03214380|76028383|FG001|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro for Intensive Treatment Period.|337||
59907247|NCT03214380|76028384|FG002|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro for Intensive Treatment Period.|336||
59907248|NCT03214380|76028385|FG003|STARTED|Treatment Period|Participants received Insulin Lispro during Lead-in Period.|0||
59907249|NCT03214380|76028386|FG004|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro for Intensive Treatment Period.|82||
59907250|NCT03214380|76028387|FG005|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro for Intensive Treatment Period.|82||
59907251|NCT03214380|76028382|FG000|Received at Least 1 Dose of Study Drug|Treatment Period||0||
59907252|NCT03214380|76028383|FG001|Received at Least 1 Dose of Study Drug|Treatment Period||337||
59907253|NCT03214380|76028384|FG002|Received at Least 1 Dose of Study Drug|Treatment Period||336||
59907254|NCT03214380|76028385|FG003|Received at Least 1 Dose of Study Drug|Treatment Period||0||
59907255|NCT03214380|76028386|FG004|Received at Least 1 Dose of Study Drug|Treatment Period||82||
59907256|NCT03214380|76028387|FG005|Received at Least 1 Dose of Study Drug|Treatment Period||82||
59907257|NCT03214380|76028382|FG000|COMPLETED|Treatment Period||0||
59907258|NCT03214380|76028383|FG001|COMPLETED|Treatment Period||319||
59907259|NCT03214380|76028384|FG002|COMPLETED|Treatment Period||320||
59907260|NCT03214380|76028385|FG003|COMPLETED|Treatment Period||0||
59907261|NCT03214380|76028386|FG004|COMPLETED|Treatment Period||73||
59907262|NCT03214380|76028387|FG005|COMPLETED|Treatment Period||71||
59907263|NCT03214380|76028382|FG000|NOT COMPLETED|Treatment Period||0||
59907264|NCT03214380|76028383|FG001|NOT COMPLETED|Treatment Period||18||
59907265|NCT03214380|76028384|FG002|NOT COMPLETED|Treatment Period||16||
59907266|NCT03214380|76028385|FG003|NOT COMPLETED|Treatment Period||0||
59907267|NCT03214380|76028386|FG004|NOT COMPLETED|Treatment Period||9||
59907268|NCT03214380|76028387|FG005|NOT COMPLETED|Treatment Period||11||
59907269|NCT02674464|76028401|FG000|STARTED|Overall Study|There were 15 practices in this arm. Each practice makes a cluster|927||15
59907270|NCT02674464|76028402|FG001|STARTED|Overall Study|There were 15 practices in the arm. Each practice makes a cluster|893||15
59907271|NCT02674464|76028401|FG000|6 Month Follow-up|Overall Study|10 deceased; 17 withdrew; 95 missed|771|6 month survey data collection of adverse events|15
59907272|NCT02674464|76028402|FG001|6 Month Follow-up|Overall Study|2 deceased; 8 withdrew; 111 missed|806|6 month survey data collection of adverse events|15
59907273|NCT02674464|76028401|FG000|COMPLETED|Overall Study||790|12 month follow-up (primary endpoint)|15
59907274|NCT02674464|76028402|FG001|COMPLETED|Overall Study||733|12 month follow-up (primary endpoint)|15
59907275|NCT02674464|76028401|FG000|NOT COMPLETED|Overall Study||137||0
59907276|NCT02674464|76028402|FG001|NOT COMPLETED|Overall Study||160||0
59907277|NCT03172026|76028410|FG000|STARTED|Overall Study||2||
59907278|NCT03172026|76028411|FG001|STARTED|Overall Study||0||
59907279|NCT03172026|76028410|FG000|8 Week Assessment|Overall Study||0||
59907280|NCT03172026|76028411|FG001|8 Week Assessment|Overall Study||0||
59907281|NCT03172026|76028410|FG000|6 Month Assessment|Overall Study||0||
59907282|NCT03172026|76028411|FG001|6 Month Assessment|Overall Study||0||
59907283|NCT03172026|76028410|FG000|COMPLETED|Overall Study||0||
59907284|NCT03172026|76028411|FG001|COMPLETED|Overall Study||0||
60015767|NCT02588833|76132039|FG000|STARTED|Part 2B||0||
60015768|NCT02588833|76132040|FG001|STARTED|Part 2B||18||
59506221|NCT01276457|75599129|FG000|COMPLETED|Extension Study||105||
59758366|NCT04932655|75877603|FG002|STARTED|Period 4||6||
59758367|NCT04932655|75877604|FG003|STARTED|Period 4||6||
59758368|NCT04932655|75877601|FG000|COMPLETED|Period 4||6||
59758369|NCT04932655|75877602|FG001|COMPLETED|Period 4||6||
59758370|NCT04932655|75877603|FG002|COMPLETED|Period 4||6||
59758371|NCT04932655|75877604|FG003|COMPLETED|Period 4||6||
59758372|NCT04932655|75877601|FG000|NOT COMPLETED|Period 4||0||
59758373|NCT04932655|75877602|FG001|NOT COMPLETED|Period 4||0||
59758374|NCT04932655|75877603|FG002|NOT COMPLETED|Period 4||0||
59506222|NCT01276457|75599130|FG001|COMPLETED|Extension Study||110||
59758375|NCT04932655|75877604|FG003|NOT COMPLETED|Period 4||0||
59758376|NCT04817332|75877620|FG000|STARTED|Overall Study||192||
59758377|NCT04817332|75877621|FG001|STARTED|Overall Study||214||
59758378|NCT04817332|75877620|FG000|COMPLETED|Overall Study|Participants with data for the primary outcome|187||
59758379|NCT04817332|75877621|FG001|COMPLETED|Overall Study|Participants with data for the primary outcome|211||
59758380|NCT04817332|75877620|FG000|NOT COMPLETED|Overall Study||5||
59907285|NCT03172026|76028410|FG000|NOT COMPLETED|Overall Study||2||
59907286|NCT03172026|76028411|FG001|NOT COMPLETED|Overall Study||0||
59907287|NCT01343888|76028421|FG000|STARTED|Overall Study|261 subject randomized; 259 subjects treated with at least one dose; 2 subjects were not treated|259||
59907288|NCT01343888|76028422|FG001|STARTED|Overall Study|262 subject randomized; 261 subjects treated with at least one dose; 1 subject was not treated|261||
59907289|NCT01343888|76028423|FG002|STARTED|Overall Study|133 subject randomized; 132 subjects treated with at least one dose; 1 subject was not treated|132||
59907290|NCT01343888|76028421|FG000|COMPLETED|Overall Study||234||
59907291|NCT01343888|76028422|FG001|COMPLETED|Overall Study||222||
59907292|NCT01343888|76028423|FG002|COMPLETED|Overall Study||110||
59907293|NCT01343888|76028421|FG000|NOT COMPLETED|Overall Study||25||
59907294|NCT01343888|76028422|FG001|NOT COMPLETED|Overall Study||39||
59758381|NCT04817332|75877621|FG001|NOT COMPLETED|Overall Study||3||
59758382|NCT04797637|75877629|FG000|STARTED|Overall Study||141||
59907295|NCT01343888|76028423|FG002|NOT COMPLETED|Overall Study||22||
59907296|NCT03589807|76028437|FG000|STARTED|Overall Study||27||
59907297|NCT03589807|76028438|FG001|STARTED|Overall Study||30||
59907298|NCT03589807|76028439|FG002|STARTED|Overall Study||33||
59907299|NCT03589807|76028440|FG003|STARTED|Overall Study||32||
59907300|NCT03589807|76028441|FG004|STARTED|Overall Study||28||
59907301|NCT03589807|76028442|FG005|STARTED|Overall Study||30||
59907302|NCT03589807|76028437|FG000|COMPLETED|Overall Study||27||
59907303|NCT03589807|76028438|FG001|COMPLETED|Overall Study||23||
59907304|NCT03589807|76028439|FG002|COMPLETED|Overall Study||31||
59907305|NCT03589807|76028440|FG003|COMPLETED|Overall Study||28||
59907306|NCT03589807|76028441|FG004|COMPLETED|Overall Study||26||
59907307|NCT03589807|76028442|FG005|COMPLETED|Overall Study||29||
59907308|NCT03589807|76028437|FG000|NOT COMPLETED|Overall Study||0||
59907309|NCT03589807|76028438|FG001|NOT COMPLETED|Overall Study||7||
59907310|NCT03589807|76028439|FG002|NOT COMPLETED|Overall Study||2||
59907311|NCT03589807|76028440|FG003|NOT COMPLETED|Overall Study||4||
59907312|NCT03589807|76028441|FG004|NOT COMPLETED|Overall Study||2||
59907313|NCT03589807|76028442|FG005|NOT COMPLETED|Overall Study||1||
59907314|NCT03544333|76028461|FG000|STARTED|Overall Study||3||
59907315|NCT03544333|76028462|FG001|STARTED|Overall Study||2||
59907316|NCT03544333|76028461|FG000|COMPLETED|Overall Study||2||
59907317|NCT03544333|76028462|FG001|COMPLETED|Overall Study||2||
59907318|NCT03544333|76028461|FG000|NOT COMPLETED|Overall Study||1||
59907319|NCT03544333|76028462|FG001|NOT COMPLETED|Overall Study||0||
59907320|NCT03560245|76028470|FG000|STARTED|Overall Study||53||
59907321|NCT03560245|76028471|FG001|STARTED|Overall Study||55||
59907322|NCT03560245|76028470|FG000|COMPLETED|Overall Study||48||
59758383|NCT04797637|75877630|FG001|STARTED|Overall Study||137||
59758384|NCT04797637|75877629|FG000|COMPLETED|Overall Study||118||
59907323|NCT03560245|76028471|FG001|COMPLETED|Overall Study||48||
59907324|NCT03560245|76028470|FG000|NOT COMPLETED|Overall Study||5||
59907325|NCT03560245|76028471|FG001|NOT COMPLETED|Overall Study||7||
59907326|NCT00707434|76028479|FG000|STARTED|Overall Study||6||
59907327|NCT00707434|76028479|FG000|COMPLETED|Overall Study||5||
59907328|NCT00707434|76028479|FG000|NOT COMPLETED|Overall Study||1||
59907329|NCT03054428|76028486|FG000|STARTED|Overall Study||85||
60015769|NCT02588833|76132039|FG000|COMPLETED|Part 2B||0||
60015770|NCT02588833|76132040|FG001|COMPLETED|Part 2B||17||
60015771|NCT02588833|76132039|FG000|NOT COMPLETED|Part 2B||0||
60015772|NCT02588833|76132040|FG001|NOT COMPLETED|Part 2B||1||
60015773|NCT02588833|76132039|FG000|STARTED|Part 2C||0||
60015774|NCT02588833|76132040|FG001|STARTED|Part 2C|17 subjects completed Part 2B and 3 entered extension study without participating in Part 2C.|14||
60015775|NCT02588833|76132039|FG000|COMPLETED|Part 2C||0||
60015776|NCT02588833|76132040|FG001|COMPLETED|Part 2C||12||
60015777|NCT02588833|76132039|FG000|NOT COMPLETED|Part 2C||0||
60015778|NCT02588833|76132040|FG001|NOT COMPLETED|Part 2C||2||
60015779|NCT02588833|76132039|FG000|STARTED|Part 3 (Safety Follow-up)|Only subjects who did not enter extension study or Part 2C entered Part 3.|3||
60015780|NCT02588833|76132040|FG001|STARTED|Part 3 (Safety Follow-up)|Only subjects who did not enter extension study or Part 2C entered Part 3.|4||
60015781|NCT02588833|76132039|FG000|COMPLETED|Part 3 (Safety Follow-up)||3||
60015782|NCT02588833|76132040|FG001|COMPLETED|Part 3 (Safety Follow-up)||2||
60015783|NCT02588833|76132039|FG000|NOT COMPLETED|Part 3 (Safety Follow-up)||0||
60015784|NCT02588833|76132040|FG001|NOT COMPLETED|Part 3 (Safety Follow-up)||2||
60015785|NCT01667107|76132049|FG000|STARTED|Overall Study||8||
60015786|NCT01667107|76132050|FG001|STARTED|Overall Study||18||
60015787|NCT01667107|76132049|FG000|COMPLETED|Overall Study||4||
60015788|NCT01667107|76132050|FG001|COMPLETED|Overall Study||11||
60015789|NCT01667107|76132049|FG000|NOT COMPLETED|Overall Study||4||
59907330|NCT03054428|76028487|FG001|STARTED|Overall Study||84||
59907331|NCT03054428|76028488|FG002|STARTED|Overall Study||82||
59907332|NCT03054428|76028486|FG000|Completed Wk 16 End of Treatment (EOT)|Overall Study||80||
59907333|NCT03054428|76028487|FG001|Completed Wk 16 End of Treatment (EOT)|Overall Study||81||
59907334|NCT03054428|76028488|FG002|Completed Wk 16 End of Treatment (EOT)|Overall Study||79||
59907335|NCT03054428|76028486|FG000|Completed Week 28 (End of Study)|Overall Study||2||
59907336|NCT03054428|76028487|FG001|Completed Week 28 (End of Study)|Overall Study||4||
59907337|NCT03054428|76028488|FG002|Completed Week 28 (End of Study)|Overall Study||3||
59907338|NCT03054428|76028486|FG000|COMPLETED|Overall Study||2||
59907339|NCT03054428|76028487|FG001|COMPLETED|Overall Study||4||
59907340|NCT03054428|76028488|FG002|COMPLETED|Overall Study||3||
59907341|NCT03054428|76028486|FG000|NOT COMPLETED|Overall Study||83||
59907342|NCT03054428|76028487|FG001|NOT COMPLETED|Overall Study||80||
59907343|NCT03054428|76028488|FG002|NOT COMPLETED|Overall Study||79||
59907344|NCT03558997|76028500|FG000|STARTED|Overall Study||25||
59907345|NCT03558997|76028501|FG001|STARTED|Overall Study||26||
59907346|NCT03558997|76028502|FG002|STARTED|Overall Study||26||
59907347|NCT03558997|76028503|FG003|STARTED|Overall Study||26||
59907348|NCT03558997|76028500|FG000|COMPLETED|Overall Study||24||
59907349|NCT03558997|76028501|FG001|COMPLETED|Overall Study||24||
59907350|NCT03558997|76028502|FG002|COMPLETED|Overall Study||18||
59907351|NCT03558997|76028503|FG003|COMPLETED|Overall Study||24||
59907352|NCT03558997|76028500|FG000|NOT COMPLETED|Overall Study||1||
59907353|NCT03558997|76028501|FG001|NOT COMPLETED|Overall Study||2||
59907354|NCT03558997|76028502|FG002|NOT COMPLETED|Overall Study||8||
59907355|NCT03558997|76028503|FG003|NOT COMPLETED|Overall Study||2||
59907356|NCT03052400|76028518|FG000|STARTED|Overall Study||4||
59907357|NCT03052400|76028519|FG001|STARTED|Overall Study||4||
59907358|NCT03052400|76028518|FG000|COMPLETED|Overall Study||3||
59506223|NCT01276457|75599129|FG000|NOT COMPLETED|Extension Study||6||
59506224|NCT01276457|75599130|FG001|NOT COMPLETED|Extension Study||2||
59506225|NCT00748865|75599136|FG000|STARTED|Overall Study||10||
59506226|NCT00748865|75599137|FG001|STARTED|Overall Study||10||
59506227|NCT00748865|75599136|FG000|COMPLETED|Overall Study||10||
59506228|NCT00748865|75599137|FG001|COMPLETED|Overall Study||10||
59758385|NCT04797637|75877630|FG001|COMPLETED|Overall Study||104||
59907359|NCT03052400|76028519|FG001|COMPLETED|Overall Study||3||
59907360|NCT03052400|76028518|FG000|NOT COMPLETED|Overall Study||1||
59907361|NCT03052400|76028519|FG001|NOT COMPLETED|Overall Study||1||
59907362|NCT03538951|76028527|FG000|STARTED|Overall Study||41||
59907363|NCT03538951|76028528|FG001|STARTED|Overall Study||42||
59907364|NCT03538951|76028527|FG000|COMPLETED|Overall Study||40||
59907365|NCT03538951|76028528|FG001|COMPLETED|Overall Study||40||
59907366|NCT03538951|76028527|FG000|NOT COMPLETED|Overall Study||1||
59907367|NCT03538951|76028528|FG001|NOT COMPLETED|Overall Study||2||
59907368|NCT03052322|76028536|FG000|STARTED|Overall Study||143||
59907369|NCT03052322|76028537|FG001|STARTED|Overall Study||145||
59907370|NCT03052322|76028536|FG000|COMPLETED|Overall Study||122||
59907371|NCT03052322|76028537|FG001|COMPLETED|Overall Study||113||
59907372|NCT03052322|76028536|FG000|NOT COMPLETED|Overall Study||21||
59907373|NCT03052322|76028537|FG001|NOT COMPLETED|Overall Study||32||
59907374|NCT03521791|76028545|FG000|STARTED|Overall Study||76||
59907375|NCT03521791|76028546|FG001|STARTED|Overall Study||90||
59907376|NCT03521791|76028545|FG000|COMPLETED|Overall Study||69||
59907377|NCT03521791|76028546|FG001|COMPLETED|Overall Study||73||
59907378|NCT03521791|76028545|FG000|NOT COMPLETED|Overall Study||7||
59907379|NCT03521791|76028546|FG001|NOT COMPLETED|Overall Study||17||
59907380|NCT03521635|76028554|FG000|STARTED|Overall Study||49||
59907381|NCT03521635|76028555|FG001|STARTED|Overall Study||49||
59907382|NCT03521635|76028554|FG000|COMPLETED|Overall Study||45||
60015790|NCT01667107|76132050|FG001|NOT COMPLETED|Overall Study||7||
60015791|NCT02410213|76132056|FG000|STARTED|Overall Study||16||
59907383|NCT03521635|76028555|FG001|COMPLETED|Overall Study||43||
59907384|NCT03521635|76028554|FG000|NOT COMPLETED|Overall Study||4||
60015792|NCT02410213|76132057|FG001|STARTED|Overall Study||19||
60015793|NCT02410213|76132056|FG000|COMPLETED|Overall Study||16||
59506229|NCT00748865|75599136|FG000|NOT COMPLETED|Overall Study||0||
59907385|NCT03521635|76028555|FG001|NOT COMPLETED|Overall Study||6||
59907386|NCT03170544|76028573|FG000|STARTED|Part 1||10||
59907387|NCT03170544|76028574|FG001|STARTED|Part 1||6||
59907388|NCT03170544|76028575|FG002|STARTED|Part 1||6||
59907389|NCT03170544|76028576|FG003|STARTED|Part 1||7||
59907390|NCT03170544|76028577|FG004|STARTED|Part 1||6||
59907391|NCT03170544|76028578|FG005|STARTED|Part 1||6||
59907392|NCT03170544|76028579|FG006|STARTED|Part 1||0||
59907393|NCT03170544|76028580|FG007|STARTED|Part 1||0||
59907394|NCT03170544|76028581|FG008|STARTED|Part 1||0||
59907395|NCT03170544|76028582|FG009|STARTED|Part 1||0||
60015794|NCT02410213|76132057|FG001|COMPLETED|Overall Study||19||
60015795|NCT02410213|76132056|FG000|NOT COMPLETED|Overall Study||0||
59758386|NCT04797637|75877629|FG000|NOT COMPLETED|Overall Study||23||
59758387|NCT04797637|75877630|FG001|NOT COMPLETED|Overall Study||33||
59758388|NCT04779489|75877636|FG000|STARTED|Overall Study||1||
59758389|NCT04779489|75877636|FG000|COMPLETED|Overall Study||0||
59758390|NCT04779489|75877636|FG000|NOT COMPLETED|Overall Study||1||
59758391|NCT04582409|75877642|FG000|STARTED|Overall Study||7||
60015796|NCT02410213|76132057|FG001|NOT COMPLETED|Overall Study||0||
60015797|NCT04638673|76132065|FG000|STARTED|Overall Study||6||
60015798|NCT04638673|76132066|FG001|STARTED|Overall Study||6||
60015799|NCT04638673|76132065|FG000|COMPLETED|Overall Study||6||
60015800|NCT04638673|76132066|FG001|COMPLETED|Overall Study||6||
60015801|NCT04638673|76132065|FG000|NOT COMPLETED|Overall Study||0||
60015802|NCT04638673|76132066|FG001|NOT COMPLETED|Overall Study||0||
60015803|NCT02590003|76132074|FG000|STARTED|Overall Study||1||
60015804|NCT02590003|76132075|FG001|STARTED|Overall Study||2||
60015805|NCT02590003|76132074|FG000|COMPLETED|Overall Study||0||
60015806|NCT02590003|76132075|FG001|COMPLETED|Overall Study||0||
59758392|NCT04582409|75877643|FG001|STARTED|Overall Study||6||
59907396|NCT03170544|76028583|FG010|STARTED|Part 1||0||
60015807|NCT02590003|76132074|FG000|NOT COMPLETED|Overall Study||1||
60015808|NCT02590003|76132075|FG001|NOT COMPLETED|Overall Study||2||
60015809|NCT04762771|76132083|FG000|STARTED|Overall Study||1||
60015810|NCT04762771|76132084|FG001|STARTED|Overall Study||1||
60015811|NCT04762771|76132083|FG000|COMPLETED|Overall Study||1||
60015812|NCT04762771|76132084|FG001|COMPLETED|Overall Study||1||
60015813|NCT04762771|76132083|FG000|NOT COMPLETED|Overall Study||0||
60015814|NCT04762771|76132084|FG001|NOT COMPLETED|Overall Study||0||
60015815|NCT04481035|76132092|FG000|STARTED|Period 1||3||
60015816|NCT04481035|76132093|FG001|STARTED|Period 1||2||
60015817|NCT04481035|76132092|FG000|COMPLETED|Period 1||3||
60015818|NCT04481035|76132093|FG001|COMPLETED|Period 1||2||
60015819|NCT04481035|76132092|FG000|NOT COMPLETED|Period 1||0||
60015820|NCT04481035|76132093|FG001|NOT COMPLETED|Period 1||0||
60015821|NCT04481035|76132092|FG000|STARTED|Period 2||3||
60015822|NCT04481035|76132093|FG001|STARTED|Period 2||2||
60015823|NCT04481035|76132092|FG000|COMPLETED|Period 2||3||
60015824|NCT04481035|76132093|FG001|COMPLETED|Period 2||2||
60015825|NCT04481035|76132092|FG000|NOT COMPLETED|Period 2||0||
60015826|NCT04481035|76132093|FG001|NOT COMPLETED|Period 2||0||
60015827|NCT02404311|76132104|FG000|STARTED|Part A: Month 0-18||210||
60015828|NCT02404311|76132105|FG001|STARTED|Part A: Month 0-18||42||
60015829|NCT02404311|76132106|FG002|STARTED|Part A: Month 0-18||0||
60015830|NCT02404311|76132107|FG003|STARTED|Part A: Month 0-18||0||
60015831|NCT02404311|76132108|FG004|STARTED|Part A: Month 0-18||0||
60015832|NCT02404311|76132104|FG000|Per Protocol|Part A: Month 0-18||185||
59758393|NCT04582409|75877642|FG000|COMPLETED|Overall Study||7||
59758394|NCT04582409|75877643|FG001|COMPLETED|Overall Study||6||
59758395|NCT04582409|75877642|FG000|NOT COMPLETED|Overall Study||0||
59758396|NCT04582409|75877643|FG001|NOT COMPLETED|Overall Study||0||
59758397|NCT04403542|75877652|FG000|STARTED|Overall Study||18||36
59758398|NCT04403542|75877653|FG001|STARTED|Overall Study||18||36
59758399|NCT04403542|75877652|FG000|COMPLETED|Overall Study||18||36
59758400|NCT04403542|75877653|FG001|COMPLETED|Overall Study||18||36
59758401|NCT04403542|75877652|FG000|NOT COMPLETED|Overall Study||0||0
59758402|NCT04403542|75877653|FG001|NOT COMPLETED|Overall Study||0||0
59758403|NCT04300296|75877667|FG000|STARTED|Treatment Period 1: Baseline to 16 Weeks||25||
59907397|NCT03170544|76028584|FG011|STARTED|Part 1||0||
59907398|NCT03170544|76028573|FG000|COMPLETED|Part 1||9||
59907399|NCT03170544|76028574|FG001|COMPLETED|Part 1||6||
59907400|NCT03170544|76028575|FG002|COMPLETED|Part 1||6||
60015833|NCT02404311|76132105|FG001|Per Protocol|Part A: Month 0-18||37||
60015834|NCT02404311|76132106|FG002|Per Protocol|Part A: Month 0-18||0||
60015835|NCT02404311|76132107|FG003|Per Protocol|Part A: Month 0-18||0||
60015836|NCT02404311|76132108|FG004|Per Protocol|Part A: Month 0-18||0||
60015837|NCT02404311|76132104|FG000|Month 6.5 Immunogenicity Timepoint|Part A: Month 0-18||194||
60015838|NCT02404311|76132105|FG001|Month 6.5 Immunogenicity Timepoint|Part A: Month 0-18||37||
60015839|NCT02404311|76132106|FG002|Month 6.5 Immunogenicity Timepoint|Part A: Month 0-18||0||
59506230|NCT00748865|75599137|FG001|NOT COMPLETED|Overall Study||0||
59907401|NCT03170544|76028576|FG003|COMPLETED|Part 1||6||
60015840|NCT02404311|76132107|FG003|Month 6.5 Immunogenicity Timepoint|Part A: Month 0-18||0||
60015841|NCT02404311|76132108|FG004|Month 6.5 Immunogenicity Timepoint|Part A: Month 0-18||0||
59907402|NCT03170544|76028577|FG004|COMPLETED|Part 1||6||
59907403|NCT03170544|76028578|FG005|COMPLETED|Part 1||6||
60015842|NCT02404311|76132104|FG000|Month 12.5 Immunogenicity Timepoint|Part A: Month 0-18||186||
60015843|NCT02404311|76132105|FG001|Month 12.5 Immunogenicity Timepoint|Part A: Month 0-18||33||
59758404|NCT04300296|75877668|FG001|STARTED|Treatment Period 1: Baseline to 16 Weeks||12||
59758405|NCT04300296|75877669|FG002|STARTED|Treatment Period 1: Baseline to 16 Weeks||24||
59758406|NCT04300296|75877670|FG003|STARTED|Treatment Period 1: Baseline to 16 Weeks||13||
59758407|NCT04300296|75877671|FG004|STARTED|Treatment Period 1: Baseline to 16 Weeks||24||
59758408|NCT04300296|75877672|FG005|STARTED|Treatment Period 1: Baseline to 16 Weeks||13||
59758409|NCT04300296|75877667|FG000|Placebo Responder|Treatment Period 1: Baseline to 16 Weeks||0||
59758410|NCT04300296|75877668|FG001|Placebo Responder|Treatment Period 1: Baseline to 16 Weeks||1||
59758411|NCT04300296|75877669|FG002|Placebo Responder|Treatment Period 1: Baseline to 16 Weeks||0||
59758412|NCT04300296|75877670|FG003|Placebo Responder|Treatment Period 1: Baseline to 16 Weeks||1||
59758413|NCT04300296|75877671|FG004|Placebo Responder|Treatment Period 1: Baseline to 16 Weeks||0||
59758414|NCT04300296|75877672|FG005|Placebo Responder|Treatment Period 1: Baseline to 16 Weeks||0||
59907404|NCT03170544|76028579|FG006|COMPLETED|Part 1||0||
59907405|NCT03170544|76028580|FG007|COMPLETED|Part 1||0||
59907406|NCT03170544|76028581|FG008|COMPLETED|Part 1||0||
59907407|NCT03170544|76028582|FG009|COMPLETED|Part 1||0||
59907408|NCT03170544|76028583|FG010|COMPLETED|Part 1||0||
59907409|NCT03170544|76028584|FG011|COMPLETED|Part 1||0||
59907410|NCT03170544|76028573|FG000|NOT COMPLETED|Part 1||1||
59907411|NCT03170544|76028574|FG001|NOT COMPLETED|Part 1||0||
59907412|NCT03170544|76028575|FG002|NOT COMPLETED|Part 1||0||
59907413|NCT03170544|76028576|FG003|NOT COMPLETED|Part 1||1||
59907414|NCT03170544|76028577|FG004|NOT COMPLETED|Part 1||0||
59907415|NCT03170544|76028578|FG005|NOT COMPLETED|Part 1||0||
59907416|NCT03170544|76028579|FG006|NOT COMPLETED|Part 1||0||
59907417|NCT03170544|76028580|FG007|NOT COMPLETED|Part 1||0||
59907418|NCT03170544|76028581|FG008|NOT COMPLETED|Part 1||0||
59907419|NCT03170544|76028582|FG009|NOT COMPLETED|Part 1||0||
59907420|NCT03170544|76028583|FG010|NOT COMPLETED|Part 1||0||
59907421|NCT03170544|76028584|FG011|NOT COMPLETED|Part 1||0||
59907422|NCT03170544|76028573|FG000|STARTED|Part 2||0||
59907423|NCT03170544|76028574|FG001|STARTED|Part 2||0||
59907424|NCT03170544|76028575|FG002|STARTED|Part 2||0||
59907425|NCT03170544|76028576|FG003|STARTED|Part 2||0||
59907426|NCT03170544|76028577|FG004|STARTED|Part 2||0||
59907427|NCT03170544|76028578|FG005|STARTED|Part 2||0||
60015844|NCT02404311|76132106|FG002|Month 12.5 Immunogenicity Timepoint|Part A: Month 0-18||0||
60015845|NCT02404311|76132107|FG003|Month 12.5 Immunogenicity Timepoint|Part A: Month 0-18||0||
60015846|NCT02404311|76132108|FG004|Month 12.5 Immunogenicity Timepoint|Part A: Month 0-18||0||
60015847|NCT02404311|76132104|FG000|COMPLETED|Part A: Month 0-18||184||
60015848|NCT02404311|76132105|FG001|COMPLETED|Part A: Month 0-18||36||
60015849|NCT02404311|76132106|FG002|COMPLETED|Part A: Month 0-18||0||
60015850|NCT02404311|76132107|FG003|COMPLETED|Part A: Month 0-18||0||
59758415|NCT04300296|75877667|FG000|COMPLETED|Treatment Period 1: Baseline to 16 Weeks||23||
59758416|NCT04300296|75877668|FG001|COMPLETED|Treatment Period 1: Baseline to 16 Weeks||10||
59907428|NCT03170544|76028579|FG006|STARTED|Part 2||4||
59907429|NCT03170544|76028580|FG007|STARTED|Part 2||0||
60015851|NCT02404311|76132108|FG004|COMPLETED|Part A: Month 0-18||0||
60015852|NCT02404311|76132104|FG000|NOT COMPLETED|Part A: Month 0-18||26||
60015853|NCT02404311|76132105|FG001|NOT COMPLETED|Part A: Month 0-18||6||
60015854|NCT02404311|76132106|FG002|NOT COMPLETED|Part A: Month 0-18||0||
60015855|NCT02404311|76132107|FG003|NOT COMPLETED|Part A: Month 0-18||0||
60015856|NCT02404311|76132108|FG004|NOT COMPLETED|Part A: Month 0-18||0||
60015857|NCT02404311|76132104|FG000|STARTED|Part B: Month 30-36||0||
60015858|NCT02404311|76132105|FG001|STARTED|Part B: Month 30-36||0||
60015859|NCT02404311|76132106|FG002|STARTED|Part B: Month 30-36||32||
60015860|NCT02404311|76132107|FG003|STARTED|Part B: Month 30-36||31||
60015861|NCT02404311|76132108|FG004|STARTED|Part B: Month 30-36||7||
60015862|NCT02404311|76132104|FG000|Month 30.5 Immunogenicity Timepoint|Part B: Month 30-36||0||
60015863|NCT02404311|76132105|FG001|Month 30.5 Immunogenicity Timepoint|Part B: Month 30-36||0||
59907430|NCT03170544|76028581|FG008|STARTED|Part 2||0||
59907431|NCT03170544|76028582|FG009|STARTED|Part 2||0||
59907432|NCT03170544|76028583|FG010|STARTED|Part 2||0||
59907433|NCT03170544|76028584|FG011|STARTED|Part 2||0||
59907434|NCT03170544|76028573|FG000|COMPLETED|Part 2||0||
59907435|NCT03170544|76028574|FG001|COMPLETED|Part 2||0||
60015864|NCT02404311|76132106|FG002|Month 30.5 Immunogenicity Timepoint|Part B: Month 30-36||28||
60015865|NCT02404311|76132107|FG003|Month 30.5 Immunogenicity Timepoint|Part B: Month 30-36||30||
60015866|NCT02404311|76132108|FG004|Month 30.5 Immunogenicity Timepoint|Part B: Month 30-36||6||
60015867|NCT02404311|76132104|FG000|COMPLETED|Part B: Month 30-36||0||
60015868|NCT02404311|76132105|FG001|COMPLETED|Part B: Month 30-36||0||
60015869|NCT02404311|76132106|FG002|COMPLETED|Part B: Month 30-36||32||
60015870|NCT02404311|76132107|FG003|COMPLETED|Part B: Month 30-36||31||
60015871|NCT02404311|76132108|FG004|COMPLETED|Part B: Month 30-36||7||
60015872|NCT02404311|76132104|FG000|NOT COMPLETED|Part B: Month 30-36||0||
60015873|NCT02404311|76132105|FG001|NOT COMPLETED|Part B: Month 30-36||0||
60015874|NCT02404311|76132106|FG002|NOT COMPLETED|Part B: Month 30-36||0||
60015875|NCT02404311|76132107|FG003|NOT COMPLETED|Part B: Month 30-36||0||
60015876|NCT02404311|76132108|FG004|NOT COMPLETED|Part B: Month 30-36||0||
59907436|NCT03170544|76028575|FG002|COMPLETED|Part 2||0||
59907437|NCT03170544|76028576|FG003|COMPLETED|Part 2||0||
59907438|NCT03170544|76028577|FG004|COMPLETED|Part 2||0||
59907439|NCT03170544|76028578|FG005|COMPLETED|Part 2||0||
60015877|NCT01650519|76132122|FG000|STARTED|Overall Study||20||
60015878|NCT01650519|76132123|FG001|STARTED|Overall Study||31||
60015879|NCT01650519|76132122|FG000|COMPLETED|Overall Study||19||
60015880|NCT01650519|76132123|FG001|COMPLETED|Overall Study||31||
60015881|NCT01650519|76132122|FG000|NOT COMPLETED|Overall Study||1||
59907440|NCT03170544|76028579|FG006|COMPLETED|Part 2||4||
59907441|NCT03170544|76028580|FG007|COMPLETED|Part 2||0||
59907442|NCT03170544|76028581|FG008|COMPLETED|Part 2||0||
59907443|NCT03170544|76028582|FG009|COMPLETED|Part 2||0||
59907444|NCT03170544|76028583|FG010|COMPLETED|Part 2||0||
59907445|NCT03170544|76028584|FG011|COMPLETED|Part 2||0||
59907446|NCT03170544|76028573|FG000|NOT COMPLETED|Part 2||0||
59907447|NCT03170544|76028574|FG001|NOT COMPLETED|Part 2||0||
60015882|NCT01650519|76132123|FG001|NOT COMPLETED|Overall Study||0||
60015883|NCT01650285|76132129|FG000|STARTED|Overall Study||5||
59758417|NCT04300296|75877669|FG002|COMPLETED|Treatment Period 1: Baseline to 16 Weeks||24||
59758418|NCT04300296|75877670|FG003|COMPLETED|Treatment Period 1: Baseline to 16 Weeks||13||
59758419|NCT04300296|75877671|FG004|COMPLETED|Treatment Period 1: Baseline to 16 Weeks||23||
59758420|NCT04300296|75877672|FG005|COMPLETED|Treatment Period 1: Baseline to 16 Weeks||12||
59758421|NCT04300296|75877667|FG000|NOT COMPLETED|Treatment Period 1: Baseline to 16 Weeks||2||
59907448|NCT03170544|76028575|FG002|NOT COMPLETED|Part 2||0||
59907449|NCT03170544|76028576|FG003|NOT COMPLETED|Part 2||0||
59907450|NCT03170544|76028577|FG004|NOT COMPLETED|Part 2||0||
59907451|NCT03170544|76028578|FG005|NOT COMPLETED|Part 2||0||
59907452|NCT03170544|76028579|FG006|NOT COMPLETED|Part 2||0||
59907453|NCT03170544|76028580|FG007|NOT COMPLETED|Part 2||0||
59907454|NCT03170544|76028581|FG008|NOT COMPLETED|Part 2||0||
59907455|NCT03170544|76028582|FG009|NOT COMPLETED|Part 2||0||
59907456|NCT03170544|76028583|FG010|NOT COMPLETED|Part 2||0||
59907457|NCT03170544|76028584|FG011|NOT COMPLETED|Part 2||0||
59907458|NCT03170544|76028573|FG000|STARTED|Part 3||0||
59907459|NCT03170544|76028574|FG001|STARTED|Part 3||0||
59907460|NCT03170544|76028575|FG002|STARTED|Part 3||0||
59907461|NCT03170544|76028576|FG003|STARTED|Part 3||0||
59907462|NCT03170544|76028577|FG004|STARTED|Part 3||0||
59907463|NCT03170544|76028578|FG005|STARTED|Part 3||0||
59907464|NCT03170544|76028579|FG006|STARTED|Part 3||0||
59907465|NCT03170544|76028580|FG007|STARTED|Part 3||4||
59907466|NCT03170544|76028581|FG008|STARTED|Part 3||6||
59907467|NCT03170544|76028582|FG009|STARTED|Part 3||6||
59907468|NCT03170544|76028583|FG010|STARTED|Part 3||0||
59907469|NCT03170544|76028584|FG011|STARTED|Part 3||0||
59907470|NCT03170544|76028573|FG000|COMPLETED|Part 3||0||
59907471|NCT03170544|76028574|FG001|COMPLETED|Part 3||0||
59907472|NCT03170544|76028575|FG002|COMPLETED|Part 3||0||
59907473|NCT03170544|76028576|FG003|COMPLETED|Part 3||0||
59907474|NCT03170544|76028577|FG004|COMPLETED|Part 3||0||
59907475|NCT03170544|76028578|FG005|COMPLETED|Part 3||0||
59907476|NCT03170544|76028579|FG006|COMPLETED|Part 3||0||
59907477|NCT03170544|76028580|FG007|COMPLETED|Part 3||4||
59907478|NCT03170544|76028581|FG008|COMPLETED|Part 3||6||
59907479|NCT03170544|76028582|FG009|COMPLETED|Part 3||6||
59907480|NCT03170544|76028583|FG010|COMPLETED|Part 3||0||
59907481|NCT03170544|76028584|FG011|COMPLETED|Part 3||0||
59907482|NCT03170544|76028573|FG000|NOT COMPLETED|Part 3||0||
59907483|NCT03170544|76028574|FG001|NOT COMPLETED|Part 3||0||
59907484|NCT03170544|76028575|FG002|NOT COMPLETED|Part 3||0||
59907485|NCT03170544|76028576|FG003|NOT COMPLETED|Part 3||0||
59907486|NCT03170544|76028577|FG004|NOT COMPLETED|Part 3||0||
59907487|NCT03170544|76028578|FG005|NOT COMPLETED|Part 3||0||
59907488|NCT03170544|76028579|FG006|NOT COMPLETED|Part 3||0||
59907489|NCT03170544|76028580|FG007|NOT COMPLETED|Part 3||0||
59907490|NCT03170544|76028581|FG008|NOT COMPLETED|Part 3||0||
59907491|NCT03170544|76028582|FG009|NOT COMPLETED|Part 3||0||
59907492|NCT03170544|76028583|FG010|NOT COMPLETED|Part 3||0||
59907493|NCT03170544|76028584|FG011|NOT COMPLETED|Part 3||0||
59907494|NCT03170544|76028573|FG000|STARTED|Part 4||0||
59907495|NCT03170544|76028574|FG001|STARTED|Part 4||0||
59907496|NCT03170544|76028575|FG002|STARTED|Part 4||0||
59907497|NCT03170544|76028576|FG003|STARTED|Part 4||0||
59907498|NCT03170544|76028577|FG004|STARTED|Part 4||0||
59907499|NCT03170544|76028578|FG005|STARTED|Part 4||0||
59907500|NCT03170544|76028579|FG006|STARTED|Part 4||0||
59907501|NCT03170544|76028580|FG007|STARTED|Part 4||0||
59907502|NCT03170544|76028581|FG008|STARTED|Part 4||0||
59907503|NCT03170544|76028582|FG009|STARTED|Part 4||0||
59907504|NCT03170544|76028583|FG010|STARTED|Part 4||3||
59907505|NCT03170544|76028584|FG011|STARTED|Part 4||6||
59907506|NCT03170544|76028573|FG000|COMPLETED|Part 4||0||
59907507|NCT03170544|76028574|FG001|COMPLETED|Part 4||0||
59907508|NCT03170544|76028575|FG002|COMPLETED|Part 4||0||
59907509|NCT03170544|76028576|FG003|COMPLETED|Part 4||0||
59907510|NCT03170544|76028577|FG004|COMPLETED|Part 4||0||
59907511|NCT03170544|76028578|FG005|COMPLETED|Part 4||0||
59907512|NCT03170544|76028579|FG006|COMPLETED|Part 4||0||
59907513|NCT03170544|76028580|FG007|COMPLETED|Part 4||0||
59758422|NCT04300296|75877668|FG001|NOT COMPLETED|Treatment Period 1: Baseline to 16 Weeks||2||
59907514|NCT03170544|76028581|FG008|COMPLETED|Part 4||0||
59907515|NCT03170544|76028582|FG009|COMPLETED|Part 4||0||
59907516|NCT03170544|76028583|FG010|COMPLETED|Part 4||3||
59907517|NCT03170544|76028584|FG011|COMPLETED|Part 4||6||
59907518|NCT03170544|76028573|FG000|NOT COMPLETED|Part 4||0||
59907519|NCT03170544|76028574|FG001|NOT COMPLETED|Part 4||0||
59907520|NCT03170544|76028575|FG002|NOT COMPLETED|Part 4||0||
59907521|NCT03170544|76028576|FG003|NOT COMPLETED|Part 4||0||
59907522|NCT03170544|76028577|FG004|NOT COMPLETED|Part 4||0||
59907523|NCT03170544|76028578|FG005|NOT COMPLETED|Part 4||0||
59907524|NCT03170544|76028579|FG006|NOT COMPLETED|Part 4||0||
59907525|NCT03170544|76028580|FG007|NOT COMPLETED|Part 4||0||
59907526|NCT03170544|76028581|FG008|NOT COMPLETED|Part 4||0||
59907527|NCT03170544|76028582|FG009|NOT COMPLETED|Part 4||0||
59907528|NCT03170544|76028583|FG010|NOT COMPLETED|Part 4||0||
59907529|NCT03170544|76028584|FG011|NOT COMPLETED|Part 4||0||
59907530|NCT03582943|76028669|FG000|STARTED|Allocated to Groups||42||
59907531|NCT03582943|76028670|FG001|STARTED|Allocated to Groups||40||
59907532|NCT03582943|76028669|FG000|COMPLETED|Allocated to Groups||41||
59907533|NCT03582943|76028670|FG001|COMPLETED|Allocated to Groups||39||
59907534|NCT03582943|76028669|FG000|NOT COMPLETED|Allocated to Groups||1||
59907535|NCT03582943|76028670|FG001|NOT COMPLETED|Allocated to Groups||1||
59907536|NCT03582943|76028669|FG000|STARTED|Intervention and Follow up||41||
59907537|NCT03582943|76028670|FG001|STARTED|Intervention and Follow up||39||
59907538|NCT03582943|76028669|FG000|COMPLETED|Intervention and Follow up||37||
59907539|NCT03582943|76028670|FG001|COMPLETED|Intervention and Follow up||37||
59907540|NCT03582943|76028669|FG000|NOT COMPLETED|Intervention and Follow up||4||
59907541|NCT03582943|76028670|FG001|NOT COMPLETED|Intervention and Follow up||2||
59907542|NCT03582943|76028669|FG000|STARTED|Analyzed||37||
59907543|NCT03582943|76028670|FG001|STARTED|Analyzed||37||
59907544|NCT03582943|76028669|FG000|COMPLETED|Analyzed||33||
59907545|NCT03582943|76028670|FG001|COMPLETED|Analyzed||36||
59907546|NCT03582943|76028669|FG000|NOT COMPLETED|Analyzed||4||
59907547|NCT03582943|76028670|FG001|NOT COMPLETED|Analyzed||1||
59907548|NCT03532009|76028678|FG000|STARTED|Overall Study||92||
59907549|NCT03532009|76028679|FG001|STARTED|Overall Study||90||
59907550|NCT03532009|76028678|FG000|Received Treatment|Overall Study||91||
59907551|NCT03532009|76028679|FG001|Received Treatment|Overall Study||90||
59907552|NCT03532009|76028678|FG000|COMPLETED|Overall Study||90||
59907553|NCT03532009|76028679|FG001|COMPLETED|Overall Study||86||
59907554|NCT03532009|76028678|FG000|NOT COMPLETED|Overall Study||2||
59907555|NCT03532009|76028679|FG001|NOT COMPLETED|Overall Study||4||
59907556|NCT03520387|76028690|FG000|STARTED|Pre-Randomization||16||
59907557|NCT03520387|76028691|FG001|STARTED|Pre-Randomization|Although participant flow is presented for each cell of the 2 x 2 contingency table in this factorial pilot trial, the primary analysis as originally planned focused on the main effects of (1) LRFA vs. simulated LRFA and (2) AcTIVE-CBT vs. TBSCE, unless there were indications of strong interactions between the two types of treatment. There are no participants in this group until the randomization period (until after the pre-randomization run-in period has ended).|0||
59907558|NCT03520387|76028692|FG002|STARTED|Pre-Randomization|Although participant flow is presented for each cell of the 2 x 2 contingency table in this factorial pilot trial, the primary analysis as originally planned focused on the main effects of (1) LRFA vs. simulated LRFA and (2) AcTIVE-CBT vs. TBSCE, unless there were indications of strong interactions between the two types of treatment. There are no participants in this group until the randomization period (until after the pre-randomization run-in period has ended).|0||
59907559|NCT03520387|76028693|FG003|STARTED|Pre-Randomization|Although participant flow is presented for each cell of the 2 x 2 contingency table in this factorial pilot trial, the primary analysis as originally planned focused on the main effects of (1) LRFA vs. simulated LRFA and (2) AcTIVE-CBT vs. TBSCE, unless there were indications of strong interactions between the two types of treatment. There are no participants in this group until the randomization period (until after the pre-randomization run-in period has ended).|0||
59951153|NCT04007367|76070076|FG002|NOT COMPLETED|Double-Blind Phase (14-Weeks)||2||
59951154|NCT03934710|76070089|FG000|STARTED|Overall Study||18||
59951155|NCT03934710|76070090|FG001|STARTED|Overall Study||19||
59951156|NCT03934710|76070091|FG002|STARTED|Overall Study||19||
59951157|NCT03934710|76070089|FG000|COMPLETED|Overall Study||18||
60015884|NCT01650285|76132129|FG000|COMPLETED|Overall Study||4||
59758423|NCT04300296|75877669|FG002|NOT COMPLETED|Treatment Period 1: Baseline to 16 Weeks||0||
59951158|NCT03934710|76070090|FG001|COMPLETED|Overall Study||19||
59951159|NCT03934710|76070091|FG002|COMPLETED|Overall Study||19||
59951160|NCT03934710|76070089|FG000|NOT COMPLETED|Overall Study||0||
59758424|NCT04300296|75877670|FG003|NOT COMPLETED|Treatment Period 1: Baseline to 16 Weeks||0||
59951161|NCT03934710|76070090|FG001|NOT COMPLETED|Overall Study||0||
59951162|NCT03934710|76070091|FG002|NOT COMPLETED|Overall Study||0||
59951163|NCT03900650|76070103|FG000|STARTED|Overall Study||74||
59951164|NCT03900650|76070104|FG001|STARTED|Overall Study||75||
59951165|NCT03900650|76070105|FG002|STARTED|Overall Study||74||
59951166|NCT03900650|76070106|FG003|STARTED|Overall Study||70||
59951167|NCT03900650|76070103|FG000|COMPLETED|Overall Study||72||
59951168|NCT03900650|76070104|FG001|COMPLETED|Overall Study||74||
59951169|NCT03900650|76070105|FG002|COMPLETED|Overall Study||74||
59951170|NCT03900650|76070106|FG003|COMPLETED|Overall Study||70||
59951171|NCT03900650|76070103|FG000|NOT COMPLETED|Overall Study||2||
59951172|NCT03900650|76070104|FG001|NOT COMPLETED|Overall Study||1||
59951173|NCT03900650|76070105|FG002|NOT COMPLETED|Overall Study||0||
59951174|NCT03900650|76070106|FG003|NOT COMPLETED|Overall Study||0||
59951175|NCT03890120|76070118|FG000|STARTED|Blinded Treatment Phase (100.3 Weeks)||278||
59951176|NCT03890120|76070119|FG001|STARTED|Blinded Treatment Phase (100.3 Weeks)||141||
59951177|NCT03890120|76070120|FG002|STARTED|Blinded Treatment Phase (100.3 Weeks)||0||
59951178|NCT03890120|76070121|FG003|STARTED|Blinded Treatment Phase (100.3 Weeks)||0||
59951179|NCT03890120|76070118|FG000|COMPLETED|Blinded Treatment Phase (100.3 Weeks)||123||
59951180|NCT03890120|76070119|FG001|COMPLETED|Blinded Treatment Phase (100.3 Weeks)||66||
59951181|NCT03890120|76070120|FG002|COMPLETED|Blinded Treatment Phase (100.3 Weeks)||0||
59951182|NCT03890120|76070121|FG003|COMPLETED|Blinded Treatment Phase (100.3 Weeks)||0||
59951183|NCT03890120|76070118|FG000|NOT COMPLETED|Blinded Treatment Phase (100.3 Weeks)||155||
59951184|NCT03890120|76070119|FG001|NOT COMPLETED|Blinded Treatment Phase (100.3 Weeks)||75||
59951185|NCT03890120|76070120|FG002|NOT COMPLETED|Blinded Treatment Phase (100.3 Weeks)||0||
59951186|NCT03890120|76070121|FG003|NOT COMPLETED|Blinded Treatment Phase (100.3 Weeks)||0||
60015885|NCT01650285|76132129|FG000|NOT COMPLETED|Overall Study||1||
59907560|NCT03520387|76028694|FG004|STARTED|Pre-Randomization|Although participant flow is presented for each cell of the 2 x 2 contingency table in this factorial pilot trial, the primary analysis as originally planned focused on the main effects of (1) LRFA vs. simulated LRFA and (2) AcTIVE-CBT vs. TBSCE, unless there were indications of strong interactions between the two types of treatment. There are no participants in this group until the randomization period (until after the pre-randomization run-in period has ended).|0||
59907561|NCT03520387|76028690|FG000|COMPLETED|Pre-Randomization||13||
59907562|NCT03520387|76028691|FG001|COMPLETED|Pre-Randomization||0||
59907563|NCT03520387|76028692|FG002|COMPLETED|Pre-Randomization||0||
59907564|NCT03520387|76028693|FG003|COMPLETED|Pre-Randomization||0||
59907565|NCT03520387|76028694|FG004|COMPLETED|Pre-Randomization||0||
59907566|NCT03520387|76028690|FG000|NOT COMPLETED|Pre-Randomization||3||
59907567|NCT03520387|76028691|FG001|NOT COMPLETED|Pre-Randomization||0||
59907568|NCT03520387|76028692|FG002|NOT COMPLETED|Pre-Randomization||0||
59907569|NCT03520387|76028693|FG003|NOT COMPLETED|Pre-Randomization||0||
59907570|NCT03520387|76028694|FG004|NOT COMPLETED|Pre-Randomization||0||
59907571|NCT03520387|76028690|FG000|STARTED|Randomized|There are no participants in this group during this period, because the pre-randomization run-in period has ended.|0||
59907572|NCT03520387|76028691|FG001|STARTED|Randomized|Although participant flow is presented for each cell of the 2 x 2 contingency table in this factorial pilot trial, the primary analysis as originally planned focused on the main effects of (1) LRFA vs. simulated LRFA and (2) AcTIVE-CBT vs. TBSCE, unless there were indications of strong interactions between the two types of treatment.|4||
59951264|NCT03672175|76070203|FG000|STARTED|Treatment Period (Days 1 to 14)||193||
59951265|NCT03672175|76070204|FG001|STARTED|Treatment Period (Days 1 to 14)||194||
59951266|NCT03672175|76070205|FG002|STARTED|Treatment Period (Days 1 to 14)||194||
59951267|NCT03672175|76070203|FG000|Safety Set|Treatment Period (Days 1 to 14)||190|Safety Set included all participants who were administered investigational product (IP) [SAGE-217 20 mg, SAGE-217 30 mg, or SAGE-217 matched placebo].|
59951268|NCT03672175|76070204|FG001|Safety Set|Treatment Period (Days 1 to 14)||188|Safety Set included all participants who were administered investigational product (IP) [SAGE-217 20 mg, SAGE-217 30 mg, or SAGE-217 matched placebo].|
59951269|NCT03672175|76070205|FG002|Safety Set|Treatment Period (Days 1 to 14)||192|Safety Set included all participants who were administered investigational product (IP) [SAGE-217 20 mg, SAGE-217 30 mg, or SAGE-217 matched placebo].|
59951270|NCT03672175|76070203|FG000|Modified Full Analysis Set (mFAS)|Treatment Period (Days 1 to 14)||157|mFAS included all randomized participants with valid baseline Hamilton Rating Scale for Depression (HAM-D) and at least 1 post-baseline HAM-D evaluation, with a total HAM-D score of at least 22 at baseline.|
59951271|NCT03672175|76070204|FG001|Modified Full Analysis Set (mFAS)|Treatment Period (Days 1 to 14)||159|mFAS included all randomized participants with valid baseline Hamilton Rating Scale for Depression (HAM-D) and at least 1 post-baseline HAM-D evaluation, with a total HAM-D score of at least 22 at baseline.|
59951272|NCT03672175|76070205|FG002|Modified Full Analysis Set (mFAS)|Treatment Period (Days 1 to 14)||166|mFAS included all randomized participants with valid baseline Hamilton Rating Scale for Depression (HAM-D) and at least 1 post-baseline HAM-D evaluation, with a total HAM-D score of at least 22 at baseline.|
59951273|NCT03672175|76070203|FG000|COMPLETED|Treatment Period (Days 1 to 14)||182||
59951274|NCT03672175|76070204|FG001|COMPLETED|Treatment Period (Days 1 to 14)||180||
59951275|NCT03672175|76070205|FG002|COMPLETED|Treatment Period (Days 1 to 14)||185||
59951276|NCT03672175|76070203|FG000|NOT COMPLETED|Treatment Period (Days 1 to 14)||11||
59951277|NCT03672175|76070204|FG001|NOT COMPLETED|Treatment Period (Days 1 to 14)||14||
59951278|NCT03672175|76070205|FG002|NOT COMPLETED|Treatment Period (Days 1 to 14)||9||
59951279|NCT03672175|76070203|FG000|STARTED|FU Period (Days 15 to 42)||182||
59951280|NCT03672175|76070204|FG001|STARTED|FU Period (Days 15 to 42)||180||
59951281|NCT03672175|76070205|FG002|STARTED|FU Period (Days 15 to 42)||185||
59951282|NCT03672175|76070203|FG000|COMPLETED|FU Period (Days 15 to 42)||178||
59951283|NCT03672175|76070204|FG001|COMPLETED|FU Period (Days 15 to 42)||170||
59951284|NCT03672175|76070205|FG002|COMPLETED|FU Period (Days 15 to 42)||178||
59951285|NCT03672175|76070203|FG000|NOT COMPLETED|FU Period (Days 15 to 42)||4||
59951286|NCT03672175|76070204|FG001|NOT COMPLETED|FU Period (Days 15 to 42)||10||
59951287|NCT03672175|76070205|FG002|NOT COMPLETED|FU Period (Days 15 to 42)||7||
59951288|NCT03672175|76070203|FG000|STARTED|Extended FU Period (Days 43 to 182)||178||
59951289|NCT03672175|76070204|FG001|STARTED|Extended FU Period (Days 43 to 182)||170||
59951290|NCT03672175|76070205|FG002|STARTED|Extended FU Period (Days 43 to 182)||178||
59951291|NCT03672175|76070203|FG000|Extended FU Safety Set|Extended FU Period (Days 43 to 182)||129|Extended FU Safety Set included all participants in the Safety Set of treatment period who consented or reconsented to participate in the study in the 6-month FU period.|
59951292|NCT03672175|76070204|FG001|Extended FU Safety Set|Extended FU Period (Days 43 to 182)||127|Extended FU Safety Set included all participants in the Safety Set of treatment period who consented or reconsented to participate in the study in the 6-month FU period.|
59951293|NCT03672175|76070205|FG002|Extended FU Safety Set|Extended FU Period (Days 43 to 182)||131|Extended FU Safety Set included all participants in the Safety Set of treatment period who consented or reconsented to participate in the study in the 6-month FU period.|
59951294|NCT03672175|76070203|FG000|COMPLETED|Extended FU Period (Days 43 to 182)||141||
59951295|NCT03672175|76070204|FG001|COMPLETED|Extended FU Period (Days 43 to 182)||131||
59951296|NCT03672175|76070205|FG002|COMPLETED|Extended FU Period (Days 43 to 182)||141||
59951297|NCT03672175|76070203|FG000|NOT COMPLETED|Extended FU Period (Days 43 to 182)||37||
59951298|NCT03672175|76070204|FG001|NOT COMPLETED|Extended FU Period (Days 43 to 182)||39||
59907573|NCT03520387|76028692|FG002|STARTED|Randomized|Although participant flow is presented for each cell of the 2 x 2 contingency table in this factorial pilot trial, the primary analysis as originally planned focused on the main effects of (1) LRFA vs. simulated LRFA and (2) AcTIVE-CBT vs. TBSCE, unless there were indications of strong interactions between the two types of treatment.|3||
59907574|NCT03520387|76028693|FG003|STARTED|Randomized|Although participant flow is presented for each cell of the 2 x 2 contingency table in this factorial pilot trial, the primary analysis as originally planned focused on the main effects of (1) LRFA vs. simulated LRFA and (2) AcTIVE-CBT vs. TBSCE, unless there were indications of strong interactions between the two types of treatment.|3||
59907575|NCT03520387|76028694|FG004|STARTED|Randomized|Although participant flow is presented for each cell of the 2 x 2 contingency table in this factorial pilot trial, the primary analysis as originally planned focused on the main effects of (1) LRFA vs. simulated LRFA and (2) AcTIVE-CBT vs. TBSCE, unless there were indications of strong interactions between the two types of treatment.|3||
59907576|NCT03520387|76028690|FG000|COMPLETED|Randomized||0||
59907577|NCT03520387|76028691|FG001|COMPLETED|Randomized||4||
59907578|NCT03520387|76028692|FG002|COMPLETED|Randomized||3||
59907579|NCT03520387|76028693|FG003|COMPLETED|Randomized||3||
59506231|NCT00766753|75599145|FG000|STARTED|Overall Study||11||
59506232|NCT00766753|75599146|FG001|STARTED|Overall Study||11||
59907580|NCT03520387|76028694|FG004|COMPLETED|Randomized||3||
59907581|NCT03520387|76028690|FG000|NOT COMPLETED|Randomized||0||
59907582|NCT03520387|76028691|FG001|NOT COMPLETED|Randomized||0||
59907583|NCT03520387|76028692|FG002|NOT COMPLETED|Randomized||0||
59907584|NCT03520387|76028693|FG003|NOT COMPLETED|Randomized||0||
59907585|NCT03520387|76028694|FG004|NOT COMPLETED|Randomized||0||
59907586|NCT03170232|76028707|FG000|STARTED|Overall Study||27||
59907587|NCT03170232|76028708|FG001|STARTED|Overall Study||27||
59907588|NCT03170232|76028707|FG000|COMPLETED|Overall Study||0||
59907589|NCT03170232|76028708|FG001|COMPLETED|Overall Study||0||
59907590|NCT03170232|76028707|FG000|NOT COMPLETED|Overall Study||27||
59907591|NCT03170232|76028708|FG001|NOT COMPLETED|Overall Study||27||
59907592|NCT03519919|76028714|FG000|STARTED|Overall Study||51||
59907593|NCT03519919|76028714|FG000|COMPLETED|Overall Study||48||
59907594|NCT03519919|76028714|FG000|NOT COMPLETED|Overall Study||3||
59907595|NCT03478969|76028747|FG000|STARTED|Overall Study||62|Full Analysis Set|
59907596|NCT03478969|76028748|FG001|STARTED|Overall Study||61|Full Analysis Set|
59907597|NCT03478969|76028749|FG002|STARTED|Overall Study||58|Full Analysis Set|
60015886|NCT02347527|76132137|FG000|STARTED|Overall Study||25||
59907598|NCT03478969|76028747|FG000|Participants at End of Parallel Phase|Overall Study||55|Week 26|
59907599|NCT03478969|76028748|FG001|Participants at End of Parallel Phase|Overall Study||58|Week 26|
59907600|NCT03478969|76028749|FG002|Participants at End of Parallel Phase|Overall Study||52|Week 26|
59907601|NCT03478969|76028747|FG000|COMPLETED|Overall Study||53|Week 39 (End of Solo Phase)|
59907602|NCT03478969|76028748|FG001|COMPLETED|Overall Study||49|Week 39 (End of Solo Phase)|
59907603|NCT03478969|76028749|FG002|COMPLETED|Overall Study||40|Week 39 (End of Solo Phase)|
59907604|NCT03478969|76028747|FG000|NOT COMPLETED|Overall Study||9||
59907605|NCT03478969|76028748|FG001|NOT COMPLETED|Overall Study||12||
59907606|NCT03478969|76028749|FG002|NOT COMPLETED|Overall Study||18||
59907607|NCT05242354|76028763|FG000|STARTED|Overall Study||10||
59907608|NCT05242354|76028764|FG001|STARTED|Overall Study||8||
59907609|NCT05242354|76028765|FG002|STARTED|Overall Study||9||
59907610|NCT05242354|76028766|FG003|STARTED|Overall Study||9||
59907611|NCT05242354|76028763|FG000|COMPLETED|Overall Study||10||
59907612|NCT05242354|76028764|FG001|COMPLETED|Overall Study||8||
59907613|NCT05242354|76028765|FG002|COMPLETED|Overall Study||9||
59907614|NCT05242354|76028766|FG003|COMPLETED|Overall Study||9||
59907615|NCT05242354|76028763|FG000|NOT COMPLETED|Overall Study||0||
59907616|NCT05242354|76028764|FG001|NOT COMPLETED|Overall Study||0||
59907617|NCT05242354|76028765|FG002|NOT COMPLETED|Overall Study||0||
59907618|NCT05242354|76028766|FG003|NOT COMPLETED|Overall Study||0||
59907619|NCT04823949|76028780|FG000|STARTED|Overall Study||101||
59907620|NCT04823949|76028781|FG001|STARTED|Overall Study||101||
59907621|NCT04823949|76028780|FG000|COMPLETED|Overall Study||101||
59907622|NCT04823949|76028781|FG001|COMPLETED|Overall Study||96||
59907623|NCT04823949|76028780|FG000|NOT COMPLETED|Overall Study||0||
59907624|NCT04823949|76028781|FG001|NOT COMPLETED|Overall Study||5||
59907625|NCT04517877|76028789|FG000|STARTED|Overall Study||82||
59907626|NCT04517877|76028790|FG001|STARTED|Overall Study||82||
59907627|NCT04517877|76028789|FG000|COMPLETED|Overall Study||63||
60015887|NCT02347527|76132138|FG001|STARTED|Overall Study||22||
60015888|NCT02347527|76132139|FG002|STARTED|Overall Study||23||
60015889|NCT02347527|76132140|FG003|STARTED|Overall Study||22||
60015890|NCT02347527|76132137|FG000|Completed Intervention|Overall Study||24||
60015891|NCT02347527|76132138|FG001|Completed Intervention|Overall Study||21||
60015892|NCT02347527|76132139|FG002|Completed Intervention|Overall Study||23||
60015893|NCT02347527|76132140|FG003|Completed Intervention|Overall Study||22||
60015894|NCT02347527|76132137|FG000|Included in Analyses|Overall Study||22||
60015895|NCT02347527|76132138|FG001|Included in Analyses|Overall Study||19||
59758425|NCT04300296|75877671|FG004|NOT COMPLETED|Treatment Period 1: Baseline to 16 Weeks||1||
59758426|NCT04300296|75877672|FG005|NOT COMPLETED|Treatment Period 1: Baseline to 16 Weeks||1||
59758427|NCT04300296|75877667|FG000|STARTED|Treatment Period 2: 16 to 32 Weeks||22||
59758428|NCT04300296|75877668|FG001|STARTED|Treatment Period 2: 16 to 32 Weeks||8||
59758429|NCT04300296|75877669|FG002|STARTED|Treatment Period 2: 16 to 32 Weeks||23||
59758430|NCT04300296|75877670|FG003|STARTED|Treatment Period 2: 16 to 32 Weeks||11||
59758431|NCT04300296|75877671|FG004|STARTED|Treatment Period 2: 16 to 32 Weeks||23||
59758432|NCT04300296|75877672|FG005|STARTED|Treatment Period 2: 16 to 32 Weeks||12||
59758433|NCT04300296|75877667|FG000|COMPLETED|Treatment Period 2: 16 to 32 Weeks||17||
59758434|NCT04300296|75877668|FG001|COMPLETED|Treatment Period 2: 16 to 32 Weeks||7||
59758435|NCT04300296|75877669|FG002|COMPLETED|Treatment Period 2: 16 to 32 Weeks||19||
59758436|NCT04300296|75877670|FG003|COMPLETED|Treatment Period 2: 16 to 32 Weeks||10||
59758437|NCT04300296|75877671|FG004|COMPLETED|Treatment Period 2: 16 to 32 Weeks||17||
59758438|NCT04300296|75877672|FG005|COMPLETED|Treatment Period 2: 16 to 32 Weeks||12||
59758439|NCT04300296|75877667|FG000|NOT COMPLETED|Treatment Period 2: 16 to 32 Weeks||5||
59758440|NCT04300296|75877668|FG001|NOT COMPLETED|Treatment Period 2: 16 to 32 Weeks||1||
59758441|NCT04300296|75877669|FG002|NOT COMPLETED|Treatment Period 2: 16 to 32 Weeks||4||
59758442|NCT04300296|75877670|FG003|NOT COMPLETED|Treatment Period 2: 16 to 32 Weeks||1||
59758443|NCT04300296|75877671|FG004|NOT COMPLETED|Treatment Period 2: 16 to 32 Weeks||6||
59758444|NCT04300296|75877672|FG005|NOT COMPLETED|Treatment Period 2: 16 to 32 Weeks||0||
59758445|NCT04144127|75877706|FG000|STARTED|Overall Study||3||
59758446|NCT04144127|75877706|FG000|COMPLETED|Overall Study||3||
59758447|NCT04144127|75877706|FG000|NOT COMPLETED|Overall Study||0||
59758448|NCT03989440|75877716|FG000|STARTED|Overall Study||6||
59758449|NCT03989440|75877717|FG001|STARTED|Overall Study||6||
60015896|NCT02347527|76132139|FG002|Included in Analyses|Overall Study||22||
59758450|NCT03989440|75877718|FG002|STARTED|Overall Study||6||
59907628|NCT04517877|76028790|FG001|COMPLETED|Overall Study||58||
59907629|NCT04517877|76028789|FG000|NOT COMPLETED|Overall Study||19||
59907630|NCT04517877|76028790|FG001|NOT COMPLETED|Overall Study||24||
59907631|NCT04499482|76028796|FG000|STARTED|Foods Containing 10 g Soy Flour||8||
60015897|NCT02347527|76132140|FG003|Included in Analyses|Overall Study||20||
60015898|NCT02347527|76132137|FG000|COMPLETED|Overall Study||22||
60015899|NCT02347527|76132138|FG001|COMPLETED|Overall Study||19||
60015900|NCT02347527|76132139|FG002|COMPLETED|Overall Study||22||
60015901|NCT02347527|76132140|FG003|COMPLETED|Overall Study||20||
60015902|NCT02347527|76132137|FG000|NOT COMPLETED|Overall Study||3||
59907632|NCT04499482|76028796|FG000|COMPLETED|Foods Containing 10 g Soy Flour||7||
60015903|NCT02347527|76132138|FG001|NOT COMPLETED|Overall Study||3||
59758451|NCT03989440|75877719|FG003|STARTED|Overall Study||7||
59758452|NCT03989440|75877720|FG004|STARTED|Overall Study||14||
59758453|NCT03989440|75877721|FG005|STARTED|Overall Study||13||
59758454|NCT03989440|75877716|FG000|COMPLETED|Overall Study||6||
59758455|NCT03989440|75877717|FG001|COMPLETED|Overall Study||6||
59758456|NCT03989440|75877718|FG002|COMPLETED|Overall Study||5||
59758457|NCT03989440|75877719|FG003|COMPLETED|Overall Study||6||
59758458|NCT03989440|75877720|FG004|COMPLETED|Overall Study||14||
59758459|NCT03989440|75877721|FG005|COMPLETED|Overall Study||13||
59758460|NCT03989440|75877716|FG000|NOT COMPLETED|Overall Study||0||
59758461|NCT03989440|75877717|FG001|NOT COMPLETED|Overall Study||0||
59907633|NCT04499482|76028796|FG000|NOT COMPLETED|Foods Containing 10 g Soy Flour||1||
59907634|NCT04499482|76028796|FG000|STARTED|Foods Containing 20 g Soy Flour||7||
59907635|NCT04499482|76028796|FG000|COMPLETED|Foods Containing 20 g Soy Flour||7||
59907636|NCT04499482|76028796|FG000|NOT COMPLETED|Foods Containing 20 g Soy Flour||0||
59907637|NCT04499482|76028796|FG000|STARTED|Foods Containing 30g Soy Flour||7||
59907638|NCT04499482|76028796|FG000|COMPLETED|Foods Containing 30g Soy Flour||7||
59907639|NCT04499482|76028796|FG000|NOT COMPLETED|Foods Containing 30g Soy Flour||0||
59907640|NCT04489303|76028808|FG000|STARTED|Overall Study||78||
59907641|NCT04489303|76028809|FG001|STARTED|Overall Study||78||
59907642|NCT04489303|76028808|FG000|COMPLETED|Overall Study||60||
59907643|NCT04489303|76028809|FG001|COMPLETED|Overall Study||55||
59907644|NCT04489303|76028808|FG000|NOT COMPLETED|Overall Study||18||
59907645|NCT04489303|76028809|FG001|NOT COMPLETED|Overall Study||23||
59907646|NCT04408794|76028815|FG000|STARTED|Overall Study||608|Participants in the enrolled analysis set who participated in the LTT phase, that is, non-missing interactive web response system baseline visit date.|
59907647|NCT04408794|76028815|FG000|Treated/Safety Analysis Set|Overall Study||603|Participants in the enrolled analysis set who took study drug, that is, non-missing study drug start date/time.|
59907648|NCT04408794|76028815|FG000|COMPLETED|Overall Study|Participants who received the study drug and completed the study.|341||
59907649|NCT04408794|76028815|FG000|NOT COMPLETED|Overall Study||267||
59907650|NCT04394754|76028823|FG000|STARTED|Overall Study||44||
59907651|NCT04394754|76028824|FG001|STARTED|Overall Study||46||
59907652|NCT04394754|76028825|FG002|STARTED|Overall Study||46||
59907653|NCT04394754|76028826|FG003|STARTED|Overall Study||46||
59907654|NCT04394754|76028823|FG000|COMPLETED|Overall Study||36||
59907655|NCT04394754|76028824|FG001|COMPLETED|Overall Study||39||
59907656|NCT04394754|76028825|FG002|COMPLETED|Overall Study||38||
59907657|NCT04394754|76028826|FG003|COMPLETED|Overall Study||38||
59907658|NCT04394754|76028823|FG000|NOT COMPLETED|Overall Study||8||
59907659|NCT04394754|76028824|FG001|NOT COMPLETED|Overall Study||7||
59907660|NCT04394754|76028825|FG002|NOT COMPLETED|Overall Study||8||
59907661|NCT04394754|76028826|FG003|NOT COMPLETED|Overall Study||8||
59907662|NCT04388176|76028841|FG000|STARTED|Overall Study||6||
59907663|NCT04388176|76028842|FG001|STARTED|Overall Study||6||
59907664|NCT04388176|76028841|FG000|COMPLETED|Overall Study||6||
59907665|NCT04388176|76028842|FG001|COMPLETED|Overall Study||6||
59907666|NCT04388176|76028841|FG000|NOT COMPLETED|Overall Study||0||
59907667|NCT04388176|76028842|FG001|NOT COMPLETED|Overall Study||0||
59907668|NCT04354168|76028848|FG000|STARTED|Overall Study||160||
59907669|NCT04354168|76028848|FG000|COMPLETED|Overall Study||138||
59907670|NCT04354168|76028848|FG000|NOT COMPLETED|Overall Study||22||
59907671|NCT04305405|76028854|FG000|STARTED|Overall Study||15||
59907672|NCT04305405|76028855|FG001|STARTED|Overall Study||15||
59907673|NCT04305405|76028854|FG000|COMPLETED|Overall Study||15||
59907674|NCT04305405|76028855|FG001|COMPLETED|Overall Study||14||
59907675|NCT04305405|76028854|FG000|NOT COMPLETED|Overall Study||0||
59907676|NCT04305405|76028855|FG001|NOT COMPLETED|Overall Study||1||
59907677|NCT04192370|76028866|FG000|STARTED|Overall Study||8||
59907678|NCT04192370|76028866|FG000|COMPLETED|Overall Study||5||
59907679|NCT04192370|76028866|FG000|NOT COMPLETED|Overall Study||3||
59907680|NCT03543410|76028873|FG000|STARTED|Overall Study||113||
59907681|NCT03543410|76028874|FG001|STARTED|Overall Study||114||
59907682|NCT03543410|76028875|FG002|STARTED|Overall Study||114||
59907683|NCT03543410|76028873|FG000|COMPLETED|Overall Study||92||
59907684|NCT03543410|76028874|FG001|COMPLETED|Overall Study||101||
59907685|NCT03543410|76028875|FG002|COMPLETED|Overall Study||99||
59907686|NCT03543410|76028873|FG000|NOT COMPLETED|Overall Study||21||
59907687|NCT03543410|76028874|FG001|NOT COMPLETED|Overall Study||13||
59907688|NCT03543410|76028875|FG002|NOT COMPLETED|Overall Study||15||
60015904|NCT02347527|76132139|FG002|NOT COMPLETED|Overall Study||1||
60015905|NCT02347527|76132140|FG003|NOT COMPLETED|Overall Study||2||
60015906|NCT02386839|76132154|FG000|STARTED|Overall Study||36||
60015907|NCT02386839|76132155|FG001|STARTED|Overall Study||40||
60015908|NCT02386839|76132154|FG000|COMPLETED|Overall Study||20||
60015909|NCT02386839|76132155|FG001|COMPLETED|Overall Study||25||
59907689|NCT02908074|76028889|FG000|STARTED|Overall Study||38||
59907690|NCT02908074|76028890|FG001|STARTED|Overall Study||33||
59758462|NCT03989440|75877718|FG002|NOT COMPLETED|Overall Study||1||
59907691|NCT02908074|76028891|FG002|STARTED|Overall Study||31||
59758463|NCT03989440|75877719|FG003|NOT COMPLETED|Overall Study||1||
59758464|NCT03989440|75877720|FG004|NOT COMPLETED|Overall Study||0||
59907692|NCT02908074|76028892|FG003|STARTED|Overall Study||13||
60015910|NCT02386839|76132154|FG000|NOT COMPLETED|Overall Study||16||
60015911|NCT02386839|76132155|FG001|NOT COMPLETED|Overall Study||15||
60015912|NCT01649271|76132167|FG000|STARTED|Overall Study||6||
60015913|NCT01649271|76132168|FG001|STARTED|Overall Study||7||
60015914|NCT01649271|76132167|FG000|COMPLETED|Overall Study||0||
60015915|NCT01649271|76132168|FG001|COMPLETED|Overall Study||0||
60015916|NCT01649271|76132167|FG000|NOT COMPLETED|Overall Study||6||
60015917|NCT01649271|76132168|FG001|NOT COMPLETED|Overall Study||7||
60015918|NCT02385669|76132175|FG000|STARTED|Overall Study||3||
59907693|NCT02908074|76028893|FG004|STARTED|Overall Study||17||
59907694|NCT02908074|76028894|FG005|STARTED|Overall Study||11||
59907695|NCT02908074|76028889|FG000|Received at Least 1 Dose of Study Drug|Overall Study||38||
59907696|NCT02908074|76028890|FG001|Received at Least 1 Dose of Study Drug|Overall Study||33||
60015919|NCT02385669|76132175|FG000|COMPLETED|Overall Study||1|Closed early due to slow enrollment.|
60015920|NCT02385669|76132175|FG000|NOT COMPLETED|Overall Study||2||
60015921|NCT02402907|76132181|FG000|STARTED|Overall Study||682||
60015922|NCT02402907|76132182|FG001|STARTED|Overall Study||674||
60015923|NCT02402907|76132181|FG000|COMPLETED|Overall Study||662||
60015924|NCT02402907|76132182|FG001|COMPLETED|Overall Study||647||
60015925|NCT02402907|76132181|FG000|NOT COMPLETED|Overall Study||20||
60015926|NCT02402907|76132182|FG001|NOT COMPLETED|Overall Study||27||
60015927|NCT02345889|76132192|FG000|STARTED|Overall Study||316||
60015928|NCT02345889|76132193|FG001|STARTED|Overall Study||316||
60015929|NCT02345889|76132194|FG002|STARTED|Overall Study||315||
60015930|NCT02345889|76132195|FG003|STARTED|Overall Study||315||
60015931|NCT02345889|76132192|FG000|COMPLETED|Overall Study||295||
60015932|NCT02345889|76132193|FG001|COMPLETED|Overall Study||299||
60015933|NCT02345889|76132194|FG002|COMPLETED|Overall Study||295||
59907697|NCT02908074|76028891|FG002|Received at Least 1 Dose of Study Drug|Overall Study||30||
59907698|NCT02908074|76028892|FG003|Received at Least 1 Dose of Study Drug|Overall Study||13||
59907699|NCT02908074|76028893|FG004|Received at Least 1 Dose of Study Drug|Overall Study||17||
60015934|NCT02345889|76132195|FG003|COMPLETED|Overall Study||299||
60015935|NCT02345889|76132192|FG000|NOT COMPLETED|Overall Study||21||
60015936|NCT02345889|76132193|FG001|NOT COMPLETED|Overall Study||17||
60015937|NCT02345889|76132194|FG002|NOT COMPLETED|Overall Study||20||
60015938|NCT02345889|76132195|FG003|NOT COMPLETED|Overall Study||16||
60015939|NCT02345811|76132205|FG000|STARTED|First Intervention||17||
60015940|NCT02345811|76132206|FG001|STARTED|First Intervention||17||
60015941|NCT02345811|76132205|FG000|COMPLETED|First Intervention||16||
60015942|NCT02345811|76132206|FG001|COMPLETED|First Intervention||16||
60015943|NCT02345811|76132205|FG000|NOT COMPLETED|First Intervention||1||
60015944|NCT02345811|76132206|FG001|NOT COMPLETED|First Intervention||1||
60015945|NCT02345811|76132205|FG000|STARTED|Second Intervention||16||
60015946|NCT02345811|76132206|FG001|STARTED|Second Intervention||16||
60015947|NCT02345811|76132205|FG000|COMPLETED|Second Intervention||16||
60015948|NCT02345811|76132206|FG001|COMPLETED|Second Intervention||16||
60015949|NCT02345811|76132205|FG000|NOT COMPLETED|Second Intervention||0||
60015950|NCT02345811|76132206|FG001|NOT COMPLETED|Second Intervention||0||
60015951|NCT02344173|76132214|FG000|STARTED|Enrollment||2035||
60015952|NCT02344173|76132214|FG000|COMPLETED|Enrollment||2035||
60015953|NCT02344173|76132214|FG000|NOT COMPLETED|Enrollment||0||
60015954|NCT02344173|76132214|FG000|STARTED|Procedure||2035||
60015955|NCT02344173|76132214|FG000|COMPLETED|Procedure||2028|Ablation procedure performed.|
60015956|NCT02344173|76132214|FG000|NOT COMPLETED|Procedure||7||
60015957|NCT02344173|76132214|FG000|STARTED|12-month Visit||2028||
60015958|NCT02344173|76132214|FG000|COMPLETED|12-month Visit||1932||
60015959|NCT02344173|76132214|FG000|NOT COMPLETED|12-month Visit||96||
60015960|NCT02586493|76132220|FG000|STARTED|Overall Study||278||
60015961|NCT02586493|76132220|FG000|COMPLETED|Overall Study||266||
60015962|NCT02586493|76132220|FG000|NOT COMPLETED|Overall Study||12||
60015963|NCT02400333|76132228|FG000|STARTED|Overall Study||9||
60015964|NCT02400333|76132229|FG001|STARTED|Overall Study||9||
60015965|NCT02400333|76132230|FG002|STARTED|Overall Study||9||
60015966|NCT02400333|76132231|FG003|STARTED|Overall Study||9||
60015967|NCT02400333|76132228|FG000|COMPLETED|Overall Study||8||
60015968|NCT02400333|76132229|FG001|COMPLETED|Overall Study||8||
60015969|NCT02400333|76132230|FG002|COMPLETED|Overall Study||7||
60015970|NCT02400333|76132231|FG003|COMPLETED|Overall Study||7||
60015971|NCT02400333|76132228|FG000|NOT COMPLETED|Overall Study||1||
60015972|NCT02400333|76132229|FG001|NOT COMPLETED|Overall Study||1||
60015973|NCT02400333|76132230|FG002|NOT COMPLETED|Overall Study||2||
59907700|NCT02908074|76028894|FG005|Received at Least 1 Dose of Study Drug|Overall Study||10||
60015974|NCT02400333|76132231|FG003|NOT COMPLETED|Overall Study||2||
60015975|NCT02399475|76132244|FG000|STARTED|Overall Study||7||
60015976|NCT02399475|76132245|FG001|STARTED|Overall Study||7||
59907701|NCT02908074|76028889|FG000|Safety Population|Overall Study||38||
59907702|NCT02908074|76028890|FG001|Safety Population|Overall Study||33||
59907703|NCT02908074|76028891|FG002|Safety Population|Overall Study||30||
59907704|NCT02908074|76028892|FG003|Safety Population|Overall Study||13||
60015977|NCT02399475|76132244|FG000|COMPLETED|Overall Study||6||
60015978|NCT02399475|76132245|FG001|COMPLETED|Overall Study||7||
60015979|NCT02399475|76132244|FG000|NOT COMPLETED|Overall Study||1||
59518992|NCT03587428|75612871|FG001|NOT COMPLETED|Period 1||0||
59611438|NCT01778556|75722408|FG001|STARTED|Long-term Follow-up|no long-term follow-up period in on-leptin arm|0||
59611439|NCT01778556|75722407|FG000|COMPLETED|Long-term Follow-up||14||
59611440|NCT01778556|75722408|FG001|COMPLETED|Long-term Follow-up|no long-term follow-up period in on-leptin arm|0||
59611441|NCT01778556|75722407|FG000|NOT COMPLETED|Long-term Follow-up||1||
59611442|NCT01778556|75722408|FG001|NOT COMPLETED|Long-term Follow-up||0||
59611443|NCT01761162|75722417|FG000|STARTED|Overall Study||229||
59611444|NCT01761162|75722417|FG000|COMPLETED|Overall Study||226||
59611445|NCT01761162|75722417|FG000|NOT COMPLETED|Overall Study||3||
59611446|NCT01778010|75722421|FG000|STARTED|Overall Study||13||
59611447|NCT01778010|75722421|FG000|COMPLETED|Overall Study||8||
59611448|NCT01778010|75722421|FG000|NOT COMPLETED|Overall Study||5||
59611449|NCT01777932|75722438|FG000|STARTED|Overall Study||220||
59611450|NCT01777932|75722438|FG000|COMPLETED|Overall Study||15||
59611451|NCT01777932|75722438|FG000|NOT COMPLETED|Overall Study||205||
59611452|NCT01777854|75722442|FG000|STARTED|Overall Study||3|Study was terminated before patients had intervention.|
59611453|NCT01777854|75722443|FG001|STARTED|Overall Study||3|Study was terminated before patients had intervention.|
59611454|NCT01777854|75722442|FG000|COMPLETED|Overall Study||0||
59758465|NCT03989440|75877721|FG005|NOT COMPLETED|Overall Study||0||
59907705|NCT02908074|76028893|FG004|Safety Population|Overall Study||17||
59907706|NCT02908074|76028894|FG005|Safety Population|Overall Study||10||
59907707|NCT02908074|76028889|FG000|Intention-to-treat (ITT) Population|Overall Study||38||
59907708|NCT02908074|76028890|FG001|Intention-to-treat (ITT) Population|Overall Study||33||
59907709|NCT02908074|76028891|FG002|Intention-to-treat (ITT) Population|Overall Study||30||
59907710|NCT02908074|76028892|FG003|Intention-to-treat (ITT) Population|Overall Study||0||
59907711|NCT02908074|76028893|FG004|Intention-to-treat (ITT) Population|Overall Study||0||
59907712|NCT02908074|76028894|FG005|Intention-to-treat (ITT) Population|Overall Study||0||
59907713|NCT02908074|76028889|FG000|COMPLETED|Overall Study||29||
59907714|NCT02908074|76028890|FG001|COMPLETED|Overall Study||27||
59907715|NCT02908074|76028891|FG002|COMPLETED|Overall Study||25||
59907716|NCT02908074|76028892|FG003|COMPLETED|Overall Study||10||
59907717|NCT02908074|76028893|FG004|COMPLETED|Overall Study||13||
59907718|NCT02908074|76028894|FG005|COMPLETED|Overall Study||7||
59907719|NCT02908074|76028889|FG000|NOT COMPLETED|Overall Study||9||
59907720|NCT02908074|76028890|FG001|NOT COMPLETED|Overall Study||6||
59907721|NCT02908074|76028891|FG002|NOT COMPLETED|Overall Study||6||
59907722|NCT02908074|76028892|FG003|NOT COMPLETED|Overall Study||3||
59907723|NCT02908074|76028893|FG004|NOT COMPLETED|Overall Study||4||
59907724|NCT02908074|76028894|FG005|NOT COMPLETED|Overall Study||4||
59907725|NCT02907359|76028913|FG000|STARTED|Overall Study||277|The Efficacy Analysis Set included all participants randomly assigned to the study treatment.|
59907726|NCT02907359|76028914|FG001|STARTED|Overall Study||140|The Efficacy Analysis Set included all participants randomly assigned to the study treatment.|
59907727|NCT02907359|76028913|FG000|Safety Analysis Set|Overall Study||270|The Safety Analysis Set included all participants randomly assigned to study treatment who received any amount of study treatment or any component of a multi-dose study treatment regimen.|
59907728|NCT02907359|76028914|FG001|Safety Analysis Set|Overall Study||122|The Safety Analysis Set included all participants randomly assigned to study treatment who received any amount of study treatment or any component of a multi-dose study treatment regimen.|
59907729|NCT02907359|76028913|FG000|COMPLETED|Overall Study||36||
59907730|NCT02907359|76028914|FG001|COMPLETED|Overall Study||12||
59907731|NCT02907359|76028913|FG000|NOT COMPLETED|Overall Study||241||
59907732|NCT02907359|76028914|FG001|NOT COMPLETED|Overall Study||128||
59907733|NCT02714205|76028922|FG000|STARTED|Overall Study||70||
59907734|NCT02714205|76028923|FG001|STARTED|Overall Study||71||
59907735|NCT02714205|76028922|FG000|COMPLETED|Overall Study||66||
59907736|NCT02714205|76028923|FG001|COMPLETED|Overall Study||70||
59907737|NCT02714205|76028922|FG000|NOT COMPLETED|Overall Study||4||
59907738|NCT02714205|76028923|FG001|NOT COMPLETED|Overall Study||1||
59907739|NCT02611206|76028932|FG000|STARTED|Overall Study||7||
59907740|NCT02611206|76028933|FG001|STARTED|Overall Study||3||
59907741|NCT02611206|76028934|FG002|STARTED|Overall Study||14||
59907742|NCT02611206|76028932|FG000|COMPLETED|Overall Study||3||
59907743|NCT02611206|76028933|FG001|COMPLETED|Overall Study||3||
59907744|NCT02611206|76028934|FG002|COMPLETED|Overall Study||8||
59907745|NCT02611206|76028932|FG000|NOT COMPLETED|Overall Study||4||
59907746|NCT02611206|76028933|FG001|NOT COMPLETED|Overall Study||0||
59518993|NCT03587428|75612872|FG002|NOT COMPLETED|Period 1||0||
59518994|NCT03587428|75612873|FG003|NOT COMPLETED|Period 1||0||
59518995|NCT03587428|75612874|FG004|NOT COMPLETED|Period 1||0||
59518996|NCT03587428|75612875|FG005|NOT COMPLETED|Period 1||0||
59518997|NCT03587428|75612870|FG000|STARTED|Period 2||3||
59518998|NCT03587428|75612871|FG001|STARTED|Period 2||2||
59518999|NCT03587428|75612872|FG002|STARTED|Period 2||3||
59519000|NCT03587428|75612873|FG003|STARTED|Period 2||3||
59519001|NCT03587428|75612874|FG004|STARTED|Period 2||2||
59519002|NCT03587428|75612875|FG005|STARTED|Period 2||2||
59519003|NCT03587428|75612870|FG000|COMPLETED|Period 2||3||
59519004|NCT03587428|75612871|FG001|COMPLETED|Period 2||2||
59519005|NCT03587428|75612872|FG002|COMPLETED|Period 2||3||
59519006|NCT03587428|75612873|FG003|COMPLETED|Period 2||3||
59519007|NCT03587428|75612874|FG004|COMPLETED|Period 2||2||
59907747|NCT02611206|76028934|FG002|NOT COMPLETED|Overall Study||6||
59907748|NCT02477124|76028941|FG000|STARTED|Overall Study||514||
59907749|NCT02477124|76028941|FG000|COMPLETED|Overall Study||514||
59907750|NCT02477124|76028941|FG000|NOT COMPLETED|Overall Study||0||
59907751|NCT00583752|76028947|FG000|STARTED|Overall Study||25||
59907752|NCT00583752|76028948|FG001|STARTED|Overall Study||25||
59907753|NCT00583752|76028947|FG000|COMPLETED|Overall Study||20||
59907754|NCT00583752|76028948|FG001|COMPLETED|Overall Study||20||
59907755|NCT00583752|76028947|FG000|NOT COMPLETED|Overall Study||5||
59907756|NCT00583752|76028948|FG001|NOT COMPLETED|Overall Study||5||
59907757|NCT02263014|76028957|FG000|STARTED|Overall Study||44||
59907758|NCT02263014|76028958|FG001|STARTED|Overall Study||208||
59907759|NCT02263014|76028957|FG000|COMPLETED|Overall Study||44||
59907760|NCT02263014|76028958|FG001|COMPLETED|Overall Study||208||
59907761|NCT02263014|76028957|FG000|NOT COMPLETED|Overall Study||0||
59907762|NCT02263014|76028958|FG001|NOT COMPLETED|Overall Study||0||
59907763|NCT03170154|76028966|FG000|STARTED|Overall Study||350||
59907764|NCT03170154|76028966|FG000|Rotational Stability Sub-study|Overall Study||141||
59907765|NCT03170154|76028966|FG000|COMPLETED|Overall Study||342||
59907766|NCT03170154|76028966|FG000|NOT COMPLETED|Overall Study||8||
59907767|NCT03518125|76028981|FG000|STARTED|Overall Study||50||
59907768|NCT03518125|76028982|FG001|STARTED|Overall Study||50||
59907769|NCT03518125|76028983|FG002|STARTED|Overall Study||49||
59907770|NCT03518125|76028984|FG003|STARTED|Overall Study||52||
59907771|NCT03518125|76028985|FG004|STARTED|Overall Study||52||
59907772|NCT03518125|76028986|FG005|STARTED|Overall Study||52||
59907773|NCT03518125|76028981|FG000|COMPLETED|Overall Study||48||
59907774|NCT03518125|76028982|FG001|COMPLETED|Overall Study||46||
59907775|NCT03518125|76028983|FG002|COMPLETED|Overall Study||49||
59907776|NCT03518125|76028984|FG003|COMPLETED|Overall Study||51||
59907777|NCT03518125|76028985|FG004|COMPLETED|Overall Study||48||
59907778|NCT03518125|76028986|FG005|COMPLETED|Overall Study||44||
59907779|NCT03518125|76028981|FG000|NOT COMPLETED|Overall Study||2||
59907780|NCT03518125|76028982|FG001|NOT COMPLETED|Overall Study||4||
59907781|NCT03518125|76028983|FG002|NOT COMPLETED|Overall Study||0||
59907782|NCT03518125|76028984|FG003|NOT COMPLETED|Overall Study||1||
59907783|NCT03518125|76028985|FG004|NOT COMPLETED|Overall Study||4||
59907784|NCT03518125|76028986|FG005|NOT COMPLETED|Overall Study||8||
59907785|NCT03169530|76029003|FG000|STARTED|Overall Study||15||
59907786|NCT03169530|76029004|FG001|STARTED|Overall Study||17||
59907787|NCT03169530|76029003|FG000|COMPLETED|Overall Study||0||
59907788|NCT03169530|76029004|FG001|COMPLETED|Overall Study||0||
59907789|NCT03169530|76029003|FG000|NOT COMPLETED|Overall Study||15||
59907790|NCT03169530|76029004|FG001|NOT COMPLETED|Overall Study||17||
59907791|NCT02513238|76029012|FG000|STARTED|Overall Study||15||
59907792|NCT02513238|76029013|FG001|STARTED|Overall Study||15||
59907793|NCT02513238|76029012|FG000|COMPLETED|Overall Study||15||
59907794|NCT02513238|76029013|FG001|COMPLETED|Overall Study||15||
60015980|NCT02399475|76132245|FG001|NOT COMPLETED|Overall Study||0||
60015981|NCT02399163|76132251|FG000|STARTED|Overall Study||62||
60015982|NCT02399163|76132251|FG000|COMPLETED|Overall Study||53||
60015983|NCT02399163|76132251|FG000|NOT COMPLETED|Overall Study||9||
60015984|NCT02398227|76132265|FG000|STARTED|Overall Study||83||
60015985|NCT02398227|76132266|FG001|STARTED|Overall Study||89||
60015986|NCT02398227|76132265|FG000|COMPLETED|Overall Study||56||
60015987|NCT02398227|76132266|FG001|COMPLETED|Overall Study||71||
60015988|NCT02398227|76132265|FG000|NOT COMPLETED|Overall Study||27||
60015989|NCT02398227|76132266|FG001|NOT COMPLETED|Overall Study||18||
60015990|NCT02397915|76132272|FG000|STARTED|Period 1||150||
60015991|NCT02397915|76132273|FG001|STARTED|Period 1||150||
59907795|NCT02513238|76029012|FG000|NOT COMPLETED|Overall Study||0||
59907796|NCT02513238|76029013|FG001|NOT COMPLETED|Overall Study||0||
59907797|NCT03478891|76029022|FG000|STARTED|Overall Study||3||
59907798|NCT03478891|76029023|FG001|STARTED|Overall Study||5||
59907799|NCT03478891|76029024|FG002|STARTED|Overall Study||11||
59907800|NCT03478891|76029022|FG000|Received MAb114|Overall Study||3||
59907801|NCT03478891|76029023|FG001|Received MAb114|Overall Study||5||
59907802|NCT03478891|76029024|FG002|Received MAb114|Overall Study|One Group 3 subject discontinued prior to MAb114 infusion due to inadequate venous access|10||
59907803|NCT03478891|76029022|FG000|COMPLETED|Overall Study||2||
59907804|NCT03478891|76029023|FG001|COMPLETED|Overall Study||5||
59907805|NCT03478891|76029024|FG002|COMPLETED|Overall Study||8||
59907806|NCT03478891|76029022|FG000|NOT COMPLETED|Overall Study||1||
59907807|NCT03478891|76029023|FG001|NOT COMPLETED|Overall Study||0||
60015992|NCT02397915|76132274|FG002|STARTED|Period 1||0||
60015993|NCT02397915|76132275|FG003|STARTED|Period 1||0||
59907808|NCT03478891|76029024|FG002|NOT COMPLETED|Overall Study||3||
59907809|NCT01585103|76029036|FG000|STARTED|Overall Study||86||
59907810|NCT01585103|76029036|FG000|COMPLETED|Overall Study||80||
59907811|NCT01585103|76029036|FG000|NOT COMPLETED|Overall Study||6||
59907812|NCT03168906|76029042|FG000|STARTED|Overall Study||6||
59907813|NCT03168906|76029043|FG001|STARTED|Overall Study||6||
59907814|NCT03168906|76029042|FG000|COMPLETED|Overall Study|Study discontinued due to futile nature of drug|0||
59907815|NCT03168906|76029043|FG001|COMPLETED|Overall Study|Study discontinued due to futile nature of drug|0||
59907816|NCT03168906|76029042|FG000|NOT COMPLETED|Overall Study||6||
59907817|NCT03168906|76029043|FG001|NOT COMPLETED|Overall Study||6||
59907818|NCT00706966|76029050|FG000|STARTED|Overall Study||10||
59907819|NCT00706966|76029050|FG000|COMPLETED|Overall Study||9||
59907820|NCT00706966|76029050|FG000|NOT COMPLETED|Overall Study||1||
59907821|NCT03478657|76029084|FG000|STARTED|Overall Study||88||
59907822|NCT03478657|76029085|FG001|STARTED|Overall Study||134||
59907823|NCT03478657|76029084|FG000|COMPLETED|Overall Study||88||
59907824|NCT03478657|76029085|FG001|COMPLETED|Overall Study||133||
59907825|NCT03478657|76029084|FG000|NOT COMPLETED|Overall Study||0||
59907826|NCT03478657|76029085|FG001|NOT COMPLETED|Overall Study||1||
59907827|NCT03515941|76029093|FG000|STARTED|Overall Study||4||
59907828|NCT03515941|76029094|FG001|STARTED|Overall Study||2||
59907829|NCT03515941|76029093|FG000|COMPLETED|Overall Study||3||
59907830|NCT03515941|76029094|FG001|COMPLETED|Overall Study||2||
59907831|NCT03515941|76029093|FG000|NOT COMPLETED|Overall Study||1||
59907832|NCT03515941|76029094|FG001|NOT COMPLETED|Overall Study||0||
59907833|NCT03011034|76029102|FG000|STARTED|Overall Study||1||
59907834|NCT03011034|76029103|FG001|STARTED|Overall Study||33||
59907835|NCT03011034|76029102|FG000|COMPLETED|Overall Study||0||
59907836|NCT03011034|76029103|FG001|COMPLETED|Overall Study||33||
59907837|NCT03011034|76029102|FG000|NOT COMPLETED|Overall Study||1||
59907838|NCT03011034|76029103|FG001|NOT COMPLETED|Overall Study||0||
59907839|NCT03515629|76029111|FG000|STARTED|Overall Study||0||
59907840|NCT03515629|76029112|FG001|STARTED|Overall Study||3||
59907841|NCT03515629|76029113|FG002|STARTED|Overall Study||2||
59907842|NCT03515629|76029111|FG000|COMPLETED|Overall Study||0|Completed study|
59907843|NCT03515629|76029112|FG001|COMPLETED|Overall Study||1|Completed study|
59907844|NCT03515629|76029113|FG002|COMPLETED|Overall Study||1|Completed study|
59907845|NCT03515629|76029111|FG000|NOT COMPLETED|Overall Study||0||
59907846|NCT03515629|76029112|FG001|NOT COMPLETED|Overall Study||2||
59907847|NCT03515629|76029113|FG002|NOT COMPLETED|Overall Study||1||
59907848|NCT03512353|76029122|FG000|STARTED|Overall Study||7||
59907849|NCT03512353|76029122|FG000|Received Treatment|Overall Study||6||
59907850|NCT03512353|76029122|FG000|COMPLETED|Overall Study||3|Study completion is defined as participants who received 12 cycles of treatment and completed the safety follow-up visit.|
59907851|NCT03512353|76029122|FG000|NOT COMPLETED|Overall Study||4||
59907852|NCT03512275|76029130|FG000|STARTED|Overall Study||24||
59907853|NCT03512275|76029131|FG001|STARTED|Overall Study||18||
59907854|NCT03512275|76029130|FG000|COMPLETED|Overall Study||22||
59907855|NCT03512275|76029131|FG001|COMPLETED|Overall Study||11||
59907856|NCT03512275|76029130|FG000|NOT COMPLETED|Overall Study||2||
59907857|NCT03512275|76029131|FG001|NOT COMPLETED|Overall Study||7||
59907858|NCT03473197|76029137|FG000|STARTED|Overall Study||61||255
59907859|NCT03473197|76029137|FG000|Diacerein 1% Ointment Irradiated|Overall Study||51||51
59907860|NCT03473197|76029137|FG000|Vehicle Ointment Irradiated|Overall Study||51||51
59907861|NCT03473197|76029137|FG000|Diacerein 1% Ointment Non-irradiated|Overall Study||51||51
59907862|NCT03473197|76029137|FG000|Vehicle Ointment Non-irradiated|Overall Study||51||51
59907863|NCT03473197|76029137|FG000|Untreated Irradiated|Overall Study||51||51
59907864|NCT03473197|76029137|FG000|COMPLETED|Overall Study||51||255
59907865|NCT03473197|76029137|FG000|NOT COMPLETED|Overall Study||10||0
59907866|NCT03511105|76029143|FG000|STARTED|Overall Study||25||
59907867|NCT03511105|76029144|FG001|STARTED|Overall Study||22||
59907868|NCT03511105|76029143|FG000|COMPLETED|Overall Study||23||
59907869|NCT03511105|76029144|FG001|COMPLETED|Overall Study||22||
59907870|NCT03511105|76029143|FG000|NOT COMPLETED|Overall Study||2||
59907871|NCT03511105|76029144|FG001|NOT COMPLETED|Overall Study||0||
59907872|NCT03342742|76029153|FG000|STARTED|Overall Study||15||
59907873|NCT03342742|76029154|FG001|STARTED|Overall Study||13||
59907874|NCT03342742|76029153|FG000|COMPLETED|Overall Study||13||
59907875|NCT03342742|76029154|FG001|COMPLETED|Overall Study||11||
59907876|NCT03342742|76029153|FG000|NOT COMPLETED|Overall Study||2||
59907877|NCT03342742|76029154|FG001|NOT COMPLETED|Overall Study||2||
59907878|NCT03510715|76029164|FG000|STARTED|Overall Study||9||
59907879|NCT03510715|76029165|FG001|STARTED|Overall Study||9||
59907880|NCT03510715|76029164|FG000|COMPLETED|Overall Study||8||
59907881|NCT03510715|76029165|FG001|COMPLETED|Overall Study||9||
59907882|NCT03510715|76029164|FG000|NOT COMPLETED|Overall Study||1||
59907883|NCT03510715|76029165|FG001|NOT COMPLETED|Overall Study||0||
59907884|NCT03508843|76029172|FG000|STARTED|Overall Study||150||
59907885|NCT03508843|76029172|FG000|COMPLETED|Overall Study||147||
59907886|NCT03508843|76029172|FG000|NOT COMPLETED|Overall Study||3||
59907887|NCT03508609|76029176|FG000|STARTED|Overall Study||20||
59907888|NCT03508609|76029176|FG000|COMPLETED|Overall Study||19||
59907889|NCT03508609|76029176|FG000|NOT COMPLETED|Overall Study||1||
59907890|NCT03054350|76029186|FG000|STARTED|Primary Efficacy Period (6 Weeks)||15||
59907891|NCT03054350|76029187|FG001|STARTED|Primary Efficacy Period (6 Weeks)||15||
59907892|NCT03054350|76029188|FG002|STARTED|Primary Efficacy Period (6 Weeks)||15||
59907893|NCT03054350|76029189|FG003|STARTED|Primary Efficacy Period (6 Weeks)||5||
59907894|NCT03054350|76029190|FG004|STARTED|Primary Efficacy Period (6 Weeks)||5||
59907895|NCT03054350|76029191|FG005|STARTED|Primary Efficacy Period (6 Weeks)||5||
59907896|NCT03054350|76029186|FG000|COMPLETED|Primary Efficacy Period (6 Weeks)||11||
59907897|NCT03054350|76029187|FG001|COMPLETED|Primary Efficacy Period (6 Weeks)||13||
59907898|NCT03054350|76029188|FG002|COMPLETED|Primary Efficacy Period (6 Weeks)||13||
59907899|NCT03054350|76029189|FG003|COMPLETED|Primary Efficacy Period (6 Weeks)||3||
59907900|NCT03054350|76029190|FG004|COMPLETED|Primary Efficacy Period (6 Weeks)||1||
59907901|NCT03054350|76029191|FG005|COMPLETED|Primary Efficacy Period (6 Weeks)||2||
59907902|NCT03054350|76029186|FG000|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||4||
59907903|NCT03054350|76029187|FG001|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||2||
59907904|NCT03054350|76029188|FG002|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||2||
59907905|NCT03054350|76029189|FG003|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||2||
59907906|NCT03054350|76029190|FG004|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||4||
59907907|NCT03054350|76029191|FG005|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||3||
59506233|NCT00766753|75599145|FG000|Received at Least One Vaccine|Overall Study||11||
59907908|NCT03054350|76029186|FG000|STARTED|Dose Adjustment and Maintenance Period||11||
59907909|NCT03054350|76029187|FG001|STARTED|Dose Adjustment and Maintenance Period||13||
59907910|NCT03054350|76029188|FG002|STARTED|Dose Adjustment and Maintenance Period||13||
59907911|NCT03054350|76029189|FG003|STARTED|Dose Adjustment and Maintenance Period||3||
59907912|NCT03054350|76029190|FG004|STARTED|Dose Adjustment and Maintenance Period||1||
59907913|NCT03054350|76029191|FG005|STARTED|Dose Adjustment and Maintenance Period||2||
59907914|NCT03054350|76029186|FG000|COMPLETED|Dose Adjustment and Maintenance Period||10||
59506234|NCT00766753|75599146|FG001|Received at Least One Vaccine|Overall Study||11||
59907915|NCT03054350|76029187|FG001|COMPLETED|Dose Adjustment and Maintenance Period||13||
59907916|NCT03054350|76029188|FG002|COMPLETED|Dose Adjustment and Maintenance Period||12||
59907917|NCT03054350|76029189|FG003|COMPLETED|Dose Adjustment and Maintenance Period||2||
59907918|NCT03054350|76029190|FG004|COMPLETED|Dose Adjustment and Maintenance Period||1||
59907919|NCT03054350|76029191|FG005|COMPLETED|Dose Adjustment and Maintenance Period||2||
59907920|NCT03054350|76029186|FG000|NOT COMPLETED|Dose Adjustment and Maintenance Period||1||
59907921|NCT03054350|76029187|FG001|NOT COMPLETED|Dose Adjustment and Maintenance Period||0||
59907922|NCT03054350|76029188|FG002|NOT COMPLETED|Dose Adjustment and Maintenance Period||1||
59907923|NCT03054350|76029189|FG003|NOT COMPLETED|Dose Adjustment and Maintenance Period||1||
59907924|NCT03054350|76029190|FG004|NOT COMPLETED|Dose Adjustment and Maintenance Period||0||
59907925|NCT03054350|76029191|FG005|NOT COMPLETED|Dose Adjustment and Maintenance Period||0||
59907926|NCT03528577|76029222|FG000|STARTED|Sequence 1||128|128 subjects with persistent bronchial asthma were randomized during the study.|
59907927|NCT03528577|76029222|FG000|COMPLETED|Sequence 1|Per report, 119 completed the trial, and all 119 received Treatment A, B, C and D.|126||
59907928|NCT03528577|76029222|FG000|NOT COMPLETED|Sequence 1||2||
59907929|NCT03528577|76029222|FG000|STARTED|Sequence 2||128||
59907930|NCT03528577|76029222|FG000|COMPLETED|Sequence 2||125||
59907931|NCT03528577|76029222|FG000|NOT COMPLETED|Sequence 2||3||
59907932|NCT03528577|76029222|FG000|STARTED|Sequence 3||128||
59907933|NCT03528577|76029222|FG000|COMPLETED|Sequence 3||127||
59907934|NCT03528577|76029222|FG000|NOT COMPLETED|Sequence 3||1||
59907935|NCT03528577|76029222|FG000|STARTED|Sequence 4||128||
59907936|NCT03528577|76029222|FG000|COMPLETED|Sequence 4||125||
59907937|NCT03528577|76029222|FG000|NOT COMPLETED|Sequence 4||3||
59907938|NCT00706654|76029232|FG000|STARTED|Conversion Phase||709||
59907939|NCT00706654|76029233|FG001|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0||
59907940|NCT00706654|76029234|FG002|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0||
59907941|NCT00706654|76029235|FG003|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0||
59907942|NCT00706654|76029232|FG000|COMPLETED|Conversion Phase||614||
59907943|NCT00706654|76029233|FG001|COMPLETED|Conversion Phase||0||
59907944|NCT00706654|76029234|FG002|COMPLETED|Conversion Phase||0||
59907945|NCT00706654|76029235|FG003|COMPLETED|Conversion Phase||0||
59907946|NCT00706654|76029232|FG000|NOT COMPLETED|Conversion Phase||95||
59907947|NCT00706654|76029233|FG001|NOT COMPLETED|Conversion Phase||0||
59907948|NCT00706654|76029234|FG002|NOT COMPLETED|Conversion Phase||0||
59907949|NCT00706654|76029235|FG003|NOT COMPLETED|Conversion Phase||0||
59907950|NCT00706654|76029232|FG000|STARTED|Oral Stabilization Phase|228 of the 842 patients who started this phase enrolled directly into this phase of the study.|842||
59907951|NCT00706654|76029233|FG001|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0||
59907952|NCT00706654|76029234|FG002|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0||
59907953|NCT00706654|76029235|FG003|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0||
59907954|NCT00706654|76029232|FG000|COMPLETED|Oral Stabilization Phase||662||
59907955|NCT00706654|76029233|FG001|COMPLETED|Oral Stabilization Phase||0||
59907956|NCT00706654|76029234|FG002|COMPLETED|Oral Stabilization Phase||0||
59907957|NCT00706654|76029235|FG003|COMPLETED|Oral Stabilization Phase||0||
59907958|NCT00706654|76029232|FG000|NOT COMPLETED|Oral Stabilization Phase||180||
59907959|NCT00706654|76029233|FG001|NOT COMPLETED|Oral Stabilization Phase||0||
59907960|NCT00706654|76029234|FG002|NOT COMPLETED|Oral Stabilization Phase||0||
59907961|NCT00706654|76029235|FG003|NOT COMPLETED|Oral Stabilization Phase||0||
59907962|NCT00706654|76029232|FG000|STARTED|Depot Maintenance Phase|Patients were randomized into the 3 aripiprazole treatment groups in this phase of the study.|0||
59907963|NCT00706654|76029233|FG001|STARTED|Depot Maintenance Phase||265||
59907964|NCT00706654|76029234|FG002|STARTED|Depot Maintenance Phase||266||
59907965|NCT00706654|76029235|FG003|STARTED|Depot Maintenance Phase||131||
59907966|NCT00706654|76029232|FG000|COMPLETED|Depot Maintenance Phase||0||
59907967|NCT00706654|76029233|FG001|COMPLETED|Depot Maintenance Phase||196||
59907968|NCT00706654|76029234|FG002|COMPLETED|Depot Maintenance Phase||178||
59907969|NCT00706654|76029235|FG003|COMPLETED|Depot Maintenance Phase||61||
59907970|NCT00706654|76029232|FG000|NOT COMPLETED|Depot Maintenance Phase||0||
59907971|NCT00706654|76029233|FG001|NOT COMPLETED|Depot Maintenance Phase||69||
59907972|NCT00706654|76029234|FG002|NOT COMPLETED|Depot Maintenance Phase||88||
59907973|NCT00706654|76029235|FG003|NOT COMPLETED|Depot Maintenance Phase||70||
59907974|NCT03471871|76029247|FG000|STARTED|Treatment Period 1(HV:1 Day, OSA:8 Days)||6||
59907975|NCT03471871|76029248|FG001|STARTED|Treatment Period 1(HV:1 Day, OSA:8 Days)||5||
59907976|NCT03471871|76029249|FG002|STARTED|Treatment Period 1(HV:1 Day, OSA:8 Days)||6||
59907977|NCT03471871|76029250|FG003|STARTED|Treatment Period 1(HV:1 Day, OSA:8 Days)||19||
59907978|NCT03471871|76029251|FG004|STARTED|Treatment Period 1(HV:1 Day, OSA:8 Days)||20||
59907979|NCT03471871|76029247|FG000|Treated|Treatment Period 1(HV:1 Day, OSA:8 Days)||6||
59907980|NCT03471871|76029248|FG001|Treated|Treatment Period 1(HV:1 Day, OSA:8 Days)||5||
59907981|NCT03471871|76029249|FG002|Treated|Treatment Period 1(HV:1 Day, OSA:8 Days)||6||
59907982|NCT03471871|76029250|FG003|Treated|Treatment Period 1(HV:1 Day, OSA:8 Days)||18||
59907983|NCT03471871|76029251|FG004|Treated|Treatment Period 1(HV:1 Day, OSA:8 Days)||20||
59907984|NCT03471871|76029247|FG000|COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||6||
59907985|NCT03471871|76029248|FG001|COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||5||
59907986|NCT03471871|76029249|FG002|COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||5||
59907987|NCT03471871|76029250|FG003|COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||18||
59907988|NCT03471871|76029251|FG004|COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||19||
59907989|NCT03471871|76029247|FG000|NOT COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||0||
59907990|NCT03471871|76029248|FG001|NOT COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||0||
59907991|NCT03471871|76029249|FG002|NOT COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||1||
59907992|NCT03471871|76029250|FG003|NOT COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||1||
59907993|NCT03471871|76029251|FG004|NOT COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||1||
59907994|NCT03471871|76029247|FG000|STARTED|Washout Period 1 (14 Days)||6||
59907995|NCT03471871|76029248|FG001|STARTED|Washout Period 1 (14 Days)||5||
59907996|NCT03471871|76029249|FG002|STARTED|Washout Period 1 (14 Days)||5||
59907997|NCT03471871|76029250|FG003|STARTED|Washout Period 1 (14 Days)||18||
59907998|NCT03471871|76029251|FG004|STARTED|Washout Period 1 (14 Days)||19||
59907999|NCT03471871|76029247|FG000|COMPLETED|Washout Period 1 (14 Days)||6||
59908000|NCT03471871|76029248|FG001|COMPLETED|Washout Period 1 (14 Days)||5||
59908001|NCT03471871|76029249|FG002|COMPLETED|Washout Period 1 (14 Days)||5||
59908002|NCT03471871|76029250|FG003|COMPLETED|Washout Period 1 (14 Days)||18||
59908003|NCT03471871|76029251|FG004|COMPLETED|Washout Period 1 (14 Days)||19||
59908004|NCT03471871|76029247|FG000|NOT COMPLETED|Washout Period 1 (14 Days)||0||
59908005|NCT03471871|76029248|FG001|NOT COMPLETED|Washout Period 1 (14 Days)||0||
59908006|NCT03471871|76029249|FG002|NOT COMPLETED|Washout Period 1 (14 Days)||0||
59908007|NCT03471871|76029250|FG003|NOT COMPLETED|Washout Period 1 (14 Days)||0||
59908008|NCT03471871|76029251|FG004|NOT COMPLETED|Washout Period 1 (14 Days)||0||
59908009|NCT03471871|76029247|FG000|STARTED|Treatment Period 2(HV:1 Day, OSA:8 Days)||6||
59908010|NCT03471871|76029248|FG001|STARTED|Treatment Period 2(HV:1 Day, OSA:8 Days)||5||
59908011|NCT03471871|76029249|FG002|STARTED|Treatment Period 2(HV:1 Day, OSA:8 Days)||5||
59908012|NCT03471871|76029250|FG003|STARTED|Treatment Period 2(HV:1 Day, OSA:8 Days)||18||
59908013|NCT03471871|76029251|FG004|STARTED|Treatment Period 2(HV:1 Day, OSA:8 Days)||19||
59908014|NCT03471871|76029247|FG000|COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||6||
59908015|NCT03471871|76029248|FG001|COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||5||
59908016|NCT03471871|76029249|FG002|COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||5||
59908017|NCT03471871|76029250|FG003|COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||18||
59908018|NCT03471871|76029251|FG004|COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||18||
59908019|NCT03471871|76029247|FG000|NOT COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||0||
59908020|NCT03471871|76029248|FG001|NOT COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||0||
59908021|NCT03471871|76029249|FG002|NOT COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||0||
59908022|NCT03471871|76029250|FG003|NOT COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||0||
59908023|NCT03471871|76029251|FG004|NOT COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||1||
59908024|NCT03471871|76029247|FG000|STARTED|Washout Period 2 (14 Days)||6||
59908025|NCT03471871|76029248|FG001|STARTED|Washout Period 2 (14 Days)||5||
59908026|NCT03471871|76029249|FG002|STARTED|Washout Period 2 (14 Days)||5||
59908027|NCT03471871|76029250|FG003|STARTED|Washout Period 2 (14 Days)|0=not applicable, as OSA cohort was treated till Treatment Period 2, then directly followed up.|0||
59908028|NCT03471871|76029251|FG004|STARTED|Washout Period 2 (14 Days)|0=not applicable, as OSA cohort was treated till Treatment Period 2, then directly followed up.|0||
59908029|NCT03471871|76029247|FG000|COMPLETED|Washout Period 2 (14 Days)||6||
59908030|NCT03471871|76029248|FG001|COMPLETED|Washout Period 2 (14 Days)||5||
59908031|NCT03471871|76029249|FG002|COMPLETED|Washout Period 2 (14 Days)||5||
59908032|NCT03471871|76029250|FG003|COMPLETED|Washout Period 2 (14 Days)||0||
59908033|NCT03471871|76029251|FG004|COMPLETED|Washout Period 2 (14 Days)||0||
59908034|NCT03471871|76029247|FG000|NOT COMPLETED|Washout Period 2 (14 Days)||0||
59908035|NCT03471871|76029248|FG001|NOT COMPLETED|Washout Period 2 (14 Days)||0||
59908036|NCT03471871|76029249|FG002|NOT COMPLETED|Washout Period 2 (14 Days)||0||
59908037|NCT03471871|76029250|FG003|NOT COMPLETED|Washout Period 2 (14 Days)||0||
59908038|NCT03471871|76029251|FG004|NOT COMPLETED|Washout Period 2 (14 Days)||0||
59908039|NCT03471871|76029247|FG000|STARTED|Treatment Period 3: ( HV:1 Day)||6||
59908040|NCT03471871|76029248|FG001|STARTED|Treatment Period 3: ( HV:1 Day)||5||
59908041|NCT03471871|76029249|FG002|STARTED|Treatment Period 3: ( HV:1 Day)||5||
59908042|NCT03471871|76029250|FG003|STARTED|Treatment Period 3: ( HV:1 Day)||0||
59908043|NCT03471871|76029251|FG004|STARTED|Treatment Period 3: ( HV:1 Day)||0||
59908044|NCT03471871|76029247|FG000|COMPLETED|Treatment Period 3: ( HV:1 Day)||6||
59908045|NCT03471871|76029248|FG001|COMPLETED|Treatment Period 3: ( HV:1 Day)||5||
59908046|NCT03471871|76029249|FG002|COMPLETED|Treatment Period 3: ( HV:1 Day)||5||
59908047|NCT03471871|76029250|FG003|COMPLETED|Treatment Period 3: ( HV:1 Day)||0||
59908048|NCT03471871|76029251|FG004|COMPLETED|Treatment Period 3: ( HV:1 Day)||0||
59908049|NCT03471871|76029247|FG000|NOT COMPLETED|Treatment Period 3: ( HV:1 Day)||0||
59908050|NCT03471871|76029248|FG001|NOT COMPLETED|Treatment Period 3: ( HV:1 Day)||0||
59908051|NCT03471871|76029249|FG002|NOT COMPLETED|Treatment Period 3: ( HV:1 Day)||0||
59908052|NCT03471871|76029250|FG003|NOT COMPLETED|Treatment Period 3: ( HV:1 Day)||0||
59908053|NCT03471871|76029251|FG004|NOT COMPLETED|Treatment Period 3: ( HV:1 Day)||0||
59908054|NCT03471871|76029247|FG000|STARTED|Follow Up (14 Days for Both HV and OSA)||6||
59908055|NCT03471871|76029248|FG001|STARTED|Follow Up (14 Days for Both HV and OSA)||5||
59908056|NCT03471871|76029249|FG002|STARTED|Follow Up (14 Days for Both HV and OSA)||5||
59908057|NCT03471871|76029250|FG003|STARTED|Follow Up (14 Days for Both HV and OSA)|OSA cohort was treated till Treatment Period 2 only and then entered in follow up period.|18||
59908058|NCT03471871|76029251|FG004|STARTED|Follow Up (14 Days for Both HV and OSA)|OSA cohort was treated till Treatment Period 2 only and then entered in follow up period.|18||
59908059|NCT03471871|76029247|FG000|COMPLETED|Follow Up (14 Days for Both HV and OSA)||6||
59908060|NCT03471871|76029248|FG001|COMPLETED|Follow Up (14 Days for Both HV and OSA)||5||
59908061|NCT03471871|76029249|FG002|COMPLETED|Follow Up (14 Days for Both HV and OSA)||5||
59908062|NCT03471871|76029250|FG003|COMPLETED|Follow Up (14 Days for Both HV and OSA)||17||
59908063|NCT03471871|76029251|FG004|COMPLETED|Follow Up (14 Days for Both HV and OSA)||17||
59908064|NCT03471871|76029247|FG000|NOT COMPLETED|Follow Up (14 Days for Both HV and OSA)||0||
59908065|NCT03471871|76029248|FG001|NOT COMPLETED|Follow Up (14 Days for Both HV and OSA)||0||
59908066|NCT03471871|76029249|FG002|NOT COMPLETED|Follow Up (14 Days for Both HV and OSA)||0||
59908067|NCT03471871|76029250|FG003|NOT COMPLETED|Follow Up (14 Days for Both HV and OSA)||1||
59908068|NCT03471871|76029251|FG004|NOT COMPLETED|Follow Up (14 Days for Both HV and OSA)||1||
59908069|NCT03503591|76029263|FG000|STARTED|Overall Study||109||
59908070|NCT03503591|76029263|FG000|COMPLETED|Overall Study||109||
59908071|NCT03503591|76029263|FG000|NOT COMPLETED|Overall Study||0||
59908072|NCT01957176|76029269|FG000|STARTED|Overall Study||8|All the subjects who were treated with at least one dose of eltrombopag were included in the All Treated Subjects analysis set (ATS analysis set)|
59908073|NCT01957176|76029270|FG001|STARTED|Overall Study||14|All the subjects who were treated with at least one dose of eltrombopag were included in the All Treated Subjects analysis set (ATS analysis set)|
59908074|NCT01957176|76029269|FG000|COMPLETED|Overall Study||3||
59908075|NCT01957176|76029270|FG001|COMPLETED|Overall Study||13||
59908076|NCT01957176|76029269|FG000|NOT COMPLETED|Overall Study||5||
59908077|NCT01957176|76029270|FG001|NOT COMPLETED|Overall Study||1||
59908078|NCT03527173|76029279|FG000|STARTED|Overall Study||36||
59908079|NCT03527173|76029280|FG001|STARTED|Overall Study||35||
59908080|NCT03527173|76029279|FG000|COMPLETED|Overall Study||29||
59908081|NCT03527173|76029280|FG001|COMPLETED|Overall Study||28||
59908082|NCT03527173|76029279|FG000|NOT COMPLETED|Overall Study||7||
59908083|NCT03527173|76029280|FG001|NOT COMPLETED|Overall Study||7||
59908084|NCT00707980|76029286|FG000|STARTED|Overall Study||836||
59908085|NCT00707980|76029286|FG000|Received Treatment|Overall Study||834||
59908086|NCT00707980|76029286|FG000|COMPLETED|Overall Study||526||
59908087|NCT00707980|76029286|FG000|NOT COMPLETED|Overall Study||310||
59908088|NCT03506425|76029293|FG000|STARTED|Overall Study||5||
59908089|NCT03506425|76029294|FG001|STARTED|Overall Study||5||
59908090|NCT03506425|76029295|FG002|STARTED|Overall Study||5||
59908091|NCT03506425|76029293|FG000|COMPLETED|Overall Study||3||
59908092|NCT03506425|76029294|FG001|COMPLETED|Overall Study||2||
59908093|NCT03506425|76029295|FG002|COMPLETED|Overall Study||4||
59908094|NCT03506425|76029293|FG000|NOT COMPLETED|Overall Study||2||
59908095|NCT03506425|76029294|FG001|NOT COMPLETED|Overall Study||3||
59908096|NCT03506425|76029295|FG002|NOT COMPLETED|Overall Study||1||
59908097|NCT03051620|76029304|FG000|STARTED|Overall Study||142||
59908098|NCT03051620|76029304|FG000|COMPLETED|Overall Study||124||
59908099|NCT03051620|76029304|FG000|NOT COMPLETED|Overall Study||18||
59908100|NCT03053492|76029310|FG000|STARTED|Overall Study||33||
59908101|NCT03053492|76029311|FG001|STARTED|Overall Study||33||
59908102|NCT03053492|76029310|FG000|COMPLETED|Overall Study||25||
59908103|NCT03053492|76029311|FG001|COMPLETED|Overall Study||27||
59908104|NCT03053492|76029310|FG000|NOT COMPLETED|Overall Study||8||
59908105|NCT03053492|76029311|FG001|NOT COMPLETED|Overall Study||6||
59908106|NCT03801707|76029317|FG000|STARTED|Overall Study||36||
59908107|NCT03801707|76029317|FG000|COMPLETED|Overall Study||30||
59908108|NCT03801707|76029317|FG000|NOT COMPLETED|Overall Study||6||
59908109|NCT04239872|76029321|FG000|STARTED|Overall Study||11||
59908110|NCT04239872|76029322|FG001|STARTED|Overall Study||9||
59908111|NCT04239872|76029321|FG000|COMPLETED|Overall Study||11||
59908112|NCT04239872|76029322|FG001|COMPLETED|Overall Study||8||
59908113|NCT04239872|76029321|FG000|NOT COMPLETED|Overall Study||0||
59908114|NCT04239872|76029322|FG001|NOT COMPLETED|Overall Study||1||
59908115|NCT03164772|76029330|FG000|STARTED|Overall Study||23|Started is defined as started treatment.|
59908116|NCT03164772|76029331|FG001|STARTED|Overall Study||34|Started is defined as started treatment.|
59908117|NCT03164772|76029330|FG000|COMPLETED|Overall Study||5|Completed is defined as completed all 12 cycles of study treatment.|
59908118|NCT03164772|76029331|FG001|COMPLETED|Overall Study||3|Completed is defined as completed all 12 cycles of study treatment.|
59908119|NCT03164772|76029330|FG000|NOT COMPLETED|Overall Study||18||
59908120|NCT03164772|76029331|FG001|NOT COMPLETED|Overall Study||31||
59908121|NCT03353753|76029342|FG000|STARTED|Overall Study||85||
59908122|NCT03353753|76029343|FG001|STARTED|Overall Study|1 patient was randomized but not dosed|44||
59908123|NCT03353753|76029342|FG000|COMPLETED|Overall Study||46|Completed patients of the double-blind period are those that have entered the open-label period, or discontinued treatment due to death or confirmed progressive disease by IRR as of the cutoff of May 31, 2019.|
59908124|NCT03353753|76029343|FG001|COMPLETED|Overall Study||35|Completed patients of the double-blind period are those that have entered the open-label period, or discontinued treatment due to death or confirmed progressive disease by IRR as of the cutoff of May 31, 2019.|
59908125|NCT03353753|76029342|FG000|NOT COMPLETED|Overall Study||39||
59908126|NCT03353753|76029343|FG001|NOT COMPLETED|Overall Study||9||
59908127|NCT03050450|76029354|FG000|STARTED|Overall Study||6||
59908128|NCT03050450|76029355|FG001|STARTED|Overall Study||0||
59908129|NCT03050450|76029356|FG002|STARTED|Overall Study||0||
59908130|NCT03050450|76029357|FG003|STARTED|Overall Study||0||
59908131|NCT03050450|76029358|FG004|STARTED|Overall Study||0||
59908132|NCT03050450|76029354|FG000|COMPLETED|Overall Study||5||
59908133|NCT03050450|76029355|FG001|COMPLETED|Overall Study||0||
59908134|NCT03050450|76029356|FG002|COMPLETED|Overall Study||0||
59908135|NCT03050450|76029357|FG003|COMPLETED|Overall Study||0||
59908136|NCT03050450|76029358|FG004|COMPLETED|Overall Study||0||
59908137|NCT03050450|76029354|FG000|NOT COMPLETED|Overall Study||1||
59908138|NCT03050450|76029355|FG001|NOT COMPLETED|Overall Study||0||
59908139|NCT03050450|76029356|FG002|NOT COMPLETED|Overall Study||0||
59908140|NCT03050450|76029357|FG003|NOT COMPLETED|Overall Study||0||
59908141|NCT03050450|76029358|FG004|NOT COMPLETED|Overall Study||0||
59908142|NCT03505021|76029372|FG000|STARTED|Overall Study||329||
59908143|NCT03505021|76029373|FG001|STARTED|Overall Study||167||
59908144|NCT03505021|76029372|FG000|COMPLETED|Overall Study||217||
59908145|NCT03505021|76029373|FG001|COMPLETED|Overall Study||112||
59908146|NCT03505021|76029372|FG000|NOT COMPLETED|Overall Study||112||
59908147|NCT03505021|76029373|FG001|NOT COMPLETED|Overall Study||55||
59908148|NCT03050372|76029379|FG000|STARTED|Adaptation Night (Night #1 PSG)||6||
59908149|NCT03050372|76029380|FG001|STARTED|Adaptation Night (Night #1 PSG)||6||
59908150|NCT03050372|76029379|FG000|COMPLETED|Adaptation Night (Night #1 PSG)|N=1 subject removed from study due to mild sleep apnea during adaptation night|5||
59908151|NCT03050372|76029380|FG001|COMPLETED|Adaptation Night (Night #1 PSG)||6||
59908152|NCT03050372|76029379|FG000|NOT COMPLETED|Adaptation Night (Night #1 PSG)||1||
59908153|NCT03050372|76029380|FG001|NOT COMPLETED|Adaptation Night (Night #1 PSG)||0||
59908154|NCT03050372|76029379|FG000|STARTED|First Intervention (Nights #2 and #3)||5||
59908155|NCT03050372|76029380|FG001|STARTED|First Intervention (Nights #2 and #3)||6||
59908156|NCT03050372|76029379|FG000|COMPLETED|First Intervention (Nights #2 and #3)||5||
59908157|NCT03050372|76029380|FG001|COMPLETED|First Intervention (Nights #2 and #3)||6||
59908158|NCT03050372|76029379|FG000|NOT COMPLETED|First Intervention (Nights #2 and #3)||0||
59908159|NCT03050372|76029380|FG001|NOT COMPLETED|First Intervention (Nights #2 and #3)||0||
59908160|NCT03050372|76029379|FG000|STARTED|Second Intervention (Nights #4 and #5)||5||
59908161|NCT03050372|76029380|FG001|STARTED|Second Intervention (Nights #4 and #5)||6||
59908162|NCT03050372|76029379|FG000|COMPLETED|Second Intervention (Nights #4 and #5)||5||
59908163|NCT03050372|76029380|FG001|COMPLETED|Second Intervention (Nights #4 and #5)|N=1 subject (blind only broken after double-blind analysis) moved out off State; lost to study|5||
59908164|NCT03050372|76029379|FG000|NOT COMPLETED|Second Intervention (Nights #4 and #5)||0||
59908165|NCT03050372|76029380|FG001|NOT COMPLETED|Second Intervention (Nights #4 and #5)||1||
59908166|NCT03470545|76029387|FG000|STARTED|Overall Study||123||
59908167|NCT03470545|76029388|FG001|STARTED|Overall Study||128||
59908168|NCT03470545|76029387|FG000|COMPLETED|Overall Study||119||
59908169|NCT03470545|76029388|FG001|COMPLETED|Overall Study||125||
59908170|NCT03470545|76029387|FG000|NOT COMPLETED|Overall Study||4||
59908171|NCT03470545|76029388|FG001|NOT COMPLETED|Overall Study||3||
59908172|NCT03163446|76029397|FG000|STARTED|Overall Study||73||
59908173|NCT03163446|76029398|FG001|STARTED|Overall Study||48||
59908174|NCT03163446|76029397|FG000|COMPLETED|Overall Study||45||
59908175|NCT03163446|76029398|FG001|COMPLETED|Overall Study||31||
59908176|NCT03163446|76029397|FG000|NOT COMPLETED|Overall Study||28||
59908177|NCT03163446|76029398|FG001|NOT COMPLETED|Overall Study||17||
59908178|NCT03722485|76029412|FG000|STARTED|Overall Study||19||
59908179|NCT03722485|76029413|FG001|STARTED|Overall Study||25||
59908180|NCT03722485|76029412|FG000|COMPLETED|Overall Study||15||
59908181|NCT03722485|76029413|FG001|COMPLETED|Overall Study||18||
59908182|NCT03722485|76029412|FG000|NOT COMPLETED|Overall Study||4||
59908183|NCT03722485|76029413|FG001|NOT COMPLETED|Overall Study||7||
59908184|NCT00852696|76029419|FG000|STARTED|Overall Study||0||
59908185|NCT00852696|76029420|FG001|STARTED|Overall Study||0||
59908186|NCT00852696|76029419|FG000|COMPLETED|Overall Study||0||
59908187|NCT00852696|76029420|FG001|COMPLETED|Overall Study||0||
59908188|NCT00852696|76029419|FG000|NOT COMPLETED|Overall Study||0||
59908189|NCT00852696|76029420|FG001|NOT COMPLETED|Overall Study||0||
59908190|NCT04286412|76029424|FG000|STARTED|Overall Study||25||
59908191|NCT04286412|76029424|FG000|COMPLETED|Overall Study||25||
59908192|NCT04286412|76029424|FG000|NOT COMPLETED|Overall Study||0||
59908193|NCT03274661|76029428|FG000|STARTED|Overall Study||52||
59908194|NCT03274661|76029428|FG000|COMPLETED|Overall Study||52||
59908195|NCT03274661|76029428|FG000|NOT COMPLETED|Overall Study||0||
59908196|NCT01605552|76029434|FG000|STARTED|Overall Study||13||
59908197|NCT01605552|76029435|FG001|STARTED|Overall Study||16||
59908198|NCT01605552|76029434|FG000|COMPLETED|Overall Study|4 dropped out before the first BtB visit; it is unlikely that the treatment was the cause of dropout|7||
59908199|NCT01605552|76029435|FG001|COMPLETED|Overall Study||14||
59908200|NCT01605552|76029434|FG000|NOT COMPLETED|Overall Study||6||
59908201|NCT01605552|76029435|FG001|NOT COMPLETED|Overall Study||2||
59908202|NCT01489176|76029441|FG000|STARTED|Overall Study||50||
59908203|NCT01489176|76029441|FG000|COMPLETED|Overall Study||50||
59908204|NCT01489176|76029441|FG000|NOT COMPLETED|Overall Study||0||
59908205|NCT03047720|76029447|FG000|STARTED|First Intervention (6weeks)||12||
59908206|NCT03047720|76029448|FG001|STARTED|First Intervention (6weeks)||0||
59908207|NCT03047720|76029447|FG000|COMPLETED|First Intervention (6weeks)||5||
59908208|NCT03047720|76029448|FG001|COMPLETED|First Intervention (6weeks)||0||
59908209|NCT03047720|76029447|FG000|NOT COMPLETED|First Intervention (6weeks)||7||
59908210|NCT03047720|76029448|FG001|NOT COMPLETED|First Intervention (6weeks)||0||
59908211|NCT03047720|76029447|FG000|STARTED|Second Intervention (6weeks)||0||
59908212|NCT03047720|76029448|FG001|STARTED|Second Intervention (6weeks)||0||
59908213|NCT03047720|76029447|FG000|COMPLETED|Second Intervention (6weeks)||0||
59908214|NCT03047720|76029448|FG001|COMPLETED|Second Intervention (6weeks)||0||
59908215|NCT03047720|76029447|FG000|NOT COMPLETED|Second Intervention (6weeks)||0||
59908216|NCT03047720|76029448|FG001|NOT COMPLETED|Second Intervention (6weeks)||0||
59908217|NCT04926077|76029454|FG000|STARTED|Overall Study||11||
59908218|NCT04926077|76029454|FG000|COMPLETED|Overall Study||11||
59908219|NCT04926077|76029454|FG000|NOT COMPLETED|Overall Study||0||
59908220|NCT03167879|76029461|FG000|STARTED|Overall Study||129||2
59908221|NCT03167879|76029462|FG001|STARTED|Overall Study||130||2
59908222|NCT03167879|76029463|FG002|STARTED|Overall Study||130||2
59908223|NCT03167879|76029461|FG000|COMPLETED|Overall Study||122||2
59908224|NCT03167879|76029462|FG001|COMPLETED|Overall Study||125||2
59908225|NCT03167879|76029463|FG002|COMPLETED|Overall Study||122||2
59908226|NCT03167879|76029461|FG000|NOT COMPLETED|Overall Study||7||0
59908227|NCT03167879|76029462|FG001|NOT COMPLETED|Overall Study||5||0
59908228|NCT03167879|76029463|FG002|NOT COMPLETED|Overall Study||8||0
59908229|NCT03626168|76029473|FG000|STARTED|First Intervention (4 Weeks)||9||
59908230|NCT03626168|76029474|FG001|STARTED|First Intervention (4 Weeks)||12||
59908231|NCT03626168|76029473|FG000|COMPLETED|First Intervention (4 Weeks)||8||
59908232|NCT03626168|76029474|FG001|COMPLETED|First Intervention (4 Weeks)||11||
59908233|NCT03626168|76029473|FG000|NOT COMPLETED|First Intervention (4 Weeks)||1||
59908234|NCT03626168|76029474|FG001|NOT COMPLETED|First Intervention (4 Weeks)||1||
59908235|NCT03626168|76029473|FG000|STARTED|Washout (2 Weeks)||8||
59908236|NCT03626168|76029474|FG001|STARTED|Washout (2 Weeks)||11||
59908237|NCT03626168|76029473|FG000|COMPLETED|Washout (2 Weeks)||8||
59908238|NCT03626168|76029474|FG001|COMPLETED|Washout (2 Weeks)||11||
59908239|NCT03626168|76029473|FG000|NOT COMPLETED|Washout (2 Weeks)||0||
59908240|NCT03626168|76029474|FG001|NOT COMPLETED|Washout (2 Weeks)||0||
59908241|NCT03626168|76029473|FG000|STARTED|Second Intervention (4 Weeks)||8||
59908242|NCT03626168|76029474|FG001|STARTED|Second Intervention (4 Weeks)||11||
59908243|NCT03626168|76029473|FG000|COMPLETED|Second Intervention (4 Weeks)||8||
59908244|NCT03626168|76029474|FG001|COMPLETED|Second Intervention (4 Weeks)||9||
59908245|NCT03626168|76029473|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0||
59908246|NCT03626168|76029474|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||2||
59908247|NCT02966873|76029482|FG000|STARTED|Overall Study||93||
59908248|NCT02966873|76029483|FG001|STARTED|Overall Study||89||
59908249|NCT02966873|76029482|FG000|COMPLETED|Overall Study|N=77 represents 77 participants who provided at least one data point at week 12.|77||
59908250|NCT02966873|76029483|FG001|COMPLETED|Overall Study|N=74 represents 74 participants who provided at least one data point at week 12.|74||
59908251|NCT02966873|76029482|FG000|NOT COMPLETED|Overall Study||16||
59908252|NCT02966873|76029483|FG001|NOT COMPLETED|Overall Study||15||
59908253|NCT01389024|76029491|FG000|STARTED|Overall Study||6||
59908254|NCT01389024|76029492|FG001|STARTED|Overall Study||6||
59908255|NCT01389024|76029491|FG000|COMPLETED|Overall Study||5||
59908256|NCT01389024|76029492|FG001|COMPLETED|Overall Study||5||
59908257|NCT01389024|76029491|FG000|NOT COMPLETED|Overall Study||1||
59908258|NCT01389024|76029492|FG001|NOT COMPLETED|Overall Study||1||
59908259|NCT03050060|76029502|FG000|STARTED|Overall Study||20||
59908260|NCT03050060|76029502|FG000|COMPLETED|Overall Study||5||
59908261|NCT03050060|76029502|FG000|NOT COMPLETED|Overall Study||15||
59908262|NCT03844646|76029508|FG000|STARTED|Overall Study||8||
59908263|NCT03844646|76029509|FG001|STARTED|Overall Study||4||
59908264|NCT03844646|76029508|FG000|COMPLETED|Overall Study||8||
59908265|NCT03844646|76029509|FG001|COMPLETED|Overall Study||4||
59908266|NCT03844646|76029508|FG000|NOT COMPLETED|Overall Study||0||
59908267|NCT03844646|76029509|FG001|NOT COMPLETED|Overall Study||0||
59908268|NCT00706342|76029515|FG000|STARTED|Overall Study||18||
59908269|NCT00706342|76029515|FG000|COMPLETED|Overall Study||0||
59908270|NCT00706342|76029515|FG000|NOT COMPLETED|Overall Study||18||
59908271|NCT03049748|76029521|FG000|STARTED|Overall Study||20||
59908272|NCT03049748|76029522|FG001|STARTED|Overall Study||20||
59908273|NCT03049748|76029521|FG000|COMPLETED|Overall Study||16||
59908274|NCT03049748|76029522|FG001|COMPLETED|Overall Study||14||
59908275|NCT03049748|76029521|FG000|NOT COMPLETED|Overall Study||4||
59908276|NCT03049748|76029522|FG001|NOT COMPLETED|Overall Study||6||
59908277|NCT03814382|76029528|FG000|STARTED|Overall Study||10||
59908278|NCT03814382|76029528|FG000|COMPLETED|Overall Study||10||
59908279|NCT03814382|76029528|FG000|NOT COMPLETED|Overall Study||0||
59908280|NCT03501277|76029536|FG000|STARTED|Intervention Period 1 (4 Days)||18||
59908281|NCT03501277|76029537|FG001|STARTED|Intervention Period 1 (4 Days)||18||
59908282|NCT03501277|76029538|FG002|STARTED|Intervention Period 1 (4 Days)||18||
59908283|NCT03501277|76029539|FG003|STARTED|Intervention Period 1 (4 Days)||18||
59908284|NCT03501277|76029536|FG000|Safety Analysis Set|Intervention Period 1 (4 Days)||18||
59908285|NCT03501277|76029537|FG001|Safety Analysis Set|Intervention Period 1 (4 Days)||18||
59908286|NCT03501277|76029538|FG002|Safety Analysis Set|Intervention Period 1 (4 Days)||17||
59908287|NCT03501277|76029539|FG003|Safety Analysis Set|Intervention Period 1 (4 Days)||17||
59908288|NCT03501277|76029536|FG000|COMPLETED|Intervention Period 1 (4 Days)||18||
59908289|NCT03501277|76029537|FG001|COMPLETED|Intervention Period 1 (4 Days)||18||
59908290|NCT03501277|76029538|FG002|COMPLETED|Intervention Period 1 (4 Days)||17||
59908291|NCT03501277|76029539|FG003|COMPLETED|Intervention Period 1 (4 Days)||17||
59908292|NCT03501277|76029536|FG000|NOT COMPLETED|Intervention Period 1 (4 Days)||0||
59908293|NCT03501277|76029537|FG001|NOT COMPLETED|Intervention Period 1 (4 Days)||0||
59908294|NCT03501277|76029538|FG002|NOT COMPLETED|Intervention Period 1 (4 Days)||1||
59908295|NCT03501277|76029539|FG003|NOT COMPLETED|Intervention Period 1 (4 Days)||1||
59908296|NCT03501277|76029536|FG000|STARTED|Washout Period 1 (7 Days)||18||
59908297|NCT03501277|76029537|FG001|STARTED|Washout Period 1 (7 Days)||18||
59908298|NCT03501277|76029538|FG002|STARTED|Washout Period 1 (7 Days)||17||
59908299|NCT03501277|76029539|FG003|STARTED|Washout Period 1 (7 Days)||17||
59908300|NCT03501277|76029536|FG000|COMPLETED|Washout Period 1 (7 Days)||18||
59908301|NCT03501277|76029537|FG001|COMPLETED|Washout Period 1 (7 Days)||18||
59908302|NCT03501277|76029538|FG002|COMPLETED|Washout Period 1 (7 Days)||17||
59908303|NCT03501277|76029539|FG003|COMPLETED|Washout Period 1 (7 Days)||17||
59908304|NCT03501277|76029536|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0||
59908305|NCT03501277|76029537|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0||
59908306|NCT03501277|76029538|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0||
59908307|NCT03501277|76029539|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0||
59908308|NCT03501277|76029536|FG000|STARTED|Intervention Period 2 (4 Days)||18||
59908309|NCT03501277|76029537|FG001|STARTED|Intervention Period 2 (4 Days)||18||
59908310|NCT03501277|76029538|FG002|STARTED|Intervention Period 2 (4 Days)||17||
59908311|NCT03501277|76029539|FG003|STARTED|Intervention Period 2 (4 Days)||17||
59908312|NCT03501277|76029536|FG000|COMPLETED|Intervention Period 2 (4 Days)||18||
59908313|NCT03501277|76029537|FG001|COMPLETED|Intervention Period 2 (4 Days)||18||
59908314|NCT03501277|76029538|FG002|COMPLETED|Intervention Period 2 (4 Days)||17||
59908315|NCT03501277|76029539|FG003|COMPLETED|Intervention Period 2 (4 Days)||16||
59908316|NCT03501277|76029536|FG000|NOT COMPLETED|Intervention Period 2 (4 Days)||0||
59908317|NCT03501277|76029537|FG001|NOT COMPLETED|Intervention Period 2 (4 Days)||0||
59908318|NCT03501277|76029538|FG002|NOT COMPLETED|Intervention Period 2 (4 Days)||0||
59908319|NCT03501277|76029539|FG003|NOT COMPLETED|Intervention Period 2 (4 Days)||1||
59908320|NCT03501277|76029536|FG000|STARTED|Washout Period 2 (7 Days)||18||
59908321|NCT03501277|76029537|FG001|STARTED|Washout Period 2 (7 Days)||18||
59908322|NCT03501277|76029538|FG002|STARTED|Washout Period 2 (7 Days)||17||
59908323|NCT03501277|76029539|FG003|STARTED|Washout Period 2 (7 Days)||16||
59908324|NCT03501277|76029536|FG000|COMPLETED|Washout Period 2 (7 Days)||18||
59908325|NCT03501277|76029537|FG001|COMPLETED|Washout Period 2 (7 Days)||18||
59908326|NCT03501277|76029538|FG002|COMPLETED|Washout Period 2 (7 Days)||17||
59908327|NCT03501277|76029539|FG003|COMPLETED|Washout Period 2 (7 Days)||16||
59908328|NCT03501277|76029536|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0||
59908329|NCT03501277|76029537|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0||
59908330|NCT03501277|76029538|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0||
59908331|NCT03501277|76029539|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0||
59908332|NCT03501277|76029536|FG000|STARTED|Intervention Period 3 (4 Days)||18||
59908333|NCT03501277|76029537|FG001|STARTED|Intervention Period 3 (4 Days)||18||
59908334|NCT03501277|76029538|FG002|STARTED|Intervention Period 3 (4 Days)||17||
59908335|NCT03501277|76029539|FG003|STARTED|Intervention Period 3 (4 Days)||16||
59908336|NCT03501277|76029536|FG000|COMPLETED|Intervention Period 3 (4 Days)||18||
59908337|NCT03501277|76029537|FG001|COMPLETED|Intervention Period 3 (4 Days)||18||
59908338|NCT03501277|76029538|FG002|COMPLETED|Intervention Period 3 (4 Days)||17||
59908339|NCT03501277|76029539|FG003|COMPLETED|Intervention Period 3 (4 Days)||15||
59908340|NCT03501277|76029536|FG000|NOT COMPLETED|Intervention Period 3 (4 Days)||0||
59908341|NCT03501277|76029537|FG001|NOT COMPLETED|Intervention Period 3 (4 Days)||0||
59908342|NCT03501277|76029538|FG002|NOT COMPLETED|Intervention Period 3 (4 Days)||0||
59908343|NCT03501277|76029539|FG003|NOT COMPLETED|Intervention Period 3 (4 Days)||1||
59908344|NCT03501277|76029536|FG000|STARTED|Washout Period 3 (7 Days)||18||
59908345|NCT03501277|76029537|FG001|STARTED|Washout Period 3 (7 Days)||18||
59908346|NCT03501277|76029538|FG002|STARTED|Washout Period 3 (7 Days)||17||
59908347|NCT03501277|76029539|FG003|STARTED|Washout Period 3 (7 Days)||15||
59908348|NCT03501277|76029536|FG000|COMPLETED|Washout Period 3 (7 Days)||18||
59908349|NCT03501277|76029537|FG001|COMPLETED|Washout Period 3 (7 Days)||18||
60015994|NCT02397915|76132272|FG000|COMPLETED|Period 1||149||
60015995|NCT02397915|76132273|FG001|COMPLETED|Period 1||149||
60015996|NCT02397915|76132274|FG002|COMPLETED|Period 1||0||
60015997|NCT02397915|76132275|FG003|COMPLETED|Period 1||0||
60015998|NCT02397915|76132272|FG000|NOT COMPLETED|Period 1||1||
60015999|NCT02397915|76132273|FG001|NOT COMPLETED|Period 1||1||
60016000|NCT02397915|76132274|FG002|NOT COMPLETED|Period 1||0||
60016001|NCT02397915|76132275|FG003|NOT COMPLETED|Period 1||0||
60016002|NCT02397915|76132272|FG000|STARTED|Period 2||0||
60016003|NCT02397915|76132273|FG001|STARTED|Period 2||0||
60016004|NCT02397915|76132274|FG002|STARTED|Period 2||149||
60016005|NCT02397915|76132275|FG003|STARTED|Period 2||149||
60016006|NCT02397915|76132272|FG000|COMPLETED|Period 2||0||
60016007|NCT02397915|76132273|FG001|COMPLETED|Period 2||0||
60016008|NCT02397915|76132274|FG002|COMPLETED|Period 2||149||
60016009|NCT02397915|76132275|FG003|COMPLETED|Period 2||149||
60016010|NCT02397915|76132272|FG000|NOT COMPLETED|Period 2||0||
60016011|NCT02397915|76132273|FG001|NOT COMPLETED|Period 2||0||
60016012|NCT02397915|76132274|FG002|NOT COMPLETED|Period 2||0||
60016013|NCT02397915|76132275|FG003|NOT COMPLETED|Period 2||0||
60016014|NCT02397837|76132285|FG000|STARTED|Overall Study||33||
60016015|NCT02397837|76132286|FG001|STARTED|Overall Study||30||
60016016|NCT02397837|76132285|FG000|COMPLETED|Overall Study||26||
60016017|NCT02397837|76132286|FG001|COMPLETED|Overall Study||24||
60016018|NCT02397837|76132285|FG000|NOT COMPLETED|Overall Study||7||
60016019|NCT02397837|76132286|FG001|NOT COMPLETED|Overall Study||6||
60016020|NCT02586415|76132294|FG000|STARTED|Overall Study||92||
60016021|NCT02586415|76132295|FG001|STARTED|Overall Study||90||
60016022|NCT02586415|76132294|FG000|24 Hour Assessment|Overall Study||91||
60016023|NCT02586415|76132295|FG001|24 Hour Assessment|Overall Study||90||
60016024|NCT02586415|76132294|FG000|Day 30 Assessment|Overall Study||81||
60016025|NCT02586415|76132295|FG001|Day 30 Assessment|Overall Study||70||
60016026|NCT02586415|76132294|FG000|Day 90 Assessment|Overall Study||78||
60016027|NCT02586415|76132295|FG001|Day 90 Assessment|Overall Study||65||
60016028|NCT02586415|76132294|FG000|COMPLETED|Overall Study||78||
60016029|NCT02586415|76132295|FG001|COMPLETED|Overall Study||65||
60016030|NCT02586415|76132294|FG000|NOT COMPLETED|Overall Study||14||
60016031|NCT02586415|76132295|FG001|NOT COMPLETED|Overall Study||25||
60016032|NCT02383017|76132304|FG000|STARTED|Overall Study||15||
60016033|NCT02383017|76132305|FG001|STARTED|Overall Study||13||
60016034|NCT02383017|76132304|FG000|COMPLETED|Overall Study||10||
59908350|NCT03501277|76029538|FG002|COMPLETED|Washout Period 3 (7 Days)||17||
59908351|NCT03501277|76029539|FG003|COMPLETED|Washout Period 3 (7 Days)||15||
59908352|NCT03501277|76029536|FG000|NOT COMPLETED|Washout Period 3 (7 Days)||0||
59908353|NCT03501277|76029537|FG001|NOT COMPLETED|Washout Period 3 (7 Days)||0||
59908354|NCT03501277|76029538|FG002|NOT COMPLETED|Washout Period 3 (7 Days)||0||
60016035|NCT02383017|76132305|FG001|COMPLETED|Overall Study||11||
60016036|NCT02383017|76132304|FG000|NOT COMPLETED|Overall Study||5||
60016037|NCT02383017|76132305|FG001|NOT COMPLETED|Overall Study||2||
60016038|NCT02382939|76132313|FG000|STARTED|Overall Study||31||
60016039|NCT02382939|76132314|FG001|STARTED|Overall Study||61||
60016040|NCT02382939|76132313|FG000|Exposed|Overall Study||31||
60016041|NCT02382939|76132314|FG001|Exposed|Overall Study||61||
60016042|NCT02382939|76132313|FG000|COMPLETED|Overall Study||28||
60016043|NCT02382939|76132314|FG001|COMPLETED|Overall Study||58||
60016044|NCT02382939|76132313|FG000|NOT COMPLETED|Overall Study||3||
60016045|NCT02382939|76132314|FG001|NOT COMPLETED|Overall Study||3||
60016046|NCT02587819|76132321|FG000|STARTED|Overall Study||21||
60016047|NCT02587819|76132321|FG000|Exposed|Overall Study||21||
60016048|NCT02587819|76132321|FG000|COMPLETED|Overall Study||19||
59908355|NCT03501277|76029539|FG003|NOT COMPLETED|Washout Period 3 (7 Days)||0||
59908356|NCT03501277|76029536|FG000|STARTED|Intervention Period 4 (4 Days)||18||
59908357|NCT03501277|76029537|FG001|STARTED|Intervention Period 4 (4 Days)||18||
59908358|NCT03501277|76029538|FG002|STARTED|Intervention Period 4 (4 Days)||17||
60016049|NCT02587819|76132321|FG000|NOT COMPLETED|Overall Study||2||
60016050|NCT01666951|76132328|FG000|STARTED|Overall Study||18||
60016051|NCT01666951|76132329|FG001|STARTED|Overall Study||18||
60016052|NCT01666951|76132328|FG000|COMPLETED|Overall Study||17||
60016053|NCT01666951|76132329|FG001|COMPLETED|Overall Study||17||
60016054|NCT01666951|76132328|FG000|NOT COMPLETED|Overall Study||1||
60016055|NCT01666951|76132329|FG001|NOT COMPLETED|Overall Study||1||
60016056|NCT02586805|76132339|FG000|STARTED|Overall Study||41||
59908359|NCT03501277|76029539|FG003|STARTED|Intervention Period 4 (4 Days)||15||
59908360|NCT03501277|76029536|FG000|COMPLETED|Intervention Period 4 (4 Days)||18||
59908361|NCT03501277|76029537|FG001|COMPLETED|Intervention Period 4 (4 Days)||18||
60016057|NCT02586805|76132340|FG001|STARTED|Overall Study||28||
60016058|NCT02586805|76132341|FG002|STARTED|Overall Study||29||
60016059|NCT02586805|76132342|FG003|STARTED|Overall Study||27||
60016060|NCT02586805|76132339|FG000|COMPLETED|Overall Study||35||
60016061|NCT02586805|76132340|FG001|COMPLETED|Overall Study||27||
60016062|NCT02586805|76132341|FG002|COMPLETED|Overall Study||26||
60016063|NCT02586805|76132342|FG003|COMPLETED|Overall Study||25||
60016064|NCT02586805|76132339|FG000|NOT COMPLETED|Overall Study||6||
60016065|NCT02586805|76132340|FG001|NOT COMPLETED|Overall Study||1||
60016066|NCT02586805|76132341|FG002|NOT COMPLETED|Overall Study||3||
60016067|NCT02586805|76132342|FG003|NOT COMPLETED|Overall Study||2||
60016068|NCT02580877|76132354|FG000|STARTED|Overall Study||45||
60016069|NCT02580877|76132355|FG001|STARTED|Overall Study||47||
60016070|NCT02580877|76132354|FG000|COMPLETED|Overall Study||44||
60016071|NCT02580877|76132355|FG001|COMPLETED|Overall Study||43||
60016072|NCT02580877|76132354|FG000|NOT COMPLETED|Overall Study||1||
60016073|NCT02580877|76132355|FG001|NOT COMPLETED|Overall Study||4||
60016074|NCT01905631|76132364|FG000|STARTED|Overall Study||10||
60016075|NCT01905631|76132365|FG001|STARTED|Overall Study||20||
59908362|NCT03501277|76029538|FG002|COMPLETED|Intervention Period 4 (4 Days)||17||
59908363|NCT03501277|76029539|FG003|COMPLETED|Intervention Period 4 (4 Days)||15||
59908364|NCT03501277|76029536|FG000|NOT COMPLETED|Intervention Period 4 (4 Days)||0||
59908365|NCT03501277|76029537|FG001|NOT COMPLETED|Intervention Period 4 (4 Days)||0||
59908366|NCT03501277|76029538|FG002|NOT COMPLETED|Intervention Period 4 (4 Days)||0||
59908367|NCT03501277|76029539|FG003|NOT COMPLETED|Intervention Period 4 (4 Days)||0||
59908368|NCT03500419|76029551|FG000|STARTED|Overall Study||27||
60016076|NCT01905631|76132364|FG000|COMPLETED|Overall Study||10||
60016077|NCT01905631|76132365|FG001|COMPLETED|Overall Study||20||
60016078|NCT01905631|76132364|FG000|NOT COMPLETED|Overall Study||0||
60016079|NCT01905631|76132365|FG001|NOT COMPLETED|Overall Study||0||
60016080|NCT02582983|76132371|FG000|STARTED|Overall Study||23||
60016081|NCT02582983|76132371|FG000|COMPLETED|Overall Study||17||
60016082|NCT02582983|76132371|FG000|NOT COMPLETED|Overall Study||6||
60016083|NCT02582749|76132377|FG000|STARTED|Overall Study||5||
60016084|NCT02582749|76132378|FG001|STARTED|Overall Study||11||
60016085|NCT02582749|76132377|FG000|COMPLETED|Overall Study||0||
60016086|NCT02582749|76132378|FG001|COMPLETED|Overall Study||0||
60016087|NCT02582749|76132377|FG000|NOT COMPLETED|Overall Study||5||
60016088|NCT02582749|76132378|FG001|NOT COMPLETED|Overall Study||11||
60016089|NCT02582671|76132384|FG000|STARTED|Overall Study||101||
60016090|NCT02582671|76132384|FG000|COMPLETED|Overall Study||99||
60016091|NCT02582671|76132384|FG000|NOT COMPLETED|Overall Study||2||
60016092|NCT02585713|76132391|FG000|STARTED|Overall Study||150||
60016093|NCT02585713|76132392|FG001|STARTED|Overall Study||150||
60016094|NCT02585713|76132391|FG000|COMPLETED|Overall Study||145|Received Treatment; Primary Analysis Population|
60016095|NCT02585713|76132392|FG001|COMPLETED|Overall Study||142|Received Treatment; Primary Analysis Population|
60016096|NCT02585713|76132391|FG000|NOT COMPLETED|Overall Study||5||
60016097|NCT02585713|76132392|FG001|NOT COMPLETED|Overall Study||8||
60016098|NCT02579863|76132400|FG000|STARTED|Overall Study||156||
60016099|NCT02579863|76132401|FG001|STARTED|Overall Study||154||
60016100|NCT02579863|76132400|FG000|Treated|Overall Study||154||
60016101|NCT02579863|76132401|FG001|Treated|Overall Study||148||
60016102|NCT02579863|76132400|FG000|COMPLETED|Overall Study||0||
60016103|NCT02579863|76132401|FG001|COMPLETED|Overall Study||0||
60016104|NCT02579863|76132400|FG000|NOT COMPLETED|Overall Study||156||
60016105|NCT02579863|76132401|FG001|NOT COMPLETED|Overall Study||154||
60016106|NCT02582515|76132409|FG000|STARTED|Overall Study||9||
60016107|NCT02582515|76132410|FG001|STARTED|Overall Study||11||
60016108|NCT02582515|76132409|FG000|Received Study Intervention|Overall Study||9||
60016109|NCT02582515|76132410|FG001|Received Study Intervention|Overall Study||10||
60016110|NCT02582515|76132409|FG000|COMPLETED|Overall Study||9||
60016111|NCT02582515|76132410|FG001|COMPLETED|Overall Study||10||
59908369|NCT03500419|76029552|FG001|STARTED|Overall Study||55||
59908370|NCT03500419|76029551|FG000|COMPLETED|Overall Study||25||
60016112|NCT02582515|76132409|FG000|NOT COMPLETED|Overall Study||0||
60016113|NCT02582515|76132410|FG001|NOT COMPLETED|Overall Study||1||
60016114|NCT02579629|76132419|FG000|STARTED|Overall Study||22||
60016115|NCT02579629|76132420|FG001|STARTED|Overall Study||20||
60016116|NCT02579629|76132421|FG002|STARTED|Overall Study||22||
60016117|NCT02579629|76132419|FG000|COMPLETED|Overall Study||20||
60016118|NCT02579629|76132420|FG001|COMPLETED|Overall Study||19||
60016119|NCT02579629|76132421|FG002|COMPLETED|Overall Study||20||
60016120|NCT02579629|76132419|FG000|NOT COMPLETED|Overall Study||2||
60016121|NCT02579629|76132420|FG001|NOT COMPLETED|Overall Study||1||
60016122|NCT02579629|76132421|FG002|NOT COMPLETED|Overall Study||2||
60016123|NCT02343939|76132438|FG000|STARTED|Overall Study||3||
60016124|NCT02343939|76132439|FG001|STARTED|Overall Study||50||
60016125|NCT02343939|76132440|FG002|STARTED|Overall Study||5||
60016126|NCT02343939|76132441|FG003|STARTED|Overall Study||6||
60016127|NCT02343939|76132442|FG004|STARTED|Overall Study||8||
60016128|NCT02343939|76132443|FG005|STARTED|Overall Study||17||
60016129|NCT02343939|76132444|FG006|STARTED|Overall Study||15||
60016130|NCT02343939|76132445|FG007|STARTED|Overall Study||37||
60016131|NCT02343939|76132446|FG008|STARTED|Overall Study||7||
60016132|NCT02343939|76132438|FG000|COMPLETED|Overall Study||0||
60016133|NCT02343939|76132439|FG001|COMPLETED|Overall Study||2||
59908371|NCT03500419|76029552|FG001|COMPLETED|Overall Study||30||
59908372|NCT03500419|76029551|FG000|NOT COMPLETED|Overall Study||2||
59908373|NCT03500419|76029552|FG001|NOT COMPLETED|Overall Study||25||
60016134|NCT02343939|76132440|FG002|COMPLETED|Overall Study||0||
60016135|NCT02343939|76132441|FG003|COMPLETED|Overall Study||0||
60016136|NCT02343939|76132442|FG004|COMPLETED|Overall Study||0||
60016137|NCT02343939|76132443|FG005|COMPLETED|Overall Study||0||
59758466|NCT03908437|75877739|FG000|STARTED|Overall Study||55||
59908374|NCT03500341|76029558|FG000|STARTED|Overall Study||16||
59908375|NCT03500341|76029558|FG000|COMPLETED|Overall Study||14||
60016138|NCT02343939|76132444|FG006|COMPLETED|Overall Study||0||
60016139|NCT02343939|76132445|FG007|COMPLETED|Overall Study||0||
60016140|NCT02343939|76132446|FG008|COMPLETED|Overall Study||0||
60016141|NCT02343939|76132438|FG000|NOT COMPLETED|Overall Study||3||
60016142|NCT02343939|76132439|FG001|NOT COMPLETED|Overall Study||48||
60016143|NCT02343939|76132440|FG002|NOT COMPLETED|Overall Study||5||
60016144|NCT02343939|76132441|FG003|NOT COMPLETED|Overall Study||6||
60016145|NCT02343939|76132442|FG004|NOT COMPLETED|Overall Study||8||
60016146|NCT02343939|76132443|FG005|NOT COMPLETED|Overall Study||17||
60016147|NCT02343939|76132444|FG006|NOT COMPLETED|Overall Study||15||
60016148|NCT02343939|76132445|FG007|NOT COMPLETED|Overall Study||37||
60016149|NCT02343939|76132446|FG008|NOT COMPLETED|Overall Study||7||
60016150|NCT02397447|76132482|FG000|STARTED|Overall Study||12||
60016151|NCT02397447|76132483|FG001|STARTED|Overall Study||12||
60016152|NCT02397447|76132482|FG000|COMPLETED|Overall Study||10||
60016153|NCT02397447|76132483|FG001|COMPLETED|Overall Study||10||
60016154|NCT02397447|76132482|FG000|NOT COMPLETED|Overall Study||2||
60016155|NCT02397447|76132483|FG001|NOT COMPLETED|Overall Study||2||
60016156|NCT02397057|76132491|FG000|STARTED|Overall Study|"Two Normal Saline participants received Injectafer. The data presented is considered accurate."|105||
60016157|NCT02397057|76132492|FG001|STARTED|Overall Study||104||
60016158|NCT02397057|76132491|FG000|COMPLETED|Overall Study||94||
60016159|NCT02397057|76132492|FG001|COMPLETED|Overall Study||91||
60016160|NCT02397057|76132491|FG000|NOT COMPLETED|Overall Study||11||
60016161|NCT02397057|76132492|FG001|NOT COMPLETED|Overall Study||13||
60016162|NCT02343549|76132498|FG000|STARTED|Overall Study||13||
60016163|NCT02343549|76132498|FG000|COMPLETED|Overall Study||0||
60016164|NCT02343549|76132498|FG000|NOT COMPLETED|Overall Study||13||
60016165|NCT02343159|76132505|FG000|STARTED|Overall Study||27||
60016166|NCT02343159|76132506|FG001|STARTED|Overall Study||27||
60016167|NCT02343159|76132507|FG002|STARTED|Overall Study||30||
60016168|NCT02343159|76132505|FG000|COMPLETED|Overall Study||1||
60016169|NCT02343159|76132506|FG001|COMPLETED|Overall Study||1||
60016170|NCT02343159|76132507|FG002|COMPLETED|Overall Study||0||
60016171|NCT02343159|76132505|FG000|NOT COMPLETED|Overall Study||26||
60016172|NCT02343159|76132506|FG001|NOT COMPLETED|Overall Study||26||
60016173|NCT02343159|76132507|FG002|NOT COMPLETED|Overall Study||30||
60016174|NCT02395653|76132516|FG000|STARTED|Overall Study||71||
60016175|NCT02395653|76132516|FG000|Received at Least 1 Dose of Study Drug|Overall Study||61|Participants included in the Safety Population.|
60016176|NCT02395653|76132516|FG000|COMPLETED|Overall Study||59||
59758467|NCT03908437|75877740|FG001|STARTED|Overall Study||49||
59758468|NCT03908437|75877739|FG000|COMPLETED|Overall Study||24||
59758469|NCT03908437|75877740|FG001|COMPLETED|Overall Study||24||
59758470|NCT03908437|75877739|FG000|NOT COMPLETED|Overall Study||31||
59758471|NCT03908437|75877740|FG001|NOT COMPLETED|Overall Study||25||
59758472|NCT03846531|75877746|FG000|STARTED|Overall Study||58||174
59758473|NCT03846531|75877746|FG000|COMPLETED|Overall Study||58||174
59758474|NCT03846531|75877746|FG000|NOT COMPLETED|Overall Study||0||0
59758475|NCT03695250|75877750|FG000|STARTED|Overall Study||8||
59908376|NCT03500341|76029558|FG000|NOT COMPLETED|Overall Study||2||
59908377|NCT03365102|76029565|FG000|STARTED|Overall Study||22||
59908378|NCT03365102|76029566|FG001|STARTED|Overall Study||22||
59908379|NCT03365102|76029567|FG002|STARTED|Overall Study||20||
59908380|NCT03365102|76029565|FG000|COMPLETED|Overall Study||18||
59908381|NCT03365102|76029566|FG001|COMPLETED|Overall Study||21||
59908382|NCT03365102|76029567|FG002|COMPLETED|Overall Study||19||
59908383|NCT03365102|76029565|FG000|NOT COMPLETED|Overall Study||4||
59908384|NCT03365102|76029566|FG001|NOT COMPLETED|Overall Study||1||
60016177|NCT02395653|76132516|FG000|NOT COMPLETED|Overall Study||12||
60016178|NCT01664923|76132522|FG000|STARTED|Period1:Double Blind Phase-29 Months||198||
60016179|NCT01664923|76132523|FG001|STARTED|Period1:Double Blind Phase-29 Months||198||
60016180|NCT01664923|76132522|FG000|Received Study Treatment|Period1:Double Blind Phase-29 Months||197||
60016181|NCT01664923|76132523|FG001|Received Study Treatment|Period1:Double Blind Phase-29 Months||198||
60016182|NCT01664923|76132522|FG000|COMPLETED|Period1:Double Blind Phase-29 Months||93||
60016183|NCT01664923|76132523|FG001|COMPLETED|Period1:Double Blind Phase-29 Months||38||
59758476|NCT03695250|75877750|FG000|COMPLETED|Overall Study||8||
59908385|NCT03365102|76029567|FG002|NOT COMPLETED|Overall Study||1||
59758477|NCT03695250|75877750|FG000|NOT COMPLETED|Overall Study||0||
59758478|NCT03329378|75877756|FG000|STARTED|Overall Study||2||
59758479|NCT03329378|75877757|FG001|STARTED|Overall Study||5||
59908386|NCT01316900|76029579|FG000|STARTED|Overall Study||209||
59908387|NCT01316900|76029580|FG001|STARTED|Overall Study||212||
59908388|NCT01316900|76029581|FG002|STARTED|Overall Study||214||
60016184|NCT01664923|76132522|FG000|NOT COMPLETED|Period1:Double Blind Phase-29 Months||105||
60016185|NCT01664923|76132523|FG001|NOT COMPLETED|Period1:Double Blind Phase-29 Months||160||
60016186|NCT01664923|76132522|FG000|STARTED|Period 2: Open-label Phase-36 Months||93||
60016187|NCT01664923|76132523|FG001|STARTED|Period 2: Open-label Phase-36 Months||38||
59908389|NCT01316900|76029582|FG003|STARTED|Overall Study||208||
59908390|NCT01316900|76029579|FG000|COMPLETED|Overall Study||165||
59908391|NCT01316900|76029580|FG001|COMPLETED|Overall Study||181||
59908392|NCT01316900|76029581|FG002|COMPLETED|Overall Study||173||
59908393|NCT01316900|76029582|FG003|COMPLETED|Overall Study||177||
59908394|NCT01316900|76029579|FG000|NOT COMPLETED|Overall Study||44||
59908395|NCT01316900|76029580|FG001|NOT COMPLETED|Overall Study||31||
59908396|NCT01316900|76029581|FG002|NOT COMPLETED|Overall Study||41||
59908397|NCT01316900|76029582|FG003|NOT COMPLETED|Overall Study||31||
59908398|NCT03499873|76029595|FG000|STARTED|Overall Study||183||
59908399|NCT03499873|76029596|FG001|STARTED|Overall Study||182||
59908400|NCT03499873|76029597|FG002|STARTED|Overall Study||83||
59908401|NCT03499873|76029595|FG000|Safety Population|Overall Study||175||
59908402|NCT03499873|76029596|FG001|Safety Population|Overall Study||174||
59908403|NCT03499873|76029597|FG002|Safety Population|Overall Study||80||
59908404|NCT03499873|76029595|FG000|Per-Protocol Population|Overall Study||144||
59908405|NCT03499873|76029596|FG001|Per-Protocol Population|Overall Study||143||
59908406|NCT03499873|76029597|FG002|Per-Protocol Population|Overall Study||58||
59908407|NCT03499873|76029595|FG000|Modified-Intent-to-Treat|Overall Study||170||
59908408|NCT03499873|76029596|FG001|Modified-Intent-to-Treat|Overall Study||168||
59908409|NCT03499873|76029597|FG002|Modified-Intent-to-Treat|Overall Study||77||
59908410|NCT03499873|76029595|FG000|COMPLETED|Overall Study||163||
59908411|NCT03499873|76029596|FG001|COMPLETED|Overall Study||162||
59908412|NCT03499873|76029597|FG002|COMPLETED|Overall Study||56||
59908413|NCT03499873|76029595|FG000|NOT COMPLETED|Overall Study||20||
59908414|NCT03499873|76029596|FG001|NOT COMPLETED|Overall Study||20||
59908415|NCT03499873|76029597|FG002|NOT COMPLETED|Overall Study||27||
59908416|NCT03467971|76029607|FG000|STARTED|Treatment Period 1||10||
59908417|NCT03467971|76029608|FG001|STARTED|Treatment Period 1||11||
59908418|NCT03467971|76029607|FG000|COMPLETED|Treatment Period 1||10||
59908419|NCT03467971|76029608|FG001|COMPLETED|Treatment Period 1||11||
59908420|NCT03467971|76029607|FG000|NOT COMPLETED|Treatment Period 1||0||
59908421|NCT03467971|76029608|FG001|NOT COMPLETED|Treatment Period 1||0||
59908422|NCT03467971|76029607|FG000|STARTED|Treatment Period 2||10||
59908423|NCT03467971|76029608|FG001|STARTED|Treatment Period 2||11||
59908424|NCT03467971|76029607|FG000|COMPLETED|Treatment Period 2||10||
59908425|NCT03467971|76029608|FG001|COMPLETED|Treatment Period 2||10||
59908426|NCT03467971|76029607|FG000|NOT COMPLETED|Treatment Period 2||0||
59908427|NCT03467971|76029608|FG001|NOT COMPLETED|Treatment Period 2||1||
59908428|NCT03138590|76029617|FG000|STARTED|Overall Study||10||
59908429|NCT03138590|76029618|FG001|STARTED|Overall Study||10||
59908430|NCT03138590|76029617|FG000|COMPLETED|Overall Study||10||
59908431|NCT03138590|76029618|FG001|COMPLETED|Overall Study||10||
59908432|NCT03138590|76029617|FG000|NOT COMPLETED|Overall Study||0||
59908433|NCT03138590|76029618|FG001|NOT COMPLETED|Overall Study||0||
59908434|NCT03049280|76029624|FG000|STARTED|Overall Study||33||
59908435|NCT03049280|76029624|FG000|COMPLETED|Overall Study||32||
59908436|NCT03049280|76029624|FG000|NOT COMPLETED|Overall Study||1||
59908437|NCT03048500|76029630|FG000|STARTED|2 Cycles of Treatment||17||
59908438|NCT03048500|76029630|FG000|Attempted 1st Cycle|2 Cycles of Treatment||17||
59908439|NCT03048500|76029630|FG000|Attempted 2nd Cycle|2 Cycles of Treatment||16||
59908440|NCT03048500|76029630|FG000|COMPLETED|2 Cycles of Treatment||16||
59908441|NCT03048500|76029630|FG000|NOT COMPLETED|2 Cycles of Treatment||1||
59908442|NCT03048500|76029630|FG000|STARTED|Reached 1st Response/Continued Treatment||16||
59908443|NCT03048500|76029630|FG000|Assessed for First Response|Reached 1st Response/Continued Treatment||16||
59908444|NCT03048500|76029630|FG000|Went on to Cycle 3 and Beyond|Reached 1st Response/Continued Treatment||9||
59908445|NCT03048500|76029630|FG000|COMPLETED|Reached 1st Response/Continued Treatment||9||
59908446|NCT03048500|76029630|FG000|NOT COMPLETED|Reached 1st Response/Continued Treatment||7||
59908447|NCT03048500|76029630|FG000|STARTED|Follow up for 3 Years|1 patient died whilst on study.|16|All patients that are treated on study go into the follow-up period.|
59908448|NCT03048500|76029630|FG000|COMPLETED|Follow up for 3 Years||0||
59908449|NCT03048500|76029630|FG000|NOT COMPLETED|Follow up for 3 Years||16||
59908450|NCT00908076|76029636|FG000|STARTED|Overall Study||27||
59908451|NCT00908076|76029637|FG001|STARTED|Overall Study||27||
59908452|NCT00908076|76029636|FG000|COMPLETED|Overall Study||26||
59908453|NCT00908076|76029637|FG001|COMPLETED|Overall Study||26||
59908454|NCT00908076|76029636|FG000|NOT COMPLETED|Overall Study||1||
59908455|NCT00908076|76029637|FG001|NOT COMPLETED|Overall Study||1||
59908456|NCT03467425|76029645|FG000|STARTED|Overall Study||1545||
59908457|NCT03467425|76029646|FG001|STARTED|Overall Study||1547||
59908458|NCT03467425|76029645|FG000|Randomized But Did Not Start IP|Overall Study||1||
59908459|NCT03467425|76029646|FG001|Randomized But Did Not Start IP|Overall Study||0||
59908460|NCT03467425|76029645|FG000|Completed IP|Overall Study||1256||
59908461|NCT03467425|76029646|FG001|Completed IP|Overall Study||1359||
59908462|NCT03467425|76029645|FG000|Not Completed IP|Overall Study||288||
59908463|NCT03467425|76029646|FG001|Not Completed IP|Overall Study||188||
59908464|NCT03467425|76029645|FG000|Withdrew IP (WIP): Lost to Follow-up|Overall Study||15||
59908465|NCT03467425|76029646|FG001|Withdrew IP (WIP): Lost to Follow-up|Overall Study||24||
59908466|NCT03467425|76029645|FG000|WIP: Protocol Deviation|Overall Study||0||
59908467|NCT03467425|76029646|FG001|WIP: Protocol Deviation|Overall Study||2||
60016188|NCT01664923|76132522|FG000|Treated|Period 2: Open-label Phase-36 Months||93||
60016189|NCT01664923|76132523|FG001|Treated|Period 2: Open-label Phase-36 Months||37||
60016190|NCT01664923|76132522|FG000|COMPLETED|Period 2: Open-label Phase-36 Months||52||
60016191|NCT01664923|76132523|FG001|COMPLETED|Period 2: Open-label Phase-36 Months||15||
59506235|NCT00766753|75599145|FG000|Completed at Least Four Vaccines|Overall Study||10||
59506236|NCT00766753|75599146|FG001|Completed at Least Four Vaccines|Overall Study||9||
59908468|NCT03467425|76029645|FG000|WIP: Adverse Event|Overall Study||112||
59908469|NCT03467425|76029646|FG001|WIP: Adverse Event|Overall Study||29||
59908470|NCT03467425|76029645|FG000|WIP: Lack of Efficacy|Overall Study||56||
59908471|NCT03467425|76029646|FG001|WIP: Lack of Efficacy|Overall Study||28||
59908472|NCT03467425|76029645|FG000|WIP: Physician Decision|Overall Study||14||
59908473|NCT03467425|76029646|FG001|WIP: Physician Decision|Overall Study||27||
59908474|NCT03467425|76029645|FG000|WIP: Withdrawal by Participant|Overall Study||91||
59908475|NCT03467425|76029646|FG001|WIP: Withdrawal by Participant|Overall Study||78||
59908476|NCT03467425|76029645|FG000|COMPLETED|Overall Study||1498||
59908477|NCT03467425|76029646|FG001|COMPLETED|Overall Study||1493||
59908478|NCT03467425|76029645|FG000|NOT COMPLETED|Overall Study||47||
59908479|NCT03467425|76029646|FG001|NOT COMPLETED|Overall Study||54||
59908480|NCT02886702|76029655|FG000|STARTED|Overall Study||284|Randomized (Safety Population)|
59908481|NCT02886702|76029656|FG001|STARTED|Overall Study||286|Randomized (Safety Population)|
59908482|NCT02886702|76029657|FG002|STARTED|Overall Study||285|Randomized (Safety Population)|
59908483|NCT02886702|76029655|FG000|Modified Intent-to Treat (mITT)|Overall Study||263|met all inclusion/exclusion criteria, received study treatment, and had a post-Baseline evaluation|
59908484|NCT02886702|76029656|FG001|Modified Intent-to Treat (mITT)|Overall Study||266|met all inclusion/exclusion criteria, received study treatment, and had a post-Baseline evaluation|
59908485|NCT02886702|76029657|FG002|Modified Intent-to Treat (mITT)|Overall Study||275|met all inclusion/exclusion criteria, received study treatment, and had a post-Baseline evaluation|
59908486|NCT02886702|76029655|FG000|Per-Protocol Population (PP)|Overall Study||208|all randomized subjects who complied with the protocol|
59908487|NCT02886702|76029656|FG001|Per-Protocol Population (PP)|Overall Study||209|all randomized subjects who complied with the protocol|
59908488|NCT02886702|76029657|FG002|Per-Protocol Population (PP)|Overall Study||201|all randomized subjects who complied with the protocol|
59908489|NCT02886702|76029655|FG000|COMPLETED|Overall Study||236||
59908490|NCT02886702|76029656|FG001|COMPLETED|Overall Study||235||
59908491|NCT02886702|76029657|FG002|COMPLETED|Overall Study||232||
59908492|NCT02886702|76029655|FG000|NOT COMPLETED|Overall Study||48||
59908493|NCT02886702|76029656|FG001|NOT COMPLETED|Overall Study||51||
59908494|NCT02886702|76029657|FG002|NOT COMPLETED|Overall Study||53||
59908495|NCT03498313|76029671|FG000|STARTED|Experimental Period 1||9||
59908496|NCT03498313|76029672|FG001|STARTED|Experimental Period 1||8||
59908497|NCT03498313|76029673|FG002|STARTED|Experimental Period 1||9||
59908498|NCT03498313|76029674|FG003|STARTED|Experimental Period 1||5||
59908499|NCT03498313|76029675|FG004|STARTED|Experimental Period 1||9||
59908500|NCT03498313|76029676|FG005|STARTED|Experimental Period 1||6||
59908501|NCT03498313|76029671|FG000|COMPLETED|Experimental Period 1||8||
59908502|NCT03498313|76029672|FG001|COMPLETED|Experimental Period 1||7||
59908503|NCT03498313|76029673|FG002|COMPLETED|Experimental Period 1||9||
59908504|NCT03498313|76029674|FG003|COMPLETED|Experimental Period 1||4||
59908505|NCT03498313|76029675|FG004|COMPLETED|Experimental Period 1||9||
59908506|NCT03498313|76029676|FG005|COMPLETED|Experimental Period 1||6||
59908507|NCT03498313|76029671|FG000|NOT COMPLETED|Experimental Period 1||1||
59908508|NCT03498313|76029672|FG001|NOT COMPLETED|Experimental Period 1||1||
59908509|NCT03498313|76029673|FG002|NOT COMPLETED|Experimental Period 1||0||
59908510|NCT03498313|76029674|FG003|NOT COMPLETED|Experimental Period 1||1||
59908511|NCT03498313|76029675|FG004|NOT COMPLETED|Experimental Period 1||0||
59908512|NCT03498313|76029676|FG005|NOT COMPLETED|Experimental Period 1||0||
59908513|NCT03498313|76029671|FG000|STARTED|Washout Period 1||8||
59908514|NCT03498313|76029672|FG001|STARTED|Washout Period 1||7||
59908515|NCT03498313|76029673|FG002|STARTED|Washout Period 1||9||
59908516|NCT03498313|76029674|FG003|STARTED|Washout Period 1||4||
59908517|NCT03498313|76029675|FG004|STARTED|Washout Period 1||9||
59908518|NCT03498313|76029676|FG005|STARTED|Washout Period 1||6||
59908519|NCT03498313|76029671|FG000|COMPLETED|Washout Period 1||7||
59908520|NCT03498313|76029672|FG001|COMPLETED|Washout Period 1||4||
59908521|NCT03498313|76029673|FG002|COMPLETED|Washout Period 1||9||
59506237|NCT00766753|75599145|FG000|COMPLETED|Overall Study||11||
59506238|NCT00766753|75599146|FG001|COMPLETED|Overall Study||11||
59908522|NCT03498313|76029674|FG003|COMPLETED|Washout Period 1||3||
59908523|NCT03498313|76029675|FG004|COMPLETED|Washout Period 1||9||
59506239|NCT00766753|75599145|FG000|NOT COMPLETED|Overall Study||0||
59506240|NCT00766753|75599146|FG001|NOT COMPLETED|Overall Study||0||
59506241|NCT00767767|75599158|FG000|STARTED|Overall Study||21||
59506242|NCT00767767|75599159|FG001|STARTED|Overall Study||20||
59506243|NCT00767767|75599160|FG002|STARTED|Overall Study||20||
59506244|NCT00767767|75599161|FG003|STARTED|Overall Study||3||
59908524|NCT03498313|76029676|FG005|COMPLETED|Washout Period 1||5||
60016192|NCT01664923|76132522|FG000|NOT COMPLETED|Period 2: Open-label Phase-36 Months||41||
60016193|NCT01664923|76132523|FG001|NOT COMPLETED|Period 2: Open-label Phase-36 Months||23||
60016194|NCT01664533|76132533|FG000|STARTED|Overall Study||57||
59506245|NCT00767767|75599162|FG004|STARTED|Overall Study||3||
59506246|NCT00767767|75599158|FG000|COMPLETED|Overall Study||21||
59506247|NCT00767767|75599159|FG001|COMPLETED|Overall Study||20||
59506248|NCT00767767|75599160|FG002|COMPLETED|Overall Study||20||
59506249|NCT00767767|75599161|FG003|COMPLETED|Overall Study||3||
59908525|NCT03498313|76029671|FG000|NOT COMPLETED|Washout Period 1||1||
59908526|NCT03498313|76029672|FG001|NOT COMPLETED|Washout Period 1||3||
59908527|NCT03498313|76029673|FG002|NOT COMPLETED|Washout Period 1||0||
59908528|NCT03498313|76029674|FG003|NOT COMPLETED|Washout Period 1||1||
59908529|NCT03498313|76029675|FG004|NOT COMPLETED|Washout Period 1||0||
59908530|NCT03498313|76029676|FG005|NOT COMPLETED|Washout Period 1||1||
59908531|NCT03498313|76029671|FG000|STARTED|Experimental Period 2||7||
59908532|NCT03498313|76029672|FG001|STARTED|Experimental Period 2||4||
59908533|NCT03498313|76029673|FG002|STARTED|Experimental Period 2||9||
59908534|NCT03498313|76029674|FG003|STARTED|Experimental Period 2||3||
59908535|NCT03498313|76029675|FG004|STARTED|Experimental Period 2||9||
59908536|NCT03498313|76029676|FG005|STARTED|Experimental Period 2||5||
59908537|NCT03498313|76029671|FG000|COMPLETED|Experimental Period 2||7||
59908538|NCT03498313|76029672|FG001|COMPLETED|Experimental Period 2||4||
59908539|NCT03498313|76029673|FG002|COMPLETED|Experimental Period 2||9||
59908540|NCT03498313|76029674|FG003|COMPLETED|Experimental Period 2||3||
59908541|NCT03498313|76029675|FG004|COMPLETED|Experimental Period 2||8||
60016195|NCT01664533|76132533|FG000|COMPLETED|Overall Study||0||
60016196|NCT01664533|76132533|FG000|NOT COMPLETED|Overall Study||57||
60016197|NCT02584855|76132538|FG000|STARTED|Open-Label Treatment Period||394||
60016198|NCT02584855|76132539|FG001|STARTED|Open-Label Treatment Period|Participants completed Open-Label Treatment Period.|0||
60016199|NCT02584855|76132540|FG002|STARTED|Open-Label Treatment Period|Participants were randomized to this arm during double-blind withdrawal period.|0||
60016200|NCT02584855|76132541|FG003|STARTED|Open-Label Treatment Period|Participants were randomized to this arm during double-blind withdrawal period.|0||
60016201|NCT02584855|76132542|FG004|STARTED|Open-Label Treatment Period||0||
60016202|NCT02584855|76132543|FG005|STARTED|Open-Label Treatment Period||0||
60016203|NCT02584855|76132538|FG000|Received at Least One Dose of Study Drug|Open-Label Treatment Period||394||
60016204|NCT02584855|76132539|FG001|Received at Least One Dose of Study Drug|Open-Label Treatment Period||0||
60016205|NCT02584855|76132540|FG002|Received at Least One Dose of Study Drug|Open-Label Treatment Period||0||
60016206|NCT02584855|76132541|FG003|Received at Least One Dose of Study Drug|Open-Label Treatment Period||0||
60016207|NCT02584855|76132542|FG004|Received at Least One Dose of Study Drug|Open-Label Treatment Period||0||
60016208|NCT02584855|76132543|FG005|Received at Least One Dose of Study Drug|Open-Label Treatment Period||0||
60016209|NCT02584855|76132538|FG000|Met Randomization Criteria|Open-Label Treatment Period||158||
60016210|NCT02584855|76132539|FG001|Met Randomization Criteria|Open-Label Treatment Period||0||
60016211|NCT02584855|76132540|FG002|Met Randomization Criteria|Open-Label Treatment Period||0||
60016212|NCT02584855|76132541|FG003|Met Randomization Criteria|Open-Label Treatment Period||0||
60016213|NCT02584855|76132542|FG004|Met Randomization Criteria|Open-Label Treatment Period||0||
60016214|NCT02584855|76132543|FG005|Met Randomization Criteria|Open-Label Treatment Period||0||
60016215|NCT02584855|76132538|FG000|Non-randomized|Open-Label Treatment Period||133||
60016216|NCT02584855|76132539|FG001|Non-randomized|Open-Label Treatment Period||0||
60016217|NCT02584855|76132540|FG002|Non-randomized|Open-Label Treatment Period||0||
60016218|NCT02584855|76132541|FG003|Non-randomized|Open-Label Treatment Period||0||
60016219|NCT02584855|76132542|FG004|Non-randomized|Open-Label Treatment Period||0||
60016220|NCT02584855|76132543|FG005|Non-randomized|Open-Label Treatment Period||0||
60016221|NCT02584855|76132538|FG000|COMPLETED|Open-Label Treatment Period||291||
60016222|NCT02584855|76132539|FG001|COMPLETED|Open-Label Treatment Period||0||
60016223|NCT02584855|76132540|FG002|COMPLETED|Open-Label Treatment Period||0||
60016224|NCT02584855|76132541|FG003|COMPLETED|Open-Label Treatment Period||0||
60016225|NCT02584855|76132542|FG004|COMPLETED|Open-Label Treatment Period||0||
60016226|NCT02584855|76132543|FG005|COMPLETED|Open-Label Treatment Period||0||
60016227|NCT02584855|76132538|FG000|NOT COMPLETED|Open-Label Treatment Period||103||
60016228|NCT02584855|76132539|FG001|NOT COMPLETED|Open-Label Treatment Period||0||
60016229|NCT02584855|76132540|FG002|NOT COMPLETED|Open-Label Treatment Period||0||
60016230|NCT02584855|76132541|FG003|NOT COMPLETED|Open-Label Treatment Period||0||
60016231|NCT02584855|76132542|FG004|NOT COMPLETED|Open-Label Treatment Period||0||
60016232|NCT02584855|76132543|FG005|NOT COMPLETED|Open-Label Treatment Period||0||
60016233|NCT02584855|76132538|FG000|STARTED|Double-Blind Withdrawal Period||0||
60016234|NCT02584855|76132539|FG001|STARTED|Double-Blind Withdrawal Period|Participants completed open label but did not meet criteria for double-blind withdrawal period.|133||
60016235|NCT02584855|76132540|FG002|STARTED|Double-Blind Withdrawal Period|Participants completed open label and met criteria for double-blind withdrawal period.|79||
59506250|NCT00767767|75599162|FG004|COMPLETED|Overall Study||3||
59506251|NCT00767767|75599158|FG000|NOT COMPLETED|Overall Study||0||
59506252|NCT00767767|75599159|FG001|NOT COMPLETED|Overall Study||0||
59506253|NCT00767767|75599160|FG002|NOT COMPLETED|Overall Study||0||
59908542|NCT03498313|76029676|FG005|COMPLETED|Experimental Period 2||3||
59908543|NCT03498313|76029671|FG000|NOT COMPLETED|Experimental Period 2||0||
59908544|NCT03498313|76029672|FG001|NOT COMPLETED|Experimental Period 2||0||
59908545|NCT03498313|76029673|FG002|NOT COMPLETED|Experimental Period 2||0||
59908546|NCT03498313|76029674|FG003|NOT COMPLETED|Experimental Period 2||0||
59908547|NCT03498313|76029675|FG004|NOT COMPLETED|Experimental Period 2||1||
59908548|NCT03498313|76029676|FG005|NOT COMPLETED|Experimental Period 2||2||
59908549|NCT03498313|76029671|FG000|STARTED|Washout Period 2||7||
59908550|NCT03498313|76029672|FG001|STARTED|Washout Period 2||4||
59908551|NCT03498313|76029673|FG002|STARTED|Washout Period 2||9||
59908552|NCT03498313|76029674|FG003|STARTED|Washout Period 2||3||
59908553|NCT03498313|76029675|FG004|STARTED|Washout Period 2||8||
59908554|NCT03498313|76029676|FG005|STARTED|Washout Period 2||3||
59908555|NCT03498313|76029671|FG000|COMPLETED|Washout Period 2||3||
59908556|NCT03498313|76029672|FG001|COMPLETED|Washout Period 2||2||
59908557|NCT03498313|76029673|FG002|COMPLETED|Washout Period 2||9||
59908558|NCT03498313|76029674|FG003|COMPLETED|Washout Period 2||2||
59908559|NCT03498313|76029675|FG004|COMPLETED|Washout Period 2||6||
59908560|NCT03498313|76029676|FG005|COMPLETED|Washout Period 2||1||
59908561|NCT03498313|76029671|FG000|NOT COMPLETED|Washout Period 2||4||
59908562|NCT03498313|76029672|FG001|NOT COMPLETED|Washout Period 2||2||
59908563|NCT03498313|76029673|FG002|NOT COMPLETED|Washout Period 2||0||
59908564|NCT03498313|76029674|FG003|NOT COMPLETED|Washout Period 2||1||
59908565|NCT03498313|76029675|FG004|NOT COMPLETED|Washout Period 2||2||
59908566|NCT03498313|76029676|FG005|NOT COMPLETED|Washout Period 2||2||
59908567|NCT03498313|76029671|FG000|STARTED|Experimental Period 3||3||
59506254|NCT00767767|75599161|FG003|NOT COMPLETED|Overall Study||0||
59506255|NCT00767767|75599162|FG004|NOT COMPLETED|Overall Study||0||
59506256|NCT00761345|75599174|FG000|STARTED|Overall Study||27||
59506257|NCT00761345|75599174|FG000|COMPLETED|Overall Study||24||
59506258|NCT00761345|75599174|FG000|NOT COMPLETED|Overall Study||3||
59506259|NCT00761813|75599180|FG000|STARTED|Overall Study||557||
59506260|NCT00761813|75599181|FG001|STARTED|Overall Study||551||
59506261|NCT00761813|75599180|FG000|COMPLETED|Overall Study||542||
59506262|NCT00761813|75599181|FG001|COMPLETED|Overall Study||537||
59506263|NCT00761813|75599180|FG000|NOT COMPLETED|Overall Study||15||
59506264|NCT00761813|75599181|FG001|NOT COMPLETED|Overall Study||14||
59506265|NCT00762515|75599189|FG000|STARTED|Overall Study||22||
59506266|NCT00762515|75599190|FG001|STARTED|Overall Study||22||
59506267|NCT00762515|75599189|FG000|COMPLETED|Overall Study||22||
59908568|NCT03498313|76029672|FG001|STARTED|Experimental Period 3||2||
59908569|NCT03498313|76029673|FG002|STARTED|Experimental Period 3||9||
59908570|NCT03498313|76029674|FG003|STARTED|Experimental Period 3||2||
59908571|NCT03498313|76029675|FG004|STARTED|Experimental Period 3||6||
59908572|NCT03498313|76029676|FG005|STARTED|Experimental Period 3||1||
59908573|NCT03498313|76029671|FG000|COMPLETED|Experimental Period 3||3||
59506268|NCT00762515|75599190|FG001|COMPLETED|Overall Study||22||
59506269|NCT00762515|75599189|FG000|NOT COMPLETED|Overall Study||0||
59506270|NCT00762515|75599190|FG001|NOT COMPLETED|Overall Study||0||
59908574|NCT03498313|76029672|FG001|COMPLETED|Experimental Period 3||2||
59908575|NCT03498313|76029673|FG002|COMPLETED|Experimental Period 3||9||
59908576|NCT03498313|76029674|FG003|COMPLETED|Experimental Period 3||2||
59908577|NCT03498313|76029675|FG004|COMPLETED|Experimental Period 3||6||
59908578|NCT03498313|76029676|FG005|COMPLETED|Experimental Period 3||1||
59908579|NCT03498313|76029671|FG000|NOT COMPLETED|Experimental Period 3||0||
59506271|NCT00753935|75599198|FG000|STARTED|Overall Study||45||
59506272|NCT00753935|75599199|FG001|STARTED|Overall Study||47||
59506273|NCT00753935|75599198|FG000|COMPLETED|Overall Study||45||
59506274|NCT00753935|75599199|FG001|COMPLETED|Overall Study||47||
59506275|NCT00753935|75599198|FG000|NOT COMPLETED|Overall Study||0||
59506276|NCT00753935|75599199|FG001|NOT COMPLETED|Overall Study||0||
59908580|NCT03498313|76029672|FG001|NOT COMPLETED|Experimental Period 3||0||
59908581|NCT03498313|76029673|FG002|NOT COMPLETED|Experimental Period 3||0||
59908582|NCT03498313|76029674|FG003|NOT COMPLETED|Experimental Period 3||0||
59908583|NCT03498313|76029675|FG004|NOT COMPLETED|Experimental Period 3||0||
59908584|NCT03498313|76029676|FG005|NOT COMPLETED|Experimental Period 3||0||
59908585|NCT02601014|76029686|FG000|STARTED|Overall Study||15||
59908586|NCT02601014|76029687|FG001|STARTED|Overall Study||15||
59506277|NCT00779285|75599205|FG000|STARTED|Overall Study||1||
59908587|NCT02601014|76029686|FG000|COMPLETED|Overall Study||5||
59908588|NCT02601014|76029687|FG001|COMPLETED|Overall Study||3||
59908589|NCT02601014|76029686|FG000|NOT COMPLETED|Overall Study||10||
59908590|NCT02601014|76029687|FG001|NOT COMPLETED|Overall Study||12||
59506278|NCT00779285|75599205|FG000|COMPLETED|Overall Study||1||
59506279|NCT00779285|75599205|FG000|NOT COMPLETED|Overall Study||0||
59506280|NCT00786643|75599211|FG000|STARTED|Overall Study||20||
59506281|NCT00786643|75599212|FG001|STARTED|Overall Study||28||
59506282|NCT00786643|75599211|FG000|COMPLETED|Overall Study||20||
59506283|NCT00786643|75599212|FG001|COMPLETED|Overall Study||28||
59506284|NCT00786643|75599211|FG000|NOT COMPLETED|Overall Study||0||
59506285|NCT00786643|75599212|FG001|NOT COMPLETED|Overall Study||0||
59506286|NCT01276379|75599220|FG000|STARTED|Overall Study||221||
59506287|NCT01276379|75599220|FG000|COMPLETED|Overall Study||181||
59506288|NCT01276379|75599220|FG000|NOT COMPLETED|Overall Study||40||
59506289|NCT00789685|75599226|FG000|STARTED|Overall Study||37||
59506290|NCT00789685|75599226|FG000|COMPLETED|Overall Study|Completed the study to Day 28|25||
59506291|NCT00789685|75599226|FG000|NOT COMPLETED|Overall Study||12||
59506292|NCT00769015|75599232|FG000|STARTED|Overall Study||96||
59506293|NCT00769015|75599233|FG001|STARTED|Overall Study||92||
59506294|NCT00769015|75599232|FG000|COMPLETED|Overall Study||87||
59506295|NCT00769015|75599233|FG001|COMPLETED|Overall Study||76||
59506296|NCT00769015|75599232|FG000|NOT COMPLETED|Overall Study||9||
59506297|NCT00769015|75599233|FG001|NOT COMPLETED|Overall Study||16||
59506298|NCT02149303|75599239|FG000|STARTED|Overall Study||191||
59506299|NCT02149303|75599239|FG000|COMPLETED|Overall Study||191||
59506300|NCT02149303|75599239|FG000|NOT COMPLETED|Overall Study||0||
59506301|NCT00771277|75599243|FG000|STARTED|Overall Study||6||
59506302|NCT00771277|75599243|FG000|COMPLETED|Overall Study||6||
59506303|NCT00771277|75599243|FG000|NOT COMPLETED|Overall Study||0||
59506304|NCT00789997|75599249|FG000|STARTED|Overall Study||41||
59506305|NCT00789997|75599250|FG001|STARTED|Overall Study||40||
59506306|NCT00789997|75599249|FG000|COMPLETED|Overall Study||40||
59506307|NCT00789997|75599250|FG001|COMPLETED|Overall Study||38||
59506308|NCT00789997|75599249|FG000|NOT COMPLETED|Overall Study||1||
59506309|NCT00789997|75599250|FG001|NOT COMPLETED|Overall Study||2||
59506310|NCT00771745|75599258|FG000|STARTED|Overall Study||6||
59506311|NCT00771745|75599259|FG001|STARTED|Overall Study||5||
59506312|NCT00771745|75599258|FG000|COMPLETED|Overall Study||6||
59506313|NCT00771745|75599259|FG001|COMPLETED|Overall Study||5||
59506314|NCT00771745|75599258|FG000|NOT COMPLETED|Overall Study||0||
59506315|NCT00771745|75599259|FG001|NOT COMPLETED|Overall Study||0||
59506316|NCT02148835|75599267|FG000|STARTED|Overall Study||22||
59506317|NCT02148835|75599268|FG001|STARTED|Overall Study||22||
59506318|NCT02148835|75599267|FG000|COMPLETED|Overall Study||22||
59506319|NCT02148835|75599268|FG001|COMPLETED|Overall Study||22||
59506320|NCT02148835|75599267|FG000|NOT COMPLETED|Overall Study||0||
59506321|NCT02148835|75599268|FG001|NOT COMPLETED|Overall Study||0||
59506322|NCT00790699|75599276|FG000|STARTED|Overall Study||17||
59506323|NCT00790699|75599277|FG001|STARTED|Overall Study||14||
59506324|NCT00790699|75599276|FG000|COMPLETED|Overall Study||16||
59506325|NCT00790699|75599277|FG001|COMPLETED|Overall Study||14||
59506326|NCT00790699|75599276|FG000|NOT COMPLETED|Overall Study||1||
59506327|NCT00790699|75599277|FG001|NOT COMPLETED|Overall Study||0||
59506328|NCT00790855|75599285|FG000|STARTED|Overall Study||25||
59506329|NCT00790855|75599285|FG000|COMPLETED|Overall Study||25||
59506330|NCT00790855|75599285|FG000|NOT COMPLETED|Overall Study||0||
59506331|NCT00791089|75599292|FG000|STARTED|Overall Study||6||
59506332|NCT00791089|75599293|FG001|STARTED|Overall Study||6||
59506333|NCT00791089|75599292|FG000|Began Actually Taking Fish Oil or Placeb|Overall Study||6||
59506334|NCT00791089|75599293|FG001|Began Actually Taking Fish Oil or Placeb|Overall Study||5||
59506335|NCT00791089|75599292|FG000|Six-month Data Collected|Overall Study||6||
59506336|NCT00791089|75599293|FG001|Six-month Data Collected|Overall Study||5||
59506337|NCT00791089|75599292|FG000|COMPLETED|Overall Study||0||
59506338|NCT00791089|75599293|FG001|COMPLETED|Overall Study||0||
59506339|NCT00791089|75599292|FG000|NOT COMPLETED|Overall Study||6||
59506340|NCT00791089|75599293|FG001|NOT COMPLETED|Overall Study||6||
59506341|NCT00791323|75599301|FG000|STARTED|Overall Study||6||
59506342|NCT00791323|75599302|FG001|STARTED|Overall Study||3||
59506343|NCT00791323|75599301|FG000|COMPLETED|Overall Study||6||
59506344|NCT00791323|75599302|FG001|COMPLETED|Overall Study||3||
59506345|NCT00791323|75599301|FG000|NOT COMPLETED|Overall Study||0||
60016236|NCT02584855|76132541|FG003|STARTED|Double-Blind Withdrawal Period|Participants completed open label and met criteria for double-blind withdrawal period.|79||
60016237|NCT02584855|76132542|FG004|STARTED|Double-Blind Withdrawal Period||0||
60016238|NCT02584855|76132543|FG005|STARTED|Double-Blind Withdrawal Period||0||
60016239|NCT02584855|76132538|FG000|Relapsed|Double-Blind Withdrawal Period||0||
60016240|NCT02584855|76132539|FG001|Relapsed|Double-Blind Withdrawal Period||0||
60016241|NCT02584855|76132540|FG002|Relapsed|Double-Blind Withdrawal Period||67||
60016242|NCT02584855|76132541|FG003|Relapsed|Double-Blind Withdrawal Period||30||
60016243|NCT02584855|76132542|FG004|Relapsed|Double-Blind Withdrawal Period||0||
60016244|NCT02584855|76132543|FG005|Relapsed|Double-Blind Withdrawal Period||0||
60016245|NCT02584855|76132538|FG000|COMPLETED|Double-Blind Withdrawal Period||0||
60016246|NCT02584855|76132539|FG001|COMPLETED|Double-Blind Withdrawal Period||118||
60016247|NCT02584855|76132540|FG002|COMPLETED|Double-Blind Withdrawal Period||77||
60016248|NCT02584855|76132541|FG003|COMPLETED|Double-Blind Withdrawal Period||78||
60016249|NCT02584855|76132542|FG004|COMPLETED|Double-Blind Withdrawal Period||0||
60016250|NCT02584855|76132543|FG005|COMPLETED|Double-Blind Withdrawal Period||0||
60016251|NCT02584855|76132538|FG000|NOT COMPLETED|Double-Blind Withdrawal Period||0||
60016252|NCT02584855|76132539|FG001|NOT COMPLETED|Double-Blind Withdrawal Period||15||
60016253|NCT02584855|76132540|FG002|NOT COMPLETED|Double-Blind Withdrawal Period||2||
60016254|NCT02584855|76132541|FG003|NOT COMPLETED|Double-Blind Withdrawal Period||1||
60016255|NCT02584855|76132542|FG004|NOT COMPLETED|Double-Blind Withdrawal Period||0||
60016256|NCT02584855|76132543|FG005|NOT COMPLETED|Double-Blind Withdrawal Period||0||
60016257|NCT02584855|76132538|FG000|STARTED|Post Treatment Follow-up Period||0||
60016258|NCT02584855|76132539|FG001|STARTED|Post Treatment Follow-up Period||0||
60016259|NCT02584855|76132540|FG002|STARTED|Post Treatment Follow-up Period||0||
60016260|NCT02584855|76132541|FG003|STARTED|Post Treatment Follow-up Period||0||
60016261|NCT02584855|76132542|FG004|STARTED|Post Treatment Follow-up Period||355||
60016262|NCT02584855|76132543|FG005|STARTED|Post Treatment Follow-up Period||12||
60016263|NCT02584855|76132538|FG000|COMPLETED|Post Treatment Follow-up Period||0||
60016264|NCT02584855|76132539|FG001|COMPLETED|Post Treatment Follow-up Period||0||
60016265|NCT02584855|76132540|FG002|COMPLETED|Post Treatment Follow-up Period||0||
60016266|NCT02584855|76132541|FG003|COMPLETED|Post Treatment Follow-up Period||0||
60016267|NCT02584855|76132542|FG004|COMPLETED|Post Treatment Follow-up Period||347||
60016268|NCT02584855|76132543|FG005|COMPLETED|Post Treatment Follow-up Period||12||
60016269|NCT02584855|76132538|FG000|NOT COMPLETED|Post Treatment Follow-up Period||0||
60016270|NCT02584855|76132539|FG001|NOT COMPLETED|Post Treatment Follow-up Period||0||
60016271|NCT02584855|76132540|FG002|NOT COMPLETED|Post Treatment Follow-up Period||0||
60016272|NCT02584855|76132541|FG003|NOT COMPLETED|Post Treatment Follow-up Period||0||
60016273|NCT02584855|76132542|FG004|NOT COMPLETED|Post Treatment Follow-up Period||8||
60016274|NCT02584855|76132543|FG005|NOT COMPLETED|Post Treatment Follow-up Period||0||
60016275|NCT02581345|76132558|FG000|STARTED|Part 1: up to Week 16||286||
60016276|NCT02581345|76132559|FG001|STARTED|Part 1: up to Week 16||286||
60016277|NCT02581345|76132560|FG002|STARTED|Part 1: up to Week 16||0||
60016278|NCT02581345|76132561|FG003|STARTED|Part 1: up to Week 16||0||
60016279|NCT02581345|76132558|FG000|COMPLETED|Part 1: up to Week 16||271||
59506346|NCT00791323|75599302|FG001|NOT COMPLETED|Overall Study||0||
59506347|NCT00772915|75599308|FG000|STARTED|Overall Study||38||
59506348|NCT00772915|75599308|FG000|COMPLETED|Overall Study||23||
59506349|NCT00772915|75599308|FG000|NOT COMPLETED|Overall Study||15||
59506350|NCT00774163|75599314|FG000|STARTED|Overall Study||30||
59506351|NCT00774163|75599315|FG001|STARTED|Overall Study||15||
59506352|NCT00774163|75599314|FG000|COMPLETED|Overall Study||30||
59506353|NCT00774163|75599315|FG001|COMPLETED|Overall Study||15||
59506354|NCT00774163|75599314|FG000|NOT COMPLETED|Overall Study||0||
59506355|NCT00774163|75599315|FG001|NOT COMPLETED|Overall Study||0||
59506356|NCT00775411|75599321|FG000|STARTED|Overall Study||44||
59506357|NCT00775411|75599321|FG000|COMPLETED|Overall Study||43||
59506358|NCT00775411|75599321|FG000|NOT COMPLETED|Overall Study||1||
59506359|NCT00808405|75599327|FG000|STARTED|Overall Study||61||
59506360|NCT00808405|75599328|FG001|STARTED|Overall Study||27||
59506361|NCT00808405|75599327|FG000|COMPLETED|Overall Study||61||
59506362|NCT00808405|75599328|FG001|COMPLETED|Overall Study||27||
59506363|NCT00808405|75599327|FG000|NOT COMPLETED|Overall Study||0||
60016280|NCT02581345|76132559|FG001|COMPLETED|Part 1: up to Week 16||263||
60016281|NCT02581345|76132560|FG002|COMPLETED|Part 1: up to Week 16||0||
60016282|NCT02581345|76132561|FG003|COMPLETED|Part 1: up to Week 16||0||
60016283|NCT02581345|76132558|FG000|NOT COMPLETED|Part 1: up to Week 16||15||
59506364|NCT00808405|75599328|FG001|NOT COMPLETED|Overall Study||0||
60016284|NCT02581345|76132559|FG001|NOT COMPLETED|Part 1: up to Week 16||23||
59506365|NCT00775645|75599336|FG000|STARTED|Overall Study||208||
59506366|NCT00775645|75599337|FG001|STARTED|Overall Study||201||
59506367|NCT00775645|75599336|FG000|COMPLETED|Overall Study||191||
60016285|NCT02581345|76132560|FG002|NOT COMPLETED|Part 1: up to Week 16||0||
60016286|NCT02581345|76132561|FG003|NOT COMPLETED|Part 1: up to Week 16||0||
60016287|NCT02581345|76132558|FG000|STARTED|Part 2: Week 17 to Week 47||271||
59506368|NCT00775645|75599337|FG001|COMPLETED|Overall Study||181||
59506369|NCT00775645|75599336|FG000|NOT COMPLETED|Overall Study||17||
59506370|NCT00775645|75599337|FG001|NOT COMPLETED|Overall Study||20||
59506371|NCT01974687|75599368|FG000|STARTED|Overall Study||6||
59506372|NCT01974687|75599369|FG001|STARTED|Overall Study||6||
59506373|NCT01974687|75599370|FG002|STARTED|Overall Study||6||
59506374|NCT01974687|75599371|FG003|STARTED|Overall Study||6||
59506375|NCT01974687|75599372|FG004|STARTED|Overall Study||2||
59506376|NCT01974687|75599373|FG005|STARTED|Overall Study||6||
59506377|NCT01974687|75599374|FG006|STARTED|Overall Study||3||
59506378|NCT01974687|75599375|FG007|STARTED|Overall Study||3||
59506379|NCT01974687|75599376|FG008|STARTED|Overall Study||3||
59506380|NCT01974687|75599377|FG009|STARTED|Overall Study||3||
59506381|NCT01974687|75599378|FG010|STARTED|Overall Study||3||
59506382|NCT01974687|75599379|FG011|STARTED|Overall Study||13||
59506383|NCT01974687|75599380|FG012|STARTED|Overall Study||13||
59506384|NCT01974687|75599381|FG013|STARTED|Overall Study||10||
59506385|NCT01974687|75599382|FG014|STARTED|Overall Study||19||
59506386|NCT01974687|75599383|FG015|STARTED|Overall Study||9||
59506387|NCT01974687|75599384|FG016|STARTED|Overall Study||9||
59506388|NCT01974687|75599385|FG017|STARTED|Overall Study||11||
59506389|NCT01974687|75599386|FG018|STARTED|Overall Study||9||
59506390|NCT01974687|75599387|FG019|STARTED|Overall Study||3||
59506391|NCT01974687|75599388|FG020|STARTED|Overall Study||3||
59506392|NCT01974687|75599389|FG021|STARTED|Overall Study||8||
59506393|NCT01974687|75599390|FG022|STARTED|Overall Study||8||
59506394|NCT01974687|75599391|FG023|STARTED|Overall Study||6||
59506395|NCT01974687|75599392|FG024|STARTED|Overall Study||10||
59506396|NCT01974687|75599368|FG000|Treated|Overall Study||6||
59506397|NCT01974687|75599369|FG001|Treated|Overall Study||6||
59506398|NCT01974687|75599370|FG002|Treated|Overall Study||6||
59506399|NCT01974687|75599371|FG003|Treated|Overall Study||6||
59506400|NCT01974687|75599372|FG004|Treated|Overall Study||2||
59506401|NCT01974687|75599373|FG005|Treated|Overall Study||6||
59506402|NCT01974687|75599374|FG006|Treated|Overall Study||3||
59506403|NCT01974687|75599375|FG007|Treated|Overall Study||3||
59506404|NCT01974687|75599376|FG008|Treated|Overall Study||3||
59506405|NCT01974687|75599377|FG009|Treated|Overall Study||3||
59506406|NCT01974687|75599378|FG010|Treated|Overall Study||3||
59506407|NCT01974687|75599379|FG011|Treated|Overall Study|2 participants discontinued prior to receiving study drug|11||
59506408|NCT01974687|75599380|FG012|Treated|Overall Study|3 participants discontinued prior to receiving study drug|10||
59506409|NCT01974687|75599381|FG013|Treated|Overall Study|2 participants discontinued prior to receiving study drug|8||
59506410|NCT01974687|75599382|FG014|Treated|Overall Study|1 participant discontinued prior to receiving study drug|18||
59506411|NCT01974687|75599383|FG015|Treated|Overall Study|1 participant discontinued prior to receiving study drug|8||
59506412|NCT01974687|75599384|FG016|Treated|Overall Study|1 participant discontinued prior to receiving study drug|8||
59506413|NCT01974687|75599385|FG017|Treated|Overall Study|3 participants discontinued prior to receiving study drug|8||
59506414|NCT01974687|75599386|FG018|Treated|Overall Study||9||
59506415|NCT01974687|75599387|FG019|Treated|Overall Study||3||
59506416|NCT01974687|75599388|FG020|Treated|Overall Study||3||
59506417|NCT01974687|75599389|FG021|Treated|Overall Study||8||
59506418|NCT01974687|75599390|FG022|Treated|Overall Study||8||
59506419|NCT01974687|75599391|FG023|Treated|Overall Study||6||
59506420|NCT01974687|75599392|FG024|Treated|Overall Study||10||
59506421|NCT01974687|75599368|FG000|COMPLETED|Overall Study||6||
59506422|NCT01974687|75599369|FG001|COMPLETED|Overall Study||6||
59506423|NCT01974687|75599370|FG002|COMPLETED|Overall Study||6||
59506424|NCT01974687|75599371|FG003|COMPLETED|Overall Study||6||
59506425|NCT01974687|75599372|FG004|COMPLETED|Overall Study||2||
59506426|NCT01974687|75599373|FG005|COMPLETED|Overall Study||6||
59506427|NCT01974687|75599374|FG006|COMPLETED|Overall Study||3||
59506428|NCT01974687|75599375|FG007|COMPLETED|Overall Study||3||
59506429|NCT01974687|75599376|FG008|COMPLETED|Overall Study||3||
59506430|NCT01974687|75599377|FG009|COMPLETED|Overall Study||3||
59506431|NCT01974687|75599378|FG010|COMPLETED|Overall Study||3||
59506432|NCT01974687|75599379|FG011|COMPLETED|Overall Study||11||
59506433|NCT01974687|75599380|FG012|COMPLETED|Overall Study||10||
59506434|NCT01974687|75599381|FG013|COMPLETED|Overall Study||8||
59506435|NCT01974687|75599382|FG014|COMPLETED|Overall Study||18||
59506436|NCT01974687|75599383|FG015|COMPLETED|Overall Study||8||
59506437|NCT01974687|75599384|FG016|COMPLETED|Overall Study||8||
59506438|NCT01974687|75599385|FG017|COMPLETED|Overall Study||8||
59506439|NCT01974687|75599386|FG018|COMPLETED|Overall Study||9||
59506440|NCT01974687|75599387|FG019|COMPLETED|Overall Study||3||
59506441|NCT01974687|75599388|FG020|COMPLETED|Overall Study||3||
59506442|NCT01974687|75599389|FG021|COMPLETED|Overall Study||8||
59506443|NCT01974687|75599390|FG022|COMPLETED|Overall Study||8||
59506444|NCT01974687|75599391|FG023|COMPLETED|Overall Study||6||
59506445|NCT01974687|75599392|FG024|COMPLETED|Overall Study||10||
59506446|NCT01974687|75599368|FG000|NOT COMPLETED|Overall Study||0||
59506447|NCT01974687|75599369|FG001|NOT COMPLETED|Overall Study||0||
59506448|NCT01974687|75599370|FG002|NOT COMPLETED|Overall Study||0||
59506449|NCT01974687|75599371|FG003|NOT COMPLETED|Overall Study||0||
59506450|NCT01974687|75599372|FG004|NOT COMPLETED|Overall Study||0||
59506451|NCT01974687|75599373|FG005|NOT COMPLETED|Overall Study||0||
59506452|NCT01974687|75599374|FG006|NOT COMPLETED|Overall Study||0||
59506453|NCT01974687|75599375|FG007|NOT COMPLETED|Overall Study||0||
60016288|NCT02581345|76132559|FG001|STARTED|Part 2: Week 17 to Week 47||0||
60016289|NCT02581345|76132560|FG002|STARTED|Part 2: Week 17 to Week 47||132||
60016290|NCT02581345|76132561|FG003|STARTED|Part 2: Week 17 to Week 47||131||
60016291|NCT02581345|76132558|FG000|COMPLETED|Part 2: Week 17 to Week 47||242||
60016292|NCT02581345|76132559|FG001|COMPLETED|Part 2: Week 17 to Week 47||0||
60016293|NCT02581345|76132560|FG002|COMPLETED|Part 2: Week 17 to Week 47||117||
60016294|NCT02581345|76132561|FG003|COMPLETED|Part 2: Week 17 to Week 47||119||
60016295|NCT02581345|76132558|FG000|NOT COMPLETED|Part 2: Week 17 to Week 47||29||
60016296|NCT02581345|76132559|FG001|NOT COMPLETED|Part 2: Week 17 to Week 47||0||
60016297|NCT02581345|76132560|FG002|NOT COMPLETED|Part 2: Week 17 to Week 47||15||
60016298|NCT02581345|76132561|FG003|NOT COMPLETED|Part 2: Week 17 to Week 47||12||
60016299|NCT02581189|76132579|FG000|STARTED|Overall Study||534||
60016300|NCT02581189|76132579|FG000|COMPLETED|Overall Study||481||
60016301|NCT02581189|76132579|FG000|NOT COMPLETED|Overall Study||53||
60016302|NCT02576977|76132588|FG000|STARTED|Overall Study||126||
60016303|NCT02576977|76132589|FG001|STARTED|Overall Study||125||
60016304|NCT02576977|76132588|FG000|Treated|Overall Study||122||
60016305|NCT02576977|76132589|FG001|Treated|Overall Study||123||
60016306|NCT02576977|76132588|FG000|COMPLETED|Overall Study||0||
60016307|NCT02576977|76132589|FG001|COMPLETED|Overall Study||0||
60016308|NCT02576977|76132588|FG000|NOT COMPLETED|Overall Study||126||
60016309|NCT02576977|76132589|FG001|NOT COMPLETED|Overall Study||125||
60016310|NCT05150964|76132595|FG000|STARTED|Overall Study||16||
60016311|NCT05150964|76132595|FG000|COMPLETED|Overall Study||14||
60016312|NCT05150964|76132595|FG000|NOT COMPLETED|Overall Study||2||
60016313|NCT04952402|76132603|FG000|STARTED|Overall Study||18||
60016314|NCT04952402|76132604|FG001|STARTED|Overall Study||25||
60016315|NCT04952402|76132603|FG000|Completed Two-dose Vaccine Series|Overall Study||18||
60016316|NCT04952402|76132604|FG001|Completed Two-dose Vaccine Series|Overall Study||25||
60016317|NCT04952402|76132603|FG000|COMPLETED|Overall Study||17||
60016318|NCT04952402|76132604|FG001|COMPLETED|Overall Study||21||
60016319|NCT04952402|76132603|FG000|NOT COMPLETED|Overall Study||1||
60016320|NCT04952402|76132604|FG001|NOT COMPLETED|Overall Study||4||
59506454|NCT01974687|75599376|FG008|NOT COMPLETED|Overall Study||0||
59506455|NCT01974687|75599377|FG009|NOT COMPLETED|Overall Study||0||
59506456|NCT01974687|75599378|FG010|NOT COMPLETED|Overall Study||0||
59506457|NCT01974687|75599379|FG011|NOT COMPLETED|Overall Study||2||
59506458|NCT01974687|75599380|FG012|NOT COMPLETED|Overall Study||3||
59506459|NCT01974687|75599381|FG013|NOT COMPLETED|Overall Study||2||
59506460|NCT01974687|75599382|FG014|NOT COMPLETED|Overall Study||1||
59506461|NCT01974687|75599383|FG015|NOT COMPLETED|Overall Study||1||
59506462|NCT01974687|75599384|FG016|NOT COMPLETED|Overall Study||1||
59506463|NCT01974687|75599385|FG017|NOT COMPLETED|Overall Study||3||
59506464|NCT01974687|75599386|FG018|NOT COMPLETED|Overall Study||0||
59506465|NCT01974687|75599387|FG019|NOT COMPLETED|Overall Study||0||
59506466|NCT01974687|75599388|FG020|NOT COMPLETED|Overall Study||0||
59506467|NCT01974687|75599389|FG021|NOT COMPLETED|Overall Study||0||
59506468|NCT01974687|75599390|FG022|NOT COMPLETED|Overall Study||0||
59506469|NCT01974687|75599391|FG023|NOT COMPLETED|Overall Study||0||
59506470|NCT01974687|75599392|FG024|NOT COMPLETED|Overall Study||0||
59506471|NCT00795145|75599474|FG000|STARTED|Cohort 1||3||
59506472|NCT00795145|75599475|FG001|STARTED|Cohort 1||3||
59506473|NCT00795145|75599476|FG002|STARTED|Cohort 1||3||
59908591|NCT01307046|76029695|FG000|STARTED|Overall Study||166||
59908592|NCT01307046|76029696|FG001|STARTED|Overall Study||170||
60016321|NCT04780815|76132618|FG000|STARTED|Overall Study||6||
60016322|NCT04780815|76132619|FG001|STARTED|Overall Study||5||
60016323|NCT04780815|76132620|FG002|STARTED|Overall Study||3||
60016324|NCT04780815|76132621|FG003|STARTED|Overall Study||2||
60016325|NCT04780815|76132618|FG000|COMPLETED|Overall Study||6||
59908593|NCT01307046|76029695|FG000|COMPLETED|Overall Study||154||
59908594|NCT01307046|76029696|FG001|COMPLETED|Overall Study||159||
59908595|NCT01307046|76029695|FG000|NOT COMPLETED|Overall Study||12||
59908596|NCT01307046|76029696|FG001|NOT COMPLETED|Overall Study||11||
59908597|NCT03495817|76029702|FG000|STARTED|26 Week Open Label||31||
59908598|NCT03495817|76029702|FG000|COMPLETED|26 Week Open Label||23||
59908599|NCT03495817|76029702|FG000|NOT COMPLETED|26 Week Open Label||8||
60016326|NCT04780815|76132619|FG001|COMPLETED|Overall Study||5||
60016327|NCT04780815|76132620|FG002|COMPLETED|Overall Study||3||
60016328|NCT04780815|76132621|FG003|COMPLETED|Overall Study||1||
60016329|NCT04780815|76132618|FG000|NOT COMPLETED|Overall Study||0||
60016330|NCT04780815|76132619|FG001|NOT COMPLETED|Overall Study||0||
60016331|NCT04780815|76132620|FG002|NOT COMPLETED|Overall Study||0||
60016332|NCT04780815|76132621|FG003|NOT COMPLETED|Overall Study||1||
60016333|NCT04560075|76132633|FG000|STARTED|Overall Study||34||
60016334|NCT04560075|76132634|FG001|STARTED|Overall Study||18||
59506474|NCT00795145|75599477|FG003|STARTED|Cohort 1||0||
59908600|NCT03495817|76029702|FG000|STARTED|26 Week Extension||19|The 26-week extension was not required, and 4 patients elected to not start the extension.|
59506475|NCT00795145|75599478|FG004|STARTED|Cohort 1||0||
59506476|NCT00795145|75599479|FG005|STARTED|Cohort 1||0||
59506477|NCT00795145|75599480|FG006|STARTED|Cohort 1||0||
59506478|NCT00795145|75599474|FG000|COMPLETED|Cohort 1||3||
60016335|NCT04560075|76132633|FG000|COMPLETED|Overall Study||34||
60016336|NCT04560075|76132634|FG001|COMPLETED|Overall Study||18||
60016337|NCT04560075|76132633|FG000|NOT COMPLETED|Overall Study||0||
60016338|NCT04560075|76132634|FG001|NOT COMPLETED|Overall Study||0||
60016339|NCT04378010|76132643|FG000|STARTED|Overall Study||32||
60016340|NCT04378010|76132644|FG001|STARTED|Overall Study||34||
60016341|NCT04378010|76132645|FG002|STARTED|Overall Study||32||
60016342|NCT04378010|76132643|FG000|COMPLETED|Overall Study||0||
60016343|NCT04378010|76132644|FG001|COMPLETED|Overall Study||0||
60016344|NCT04378010|76132645|FG002|COMPLETED|Overall Study||0||
60016345|NCT04378010|76132643|FG000|NOT COMPLETED|Overall Study||32||
60016346|NCT04378010|76132644|FG001|NOT COMPLETED|Overall Study||34||
60016347|NCT04378010|76132645|FG002|NOT COMPLETED|Overall Study||32||
60016348|NCT04349072|76132656|FG000|STARTED|Randomization Period||56||
60016349|NCT04349072|76132657|FG001|STARTED|Randomization Period||56||
60016350|NCT04349072|76132656|FG000|COMPLETED|Randomization Period||56||
60016351|NCT04349072|76132657|FG001|COMPLETED|Randomization Period||55||
60016352|NCT04349072|76132656|FG000|NOT COMPLETED|Randomization Period||0||
60016353|NCT04349072|76132657|FG001|NOT COMPLETED|Randomization Period||1||
60016354|NCT04349072|76132656|FG000|STARTED|Treatment Period||56||
60016355|NCT04349072|76132657|FG001|STARTED|Treatment Period||55||
60016356|NCT04349072|76132656|FG000|Discontinued Treatment During the Placebo-controlled Period (Day 1 to Week 16)|Treatment Period||2||
60016357|NCT04349072|76132657|FG001|Discontinued Treatment During the Placebo-controlled Period (Day 1 to Week 16)|Treatment Period||3||
60016358|NCT04349072|76132656|FG000|COMPLETED|Treatment Period||52|Ongoing treatment|
60016359|NCT04349072|76132657|FG001|COMPLETED|Treatment Period||45|Ongoing treatment|
60016360|NCT04349072|76132656|FG000|NOT COMPLETED|Treatment Period||4||
60016361|NCT04349072|76132657|FG001|NOT COMPLETED|Treatment Period||10||
60016362|NCT04240886|76132663|FG000|STARTED|Treatment Phase||21||
60016363|NCT04240886|76132663|FG000|COMPLETED|Treatment Phase||11||
60016364|NCT04240886|76132663|FG000|NOT COMPLETED|Treatment Phase||10||
60016365|NCT04240886|76132663|FG000|STARTED|Follow-up Phase|Eligible participants entered follow-up period following discontinuation of study treatment|17||
60016366|NCT04240886|76132663|FG000|COMPLETED|Follow-up Phase||13||
60016367|NCT04240886|76132663|FG000|NOT COMPLETED|Follow-up Phase||4||
60016368|NCT04223154|76132669|FG000|STARTED|Overall Study||8||
60016369|NCT04223154|76132670|FG001|STARTED|Overall Study||3||
60016370|NCT04223154|76132669|FG000|COMPLETED|Overall Study||8||
60016371|NCT04223154|76132670|FG001|COMPLETED|Overall Study||3||
60016372|NCT04223154|76132669|FG000|NOT COMPLETED|Overall Study||0||
60016373|NCT04223154|76132670|FG001|NOT COMPLETED|Overall Study||0||
60016374|NCT04074161|76132679|FG000|STARTED|Overall Study||126||
60016375|NCT04074161|76132680|FG001|STARTED|Overall Study||127||
60016376|NCT04074161|76132681|FG002|STARTED|Overall Study||85||
60016377|NCT04074161|76132679|FG000|Full Analysis Set|Overall Study||126||
60016378|NCT04074161|76132680|FG001|Full Analysis Set|Overall Study||127||
60016379|NCT04074161|76132681|FG002|Full Analysis Set|Overall Study||85||
60016380|NCT04074161|76132679|FG000|Safety Analysis Set|Overall Study||126||
60016381|NCT04074161|76132680|FG001|Safety Analysis Set|Overall Study||127||
60016382|NCT04074161|76132681|FG002|Safety Analysis Set|Overall Study||85||
60016383|NCT04074161|76132679|FG000|COMPLETED|Overall Study||120||
60016384|NCT04074161|76132680|FG001|COMPLETED|Overall Study||118||
60016385|NCT04074161|76132681|FG002|COMPLETED|Overall Study||81||
60016386|NCT04074161|76132679|FG000|NOT COMPLETED|Overall Study||6||
60016387|NCT04074161|76132680|FG001|NOT COMPLETED|Overall Study||9||
60016388|NCT04074161|76132681|FG002|NOT COMPLETED|Overall Study||4||
60016389|NCT03966157|76132691|FG000|STARTED|Overall Study||17||
60016390|NCT03966157|76132692|FG001|STARTED|Overall Study||14||
60016391|NCT03966157|76132691|FG000|COMPLETED|Overall Study||16||
60016392|NCT03966157|76132692|FG001|COMPLETED|Overall Study||14||
60016393|NCT03966157|76132691|FG000|NOT COMPLETED|Overall Study||1||
59506479|NCT00795145|75599475|FG001|COMPLETED|Cohort 1||3||
60016394|NCT03966157|76132692|FG001|NOT COMPLETED|Overall Study||0||
60016395|NCT03733210|76132700|FG000|STARTED|Overall Study||7||
60016396|NCT03733210|76132701|FG001|STARTED|Overall Study||7||
60016397|NCT03733210|76132700|FG000|COMPLETED|Overall Study||3||
60016398|NCT03733210|76132701|FG001|COMPLETED|Overall Study||5||
60016399|NCT03733210|76132700|FG000|NOT COMPLETED|Overall Study||4||
60016400|NCT03733210|76132701|FG001|NOT COMPLETED|Overall Study||2||
60016401|NCT03627468|76132709|FG000|STARTED|Overall Study||103||
60016402|NCT03627468|76132710|FG001|STARTED|Overall Study||197||
60016403|NCT03627468|76132709|FG000|COMPLETED|Overall Study||72||
59506480|NCT00795145|75599476|FG002|COMPLETED|Cohort 1||3||
60016404|NCT03627468|76132710|FG001|COMPLETED|Overall Study||118||
60016405|NCT03627468|76132709|FG000|NOT COMPLETED|Overall Study||31||
60016406|NCT03627468|76132710|FG001|NOT COMPLETED|Overall Study||79||
60016407|NCT03595176|76132718|FG000|STARTED|Overall Study||47||
60016408|NCT03595176|76132719|FG001|STARTED|Overall Study||384||
60016409|NCT03595176|76132718|FG000|COMPLETED|Overall Study||47||
60016410|NCT03595176|76132719|FG001|COMPLETED|Overall Study||381||
60016411|NCT03595176|76132718|FG000|NOT COMPLETED|Overall Study||0||
60016412|NCT03595176|76132719|FG001|NOT COMPLETED|Overall Study||3||
60016413|NCT03052816|76132728|FG000|STARTED|Overall Study||33||
60016414|NCT03052816|76132729|FG001|STARTED|Overall Study||33||
60016415|NCT03052816|76132728|FG000|COMPLETED|Overall Study||30||
60016416|NCT03052816|76132729|FG001|COMPLETED|Overall Study||33||
60016417|NCT03052816|76132728|FG000|NOT COMPLETED|Overall Study||3||
60016418|NCT03052816|76132729|FG001|NOT COMPLETED|Overall Study||0||
60016419|NCT03029156|76132739|FG000|STARTED|Overall Study||15||
60016420|NCT03029156|76132740|FG001|STARTED|Overall Study||16||
60016421|NCT03029156|76132739|FG000|COMPLETED|Overall Study||15||
60016422|NCT03029156|76132740|FG001|COMPLETED|Overall Study||16||
60016423|NCT03029156|76132739|FG000|NOT COMPLETED|Overall Study||0||
60016424|NCT03029156|76132740|FG001|NOT COMPLETED|Overall Study||0||
60016425|NCT02682238|76132748|FG000|STARTED|Overall Study||25||
60016426|NCT02682238|76132749|FG001|STARTED|Overall Study||25||
60016427|NCT02682238|76132748|FG000|COMPLETED|Overall Study||22||
60016428|NCT02682238|76132749|FG001|COMPLETED|Overall Study||21||
60016429|NCT02682238|76132748|FG000|NOT COMPLETED|Overall Study||3||
60016430|NCT02682238|76132749|FG001|NOT COMPLETED|Overall Study||4||
60016431|NCT02674711|76132764|FG000|STARTED|Overall Study||60||
60016432|NCT02674711|76132765|FG001|STARTED|Overall Study||60||
60016433|NCT02674711|76132764|FG000|COMPLETED|Overall Study||60||
60016434|NCT02674711|76132765|FG001|COMPLETED|Overall Study||60||
60016435|NCT02674711|76132764|FG000|NOT COMPLETED|Overall Study||0||
60016436|NCT02674711|76132765|FG001|NOT COMPLETED|Overall Study||0||
60016437|NCT02657356|76132773|FG000|STARTED|Overall Study||102||
60016438|NCT02657356|76132774|FG001|STARTED|Overall Study||100||
60016439|NCT02657356|76132773|FG000|COMPLETED|Overall Study||82||
60016440|NCT02657356|76132774|FG001|COMPLETED|Overall Study||85||
60016441|NCT02657356|76132773|FG000|NOT COMPLETED|Overall Study||20||
60016442|NCT02657356|76132774|FG001|NOT COMPLETED|Overall Study||15||
60016443|NCT02577978|76132782|FG000|STARTED|Overall Study||32||
60016444|NCT02577978|76132783|FG001|STARTED|Overall Study||29||
60016445|NCT02577978|76132782|FG000|COMPLETED|Overall Study||25||
60016446|NCT02577978|76132783|FG001|COMPLETED|Overall Study||25||
60016447|NCT02577978|76132782|FG000|NOT COMPLETED|Overall Study||7||
60016448|NCT02577978|76132783|FG001|NOT COMPLETED|Overall Study||4||
60016449|NCT01732120|76132791|FG000|STARTED|Overall Study||40||
60016450|NCT01732120|76132792|FG001|STARTED|Overall Study||40||
60016451|NCT01732120|76132791|FG000|COMPLETED|Overall Study||40||
60016452|NCT01732120|76132792|FG001|COMPLETED|Overall Study||40||
60016453|NCT01732120|76132791|FG000|NOT COMPLETED|Overall Study||0||
60016454|NCT01732120|76132792|FG001|NOT COMPLETED|Overall Study||0||
60016455|NCT01719562|76132800|FG000|STARTED|Overall Study||20||
60016456|NCT01719562|76132801|FG001|STARTED|Overall Study||8||
60016457|NCT01719562|76132800|FG000|COMPLETED|Overall Study||17||
60016458|NCT01719562|76132801|FG001|COMPLETED|Overall Study||8||
60016459|NCT01719562|76132800|FG000|NOT COMPLETED|Overall Study||3||
60016460|NCT01719562|76132801|FG001|NOT COMPLETED|Overall Study||0||
60016461|NCT01700439|76132807|FG000|STARTED|Overall Study||934||
60016462|NCT01700439|76132807|FG000|Study Valve Group|Overall Study|Received the Edwards INTUITY surgical aortic heart valve.|885||
60016463|NCT01700439|76132807|FG000|Discharge|Overall Study||925||
60016464|NCT01700439|76132807|FG000|3 Month|Overall Study||862||
60016465|NCT01700439|76132807|FG000|1 Year|Overall Study||842||
60016466|NCT01700439|76132807|FG000|2 Year|Overall Study||795||
60016467|NCT01700439|76132807|FG000|3 Year|Overall Study||720||
60016468|NCT01700439|76132807|FG000|4 Year|Overall Study||667||
60016469|NCT01700439|76132807|FG000|5 Year|Overall Study||577||
59611455|NCT01777854|75722443|FG001|COMPLETED|Overall Study||0||
59611456|NCT01777854|75722442|FG000|NOT COMPLETED|Overall Study||3||
60016470|NCT01700439|76132807|FG000|6 Year|Overall Study||357||
59611457|NCT01777854|75722443|FG001|NOT COMPLETED|Overall Study||3||
60016471|NCT01700439|76132807|FG000|7 Year|Overall Study||164||
60016472|NCT01700439|76132807|FG000|8 Year|Overall Study||40||
60016473|NCT01700439|76132807|FG000|COMPLETED|Overall Study||518||
60016474|NCT01700439|76132807|FG000|NOT COMPLETED|Overall Study||416||
60016475|NCT01433289|76132829|FG000|STARTED|Overall Study||6||
60016476|NCT01433289|76132830|FG001|STARTED|Overall Study||6||
60016477|NCT01433289|76132831|FG002|STARTED|Overall Study||5||
60016478|NCT01433289|76132832|FG003|STARTED|Overall Study||6||
60016479|NCT01433289|76132829|FG000|COMPLETED|Overall Study||6||
59611458|NCT01777776|75722451|FG000|STARTED|Overall Study||6||
59611459|NCT01777776|75722452|FG001|STARTED|Overall Study||12||
59611460|NCT01777776|75722453|FG002|STARTED|Overall Study||6||
59611461|NCT01777776|75722454|FG003|STARTED|Overall Study||4||
60016480|NCT01433289|76132830|FG001|COMPLETED|Overall Study||5||
60016481|NCT01433289|76132831|FG002|COMPLETED|Overall Study||5||
60016482|NCT01433289|76132832|FG003|COMPLETED|Overall Study||6||
60016483|NCT01433289|76132829|FG000|NOT COMPLETED|Overall Study||0||
60016484|NCT01433289|76132830|FG001|NOT COMPLETED|Overall Study||1||
60016485|NCT01433289|76132831|FG002|NOT COMPLETED|Overall Study||0||
60016486|NCT01433289|76132832|FG003|NOT COMPLETED|Overall Study||0||
60016487|NCT00995475|76132845|FG000|STARTED|First Intervention||9||
60016488|NCT00995475|76132846|FG001|STARTED|First Intervention||9||
60016489|NCT00995475|76132845|FG000|COMPLETED|First Intervention||9||
60016490|NCT00995475|76132846|FG001|COMPLETED|First Intervention||9||
60016491|NCT00995475|76132845|FG000|NOT COMPLETED|First Intervention||0||
60016492|NCT00995475|76132846|FG001|NOT COMPLETED|First Intervention||0||
60016493|NCT00995475|76132845|FG000|STARTED|Wash-out Two Week||9||
60016494|NCT00995475|76132846|FG001|STARTED|Wash-out Two Week||9||
60016495|NCT00995475|76132845|FG000|COMPLETED|Wash-out Two Week||9||
60016496|NCT00995475|76132846|FG001|COMPLETED|Wash-out Two Week||9||
60016497|NCT00995475|76132845|FG000|NOT COMPLETED|Wash-out Two Week||0||
60016498|NCT00995475|76132846|FG001|NOT COMPLETED|Wash-out Two Week||0||
60016499|NCT00995475|76132845|FG000|STARTED|Second Intervention||9||
60016500|NCT00995475|76132846|FG001|STARTED|Second Intervention||9||
60016501|NCT00995475|76132845|FG000|COMPLETED|Second Intervention||9||
60016502|NCT00995475|76132846|FG001|COMPLETED|Second Intervention||9||
60016503|NCT00995475|76132845|FG000|NOT COMPLETED|Second Intervention||0||
60016504|NCT00995475|76132846|FG001|NOT COMPLETED|Second Intervention||0||
60016505|NCT00945529|76132854|FG000|STARTED|Overall Study|Historical controls consisted of patients prior to February 2008 who did not receive iNO.|23|Data collection only - waiver of consent|
60016506|NCT00945529|76132855|FG001|STARTED|Overall Study||21|Data collection only - waiver of consent|
60016507|NCT00945529|76132854|FG000|COMPLETED|Overall Study||23||
60016508|NCT00945529|76132855|FG001|COMPLETED|Overall Study||21||
60016509|NCT00945529|76132854|FG000|NOT COMPLETED|Overall Study||0||
60016510|NCT00945529|76132855|FG001|NOT COMPLETED|Overall Study||0||
60016511|NCT00921115|76132861|FG000|STARTED|Overall Study||42||
60016512|NCT00921115|76132861|FG000|COMPLETED|Overall Study||42||
60016513|NCT00921115|76132861|FG000|NOT COMPLETED|Overall Study||0||
60016514|NCT03730207|76132867|FG000|STARTED|Overall Study||89||
60016515|NCT03730207|76132868|FG001|STARTED|Overall Study||91||
60016516|NCT03730207|76132867|FG000|COMPLETED|Overall Study||83||
60016517|NCT03730207|76132868|FG001|COMPLETED|Overall Study||88||
60016518|NCT03730207|76132867|FG000|NOT COMPLETED|Overall Study||6||
60016519|NCT03730207|76132868|FG001|NOT COMPLETED|Overall Study||3||
60016520|NCT02576587|76132876|FG000|STARTED|Baseline|Total cases baseline visit|161||
60016521|NCT02576587|76132877|FG001|STARTED|Baseline|Total controls baseline visit|156||
60016522|NCT02576587|76132876|FG000|COMPLETED|Baseline|Baseline visit completed|161||
60016523|NCT02576587|76132877|FG001|COMPLETED|Baseline|Baseline visit completed|155||
60016524|NCT02576587|76132876|FG000|NOT COMPLETED|Baseline||0||
60016525|NCT02576587|76132877|FG001|NOT COMPLETED|Baseline||1||
60016526|NCT02576587|76132876|FG000|STARTED|Follow up Period (Case Only)|Completed baseline.|161||
60016527|NCT02576587|76132877|FG001|STARTED|Follow up Period (Case Only)|Controls not eligible for follow-up|155||
60016528|NCT02576587|76132876|FG000|Selected for Follow up|Follow up Period (Case Only)||61|Cases with apnea hypopnea index greater or equal to 15 were selected for follow up.|
60016529|NCT02576587|76132877|FG001|Selected for Follow up|Follow up Period (Case Only)||0|Cases with apnea hypopnea index greater or equal to 15 were selected for follow up.|
60016530|NCT02576587|76132876|FG000|COMPLETED|Follow up Period (Case Only)||44||
60016531|NCT02576587|76132877|FG001|COMPLETED|Follow up Period (Case Only)||0||
60016532|NCT02576587|76132876|FG000|NOT COMPLETED|Follow up Period (Case Only)||117||
60016533|NCT02576587|76132877|FG001|NOT COMPLETED|Follow up Period (Case Only)||155||
60016534|NCT03648073|76132885|FG000|STARTED|Overall Study||12||
60016535|NCT03648073|76132885|FG000|COMPLETED|Overall Study||12||
60016536|NCT03648073|76132885|FG000|NOT COMPLETED|Overall Study||0||
60016537|NCT03244033|76132891|FG000|STARTED|Overall Study||177||
60016538|NCT03244033|76132892|FG001|STARTED|Overall Study||275||
60016539|NCT03244033|76132891|FG000|COMPLETED|Overall Study||177||
60016540|NCT03244033|76132892|FG001|COMPLETED|Overall Study||275||
60016541|NCT03244033|76132891|FG000|NOT COMPLETED|Overall Study||0||
60016542|NCT03244033|76132892|FG001|NOT COMPLETED|Overall Study||0||
60016543|NCT03009019|76132900|FG000|STARTED|Double-blind Period 1 (DB1)|4 subjects included in the 'Started' & 'Not Completed' tallies were randomized but not dosed|316|Randomized|
60016544|NCT03009019|76132901|FG001|STARTED|Double-blind Period 1 (DB1)|2 subjects included in the 'Started' & 'Not Completed' tallies were randomized but not dosed|315|Randomized|
60016545|NCT03009019|76132900|FG000|COMPLETED|Double-blind Period 1 (DB1)||280|Completed DB1|
60016546|NCT03009019|76132901|FG001|COMPLETED|Double-blind Period 1 (DB1)||264|Completed DB1|
60016547|NCT03009019|76132900|FG000|NOT COMPLETED|Double-blind Period 1 (DB1)||36||
60016548|NCT03009019|76132901|FG001|NOT COMPLETED|Double-blind Period 1 (DB1)||51||
60016549|NCT03009019|76132900|FG000|STARTED|Double-blind Period 2 (DB2)|4 subjects included in the 'Started' & 'Not Completed' tallies were randomized but not dosed|272|Re-randomized for DB2|
60016550|NCT03009019|76132901|FG001|STARTED|Double-blind Period 2 (DB2)|1 subject included in the 'Started' & 'Not Completed' tallies was randomized but not dosed|273|Re-randomized for DB2|
60016551|NCT03009019|76132900|FG000|COMPLETED|Double-blind Period 2 (DB2)||251|Completed DB2|
60016552|NCT03009019|76132901|FG001|COMPLETED|Double-blind Period 2 (DB2)||253|Completed DB2|
60016553|NCT03009019|76132900|FG000|NOT COMPLETED|Double-blind Period 2 (DB2)||21||
60016554|NCT03009019|76132901|FG001|NOT COMPLETED|Double-blind Period 2 (DB2)||20||
60016555|NCT05340751|76132942|FG000|STARTED|Overall Study||35||
60016556|NCT05340751|76132942|FG000|COMPLETED|Overall Study||32||
60016557|NCT05340751|76132942|FG000|NOT COMPLETED|Overall Study||3||
60016558|NCT02575807|76132951|FG000|STARTED|Overall Study||9||
60016559|NCT02575807|76132952|FG001|STARTED|Overall Study||4||
60016560|NCT02575807|76132953|FG002|STARTED|Overall Study||16||
60016561|NCT02575807|76132954|FG003|STARTED|Overall Study||2||
60016562|NCT02575807|76132955|FG004|STARTED|Overall Study||4||
60067722|NCT01617187|76182892|FG001|COMPLETED|Treatment Through Study Completion||102||
60016563|NCT02575807|76132951|FG000|Treated|Overall Study||8|Subjects who received at least 1 dose of protocol-specified drug.|
60016564|NCT02575807|76132952|FG001|Treated|Overall Study||4|Subjects who received at least 1 dose of protocol-specified drug.|
60016565|NCT02575807|76132953|FG002|Treated|Overall Study||16|Subjects who received at least 1 dose of protocol-specified drug.|
60016566|NCT02575807|76132954|FG003|Treated|Overall Study||1|Subjects who received at least 1 dose of protocol-specified drug.|
60016567|NCT02575807|76132955|FG004|Treated|Overall Study||3|Subjects who received at least 1 dose of protocol-specified drug.|
60016568|NCT02575807|76132951|FG000|COMPLETED|Overall Study|Subjects followed until lost to follow-up/consent withdrawn/study termination/death.|0|No predetermined study completion date or study completion event specified in protocol.|
59908601|NCT03495817|76029702|FG000|COMPLETED|26 Week Extension||17||
59908602|NCT03495817|76029702|FG000|NOT COMPLETED|26 Week Extension||2||
59908603|NCT02886624|76029706|FG000|STARTED|8-week Treatment||30||
59908604|NCT02886624|76029706|FG000|COMPLETED|8-week Treatment||30||
59908605|NCT02886624|76029706|FG000|NOT COMPLETED|8-week Treatment||0||
59506481|NCT00795145|75599477|FG003|COMPLETED|Cohort 1||0||
59506482|NCT00795145|75599478|FG004|COMPLETED|Cohort 1||0||
59506483|NCT00795145|75599479|FG005|COMPLETED|Cohort 1||0||
59506484|NCT00795145|75599480|FG006|COMPLETED|Cohort 1||0||
60016569|NCT02575807|76132952|FG001|COMPLETED|Overall Study|Subjects followed until lost to follow-up/consent withdrawn/study termination/death.|0|No predetermined study completion date or study completion event specified in protocol.|
60016570|NCT02575807|76132953|FG002|COMPLETED|Overall Study|Subjects followed until lost to follow-up/consent withdrawn/study termination/death.|0|No predetermined study completion date or study completion event specified in protocol.|
60016571|NCT02575807|76132954|FG003|COMPLETED|Overall Study|Subjects followed until lost to follow-up/consent withdrawn/study termination/death.|0|No predetermined study completion date or study completion event specified in protocol.|
60016572|NCT02575807|76132955|FG004|COMPLETED|Overall Study|Subjects followed until lost to follow-up/consent withdrawn/study termination/death.|0|No predetermined study completion date or study completion event specified in protocol.|
60016573|NCT02575807|76132951|FG000|NOT COMPLETED|Overall Study||9||
60016574|NCT02575807|76132952|FG001|NOT COMPLETED|Overall Study||4||
60016575|NCT02575807|76132953|FG002|NOT COMPLETED|Overall Study||16||
60016576|NCT02575807|76132954|FG003|NOT COMPLETED|Overall Study||2||
60016577|NCT02575807|76132955|FG004|NOT COMPLETED|Overall Study||4||
60016578|NCT02006251|76132971|FG000|STARTED|Overall Study||12||
60016579|NCT02006251|76132972|FG001|STARTED|Overall Study||12||
60016580|NCT02006251|76132971|FG000|COMPLETED|Overall Study||10||
59506485|NCT00795145|75599474|FG000|NOT COMPLETED|Cohort 1||0||
59506486|NCT00795145|75599475|FG001|NOT COMPLETED|Cohort 1||0||
59506487|NCT00795145|75599476|FG002|NOT COMPLETED|Cohort 1||0||
59506488|NCT00795145|75599477|FG003|NOT COMPLETED|Cohort 1||0||
59506489|NCT00795145|75599478|FG004|NOT COMPLETED|Cohort 1||0||
59506490|NCT00795145|75599479|FG005|NOT COMPLETED|Cohort 1||0||
59506491|NCT00795145|75599480|FG006|NOT COMPLETED|Cohort 1||0||
59506492|NCT00795145|75599474|FG000|STARTED|Cohort 2||0||
59506493|NCT00795145|75599475|FG001|STARTED|Cohort 2||0||
59506494|NCT00795145|75599476|FG002|STARTED|Cohort 2||0||
59506495|NCT00795145|75599477|FG003|STARTED|Cohort 2||10||
59506496|NCT00795145|75599478|FG004|STARTED|Cohort 2||10||
59506497|NCT00795145|75599479|FG005|STARTED|Cohort 2||10||
59506498|NCT00795145|75599480|FG006|STARTED|Cohort 2||10||
59506499|NCT00795145|75599474|FG000|COMPLETED|Cohort 2||0||
59506500|NCT00795145|75599475|FG001|COMPLETED|Cohort 2||0||
59506501|NCT00795145|75599476|FG002|COMPLETED|Cohort 2||0||
59506502|NCT00795145|75599477|FG003|COMPLETED|Cohort 2||10||
59506503|NCT00795145|75599478|FG004|COMPLETED|Cohort 2||10||
59506504|NCT00795145|75599479|FG005|COMPLETED|Cohort 2||10||
59506505|NCT00795145|75599480|FG006|COMPLETED|Cohort 2||10||
59506506|NCT00795145|75599474|FG000|NOT COMPLETED|Cohort 2||0||
59506507|NCT00795145|75599475|FG001|NOT COMPLETED|Cohort 2||0||
59506508|NCT00795145|75599476|FG002|NOT COMPLETED|Cohort 2||0||
59506509|NCT00795145|75599477|FG003|NOT COMPLETED|Cohort 2||0||
59506510|NCT00795145|75599478|FG004|NOT COMPLETED|Cohort 2||0||
59506511|NCT00795145|75599479|FG005|NOT COMPLETED|Cohort 2||0||
59506512|NCT00795145|75599480|FG006|NOT COMPLETED|Cohort 2||0||
59506513|NCT00809185|75599507|FG000|STARTED|Overall Study||7||
59506514|NCT00809185|75599507|FG000|COMPLETED|Overall Study||7||
59506515|NCT00809185|75599507|FG000|NOT COMPLETED|Overall Study||0||
59611462|NCT01777776|75722451|FG000|COMPLETED|Overall Study||0||
59908606|NCT02886624|76029706|FG000|STARTED|12-week Post Treatment Follow-up||30||
59908607|NCT02886624|76029706|FG000|COMPLETED|12-week Post Treatment Follow-up||29||
59908608|NCT02886624|76029706|FG000|NOT COMPLETED|12-week Post Treatment Follow-up||1||
59908609|NCT02886624|76029706|FG000|STARTED|48-week Post Treatment Follow-up||29||
59908610|NCT02886624|76029706|FG000|COMPLETED|48-week Post Treatment Follow-up||28||
59908611|NCT02886624|76029706|FG000|NOT COMPLETED|48-week Post Treatment Follow-up||1||
59506516|NCT03809663|75599516|FG000|STARTED|Overall Study||63||
59506517|NCT03809663|75599517|FG001|STARTED|Overall Study||62||
59506518|NCT03809663|75599518|FG002|STARTED|Overall Study||63||
59506519|NCT03809663|75599519|FG003|STARTED|Overall Study||63||
59506520|NCT03809663|75599520|FG004|STARTED|Overall Study||0||
59506521|NCT03809663|75599521|FG005|STARTED|Overall Study||0||
59506522|NCT03809663|75599516|FG000|Participants Who Received Investigational Product|Overall Study||63||
59611463|NCT01777776|75722452|FG001|COMPLETED|Overall Study||0||
60016581|NCT02006251|76132972|FG001|COMPLETED|Overall Study||11||
60016582|NCT02006251|76132971|FG000|NOT COMPLETED|Overall Study||2||
60016583|NCT02006251|76132972|FG001|NOT COMPLETED|Overall Study||1||
60016584|NCT02575339|76132981|FG000|STARTED|Study Treatment||7||
60016585|NCT02575339|76132982|FG001|STARTED|Study Treatment|This study was terminated at Phase I.|4||
60016586|NCT02575339|76132983|FG002|STARTED|Study Treatment|This study was terminated at Phase I.|0||
60016587|NCT02575339|76132981|FG000|COMPLETED|Study Treatment||0||
60016588|NCT02575339|76132982|FG001|COMPLETED|Study Treatment||0||
60016589|NCT02575339|76132983|FG002|COMPLETED|Study Treatment||0||
60016590|NCT02575339|76132981|FG000|NOT COMPLETED|Study Treatment||7||
60016591|NCT02575339|76132982|FG001|NOT COMPLETED|Study Treatment||4||
60016592|NCT02575339|76132983|FG002|NOT COMPLETED|Study Treatment||0||
60016593|NCT02575339|76132981|FG000|STARTED|Follow up||7||
60016594|NCT02575339|76132982|FG001|STARTED|Follow up||4||
60016595|NCT02575339|76132983|FG002|STARTED|Follow up||0||
60016596|NCT02575339|76132981|FG000|COMPLETED|Follow up||0||
60016597|NCT02575339|76132982|FG001|COMPLETED|Follow up||0||
60016598|NCT02575339|76132983|FG002|COMPLETED|Follow up||0||
60016599|NCT02575339|76132981|FG000|NOT COMPLETED|Follow up||7||
60016600|NCT02575339|76132982|FG001|NOT COMPLETED|Follow up||4||
60016601|NCT02575339|76132983|FG002|NOT COMPLETED|Follow up||0||
60016602|NCT01712659|76132996|FG000|STARTED|Dose Escalation||1||
60016603|NCT01712659|76132997|FG001|STARTED|Dose Escalation||5||
60016604|NCT01712659|76132998|FG002|STARTED|Dose Escalation||1||
60016605|NCT01712659|76132999|FG003|STARTED|Dose Escalation||0||
60016606|NCT01712659|76133000|FG004|STARTED|Dose Escalation||0||
60016607|NCT01712659|76132996|FG000|COMPLETED|Dose Escalation||1||
60016608|NCT01712659|76132997|FG001|COMPLETED|Dose Escalation||3||
60016609|NCT01712659|76132998|FG002|COMPLETED|Dose Escalation||1||
60016610|NCT01712659|76132999|FG003|COMPLETED|Dose Escalation||0||
60016611|NCT01712659|76133000|FG004|COMPLETED|Dose Escalation||0||
60016612|NCT01712659|76132996|FG000|NOT COMPLETED|Dose Escalation||0||
60016613|NCT01712659|76132997|FG001|NOT COMPLETED|Dose Escalation||2||
60016614|NCT01712659|76132998|FG002|NOT COMPLETED|Dose Escalation||0||
60016615|NCT01712659|76132999|FG003|NOT COMPLETED|Dose Escalation||0||
60016616|NCT01712659|76133000|FG004|NOT COMPLETED|Dose Escalation||0||
60016617|NCT01712659|76132996|FG000|STARTED|Dose Expansion||12||
60016618|NCT01712659|76132997|FG001|STARTED|Dose Expansion||0||
60016619|NCT01712659|76132998|FG002|STARTED|Dose Expansion||0||
60016620|NCT01712659|76132999|FG003|STARTED|Dose Expansion||0||
60016621|NCT01712659|76133000|FG004|STARTED|Dose Expansion||0||
60016622|NCT01712659|76132996|FG000|COMPLETED|Dose Expansion||10||
60016623|NCT01712659|76132997|FG001|COMPLETED|Dose Expansion||0||
60016624|NCT01712659|76132998|FG002|COMPLETED|Dose Expansion||0||
60016625|NCT01712659|76132999|FG003|COMPLETED|Dose Expansion||0||
60016626|NCT01712659|76133000|FG004|COMPLETED|Dose Expansion||0||
60016627|NCT01712659|76132996|FG000|NOT COMPLETED|Dose Expansion||2||
60016628|NCT01712659|76132997|FG001|NOT COMPLETED|Dose Expansion||0||
60016629|NCT01712659|76132998|FG002|NOT COMPLETED|Dose Expansion||0||
60016630|NCT01712659|76132999|FG003|NOT COMPLETED|Dose Expansion||0||
60016631|NCT01712659|76133000|FG004|NOT COMPLETED|Dose Expansion||0||
60016632|NCT01712659|76132996|FG000|STARTED|Participants Re-Enrolled and Treated||0||
60016633|NCT01712659|76132997|FG001|STARTED|Participants Re-Enrolled and Treated|Participant treated in the original 20 mg group was re-enrolled and treated at 30 mg twice daily (the protocol allowed this)|1||
60016634|NCT01712659|76132998|FG002|STARTED|Participants Re-Enrolled and Treated||0||
60016635|NCT01712659|76132999|FG003|STARTED|Participants Re-Enrolled and Treated||0||
60016636|NCT01712659|76133000|FG004|STARTED|Participants Re-Enrolled and Treated||0||
60016637|NCT01712659|76132996|FG000|COMPLETED|Participants Re-Enrolled and Treated||0||
60016638|NCT01712659|76132997|FG001|COMPLETED|Participants Re-Enrolled and Treated||1||
60016639|NCT01712659|76132998|FG002|COMPLETED|Participants Re-Enrolled and Treated||0||
60016640|NCT01712659|76132999|FG003|COMPLETED|Participants Re-Enrolled and Treated||0||
60016641|NCT01712659|76133000|FG004|COMPLETED|Participants Re-Enrolled and Treated||0||
60016642|NCT01712659|76132996|FG000|NOT COMPLETED|Participants Re-Enrolled and Treated||0||
60016643|NCT01712659|76132997|FG001|NOT COMPLETED|Participants Re-Enrolled and Treated||0||
60016644|NCT01712659|76132998|FG002|NOT COMPLETED|Participants Re-Enrolled and Treated||0||
60016645|NCT01712659|76132999|FG003|NOT COMPLETED|Participants Re-Enrolled and Treated||0||
60016646|NCT01712659|76133000|FG004|NOT COMPLETED|Participants Re-Enrolled and Treated||0||
60016647|NCT01610713|76133026|FG000|STARTED|Overall Study||77||
60016648|NCT01610713|76133027|FG001|STARTED|Overall Study||77||
60016649|NCT01610713|76133026|FG000|COMPLETED|Overall Study||71||
60016650|NCT01610713|76133027|FG001|COMPLETED|Overall Study||76||
60016651|NCT01610713|76133026|FG000|NOT COMPLETED|Overall Study||6||
60016652|NCT01610713|76133027|FG001|NOT COMPLETED|Overall Study||1||
60016653|NCT01606189|76133033|FG000|STARTED|First Intenvention (14-20 Days)||8||
60016654|NCT01606189|76133034|FG001|STARTED|First Intenvention (14-20 Days)||8||
60016655|NCT01606189|76133035|FG002|STARTED|First Intenvention (14-20 Days)||8||
60016656|NCT01606189|76133036|FG003|STARTED|First Intenvention (14-20 Days)||8||
60016657|NCT01606189|76133037|FG004|STARTED|First Intenvention (14-20 Days)||8||
60016658|NCT01606189|76133038|FG005|STARTED|First Intenvention (14-20 Days)||8||
60016659|NCT01606189|76133033|FG000|COMPLETED|First Intenvention (14-20 Days)||8||
60016660|NCT01606189|76133034|FG001|COMPLETED|First Intenvention (14-20 Days)||8||
60016661|NCT01606189|76133035|FG002|COMPLETED|First Intenvention (14-20 Days)||8||
60016662|NCT01606189|76133036|FG003|COMPLETED|First Intenvention (14-20 Days)||8||
60016663|NCT01606189|76133037|FG004|COMPLETED|First Intenvention (14-20 Days)||8||
59506523|NCT03809663|75599517|FG001|Participants Who Received Investigational Product|Overall Study||61||
59506524|NCT03809663|75599518|FG002|Participants Who Received Investigational Product|Overall Study||63||
59506525|NCT03809663|75599519|FG003|Participants Who Received Investigational Product|Overall Study||63||
60016664|NCT01606189|76133038|FG005|COMPLETED|First Intenvention (14-20 Days)||8||
60016665|NCT01606189|76133033|FG000|NOT COMPLETED|First Intenvention (14-20 Days)||0||
60016666|NCT01606189|76133034|FG001|NOT COMPLETED|First Intenvention (14-20 Days)||0||
60016667|NCT01606189|76133035|FG002|NOT COMPLETED|First Intenvention (14-20 Days)||0||
60016668|NCT01606189|76133036|FG003|NOT COMPLETED|First Intenvention (14-20 Days)||0||
60016669|NCT01606189|76133037|FG004|NOT COMPLETED|First Intenvention (14-20 Days)||0||
60016670|NCT01606189|76133038|FG005|NOT COMPLETED|First Intenvention (14-20 Days)||0||
60016671|NCT01606189|76133033|FG000|STARTED|Second Intenvention (14-20 Days)||8||
60016672|NCT01606189|76133034|FG001|STARTED|Second Intenvention (14-20 Days)||8||
60016673|NCT01606189|76133035|FG002|STARTED|Second Intenvention (14-20 Days)||8||
60016674|NCT01606189|76133036|FG003|STARTED|Second Intenvention (14-20 Days)||8||
60016675|NCT01606189|76133037|FG004|STARTED|Second Intenvention (14-20 Days)||8||
60016676|NCT01606189|76133038|FG005|STARTED|Second Intenvention (14-20 Days)||8||
60016677|NCT01606189|76133033|FG000|COMPLETED|Second Intenvention (14-20 Days)||8||
60016678|NCT01606189|76133034|FG001|COMPLETED|Second Intenvention (14-20 Days)||8||
60016679|NCT01606189|76133035|FG002|COMPLETED|Second Intenvention (14-20 Days)||8||
60016680|NCT01606189|76133036|FG003|COMPLETED|Second Intenvention (14-20 Days)||8||
60016681|NCT01606189|76133037|FG004|COMPLETED|Second Intenvention (14-20 Days)||8||
60016682|NCT01606189|76133038|FG005|COMPLETED|Second Intenvention (14-20 Days)||7||
60016683|NCT01606189|76133033|FG000|NOT COMPLETED|Second Intenvention (14-20 Days)||0||
60016684|NCT01606189|76133034|FG001|NOT COMPLETED|Second Intenvention (14-20 Days)||0||
60016685|NCT01606189|76133035|FG002|NOT COMPLETED|Second Intenvention (14-20 Days)||0||
60016686|NCT01606189|76133036|FG003|NOT COMPLETED|Second Intenvention (14-20 Days)||0||
60016687|NCT01606189|76133037|FG004|NOT COMPLETED|Second Intenvention (14-20 Days)||0||
60016688|NCT01606189|76133038|FG005|NOT COMPLETED|Second Intenvention (14-20 Days)||1||
60016689|NCT01606189|76133033|FG000|STARTED|Third Intenvention (14-20 Days)||8||
60016690|NCT01606189|76133034|FG001|STARTED|Third Intenvention (14-20 Days)||8||
60016691|NCT01606189|76133035|FG002|STARTED|Third Intenvention (14-20 Days)||8||
60016692|NCT01606189|76133036|FG003|STARTED|Third Intenvention (14-20 Days)||8||
60016693|NCT01606189|76133037|FG004|STARTED|Third Intenvention (14-20 Days)||8||
60016694|NCT01606189|76133038|FG005|STARTED|Third Intenvention (14-20 Days)||7||
60016695|NCT01606189|76133033|FG000|COMPLETED|Third Intenvention (14-20 Days)||8||
60016696|NCT01606189|76133034|FG001|COMPLETED|Third Intenvention (14-20 Days)||8||
60016697|NCT01606189|76133035|FG002|COMPLETED|Third Intenvention (14-20 Days)||8||
60016698|NCT01606189|76133036|FG003|COMPLETED|Third Intenvention (14-20 Days)||8||
60016699|NCT01606189|76133037|FG004|COMPLETED|Third Intenvention (14-20 Days)||8||
60016700|NCT01606189|76133038|FG005|COMPLETED|Third Intenvention (14-20 Days)||6||
60016701|NCT01606189|76133033|FG000|NOT COMPLETED|Third Intenvention (14-20 Days)||0||
60016702|NCT01606189|76133034|FG001|NOT COMPLETED|Third Intenvention (14-20 Days)||0||
60016703|NCT01606189|76133035|FG002|NOT COMPLETED|Third Intenvention (14-20 Days)||0||
60016704|NCT01606189|76133036|FG003|NOT COMPLETED|Third Intenvention (14-20 Days)||0||
60016705|NCT01606189|76133037|FG004|NOT COMPLETED|Third Intenvention (14-20 Days)||0||
60016706|NCT01606189|76133038|FG005|NOT COMPLETED|Third Intenvention (14-20 Days)||1||
60016707|NCT01663987|76133048|FG000|STARTED|Overall Study||39||
60016708|NCT01663987|76133049|FG001|STARTED|Overall Study||40||
60016709|NCT01663987|76133048|FG000|COMPLETED|Overall Study||26||
60016710|NCT01663987|76133049|FG001|COMPLETED|Overall Study||34||
60016711|NCT01663987|76133048|FG000|NOT COMPLETED|Overall Study||13||
60016712|NCT01663987|76133049|FG001|NOT COMPLETED|Overall Study||6||
60016713|NCT02380677|76133067|FG000|STARTED|Overall Study||1||
60016714|NCT02380677|76133068|FG001|STARTED|Overall Study||1||
60016715|NCT02380677|76133069|FG002|STARTED|Overall Study||3||
60016716|NCT02380677|76133070|FG003|STARTED|Overall Study||3||
60016717|NCT02380677|76133071|FG004|STARTED|Overall Study||6||
60016718|NCT02380677|76133072|FG005|STARTED|Overall Study||6||
60016719|NCT02380677|76133073|FG006|STARTED|Overall Study||3||
60016720|NCT02380677|76133074|FG007|STARTED|Overall Study||4||
60016721|NCT02380677|76133075|FG008|STARTED|Overall Study||4||
60016722|NCT02380677|76133076|FG009|STARTED|Overall Study||2||
60016723|NCT02380677|76133077|FG010|STARTED|Overall Study||4||
60016724|NCT02380677|76133078|FG011|STARTED|Overall Study||5||
60016725|NCT02380677|76133067|FG000|COMPLETED|Overall Study||0||
60016726|NCT02380677|76133068|FG001|COMPLETED|Overall Study||0||
60016727|NCT02380677|76133069|FG002|COMPLETED|Overall Study||0||
60016728|NCT02380677|76133070|FG003|COMPLETED|Overall Study||0||
60016729|NCT02380677|76133071|FG004|COMPLETED|Overall Study||0||
60016730|NCT02380677|76133072|FG005|COMPLETED|Overall Study||0||
60016731|NCT02380677|76133073|FG006|COMPLETED|Overall Study||0||
60016732|NCT02380677|76133074|FG007|COMPLETED|Overall Study||0||
60016733|NCT02380677|76133075|FG008|COMPLETED|Overall Study||0||
60016734|NCT02380677|76133076|FG009|COMPLETED|Overall Study||0||
60016735|NCT02380677|76133077|FG010|COMPLETED|Overall Study||0||
59506526|NCT03809663|75599520|FG004|Participants Who Received Investigational Product|Overall Study||0||
60016736|NCT02380677|76133078|FG011|COMPLETED|Overall Study||0||
60016737|NCT02380677|76133067|FG000|NOT COMPLETED|Overall Study||1||
60016738|NCT02380677|76133068|FG001|NOT COMPLETED|Overall Study||1||
60016739|NCT02380677|76133069|FG002|NOT COMPLETED|Overall Study||3||
60016740|NCT02380677|76133070|FG003|NOT COMPLETED|Overall Study||3||
60016741|NCT02380677|76133071|FG004|NOT COMPLETED|Overall Study||6||
60016742|NCT02380677|76133072|FG005|NOT COMPLETED|Overall Study||6||
60016743|NCT02380677|76133073|FG006|NOT COMPLETED|Overall Study||3||
60016744|NCT02380677|76133074|FG007|NOT COMPLETED|Overall Study||4||
60016745|NCT02380677|76133075|FG008|NOT COMPLETED|Overall Study||4||
60016746|NCT02380677|76133076|FG009|NOT COMPLETED|Overall Study||2||
60016747|NCT02380677|76133077|FG010|NOT COMPLETED|Overall Study||4||
60016748|NCT02380677|76133078|FG011|NOT COMPLETED|Overall Study||5||
60016749|NCT02380287|76133114|FG000|STARTED|Overall Study||1||
60016750|NCT02380287|76133115|FG001|STARTED|Overall Study||3||
60016751|NCT02380287|76133116|FG002|STARTED|Overall Study||3||
60016752|NCT02380287|76133117|FG003|STARTED|Overall Study||3||
60016753|NCT02380287|76133118|FG004|STARTED|Overall Study||3||
60016754|NCT02380287|76133119|FG005|STARTED|Overall Study||3||
60016755|NCT02380287|76133120|FG006|STARTED|Overall Study||3||
60016756|NCT02380287|76133121|FG007|STARTED|Overall Study||3||
60016757|NCT02380287|76133114|FG000|COMPLETED|Overall Study||1||
60016758|NCT02380287|76133115|FG001|COMPLETED|Overall Study||3||
60016759|NCT02380287|76133116|FG002|COMPLETED|Overall Study||2||
60016760|NCT02380287|76133117|FG003|COMPLETED|Overall Study||3||
60016761|NCT02380287|76133118|FG004|COMPLETED|Overall Study||3||
60016762|NCT02380287|76133119|FG005|COMPLETED|Overall Study||3||
60016763|NCT02380287|76133120|FG006|COMPLETED|Overall Study||3||
60016764|NCT02380287|76133121|FG007|COMPLETED|Overall Study||3||
60016765|NCT02380287|76133114|FG000|NOT COMPLETED|Overall Study||0||
60016766|NCT02380287|76133115|FG001|NOT COMPLETED|Overall Study||0||
60016767|NCT02380287|76133116|FG002|NOT COMPLETED|Overall Study||1||
60016768|NCT02380287|76133117|FG003|NOT COMPLETED|Overall Study||0||
60016769|NCT02380287|76133118|FG004|NOT COMPLETED|Overall Study||0||
60016770|NCT02380287|76133119|FG005|NOT COMPLETED|Overall Study||0||
60016771|NCT02380287|76133120|FG006|NOT COMPLETED|Overall Study||0||
60016772|NCT02380287|76133121|FG007|NOT COMPLETED|Overall Study||0||
60016773|NCT02343003|76133148|FG000|STARTED|Overall Study||76||
60016774|NCT02343003|76133149|FG001|STARTED|Overall Study||75||
60016775|NCT02343003|76133148|FG000|COMPLETED|Overall Study||58|Completion is with respect to the 6-month primary outcome.|
60016776|NCT02343003|76133149|FG001|COMPLETED|Overall Study||68|Completion is with respect to the 6-month primary outcome.|
60016777|NCT02343003|76133148|FG000|NOT COMPLETED|Overall Study||18||
60016778|NCT02343003|76133149|FG001|NOT COMPLETED|Overall Study||7||
60016779|NCT02394561|76133157|FG000|STARTED|CORE Phase||185||
60016780|NCT02394561|76133158|FG001|STARTED|CORE Phase||246||
60016781|NCT02394561|76133157|FG000|Full Analysis Set|CORE Phase||185||
60016782|NCT02394561|76133158|FG001|Full Analysis Set|CORE Phase||246||
60016783|NCT02394561|76133157|FG000|Safety Set|CORE Phase||185||
60016784|NCT02394561|76133158|FG001|Safety Set|CORE Phase||246||
60016785|NCT02394561|76133157|FG000|ITT Set|CORE Phase||184||
60016786|NCT02394561|76133158|FG001|ITT Set|CORE Phase||246||
60016787|NCT02394561|76133157|FG000|COMPLETED|CORE Phase||172||
60016788|NCT02394561|76133158|FG001|COMPLETED|CORE Phase||227||
60016789|NCT02394561|76133157|FG000|NOT COMPLETED|CORE Phase||13||
60016790|NCT02394561|76133158|FG001|NOT COMPLETED|CORE Phase||19||
60016791|NCT02394561|76133157|FG000|STARTED|Extension Phase||162||
60016792|NCT02394561|76133158|FG001|STARTED|Extension Phase||219||
60016793|NCT02394561|76133157|FG000|COMPLETED|Extension Phase||151||
60016794|NCT02394561|76133158|FG001|COMPLETED|Extension Phase||207||
60016795|NCT02394561|76133157|FG000|NOT COMPLETED|Extension Phase||11||
59506527|NCT03809663|75599521|FG005|Participants Who Received Investigational Product|Overall Study||0||
59506528|NCT03809663|75599516|FG000|EASI 50 Non-responder at Week 16|Overall Study||40||
59506529|NCT03809663|75599517|FG001|EASI 50 Non-responder at Week 16|Overall Study||26||
60016796|NCT02394561|76133158|FG001|NOT COMPLETED|Extension Phase||12||
60016797|NCT02342223|76133167|FG000|STARTED|Overall Study||20||
60016798|NCT02342223|76133167|FG000|COMPLETED|Overall Study||19||
60016799|NCT02342223|76133167|FG000|NOT COMPLETED|Overall Study||1||
60016800|NCT02393547|76133171|FG000|STARTED|Overall Study||20||
60016801|NCT02393547|76133171|FG000|COMPLETED|Overall Study||14||
60016802|NCT02393547|76133171|FG000|NOT COMPLETED|Overall Study||6||
60016803|NCT02574637|76133180|FG000|STARTED|Double-blind Period||5||
60016804|NCT02574637|76133181|FG001|STARTED|Double-blind Period||5||
60016805|NCT02574637|76133182|FG002|STARTED|Double-blind Period||9||
60016806|NCT02574637|76133183|FG003|STARTED|Double-blind Period||7||
60016807|NCT02574637|76133184|FG004|STARTED|Double-blind Period||3||
60016808|NCT02574637|76133185|FG005|STARTED|Double-blind Period||0||
60016809|NCT02574637|76133186|FG006|STARTED|Double-blind Period||0||
60016810|NCT02574637|76133187|FG007|STARTED|Double-blind Period||0||
60016811|NCT02574637|76133188|FG008|STARTED|Double-blind Period||0||
60016812|NCT02574637|76133189|FG009|STARTED|Double-blind Period||0||
59506530|NCT03809663|75599518|FG002|EASI 50 Non-responder at Week 16|Overall Study||30||
59506531|NCT03809663|75599519|FG003|EASI 50 Non-responder at Week 16|Overall Study||38||
59506532|NCT03809663|75599520|FG004|EASI 50 Non-responder at Week 16|Overall Study||0||
59506533|NCT03809663|75599521|FG005|EASI 50 Non-responder at Week 16|Overall Study||0||
59506534|NCT03809663|75599516|FG000|Switched to Tezepelumab 420 mg Q2W After Week 16|Overall Study||39||
59506535|NCT03809663|75599517|FG001|Switched to Tezepelumab 420 mg Q2W After Week 16|Overall Study||24||
59506536|NCT03809663|75599518|FG002|Switched to Tezepelumab 420 mg Q2W After Week 16|Overall Study||30||
59506537|NCT03809663|75599519|FG003|Switched to Tezepelumab 420 mg Q2W After Week 16|Overall Study||38||
59506538|NCT03809663|75599520|FG004|Switched to Tezepelumab 420 mg Q2W After Week 16|Overall Study||0||
59506539|NCT03809663|75599521|FG005|Switched to Tezepelumab 420 mg Q2W After Week 16|Overall Study||0||
59506540|NCT03809663|75599516|FG000|COMPLETED|Overall Study||12||
60016813|NCT02574637|76133180|FG000|COMPLETED|Double-blind Period||2||
60016814|NCT02574637|76133181|FG001|COMPLETED|Double-blind Period||4||
60016815|NCT02574637|76133182|FG002|COMPLETED|Double-blind Period||2||
60016816|NCT02574637|76133183|FG003|COMPLETED|Double-blind Period||3||
60016817|NCT02574637|76133184|FG004|COMPLETED|Double-blind Period||1||
60016818|NCT02574637|76133185|FG005|COMPLETED|Double-blind Period||0||
60016819|NCT02574637|76133186|FG006|COMPLETED|Double-blind Period||0||
60016820|NCT02574637|76133187|FG007|COMPLETED|Double-blind Period||0||
60016821|NCT02574637|76133188|FG008|COMPLETED|Double-blind Period||0||
60016822|NCT02574637|76133189|FG009|COMPLETED|Double-blind Period||0||
60016823|NCT02574637|76133180|FG000|NOT COMPLETED|Double-blind Period||3||
60016824|NCT02574637|76133181|FG001|NOT COMPLETED|Double-blind Period||1||
60016825|NCT02574637|76133182|FG002|NOT COMPLETED|Double-blind Period||7||
60016826|NCT02574637|76133183|FG003|NOT COMPLETED|Double-blind Period||4||
60016827|NCT02574637|76133184|FG004|NOT COMPLETED|Double-blind Period||2||
60016828|NCT02574637|76133185|FG005|NOT COMPLETED|Double-blind Period||0||
60016829|NCT02574637|76133186|FG006|NOT COMPLETED|Double-blind Period||0||
60016830|NCT02574637|76133187|FG007|NOT COMPLETED|Double-blind Period||0||
60016831|NCT02574637|76133188|FG008|NOT COMPLETED|Double-blind Period||0||
60016832|NCT02574637|76133189|FG009|NOT COMPLETED|Double-blind Period||0||
60016833|NCT02574637|76133180|FG000|STARTED|Open-label (OL) Period||0||
60016834|NCT02574637|76133181|FG001|STARTED|Open-label (OL) Period||0||
60016835|NCT02574637|76133182|FG002|STARTED|Open-label (OL) Period||0||
60016836|NCT02574637|76133183|FG003|STARTED|Open-label (OL) Period||0||
60016837|NCT02574637|76133184|FG004|STARTED|Open-label (OL) Period||0||
60016838|NCT02574637|76133185|FG005|STARTED|Open-label (OL) Period||2||
60016839|NCT02574637|76133186|FG006|STARTED|Open-label (OL) Period||3||
60016840|NCT02574637|76133187|FG007|STARTED|Open-label (OL) Period||2||
60016841|NCT02574637|76133188|FG008|STARTED|Open-label (OL) Period||3||
59506541|NCT03809663|75599517|FG001|COMPLETED|Overall Study||18||
59506542|NCT03809663|75599518|FG002|COMPLETED|Overall Study||15||
60016842|NCT02574637|76133189|FG009|STARTED|Open-label (OL) Period||1||
60016843|NCT02574637|76133180|FG000|COMPLETED|Open-label (OL) Period||0||
60016844|NCT02574637|76133181|FG001|COMPLETED|Open-label (OL) Period||0||
60016845|NCT02574637|76133182|FG002|COMPLETED|Open-label (OL) Period||0||
60016846|NCT02574637|76133183|FG003|COMPLETED|Open-label (OL) Period||0||
60016847|NCT02574637|76133184|FG004|COMPLETED|Open-label (OL) Period||0||
60016848|NCT02574637|76133185|FG005|COMPLETED|Open-label (OL) Period||0||
60016849|NCT02574637|76133186|FG006|COMPLETED|Open-label (OL) Period||1||
60016850|NCT02574637|76133187|FG007|COMPLETED|Open-label (OL) Period||1||
60016851|NCT02574637|76133188|FG008|COMPLETED|Open-label (OL) Period||1||
60016852|NCT02574637|76133189|FG009|COMPLETED|Open-label (OL) Period||0||
60016853|NCT02574637|76133180|FG000|NOT COMPLETED|Open-label (OL) Period||0||
60016854|NCT02574637|76133181|FG001|NOT COMPLETED|Open-label (OL) Period||0||
60016855|NCT02574637|76133182|FG002|NOT COMPLETED|Open-label (OL) Period||0||
60016856|NCT02574637|76133183|FG003|NOT COMPLETED|Open-label (OL) Period||0||
60016857|NCT02574637|76133184|FG004|NOT COMPLETED|Open-label (OL) Period||0||
60016858|NCT02574637|76133185|FG005|NOT COMPLETED|Open-label (OL) Period||2||
60016859|NCT02574637|76133186|FG006|NOT COMPLETED|Open-label (OL) Period||2||
59758480|NCT03329378|75877756|FG000|COMPLETED|Overall Study||2||
59758481|NCT03329378|75877757|FG001|COMPLETED|Overall Study||5||
59758482|NCT03329378|75877756|FG000|NOT COMPLETED|Overall Study||0||
59758483|NCT03329378|75877757|FG001|NOT COMPLETED|Overall Study||0||
59758484|NCT03274895|75877765|FG000|STARTED|Overall Study|3 patients had no confirmation of diagnosis and therefore the overall number of participants analyzed is 66|69||
59758485|NCT03274895|75877766|FG001|STARTED|Overall Study|4 patients had no confimation of diagnosis and therefore the overall number of participants analyzed is 61|65||
59758486|NCT03274895|75877765|FG000|COMPLETED|Overall Study||56||
59758487|NCT03274895|75877766|FG001|COMPLETED|Overall Study||54||
59758488|NCT03274895|75877765|FG000|NOT COMPLETED|Overall Study||13||
59758489|NCT03274895|75877766|FG001|NOT COMPLETED|Overall Study||11||
59758490|NCT03057106|75877777|FG000|STARTED|Overall Study|1 patient refused the treatment|149|4 patient refused study treatment|
59506543|NCT03809663|75599519|FG003|COMPLETED|Overall Study||16||
59506544|NCT03809663|75599520|FG004|COMPLETED|Overall Study||0||
59506545|NCT03809663|75599521|FG005|COMPLETED|Overall Study||0||
59506546|NCT03809663|75599516|FG000|NOT COMPLETED|Overall Study||51||
59506547|NCT03809663|75599517|FG001|NOT COMPLETED|Overall Study||44||
59506548|NCT03809663|75599518|FG002|NOT COMPLETED|Overall Study||48||
59506549|NCT03809663|75599519|FG003|NOT COMPLETED|Overall Study||47||
59506550|NCT03809663|75599520|FG004|NOT COMPLETED|Overall Study||0||
59506551|NCT03809663|75599521|FG005|NOT COMPLETED|Overall Study||0||
59506552|NCT00795769|75599546|FG000|STARTED|Overall Study||49||
59908612|NCT02963766|76029713|FG000|STARTED|Double-Blind Period||51||
59908613|NCT02963766|76029714|FG001|STARTED|Double-Blind Period||51||
59908614|NCT02963766|76029715|FG002|STARTED|Double-Blind Period||52||
59908615|NCT02963766|76029713|FG000|Received at Least 1 Dose of Study Drug|Double-Blind Period||51||
59908616|NCT02963766|76029714|FG001|Received at Least 1 Dose of Study Drug|Double-Blind Period||51||
59908617|NCT02963766|76029715|FG002|Received at Least 1 Dose of Study Drug|Double-Blind Period||52||
59908618|NCT02963766|76029713|FG000|COMPLETED|Double-Blind Period||47||
59908619|NCT02963766|76029714|FG001|COMPLETED|Double-Blind Period||49||
59908620|NCT02963766|76029715|FG002|COMPLETED|Double-Blind Period||50||
59908621|NCT02963766|76029713|FG000|NOT COMPLETED|Double-Blind Period||4||
59908622|NCT02963766|76029714|FG001|NOT COMPLETED|Double-Blind Period||2||
59908623|NCT02963766|76029715|FG002|NOT COMPLETED|Double-Blind Period||2||
59908624|NCT02963766|76029713|FG000|STARTED|Open Label Extension (OLE)||47||
59908625|NCT02963766|76029714|FG001|STARTED|Open Label Extension (OLE)||49||
59908626|NCT02963766|76029715|FG002|STARTED|Open Label Extension (OLE)||50||
59908627|NCT02963766|76029713|FG000|COMPLETED|Open Label Extension (OLE)||45||
59908628|NCT02963766|76029714|FG001|COMPLETED|Open Label Extension (OLE)||46||
59506553|NCT00795769|75599546|FG000|COMPLETED|Overall Study||49||
59611464|NCT01777776|75722453|FG002|COMPLETED|Overall Study||0||
59758491|NCT03057106|75877778|FG001|STARTED|Overall Study|3 patients refused the treatment|148|4 patient refused study treatment|
59758492|NCT03057106|75877777|FG000|COMPLETED|Overall Study||149||
59758493|NCT03057106|75877778|FG001|COMPLETED|Overall Study||148||
59758494|NCT03057106|75877777|FG000|NOT COMPLETED|Overall Study||0||
59758495|NCT03057106|75877778|FG001|NOT COMPLETED|Overall Study||0||
59758496|NCT03035201|75877788|FG000|STARTED|Overall Study||571||
59758497|NCT03035201|75877789|FG001|STARTED|Overall Study||553||
59758498|NCT03035201|75877790|FG002|STARTED|Overall Study||551||
59758499|NCT03035201|75877791|FG003|STARTED|Overall Study||587||
59758500|NCT03035201|75877788|FG000|COMPLETED|Overall Study||444||
59758501|NCT03035201|75877789|FG001|COMPLETED|Overall Study||441||
59908629|NCT02963766|76029715|FG002|COMPLETED|Open Label Extension (OLE)||48||
59908630|NCT02963766|76029713|FG000|NOT COMPLETED|Open Label Extension (OLE)||2||
59908631|NCT02963766|76029714|FG001|NOT COMPLETED|Open Label Extension (OLE)||3||
59908632|NCT02963766|76029715|FG002|NOT COMPLETED|Open Label Extension (OLE)||2||
59908633|NCT04839965|76029735|FG000|STARTED|Overall Study||21||
59908634|NCT04839965|76029736|FG001|STARTED|Overall Study||15||
59908635|NCT04839965|76029735|FG000|COMPLETED|Overall Study||14||
59908636|NCT04839965|76029736|FG001|COMPLETED|Overall Study||9||
59908637|NCT04839965|76029735|FG000|NOT COMPLETED|Overall Study||7||
59908638|NCT04839965|76029736|FG001|NOT COMPLETED|Overall Study||6||
59758502|NCT03035201|75877790|FG002|COMPLETED|Overall Study||441||
59758503|NCT03035201|75877791|FG003|COMPLETED|Overall Study||462||
59908639|NCT03466099|76029745|FG000|STARTED|Overall Study||41||
59506554|NCT00795769|75599546|FG000|NOT COMPLETED|Overall Study||0||
59506555|NCT00796627|75599552|FG000|STARTED|Overall Study||10||
59506556|NCT00796627|75599553|FG001|STARTED|Overall Study||31||
59908640|NCT03466099|76029746|FG001|STARTED|Overall Study||44||
59908641|NCT03466099|76029747|FG002|STARTED|Overall Study|One study subject consented and was randomized, but withdrew prior to receiving any study treatments|45||
59908642|NCT03466099|76029745|FG000|Treated|Overall Study||41||
59908643|NCT03466099|76029746|FG001|Treated|Overall Study||44||
59908644|NCT03466099|76029747|FG002|Treated|Overall Study||44||
59908645|NCT03466099|76029745|FG000|COMPLETED|Overall Study||24||
59908646|NCT03466099|76029746|FG001|COMPLETED|Overall Study||30||
60016860|NCT02574637|76133187|FG007|NOT COMPLETED|Open-label (OL) Period||1||
60016861|NCT02574637|76133188|FG008|NOT COMPLETED|Open-label (OL) Period||2||
60016862|NCT02574637|76133189|FG009|NOT COMPLETED|Open-label (OL) Period||1||
60016863|NCT02392611|76133219|FG000|STARTED|Overall Study||2||
60016864|NCT02392611|76133220|FG001|STARTED|Overall Study||1||
60016865|NCT02392611|76133221|FG002|STARTED|Overall Study||1||
60016866|NCT02392611|76133222|FG003|STARTED|Overall Study||9||
60016867|NCT02392611|76133223|FG004|STARTED|Overall Study||6||
60016868|NCT02392611|76133224|FG005|STARTED|Overall Study||4||
60016869|NCT02392611|76133225|FG006|STARTED|Overall Study||4||
60016870|NCT02392611|76133226|FG007|STARTED|Overall Study||3||
60016871|NCT02392611|76133227|FG008|STARTED|Overall Study||3||
60016872|NCT02392611|76133219|FG000|COMPLETED|Overall Study||1||
60016873|NCT02392611|76133220|FG001|COMPLETED|Overall Study||1||
60016874|NCT02392611|76133221|FG002|COMPLETED|Overall Study||1||
60016875|NCT02392611|76133222|FG003|COMPLETED|Overall Study||3||
60016876|NCT02392611|76133223|FG004|COMPLETED|Overall Study||5||
60016877|NCT02392611|76133224|FG005|COMPLETED|Overall Study||3||
60016878|NCT02392611|76133225|FG006|COMPLETED|Overall Study||3||
60016879|NCT02392611|76133226|FG007|COMPLETED|Overall Study||3||
60016880|NCT02392611|76133227|FG008|COMPLETED|Overall Study||3||
60016881|NCT02392611|76133219|FG000|NOT COMPLETED|Overall Study||1||
60016882|NCT02392611|76133220|FG001|NOT COMPLETED|Overall Study||0||
60016883|NCT02392611|76133221|FG002|NOT COMPLETED|Overall Study||0||
60016884|NCT02392611|76133222|FG003|NOT COMPLETED|Overall Study||6||
60016885|NCT02392611|76133223|FG004|NOT COMPLETED|Overall Study||1||
60016886|NCT02392611|76133224|FG005|NOT COMPLETED|Overall Study||1||
60016887|NCT02392611|76133225|FG006|NOT COMPLETED|Overall Study||1||
60016888|NCT02392611|76133226|FG007|NOT COMPLETED|Overall Study||0||
60016889|NCT02392611|76133227|FG008|NOT COMPLETED|Overall Study||0||
60016890|NCT02378961|76133251|FG000|STARTED|Overall Study||33||
60016891|NCT02378961|76133252|FG001|STARTED|Overall Study||30||
60016892|NCT02378961|76133253|FG002|STARTED|Overall Study||36||
60016893|NCT02378961|76133254|FG003|STARTED|Overall Study||29||
60016894|NCT02378961|76133251|FG000|COMPLETED|Overall Study||29||
60016895|NCT02378961|76133252|FG001|COMPLETED|Overall Study||28||
60016896|NCT02378961|76133253|FG002|COMPLETED|Overall Study||35||
60016897|NCT02378961|76133254|FG003|COMPLETED|Overall Study||28||
60016898|NCT02378961|76133251|FG000|NOT COMPLETED|Overall Study||4||
60016899|NCT02378961|76133252|FG001|NOT COMPLETED|Overall Study||2||
60016900|NCT02378961|76133253|FG002|NOT COMPLETED|Overall Study||1||
60016901|NCT02378961|76133254|FG003|NOT COMPLETED|Overall Study||1||
60016902|NCT02378883|76133264|FG000|STARTED|Enrollment|Participants consented and assessed for eligibility|121||
60016903|NCT02378883|76133264|FG000|COMPLETED|Enrollment|Attempted with study device - intent to treat population|112||
59908647|NCT03466099|76029747|FG002|COMPLETED|Overall Study||28||
60016904|NCT02378883|76133264|FG000|NOT COMPLETED|Enrollment||9||
59506557|NCT00796627|75599552|FG000|COMPLETED|Overall Study||10||
59506558|NCT00796627|75599553|FG001|COMPLETED|Overall Study||31||
59908648|NCT03466099|76029745|FG000|NOT COMPLETED|Overall Study||17||
60016905|NCT02378883|76133264|FG000|STARTED|Discharge||112||
60016906|NCT02378883|76133264|FG000|COMPLETED|Discharge||112||
60016907|NCT02378883|76133264|FG000|NOT COMPLETED|Discharge||0||
60016908|NCT02378883|76133264|FG000|STARTED|30 Day Follow-Up||112||
60016909|NCT02378883|76133264|FG000|COMPLETED|30 Day Follow-Up||106|Includes 66 subjects with no tip retained. Subjects eligible to exit study per protocol.|
60016910|NCT02378883|76133264|FG000|NOT COMPLETED|30 Day Follow-Up||6||
59908649|NCT03466099|76029746|FG001|NOT COMPLETED|Overall Study||14||
59908650|NCT03466099|76029747|FG002|NOT COMPLETED|Overall Study||17||
59908651|NCT00739674|76029757|FG000|STARTED|Overall Study||535||
59908652|NCT00739674|76029758|FG001|STARTED|Overall Study||457||
59908653|NCT00739674|76029757|FG000|Screening Failures|Overall Study||19||
59908654|NCT00739674|76029758|FG001|Screening Failures|Overall Study|ITT population took at least one dose of the study medication and had one follow-up visit.|17||
59908655|NCT00739674|76029757|FG000|Site 212 Removal|Overall Study|lack of source documentation & frequent discrepancies between source notes and case report entries.|19||
59908656|NCT00739674|76029758|FG001|Site 212 Removal|Overall Study|lack of source documentation & frequent discrepancies between source notes and case report entries.|13||
59908657|NCT00739674|76029757|FG000|No Follow-up Data|Overall Study||33||
59908658|NCT00739674|76029758|FG001|No Follow-up Data|Overall Study||18||
59908659|NCT00739674|76029757|FG000|Dietician Consultation >30 Days|Overall Study|Patients with dietician consultations >30 days after visit 1 were not included in the data analysis.|1||
59908660|NCT00739674|76029758|FG001|Dietician Consultation >30 Days|Overall Study|Patients with dietician consultations >30 days after visit 1 were not included in the data analysis.|9||
59908661|NCT00739674|76029757|FG000|Intent-to-treat (ITT) Population|Overall Study|ITT population took at least one dose of the study medication and had one follow-up visit.|463||
59908662|NCT00739674|76029758|FG001|Intent-to-treat (ITT) Population|Overall Study|ITT population took at least one dose of the study medication and had one follow-up visit.|400||
59908663|NCT00739674|76029757|FG000|COMPLETED|Overall Study||354||
59908664|NCT00739674|76029758|FG001|COMPLETED|Overall Study||335||
59908665|NCT00739674|76029757|FG000|NOT COMPLETED|Overall Study||181||
59908666|NCT00739674|76029758|FG001|NOT COMPLETED|Overall Study||122||
59908667|NCT03494725|76029766|FG000|STARTED|Overall Study||60||
59908668|NCT03494725|76029767|FG001|STARTED|Overall Study||60||
59506559|NCT00796627|75599552|FG000|NOT COMPLETED|Overall Study||0||
59506560|NCT00796627|75599553|FG001|NOT COMPLETED|Overall Study||0||
59506561|NCT01975935|75599561|FG000|STARTED|Overall Study||21||
59506562|NCT01975935|75599562|FG001|STARTED|Overall Study||21||
59908669|NCT03494725|76029766|FG000|Intervention (Post 2 Weeks run-in)|Overall Study||59|N=2 did not receive any treatment. Reasons: antibiotic therapy and consent withdrawn during run-in.|
59908670|NCT03494725|76029767|FG001|Intervention (Post 2 Weeks run-in)|Overall Study||59|N=2 did not receive any treatment. Reasons: antibiotic therapy and consent withdrawn during run-in.|
59908671|NCT03494725|76029766|FG000|COMPLETED|Overall Study||59||
59908672|NCT03494725|76029767|FG001|COMPLETED|Overall Study||58||
59908673|NCT03494725|76029766|FG000|NOT COMPLETED|Overall Study||1||
59908674|NCT03494725|76029767|FG001|NOT COMPLETED|Overall Study||2||
59908675|NCT00705718|76029781|FG000|STARTED|Overall Study||44||
59908676|NCT00705718|76029782|FG001|STARTED|Overall Study||150||
59908677|NCT00705718|76029781|FG000|1 Month Follow up|Overall Study|1 Death|43||
59908678|NCT00705718|76029782|FG001|1 Month Follow up|Overall Study|1 Subject Missed Visit|149||
59908679|NCT00705718|76029781|FG000|6 Month Follow up|Overall Study|3 Deaths|40||
59908680|NCT00705718|76029782|FG001|6 Month Follow up|Overall Study|2 Deaths, 5 Subjects Missed Visit|143||
59908681|NCT00705718|76029781|FG000|12 Month Follow up|Overall Study|2 Deaths|37||
59908682|NCT00705718|76029782|FG001|12 Month Follow up|Overall Study|4 Deaths, 12 Subjects Not due for next visit, 4 Subjects Missed Visit|128||
60016911|NCT02378883|76133264|FG000|STARTED|12 Months Follow-Up|Two deaths occurred between 30 day FU and prior to 12 month FU.|46|As per protocol only 46 subjects were eligible for 12 month visit due to tip retention.|
60016912|NCT02378883|76133264|FG000|COMPLETED|12 Months Follow-Up||41||
60016913|NCT02378883|76133264|FG000|NOT COMPLETED|12 Months Follow-Up||5||
60016914|NCT02340975|76133275|FG000|STARTED|Overall Study||6||
59908683|NCT00705718|76029781|FG000|COMPLETED|Overall Study||37||
59908684|NCT00705718|76029782|FG001|COMPLETED|Overall Study||128||
59908685|NCT00705718|76029781|FG000|NOT COMPLETED|Overall Study||7||
59908686|NCT00705718|76029782|FG001|NOT COMPLETED|Overall Study||22||
60016915|NCT02340975|76133276|FG001|STARTED|Overall Study||27||
60016916|NCT02340975|76133277|FG002|STARTED|Overall Study||24||
60016917|NCT02340975|76133278|FG003|STARTED|Overall Study||12||
60016918|NCT02340975|76133279|FG004|STARTED|Overall Study||25||
60016919|NCT02340975|76133280|FG005|STARTED|Overall Study||19||
60016920|NCT02340975|76133275|FG000|COMPLETED|Overall Study||0||
60016921|NCT02340975|76133276|FG001|COMPLETED|Overall Study||0||
60016922|NCT02340975|76133277|FG002|COMPLETED|Overall Study||0||
60016923|NCT02340975|76133278|FG003|COMPLETED|Overall Study||0||
60016924|NCT02340975|76133279|FG004|COMPLETED|Overall Study||0||
60016925|NCT02340975|76133280|FG005|COMPLETED|Overall Study||0||
60016926|NCT02340975|76133275|FG000|NOT COMPLETED|Overall Study||6||
60016927|NCT02340975|76133276|FG001|NOT COMPLETED|Overall Study||27||
59908687|NCT03435211|76029788|FG000|STARTED|Overall Study||26||
59908688|NCT03435211|76029788|FG000|COMPLETED|Overall Study||25||
60016928|NCT02340975|76133277|FG002|NOT COMPLETED|Overall Study||24||
60016929|NCT02340975|76133278|FG003|NOT COMPLETED|Overall Study||12||
60016930|NCT02340975|76133279|FG004|NOT COMPLETED|Overall Study||25||
60016931|NCT02340975|76133280|FG005|NOT COMPLETED|Overall Study||19||
60016932|NCT02392377|76133297|FG000|STARTED|Overall Study||0||
60016933|NCT02392377|76133298|FG001|STARTED|Overall Study||1||
60016934|NCT02392377|76133297|FG000|COMPLETED|Overall Study||0||
60016935|NCT02392377|76133298|FG001|COMPLETED|Overall Study||0||
60016936|NCT02392377|76133297|FG000|NOT COMPLETED|Overall Study||0||
60016937|NCT02392377|76133298|FG001|NOT COMPLETED|Overall Study||1||
60016938|NCT02340819|76133306|FG000|STARTED|Overall Study||11||
60016939|NCT02340819|76133306|FG000|Started Stage 2|Overall Study||11||
60016940|NCT02340819|76133306|FG000|Completed Stage 2|Overall Study||9||
60016941|NCT02340819|76133306|FG000|Started Stage 3|Overall Study||8||
60016942|NCT02340819|76133306|FG000|Completed Stage 3|Overall Study||7||
60016943|NCT02340819|76133306|FG000|Started Stage 4|Overall Study||7||
60016944|NCT02340819|76133306|FG000|Completed Stage 4|Overall Study||7||
60016945|NCT02340819|76133306|FG000|COMPLETED|Overall Study||7||
59506563|NCT01975935|75599561|FG000|COMPLETED|Overall Study||18||
59506564|NCT01975935|75599562|FG001|COMPLETED|Overall Study||20||
59506565|NCT01975935|75599561|FG000|NOT COMPLETED|Overall Study||3||
59506566|NCT01975935|75599562|FG001|NOT COMPLETED|Overall Study||1||
59506567|NCT02305017|75599570|FG000|STARTED|Overall Study||14||
59506568|NCT02305017|75599571|FG001|STARTED|Overall Study||14||
59908689|NCT03435211|76029788|FG000|NOT COMPLETED|Overall Study||1||
60016946|NCT02340819|76133306|FG000|NOT COMPLETED|Overall Study||4||
59908690|NCT01928732|76029794|FG000|STARTED|Overall Study||455||
59908691|NCT01928732|76029795|FG001|STARTED|Overall Study||461||
59908692|NCT01928732|76029794|FG000|COMPLETED|Overall Study||326||
59908693|NCT01928732|76029795|FG001|COMPLETED|Overall Study||334||
59908694|NCT01928732|76029794|FG000|NOT COMPLETED|Overall Study||129||
59908695|NCT01928732|76029795|FG001|NOT COMPLETED|Overall Study||127||
60016947|NCT02340663|76133312|FG000|STARTED|Overall Study||35||
60016948|NCT02340663|76133313|FG001|STARTED|Overall Study||32||
60016949|NCT02340663|76133312|FG000|Clinical Exam, Impressions|Overall Study||35||
60016950|NCT02340663|76133313|FG001|Clinical Exam, Impressions|Overall Study||32||
59506569|NCT02305017|75599570|FG000|COMPLETED|Overall Study||14||
59506570|NCT02305017|75599571|FG001|COMPLETED|Overall Study||14||
59506571|NCT02305017|75599570|FG000|NOT COMPLETED|Overall Study||0||
59506572|NCT02305017|75599571|FG001|NOT COMPLETED|Overall Study||0||
59908696|NCT03465709|76029801|FG000|STARTED|Overall Study||17|Received at least 1 dose pegcetacoplan.|
59908697|NCT03465709|76029801|FG000|COMPLETED|Overall Study||0|Completed planned treatment phase to Visit 15.|
59908698|NCT03465709|76029801|FG000|NOT COMPLETED|Overall Study||17||
59908699|NCT03435055|76029807|FG000|STARTED|Screening||21||
59908700|NCT03435055|76029807|FG000|COMPLETED|Screening||19||
59908701|NCT03435055|76029807|FG000|NOT COMPLETED|Screening||2||
59908702|NCT03435055|76029807|FG000|STARTED|Received Intervention||19||
59908703|NCT03435055|76029807|FG000|COMPLETED|Received Intervention||16||
59908704|NCT03435055|76029807|FG000|NOT COMPLETED|Received Intervention||3||
59908705|NCT03434977|76029820|FG000|STARTED|Intervention Period 1 (6 Days)||6||
59908706|NCT03434977|76029821|FG001|STARTED|Intervention Period 1 (6 Days)||6||
59908707|NCT03434977|76029820|FG000|COMPLETED|Intervention Period 1 (6 Days)||6||
59908708|NCT03434977|76029821|FG001|COMPLETED|Intervention Period 1 (6 Days)||6||
59506573|NCT00249821|75599583|FG000|STARTED|Overall Study||10||
59506574|NCT00249821|75599584|FG001|STARTED|Overall Study||12||
59506575|NCT00249821|75599583|FG000|COMPLETED|Overall Study||10||
59506576|NCT00249821|75599584|FG001|COMPLETED|Overall Study||11||
59506577|NCT00249821|75599583|FG000|NOT COMPLETED|Overall Study||0||
59908709|NCT03434977|76029820|FG000|NOT COMPLETED|Intervention Period 1 (6 Days)||0||
59908710|NCT03434977|76029821|FG001|NOT COMPLETED|Intervention Period 1 (6 Days)||0||
59908711|NCT03434977|76029820|FG000|STARTED|Washout Period (at Least 6 Days)||6||
59908712|NCT03434977|76029821|FG001|STARTED|Washout Period (at Least 6 Days)||6||
59908713|NCT03434977|76029820|FG000|COMPLETED|Washout Period (at Least 6 Days)||6||
59908714|NCT03434977|76029821|FG001|COMPLETED|Washout Period (at Least 6 Days)||5||
59908715|NCT03434977|76029820|FG000|NOT COMPLETED|Washout Period (at Least 6 Days)||0||
59908716|NCT03434977|76029821|FG001|NOT COMPLETED|Washout Period (at Least 6 Days)||1||
59908717|NCT03434977|76029820|FG000|STARTED|Intervention Period 2 (6 Days)||6||
59908718|NCT03434977|76029821|FG001|STARTED|Intervention Period 2 (6 Days)||5||
59908719|NCT03434977|76029820|FG000|COMPLETED|Intervention Period 2 (6 Days)||6||
59908720|NCT03434977|76029821|FG001|COMPLETED|Intervention Period 2 (6 Days)||5||
59908721|NCT03434977|76029820|FG000|NOT COMPLETED|Intervention Period 2 (6 Days)||0||
59908722|NCT03434977|76029821|FG001|NOT COMPLETED|Intervention Period 2 (6 Days)||0||
59908723|NCT03434119|76029829|FG000|STARTED|Overall Study||116||
59908724|NCT03434119|76029830|FG001|STARTED|Overall Study||125||
59908725|NCT03434119|76029829|FG000|Treated|Overall Study||115||
59908726|NCT03434119|76029830|FG001|Treated|Overall Study||125||
59908727|NCT03434119|76029829|FG000|COMPLETED|Overall Study||9||
59908728|NCT03434119|76029830|FG001|COMPLETED|Overall Study||12||
59908729|NCT03434119|76029829|FG000|NOT COMPLETED|Overall Study||107||
59908730|NCT03434119|76029830|FG001|NOT COMPLETED|Overall Study||113||
59908731|NCT00378378|76029839|FG000|STARTED|Overall Study||51||
59908732|NCT00378378|76029840|FG001|STARTED|Overall Study||50||
59908733|NCT00378378|76029841|FG002|STARTED|Overall Study||26||
59908734|NCT00378378|76029839|FG000|COMPLETED|Overall Study||51||
59908735|NCT00378378|76029840|FG001|COMPLETED|Overall Study||49||
59908736|NCT00378378|76029841|FG002|COMPLETED|Overall Study||24||
59908737|NCT00378378|76029839|FG000|NOT COMPLETED|Overall Study||0||
59908738|NCT00378378|76029840|FG001|NOT COMPLETED|Overall Study||1||
59908739|NCT00378378|76029841|FG002|NOT COMPLETED|Overall Study||2||
60016951|NCT02340663|76133312|FG000|Splint Delivery, Assessments|Overall Study||33||
59506578|NCT00249821|75599584|FG001|NOT COMPLETED|Overall Study||1||
59611465|NCT01777776|75722454|FG003|COMPLETED|Overall Study||0||
59908740|NCT03490981|76029851|FG000|STARTED|Overall Study||15||
59908741|NCT03490981|76029852|FG001|STARTED|Overall Study||15||
59908742|NCT03490981|76029851|FG000|COMPLETED|Overall Study||14||
59506579|NCT01976871|75599590|FG000|STARTED|Overall Study||21||
60016952|NCT02340663|76133313|FG001|Splint Delivery, Assessments|Overall Study||31||
60016953|NCT02340663|76133312|FG000|1 Week Follow-up, Assessments|Overall Study||33||
60016954|NCT02340663|76133313|FG001|1 Week Follow-up, Assessments|Overall Study||31||
60016955|NCT02340663|76133312|FG000|4 Month Follow-up, Assessments|Overall Study||30||
60016956|NCT02340663|76133313|FG001|4 Month Follow-up, Assessments|Overall Study||31||
60016957|NCT02340663|76133312|FG000|COMPLETED|Overall Study||30||
60016958|NCT02340663|76133313|FG001|COMPLETED|Overall Study||31||
60016959|NCT02340663|76133312|FG000|NOT COMPLETED|Overall Study||5||
60016960|NCT02340663|76133313|FG001|NOT COMPLETED|Overall Study||1||
60016961|NCT02573467|76133323|FG000|STARTED|Double-blind Treatment Epoch||53|Mean duration of exposure during the extension double-blind treatment period was 197.2 to 212.3 days|
60016962|NCT02573467|76133324|FG001|STARTED|Double-blind Treatment Epoch||52|Mean duration of exposure during the extension double-blind treatment period was 197.2 to 212.3 days|
60016963|NCT02573467|76133325|FG002|STARTED|Double-blind Treatment Epoch||51|Mean duration of exposure during the extension double-blind treatment period was 197.2 to 212.3 days|
60016964|NCT02573467|76133326|FG003|STARTED|Double-blind Treatment Epoch||55|Mean duration of exposure during the extension double-blind treatment period was 197.2 to 212.3 days|
60016965|NCT02573467|76133323|FG000|Full Analysis Set|Double-blind Treatment Epoch||53||
60016966|NCT02573467|76133324|FG001|Full Analysis Set|Double-blind Treatment Epoch||52||
60016967|NCT02573467|76133325|FG002|Full Analysis Set|Double-blind Treatment Epoch||51||
60016968|NCT02573467|76133326|FG003|Full Analysis Set|Double-blind Treatment Epoch||55||
60016969|NCT02573467|76133323|FG000|COMPLETED|Double-blind Treatment Epoch||0||
60016970|NCT02573467|76133324|FG001|COMPLETED|Double-blind Treatment Epoch||0||
60016971|NCT02573467|76133325|FG002|COMPLETED|Double-blind Treatment Epoch||0||
60016972|NCT02573467|76133326|FG003|COMPLETED|Double-blind Treatment Epoch||0||
60016973|NCT02573467|76133323|FG000|NOT COMPLETED|Double-blind Treatment Epoch||53||
60016974|NCT02573467|76133324|FG001|NOT COMPLETED|Double-blind Treatment Epoch||52||
60016975|NCT02573467|76133325|FG002|NOT COMPLETED|Double-blind Treatment Epoch||51||
60016976|NCT02573467|76133326|FG003|NOT COMPLETED|Double-blind Treatment Epoch||55||
59611466|NCT01777776|75722451|FG000|NOT COMPLETED|Overall Study||6||
59611467|NCT01777776|75722452|FG001|NOT COMPLETED|Overall Study||12||
59611468|NCT01777776|75722453|FG002|NOT COMPLETED|Overall Study||6||
59611469|NCT01777776|75722454|FG003|NOT COMPLETED|Overall Study||4||
59611470|NCT01777620|75722475|FG000|STARTED|Overall Study||63||
59506580|NCT01976871|75599590|FG000|COMPLETED|Overall Study||20||
59506581|NCT01976871|75599590|FG000|NOT COMPLETED|Overall Study||1||
59506582|NCT02280239|75599596|FG000|STARTED|Overall Study||1||
59506583|NCT02280239|75599597|FG001|STARTED|Overall Study||5||
59611471|NCT01777620|75722476|FG001|STARTED|Overall Study||62||
59611472|NCT01777620|75722475|FG000|COMPLETED|Overall Study||62||
59611473|NCT01777620|75722476|FG001|COMPLETED|Overall Study||62||
59611474|NCT01777620|75722475|FG000|NOT COMPLETED|Overall Study||1||
59611475|NCT01777620|75722476|FG001|NOT COMPLETED|Overall Study||0||
59611476|NCT01777542|75722482|FG000|STARTED|First Intervention (20 Weeks)||15||
59611477|NCT01777542|75722483|FG001|STARTED|First Intervention (20 Weeks)||15||
60016977|NCT02573467|76133323|FG000|STARTED|Post-treatment Follow up Epoch||41||
60016978|NCT02573467|76133324|FG001|STARTED|Post-treatment Follow up Epoch||46||
60016979|NCT02573467|76133325|FG002|STARTED|Post-treatment Follow up Epoch||44||
60016980|NCT02573467|76133326|FG003|STARTED|Post-treatment Follow up Epoch||47||
60016981|NCT02573467|76133323|FG000|COMPLETED|Post-treatment Follow up Epoch||35||
60016982|NCT02573467|76133324|FG001|COMPLETED|Post-treatment Follow up Epoch||41||
60016983|NCT02573467|76133325|FG002|COMPLETED|Post-treatment Follow up Epoch||34||
60016984|NCT02573467|76133326|FG003|COMPLETED|Post-treatment Follow up Epoch||44||
60016985|NCT02573467|76133323|FG000|NOT COMPLETED|Post-treatment Follow up Epoch||6||
60016986|NCT02573467|76133324|FG001|NOT COMPLETED|Post-treatment Follow up Epoch||5||
60016987|NCT02573467|76133325|FG002|NOT COMPLETED|Post-treatment Follow up Epoch||10||
60016988|NCT02573467|76133326|FG003|NOT COMPLETED|Post-treatment Follow up Epoch||3||
60016989|NCT02337387|76133341|FG000|STARTED|Overall Study||14||
60016990|NCT02337387|76133342|FG001|STARTED|Overall Study||8||
60016991|NCT02337387|76133343|FG002|STARTED|Overall Study||3||
60016992|NCT02337387|76133344|FG003|STARTED|Overall Study||3||
60016993|NCT02337387|76133341|FG000|Received at Least 1 Dose of Study Drug|Overall Study||14||
59506584|NCT02280239|75599596|FG000|COMPLETED|Overall Study||1||
59506585|NCT02280239|75599597|FG001|COMPLETED|Overall Study||5||
60016994|NCT02337387|76133342|FG001|Received at Least 1 Dose of Study Drug|Overall Study||8||
59506586|NCT02280239|75599596|FG000|NOT COMPLETED|Overall Study||0||
59506587|NCT02280239|75599597|FG001|NOT COMPLETED|Overall Study||0||
59611478|NCT01777542|75722482|FG000|COMPLETED|First Intervention (20 Weeks)||15||
59611479|NCT01777542|75722483|FG001|COMPLETED|First Intervention (20 Weeks)||15||
59611480|NCT01777542|75722482|FG000|NOT COMPLETED|First Intervention (20 Weeks)||0||
60016995|NCT02337387|76133343|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3||
60016996|NCT02337387|76133344|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3||
60016997|NCT02337387|76133341|FG000|COMPLETED|Overall Study||0||
59506588|NCT01993875|75599607|FG000|STARTED|Overall Study||82||
59611481|NCT01777542|75722483|FG001|NOT COMPLETED|First Intervention (20 Weeks)||0||
59611482|NCT01777542|75722482|FG000|STARTED|Washout Period (28 +/- 2 Weeks)||15||
59506589|NCT01993875|75599608|FG001|STARTED|Overall Study||82||
59908743|NCT03490981|76029852|FG001|COMPLETED|Overall Study||13||
59908744|NCT03490981|76029851|FG000|NOT COMPLETED|Overall Study||1||
59908745|NCT03490981|76029852|FG001|NOT COMPLETED|Overall Study||2||
59908746|NCT03160716|76029858|FG000|STARTED|Overall Study||60||
59908747|NCT03160716|76029858|FG000|COMPLETED|Overall Study||59||
59908748|NCT03160716|76029858|FG000|NOT COMPLETED|Overall Study||1||
59908749|NCT03713021|76029862|FG000|STARTED|Overall Study||27||
59908750|NCT03713021|76029862|FG000|COMPLETED|Overall Study||12||
59908751|NCT03713021|76029862|FG000|NOT COMPLETED|Overall Study||15||
59908752|NCT03160560|76029870|FG000|STARTED|First Intervention (3 Weeks)||25||
59908753|NCT03160560|76029871|FG001|STARTED|First Intervention (3 Weeks)||25||
59506590|NCT01993875|75599607|FG000|COMPLETED|Overall Study||75||
59758504|NCT03035201|75877788|FG000|NOT COMPLETED|Overall Study||127||
59758505|NCT03035201|75877789|FG001|NOT COMPLETED|Overall Study||112||
59758506|NCT03035201|75877790|FG002|NOT COMPLETED|Overall Study||110||
59758507|NCT03035201|75877791|FG003|NOT COMPLETED|Overall Study||125||
59908754|NCT03160560|76029872|FG002|STARTED|First Intervention (3 Weeks)||25||
59908755|NCT03160560|76029873|FG003|STARTED|First Intervention (3 Weeks)||25||
59908756|NCT03160560|76029870|FG000|COMPLETED|First Intervention (3 Weeks)||23||
59908757|NCT03160560|76029871|FG001|COMPLETED|First Intervention (3 Weeks)||24||
59908758|NCT03160560|76029872|FG002|COMPLETED|First Intervention (3 Weeks)||24||
59908759|NCT03160560|76029873|FG003|COMPLETED|First Intervention (3 Weeks)||25||
59908760|NCT03160560|76029870|FG000|NOT COMPLETED|First Intervention (3 Weeks)||2||
59908761|NCT03160560|76029871|FG001|NOT COMPLETED|First Intervention (3 Weeks)||1||
59908762|NCT03160560|76029872|FG002|NOT COMPLETED|First Intervention (3 Weeks)||1||
59908763|NCT03160560|76029873|FG003|NOT COMPLETED|First Intervention (3 Weeks)||0||
59908764|NCT03160560|76029870|FG000|STARTED|Washout (2 Weeks)||23||
59908765|NCT03160560|76029871|FG001|STARTED|Washout (2 Weeks)||24||
59908766|NCT03160560|76029872|FG002|STARTED|Washout (2 Weeks)||24||
59908767|NCT03160560|76029873|FG003|STARTED|Washout (2 Weeks)||25||
59908768|NCT03160560|76029870|FG000|COMPLETED|Washout (2 Weeks)||23||
59908769|NCT03160560|76029871|FG001|COMPLETED|Washout (2 Weeks)||24||
59908770|NCT03160560|76029872|FG002|COMPLETED|Washout (2 Weeks)||24||
59908771|NCT03160560|76029873|FG003|COMPLETED|Washout (2 Weeks)||25||
59908772|NCT03160560|76029870|FG000|NOT COMPLETED|Washout (2 Weeks)||0||
59908773|NCT03160560|76029871|FG001|NOT COMPLETED|Washout (2 Weeks)||0||
59908774|NCT03160560|76029872|FG002|NOT COMPLETED|Washout (2 Weeks)||0||
59908775|NCT03160560|76029873|FG003|NOT COMPLETED|Washout (2 Weeks)||0||
59908776|NCT03160560|76029870|FG000|STARTED|Second Intervention (3 Weeks)||23||
59908777|NCT03160560|76029871|FG001|STARTED|Second Intervention (3 Weeks)||24||
59908778|NCT03160560|76029872|FG002|STARTED|Second Intervention (3 Weeks)||24||
59908779|NCT03160560|76029873|FG003|STARTED|Second Intervention (3 Weeks)||25||
59908780|NCT03160560|76029870|FG000|COMPLETED|Second Intervention (3 Weeks)||22||
59908781|NCT03160560|76029871|FG001|COMPLETED|Second Intervention (3 Weeks)||24||
59908782|NCT03160560|76029872|FG002|COMPLETED|Second Intervention (3 Weeks)||24||
59908783|NCT03160560|76029873|FG003|COMPLETED|Second Intervention (3 Weeks)||25||
59908784|NCT03160560|76029870|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||1||
59908785|NCT03160560|76029871|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0||
59908786|NCT03160560|76029872|FG002|NOT COMPLETED|Second Intervention (3 Weeks)||0||
59908787|NCT03160560|76029873|FG003|NOT COMPLETED|Second Intervention (3 Weeks)||0||
59908788|NCT03489343|76029890|FG000|STARTED|Overall Study||1||
59908789|NCT03489343|76029891|FG001|STARTED|Overall Study||1||
59908790|NCT03489343|76029892|FG002|STARTED|Overall Study||3||
59908791|NCT03489343|76029893|FG003|STARTED|Overall Study||3||
59908792|NCT03489343|76029894|FG004|STARTED|Overall Study||3||
59908793|NCT03489343|76029895|FG005|STARTED|Overall Study||7||
59908794|NCT03489343|76029896|FG006|STARTED|Overall Study||6||
59908795|NCT03489343|76029890|FG000|COMPLETED|Overall Study||0||
59908796|NCT03489343|76029891|FG001|COMPLETED|Overall Study||0||
59908797|NCT03489343|76029892|FG002|COMPLETED|Overall Study||0||
59908798|NCT03489343|76029893|FG003|COMPLETED|Overall Study||0||
59908799|NCT03489343|76029894|FG004|COMPLETED|Overall Study||0||
59908800|NCT03489343|76029895|FG005|COMPLETED|Overall Study||0||
59908801|NCT03489343|76029896|FG006|COMPLETED|Overall Study||0||
59908802|NCT03489343|76029890|FG000|NOT COMPLETED|Overall Study||1||
59908803|NCT03489343|76029891|FG001|NOT COMPLETED|Overall Study||1||
59908804|NCT03489343|76029892|FG002|NOT COMPLETED|Overall Study||3||
60016998|NCT02337387|76133342|FG001|COMPLETED|Overall Study||0||
60016999|NCT02337387|76133343|FG002|COMPLETED|Overall Study||0||
60017000|NCT02337387|76133344|FG003|COMPLETED|Overall Study||0||
60017001|NCT02337387|76133341|FG000|NOT COMPLETED|Overall Study||14||
60017002|NCT02337387|76133342|FG001|NOT COMPLETED|Overall Study||8||
60017003|NCT02337387|76133343|FG002|NOT COMPLETED|Overall Study||3||
60017004|NCT02337387|76133344|FG003|NOT COMPLETED|Overall Study||3||
60017005|NCT02574247|76133357|FG000|STARTED|Overall Study||10||
60017006|NCT02574247|76133358|FG001|STARTED|Overall Study||8||
60017007|NCT02574247|76133359|FG002|STARTED|Overall Study||10||
60017008|NCT02574247|76133357|FG000|COMPLETED|Overall Study||5||
60017009|NCT02574247|76133358|FG001|COMPLETED|Overall Study||5||
60017010|NCT02574247|76133359|FG002|COMPLETED|Overall Study||5||
59758508|NCT02969915|75877813|FG000|STARTED|Overall Study||1114||8
59758509|NCT02969915|75877814|FG001|STARTED|Overall Study||1200||8
60017011|NCT02574247|76133357|FG000|NOT COMPLETED|Overall Study||5||
60017012|NCT02574247|76133358|FG001|NOT COMPLETED|Overall Study||3||
60017013|NCT02574247|76133359|FG002|NOT COMPLETED|Overall Study||5||
60017014|NCT02391363|76133371|FG000|STARTED|Overall Study||70||
60017015|NCT02391363|76133372|FG001|STARTED|Overall Study||64||
60017016|NCT02391363|76133371|FG000|COMPLETED|Overall Study||59||
60017017|NCT02391363|76133372|FG001|COMPLETED|Overall Study||56||
60017018|NCT02391363|76133371|FG000|NOT COMPLETED|Overall Study||11||
60017019|NCT02391363|76133372|FG001|NOT COMPLETED|Overall Study||8||
60017020|NCT02569957|76133380|FG000|STARTED|Overall Study||0||
60017021|NCT02569957|76133381|FG001|STARTED|Overall Study||1||
60017022|NCT02569957|76133380|FG000|COMPLETED|Overall Study||0||
60017023|NCT02569957|76133381|FG001|COMPLETED|Overall Study||0||
60017024|NCT02569957|76133380|FG000|NOT COMPLETED|Overall Study||0||
60017025|NCT02569957|76133381|FG001|NOT COMPLETED|Overall Study||1||
60017026|NCT01649427|76133389|FG000|STARTED|Overall Study||35||
60017027|NCT01649427|76133390|FG001|STARTED|Overall Study||38||
60017028|NCT01649427|76133389|FG000|COMPLETED|Overall Study||24||
60017029|NCT01649427|76133390|FG001|COMPLETED|Overall Study||26||
60017030|NCT01649427|76133389|FG000|NOT COMPLETED|Overall Study||11||
60017031|NCT01649427|76133390|FG001|NOT COMPLETED|Overall Study||12||
60017032|NCT02375373|76133396|FG000|STARTED|Overall Study||12||
60017033|NCT02375373|76133396|FG000|COMPLETED|Overall Study||1||
60017034|NCT02375373|76133396|FG000|NOT COMPLETED|Overall Study||11||
60017035|NCT02336607|76133404|FG000|STARTED|Overall Study||85||
60017036|NCT02336607|76133405|FG001|STARTED|Overall Study||85||
60017037|NCT02336607|76133406|FG002|STARTED|Overall Study||92||
60017038|NCT02336607|76133407|FG003|STARTED|Overall Study||267||
60017039|NCT02336607|76133404|FG000|Patients Included in ITT Population|Overall Study||84||
60017040|NCT02336607|76133405|FG001|Patients Included in ITT Population|Overall Study||84||
60017041|NCT02336607|76133406|FG002|Patients Included in ITT Population|Overall Study||91||
60017042|NCT02336607|76133407|FG003|Patients Included in ITT Population|Overall Study||222||
60017043|NCT02336607|76133404|FG000|Patients Included in PP Population|Overall Study||78||
60017044|NCT02336607|76133405|FG001|Patients Included in PP Population|Overall Study||75||
60017045|NCT02336607|76133406|FG002|Patients Included in PP Population|Overall Study||75||
60017046|NCT02336607|76133407|FG003|Patients Included in PP Population|Overall Study||162||
60017047|NCT02336607|76133404|FG000|Patients Included in Safety Population|Overall Study||85||
60017048|NCT02336607|76133405|FG001|Patients Included in Safety Population|Overall Study||85||
60017049|NCT02336607|76133406|FG002|Patients Included in Safety Population|Overall Study||92||
60017050|NCT02336607|76133407|FG003|Patients Included in Safety Population|Overall Study||260||
60017051|NCT02336607|76133404|FG000|COMPLETED|Overall Study||81||
60017052|NCT02336607|76133405|FG001|COMPLETED|Overall Study||75||
60017053|NCT02336607|76133406|FG002|COMPLETED|Overall Study||86||
60017054|NCT02336607|76133407|FG003|COMPLETED|Overall Study||180||
60017055|NCT02336607|76133404|FG000|NOT COMPLETED|Overall Study||4||
60017056|NCT02336607|76133405|FG001|NOT COMPLETED|Overall Study||10||
59506591|NCT01993875|75599608|FG001|COMPLETED|Overall Study||76||
60017057|NCT02336607|76133406|FG002|NOT COMPLETED|Overall Study||6||
60017058|NCT02336607|76133407|FG003|NOT COMPLETED|Overall Study||87||
60017059|NCT02374671|76133420|FG000|STARTED|Observation (Deferred Implantation)||0||0
60017060|NCT02374671|76133421|FG001|STARTED|Observation (Deferred Implantation)||0||0
60017061|NCT02374671|76133422|FG002|STARTED|Observation (Deferred Implantation)||31||62
60017062|NCT02374671|76133420|FG000|COMPLETED|Observation (Deferred Implantation)||0||0
60017063|NCT02374671|76133421|FG001|COMPLETED|Observation (Deferred Implantation)||0||0
60017064|NCT02374671|76133422|FG002|COMPLETED|Observation (Deferred Implantation)||26||52
60017065|NCT02374671|76133420|FG000|NOT COMPLETED|Observation (Deferred Implantation)||0||0
60017066|NCT02374671|76133421|FG001|NOT COMPLETED|Observation (Deferred Implantation)||0||0
60017067|NCT02374671|76133422|FG002|NOT COMPLETED|Observation (Deferred Implantation)||5||10
60017068|NCT02374671|76133420|FG000|STARTED|Implantation- Nonrandomized & Randomized|(8) subjects were unilaterally implanted|306||604
60017069|NCT02374671|76133421|FG001|STARTED|Implantation- Nonrandomized & Randomized|(1) subject was unilaterally implanted|28||55
60017070|NCT02374671|76133422|FG002|STARTED|Implantation- Nonrandomized & Randomized|(3) subjects were unilaterally implanted|26||49
60017071|NCT02374671|76133420|FG000|COMPLETED|Implantation- Nonrandomized & Randomized||281||571
60017072|NCT02374671|76133421|FG001|COMPLETED|Implantation- Nonrandomized & Randomized||27||53
60017073|NCT02374671|76133422|FG002|COMPLETED|Implantation- Nonrandomized & Randomized|(1) unilaterally implanted subject discontinued (1 eye)|23||44
60017074|NCT02374671|76133420|FG000|NOT COMPLETED|Implantation- Nonrandomized & Randomized||25||33
60017075|NCT02374671|76133421|FG001|NOT COMPLETED|Implantation- Nonrandomized & Randomized||1||2
60017076|NCT02374671|76133422|FG002|NOT COMPLETED|Implantation- Nonrandomized & Randomized||3||5
60017077|NCT02569801|76133430|FG000|STARTED|Overall Study||36|Started=Randomized|
60017078|NCT02569801|76133431|FG001|STARTED|Overall Study||35|Started=Randomized|
60017079|NCT02569801|76133430|FG000|Received Treatment|Overall Study||35||
60017080|NCT02569801|76133431|FG001|Received Treatment|Overall Study||35||
60017081|NCT02569801|76133430|FG000|COMPLETED|Overall Study||0||
60017082|NCT02569801|76133431|FG001|COMPLETED|Overall Study||0||
60017083|NCT02569801|76133430|FG000|NOT COMPLETED|Overall Study||36||
60017084|NCT02569801|76133431|FG001|NOT COMPLETED|Overall Study||35||
60017085|NCT02573311|76133439|FG000|STARTED|Disposition for Part 1|Started are subjects who entered Part 1 and answered the purchase question|1737||
60017086|NCT02573311|76133440|FG001|STARTED|Disposition for Part 1|Started are subjects who entered Part 1 and answered the purchase question|364||
60017087|NCT02573311|76133439|FG000|COMPLETED|Disposition for Part 1|Completed are the subjects who actually completed Part 1|1730||
60017088|NCT02573311|76133440|FG001|COMPLETED|Disposition for Part 1|Completed are the subjects who actually completed Part 1|361||
60017089|NCT02573311|76133439|FG000|NOT COMPLETED|Disposition for Part 1||7||
60017090|NCT02573311|76133440|FG001|NOT COMPLETED|Disposition for Part 1||3||
60017091|NCT02573311|76133439|FG000|STARTED|Disposition for Part 2|Started are subjects who purchased study product and are eligible to enter Part-2 of study.|964||
60017092|NCT02573311|76133440|FG001|STARTED|Disposition for Part 2|Started are subjects who purchased study product and are eligible to enter Part-2 of study.|153||
60017093|NCT02573311|76133439|FG000|COMPLETED|Disposition for Part 2|Completed are the subjects who completed use phase Part-2 (Week 24 and EOS-P2 interviews).|754||
60017094|NCT02573311|76133440|FG001|COMPLETED|Disposition for Part 2|Completed are the subjects who completed use phase Part-2 (Week 24 and EOS-P2 interviews).|127||
60017095|NCT02573311|76133439|FG000|NOT COMPLETED|Disposition for Part 2||210||
60017096|NCT02573311|76133440|FG001|NOT COMPLETED|Disposition for Part 2||26||
60017097|NCT02571049|76133446|FG000|STARTED|Screening||10||
60017098|NCT02571049|76133447|FG001|STARTED|Screening||14||
60017099|NCT02571049|76133446|FG000|COMPLETED|Screening||8||
60017100|NCT02571049|76133447|FG001|COMPLETED|Screening||12||
60017101|NCT02571049|76133446|FG000|NOT COMPLETED|Screening||2||
60017102|NCT02571049|76133447|FG001|NOT COMPLETED|Screening||2||
60017103|NCT02571049|76133446|FG000|STARTED|Randomization||8||
60017104|NCT02571049|76133447|FG001|STARTED|Randomization||12||
60017105|NCT02571049|76133446|FG000|COMPLETED|Randomization||8||
60017106|NCT02571049|76133447|FG001|COMPLETED|Randomization||10||
60017107|NCT02571049|76133446|FG000|NOT COMPLETED|Randomization||0||
60017108|NCT02571049|76133447|FG001|NOT COMPLETED|Randomization||2||
60017109|NCT02573155|76133455|FG000|STARTED|Treatment Period 1||16||
60017110|NCT02573155|76133456|FG001|STARTED|Treatment Period 1||38||
60017111|NCT02573155|76133455|FG000|COMPLETED|Treatment Period 1||16||
60017112|NCT02573155|76133456|FG001|COMPLETED|Treatment Period 1||38||
60017113|NCT02573155|76133455|FG000|NOT COMPLETED|Treatment Period 1||0||
60017114|NCT02573155|76133456|FG001|NOT COMPLETED|Treatment Period 1||0||
60017115|NCT02573155|76133455|FG000|STARTED|Washout Between Treatment Period 1 and 2||16||
60017116|NCT02573155|76133456|FG001|STARTED|Washout Between Treatment Period 1 and 2||38||
60017117|NCT02573155|76133455|FG000|COMPLETED|Washout Between Treatment Period 1 and 2||16||
60017118|NCT02573155|76133456|FG001|COMPLETED|Washout Between Treatment Period 1 and 2||33||
60017119|NCT02573155|76133455|FG000|NOT COMPLETED|Washout Between Treatment Period 1 and 2||0||
60017120|NCT02573155|76133456|FG001|NOT COMPLETED|Washout Between Treatment Period 1 and 2||5||
60017121|NCT02573155|76133455|FG000|STARTED|Period 2||16||
60017122|NCT02573155|76133456|FG001|STARTED|Period 2||33||
60017123|NCT02573155|76133455|FG000|COMPLETED|Period 2||16||
60017124|NCT02573155|76133456|FG001|COMPLETED|Period 2||33||
60017125|NCT02573155|76133455|FG000|NOT COMPLETED|Period 2||0||
60017126|NCT02573155|76133456|FG001|NOT COMPLETED|Period 2||0||
60017127|NCT02573155|76133455|FG000|STARTED|Washout Between Treatment Period 2 and 3||16||
60017128|NCT02573155|76133456|FG001|STARTED|Washout Between Treatment Period 2 and 3||33||
60017129|NCT02573155|76133455|FG000|COMPLETED|Washout Between Treatment Period 2 and 3||15||
60017130|NCT02573155|76133456|FG001|COMPLETED|Washout Between Treatment Period 2 and 3||31||
60017131|NCT02573155|76133455|FG000|NOT COMPLETED|Washout Between Treatment Period 2 and 3||1||
60017132|NCT02573155|76133456|FG001|NOT COMPLETED|Washout Between Treatment Period 2 and 3||2||
60017133|NCT02573155|76133455|FG000|STARTED|Period 3||15||
60017134|NCT02573155|76133456|FG001|STARTED|Period 3||31||
60017135|NCT02573155|76133455|FG000|COMPLETED|Period 3||15||
60017136|NCT02573155|76133456|FG001|COMPLETED|Period 3||31||
60017137|NCT02573155|76133455|FG000|NOT COMPLETED|Period 3||0||
60017138|NCT02573155|76133456|FG001|NOT COMPLETED|Period 3||0||
60017139|NCT02573155|76133455|FG000|STARTED|Washout Between Treatment Period 3 and 4|Part 1 comprised 3 treatment periods only|0||
60017140|NCT02573155|76133456|FG001|STARTED|Washout Between Treatment Period 3 and 4||31||
60017141|NCT02573155|76133455|FG000|COMPLETED|Washout Between Treatment Period 3 and 4|Part 1 comprised 3 treatment periods only|0||
60017142|NCT02573155|76133456|FG001|COMPLETED|Washout Between Treatment Period 3 and 4||29||
60017143|NCT02573155|76133455|FG000|NOT COMPLETED|Washout Between Treatment Period 3 and 4||0||
60017144|NCT02573155|76133456|FG001|NOT COMPLETED|Washout Between Treatment Period 3 and 4||2||
59908805|NCT03489343|76029893|FG003|NOT COMPLETED|Overall Study||3||
59908806|NCT03489343|76029894|FG004|NOT COMPLETED|Overall Study||3||
59908807|NCT03489343|76029895|FG005|NOT COMPLETED|Overall Study||7||
59908808|NCT03489343|76029896|FG006|NOT COMPLETED|Overall Study||6||
59908809|NCT03489109|76029914|FG000|STARTED|Overall Study||14||
59908810|NCT03489109|76029915|FG001|STARTED|Overall Study||16||
59908811|NCT03489109|76029914|FG000|COMPLETED|Overall Study||13||
59908812|NCT03489109|76029915|FG001|COMPLETED|Overall Study||14||
59908813|NCT03489109|76029914|FG000|NOT COMPLETED|Overall Study||1||
59908814|NCT03489109|76029915|FG001|NOT COMPLETED|Overall Study||2||
59908815|NCT03709823|76029927|FG000|STARTED|Overall Study||51||
59908816|NCT03709823|76029928|FG001|STARTED|Overall Study||50||
59908817|NCT03709823|76029929|FG002|STARTED|Overall Study||25||
59908818|NCT03709823|76029930|FG003|STARTED|Overall Study||52||
59908819|NCT03709823|76029931|FG004|STARTED|Overall Study||50||
59908820|NCT03709823|76029932|FG005|STARTED|Overall Study||26||
59908821|NCT03709823|76029927|FG000|COMPLETED|Overall Study||48||
59908822|NCT03709823|76029928|FG001|COMPLETED|Overall Study||45||
60017145|NCT02573155|76133455|FG000|STARTED|Period 4|Part 1 comprised 3 treatment periods only|0||
60017146|NCT02573155|76133456|FG001|STARTED|Period 4||29||
60017147|NCT02573155|76133455|FG000|COMPLETED|Period 4|Part 1 comprised 3 treatment periods only|0||
60017148|NCT02573155|76133456|FG001|COMPLETED|Period 4||29||
60017149|NCT02573155|76133455|FG000|NOT COMPLETED|Period 4||0||
60017150|NCT02573155|76133456|FG001|NOT COMPLETED|Period 4||0||
60017151|NCT02573155|76133455|FG000|STARTED|Washout Between Treatment Period 4 and 5|Part 1 comprised 3 treatment periods only|0||
60017152|NCT02573155|76133456|FG001|STARTED|Washout Between Treatment Period 4 and 5||29||
60017153|NCT02573155|76133455|FG000|COMPLETED|Washout Between Treatment Period 4 and 5|Part 1 comprised 3 treatment periods only|0||
60017154|NCT02573155|76133456|FG001|COMPLETED|Washout Between Treatment Period 4 and 5||28||
60017155|NCT02573155|76133455|FG000|NOT COMPLETED|Washout Between Treatment Period 4 and 5||0||
60017156|NCT02573155|76133456|FG001|NOT COMPLETED|Washout Between Treatment Period 4 and 5||1||
59908823|NCT03709823|76029929|FG002|COMPLETED|Overall Study||22||
59908824|NCT03709823|76029930|FG003|COMPLETED|Overall Study||50||
59908825|NCT03709823|76029931|FG004|COMPLETED|Overall Study||49||
59908826|NCT03709823|76029932|FG005|COMPLETED|Overall Study||26||
59908827|NCT03709823|76029927|FG000|NOT COMPLETED|Overall Study||3||
59908828|NCT03709823|76029928|FG001|NOT COMPLETED|Overall Study||5||
59908829|NCT03709823|76029929|FG002|NOT COMPLETED|Overall Study||3||
59908830|NCT03709823|76029930|FG003|NOT COMPLETED|Overall Study||2||
59908831|NCT03709823|76029931|FG004|NOT COMPLETED|Overall Study||1||
59908832|NCT03709823|76029932|FG005|NOT COMPLETED|Overall Study||0||
59908833|NCT03488563|76029952|FG000|STARTED|Overall Study||105|Number of subjects treated with study drug.|
59908834|NCT03488563|76029953|FG001|STARTED|Overall Study||104|Number of subjects treated with study drug.|
60017157|NCT02573155|76133455|FG000|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0||
60017158|NCT02573155|76133456|FG001|STARTED|Period 5||28||
60017159|NCT02573155|76133455|FG000|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0||
59908835|NCT03488563|76029954|FG002|STARTED|Overall Study||104|Number of subjects treated with study drug.|
59908836|NCT03488563|76029952|FG000|COMPLETED|Overall Study||83||
59908837|NCT03488563|76029953|FG001|COMPLETED|Overall Study||88||
59908838|NCT03488563|76029954|FG002|COMPLETED|Overall Study||81||
59908839|NCT03488563|76029952|FG000|NOT COMPLETED|Overall Study||22||
59908840|NCT03488563|76029953|FG001|NOT COMPLETED|Overall Study||16||
59908841|NCT03488563|76029954|FG002|NOT COMPLETED|Overall Study||23||
59908842|NCT00706030|76029968|FG000|STARTED|Overall Study||6||
59908843|NCT00706030|76029969|FG001|STARTED|Overall Study||6||
59908844|NCT00706030|76029970|FG002|STARTED|Overall Study||64||
59908845|NCT00706030|76029971|FG003|STARTED|Overall Study||16||
59908846|NCT00706030|76029968|FG000|Treated|Overall Study||6||
59908847|NCT00706030|76029969|FG001|Treated|Overall Study||6||
59908848|NCT00706030|76029970|FG002|Treated|Overall Study||64||
59908849|NCT00706030|76029971|FG003|Treated|Overall Study||15||
59908850|NCT00706030|76029968|FG000|COMPLETED|Overall Study||0||
59908851|NCT00706030|76029969|FG001|COMPLETED|Overall Study||0||
59908852|NCT00706030|76029970|FG002|COMPLETED|Overall Study||4||
59908853|NCT00706030|76029971|FG003|COMPLETED|Overall Study||0||
60017160|NCT02573155|76133456|FG001|COMPLETED|Period 5||28||
60017161|NCT02573155|76133455|FG000|NOT COMPLETED|Period 5||0||
60017162|NCT02573155|76133456|FG001|NOT COMPLETED|Period 5||0||
60017163|NCT02568475|76133484|FG000|STARTED|Overall Study||97||
60017164|NCT02568475|76133485|FG001|STARTED|Overall Study||95||
60017165|NCT02568475|76133484|FG000|Post-test|Overall Study||85||
60017166|NCT02568475|76133485|FG001|Post-test|Overall Study||82||
60017167|NCT02568475|76133484|FG000|COMPLETED|Overall Study||46|3 month follow-up|
60017168|NCT02568475|76133485|FG001|COMPLETED|Overall Study||52|3 month follow-up|
60017169|NCT02568475|76133484|FG000|NOT COMPLETED|Overall Study||51||
60017170|NCT02568475|76133485|FG001|NOT COMPLETED|Overall Study||43||
60017171|NCT02568397|76133491|FG000|STARTED|Period 1||60||
59506592|NCT01993875|75599607|FG000|NOT COMPLETED|Overall Study||7||
60017172|NCT02568397|76133492|FG001|STARTED|Period 1||0||
60017173|NCT02568397|76133491|FG000|Received at Least 1 Dose of Study Drug|Period 1||60||
60017174|NCT02568397|76133492|FG001|Received at Least 1 Dose of Study Drug|Period 1||0||
60017175|NCT02568397|76133491|FG000|COMPLETED|Period 1||60||
60017176|NCT02568397|76133492|FG001|COMPLETED|Period 1||0||
60017177|NCT02568397|76133491|FG000|NOT COMPLETED|Period 1||0||
60017178|NCT02568397|76133492|FG001|NOT COMPLETED|Period 1||0||
60017179|NCT02568397|76133491|FG000|STARTED|Period 2|A single oral dose of 150 mg dabigatran etexilate was administered on Day 1 of Period 1.|0||
60017180|NCT02568397|76133492|FG001|STARTED|Period 2|Daily doses of 50 mg LY3314814 were administered daily on Days 3 to 21 of Period 2.|60||
60017181|NCT02568397|76133491|FG000|COMPLETED|Period 2||0||
60017182|NCT02568397|76133492|FG001|COMPLETED|Period 2||58||
60017183|NCT02568397|76133491|FG000|NOT COMPLETED|Period 2||0||
60017184|NCT02568397|76133492|FG001|NOT COMPLETED|Period 2||2||
60017185|NCT02566525|76133509|FG000|STARTED|Overall Study|FPI - CytoSorb Patient 15 Jan 2016|23||
60017186|NCT02566525|76133510|FG001|STARTED|Overall Study|FPI - Control Patient 8 Dec 2015|23||
60017187|NCT02566525|76133509|FG000|COMPLETED|Overall Study|LPI - CytoSorb Patient 19 Aug 2016|20||
59908854|NCT00706030|76029968|FG000|NOT COMPLETED|Overall Study||6||
59908855|NCT00706030|76029969|FG001|NOT COMPLETED|Overall Study||6||
59908856|NCT00706030|76029970|FG002|NOT COMPLETED|Overall Study||60||
59908857|NCT00706030|76029971|FG003|NOT COMPLETED|Overall Study||16||
59908858|NCT03488251|76029986|FG000|STARTED|Part 1:Dose Escalation (Up to 168 Days)||8||
59908859|NCT03488251|76029987|FG001|STARTED|Part 1:Dose Escalation (Up to 168 Days)||0||
59908860|NCT03488251|76029988|FG002|STARTED|Part 1:Dose Escalation (Up to 168 Days)||0||
59908861|NCT03488251|76029989|FG003|STARTED|Part 1:Dose Escalation (Up to 168 Days)||0||
59908862|NCT03488251|76029986|FG000|COMPLETED|Part 1:Dose Escalation (Up to 168 Days)||0||
59908863|NCT03488251|76029987|FG001|COMPLETED|Part 1:Dose Escalation (Up to 168 Days)||0||
60017188|NCT02566525|76133510|FG001|COMPLETED|Overall Study|LPI - Control 16 Aug 2016|18||
60017189|NCT02566525|76133509|FG000|NOT COMPLETED|Overall Study||3||
59908864|NCT03488251|76029988|FG002|COMPLETED|Part 1:Dose Escalation (Up to 168 Days)||0||
59908865|NCT03488251|76029989|FG003|COMPLETED|Part 1:Dose Escalation (Up to 168 Days)||0||
59908866|NCT03488251|76029986|FG000|NOT COMPLETED|Part 1:Dose Escalation (Up to 168 Days)||8||
60017190|NCT02566525|76133510|FG001|NOT COMPLETED|Overall Study||5||
60017191|NCT02567227|76133520|FG000|STARTED|9 Weeks||192||
60017192|NCT02567227|76133521|FG001|STARTED|9 Weeks||191||
60017193|NCT02567227|76133520|FG000|COMPLETED|9 Weeks||158||
60017194|NCT02567227|76133521|FG001|COMPLETED|9 Weeks||167||
59908867|NCT03488251|76029987|FG001|NOT COMPLETED|Part 1:Dose Escalation (Up to 168 Days)||0||
59908868|NCT03488251|76029988|FG002|NOT COMPLETED|Part 1:Dose Escalation (Up to 168 Days)||0||
59908869|NCT03488251|76029989|FG003|NOT COMPLETED|Part 1:Dose Escalation (Up to 168 Days)||0||
59908870|NCT03488251|76029986|FG000|STARTED|Part 2:Dose Expansion (Up to 168 Days)||0||
59908871|NCT03488251|76029987|FG001|STARTED|Part 2:Dose Expansion (Up to 168 Days)||0||
59908872|NCT03488251|76029988|FG002|STARTED|Part 2:Dose Expansion (Up to 168 Days)||0||
59908873|NCT03488251|76029989|FG003|STARTED|Part 2:Dose Expansion (Up to 168 Days)||0||
59908874|NCT03488251|76029986|FG000|COMPLETED|Part 2:Dose Expansion (Up to 168 Days)||0||
59908875|NCT03488251|76029987|FG001|COMPLETED|Part 2:Dose Expansion (Up to 168 Days)||0||
59908876|NCT03488251|76029988|FG002|COMPLETED|Part 2:Dose Expansion (Up to 168 Days)||0||
59908877|NCT03488251|76029989|FG003|COMPLETED|Part 2:Dose Expansion (Up to 168 Days)||0||
59908878|NCT03488251|76029986|FG000|NOT COMPLETED|Part 2:Dose Expansion (Up to 168 Days)||0||
59908879|NCT03488251|76029987|FG001|NOT COMPLETED|Part 2:Dose Expansion (Up to 168 Days)||0||
59908880|NCT03488251|76029988|FG002|NOT COMPLETED|Part 2:Dose Expansion (Up to 168 Days)||0||
59908881|NCT03488251|76029989|FG003|NOT COMPLETED|Part 2:Dose Expansion (Up to 168 Days)||0||
59908882|NCT02727322|76030002|FG000|STARTED|Overall Study||77||
59908883|NCT02727322|76030003|FG001|STARTED|Overall Study||77||
59908884|NCT02727322|76030002|FG000|COMPLETED|Overall Study||75||
59908885|NCT02727322|76030003|FG001|COMPLETED|Overall Study||76||
59908886|NCT02727322|76030002|FG000|NOT COMPLETED|Overall Study||2||
59908887|NCT02727322|76030003|FG001|NOT COMPLETED|Overall Study||1||
59908888|NCT03431857|76030013|FG000|STARTED|Overall Study||106||
59908889|NCT03431857|76030013|FG000|COMPLETED|Overall Study|52 subjects have completed the study, and 50 had complete data (all pages of CRF visit are complete)|52||
59908890|NCT03431857|76030013|FG000|NOT COMPLETED|Overall Study||54||
59908891|NCT03487549|76030019|FG000|STARTED|Overall Study||21||
59908892|NCT03487549|76030020|FG001|STARTED|Overall Study||35||
59908893|NCT03487549|76030019|FG000|COMPLETED|Overall Study||17||
59908894|NCT03487549|76030020|FG001|COMPLETED|Overall Study||33||
59908895|NCT03487549|76030019|FG000|NOT COMPLETED|Overall Study||4||
59908896|NCT03487549|76030020|FG001|NOT COMPLETED|Overall Study||2||
59908897|NCT03464383|76030029|FG000|STARTED|Overall Study||3||
59908898|NCT03464383|76030030|FG001|STARTED|Overall Study||3||
59908899|NCT03464383|76030031|FG002|STARTED|Overall Study||63||
59908900|NCT03464383|76030029|FG000|COMPLETED|Overall Study||2||
59908901|NCT03464383|76030030|FG001|COMPLETED|Overall Study||2||
59908902|NCT03464383|76030031|FG002|COMPLETED|Overall Study||63||
59908903|NCT03464383|76030029|FG000|NOT COMPLETED|Overall Study||1||
59908904|NCT03464383|76030030|FG001|NOT COMPLETED|Overall Study||1||
59908905|NCT03464383|76030031|FG002|NOT COMPLETED|Overall Study||0||
59908906|NCT01444092|76030040|FG000|STARTED|Overall Study||108||
59908907|NCT01444092|76030040|FG000|INFORMED CONSENT OBTAINED|Overall Study||108||
59908908|NCT01444092|76030040|FG000|COMPLETED|Overall Study||91||
59908909|NCT01444092|76030040|FG000|NOT COMPLETED|Overall Study||17||
59908910|NCT01265784|76030047|FG000|STARTED|Overall Study||56||
59908911|NCT01265784|76030048|FG001|STARTED|Overall Study||57||
59908912|NCT01265784|76030049|FG002|STARTED|Overall Study||30||
59908913|NCT01265784|76030047|FG000|Received at Least 1 Dose of Study Drug|Overall Study|1 participant randomized to TP-434 1.5 mg/kg took ertapenem. Results are included in ertapenem arm.|54||
59908914|NCT01265784|76030048|FG001|Received at Least 1 Dose of Study Drug|Overall Study||56||
59908915|NCT01265784|76030049|FG002|Received at Least 1 Dose of Study Drug|Overall Study||29||
59908916|NCT01265784|76030047|FG000|COMPLETED|Overall Study||44||
59908917|NCT01265784|76030048|FG001|COMPLETED|Overall Study||49||
59908918|NCT01265784|76030049|FG002|COMPLETED|Overall Study||26||
59908919|NCT01265784|76030047|FG000|NOT COMPLETED|Overall Study||12||
59908920|NCT01265784|76030048|FG001|NOT COMPLETED|Overall Study||8||
59908921|NCT01265784|76030049|FG002|NOT COMPLETED|Overall Study||4||
59908922|NCT03156504|76030057|FG000|STARTED|Overall Study||75||
59908923|NCT03156504|76030057|FG000|COMPLETED|Overall Study||74||
59908924|NCT03156504|76030057|FG000|NOT COMPLETED|Overall Study||1||
59908925|NCT03159468|76030067|FG000|STARTED|Overall Study||35||
59908926|NCT03159468|76030068|FG001|STARTED|Overall Study||35||
59908927|NCT03159468|76030069|FG002|STARTED|Overall Study||37||
59908928|NCT03159468|76030070|FG003|STARTED|Overall Study||34||
59908929|NCT03159468|76030071|FG004|STARTED|Overall Study||34||
59908930|NCT03159468|76030072|FG005|STARTED|Overall Study||34||
59908931|NCT03159468|76030067|FG000|COMPLETED|Overall Study||35||
59908932|NCT03159468|76030068|FG001|COMPLETED|Overall Study||35||
59908933|NCT03159468|76030069|FG002|COMPLETED|Overall Study||34||
59908934|NCT03159468|76030070|FG003|COMPLETED|Overall Study||34||
59908935|NCT03159468|76030071|FG004|COMPLETED|Overall Study||34||
59908936|NCT03159468|76030072|FG005|COMPLETED|Overall Study||34||
59908937|NCT03159468|76030067|FG000|NOT COMPLETED|Overall Study||0||
59908938|NCT03159468|76030068|FG001|NOT COMPLETED|Overall Study||0||
59908939|NCT03159468|76030069|FG002|NOT COMPLETED|Overall Study||3||
59908940|NCT03159468|76030070|FG003|NOT COMPLETED|Overall Study||0||
60017195|NCT02567227|76133520|FG000|NOT COMPLETED|9 Weeks||34||
60017196|NCT02567227|76133521|FG001|NOT COMPLETED|9 Weeks||24||
60017197|NCT02567227|76133520|FG000|STARTED|6 Month||158||
60017198|NCT02567227|76133521|FG001|STARTED|6 Month||167||
60017199|NCT02567227|76133520|FG000|COMPLETED|6 Month||113||
60017200|NCT02567227|76133521|FG001|COMPLETED|6 Month||127||
60017201|NCT02567227|76133520|FG000|NOT COMPLETED|6 Month||45||
60017202|NCT02567227|76133521|FG001|NOT COMPLETED|6 Month||40||
60017203|NCT02567227|76133520|FG000|STARTED|12 Months||113||
60017204|NCT02567227|76133521|FG001|STARTED|12 Months||127||
60017205|NCT02567227|76133520|FG000|COMPLETED|12 Months||82||
60017206|NCT02567227|76133521|FG001|COMPLETED|12 Months||93||
60017207|NCT02567227|76133520|FG000|NOT COMPLETED|12 Months||31||
60017208|NCT02567227|76133521|FG001|NOT COMPLETED|12 Months||34||
60017209|NCT02336451|76133532|FG000|STARTED|Overall Study||42||
60017210|NCT02336451|76133533|FG001|STARTED|Overall Study||40||
60017211|NCT02336451|76133534|FG002|STARTED|Overall Study||12||
60017212|NCT02336451|76133535|FG003|STARTED|Overall Study||44||
60017213|NCT02336451|76133536|FG004|STARTED|Overall Study||18||
60017214|NCT02336451|76133532|FG000|COMPLETED|Overall Study||0||
60017215|NCT02336451|76133533|FG001|COMPLETED|Overall Study||0||
60017216|NCT02336451|76133534|FG002|COMPLETED|Overall Study||0||
60017217|NCT02336451|76133535|FG003|COMPLETED|Overall Study||0||
60017218|NCT02336451|76133536|FG004|COMPLETED|Overall Study||0||
60017219|NCT02336451|76133532|FG000|NOT COMPLETED|Overall Study||42||
59506593|NCT01993875|75599608|FG001|NOT COMPLETED|Overall Study||6||
59506594|NCT00796705|75599619|FG000|STARTED|Overall Study||3||
59506595|NCT00796705|75599620|FG001|STARTED|Overall Study||4||
59506596|NCT00796705|75599621|FG002|STARTED|Overall Study||4||
59506597|NCT00796705|75599622|FG003|STARTED|Overall Study||2||
59506598|NCT00796705|75599619|FG000|COMPLETED|Overall Study||3||
59506599|NCT00796705|75599620|FG001|COMPLETED|Overall Study||4||
59506600|NCT00796705|75599621|FG002|COMPLETED|Overall Study||4||
59506601|NCT00796705|75599622|FG003|COMPLETED|Overall Study||2||
59506602|NCT00796705|75599619|FG000|NOT COMPLETED|Overall Study||0||
59506603|NCT00796705|75599620|FG001|NOT COMPLETED|Overall Study||0||
59506604|NCT00796705|75599621|FG002|NOT COMPLETED|Overall Study||0||
59506605|NCT00796705|75599622|FG003|NOT COMPLETED|Overall Study||0||
59506606|NCT02148523|75599637|FG000|STARTED|Overall Study||67||
60017220|NCT02336451|76133533|FG001|NOT COMPLETED|Overall Study||40||
60017221|NCT02336451|76133534|FG002|NOT COMPLETED|Overall Study||12||
60017222|NCT02336451|76133535|FG003|NOT COMPLETED|Overall Study||44||
60017223|NCT02336451|76133536|FG004|NOT COMPLETED|Overall Study||18||
60017224|NCT02374593|76133552|FG000|STARTED|Overall Study||24||
60017225|NCT02374593|76133553|FG001|STARTED|Overall Study||44||
60017226|NCT02374593|76133552|FG000|COMPLETED|Overall Study||22||
60017227|NCT02374593|76133553|FG001|COMPLETED|Overall Study||44||
60017228|NCT02374593|76133552|FG000|NOT COMPLETED|Overall Study||2||
60017229|NCT02374593|76133553|FG001|NOT COMPLETED|Overall Study||0||
60017230|NCT01648101|76133566|FG000|STARTED|Titration Phase (4 Weeks)||25||
60017231|NCT01648101|76133567|FG001|STARTED|Titration Phase (4 Weeks)||26||
60017232|NCT01648101|76133568|FG002|STARTED|Titration Phase (4 Weeks)||24||
60017233|NCT01648101|76133566|FG000|COMPLETED|Titration Phase (4 Weeks)||23||
60017234|NCT01648101|76133567|FG001|COMPLETED|Titration Phase (4 Weeks)||23||
59506607|NCT02148523|75599638|FG001|STARTED|Overall Study||67||
59506608|NCT02148523|75599639|FG002|STARTED|Overall Study||67||
59506609|NCT02148523|75599637|FG000|COMPLETED|Overall Study||67||
59506610|NCT02148523|75599638|FG001|COMPLETED|Overall Study||67||
59506611|NCT02148523|75599639|FG002|COMPLETED|Overall Study||67||
59506612|NCT02148523|75599637|FG000|NOT COMPLETED|Overall Study||0||
59506613|NCT02148523|75599638|FG001|NOT COMPLETED|Overall Study||0||
60017235|NCT01648101|76133568|FG002|COMPLETED|Titration Phase (4 Weeks)||18||
60017236|NCT01648101|76133566|FG000|NOT COMPLETED|Titration Phase (4 Weeks)||2||
60017237|NCT01648101|76133567|FG001|NOT COMPLETED|Titration Phase (4 Weeks)||3||
60017238|NCT01648101|76133568|FG002|NOT COMPLETED|Titration Phase (4 Weeks)||6||
60017239|NCT01648101|76133566|FG000|STARTED|Maintenance Phase (12 Weeks)||23||
60017240|NCT01648101|76133567|FG001|STARTED|Maintenance Phase (12 Weeks)||23||
60017241|NCT01648101|76133568|FG002|STARTED|Maintenance Phase (12 Weeks)||18||
60017242|NCT01648101|76133566|FG000|COMPLETED|Maintenance Phase (12 Weeks)||20||
60017243|NCT01648101|76133567|FG001|COMPLETED|Maintenance Phase (12 Weeks)||20||
60017244|NCT01648101|76133568|FG002|COMPLETED|Maintenance Phase (12 Weeks)||12||
60017245|NCT01648101|76133566|FG000|NOT COMPLETED|Maintenance Phase (12 Weeks)||3||
59908941|NCT03159468|76030071|FG004|NOT COMPLETED|Overall Study||0||
59506614|NCT02148523|75599639|FG002|NOT COMPLETED|Overall Study||0||
59908942|NCT03159468|76030072|FG005|NOT COMPLETED|Overall Study||0||
59908943|NCT03430063|76030089|FG000|STARTED|Overall Study||8|All randomized participants|
59908944|NCT03430063|76030090|FG001|STARTED|Overall Study||11|All randomized participants|
59908945|NCT03430063|76030091|FG002|STARTED|Overall Study||9|All randomized participants|
59908946|NCT03430063|76030089|FG000|Treated|Overall Study||8|All randomized participants who received any study treatment|
59908947|NCT03430063|76030090|FG001|Treated|Overall Study||11|All randomized participants who received any study treatment|
59908948|NCT03430063|76030091|FG002|Treated|Overall Study||8|All randomized participants who received any study treatment|
59908949|NCT03430063|76030089|FG000|COMPLETED|Overall Study||0|Completed study|
59908950|NCT03430063|76030090|FG001|COMPLETED|Overall Study||3|Completed study|
59908951|NCT03430063|76030091|FG002|COMPLETED|Overall Study||1|Completed study|
59908952|NCT03430063|76030089|FG000|NOT COMPLETED|Overall Study||8||
60017246|NCT01648101|76133567|FG001|NOT COMPLETED|Maintenance Phase (12 Weeks)||3||
60017247|NCT01648101|76133568|FG002|NOT COMPLETED|Maintenance Phase (12 Weeks)||6||
59908953|NCT03430063|76030090|FG001|NOT COMPLETED|Overall Study||8||
59908954|NCT03430063|76030091|FG002|NOT COMPLETED|Overall Study||8||
59908955|NCT03158220|76030102|FG000|STARTED|Overall Study||570||
59908956|NCT03158220|76030103|FG001|STARTED|Overall Study||642||
59908957|NCT03158220|76030102|FG000|Vaccination 1|Overall Study||570||
59908958|NCT03158220|76030103|FG001|Vaccination 1|Overall Study||640||
59908959|NCT03158220|76030102|FG000|Vaccination 2|Overall Study||563||
59908960|NCT03158220|76030103|FG001|Vaccination 2|Overall Study||635||
59908961|NCT03158220|76030102|FG000|Vaccination 3|Overall Study||556||
59908962|NCT03158220|76030103|FG001|Vaccination 3|Overall Study||629||
59908963|NCT03158220|76030102|FG000|COMPLETED|Overall Study||553||
59908964|NCT03158220|76030103|FG001|COMPLETED|Overall Study||626||
59908965|NCT03158220|76030102|FG000|NOT COMPLETED|Overall Study||17||
59908966|NCT03158220|76030103|FG001|NOT COMPLETED|Overall Study||16||
59908967|NCT03156270|76030109|FG000|STARTED|Overall Study||20||
59908968|NCT03156270|76030109|FG000|COMPLETED|Overall Study||18||
59908969|NCT03156270|76030109|FG000|NOT COMPLETED|Overall Study||2||
59908970|NCT03429049|76030117|FG000|STARTED|Overall Study||138||
59908971|NCT03429049|76030118|FG001|STARTED|Overall Study||194||
59908972|NCT03429049|76030117|FG000|Treated|Overall Study||136||
59908973|NCT03429049|76030118|FG001|Treated|Overall Study||189||
59908974|NCT03429049|76030117|FG000|COMPLETED|Overall Study||110||
59908975|NCT03429049|76030118|FG001|COMPLETED|Overall Study||152||
59908976|NCT03429049|76030117|FG000|NOT COMPLETED|Overall Study||28||
59908977|NCT03429049|76030118|FG001|NOT COMPLETED|Overall Study||42||
59908978|NCT03428815|76030126|FG000|STARTED|Overall Study||17||
59908979|NCT03428815|76030127|FG001|STARTED|Overall Study||19||
59908980|NCT03428815|76030126|FG000|COMPLETED|Overall Study||7||
59908981|NCT03428815|76030127|FG001|COMPLETED|Overall Study||14||
59908982|NCT03428815|76030126|FG000|NOT COMPLETED|Overall Study||10||
59908983|NCT03428815|76030127|FG001|NOT COMPLETED|Overall Study||5||
59908984|NCT03155724|76030133|FG000|STARTED|Overall Study||53||
59908985|NCT03155724|76030133|FG000|COMPLETED|Overall Study||42||
59908986|NCT03155724|76030133|FG000|NOT COMPLETED|Overall Study||11||
59908987|NCT03426787|76030137|FG000|STARTED|Overall Study||70||
59908988|NCT03426787|76030137|FG000|COMPLETED|Overall Study||56||
59908989|NCT03426787|76030137|FG000|NOT COMPLETED|Overall Study||14||
59908990|NCT03426631|76030147|FG000|STARTED|Overall Study||7||
59908991|NCT03426631|76030148|FG001|STARTED|Overall Study||6||
59908992|NCT03426631|76030147|FG000|COMPLETED|Overall Study||7||
59908993|NCT03426631|76030148|FG001|COMPLETED|Overall Study||5||
59908994|NCT03426631|76030147|FG000|NOT COMPLETED|Overall Study||0||
59908995|NCT03426631|76030148|FG001|NOT COMPLETED|Overall Study||1||
59908996|NCT03484429|76030156|FG000|STARTED|Overall Study||8||
59908997|NCT03484429|76030157|FG001|STARTED|Overall Study||8||
59908998|NCT03484429|76030156|FG000|Postamputation Week 1-4|Overall Study||8||
59908999|NCT03484429|76030157|FG001|Postamputation Week 1-4|Overall Study||8||
59909000|NCT03484429|76030156|FG000|Postamputation Week 5-8|Overall Study||5||
59909001|NCT03484429|76030157|FG001|Postamputation Week 5-8|Overall Study||8||
59909002|NCT03484429|76030156|FG000|Postamputation Month 3|Overall Study||5||
59909003|NCT03484429|76030157|FG001|Postamputation Month 3|Overall Study||7||
59909004|NCT03484429|76030156|FG000|COMPLETED|Overall Study||5||
59909005|NCT03484429|76030157|FG001|COMPLETED|Overall Study||8||
59909006|NCT03484429|76030156|FG000|NOT COMPLETED|Overall Study||3||
59909007|NCT03484429|76030157|FG001|NOT COMPLETED|Overall Study||0||
59909008|NCT03484273|76030163|FG000|STARTED|Overall Study|This was a crossover trial. A total of 32 participants were enrolled in this study.|32||
59909009|NCT03484273|76030163|FG000|COMPLETED|Overall Study|This was a crossover trial. A total of 30 participants completed all 4 arms.|30||
59909010|NCT03484273|76030163|FG000|NOT COMPLETED|Overall Study||2||
59909011|NCT02724592|76030177|FG000|STARTED|Overall Study||35||
59909012|NCT02724592|76030178|FG001|STARTED|Overall Study||35||
59909013|NCT02724592|76030177|FG000|COMPLETED|Overall Study||31||
59909014|NCT02724592|76030178|FG001|COMPLETED|Overall Study||34||
59909015|NCT02724592|76030177|FG000|NOT COMPLETED|Overall Study||4||
59909016|NCT02724592|76030178|FG001|NOT COMPLETED|Overall Study||1||
59909017|NCT03154476|76030186|FG000|STARTED|Overall Study||10||
59909018|NCT03154476|76030187|FG001|STARTED|Overall Study||10||
59909019|NCT03154476|76030186|FG000|COMPLETED|Overall Study||6||
59909020|NCT03154476|76030187|FG001|COMPLETED|Overall Study||6||
59909021|NCT03154476|76030186|FG000|NOT COMPLETED|Overall Study||4||
59909022|NCT03154476|76030187|FG001|NOT COMPLETED|Overall Study||4||
59909023|NCT02726074|76030193|FG000|STARTED|Overall Study||106||
59909024|NCT02726074|76030193|FG000|Treated|Overall Study||102||
59909025|NCT02726074|76030193|FG000|COMPLETED|Overall Study||80||
59909026|NCT02726074|76030193|FG000|NOT COMPLETED|Overall Study||26||
59909027|NCT03482635|76030201|FG000|STARTED|Overall Study||23||
59909028|NCT03482635|76030202|FG001|STARTED|Overall Study||24||
59909029|NCT03482635|76030203|FG002|STARTED|Overall Study||23||
59909030|NCT03482635|76030204|FG003|STARTED|Overall Study||28||
59909031|NCT03482635|76030201|FG000|Treated|Overall Study||23||
59909032|NCT03482635|76030202|FG001|Treated|Overall Study||24||
59909033|NCT03482635|76030203|FG002|Treated|Overall Study||23||
59909034|NCT03482635|76030204|FG003|Treated|Overall Study||27||
59909035|NCT03482635|76030201|FG000|COMPLETED|Overall Study||18|Completed trial medication|
59909036|NCT03482635|76030202|FG001|COMPLETED|Overall Study||21|Completed trial medication|
59909037|NCT03482635|76030203|FG002|COMPLETED|Overall Study||22|Completed trial medication|
59909038|NCT03482635|76030204|FG003|COMPLETED|Overall Study||20|Completed trial medication|
59909039|NCT03482635|76030201|FG000|NOT COMPLETED|Overall Study||5||
59909040|NCT03482635|76030202|FG001|NOT COMPLETED|Overall Study||3||
59909041|NCT03482635|76030203|FG002|NOT COMPLETED|Overall Study||1||
59909042|NCT03482635|76030204|FG003|NOT COMPLETED|Overall Study||8||
59909043|NCT03712787|76030218|FG000|STARTED|Overall Study||87|enrolled and treated|
59909044|NCT03712787|76030219|FG001|STARTED|Overall Study||97|enrolled and treated|
59909045|NCT03712787|76030220|FG002|STARTED|Overall Study||88|enrolled and treated|
59909046|NCT03712787|76030221|FG003|STARTED|Overall Study||91|enrolled and treated|
59909047|NCT03712787|76030218|FG000|COMPLETED|Overall Study||0||
59909048|NCT03712787|76030219|FG001|COMPLETED|Overall Study||0||
59909049|NCT03712787|76030220|FG002|COMPLETED|Overall Study||0||
59909050|NCT03712787|76030221|FG003|COMPLETED|Overall Study||0||
59909051|NCT03712787|76030218|FG000|NOT COMPLETED|Overall Study||87||
59909052|NCT03712787|76030219|FG001|NOT COMPLETED|Overall Study||97||
59909053|NCT03712787|76030220|FG002|NOT COMPLETED|Overall Study||88||
59909054|NCT03712787|76030221|FG003|NOT COMPLETED|Overall Study||91||
59909055|NCT04600505|76030237|FG000|STARTED|Overall Study||8||
59909056|NCT04600505|76030238|FG001|STARTED|Overall Study||8||
59909057|NCT04600505|76030239|FG002|STARTED|Overall Study||8||
59909058|NCT04600505|76030240|FG003|STARTED|Overall Study||8||
59909059|NCT04600505|76030241|FG004|STARTED|Overall Study||7||
59909060|NCT04600505|76030242|FG005|STARTED|Overall Study||8||
59909061|NCT04600505|76030237|FG000|COMPLETED|Overall Study||8||
59909062|NCT04600505|76030238|FG001|COMPLETED|Overall Study||8||
59909063|NCT04600505|76030239|FG002|COMPLETED|Overall Study||8||
59909064|NCT04600505|76030240|FG003|COMPLETED|Overall Study||8||
59909065|NCT04600505|76030241|FG004|COMPLETED|Overall Study||7||
59909066|NCT04600505|76030242|FG005|COMPLETED|Overall Study||8||
59909067|NCT04600505|76030237|FG000|NOT COMPLETED|Overall Study||0||
59909068|NCT04600505|76030238|FG001|NOT COMPLETED|Overall Study||0||
59909069|NCT04600505|76030239|FG002|NOT COMPLETED|Overall Study||0||
59909070|NCT04600505|76030240|FG003|NOT COMPLETED|Overall Study||0||
59909071|NCT04600505|76030241|FG004|NOT COMPLETED|Overall Study||0||
59909072|NCT04600505|76030242|FG005|NOT COMPLETED|Overall Study||0||
59909073|NCT03048422|76030253|FG000|STARTED|Overall Study||217||
59909074|NCT03048422|76030254|FG001|STARTED|Overall Study||215||
59909075|NCT03048422|76030255|FG002|STARTED|Overall Study||211||
59909076|NCT03048422|76030253|FG000|COMPLETED|Overall Study||200||
59909077|NCT03048422|76030254|FG001|COMPLETED|Overall Study||205||
59909078|NCT03048422|76030255|FG002|COMPLETED|Overall Study||202||
59909079|NCT03048422|76030253|FG000|NOT COMPLETED|Overall Study||17||
59909080|NCT03048422|76030254|FG001|NOT COMPLETED|Overall Study||10||
59909081|NCT03048422|76030255|FG002|NOT COMPLETED|Overall Study||9||
59909082|NCT04664855|76030275|FG000|STARTED|Overall Study||23||
59909083|NCT04664855|76030276|FG001|STARTED|Overall Study||24||
59909084|NCT04664855|76030275|FG000|COMPLETED|Overall Study||23||
59909085|NCT04664855|76030276|FG001|COMPLETED|Overall Study||22||
59909086|NCT04664855|76030275|FG000|NOT COMPLETED|Overall Study||0||
59909087|NCT04664855|76030276|FG001|NOT COMPLETED|Overall Study||2||
59909088|NCT04664153|76030286|FG000|STARTED|Overall Study||34||
59909089|NCT04664153|76030287|FG001|STARTED|Overall Study||36||
59909090|NCT04664153|76030288|FG002|STARTED|Overall Study||17||
59909091|NCT04664153|76030289|FG003|STARTED|Overall Study||17||
59909092|NCT04664153|76030286|FG000|COMPLETED|Overall Study||27||
59909093|NCT04664153|76030287|FG001|COMPLETED|Overall Study||33||
59909094|NCT04664153|76030288|FG002|COMPLETED|Overall Study||13||
59909095|NCT04664153|76030289|FG003|COMPLETED|Overall Study||15||
59909096|NCT04664153|76030286|FG000|NOT COMPLETED|Overall Study||7||
59909097|NCT04664153|76030287|FG001|NOT COMPLETED|Overall Study||3||
59909098|NCT04664153|76030288|FG002|NOT COMPLETED|Overall Study||4||
59909099|NCT04664153|76030289|FG003|NOT COMPLETED|Overall Study||2||
59909100|NCT04663295|76030301|FG000|STARTED|Run-in Period||65||
59909101|NCT04663295|76030301|FG000|COMPLETED|Run-in Period||62||
59909102|NCT04663295|76030301|FG000|NOT COMPLETED|Run-in Period||3||
60017248|NCT01648101|76133566|FG000|STARTED|Transition Phase (4 Weeks)|After completing the MP, only those par. that chose to enter the OLE study started the TnP|17||
60017249|NCT01648101|76133567|FG001|STARTED|Transition Phase (4 Weeks)|After completing the MP, only those par. that chose to enter the OLE study started the TnP|18||
60017250|NCT01648101|76133568|FG002|STARTED|Transition Phase (4 Weeks)|After completing the MP, only those par. that chose to enter the OLE study started the TnP|9||
60017251|NCT01648101|76133566|FG000|COMPLETED|Transition Phase (4 Weeks)||12||
60017252|NCT01648101|76133567|FG001|COMPLETED|Transition Phase (4 Weeks)||13||
60017253|NCT01648101|76133568|FG002|COMPLETED|Transition Phase (4 Weeks)||5||
60017254|NCT01648101|76133566|FG000|NOT COMPLETED|Transition Phase (4 Weeks)||5||
60017255|NCT01648101|76133567|FG001|NOT COMPLETED|Transition Phase (4 Weeks)||5||
60017256|NCT01648101|76133568|FG002|NOT COMPLETED|Transition Phase (4 Weeks)||4||
60017257|NCT01648101|76133566|FG000|STARTED|Taper/Follow-up Phase (4 Weeks)|Includes only those par. who completed the Titration + MN phase, but opted not to enroll in the OLE|1||
60017258|NCT01648101|76133567|FG001|STARTED|Taper/Follow-up Phase (4 Weeks)|Includes only those par. who completed the Titration + MN phase, but opted not to enroll in the OLE|2||
60017259|NCT01648101|76133568|FG002|STARTED|Taper/Follow-up Phase (4 Weeks)|Includes only those par. who completed the Titration + MN phase, but opted not to enroll in the OLE|3||
60017260|NCT01648101|76133566|FG000|COMPLETED|Taper/Follow-up Phase (4 Weeks)||1||
60017261|NCT01648101|76133567|FG001|COMPLETED|Taper/Follow-up Phase (4 Weeks)||1||
60017262|NCT01648101|76133568|FG002|COMPLETED|Taper/Follow-up Phase (4 Weeks)||3||
60017263|NCT01648101|76133566|FG000|NOT COMPLETED|Taper/Follow-up Phase (4 Weeks)||0||
60017264|NCT01648101|76133567|FG001|NOT COMPLETED|Taper/Follow-up Phase (4 Weeks)||1||
60017265|NCT01648101|76133568|FG002|NOT COMPLETED|Taper/Follow-up Phase (4 Weeks)||0||
60017266|NCT02336373|76133580|FG000|STARTED|Overall Study||32||
60017267|NCT02336373|76133580|FG000|COMPLETED|Overall Study||14||
60017268|NCT02336373|76133580|FG000|NOT COMPLETED|Overall Study||18||
60017269|NCT02372799|76133589|FG000|STARTED|Treatment Period||186||
60017270|NCT02372799|76133590|FG001|STARTED|Treatment Period||187||
60017271|NCT02372799|76133591|FG002|STARTED|Treatment Period||97||
60017272|NCT02372799|76133589|FG000|COMPLETED|Treatment Period||152||
60017273|NCT02372799|76133590|FG001|COMPLETED|Treatment Period||155||
60017274|NCT02372799|76133591|FG002|COMPLETED|Treatment Period||82||
60017275|NCT02372799|76133589|FG000|NOT COMPLETED|Treatment Period||34||
60017276|NCT02372799|76133590|FG001|NOT COMPLETED|Treatment Period||32||
60017277|NCT02372799|76133591|FG002|NOT COMPLETED|Treatment Period||15||
60017278|NCT02372799|76133589|FG000|STARTED|Down-taper Period||152||
60017279|NCT02372799|76133590|FG001|STARTED|Down-taper Period||159||
60017280|NCT02372799|76133591|FG002|STARTED|Down-taper Period||82||
60017281|NCT02372799|76133589|FG000|COMPLETED|Down-taper Period||151||
60017282|NCT02372799|76133590|FG001|COMPLETED|Down-taper Period||157||
60017283|NCT02372799|76133591|FG002|COMPLETED|Down-taper Period||80||
60017284|NCT02372799|76133589|FG000|NOT COMPLETED|Down-taper Period||1||
60017285|NCT02372799|76133590|FG001|NOT COMPLETED|Down-taper Period||2||
60017286|NCT02372799|76133591|FG002|NOT COMPLETED|Down-taper Period||2||
59909103|NCT04663295|76030301|FG000|STARTED|Overall Study Period||62||
59909104|NCT04663295|76030301|FG000|COMPLETED|Overall Study Period||60||
59909105|NCT04663295|76030301|FG000|NOT COMPLETED|Overall Study Period||2||
59909106|NCT04228445|76030312|FG000|STARTED|Overall Study||62||
59909107|NCT04228445|76030313|FG001|STARTED|Overall Study||59||
59909108|NCT04228445|76030312|FG000|COMPLETED|Overall Study||59||
59909109|NCT04228445|76030313|FG001|COMPLETED|Overall Study||55||
59909110|NCT04228445|76030312|FG000|NOT COMPLETED|Overall Study||3||
59909111|NCT04228445|76030313|FG001|NOT COMPLETED|Overall Study||4||
60017287|NCT02566993|76133601|FG000|STARTED|Overall Study||307||
60017288|NCT02566993|76133602|FG001|STARTED|Overall Study||306||
60017289|NCT02566993|76133601|FG000|COMPLETED|Overall Study||0||
60017290|NCT02566993|76133602|FG001|COMPLETED|Overall Study||0||
60017291|NCT02566993|76133601|FG000|NOT COMPLETED|Overall Study||307||
60017292|NCT02566993|76133602|FG001|NOT COMPLETED|Overall Study||306||
60017293|NCT02311881|76133613|FG000|STARTED|Overall Study|Started refers to all randomized participants.|235||
60017294|NCT02311881|76133614|FG001|STARTED|Overall Study|Started refers to all randomized participants.|236||
60017295|NCT02311881|76133615|FG002|STARTED|Overall Study|Started refers to all randomized participants.|237||
60017296|NCT02311881|76133613|FG000|Safety Population|Overall Study|All treated participants: One participant was randomized but did not receive any treatment.|234||
60017297|NCT02311881|76133614|FG001|Safety Population|Overall Study|All treated participants: One participant was randomized but did not receive any treatment.|236||
60067723|NCT01617187|76182893|FG002|COMPLETED|Treatment Through Study Completion||41||
59909112|NCT04641299|76030325|FG000|STARTED|Overall Study||30||
59909113|NCT04641299|76030326|FG001|STARTED|Overall Study||30||
59909114|NCT04641299|76030327|FG002|STARTED|Overall Study||29||
59909115|NCT04641299|76030328|FG003|STARTED|Overall Study||30||
59909116|NCT04641299|76030325|FG000|COMPLETED|Overall Study||28||
59909117|NCT04641299|76030326|FG001|COMPLETED|Overall Study||29||
59909118|NCT04641299|76030327|FG002|COMPLETED|Overall Study||27||
59909119|NCT04641299|76030328|FG003|COMPLETED|Overall Study||30||
59909120|NCT04641299|76030325|FG000|NOT COMPLETED|Overall Study||2||
59909121|NCT04641299|76030326|FG001|NOT COMPLETED|Overall Study||1||
60017298|NCT02311881|76133615|FG002|Safety Population|Overall Study|All treated participants: One participant was randomized but did not receive any treatment.|237||
60017299|NCT02311881|76133613|FG000|COMPLETED|Overall Study||200||
60017300|NCT02311881|76133614|FG001|COMPLETED|Overall Study||193||
60017301|NCT02311881|76133615|FG002|COMPLETED|Overall Study||196||
60017302|NCT02311881|76133613|FG000|NOT COMPLETED|Overall Study||35||
60017303|NCT02311881|76133614|FG001|NOT COMPLETED|Overall Study||43||
60017304|NCT02311881|76133615|FG002|NOT COMPLETED|Overall Study||41||
60017305|NCT02565511|76133630|FG000|STARTED|Overall Study||42||
60017306|NCT02565511|76133631|FG001|STARTED|Overall Study||23||
60017307|NCT02565511|76133632|FG002|STARTED|Overall Study||251||
60017308|NCT02565511|76133633|FG003|STARTED|Overall Study||164||
60017309|NCT02565511|76133630|FG000|3 Patients Were Mis-randomized|Overall Study||0||
60017310|NCT02565511|76133631|FG001|3 Patients Were Mis-randomized|Overall Study||0||
60017311|NCT02565511|76133632|FG002|3 Patients Were Mis-randomized|Overall Study||2||
60017312|NCT02565511|76133633|FG003|3 Patients Were Mis-randomized|Overall Study||1||
60017313|NCT02565511|76133630|FG000|COMPLETED|Overall Study||0||
60017314|NCT02565511|76133631|FG001|COMPLETED|Overall Study||0||
60017315|NCT02565511|76133632|FG002|COMPLETED|Overall Study||0||
60017316|NCT02565511|76133633|FG003|COMPLETED|Overall Study||0||
60017317|NCT02565511|76133630|FG000|NOT COMPLETED|Overall Study||42||
60017318|NCT02565511|76133631|FG001|NOT COMPLETED|Overall Study||23||
60017319|NCT02565511|76133632|FG002|NOT COMPLETED|Overall Study||251||
60017320|NCT02565511|76133633|FG003|NOT COMPLETED|Overall Study||164||
60017321|NCT02561455|76133647|FG000|STARTED|Overall Study||2||
59909122|NCT04641299|76030327|FG002|NOT COMPLETED|Overall Study||2||
59909123|NCT04641299|76030328|FG003|NOT COMPLETED|Overall Study||0||
59909124|NCT03703817|76030344|FG000|STARTED|Overall Study||288||
59909125|NCT03703817|76030345|FG001|STARTED|Overall Study||133||
60017322|NCT02561455|76133648|FG001|STARTED|Overall Study||3||
60017323|NCT02561455|76133649|FG002|STARTED|Overall Study||3||
60017324|NCT02561455|76133650|FG003|STARTED|Overall Study||1||
59909126|NCT03703817|76030344|FG000|COMPLETED|Overall Study||281||
59909127|NCT03703817|76030345|FG001|COMPLETED|Overall Study||129||
59909128|NCT03703817|76030344|FG000|NOT COMPLETED|Overall Study||7||
59909129|NCT03703817|76030345|FG001|NOT COMPLETED|Overall Study||4||
59909130|NCT03698591|76030353|FG000|STARTED|Overall Study||20||
59909131|NCT03698591|76030354|FG001|STARTED|Overall Study||20||
59909132|NCT03698591|76030353|FG000|COMPLETED|Overall Study||15||
59909133|NCT03698591|76030354|FG001|COMPLETED|Overall Study||15||
59909134|NCT03698591|76030353|FG000|NOT COMPLETED|Overall Study||5||
59909135|NCT03698591|76030354|FG001|NOT COMPLETED|Overall Study||5||
59909136|NCT04606199|76030360|FG000|STARTED|Overall Study||53||
59909137|NCT04606199|76030360|FG000|COMPLETED|Overall Study||51||
59909138|NCT04606199|76030360|FG000|NOT COMPLETED|Overall Study||2||
59909139|NCT05085665|76030366|FG000|STARTED|Overall Study||41||
59909140|NCT05085665|76030366|FG000|COMPLETED|Overall Study||39||
59909141|NCT05085665|76030366|FG000|NOT COMPLETED|Overall Study||2||
59909142|NCT05017493|76030372|FG000|STARTED|Overall Study||483|483 patients enrolled in treatment arm|
59909143|NCT05017493|76030373|FG001|STARTED|Overall Study||178|483 patients enrolled in treatment arm|
59909144|NCT05017493|76030372|FG000|Treatment & Care|Overall Study||483|483 patients received Xagrotin|
59909145|NCT05017493|76030373|FG001|Treatment & Care|Overall Study||178|483 patients received Xagrotin|
59909146|NCT05017493|76030372|FG000|Follow up|Overall Study||483|483 patients were followed up|
59909147|NCT05017493|76030373|FG001|Follow up|Overall Study||178|483 patients were followed up|
59909148|NCT05017493|76030372|FG000|Mortality Check|Overall Study||483|483 patients were checked for mortality|
59909149|NCT05017493|76030373|FG001|Mortality Check|Overall Study||178|483 patients were checked for mortality|
59909150|NCT05017493|76030372|FG000|COMPLETED|Overall Study||361|361 patients completed pr protocol|
59909151|NCT05017493|76030373|FG001|COMPLETED|Overall Study||178|361 patients completed pr protocol|
59909152|NCT05017493|76030372|FG000|NOT COMPLETED|Overall Study||122||
59909153|NCT05017493|76030373|FG001|NOT COMPLETED|Overall Study||0||
59909154|NCT04599803|76030379|FG000|STARTED|Overall Study|Defined for the purpose of this table to have met eligibility criteria and signed into the Verily Sleep Apnea (VSA) app|187||
60017325|NCT02561455|76133647|FG000|COMPLETED|Overall Study||0||
60017326|NCT02561455|76133648|FG001|COMPLETED|Overall Study||1||
60017327|NCT02561455|76133649|FG002|COMPLETED|Overall Study||0||
60017328|NCT02561455|76133650|FG003|COMPLETED|Overall Study||0||
60017329|NCT02561455|76133647|FG000|NOT COMPLETED|Overall Study||2||
60017330|NCT02561455|76133648|FG001|NOT COMPLETED|Overall Study||2||
60017331|NCT02561455|76133649|FG002|NOT COMPLETED|Overall Study||3||
59909155|NCT04599803|76030379|FG000|COMPLETED|Overall Study||156||
59909156|NCT04599803|76030379|FG000|NOT COMPLETED|Overall Study||31||
59909157|NCT05002985|76030383|FG000|STARTED|Overall Study||49||
60017332|NCT02561455|76133650|FG003|NOT COMPLETED|Overall Study||1||
60017333|NCT02561299|76133662|FG000|STARTED|Overall Study||32||
60017334|NCT02561299|76133663|FG001|STARTED|Overall Study||34||
60017335|NCT02561299|76133662|FG000|COMPLETED|Overall Study||27||
60017336|NCT02561299|76133663|FG001|COMPLETED|Overall Study||28||
60017337|NCT02561299|76133662|FG000|NOT COMPLETED|Overall Study||5||
60017338|NCT02561299|76133663|FG001|NOT COMPLETED|Overall Study||6||
60017339|NCT02566759|76133686|FG000|STARTED|All Parts||12||
60017340|NCT02566759|76133687|FG001|STARTED|All Parts||6||
60017341|NCT02566759|76133688|FG002|STARTED|All Parts||6||
60017342|NCT02566759|76133689|FG003|STARTED|All Parts||6||
60017343|NCT02566759|76133690|FG004|STARTED|All Parts||6||
60017344|NCT02566759|76133691|FG005|STARTED|All Parts||6||
60017345|NCT02566759|76133692|FG006|STARTED|All Parts||6||
60017346|NCT02566759|76133693|FG007|STARTED|All Parts||8||
60017347|NCT02566759|76133694|FG008|STARTED|All Parts||6||
60017348|NCT02566759|76133695|FG009|STARTED|All Parts||6||
60017349|NCT02566759|76133696|FG010|STARTED|All Parts||6||
60017350|NCT02566759|76133697|FG011|STARTED|All Parts||6||
60017351|NCT02566759|76133698|FG012|STARTED|All Parts||1||
60017352|NCT02566759|76133699|FG013|STARTED|All Parts||5||
60017353|NCT02566759|76133700|FG014|STARTED|All Parts||8||
60017354|NCT02566759|76133701|FG015|STARTED|All Parts||8||
60017355|NCT02566759|76133702|FG016|STARTED|All Parts||8||
60017356|NCT02566759|76133686|FG000|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|12||
60017357|NCT02566759|76133687|FG001|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|5||
60017358|NCT02566759|76133688|FG002|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6||
60017359|NCT02566759|76133689|FG003|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6||
60017360|NCT02566759|76133690|FG004|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6||
60017361|NCT02566759|76133691|FG005|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6||
60017362|NCT02566759|76133692|FG006|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6||
60017363|NCT02566759|76133693|FG007|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|8||
60017364|NCT02566759|76133694|FG008|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6||
60017365|NCT02566759|76133695|FG009|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6||
60017366|NCT02566759|76133696|FG010|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6||
60017367|NCT02566759|76133697|FG011|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6||
60017368|NCT02566759|76133698|FG012|COMPLETED|All Parts||0||
60017369|NCT02566759|76133699|FG013|COMPLETED|All Parts||0||
60017370|NCT02566759|76133700|FG014|COMPLETED|All Parts|Only participants of Part 4 continued in next period.|8||
60017371|NCT02566759|76133701|FG015|COMPLETED|All Parts|Only participants of Part 4 continued in next period.|8||
60017372|NCT02566759|76133702|FG016|COMPLETED|All Parts|Only participants of Part 4 continued in next period.|8||
60017373|NCT02566759|76133686|FG000|NOT COMPLETED|All Parts||0||
60017374|NCT02566759|76133687|FG001|NOT COMPLETED|All Parts||1||
60017375|NCT02566759|76133688|FG002|NOT COMPLETED|All Parts||0||
60017376|NCT02566759|76133689|FG003|NOT COMPLETED|All Parts||0||
60017377|NCT02566759|76133690|FG004|NOT COMPLETED|All Parts||0||
60017378|NCT02566759|76133691|FG005|NOT COMPLETED|All Parts||0||
60017379|NCT02566759|76133692|FG006|NOT COMPLETED|All Parts||0||
60017380|NCT02566759|76133693|FG007|NOT COMPLETED|All Parts||0||
60017381|NCT02566759|76133694|FG008|NOT COMPLETED|All Parts||0||
60017382|NCT02566759|76133695|FG009|NOT COMPLETED|All Parts||0||
60017383|NCT02566759|76133696|FG010|NOT COMPLETED|All Parts||0||
60017384|NCT02566759|76133697|FG011|NOT COMPLETED|All Parts||0||
60017385|NCT02566759|76133698|FG012|NOT COMPLETED|All Parts||1||
60017386|NCT02566759|76133699|FG013|NOT COMPLETED|All Parts||5||
60017387|NCT02566759|76133700|FG014|NOT COMPLETED|All Parts||0||
60017388|NCT02566759|76133701|FG015|NOT COMPLETED|All Parts||0||
60017389|NCT02566759|76133702|FG016|NOT COMPLETED|All Parts||0||
60017390|NCT02566759|76133686|FG000|STARTED|Washout Crossover Period (Part 4:5 Days)||0||
60017391|NCT02566759|76133687|FG001|STARTED|Washout Crossover Period (Part 4:5 Days)||0||
60017392|NCT02566759|76133688|FG002|STARTED|Washout Crossover Period (Part 4:5 Days)||0||
60017393|NCT02566759|76133689|FG003|STARTED|Washout Crossover Period (Part 4:5 Days)||0||
60017394|NCT02566759|76133690|FG004|STARTED|Washout Crossover Period (Part 4:5 Days)||0||
60017395|NCT02566759|76133691|FG005|STARTED|Washout Crossover Period (Part 4:5 Days)||0||
60017396|NCT02566759|76133692|FG006|STARTED|Washout Crossover Period (Part 4:5 Days)||0||
60017397|NCT02566759|76133693|FG007|STARTED|Washout Crossover Period (Part 4:5 Days)||0||
60017398|NCT02566759|76133694|FG008|STARTED|Washout Crossover Period (Part 4:5 Days)||0||
60017399|NCT02566759|76133695|FG009|STARTED|Washout Crossover Period (Part 4:5 Days)||0||
60017400|NCT02566759|76133696|FG010|STARTED|Washout Crossover Period (Part 4:5 Days)||0||
60017401|NCT02566759|76133697|FG011|STARTED|Washout Crossover Period (Part 4:5 Days)||0||
60017402|NCT02566759|76133698|FG012|STARTED|Washout Crossover Period (Part 4:5 Days)||0||
60017403|NCT02566759|76133699|FG013|STARTED|Washout Crossover Period (Part 4:5 Days)||0||
60017404|NCT02566759|76133700|FG014|STARTED|Washout Crossover Period (Part 4:5 Days)||8||
60017405|NCT02566759|76133701|FG015|STARTED|Washout Crossover Period (Part 4:5 Days)||8||
60017406|NCT02566759|76133702|FG016|STARTED|Washout Crossover Period (Part 4:5 Days)||8||
60017407|NCT02566759|76133686|FG000|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
60017408|NCT02566759|76133687|FG001|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
60017409|NCT02566759|76133688|FG002|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
60017410|NCT02566759|76133689|FG003|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
59909158|NCT05002985|76030383|FG000|COMPLETED|Overall Study||48||
59909159|NCT05002985|76030383|FG000|NOT COMPLETED|Overall Study||1||
59909160|NCT04580303|76030389|FG000|STARTED|Overall Study||7||14
59909161|NCT04580303|76030390|FG001|STARTED|Overall Study||9||18
59909162|NCT04580303|76030391|FG002|STARTED|Overall Study||9||18
59909163|NCT04580303|76030392|FG003|STARTED|Overall Study||10||20
59909164|NCT04580303|76030389|FG000|COMPLETED|Overall Study||7||14
59909165|NCT04580303|76030390|FG001|COMPLETED|Overall Study||8||16
59909166|NCT04580303|76030391|FG002|COMPLETED|Overall Study||8||16
59909167|NCT04580303|76030392|FG003|COMPLETED|Overall Study||10||20
59909168|NCT04580303|76030389|FG000|NOT COMPLETED|Overall Study||0||0
59909169|NCT04580303|76030390|FG001|NOT COMPLETED|Overall Study||1||2
59909170|NCT04580303|76030391|FG002|NOT COMPLETED|Overall Study||1||2
59909171|NCT04580303|76030392|FG003|NOT COMPLETED|Overall Study||0||0
59909172|NCT04577183|76030402|FG000|STARTED|Overall Study||13||
59909173|NCT04577183|76030402|FG000|COMPLETED|Overall Study||7||
59909174|NCT04577183|76030402|FG000|NOT COMPLETED|Overall Study||6||
59909175|NCT04574999|76030408|FG000|STARTED|Overall Study||114||
59909176|NCT04574999|76030409|FG001|STARTED|Overall Study||53||
59909177|NCT04574999|76030408|FG000|COMPLETED|Overall Study||105||
59909178|NCT04574999|76030409|FG001|COMPLETED|Overall Study||48||
59909179|NCT04574999|76030408|FG000|NOT COMPLETED|Overall Study||9||
59909180|NCT04574999|76030409|FG001|NOT COMPLETED|Overall Study||5||
59909181|NCT04565249|76030419|FG000|STARTED|Overall Study||5||
59909182|NCT04565249|76030420|FG001|STARTED|Overall Study||0||
59909183|NCT04565249|76030421|FG002|STARTED|Overall Study||0||
59909184|NCT04565249|76030422|FG003|STARTED|Overall Study||1||
59909185|NCT04565249|76030419|FG000|COMPLETED|Overall Study||5||
59909186|NCT04565249|76030420|FG001|COMPLETED|Overall Study||0||
59909187|NCT04565249|76030421|FG002|COMPLETED|Overall Study||0||
59909188|NCT04565249|76030422|FG003|COMPLETED|Overall Study||0||
59909189|NCT04565249|76030419|FG000|NOT COMPLETED|Overall Study||0||
59909190|NCT04565249|76030420|FG001|NOT COMPLETED|Overall Study||0||
59909191|NCT04565249|76030421|FG002|NOT COMPLETED|Overall Study||0||
59909192|NCT04565249|76030422|FG003|NOT COMPLETED|Overall Study||1||
59909193|NCT04942925|76030434|FG000|STARTED|First Wear Period (8 -0/+3 Days)||32||64
59909194|NCT04942925|76030435|FG001|STARTED|First Wear Period (8 -0/+3 Days)||28||56
59909195|NCT04942925|76030434|FG000|COMPLETED|First Wear Period (8 -0/+3 Days)||32||64
59909196|NCT04942925|76030435|FG001|COMPLETED|First Wear Period (8 -0/+3 Days)||26||52
59909197|NCT04942925|76030434|FG000|NOT COMPLETED|First Wear Period (8 -0/+3 Days)||0||0
59909198|NCT04942925|76030435|FG001|NOT COMPLETED|First Wear Period (8 -0/+3 Days)||2||4
59909199|NCT04942925|76030434|FG000|STARTED|Second Wear Period (8 -0/+3 Days)||32||64
59909200|NCT04942925|76030435|FG001|STARTED|Second Wear Period (8 -0/+3 Days)||26||52
59909201|NCT04942925|76030434|FG000|COMPLETED|Second Wear Period (8 -0/+3 Days)||32||62
59909202|NCT04942925|76030435|FG001|COMPLETED|Second Wear Period (8 -0/+3 Days)||26||52
59909203|NCT04942925|76030434|FG000|NOT COMPLETED|Second Wear Period (8 -0/+3 Days)||0||2
59909204|NCT04942925|76030435|FG001|NOT COMPLETED|Second Wear Period (8 -0/+3 Days)||0||0
59909205|NCT04854707|76030447|FG000|STARTED|Overall Study||2625||
59909206|NCT04854707|76030448|FG001|STARTED|Overall Study||2183||
59909207|NCT04854707|76030449|FG002|STARTED|Overall Study||676||
59909208|NCT04854707|76030447|FG000|COMPLETED|Overall Study||2547||
59909209|NCT04854707|76030448|FG001|COMPLETED|Overall Study||2124||
59909210|NCT04854707|76030449|FG002|COMPLETED|Overall Study||646||
59909211|NCT04854707|76030447|FG000|NOT COMPLETED|Overall Study||78||
59909212|NCT04854707|76030448|FG001|NOT COMPLETED|Overall Study||59||
59909213|NCT04854707|76030449|FG002|NOT COMPLETED|Overall Study||30||
59909214|NCT04557371|76030464|FG000|STARTED|Overall Study||50||
59909215|NCT04557371|76030465|FG001|STARTED|Overall Study||49||
59909216|NCT04557371|76030466|FG002|STARTED|Overall Study||51||
59909217|NCT04557371|76030464|FG000|COMPLETED|Overall Study||49||
59909218|NCT04557371|76030465|FG001|COMPLETED|Overall Study||47||
59909219|NCT04557371|76030466|FG002|COMPLETED|Overall Study||51||
59909220|NCT04557371|76030464|FG000|NOT COMPLETED|Overall Study||1||
59909221|NCT04557371|76030465|FG001|NOT COMPLETED|Overall Study||2||
59909222|NCT04557371|76030466|FG002|NOT COMPLETED|Overall Study||0||
59506615|NCT00809809|75599649|FG000|STARTED|Overall Study||78||
59909223|NCT04821245|76030474|FG000|STARTED|Overall Study||36||
59909224|NCT04821245|76030474|FG000|COMPLETED|Overall Study||27||
59909225|NCT04821245|76030474|FG000|NOT COMPLETED|Overall Study||9||
59909226|NCT04539275|76030482|FG000|STARTED|Overall Study||35||
59909227|NCT04539275|76030483|FG001|STARTED|Overall Study||40||
59909228|NCT04539275|76030482|FG000|Received Study Product|Overall Study||32||
59909229|NCT04539275|76030483|FG001|Received Study Product|Overall Study||40||
59909230|NCT04539275|76030482|FG000|COMPLETED|Overall Study||29||
59909231|NCT04539275|76030483|FG001|COMPLETED|Overall Study||35||
59909232|NCT04539275|76030482|FG000|NOT COMPLETED|Overall Study||6||
59909233|NCT04539275|76030483|FG001|NOT COMPLETED|Overall Study||5||
59909234|NCT04784897|76030492|FG000|STARTED|Overall Study||60||
59909235|NCT04784897|76030493|FG001|STARTED|Overall Study||16||
59909236|NCT04784897|76030494|FG002|STARTED|Overall Study||44||
59909237|NCT04784897|76030492|FG000|COMPLETED|Overall Study||56||
59909238|NCT04784897|76030493|FG001|COMPLETED|Overall Study||14||
59909239|NCT04784897|76030494|FG002|COMPLETED|Overall Study||42||
60017411|NCT02566759|76133690|FG004|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
60017412|NCT02566759|76133691|FG005|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
60017413|NCT02566759|76133692|FG006|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
60017414|NCT02566759|76133693|FG007|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
60017415|NCT02566759|76133694|FG008|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
60017416|NCT02566759|76133695|FG009|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
60017417|NCT02566759|76133696|FG010|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
60017418|NCT02566759|76133697|FG011|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
60017419|NCT02566759|76133698|FG012|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
60017420|NCT02566759|76133699|FG013|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
60017421|NCT02566759|76133700|FG014|COMPLETED|Washout Crossover Period (Part 4:5 Days)||8||
60017422|NCT02566759|76133701|FG015|COMPLETED|Washout Crossover Period (Part 4:5 Days)||8||
60017423|NCT02566759|76133702|FG016|COMPLETED|Washout Crossover Period (Part 4:5 Days)||8||
60017424|NCT02566759|76133686|FG000|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
60017425|NCT02566759|76133687|FG001|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
60017426|NCT02566759|76133688|FG002|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
60017427|NCT02566759|76133689|FG003|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
60017428|NCT02566759|76133690|FG004|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
60017429|NCT02566759|76133691|FG005|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
60017430|NCT02566759|76133692|FG006|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
60017431|NCT02566759|76133693|FG007|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
60017432|NCT02566759|76133694|FG008|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
60017433|NCT02566759|76133695|FG009|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
60017434|NCT02566759|76133696|FG010|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
60017435|NCT02566759|76133697|FG011|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
60017436|NCT02566759|76133698|FG012|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
60017437|NCT02566759|76133699|FG013|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
60017438|NCT02566759|76133700|FG014|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
60017439|NCT02566759|76133701|FG015|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
60017440|NCT02566759|76133702|FG016|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
60017441|NCT02566759|76133686|FG000|STARTED|Crossover Treatment (Part 4: 1 Day)||0||
60017442|NCT02566759|76133687|FG001|STARTED|Crossover Treatment (Part 4: 1 Day)||0||
60017443|NCT02566759|76133688|FG002|STARTED|Crossover Treatment (Part 4: 1 Day)||0||
60017444|NCT02566759|76133689|FG003|STARTED|Crossover Treatment (Part 4: 1 Day)||0||
60017445|NCT02566759|76133690|FG004|STARTED|Crossover Treatment (Part 4: 1 Day)||0||
60017446|NCT02566759|76133691|FG005|STARTED|Crossover Treatment (Part 4: 1 Day)||0||
59909240|NCT04784897|76030492|FG000|NOT COMPLETED|Overall Study||4||
59909241|NCT04784897|76030493|FG001|NOT COMPLETED|Overall Study||2||
59909242|NCT04784897|76030494|FG002|NOT COMPLETED|Overall Study||2||
59909243|NCT04532099|76030508|FG000|STARTED|First Wear Period (30 Days)||33||
59909244|NCT04532099|76030509|FG001|STARTED|First Wear Period (30 Days)||33||
60017447|NCT02566759|76133692|FG006|STARTED|Crossover Treatment (Part 4: 1 Day)||0||
60017448|NCT02566759|76133693|FG007|STARTED|Crossover Treatment (Part 4: 1 Day)||0||
60017449|NCT02566759|76133694|FG008|STARTED|Crossover Treatment (Part 4: 1 Day)||0||
60017450|NCT02566759|76133695|FG009|STARTED|Crossover Treatment (Part 4: 1 Day)||0||
60017451|NCT02566759|76133696|FG010|STARTED|Crossover Treatment (Part 4: 1 Day)||0||
60017452|NCT02566759|76133697|FG011|STARTED|Crossover Treatment (Part 4: 1 Day)||0||
60017453|NCT02566759|76133698|FG012|STARTED|Crossover Treatment (Part 4: 1 Day)||0||
60017454|NCT02566759|76133699|FG013|STARTED|Crossover Treatment (Part 4: 1 Day)||0||
60017455|NCT02566759|76133700|FG014|STARTED|Crossover Treatment (Part 4: 1 Day)||8||
60017456|NCT02566759|76133701|FG015|STARTED|Crossover Treatment (Part 4: 1 Day)||8||
59909245|NCT04532099|76030510|FG002|STARTED|First Wear Period (30 Days)||66||
59909246|NCT04532099|76030508|FG000|COMPLETED|First Wear Period (30 Days)||32||
59909247|NCT04532099|76030509|FG001|COMPLETED|First Wear Period (30 Days)||33||
59909248|NCT04532099|76030510|FG002|COMPLETED|First Wear Period (30 Days)||66||
59909249|NCT04532099|76030508|FG000|NOT COMPLETED|First Wear Period (30 Days)||1||
59909250|NCT04532099|76030509|FG001|NOT COMPLETED|First Wear Period (30 Days)||0||
60017457|NCT02566759|76133702|FG016|STARTED|Crossover Treatment (Part 4: 1 Day)||8||
60017458|NCT02566759|76133686|FG000|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
60017459|NCT02566759|76133687|FG001|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
60017460|NCT02566759|76133688|FG002|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
60017461|NCT02566759|76133689|FG003|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
60017462|NCT02566759|76133690|FG004|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
60017463|NCT02566759|76133691|FG005|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
60017464|NCT02566759|76133692|FG006|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
60017465|NCT02566759|76133693|FG007|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
60017466|NCT02566759|76133694|FG008|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
60017467|NCT02566759|76133695|FG009|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
60017468|NCT02566759|76133696|FG010|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
60017469|NCT02566759|76133697|FG011|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
60017470|NCT02566759|76133698|FG012|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
60017471|NCT02566759|76133699|FG013|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
60017472|NCT02566759|76133700|FG014|COMPLETED|Crossover Treatment (Part 4: 1 Day)||8||
60017473|NCT02566759|76133701|FG015|COMPLETED|Crossover Treatment (Part 4: 1 Day)||8||
60017474|NCT02566759|76133702|FG016|COMPLETED|Crossover Treatment (Part 4: 1 Day)||7||
60017475|NCT02566759|76133686|FG000|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
60017476|NCT02566759|76133687|FG001|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
60017477|NCT02566759|76133688|FG002|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
60017478|NCT02566759|76133689|FG003|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
60017479|NCT02566759|76133690|FG004|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
60017480|NCT02566759|76133691|FG005|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
60017481|NCT02566759|76133692|FG006|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
60017482|NCT02566759|76133693|FG007|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
60017483|NCT02566759|76133694|FG008|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
60017484|NCT02566759|76133695|FG009|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
60017485|NCT02566759|76133696|FG010|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
60017486|NCT02566759|76133697|FG011|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
60017487|NCT02566759|76133698|FG012|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
60017488|NCT02566759|76133699|FG013|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
60017489|NCT02566759|76133700|FG014|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
60017490|NCT02566759|76133701|FG015|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
60017491|NCT02566759|76133702|FG016|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||1||
60017492|NCT02566759|76133686|FG000|STARTED|Washout Crossover Period (Part 4:5 Days)||0||
60017493|NCT02566759|76133687|FG001|STARTED|Washout Crossover Period (Part 4:5 Days)||0||
60017494|NCT02566759|76133688|FG002|STARTED|Washout Crossover Period (Part 4:5 Days)||0||
60017495|NCT02566759|76133689|FG003|STARTED|Washout Crossover Period (Part 4:5 Days)||0||
60017496|NCT02566759|76133690|FG004|STARTED|Washout Crossover Period (Part 4:5 Days)||0||
60017497|NCT02566759|76133691|FG005|STARTED|Washout Crossover Period (Part 4:5 Days)||0||
60017498|NCT02566759|76133692|FG006|STARTED|Washout Crossover Period (Part 4:5 Days)||0||
60017499|NCT02566759|76133693|FG007|STARTED|Washout Crossover Period (Part 4:5 Days)||0||
60017500|NCT02566759|76133694|FG008|STARTED|Washout Crossover Period (Part 4:5 Days)||0||
60017501|NCT02566759|76133695|FG009|STARTED|Washout Crossover Period (Part 4:5 Days)||0||
60017502|NCT02566759|76133696|FG010|STARTED|Washout Crossover Period (Part 4:5 Days)||0||
60017503|NCT02566759|76133697|FG011|STARTED|Washout Crossover Period (Part 4:5 Days)||0||
60017504|NCT02566759|76133698|FG012|STARTED|Washout Crossover Period (Part 4:5 Days)||0||
60017505|NCT02566759|76133699|FG013|STARTED|Washout Crossover Period (Part 4:5 Days)||0||
60017506|NCT02566759|76133700|FG014|STARTED|Washout Crossover Period (Part 4:5 Days)||8||
60017507|NCT02566759|76133701|FG015|STARTED|Washout Crossover Period (Part 4:5 Days)||8||
60017508|NCT02566759|76133702|FG016|STARTED|Washout Crossover Period (Part 4:5 Days)||7||
60017509|NCT02566759|76133686|FG000|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
60017510|NCT02566759|76133687|FG001|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
60017511|NCT02566759|76133688|FG002|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
60017512|NCT02566759|76133689|FG003|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
60017513|NCT02566759|76133690|FG004|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
60017514|NCT02566759|76133691|FG005|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
60017515|NCT02566759|76133692|FG006|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
60017516|NCT02566759|76133693|FG007|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
59506616|NCT00809809|75599650|FG001|STARTED|Overall Study||79||
60017517|NCT02566759|76133694|FG008|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
60017518|NCT02566759|76133695|FG009|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
60017519|NCT02566759|76133696|FG010|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
60017520|NCT02566759|76133697|FG011|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
59506617|NCT00809809|75599649|FG000|COMPLETED|Overall Study|3 dropped from the study when it was discovered they met the exclusion criteria|75||
59506618|NCT00809809|75599650|FG001|COMPLETED|Overall Study|2 dropped from the study when it was discovered they met the exclusion criteria|77||
59506619|NCT00809809|75599649|FG000|NOT COMPLETED|Overall Study||3||
59506620|NCT00809809|75599650|FG001|NOT COMPLETED|Overall Study||2||
60017521|NCT02566759|76133698|FG012|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
60017522|NCT02566759|76133699|FG013|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
60017523|NCT02566759|76133700|FG014|COMPLETED|Washout Crossover Period (Part 4:5 Days)||8||
60017524|NCT02566759|76133701|FG015|COMPLETED|Washout Crossover Period (Part 4:5 Days)||8||
60017525|NCT02566759|76133702|FG016|COMPLETED|Washout Crossover Period (Part 4:5 Days)||7||
60017526|NCT02566759|76133686|FG000|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
60017527|NCT02566759|76133687|FG001|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
60017528|NCT02566759|76133688|FG002|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
60017529|NCT02566759|76133689|FG003|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
60017530|NCT02566759|76133690|FG004|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
60017531|NCT02566759|76133691|FG005|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
60017532|NCT02566759|76133692|FG006|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
59506621|NCT00248651|75599659|FG000|STARTED|Overall Study||97||
59909251|NCT04532099|76030510|FG002|NOT COMPLETED|First Wear Period (30 Days)||0||
59909252|NCT04532099|76030508|FG000|STARTED|Second Wear Period (30 Days)||32||
59909253|NCT04532099|76030509|FG001|STARTED|Second Wear Period (30 Days)||33||
59909254|NCT04532099|76030510|FG002|STARTED|Second Wear Period (30 Days)|Part B is single product; therefore, only one wear period.|0||
59909255|NCT04532099|76030508|FG000|COMPLETED|Second Wear Period (30 Days)||32||
59909256|NCT04532099|76030509|FG001|COMPLETED|Second Wear Period (30 Days)||33||
59909257|NCT04532099|76030510|FG002|COMPLETED|Second Wear Period (30 Days)||0||
59909258|NCT04532099|76030508|FG000|NOT COMPLETED|Second Wear Period (30 Days)||0||
59909259|NCT04532099|76030509|FG001|NOT COMPLETED|Second Wear Period (30 Days)||0||
59909260|NCT04532099|76030510|FG002|NOT COMPLETED|Second Wear Period (30 Days)||0||
59909261|NCT03041792|76030524|FG000|STARTED|Overall Study||32||
59909262|NCT03041792|76030525|FG001|STARTED|Overall Study||29||
59909263|NCT03041792|76030524|FG000|Received Treatment|Overall Study||32||
59909264|NCT03041792|76030525|FG001|Received Treatment|Overall Study||28||
59909265|NCT03041792|76030524|FG000|COMPLETED|Overall Study||28||
59909266|NCT03041792|76030525|FG001|COMPLETED|Overall Study||26||
59909267|NCT03041792|76030524|FG000|NOT COMPLETED|Overall Study||4||
59909268|NCT03041792|76030525|FG001|NOT COMPLETED|Overall Study||3||
59909269|NCT04507763|76030531|FG000|STARTED|Overall Study||763||
59909270|NCT04507763|76030531|FG000|COMPLETED|Overall Study||562||
59909271|NCT04507763|76030531|FG000|NOT COMPLETED|Overall Study||201||
59909272|NCT03045302|76030538|FG000|STARTED|Overall Study||4||
59909273|NCT03045302|76030538|FG000|COMPLETED|Overall Study||3||
59909274|NCT03045302|76030538|FG000|NOT COMPLETED|Overall Study||1||
59909275|NCT00705484|76030544|FG000|STARTED|Overall Study|Number Enrolled|1059||
59909276|NCT00705484|76030545|FG001|STARTED|Overall Study|Number Enrolled|1180||
59909277|NCT00705484|76030544|FG000|Follow-up Period|Overall Study||1059||
59909278|NCT00705484|76030545|FG001|Follow-up Period|Overall Study|Switched From Standard Therapy to Remicade|296||
59909279|NCT00705484|76030544|FG000|COMPLETED|Overall Study||677||
59909280|NCT00705484|76030545|FG001|COMPLETED|Overall Study||772||
60017533|NCT02566759|76133693|FG007|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
59506622|NCT00248651|75599660|FG001|STARTED|Overall Study||98||
59506623|NCT00248651|75599661|FG002|STARTED|Overall Study||97||
59506624|NCT00248651|75599659|FG000|Completed 12 Weeks of Treatment|Overall Study||78||
59506625|NCT00248651|75599660|FG001|Completed 12 Weeks of Treatment|Overall Study||66||
59909281|NCT00705484|76030544|FG000|NOT COMPLETED|Overall Study||382||
59909282|NCT00705484|76030545|FG001|NOT COMPLETED|Overall Study||408||
59909283|NCT04523831|76030555|FG000|STARTED|Overall Study||200||
59909284|NCT04523831|76030556|FG001|STARTED|Overall Study||200||
59909285|NCT04523831|76030555|FG000|COMPLETED|Overall Study||183||
59909286|NCT04523831|76030556|FG001|COMPLETED|Overall Study||180||
59909287|NCT04523831|76030555|FG000|NOT COMPLETED|Overall Study||17||
59909288|NCT04523831|76030556|FG001|NOT COMPLETED|Overall Study||20||
59909289|NCT04707664|76030567|FG000|STARTED|Overall Study||301|All randomized patients|
59506626|NCT00248651|75599661|FG002|Completed 12 Weeks of Treatment|Overall Study||75||
59506627|NCT00248651|75599659|FG000|COMPLETED|Overall Study||69||
59506628|NCT00248651|75599660|FG001|COMPLETED|Overall Study||58||
59506629|NCT00248651|75599661|FG002|COMPLETED|Overall Study||65||
59909290|NCT04707664|76030568|FG001|STARTED|Overall Study||299|All randomized patients|
59909291|NCT04707664|76030567|FG000|Full Analysis Set|Overall Study||301|Patients evaluated for efficacy|
59909292|NCT04707664|76030568|FG001|Full Analysis Set|Overall Study||299|Patients evaluated for efficacy|
59909293|NCT04707664|76030567|FG000|Safety Population|Overall Study||297|Patients who had at least 1 dose of assigned study treatment|
59909294|NCT04707664|76030568|FG001|Safety Population|Overall Study||290|Patients who had at least 1 dose of assigned study treatment|
59909295|NCT04707664|76030567|FG000|COMPLETED|Overall Study||272||
59909296|NCT04707664|76030568|FG001|COMPLETED|Overall Study||263||
59909297|NCT04707664|76030567|FG000|NOT COMPLETED|Overall Study||29||
59909298|NCT04707664|76030568|FG001|NOT COMPLETED|Overall Study||36||
59909299|NCT01316276|76030574|FG000|STARTED|Overall Study||206||
59909300|NCT01316276|76030574|FG000|COMPLETED|Overall Study||139||
59909301|NCT01316276|76030574|FG000|NOT COMPLETED|Overall Study||67||
59909302|NCT04668989|76030579|FG000|STARTED|First Intervention||36||
59909303|NCT04668989|76030580|FG001|STARTED|First Intervention||30||
59909304|NCT04668989|76030579|FG000|COMPLETED|First Intervention||36||
59909305|NCT04668989|76030580|FG001|COMPLETED|First Intervention||29||
59909306|NCT04668989|76030579|FG000|NOT COMPLETED|First Intervention||0||
59909307|NCT04668989|76030580|FG001|NOT COMPLETED|First Intervention||1||
59909308|NCT04668989|76030579|FG000|STARTED|Second Intervention||36||
59909309|NCT04668989|76030580|FG001|STARTED|Second Intervention||29||
59909310|NCT04668989|76030579|FG000|COMPLETED|Second Intervention||36||
59909311|NCT04668989|76030580|FG001|COMPLETED|Second Intervention||28||
59909312|NCT04668989|76030579|FG000|NOT COMPLETED|Second Intervention||0||
59909313|NCT04668989|76030580|FG001|NOT COMPLETED|Second Intervention||1||
59909314|NCT03700385|76030586|FG000|STARTED|Overall Study||40||
59909315|NCT03700385|76030586|FG000|COMPLETED|Overall Study||39||
59909316|NCT03700385|76030586|FG000|NOT COMPLETED|Overall Study||1||
59909317|NCT04498403|76030592|FG000|STARTED|Overall Study||30||
59909318|NCT04498403|76030593|FG001|STARTED|Overall Study||10||
59909319|NCT04498403|76030592|FG000|Completed Follow up|Overall Study||30||
59909320|NCT04498403|76030593|FG001|Completed Follow up|Overall Study||10||
59909321|NCT04498403|76030592|FG000|COMPLETED|Overall Study||0||
59909322|NCT04498403|76030593|FG001|COMPLETED|Overall Study||0||
59909323|NCT04498403|76030592|FG000|NOT COMPLETED|Overall Study||30||
59909324|NCT04498403|76030593|FG001|NOT COMPLETED|Overall Study||10||
59909325|NCT04362137|76030601|FG000|STARTED|Overall Study||287|Randomized participants.|
59909326|NCT04362137|76030602|FG001|STARTED|Overall Study||145|Randomized participants.|
59909327|NCT04362137|76030601|FG000|Safety Set|Overall Study||281|The Safety Set included all participants who received at least one dose of double-blind treatment.|
59909328|NCT04362137|76030602|FG001|Safety Set|Overall Study||143|The Safety Set included all participants who received at least one dose of double-blind treatment.|
59909329|NCT04362137|76030601|FG000|COMPLETED|Overall Study||269||
59909330|NCT04362137|76030602|FG001|COMPLETED|Overall Study||139||
59909331|NCT04362137|76030601|FG000|NOT COMPLETED|Overall Study||18||
59909332|NCT04362137|76030602|FG001|NOT COMPLETED|Overall Study||6||
59909333|NCT05099380|76030610|FG000|STARTED|Overall Study||150||
59909334|NCT05099380|76030611|FG001|STARTED|Overall Study||145||
59909335|NCT05099380|76030610|FG000|COMPLETED|Overall Study||145||
59909336|NCT05099380|76030611|FG001|COMPLETED|Overall Study||144||
59909337|NCT05099380|76030610|FG000|NOT COMPLETED|Overall Study||5||
59909338|NCT05099380|76030611|FG001|NOT COMPLETED|Overall Study||1||
59909339|NCT03614728|76030621|FG000|STARTED|Part 1 (Up to 30.8 Months)||13||
59909340|NCT03614728|76030622|FG001|STARTED|Part 1 (Up to 30.8 Months)||17||
59909341|NCT03614728|76030623|FG002|STARTED|Part 1 (Up to 30.8 Months)||0||
59909342|NCT03614728|76030624|FG003|STARTED|Part 1 (Up to 30.8 Months)||0||
59909343|NCT03614728|76030621|FG000|COMPLETED|Part 1 (Up to 30.8 Months)||12||
59909344|NCT03614728|76030622|FG001|COMPLETED|Part 1 (Up to 30.8 Months)||16||
59909345|NCT03614728|76030623|FG002|COMPLETED|Part 1 (Up to 30.8 Months)||0||
59909346|NCT03614728|76030624|FG003|COMPLETED|Part 1 (Up to 30.8 Months)||0||
59909347|NCT03614728|76030621|FG000|NOT COMPLETED|Part 1 (Up to 30.8 Months)||1||
59909348|NCT03614728|76030622|FG001|NOT COMPLETED|Part 1 (Up to 30.8 Months)||1||
59909349|NCT03614728|76030623|FG002|NOT COMPLETED|Part 1 (Up to 30.8 Months)||0||
59909350|NCT03614728|76030624|FG003|NOT COMPLETED|Part 1 (Up to 30.8 Months)||0||
59909351|NCT03614728|76030621|FG000|STARTED|Part 2 (Up to 3 Years and 2 Months)||0||
59909352|NCT03614728|76030622|FG001|STARTED|Part 2 (Up to 3 Years and 2 Months)||0||
59909353|NCT03614728|76030623|FG002|STARTED|Part 2 (Up to 3 Years and 2 Months)||0||
59909354|NCT03614728|76030624|FG003|STARTED|Part 2 (Up to 3 Years and 2 Months)||0||
59909355|NCT03614728|76030621|FG000|COMPLETED|Part 2 (Up to 3 Years and 2 Months)||0||
59909356|NCT03614728|76030622|FG001|COMPLETED|Part 2 (Up to 3 Years and 2 Months)||0||
59909357|NCT03614728|76030623|FG002|COMPLETED|Part 2 (Up to 3 Years and 2 Months)||0||
59909358|NCT03614728|76030624|FG003|COMPLETED|Part 2 (Up to 3 Years and 2 Months)||0||
59909359|NCT03614728|76030621|FG000|NOT COMPLETED|Part 2 (Up to 3 Years and 2 Months)||0||
59909360|NCT03614728|76030622|FG001|NOT COMPLETED|Part 2 (Up to 3 Years and 2 Months)||0||
59909361|NCT03614728|76030623|FG002|NOT COMPLETED|Part 2 (Up to 3 Years and 2 Months)||0||
59909362|NCT03614728|76030624|FG003|NOT COMPLETED|Part 2 (Up to 3 Years and 2 Months)||0||
59909363|NCT03154086|76030647|FG000|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||2||
59909364|NCT03154086|76030648|FG001|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||2||
59909365|NCT03154086|76030649|FG002|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||2||
59909366|NCT03154086|76030650|FG003|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||2||
59909367|NCT03154086|76030651|FG004|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0||
59909368|NCT03154086|76030652|FG005|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0||
59909369|NCT03154086|76030653|FG006|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0||
59909370|NCT03154086|76030654|FG007|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0||
59909371|NCT03154086|76030655|FG008|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0||
59909372|NCT03154086|76030656|FG009|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0||
59909373|NCT03154086|76030657|FG010|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0||
59909374|NCT03154086|76030658|FG011|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0||
59909375|NCT03154086|76030659|FG012|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0||
59909376|NCT03154086|76030660|FG013|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0||
59909377|NCT03154086|76030661|FG014|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0||
59909378|NCT03154086|76030647|FG000|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||2||
59909379|NCT03154086|76030648|FG001|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||2||
59909380|NCT03154086|76030649|FG002|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||2||
59909381|NCT03154086|76030650|FG003|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||2||
59909382|NCT03154086|76030651|FG004|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0||
59909383|NCT03154086|76030652|FG005|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0||
59909384|NCT03154086|76030653|FG006|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0||
59909385|NCT03154086|76030654|FG007|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0||
59909386|NCT03154086|76030655|FG008|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0||
59909387|NCT03154086|76030656|FG009|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0||
59909388|NCT03154086|76030657|FG010|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0||
59909389|NCT03154086|76030658|FG011|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0||
59909390|NCT03154086|76030659|FG012|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0||
59909391|NCT03154086|76030660|FG013|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0||
59909392|NCT03154086|76030661|FG014|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0||
59909393|NCT03154086|76030647|FG000|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0||
59909394|NCT03154086|76030648|FG001|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0||
59909395|NCT03154086|76030649|FG002|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0||
59909396|NCT03154086|76030650|FG003|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0||
59909397|NCT03154086|76030651|FG004|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0||
59909398|NCT03154086|76030652|FG005|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0||
59909399|NCT03154086|76030653|FG006|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0||
59909400|NCT03154086|76030654|FG007|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0||
59909401|NCT03154086|76030655|FG008|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0||
59909402|NCT03154086|76030656|FG009|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0||
59909403|NCT03154086|76030657|FG010|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0||
59909404|NCT03154086|76030658|FG011|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0||
59909405|NCT03154086|76030659|FG012|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0||
59909406|NCT03154086|76030660|FG013|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0||
59909407|NCT03154086|76030661|FG014|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0||
59909408|NCT03154086|76030647|FG000|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||2||
59506630|NCT00248651|75599659|FG000|NOT COMPLETED|Overall Study||28||
59506631|NCT00248651|75599660|FG001|NOT COMPLETED|Overall Study||40||
60017534|NCT02566759|76133694|FG008|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
60017535|NCT02566759|76133695|FG009|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
60017536|NCT02566759|76133696|FG010|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
60017537|NCT02566759|76133697|FG011|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
60017538|NCT02566759|76133698|FG012|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
60017539|NCT02566759|76133699|FG013|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
60017540|NCT02566759|76133700|FG014|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
60017541|NCT02566759|76133701|FG015|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
60017542|NCT02566759|76133702|FG016|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0||
60017543|NCT02566759|76133686|FG000|STARTED|Crossover Treatment (Part 4: 1 Day)||0||
60017544|NCT02566759|76133687|FG001|STARTED|Crossover Treatment (Part 4: 1 Day)||0||
59909409|NCT03154086|76030648|FG001|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||2||
59909410|NCT03154086|76030649|FG002|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||2||
59909411|NCT03154086|76030650|FG003|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||2||
59909412|NCT03154086|76030651|FG004|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0||
60017545|NCT02566759|76133688|FG002|STARTED|Crossover Treatment (Part 4: 1 Day)||0||
60017546|NCT02566759|76133689|FG003|STARTED|Crossover Treatment (Part 4: 1 Day)||0||
60017547|NCT02566759|76133690|FG004|STARTED|Crossover Treatment (Part 4: 1 Day)||0||
60017548|NCT02566759|76133691|FG005|STARTED|Crossover Treatment (Part 4: 1 Day)||0||
60017549|NCT02566759|76133692|FG006|STARTED|Crossover Treatment (Part 4: 1 Day)||0||
60017550|NCT02566759|76133693|FG007|STARTED|Crossover Treatment (Part 4: 1 Day)||0||
60017551|NCT02566759|76133694|FG008|STARTED|Crossover Treatment (Part 4: 1 Day)||0||
59909413|NCT03154086|76030652|FG005|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0||
59909414|NCT03154086|76030653|FG006|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0||
59909415|NCT03154086|76030654|FG007|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0||
60017552|NCT02566759|76133695|FG009|STARTED|Crossover Treatment (Part 4: 1 Day)||0||
60017553|NCT02566759|76133696|FG010|STARTED|Crossover Treatment (Part 4: 1 Day)||0||
60017554|NCT02566759|76133697|FG011|STARTED|Crossover Treatment (Part 4: 1 Day)||0||
60017555|NCT02566759|76133698|FG012|STARTED|Crossover Treatment (Part 4: 1 Day)||0||
60017556|NCT02566759|76133699|FG013|STARTED|Crossover Treatment (Part 4: 1 Day)||0||
60017557|NCT02566759|76133700|FG014|STARTED|Crossover Treatment (Part 4: 1 Day)||8||
60017558|NCT02566759|76133701|FG015|STARTED|Crossover Treatment (Part 4: 1 Day)||8||
60017559|NCT02566759|76133702|FG016|STARTED|Crossover Treatment (Part 4: 1 Day)||7||
60017560|NCT02566759|76133686|FG000|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
60017561|NCT02566759|76133687|FG001|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
60017562|NCT02566759|76133688|FG002|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
60017563|NCT02566759|76133689|FG003|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
60017564|NCT02566759|76133690|FG004|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
60017565|NCT02566759|76133691|FG005|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
60017566|NCT02566759|76133692|FG006|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
60017567|NCT02566759|76133693|FG007|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
59909416|NCT03154086|76030655|FG008|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0||
59909417|NCT03154086|76030656|FG009|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0||
59909418|NCT03154086|76030657|FG010|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0||
59909419|NCT03154086|76030658|FG011|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0||
59909420|NCT03154086|76030659|FG012|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0||
59909421|NCT03154086|76030660|FG013|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0||
59909422|NCT03154086|76030661|FG014|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0||
59909423|NCT03154086|76030647|FG000|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||2||
59909424|NCT03154086|76030648|FG001|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||2||
59909425|NCT03154086|76030649|FG002|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||2||
59909426|NCT03154086|76030650|FG003|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||1||
60017568|NCT02566759|76133694|FG008|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
60017569|NCT02566759|76133695|FG009|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
59506632|NCT00248651|75599661|FG002|NOT COMPLETED|Overall Study||32||
59909427|NCT03154086|76030651|FG004|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0||
59909428|NCT03154086|76030652|FG005|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0||
59909429|NCT03154086|76030653|FG006|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0||
59909430|NCT03154086|76030654|FG007|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0||
60017570|NCT02566759|76133696|FG010|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
60017571|NCT02566759|76133697|FG011|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
60017572|NCT02566759|76133698|FG012|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
60017573|NCT02566759|76133699|FG013|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
60017574|NCT02566759|76133700|FG014|COMPLETED|Crossover Treatment (Part 4: 1 Day)||8||
59909431|NCT03154086|76030655|FG008|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0||
59909432|NCT03154086|76030656|FG009|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0||
59909433|NCT03154086|76030657|FG010|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0||
59909434|NCT03154086|76030658|FG011|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0||
59909435|NCT03154086|76030659|FG012|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0||
59909436|NCT03154086|76030660|FG013|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0||
59909437|NCT03154086|76030661|FG014|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0||
59909438|NCT03154086|76030647|FG000|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0||
60017575|NCT02566759|76133701|FG015|COMPLETED|Crossover Treatment (Part 4: 1 Day)||8||
59909439|NCT03154086|76030648|FG001|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0||
59909440|NCT03154086|76030649|FG002|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0||
59909441|NCT03154086|76030650|FG003|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||1||
59909442|NCT03154086|76030651|FG004|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0||
59909443|NCT03154086|76030652|FG005|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0||
59909444|NCT03154086|76030653|FG006|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0||
59909445|NCT03154086|76030654|FG007|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0||
59909446|NCT03154086|76030655|FG008|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0||
59909447|NCT03154086|76030656|FG009|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0||
59909448|NCT03154086|76030657|FG010|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0||
59909449|NCT03154086|76030658|FG011|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0||
59909450|NCT03154086|76030659|FG012|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0||
59909451|NCT03154086|76030660|FG013|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0||
59909452|NCT03154086|76030661|FG014|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0||
59909453|NCT03154086|76030647|FG000|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||2||
59909454|NCT03154086|76030648|FG001|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||2||
59909455|NCT03154086|76030649|FG002|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||2||
59909456|NCT03154086|76030650|FG003|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)|One replacement participant (par) was enrolled and dosed|2||
59909457|NCT03154086|76030651|FG004|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0||
59909458|NCT03154086|76030652|FG005|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0||
59909459|NCT03154086|76030653|FG006|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0||
59909460|NCT03154086|76030654|FG007|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0||
59909461|NCT03154086|76030655|FG008|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0||
59909462|NCT03154086|76030656|FG009|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0||
59909463|NCT03154086|76030657|FG010|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0||
59909464|NCT03154086|76030658|FG011|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0||
59909465|NCT03154086|76030659|FG012|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0||
59909466|NCT03154086|76030660|FG013|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0||
59909467|NCT03154086|76030661|FG014|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0||
59909468|NCT03154086|76030647|FG000|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||2||
59909469|NCT03154086|76030648|FG001|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||2||
59909470|NCT03154086|76030649|FG002|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||2||
59909471|NCT03154086|76030650|FG003|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||2||
59909472|NCT03154086|76030651|FG004|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0||
59909473|NCT03154086|76030652|FG005|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0||
60017576|NCT02566759|76133702|FG016|COMPLETED|Crossover Treatment (Part 4: 1 Day)||7||
60017577|NCT02566759|76133686|FG000|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
60017578|NCT02566759|76133687|FG001|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
60017579|NCT02566759|76133688|FG002|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
60017580|NCT02566759|76133689|FG003|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
59506633|NCT01994109|75599672|FG000|STARTED|Double-blind Phase (Part A)||63||
59909474|NCT03154086|76030653|FG006|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0||
59909475|NCT03154086|76030654|FG007|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0||
59909476|NCT03154086|76030655|FG008|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0||
59909477|NCT03154086|76030656|FG009|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0||
59909478|NCT03154086|76030657|FG010|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0||
59909479|NCT03154086|76030658|FG011|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0||
59909480|NCT03154086|76030659|FG012|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0||
59909481|NCT03154086|76030660|FG013|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0||
59909482|NCT03154086|76030661|FG014|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0||
59909483|NCT03154086|76030647|FG000|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0||
59758510|NCT02969915|75877813|FG000|6-month Follow-up|Overall Study||901||8
59758511|NCT02969915|75877814|FG001|6-month Follow-up|Overall Study||968||8
59758512|NCT02969915|75877813|FG000|12-month Follow-up|Overall Study||826||8
59758513|NCT02969915|75877814|FG001|12-month Follow-up|Overall Study||885||8
59758514|NCT02969915|75877813|FG000|18-month Follow-up|Overall Study||778||8
59611483|NCT01777542|75722483|FG001|STARTED|Washout Period (28 +/- 2 Weeks)||15||
59758515|NCT02969915|75877814|FG001|18-month Follow-up|Overall Study||824||8
59758516|NCT02969915|75877813|FG000|COMPLETED|Overall Study||421|24-month follow-up|8
59909484|NCT03154086|76030648|FG001|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0||
59909485|NCT03154086|76030649|FG002|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0||
59909486|NCT03154086|76030650|FG003|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0||
59909487|NCT03154086|76030651|FG004|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0||
59909488|NCT03154086|76030652|FG005|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0||
59909489|NCT03154086|76030653|FG006|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0||
59909490|NCT03154086|76030654|FG007|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0||
59909491|NCT03154086|76030655|FG008|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0||
59909492|NCT03154086|76030656|FG009|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0||
59909493|NCT03154086|76030657|FG010|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0||
59909494|NCT03154086|76030658|FG011|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0||
59909495|NCT03154086|76030659|FG012|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0||
59909496|NCT03154086|76030660|FG013|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0||
59909497|NCT03154086|76030661|FG014|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0||
59909498|NCT03154086|76030647|FG000|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||2||
59909499|NCT03154086|76030648|FG001|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||2||
59909500|NCT03154086|76030649|FG002|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||2||
59909501|NCT03154086|76030650|FG003|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||2||
59909502|NCT03154086|76030651|FG004|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0||
59909503|NCT03154086|76030652|FG005|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0||
59909504|NCT03154086|76030653|FG006|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0||
59909505|NCT03154086|76030654|FG007|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0||
59909506|NCT03154086|76030655|FG008|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0||
59909507|NCT03154086|76030656|FG009|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0||
59909508|NCT03154086|76030657|FG010|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0||
59909509|NCT03154086|76030658|FG011|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0||
59909510|NCT03154086|76030659|FG012|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0||
59909511|NCT03154086|76030660|FG013|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0||
59909512|NCT03154086|76030661|FG014|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0||
59909513|NCT03154086|76030647|FG000|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||2||
59909514|NCT03154086|76030648|FG001|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||1||
59909515|NCT03154086|76030649|FG002|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||2||
59909516|NCT03154086|76030650|FG003|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||2||
59909517|NCT03154086|76030651|FG004|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0||
59909518|NCT03154086|76030652|FG005|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0||
59909519|NCT03154086|76030653|FG006|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0||
59909520|NCT03154086|76030654|FG007|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0||
59909521|NCT03154086|76030655|FG008|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0||
59909522|NCT03154086|76030656|FG009|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0||
59909523|NCT03154086|76030657|FG010|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0||
59909524|NCT03154086|76030658|FG011|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0||
59909525|NCT03154086|76030659|FG012|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0||
59909526|NCT03154086|76030660|FG013|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0||
59909527|NCT03154086|76030661|FG014|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0||
59909528|NCT03154086|76030647|FG000|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0||
59909529|NCT03154086|76030648|FG001|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||1||
59909530|NCT03154086|76030649|FG002|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0||
59909531|NCT03154086|76030650|FG003|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0||
59909532|NCT03154086|76030651|FG004|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0||
59909533|NCT03154086|76030652|FG005|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0||
59909534|NCT03154086|76030653|FG006|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0||
59758517|NCT02969915|75877814|FG001|COMPLETED|Overall Study||492|24-month follow-up|8
59758518|NCT02969915|75877813|FG000|NOT COMPLETED|Overall Study||693||0
59758519|NCT02969915|75877814|FG001|NOT COMPLETED|Overall Study||708||0
59758520|NCT02906332|75877820|FG000|STARTED|Overall Study||12||
59758521|NCT02906332|75877820|FG000|COMPLETED|Overall Study||11||
59758522|NCT02906332|75877820|FG000|NOT COMPLETED|Overall Study||1||
59758523|NCT02864732|75877826|FG000|STARTED|Overall Study||15||
59758524|NCT02864732|75877827|FG001|STARTED|Overall Study||15||
59758525|NCT02864732|75877826|FG000|COMPLETED|Overall Study||13||
59611484|NCT01777542|75722482|FG000|COMPLETED|Washout Period (28 +/- 2 Weeks)||15||
59758526|NCT02864732|75877827|FG001|COMPLETED|Overall Study||13||
59758527|NCT02864732|75877826|FG000|NOT COMPLETED|Overall Study||2||
59909535|NCT03154086|76030654|FG007|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0||
59909536|NCT03154086|76030655|FG008|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0||
59909537|NCT03154086|76030656|FG009|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0||
59909538|NCT03154086|76030657|FG010|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0||
59909539|NCT03154086|76030658|FG011|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0||
59909540|NCT03154086|76030659|FG012|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0||
59909541|NCT03154086|76030660|FG013|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0||
59909542|NCT03154086|76030661|FG014|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0||
59909543|NCT03154086|76030647|FG000|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||2||
59909544|NCT03154086|76030648|FG001|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)|One replacement par was enrolled and dosed|2||
59909545|NCT03154086|76030649|FG002|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||2||
59909546|NCT03154086|76030650|FG003|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||2||
59909547|NCT03154086|76030651|FG004|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0||
59909548|NCT03154086|76030652|FG005|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0||
59909549|NCT03154086|76030653|FG006|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0||
59909550|NCT03154086|76030654|FG007|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0||
59909551|NCT03154086|76030655|FG008|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0||
59909552|NCT03154086|76030656|FG009|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0||
59909553|NCT03154086|76030657|FG010|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0||
59909554|NCT03154086|76030658|FG011|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0||
59909555|NCT03154086|76030659|FG012|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0||
59909556|NCT03154086|76030660|FG013|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0||
59909557|NCT03154086|76030661|FG014|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0||
59909558|NCT03154086|76030647|FG000|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||2||
59909559|NCT03154086|76030648|FG001|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||2||
59909560|NCT03154086|76030649|FG002|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||2||
59909561|NCT03154086|76030650|FG003|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||2||
59909562|NCT03154086|76030651|FG004|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0||
59909563|NCT03154086|76030652|FG005|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0||
59909564|NCT03154086|76030653|FG006|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0||
59909565|NCT03154086|76030654|FG007|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0||
59909566|NCT03154086|76030655|FG008|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0||
59909567|NCT03154086|76030656|FG009|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0||
59909568|NCT03154086|76030657|FG010|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0||
59909569|NCT03154086|76030658|FG011|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0||
59909570|NCT03154086|76030659|FG012|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0||
59909571|NCT03154086|76030660|FG013|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0||
59909572|NCT03154086|76030661|FG014|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0||
59909573|NCT03154086|76030647|FG000|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0||
59909574|NCT03154086|76030648|FG001|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0||
59909575|NCT03154086|76030649|FG002|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0||
59909576|NCT03154086|76030650|FG003|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0||
59909577|NCT03154086|76030651|FG004|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0||
59909578|NCT03154086|76030652|FG005|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0||
59909579|NCT03154086|76030653|FG006|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0||
59909580|NCT03154086|76030654|FG007|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0||
59909581|NCT03154086|76030655|FG008|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0||
59909582|NCT03154086|76030656|FG009|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0||
59909583|NCT03154086|76030657|FG010|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0||
59909584|NCT03154086|76030658|FG011|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0||
59909585|NCT03154086|76030659|FG012|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0||
59909586|NCT03154086|76030660|FG013|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0||
59909587|NCT03154086|76030661|FG014|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0||
59909588|NCT03154086|76030647|FG000|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||2||
59909589|NCT03154086|76030648|FG001|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||2||
59909590|NCT03154086|76030649|FG002|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||2||
59909591|NCT03154086|76030650|FG003|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||2||
59909592|NCT03154086|76030651|FG004|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0||
59909593|NCT03154086|76030652|FG005|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0||
59909594|NCT03154086|76030653|FG006|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0||
59909595|NCT03154086|76030654|FG007|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0||
59909596|NCT03154086|76030655|FG008|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0||
59909597|NCT03154086|76030656|FG009|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0||
59909598|NCT03154086|76030657|FG010|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0||
59909599|NCT03154086|76030658|FG011|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0||
59909600|NCT03154086|76030659|FG012|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0||
59909601|NCT03154086|76030660|FG013|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0||
59909602|NCT03154086|76030661|FG014|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0||
59909603|NCT03154086|76030647|FG000|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||2||
59909604|NCT03154086|76030648|FG001|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||2||
59909605|NCT03154086|76030649|FG002|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||1||
59909606|NCT03154086|76030650|FG003|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||2||
59909607|NCT03154086|76030651|FG004|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0||
59909608|NCT03154086|76030652|FG005|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0||
59909609|NCT03154086|76030653|FG006|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0||
59909610|NCT03154086|76030654|FG007|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0||
59909611|NCT03154086|76030655|FG008|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0||
59909612|NCT03154086|76030656|FG009|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0||
59909613|NCT03154086|76030657|FG010|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0||
59909614|NCT03154086|76030658|FG011|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0||
59909615|NCT03154086|76030659|FG012|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0||
59909616|NCT03154086|76030660|FG013|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0||
59909617|NCT03154086|76030661|FG014|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0||
59909618|NCT03154086|76030647|FG000|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0||
59909619|NCT03154086|76030648|FG001|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0||
59909620|NCT03154086|76030649|FG002|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||1||
59909621|NCT03154086|76030650|FG003|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0||
59909622|NCT03154086|76030651|FG004|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0||
59909623|NCT03154086|76030652|FG005|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0||
59909624|NCT03154086|76030653|FG006|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0||
59909625|NCT03154086|76030654|FG007|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0||
59909626|NCT03154086|76030655|FG008|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0||
59909627|NCT03154086|76030656|FG009|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0||
59909628|NCT03154086|76030657|FG010|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0||
59909629|NCT03154086|76030658|FG011|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0||
59909630|NCT03154086|76030659|FG012|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0||
59909631|NCT03154086|76030660|FG013|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0||
59909632|NCT03154086|76030661|FG014|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0||
59909633|NCT03154086|76030647|FG000|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)|1 par was not dosed on day of dosing due to elevated lab; hence 1 replacement was enrolled and dosed|3||
59909634|NCT03154086|76030648|FG001|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||2||
59909635|NCT03154086|76030649|FG002|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||1||
59909636|NCT03154086|76030650|FG003|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||2||
59909637|NCT03154086|76030651|FG004|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0||
59909638|NCT03154086|76030652|FG005|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0||
59909639|NCT03154086|76030653|FG006|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0||
59909640|NCT03154086|76030654|FG007|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0||
59909641|NCT03154086|76030655|FG008|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0||
59909642|NCT03154086|76030656|FG009|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0||
59909643|NCT03154086|76030657|FG010|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0||
59909644|NCT03154086|76030658|FG011|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0||
59909645|NCT03154086|76030659|FG012|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0||
59909646|NCT03154086|76030660|FG013|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0||
59909647|NCT03154086|76030661|FG014|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0||
59909648|NCT03154086|76030647|FG000|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||2||
59909649|NCT03154086|76030648|FG001|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||2||
59909650|NCT03154086|76030649|FG002|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||1||
59909651|NCT03154086|76030650|FG003|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||2||
59909652|NCT03154086|76030651|FG004|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0||
59909653|NCT03154086|76030652|FG005|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0||
59909654|NCT03154086|76030653|FG006|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0||
59909655|NCT03154086|76030654|FG007|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0||
59909656|NCT03154086|76030655|FG008|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0||
59909657|NCT03154086|76030656|FG009|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0||
59909658|NCT03154086|76030657|FG010|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0||
59909659|NCT03154086|76030658|FG011|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0||
59909660|NCT03154086|76030659|FG012|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0||
59909661|NCT03154086|76030660|FG013|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0||
59909662|NCT03154086|76030661|FG014|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0||
60017581|NCT02566759|76133690|FG004|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
60017582|NCT02566759|76133691|FG005|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
60017583|NCT02566759|76133692|FG006|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
60017584|NCT02566759|76133693|FG007|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
60017585|NCT02566759|76133694|FG008|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
59909663|NCT03154086|76030647|FG000|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||1||
59909664|NCT03154086|76030648|FG001|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0||
59909665|NCT03154086|76030649|FG002|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0||
59909666|NCT03154086|76030650|FG003|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0||
59909667|NCT03154086|76030651|FG004|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0||
59909668|NCT03154086|76030652|FG005|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0||
60017586|NCT02566759|76133695|FG009|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
60017587|NCT02566759|76133696|FG010|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
60017588|NCT02566759|76133697|FG011|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
60017589|NCT02566759|76133698|FG012|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
60017590|NCT02566759|76133699|FG013|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
60017591|NCT02566759|76133700|FG014|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
59909669|NCT03154086|76030653|FG006|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0||
59909670|NCT03154086|76030654|FG007|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0||
59909671|NCT03154086|76030655|FG008|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0||
59909672|NCT03154086|76030656|FG009|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0||
59909673|NCT03154086|76030657|FG010|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0||
59909674|NCT03154086|76030658|FG011|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0||
59909675|NCT03154086|76030659|FG012|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0||
59909676|NCT03154086|76030660|FG013|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0||
59909677|NCT03154086|76030661|FG014|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0||
59909678|NCT03154086|76030647|FG000|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0||
59909679|NCT03154086|76030648|FG001|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0||
59909680|NCT03154086|76030649|FG002|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0||
59909681|NCT03154086|76030650|FG003|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0||
59909682|NCT03154086|76030651|FG004|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||6||
59909683|NCT03154086|76030652|FG005|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||2||
59909684|NCT03154086|76030653|FG006|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0||
59909685|NCT03154086|76030654|FG007|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0||
59909686|NCT03154086|76030655|FG008|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0||
59909687|NCT03154086|76030656|FG009|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0||
59909688|NCT03154086|76030657|FG010|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0||
59909689|NCT03154086|76030658|FG011|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0||
59909690|NCT03154086|76030659|FG012|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0||
59909691|NCT03154086|76030660|FG013|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0||
59909692|NCT03154086|76030661|FG014|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0||
59909693|NCT03154086|76030647|FG000|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0||
59909694|NCT03154086|76030648|FG001|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0||
59909695|NCT03154086|76030649|FG002|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0||
59909696|NCT03154086|76030650|FG003|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0||
59909697|NCT03154086|76030651|FG004|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||6||
59909698|NCT03154086|76030652|FG005|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||2||
59909699|NCT03154086|76030653|FG006|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0||
60017592|NCT02566759|76133701|FG015|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
60017593|NCT02566759|76133702|FG016|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0||
60017594|NCT02335983|76133767|FG000|STARTED|Overall Study||10||
60017595|NCT02335983|76133768|FG001|STARTED|Overall Study||12||
60017596|NCT02335983|76133769|FG002|STARTED|Overall Study||34||
60017597|NCT02335983|76133770|FG003|STARTED|Overall Study||9||
60017598|NCT02335983|76133771|FG004|STARTED|Overall Study||9||
60017599|NCT02335983|76133772|FG005|STARTED|Overall Study||33||
59909700|NCT03154086|76030654|FG007|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0||
59909701|NCT03154086|76030655|FG008|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0||
59909702|NCT03154086|76030656|FG009|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0||
59909703|NCT03154086|76030657|FG010|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0||
59909704|NCT03154086|76030658|FG011|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0||
59909705|NCT03154086|76030659|FG012|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0||
59909706|NCT03154086|76030660|FG013|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0||
60017600|NCT02335983|76133767|FG000|COMPLETED|Overall Study||2||
60017601|NCT02335983|76133768|FG001|COMPLETED|Overall Study||3||
60017602|NCT02335983|76133769|FG002|COMPLETED|Overall Study||2||
60017603|NCT02335983|76133770|FG003|COMPLETED|Overall Study||0||
60017604|NCT02335983|76133771|FG004|COMPLETED|Overall Study||1||
60017605|NCT02335983|76133772|FG005|COMPLETED|Overall Study||1||
60017606|NCT02335983|76133767|FG000|NOT COMPLETED|Overall Study||8||
59506634|NCT01994109|75599673|FG001|STARTED|Double-blind Phase (Part A)||64||
59506635|NCT01994109|75599674|FG002|STARTED|Double-blind Phase (Part A)||60||
59506636|NCT01994109|75599675|FG003|STARTED|Double-blind Phase (Part A)||0||
59506637|NCT01994109|75599672|FG000|COMPLETED|Double-blind Phase (Part A)||62||
59506638|NCT01994109|75599673|FG001|COMPLETED|Double-blind Phase (Part A)||61||
59506639|NCT01994109|75599674|FG002|COMPLETED|Double-blind Phase (Part A)||53||
59506640|NCT01994109|75599675|FG003|COMPLETED|Double-blind Phase (Part A)||0||
59506641|NCT01994109|75599672|FG000|NOT COMPLETED|Double-blind Phase (Part A)||1||
59506642|NCT01994109|75599673|FG001|NOT COMPLETED|Double-blind Phase (Part A)||3||
59506643|NCT01994109|75599674|FG002|NOT COMPLETED|Double-blind Phase (Part A)||7||
59506644|NCT01994109|75599675|FG003|NOT COMPLETED|Double-blind Phase (Part A)||0||
59506645|NCT01994109|75599672|FG000|STARTED|Open-label Phase (Part B)||0||
59506646|NCT01994109|75599673|FG001|STARTED|Open-label Phase (Part B)||0||
59506647|NCT01994109|75599674|FG002|STARTED|Open-label Phase (Part B)|No placebo group in Part B.|0||
59506648|NCT01994109|75599675|FG003|STARTED|Open-label Phase (Part B)|61 from 2500 U group, 57 from 3500 U group, 52 from Placebo group continued to Part B|170||
59506649|NCT01994109|75599672|FG000|COMPLETED|Open-label Phase (Part B)||0||
59506650|NCT01994109|75599673|FG001|COMPLETED|Open-label Phase (Part B)||0||
59506651|NCT01994109|75599674|FG002|COMPLETED|Open-label Phase (Part B)|No placebo group in Part B.|0||
59909707|NCT03154086|76030661|FG014|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0||
59909708|NCT03154086|76030647|FG000|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0||
59909709|NCT03154086|76030648|FG001|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0||
59506652|NCT01994109|75599675|FG003|COMPLETED|Open-label Phase (Part B)||128||
59506653|NCT01994109|75599672|FG000|NOT COMPLETED|Open-label Phase (Part B)||0||
59506654|NCT01994109|75599673|FG001|NOT COMPLETED|Open-label Phase (Part B)||0||
59506655|NCT01994109|75599674|FG002|NOT COMPLETED|Open-label Phase (Part B)||0||
59909710|NCT03154086|76030649|FG002|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0||
59909711|NCT03154086|76030650|FG003|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0||
59909712|NCT03154086|76030651|FG004|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0||
59909713|NCT03154086|76030652|FG005|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0||
59909714|NCT03154086|76030653|FG006|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0||
59909715|NCT03154086|76030654|FG007|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0||
59909716|NCT03154086|76030655|FG008|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0||
59909717|NCT03154086|76030656|FG009|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0||
59909718|NCT03154086|76030657|FG010|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0||
59909719|NCT03154086|76030658|FG011|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0||
59909720|NCT03154086|76030659|FG012|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0||
59909721|NCT03154086|76030660|FG013|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0||
59909722|NCT03154086|76030661|FG014|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0||
59909723|NCT03154086|76030647|FG000|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0||
59909724|NCT03154086|76030648|FG001|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0||
59909725|NCT03154086|76030649|FG002|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0||
59909726|NCT03154086|76030650|FG003|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0||
59909727|NCT03154086|76030651|FG004|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||6||
59909728|NCT03154086|76030652|FG005|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||2||
59909729|NCT03154086|76030653|FG006|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0||
59909730|NCT03154086|76030654|FG007|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0||
59909731|NCT03154086|76030655|FG008|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0||
59909732|NCT03154086|76030656|FG009|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0||
59909733|NCT03154086|76030657|FG010|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0||
59909734|NCT03154086|76030658|FG011|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0||
59909735|NCT03154086|76030659|FG012|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0||
59909736|NCT03154086|76030660|FG013|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0||
59909737|NCT03154086|76030661|FG014|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0||
59909738|NCT03154086|76030647|FG000|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0||
59909739|NCT03154086|76030648|FG001|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0||
59909740|NCT03154086|76030649|FG002|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0||
59909741|NCT03154086|76030650|FG003|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0||
59909742|NCT03154086|76030651|FG004|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||6||
59909743|NCT03154086|76030652|FG005|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||2||
59909744|NCT03154086|76030653|FG006|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0||
59506656|NCT01994109|75599675|FG003|NOT COMPLETED|Open-label Phase (Part B)||42||
59506657|NCT01978509|75599688|FG000|STARTED|Overall Study||10||
59506658|NCT01978509|75599689|FG001|STARTED|Overall Study||13||
59506659|NCT01978509|75599690|FG002|STARTED|Overall Study||9||
59506660|NCT01978509|75599688|FG000|COMPLETED|Overall Study||8||
59506661|NCT01978509|75599689|FG001|COMPLETED|Overall Study||8||
59506662|NCT01978509|75599690|FG002|COMPLETED|Overall Study||9||
59506663|NCT01978509|75599688|FG000|NOT COMPLETED|Overall Study||2||
59506664|NCT01978509|75599689|FG001|NOT COMPLETED|Overall Study||5||
59506665|NCT01978509|75599690|FG002|NOT COMPLETED|Overall Study||0||
59909745|NCT03154086|76030654|FG007|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0||
59909746|NCT03154086|76030655|FG008|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0||
59909747|NCT03154086|76030656|FG009|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0||
59909748|NCT03154086|76030657|FG010|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0||
59758528|NCT02864732|75877827|FG001|NOT COMPLETED|Overall Study||2||
59758529|NCT02827877|75877834|FG000|STARTED|Overall Study||18||
59758530|NCT02827877|75877834|FG000|COMPLETED|Overall Study||17||
59758531|NCT02827877|75877834|FG000|NOT COMPLETED|Overall Study||1||
59909749|NCT03154086|76030658|FG011|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0||
59909750|NCT03154086|76030659|FG012|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0||
59909751|NCT03154086|76030660|FG013|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0||
59909752|NCT03154086|76030661|FG014|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0||
59909753|NCT03154086|76030647|FG000|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0||
59909754|NCT03154086|76030648|FG001|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0||
59909755|NCT03154086|76030649|FG002|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0||
59909756|NCT03154086|76030650|FG003|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0||
59909757|NCT03154086|76030651|FG004|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0||
59909758|NCT03154086|76030652|FG005|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0||
59909759|NCT03154086|76030653|FG006|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0||
59909760|NCT03154086|76030654|FG007|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0||
59909761|NCT03154086|76030655|FG008|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0||
59909762|NCT03154086|76030656|FG009|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0||
59909763|NCT03154086|76030657|FG010|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0||
59909764|NCT03154086|76030658|FG011|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0||
59909765|NCT03154086|76030659|FG012|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0||
59909766|NCT03154086|76030660|FG013|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0||
59909767|NCT03154086|76030661|FG014|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0||
59909768|NCT03154086|76030647|FG000|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0||
59909769|NCT03154086|76030648|FG001|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0||
59909770|NCT03154086|76030649|FG002|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0||
59909771|NCT03154086|76030650|FG003|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0||
59909772|NCT03154086|76030651|FG004|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||6||
59909773|NCT03154086|76030652|FG005|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||2||
59909774|NCT03154086|76030653|FG006|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0||
59909775|NCT03154086|76030654|FG007|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0||
59909776|NCT03154086|76030655|FG008|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0||
59909777|NCT03154086|76030656|FG009|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0||
59909778|NCT03154086|76030657|FG010|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0||
59909779|NCT03154086|76030658|FG011|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0||
59909780|NCT03154086|76030659|FG012|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0||
59909781|NCT03154086|76030660|FG013|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0||
59909782|NCT03154086|76030661|FG014|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0||
59909783|NCT03154086|76030647|FG000|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0||
59909784|NCT03154086|76030648|FG001|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0||
59909785|NCT03154086|76030649|FG002|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0||
59909786|NCT03154086|76030650|FG003|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0||
59909787|NCT03154086|76030651|FG004|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||6||
59909788|NCT03154086|76030652|FG005|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||2||
59909789|NCT03154086|76030653|FG006|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0||
59909790|NCT03154086|76030654|FG007|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0||
59909791|NCT03154086|76030655|FG008|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0||
59909792|NCT03154086|76030656|FG009|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0||
59909793|NCT03154086|76030657|FG010|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0||
59909794|NCT03154086|76030658|FG011|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0||
59909795|NCT03154086|76030659|FG012|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0||
59909796|NCT03154086|76030660|FG013|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0||
59909797|NCT03154086|76030661|FG014|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0||
59909798|NCT03154086|76030647|FG000|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0||
59758532|NCT02755597|75877840|FG000|STARTED|Overall Study||194||
59758533|NCT02755597|75877841|FG001|STARTED|Overall Study||97||
59758534|NCT02755597|75877840|FG000|COMPLETED|Overall Study||0||
59758535|NCT02755597|75877841|FG001|COMPLETED|Overall Study||0||
59758536|NCT02755597|75877840|FG000|NOT COMPLETED|Overall Study||194||
59758537|NCT02755597|75877841|FG001|NOT COMPLETED|Overall Study||97||
59758538|NCT02598557|75877850|FG000|STARTED|Overall Study||59||
59758539|NCT02598557|75877851|FG001|STARTED|Overall Study||58||
59758540|NCT02598557|75877852|FG002|STARTED|Overall Study||63||
59758541|NCT02598557|75877850|FG000|COMPLETED|Overall Study||55||
59758542|NCT02598557|75877851|FG001|COMPLETED|Overall Study||56||
59758543|NCT02598557|75877852|FG002|COMPLETED|Overall Study||60||
59758544|NCT02598557|75877850|FG000|NOT COMPLETED|Overall Study||4||
59758545|NCT02598557|75877851|FG001|NOT COMPLETED|Overall Study||2||
60017607|NCT02335983|76133768|FG001|NOT COMPLETED|Overall Study||9||
60017608|NCT02335983|76133769|FG002|NOT COMPLETED|Overall Study||32||
60017609|NCT02335983|76133770|FG003|NOT COMPLETED|Overall Study||9||
60017610|NCT02335983|76133771|FG004|NOT COMPLETED|Overall Study||8||
60017611|NCT02335983|76133772|FG005|NOT COMPLETED|Overall Study||32||
60017612|NCT04640311|76133808|FG000|STARTED|Part A:Treatment Period 1 (Up to 2 Days)||16||
60017613|NCT04640311|76133809|FG001|STARTED|Part A:Treatment Period 1 (Up to 2 Days)||18||
60017614|NCT04640311|76133810|FG002|STARTED|Part A:Treatment Period 1 (Up to 2 Days)||18||
60017615|NCT04640311|76133811|FG003|STARTED|Part A:Treatment Period 1 (Up to 2 Days)||0||
60017616|NCT04640311|76133812|FG004|STARTED|Part A:Treatment Period 1 (Up to 2 Days)||0||
60017617|NCT04640311|76133813|FG005|STARTED|Part A:Treatment Period 1 (Up to 2 Days)||0||
60017618|NCT04640311|76133814|FG006|STARTED|Part A:Treatment Period 1 (Up to 2 Days)||0||
60017619|NCT04640311|76133815|FG007|STARTED|Part A:Treatment Period 1 (Up to 2 Days)||0||
60017620|NCT04640311|76133816|FG008|STARTED|Part A:Treatment Period 1 (Up to 2 Days)||0||
59909799|NCT03154086|76030648|FG001|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0||
59909800|NCT03154086|76030649|FG002|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0||
59909801|NCT03154086|76030650|FG003|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0||
59909802|NCT03154086|76030651|FG004|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0||
59909803|NCT03154086|76030652|FG005|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0||
60017621|NCT04640311|76133817|FG009|STARTED|Part A:Treatment Period 1 (Up to 2 Days)||0||
60017622|NCT04640311|76133818|FG010|STARTED|Part A:Treatment Period 1 (Up to 2 Days)||0||
60017623|NCT04640311|76133819|FG011|STARTED|Part A:Treatment Period 1 (Up to 2 Days)||0||
60017624|NCT04640311|76133820|FG012|STARTED|Part A:Treatment Period 1 (Up to 2 Days)||0||
60017625|NCT04640311|76133808|FG000|COMPLETED|Part A:Treatment Period 1 (Up to 2 Days)||15||
59909804|NCT03154086|76030653|FG006|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0||
59909805|NCT03154086|76030654|FG007|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0||
59909806|NCT03154086|76030655|FG008|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0||
59909807|NCT03154086|76030656|FG009|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0||
60017626|NCT04640311|76133809|FG001|COMPLETED|Part A:Treatment Period 1 (Up to 2 Days)||16||
60017627|NCT04640311|76133810|FG002|COMPLETED|Part A:Treatment Period 1 (Up to 2 Days)||18||
60017628|NCT04640311|76133811|FG003|COMPLETED|Part A:Treatment Period 1 (Up to 2 Days)||0||
60017629|NCT04640311|76133812|FG004|COMPLETED|Part A:Treatment Period 1 (Up to 2 Days)||0||
60017630|NCT04640311|76133813|FG005|COMPLETED|Part A:Treatment Period 1 (Up to 2 Days)||0||
60017631|NCT04640311|76133814|FG006|COMPLETED|Part A:Treatment Period 1 (Up to 2 Days)||0||
60017632|NCT04640311|76133815|FG007|COMPLETED|Part A:Treatment Period 1 (Up to 2 Days)||0||
60017633|NCT04640311|76133816|FG008|COMPLETED|Part A:Treatment Period 1 (Up to 2 Days)||0||
60017634|NCT04640311|76133817|FG009|COMPLETED|Part A:Treatment Period 1 (Up to 2 Days)||0||
60017635|NCT04640311|76133818|FG010|COMPLETED|Part A:Treatment Period 1 (Up to 2 Days)||0||
60017636|NCT04640311|76133819|FG011|COMPLETED|Part A:Treatment Period 1 (Up to 2 Days)||0||
60017637|NCT04640311|76133820|FG012|COMPLETED|Part A:Treatment Period 1 (Up to 2 Days)||0||
60017638|NCT04640311|76133808|FG000|NOT COMPLETED|Part A:Treatment Period 1 (Up to 2 Days)||1||
60017639|NCT04640311|76133809|FG001|NOT COMPLETED|Part A:Treatment Period 1 (Up to 2 Days)||2||
60017640|NCT04640311|76133810|FG002|NOT COMPLETED|Part A:Treatment Period 1 (Up to 2 Days)||0||
60017641|NCT04640311|76133811|FG003|NOT COMPLETED|Part A:Treatment Period 1 (Up to 2 Days)||0||
60017642|NCT04640311|76133812|FG004|NOT COMPLETED|Part A:Treatment Period 1 (Up to 2 Days)||0||
60017643|NCT04640311|76133813|FG005|NOT COMPLETED|Part A:Treatment Period 1 (Up to 2 Days)||0||
60017644|NCT04640311|76133814|FG006|NOT COMPLETED|Part A:Treatment Period 1 (Up to 2 Days)||0||
60017645|NCT04640311|76133815|FG007|NOT COMPLETED|Part A:Treatment Period 1 (Up to 2 Days)||0||
60017646|NCT04640311|76133816|FG008|NOT COMPLETED|Part A:Treatment Period 1 (Up to 2 Days)||0||
60017647|NCT04640311|76133817|FG009|NOT COMPLETED|Part A:Treatment Period 1 (Up to 2 Days)||0||
60017648|NCT04640311|76133818|FG010|NOT COMPLETED|Part A:Treatment Period 1 (Up to 2 Days)||0||
60017649|NCT04640311|76133819|FG011|NOT COMPLETED|Part A:Treatment Period 1 (Up to 2 Days)||0||
60017650|NCT04640311|76133820|FG012|NOT COMPLETED|Part A:Treatment Period 1 (Up to 2 Days)||0||
60017651|NCT04640311|76133808|FG000|STARTED|Part A: Washout 1 (Up to 7 Days)||15||
60017652|NCT04640311|76133809|FG001|STARTED|Part A: Washout 1 (Up to 7 Days)||16||
60017653|NCT04640311|76133810|FG002|STARTED|Part A: Washout 1 (Up to 7 Days)||18||
60017654|NCT04640311|76133811|FG003|STARTED|Part A: Washout 1 (Up to 7 Days)||0||
60017655|NCT04640311|76133812|FG004|STARTED|Part A: Washout 1 (Up to 7 Days)||0||
59506666|NCT00248495|75599698|FG000|STARTED|Overall Study||38||
59506667|NCT00248495|75599698|FG000|COMPLETED|Overall Study||37||
59506668|NCT00248495|75599698|FG000|NOT COMPLETED|Overall Study||1||
59506669|NCT02307123|75599702|FG000|STARTED|Overall Study||483||
59909808|NCT03154086|76030657|FG010|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0||
59909809|NCT03154086|76030658|FG011|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0||
59758546|NCT02598557|75877852|FG002|NOT COMPLETED|Overall Study||3||
59758547|NCT02340780|75877860|FG000|STARTED|Overall Study|A total of 14 patients enrolled, one patient was found ineligible after the enrollment.|14||
59758548|NCT02340780|75877860|FG000|COMPLETED|Overall Study||13||
59758549|NCT02340780|75877860|FG000|NOT COMPLETED|Overall Study||1||
59758550|NCT02033993|75877866|FG000|STARTED|Overall Study||99||
59758551|NCT02033993|75877867|FG001|STARTED|Overall Study||100||
59758552|NCT02033993|75877866|FG000|COMPLETED|Overall Study||96||
59758553|NCT02033993|75877867|FG001|COMPLETED|Overall Study||91||
59758554|NCT02033993|75877866|FG000|NOT COMPLETED|Overall Study||3||
59758555|NCT02033993|75877867|FG001|NOT COMPLETED|Overall Study||9||
59909810|NCT03154086|76030659|FG012|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0||
59909811|NCT03154086|76030660|FG013|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0||
59909812|NCT03154086|76030661|FG014|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0||
59909813|NCT03154086|76030647|FG000|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0||
59909814|NCT03154086|76030648|FG001|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0||
59909815|NCT03154086|76030649|FG002|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0||
59909816|NCT03154086|76030650|FG003|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0||
59909817|NCT03154086|76030651|FG004|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0||
59909818|NCT03154086|76030652|FG005|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0||
59909819|NCT03154086|76030653|FG006|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||2||
59909820|NCT03154086|76030654|FG007|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||2||
59909821|NCT03154086|76030655|FG008|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||4||
59909822|NCT03154086|76030656|FG009|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0||
59506670|NCT02307123|75599702|FG000|COMPLETED|Overall Study||483||
59758556|NCT01470417|75877875|FG000|STARTED|Overall Study||3||
59758557|NCT01470417|75877876|FG001|STARTED|Overall Study||7||
59758558|NCT01470417|75877875|FG000|COMPLETED|Overall Study||3||
59909823|NCT03154086|76030657|FG010|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0||
59506671|NCT02307123|75599702|FG000|NOT COMPLETED|Overall Study||0||
59758559|NCT01470417|75877876|FG001|COMPLETED|Overall Study||5||
59758560|NCT01470417|75877875|FG000|NOT COMPLETED|Overall Study||0||
59758561|NCT01470417|75877876|FG001|NOT COMPLETED|Overall Study||2||
59758562|NCT01463072|75877882|FG000|STARTED|Overall Study||40||
59758563|NCT01463072|75877882|FG000|COMPLETED|Overall Study||40||
59758564|NCT01463072|75877882|FG000|NOT COMPLETED|Overall Study||0||
59758565|NCT01331083|75877888|FG000|STARTED|Overall Study||43||
59758566|NCT01331083|75877889|FG001|STARTED|Overall Study||25||
59758567|NCT01331083|75877888|FG000|COMPLETED|Overall Study||43||
59758568|NCT01331083|75877889|FG001|COMPLETED|Overall Study||25||
59758569|NCT01331083|75877888|FG000|NOT COMPLETED|Overall Study||0||
59758570|NCT01331083|75877889|FG001|NOT COMPLETED|Overall Study||0||
59758571|NCT00999336|75877899|FG000|STARTED|Overall Study||8||
59758572|NCT00999336|75877900|FG001|STARTED|Overall Study||8||
59758573|NCT00999336|75877901|FG002|STARTED|Overall Study||8||
59758574|NCT00999336|75877902|FG003|STARTED|Overall Study||8||
60017656|NCT04640311|76133813|FG005|STARTED|Part A: Washout 1 (Up to 7 Days)||0||
60017657|NCT04640311|76133814|FG006|STARTED|Part A: Washout 1 (Up to 7 Days)||0||
60017658|NCT04640311|76133815|FG007|STARTED|Part A: Washout 1 (Up to 7 Days)||0||
60017659|NCT04640311|76133816|FG008|STARTED|Part A: Washout 1 (Up to 7 Days)||0||
59758575|NCT00999336|75877899|FG000|COMPLETED|Overall Study||8||
59758576|NCT00999336|75877900|FG001|COMPLETED|Overall Study||8||
59758577|NCT00999336|75877901|FG002|COMPLETED|Overall Study||8||
59909824|NCT03154086|76030658|FG011|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0||
59909825|NCT03154086|76030659|FG012|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0||
59909826|NCT03154086|76030660|FG013|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0||
59909827|NCT03154086|76030661|FG014|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0||
59909828|NCT03154086|76030647|FG000|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0||
59909829|NCT03154086|76030648|FG001|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0||
59909830|NCT03154086|76030649|FG002|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0||
59909831|NCT03154086|76030650|FG003|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0||
59909832|NCT03154086|76030651|FG004|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0||
59909833|NCT03154086|76030652|FG005|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0||
59909834|NCT03154086|76030653|FG006|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||2||
59909835|NCT03154086|76030654|FG007|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||2||
60017660|NCT04640311|76133817|FG009|STARTED|Part A: Washout 1 (Up to 7 Days)||0||
59758578|NCT00999336|75877902|FG003|COMPLETED|Overall Study||8||
59758579|NCT00999336|75877899|FG000|NOT COMPLETED|Overall Study||0||
59758580|NCT00999336|75877900|FG001|NOT COMPLETED|Overall Study||0||
59758581|NCT00999336|75877901|FG002|NOT COMPLETED|Overall Study||0||
59758582|NCT00999336|75877902|FG003|NOT COMPLETED|Overall Study||0||
59758583|NCT00820248|75877914|FG000|STARTED|Overall Study||160||
59758584|NCT00820248|75877915|FG001|STARTED|Overall Study||160||
59758585|NCT00820248|75877914|FG000|Received Protocol Treatment|Overall Study||156|Only treated patients were evaluated for adverse event.|
59758586|NCT00820248|75877915|FG001|Received Protocol Treatment|Overall Study||159|Only treated patients were evaluated for adverse event.|
59758587|NCT00820248|75877914|FG000|COMPLETED|Overall Study||156||
59758588|NCT00820248|75877915|FG001|COMPLETED|Overall Study||159||
59758589|NCT00820248|75877914|FG000|NOT COMPLETED|Overall Study||4||
59758590|NCT00820248|75877915|FG001|NOT COMPLETED|Overall Study||1||
59758591|NCT00795340|75877923|FG000|STARTED|Overall Study||153||
59758592|NCT00795340|75877924|FG001|STARTED|Overall Study||153||
59758593|NCT00795340|75877923|FG000|COMPLETED|Overall Study||146||
59758594|NCT00795340|75877924|FG001|COMPLETED|Overall Study||153||
60017661|NCT04640311|76133818|FG010|STARTED|Part A: Washout 1 (Up to 7 Days)||0||
60017662|NCT04640311|76133819|FG011|STARTED|Part A: Washout 1 (Up to 7 Days)||0||
60017663|NCT04640311|76133820|FG012|STARTED|Part A: Washout 1 (Up to 7 Days)||0||
59758595|NCT00795340|75877923|FG000|NOT COMPLETED|Overall Study||7||
59909836|NCT03154086|76030655|FG008|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||4||
59909837|NCT03154086|76030656|FG009|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0||
59909838|NCT03154086|76030657|FG010|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0||
59909839|NCT03154086|76030658|FG011|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0||
59909840|NCT03154086|76030659|FG012|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0||
59909841|NCT03154086|76030660|FG013|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0||
59909842|NCT03154086|76030661|FG014|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0||
60017664|NCT04640311|76133808|FG000|COMPLETED|Part A: Washout 1 (Up to 7 Days)||15||
60017665|NCT04640311|76133809|FG001|COMPLETED|Part A: Washout 1 (Up to 7 Days)||16||
60017666|NCT04640311|76133810|FG002|COMPLETED|Part A: Washout 1 (Up to 7 Days)||18||
60017667|NCT04640311|76133811|FG003|COMPLETED|Part A: Washout 1 (Up to 7 Days)||0||
60017668|NCT04640311|76133812|FG004|COMPLETED|Part A: Washout 1 (Up to 7 Days)||0||
59506672|NCT01978743|75599706|FG000|STARTED|Overall Study||10||
59506673|NCT01978743|75599706|FG000|COMPLETED|Overall Study||10||
59506674|NCT01978743|75599706|FG000|NOT COMPLETED|Overall Study||0||
59506675|NCT00763061|75599713|FG000|STARTED|Overall Study||54||
59506676|NCT00763061|75599714|FG001|STARTED|Overall Study||57||
59506677|NCT00763061|75599713|FG000|COMPLETED|Overall Study||49||
59506678|NCT00763061|75599714|FG001|COMPLETED|Overall Study||44||
59506679|NCT00763061|75599713|FG000|NOT COMPLETED|Overall Study||5||
59506680|NCT00763061|75599714|FG001|NOT COMPLETED|Overall Study||13||
59506681|NCT01979133|75599720|FG000|STARTED|Overall Study||10||
59506682|NCT01979133|75599720|FG000|COMPLETED|Overall Study||7||
59506683|NCT01979133|75599720|FG000|NOT COMPLETED|Overall Study||3||
59611485|NCT01777542|75722483|FG001|COMPLETED|Washout Period (28 +/- 2 Weeks)||15||
59611486|NCT01777542|75722482|FG000|NOT COMPLETED|Washout Period (28 +/- 2 Weeks)||0||
60017669|NCT04640311|76133813|FG005|COMPLETED|Part A: Washout 1 (Up to 7 Days)||0||
60017670|NCT04640311|76133814|FG006|COMPLETED|Part A: Washout 1 (Up to 7 Days)||0||
60017671|NCT04640311|76133815|FG007|COMPLETED|Part A: Washout 1 (Up to 7 Days)||0||
60017672|NCT04640311|76133816|FG008|COMPLETED|Part A: Washout 1 (Up to 7 Days)||0||
60017673|NCT04640311|76133817|FG009|COMPLETED|Part A: Washout 1 (Up to 7 Days)||0||
60017674|NCT04640311|76133818|FG010|COMPLETED|Part A: Washout 1 (Up to 7 Days)||0||
60017675|NCT04640311|76133819|FG011|COMPLETED|Part A: Washout 1 (Up to 7 Days)||0||
60017676|NCT04640311|76133820|FG012|COMPLETED|Part A: Washout 1 (Up to 7 Days)||0||
60017677|NCT04640311|76133808|FG000|NOT COMPLETED|Part A: Washout 1 (Up to 7 Days)||0||
60017678|NCT04640311|76133809|FG001|NOT COMPLETED|Part A: Washout 1 (Up to 7 Days)||0||
60017679|NCT04640311|76133810|FG002|NOT COMPLETED|Part A: Washout 1 (Up to 7 Days)||0||
60017680|NCT04640311|76133811|FG003|NOT COMPLETED|Part A: Washout 1 (Up to 7 Days)||0||
60017681|NCT04640311|76133812|FG004|NOT COMPLETED|Part A: Washout 1 (Up to 7 Days)||0||
60017682|NCT04640311|76133813|FG005|NOT COMPLETED|Part A: Washout 1 (Up to 7 Days)||0||
60017683|NCT04640311|76133814|FG006|NOT COMPLETED|Part A: Washout 1 (Up to 7 Days)||0||
60017684|NCT04640311|76133815|FG007|NOT COMPLETED|Part A: Washout 1 (Up to 7 Days)||0||
60017685|NCT04640311|76133816|FG008|NOT COMPLETED|Part A: Washout 1 (Up to 7 Days)||0||
60017686|NCT04640311|76133817|FG009|NOT COMPLETED|Part A: Washout 1 (Up to 7 Days)||0||
59506684|NCT00754247|75599740|FG000|STARTED|Overall Study||10||
59611487|NCT01777542|75722483|FG001|NOT COMPLETED|Washout Period (28 +/- 2 Weeks)||0||
59506685|NCT00754247|75599741|FG001|STARTED|Overall Study||10||
59506686|NCT00754247|75599742|FG002|STARTED|Overall Study||10||
59909843|NCT03154086|76030647|FG000|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0||
59909844|NCT03154086|76030648|FG001|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0||
59909845|NCT03154086|76030649|FG002|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0||
59909846|NCT03154086|76030650|FG003|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0||
59909847|NCT03154086|76030651|FG004|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0||
59909848|NCT03154086|76030652|FG005|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0||
59909849|NCT03154086|76030653|FG006|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0||
59909850|NCT03154086|76030654|FG007|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0||
59909851|NCT03154086|76030655|FG008|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0||
59909852|NCT03154086|76030656|FG009|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0||
59909853|NCT03154086|76030657|FG010|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0||
59909854|NCT03154086|76030658|FG011|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0||
59909855|NCT03154086|76030659|FG012|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0||
59909856|NCT03154086|76030660|FG013|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0||
59909857|NCT03154086|76030661|FG014|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0||
59909858|NCT03154086|76030647|FG000|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0||
59909859|NCT03154086|76030648|FG001|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0||
59909860|NCT03154086|76030649|FG002|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0||
59909861|NCT03154086|76030650|FG003|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0||
59909862|NCT03154086|76030651|FG004|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0||
59909863|NCT03154086|76030652|FG005|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0||
59909864|NCT03154086|76030653|FG006|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||2||
59909865|NCT03154086|76030654|FG007|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||2||
59909866|NCT03154086|76030655|FG008|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||4||
59909867|NCT03154086|76030656|FG009|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0||
59909868|NCT03154086|76030657|FG010|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0||
59909869|NCT03154086|76030658|FG011|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0||
59909870|NCT03154086|76030659|FG012|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0||
59909871|NCT03154086|76030660|FG013|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0||
59909872|NCT03154086|76030661|FG014|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0||
59909873|NCT03154086|76030647|FG000|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0||
59909874|NCT03154086|76030648|FG001|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0||
59909875|NCT03154086|76030649|FG002|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0||
59909876|NCT03154086|76030650|FG003|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0||
59909877|NCT03154086|76030651|FG004|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0||
59909878|NCT03154086|76030652|FG005|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0||
59909879|NCT03154086|76030653|FG006|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||2||
59909880|NCT03154086|76030654|FG007|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||2||
59909881|NCT03154086|76030655|FG008|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||4||
59909882|NCT03154086|76030656|FG009|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0||
59909883|NCT03154086|76030657|FG010|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0||
59909884|NCT03154086|76030658|FG011|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0||
59909885|NCT03154086|76030659|FG012|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0||
59909886|NCT03154086|76030660|FG013|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0||
59909887|NCT03154086|76030661|FG014|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0||
59909888|NCT03154086|76030647|FG000|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0||
59909889|NCT03154086|76030648|FG001|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0||
59909890|NCT03154086|76030649|FG002|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0||
59909891|NCT03154086|76030650|FG003|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0||
59909892|NCT03154086|76030651|FG004|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0||
59909893|NCT03154086|76030652|FG005|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0||
59909894|NCT03154086|76030653|FG006|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0||
59909895|NCT03154086|76030654|FG007|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0||
59909896|NCT03154086|76030655|FG008|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0||
59909897|NCT03154086|76030656|FG009|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0||
59909898|NCT03154086|76030657|FG010|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0||
59909899|NCT03154086|76030658|FG011|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0||
59909900|NCT03154086|76030659|FG012|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0||
59909901|NCT03154086|76030660|FG013|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0||
59909902|NCT03154086|76030661|FG014|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0||
59909903|NCT03154086|76030647|FG000|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0||
59909904|NCT03154086|76030648|FG001|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0||
59909905|NCT03154086|76030649|FG002|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0||
59909906|NCT03154086|76030650|FG003|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0||
59909907|NCT03154086|76030651|FG004|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0||
59909908|NCT03154086|76030652|FG005|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0||
59909909|NCT03154086|76030653|FG006|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||2||
60017687|NCT04640311|76133818|FG010|NOT COMPLETED|Part A: Washout 1 (Up to 7 Days)||0||
60017688|NCT04640311|76133819|FG011|NOT COMPLETED|Part A: Washout 1 (Up to 7 Days)||0||
60017689|NCT04640311|76133820|FG012|NOT COMPLETED|Part A: Washout 1 (Up to 7 Days)||0||
60017690|NCT04640311|76133808|FG000|STARTED|Part A:Treatment Period 2 (Up to 2 Days)||15||
60017691|NCT04640311|76133809|FG001|STARTED|Part A:Treatment Period 2 (Up to 2 Days)||16||
60017692|NCT04640311|76133810|FG002|STARTED|Part A:Treatment Period 2 (Up to 2 Days)||18||
60017693|NCT04640311|76133811|FG003|STARTED|Part A:Treatment Period 2 (Up to 2 Days)||0||
60017694|NCT04640311|76133812|FG004|STARTED|Part A:Treatment Period 2 (Up to 2 Days)||0||
60017695|NCT04640311|76133813|FG005|STARTED|Part A:Treatment Period 2 (Up to 2 Days)||0||
60017696|NCT04640311|76133814|FG006|STARTED|Part A:Treatment Period 2 (Up to 2 Days)||0||
60017697|NCT04640311|76133815|FG007|STARTED|Part A:Treatment Period 2 (Up to 2 Days)||0||
60017698|NCT04640311|76133816|FG008|STARTED|Part A:Treatment Period 2 (Up to 2 Days)||0||
59909910|NCT03154086|76030654|FG007|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||2||
59909911|NCT03154086|76030655|FG008|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)|1 par was unwell on Day-1 of Period 2 and discontinued; hence,1 replacement was enrolled and dosed|5||
59909912|NCT03154086|76030656|FG009|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0||
59909913|NCT03154086|76030657|FG010|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0||
59909914|NCT03154086|76030658|FG011|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0||
59909915|NCT03154086|76030659|FG012|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0||
59909916|NCT03154086|76030660|FG013|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0||
59909917|NCT03154086|76030661|FG014|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0||
59909918|NCT03154086|76030647|FG000|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0||
59909919|NCT03154086|76030648|FG001|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0||
59909920|NCT03154086|76030649|FG002|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0||
59909921|NCT03154086|76030650|FG003|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0||
59909922|NCT03154086|76030651|FG004|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0||
59909923|NCT03154086|76030652|FG005|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0||
59909924|NCT03154086|76030653|FG006|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||2||
59909925|NCT03154086|76030654|FG007|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||1||
59909926|NCT03154086|76030655|FG008|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||4||
60017699|NCT04640311|76133817|FG009|STARTED|Part A:Treatment Period 2 (Up to 2 Days)||0||
60017700|NCT04640311|76133818|FG010|STARTED|Part A:Treatment Period 2 (Up to 2 Days)||0||
60017701|NCT04640311|76133819|FG011|STARTED|Part A:Treatment Period 2 (Up to 2 Days)||0||
60017702|NCT04640311|76133820|FG012|STARTED|Part A:Treatment Period 2 (Up to 2 Days)||0||
60017703|NCT04640311|76133808|FG000|COMPLETED|Part A:Treatment Period 2 (Up to 2 Days)||12||
60017704|NCT04640311|76133809|FG001|COMPLETED|Part A:Treatment Period 2 (Up to 2 Days)||11||
60017705|NCT04640311|76133810|FG002|COMPLETED|Part A:Treatment Period 2 (Up to 2 Days)||10||
60017706|NCT04640311|76133811|FG003|COMPLETED|Part A:Treatment Period 2 (Up to 2 Days)||0||
60017707|NCT04640311|76133812|FG004|COMPLETED|Part A:Treatment Period 2 (Up to 2 Days)||0||
60017708|NCT04640311|76133813|FG005|COMPLETED|Part A:Treatment Period 2 (Up to 2 Days)||0||
60017709|NCT04640311|76133814|FG006|COMPLETED|Part A:Treatment Period 2 (Up to 2 Days)||0||
60017710|NCT04640311|76133815|FG007|COMPLETED|Part A:Treatment Period 2 (Up to 2 Days)||0||
60017711|NCT04640311|76133816|FG008|COMPLETED|Part A:Treatment Period 2 (Up to 2 Days)||0||
60017712|NCT04640311|76133817|FG009|COMPLETED|Part A:Treatment Period 2 (Up to 2 Days)||0||
60017713|NCT04640311|76133818|FG010|COMPLETED|Part A:Treatment Period 2 (Up to 2 Days)||0||
60017714|NCT04640311|76133819|FG011|COMPLETED|Part A:Treatment Period 2 (Up to 2 Days)||0||
60017715|NCT04640311|76133820|FG012|COMPLETED|Part A:Treatment Period 2 (Up to 2 Days)||0||
60017716|NCT04640311|76133808|FG000|NOT COMPLETED|Part A:Treatment Period 2 (Up to 2 Days)||3||
60017717|NCT04640311|76133809|FG001|NOT COMPLETED|Part A:Treatment Period 2 (Up to 2 Days)||5||
60017718|NCT04640311|76133810|FG002|NOT COMPLETED|Part A:Treatment Period 2 (Up to 2 Days)||8||
60017719|NCT04640311|76133811|FG003|NOT COMPLETED|Part A:Treatment Period 2 (Up to 2 Days)||0||
60017720|NCT04640311|76133812|FG004|NOT COMPLETED|Part A:Treatment Period 2 (Up to 2 Days)||0||
60017721|NCT04640311|76133813|FG005|NOT COMPLETED|Part A:Treatment Period 2 (Up to 2 Days)||0||
59506687|NCT00754247|75599740|FG000|COMPLETED|Overall Study||5||
59909927|NCT03154086|76030656|FG009|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0||
59909928|NCT03154086|76030657|FG010|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0||
59909929|NCT03154086|76030658|FG011|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0||
59909930|NCT03154086|76030659|FG012|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0||
59909931|NCT03154086|76030660|FG013|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0||
59909932|NCT03154086|76030661|FG014|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0||
59909933|NCT03154086|76030647|FG000|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0||
59909934|NCT03154086|76030648|FG001|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0||
59909935|NCT03154086|76030649|FG002|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0||
59909936|NCT03154086|76030650|FG003|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0||
59909937|NCT03154086|76030651|FG004|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0||
60017722|NCT04640311|76133814|FG006|NOT COMPLETED|Part A:Treatment Period 2 (Up to 2 Days)||0||
60017723|NCT04640311|76133815|FG007|NOT COMPLETED|Part A:Treatment Period 2 (Up to 2 Days)||0||
60017724|NCT04640311|76133816|FG008|NOT COMPLETED|Part A:Treatment Period 2 (Up to 2 Days)||0||
59909938|NCT03154086|76030652|FG005|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0||
59909939|NCT03154086|76030653|FG006|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0||
59909940|NCT03154086|76030654|FG007|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||1||
59909941|NCT03154086|76030655|FG008|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||1||
59909942|NCT03154086|76030656|FG009|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0||
59909943|NCT03154086|76030657|FG010|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0||
59909944|NCT03154086|76030658|FG011|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0||
59909945|NCT03154086|76030659|FG012|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0||
59506688|NCT00754247|75599741|FG001|COMPLETED|Overall Study||5||
59506689|NCT00754247|75599742|FG002|COMPLETED|Overall Study||5||
59909946|NCT03154086|76030660|FG013|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0||
59909947|NCT03154086|76030661|FG014|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0||
59909948|NCT03154086|76030647|FG000|STARTED|Part B (Up to 25 Days)||0||
59909949|NCT03154086|76030648|FG001|STARTED|Part B (Up to 25 Days)||0||
59909950|NCT03154086|76030649|FG002|STARTED|Part B (Up to 25 Days)||0||
59909951|NCT03154086|76030650|FG003|STARTED|Part B (Up to 25 Days)||0||
59909952|NCT03154086|76030651|FG004|STARTED|Part B (Up to 25 Days)||0||
59909953|NCT03154086|76030652|FG005|STARTED|Part B (Up to 25 Days)||0||
59909954|NCT03154086|76030653|FG006|STARTED|Part B (Up to 25 Days)||0||
59909955|NCT03154086|76030654|FG007|STARTED|Part B (Up to 25 Days)||0||
59909956|NCT03154086|76030655|FG008|STARTED|Part B (Up to 25 Days)||0||
59909957|NCT03154086|76030656|FG009|STARTED|Part B (Up to 25 Days)||10||
59909958|NCT03154086|76030657|FG010|STARTED|Part B (Up to 25 Days)||6||
59909959|NCT03154086|76030658|FG011|STARTED|Part B (Up to 25 Days)||6||
59909960|NCT03154086|76030659|FG012|STARTED|Part B (Up to 25 Days)||6||
59909961|NCT03154086|76030660|FG013|STARTED|Part B (Up to 25 Days)||6||
59909962|NCT03154086|76030661|FG014|STARTED|Part B (Up to 25 Days)||6||
59909963|NCT03154086|76030647|FG000|COMPLETED|Part B (Up to 25 Days)||0||
59909964|NCT03154086|76030648|FG001|COMPLETED|Part B (Up to 25 Days)||0||
59909965|NCT03154086|76030649|FG002|COMPLETED|Part B (Up to 25 Days)||0||
59909966|NCT03154086|76030650|FG003|COMPLETED|Part B (Up to 25 Days)||0||
59909967|NCT03154086|76030651|FG004|COMPLETED|Part B (Up to 25 Days)||0||
59909968|NCT03154086|76030652|FG005|COMPLETED|Part B (Up to 25 Days)||0||
59909969|NCT03154086|76030653|FG006|COMPLETED|Part B (Up to 25 Days)||0||
59506690|NCT00754247|75599740|FG000|NOT COMPLETED|Overall Study||5||
59506691|NCT00754247|75599741|FG001|NOT COMPLETED|Overall Study||5||
59909970|NCT03154086|76030654|FG007|COMPLETED|Part B (Up to 25 Days)||0||
59909971|NCT03154086|76030655|FG008|COMPLETED|Part B (Up to 25 Days)||0||
59909972|NCT03154086|76030656|FG009|COMPLETED|Part B (Up to 25 Days)||10||
59506692|NCT00754247|75599742|FG002|NOT COMPLETED|Overall Study||5||
59506693|NCT02305329|75599754|FG000|STARTED|Overall Study||14||
59506694|NCT02305329|75599755|FG001|STARTED|Overall Study||14||
59909973|NCT03154086|76030657|FG010|COMPLETED|Part B (Up to 25 Days)||5||
59909974|NCT03154086|76030658|FG011|COMPLETED|Part B (Up to 25 Days)||6||
59909975|NCT03154086|76030659|FG012|COMPLETED|Part B (Up to 25 Days)||6||
59909976|NCT03154086|76030660|FG013|COMPLETED|Part B (Up to 25 Days)||6||
59909977|NCT03154086|76030661|FG014|COMPLETED|Part B (Up to 25 Days)||6||
59909978|NCT03154086|76030647|FG000|NOT COMPLETED|Part B (Up to 25 Days)||0||
59909979|NCT03154086|76030648|FG001|NOT COMPLETED|Part B (Up to 25 Days)||0||
59909980|NCT03154086|76030649|FG002|NOT COMPLETED|Part B (Up to 25 Days)||0||
59909981|NCT03154086|76030650|FG003|NOT COMPLETED|Part B (Up to 25 Days)||0||
59909982|NCT03154086|76030651|FG004|NOT COMPLETED|Part B (Up to 25 Days)||0||
59909983|NCT03154086|76030652|FG005|NOT COMPLETED|Part B (Up to 25 Days)||0||
59909984|NCT03154086|76030653|FG006|NOT COMPLETED|Part B (Up to 25 Days)||0||
59909985|NCT03154086|76030654|FG007|NOT COMPLETED|Part B (Up to 25 Days)||0||
59909986|NCT03154086|76030655|FG008|NOT COMPLETED|Part B (Up to 25 Days)||0||
59909987|NCT03154086|76030656|FG009|NOT COMPLETED|Part B (Up to 25 Days)||0||
59909988|NCT03154086|76030657|FG010|NOT COMPLETED|Part B (Up to 25 Days)||1||
59909989|NCT03154086|76030658|FG011|NOT COMPLETED|Part B (Up to 25 Days)||0||
59909990|NCT03154086|76030659|FG012|NOT COMPLETED|Part B (Up to 25 Days)||0||
59909991|NCT03154086|76030660|FG013|NOT COMPLETED|Part B (Up to 25 Days)||0||
59909992|NCT03154086|76030661|FG014|NOT COMPLETED|Part B (Up to 25 Days)||0||
59909993|NCT02723344|76030719|FG000|STARTED|Overall Study||15||
59909994|NCT02723344|76030720|FG001|STARTED|Overall Study||16||
59909995|NCT02723344|76030719|FG000|COMPLETED|Overall Study||15||
59909996|NCT02723344|76030720|FG001|COMPLETED|Overall Study||12||
59909997|NCT02723344|76030719|FG000|NOT COMPLETED|Overall Study||0||
59909998|NCT02723344|76030720|FG001|NOT COMPLETED|Overall Study||4||
59909999|NCT02723188|76030729|FG000|STARTED|Overall Study||15||
59910000|NCT02723188|76030730|FG001|STARTED|Overall Study||15||
59910001|NCT02723188|76030731|FG002|STARTED|Overall Study||15||
59910002|NCT02723188|76030729|FG000|COMPLETED|Overall Study||14||
59910003|NCT02723188|76030730|FG001|COMPLETED|Overall Study||15||
59910004|NCT02723188|76030731|FG002|COMPLETED|Overall Study||15||
59910005|NCT02723188|76030729|FG000|NOT COMPLETED|Overall Study||1||
59910006|NCT02723188|76030730|FG001|NOT COMPLETED|Overall Study||0||
59910007|NCT02723188|76030731|FG002|NOT COMPLETED|Overall Study||0||
59910008|NCT00705406|76030741|FG000|STARTED|Overall Study||203||
59910009|NCT00705406|76030742|FG001|STARTED|Overall Study||202||
59910010|NCT00705406|76030741|FG000|COMPLETED|Overall Study||199||
59910011|NCT00705406|76030742|FG001|COMPLETED|Overall Study||197||
59910012|NCT00705406|76030741|FG000|NOT COMPLETED|Overall Study||4||
59910013|NCT00705406|76030742|FG001|NOT COMPLETED|Overall Study||5||
59910014|NCT03155178|76030753|FG000|STARTED|Overall Study||69||69
59910015|NCT03155178|76030754|FG001|STARTED|Overall Study||69||69
59910016|NCT03155178|76030755|FG002|STARTED|Overall Study||69||69
59910017|NCT03155178|76030756|FG003|STARTED|Overall Study||69||69
59910018|NCT03155178|76030753|FG000|COMPLETED|Overall Study||62||62
59910019|NCT03155178|76030754|FG001|COMPLETED|Overall Study||62||62
59910020|NCT03155178|76030755|FG002|COMPLETED|Overall Study||62||62
59910021|NCT03155178|76030756|FG003|COMPLETED|Overall Study||62||62
59910022|NCT03155178|76030753|FG000|NOT COMPLETED|Overall Study||7||7
59910023|NCT03155178|76030754|FG001|NOT COMPLETED|Overall Study||7||7
59910024|NCT03155178|76030755|FG002|NOT COMPLETED|Overall Study||7||7
59910025|NCT03155178|76030756|FG003|NOT COMPLETED|Overall Study||7||7
59910026|NCT03998046|76030772|FG000|STARTED|Overall Study||38||
59910027|NCT03998046|76030773|FG001|STARTED|Overall Study||42||
59910028|NCT03998046|76030772|FG000|COMPLETED|Overall Study||38||
59910029|NCT03998046|76030773|FG001|COMPLETED|Overall Study||42||
59910030|NCT03998046|76030772|FG000|NOT COMPLETED|Overall Study||0||
59910031|NCT03998046|76030773|FG001|NOT COMPLETED|Overall Study||0||
59910032|NCT00705250|76030780|FG000|STARTED|Overall Study||36||
59910033|NCT00705250|76030780|FG000|COMPLETED|Overall Study||34||
59910034|NCT00705250|76030780|FG000|NOT COMPLETED|Overall Study||2||
59910035|NCT05553600|76030786|FG000|STARTED|Prior to First Menstrual Cycle Starting||201||
59910036|NCT05553600|76030787|FG001|STARTED|Prior to First Menstrual Cycle Starting||203||
59910037|NCT05553600|76030788|FG002|STARTED|Prior to First Menstrual Cycle Starting||166||
59910038|NCT05553600|76030789|FG003|STARTED|Prior to First Menstrual Cycle Starting||162||
59910039|NCT05553600|76030786|FG000|COMPLETED|Prior to First Menstrual Cycle Starting||174||
59910040|NCT05553600|76030787|FG001|COMPLETED|Prior to First Menstrual Cycle Starting||173||
59910041|NCT05553600|76030788|FG002|COMPLETED|Prior to First Menstrual Cycle Starting||145||
59910042|NCT05553600|76030789|FG003|COMPLETED|Prior to First Menstrual Cycle Starting||140||
59910043|NCT05553600|76030786|FG000|NOT COMPLETED|Prior to First Menstrual Cycle Starting||27||
59910044|NCT05553600|76030787|FG001|NOT COMPLETED|Prior to First Menstrual Cycle Starting||30||
59910045|NCT05553600|76030788|FG002|NOT COMPLETED|Prior to First Menstrual Cycle Starting||21||
59910046|NCT05553600|76030789|FG003|NOT COMPLETED|Prior to First Menstrual Cycle Starting||22||
59910047|NCT05553600|76030786|FG000|STARTED|Prior to Second Menstrual Cycle Starting||174||
59910048|NCT05553600|76030787|FG001|STARTED|Prior to Second Menstrual Cycle Starting||173||
59910049|NCT05553600|76030788|FG002|STARTED|Prior to Second Menstrual Cycle Starting||145||
59910050|NCT05553600|76030789|FG003|STARTED|Prior to Second Menstrual Cycle Starting||140||
60017725|NCT04640311|76133817|FG009|NOT COMPLETED|Part A:Treatment Period 2 (Up to 2 Days)||0||
59910051|NCT05553600|76030786|FG000|COMPLETED|Prior to Second Menstrual Cycle Starting||156||
59910052|NCT05553600|76030787|FG001|COMPLETED|Prior to Second Menstrual Cycle Starting||151||
59910053|NCT05553600|76030788|FG002|COMPLETED|Prior to Second Menstrual Cycle Starting||132||
59910054|NCT05553600|76030789|FG003|COMPLETED|Prior to Second Menstrual Cycle Starting||121||
59910055|NCT05553600|76030786|FG000|NOT COMPLETED|Prior to Second Menstrual Cycle Starting||18||
59910056|NCT05553600|76030787|FG001|NOT COMPLETED|Prior to Second Menstrual Cycle Starting||22||
59910057|NCT05553600|76030788|FG002|NOT COMPLETED|Prior to Second Menstrual Cycle Starting||13||
59910058|NCT05553600|76030789|FG003|NOT COMPLETED|Prior to Second Menstrual Cycle Starting||19||
59910059|NCT05553600|76030786|FG000|STARTED|After Second Menstrual Cycle Began||156||
59910060|NCT05553600|76030787|FG001|STARTED|After Second Menstrual Cycle Began||151||
59910061|NCT05553600|76030788|FG002|STARTED|After Second Menstrual Cycle Began||132||
59910062|NCT05553600|76030789|FG003|STARTED|After Second Menstrual Cycle Began||121||
59910063|NCT05553600|76030786|FG000|COMPLETED|After Second Menstrual Cycle Began||155||
59910064|NCT05553600|76030787|FG001|COMPLETED|After Second Menstrual Cycle Began||151||
59910065|NCT05553600|76030788|FG002|COMPLETED|After Second Menstrual Cycle Began||132||
59910066|NCT05553600|76030789|FG003|COMPLETED|After Second Menstrual Cycle Began||121||
59910067|NCT05553600|76030786|FG000|NOT COMPLETED|After Second Menstrual Cycle Began||1||
59910068|NCT05553600|76030787|FG001|NOT COMPLETED|After Second Menstrual Cycle Began||0||
59910069|NCT05553600|76030788|FG002|NOT COMPLETED|After Second Menstrual Cycle Began||0||
59910070|NCT05553600|76030789|FG003|NOT COMPLETED|After Second Menstrual Cycle Began||0||
59910071|NCT05451329|76030803|FG000|STARTED|Overall Study||23||
59910072|NCT05451329|76030804|FG001|STARTED|Overall Study||22||
59910073|NCT05451329|76030805|FG002|STARTED|Overall Study||23||
59910074|NCT05451329|76030803|FG000|COMPLETED|Overall Study||20||
59910075|NCT05451329|76030804|FG001|COMPLETED|Overall Study||20||
59910076|NCT05451329|76030805|FG002|COMPLETED|Overall Study||23||
59910077|NCT05451329|76030803|FG000|NOT COMPLETED|Overall Study||3||
59910078|NCT05451329|76030804|FG001|NOT COMPLETED|Overall Study||2||
59910079|NCT05451329|76030805|FG002|NOT COMPLETED|Overall Study||0||
59910080|NCT05254080|76030815|FG000|STARTED|Overall Study||12||
59910081|NCT05254080|76030816|FG001|STARTED|Overall Study||12||
59910082|NCT05254080|76030815|FG000|COMPLETED|Overall Study||10||
59910083|NCT05254080|76030816|FG001|COMPLETED|Overall Study||11||
59910084|NCT05254080|76030815|FG000|NOT COMPLETED|Overall Study||2||
59910085|NCT05254080|76030816|FG001|NOT COMPLETED|Overall Study||1||
59910086|NCT05051982|76030825|FG000|STARTED|Overall Study||55||
59910087|NCT05051982|76030826|FG001|STARTED|Overall Study||55||
59910088|NCT05051982|76030825|FG000|COMPLETED|Overall Study||51||
59910089|NCT05051982|76030826|FG001|COMPLETED|Overall Study||51||
59910090|NCT05051982|76030825|FG000|NOT COMPLETED|Overall Study||4||
59910091|NCT05051982|76030826|FG001|NOT COMPLETED|Overall Study||4||
59910092|NCT05013905|76030833|FG000|STARTED|Overall Study||55||
59910093|NCT05013905|76030833|FG000|COMPLETED|Overall Study|Completed Induction Period|53||
59910094|NCT05013905|76030833|FG000|NOT COMPLETED|Overall Study||2||
59910095|NCT04930562|76030837|FG000|STARTED|Overall Study||30||
59910096|NCT04930562|76030837|FG000|COMPLETED|Overall Study||30||
59910097|NCT04930562|76030837|FG000|NOT COMPLETED|Overall Study||0||
59910098|NCT04887506|76030843|FG000|STARTED|Overall Study||54||
59910099|NCT04887506|76030844|FG001|STARTED|Overall Study||53||
59910100|NCT04887506|76030843|FG000|Modified Intent-to-treat (mITT) Population|Overall Study||54|Modified intent-to-treat (mITT) population included all randomized patients who received at least one dose of study medication|
59910101|NCT04887506|76030844|FG001|Modified Intent-to-treat (mITT) Population|Overall Study||49|Modified intent-to-treat (mITT) population included all randomized patients who received at least one dose of study medication|
59910102|NCT04887506|76030843|FG000|COMPLETED|Overall Study||48||
59910103|NCT04887506|76030844|FG001|COMPLETED|Overall Study||45||
59910104|NCT04887506|76030843|FG000|NOT COMPLETED|Overall Study||6||
59910105|NCT04887506|76030844|FG001|NOT COMPLETED|Overall Study||8||
59910106|NCT04872569|76030854|FG000|STARTED|Overall Study||23||
59910107|NCT04872569|76030854|FG000|COMPLETED|Overall Study||21||
59910108|NCT04872569|76030854|FG000|NOT COMPLETED|Overall Study||2||
59910109|NCT04871776|76030862|FG000|STARTED|Overall Study||1200||
59910110|NCT04871776|76030863|FG001|STARTED|Overall Study||1252||
59910111|NCT04871776|76030864|FG002|STARTED|Overall Study||1219||
59910112|NCT04871776|76030862|FG000|COMPLETED|Overall Study||1199||
59910113|NCT04871776|76030863|FG001|COMPLETED|Overall Study||1249||
59910114|NCT04871776|76030864|FG002|COMPLETED|Overall Study||1217||
59910115|NCT04871776|76030862|FG000|NOT COMPLETED|Overall Study||1||
59910116|NCT04871776|76030863|FG001|NOT COMPLETED|Overall Study||3||
59910117|NCT04871776|76030864|FG002|NOT COMPLETED|Overall Study||2||
59910118|NCT04854642|76030872|FG000|STARTED|Overall Study||18||
59910119|NCT04854642|76030873|FG001|STARTED|Overall Study||18||
59910120|NCT04854642|76030872|FG000|Safety Set|Overall Study||18||
59910121|NCT04854642|76030873|FG001|Safety Set|Overall Study||18||
59910122|NCT04854642|76030872|FG000|PK Set 1|Overall Study||18||
59910123|NCT04854642|76030873|FG001|PK Set 1|Overall Study||18||
59910124|NCT04854642|76030872|FG000|PK Set 2|Overall Study||18||
59910125|NCT04854642|76030873|FG001|PK Set 2|Overall Study||18||
59910126|NCT04854642|76030872|FG000|COMPLETED|Overall Study||17||
59910127|NCT04854642|76030873|FG001|COMPLETED|Overall Study||15||
59910128|NCT04854642|76030872|FG000|NOT COMPLETED|Overall Study||1||
59910129|NCT04854642|76030873|FG001|NOT COMPLETED|Overall Study||3||
59910130|NCT04832971|76030885|FG000|STARTED|Overall Study||51||
59910131|NCT04832971|76030886|FG001|STARTED|Overall Study||51||
59910132|NCT04832971|76030887|FG002|STARTED|Overall Study||51||
59910133|NCT04832971|76030888|FG003|STARTED|Overall Study||51||
59910134|NCT04832971|76030885|FG000|COMPLETED|Overall Study||48|Completed Double-Blind (DB) Treatment Period|
59910135|NCT04832971|76030886|FG001|COMPLETED|Overall Study||47|Completed Double-Blind (DB) Treatment Period|
59910136|NCT04832971|76030887|FG002|COMPLETED|Overall Study||47|Completed Double-Blind (DB) Treatment Period|
59910137|NCT04832971|76030888|FG003|COMPLETED|Overall Study||49|Completed Double-Blind (DB) Treatment Period|
59910138|NCT04832971|76030885|FG000|NOT COMPLETED|Overall Study||3||
59910139|NCT04832971|76030886|FG001|NOT COMPLETED|Overall Study||4||
59910140|NCT04832971|76030887|FG002|NOT COMPLETED|Overall Study||4||
59910141|NCT04832971|76030888|FG003|NOT COMPLETED|Overall Study||2||
59910142|NCT04824521|76030900|FG000|STARTED|Overall Study||1||
59910143|NCT04824521|76030900|FG000|COMPLETED|Overall Study||0||
59910144|NCT04824521|76030900|FG000|NOT COMPLETED|Overall Study||1||
59910145|NCT04718194|76030906|FG000|STARTED|Overall Study||60||
59910146|NCT04718194|76030907|FG001|STARTED|Overall Study||60||
59910147|NCT04718194|76030906|FG000|Completed ≥ 1 Module of the Intervention|Overall Study||58||
59910148|NCT04718194|76030907|FG001|Completed ≥ 1 Module of the Intervention|Overall Study||60||
59910149|NCT04718194|76030906|FG000|Completed 4-month Follow-up|Overall Study||54||
59910150|NCT04718194|76030907|FG001|Completed 4-month Follow-up|Overall Study||60||
59910151|NCT04718194|76030906|FG000|Completed 8-month Follow-up|Overall Study||54||
59910152|NCT04718194|76030907|FG001|Completed 8-month Follow-up|Overall Study||60||
59910153|NCT04718194|76030906|FG000|COMPLETED|Overall Study||54||
59910154|NCT04718194|76030907|FG001|COMPLETED|Overall Study||60||
59910155|NCT04718194|76030906|FG000|NOT COMPLETED|Overall Study||6||
59910156|NCT04718194|76030907|FG001|NOT COMPLETED|Overall Study||0||
59910157|NCT04706091|76030915|FG000|STARTED|Treatment 1||18||
59910158|NCT04706091|76030916|FG001|STARTED|Treatment 1||16||
59910159|NCT04706091|76030915|FG000|COMPLETED|Treatment 1||18||
59910160|NCT04706091|76030916|FG001|COMPLETED|Treatment 1||16||
59910161|NCT04706091|76030915|FG000|NOT COMPLETED|Treatment 1||0||
59910162|NCT04706091|76030916|FG001|NOT COMPLETED|Treatment 1||0||
59910163|NCT04706091|76030915|FG000|STARTED|Treatment 2||17|One participant in the Treatment --> Placebo group withdrew before treatment period 2 due to starting CBT.|
59910164|NCT04706091|76030916|FG001|STARTED|Treatment 2||16|One participant in the Treatment --> Placebo group withdrew before treatment period 2 due to starting CBT.|
59910165|NCT04706091|76030915|FG000|COMPLETED|Treatment 2||16||
59910166|NCT04706091|76030916|FG001|COMPLETED|Treatment 2||16||
59910167|NCT04706091|76030915|FG000|NOT COMPLETED|Treatment 2||1||
59910168|NCT04706091|76030916|FG001|NOT COMPLETED|Treatment 2||0||
59910169|NCT04669691|76030928|FG000|STARTED|Overall Study||69||
59910170|NCT04669691|76030929|FG001|STARTED|Overall Study||72||
59910171|NCT04669691|76030930|FG002|STARTED|Overall Study||70||
59910172|NCT04669691|76030931|FG003|STARTED|Overall Study||70||
59910173|NCT04669691|76030932|FG004|STARTED|Overall Study||69||
59910174|NCT04669691|76030933|FG005|STARTED|Overall Study||70||
59910175|NCT04669691|76030928|FG000|COMPLETED|Overall Study||69||
59910176|NCT04669691|76030929|FG001|COMPLETED|Overall Study||71||
59910177|NCT04669691|76030930|FG002|COMPLETED|Overall Study||70||
59910178|NCT04669691|76030931|FG003|COMPLETED|Overall Study||70||
59910179|NCT04669691|76030932|FG004|COMPLETED|Overall Study||69||
59910180|NCT04669691|76030933|FG005|COMPLETED|Overall Study||70||
59910181|NCT04669691|76030928|FG000|NOT COMPLETED|Overall Study||0||
59910182|NCT04669691|76030929|FG001|NOT COMPLETED|Overall Study||1||
59910183|NCT04669691|76030930|FG002|NOT COMPLETED|Overall Study||0||
59910184|NCT04669691|76030931|FG003|NOT COMPLETED|Overall Study||0||
59910185|NCT04669691|76030932|FG004|NOT COMPLETED|Overall Study||0||
59910186|NCT04669691|76030933|FG005|NOT COMPLETED|Overall Study||0||
59910187|NCT04610580|76030947|FG000|STARTED|Two-way Crossover Period||24||
59910188|NCT04610580|76030948|FG001|STARTED|Two-way Crossover Period||24||
59506695|NCT02305329|75599756|FG002|STARTED|Overall Study||14||
59910189|NCT04610580|76030949|FG002|STARTED|Two-way Crossover Period||0||
59910190|NCT04610580|76030950|FG003|STARTED|Two-way Crossover Period||0||
59910191|NCT04610580|76030951|FG004|STARTED|Two-way Crossover Period||0||
59910192|NCT04610580|76030952|FG005|STARTED|Two-way Crossover Period||0||
59910193|NCT04610580|76030947|FG000|Received at Least 1 Dose of Study Drug|Two-way Crossover Period||24||
59910194|NCT04610580|76030948|FG001|Received at Least 1 Dose of Study Drug|Two-way Crossover Period||24||
59506696|NCT02305329|75599757|FG003|STARTED|Overall Study||14||
59611488|NCT01777542|75722482|FG000|STARTED|Second Intervention (20 Weeks)||15||
59611489|NCT01777542|75722483|FG001|STARTED|Second Intervention (20 Weeks)||15||
59611490|NCT01777542|75722482|FG000|COMPLETED|Second Intervention (20 Weeks)||15||
59611491|NCT01777542|75722483|FG001|COMPLETED|Second Intervention (20 Weeks)||14||
59611492|NCT01777542|75722482|FG000|NOT COMPLETED|Second Intervention (20 Weeks)||0||
59611493|NCT01777542|75722483|FG001|NOT COMPLETED|Second Intervention (20 Weeks)||1||
59611494|NCT01736124|75722492|FG000|STARTED|Baseline||90||
59611495|NCT01736124|75722493|FG001|STARTED|Baseline||90||
59611496|NCT01736124|75722492|FG000|COMPLETED|Baseline||90||
59611497|NCT01736124|75722493|FG001|COMPLETED|Baseline||90||
59611498|NCT01736124|75722492|FG000|NOT COMPLETED|Baseline||0||
59611499|NCT01736124|75722493|FG001|NOT COMPLETED|Baseline||0||
59611500|NCT01736124|75722492|FG000|STARTED|Post-intervention Assessment||90||
59611501|NCT01736124|75722493|FG001|STARTED|Post-intervention Assessment||90||
59611502|NCT01736124|75722492|FG000|COMPLETED|Post-intervention Assessment||59||
59611503|NCT01736124|75722493|FG001|COMPLETED|Post-intervention Assessment||69||
59611504|NCT01736124|75722492|FG000|NOT COMPLETED|Post-intervention Assessment||31||
59611505|NCT01736124|75722493|FG001|NOT COMPLETED|Post-intervention Assessment||21||
59611506|NCT01736124|75722492|FG000|STARTED|6 Mo. Post-Intervention Assessment|"Includes 3 who were temporarily away at Period 2 who did not permanently withdraw from the study."|62||
59611507|NCT01736124|75722493|FG001|STARTED|6 Mo. Post-Intervention Assessment|"Includes 1 who was temporarily away at Period 2 but did not permanently withdraw."|70||
59611508|NCT01736124|75722492|FG000|COMPLETED|6 Mo. Post-Intervention Assessment||57||
59611509|NCT01736124|75722493|FG001|COMPLETED|6 Mo. Post-Intervention Assessment||58||
59611510|NCT01736124|75722492|FG000|NOT COMPLETED|6 Mo. Post-Intervention Assessment||5||
59910195|NCT04610580|76030949|FG002|Received at Least 1 Dose of Study Drug|Two-way Crossover Period||0||
59910196|NCT04610580|76030950|FG003|Received at Least 1 Dose of Study Drug|Two-way Crossover Period||0||
59910197|NCT04610580|76030951|FG004|Received at Least 1 Dose of Study Drug|Two-way Crossover Period||0||
59910198|NCT04610580|76030952|FG005|Received at Least 1 Dose of Study Drug|Two-way Crossover Period||0||
59910199|NCT04610580|76030947|FG000|COMPLETED|Two-way Crossover Period||22||
59910200|NCT04610580|76030948|FG001|COMPLETED|Two-way Crossover Period||22||
59910201|NCT04610580|76030949|FG002|COMPLETED|Two-way Crossover Period||0||
59910202|NCT04610580|76030950|FG003|COMPLETED|Two-way Crossover Period||0||
59910203|NCT04610580|76030951|FG004|COMPLETED|Two-way Crossover Period||0||
59910204|NCT04610580|76030952|FG005|COMPLETED|Two-way Crossover Period||0||
59910205|NCT04610580|76030947|FG000|NOT COMPLETED|Two-way Crossover Period||2||
59910206|NCT04610580|76030948|FG001|NOT COMPLETED|Two-way Crossover Period||2||
59910207|NCT04610580|76030949|FG002|NOT COMPLETED|Two-way Crossover Period||0||
59910208|NCT04610580|76030950|FG003|NOT COMPLETED|Two-way Crossover Period||0||
59910209|NCT04610580|76030951|FG004|NOT COMPLETED|Two-way Crossover Period||0||
59910210|NCT04610580|76030952|FG005|NOT COMPLETED|Two-way Crossover Period||0||
59910211|NCT04610580|76030947|FG000|STARTED|Washout Before Extension Period||22||
59910212|NCT04610580|76030948|FG001|STARTED|Washout Before Extension Period||22||
59910213|NCT04610580|76030949|FG002|STARTED|Washout Before Extension Period||0||
59910214|NCT04610580|76030950|FG003|STARTED|Washout Before Extension Period||0||
59910215|NCT04610580|76030951|FG004|STARTED|Washout Before Extension Period||0||
59910216|NCT04610580|76030952|FG005|STARTED|Washout Before Extension Period||0||
59910217|NCT04610580|76030947|FG000|COMPLETED|Washout Before Extension Period||22||
59910218|NCT04610580|76030948|FG001|COMPLETED|Washout Before Extension Period||19||
59910219|NCT04610580|76030949|FG002|COMPLETED|Washout Before Extension Period||0||
59611511|NCT01736124|75722493|FG001|NOT COMPLETED|6 Mo. Post-Intervention Assessment||12||
59611512|NCT01736124|75722492|FG000|STARTED|12 Mo. Post-Intervention Assessment|"Includes 1 who was temporarily away at Period 3 but did not permanently withdraw."|58||
59611513|NCT01736124|75722493|FG001|STARTED|12 Mo. Post-Intervention Assessment|"Includes 4 who were temporarily away at Period 3 but did not permanently withdraw."|62||
59611514|NCT01736124|75722492|FG000|COMPLETED|12 Mo. Post-Intervention Assessment||46||
59611515|NCT01736124|75722493|FG001|COMPLETED|12 Mo. Post-Intervention Assessment||50||
59611516|NCT01736124|75722492|FG000|NOT COMPLETED|12 Mo. Post-Intervention Assessment||12||
59611517|NCT01736124|75722493|FG001|NOT COMPLETED|12 Mo. Post-Intervention Assessment||12||
59611518|NCT01759446|75722506|FG000|STARTED|Overall Study||9||
59611519|NCT01759446|75722507|FG001|STARTED|Overall Study||9||
59611520|NCT01759446|75722508|FG002|STARTED|Overall Study||9||
59611521|NCT01759446|75722509|FG003|STARTED|Overall Study||9||
59611522|NCT01759446|75722510|FG004|STARTED|Overall Study||8||
59611523|NCT01759446|75722506|FG000|COMPLETED|Overall Study||8||
59611524|NCT01759446|75722507|FG001|COMPLETED|Overall Study||8||
59910220|NCT04610580|76030950|FG003|COMPLETED|Washout Before Extension Period||0||
59910221|NCT04610580|76030951|FG004|COMPLETED|Washout Before Extension Period||0||
59910222|NCT04610580|76030952|FG005|COMPLETED|Washout Before Extension Period||0||
59910223|NCT04610580|76030947|FG000|NOT COMPLETED|Washout Before Extension Period||0||
59910224|NCT04610580|76030948|FG001|NOT COMPLETED|Washout Before Extension Period||3||
59910225|NCT04610580|76030949|FG002|NOT COMPLETED|Washout Before Extension Period||0||
59910226|NCT04610580|76030950|FG003|NOT COMPLETED|Washout Before Extension Period||0||
59910227|NCT04610580|76030951|FG004|NOT COMPLETED|Washout Before Extension Period||0||
59910228|NCT04610580|76030952|FG005|NOT COMPLETED|Washout Before Extension Period||0||
59910229|NCT04610580|76030947|FG000|STARTED|Dose-Proportionality Extension Period||0||
59910230|NCT04610580|76030948|FG001|STARTED|Dose-Proportionality Extension Period||0||
59910231|NCT04610580|76030949|FG002|STARTED|Dose-Proportionality Extension Period||10||
59910232|NCT04610580|76030950|FG003|STARTED|Dose-Proportionality Extension Period||11||
59910233|NCT04610580|76030951|FG004|STARTED|Dose-Proportionality Extension Period||9||
59910234|NCT04610580|76030952|FG005|STARTED|Dose-Proportionality Extension Period||11||
59910235|NCT04610580|76030947|FG000|Received at Least 1 Dose of Study Drug|Dose-Proportionality Extension Period||0||
59910236|NCT04610580|76030948|FG001|Received at Least 1 Dose of Study Drug|Dose-Proportionality Extension Period||0||
59910237|NCT04610580|76030949|FG002|Received at Least 1 Dose of Study Drug|Dose-Proportionality Extension Period||10||
59910238|NCT04610580|76030950|FG003|Received at Least 1 Dose of Study Drug|Dose-Proportionality Extension Period||11||
59910239|NCT04610580|76030951|FG004|Received at Least 1 Dose of Study Drug|Dose-Proportionality Extension Period||9||
59910240|NCT04610580|76030952|FG005|Received at Least 1 Dose of Study Drug|Dose-Proportionality Extension Period||11||
59910241|NCT04610580|76030947|FG000|COMPLETED|Dose-Proportionality Extension Period||0||
59910242|NCT04610580|76030948|FG001|COMPLETED|Dose-Proportionality Extension Period||0||
59910243|NCT04610580|76030949|FG002|COMPLETED|Dose-Proportionality Extension Period||10||
59910244|NCT04610580|76030950|FG003|COMPLETED|Dose-Proportionality Extension Period||11||
59910245|NCT04610580|76030951|FG004|COMPLETED|Dose-Proportionality Extension Period||8||
59910246|NCT04610580|76030952|FG005|COMPLETED|Dose-Proportionality Extension Period||11||
59910247|NCT04610580|76030947|FG000|NOT COMPLETED|Dose-Proportionality Extension Period||0||
59910248|NCT04610580|76030948|FG001|NOT COMPLETED|Dose-Proportionality Extension Period||0||
59910249|NCT04610580|76030949|FG002|NOT COMPLETED|Dose-Proportionality Extension Period||0||
59910250|NCT04610580|76030950|FG003|NOT COMPLETED|Dose-Proportionality Extension Period||0||
59910251|NCT04610580|76030951|FG004|NOT COMPLETED|Dose-Proportionality Extension Period||1||
59910252|NCT04610580|76030952|FG005|NOT COMPLETED|Dose-Proportionality Extension Period||0||
59910253|NCT04564833|76030972|FG000|STARTED|Overall Study||46||
59910254|NCT04564833|76030973|FG001|STARTED|Overall Study||45||
59910255|NCT04564833|76030974|FG002|STARTED|Overall Study||44||
59910256|NCT04564833|76030972|FG000|COMPLETED|Overall Study||46||
59910257|NCT04564833|76030973|FG001|COMPLETED|Overall Study||45||
59910258|NCT04564833|76030974|FG002|COMPLETED|Overall Study||44||
59910259|NCT04564833|76030972|FG000|NOT COMPLETED|Overall Study||0||
59910260|NCT04564833|76030973|FG001|NOT COMPLETED|Overall Study||0||
59910261|NCT04564833|76030974|FG002|NOT COMPLETED|Overall Study||0||
59910262|NCT04469218|76030987|FG000|STARTED|Overall Study||74||
59910263|NCT04469218|76030988|FG001|STARTED|Overall Study||74||
59910264|NCT04469218|76030987|FG000|COMPLETED|Overall Study||69||
59910265|NCT04469218|76030988|FG001|COMPLETED|Overall Study||70||
59910266|NCT04469218|76030987|FG000|NOT COMPLETED|Overall Study||5||
59910267|NCT04469218|76030988|FG001|NOT COMPLETED|Overall Study||4||
59910268|NCT04398316|76030996|FG000|STARTED|Overall Study||3||
59910269|NCT04398316|76030997|FG001|STARTED|Overall Study||1||
59910270|NCT04398316|76030996|FG000|COMPLETED|Overall Study||3||
59910271|NCT04398316|76030997|FG001|COMPLETED|Overall Study||1||
59910272|NCT04398316|76030996|FG000|NOT COMPLETED|Overall Study||0||
59910273|NCT04398316|76030997|FG001|NOT COMPLETED|Overall Study||0||
59910274|NCT04359758|76031005|FG000|STARTED|Overall Study||56||
59910275|NCT04359758|76031006|FG001|STARTED|Overall Study||56||
59611525|NCT01759446|75722508|FG002|COMPLETED|Overall Study||8||
59611526|NCT01759446|75722509|FG003|COMPLETED|Overall Study||8||
59611527|NCT01759446|75722510|FG004|COMPLETED|Overall Study||8||
59611528|NCT01759446|75722506|FG000|NOT COMPLETED|Overall Study||1||
59611529|NCT01759446|75722507|FG001|NOT COMPLETED|Overall Study||1||
59611530|NCT01759446|75722508|FG002|NOT COMPLETED|Overall Study||1||
59758596|NCT00795340|75877924|FG001|NOT COMPLETED|Overall Study||0||
59758597|NCT00668642|75877932|FG000|STARTED|First Off-cycle||7||
59758598|NCT00668642|75877933|FG001|STARTED|First Off-cycle||6||
59758599|NCT00668642|75877932|FG000|Research Biopsy|First Off-cycle||4|A research biopsy of the prostate was planned at end of off-cycle 1 to determine expression of U19 tumor suppressor gene|
59758600|NCT00668642|75877933|FG001|Research Biopsy|First Off-cycle||3|A research biopsy of the prostate was planned at end of off-cycle 1 to determine expression of U19 tumor suppressor gene|
59758601|NCT00668642|75877932|FG000|COMPLETED|First Off-cycle||6||
59758602|NCT00668642|75877933|FG001|COMPLETED|First Off-cycle||6||
59758603|NCT00668642|75877932|FG000|NOT COMPLETED|First Off-cycle||1||
59611531|NCT01759446|75722509|FG003|NOT COMPLETED|Overall Study||1||
59611532|NCT01759446|75722510|FG004|NOT COMPLETED|Overall Study||0||
59611533|NCT01777308|75722524|FG000|STARTED|Overall Study||119||
60017726|NCT04640311|76133818|FG010|NOT COMPLETED|Part A:Treatment Period 2 (Up to 2 Days)||0||
60017727|NCT04640311|76133819|FG011|NOT COMPLETED|Part A:Treatment Period 2 (Up to 2 Days)||0||
60017728|NCT04640311|76133820|FG012|NOT COMPLETED|Part A:Treatment Period 2 (Up to 2 Days)||0||
60017729|NCT04640311|76133808|FG000|STARTED|Part A: Washout 2 (Up to 7 Days)||12||
60017730|NCT04640311|76133809|FG001|STARTED|Part A: Washout 2 (Up to 7 Days)||11||
60017731|NCT04640311|76133810|FG002|STARTED|Part A: Washout 2 (Up to 7 Days)||10||
60017732|NCT04640311|76133811|FG003|STARTED|Part A: Washout 2 (Up to 7 Days)||0||
60017733|NCT04640311|76133812|FG004|STARTED|Part A: Washout 2 (Up to 7 Days)||0||
60017734|NCT04640311|76133813|FG005|STARTED|Part A: Washout 2 (Up to 7 Days)||0||
60017735|NCT04640311|76133814|FG006|STARTED|Part A: Washout 2 (Up to 7 Days)||0||
60017736|NCT04640311|76133815|FG007|STARTED|Part A: Washout 2 (Up to 7 Days)||0||
60017737|NCT04640311|76133816|FG008|STARTED|Part A: Washout 2 (Up to 7 Days)||0||
60017738|NCT04640311|76133817|FG009|STARTED|Part A: Washout 2 (Up to 7 Days)||0||
60017739|NCT04640311|76133818|FG010|STARTED|Part A: Washout 2 (Up to 7 Days)||0||
60017740|NCT04640311|76133819|FG011|STARTED|Part A: Washout 2 (Up to 7 Days)||0||
60017741|NCT04640311|76133820|FG012|STARTED|Part A: Washout 2 (Up to 7 Days)||0||
60017742|NCT04640311|76133808|FG000|COMPLETED|Part A: Washout 2 (Up to 7 Days)||12||
60017743|NCT04640311|76133809|FG001|COMPLETED|Part A: Washout 2 (Up to 7 Days)||11||
60017744|NCT04640311|76133810|FG002|COMPLETED|Part A: Washout 2 (Up to 7 Days)||10||
60017745|NCT04640311|76133811|FG003|COMPLETED|Part A: Washout 2 (Up to 7 Days)||0||
60017746|NCT04640311|76133812|FG004|COMPLETED|Part A: Washout 2 (Up to 7 Days)||0||
60017747|NCT04640311|76133813|FG005|COMPLETED|Part A: Washout 2 (Up to 7 Days)||0||
60017748|NCT04640311|76133814|FG006|COMPLETED|Part A: Washout 2 (Up to 7 Days)||0||
60017749|NCT04640311|76133815|FG007|COMPLETED|Part A: Washout 2 (Up to 7 Days)||0||
60017750|NCT04640311|76133816|FG008|COMPLETED|Part A: Washout 2 (Up to 7 Days)||0||
60017751|NCT04640311|76133817|FG009|COMPLETED|Part A: Washout 2 (Up to 7 Days)||0||
60017752|NCT04640311|76133818|FG010|COMPLETED|Part A: Washout 2 (Up to 7 Days)||0||
60017753|NCT04640311|76133819|FG011|COMPLETED|Part A: Washout 2 (Up to 7 Days)||0||
60017754|NCT04640311|76133820|FG012|COMPLETED|Part A: Washout 2 (Up to 7 Days)||0||
60017755|NCT04640311|76133808|FG000|NOT COMPLETED|Part A: Washout 2 (Up to 7 Days)||0||
60017756|NCT04640311|76133809|FG001|NOT COMPLETED|Part A: Washout 2 (Up to 7 Days)||0||
60017757|NCT04640311|76133810|FG002|NOT COMPLETED|Part A: Washout 2 (Up to 7 Days)||0||
60017758|NCT04640311|76133811|FG003|NOT COMPLETED|Part A: Washout 2 (Up to 7 Days)||0||
60017759|NCT04640311|76133812|FG004|NOT COMPLETED|Part A: Washout 2 (Up to 7 Days)||0||
60017760|NCT04640311|76133813|FG005|NOT COMPLETED|Part A: Washout 2 (Up to 7 Days)||0||
60017761|NCT04640311|76133814|FG006|NOT COMPLETED|Part A: Washout 2 (Up to 7 Days)||0||
60017762|NCT04640311|76133815|FG007|NOT COMPLETED|Part A: Washout 2 (Up to 7 Days)||0||
60017763|NCT04640311|76133816|FG008|NOT COMPLETED|Part A: Washout 2 (Up to 7 Days)||0||
60017764|NCT04640311|76133817|FG009|NOT COMPLETED|Part A: Washout 2 (Up to 7 Days)||0||
60017765|NCT04640311|76133818|FG010|NOT COMPLETED|Part A: Washout 2 (Up to 7 Days)||0||
60017766|NCT04640311|76133819|FG011|NOT COMPLETED|Part A: Washout 2 (Up to 7 Days)||0||
60017767|NCT04640311|76133820|FG012|NOT COMPLETED|Part A: Washout 2 (Up to 7 Days)||0||
60017768|NCT04640311|76133808|FG000|STARTED|Part A:Treatment Period 3 (Up to 2 Days)||12||
60017769|NCT04640311|76133809|FG001|STARTED|Part A:Treatment Period 3 (Up to 2 Days)||11||
60017770|NCT04640311|76133810|FG002|STARTED|Part A:Treatment Period 3 (Up to 2 Days)||10||
60017771|NCT04640311|76133811|FG003|STARTED|Part A:Treatment Period 3 (Up to 2 Days)||0||
60017772|NCT04640311|76133812|FG004|STARTED|Part A:Treatment Period 3 (Up to 2 Days)||0||
60017773|NCT04640311|76133813|FG005|STARTED|Part A:Treatment Period 3 (Up to 2 Days)||0||
60017774|NCT04640311|76133814|FG006|STARTED|Part A:Treatment Period 3 (Up to 2 Days)||0||
60017775|NCT04640311|76133815|FG007|STARTED|Part A:Treatment Period 3 (Up to 2 Days)||0||
59506697|NCT02305329|75599754|FG000|Period 1|Overall Study||14||
59506698|NCT02305329|75599755|FG001|Period 1|Overall Study||14||
59506699|NCT02305329|75599756|FG002|Period 1|Overall Study||14||
59506700|NCT02305329|75599757|FG003|Period 1|Overall Study||14||
59506701|NCT02305329|75599754|FG000|Period 2|Overall Study||14||
59506702|NCT02305329|75599755|FG001|Period 2|Overall Study||13||
59506703|NCT02305329|75599756|FG002|Period 2|Overall Study||14||
59506704|NCT02305329|75599757|FG003|Period 2|Overall Study||14||
59611534|NCT01777308|75722525|FG001|STARTED|Overall Study||37||
60017776|NCT04640311|76133816|FG008|STARTED|Part A:Treatment Period 3 (Up to 2 Days)||0||
60017777|NCT04640311|76133817|FG009|STARTED|Part A:Treatment Period 3 (Up to 2 Days)||0||
60017778|NCT04640311|76133818|FG010|STARTED|Part A:Treatment Period 3 (Up to 2 Days)||0||
60017779|NCT04640311|76133819|FG011|STARTED|Part A:Treatment Period 3 (Up to 2 Days)||0||
60017780|NCT04640311|76133820|FG012|STARTED|Part A:Treatment Period 3 (Up to 2 Days)||0||
60017781|NCT04640311|76133808|FG000|COMPLETED|Part A:Treatment Period 3 (Up to 2 Days)||12||
60017782|NCT04640311|76133809|FG001|COMPLETED|Part A:Treatment Period 3 (Up to 2 Days)||11||
60017783|NCT04640311|76133810|FG002|COMPLETED|Part A:Treatment Period 3 (Up to 2 Days)||10||
60017784|NCT04640311|76133811|FG003|COMPLETED|Part A:Treatment Period 3 (Up to 2 Days)||0||
60017785|NCT04640311|76133812|FG004|COMPLETED|Part A:Treatment Period 3 (Up to 2 Days)||0||
60017786|NCT04640311|76133813|FG005|COMPLETED|Part A:Treatment Period 3 (Up to 2 Days)||0||
60017787|NCT04640311|76133814|FG006|COMPLETED|Part A:Treatment Period 3 (Up to 2 Days)||0||
60017788|NCT04640311|76133815|FG007|COMPLETED|Part A:Treatment Period 3 (Up to 2 Days)||0||
60017789|NCT04640311|76133816|FG008|COMPLETED|Part A:Treatment Period 3 (Up to 2 Days)||0||
60017790|NCT04640311|76133817|FG009|COMPLETED|Part A:Treatment Period 3 (Up to 2 Days)||0||
60017791|NCT04640311|76133818|FG010|COMPLETED|Part A:Treatment Period 3 (Up to 2 Days)||0||
60017792|NCT04640311|76133819|FG011|COMPLETED|Part A:Treatment Period 3 (Up to 2 Days)||0||
60017793|NCT04640311|76133820|FG012|COMPLETED|Part A:Treatment Period 3 (Up to 2 Days)||0||
60017794|NCT04640311|76133808|FG000|NOT COMPLETED|Part A:Treatment Period 3 (Up to 2 Days)||0||
60017795|NCT04640311|76133809|FG001|NOT COMPLETED|Part A:Treatment Period 3 (Up to 2 Days)||0||
60017796|NCT04640311|76133810|FG002|NOT COMPLETED|Part A:Treatment Period 3 (Up to 2 Days)||0||
60017797|NCT04640311|76133811|FG003|NOT COMPLETED|Part A:Treatment Period 3 (Up to 2 Days)||0||
60017798|NCT04640311|76133812|FG004|NOT COMPLETED|Part A:Treatment Period 3 (Up to 2 Days)||0||
60017799|NCT04640311|76133813|FG005|NOT COMPLETED|Part A:Treatment Period 3 (Up to 2 Days)||0||
60017800|NCT04640311|76133814|FG006|NOT COMPLETED|Part A:Treatment Period 3 (Up to 2 Days)||0||
60017801|NCT04640311|76133815|FG007|NOT COMPLETED|Part A:Treatment Period 3 (Up to 2 Days)||0||
60017802|NCT04640311|76133816|FG008|NOT COMPLETED|Part A:Treatment Period 3 (Up to 2 Days)||0||
60017803|NCT04640311|76133817|FG009|NOT COMPLETED|Part A:Treatment Period 3 (Up to 2 Days)||0||
60017804|NCT04640311|76133818|FG010|NOT COMPLETED|Part A:Treatment Period 3 (Up to 2 Days)||0||
60017805|NCT04640311|76133819|FG011|NOT COMPLETED|Part A:Treatment Period 3 (Up to 2 Days)||0||
60017806|NCT04640311|76133820|FG012|NOT COMPLETED|Part A:Treatment Period 3 (Up to 2 Days)||0||
60017807|NCT04640311|76133808|FG000|STARTED|Part B:Treatment Period 1 (Up to 2 Days)||0||
59506705|NCT02305329|75599754|FG000|COMPLETED|Overall Study||14||
59506706|NCT02305329|75599755|FG001|COMPLETED|Overall Study||13||
59506707|NCT02305329|75599756|FG002|COMPLETED|Overall Study||14||
59506708|NCT02305329|75599757|FG003|COMPLETED|Overall Study||14||
59506709|NCT02305329|75599754|FG000|NOT COMPLETED|Overall Study||0||
59506710|NCT02305329|75599755|FG001|NOT COMPLETED|Overall Study||1||
59506711|NCT02305329|75599756|FG002|NOT COMPLETED|Overall Study||0||
59506712|NCT02305329|75599757|FG003|NOT COMPLETED|Overall Study||0||
59506713|NCT01979445|75599769|FG000|STARTED|Overall Study||3||
59506714|NCT01979445|75599770|FG001|STARTED|Overall Study||3||
59506715|NCT01979445|75599771|FG002|STARTED|Overall Study||6||
60017808|NCT04640311|76133809|FG001|STARTED|Part B:Treatment Period 1 (Up to 2 Days)||0||
60017809|NCT04640311|76133810|FG002|STARTED|Part B:Treatment Period 1 (Up to 2 Days)||0||
60017810|NCT04640311|76133811|FG003|STARTED|Part B:Treatment Period 1 (Up to 2 Days)||21||
60017811|NCT04640311|76133812|FG004|STARTED|Part B:Treatment Period 1 (Up to 2 Days)||19||
60017812|NCT04640311|76133813|FG005|STARTED|Part B:Treatment Period 1 (Up to 2 Days)||21||
60017813|NCT04640311|76133814|FG006|STARTED|Part B:Treatment Period 1 (Up to 2 Days)||22||
60017814|NCT04640311|76133815|FG007|STARTED|Part B:Treatment Period 1 (Up to 2 Days)||21||
60017815|NCT04640311|76133816|FG008|STARTED|Part B:Treatment Period 1 (Up to 2 Days)||21||
60017816|NCT04640311|76133817|FG009|STARTED|Part B:Treatment Period 1 (Up to 2 Days)||21||
60017817|NCT04640311|76133818|FG010|STARTED|Part B:Treatment Period 1 (Up to 2 Days)||21||
60017818|NCT04640311|76133819|FG011|STARTED|Part B:Treatment Period 1 (Up to 2 Days)||20||
60017819|NCT04640311|76133820|FG012|STARTED|Part B:Treatment Period 1 (Up to 2 Days)||20||
60017820|NCT04640311|76133808|FG000|COMPLETED|Part B:Treatment Period 1 (Up to 2 Days)||0||
60017821|NCT04640311|76133809|FG001|COMPLETED|Part B:Treatment Period 1 (Up to 2 Days)||0||
60017822|NCT04640311|76133810|FG002|COMPLETED|Part B:Treatment Period 1 (Up to 2 Days)||0||
60017823|NCT04640311|76133811|FG003|COMPLETED|Part B:Treatment Period 1 (Up to 2 Days)||20||
60017824|NCT04640311|76133812|FG004|COMPLETED|Part B:Treatment Period 1 (Up to 2 Days)||19||
60017825|NCT04640311|76133813|FG005|COMPLETED|Part B:Treatment Period 1 (Up to 2 Days)||20||
59758604|NCT00668642|75877933|FG001|NOT COMPLETED|First Off-cycle||0||
59758605|NCT00668642|75877932|FG000|STARTED|Second AAT Treatment (On-cycle 2)||6||
59910276|NCT04359758|76031005|FG000|COMPLETED|Overall Study||53||
59910277|NCT04359758|76031006|FG001|COMPLETED|Overall Study||54||
59910278|NCT04359758|76031005|FG000|NOT COMPLETED|Overall Study||3||
59910279|NCT04359758|76031006|FG001|NOT COMPLETED|Overall Study||2||
59910280|NCT04347291|76031014|FG000|STARTED|Overall Study||314|Patient participants were randomized with their support person (if enrolled), but support person participation was not required. There were 294 patient/support person dyads (329 patient participants, 294 support persons; 35 patients participated without a support person).|
59910281|NCT04347291|76031015|FG001|STARTED|Overall Study||309|Patient participants were randomized with their support person (if enrolled), but support person participation was not required. There were 294 patient/support person dyads (329 patient participants, 294 support persons; 35 patients participated without a support person).|
59910282|NCT04347291|76031014|FG000|Patient Participants|Overall Study||164||
59910283|NCT04347291|76031015|FG001|Patient Participants|Overall Study||165||
59910284|NCT04347291|76031014|FG000|Support Persons|Overall Study||150||
59910285|NCT04347291|76031015|FG001|Support Persons|Overall Study||144||
59910286|NCT04347291|76031014|FG000|COMPLETED|Overall Study||304||
60017826|NCT04640311|76133814|FG006|COMPLETED|Part B:Treatment Period 1 (Up to 2 Days)||20||
60017827|NCT04640311|76133815|FG007|COMPLETED|Part B:Treatment Period 1 (Up to 2 Days)||21||
60017828|NCT04640311|76133816|FG008|COMPLETED|Part B:Treatment Period 1 (Up to 2 Days)||19||
60017829|NCT04640311|76133817|FG009|COMPLETED|Part B:Treatment Period 1 (Up to 2 Days)||21||
60017830|NCT04640311|76133818|FG010|COMPLETED|Part B:Treatment Period 1 (Up to 2 Days)||20||
60017831|NCT04640311|76133819|FG011|COMPLETED|Part B:Treatment Period 1 (Up to 2 Days)||20||
60017832|NCT04640311|76133820|FG012|COMPLETED|Part B:Treatment Period 1 (Up to 2 Days)||20||
60017833|NCT04640311|76133808|FG000|NOT COMPLETED|Part B:Treatment Period 1 (Up to 2 Days)||0||
60017834|NCT04640311|76133809|FG001|NOT COMPLETED|Part B:Treatment Period 1 (Up to 2 Days)||0||
60017835|NCT04640311|76133810|FG002|NOT COMPLETED|Part B:Treatment Period 1 (Up to 2 Days)||0||
60017836|NCT04640311|76133811|FG003|NOT COMPLETED|Part B:Treatment Period 1 (Up to 2 Days)||1||
60017837|NCT04640311|76133812|FG004|NOT COMPLETED|Part B:Treatment Period 1 (Up to 2 Days)||0||
60017838|NCT04640311|76133813|FG005|NOT COMPLETED|Part B:Treatment Period 1 (Up to 2 Days)||1||
60017839|NCT04640311|76133814|FG006|NOT COMPLETED|Part B:Treatment Period 1 (Up to 2 Days)||2||
60017840|NCT04640311|76133815|FG007|NOT COMPLETED|Part B:Treatment Period 1 (Up to 2 Days)||0||
60017841|NCT04640311|76133816|FG008|NOT COMPLETED|Part B:Treatment Period 1 (Up to 2 Days)||2||
60017842|NCT04640311|76133817|FG009|NOT COMPLETED|Part B:Treatment Period 1 (Up to 2 Days)||0||
60017843|NCT04640311|76133818|FG010|NOT COMPLETED|Part B:Treatment Period 1 (Up to 2 Days)||1||
60017844|NCT04640311|76133819|FG011|NOT COMPLETED|Part B:Treatment Period 1 (Up to 2 Days)||0||
60017845|NCT04640311|76133820|FG012|NOT COMPLETED|Part B:Treatment Period 1 (Up to 2 Days)||0||
60017846|NCT04640311|76133808|FG000|STARTED|Part B: Washout 1 (Up to 7 Days)||0||
60017847|NCT04640311|76133809|FG001|STARTED|Part B: Washout 1 (Up to 7 Days)||0||
60017848|NCT04640311|76133810|FG002|STARTED|Part B: Washout 1 (Up to 7 Days)||0||
60017849|NCT04640311|76133811|FG003|STARTED|Part B: Washout 1 (Up to 7 Days)||20||
60017850|NCT04640311|76133812|FG004|STARTED|Part B: Washout 1 (Up to 7 Days)||19||
60017851|NCT04640311|76133813|FG005|STARTED|Part B: Washout 1 (Up to 7 Days)||20||
60017852|NCT04640311|76133814|FG006|STARTED|Part B: Washout 1 (Up to 7 Days)||20||
60017853|NCT04640311|76133815|FG007|STARTED|Part B: Washout 1 (Up to 7 Days)||21||
60017854|NCT04640311|76133816|FG008|STARTED|Part B: Washout 1 (Up to 7 Days)||19||
60017855|NCT04640311|76133817|FG009|STARTED|Part B: Washout 1 (Up to 7 Days)||21||
60017856|NCT04640311|76133818|FG010|STARTED|Part B: Washout 1 (Up to 7 Days)||20||
60017857|NCT04640311|76133819|FG011|STARTED|Part B: Washout 1 (Up to 7 Days)||20||
60017858|NCT04640311|76133820|FG012|STARTED|Part B: Washout 1 (Up to 7 Days)||20||
60017859|NCT04640311|76133808|FG000|COMPLETED|Part B: Washout 1 (Up to 7 Days)||0||
60017860|NCT04640311|76133809|FG001|COMPLETED|Part B: Washout 1 (Up to 7 Days)||0||
59506716|NCT01979445|75599772|FG003|STARTED|Overall Study||3||
59506717|NCT01979445|75599769|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3|Safety Population included all participants who received at least 1 dose of study drug.|
59506718|NCT01979445|75599770|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3|Safety Population included all participants who received at least 1 dose of study drug.|
59506719|NCT01979445|75599771|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6|Safety Population included all participants who received at least 1 dose of study drug.|
59506720|NCT01979445|75599772|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3|Safety Population included all participants who received at least 1 dose of study drug.|
59506721|NCT01979445|75599769|FG000|ITT Population|Overall Study||3|Intent to treat (ITT) Population included all enrolled participants in the study.|
59506722|NCT01979445|75599770|FG001|ITT Population|Overall Study||3|Intent to treat (ITT) Population included all enrolled participants in the study.|
59506723|NCT01979445|75599771|FG002|ITT Population|Overall Study||6|Intent to treat (ITT) Population included all enrolled participants in the study.|
59506724|NCT01979445|75599772|FG003|ITT Population|Overall Study||3|Intent to treat (ITT) Population included all enrolled participants in the study.|
59506725|NCT01979445|75599769|FG000|COMPLETED|Overall Study||3||
59506726|NCT01979445|75599770|FG001|COMPLETED|Overall Study||3||
59506727|NCT01979445|75599771|FG002|COMPLETED|Overall Study||6||
59506728|NCT01979445|75599772|FG003|COMPLETED|Overall Study||3||
59506729|NCT01979445|75599769|FG000|NOT COMPLETED|Overall Study||0||
59506730|NCT01979445|75599770|FG001|NOT COMPLETED|Overall Study||0||
59506731|NCT01979445|75599771|FG002|NOT COMPLETED|Overall Study||0||
59506732|NCT01979445|75599772|FG003|NOT COMPLETED|Overall Study||0||
59506733|NCT03802565|75599795|FG000|STARTED|Overall Study||82||
59506734|NCT03802565|75599796|FG001|STARTED|Overall Study||87||
59506735|NCT03802565|75599797|FG002|STARTED|Overall Study||83||
59506736|NCT03802565|75599798|FG003|STARTED|Overall Study||85||
59506737|NCT03802565|75599799|FG004|STARTED|Overall Study||78||
59506738|NCT03802565|75599795|FG000|COMPLETED|Overall Study||77||
59506739|NCT03802565|75599796|FG001|COMPLETED|Overall Study||83||
59506740|NCT03802565|75599797|FG002|COMPLETED|Overall Study||74||
59506741|NCT03802565|75599798|FG003|COMPLETED|Overall Study||77||
59506742|NCT03802565|75599799|FG004|COMPLETED|Overall Study||72||
59506743|NCT03802565|75599795|FG000|NOT COMPLETED|Overall Study||5||
59506744|NCT03802565|75599796|FG001|NOT COMPLETED|Overall Study||4||
59506745|NCT03802565|75599797|FG002|NOT COMPLETED|Overall Study||9||
59506746|NCT03802565|75599798|FG003|NOT COMPLETED|Overall Study||8||
59506747|NCT03802565|75599799|FG004|NOT COMPLETED|Overall Study||6||
59506748|NCT02308371|75599813|FG000|STARTED|Overall Study|Started enrollment and recruitment 11/26/2014|50||
59506749|NCT02308371|75599814|FG001|STARTED|Overall Study|Consider eligible for retrospective enrollment if admitted after 4/1/2012|50||
59910287|NCT04347291|76031015|FG001|COMPLETED|Overall Study||297||
59910288|NCT04347291|76031014|FG000|NOT COMPLETED|Overall Study||10||
59910289|NCT04347291|76031015|FG001|NOT COMPLETED|Overall Study||12||
59910290|NCT04186871|76031029|FG000|STARTED|Overall Study||5||
59910291|NCT04186871|76031030|FG001|STARTED|Overall Study||15||
59910292|NCT04186871|76031031|FG002|STARTED|Overall Study||4||
59910293|NCT04186871|76031032|FG003|STARTED|Overall Study||10||
59910294|NCT04186871|76031033|FG004|STARTED|Overall Study||21||
59910295|NCT04186871|76031034|FG005|STARTED|Overall Study||64||
59910296|NCT04186871|76031029|FG000|Double Blind Period|Overall Study||5||
59910297|NCT04186871|76031030|FG001|Double Blind Period|Overall Study||15||
59910298|NCT04186871|76031031|FG002|Double Blind Period|Overall Study||4||
59910299|NCT04186871|76031032|FG003|Double Blind Period|Overall Study||10||
59910300|NCT04186871|76031033|FG004|Double Blind Period|Overall Study||21||
59910301|NCT04186871|76031034|FG005|Double Blind Period|Overall Study||64||
59910302|NCT04186871|76031029|FG000|Open Label Period|Overall Study||0|The Open Label Period was available to RA sub-study participants only.|
59910303|NCT04186871|76031030|FG001|Open Label Period|Overall Study||0|The Open Label Period was available to RA sub-study participants only.|
59910304|NCT04186871|76031031|FG002|Open Label Period|Overall Study||0|The Open Label Period was available to RA sub-study participants only.|
59910305|NCT04186871|76031032|FG003|Open Label Period|Overall Study||0|The Open Label Period was available to RA sub-study participants only.|
59910306|NCT04186871|76031033|FG004|Open Label Period|Overall Study||20|The Open Label Period was available to RA sub-study participants only.|
59910307|NCT04186871|76031034|FG005|Open Label Period|Overall Study||61|The Open Label Period was available to RA sub-study participants only.|
59910308|NCT04186871|76031029|FG000|COMPLETED|Overall Study||3||
59910309|NCT04186871|76031030|FG001|COMPLETED|Overall Study||11||
59910310|NCT04186871|76031031|FG002|COMPLETED|Overall Study||4||
59910311|NCT04186871|76031032|FG003|COMPLETED|Overall Study||9||
59910312|NCT04186871|76031033|FG004|COMPLETED|Overall Study||20||
59910313|NCT04186871|76031034|FG005|COMPLETED|Overall Study||58||
59910314|NCT04186871|76031029|FG000|NOT COMPLETED|Overall Study||2||
59910315|NCT04186871|76031030|FG001|NOT COMPLETED|Overall Study||4||
59910316|NCT04186871|76031031|FG002|NOT COMPLETED|Overall Study||0||
59910317|NCT04186871|76031032|FG003|NOT COMPLETED|Overall Study||1||
59910318|NCT04186871|76031033|FG004|NOT COMPLETED|Overall Study||1||
59910319|NCT04186871|76031034|FG005|NOT COMPLETED|Overall Study||6||
59910320|NCT04058366|76031049|FG000|STARTED|Overall Study||251||
59910321|NCT04058366|76031049|FG000|COMPLETED|Overall Study||215||
59519008|NCT03587428|75612875|FG005|COMPLETED|Period 2||2||
59910322|NCT04058366|76031049|FG000|NOT COMPLETED|Overall Study||36||
59506750|NCT02308371|75599813|FG000|COMPLETED|Overall Study|Ended enrollment and recruitment 3/1/2016|50||
59506751|NCT02308371|75599814|FG001|COMPLETED|Overall Study|Consider eligible for retrospective enrollment if admitted up until 10/15/2012|50||
59506752|NCT02308371|75599813|FG000|NOT COMPLETED|Overall Study||0||
59506753|NCT02308371|75599814|FG001|NOT COMPLETED|Overall Study||0||
59506754|NCT01980771|75599824|FG000|STARTED|Overall Study||436||
59506755|NCT01980771|75599825|FG001|STARTED|Overall Study||424||
59506756|NCT01980771|75599824|FG000|COMPLETED|Overall Study||352||
59506757|NCT01980771|75599825|FG001|COMPLETED|Overall Study||305||
59506758|NCT01980771|75599824|FG000|NOT COMPLETED|Overall Study||84||
59506759|NCT01980771|75599825|FG001|NOT COMPLETED|Overall Study||119||
59506760|NCT01981863|75599833|FG000|STARTED|Overall Study||20||
59910323|NCT03992131|76031061|FG000|STARTED|Overall Study||6||
59910324|NCT03992131|76031062|FG001|STARTED|Overall Study||4||
59910325|NCT03992131|76031063|FG002|STARTED|Overall Study||3||
59910326|NCT03992131|76031064|FG003|STARTED|Overall Study||6||
59910327|NCT03992131|76031065|FG004|STARTED|Overall Study||3||
59910328|NCT03992131|76031066|FG005|STARTED|Overall Study||3||
59910329|NCT03992131|76031061|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6||
59910330|NCT03992131|76031062|FG001|Received at Least 1 Dose of Study Drug|Overall Study||4||
59910331|NCT03992131|76031063|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3||
59910332|NCT03992131|76031064|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6||
59910333|NCT03992131|76031065|FG004|Received at Least 1 Dose of Study Drug|Overall Study||3||
59910334|NCT03992131|76031066|FG005|Received at Least 1 Dose of Study Drug|Overall Study||3||
59910335|NCT03992131|76031061|FG000|COMPLETED|Overall Study||6||
59910336|NCT03992131|76031062|FG001|COMPLETED|Overall Study||4||
59910337|NCT03992131|76031063|FG002|COMPLETED|Overall Study||3||
59910338|NCT03992131|76031064|FG003|COMPLETED|Overall Study||6||
59910339|NCT03992131|76031065|FG004|COMPLETED|Overall Study||3||
59910340|NCT03992131|76031066|FG005|COMPLETED|Overall Study||3||
59910341|NCT03992131|76031061|FG000|NOT COMPLETED|Overall Study||0||
59910342|NCT03992131|76031062|FG001|NOT COMPLETED|Overall Study||0||
59910343|NCT03992131|76031063|FG002|NOT COMPLETED|Overall Study||0||
59910344|NCT03992131|76031064|FG003|NOT COMPLETED|Overall Study||0||
59910345|NCT03992131|76031065|FG004|NOT COMPLETED|Overall Study||0||
59910346|NCT03992131|76031066|FG005|NOT COMPLETED|Overall Study||0||
59910347|NCT03857256|76031084|FG000|STARTED|Overall Study||65||
59910348|NCT03857256|76031085|FG001|STARTED|Overall Study||66||
59910349|NCT03857256|76031086|FG002|STARTED|Overall Study||66||
59910350|NCT03857256|76031087|FG003|STARTED|Overall Study||66||
59910351|NCT03857256|76031084|FG000|COMPLETED|Overall Study||64||
59910352|NCT03857256|76031085|FG001|COMPLETED|Overall Study||63||
59910353|NCT03857256|76031086|FG002|COMPLETED|Overall Study||65||
59910354|NCT03857256|76031087|FG003|COMPLETED|Overall Study||63||
59910355|NCT03857256|76031084|FG000|NOT COMPLETED|Overall Study||1||
59910356|NCT03857256|76031085|FG001|NOT COMPLETED|Overall Study||3||
59910357|NCT03857256|76031086|FG002|NOT COMPLETED|Overall Study||1||
59910358|NCT03857256|76031087|FG003|NOT COMPLETED|Overall Study||3||
59910359|NCT03850691|76031099|FG000|STARTED|Overall Study||1||
59910360|NCT03850691|76031100|FG001|STARTED|Overall Study||3||
59910361|NCT03850691|76031099|FG000|COMPLETED|Overall Study||1||
59910362|NCT03850691|76031100|FG001|COMPLETED|Overall Study||3||
59910363|NCT03850691|76031099|FG000|NOT COMPLETED|Overall Study||0||
59910364|NCT03850691|76031100|FG001|NOT COMPLETED|Overall Study||0||
59910365|NCT03840902|76031108|FG000|STARTED|Overall Study||75||
59910366|NCT03840902|76031109|FG001|STARTED|Overall Study||78||
59910367|NCT03840902|76031108|FG000|Treated|Overall Study||74||
59910368|NCT03840902|76031109|FG001|Treated|Overall Study||77||
59910369|NCT03840902|76031108|FG000|COMPLETED|Overall Study||74||
59910370|NCT03840902|76031109|FG001|COMPLETED|Overall Study||77||
59910371|NCT03840902|76031108|FG000|NOT COMPLETED|Overall Study||1||
59506761|NCT01981863|75599834|FG001|STARTED|Overall Study||20||
59506762|NCT01981863|75599833|FG000|COMPLETED|Overall Study||20||
59506763|NCT01981863|75599834|FG001|COMPLETED|Overall Study||20||
59506764|NCT01981863|75599833|FG000|NOT COMPLETED|Overall Study||0||
59506765|NCT01981863|75599834|FG001|NOT COMPLETED|Overall Study||0||
59506766|NCT00245765|75599843|FG000|STARTED|Overall Study||59||
59910372|NCT03840902|76031109|FG001|NOT COMPLETED|Overall Study||1||
59910373|NCT03820986|76031117|FG000|STARTED|Overall Study||334||
59910374|NCT03820986|76031118|FG001|STARTED|Overall Study||340||
59910375|NCT03820986|76031117|FG000|COMPLETED|Overall Study||0||
59910376|NCT03820986|76031118|FG001|COMPLETED|Overall Study||0||
59910377|NCT03820986|76031117|FG000|NOT COMPLETED|Overall Study||334||
59910378|NCT03820986|76031118|FG001|NOT COMPLETED|Overall Study||340||
59910379|NCT03775486|76031128|FG000|STARTED|Initial Therapy Phase|All 401 participants received the same initial therapy prior to randomization. As such, the subjects listed under the placebo arm for this period are representative of all subjects in the initial therapy phase.|0||
59910380|NCT03775486|76031129|FG001|STARTED|Initial Therapy Phase|All 401 participants received the same initial therapy prior to randomization. As such, the subjects listed under the placebo arm for this period are representative of all subjects in the initial therapy phase.|401||
59910381|NCT03775486|76031128|FG000|COMPLETED|Initial Therapy Phase||0||
59910382|NCT03775486|76031129|FG001|COMPLETED|Initial Therapy Phase||269||
59910383|NCT03775486|76031128|FG000|NOT COMPLETED|Initial Therapy Phase||0||
59910384|NCT03775486|76031129|FG001|NOT COMPLETED|Initial Therapy Phase||132||
59910385|NCT03775486|76031128|FG000|STARTED|Maintenance Phase|All participants received the same initial therapy prior to randomization.|134||
59910386|NCT03775486|76031129|FG001|STARTED|Maintenance Phase|All participants received the same initial therapy prior to randomization.|135||
59910387|NCT03775486|76031128|FG000|Participants Who Received Durvalumab|Maintenance Phase||134||
59910388|NCT03775486|76031129|FG001|Participants Who Received Durvalumab|Maintenance Phase||134||
59910389|NCT03775486|76031128|FG000|Participants Who Received Olaparib/Placebo|Maintenance Phase||128||
59910390|NCT03775486|76031129|FG001|Participants Who Received Olaparib/Placebo|Maintenance Phase||128||
59910391|NCT03775486|76031128|FG000|Participants Who Terminated the Study|Maintenance Phase||57||
59910392|NCT03775486|76031129|FG001|Participants Who Terminated the Study|Maintenance Phase||57||
59910393|NCT03775486|76031128|FG000|COMPLETED|Maintenance Phase||77|Participants ongoing study at data cut-off|
59910394|NCT03775486|76031129|FG001|COMPLETED|Maintenance Phase||78|Participants ongoing study at data cut-off|
59910395|NCT03775486|76031128|FG000|NOT COMPLETED|Maintenance Phase||57||
59910396|NCT03775486|76031129|FG001|NOT COMPLETED|Maintenance Phase||57||
59910397|NCT03715790|76031136|FG000|STARTED|3-months||1491||
59910398|NCT03715790|76031136|FG000|COMPLETED|3-months||1170||
59910399|NCT03715790|76031136|FG000|NOT COMPLETED|3-months||321||
59910400|NCT03715790|76031136|FG000|STARTED|6-months||1170||
59910401|NCT03715790|76031136|FG000|COMPLETED|6-months||916||
59910402|NCT03715790|76031136|FG000|NOT COMPLETED|6-months||254||
59910403|NCT03715790|76031136|FG000|STARTED|12-months||916||
59910404|NCT03715790|76031136|FG000|COMPLETED|12-months||887||
59910405|NCT03715790|76031136|FG000|NOT COMPLETED|12-months||29||
59910406|NCT03675737|76031147|FG000|STARTED|Overall Study||790||
59910407|NCT03675737|76031148|FG001|STARTED|Overall Study||789||
59910408|NCT03675737|76031147|FG000|Treated|Overall Study||785||
59910409|NCT03675737|76031148|FG001|Treated|Overall Study||787||
59910410|NCT03675737|76031147|FG000|COMPLETED|Overall Study||0||
59910411|NCT03675737|76031148|FG001|COMPLETED|Overall Study||0||
59910412|NCT03675737|76031147|FG000|NOT COMPLETED|Overall Study||790||
59910413|NCT03675737|76031148|FG001|NOT COMPLETED|Overall Study||789||
59910414|NCT03651271|76031160|FG000|STARTED|Overall Study||7||
59910415|NCT03651271|76031161|FG001|STARTED|Overall Study||72||
59910416|NCT03651271|76031162|FG002|STARTED|Overall Study||1||
59910417|NCT03651271|76031163|FG003|STARTED|Overall Study||5||
59910418|NCT03651271|76031164|FG004|STARTED|Overall Study||15||
59910419|NCT03651271|76031160|FG000|COMPLETED|Overall Study||1||
59910420|NCT03651271|76031161|FG001|COMPLETED|Overall Study||13||
59910421|NCT03651271|76031162|FG002|COMPLETED|Overall Study||1||
59910422|NCT03651271|76031163|FG003|COMPLETED|Overall Study||1||
59910423|NCT03651271|76031164|FG004|COMPLETED|Overall Study||8||
59910424|NCT03651271|76031160|FG000|NOT COMPLETED|Overall Study||6||
59910425|NCT03651271|76031161|FG001|NOT COMPLETED|Overall Study||59||
59910426|NCT03651271|76031162|FG002|NOT COMPLETED|Overall Study||0||
59910427|NCT03651271|76031163|FG003|NOT COMPLETED|Overall Study||4||
59910428|NCT03651271|76031164|FG004|NOT COMPLETED|Overall Study||7||
59910429|NCT03643562|76031181|FG000|STARTED|Overall Study||9||
59910430|NCT03643562|76031182|FG001|STARTED|Overall Study||18||
59910431|NCT03643562|76031181|FG000|Received at Least 1 Dose of Study Drug|Overall Study||9||
59910432|NCT03643562|76031182|FG001|Received at Least 1 Dose of Study Drug|Overall Study||18||
59910433|NCT03643562|76031181|FG000|COMPLETED|Overall Study||1||
59910434|NCT03643562|76031182|FG001|COMPLETED|Overall Study||2||
59910435|NCT03643562|76031181|FG000|NOT COMPLETED|Overall Study||8||
59910436|NCT03643562|76031182|FG001|NOT COMPLETED|Overall Study||16||
59910437|NCT03635567|76031190|FG000|STARTED|Overall Study||308||
59910438|NCT03635567|76031191|FG001|STARTED|Overall Study||309||
59506767|NCT00245765|75599844|FG001|STARTED|Overall Study||59||
59506768|NCT00245765|75599845|FG002|STARTED|Overall Study||58||
60017861|NCT04640311|76133810|FG002|COMPLETED|Part B: Washout 1 (Up to 7 Days)||0||
60017862|NCT04640311|76133811|FG003|COMPLETED|Part B: Washout 1 (Up to 7 Days)||20||
60017863|NCT04640311|76133812|FG004|COMPLETED|Part B: Washout 1 (Up to 7 Days)||19||
60017864|NCT04640311|76133813|FG005|COMPLETED|Part B: Washout 1 (Up to 7 Days)||20||
60017865|NCT04640311|76133814|FG006|COMPLETED|Part B: Washout 1 (Up to 7 Days)||20||
59506769|NCT00245765|75599843|FG000|Safety Population|Overall Study|One subject in the Placebo (PBO) group received one injection of CDP870 200 mg on one occasion.|58|The safety population consisted of all subjects who were exposed to study medication.|
59506770|NCT00245765|75599844|FG001|Safety Population|Overall Study|For safety analysis, the PBO group subj. who received CDP870 was considered to be in the 200mg group|60|The safety population consisted of all subjects who were exposed to study medication.|
59506771|NCT00245765|75599845|FG002|Safety Population|Overall Study|One subject in the 400 mg group was randomized by mistake but did not receive study medication.|57|The safety population consisted of all subjects who were exposed to study medication.|
59506772|NCT00245765|75599843|FG000|COMPLETED|Overall Study||27||
59506773|NCT00245765|75599844|FG001|COMPLETED|Overall Study||45||
59506774|NCT00245765|75599845|FG002|COMPLETED|Overall Study||50||
59506775|NCT00245765|75599843|FG000|NOT COMPLETED|Overall Study||32||
59506776|NCT00245765|75599844|FG001|NOT COMPLETED|Overall Study||14||
59506777|NCT00245765|75599845|FG002|NOT COMPLETED|Overall Study||8||
59506778|NCT01995045|75599855|FG000|STARTED|Overall Study||29||
59506779|NCT01995045|75599856|FG001|STARTED|Overall Study||28||
59506780|NCT01995045|75599855|FG000|COMPLETED|Overall Study||29||
59506781|NCT01995045|75599856|FG001|COMPLETED|Overall Study||28||
59506782|NCT01995045|75599855|FG000|NOT COMPLETED|Overall Study||0||
59506783|NCT01995045|75599856|FG001|NOT COMPLETED|Overall Study||0||
59506784|NCT01995123|75599864|FG000|STARTED|Overall Study||63||
59506785|NCT01995123|75599865|FG001|STARTED|Overall Study||61||
59506786|NCT01995123|75599864|FG000|COMPLETED|Overall Study||45||
59506787|NCT01995123|75599865|FG001|COMPLETED|Overall Study||46||
59506788|NCT01995123|75599864|FG000|NOT COMPLETED|Overall Study||18||
59506789|NCT01995123|75599865|FG001|NOT COMPLETED|Overall Study||15||
59506790|NCT00781079|75599873|FG000|STARTED|Overall Study||149||
59506791|NCT00781079|75599874|FG001|STARTED|Overall Study||133||
59910439|NCT03635567|76031190|FG000|Treated|Overall Study||307||
59910440|NCT03635567|76031191|FG001|Treated|Overall Study||309||
59910441|NCT03635567|76031190|FG000|Received Second Course of Pembrolizumab|Overall Study||8||
59910442|NCT03635567|76031191|FG001|Received Second Course of Pembrolizumab|Overall Study||0||
59910443|NCT03635567|76031190|FG000|COMPLETED|Overall Study||0||
59910444|NCT03635567|76031191|FG001|COMPLETED|Overall Study||0||
59910445|NCT03635567|76031190|FG000|NOT COMPLETED|Overall Study||308||
60017866|NCT04640311|76133815|FG007|COMPLETED|Part B: Washout 1 (Up to 7 Days)||21||
60017867|NCT04640311|76133816|FG008|COMPLETED|Part B: Washout 1 (Up to 7 Days)||19||
60017868|NCT04640311|76133817|FG009|COMPLETED|Part B: Washout 1 (Up to 7 Days)||21||
60017869|NCT04640311|76133818|FG010|COMPLETED|Part B: Washout 1 (Up to 7 Days)||20||
60017870|NCT04640311|76133819|FG011|COMPLETED|Part B: Washout 1 (Up to 7 Days)||20||
59910446|NCT03635567|76031191|FG001|NOT COMPLETED|Overall Study||309||
60017871|NCT04640311|76133820|FG012|COMPLETED|Part B: Washout 1 (Up to 7 Days)||20||
59910447|NCT03606486|76031198|FG000|STARTED|Overall Study||52||
59910448|NCT03606486|76031198|FG000|COMPLETED|Overall Study||47||
59910449|NCT03606486|76031198|FG000|NOT COMPLETED|Overall Study||5||
60017872|NCT04640311|76133808|FG000|NOT COMPLETED|Part B: Washout 1 (Up to 7 Days)||0||
60017873|NCT04640311|76133809|FG001|NOT COMPLETED|Part B: Washout 1 (Up to 7 Days)||0||
60017874|NCT04640311|76133810|FG002|NOT COMPLETED|Part B: Washout 1 (Up to 7 Days)||0||
60017875|NCT04640311|76133811|FG003|NOT COMPLETED|Part B: Washout 1 (Up to 7 Days)||0||
60017876|NCT04640311|76133812|FG004|NOT COMPLETED|Part B: Washout 1 (Up to 7 Days)||0||
60017877|NCT04640311|76133813|FG005|NOT COMPLETED|Part B: Washout 1 (Up to 7 Days)||0||
60017878|NCT04640311|76133814|FG006|NOT COMPLETED|Part B: Washout 1 (Up to 7 Days)||0||
60017879|NCT04640311|76133815|FG007|NOT COMPLETED|Part B: Washout 1 (Up to 7 Days)||0||
60017880|NCT04640311|76133816|FG008|NOT COMPLETED|Part B: Washout 1 (Up to 7 Days)||0||
60017881|NCT04640311|76133817|FG009|NOT COMPLETED|Part B: Washout 1 (Up to 7 Days)||0||
59910450|NCT03578536|76031202|FG000|STARTED|Overall Study||3||
60017882|NCT04640311|76133818|FG010|NOT COMPLETED|Part B: Washout 1 (Up to 7 Days)||0||
60017883|NCT04640311|76133819|FG011|NOT COMPLETED|Part B: Washout 1 (Up to 7 Days)||0||
60017884|NCT04640311|76133820|FG012|NOT COMPLETED|Part B: Washout 1 (Up to 7 Days)||0||
60017885|NCT04640311|76133808|FG000|STARTED|Part B: Treatment Period 2(Up to 2 Days)||0||
60017886|NCT04640311|76133809|FG001|STARTED|Part B: Treatment Period 2(Up to 2 Days)||0||
60017887|NCT04640311|76133810|FG002|STARTED|Part B: Treatment Period 2(Up to 2 Days)||0||
60017888|NCT04640311|76133811|FG003|STARTED|Part B: Treatment Period 2(Up to 2 Days)||20||
60017889|NCT04640311|76133812|FG004|STARTED|Part B: Treatment Period 2(Up to 2 Days)||19||
60017890|NCT04640311|76133813|FG005|STARTED|Part B: Treatment Period 2(Up to 2 Days)||20||
60017891|NCT04640311|76133814|FG006|STARTED|Part B: Treatment Period 2(Up to 2 Days)||20||
60017892|NCT04640311|76133815|FG007|STARTED|Part B: Treatment Period 2(Up to 2 Days)||21||
60017893|NCT04640311|76133816|FG008|STARTED|Part B: Treatment Period 2(Up to 2 Days)||19||
60017894|NCT04640311|76133817|FG009|STARTED|Part B: Treatment Period 2(Up to 2 Days)||21||
60017895|NCT04640311|76133818|FG010|STARTED|Part B: Treatment Period 2(Up to 2 Days)||20||
60017896|NCT04640311|76133819|FG011|STARTED|Part B: Treatment Period 2(Up to 2 Days)||20||
60017897|NCT04640311|76133820|FG012|STARTED|Part B: Treatment Period 2(Up to 2 Days)||20||
60017898|NCT04640311|76133808|FG000|COMPLETED|Part B: Treatment Period 2(Up to 2 Days)||0||
60017899|NCT04640311|76133809|FG001|COMPLETED|Part B: Treatment Period 2(Up to 2 Days)||0||
60017900|NCT04640311|76133810|FG002|COMPLETED|Part B: Treatment Period 2(Up to 2 Days)||0||
60017901|NCT04640311|76133811|FG003|COMPLETED|Part B: Treatment Period 2(Up to 2 Days)||20||
60017902|NCT04640311|76133812|FG004|COMPLETED|Part B: Treatment Period 2(Up to 2 Days)||19||
59506792|NCT00781079|75599873|FG000|COMPLETED|Overall Study||122||
59506793|NCT00781079|75599874|FG001|COMPLETED|Overall Study||116||
59506794|NCT00781079|75599873|FG000|NOT COMPLETED|Overall Study||27||
59506795|NCT00781079|75599874|FG001|NOT COMPLETED|Overall Study||17||
59506796|NCT01982643|75599880|FG000|STARTED|Overall Study||49||
59506797|NCT01982643|75599880|FG000|COMPLETED|Overall Study||37||
59506798|NCT01982643|75599880|FG000|NOT COMPLETED|Overall Study||12||
59506799|NCT01996839|75599887|FG000|STARTED|Overall Study||172||
59506800|NCT01996839|75599888|FG001|STARTED|Overall Study||171||
59506801|NCT01996839|75599889|FG002|STARTED|Overall Study||171||
59506802|NCT01996839|75599887|FG000|COMPLETED|Overall Study||80||
59506803|NCT01996839|75599888|FG001|COMPLETED|Overall Study||133||
60017903|NCT04640311|76133813|FG005|COMPLETED|Part B: Treatment Period 2(Up to 2 Days)||20||
60017904|NCT04640311|76133814|FG006|COMPLETED|Part B: Treatment Period 2(Up to 2 Days)||20||
60017905|NCT04640311|76133815|FG007|COMPLETED|Part B: Treatment Period 2(Up to 2 Days)||21||
60017906|NCT04640311|76133816|FG008|COMPLETED|Part B: Treatment Period 2(Up to 2 Days)||19||
60017907|NCT04640311|76133817|FG009|COMPLETED|Part B: Treatment Period 2(Up to 2 Days)||21||
60017908|NCT04640311|76133818|FG010|COMPLETED|Part B: Treatment Period 2(Up to 2 Days)||20||
60017909|NCT04640311|76133819|FG011|COMPLETED|Part B: Treatment Period 2(Up to 2 Days)||19||
60017910|NCT04640311|76133820|FG012|COMPLETED|Part B: Treatment Period 2(Up to 2 Days)||20||
60017911|NCT04640311|76133808|FG000|NOT COMPLETED|Part B: Treatment Period 2(Up to 2 Days)||0||
60017912|NCT04640311|76133809|FG001|NOT COMPLETED|Part B: Treatment Period 2(Up to 2 Days)||0||
60017913|NCT04640311|76133810|FG002|NOT COMPLETED|Part B: Treatment Period 2(Up to 2 Days)||0||
60017914|NCT04640311|76133811|FG003|NOT COMPLETED|Part B: Treatment Period 2(Up to 2 Days)||0||
60017915|NCT04640311|76133812|FG004|NOT COMPLETED|Part B: Treatment Period 2(Up to 2 Days)||0||
60017916|NCT04640311|76133813|FG005|NOT COMPLETED|Part B: Treatment Period 2(Up to 2 Days)||0||
60017917|NCT04640311|76133814|FG006|NOT COMPLETED|Part B: Treatment Period 2(Up to 2 Days)||0||
60017918|NCT04640311|76133815|FG007|NOT COMPLETED|Part B: Treatment Period 2(Up to 2 Days)||0||
60017919|NCT04640311|76133816|FG008|NOT COMPLETED|Part B: Treatment Period 2(Up to 2 Days)||0||
60017920|NCT04640311|76133817|FG009|NOT COMPLETED|Part B: Treatment Period 2(Up to 2 Days)||0||
60017921|NCT04640311|76133818|FG010|NOT COMPLETED|Part B: Treatment Period 2(Up to 2 Days)||0||
60017922|NCT04640311|76133819|FG011|NOT COMPLETED|Part B: Treatment Period 2(Up to 2 Days)||1||
60017923|NCT04640311|76133820|FG012|NOT COMPLETED|Part B: Treatment Period 2(Up to 2 Days)||0||
60017924|NCT02334423|76133851|FG000|STARTED|Overall Study||246||
60017925|NCT02334423|76133852|FG001|STARTED|Overall Study||84||
60017926|NCT02334423|76133851|FG000|COMPLETED|Overall Study||236||
60017927|NCT02334423|76133852|FG001|COMPLETED|Overall Study||81||
60017928|NCT02334423|76133851|FG000|NOT COMPLETED|Overall Study||10||
60017929|NCT02334423|76133852|FG001|NOT COMPLETED|Overall Study||3||
60017930|NCT02310789|76133858|FG000|STARTED|Overall Study||8||
60017931|NCT02310789|76133858|FG000|COMPLETED|Overall Study||7||
60017932|NCT02310789|76133858|FG000|NOT COMPLETED|Overall Study||1||
60017933|NCT02372253|76133864|FG000|STARTED|Overall Study||13||
59506804|NCT01996839|75599889|FG002|COMPLETED|Overall Study||139||
59506805|NCT01996839|75599887|FG000|NOT COMPLETED|Overall Study||92||
59506806|NCT01996839|75599888|FG001|NOT COMPLETED|Overall Study||38||
59506807|NCT01996839|75599889|FG002|NOT COMPLETED|Overall Study||32||
60017934|NCT02372253|76133865|FG001|STARTED|Overall Study||13||
59506808|NCT00797797|75599899|FG000|STARTED|Overall Study|Two patients took no background stable dose of pregabalin after randomization and are not included.|178||
59506809|NCT00797797|75599900|FG001|STARTED|Overall Study||184||
59506810|NCT00797797|75599899|FG000|COMPLETED|Overall Study||123||
59506811|NCT00797797|75599900|FG001|COMPLETED|Overall Study||141||
59506812|NCT00797797|75599899|FG000|NOT COMPLETED|Overall Study||55||
59506813|NCT00797797|75599900|FG001|NOT COMPLETED|Overall Study||43||
60017935|NCT02372253|76133864|FG000|COMPLETED|Overall Study||11||
60017936|NCT02372253|76133865|FG001|COMPLETED|Overall Study||13||
60017937|NCT02372253|76133864|FG000|NOT COMPLETED|Overall Study||2||
60017938|NCT02372253|76133865|FG001|NOT COMPLETED|Overall Study||0||
60017939|NCT02559895|76133877|FG000|STARTED|Overall Study||224||
60017940|NCT02559895|76133878|FG001|STARTED|Overall Study||225||
60017941|NCT02559895|76133879|FG002|STARTED|Overall Study||224||
60017942|NCT02559895|76133880|FG003|STARTED|Overall Study||225||
60017943|NCT02559895|76133877|FG000|Participants Treated|Overall Study||222|2 participants received duplicate randomization, participants are summarized in first group assigned|
60017944|NCT02559895|76133878|FG001|Participants Treated|Overall Study||221|2 participants received duplicate randomization, participants are summarized in first group assigned|
59910451|NCT03578536|76031202|FG000|COMPLETED|Overall Study||2||
59910452|NCT03578536|76031202|FG000|NOT COMPLETED|Overall Study||1||
59910453|NCT03564496|76031209|FG000|STARTED|Overall Study||27||
59910454|NCT03564496|76031210|FG001|STARTED|Overall Study||40||
59910455|NCT03564496|76031211|FG002|STARTED|Overall Study||6||
59910456|NCT03564496|76031209|FG000|COMPLETED|Overall Study||26||
59910457|NCT03564496|76031210|FG001|COMPLETED|Overall Study||36||
59910458|NCT03564496|76031211|FG002|COMPLETED|Overall Study||6||
59910459|NCT03564496|76031209|FG000|NOT COMPLETED|Overall Study||1||
59910460|NCT03564496|76031210|FG001|NOT COMPLETED|Overall Study||4||
59910461|NCT03564496|76031211|FG002|NOT COMPLETED|Overall Study||0||
59910462|NCT03562247|76031226|FG000|STARTED|Overall Study||10||
59910463|NCT03562247|76031227|FG001|STARTED|Overall Study||11||
59910464|NCT03562247|76031228|FG002|STARTED|Overall Study||10||
59910465|NCT03562247|76031226|FG000|COMPLETED|Overall Study||7||
59910466|NCT03562247|76031227|FG001|COMPLETED|Overall Study||10||
59910467|NCT03562247|76031228|FG002|COMPLETED|Overall Study||9||
59910468|NCT03562247|76031226|FG000|NOT COMPLETED|Overall Study||3||
59910469|NCT03562247|76031227|FG001|NOT COMPLETED|Overall Study||1||
59910470|NCT03562247|76031228|FG002|NOT COMPLETED|Overall Study||1||
59910471|NCT03515837|76031238|FG000|STARTED|Overall Study||245||
59910472|NCT03515837|76031239|FG001|STARTED|Overall Study||247||
59910473|NCT03515837|76031238|FG000|Treated|Overall Study||245||
59910474|NCT03515837|76031239|FG001|Treated|Overall Study||246||
59910475|NCT03515837|76031238|FG000|Switched Over to Pembro Monotherapy|Overall Study||0||
59910476|NCT03515837|76031239|FG001|Switched Over to Pembro Monotherapy|Overall Study||50||
59910477|NCT03515837|76031238|FG000|COMPLETED|Overall Study||0||
59910478|NCT03515837|76031239|FG001|COMPLETED|Overall Study||0||
59910479|NCT03515837|76031238|FG000|NOT COMPLETED|Overall Study||245||
59910480|NCT03515837|76031239|FG001|NOT COMPLETED|Overall Study||247||
59910481|NCT03495713|76031246|FG000|STARTED|Overall Study||7||
59910482|NCT03495713|76031246|FG000|COMPLETED|Overall Study||7||
59910483|NCT03495713|76031246|FG000|NOT COMPLETED|Overall Study||0||
59910484|NCT03443973|76031252|FG000|STARTED|Double-blind Treatment Period||477||
59910485|NCT03443973|76031253|FG001|STARTED|Double-blind Treatment Period||498||
59910486|NCT03443973|76031254|FG002|STARTED|Double-blind Treatment Period||0||
59910487|NCT03443973|76031255|FG003|STARTED|Double-blind Treatment Period||0||
59910488|NCT03443973|76031252|FG000|Safety-evaluable Set|Double-blind Treatment Period||474|Safety-evaluable set included all participants randomized during the global phase, who received at least one dose of study drug. In DBT period, three participants randomized to placebo arm received at least one dose of gantenerumab and were considered in the gantenerumab arm for safety evaluable set.|
59910489|NCT03443973|76031253|FG001|Safety-evaluable Set|Double-blind Treatment Period||501|Safety-evaluable set included all participants randomized during the global phase, who received at least one dose of study drug. In DBT period, three participants randomized to placebo arm received at least one dose of gantenerumab and were considered in the gantenerumab arm for safety evaluable set.|
59910490|NCT03443973|76031254|FG002|Safety-evaluable Set|Double-blind Treatment Period||0|Safety-evaluable set included all participants randomized during the global phase, who received at least one dose of study drug. In DBT period, three participants randomized to placebo arm received at least one dose of gantenerumab and were considered in the gantenerumab arm for safety evaluable set.|
59910491|NCT03443973|76031255|FG003|Safety-evaluable Set|Double-blind Treatment Period||0|Safety-evaluable set included all participants randomized during the global phase, who received at least one dose of study drug. In DBT period, three participants randomized to placebo arm received at least one dose of gantenerumab and were considered in the gantenerumab arm for safety evaluable set.|
59910492|NCT03443973|76031252|FG000|COMPLETED|Double-blind Treatment Period||397||
59910493|NCT03443973|76031253|FG001|COMPLETED|Double-blind Treatment Period||372||
59910494|NCT03443973|76031254|FG002|COMPLETED|Double-blind Treatment Period||0||
59910495|NCT03443973|76031255|FG003|COMPLETED|Double-blind Treatment Period||0||
59910496|NCT03443973|76031252|FG000|NOT COMPLETED|Double-blind Treatment Period||80||
59910497|NCT03443973|76031253|FG001|NOT COMPLETED|Double-blind Treatment Period||126||
59910498|NCT03443973|76031254|FG002|NOT COMPLETED|Double-blind Treatment Period||0||
59910499|NCT03443973|76031255|FG003|NOT COMPLETED|Double-blind Treatment Period||0||
59910500|NCT03443973|76031252|FG000|STARTED|Open-label Extension Period|Participants who completed the DBT Period were given the option to enroll in the OLE Period to receive gantenerumab.|0||
59910501|NCT03443973|76031253|FG001|STARTED|Open-label Extension Period|Participants who completed the DBT Period were given the option to enroll in the OLE Period to receive gantenerumab.|0||
59910502|NCT03443973|76031254|FG002|STARTED|Open-label Extension Period|13 Participants who completed the DBT Period enrolled into the OLE Period.|13||
59910503|NCT03443973|76031255|FG003|STARTED|Open-label Extension Period|14 Participants who completed the DBT Period enrolled into the OLE Period.|14||
59910504|NCT03443973|76031252|FG000|COMPLETED|Open-label Extension Period||0||
59910505|NCT03443973|76031253|FG001|COMPLETED|Open-label Extension Period||0||
59910506|NCT03443973|76031254|FG002|COMPLETED|Open-label Extension Period||8||
59910507|NCT03443973|76031255|FG003|COMPLETED|Open-label Extension Period||13||
59910508|NCT03443973|76031252|FG000|NOT COMPLETED|Open-label Extension Period||0||
59910509|NCT03443973|76031253|FG001|NOT COMPLETED|Open-label Extension Period||0||
59910510|NCT03443973|76031254|FG002|NOT COMPLETED|Open-label Extension Period||5||
59910511|NCT03443973|76031255|FG003|NOT COMPLETED|Open-label Extension Period||1||
59910512|NCT03422679|76031279|FG000|STARTED|Overall Study||5|Part A - dose escalation was completed. Part B - dose expansion was never opened.|
59506814|NCT01996917|75599906|FG000|STARTED|Overall Study||21||42
59506815|NCT01996917|75599906|FG000|COMPLETED|Overall Study||21||42
59506816|NCT01996917|75599906|FG000|NOT COMPLETED|Overall Study||0||0
59506817|NCT01984515|75599911|FG000|STARTED|Overall Study||59||
59506818|NCT01984515|75599911|FG000|Received CBT Session|Overall Study||40||
59506819|NCT01984515|75599911|FG000|COMPLETED|Overall Study||40||
59506820|NCT01984515|75599911|FG000|NOT COMPLETED|Overall Study||19||
59506821|NCT00245063|75599917|FG000|STARTED|Overall Study||12||
59506822|NCT00245063|75599918|FG001|STARTED|Overall Study||13||
59506823|NCT00245063|75599917|FG000|COMPLETED|Overall Study||5||
59506824|NCT00245063|75599918|FG001|COMPLETED|Overall Study||8||
59506825|NCT00245063|75599917|FG000|NOT COMPLETED|Overall Study||7||
59506826|NCT00245063|75599918|FG001|NOT COMPLETED|Overall Study||5||
59910513|NCT03422679|76031280|FG001|STARTED|Overall Study||3|Part A - dose escalation was completed. Part B - dose expansion was never opened.|
59910514|NCT03422679|76031281|FG002|STARTED|Overall Study||7|Part A - dose escalation was completed. Part B - dose expansion was never opened.|
59910515|NCT03422679|76031282|FG003|STARTED|Overall Study||7|Part A - dose escalation was completed. Part B - dose expansion was never opened.|
59910516|NCT03422679|76031283|FG004|STARTED|Overall Study||3|Part A - dose escalation was completed. Part B - dose expansion was never opened.|
59910517|NCT03422679|76031284|FG005|STARTED|Overall Study||4|Part A - dose escalation was completed. Part B - dose expansion was never opened.|
59506827|NCT02151487|75599928|FG000|STARTED|Overall Study||27||
59506828|NCT02151487|75599929|FG001|STARTED|Overall Study||27||
59506829|NCT02151487|75599930|FG002|STARTED|Overall Study||20||
59910518|NCT03422679|76031285|FG006|STARTED|Overall Study||3|Part A - dose escalation was completed. Part B - dose expansion was never opened.|
59910519|NCT03422679|76031286|FG007|STARTED|Overall Study||9|Part A - dose escalation was completed. Part B - dose expansion was never opened.|
59910520|NCT03422679|76031287|FG008|STARTED|Overall Study||5|Part A - dose escalation was completed. Part B - dose expansion was never opened.|
59910521|NCT03422679|76031288|FG009|STARTED|Overall Study||6|Part A - dose escalation was completed. Part B - dose expansion was never opened.|
59910522|NCT03422679|76031289|FG010|STARTED|Overall Study||4|Part A - dose escalation was completed. Part B - dose expansion was never opened.|
59910523|NCT03422679|76031290|FG011|STARTED|Overall Study||8|Part A - dose escalation was completed. Part B - dose expansion was never opened.|
59910524|NCT03422679|76031291|FG012|STARTED|Overall Study||15|Part A - dose escalation was completed. Part B - dose expansion was never opened.|
59910525|NCT03422679|76031279|FG000|COMPLETED|Overall Study||5|Part A - dose escalation was completed. Part B - dose expansion was never opened.|
59910526|NCT03422679|76031280|FG001|COMPLETED|Overall Study||3|Part A - dose escalation was completed. Part B - dose expansion was never opened.|
59910527|NCT03422679|76031281|FG002|COMPLETED|Overall Study||7|Part A - dose escalation was completed. Part B - dose expansion was never opened.|
59910528|NCT03422679|76031282|FG003|COMPLETED|Overall Study||7|Part A - dose escalation was completed. Part B - dose expansion was never opened.|
59910529|NCT03422679|76031283|FG004|COMPLETED|Overall Study||3|Part A - dose escalation was completed. Part B - dose expansion was never opened.|
59951299|NCT03672175|76070205|FG002|NOT COMPLETED|Extended FU Period (Days 43 to 182)||37||
59506830|NCT02151487|75599931|FG003|STARTED|Overall Study||23||
59506831|NCT02151487|75599928|FG000|COMPLETED|Overall Study||25||
59506832|NCT02151487|75599929|FG001|COMPLETED|Overall Study||22||
60017945|NCT02559895|76133879|FG002|Participants Treated|Overall Study||223|2 participants received duplicate randomization, participants are summarized in first group assigned|
60017946|NCT02559895|76133880|FG003|Participants Treated|Overall Study||222|2 participants received duplicate randomization, participants are summarized in first group assigned|
60017947|NCT02559895|76133877|FG000|COMPLETED|Overall Study||169||
60017948|NCT02559895|76133878|FG001|COMPLETED|Overall Study||172||
60017949|NCT02559895|76133879|FG002|COMPLETED|Overall Study||170||
60017950|NCT02559895|76133880|FG003|COMPLETED|Overall Study||165||
60017951|NCT02559895|76133877|FG000|NOT COMPLETED|Overall Study||55||
60017952|NCT02559895|76133878|FG001|NOT COMPLETED|Overall Study||53||
60017953|NCT02559895|76133879|FG002|NOT COMPLETED|Overall Study||54||
60017954|NCT02559895|76133880|FG003|NOT COMPLETED|Overall Study||60||
60017955|NCT02371629|76133892|FG000|STARTED|Overall Study||388||
60017956|NCT02371629|76133893|FG001|STARTED|Overall Study||388||
60017957|NCT02371629|76133892|FG000|COMPLETED|Overall Study||362||
60017958|NCT02371629|76133893|FG001|COMPLETED|Overall Study||363||
60017959|NCT02371629|76133892|FG000|NOT COMPLETED|Overall Study||26||
60017960|NCT02371629|76133893|FG001|NOT COMPLETED|Overall Study||25||
60017961|NCT02559817|76133904|FG000|STARTED|Treatment Period||19||
60017962|NCT02559817|76133905|FG001|STARTED|Treatment Period||29||
60017963|NCT02559817|76133906|FG002|STARTED|Treatment Period||21||
60017964|NCT02559817|76133907|FG003|STARTED|Treatment Period||24||
60017965|NCT02559817|76133908|FG004|STARTED|Treatment Period||8||
60017966|NCT02559817|76133904|FG000|COMPLETED|Treatment Period||18||
60017967|NCT02559817|76133905|FG001|COMPLETED|Treatment Period||27||
60017968|NCT02559817|76133906|FG002|COMPLETED|Treatment Period||19||
60017969|NCT02559817|76133907|FG003|COMPLETED|Treatment Period||22||
60017970|NCT02559817|76133908|FG004|COMPLETED|Treatment Period||8||
60017971|NCT02559817|76133904|FG000|NOT COMPLETED|Treatment Period||1||
59506833|NCT02151487|75599930|FG002|COMPLETED|Overall Study||16||
59506834|NCT02151487|75599931|FG003|COMPLETED|Overall Study||20||
59506835|NCT02151487|75599928|FG000|NOT COMPLETED|Overall Study||2||
59506836|NCT02151487|75599929|FG001|NOT COMPLETED|Overall Study||5||
59506837|NCT02151487|75599930|FG002|NOT COMPLETED|Overall Study||4||
59506838|NCT02151487|75599931|FG003|NOT COMPLETED|Overall Study||3||
59506839|NCT02148809|75599941|FG000|STARTED|Overall Study||14||
59506840|NCT02148809|75599941|FG000|COMPLETED|Overall Study||14||
59506841|NCT02148809|75599941|FG000|NOT COMPLETED|Overall Study||0||
59506842|NCT00763919|75599946|FG000|STARTED|Overall Study||43||
59506843|NCT00763919|75599946|FG000|COMPLETED|Overall Study||30||
59506844|NCT00763919|75599946|FG000|NOT COMPLETED|Overall Study||13||
59506845|NCT00764309|75599950|FG000|STARTED|Overall Study|Number of participants treated.|31||
59506846|NCT00764309|75599950|FG000|COMPLETED|Overall Study|Completed=off study. Major Reasons for off study: AE-13; withdrawn by sponsor-10; Lack of efficacy-3|31||
59506847|NCT00764309|75599950|FG000|NOT COMPLETED|Overall Study||0||
59506848|NCT02151877|75599956|FG000|STARTED|Overall Study||12||
59506849|NCT02151877|75599957|FG001|STARTED|Overall Study||12||
59506850|NCT02151877|75599956|FG000|COMPLETED|Overall Study||12||
59506851|NCT02151877|75599957|FG001|COMPLETED|Overall Study||12||
59506852|NCT02151877|75599956|FG000|NOT COMPLETED|Overall Study||0||
59506853|NCT02151877|75599957|FG001|NOT COMPLETED|Overall Study||0||
59506854|NCT00798577|75599967|FG000|STARTED|Overall Study||17||
59506855|NCT00798577|75599968|FG001|STARTED|Overall Study||7||
59506856|NCT00798577|75599967|FG000|COMPLETED|Overall Study||17||
59506857|NCT00798577|75599968|FG001|COMPLETED|Overall Study||7||
59506858|NCT00798577|75599967|FG000|NOT COMPLETED|Overall Study||0||
59506859|NCT00798577|75599968|FG001|NOT COMPLETED|Overall Study||0||
59506860|NCT00799435|75599976|FG000|STARTED|Overall Study||1||
59506861|NCT00799435|75599977|FG001|STARTED|Overall Study||1||
60017972|NCT02559817|76133905|FG001|NOT COMPLETED|Treatment Period||2||
60017973|NCT02559817|76133906|FG002|NOT COMPLETED|Treatment Period||2||
60017974|NCT02559817|76133907|FG003|NOT COMPLETED|Treatment Period||2||
60017975|NCT02559817|76133908|FG004|NOT COMPLETED|Treatment Period||0||
60017976|NCT02559817|76133904|FG000|STARTED|Post-treatment Period||18||
60017977|NCT02559817|76133905|FG001|STARTED|Post-treatment Period||27||
59506862|NCT00799435|75599976|FG000|COMPLETED|Overall Study||1||
59506863|NCT00799435|75599977|FG001|COMPLETED|Overall Study||1||
59506864|NCT00799435|75599976|FG000|NOT COMPLETED|Overall Study||0||
60017978|NCT02559817|76133906|FG002|STARTED|Post-treatment Period|1 participant who did not complete the first period, entered and completed the Post-treatment Period|20||
59611535|NCT01777308|75722524|FG000|Completed up to Month 73|Overall Study||118||
60017979|NCT02559817|76133907|FG003|STARTED|Post-treatment Period||22||
59506865|NCT00799435|75599977|FG001|NOT COMPLETED|Overall Study||0||
59506866|NCT04329091|75599983|FG000|STARTED|Overall Study|First subject enrolled|9||
59506867|NCT04329091|75599983|FG000|COMPLETED|Overall Study|Last subject follow up.|4||
59506868|NCT04329091|75599983|FG000|NOT COMPLETED|Overall Study||5||
60017980|NCT02559817|76133908|FG004|STARTED|Post-treatment Period||8||
60017981|NCT02559817|76133904|FG000|COMPLETED|Post-treatment Period||18||
59762680|NCT00857259|75882527|FG000|COMPLETED|Overall Study||7||
59506869|NCT00244751|75599990|FG000|STARTED|Overall Study||88||
59506870|NCT00244751|75599991|FG001|STARTED|Overall Study||89||
59506871|NCT00244751|75599992|FG002|STARTED|Overall Study||88||
59506872|NCT00244751|75599990|FG000|COMPLETED|Overall Study||72||
59910530|NCT03422679|76031284|FG005|COMPLETED|Overall Study||4|Part A - dose escalation was completed. Part B - dose expansion was never opened.|
59910531|NCT03422679|76031285|FG006|COMPLETED|Overall Study||3|Part A - dose escalation was completed. Part B - dose expansion was never opened.|
59910532|NCT03422679|76031286|FG007|COMPLETED|Overall Study||9|Part A - dose escalation was completed. Part B - dose expansion was never opened.|
59910533|NCT03422679|76031287|FG008|COMPLETED|Overall Study||5|Part A - dose escalation was completed. Part B - dose expansion was never opened.|
59910534|NCT03422679|76031288|FG009|COMPLETED|Overall Study||6|Part A - dose escalation was completed. Part B - dose expansion was never opened.|
59910535|NCT03422679|76031289|FG010|COMPLETED|Overall Study||4|Part A - dose escalation was completed. Part B - dose expansion was never opened.|
59910536|NCT03422679|76031290|FG011|COMPLETED|Overall Study||8|Part A - dose escalation was completed. Part B - dose expansion was never opened.|
59910537|NCT03422679|76031291|FG012|COMPLETED|Overall Study||15|Part A - dose escalation was completed. Part B - dose expansion was never opened.|
59910538|NCT03422679|76031279|FG000|NOT COMPLETED|Overall Study||0||
59910539|NCT03422679|76031280|FG001|NOT COMPLETED|Overall Study||0||
59910540|NCT03422679|76031281|FG002|NOT COMPLETED|Overall Study||0||
59910541|NCT03422679|76031282|FG003|NOT COMPLETED|Overall Study||0||
59611536|NCT01777308|75722525|FG001|Completed up to Month 73|Overall Study||37||
59611537|NCT01777308|75722524|FG000|COMPLETED|Overall Study||105|Completed up to Month 96|
59910542|NCT03422679|76031283|FG004|NOT COMPLETED|Overall Study||0||
59910543|NCT03422679|76031284|FG005|NOT COMPLETED|Overall Study||0||
60017982|NCT02559817|76133905|FG001|COMPLETED|Post-treatment Period||27||
60017983|NCT02559817|76133906|FG002|COMPLETED|Post-treatment Period||20||
60017984|NCT02559817|76133907|FG003|COMPLETED|Post-treatment Period||22||
60017985|NCT02559817|76133908|FG004|COMPLETED|Post-treatment Period||8||
60017986|NCT02559817|76133904|FG000|NOT COMPLETED|Post-treatment Period||0||
60017987|NCT02559817|76133905|FG001|NOT COMPLETED|Post-treatment Period||0||
60017988|NCT02559817|76133906|FG002|NOT COMPLETED|Post-treatment Period||0||
60017989|NCT02559817|76133907|FG003|NOT COMPLETED|Post-treatment Period||0||
60017990|NCT02559817|76133908|FG004|NOT COMPLETED|Post-treatment Period||0||
60017991|NCT02564887|76133922|FG000|STARTED|Overall Study||16||
60017992|NCT02564887|76133923|FG001|STARTED|Overall Study||10||
60017993|NCT02564887|76133922|FG000|COMPLETED|Overall Study||10||
60017994|NCT02564887|76133923|FG001|COMPLETED|Overall Study||10||
60017995|NCT02564887|76133922|FG000|NOT COMPLETED|Overall Study||6||
60017996|NCT02564887|76133923|FG001|NOT COMPLETED|Overall Study||0||
60017997|NCT02333487|76133934|FG000|STARTED|Overall Study||6||
60017998|NCT02333487|76133935|FG001|STARTED|Overall Study||8||
60017999|NCT02333487|76133936|FG002|STARTED|Overall Study||8||
60018000|NCT02333487|76133934|FG000|COMPLETED|Overall Study||6||
60018001|NCT02333487|76133935|FG001|COMPLETED|Overall Study||6||
59611538|NCT01777308|75722525|FG001|COMPLETED|Overall Study||34|Completed up to Month 96|
60018002|NCT02333487|76133936|FG002|COMPLETED|Overall Study||8||
60018003|NCT02333487|76133934|FG000|NOT COMPLETED|Overall Study||0||
60018004|NCT02333487|76133935|FG001|NOT COMPLETED|Overall Study||2||
60018005|NCT02333487|76133936|FG002|NOT COMPLETED|Overall Study||0||
60018006|NCT02333331|76133949|FG000|STARTED|Overall Study||19||
60018007|NCT02333331|76133950|FG001|STARTED|Overall Study||18||
60018008|NCT02333331|76133951|FG002|STARTED|Overall Study||113||
60018009|NCT02333331|76133952|FG003|STARTED|Overall Study||67||
60018010|NCT02333331|76133949|FG000|COMPLETED|Overall Study||17||
60018011|NCT02333331|76133950|FG001|COMPLETED|Overall Study||12||
60018012|NCT02333331|76133951|FG002|COMPLETED|Overall Study||95||
60018013|NCT02333331|76133952|FG003|COMPLETED|Overall Study||64||
60018014|NCT02333331|76133949|FG000|NOT COMPLETED|Overall Study||2||
60018015|NCT02333331|76133950|FG001|NOT COMPLETED|Overall Study||6||
60018016|NCT02333331|76133951|FG002|NOT COMPLETED|Overall Study||18||
60018017|NCT02333331|76133952|FG003|NOT COMPLETED|Overall Study||3||
60018018|NCT02563561|76133965|FG000|STARTED|Overall Study||19||
60018019|NCT02563561|76133966|FG001|STARTED|Overall Study||23||
60018020|NCT02563561|76133967|FG002|STARTED|Overall Study||20||
60018021|NCT02563561|76133965|FG000|Safety Population|Overall Study||19||
60018022|NCT02563561|76133966|FG001|Safety Population|Overall Study||21||
60018023|NCT02563561|76133967|FG002|Safety Population|Overall Study||17||
60018024|NCT02563561|76133965|FG000|COMPLETED|Overall Study||1||
59611539|NCT01777308|75722524|FG000|NOT COMPLETED|Overall Study||14||
59611540|NCT01777308|75722525|FG001|NOT COMPLETED|Overall Study||3||
60018025|NCT02563561|76133966|FG001|COMPLETED|Overall Study||2||
60018026|NCT02563561|76133967|FG002|COMPLETED|Overall Study||3||
60018027|NCT02563561|76133965|FG000|NOT COMPLETED|Overall Study||18||
59611541|NCT01759368|75722534|FG000|STARTED|Overall Study||47||
59611542|NCT01759368|75722535|FG001|STARTED|Overall Study||47||
59611543|NCT01759368|75722534|FG000|COMPLETED|Overall Study||46||
59611544|NCT01759368|75722535|FG001|COMPLETED|Overall Study||47||
59910544|NCT03422679|76031285|FG006|NOT COMPLETED|Overall Study||0||
59910545|NCT03422679|76031286|FG007|NOT COMPLETED|Overall Study||0||
59910546|NCT03422679|76031287|FG008|NOT COMPLETED|Overall Study||0||
59910547|NCT03422679|76031288|FG009|NOT COMPLETED|Overall Study||0||
59910548|NCT03422679|76031289|FG010|NOT COMPLETED|Overall Study||0||
59910549|NCT03422679|76031290|FG011|NOT COMPLETED|Overall Study||0||
59910550|NCT03422679|76031291|FG012|NOT COMPLETED|Overall Study||0||
59910551|NCT03361306|76031319|FG000|STARTED|Overall Study||15||
59910552|NCT03361306|76031319|FG000|COMPLETED|Overall Study||0||
59910553|NCT03361306|76031319|FG000|NOT COMPLETED|Overall Study||15||
59910554|NCT03325439|76031323|FG000|STARTED|Overall Study||9||
59910555|NCT03325439|76031323|FG000|Treated|Overall Study||6|Only 6 of 9 participants were treated with BRV.|
59910556|NCT03325439|76031323|FG000|COMPLETED|Overall Study||6||
59910557|NCT03325439|76031323|FG000|NOT COMPLETED|Overall Study||3||
59910558|NCT03301532|76031329|FG000|STARTED|Overall Study||10||
59910559|NCT03301532|76031329|FG000|COMPLETED|Overall Study||10||
59910560|NCT03301532|76031329|FG000|NOT COMPLETED|Overall Study||0||
59910561|NCT03246347|76031335|FG000|STARTED|Overall Study||40||
59910562|NCT03246347|76031335|FG000|COMPLETED|Overall Study|At the time of reporting for the primary objective, seventeen subjects have completed the study. Reasons for completion include death (N=13), consent withdrawal (N=3), and loss to follow-up (N=1). Twenty-three subjects remain on study and data is still captured.|17||
59910563|NCT03246347|76031335|FG000|NOT COMPLETED|Overall Study||23||
59910564|NCT03141177|76031342|FG000|STARTED|Overall Study||323|Started=Randomized|
59910565|NCT03141177|76031343|FG001|STARTED|Overall Study||50|Started=Randomized|
59910566|NCT03141177|76031344|FG002|STARTED|Overall Study||328|Started=Randomized|
59910567|NCT03141177|76031342|FG000|Treated|Overall Study||320|Treated=Started treatment period|
59910568|NCT03141177|76031343|FG001|Treated|Overall Study||50|Treated=Started treatment period|
59910569|NCT03141177|76031344|FG002|Treated|Overall Study||320|Treated=Started treatment period|
59910570|NCT03141177|76031342|FG000|COMPLETED|Overall Study||242|Completed=Continuing in the Study|
59910571|NCT03141177|76031343|FG001|COMPLETED|Overall Study||34|Completed=Continuing in the Study|
59910572|NCT03141177|76031344|FG002|COMPLETED|Overall Study||210|Completed=Continuing in the Study|
59910573|NCT03141177|76031342|FG000|NOT COMPLETED|Overall Study||81||
59910574|NCT03141177|76031343|FG001|NOT COMPLETED|Overall Study||16||
59910575|NCT03141177|76031344|FG002|NOT COMPLETED|Overall Study||118||
59951187|NCT03890120|76070118|FG000|STARTED|Open-Label Extension Phase (45 Weeks)|Participants who consented to enter the OLE Phase and completed the Blinded Study Phase Week 96 with an evaluable biopsy (noncirrhotic F0, F1, F2, and F3) as determined by the central reader and Blinded Study Phase follow-up visit entered OLE Phase.|0||
59951188|NCT03890120|76070119|FG001|STARTED|Open-Label Extension Phase (45 Weeks)|Participants who consented to enter the OLE Phase and completed the Blinded Study Phase Week 96 with an evaluable biopsy (noncirrhotic F0, F1, F2, and F3) as determined by the central reader and Blinded Study Phase follow-up visit entered OLE Phase.|0||
59951189|NCT03890120|76070120|FG002|STARTED|Open-Label Extension Phase (45 Weeks)|Participants who consented to enter the OLE Phase and completed the Blinded Study Phase Week 96 with an evaluable biopsy (noncirrhotic F0, F1, F2, and F3) as determined by the central reader and Blinded Study Phase follow-up visit entered OLE Phase.|80||
59951190|NCT03890120|76070121|FG003|STARTED|Open-Label Extension Phase (45 Weeks)|Participants who consented to enter the OLE Phase and completed the Blinded Study Phase Week 96 with an evaluable biopsy (noncirrhotic F0, F1, F2, and F3) as determined by the central reader and Blinded Study Phase follow-up visit entered OLE Phase.|45||
59951191|NCT03890120|76070118|FG000|COMPLETED|Open-Label Extension Phase (45 Weeks)||0||
59951192|NCT03890120|76070119|FG001|COMPLETED|Open-Label Extension Phase (45 Weeks)||0||
59951193|NCT03890120|76070120|FG002|COMPLETED|Open-Label Extension Phase (45 Weeks)||0||
59951194|NCT03890120|76070121|FG003|COMPLETED|Open-Label Extension Phase (45 Weeks)||0||
59951195|NCT03890120|76070118|FG000|NOT COMPLETED|Open-Label Extension Phase (45 Weeks)||0||
59951196|NCT03890120|76070119|FG001|NOT COMPLETED|Open-Label Extension Phase (45 Weeks)||0||
59951197|NCT03890120|76070120|FG002|NOT COMPLETED|Open-Label Extension Phase (45 Weeks)||80||
59951198|NCT03890120|76070121|FG003|NOT COMPLETED|Open-Label Extension Phase (45 Weeks)||45||
59951199|NCT03875235|76070133|FG000|STARTED|Overall Study||341||
59951200|NCT03875235|76070134|FG001|STARTED|Overall Study||344||
59951201|NCT03875235|76070133|FG000|Treated|Overall Study||338||
59951202|NCT03875235|76070134|FG001|Treated|Overall Study||342||
59951203|NCT03875235|76070133|FG000|COMPLETED|Overall Study||0||
59951204|NCT03875235|76070134|FG001|COMPLETED|Overall Study||0||
59951205|NCT03875235|76070133|FG000|NOT COMPLETED|Overall Study||341||
59951206|NCT03875235|76070134|FG001|NOT COMPLETED|Overall Study||344||
59951207|NCT03848325|76070140|FG000|STARTED|Overall Study||20||
59951208|NCT03848325|76070140|FG000|COMPLETED|Overall Study||20||
59910576|NCT03035864|76031355|FG000|STARTED|Treatment Period||120||
59910577|NCT03035864|76031356|FG001|STARTED|Treatment Period||60||
59910578|NCT03035864|76031355|FG000|COMPLETED|Treatment Period||116||
59910579|NCT03035864|76031356|FG001|COMPLETED|Treatment Period||59||
59910580|NCT03035864|76031355|FG000|NOT COMPLETED|Treatment Period||4||
59910581|NCT03035864|76031356|FG001|NOT COMPLETED|Treatment Period||1||
59910582|NCT03035864|76031355|FG000|STARTED|Follow-up Period||116||
59910583|NCT03035864|76031356|FG001|STARTED|Follow-up Period||59||
59910584|NCT03035864|76031355|FG000|COMPLETED|Follow-up Period||105||
59910585|NCT03035864|76031356|FG001|COMPLETED|Follow-up Period||55||
59910586|NCT03035864|76031355|FG000|NOT COMPLETED|Follow-up Period||11||
59910587|NCT03035864|76031356|FG001|NOT COMPLETED|Follow-up Period||4||
59910588|NCT02944071|76031362|FG000|STARTED|Overall Study||123||
59910589|NCT02944071|76031362|FG000|COMPLETED|Overall Study||113||
59910590|NCT02944071|76031362|FG000|NOT COMPLETED|Overall Study||10||
59910591|NCT02889809|76031368|FG000|STARTED|Overall Study||239||
59910592|NCT02889809|76031369|FG001|STARTED|Overall Study||238||
59910593|NCT02889809|76031368|FG000|COMPLETED|Overall Study||196||
59910594|NCT02889809|76031369|FG001|COMPLETED|Overall Study||205||
59910595|NCT02889809|76031368|FG000|NOT COMPLETED|Overall Study||43||
59910596|NCT02889809|76031369|FG001|NOT COMPLETED|Overall Study||33||
59910597|NCT02759107|76031393|FG000|STARTED|Overall Study||14||
59910598|NCT02759107|76031394|FG001|STARTED|Overall Study||6||
59910599|NCT02759107|76031395|FG002|STARTED|Overall Study||12||
59910600|NCT02759107|76031396|FG003|STARTED|Overall Study||5||
59910601|NCT02759107|76031397|FG004|STARTED|Overall Study||6||
59910602|NCT02759107|76031398|FG005|STARTED|Overall Study||6||
59910603|NCT02759107|76031399|FG006|STARTED|Overall Study||7||
59910604|NCT02759107|76031400|FG007|STARTED|Overall Study||4||
59910605|NCT02759107|76031401|FG008|STARTED|Overall Study||4||
59910606|NCT02759107|76031402|FG009|STARTED|Overall Study||6||
59910607|NCT02759107|76031403|FG010|STARTED|Overall Study||6||
59910608|NCT02759107|76031404|FG011|STARTED|Overall Study||6||
59910609|NCT02759107|76031405|FG012|STARTED|Overall Study||7||
59910610|NCT02759107|76031406|FG013|STARTED|Overall Study||11||
59910611|NCT02759107|76031407|FG014|STARTED|Overall Study||9||
59910612|NCT02759107|76031408|FG015|STARTED|Overall Study||9||
59910613|NCT02759107|76031409|FG016|STARTED|Overall Study||12||
59910614|NCT02759107|76031410|FG017|STARTED|Overall Study||12||
59910615|NCT02759107|76031393|FG000|Received at Least One Dose of Study Drug|Overall Study||14||
59910616|NCT02759107|76031394|FG001|Received at Least One Dose of Study Drug|Overall Study||6||
59910617|NCT02759107|76031395|FG002|Received at Least One Dose of Study Drug|Overall Study||12||
59910618|NCT02759107|76031396|FG003|Received at Least One Dose of Study Drug|Overall Study||5||
59910619|NCT02759107|76031397|FG004|Received at Least One Dose of Study Drug|Overall Study||6||
59910620|NCT02759107|76031398|FG005|Received at Least One Dose of Study Drug|Overall Study||6||
59910621|NCT02759107|76031399|FG006|Received at Least One Dose of Study Drug|Overall Study||7||
59910622|NCT02759107|76031400|FG007|Received at Least One Dose of Study Drug|Overall Study||4||
59910623|NCT02759107|76031401|FG008|Received at Least One Dose of Study Drug|Overall Study||4||
59910624|NCT02759107|76031402|FG009|Received at Least One Dose of Study Drug|Overall Study||6||
59910625|NCT02759107|76031403|FG010|Received at Least One Dose of Study Drug|Overall Study||6||
59910626|NCT02759107|76031404|FG011|Received at Least One Dose of Study Drug|Overall Study||6||
59910627|NCT02759107|76031405|FG012|Received at Least One Dose of Study Drug|Overall Study||7||
59910628|NCT02759107|76031406|FG013|Received at Least One Dose of Study Drug|Overall Study||11||
59910629|NCT02759107|76031407|FG014|Received at Least One Dose of Study Drug|Overall Study||9||
59910630|NCT02759107|76031408|FG015|Received at Least One Dose of Study Drug|Overall Study||9||
59910631|NCT02759107|76031409|FG016|Received at Least One Dose of Study Drug|Overall Study||12||
59910632|NCT02759107|76031410|FG017|Received at Least One Dose of Study Drug|Overall Study||12||
59910633|NCT02759107|76031393|FG000|COMPLETED|Overall Study||14||
59910634|NCT02759107|76031394|FG001|COMPLETED|Overall Study||6||
59506873|NCT00244751|75599991|FG001|COMPLETED|Overall Study||74||
59506874|NCT00244751|75599992|FG002|COMPLETED|Overall Study||78||
59506875|NCT00244751|75599990|FG000|NOT COMPLETED|Overall Study||16||
59910635|NCT02759107|76031395|FG002|COMPLETED|Overall Study||12||
59910636|NCT02759107|76031396|FG003|COMPLETED|Overall Study||5||
59910637|NCT02759107|76031397|FG004|COMPLETED|Overall Study||6||
59910638|NCT02759107|76031398|FG005|COMPLETED|Overall Study||6||
59506876|NCT00244751|75599991|FG001|NOT COMPLETED|Overall Study||15||
59910639|NCT02759107|76031399|FG006|COMPLETED|Overall Study||7||
59910640|NCT02759107|76031400|FG007|COMPLETED|Overall Study||4||
59910641|NCT02759107|76031401|FG008|COMPLETED|Overall Study||4||
59758606|NCT00668642|75877933|FG001|STARTED|Second AAT Treatment (On-cycle 2)||6||
59758607|NCT00668642|75877932|FG000|COMPLETED|Second AAT Treatment (On-cycle 2)||4||
60018028|NCT02563561|76133966|FG001|NOT COMPLETED|Overall Study||21||
60018029|NCT02563561|76133967|FG002|NOT COMPLETED|Overall Study||17||
60018030|NCT02559505|76133983|FG000|STARTED|Overall Study||49||
60018031|NCT02559505|76133984|FG001|STARTED|Overall Study||84||
60018032|NCT02559505|76133983|FG000|COMPLETED|Overall Study||22||
60018033|NCT02559505|76133984|FG001|COMPLETED|Overall Study||62||
60018034|NCT02559505|76133983|FG000|NOT COMPLETED|Overall Study||27||
60018035|NCT02559505|76133984|FG001|NOT COMPLETED|Overall Study||22||
60018036|NCT04201639|76134002|FG000|STARTED|Overall Study||32||
60018037|NCT04201639|76134002|FG000|COMPLETED|Overall Study||32||
60018038|NCT04201639|76134002|FG000|NOT COMPLETED|Overall Study||0||
60018039|NCT04191967|76134006|FG000|STARTED|Screening & Thermocoagulation (Ablation)|Participants screened for cervical cancer using HPV testing|379||
60018040|NCT04191967|76134006|FG000|COMPLETED|Screening & Thermocoagulation (Ablation)||293||
60018041|NCT04191967|76134006|FG000|NOT COMPLETED|Screening & Thermocoagulation (Ablation)||86||
60018042|NCT04191967|76134006|FG000|STARTED|12 Month Follow-up||58||
60018043|NCT04191967|76134006|FG000|COMPLETED|12 Month Follow-up||54||
60018044|NCT04191967|76134006|FG000|NOT COMPLETED|12 Month Follow-up||4||
60018045|NCT02556307|76134012|FG000|STARTED|Overall Study||270||
60018046|NCT02556307|76134012|FG000|Treated|Overall Study||268||
60018047|NCT02556307|76134012|FG000|COMPLETED|Overall Study||217||
60018048|NCT02556307|76134012|FG000|NOT COMPLETED|Overall Study||53||
60018049|NCT04364737|76134018|FG000|STARTED|Overall Study||468||
60018050|NCT04364737|76134019|FG001|STARTED|Overall Study||473||
60018051|NCT04364737|76134018|FG000|COMPLETED|Overall Study||463||
60018052|NCT04364737|76134019|FG001|COMPLETED|Overall Study||463||
60018053|NCT04364737|76134018|FG000|NOT COMPLETED|Overall Study||5||
60018054|NCT04364737|76134019|FG001|NOT COMPLETED|Overall Study||10||
60018055|NCT02559115|76134025|FG000|STARTED|Overall Study||19||
60018056|NCT02559115|76134025|FG000|COMPLETED|Overall Study||16||
60018057|NCT02559115|76134025|FG000|NOT COMPLETED|Overall Study||3||
60018058|NCT00609115|76134031|FG000|STARTED|Controlled Period||44||
60018059|NCT00609115|76134032|FG001|STARTED|Controlled Period||39||
60018060|NCT00609115|76134033|FG002|STARTED|Controlled Period||0||
60018061|NCT00609115|76134031|FG000|COMPLETED|Controlled Period||38||
60018062|NCT00609115|76134032|FG001|COMPLETED|Controlled Period||35||
60018063|NCT00609115|76134033|FG002|COMPLETED|Controlled Period||0||
60018064|NCT00609115|76134031|FG000|NOT COMPLETED|Controlled Period||6||
60018065|NCT00609115|76134032|FG001|NOT COMPLETED|Controlled Period||4||
60018066|NCT00609115|76134033|FG002|NOT COMPLETED|Controlled Period||0||
60018067|NCT00609115|76134031|FG000|STARTED|Crossover Period||0||
60018068|NCT00609115|76134032|FG001|STARTED|Crossover Period||0||
60018069|NCT00609115|76134033|FG002|STARTED|Crossover Period||27||
60018070|NCT00609115|76134031|FG000|COMPLETED|Crossover Period||0||
60018071|NCT00609115|76134032|FG001|COMPLETED|Crossover Period||0||
60018072|NCT00609115|76134033|FG002|COMPLETED|Crossover Period||22||
60018073|NCT00609115|76134031|FG000|NOT COMPLETED|Crossover Period||0||
60018074|NCT00609115|76134032|FG001|NOT COMPLETED|Crossover Period||0||
60018075|NCT00609115|76134033|FG002|NOT COMPLETED|Crossover Period||5||
60018076|NCT01662895|76134043|FG000|STARTED|Overall Study||21||
60018077|NCT01662895|76134044|FG001|STARTED|Overall Study||21||
60018078|NCT01662895|76134043|FG000|Initiated Study Drug|Overall Study||21||
60018079|NCT01662895|76134044|FG001|Initiated Study Drug|Overall Study||21||
60018080|NCT01662895|76134043|FG000|COMPLETED|Overall Study||21||
60018081|NCT01662895|76134044|FG001|COMPLETED|Overall Study||20||
60018082|NCT01662895|76134043|FG000|NOT COMPLETED|Overall Study||0||
60018083|NCT01662895|76134044|FG001|NOT COMPLETED|Overall Study||1||
60018084|NCT02557399|76134052|FG000|STARTED|Overall Study||172||
60018085|NCT02557399|76134053|FG001|STARTED|Overall Study||177||
60018086|NCT02557399|76134052|FG000|COMPLETED|Overall Study||165||
60018087|NCT02557399|76134053|FG001|COMPLETED|Overall Study||169||
60018088|NCT02557399|76134052|FG000|NOT COMPLETED|Overall Study||7||
60018089|NCT02557399|76134053|FG001|NOT COMPLETED|Overall Study||8||
60018090|NCT02555371|76134062|FG000|STARTED|PartA(Upto 132W)+PartB(Upto 8W)||306|Variable & fixed run-in periods have been combined since all par. received OL mepolizumab 100 mg SC|
60018091|NCT02555371|76134063|FG001|STARTED|PartA(Upto 132W)+PartB(Upto 8W)||0|Variable & fixed run-in periods have been combined since all par. received OL mepolizumab 100 mg SC|
59758608|NCT00668642|75877933|FG001|COMPLETED|Second AAT Treatment (On-cycle 2)||5||
59758609|NCT00668642|75877932|FG000|NOT COMPLETED|Second AAT Treatment (On-cycle 2)||2||
59758610|NCT00668642|75877933|FG001|NOT COMPLETED|Second AAT Treatment (On-cycle 2)||1||
59758611|NCT00668642|75877932|FG000|STARTED|Second Off Treatment (Off-cycle 2)||4||
59758612|NCT00668642|75877933|FG001|STARTED|Second Off Treatment (Off-cycle 2)||5||
59758613|NCT00668642|75877932|FG000|Research Biopsy|Second Off Treatment (Off-cycle 2)||2|A research biopsy of the prostate was planned at end of off-cycle 2 to determine expression of U19 tumor suppressor gene|
59758614|NCT00668642|75877933|FG001|Research Biopsy|Second Off Treatment (Off-cycle 2)||2|A research biopsy of the prostate was planned at end of off-cycle 2 to determine expression of U19 tumor suppressor gene|
59758615|NCT00668642|75877932|FG000|COMPLETED|Second Off Treatment (Off-cycle 2)||4||
59758616|NCT00668642|75877933|FG001|COMPLETED|Second Off Treatment (Off-cycle 2)||5||
59758617|NCT00668642|75877932|FG000|NOT COMPLETED|Second Off Treatment (Off-cycle 2)||0||
59758618|NCT00668642|75877933|FG001|NOT COMPLETED|Second Off Treatment (Off-cycle 2)||0||
59758619|NCT00609791|75877939|FG000|STARTED|Overall Study||40||
59758620|NCT00609791|75877939|FG000|COMPLETED|Overall Study||39||
59758621|NCT00609791|75877939|FG000|NOT COMPLETED|Overall Study||1||
59758622|NCT00482677|75877945|FG000|STARTED|Overall Study||281||
59758623|NCT00482677|75877946|FG001|STARTED|Overall Study||281||
59910642|NCT02759107|76031402|FG009|COMPLETED|Overall Study||5||
59910643|NCT02759107|76031403|FG010|COMPLETED|Overall Study||6||
59910644|NCT02759107|76031404|FG011|COMPLETED|Overall Study||6||
59910645|NCT02759107|76031405|FG012|COMPLETED|Overall Study||5||
59910646|NCT02759107|76031406|FG013|COMPLETED|Overall Study||11||
59910647|NCT02759107|76031407|FG014|COMPLETED|Overall Study||9||
59910648|NCT02759107|76031408|FG015|COMPLETED|Overall Study||8||
59910649|NCT02759107|76031409|FG016|COMPLETED|Overall Study||12||
59910650|NCT02759107|76031410|FG017|COMPLETED|Overall Study||10||
59910651|NCT02759107|76031393|FG000|NOT COMPLETED|Overall Study||0||
59910652|NCT02759107|76031394|FG001|NOT COMPLETED|Overall Study||0||
59910653|NCT02759107|76031395|FG002|NOT COMPLETED|Overall Study||0||
59910654|NCT02759107|76031396|FG003|NOT COMPLETED|Overall Study||0||
59910655|NCT02759107|76031397|FG004|NOT COMPLETED|Overall Study||0||
59910656|NCT02759107|76031398|FG005|NOT COMPLETED|Overall Study||0||
59910657|NCT02759107|76031399|FG006|NOT COMPLETED|Overall Study||0||
59910658|NCT02759107|76031400|FG007|NOT COMPLETED|Overall Study||0||
59910659|NCT02759107|76031401|FG008|NOT COMPLETED|Overall Study||0||
59910660|NCT02759107|76031402|FG009|NOT COMPLETED|Overall Study||1||
59910661|NCT02759107|76031403|FG010|NOT COMPLETED|Overall Study||0||
59910662|NCT02759107|76031404|FG011|NOT COMPLETED|Overall Study||0||
59910663|NCT02759107|76031405|FG012|NOT COMPLETED|Overall Study||2||
59910664|NCT02759107|76031406|FG013|NOT COMPLETED|Overall Study||0||
59910665|NCT02759107|76031407|FG014|NOT COMPLETED|Overall Study||0||
59910666|NCT02759107|76031408|FG015|NOT COMPLETED|Overall Study||1||
59910667|NCT02759107|76031409|FG016|NOT COMPLETED|Overall Study||0||
59910668|NCT02759107|76031410|FG017|NOT COMPLETED|Overall Study||2||
59910669|NCT02658968|76031456|FG000|STARTED|Received Rituximab||3||
59910670|NCT02658968|76031457|FG001|STARTED|Received Rituximab||3||
59910671|NCT02658968|76031458|FG002|STARTED|Received Rituximab||3||
59910672|NCT02658968|76031459|FG003|STARTED|Received Rituximab||7||
59910673|NCT02658968|76031460|FG004|STARTED|Received Rituximab||2||
59910674|NCT02658968|76031456|FG000|COMPLETED|Received Rituximab||3||
59758624|NCT00482677|75877945|FG000|COMPLETED|Overall Study||281||
59910675|NCT02658968|76031457|FG001|COMPLETED|Received Rituximab||3||
59910676|NCT02658968|76031458|FG002|COMPLETED|Received Rituximab||3||
59910677|NCT02658968|76031459|FG003|COMPLETED|Received Rituximab||7||
59910678|NCT02658968|76031460|FG004|COMPLETED|Received Rituximab||0||
60018092|NCT02555371|76134064|FG002|STARTED|PartA(Upto 132W)+PartB(Upto 8W)||0|Variable & fixed run-in periods have been combined since all par. received OL mepolizumab 100 mg SC|
60067724|NCT01617187|76182894|FG003|COMPLETED|Treatment Through Study Completion||91||
59506877|NCT00244751|75599992|FG002|NOT COMPLETED|Overall Study||10||
59506878|NCT00799981|75600009|FG000|STARTED|Overall Study||10|It differs between subjects if they are catheterisized twice per visit or one catheterisation at each visit. The subjects that were catheterisized twice during one day had at least 2 hours between 2 catheterizations.|
59519009|NCT03587428|75612870|FG000|NOT COMPLETED|Period 2||0||
59758625|NCT00482677|75877946|FG001|COMPLETED|Overall Study||281||
59758626|NCT00482677|75877945|FG000|NOT COMPLETED|Overall Study||0||
59758627|NCT00482677|75877946|FG001|NOT COMPLETED|Overall Study||0||
59910679|NCT02658968|76031456|FG000|NOT COMPLETED|Received Rituximab||0||
59758628|NCT00101101|75877952|FG000|STARTED|Overall Study||43||
59758629|NCT00101101|75877952|FG000|COMPLETED|Overall Study|Participants who received at least one vaccine injection.|23||
59758630|NCT00101101|75877952|FG000|NOT COMPLETED|Overall Study||20||
59758631|NCT03962101|75877956|FG000|STARTED|Overall Study||45||
59758632|NCT03962101|75877956|FG000|COMPLETED|Overall Study||41||
59758633|NCT03962101|75877956|FG000|NOT COMPLETED|Overall Study||4||
59758634|NCT00923351|75877963|FG000|STARTED|Overall Study||6||
59758635|NCT00923351|75877964|FG001|STARTED|Overall Study||26||
59758636|NCT00923351|75877965|FG002|STARTED|Overall Study||12||
59758637|NCT00923351|75877963|FG000|COMPLETED|Overall Study||6||
59758638|NCT00923351|75877964|FG001|COMPLETED|Overall Study||26||
59758639|NCT00923351|75877965|FG002|COMPLETED|Overall Study||0||
59758640|NCT00923351|75877963|FG000|NOT COMPLETED|Overall Study||0||
59910680|NCT02658968|76031457|FG001|NOT COMPLETED|Received Rituximab||0||
59910681|NCT02658968|76031458|FG002|NOT COMPLETED|Received Rituximab||0||
59910682|NCT02658968|76031459|FG003|NOT COMPLETED|Received Rituximab||0||
59910683|NCT02658968|76031460|FG004|NOT COMPLETED|Received Rituximab||2||
59910684|NCT02658968|76031456|FG000|STARTED|Received Lilotomab and Betalutin||3||
59910685|NCT02658968|76031457|FG001|STARTED|Received Lilotomab and Betalutin||3||
59910686|NCT02658968|76031458|FG002|STARTED|Received Lilotomab and Betalutin||3||
59910687|NCT02658968|76031459|FG003|STARTED|Received Lilotomab and Betalutin||7||
59910688|NCT02658968|76031460|FG004|STARTED|Received Lilotomab and Betalutin||0||
59910689|NCT02658968|76031456|FG000|COMPLETED|Received Lilotomab and Betalutin||0||
59910690|NCT02658968|76031457|FG001|COMPLETED|Received Lilotomab and Betalutin||0||
59910691|NCT02658968|76031458|FG002|COMPLETED|Received Lilotomab and Betalutin||0||
59506879|NCT00799981|75600010|FG001|STARTED|Overall Study||9|It differs between subjects if they are catheterisized twice per visit or one catheterisation at each visit. The subjects that were catheterisized twice during one day had at least 2 hours between 2 catheterizations.|
59506880|NCT00799981|75600011|FG002|STARTED|Overall Study||10|It differs between subjects if they are catheterisized twice per visit or one catheterisation at each visit. The subjects that were catheterisized twice during one day had at least 2 hours between 2 catheterizations.|
59506881|NCT00799981|75600012|FG003|STARTED|Overall Study||10|It differs between subjects if they are catheterisized twice per visit or one catheterisation at each visit. The subjects that were catheterisized twice during one day had at least 2 hours between 2 catheterizations.|
59506882|NCT00799981|75600013|FG004|STARTED|Overall Study||11|It differs between subjects if they are catheterisized twice per visit or one catheterisation at each visit. The subjects that were catheterisized twice during one day had at least 2 hours between 2 catheterizations.|
59506883|NCT00799981|75600014|FG005|STARTED|Overall Study||10|It differs between subjects if they are catheterisized twice per visit or one catheterisation at each visit. The subjects that were catheterisized twice during one day had at least 2 hours between 2 catheterizations.|
59758641|NCT00923351|75877964|FG001|NOT COMPLETED|Overall Study||0||
59758642|NCT00923351|75877965|FG002|NOT COMPLETED|Overall Study||12||
60018093|NCT02555371|76134065|FG003|STARTED|PartA(Upto 132W)+PartB(Upto 8W)||0|Variable & fixed run-in periods have been combined since all par. received OL mepolizumab 100 mg SC|
60018094|NCT02555371|76134066|FG004|STARTED|PartA(Upto 132W)+PartB(Upto 8W)||0|Variable & fixed run-in periods have been combined since all par. received OL mepolizumab 100 mg SC|
60018095|NCT02555371|76134062|FG000|COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||295||
60018096|NCT02555371|76134063|FG001|COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0||
60018097|NCT02555371|76134064|FG002|COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0||
60018098|NCT02555371|76134065|FG003|COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0||
60018099|NCT02555371|76134066|FG004|COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0||
60018100|NCT02555371|76134062|FG000|NOT COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||11||
60018101|NCT02555371|76134063|FG001|NOT COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0||
60018102|NCT02555371|76134064|FG002|NOT COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0||
60018103|NCT02555371|76134065|FG003|NOT COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0||
60018104|NCT02555371|76134066|FG004|NOT COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0||
60018105|NCT02555371|76134062|FG000|STARTED|Part C (DB Period: Up to 52W)||0|Double-blind Treatment Period|
60018106|NCT02555371|76134063|FG001|STARTED|Part C (DB Period: Up to 52W)||151|Double-blind Treatment Period|
60018107|NCT02555371|76134064|FG002|STARTED|Part C (DB Period: Up to 52W)||144|Double-blind Treatment Period|
60018108|NCT02555371|76134065|FG003|STARTED|Part C (DB Period: Up to 52W)||0|Double-blind Treatment Period|
60018109|NCT02555371|76134066|FG004|STARTED|Part C (DB Period: Up to 52W)||0|Double-blind Treatment Period|
60018110|NCT02555371|76134062|FG000|COMPLETED|Part C (DB Period: Up to 52W)||0||
60018111|NCT02555371|76134063|FG001|COMPLETED|Part C (DB Period: Up to 52W)||62||
60018112|NCT02555371|76134064|FG002|COMPLETED|Part C (DB Period: Up to 52W)||96||
60018113|NCT02555371|76134065|FG003|COMPLETED|Part C (DB Period: Up to 52W)||0||
60018114|NCT02555371|76134066|FG004|COMPLETED|Part C (DB Period: Up to 52W)||0||
60018115|NCT02555371|76134062|FG000|NOT COMPLETED|Part C (DB Period: Up to 52W)||0||
60018116|NCT02555371|76134063|FG001|NOT COMPLETED|Part C (DB Period: Up to 52W)||89||
60018117|NCT02555371|76134064|FG002|NOT COMPLETED|Part C (DB Period: Up to 52W)||48||
60018118|NCT02555371|76134065|FG003|NOT COMPLETED|Part C (DB Period: Up to 52W)||0||
60018119|NCT02555371|76134066|FG004|NOT COMPLETED|Part C (DB Period: Up to 52W)||0||
60018120|NCT02555371|76134062|FG000|STARTED|PartD(OL: 52W Post-randomization PartC)||0||
60018121|NCT02555371|76134063|FG001|STARTED|PartD(OL: 52W Post-randomization PartC)||0||
60018122|NCT02555371|76134064|FG002|STARTED|PartD(OL: 52W Post-randomization PartC)||0||
60018123|NCT02555371|76134065|FG003|STARTED|PartD(OL: 52W Post-randomization PartC)||84||
60018124|NCT02555371|76134066|FG004|STARTED|PartD(OL: 52W Post-randomization PartC)||45||
60018125|NCT02555371|76134062|FG000|COMPLETED|PartD(OL: 52W Post-randomization PartC)||0||
59506884|NCT00799981|75600009|FG000|COMPLETED|Overall Study||10||
59506885|NCT00799981|75600010|FG001|COMPLETED|Overall Study||9||
59506886|NCT00799981|75600011|FG002|COMPLETED|Overall Study||10||
59506887|NCT00799981|75600012|FG003|COMPLETED|Overall Study||10||
59506888|NCT00799981|75600013|FG004|COMPLETED|Overall Study||11||
59506889|NCT00799981|75600014|FG005|COMPLETED|Overall Study||10||
59506890|NCT00799981|75600009|FG000|NOT COMPLETED|Overall Study||0||
59506891|NCT00799981|75600010|FG001|NOT COMPLETED|Overall Study||0||
59506892|NCT00799981|75600011|FG002|NOT COMPLETED|Overall Study||0||
59506893|NCT00799981|75600012|FG003|NOT COMPLETED|Overall Study||0||
59506894|NCT00799981|75600013|FG004|NOT COMPLETED|Overall Study||0||
59506895|NCT00799981|75600014|FG005|NOT COMPLETED|Overall Study||0||
59506896|NCT00813319|75600025|FG000|STARTED|Overall Study||108||
59506897|NCT00813319|75600026|FG001|STARTED|Overall Study||108||
59506898|NCT00813319|75600025|FG000|COMPLETED|Overall Study|100 out of 108 have complete follow-up data, there were 8 missing charts 7 months post-randomization|108||
59506899|NCT00813319|75600026|FG001|COMPLETED|Overall Study|104 out of 108 have complete follow-up data, there were 4 missing charts 7 months post-randomization|108||
59506900|NCT00813319|75600025|FG000|NOT COMPLETED|Overall Study||0||
59910692|NCT02658968|76031459|FG003|COMPLETED|Received Lilotomab and Betalutin||1||
59910693|NCT02658968|76031460|FG004|COMPLETED|Received Lilotomab and Betalutin||0||
59910694|NCT02658968|76031456|FG000|NOT COMPLETED|Received Lilotomab and Betalutin||3||
59910695|NCT02658968|76031457|FG001|NOT COMPLETED|Received Lilotomab and Betalutin||3||
59910696|NCT02658968|76031458|FG002|NOT COMPLETED|Received Lilotomab and Betalutin||3||
59910697|NCT02658968|76031459|FG003|NOT COMPLETED|Received Lilotomab and Betalutin||6||
59910698|NCT02658968|76031460|FG004|NOT COMPLETED|Received Lilotomab and Betalutin||0||
59910699|NCT02604940|76031473|FG000|STARTED|Overall Study||26||
59910700|NCT02604940|76031474|FG001|STARTED|Overall Study||20||
59910701|NCT02604940|76031473|FG000|COMPLETED|Overall Study||26||
59910702|NCT02604940|76031474|FG001|COMPLETED|Overall Study||20||
59910703|NCT02604940|76031473|FG000|NOT COMPLETED|Overall Study||0||
59910704|NCT02604940|76031474|FG001|NOT COMPLETED|Overall Study||0||
59910705|NCT02581137|76031480|FG000|STARTED|Overall Study||26||
59910706|NCT02581137|76031480|FG000|COMPLETED|Overall Study||22||
59910707|NCT02581137|76031480|FG000|NOT COMPLETED|Overall Study||4||
59910708|NCT02441803|76031487|FG000|STARTED|Overall Study||1||
59506901|NCT00813319|75600026|FG001|NOT COMPLETED|Overall Study||0||
59506902|NCT00243659|75600034|FG000|STARTED|Overall Study||22||
59506903|NCT00243659|75600035|FG001|STARTED|Overall Study||8||
59506904|NCT00243659|75600034|FG000|COMPLETED|Overall Study||20||
59506905|NCT00243659|75600035|FG001|COMPLETED|Overall Study||5||
59506906|NCT00243659|75600034|FG000|NOT COMPLETED|Overall Study||2||
59910709|NCT02441803|76031488|FG001|STARTED|Overall Study||8||
59910710|NCT02441803|76031489|FG002|STARTED|Overall Study||2||
59506907|NCT00243659|75600035|FG001|NOT COMPLETED|Overall Study||3||
59910711|NCT02441803|76031487|FG000|COMPLETED|Overall Study||1||
59910712|NCT02441803|76031488|FG001|COMPLETED|Overall Study||6||
59910713|NCT02441803|76031489|FG002|COMPLETED|Overall Study||0||
59910714|NCT02441803|76031487|FG000|NOT COMPLETED|Overall Study||0||
59910715|NCT02441803|76031488|FG001|NOT COMPLETED|Overall Study||2||
59910716|NCT02441803|76031489|FG002|NOT COMPLETED|Overall Study||2||
59506908|NCT00814177|75600043|FG000|STARTED|Overall Study||80||
59506909|NCT00814177|75600044|FG001|STARTED|Overall Study||80||
59506910|NCT00814177|75600043|FG000|COMPLETED|Overall Study||80||
59910717|NCT02418026|76031499|FG000|STARTED|Overall Study||44||
59910718|NCT02418026|76031500|FG001|STARTED|Overall Study||35||
59910719|NCT02418026|76031499|FG000|COMPLETED|Overall Study||44||
59910720|NCT02418026|76031500|FG001|COMPLETED|Overall Study||35||
59910721|NCT02418026|76031499|FG000|NOT COMPLETED|Overall Study||0||
59910722|NCT02418026|76031500|FG001|NOT COMPLETED|Overall Study||0||
59506911|NCT00814177|75600044|FG001|COMPLETED|Overall Study||80||
59506912|NCT00814177|75600043|FG000|NOT COMPLETED|Overall Study||0||
59506913|NCT00814177|75600044|FG001|NOT COMPLETED|Overall Study||0||
59506914|NCT00243347|75600050|FG000|STARTED|Overall Study|Treated|19||
59506915|NCT00243347|75600050|FG000|COMPLETED|Overall Study|Completed study|0||
59506916|NCT00243347|75600050|FG000|NOT COMPLETED|Overall Study||19||
59506917|NCT00243269|75600058|FG000|STARTED|Overall Study||31||
59758643|NCT00755937|75877971|FG000|STARTED|Recruitment|Subjects registered in the program|556||
59910723|NCT02385110|76031508|FG000|STARTED|Overall Study||2||
59910724|NCT02385110|76031509|FG001|STARTED|Overall Study||16||
59506918|NCT00243269|75600059|FG001|STARTED|Overall Study||11||
59506919|NCT00243269|75600060|FG002|STARTED|Overall Study||12||
59506920|NCT00243269|75600061|FG003|STARTED|Overall Study||29||
59506921|NCT00243269|75600058|FG000|COMPLETED|Overall Study||28||
59506922|NCT00243269|75600059|FG001|COMPLETED|Overall Study||10||
59506923|NCT00243269|75600060|FG002|COMPLETED|Overall Study||11||
59506924|NCT00243269|75600061|FG003|COMPLETED|Overall Study||25||
59611545|NCT01759368|75722534|FG000|NOT COMPLETED|Overall Study||1||
59758644|NCT00755937|75877971|FG000|COMPLETED|Recruitment|Subjects who had a baseline visit and at least 1 additional follow-up visit (analyzed population)|392||
59910725|NCT02385110|76031508|FG000|COMPLETED|Overall Study||1||
59910726|NCT02385110|76031509|FG001|COMPLETED|Overall Study||16||
59910727|NCT02385110|76031508|FG000|NOT COMPLETED|Overall Study||1||
59910728|NCT02385110|76031509|FG001|NOT COMPLETED|Overall Study||0||
60018126|NCT02555371|76134063|FG001|COMPLETED|PartD(OL: 52W Post-randomization PartC)||0||
60018127|NCT02555371|76134064|FG002|COMPLETED|PartD(OL: 52W Post-randomization PartC)||0||
60018128|NCT02555371|76134065|FG003|COMPLETED|PartD(OL: 52W Post-randomization PartC)||80||
60018129|NCT02555371|76134066|FG004|COMPLETED|PartD(OL: 52W Post-randomization PartC)||42||
60018130|NCT02555371|76134062|FG000|NOT COMPLETED|PartD(OL: 52W Post-randomization PartC)||0||
60018131|NCT02555371|76134063|FG001|NOT COMPLETED|PartD(OL: 52W Post-randomization PartC)||0||
60018132|NCT02555371|76134064|FG002|NOT COMPLETED|PartD(OL: 52W Post-randomization PartC)||0||
60018133|NCT02555371|76134065|FG003|NOT COMPLETED|PartD(OL: 52W Post-randomization PartC)||4||
60018134|NCT02555371|76134066|FG004|NOT COMPLETED|PartD(OL: 52W Post-randomization PartC)||3||
60018135|NCT02555215|76134075|FG000|STARTED|Overall Study||20||
60018136|NCT02555215|76134075|FG000|COMPLETED|Overall Study||17||
60018137|NCT02555215|76134075|FG000|NOT COMPLETED|Overall Study||3||
60018138|NCT02555683|76134082|FG000|STARTED|Overall Study||301||
59611546|NCT01759368|75722535|FG001|NOT COMPLETED|Overall Study||0||
59758645|NCT00755937|75877971|FG000|NOT COMPLETED|Recruitment||164||
59758646|NCT00755937|75877971|FG000|STARTED|Observational Follow-up||392||
59758647|NCT00755937|75877971|FG000|COMPLETED|Observational Follow-up|Subjects followed until end of study/subjects for whom end of participation data were collected|244||
59758648|NCT00755937|75877971|FG000|NOT COMPLETED|Observational Follow-up||148||
59758649|NCT00755079|75877977|FG000|STARTED|Overall Study||18||
59758650|NCT00755079|75877978|FG001|STARTED|Overall Study||22||
59910729|NCT02138110|76031515|FG000|STARTED|Enrolled in Study||20||
59910730|NCT02138110|76031515|FG000|COMPLETED|Enrolled in Study||20||
59910731|NCT02138110|76031515|FG000|NOT COMPLETED|Enrolled in Study||0||
59910732|NCT02138110|76031515|FG000|STARTED|Enrolled for Scaffold Implantation||20||
60018139|NCT02555683|76134083|FG001|STARTED|Overall Study||295||
60018140|NCT02555683|76134084|FG002|STARTED|Overall Study||298||
60018141|NCT02555683|76134082|FG000|FAS/SAF: High Eosinophil Subpopulation|Overall Study||200|Full analysis set/safety set. All patients who received study drug and had high eosinophils count|
59910733|NCT02138110|76031515|FG000|COMPLETED|Enrolled for Scaffold Implantation||19||
59910734|NCT02138110|76031515|FG000|NOT COMPLETED|Enrolled for Scaffold Implantation||1||
59910735|NCT02138110|76031515|FG000|STARTED|Overall Scaffold Implantation||19||
59910736|NCT02138110|76031515|FG000|6-month Follow-Up|Overall Scaffold Implantation||16||
59910737|NCT02138110|76031515|FG000|COMPLETED|Overall Scaffold Implantation||16||
59910738|NCT02138110|76031515|FG000|NOT COMPLETED|Overall Scaffold Implantation||3||
59611547|NCT01777152|75722545|FG000|STARTED|Overall Study||226||
59611548|NCT01777152|75722546|FG001|STARTED|Overall Study||226||
59611549|NCT01777152|75722545|FG000|COMPLETED|Overall Study||131|Completed due to study closure by sponsor|
59611550|NCT01777152|75722546|FG001|COMPLETED|Overall Study||116|Completed due to study closure by sponsor|
59611551|NCT01777152|75722545|FG000|NOT COMPLETED|Overall Study||95||
59910739|NCT01898793|76031526|FG000|STARTED|Overall Study||5||
59910740|NCT01898793|76031527|FG001|STARTED|Overall Study||5||
59910741|NCT01898793|76031528|FG002|STARTED|Overall Study||9||
59910742|NCT01898793|76031529|FG003|STARTED|Overall Study||8||
59910743|NCT01898793|76031530|FG004|STARTED|Overall Study||9||
59910744|NCT01898793|76031531|FG005|STARTED|Overall Study||8||
59910745|NCT01898793|76031532|FG006|STARTED|Overall Study||45||
59910746|NCT01898793|76031526|FG000|COMPLETED|Overall Study||3||
59910747|NCT01898793|76031527|FG001|COMPLETED|Overall Study||4||
59910748|NCT01898793|76031528|FG002|COMPLETED|Overall Study||5||
59910749|NCT01898793|76031529|FG003|COMPLETED|Overall Study||8||
59910750|NCT01898793|76031530|FG004|COMPLETED|Overall Study||9||
59910751|NCT01898793|76031531|FG005|COMPLETED|Overall Study||8||
59910752|NCT01898793|76031532|FG006|COMPLETED|Overall Study||45||
59910753|NCT01898793|76031526|FG000|NOT COMPLETED|Overall Study||2||
59910754|NCT01898793|76031527|FG001|NOT COMPLETED|Overall Study||1||
59910755|NCT01898793|76031528|FG002|NOT COMPLETED|Overall Study||4||
59910756|NCT01898793|76031529|FG003|NOT COMPLETED|Overall Study||0||
59910757|NCT01898793|76031530|FG004|NOT COMPLETED|Overall Study||0||
59910758|NCT01898793|76031531|FG005|NOT COMPLETED|Overall Study||0||
59910759|NCT01898793|76031532|FG006|NOT COMPLETED|Overall Study||0||
59910760|NCT01857934|76031551|FG000|STARTED|Overall Study||64||
59910761|NCT01857934|76031551|FG000|COMPLETED|Overall Study||54||
59910762|NCT01857934|76031551|FG000|NOT COMPLETED|Overall Study||10||
59910763|NCT01849575|76031561|FG000|STARTED|Overall Study||1749||
59910764|NCT01849575|76031562|FG001|STARTED|Overall Study||1783||
59910765|NCT01849575|76031561|FG000|COMPLETED|Overall Study||1599||
59910766|NCT01849575|76031562|FG001|COMPLETED|Overall Study||1576||
59910767|NCT01849575|76031561|FG000|NOT COMPLETED|Overall Study||150||
59910768|NCT01849575|76031562|FG001|NOT COMPLETED|Overall Study||207||
59910769|NCT01842282|76031571|FG000|STARTED|Overall Study||7||
59910770|NCT01842282|76031571|FG000|COMPLETED|Overall Study||6||
59910771|NCT01842282|76031571|FG000|NOT COMPLETED|Overall Study||1||
59910772|NCT01757665|76031577|FG000|STARTED|Overall Study||694||
59910773|NCT01757665|76031578|FG001|STARTED|Overall Study||83||
59910774|NCT01757665|76031577|FG000|Implanted With Device|Overall Study||689||
59910775|NCT01757665|76031578|FG001|Implanted With Device|Overall Study||82||
59910776|NCT01757665|76031577|FG000|COMPLETED|Overall Study||0||
59910777|NCT01757665|76031578|FG001|COMPLETED|Overall Study||0||
59910778|NCT01757665|76031577|FG000|NOT COMPLETED|Overall Study||694||
59910779|NCT01757665|76031578|FG001|NOT COMPLETED|Overall Study||83||
59910780|NCT01501513|76031602|FG000|STARTED|Overall Study||184||
59910781|NCT01501513|76031603|FG001|STARTED|Overall Study||180||
59910782|NCT01501513|76031604|FG002|STARTED|Overall Study||177||
59910783|NCT01501513|76031602|FG000|COMPLETED|Overall Study||168||
59910784|NCT01501513|76031603|FG001|COMPLETED|Overall Study||165||
59910785|NCT01501513|76031604|FG002|COMPLETED|Overall Study||164||
59910786|NCT01501513|76031602|FG000|NOT COMPLETED|Overall Study||16||
59910787|NCT01501513|76031603|FG001|NOT COMPLETED|Overall Study||15||
59910788|NCT01501513|76031604|FG002|NOT COMPLETED|Overall Study||13||
59910789|NCT01459497|76031614|FG000|STARTED|Overall Study||52||
59910790|NCT01459497|76031615|FG001|STARTED|Overall Study||51||
59910791|NCT01459497|76031614|FG000|COMPLETED|Overall Study||50||
59910792|NCT01459497|76031615|FG001|COMPLETED|Overall Study||46||
59910793|NCT01459497|76031614|FG000|NOT COMPLETED|Overall Study||2||
59910794|NCT01459497|76031615|FG001|NOT COMPLETED|Overall Study||5||
59910795|NCT01275677|76031623|FG000|STARTED|Overall Study||1630||
59910796|NCT01275677|76031624|FG001|STARTED|Overall Study||1640||
59910797|NCT01275677|76031623|FG000|COMPLETED|Overall Study||1602||
59910798|NCT01275677|76031624|FG001|COMPLETED|Overall Study||1598||
59910799|NCT01275677|76031623|FG000|NOT COMPLETED|Overall Study||28||
59910800|NCT01275677|76031624|FG001|NOT COMPLETED|Overall Study||42||
59910801|NCT01063751|76031630|FG000|STARTED|Overall Study||234||241
59611552|NCT01777152|75722546|FG001|NOT COMPLETED|Overall Study||110||
59611553|NCT01759290|75722553|FG000|STARTED|Overall Study||1800||
59910802|NCT01063751|76031630|FG000|Censored (Device Not Implanted)|Overall Study||25||0
59611554|NCT01759290|75722553|FG000|COMPLETED|Overall Study||1719||
59910803|NCT01063751|76031630|FG000|COMPLETED|Overall Study||23||25
59611555|NCT01759290|75722553|FG000|NOT COMPLETED|Overall Study||81||
59506925|NCT00243269|75600058|FG000|NOT COMPLETED|Overall Study||3||
59506926|NCT00243269|75600059|FG001|NOT COMPLETED|Overall Study||1||
59506927|NCT00243269|75600060|FG002|NOT COMPLETED|Overall Study||1||
59506928|NCT00243269|75600061|FG003|NOT COMPLETED|Overall Study||4||
59506929|NCT03364491|75600073|FG000|STARTED|Overall Study||5529||
59506930|NCT03364491|75600074|FG001|STARTED|Overall Study||5471||
59506931|NCT03364491|75600073|FG000|COMPLETED|Overall Study||5529||
59506932|NCT03364491|75600074|FG001|COMPLETED|Overall Study||5471||
59506933|NCT03364491|75600073|FG000|NOT COMPLETED|Overall Study||0||
59758651|NCT00755079|75877977|FG000|COMPLETED|Overall Study||17||
59910804|NCT01063751|76031630|FG000|NOT COMPLETED|Overall Study||211||216
59910805|NCT00680901|76031637|FG000|STARTED|Overall Study||272||
60018142|NCT02555683|76134083|FG001|FAS/SAF: High Eosinophil Subpopulation|Overall Study||201|Full analysis set/safety set. All patients who received study drug and had high eosinophils count|
60018143|NCT02555683|76134084|FG002|FAS/SAF: High Eosinophil Subpopulation|Overall Study||201|Full analysis set/safety set. All patients who received study drug and had high eosinophils count|
60018144|NCT02555683|76134082|FG000|FAS/SAF: Overall Population|Overall Study||299|Full analysis set/safety set. All patients who received study drug|
60018145|NCT02555683|76134083|FG001|FAS/SAF: Overall Population|Overall Study||293|Full analysis set/safety set. All patients who received study drug|
60018146|NCT02555683|76134084|FG002|FAS/SAF: Overall Population|Overall Study||298|Full analysis set/safety set. All patients who received study drug|
60018147|NCT02555683|76134082|FG000|COMPLETED|Overall Study||282||
60018148|NCT02555683|76134083|FG001|COMPLETED|Overall Study||278||
60018149|NCT02555683|76134084|FG002|COMPLETED|Overall Study||269||
59910806|NCT00680901|76031638|FG001|STARTED|Overall Study||273||
59910807|NCT00680901|76031637|FG000|Ongoing: On Study Treatment|Overall Study||16||
59910808|NCT00680901|76031638|FG001|Ongoing: On Study Treatment|Overall Study||13||
60018150|NCT02555683|76134082|FG000|NOT COMPLETED|Overall Study||19||
60018151|NCT02555683|76134083|FG001|NOT COMPLETED|Overall Study||17||
60018152|NCT02555683|76134084|FG002|NOT COMPLETED|Overall Study||29||
60018153|NCT02554981|76134092|FG000|STARTED|Overall Study||51||
59910809|NCT00680901|76031637|FG000|Ongoing: In Follow Up|Overall Study||45||
59910810|NCT00680901|76031638|FG001|Ongoing: In Follow Up|Overall Study||41||
59910811|NCT00680901|76031637|FG000|COMPLETED|Overall Study||199||
60018154|NCT02554981|76134092|FG000|COMPLETED|Overall Study||46||
60018155|NCT02554981|76134092|FG000|NOT COMPLETED|Overall Study||5||
60018156|NCT02556775|76134100|FG000|STARTED|Overall Study||7||
60018157|NCT02556775|76134101|FG001|STARTED|Overall Study||2||
60018158|NCT02556775|76134102|FG002|STARTED|Overall Study||5||
60018159|NCT02556775|76134103|FG003|STARTED|Overall Study||2||
59506934|NCT03364491|75600074|FG001|NOT COMPLETED|Overall Study||0||
59506935|NCT00782639|75600082|FG000|STARTED|Overall Study||12||
59758652|NCT00755079|75877978|FG001|COMPLETED|Overall Study||16||
59758653|NCT00755079|75877977|FG000|NOT COMPLETED|Overall Study||1||
59758654|NCT00755079|75877978|FG001|NOT COMPLETED|Overall Study||6||
59910812|NCT00680901|76031638|FG001|COMPLETED|Overall Study||197||
60018160|NCT02556775|76134100|FG000|COMPLETED|Overall Study||5||
60018161|NCT02556775|76134101|FG001|COMPLETED|Overall Study||2||
60018162|NCT02556775|76134102|FG002|COMPLETED|Overall Study||4||
60018163|NCT02556775|76134103|FG003|COMPLETED|Overall Study||2||
60018164|NCT02556775|76134100|FG000|NOT COMPLETED|Overall Study||2||
60018165|NCT02556775|76134101|FG001|NOT COMPLETED|Overall Study||0||
60018166|NCT02556775|76134102|FG002|NOT COMPLETED|Overall Study||1||
60018167|NCT02556775|76134103|FG003|NOT COMPLETED|Overall Study||0||
60018168|NCT01662505|76134118|FG000|STARTED|Overall Study||7||
60018169|NCT01662505|76134119|FG001|STARTED|Overall Study||4||
60018170|NCT01662505|76134120|FG002|STARTED|Overall Study||8||
60018171|NCT01662505|76134118|FG000|COMPLETED|Overall Study||0||
60018172|NCT01662505|76134119|FG001|COMPLETED|Overall Study||0||
60018173|NCT01662505|76134120|FG002|COMPLETED|Overall Study||0||
60018174|NCT01662505|76134118|FG000|NOT COMPLETED|Overall Study||7||
60018175|NCT01662505|76134119|FG001|NOT COMPLETED|Overall Study||4||
60018176|NCT01662505|76134120|FG002|NOT COMPLETED|Overall Study||8||
60018177|NCT03796195|76134129|FG000|STARTED|Overall Study||1||
60018178|NCT03796195|76134129|FG000|COMPLETED|Overall Study||0||
60018179|NCT03796195|76134129|FG000|NOT COMPLETED|Overall Study||1||
60018180|NCT02554513|76134133|FG000|STARTED|First Treatment Phase (7 Weeks)||3||
60018181|NCT02554513|76134134|FG001|STARTED|First Treatment Phase (7 Weeks)||3||
59506936|NCT00782639|75600083|FG001|STARTED|Overall Study||11||
59506937|NCT00782639|75600082|FG000|COMPLETED|Overall Study|This study was terminated due to low enrollment.|12||
59506938|NCT00782639|75600083|FG001|COMPLETED|Overall Study|This study was terminated due to low enrollment.|11||
59506939|NCT00782639|75600082|FG000|NOT COMPLETED|Overall Study||0||
59506940|NCT00782639|75600083|FG001|NOT COMPLETED|Overall Study||0||
59758655|NCT00925301|75877986|FG000|STARTED|6-Month Double-blind (Stage 1)||34||
59910813|NCT00680901|76031637|FG000|NOT COMPLETED|Overall Study||73||
59910814|NCT00680901|76031638|FG001|NOT COMPLETED|Overall Study||76||
60018182|NCT02554513|76134133|FG000|COMPLETED|First Treatment Phase (7 Weeks)||3||
60018183|NCT02554513|76134134|FG001|COMPLETED|First Treatment Phase (7 Weeks)||2||
60018184|NCT02554513|76134133|FG000|NOT COMPLETED|First Treatment Phase (7 Weeks)||0||
60018185|NCT02554513|76134134|FG001|NOT COMPLETED|First Treatment Phase (7 Weeks)||1||
60018186|NCT02554513|76134133|FG000|STARTED|Washout (2 Weeks)||3||
59758656|NCT00925301|75877987|FG001|STARTED|6-Month Double-blind (Stage 1)||33||
59758657|NCT00925301|75877988|FG002|STARTED|6-Month Double-blind (Stage 1)|Zero participants noted because participants did not start Stage 2 yet.|0||
59758658|NCT00925301|75877989|FG003|STARTED|6-Month Double-blind (Stage 1)|Zero participants noted because participants did not start the OLE yet.|0||
59758659|NCT00925301|75877986|FG000|Received at Least 1 Dose of Study Drug|6-Month Double-blind (Stage 1)||34||
59758660|NCT00925301|75877987|FG001|Received at Least 1 Dose of Study Drug|6-Month Double-blind (Stage 1)||33||
59758661|NCT00925301|75877988|FG002|Received at Least 1 Dose of Study Drug|6-Month Double-blind (Stage 1)||0||
59758662|NCT00925301|75877989|FG003|Received at Least 1 Dose of Study Drug|6-Month Double-blind (Stage 1)||0||
59762593|NCT03888235|75882410|FG000|STARTED|Overall Study|1 Participant dropped out after the first visit and was replaced.|21||
59910815|NCT00601900|76031646|FG000|STARTED|Overall Study||195||
59910816|NCT00601900|76031647|FG001|STARTED|Overall Study||199||
59910817|NCT00601900|76031646|FG000|COMPLETED|Overall Study||195||
59910818|NCT00601900|76031647|FG001|COMPLETED|Overall Study||196||
59910819|NCT00601900|76031646|FG000|NOT COMPLETED|Overall Study||0||
59910820|NCT00601900|76031647|FG001|NOT COMPLETED|Overall Study||3||
59910821|NCT00557193|76031653|FG000|STARTED|Induction||218||
59910822|NCT00557193|76031654|FG001|STARTED|Induction||0||
59910823|NCT00557193|76031655|FG002|STARTED|Induction||0||
59910824|NCT00557193|76031656|FG003|STARTED|Induction||0||
59910825|NCT00557193|76031657|FG004|STARTED|Induction||0||
59910826|NCT00557193|76031658|FG005|STARTED|Induction||0||
59910827|NCT00557193|76031653|FG000|COMPLETED|Induction||192||
59910828|NCT00557193|76031654|FG001|COMPLETED|Induction||0||
59910829|NCT00557193|76031655|FG002|COMPLETED|Induction||0||
59910830|NCT00557193|76031656|FG003|COMPLETED|Induction||0||
59910831|NCT00557193|76031657|FG004|COMPLETED|Induction||0||
59910832|NCT00557193|76031658|FG005|COMPLETED|Induction||0||
59910833|NCT00557193|76031653|FG000|NOT COMPLETED|Induction||26||
59910834|NCT00557193|76031654|FG001|NOT COMPLETED|Induction||0||
59910835|NCT00557193|76031655|FG002|NOT COMPLETED|Induction||0||
59910836|NCT00557193|76031656|FG003|NOT COMPLETED|Induction||0||
59910837|NCT00557193|76031657|FG004|NOT COMPLETED|Induction||0||
59910838|NCT00557193|76031658|FG005|NOT COMPLETED|Induction||0||
59910839|NCT00557193|76031653|FG000|STARTED|Post Induction Therapy by Tx Assignment||0||
59910840|NCT00557193|76031654|FG001|STARTED|Post Induction Therapy by Tx Assignment||60||
59910841|NCT00557193|76031655|FG002|STARTED|Post Induction Therapy by Tx Assignment||54||
59910842|NCT00557193|76031656|FG003|STARTED|Post Induction Therapy by Tx Assignment||11||
59910843|NCT00557193|76031657|FG004|STARTED|Post Induction Therapy by Tx Assignment||11||
59910844|NCT00557193|76031658|FG005|STARTED|Post Induction Therapy by Tx Assignment||56||
59910845|NCT00557193|76031653|FG000|COMPLETED|Post Induction Therapy by Tx Assignment||0||
59910846|NCT00557193|76031654|FG001|COMPLETED|Post Induction Therapy by Tx Assignment||50||
59910847|NCT00557193|76031655|FG002|COMPLETED|Post Induction Therapy by Tx Assignment||22||
59910848|NCT00557193|76031656|FG003|COMPLETED|Post Induction Therapy by Tx Assignment||4||
59910849|NCT00557193|76031657|FG004|COMPLETED|Post Induction Therapy by Tx Assignment||4||
59910850|NCT00557193|76031658|FG005|COMPLETED|Post Induction Therapy by Tx Assignment||19||
59910851|NCT00557193|76031653|FG000|NOT COMPLETED|Post Induction Therapy by Tx Assignment||0||
59910852|NCT00557193|76031654|FG001|NOT COMPLETED|Post Induction Therapy by Tx Assignment||10||
59910853|NCT00557193|76031655|FG002|NOT COMPLETED|Post Induction Therapy by Tx Assignment||32||
59910854|NCT00557193|76031656|FG003|NOT COMPLETED|Post Induction Therapy by Tx Assignment||7||
59910855|NCT00557193|76031657|FG004|NOT COMPLETED|Post Induction Therapy by Tx Assignment||7||
59910856|NCT00557193|76031658|FG005|NOT COMPLETED|Post Induction Therapy by Tx Assignment||37||
59910857|NCT00408590|76031685|FG000|STARTED|Overall Study||3||
59910858|NCT00408590|76031686|FG001|STARTED|Overall Study||3||
59910859|NCT00408590|76031687|FG002|STARTED|Overall Study||3||
59910860|NCT00408590|76031688|FG003|STARTED|Overall Study||3||
59910861|NCT00408590|76031689|FG004|STARTED|Overall Study||3||
59910862|NCT00408590|76031690|FG005|STARTED|Overall Study||3||
59910863|NCT00408590|76031691|FG006|STARTED|Overall Study||3||
59910864|NCT00408590|76031692|FG007|STARTED|Overall Study||3||
59506941|NCT01997229|75600093|FG000|STARTED|Overall Study||62||
59506942|NCT01997229|75600094|FG001|STARTED|Overall Study||63||
59506943|NCT01997229|75600093|FG000|COMPLETED|Overall Study||57||
60018187|NCT02554513|76134134|FG001|STARTED|Washout (2 Weeks)||2||
60018188|NCT02554513|76134133|FG000|COMPLETED|Washout (2 Weeks)||3||
60018189|NCT02554513|76134134|FG001|COMPLETED|Washout (2 Weeks)||2||
60018190|NCT02554513|76134133|FG000|NOT COMPLETED|Washout (2 Weeks)||0||
60018191|NCT02554513|76134134|FG001|NOT COMPLETED|Washout (2 Weeks)||0||
59506944|NCT01997229|75600094|FG001|COMPLETED|Overall Study||61||
59506945|NCT01997229|75600093|FG000|NOT COMPLETED|Overall Study||5||
59506946|NCT01997229|75600094|FG001|NOT COMPLETED|Overall Study||2||
59506947|NCT00800839|75600100|FG000|STARTED|Overall Study||56||
59506948|NCT00800839|75600100|FG000|COMPLETED|Overall Study||49||
59611556|NCT01758900|75722559|FG000|STARTED|Overall Study||106||
59910865|NCT00408590|76031693|FG008|STARTED|Overall Study||13||
59910866|NCT00408590|76031685|FG000|COMPLETED|Overall Study||3||
59910867|NCT00408590|76031686|FG001|COMPLETED|Overall Study||3||
59910868|NCT00408590|76031687|FG002|COMPLETED|Overall Study||3||
59910869|NCT00408590|76031688|FG003|COMPLETED|Overall Study||3||
59910870|NCT00408590|76031689|FG004|COMPLETED|Overall Study||3||
59910871|NCT00408590|76031690|FG005|COMPLETED|Overall Study||3||
59910872|NCT00408590|76031691|FG006|COMPLETED|Overall Study||3||
60018192|NCT02554513|76134133|FG000|STARTED|Second Treatment Phase (7 Weeks)||3||
60018193|NCT02554513|76134134|FG001|STARTED|Second Treatment Phase (7 Weeks)||2||
60018194|NCT02554513|76134133|FG000|COMPLETED|Second Treatment Phase (7 Weeks)||3||
60018195|NCT02554513|76134134|FG001|COMPLETED|Second Treatment Phase (7 Weeks)||2||
60018196|NCT02554513|76134133|FG000|NOT COMPLETED|Second Treatment Phase (7 Weeks)||0||
59506949|NCT00800839|75600100|FG000|NOT COMPLETED|Overall Study||7||
59506950|NCT02000583|75600106|FG000|STARTED|Overall Study||78||
59506951|NCT02000583|75600107|FG001|STARTED|Overall Study||39||
59506952|NCT02000583|75600106|FG000|COMPLETED|Overall Study||75||
59506953|NCT02000583|75600107|FG001|COMPLETED|Overall Study||34||
59910873|NCT00408590|76031692|FG007|COMPLETED|Overall Study||3||
59910874|NCT00408590|76031693|FG008|COMPLETED|Overall Study||13||
59910875|NCT00408590|76031685|FG000|NOT COMPLETED|Overall Study||0||
59910876|NCT00408590|76031686|FG001|NOT COMPLETED|Overall Study||0||
60018197|NCT02554513|76134134|FG001|NOT COMPLETED|Second Treatment Phase (7 Weeks)||0||
60018198|NCT02554903|76134148|FG000|STARTED|Overall Study||28||
60018199|NCT02554903|76134149|FG001|STARTED|Overall Study||29||
60018200|NCT02554903|76134148|FG000|COMPLETED|Overall Study||24||
59506954|NCT02000583|75600106|FG000|NOT COMPLETED|Overall Study||3||
59506955|NCT02000583|75600107|FG001|NOT COMPLETED|Overall Study||5||
59506956|NCT00814255|75600116|FG000|STARTED|Overall Study||8||
59506957|NCT00814255|75600117|FG001|STARTED|Overall Study||7||
59910877|NCT00408590|76031687|FG002|NOT COMPLETED|Overall Study||0||
59910878|NCT00408590|76031688|FG003|NOT COMPLETED|Overall Study||0||
60018201|NCT02554903|76134149|FG001|COMPLETED|Overall Study||24||
60018202|NCT02554903|76134148|FG000|NOT COMPLETED|Overall Study||4||
59611557|NCT01758900|75722560|FG001|STARTED|Overall Study||108||
59910879|NCT00408590|76031689|FG004|NOT COMPLETED|Overall Study||0||
59910880|NCT00408590|76031690|FG005|NOT COMPLETED|Overall Study||0||
59758663|NCT00925301|75877986|FG000|Intent-to-Treat (ITT)|6-Month Double-blind (Stage 1)||34|All randomized participants regardless of their participation in the study beyond Randomization.|
59758664|NCT00925301|75877987|FG001|Intent-to-Treat (ITT)|6-Month Double-blind (Stage 1)||33|All randomized participants regardless of their participation in the study beyond Randomization.|
60018203|NCT02554903|76134149|FG001|NOT COMPLETED|Overall Study||5||
60018204|NCT02332707|76134174|FG000|STARTED|Overall Study||23||
60018205|NCT02332707|76134175|FG001|STARTED|Overall Study||24||
60018206|NCT02332707|76134176|FG002|STARTED|Overall Study||16||
60018207|NCT02332707|76134177|FG003|STARTED|Overall Study||14||
60018208|NCT02332707|76134178|FG004|STARTED|Overall Study||23||
60018209|NCT02332707|76134179|FG005|STARTED|Overall Study||23||
60018210|NCT02332707|76134180|FG006|STARTED|Overall Study||15||
60018211|NCT02332707|76134181|FG007|STARTED|Overall Study||16||
60018212|NCT02332707|76134182|FG008|STARTED|Overall Study||48||
60018213|NCT02332707|76134183|FG009|STARTED|Overall Study||31||
60018214|NCT02332707|76134184|FG010|STARTED|Overall Study||31||
60018215|NCT02332707|76134185|FG011|STARTED|Overall Study||35||
60018216|NCT02332707|76134186|FG012|STARTED|Overall Study||40||
60018217|NCT02332707|76134187|FG013|STARTED|Overall Study||15||
60018218|NCT02332707|76134188|FG014|STARTED|Overall Study||16||
60018219|NCT02332707|76134189|FG015|STARTED|Overall Study||26||
60018220|NCT02332707|76134190|FG016|STARTED|Overall Study||30||
60018221|NCT02332707|76134191|FG017|STARTED|Overall Study||16||
60018222|NCT02332707|76134174|FG000|COMPLETED|Overall Study||23||
60018223|NCT02332707|76134175|FG001|COMPLETED|Overall Study||24||
60018224|NCT02332707|76134176|FG002|COMPLETED|Overall Study||15||
60018225|NCT02332707|76134177|FG003|COMPLETED|Overall Study||13||
60018226|NCT02332707|76134178|FG004|COMPLETED|Overall Study||23||
60018227|NCT02332707|76134179|FG005|COMPLETED|Overall Study||22||
60018228|NCT02332707|76134180|FG006|COMPLETED|Overall Study||15||
60018229|NCT02332707|76134181|FG007|COMPLETED|Overall Study||16||
60018230|NCT02332707|76134182|FG008|COMPLETED|Overall Study||48||
60018231|NCT02332707|76134183|FG009|COMPLETED|Overall Study||28||
60018232|NCT02332707|76134184|FG010|COMPLETED|Overall Study||29||
60018233|NCT02332707|76134185|FG011|COMPLETED|Overall Study||35||
60018234|NCT02332707|76134186|FG012|COMPLETED|Overall Study||35||
60018235|NCT02332707|76134187|FG013|COMPLETED|Overall Study||15||
60018236|NCT02332707|76134188|FG014|COMPLETED|Overall Study||16||
60018237|NCT02332707|76134189|FG015|COMPLETED|Overall Study||26||
60018238|NCT02332707|76134190|FG016|COMPLETED|Overall Study||30||
60018239|NCT02332707|76134191|FG017|COMPLETED|Overall Study||16||
60018240|NCT02332707|76134174|FG000|NOT COMPLETED|Overall Study||0||
60018241|NCT02332707|76134175|FG001|NOT COMPLETED|Overall Study||0||
60018242|NCT02332707|76134176|FG002|NOT COMPLETED|Overall Study||1||
60018243|NCT02332707|76134177|FG003|NOT COMPLETED|Overall Study||1||
60018244|NCT02332707|76134178|FG004|NOT COMPLETED|Overall Study||0||
60018245|NCT02332707|76134179|FG005|NOT COMPLETED|Overall Study||1||
60018246|NCT02332707|76134180|FG006|NOT COMPLETED|Overall Study||0||
60018247|NCT02332707|76134181|FG007|NOT COMPLETED|Overall Study||0||
60018248|NCT02332707|76134182|FG008|NOT COMPLETED|Overall Study||0||
60018249|NCT02332707|76134183|FG009|NOT COMPLETED|Overall Study||3||
60018250|NCT02332707|76134184|FG010|NOT COMPLETED|Overall Study||2||
59506958|NCT00814255|75600118|FG002|STARTED|Overall Study||8||
59506959|NCT00814255|75600116|FG000|COMPLETED|Overall Study||7||
59506960|NCT00814255|75600117|FG001|COMPLETED|Overall Study||7||
59506961|NCT00814255|75600118|FG002|COMPLETED|Overall Study||7||
60018251|NCT02332707|76134185|FG011|NOT COMPLETED|Overall Study||0||
60018252|NCT02332707|76134186|FG012|NOT COMPLETED|Overall Study||5||
59506962|NCT00814255|75600116|FG000|NOT COMPLETED|Overall Study||1||
59506963|NCT00814255|75600117|FG001|NOT COMPLETED|Overall Study||0||
59506964|NCT00814255|75600118|FG002|NOT COMPLETED|Overall Study||1||
60018253|NCT02332707|76134187|FG013|NOT COMPLETED|Overall Study||0||
60018254|NCT02332707|76134188|FG014|NOT COMPLETED|Overall Study||0||
60018255|NCT02332707|76134189|FG015|NOT COMPLETED|Overall Study||0||
60018256|NCT02332707|76134190|FG016|NOT COMPLETED|Overall Study||0||
60018257|NCT02332707|76134191|FG017|NOT COMPLETED|Overall Study||0||
60018258|NCT02370615|76134231|FG000|STARTED|Overall Study||16||
60018259|NCT02370615|76134232|FG001|STARTED|Overall Study||18||
60018260|NCT02370615|76134231|FG000|COMPLETED|Overall Study||15||
60018261|NCT02370615|76134232|FG001|COMPLETED|Overall Study||18||
60018262|NCT02370615|76134231|FG000|NOT COMPLETED|Overall Study||1||
60018263|NCT02370615|76134232|FG001|NOT COMPLETED|Overall Study||0||
60018264|NCT02307513|76134247|FG000|STARTED|Placebo Controlled Phase (Weeks 0-12)||103||
60018265|NCT02307513|76134248|FG001|STARTED|Placebo Controlled Phase (Weeks 0-12)||104||
60018266|NCT02307513|76134247|FG000|COMPLETED|Placebo Controlled Phase (Weeks 0-12)||83||
60018267|NCT02307513|76134248|FG001|COMPLETED|Placebo Controlled Phase (Weeks 0-12)||96||
60018268|NCT02307513|76134247|FG000|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-12)||20||
60018269|NCT02307513|76134248|FG001|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-12)||8||
60018270|NCT02307513|76134247|FG000|STARTED|Active Treatment Phase (Weeks 13-64)||83||
60018271|NCT02307513|76134248|FG001|STARTED|Active Treatment Phase (Weeks 13-64)|1 participant completed Week 12; did not enter into active treatment|95||
60018272|NCT02307513|76134247|FG000|COMPLETED|Active Treatment Phase (Weeks 13-64)||68||
60018273|NCT02307513|76134248|FG001|COMPLETED|Active Treatment Phase (Weeks 13-64)||75||
60018274|NCT02307513|76134247|FG000|NOT COMPLETED|Active Treatment Phase (Weeks 13-64)||15||
60018275|NCT02307513|76134248|FG001|NOT COMPLETED|Active Treatment Phase (Weeks 13-64)||20||
60018276|NCT02307513|76134247|FG000|STARTED|Long-term Extension||2|Only participants in Germany had the option to continue receiving apremilast 30 mg BID in the extension phase.|
60018277|NCT02307513|76134248|FG001|STARTED|Long-term Extension||0|Only participants in Germany had the option to continue receiving apremilast 30 mg BID in the extension phase.|
60018278|NCT02307513|76134247|FG000|COMPLETED|Long-term Extension||1||
60018279|NCT02307513|76134248|FG001|COMPLETED|Long-term Extension||0||
60018280|NCT02307513|76134247|FG000|NOT COMPLETED|Long-term Extension||1||
60018281|NCT02307513|76134248|FG001|NOT COMPLETED|Long-term Extension||0||
60018282|NCT02332239|76134260|FG000|STARTED|Overall Study||58||
60018283|NCT02332239|76134261|FG001|STARTED|Overall Study||58||
60018284|NCT02332239|76134260|FG000|COMPLETED|Overall Study||54||
60018285|NCT02332239|76134261|FG001|COMPLETED|Overall Study||52||
60018286|NCT02332239|76134260|FG000|NOT COMPLETED|Overall Study||4||
60018287|NCT02332239|76134261|FG001|NOT COMPLETED|Overall Study||6||
60018288|NCT02370537|76134272|FG000|STARTED|Part A (Open-label Recruitment)||16||
60018289|NCT02370537|76134273|FG001|STARTED|Part A (Open-label Recruitment)||16||
60018290|NCT02370537|76134274|FG002|STARTED|Part A (Open-label Recruitment)||283||
60018291|NCT02370537|76134272|FG000|COMPLETED|Part A (Open-label Recruitment)||16||
60018292|NCT02370537|76134273|FG001|COMPLETED|Part A (Open-label Recruitment)||15||
60018293|NCT02370537|76134274|FG002|COMPLETED|Part A (Open-label Recruitment)||282||
60018294|NCT02370537|76134272|FG000|NOT COMPLETED|Part A (Open-label Recruitment)||0||
60018295|NCT02370537|76134273|FG001|NOT COMPLETED|Part A (Open-label Recruitment)||1||
60018296|NCT02370537|76134274|FG002|NOT COMPLETED|Part A (Open-label Recruitment)||1||
60018297|NCT02370537|76134272|FG000|STARTED|Part B||16||
60018298|NCT02370537|76134273|FG001|STARTED|Part B||15||
60018299|NCT02370537|76134274|FG002|STARTED|Part B||282||
60018300|NCT02370537|76134272|FG000|Eligible for Randomisation|Part B||15||
60018301|NCT02370537|76134273|FG001|Eligible for Randomisation|Part B||13||
60018302|NCT02370537|76134274|FG002|Eligible for Randomisation|Part B||23||
60018303|NCT02370537|76134272|FG000|Period 1 Sequence AB|Part B||8||
60018304|NCT02370537|76134273|FG001|Period 1 Sequence AB|Part B||6||
60018305|NCT02370537|76134274|FG002|Period 1 Sequence AB|Part B||11||
60018306|NCT02370537|76134272|FG000|Period 1 Sequence BA|Part B||7||
60018307|NCT02370537|76134273|FG001|Period 1 Sequence BA|Part B||7||
60018308|NCT02370537|76134274|FG002|Period 1 Sequence BA|Part B||12||
60018309|NCT02370537|76134272|FG000|Period 2 Sequence AB|Part B||8||
60018310|NCT02370537|76134273|FG001|Period 2 Sequence AB|Part B||5||
60018311|NCT02370537|76134274|FG002|Period 2 Sequence AB|Part B||11||
60018312|NCT02370537|76134272|FG000|Period 2 Sequence BA|Part B||7||
60018313|NCT02370537|76134273|FG001|Period 2 Sequence BA|Part B||7||
60018314|NCT02370537|76134274|FG002|Period 2 Sequence BA|Part B||12||
60018315|NCT02370537|76134272|FG000|COMPLETED|Part B||15||
60018316|NCT02370537|76134273|FG001|COMPLETED|Part B||12||
60018317|NCT02370537|76134274|FG002|COMPLETED|Part B||23||
60018318|NCT02370537|76134272|FG000|NOT COMPLETED|Part B||1||
60018319|NCT02370537|76134273|FG001|NOT COMPLETED|Part B||3||
59910881|NCT00408590|76031691|FG006|NOT COMPLETED|Overall Study||0||
59910882|NCT00408590|76031692|FG007|NOT COMPLETED|Overall Study||0||
59910883|NCT00408590|76031693|FG008|NOT COMPLETED|Overall Study||0||
59910884|NCT00186888|76031711|FG000|STARTED|Overall Study||23||
59910885|NCT00186888|76031712|FG001|STARTED|Overall Study||27||
59910886|NCT00186888|76031713|FG002|STARTED|Overall Study||55||
59910887|NCT00186888|76031711|FG000|Window Therapy|Overall Study||0||
59910888|NCT00186888|76031712|FG001|Window Therapy|Overall Study||27||
59910889|NCT00186888|76031713|FG002|Window Therapy|Overall Study||0||
59910890|NCT00186888|76031711|FG000|COMPLETED|Overall Study||19||
59910891|NCT00186888|76031712|FG001|COMPLETED|Overall Study||24||
59910892|NCT00186888|76031713|FG002|COMPLETED|Overall Study||55||
59910893|NCT00186888|76031711|FG000|NOT COMPLETED|Overall Study||4||
59910894|NCT00186888|76031712|FG001|NOT COMPLETED|Overall Study||3||
59910895|NCT00186888|76031713|FG002|NOT COMPLETED|Overall Study||0||
59910896|NCT03078192|76031750|FG000|STARTED|Overall Study||30||
59910897|NCT03078192|76031751|FG001|STARTED|Overall Study||32||
59910898|NCT03078192|76031750|FG000|COMPLETED|Overall Study||28||
59910899|NCT03078192|76031751|FG001|COMPLETED|Overall Study||28||
59910900|NCT03078192|76031750|FG000|NOT COMPLETED|Overall Study||2||
59910901|NCT03078192|76031751|FG001|NOT COMPLETED|Overall Study||4||
59910902|NCT00703846|76031757|FG000|STARTED|Overall Study||500||
59910903|NCT00703846|76031757|FG000|COMPLETED|Overall Study||363||
59910904|NCT00703846|76031757|FG000|NOT COMPLETED|Overall Study||137||
59910905|NCT05454813|76031761|FG000|STARTED|Overall Study||56||
59910906|NCT05454813|76031761|FG000|COMPLETED|Overall Study||56||
59910907|NCT05454813|76031761|FG000|NOT COMPLETED|Overall Study||0||
59910908|NCT05372575|76031767|FG000|STARTED|Overall Study||101||
59910909|NCT05372575|76031768|FG001|STARTED|Overall Study||199||
59910910|NCT05372575|76031767|FG000|COMPLETED|Overall Study||94||
59910911|NCT05372575|76031768|FG001|COMPLETED|Overall Study||183||
59910912|NCT05372575|76031767|FG000|NOT COMPLETED|Overall Study||7||
59910913|NCT05372575|76031768|FG001|NOT COMPLETED|Overall Study||16||
59910914|NCT05132127|76031779|FG000|STARTED|Overall Study||7||
59910915|NCT05132127|76031779|FG000|COMPLETED|Overall Study||6||
59910916|NCT05132127|76031779|FG000|NOT COMPLETED|Overall Study||1||
59910917|NCT05064449|76031785|FG000|STARTED|Period 1 (1 Day)||14||
59910918|NCT05064449|76031786|FG001|STARTED|Period 1 (1 Day)||14||
59910919|NCT05064449|76031785|FG000|COMPLETED|Period 1 (1 Day)||14||
59910920|NCT05064449|76031786|FG001|COMPLETED|Period 1 (1 Day)||14||
59910921|NCT05064449|76031785|FG000|NOT COMPLETED|Period 1 (1 Day)||0||
59910922|NCT05064449|76031786|FG001|NOT COMPLETED|Period 1 (1 Day)||0||
59910923|NCT05064449|76031785|FG000|STARTED|Washout Period (4 Days)||14||
59910924|NCT05064449|76031786|FG001|STARTED|Washout Period (4 Days)||14||
59910925|NCT05064449|76031785|FG000|COMPLETED|Washout Period (4 Days)||14||
59910926|NCT05064449|76031786|FG001|COMPLETED|Washout Period (4 Days)||14||
59910927|NCT05064449|76031785|FG000|NOT COMPLETED|Washout Period (4 Days)||0||
59910928|NCT05064449|76031786|FG001|NOT COMPLETED|Washout Period (4 Days)||0||
59910929|NCT05064449|76031785|FG000|STARTED|Period 2(Part 1:Day 1-12;Part 2:Day 1-8)||14||
59910930|NCT05064449|76031786|FG001|STARTED|Period 2(Part 1:Day 1-12;Part 2:Day 1-8)||14||
59910931|NCT05064449|76031785|FG000|COMPLETED|Period 2(Part 1:Day 1-12;Part 2:Day 1-8)||14||
59910932|NCT05064449|76031786|FG001|COMPLETED|Period 2(Part 1:Day 1-12;Part 2:Day 1-8)||14||
59910933|NCT05064449|76031785|FG000|NOT COMPLETED|Period 2(Part 1:Day 1-12;Part 2:Day 1-8)||0||
59910934|NCT05064449|76031786|FG001|NOT COMPLETED|Period 2(Part 1:Day 1-12;Part 2:Day 1-8)||0||
59910935|NCT04969276|76031806|FG000|STARTED|Overall Study||100||
59910936|NCT04969276|76031807|FG001|STARTED|Overall Study||101||
59910937|NCT04969276|76031808|FG002|STARTED|Overall Study||105||
59910938|NCT04969276|76031806|FG000|Safety Analysis Set (SafAS)|Overall Study||100|SafAS included all participants who had received the study vaccine(s) and were analyzed according to the vaccine they actually received and study intervention group.|
59910939|NCT04969276|76031807|FG001|Safety Analysis Set (SafAS)|Overall Study||92|SafAS included all participants who had received the study vaccine(s) and were analyzed according to the vaccine they actually received and study intervention group.|
59910940|NCT04969276|76031808|FG002|Safety Analysis Set (SafAS)|Overall Study||104|SafAS included all participants who had received the study vaccine(s) and were analyzed according to the vaccine they actually received and study intervention group.|
60018320|NCT02370537|76134274|FG002|NOT COMPLETED|Part B||259||
60018321|NCT02330055|76134293|FG000|STARTED|Overall Study||50||
60018322|NCT02330055|76134294|FG001|STARTED|Overall Study||49||
60018323|NCT02330055|76134293|FG000|COMPLETED|Overall Study||40||
60018324|NCT02330055|76134294|FG001|COMPLETED|Overall Study||40||
60018325|NCT02330055|76134293|FG000|NOT COMPLETED|Overall Study||10||
60018326|NCT02330055|76134294|FG001|NOT COMPLETED|Overall Study||9||
60018327|NCT02306265|76134300|FG000|STARTED|Overall Study||250||
60018328|NCT02306265|76134300|FG000|COMPLETED|Overall Study||249||
60018329|NCT02306265|76134300|FG000|NOT COMPLETED|Overall Study||1||
60018330|NCT02329743|76134308|FG000|STARTED|Overall Study||84||
60018331|NCT02329743|76134309|FG001|STARTED|Overall Study||87||
60018332|NCT02329743|76134310|FG002|STARTED|Overall Study||85||
60018333|NCT02329743|76134308|FG000|COMPLETED|Overall Study||78||
60018334|NCT02329743|76134309|FG001|COMPLETED|Overall Study||80||
60018335|NCT02329743|76134310|FG002|COMPLETED|Overall Study||77||
60018336|NCT02329743|76134308|FG000|NOT COMPLETED|Overall Study||6||
60018337|NCT02329743|76134309|FG001|NOT COMPLETED|Overall Study||7||
60018338|NCT02329743|76134310|FG002|NOT COMPLETED|Overall Study||8||
60018339|NCT02329431|76134320|FG000|STARTED|Overall Study||92||
60018340|NCT02329431|76134321|FG001|STARTED|Overall Study||89||
60018341|NCT02329431|76134320|FG000|Baseline Interview|Overall Study||87||
60018342|NCT02329431|76134321|FG001|Baseline Interview|Overall Study||85||
60018343|NCT02329431|76134320|FG000|COMPLETED|Overall Study||72||
60018344|NCT02329431|76134321|FG001|COMPLETED|Overall Study||76||
60018345|NCT02329431|76134320|FG000|NOT COMPLETED|Overall Study||20||
60018346|NCT02329431|76134321|FG001|NOT COMPLETED|Overall Study||13||
60018347|NCT02328105|76134327|FG000|STARTED|Overall Study||11||
60018348|NCT02328105|76134327|FG000|COMPLETED|Overall Study||0||
60018349|NCT02328105|76134327|FG000|NOT COMPLETED|Overall Study||11||
60018350|NCT02305797|76134333|FG000|STARTED|Overall Study||247||
60018351|NCT02305797|76134334|FG001|STARTED|Overall Study||248||
60018352|NCT02305797|76134333|FG000|COMPLETED|Overall Study||202||
60018353|NCT02305797|76134334|FG001|COMPLETED|Overall Study||210||
60018354|NCT02305797|76134333|FG000|NOT COMPLETED|Overall Study||45||
60018355|NCT02305797|76134334|FG001|NOT COMPLETED|Overall Study||38||
60018356|NCT01646073|76134342|FG000|STARTED|Period A (12 Weeks)||87||
60018357|NCT01646073|76134343|FG001|STARTED|Period A (12 Weeks)||338||
60018358|NCT01646073|76134342|FG000|COMPLETED|Period A (12 Weeks)||85||
60018359|NCT01646073|76134343|FG001|COMPLETED|Period A (12 Weeks)||333||
60018360|NCT01646073|76134342|FG000|NOT COMPLETED|Period A (12 Weeks)||2||
60018361|NCT01646073|76134343|FG001|NOT COMPLETED|Period A (12 Weeks)||5||
60018362|NCT01646073|76134342|FG000|STARTED|Period B (12 Weeks)||85||
60018363|NCT01646073|76134343|FG001|STARTED|Period B (12 Weeks)||333||
60018364|NCT01646073|76134342|FG000|COMPLETED|Period B (12 Weeks)||84||
60018365|NCT01646073|76134343|FG001|COMPLETED|Period B (12 Weeks)||320||
60018366|NCT01646073|76134342|FG000|NOT COMPLETED|Period B (12 Weeks)||1||
60018367|NCT01646073|76134343|FG001|NOT COMPLETED|Period B (12 Weeks)||13||
60018368|NCT02328027|76134354|FG000|STARTED|Overall Study||5||
60018369|NCT02328027|76134355|FG001|STARTED|Overall Study||11||
60018370|NCT02328027|76134354|FG000|COMPLETED|Overall Study||5||
60018371|NCT02328027|76134355|FG001|COMPLETED|Overall Study||10||
60018372|NCT02328027|76134354|FG000|NOT COMPLETED|Overall Study||0||
60018373|NCT02328027|76134355|FG001|NOT COMPLETED|Overall Study||1||
60018374|NCT02551159|76134365|FG000|STARTED|Overall Study||413||
60018375|NCT02551159|76134366|FG001|STARTED|Overall Study||204||
60018376|NCT02551159|76134367|FG002|STARTED|Overall Study||206||
60018377|NCT02551159|76134365|FG000|Full Analysis Set|Overall Study||413|All patients randomized|
59506965|NCT02000973|75600133|FG000|STARTED|Overall Study||20||
59506966|NCT02000973|75600134|FG001|STARTED|Overall Study||20||
59506967|NCT02000973|75600135|FG002|STARTED|Overall Study||20||
59506968|NCT02000973|75600136|FG003|STARTED|Overall Study||20||
59506969|NCT02000973|75600133|FG000|COMPLETED|Overall Study||20||
59506970|NCT02000973|75600134|FG001|COMPLETED|Overall Study||20||
59506971|NCT02000973|75600135|FG002|COMPLETED|Overall Study||20||
59506972|NCT02000973|75600136|FG003|COMPLETED|Overall Study||20||
59506973|NCT02000973|75600133|FG000|NOT COMPLETED|Overall Study||0||
59506974|NCT02000973|75600134|FG001|NOT COMPLETED|Overall Study||0||
59506975|NCT02000973|75600135|FG002|NOT COMPLETED|Overall Study||0||
59506976|NCT02000973|75600136|FG003|NOT COMPLETED|Overall Study||0||
59506977|NCT02002767|75600148|FG000|STARTED|Overall Study||9||
59506978|NCT02002767|75600149|FG001|STARTED|Overall Study||10||
60018378|NCT02551159|76134366|FG001|Full Analysis Set|Overall Study||204|All patients randomized|
60018379|NCT02551159|76134367|FG002|Full Analysis Set|Overall Study||206|All patients randomized|
60018380|NCT02551159|76134365|FG000|Safety Analysis Set|Overall Study||408|All patients who received at least one dose of study treatment|
59506979|NCT02002767|75600148|FG000|COMPLETED|Overall Study||9||
60018381|NCT02551159|76134366|FG001|Safety Analysis Set|Overall Study||202|All patients who received at least one dose of study treatment|
60018382|NCT02551159|76134367|FG002|Safety Analysis Set|Overall Study||196|All patients who received at least one dose of study treatment|
60018383|NCT02551159|76134365|FG000|PD-L1 TC/IC High Subgroup Analysis Set|Overall Study||190|Patients in the full analysis set with PD-L1 high|
60018384|NCT02551159|76134366|FG001|PD-L1 TC/IC High Subgroup Analysis Set|Overall Study||99|Patients in the full analysis set with PD-L1 high|
60018385|NCT02551159|76134367|FG002|PD-L1 TC/IC High Subgroup Analysis Set|Overall Study||94|Patients in the full analysis set with PD-L1 high|
60018386|NCT02551159|76134365|FG000|COMPLETED|Overall Study||0||
60018387|NCT02551159|76134366|FG001|COMPLETED|Overall Study||0||
60018388|NCT02551159|76134367|FG002|COMPLETED|Overall Study||0||
60018389|NCT02551159|76134365|FG000|NOT COMPLETED|Overall Study||413||
60018390|NCT02551159|76134366|FG001|NOT COMPLETED|Overall Study||204||
60018391|NCT02551159|76134367|FG002|NOT COMPLETED|Overall Study||206||
60018392|NCT02305563|76134380|FG000|STARTED|Treatment Period||3|Started = Randomized|
60018393|NCT02305563|76134381|FG001|STARTED|Treatment Period||3|Started = Randomized|
60018394|NCT02305563|76134382|FG002|STARTED|Treatment Period||26|Started = Randomized|
60018395|NCT02305563|76134383|FG003|STARTED|Treatment Period||14|Started = Randomized|
60018396|NCT02305563|76134384|FG004|STARTED|Treatment Period||24|Started = Randomized|
60018397|NCT02305563|76134380|FG000|COMPLETED|Treatment Period|At the time of the Phase 1 lock, 1 participant was still continuing on treatment|1|Completed = Continuing in the treatment period|
60018398|NCT02305563|76134381|FG001|COMPLETED|Treatment Period|At the time of the Phase 1 lock, 1 participant was still continuing on treatment|1|Completed = Continuing in the treatment period|
60018399|NCT02305563|76134382|FG002|COMPLETED|Treatment Period||0|Completed = Continuing in the treatment period|
60018400|NCT02305563|76134383|FG003|COMPLETED|Treatment Period||0|Completed = Continuing in the treatment period|
60018401|NCT02305563|76134384|FG004|COMPLETED|Treatment Period||0|Completed = Continuing in the treatment period|
60018402|NCT02305563|76134380|FG000|NOT COMPLETED|Treatment Period||2||
60018403|NCT02305563|76134381|FG001|NOT COMPLETED|Treatment Period||2||
60018404|NCT02305563|76134382|FG002|NOT COMPLETED|Treatment Period||26||
60018405|NCT02305563|76134383|FG003|NOT COMPLETED|Treatment Period||14||
60018406|NCT02305563|76134384|FG004|NOT COMPLETED|Treatment Period||24||
59506980|NCT02002767|75600149|FG001|COMPLETED|Overall Study||10||
59506981|NCT02002767|75600148|FG000|NOT COMPLETED|Overall Study||0||
59506982|NCT02002767|75600149|FG001|NOT COMPLETED|Overall Study||0||
59506983|NCT00815035|75600157|FG000|STARTED|Blinded Phase||10||
59506984|NCT00815035|75600158|FG001|STARTED|Blinded Phase||6||
59506985|NCT00815035|75600159|FG002|STARTED|Blinded Phase||0||
59506986|NCT00815035|75600157|FG000|COMPLETED|Blinded Phase||9||
59506987|NCT00815035|75600158|FG001|COMPLETED|Blinded Phase||6||
59506988|NCT00815035|75600159|FG002|COMPLETED|Blinded Phase||0||
59506989|NCT00815035|75600157|FG000|NOT COMPLETED|Blinded Phase||1||
59910941|NCT04969276|76031806|FG000|COMPLETED|Overall Study||99||
59910942|NCT04969276|76031807|FG001|COMPLETED|Overall Study||89||
59910943|NCT04969276|76031808|FG002|COMPLETED|Overall Study||105||
59910944|NCT04969276|76031806|FG000|NOT COMPLETED|Overall Study||1||
59910945|NCT04969276|76031807|FG001|NOT COMPLETED|Overall Study||12||
59910946|NCT04969276|76031808|FG002|NOT COMPLETED|Overall Study||0||
59910947|NCT04969224|76031816|FG000|STARTED|Overall Study||82||
59910948|NCT04969224|76031816|FG000|COMPLETED|Overall Study||80||
59910949|NCT04969224|76031816|FG000|NOT COMPLETED|Overall Study||2||
59910950|NCT04738279|76031822|FG000|STARTED|Overall Study||5||
59910951|NCT04738279|76031823|FG001|STARTED|Overall Study||15||
59910952|NCT04738279|76031822|FG000|COMPLETED|Overall Study||4||
59910953|NCT04738279|76031823|FG001|COMPLETED|Overall Study||13||
59910954|NCT04738279|76031822|FG000|NOT COMPLETED|Overall Study||1||
59910955|NCT04738279|76031823|FG001|NOT COMPLETED|Overall Study||2||
59910956|NCT04551677|76031832|FG000|STARTED|Overall Study||29||
59910957|NCT04551677|76031833|FG001|STARTED|Overall Study||31||
59910958|NCT04551677|76031834|FG002|STARTED|Overall Study||30||
59910959|NCT04551677|76031832|FG000|Vaccinated|Overall Study||29||
59910960|NCT04551677|76031833|FG001|Vaccinated|Overall Study||31||
59910961|NCT04551677|76031834|FG002|Vaccinated|Overall Study||30||
59910962|NCT04551677|76031832|FG000|COMPLETED|Overall Study||29||
59910963|NCT04551677|76031833|FG001|COMPLETED|Overall Study||31||
59910964|NCT04551677|76031834|FG002|COMPLETED|Overall Study||30||
59910965|NCT04551677|76031832|FG000|NOT COMPLETED|Overall Study||0||
59910966|NCT04551677|76031833|FG001|NOT COMPLETED|Overall Study||0||
59910967|NCT04551677|76031834|FG002|NOT COMPLETED|Overall Study||0||
59910968|NCT04507126|76031842|FG000|STARTED|Overall Study||20||
59910969|NCT04507126|76031842|FG000|COMPLETED|Overall Study||16||
59910970|NCT04507126|76031842|FG000|NOT COMPLETED|Overall Study||4||
59910971|NCT04498832|76031849|FG000|STARTED|Overall Study||1049||
59910972|NCT04498832|76031850|FG001|STARTED|Overall Study||1051||
59910973|NCT04498832|76031849|FG000|COMPLETED|Overall Study||1048||
59910974|NCT04498832|76031850|FG001|COMPLETED|Overall Study||1047||
59910975|NCT04498832|76031849|FG000|NOT COMPLETED|Overall Study||1||
59910976|NCT04498832|76031850|FG001|NOT COMPLETED|Overall Study||4||
59910977|NCT04490018|76031859|FG000|STARTED|Overall Study||173||
59910978|NCT04490018|76031860|FG001|STARTED|Overall Study||173||
59910979|NCT04490018|76031861|FG002|STARTED|Overall Study||117||
59910980|NCT04490018|76031859|FG000|Safety Analysis Set|Overall Study||171|Participants who had received at least one dose of the study vaccines (all groups) and had any safety data available.|
59910981|NCT04490018|76031860|FG001|Safety Analysis Set|Overall Study||171|Participants who had received at least one dose of the study vaccines (all groups) and had any safety data available.|
59910982|NCT04490018|76031861|FG002|Safety Analysis Set|Overall Study||116|Participants who had received at least one dose of the study vaccines (all groups) and had any safety data available.|
59910983|NCT04490018|76031859|FG000|Vaccinated at Day 01|Overall Study||170||
59910984|NCT04490018|76031860|FG001|Vaccinated at Day 01|Overall Study||172||
59910985|NCT04490018|76031861|FG002|Vaccinated at Day 01|Overall Study||116||
59910986|NCT04490018|76031859|FG000|Vaccinated at Day 31|Overall Study||168||
59910987|NCT04490018|76031860|FG001|Vaccinated at Day 31|Overall Study||169||
59910988|NCT04490018|76031861|FG002|Vaccinated at Day 31|Overall Study|Group 3 participants did not receive any vaccination at Day 31.|0||
59910989|NCT04490018|76031859|FG000|COMPLETED|Overall Study||167||
59910990|NCT04490018|76031860|FG001|COMPLETED|Overall Study||165||
59910991|NCT04490018|76031861|FG002|COMPLETED|Overall Study||116||
59910992|NCT04490018|76031859|FG000|NOT COMPLETED|Overall Study||6||
59910993|NCT04490018|76031860|FG001|NOT COMPLETED|Overall Study||8||
59910994|NCT04490018|76031861|FG002|NOT COMPLETED|Overall Study||1||
59910995|NCT04296396|76031873|FG000|STARTED|Overall Study||2748||
59910996|NCT04296396|76031874|FG001|STARTED|Overall Study||2773||
59910997|NCT04296396|76031873|FG000|COMPLETED|Overall Study||2386|Participants who completed the 90 day visit.|
59910998|NCT04296396|76031874|FG001|COMPLETED|Overall Study||2426|Participants who completed the 90 day visit.|
59910999|NCT04296396|76031873|FG000|NOT COMPLETED|Overall Study||362||
59911000|NCT04296396|76031874|FG001|NOT COMPLETED|Overall Study||347||
59911001|NCT04107675|76031890|FG000|STARTED|Overall Study||2||
59911002|NCT04107675|76031891|FG001|STARTED|Overall Study||2||
59911003|NCT04107675|76031892|FG002|STARTED|Overall Study||2||
59911004|NCT04107675|76031890|FG000|COMPLETED|Overall Study||2||
59911005|NCT04107675|76031891|FG001|COMPLETED|Overall Study||2||
59911006|NCT04107675|76031892|FG002|COMPLETED|Overall Study||2||
59911007|NCT04107675|76031890|FG000|NOT COMPLETED|Overall Study||0||
59911008|NCT04107675|76031891|FG001|NOT COMPLETED|Overall Study||0||
59911009|NCT04107675|76031892|FG002|NOT COMPLETED|Overall Study||0||
59911010|NCT03717753|76031902|FG000|STARTED|Overall Study||70||
59911011|NCT03717753|76031903|FG001|STARTED|Overall Study||70||
59911012|NCT03717753|76031902|FG000|COMPLETED|Overall Study||70||
59911013|NCT03717753|76031903|FG001|COMPLETED|Overall Study||70||
59911014|NCT03717753|76031902|FG000|NOT COMPLETED|Overall Study||0||
59911015|NCT03717753|76031903|FG001|NOT COMPLETED|Overall Study||0||
59911016|NCT03672461|76031912|FG000|STARTED|Overall Study||121||
59911017|NCT03672461|76031913|FG001|STARTED|Overall Study||119||
59911018|NCT03672461|76031912|FG000|COMPLETED|Overall Study||101||
59911019|NCT03672461|76031913|FG001|COMPLETED|Overall Study||109||
60018407|NCT02305563|76134380|FG000|STARTED|Follow-up Period||3|Started = Entered follow-up|
60018408|NCT02305563|76134381|FG001|STARTED|Follow-up Period||3|Started = Entered follow-up|
60018409|NCT02305563|76134382|FG002|STARTED|Follow-up Period||11|Started = Entered follow-up|
60018410|NCT02305563|76134383|FG003|STARTED|Follow-up Period||6|Started = Entered follow-up|
60018411|NCT02305563|76134384|FG004|STARTED|Follow-up Period||12|Started = Entered follow-up|
60018412|NCT02305563|76134380|FG000|COMPLETED|Follow-up Period||0|Completed = Continuing in the follow-up period|
60018413|NCT02305563|76134381|FG001|COMPLETED|Follow-up Period||0|Completed = Continuing in the follow-up period|
60018414|NCT02305563|76134382|FG002|COMPLETED|Follow-up Period||0|Completed = Continuing in the follow-up period|
60018415|NCT02305563|76134383|FG003|COMPLETED|Follow-up Period||0|Completed = Continuing in the follow-up period|
60018416|NCT02305563|76134384|FG004|COMPLETED|Follow-up Period||0|Completed = Continuing in the follow-up period|
60018417|NCT02305563|76134380|FG000|NOT COMPLETED|Follow-up Period||3||
60018418|NCT02305563|76134381|FG001|NOT COMPLETED|Follow-up Period||3||
60018419|NCT02305563|76134382|FG002|NOT COMPLETED|Follow-up Period||11||
60018420|NCT02305563|76134383|FG003|NOT COMPLETED|Follow-up Period||6||
60018421|NCT02305563|76134384|FG004|NOT COMPLETED|Follow-up Period||12||
60018422|NCT02327325|76134403|FG000|STARTED|Overall Study||20||
59911020|NCT03672461|76031912|FG000|NOT COMPLETED|Overall Study||20||
59911021|NCT03672461|76031913|FG001|NOT COMPLETED|Overall Study||10||
59911022|NCT03611556|76031926|FG000|STARTED|Overall Study||7||
59911023|NCT03611556|76031927|FG001|STARTED|Overall Study||7||
59911024|NCT03611556|76031928|FG002|STARTED|Overall Study||3||
59911025|NCT03611556|76031929|FG003|STARTED|Overall Study||8||
59911026|NCT03611556|76031930|FG004|STARTED|Overall Study||62||
59911027|NCT03611556|76031931|FG005|STARTED|Overall Study||38||
59911028|NCT03611556|76031932|FG006|STARTED|Overall Study||70||
60018423|NCT02327325|76134404|FG001|STARTED|Overall Study||20||
60018424|NCT02327325|76134405|FG002|STARTED|Overall Study||20||
60018425|NCT02327325|76134403|FG000|COMPLETED|Overall Study||19||
60018426|NCT02327325|76134404|FG001|COMPLETED|Overall Study||16||
60018427|NCT02327325|76134405|FG002|COMPLETED|Overall Study||15||
60018428|NCT02327325|76134403|FG000|NOT COMPLETED|Overall Study||1||
60018429|NCT02327325|76134404|FG001|NOT COMPLETED|Overall Study||4||
60018430|NCT02327325|76134405|FG002|NOT COMPLETED|Overall Study||5||
60018431|NCT02304705|76134415|FG000|STARTED|Overall Study||16||
60018432|NCT02304705|76134416|FG001|STARTED|Overall Study||17||
60018433|NCT02304705|76134415|FG000|COMPLETED|Overall Study||12||
60018434|NCT02304705|76134416|FG001|COMPLETED|Overall Study||10||
60018435|NCT02304705|76134415|FG000|NOT COMPLETED|Overall Study||4||
60018436|NCT02304705|76134416|FG001|NOT COMPLETED|Overall Study||7||
60018437|NCT02553499|76134436|FG000|STARTED|Overall Study||2||
60018438|NCT02553499|76134437|FG001|STARTED|Overall Study||2||
60018439|NCT02553499|76134438|FG002|STARTED|Overall Study||2||
60018440|NCT02553499|76134439|FG003|STARTED|Overall Study||2||
60018441|NCT02553499|76134440|FG004|STARTED|Overall Study||3||
60018442|NCT02553499|76134441|FG005|STARTED|Overall Study||3||
60018443|NCT02553499|76134442|FG006|STARTED|Overall Study||3||
60018444|NCT02553499|76134443|FG007|STARTED|Overall Study||3||
60018445|NCT02553499|76134444|FG008|STARTED|Overall Study||3||
60018446|NCT02553499|76134445|FG009|STARTED|Overall Study||3||
60018447|NCT02553499|76134446|FG010|STARTED|Overall Study||3||
60018448|NCT02553499|76134447|FG011|STARTED|Overall Study||3||
60018449|NCT02553499|76134448|FG012|STARTED|Overall Study||3||
60018450|NCT02553499|76134449|FG013|STARTED|Overall Study||2||
60018451|NCT02553499|76134436|FG000|COMPLETED|Overall Study||0||
60018452|NCT02553499|76134437|FG001|COMPLETED|Overall Study||0||
60018453|NCT02553499|76134438|FG002|COMPLETED|Overall Study||0||
60018454|NCT02553499|76134439|FG003|COMPLETED|Overall Study||0||
60018455|NCT02553499|76134440|FG004|COMPLETED|Overall Study||0||
59911029|NCT03611556|76031926|FG000|COMPLETED|Overall Study||0||
59911030|NCT03611556|76031927|FG001|COMPLETED|Overall Study||0||
59911031|NCT03611556|76031928|FG002|COMPLETED|Overall Study||0||
59911032|NCT03611556|76031929|FG003|COMPLETED|Overall Study||0||
60018456|NCT02553499|76134441|FG005|COMPLETED|Overall Study||0||
60018457|NCT02553499|76134442|FG006|COMPLETED|Overall Study||0||
60018458|NCT02553499|76134443|FG007|COMPLETED|Overall Study||0||
60018459|NCT02553499|76134444|FG008|COMPLETED|Overall Study||0||
60018460|NCT02553499|76134445|FG009|COMPLETED|Overall Study||0||
60018461|NCT02553499|76134446|FG010|COMPLETED|Overall Study||0||
60018462|NCT02553499|76134447|FG011|COMPLETED|Overall Study||0||
60018463|NCT02553499|76134448|FG012|COMPLETED|Overall Study||0||
59911033|NCT03611556|76031930|FG004|COMPLETED|Overall Study||0||
59911034|NCT03611556|76031931|FG005|COMPLETED|Overall Study||0||
59911035|NCT03611556|76031932|FG006|COMPLETED|Overall Study||0||
59911036|NCT03611556|76031926|FG000|NOT COMPLETED|Overall Study||7||
59911037|NCT03611556|76031927|FG001|NOT COMPLETED|Overall Study||7||
59911038|NCT03611556|76031928|FG002|NOT COMPLETED|Overall Study||3||
59911039|NCT03611556|76031929|FG003|NOT COMPLETED|Overall Study||8||
59911040|NCT03611556|76031930|FG004|NOT COMPLETED|Overall Study||62||
59911041|NCT03611556|76031931|FG005|NOT COMPLETED|Overall Study||38||
59911042|NCT03611556|76031932|FG006|NOT COMPLETED|Overall Study||70||
59911043|NCT03580525|76031959|FG000|STARTED|Overall Study||23||
59911044|NCT03580525|76031959|FG000|Nicotine Saline Infusion 0.00mcg/kg/s|Overall Study||22||
59911045|NCT03580525|76031959|FG000|Nicotine Infusion 0.24mcg/kg/s|Overall Study||23||
59911046|NCT03580525|76031959|FG000|Nicotine Infusion 0.096mcg/kg/s|Overall Study||23||
59911047|NCT03580525|76031959|FG000|Nicotine Infusion 0.048mcg/kg/s|Overall Study||22||
59911048|NCT03580525|76031959|FG000|Nicotine Infusion 0.024mcg/kg/s|Overall Study||23||
59911049|NCT03580525|76031959|FG000|COMPLETED|Overall Study||22||
59911050|NCT03580525|76031959|FG000|NOT COMPLETED|Overall Study||1||
59911051|NCT03477162|76031969|FG000|STARTED|Overall Study||17||
59911052|NCT03477162|76031970|FG001|STARTED|Overall Study||1||
59911053|NCT03477162|76031969|FG000|COMPLETED|Overall Study||14||
59911054|NCT03477162|76031970|FG001|COMPLETED|Overall Study||1||
59911055|NCT03477162|76031969|FG000|NOT COMPLETED|Overall Study||3||
59911056|NCT03477162|76031970|FG001|NOT COMPLETED|Overall Study||0||
59911057|NCT03392974|76031976|FG000|STARTED|Overall Study||1||
59911058|NCT03392974|76031976|FG000|COMPLETED|Overall Study||1||
59911059|NCT03392974|76031976|FG000|NOT COMPLETED|Overall Study||0||
59911060|NCT03309813|76031983|FG000|STARTED|Main Randomized Study||5||
59911061|NCT03309813|76031984|FG001|STARTED|Main Randomized Study||5||
59911062|NCT03309813|76031983|FG000|COMPLETED|Main Randomized Study||4||
59911063|NCT03309813|76031984|FG001|COMPLETED|Main Randomized Study||5||
59911064|NCT03309813|76031983|FG000|NOT COMPLETED|Main Randomized Study||1||
59911065|NCT03309813|76031984|FG001|NOT COMPLETED|Main Randomized Study||0||
59911066|NCT03309813|76031983|FG000|STARTED|Crossover Transcranial Exablate||0|Subjects randomized to Sham Transcranial Exablate (n=5) were given the option to receive the Exablate treatment and follow up in the Crossover Exablate group. Thus, the number of subjects participating in the Crossover Exablate group may not equal the number of subjects completing the Sham group 3 Month visit.|
59911067|NCT03309813|76031984|FG001|STARTED|Crossover Transcranial Exablate||3|Subjects randomized to Sham Transcranial Exablate (n=5) were given the option to receive the Exablate treatment and follow up in the Crossover Exablate group. Thus, the number of subjects participating in the Crossover Exablate group may not equal the number of subjects completing the Sham group 3 Month visit.|
59911068|NCT03309813|76031983|FG000|COMPLETED|Crossover Transcranial Exablate||0||
59911069|NCT03309813|76031984|FG001|COMPLETED|Crossover Transcranial Exablate||3||
59911070|NCT03309813|76031983|FG000|NOT COMPLETED|Crossover Transcranial Exablate||0||
59911071|NCT03309813|76031984|FG001|NOT COMPLETED|Crossover Transcranial Exablate||0||
59911072|NCT02968992|76031997|FG000|STARTED|Overall Study||18||
59911073|NCT02968992|76031998|FG001|STARTED|Overall Study||18||
59911074|NCT02968992|76031997|FG000|COMPLETED|Overall Study||18||
59911075|NCT02968992|76031998|FG001|COMPLETED|Overall Study||17||
59911076|NCT02968992|76031997|FG000|NOT COMPLETED|Overall Study||0||
59911077|NCT02968992|76031998|FG001|NOT COMPLETED|Overall Study||1||
59911078|NCT02744092|76032008|FG000|STARTED|Enrolled & Received Selected Treatment||335||
59911079|NCT02744092|76032009|FG001|STARTED|Enrolled & Received Selected Treatment||336||
59911080|NCT02744092|76032010|FG002|STARTED|Enrolled & Received Selected Treatment||108||
59911081|NCT02744092|76032011|FG003|STARTED|Enrolled & Received Selected Treatment||32||
59911082|NCT02744092|76032008|FG000|Received Assigned Treatment (Apixaban)|Enrolled & Received Selected Treatment||193||
59911083|NCT02744092|76032009|FG001|Received Assigned Treatment (Apixaban)|Enrolled & Received Selected Treatment||0||
59911084|NCT02744092|76032010|FG002|Received Assigned Treatment (Apixaban)|Enrolled & Received Selected Treatment||57||
59911085|NCT02744092|76032011|FG003|Received Assigned Treatment (Apixaban)|Enrolled & Received Selected Treatment||0||
59911086|NCT02744092|76032008|FG000|Received Assigned Treatment (Rivaroxaban)|Enrolled & Received Selected Treatment||122||
60018464|NCT02553499|76134449|FG013|COMPLETED|Overall Study||0||
59911087|NCT02744092|76032009|FG001|Received Assigned Treatment (Rivaroxaban)|Enrolled & Received Selected Treatment||0||
59911088|NCT02744092|76032010|FG002|Received Assigned Treatment (Rivaroxaban)|Enrolled & Received Selected Treatment||48||
59911089|NCT02744092|76032011|FG003|Received Assigned Treatment (Rivaroxaban)|Enrolled & Received Selected Treatment||0||
59911090|NCT02744092|76032008|FG000|Received Assigned Treatment (Dabigatran)|Enrolled & Received Selected Treatment||9||
59911091|NCT02744092|76032009|FG001|Received Assigned Treatment (Dabigatran)|Enrolled & Received Selected Treatment||0||
59911092|NCT02744092|76032010|FG002|Received Assigned Treatment (Dabigatran)|Enrolled & Received Selected Treatment||2||
59911093|NCT02744092|76032011|FG003|Received Assigned Treatment (Dabigatran)|Enrolled & Received Selected Treatment||0||
59911094|NCT02744092|76032008|FG000|Received Assigned Treatment (Edoxaban)|Enrolled & Received Selected Treatment||6||
59911095|NCT02744092|76032009|FG001|Received Assigned Treatment (Edoxaban)|Enrolled & Received Selected Treatment||0||
59911096|NCT02744092|76032010|FG002|Received Assigned Treatment (Edoxaban)|Enrolled & Received Selected Treatment||0||
59911097|NCT02744092|76032011|FG003|Received Assigned Treatment (Edoxaban)|Enrolled & Received Selected Treatment||0||
60018465|NCT02553499|76134436|FG000|NOT COMPLETED|Overall Study||2||
60018466|NCT02553499|76134437|FG001|NOT COMPLETED|Overall Study||2||
59758665|NCT00925301|75877988|FG002|Intent-to-Treat (ITT)|6-Month Double-blind (Stage 1)||0|All randomized participants regardless of their participation in the study beyond Randomization.|
59758666|NCT00925301|75877989|FG003|Intent-to-Treat (ITT)|6-Month Double-blind (Stage 1)||0|All randomized participants regardless of their participation in the study beyond Randomization.|
59758667|NCT00925301|75877986|FG000|Modified Intent-to-Treat (mITT)|6-Month Double-blind (Stage 1)||30|Participants with Baseline and Month 6 biopsy results.|
59758668|NCT00925301|75877987|FG001|Modified Intent-to-Treat (mITT)|6-Month Double-blind (Stage 1)||30|Participants with Baseline and Month 6 biopsy results.|
60018467|NCT02553499|76134438|FG002|NOT COMPLETED|Overall Study||2||
60018468|NCT02553499|76134439|FG003|NOT COMPLETED|Overall Study||2||
60018469|NCT02553499|76134440|FG004|NOT COMPLETED|Overall Study||3||
60018470|NCT02553499|76134441|FG005|NOT COMPLETED|Overall Study||3||
60018471|NCT02553499|76134442|FG006|NOT COMPLETED|Overall Study||3||
60018472|NCT02553499|76134443|FG007|NOT COMPLETED|Overall Study||3||
60018473|NCT02553499|76134444|FG008|NOT COMPLETED|Overall Study||3||
60018474|NCT02553499|76134445|FG009|NOT COMPLETED|Overall Study||3||
60018475|NCT02553499|76134446|FG010|NOT COMPLETED|Overall Study||3||
60018476|NCT02553499|76134447|FG011|NOT COMPLETED|Overall Study||3||
60018477|NCT02553499|76134448|FG012|NOT COMPLETED|Overall Study||3||
60018478|NCT02553499|76134449|FG013|NOT COMPLETED|Overall Study||2||
60018479|NCT02553421|76134482|FG000|STARTED|Overall Study||185||
60018480|NCT02553421|76134483|FG001|STARTED|Overall Study||58||
59758669|NCT00925301|75877988|FG002|Modified Intent-to-Treat (mITT)|6-Month Double-blind (Stage 1)||0|Participants with Baseline and Month 6 biopsy results.|
59911098|NCT02744092|76032008|FG000|Received Assigned Treatment (Enoxaparin)|Enrolled & Received Selected Treatment||0||
59911099|NCT02744092|76032009|FG001|Received Assigned Treatment (Enoxaparin)|Enrolled & Received Selected Treatment||277||
59911100|NCT02744092|76032010|FG002|Received Assigned Treatment (Enoxaparin)|Enrolled & Received Selected Treatment||0||
59911101|NCT02744092|76032011|FG003|Received Assigned Treatment (Enoxaparin)|Enrolled & Received Selected Treatment||24||
59911102|NCT02744092|76032008|FG000|Received Assigned Treatment (Fondaparinux)|Enrolled & Received Selected Treatment||0||
59911103|NCT02744092|76032009|FG001|Received Assigned Treatment (Fondaparinux)|Enrolled & Received Selected Treatment||23||
59911104|NCT02744092|76032010|FG002|Received Assigned Treatment (Fondaparinux)|Enrolled & Received Selected Treatment||0||
59911105|NCT02744092|76032011|FG003|Received Assigned Treatment (Fondaparinux)|Enrolled & Received Selected Treatment||6||
59911106|NCT02744092|76032008|FG000|Received Assigned Treatment (Dalteparin)|Enrolled & Received Selected Treatment||0||
59951209|NCT03848325|76070140|FG000|NOT COMPLETED|Overall Study||0||
60018481|NCT02553421|76134482|FG000|COMPLETED|Overall Study||156||
60018482|NCT02553421|76134483|FG001|COMPLETED|Overall Study||57||
59758670|NCT00925301|75877989|FG003|Modified Intent-to-Treat (mITT)|6-Month Double-blind (Stage 1)||0|Participants with Baseline and Month 6 biopsy results.|
59758671|NCT00925301|75877986|FG000|COMPLETED|6-Month Double-blind (Stage 1)||34||
59758672|NCT00925301|75877987|FG001|COMPLETED|6-Month Double-blind (Stage 1)||30||
59758673|NCT00925301|75877988|FG002|COMPLETED|6-Month Double-blind (Stage 1)||0||
59758674|NCT00925301|75877989|FG003|COMPLETED|6-Month Double-blind (Stage 1)||0||
59758675|NCT00925301|75877986|FG000|NOT COMPLETED|6-Month Double-blind (Stage 1)||0||
59758676|NCT00925301|75877987|FG001|NOT COMPLETED|6-Month Double-blind (Stage 1)||3||
59758677|NCT00925301|75877988|FG002|NOT COMPLETED|6-Month Double-blind (Stage 1)||0||
59758678|NCT00925301|75877989|FG003|NOT COMPLETED|6-Month Double-blind (Stage 1)||0||
59758679|NCT00925301|75877986|FG000|STARTED|6-Month Open-label (Stage 2)|Zero participants noted because participants had completed Stage 1.|0||
60018483|NCT02553421|76134482|FG000|NOT COMPLETED|Overall Study||29||
59506990|NCT00815035|75600158|FG001|NOT COMPLETED|Blinded Phase||0||
59506991|NCT00815035|75600159|FG002|NOT COMPLETED|Blinded Phase||0||
59506992|NCT00815035|75600157|FG000|STARTED|Open Label Extension Phase|After unblinding, subjects completing the blinded phase moved to the open-label phase of the study|0||
59506993|NCT00815035|75600158|FG001|STARTED|Open Label Extension Phase|After unblinding, subjects completing the blinded phase moved to the open-label phase of the study|0||
59506994|NCT00815035|75600159|FG002|STARTED|Open Label Extension Phase|After unblinding, subjects completing the blinded phase moved to the open-label phase of the study|15||
59506995|NCT00815035|75600157|FG000|COMPLETED|Open Label Extension Phase||0||
59506996|NCT00815035|75600158|FG001|COMPLETED|Open Label Extension Phase||0||
59911107|NCT02744092|76032009|FG001|Received Assigned Treatment (Dalteparin)|Enrolled & Received Selected Treatment||8||
60018484|NCT02553421|76134483|FG001|NOT COMPLETED|Overall Study||1||
59911108|NCT02744092|76032010|FG002|Received Assigned Treatment (Dalteparin)|Enrolled & Received Selected Treatment||0||
59911109|NCT02744092|76032011|FG003|Received Assigned Treatment (Dalteparin)|Enrolled & Received Selected Treatment||0||
59911110|NCT02744092|76032008|FG000|Did Not Receive Assigned/Selected Treatment|Enrolled & Received Selected Treatment||5||
59911111|NCT02744092|76032009|FG001|Did Not Receive Assigned/Selected Treatment|Enrolled & Received Selected Treatment||28||
59911112|NCT02744092|76032010|FG002|Did Not Receive Assigned/Selected Treatment|Enrolled & Received Selected Treatment||1||
59911113|NCT02744092|76032011|FG003|Did Not Receive Assigned/Selected Treatment|Enrolled & Received Selected Treatment||2||
60018485|NCT02549287|76134492|FG000|STARTED|Overall Study||193||17
60018486|NCT02549287|76134493|FG001|STARTED|Overall Study||96||15
60018487|NCT02549287|76134492|FG000|COMPLETED|Overall Study||113||17
60018488|NCT02549287|76134493|FG001|COMPLETED|Overall Study||64||15
60018489|NCT02549287|76134492|FG000|NOT COMPLETED|Overall Study||80||0
60018490|NCT02549287|76134493|FG001|NOT COMPLETED|Overall Study||32||0
60018491|NCT02553265|76134499|FG000|STARTED|Enrollment||9||
60018492|NCT02553265|76134500|FG001|STARTED|Enrollment||7||
60018493|NCT02553265|76134501|FG002|STARTED|Enrollment||6||
60018494|NCT02553265|76134499|FG000|COMPLETED|Enrollment||9||
60018495|NCT02553265|76134500|FG001|COMPLETED|Enrollment||7||
60018496|NCT02553265|76134501|FG002|COMPLETED|Enrollment||5||
60018497|NCT02553265|76134499|FG000|NOT COMPLETED|Enrollment||0||
60018498|NCT02553265|76134500|FG001|NOT COMPLETED|Enrollment||0||
60018499|NCT02553265|76134501|FG002|NOT COMPLETED|Enrollment||1||
60018500|NCT02553265|76134499|FG000|STARTED|First Intervention (28 Days)||9||
60018501|NCT02553265|76134500|FG001|STARTED|First Intervention (28 Days)||7||
60018502|NCT02553265|76134501|FG002|STARTED|First Intervention (28 Days)||5||
60018503|NCT02553265|76134499|FG000|COMPLETED|First Intervention (28 Days)||8||
60018504|NCT02553265|76134500|FG001|COMPLETED|First Intervention (28 Days)||7||
60018505|NCT02553265|76134501|FG002|COMPLETED|First Intervention (28 Days)||4||
60018506|NCT02553265|76134499|FG000|NOT COMPLETED|First Intervention (28 Days)||1||
60018507|NCT02553265|76134500|FG001|NOT COMPLETED|First Intervention (28 Days)||0||
60018508|NCT02553265|76134501|FG002|NOT COMPLETED|First Intervention (28 Days)||1||
60018509|NCT02553265|76134499|FG000|STARTED|Second Intervention (28 Days)||8||
60018510|NCT02553265|76134500|FG001|STARTED|Second Intervention (28 Days)||7||
60018511|NCT02553265|76134501|FG002|STARTED|Second Intervention (28 Days)||4||
60018512|NCT02553265|76134499|FG000|COMPLETED|Second Intervention (28 Days)||7||
60018513|NCT02553265|76134500|FG001|COMPLETED|Second Intervention (28 Days)||7||
60018514|NCT02553265|76134501|FG002|COMPLETED|Second Intervention (28 Days)||4||
60018515|NCT02553265|76134499|FG000|NOT COMPLETED|Second Intervention (28 Days)||1||
60018516|NCT02553265|76134500|FG001|NOT COMPLETED|Second Intervention (28 Days)||0||
60018517|NCT02553265|76134501|FG002|NOT COMPLETED|Second Intervention (28 Days)||0||
59762594|NCT03888235|75882411|FG001|STARTED|Overall Study|1 participants dropped out after the first visit and was replaced|21||
60018518|NCT02553265|76134499|FG000|STARTED|Third Intervention (28 Days)||7||
60018519|NCT02553265|76134500|FG001|STARTED|Third Intervention (28 Days)||7||
60018520|NCT02553265|76134501|FG002|STARTED|Third Intervention (28 Days)||4||
60018521|NCT02553265|76134499|FG000|COMPLETED|Third Intervention (28 Days)||6||
60018522|NCT02553265|76134500|FG001|COMPLETED|Third Intervention (28 Days)||7||
60018523|NCT02553265|76134501|FG002|COMPLETED|Third Intervention (28 Days)||3||
60018524|NCT02553265|76134499|FG000|NOT COMPLETED|Third Intervention (28 Days)||1||
60018525|NCT02553265|76134500|FG001|NOT COMPLETED|Third Intervention (28 Days)||0||
60018526|NCT02553265|76134501|FG002|NOT COMPLETED|Third Intervention (28 Days)||1||
60018527|NCT02561195|76134518|FG000|STARTED|Vaccination 1 to 3||183||
60018528|NCT02561195|76134519|FG001|STARTED|Vaccination 1 to 3||184||
60018529|NCT02561195|76134520|FG002|STARTED|Vaccination 1 to 3||61||
60018530|NCT02561195|76134521|FG003|STARTED|Vaccination 1 to 3||183||
60018531|NCT02561195|76134522|FG004|STARTED|Vaccination 1 to 3||183||
60018532|NCT02561195|76134523|FG005|STARTED|Vaccination 1 to 3||61||
60018533|NCT02561195|76134524|FG006|STARTED|Vaccination 1 to 3||0||
60018534|NCT02561195|76134525|FG007|STARTED|Vaccination 1 to 3||0||
60018535|NCT02561195|76134526|FG008|STARTED|Vaccination 1 to 3||0||
60018536|NCT02561195|76134527|FG009|STARTED|Vaccination 1 to 3||0||
59506997|NCT00815035|75600159|FG002|COMPLETED|Open Label Extension Phase||9||
59506998|NCT00815035|75600157|FG000|NOT COMPLETED|Open Label Extension Phase||0||
59506999|NCT00815035|75600158|FG001|NOT COMPLETED|Open Label Extension Phase||0||
59507000|NCT00815035|75600159|FG002|NOT COMPLETED|Open Label Extension Phase||6||
59507001|NCT01985685|75600170|FG000|STARTED|Overall Study||27||
59507002|NCT01985685|75600171|FG001|STARTED|Overall Study||29||
59507003|NCT01985685|75600170|FG000|COMPLETED|Overall Study||27||
59507004|NCT01985685|75600171|FG001|COMPLETED|Overall Study||29||
59507005|NCT01985685|75600170|FG000|NOT COMPLETED|Overall Study||0||
59507006|NCT01985685|75600171|FG001|NOT COMPLETED|Overall Study||0||
59507007|NCT00815347|75600177|FG000|STARTED|Overall Study||11||
59507008|NCT00815347|75600177|FG000|COMPLETED|Overall Study||7||
59507009|NCT00815347|75600177|FG000|NOT COMPLETED|Overall Study||4||
59507010|NCT01985763|75600183|FG000|STARTED|Overall Study||13||
59507011|NCT01985763|75600183|FG000|COMPLETED|Overall Study||13||
59507012|NCT01985763|75600183|FG000|NOT COMPLETED|Overall Study||0||
59507013|NCT02061969|75600190|FG000|STARTED|Overall Study||73||
59507014|NCT02061969|75600191|FG001|STARTED|Overall Study||67||
59507015|NCT02061969|75600190|FG000|COMPLETED|Overall Study||73||
59507016|NCT02061969|75600191|FG001|COMPLETED|Overall Study||67||
59507017|NCT02061969|75600190|FG000|NOT COMPLETED|Overall Study||0||
59507018|NCT02061969|75600191|FG001|NOT COMPLETED|Overall Study||0||
59507019|NCT02003625|75600199|FG000|STARTED|Overall Study||15||
59611558|NCT01758900|75722559|FG000|COMPLETED|Overall Study||99||
60018537|NCT02561195|76134528|FG010|STARTED|Vaccination 1 to 3||0||
60018538|NCT02561195|76134529|FG011|STARTED|Vaccination 1 to 3||0||
60018539|NCT02561195|76134530|FG012|STARTED|Vaccination 1 to 3||0||
60018540|NCT02561195|76134531|FG013|STARTED|Vaccination 1 to 3||0||
60018541|NCT02561195|76134518|FG000|Treated|Vaccination 1 to 3||182||
60018542|NCT02561195|76134519|FG001|Treated|Vaccination 1 to 3||184||
60018543|NCT02561195|76134520|FG002|Treated|Vaccination 1 to 3||61||
60018544|NCT02561195|76134521|FG003|Treated|Vaccination 1 to 3||183||
59507020|NCT02003625|75600200|FG001|STARTED|Overall Study||15||
59611559|NCT01758900|75722560|FG001|COMPLETED|Overall Study||100||
59611560|NCT01758900|75722559|FG000|NOT COMPLETED|Overall Study||7||
59611561|NCT01758900|75722560|FG001|NOT COMPLETED|Overall Study||8||
59507021|NCT02003625|75600199|FG000|Received Transplant|Overall Study||14||
59507022|NCT02003625|75600200|FG001|Received Transplant|Overall Study||12||
59507023|NCT02003625|75600199|FG000|COMPLETED|Overall Study||14||
59507024|NCT02003625|75600200|FG001|COMPLETED|Overall Study||12||
59507025|NCT02003625|75600199|FG000|NOT COMPLETED|Overall Study||1||
59507026|NCT02003625|75600200|FG001|NOT COMPLETED|Overall Study||3||
60018545|NCT02561195|76134522|FG004|Treated|Vaccination 1 to 3||183||
60018546|NCT02561195|76134523|FG005|Treated|Vaccination 1 to 3||61||
60018547|NCT02561195|76134524|FG006|Treated|Vaccination 1 to 3||0||
59507027|NCT02395185|75600206|FG000|STARTED|Overall Study|32 guardians participated with these infants. one infant did not have a guardian participate.|33||
59507028|NCT02395185|75600206|FG000|Sequence 1 (s,s,m,m,w,w)|Overall Study|one of the participants in this milestone did not have a guardian enrolled due to age.|2||
59507029|NCT02395185|75600206|FG000|Sequence 2 (w,s,s,m,m,w)|Overall Study||2||
59911114|NCT02744092|76032008|FG000|COMPLETED|Enrolled & Received Selected Treatment||330||
59911115|NCT02744092|76032009|FG001|COMPLETED|Enrolled & Received Selected Treatment||308||
59911116|NCT02744092|76032010|FG002|COMPLETED|Enrolled & Received Selected Treatment||107||
59911117|NCT02744092|76032011|FG003|COMPLETED|Enrolled & Received Selected Treatment||30||
59911118|NCT02744092|76032008|FG000|NOT COMPLETED|Enrolled & Received Selected Treatment||5||
59911119|NCT02744092|76032009|FG001|NOT COMPLETED|Enrolled & Received Selected Treatment||28||
59507030|NCT02395185|75600206|FG000|Sequence 3 (w,w,s,s,m,m)|Overall Study||2||
59507031|NCT02395185|75600206|FG000|Sequence 4 (m,w,w,s,s,m)|Overall Study||2||
59507032|NCT02395185|75600206|FG000|Sequence 5 (m,m,w,w,s,s)|Overall Study||2||
59507033|NCT02395185|75600206|FG000|Sequence 6 (s,m,m,w,w,s)|Overall Study||2||
59507034|NCT02395185|75600206|FG000|Sequence 7 (s,s,w,w,m,m)|Overall Study||2||
59507035|NCT02395185|75600206|FG000|Sequence 8 (m,s,s,w,w,m)|Overall Study||2||
59507036|NCT02395185|75600206|FG000|Sequence 9 (m,m,s,s,w,w)|Overall Study||2||
59507037|NCT02395185|75600206|FG000|Sequence 10 (w,m,m,s,s,w)|Overall Study||2||
59507038|NCT02395185|75600206|FG000|Sequence 11 (w,w,m,m,s,s)|Overall Study||2||
59507039|NCT02395185|75600206|FG000|Sequence 12 (s,w,w,m,m,s)|Overall Study||2||
59507040|NCT02395185|75600206|FG000|Sequence 13 (s,m,w,m,s,w)|Overall Study||2||
59507041|NCT02395185|75600206|FG000|Sequence 14 (w,s,m,w,m,s)|Overall Study||2||
59611562|NCT01757184|75722568|FG000|STARTED|Double-blind Period||36||
59611563|NCT01757184|75722569|FG001|STARTED|Double-blind Period||30||
59911120|NCT02744092|76032010|FG002|NOT COMPLETED|Enrolled & Received Selected Treatment||1||
59911121|NCT02744092|76032011|FG003|NOT COMPLETED|Enrolled & Received Selected Treatment||2||
59911122|NCT02744092|76032008|FG000|STARTED|6-Month Clinical Outcomes(Chart Review)||330||
59911123|NCT02744092|76032009|FG001|STARTED|6-Month Clinical Outcomes(Chart Review)||308||
60018548|NCT02561195|76134525|FG007|Treated|Vaccination 1 to 3||0||
60018549|NCT02561195|76134526|FG008|Treated|Vaccination 1 to 3||0||
60018550|NCT02561195|76134527|FG009|Treated|Vaccination 1 to 3||0||
60018551|NCT02561195|76134528|FG010|Treated|Vaccination 1 to 3||0||
59911124|NCT02744092|76032010|FG002|STARTED|6-Month Clinical Outcomes(Chart Review)||107||
59911125|NCT02744092|76032011|FG003|STARTED|6-Month Clinical Outcomes(Chart Review)||30||
60018552|NCT02561195|76134529|FG011|Treated|Vaccination 1 to 3||0||
60018553|NCT02561195|76134530|FG012|Treated|Vaccination 1 to 3||0||
60018554|NCT02561195|76134531|FG013|Treated|Vaccination 1 to 3||0||
60018555|NCT02561195|76134518|FG000|COMPLETED|Vaccination 1 to 3||160||
60018556|NCT02561195|76134519|FG001|COMPLETED|Vaccination 1 to 3||162||
60018557|NCT02561195|76134520|FG002|COMPLETED|Vaccination 1 to 3||55||
60018558|NCT02561195|76134521|FG003|COMPLETED|Vaccination 1 to 3||157||
60018559|NCT02561195|76134522|FG004|COMPLETED|Vaccination 1 to 3||155||
60018560|NCT02561195|76134523|FG005|COMPLETED|Vaccination 1 to 3||51||
60018561|NCT02561195|76134524|FG006|COMPLETED|Vaccination 1 to 3||0||
60018562|NCT02561195|76134525|FG007|COMPLETED|Vaccination 1 to 3||0||
60018563|NCT02561195|76134526|FG008|COMPLETED|Vaccination 1 to 3||0||
60018564|NCT02561195|76134527|FG009|COMPLETED|Vaccination 1 to 3||0||
60018565|NCT02561195|76134528|FG010|COMPLETED|Vaccination 1 to 3||0||
60018566|NCT02561195|76134529|FG011|COMPLETED|Vaccination 1 to 3||0||
60018567|NCT02561195|76134530|FG012|COMPLETED|Vaccination 1 to 3||0||
60018568|NCT02561195|76134531|FG013|COMPLETED|Vaccination 1 to 3||0||
60018569|NCT02561195|76134518|FG000|NOT COMPLETED|Vaccination 1 to 3||23||
60018570|NCT02561195|76134519|FG001|NOT COMPLETED|Vaccination 1 to 3||22||
60018571|NCT02561195|76134520|FG002|NOT COMPLETED|Vaccination 1 to 3||6||
60018572|NCT02561195|76134521|FG003|NOT COMPLETED|Vaccination 1 to 3||26||
60018573|NCT02561195|76134522|FG004|NOT COMPLETED|Vaccination 1 to 3||28||
60018574|NCT02561195|76134523|FG005|NOT COMPLETED|Vaccination 1 to 3||10||
60018575|NCT02561195|76134524|FG006|NOT COMPLETED|Vaccination 1 to 3||0||
60018576|NCT02561195|76134525|FG007|NOT COMPLETED|Vaccination 1 to 3||0||
60018577|NCT02561195|76134526|FG008|NOT COMPLETED|Vaccination 1 to 3||0||
60018578|NCT02561195|76134527|FG009|NOT COMPLETED|Vaccination 1 to 3||0||
60018579|NCT02561195|76134528|FG010|NOT COMPLETED|Vaccination 1 to 3||0||
59611564|NCT01757184|75722570|FG002|STARTED|Double-blind Period||0||
60018580|NCT02561195|76134529|FG011|NOT COMPLETED|Vaccination 1 to 3||0||
60018581|NCT02561195|76134530|FG012|NOT COMPLETED|Vaccination 1 to 3||0||
60018582|NCT02561195|76134531|FG013|NOT COMPLETED|Vaccination 1 to 3||0||
60018583|NCT02561195|76134518|FG000|STARTED|Extension Stage (Vaccination 4)||0||
60018584|NCT02561195|76134519|FG001|STARTED|Extension Stage (Vaccination 4)||0||
60018585|NCT02561195|76134520|FG002|STARTED|Extension Stage (Vaccination 4)||0||
60018586|NCT02561195|76134521|FG003|STARTED|Extension Stage (Vaccination 4)||0||
60018587|NCT02561195|76134522|FG004|STARTED|Extension Stage (Vaccination 4)||0||
60018588|NCT02561195|76134523|FG005|STARTED|Extension Stage (Vaccination 4)||0||
60018589|NCT02561195|76134524|FG006|STARTED|Extension Stage (Vaccination 4)|Participants who met predefined eligibility criteria enrolled into extension stage.|16||
59507042|NCT02395185|75600206|FG000|Sequence 15 (s,w,s,m,w,m)|Overall Study||2||
59507043|NCT02395185|75600206|FG000|Sequence 16 (m,s,w,s,m,w)|Overall Study||1||
59507044|NCT02395185|75600206|FG000|Sequence 17 (w,m,s,w,s,m)|Overall Study||1||
59758680|NCT00925301|75877987|FG001|STARTED|6-Month Open-label (Stage 2)|Zero participants noted because participants had completed Stage 1.|0||
59911126|NCT02744092|76032008|FG000|COMPLETED|6-Month Clinical Outcomes(Chart Review)||330||
59911127|NCT02744092|76032009|FG001|COMPLETED|6-Month Clinical Outcomes(Chart Review)||308||
59911128|NCT02744092|76032010|FG002|COMPLETED|6-Month Clinical Outcomes(Chart Review)||107||
59911129|NCT02744092|76032011|FG003|COMPLETED|6-Month Clinical Outcomes(Chart Review)||30||
60018590|NCT02561195|76134525|FG007|STARTED|Extension Stage (Vaccination 4)|Participants who met predefined eligibility criteria enrolled into extension stage.|18||
60018591|NCT02561195|76134526|FG008|STARTED|Extension Stage (Vaccination 4)|Participants who met predefined eligibility criteria enrolled into extension stage.|24||
60018592|NCT02561195|76134527|FG009|STARTED|Extension Stage (Vaccination 4)|Participants who met predefined eligibility criteria enrolled into extension stage.|22||
60018593|NCT02561195|76134528|FG010|STARTED|Extension Stage (Vaccination 4)|Participants who met predefined eligibility criteria enrolled into extension stage.|51||
60018594|NCT02561195|76134529|FG011|STARTED|Extension Stage (Vaccination 4)|Participants who met predefined eligibility criteria enrolled into extension stage.|52||
60018595|NCT02561195|76134530|FG012|STARTED|Extension Stage (Vaccination 4)|Participants who met predefined eligibility criteria enrolled into extension stage.|58||
59911130|NCT02744092|76032008|FG000|NOT COMPLETED|6-Month Clinical Outcomes(Chart Review)||0||
59911131|NCT02744092|76032009|FG001|NOT COMPLETED|6-Month Clinical Outcomes(Chart Review)||0||
60018596|NCT02561195|76134531|FG013|STARTED|Extension Stage (Vaccination 4)|Participants who met predefined eligibility criteria enrolled into extension stage.|59||
60018597|NCT02561195|76134518|FG000|COMPLETED|Extension Stage (Vaccination 4)||0||
60018598|NCT02561195|76134519|FG001|COMPLETED|Extension Stage (Vaccination 4)||0||
60018599|NCT02561195|76134520|FG002|COMPLETED|Extension Stage (Vaccination 4)||0||
60018600|NCT02561195|76134521|FG003|COMPLETED|Extension Stage (Vaccination 4)||0||
60018601|NCT02561195|76134522|FG004|COMPLETED|Extension Stage (Vaccination 4)||0||
60018602|NCT02561195|76134523|FG005|COMPLETED|Extension Stage (Vaccination 4)||0||
60018603|NCT02561195|76134524|FG006|COMPLETED|Extension Stage (Vaccination 4)||14||
60018604|NCT02561195|76134525|FG007|COMPLETED|Extension Stage (Vaccination 4)||17||
60018605|NCT02561195|76134526|FG008|COMPLETED|Extension Stage (Vaccination 4)||21||
60018606|NCT02561195|76134527|FG009|COMPLETED|Extension Stage (Vaccination 4)||20||
60018607|NCT02561195|76134528|FG010|COMPLETED|Extension Stage (Vaccination 4)||43||
60018608|NCT02561195|76134529|FG011|COMPLETED|Extension Stage (Vaccination 4)||45||
60018609|NCT02561195|76134530|FG012|COMPLETED|Extension Stage (Vaccination 4)||51||
60018610|NCT02561195|76134531|FG013|COMPLETED|Extension Stage (Vaccination 4)||54||
59507045|NCT02395185|75600206|FG000|Sequence 18 (m,w,m,s,w,s)|Overall Study||1||
59507046|NCT02395185|75600206|FG000|COMPLETED|Overall Study||33||
59507047|NCT02395185|75600206|FG000|NOT COMPLETED|Overall Study||0||
59507048|NCT02396511|75600214|FG000|STARTED|Overall Study||2||
59507049|NCT02396511|75600214|FG000|COMPLETED|Overall Study||2||
59758681|NCT00925301|75877988|FG002|STARTED|6-Month Open-label (Stage 2)|One participant (Migalastat [0-6 Months]) withdrew consent after completing Month 6.|63||
59758682|NCT00925301|75877989|FG003|STARTED|6-Month Open-label (Stage 2)|Zero participants noted because participants did not start the OLE yet.|0||
59758683|NCT00925301|75877986|FG000|ITT-amenable|6-Month Open-label (Stage 2)||0|Amenable mutations based on Good Laboratory Practice (GLP) Human Embryonic Kidney (HEK) assay.|
59758684|NCT00925301|75877987|FG001|ITT-amenable|6-Month Open-label (Stage 2)||0|Amenable mutations based on Good Laboratory Practice (GLP) Human Embryonic Kidney (HEK) assay.|
59911132|NCT02744092|76032010|FG002|NOT COMPLETED|6-Month Clinical Outcomes(Chart Review)||0||
59911133|NCT02744092|76032011|FG003|NOT COMPLETED|6-Month Clinical Outcomes(Chart Review)||0||
59911134|NCT02744092|76032008|FG000|STARTED|3-Month Patient-Reported Outcomes Survey||330||
59911135|NCT02744092|76032009|FG001|STARTED|3-Month Patient-Reported Outcomes Survey||308||
59911136|NCT02744092|76032010|FG002|STARTED|3-Month Patient-Reported Outcomes Survey||107||
59911137|NCT02744092|76032011|FG003|STARTED|3-Month Patient-Reported Outcomes Survey||30||
59911138|NCT02744092|76032008|FG000|Approached for 3-month Survey|3-Month Patient-Reported Outcomes Survey||295||
59911139|NCT02744092|76032009|FG001|Approached for 3-month Survey|3-Month Patient-Reported Outcomes Survey||280||
59911140|NCT02744092|76032010|FG002|Approached for 3-month Survey|3-Month Patient-Reported Outcomes Survey||99||
59911141|NCT02744092|76032011|FG003|Approached for 3-month Survey|3-Month Patient-Reported Outcomes Survey||26||
59911142|NCT02744092|76032008|FG000|COMPLETED|3-Month Patient-Reported Outcomes Survey||212||
59911143|NCT02744092|76032009|FG001|COMPLETED|3-Month Patient-Reported Outcomes Survey||197||
59911144|NCT02744092|76032010|FG002|COMPLETED|3-Month Patient-Reported Outcomes Survey||77||
59911145|NCT02744092|76032011|FG003|COMPLETED|3-Month Patient-Reported Outcomes Survey||16||
60018611|NCT02561195|76134518|FG000|NOT COMPLETED|Extension Stage (Vaccination 4)||0||
60018612|NCT02561195|76134519|FG001|NOT COMPLETED|Extension Stage (Vaccination 4)||0||
59507050|NCT02396511|75600214|FG000|NOT COMPLETED|Overall Study||0||
59911146|NCT02744092|76032008|FG000|NOT COMPLETED|3-Month Patient-Reported Outcomes Survey||118||
59911147|NCT02744092|76032009|FG001|NOT COMPLETED|3-Month Patient-Reported Outcomes Survey||111||
59911148|NCT02744092|76032010|FG002|NOT COMPLETED|3-Month Patient-Reported Outcomes Survey||30||
59911149|NCT02744092|76032011|FG003|NOT COMPLETED|3-Month Patient-Reported Outcomes Survey||14||
59911150|NCT02744092|76032008|FG000|STARTED|6-Month Patient-Reported Outcomes Survey||330|All patients were eligible to be included in the 6-month survey, regardless of whether or not they completed the 3-month survey.|
59911151|NCT02744092|76032009|FG001|STARTED|6-Month Patient-Reported Outcomes Survey||308|All patients were eligible to be included in the 6-month survey, regardless of whether or not they completed the 3-month survey.|
59911152|NCT02744092|76032010|FG002|STARTED|6-Month Patient-Reported Outcomes Survey||107|All patients were eligible to be included in the 6-month survey, regardless of whether or not they completed the 3-month survey.|
59911153|NCT02744092|76032011|FG003|STARTED|6-Month Patient-Reported Outcomes Survey||30|All patients were eligible to be included in the 6-month survey, regardless of whether or not they completed the 3-month survey.|
59911154|NCT02744092|76032008|FG000|Approached for 6-month Survey|6-Month Patient-Reported Outcomes Survey||262||
59911155|NCT02744092|76032009|FG001|Approached for 6-month Survey|6-Month Patient-Reported Outcomes Survey||253||
59911156|NCT02744092|76032010|FG002|Approached for 6-month Survey|6-Month Patient-Reported Outcomes Survey||89||
59911157|NCT02744092|76032011|FG003|Approached for 6-month Survey|6-Month Patient-Reported Outcomes Survey||21||
59911158|NCT02744092|76032008|FG000|COMPLETED|6-Month Patient-Reported Outcomes Survey||191||
59911159|NCT02744092|76032009|FG001|COMPLETED|6-Month Patient-Reported Outcomes Survey||177||
59911160|NCT02744092|76032010|FG002|COMPLETED|6-Month Patient-Reported Outcomes Survey||75||
59911161|NCT02744092|76032011|FG003|COMPLETED|6-Month Patient-Reported Outcomes Survey||12||
59911162|NCT02744092|76032008|FG000|NOT COMPLETED|6-Month Patient-Reported Outcomes Survey||139||
59911163|NCT02744092|76032009|FG001|NOT COMPLETED|6-Month Patient-Reported Outcomes Survey||131||
59911164|NCT02744092|76032010|FG002|NOT COMPLETED|6-Month Patient-Reported Outcomes Survey||32||
59911165|NCT02744092|76032011|FG003|NOT COMPLETED|6-Month Patient-Reported Outcomes Survey||18||
59911166|NCT02546375|76032021|FG000|STARTED|Overall Study||87||
59911167|NCT02546375|76032021|FG000|COMPLETED|Overall Study||87||
59911168|NCT02546375|76032021|FG000|NOT COMPLETED|Overall Study||0||
59911169|NCT02273388|76032037|FG000|STARTED|Overall Study||4|Started are treated|
59911170|NCT02273388|76032038|FG001|STARTED|Overall Study||3|Started are treated|
59911171|NCT02273388|76032039|FG002|STARTED|Overall Study||3|Started are treated|
59911172|NCT02273388|76032040|FG003|STARTED|Overall Study||2|Started are treated|
59911173|NCT02273388|76032041|FG004|STARTED|Overall Study||4|Started are treated|
59911174|NCT02273388|76032042|FG005|STARTED|Overall Study||3|Started are treated|
59911175|NCT02273388|76032043|FG006|STARTED|Overall Study||15|Started are treated|
59911176|NCT02273388|76032044|FG007|STARTED|Overall Study||8|Started are treated|
59911177|NCT02273388|76032045|FG008|STARTED|Overall Study||6|Started are treated|
59911178|NCT02273388|76032046|FG009|STARTED|Overall Study||5|Started are treated|
59911179|NCT02273388|76032047|FG010|STARTED|Overall Study||10|Started are treated|
59911180|NCT02273388|76032048|FG011|STARTED|Overall Study||2|Started are treated|
59911181|NCT02273388|76032037|FG000|COMPLETED|Overall Study||0||
59911182|NCT02273388|76032038|FG001|COMPLETED|Overall Study||0||
59911183|NCT02273388|76032039|FG002|COMPLETED|Overall Study||0||
59911184|NCT02273388|76032040|FG003|COMPLETED|Overall Study||0||
59911185|NCT02273388|76032041|FG004|COMPLETED|Overall Study||0||
59911186|NCT02273388|76032042|FG005|COMPLETED|Overall Study||0||
59911187|NCT02273388|76032043|FG006|COMPLETED|Overall Study||0||
59911188|NCT02273388|76032044|FG007|COMPLETED|Overall Study||0||
59911189|NCT02273388|76032045|FG008|COMPLETED|Overall Study||0||
59911190|NCT02273388|76032046|FG009|COMPLETED|Overall Study||0||
59911191|NCT02273388|76032047|FG010|COMPLETED|Overall Study||0||
59911192|NCT02273388|76032048|FG011|COMPLETED|Overall Study||0||
59911193|NCT02273388|76032037|FG000|NOT COMPLETED|Overall Study||4||
59911194|NCT02273388|76032038|FG001|NOT COMPLETED|Overall Study||3||
59911195|NCT02273388|76032039|FG002|NOT COMPLETED|Overall Study||3||
59911196|NCT02273388|76032040|FG003|NOT COMPLETED|Overall Study||2||
59911197|NCT02273388|76032041|FG004|NOT COMPLETED|Overall Study||4||
59911198|NCT02273388|76032042|FG005|NOT COMPLETED|Overall Study||3||
59911199|NCT02273388|76032043|FG006|NOT COMPLETED|Overall Study||15||
59911200|NCT02273388|76032044|FG007|NOT COMPLETED|Overall Study||8||
59911201|NCT02273388|76032045|FG008|NOT COMPLETED|Overall Study||6||
59911202|NCT02273388|76032046|FG009|NOT COMPLETED|Overall Study||5||
59911203|NCT02273388|76032047|FG010|NOT COMPLETED|Overall Study||10||
59911204|NCT02273388|76032048|FG011|NOT COMPLETED|Overall Study||2||
59911205|NCT02272790|76032083|FG000|STARTED|Overall Study||9||
59911206|NCT02272790|76032084|FG001|STARTED|Overall Study||39||
59911207|NCT02272790|76032085|FG002|STARTED|Overall Study||23||
59911208|NCT02272790|76032086|FG003|STARTED|Overall Study||12||
59911209|NCT02272790|76032087|FG004|STARTED|Overall Study||6||
59911210|NCT02272790|76032088|FG005|STARTED|Overall Study||6||
59911211|NCT02272790|76032083|FG000|COMPLETED|Overall Study||9||
59911212|NCT02272790|76032084|FG001|COMPLETED|Overall Study||38||
59911213|NCT02272790|76032085|FG002|COMPLETED|Overall Study||23||
59911214|NCT02272790|76032086|FG003|COMPLETED|Overall Study||12||
59911215|NCT02272790|76032087|FG004|COMPLETED|Overall Study||6||
59911216|NCT02272790|76032088|FG005|COMPLETED|Overall Study||6||
59911217|NCT02272790|76032083|FG000|NOT COMPLETED|Overall Study||0||
59911218|NCT02272790|76032084|FG001|NOT COMPLETED|Overall Study||1||
59911219|NCT02272790|76032085|FG002|NOT COMPLETED|Overall Study||0||
59911220|NCT02272790|76032086|FG003|NOT COMPLETED|Overall Study||0||
59911221|NCT02272790|76032087|FG004|NOT COMPLETED|Overall Study||0||
59911222|NCT02272790|76032088|FG005|NOT COMPLETED|Overall Study||0||
59911223|NCT02100956|76032110|FG000|STARTED|First Injection||3||
59911224|NCT02100956|76032111|FG001|STARTED|First Injection||3||
59911225|NCT02100956|76032110|FG000|COMPLETED|First Injection||3||
59911226|NCT02100956|76032111|FG001|COMPLETED|First Injection||3||
59911227|NCT02100956|76032110|FG000|NOT COMPLETED|First Injection||0||
59911228|NCT02100956|76032111|FG001|NOT COMPLETED|First Injection||0||
59911229|NCT02100956|76032110|FG000|STARTED|At Least One Week Between Injections||3||
59911230|NCT02100956|76032111|FG001|STARTED|At Least One Week Between Injections||3||
59911231|NCT02100956|76032110|FG000|COMPLETED|At Least One Week Between Injections||3||
59911232|NCT02100956|76032111|FG001|COMPLETED|At Least One Week Between Injections||2||
59911233|NCT02100956|76032110|FG000|NOT COMPLETED|At Least One Week Between Injections||0||
59911234|NCT02100956|76032111|FG001|NOT COMPLETED|At Least One Week Between Injections||1||
59911235|NCT02100956|76032110|FG000|STARTED|Second Injection||3||
59911236|NCT02100956|76032111|FG001|STARTED|Second Injection||2||
59911237|NCT02100956|76032110|FG000|COMPLETED|Second Injection||3||
59911238|NCT02100956|76032111|FG001|COMPLETED|Second Injection||2||
59911239|NCT02100956|76032110|FG000|NOT COMPLETED|Second Injection||0||
59911240|NCT02100956|76032111|FG001|NOT COMPLETED|Second Injection||0||
59911241|NCT01438411|76032117|FG000|STARTED|Overall Study||53||
59911242|NCT01438411|76032117|FG000|COMPLETED|Overall Study||40||
59911243|NCT01438411|76032117|FG000|NOT COMPLETED|Overall Study||13||
59911244|NCT01302834|76032123|FG000|STARTED|Overall Study||424||
59911245|NCT01302834|76032124|FG001|STARTED|Overall Study||425||
59911246|NCT01302834|76032123|FG000|Eligible|Overall Study||406|All eligible participants|
59911247|NCT01302834|76032124|FG001|Eligible|Overall Study||399|All eligible participants|
60018613|NCT02561195|76134520|FG002|NOT COMPLETED|Extension Stage (Vaccination 4)||0||
59911248|NCT01302834|76032123|FG000|Started Treatment|Overall Study||398|Eligible and started study treatment|
59911249|NCT01302834|76032124|FG001|Started Treatment|Overall Study||394|Eligible and started study treatment|
59911250|NCT01302834|76032123|FG000|AE Assessed 1 Month Post-treatment (PT)|Overall Study||369|Eligible, started study treatment, and had adverse events (AE) assessment 1 month post-treatment|
59911251|NCT01302834|76032124|FG001|AE Assessed 1 Month Post-treatment (PT)|Overall Study||363|Eligible, started study treatment, and had adverse events (AE) assessment 1 month post-treatment|
59911252|NCT01302834|76032123|FG000|AE Assessed 3 Months PT|Overall Study||359|Eligible, started study treatment, and had adverse events assessment 3 months post-treatment|
59951210|NCT03783689|76070148|FG000|STARTED|Overall Study||19||
59951211|NCT03783689|76070149|FG001|STARTED|Overall Study||19||
59951212|NCT03783689|76070148|FG000|Safety Set|Overall Study||19|All subjects who were consented, randomized, and underwent Lead placement.|
59951213|NCT03783689|76070149|FG001|Safety Set|Overall Study||19|All subjects who were consented, randomized, and underwent Lead placement.|
59951214|NCT03783689|76070148|FG000|Full Analysis Set|Overall Study||18|Subjects who were consented, randomized, and continued to meet eligibility criteria prior to undergoing Lead placement.|
59951215|NCT03783689|76070149|FG001|Full Analysis Set|Overall Study||18|Subjects who were consented, randomized, and continued to meet eligibility criteria prior to undergoing Lead placement.|
59951216|NCT03783689|76070148|FG000|Per Protocol Set|Overall Study||13|Subjects who were consented, randomized, continued to meet eligibility criteria prior to undergoing Lead placement, were implanted with at least one Lead, reported coverage of comfortable sensations in the target areas during weeks 5 to 8 post-start of treatment (SOT), have adequate diary completion for each qualifying region of pain, and continued eligibility during weeks 1 to 8 post-SOT.|
59951300|NCT03641287|76070233|FG000|STARTED|Overall Study||31||
59911253|NCT01302834|76032124|FG001|AE Assessed 3 Months PT|Overall Study||367|Eligible, started study treatment, and had adverse events assessment 3 months post-treatment|
59911254|NCT01302834|76032123|FG000|AE Assessed 6 Months PT|Overall Study||361|Eligible, started study treatment, and had adverse events assessment 6 months post-treatment|
59911255|NCT01302834|76032124|FG001|AE Assessed 6 Months PT|Overall Study||352|Eligible, started study treatment, and had adverse events assessment 6 months post-treatment|
59911256|NCT01302834|76032123|FG000|AE Assessment 1 Year PT|Overall Study||360|Eligible, started study treatment, and had adverse events assessment 1 year post-treatment|
59507051|NCT02396745|75600218|FG000|STARTED|Overall Study||1||
59507052|NCT02396745|75600218|FG000|COMPLETED|Overall Study||1||
59911257|NCT01302834|76032124|FG001|AE Assessment 1 Year PT|Overall Study||351|Eligible, started study treatment, and had adverse events assessment 1 year post-treatment|
59911258|NCT01302834|76032123|FG000|AE Assessed 2 Years PT|Overall Study||311|Eligible, started study treatment, and had adverse events assessment 2 years post-treatment|
59911259|NCT01302834|76032124|FG001|AE Assessed 2 Years PT|Overall Study||303|Eligible, started study treatment, and had adverse events assessment 2 years post-treatment|
59911260|NCT01302834|76032123|FG000|AE Assessed 5 Years PT|Overall Study||92|Eligible, started study treatment, and had adverse events assessment 5 years post-treatment|
59911261|NCT01302834|76032124|FG001|AE Assessed 5 Years PT|Overall Study||86|Eligible, started study treatment, and had adverse events assessment 5 years post-treatment|
59911262|NCT01302834|76032123|FG000|Dental Health Assessed 1 Year PT|Overall Study||267|Eligible, started study treatment, and had dental health assessment 1 year post-treatment|
59911263|NCT01302834|76032124|FG001|Dental Health Assessed 1 Year PT|Overall Study||267|Eligible, started study treatment, and had dental health assessment 1 year post-treatment|
59911264|NCT01302834|76032123|FG000|Dental Health Assessed 2 Years PT|Overall Study||208|Eligible, started study treatment, and had dental health assessment 2 years post-treatment|
59911265|NCT01302834|76032124|FG001|Dental Health Assessed 2 Years PT|Overall Study||201|Eligible, started study treatment, and had dental health assessment 2 years post-treatment|
59911266|NCT01302834|76032123|FG000|Dental Health Assessed 5 Years PT|Overall Study||44|Eligible, started study treatment, and had dental health assessment 5 years post-treatment|
59911267|NCT01302834|76032124|FG001|Dental Health Assessed 5 Years PT|Overall Study||43|Eligible, started study treatment, and had dental health assessment 5 years post-treatment|
59911268|NCT01302834|76032123|FG000|Feeding Tube Assessed|Overall Study||368|Eligible, started study treatment, and had feeding tube assessment 1 year post-treatment|
59911269|NCT01302834|76032124|FG001|Feeding Tube Assessed|Overall Study||356|Eligible, started study treatment, and had feeding tube assessment 1 year post-treatment|
59911270|NCT01302834|76032123|FG000|Progressed|Overall Study||76|Eligible and experienced local, regional, or distant progression or death|
59911271|NCT01302834|76032124|FG001|Progressed|Overall Study||122|Eligible and experienced local, regional, or distant progression or death|
59911272|NCT01302834|76032123|FG000|COMPLETED|Overall Study||406|Subjects contributing any data to analysis are considered to have completed the study|
59911273|NCT01302834|76032124|FG001|COMPLETED|Overall Study||399|Subjects contributing any data to analysis are considered to have completed the study|
59911274|NCT01302834|76032123|FG000|NOT COMPLETED|Overall Study||18||
59911275|NCT01302834|76032124|FG001|NOT COMPLETED|Overall Study||26||
59911276|NCT01153698|76032130|FG000|STARTED|Overall Study|Entered and treated.|168||
59911277|NCT01153698|76032130|FG000|COMPLETED|Overall Study|Completed Pradaxa treatment.|139||
59911278|NCT01153698|76032130|FG000|NOT COMPLETED|Overall Study||29||
59911279|NCT01115582|76032135|FG000|STARTED|Overall Study||16||
59911280|NCT01115582|76032135|FG000|COMPLETED|Overall Study||16||
59911281|NCT01115582|76032135|FG000|NOT COMPLETED|Overall Study||0||
59911282|NCT01040624|76032141|FG000|STARTED|Overall Study||58||
59911283|NCT01040624|76032142|FG001|STARTED|Overall Study||19||
59911284|NCT01040624|76032141|FG000|COMPLETED|Overall Study||58||
59911285|NCT01040624|76032142|FG001|COMPLETED|Overall Study||19||
59911286|NCT01040624|76032141|FG000|NOT COMPLETED|Overall Study||0||
59911287|NCT01040624|76032142|FG001|NOT COMPLETED|Overall Study||0||
59911288|NCT00804856|76032163|FG000|STARTED|Overall Study||4||
59911289|NCT00804856|76032164|FG001|STARTED|Overall Study||3||
59911290|NCT00804856|76032165|FG002|STARTED|Overall Study||5||
59911291|NCT00804856|76032166|FG003|STARTED|Overall Study||9||
59911292|NCT00804856|76032167|FG004|STARTED|Overall Study||8||
59911293|NCT00804856|76032168|FG005|STARTED|Overall Study||3||
59911294|NCT00804856|76032169|FG006|STARTED|Overall Study||11||
59911295|NCT00804856|76032170|FG007|STARTED|Overall Study||2||
59911296|NCT00804856|76032171|FG008|STARTED|Overall Study||5||
59911297|NCT00804856|76032172|FG009|STARTED|Overall Study||6||
59911298|NCT00804856|76032173|FG010|STARTED|Overall Study||23||
59911299|NCT00804856|76032174|FG011|STARTED|Overall Study||5||
59911300|NCT00804856|76032175|FG012|STARTED|Overall Study||4||
59911301|NCT00804856|76032176|FG013|STARTED|Overall Study||45||
59911302|NCT00804856|76032177|FG014|STARTED|Overall Study||42||
59911303|NCT00804856|76032163|FG000|COMPLETED|Overall Study||0||
59911304|NCT00804856|76032164|FG001|COMPLETED|Overall Study||0||
59911305|NCT00804856|76032165|FG002|COMPLETED|Overall Study||0||
59911306|NCT00804856|76032166|FG003|COMPLETED|Overall Study||0||
59911307|NCT00804856|76032167|FG004|COMPLETED|Overall Study||0||
59911308|NCT00804856|76032168|FG005|COMPLETED|Overall Study||0||
59911309|NCT00804856|76032169|FG006|COMPLETED|Overall Study||0||
59911310|NCT00804856|76032170|FG007|COMPLETED|Overall Study||0||
59911311|NCT00804856|76032171|FG008|COMPLETED|Overall Study||0||
60018614|NCT02561195|76134521|FG003|NOT COMPLETED|Extension Stage (Vaccination 4)||0||
59911312|NCT00804856|76032172|FG009|COMPLETED|Overall Study||0||
59911313|NCT00804856|76032173|FG010|COMPLETED|Overall Study||0||
59911314|NCT00804856|76032174|FG011|COMPLETED|Overall Study||0||
60018615|NCT02561195|76134522|FG004|NOT COMPLETED|Extension Stage (Vaccination 4)||0||
60018616|NCT02561195|76134523|FG005|NOT COMPLETED|Extension Stage (Vaccination 4)||0||
60018617|NCT02561195|76134524|FG006|NOT COMPLETED|Extension Stage (Vaccination 4)||2||
60018618|NCT02561195|76134525|FG007|NOT COMPLETED|Extension Stage (Vaccination 4)||1||
60018619|NCT02561195|76134526|FG008|NOT COMPLETED|Extension Stage (Vaccination 4)||3||
60018620|NCT02561195|76134527|FG009|NOT COMPLETED|Extension Stage (Vaccination 4)||2||
60018621|NCT02561195|76134528|FG010|NOT COMPLETED|Extension Stage (Vaccination 4)||8||
59911315|NCT00804856|76032175|FG012|COMPLETED|Overall Study||0||
59911316|NCT00804856|76032176|FG013|COMPLETED|Overall Study||0||
59911317|NCT00804856|76032177|FG014|COMPLETED|Overall Study||0||
59911318|NCT00804856|76032163|FG000|NOT COMPLETED|Overall Study||4||
59911319|NCT00804856|76032164|FG001|NOT COMPLETED|Overall Study||3||
59911320|NCT00804856|76032165|FG002|NOT COMPLETED|Overall Study||5||
59911321|NCT00804856|76032166|FG003|NOT COMPLETED|Overall Study||9||
59911322|NCT00804856|76032167|FG004|NOT COMPLETED|Overall Study||8||
59911323|NCT00804856|76032168|FG005|NOT COMPLETED|Overall Study||3||
60018622|NCT02561195|76134529|FG011|NOT COMPLETED|Extension Stage (Vaccination 4)||7||
60018623|NCT02561195|76134530|FG012|NOT COMPLETED|Extension Stage (Vaccination 4)||7||
60018624|NCT02561195|76134531|FG013|NOT COMPLETED|Extension Stage (Vaccination 4)||5||
60018625|NCT01663103|76134565|FG000|STARTED|Overall Study||21||
60018626|NCT01663103|76134566|FG001|STARTED|Overall Study||21||
60018627|NCT01663103|76134565|FG000|COMPLETED|Overall Study||18||
60018628|NCT01663103|76134566|FG001|COMPLETED|Overall Study||19||
60018629|NCT01663103|76134565|FG000|NOT COMPLETED|Overall Study||3||
60018630|NCT01663103|76134566|FG001|NOT COMPLETED|Overall Study||2||
60018631|NCT04535531|76134578|FG000|STARTED|Overall Study||444||
60018632|NCT04535531|76134579|FG001|STARTED|Overall Study||447||
60018633|NCT04535531|76134578|FG000|COMPLETED|Overall Study||363||
60018634|NCT04535531|76134579|FG001|COMPLETED|Overall Study||390||
60018635|NCT04535531|76134578|FG000|NOT COMPLETED|Overall Study||81||
60018636|NCT04535531|76134579|FG001|NOT COMPLETED|Overall Study||57||
60018637|NCT02560025|76134585|FG000|STARTED|Overall Study||42||
60018638|NCT02560025|76134585|FG000|COMPLETED|Overall Study||39||
60018639|NCT02560025|76134585|FG000|NOT COMPLETED|Overall Study||3||
60018640|NCT04640519|76134591|FG000|STARTED|Overall Study||25||
60018641|NCT04640519|76134592|FG001|STARTED|Overall Study||25||
60018642|NCT04640519|76134591|FG000|COMPLETED|Overall Study||25||
60018643|NCT04640519|76134592|FG001|COMPLETED|Overall Study||25||
60018644|NCT04640519|76134591|FG000|NOT COMPLETED|Overall Study||0||
60018645|NCT04640519|76134592|FG001|NOT COMPLETED|Overall Study||0||
60018646|NCT02566889|76134600|FG000|STARTED|Overall Study||45||
60018647|NCT02566889|76134601|FG001|STARTED|Overall Study||8||
60018648|NCT02566889|76134600|FG000|Cross-over to Dose Escalation Group|Overall Study||1|This participant was counted in both arms for safety analysis.|
59911324|NCT00804856|76032169|FG006|NOT COMPLETED|Overall Study||11||
59911325|NCT00804856|76032170|FG007|NOT COMPLETED|Overall Study||2||
59911326|NCT00804856|76032171|FG008|NOT COMPLETED|Overall Study||5||
59911327|NCT00804856|76032172|FG009|NOT COMPLETED|Overall Study||6||
59911328|NCT00804856|76032173|FG010|NOT COMPLETED|Overall Study||23||
59911329|NCT00804856|76032174|FG011|NOT COMPLETED|Overall Study||5||
60018649|NCT02566889|76134601|FG001|Cross-over to Dose Escalation Group|Overall Study||0|This participant was counted in both arms for safety analysis.|
60018650|NCT02566889|76134600|FG000|COMPLETED|Overall Study||32||
60018651|NCT02566889|76134601|FG001|COMPLETED|Overall Study||3||
60018652|NCT02566889|76134600|FG000|NOT COMPLETED|Overall Study||13||
60018653|NCT02566889|76134601|FG001|NOT COMPLETED|Overall Study||5||
60018654|NCT02566577|76134608|FG000|STARTED|Overall Study||9||
60018655|NCT02566577|76134609|FG001|STARTED|Overall Study||6||
60018656|NCT02566577|76134608|FG000|COMPLETED|Overall Study||6||
60018657|NCT02566577|76134609|FG001|COMPLETED|Overall Study||4||
60018658|NCT02566577|76134608|FG000|NOT COMPLETED|Overall Study||3||
59507053|NCT02396745|75600218|FG000|NOT COMPLETED|Overall Study||0||
59507054|NCT00816829|75600224|FG000|STARTED|Overall Study||16||
59507055|NCT00816829|75600225|FG001|STARTED|Overall Study||18||
59507056|NCT00816829|75600224|FG000|COMPLETED|Overall Study||16||
59507057|NCT00816829|75600225|FG001|COMPLETED|Overall Study||18||
59507058|NCT00816829|75600224|FG000|NOT COMPLETED|Overall Study||0||
59507059|NCT00816829|75600225|FG001|NOT COMPLETED|Overall Study||0||
59507060|NCT02062359|75600231|FG000|STARTED|Overall Study||2||
59911330|NCT00804856|76032175|FG012|NOT COMPLETED|Overall Study||4||
59911331|NCT00804856|76032176|FG013|NOT COMPLETED|Overall Study||45||
59911332|NCT00804856|76032177|FG014|NOT COMPLETED|Overall Study||42||
59911333|NCT00769652|76032247|FG000|STARTED|Overall Study||6||
59911334|NCT00769652|76032248|FG001|STARTED|Overall Study||1||
59911335|NCT00769652|76032247|FG000|COMPLETED|Overall Study||6||
59911336|NCT00769652|76032248|FG001|COMPLETED|Overall Study||1||
59911337|NCT00769652|76032247|FG000|NOT COMPLETED|Overall Study||0||
59911338|NCT00769652|76032248|FG001|NOT COMPLETED|Overall Study||0||
59911339|NCT01314872|76032265|FG000|STARTED|Treatment Period 1||141||
59911340|NCT01314872|76032266|FG001|STARTED|Treatment Period 1||144||
59911341|NCT01314872|76032267|FG002|STARTED|Treatment Period 1||134||
59507061|NCT02062359|75600231|FG000|COMPLETED|Overall Study||2||
59507062|NCT02062359|75600231|FG000|NOT COMPLETED|Overall Study||0||
59507063|NCT02397291|75600237|FG000|STARTED|Overall Study||19||
59507064|NCT02397291|75600238|FG001|STARTED|Overall Study||5||
59507065|NCT02397291|75600237|FG000|COMPLETED|Overall Study||19||
59507066|NCT02397291|75600238|FG001|COMPLETED|Overall Study||5||
59507067|NCT02397291|75600237|FG000|NOT COMPLETED|Overall Study||0||
59507068|NCT02397291|75600238|FG001|NOT COMPLETED|Overall Study||0||
59507069|NCT00816907|75600246|FG000|STARTED|Overall Study||71||
59507070|NCT00816907|75600247|FG001|STARTED|Overall Study||75||
59507071|NCT00816907|75600246|FG000|COMPLETED|Overall Study||58||
59507072|NCT00816907|75600247|FG001|COMPLETED|Overall Study||58||
59507073|NCT00816907|75600246|FG000|NOT COMPLETED|Overall Study||13||
59911342|NCT01314872|76032268|FG003|STARTED|Treatment Period 1||150||
59911343|NCT01314872|76032269|FG004|STARTED|Treatment Period 1||149||
59911344|NCT01314872|76032270|FG005|STARTED|Treatment Period 1||135||
59911345|NCT01314872|76032271|FG006|STARTED|Treatment Period 1||134||
59911346|NCT01314872|76032272|FG007|STARTED|Treatment Period 1||64||
59911347|NCT01314872|76032273|FG008|STARTED|Treatment Period 1||112||
59911348|NCT01314872|76032274|FG009|STARTED|Treatment Period 1||122||
59911349|NCT01314872|76032275|FG010|STARTED|Treatment Period 1||110||
59911350|NCT01314872|76032276|FG011|STARTED|Treatment Period 1||0||
59911351|NCT01314872|76032277|FG012|STARTED|Treatment Period 1||0||
59911352|NCT01314872|76032278|FG013|STARTED|Treatment Period 1||0||
59911353|NCT01314872|76032279|FG014|STARTED|Treatment Period 1||0||
59911354|NCT01314872|76032265|FG000|COMPLETED|Treatment Period 1||131||
59911355|NCT01314872|76032266|FG001|COMPLETED|Treatment Period 1||138||
59911356|NCT01314872|76032267|FG002|COMPLETED|Treatment Period 1||128||
59911357|NCT01314872|76032268|FG003|COMPLETED|Treatment Period 1||143||
59911358|NCT01314872|76032269|FG004|COMPLETED|Treatment Period 1||142||
59911359|NCT01314872|76032270|FG005|COMPLETED|Treatment Period 1||128||
59911360|NCT01314872|76032271|FG006|COMPLETED|Treatment Period 1||126||
59911361|NCT01314872|76032272|FG007|COMPLETED|Treatment Period 1||57||
59911362|NCT01314872|76032273|FG008|COMPLETED|Treatment Period 1||106||
59911363|NCT01314872|76032274|FG009|COMPLETED|Treatment Period 1||118||
59911364|NCT01314872|76032275|FG010|COMPLETED|Treatment Period 1||107||
60018659|NCT02566577|76134609|FG001|NOT COMPLETED|Overall Study||2||
60018660|NCT04475549|76134617|FG000|STARTED|Overall Study||8||
60018661|NCT04475549|76134617|FG000|COMPLETED|Overall Study||8||
60018662|NCT04475549|76134617|FG000|NOT COMPLETED|Overall Study||0||
60018663|NCT02559713|76134621|FG000|STARTED|Overall Study||11||
60018664|NCT02559713|76134621|FG000|Safety Set|Overall Study||11||
60018665|NCT02559713|76134621|FG000|Pharmacokinetic Set|Overall Study||11||
60018666|NCT02559713|76134621|FG000|COMPLETED|Overall Study||10||
60018667|NCT02559713|76134621|FG000|NOT COMPLETED|Overall Study||1||
60018668|NCT01358981|76134632|FG000|STARTED|Period 1||2||
60018669|NCT01358981|76134633|FG001|STARTED|Period 1||2||
60018670|NCT01358981|76134634|FG002|STARTED|Period 1||2||
60018671|NCT01358981|76134635|FG003|STARTED|Period 1||2||
60018672|NCT01358981|76134636|FG004|STARTED|Period 1||3||
60018673|NCT01358981|76134637|FG005|STARTED|Period 1||3||
60018674|NCT01358981|76134638|FG006|STARTED|Period 1||3||
60018675|NCT01358981|76134632|FG000|Received at Least 1dose of Study Drug|Period 1||2||
60018676|NCT01358981|76134633|FG001|Received at Least 1dose of Study Drug|Period 1||2||
60018677|NCT01358981|76134634|FG002|Received at Least 1dose of Study Drug|Period 1||2||
60018678|NCT01358981|76134635|FG003|Received at Least 1dose of Study Drug|Period 1||2||
60018679|NCT01358981|76134636|FG004|Received at Least 1dose of Study Drug|Period 1||3||
60018680|NCT01358981|76134637|FG005|Received at Least 1dose of Study Drug|Period 1||3||
60018681|NCT01358981|76134638|FG006|Received at Least 1dose of Study Drug|Period 1||3||
60018682|NCT01358981|76134632|FG000|COMPLETED|Period 1||2||
60018683|NCT01358981|76134633|FG001|COMPLETED|Period 1||2||
60018684|NCT01358981|76134634|FG002|COMPLETED|Period 1||2||
60018685|NCT01358981|76134635|FG003|COMPLETED|Period 1||1||
60018686|NCT01358981|76134636|FG004|COMPLETED|Period 1||3||
60018687|NCT01358981|76134637|FG005|COMPLETED|Period 1||3||
60018688|NCT01358981|76134638|FG006|COMPLETED|Period 1||3||
60018689|NCT01358981|76134632|FG000|NOT COMPLETED|Period 1||0||
60018690|NCT01358981|76134633|FG001|NOT COMPLETED|Period 1||0||
60018691|NCT01358981|76134634|FG002|NOT COMPLETED|Period 1||0||
60018692|NCT01358981|76134635|FG003|NOT COMPLETED|Period 1||1||
59911365|NCT01314872|76032276|FG011|COMPLETED|Treatment Period 1||0||
59911366|NCT01314872|76032277|FG012|COMPLETED|Treatment Period 1||0||
60018693|NCT01358981|76134636|FG004|NOT COMPLETED|Period 1||0||
60018694|NCT01358981|76134637|FG005|NOT COMPLETED|Period 1||0||
60018695|NCT01358981|76134638|FG006|NOT COMPLETED|Period 1||0||
60018696|NCT01358981|76134632|FG000|STARTED|Period 2||2||
60018697|NCT01358981|76134633|FG001|STARTED|Period 2||2||
60018698|NCT01358981|76134634|FG002|STARTED|Period 2||2||
59507074|NCT00816907|75600247|FG001|NOT COMPLETED|Overall Study||17||
59507075|NCT02007291|75600255|FG000|STARTED|Overall Study||48||
59507076|NCT02007291|75600256|FG001|STARTED|Overall Study||23||
59507077|NCT02007291|75600255|FG000|COMPLETED|Overall Study||48||
59507078|NCT02007291|75600256|FG001|COMPLETED|Overall Study||23||
59507079|NCT02007291|75600255|FG000|NOT COMPLETED|Overall Study||0||
59507080|NCT02007291|75600256|FG001|NOT COMPLETED|Overall Study||0||
59758685|NCT00925301|75877988|FG002|ITT-amenable|6-Month Open-label (Stage 2)||47|Amenable mutations based on Good Laboratory Practice (GLP) Human Embryonic Kidney (HEK) assay.|
59758686|NCT00925301|75877989|FG003|ITT-amenable|6-Month Open-label (Stage 2)||0|Amenable mutations based on Good Laboratory Practice (GLP) Human Embryonic Kidney (HEK) assay.|
59758687|NCT00925301|75877986|FG000|COMPLETED|6-Month Open-label (Stage 2)||0||
59758688|NCT00925301|75877987|FG001|COMPLETED|6-Month Open-label (Stage 2)||0||
59758689|NCT00925301|75877988|FG002|COMPLETED|6-Month Open-label (Stage 2)||60||
59758690|NCT00925301|75877989|FG003|COMPLETED|6-Month Open-label (Stage 2)||0||
59758691|NCT00925301|75877986|FG000|NOT COMPLETED|6-Month Open-label (Stage 2)||0||
60018699|NCT01358981|76134635|FG003|STARTED|Period 2|One participant who withdrew in period 1 was replaced by another participant in period 2.|2||
60018700|NCT01358981|76134636|FG004|STARTED|Period 2||3||
60018701|NCT01358981|76134637|FG005|STARTED|Period 2||3||
60018702|NCT01358981|76134638|FG006|STARTED|Period 2||3||
60018703|NCT01358981|76134632|FG000|COMPLETED|Period 2||2||
60018704|NCT01358981|76134633|FG001|COMPLETED|Period 2||2||
60018705|NCT01358981|76134634|FG002|COMPLETED|Period 2||2||
60018706|NCT01358981|76134635|FG003|COMPLETED|Period 2||2||
60018707|NCT01358981|76134636|FG004|COMPLETED|Period 2||3||
60018708|NCT01358981|76134637|FG005|COMPLETED|Period 2||3||
59758692|NCT00925301|75877987|FG001|NOT COMPLETED|6-Month Open-label (Stage 2)||0||
59758693|NCT00925301|75877988|FG002|NOT COMPLETED|6-Month Open-label (Stage 2)||3||
59758694|NCT00925301|75877989|FG003|NOT COMPLETED|6-Month Open-label (Stage 2)||0||
59762595|NCT03888235|75882412|FG002|STARTED|Overall Study||20||
60018709|NCT01358981|76134638|FG006|COMPLETED|Period 2||3||
60018710|NCT01358981|76134632|FG000|NOT COMPLETED|Period 2||0||
60018711|NCT01358981|76134633|FG001|NOT COMPLETED|Period 2||0||
60018712|NCT01358981|76134634|FG002|NOT COMPLETED|Period 2||0||
60018713|NCT01358981|76134635|FG003|NOT COMPLETED|Period 2||0||
60018714|NCT01358981|76134636|FG004|NOT COMPLETED|Period 2||0||
60018715|NCT01358981|76134637|FG005|NOT COMPLETED|Period 2||0||
60018716|NCT01358981|76134638|FG006|NOT COMPLETED|Period 2||0||
60018717|NCT01358981|76134632|FG000|STARTED|Period 3||2||
60018718|NCT01358981|76134633|FG001|STARTED|Period 3||2||
60018719|NCT01358981|76134634|FG002|STARTED|Period 3||2||
60018720|NCT01358981|76134635|FG003|STARTED|Period 3||2||
60018721|NCT01358981|76134636|FG004|STARTED|Period 3||3||
60018722|NCT01358981|76134637|FG005|STARTED|Period 3||3||
60018723|NCT01358981|76134638|FG006|STARTED|Period 3||3||
59507081|NCT00817219|75600262|FG000|STARTED|Overall Study||33||
59507082|NCT00817219|75600262|FG000|COMPLETED|Overall Study||33||
59507083|NCT00817219|75600262|FG000|NOT COMPLETED|Overall Study||0||
59507084|NCT02007369|75600269|FG000|STARTED|Overall Study||42||
59507085|NCT02007369|75600270|FG001|STARTED|Overall Study||40||
59507086|NCT02007369|75600271|FG002|STARTED|Overall Study||54||
59507087|NCT02007369|75600269|FG000|COMPLETED|Overall Study||42||
59507088|NCT02007369|75600270|FG001|COMPLETED|Overall Study||40||
59507089|NCT02007369|75600271|FG002|COMPLETED|Overall Study||54||
59507090|NCT02007369|75600269|FG000|NOT COMPLETED|Overall Study||0||
59507091|NCT02007369|75600270|FG001|NOT COMPLETED|Overall Study||0||
59507092|NCT02007369|75600271|FG002|NOT COMPLETED|Overall Study||0||
59507093|NCT00817843|75600279|FG000|STARTED|First Period (6 Weeks)||50||
59758695|NCT00925301|75877986|FG000|STARTED|12-Month Open-label Extension (Optional)|Zero participants noted because participants had completed Stage 1.|0||
59762596|NCT03888235|75882410|FG000|COMPLETED|Overall Study||20||
59911367|NCT01314872|76032278|FG013|COMPLETED|Treatment Period 1||0||
59911368|NCT01314872|76032279|FG014|COMPLETED|Treatment Period 1||0||
59911369|NCT01314872|76032265|FG000|NOT COMPLETED|Treatment Period 1||10||
59911370|NCT01314872|76032266|FG001|NOT COMPLETED|Treatment Period 1||6||
59911371|NCT01314872|76032267|FG002|NOT COMPLETED|Treatment Period 1||6||
59911372|NCT01314872|76032268|FG003|NOT COMPLETED|Treatment Period 1||7||
59911373|NCT01314872|76032269|FG004|NOT COMPLETED|Treatment Period 1||7||
60018724|NCT01358981|76134632|FG000|COMPLETED|Period 3||2||
60018725|NCT01358981|76134633|FG001|COMPLETED|Period 3||2||
60018726|NCT01358981|76134634|FG002|COMPLETED|Period 3||2||
60018727|NCT01358981|76134635|FG003|COMPLETED|Period 3||2||
60018728|NCT01358981|76134636|FG004|COMPLETED|Period 3||3||
60018729|NCT01358981|76134637|FG005|COMPLETED|Period 3||3||
60018730|NCT01358981|76134638|FG006|COMPLETED|Period 3||3||
60018731|NCT01358981|76134632|FG000|NOT COMPLETED|Period 3||0||
60018732|NCT01358981|76134633|FG001|NOT COMPLETED|Period 3||0||
60018733|NCT01358981|76134634|FG002|NOT COMPLETED|Period 3||0||
60018734|NCT01358981|76134635|FG003|NOT COMPLETED|Period 3||0||
60018735|NCT01358981|76134636|FG004|NOT COMPLETED|Period 3||0||
60018736|NCT01358981|76134637|FG005|NOT COMPLETED|Period 3||0||
60018737|NCT01358981|76134638|FG006|NOT COMPLETED|Period 3||0||
60018738|NCT01358981|76134632|FG000|STARTED|Period 4||2||
60018739|NCT01358981|76134633|FG001|STARTED|Period 4||2||
60018740|NCT01358981|76134634|FG002|STARTED|Period 4||2||
60018741|NCT01358981|76134635|FG003|STARTED|Period 4||2||
60018742|NCT01358981|76134636|FG004|STARTED|Period 4|Part B was planned for only 3 dosing periods.|0||
60018743|NCT01358981|76134637|FG005|STARTED|Period 4|Part B was planned for only 3 dosing periods.|0||
60018744|NCT01358981|76134638|FG006|STARTED|Period 4|Part B was planned for only 3 dosing periods.|0||
60018745|NCT01358981|76134632|FG000|COMPLETED|Period 4||2||
60018746|NCT01358981|76134633|FG001|COMPLETED|Period 4||2||
60018747|NCT01358981|76134634|FG002|COMPLETED|Period 4||2||
60018748|NCT01358981|76134635|FG003|COMPLETED|Period 4||2||
60018749|NCT01358981|76134636|FG004|COMPLETED|Period 4||0||
60018750|NCT01358981|76134637|FG005|COMPLETED|Period 4||0||
60018751|NCT01358981|76134638|FG006|COMPLETED|Period 4||0||
60018752|NCT01358981|76134632|FG000|NOT COMPLETED|Period 4||0||
60018753|NCT01358981|76134633|FG001|NOT COMPLETED|Period 4||0||
60018754|NCT01358981|76134634|FG002|NOT COMPLETED|Period 4||0||
59911374|NCT01314872|76032270|FG005|NOT COMPLETED|Treatment Period 1||7||
59911375|NCT01314872|76032271|FG006|NOT COMPLETED|Treatment Period 1||8||
59911376|NCT01314872|76032272|FG007|NOT COMPLETED|Treatment Period 1||7||
60018755|NCT01358981|76134635|FG003|NOT COMPLETED|Period 4||0||
60018756|NCT01358981|76134636|FG004|NOT COMPLETED|Period 4||0||
60018757|NCT01358981|76134637|FG005|NOT COMPLETED|Period 4||0||
60018758|NCT01358981|76134638|FG006|NOT COMPLETED|Period 4||0||
60018759|NCT02548585|76134670|FG000|STARTED|Overall Study||45||
60018760|NCT02548585|76134671|FG001|STARTED|Overall Study||6||
59911377|NCT01314872|76032273|FG008|NOT COMPLETED|Treatment Period 1||6||
60018761|NCT02548585|76134672|FG002|STARTED|Overall Study||6||
59507094|NCT00817843|75600280|FG001|STARTED|First Period (6 Weeks)||50||
59911378|NCT01314872|76032274|FG009|NOT COMPLETED|Treatment Period 1||4||
60018762|NCT02548585|76134673|FG003|STARTED|Overall Study||7||
60018763|NCT02548585|76134674|FG004|STARTED|Overall Study||25||
60018764|NCT02548585|76134675|FG005|STARTED|Overall Study||12||
60018765|NCT02548585|76134676|FG006|STARTED|Overall Study||12||
60018766|NCT02548585|76134670|FG000|Treated|Overall Study||45||
60018767|NCT02548585|76134671|FG001|Treated|Overall Study||6||
60018768|NCT02548585|76134672|FG002|Treated|Overall Study||6||
60018769|NCT02548585|76134673|FG003|Treated|Overall Study||7||
60018770|NCT02548585|76134674|FG004|Treated|Overall Study||25||
60018771|NCT02548585|76134675|FG005|Treated|Overall Study||11||
60018772|NCT02548585|76134676|FG006|Treated|Overall Study||12||
60018773|NCT02548585|76134670|FG000|COMPLETED|Overall Study||43||
60018774|NCT02548585|76134671|FG001|COMPLETED|Overall Study||6||
60018775|NCT02548585|76134672|FG002|COMPLETED|Overall Study||6||
60018776|NCT02548585|76134673|FG003|COMPLETED|Overall Study||5||
60018777|NCT02548585|76134674|FG004|COMPLETED|Overall Study||22||
60018778|NCT02548585|76134675|FG005|COMPLETED|Overall Study||10||
60018779|NCT02548585|76134676|FG006|COMPLETED|Overall Study||11||
60018780|NCT02548585|76134670|FG000|NOT COMPLETED|Overall Study||2||
60018781|NCT02548585|76134671|FG001|NOT COMPLETED|Overall Study||0||
60018782|NCT02548585|76134672|FG002|NOT COMPLETED|Overall Study||0||
60018783|NCT02548585|76134673|FG003|NOT COMPLETED|Overall Study||2||
60018784|NCT02548585|76134674|FG004|NOT COMPLETED|Overall Study||3||
60018785|NCT02548585|76134675|FG005|NOT COMPLETED|Overall Study||2||
60018786|NCT02548585|76134676|FG006|NOT COMPLETED|Overall Study||1||
60018787|NCT02547649|76134720|FG000|STARTED|Overall Study||231|Randomized|
60018788|NCT02547649|76134721|FG001|STARTED|Overall Study||231|Randomized|
60018789|NCT02547649|76134722|FG002|STARTED|Overall Study||228|Randomized|
60018790|NCT02547649|76134720|FG000|Vaccinated|Overall Study||231||
60018791|NCT02547649|76134721|FG001|Vaccinated|Overall Study||231||
60018792|NCT02547649|76134722|FG002|Vaccinated|Overall Study||227||
60018793|NCT02547649|76134720|FG000|COMPLETED|Overall Study||228||
60018794|NCT02547649|76134721|FG001|COMPLETED|Overall Study||226||
60018795|NCT02547649|76134722|FG002|COMPLETED|Overall Study||224||
60018796|NCT02547649|76134720|FG000|NOT COMPLETED|Overall Study||3||
60018797|NCT02547649|76134721|FG001|NOT COMPLETED|Overall Study||5||
60018798|NCT02547649|76134722|FG002|NOT COMPLETED|Overall Study||4||
60018799|NCT03079297|76134732|FG000|STARTED|First Intervention (14 Days)||2||
60018800|NCT03079297|76134733|FG001|STARTED|First Intervention (14 Days)||2||
60018801|NCT03079297|76134732|FG000|COMPLETED|First Intervention (14 Days)||2||
60018802|NCT03079297|76134733|FG001|COMPLETED|First Intervention (14 Days)||2||
60018803|NCT03079297|76134732|FG000|NOT COMPLETED|First Intervention (14 Days)||0||
60018804|NCT03079297|76134733|FG001|NOT COMPLETED|First Intervention (14 Days)||0||
60018805|NCT03079297|76134732|FG000|STARTED|Washout (14 Days)||2||
60018806|NCT03079297|76134733|FG001|STARTED|Washout (14 Days)||2||
60018807|NCT03079297|76134732|FG000|COMPLETED|Washout (14 Days)||2||
59911379|NCT01314872|76032275|FG010|NOT COMPLETED|Treatment Period 1||3||
59911380|NCT01314872|76032276|FG011|NOT COMPLETED|Treatment Period 1||0||
59911381|NCT01314872|76032277|FG012|NOT COMPLETED|Treatment Period 1||0||
59911382|NCT01314872|76032278|FG013|NOT COMPLETED|Treatment Period 1||0||
59911383|NCT01314872|76032279|FG014|NOT COMPLETED|Treatment Period 1||0||
59911384|NCT01314872|76032265|FG000|STARTED|Period 2||0||
59911385|NCT01314872|76032266|FG001|STARTED|Period 2||0||
59911386|NCT01314872|76032267|FG002|STARTED|Period 2||0||
59911387|NCT01314872|76032268|FG003|STARTED|Period 2||0||
59911388|NCT01314872|76032269|FG004|STARTED|Period 2||0||
59911389|NCT01314872|76032270|FG005|STARTED|Period 2||0||
59911390|NCT01314872|76032271|FG006|STARTED|Period 2||0||
59911391|NCT01314872|76032272|FG007|STARTED|Period 2||0||
59911392|NCT01314872|76032273|FG008|STARTED|Period 2||0||
59911393|NCT01314872|76032274|FG009|STARTED|Period 2||0||
59911394|NCT01314872|76032275|FG010|STARTED|Period 2||0||
59911395|NCT01314872|76032276|FG011|STARTED|Period 2||223||
59911396|NCT01314872|76032277|FG012|STARTED|Period 2||248||
59911397|NCT01314872|76032278|FG013|STARTED|Period 2||240||
59911398|NCT01314872|76032279|FG014|STARTED|Period 2||134||
60018808|NCT03079297|76134733|FG001|COMPLETED|Washout (14 Days)||2||
60018809|NCT03079297|76134732|FG000|NOT COMPLETED|Washout (14 Days)||0||
60018810|NCT03079297|76134733|FG001|NOT COMPLETED|Washout (14 Days)||0||
60018811|NCT03079297|76134732|FG000|STARTED|Second Intervention (14 Days)||2||
60018812|NCT03079297|76134733|FG001|STARTED|Second Intervention (14 Days)||2||
60018813|NCT03079297|76134732|FG000|COMPLETED|Second Intervention (14 Days)||2||
60018814|NCT03079297|76134733|FG001|COMPLETED|Second Intervention (14 Days)||2||
59911399|NCT01314872|76032265|FG000|COMPLETED|Period 2||0||
59911400|NCT01314872|76032266|FG001|COMPLETED|Period 2||0||
59911401|NCT01314872|76032267|FG002|COMPLETED|Period 2||0||
59911402|NCT01314872|76032268|FG003|COMPLETED|Period 2||0||
59911403|NCT01314872|76032269|FG004|COMPLETED|Period 2||0||
59911404|NCT01314872|76032270|FG005|COMPLETED|Period 2||0||
59911405|NCT01314872|76032271|FG006|COMPLETED|Period 2||0||
59911406|NCT01314872|76032272|FG007|COMPLETED|Period 2||0||
59911407|NCT01314872|76032273|FG008|COMPLETED|Period 2||0||
60018815|NCT03079297|76134732|FG000|NOT COMPLETED|Second Intervention (14 Days)||0||
60018816|NCT03079297|76134733|FG001|NOT COMPLETED|Second Intervention (14 Days)||0||
60018817|NCT02535715|76134742|FG000|STARTED|Overall Study||4||
60018818|NCT02535715|76134743|FG001|STARTED|Overall Study||4||
60018819|NCT02535715|76134744|FG002|STARTED|Overall Study||3||
60018820|NCT02535715|76134742|FG000|COMPLETED|Overall Study||4||
60018821|NCT02535715|76134743|FG001|COMPLETED|Overall Study||4||
60018822|NCT02535715|76134744|FG002|COMPLETED|Overall Study||2||
60018823|NCT02535715|76134742|FG000|NOT COMPLETED|Overall Study||0||
60018824|NCT02535715|76134743|FG001|NOT COMPLETED|Overall Study||0||
60018825|NCT02535715|76134744|FG002|NOT COMPLETED|Overall Study||1||
60018826|NCT02336815|76134757|FG000|STARTED|Overall Study||79||
60018827|NCT02336815|76134758|FG001|STARTED|Overall Study||123||
60018828|NCT02336815|76134757|FG000|COMPLETED|Overall Study||0||
60018829|NCT02336815|76134758|FG001|COMPLETED|Overall Study||0||
60018830|NCT02336815|76134757|FG000|NOT COMPLETED|Overall Study||79||
60018831|NCT02336815|76134758|FG001|NOT COMPLETED|Overall Study||123||
60018832|NCT02543203|76134768|FG000|STARTED|Overall Study||13||
60018833|NCT02543203|76134769|FG001|STARTED|Overall Study||15||
60018834|NCT02543203|76134768|FG000|COMPLETED|Overall Study||7||
60018835|NCT02543203|76134769|FG001|COMPLETED|Overall Study||10||
60018836|NCT02543203|76134768|FG000|NOT COMPLETED|Overall Study||6||
60018837|NCT02543203|76134769|FG001|NOT COMPLETED|Overall Study||5||
60018838|NCT02546323|76134785|FG000|STARTED|Overall Study||272|Randomized patients|
60018839|NCT02546323|76134786|FG001|STARTED|Overall Study||271|Randomized patients|
60018840|NCT02546323|76134785|FG000|Received Treatment|Overall Study||272||
60018841|NCT02546323|76134786|FG001|Received Treatment|Overall Study||268||
60018842|NCT02546323|76134785|FG000|COMPLETED|Overall Study||212||
60018843|NCT02546323|76134786|FG001|COMPLETED|Overall Study||205||
60018844|NCT02546323|76134785|FG000|NOT COMPLETED|Overall Study||60||
60018845|NCT02546323|76134786|FG001|NOT COMPLETED|Overall Study||66||
60018846|NCT02545933|76134795|FG000|STARTED|Overall Study||44||
60018847|NCT02545933|76134796|FG001|STARTED|Overall Study||43||
60018848|NCT02545933|76134797|FG002|STARTED|Overall Study||43||
60018849|NCT02545933|76134795|FG000|COMPLETED|Overall Study||38||
60018850|NCT02545933|76134796|FG001|COMPLETED|Overall Study||40||
60018851|NCT02545933|76134797|FG002|COMPLETED|Overall Study||39||
60018852|NCT02545933|76134795|FG000|NOT COMPLETED|Overall Study||6||
60018853|NCT02545933|76134796|FG001|NOT COMPLETED|Overall Study||3||
60018854|NCT02545933|76134797|FG002|NOT COMPLETED|Overall Study||4||
60018855|NCT01661179|76134805|FG000|STARTED|Overall Study||14||
60018856|NCT01661179|76134805|FG000|COMPLETED|Overall Study||8||
60018857|NCT01661179|76134805|FG000|NOT COMPLETED|Overall Study||6||
60018858|NCT02545543|76134811|FG000|STARTED|Overall Study||1709||
60018859|NCT02545543|76134812|FG001|STARTED|Overall Study||569||
60018860|NCT02545543|76134811|FG000|COMPLETED|Overall Study||1628||
60018861|NCT02545543|76134812|FG001|COMPLETED|Overall Study||535||
60018862|NCT02545543|76134811|FG000|NOT COMPLETED|Overall Study||81||
60018863|NCT02545543|76134812|FG001|NOT COMPLETED|Overall Study||34||
60018864|NCT02545075|76134822|FG000|STARTED|Randomization||122|Partipants who were randomized|
60018865|NCT02545075|76134823|FG001|STARTED|Randomization||60|Partipants who were randomized|
60018866|NCT02545075|76134822|FG000|COMPLETED|Randomization||122|participants who were treated|
60018867|NCT02545075|76134823|FG001|COMPLETED|Randomization||53|participants who were treated|
60018868|NCT02545075|76134822|FG000|NOT COMPLETED|Randomization||0||
60018869|NCT02545075|76134823|FG001|NOT COMPLETED|Randomization||7||
60018870|NCT02545075|76134822|FG000|STARTED|Treatment||122|Participants who were treated|
60018871|NCT02545075|76134823|FG001|STARTED|Treatment||53|Participants who were treated|
60018872|NCT02545075|76134822|FG000|COMPLETED|Treatment||0|Participants who were continuing treatment period|
60018873|NCT02545075|76134823|FG001|COMPLETED|Treatment||0|Participants who were continuing treatment period|
60018874|NCT02545075|76134822|FG000|NOT COMPLETED|Treatment||122||
60018875|NCT02545075|76134823|FG001|NOT COMPLETED|Treatment||53||
60018876|NCT03007537|76134831|FG000|STARTED|Overall Study||51||
60018877|NCT03007537|76134832|FG001|STARTED|Overall Study||50||
60018878|NCT03007537|76134831|FG000|COMPLETED|Overall Study||46||
60018879|NCT03007537|76134832|FG001|COMPLETED|Overall Study||46||
60018880|NCT03007537|76134831|FG000|NOT COMPLETED|Overall Study||5||
60018881|NCT03007537|76134832|FG001|NOT COMPLETED|Overall Study||4||
60018882|NCT03004183|76134838|FG000|STARTED|Overall Study||57||
60018883|NCT03004183|76134838|FG000|TNBC|Overall Study||28||
60018884|NCT03004183|76134838|FG000|NSCLC|Overall Study||29||
60018885|NCT03004183|76134838|FG000|COMPLETED|Overall Study|1 TNBC and 6 NSCLC|7||
60018886|NCT03004183|76134838|FG000|NOT COMPLETED|Overall Study||50||
60018887|NCT02544763|76134845|FG000|STARTED|Overall Study||75||
60018888|NCT02544763|76134846|FG001|STARTED|Overall Study||73||
60018889|NCT02544763|76134847|FG002|STARTED|Overall Study||76||
60018890|NCT02544763|76134845|FG000|COMPLETED|Overall Study||65||
60018891|NCT02544763|76134846|FG001|COMPLETED|Overall Study||61||
60018892|NCT02544763|76134847|FG002|COMPLETED|Overall Study||75||
60018893|NCT02544763|76134845|FG000|NOT COMPLETED|Overall Study||10||
60018894|NCT02544763|76134846|FG001|NOT COMPLETED|Overall Study||12||
60018895|NCT02544763|76134847|FG002|NOT COMPLETED|Overall Study||1||
60018896|NCT02556203|76134857|FG000|STARTED|Overall Study||826||
60018897|NCT02556203|76134858|FG001|STARTED|Overall Study||818||
60018898|NCT02556203|76134857|FG000|Received Treatment|Overall Study||801||
60018899|NCT02556203|76134858|FG001|Received Treatment|Overall Study||807||
60018900|NCT02556203|76134857|FG000|COMPLETED|Overall Study||799|Completed study procedures|
60018901|NCT02556203|76134858|FG001|COMPLETED|Overall Study||792|Completed study procedures|
60018902|NCT02556203|76134857|FG000|NOT COMPLETED|Overall Study||27||
60018903|NCT02556203|76134858|FG001|NOT COMPLETED|Overall Study||26||
60018904|NCT04157621|76134866|FG000|STARTED|Overall Study||17||
60018905|NCT04157621|76134867|FG001|STARTED|Overall Study||16||
60018906|NCT04157621|76134866|FG000|COMPLETED|Overall Study||17||
60018907|NCT04157621|76134867|FG001|COMPLETED|Overall Study||16||
60018908|NCT04157621|76134866|FG000|NOT COMPLETED|Overall Study||0||
60018909|NCT04157621|76134867|FG001|NOT COMPLETED|Overall Study||0||
60018910|NCT02558231|76134875|FG000|STARTED|Overall Study||123||
60018911|NCT02558231|76134876|FG001|STARTED|Overall Study||124||
60018912|NCT02558231|76134875|FG000|Treated|Overall Study||123||
60018913|NCT02558231|76134876|FG001|Treated|Overall Study||123||
60018914|NCT02558231|76134875|FG000|COMPLETED|Overall Study||98||
60018915|NCT02558231|76134876|FG001|COMPLETED|Overall Study||98||
60018916|NCT02558231|76134875|FG000|NOT COMPLETED|Overall Study||25||
60018917|NCT02558231|76134876|FG001|NOT COMPLETED|Overall Study||26||
60018918|NCT02554877|76134886|FG000|STARTED|Overall Study||51||
60018919|NCT02554877|76134887|FG001|STARTED|Overall Study||51||
60018920|NCT02554877|76134888|FG002|STARTED|Overall Study||52||
60018921|NCT02554877|76134889|FG003|STARTED|Overall Study||52||
60018922|NCT02554877|76134886|FG000|COMPLETED|Overall Study||39||
60018923|NCT02554877|76134887|FG001|COMPLETED|Overall Study||44||
60018924|NCT02554877|76134888|FG002|COMPLETED|Overall Study||46||
60018925|NCT02554877|76134889|FG003|COMPLETED|Overall Study||45||
60018926|NCT02554877|76134886|FG000|NOT COMPLETED|Overall Study||12||
60018927|NCT02554877|76134887|FG001|NOT COMPLETED|Overall Study||7||
60018928|NCT02554877|76134888|FG002|NOT COMPLETED|Overall Study||6||
59758696|NCT00925301|75877987|FG001|STARTED|12-Month Open-label Extension (Optional)|Zero participants noted because participants had completed Stage 1.|0||
60018929|NCT02554877|76134889|FG003|NOT COMPLETED|Overall Study||7||
60018930|NCT02554721|76134904|FG000|STARTED|Overall Study||20||
60018931|NCT02554721|76134905|FG001|STARTED|Overall Study||19||
60018932|NCT02554721|76134906|FG002|STARTED|Overall Study||19||
60018933|NCT02554721|76134907|FG003|STARTED|Overall Study||17||
60018934|NCT02554721|76134908|FG004|STARTED|Overall Study||2||
60018935|NCT02554721|76134904|FG000|COMPLETED|Overall Study||19||
60018936|NCT02554721|76134905|FG001|COMPLETED|Overall Study||19||
60018937|NCT02554721|76134906|FG002|COMPLETED|Overall Study||19||
60018938|NCT02554721|76134907|FG003|COMPLETED|Overall Study||17||
59758697|NCT00925301|75877988|FG002|STARTED|12-Month Open-label Extension (Optional)|Zero participants noted because participants had completed Stage 2.|0||
60018939|NCT02554721|76134908|FG004|COMPLETED|Overall Study||0||
60018940|NCT02554721|76134904|FG000|NOT COMPLETED|Overall Study||1||
60018941|NCT02554721|76134905|FG001|NOT COMPLETED|Overall Study||0||
59611565|NCT01757184|75722571|FG003|STARTED|Double-blind Period||0||
59611566|NCT01757184|75722568|FG000|Received at Least 1 Dose of Study Drug|Double-blind Period||36||
59758698|NCT00925301|75877989|FG003|STARTED|12-Month Open-label Extension (Optional)|The OLE was optional for those who completed Stage 2. Reasons for not entering were not recorded.|57||
60018942|NCT02554721|76134906|FG002|NOT COMPLETED|Overall Study||0||
60018943|NCT02554721|76134907|FG003|NOT COMPLETED|Overall Study||0||
60018944|NCT02554721|76134908|FG004|NOT COMPLETED|Overall Study||2||
60018945|NCT02552225|76134919|FG000|STARTED|Overall Study||3||
60018946|NCT02552225|76134920|FG001|STARTED|Overall Study||3||
59611567|NCT01757184|75722569|FG001|Received at Least 1 Dose of Study Drug|Double-blind Period||30||
59758699|NCT00925301|75877986|FG000|ITT-amenable|12-Month Open-label Extension (Optional)||0|Amenable mutations based on GLP HEK assay.|
59758700|NCT00925301|75877987|FG001|ITT-amenable|12-Month Open-label Extension (Optional)||0|Amenable mutations based on GLP HEK assay.|
59758701|NCT00925301|75877988|FG002|ITT-amenable|12-Month Open-label Extension (Optional)||0|Amenable mutations based on GLP HEK assay.|
59758702|NCT00925301|75877989|FG003|ITT-amenable|12-Month Open-label Extension (Optional)||42|Amenable mutations based on GLP HEK assay.|
59758703|NCT00925301|75877986|FG000|COMPLETED|12-Month Open-label Extension (Optional)||0||
60018947|NCT02552225|76134919|FG000|COMPLETED|Overall Study||2||
60018948|NCT02552225|76134920|FG001|COMPLETED|Overall Study||3||
60018949|NCT02552225|76134919|FG000|NOT COMPLETED|Overall Study||1||
60018950|NCT02552225|76134920|FG001|NOT COMPLETED|Overall Study||0||
60018951|NCT02552147|76134926|FG000|STARTED|First Intervention (7 Days)||4||
60018952|NCT02552147|76134927|FG001|STARTED|First Intervention (7 Days)||4||
60018953|NCT02552147|76134926|FG000|COMPLETED|First Intervention (7 Days)||3||
60018954|NCT02552147|76134927|FG001|COMPLETED|First Intervention (7 Days)||4||
60018955|NCT02552147|76134926|FG000|NOT COMPLETED|First Intervention (7 Days)||1||
60018956|NCT02552147|76134927|FG001|NOT COMPLETED|First Intervention (7 Days)||0||
60018957|NCT02552147|76134926|FG000|STARTED|Washout (7 Days)||3||
60018958|NCT02552147|76134927|FG001|STARTED|Washout (7 Days)||4||
60018959|NCT02552147|76134926|FG000|COMPLETED|Washout (7 Days)||3||
60018960|NCT02552147|76134927|FG001|COMPLETED|Washout (7 Days)||4||
60018961|NCT02552147|76134926|FG000|NOT COMPLETED|Washout (7 Days)||0||
60018962|NCT02552147|76134927|FG001|NOT COMPLETED|Washout (7 Days)||0||
60018963|NCT02552147|76134926|FG000|STARTED|Second Intervention (7 Days)||3||
60018964|NCT02552147|76134927|FG001|STARTED|Second Intervention (7 Days)||4||
60018965|NCT02552147|76134926|FG000|COMPLETED|Second Intervention (7 Days)||1||
60018966|NCT02552147|76134927|FG001|COMPLETED|Second Intervention (7 Days)||4||
60018967|NCT02552147|76134926|FG000|NOT COMPLETED|Second Intervention (7 Days)||2||
60018968|NCT02552147|76134927|FG001|NOT COMPLETED|Second Intervention (7 Days)||0||
60018969|NCT01662635|76134933|FG000|STARTED|Overall Study||230||
60018970|NCT01662635|76134933|FG000|COMPLETED|Overall Study||200||
60018971|NCT01662635|76134933|FG000|NOT COMPLETED|Overall Study||30||
60018972|NCT02534935|76134942|FG000|STARTED|Stage 1: 24 Months||44||
60018973|NCT02534935|76134943|FG001|STARTED|Stage 1: 24 Months||220||
60018974|NCT02534935|76134944|FG002|STARTED|Stage 1: 24 Months||132||
60018975|NCT02534935|76134942|FG000|COMPLETED|Stage 1: 24 Months||44||
60018976|NCT02534935|76134943|FG001|COMPLETED|Stage 1: 24 Months||210||
60018977|NCT02534935|76134944|FG002|COMPLETED|Stage 1: 24 Months||127||
60018978|NCT02534935|76134942|FG000|NOT COMPLETED|Stage 1: 24 Months||0||
60018979|NCT02534935|76134943|FG001|NOT COMPLETED|Stage 1: 24 Months||10||
60018980|NCT02534935|76134944|FG002|NOT COMPLETED|Stage 1: 24 Months||5||
60018981|NCT02534935|76134942|FG000|STARTED|Stage 2: 8 Months|Participants entered into Stage 2.|40||
60018982|NCT02534935|76134943|FG001|STARTED|Stage 2: 8 Months|Participants who received all 3 doses and entered Stage 2.|174||
60018983|NCT02534935|76134944|FG002|STARTED|Stage 2: 8 Months|Participants of HAV/Saline were not eligible for Stage 2.|0||
60018984|NCT02534935|76134942|FG000|COMPLETED|Stage 2: 8 Months||40||
60018985|NCT02534935|76134943|FG001|COMPLETED|Stage 2: 8 Months||170||
60018986|NCT02534935|76134944|FG002|COMPLETED|Stage 2: 8 Months||0||
60018987|NCT02534935|76134942|FG000|NOT COMPLETED|Stage 2: 8 Months||0||
60018988|NCT02534935|76134943|FG001|NOT COMPLETED|Stage 2: 8 Months||4||
60018989|NCT02534935|76134944|FG002|NOT COMPLETED|Stage 2: 8 Months||0||
59507095|NCT00817843|75600279|FG000|COMPLETED|First Period (6 Weeks)|All patients with >=1 postrandomization dose and measurement were analyzed|42||
60018990|NCT02534935|76134942|FG000|STARTED|Stage 2: Booster Phase (6 Months)|Participants were not eligible for Booster vaccination in Stage 2.|0||
60018991|NCT02534935|76134943|FG001|STARTED|Stage 2: Booster Phase (6 Months)|Participants who received 3 doses of bivalent rLP2086 in Stage 1 and gave consent for booster vaccination.|148||
60018992|NCT02534935|76134944|FG002|STARTED|Stage 2: Booster Phase (6 Months)|Participants of HAV/Saline were not eligible for Stage 2.|0||
60018993|NCT02534935|76134942|FG000|COMPLETED|Stage 2: Booster Phase (6 Months)||0||
60018994|NCT02534935|76134943|FG001|COMPLETED|Stage 2: Booster Phase (6 Months)||147||
60018995|NCT02534935|76134944|FG002|COMPLETED|Stage 2: Booster Phase (6 Months)||0||
60018996|NCT02534935|76134942|FG000|NOT COMPLETED|Stage 2: Booster Phase (6 Months)||0||
60018997|NCT02534935|76134943|FG001|NOT COMPLETED|Stage 2: Booster Phase (6 Months)||1||
60018998|NCT02534935|76134944|FG002|NOT COMPLETED|Stage 2: Booster Phase (6 Months)||0||
60018999|NCT02544451|76134973|FG000|STARTED|Treatment Period 1 (96 Weeks)||143||
60019000|NCT02544451|76134974|FG001|STARTED|Treatment Period 1 (96 Weeks)||96||
60019001|NCT02544451|76134975|FG002|STARTED|Treatment Period 1 (96 Weeks)||6||
60019002|NCT02544451|76134976|FG003|STARTED|Treatment Period 1 (96 Weeks)||0||
60019003|NCT02544451|76134973|FG000|COMPLETED|Treatment Period 1 (96 Weeks)||129||
60019004|NCT02544451|76134974|FG001|COMPLETED|Treatment Period 1 (96 Weeks)||84||
60019005|NCT02544451|76134975|FG002|COMPLETED|Treatment Period 1 (96 Weeks)||5||
60019006|NCT02544451|76134976|FG003|COMPLETED|Treatment Period 1 (96 Weeks)||0||
60019007|NCT02544451|76134973|FG000|NOT COMPLETED|Treatment Period 1 (96 Weeks)||14||
60019008|NCT02544451|76134974|FG001|NOT COMPLETED|Treatment Period 1 (96 Weeks)||12||
60019009|NCT02544451|76134975|FG002|NOT COMPLETED|Treatment Period 1 (96 Weeks)||1||
60019010|NCT02544451|76134976|FG003|NOT COMPLETED|Treatment Period 1 (96 Weeks)||0||
60019011|NCT02544451|76134973|FG000|STARTED|Treatment Period 2 (168 Weeks)||0||
60019012|NCT02544451|76134974|FG001|STARTED|Treatment Period 2 (168 Weeks)||0||
60019013|NCT02544451|76134975|FG002|STARTED|Treatment Period 2 (168 Weeks)||0||
59507096|NCT00817843|75600280|FG001|COMPLETED|First Period (6 Weeks)||46||
60019014|NCT02544451|76134976|FG003|STARTED|Treatment Period 2 (168 Weeks)||10||
60019015|NCT02544451|76134973|FG000|COMPLETED|Treatment Period 2 (168 Weeks)||0||
60019016|NCT02544451|76134974|FG001|COMPLETED|Treatment Period 2 (168 Weeks)||0||
60019017|NCT02544451|76134975|FG002|COMPLETED|Treatment Period 2 (168 Weeks)||0||
60019018|NCT02544451|76134976|FG003|COMPLETED|Treatment Period 2 (168 Weeks)||0||
60019019|NCT02544451|76134973|FG000|NOT COMPLETED|Treatment Period 2 (168 Weeks)||0||
59611568|NCT01757184|75722570|FG002|Received at Least 1 Dose of Study Drug|Double-blind Period||0||
59611569|NCT01757184|75722571|FG003|Received at Least 1 Dose of Study Drug|Double-blind Period||0||
59611570|NCT01757184|75722568|FG000|COMPLETED|Double-blind Period||35||
59611571|NCT01757184|75722569|FG001|COMPLETED|Double-blind Period||30||
59611572|NCT01757184|75722570|FG002|COMPLETED|Double-blind Period||0||
59611573|NCT01757184|75722571|FG003|COMPLETED|Double-blind Period||0||
60019020|NCT02544451|76134974|FG001|NOT COMPLETED|Treatment Period 2 (168 Weeks)||0||
60019021|NCT02544451|76134975|FG002|NOT COMPLETED|Treatment Period 2 (168 Weeks)||0||
60019022|NCT02544451|76134976|FG003|NOT COMPLETED|Treatment Period 2 (168 Weeks)||10||
60019023|NCT02544373|76134996|FG000|STARTED|Overall Study||71||
60019024|NCT02544373|76134997|FG001|STARTED|Overall Study||40||
60019025|NCT02544373|76134996|FG000|COMPLETED|Overall Study||58||
60019026|NCT02544373|76134997|FG001|COMPLETED|Overall Study||35||
60019027|NCT02544373|76134996|FG000|NOT COMPLETED|Overall Study||13||
60019028|NCT02544373|76134997|FG001|NOT COMPLETED|Overall Study||5||
60019029|NCT02551991|76135009|FG000|STARTED|Overall Study||7||
59507097|NCT00817843|75600279|FG000|NOT COMPLETED|First Period (6 Weeks)||8||
59507098|NCT00817843|75600280|FG001|NOT COMPLETED|First Period (6 Weeks)||4||
59507099|NCT00817843|75600279|FG000|STARTED|Washout Period (6 Weeks)||42||
59507100|NCT00817843|75600280|FG001|STARTED|Washout Period (6 Weeks)||46||
59507101|NCT00817843|75600279|FG000|COMPLETED|Washout Period (6 Weeks)||41||
59507102|NCT00817843|75600280|FG001|COMPLETED|Washout Period (6 Weeks)||45||
59507103|NCT00817843|75600279|FG000|NOT COMPLETED|Washout Period (6 Weeks)||1||
59911408|NCT01314872|76032274|FG009|COMPLETED|Period 2||0||
59507104|NCT00817843|75600280|FG001|NOT COMPLETED|Washout Period (6 Weeks)||1||
59507105|NCT00817843|75600279|FG000|STARTED|Second Period (6 Weeks)||41||
59507106|NCT00817843|75600280|FG001|STARTED|Second Period (6 Weeks)||45||
59911409|NCT01314872|76032275|FG010|COMPLETED|Period 2||0||
59911410|NCT01314872|76032276|FG011|COMPLETED|Period 2||175||
59911411|NCT01314872|76032277|FG012|COMPLETED|Period 2||188||
59911412|NCT01314872|76032278|FG013|COMPLETED|Period 2||187||
59911413|NCT01314872|76032279|FG014|COMPLETED|Period 2||110||
59911414|NCT01314872|76032265|FG000|NOT COMPLETED|Period 2||0||
59911415|NCT01314872|76032266|FG001|NOT COMPLETED|Period 2||0||
59911416|NCT01314872|76032267|FG002|NOT COMPLETED|Period 2||0||
59911417|NCT01314872|76032268|FG003|NOT COMPLETED|Period 2||0||
59911418|NCT01314872|76032269|FG004|NOT COMPLETED|Period 2||0||
59911419|NCT01314872|76032270|FG005|NOT COMPLETED|Period 2||0||
60019030|NCT02551991|76135010|FG001|STARTED|Overall Study||7||
60019031|NCT02551991|76135011|FG002|STARTED|Overall Study||10||
60019032|NCT02551991|76135012|FG003|STARTED|Overall Study||7||
60019033|NCT02551991|76135013|FG004|STARTED|Overall Study||25||
60019034|NCT02551991|76135009|FG000|COMPLETED|Overall Study||0||
60019035|NCT02551991|76135010|FG001|COMPLETED|Overall Study||0||
60019036|NCT02551991|76135011|FG002|COMPLETED|Overall Study||0||
60019037|NCT02551991|76135012|FG003|COMPLETED|Overall Study||0||
60019038|NCT02551991|76135013|FG004|COMPLETED|Overall Study||0||
59507107|NCT00817843|75600279|FG000|COMPLETED|Second Period (6 Weeks)|All patients with >=1 postrandomization dose and measurement were analyzed|41||
59507108|NCT00817843|75600280|FG001|COMPLETED|Second Period (6 Weeks)||44||
59507109|NCT00817843|75600279|FG000|NOT COMPLETED|Second Period (6 Weeks)||0||
59507110|NCT00817843|75600280|FG001|NOT COMPLETED|Second Period (6 Weeks)||1||
59507111|NCT02008149|75600288|FG000|STARTED|Overall Study||7||
59507112|NCT02008149|75600289|FG001|STARTED|Overall Study||1||
59507113|NCT02008149|75600290|FG002|STARTED|Overall Study||1||
59507114|NCT02008149|75600288|FG000|COMPLETED|Overall Study||4||
59911420|NCT01314872|76032271|FG006|NOT COMPLETED|Period 2||0||
60019039|NCT02551991|76135009|FG000|NOT COMPLETED|Overall Study||7||
60019040|NCT02551991|76135010|FG001|NOT COMPLETED|Overall Study||7||
59911421|NCT01314872|76032272|FG007|NOT COMPLETED|Period 2||0||
59911422|NCT01314872|76032273|FG008|NOT COMPLETED|Period 2||0||
59911423|NCT01314872|76032274|FG009|NOT COMPLETED|Period 2||0||
59911424|NCT01314872|76032275|FG010|NOT COMPLETED|Period 2||0||
59911425|NCT01314872|76032276|FG011|NOT COMPLETED|Period 2||48||
59911426|NCT01314872|76032277|FG012|NOT COMPLETED|Period 2||60||
59911427|NCT01314872|76032278|FG013|NOT COMPLETED|Period 2||53||
59911428|NCT01314872|76032279|FG014|NOT COMPLETED|Period 2||24||
59911429|NCT00703924|76032313|FG000|STARTED|Overall Study||50||
59911430|NCT00703924|76032314|FG001|STARTED|Overall Study||42||
59911431|NCT00703924|76032313|FG000|COMPLETED|Overall Study||49||
59911432|NCT00703924|76032314|FG001|COMPLETED|Overall Study||41||
59911433|NCT00703924|76032313|FG000|NOT COMPLETED|Overall Study||1||
59911434|NCT00703924|76032314|FG001|NOT COMPLETED|Overall Study||1||
59911435|NCT03152526|76032326|FG000|STARTED|Overall Study|No participants were enrolled on this arm.|0||
60019041|NCT02551991|76135011|FG002|NOT COMPLETED|Overall Study||10||
60019042|NCT02551991|76135012|FG003|NOT COMPLETED|Overall Study||7||
59911436|NCT03152526|76032327|FG001|STARTED|Overall Study|One participant was enrolled on this arm.|1||
59911437|NCT03152526|76032326|FG000|COMPLETED|Overall Study|No participants were enrolled on this arm.|0||
59911438|NCT03152526|76032327|FG001|COMPLETED|Overall Study|The one participant enrolled on this arm withdrew from the study early.|0||
60019043|NCT02551991|76135013|FG004|NOT COMPLETED|Overall Study||25||
60019044|NCT01661933|76135026|FG000|STARTED|Gluten Micro-challenge|All 12 enrolled completed hookworm inoculation and gluten micro-challenge.|12||
60019045|NCT01661933|76135026|FG000|COMPLETED|Gluten Micro-challenge|Two gluten intolerant participants did not proceed to the low-dose challenge.|12||
60019046|NCT01661933|76135026|FG000|NOT COMPLETED|Gluten Micro-challenge||0||
60019047|NCT01661933|76135026|FG000|STARTED|Low-dose Gluten Challenge|One was symptomatically intolerant to gluten >25 mg. One had active CeD pre- & post-micro-challenge|12||
60019048|NCT01661933|76135026|FG000|COMPLETED|Low-dose Gluten Challenge|Two had challenge interrupted for 1-2 weeks. All completed challenge.|10||
60019049|NCT01661933|76135026|FG000|NOT COMPLETED|Low-dose Gluten Challenge||2||
60019050|NCT01661933|76135026|FG000|STARTED|High-dose Gluten Challenge|2 of 10 available after post-GC-1g did not enroll for reasons unrelated to gluten.|10||
60019051|NCT01661933|76135026|FG000|COMPLETED|High-dose Gluten Challenge||8||
60019052|NCT01661933|76135026|FG000|NOT COMPLETED|High-dose Gluten Challenge||2||
60019053|NCT02544217|76135038|FG000|STARTED|Overall Study||7||
60019054|NCT02544217|76135039|FG001|STARTED|Overall Study||7||
60019055|NCT02544217|76135040|FG002|STARTED|Overall Study||4||
60019056|NCT02544217|76135041|FG003|STARTED|Overall Study||4||
60019057|NCT02544217|76135042|FG004|STARTED|Overall Study||4||
60019058|NCT02544217|76135043|FG005|STARTED|Overall Study||6||
60019059|NCT02544217|76135038|FG000|COMPLETED|Overall Study||6||
60019060|NCT02544217|76135039|FG001|COMPLETED|Overall Study|Two subjects prematurely withdrew from the study for non-medical reasons and were replaced.|6||
60019061|NCT02544217|76135040|FG002|COMPLETED|Overall Study||4||
60019062|NCT02544217|76135041|FG003|COMPLETED|Overall Study||4||
60019063|NCT02544217|76135042|FG004|COMPLETED|Overall Study||4||
60019064|NCT02544217|76135043|FG005|COMPLETED|Overall Study||6||
60019065|NCT02544217|76135038|FG000|NOT COMPLETED|Overall Study||1||
60019066|NCT02544217|76135039|FG001|NOT COMPLETED|Overall Study||1||
60019067|NCT02544217|76135040|FG002|NOT COMPLETED|Overall Study||0||
60019068|NCT02544217|76135041|FG003|NOT COMPLETED|Overall Study||0||
60019069|NCT02544217|76135042|FG004|NOT COMPLETED|Overall Study||0||
60019070|NCT02544217|76135043|FG005|NOT COMPLETED|Overall Study||0||
60019071|NCT02533999|76135112|FG000|STARTED|Overall Study||38||
60019072|NCT02533999|76135113|FG001|STARTED|Overall Study||37||
60019073|NCT02533999|76135112|FG000|COMPLETED|Overall Study||32||
60019074|NCT02533999|76135113|FG001|COMPLETED|Overall Study||30||
60019075|NCT02533999|76135112|FG000|NOT COMPLETED|Overall Study||6||
60019076|NCT02533999|76135113|FG001|NOT COMPLETED|Overall Study||7||
60019077|NCT02533531|76135119|FG000|STARTED|Overall Study||1||
60019078|NCT02533531|76135119|FG000|COMPLETED|Overall Study||0||
60019079|NCT02533531|76135119|FG000|NOT COMPLETED|Overall Study||1||
60019080|NCT02533453|76135123|FG000|STARTED|Overall Study||110||
60019081|NCT02533453|76135123|FG000|COMPLETED|Overall Study||101||
60019082|NCT02533453|76135123|FG000|NOT COMPLETED|Overall Study||9||
60019083|NCT02533375|76135127|FG000|STARTED|Overall Study||10||
60019084|NCT02533375|76135127|FG000|COMPLETED|Overall Study||5||
59507115|NCT02008149|75600289|FG001|COMPLETED|Overall Study||0||
59911439|NCT03152526|76032326|FG000|NOT COMPLETED|Overall Study||0||
59911440|NCT03152526|76032327|FG001|NOT COMPLETED|Overall Study||1||
59911441|NCT03149328|76032335|FG000|STARTED|Overall Study||284||
59507116|NCT02008149|75600290|FG002|COMPLETED|Overall Study||1||
59911442|NCT03149328|76032336|FG001|STARTED|Overall Study||259||
59911443|NCT03149328|76032335|FG000|COMPLETED|Overall Study||200||
59911444|NCT03149328|76032336|FG001|COMPLETED|Overall Study||213||
59911445|NCT03149328|76032335|FG000|NOT COMPLETED|Overall Study||84||
59911446|NCT03149328|76032336|FG001|NOT COMPLETED|Overall Study||46||
59911447|NCT00739050|76032342|FG000|STARTED|Overall Study||4||
59911448|NCT00739050|76032343|FG001|STARTED|Overall Study||0||
59911449|NCT00739050|76032342|FG000|COMPLETED|Overall Study|These 3 patients completing treatment did not complete the required procedures during the trial.|3||
59911450|NCT00739050|76032343|FG001|COMPLETED|Overall Study||0||
59911451|NCT00739050|76032342|FG000|NOT COMPLETED|Overall Study||1||
59911452|NCT00739050|76032343|FG001|NOT COMPLETED|Overall Study||0||
59911453|NCT00604812|76032352|FG000|STARTED|Overall Study||9||
59911454|NCT00604812|76032353|FG001|STARTED|Overall Study||3||
59911455|NCT00604812|76032354|FG002|STARTED|Overall Study||10||
59911456|NCT00604812|76032355|FG003|STARTED|Overall Study||3||
59911457|NCT00604812|76032356|FG004|STARTED|Overall Study||5||
59911458|NCT00604812|76032357|FG005|STARTED|Overall Study||1||
59911459|NCT00604812|76032352|FG000|COMPLETED|Overall Study||9||
59911460|NCT00604812|76032353|FG001|COMPLETED|Overall Study||3||
59911461|NCT00604812|76032354|FG002|COMPLETED|Overall Study||10||
59911462|NCT00604812|76032355|FG003|COMPLETED|Overall Study||3||
59911463|NCT00604812|76032356|FG004|COMPLETED|Overall Study||5||
59911464|NCT00604812|76032357|FG005|COMPLETED|Overall Study||1||
59911465|NCT00604812|76032352|FG000|NOT COMPLETED|Overall Study||0||
59911466|NCT00604812|76032353|FG001|NOT COMPLETED|Overall Study||0||
59911467|NCT00604812|76032354|FG002|NOT COMPLETED|Overall Study||0||
59911468|NCT00604812|76032355|FG003|NOT COMPLETED|Overall Study||0||
59911469|NCT00604812|76032356|FG004|NOT COMPLETED|Overall Study||0||
59911470|NCT00604812|76032357|FG005|NOT COMPLETED|Overall Study||0||
59911471|NCT04347408|76032368|FG000|STARTED|Overall Study||992||
59911472|NCT04347408|76032368|FG000|COMPLETED|Overall Study||992||
59911473|NCT04347408|76032368|FG000|NOT COMPLETED|Overall Study||0||
59911474|NCT04502472|76032374|FG000|STARTED|Overall Study||61||
59911475|NCT04502472|76032375|FG001|STARTED|Overall Study||48||
59911476|NCT04502472|76032374|FG000|COMPLETED|Overall Study||58||
59911477|NCT04502472|76032375|FG001|COMPLETED|Overall Study||45||
59507117|NCT02008149|75600288|FG000|NOT COMPLETED|Overall Study||3||
59507118|NCT02008149|75600289|FG001|NOT COMPLETED|Overall Study||1||
59507119|NCT02008149|75600290|FG002|NOT COMPLETED|Overall Study||0||
59507120|NCT00817999|75600300|FG000|STARTED|Grapefruit Juice||15||
59507121|NCT00817999|75600301|FG001|STARTED|Grapefruit Juice||17||
59507122|NCT00817999|75600300|FG000|COMPLETED|Grapefruit Juice||15||
59507123|NCT00817999|75600301|FG001|COMPLETED|Grapefruit Juice||17||
59507124|NCT00817999|75600300|FG000|NOT COMPLETED|Grapefruit Juice||0||
59507125|NCT00817999|75600301|FG001|NOT COMPLETED|Grapefruit Juice||0||
59507126|NCT00817999|75600300|FG000|STARTED|No Grapefruit Juice||15||
59507127|NCT00817999|75600301|FG001|STARTED|No Grapefruit Juice||17||
59911478|NCT04502472|76032374|FG000|NOT COMPLETED|Overall Study||3||
59911479|NCT04502472|76032375|FG001|NOT COMPLETED|Overall Study||3||
59911480|NCT04296942|76032385|FG000|STARTED|Overall Study||1||
59911481|NCT04296942|76032386|FG001|STARTED|Overall Study||0||
59911482|NCT04296942|76032387|FG002|STARTED|Overall Study||0||
59911483|NCT04296942|76032385|FG000|COMPLETED|Overall Study||0||
59911484|NCT04296942|76032386|FG001|COMPLETED|Overall Study||0||
59911485|NCT04296942|76032387|FG002|COMPLETED|Overall Study||0||
59911486|NCT04296942|76032385|FG000|NOT COMPLETED|Overall Study||1||
59911487|NCT04296942|76032386|FG001|NOT COMPLETED|Overall Study||0||
59911488|NCT04296942|76032387|FG002|NOT COMPLETED|Overall Study||0||
59911489|NCT04442230|76032399|FG000|STARTED|Overall Study||23||
59911490|NCT04442230|76032400|FG001|STARTED|Overall Study||25||
59911491|NCT04442230|76032399|FG000|COMPLETED|Overall Study||23||
59911492|NCT04442230|76032400|FG001|COMPLETED|Overall Study||24||
59911493|NCT04442230|76032399|FG000|NOT COMPLETED|Overall Study||0||
59911494|NCT04442230|76032400|FG001|NOT COMPLETED|Overall Study||1||
59911495|NCT03220854|76032409|FG000|STARTED|Overall Study||4||
59911496|NCT03220854|76032410|FG001|STARTED|Overall Study||0||
59911497|NCT03220854|76032411|FG002|STARTED|Overall Study||1||
59911498|NCT03220854|76032409|FG000|COMPLETED|Overall Study||4||
59911499|NCT03220854|76032410|FG001|COMPLETED|Overall Study||0||
59911500|NCT03220854|76032411|FG002|COMPLETED|Overall Study||1||
59911501|NCT03220854|76032409|FG000|NOT COMPLETED|Overall Study||0||
59911502|NCT03220854|76032410|FG001|NOT COMPLETED|Overall Study||0||
59911503|NCT03220854|76032411|FG002|NOT COMPLETED|Overall Study||0||
59911504|NCT04763044|76032426|FG000|STARTED|Period 1||3||
59507128|NCT00817999|75600300|FG000|COMPLETED|No Grapefruit Juice||15||
59507129|NCT00817999|75600301|FG001|COMPLETED|No Grapefruit Juice||17||
59507130|NCT00817999|75600300|FG000|NOT COMPLETED|No Grapefruit Juice||0||
59507131|NCT00817999|75600301|FG001|NOT COMPLETED|No Grapefruit Juice||0||
59507132|NCT02008617|75600311|FG000|STARTED|Overall Study||8||
59507133|NCT02008617|75600312|FG001|STARTED|Overall Study||10||
59507134|NCT02008617|75600311|FG000|COMPLETED|Overall Study||8||
59507135|NCT02008617|75600312|FG001|COMPLETED|Overall Study||10||
59507136|NCT02008617|75600311|FG000|NOT COMPLETED|Overall Study||0||
59507137|NCT02008617|75600312|FG001|NOT COMPLETED|Overall Study||0||
59507138|NCT00819403|75600320|FG000|STARTED|First Intervention (6 Weeks)||7||
59507139|NCT00819403|75600321|FG001|STARTED|First Intervention (6 Weeks)||8||
59507140|NCT00819403|75600320|FG000|COMPLETED|First Intervention (6 Weeks)||7||
59507141|NCT00819403|75600321|FG001|COMPLETED|First Intervention (6 Weeks)||8||
59507142|NCT00819403|75600320|FG000|NOT COMPLETED|First Intervention (6 Weeks)||0||
59507143|NCT00819403|75600321|FG001|NOT COMPLETED|First Intervention (6 Weeks)||0||
59507144|NCT00819403|75600320|FG000|STARTED|Washout (14 Days)||7||
59507145|NCT00819403|75600321|FG001|STARTED|Washout (14 Days)||8||
59507146|NCT00819403|75600320|FG000|COMPLETED|Washout (14 Days)||7||
59507147|NCT00819403|75600321|FG001|COMPLETED|Washout (14 Days)||8||
59911505|NCT04763044|76032427|FG001|STARTED|Period 1||4||
59911506|NCT04763044|76032428|FG002|STARTED|Period 1||4||
59911507|NCT04763044|76032429|FG003|STARTED|Period 1||4||
59911508|NCT04763044|76032426|FG000|COMPLETED|Period 1||3||
59911509|NCT04763044|76032427|FG001|COMPLETED|Period 1||4||
60019085|NCT02533375|76135127|FG000|NOT COMPLETED|Overall Study||5||
60019086|NCT02551055|76135138|FG000|STARTED|Overall Study||4||
60019087|NCT02551055|76135139|FG001|STARTED|Overall Study||6||
60019088|NCT02551055|76135140|FG002|STARTED|Overall Study||3||
60019089|NCT02551055|76135141|FG003|STARTED|Overall Study||6||
59911510|NCT04763044|76032428|FG002|COMPLETED|Period 1||4||
59911511|NCT04763044|76032429|FG003|COMPLETED|Period 1||3||
59911512|NCT04763044|76032426|FG000|NOT COMPLETED|Period 1||0||
59911513|NCT04763044|76032427|FG001|NOT COMPLETED|Period 1||0||
59911514|NCT04763044|76032428|FG002|NOT COMPLETED|Period 1||0||
59911515|NCT04763044|76032429|FG003|NOT COMPLETED|Period 1||1||
60019090|NCT02551055|76135142|FG004|STARTED|Overall Study||7||
60019091|NCT02551055|76135143|FG005|STARTED|Overall Study||2||
60019092|NCT02551055|76135144|FG006|STARTED|Overall Study||4||
60019093|NCT02551055|76135145|FG007|STARTED|Overall Study||0||
60019094|NCT02551055|76135138|FG000|COMPLETED|Overall Study||0||
60019095|NCT02551055|76135139|FG001|COMPLETED|Overall Study||0||
60019096|NCT02551055|76135140|FG002|COMPLETED|Overall Study||1||
60019097|NCT02551055|76135141|FG003|COMPLETED|Overall Study||1||
60019098|NCT02551055|76135142|FG004|COMPLETED|Overall Study||0||
60019099|NCT02551055|76135143|FG005|COMPLETED|Overall Study||1||
60019100|NCT02551055|76135144|FG006|COMPLETED|Overall Study||1||
60019101|NCT02551055|76135145|FG007|COMPLETED|Overall Study||0||
60019102|NCT02551055|76135138|FG000|NOT COMPLETED|Overall Study||4||
60019103|NCT02551055|76135139|FG001|NOT COMPLETED|Overall Study||6||
60019104|NCT02551055|76135140|FG002|NOT COMPLETED|Overall Study||2||
60019105|NCT02551055|76135141|FG003|NOT COMPLETED|Overall Study||5||
60019106|NCT02551055|76135142|FG004|NOT COMPLETED|Overall Study||7||
60019107|NCT02551055|76135143|FG005|NOT COMPLETED|Overall Study||1||
59911516|NCT04763044|76032426|FG000|STARTED|Period 2||3||
60019108|NCT02551055|76135144|FG006|NOT COMPLETED|Overall Study||3||
60019109|NCT02551055|76135145|FG007|NOT COMPLETED|Overall Study||0||
60019110|NCT02542943|76135166|FG000|STARTED|Overall Study||79||
60019111|NCT02542943|76135167|FG001|STARTED|Overall Study||80||
60019112|NCT02542943|76135168|FG002|STARTED|Overall Study||81||
60019113|NCT02542943|76135166|FG000|COMPLETED|Overall Study||78||
60019114|NCT02542943|76135167|FG001|COMPLETED|Overall Study||79||
60019115|NCT02542943|76135168|FG002|COMPLETED|Overall Study||81||
60019116|NCT02542943|76135166|FG000|NOT COMPLETED|Overall Study||1||
60019117|NCT02542943|76135167|FG001|NOT COMPLETED|Overall Study||1||
60019118|NCT02542943|76135168|FG002|NOT COMPLETED|Overall Study||0||
60019119|NCT02542865|76135179|FG000|STARTED|Overall Study||462|Participants randomized to the treatment arms|
60019120|NCT02542865|76135180|FG001|STARTED|Overall Study||462|Participants randomized to the treatment arms|
60019121|NCT02542865|76135179|FG000|Treated|Overall Study||460|2 participants withdrew their consent before starting the treatment.|
59507148|NCT00819403|75600320|FG000|NOT COMPLETED|Washout (14 Days)||0||
59507149|NCT00819403|75600321|FG001|NOT COMPLETED|Washout (14 Days)||0||
59507150|NCT00819403|75600320|FG000|STARTED|Second Intervention (6 Weeks)||7||
60019122|NCT02542865|76135180|FG001|Treated|Overall Study||462|2 participants withdrew their consent before starting the treatment.|
60019123|NCT02542865|76135179|FG000|COMPLETED|Overall Study||445||
60019124|NCT02542865|76135180|FG001|COMPLETED|Overall Study||462||
60019125|NCT02542865|76135179|FG000|NOT COMPLETED|Overall Study||17||
60019126|NCT02542865|76135180|FG001|NOT COMPLETED|Overall Study||0||
60019127|NCT03644927|76135186|FG000|STARTED|Overall Study||1||
60019128|NCT03644927|76135187|FG001|STARTED|Overall Study||0||
60019129|NCT03644927|76135186|FG000|COMPLETED|Overall Study||0||
60019130|NCT03644927|76135187|FG001|COMPLETED|Overall Study||0||
60019131|NCT03644927|76135186|FG000|NOT COMPLETED|Overall Study||1||
60019132|NCT03644927|76135187|FG001|NOT COMPLETED|Overall Study||0||
60019133|NCT02542631|76135194|FG000|STARTED|Overall Study||139|278|
60019134|NCT02542631|76135195|FG001|STARTED|Overall Study||139|278|
60019135|NCT02542631|76135194|FG000|COMPLETED|Overall Study||108|216|
60019136|NCT02542631|76135195|FG001|COMPLETED|Overall Study||108|216|
60019137|NCT02542631|76135194|FG000|NOT COMPLETED|Overall Study||31||
60019138|NCT02542631|76135195|FG001|NOT COMPLETED|Overall Study||31||
60019139|NCT02542397|76135201|FG000|STARTED|Overall Study|75 subjects were enrolled to the study (i.e., submitted buccal swab).|75||
60019140|NCT02542397|76135201|FG000|COMPLETED|Overall Study|54 enrolled subjects provided pain scores at baseline and final assessments within 30 +/- 7 days.|59||
60019141|NCT02542397|76135201|FG000|NOT COMPLETED|Overall Study||16||
60019142|NCT02549339|76135208|FG000|STARTED|3-day Treatment and 8-week Follow-up||205||
60019143|NCT02549339|76135209|FG001|STARTED|3-day Treatment and 8-week Follow-up||104||
60019144|NCT02549339|76135208|FG000|Treated|3-day Treatment and 8-week Follow-up||202||
60019145|NCT02549339|76135209|FG001|Treated|3-day Treatment and 8-week Follow-up||104||
60019146|NCT02549339|76135208|FG000|COMPLETED|3-day Treatment and 8-week Follow-up||201||
60019147|NCT02549339|76135209|FG001|COMPLETED|3-day Treatment and 8-week Follow-up||99||
60019148|NCT02549339|76135208|FG000|NOT COMPLETED|3-day Treatment and 8-week Follow-up||4||
60019149|NCT02549339|76135209|FG001|NOT COMPLETED|3-day Treatment and 8-week Follow-up||5||
60019150|NCT02549339|76135208|FG000|STARTED|12-month Follow-up||201||
60019151|NCT02549339|76135209|FG001|STARTED|12-month Follow-up||98||
60019152|NCT02549339|76135208|FG000|COMPLETED|12-month Follow-up||192||
60019153|NCT02549339|76135209|FG001|COMPLETED|12-month Follow-up||87||
60019154|NCT02549339|76135208|FG000|NOT COMPLETED|12-month Follow-up||9||
60019155|NCT02549339|76135209|FG001|NOT COMPLETED|12-month Follow-up||11||
60019156|NCT02549027|76135217|FG000|STARTED|Period 1 - MK-1064 or Placebo||5||
60019157|NCT02549027|76135218|FG001|STARTED|Period 1 - MK-1064 or Placebo||5||
60019158|NCT02549027|76135219|FG002|STARTED|Period 1 - MK-1064 or Placebo||5||
60019159|NCT02549027|76135220|FG003|STARTED|Period 1 - MK-1064 or Placebo||5||
60019160|NCT02549027|76135221|FG004|STARTED|Period 1 - MK-1064 or Placebo||0||
60019161|NCT02549027|76135222|FG005|STARTED|Period 1 - MK-1064 or Placebo||0||
60019162|NCT02549027|76135217|FG000|COMPLETED|Period 1 - MK-1064 or Placebo||5||
60019163|NCT02549027|76135218|FG001|COMPLETED|Period 1 - MK-1064 or Placebo||5||
60019164|NCT02549027|76135219|FG002|COMPLETED|Period 1 - MK-1064 or Placebo||5||
60019165|NCT02549027|76135220|FG003|COMPLETED|Period 1 - MK-1064 or Placebo||5||
60019166|NCT02549027|76135221|FG004|COMPLETED|Period 1 - MK-1064 or Placebo||0||
60019167|NCT02549027|76135222|FG005|COMPLETED|Period 1 - MK-1064 or Placebo||0||
60019168|NCT02549027|76135217|FG000|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0||
60019169|NCT02549027|76135218|FG001|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0||
60019170|NCT02549027|76135219|FG002|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0||
60019171|NCT02549027|76135220|FG003|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0||
60019172|NCT02549027|76135221|FG004|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0||
60019173|NCT02549027|76135222|FG005|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0||
60019174|NCT02549027|76135217|FG000|STARTED|Washout After Period 1||5||
60019175|NCT02549027|76135218|FG001|STARTED|Washout After Period 1||5||
60019176|NCT02549027|76135219|FG002|STARTED|Washout After Period 1||5||
60019177|NCT02549027|76135220|FG003|STARTED|Washout After Period 1||5||
60019178|NCT02549027|76135221|FG004|STARTED|Washout After Period 1||0||
60019179|NCT02549027|76135222|FG005|STARTED|Washout After Period 1||0||
60019180|NCT02549027|76135217|FG000|COMPLETED|Washout After Period 1||5||
60019181|NCT02549027|76135218|FG001|COMPLETED|Washout After Period 1||5||
60019182|NCT02549027|76135219|FG002|COMPLETED|Washout After Period 1||5||
60019183|NCT02549027|76135220|FG003|COMPLETED|Washout After Period 1||5||
60019184|NCT02549027|76135221|FG004|COMPLETED|Washout After Period 1||0||
60019185|NCT02549027|76135222|FG005|COMPLETED|Washout After Period 1||0||
60019186|NCT02549027|76135217|FG000|NOT COMPLETED|Washout After Period 1||0||
60019187|NCT02549027|76135218|FG001|NOT COMPLETED|Washout After Period 1||0||
60019188|NCT02549027|76135219|FG002|NOT COMPLETED|Washout After Period 1||0||
60019189|NCT02549027|76135220|FG003|NOT COMPLETED|Washout After Period 1||0||
60019190|NCT02549027|76135221|FG004|NOT COMPLETED|Washout After Period 1||0||
60019191|NCT02549027|76135222|FG005|NOT COMPLETED|Washout After Period 1||0||
60019192|NCT02549027|76135217|FG000|STARTED|Period 2 - MK-1064 or Placebo||5||
60019193|NCT02549027|76135218|FG001|STARTED|Period 2 - MK-1064 or Placebo||5||
60019194|NCT02549027|76135219|FG002|STARTED|Period 2 - MK-1064 or Placebo||5||
60019195|NCT02549027|76135220|FG003|STARTED|Period 2 - MK-1064 or Placebo||5||
60019196|NCT02549027|76135221|FG004|STARTED|Period 2 - MK-1064 or Placebo||0||
60019197|NCT02549027|76135222|FG005|STARTED|Period 2 - MK-1064 or Placebo||0||
60019198|NCT02549027|76135217|FG000|COMPLETED|Period 2 - MK-1064 or Placebo||5||
60019199|NCT02549027|76135218|FG001|COMPLETED|Period 2 - MK-1064 or Placebo||5||
60019200|NCT02549027|76135219|FG002|COMPLETED|Period 2 - MK-1064 or Placebo||5||
60019201|NCT02549027|76135220|FG003|COMPLETED|Period 2 - MK-1064 or Placebo||5||
60019202|NCT02549027|76135221|FG004|COMPLETED|Period 2 - MK-1064 or Placebo||0||
60019203|NCT02549027|76135222|FG005|COMPLETED|Period 2 - MK-1064 or Placebo||0||
60019204|NCT02549027|76135217|FG000|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0||
60019205|NCT02549027|76135218|FG001|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0||
60019206|NCT02549027|76135219|FG002|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0||
60019207|NCT02549027|76135220|FG003|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0||
60019208|NCT02549027|76135221|FG004|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0||
60019209|NCT02549027|76135222|FG005|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0||
60019210|NCT02549027|76135217|FG000|STARTED|Washout After Period 2||5||
60019211|NCT02549027|76135218|FG001|STARTED|Washout After Period 2||5||
60019212|NCT02549027|76135219|FG002|STARTED|Washout After Period 2||5||
60019213|NCT02549027|76135220|FG003|STARTED|Washout After Period 2||5||
60019214|NCT02549027|76135221|FG004|STARTED|Washout After Period 2||0||
60019215|NCT02549027|76135222|FG005|STARTED|Washout After Period 2||0||
60019216|NCT02549027|76135217|FG000|COMPLETED|Washout After Period 2||5||
60019217|NCT02549027|76135218|FG001|COMPLETED|Washout After Period 2||5||
60019218|NCT02549027|76135219|FG002|COMPLETED|Washout After Period 2||5||
60019219|NCT02549027|76135220|FG003|COMPLETED|Washout After Period 2||5||
60019220|NCT02549027|76135221|FG004|COMPLETED|Washout After Period 2||0||
60019221|NCT02549027|76135222|FG005|COMPLETED|Washout After Period 2||0||
60019222|NCT02549027|76135217|FG000|NOT COMPLETED|Washout After Period 2||0||
60019223|NCT02549027|76135218|FG001|NOT COMPLETED|Washout After Period 2||0||
59611574|NCT01757184|75722568|FG000|NOT COMPLETED|Double-blind Period||1||
59758704|NCT00925301|75877987|FG001|COMPLETED|12-Month Open-label Extension (Optional)||0||
59758705|NCT00925301|75877988|FG002|COMPLETED|12-Month Open-label Extension (Optional)||0||
59758706|NCT00925301|75877989|FG003|COMPLETED|12-Month Open-label Extension (Optional)||54||
59758707|NCT00925301|75877986|FG000|NOT COMPLETED|12-Month Open-label Extension (Optional)||0||
59758708|NCT00925301|75877987|FG001|NOT COMPLETED|12-Month Open-label Extension (Optional)||0||
59758709|NCT00925301|75877988|FG002|NOT COMPLETED|12-Month Open-label Extension (Optional)||0||
59758710|NCT00925301|75877989|FG003|NOT COMPLETED|12-Month Open-label Extension (Optional)||3||
59758711|NCT00754065|75878002|FG000|STARTED|Overall Study||203||
59758712|NCT00754065|75878003|FG001|STARTED|Overall Study||206||
59758713|NCT00754065|75878002|FG000|Participants Received Treatment|Overall Study||191||
59758714|NCT00754065|75878003|FG001|Participants Received Treatment|Overall Study||204||
59758715|NCT00754065|75878002|FG000|Cycle 6|Overall Study||141||
59758716|NCT00754065|75878003|FG001|Cycle 6|Overall Study||153||
59758717|NCT00754065|75878002|FG000|COMPLETED|Overall Study||122||
59758718|NCT00754065|75878003|FG001|COMPLETED|Overall Study||126||
59758719|NCT00754065|75878002|FG000|NOT COMPLETED|Overall Study||81||
59758720|NCT00754065|75878003|FG001|NOT COMPLETED|Overall Study||80||
59758721|NCT02972996|75878011|FG000|STARTED|Overall Study||27||
59758722|NCT02972996|75878012|FG001|STARTED|Overall Study||28||
59758723|NCT02972996|75878011|FG000|COMPLETED|Overall Study||26||
60019224|NCT02549027|76135219|FG002|NOT COMPLETED|Washout After Period 2||0||
60019225|NCT02549027|76135220|FG003|NOT COMPLETED|Washout After Period 2||0||
60019226|NCT02549027|76135221|FG004|NOT COMPLETED|Washout After Period 2||0||
60019227|NCT02549027|76135222|FG005|NOT COMPLETED|Washout After Period 2||0||
60019228|NCT02549027|76135217|FG000|STARTED|Period 3 - MK-1064 or Placebo||5||
60019229|NCT02549027|76135218|FG001|STARTED|Period 3 - MK-1064 or Placebo||5||
60019230|NCT02549027|76135219|FG002|STARTED|Period 3 - MK-1064 or Placebo||5||
60019231|NCT02549027|76135220|FG003|STARTED|Period 3 - MK-1064 or Placebo||5||
59911517|NCT04763044|76032427|FG001|STARTED|Period 2||4||
59911518|NCT04763044|76032428|FG002|STARTED|Period 2||4||
59911519|NCT04763044|76032429|FG003|STARTED|Period 2||3||
59911520|NCT04763044|76032426|FG000|COMPLETED|Period 2||3||
59911521|NCT04763044|76032427|FG001|COMPLETED|Period 2||4||
59911522|NCT04763044|76032428|FG002|COMPLETED|Period 2||4||
59911523|NCT04763044|76032429|FG003|COMPLETED|Period 2||3||
59911524|NCT04763044|76032426|FG000|NOT COMPLETED|Period 2||0||
59911525|NCT04763044|76032427|FG001|NOT COMPLETED|Period 2||0||
59911526|NCT04763044|76032428|FG002|NOT COMPLETED|Period 2||0||
59911527|NCT04763044|76032429|FG003|NOT COMPLETED|Period 2||0||
59911528|NCT04763044|76032426|FG000|STARTED|Period 3||3||
59911529|NCT04763044|76032427|FG001|STARTED|Period 3||4||
59911530|NCT04763044|76032428|FG002|STARTED|Period 3||4||
59911531|NCT04763044|76032429|FG003|STARTED|Period 3||3||
59911532|NCT04763044|76032426|FG000|COMPLETED|Period 3||3||
59911533|NCT04763044|76032427|FG001|COMPLETED|Period 3||4||
59911534|NCT04763044|76032428|FG002|COMPLETED|Period 3||4||
59911535|NCT04763044|76032429|FG003|COMPLETED|Period 3||3||
59911536|NCT04763044|76032426|FG000|NOT COMPLETED|Period 3||0||
59911537|NCT04763044|76032427|FG001|NOT COMPLETED|Period 3||0||
60019232|NCT02549027|76135221|FG004|STARTED|Period 3 - MK-1064 or Placebo||0||
60019233|NCT02549027|76135222|FG005|STARTED|Period 3 - MK-1064 or Placebo||0||
60019234|NCT02549027|76135217|FG000|COMPLETED|Period 3 - MK-1064 or Placebo||5||
60019235|NCT02549027|76135218|FG001|COMPLETED|Period 3 - MK-1064 or Placebo||5||
60019236|NCT02549027|76135219|FG002|COMPLETED|Period 3 - MK-1064 or Placebo||5||
60019237|NCT02549027|76135220|FG003|COMPLETED|Period 3 - MK-1064 or Placebo||5||
60019238|NCT02549027|76135221|FG004|COMPLETED|Period 3 - MK-1064 or Placebo||0||
60019239|NCT02549027|76135222|FG005|COMPLETED|Period 3 - MK-1064 or Placebo||0||
60019240|NCT02549027|76135217|FG000|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0||
60019241|NCT02549027|76135218|FG001|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0||
60019242|NCT02549027|76135219|FG002|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0||
60019243|NCT02549027|76135220|FG003|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0||
60019244|NCT02549027|76135221|FG004|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0||
60019245|NCT02549027|76135222|FG005|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0||
60019246|NCT02549027|76135217|FG000|STARTED|Washout After Period 3||5||
60019247|NCT02549027|76135218|FG001|STARTED|Washout After Period 3||5||
60019248|NCT02549027|76135219|FG002|STARTED|Washout After Period 3||5||
60019249|NCT02549027|76135220|FG003|STARTED|Washout After Period 3||5||
60019250|NCT02549027|76135221|FG004|STARTED|Washout After Period 3||0||
60019251|NCT02549027|76135222|FG005|STARTED|Washout After Period 3||0||
60019252|NCT02549027|76135217|FG000|COMPLETED|Washout After Period 3||5||
60019253|NCT02549027|76135218|FG001|COMPLETED|Washout After Period 3||5||
60019254|NCT02549027|76135219|FG002|COMPLETED|Washout After Period 3||5||
60019255|NCT02549027|76135220|FG003|COMPLETED|Washout After Period 3||5||
60019256|NCT02549027|76135221|FG004|COMPLETED|Washout After Period 3||0||
60019257|NCT02549027|76135222|FG005|COMPLETED|Washout After Period 3||0||
60019258|NCT02549027|76135217|FG000|NOT COMPLETED|Washout After Period 3||0||
60019259|NCT02549027|76135218|FG001|NOT COMPLETED|Washout After Period 3||0||
59911538|NCT04763044|76032428|FG002|NOT COMPLETED|Period 3||0||
59911539|NCT04763044|76032429|FG003|NOT COMPLETED|Period 3||0||
59911540|NCT04763044|76032426|FG000|STARTED|Period 4||3||
59911541|NCT04763044|76032427|FG001|STARTED|Period 4||3||
59911542|NCT04763044|76032428|FG002|STARTED|Period 4||4||
59911543|NCT04763044|76032429|FG003|STARTED|Period 4||3||
59911544|NCT04763044|76032426|FG000|COMPLETED|Period 4||3||
59911545|NCT04763044|76032427|FG001|COMPLETED|Period 4||3||
59911546|NCT04763044|76032428|FG002|COMPLETED|Period 4||4||
59911547|NCT04763044|76032429|FG003|COMPLETED|Period 4||3||
59911548|NCT04763044|76032426|FG000|NOT COMPLETED|Period 4||0||
60019260|NCT02549027|76135219|FG002|NOT COMPLETED|Washout After Period 3||0||
60019261|NCT02549027|76135220|FG003|NOT COMPLETED|Washout After Period 3||0||
59911549|NCT04763044|76032427|FG001|NOT COMPLETED|Period 4||0||
59911550|NCT04763044|76032428|FG002|NOT COMPLETED|Period 4||0||
59911551|NCT04763044|76032429|FG003|NOT COMPLETED|Period 4||0||
59911552|NCT04763044|76032426|FG000|STARTED|Period 5||3||
59911553|NCT04763044|76032427|FG001|STARTED|Period 5||3||
59911554|NCT04763044|76032428|FG002|STARTED|Period 5||4||
59911555|NCT04763044|76032429|FG003|STARTED|Period 5||3||
59911556|NCT04763044|76032426|FG000|COMPLETED|Period 5||2||
60019262|NCT02549027|76135221|FG004|NOT COMPLETED|Washout After Period 3||0||
60019263|NCT02549027|76135222|FG005|NOT COMPLETED|Washout After Period 3||0||
60019264|NCT02549027|76135217|FG000|STARTED|Period 4 - MK-1064 or Placebo||5||
60019265|NCT02549027|76135218|FG001|STARTED|Period 4 - MK-1064 or Placebo||5||
60019266|NCT02549027|76135219|FG002|STARTED|Period 4 - MK-1064 or Placebo||5||
60019267|NCT02549027|76135220|FG003|STARTED|Period 4 - MK-1064 or Placebo||5||
60019268|NCT02549027|76135221|FG004|STARTED|Period 4 - MK-1064 or Placebo||0||
60019269|NCT02549027|76135222|FG005|STARTED|Period 4 - MK-1064 or Placebo||0||
60019270|NCT02549027|76135217|FG000|COMPLETED|Period 4 - MK-1064 or Placebo||5||
60019271|NCT02549027|76135218|FG001|COMPLETED|Period 4 - MK-1064 or Placebo||5||
60019272|NCT02549027|76135219|FG002|COMPLETED|Period 4 - MK-1064 or Placebo||5||
60019273|NCT02549027|76135220|FG003|COMPLETED|Period 4 - MK-1064 or Placebo||5||
60019274|NCT02549027|76135221|FG004|COMPLETED|Period 4 - MK-1064 or Placebo||0||
59911557|NCT04763044|76032427|FG001|COMPLETED|Period 5||3||
59911558|NCT04763044|76032428|FG002|COMPLETED|Period 5||4||
59911559|NCT04763044|76032429|FG003|COMPLETED|Period 5||3||
59911560|NCT04763044|76032426|FG000|NOT COMPLETED|Period 5||1||
59911561|NCT04763044|76032427|FG001|NOT COMPLETED|Period 5||0||
59911562|NCT04763044|76032428|FG002|NOT COMPLETED|Period 5||0||
59911563|NCT04763044|76032429|FG003|NOT COMPLETED|Period 5||0||
59911564|NCT01315028|76032443|FG000|STARTED|Overall Study||10||
59911565|NCT01315028|76032444|FG001|STARTED|Overall Study||10||
59911566|NCT01315028|76032443|FG000|COMPLETED|Overall Study||9||
59911567|NCT01315028|76032444|FG001|COMPLETED|Overall Study||9||
59911568|NCT01315028|76032443|FG000|NOT COMPLETED|Overall Study||1||
59911569|NCT01315028|76032444|FG001|NOT COMPLETED|Overall Study||1||
59911570|NCT02720536|76032450|FG000|STARTED|Overall Study||53||
59911571|NCT02720536|76032450|FG000|COMPLETED|Overall Study||34||
59911572|NCT02720536|76032450|FG000|NOT COMPLETED|Overall Study||19||
59911573|NCT03168438|76032462|FG000|STARTED|Overall Study||3||
59911574|NCT03168438|76032463|FG001|STARTED|Overall Study||3||
59911575|NCT03168438|76032462|FG000|COMPLETED|Overall Study||3||
59911576|NCT03168438|76032463|FG001|COMPLETED|Overall Study||2||
59911577|NCT03168438|76032462|FG000|NOT COMPLETED|Overall Study||0||
59911578|NCT03168438|76032463|FG001|NOT COMPLETED|Overall Study||1||
59911579|NCT03137784|76032470|FG000|STARTED|Overall Study||24||
59911580|NCT03137784|76032471|FG001|STARTED|Overall Study||25||
59911581|NCT03137784|76032472|FG002|STARTED|Overall Study||25||
59911582|NCT03137784|76032473|FG003|STARTED|Overall Study||24||
59911583|NCT03137784|76032474|FG004|STARTED|Overall Study||25||
59911584|NCT03137784|76032475|FG005|STARTED|Overall Study||25||
59911585|NCT03137784|76032470|FG000|COMPLETED|Overall Study||22||
59911586|NCT03137784|76032471|FG001|COMPLETED|Overall Study||24||
59911587|NCT03137784|76032472|FG002|COMPLETED|Overall Study||25||
59911588|NCT03137784|76032473|FG003|COMPLETED|Overall Study||24||
59911589|NCT03137784|76032474|FG004|COMPLETED|Overall Study||24||
59911590|NCT03137784|76032475|FG005|COMPLETED|Overall Study||25||
59911591|NCT03137784|76032470|FG000|NOT COMPLETED|Overall Study||2||
59911592|NCT03137784|76032471|FG001|NOT COMPLETED|Overall Study||1||
59911593|NCT03137784|76032472|FG002|NOT COMPLETED|Overall Study||0||
59911594|NCT03137784|76032473|FG003|NOT COMPLETED|Overall Study||0||
59911595|NCT03137784|76032474|FG004|NOT COMPLETED|Overall Study||1||
59911596|NCT03137784|76032475|FG005|NOT COMPLETED|Overall Study||0||
59911597|NCT01314716|76032485|FG000|STARTED|Double-Blind Phase||136||
59911598|NCT01314716|76032486|FG001|STARTED|Double-Blind Phase||138||
59911599|NCT01314716|76032485|FG000|Randomized and Treated|Double-Blind Phase||135||
59911600|NCT01314716|76032486|FG001|Randomized and Treated|Double-Blind Phase||137||
59911601|NCT01314716|76032485|FG000|COMPLETED|Double-Blind Phase||119||
59911602|NCT01314716|76032486|FG001|COMPLETED|Double-Blind Phase||123||
59911603|NCT01314716|76032485|FG000|NOT COMPLETED|Double-Blind Phase||17||
59911604|NCT01314716|76032486|FG001|NOT COMPLETED|Double-Blind Phase||15||
59911605|NCT01314716|76032485|FG000|STARTED|Open-Label Phase|7 participants in this group did not continue from the randomized to the open-label phase.|112||
59911606|NCT01314716|76032486|FG001|STARTED|Open-Label Phase|13 participants in this group did not continue from the randomized to the open-label phase.|110||
59911607|NCT01314716|76032485|FG000|COMPLETED|Open-Label Phase||102||
59911608|NCT01314716|76032486|FG001|COMPLETED|Open-Label Phase||98||
59911609|NCT01314716|76032485|FG000|NOT COMPLETED|Open-Label Phase||10||
59911610|NCT01314716|76032486|FG001|NOT COMPLETED|Open-Label Phase||12||
59911611|NCT03144180|76032496|FG000|STARTED|Overall Study||16||
59911612|NCT03144180|76032497|FG001|STARTED|Overall Study||16||
59911613|NCT03144180|76032496|FG000|COMPLETED|Overall Study||14||
59911614|NCT03144180|76032497|FG001|COMPLETED|Overall Study||10||
59911615|NCT03144180|76032496|FG000|NOT COMPLETED|Overall Study||2||
59911616|NCT03144180|76032497|FG001|NOT COMPLETED|Overall Study||6||
59911617|NCT01465334|76032507|FG000|STARTED|Overall Study||15||
59507151|NCT00819403|75600321|FG001|STARTED|Second Intervention (6 Weeks)||8||
59507152|NCT00819403|75600320|FG000|COMPLETED|Second Intervention (6 Weeks)||7||
59507153|NCT00819403|75600321|FG001|COMPLETED|Second Intervention (6 Weeks)||8||
59507154|NCT00819403|75600320|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0||
59911618|NCT01465334|76032508|FG001|STARTED|Overall Study||15||
59911619|NCT01465334|76032507|FG000|Complete Part A Induction|Overall Study||12||
59911620|NCT01465334|76032508|FG001|Complete Part A Induction|Overall Study||15||
59911621|NCT01465334|76032507|FG000|Complete Part B Induction|Overall Study||7||
59911622|NCT01465334|76032508|FG001|Complete Part B Induction|Overall Study||15||
59911623|NCT01465334|76032507|FG000|Eligible for Allogeneic Transplant|Overall Study||9||
59911624|NCT01465334|76032508|FG001|Eligible for Allogeneic Transplant|Overall Study||9||
59911625|NCT01465334|76032507|FG000|COMPLETED|Overall Study||13||
59911626|NCT01465334|76032508|FG001|COMPLETED|Overall Study||9||
59911627|NCT01465334|76032507|FG000|NOT COMPLETED|Overall Study||2||
59911628|NCT01465334|76032508|FG001|NOT COMPLETED|Overall Study||6||
59911629|NCT00702208|76032514|FG000|STARTED|Overall Study||198||
59911630|NCT00702208|76032514|FG000|COMPLETED|Overall Study||167||
59911631|NCT00702208|76032514|FG000|NOT COMPLETED|Overall Study||31||
59911632|NCT00973856|76032521|FG000|STARTED|Overall Study||3||5
59911633|NCT00973856|76032522|FG001|STARTED|Overall Study||2||5
59911634|NCT00973856|76032521|FG000|COMPLETED|Overall Study||3||5
59911635|NCT00973856|76032522|FG001|COMPLETED|Overall Study||2||5
59911636|NCT00973856|76032521|FG000|NOT COMPLETED|Overall Study||0||0
59911637|NCT00973856|76032522|FG001|NOT COMPLETED|Overall Study||0||0
59911638|NCT02718898|76032531|FG000|STARTED|Blinded Treatment Period||74||
59911639|NCT02718898|76032532|FG001|STARTED|Blinded Treatment Period||75||
59911640|NCT02718898|76032533|FG002|STARTED|Blinded Treatment Period||0||
59911641|NCT02718898|76032534|FG003|STARTED|Blinded Treatment Period||0||
59911642|NCT02718898|76032535|FG004|STARTED|Blinded Treatment Period||0||
59911643|NCT02718898|76032536|FG005|STARTED|Blinded Treatment Period||0||
59911644|NCT02718898|76032537|FG006|STARTED|Blinded Treatment Period||0||
59911645|NCT02718898|76032531|FG000|COMPLETED|Blinded Treatment Period||65||
59911646|NCT02718898|76032532|FG001|COMPLETED|Blinded Treatment Period||74||
59911647|NCT02718898|76032533|FG002|COMPLETED|Blinded Treatment Period||0||
59911648|NCT02718898|76032534|FG003|COMPLETED|Blinded Treatment Period||0||
59911649|NCT02718898|76032535|FG004|COMPLETED|Blinded Treatment Period||0||
59911650|NCT02718898|76032536|FG005|COMPLETED|Blinded Treatment Period||0||
59911651|NCT02718898|76032537|FG006|COMPLETED|Blinded Treatment Period||0||
59911652|NCT02718898|76032531|FG000|NOT COMPLETED|Blinded Treatment Period||9||
59911653|NCT02718898|76032532|FG001|NOT COMPLETED|Blinded Treatment Period||1||
59911654|NCT02718898|76032533|FG002|NOT COMPLETED|Blinded Treatment Period||0||
59911655|NCT02718898|76032534|FG003|NOT COMPLETED|Blinded Treatment Period||0||
59911656|NCT02718898|76032535|FG004|NOT COMPLETED|Blinded Treatment Period||0||
59911657|NCT02718898|76032536|FG005|NOT COMPLETED|Blinded Treatment Period||0||
59911658|NCT02718898|76032537|FG006|NOT COMPLETED|Blinded Treatment Period||0||
59911659|NCT02718898|76032531|FG000|STARTED|Open Label Treatment Period (OLTP)||0||
59911660|NCT02718898|76032532|FG001|STARTED|Open Label Treatment Period (OLTP)||0||
59911661|NCT02718898|76032533|FG002|STARTED|Open Label Treatment Period (OLTP)||65||
59911662|NCT02718898|76032534|FG003|STARTED|Open Label Treatment Period (OLTP)||74||
59911663|NCT02718898|76032535|FG004|STARTED|Open Label Treatment Period (OLTP)||0||
59911664|NCT02718898|76032536|FG005|STARTED|Open Label Treatment Period (OLTP)||0||
59911665|NCT02718898|76032537|FG006|STARTED|Open Label Treatment Period (OLTP)||0||
59911666|NCT02718898|76032531|FG000|COMPLETED|Open Label Treatment Period (OLTP)||0||
59911667|NCT02718898|76032532|FG001|COMPLETED|Open Label Treatment Period (OLTP)||0||
59911668|NCT02718898|76032533|FG002|COMPLETED|Open Label Treatment Period (OLTP)||62||
59911669|NCT02718898|76032534|FG003|COMPLETED|Open Label Treatment Period (OLTP)||64||
59911670|NCT02718898|76032535|FG004|COMPLETED|Open Label Treatment Period (OLTP)||0||
59911671|NCT02718898|76032536|FG005|COMPLETED|Open Label Treatment Period (OLTP)||0||
59911672|NCT02718898|76032537|FG006|COMPLETED|Open Label Treatment Period (OLTP)||0||
59911673|NCT02718898|76032531|FG000|NOT COMPLETED|Open Label Treatment Period (OLTP)||0||
59911674|NCT02718898|76032532|FG001|NOT COMPLETED|Open Label Treatment Period (OLTP)||0||
59911675|NCT02718898|76032533|FG002|NOT COMPLETED|Open Label Treatment Period (OLTP)||3||
59911676|NCT02718898|76032534|FG003|NOT COMPLETED|Open Label Treatment Period (OLTP)||10||
59911677|NCT02718898|76032535|FG004|NOT COMPLETED|Open Label Treatment Period (OLTP)||0||
59911678|NCT02718898|76032536|FG005|NOT COMPLETED|Open Label Treatment Period (OLTP)||0||
59911679|NCT02718898|76032537|FG006|NOT COMPLETED|Open Label Treatment Period (OLTP)||0||
59911680|NCT02718898|76032531|FG000|STARTED|Post Treatment Follow-up Period||0||
59911681|NCT02718898|76032532|FG001|STARTED|Post Treatment Follow-up Period||0||
59911682|NCT02718898|76032533|FG002|STARTED|Post Treatment Follow-up Period||0||
59911683|NCT02718898|76032534|FG003|STARTED|Post Treatment Follow-up Period||0||
59911684|NCT02718898|76032535|FG004|STARTED|Post Treatment Follow-up Period|One participant who discontinued from placebo blinded treatment had entered post-treatment follow-up|1||
59911685|NCT02718898|76032536|FG005|STARTED|Post Treatment Follow-up Period||78||
59911686|NCT02718898|76032537|FG006|STARTED|Post Treatment Follow-up Period||49||
59911687|NCT02718898|76032531|FG000|COMPLETED|Post Treatment Follow-up Period||0||
59911688|NCT02718898|76032532|FG001|COMPLETED|Post Treatment Follow-up Period||0||
59911689|NCT02718898|76032533|FG002|COMPLETED|Post Treatment Follow-up Period||0||
59911690|NCT02718898|76032534|FG003|COMPLETED|Post Treatment Follow-up Period||0||
59911691|NCT02718898|76032535|FG004|COMPLETED|Post Treatment Follow-up Period||0||
59911692|NCT02718898|76032536|FG005|COMPLETED|Post Treatment Follow-up Period||67||
59911693|NCT02718898|76032537|FG006|COMPLETED|Post Treatment Follow-up Period||44||
59911694|NCT02718898|76032531|FG000|NOT COMPLETED|Post Treatment Follow-up Period||0||
59911695|NCT02718898|76032532|FG001|NOT COMPLETED|Post Treatment Follow-up Period||0||
59911696|NCT02718898|76032533|FG002|NOT COMPLETED|Post Treatment Follow-up Period||0||
59911697|NCT02718898|76032534|FG003|NOT COMPLETED|Post Treatment Follow-up Period||0||
59911698|NCT02718898|76032535|FG004|NOT COMPLETED|Post Treatment Follow-up Period||1||
59911699|NCT02718898|76032536|FG005|NOT COMPLETED|Post Treatment Follow-up Period||11||
59911700|NCT02718898|76032537|FG006|NOT COMPLETED|Post Treatment Follow-up Period||5||
59911701|NCT04643782|76032550|FG000|STARTED|Overall Study||287||
59911702|NCT04643782|76032550|FG000|COMPLETED|Overall Study||225||
59911703|NCT04643782|76032550|FG000|NOT COMPLETED|Overall Study||62||
59911704|NCT03143166|76032554|FG000|STARTED|Period 1||36||
59911705|NCT03143166|76032554|FG000|COMPLETED|Period 1||36||
59911706|NCT03143166|76032554|FG000|NOT COMPLETED|Period 1||0||
59911707|NCT03143166|76032554|FG000|STARTED|Period 2 (Washout of at Least 4 Days)||36||
59911708|NCT03143166|76032554|FG000|COMPLETED|Period 2 (Washout of at Least 4 Days)||35||
59911709|NCT03143166|76032554|FG000|NOT COMPLETED|Period 2 (Washout of at Least 4 Days)||1||
59911710|NCT02879994|76032560|FG000|STARTED|Overall Study||11||
59911711|NCT02879994|76032560|FG000|COMPLETED|Overall Study||0||
59911712|NCT02879994|76032560|FG000|NOT COMPLETED|Overall Study||11||
59911713|NCT03142932|76032566|FG000|STARTED|Overall Study||52||
59911714|NCT03142932|76032567|FG001|STARTED|Overall Study||50||
59911715|NCT03142932|76032566|FG000|COMPLETED|Overall Study||50||
59911716|NCT03142932|76032567|FG001|COMPLETED|Overall Study||39||
59911717|NCT03142932|76032566|FG000|NOT COMPLETED|Overall Study||2||
59911718|NCT03142932|76032567|FG001|NOT COMPLETED|Overall Study||11||
59911719|NCT00702052|76032573|FG000|STARTED|Overall Study||58||
59911720|NCT00702052|76032573|FG000|COMPLETED|Overall Study||0||
59911721|NCT00702052|76032573|FG000|NOT COMPLETED|Overall Study||58||
59911722|NCT03140280|76032577|FG000|STARTED|Overall Study||23||
59911723|NCT03140280|76032577|FG000|COMPLETED|Overall Study||18||
59911724|NCT03140280|76032577|FG000|NOT COMPLETED|Overall Study||5||
59911725|NCT03136380|76032583|FG000|STARTED|Part 1, Period 1 (3 Days)||6||
59911726|NCT03136380|76032584|FG001|STARTED|Part 1, Period 1 (3 Days)||6||
59911727|NCT03136380|76032585|FG002|STARTED|Part 1, Period 1 (3 Days)||6||
59911728|NCT03136380|76032586|FG003|STARTED|Part 1, Period 1 (3 Days)||0||
59911729|NCT03136380|76032587|FG004|STARTED|Part 1, Period 1 (3 Days)||0||
59911730|NCT03136380|76032583|FG000|COMPLETED|Part 1, Period 1 (3 Days)||6||
59911731|NCT03136380|76032584|FG001|COMPLETED|Part 1, Period 1 (3 Days)||6||
59911732|NCT03136380|76032585|FG002|COMPLETED|Part 1, Period 1 (3 Days)||6||
59911733|NCT03136380|76032586|FG003|COMPLETED|Part 1, Period 1 (3 Days)||0||
59911734|NCT03136380|76032587|FG004|COMPLETED|Part 1, Period 1 (3 Days)||0||
59911735|NCT03136380|76032583|FG000|NOT COMPLETED|Part 1, Period 1 (3 Days)||0||
59911736|NCT03136380|76032584|FG001|NOT COMPLETED|Part 1, Period 1 (3 Days)||0||
59911737|NCT03136380|76032585|FG002|NOT COMPLETED|Part 1, Period 1 (3 Days)||0||
59911738|NCT03136380|76032586|FG003|NOT COMPLETED|Part 1, Period 1 (3 Days)||0||
59911739|NCT03136380|76032587|FG004|NOT COMPLETED|Part 1, Period 1 (3 Days)||0||
59911740|NCT03136380|76032583|FG000|STARTED|Part 1, Washout Period 1 (7 Days)||6||
59911741|NCT03136380|76032584|FG001|STARTED|Part 1, Washout Period 1 (7 Days)||6||
59911742|NCT03136380|76032585|FG002|STARTED|Part 1, Washout Period 1 (7 Days)||6||
59911743|NCT03136380|76032586|FG003|STARTED|Part 1, Washout Period 1 (7 Days)||0||
59911744|NCT03136380|76032587|FG004|STARTED|Part 1, Washout Period 1 (7 Days)||0||
59911745|NCT03136380|76032583|FG000|COMPLETED|Part 1, Washout Period 1 (7 Days)||6||
59911746|NCT03136380|76032584|FG001|COMPLETED|Part 1, Washout Period 1 (7 Days)||6||
59911747|NCT03136380|76032585|FG002|COMPLETED|Part 1, Washout Period 1 (7 Days)||6||
59911748|NCT03136380|76032586|FG003|COMPLETED|Part 1, Washout Period 1 (7 Days)||0||
59911749|NCT03136380|76032587|FG004|COMPLETED|Part 1, Washout Period 1 (7 Days)||0||
59911750|NCT03136380|76032583|FG000|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0||
59758724|NCT02972996|75878012|FG001|COMPLETED|Overall Study||26||
59758725|NCT02972996|75878011|FG000|NOT COMPLETED|Overall Study||1||
59911751|NCT03136380|76032584|FG001|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0||
59911752|NCT03136380|76032585|FG002|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0||
59911753|NCT03136380|76032586|FG003|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0||
59911754|NCT03136380|76032587|FG004|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0||
59911755|NCT03136380|76032583|FG000|STARTED|Part 1, Period 2 (3 Days)||6||
59911756|NCT03136380|76032584|FG001|STARTED|Part 1, Period 2 (3 Days)||6||
59911757|NCT03136380|76032585|FG002|STARTED|Part 1, Period 2 (3 Days)||6||
59911758|NCT03136380|76032586|FG003|STARTED|Part 1, Period 2 (3 Days)||0||
59911759|NCT03136380|76032587|FG004|STARTED|Part 1, Period 2 (3 Days)||0||
59911760|NCT03136380|76032583|FG000|COMPLETED|Part 1, Period 2 (3 Days)||6||
59911761|NCT03136380|76032584|FG001|COMPLETED|Part 1, Period 2 (3 Days)||6||
59911762|NCT03136380|76032585|FG002|COMPLETED|Part 1, Period 2 (3 Days)||6||
59911763|NCT03136380|76032586|FG003|COMPLETED|Part 1, Period 2 (3 Days)||0||
59911764|NCT03136380|76032587|FG004|COMPLETED|Part 1, Period 2 (3 Days)||0||
59911765|NCT03136380|76032583|FG000|NOT COMPLETED|Part 1, Period 2 (3 Days)||0||
59911766|NCT03136380|76032584|FG001|NOT COMPLETED|Part 1, Period 2 (3 Days)||0||
59911767|NCT03136380|76032585|FG002|NOT COMPLETED|Part 1, Period 2 (3 Days)||0||
59911768|NCT03136380|76032586|FG003|NOT COMPLETED|Part 1, Period 2 (3 Days)||0||
59911769|NCT03136380|76032587|FG004|NOT COMPLETED|Part 1, Period 2 (3 Days)||0||
59911770|NCT03136380|76032583|FG000|STARTED|Part 1, Washout Period 2 (7 Days)||6||
59911771|NCT03136380|76032584|FG001|STARTED|Part 1, Washout Period 2 (7 Days)||6||
59911772|NCT03136380|76032585|FG002|STARTED|Part 1, Washout Period 2 (7 Days)||6||
59911773|NCT03136380|76032586|FG003|STARTED|Part 1, Washout Period 2 (7 Days)||0||
59911774|NCT03136380|76032587|FG004|STARTED|Part 1, Washout Period 2 (7 Days)||0||
59911775|NCT03136380|76032583|FG000|COMPLETED|Part 1, Washout Period 2 (7 Days)||6||
59758726|NCT02972996|75878012|FG001|NOT COMPLETED|Overall Study||2||
59911776|NCT03136380|76032584|FG001|COMPLETED|Part 1, Washout Period 2 (7 Days)||5||
59911777|NCT03136380|76032585|FG002|COMPLETED|Part 1, Washout Period 2 (7 Days)||6||
59911778|NCT03136380|76032586|FG003|COMPLETED|Part 1, Washout Period 2 (7 Days)||0||
59911779|NCT03136380|76032587|FG004|COMPLETED|Part 1, Washout Period 2 (7 Days)||0||
59911780|NCT03136380|76032583|FG000|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0||
59911781|NCT03136380|76032584|FG001|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||1||
59911782|NCT03136380|76032585|FG002|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0||
59758727|NCT04138056|75878023|FG000|STARTED|Primary Study||101||
59758728|NCT04138056|75878024|FG001|STARTED|Primary Study||101||
59758729|NCT04138056|75878025|FG002|STARTED|Primary Study||103||
59758730|NCT04138056|75878026|FG003|STARTED|Primary Study||102||
59911783|NCT03136380|76032586|FG003|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0||
59911784|NCT03136380|76032587|FG004|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0||
59911785|NCT03136380|76032583|FG000|STARTED|Part 1, Period 3 (4 Days)||6||
59911786|NCT03136380|76032584|FG001|STARTED|Part 1, Period 3 (4 Days)||5||
59911787|NCT03136380|76032585|FG002|STARTED|Part 1, Period 3 (4 Days)||6||
59911788|NCT03136380|76032586|FG003|STARTED|Part 1, Period 3 (4 Days)||0||
59911789|NCT03136380|76032587|FG004|STARTED|Part 1, Period 3 (4 Days)||0||
59911790|NCT03136380|76032583|FG000|COMPLETED|Part 1, Period 3 (4 Days)||6||
59911791|NCT03136380|76032584|FG001|COMPLETED|Part 1, Period 3 (4 Days)||5||
59911792|NCT03136380|76032585|FG002|COMPLETED|Part 1, Period 3 (4 Days)||6||
59911793|NCT03136380|76032586|FG003|COMPLETED|Part 1, Period 3 (4 Days)||0||
59911794|NCT03136380|76032587|FG004|COMPLETED|Part 1, Period 3 (4 Days)||0||
59911795|NCT03136380|76032583|FG000|NOT COMPLETED|Part 1, Period 3 (4 Days)||0||
59911796|NCT03136380|76032584|FG001|NOT COMPLETED|Part 1, Period 3 (4 Days)||0||
59911797|NCT03136380|76032585|FG002|NOT COMPLETED|Part 1, Period 3 (4 Days)||0||
59911798|NCT03136380|76032586|FG003|NOT COMPLETED|Part 1, Period 3 (4 Days)||0||
59911799|NCT03136380|76032587|FG004|NOT COMPLETED|Part 1, Period 3 (4 Days)||0||
59911800|NCT03136380|76032583|FG000|STARTED|Part 2, Period 1 (3 Days)||0||
59911801|NCT03136380|76032584|FG001|STARTED|Part 2, Period 1 (3 Days)||0||
59911802|NCT03136380|76032585|FG002|STARTED|Part 2, Period 1 (3 Days)||0||
59911803|NCT03136380|76032586|FG003|STARTED|Part 2, Period 1 (3 Days)||8||
59911804|NCT03136380|76032587|FG004|STARTED|Part 2, Period 1 (3 Days)||8||
59911805|NCT03136380|76032583|FG000|COMPLETED|Part 2, Period 1 (3 Days)||0||
59911806|NCT03136380|76032584|FG001|COMPLETED|Part 2, Period 1 (3 Days)||0||
59911807|NCT03136380|76032585|FG002|COMPLETED|Part 2, Period 1 (3 Days)||0||
59911808|NCT03136380|76032586|FG003|COMPLETED|Part 2, Period 1 (3 Days)||8||
59911809|NCT03136380|76032587|FG004|COMPLETED|Part 2, Period 1 (3 Days)||8||
59911810|NCT03136380|76032583|FG000|NOT COMPLETED|Part 2, Period 1 (3 Days)||0||
59911811|NCT03136380|76032584|FG001|NOT COMPLETED|Part 2, Period 1 (3 Days)||0||
59911812|NCT03136380|76032585|FG002|NOT COMPLETED|Part 2, Period 1 (3 Days)||0||
59911813|NCT03136380|76032586|FG003|NOT COMPLETED|Part 2, Period 1 (3 Days)||0||
59911814|NCT03136380|76032587|FG004|NOT COMPLETED|Part 2, Period 1 (3 Days)||0||
59911815|NCT03136380|76032583|FG000|STARTED|Part 2, Washout Period 1 (7 Days)||0||
59911816|NCT03136380|76032584|FG001|STARTED|Part 2, Washout Period 1 (7 Days)||0||
59911817|NCT03136380|76032585|FG002|STARTED|Part 2, Washout Period 1 (7 Days)||0||
59911818|NCT03136380|76032586|FG003|STARTED|Part 2, Washout Period 1 (7 Days)||8||
59911819|NCT03136380|76032587|FG004|STARTED|Part 2, Washout Period 1 (7 Days)||8||
59911820|NCT03136380|76032583|FG000|COMPLETED|Part 2, Washout Period 1 (7 Days)||0||
59911821|NCT03136380|76032584|FG001|COMPLETED|Part 2, Washout Period 1 (7 Days)||0||
59951301|NCT03641287|76070234|FG001|STARTED|Overall Study||33||
59758731|NCT04138056|75878027|FG004|STARTED|Primary Study||102||
59758732|NCT04138056|75878023|FG000|COMPLETED|Primary Study||95||
59758733|NCT04138056|75878024|FG001|COMPLETED|Primary Study||93||
59758734|NCT04138056|75878025|FG002|COMPLETED|Primary Study||100||
59758735|NCT04138056|75878026|FG003|COMPLETED|Primary Study||100||
59758736|NCT04138056|75878027|FG004|COMPLETED|Primary Study||98||
59758737|NCT04138056|75878023|FG000|NOT COMPLETED|Primary Study||6||
59758738|NCT04138056|75878024|FG001|NOT COMPLETED|Primary Study||8||
59758739|NCT04138056|75878025|FG002|NOT COMPLETED|Primary Study||3||
59758740|NCT04138056|75878026|FG003|NOT COMPLETED|Primary Study||2||
59758741|NCT04138056|75878027|FG004|NOT COMPLETED|Primary Study||4||
59758742|NCT04138056|75878023|FG000|STARTED|Extension Study|Out of 95 subjects who completed the Primary Study, 56 subjects did not participate in the Extension Study due to non-compliance of protocol requirements (e.g. completion of the diary card, return for follow-up visits, no willingness/no informed consent obtained).|39||
59758743|NCT04138056|75878024|FG001|STARTED|Extension Study|Out of 93 subjects, who completed the Primary Study, 52 subjects did not participate in the Extension Study due to non-compliance of protocol requirements (e.g. completion of the diary card, return for follow-up visits, no willingness/no informed consent obtained).|41||
59758744|NCT04138056|75878025|FG002|STARTED|Extension Study|Out of 100 subjects, who completed the Primary Study, 54 subjects did not participate in the Extension Study due to non-compliance of protocol requirements (e.g. completion of the diary card, return for follow-up visits, no willingness/no informed consent obtained).|46||
59758745|NCT04138056|75878026|FG003|STARTED|Extension Study|Out of 100 subjects, who completed the Primary Study, 59 subjects did not participate in the Extension Study due to non-compliance of protocol requirements (e.g. completion of the diary card, return for follow-up visits, no willingness/no informed consent obtained).|41||
59758746|NCT04138056|75878027|FG004|STARTED|Extension Study|Out of 98 subjects, who completed the Primary Study, 52 subjects did not participate in the Extension Study due to non-compliance of protocol requirements (e.g. completion of the diary card, return for follow-up visits, no willingness/no informed consent obtained).|46||
59758747|NCT04138056|75878023|FG000|COMPLETED|Extension Study||38||
59758748|NCT04138056|75878024|FG001|COMPLETED|Extension Study||39||
59758749|NCT04138056|75878025|FG002|COMPLETED|Extension Study||45||
59758750|NCT04138056|75878026|FG003|COMPLETED|Extension Study||41||
59758751|NCT04138056|75878027|FG004|COMPLETED|Extension Study||45||
59758752|NCT04138056|75878023|FG000|NOT COMPLETED|Extension Study||1||
59758753|NCT04138056|75878024|FG001|NOT COMPLETED|Extension Study||2||
59911822|NCT03136380|76032585|FG002|COMPLETED|Part 2, Washout Period 1 (7 Days)||0||
59911823|NCT03136380|76032586|FG003|COMPLETED|Part 2, Washout Period 1 (7 Days)||8||
59911824|NCT03136380|76032587|FG004|COMPLETED|Part 2, Washout Period 1 (7 Days)||8||
59911825|NCT03136380|76032583|FG000|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0||
59911826|NCT03136380|76032584|FG001|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0||
59911827|NCT03136380|76032585|FG002|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0||
60019275|NCT02549027|76135222|FG005|COMPLETED|Period 4 - MK-1064 or Placebo||0||
60019276|NCT02549027|76135217|FG000|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0||
60019277|NCT02549027|76135218|FG001|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0||
60019278|NCT02549027|76135219|FG002|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0||
60019279|NCT02549027|76135220|FG003|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0||
60019280|NCT02549027|76135221|FG004|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0||
60019281|NCT02549027|76135222|FG005|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0||
60019282|NCT02549027|76135217|FG000|STARTED|Washout After Period 4||5||
60019283|NCT02549027|76135218|FG001|STARTED|Washout After Period 4||5||
60019284|NCT02549027|76135219|FG002|STARTED|Washout After Period 4||5||
60019285|NCT02549027|76135220|FG003|STARTED|Washout After Period 4||5||
60019286|NCT02549027|76135221|FG004|STARTED|Washout After Period 4||0||
59911828|NCT03136380|76032586|FG003|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0||
59911829|NCT03136380|76032587|FG004|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0||
59911830|NCT03136380|76032583|FG000|STARTED|Part 2, Period 2 (3 Days)||0||
59911831|NCT03136380|76032584|FG001|STARTED|Part 2, Period 2 (3 Days)||0||
59911832|NCT03136380|76032585|FG002|STARTED|Part 2, Period 2 (3 Days)||0||
59911833|NCT03136380|76032586|FG003|STARTED|Part 2, Period 2 (3 Days)||8||
59911834|NCT03136380|76032587|FG004|STARTED|Part 2, Period 2 (3 Days)||8||
59911835|NCT03136380|76032583|FG000|COMPLETED|Part 2, Period 2 (3 Days)||0||
59911836|NCT03136380|76032584|FG001|COMPLETED|Part 2, Period 2 (3 Days)||0||
59911837|NCT03136380|76032585|FG002|COMPLETED|Part 2, Period 2 (3 Days)||0||
59911838|NCT03136380|76032586|FG003|COMPLETED|Part 2, Period 2 (3 Days)||8||
60019287|NCT02549027|76135222|FG005|STARTED|Washout After Period 4||0||
60019288|NCT02549027|76135217|FG000|COMPLETED|Washout After Period 4||5||
60019289|NCT02549027|76135218|FG001|COMPLETED|Washout After Period 4||4||
60019290|NCT02549027|76135219|FG002|COMPLETED|Washout After Period 4||4||
60019291|NCT02549027|76135220|FG003|COMPLETED|Washout After Period 4||4||
60019292|NCT02549027|76135221|FG004|COMPLETED|Washout After Period 4||0||
60019293|NCT02549027|76135222|FG005|COMPLETED|Washout After Period 4||0||
60019294|NCT02549027|76135217|FG000|NOT COMPLETED|Washout After Period 4||0||
60019295|NCT02549027|76135218|FG001|NOT COMPLETED|Washout After Period 4||1||
60019296|NCT02549027|76135219|FG002|NOT COMPLETED|Washout After Period 4||1||
60019297|NCT02549027|76135220|FG003|NOT COMPLETED|Washout After Period 4||1||
60019298|NCT02549027|76135221|FG004|NOT COMPLETED|Washout After Period 4||0||
60019299|NCT02549027|76135222|FG005|NOT COMPLETED|Washout After Period 4||0||
59911839|NCT03136380|76032587|FG004|COMPLETED|Part 2, Period 2 (3 Days)||8||
60019300|NCT02549027|76135217|FG000|STARTED|Period 5 - MK-6096 or Placebo|In Period 5, participants previously in this arm appear in MK-6096 20 mg/Placebo (Period 5) arms|0||
60019301|NCT02549027|76135218|FG001|STARTED|Period 5 - MK-6096 or Placebo|In Period 5, participants previously in this arm appear in MK-6096 20 mg (Period 5) arm|0||
60019302|NCT02549027|76135219|FG002|STARTED|Period 5 - MK-6096 or Placebo|In Period 5, participants previously in this arm appear in MK-6096 20 mg (Period 5) arm|0||
60019303|NCT02549027|76135220|FG003|STARTED|Period 5 - MK-6096 or Placebo|In Period 5, participants previously in this arm appear in MK-6096 20 mg (Period 5) arm|0||
60019304|NCT02549027|76135221|FG004|STARTED|Period 5 - MK-6096 or Placebo|Participants entering Period 5 were previously in MK-1064/Placebo (Period 1-4) arms|16||
60019305|NCT02549027|76135222|FG005|STARTED|Period 5 - MK-6096 or Placebo|Participants entering Period 5 were previously in MK-1064/Placebo (Period 1-4) arms|1||
60019306|NCT02549027|76135217|FG000|COMPLETED|Period 5 - MK-6096 or Placebo||0||
60019307|NCT02549027|76135218|FG001|COMPLETED|Period 5 - MK-6096 or Placebo||0||
60019308|NCT02549027|76135219|FG002|COMPLETED|Period 5 - MK-6096 or Placebo||0||
60019309|NCT02549027|76135220|FG003|COMPLETED|Period 5 - MK-6096 or Placebo||0||
60019310|NCT02549027|76135221|FG004|COMPLETED|Period 5 - MK-6096 or Placebo|The 2 participants who did not complete Period 5 did not receive study drug in Period 5|14||
60019311|NCT02549027|76135222|FG005|COMPLETED|Period 5 - MK-6096 or Placebo||1||
60019312|NCT02549027|76135217|FG000|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0||
59911840|NCT03136380|76032583|FG000|NOT COMPLETED|Part 2, Period 2 (3 Days)||0||
59911841|NCT03136380|76032584|FG001|NOT COMPLETED|Part 2, Period 2 (3 Days)||0||
59911842|NCT03136380|76032585|FG002|NOT COMPLETED|Part 2, Period 2 (3 Days)||0||
59911843|NCT03136380|76032586|FG003|NOT COMPLETED|Part 2, Period 2 (3 Days)||0||
59911844|NCT03136380|76032587|FG004|NOT COMPLETED|Part 2, Period 2 (3 Days)||0||
59911845|NCT03136068|76032607|FG000|STARTED|Overall Study||88||
60019313|NCT02549027|76135218|FG001|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0||
60019314|NCT02549027|76135219|FG002|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0||
60019315|NCT02549027|76135220|FG003|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0||
60019316|NCT02549027|76135221|FG004|NOT COMPLETED|Period 5 - MK-6096 or Placebo||2||
60019317|NCT02549027|76135222|FG005|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0||
60019318|NCT02709395|76135237|FG000|STARTED|Overall Study|28 subjects enrolled and found to be eligible for further study participation after screening.|28||
60019319|NCT02709395|76135237|FG000|COMPLETED|Overall Study||19||
60019320|NCT02709395|76135237|FG000|NOT COMPLETED|Overall Study||9||
59911846|NCT03136068|76032608|FG001|STARTED|Overall Study||90||
59911847|NCT03136068|76032607|FG000|COMPLETED|Overall Study||86||
59911848|NCT03136068|76032608|FG001|COMPLETED|Overall Study||89||
59911849|NCT03136068|76032607|FG000|NOT COMPLETED|Overall Study||2||
59911850|NCT03136068|76032608|FG001|NOT COMPLETED|Overall Study||1||
59911851|NCT02585232|76032616|FG000|STARTED|Overall Study||40|Dyads at Baseline in the CC group included n = 40 Caregivers and n = 32 Veterans with dementia. Dyads at Baseline in the CC+C group included n = 42 Caregivers and n = 30 Veterans with dementia.|
59911852|NCT02585232|76032617|FG001|STARTED|Overall Study||42|Dyads at Baseline in the CC group included n = 40 Caregivers and n = 32 Veterans with dementia. Dyads at Baseline in the CC+C group included n = 42 Caregivers and n = 30 Veterans with dementia.|
59911853|NCT02585232|76032616|FG000|COMPLETED|Overall Study||28|Dyads at 6-months in the CC group included n = 28 Caregivers and n = 17 Veterans with dementia. Dyads at 6-months in the CC+C group included n = 26 Caregivers and n = 16 Veterans with dementia.|
59911854|NCT02585232|76032617|FG001|COMPLETED|Overall Study||26|Dyads at 6-months in the CC group included n = 28 Caregivers and n = 17 Veterans with dementia. Dyads at 6-months in the CC+C group included n = 26 Caregivers and n = 16 Veterans with dementia.|
59911855|NCT02585232|76032616|FG000|NOT COMPLETED|Overall Study||12||
60019321|NCT02529553|76135250|FG000|STARTED|Overall Study||1||
60019322|NCT02529553|76135251|FG001|STARTED|Overall Study||1||
60019323|NCT02529553|76135252|FG002|STARTED|Overall Study||1||
60019324|NCT02529553|76135253|FG003|STARTED|Overall Study||3||
60019325|NCT02529553|76135254|FG004|STARTED|Overall Study||3||
60019326|NCT02529553|76135255|FG005|STARTED|Overall Study||4||
60019327|NCT02529553|76135256|FG006|STARTED|Overall Study||3||
60019328|NCT02529553|76135257|FG007|STARTED|Overall Study||6||
60019329|NCT02529553|76135258|FG008|STARTED|Overall Study||3||
60019330|NCT02529553|76135250|FG000|COMPLETED|Overall Study||0||
60019331|NCT02529553|76135251|FG001|COMPLETED|Overall Study||0||
60019332|NCT02529553|76135252|FG002|COMPLETED|Overall Study||0||
60019333|NCT02529553|76135253|FG003|COMPLETED|Overall Study||0||
60019334|NCT02529553|76135254|FG004|COMPLETED|Overall Study||0||
60019335|NCT02529553|76135255|FG005|COMPLETED|Overall Study||0||
60019336|NCT02529553|76135256|FG006|COMPLETED|Overall Study||0||
60019337|NCT02529553|76135257|FG007|COMPLETED|Overall Study||0||
60019338|NCT02529553|76135258|FG008|COMPLETED|Overall Study||0||
60019339|NCT02529553|76135250|FG000|NOT COMPLETED|Overall Study||1||
60019340|NCT02529553|76135251|FG001|NOT COMPLETED|Overall Study||1||
60019341|NCT02529553|76135252|FG002|NOT COMPLETED|Overall Study||1||
60019342|NCT02529553|76135253|FG003|NOT COMPLETED|Overall Study||3||
60019343|NCT02529553|76135254|FG004|NOT COMPLETED|Overall Study||3||
60019344|NCT02529553|76135255|FG005|NOT COMPLETED|Overall Study||4||
60019345|NCT02529553|76135256|FG006|NOT COMPLETED|Overall Study||3||
60019346|NCT02529553|76135257|FG007|NOT COMPLETED|Overall Study||6||
60019347|NCT02529553|76135258|FG008|NOT COMPLETED|Overall Study||3||
60019348|NCT02547935|76135282|FG000|STARTED|Overall Study||155|Patients randomised to 24-week double-blind treatment period.|
60019349|NCT02547935|76135283|FG001|STARTED|Overall Study||145|Patients randomised to 24-week double-blind treatment period.|
60019350|NCT02547935|76135284|FG002|STARTED|Overall Study||148|Patients randomised to 24-week double-blind treatment period.|
60019351|NCT02547935|76135282|FG000|Received Treatment|Overall Study||152||
60019352|NCT02547935|76135283|FG001|Received Treatment|Overall Study||145||
60019353|NCT02547935|76135284|FG002|Received Treatment|Overall Study||148||
60019354|NCT02547935|76135282|FG000|Full Analysis Set|Overall Study||152||
60019355|NCT02547935|76135283|FG001|Full Analysis Set|Overall Study||144||
60019356|NCT02547935|76135284|FG002|Full Analysis Set|Overall Study||148||
60019357|NCT02547935|76135282|FG000|Safety Analysis Set|Overall Study||152||
60019358|NCT02547935|76135283|FG001|Safety Analysis Set|Overall Study||145||
60019359|NCT02547935|76135284|FG002|Safety Analysis Set|Overall Study||148||
60019360|NCT02547935|76135282|FG000|COMPLETED|Overall Study||150||
60019361|NCT02547935|76135283|FG001|COMPLETED|Overall Study||137||
60019362|NCT02547935|76135284|FG002|COMPLETED|Overall Study||143||
60019363|NCT02547935|76135282|FG000|NOT COMPLETED|Overall Study||5||
60019364|NCT02547935|76135283|FG001|NOT COMPLETED|Overall Study||8||
60019365|NCT02547935|76135284|FG002|NOT COMPLETED|Overall Study||5||
60019366|NCT02554019|76135297|FG000|STARTED|Overall Study||12||
60019367|NCT02554019|76135298|FG001|STARTED|Overall Study||12||
60019368|NCT02554019|76135299|FG002|STARTED|Overall Study||12||
60019369|NCT02554019|76135297|FG000|COMPLETED|Overall Study||10||
60019370|NCT02554019|76135298|FG001|COMPLETED|Overall Study||12||
60019371|NCT02554019|76135299|FG002|COMPLETED|Overall Study||10||
60019372|NCT02554019|76135297|FG000|NOT COMPLETED|Overall Study||2||
60019373|NCT02554019|76135298|FG001|NOT COMPLETED|Overall Study||0||
60019374|NCT02554019|76135299|FG002|NOT COMPLETED|Overall Study||2||
60019375|NCT02327169|76135322|FG000|STARTED|Overall Study||4||
60019376|NCT02327169|76135323|FG001|STARTED|Overall Study||3||
60019377|NCT02327169|76135324|FG002|STARTED|Overall Study||7||
60019378|NCT02327169|76135325|FG003|STARTED|Overall Study||3||
60019379|NCT02327169|76135326|FG004|STARTED|Overall Study||8||
60019380|NCT02327169|76135327|FG005|STARTED|Overall Study||4||
60019381|NCT02327169|76135328|FG006|STARTED|Overall Study||3||
60019382|NCT02327169|76135329|FG007|STARTED|Overall Study||4||
60019383|NCT02327169|76135330|FG008|STARTED|Overall Study||6||
60019384|NCT02327169|76135331|FG009|STARTED|Overall Study||8||
60019385|NCT02327169|76135332|FG010|STARTED|Overall Study||6||
60019386|NCT02327169|76135333|FG011|STARTED|Overall Study||7||
60019387|NCT02327169|76135334|FG012|STARTED|Overall Study||1||
60019388|NCT02327169|76135335|FG013|STARTED|Overall Study||7||
60019389|NCT02327169|76135336|FG014|STARTED|Overall Study||10||
60019390|NCT02327169|76135322|FG000|COMPLETED|Overall Study||0||
60019391|NCT02327169|76135323|FG001|COMPLETED|Overall Study||0||
60019392|NCT02327169|76135324|FG002|COMPLETED|Overall Study||0||
60019393|NCT02327169|76135325|FG003|COMPLETED|Overall Study||0||
60019394|NCT02327169|76135326|FG004|COMPLETED|Overall Study||0||
60019395|NCT02327169|76135327|FG005|COMPLETED|Overall Study||0||
60019396|NCT02327169|76135328|FG006|COMPLETED|Overall Study||0||
60019397|NCT02327169|76135329|FG007|COMPLETED|Overall Study||0||
60019398|NCT02327169|76135330|FG008|COMPLETED|Overall Study||0||
60019399|NCT02327169|76135331|FG009|COMPLETED|Overall Study||0||
60019400|NCT02327169|76135332|FG010|COMPLETED|Overall Study||0||
60019401|NCT02327169|76135333|FG011|COMPLETED|Overall Study||0||
60019402|NCT02327169|76135334|FG012|COMPLETED|Overall Study||0||
60019403|NCT02327169|76135335|FG013|COMPLETED|Overall Study||0||
60019404|NCT02327169|76135336|FG014|COMPLETED|Overall Study||0||
60019405|NCT02327169|76135322|FG000|NOT COMPLETED|Overall Study||4||
60019406|NCT02327169|76135323|FG001|NOT COMPLETED|Overall Study||3||
60019407|NCT02327169|76135324|FG002|NOT COMPLETED|Overall Study||7||
60019408|NCT02327169|76135325|FG003|NOT COMPLETED|Overall Study||3||
60019409|NCT02327169|76135326|FG004|NOT COMPLETED|Overall Study||8||
60019410|NCT02327169|76135327|FG005|NOT COMPLETED|Overall Study||4||
60019411|NCT02327169|76135328|FG006|NOT COMPLETED|Overall Study||3||
60019412|NCT02327169|76135329|FG007|NOT COMPLETED|Overall Study||4||
60019413|NCT02327169|76135330|FG008|NOT COMPLETED|Overall Study||6||
60019414|NCT02327169|76135331|FG009|NOT COMPLETED|Overall Study||8||
60019415|NCT02327169|76135332|FG010|NOT COMPLETED|Overall Study||6||
60019416|NCT02327169|76135333|FG011|NOT COMPLETED|Overall Study||7||
60019417|NCT02327169|76135334|FG012|NOT COMPLETED|Overall Study||1||
60019418|NCT02327169|76135335|FG013|NOT COMPLETED|Overall Study||7||
60019419|NCT02327169|76135336|FG014|NOT COMPLETED|Overall Study||10||
60019420|NCT02327013|76135381|FG000|STARTED|Overall Study||49||
60019421|NCT02327013|76135382|FG001|STARTED|Overall Study||45||
60019422|NCT02327013|76135383|FG002|STARTED|Overall Study||96||
60019423|NCT02327013|76135384|FG003|STARTED|Overall Study||21||
60019424|NCT02327013|76135385|FG004|STARTED|Overall Study||16||
60019425|NCT02327013|76135381|FG000|COMPLETED|Overall Study||36||
60019426|NCT02327013|76135382|FG001|COMPLETED|Overall Study||29||
60019427|NCT02327013|76135383|FG002|COMPLETED|Overall Study||54||
60019428|NCT02327013|76135384|FG003|COMPLETED|Overall Study||20||
60019429|NCT02327013|76135385|FG004|COMPLETED|Overall Study||12||
60019430|NCT02327013|76135381|FG000|NOT COMPLETED|Overall Study||13||
60019431|NCT02327013|76135382|FG001|NOT COMPLETED|Overall Study||16||
60019432|NCT02327013|76135383|FG002|NOT COMPLETED|Overall Study||42||
60019433|NCT02327013|76135384|FG003|NOT COMPLETED|Overall Study||1||
60019434|NCT02327013|76135385|FG004|NOT COMPLETED|Overall Study||4||
60019435|NCT02301975|76135408|FG000|STARTED|Overall Study||504||
60019436|NCT02301975|76135409|FG001|STARTED|Overall Study||501||
60019437|NCT02301975|76135410|FG002|STARTED|Overall Study||499||
60019438|NCT02301975|76135408|FG000|COMPLETED|Overall Study||473||
60019439|NCT02301975|76135409|FG001|COMPLETED|Overall Study||476||
60019440|NCT02301975|76135410|FG002|COMPLETED|Overall Study||477||
60019441|NCT02301975|76135408|FG000|NOT COMPLETED|Overall Study||31||
60019442|NCT02301975|76135409|FG001|NOT COMPLETED|Overall Study||25||
60019443|NCT02301975|76135410|FG002|NOT COMPLETED|Overall Study||22||
60019444|NCT02301897|76135421|FG000|STARTED|Treatment Course 1||12||
60019445|NCT02301897|76135422|FG001|STARTED|Treatment Course 1||17||
60019446|NCT02301897|76135423|FG002|STARTED|Treatment Course 1||14||
60019447|NCT02301897|76135421|FG000|COMPLETED|Treatment Course 1||9||
60019448|NCT02301897|76135422|FG001|COMPLETED|Treatment Course 1||14||
60019449|NCT02301897|76135423|FG002|COMPLETED|Treatment Course 1||8||
60019450|NCT02301897|76135421|FG000|NOT COMPLETED|Treatment Course 1||3||
60019451|NCT02301897|76135422|FG001|NOT COMPLETED|Treatment Course 1||3||
60019452|NCT02301897|76135423|FG002|NOT COMPLETED|Treatment Course 1||6||
60019453|NCT02301897|76135421|FG000|STARTED|Treatment Course 2||9||
60019454|NCT02301897|76135422|FG001|STARTED|Treatment Course 2||14||
60019455|NCT02301897|76135423|FG002|STARTED|Treatment Course 2||8||
60019456|NCT02301897|76135421|FG000|COMPLETED|Treatment Course 2||8||
60019457|NCT02301897|76135422|FG001|COMPLETED|Treatment Course 2||9||
60019458|NCT02301897|76135423|FG002|COMPLETED|Treatment Course 2||7||
60019459|NCT02301897|76135421|FG000|NOT COMPLETED|Treatment Course 2||1||
60019460|NCT02301897|76135422|FG001|NOT COMPLETED|Treatment Course 2||5||
60019461|NCT02301897|76135423|FG002|NOT COMPLETED|Treatment Course 2||1||
60019462|NCT02301429|76135431|FG000|STARTED|Overall Study||16||
60019463|NCT02301429|76135431|FG000|COMPLETED|Overall Study||13||
60019464|NCT02301429|76135431|FG000|NOT COMPLETED|Overall Study||3||
60019465|NCT02300259|76135438|FG000|STARTED|Period 1||16||
60019466|NCT02300259|76135439|FG001|STARTED|Period 1||16||
60019467|NCT02300259|76135440|FG002|STARTED|Period 1||16||
60019468|NCT02300259|76135438|FG000|Received at Least One Dose of Study Drug|Period 1||16||
60019469|NCT02300259|76135439|FG001|Received at Least One Dose of Study Drug|Period 1||16||
60019470|NCT02300259|76135440|FG002|Received at Least One Dose of Study Drug|Period 1||16||
60019471|NCT02300259|76135438|FG000|COMPLETED|Period 1||16||
60019472|NCT02300259|76135439|FG001|COMPLETED|Period 1||16||
60019473|NCT02300259|76135440|FG002|COMPLETED|Period 1||14||
60019474|NCT02300259|76135438|FG000|NOT COMPLETED|Period 1||0||
60019475|NCT02300259|76135439|FG001|NOT COMPLETED|Period 1||0||
60019476|NCT02300259|76135440|FG002|NOT COMPLETED|Period 1||2||
60019477|NCT02300259|76135438|FG000|STARTED|Period 2||16||
59911856|NCT02585232|76032617|FG001|NOT COMPLETED|Overall Study||16||
59911857|NCT02556606|76032627|FG000|STARTED|Overall Study||4||
59911858|NCT02556606|76032628|FG001|STARTED|Overall Study||5||
59911859|NCT02556606|76032629|FG002|STARTED|Overall Study||11||
59911860|NCT02556606|76032630|FG003|STARTED|Overall Study||13||
59911861|NCT02556606|76032627|FG000|COMPLETED|Overall Study||4||
59911862|NCT02556606|76032628|FG001|COMPLETED|Overall Study||5||
59911863|NCT02556606|76032629|FG002|COMPLETED|Overall Study||11||
59911864|NCT02556606|76032630|FG003|COMPLETED|Overall Study||13||
59911865|NCT02556606|76032627|FG000|NOT COMPLETED|Overall Study||0||
59911866|NCT02556606|76032628|FG001|NOT COMPLETED|Overall Study||0||
59911867|NCT02556606|76032629|FG002|NOT COMPLETED|Overall Study||0||
59911868|NCT02556606|76032630|FG003|NOT COMPLETED|Overall Study||0||
59911869|NCT03377790|76032646|FG000|STARTED|Overall Study||160||
60019478|NCT02300259|76135439|FG001|STARTED|Period 2|There was no period 2 for Group 2.|0||
60019479|NCT02300259|76135440|FG002|STARTED|Period 2||14||
60019480|NCT02300259|76135438|FG000|COMPLETED|Period 2||15||
60019481|NCT02300259|76135439|FG001|COMPLETED|Period 2||0||
59911870|NCT03377790|76032647|FG001|STARTED|Overall Study||106||
59911871|NCT03377790|76032646|FG000|COMPLETED|Overall Study||150||
59911872|NCT03377790|76032647|FG001|COMPLETED|Overall Study||100||
59911873|NCT03377790|76032646|FG000|NOT COMPLETED|Overall Study||10||
59911874|NCT03377790|76032647|FG001|NOT COMPLETED|Overall Study||6||
59911875|NCT02717494|76032656|FG000|STARTED|First Intervention (Step 1)||115||
59911876|NCT02717494|76032657|FG001|STARTED|First Intervention (Step 1)||115||
59911877|NCT02717494|76032658|FG002|STARTED|First Intervention (Step 1)||116||
59911878|NCT02717494|76032656|FG000|Were Randomized to Step 2A (PPV-23)|First Intervention (Step 1)||0|Women who received Placebo in Step 1, and were randomized to Step 2A to receive PPV-23.|
59911879|NCT02717494|76032657|FG001|Were Randomized to Step 2A (PPV-23)|First Intervention (Step 1)||0|Women who received Placebo in Step 1, and were randomized to Step 2A to receive PPV-23.|
59911880|NCT02717494|76032658|FG002|Were Randomized to Step 2A (PPV-23)|First Intervention (Step 1)||53|Women who received Placebo in Step 1, and were randomized to Step 2A to receive PPV-23.|
59911881|NCT02717494|76032656|FG000|Were Randomized to Step 2B (PCV-10)|First Intervention (Step 1)||0|Women who received Placebo in Step 1, and were randomized to Step 2B to receive PCV-10.|
59911882|NCT02717494|76032657|FG001|Were Randomized to Step 2B (PCV-10)|First Intervention (Step 1)||0|Women who received Placebo in Step 1, and were randomized to Step 2B to receive PCV-10.|
59911883|NCT02717494|76032658|FG002|Were Randomized to Step 2B (PCV-10)|First Intervention (Step 1)||53|Women who received Placebo in Step 1, and were randomized to Step 2B to receive PCV-10.|
60019482|NCT02300259|76135440|FG002|COMPLETED|Period 2||13||
60019483|NCT02300259|76135438|FG000|NOT COMPLETED|Period 2||1||
59611575|NCT01757184|75722569|FG001|NOT COMPLETED|Double-blind Period||0||
59611576|NCT01757184|75722570|FG002|NOT COMPLETED|Double-blind Period||0||
59911884|NCT02717494|76032656|FG000|Were Enrolled in Step 3 (PCV-10)|First Intervention (Step 1)||0|Women who received Placebo in Step 1 but were pregnant again, enrolled in Step 3.|
60019484|NCT02300259|76135439|FG001|NOT COMPLETED|Period 2||0||
60019485|NCT02300259|76135440|FG002|NOT COMPLETED|Period 2||1||
60019486|NCT02367885|76135462|FG000|STARTED|Overall Study||33||
60019487|NCT02367885|76135463|FG001|STARTED|Overall Study||33||
60019488|NCT02367885|76135464|FG002|STARTED|Overall Study||33||
60019489|NCT02367885|76135462|FG000|COMPLETED|Overall Study||31||
60019490|NCT02367885|76135463|FG001|COMPLETED|Overall Study||33||
60019491|NCT02367885|76135464|FG002|COMPLETED|Overall Study||33||
59611577|NCT01757184|75722571|FG003|NOT COMPLETED|Double-blind Period||0||
59611578|NCT01757184|75722568|FG000|STARTED|Open-label Period||0||
59758754|NCT04138056|75878025|FG002|NOT COMPLETED|Extension Study||1||
60019492|NCT02367885|76135462|FG000|NOT COMPLETED|Overall Study||2||
59911885|NCT02717494|76032657|FG001|Were Enrolled in Step 3 (PCV-10)|First Intervention (Step 1)||0|Women who received Placebo in Step 1 but were pregnant again, enrolled in Step 3.|
59911886|NCT02717494|76032658|FG002|Were Enrolled in Step 3 (PCV-10)|First Intervention (Step 1)||4|Women who received Placebo in Step 1 but were pregnant again, enrolled in Step 3.|
59911887|NCT02717494|76032656|FG000|COMPLETED|First Intervention (Step 1)||109||
59911888|NCT02717494|76032657|FG001|COMPLETED|First Intervention (Step 1)||108||
59911889|NCT02717494|76032658|FG002|COMPLETED|First Intervention (Step 1)||111||
59911890|NCT02717494|76032656|FG000|NOT COMPLETED|First Intervention (Step 1)||6||
59911891|NCT02717494|76032657|FG001|NOT COMPLETED|First Intervention (Step 1)||7||
59611579|NCT01757184|75722569|FG001|STARTED|Open-label Period||0||
59611580|NCT01757184|75722570|FG002|STARTED|Open-label Period|1 participant who did not complete Double-blind Period due to AE rechallenged for Open-label Period|36||
59611581|NCT01757184|75722571|FG003|STARTED|Open-label Period||30||
59911892|NCT02717494|76032658|FG002|NOT COMPLETED|First Intervention (Step 1)||5||
59911893|NCT02717494|76032656|FG000|STARTED|Second Intervention (Step 2 or Step 3)|Only Step 1 placebo recipients were enrolled in Step 2.|0||
59911894|NCT02717494|76032657|FG001|STARTED|Second Intervention (Step 2 or Step 3)|Only Step 1 placebo recipients were enrolled in Step 2.|0||
59911895|NCT02717494|76032658|FG002|STARTED|Second Intervention (Step 2 or Step 3)|One participant who completed Step 1 did not enroll in Step 2.|110||
60019493|NCT02367885|76135463|FG001|NOT COMPLETED|Overall Study||0||
59611582|NCT01757184|75722568|FG000|Received at Least 1 Dose of Study Drug|Open-label Period||0||
59611583|NCT01757184|75722569|FG001|Received at Least 1 Dose of Study Drug|Open-label Period||0||
59611584|NCT01757184|75722570|FG002|Received at Least 1 Dose of Study Drug|Open-label Period||36||
59611585|NCT01757184|75722571|FG003|Received at Least 1 Dose of Study Drug|Open-label Period||30||
59611586|NCT01757184|75722568|FG000|COMPLETED|Open-label Period||0||
60019494|NCT02367885|76135464|FG002|NOT COMPLETED|Overall Study||0||
60019495|NCT02367729|76135477|FG000|STARTED|Overall Study||60||
60019496|NCT02367729|76135478|FG001|STARTED|Overall Study||55||
60019497|NCT02367729|76135477|FG000|COMPLETED|Overall Study||57||
60019498|NCT02367729|76135478|FG001|COMPLETED|Overall Study||47||
60019499|NCT02367729|76135477|FG000|NOT COMPLETED|Overall Study||3||
60019500|NCT02367729|76135478|FG001|NOT COMPLETED|Overall Study||8||
60019501|NCT02366637|76135485|FG000|STARTED|First Intervention Period||7||
60019502|NCT02366637|76135486|FG001|STARTED|First Intervention Period||6||
60019503|NCT02366637|76135485|FG000|COMPLETED|First Intervention Period||1||
60019504|NCT02366637|76135486|FG001|COMPLETED|First Intervention Period||1||
60019505|NCT02366637|76135485|FG000|NOT COMPLETED|First Intervention Period||6||
60019506|NCT02366637|76135486|FG001|NOT COMPLETED|First Intervention Period||5||
60019507|NCT02366637|76135485|FG000|STARTED|Washout Period 28 to 49 Days||1||
60019508|NCT02366637|76135486|FG001|STARTED|Washout Period 28 to 49 Days||1||
60019509|NCT02366637|76135485|FG000|COMPLETED|Washout Period 28 to 49 Days||1||
60019510|NCT02366637|76135486|FG001|COMPLETED|Washout Period 28 to 49 Days||1||
60019511|NCT02366637|76135485|FG000|NOT COMPLETED|Washout Period 28 to 49 Days||0||
60019512|NCT02366637|76135486|FG001|NOT COMPLETED|Washout Period 28 to 49 Days||0||
60019513|NCT02366637|76135485|FG000|STARTED|Second Intervention Period||1||
60019514|NCT02366637|76135486|FG001|STARTED|Second Intervention Period||1||
60019515|NCT02366637|76135485|FG000|COMPLETED|Second Intervention Period||0||
60019516|NCT02366637|76135486|FG001|COMPLETED|Second Intervention Period||0||
60019517|NCT02366637|76135485|FG000|NOT COMPLETED|Second Intervention Period||1||
60019518|NCT02366637|76135486|FG001|NOT COMPLETED|Second Intervention Period||1||
60019519|NCT02300103|76135492|FG000|STARTED|Overall Study||69||
60019520|NCT02300103|76135492|FG000|COMPLETED|Overall Study||63||
60019521|NCT02300103|76135492|FG000|NOT COMPLETED|Overall Study||6||
60019522|NCT02326467|76135496|FG000|STARTED|Overall Study||10||
60019523|NCT02326467|76135496|FG000|COMPLETED|Overall Study||9||
60019524|NCT02326467|76135496|FG000|NOT COMPLETED|Overall Study||1||
60019525|NCT02299635|76135501|FG000|STARTED|Overall Study||19||
60019526|NCT02299635|76135501|FG000|COMPLETED|Overall Study||0||
60019527|NCT02299635|76135501|FG000|NOT COMPLETED|Overall Study||19||
60019528|NCT02366091|76135509|FG000|STARTED|Overall Study||24||
60019529|NCT02366091|76135510|FG001|STARTED|Overall Study||23||
60019530|NCT02366091|76135511|FG002|STARTED|Overall Study||24||
59611587|NCT01757184|75722569|FG001|COMPLETED|Open-label Period||0||
59911896|NCT02717494|76032656|FG000|Completed Step 2A|Second Intervention (Step 2 or Step 3)||0||
59911897|NCT02717494|76032657|FG001|Completed Step 2A|Second Intervention (Step 2 or Step 3)||0||
60019531|NCT02366091|76135512|FG003|STARTED|Overall Study||23||
60019532|NCT02366091|76135509|FG000|COMPLETED|Overall Study||21||
60019533|NCT02366091|76135510|FG001|COMPLETED|Overall Study||16||
59611588|NCT01757184|75722570|FG002|COMPLETED|Open-label Period||32||
59611589|NCT01757184|75722571|FG003|COMPLETED|Open-label Period||27||
59611590|NCT01757184|75722568|FG000|NOT COMPLETED|Open-label Period||0||
59611591|NCT01757184|75722569|FG001|NOT COMPLETED|Open-label Period||0||
59911898|NCT02717494|76032658|FG002|Completed Step 2A|Second Intervention (Step 2 or Step 3)||52||
59911899|NCT02717494|76032656|FG000|Completed Step 2B|Second Intervention (Step 2 or Step 3)||0||
59911900|NCT02717494|76032657|FG001|Completed Step 2B|Second Intervention (Step 2 or Step 3)||0||
59911901|NCT02717494|76032658|FG002|Completed Step 2B|Second Intervention (Step 2 or Step 3)||50||
59911902|NCT02717494|76032656|FG000|Completed Step 3|Second Intervention (Step 2 or Step 3)||0||
59911903|NCT02717494|76032657|FG001|Completed Step 3|Second Intervention (Step 2 or Step 3)||0||
59911904|NCT02717494|76032658|FG002|Completed Step 3|Second Intervention (Step 2 or Step 3)||4||
59911905|NCT02717494|76032656|FG000|COMPLETED|Second Intervention (Step 2 or Step 3)||0||
59911906|NCT02717494|76032657|FG001|COMPLETED|Second Intervention (Step 2 or Step 3)||0||
59911907|NCT02717494|76032658|FG002|COMPLETED|Second Intervention (Step 2 or Step 3)||106||
59911908|NCT02717494|76032656|FG000|NOT COMPLETED|Second Intervention (Step 2 or Step 3)||0||
59911909|NCT02717494|76032657|FG001|NOT COMPLETED|Second Intervention (Step 2 or Step 3)||0||
59911910|NCT02717494|76032658|FG002|NOT COMPLETED|Second Intervention (Step 2 or Step 3)||4||
59911911|NCT01844856|76032686|FG000|STARTED|Overall Study||270||
59911912|NCT01844856|76032687|FG001|STARTED|Overall Study||271||
59911913|NCT01844856|76032686|FG000|Received at Least 1 Dose of Study Drug|Overall Study||270||
59911914|NCT01844856|76032687|FG001|Received at Least 1 Dose of Study Drug|Overall Study||268||
59911915|NCT01844856|76032686|FG000|COMPLETED|Overall Study||246||
59911916|NCT01844856|76032687|FG001|COMPLETED|Overall Study||255||
59911917|NCT01844856|76032686|FG000|NOT COMPLETED|Overall Study||24||
59911918|NCT01844856|76032687|FG001|NOT COMPLETED|Overall Study||16||
59911919|NCT00618098|76032695|FG000|STARTED|Overall Study||97||
59911920|NCT00618098|76032696|FG001|STARTED|Overall Study||103||
59911921|NCT00618098|76032695|FG000|COMPLETED|Overall Study||66||
59911922|NCT00618098|76032696|FG001|COMPLETED|Overall Study||69||
59911923|NCT00618098|76032695|FG000|NOT COMPLETED|Overall Study||31||
59911924|NCT00618098|76032696|FG001|NOT COMPLETED|Overall Study||34||
59911925|NCT01788306|76032708|FG000|STARTED|Overall Study||125||
59911926|NCT01788306|76032709|FG001|STARTED|Overall Study||131||
59911927|NCT01788306|76032708|FG000|COMPLETED|Overall Study||115||
59911928|NCT01788306|76032709|FG001|COMPLETED|Overall Study||126||
59911929|NCT01788306|76032708|FG000|NOT COMPLETED|Overall Study||10||
59911930|NCT01788306|76032709|FG001|NOT COMPLETED|Overall Study||5||
59911931|NCT03135210|76032723|FG000|STARTED|Overall Study||2||
59911932|NCT03135210|76032724|FG001|STARTED|Overall Study||2||
59911933|NCT03135210|76032723|FG000|COMPLETED|Overall Study||2||
59911934|NCT03135210|76032724|FG001|COMPLETED|Overall Study||1||
59911935|NCT03135210|76032723|FG000|NOT COMPLETED|Overall Study||0||
59911936|NCT03135210|76032724|FG001|NOT COMPLETED|Overall Study||1||
59911937|NCT00701662|76032730|FG000|STARTED|Overall Study||8||
59911938|NCT00701662|76032730|FG000|COMPLETED|Overall Study||7||
59911939|NCT00701662|76032730|FG000|NOT COMPLETED|Overall Study||1||
59911940|NCT02878590|76032734|FG000|STARTED|Overall Study||12||
59911941|NCT02878590|76032734|FG000|COMPLETED|Overall Study||10||
59911942|NCT02878590|76032734|FG000|NOT COMPLETED|Overall Study||2||
59911943|NCT04634409|76032765|FG000|STARTED|Overall Study||155||
59911944|NCT04634409|76032766|FG001|STARTED|Overall Study||83||
59911945|NCT04634409|76032767|FG002|STARTED|Overall Study||158||
59911946|NCT04634409|76032768|FG003|STARTED|Overall Study||103||
59911947|NCT04634409|76032769|FG004|STARTED|Overall Study||105||
59911948|NCT04634409|76032770|FG005|STARTED|Overall Study||101||
59911949|NCT04634409|76032771|FG006|STARTED|Overall Study|During the study period, 20 participants from the BAM 175-mg + ETE 350-mg arm potentially received 700 mg bamlanivimab + 700 mg etesevimab instead. These 20 participants, who were randomized at 8 different sites were identified through pharmacokinetics analyses.|20||
59911950|NCT04634409|76032772|FG007|STARTED|Overall Study||101||
59911951|NCT04634409|76032773|FG008|STARTED|Overall Study||101||
59911952|NCT04634409|76032774|FG009|STARTED|Overall Study||125||
59911953|NCT04634409|76032775|FG010|STARTED|Overall Study||127||
59911954|NCT04634409|76032776|FG011|STARTED|Overall Study||128||
59911955|NCT04634409|76032777|FG012|STARTED|Overall Study||100||
59911956|NCT04634409|76032778|FG013|STARTED|Overall Study||50||
59911957|NCT04634409|76032779|FG014|STARTED|Overall Study||176||
59911958|NCT04634409|76032780|FG015|STARTED|Overall Study||30||
59911959|NCT04634409|76032781|FG016|STARTED|Overall Study||6||
59911960|NCT04634409|76032782|FG017|STARTED|Overall Study||30||
59911961|NCT04634409|76032783|FG018|STARTED|Overall Study||10||
59911962|NCT04634409|76032784|FG019|STARTED|Overall Study||6||
59911963|NCT04634409|76032785|FG020|STARTED|Overall Study||6||
59911964|NCT04634409|76032786|FG021|STARTED|Overall Study||6||
59911965|NCT04634409|76032787|FG022|STARTED|Overall Study||6||
59911966|NCT04634409|76032788|FG023|STARTED|Overall Study||6||
59911967|NCT04634409|76032789|FG024|STARTED|Overall Study||4||
59911968|NCT04634409|76032790|FG025|STARTED|Overall Study||6||
59911969|NCT04634409|76032791|FG026|STARTED|Overall Study||6||
59911970|NCT04634409|76032765|FG000|Received at Least One Dose of Study Drug|Overall Study||155||
59911971|NCT04634409|76032766|FG001|Received at Least One Dose of Study Drug|Overall Study||83||
59911972|NCT04634409|76032767|FG002|Received at Least One Dose of Study Drug|Overall Study||158||
59911973|NCT04634409|76032768|FG003|Received at Least One Dose of Study Drug|Overall Study||103||
59911974|NCT04634409|76032769|FG004|Received at Least One Dose of Study Drug|Overall Study||105||
59911975|NCT04634409|76032770|FG005|Received at Least One Dose of Study Drug|Overall Study||101||
60019534|NCT02366091|76135511|FG002|COMPLETED|Overall Study||21||
59911976|NCT04634409|76032771|FG006|Received at Least One Dose of Study Drug|Overall Study||20||
59911977|NCT04634409|76032772|FG007|Received at Least One Dose of Study Drug|Overall Study||101||
59911978|NCT04634409|76032773|FG008|Received at Least One Dose of Study Drug|Overall Study||101||
59911979|NCT04634409|76032774|FG009|Received at Least One Dose of Study Drug|Overall Study||125||
59911980|NCT04634409|76032775|FG010|Received at Least One Dose of Study Drug|Overall Study||127||
59911981|NCT04634409|76032776|FG011|Received at Least One Dose of Study Drug|Overall Study||128||
59911982|NCT04634409|76032777|FG012|Received at Least One Dose of Study Drug|Overall Study||100||
59911983|NCT04634409|76032778|FG013|Received at Least One Dose of Study Drug|Overall Study||50||
59911984|NCT04634409|76032779|FG014|Received at Least One Dose of Study Drug|Overall Study||176||
59911985|NCT04634409|76032780|FG015|Received at Least One Dose of Study Drug|Overall Study||30||
59911986|NCT04634409|76032781|FG016|Received at Least One Dose of Study Drug|Overall Study||6||
59911987|NCT04634409|76032782|FG017|Received at Least One Dose of Study Drug|Overall Study||30||
59911988|NCT04634409|76032783|FG018|Received at Least One Dose of Study Drug|Overall Study||10||
59911989|NCT04634409|76032784|FG019|Received at Least One Dose of Study Drug|Overall Study||6||
59911990|NCT04634409|76032785|FG020|Received at Least One Dose of Study Drug|Overall Study||6||
59911991|NCT04634409|76032786|FG021|Received at Least One Dose of Study Drug|Overall Study||6||
59911992|NCT04634409|76032787|FG022|Received at Least One Dose of Study Drug|Overall Study||6||
60019535|NCT02366091|76135512|FG003|COMPLETED|Overall Study||22||
60019536|NCT02366091|76135509|FG000|NOT COMPLETED|Overall Study||3||
60019537|NCT02366091|76135510|FG001|NOT COMPLETED|Overall Study||7||
60019538|NCT02366091|76135511|FG002|NOT COMPLETED|Overall Study||3||
60019539|NCT02366091|76135512|FG003|NOT COMPLETED|Overall Study||1||
60019540|NCT02326155|76135524|FG000|STARTED|Overall Study||407||
60019541|NCT02326155|76135525|FG001|STARTED|Overall Study||63||
60019542|NCT02326155|76135524|FG000|COMPLETED|Overall Study||13||
60019543|NCT02326155|76135525|FG001|COMPLETED|Overall Study||1||
60019544|NCT02326155|76135524|FG000|NOT COMPLETED|Overall Study||394||
60019545|NCT02326155|76135525|FG001|NOT COMPLETED|Overall Study||62||
59911993|NCT04634409|76032788|FG023|Received at Least One Dose of Study Drug|Overall Study||6||
59911994|NCT04634409|76032789|FG024|Received at Least One Dose of Study Drug|Overall Study||4||
59911995|NCT04634409|76032790|FG025|Received at Least One Dose of Study Drug|Overall Study||6||
59911996|NCT04634409|76032791|FG026|Received at Least One Dose of Study Drug|Overall Study||6||
59911997|NCT04634409|76032765|FG000|COMPLETED|Overall Study||148||
59911998|NCT04634409|76032766|FG001|COMPLETED|Overall Study||81||
59911999|NCT04634409|76032767|FG002|COMPLETED|Overall Study||150||
59912000|NCT04634409|76032768|FG003|COMPLETED|Overall Study||96||
59912001|NCT04634409|76032769|FG004|COMPLETED|Overall Study||102||
59912002|NCT04634409|76032770|FG005|COMPLETED|Overall Study||99||
59912003|NCT04634409|76032771|FG006|COMPLETED|Overall Study||19||
59912004|NCT04634409|76032772|FG007|COMPLETED|Overall Study||90||
59912005|NCT04634409|76032773|FG008|COMPLETED|Overall Study||91||
59912006|NCT04634409|76032774|FG009|COMPLETED|Overall Study||112||
59912007|NCT04634409|76032775|FG010|COMPLETED|Overall Study||114||
59912008|NCT04634409|76032776|FG011|COMPLETED|Overall Study||109||
59912009|NCT04634409|76032777|FG012|COMPLETED|Overall Study||92||
59912010|NCT04634409|76032778|FG013|COMPLETED|Overall Study||46||
59912011|NCT04634409|76032779|FG014|COMPLETED|Overall Study||164||
59912012|NCT04634409|76032780|FG015|COMPLETED|Overall Study||30||
59912013|NCT04634409|76032781|FG016|COMPLETED|Overall Study||6||
59912014|NCT04634409|76032782|FG017|COMPLETED|Overall Study||29||
59912015|NCT04634409|76032783|FG018|COMPLETED|Overall Study||10||
59912016|NCT04634409|76032784|FG019|COMPLETED|Overall Study||6||
59912017|NCT04634409|76032785|FG020|COMPLETED|Overall Study||6||
59912018|NCT04634409|76032786|FG021|COMPLETED|Overall Study||6||
59912019|NCT04634409|76032787|FG022|COMPLETED|Overall Study||6||
59912020|NCT04634409|76032788|FG023|COMPLETED|Overall Study||5||
59912021|NCT04634409|76032789|FG024|COMPLETED|Overall Study||4||
59912022|NCT04634409|76032790|FG025|COMPLETED|Overall Study||6||
60019546|NCT02299167|76135531|FG000|STARTED|Overall Study||35||
59912023|NCT04634409|76032791|FG026|COMPLETED|Overall Study||6||
59912024|NCT04634409|76032765|FG000|NOT COMPLETED|Overall Study||7||
59912025|NCT04634409|76032766|FG001|NOT COMPLETED|Overall Study||2||
59912026|NCT04634409|76032767|FG002|NOT COMPLETED|Overall Study||8||
59912027|NCT04634409|76032768|FG003|NOT COMPLETED|Overall Study||7||
59912028|NCT04634409|76032769|FG004|NOT COMPLETED|Overall Study||3||
59912029|NCT04634409|76032770|FG005|NOT COMPLETED|Overall Study||2||
59912030|NCT04634409|76032771|FG006|NOT COMPLETED|Overall Study||1||
59912031|NCT04634409|76032772|FG007|NOT COMPLETED|Overall Study||11||
59912032|NCT04634409|76032773|FG008|NOT COMPLETED|Overall Study||10||
59912033|NCT04634409|76032774|FG009|NOT COMPLETED|Overall Study||13||
59912034|NCT04634409|76032775|FG010|NOT COMPLETED|Overall Study||13||
59912035|NCT04634409|76032776|FG011|NOT COMPLETED|Overall Study||19||
59912036|NCT04634409|76032777|FG012|NOT COMPLETED|Overall Study||8||
59912037|NCT04634409|76032778|FG013|NOT COMPLETED|Overall Study||4||
59912038|NCT04634409|76032779|FG014|NOT COMPLETED|Overall Study||12||
59912039|NCT04634409|76032780|FG015|NOT COMPLETED|Overall Study||0||
59912040|NCT04634409|76032781|FG016|NOT COMPLETED|Overall Study||0||
59912041|NCT04634409|76032782|FG017|NOT COMPLETED|Overall Study||1||
59912042|NCT04634409|76032783|FG018|NOT COMPLETED|Overall Study||0||
59912043|NCT04634409|76032784|FG019|NOT COMPLETED|Overall Study||0||
59912044|NCT04634409|76032785|FG020|NOT COMPLETED|Overall Study||0||
59912045|NCT04634409|76032786|FG021|NOT COMPLETED|Overall Study||0||
59912046|NCT04634409|76032787|FG022|NOT COMPLETED|Overall Study||0||
59912047|NCT04634409|76032788|FG023|NOT COMPLETED|Overall Study||1||
59912048|NCT04634409|76032789|FG024|NOT COMPLETED|Overall Study||0||
59912049|NCT04634409|76032790|FG025|NOT COMPLETED|Overall Study||0||
59912050|NCT04634409|76032791|FG026|NOT COMPLETED|Overall Study||0||
59912051|NCT00005780|76032869|FG000|STARTED|EPOCH-R Administration||26||
59912052|NCT00005780|76032869|FG000|COMPLETED|EPOCH-R Administration|26 completed the EPOCH-R treatment and 23/26 moved on to vaccine treatment.|26||
59912053|NCT00005780|76032869|FG000|NOT COMPLETED|EPOCH-R Administration||0||
59912054|NCT00005780|76032869|FG000|STARTED|Vaccine Administration Following EPOCH-R||24||
59912055|NCT00005780|76032869|FG000|COMPLETED|Vaccine Administration Following EPOCH-R||23||
59912056|NCT00005780|76032869|FG000|NOT COMPLETED|Vaccine Administration Following EPOCH-R||1||
59912057|NCT01978938|76032878|FG000|STARTED|Overall Study||455||
59912058|NCT01978938|76032879|FG001|STARTED|Overall Study||453||
59912059|NCT01978938|76032878|FG000|Received at Least 1 Dose of Study Drug|Overall Study||454|1 participant in the eravacycline group and 2 in the levofloxacin group did not receive study drug.|
59912060|NCT01978938|76032879|FG001|Received at Least 1 Dose of Study Drug|Overall Study||451|1 participant in the eravacycline group and 2 in the levofloxacin group did not receive study drug.|
59912061|NCT01978938|76032878|FG000|COMPLETED|Overall Study||432||
59912062|NCT01978938|76032879|FG001|COMPLETED|Overall Study||439||
59912063|NCT01978938|76032878|FG000|NOT COMPLETED|Overall Study||23||
59912064|NCT01978938|76032879|FG001|NOT COMPLETED|Overall Study||14||
59912065|NCT03041090|76032887|FG000|STARTED|Overall Study||109||
59912066|NCT03041090|76032888|FG001|STARTED|Overall Study||24||
59912067|NCT03041090|76032887|FG000|COMPLETED|Overall Study||109||
59912068|NCT03041090|76032888|FG001|COMPLETED|Overall Study|3 consented subjects in the dynamic arm were not included in analysis due to technical errors.|21||
59912069|NCT03041090|76032887|FG000|NOT COMPLETED|Overall Study||0||
59912070|NCT03041090|76032888|FG001|NOT COMPLETED|Overall Study||3||
59912071|NCT00116142|76032896|FG000|STARTED|Overall Study||175||
59912072|NCT00116142|76032897|FG001|STARTED|Overall Study||175||
59912073|NCT00116142|76032896|FG000|Treated|Overall Study||174||
59912074|NCT00116142|76032897|FG001|Treated|Overall Study||171||
59912075|NCT00116142|76032896|FG000|COMPLETED|Overall Study||156||
59912076|NCT00116142|76032897|FG001|COMPLETED|Overall Study||155||
59912077|NCT00116142|76032896|FG000|NOT COMPLETED|Overall Study||19||
59912078|NCT00116142|76032897|FG001|NOT COMPLETED|Overall Study||20||
59912079|NCT03135522|76032908|FG000|STARTED|Overall Study||17||
59912080|NCT03135522|76032909|FG001|STARTED|Overall Study||17||
59912081|NCT03135522|76032908|FG000|COMPLETED|Overall Study||16||
59912082|NCT03135522|76032909|FG001|COMPLETED|Overall Study||17||
59912083|NCT03135522|76032908|FG000|NOT COMPLETED|Overall Study||1||
59912084|NCT03135522|76032909|FG001|NOT COMPLETED|Overall Study||0||
59912085|NCT02023905|76032918|FG000|STARTED|Overall Study||16||
59912086|NCT02023905|76032919|FG001|STARTED|Overall Study||2||
59912087|NCT02023905|76032920|FG002|STARTED|Overall Study||9||
59912088|NCT02023905|76032918|FG000|COMPLETED|Overall Study||16||
59912089|NCT02023905|76032919|FG001|COMPLETED|Overall Study|One participant went off treatment after a few days of beginning therapy due to adverse events, but is included in the efficacy analysis as completed under the intent-to-treat (ITT) model.|2||
59912090|NCT02023905|76032920|FG002|COMPLETED|Overall Study||9||
59912091|NCT02023905|76032918|FG000|NOT COMPLETED|Overall Study||0||
59912092|NCT02023905|76032919|FG001|NOT COMPLETED|Overall Study||0||
59912093|NCT02023905|76032920|FG002|NOT COMPLETED|Overall Study||0||
59912094|NCT02875080|76032932|FG000|STARTED|Overall Study||6||
59912095|NCT02875080|76032933|FG001|STARTED|Overall Study||6||
59912096|NCT02875080|76032934|FG002|STARTED|Overall Study||6||
59912097|NCT02875080|76032932|FG000|COMPLETED|Overall Study||4||
59912098|NCT02875080|76032933|FG001|COMPLETED|Overall Study||6||
59912099|NCT02875080|76032934|FG002|COMPLETED|Overall Study||6||
60019547|NCT02299167|76135531|FG000|Dural Puncture|Overall Study||24|Dural puncture to inject the study drug|
60019548|NCT02299167|76135531|FG000|Success Rate|Overall Study||24|10 min after Dural puncture (to test the success of the block)|
60019549|NCT02299167|76135531|FG000|Adverse Effects|Overall Study||24|24 after surgery to record any complication|
60019550|NCT02299167|76135531|FG000|COMPLETED|Overall Study||24||
60019551|NCT02299167|76135531|FG000|NOT COMPLETED|Overall Study||11||
60019552|NCT01647711|76135540|FG000|STARTED|Overall Study||6||
60019553|NCT01647711|76135541|FG001|STARTED|Overall Study||3||
60019554|NCT01647711|76135542|FG002|STARTED|Overall Study||9||
60019555|NCT01647711|76135543|FG003|STARTED|Overall Study||11||
60019556|NCT01647711|76135544|FG004|STARTED|Overall Study||6||
60019557|NCT01647711|76135540|FG000|COMPLETED|Overall Study||0||
60019558|NCT01647711|76135541|FG001|COMPLETED|Overall Study||0||
60019559|NCT01647711|76135542|FG002|COMPLETED|Overall Study||0||
60019560|NCT01647711|76135543|FG003|COMPLETED|Overall Study||0||
60019561|NCT01647711|76135544|FG004|COMPLETED|Overall Study||0||
60019562|NCT01647711|76135540|FG000|NOT COMPLETED|Overall Study||6||
60019563|NCT01647711|76135541|FG001|NOT COMPLETED|Overall Study||3||
60019564|NCT01647711|76135542|FG002|NOT COMPLETED|Overall Study||9||
60019565|NCT01647711|76135543|FG003|NOT COMPLETED|Overall Study||11||
60019566|NCT01647711|76135544|FG004|NOT COMPLETED|Overall Study||6||
60019567|NCT02547233|76135560|FG000|STARTED|3-day Treatment and 8-week Follow-up||205||
60019568|NCT02547233|76135561|FG001|STARTED|3-day Treatment and 8-week Follow-up||102||
60019569|NCT02547233|76135560|FG000|Treated|3-day Treatment and 8-week Follow-up||205||
60019570|NCT02547233|76135561|FG001|Treated|3-day Treatment and 8-week Follow-up||100||
60019571|NCT02547233|76135560|FG000|COMPLETED|3-day Treatment and 8-week Follow-up||203||
60019572|NCT02547233|76135561|FG001|COMPLETED|3-day Treatment and 8-week Follow-up||92||
60019573|NCT02547233|76135560|FG000|NOT COMPLETED|3-day Treatment and 8-week Follow-up||2||
60019574|NCT02547233|76135561|FG001|NOT COMPLETED|3-day Treatment and 8-week Follow-up||10||
60019575|NCT02547233|76135560|FG000|STARTED|12-month Follow-up||199||
60019576|NCT02547233|76135561|FG001|STARTED|12-month Follow-up||84||
60019577|NCT02547233|76135560|FG000|COMPLETED|12-month Follow-up||185||
60019578|NCT02547233|76135561|FG001|COMPLETED|12-month Follow-up||67||
60019579|NCT02547233|76135560|FG000|NOT COMPLETED|12-month Follow-up||14||
60019580|NCT02547233|76135561|FG001|NOT COMPLETED|12-month Follow-up||17||
60019581|NCT05476679|76135574|FG000|STARTED|Overall Study||8||
60019582|NCT05476679|76135575|FG001|STARTED|Overall Study||10||
60019583|NCT05476679|76135576|FG002|STARTED|Overall Study||9||
60019584|NCT05476679|76135577|FG003|STARTED|Overall Study||11||
60019585|NCT05476679|76135578|FG004|STARTED|Overall Study||10||
60019586|NCT05476679|76135574|FG000|COMPLETED|Overall Study||8||
60019587|NCT05476679|76135575|FG001|COMPLETED|Overall Study||10||
60019588|NCT05476679|76135576|FG002|COMPLETED|Overall Study||9||
60019589|NCT05476679|76135577|FG003|COMPLETED|Overall Study||9||
60019590|NCT05476679|76135578|FG004|COMPLETED|Overall Study||10||
60019591|NCT05476679|76135574|FG000|NOT COMPLETED|Overall Study||0||
60019592|NCT05476679|76135575|FG001|NOT COMPLETED|Overall Study||0||
60019593|NCT05476679|76135576|FG002|NOT COMPLETED|Overall Study||0||
60019594|NCT05476679|76135577|FG003|NOT COMPLETED|Overall Study||2||
60019595|NCT05476679|76135578|FG004|NOT COMPLETED|Overall Study||0||
60019596|NCT02546765|76135596|FG000|STARTED|Overall Study||31||
60019597|NCT02546765|76135597|FG001|STARTED|Overall Study||30||
60019598|NCT02546765|76135598|FG002|STARTED|Overall Study||30||
60019599|NCT02546765|76135599|FG003|STARTED|Overall Study||30||
60019600|NCT02546765|76135596|FG000|COMPLETED|Overall Study||31||
60019601|NCT02546765|76135597|FG001|COMPLETED|Overall Study|29 Received study drug; 1 withdrew before surgery and after randomization|29||
60019602|NCT02546765|76135598|FG002|COMPLETED|Overall Study||30||
60019603|NCT02546765|76135599|FG003|COMPLETED|Overall Study||30||
60019604|NCT02546765|76135596|FG000|NOT COMPLETED|Overall Study||0||
60019605|NCT02546765|76135597|FG001|NOT COMPLETED|Overall Study||1||
60019606|NCT02546765|76135598|FG002|NOT COMPLETED|Overall Study||0||
60019607|NCT02546765|76135599|FG003|NOT COMPLETED|Overall Study||0||
60019608|NCT02553629|76135622|FG000|STARTED|Overall Study||53||
60019609|NCT02553629|76135623|FG001|STARTED|Overall Study||56||
60019610|NCT02553629|76135622|FG000|COMPLETED|Overall Study||50||
60019611|NCT02553629|76135623|FG001|COMPLETED|Overall Study||50||
60019612|NCT02553629|76135622|FG000|NOT COMPLETED|Overall Study||3||
60019613|NCT02553629|76135623|FG001|NOT COMPLETED|Overall Study||6||
60019614|NCT02546609|76135632|FG000|STARTED|Overall Study||24||
60019615|NCT02546609|76135633|FG001|STARTED|Overall Study||35||
60019616|NCT02546609|76135634|FG002|STARTED|Overall Study||32||
60019617|NCT02546609|76135632|FG000|COMPLETED|Overall Study||22||
60019618|NCT02546609|76135633|FG001|COMPLETED|Overall Study||24||
60019619|NCT02546609|76135634|FG002|COMPLETED|Overall Study||25||
60019620|NCT02546609|76135632|FG000|NOT COMPLETED|Overall Study||2||
60019621|NCT02546609|76135633|FG001|NOT COMPLETED|Overall Study||11||
60019622|NCT02546609|76135634|FG002|NOT COMPLETED|Overall Study||7||
60019623|NCT02553317|76135644|FG000|STARTED|Overall Treatment Period + Follow-up||72||
60019624|NCT02553317|76135645|FG001|STARTED|Overall Treatment Period + Follow-up||73||
60019625|NCT02553317|76135644|FG000|Received Study Drug|Overall Treatment Period + Follow-up||71||
60019626|NCT02553317|76135645|FG001|Received Study Drug|Overall Treatment Period + Follow-up||73||
60019627|NCT02553317|76135644|FG000|COMPLETED|Overall Treatment Period + Follow-up||58||
60019628|NCT02553317|76135645|FG001|COMPLETED|Overall Treatment Period + Follow-up||50||
60019629|NCT02553317|76135644|FG000|NOT COMPLETED|Overall Treatment Period + Follow-up||14||
60019630|NCT02553317|76135645|FG001|NOT COMPLETED|Overall Treatment Period + Follow-up||23||
59912100|NCT02875080|76032932|FG000|NOT COMPLETED|Overall Study||2||
59912101|NCT02875080|76032933|FG001|NOT COMPLETED|Overall Study||0||
59912102|NCT02875080|76032934|FG002|NOT COMPLETED|Overall Study||0||
59912103|NCT03129360|76032945|FG000|STARTED|Overall Study||9||
59912104|NCT03129360|76032946|FG001|STARTED|Overall Study||8||
60019631|NCT02553317|76135644|FG000|STARTED|Double-blind (DB) Treatment Period|One patient withdrew consent prior to first dosing and did not start the DB treatment period.|71||
59912105|NCT03129360|76032947|FG002|STARTED|Overall Study||8||
59912106|NCT03129360|76032945|FG000|COMPLETED|Overall Study||8||
59912107|NCT03129360|76032946|FG001|COMPLETED|Overall Study||6||
59912108|NCT03129360|76032947|FG002|COMPLETED|Overall Study||7||
59912109|NCT03129360|76032945|FG000|NOT COMPLETED|Overall Study||1||
59912110|NCT03129360|76032946|FG001|NOT COMPLETED|Overall Study||2||
59912111|NCT03129360|76032947|FG002|NOT COMPLETED|Overall Study||1||
59912112|NCT03165045|76032955|FG000|STARTED|Visit 1||1351||
59912113|NCT03165045|76032955|FG000|COMPLETED|Visit 1||1322||
59912114|NCT03165045|76032955|FG000|NOT COMPLETED|Visit 1||29||
59912115|NCT03165045|76032955|FG000|STARTED|Visit 2||1322||
59912116|NCT03165045|76032955|FG000|COMPLETED|Visit 2||1140||
59912117|NCT03165045|76032955|FG000|NOT COMPLETED|Visit 2||182||
59912118|NCT01928199|76032963|FG000|STARTED|Overall Study||32||
59912119|NCT01928199|76032964|FG001|STARTED|Overall Study||29||
59912120|NCT01928199|76032963|FG000|COMPLETED|Overall Study||27||
59912121|NCT01928199|76032964|FG001|COMPLETED|Overall Study||23||
59912122|NCT01928199|76032963|FG000|NOT COMPLETED|Overall Study||5||
59912123|NCT01928199|76032964|FG001|NOT COMPLETED|Overall Study||6||
59912124|NCT03128892|76032970|FG000|STARTED|Overall Study||34||
59912125|NCT03128892|76032970|FG000|COMPLETED|Overall Study||31||
59912126|NCT03128892|76032970|FG000|NOT COMPLETED|Overall Study||3||
59912127|NCT01845441|76032976|FG000|STARTED|Overall Study||4||
59912128|NCT01845441|76032977|FG001|STARTED|Overall Study||3||
59912129|NCT01845441|76032976|FG000|COMPLETED|Overall Study||4||
59912130|NCT01845441|76032977|FG001|COMPLETED|Overall Study||3||
59912131|NCT01845441|76032976|FG000|NOT COMPLETED|Overall Study||0||
59912132|NCT01845441|76032977|FG001|NOT COMPLETED|Overall Study||0||
59912133|NCT03039686|76032986|FG000|STARTED|Double-blind Period||56||
59912134|NCT03039686|76032987|FG001|STARTED|Double-blind Period||55||
59912135|NCT03039686|76032988|FG002|STARTED|Double-blind Period||55||
59912136|NCT03039686|76032986|FG000|COMPLETED|Double-blind Period||29||
60019632|NCT02553317|76135645|FG001|STARTED|Double-blind (DB) Treatment Period||73||
60019633|NCT02553317|76135644|FG000|COMPLETED|Double-blind (DB) Treatment Period||68||
59912137|NCT03039686|76032987|FG001|COMPLETED|Double-blind Period||26||
59912138|NCT03039686|76032988|FG002|COMPLETED|Double-blind Period||32||
59912139|NCT03039686|76032986|FG000|NOT COMPLETED|Double-blind Period||27||
59912140|NCT03039686|76032987|FG001|NOT COMPLETED|Double-blind Period||29||
59912141|NCT03039686|76032988|FG002|NOT COMPLETED|Double-blind Period||23||
59912142|NCT03039686|76032986|FG000|STARTED|Open Label Period|Double-blind (DB) placebo participants switched to RO7239361 (RO) for the open label phase.|0||
59912143|NCT03039686|76032987|FG001|STARTED|Open Label Period|14 DB placebo participants switched to the RO Low Dose for the open-label phase.|38||
59912144|NCT03039686|76032988|FG002|STARTED|Open Label Period|13 DB placebo participants switched to the RO High Dose for the open-label phase.|42||
59912145|NCT03039686|76032986|FG000|Completed DB, Did Not Start OL|Open Label Period||2||
59912146|NCT03039686|76032987|FG001|Completed DB, Did Not Start OL|Open Label Period||2||
59912147|NCT03039686|76032988|FG002|Completed DB, Did Not Start OL|Open Label Period||3||
59912148|NCT03039686|76032986|FG000|COMPLETED|Open Label Period||0||
59912149|NCT03039686|76032987|FG001|COMPLETED|Open Label Period||0||
59912150|NCT03039686|76032988|FG002|COMPLETED|Open Label Period||0||
59912151|NCT03039686|76032986|FG000|NOT COMPLETED|Open Label Period||0||
59912152|NCT03039686|76032987|FG001|NOT COMPLETED|Open Label Period||38||
59912153|NCT03039686|76032988|FG002|NOT COMPLETED|Open Label Period||42||
59912154|NCT01822275|76033006|FG000|STARTED|Overall Study||24||
59912155|NCT01822275|76033006|FG000|COMPLETED|Overall Study||2||
59912156|NCT01822275|76033006|FG000|NOT COMPLETED|Overall Study||22||
59912157|NCT04631796|76033010|FG000|STARTED|Overall Study||35||70
59912158|NCT04631796|76033010|FG000|COMPLETED|Overall Study||35||70
59912159|NCT04631796|76033010|FG000|NOT COMPLETED|Overall Study||0||0
59912160|NCT01656434|76033018|FG000|STARTED|Overall Study||2553||
59912161|NCT01656434|76033019|FG001|STARTED|Overall Study||620||
59912162|NCT01656434|76033018|FG000|Treated|Overall Study|One treated participant had incomplete data and was not included in the Safety Analyses.|2466||
59912163|NCT01656434|76033019|FG001|Treated|Overall Study||604||
59912164|NCT01656434|76033018|FG000|COMPLETED|Overall Study||152||
59912165|NCT01656434|76033019|FG001|COMPLETED|Overall Study||40||
59912166|NCT01656434|76033018|FG000|NOT COMPLETED|Overall Study||2401||
59912167|NCT01656434|76033019|FG001|NOT COMPLETED|Overall Study||580||
59912168|NCT02931396|76033027|FG000|STARTED|Overall Study||10||
59912169|NCT02931396|76033028|FG001|STARTED|Overall Study||10||
59912170|NCT02931396|76033027|FG000|COMPLETED|Overall Study||5||
59912171|NCT02931396|76033028|FG001|COMPLETED|Overall Study||10||
59912172|NCT02931396|76033027|FG000|NOT COMPLETED|Overall Study||5||
59912173|NCT02931396|76033028|FG001|NOT COMPLETED|Overall Study||0||
59912174|NCT03037580|76033036|FG000|STARTED|Overall Study||41||
59912175|NCT03037580|76033037|FG001|STARTED|Overall Study||43||
59912176|NCT03037580|76033036|FG000|COMPLETED|Overall Study||25||
59912177|NCT03037580|76033037|FG001|COMPLETED|Overall Study||27||
59912178|NCT03037580|76033036|FG000|NOT COMPLETED|Overall Study||16||
59912179|NCT03037580|76033037|FG001|NOT COMPLETED|Overall Study||16||
59912180|NCT00897104|76033046|FG000|STARTED|Overall Study|Participants who were allocated study drug|418||
59912181|NCT00897104|76033047|FG001|STARTED|Overall Study|Participants who were allocated study drug|428||
59912182|NCT00897104|76033048|FG002|STARTED|Overall Study|Participants who were allocated study drug|87||
59912183|NCT00897104|76033046|FG000|Participants Treated|Overall Study|Participants who took study drug|355||
59912184|NCT00897104|76033047|FG001|Participants Treated|Overall Study|Participants who took study drug|357||
59912185|NCT00897104|76033048|FG002|Participants Treated|Overall Study|Participants who took study drug|80||
59912186|NCT00897104|76033046|FG000|Participants Not Treated|Overall Study|Participants who did not take study drug|63||
59912187|NCT00897104|76033047|FG001|Participants Not Treated|Overall Study|Participants who did not take study drug|71||
59912188|NCT00897104|76033048|FG002|Participants Not Treated|Overall Study|Participants who did not take study drug|7||
59912189|NCT00897104|76033046|FG000|COMPLETED|Overall Study|Participants who took study drug and completed the study|354||
59912190|NCT00897104|76033047|FG001|COMPLETED|Overall Study|Participants who took study drug and completed the study|357||
59912191|NCT00897104|76033048|FG002|COMPLETED|Overall Study|Participants who took study drug and completed the study|79||
59912192|NCT00897104|76033046|FG000|NOT COMPLETED|Overall Study||64||
59912193|NCT00897104|76033047|FG001|NOT COMPLETED|Overall Study||71||
59912194|NCT00897104|76033048|FG002|NOT COMPLETED|Overall Study||8||
59912195|NCT01339689|76033058|FG000|STARTED|Overall Study||59||
59912196|NCT01339689|76033059|FG001|STARTED|Overall Study||53||
59912197|NCT01339689|76033058|FG000|COMPLETED|Overall Study||42||
59912198|NCT01339689|76033059|FG001|COMPLETED|Overall Study||44||
59912199|NCT01339689|76033058|FG000|NOT COMPLETED|Overall Study||17||
59912200|NCT01339689|76033059|FG001|NOT COMPLETED|Overall Study||9||
59912201|NCT03038126|76033067|FG000|STARTED|Overall Study||63||
59912202|NCT03038126|76033068|FG001|STARTED|Overall Study||55||
59912203|NCT03038126|76033067|FG000|COMPLETED|Overall Study||54||
59912204|NCT03038126|76033068|FG001|COMPLETED|Overall Study||51||
59912205|NCT03038126|76033067|FG000|NOT COMPLETED|Overall Study||9||
59912206|NCT03038126|76033068|FG001|NOT COMPLETED|Overall Study||4||
59912207|NCT00696878|76033074|FG000|STARTED|Overall Study||682||
59912208|NCT00696878|76033074|FG000|COMPLETED|Overall Study||178||
59912209|NCT00696878|76033074|FG000|NOT COMPLETED|Overall Study||504||
59912210|NCT00696800|76033080|FG000|STARTED|Overall Study||757||
59912211|NCT00696800|76033081|FG001|STARTED|Overall Study||752||
59912212|NCT00696800|76033080|FG000|Treated (ITT)|Overall Study|The ITT group|756||
59912213|NCT00696800|76033081|FG001|Treated (ITT)|Overall Study|The ITT group|750||
59912214|NCT00696800|76033080|FG000|COMPLETED|Overall Study|Participants who had embryos transferred|672||
59912215|NCT00696800|76033081|FG001|COMPLETED|Overall Study|Participants who had embryos transferred|704||
59912216|NCT00696800|76033080|FG000|NOT COMPLETED|Overall Study||85||
59912217|NCT00696800|76033081|FG001|NOT COMPLETED|Overall Study||48||
59912218|NCT00289874|76033089|FG000|STARTED|Overall Study||203||
59912219|NCT00289874|76033090|FG001|STARTED|Overall Study||218||
59912220|NCT00289874|76033089|FG000|COMPLETED|Overall Study||197||
59912221|NCT00289874|76033090|FG001|COMPLETED|Overall Study||210||
59912222|NCT00289874|76033089|FG000|NOT COMPLETED|Overall Study||6||
59912223|NCT00289874|76033090|FG001|NOT COMPLETED|Overall Study||8||
59912224|NCT00245570|76033096|FG000|STARTED|Treatment Period II||7||
59912225|NCT00245570|76033097|FG001|STARTED|Treatment Period II||8||
59912226|NCT00245570|76033098|FG002|STARTED|Treatment Period II||8||
59912227|NCT00245570|76033099|FG003|STARTED|Treatment Period II||8||
59912228|NCT00245570|76033100|FG004|STARTED|Treatment Period II||8||
59912229|NCT00245570|76033101|FG005|STARTED|Treatment Period II||8||
59912230|NCT00245570|76033096|FG000|COMPLETED|Treatment Period II||7||
59912231|NCT00245570|76033097|FG001|COMPLETED|Treatment Period II||8||
59912232|NCT00245570|76033098|FG002|COMPLETED|Treatment Period II||8||
59912233|NCT00245570|76033099|FG003|COMPLETED|Treatment Period II||8||
59912234|NCT00245570|76033100|FG004|COMPLETED|Treatment Period II||8||
59912235|NCT00245570|76033101|FG005|COMPLETED|Treatment Period II||8||
59912236|NCT00245570|76033096|FG000|NOT COMPLETED|Treatment Period II||0||
59912237|NCT00245570|76033097|FG001|NOT COMPLETED|Treatment Period II||0||
59912238|NCT00245570|76033098|FG002|NOT COMPLETED|Treatment Period II||0||
59912239|NCT00245570|76033099|FG003|NOT COMPLETED|Treatment Period II||0||
59912240|NCT00245570|76033100|FG004|NOT COMPLETED|Treatment Period II||0||
59912241|NCT00245570|76033101|FG005|NOT COMPLETED|Treatment Period II||0||
59912242|NCT00245570|76033096|FG000|STARTED|Washout Between Periods II and III||7||
59912243|NCT00245570|76033097|FG001|STARTED|Washout Between Periods II and III||8||
59912244|NCT00245570|76033098|FG002|STARTED|Washout Between Periods II and III||8||
59912245|NCT00245570|76033099|FG003|STARTED|Washout Between Periods II and III||8||
59507155|NCT00819403|75600321|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||0||
59507156|NCT02010021|75600330|FG000|STARTED|Overall Study||10||
59507157|NCT02010021|75600331|FG001|STARTED|Overall Study||7||
59912246|NCT00245570|76033100|FG004|STARTED|Washout Between Periods II and III||8||
59912247|NCT00245570|76033101|FG005|STARTED|Washout Between Periods II and III||8||
59912248|NCT00245570|76033096|FG000|COMPLETED|Washout Between Periods II and III||7||
59912249|NCT00245570|76033097|FG001|COMPLETED|Washout Between Periods II and III||8||
59912250|NCT00245570|76033098|FG002|COMPLETED|Washout Between Periods II and III||8||
59912251|NCT00245570|76033099|FG003|COMPLETED|Washout Between Periods II and III||8||
59912252|NCT00245570|76033100|FG004|COMPLETED|Washout Between Periods II and III||8||
59912253|NCT00245570|76033101|FG005|COMPLETED|Washout Between Periods II and III||8||
59912254|NCT00245570|76033096|FG000|NOT COMPLETED|Washout Between Periods II and III||0||
59912255|NCT00245570|76033097|FG001|NOT COMPLETED|Washout Between Periods II and III||0||
59912256|NCT00245570|76033098|FG002|NOT COMPLETED|Washout Between Periods II and III||0||
59912257|NCT00245570|76033099|FG003|NOT COMPLETED|Washout Between Periods II and III||0||
59912258|NCT00245570|76033100|FG004|NOT COMPLETED|Washout Between Periods II and III||0||
59912259|NCT00245570|76033101|FG005|NOT COMPLETED|Washout Between Periods II and III||0||
59912260|NCT00245570|76033096|FG000|STARTED|Treatment Period III||7||
59912261|NCT00245570|76033097|FG001|STARTED|Treatment Period III||8||
59912262|NCT00245570|76033098|FG002|STARTED|Treatment Period III||8||
59912263|NCT00245570|76033099|FG003|STARTED|Treatment Period III||8||
60019634|NCT02553317|76135645|FG001|COMPLETED|Double-blind (DB) Treatment Period||65||
60019635|NCT02553317|76135644|FG000|NOT COMPLETED|Double-blind (DB) Treatment Period||3||
60019636|NCT02553317|76135645|FG001|NOT COMPLETED|Double-blind (DB) Treatment Period||8||
60019637|NCT02553317|76135644|FG000|STARTED|Open-label (OL) Treatment Period|2 patients on caplacizumab had a recurrence of TTP during the DB period and started OL treatment.|2||
60019638|NCT02553317|76135645|FG001|STARTED|Open-label (OL) Treatment Period|26 patients on placebo had a recurrence of TTP during the DB period and started OL treatment.|26||
60019639|NCT02553317|76135644|FG000|COMPLETED|Open-label (OL) Treatment Period||2||
60019640|NCT02553317|76135645|FG001|COMPLETED|Open-label (OL) Treatment Period||22||
60019641|NCT02553317|76135644|FG000|NOT COMPLETED|Open-label (OL) Treatment Period||0||
60019642|NCT02553317|76135645|FG001|NOT COMPLETED|Open-label (OL) Treatment Period||4||
60019643|NCT02325219|76135655|FG000|STARTED|Controlled Period (Week 0 - 16)||64||
60019644|NCT02325219|76135656|FG001|STARTED|Controlled Period (Week 0 - 16)||65||
60019645|NCT02325219|76135657|FG002|STARTED|Controlled Period (Week 0 - 16)||63||
59912264|NCT00245570|76033100|FG004|STARTED|Treatment Period III||8||
59912265|NCT00245570|76033101|FG005|STARTED|Treatment Period III||8||
60019646|NCT02325219|76135658|FG003|STARTED|Controlled Period (Week 0 - 16)||0||
60019647|NCT02325219|76135659|FG004|STARTED|Controlled Period (Week 0 - 16)||0||
60019648|NCT02325219|76135655|FG000|COMPLETED|Controlled Period (Week 0 - 16)||52||
60019649|NCT02325219|76135656|FG001|COMPLETED|Controlled Period (Week 0 - 16)||63||
60019650|NCT02325219|76135657|FG002|COMPLETED|Controlled Period (Week 0 - 16)||62||
60019651|NCT02325219|76135658|FG003|COMPLETED|Controlled Period (Week 0 - 16)||0||
60019652|NCT02325219|76135659|FG004|COMPLETED|Controlled Period (Week 0 - 16)||0||
59507158|NCT02010021|75600330|FG000|COMPLETED|Overall Study||10||
59507159|NCT02010021|75600331|FG001|COMPLETED|Overall Study||7||
59507160|NCT02010021|75600330|FG000|NOT COMPLETED|Overall Study||0||
60019653|NCT02325219|76135655|FG000|NOT COMPLETED|Controlled Period (Week 0 - 16)||12||
59912266|NCT00245570|76033096|FG000|COMPLETED|Treatment Period III||7||
59912267|NCT00245570|76033097|FG001|COMPLETED|Treatment Period III||8||
59912268|NCT00245570|76033098|FG002|COMPLETED|Treatment Period III||8||
59912269|NCT00245570|76033099|FG003|COMPLETED|Treatment Period III||8||
59912270|NCT00245570|76033100|FG004|COMPLETED|Treatment Period III||8||
59912271|NCT00245570|76033101|FG005|COMPLETED|Treatment Period III||8||
59912272|NCT00245570|76033096|FG000|NOT COMPLETED|Treatment Period III||0||
59912273|NCT00245570|76033097|FG001|NOT COMPLETED|Treatment Period III||0||
59912274|NCT00245570|76033098|FG002|NOT COMPLETED|Treatment Period III||0||
59912275|NCT00245570|76033099|FG003|NOT COMPLETED|Treatment Period III||0||
59912276|NCT00245570|76033100|FG004|NOT COMPLETED|Treatment Period III||0||
59912277|NCT00245570|76033101|FG005|NOT COMPLETED|Treatment Period III||0||
59912278|NCT00245570|76033096|FG000|STARTED|Washout Between Periods III and IV||7||
59912279|NCT00245570|76033097|FG001|STARTED|Washout Between Periods III and IV|1 pt in the montelukast/placebo/salmeterol group discontinued during washout period 2 after placebo|8||
59912280|NCT00245570|76033098|FG002|STARTED|Washout Between Periods III and IV||8||
59912281|NCT00245570|76033099|FG003|STARTED|Washout Between Periods III and IV||8||
59912282|NCT00245570|76033100|FG004|STARTED|Washout Between Periods III and IV||8||
59912283|NCT00245570|76033101|FG005|STARTED|Washout Between Periods III and IV||8||
59912284|NCT00245570|76033096|FG000|COMPLETED|Washout Between Periods III and IV||7||
59912285|NCT00245570|76033097|FG001|COMPLETED|Washout Between Periods III and IV||7||
59912286|NCT00245570|76033098|FG002|COMPLETED|Washout Between Periods III and IV||8||
59912287|NCT00245570|76033099|FG003|COMPLETED|Washout Between Periods III and IV||8||
59912288|NCT00245570|76033100|FG004|COMPLETED|Washout Between Periods III and IV||8||
59912289|NCT00245570|76033101|FG005|COMPLETED|Washout Between Periods III and IV||8||
59912290|NCT00245570|76033096|FG000|NOT COMPLETED|Washout Between Periods III and IV||0||
59912291|NCT00245570|76033097|FG001|NOT COMPLETED|Washout Between Periods III and IV||1||
59912292|NCT00245570|76033098|FG002|NOT COMPLETED|Washout Between Periods III and IV||0||
59912293|NCT00245570|76033099|FG003|NOT COMPLETED|Washout Between Periods III and IV||0||
59912294|NCT00245570|76033100|FG004|NOT COMPLETED|Washout Between Periods III and IV||0||
59912295|NCT00245570|76033101|FG005|NOT COMPLETED|Washout Between Periods III and IV||0||
59912296|NCT00245570|76033096|FG000|STARTED|Treatment Period IV||7||
59912297|NCT00245570|76033097|FG001|STARTED|Treatment Period IV||7||
59912298|NCT00245570|76033098|FG002|STARTED|Treatment Period IV||8||
59912299|NCT00245570|76033099|FG003|STARTED|Treatment Period IV||8||
59912300|NCT00245570|76033100|FG004|STARTED|Treatment Period IV||8||
59912301|NCT00245570|76033101|FG005|STARTED|Treatment Period IV||8||
59912302|NCT00245570|76033096|FG000|COMPLETED|Treatment Period IV||7||
59912303|NCT00245570|76033097|FG001|COMPLETED|Treatment Period IV||7||
59912304|NCT00245570|76033098|FG002|COMPLETED|Treatment Period IV||8||
59912305|NCT00245570|76033099|FG003|COMPLETED|Treatment Period IV||8||
59912306|NCT00245570|76033100|FG004|COMPLETED|Treatment Period IV||8||
59912307|NCT00245570|76033101|FG005|COMPLETED|Treatment Period IV||8||
59912308|NCT00245570|76033096|FG000|NOT COMPLETED|Treatment Period IV||0||
59912309|NCT00245570|76033097|FG001|NOT COMPLETED|Treatment Period IV||0||
59912310|NCT00245570|76033098|FG002|NOT COMPLETED|Treatment Period IV||0||
59912311|NCT00245570|76033099|FG003|NOT COMPLETED|Treatment Period IV||0||
59912312|NCT00245570|76033100|FG004|NOT COMPLETED|Treatment Period IV||0||
59912313|NCT00245570|76033101|FG005|NOT COMPLETED|Treatment Period IV||0||
59912314|NCT00229970|76033115|FG000|STARTED|Overall Study||78||
59912315|NCT00229970|76033116|FG001|STARTED|Overall Study||72||
59912316|NCT00229970|76033117|FG002|STARTED|Overall Study||75||
59912317|NCT00229970|76033115|FG000|COMPLETED|Overall Study||78||
59912318|NCT00229970|76033116|FG001|COMPLETED|Overall Study||72||
59912319|NCT00229970|76033117|FG002|COMPLETED|Overall Study||75||
59912320|NCT00229970|76033115|FG000|NOT COMPLETED|Overall Study||0||
59912321|NCT00229970|76033116|FG001|NOT COMPLETED|Overall Study||0||
59912322|NCT00229970|76033117|FG002|NOT COMPLETED|Overall Study||0||
59912323|NCT04767061|76033127|FG000|STARTED|On or Off Beta Blockers Up to 6 Wks||5||
59912324|NCT04767061|76033128|FG001|STARTED|On or Off Beta Blockers Up to 6 Wks||4||
59912325|NCT04767061|76033127|FG000|COMPLETED|On or Off Beta Blockers Up to 6 Wks||5||
59912326|NCT04767061|76033128|FG001|COMPLETED|On or Off Beta Blockers Up to 6 Wks||4||
59912327|NCT04767061|76033127|FG000|NOT COMPLETED|On or Off Beta Blockers Up to 6 Wks||0||
59912328|NCT04767061|76033128|FG001|NOT COMPLETED|On or Off Beta Blockers Up to 6 Wks||0||
59912329|NCT04767061|76033127|FG000|STARTED|Down-titration/Up-titration Up to 6 Wks||5||
59912330|NCT04767061|76033128|FG001|STARTED|Down-titration/Up-titration Up to 6 Wks||4||
59912331|NCT04767061|76033127|FG000|COMPLETED|Down-titration/Up-titration Up to 6 Wks||5||
59912332|NCT04767061|76033128|FG001|COMPLETED|Down-titration/Up-titration Up to 6 Wks||4||
59912333|NCT04767061|76033127|FG000|NOT COMPLETED|Down-titration/Up-titration Up to 6 Wks||0||
59912334|NCT04767061|76033128|FG001|NOT COMPLETED|Down-titration/Up-titration Up to 6 Wks||0||
59912335|NCT04767061|76033127|FG000|STARTED|Up-titration/Down-titration Up to 6 Wks|All 5 subjects on the ABAB Arm chose to complete the intervention phase after the completion of their 2nd period, and move onto the follow-up phase|0||
59912336|NCT04767061|76033128|FG001|STARTED|Up-titration/Down-titration Up to 6 Wks|2 subjects on the BABA Arm chose to complete the intervention phase after the completion of their 2nd period, and move on to the follow-up phase. The remaining 2 subjects on the BABA Arm chose to continue onto a 3rd period.|2||
60019654|NCT02325219|76135656|FG001|NOT COMPLETED|Controlled Period (Week 0 - 16)||2||
60019655|NCT02325219|76135657|FG002|NOT COMPLETED|Controlled Period (Week 0 - 16)||1||
60019656|NCT02325219|76135658|FG003|NOT COMPLETED|Controlled Period (Week 0 - 16)||0||
60019657|NCT02325219|76135659|FG004|NOT COMPLETED|Controlled Period (Week 0 - 16)||0||
60019658|NCT02325219|76135655|FG000|STARTED|After Controlled Period (Week 16 - 52)||0||
60019659|NCT02325219|76135656|FG001|STARTED|After Controlled Period (Week 16 - 52)||63||
60019660|NCT02325219|76135657|FG002|STARTED|After Controlled Period (Week 16 - 52)||62||
60019661|NCT02325219|76135658|FG003|STARTED|After Controlled Period (Week 16 - 52)|Participants who completed CP and re-randomized to Guselkumab 50 mg.|26||
60019662|NCT02325219|76135659|FG004|STARTED|After Controlled Period (Week 16 - 52)|Participants who completed CP and re-randomized to Guselkumab 100 mg.|26||
60019663|NCT02325219|76135655|FG000|COMPLETED|After Controlled Period (Week 16 - 52)||0||
60019664|NCT02325219|76135656|FG001|COMPLETED|After Controlled Period (Week 16 - 52)||60||
60019665|NCT02325219|76135657|FG002|COMPLETED|After Controlled Period (Week 16 - 52)||62||
60019666|NCT02325219|76135658|FG003|COMPLETED|After Controlled Period (Week 16 - 52)||26||
60019667|NCT02325219|76135659|FG004|COMPLETED|After Controlled Period (Week 16 - 52)||25||
60019668|NCT02325219|76135655|FG000|NOT COMPLETED|After Controlled Period (Week 16 - 52)||0||
60019669|NCT02325219|76135656|FG001|NOT COMPLETED|After Controlled Period (Week 16 - 52)||3||
60019670|NCT02325219|76135657|FG002|NOT COMPLETED|After Controlled Period (Week 16 - 52)||0||
60019671|NCT02325219|76135658|FG003|NOT COMPLETED|After Controlled Period (Week 16 - 52)||0||
60019672|NCT02325219|76135659|FG004|NOT COMPLETED|After Controlled Period (Week 16 - 52)||1||
60019673|NCT02297841|76135675|FG000|STARTED|Overall Study||209||
60019674|NCT02297841|76135675|FG000|Induction Phase|Overall Study||209||
60019675|NCT02297841|76135675|FG000|Challenge Phase|Overall Study||201||
59758755|NCT04138056|75878026|FG003|NOT COMPLETED|Extension Study||0||
59758756|NCT04138056|75878027|FG004|NOT COMPLETED|Extension Study||1||
60019676|NCT02297841|76135675|FG000|COMPLETED|Overall Study||201||
60019677|NCT02297841|76135675|FG000|NOT COMPLETED|Overall Study||8||
60019678|NCT02324361|76135681|FG000|STARTED|Overall Study||24||
60019679|NCT02324361|76135682|FG001|STARTED|Overall Study||24||
60019680|NCT02324361|76135681|FG000|COMPLETED|Overall Study||19||
60019681|NCT02324361|76135682|FG001|COMPLETED|Overall Study||22||
60019682|NCT02324361|76135681|FG000|NOT COMPLETED|Overall Study||5||
60019683|NCT02324361|76135682|FG001|NOT COMPLETED|Overall Study||2||
60019684|NCT02365233|76135691|FG000|STARTED|Overall Study||1||
60019685|NCT02365233|76135692|FG001|STARTED|Overall Study||2||
60019686|NCT02365233|76135693|FG002|STARTED|Overall Study||2||
60019687|NCT02365233|76135691|FG000|COMPLETED|Overall Study||0||
59758757|NCT04094064|75878056|FG000|STARTED|Overall Study||20||
59758758|NCT04094064|75878056|FG000|COMPLETED|Overall Study||20||
60019688|NCT02365233|76135692|FG001|COMPLETED|Overall Study||0||
60019689|NCT02365233|76135693|FG002|COMPLETED|Overall Study||0||
60019690|NCT02365233|76135691|FG000|NOT COMPLETED|Overall Study||1||
60019691|NCT02365233|76135692|FG001|NOT COMPLETED|Overall Study||2||
60019692|NCT02365233|76135693|FG002|NOT COMPLETED|Overall Study||2||
60019693|NCT02324205|76135701|FG000|STARTED|Overall Study||196||
60019694|NCT02324205|76135701|FG000|COMPLETED|Overall Study||159||
60019695|NCT02324205|76135701|FG000|NOT COMPLETED|Overall Study||37||
60019696|NCT02324049|76135705|FG000|STARTED|Part A||11||
60019697|NCT02324049|76135705|FG000|Safety Analysis Set|Part A|Participants with informed consent, confirmed MPS IIIB diagnosis, and received any amount of SBC-103|11||
60019698|NCT02324049|76135705|FG000|COMPLETED|Part A||11||
60019699|NCT02324049|76135705|FG000|NOT COMPLETED|Part A||0||
60019700|NCT02324049|76135705|FG000|STARTED|Part B||11||
60019701|NCT02324049|76135705|FG000|Safety Analysis Set|Part B||11||
60019702|NCT02324049|76135705|FG000|COMPLETED|Part B||11||
60019703|NCT02324049|76135705|FG000|NOT COMPLETED|Part B||0||
60019704|NCT02324049|76135705|FG000|STARTED|Part C||11||
60019705|NCT02324049|76135705|FG000|Safety Analysis Set|Part C||11||
60019706|NCT02324049|76135705|FG000|COMPLETED|Part C||0||
60019707|NCT02324049|76135705|FG000|NOT COMPLETED|Part C||11||
60019708|NCT02364999|76135711|FG000|STARTED|Overall Study||358||
60019709|NCT02364999|76135712|FG001|STARTED|Overall Study||361||
60019710|NCT02364999|76135711|FG000|Received Treatment|Overall Study||356||
60019711|NCT02364999|76135712|FG001|Received Treatment|Overall Study||358||
60019712|NCT02364999|76135711|FG000|COMPLETED|Overall Study||193||
60019713|NCT02364999|76135712|FG001|COMPLETED|Overall Study||188||
60019714|NCT02364999|76135711|FG000|NOT COMPLETED|Overall Study||165||
60019715|NCT02364999|76135712|FG001|NOT COMPLETED|Overall Study||173||
60019716|NCT02322879|76135721|FG000|STARTED|First Intervention||11||
60019717|NCT02322879|76135722|FG001|STARTED|First Intervention||10||
60019718|NCT02322879|76135721|FG000|COMPLETED|First Intervention||10||
60019719|NCT02322879|76135722|FG001|COMPLETED|First Intervention||10||
60019720|NCT02322879|76135721|FG000|NOT COMPLETED|First Intervention||1||
60019721|NCT02322879|76135722|FG001|NOT COMPLETED|First Intervention||0||
60019722|NCT02322879|76135721|FG000|STARTED|Washout||10||
60019723|NCT02322879|76135722|FG001|STARTED|Washout||10||
60019724|NCT02322879|76135721|FG000|COMPLETED|Washout||10||
60019725|NCT02322879|76135722|FG001|COMPLETED|Washout||10||
60019726|NCT02322879|76135721|FG000|NOT COMPLETED|Washout||0||
60019727|NCT02322879|76135722|FG001|NOT COMPLETED|Washout||0||
60019728|NCT02322879|76135721|FG000|STARTED|Second Intervention||10||
60019729|NCT02322879|76135722|FG001|STARTED|Second Intervention||10||
60019730|NCT02322879|76135721|FG000|COMPLETED|Second Intervention||10||
60019731|NCT02322879|76135722|FG001|COMPLETED|Second Intervention||10||
60019732|NCT02322879|76135721|FG000|NOT COMPLETED|Second Intervention||0||
60019733|NCT02322879|76135722|FG001|NOT COMPLETED|Second Intervention||0||
60019734|NCT02322411|76135730|FG000|STARTED|Overall Study||14||
60019735|NCT02322411|76135731|FG001|STARTED|Overall Study||16||
60019736|NCT02322411|76135730|FG000|Randomized|Overall Study||14||
60019737|NCT02322411|76135731|FG001|Randomized|Overall Study||16||
59758759|NCT04094064|75878056|FG000|NOT COMPLETED|Overall Study||0||
59758760|NCT03251144|75878063|FG000|STARTED|Overall Study||15||
60019738|NCT02322411|76135730|FG000|All Baseline Measures Analyzed|Overall Study||13||
60019739|NCT02322411|76135731|FG001|All Baseline Measures Analyzed|Overall Study||16||
60019740|NCT02322411|76135730|FG000|COMPLETED|Overall Study||9||
60019741|NCT02322411|76135731|FG001|COMPLETED|Overall Study||9||
60019742|NCT02322411|76135730|FG000|NOT COMPLETED|Overall Study||5||
60019743|NCT02322411|76135731|FG001|NOT COMPLETED|Overall Study||7||
60019744|NCT02322021|76135741|FG000|STARTED|Core Phase||17||
60019745|NCT02322021|76135742|FG001|STARTED|Core Phase||17||
60019746|NCT02322021|76135743|FG002|STARTED|Core Phase||19||
59507161|NCT02010021|75600331|FG001|NOT COMPLETED|Overall Study||0||
59507162|NCT02062905|75600339|FG000|STARTED|Overall Study||35||
59507163|NCT02062905|75600340|FG001|STARTED|Overall Study||33||
59758761|NCT03251144|75878064|FG001|STARTED|Overall Study||11||
59758762|NCT03251144|75878063|FG000|COMPLETED|Overall Study||15||
59758763|NCT03251144|75878064|FG001|COMPLETED|Overall Study||11||
59758764|NCT03251144|75878063|FG000|NOT COMPLETED|Overall Study||0||
59758765|NCT03251144|75878064|FG001|NOT COMPLETED|Overall Study||0||
59758766|NCT00753675|75878073|FG000|STARTED|Overall Study||59||
59758767|NCT00753675|75878074|FG001|STARTED|Overall Study||59||
59758768|NCT00753675|75878075|FG002|STARTED|Overall Study||56||
59758769|NCT00753675|75878073|FG000|COMPLETED|Overall Study||0||
59758770|NCT00753675|75878074|FG001|COMPLETED|Overall Study||0||
59758771|NCT00753675|75878075|FG002|COMPLETED|Overall Study||0||
59758772|NCT00753675|75878073|FG000|NOT COMPLETED|Overall Study||59||
59758773|NCT00753675|75878074|FG001|NOT COMPLETED|Overall Study||59||
59758774|NCT00753675|75878075|FG002|NOT COMPLETED|Overall Study||56||
59758775|NCT00586521|75878083|FG000|STARTED|On Demand Treatment (Months 1-6)||20||
59758776|NCT00586521|75878083|FG000|COMPLETED|On Demand Treatment (Months 1-6)||19||
59758777|NCT00586521|75878083|FG000|NOT COMPLETED|On Demand Treatment (Months 1-6)||1||
59758778|NCT00586521|75878083|FG000|STARTED|Prophylactic Treatment (Months 8-13)||19||
59758779|NCT00586521|75878083|FG000|COMPLETED|Prophylactic Treatment (Months 8-13)||19||
59758780|NCT00586521|75878083|FG000|NOT COMPLETED|Prophylactic Treatment (Months 8-13)||0||
59758781|NCT00923273|75878092|FG000|STARTED|Phase I Treatment Period|The phase I portion will establish the maximum tolerated dose. 4 subjects peme naive.|4||
59758782|NCT00923273|75878093|FG001|STARTED|Phase I Treatment Period|3 subjects peme naive.|3||
59758783|NCT00923273|75878094|FG002|STARTED|Phase I Treatment Period|3 subjects peme naive.|3||
59912337|NCT04767061|76033127|FG000|COMPLETED|Up-titration/Down-titration Up to 6 Wks||0||
59912338|NCT04767061|76033128|FG001|COMPLETED|Up-titration/Down-titration Up to 6 Wks||2||
59912339|NCT04767061|76033127|FG000|NOT COMPLETED|Up-titration/Down-titration Up to 6 Wks||0||
59912340|NCT04767061|76033128|FG001|NOT COMPLETED|Up-titration/Down-titration Up to 6 Wks||0||
59912341|NCT04767061|76033127|FG000|STARTED|Down-titration/Up-Titration Up to 6 Wks||0||
59912342|NCT04767061|76033128|FG001|STARTED|Down-titration/Up-Titration Up to 6 Wks|The remaining 2 subjects on the BABA Arm chose to complete the intervention phase after the completion of their 3rd period, and move on to the follow-up phase.|0||
59912343|NCT04767061|76033127|FG000|COMPLETED|Down-titration/Up-Titration Up to 6 Wks||0||
59912344|NCT04767061|76033128|FG001|COMPLETED|Down-titration/Up-Titration Up to 6 Wks||0||
59912345|NCT04767061|76033127|FG000|NOT COMPLETED|Down-titration/Up-Titration Up to 6 Wks||0||
59912346|NCT04767061|76033128|FG001|NOT COMPLETED|Down-titration/Up-Titration Up to 6 Wks||0||
59912347|NCT04767061|76033127|FG000|STARTED|Follow-up||5|After each of the subjects complete their intervention phase, they proceed to a follow-up phase, which lasts for 12 months.|
59912348|NCT04767061|76033128|FG001|STARTED|Follow-up||4|After each of the subjects complete their intervention phase, they proceed to a follow-up phase, which lasts for 12 months.|
59912349|NCT04767061|76033127|FG000|COMPLETED|Follow-up||5||
59912350|NCT04767061|76033128|FG001|COMPLETED|Follow-up||4||
59912351|NCT04767061|76033127|FG000|NOT COMPLETED|Follow-up||0||
59912352|NCT04767061|76033128|FG001|NOT COMPLETED|Follow-up||0||
59912353|NCT04638660|76033137|FG000|STARTED|Overall Study||71||
59912354|NCT04638660|76033138|FG001|STARTED|Overall Study||73||
59912355|NCT04638660|76033137|FG000|COMPLETED|Overall Study||68||
60019747|NCT02322021|76135744|FG003|STARTED|Core Phase||17||
60019748|NCT02322021|76135745|FG004|STARTED|Core Phase||0||
60019749|NCT02322021|76135741|FG000|COMPLETED|Core Phase||12||
60019750|NCT02322021|76135742|FG001|COMPLETED|Core Phase||9||
60019751|NCT02322021|76135743|FG002|COMPLETED|Core Phase||10||
60019752|NCT02322021|76135744|FG003|COMPLETED|Core Phase||12||
60019753|NCT02322021|76135745|FG004|COMPLETED|Core Phase||0||
60019754|NCT02322021|76135741|FG000|NOT COMPLETED|Core Phase||5||
60019755|NCT02322021|76135742|FG001|NOT COMPLETED|Core Phase||8||
60019756|NCT02322021|76135743|FG002|NOT COMPLETED|Core Phase||9||
60019757|NCT02322021|76135744|FG003|NOT COMPLETED|Core Phase||5||
60019758|NCT02322021|76135745|FG004|NOT COMPLETED|Core Phase||0||
60019759|NCT02322021|76135741|FG000|STARTED|Extension Phase||0||
60019760|NCT02322021|76135742|FG001|STARTED|Extension Phase||0||
60019761|NCT02322021|76135743|FG002|STARTED|Extension Phase||0||
60019762|NCT02322021|76135744|FG003|STARTED|Extension Phase||0||
60019763|NCT02322021|76135745|FG004|STARTED|Extension Phase|Participants who completed Core Phase, were eligible and gave consent, entered Extension Phase.|41||
60019764|NCT02322021|76135741|FG000|COMPLETED|Extension Phase||0||
60019765|NCT02322021|76135742|FG001|COMPLETED|Extension Phase||0||
60019766|NCT02322021|76135743|FG002|COMPLETED|Extension Phase||0||
60019767|NCT02322021|76135744|FG003|COMPLETED|Extension Phase||0||
60019768|NCT02322021|76135745|FG004|COMPLETED|Extension Phase||0||
60019769|NCT02322021|76135741|FG000|NOT COMPLETED|Extension Phase||0||
60019770|NCT02322021|76135742|FG001|NOT COMPLETED|Extension Phase||0||
60019771|NCT02322021|76135743|FG002|NOT COMPLETED|Extension Phase||0||
60019772|NCT02322021|76135744|FG003|NOT COMPLETED|Extension Phase||0||
59912356|NCT04638660|76033138|FG001|COMPLETED|Overall Study||73||
59912357|NCT04638660|76033137|FG000|NOT COMPLETED|Overall Study||3||
59912358|NCT04638660|76033138|FG001|NOT COMPLETED|Overall Study||0||
60019773|NCT02322021|76135745|FG004|NOT COMPLETED|Extension Phase||41||
60019774|NCT02363439|76135760|FG000|STARTED|Overall Study||5||
60019775|NCT02363439|76135760|FG000|COMPLETED|Overall Study||1||
60019776|NCT02363439|76135760|FG000|NOT COMPLETED|Overall Study||4||
60019777|NCT02363283|76135764|FG000|STARTED|Overall Study||37||
60019778|NCT02363283|76135764|FG000|COMPLETED|Overall Study||35||
60019779|NCT02363283|76135764|FG000|NOT COMPLETED|Overall Study||2||
60019780|NCT02321319|76135768|FG000|STARTED|Overall Study||5||
60019781|NCT02321319|76135768|FG000|COMPLETED|Overall Study||0||
60019782|NCT02321319|76135768|FG000|NOT COMPLETED|Overall Study||5||
60019783|NCT02294175|76135774|FG000|STARTED|Overall Study||23||
60019784|NCT02294175|76135775|FG001|STARTED|Overall Study||22||
60019785|NCT02294175|76135774|FG000|COMPLETED|Overall Study||18||
60019786|NCT02294175|76135775|FG001|COMPLETED|Overall Study||16||
60019787|NCT02294175|76135774|FG000|NOT COMPLETED|Overall Study||5||
60019788|NCT02294175|76135775|FG001|NOT COMPLETED|Overall Study||6||
60019789|NCT02088541|76135786|FG000|STARTED|Overall Study||71||
60019790|NCT02088541|76135787|FG001|STARTED|Overall Study||27||
60019791|NCT02088541|76135788|FG002|STARTED|Overall Study||117||
60019792|NCT02088541|76135789|FG003|STARTED|Overall Study||44||
60019793|NCT02088541|76135790|FG004|STARTED|Overall Study||58||
60019794|NCT02088541|76135786|FG000|Safety Population|Overall Study||71||
60019795|NCT02088541|76135787|FG001|Safety Population|Overall Study||27||
60019796|NCT02088541|76135788|FG002|Safety Population|Overall Study||115||
60019797|NCT02088541|76135789|FG003|Safety Population|Overall Study||39||
60019798|NCT02088541|76135790|FG004|Safety Population|Overall Study||45||
60019799|NCT02088541|76135786|FG000|Intent-to-treat (ITT) Population|Overall Study||0||
60019800|NCT02088541|76135787|FG001|Intent-to-treat (ITT) Population|Overall Study||0||
60019801|NCT02088541|76135788|FG002|Intent-to-treat (ITT) Population|Overall Study|1 randomized to Selinexor 60mg (PV>=5) but treated with physician choice 2, counted under this arm.|118||
60019802|NCT02088541|76135789|FG003|Intent-to-treat (ITT) Population|Overall Study||0||
60019803|NCT02088541|76135790|FG004|Intent-to-treat (ITT) Population|Overall Study||57||
60019804|NCT02088541|76135786|FG000|COMPLETED|Overall Study||0||
59912359|NCT04367480|76033147|FG000|STARTED|Overall Study||72||
59912360|NCT04367480|76033148|FG001|STARTED|Overall Study||72||
59912361|NCT04367480|76033147|FG000|Received Intervention and Completed Baseline Assessments|Overall Study||72||
59912362|NCT04367480|76033148|FG001|Received Intervention and Completed Baseline Assessments|Overall Study||70||
59912363|NCT04367480|76033147|FG000|COMPLETED|Overall Study||68||
59912364|NCT04367480|76033148|FG001|COMPLETED|Overall Study||62||
59912365|NCT04367480|76033147|FG000|NOT COMPLETED|Overall Study||4||
59912366|NCT04367480|76033148|FG001|NOT COMPLETED|Overall Study||10||
59912367|NCT04249219|76033155|FG000|STARTED|Overall Study||62||
59912368|NCT04249219|76033155|FG000|COMPLETED|Overall Study||62||
59912369|NCT04249219|76033155|FG000|NOT COMPLETED|Overall Study||0||
60019805|NCT02088541|76135787|FG001|COMPLETED|Overall Study||0||
60019806|NCT02088541|76135788|FG002|COMPLETED|Overall Study||0||
59912370|NCT04178941|76033162|FG000|STARTED|Overall Study||1051||
59912371|NCT04178941|76033163|FG001|STARTED|Overall Study||847||
60019807|NCT02088541|76135789|FG003|COMPLETED|Overall Study||0||
60019808|NCT02088541|76135790|FG004|COMPLETED|Overall Study||0||
60019809|NCT02088541|76135786|FG000|NOT COMPLETED|Overall Study||71||
60019810|NCT02088541|76135787|FG001|NOT COMPLETED|Overall Study||27||
60019811|NCT02088541|76135788|FG002|NOT COMPLETED|Overall Study||117||
60019812|NCT02088541|76135789|FG003|NOT COMPLETED|Overall Study||44||
60019813|NCT02088541|76135790|FG004|NOT COMPLETED|Overall Study||58||
60019814|NCT02294019|76135800|FG000|STARTED|Overall Study||738||
60019815|NCT02294019|76135800|FG000|COMPLETED|Overall Study||635||
60019816|NCT02294019|76135800|FG000|NOT COMPLETED|Overall Study||103||
60019817|NCT02320149|76135806|FG000|STARTED|Overall Study||483||
60019818|NCT02320149|76135807|FG001|STARTED|Overall Study||485||
60019819|NCT02320149|76135806|FG000|COMPLETED|Overall Study||420||
60019820|NCT02320149|76135807|FG001|COMPLETED|Overall Study||405||
60019821|NCT02320149|76135806|FG000|NOT COMPLETED|Overall Study||63||
60019822|NCT02320149|76135807|FG001|NOT COMPLETED|Overall Study||80||
60019823|NCT02540083|76135813|FG000|STARTED|Overall Study||94||
60019824|NCT02540083|76135813|FG000|COMPLETED|Overall Study||78||
60019825|NCT02540083|76135813|FG000|NOT COMPLETED|Overall Study||16||
60019826|NCT02293863|76135820|FG000|STARTED|Overall Study||56||
60019827|NCT02293863|76135821|FG001|STARTED|Overall Study||55||
60019828|NCT02293863|76135822|FG002|STARTED|Overall Study||47||
60019829|NCT02293863|76135820|FG000|COMPLETED|Overall Study||47||
60019830|NCT02293863|76135821|FG001|COMPLETED|Overall Study||42||
60019831|NCT02293863|76135822|FG002|COMPLETED|Overall Study||38||
60019832|NCT02293863|76135820|FG000|NOT COMPLETED|Overall Study||9||
60019833|NCT02293863|76135821|FG001|NOT COMPLETED|Overall Study||13||
60019834|NCT02293863|76135822|FG002|NOT COMPLETED|Overall Study||9||
60019835|NCT02293395|76135834|FG000|STARTED|Overall Study||1519||
60019836|NCT02293395|76135835|FG001|STARTED|Overall Study||1518||
60019837|NCT02293395|76135834|FG000|Treated|Overall Study||1510||
60019838|NCT02293395|76135835|FG001|Treated|Overall Study||1506||
60019839|NCT02293395|76135834|FG000|COMPLETED|Overall Study||1510||
60019840|NCT02293395|76135835|FG001|COMPLETED|Overall Study||1511||
60019841|NCT02293395|76135834|FG000|NOT COMPLETED|Overall Study||9||
60019842|NCT02293395|76135835|FG001|NOT COMPLETED|Overall Study||7||
60019843|NCT02025985|76135846|FG000|STARTED|Overall Study||25||
60019844|NCT02025985|76135847|FG001|STARTED|Overall Study||23||
60019845|NCT02025985|76135848|FG002|STARTED|Overall Study||25||
60019846|NCT02025985|76135849|FG003|STARTED|Overall Study||21||
60019847|NCT02025985|76135850|FG004|STARTED|Overall Study||20||
60019848|NCT02025985|76135846|FG000|Modified Intent-to-treat(mITT)Population|Overall Study||23||
60019849|NCT02025985|76135847|FG001|Modified Intent-to-treat(mITT)Population|Overall Study||22||
60019850|NCT02025985|76135848|FG002|Modified Intent-to-treat(mITT)Population|Overall Study||25||
60019851|NCT02025985|76135849|FG003|Modified Intent-to-treat(mITT)Population|Overall Study||21||
60019852|NCT02025985|76135850|FG004|Modified Intent-to-treat(mITT)Population|Overall Study||20||
60019853|NCT02025985|76135846|FG000|COMPLETED|Overall Study||0||
60019854|NCT02025985|76135847|FG001|COMPLETED|Overall Study||0||
60019855|NCT02025985|76135848|FG002|COMPLETED|Overall Study||0||
60019856|NCT02025985|76135849|FG003|COMPLETED|Overall Study||0||
60019857|NCT02025985|76135850|FG004|COMPLETED|Overall Study||0||
60019858|NCT02025985|76135846|FG000|NOT COMPLETED|Overall Study||25||
60019859|NCT02025985|76135847|FG001|NOT COMPLETED|Overall Study||23||
60019860|NCT02025985|76135848|FG002|NOT COMPLETED|Overall Study||25||
60019861|NCT02025985|76135849|FG003|NOT COMPLETED|Overall Study||21||
60019862|NCT02025985|76135850|FG004|NOT COMPLETED|Overall Study||20||
60019863|NCT02528305|76135864|FG000|STARTED|Overall Study||12||
60019864|NCT02528305|76135864|FG000|End of Control Period Assessment|Overall Study||11||
60019865|NCT02528305|76135864|FG000|End of Intervention Period Assessment|Overall Study||9||
60019866|NCT02528305|76135864|FG000|COMPLETED|Overall Study||9||
60019867|NCT02528305|76135864|FG000|NOT COMPLETED|Overall Study||3||
60019868|NCT02532517|76135870|FG000|STARTED|Overall Study||45||
60019869|NCT02532517|76135870|FG000|mITT Analysis Set|Overall Study||44||
60019870|NCT02532517|76135870|FG000|COMPLETED|Overall Study||28||
60019871|NCT02532517|76135870|FG000|NOT COMPLETED|Overall Study||17||
60019872|NCT02545049|76135876|FG000|STARTED|Overall Study||3723|Randomized|
60019873|NCT02545049|76135877|FG001|STARTED|Overall Study||3714|Randomized|
60019874|NCT02545049|76135876|FG000|Treated|Overall Study||3683|One partcipant was randomized to placebo but received finerenone.|
60019875|NCT02545049|76135877|FG001|Treated|Overall Study||3658|One partcipant was randomized to placebo but received finerenone.|
60019876|NCT02545049|76135876|FG000|Included in FAS|Overall Study||3686|85 participants were prospectively excluded from the analyses because of critical GCP violations|
60019877|NCT02545049|76135877|FG001|Included in FAS|Overall Study||3666|85 participants were prospectively excluded from the analyses because of critical GCP violations|
60019878|NCT02545049|76135876|FG000|COMPLETED|Overall Study||3681|Participants (except those with critical GCP violations) were followed up regardless of having started treatment or not, and study completion is independent of administration of study treatment. A participant included in the FAS was considered as having completed the study if there was a contact with the participant after the end-of-study (EOS) notification or if the participant died.|
60019879|NCT02545049|76135877|FG001|COMPLETED|Overall Study||3653|Participants (except those with critical GCP violations) were followed up regardless of having started treatment or not, and study completion is independent of administration of study treatment. A participant included in the FAS was considered as having completed the study if there was a contact with the participant after the end-of-study (EOS) notification or if the participant died.|
60019880|NCT02545049|76135876|FG000|NOT COMPLETED|Overall Study||42||
60019881|NCT02545049|76135877|FG001|NOT COMPLETED|Overall Study||61||
60019882|NCT02532283|76135885|FG000|STARTED|Overall Study||64||
60019883|NCT02532283|76135886|FG001|STARTED|Overall Study||35||
60019884|NCT02532283|76135885|FG000|Full Analysis Set|Overall Study||63||
60019885|NCT02532283|76135886|FG001|Full Analysis Set|Overall Study||32||
60019886|NCT02532283|76135885|FG000|COMPLETED|Overall Study||55||
60019887|NCT02532283|76135886|FG001|COMPLETED|Overall Study||30||
60019888|NCT02532283|76135885|FG000|NOT COMPLETED|Overall Study||9||
60019889|NCT02532283|76135886|FG001|NOT COMPLETED|Overall Study||5||
60019890|NCT01807897|76135897|FG000|STARTED|Overall Study||31||
60019891|NCT01807897|76135898|FG001|STARTED|Overall Study||29||
60019892|NCT01807897|76135899|FG002|STARTED|Overall Study||14||
60019893|NCT01807897|76135897|FG000|COMPLETED|Overall Study||24||
60019894|NCT01807897|76135898|FG001|COMPLETED|Overall Study||27||
60019895|NCT01807897|76135899|FG002|COMPLETED|Overall Study||13||
60019896|NCT01807897|76135897|FG000|NOT COMPLETED|Overall Study||7||
60019897|NCT01807897|76135898|FG001|NOT COMPLETED|Overall Study||2||
60019898|NCT01807897|76135899|FG002|NOT COMPLETED|Overall Study||1||
60019899|NCT01295125|76135907|FG000|STARTED|Overall Study||9||
60019900|NCT01295125|76135907|FG000|COMPLETED|Overall Study||0||
60019901|NCT01295125|76135907|FG000|NOT COMPLETED|Overall Study||9||
60019902|NCT02540291|76135915|FG000|STARTED|Overall Study||8||
60019903|NCT02540291|76135916|FG001|STARTED|Overall Study||8||
60019904|NCT02540291|76135917|FG002|STARTED|Overall Study||7||
60019905|NCT02540291|76135918|FG003|STARTED|Overall Study||7||
60019906|NCT02540291|76135915|FG000|COMPLETED|Overall Study||0||
60019907|NCT02540291|76135916|FG001|COMPLETED|Overall Study||0||
60019908|NCT02540291|76135917|FG002|COMPLETED|Overall Study||0||
60019909|NCT02540291|76135918|FG003|COMPLETED|Overall Study||0||
60019910|NCT02540291|76135915|FG000|NOT COMPLETED|Overall Study||8||
60019911|NCT02540291|76135916|FG001|NOT COMPLETED|Overall Study||8||
60019912|NCT02540291|76135917|FG002|NOT COMPLETED|Overall Study||7||
60019913|NCT02540291|76135918|FG003|NOT COMPLETED|Overall Study||7||
60019914|NCT02540213|76135930|FG000|STARTED|Overall Study||240||
60019915|NCT02540213|76135930|FG000|COMPLETED|Overall Study||201||
60019916|NCT02540213|76135930|FG000|NOT COMPLETED|Overall Study||39||
60019917|NCT02552303|76135938|FG000|STARTED|Allocation||10||
60019918|NCT02552303|76135939|FG001|STARTED|Allocation||10||
60019919|NCT02552303|76135940|FG002|STARTED|Allocation||8||
60019920|NCT02552303|76135941|FG003|STARTED|Allocation||11||
60019921|NCT02552303|76135938|FG000|COMPLETED|Allocation||7||
60019922|NCT02552303|76135939|FG001|COMPLETED|Allocation||8||
59507164|NCT02062905|75600339|FG000|COMPLETED|Overall Study||28||
59507165|NCT02062905|75600340|FG001|COMPLETED|Overall Study||31||
59507166|NCT02062905|75600339|FG000|NOT COMPLETED|Overall Study||7||
59507167|NCT02062905|75600340|FG001|NOT COMPLETED|Overall Study||2||
59507168|NCT00820573|75600350|FG000|STARTED|Overall Study||4||
59507169|NCT00820573|75600351|FG001|STARTED|Overall Study||4||
59507170|NCT00820573|75600352|FG002|STARTED|Overall Study||4||
59507171|NCT00820573|75600353|FG003|STARTED|Overall Study||4||
60019923|NCT02552303|76135940|FG002|COMPLETED|Allocation||7||
60019924|NCT02552303|76135941|FG003|COMPLETED|Allocation||10||
60019925|NCT02552303|76135938|FG000|NOT COMPLETED|Allocation||3||
60019926|NCT02552303|76135939|FG001|NOT COMPLETED|Allocation||2||
60019927|NCT02552303|76135940|FG002|NOT COMPLETED|Allocation||1||
60019928|NCT02552303|76135941|FG003|NOT COMPLETED|Allocation||1||
60019929|NCT02552303|76135938|FG000|STARTED|Follow-Up||7||
60019930|NCT02552303|76135939|FG001|STARTED|Follow-Up||8||
60019931|NCT02552303|76135940|FG002|STARTED|Follow-Up||7||
60019932|NCT02552303|76135941|FG003|STARTED|Follow-Up||10||
60019933|NCT02552303|76135938|FG000|COMPLETED|Follow-Up||7||
59507172|NCT00820573|75600350|FG000|COMPLETED|Overall Study||4||
59507173|NCT00820573|75600351|FG001|COMPLETED|Overall Study||4||
59507174|NCT00820573|75600352|FG002|COMPLETED|Overall Study||4||
59507175|NCT00820573|75600353|FG003|COMPLETED|Overall Study||4||
59507176|NCT00820573|75600350|FG000|NOT COMPLETED|Overall Study||0||
60019934|NCT02552303|76135939|FG001|COMPLETED|Follow-Up||6||
60019935|NCT02552303|76135940|FG002|COMPLETED|Follow-Up||6||
60019936|NCT02552303|76135941|FG003|COMPLETED|Follow-Up||10||
60019937|NCT02552303|76135938|FG000|NOT COMPLETED|Follow-Up||0||
60019938|NCT02552303|76135939|FG001|NOT COMPLETED|Follow-Up||2||
60019939|NCT02552303|76135940|FG002|NOT COMPLETED|Follow-Up||1||
60019940|NCT02552303|76135941|FG003|NOT COMPLETED|Follow-Up||0||
60019941|NCT01660711|76135951|FG000|STARTED|Overall Study||22||
60019942|NCT01660711|76135951|FG000|COMPLETED|Overall Study||14||
60019943|NCT01660711|76135951|FG000|NOT COMPLETED|Overall Study||8||
60019944|NCT02544113|76135957|FG000|STARTED|Overall Study||55||
60019945|NCT02544113|76135958|FG001|STARTED|Overall Study||55||
60019946|NCT02544113|76135957|FG000|COMPLETED|Overall Study||52||
60019947|NCT02544113|76135958|FG001|COMPLETED|Overall Study||51||
60019948|NCT02544113|76135957|FG000|NOT COMPLETED|Overall Study||3||
60019949|NCT02544113|76135958|FG001|NOT COMPLETED|Overall Study||4||
60019950|NCT02538965|76135964|FG000|STARTED|Treatment Period||17||
60019951|NCT02538965|76135964|FG000|COMPLETED|Treatment Period||0||
60019952|NCT02538965|76135964|FG000|NOT COMPLETED|Treatment Period||17||
60019953|NCT02538965|76135964|FG000|STARTED|Follow-Up Period||17||
60019954|NCT02538965|76135964|FG000|COMPLETED|Follow-Up Period||0||
60019955|NCT02538965|76135964|FG000|NOT COMPLETED|Follow-Up Period||17||
60019956|NCT02543801|76135972|FG000|STARTED|Overall Study||61||
60019957|NCT02543801|76135973|FG001|STARTED|Overall Study||60||
60019958|NCT02543801|76135974|FG002|STARTED|Overall Study||59||
60019959|NCT02543801|76135975|FG003|STARTED|Overall Study||59||
59912372|NCT04178941|76033162|FG000|COMPLETED|Overall Study||1051||
59912373|NCT04178941|76033163|FG001|COMPLETED|Overall Study||847||
59912374|NCT04178941|76033162|FG000|NOT COMPLETED|Overall Study||0||
59912375|NCT04178941|76033163|FG001|NOT COMPLETED|Overall Study||0||
59912376|NCT04137731|76033171|FG000|STARTED|Overall Study||20||
59912377|NCT04137731|76033172|FG001|STARTED|Overall Study||20||
59912378|NCT04137731|76033171|FG000|COMPLETED|Overall Study||17||
59912379|NCT04137731|76033172|FG001|COMPLETED|Overall Study||17||
59912380|NCT04137731|76033171|FG000|NOT COMPLETED|Overall Study||3||
59912381|NCT04137731|76033172|FG001|NOT COMPLETED|Overall Study||3||
59912382|NCT04114071|76033180|FG000|STARTED|Overall Study||15||
59912383|NCT04114071|76033181|FG001|STARTED|Overall Study||15||
59912384|NCT04114071|76033180|FG000|COMPLETED|Overall Study||14||
59912385|NCT04114071|76033181|FG001|COMPLETED|Overall Study||15||
59912386|NCT04114071|76033180|FG000|NOT COMPLETED|Overall Study||1||
59912387|NCT04114071|76033181|FG001|NOT COMPLETED|Overall Study||0||
59912388|NCT04088760|76033187|FG000|STARTED|Overall Study||15||
59912389|NCT04088760|76033187|FG000|COMPLETED|Overall Study||14||
59912390|NCT04088760|76033187|FG000|NOT COMPLETED|Overall Study||1||
59912391|NCT03826628|76033194|FG000|STARTED|Overall Study||36||
60019960|NCT02543801|76135972|FG000|COMPLETED|Overall Study||60||
60019961|NCT02543801|76135973|FG001|COMPLETED|Overall Study||58||
60019962|NCT02543801|76135974|FG002|COMPLETED|Overall Study||59||
60019963|NCT02543801|76135975|FG003|COMPLETED|Overall Study||59||
60019964|NCT02543801|76135972|FG000|NOT COMPLETED|Overall Study||1||
60019965|NCT02543801|76135973|FG001|NOT COMPLETED|Overall Study||2||
60019966|NCT02543801|76135974|FG002|NOT COMPLETED|Overall Study||0||
60019967|NCT02543801|76135975|FG003|NOT COMPLETED|Overall Study||0||
60019968|NCT02535065|76135985|FG000|STARTED|Overall Study||62||
60019969|NCT02535065|76135985|FG000|1-Month Follow-up|Overall Study||62||
60019970|NCT02535065|76135985|FG000|12-Month Follow-up|Overall Study||61||
60019971|NCT02535065|76135985|FG000|COMPLETED|Overall Study||42||
60019972|NCT02535065|76135985|FG000|NOT COMPLETED|Overall Study||20||
60019973|NCT02530619|76135989|FG000|STARTED|Registered for Study||26||
60019974|NCT02530619|76135989|FG000|Registered|Registered for Study||26||
60019975|NCT02530619|76135989|FG000|Received 1st Dose of Alisertib|Registered for Study||24||
60019976|NCT02530619|76135989|FG000|COMPLETED|Registered for Study||24||
60019977|NCT02530619|76135989|FG000|NOT COMPLETED|Registered for Study||2||
60019978|NCT02530619|76135989|FG000|STARTED|Completed 1st Cycle of Treatment||24||
60019979|NCT02530619|76135989|FG000|COMPLETED|Completed 1st Cycle of Treatment||24||
60019980|NCT02530619|76135989|FG000|NOT COMPLETED|Completed 1st Cycle of Treatment||0||
60019981|NCT02530619|76135989|FG000|STARTED|Continued Treatment Cycles 2 Through 6||24||
60019982|NCT02530619|76135989|FG000|COMPLETED|Continued Treatment Cycles 2 Through 6||14||
60019983|NCT02530619|76135989|FG000|NOT COMPLETED|Continued Treatment Cycles 2 Through 6||10||
60019984|NCT02530619|76135989|FG000|STARTED|Continued Treatment Cycle 7+||14||
60019985|NCT02530619|76135989|FG000|COMPLETED|Continued Treatment Cycle 7+||14||
60019986|NCT02530619|76135989|FG000|NOT COMPLETED|Continued Treatment Cycle 7+||0||
60019987|NCT02530619|76135989|FG000|STARTED|Follow-up Period (6 Months)|Patients who received at least one dose of study drug go into follow-up.|21|3 patients are still on treatment and have not entered the follow-up period.|
60019988|NCT02530619|76135989|FG000|COMPLETED|Follow-up Period (6 Months)||10||
60019989|NCT02530619|76135989|FG000|NOT COMPLETED|Follow-up Period (6 Months)||11||
60019990|NCT02530385|76135995|FG000|STARTED|Overall Study||12||
59912392|NCT03826628|76033195|FG001|STARTED|Overall Study||33||
59912393|NCT03826628|76033196|FG002|STARTED|Overall Study||38||
59912394|NCT03826628|76033194|FG000|COMPLETED|Overall Study||32||
59912395|NCT03826628|76033195|FG001|COMPLETED|Overall Study||31||
59912396|NCT03826628|76033196|FG002|COMPLETED|Overall Study||35||
59912397|NCT03826628|76033194|FG000|NOT COMPLETED|Overall Study||4||
59912398|NCT03826628|76033195|FG001|NOT COMPLETED|Overall Study||2||
59912399|NCT03826628|76033196|FG002|NOT COMPLETED|Overall Study||3||
59912400|NCT03813238|76033206|FG000|STARTED|Overall Study||22||
59912401|NCT03813238|76033207|FG001|STARTED|Overall Study||41||
59912402|NCT03813238|76033206|FG000|Received at Least 1 Dose of Study Drug|Overall Study||22||
59912403|NCT03813238|76033207|FG001|Received at Least 1 Dose of Study Drug|Overall Study||40||
59912404|NCT03813238|76033206|FG000|Modified Intent-to-treat (mITT) Analysis Set|Overall Study||21|All randomized participants with at least 1 postbaseline centrally read Movement Disorder-Childhood Rating Scale (MD-CRS) part II assessment.|
59912405|NCT03813238|76033207|FG001|Modified Intent-to-treat (mITT) Analysis Set|Overall Study||40|All randomized participants with at least 1 postbaseline centrally read Movement Disorder-Childhood Rating Scale (MD-CRS) part II assessment.|
59912406|NCT03813238|76033206|FG000|COMPLETED|Overall Study||21||
59912407|NCT03813238|76033207|FG001|COMPLETED|Overall Study||30||
60019991|NCT02530385|76135996|FG001|STARTED|Overall Study||12||
60019992|NCT02530385|76135995|FG000|COMPLETED|Overall Study||12||
60019993|NCT02530385|76135996|FG001|COMPLETED|Overall Study||11||
60019994|NCT02530385|76135995|FG000|NOT COMPLETED|Overall Study||0||
59912408|NCT03813238|76033206|FG000|NOT COMPLETED|Overall Study||1||
59912409|NCT03813238|76033207|FG001|NOT COMPLETED|Overall Study||11||
59912410|NCT03737240|76033215|FG000|STARTED|Overall Study||72||
59912411|NCT03737240|76033216|FG001|STARTED|Overall Study||73||
59912412|NCT03737240|76033215|FG000|COMPLETED|Overall Study||56||
59912413|NCT03737240|76033216|FG001|COMPLETED|Overall Study||58||
59912414|NCT03737240|76033215|FG000|NOT COMPLETED|Overall Study||16||
59912415|NCT03737240|76033216|FG001|NOT COMPLETED|Overall Study||15||
59912416|NCT03532178|76033224|FG000|STARTED|First Period||23||
59912417|NCT03532178|76033225|FG001|STARTED|First Period||21||
59912418|NCT03532178|76033224|FG000|COMPLETED|First Period||22||
59912419|NCT03532178|76033225|FG001|COMPLETED|First Period||17||
59912420|NCT03532178|76033224|FG000|NOT COMPLETED|First Period||1||
59912421|NCT03532178|76033225|FG001|NOT COMPLETED|First Period||4||
59912422|NCT03532178|76033224|FG000|STARTED|Second Period||22||
59912423|NCT03532178|76033225|FG001|STARTED|Second Period||17||
59912424|NCT03532178|76033224|FG000|COMPLETED|Second Period||21||
59912425|NCT03532178|76033225|FG001|COMPLETED|Second Period||15||
59912426|NCT03532178|76033224|FG000|NOT COMPLETED|Second Period||1||
59912427|NCT03532178|76033225|FG001|NOT COMPLETED|Second Period||2||
59912428|NCT03526549|76033233|FG000|STARTED|180 Days Observational Phase||243||
59912429|NCT03526549|76033234|FG001|STARTED|180 Days Observational Phase||240||
59912430|NCT03526549|76033233|FG000|Completed Day 180|180 Days Observational Phase||243||
59912431|NCT03526549|76033234|FG001|Completed Day 180|180 Days Observational Phase||240||
59912432|NCT03526549|76033233|FG000|COMPLETED|180 Days Observational Phase||202|Completed 180 days of observation and consented to continue in the Open-label Phase.|
59912433|NCT03526549|76033234|FG001|COMPLETED|180 Days Observational Phase|After Day 180, all participants who received placebo during the double-blind studies were discontinued.|0|Completed 180 days of observation and consented to continue in the Open-label Phase.|
59912434|NCT03526549|76033233|FG000|NOT COMPLETED|180 Days Observational Phase||41||
59912435|NCT03526549|76033234|FG001|NOT COMPLETED|180 Days Observational Phase||240||
59912436|NCT03526549|76033233|FG000|STARTED|Open-label Phase|All participants who received CCH-aaes in parent studies and consented to continue in the Open-label Phase of the study.|202||
59912437|NCT03526549|76033234|FG001|STARTED|Open-label Phase||0||
59912438|NCT03526549|76033233|FG000|CCH-aaes Retreatment|Open-label Phase||55|Participants who qualified and opted for CCH-aaes retreatment in the Open-label Phase.|
59912439|NCT03526549|76033234|FG001|CCH-aaes Retreatment|Open-label Phase||0|Participants who qualified and opted for CCH-aaes retreatment in the Open-label Phase.|
59912440|NCT03526549|76033233|FG000|COMPLETED|Open-label Phase||104||
59912441|NCT03526549|76033234|FG001|COMPLETED|Open-label Phase||0||
59912442|NCT03526549|76033233|FG000|NOT COMPLETED|Open-label Phase||98||
59912443|NCT03526549|76033234|FG001|NOT COMPLETED|Open-label Phase||0||
59912444|NCT03449901|76033248|FG000|STARTED|Overall Study||82||
59912445|NCT03449901|76033249|FG001|STARTED|Overall Study||15||
59912446|NCT03449901|76033248|FG000|COMPLETED|Overall Study|1 patient completed treatment per protocol.|1||
59912447|NCT03449901|76033249|FG001|COMPLETED|Overall Study||0||
59912448|NCT03449901|76033248|FG000|NOT COMPLETED|Overall Study||81||
59912449|NCT03449901|76033249|FG001|NOT COMPLETED|Overall Study||15||
59912450|NCT03435380|76033264|FG000|STARTED|Overall Study||90||
59912451|NCT03435380|76033265|FG001|STARTED|Overall Study||91||
59912452|NCT03435380|76033266|FG002|STARTED|Overall Study||90||
59912453|NCT03435380|76033264|FG000|COMPLETED|Overall Study||76||
59912454|NCT03435380|76033265|FG001|COMPLETED|Overall Study||79||
59912455|NCT03435380|76033266|FG002|COMPLETED|Overall Study||81||
59912456|NCT03435380|76033264|FG000|NOT COMPLETED|Overall Study||14||
59912457|NCT03435380|76033265|FG001|NOT COMPLETED|Overall Study||12||
59912458|NCT03435380|76033266|FG002|NOT COMPLETED|Overall Study||9||
59912459|NCT03363659|76033274|FG000|STARTED|Overall Study|Of 15 subjects consented, 1 subject was a screen fail and 1 subject withdrew before any planned intervention.|15||
59912460|NCT03363659|76033274|FG000|COMPLETED|Overall Study||12||
59912461|NCT03363659|76033274|FG000|NOT COMPLETED|Overall Study||3||
59912462|NCT03299166|76033280|FG000|STARTED|Overall Study||124|Participants who were randomized.|
59912463|NCT03299166|76033281|FG001|STARTED|Overall Study||124|Participants who were randomized.|
59912464|NCT03299166|76033280|FG000|Treated|Overall Study||122||
59912465|NCT03299166|76033281|FG001|Treated|Overall Study||122||
59912466|NCT03299166|76033280|FG000|Modified Intent-to- Treat (mITT) Participants|Overall Study||115|Modified intent-to-treat (mITT) participants in the randomization phase included randomized participants who received at least 1 dose of blinded study drug and provided a non-missing baseline assessment and at least 1 non-missing post-baseline efficacy assessment.|
59912467|NCT03299166|76033281|FG001|Modified Intent-to- Treat (mITT) Participants|Overall Study||117|Modified intent-to-treat (mITT) participants in the randomization phase included randomized participants who received at least 1 dose of blinded study drug and provided a non-missing baseline assessment and at least 1 non-missing post-baseline efficacy assessment.|
59912468|NCT03299166|76033280|FG000|COMPLETED|Overall Study||101||
59912469|NCT03299166|76033281|FG001|COMPLETED|Overall Study||109||
59912470|NCT03299166|76033280|FG000|NOT COMPLETED|Overall Study||23||
59912471|NCT03299166|76033281|FG001|NOT COMPLETED|Overall Study||15||
59912472|NCT03204812|76033287|FG000|STARTED|Overall Study||26||
59912473|NCT03204812|76033287|FG000|COMPLETED|Overall Study||23||
59912474|NCT03204812|76033287|FG000|NOT COMPLETED|Overall Study||3||
59912475|NCT03201250|76033294|FG000|STARTED|Overall Study||8||
59912476|NCT03201250|76033295|FG001|STARTED|Overall Study||3||
59912477|NCT03201250|76033296|FG002|STARTED|Overall Study||0||
59912478|NCT03201250|76033294|FG000|COMPLETED|Overall Study||5||
59912479|NCT03201250|76033295|FG001|COMPLETED|Overall Study||3||
59912480|NCT03201250|76033296|FG002|COMPLETED|Overall Study||0||
59912481|NCT03201250|76033294|FG000|NOT COMPLETED|Overall Study||3||
59912482|NCT03201250|76033295|FG001|NOT COMPLETED|Overall Study||0||
59912483|NCT03201250|76033296|FG002|NOT COMPLETED|Overall Study||0||
59912484|NCT03149029|76033307|FG000|STARTED|Overall Study||16||
59912485|NCT03149029|76033308|FG001|STARTED|Overall Study||0||
59912486|NCT03149029|76033307|FG000|COMPLETED|Overall Study||14||
59912487|NCT03149029|76033308|FG001|COMPLETED|Overall Study||0||
59912488|NCT03149029|76033307|FG000|NOT COMPLETED|Overall Study||2||
59912489|NCT03149029|76033308|FG001|NOT COMPLETED|Overall Study||0||
59912490|NCT02853305|76033318|FG000|STARTED|Overall Study||351||
59912491|NCT02853305|76033319|FG001|STARTED|Overall Study||307||
59912492|NCT02853305|76033320|FG002|STARTED|Overall Study||352||
59912493|NCT02853305|76033318|FG000|Received First Course of Pembrolizumab|Overall Study|Includes 2 participants randomized to Pembrolizumab alone|349||
59912494|NCT02853305|76033319|FG001|Received First Course of Pembrolizumab|Overall Study||302||
60019995|NCT02530385|76135996|FG001|NOT COMPLETED|Overall Study||1||
60019996|NCT02362425|76136006|FG000|STARTED|Phase 1 (up to 6 Months)||53||
60019997|NCT02362425|76136007|FG001|STARTED|Phase 1 (up to 6 Months)||10||
60019998|NCT02362425|76136008|FG002|STARTED|Phase 1 (up to 6 Months)||0||
60019999|NCT02362425|76136009|FG003|STARTED|Phase 1 (up to 6 Months)||0||
60020000|NCT02362425|76136006|FG000|COMPLETED|Phase 1 (up to 6 Months)||37||
60020001|NCT02362425|76136007|FG001|COMPLETED|Phase 1 (up to 6 Months)||10||
60020002|NCT02362425|76136008|FG002|COMPLETED|Phase 1 (up to 6 Months)||0||
60020003|NCT02362425|76136009|FG003|COMPLETED|Phase 1 (up to 6 Months)||0||
60020004|NCT02362425|76136006|FG000|NOT COMPLETED|Phase 1 (up to 6 Months)||16||
60020005|NCT02362425|76136007|FG001|NOT COMPLETED|Phase 1 (up to 6 Months)||0||
60020006|NCT02362425|76136008|FG002|NOT COMPLETED|Phase 1 (up to 6 Months)||0||
60020007|NCT02362425|76136009|FG003|NOT COMPLETED|Phase 1 (up to 6 Months)||0||
60020008|NCT02362425|76136006|FG000|STARTED|Phase 2 (up to 6 Months, Randomized)||0||
60020009|NCT02362425|76136007|FG001|STARTED|Phase 2 (up to 6 Months, Randomized)||0||
60020010|NCT02362425|76136008|FG002|STARTED|Phase 2 (up to 6 Months, Randomized)||16||
60020011|NCT02362425|76136009|FG003|STARTED|Phase 2 (up to 6 Months, Randomized)||17||
60020012|NCT02362425|76136006|FG000|COMPLETED|Phase 2 (up to 6 Months, Randomized)||0||
60020013|NCT02362425|76136007|FG001|COMPLETED|Phase 2 (up to 6 Months, Randomized)||0||
60020014|NCT02362425|76136008|FG002|COMPLETED|Phase 2 (up to 6 Months, Randomized)||15||
60020015|NCT02362425|76136009|FG003|COMPLETED|Phase 2 (up to 6 Months, Randomized)||14||
60020016|NCT02362425|76136006|FG000|NOT COMPLETED|Phase 2 (up to 6 Months, Randomized)||0||
60020017|NCT02362425|76136007|FG001|NOT COMPLETED|Phase 2 (up to 6 Months, Randomized)||0||
60020018|NCT02362425|76136008|FG002|NOT COMPLETED|Phase 2 (up to 6 Months, Randomized)||1||
60020019|NCT02362425|76136009|FG003|NOT COMPLETED|Phase 2 (up to 6 Months, Randomized)||3||
60020020|NCT02362269|76136022|FG000|STARTED|Overall Study||83||
60020021|NCT02362269|76136023|FG001|STARTED|Overall Study||86||
60020022|NCT02362269|76136022|FG000|COMPLETED|Overall Study||82||
60020023|NCT02362269|76136023|FG001|COMPLETED|Overall Study||80||
60020024|NCT02362269|76136022|FG000|NOT COMPLETED|Overall Study||1||
60020025|NCT02362269|76136023|FG001|NOT COMPLETED|Overall Study||6||
60020026|NCT02529995|76136031|FG000|STARTED|Part A||15||
60020027|NCT02529995|76136032|FG001|STARTED|Part A||16||
60020028|NCT02529995|76136031|FG000|COMPLETED|Part A|'Completed' means 'Completed the Study', i.e. zero patient completed the study in part A.|0||
60020029|NCT02529995|76136032|FG001|COMPLETED|Part A|'Completed' means 'Completed the Study', i.e. zero patient completed the study in part A.|0||
60020030|NCT02529995|76136031|FG000|NOT COMPLETED|Part A||15||
60020031|NCT02529995|76136032|FG001|NOT COMPLETED|Part A||16||
60020032|NCT02529995|76136031|FG000|STARTED|Part B||15||
60020033|NCT02529995|76136032|FG001|STARTED|Part B||16||
60020034|NCT02529995|76136031|FG000|COMPLETED|Part B||9||
60020035|NCT02529995|76136032|FG001|COMPLETED|Part B||4||
60020036|NCT02529995|76136031|FG000|NOT COMPLETED|Part B||6||
60020037|NCT02529995|76136032|FG001|NOT COMPLETED|Part B||12||
60020038|NCT02529137|76136038|FG000|STARTED|Overall Study||2000|Instead of participants, retrospective cases were enrolled in the study|
60020039|NCT02529137|76136038|FG000|COMPLETED|Overall Study||1992|Instead of participants, retrospective cases were enrolled in the study|
60020040|NCT02529137|76136038|FG000|NOT COMPLETED|Overall Study||8||
60020041|NCT02319759|76136045|FG000|STARTED|Week 0 - 16||49||
60020042|NCT02319759|76136046|FG001|STARTED|Week 0 - 16||0||
60020043|NCT02319759|76136047|FG002|STARTED|Week 0 - 16||100||
60020044|NCT02319759|76136048|FG003|STARTED|Week 0 - 16||0||
60020045|NCT02319759|76136049|FG004|STARTED|Week 0 - 16||0||
60020046|NCT02319759|76136045|FG000|COMPLETED|Week 0 - 16||48||
60020047|NCT02319759|76136046|FG001|COMPLETED|Week 0 - 16||0||
60020048|NCT02319759|76136047|FG002|COMPLETED|Week 0 - 16||99||
60020049|NCT02319759|76136048|FG003|COMPLETED|Week 0 - 16||0||
60020050|NCT02319759|76136049|FG004|COMPLETED|Week 0 - 16||0||
60020051|NCT02319759|76136045|FG000|NOT COMPLETED|Week 0 - 16||1||
60020052|NCT02319759|76136046|FG001|NOT COMPLETED|Week 0 - 16||0||
60020053|NCT02319759|76136047|FG002|NOT COMPLETED|Week 0 - 16||1||
60020054|NCT02319759|76136048|FG003|NOT COMPLETED|Week 0 - 16||0||
60020055|NCT02319759|76136049|FG004|NOT COMPLETED|Week 0 - 16||0||
60020056|NCT02319759|76136045|FG000|STARTED|Week 16 - 24||31||
60020057|NCT02319759|76136046|FG001|STARTED|Week 16 - 24||0||
59912495|NCT02853305|76033320|FG002|Received First Course of Pembrolizumab|Overall Study||342||
59912496|NCT02853305|76033318|FG000|Received Second Course of Pembrolizumab|Overall Study||14||
59912497|NCT02853305|76033319|FG001|Received Second Course of Pembrolizumab|Overall Study||15||
59912498|NCT02853305|76033320|FG002|Received Second Course of Pembrolizumab|Overall Study||0||
59912499|NCT02853305|76033318|FG000|COMPLETED|Overall Study||0||
59912500|NCT02853305|76033319|FG001|COMPLETED|Overall Study||0||
59912501|NCT02853305|76033320|FG002|COMPLETED|Overall Study||0||
59912502|NCT02853305|76033318|FG000|NOT COMPLETED|Overall Study||351||
59912503|NCT02853305|76033319|FG001|NOT COMPLETED|Overall Study||307||
59912504|NCT02853305|76033320|FG002|NOT COMPLETED|Overall Study||352||
59912505|NCT02524275|76033330|FG000|STARTED|Overall Study||14||
59912506|NCT02524275|76033330|FG000|COMPLETED|Overall Study||9||
59912507|NCT02524275|76033330|FG000|NOT COMPLETED|Overall Study||5||
59912508|NCT02499120|76033336|FG000|STARTED|Overall Study||65||
59912509|NCT02499120|76033337|FG001|STARTED|Overall Study||60||
59912510|NCT02499120|76033336|FG000|Received Treatment|Overall Study||64||
59912511|NCT02499120|76033337|FG001|Received Treatment|Overall Study||60||
59912512|NCT02499120|76033336|FG000|COMPLETED|Overall Study||0||
59912513|NCT02499120|76033337|FG001|COMPLETED|Overall Study||0||
59912514|NCT02499120|76033336|FG000|NOT COMPLETED|Overall Study||65||
59912515|NCT02499120|76033337|FG001|NOT COMPLETED|Overall Study||60||
59912516|NCT02227992|76033345|FG000|STARTED|Overall Study||20||
59912517|NCT02227992|76033346|FG001|STARTED|Overall Study||20||
59912518|NCT02227992|76033345|FG000|COMPLETED|Overall Study||19||
59912519|NCT02227992|76033346|FG001|COMPLETED|Overall Study||19||
59912520|NCT02227992|76033345|FG000|NOT COMPLETED|Overall Study||1||
59912521|NCT02227992|76033346|FG001|NOT COMPLETED|Overall Study||1||
59912522|NCT01033565|76033352|FG000|STARTED|Overall Study||1||
59912523|NCT01033565|76033352|FG000|COMPLETED|Overall Study||1||
59912524|NCT01033565|76033352|FG000|NOT COMPLETED|Overall Study||0||
59912525|NCT01027143|76033358|FG000|STARTED|Overall Study||77||
59912526|NCT01027143|76033359|FG001|STARTED|Overall Study||21||
59912527|NCT01027143|76033358|FG000|COMPLETED|Overall Study||68||
59912528|NCT01027143|76033359|FG001|COMPLETED|Overall Study||17||
59912529|NCT01027143|76033358|FG000|NOT COMPLETED|Overall Study||9||
59912530|NCT01027143|76033359|FG001|NOT COMPLETED|Overall Study||4||
59912531|NCT00981656|76033365|FG000|STARTED|Overall Study||37||
59912532|NCT00981656|76033365|FG000|Eligible and Started Study Treatment|Overall Study||34||
59912533|NCT00981656|76033365|FG000|COMPLETED|Overall Study||34|Participants contributing data to results are considered to have completed the study.|
59912534|NCT00981656|76033365|FG000|NOT COMPLETED|Overall Study||3||
59912535|NCT00895622|76033372|FG000|STARTED|Overall Study||65||
59912536|NCT00895622|76033373|FG001|STARTED|Overall Study||56||
59912537|NCT00895622|76033374|FG002|STARTED|Overall Study||57||
59912538|NCT00895622|76033372|FG000|COMPLETED|Overall Study||60||
59912539|NCT00895622|76033373|FG001|COMPLETED|Overall Study||52||
59912540|NCT00895622|76033374|FG002|COMPLETED|Overall Study||53||
59912541|NCT00895622|76033372|FG000|NOT COMPLETED|Overall Study||5||
59912542|NCT00895622|76033373|FG001|NOT COMPLETED|Overall Study||4||
59912543|NCT00895622|76033374|FG002|NOT COMPLETED|Overall Study||4||
59912544|NCT00847535|76033390|FG000|STARTED|Overall Study||24||
59912545|NCT00847535|76033391|FG001|STARTED|Overall Study||24||
59912546|NCT00847535|76033392|FG002|STARTED|Overall Study||16||
59912547|NCT00847535|76033390|FG000|10 Million AMDC|Overall Study||8||
59912548|NCT00847535|76033391|FG001|10 Million AMDC|Overall Study||8||
59912549|NCT00847535|76033392|FG002|10 Million AMDC|Overall Study||0||
59912550|NCT00847535|76033390|FG000|50 Million AMDC|Overall Study||8||
59912551|NCT00847535|76033391|FG001|50 Million AMDC|Overall Study||8||
59912552|NCT00847535|76033392|FG002|50 Million AMDC|Overall Study||0||
59912553|NCT00847535|76033390|FG000|100 Million AMDC|Overall Study||8||
59912554|NCT00847535|76033391|FG001|100 Million AMDC|Overall Study||8||
59912555|NCT00847535|76033392|FG002|100 Million AMDC|Overall Study||8||
59912556|NCT00847535|76033390|FG000|200 Million AMDC|Overall Study||0||
59912557|NCT00847535|76033391|FG001|200 Million AMDC|Overall Study||0||
59912558|NCT00847535|76033392|FG002|200 Million AMDC|Overall Study||8||
59912559|NCT00847535|76033390|FG000|COMPLETED|Overall Study||22||
59912560|NCT00847535|76033391|FG001|COMPLETED|Overall Study||22||
59912561|NCT00847535|76033392|FG002|COMPLETED|Overall Study||15||
59912562|NCT00847535|76033390|FG000|NOT COMPLETED|Overall Study||2||
59912563|NCT00847535|76033391|FG001|NOT COMPLETED|Overall Study||2||
59912564|NCT00847535|76033392|FG002|NOT COMPLETED|Overall Study||1||
59912565|NCT00742157|76033397|FG000|STARTED|Overall Study||5||
59912566|NCT00742157|76033397|FG000|COMPLETED|Overall Study||5||
59912567|NCT00742157|76033397|FG000|NOT COMPLETED|Overall Study||0||
59912568|NCT00539591|76033404|FG000|STARTED|Overall Study||23||
59912569|NCT00539591|76033405|FG001|STARTED|Overall Study||2||
59912570|NCT00539591|76033406|FG002|STARTED|Overall Study||4||
59912571|NCT00539591|76033404|FG000|COMPLETED|Overall Study||18||
59912572|NCT00539591|76033405|FG001|COMPLETED|Overall Study||0||
59912573|NCT00539591|76033406|FG002|COMPLETED|Overall Study||1||
59912574|NCT00539591|76033404|FG000|NOT COMPLETED|Overall Study||5||
59912575|NCT00539591|76033405|FG001|NOT COMPLETED|Overall Study||2||
59912576|NCT00539591|76033406|FG002|NOT COMPLETED|Overall Study||3||
60020058|NCT02319759|76136047|FG002|STARTED|Week 16 - 24||89||
60020059|NCT02319759|76136048|FG003|STARTED|Week 16 - 24||17||
59912577|NCT03878277|76033442|FG000|STARTED|Overall Study||10||
59912578|NCT03878277|76033442|FG000|COMPLETED|Overall Study||10||
59912579|NCT03878277|76033442|FG000|NOT COMPLETED|Overall Study||0||
59912580|NCT03512210|76033446|FG000|STARTED|Step 1: MINMON Intervention||400||
59912581|NCT03512210|76033446|FG000|COMPLETED|Step 1: MINMON Intervention||396||
59912582|NCT03512210|76033446|FG000|NOT COMPLETED|Step 1: MINMON Intervention||4||
59912583|NCT03512210|76033446|FG000|STARTED|Step 2:Post-MINMON||396||
60020060|NCT02319759|76136049|FG004|STARTED|Week 16 - 24||10||
60020061|NCT02319759|76136045|FG000|COMPLETED|Week 16 - 24||29||
60020062|NCT02319759|76136046|FG001|COMPLETED|Week 16 - 24||0||
60020063|NCT02319759|76136047|FG002|COMPLETED|Week 16 - 24||86||
60020064|NCT02319759|76136048|FG003|COMPLETED|Week 16 - 24||17||
60020065|NCT02319759|76136049|FG004|COMPLETED|Week 16 - 24||10||
60020066|NCT02319759|76136045|FG000|NOT COMPLETED|Week 16 - 24||2||
60020067|NCT02319759|76136046|FG001|NOT COMPLETED|Week 16 - 24||0||
60020068|NCT02319759|76136047|FG002|NOT COMPLETED|Week 16 - 24||3||
60020069|NCT02319759|76136048|FG003|NOT COMPLETED|Week 16 - 24||0||
60020070|NCT02319759|76136049|FG004|NOT COMPLETED|Week 16 - 24||0||
60020071|NCT02319759|76136045|FG000|STARTED|Week 24 - 56||0||
60020072|NCT02319759|76136046|FG001|STARTED|Week 24 - 56||29||
60020073|NCT02319759|76136047|FG002|STARTED|Week 24 - 56||86||
60020074|NCT02319759|76136048|FG003|STARTED|Week 24 - 56||17||
60020075|NCT02319759|76136049|FG004|STARTED|Week 24 - 56||10||
60020076|NCT02319759|76136045|FG000|COMPLETED|Week 24 - 56||0||
60020077|NCT02319759|76136046|FG001|COMPLETED|Week 24 - 56||28||
60020078|NCT02319759|76136047|FG002|COMPLETED|Week 24 - 56||84||
60020079|NCT02319759|76136048|FG003|COMPLETED|Week 24 - 56||15||
60020080|NCT02319759|76136049|FG004|COMPLETED|Week 24 - 56||8||
60020081|NCT02319759|76136045|FG000|NOT COMPLETED|Week 24 - 56||0||
60020082|NCT02319759|76136046|FG001|NOT COMPLETED|Week 24 - 56||1||
60020083|NCT02319759|76136047|FG002|NOT COMPLETED|Week 24 - 56||2||
60020084|NCT02319759|76136048|FG003|NOT COMPLETED|Week 24 - 56||2||
60020085|NCT02319759|76136049|FG004|NOT COMPLETED|Week 24 - 56||2||
60020086|NCT02293005|76136062|FG000|STARTED|Overall Study||26||
60020087|NCT02293005|76136062|FG000|COMPLETED|Overall Study||0||
60020088|NCT02293005|76136062|FG000|NOT COMPLETED|Overall Study||26||
60020089|NCT02319525|76136068|FG000|STARTED|Overall Study||153||
60020090|NCT02319525|76136069|FG001|STARTED|Overall Study||148||
60020091|NCT02319525|76136068|FG000|Primary Research Completion|Overall Study||151||
60020092|NCT02319525|76136069|FG001|Primary Research Completion|Overall Study||147||
60020093|NCT02319525|76136068|FG000|COMPLETED|Overall Study||151||
60020094|NCT02319525|76136069|FG001|COMPLETED|Overall Study||147||
60020095|NCT02319525|76136068|FG000|NOT COMPLETED|Overall Study||2||
60020096|NCT02319525|76136069|FG001|NOT COMPLETED|Overall Study||1||
60020097|NCT02292927|76136077|FG000|STARTED|Overall Study||13||
60020098|NCT02292927|76136078|FG001|STARTED|Overall Study||12||
60020099|NCT02292927|76136077|FG000|COMPLETED|Overall Study||0||
59912584|NCT03512210|76033446|FG000|COMPLETED|Step 2:Post-MINMON||362||
59912585|NCT03512210|76033446|FG000|NOT COMPLETED|Step 2:Post-MINMON||34||
59912586|NCT00383721|76033455|FG000|STARTED|26-Week Double-Blind Treatment Period||225||
59912587|NCT00383721|76033456|FG001|STARTED|26-Week Double-Blind Treatment Period||239||
59912588|NCT00383721|76033457|FG002|STARTED|26-Week Double-Blind Treatment Period||253||
59912589|NCT00383721|76033458|FG003|STARTED|26-Week Double-Blind Treatment Period||243||
59912590|NCT00383721|76033459|FG004|STARTED|26-Week Double-Blind Treatment Period||236||
59912591|NCT00383721|76033455|FG000|COMPLETED|26-Week Double-Blind Treatment Period|"1 participant listed as ongoing since the participant status could not be formally confirmed."|190||
59912592|NCT00383721|76033456|FG001|COMPLETED|26-Week Double-Blind Treatment Period||202||
59912593|NCT00383721|76033457|FG002|COMPLETED|26-Week Double-Blind Treatment Period||202||
59951302|NCT03641287|76070233|FG000|COMPLETED|Overall Study||28||
60020100|NCT02292927|76136078|FG001|COMPLETED|Overall Study||5||
60020101|NCT02292927|76136077|FG000|NOT COMPLETED|Overall Study||13||
60020102|NCT02292927|76136078|FG001|NOT COMPLETED|Overall Study||7||
60020103|NCT02292849|76136090|FG000|STARTED|Overall Study||11||
60020104|NCT02292849|76136091|FG001|STARTED|Overall Study||8||
60020105|NCT02292849|76136092|FG002|STARTED|Overall Study||10||
60020106|NCT02292849|76136090|FG000|COMPLETED|Overall Study||7||
60020107|NCT02292849|76136091|FG001|COMPLETED|Overall Study||6||
60020108|NCT02292849|76136092|FG002|COMPLETED|Overall Study||8||
60020109|NCT02292849|76136090|FG000|NOT COMPLETED|Overall Study||4||
60020110|NCT02292849|76136091|FG001|NOT COMPLETED|Overall Study||2||
60020111|NCT02292849|76136092|FG002|NOT COMPLETED|Overall Study||2||
60020112|NCT02318667|76136100|FG000|STARTED|Overall Study||38||
60020113|NCT02318667|76136100|FG000|COMPLETED|Overall Study||29||
60020114|NCT02318667|76136100|FG000|NOT COMPLETED|Overall Study||9||
60020115|NCT02292771|76136110|FG000|STARTED|Overall Study||47||
60020116|NCT02292771|76136111|FG001|STARTED|Overall Study||50||
60020117|NCT02292771|76136110|FG000|COMPLETED|Overall Study||43||
60020118|NCT02292771|76136111|FG001|COMPLETED|Overall Study||48||
60020119|NCT02292771|76136110|FG000|NOT COMPLETED|Overall Study||4||
60020120|NCT02292771|76136111|FG001|NOT COMPLETED|Overall Study||2||
60020121|NCT02291913|76136121|FG000|STARTED|Overall Study||48||
60020122|NCT02291913|76136121|FG000|COMPLETED|Overall Study||0||
60020123|NCT02291913|76136121|FG000|NOT COMPLETED|Overall Study||48||
60020124|NCT02291679|76136128|FG000|STARTED|Overall Study||401||
60020125|NCT02291679|76136129|FG001|STARTED|Overall Study||411||
60020126|NCT02291679|76136130|FG002|STARTED|Overall Study||411||
60020127|NCT02291679|76136128|FG000|COMPLETED|Overall Study||357||
60020128|NCT02291679|76136129|FG001|COMPLETED|Overall Study||369||
60020129|NCT02291679|76136130|FG002|COMPLETED|Overall Study||352||
60020130|NCT02291679|76136128|FG000|NOT COMPLETED|Overall Study||44||
60020131|NCT02291679|76136129|FG001|NOT COMPLETED|Overall Study||42||
60020132|NCT02291679|76136130|FG002|NOT COMPLETED|Overall Study||59||
60020133|NCT02291601|76136137|FG000|STARTED|Abdomen||638||638
60020134|NCT02291601|76136138|FG001|STARTED|Abdomen||108||108
60020135|NCT02291601|76136139|FG002|STARTED|Abdomen||642||642
60020136|NCT02291601|76136137|FG000|COMPLETED|Abdomen|638 participants received CHG cloth|305|Completed is a lower participant number than started due to failed treatment day baselines|305
60020137|NCT02291601|76136138|FG001|COMPLETED|Abdomen|108 participants received vehicle|54|Completed is a lower participant number than started due to failed treatment day baselines|54
60020138|NCT02291601|76136139|FG002|COMPLETED|Abdomen|642 participants received comparator CHG|303|Completed is a lower participant number than started due to failed treatment day baselines|303
60020139|NCT02291601|76136137|FG000|NOT COMPLETED|Abdomen||333||333
60020140|NCT02291601|76136138|FG001|NOT COMPLETED|Abdomen||54||54
60020141|NCT02291601|76136139|FG002|NOT COMPLETED|Abdomen||339||339
60020142|NCT02291601|76136137|FG000|STARTED|Groin||520||520
60020143|NCT02291601|76136138|FG001|STARTED|Groin||93||93
60020144|NCT02291601|76136139|FG002|STARTED|Groin||515||515
60020145|NCT02291601|76136137|FG000|COMPLETED|Groin|520 participants received CHG cloth|337|Completed is a lower participant number than started due to failed treatment day baselines|337
60020146|NCT02291601|76136138|FG001|COMPLETED|Groin|93 participants received vehicle|63|Completed is a lower participant number than started due to failed treatment day baselines|63
60020147|NCT02291601|76136139|FG002|COMPLETED|Groin|515 participants received Comparator CHG|338|Completed is a lower participant number than started due to failed treatment day baselines|338
60020148|NCT02291601|76136137|FG000|NOT COMPLETED|Groin||183||183
60020149|NCT02291601|76136138|FG001|NOT COMPLETED|Groin||30||30
60020150|NCT02291601|76136139|FG002|NOT COMPLETED|Groin||177||177
60020151|NCT02360475|76136154|FG000|STARTED|Overall Study||126|A total of 507 subjects were screened, but only 500 subjects received vaccination.|
60020152|NCT02360475|76136155|FG001|STARTED|Overall Study||124|A total of 507 subjects were screened, but only 500 subjects received vaccination.|
60020153|NCT02360475|76136156|FG002|STARTED|Overall Study||125|A total of 507 subjects were screened, but only 500 subjects received vaccination.|
60020154|NCT02360475|76136157|FG003|STARTED|Overall Study||125|A total of 507 subjects were screened, but only 500 subjects received vaccination.|
60020155|NCT02360475|76136154|FG000|COMPLETED|Overall Study||122||
60020156|NCT02360475|76136155|FG001|COMPLETED|Overall Study||111||
60020157|NCT02360475|76136156|FG002|COMPLETED|Overall Study||117||
60020158|NCT02360475|76136157|FG003|COMPLETED|Overall Study||120||
60020159|NCT02360475|76136154|FG000|NOT COMPLETED|Overall Study||4||
60020160|NCT02360475|76136155|FG001|NOT COMPLETED|Overall Study||13||
60020161|NCT02360475|76136156|FG002|NOT COMPLETED|Overall Study||8||
60020162|NCT02360475|76136157|FG003|NOT COMPLETED|Overall Study||5||
60020163|NCT02360397|76136167|FG000|STARTED|Overall Study||6||
60020164|NCT02360397|76136167|FG000|COMPLETED|Overall Study||2||
60020165|NCT02360397|76136167|FG000|NOT COMPLETED|Overall Study||4||
60020166|NCT02317809|76136172|FG000|STARTED|First Intervention Period (8 Days)||17||
60020167|NCT02317809|76136173|FG001|STARTED|First Intervention Period (8 Days)||17||
60020168|NCT02317809|76136172|FG000|COMPLETED|First Intervention Period (8 Days)||14||
60020169|NCT02317809|76136173|FG001|COMPLETED|First Intervention Period (8 Days)||17||
60020170|NCT02317809|76136172|FG000|NOT COMPLETED|First Intervention Period (8 Days)||3||
60020171|NCT02317809|76136173|FG001|NOT COMPLETED|First Intervention Period (8 Days)||0||
60020172|NCT02317809|76136172|FG000|STARTED|Second Intervention Period (8 Days)||14||
60020173|NCT02317809|76136173|FG001|STARTED|Second Intervention Period (8 Days)||17||
60020174|NCT02317809|76136172|FG000|COMPLETED|Second Intervention Period (8 Days)||14||
60020175|NCT02317809|76136173|FG001|COMPLETED|Second Intervention Period (8 Days)||17||
60020176|NCT02317809|76136172|FG000|NOT COMPLETED|Second Intervention Period (8 Days)||0||
60020177|NCT02317809|76136173|FG001|NOT COMPLETED|Second Intervention Period (8 Days)||0||
60020178|NCT02359851|76136182|FG000|STARTED|Overall Study||5||
60020179|NCT02359851|76136182|FG000|COMPLETED|Overall Study||3||
60020180|NCT02359851|76136182|FG000|NOT COMPLETED|Overall Study||2||
60020181|NCT01607905|76136193|FG000|STARTED|Overall Study||60||
59507177|NCT00820573|75600351|FG001|NOT COMPLETED|Overall Study||0||
59507178|NCT00820573|75600352|FG002|NOT COMPLETED|Overall Study||0||
60020182|NCT01607905|76136194|FG001|STARTED|Overall Study||20||
60020183|NCT01607905|76136195|FG002|STARTED|Overall Study||21||
60020184|NCT01607905|76136196|FG003|STARTED|Overall Study||21||
60020185|NCT01607905|76136197|FG004|STARTED|Overall Study||7||
60020186|NCT01607905|76136198|FG005|STARTED|Overall Study||15||
60020187|NCT01607905|76136199|FG006|STARTED|Overall Study||47||
59507179|NCT00820573|75600353|FG003|NOT COMPLETED|Overall Study||0||
60020188|NCT01607905|76136193|FG000|Received Study Drug|Overall Study||59||
59912594|NCT00383721|76033458|FG003|COMPLETED|26-Week Double-Blind Treatment Period||193||
59912595|NCT00383721|76033459|FG004|COMPLETED|26-Week Double-Blind Treatment Period||169||
59912596|NCT00383721|76033455|FG000|NOT COMPLETED|26-Week Double-Blind Treatment Period||35||
59912597|NCT00383721|76033456|FG001|NOT COMPLETED|26-Week Double-Blind Treatment Period||37||
59912598|NCT00383721|76033457|FG002|NOT COMPLETED|26-Week Double-Blind Treatment Period||51||
59912599|NCT00383721|76033458|FG003|NOT COMPLETED|26-Week Double-Blind Treatment Period||50||
59912600|NCT00383721|76033459|FG004|NOT COMPLETED|26-Week Double-Blind Treatment Period||67||
59912601|NCT00383721|76033455|FG000|STARTED|26-Week Treatment Safety Extension||145||
59912602|NCT00383721|76033456|FG001|STARTED|26-Week Treatment Safety Extension||153||
59912603|NCT00383721|76033457|FG002|STARTED|26-Week Treatment Safety Extension||149||
59912604|NCT00383721|76033458|FG003|STARTED|26-Week Treatment Safety Extension||148||
59912605|NCT00383721|76033459|FG004|STARTED|26-Week Treatment Safety Extension||8||
59912606|NCT00383721|76033455|FG000|COMPLETED|26-Week Treatment Safety Extension||126||
59912607|NCT00383721|76033456|FG001|COMPLETED|26-Week Treatment Safety Extension||136||
59912608|NCT00383721|76033457|FG002|COMPLETED|26-Week Treatment Safety Extension||126||
59912609|NCT00383721|76033458|FG003|COMPLETED|26-Week Treatment Safety Extension||131||
59912610|NCT00383721|76033459|FG004|COMPLETED|26-Week Treatment Safety Extension||8||
59912611|NCT00383721|76033455|FG000|NOT COMPLETED|26-Week Treatment Safety Extension||19||
59912612|NCT00383721|76033456|FG001|NOT COMPLETED|26-Week Treatment Safety Extension||17||
59912613|NCT00383721|76033457|FG002|NOT COMPLETED|26-Week Treatment Safety Extension||23||
59912614|NCT00383721|76033458|FG003|NOT COMPLETED|26-Week Treatment Safety Extension||17||
59912615|NCT00383721|76033459|FG004|NOT COMPLETED|26-Week Treatment Safety Extension||0||
59912616|NCT03395288|76033474|FG000|STARTED|Overall Study||28||
59912617|NCT03395288|76033475|FG001|STARTED|Overall Study||29||
59912618|NCT03395288|76033476|FG002|STARTED|Overall Study||4||
59912619|NCT03395288|76033474|FG000|COMPLETED|Overall Study||19||
59912620|NCT03395288|76033475|FG001|COMPLETED|Overall Study||25||
59912621|NCT03395288|76033476|FG002|COMPLETED|Overall Study||3||
59912622|NCT03395288|76033474|FG000|NOT COMPLETED|Overall Study||9||
59912623|NCT03395288|76033475|FG001|NOT COMPLETED|Overall Study||4||
59912624|NCT03395288|76033476|FG002|NOT COMPLETED|Overall Study||1||
59912625|NCT03035942|76033487|FG000|STARTED|Overall Study||45||
59912626|NCT03035942|76033488|FG001|STARTED|Overall Study||45||
59912627|NCT03035942|76033489|FG002|STARTED|Overall Study||45||
59912628|NCT03035942|76033487|FG000|COMPLETED|Overall Study||37||
59912629|NCT03035942|76033488|FG001|COMPLETED|Overall Study||41||
59912630|NCT03035942|76033489|FG002|COMPLETED|Overall Study||40||
59912631|NCT03035942|76033487|FG000|NOT COMPLETED|Overall Study||8||
59912632|NCT03035942|76033488|FG001|NOT COMPLETED|Overall Study||4||
59912633|NCT03035942|76033489|FG002|NOT COMPLETED|Overall Study||5||
59912634|NCT02616146|76033501|FG000|STARTED|Overall Study||1512||
59912635|NCT02616146|76033502|FG001|STARTED|Overall Study||504||
59912636|NCT02616146|76033501|FG000|COMPLETED|Overall Study|Due to termination of study, ENG-E2 reporting group received only up to 10 cycles of treatment.|0||
59912637|NCT02616146|76033502|FG001|COMPLETED|Overall Study|Due to termination of study, LNG-EE reporting group received only up to 9 cycles of treatment.|0||
59912638|NCT02616146|76033501|FG000|NOT COMPLETED|Overall Study||1512||
59912639|NCT02616146|76033502|FG001|NOT COMPLETED|Overall Study||504||
59912640|NCT04850313|76033510|FG000|STARTED|Overall Study||1||
59912641|NCT04850313|76033511|FG001|STARTED|Overall Study||2||
59912642|NCT04850313|76033510|FG000|COMPLETED|Overall Study||1||
59912643|NCT04850313|76033511|FG001|COMPLETED|Overall Study||1||
59912644|NCT04850313|76033510|FG000|NOT COMPLETED|Overall Study||0||
59912645|NCT04850313|76033511|FG001|NOT COMPLETED|Overall Study||1||
59912646|NCT03135249|76033517|FG000|STARTED|Overall Study|Nine patient entered the study|9||
59912647|NCT03135249|76033517|FG000|COMPLETED|Overall Study|Eight patient completed the study.|7||
59912648|NCT03135249|76033517|FG000|NOT COMPLETED|Overall Study||2||
59912649|NCT03291964|76033521|FG000|STARTED|Overall Study||73||
59912650|NCT03291964|76033521|FG000|COMPLETED|Overall Study||73||
59912651|NCT03291964|76033521|FG000|NOT COMPLETED|Overall Study||0||
59912652|NCT02885181|76033529|FG000|STARTED|Overall Study||20||
59912653|NCT02885181|76033530|FG001|STARTED|Overall Study||20||
59912654|NCT02885181|76033531|FG002|STARTED|Overall Study||21||
59912655|NCT02885181|76033532|FG003|STARTED|Overall Study||22||
59912656|NCT02885181|76033529|FG000|COMPLETED|Overall Study||20||
59912657|NCT02885181|76033530|FG001|COMPLETED|Overall Study||19||
59912658|NCT02885181|76033531|FG002|COMPLETED|Overall Study||21||
59912659|NCT02885181|76033532|FG003|COMPLETED|Overall Study||19||
59912660|NCT02885181|76033529|FG000|NOT COMPLETED|Overall Study||0||
59912661|NCT02885181|76033530|FG001|NOT COMPLETED|Overall Study||1||
59912662|NCT02885181|76033531|FG002|NOT COMPLETED|Overall Study||0||
59912663|NCT02885181|76033532|FG003|NOT COMPLETED|Overall Study||3||
59912664|NCT02884089|76033546|FG000|STARTED|Period 1||11||
59912665|NCT02884089|76033547|FG001|STARTED|Period 1||11||
59912666|NCT02884089|76033548|FG002|STARTED|Period 1||9||
59912667|NCT02884089|76033549|FG003|STARTED|Period 1||9||
59912668|NCT02884089|76033546|FG000|Received at Least One Dose of Study Drug|Period 1||11||
59912669|NCT02884089|76033547|FG001|Received at Least One Dose of Study Drug|Period 1||11||
59912670|NCT02884089|76033548|FG002|Received at Least One Dose of Study Drug|Period 1||9||
59912671|NCT02884089|76033549|FG003|Received at Least One Dose of Study Drug|Period 1||9||
59912672|NCT02884089|76033546|FG000|COMPLETED|Period 1||9||
59912673|NCT02884089|76033547|FG001|COMPLETED|Period 1||9||
59912674|NCT02884089|76033548|FG002|COMPLETED|Period 1||9||
59912675|NCT02884089|76033549|FG003|COMPLETED|Period 1||9||
59912676|NCT02884089|76033546|FG000|NOT COMPLETED|Period 1||2||
59912677|NCT02884089|76033547|FG001|NOT COMPLETED|Period 1||2||
59912678|NCT02884089|76033548|FG002|NOT COMPLETED|Period 1||0||
59912679|NCT02884089|76033549|FG003|NOT COMPLETED|Period 1||0||
59912680|NCT02884089|76033546|FG000|STARTED|Washout Period 1||9||
59912681|NCT02884089|76033547|FG001|STARTED|Washout Period 1||9||
59912682|NCT02884089|76033548|FG002|STARTED|Washout Period 1||9||
59912683|NCT02884089|76033549|FG003|STARTED|Washout Period 1||9||
59912684|NCT02884089|76033546|FG000|COMPLETED|Washout Period 1||9||
59912685|NCT02884089|76033547|FG001|COMPLETED|Washout Period 1||7||
59912686|NCT02884089|76033548|FG002|COMPLETED|Washout Period 1||9||
59912687|NCT02884089|76033549|FG003|COMPLETED|Washout Period 1||8||
59912688|NCT02884089|76033546|FG000|NOT COMPLETED|Washout Period 1||0||
59912689|NCT02884089|76033547|FG001|NOT COMPLETED|Washout Period 1||2||
59912690|NCT02884089|76033548|FG002|NOT COMPLETED|Washout Period 1||0||
59912691|NCT02884089|76033549|FG003|NOT COMPLETED|Washout Period 1||1||
59912692|NCT02884089|76033546|FG000|STARTED|Period 2||9||
59912693|NCT02884089|76033547|FG001|STARTED|Period 2||7||
59912694|NCT02884089|76033548|FG002|STARTED|Period 2||9||
59912695|NCT02884089|76033549|FG003|STARTED|Period 2||8||
59912696|NCT02884089|76033546|FG000|COMPLETED|Period 2||8||
59912697|NCT02884089|76033547|FG001|COMPLETED|Period 2||7||
59912698|NCT02884089|76033548|FG002|COMPLETED|Period 2||9||
59912699|NCT02884089|76033549|FG003|COMPLETED|Period 2||8||
59912700|NCT02884089|76033546|FG000|NOT COMPLETED|Period 2||1||
59912701|NCT02884089|76033547|FG001|NOT COMPLETED|Period 2||0||
59912702|NCT02884089|76033548|FG002|NOT COMPLETED|Period 2||0||
59912703|NCT02884089|76033549|FG003|NOT COMPLETED|Period 2||0||
59912704|NCT02884089|76033546|FG000|STARTED|Washout Period 2||8||
59912705|NCT02884089|76033547|FG001|STARTED|Washout Period 2||7||
59912706|NCT02884089|76033548|FG002|STARTED|Washout Period 2||9||
59912707|NCT02884089|76033549|FG003|STARTED|Washout Period 2||8||
59912708|NCT02884089|76033546|FG000|COMPLETED|Washout Period 2||8||
59912709|NCT02884089|76033547|FG001|COMPLETED|Washout Period 2||7||
59912710|NCT02884089|76033548|FG002|COMPLETED|Washout Period 2||9||
59912711|NCT02884089|76033549|FG003|COMPLETED|Washout Period 2||8||
59912712|NCT02884089|76033546|FG000|NOT COMPLETED|Washout Period 2||0||
59912713|NCT02884089|76033547|FG001|NOT COMPLETED|Washout Period 2||0||
59912714|NCT02884089|76033548|FG002|NOT COMPLETED|Washout Period 2||0||
59912715|NCT02884089|76033549|FG003|NOT COMPLETED|Washout Period 2||0||
59912716|NCT02884089|76033546|FG000|STARTED|Period 3||8||
59912717|NCT02884089|76033547|FG001|STARTED|Period 3||7||
59912718|NCT02884089|76033548|FG002|STARTED|Period 3||9||
59912719|NCT02884089|76033549|FG003|STARTED|Period 3||8||
59912720|NCT02884089|76033546|FG000|COMPLETED|Period 3||8||
59912721|NCT02884089|76033547|FG001|COMPLETED|Period 3||7||
59912722|NCT02884089|76033548|FG002|COMPLETED|Period 3||8||
59912723|NCT02884089|76033549|FG003|COMPLETED|Period 3||8||
59912724|NCT02884089|76033546|FG000|NOT COMPLETED|Period 3||0||
59912725|NCT02884089|76033547|FG001|NOT COMPLETED|Period 3||0||
59912726|NCT02884089|76033548|FG002|NOT COMPLETED|Period 3||1||
59912727|NCT02884089|76033549|FG003|NOT COMPLETED|Period 3||0||
59912728|NCT02884089|76033546|FG000|STARTED|Washout Period 3||8||
59912729|NCT02884089|76033547|FG001|STARTED|Washout Period 3||7||
59912730|NCT02884089|76033548|FG002|STARTED|Washout Period 3||8||
59912731|NCT02884089|76033549|FG003|STARTED|Washout Period 3||8||
59912732|NCT02884089|76033546|FG000|COMPLETED|Washout Period 3||8||
59912733|NCT02884089|76033547|FG001|COMPLETED|Washout Period 3||7||
59912734|NCT02884089|76033548|FG002|COMPLETED|Washout Period 3||7||
59912735|NCT02884089|76033549|FG003|COMPLETED|Washout Period 3||7||
59912736|NCT02884089|76033546|FG000|NOT COMPLETED|Washout Period 3||0||
59912737|NCT02884089|76033547|FG001|NOT COMPLETED|Washout Period 3||0||
59912738|NCT02884089|76033548|FG002|NOT COMPLETED|Washout Period 3||1||
59912739|NCT02884089|76033549|FG003|NOT COMPLETED|Washout Period 3||1||
59912740|NCT02884089|76033546|FG000|STARTED|Period 4||8||
59912741|NCT02884089|76033547|FG001|STARTED|Period 4||7||
59912742|NCT02884089|76033548|FG002|STARTED|Period 4||7||
59912743|NCT02884089|76033549|FG003|STARTED|Period 4||7||
59912744|NCT02884089|76033546|FG000|COMPLETED|Period 4||7||
59912745|NCT02884089|76033547|FG001|COMPLETED|Period 4||6||
59912746|NCT02884089|76033548|FG002|COMPLETED|Period 4||7||
59912747|NCT02884089|76033549|FG003|COMPLETED|Period 4||7||
59912748|NCT02884089|76033546|FG000|NOT COMPLETED|Period 4||1||
59912749|NCT02884089|76033547|FG001|NOT COMPLETED|Period 4||1||
59912750|NCT02884089|76033548|FG002|NOT COMPLETED|Period 4||0||
59912751|NCT02884089|76033549|FG003|NOT COMPLETED|Period 4||0||
59912752|NCT02884089|76033546|FG000|STARTED|Follow-up Visit||7||
59912753|NCT02884089|76033547|FG001|STARTED|Follow-up Visit||6||
59912754|NCT02884089|76033548|FG002|STARTED|Follow-up Visit||7||
59912755|NCT02884089|76033549|FG003|STARTED|Follow-up Visit||7||
59912756|NCT02884089|76033546|FG000|COMPLETED|Follow-up Visit||6||
59912757|NCT02884089|76033547|FG001|COMPLETED|Follow-up Visit||6||
59912758|NCT02884089|76033548|FG002|COMPLETED|Follow-up Visit||7||
59912759|NCT02884089|76033549|FG003|COMPLETED|Follow-up Visit||6||
59912760|NCT02884089|76033546|FG000|NOT COMPLETED|Follow-up Visit||1||
59912761|NCT02884089|76033547|FG001|NOT COMPLETED|Follow-up Visit||0||
59912762|NCT02884089|76033548|FG002|NOT COMPLETED|Follow-up Visit||0||
59912763|NCT02884089|76033549|FG003|NOT COMPLETED|Follow-up Visit||1||
59912764|NCT02809677|76033559|FG000|STARTED|Overall Study||205||
59912765|NCT02809677|76033559|FG000|COMPLETED|Overall Study||197||
59912766|NCT02809677|76033559|FG000|NOT COMPLETED|Overall Study||8||
59912767|NCT02881047|76033564|FG000|STARTED|Overall Study||8||
59912768|NCT02881047|76033564|FG000|COMPLETED|Overall Study||6||
59912769|NCT02881047|76033564|FG000|NOT COMPLETED|Overall Study||2||
59912770|NCT03157089|76033570|FG000|STARTED|Overall Study||12||
59912771|NCT03157089|76033571|FG001|STARTED|Overall Study||12||
59912772|NCT03157089|76033570|FG000|Treated|Overall Study||12|Treated with afatinib+pembrolizumab|
59912773|NCT03157089|76033571|FG001|Treated|Overall Study||12|Treated with afatinib+pembrolizumab|
59912774|NCT03157089|76033570|FG000|COMPLETED|Overall Study||0||
59912775|NCT03157089|76033571|FG001|COMPLETED|Overall Study||0||
59912776|NCT03157089|76033570|FG000|NOT COMPLETED|Overall Study||12||
59912777|NCT03157089|76033571|FG001|NOT COMPLETED|Overall Study||12||
59912778|NCT03158727|76033580|FG000|STARTED|Overall Study||42||
59912779|NCT03158727|76033581|FG001|STARTED|Overall Study||42||
59912780|NCT03158727|76033580|FG000|Enrolled, Not Treated|Overall Study||1||
59912781|NCT03158727|76033581|FG001|Enrolled, Not Treated|Overall Study||0||
59912782|NCT03158727|76033580|FG000|COMPLETED|Overall Study||25||
59912783|NCT03158727|76033581|FG001|COMPLETED|Overall Study||23||
59912784|NCT03158727|76033580|FG000|NOT COMPLETED|Overall Study||17||
59912785|NCT03158727|76033581|FG001|NOT COMPLETED|Overall Study||19||
59912786|NCT00089895|76033589|FG000|STARTED|Overall Study|Number of Subjects Randomized with Intent to Treat|4722||
59912787|NCT00089895|76033590|FG001|STARTED|Overall Study|Number of Subjects Randomized with Intent to Treat|4684||
59912788|NCT00089895|76033589|FG000|COMPLETED|Overall Study|Number of Subjects treated|4687||
59912789|NCT00089895|76033590|FG001|COMPLETED|Overall Study|Number of Subjects treated|4642||
59912790|NCT00089895|76033589|FG000|NOT COMPLETED|Overall Study||35||
59912791|NCT00089895|76033590|FG001|NOT COMPLETED|Overall Study||42||
59912792|NCT02714218|76033599|FG000|STARTED|Pre-Treatment Period||180||
59912793|NCT02714218|76033600|FG001|STARTED|Pre-Treatment Period||180||
59912794|NCT02714218|76033601|FG002|STARTED|Pre-Treatment Period||27||
59912795|NCT02714218|76033599|FG000|COMPLETED|Pre-Treatment Period||180|Moved to treatment period|
59912796|NCT02714218|76033600|FG001|COMPLETED|Pre-Treatment Period||178|Moved to treatment period|
59912797|NCT02714218|76033601|FG002|COMPLETED|Pre-Treatment Period||27|Moved to treatment period|
59912798|NCT02714218|76033599|FG000|NOT COMPLETED|Pre-Treatment Period||0||
59912799|NCT02714218|76033600|FG001|NOT COMPLETED|Pre-Treatment Period||2||
59912800|NCT02714218|76033601|FG002|NOT COMPLETED|Pre-Treatment Period||0||
59912801|NCT02714218|76033599|FG000|STARTED|Treatment Period||180||
59912802|NCT02714218|76033600|FG001|STARTED|Treatment Period||178||
59912803|NCT02714218|76033601|FG002|STARTED|Treatment Period||27||
59912804|NCT02714218|76033599|FG000|COMPLETED|Treatment Period||6||
59912805|NCT02714218|76033600|FG001|COMPLETED|Treatment Period||2||
59912806|NCT02714218|76033601|FG002|COMPLETED|Treatment Period||2||
59912807|NCT02714218|76033599|FG000|NOT COMPLETED|Treatment Period||174||
59912808|NCT02714218|76033600|FG001|NOT COMPLETED|Treatment Period||176||
59912809|NCT02714218|76033601|FG002|NOT COMPLETED|Treatment Period||25||
59912810|NCT03154047|76033608|FG000|STARTED|Overall Study||80||
59912811|NCT03154047|76033608|FG000|Number of Patients Dosed|Overall Study||80||
59912812|NCT03154047|76033608|FG000|COMPLETED|Overall Study||0||
59912813|NCT03154047|76033608|FG000|NOT COMPLETED|Overall Study||80||
59912814|NCT03156621|76033614|FG000|STARTED|Double-Blind Treatment Period (DBTP)||24||
59912815|NCT03156621|76033615|FG001|STARTED|Double-Blind Treatment Period (DBTP)||45||
59912816|NCT03156621|76033614|FG000|COMPLETED|Double-Blind Treatment Period (DBTP)||24||
59912817|NCT03156621|76033615|FG001|COMPLETED|Double-Blind Treatment Period (DBTP)||45||
59912818|NCT03156621|76033614|FG000|NOT COMPLETED|Double-Blind Treatment Period (DBTP)||0||
59912819|NCT03156621|76033615|FG001|NOT COMPLETED|Double-Blind Treatment Period (DBTP)||0||
59912820|NCT03156621|76033614|FG000|STARTED|Open-Label Treatment Period (OLTP)||24||
59912821|NCT03156621|76033615|FG001|STARTED|Open-Label Treatment Period (OLTP)||45||
59912822|NCT03156621|76033614|FG000|COMPLETED|Open-Label Treatment Period (OLTP)||24||
59912823|NCT03156621|76033615|FG001|COMPLETED|Open-Label Treatment Period (OLTP)||42||
59912824|NCT03156621|76033614|FG000|NOT COMPLETED|Open-Label Treatment Period (OLTP)||0||
59912825|NCT03156621|76033615|FG001|NOT COMPLETED|Open-Label Treatment Period (OLTP)||3||
59912826|NCT03156543|76033626|FG000|STARTED|Overall Study||9||
59912827|NCT03156543|76033627|FG001|STARTED|Overall Study||23||
59912828|NCT03156543|76033626|FG000|COMPLETED|Overall Study||8||
59912829|NCT03156543|76033627|FG001|COMPLETED|Overall Study||23||
59912830|NCT03156543|76033626|FG000|NOT COMPLETED|Overall Study||1||
59912831|NCT03156543|76033627|FG001|NOT COMPLETED|Overall Study||0||
59912832|NCT02713594|76033635|FG000|STARTED|Overall Study||952||
59912833|NCT02713594|76033636|FG001|STARTED|Overall Study||948||
59912834|NCT02713594|76033635|FG000|COMPLETED|Overall Study||562||
59912835|NCT02713594|76033636|FG001|COMPLETED|Overall Study||552||
59912836|NCT02713594|76033635|FG000|NOT COMPLETED|Overall Study||390||
59912837|NCT02713594|76033636|FG001|NOT COMPLETED|Overall Study||396||
59912838|NCT03152019|76033646|FG000|STARTED|Overall Study||25||
59912839|NCT03152019|76033647|FG001|STARTED|Overall Study||25||
59912840|NCT03152019|76033646|FG000|COMPLETED|Overall Study||25||
59912841|NCT03152019|76033647|FG001|COMPLETED|Overall Study||24||
59912842|NCT03152019|76033646|FG000|NOT COMPLETED|Overall Study||0||
59912843|NCT03152019|76033647|FG001|NOT COMPLETED|Overall Study||1||
59912844|NCT05007639|76033653|FG000|STARTED|Overall Study||274||
59912845|NCT05007639|76033653|FG000|COMPLETED|Overall Study||274||
59912846|NCT05007639|76033653|FG000|NOT COMPLETED|Overall Study||0||
59912847|NCT02714062|76033660|FG000|STARTED|Overall Study||14||
59912848|NCT02714062|76033661|FG001|STARTED|Overall Study||15||
59912849|NCT02714062|76033662|FG002|STARTED|Overall Study||13||
59912850|NCT02714062|76033660|FG000|COMPLETED|Overall Study||13||
59912851|NCT02714062|76033661|FG001|COMPLETED|Overall Study||14||
59912852|NCT02714062|76033662|FG002|COMPLETED|Overall Study||10||
59912853|NCT02714062|76033660|FG000|NOT COMPLETED|Overall Study||1||
59912854|NCT02714062|76033661|FG001|NOT COMPLETED|Overall Study||1||
59912855|NCT02714062|76033662|FG002|NOT COMPLETED|Overall Study||3||
59912856|NCT03151395|76033672|FG000|STARTED|Overall Study||197||
59912857|NCT03151395|76033672|FG000|COMPLETED|Overall Study||182||
59912858|NCT03151395|76033672|FG000|NOT COMPLETED|Overall Study||15||
59912859|NCT02713828|76033678|FG000|STARTED|Overall Study||13||
59912860|NCT02713828|76033679|FG001|STARTED|Overall Study||0||
59912861|NCT02713828|76033678|FG000|COMPLETED|Overall Study||8||
59912862|NCT02713828|76033679|FG001|COMPLETED|Overall Study||0||
59912863|NCT02713828|76033678|FG000|NOT COMPLETED|Overall Study||5||
59912864|NCT02713828|76033679|FG001|NOT COMPLETED|Overall Study||0||
59912865|NCT02875860|76033686|FG000|STARTED|Overall Study||2||
59912866|NCT02875860|76033687|FG001|STARTED|Overall Study||3||
59912867|NCT02875860|76033686|FG000|COMPLETED|Overall Study||2||
59912868|NCT02875860|76033687|FG001|COMPLETED|Overall Study||2||
59912869|NCT02875860|76033686|FG000|NOT COMPLETED|Overall Study||0||
59912870|NCT02875860|76033687|FG001|NOT COMPLETED|Overall Study||1||
59912871|NCT02875392|76033695|FG000|STARTED|Overall Study||28||
59912872|NCT02875392|76033696|FG001|STARTED|Overall Study||29||
59912873|NCT02875392|76033695|FG000|COMPLETED|Overall Study||21||
59912874|NCT02875392|76033696|FG001|COMPLETED|Overall Study||21||
59912875|NCT02875392|76033695|FG000|NOT COMPLETED|Overall Study||7||
59912876|NCT02875392|76033696|FG001|NOT COMPLETED|Overall Study||8||
59912877|NCT03127644|76033705|FG000|STARTED|Overall Study||34||
59912878|NCT03127644|76033706|FG001|STARTED|Overall Study||36||
59912879|NCT03127644|76033707|FG002|STARTED|Overall Study||33||
59912880|NCT03127644|76033705|FG000|COMPLETED|Overall Study||34||
59912881|NCT03127644|76033706|FG001|COMPLETED|Overall Study||36||
59912882|NCT03127644|76033707|FG002|COMPLETED|Overall Study||31||
59912883|NCT03127644|76033705|FG000|NOT COMPLETED|Overall Study||0||
59912884|NCT03127644|76033706|FG001|NOT COMPLETED|Overall Study||0||
59912885|NCT03127644|76033707|FG002|NOT COMPLETED|Overall Study||2||
59912886|NCT03965962|76033721|FG000|STARTED|Overall Study||320||
59912887|NCT03965962|76033722|FG001|STARTED|Overall Study||107||
59912888|NCT03965962|76033723|FG002|STARTED|Overall Study||107||
59912889|NCT03965962|76033724|FG003|STARTED|Overall Study||106||
59912890|NCT03965962|76033721|FG000|Vaccination 1 (Day 0)|Overall Study||318||
59912891|NCT03965962|76033722|FG001|Vaccination 1 (Day 0)|Overall Study||107||
59912892|NCT03965962|76033723|FG002|Vaccination 1 (Day 0)|Overall Study||107||
59912893|NCT03965962|76033724|FG003|Vaccination 1 (Day 0)|Overall Study||106||
59912894|NCT03965962|76033721|FG000|Vaccination 2 (Day 3)|Overall Study||317||
59912895|NCT03965962|76033722|FG001|Vaccination 2 (Day 3)|Overall Study||104||
59912896|NCT03965962|76033723|FG002|Vaccination 2 (Day 3)|Overall Study||107||
59912897|NCT03965962|76033724|FG003|Vaccination 2 (Day 3)|Overall Study||106||
59912898|NCT03965962|76033721|FG000|Vaccination 3 (Day 7)|Overall Study||311||
59507180|NCT00821041|75600374|FG000|STARTED|Overall Study||59||
59507181|NCT00821041|75600375|FG001|STARTED|Overall Study||59||
59507182|NCT00821041|75600374|FG000|COMPLETED|Overall Study||59||
59507183|NCT00821041|75600375|FG001|COMPLETED|Overall Study||59||
59507184|NCT00821041|75600374|FG000|NOT COMPLETED|Overall Study||0||
59507185|NCT00821041|75600375|FG001|NOT COMPLETED|Overall Study||0||
59507186|NCT00821119|75600383|FG000|STARTED|Overall Study||100||
59507187|NCT00821119|75600384|FG001|STARTED|Overall Study||100||
59507188|NCT00821119|75600383|FG000|COMPLETED|Overall Study||100||
59507189|NCT00821119|75600384|FG001|COMPLETED|Overall Study||100||
59507190|NCT00821119|75600383|FG000|NOT COMPLETED|Overall Study||0||
59507191|NCT00821119|75600384|FG001|NOT COMPLETED|Overall Study||0||
59507192|NCT02064855|75600392|FG000|STARTED|Overall Study||108||
59507193|NCT02064855|75600392|FG000|COMPLETED|Overall Study||53||
59507194|NCT02064855|75600392|FG000|NOT COMPLETED|Overall Study||55||
59507195|NCT02010645|75600439|FG000|STARTED|Overall Study||6||
59507196|NCT02010645|75600439|FG000|COMPLETED|Overall Study||6||
59507197|NCT02010645|75600439|FG000|NOT COMPLETED|Overall Study||0||
59507198|NCT02065479|75600445|FG000|STARTED|Overall Study||33||
59507199|NCT02065479|75600446|FG001|STARTED|Overall Study||32||
59507200|NCT02065479|75600445|FG000|COMPLETED|Overall Study||33||
59507201|NCT02065479|75600446|FG001|COMPLETED|Overall Study||32||
59507202|NCT02065479|75600445|FG000|NOT COMPLETED|Overall Study||0||
59507203|NCT02065479|75600446|FG001|NOT COMPLETED|Overall Study||0||
59507204|NCT02066727|75600454|FG000|STARTED|Overall Study||30||
59507205|NCT02066727|75600455|FG001|STARTED|Overall Study||30||
59507206|NCT02066727|75600454|FG000|COMPLETED|Overall Study||30||
59507207|NCT02066727|75600455|FG001|COMPLETED|Overall Study||30||
59507208|NCT02066727|75600454|FG000|NOT COMPLETED|Overall Study||0||
59507209|NCT02066727|75600455|FG001|NOT COMPLETED|Overall Study||0||
59507210|NCT02012283|75600463|FG000|STARTED|First Intervention||10||
59507211|NCT02012283|75600464|FG001|STARTED|First Intervention||10||
59507212|NCT02012283|75600463|FG000|COMPLETED|First Intervention||10||
59507213|NCT02012283|75600464|FG001|COMPLETED|First Intervention||10||
59507214|NCT02012283|75600463|FG000|NOT COMPLETED|First Intervention||0||
59507215|NCT02012283|75600464|FG001|NOT COMPLETED|First Intervention||0||
59507216|NCT02012283|75600463|FG000|STARTED|Second Intervention||10||
59507217|NCT02012283|75600464|FG001|STARTED|Second Intervention||10||
59507218|NCT02012283|75600463|FG000|COMPLETED|Second Intervention||10||
59507219|NCT02012283|75600464|FG001|COMPLETED|Second Intervention||10||
59507220|NCT02012283|75600463|FG000|NOT COMPLETED|Second Intervention||0||
59507221|NCT02012283|75600464|FG001|NOT COMPLETED|Second Intervention||0||
59507222|NCT02012283|75600463|FG000|STARTED|Third Intervention||10||
59507223|NCT02012283|75600464|FG001|STARTED|Third Intervention||10||
59507224|NCT02012283|75600463|FG000|COMPLETED|Third Intervention||10||
59507225|NCT02012283|75600464|FG001|COMPLETED|Third Intervention||10||
59507226|NCT02012283|75600463|FG000|NOT COMPLETED|Third Intervention||0||
59507227|NCT02012283|75600464|FG001|NOT COMPLETED|Third Intervention||0||
59507228|NCT02402127|75600481|FG000|STARTED|First Wear Period (1 Day)||4||
59507229|NCT02402127|75600482|FG001|STARTED|First Wear Period (1 Day)||4||
59507230|NCT02402127|75600483|FG002|STARTED|First Wear Period (1 Day)||4||
59507231|NCT02402127|75600484|FG003|STARTED|First Wear Period (1 Day)||4||
59507232|NCT02402127|75600485|FG004|STARTED|First Wear Period (1 Day)||4||
59507233|NCT02402127|75600486|FG005|STARTED|First Wear Period (1 Day)||4||
59507234|NCT02402127|75600481|FG000|Randomized and Treated|First Wear Period (1 Day)||4||
59507235|NCT02402127|75600482|FG001|Randomized and Treated|First Wear Period (1 Day)||4||
59507236|NCT02402127|75600483|FG002|Randomized and Treated|First Wear Period (1 Day)||4||
59758784|NCT00923273|75878095|FG003|STARTED|Phase I Treatment Period|3 subjects initially enrolled and 4 subjects added after dose level 5; peme naive.|7||
59758785|NCT00923273|75878096|FG004|STARTED|Phase I Treatment Period|5 subjects peme naive.|5||
59758786|NCT00923273|75878092|FG000|COMPLETED|Phase I Treatment Period||4||
59912899|NCT03965962|76033722|FG001|Vaccination 3 (Day 7)|Overall Study||103||
59912900|NCT03965962|76033723|FG002|Vaccination 3 (Day 7)|Overall Study||105||
59507237|NCT02402127|75600484|FG003|Randomized and Treated|First Wear Period (1 Day)||4||
59507238|NCT02402127|75600485|FG004|Randomized and Treated|First Wear Period (1 Day)||4||
59507239|NCT02402127|75600486|FG005|Randomized and Treated|First Wear Period (1 Day)||4||
59507240|NCT02402127|75600481|FG000|COMPLETED|First Wear Period (1 Day)||4||
59507241|NCT02402127|75600482|FG001|COMPLETED|First Wear Period (1 Day)||4||
59507242|NCT02402127|75600483|FG002|COMPLETED|First Wear Period (1 Day)||4||
59507243|NCT02402127|75600484|FG003|COMPLETED|First Wear Period (1 Day)||4||
59507244|NCT02402127|75600485|FG004|COMPLETED|First Wear Period (1 Day)||4||
59507245|NCT02402127|75600486|FG005|COMPLETED|First Wear Period (1 Day)||4||
59507246|NCT02402127|75600481|FG000|NOT COMPLETED|First Wear Period (1 Day)||0||
59758787|NCT00923273|75878093|FG001|COMPLETED|Phase I Treatment Period||3||
59758788|NCT00923273|75878094|FG002|COMPLETED|Phase I Treatment Period||3||
59758789|NCT00923273|75878095|FG003|COMPLETED|Phase I Treatment Period||7||
59758790|NCT00923273|75878096|FG004|COMPLETED|Phase I Treatment Period||5||
59758791|NCT00923273|75878092|FG000|NOT COMPLETED|Phase I Treatment Period||0||
59507247|NCT02402127|75600482|FG001|NOT COMPLETED|First Wear Period (1 Day)||0||
59611592|NCT01757184|75722570|FG002|NOT COMPLETED|Open-label Period||4||
59912901|NCT03965962|76033724|FG003|Vaccination 3 (Day 7)|Overall Study||105||
59912902|NCT03965962|76033721|FG000|Vaccination 4 (Day 14)|Overall Study||301||
59912903|NCT03965962|76033722|FG001|Vaccination 4 (Day 14)|Overall Study||101||
59912904|NCT03965962|76033723|FG002|Vaccination 4 (Day 14)|Overall Study||101||
59912905|NCT03965962|76033724|FG003|Vaccination 4 (Day 14)|Overall Study||103||
59912906|NCT03965962|76033721|FG000|Vaccination 5 (Day 28)|Overall Study||294||
59912907|NCT03965962|76033722|FG001|Vaccination 5 (Day 28)|Overall Study||98||
59912908|NCT03965962|76033723|FG002|Vaccination 5 (Day 28)|Overall Study||97||
59912909|NCT03965962|76033724|FG003|Vaccination 5 (Day 28)|Overall Study||98||
59912910|NCT03965962|76033721|FG000|Safety Analysis Set (SafAS)|Overall Study|2 participants randomized to Group 4: VRVg-2 received vaccination in Group 1: VRVg-2+HRIG and were considered in Group 1 for safety analysis purpose.|320|SafAS: Participant who received at least one dose of vaccine and were analyzed as per actual vaccination received.|
59912911|NCT03965962|76033722|FG001|Safety Analysis Set (SafAS)|Overall Study||107|SafAS: Participant who received at least one dose of vaccine and were analyzed as per actual vaccination received.|
59912912|NCT03965962|76033723|FG002|Safety Analysis Set (SafAS)|Overall Study||107|SafAS: Participant who received at least one dose of vaccine and were analyzed as per actual vaccination received.|
59912913|NCT03965962|76033724|FG003|Safety Analysis Set (SafAS)|Overall Study|2 participants randomized to Group 4: VRVg-2 received vaccination in Group 1: VRVg-2+HRIG and were considered in Group 1 for safety analysis purpose.|104|SafAS: Participant who received at least one dose of vaccine and were analyzed as per actual vaccination received.|
59912914|NCT03965962|76033721|FG000|COMPLETED|Overall Study||295||
59912915|NCT03965962|76033722|FG001|COMPLETED|Overall Study||102||
59912916|NCT03965962|76033723|FG002|COMPLETED|Overall Study||97||
59912917|NCT03965962|76033724|FG003|COMPLETED|Overall Study||100||
59912918|NCT03965962|76033721|FG000|NOT COMPLETED|Overall Study||25||
59912919|NCT03965962|76033722|FG001|NOT COMPLETED|Overall Study||5||
59912920|NCT03965962|76033723|FG002|NOT COMPLETED|Overall Study||10||
59912921|NCT03965962|76033724|FG003|NOT COMPLETED|Overall Study||6||
59912922|NCT03151551|76033736|FG000|STARTED|Open-Label Treatment Period||283||
59912923|NCT03151551|76033737|FG001|STARTED|Open-Label Treatment Period||283||
59912924|NCT03151551|76033736|FG000|Received at Least One Dose of Study Drug|Open-Label Treatment Period||283||
59912925|NCT03151551|76033737|FG001|Received at Least One Dose of Study Drug|Open-Label Treatment Period||283||
59912926|NCT03151551|76033736|FG000|IXE 160 mg at Baseline, 80 mg Q2W/Q4W|Open-Label Treatment Period||49||
59912927|NCT03151551|76033737|FG001|IXE 160 mg at Baseline, 80 mg Q2W/Q4W|Open-Label Treatment Period|Row represents Ixekizumab data only.|0||
59912928|NCT03151551|76033736|FG000|IXE 160 mg at Baseline, 80 mg Q4W|Open-Label Treatment Period||218||
59912929|NCT03151551|76033737|FG001|IXE 160 mg at Baseline, 80 mg Q4W|Open-Label Treatment Period|Row represents Ixekizumab data only.|0||
59912930|NCT03151551|76033736|FG000|ADA 80 mg at Baseline, 40 mg Q2W|Open-Label Treatment Period|Row represents adalimumab data only.|0||
59912931|NCT03151551|76033737|FG001|ADA 80 mg at Baseline, 40 mg Q2W|Open-Label Treatment Period||51||
59912932|NCT03151551|76033736|FG000|ADA 40 mg at Baseline, 40 mg Q2W|Open-Label Treatment Period|Row represents adalimumab data only.|0||
59912933|NCT03151551|76033737|FG001|ADA 40 mg at Baseline, 40 mg Q2W|Open-Label Treatment Period||219||
59912934|NCT03151551|76033736|FG000|COMPLETED|Open-Label Treatment Period||265||
59912935|NCT03151551|76033737|FG001|COMPLETED|Open-Label Treatment Period||259||
59912936|NCT03151551|76033736|FG000|NOT COMPLETED|Open-Label Treatment Period||18||
59912937|NCT03151551|76033737|FG001|NOT COMPLETED|Open-Label Treatment Period||24||
59912938|NCT03151551|76033736|FG000|STARTED|Post-Treatment Follow-Up Period|All participants who received at least one dose of study drug could enter the follow-up period.|265||
59912939|NCT03151551|76033737|FG001|STARTED|Post-Treatment Follow-Up Period|All participants who received at least one dose of study drug could enter the follow-up period.|258||
59912940|NCT03151551|76033736|FG000|COMPLETED|Post-Treatment Follow-Up Period||240||
59912941|NCT03151551|76033737|FG001|COMPLETED|Post-Treatment Follow-Up Period||230||
59912942|NCT03151551|76033736|FG000|NOT COMPLETED|Post-Treatment Follow-Up Period||25||
59912943|NCT03151551|76033737|FG001|NOT COMPLETED|Post-Treatment Follow-Up Period||28||
59912944|NCT03147495|76033747|FG000|STARTED|Overall Study||40||
59912945|NCT03147495|76033748|FG001|STARTED|Overall Study||46||
59912946|NCT03147495|76033747|FG000|COMPLETED|Overall Study||40||
59912947|NCT03147495|76033748|FG001|COMPLETED|Overall Study||40||
59758792|NCT00923273|75878093|FG001|NOT COMPLETED|Phase I Treatment Period||0||
59912948|NCT03147495|76033747|FG000|NOT COMPLETED|Overall Study||0||
59912949|NCT03147495|76033748|FG001|NOT COMPLETED|Overall Study||6||
59912950|NCT03126786|76033756|FG000|STARTED|Overall Study||36||
59912951|NCT03126786|76033757|FG001|STARTED|Overall Study||35||
59912952|NCT03126786|76033756|FG000|COMPLETED|Overall Study||30||
59912953|NCT03126786|76033757|FG001|COMPLETED|Overall Study||33||
59912954|NCT03126786|76033756|FG000|NOT COMPLETED|Overall Study||6||
59912955|NCT03126786|76033757|FG001|NOT COMPLETED|Overall Study||2||
59912956|NCT03146403|76033765|FG000|STARTED|Overall Study||16||
59912957|NCT03146403|76033766|FG001|STARTED|Overall Study||17||
59912958|NCT03146403|76033765|FG000|COMPLETED|Overall Study||14||
59912959|NCT03146403|76033766|FG001|COMPLETED|Overall Study||14||
59912960|NCT03146403|76033765|FG000|NOT COMPLETED|Overall Study||2||
59912961|NCT03146403|76033766|FG001|NOT COMPLETED|Overall Study||3||
59912962|NCT02713204|76033775|FG000|STARTED|Baseline (Day 1) up to Week 12||60||
59912963|NCT02713204|76033776|FG001|STARTED|Baseline (Day 1) up to Week 12||122||
59912964|NCT02713204|76033777|FG002|STARTED|Baseline (Day 1) up to Week 12||183||
59912965|NCT02713204|76033778|FG003|STARTED|Baseline (Day 1) up to Week 12||0||
59912966|NCT02713204|76033779|FG004|STARTED|Baseline (Day 1) up to Week 12||0||
59912967|NCT02713204|76033780|FG005|STARTED|Baseline (Day 1) up to Week 12||0||
59912968|NCT02713204|76033781|FG006|STARTED|Baseline (Day 1) up to Week 12||0||
59912969|NCT02713204|76033782|FG007|STARTED|Baseline (Day 1) up to Week 12||0||
59912970|NCT02713204|76033775|FG000|COMPLETED|Baseline (Day 1) up to Week 12||59||
59912971|NCT02713204|76033776|FG001|COMPLETED|Baseline (Day 1) up to Week 12||121||
59912972|NCT02713204|76033777|FG002|COMPLETED|Baseline (Day 1) up to Week 12||181||
59912973|NCT02713204|76033778|FG003|COMPLETED|Baseline (Day 1) up to Week 12||0||
59912974|NCT02713204|76033779|FG004|COMPLETED|Baseline (Day 1) up to Week 12||0||
59912975|NCT02713204|76033780|FG005|COMPLETED|Baseline (Day 1) up to Week 12||0||
59912976|NCT02713204|76033781|FG006|COMPLETED|Baseline (Day 1) up to Week 12||0||
59912977|NCT02713204|76033782|FG007|COMPLETED|Baseline (Day 1) up to Week 12||0||
59912978|NCT02713204|76033775|FG000|NOT COMPLETED|Baseline (Day 1) up to Week 12||1||
59912979|NCT02713204|76033776|FG001|NOT COMPLETED|Baseline (Day 1) up to Week 12||1||
59912980|NCT02713204|76033777|FG002|NOT COMPLETED|Baseline (Day 1) up to Week 12||2||
59912981|NCT02713204|76033778|FG003|NOT COMPLETED|Baseline (Day 1) up to Week 12||0||
59912982|NCT02713204|76033779|FG004|NOT COMPLETED|Baseline (Day 1) up to Week 12||0||
59912983|NCT02713204|76033780|FG005|NOT COMPLETED|Baseline (Day 1) up to Week 12||0||
59912984|NCT02713204|76033781|FG006|NOT COMPLETED|Baseline (Day 1) up to Week 12||0||
59912985|NCT02713204|76033782|FG007|NOT COMPLETED|Baseline (Day 1) up to Week 12||0||
59912986|NCT02713204|76033775|FG000|STARTED|From Week 12 up to Week 36||58||
59912987|NCT02713204|76033776|FG001|STARTED|From Week 12 up to Week 36||0||
59912988|NCT02713204|76033777|FG002|STARTED|From Week 12 up to Week 36||0||
59912989|NCT02713204|76033778|FG003|STARTED|From Week 12 up to Week 36||57||
59912990|NCT02713204|76033779|FG004|STARTED|From Week 12 up to Week 36||62||
59912991|NCT02713204|76033780|FG005|STARTED|From Week 12 up to Week 36||60||
59912992|NCT02713204|76033781|FG006|STARTED|From Week 12 up to Week 36||62||
59912993|NCT02713204|76033782|FG007|STARTED|From Week 12 up to Week 36||58||
59912994|NCT02713204|76033775|FG000|COMPLETED|From Week 12 up to Week 36||57||
59912995|NCT02713204|76033776|FG001|COMPLETED|From Week 12 up to Week 36||0||
59758793|NCT00923273|75878094|FG002|NOT COMPLETED|Phase I Treatment Period||0||
59912996|NCT02713204|76033777|FG002|COMPLETED|From Week 12 up to Week 36||0||
59912997|NCT02713204|76033778|FG003|COMPLETED|From Week 12 up to Week 36||53||
59912998|NCT02713204|76033779|FG004|COMPLETED|From Week 12 up to Week 36||60||
59912999|NCT02713204|76033780|FG005|COMPLETED|From Week 12 up to Week 36||59||
59913000|NCT02713204|76033781|FG006|COMPLETED|From Week 12 up to Week 36||60||
59913001|NCT02713204|76033782|FG007|COMPLETED|From Week 12 up to Week 36||54||
59913002|NCT02713204|76033775|FG000|NOT COMPLETED|From Week 12 up to Week 36||1||
59913003|NCT02713204|76033776|FG001|NOT COMPLETED|From Week 12 up to Week 36||0||
59913004|NCT02713204|76033777|FG002|NOT COMPLETED|From Week 12 up to Week 36||0||
59913005|NCT02713204|76033778|FG003|NOT COMPLETED|From Week 12 up to Week 36||4||
59913006|NCT02713204|76033779|FG004|NOT COMPLETED|From Week 12 up to Week 36||2||
59913007|NCT02713204|76033780|FG005|NOT COMPLETED|From Week 12 up to Week 36||1||
59913008|NCT02713204|76033781|FG006|NOT COMPLETED|From Week 12 up to Week 36||2||
59913009|NCT02713204|76033782|FG007|NOT COMPLETED|From Week 12 up to Week 36||4||
59913010|NCT03695172|76033802|FG000|STARTED|Overall Study||5||
59913011|NCT03695172|76033803|FG001|STARTED|Overall Study||4||
59913012|NCT03695172|76033804|FG002|STARTED|Overall Study||3||
59762597|NCT03888235|75882411|FG001|COMPLETED|Overall Study||20||
59519010|NCT03587428|75612871|FG001|NOT COMPLETED|Period 2||0||
59913013|NCT03695172|76033802|FG000|COMPLETED|Overall Study||4||
59913014|NCT03695172|76033803|FG001|COMPLETED|Overall Study||3||
59913015|NCT03695172|76033804|FG002|COMPLETED|Overall Study||3||
59913016|NCT03695172|76033802|FG000|NOT COMPLETED|Overall Study||1||
59913017|NCT03695172|76033803|FG001|NOT COMPLETED|Overall Study||1||
59913018|NCT03695172|76033804|FG002|NOT COMPLETED|Overall Study||0||
59913019|NCT03721107|76033816|FG000|STARTED|Overall Study||80||
60020189|NCT01607905|76136194|FG001|Received Study Drug|Overall Study||20||
60020190|NCT01607905|76136195|FG002|Received Study Drug|Overall Study||21||
60020191|NCT01607905|76136196|FG003|Received Study Drug|Overall Study||21||
60020192|NCT01607905|76136197|FG004|Received Study Drug|Overall Study||6||
60020193|NCT01607905|76136198|FG005|Received Study Drug|Overall Study||15||
60020194|NCT01607905|76136199|FG006|Received Study Drug|Overall Study||47||
59913020|NCT03721107|76033817|FG001|STARTED|Overall Study||84||
59913021|NCT03721107|76033818|FG002|STARTED|Overall Study||98||
59913022|NCT03721107|76033819|FG003|STARTED|Overall Study||104||
59913023|NCT03721107|76033816|FG000|Treated|Overall Study||80||
59913024|NCT03721107|76033817|FG001|Treated|Overall Study||84||
59913025|NCT03721107|76033818|FG002|Treated|Overall Study||97||
59913026|NCT03721107|76033819|FG003|Treated|Overall Study||104||
59913027|NCT03721107|76033816|FG000|COMPLETED|Overall Study||75||
60020195|NCT01607905|76136193|FG000|Low Dose (<30 mg/m^2)|Overall Study||16||
60020196|NCT01607905|76136194|FG001|Low Dose (<30 mg/m^2)|Overall Study||5||
60020197|NCT01607905|76136195|FG002|Low Dose (<30 mg/m^2)|Overall Study||3||
60020198|NCT01607905|76136196|FG003|Low Dose (<30 mg/m^2)|Overall Study||0||
60020199|NCT01607905|76136197|FG004|Low Dose (<30 mg/m^2)|Overall Study||0||
60020200|NCT01607905|76136198|FG005|Low Dose (<30 mg/m^2)|Overall Study||2||
60020201|NCT01607905|76136199|FG006|Low Dose (<30 mg/m^2)|Overall Study||8||
60020202|NCT01607905|76136193|FG000|Medium Dose (>=30 mg/m^2 and <55 mg/m^2)|Overall Study||27||
60020203|NCT01607905|76136194|FG001|Medium Dose (>=30 mg/m^2 and <55 mg/m^2)|Overall Study||11||
60020204|NCT01607905|76136195|FG002|Medium Dose (>=30 mg/m^2 and <55 mg/m^2)|Overall Study||15||
60020205|NCT01607905|76136196|FG003|Medium Dose (>=30 mg/m^2 and <55 mg/m^2)|Overall Study||8||
60020206|NCT01607905|76136197|FG004|Medium Dose (>=30 mg/m^2 and <55 mg/m^2)|Overall Study||6||
60020207|NCT01607905|76136198|FG005|Medium Dose (>=30 mg/m^2 and <55 mg/m^2)|Overall Study||3||
60020208|NCT01607905|76136199|FG006|Medium Dose (>=30 mg/m^2 and <55 mg/m^2)|Overall Study||21||
60020209|NCT01607905|76136193|FG000|High Dose (>= 55 mg/m^2)|Overall Study||16||
60020210|NCT01607905|76136194|FG001|High Dose (>= 55 mg/m^2)|Overall Study||4||
60020211|NCT01607905|76136195|FG002|High Dose (>= 55 mg/m^2)|Overall Study||3||
60020212|NCT01607905|76136196|FG003|High Dose (>= 55 mg/m^2)|Overall Study||13||
60020213|NCT01607905|76136197|FG004|High Dose (>= 55 mg/m^2)|Overall Study||0||
60020214|NCT01607905|76136198|FG005|High Dose (>= 55 mg/m^2)|Overall Study||10||
60020215|NCT01607905|76136199|FG006|High Dose (>= 55 mg/m^2)|Overall Study||18||
60020216|NCT01607905|76136193|FG000|COMPLETED|Overall Study||0|Participants who completed study treatment.|
60020217|NCT01607905|76136194|FG001|COMPLETED|Overall Study||0|Participants who completed study treatment.|
60020218|NCT01607905|76136195|FG002|COMPLETED|Overall Study||0|Participants who completed study treatment.|
60020219|NCT01607905|76136196|FG003|COMPLETED|Overall Study||0|Participants who completed study treatment.|
60020220|NCT01607905|76136197|FG004|COMPLETED|Overall Study||0|Participants who completed study treatment.|
60020221|NCT01607905|76136198|FG005|COMPLETED|Overall Study||0|Participants who completed study treatment.|
60020222|NCT01607905|76136199|FG006|COMPLETED|Overall Study||0|Participants who completed study treatment.|
60020223|NCT01607905|76136193|FG000|NOT COMPLETED|Overall Study||60||
60020224|NCT01607905|76136194|FG001|NOT COMPLETED|Overall Study||20||
60020225|NCT01607905|76136195|FG002|NOT COMPLETED|Overall Study||21||
60020226|NCT01607905|76136196|FG003|NOT COMPLETED|Overall Study||21||
60020227|NCT01607905|76136197|FG004|NOT COMPLETED|Overall Study||7||
60020228|NCT01607905|76136198|FG005|NOT COMPLETED|Overall Study||15||
60020229|NCT01607905|76136199|FG006|NOT COMPLETED|Overall Study||47||
60020230|NCT02536963|76136257|FG000|STARTED|Overall Study||318||
60020231|NCT02536963|76136257|FG000|COMPLETED|Overall Study||300||
60020232|NCT02536963|76136257|FG000|NOT COMPLETED|Overall Study||18||
60020233|NCT02531035|76136263|FG000|STARTED|Overall Study||705||
60020234|NCT02531035|76136264|FG001|STARTED|Overall Study||700||
60020235|NCT02531035|76136263|FG000|Treated|Overall Study||703||
60020236|NCT02531035|76136264|FG001|Treated|Overall Study||699||
60020237|NCT02531035|76136263|FG000|COMPLETED|Overall Study||624||
60020238|NCT02531035|76136264|FG001|COMPLETED|Overall Study||605||
60020239|NCT02531035|76136263|FG000|NOT COMPLETED|Overall Study||81||
60020240|NCT02531035|76136264|FG001|NOT COMPLETED|Overall Study||95||
60020241|NCT03937999|76136272|FG000|STARTED|Overall Study||0||
60020242|NCT03937999|76136273|FG001|STARTED|Overall Study||1||
60020243|NCT03937999|76136272|FG000|COMPLETED|Overall Study||0||
59913028|NCT03721107|76033817|FG001|COMPLETED|Overall Study||81||
59913029|NCT03721107|76033818|FG002|COMPLETED|Overall Study||83||
59913030|NCT03721107|76033819|FG003|COMPLETED|Overall Study||92||
59913031|NCT03721107|76033816|FG000|NOT COMPLETED|Overall Study||5||
59913032|NCT03721107|76033817|FG001|NOT COMPLETED|Overall Study||3||
60020244|NCT03937999|76136273|FG001|COMPLETED|Overall Study||1||
60020245|NCT03937999|76136272|FG000|NOT COMPLETED|Overall Study||0||
60020246|NCT03937999|76136273|FG001|NOT COMPLETED|Overall Study||0||
59913033|NCT03721107|76033818|FG002|NOT COMPLETED|Overall Study||15||
59913034|NCT03721107|76033819|FG003|NOT COMPLETED|Overall Study||12||
59913035|NCT03237234|76033831|FG000|STARTED|Overall Study||14||
59913036|NCT03237234|76033832|FG001|STARTED|Overall Study||11||
59913037|NCT03237234|76033831|FG000|COMPLETED|Overall Study||14||
59913038|NCT03237234|76033832|FG001|COMPLETED|Overall Study||11||
59913039|NCT03237234|76033831|FG000|NOT COMPLETED|Overall Study||0||
59913040|NCT03237234|76033832|FG001|NOT COMPLETED|Overall Study||0||
59913041|NCT03052920|76033838|FG000|STARTED|Overall Study||40||
59913042|NCT03052920|76033838|FG000|COMPLETED|Overall Study||39||
59913043|NCT03052920|76033838|FG000|NOT COMPLETED|Overall Study||1||
59913044|NCT02930226|76033848|FG000|STARTED|Overall Study||4||
59913045|NCT02930226|76033849|FG001|STARTED|Overall Study||4||
59913046|NCT02930226|76033850|FG002|STARTED|Overall Study||4||
59913047|NCT02930226|76033851|FG003|STARTED|Overall Study||4||
59913048|NCT02930226|76033852|FG004|STARTED|Overall Study||4||
59913049|NCT02930226|76033853|FG005|STARTED|Overall Study||4||
59913050|NCT02930226|76033848|FG000|COMPLETED|Overall Study||4||
60020247|NCT01659853|76136280|FG000|STARTED|Treatment Period 1||35||
59913051|NCT02930226|76033849|FG001|COMPLETED|Overall Study||4||
59913052|NCT02930226|76033850|FG002|COMPLETED|Overall Study||4||
59913053|NCT02930226|76033851|FG003|COMPLETED|Overall Study||4||
59913054|NCT02930226|76033852|FG004|COMPLETED|Overall Study||3||
59913055|NCT02930226|76033853|FG005|COMPLETED|Overall Study||4||
59913056|NCT02930226|76033848|FG000|NOT COMPLETED|Overall Study||0||
60020248|NCT01659853|76136281|FG001|STARTED|Treatment Period 1||35||
59507248|NCT02402127|75600483|FG002|NOT COMPLETED|First Wear Period (1 Day)||0||
59507249|NCT02402127|75600484|FG003|NOT COMPLETED|First Wear Period (1 Day)||0||
59507250|NCT02402127|75600485|FG004|NOT COMPLETED|First Wear Period (1 Day)||0||
59507251|NCT02402127|75600486|FG005|NOT COMPLETED|First Wear Period (1 Day)||0||
59507252|NCT02402127|75600481|FG000|STARTED|Second Wear Period (1 Day)||4||
59507253|NCT02402127|75600482|FG001|STARTED|Second Wear Period (1 Day)||4||
59913057|NCT02930226|76033849|FG001|NOT COMPLETED|Overall Study||0||
59913058|NCT02930226|76033850|FG002|NOT COMPLETED|Overall Study||0||
59913059|NCT02930226|76033851|FG003|NOT COMPLETED|Overall Study||0||
60020249|NCT01659853|76136280|FG000|COMPLETED|Treatment Period 1||35||
60020250|NCT01659853|76136281|FG001|COMPLETED|Treatment Period 1||35||
59913060|NCT02930226|76033852|FG004|NOT COMPLETED|Overall Study||1||
59913061|NCT02930226|76033853|FG005|NOT COMPLETED|Overall Study||0||
59913062|NCT03160521|76033872|FG000|STARTED|Overall Study|From 145 randomized patients in the 75 mg dose arm, one of them withdrew consent before receiving the study treatment. Due to, only 144 patients received allocated intervention.|144||
59913063|NCT03160521|76033873|FG001|STARTED|Overall Study||146||
59913064|NCT03160521|76033874|FG002|STARTED|Overall Study||147||
59913065|NCT03160521|76033872|FG000|COMPLETED|Overall Study||107||
59913066|NCT03160521|76033873|FG001|COMPLETED|Overall Study||95||
59913067|NCT03160521|76033874|FG002|COMPLETED|Overall Study||88||
60020251|NCT01659853|76136280|FG000|NOT COMPLETED|Treatment Period 1||0||
60020252|NCT01659853|76136281|FG001|NOT COMPLETED|Treatment Period 1||0||
60020253|NCT01659853|76136280|FG000|STARTED|Washout , 3 to 7 Days||35||
59913068|NCT03160521|76033872|FG000|NOT COMPLETED|Overall Study||37||
59913069|NCT03160521|76033873|FG001|NOT COMPLETED|Overall Study||51||
59913070|NCT03160521|76033874|FG002|NOT COMPLETED|Overall Study||59||
59913071|NCT02722434|76033890|FG000|STARTED|Overall Study||25|Registered/Randomized|
60020254|NCT01659853|76136281|FG001|STARTED|Washout , 3 to 7 Days||35||
60020255|NCT01659853|76136280|FG000|COMPLETED|Washout , 3 to 7 Days||33||
60020256|NCT01659853|76136281|FG001|COMPLETED|Washout , 3 to 7 Days||35||
60020257|NCT01659853|76136280|FG000|NOT COMPLETED|Washout , 3 to 7 Days||2||
60020258|NCT01659853|76136281|FG001|NOT COMPLETED|Washout , 3 to 7 Days||0||
60020259|NCT01659853|76136280|FG000|STARTED|Treatment Period 2||33||
60020260|NCT01659853|76136281|FG001|STARTED|Treatment Period 2||35||
60020261|NCT01659853|76136280|FG000|COMPLETED|Treatment Period 2||33||
59913072|NCT02722434|76033891|FG001|STARTED|Overall Study||25|Registered/Randomized|
59913073|NCT02722434|76033890|FG000|Started Treatment|Overall Study||24||
59913074|NCT02722434|76033891|FG001|Started Treatment|Overall Study||25||
59913075|NCT02722434|76033890|FG000|COMPLETED|Overall Study||24|Completed Treatment|
59913076|NCT02722434|76033891|FG001|COMPLETED|Overall Study||22|Completed Treatment|
59913077|NCT02722434|76033890|FG000|NOT COMPLETED|Overall Study||1||
59913078|NCT02722434|76033891|FG001|NOT COMPLETED|Overall Study||3||
59913079|NCT03539601|76033901|FG000|STARTED|Overall Study||60||
59913080|NCT03539601|76033902|FG001|STARTED|Overall Study||59||
60020262|NCT01659853|76136281|FG001|COMPLETED|Treatment Period 2||35||
60020263|NCT01659853|76136280|FG000|NOT COMPLETED|Treatment Period 2||0||
59507254|NCT02402127|75600483|FG002|STARTED|Second Wear Period (1 Day)||4||
59507255|NCT02402127|75600484|FG003|STARTED|Second Wear Period (1 Day)||4||
59507256|NCT02402127|75600485|FG004|STARTED|Second Wear Period (1 Day)||4||
59913081|NCT03539601|76033903|FG002|STARTED|Overall Study||71||
60020264|NCT01659853|76136281|FG001|NOT COMPLETED|Treatment Period 2||0||
60020265|NCT01660243|76136293|FG000|STARTED|Overall Study||10||
60020266|NCT01660243|76136294|FG001|STARTED|Overall Study||13||
60020267|NCT01660243|76136295|FG002|STARTED|Overall Study||11||
60020268|NCT01660243|76136296|FG003|STARTED|Overall Study||11||
60020269|NCT01660243|76136293|FG000|COMPLETED|Overall Study||8||
60020270|NCT01660243|76136294|FG001|COMPLETED|Overall Study||13||
60020271|NCT01660243|76136295|FG002|COMPLETED|Overall Study||9||
60020272|NCT01660243|76136296|FG003|COMPLETED|Overall Study||10||
60020273|NCT01660243|76136293|FG000|NOT COMPLETED|Overall Study||2||
60020274|NCT01660243|76136294|FG001|NOT COMPLETED|Overall Study||0||
60020275|NCT01660243|76136295|FG002|NOT COMPLETED|Overall Study||2||
60020276|NCT01660243|76136296|FG003|NOT COMPLETED|Overall Study||1||
60020277|NCT02531113|76136306|FG000|STARTED|Induction Period: Week 0 to 12||69||
60020278|NCT02531113|76136306|FG000|COMPLETED|Induction Period: Week 0 to 12||58|Completed = completed induction period and eligible to enter extension period.|
60020279|NCT02531113|76136306|FG000|NOT COMPLETED|Induction Period: Week 0 to 12||11||
60020280|NCT02531113|76136306|FG000|STARTED|Extension Period: Week 12 up to Week 160|6 participants completed induction; did not advance to extension due to lack efficacy.|52||
60020281|NCT02531113|76136306|FG000|COMPLETED|Extension Period: Week 12 up to Week 160||14|Completed = Defined as participants who had 160 visit|
60020282|NCT02531113|76136306|FG000|NOT COMPLETED|Extension Period: Week 12 up to Week 160||38||
60067725|NCT01617187|76182891|FG000|NOT COMPLETED|Treatment Through Study Completion||11||
60067726|NCT01617187|76182892|FG001|NOT COMPLETED|Treatment Through Study Completion||11||
60067727|NCT01617187|76182893|FG002|NOT COMPLETED|Treatment Through Study Completion||5||
60067728|NCT01617187|76182894|FG003|NOT COMPLETED|Treatment Through Study Completion||10||
60067729|NCT01759407|76182906|FG000|STARTED|Overall Study||10||
60067730|NCT01759407|76182907|FG001|STARTED|Overall Study||9||
60067731|NCT01759407|76182906|FG000|COMPLETED|Overall Study||10||
60067732|NCT01759407|76182907|FG001|COMPLETED|Overall Study||7||
60067733|NCT01759407|76182906|FG000|NOT COMPLETED|Overall Study||0||
60067734|NCT01759407|76182907|FG001|NOT COMPLETED|Overall Study||2||
60067735|NCT01787331|76182913|FG000|STARTED|Overall Study||21||
60067736|NCT01787331|76182913|FG000|COMPLETED|Overall Study||19||
60067737|NCT01787331|76182913|FG000|NOT COMPLETED|Overall Study||2||
60067738|NCT01757847|76182919|FG000|STARTED|Overall Study||44||
60067739|NCT01757847|76182920|FG001|STARTED|Overall Study||46||
60067740|NCT01757847|76182919|FG000|COMPLETED|Overall Study||41||
60067741|NCT01757847|76182920|FG001|COMPLETED|Overall Study||42||
60067742|NCT01757847|76182919|FG000|NOT COMPLETED|Overall Study||3||
60067743|NCT01757847|76182920|FG001|NOT COMPLETED|Overall Study||4||
60067744|NCT01787097|76182926|FG000|STARTED|Overall Study|Study started in 2012/2013|8||
60067745|NCT01787097|76182927|FG001|STARTED|Overall Study||7||
60067746|NCT01787097|76182928|FG002|STARTED|Overall Study||7||
60067747|NCT01787097|76182929|FG003|STARTED|Overall Study||9||
60067748|NCT01787097|76182926|FG000|COMPLETED|Overall Study|Study completed|7||
60067749|NCT01787097|76182927|FG001|COMPLETED|Overall Study||7||
60067750|NCT01787097|76182928|FG002|COMPLETED|Overall Study||7||
60067751|NCT01787097|76182929|FG003|COMPLETED|Overall Study||9||
60067752|NCT01787097|76182926|FG000|NOT COMPLETED|Overall Study||1||
60067753|NCT01787097|76182927|FG001|NOT COMPLETED|Overall Study||0||
60067754|NCT01787097|76182928|FG002|NOT COMPLETED|Overall Study||0||
60067755|NCT01787097|76182929|FG003|NOT COMPLETED|Overall Study||0||
60067756|NCT01757691|76182949|FG000|STARTED|Overall Study||2||
60067757|NCT01757691|76182950|FG001|STARTED|Overall Study||0||
60067758|NCT01757691|76182949|FG000|COMPLETED|Overall Study||0||
60067759|NCT01757691|76182950|FG001|COMPLETED|Overall Study||0||
60067760|NCT01757691|76182949|FG000|NOT COMPLETED|Overall Study||2||
60067761|NCT01757691|76182950|FG001|NOT COMPLETED|Overall Study||0||
60067762|NCT01786707|76182958|FG000|STARTED|Overall Study||1||
60067763|NCT01786707|76182959|FG001|STARTED|Overall Study||1||
60067764|NCT01786707|76182958|FG000|COMPLETED|Overall Study||0||
60067765|NCT01786707|76182959|FG001|COMPLETED|Overall Study||0||
60067766|NCT01786707|76182958|FG000|NOT COMPLETED|Overall Study||1||
60067767|NCT01786707|76182959|FG001|NOT COMPLETED|Overall Study||1||
60067768|NCT01786629|76182967|FG000|STARTED|Overall Study||169||
60067769|NCT01786629|76182968|FG001|STARTED|Overall Study||169||
60067770|NCT01786629|76182967|FG000|COMPLETED|Overall Study||169||
60067771|NCT01786629|76182968|FG001|COMPLETED|Overall Study||164||
60067772|NCT01786629|76182967|FG000|NOT COMPLETED|Overall Study||0||
60067773|NCT01786629|76182968|FG001|NOT COMPLETED|Overall Study||5||
60067774|NCT01786551|76182974|FG000|STARTED|Overall Study||16||
60067775|NCT01786551|76182974|FG000|COMPLETED|Overall Study||14||
60067776|NCT01786551|76182974|FG000|NOT COMPLETED|Overall Study||2||
60067777|NCT01973569|76182981|FG000|STARTED|Overall Study||228||
60067778|NCT01973569|76182982|FG001|STARTED|Overall Study||225||
60067779|NCT01973569|76182983|FG002|STARTED|Overall Study||226||
60067780|NCT01973569|76182981|FG000|Received Study Drug|Overall Study||222||
60067781|NCT01973569|76182982|FG001|Received Study Drug|Overall Study||222||
60067782|NCT01973569|76182983|FG002|Received Study Drug|Overall Study||223||
60067783|NCT01973569|76182981|FG000|Did Not Receive Study Drug|Overall Study||6||
60067784|NCT01973569|76182982|FG001|Did Not Receive Study Drug|Overall Study||3||
60067785|NCT01973569|76182983|FG002|Did Not Receive Study Drug|Overall Study||3||
60067786|NCT01973569|76182981|FG000|Discontinued Study Treatment|Overall Study||23||
59758794|NCT00923273|75878095|FG003|NOT COMPLETED|Phase I Treatment Period||0||
59758795|NCT00923273|75878096|FG004|NOT COMPLETED|Phase I Treatment Period||0||
59758796|NCT00923273|75878092|FG000|STARTED|Phase II Treatment Period|The phase II portion will utilize the MTD from the phase I portion.|0||
59758797|NCT00923273|75878093|FG001|STARTED|Phase II Treatment Period||0||
59758798|NCT00923273|75878094|FG002|STARTED|Phase II Treatment Period||0||
59758799|NCT00923273|75878095|FG003|STARTED|Phase II Treatment Period|Includes 8 subjects with prior peme;12 subjects who were peme naive; 7 subjects rolled over from phI|27||
59758800|NCT00923273|75878096|FG004|STARTED|Phase II Treatment Period||0||
59758801|NCT00923273|75878092|FG000|COMPLETED|Phase II Treatment Period||0||
59758802|NCT00923273|75878093|FG001|COMPLETED|Phase II Treatment Period||0||
59758803|NCT00923273|75878094|FG002|COMPLETED|Phase II Treatment Period||0||
59758804|NCT00923273|75878095|FG003|COMPLETED|Phase II Treatment Period||20||
59758805|NCT00923273|75878096|FG004|COMPLETED|Phase II Treatment Period||0||
59758806|NCT00923273|75878092|FG000|NOT COMPLETED|Phase II Treatment Period||0||
59758807|NCT00923273|75878093|FG001|NOT COMPLETED|Phase II Treatment Period||0||
59758808|NCT00923273|75878094|FG002|NOT COMPLETED|Phase II Treatment Period||0||
59758809|NCT00923273|75878095|FG003|NOT COMPLETED|Phase II Treatment Period||7||
59913082|NCT03539601|76033904|FG003|STARTED|Overall Study||47||
59913083|NCT03539601|76033901|FG000|Treated|Overall Study||59||
59913084|NCT03539601|76033902|FG001|Treated|Overall Study||58||
59758810|NCT00923273|75878096|FG004|NOT COMPLETED|Phase II Treatment Period||0||
59758811|NCT00923195|75878116|FG000|STARTED|Overall Study||2||
59758812|NCT00923195|75878117|FG001|STARTED|Overall Study||2||
59758813|NCT00923195|75878116|FG000|COMPLETED|Overall Study||2||
59758814|NCT00923195|75878117|FG001|COMPLETED|Overall Study||1||
59758815|NCT00923195|75878116|FG000|NOT COMPLETED|Overall Study||0||
59758816|NCT00923195|75878117|FG001|NOT COMPLETED|Overall Study||1||
59913085|NCT03539601|76033903|FG002|Treated|Overall Study||71||
59913086|NCT03539601|76033904|FG003|Treated|Overall Study||47||
59913087|NCT03539601|76033901|FG000|COMPLETED|Overall Study||54||
59913088|NCT03539601|76033902|FG001|COMPLETED|Overall Study||52||
59913089|NCT03539601|76033903|FG002|COMPLETED|Overall Study||65||
59913090|NCT03539601|76033904|FG003|COMPLETED|Overall Study||46||
59913091|NCT03539601|76033901|FG000|NOT COMPLETED|Overall Study||6||
59913092|NCT03539601|76033902|FG001|NOT COMPLETED|Overall Study||7||
59913093|NCT03539601|76033903|FG002|NOT COMPLETED|Overall Study||6||
59913094|NCT03539601|76033904|FG003|NOT COMPLETED|Overall Study||1||
59913095|NCT00700804|76033924|FG000|STARTED|Overall Study||17||
59913096|NCT00700804|76033925|FG001|STARTED|Overall Study||17||
59913097|NCT00700804|76033924|FG000|COMPLETED|Overall Study||14||
59913098|NCT00700804|76033925|FG001|COMPLETED|Overall Study||13||
59913099|NCT00700804|76033924|FG000|NOT COMPLETED|Overall Study||3||
59913100|NCT00700804|76033925|FG001|NOT COMPLETED|Overall Study||4||
59913101|NCT02903823|76033931|FG000|STARTED|Overall Study|First subject enrollment|27||
59913102|NCT02903823|76033931|FG000|COMPLETED|Overall Study||20||
59913103|NCT02903823|76033931|FG000|NOT COMPLETED|Overall Study||7||
59913104|NCT03894501|76033938|FG000|STARTED|Overall Study||15||
59913105|NCT03894501|76033939|FG001|STARTED|Overall Study||15||
59913106|NCT03894501|76033938|FG000|COMPLETED|Overall Study||15||
59913107|NCT03894501|76033939|FG001|COMPLETED|Overall Study||15||
59913108|NCT03894501|76033938|FG000|NOT COMPLETED|Overall Study||0||
59913109|NCT03894501|76033939|FG001|NOT COMPLETED|Overall Study||0||
59913110|NCT00832455|76033960|FG000|STARTED|Overall Study|445 - number of patients that signed the informed consent form (Safety population)|445||
59913111|NCT00832455|76033960|FG000|Baseline|Overall Study|420 -patients that received at least one dose of study medication and had 1 follow-up visit (ITT)|420||
59913112|NCT00832455|76033960|FG000|Week 4|Overall Study||411||
59913113|NCT00832455|76033960|FG000|Week 8 (Optional)|Overall Study||247||
59913114|NCT00832455|76033960|FG000|Week 12|Overall Study||373||
59913115|NCT00832455|76033960|FG000|COMPLETED|Overall Study||373||
59913116|NCT00832455|76033960|FG000|NOT COMPLETED|Overall Study||72||
59913117|NCT00687531|76033973|FG000|STARTED|Overall Study|Completed screening procedures|385||
59913118|NCT00687531|76033973|FG000|RECEIVED TREATMENT|Overall Study||281||
59913119|NCT00687531|76033973|FG000|COMPLETED|Overall Study||250||
59913120|NCT00687531|76033973|FG000|NOT COMPLETED|Overall Study||135||
59913121|NCT00423579|76033979|FG000|STARTED|Overall Study|61 enrolled, however one subject was ineligible and was removed.|60||
59913122|NCT00423579|76033980|FG001|STARTED|Overall Study||60||
59913123|NCT00423579|76033979|FG000|COMPLETED|Overall Study|These 56 subjects were the Intent-to-Treat population. Analysis based on ITT population.|56||
59913124|NCT00423579|76033980|FG001|COMPLETED|Overall Study|These 56 subjects were the Intent-to-Treat population. Analysis based on ITT population.|56||
60020283|NCT04247425|76136310|FG000|STARTED|Overall Study||10||
59758817|NCT00753519|75878125|FG000|STARTED|Overall Study||13||
59758818|NCT00753519|75878126|FG001|STARTED|Overall Study||15||
59758819|NCT00753519|75878125|FG000|COMPLETED|Overall Study||13||
59758820|NCT00753519|75878126|FG001|COMPLETED|Overall Study||13||
59758821|NCT00753519|75878125|FG000|NOT COMPLETED|Overall Study||0||
59758822|NCT00753519|75878126|FG001|NOT COMPLETED|Overall Study||2||
59758823|NCT00919061|75878134|FG000|STARTED|Overall Study||39||
59913125|NCT00423579|76033979|FG000|NOT COMPLETED|Overall Study||4||
59913126|NCT00423579|76033980|FG001|NOT COMPLETED|Overall Study||4||
59913127|NCT03268005|76033988|FG000|STARTED|Overall Study||546||
60020284|NCT04247425|76136310|FG000|COMPLETED|Overall Study||9||
60020285|NCT04247425|76136310|FG000|NOT COMPLETED|Overall Study||1||
60020286|NCT02522767|76136316|FG000|STARTED|Double-blind||114||
60020287|NCT02522767|76136317|FG001|STARTED|Double-blind||114||
60020288|NCT02522767|76136316|FG000|COMPLETED|Double-blind||103||
60020289|NCT02522767|76136317|FG001|COMPLETED|Double-blind||90||
59611593|NCT01757184|75722571|FG003|NOT COMPLETED|Open-label Period||3||
59611594|NCT01775904|75722585|FG000|STARTED|LY2886721 ODT (no Water, Fasting)||26||
59611595|NCT01775904|75722585|FG000|Received at Least One Dose of Drug|LY2886721 ODT (no Water, Fasting)||26||
60020290|NCT02522767|76136316|FG000|NOT COMPLETED|Double-blind||11||
60020291|NCT02522767|76136317|FG001|NOT COMPLETED|Double-blind||24||
60020292|NCT02522767|76136316|FG000|STARTED|Open-label|Subjects provided their consent to receive additional 8 weeks open-label treatment with mesalamine.|88||
60020293|NCT02522767|76136317|FG001|STARTED|Open-label|Subjects provided their consent to receive additional 8 weeks open-label treatment with mesalamine.|82||
60020294|NCT02522767|76136316|FG000|COMPLETED|Open-label||83||
60020295|NCT02522767|76136317|FG001|COMPLETED|Open-label||75||
60020296|NCT02522767|76136316|FG000|NOT COMPLETED|Open-label||5||
60020297|NCT02522767|76136317|FG001|NOT COMPLETED|Open-label||7||
60020298|NCT02522377|76136327|FG000|STARTED|Overall Study||7||
60020299|NCT02522377|76136328|FG001|STARTED|Overall Study||5||
60020300|NCT02522377|76136327|FG000|COMPLETED|Overall Study||3||
60020301|NCT02522377|76136328|FG001|COMPLETED|Overall Study||5||
60020302|NCT02522377|76136327|FG000|NOT COMPLETED|Overall Study||4||
60020303|NCT02522377|76136328|FG001|NOT COMPLETED|Overall Study||0||
60020304|NCT01657903|76136334|FG000|STARTED|Overall Study||56||
60020305|NCT01657903|76136334|FG000|Received Placebo (No NaF/KNO3)Toothpaste|Overall Study|One participant was lost to follow up in study period 1|56||
60020306|NCT01657903|76136334|FG000|Received NaF/KNO3 Toothpaste 1|Overall Study|One participant withdrew consent in study period 3|55||
60020307|NCT01657903|76136334|FG000|Received NaF/KNO3 Toothpaste 3|Overall Study||54||
60020308|NCT01657903|76136334|FG000|Received NaF/KNO3 Toothpaste 2|Overall Study||55||
60020309|NCT01657903|76136334|FG000|COMPLETED|Overall Study||54||
60020310|NCT01657903|76136334|FG000|NOT COMPLETED|Overall Study||2||
60020311|NCT01656733|76136347|FG000|STARTED|Overall Study|4 discontinued after BL visit (lost to follow up)|67|Baseline Visit (randomization)|
60020312|NCT01656733|76136348|FG001|STARTED|Overall Study|5 discontinued after BL visit ( lost to follow up)|70|Baseline Visit (randomization)|
60020313|NCT01656733|76136347|FG000|Visit 1 (1 Week After Quit Date)|Overall Study||45||
60020314|NCT01656733|76136348|FG001|Visit 1 (1 Week After Quit Date)|Overall Study||42||
60020315|NCT01656733|76136347|FG000|Visit 2 (2 Weeks After Quit Date)|Overall Study||32||
60020316|NCT01656733|76136348|FG001|Visit 2 (2 Weeks After Quit Date)|Overall Study||44||
60020317|NCT01656733|76136347|FG000|Visit 3 (3 Weeks After Quit Date)|Overall Study||33||
60020318|NCT01656733|76136348|FG001|Visit 3 (3 Weeks After Quit Date)|Overall Study||34||
60020319|NCT01656733|76136347|FG000|Visit 4 (4 Weeks After Quit Date)|Overall Study||32||
60020320|NCT01656733|76136348|FG001|Visit 4 (4 Weeks After Quit Date)|Overall Study||30||
60020321|NCT01656733|76136347|FG000|Visit 5 (6 Weeks After Quit Date)|Overall Study||37||
60020322|NCT01656733|76136348|FG001|Visit 5 (6 Weeks After Quit Date)|Overall Study||36||
60020323|NCT01656733|76136347|FG000|Visit 6 ( 32-36 Weeks Gestation)|Overall Study||39||
60020324|NCT01656733|76136348|FG001|Visit 6 ( 32-36 Weeks Gestation)|Overall Study||47||
60020325|NCT01656733|76136347|FG000|Participants With Perinatal Outcomes|Overall Study||67||
60020326|NCT01656733|76136348|FG001|Participants With Perinatal Outcomes|Overall Study||66||
60020327|NCT01656733|76136347|FG000|Visit 7 (1 Month Postpartum) Phone Call|Overall Study||47||
60020328|NCT01656733|76136348|FG001|Visit 7 (1 Month Postpartum) Phone Call|Overall Study||50||
60020329|NCT01656733|76136347|FG000|Visit 8 (6 Months Postpartum)|Overall Study||30||
60020330|NCT01656733|76136348|FG001|Visit 8 (6 Months Postpartum)|Overall Study||28||
60020331|NCT01656733|76136347|FG000|COMPLETED|Overall Study||67||
60020332|NCT01656733|76136348|FG001|COMPLETED|Overall Study||66||
60020333|NCT01656733|76136347|FG000|NOT COMPLETED|Overall Study||0||
60020334|NCT01656733|76136348|FG001|NOT COMPLETED|Overall Study||4||
60020335|NCT01656967|76136356|FG000|STARTED|Overall Study||33||
60020336|NCT01656967|76136357|FG001|STARTED|Overall Study||33||
60020337|NCT01656967|76136356|FG000|SGA Placement|Overall Study||32||
60020338|NCT01656967|76136357|FG001|SGA Placement|Overall Study||33||
60020339|NCT01656967|76136356|FG000|ETT Insertion|Overall Study||29||
60020340|NCT01656967|76136357|FG001|ETT Insertion|Overall Study||31||
60020341|NCT01656967|76136356|FG000|COMPLETED|Overall Study||29||
60020342|NCT01656967|76136357|FG001|COMPLETED|Overall Study||31||
60020343|NCT01656967|76136356|FG000|NOT COMPLETED|Overall Study||4||
60020344|NCT01656967|76136357|FG001|NOT COMPLETED|Overall Study||2||
60020345|NCT01656889|76136369|FG000|STARTED|Treatment Period, 12 Weeks|Randomized (Met all I/E criteria at completion of run-in)|222||
60020346|NCT01656889|76136370|FG001|STARTED|Treatment Period, 12 Weeks|Randomized (Met all I/E criteria at completion of run-in)|225||
60020347|NCT01656889|76136369|FG000|COMPLETED|Treatment Period, 12 Weeks|Completed treatment|210||
60020348|NCT01656889|76136370|FG001|COMPLETED|Treatment Period, 12 Weeks|Completed treatment|214||
60020349|NCT01656889|76136369|FG000|NOT COMPLETED|Treatment Period, 12 Weeks||12||
60020350|NCT01656889|76136370|FG001|NOT COMPLETED|Treatment Period, 12 Weeks||11||
60020351|NCT01656889|76136369|FG000|STARTED|Post Treatment Follow-Up, 3 Months||210||
60020352|NCT01656889|76136370|FG001|STARTED|Post Treatment Follow-Up, 3 Months||213||
60020353|NCT01656889|76136369|FG000|COMPLETED|Post Treatment Follow-Up, 3 Months||206||
60020354|NCT01656889|76136370|FG001|COMPLETED|Post Treatment Follow-Up, 3 Months||204||
60020355|NCT01656889|76136369|FG000|NOT COMPLETED|Post Treatment Follow-Up, 3 Months||4||
60020356|NCT01656889|76136370|FG001|NOT COMPLETED|Post Treatment Follow-Up, 3 Months||9||
60020357|NCT02522299|76136378|FG000|STARTED|Overall Study||22||
60020358|NCT02522299|76136379|FG001|STARTED|Overall Study||22||
60020359|NCT02522299|76136378|FG000|COMPLETED|Overall Study||18||
60020360|NCT02522299|76136379|FG001|COMPLETED|Overall Study||21||
60020361|NCT02522299|76136378|FG000|NOT COMPLETED|Overall Study||4||
60020362|NCT02522299|76136379|FG001|NOT COMPLETED|Overall Study||1||
60020363|NCT01365091|76136403|FG000|STARTED|Period 1||28||
60020364|NCT01365091|76136404|FG001|STARTED|Period 1||28||
60020365|NCT01365091|76136405|FG002|STARTED|Period 1||28||
60020366|NCT01365091|76136406|FG003|STARTED|Period 1||28||
60020367|NCT01365091|76136403|FG000|COMPLETED|Period 1||26||
60020368|NCT01365091|76136404|FG001|COMPLETED|Period 1||26||
60020369|NCT01365091|76136405|FG002|COMPLETED|Period 1||25||
60020370|NCT01365091|76136406|FG003|COMPLETED|Period 1||25||
60020371|NCT01365091|76136403|FG000|NOT COMPLETED|Period 1||2||
60020372|NCT01365091|76136404|FG001|NOT COMPLETED|Period 1||2||
60020373|NCT01365091|76136405|FG002|NOT COMPLETED|Period 1||3||
60020374|NCT01365091|76136406|FG003|NOT COMPLETED|Period 1||3||
60020375|NCT01365091|76136403|FG000|STARTED|Period 2||26||
60020376|NCT01365091|76136404|FG001|STARTED|Period 2||26||
60020377|NCT01365091|76136405|FG002|STARTED|Period 2||25||
60020378|NCT01365091|76136406|FG003|STARTED|Period 2||25||
60020379|NCT01365091|76136403|FG000|COMPLETED|Period 2||25||
60020380|NCT01365091|76136404|FG001|COMPLETED|Period 2||26||
60020381|NCT01365091|76136405|FG002|COMPLETED|Period 2||24||
60020382|NCT01365091|76136406|FG003|COMPLETED|Period 2||25||
60020383|NCT01365091|76136403|FG000|NOT COMPLETED|Period 2||1||
60020384|NCT01365091|76136404|FG001|NOT COMPLETED|Period 2||0||
60020385|NCT01365091|76136405|FG002|NOT COMPLETED|Period 2||1||
60020386|NCT01365091|76136406|FG003|NOT COMPLETED|Period 2||0||
60020387|NCT01364467|76136432|FG000|STARTED|Overall Study||10||
60020388|NCT01364467|76136433|FG001|STARTED|Overall Study||20||
60020389|NCT01364467|76136432|FG000|COMPLETED|Overall Study||9||
60020390|NCT01364467|76136433|FG001|COMPLETED|Overall Study||18||
60020391|NCT01364467|76136432|FG000|NOT COMPLETED|Overall Study||1||
60020392|NCT01364467|76136433|FG001|NOT COMPLETED|Overall Study||2||
60020393|NCT02520661|76136441|FG000|STARTED|Overall Study||992||
60020394|NCT02520661|76136442|FG001|STARTED|Overall Study||987||
60020395|NCT02520661|76136441|FG000|Removed Following Randomization|Overall Study||124|Reasons include, admitted from ED, ED stay greater than 24 hours, other ineligibility|
60020396|NCT02520661|76136442|FG001|Removed Following Randomization|Overall Study||99|Reasons include, admitted from ED, ED stay greater than 24 hours, other ineligibility|
60020397|NCT02520661|76136441|FG000|CTI Home Visit Scheduled|Overall Study||0|CTI = Care Transitions Intervention|
60020398|NCT02520661|76136442|FG001|CTI Home Visit Scheduled|Overall Study||863|CTI = Care Transitions Intervention|
60020399|NCT02520661|76136441|FG000|Participants in Dataset|Overall Study||893||
60020400|NCT02520661|76136442|FG001|Participants in Dataset|Overall Study||863||
60020401|NCT02520661|76136441|FG000|Participants Completing Home Visit|Overall Study||0|Intervention arm|
60020402|NCT02520661|76136442|FG001|Participants Completing Home Visit|Overall Study||726|Intervention arm|
60020403|NCT02520661|76136441|FG000|Participants With Primary Outcome Data (ITT)|Overall Study||886|ITT = Intent to Treat|
60020404|NCT02520661|76136442|FG001|Participants With Primary Outcome Data (ITT)|Overall Study||860|ITT = Intent to Treat|
60020405|NCT02520661|76136441|FG000|Participants With Primary Outcome Data (PP)|Overall Study||886|PP = Per Protocol|
60020406|NCT02520661|76136442|FG001|Participants With Primary Outcome Data (PP)|Overall Study||725|PP = Per Protocol|
60020407|NCT02520661|76136441|FG000|COMPLETED|Overall Study||886||
60020408|NCT02520661|76136442|FG001|COMPLETED|Overall Study||860||
60020409|NCT02520661|76136441|FG000|NOT COMPLETED|Overall Study||106||
60020410|NCT02520661|76136442|FG001|NOT COMPLETED|Overall Study||127||
60020411|NCT01364389|76136455|FG000|STARTED|Overall Study||5||
60020412|NCT01364389|76136456|FG001|STARTED|Overall Study||6||
60020413|NCT01364389|76136457|FG002|STARTED|Overall Study||5||
60020414|NCT01364389|76136455|FG000|Pharmacodynamic (PD) Analysis Set|Overall Study||5||
60020415|NCT01364389|76136456|FG001|Pharmacodynamic (PD) Analysis Set|Overall Study||6||
60020416|NCT01364389|76136457|FG002|Pharmacodynamic (PD) Analysis Set|Overall Study|One patient excluded: did not receive study drug; received placebo caps. and infusion only in error.|4||
60020417|NCT01364389|76136455|FG000|COMPLETED|Overall Study||3||
60020418|NCT01364389|76136456|FG001|COMPLETED|Overall Study||5||
60020419|NCT01364389|76136457|FG002|COMPLETED|Overall Study||4||
60020420|NCT01364389|76136455|FG000|NOT COMPLETED|Overall Study||2||
60020421|NCT01364389|76136456|FG001|NOT COMPLETED|Overall Study||1||
60020422|NCT01364389|76136457|FG002|NOT COMPLETED|Overall Study||1||
60020423|NCT01364233|76136465|FG000|STARTED|Overall Study||10||
60020424|NCT01364233|76136465|FG000|COMPLETED|Overall Study||9||
60020425|NCT01364233|76136465|FG000|NOT COMPLETED|Overall Study||1||
60020426|NCT02291289|76136473|FG000|STARTED|Induction Treatment||60||
60020427|NCT02291289|76136474|FG001|STARTED|Induction Treatment||0||
60020428|NCT02291289|76136475|FG002|STARTED|Induction Treatment||0||
60020429|NCT02291289|76136476|FG003|STARTED|Induction Treatment||445||
60020430|NCT02291289|76136477|FG004|STARTED|Induction Treatment||0||
60020431|NCT02291289|76136478|FG005|STARTED|Induction Treatment||0||
60020432|NCT02291289|76136479|FG006|STARTED|Induction Treatment||5||
60020433|NCT02291289|76136480|FG007|STARTED|Induction Treatment||0||
60020434|NCT02291289|76136481|FG008|STARTED|Induction Treatment||0||
60020435|NCT02291289|76136482|FG009|STARTED|Induction Treatment||99||
60020436|NCT02291289|76136483|FG010|STARTED|Induction Treatment||0||
60020437|NCT02291289|76136484|FG011|STARTED|Induction Treatment||0||
59758824|NCT00919061|75878134|FG000|COMPLETED|Overall Study||37||
59758825|NCT00919061|75878134|FG000|NOT COMPLETED|Overall Study||2||
59913128|NCT03268005|76033989|FG001|STARTED|Overall Study||545||
59913129|NCT03268005|76033988|FG000|Full Analysis Set|Overall Study||546||
59507257|NCT02402127|75600486|FG005|STARTED|Second Wear Period (1 Day)||4||
59758826|NCT00747435|75878138|FG000|STARTED|Overall Study||73||
59758827|NCT00747435|75878138|FG000|COMPLETED|Overall Study||67||
59758828|NCT00747435|75878138|FG000|NOT COMPLETED|Overall Study||6||
59913130|NCT03268005|76033989|FG001|Full Analysis Set|Overall Study||545||
59913131|NCT03268005|76033988|FG000|Safety Analysis Set|Overall Study||544||
60020438|NCT02291289|76136473|FG000|COMPLETED|Induction Treatment||58|Completed = dosed|
60020439|NCT02291289|76136474|FG001|COMPLETED|Induction Treatment||0|Completed = dosed|
60020440|NCT02291289|76136475|FG002|COMPLETED|Induction Treatment||0|Completed = dosed|
60020441|NCT02291289|76136476|FG003|COMPLETED|Induction Treatment||436|Completed = dosed|
60020442|NCT02291289|76136477|FG004|COMPLETED|Induction Treatment||0|Completed = dosed|
60020443|NCT02291289|76136478|FG005|COMPLETED|Induction Treatment||0|Completed = dosed|
59758829|NCT00918749|75878145|FG000|STARTED|Overall Study||70||
59913132|NCT03268005|76033989|FG001|Safety Analysis Set|Overall Study||544||
59913133|NCT03268005|76033988|FG000|COMPLETED|Overall Study||531||
59913134|NCT03268005|76033989|FG001|COMPLETED|Overall Study||531||
59913135|NCT03268005|76033988|FG000|NOT COMPLETED|Overall Study||15||
59913136|NCT03268005|76033989|FG001|NOT COMPLETED|Overall Study||14||
59913137|NCT03149055|76033995|FG000|STARTED|Overall Study||99||
59913138|NCT03149055|76033995|FG000|COMPLETED|Overall Study||95||
59913139|NCT03149055|76033995|FG000|NOT COMPLETED|Overall Study||4||
59913140|NCT02964897|76034001|FG000|STARTED|Overall Study||43||
59913141|NCT02964897|76034002|FG001|STARTED|Overall Study||36||
59913142|NCT02964897|76034001|FG000|COMPLETED|Overall Study||43||
59913143|NCT02964897|76034002|FG001|COMPLETED|Overall Study||36||
59913144|NCT02964897|76034001|FG000|NOT COMPLETED|Overall Study||0||
59913145|NCT02964897|76034002|FG001|NOT COMPLETED|Overall Study||0||
59913146|NCT03137121|76034010|FG000|STARTED|Overall Study||15||
59913147|NCT03137121|76034011|FG001|STARTED|Overall Study||15||
60020444|NCT02291289|76136479|FG006|COMPLETED|Induction Treatment||5|Completed = dosed|
60020445|NCT02291289|76136480|FG007|COMPLETED|Induction Treatment||0|Completed = dosed|
60020446|NCT02291289|76136481|FG008|COMPLETED|Induction Treatment||0|Completed = dosed|
60020447|NCT02291289|76136482|FG009|COMPLETED|Induction Treatment||98|Completed = dosed|
60020448|NCT02291289|76136483|FG010|COMPLETED|Induction Treatment||0|Completed = dosed|
60020449|NCT02291289|76136484|FG011|COMPLETED|Induction Treatment||0|Completed = dosed|
60020450|NCT02291289|76136473|FG000|NOT COMPLETED|Induction Treatment||2||
60020451|NCT02291289|76136474|FG001|NOT COMPLETED|Induction Treatment||0||
60020452|NCT02291289|76136475|FG002|NOT COMPLETED|Induction Treatment||0||
60020453|NCT02291289|76136476|FG003|NOT COMPLETED|Induction Treatment||9||
60020454|NCT02291289|76136477|FG004|NOT COMPLETED|Induction Treatment||0||
60020455|NCT02291289|76136478|FG005|NOT COMPLETED|Induction Treatment||0||
60020456|NCT02291289|76136479|FG006|NOT COMPLETED|Induction Treatment||0||
60020457|NCT02291289|76136480|FG007|NOT COMPLETED|Induction Treatment||0||
60020458|NCT02291289|76136481|FG008|NOT COMPLETED|Induction Treatment||0||
60020459|NCT02291289|76136482|FG009|NOT COMPLETED|Induction Treatment||1||
60020460|NCT02291289|76136483|FG010|NOT COMPLETED|Induction Treatment||0||
60020461|NCT02291289|76136484|FG011|NOT COMPLETED|Induction Treatment||0||
60020462|NCT02291289|76136473|FG000|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|0||
60020463|NCT02291289|76136474|FG001|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|40||
60020464|NCT02291289|76136475|FG002|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|20||
60020465|NCT02291289|76136476|FG003|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|0||
60020466|NCT02291289|76136477|FG004|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|297||
60020467|NCT02291289|76136478|FG005|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|148||
60020468|NCT02291289|76136479|FG006|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|0||
60020469|NCT02291289|76136480|FG007|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|3||
60020470|NCT02291289|76136481|FG008|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|2||
60020471|NCT02291289|76136482|FG009|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|0||
60020472|NCT02291289|76136483|FG010|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|65||
60020473|NCT02291289|76136484|FG011|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|34||
60020474|NCT02291289|76136473|FG000|Dosed|Maintenance Treatment Phase||0||
59758830|NCT00918749|75878146|FG001|STARTED|Overall Study||66||
59758831|NCT00918749|75878147|FG002|STARTED|Overall Study||69||
59758832|NCT00918749|75878145|FG000|ITT (Intent to Treat) Population|Overall Study|One subject took no study drug and was not included in ITT Population|69||
59758833|NCT00918749|75878146|FG001|ITT (Intent to Treat) Population|Overall Study||66||
59758834|NCT00918749|75878147|FG002|ITT (Intent to Treat) Population|Overall Study||69||
59758835|NCT00918749|75878145|FG000|COMPLETED|Overall Study||63||
59758836|NCT00918749|75878146|FG001|COMPLETED|Overall Study||63||
59758837|NCT00918749|75878147|FG002|COMPLETED|Overall Study||62||
59758838|NCT00918749|75878145|FG000|NOT COMPLETED|Overall Study||7||
59758839|NCT00918749|75878146|FG001|NOT COMPLETED|Overall Study||3||
59758840|NCT00918749|75878147|FG002|NOT COMPLETED|Overall Study||7||
59758841|NCT00746733|75878155|FG000|STARTED|First Intervention||12||
59758842|NCT00746733|75878156|FG001|STARTED|First Intervention||12||
59758843|NCT00746733|75878155|FG000|COMPLETED|First Intervention||12||
59758844|NCT00746733|75878156|FG001|COMPLETED|First Intervention||12||
59758845|NCT00746733|75878155|FG000|NOT COMPLETED|First Intervention||0||
59758846|NCT00746733|75878156|FG001|NOT COMPLETED|First Intervention||0||
59758847|NCT00746733|75878155|FG000|STARTED|Second Intervention||12||
59758848|NCT00746733|75878156|FG001|STARTED|Second Intervention||12||
59758849|NCT00746733|75878155|FG000|COMPLETED|Second Intervention||11||
59758850|NCT00746733|75878156|FG001|COMPLETED|Second Intervention||12||
59758851|NCT00746733|75878155|FG000|NOT COMPLETED|Second Intervention||1||
59758852|NCT00746733|75878156|FG001|NOT COMPLETED|Second Intervention||0||
59913148|NCT03137121|76034010|FG000|COMPLETED|Overall Study||15||
59913149|NCT03137121|76034011|FG001|COMPLETED|Overall Study||14||
59913150|NCT03137121|76034010|FG000|NOT COMPLETED|Overall Study||0||
59913151|NCT03137121|76034011|FG001|NOT COMPLETED|Overall Study||1||
59913152|NCT04461483|76034023|FG000|STARTED|Part 1 (Day 1)||6||
59913153|NCT04461483|76034024|FG001|STARTED|Part 1 (Day 1)||6||
59913154|NCT04461483|76034025|FG002|STARTED|Part 1 (Day 1)||6||
59913155|NCT04461483|76034026|FG003|STARTED|Part 1 (Day 1)||6||
59913156|NCT04461483|76034027|FG004|STARTED|Part 1 (Day 1)||0||
59913157|NCT04461483|76034028|FG005|STARTED|Part 1 (Day 1)||0||
59913158|NCT04461483|76034023|FG000|COMPLETED|Part 1 (Day 1)||6||
59913159|NCT04461483|76034024|FG001|COMPLETED|Part 1 (Day 1)||6||
59913160|NCT04461483|76034025|FG002|COMPLETED|Part 1 (Day 1)||6||
59913161|NCT04461483|76034026|FG003|COMPLETED|Part 1 (Day 1)||6||
59913162|NCT04461483|76034027|FG004|COMPLETED|Part 1 (Day 1)||0||
59913163|NCT04461483|76034028|FG005|COMPLETED|Part 1 (Day 1)||0||
59913164|NCT04461483|76034023|FG000|NOT COMPLETED|Part 1 (Day 1)||0||
59913165|NCT04461483|76034024|FG001|NOT COMPLETED|Part 1 (Day 1)||0||
59913166|NCT04461483|76034025|FG002|NOT COMPLETED|Part 1 (Day 1)||0||
59913167|NCT04461483|76034026|FG003|NOT COMPLETED|Part 1 (Day 1)||0||
59913168|NCT04461483|76034027|FG004|NOT COMPLETED|Part 1 (Day 1)||0||
59913169|NCT04461483|76034028|FG005|NOT COMPLETED|Part 1 (Day 1)||0||
59913170|NCT04461483|76034023|FG000|STARTED|Part 2 (Day 1 to 21)||0||
59913171|NCT04461483|76034024|FG001|STARTED|Part 2 (Day 1 to 21)||0||
59913172|NCT04461483|76034025|FG002|STARTED|Part 2 (Day 1 to 21)||0||
59913173|NCT04461483|76034026|FG003|STARTED|Part 2 (Day 1 to 21)||0||
59913174|NCT04461483|76034027|FG004|STARTED|Part 2 (Day 1 to 21)||3||
59758853|NCT00746733|75878155|FG000|STARTED|Third Intervention||11||
59758854|NCT00746733|75878156|FG001|STARTED|Third Intervention||12||
59913175|NCT04461483|76034028|FG005|STARTED|Part 2 (Day 1 to 21)||6||
59913176|NCT04461483|76034023|FG000|COMPLETED|Part 2 (Day 1 to 21)||0||
59913177|NCT04461483|76034024|FG001|COMPLETED|Part 2 (Day 1 to 21)||0||
59913178|NCT04461483|76034025|FG002|COMPLETED|Part 2 (Day 1 to 21)||0||
59913179|NCT04461483|76034026|FG003|COMPLETED|Part 2 (Day 1 to 21)||0||
59913180|NCT04461483|76034027|FG004|COMPLETED|Part 2 (Day 1 to 21)||3||
59913181|NCT04461483|76034028|FG005|COMPLETED|Part 2 (Day 1 to 21)||6||
59913182|NCT04461483|76034023|FG000|NOT COMPLETED|Part 2 (Day 1 to 21)||0||
59913183|NCT04461483|76034024|FG001|NOT COMPLETED|Part 2 (Day 1 to 21)||0||
59913184|NCT04461483|76034025|FG002|NOT COMPLETED|Part 2 (Day 1 to 21)||0||
59913185|NCT04461483|76034026|FG003|NOT COMPLETED|Part 2 (Day 1 to 21)||0||
59913186|NCT04461483|76034027|FG004|NOT COMPLETED|Part 2 (Day 1 to 21)||0||
59913187|NCT04461483|76034028|FG005|NOT COMPLETED|Part 2 (Day 1 to 21)||0||
59913188|NCT00700570|76034054|FG000|STARTED|Overall Study||19||
59913189|NCT00700570|76034055|FG001|STARTED|Overall Study||26||
59913190|NCT00700570|76034054|FG000|COMPLETED|Overall Study||8||
59913191|NCT00700570|76034055|FG001|COMPLETED|Overall Study||0||
59913192|NCT00700570|76034054|FG000|NOT COMPLETED|Overall Study||11||
59913193|NCT00700570|76034055|FG001|NOT COMPLETED|Overall Study||26||
59913194|NCT01744041|76034063|FG000|STARTED|Overall Study||21||
59913195|NCT01744041|76034064|FG001|STARTED|Overall Study||21||
59913196|NCT01744041|76034063|FG000|COMPLETED|Overall Study||15||
59913197|NCT01744041|76034064|FG001|COMPLETED|Overall Study||13||
59913198|NCT01744041|76034063|FG000|NOT COMPLETED|Overall Study||6||
59913199|NCT01744041|76034064|FG001|NOT COMPLETED|Overall Study||8||
59913200|NCT02874924|76034073|FG000|STARTED|Overall Study||14||
59913201|NCT02874924|76034074|FG001|STARTED|Overall Study||14||
59913202|NCT02874924|76034075|FG002|STARTED|Overall Study||6||
59913203|NCT02874924|76034073|FG000|COMPLETED|Overall Study||11||
59913204|NCT02874924|76034074|FG001|COMPLETED|Overall Study||14||
59913205|NCT02874924|76034075|FG002|COMPLETED|Overall Study||6||
59913206|NCT02874924|76034073|FG000|NOT COMPLETED|Overall Study||3||
59913207|NCT02874924|76034074|FG001|NOT COMPLETED|Overall Study||0||
59913208|NCT02874924|76034075|FG002|NOT COMPLETED|Overall Study||0||
59913209|NCT04425863|76034086|FG000|STARTED|Overall Study||135||
59913210|NCT04425863|76034087|FG001|STARTED|Overall Study||12||
59913211|NCT04425863|76034088|FG002|STARTED|Overall Study||20||
59913212|NCT04425863|76034086|FG000|COMPLETED|Overall Study||135||
59913213|NCT04425863|76034087|FG001|COMPLETED|Overall Study||12||
59913214|NCT04425863|76034088|FG002|COMPLETED|Overall Study||19||
59913215|NCT04425863|76034086|FG000|NOT COMPLETED|Overall Study||0||
59913216|NCT04425863|76034087|FG001|NOT COMPLETED|Overall Study||0||
59913217|NCT04425863|76034088|FG002|NOT COMPLETED|Overall Study||1||
59913218|NCT04360187|76034110|FG000|STARTED|Double-Blind Treatment||131||
59913219|NCT04360187|76034111|FG001|STARTED|Double-Blind Treatment||260||
59913220|NCT04360187|76034110|FG000|COMPLETED|Double-Blind Treatment||108||
59913221|NCT04360187|76034111|FG001|COMPLETED|Double-Blind Treatment||245||
59913222|NCT04360187|76034110|FG000|NOT COMPLETED|Double-Blind Treatment||23||
59913223|NCT04360187|76034111|FG001|NOT COMPLETED|Double-Blind Treatment||15||
59913224|NCT04360187|76034110|FG000|STARTED|Follow-Up||114||
59913225|NCT04360187|76034111|FG001|STARTED|Follow-Up||232||
59913226|NCT04360187|76034110|FG000|COMPLETED|Follow-Up||113||
59913227|NCT04360187|76034111|FG001|COMPLETED|Follow-Up||232||
59913228|NCT04360187|76034110|FG000|NOT COMPLETED|Follow-Up||1||
59913229|NCT04360187|76034111|FG001|NOT COMPLETED|Follow-Up||0||
59913230|NCT04498169|76034119|FG000|STARTED|Modified Intent-to-Treat Population||20||
59913231|NCT04498169|76034120|FG001|STARTED|Modified Intent-to-Treat Population||20||
59913232|NCT04498169|76034119|FG000|COMPLETED|Modified Intent-to-Treat Population||19||
59913233|NCT04498169|76034120|FG001|COMPLETED|Modified Intent-to-Treat Population||19||
59913234|NCT04498169|76034119|FG000|NOT COMPLETED|Modified Intent-to-Treat Population||1||
59913235|NCT04498169|76034120|FG001|NOT COMPLETED|Modified Intent-to-Treat Population||1||
59913236|NCT04498169|76034119|FG000|STARTED|Safety Population||20||
59913237|NCT04498169|76034120|FG001|STARTED|Safety Population||20||
59913238|NCT04498169|76034119|FG000|COMPLETED|Safety Population||19||
59913239|NCT04498169|76034120|FG001|COMPLETED|Safety Population||19||
59913240|NCT04498169|76034119|FG000|NOT COMPLETED|Safety Population||1||
59913241|NCT04498169|76034120|FG001|NOT COMPLETED|Safety Population||1||
59913242|NCT04498169|76034119|FG000|STARTED|Per-Protocol Population||18||
59913243|NCT04498169|76034120|FG001|STARTED|Per-Protocol Population||16||
59913244|NCT04498169|76034119|FG000|COMPLETED|Per-Protocol Population||18||
59913245|NCT04498169|76034120|FG001|COMPLETED|Per-Protocol Population||15||
59913246|NCT04498169|76034119|FG000|NOT COMPLETED|Per-Protocol Population||0||
59913247|NCT04498169|76034120|FG001|NOT COMPLETED|Per-Protocol Population||1||
59913248|NCT04498169|76034119|FG000|STARTED|Study Completion||20||
59913249|NCT04498169|76034120|FG001|STARTED|Study Completion||20||
59913250|NCT04498169|76034119|FG000|COMPLETED|Study Completion||19||
59913251|NCT04498169|76034120|FG001|COMPLETED|Study Completion||19||
59913252|NCT04498169|76034119|FG000|NOT COMPLETED|Study Completion||1||
59913253|NCT04498169|76034120|FG001|NOT COMPLETED|Study Completion||1||
59913254|NCT03695393|76034128|FG000|STARTED|Overall Study||67||
59913255|NCT03695393|76034129|FG001|STARTED|Overall Study||33||
59913256|NCT03695393|76034128|FG000|1-month|Overall Study||66||
59913257|NCT03695393|76034129|FG001|1-month|Overall Study||32||
59913258|NCT03695393|76034128|FG000|6-month|Overall Study||64||
59913259|NCT03695393|76034129|FG001|6-month|Overall Study||31||
59913260|NCT03695393|76034128|FG000|COMPLETED|Overall Study||64||
59913261|NCT03695393|76034129|FG001|COMPLETED|Overall Study||31||
60020475|NCT02291289|76136474|FG001|Dosed|Maintenance Treatment Phase||40||
60020476|NCT02291289|76136475|FG002|Dosed|Maintenance Treatment Phase||18||
60020477|NCT02291289|76136476|FG003|Dosed|Maintenance Treatment Phase||0||
60020478|NCT02291289|76136477|FG004|Dosed|Maintenance Treatment Phase||293||
60020479|NCT02291289|76136478|FG005|Dosed|Maintenance Treatment Phase||143||
60020480|NCT02291289|76136479|FG006|Dosed|Maintenance Treatment Phase||0||
60020481|NCT02291289|76136480|FG007|Dosed|Maintenance Treatment Phase||3||
60020482|NCT02291289|76136481|FG008|Dosed|Maintenance Treatment Phase||2||
60020483|NCT02291289|76136482|FG009|Dosed|Maintenance Treatment Phase||0||
60020484|NCT02291289|76136483|FG010|Dosed|Maintenance Treatment Phase||64||
60020485|NCT02291289|76136484|FG011|Dosed|Maintenance Treatment Phase||34||
59507258|NCT02402127|75600481|FG000|COMPLETED|Second Wear Period (1 Day)||4||
59507259|NCT02402127|75600482|FG001|COMPLETED|Second Wear Period (1 Day)||4||
59507260|NCT02402127|75600483|FG002|COMPLETED|Second Wear Period (1 Day)||4||
59507261|NCT02402127|75600484|FG003|COMPLETED|Second Wear Period (1 Day)||4||
59507262|NCT02402127|75600485|FG004|COMPLETED|Second Wear Period (1 Day)||4||
59507263|NCT02402127|75600486|FG005|COMPLETED|Second Wear Period (1 Day)||4||
59913262|NCT03695393|76034128|FG000|NOT COMPLETED|Overall Study||3||
59913263|NCT03695393|76034129|FG001|NOT COMPLETED|Overall Study||2||
59913264|NCT03694925|76034138|FG000|STARTED|Overall Study||30||
59913265|NCT03694925|76034139|FG001|STARTED|Overall Study||73||
59913266|NCT03694925|76034140|FG002|STARTED|Overall Study||53||
59913267|NCT03694925|76034138|FG000|COMPLETED|Overall Study||30||
59913268|NCT03694925|76034139|FG001|COMPLETED|Overall Study||70||
59913269|NCT03694925|76034140|FG002|COMPLETED|Overall Study||53||
59913270|NCT03694925|76034138|FG000|NOT COMPLETED|Overall Study||0||
59913271|NCT03694925|76034139|FG001|NOT COMPLETED|Overall Study||3||
59913272|NCT03694925|76034140|FG002|NOT COMPLETED|Overall Study||0||
59913273|NCT04258020|76034152|FG000|STARTED|Overall Study||4||
59913274|NCT04258020|76034153|FG001|STARTED|Overall Study||0||
59913275|NCT04258020|76034152|FG000|COMPLETED|Overall Study||3||
59913276|NCT04258020|76034153|FG001|COMPLETED|Overall Study||0||
59913277|NCT04258020|76034152|FG000|NOT COMPLETED|Overall Study||1||
59913278|NCT04258020|76034153|FG001|NOT COMPLETED|Overall Study||0||
59913279|NCT04495283|76034162|FG000|STARTED|Overall Study||35||
59913280|NCT04495283|76034163|FG001|STARTED|Overall Study||35||
59913281|NCT04495283|76034164|FG002|STARTED|Overall Study||17||
59913282|NCT04495283|76034162|FG000|COMPLETED|Overall Study||34||
59913283|NCT04495283|76034163|FG001|COMPLETED|Overall Study||34||
59913284|NCT04495283|76034164|FG002|COMPLETED|Overall Study||14||
60020486|NCT02291289|76136473|FG000|COMPLETED|Maintenance Treatment Phase||0||
60020487|NCT02291289|76136474|FG001|COMPLETED|Maintenance Treatment Phase||16||
60020488|NCT02291289|76136475|FG002|COMPLETED|Maintenance Treatment Phase||4||
60020489|NCT02291289|76136476|FG003|COMPLETED|Maintenance Treatment Phase||0||
60020490|NCT02291289|76136477|FG004|COMPLETED|Maintenance Treatment Phase||45||
60020491|NCT02291289|76136478|FG005|COMPLETED|Maintenance Treatment Phase||19||
60020492|NCT02291289|76136479|FG006|COMPLETED|Maintenance Treatment Phase||0||
60020493|NCT02291289|76136480|FG007|COMPLETED|Maintenance Treatment Phase||1||
59507264|NCT02402127|75600481|FG000|NOT COMPLETED|Second Wear Period (1 Day)||0||
59507265|NCT02402127|75600482|FG001|NOT COMPLETED|Second Wear Period (1 Day)||0||
59507266|NCT02402127|75600483|FG002|NOT COMPLETED|Second Wear Period (1 Day)||0||
59913285|NCT04495283|76034162|FG000|NOT COMPLETED|Overall Study||1||
59913286|NCT04495283|76034163|FG001|NOT COMPLETED|Overall Study||1||
60020494|NCT02291289|76136481|FG008|COMPLETED|Maintenance Treatment Phase||0||
60020495|NCT02291289|76136482|FG009|COMPLETED|Maintenance Treatment Phase||0||
60020496|NCT02291289|76136483|FG010|COMPLETED|Maintenance Treatment Phase||34||
60020497|NCT02291289|76136484|FG011|COMPLETED|Maintenance Treatment Phase||18||
60020498|NCT02291289|76136473|FG000|NOT COMPLETED|Maintenance Treatment Phase||0||
60020499|NCT02291289|76136474|FG001|NOT COMPLETED|Maintenance Treatment Phase||24||
60020500|NCT02291289|76136475|FG002|NOT COMPLETED|Maintenance Treatment Phase||16||
60020501|NCT02291289|76136476|FG003|NOT COMPLETED|Maintenance Treatment Phase||0||
60020502|NCT02291289|76136477|FG004|NOT COMPLETED|Maintenance Treatment Phase||252||
60020503|NCT02291289|76136478|FG005|NOT COMPLETED|Maintenance Treatment Phase||129||
60020504|NCT02291289|76136479|FG006|NOT COMPLETED|Maintenance Treatment Phase||0||
60020505|NCT02291289|76136480|FG007|NOT COMPLETED|Maintenance Treatment Phase||2||
60020506|NCT02291289|76136481|FG008|NOT COMPLETED|Maintenance Treatment Phase||2||
60020507|NCT02291289|76136482|FG009|NOT COMPLETED|Maintenance Treatment Phase||0||
60020508|NCT02291289|76136483|FG010|NOT COMPLETED|Maintenance Treatment Phase||31||
59507267|NCT02402127|75600484|FG003|NOT COMPLETED|Second Wear Period (1 Day)||0||
59913287|NCT04495283|76034164|FG002|NOT COMPLETED|Overall Study||3||
59913288|NCT03117738|76034177|FG000|STARTED|Overall Study||11||
59913289|NCT03117738|76034178|FG001|STARTED|Overall Study||10||
59913290|NCT03117738|76034177|FG000|COMPLETED|Overall Study||7||
59913291|NCT03117738|76034178|FG001|COMPLETED|Overall Study||5||
59913292|NCT03117738|76034177|FG000|NOT COMPLETED|Overall Study||4||
59913293|NCT03117738|76034178|FG001|NOT COMPLETED|Overall Study||5||
59913294|NCT04234464|76034186|FG000|STARTED|Period 1 (First Treatment Intervention)||29||
60020509|NCT02291289|76136484|FG011|NOT COMPLETED|Maintenance Treatment Phase||16||
60020510|NCT02317575|76136509|FG000|STARTED|Period 1||5||
60020511|NCT02317575|76136510|FG001|STARTED|Period 1||6||
60020512|NCT02317575|76136511|FG002|STARTED|Period 1||6||
60020513|NCT02317575|76136512|FG003|STARTED|Period 1||6||
60020514|NCT02317575|76136513|FG004|STARTED|Period 1||6||
60020515|NCT02317575|76136509|FG000|Received at Least 1 Dose of Study Drug|Period 1||5||
60020516|NCT02317575|76136510|FG001|Received at Least 1 Dose of Study Drug|Period 1||5||
60020517|NCT02317575|76136511|FG002|Received at Least 1 Dose of Study Drug|Period 1||6||
60020518|NCT02317575|76136512|FG003|Received at Least 1 Dose of Study Drug|Period 1||6||
60020519|NCT02317575|76136513|FG004|Received at Least 1 Dose of Study Drug|Period 1||6||
60020520|NCT02317575|76136509|FG000|COMPLETED|Period 1||4||
60020521|NCT02317575|76136510|FG001|COMPLETED|Period 1||5||
60020522|NCT02317575|76136511|FG002|COMPLETED|Period 1||6||
60020523|NCT02317575|76136512|FG003|COMPLETED|Period 1||6||
60020524|NCT02317575|76136513|FG004|COMPLETED|Period 1||6||
60020525|NCT02317575|76136509|FG000|NOT COMPLETED|Period 1||1||
60020526|NCT02317575|76136510|FG001|NOT COMPLETED|Period 1||1||
60020527|NCT02317575|76136511|FG002|NOT COMPLETED|Period 1||0||
60020528|NCT02317575|76136512|FG003|NOT COMPLETED|Period 1||0||
60020529|NCT02317575|76136513|FG004|NOT COMPLETED|Period 1||0||
60020530|NCT02317575|76136509|FG000|STARTED|Period 2||4||
60020531|NCT02317575|76136510|FG001|STARTED|Period 2||5||
60020532|NCT02317575|76136511|FG002|STARTED|Period 2||6||
60020533|NCT02317575|76136512|FG003|STARTED|Period 2||6||
60020534|NCT02317575|76136513|FG004|STARTED|Period 2||6||
60020535|NCT02317575|76136509|FG000|COMPLETED|Period 2||4||
60020536|NCT02317575|76136510|FG001|COMPLETED|Period 2||5||
60020537|NCT02317575|76136511|FG002|COMPLETED|Period 2||6||
60020538|NCT02317575|76136512|FG003|COMPLETED|Period 2||6||
60020539|NCT02317575|76136513|FG004|COMPLETED|Period 2||6||
60020540|NCT02317575|76136509|FG000|NOT COMPLETED|Period 2||0||
60020541|NCT02317575|76136510|FG001|NOT COMPLETED|Period 2||0||
60020542|NCT02317575|76136511|FG002|NOT COMPLETED|Period 2||0||
60020543|NCT02317575|76136512|FG003|NOT COMPLETED|Period 2||0||
60020544|NCT02317575|76136513|FG004|NOT COMPLETED|Period 2||0||
60020545|NCT02317575|76136509|FG000|STARTED|Period 3||4||
60020546|NCT02317575|76136510|FG001|STARTED|Period 3||5||
60020547|NCT02317575|76136511|FG002|STARTED|Period 3||6||
60020548|NCT02317575|76136512|FG003|STARTED|Period 3||6||
60020549|NCT02317575|76136513|FG004|STARTED|Period 3||6||
60020550|NCT02317575|76136509|FG000|COMPLETED|Period 3||4||
60020551|NCT02317575|76136510|FG001|COMPLETED|Period 3||5||
60020552|NCT02317575|76136511|FG002|COMPLETED|Period 3||6||
60020553|NCT02317575|76136512|FG003|COMPLETED|Period 3||6||
60020554|NCT02317575|76136513|FG004|COMPLETED|Period 3||6||
60020555|NCT02317575|76136509|FG000|NOT COMPLETED|Period 3||0||
60020556|NCT02317575|76136510|FG001|NOT COMPLETED|Period 3||0||
60020557|NCT02317575|76136511|FG002|NOT COMPLETED|Period 3||0||
60020558|NCT02317575|76136512|FG003|NOT COMPLETED|Period 3||0||
60020559|NCT02317575|76136513|FG004|NOT COMPLETED|Period 3||0||
60020560|NCT02317575|76136509|FG000|STARTED|Period 4||4||
60020561|NCT02317575|76136510|FG001|STARTED|Period 4||5||
60020562|NCT02317575|76136511|FG002|STARTED|Period 4||6||
60020563|NCT02317575|76136512|FG003|STARTED|Period 4||6||
60020564|NCT02317575|76136513|FG004|STARTED|Period 4||6||
60020565|NCT02317575|76136509|FG000|COMPLETED|Period 4||4||
60020566|NCT02317575|76136510|FG001|COMPLETED|Period 4||5||
60020567|NCT02317575|76136511|FG002|COMPLETED|Period 4||6||
60020568|NCT02317575|76136512|FG003|COMPLETED|Period 4||6||
60020569|NCT02317575|76136513|FG004|COMPLETED|Period 4||6||
60020570|NCT02317575|76136509|FG000|NOT COMPLETED|Period 4||0||
60020571|NCT02317575|76136510|FG001|NOT COMPLETED|Period 4||0||
60020572|NCT02317575|76136511|FG002|NOT COMPLETED|Period 4||0||
60020573|NCT02317575|76136512|FG003|NOT COMPLETED|Period 4||0||
60020574|NCT02317575|76136513|FG004|NOT COMPLETED|Period 4||0||
60020575|NCT02317575|76136509|FG000|STARTED|Period 5||4||
60020576|NCT02317575|76136510|FG001|STARTED|Period 5||5||
60020577|NCT02317575|76136511|FG002|STARTED|Period 5||6||
60020578|NCT02317575|76136512|FG003|STARTED|Period 5||6||
60020579|NCT02317575|76136513|FG004|STARTED|Period 5||6||
60020580|NCT02317575|76136509|FG000|COMPLETED|Period 5||4||
60020581|NCT02317575|76136510|FG001|COMPLETED|Period 5||5||
60020582|NCT02317575|76136511|FG002|COMPLETED|Period 5||6||
60020583|NCT02317575|76136512|FG003|COMPLETED|Period 5||6||
60020584|NCT02317575|76136513|FG004|COMPLETED|Period 5||6||
60020585|NCT02317575|76136509|FG000|NOT COMPLETED|Period 5||0||
60020586|NCT02317575|76136510|FG001|NOT COMPLETED|Period 5||0||
60020587|NCT02317575|76136511|FG002|NOT COMPLETED|Period 5||0||
60020588|NCT02317575|76136512|FG003|NOT COMPLETED|Period 5||0||
60020589|NCT02317575|76136513|FG004|NOT COMPLETED|Period 5||0||
60020590|NCT02316717|76136534|FG000|STARTED|Overall Study||43||
60020591|NCT02316717|76136535|FG001|STARTED|Overall Study||46||
60020592|NCT02316717|76136536|FG002|STARTED|Overall Study||44||
60020593|NCT02316717|76136534|FG000|COMPLETED|Overall Study||32||
60020594|NCT02316717|76136535|FG001|COMPLETED|Overall Study||39||
60020595|NCT02316717|76136536|FG002|COMPLETED|Overall Study||41||
60020596|NCT02316717|76136534|FG000|NOT COMPLETED|Overall Study||11||
60020597|NCT02316717|76136535|FG001|NOT COMPLETED|Overall Study||7||
60020598|NCT02316717|76136536|FG002|NOT COMPLETED|Overall Study||3||
60020599|NCT02290821|76136549|FG000|STARTED|Overall Study||109||
60020600|NCT02290821|76136550|FG001|STARTED|Overall Study||106||
60020601|NCT02290821|76136549|FG000|COMPLETED|Overall Study||103||
60020602|NCT02290821|76136550|FG001|COMPLETED|Overall Study||103||
60020603|NCT02290821|76136549|FG000|NOT COMPLETED|Overall Study||6||
60020604|NCT02290821|76136550|FG001|NOT COMPLETED|Overall Study||3||
60020605|NCT02289963|76136558|FG000|STARTED|Overall Study|Randomized|102||
60020606|NCT02289963|76136559|FG001|STARTED|Overall Study|Randomized|97||
60020607|NCT02289963|76136558|FG000|Treated|Overall Study||102||
60020608|NCT02289963|76136559|FG001|Treated|Overall Study||97||
60020609|NCT02289963|76136558|FG000|COMPLETED|Overall Study||97||
60020610|NCT02289963|76136559|FG001|COMPLETED|Overall Study||87||
60020611|NCT02289963|76136558|FG000|NOT COMPLETED|Overall Study||5||
60020612|NCT02289963|76136559|FG001|NOT COMPLETED|Overall Study||10||
60020613|NCT02358369|76136568|FG000|STARTED|Pre-Randomization Washout Period||156||
60020614|NCT02358369|76136569|FG001|STARTED|Pre-Randomization Washout Period||0||
60020615|NCT02358369|76136570|FG002|STARTED|Pre-Randomization Washout Period||0||
60020616|NCT02358369|76136571|FG003|STARTED|Pre-Randomization Washout Period||0||
60020617|NCT02358369|76136572|FG004|STARTED|Pre-Randomization Washout Period||0||
60020618|NCT02358369|76136568|FG000|COMPLETED|Pre-Randomization Washout Period||121||
60020619|NCT02358369|76136569|FG001|COMPLETED|Pre-Randomization Washout Period||0||
60020620|NCT02358369|76136570|FG002|COMPLETED|Pre-Randomization Washout Period||0||
60020621|NCT02358369|76136571|FG003|COMPLETED|Pre-Randomization Washout Period||0||
60020622|NCT02358369|76136572|FG004|COMPLETED|Pre-Randomization Washout Period||0||
60020623|NCT02358369|76136568|FG000|NOT COMPLETED|Pre-Randomization Washout Period||35||
60020624|NCT02358369|76136569|FG001|NOT COMPLETED|Pre-Randomization Washout Period||0||
60020625|NCT02358369|76136570|FG002|NOT COMPLETED|Pre-Randomization Washout Period||0||
60020626|NCT02358369|76136571|FG003|NOT COMPLETED|Pre-Randomization Washout Period||0||
60020627|NCT02358369|76136572|FG004|NOT COMPLETED|Pre-Randomization Washout Period||0||
60020628|NCT02358369|76136568|FG000|STARTED|Treatment Period A/B||0||
60020629|NCT02358369|76136569|FG001|STARTED|Treatment Period A/B||40||
60020630|NCT02358369|76136570|FG002|STARTED|Treatment Period A/B||40||
60020631|NCT02358369|76136571|FG003|STARTED|Treatment Period A/B||41||
60020632|NCT02358369|76136572|FG004|STARTED|Treatment Period A/B||0||
60020633|NCT02358369|76136568|FG000|COMPLETED|Treatment Period A/B||0||
60020634|NCT02358369|76136569|FG001|COMPLETED|Treatment Period A/B||38||
60020635|NCT02358369|76136570|FG002|COMPLETED|Treatment Period A/B||38||
60020636|NCT02358369|76136571|FG003|COMPLETED|Treatment Period A/B||37||
60020637|NCT02358369|76136572|FG004|COMPLETED|Treatment Period A/B||0||
60020638|NCT02358369|76136568|FG000|NOT COMPLETED|Treatment Period A/B||0||
60020639|NCT02358369|76136569|FG001|NOT COMPLETED|Treatment Period A/B||2||
60020640|NCT02358369|76136570|FG002|NOT COMPLETED|Treatment Period A/B||2||
60020641|NCT02358369|76136571|FG003|NOT COMPLETED|Treatment Period A/B||4||
60020642|NCT02358369|76136572|FG004|NOT COMPLETED|Treatment Period A/B||0||
60020643|NCT02358369|76136568|FG000|STARTED|Treatment Period C||0||
60020644|NCT02358369|76136569|FG001|STARTED|Treatment Period C||0||
60020645|NCT02358369|76136570|FG002|STARTED|Treatment Period C||0||
60020646|NCT02358369|76136571|FG003|STARTED|Treatment Period C||0||
60020647|NCT02358369|76136572|FG004|STARTED|Treatment Period C||113||
60020648|NCT02358369|76136568|FG000|COMPLETED|Treatment Period C||0||
60020649|NCT02358369|76136569|FG001|COMPLETED|Treatment Period C||0||
60020650|NCT02358369|76136570|FG002|COMPLETED|Treatment Period C||0||
60020651|NCT02358369|76136571|FG003|COMPLETED|Treatment Period C||0||
60020652|NCT02358369|76136572|FG004|COMPLETED|Treatment Period C||106||
60020653|NCT02358369|76136568|FG000|NOT COMPLETED|Treatment Period C||0||
60020654|NCT02358369|76136569|FG001|NOT COMPLETED|Treatment Period C||0||
60020655|NCT02358369|76136570|FG002|NOT COMPLETED|Treatment Period C||0||
60020656|NCT02358369|76136571|FG003|NOT COMPLETED|Treatment Period C||0||
60020657|NCT02358369|76136572|FG004|NOT COMPLETED|Treatment Period C||7||
60020658|NCT02316171|76136584|FG000|STARTED|Overall Study||4||
60020659|NCT02316171|76136585|FG001|STARTED|Overall Study||6||
60020660|NCT02316171|76136586|FG002|STARTED|Overall Study||3||
60020661|NCT02316171|76136587|FG003|STARTED|Overall Study||3||
60020662|NCT02316171|76136584|FG000|COMPLETED|Overall Study||3||
60020663|NCT02316171|76136585|FG001|COMPLETED|Overall Study||6||
60020664|NCT02316171|76136586|FG002|COMPLETED|Overall Study||3||
60020665|NCT02316171|76136587|FG003|COMPLETED|Overall Study||3||
60020666|NCT02316171|76136584|FG000|NOT COMPLETED|Overall Study||1||
60020667|NCT02316171|76136585|FG001|NOT COMPLETED|Overall Study||0||
60020668|NCT02316171|76136586|FG002|NOT COMPLETED|Overall Study||0||
60020669|NCT02316171|76136587|FG003|NOT COMPLETED|Overall Study||0||
60020670|NCT02289729|76136593|FG000|STARTED|Overall Study||59||
60020671|NCT02289729|76136593|FG000|COMPLETED|Overall Study||53||
60020672|NCT02289729|76136593|FG000|NOT COMPLETED|Overall Study||6||
60020673|NCT02315625|76136599|FG000|STARTED|First Intervention||14||
60020674|NCT02315625|76136600|FG001|STARTED|First Intervention||2||
60020675|NCT02315625|76136599|FG000|COMPLETED|First Intervention||13||
60020676|NCT02315625|76136600|FG001|COMPLETED|First Intervention||2||
60020677|NCT02315625|76136599|FG000|NOT COMPLETED|First Intervention||1||
60020678|NCT02315625|76136600|FG001|NOT COMPLETED|First Intervention||0||
60020679|NCT02315625|76136599|FG000|STARTED|Second Intervention||13||
60020680|NCT02315625|76136600|FG001|STARTED|Second Intervention||2||
60020681|NCT02315625|76136599|FG000|COMPLETED|Second Intervention||9||
60020682|NCT02315625|76136600|FG001|COMPLETED|Second Intervention||1||
60020683|NCT02315625|76136599|FG000|NOT COMPLETED|Second Intervention||4||
60020684|NCT02315625|76136600|FG001|NOT COMPLETED|Second Intervention||1||
60020685|NCT02357979|76136610|FG000|STARTED|Overall Study||60|Each participant provided two units - one right, one left second molar|60
60020686|NCT02357979|76136611|FG001|STARTED|Overall Study||60|Each participant provided two units - one right, one left second molar|60
60020687|NCT02357979|76136610|FG000|COMPLETED|Overall Study||55||55
59913295|NCT04234464|76034187|FG001|STARTED|Period 1 (First Treatment Intervention)||31||
59913296|NCT04234464|76034186|FG000|COMPLETED|Period 1 (First Treatment Intervention)||29||
59913297|NCT04234464|76034187|FG001|COMPLETED|Period 1 (First Treatment Intervention)||31||
59913298|NCT04234464|76034186|FG000|NOT COMPLETED|Period 1 (First Treatment Intervention)||0||
59913299|NCT04234464|76034187|FG001|NOT COMPLETED|Period 1 (First Treatment Intervention)||0||
59913300|NCT04234464|76034186|FG000|STARTED|Period 2 (Second Treatment Intervention)||29||
60020688|NCT02357979|76136611|FG001|COMPLETED|Overall Study||55||55
60020689|NCT02357979|76136610|FG000|NOT COMPLETED|Overall Study||5||5
60020690|NCT02357979|76136611|FG001|NOT COMPLETED|Overall Study||5||5
60020691|NCT02357901|76136620|FG000|STARTED|Run-In Period (Days -14 to Day -1)|Received at least one dose of SUBOXONE sublingual film.|665||
60020692|NCT02357901|76136621|FG001|STARTED|Run-In Period (Days -14 to Day -1)||0||
60020693|NCT02357901|76136622|FG002|STARTED|Run-In Period (Days -14 to Day -1)||0||
60020694|NCT02357901|76136623|FG003|STARTED|Run-In Period (Days -14 to Day -1)||0||
60020695|NCT02357901|76136620|FG000|COMPLETED|Run-In Period (Days -14 to Day -1)||504||
60020696|NCT02357901|76136621|FG001|COMPLETED|Run-In Period (Days -14 to Day -1)||0||
60020697|NCT02357901|76136622|FG002|COMPLETED|Run-In Period (Days -14 to Day -1)||0||
60020698|NCT02357901|76136623|FG003|COMPLETED|Run-In Period (Days -14 to Day -1)||0||
60020699|NCT02357901|76136620|FG000|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||161||
60020700|NCT02357901|76136621|FG001|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0||
60020701|NCT02357901|76136622|FG002|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0||
60020702|NCT02357901|76136623|FG003|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0||
60020703|NCT02357901|76136620|FG000|STARTED|Treatment Period (Day 1 to Week 24)||0||
60020704|NCT02357901|76136621|FG001|STARTED|Treatment Period (Day 1 to Week 24)||203||
60020705|NCT02357901|76136622|FG002|STARTED|Treatment Period (Day 1 to Week 24)||201||
60020706|NCT02357901|76136623|FG003|STARTED|Treatment Period (Day 1 to Week 24)||100||
60020707|NCT02357901|76136620|FG000|Safety Analysis Set|Treatment Period (Day 1 to Week 24)||0|Analyzed as treated.|
60020708|NCT02357901|76136621|FG001|Safety Analysis Set|Treatment Period (Day 1 to Week 24)||203|Analyzed as treated.|
60020709|NCT02357901|76136622|FG002|Safety Analysis Set|Treatment Period (Day 1 to Week 24)||201|Analyzed as treated.|
60020710|NCT02357901|76136623|FG003|Safety Analysis Set|Treatment Period (Day 1 to Week 24)||100|Analyzed as treated.|
60020711|NCT02357901|76136620|FG000|Full Analysis Set|Treatment Period (Day 1 to Week 24)||0|Analyzed as randomized. One site excluded from efficacy analyses due to compliance issues.|
60020712|NCT02357901|76136621|FG001|Full Analysis Set|Treatment Period (Day 1 to Week 24)||194|Analyzed as randomized. One site excluded from efficacy analyses due to compliance issues.|
60020713|NCT02357901|76136622|FG002|Full Analysis Set|Treatment Period (Day 1 to Week 24)||196|Analyzed as randomized. One site excluded from efficacy analyses due to compliance issues.|
60020714|NCT02357901|76136623|FG003|Full Analysis Set|Treatment Period (Day 1 to Week 24)||99|Analyzed as randomized. One site excluded from efficacy analyses due to compliance issues.|
60020715|NCT02357901|76136620|FG000|COMPLETED|Treatment Period (Day 1 to Week 24)||0||
60020716|NCT02357901|76136621|FG001|COMPLETED|Treatment Period (Day 1 to Week 24)||125||
60020717|NCT02357901|76136622|FG002|COMPLETED|Treatment Period (Day 1 to Week 24)||129||
60020718|NCT02357901|76136623|FG003|COMPLETED|Treatment Period (Day 1 to Week 24)||34||
60020719|NCT02357901|76136620|FG000|NOT COMPLETED|Treatment Period (Day 1 to Week 24)||0||
60020720|NCT02357901|76136621|FG001|NOT COMPLETED|Treatment Period (Day 1 to Week 24)||78||
60020721|NCT02357901|76136622|FG002|NOT COMPLETED|Treatment Period (Day 1 to Week 24)||72||
60020722|NCT02357901|76136623|FG003|NOT COMPLETED|Treatment Period (Day 1 to Week 24)||66||
60020723|NCT01601847|76136633|FG000|STARTED|Overall Study||153||
60020724|NCT01601847|76136634|FG001|STARTED|Overall Study||147||
60020725|NCT01601847|76136633|FG000|COMPLETED|Overall Study||140||
60020726|NCT01601847|76136634|FG001|COMPLETED|Overall Study||137||
60020727|NCT01601847|76136633|FG000|NOT COMPLETED|Overall Study||13||
60020728|NCT01601847|76136634|FG001|NOT COMPLETED|Overall Study||10||
60020729|NCT02515669|76136644|FG000|STARTED|24 Week Double-Blind Phase||11||
60020730|NCT02515669|76136645|FG001|STARTED|24 Week Double-Blind Phase||7||
60020731|NCT02515669|76136646|FG002|STARTED|24 Week Double-Blind Phase||6||
59913301|NCT04234464|76034187|FG001|STARTED|Period 2 (Second Treatment Intervention)||31||
59913302|NCT04234464|76034186|FG000|COMPLETED|Period 2 (Second Treatment Intervention)||28||
59913303|NCT04234464|76034187|FG001|COMPLETED|Period 2 (Second Treatment Intervention)||31||
59913304|NCT04234464|76034186|FG000|NOT COMPLETED|Period 2 (Second Treatment Intervention)||1||
59913305|NCT04234464|76034187|FG001|NOT COMPLETED|Period 2 (Second Treatment Intervention)||0||
60020732|NCT02515669|76136647|FG003|STARTED|24 Week Double-Blind Phase||19||
60020733|NCT02515669|76136644|FG000|COMPLETED|24 Week Double-Blind Phase||11||
60020734|NCT02515669|76136645|FG001|COMPLETED|24 Week Double-Blind Phase||7||
60020735|NCT02515669|76136646|FG002|COMPLETED|24 Week Double-Blind Phase||6||
60020736|NCT02515669|76136647|FG003|COMPLETED|24 Week Double-Blind Phase||19||
60020737|NCT02515669|76136644|FG000|NOT COMPLETED|24 Week Double-Blind Phase||0||
60020738|NCT02515669|76136645|FG001|NOT COMPLETED|24 Week Double-Blind Phase||0||
60020739|NCT02515669|76136646|FG002|NOT COMPLETED|24 Week Double-Blind Phase||0||
60020740|NCT02515669|76136647|FG003|NOT COMPLETED|24 Week Double-Blind Phase||0||
60020741|NCT02515669|76136644|FG000|STARTED|228 Week Open-Label Phase|Double-blind (DB) placebo participants switched to RO7239361 (RO) for the open label phase.|0|Participants assigned to placebo in the double blind phase switched to RO for the open-label phase|
60020742|NCT02515669|76136645|FG001|STARTED|228 Week Open-Label Phase|2 DB placebo participants switched to the Panel 1 RO cohort for the open-label phase.|9|Participants assigned to placebo in the double blind phase switched to RO for the open-label phase|
60020743|NCT02515669|76136646|FG002|STARTED|228 Week Open-Label Phase|2 DB placebo participants switched to the Panel 2 RO cohort for the open-label phase.|8|Participants assigned to placebo in the double blind phase switched to RO for the open-label phase|
60020744|NCT02515669|76136647|FG003|STARTED|228 Week Open-Label Phase|7 DB placebo participants switched to the Panel 3/Expansion RO cohort for the open-label phase.|26|Participants assigned to placebo in the double blind phase switched to RO for the open-label phase|
60020745|NCT02515669|76136644|FG000|COMPLETED|228 Week Open-Label Phase||0||
60020746|NCT02515669|76136645|FG001|COMPLETED|228 Week Open-Label Phase||0||
60020747|NCT02515669|76136646|FG002|COMPLETED|228 Week Open-Label Phase||0||
60020748|NCT02515669|76136647|FG003|COMPLETED|228 Week Open-Label Phase||0||
60020749|NCT02515669|76136644|FG000|NOT COMPLETED|228 Week Open-Label Phase||0||
60020750|NCT02515669|76136645|FG001|NOT COMPLETED|228 Week Open-Label Phase||9||
60020751|NCT02515669|76136646|FG002|NOT COMPLETED|228 Week Open-Label Phase||8||
60020752|NCT02515669|76136647|FG003|NOT COMPLETED|228 Week Open-Label Phase||26||
60020753|NCT02515279|76136677|FG000|STARTED|Overall Study||463||
60020754|NCT02515279|76136677|FG000|COMPLETED|Overall Study||359||
60020755|NCT02515279|76136677|FG000|NOT COMPLETED|Overall Study||104||
60020756|NCT02515045|76136683|FG000|STARTED|Overall Study||29||29
60020757|NCT02515045|76136684|FG001|STARTED|Overall Study||30||30
60020758|NCT02515045|76136685|FG002|STARTED|Overall Study||59||59
60020759|NCT02515045|76136683|FG000|COMPLETED|Overall Study||29||29
60020760|NCT02515045|76136684|FG001|COMPLETED|Overall Study||26||26
60020761|NCT02515045|76136685|FG002|COMPLETED|Overall Study||55||55
60020762|NCT02515045|76136683|FG000|NOT COMPLETED|Overall Study||0||0
60020763|NCT02515045|76136684|FG001|NOT COMPLETED|Overall Study||4||4
60020764|NCT02515045|76136685|FG002|NOT COMPLETED|Overall Study||4||4
60020765|NCT02514577|76136695|FG000|STARTED|Overall Study||143||
60020766|NCT02514577|76136696|FG001|STARTED|Overall Study||74||
60020767|NCT02514577|76136695|FG000|Intent-to-Treat (ITT) Population|Overall Study||143|Participants who were randomized and dispensed study drug.|
60020768|NCT02514577|76136696|FG001|Intent-to-Treat (ITT) Population|Overall Study||74|Participants who were randomized and dispensed study drug.|
60020769|NCT02514577|76136695|FG000|Safety Population|Overall Study||142|Randomized participants with ≥1 confirmed dose of study drug and ≥1 post-Baseline safety assessment.|
60020770|NCT02514577|76136696|FG001|Safety Population|Overall Study||72|Randomized participants with ≥1 confirmed dose of study drug and ≥1 post-Baseline safety assessment.|
60020771|NCT02514577|76136695|FG000|COMPLETED|Overall Study||129||
60020772|NCT02514577|76136696|FG001|COMPLETED|Overall Study||61||
60020773|NCT02514577|76136695|FG000|NOT COMPLETED|Overall Study||14||
60020774|NCT02514577|76136696|FG001|NOT COMPLETED|Overall Study||13||
60020775|NCT02513485|76136704|FG000|STARTED|Overall Study||28||
60020776|NCT02513485|76136705|FG001|STARTED|Overall Study||29||
60020777|NCT02513485|76136704|FG000|COMPLETED|Overall Study||27||
60020778|NCT02513485|76136705|FG001|COMPLETED|Overall Study||29||
60020779|NCT02513485|76136704|FG000|NOT COMPLETED|Overall Study||1||
60020780|NCT02513485|76136705|FG001|NOT COMPLETED|Overall Study||0||
60020781|NCT02289417|76136714|FG000|STARTED|Placebo-Controlled Phase Weeks 0-12||58||
60020782|NCT02289417|76136715|FG001|STARTED|Placebo-Controlled Phase Weeks 0-12||57||
60020783|NCT02289417|76136716|FG002|STARTED|Placebo-Controlled Phase Weeks 0-12||55||
60020784|NCT02289417|76136717|FG003|STARTED|Placebo-Controlled Phase Weeks 0-12||0||
60020785|NCT02289417|76136718|FG004|STARTED|Placebo-Controlled Phase Weeks 0-12||0||
60020786|NCT02289417|76136719|FG005|STARTED|Placebo-Controlled Phase Weeks 0-12||0||
60020787|NCT02289417|76136720|FG006|STARTED|Placebo-Controlled Phase Weeks 0-12||0||
60020788|NCT02289417|76136721|FG007|STARTED|Placebo-Controlled Phase Weeks 0-12||0||
60020789|NCT02289417|76136722|FG008|STARTED|Placebo-Controlled Phase Weeks 0-12||0||
60020790|NCT02289417|76136714|FG000|COMPLETED|Placebo-Controlled Phase Weeks 0-12||51||
60020791|NCT02289417|76136715|FG001|COMPLETED|Placebo-Controlled Phase Weeks 0-12||53||
60020792|NCT02289417|76136716|FG002|COMPLETED|Placebo-Controlled Phase Weeks 0-12||52||
60020793|NCT02289417|76136717|FG003|COMPLETED|Placebo-Controlled Phase Weeks 0-12||0||
60020794|NCT02289417|76136718|FG004|COMPLETED|Placebo-Controlled Phase Weeks 0-12||0||
60020795|NCT02289417|76136719|FG005|COMPLETED|Placebo-Controlled Phase Weeks 0-12||0||
60020796|NCT02289417|76136720|FG006|COMPLETED|Placebo-Controlled Phase Weeks 0-12||0||
60020797|NCT02289417|76136721|FG007|COMPLETED|Placebo-Controlled Phase Weeks 0-12||0||
60020798|NCT02289417|76136722|FG008|COMPLETED|Placebo-Controlled Phase Weeks 0-12||0||
60020799|NCT02289417|76136714|FG000|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||7||
60020800|NCT02289417|76136715|FG001|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||4||
60020801|NCT02289417|76136716|FG002|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||3||
60020802|NCT02289417|76136717|FG003|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||0||
60020803|NCT02289417|76136718|FG004|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||0||
60020804|NCT02289417|76136719|FG005|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||0||
60020805|NCT02289417|76136720|FG006|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||0||
60020806|NCT02289417|76136721|FG007|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||0||
60020807|NCT02289417|76136722|FG008|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||0||
60020808|NCT02289417|76136714|FG000|STARTED|Active Treatment Phase Weeks 12-52||0||
60020809|NCT02289417|76136715|FG001|STARTED|Active Treatment Phase Weeks 12-52||41||
60020810|NCT02289417|76136716|FG002|STARTED|Active Treatment Phase Weeks 12-52||42||
60020811|NCT02289417|76136717|FG003|STARTED|Active Treatment Phase Weeks 12-52||26||
60020812|NCT02289417|76136718|FG004|STARTED|Active Treatment Phase Weeks 12-52||25||
60020813|NCT02289417|76136719|FG005|STARTED|Active Treatment Phase Weeks 12-52|1 participant went only to Week 20|12||
60020814|NCT02289417|76136720|FG006|STARTED|Active Treatment Phase Weeks 12-52|Week 12 TMS were missing for 3 participants|7||
60020815|NCT02289417|76136721|FG007|STARTED|Active Treatment Phase Weeks 12-52||0||
60020816|NCT02289417|76136722|FG008|STARTED|Active Treatment Phase Weeks 12-52||0||
60020817|NCT02289417|76136714|FG000|COMPLETED|Active Treatment Phase Weeks 12-52||0||
60020818|NCT02289417|76136715|FG001|COMPLETED|Active Treatment Phase Weeks 12-52||39||
60020819|NCT02289417|76136716|FG002|COMPLETED|Active Treatment Phase Weeks 12-52||32||
60020820|NCT02289417|76136717|FG003|COMPLETED|Active Treatment Phase Weeks 12-52||17||
60020821|NCT02289417|76136718|FG004|COMPLETED|Active Treatment Phase Weeks 12-52||20||
60020822|NCT02289417|76136719|FG005|COMPLETED|Active Treatment Phase Weeks 12-52||7||
60020823|NCT02289417|76136720|FG006|COMPLETED|Active Treatment Phase Weeks 12-52||5||
60020824|NCT02289417|76136721|FG007|COMPLETED|Active Treatment Phase Weeks 12-52||0||
60020825|NCT02289417|76136722|FG008|COMPLETED|Active Treatment Phase Weeks 12-52||0||
60020826|NCT02289417|76136714|FG000|NOT COMPLETED|Active Treatment Phase Weeks 12-52||0||
60020827|NCT02289417|76136715|FG001|NOT COMPLETED|Active Treatment Phase Weeks 12-52||2||
60020828|NCT02289417|76136716|FG002|NOT COMPLETED|Active Treatment Phase Weeks 12-52||10||
60020829|NCT02289417|76136717|FG003|NOT COMPLETED|Active Treatment Phase Weeks 12-52||9||
60020830|NCT02289417|76136718|FG004|NOT COMPLETED|Active Treatment Phase Weeks 12-52||5||
60020831|NCT02289417|76136719|FG005|NOT COMPLETED|Active Treatment Phase Weeks 12-52||5||
60020832|NCT02289417|76136720|FG006|NOT COMPLETED|Active Treatment Phase Weeks 12-52||2||
60020833|NCT02289417|76136721|FG007|NOT COMPLETED|Active Treatment Phase Weeks 12-52||0||
60020834|NCT02289417|76136722|FG008|NOT COMPLETED|Active Treatment Phase Weeks 12-52||0||
60020835|NCT02289417|76136714|FG000|STARTED|Extension Phase Weeks 52-104||0||
60020836|NCT02289417|76136715|FG001|STARTED|Extension Phase Weeks 52-104||0||
60020837|NCT02289417|76136716|FG002|STARTED|Extension Phase Weeks 52-104||0||
60020838|NCT02289417|76136717|FG003|STARTED|Extension Phase Weeks 52-104||0||
60020839|NCT02289417|76136718|FG004|STARTED|Extension Phase Weeks 52-104||0||
60020840|NCT02289417|76136719|FG005|STARTED|Extension Phase Weeks 52-104||0||
60020841|NCT02289417|76136720|FG006|STARTED|Extension Phase Weeks 52-104||0||
60020842|NCT02289417|76136721|FG007|STARTED|Extension Phase Weeks 52-104||45||
60020843|NCT02289417|76136722|FG008|STARTED|Extension Phase Weeks 52-104||54||
60020844|NCT02289417|76136714|FG000|COMPLETED|Extension Phase Weeks 52-104||0||
60020845|NCT02289417|76136715|FG001|COMPLETED|Extension Phase Weeks 52-104||0||
60020846|NCT02289417|76136716|FG002|COMPLETED|Extension Phase Weeks 52-104||0||
60020847|NCT02289417|76136717|FG003|COMPLETED|Extension Phase Weeks 52-104||0||
60020848|NCT02289417|76136718|FG004|COMPLETED|Extension Phase Weeks 52-104||0||
60020849|NCT02289417|76136719|FG005|COMPLETED|Extension Phase Weeks 52-104||0||
60020850|NCT02289417|76136720|FG006|COMPLETED|Extension Phase Weeks 52-104||0||
59613508|NCT01684722|75724630|FG003|NOT COMPLETED|Overall Study||110||
60020851|NCT02289417|76136721|FG007|COMPLETED|Extension Phase Weeks 52-104||38||
60020852|NCT02289417|76136722|FG008|COMPLETED|Extension Phase Weeks 52-104||48||
60020853|NCT02289417|76136714|FG000|NOT COMPLETED|Extension Phase Weeks 52-104||0||
60020854|NCT02289417|76136715|FG001|NOT COMPLETED|Extension Phase Weeks 52-104||0||
60020855|NCT02289417|76136716|FG002|NOT COMPLETED|Extension Phase Weeks 52-104||0||
60020856|NCT02289417|76136717|FG003|NOT COMPLETED|Extension Phase Weeks 52-104||0||
60020857|NCT02289417|76136718|FG004|NOT COMPLETED|Extension Phase Weeks 52-104||0||
60020858|NCT02289417|76136719|FG005|NOT COMPLETED|Extension Phase Weeks 52-104||0||
60020859|NCT02289417|76136720|FG006|NOT COMPLETED|Extension Phase Weeks 52-104||0||
60020860|NCT02289417|76136721|FG007|NOT COMPLETED|Extension Phase Weeks 52-104||7||
60020861|NCT02289417|76136722|FG008|NOT COMPLETED|Extension Phase Weeks 52-104||6||
60020862|NCT02512861|76136740|FG000|STARTED|Overall Study||44||
60020863|NCT02512861|76136741|FG001|STARTED|Overall Study||49||
60020864|NCT02512861|76136740|FG000|COMPLETED|Overall Study||38||
60020865|NCT02512861|76136741|FG001|COMPLETED|Overall Study||40||
60020866|NCT02512861|76136740|FG000|NOT COMPLETED|Overall Study||6||
60020867|NCT02512861|76136741|FG001|NOT COMPLETED|Overall Study||9||
60020868|NCT02288559|76136751|FG000|STARTED|Overall Study||10||
60020869|NCT02288559|76136752|FG001|STARTED|Overall Study||11||
60020870|NCT02288559|76136753|FG002|STARTED|Overall Study||46||
60020871|NCT02288559|76136754|FG003|STARTED|Overall Study||22||
60020872|NCT02288559|76136751|FG000|COMPLETED|Overall Study||9||
60020873|NCT02288559|76136752|FG001|COMPLETED|Overall Study||10||
60020874|NCT02288559|76136753|FG002|COMPLETED|Overall Study||35||
60020875|NCT02288559|76136754|FG003|COMPLETED|Overall Study||20||
60020876|NCT02288559|76136751|FG000|NOT COMPLETED|Overall Study||1||
60020877|NCT02288559|76136752|FG001|NOT COMPLETED|Overall Study||1||
60020878|NCT02288559|76136753|FG002|NOT COMPLETED|Overall Study||11||
60020879|NCT02288559|76136754|FG003|NOT COMPLETED|Overall Study||2||
60020880|NCT02288325|76136766|FG000|STARTED|Run-in Period||644||
60020881|NCT02288325|76136767|FG001|STARTED|Run-in Period||0||
60020882|NCT02288325|76136768|FG002|STARTED|Run-in Period||0||
60020883|NCT02288325|76136766|FG000|COMPLETED|Run-in Period||499||
60020884|NCT02288325|76136767|FG001|COMPLETED|Run-in Period||0||
60020885|NCT02288325|76136768|FG002|COMPLETED|Run-in Period||0||
60020886|NCT02288325|76136766|FG000|NOT COMPLETED|Run-in Period||145||
60020887|NCT02288325|76136767|FG001|NOT COMPLETED|Run-in Period||0||
60020888|NCT02288325|76136768|FG002|NOT COMPLETED|Run-in Period||0||
60020889|NCT02288325|76136766|FG000|STARTED|Stabilization Period|70 participants did not enter Stabilization Period (69 did not meet entry criteria; 1 other reason)|429||
60020890|NCT02288325|76136767|FG001|STARTED|Stabilization Period||0||
60020891|NCT02288325|76136768|FG002|STARTED|Stabilization Period||0||
60020892|NCT02288325|76136766|FG000|COMPLETED|Stabilization Period||331||
60020893|NCT02288325|76136767|FG001|COMPLETED|Stabilization Period||0||
60020894|NCT02288325|76136768|FG002|COMPLETED|Stabilization Period||0||
60020895|NCT02288325|76136766|FG000|NOT COMPLETED|Stabilization Period||98||
60020896|NCT02288325|76136767|FG001|NOT COMPLETED|Stabilization Period||0||
60020897|NCT02288325|76136768|FG002|NOT COMPLETED|Stabilization Period||0||
60020898|NCT02288325|76136766|FG000|STARTED|Double-blind Treatment Period||0||
60020899|NCT02288325|76136767|FG001|STARTED|Double-blind Treatment Period|7 participants did not enter Double-Blind Period (2 did not meet entry criteria; 5 other reasons)|159||
60020900|NCT02288325|76136768|FG002|STARTED|Double-blind Treatment Period|7 participants did not enter Double-Blind Period (2 did not meet entry criteria; 5 other reasons)|165||
60020901|NCT02288325|76136766|FG000|COMPLETED|Double-blind Treatment Period||0||
60020902|NCT02288325|76136767|FG001|COMPLETED|Double-blind Treatment Period||135||
60020903|NCT02288325|76136768|FG002|COMPLETED|Double-blind Treatment Period||139||
60020904|NCT02288325|76136766|FG000|NOT COMPLETED|Double-blind Treatment Period||0||
60020905|NCT02288325|76136767|FG001|NOT COMPLETED|Double-blind Treatment Period||24||
60020906|NCT02288325|76136768|FG002|NOT COMPLETED|Double-blind Treatment Period||26||
60020907|NCT02509117|76136785|FG000|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||2||
60020908|NCT02509117|76136786|FG001|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||2||
60020909|NCT02509117|76136787|FG002|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||2||
60020910|NCT02509117|76136788|FG003|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||2||
60020911|NCT02509117|76136789|FG004|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||8||
60020912|NCT02509117|76136790|FG005|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||8||
60020913|NCT02509117|76136791|FG006|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||8||
60020914|NCT02509117|76136792|FG007|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||8||
60020915|NCT02509117|76136793|FG008|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||4||
60020916|NCT02509117|76136794|FG009|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||10||
60020917|NCT02509117|76136785|FG000|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||2||
60020918|NCT02509117|76136786|FG001|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||1||
60020919|NCT02509117|76136787|FG002|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||2||
60020920|NCT02509117|76136788|FG003|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||2||
60020921|NCT02509117|76136789|FG004|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||8||
60020922|NCT02509117|76136790|FG005|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||8||
60020923|NCT02509117|76136791|FG006|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||8||
60020924|NCT02509117|76136792|FG007|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||8||
60020925|NCT02509117|76136793|FG008|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||4||
60020926|NCT02509117|76136794|FG009|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||10||
60020927|NCT02509117|76136785|FG000|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||2||
60020928|NCT02509117|76136786|FG001|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||1||
60020929|NCT02509117|76136787|FG002|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||2||
60020930|NCT02509117|76136788|FG003|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||2||
60020931|NCT02509117|76136789|FG004|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||8||
60020932|NCT02509117|76136790|FG005|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||8||
60020933|NCT02509117|76136791|FG006|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||8||
60020934|NCT02509117|76136792|FG007|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||8||
60020935|NCT02509117|76136793|FG008|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||4||
60020936|NCT02509117|76136794|FG009|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||8||
60020937|NCT02509117|76136785|FG000|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0||
60020938|NCT02509117|76136786|FG001|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||1||
60020939|NCT02509117|76136787|FG002|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0||
60020940|NCT02509117|76136788|FG003|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0||
60020941|NCT02509117|76136789|FG004|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0||
60020942|NCT02509117|76136790|FG005|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0||
60020943|NCT02509117|76136791|FG006|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0||
60020944|NCT02509117|76136792|FG007|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0||
60020945|NCT02509117|76136793|FG008|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0||
60020946|NCT02509117|76136794|FG009|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||2||
60020947|NCT02509117|76136785|FG000|STARTED|Washout Period 1 (Part A: 7 Days)||2||
60020948|NCT02509117|76136786|FG001|STARTED|Washout Period 1 (Part A: 7 Days)||1||
60020949|NCT02509117|76136787|FG002|STARTED|Washout Period 1 (Part A: 7 Days)||2||
60020950|NCT02509117|76136788|FG003|STARTED|Washout Period 1 (Part A: 7 Days)||2||
60020951|NCT02509117|76136789|FG004|STARTED|Washout Period 1 (Part A: 7 Days)||0||
60020952|NCT02509117|76136790|FG005|STARTED|Washout Period 1 (Part A: 7 Days)||0||
60020953|NCT02509117|76136791|FG006|STARTED|Washout Period 1 (Part A: 7 Days)||0||
60020954|NCT02509117|76136792|FG007|STARTED|Washout Period 1 (Part A: 7 Days)||0||
60020955|NCT02509117|76136793|FG008|STARTED|Washout Period 1 (Part A: 7 Days)||0||
60020956|NCT02509117|76136794|FG009|STARTED|Washout Period 1 (Part A: 7 Days)||0||
60020957|NCT02509117|76136785|FG000|COMPLETED|Washout Period 1 (Part A: 7 Days)||2||
60020958|NCT02509117|76136786|FG001|COMPLETED|Washout Period 1 (Part A: 7 Days)||1||
60020959|NCT02509117|76136787|FG002|COMPLETED|Washout Period 1 (Part A: 7 Days)||2||
60020960|NCT02509117|76136788|FG003|COMPLETED|Washout Period 1 (Part A: 7 Days)||2||
60020961|NCT02509117|76136789|FG004|COMPLETED|Washout Period 1 (Part A: 7 Days)||0||
60020962|NCT02509117|76136790|FG005|COMPLETED|Washout Period 1 (Part A: 7 Days)||0||
60020963|NCT02509117|76136791|FG006|COMPLETED|Washout Period 1 (Part A: 7 Days)||0||
60020964|NCT02509117|76136792|FG007|COMPLETED|Washout Period 1 (Part A: 7 Days)||0||
60020965|NCT02509117|76136793|FG008|COMPLETED|Washout Period 1 (Part A: 7 Days)||0||
60020966|NCT02509117|76136794|FG009|COMPLETED|Washout Period 1 (Part A: 7 Days)||0||
60020967|NCT02509117|76136785|FG000|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0||
60020968|NCT02509117|76136786|FG001|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0||
60020969|NCT02509117|76136787|FG002|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0||
60020970|NCT02509117|76136788|FG003|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0||
60020971|NCT02509117|76136789|FG004|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0||
60020972|NCT02509117|76136790|FG005|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0||
60020973|NCT02509117|76136791|FG006|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0||
60020974|NCT02509117|76136792|FG007|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0||
60020975|NCT02509117|76136793|FG008|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0||
60020976|NCT02509117|76136794|FG009|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0||
60020977|NCT02509117|76136785|FG000|STARTED|Period 2 -Part A: 4 Days||2||
60020978|NCT02509117|76136786|FG001|STARTED|Period 2 -Part A: 4 Days|1 participant was added in intervention period 2|2||
60020979|NCT02509117|76136787|FG002|STARTED|Period 2 -Part A: 4 Days||2||
60020980|NCT02509117|76136788|FG003|STARTED|Period 2 -Part A: 4 Days||2||
60020981|NCT02509117|76136789|FG004|STARTED|Period 2 -Part A: 4 Days||0||
60020982|NCT02509117|76136790|FG005|STARTED|Period 2 -Part A: 4 Days||0||
60020983|NCT02509117|76136791|FG006|STARTED|Period 2 -Part A: 4 Days||0||
60020984|NCT02509117|76136792|FG007|STARTED|Period 2 -Part A: 4 Days||0||
60020985|NCT02509117|76136793|FG008|STARTED|Period 2 -Part A: 4 Days||0||
60020986|NCT02509117|76136794|FG009|STARTED|Period 2 -Part A: 4 Days||0||
60020987|NCT02509117|76136785|FG000|Treated|Period 2 -Part A: 4 Days||2||
60020988|NCT02509117|76136786|FG001|Treated|Period 2 -Part A: 4 Days||2||
60020989|NCT02509117|76136787|FG002|Treated|Period 2 -Part A: 4 Days||2||
60020990|NCT02509117|76136788|FG003|Treated|Period 2 -Part A: 4 Days||2||
60020991|NCT02509117|76136789|FG004|Treated|Period 2 -Part A: 4 Days||0||
60020992|NCT02509117|76136790|FG005|Treated|Period 2 -Part A: 4 Days||0||
60020993|NCT02509117|76136791|FG006|Treated|Period 2 -Part A: 4 Days||0||
60020994|NCT02509117|76136792|FG007|Treated|Period 2 -Part A: 4 Days||0||
60020995|NCT02509117|76136793|FG008|Treated|Period 2 -Part A: 4 Days||0||
59507268|NCT02402127|75600485|FG004|NOT COMPLETED|Second Wear Period (1 Day)||0||
60020996|NCT02509117|76136794|FG009|Treated|Period 2 -Part A: 4 Days||0||
60020997|NCT02509117|76136785|FG000|COMPLETED|Period 2 -Part A: 4 Days||2||
60020998|NCT02509117|76136786|FG001|COMPLETED|Period 2 -Part A: 4 Days||2||
60020999|NCT02509117|76136787|FG002|COMPLETED|Period 2 -Part A: 4 Days||2||
60021000|NCT02509117|76136788|FG003|COMPLETED|Period 2 -Part A: 4 Days||2||
60021001|NCT02509117|76136789|FG004|COMPLETED|Period 2 -Part A: 4 Days||0||
60021002|NCT02509117|76136790|FG005|COMPLETED|Period 2 -Part A: 4 Days||0||
60021003|NCT02509117|76136791|FG006|COMPLETED|Period 2 -Part A: 4 Days||0||
60021004|NCT02509117|76136792|FG007|COMPLETED|Period 2 -Part A: 4 Days||0||
60021005|NCT02509117|76136793|FG008|COMPLETED|Period 2 -Part A: 4 Days||0||
60021006|NCT02509117|76136794|FG009|COMPLETED|Period 2 -Part A: 4 Days||0||
60021007|NCT02509117|76136785|FG000|NOT COMPLETED|Period 2 -Part A: 4 Days||0||
60021008|NCT02509117|76136786|FG001|NOT COMPLETED|Period 2 -Part A: 4 Days||0||
60021009|NCT02509117|76136787|FG002|NOT COMPLETED|Period 2 -Part A: 4 Days||0||
60021010|NCT02509117|76136788|FG003|NOT COMPLETED|Period 2 -Part A: 4 Days||0||
60021011|NCT02509117|76136789|FG004|NOT COMPLETED|Period 2 -Part A: 4 Days||0||
60021012|NCT02509117|76136790|FG005|NOT COMPLETED|Period 2 -Part A: 4 Days||0||
60021013|NCT02509117|76136791|FG006|NOT COMPLETED|Period 2 -Part A: 4 Days||0||
60021014|NCT02509117|76136792|FG007|NOT COMPLETED|Period 2 -Part A: 4 Days||0||
60021015|NCT02509117|76136793|FG008|NOT COMPLETED|Period 2 -Part A: 4 Days||0||
60021016|NCT02509117|76136794|FG009|NOT COMPLETED|Period 2 -Part A: 4 Days||0||
60021017|NCT02509117|76136785|FG000|STARTED|Washout Period 2 (Part A: 7 Days)||2||
60021018|NCT02509117|76136786|FG001|STARTED|Washout Period 2 (Part A: 7 Days)||2||
60021019|NCT02509117|76136787|FG002|STARTED|Washout Period 2 (Part A: 7 Days)||2||
60021020|NCT02509117|76136788|FG003|STARTED|Washout Period 2 (Part A: 7 Days)||2||
60021021|NCT02509117|76136789|FG004|STARTED|Washout Period 2 (Part A: 7 Days)||0||
60021022|NCT02509117|76136790|FG005|STARTED|Washout Period 2 (Part A: 7 Days)||0||
60021023|NCT02509117|76136791|FG006|STARTED|Washout Period 2 (Part A: 7 Days)||0||
60021024|NCT02509117|76136792|FG007|STARTED|Washout Period 2 (Part A: 7 Days)||0||
60021025|NCT02509117|76136793|FG008|STARTED|Washout Period 2 (Part A: 7 Days)||0||
60021026|NCT02509117|76136794|FG009|STARTED|Washout Period 2 (Part A: 7 Days)||0||
60021027|NCT02509117|76136785|FG000|COMPLETED|Washout Period 2 (Part A: 7 Days)||2||
60021028|NCT02509117|76136786|FG001|COMPLETED|Washout Period 2 (Part A: 7 Days)||2||
60021029|NCT02509117|76136787|FG002|COMPLETED|Washout Period 2 (Part A: 7 Days)||2||
60021030|NCT02509117|76136788|FG003|COMPLETED|Washout Period 2 (Part A: 7 Days)||2||
60021031|NCT02509117|76136789|FG004|COMPLETED|Washout Period 2 (Part A: 7 Days)||0||
60021032|NCT02509117|76136790|FG005|COMPLETED|Washout Period 2 (Part A: 7 Days)||0||
60021033|NCT02509117|76136791|FG006|COMPLETED|Washout Period 2 (Part A: 7 Days)||0||
60021034|NCT02509117|76136792|FG007|COMPLETED|Washout Period 2 (Part A: 7 Days)||0||
60021035|NCT02509117|76136793|FG008|COMPLETED|Washout Period 2 (Part A: 7 Days)||0||
60021036|NCT02509117|76136794|FG009|COMPLETED|Washout Period 2 (Part A: 7 Days)||0||
60021037|NCT02509117|76136785|FG000|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0||
60021038|NCT02509117|76136786|FG001|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0||
60021039|NCT02509117|76136787|FG002|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0||
60021040|NCT02509117|76136788|FG003|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0||
60021041|NCT02509117|76136789|FG004|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0||
60021042|NCT02509117|76136790|FG005|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0||
60021043|NCT02509117|76136791|FG006|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0||
60021044|NCT02509117|76136792|FG007|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0||
60021045|NCT02509117|76136793|FG008|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0||
60021046|NCT02509117|76136794|FG009|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0||
60021047|NCT02509117|76136785|FG000|STARTED|Period 3 -Part A: 4 Days||2||
60021048|NCT02509117|76136786|FG001|STARTED|Period 3 -Part A: 4 Days||2||
60021049|NCT02509117|76136787|FG002|STARTED|Period 3 -Part A: 4 Days||2||
60021050|NCT02509117|76136788|FG003|STARTED|Period 3 -Part A: 4 Days||2||
60021051|NCT02509117|76136789|FG004|STARTED|Period 3 -Part A: 4 Days||0||
60021052|NCT02509117|76136790|FG005|STARTED|Period 3 -Part A: 4 Days||0||
60021053|NCT02509117|76136791|FG006|STARTED|Period 3 -Part A: 4 Days||0||
60021054|NCT02509117|76136792|FG007|STARTED|Period 3 -Part A: 4 Days||0||
60021055|NCT02509117|76136793|FG008|STARTED|Period 3 -Part A: 4 Days||0||
60021056|NCT02509117|76136794|FG009|STARTED|Period 3 -Part A: 4 Days||0||
60021057|NCT02509117|76136785|FG000|COMPLETED|Period 3 -Part A: 4 Days||2||
60021058|NCT02509117|76136786|FG001|COMPLETED|Period 3 -Part A: 4 Days||2||
60021059|NCT02509117|76136787|FG002|COMPLETED|Period 3 -Part A: 4 Days||2||
60021060|NCT02509117|76136788|FG003|COMPLETED|Period 3 -Part A: 4 Days||2||
60021061|NCT02509117|76136789|FG004|COMPLETED|Period 3 -Part A: 4 Days||0||
60021062|NCT02509117|76136790|FG005|COMPLETED|Period 3 -Part A: 4 Days||0||
60021063|NCT02509117|76136791|FG006|COMPLETED|Period 3 -Part A: 4 Days||0||
60021064|NCT02509117|76136792|FG007|COMPLETED|Period 3 -Part A: 4 Days||0||
60021065|NCT02509117|76136793|FG008|COMPLETED|Period 3 -Part A: 4 Days||0||
60021066|NCT02509117|76136794|FG009|COMPLETED|Period 3 -Part A: 4 Days||0||
60021067|NCT02509117|76136785|FG000|NOT COMPLETED|Period 3 -Part A: 4 Days||0||
60021068|NCT02509117|76136786|FG001|NOT COMPLETED|Period 3 -Part A: 4 Days||0||
60021069|NCT02509117|76136787|FG002|NOT COMPLETED|Period 3 -Part A: 4 Days||0||
60021070|NCT02509117|76136788|FG003|NOT COMPLETED|Period 3 -Part A: 4 Days||0||
60021071|NCT02509117|76136789|FG004|NOT COMPLETED|Period 3 -Part A: 4 Days||0||
60021072|NCT02509117|76136790|FG005|NOT COMPLETED|Period 3 -Part A: 4 Days||0||
60021073|NCT02509117|76136791|FG006|NOT COMPLETED|Period 3 -Part A: 4 Days||0||
60021074|NCT02509117|76136792|FG007|NOT COMPLETED|Period 3 -Part A: 4 Days||0||
60021075|NCT02509117|76136793|FG008|NOT COMPLETED|Period 3 -Part A: 4 Days||0||
60021076|NCT02509117|76136794|FG009|NOT COMPLETED|Period 3 -Part A: 4 Days||0||
59913306|NCT03123588|76034195|FG000|STARTED|Overall Study||6||
59913307|NCT03123588|76034196|FG001|STARTED|Overall Study||6||
59913308|NCT03123588|76034195|FG000|COMPLETED|Overall Study||0||
59913309|NCT03123588|76034196|FG001|COMPLETED|Overall Study||0||
59913310|NCT03123588|76034195|FG000|NOT COMPLETED|Overall Study||6||
59913311|NCT03123588|76034196|FG001|NOT COMPLETED|Overall Study||6||
59913312|NCT03123354|76034203|FG000|STARTED|Overall Study||44||
59913313|NCT03123354|76034203|FG000|COMPLETED|Overall Study||38||
59913314|NCT03123354|76034203|FG000|NOT COMPLETED|Overall Study||6||
59913315|NCT04421027|76034209|FG000|STARTED|Treatment Period||761||
59913316|NCT04421027|76034210|FG001|STARTED|Treatment Period||764||
59913317|NCT04421027|76034211|FG002|STARTED|Treatment Period||0||
59913318|NCT04421027|76034212|FG003|STARTED|Treatment Period||0||
59913319|NCT04421027|76034209|FG000|Received at Least One Dose of Study Drug|Treatment Period||752||
59913320|NCT04421027|76034210|FG001|Received at Least One Dose of Study Drug|Treatment Period||750||
59913321|NCT04421027|76034211|FG002|Received at Least One Dose of Study Drug|Treatment Period||0||
59913322|NCT04421027|76034212|FG003|Received at Least One Dose of Study Drug|Treatment Period||0||
59913323|NCT04421027|76034209|FG000|COMPLETED|Treatment Period||604||
59913324|NCT04421027|76034210|FG001|COMPLETED|Treatment Period||644||
59913325|NCT04421027|76034211|FG002|COMPLETED|Treatment Period||0||
59913326|NCT04421027|76034212|FG003|COMPLETED|Treatment Period||0||
59913327|NCT04421027|76034209|FG000|NOT COMPLETED|Treatment Period||157||
59913328|NCT04421027|76034210|FG001|NOT COMPLETED|Treatment Period||120||
59913329|NCT04421027|76034211|FG002|NOT COMPLETED|Treatment Period||0||
59913330|NCT04421027|76034212|FG003|NOT COMPLETED|Treatment Period||0||
59913331|NCT04421027|76034209|FG000|STARTED|Follow-Up Period||0||
59913332|NCT04421027|76034210|FG001|STARTED|Follow-Up Period||0||
59913333|NCT04421027|76034211|FG002|STARTED|Follow-Up Period||613||
59913334|NCT04421027|76034212|FG003|STARTED|Follow-Up Period||645||
59913335|NCT04421027|76034209|FG000|COMPLETED|Follow-Up Period||0||
59913336|NCT04421027|76034210|FG001|COMPLETED|Follow-Up Period||0||
59913337|NCT04421027|76034211|FG002|COMPLETED|Follow-Up Period||588||
59913338|NCT04421027|76034212|FG003|COMPLETED|Follow-Up Period|One participants study disposition case report form was not completed, therefore the participant appeared as 'ongoing' at Day 60. The participant completed Day 60 Clinical Status Assessment (CSA) and is considered as completing the study.|615||
59913339|NCT04421027|76034209|FG000|NOT COMPLETED|Follow-Up Period||0||
59913340|NCT04421027|76034210|FG001|NOT COMPLETED|Follow-Up Period||0||
59913341|NCT04421027|76034211|FG002|NOT COMPLETED|Follow-Up Period||25||
59913342|NCT04421027|76034212|FG003|NOT COMPLETED|Follow-Up Period||30||
59913343|NCT04419311|76034222|FG000|STARTED|Overall Study||33||
59913344|NCT04419311|76034223|FG001|STARTED|Overall Study||33||
59913345|NCT04419311|76034222|FG000|COMPLETED|Overall Study||32||
59913346|NCT04419311|76034223|FG001|COMPLETED|Overall Study||33||
59913347|NCT04419311|76034222|FG000|NOT COMPLETED|Overall Study||1||
59913348|NCT04419311|76034223|FG001|NOT COMPLETED|Overall Study||0||
59913349|NCT04411667|76034233|FG000|STARTED|Overall Study||17||
59913350|NCT04411667|76034234|FG001|STARTED|Overall Study||17||
59913351|NCT04411667|76034233|FG000|COMPLETED|Overall Study||16||
59913352|NCT04411667|76034234|FG001|COMPLETED|Overall Study||17||
59913353|NCT04411667|76034233|FG000|NOT COMPLETED|Overall Study||1||
59913354|NCT04411667|76034234|FG001|NOT COMPLETED|Overall Study||0||
59913355|NCT04358549|76034242|FG000|STARTED|Overall Study||25||
59913356|NCT04358549|76034243|FG001|STARTED|Overall Study||25||
59913357|NCT04358549|76034242|FG000|ITT Population (Randomized Subjects)|Overall Study||25||
59913358|NCT04358549|76034243|FG001|ITT Population (Randomized Subjects)|Overall Study||25||
59913359|NCT04358549|76034242|FG000|Safety Population (Patients Who Received Either Favipiravir + SOC or SOC Alone)|Overall Study||24|One patient randomized in favipiravir + SOC arm withdrew before the first dose of favipiravir.|
59913360|NCT04358549|76034243|FG001|Safety Population (Patients Who Received Either Favipiravir + SOC or SOC Alone)|Overall Study||25|One patient randomized in favipiravir + SOC arm withdrew before the first dose of favipiravir.|
59913361|NCT04358549|76034242|FG000|COMPLETED|Overall Study||15||
59913362|NCT04358549|76034243|FG001|COMPLETED|Overall Study||17||
59913363|NCT04358549|76034242|FG000|NOT COMPLETED|Overall Study||10||
59913364|NCT04358549|76034243|FG001|NOT COMPLETED|Overall Study||8||
59913365|NCT00700180|76034251|FG000|STARTED|Overall Study||154||
59913366|NCT00700180|76034252|FG001|STARTED|Overall Study||149||
59913367|NCT00700180|76034251|FG000|COMPLETED|Overall Study|Clinical cutoff date: July 11, 2011|0||
59913368|NCT00700180|76034252|FG001|COMPLETED|Overall Study|Clinical cutoff date: July 11, 2011|0||
59913369|NCT00700180|76034251|FG000|NOT COMPLETED|Overall Study||154||
59913370|NCT00700180|76034252|FG001|NOT COMPLETED|Overall Study||149||
59913371|NCT00238420|76034260|FG000|STARTED|Overall Study||22||
59913372|NCT00238420|76034261|FG001|STARTED|Overall Study||48||
59913373|NCT00238420|76034260|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|21||
59913374|NCT00238420|76034261|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|47||
59913375|NCT00238420|76034260|FG000|NOT COMPLETED|Overall Study||1||
59913376|NCT00238420|76034261|FG001|NOT COMPLETED|Overall Study||1||
59913377|NCT04492475|76034269|FG000|STARTED|Overall Study||487||
59913378|NCT04492475|76034270|FG001|STARTED|Overall Study||482||
59913379|NCT04492475|76034269|FG000|ITT and Modified ITT Population|Overall Study||487||
60021077|NCT02509117|76136785|FG000|STARTED|Washout Period 3 (Part A: 7 Days)||2||
60021078|NCT02509117|76136786|FG001|STARTED|Washout Period 3 (Part A: 7 Days)||2||
60021079|NCT02509117|76136787|FG002|STARTED|Washout Period 3 (Part A: 7 Days)||2||
60021080|NCT02509117|76136788|FG003|STARTED|Washout Period 3 (Part A: 7 Days)||2||
60021081|NCT02509117|76136789|FG004|STARTED|Washout Period 3 (Part A: 7 Days)||0||
60021082|NCT02509117|76136790|FG005|STARTED|Washout Period 3 (Part A: 7 Days)||0||
60021083|NCT02509117|76136791|FG006|STARTED|Washout Period 3 (Part A: 7 Days)||0||
60021084|NCT02509117|76136792|FG007|STARTED|Washout Period 3 (Part A: 7 Days)||0||
60021085|NCT02509117|76136793|FG008|STARTED|Washout Period 3 (Part A: 7 Days)||0||
60021086|NCT02509117|76136794|FG009|STARTED|Washout Period 3 (Part A: 7 Days)||0||
60021087|NCT02509117|76136785|FG000|COMPLETED|Washout Period 3 (Part A: 7 Days)||2||
60021088|NCT02509117|76136786|FG001|COMPLETED|Washout Period 3 (Part A: 7 Days)||2||
60021089|NCT02509117|76136787|FG002|COMPLETED|Washout Period 3 (Part A: 7 Days)||2||
60021090|NCT02509117|76136788|FG003|COMPLETED|Washout Period 3 (Part A: 7 Days)||2||
60021091|NCT02509117|76136789|FG004|COMPLETED|Washout Period 3 (Part A: 7 Days)||0||
60021092|NCT02509117|76136790|FG005|COMPLETED|Washout Period 3 (Part A: 7 Days)||0||
60021093|NCT02509117|76136791|FG006|COMPLETED|Washout Period 3 (Part A: 7 Days)||0||
60021094|NCT02509117|76136792|FG007|COMPLETED|Washout Period 3 (Part A: 7 Days)||0||
60021095|NCT02509117|76136793|FG008|COMPLETED|Washout Period 3 (Part A: 7 Days)||0||
60021096|NCT02509117|76136794|FG009|COMPLETED|Washout Period 3 (Part A: 7 Days)||0||
60021097|NCT02509117|76136785|FG000|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0||
60021098|NCT02509117|76136786|FG001|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0||
60021099|NCT02509117|76136787|FG002|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0||
60021100|NCT02509117|76136788|FG003|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0||
60021101|NCT02509117|76136789|FG004|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0||
60021102|NCT02509117|76136790|FG005|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0||
60021103|NCT02509117|76136791|FG006|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0||
60021104|NCT02509117|76136792|FG007|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0||
60021105|NCT02509117|76136793|FG008|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0||
60021106|NCT02509117|76136794|FG009|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0||
60021107|NCT02509117|76136785|FG000|STARTED|Period 4 -Part A: 4 Days||2||
60021108|NCT02509117|76136786|FG001|STARTED|Period 4 -Part A: 4 Days||2||
60021109|NCT02509117|76136787|FG002|STARTED|Period 4 -Part A: 4 Days||2||
60021110|NCT02509117|76136788|FG003|STARTED|Period 4 -Part A: 4 Days||2||
60021111|NCT02509117|76136789|FG004|STARTED|Period 4 -Part A: 4 Days||0||
60021112|NCT02509117|76136790|FG005|STARTED|Period 4 -Part A: 4 Days||0||
60021113|NCT02509117|76136791|FG006|STARTED|Period 4 -Part A: 4 Days||0||
60021114|NCT02509117|76136792|FG007|STARTED|Period 4 -Part A: 4 Days||0||
60021115|NCT02509117|76136793|FG008|STARTED|Period 4 -Part A: 4 Days||0||
60021116|NCT02509117|76136794|FG009|STARTED|Period 4 -Part A: 4 Days||0||
60021117|NCT02509117|76136785|FG000|COMPLETED|Period 4 -Part A: 4 Days||2||
60021118|NCT02509117|76136786|FG001|COMPLETED|Period 4 -Part A: 4 Days||2||
60021119|NCT02509117|76136787|FG002|COMPLETED|Period 4 -Part A: 4 Days||2||
60021120|NCT02509117|76136788|FG003|COMPLETED|Period 4 -Part A: 4 Days||2||
60021121|NCT02509117|76136789|FG004|COMPLETED|Period 4 -Part A: 4 Days||0||
60021122|NCT02509117|76136790|FG005|COMPLETED|Period 4 -Part A: 4 Days||0||
60021123|NCT02509117|76136791|FG006|COMPLETED|Period 4 -Part A: 4 Days||0||
60021124|NCT02509117|76136792|FG007|COMPLETED|Period 4 -Part A: 4 Days||0||
60021125|NCT02509117|76136793|FG008|COMPLETED|Period 4 -Part A: 4 Days||0||
60021126|NCT02509117|76136794|FG009|COMPLETED|Period 4 -Part A: 4 Days||0||
60021127|NCT02509117|76136785|FG000|NOT COMPLETED|Period 4 -Part A: 4 Days||0||
60021128|NCT02509117|76136786|FG001|NOT COMPLETED|Period 4 -Part A: 4 Days||0||
60021129|NCT02509117|76136787|FG002|NOT COMPLETED|Period 4 -Part A: 4 Days||0||
60021130|NCT02509117|76136788|FG003|NOT COMPLETED|Period 4 -Part A: 4 Days||0||
60021131|NCT02509117|76136789|FG004|NOT COMPLETED|Period 4 -Part A: 4 Days||0||
60021132|NCT02509117|76136790|FG005|NOT COMPLETED|Period 4 -Part A: 4 Days||0||
60021133|NCT02509117|76136791|FG006|NOT COMPLETED|Period 4 -Part A: 4 Days||0||
60021134|NCT02509117|76136792|FG007|NOT COMPLETED|Period 4 -Part A: 4 Days||0||
60021135|NCT02509117|76136793|FG008|NOT COMPLETED|Period 4 -Part A: 4 Days||0||
60021136|NCT02509117|76136794|FG009|NOT COMPLETED|Period 4 -Part A: 4 Days||0||
60021137|NCT01654549|76136834|FG000|STARTED|Overall Study||20||
60021138|NCT01654549|76136835|FG001|STARTED|Overall Study||20||
60021139|NCT01654549|76136834|FG000|COMPLETED|Overall Study||20||
60021140|NCT01654549|76136835|FG001|COMPLETED|Overall Study||19||
60021141|NCT01654549|76136834|FG000|NOT COMPLETED|Overall Study||0||
60021142|NCT01654549|76136835|FG001|NOT COMPLETED|Overall Study||1||
60021143|NCT02508649|76136849|FG000|STARTED|Overall Study||283||
60021144|NCT02508649|76136850|FG001|STARTED|Overall Study||197||
60021145|NCT02508649|76136851|FG002|STARTED|Overall Study||189||
60021146|NCT02508649|76136852|FG003|STARTED|Overall Study||199||
60021147|NCT02508649|76136849|FG000|Dosed|Overall Study||266||
60021148|NCT02508649|76136850|FG001|Dosed|Overall Study||191||
60021149|NCT02508649|76136851|FG002|Dosed|Overall Study||177||
60021150|NCT02508649|76136852|FG003|Dosed|Overall Study||194||
60021151|NCT02508649|76136849|FG000|COMPLETED|Overall Study||265||
59758855|NCT00746733|75878155|FG000|COMPLETED|Third Intervention||10||
59758856|NCT00746733|75878156|FG001|COMPLETED|Third Intervention||11||
59758857|NCT00746733|75878155|FG000|NOT COMPLETED|Third Intervention||1||
59758858|NCT00746733|75878156|FG001|NOT COMPLETED|Third Intervention||1||
59758859|NCT00746733|75878155|FG000|STARTED|Fourth Intervention||10||
59758860|NCT00746733|75878156|FG001|STARTED|Fourth Intervention||11||
59758861|NCT00746733|75878155|FG000|COMPLETED|Fourth Intervention||10||
59913380|NCT04492475|76034270|FG001|ITT and Modified ITT Population|Overall Study||482||
59913381|NCT04492475|76034269|FG000|As Treated Population|Overall Study||477||
59913382|NCT04492475|76034270|FG001|As Treated Population|Overall Study||468||
59913383|NCT04492475|76034269|FG000|COMPLETED|Overall Study||473||
59913384|NCT04492475|76034270|FG001|COMPLETED|Overall Study||474||
59913385|NCT04492475|76034269|FG000|NOT COMPLETED|Overall Study||14||
59913386|NCT04492475|76034270|FG001|NOT COMPLETED|Overall Study||8||
59913387|NCT04486235|76034285|FG000|STARTED|Overall Study||32||
59913388|NCT04486235|76034286|FG001|STARTED|Overall Study||30||
59913389|NCT04486235|76034285|FG000|Analysis|Overall Study||30||
59913390|NCT04486235|76034286|FG001|Analysis|Overall Study||30||
59913391|NCT04486235|76034285|FG000|COMPLETED|Overall Study||30||
59913392|NCT04486235|76034286|FG001|COMPLETED|Overall Study||30||
59913393|NCT04486235|76034285|FG000|NOT COMPLETED|Overall Study||2||
59913394|NCT04486235|76034286|FG001|NOT COMPLETED|Overall Study||0||
59913395|NCT04358081|76034296|FG000|STARTED|Treatment Phase of Study||7||
59913396|NCT04358081|76034297|FG001|STARTED|Treatment Phase of Study||7||
59913397|NCT04358081|76034298|FG002|STARTED|Treatment Phase of Study||5||
59913398|NCT04358081|76034296|FG000|COMPLETED|Treatment Phase of Study||3||
59913399|NCT04358081|76034297|FG001|COMPLETED|Treatment Phase of Study||6||
59913400|NCT04358081|76034298|FG002|COMPLETED|Treatment Phase of Study||2||
59913401|NCT04358081|76034296|FG000|NOT COMPLETED|Treatment Phase of Study||4||
59913402|NCT04358081|76034297|FG001|NOT COMPLETED|Treatment Phase of Study||1||
59913403|NCT04358081|76034298|FG002|NOT COMPLETED|Treatment Phase of Study||3||
59913404|NCT04358081|76034296|FG000|STARTED|Study Completion Phase||7||
59913405|NCT04358081|76034297|FG001|STARTED|Study Completion Phase||7||
59913406|NCT04358081|76034298|FG002|STARTED|Study Completion Phase||5||
59913407|NCT04358081|76034296|FG000|COMPLETED|Study Completion Phase||6||
59913408|NCT04358081|76034297|FG001|COMPLETED|Study Completion Phase||7||
59913409|NCT04358081|76034298|FG002|COMPLETED|Study Completion Phase||3||
59913410|NCT04358081|76034296|FG000|NOT COMPLETED|Study Completion Phase||1||
59913411|NCT04358081|76034297|FG001|NOT COMPLETED|Study Completion Phase||0||
59913412|NCT04358081|76034298|FG002|NOT COMPLETED|Study Completion Phase||2||
59913413|NCT04355663|76034311|FG000|STARTED|Overall Study||42||
59913414|NCT04355663|76034312|FG001|STARTED|Overall Study||29||
59913415|NCT04355663|76034313|FG002|STARTED|Overall Study||21||
59913416|NCT04355663|76034311|FG000|COMPLETED|Overall Study||40||
59913417|NCT04355663|76034312|FG001|COMPLETED|Overall Study||14||
59913418|NCT04355663|76034313|FG002|COMPLETED|Overall Study||17||
59913419|NCT04355663|76034311|FG000|NOT COMPLETED|Overall Study||2||
59913420|NCT04355663|76034312|FG001|NOT COMPLETED|Overall Study||15||
59913421|NCT04355663|76034313|FG002|NOT COMPLETED|Overall Study||4||
59913422|NCT04345367|76034323|FG000|STARTED|Overall Study||362||
59913423|NCT04345367|76034324|FG001|STARTED|Overall Study||365||
59913424|NCT04345367|76034323|FG000|COMPLETED|Overall Study||327||
59913425|NCT04345367|76034324|FG001|COMPLETED|Overall Study||334||
59913426|NCT04345367|76034323|FG000|NOT COMPLETED|Overall Study||35||
59913427|NCT04345367|76034324|FG001|NOT COMPLETED|Overall Study||31||
59913428|NCT04404725|76034330|FG000|STARTED|First Intervention||32||
59913429|NCT04404725|76034331|FG001|STARTED|First Intervention||31||
59913430|NCT04404725|76034330|FG000|COMPLETED|First Intervention||32||
59913431|NCT04404725|76034331|FG001|COMPLETED|First Intervention||29||
59913432|NCT04404725|76034330|FG000|NOT COMPLETED|First Intervention||0||
59913433|NCT04404725|76034331|FG001|NOT COMPLETED|First Intervention||2||
59913434|NCT04404725|76034330|FG000|STARTED|Second Intervention||32||
59913435|NCT04404725|76034331|FG001|STARTED|Second Intervention||29||
59913436|NCT04404725|76034330|FG000|COMPLETED|Second Intervention||31||
59913437|NCT04404725|76034331|FG001|COMPLETED|Second Intervention||27||
59913438|NCT04404725|76034330|FG000|NOT COMPLETED|Second Intervention||1||
59913439|NCT04404725|76034331|FG001|NOT COMPLETED|Second Intervention||2||
59913440|NCT04343261|76034337|FG000|STARTED|Overall Study||48||
59913441|NCT04343261|76034337|FG000|COMPLETED|Overall Study||40||
59913442|NCT04343261|76034337|FG000|NOT COMPLETED|Overall Study||8||
59913443|NCT04336475|76034343|FG000|STARTED|Overall Study||30||
59913444|NCT04336475|76034344|FG001|STARTED|Overall Study||30||
59913445|NCT04336475|76034343|FG000|COMPLETED|Overall Study||28||
59913446|NCT04336475|76034344|FG001|COMPLETED|Overall Study||28||
59913447|NCT04336475|76034343|FG000|NOT COMPLETED|Overall Study||2||
59913448|NCT04336475|76034344|FG001|NOT COMPLETED|Overall Study||2||
59913449|NCT04335929|76034350|FG000|STARTED|Overall Study||32||
59758862|NCT00746733|75878156|FG001|COMPLETED|Fourth Intervention||11||
59913450|NCT04335929|76034350|FG000|COMPLETED|Overall Study||22||
59913451|NCT04335929|76034350|FG000|NOT COMPLETED|Overall Study||10||
59913452|NCT04333199|76034357|FG000|STARTED|Evaluated Patients||1669||
59913453|NCT04333199|76034358|FG001|STARTED|Evaluated Patients||1672||
60021152|NCT02508649|76136850|FG001|COMPLETED|Overall Study||184||
60021153|NCT02508649|76136851|FG002|COMPLETED|Overall Study||174||
60021154|NCT02508649|76136852|FG003|COMPLETED|Overall Study||189||
60021155|NCT02508649|76136849|FG000|NOT COMPLETED|Overall Study||18||
60021156|NCT02508649|76136850|FG001|NOT COMPLETED|Overall Study||13||
60021157|NCT02508649|76136851|FG002|NOT COMPLETED|Overall Study||15||
59913454|NCT04333199|76034359|FG002|STARTED|Evaluated Patients||1671||
59913455|NCT04333199|76034357|FG000|COMPLETED|Evaluated Patients||1669|Removed patients not found in EHR|
59913456|NCT04333199|76034358|FG001|COMPLETED|Evaluated Patients||1671|Removed patients not found in EHR|
59913457|NCT04333199|76034359|FG002|COMPLETED|Evaluated Patients||1669|Removed patients not found in EHR|
59913458|NCT04333199|76034357|FG000|NOT COMPLETED|Evaluated Patients||0||
59913459|NCT04333199|76034358|FG001|NOT COMPLETED|Evaluated Patients||1||
59913460|NCT04333199|76034359|FG002|NOT COMPLETED|Evaluated Patients||2||
59913461|NCT04333199|76034357|FG000|STARTED|Emailed Patients|Patients in this group were not emailed|0||
59913462|NCT04333199|76034358|FG001|STARTED|Emailed Patients||1671||
59913463|NCT04333199|76034359|FG002|STARTED|Emailed Patients||1669||
59913464|NCT04333199|76034357|FG000|Valid Email Address|Emailed Patients|Patients in this group were not emailed|0|Email address not flagged as invalid by email delivery software|
59913465|NCT04333199|76034358|FG001|Valid Email Address|Emailed Patients||1495|Email address not flagged as invalid by email delivery software|
59913466|NCT04333199|76034359|FG002|Valid Email Address|Emailed Patients||1441|Email address not flagged as invalid by email delivery software|
59913467|NCT04333199|76034357|FG000|COMPLETED|Emailed Patients|Patients in this group were not emailed|0|Email delivered (did not bounce back)|
59913468|NCT04333199|76034358|FG001|COMPLETED|Emailed Patients||1399|Email delivered (did not bounce back)|
59913469|NCT04333199|76034359|FG002|COMPLETED|Emailed Patients||1351|Email delivered (did not bounce back)|
59913470|NCT04333199|76034357|FG000|NOT COMPLETED|Emailed Patients||0||
59913471|NCT04333199|76034358|FG001|NOT COMPLETED|Emailed Patients||272||
59913472|NCT04333199|76034359|FG002|NOT COMPLETED|Emailed Patients||318||
59913473|NCT04332419|76034368|FG000|STARTED|Overall Study||11||
59913474|NCT04332419|76034368|FG000|COMPLETED|Overall Study||10||
59913475|NCT04332419|76034368|FG000|NOT COMPLETED|Overall Study||1||
59913476|NCT04330157|76034372|FG000|STARTED|Overall Study||50||
59913477|NCT04330157|76034372|FG000|COMPLETED|Overall Study||43||
59913478|NCT04330157|76034372|FG000|NOT COMPLETED|Overall Study||7||
59913479|NCT04329923|76034387|FG000|STARTED|Overall Study||17||
59913480|NCT04329923|76034388|FG001|STARTED|Overall Study||17||
59913481|NCT04329923|76034389|FG002|STARTED|Overall Study||4||
59913482|NCT04329923|76034390|FG003|STARTED|Overall Study||3||
59913483|NCT04329923|76034391|FG004|STARTED|Overall Study||66||
59913484|NCT04329923|76034392|FG005|STARTED|Overall Study||66||
59913485|NCT04329923|76034387|FG000|COMPLETED|Overall Study||16||
59913486|NCT04329923|76034388|FG001|COMPLETED|Overall Study||13||
59913487|NCT04329923|76034389|FG002|COMPLETED|Overall Study||3||
59913488|NCT04329923|76034390|FG003|COMPLETED|Overall Study||2||
59913489|NCT04329923|76034391|FG004|COMPLETED|Overall Study||64||
59913490|NCT04329923|76034392|FG005|COMPLETED|Overall Study||61||
59913491|NCT04329923|76034387|FG000|NOT COMPLETED|Overall Study||1||
59913492|NCT04329923|76034388|FG001|NOT COMPLETED|Overall Study||4||
59913493|NCT04329923|76034389|FG002|NOT COMPLETED|Overall Study||1||
59913494|NCT04329923|76034390|FG003|NOT COMPLETED|Overall Study||1||
59913495|NCT04329923|76034391|FG004|NOT COMPLETED|Overall Study||2||
59913496|NCT04329923|76034392|FG005|NOT COMPLETED|Overall Study||5||
59913497|NCT04403399|76034408|FG000|STARTED|Period 1||18||
59913498|NCT04403399|76034409|FG001|STARTED|Period 1||16||
59913499|NCT04403399|76034408|FG000|COMPLETED|Period 1||18||
59913500|NCT04403399|76034409|FG001|COMPLETED|Period 1||16||
59913501|NCT04403399|76034408|FG000|NOT COMPLETED|Period 1||0||
60021158|NCT02508649|76136852|FG003|NOT COMPLETED|Overall Study||10||
60021159|NCT02505217|76136867|FG000|STARTED|Overall Study||105||
60021160|NCT02505217|76136868|FG001|STARTED|Overall Study||95||
60021161|NCT02505217|76136867|FG000|COMPLETED|Overall Study||104||
60021162|NCT02505217|76136868|FG001|COMPLETED|Overall Study||93||
60021163|NCT02505217|76136867|FG000|NOT COMPLETED|Overall Study||1||
60021164|NCT02505217|76136868|FG001|NOT COMPLETED|Overall Study||2||
60021165|NCT02504827|76136874|FG000|STARTED|Overall Study||12||
60021166|NCT02504827|76136874|FG000|COMPLETED|Overall Study||11||
59913502|NCT04403399|76034409|FG001|NOT COMPLETED|Period 1||0||
59913503|NCT04403399|76034408|FG000|STARTED|Period 2||18||
59913504|NCT04403399|76034409|FG001|STARTED|Period 2||16||
59913505|NCT04403399|76034408|FG000|COMPLETED|Period 2||18||
59913506|NCT04403399|76034409|FG001|COMPLETED|Period 2||15||
59913507|NCT04403399|76034408|FG000|NOT COMPLETED|Period 2||0||
59913508|NCT04403399|76034409|FG001|NOT COMPLETED|Period 2||1||
59913509|NCT04401293|76034417|FG000|STARTED|Overall Study||130||
59913510|NCT04401293|76034418|FG001|STARTED|Overall Study||127||
59913511|NCT04401293|76034417|FG000|COMPLETED|Overall Study||129||
59913512|NCT04401293|76034418|FG001|COMPLETED|Overall Study||124||
59913513|NCT04401293|76034417|FG000|NOT COMPLETED|Overall Study||1||
60021167|NCT02504827|76136874|FG000|NOT COMPLETED|Overall Study||1||
60021168|NCT02504671|76136884|FG000|STARTED|Overall Study||37||
60021169|NCT02504671|76136885|FG001|STARTED|Overall Study||37||
60021170|NCT02504671|76136886|FG002|STARTED|Overall Study||37||
60021171|NCT02504671|76136887|FG003|STARTED|Overall Study||37||
60021172|NCT02504671|76136888|FG004|STARTED|Overall Study||37||
60021173|NCT02504671|76136889|FG005|STARTED|Overall Study||37||
60021174|NCT02504671|76136884|FG000|COMPLETED|Overall Study||25||
60021175|NCT02504671|76136885|FG001|COMPLETED|Overall Study||23||
60021176|NCT02504671|76136886|FG002|COMPLETED|Overall Study||27||
60021177|NCT02504671|76136887|FG003|COMPLETED|Overall Study||27||
60021178|NCT02504671|76136888|FG004|COMPLETED|Overall Study||25||
60021179|NCT02504671|76136889|FG005|COMPLETED|Overall Study||23||
60021180|NCT02504671|76136884|FG000|NOT COMPLETED|Overall Study||12||
60021181|NCT02504671|76136885|FG001|NOT COMPLETED|Overall Study||14||
60021182|NCT02504671|76136886|FG002|NOT COMPLETED|Overall Study||10||
60021183|NCT02504671|76136887|FG003|NOT COMPLETED|Overall Study||10||
60021184|NCT02504671|76136888|FG004|NOT COMPLETED|Overall Study||12||
60021185|NCT02504671|76136889|FG005|NOT COMPLETED|Overall Study||14||
60021186|NCT02314143|76136906|FG000|STARTED|Overall Study||16||
60021187|NCT02314143|76136907|FG001|STARTED|Overall Study||16||
60021188|NCT02314143|76136908|FG002|STARTED|Overall Study||16||
60021189|NCT02314143|76136906|FG000|COMPLETED|Overall Study||8||
60021190|NCT02314143|76136907|FG001|COMPLETED|Overall Study||6||
60021191|NCT02314143|76136908|FG002|COMPLETED|Overall Study||7||
60021192|NCT02314143|76136906|FG000|NOT COMPLETED|Overall Study||8||
60021193|NCT02314143|76136907|FG001|NOT COMPLETED|Overall Study||10||
60021194|NCT02314143|76136908|FG002|NOT COMPLETED|Overall Study||9||
60021195|NCT02288091|76136917|FG000|STARTED|Overall Study||32||
60021196|NCT02288091|76136917|FG000|Randomized/Treated|Overall Study||25||
60021197|NCT02288091|76136917|FG000|COMPLETED|Overall Study||24||
60021198|NCT02288091|76136917|FG000|NOT COMPLETED|Overall Study||8||
60021199|NCT02503501|76136923|FG000|STARTED|Overall Study||19||
60021200|NCT02503501|76136924|FG001|STARTED|Overall Study||16||
60021201|NCT02503501|76136923|FG000|COMPLETED|Overall Study||18||
60021202|NCT02503501|76136924|FG001|COMPLETED|Overall Study||13||
60021203|NCT02503501|76136923|FG000|NOT COMPLETED|Overall Study||1||
60021204|NCT02503501|76136924|FG001|NOT COMPLETED|Overall Study||3||
60021205|NCT02502097|76136934|FG000|STARTED|Period 1||4||
60021206|NCT02502097|76136935|FG001|STARTED|Period 1||3||
60021207|NCT02502097|76136936|FG002|STARTED|Period 1||22||
60021208|NCT02502097|76136937|FG003|STARTED|Period 1||22||
60021209|NCT02502097|76136934|FG000|COMPLETED|Period 1||4||
60021210|NCT02502097|76136935|FG001|COMPLETED|Period 1||3||
60021211|NCT02502097|76136936|FG002|COMPLETED|Period 1||21||
60021212|NCT02502097|76136937|FG003|COMPLETED|Period 1||22||
60021213|NCT02502097|76136934|FG000|NOT COMPLETED|Period 1||0||
60021214|NCT02502097|76136935|FG001|NOT COMPLETED|Period 1||0||
60021215|NCT02502097|76136936|FG002|NOT COMPLETED|Period 1||1||
60021216|NCT02502097|76136937|FG003|NOT COMPLETED|Period 1||0||
60021217|NCT02502097|76136934|FG000|STARTED|Wash Out Period||4||
60021218|NCT02502097|76136935|FG001|STARTED|Wash Out Period||3||
60021219|NCT02502097|76136936|FG002|STARTED|Wash Out Period||21||
60021220|NCT02502097|76136937|FG003|STARTED|Wash Out Period||22||
60021221|NCT02502097|76136934|FG000|COMPLETED|Wash Out Period||4||
60021222|NCT02502097|76136935|FG001|COMPLETED|Wash Out Period||2||
60021223|NCT02502097|76136936|FG002|COMPLETED|Wash Out Period||20||
60021224|NCT02502097|76136937|FG003|COMPLETED|Wash Out Period||21||
60021225|NCT02502097|76136934|FG000|NOT COMPLETED|Wash Out Period||0||
60021226|NCT02502097|76136935|FG001|NOT COMPLETED|Wash Out Period||1||
60021227|NCT02502097|76136936|FG002|NOT COMPLETED|Wash Out Period||1||
60021228|NCT02502097|76136937|FG003|NOT COMPLETED|Wash Out Period||1||
60021229|NCT02502097|76136934|FG000|STARTED|Period 2||4||
60021230|NCT02502097|76136935|FG001|STARTED|Period 2||2||
60021231|NCT02502097|76136936|FG002|STARTED|Period 2||20||
60021232|NCT02502097|76136937|FG003|STARTED|Period 2||21||
60021233|NCT02502097|76136934|FG000|COMPLETED|Period 2||4||
60021234|NCT02502097|76136935|FG001|COMPLETED|Period 2||2||
60021235|NCT02502097|76136936|FG002|COMPLETED|Period 2||19||
60021236|NCT02502097|76136937|FG003|COMPLETED|Period 2||21||
60021237|NCT02502097|76136934|FG000|NOT COMPLETED|Period 2||0||
60021238|NCT02502097|76136935|FG001|NOT COMPLETED|Period 2||0||
60021239|NCT02502097|76136936|FG002|NOT COMPLETED|Period 2||1||
60021240|NCT02502097|76136937|FG003|NOT COMPLETED|Period 2||0||
60021241|NCT02501629|76136946|FG000|STARTED|Overall Study||89||
60021242|NCT02501629|76136947|FG001|STARTED|Overall Study||88||
60021243|NCT02501629|76136946|FG000|COMPLETED|Overall Study||84|Participants who completed the 8-week follow-up visit or enrolled in NCT03052725|
60021244|NCT02501629|76136947|FG001|COMPLETED|Overall Study||81|Participants who completed the 8-week follow-up visit or enrolled in NCT03052725|
60021245|NCT02501629|76136946|FG000|NOT COMPLETED|Overall Study||5||
60021246|NCT02501629|76136947|FG001|NOT COMPLETED|Overall Study||7||
60021247|NCT02501473|76136960|FG000|STARTED|Overall Study||3||
60021248|NCT02501473|76136961|FG001|STARTED|Overall Study||3||
60021249|NCT02501473|76136962|FG002|STARTED|Overall Study||13||
60021250|NCT02501473|76136963|FG003|STARTED|Overall Study||14||
60021251|NCT02501473|76136964|FG004|STARTED|Overall Study||4||
60021252|NCT02501473|76136965|FG005|STARTED|Overall Study||14||
60021253|NCT02501473|76136966|FG006|STARTED|Overall Study||1||
60021254|NCT02501473|76136967|FG007|STARTED|Overall Study||0||
60021255|NCT02501473|76136960|FG000|Treated|Overall Study||3||
60021256|NCT02501473|76136961|FG001|Treated|Overall Study||3||
60021257|NCT02501473|76136962|FG002|Treated|Overall Study||13||
60021258|NCT02501473|76136963|FG003|Treated|Overall Study||13||
60021259|NCT02501473|76136964|FG004|Treated|Overall Study||4||
60021260|NCT02501473|76136965|FG005|Treated|Overall Study||14||
60021261|NCT02501473|76136966|FG006|Treated|Overall Study||1||
60021262|NCT02501473|76136967|FG007|Treated|Overall Study||0||
60021263|NCT02501473|76136960|FG000|COMPLETED|Overall Study||0||
60021264|NCT02501473|76136961|FG001|COMPLETED|Overall Study||0||
60021265|NCT02501473|76136962|FG002|COMPLETED|Overall Study||0||
60021266|NCT02501473|76136963|FG003|COMPLETED|Overall Study||0||
60021267|NCT02501473|76136964|FG004|COMPLETED|Overall Study||0||
60021268|NCT02501473|76136965|FG005|COMPLETED|Overall Study||0||
60021269|NCT02501473|76136966|FG006|COMPLETED|Overall Study||0||
60021270|NCT02501473|76136967|FG007|COMPLETED|Overall Study||0||
60021271|NCT02501473|76136960|FG000|NOT COMPLETED|Overall Study||3||
60021272|NCT02501473|76136961|FG001|NOT COMPLETED|Overall Study||3||
60021273|NCT02501473|76136962|FG002|NOT COMPLETED|Overall Study||13||
60021274|NCT02501473|76136963|FG003|NOT COMPLETED|Overall Study||14||
60021275|NCT02501473|76136964|FG004|NOT COMPLETED|Overall Study||4||
60021276|NCT02501473|76136965|FG005|NOT COMPLETED|Overall Study||14||
60021277|NCT02501473|76136966|FG006|NOT COMPLETED|Overall Study||1||
60021278|NCT02501473|76136967|FG007|NOT COMPLETED|Overall Study||0||
59913514|NCT04401293|76034418|FG001|NOT COMPLETED|Overall Study||3||
59913515|NCT04319159|76034426|FG000|STARTED|Overall Study||48||
59913516|NCT04319159|76034426|FG000|COMPLETED|Overall Study||32||
59913517|NCT04319159|76034426|FG000|NOT COMPLETED|Overall Study||16||
59913518|NCT04318535|76034432|FG000|STARTED|Treatment Period 1 (Day -1 to Day 5)||12||
59913519|NCT04318535|76034433|FG001|STARTED|Treatment Period 1 (Day -1 to Day 5)||12||
60021279|NCT02501161|76136985|FG000|STARTED|Overall Study||506||
60021280|NCT02501161|76136986|FG001|STARTED|Overall Study||506||
60021281|NCT02501161|76136985|FG000|Exposed|Overall Study||506||
60021282|NCT02501161|76136986|FG001|Exposed|Overall Study||504||
60021283|NCT02501161|76136985|FG000|COMPLETED|Overall Study||484||
60021284|NCT02501161|76136986|FG001|COMPLETED|Overall Study||481||
60021285|NCT02501161|76136985|FG000|NOT COMPLETED|Overall Study||22||
60021286|NCT02501161|76136986|FG001|NOT COMPLETED|Overall Study||25||
60021287|NCT02500537|76136994|FG000|STARTED|Overall Study||60||
60021288|NCT02500537|76136995|FG001|STARTED|Overall Study||40||
59611596|NCT01775904|75722585|FG000|COMPLETED|LY2886721 ODT (no Water, Fasting)||26||
59611597|NCT01775904|75722585|FG000|NOT COMPLETED|LY2886721 ODT (no Water, Fasting)||0||
59611598|NCT01775904|75722585|FG000|STARTED|First Washout (7 Days)||26||
59611599|NCT01775904|75722585|FG000|COMPLETED|First Washout (7 Days)||26||
59611600|NCT01775904|75722585|FG000|NOT COMPLETED|First Washout (7 Days)||0||
59758863|NCT00746733|75878155|FG000|NOT COMPLETED|Fourth Intervention||0||
59758864|NCT00746733|75878156|FG001|NOT COMPLETED|Fourth Intervention||0||
59758865|NCT00745875|75878171|FG000|STARTED|Overall Study|Started - Number of patients randomised|36||
60021289|NCT02500537|76136994|FG000|COMPLETED|Overall Study||57||
60021290|NCT02500537|76136995|FG001|COMPLETED|Overall Study||39||
60021291|NCT02500537|76136994|FG000|NOT COMPLETED|Overall Study||3||
60021292|NCT02500537|76136995|FG001|NOT COMPLETED|Overall Study||1||
60021293|NCT02498821|76137004|FG000|STARTED|Overall Study||63||
60021294|NCT02498821|76137005|FG001|STARTED|Overall Study||65||
60021295|NCT02498821|76137004|FG000|COMPLETED|Overall Study||60||
60021296|NCT02498821|76137005|FG001|COMPLETED|Overall Study||60||
60021297|NCT02498821|76137004|FG000|NOT COMPLETED|Overall Study||3||
60021298|NCT02498821|76137005|FG001|NOT COMPLETED|Overall Study||5||
60021299|NCT02313909|76137013|FG000|STARTED|Overall Study||3609||
60021300|NCT02313909|76137014|FG001|STARTED|Overall Study||3604||
59758866|NCT00745875|75878172|FG001|STARTED|Overall Study|Started - Number of patients randomised|30||
59758867|NCT00745875|75878171|FG000|COMPLETED|Overall Study|Completed - Number of patients discontinued study treatment at data cut-off (17th January 2010)|32||
59913520|NCT04318535|76034434|FG002|STARTED|Treatment Period 1 (Day -1 to Day 5)||12||
59913521|NCT04318535|76034432|FG000|COMPLETED|Treatment Period 1 (Day -1 to Day 5)||12||
59913522|NCT04318535|76034433|FG001|COMPLETED|Treatment Period 1 (Day -1 to Day 5)||12||
59913523|NCT04318535|76034434|FG002|COMPLETED|Treatment Period 1 (Day -1 to Day 5)||12||
59913524|NCT04318535|76034432|FG000|NOT COMPLETED|Treatment Period 1 (Day -1 to Day 5)||0||
59913525|NCT04318535|76034433|FG001|NOT COMPLETED|Treatment Period 1 (Day -1 to Day 5)||0||
60021301|NCT02313909|76137013|FG000|Treated|Overall Study||3562||
59913526|NCT04318535|76034434|FG002|NOT COMPLETED|Treatment Period 1 (Day -1 to Day 5)||0||
60021302|NCT02313909|76137014|FG001|Treated|Overall Study||3559||
60021303|NCT02313909|76137013|FG000|COMPLETED|Overall Study||3552||
60021304|NCT02313909|76137014|FG001|COMPLETED|Overall Study||3554||
60021305|NCT02313909|76137013|FG000|NOT COMPLETED|Overall Study||57||
60021306|NCT02313909|76137014|FG001|NOT COMPLETED|Overall Study||50||
60021307|NCT02287467|76137022|FG000|STARTED|Overall Study||168||
60021308|NCT02287467|76137023|FG001|STARTED|Overall Study||161||
60021309|NCT02287467|76137022|FG000|COMPLETED|Overall Study||156||
60021310|NCT02287467|76137023|FG001|COMPLETED|Overall Study||152||
60021311|NCT02287467|76137022|FG000|NOT COMPLETED|Overall Study||12||
60021312|NCT02287467|76137023|FG001|NOT COMPLETED|Overall Study||9||
60021313|NCT02287233|76137035|FG000|STARTED|Overall Study||8||
60021314|NCT02287233|76137036|FG001|STARTED|Overall Study||10||
60021315|NCT02287233|76137037|FG002|STARTED|Overall Study||76||
60021316|NCT02287233|76137035|FG000|Treated|Overall Study||8||
60021317|NCT02287233|76137036|FG001|Treated|Overall Study||10||
60021318|NCT02287233|76137037|FG002|Treated|Overall Study||74||
60021319|NCT02287233|76137035|FG000|COMPLETED|Overall Study||0|Indicates participants remaining on study|
60021320|NCT02287233|76137036|FG001|COMPLETED|Overall Study||0|Indicates participants remaining on study|
59913527|NCT04318535|76034432|FG000|STARTED|Period1washout(Atleast 7 Days Post-dose)||12||
59913528|NCT04318535|76034433|FG001|STARTED|Period1washout(Atleast 7 Days Post-dose)||12||
59913529|NCT04318535|76034434|FG002|STARTED|Period1washout(Atleast 7 Days Post-dose)||12||
59913530|NCT04318535|76034432|FG000|COMPLETED|Period1washout(Atleast 7 Days Post-dose)||12||
59913531|NCT04318535|76034433|FG001|COMPLETED|Period1washout(Atleast 7 Days Post-dose)||12||
59913532|NCT04318535|76034434|FG002|COMPLETED|Period1washout(Atleast 7 Days Post-dose)||12||
60021321|NCT02287233|76137037|FG002|COMPLETED|Overall Study||0|Indicates participants remaining on study|
60021322|NCT02287233|76137035|FG000|NOT COMPLETED|Overall Study||8||
60021323|NCT02287233|76137036|FG001|NOT COMPLETED|Overall Study||10||
60021324|NCT02287233|76137037|FG002|NOT COMPLETED|Overall Study||76||
60021325|NCT01646385|76137050|FG000|STARTED|Overall Study||3529||
60021326|NCT01646385|76137051|FG001|STARTED|Overall Study||2864||
60021327|NCT01646385|76137050|FG000|COMPLETED|Overall Study|Completed refers to participants who continued up to last follow-up.|2691||
60021328|NCT01646385|76137051|FG001|COMPLETED|Overall Study|Completed refers to participants who continued up to last follow-up.|1993||
60021329|NCT01646385|76137050|FG000|NOT COMPLETED|Overall Study||838||
60021330|NCT01646385|76137051|FG001|NOT COMPLETED|Overall Study||871||
60021331|NCT02286843|76137057|FG000|STARTED|Overall Study||49||
60021332|NCT02286843|76137057|FG000|COMPLETED|Overall Study||43||
60021333|NCT02286843|76137057|FG000|NOT COMPLETED|Overall Study||6||
60021334|NCT02282163|76137061|FG000|STARTED|Overall Study||13||
60021335|NCT02282163|76137061|FG000|COMPLETED|Overall Study||12||
60021336|NCT02282163|76137061|FG000|NOT COMPLETED|Overall Study||1||
60021337|NCT02281773|76137079|FG000|STARTED|Overall Study||87||
60021338|NCT02281773|76137080|FG001|STARTED|Overall Study|Started are the treated patients|85||
60021339|NCT02281773|76137081|FG002|STARTED|Overall Study||85||
60021340|NCT02281773|76137082|FG003|STARTED|Overall Study||86||
60021341|NCT02281773|76137083|FG004|STARTED|Overall Study|Started are the treated patients|173||
60021342|NCT02281773|76137079|FG000|COMPLETED|Overall Study||76||
60021343|NCT02281773|76137080|FG001|COMPLETED|Overall Study||70||
60021344|NCT02281773|76137081|FG002|COMPLETED|Overall Study||67||
60021345|NCT02281773|76137082|FG003|COMPLETED|Overall Study||65||
60021346|NCT02281773|76137083|FG004|COMPLETED|Overall Study||143||
60021347|NCT02281773|76137079|FG000|NOT COMPLETED|Overall Study||11||
60021348|NCT02281773|76137080|FG001|NOT COMPLETED|Overall Study||15||
60021349|NCT02281773|76137081|FG002|NOT COMPLETED|Overall Study||18||
60021350|NCT02281773|76137082|FG003|NOT COMPLETED|Overall Study||21||
60021351|NCT02281773|76137083|FG004|NOT COMPLETED|Overall Study||30||
60021352|NCT02285361|76137095|FG000|STARTED|Overall Study||1272||
60021353|NCT02285361|76137095|FG000|COMPLETED|Overall Study||1221|All Participants whose case report forms (CRFs) were retrieved during the re-examination period and who did not violate the inclusion/exclusion criteria.|
60021354|NCT02285361|76137095|FG000|NOT COMPLETED|Overall Study||51||
60021355|NCT02354235|76137101|FG000|STARTED|Overall Study||70||
60021356|NCT02354235|76137102|FG001|STARTED|Overall Study||68||
60021357|NCT02354235|76137101|FG000|COMPLETED|Overall Study||67||
60021358|NCT02354235|76137102|FG001|COMPLETED|Overall Study||61||
60021359|NCT02354235|76137101|FG000|NOT COMPLETED|Overall Study||3||
60021360|NCT02354235|76137102|FG001|NOT COMPLETED|Overall Study||7||
60021361|NCT02280291|76137112|FG000|STARTED|Overall Study||25||
60021362|NCT02280291|76137113|FG001|STARTED|Overall Study||25||
60021363|NCT02280291|76137114|FG002|STARTED|Overall Study||24||
60021364|NCT02280291|76137115|FG003|STARTED|Overall Study||26||
60021365|NCT02280291|76137112|FG000|COMPLETED|Overall Study||21||
60021366|NCT02280291|76137113|FG001|COMPLETED|Overall Study||23||
60021367|NCT02280291|76137114|FG002|COMPLETED|Overall Study||21||
60021368|NCT02280291|76137115|FG003|COMPLETED|Overall Study||18||
60021369|NCT02280291|76137112|FG000|NOT COMPLETED|Overall Study||4||
60021370|NCT02280291|76137113|FG001|NOT COMPLETED|Overall Study||2||
60021371|NCT02280291|76137114|FG002|NOT COMPLETED|Overall Study||3||
60021372|NCT02280291|76137115|FG003|NOT COMPLETED|Overall Study||8||
59913533|NCT04318535|76034432|FG000|NOT COMPLETED|Period1washout(Atleast 7 Days Post-dose)||0||
60021373|NCT02284893|76137129|FG000|STARTED|26 Week (Short Term)||232||
59913534|NCT04318535|76034433|FG001|NOT COMPLETED|Period1washout(Atleast 7 Days Post-dose)||0||
59951303|NCT03641287|76070234|FG001|COMPLETED|Overall Study||33||
60021374|NCT02284893|76137130|FG001|STARTED|26 Week (Short Term)||229||
60021375|NCT02284893|76137129|FG000|COMPLETED|26 Week (Short Term)||213||
60021376|NCT02284893|76137130|FG001|COMPLETED|26 Week (Short Term)||198||
60021377|NCT02284893|76137129|FG000|NOT COMPLETED|26 Week (Short Term)||19||
60021378|NCT02284893|76137130|FG001|NOT COMPLETED|26 Week (Short Term)||31||
60021379|NCT02284893|76137129|FG000|STARTED|52 Week (Long Term)||209||
60021380|NCT02284893|76137130|FG001|STARTED|52 Week (Long Term)||193||
60021381|NCT02284893|76137129|FG000|COMPLETED|52 Week (Long Term)||198||
60021382|NCT02284893|76137130|FG001|COMPLETED|52 Week (Long Term)||180||
59507269|NCT02402127|75600486|FG005|NOT COMPLETED|Second Wear Period (1 Day)||0||
59507270|NCT02402127|75600481|FG000|STARTED|Third Wear Period (1 Day)||4||
59913535|NCT04318535|76034434|FG002|NOT COMPLETED|Period1washout(Atleast 7 Days Post-dose)||0||
59913536|NCT04318535|76034432|FG000|STARTED|Treatment Period 2 (Day 7 to Day 12)||12||
59913537|NCT04318535|76034433|FG001|STARTED|Treatment Period 2 (Day 7 to Day 12)||12||
59913538|NCT04318535|76034434|FG002|STARTED|Treatment Period 2 (Day 7 to Day 12)||12||
59913539|NCT04318535|76034432|FG000|COMPLETED|Treatment Period 2 (Day 7 to Day 12)||12||
59913540|NCT04318535|76034433|FG001|COMPLETED|Treatment Period 2 (Day 7 to Day 12)||12||
59913541|NCT04318535|76034434|FG002|COMPLETED|Treatment Period 2 (Day 7 to Day 12)||12||
59913542|NCT04318535|76034432|FG000|NOT COMPLETED|Treatment Period 2 (Day 7 to Day 12)||0||
59913543|NCT04318535|76034433|FG001|NOT COMPLETED|Treatment Period 2 (Day 7 to Day 12)||0||
59913544|NCT04318535|76034434|FG002|NOT COMPLETED|Treatment Period 2 (Day 7 to Day 12)||0||
59913545|NCT04318535|76034432|FG000|STARTED|Period2washout(Atleast 7 Days Post-dose)||12||
59913546|NCT04318535|76034433|FG001|STARTED|Period2washout(Atleast 7 Days Post-dose)||12||
59913547|NCT04318535|76034434|FG002|STARTED|Period2washout(Atleast 7 Days Post-dose)||12||
59913548|NCT04318535|76034432|FG000|COMPLETED|Period2washout(Atleast 7 Days Post-dose)||12||
59913549|NCT04318535|76034433|FG001|COMPLETED|Period2washout(Atleast 7 Days Post-dose)||11||
59913550|NCT04318535|76034434|FG002|COMPLETED|Period2washout(Atleast 7 Days Post-dose)||12||
59913551|NCT04318535|76034432|FG000|NOT COMPLETED|Period2washout(Atleast 7 Days Post-dose)||0||
59913552|NCT04318535|76034433|FG001|NOT COMPLETED|Period2washout(Atleast 7 Days Post-dose)||1||
59913553|NCT04318535|76034434|FG002|NOT COMPLETED|Period2washout(Atleast 7 Days Post-dose)||0||
59913554|NCT04318535|76034432|FG000|STARTED|Treatment Period 3 (Day 17 to Day 22)||12||
59913555|NCT04318535|76034433|FG001|STARTED|Treatment Period 3 (Day 17 to Day 22)||11||
59913556|NCT04318535|76034434|FG002|STARTED|Treatment Period 3 (Day 17 to Day 22)||12||
59913557|NCT04318535|76034432|FG000|COMPLETED|Treatment Period 3 (Day 17 to Day 22)||12||
59913558|NCT04318535|76034433|FG001|COMPLETED|Treatment Period 3 (Day 17 to Day 22)||11||
59913559|NCT04318535|76034434|FG002|COMPLETED|Treatment Period 3 (Day 17 to Day 22)||12||
59913560|NCT04318535|76034432|FG000|NOT COMPLETED|Treatment Period 3 (Day 17 to Day 22)||0||
59913561|NCT04318535|76034433|FG001|NOT COMPLETED|Treatment Period 3 (Day 17 to Day 22)||0||
59913562|NCT04318535|76034434|FG002|NOT COMPLETED|Treatment Period 3 (Day 17 to Day 22)||0||
59913563|NCT04454567|76034445|FG000|STARTED|Overall Study||1||
59913564|NCT04454567|76034446|FG001|STARTED|Overall Study||1||
59913565|NCT04454567|76034445|FG000|COMPLETED|Overall Study||0||
59913566|NCT04454567|76034446|FG001|COMPLETED|Overall Study||0||
59913567|NCT04454567|76034445|FG000|NOT COMPLETED|Overall Study||1||
59913568|NCT04454567|76034446|FG001|NOT COMPLETED|Overall Study||1||
59913569|NCT04449341|76034454|FG000|STARTED|Overall Study||31||
59913570|NCT04449341|76034455|FG001|STARTED|Overall Study||28||
59913571|NCT04449341|76034454|FG000|COMPLETED|Overall Study||30||
59913572|NCT04449341|76034455|FG001|COMPLETED|Overall Study||28||
59913573|NCT04449341|76034454|FG000|NOT COMPLETED|Overall Study||1||
59913574|NCT04449341|76034455|FG001|NOT COMPLETED|Overall Study||0||
59913575|NCT04448561|76034463|FG000|STARTED|Overall Study||16||
59913576|NCT04448561|76034464|FG001|STARTED|Overall Study||8||
59913577|NCT04448561|76034463|FG000|COMPLETED|Overall Study||15||
59913578|NCT04448561|76034464|FG001|COMPLETED|Overall Study||8||
59507271|NCT02402127|75600482|FG001|STARTED|Third Wear Period (1 Day)||4||
59507272|NCT02402127|75600483|FG002|STARTED|Third Wear Period (1 Day)||4||
59507273|NCT02402127|75600484|FG003|STARTED|Third Wear Period (1 Day)||4||
59507274|NCT02402127|75600485|FG004|STARTED|Third Wear Period (1 Day)||4||
59507275|NCT02402127|75600486|FG005|STARTED|Third Wear Period (1 Day)||4||
59913579|NCT04448561|76034463|FG000|NOT COMPLETED|Overall Study||1||
59913580|NCT04448561|76034464|FG001|NOT COMPLETED|Overall Study||0||
59913581|NCT04308239|76034480|FG000|STARTED|Pre-intervention Evaluation (1 Week)||20||
59913582|NCT04308239|76034481|FG001|STARTED|Pre-intervention Evaluation (1 Week)||14||
59913583|NCT04308239|76034480|FG000|COMPLETED|Pre-intervention Evaluation (1 Week)|No withdrawals. These participants just missed this evaluation but stayed in study.|17||
59913584|NCT04308239|76034481|FG001|COMPLETED|Pre-intervention Evaluation (1 Week)|No withdrawals. These participants just missed this evaluation but stayed in study.|11||
59913585|NCT04308239|76034480|FG000|NOT COMPLETED|Pre-intervention Evaluation (1 Week)||3||
59913586|NCT04308239|76034481|FG001|NOT COMPLETED|Pre-intervention Evaluation (1 Week)||3||
59913587|NCT04308239|76034480|FG000|STARTED|Intervention (2 Weeks)||20||
59913588|NCT04308239|76034481|FG001|STARTED|Intervention (2 Weeks)||14||
59913589|NCT04308239|76034480|FG000|COMPLETED|Intervention (2 Weeks)||20||
59913590|NCT04308239|76034481|FG001|COMPLETED|Intervention (2 Weeks)||14||
59913591|NCT04308239|76034480|FG000|NOT COMPLETED|Intervention (2 Weeks)||0||
59913592|NCT04308239|76034481|FG001|NOT COMPLETED|Intervention (2 Weeks)||0||
59913593|NCT04308239|76034480|FG000|STARTED|Post-intervention Evaluation (1 Week)||20||
59913594|NCT04308239|76034481|FG001|STARTED|Post-intervention Evaluation (1 Week)||14||
59913595|NCT04308239|76034480|FG000|COMPLETED|Post-intervention Evaluation (1 Week)||19||
59913596|NCT04308239|76034481|FG001|COMPLETED|Post-intervention Evaluation (1 Week)||10||
59913597|NCT04308239|76034480|FG000|NOT COMPLETED|Post-intervention Evaluation (1 Week)||1||
59913598|NCT04308239|76034481|FG001|NOT COMPLETED|Post-intervention Evaluation (1 Week)||4||
59519011|NCT03587428|75612872|FG002|NOT COMPLETED|Period 2||0||
60021383|NCT02284893|76137129|FG000|NOT COMPLETED|52 Week (Long Term)||11||
60021384|NCT02284893|76137130|FG001|NOT COMPLETED|52 Week (Long Term)||13||
60021385|NCT02284347|76137136|FG000|STARTED|Overall Study||51||
60021386|NCT02284347|76137136|FG000|COMPLETED|Overall Study||48||
60021387|NCT02284347|76137136|FG000|NOT COMPLETED|Overall Study||3||
60021388|NCT02279043|76137143|FG000|STARTED|Overall Study||175||
60021389|NCT02279043|76137144|FG001|STARTED|Overall Study||315||
60021390|NCT02279043|76137145|FG002|STARTED|Overall Study||140||
60021391|NCT02279043|76137143|FG000|COMPLETED|Overall Study||128||
60021392|NCT02279043|76137144|FG001|COMPLETED|Overall Study||226||
60021393|NCT02279043|76137145|FG002|COMPLETED|Overall Study||140||
60021394|NCT02279043|76137143|FG000|NOT COMPLETED|Overall Study||47||
60021395|NCT02279043|76137144|FG001|NOT COMPLETED|Overall Study||89||
60021396|NCT02279043|76137145|FG002|NOT COMPLETED|Overall Study||0||
60021397|NCT02283411|76137151|FG000|STARTED|Overall Study||156||
60021398|NCT02283411|76137151|FG000|COMPLETED|Overall Study||125||
60021399|NCT02283411|76137151|FG000|NOT COMPLETED|Overall Study||31||
60021400|NCT02351817|76137155|FG000|STARTED|Baseline Period||5||
60021401|NCT02351817|76137156|FG001|STARTED|Baseline Period||5||
60021402|NCT02351817|76137155|FG000|COMPLETED|Baseline Period||5||
60021403|NCT02351817|76137156|FG001|COMPLETED|Baseline Period||5||
60021404|NCT02351817|76137155|FG000|NOT COMPLETED|Baseline Period||0||
60021405|NCT02351817|76137156|FG001|NOT COMPLETED|Baseline Period||0||
60021406|NCT02351817|76137155|FG000|STARTED|Period 1||5||
60021407|NCT02351817|76137156|FG001|STARTED|Period 1||5||
60021408|NCT02351817|76137155|FG000|COMPLETED|Period 1||4||
60021409|NCT02351817|76137156|FG001|COMPLETED|Period 1||2||
60021410|NCT02351817|76137155|FG000|NOT COMPLETED|Period 1||1||
60021411|NCT02351817|76137156|FG001|NOT COMPLETED|Period 1||3||
60021412|NCT02351817|76137155|FG000|STARTED|Period 2|Subjects who did not complete Period 1 as planned were allowed to continue to Period 2|5||
60021413|NCT02351817|76137156|FG001|STARTED|Period 2|Subjects who did not complete Period 1 as planned were allowed to continue to Period 2|5||
60021414|NCT02351817|76137155|FG000|COMPLETED|Period 2||4||
60021415|NCT02351817|76137156|FG001|COMPLETED|Period 2||3||
60021416|NCT02351817|76137155|FG000|NOT COMPLETED|Period 2||1||
60021417|NCT02351817|76137156|FG001|NOT COMPLETED|Period 2||2||
60021418|NCT02351349|76137165|FG000|STARTED|Overall Study||6||
60021419|NCT02351349|76137166|FG001|STARTED|Overall Study||8||
60021420|NCT02351349|76137165|FG000|COMPLETED|Overall Study||4||
60021421|NCT02351349|76137166|FG001|COMPLETED|Overall Study||5||
60021422|NCT02351349|76137165|FG000|NOT COMPLETED|Overall Study||2||
60021423|NCT02351349|76137166|FG001|NOT COMPLETED|Overall Study||3||
60021424|NCT02484547|76137180|FG000|STARTED|Placebo-Controlled Period||548||
60021425|NCT02484547|76137181|FG001|STARTED|Placebo-Controlled Period||543||
60021426|NCT02484547|76137182|FG002|STARTED|Placebo-Controlled Period||547||
60021427|NCT02484547|76137183|FG003|STARTED|Placebo-Controlled Period||0||
60021428|NCT02484547|76137184|FG004|STARTED|Placebo-Controlled Period||0||
60021429|NCT02484547|76137185|FG005|STARTED|Placebo-Controlled Period||0||
60021430|NCT02484547|76137186|FG006|STARTED|Placebo-Controlled Period||0||
60021431|NCT02484547|76137180|FG000|COMPLETED|Placebo-Controlled Period||288||
60021432|NCT02484547|76137181|FG001|COMPLETED|Placebo-Controlled Period||291||
60021433|NCT02484547|76137182|FG002|COMPLETED|Placebo-Controlled Period||295||
60021434|NCT02484547|76137183|FG003|COMPLETED|Placebo-Controlled Period||0||
60021435|NCT02484547|76137184|FG004|COMPLETED|Placebo-Controlled Period||0||
60021436|NCT02484547|76137185|FG005|COMPLETED|Placebo-Controlled Period||0||
60021437|NCT02484547|76137186|FG006|COMPLETED|Placebo-Controlled Period||0||
60021438|NCT02484547|76137180|FG000|NOT COMPLETED|Placebo-Controlled Period||260||
60021439|NCT02484547|76137181|FG001|NOT COMPLETED|Placebo-Controlled Period||252||
60021440|NCT02484547|76137182|FG002|NOT COMPLETED|Placebo-Controlled Period||252||
60021441|NCT02484547|76137183|FG003|NOT COMPLETED|Placebo-Controlled Period||0||
60021442|NCT02484547|76137184|FG004|NOT COMPLETED|Placebo-Controlled Period||0||
60021443|NCT02484547|76137185|FG005|NOT COMPLETED|Placebo-Controlled Period||0||
60021444|NCT02484547|76137186|FG006|NOT COMPLETED|Placebo-Controlled Period||0||
60021445|NCT02484547|76137180|FG000|STARTED|Long-Term Extension Period||0||
60021446|NCT02484547|76137181|FG001|STARTED|Long-Term Extension Period||0||
60021447|NCT02484547|76137182|FG002|STARTED|Long-Term Extension Period||0||
60021448|NCT02484547|76137183|FG003|STARTED|Long-Term Extension Period|11 PC completers did not enter LTE.|131||
60021449|NCT02484547|76137184|FG004|STARTED|Long-Term Extension Period|14 PC completers did not enter LTE.|132||
60021450|NCT02484547|76137185|FG005|STARTED|Long-Term Extension Period|40 PC completers did not enter LTE.|251||
60021451|NCT02484547|76137186|FG006|STARTED|Long-Term Extension Period|38 PC completers did not enter LTE.|257||
60021452|NCT02484547|76137180|FG000|COMPLETED|Long-Term Extension Period||0||
60021453|NCT02484547|76137181|FG001|COMPLETED|Long-Term Extension Period||0||
60021454|NCT02484547|76137182|FG002|COMPLETED|Long-Term Extension Period||0||
60021455|NCT02484547|76137183|FG003|COMPLETED|Long-Term Extension Period||0||
60021456|NCT02484547|76137184|FG004|COMPLETED|Long-Term Extension Period||0||
60021457|NCT02484547|76137185|FG005|COMPLETED|Long-Term Extension Period||0||
60021458|NCT02484547|76137186|FG006|COMPLETED|Long-Term Extension Period||0||
60021459|NCT02484547|76137180|FG000|NOT COMPLETED|Long-Term Extension Period||0||
60021460|NCT02484547|76137181|FG001|NOT COMPLETED|Long-Term Extension Period||0||
60021461|NCT02484547|76137182|FG002|NOT COMPLETED|Long-Term Extension Period||0||
60021462|NCT02484547|76137183|FG003|NOT COMPLETED|Long-Term Extension Period||131||
60021463|NCT02484547|76137184|FG004|NOT COMPLETED|Long-Term Extension Period||132||
60021464|NCT02484547|76137185|FG005|NOT COMPLETED|Long-Term Extension Period||251||
60021465|NCT02484547|76137186|FG006|NOT COMPLETED|Long-Term Extension Period||257||
60021466|NCT02517541|76137198|FG000|STARTED|Baseline Period (Own Product)||74||
60021467|NCT02517541|76137198|FG000|COMPLETED|Baseline Period (Own Product)||73||
60021468|NCT02517541|76137198|FG000|NOT COMPLETED|Baseline Period (Own Product)||1||
60021469|NCT02517541|76137198|FG000|STARTED|Test Period (SenSura Mio Convex Soft)||73||
60021470|NCT02517541|76137198|FG000|COMPLETED|Test Period (SenSura Mio Convex Soft)||61||
60021471|NCT02517541|76137198|FG000|NOT COMPLETED|Test Period (SenSura Mio Convex Soft)||12||
60021472|NCT02496091|76137204|FG000|STARTED|Overall Study||144||263
60021473|NCT02496091|76137204|FG000|COMPLETED|Overall Study||142||259
60021474|NCT02496091|76137204|FG000|NOT COMPLETED|Overall Study||2||4
60021475|NCT02483611|76137212|FG000|STARTED|Overall Study||16||
60021476|NCT02483611|76137213|FG001|STARTED|Overall Study||16||
60021477|NCT02483611|76137214|FG002|STARTED|Overall Study||16||
60021478|NCT02483611|76137212|FG000|COMPLETED|Overall Study||16||
60021479|NCT02483611|76137213|FG001|COMPLETED|Overall Study||16||
60021480|NCT02483611|76137214|FG002|COMPLETED|Overall Study|One patient required decurarization|15||
60021481|NCT02483611|76137212|FG000|NOT COMPLETED|Overall Study||0||
60021482|NCT02483611|76137213|FG001|NOT COMPLETED|Overall Study||0||
60021483|NCT02483611|76137214|FG002|NOT COMPLETED|Overall Study||1||
60021484|NCT02483533|76137224|FG000|STARTED|Overall Study||50|Lack of efficacy - not completed|
60021485|NCT02483533|76137225|FG001|STARTED|Overall Study||50|Lack of efficacy - not completed|
60021486|NCT02483533|76137224|FG000|COMPLETED|Overall Study||0|Lack of efficacy - not completed|
60021487|NCT02483533|76137225|FG001|COMPLETED|Overall Study||0|Lack of efficacy - not completed|
60021488|NCT02483533|76137224|FG000|NOT COMPLETED|Overall Study||50||
60021489|NCT02483533|76137225|FG001|NOT COMPLETED|Overall Study||50||
60021490|NCT02482129|76137233|FG000|STARTED|Overall Study||32||
60021491|NCT02482129|76137234|FG001|STARTED|Overall Study||11||
60021492|NCT02482129|76137233|FG000|Treated, as Randomized|Overall Study||30||
60021493|NCT02482129|76137234|FG001|Treated, as Randomized|Overall Study||9||
60021494|NCT02482129|76137233|FG000|COMPLETED|Overall Study||26||
60021495|NCT02482129|76137234|FG001|COMPLETED|Overall Study||9||
60021496|NCT02482129|76137233|FG000|NOT COMPLETED|Overall Study||6||
60021497|NCT02482129|76137234|FG001|NOT COMPLETED|Overall Study||2||
60021498|NCT02495857|76137245|FG000|STARTED|Overall Study||200||
60021499|NCT02495857|76137246|FG001|STARTED|Overall Study||200||
60021500|NCT02495857|76137247|FG002|STARTED|Overall Study||199||
60021501|NCT02495857|76137245|FG000|COMPLETED|Overall Study||178||
59507276|NCT02402127|75600481|FG000|COMPLETED|Third Wear Period (1 Day)||4||
59507277|NCT02402127|75600482|FG001|COMPLETED|Third Wear Period (1 Day)||4||
60021502|NCT02495857|76137246|FG001|COMPLETED|Overall Study||184||
60021503|NCT02495857|76137247|FG002|COMPLETED|Overall Study||181||
60021504|NCT02495857|76137245|FG000|NOT COMPLETED|Overall Study||22||
60021505|NCT02495857|76137246|FG001|NOT COMPLETED|Overall Study||16||
60021506|NCT02495857|76137247|FG002|NOT COMPLETED|Overall Study||18||
60021507|NCT02495389|76137255|FG000|STARTED|Overall Study||84||
60021508|NCT02495389|76137255|FG000|COMPLETED|Overall Study||44||
60021509|NCT02495389|76137255|FG000|NOT COMPLETED|Overall Study||40||
60021510|NCT02495233|76137261|FG000|STARTED|Overall Study||3||
60021511|NCT02495233|76137262|FG001|STARTED|Overall Study||7||
60021512|NCT02495233|76137261|FG000|COMPLETED|Overall Study||3||
60021513|NCT02495233|76137262|FG001|COMPLETED|Overall Study||6||
59507278|NCT02402127|75600483|FG002|COMPLETED|Third Wear Period (1 Day)||4||
60021514|NCT02495233|76137261|FG000|NOT COMPLETED|Overall Study||0||
60021515|NCT02495233|76137262|FG001|NOT COMPLETED|Overall Study||1||
60021516|NCT02495077|76137270|FG000|STARTED|Overall Study||113||
60021517|NCT02495077|76137271|FG001|STARTED|Overall Study||112||
60021518|NCT02495077|76137272|FG002|STARTED|Overall Study||17||
60021519|NCT02495077|76137273|FG003|STARTED|Overall Study||48||
60021520|NCT02495077|76137270|FG000|COMPLETED|Overall Study||93||
60021521|NCT02495077|76137271|FG001|COMPLETED|Overall Study||91||
60021522|NCT02495077|76137272|FG002|COMPLETED|Overall Study||0||
60021523|NCT02495077|76137273|FG003|COMPLETED|Overall Study||0||
60021524|NCT02495077|76137270|FG000|NOT COMPLETED|Overall Study||20||
60021525|NCT02495077|76137271|FG001|NOT COMPLETED|Overall Study||21||
60021526|NCT02495077|76137272|FG002|NOT COMPLETED|Overall Study||17||
60021527|NCT02495077|76137273|FG003|NOT COMPLETED|Overall Study||48||
60021528|NCT02278341|76137281|FG000|STARTED|Overall Study||415||
60021529|NCT02278341|76137282|FG001|STARTED|Overall Study||421||
60021530|NCT02278341|76137281|FG000|Received Treatment|Overall Study||414||
59507279|NCT02402127|75600484|FG003|COMPLETED|Third Wear Period (1 Day)||4||
59507280|NCT02402127|75600485|FG004|COMPLETED|Third Wear Period (1 Day)||4||
60021531|NCT02278341|76137282|FG001|Received Treatment|Overall Study||420||
60021532|NCT02278341|76137281|FG000|COMPLETED|Overall Study||297||
60021533|NCT02278341|76137282|FG001|COMPLETED|Overall Study||329||
60021534|NCT02278341|76137281|FG000|NOT COMPLETED|Overall Study||118||
60021535|NCT02278341|76137282|FG001|NOT COMPLETED|Overall Study||92||
60021536|NCT02282631|76137291|FG000|STARTED|Overall Study|The two dropouts happened on the 2nd and 3rd weeks post-baseline, respectively|14||
60021537|NCT02282631|76137292|FG001|STARTED|Overall Study||15||
60021538|NCT02282631|76137291|FG000|COMPLETED|Overall Study||12||
60021539|NCT02282631|76137292|FG001|COMPLETED|Overall Study||15||
60021540|NCT02282631|76137291|FG000|NOT COMPLETED|Overall Study||2||
60021541|NCT02282631|76137292|FG001|NOT COMPLETED|Overall Study||0||
60021542|NCT02278263|76137307|FG000|STARTED|Overall Study||30||
60021543|NCT02278263|76137308|FG001|STARTED|Overall Study||60||
60021544|NCT02278263|76137309|FG002|STARTED|Overall Study||60||
60021545|NCT02278263|76137307|FG000|COMPLETED|Overall Study||23||
60021546|NCT02278263|76137308|FG001|COMPLETED|Overall Study|Correction|60||
60021547|NCT02278263|76137309|FG002|COMPLETED|Overall Study||51||
60021548|NCT02278263|76137307|FG000|NOT COMPLETED|Overall Study||7||
60021549|NCT02278263|76137308|FG001|NOT COMPLETED|Overall Study||0||
60021550|NCT02278263|76137309|FG002|NOT COMPLETED|Overall Study||9||
60021551|NCT02349789|76137320|FG000|STARTED|Overall Study||11||
60021552|NCT02349789|76137320|FG000|COMPLETED|Overall Study||9||
60021553|NCT02349789|76137320|FG000|NOT COMPLETED|Overall Study||2||
60021554|NCT02349711|76137326|FG000|STARTED|Overall Study||87||
60021555|NCT02349711|76137327|FG001|STARTED|Overall Study||86||
60021556|NCT02349711|76137326|FG000|COMPLETED|Overall Study||84||
60021557|NCT02349711|76137327|FG001|COMPLETED|Overall Study||84||
60021558|NCT02349711|76137326|FG000|NOT COMPLETED|Overall Study||3||
60021559|NCT02349711|76137327|FG001|NOT COMPLETED|Overall Study||2||
60021560|NCT02494921|76137338|FG000|STARTED|Phase 1b, Dose Level I||5||
60021561|NCT02494921|76137339|FG001|STARTED|Phase 1b, Dose Level I||0||
60021562|NCT02494921|76137340|FG002|STARTED|Phase 1b, Dose Level I||0||
60021563|NCT02494921|76137341|FG003|STARTED|Phase 1b, Dose Level I||0||
60021564|NCT02494921|76137342|FG004|STARTED|Phase 1b, Dose Level I||0||
60021565|NCT02494921|76137338|FG000|COMPLETED|Phase 1b, Dose Level I||3||
60021566|NCT02494921|76137339|FG001|COMPLETED|Phase 1b, Dose Level I||0||
60021567|NCT02494921|76137340|FG002|COMPLETED|Phase 1b, Dose Level I||0||
60021568|NCT02494921|76137341|FG003|COMPLETED|Phase 1b, Dose Level I||0||
60021569|NCT02494921|76137342|FG004|COMPLETED|Phase 1b, Dose Level I||0||
60021570|NCT02494921|76137338|FG000|NOT COMPLETED|Phase 1b, Dose Level I||2||
60021571|NCT02494921|76137339|FG001|NOT COMPLETED|Phase 1b, Dose Level I||0||
60021572|NCT02494921|76137340|FG002|NOT COMPLETED|Phase 1b, Dose Level I||0||
60021573|NCT02494921|76137341|FG003|NOT COMPLETED|Phase 1b, Dose Level I||0||
60021574|NCT02494921|76137342|FG004|NOT COMPLETED|Phase 1b, Dose Level I||0||
60021575|NCT02494921|76137338|FG000|STARTED|Phase 1b, Dose Level IA||0||
60021576|NCT02494921|76137339|FG001|STARTED|Phase 1b, Dose Level IA||4||
60021577|NCT02494921|76137340|FG002|STARTED|Phase 1b, Dose Level IA||0||
60021578|NCT02494921|76137341|FG003|STARTED|Phase 1b, Dose Level IA||0||
60021579|NCT02494921|76137342|FG004|STARTED|Phase 1b, Dose Level IA||0||
60021580|NCT02494921|76137338|FG000|COMPLETED|Phase 1b, Dose Level IA||0||
60021581|NCT02494921|76137339|FG001|COMPLETED|Phase 1b, Dose Level IA||3||
60021582|NCT02494921|76137340|FG002|COMPLETED|Phase 1b, Dose Level IA||0||
60021583|NCT02494921|76137341|FG003|COMPLETED|Phase 1b, Dose Level IA||0||
60021584|NCT02494921|76137342|FG004|COMPLETED|Phase 1b, Dose Level IA||0||
60021585|NCT02494921|76137338|FG000|NOT COMPLETED|Phase 1b, Dose Level IA||0||
60021586|NCT02494921|76137339|FG001|NOT COMPLETED|Phase 1b, Dose Level IA||1||
60021587|NCT02494921|76137340|FG002|NOT COMPLETED|Phase 1b, Dose Level IA||0||
60021588|NCT02494921|76137341|FG003|NOT COMPLETED|Phase 1b, Dose Level IA||0||
60021589|NCT02494921|76137342|FG004|NOT COMPLETED|Phase 1b, Dose Level IA||0||
60021590|NCT02494921|76137338|FG000|STARTED|Phase 1b, Dose Level IIC||0||
60021591|NCT02494921|76137339|FG001|STARTED|Phase 1b, Dose Level IIC||0||
60021592|NCT02494921|76137340|FG002|STARTED|Phase 1b, Dose Level IIC||4||
60021593|NCT02494921|76137341|FG003|STARTED|Phase 1b, Dose Level IIC||0||
60021594|NCT02494921|76137342|FG004|STARTED|Phase 1b, Dose Level IIC||0||
60021595|NCT02494921|76137338|FG000|COMPLETED|Phase 1b, Dose Level IIC||0||
60021596|NCT02494921|76137339|FG001|COMPLETED|Phase 1b, Dose Level IIC||0||
60021597|NCT02494921|76137340|FG002|COMPLETED|Phase 1b, Dose Level IIC||3||
60021598|NCT02494921|76137341|FG003|COMPLETED|Phase 1b, Dose Level IIC||0||
60021599|NCT02494921|76137342|FG004|COMPLETED|Phase 1b, Dose Level IIC||0||
60021600|NCT02494921|76137338|FG000|NOT COMPLETED|Phase 1b, Dose Level IIC||0||
60021601|NCT02494921|76137339|FG001|NOT COMPLETED|Phase 1b, Dose Level IIC||0||
60021602|NCT02494921|76137340|FG002|NOT COMPLETED|Phase 1b, Dose Level IIC||1||
60021603|NCT02494921|76137341|FG003|NOT COMPLETED|Phase 1b, Dose Level IIC||0||
60021604|NCT02494921|76137342|FG004|NOT COMPLETED|Phase 1b, Dose Level IIC||0||
60021605|NCT02494921|76137338|FG000|STARTED|Phase 1b, Dose Level IIIC, RP2D||0||
60021606|NCT02494921|76137339|FG001|STARTED|Phase 1b, Dose Level IIIC, RP2D||0||
60021607|NCT02494921|76137340|FG002|STARTED|Phase 1b, Dose Level IIIC, RP2D||0||
60021608|NCT02494921|76137341|FG003|STARTED|Phase 1b, Dose Level IIIC, RP2D||6||
60021609|NCT02494921|76137342|FG004|STARTED|Phase 1b, Dose Level IIIC, RP2D||0||
60021610|NCT02494921|76137338|FG000|COMPLETED|Phase 1b, Dose Level IIIC, RP2D||0||
60021611|NCT02494921|76137339|FG001|COMPLETED|Phase 1b, Dose Level IIIC, RP2D||0||
60021612|NCT02494921|76137340|FG002|COMPLETED|Phase 1b, Dose Level IIIC, RP2D||0||
60021613|NCT02494921|76137341|FG003|COMPLETED|Phase 1b, Dose Level IIIC, RP2D||6||
60021614|NCT02494921|76137342|FG004|COMPLETED|Phase 1b, Dose Level IIIC, RP2D||0||
60021615|NCT02494921|76137338|FG000|NOT COMPLETED|Phase 1b, Dose Level IIIC, RP2D||0||
60021616|NCT02494921|76137339|FG001|NOT COMPLETED|Phase 1b, Dose Level IIIC, RP2D||0||
60021617|NCT02494921|76137340|FG002|NOT COMPLETED|Phase 1b, Dose Level IIIC, RP2D||0||
60021618|NCT02494921|76137341|FG003|NOT COMPLETED|Phase 1b, Dose Level IIIC, RP2D||0||
60021619|NCT02494921|76137342|FG004|NOT COMPLETED|Phase 1b, Dose Level IIIC, RP2D||0||
60021620|NCT02494921|76137338|FG000|STARTED|Phase 2, RP2D||0||
60021621|NCT02494921|76137339|FG001|STARTED|Phase 2, RP2D||0||
60021622|NCT02494921|76137340|FG002|STARTED|Phase 2, RP2D||0||
60021623|NCT02494921|76137341|FG003|STARTED|Phase 2, RP2D||0||
60021624|NCT02494921|76137342|FG004|STARTED|Phase 2, RP2D||24||
60021625|NCT02494921|76137338|FG000|COMPLETED|Phase 2, RP2D||0||
60021626|NCT02494921|76137339|FG001|COMPLETED|Phase 2, RP2D||0||
60021627|NCT02494921|76137340|FG002|COMPLETED|Phase 2, RP2D||0||
60021628|NCT02494921|76137341|FG003|COMPLETED|Phase 2, RP2D||0||
60021629|NCT02494921|76137342|FG004|COMPLETED|Phase 2, RP2D||24||
60021630|NCT02494921|76137338|FG000|NOT COMPLETED|Phase 2, RP2D||0||
60021631|NCT02494921|76137339|FG001|NOT COMPLETED|Phase 2, RP2D||0||
60021632|NCT02494921|76137340|FG002|NOT COMPLETED|Phase 2, RP2D||0||
60021633|NCT02494921|76137341|FG003|NOT COMPLETED|Phase 2, RP2D||0||
60021634|NCT02494921|76137342|FG004|NOT COMPLETED|Phase 2, RP2D||0||
60021635|NCT01653847|76137362|FG000|STARTED|Overall Study||20||
60021636|NCT01653847|76137363|FG001|STARTED|Overall Study||20||
60021637|NCT01653847|76137362|FG000|COMPLETED|Overall Study||19||
60021638|NCT01653847|76137363|FG001|COMPLETED|Overall Study||20||
60021639|NCT01653847|76137362|FG000|NOT COMPLETED|Overall Study||1||
60021640|NCT01653847|76137363|FG001|NOT COMPLETED|Overall Study||0||
60021641|NCT02493751|76137371|FG000|STARTED|Overall Study||16||
60021642|NCT02493751|76137372|FG001|STARTED|Overall Study||39||
60021643|NCT02493751|76137371|FG000|COMPLETED|Overall Study||0||
60021644|NCT02493751|76137372|FG001|COMPLETED|Overall Study||0||
60021645|NCT02493751|76137371|FG000|NOT COMPLETED|Overall Study||16||
60021646|NCT02493751|76137372|FG001|NOT COMPLETED|Overall Study||39||
60021647|NCT02493517|76137381|FG000|STARTED|Overall Study||64||
60021648|NCT02493517|76137382|FG001|STARTED|Overall Study||64||
60021649|NCT02493517|76137381|FG000|COMPLETED|Overall Study||62||
60021650|NCT02493517|76137382|FG001|COMPLETED|Overall Study||57||
60021651|NCT02493517|76137381|FG000|NOT COMPLETED|Overall Study||2||
60021652|NCT02493517|76137382|FG001|NOT COMPLETED|Overall Study||7||
60021653|NCT02493361|76137390|FG000|STARTED|Overall Study||24||
60021654|NCT02493361|76137390|FG000|Week 24 Assessment|Overall Study||21||
60021655|NCT02493361|76137390|FG000|COMPLETED|Overall Study||21||
60021656|NCT02493361|76137390|FG000|NOT COMPLETED|Overall Study||3||
60021657|NCT02493127|76137396|FG000|STARTED|Overall Study||61||
60021658|NCT02493127|76137397|FG001|STARTED|Overall Study||61||
60021659|NCT02493127|76137396|FG000|COMPLETED|Overall Study||60||
60021660|NCT02493127|76137397|FG001|COMPLETED|Overall Study||60||
60021661|NCT02493127|76137396|FG000|NOT COMPLETED|Overall Study||1||
60021662|NCT02493127|76137397|FG001|NOT COMPLETED|Overall Study||1||
60021663|NCT02478463|76137405|FG000|STARTED|Treatment Period 1 (Up to Day 29)||19||
60021664|NCT02478463|76137405|FG000|COMPLETED|Treatment Period 1 (Up to Day 29)||18||
60021665|NCT02478463|76137405|FG000|NOT COMPLETED|Treatment Period 1 (Up to Day 29)||1||
60021666|NCT02478463|76137405|FG000|STARTED|Washout Period (Up to 42 Days)||18||
60021667|NCT02478463|76137405|FG000|COMPLETED|Washout Period (Up to 42 Days)||17||
60021668|NCT02478463|76137405|FG000|NOT COMPLETED|Washout Period (Up to 42 Days)||1||
60021669|NCT02478463|76137405|FG000|STARTED|Treatment Period 2 (Up to 52 Weeks)||17||
60021670|NCT02478463|76137405|FG000|COMPLETED|Treatment Period 2 (Up to 52 Weeks)||16||
60021671|NCT02478463|76137405|FG000|NOT COMPLETED|Treatment Period 2 (Up to 52 Weeks)||1||
60021672|NCT02491411|76137411|FG000|STARTED|Overall Study||4||
60021673|NCT02491411|76137411|FG000|COMPLETED|Overall Study||0||
60021674|NCT02491411|76137411|FG000|NOT COMPLETED|Overall Study||4||
60021675|NCT02517463|76137417|FG000|STARTED|Overall Study||369||
60021676|NCT02517463|76137418|FG001|STARTED|Overall Study||331||
60021677|NCT02517463|76137417|FG000|COMPLETED|Overall Study||364||
60021678|NCT02517463|76137418|FG001|COMPLETED|Overall Study||329||
60021679|NCT02517463|76137417|FG000|NOT COMPLETED|Overall Study||5||
60021680|NCT02517463|76137418|FG001|NOT COMPLETED|Overall Study||2||
60021681|NCT02516605|76137429|FG000|STARTED|Overall Study||11||
60021682|NCT02516605|76137430|FG001|STARTED|Overall Study||9||
60021683|NCT02516605|76137431|FG002|STARTED|Overall Study||12||
60021684|NCT02516605|76137432|FG003|STARTED|Overall Study||8||
60021685|NCT02516605|76137433|FG004|STARTED|Overall Study||21||
60021686|NCT02516605|76137429|FG000|COMPLETED|Overall Study||11||
60021687|NCT02516605|76137430|FG001|COMPLETED|Overall Study||9||
60021688|NCT02516605|76137431|FG002|COMPLETED|Overall Study||12||
60021689|NCT02516605|76137432|FG003|COMPLETED|Overall Study||7||
60021690|NCT02516605|76137433|FG004|COMPLETED|Overall Study||20||
60021691|NCT02516605|76137429|FG000|NOT COMPLETED|Overall Study||0||
60021692|NCT02516605|76137430|FG001|NOT COMPLETED|Overall Study||0||
60021693|NCT02516605|76137431|FG002|NOT COMPLETED|Overall Study||0||
60021694|NCT02516605|76137432|FG003|NOT COMPLETED|Overall Study||1||
60021695|NCT02516605|76137433|FG004|NOT COMPLETED|Overall Study||1||
60021696|NCT02490475|76137453|FG000|STARTED|Period 1: First 6 Cycles||6||
60021697|NCT02490475|76137454|FG001|STARTED|Period 1: First 6 Cycles||2||
60021698|NCT02490475|76137455|FG002|STARTED|Period 1: First 6 Cycles||6||
60021699|NCT02490475|76137456|FG003|STARTED|Period 1: First 6 Cycles||5||
60021700|NCT02490475|76137453|FG000|COMPLETED|Period 1: First 6 Cycles||0||
60021701|NCT02490475|76137454|FG001|COMPLETED|Period 1: First 6 Cycles||0||
60021702|NCT02490475|76137455|FG002|COMPLETED|Period 1: First 6 Cycles||0||
60021703|NCT02490475|76137456|FG003|COMPLETED|Period 1: First 6 Cycles||0||
60021704|NCT02490475|76137453|FG000|NOT COMPLETED|Period 1: First 6 Cycles||6||
60021705|NCT02490475|76137454|FG001|NOT COMPLETED|Period 1: First 6 Cycles||2||
60021706|NCT02490475|76137455|FG002|NOT COMPLETED|Period 1: First 6 Cycles||6||
60021707|NCT02490475|76137456|FG003|NOT COMPLETED|Period 1: First 6 Cycles||5||
60021708|NCT02490475|76137453|FG000|STARTED|Period 2: Extension Phase||1||
60021709|NCT02490475|76137454|FG001|STARTED|Period 2: Extension Phase||0||
60021710|NCT02490475|76137455|FG002|STARTED|Period 2: Extension Phase||3||
60021711|NCT02490475|76137456|FG003|STARTED|Period 2: Extension Phase||1||
60021712|NCT02490475|76137453|FG000|COMPLETED|Period 2: Extension Phase||0||
60021713|NCT02490475|76137454|FG001|COMPLETED|Period 2: Extension Phase||0||
60021714|NCT02490475|76137455|FG002|COMPLETED|Period 2: Extension Phase||0||
60021715|NCT02490475|76137456|FG003|COMPLETED|Period 2: Extension Phase||0||
60021716|NCT02490475|76137453|FG000|NOT COMPLETED|Period 2: Extension Phase||1||
60021717|NCT02490475|76137454|FG001|NOT COMPLETED|Period 2: Extension Phase||0||
60021718|NCT02490475|76137455|FG002|NOT COMPLETED|Period 2: Extension Phase||3||
60021719|NCT02490475|76137456|FG003|NOT COMPLETED|Period 2: Extension Phase||1||
60021720|NCT02477839|76137479|FG000|STARTED|Overall Study||127||
60021721|NCT02477839|76137480|FG001|STARTED|Overall Study||128||
60021722|NCT02477839|76137479|FG000|Completed Transition Period|Overall Study||124||
60021723|NCT02477839|76137480|FG001|Completed Transition Period|Overall Study||117||
60021724|NCT02477839|76137479|FG000|Completed Taper After Maintenance|Overall Study||0||
60021725|NCT02477839|76137480|FG001|Completed Taper After Maintenance|Overall Study||1||
60021726|NCT02477839|76137479|FG000|COMPLETED|Overall Study||124||
60021727|NCT02477839|76137480|FG001|COMPLETED|Overall Study||118||
60021728|NCT02477839|76137479|FG000|NOT COMPLETED|Overall Study||3||
60021729|NCT02477839|76137480|FG001|NOT COMPLETED|Overall Study||10||
60021730|NCT02489773|76137490|FG000|STARTED|Overall Study||98||
60021731|NCT02489773|76137491|FG001|STARTED|Overall Study||52||
60021732|NCT02489773|76137490|FG000|COMPLETED|Overall Study||91||
60021733|NCT02489773|76137491|FG001|COMPLETED|Overall Study||50||
60021734|NCT02489773|76137490|FG000|NOT COMPLETED|Overall Study||7||
60021735|NCT02489773|76137491|FG001|NOT COMPLETED|Overall Study||2||
60021736|NCT02488915|76137497|FG000|STARTED|Overall Study||228||
60021737|NCT02488915|76137497|FG000|COMPLETED|Overall Study||202||
60021738|NCT02488915|76137497|FG000|NOT COMPLETED|Overall Study||26||
60021739|NCT02488681|76137501|FG000|STARTED|Overall Study|Patients with Micra implant attempt|276||
60021740|NCT02488681|76137501|FG000|COMPLETED|Overall Study|Patients successfully implanted with Micra|269||
60021741|NCT02488681|76137501|FG000|NOT COMPLETED|Overall Study||7||
60021742|NCT02477605|76137507|FG000|STARTED|Overall Study||68||
60021743|NCT02477605|76137508|FG001|STARTED|Overall Study||68||
60021744|NCT02477605|76137507|FG000|Randomized and Treated|Overall Study||67||
60021745|NCT02477605|76137508|FG001|Randomized and Treated|Overall Study||68||
60021746|NCT02477605|76137507|FG000|COMPLETED|Overall Study||67||
60021747|NCT02477605|76137508|FG001|COMPLETED|Overall Study||64||
60021748|NCT02477605|76137507|FG000|NOT COMPLETED|Overall Study||1||
60021749|NCT02477605|76137508|FG001|NOT COMPLETED|Overall Study||4||
60021750|NCT02477527|76137518|FG000|STARTED|Overall Study||27||
60021751|NCT02477527|76137518|FG000|COMPLETED|Overall Study||21||
60021752|NCT02477527|76137518|FG000|NOT COMPLETED|Overall Study||6||
60021753|NCT02477215|76137526|FG000|STARTED|Dose Escalation Phase||4||
60021754|NCT02477215|76137527|FG001|STARTED|Dose Escalation Phase||8||
60021755|NCT02477215|76137528|FG002|STARTED|Dose Escalation Phase||6||
60021756|NCT02477215|76137526|FG000|COMPLETED|Dose Escalation Phase||3||
60021757|NCT02477215|76137527|FG001|COMPLETED|Dose Escalation Phase||6||
60021758|NCT02477215|76137528|FG002|COMPLETED|Dose Escalation Phase||6||
60021759|NCT02477215|76137526|FG000|NOT COMPLETED|Dose Escalation Phase||1||
60021760|NCT02477215|76137527|FG001|NOT COMPLETED|Dose Escalation Phase||2||
60021761|NCT02477215|76137528|FG002|NOT COMPLETED|Dose Escalation Phase||0||
60021762|NCT02477215|76137526|FG000|STARTED|Fixed Dose Phase|No subjects were started in this group as it was not the optimal dose.|0||
60021763|NCT02477215|76137527|FG001|STARTED|Fixed Dose Phase|Subjects in Period 1 did not continue into Period 2. This is a new subject population.|20||
60021764|NCT02477215|76137528|FG002|STARTED|Fixed Dose Phase|No subjects were started in this group as it was not the optimal dose.|0||
60021765|NCT02477215|76137526|FG000|COMPLETED|Fixed Dose Phase||0||
60021766|NCT02477215|76137527|FG001|COMPLETED|Fixed Dose Phase||13||
60021767|NCT02477215|76137528|FG002|COMPLETED|Fixed Dose Phase||0||
60021768|NCT02477215|76137526|FG000|NOT COMPLETED|Fixed Dose Phase||0||
60021769|NCT02477215|76137527|FG001|NOT COMPLETED|Fixed Dose Phase||7||
60021770|NCT02477215|76137528|FG002|NOT COMPLETED|Fixed Dose Phase||0||
60021771|NCT02487199|76137541|FG000|STARTED|Overall Study||13||
60021772|NCT02487199|76137542|FG001|STARTED|Overall Study||5||
60021773|NCT02487199|76137541|FG000|COMPLETED|Overall Study||13||
60021774|NCT02487199|76137542|FG001|COMPLETED|Overall Study||4||
60021775|NCT02487199|76137541|FG000|NOT COMPLETED|Overall Study||0||
60021776|NCT02487199|76137542|FG001|NOT COMPLETED|Overall Study||1||
60021777|NCT02475733|76137550|FG000|STARTED|Overall Study||61||
60021778|NCT02475733|76137551|FG001|STARTED|Overall Study||22||
60021779|NCT02475733|76137550|FG000|COMPLETED|Overall Study||59||
60021780|NCT02475733|76137551|FG001|COMPLETED|Overall Study||22||
60021781|NCT02475733|76137550|FG000|NOT COMPLETED|Overall Study||2||
60021782|NCT02475733|76137551|FG001|NOT COMPLETED|Overall Study||0||
60021783|NCT02486653|76137559|FG000|STARTED|Overall Study||76||
60021784|NCT02486653|76137560|FG001|STARTED|Overall Study||75||
60021785|NCT02486653|76137559|FG000|COMPLETED|Overall Study||70||
60021786|NCT02486653|76137560|FG001|COMPLETED|Overall Study||71||
60021787|NCT02486653|76137559|FG000|NOT COMPLETED|Overall Study||6||
60021788|NCT02486653|76137560|FG001|NOT COMPLETED|Overall Study||4||
60021789|NCT02475655|76137568|FG000|STARTED|Overall Study||40||
60021790|NCT02475655|76137569|FG001|STARTED|Overall Study||20||
60021791|NCT02475655|76137568|FG000|COMPLETED|Overall Study||40||
60021792|NCT02475655|76137569|FG001|COMPLETED|Overall Study||19||
60021793|NCT02475655|76137568|FG000|NOT COMPLETED|Overall Study||0||
60021794|NCT02475655|76137569|FG001|NOT COMPLETED|Overall Study||1||
60021795|NCT02475265|76137575|FG000|STARTED|Overall Study||11||
60021796|NCT02475265|76137575|FG000|COMPLETED|Overall Study||8||
60021797|NCT02475265|76137575|FG000|NOT COMPLETED|Overall Study||3||
60021798|NCT02485717|76137582|FG000|STARTED|Overall Study||142||
60021799|NCT02485717|76137583|FG001|STARTED|Overall Study||129||
60021800|NCT02485717|76137584|FG002|STARTED|Overall Study||20||
60021801|NCT02485717|76137582|FG000|COMPLETED|Overall Study||136||
60021802|NCT02485717|76137583|FG001|COMPLETED|Overall Study||127||
60021803|NCT02485717|76137584|FG002|COMPLETED|Overall Study||19||
60021804|NCT02485717|76137582|FG000|NOT COMPLETED|Overall Study||6||
60021805|NCT02485717|76137583|FG001|NOT COMPLETED|Overall Study||2||
60021806|NCT02485717|76137584|FG002|NOT COMPLETED|Overall Study||1||
60021807|NCT02451007|76137592|FG000|STARTED|Overall Study||39||
60021808|NCT02451007|76137592|FG000|COMPLETED|Overall Study||32||
60021809|NCT02451007|76137592|FG000|NOT COMPLETED|Overall Study||7||
60021810|NCT02485483|76137598|FG000|STARTED|Overall Study||277||
60021811|NCT02485483|76137599|FG001|STARTED|Overall Study||1015||
60021812|NCT02485483|76137598|FG000|COMPLETED|Overall Study||223||
60021813|NCT02485483|76137599|FG001|COMPLETED|Overall Study||1015||
60021814|NCT02485483|76137598|FG000|NOT COMPLETED|Overall Study||54||
60021815|NCT02485483|76137599|FG001|NOT COMPLETED|Overall Study||0||
60021816|NCT02473471|76137605|FG000|STARTED|Overall Study||35||
60021817|NCT02473471|76137605|FG000|Received Allocated Intervention|Overall Study||33||
60021818|NCT02473471|76137605|FG000|Randomized Not Treated|Overall Study||2||
60021819|NCT02473471|76137605|FG000|COMPLETED|Overall Study||32||
60021820|NCT02473471|76137605|FG000|NOT COMPLETED|Overall Study||3||
60021821|NCT02450539|76137617|FG000|STARTED|Overall Study||106||
60021822|NCT02450539|76137618|FG001|STARTED|Overall Study||53||
60021823|NCT02450539|76137617|FG000|Received at Least One Dose of Study Drug|Overall Study||106||
60021824|NCT02450539|76137618|FG001|Received at Least One Dose of Study Drug|Overall Study||52||
60021825|NCT02450539|76137617|FG000|COMPLETED|Overall Study||90||
60021826|NCT02450539|76137618|FG001|COMPLETED|Overall Study||46||
60021827|NCT02450539|76137617|FG000|NOT COMPLETED|Overall Study||16||
60021828|NCT02450539|76137618|FG001|NOT COMPLETED|Overall Study||7||
60021829|NCT02449915|76137629|FG000|STARTED|Overall Study||35||
60021830|NCT02449915|76137630|FG001|STARTED|Overall Study||35||
60021831|NCT02449915|76137629|FG000|COMPLETED|Overall Study||33||
60021832|NCT02449915|76137630|FG001|COMPLETED|Overall Study||31||
60021833|NCT02449915|76137629|FG000|NOT COMPLETED|Overall Study||2||
60021834|NCT02449915|76137630|FG001|NOT COMPLETED|Overall Study||4||
60021835|NCT02420119|76137636|FG000|STARTED|Overall Study||53||
60021836|NCT02420119|76137636|FG000|COMPLETED|Overall Study||48||
60021837|NCT02420119|76137636|FG000|NOT COMPLETED|Overall Study||5||
60021838|NCT02473393|76137644|FG000|STARTED|Overall Study||5||
60021839|NCT02473393|76137645|FG001|STARTED|Overall Study||12||
60021840|NCT02473393|76137646|FG002|STARTED|Overall Study||13||
60021841|NCT02473393|76137647|FG003|STARTED|Overall Study||13||
60021842|NCT02473393|76137644|FG000|COMPLETED|Overall Study||5||
60021843|NCT02473393|76137645|FG001|COMPLETED|Overall Study||12||
60021844|NCT02473393|76137646|FG002|COMPLETED|Overall Study||11||
60021845|NCT02473393|76137647|FG003|COMPLETED|Overall Study||12||
60021846|NCT02473393|76137644|FG000|NOT COMPLETED|Overall Study||0||
60021847|NCT02473393|76137645|FG001|NOT COMPLETED|Overall Study||0||
60021848|NCT02473393|76137646|FG002|NOT COMPLETED|Overall Study||2||
60021849|NCT02473393|76137647|FG003|NOT COMPLETED|Overall Study||1||
60021850|NCT02419573|76137659|FG000|STARTED|Overall Study||1499||
60021851|NCT02419573|76137660|FG001|STARTED|Overall Study||1505||
60021852|NCT02419573|76137659|FG000|COMPLETED|Overall Study||1495||
60021853|NCT02419573|76137660|FG001|COMPLETED|Overall Study||1505||
60021854|NCT02419573|76137659|FG000|NOT COMPLETED|Overall Study||4||
60021855|NCT02419573|76137660|FG001|NOT COMPLETED|Overall Study||0||
60021856|NCT02472847|76137668|FG000|STARTED|Overall Study||24||
60021857|NCT02472847|76137669|FG001|STARTED|Overall Study||26||
60021858|NCT02472847|76137668|FG000|COMPLETED|Overall Study||23||
60021859|NCT02472847|76137669|FG001|COMPLETED|Overall Study||21||
60021860|NCT02472847|76137668|FG000|NOT COMPLETED|Overall Study||1||
60021861|NCT02472847|76137669|FG001|NOT COMPLETED|Overall Study||5||
60021862|NCT02472145|76137678|FG000|STARTED|Overall Study||10||
60021863|NCT02472145|76137679|FG001|STARTED|Overall Study||159||
60021864|NCT02472145|76137680|FG002|STARTED|Overall Study||157||
60021865|NCT02472145|76137678|FG000|Treated|Overall Study||10||
60021866|NCT02472145|76137679|FG001|Treated|Overall Study||156||
60021867|NCT02472145|76137680|FG002|Treated|Overall Study||156||
60021868|NCT02472145|76137678|FG000|Safety|Overall Study||10||
60021869|NCT02472145|76137679|FG001|Safety|Overall Study|9 participants who received decitabine,not JNJ-56022473 included,3 untreated participant excluded.|165||
60021870|NCT02472145|76137680|FG002|Safety|Overall Study|1 participant who was not treated and 9 participants who received only decitabine were excluded.|147||
60021871|NCT02472145|76137678|FG000|COMPLETED|Overall Study||0||
60021872|NCT02472145|76137679|FG001|COMPLETED|Overall Study||0||
60021873|NCT02472145|76137680|FG002|COMPLETED|Overall Study||0||
60021874|NCT02472145|76137678|FG000|NOT COMPLETED|Overall Study||10||
60021875|NCT02472145|76137679|FG001|NOT COMPLETED|Overall Study||159||
60021876|NCT02472145|76137680|FG002|NOT COMPLETED|Overall Study||157||
60021877|NCT02448043|76137689|FG000|STARTED|Overall Study||23||
60021878|NCT02448043|76137690|FG001|STARTED|Overall Study||22||
60021879|NCT02448043|76137689|FG000|COMPLETED|Overall Study||20||
60021880|NCT02448043|76137690|FG001|COMPLETED|Overall Study||18||
60021881|NCT02448043|76137689|FG000|NOT COMPLETED|Overall Study||3||
60021882|NCT02448043|76137690|FG001|NOT COMPLETED|Overall Study||4||
60021883|NCT02447887|76137699|FG000|STARTED|Overall Study||3||
60021884|NCT02447887|76137699|FG000|COMPLETED|Overall Study||0||
60021885|NCT02447887|76137699|FG000|NOT COMPLETED|Overall Study||3||
60021886|NCT02471755|76137705|FG000|STARTED|Overall Study||45||
60021887|NCT02471755|76137706|FG001|STARTED|Overall Study||45||
60021888|NCT02471755|76137705|FG000|COMPLETED|Overall Study||44||
60021889|NCT02471755|76137706|FG001|COMPLETED|Overall Study||44||
60021890|NCT02471755|76137705|FG000|NOT COMPLETED|Overall Study||1||
60021891|NCT02471755|76137706|FG001|NOT COMPLETED|Overall Study||1||
60021892|NCT02470429|76137714|FG000|STARTED|Overall Study||50||
60021893|NCT02470429|76137715|FG001|STARTED|Overall Study||49||
60021894|NCT02470429|76137714|FG000|COMPLETED|Overall Study||48||
60021895|NCT02470429|76137715|FG001|COMPLETED|Overall Study||49||
60021896|NCT02470429|76137714|FG000|NOT COMPLETED|Overall Study||2||
60021897|NCT02470429|76137715|FG001|NOT COMPLETED|Overall Study||0||
60021898|NCT02447497|76137726|FG000|STARTED|Overall Study||25||25
60021899|NCT02447497|76137727|FG001|STARTED|Overall Study||25||25
60021900|NCT02447497|76137728|FG002|STARTED|Overall Study||23||23
60021901|NCT02447497|76137729|FG003|STARTED|Overall Study||23||23
60021902|NCT02447497|76137726|FG000|COMPLETED|Overall Study||19||19
60021903|NCT02447497|76137727|FG001|COMPLETED|Overall Study||19||19
60021904|NCT02447497|76137728|FG002|COMPLETED|Overall Study||21||21
60021905|NCT02447497|76137729|FG003|COMPLETED|Overall Study||21||21
60021906|NCT02447497|76137726|FG000|NOT COMPLETED|Overall Study||6||6
60021907|NCT02447497|76137727|FG001|NOT COMPLETED|Overall Study||6||6
60021908|NCT02447497|76137728|FG002|NOT COMPLETED|Overall Study||2||2
60021909|NCT02447497|76137729|FG003|NOT COMPLETED|Overall Study||2||2
60021910|NCT02417935|76137749|FG000|STARTED|Treatment Period||151||
60021911|NCT02417935|76137750|FG001|STARTED|Treatment Period||153||
60021912|NCT02417935|76137749|FG000|Received at Least One Dose of Study Drug|Treatment Period||151||
60021913|NCT02417935|76137750|FG001|Received at Least One Dose of Study Drug|Treatment Period||152||
60021914|NCT02417935|76137749|FG000|COMPLETED|Treatment Period||130||
60021915|NCT02417935|76137750|FG001|COMPLETED|Treatment Period||137||
60021916|NCT02417935|76137749|FG000|NOT COMPLETED|Treatment Period||21||
60021917|NCT02417935|76137750|FG001|NOT COMPLETED|Treatment Period||16||
60021918|NCT02417935|76137749|FG000|STARTED|Tapering Period|Participants who discontinued treatment period had an option to enter the taper period|134||
60021919|NCT02417935|76137750|FG001|STARTED|Tapering Period|Participants who discontinued treatment period had an option to enter the taper period|142||
60021920|NCT02417935|76137749|FG000|COMPLETED|Tapering Period||134||
60021921|NCT02417935|76137750|FG001|COMPLETED|Tapering Period||142||
60021922|NCT02417935|76137749|FG000|NOT COMPLETED|Tapering Period||0||
60021923|NCT02417935|76137750|FG001|NOT COMPLETED|Tapering Period||0||
60021924|NCT02417233|76137759|FG000|STARTED|Overall Study||169||
60021925|NCT02417233|76137760|FG001|STARTED|Overall Study||289||
60021926|NCT02417233|76137761|FG002|STARTED|Overall Study||298||
60021927|NCT02417233|76137759|FG000|COMPLETED|Overall Study||133||
60021928|NCT02417233|76137760|FG001|COMPLETED|Overall Study||238||
60021929|NCT02417233|76137761|FG002|COMPLETED|Overall Study||239||
60021930|NCT02417233|76137759|FG000|NOT COMPLETED|Overall Study||36||
60021931|NCT02417233|76137760|FG001|NOT COMPLETED|Overall Study||51||
60021932|NCT02417233|76137761|FG002|NOT COMPLETED|Overall Study||59||
60021933|NCT02447029|76137772|FG000|STARTED|Overall Study||72||
60021934|NCT02447029|76137773|FG001|STARTED|Overall Study||70||
60021935|NCT02447029|76137772|FG000|Treated|Overall Study||69||
60021936|NCT02447029|76137773|FG001|Treated|Overall Study||68||
60021937|NCT02447029|76137772|FG000|COMPLETED|Overall Study||69||
60021938|NCT02447029|76137773|FG001|COMPLETED|Overall Study||68||
60021939|NCT02447029|76137772|FG000|NOT COMPLETED|Overall Study||3||
60021940|NCT02447029|76137773|FG001|NOT COMPLETED|Overall Study||2||
60021941|NCT02416453|76137790|FG000|STARTED|Overall Study||10||
60021942|NCT02416453|76137791|FG001|STARTED|Overall Study||10||
60021943|NCT02416453|76137792|FG002|STARTED|Overall Study||10||
60021944|NCT02416453|76137793|FG003|STARTED|Overall Study||112||
60021945|NCT02416453|76137794|FG004|STARTED|Overall Study||13||
60021946|NCT02416453|76137795|FG005|STARTED|Overall Study||114||
60021947|NCT02416453|76137796|FG006|STARTED|Overall Study||13||
60021948|NCT02416453|76137797|FG007|STARTED|Overall Study||106||
60021949|NCT02416453|76137798|FG008|STARTED|Overall Study||18||
60021950|NCT02416453|76137799|FG009|STARTED|Overall Study||13||
60021951|NCT02416453|76137800|FG010|STARTED|Overall Study||2||
60021952|NCT02416453|76137790|FG000|COMPLETED|Overall Study||7||
60021953|NCT02416453|76137791|FG001|COMPLETED|Overall Study||7||
60021954|NCT02416453|76137792|FG002|COMPLETED|Overall Study||9||
60021955|NCT02416453|76137793|FG003|COMPLETED|Overall Study||97||
60021956|NCT02416453|76137794|FG004|COMPLETED|Overall Study||12||
60021957|NCT02416453|76137795|FG005|COMPLETED|Overall Study||98||
60021958|NCT02416453|76137796|FG006|COMPLETED|Overall Study||11||
60021959|NCT02416453|76137797|FG007|COMPLETED|Overall Study||94||
60021960|NCT02416453|76137798|FG008|COMPLETED|Overall Study||13||
60021961|NCT02416453|76137799|FG009|COMPLETED|Overall Study||13||
60021962|NCT02416453|76137800|FG010|COMPLETED|Overall Study||2||
60021963|NCT02416453|76137790|FG000|NOT COMPLETED|Overall Study||3||
60021964|NCT02416453|76137791|FG001|NOT COMPLETED|Overall Study||3||
60021965|NCT02416453|76137792|FG002|NOT COMPLETED|Overall Study||1||
60021966|NCT02416453|76137793|FG003|NOT COMPLETED|Overall Study||15||
60021967|NCT02416453|76137794|FG004|NOT COMPLETED|Overall Study||1||
60021968|NCT02416453|76137795|FG005|NOT COMPLETED|Overall Study||16||
60021969|NCT02416453|76137796|FG006|NOT COMPLETED|Overall Study||2||
60021970|NCT02416453|76137797|FG007|NOT COMPLETED|Overall Study||12||
60021971|NCT02416453|76137798|FG008|NOT COMPLETED|Overall Study||5||
60021972|NCT02416453|76137799|FG009|NOT COMPLETED|Overall Study||0||
60021973|NCT02416453|76137800|FG010|NOT COMPLETED|Overall Study||0||
60021974|NCT02469961|76137832|FG000|STARTED|Overall Study||25||
60021975|NCT02469961|76137833|FG001|STARTED|Overall Study||25||
60021976|NCT02469961|76137832|FG000|COMPLETED|Overall Study||21||
60021977|NCT02469961|76137833|FG001|COMPLETED|Overall Study||24||
60021978|NCT02469961|76137832|FG000|NOT COMPLETED|Overall Study||4||
60021979|NCT02469961|76137833|FG001|NOT COMPLETED|Overall Study||1||
60021980|NCT02415595|76137848|FG000|STARTED|Overall Study||50||
60021981|NCT02415595|76137849|FG001|STARTED|Overall Study||52||
60021982|NCT02415595|76137850|FG002|STARTED|Overall Study||51||
60021983|NCT02415595|76137851|FG003|STARTED|Overall Study||53||
60021984|NCT02415595|76137848|FG000|COMPLETED|Overall Study||0||
60021985|NCT02415595|76137849|FG001|COMPLETED|Overall Study||0||
60021986|NCT02415595|76137850|FG002|COMPLETED|Overall Study||0||
60021987|NCT02415595|76137851|FG003|COMPLETED|Overall Study||0||
60021988|NCT02415595|76137848|FG000|NOT COMPLETED|Overall Study||50||
60021989|NCT02415595|76137849|FG001|NOT COMPLETED|Overall Study||52||
60021990|NCT02415595|76137850|FG002|NOT COMPLETED|Overall Study||51||
60021991|NCT02415595|76137851|FG003|NOT COMPLETED|Overall Study||53||
60021992|NCT02446717|76137867|FG000|STARTED|Overall Study||6||
60021993|NCT02446717|76137868|FG001|STARTED|Overall Study||22||
60021994|NCT02446717|76137869|FG002|STARTED|Overall Study||22||
60021995|NCT02446717|76137870|FG003|STARTED|Overall Study||44||
60021996|NCT02446717|76137871|FG004|STARTED|Overall Study||47||
60021997|NCT02446717|76137867|FG000|COMPLETED|Overall Study||6||
60021998|NCT02446717|76137868|FG001|COMPLETED|Overall Study||21||
60021999|NCT02446717|76137869|FG002|COMPLETED|Overall Study||20||
60022000|NCT02446717|76137870|FG003|COMPLETED|Overall Study||43||
60022001|NCT02446717|76137871|FG004|COMPLETED|Overall Study||46||
60022002|NCT02446717|76137867|FG000|NOT COMPLETED|Overall Study||0||
60022003|NCT02446717|76137868|FG001|NOT COMPLETED|Overall Study||1||
60022004|NCT02446717|76137869|FG002|NOT COMPLETED|Overall Study||2||
60022005|NCT02446717|76137870|FG003|NOT COMPLETED|Overall Study||1||
60022006|NCT02446717|76137871|FG004|NOT COMPLETED|Overall Study||1||
60022007|NCT02469415|76137883|FG000|STARTED|Overall Study||3||
60022008|NCT02469415|76137883|FG000|COMPLETED|Overall Study||0||
60022009|NCT02469415|76137883|FG000|NOT COMPLETED|Overall Study||3||
60022010|NCT02446171|76137891|FG000|STARTED|Overall Study||11||
60022011|NCT02446171|76137892|FG001|STARTED|Overall Study||11||
60022012|NCT02446171|76137893|FG002|STARTED|Overall Study||11||
60022013|NCT02446171|76137894|FG003|STARTED|Overall Study||11||
60022014|NCT02446171|76137891|FG000|COMPLETED|Overall Study||11||
60022015|NCT02446171|76137892|FG001|COMPLETED|Overall Study||11||
60022016|NCT02446171|76137893|FG002|COMPLETED|Overall Study||9||
60022017|NCT02446171|76137894|FG003|COMPLETED|Overall Study||11||
60022018|NCT02446171|76137891|FG000|NOT COMPLETED|Overall Study||0||
60022019|NCT02446171|76137892|FG001|NOT COMPLETED|Overall Study||0||
60022020|NCT02446171|76137893|FG002|NOT COMPLETED|Overall Study||2||
60022021|NCT02446171|76137894|FG003|NOT COMPLETED|Overall Study||0||
60022022|NCT02446015|76137908|FG000|STARTED|Overall Study||34||
60022023|NCT02446015|76137909|FG001|STARTED|Overall Study||63||
60022024|NCT02446015|76137908|FG000|COMPLETED|Overall Study||33||
60022025|NCT02446015|76137909|FG001|COMPLETED|Overall Study||62||
60022026|NCT02446015|76137908|FG000|NOT COMPLETED|Overall Study||1||
60022027|NCT02446015|76137909|FG001|NOT COMPLETED|Overall Study||1||
60022028|NCT02415127|76137918|FG000|STARTED|Overall Study||47||
60022029|NCT02415127|76137919|FG001|STARTED|Overall Study||45||
60022030|NCT02415127|76137918|FG000|COMPLETED|Overall Study||46||
60022031|NCT02415127|76137919|FG001|COMPLETED|Overall Study||45||
60022032|NCT02415127|76137918|FG000|NOT COMPLETED|Overall Study||1||
60022033|NCT02415127|76137919|FG001|NOT COMPLETED|Overall Study||0||
60022034|NCT02468557|76137925|FG000|STARTED|Overall Study||16||
60022035|NCT02468557|76137925|FG000|COMPLETED|Overall Study||0||
60022036|NCT02468557|76137925|FG000|NOT COMPLETED|Overall Study||16||
60022037|NCT02413489|76137936|FG000|STARTED|Overall Study||15||
60022038|NCT02413489|76137937|FG001|STARTED|Overall Study||16||
60022039|NCT02413489|76137938|FG002|STARTED|Overall Study||5||
60022040|NCT02413489|76137936|FG000|COMPLETED|Overall Study||0||
60022041|NCT02413489|76137937|FG001|COMPLETED|Overall Study||0||
60022042|NCT02413489|76137938|FG002|COMPLETED|Overall Study||0||
60022043|NCT02413489|76137936|FG000|NOT COMPLETED|Overall Study||15||
60022044|NCT02413489|76137937|FG001|NOT COMPLETED|Overall Study||16||
60022045|NCT02413489|76137938|FG002|NOT COMPLETED|Overall Study||5||
60022046|NCT02413333|76137950|FG000|STARTED|Period 1||66||
60022047|NCT02413333|76137951|FG001|STARTED|Period 1||66||
60022048|NCT02413333|76137950|FG000|Randomized and Treated|Period 1||66||
60022049|NCT02413333|76137951|FG001|Randomized and Treated|Period 1||66||
60022050|NCT02413333|76137950|FG000|COMPLETED|Period 1||65||
60022051|NCT02413333|76137951|FG001|COMPLETED|Period 1||65||
60022052|NCT02413333|76137950|FG000|NOT COMPLETED|Period 1||1||
60022053|NCT02413333|76137951|FG001|NOT COMPLETED|Period 1||1||
60022054|NCT02413333|76137950|FG000|STARTED|Period 2||65||
60022055|NCT02413333|76137951|FG001|STARTED|Period 2||65||
60022056|NCT02413333|76137950|FG000|COMPLETED|Period 2||64||
60022057|NCT02413333|76137951|FG001|COMPLETED|Period 2||65||
60022058|NCT02413333|76137950|FG000|NOT COMPLETED|Period 2||1||
60022059|NCT02413333|76137951|FG001|NOT COMPLETED|Period 2||0||
60022060|NCT02413255|76137974|FG000|STARTED|Overall Study||18||
60022061|NCT02413255|76137975|FG001|STARTED|Overall Study||6||
60022062|NCT02413255|76137976|FG002|STARTED|Overall Study||6||
60022063|NCT02413255|76137977|FG003|STARTED|Overall Study||6||
60022064|NCT02413255|76137978|FG004|STARTED|Overall Study||6||
60022065|NCT02413255|76137979|FG005|STARTED|Overall Study||6||
60022066|NCT02413255|76137980|FG006|STARTED|Overall Study||6||
60022067|NCT02413255|76137981|FG007|STARTED|Overall Study||6||
60022068|NCT02413255|76137982|FG008|STARTED|Overall Study||6||
60022069|NCT02413255|76137983|FG009|STARTED|Overall Study||6||
60022070|NCT02413255|76137984|FG010|STARTED|Overall Study||12||
60022071|NCT02413255|76137985|FG011|STARTED|Overall Study||6||
60022072|NCT02413255|76137986|FG012|STARTED|Overall Study||6||
60022073|NCT02413255|76137987|FG013|STARTED|Overall Study||6||
60022074|NCT02413255|76137988|FG014|STARTED|Overall Study||6||
60022075|NCT02413255|76137989|FG015|STARTED|Overall Study||6||
60022076|NCT02413255|76137990|FG016|STARTED|Overall Study||6||
60022077|NCT02413255|76137974|FG000|COMPLETED|Overall Study||18||
60022078|NCT02413255|76137975|FG001|COMPLETED|Overall Study||6||
60022079|NCT02413255|76137976|FG002|COMPLETED|Overall Study||6||
60022080|NCT02413255|76137977|FG003|COMPLETED|Overall Study||6||
60022081|NCT02413255|76137978|FG004|COMPLETED|Overall Study||6||
60022082|NCT02413255|76137979|FG005|COMPLETED|Overall Study||6||
60022083|NCT02413255|76137980|FG006|COMPLETED|Overall Study||6||
60022084|NCT02413255|76137981|FG007|COMPLETED|Overall Study||6||
60022085|NCT02413255|76137982|FG008|COMPLETED|Overall Study||6||
60022086|NCT02413255|76137983|FG009|COMPLETED|Overall Study||6||
60022087|NCT02413255|76137984|FG010|COMPLETED|Overall Study||12||
60022088|NCT02413255|76137985|FG011|COMPLETED|Overall Study||6||
60022089|NCT02413255|76137986|FG012|COMPLETED|Overall Study||6||
60022090|NCT02413255|76137987|FG013|COMPLETED|Overall Study||6||
60022091|NCT02413255|76137988|FG014|COMPLETED|Overall Study||5||
60022092|NCT02413255|76137989|FG015|COMPLETED|Overall Study||6||
60022093|NCT02413255|76137990|FG016|COMPLETED|Overall Study||6||
60022094|NCT02413255|76137974|FG000|NOT COMPLETED|Overall Study||0||
60022095|NCT02413255|76137975|FG001|NOT COMPLETED|Overall Study||0||
60022096|NCT02413255|76137976|FG002|NOT COMPLETED|Overall Study||0||
60022097|NCT02413255|76137977|FG003|NOT COMPLETED|Overall Study||0||
60022098|NCT02413255|76137978|FG004|NOT COMPLETED|Overall Study||0||
60022099|NCT02413255|76137979|FG005|NOT COMPLETED|Overall Study||0||
60022100|NCT02413255|76137980|FG006|NOT COMPLETED|Overall Study||0||
60022101|NCT02413255|76137981|FG007|NOT COMPLETED|Overall Study||0||
60022102|NCT02413255|76137982|FG008|NOT COMPLETED|Overall Study||0||
60022103|NCT02413255|76137983|FG009|NOT COMPLETED|Overall Study||0||
60022104|NCT02413255|76137984|FG010|NOT COMPLETED|Overall Study||0||
60022105|NCT02413255|76137985|FG011|NOT COMPLETED|Overall Study||0||
60022106|NCT02413255|76137986|FG012|NOT COMPLETED|Overall Study||0||
60022107|NCT02413255|76137987|FG013|NOT COMPLETED|Overall Study||0||
60022108|NCT02413255|76137988|FG014|NOT COMPLETED|Overall Study||1||
59913599|NCT04302545|76034493|FG000|STARTED|Overall Study||107||
59913600|NCT04302545|76034494|FG001|STARTED|Overall Study||107||
59913601|NCT04302545|76034493|FG000|COMPLETED|Overall Study||104||
59913602|NCT04302545|76034494|FG001|COMPLETED|Overall Study||103||
59913603|NCT04302545|76034493|FG000|NOT COMPLETED|Overall Study||3||
59913604|NCT04302545|76034494|FG001|NOT COMPLETED|Overall Study||4||
59913605|NCT04297241|76034511|FG000|STARTED|Overall Study||20||
59913606|NCT04297241|76034511|FG000|COMPLETED|Overall Study||15||
59913607|NCT04297241|76034511|FG000|NOT COMPLETED|Overall Study||5||
59913608|NCT04292171|76034527|FG000|STARTED|Overall Study||109||
59913609|NCT04292171|76034528|FG001|STARTED|Overall Study||110||
59913610|NCT04292171|76034527|FG000|COMPLETED|Overall Study||107||
59913611|NCT04292171|76034528|FG001|COMPLETED|Overall Study||109||
59913612|NCT04292171|76034527|FG000|NOT COMPLETED|Overall Study||2||
59913613|NCT04292171|76034528|FG001|NOT COMPLETED|Overall Study||1||
59913614|NCT04393493|76034536|FG000|STARTED|Follow up||40||
59913615|NCT04393493|76034537|FG001|STARTED|Follow up||40||
59913616|NCT04393493|76034536|FG000|COMPLETED|Follow up||40||
59913617|NCT04393493|76034537|FG001|COMPLETED|Follow up||40||
59913618|NCT04393493|76034536|FG000|NOT COMPLETED|Follow up||0||
59913619|NCT04393493|76034537|FG001|NOT COMPLETED|Follow up||0||
59913620|NCT04393493|76034536|FG000|STARTED|First 4 Days of Intervention||40||
59913621|NCT04393493|76034537|FG001|STARTED|First 4 Days of Intervention||40||
59913622|NCT04393493|76034536|FG000|COMPLETED|First 4 Days of Intervention||35||
59913623|NCT04393493|76034537|FG001|COMPLETED|First 4 Days of Intervention||33||
59913624|NCT04393493|76034536|FG000|NOT COMPLETED|First 4 Days of Intervention||5||
59913625|NCT04393493|76034537|FG001|NOT COMPLETED|First 4 Days of Intervention||7||
59913626|NCT04280705|76034547|FG000|STARTED|Overall Study||521||
59913627|NCT04280705|76034548|FG001|STARTED|Overall Study||541||
59913628|NCT04280705|76034547|FG000|Received Treatment|Overall Study||517||
59913629|NCT04280705|76034548|FG001|Received Treatment|Overall Study||531||
59913630|NCT04280705|76034547|FG000|COMPLETED|Overall Study||508||
59913631|NCT04280705|76034548|FG001|COMPLETED|Overall Study||517||
59913632|NCT04280705|76034547|FG000|NOT COMPLETED|Overall Study||13||
59913633|NCT04280705|76034548|FG001|NOT COMPLETED|Overall Study||24||
59913634|NCT02077166|76034561|FG000|STARTED|Overall Study||12||
59913635|NCT02077166|76034562|FG001|STARTED|Overall Study||7||
59913636|NCT02077166|76034563|FG002|STARTED|Overall Study||9||
59913637|NCT02077166|76034564|FG003|STARTED|Overall Study||9||
59913638|NCT02077166|76034565|FG004|STARTED|Overall Study||8||
59913639|NCT02077166|76034566|FG005|STARTED|Overall Study||55||
59913640|NCT02077166|76034567|FG006|STARTED|Overall Study||34||
59913641|NCT02077166|76034561|FG000|COMPLETED|Overall Study||0|"Participants remained on study until disease progression or unacceptable toxicity. Reason Not Completed rows display participants' primary reason for exiting the study."|
59913642|NCT02077166|76034562|FG001|COMPLETED|Overall Study||0|"Participants remained on study until disease progression or unacceptable toxicity. Reason Not Completed rows display participants' primary reason for exiting the study."|
59913643|NCT02077166|76034563|FG002|COMPLETED|Overall Study||0|"Participants remained on study until disease progression or unacceptable toxicity. Reason Not Completed rows display participants' primary reason for exiting the study."|
59913644|NCT02077166|76034564|FG003|COMPLETED|Overall Study||0|"Participants remained on study until disease progression or unacceptable toxicity. Reason Not Completed rows display participants' primary reason for exiting the study."|
59913645|NCT02077166|76034565|FG004|COMPLETED|Overall Study||0|"Participants remained on study until disease progression or unacceptable toxicity. Reason Not Completed rows display participants' primary reason for exiting the study."|
59913646|NCT02077166|76034566|FG005|COMPLETED|Overall Study||0|"Participants remained on study until disease progression or unacceptable toxicity. Reason Not Completed rows display participants' primary reason for exiting the study."|
59913647|NCT02077166|76034567|FG006|COMPLETED|Overall Study||0|"Participants remained on study until disease progression or unacceptable toxicity. Reason Not Completed rows display participants' primary reason for exiting the study."|
59913648|NCT02077166|76034561|FG000|NOT COMPLETED|Overall Study||12||
59913649|NCT02077166|76034562|FG001|NOT COMPLETED|Overall Study||7||
59913650|NCT02077166|76034563|FG002|NOT COMPLETED|Overall Study||9||
59913651|NCT02077166|76034564|FG003|NOT COMPLETED|Overall Study||9||
59913652|NCT02077166|76034565|FG004|NOT COMPLETED|Overall Study||8||
59913653|NCT02077166|76034566|FG005|NOT COMPLETED|Overall Study||55||
59913654|NCT02077166|76034567|FG006|NOT COMPLETED|Overall Study||34||
59913655|NCT04273217|76034594|FG000|STARTED|Overall Study||6||
59913656|NCT04273217|76034595|FG001|STARTED|Overall Study||6||
59913657|NCT04273217|76034596|FG002|STARTED|Overall Study||6||
59913658|NCT04273217|76034597|FG003|STARTED|Overall Study||6||
59913659|NCT04273217|76034598|FG004|STARTED|Overall Study||7||
59913660|NCT04273217|76034599|FG005|STARTED|Overall Study||11||
59913661|NCT04273217|76034594|FG000|COMPLETED|Overall Study||5||
59913662|NCT04273217|76034595|FG001|COMPLETED|Overall Study||6||
59913663|NCT04273217|76034596|FG002|COMPLETED|Overall Study||5||
59913664|NCT04273217|76034597|FG003|COMPLETED|Overall Study||6||
59913665|NCT04273217|76034598|FG004|COMPLETED|Overall Study||6||
59913666|NCT04273217|76034599|FG005|COMPLETED|Overall Study||9||
59913667|NCT04273217|76034594|FG000|NOT COMPLETED|Overall Study||1||
59913668|NCT04273217|76034595|FG001|NOT COMPLETED|Overall Study||0||
59913669|NCT04273217|76034596|FG002|NOT COMPLETED|Overall Study||1||
59913670|NCT04273217|76034597|FG003|NOT COMPLETED|Overall Study||0||
59913671|NCT04273217|76034598|FG004|NOT COMPLETED|Overall Study||1||
59913672|NCT04273217|76034599|FG005|NOT COMPLETED|Overall Study||2||
59913673|NCT04384523|76034619|FG000|STARTED|Overall Study||10||
59913674|NCT04384523|76034620|FG001|STARTED|Overall Study||6||
59913675|NCT04384523|76034621|FG002|STARTED|Overall Study||6||
59913676|NCT04384523|76034622|FG003|STARTED|Overall Study||6||
59913677|NCT04384523|76034623|FG004|STARTED|Overall Study||7||
59913678|NCT04384523|76034624|FG005|STARTED|Overall Study||6||
59913679|NCT04384523|76034619|FG000|COMPLETED|Overall Study||9||
59913680|NCT04384523|76034620|FG001|COMPLETED|Overall Study||5||
59913681|NCT04384523|76034621|FG002|COMPLETED|Overall Study||6||
59913682|NCT04384523|76034622|FG003|COMPLETED|Overall Study||6||
59913683|NCT04384523|76034623|FG004|COMPLETED|Overall Study||7||
59913684|NCT04384523|76034624|FG005|COMPLETED|Overall Study||5||
59913685|NCT04384523|76034619|FG000|NOT COMPLETED|Overall Study||1||
59913686|NCT04384523|76034620|FG001|NOT COMPLETED|Overall Study||1||
59913687|NCT04384523|76034621|FG002|NOT COMPLETED|Overall Study||0||
59913688|NCT04384523|76034622|FG003|NOT COMPLETED|Overall Study||0||
59913689|NCT04384523|76034623|FG004|NOT COMPLETED|Overall Study||0||
59913690|NCT04384523|76034624|FG005|NOT COMPLETED|Overall Study||1||
59913691|NCT01044056|76034647|FG000|STARTED|Overall Study||8||
59913692|NCT01044056|76034648|FG001|STARTED|Overall Study||8||
59913693|NCT01044056|76034649|FG002|STARTED|Overall Study||8||
59913694|NCT01044056|76034647|FG000|COMPLETED|Overall Study||8||
59913695|NCT01044056|76034648|FG001|COMPLETED|Overall Study||8||
59913696|NCT01044056|76034649|FG002|COMPLETED|Overall Study||8||
59913697|NCT01044056|76034647|FG000|NOT COMPLETED|Overall Study||0||
59913698|NCT01044056|76034648|FG001|NOT COMPLETED|Overall Study||0||
59913699|NCT01044056|76034649|FG002|NOT COMPLETED|Overall Study||0||
59913700|NCT04382651|76034659|FG000|STARTED|Overall Study||69|All randomized participants|
59913701|NCT04382651|76034660|FG001|STARTED|Overall Study||71|All randomized participants|
59913702|NCT04382651|76034659|FG000|Safety Analysis Set|Overall Study||68|All randomized participants that have received any study drug|
59913703|NCT04382651|76034660|FG001|Safety Analysis Set|Overall Study||70|All randomized participants that have received any study drug|
59913704|NCT04382651|76034659|FG000|Pharmacokinetics (PK) Analysis Set|Overall Study||63|All randomized participants with at least one valid PK concentration measurement, who received MAS825 and no protocol deviations with relevant impact on PK data.|
59913705|NCT04382651|76034660|FG001|Pharmacokinetics (PK) Analysis Set|Overall Study||0|All randomized participants with at least one valid PK concentration measurement, who received MAS825 and no protocol deviations with relevant impact on PK data.|
59913706|NCT04382651|76034659|FG000|COMPLETED|Overall Study||38||
60022109|NCT02413255|76137989|FG015|NOT COMPLETED|Overall Study||0||
60022110|NCT02413255|76137990|FG016|NOT COMPLETED|Overall Study||0||
60022111|NCT02444533|76138043|FG000|STARTED|Overall Study||17||
60022112|NCT02444533|76138044|FG001|STARTED|Overall Study||22||
60022113|NCT02444533|76138043|FG000|COMPLETED|Overall Study||15||
59913707|NCT04382651|76034660|FG001|COMPLETED|Overall Study||43||
59913708|NCT04382651|76034659|FG000|NOT COMPLETED|Overall Study||31||
59913709|NCT04382651|76034660|FG001|NOT COMPLETED|Overall Study||28||
59913710|NCT00944216|76034667|FG000|STARTED|Overall Study||1||
59913711|NCT00944216|76034667|FG000|COMPLETED|Overall Study||1||
59913712|NCT00944216|76034667|FG000|NOT COMPLETED|Overall Study||0||
59913713|NCT03442088|76034672|FG000|STARTED|Overall Study||28||
59913714|NCT03442088|76034672|FG000|COMPLETED|Overall Study||23||
59913715|NCT03442088|76034672|FG000|NOT COMPLETED|Overall Study||5||
60022114|NCT02444533|76138044|FG001|COMPLETED|Overall Study||18||
60022115|NCT02444533|76138043|FG000|NOT COMPLETED|Overall Study||2||
60022116|NCT02444533|76138044|FG001|NOT COMPLETED|Overall Study||4||
60022117|NCT01651039|76138050|FG000|STARTED|Overall Study||32||
60022118|NCT01651039|76138050|FG000|COMPLETED|Overall Study||2||
60022119|NCT01651039|76138050|FG000|NOT COMPLETED|Overall Study||30||
60022120|NCT02349633|76138068|FG000|STARTED|Overall Study||4||
60022121|NCT02349633|76138069|FG001|STARTED|Overall Study||3||
60022122|NCT02349633|76138070|FG002|STARTED|Overall Study||4||
60022123|NCT02349633|76138071|FG003|STARTED|Overall Study||4||
60022124|NCT02349633|76138072|FG004|STARTED|Overall Study||3||
60022125|NCT02349633|76138073|FG005|STARTED|Overall Study||4||
60022126|NCT02349633|76138074|FG006|STARTED|Overall Study||4||
60022127|NCT02349633|76138075|FG007|STARTED|Overall Study||29||
60022128|NCT02349633|76138076|FG008|STARTED|Overall Study||5||
60022129|NCT02349633|76138077|FG009|STARTED|Overall Study||5||
60022130|NCT02349633|76138078|FG010|STARTED|Overall Study|No participants were enrolled in this cohort/arm prior to study termination.|0||
60022131|NCT02349633|76138079|FG011|STARTED|Overall Study|No participants were enrolled in this cohort/arm prior to study termination.|0||
60022132|NCT02349633|76138080|FG012|STARTED|Overall Study|No participants were enrolled in this cohort/arm prior to study termination.|0||
60022133|NCT02349633|76138081|FG013|STARTED|Overall Study|No participants were enrolled in this cohort/arm prior to study termination.|0||
59913716|NCT04223687|76034678|FG000|STARTED|Overall Study||163||
59913717|NCT04223687|76034679|FG001|STARTED|Overall Study||163||
59913718|NCT04223687|76034678|FG000|COMPLETED|Overall Study||162||
59913719|NCT04223687|76034679|FG001|COMPLETED|Overall Study||163||
59913720|NCT04223687|76034678|FG000|NOT COMPLETED|Overall Study||1||
59913721|NCT04223687|76034679|FG001|NOT COMPLETED|Overall Study||0||
59913722|NCT03722576|76034685|FG000|STARTED|Overall Study||18||
59913723|NCT03722576|76034685|FG000|COMPLETED|Overall Study||11||
59913724|NCT03722576|76034685|FG000|NOT COMPLETED|Overall Study||7||
59913725|NCT03693989|76034691|FG000|STARTED|Overall Study||88||
59913726|NCT03693989|76034692|FG001|STARTED|Overall Study||90||
59507281|NCT02402127|75600486|FG005|COMPLETED|Third Wear Period (1 Day)||4||
59507282|NCT02402127|75600481|FG000|NOT COMPLETED|Third Wear Period (1 Day)||0||
59507283|NCT02402127|75600482|FG001|NOT COMPLETED|Third Wear Period (1 Day)||0||
59507284|NCT02402127|75600483|FG002|NOT COMPLETED|Third Wear Period (1 Day)||0||
59762598|NCT03888235|75882412|FG002|COMPLETED|Overall Study||20||
59913727|NCT03693989|76034691|FG000|COMPLETED|Overall Study||85||
59913728|NCT03693989|76034692|FG001|COMPLETED|Overall Study||86||
59913729|NCT03693989|76034691|FG000|NOT COMPLETED|Overall Study||3||
59913730|NCT03693989|76034692|FG001|NOT COMPLETED|Overall Study||4||
59913731|NCT04206293|76034698|FG000|STARTED|Overall Study||11||
59913732|NCT04206293|76034698|FG000|COMPLETED|Overall Study||10||
59913733|NCT04206293|76034698|FG000|NOT COMPLETED|Overall Study||1||
59913734|NCT02727998|76034705|FG000|STARTED|Overall Study||14||
59913735|NCT02727998|76034706|FG001|STARTED|Overall Study|1 participant immediately withdrew after the first infusion session.|14||
59913736|NCT02727998|76034705|FG000|End of Treatment (7 Days)|Overall Study||13||
59913737|NCT02727998|76034706|FG001|End of Treatment (7 Days)|Overall Study||13||
59913738|NCT02727998|76034705|FG000|30 Days Follow Up|Overall Study||13||
59913739|NCT02727998|76034706|FG001|30 Days Follow Up|Overall Study||11||
59913740|NCT02727998|76034705|FG000|90 Days Follow Up|Overall Study||11||
59913741|NCT02727998|76034706|FG001|90 Days Follow Up|Overall Study||10||
59913742|NCT02727998|76034705|FG000|COMPLETED|Overall Study||11||
59913743|NCT02727998|76034706|FG001|COMPLETED|Overall Study||10||
59913744|NCT02727998|76034705|FG000|NOT COMPLETED|Overall Study||3||
59913745|NCT02727998|76034706|FG001|NOT COMPLETED|Overall Study||4||
59913746|NCT04366349|76034718|FG000|STARTED|Overall Study||13||
59913747|NCT04366349|76034719|FG001|STARTED|Overall Study||18||
59913748|NCT04366349|76034720|FG002|STARTED|Overall Study||18||
59913749|NCT04366349|76034721|FG003|STARTED|Overall Study||4||
59913750|NCT04366349|76034722|FG004|STARTED|Overall Study||6||
59913751|NCT04366349|76034723|FG005|STARTED|Overall Study||6||
59913752|NCT04366349|76034718|FG000|COMPLETED|Overall Study||12||
59913753|NCT04366349|76034719|FG001|COMPLETED|Overall Study||18||
59913754|NCT04366349|76034720|FG002|COMPLETED|Overall Study||18||
59913755|NCT04366349|76034721|FG003|COMPLETED|Overall Study||4||
59913756|NCT04366349|76034722|FG004|COMPLETED|Overall Study||6||
59913757|NCT04366349|76034723|FG005|COMPLETED|Overall Study||6||
59913758|NCT04366349|76034718|FG000|NOT COMPLETED|Overall Study||1||
59913759|NCT04366349|76034719|FG001|NOT COMPLETED|Overall Study||0||
59913760|NCT04366349|76034720|FG002|NOT COMPLETED|Overall Study||0||
59913761|NCT04366349|76034721|FG003|NOT COMPLETED|Overall Study||0||
59913762|NCT04366349|76034722|FG004|NOT COMPLETED|Overall Study||0||
59913763|NCT04366349|76034723|FG005|NOT COMPLETED|Overall Study||0||
59913764|NCT04179461|76034741|FG000|STARTED|Overall Study||21||
59913765|NCT04179461|76034741|FG000|COMPLETED|Overall Study||17||
59913766|NCT04179461|76034741|FG000|NOT COMPLETED|Overall Study||4||
59913767|NCT04017611|76034745|FG000|STARTED|Overall Study||13||
59913768|NCT04017611|76034745|FG000|COMPLETED|Overall Study||12||
59913769|NCT04017611|76034745|FG000|NOT COMPLETED|Overall Study||1||
59913770|NCT03117296|76034751|FG000|STARTED|Overall Study||74||
59913771|NCT03117296|76034752|FG001|STARTED|Overall Study||115||
59913772|NCT03117296|76034751|FG000|COMPLETED|Overall Study||74||
59913773|NCT03117296|76034752|FG001|COMPLETED|Overall Study||115||
59913774|NCT03117296|76034751|FG000|NOT COMPLETED|Overall Study||0||
59913775|NCT03117296|76034752|FG001|NOT COMPLETED|Overall Study||0||
59913776|NCT04172831|76034760|FG000|STARTED|Overall Study||248||
59913777|NCT04172831|76034761|FG001|STARTED|Overall Study||255||
59913778|NCT04172831|76034760|FG000|COMPLETED|Overall Study||204||
59913779|NCT04172831|76034761|FG001|COMPLETED|Overall Study||213||
59913780|NCT04172831|76034760|FG000|NOT COMPLETED|Overall Study||44||
59913781|NCT04172831|76034761|FG001|NOT COMPLETED|Overall Study||42||
59913782|NCT03111914|76034767|FG000|STARTED|Overall Study||7||
59913783|NCT03111914|76034767|FG000|COMPLETED|Overall Study||0||
59913784|NCT03111914|76034767|FG000|NOT COMPLETED|Overall Study||7||
59913785|NCT04165031|76034778|FG000|STARTED|Overall Study||2||
59913786|NCT04165031|76034779|FG001|STARTED|Overall Study||1||
59913787|NCT04165031|76034780|FG002|STARTED|Overall Study||2||
59913788|NCT04165031|76034781|FG003|STARTED|Overall Study||0||
59913789|NCT04165031|76034782|FG004|STARTED|Overall Study||0||
59913790|NCT04165031|76034783|FG005|STARTED|Overall Study||0||
59913791|NCT04165031|76034778|FG000|Received at Least One Dose of Study Drug|Overall Study||2||
59913792|NCT04165031|76034779|FG001|Received at Least One Dose of Study Drug|Overall Study||1||
59913793|NCT04165031|76034780|FG002|Received at Least One Dose of Study Drug|Overall Study||2||
59913794|NCT04165031|76034781|FG003|Received at Least One Dose of Study Drug|Overall Study||0||
59913795|NCT04165031|76034782|FG004|Received at Least One Dose of Study Drug|Overall Study||0||
59913796|NCT04165031|76034783|FG005|Received at Least One Dose of Study Drug|Overall Study||0||
59913797|NCT04165031|76034778|FG000|COMPLETED|Overall Study||1||
59913798|NCT04165031|76034779|FG001|COMPLETED|Overall Study||0||
59913799|NCT04165031|76034780|FG002|COMPLETED|Overall Study||1||
59611601|NCT01775904|75722585|FG000|STARTED|LY2886721 Capsule (Water, Fasting)||26||
60022134|NCT02349633|76138068|FG000|COMPLETED|Overall Study||4||
60022135|NCT02349633|76138069|FG001|COMPLETED|Overall Study||2||
60022136|NCT02349633|76138070|FG002|COMPLETED|Overall Study||4||
60022137|NCT02349633|76138071|FG003|COMPLETED|Overall Study||2||
60022138|NCT02349633|76138072|FG004|COMPLETED|Overall Study||1||
60022139|NCT02349633|76138073|FG005|COMPLETED|Overall Study||3||
60022140|NCT02349633|76138074|FG006|COMPLETED|Overall Study||3||
60022141|NCT02349633|76138075|FG007|COMPLETED|Overall Study||13||
60022142|NCT02349633|76138076|FG008|COMPLETED|Overall Study||3||
60022143|NCT02349633|76138077|FG009|COMPLETED|Overall Study||0||
60022144|NCT02349633|76138078|FG010|COMPLETED|Overall Study||0||
60022145|NCT02349633|76138079|FG011|COMPLETED|Overall Study||0||
60022146|NCT02349633|76138080|FG012|COMPLETED|Overall Study||0||
60022147|NCT02349633|76138081|FG013|COMPLETED|Overall Study||0||
60022148|NCT02349633|76138068|FG000|NOT COMPLETED|Overall Study||0||
60022149|NCT02349633|76138069|FG001|NOT COMPLETED|Overall Study||1||
60022150|NCT02349633|76138070|FG002|NOT COMPLETED|Overall Study||0||
60022151|NCT02349633|76138071|FG003|NOT COMPLETED|Overall Study||2||
60022152|NCT02349633|76138072|FG004|NOT COMPLETED|Overall Study||2||
60022153|NCT02349633|76138073|FG005|NOT COMPLETED|Overall Study||1||
60022154|NCT02349633|76138074|FG006|NOT COMPLETED|Overall Study||1||
60022155|NCT02349633|76138075|FG007|NOT COMPLETED|Overall Study||16||
60022156|NCT02349633|76138076|FG008|NOT COMPLETED|Overall Study||2||
60022157|NCT02349633|76138077|FG009|NOT COMPLETED|Overall Study||5||
60022158|NCT02349633|76138078|FG010|NOT COMPLETED|Overall Study||0||
60022159|NCT02349633|76138079|FG011|NOT COMPLETED|Overall Study||0||
60022160|NCT02349633|76138080|FG012|NOT COMPLETED|Overall Study||0||
60022161|NCT02349633|76138081|FG013|NOT COMPLETED|Overall Study||0||
60022162|NCT02275611|76138146|FG000|STARTED|Inpatient Withdrawal||5||
60022163|NCT02275611|76138147|FG001|STARTED|Inpatient Withdrawal||4||
60022164|NCT02275611|76138148|FG002|STARTED|Inpatient Withdrawal||0||
60022165|NCT02275611|76138149|FG003|STARTED|Inpatient Withdrawal||0||
60022166|NCT02275611|76138146|FG000|COMPLETED|Inpatient Withdrawal||4||
60022167|NCT02275611|76138147|FG001|COMPLETED|Inpatient Withdrawal||4||
60022168|NCT02275611|76138148|FG002|COMPLETED|Inpatient Withdrawal||0||
60022169|NCT02275611|76138149|FG003|COMPLETED|Inpatient Withdrawal||0||
60022170|NCT02275611|76138146|FG000|NOT COMPLETED|Inpatient Withdrawal||1||
60022171|NCT02275611|76138147|FG001|NOT COMPLETED|Inpatient Withdrawal||0||
60022172|NCT02275611|76138148|FG002|NOT COMPLETED|Inpatient Withdrawal||0||
60022173|NCT02275611|76138149|FG003|NOT COMPLETED|Inpatient Withdrawal||0||
60022174|NCT02275611|76138146|FG000|STARTED|Outpatient Drinking||0||
60022175|NCT02275611|76138147|FG001|STARTED|Outpatient Drinking||0||
60022176|NCT02275611|76138148|FG002|STARTED|Outpatient Drinking||6||
60022177|NCT02275611|76138149|FG003|STARTED|Outpatient Drinking||3||
60022178|NCT02275611|76138146|FG000|COMPLETED|Outpatient Drinking||0||
60022179|NCT02275611|76138147|FG001|COMPLETED|Outpatient Drinking||0||
60022180|NCT02275611|76138148|FG002|COMPLETED|Outpatient Drinking||6||
60022181|NCT02275611|76138149|FG003|COMPLETED|Outpatient Drinking||3||
60022182|NCT02275611|76138146|FG000|NOT COMPLETED|Outpatient Drinking||0||
60022183|NCT02275611|76138147|FG001|NOT COMPLETED|Outpatient Drinking||0||
60022184|NCT02275611|76138148|FG002|NOT COMPLETED|Outpatient Drinking||0||
60022185|NCT02275611|76138149|FG003|NOT COMPLETED|Outpatient Drinking||0||
60022186|NCT02275065|76138166|FG000|STARTED|Overall Study||5||
60022187|NCT02275065|76138167|FG001|STARTED|Overall Study||4||
60022188|NCT02275065|76138168|FG002|STARTED|Overall Study||5||
60022189|NCT02275065|76138169|FG003|STARTED|Overall Study||5||
60022190|NCT02275065|76138170|FG004|STARTED|Overall Study||4||
60022191|NCT02275065|76138166|FG000|COMPLETED|Overall Study||4||
60022192|NCT02275065|76138167|FG001|COMPLETED|Overall Study||4||
60022193|NCT02275065|76138168|FG002|COMPLETED|Overall Study||4||
60022194|NCT02275065|76138169|FG003|COMPLETED|Overall Study||4||
60022195|NCT02275065|76138170|FG004|COMPLETED|Overall Study||4||
60022196|NCT02275065|76138166|FG000|NOT COMPLETED|Overall Study||1||
60022197|NCT02275065|76138167|FG001|NOT COMPLETED|Overall Study||0||
60022198|NCT02275065|76138168|FG002|NOT COMPLETED|Overall Study||1||
60022199|NCT02275065|76138169|FG003|NOT COMPLETED|Overall Study||1||
60022200|NCT02275065|76138170|FG004|NOT COMPLETED|Overall Study||0||
60022201|NCT02273973|76138184|FG000|STARTED|Overall Study||166||
60022202|NCT02273973|76138185|FG001|STARTED|Overall Study||168||
60022203|NCT02273973|76138184|FG000|COMPLETED|Overall Study||157||
60022204|NCT02273973|76138185|FG001|COMPLETED|Overall Study||160||
60022205|NCT02273973|76138184|FG000|NOT COMPLETED|Overall Study||9||
60022206|NCT02273973|76138185|FG001|NOT COMPLETED|Overall Study||8||
60022207|NCT02273739|76138195|FG000|STARTED|Overall Study||3||
60022208|NCT02273739|76138196|FG001|STARTED|Overall Study||4||
59613509|NCT01592292|75724647|FG000|STARTED|Overall Study||46||
60022209|NCT02273739|76138197|FG002|STARTED|Overall Study||7||
60022210|NCT02273739|76138198|FG003|STARTED|Overall Study||7||
60022211|NCT02273739|76138195|FG000|COMPLETED|Overall Study||0|Participants ongoing treatment|
60022212|NCT02273739|76138196|FG001|COMPLETED|Overall Study||0|Participants ongoing treatment|
60022213|NCT02273739|76138197|FG002|COMPLETED|Overall Study||0|Participants ongoing treatment|
59758868|NCT00745875|75878172|FG001|COMPLETED|Overall Study|Completed - Number of patients discontinued study treatment at data cut-off (17th January 2010)|26||
59913800|NCT04165031|76034781|FG003|COMPLETED|Overall Study||0||
59913801|NCT04165031|76034782|FG004|COMPLETED|Overall Study||0||
59913802|NCT04165031|76034783|FG005|COMPLETED|Overall Study||0||
59913803|NCT04165031|76034778|FG000|NOT COMPLETED|Overall Study||1||
59913804|NCT04165031|76034779|FG001|NOT COMPLETED|Overall Study||1||
59913805|NCT04165031|76034780|FG002|NOT COMPLETED|Overall Study||1||
59913806|NCT04165031|76034781|FG003|NOT COMPLETED|Overall Study||0||
59913807|NCT04165031|76034782|FG004|NOT COMPLETED|Overall Study||0||
59913808|NCT04165031|76034783|FG005|NOT COMPLETED|Overall Study||0||
59758869|NCT00745875|75878171|FG000|NOT COMPLETED|Overall Study||4||
59758870|NCT00745875|75878172|FG001|NOT COMPLETED|Overall Study||4||
59758871|NCT00555217|75878180|FG000|STARTED|Overall Study||724||
59758872|NCT00555217|75878181|FG001|STARTED|Overall Study||724||
59758873|NCT00555217|75878180|FG000|COMPLETED|Overall Study||649||
59758874|NCT00555217|75878181|FG001|COMPLETED|Overall Study||656||
59758875|NCT00555217|75878180|FG000|NOT COMPLETED|Overall Study||75||
59913809|NCT02712424|76034800|FG000|STARTED|Overall Study||315||
59913810|NCT02712424|76034801|FG001|STARTED|Overall Study||310||
59913811|NCT02712424|76034800|FG000|COMPLETED|Overall Study||281||
59913812|NCT02712424|76034801|FG001|COMPLETED|Overall Study||278||
59913813|NCT02712424|76034800|FG000|NOT COMPLETED|Overall Study||34||
59913814|NCT02712424|76034801|FG001|NOT COMPLETED|Overall Study||32||
59913815|NCT02968004|76034809|FG000|STARTED|Overall Study||109||
59913816|NCT02968004|76034810|FG001|STARTED|Overall Study||115||
59913817|NCT02968004|76034809|FG000|COMPLETED|Overall Study||108||
59913818|NCT02968004|76034810|FG001|COMPLETED|Overall Study||114||
59913819|NCT02968004|76034809|FG000|NOT COMPLETED|Overall Study||1||
59913820|NCT02968004|76034810|FG001|NOT COMPLETED|Overall Study||1||
59913821|NCT03034772|76034818|FG000|STARTED|Overall Study||27||
59913822|NCT03034772|76034819|FG001|STARTED|Overall Study||25||
59913823|NCT03034772|76034818|FG000|COMPLETED|Overall Study||27||
59913824|NCT03034772|76034819|FG001|COMPLETED|Overall Study||23||
59913825|NCT03034772|76034818|FG000|NOT COMPLETED|Overall Study||0||
59913826|NCT03034772|76034819|FG001|NOT COMPLETED|Overall Study||2||
59913827|NCT03032198|76034825|FG000|STARTED|Overall Study||37||
59913828|NCT03032198|76034825|FG000|COMPLETED|Overall Study||36|Trial was terminated early due to change in corporate strategy|
59913829|NCT03032198|76034825|FG000|NOT COMPLETED|Overall Study||1||
59913830|NCT02431364|76034834|FG000|STARTED|Overall Study||8||
59913831|NCT02431364|76034835|FG001|STARTED|Overall Study||6||
59913832|NCT02431364|76034836|FG002|STARTED|Overall Study||6||
59913833|NCT02431364|76034837|FG003|STARTED|Overall Study||7||
59913834|NCT02431364|76034838|FG004|STARTED|Overall Study||6||
59913835|NCT02431364|76034834|FG000|Treated|Overall Study||8||
59913836|NCT02431364|76034835|FG001|Treated|Overall Study||6||
59913837|NCT02431364|76034836|FG002|Treated|Overall Study||6||
59913838|NCT02431364|76034837|FG003|Treated|Overall Study||6||
59913839|NCT02431364|76034838|FG004|Treated|Overall Study||6||
59913840|NCT02431364|76034834|FG000|COMPLETED|Overall Study||8||
59913841|NCT02431364|76034835|FG001|COMPLETED|Overall Study||5||
59913842|NCT02431364|76034836|FG002|COMPLETED|Overall Study||6||
59913843|NCT02431364|76034837|FG003|COMPLETED|Overall Study||6||
59913844|NCT02431364|76034838|FG004|COMPLETED|Overall Study||6||
59913845|NCT02431364|76034834|FG000|NOT COMPLETED|Overall Study||0||
59913846|NCT02431364|76034835|FG001|NOT COMPLETED|Overall Study||1||
59913847|NCT02431364|76034836|FG002|NOT COMPLETED|Overall Study||0||
59913848|NCT02431364|76034837|FG003|NOT COMPLETED|Overall Study||1||
59913849|NCT02431364|76034838|FG004|NOT COMPLETED|Overall Study||0||
59913850|NCT03034460|76034856|FG000|STARTED|Overall Study||48||
59913851|NCT03034460|76034857|FG001|STARTED|Overall Study||22||
59913852|NCT03034460|76034856|FG000|COMPLETED|Overall Study||45||
59913853|NCT03034460|76034857|FG001|COMPLETED|Overall Study||19||
59913854|NCT03034460|76034856|FG000|NOT COMPLETED|Overall Study||3||
59913855|NCT03034460|76034857|FG001|NOT COMPLETED|Overall Study||3||
59913856|NCT04162769|76034870|FG000|STARTED|Double-blind Treatment (12-Week)||47||
59913857|NCT04162769|76034871|FG001|STARTED|Double-blind Treatment (12-Week)||47||
59913858|NCT04162769|76034872|FG002|STARTED|Double-blind Treatment (12-Week)||46||
59913859|NCT04162769|76034873|FG003|STARTED|Double-blind Treatment (12-Week)||0||
59913860|NCT04162769|76034870|FG000|COMPLETED|Double-blind Treatment (12-Week)||34||
59913861|NCT04162769|76034871|FG001|COMPLETED|Double-blind Treatment (12-Week)||36||
59913862|NCT04162769|76034872|FG002|COMPLETED|Double-blind Treatment (12-Week)||37||
59913863|NCT04162769|76034873|FG003|COMPLETED|Double-blind Treatment (12-Week)||0||
59913864|NCT04162769|76034870|FG000|NOT COMPLETED|Double-blind Treatment (12-Week)||13||
59913865|NCT04162769|76034871|FG001|NOT COMPLETED|Double-blind Treatment (12-Week)||11||
59913866|NCT04162769|76034872|FG002|NOT COMPLETED|Double-blind Treatment (12-Week)||9||
59913867|NCT04162769|76034873|FG003|NOT COMPLETED|Double-blind Treatment (12-Week)||0||
59913868|NCT04162769|76034870|FG000|STARTED|OLE Period (52-Week)||0||
59913869|NCT04162769|76034871|FG001|STARTED|OLE Period (52-Week)||0||
59913870|NCT04162769|76034872|FG002|STARTED|OLE Period (52-Week)||0||
59913871|NCT04162769|76034873|FG003|STARTED|OLE Period (52-Week)|12 participants completed the Double-blind treatment period but did not enter the OLE Phase|95||
59758876|NCT00555217|75878181|FG001|NOT COMPLETED|Overall Study||68||
59758877|NCT00745251|75878189|FG000|STARTED|Overall Study||23||
59758878|NCT00745251|75878190|FG001|STARTED|Overall Study||22||
59758879|NCT00745251|75878189|FG000|COMPLETED|Overall Study||21||
59758880|NCT00745251|75878190|FG001|COMPLETED|Overall Study||19||
59758881|NCT00745251|75878189|FG000|NOT COMPLETED|Overall Study||2||
59758882|NCT00745251|75878190|FG001|NOT COMPLETED|Overall Study||3||
59758883|NCT00745095|75878202|FG000|STARTED|Overall Study||15||
59758884|NCT00745095|75878203|FG001|STARTED|Overall Study||15||
59758885|NCT00745095|75878204|FG002|STARTED|Overall Study||15||
59913872|NCT04162769|76034870|FG000|COMPLETED|OLE Period (52-Week)||0||
59913873|NCT04162769|76034871|FG001|COMPLETED|OLE Period (52-Week)||0||
59913874|NCT04162769|76034872|FG002|COMPLETED|OLE Period (52-Week)||0||
59913875|NCT04162769|76034873|FG003|COMPLETED|OLE Period (52-Week)||68||
59758886|NCT00745095|75878205|FG003|STARTED|Overall Study||15||
59758887|NCT00745095|75878206|FG004|STARTED|Overall Study||150||
59758888|NCT00745095|75878207|FG005|STARTED|Overall Study||150||
59758889|NCT00745095|75878202|FG000|COMPLETED|Overall Study||14||
59758890|NCT00745095|75878203|FG001|COMPLETED|Overall Study||13||
59758891|NCT00745095|75878204|FG002|COMPLETED|Overall Study||12||
59758892|NCT00745095|75878205|FG003|COMPLETED|Overall Study||12||
59758893|NCT00745095|75878206|FG004|COMPLETED|Overall Study||28||
59758894|NCT00745095|75878207|FG005|COMPLETED|Overall Study||27||
59758895|NCT00745095|75878202|FG000|NOT COMPLETED|Overall Study||1||
59758896|NCT00745095|75878203|FG001|NOT COMPLETED|Overall Study||2||
59913876|NCT04162769|76034870|FG000|NOT COMPLETED|OLE Period (52-Week)||0||
59913877|NCT04162769|76034871|FG001|NOT COMPLETED|OLE Period (52-Week)||0||
59913878|NCT04162769|76034872|FG002|NOT COMPLETED|OLE Period (52-Week)||0||
59913879|NCT04162769|76034873|FG003|NOT COMPLETED|OLE Period (52-Week)||27||
59913880|NCT04161131|76034884|FG000|STARTED|Overall Study||28||
59913881|NCT04161131|76034884|FG000|Completed Baseline Surveys|Overall Study||27||
59913882|NCT04161131|76034884|FG000|Received Intervention|Overall Study||22||
59913883|NCT04161131|76034884|FG000|COMPLETED|Overall Study||22||
59913884|NCT04161131|76034884|FG000|NOT COMPLETED|Overall Study||6||
59913885|NCT04155047|76034890|FG000|STARTED|Overall Study||11||
59913886|NCT04155047|76034891|FG001|STARTED|Overall Study||11||
59913887|NCT04155047|76034890|FG000|COMPLETED|Overall Study||9||
59913888|NCT04155047|76034891|FG001|COMPLETED|Overall Study||11||
59913889|NCT04155047|76034890|FG000|NOT COMPLETED|Overall Study||2||
59913890|NCT04155047|76034891|FG001|NOT COMPLETED|Overall Study||0||
59913891|NCT04152083|76034899|FG000|STARTED|Overall Study||241||
59913892|NCT04152083|76034900|FG001|STARTED|Overall Study||244||
59913893|NCT04152083|76034899|FG000|Received at Least 1 Dose of Study Drug|Overall Study||238||
59913894|NCT04152083|76034900|FG001|Received at Least 1 Dose of Study Drug|Overall Study||242||
59913895|NCT04152083|76034899|FG000|COMPLETED|Overall Study||235||
59913896|NCT04152083|76034900|FG001|COMPLETED|Overall Study||241||
59913897|NCT04152083|76034899|FG000|NOT COMPLETED|Overall Study||6||
59913898|NCT04152083|76034900|FG001|NOT COMPLETED|Overall Study||3||
59913899|NCT02711956|76034921|FG000|STARTED|Overall Study||2||
59913900|NCT02711956|76034922|FG001|STARTED|Overall Study||2||
59913901|NCT02711956|76034923|FG002|STARTED|Overall Study||3||
59913902|NCT02711956|76034924|FG003|STARTED|Overall Study||5||
59913903|NCT02711956|76034925|FG004|STARTED|Overall Study||4||
59913904|NCT02711956|76034926|FG005|STARTED|Overall Study||3||
59913905|NCT02711956|76034927|FG006|STARTED|Overall Study||4||
59913906|NCT02711956|76034928|FG007|STARTED|Overall Study||4||
59913907|NCT02711956|76034929|FG008|STARTED|Overall Study||4||
59913908|NCT02711956|76034930|FG009|STARTED|Overall Study||3||
59913909|NCT02711956|76034931|FG010|STARTED|Overall Study||1||
59913910|NCT02711956|76034932|FG011|STARTED|Overall Study||9||
59913911|NCT02711956|76034933|FG012|STARTED|Overall Study||17||
59913912|NCT02711956|76034934|FG013|STARTED|Overall Study||6||
59913913|NCT02711956|76034935|FG014|STARTED|Overall Study||8||
59913914|NCT02711956|76034921|FG000|COMPLETED|Overall Study||0||
59913915|NCT02711956|76034922|FG001|COMPLETED|Overall Study||0||
59913916|NCT02711956|76034923|FG002|COMPLETED|Overall Study||1||
59913917|NCT02711956|76034924|FG003|COMPLETED|Overall Study||2||
59913918|NCT02711956|76034925|FG004|COMPLETED|Overall Study||0||
59913919|NCT02711956|76034926|FG005|COMPLETED|Overall Study||1||
59913920|NCT02711956|76034927|FG006|COMPLETED|Overall Study||0||
59913921|NCT02711956|76034928|FG007|COMPLETED|Overall Study||2||
59913922|NCT02711956|76034929|FG008|COMPLETED|Overall Study||0||
59913923|NCT02711956|76034930|FG009|COMPLETED|Overall Study||0||
59913924|NCT02711956|76034931|FG010|COMPLETED|Overall Study||0||
59913925|NCT02711956|76034932|FG011|COMPLETED|Overall Study||0||
59913926|NCT02711956|76034933|FG012|COMPLETED|Overall Study||1||
59913927|NCT02711956|76034934|FG013|COMPLETED|Overall Study||1||
59913928|NCT02711956|76034935|FG014|COMPLETED|Overall Study||0||
59758897|NCT00745095|75878204|FG002|NOT COMPLETED|Overall Study||3||
59913929|NCT02711956|76034921|FG000|NOT COMPLETED|Overall Study||2||
59913930|NCT02711956|76034922|FG001|NOT COMPLETED|Overall Study||2||
59913931|NCT02711956|76034923|FG002|NOT COMPLETED|Overall Study||2||
59913932|NCT02711956|76034924|FG003|NOT COMPLETED|Overall Study||3||
59913933|NCT02711956|76034925|FG004|NOT COMPLETED|Overall Study||4||
59913934|NCT02711956|76034926|FG005|NOT COMPLETED|Overall Study||2||
60022214|NCT02273739|76138198|FG003|COMPLETED|Overall Study||0|Participants ongoing treatment|
60022215|NCT02273739|76138195|FG000|NOT COMPLETED|Overall Study||3||
60022216|NCT02273739|76138196|FG001|NOT COMPLETED|Overall Study||4||
60022217|NCT02273739|76138197|FG002|NOT COMPLETED|Overall Study||7||
60022218|NCT02273739|76138198|FG003|NOT COMPLETED|Overall Study||7||
60022219|NCT02273037|76138215|FG000|STARTED|Overall Study||987||
60022220|NCT02273037|76138216|FG001|STARTED|Overall Study||1000||
60022221|NCT02273037|76138215|FG000|COMPLETED|Overall Study||979||
60022222|NCT02273037|76138216|FG001|COMPLETED|Overall Study||992||
60022223|NCT02273037|76138215|FG000|NOT COMPLETED|Overall Study||8||
60022224|NCT02273037|76138216|FG001|NOT COMPLETED|Overall Study||8||
60022225|NCT02465515|76138226|FG000|STARTED|Overall Study||4732||
60022226|NCT02465515|76138227|FG001|STARTED|Overall Study||4731||
60022227|NCT02465515|76138226|FG000|COMPLETED|Overall Study||4578||
60022228|NCT02465515|76138227|FG001|COMPLETED|Overall Study||4620||
60022229|NCT02465515|76138226|FG000|NOT COMPLETED|Overall Study||154||
60022230|NCT02465515|76138227|FG001|NOT COMPLETED|Overall Study||111||
60022231|NCT02412631|76138235|FG000|STARTED|Overall Study||44||
60022232|NCT02412631|76138236|FG001|STARTED|Overall Study||40||
60022233|NCT02412631|76138235|FG000|COMPLETED|Overall Study||18||
60022234|NCT02412631|76138236|FG001|COMPLETED|Overall Study||16||
60022235|NCT02412631|76138235|FG000|NOT COMPLETED|Overall Study||26||
60022236|NCT02412631|76138236|FG001|NOT COMPLETED|Overall Study||24||
60022237|NCT02272803|76138244|FG000|STARTED|Overall Study||40||
60022238|NCT02272803|76138245|FG001|STARTED|Overall Study||42||
60022239|NCT02272803|76138244|FG000|COMPLETED|Overall Study||0||
60022240|NCT02272803|76138245|FG001|COMPLETED|Overall Study||0||
60022241|NCT02272803|76138244|FG000|NOT COMPLETED|Overall Study||40||
60022242|NCT02272803|76138245|FG001|NOT COMPLETED|Overall Study||42||
60022243|NCT02272725|76138253|FG000|STARTED|Overall Study||49||
60022244|NCT02272725|76138254|FG001|STARTED|Overall Study||42||
60022245|NCT02272725|76138253|FG000|COMPLETED|Overall Study||47||
60022246|NCT02272725|76138254|FG001|COMPLETED|Overall Study||42||
60022247|NCT02272725|76138253|FG000|NOT COMPLETED|Overall Study||2||
60022248|NCT02272725|76138254|FG001|NOT COMPLETED|Overall Study||0||
59758898|NCT00745095|75878205|FG003|NOT COMPLETED|Overall Study||3||
59758899|NCT00745095|75878206|FG004|NOT COMPLETED|Overall Study||122||
60022249|NCT01650805|76138262|FG000|STARTED|Overall Study|Started means patient has been randomized.|155||
60022250|NCT01650805|76138263|FG001|STARTED|Overall Study||152||
60022251|NCT01650805|76138262|FG000|COMPLETED|Overall Study|Completed means patient initiated and discontinued study treatment.|154||
60022252|NCT01650805|76138263|FG001|COMPLETED|Overall Study||152||
60022253|NCT01650805|76138262|FG000|NOT COMPLETED|Overall Study||1||
60022254|NCT01650805|76138263|FG001|NOT COMPLETED|Overall Study||0||
60022255|NCT02442349|76138269|FG000|STARTED|Overall Study||171||
60022256|NCT02442349|76138269|FG000|COMPLETED|Overall Study||0||
60022257|NCT02442349|76138269|FG000|NOT COMPLETED|Overall Study||171||
60022258|NCT02411539|76138275|FG000|STARTED|Overall Study||20||
60022259|NCT02411539|76138276|FG001|STARTED|Overall Study||20||
60022260|NCT02411539|76138275|FG000|COMPLETED|Overall Study||18||
60022261|NCT02411539|76138276|FG001|COMPLETED|Overall Study||19||
60022262|NCT02411539|76138275|FG000|NOT COMPLETED|Overall Study||2||
60022263|NCT02411539|76138276|FG001|NOT COMPLETED|Overall Study||1||
60022264|NCT02465437|76138289|FG000|STARTED|Overall Study||9||
60022265|NCT02465437|76138290|FG001|STARTED|Overall Study||9||
60022266|NCT02465437|76138291|FG002|STARTED|Overall Study||9||
60022267|NCT02465437|76138292|FG003|STARTED|Overall Study||15||
60022268|NCT02465437|76138289|FG000|COMPLETED|Overall Study||8||
60022269|NCT02465437|76138290|FG001|COMPLETED|Overall Study||8||
60022270|NCT02465437|76138291|FG002|COMPLETED|Overall Study||8||
59758900|NCT00745095|75878207|FG005|NOT COMPLETED|Overall Study||123||
59758901|NCT00744939|75878228|FG000|STARTED|Overall Study||168||
59758902|NCT00744939|75878228|FG000|Treatment Received|Overall Study||141||
59758903|NCT00744939|75878228|FG000|COMPLETED|Overall Study||77||
59758904|NCT00744939|75878228|FG000|NOT COMPLETED|Overall Study||91||
59758905|NCT00744861|75878244|FG000|STARTED|Feasibility Stage 1|Stage 1: Study phase to determine the feasibility of the study treatment and assessments|8||
59762599|NCT03888235|75882410|FG000|NOT COMPLETED|Overall Study||1||
60022271|NCT02465437|76138292|FG003|COMPLETED|Overall Study||14||
60022272|NCT02465437|76138289|FG000|NOT COMPLETED|Overall Study||1||
60022273|NCT02465437|76138290|FG001|NOT COMPLETED|Overall Study||1||
60022274|NCT02465437|76138291|FG002|NOT COMPLETED|Overall Study||1||
60022275|NCT02465437|76138292|FG003|NOT COMPLETED|Overall Study||1||
60022276|NCT02442271|76138300|FG000|STARTED|Overall Study||222||
60022277|NCT02442271|76138300|FG000|COMPLETED|Overall Study||218||
60022278|NCT02442271|76138300|FG000|NOT COMPLETED|Overall Study||4||
60022279|NCT02465203|76138321|FG000|STARTED|Overall Study||56||
60022280|NCT02465203|76138322|FG001|STARTED|Overall Study||36||
60022281|NCT02465203|76138323|FG002|STARTED|Overall Study||13||
60022282|NCT02465203|76138321|FG000|COMPLETED|Overall Study||0||
60022283|NCT02465203|76138322|FG001|COMPLETED|Overall Study||0||
60022284|NCT02465203|76138323|FG002|COMPLETED|Overall Study||0||
60022285|NCT02465203|76138321|FG000|NOT COMPLETED|Overall Study||56||
60022286|NCT02465203|76138322|FG001|NOT COMPLETED|Overall Study||36||
60022287|NCT02465203|76138323|FG002|NOT COMPLETED|Overall Study||13||
59507285|NCT02402127|75600484|FG003|NOT COMPLETED|Third Wear Period (1 Day)||0||
59507286|NCT02402127|75600485|FG004|NOT COMPLETED|Third Wear Period (1 Day)||0||
59507287|NCT02402127|75600486|FG005|NOT COMPLETED|Third Wear Period (1 Day)||0||
59507288|NCT02067039|75600499|FG000|STARTED|Overall Study||1325||
59507289|NCT02067039|75600500|FG001|STARTED|Overall Study||1340||
59507290|NCT02067039|75600499|FG000|3 Month Survey|Overall Study||824||
59507291|NCT02067039|75600500|FG001|3 Month Survey|Overall Study||766||
59507292|NCT02067039|75600499|FG000|6 Month Survey|Overall Study||735||
59507293|NCT02067039|75600500|FG001|6 Month Survey|Overall Study||756||
59507294|NCT02067039|75600499|FG000|9 Month Survey|Overall Study||748||
59507295|NCT02067039|75600500|FG001|9 Month Survey|Overall Study||838||
59507296|NCT02067039|75600499|FG000|COMPLETED|Overall Study||752|12 month survey|
59507297|NCT02067039|75600500|FG001|COMPLETED|Overall Study||832|12 month survey|
59507298|NCT02067039|75600499|FG000|NOT COMPLETED|Overall Study||573||
59507299|NCT02067039|75600500|FG001|NOT COMPLETED|Overall Study||508||
60022288|NCT02463409|76138330|FG000|STARTED|Overall Study||6||
60022289|NCT02463409|76138330|FG000|COMPLETED|Overall Study||4||
60022290|NCT02463409|76138330|FG000|NOT COMPLETED|Overall Study||2||
59507300|NCT02067273|75600510|FG000|STARTED|Overall Study||5||
59507301|NCT02067273|75600511|FG001|STARTED|Overall Study||15||
60022291|NCT02528357|76138353|FG000|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||1||
60022292|NCT02528357|76138354|FG001|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||1||
60022293|NCT02528357|76138355|FG002|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||8||
60022294|NCT02528357|76138356|FG003|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||10||
60022295|NCT02528357|76138357|FG004|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||10||
60022296|NCT02528357|76138358|FG005|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||4||
60022297|NCT02528357|76138359|FG006|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||7||
60022298|NCT02528357|76138360|FG007|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||4||
60022299|NCT02528357|76138361|FG008|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0||
59507302|NCT02067273|75600510|FG000|COMPLETED|Overall Study||5||
59507303|NCT02067273|75600511|FG001|COMPLETED|Overall Study||12||
60022300|NCT02528357|76138362|FG009|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0||
60022301|NCT02528357|76138363|FG010|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0||
60022302|NCT02528357|76138364|FG011|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0||
59913935|NCT02711956|76034927|FG006|NOT COMPLETED|Overall Study||4||
59913936|NCT02711956|76034928|FG007|NOT COMPLETED|Overall Study||2||
59913937|NCT02711956|76034929|FG008|NOT COMPLETED|Overall Study||4||
59913938|NCT02711956|76034930|FG009|NOT COMPLETED|Overall Study||3||
59913939|NCT02711956|76034931|FG010|NOT COMPLETED|Overall Study||1||
59913940|NCT02711956|76034932|FG011|NOT COMPLETED|Overall Study||9||
60022303|NCT02528357|76138365|FG012|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0||
60022304|NCT02528357|76138366|FG013|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0||
60022305|NCT02528357|76138367|FG014|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0||
60022306|NCT02528357|76138368|FG015|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0||
60022307|NCT02528357|76138369|FG016|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0||
60022308|NCT02528357|76138370|FG017|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0||
60022309|NCT02528357|76138371|FG018|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0||
60022310|NCT02528357|76138353|FG000|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||1||
60022311|NCT02528357|76138354|FG001|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0||
60022312|NCT02528357|76138355|FG002|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||6||
60022313|NCT02528357|76138356|FG003|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||9||
60022314|NCT02528357|76138357|FG004|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||6||
60022315|NCT02528357|76138358|FG005|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||2||
60022316|NCT02528357|76138359|FG006|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||5||
60022317|NCT02528357|76138360|FG007|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||2||
60022318|NCT02528357|76138361|FG008|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0||
60022319|NCT02528357|76138362|FG009|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0||
60022320|NCT02528357|76138363|FG010|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0||
60022321|NCT02528357|76138364|FG011|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0||
60022322|NCT02528357|76138365|FG012|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0||
60022323|NCT02528357|76138366|FG013|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0||
60022324|NCT02528357|76138367|FG014|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0||
60022325|NCT02528357|76138368|FG015|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0||
60022326|NCT02528357|76138369|FG016|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0||
60022327|NCT02528357|76138370|FG017|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0||
60022328|NCT02528357|76138371|FG018|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0||
60022329|NCT02528357|76138353|FG000|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0||
59913941|NCT02711956|76034933|FG012|NOT COMPLETED|Overall Study||16||
59913942|NCT02711956|76034934|FG013|NOT COMPLETED|Overall Study||5||
59913943|NCT02711956|76034935|FG014|NOT COMPLETED|Overall Study||8||
59913944|NCT04149353|76034976|FG000|STARTED|Overall Study|The study was terminated for low recruitment before this subject's second imaging scan was due.|1||
59913945|NCT04149353|76034976|FG000|COMPLETED|Overall Study||0||
59913946|NCT04149353|76034976|FG000|NOT COMPLETED|Overall Study||1||
59913947|NCT02711800|76034981|FG000|STARTED|Overall Study||9||
59913948|NCT02711800|76034981|FG000|COMPLETED|Overall Study||7||
59913949|NCT02711800|76034981|FG000|NOT COMPLETED|Overall Study||2||
59913950|NCT03031496|76034985|FG000|STARTED|Period 1||21||
59913951|NCT03031496|76034986|FG001|STARTED|Period 1||21||
59913952|NCT03031496|76034985|FG000|COMPLETED|Period 1||19||
59913953|NCT03031496|76034986|FG001|COMPLETED|Period 1||19||
59913954|NCT03031496|76034985|FG000|NOT COMPLETED|Period 1||2||
59913955|NCT03031496|76034986|FG001|NOT COMPLETED|Period 1||2||
59913956|NCT03031496|76034985|FG000|STARTED|Period 2||19||
59913957|NCT03031496|76034986|FG001|STARTED|Period 2||19||
59913958|NCT03031496|76034985|FG000|COMPLETED|Period 2||19||
59913959|NCT03031496|76034986|FG001|COMPLETED|Period 2||19||
59913960|NCT03031496|76034985|FG000|NOT COMPLETED|Period 2||0||
59913961|NCT03031496|76034986|FG001|NOT COMPLETED|Period 2||0||
60022330|NCT02528357|76138354|FG001|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||1||
60022331|NCT02528357|76138355|FG002|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||2||
60022332|NCT02528357|76138356|FG003|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||1||
60022333|NCT02528357|76138357|FG004|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||4||
60022334|NCT02528357|76138358|FG005|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||2||
59913962|NCT02659020|76034999|FG000|STARTED|Overall Study||21||
59913963|NCT02659020|76035000|FG001|STARTED|Overall Study||18||
59913964|NCT02659020|76035001|FG002|STARTED|Overall Study||15||
59913965|NCT02659020|76035002|FG003|STARTED|Overall Study||81||
59913966|NCT02659020|76035003|FG004|STARTED|Overall Study||46||
59913967|NCT02659020|76035004|FG005|STARTED|Overall Study||86||
59913968|NCT02659020|76035005|FG006|STARTED|Overall Study||43||
60022335|NCT02528357|76138359|FG006|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||2||
60022336|NCT02528357|76138360|FG007|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||2||
60022337|NCT02528357|76138361|FG008|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0||
60022338|NCT02528357|76138362|FG009|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0||
60022339|NCT02528357|76138363|FG010|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0||
60022340|NCT02528357|76138364|FG011|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0||
60022341|NCT02528357|76138365|FG012|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0||
60022342|NCT02528357|76138366|FG013|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0||
60022343|NCT02528357|76138367|FG014|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0||
60022344|NCT02528357|76138368|FG015|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0||
60022345|NCT02528357|76138369|FG016|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0||
60022346|NCT02528357|76138370|FG017|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0||
60022347|NCT02528357|76138371|FG018|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0||
60022348|NCT02528357|76138353|FG000|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0||
60022349|NCT02528357|76138354|FG001|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0||
60022350|NCT02528357|76138355|FG002|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0||
60022351|NCT02528357|76138356|FG003|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0||
60022352|NCT02528357|76138357|FG004|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0||
60022353|NCT02528357|76138358|FG005|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0||
60022354|NCT02528357|76138359|FG006|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0||
60022355|NCT02528357|76138360|FG007|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0||
60022356|NCT02528357|76138361|FG008|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||5||
60022357|NCT02528357|76138362|FG009|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||5||
60022358|NCT02528357|76138363|FG010|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||10||
60022359|NCT02528357|76138364|FG011|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||12||
60022360|NCT02528357|76138365|FG012|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||14||
60022361|NCT02528357|76138366|FG013|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||12||
60022362|NCT02528357|76138367|FG014|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||12||
60022363|NCT02528357|76138368|FG015|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||4||
60022364|NCT02528357|76138369|FG016|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0||
60022365|NCT02528357|76138370|FG017|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0||
60022366|NCT02528357|76138371|FG018|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0||
60022367|NCT02528357|76138353|FG000|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0||
60022368|NCT02528357|76138354|FG001|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0||
60022369|NCT02528357|76138355|FG002|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0||
60022370|NCT02528357|76138356|FG003|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0||
60022371|NCT02528357|76138357|FG004|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0||
59913969|NCT02659020|76034999|FG000|Received at Least 1 Dose of Study Drug|Overall Study||21||
59913970|NCT02659020|76035000|FG001|Received at Least 1 Dose of Study Drug|Overall Study||18||
59913971|NCT02659020|76035001|FG002|Received at Least 1 Dose of Study Drug|Overall Study||15||
59913972|NCT02659020|76035002|FG003|Received at Least 1 Dose of Study Drug|Overall Study||81||
59913973|NCT02659020|76035003|FG004|Received at Least 1 Dose of Study Drug|Overall Study||45||
59913974|NCT02659020|76035004|FG005|Received at Least 1 Dose of Study Drug|Overall Study||86||
59913975|NCT02659020|76035005|FG006|Received at Least 1 Dose of Study Drug|Overall Study||43||
59913976|NCT02659020|76034999|FG000|COMPLETED|Overall Study||18||
59913977|NCT02659020|76035000|FG001|COMPLETED|Overall Study||15||
59913978|NCT02659020|76035001|FG002|COMPLETED|Overall Study||14||
59913979|NCT02659020|76035002|FG003|COMPLETED|Overall Study||65||
59913980|NCT02659020|76035003|FG004|COMPLETED|Overall Study||40||
59913981|NCT02659020|76035004|FG005|COMPLETED|Overall Study||75||
59913982|NCT02659020|76035005|FG006|COMPLETED|Overall Study||35||
59913983|NCT02659020|76034999|FG000|NOT COMPLETED|Overall Study||3||
59913984|NCT02659020|76035000|FG001|NOT COMPLETED|Overall Study||3||
59913985|NCT02659020|76035001|FG002|NOT COMPLETED|Overall Study||1||
59913986|NCT02659020|76035002|FG003|NOT COMPLETED|Overall Study||16||
59913987|NCT02659020|76035003|FG004|NOT COMPLETED|Overall Study||6||
59913988|NCT02659020|76035004|FG005|NOT COMPLETED|Overall Study||11||
59913989|NCT02659020|76035005|FG006|NOT COMPLETED|Overall Study||8||
59913990|NCT03482011|76035030|FG000|STARTED|Induction Period (16 Weeks)||107||
59913991|NCT03482011|76035031|FG001|STARTED|Induction Period (16 Weeks)||423||
59913992|NCT03482011|76035032|FG002|STARTED|Induction Period (16 Weeks)|Participants were assigned to this arm during maintenance period.|0||
59913993|NCT03482011|76035033|FG003|STARTED|Induction Period (16 Weeks)|Participants were assigned to this arm during maintenance period.|0||
59913994|NCT03482011|76035034|FG004|STARTED|Induction Period (16 Weeks)|Participants were assigned to this arm during maintenance period.|0||
59913995|NCT03482011|76035035|FG005|STARTED|Induction Period (16 Weeks)|Participants were assigned to this arm during maintenance period.|0||
59913996|NCT03482011|76035036|FG006|STARTED|Induction Period (16 Weeks)|Participants were assigned to this arm during maintenance period.|0||
59913997|NCT03482011|76035037|FG007|STARTED|Induction Period (16 Weeks)|Participants were assigned to this arm during maintenance period.|0||
59913998|NCT03482011|76035030|FG000|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||107||
59913999|NCT03482011|76035031|FG001|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||422||
59914000|NCT03482011|76035032|FG002|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0||
59914001|NCT03482011|76035033|FG003|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0||
59914002|NCT03482011|76035034|FG004|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0||
59914003|NCT03482011|76035035|FG005|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0||
59914004|NCT03482011|76035036|FG006|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0||
59914005|NCT03482011|76035037|FG007|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0||
59914006|NCT03482011|76035030|FG000|COMPLETED|Induction Period (16 Weeks)||101||
59914007|NCT03482011|76035031|FG001|COMPLETED|Induction Period (16 Weeks)||412||
59914008|NCT03482011|76035032|FG002|COMPLETED|Induction Period (16 Weeks)||0||
59914009|NCT03482011|76035033|FG003|COMPLETED|Induction Period (16 Weeks)||0||
59914010|NCT03482011|76035034|FG004|COMPLETED|Induction Period (16 Weeks)||0||
59914011|NCT03482011|76035035|FG005|COMPLETED|Induction Period (16 Weeks)||0||
59914012|NCT03482011|76035036|FG006|COMPLETED|Induction Period (16 Weeks)||0||
59914013|NCT03482011|76035037|FG007|COMPLETED|Induction Period (16 Weeks)||0||
59914014|NCT03482011|76035030|FG000|NOT COMPLETED|Induction Period (16 Weeks)||6||
59914015|NCT03482011|76035031|FG001|NOT COMPLETED|Induction Period (16 Weeks)||11||
59914016|NCT03482011|76035032|FG002|NOT COMPLETED|Induction Period (16 Weeks)||0||
59914017|NCT03482011|76035033|FG003|NOT COMPLETED|Induction Period (16 Weeks)||0||
59914018|NCT03482011|76035034|FG004|NOT COMPLETED|Induction Period (16 Weeks)||0||
59914019|NCT03482011|76035035|FG005|NOT COMPLETED|Induction Period (16 Weeks)||0||
59914020|NCT03482011|76035036|FG006|NOT COMPLETED|Induction Period (16 Weeks)||0||
59914021|NCT03482011|76035037|FG007|NOT COMPLETED|Induction Period (16 Weeks)||0||
59914022|NCT03482011|76035030|FG000|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during induction period.|0||
59914023|NCT03482011|76035031|FG001|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during induction period.|0||
59914024|NCT03482011|76035032|FG002|STARTED|Maintenance Period (36 Weeks)||7||
59914025|NCT03482011|76035033|FG003|STARTED|Maintenance Period (36 Weeks)||94||
59914026|NCT03482011|76035034|FG004|STARTED|Maintenance Period (36 Weeks)||91||
59914027|NCT03482011|76035035|FG005|STARTED|Maintenance Period (36 Weeks)||90||
59914028|NCT03482011|76035036|FG006|STARTED|Maintenance Period (36 Weeks)||91||
59914029|NCT03482011|76035037|FG007|STARTED|Maintenance Period (36 Weeks)||140||
59914030|NCT03482011|76035030|FG000|Relapse|Maintenance Period (36 Weeks)||0||
59914031|NCT03482011|76035031|FG001|Relapse|Maintenance Period (36 Weeks)||0||
59914032|NCT03482011|76035032|FG002|Relapse|Maintenance Period (36 Weeks)||1||
59914033|NCT03482011|76035033|FG003|Relapse|Maintenance Period (36 Weeks)||0||
59914034|NCT03482011|76035034|FG004|Relapse|Maintenance Period (36 Weeks)||41||
59914035|NCT03482011|76035035|FG005|Relapse|Maintenance Period (36 Weeks)||3||
59914036|NCT03482011|76035036|FG006|Relapse|Maintenance Period (36 Weeks)||2||
59914037|NCT03482011|76035037|FG007|Relapse|Maintenance Period (36 Weeks)||0||
59914038|NCT03482011|76035030|FG000|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||0||
59914039|NCT03482011|76035031|FG001|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||0||
59914040|NCT03482011|76035032|FG002|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||6||
59914041|NCT03482011|76035033|FG003|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||88||
59914042|NCT03482011|76035034|FG004|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||86||
59914043|NCT03482011|76035035|FG005|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||85||
59914044|NCT03482011|76035036|FG006|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||87||
59914045|NCT03482011|76035037|FG007|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||121||
59914046|NCT03482011|76035030|FG000|COMPLETED|Maintenance Period (36 Weeks)||0||
59914047|NCT03482011|76035031|FG001|COMPLETED|Maintenance Period (36 Weeks)||0||
59914048|NCT03482011|76035032|FG002|COMPLETED|Maintenance Period (36 Weeks)||6||
59914049|NCT03482011|76035033|FG003|COMPLETED|Maintenance Period (36 Weeks)||90||
59914050|NCT03482011|76035034|FG004|COMPLETED|Maintenance Period (36 Weeks)||86||
59914051|NCT03482011|76035035|FG005|COMPLETED|Maintenance Period (36 Weeks)||86||
60022372|NCT02528357|76138358|FG005|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0||
60022373|NCT02528357|76138359|FG006|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0||
60022374|NCT02528357|76138360|FG007|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0||
60022375|NCT02528357|76138361|FG008|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||4||
60022376|NCT02528357|76138362|FG009|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||4||
60022377|NCT02528357|76138363|FG010|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||7||
60022378|NCT02528357|76138364|FG011|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||9||
60022379|NCT02528357|76138365|FG012|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||9||
60022380|NCT02528357|76138366|FG013|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||6||
60022381|NCT02528357|76138367|FG014|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||5||
60022382|NCT02528357|76138368|FG015|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||4||
60022383|NCT02528357|76138369|FG016|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0||
60022384|NCT02528357|76138370|FG017|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0||
60022385|NCT02528357|76138371|FG018|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0||
60022386|NCT02528357|76138353|FG000|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0||
60022387|NCT02528357|76138354|FG001|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0||
60022388|NCT02528357|76138355|FG002|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0||
60022389|NCT02528357|76138356|FG003|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0||
60022390|NCT02528357|76138357|FG004|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0||
60022391|NCT02528357|76138358|FG005|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0||
60022392|NCT02528357|76138359|FG006|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0||
60022393|NCT02528357|76138360|FG007|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0||
60022394|NCT02528357|76138361|FG008|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||1||
60022395|NCT02528357|76138362|FG009|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||1||
60022396|NCT02528357|76138363|FG010|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||3||
60022397|NCT02528357|76138364|FG011|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||3||
60022398|NCT02528357|76138365|FG012|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||5||
60022399|NCT02528357|76138366|FG013|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||6||
60022400|NCT02528357|76138367|FG014|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||7||
60022401|NCT02528357|76138368|FG015|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0||
60022402|NCT02528357|76138369|FG016|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0||
60022403|NCT02528357|76138370|FG017|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0||
60022404|NCT02528357|76138371|FG018|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0||
60022405|NCT02528357|76138353|FG000|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0||
60022406|NCT02528357|76138354|FG001|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0||
60022407|NCT02528357|76138355|FG002|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0||
60022408|NCT02528357|76138356|FG003|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0||
60022409|NCT02528357|76138357|FG004|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0||
60022410|NCT02528357|76138358|FG005|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0||
60022411|NCT02528357|76138359|FG006|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0||
60022412|NCT02528357|76138360|FG007|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0||
60022413|NCT02528357|76138361|FG008|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0||
60022414|NCT02528357|76138362|FG009|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0||
60022415|NCT02528357|76138363|FG010|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0||
60022416|NCT02528357|76138364|FG011|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0||
60022417|NCT02528357|76138365|FG012|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0||
60022418|NCT02528357|76138366|FG013|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0||
60022419|NCT02528357|76138367|FG014|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0||
60022420|NCT02528357|76138368|FG015|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0||
60022421|NCT02528357|76138369|FG016|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||9||
60022422|NCT02528357|76138370|FG017|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||8||
60022423|NCT02528357|76138371|FG018|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||5||
60022424|NCT02528357|76138353|FG000|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0||
60022425|NCT02528357|76138354|FG001|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0||
60022426|NCT02528357|76138355|FG002|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0||
60022427|NCT02528357|76138356|FG003|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0||
60022428|NCT02528357|76138357|FG004|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0||
60022429|NCT02528357|76138358|FG005|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0||
60022430|NCT02528357|76138359|FG006|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0||
60022431|NCT02528357|76138360|FG007|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0||
60022432|NCT02528357|76138361|FG008|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0||
60022433|NCT02528357|76138362|FG009|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0||
60022434|NCT02528357|76138363|FG010|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0||
60022435|NCT02528357|76138364|FG011|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0||
60022436|NCT02528357|76138365|FG012|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0||
60022437|NCT02528357|76138366|FG013|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0||
60022438|NCT02528357|76138367|FG014|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0||
60022439|NCT02528357|76138368|FG015|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0||
60022440|NCT02528357|76138369|FG016|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||6||
60022441|NCT02528357|76138370|FG017|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||4||
60022442|NCT02528357|76138371|FG018|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||2||
60022443|NCT02528357|76138353|FG000|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0||
60022444|NCT02528357|76138354|FG001|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0||
60022445|NCT02528357|76138355|FG002|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0||
60022446|NCT02528357|76138356|FG003|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0||
60022447|NCT02528357|76138357|FG004|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0||
60022448|NCT02528357|76138358|FG005|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0||
60022449|NCT02528357|76138359|FG006|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0||
60022450|NCT02528357|76138360|FG007|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0||
60022451|NCT02528357|76138361|FG008|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0||
60022452|NCT02528357|76138362|FG009|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0||
60022453|NCT02528357|76138363|FG010|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0||
60022454|NCT02528357|76138364|FG011|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0||
60022455|NCT02528357|76138365|FG012|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0||
60022456|NCT02528357|76138366|FG013|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0||
60022457|NCT02528357|76138367|FG014|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0||
60022458|NCT02528357|76138368|FG015|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0||
60022459|NCT02528357|76138369|FG016|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||3||
60022460|NCT02528357|76138370|FG017|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||4||
60022461|NCT02528357|76138371|FG018|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||3||
60022462|NCT02463331|76138413|FG000|STARTED|Overall Study||26||
60022463|NCT02463331|76138414|FG001|STARTED|Overall Study||31||
60022464|NCT02463331|76138413|FG000|COMPLETED|Overall Study||10||
60022465|NCT02463331|76138414|FG001|COMPLETED|Overall Study||25||
60022466|NCT02463331|76138413|FG000|NOT COMPLETED|Overall Study||16||
60022467|NCT02463331|76138414|FG001|NOT COMPLETED|Overall Study||6||
60022468|NCT02410837|76138420|FG000|STARTED|Overall Study||1388||
60022469|NCT02410837|76138420|FG000|Procedure|Overall Study||1388||
60022470|NCT02410837|76138420|FG000|1-Month|Overall Study||1374||
60022471|NCT02410837|76138420|FG000|12-Month|Overall Study||1121||
60022472|NCT02410837|76138420|FG000|24-Month|Overall Study||900||
60022473|NCT02410837|76138420|FG000|COMPLETED|Overall Study||900||
60022474|NCT02410837|76138420|FG000|NOT COMPLETED|Overall Study||488||
60022475|NCT02314247|76138426|FG000|STARTED|Overall Study||9||
60022476|NCT02314247|76138427|FG001|STARTED|Overall Study||6||
60022477|NCT02314247|76138428|FG002|STARTED|Overall Study||1||
60022478|NCT02314247|76138426|FG000|COMPLETED|Overall Study||0||
60022479|NCT02314247|76138427|FG001|COMPLETED|Overall Study||0||
60022480|NCT02314247|76138428|FG002|COMPLETED|Overall Study||0||
60022481|NCT02314247|76138426|FG000|NOT COMPLETED|Overall Study||9||
60022482|NCT02314247|76138427|FG001|NOT COMPLETED|Overall Study||6||
60022483|NCT02314247|76138428|FG002|NOT COMPLETED|Overall Study||1||
60022484|NCT02463097|76138438|FG000|STARTED|Overall Study||124||
60022485|NCT02463097|76138438|FG000|COMPLETED|Overall Study||123||
60022486|NCT02463097|76138438|FG000|NOT COMPLETED|Overall Study||1||
60022487|NCT02441179|76138444|FG000|STARTED|Overall Study||18||
60022488|NCT02441179|76138445|FG001|STARTED|Overall Study||17||
60022489|NCT02441179|76138444|FG000|COMPLETED|Overall Study||17||
60022490|NCT02441179|76138445|FG001|COMPLETED|Overall Study||16||
60022491|NCT02441179|76138444|FG000|NOT COMPLETED|Overall Study||1||
60022492|NCT02441179|76138445|FG001|NOT COMPLETED|Overall Study||1||
60022493|NCT02462473|76138452|FG000|STARTED|Overall Study||9||
60022494|NCT02462473|76138452|FG000|COMPLETED|Overall Study||5||
60022495|NCT02462473|76138452|FG000|NOT COMPLETED|Overall Study||4||
60022496|NCT01462097|76138458|FG000|STARTED|Overall Study||49||
60022497|NCT01462097|76138459|FG001|STARTED|Overall Study||50||
60022498|NCT01462097|76138458|FG000|6 Month|Overall Study||35||
60022499|NCT01462097|76138459|FG001|6 Month|Overall Study||37||
60022500|NCT01462097|76138458|FG000|COMPLETED|Overall Study||30||
60022501|NCT01462097|76138459|FG001|COMPLETED|Overall Study||38||
60022502|NCT01462097|76138458|FG000|NOT COMPLETED|Overall Study||19||
60022503|NCT01462097|76138459|FG001|NOT COMPLETED|Overall Study||12||
60022504|NCT02440789|76138465|FG000|STARTED|Overall Study||32||
60022505|NCT02440789|76138465|FG000|Initiated Sirolimus|Overall Study||30|2 participants withdrew consent prior to initiating Sirolimus|
60022506|NCT02440789|76138465|FG000|Completed 20 Weeks of Sirolimus|Overall Study||16|14 participants completed less than 20 weeks of Sirolimus|
60022507|NCT02440789|76138465|FG000|COMPLETED|Overall Study||28||
60022508|NCT02440789|76138465|FG000|NOT COMPLETED|Overall Study||4||
60022509|NCT02462083|76138469|FG000|STARTED|Overall Study||555||
60022510|NCT02462083|76138469|FG000|Safety Population|Overall Study||550|All participants with >=1 confirmed dose of study drug & >=1 post-Baseline safety assessment.|
60022511|NCT02462083|76138469|FG000|COMPLETED|Overall Study||136||
60022512|NCT02462083|76138469|FG000|NOT COMPLETED|Overall Study||419||
60022513|NCT02538341|76138475|FG000|STARTED|Overall Study||310||
60022514|NCT02538341|76138476|FG001|STARTED|Overall Study||307||
59611602|NCT01775904|75722585|FG000|Received at Least One Dose of Drug|LY2886721 Capsule (Water, Fasting)||26||
59611603|NCT01775904|75722585|FG000|COMPLETED|LY2886721 Capsule (Water, Fasting)||25||
59611604|NCT01775904|75722585|FG000|NOT COMPLETED|LY2886721 Capsule (Water, Fasting)||1||
59611605|NCT01775904|75722585|FG000|STARTED|Second Washout (7 Days)||25||
59611606|NCT01775904|75722585|FG000|COMPLETED|Second Washout (7 Days)||25||
60022515|NCT02538341|76138475|FG000|Week 6 (Primary Outcome)|Overall Study||303||
60022516|NCT02538341|76138476|FG001|Week 6 (Primary Outcome)|Overall Study||299||
60022517|NCT02538341|76138475|FG000|Month 6 (Safety Outcome)|Overall Study||276|All participants were followed in a blinded manner until Month 6 when clinical sites and participants were unblinded. Participants randomized to placebo completed the study at Month 6.|
60022518|NCT02538341|76138476|FG001|Month 6 (Safety Outcome)|Overall Study||260|All participants were followed in a blinded manner until Month 6 when clinical sites and participants were unblinded. Participants randomized to placebo completed the study at Month 6.|
60022519|NCT02538341|76138475|FG000|1 Year Visit|Overall Study||254|As an exploratory outcome to assess the immunologic persistence of live herpes zoster vaccine among participants randomized to the vaccine, only those participants were invited to provide a Year 1 blood sample for the same lab assessments.|
60022520|NCT02538341|76138476|FG001|1 Year Visit|Overall Study||0|As an exploratory outcome to assess the immunologic persistence of live herpes zoster vaccine among participants randomized to the vaccine, only those participants were invited to provide a Year 1 blood sample for the same lab assessments.|
60022521|NCT02538341|76138475|FG000|COMPLETED|Overall Study||254||
60022522|NCT02538341|76138476|FG001|COMPLETED|Overall Study||260||
60022523|NCT02538341|76138475|FG000|NOT COMPLETED|Overall Study||56||
60022524|NCT02538341|76138476|FG001|NOT COMPLETED|Overall Study||47||
60022525|NCT02538107|76138482|FG000|STARTED|Overall Study||290||
60022526|NCT02538107|76138482|FG000|COMPLETED|Overall Study||180||
60022527|NCT02538107|76138482|FG000|NOT COMPLETED|Overall Study||110||
60022528|NCT02538029|76138499|FG000|STARTED|Overall Study||24||
60022529|NCT02538029|76138500|FG001|STARTED|Overall Study||10||
60022530|NCT02538029|76138501|FG002|STARTED|Overall Study||11||
60022531|NCT02538029|76138499|FG000|COMPLETED|Overall Study||23||
60022532|NCT02538029|76138500|FG001|COMPLETED|Overall Study||10||
60022533|NCT02538029|76138501|FG002|COMPLETED|Overall Study||10||
60022534|NCT02538029|76138499|FG000|NOT COMPLETED|Overall Study||1||
60022535|NCT02538029|76138500|FG001|NOT COMPLETED|Overall Study||0||
60022536|NCT02538029|76138501|FG002|NOT COMPLETED|Overall Study||1||
60022537|NCT02272413|76138513|FG000|STARTED|Randomized Through Treatment Start|Started for this period|338|Started are randomized|
60022538|NCT02272413|76138514|FG001|STARTED|Randomized Through Treatment Start|Started for this period|333|Started are randomized|
60022539|NCT02272413|76138513|FG000|Treated|Randomized Through Treatment Start||335||
60022540|NCT02272413|76138514|FG001|Treated|Randomized Through Treatment Start||328||
60022541|NCT02272413|76138513|FG000|COMPLETED|Randomized Through Treatment Start||335|Completed are treated|
60022542|NCT02272413|76138514|FG001|COMPLETED|Randomized Through Treatment Start||328|Completed are treated|
60022543|NCT02272413|76138513|FG000|NOT COMPLETED|Randomized Through Treatment Start||3||
60022544|NCT02272413|76138514|FG001|NOT COMPLETED|Randomized Through Treatment Start||5||
60022545|NCT02272413|76138513|FG000|STARTED|Pre-switch Period|Started for this period|335|Started are treated|
60022546|NCT02272413|76138514|FG001|STARTED|Pre-switch Period|Started for this period|328|Started are treated|
60022547|NCT02272413|76138513|FG000|COMPLETED|Pre-switch Period||42||
60022548|NCT02272413|76138514|FG001|COMPLETED|Pre-switch Period||46||
60022549|NCT02272413|76138513|FG000|NOT COMPLETED|Pre-switch Period||293||
60022550|NCT02272413|76138514|FG001|NOT COMPLETED|Pre-switch Period||282||
60022551|NCT02272413|76138513|FG000|STARTED|Post-switch Period|Started for this period|42||
60022552|NCT02272413|76138514|FG001|STARTED|Post-switch Period|Started for this period|46||
60022553|NCT02272413|76138513|FG000|COMPLETED|Post-switch Period||0||
60022554|NCT02272413|76138514|FG001|COMPLETED|Post-switch Period||0||
60022555|NCT02272413|76138513|FG000|NOT COMPLETED|Post-switch Period||42||
60022556|NCT02272413|76138514|FG001|NOT COMPLETED|Post-switch Period||46||
60022557|NCT02396381|76138526|FG000|STARTED|Overall Study||488|Randomized|
60022558|NCT02396381|76138527|FG001|STARTED|Overall Study||496|Randomized|
60022559|NCT02396381|76138526|FG000|Full Analysis Set - As Exposed (FAS-EX)|Overall Study||414|Subjects with at least one record of reported use post-randomization.|
60022560|NCT02396381|76138527|FG001|Full Analysis Set - As Exposed (FAS-EX)|Overall Study||443|Subjects with at least one record of reported use post-randomization.|
60022561|NCT02396381|76138526|FG000|COMPLETED|Overall Study||381||
60022562|NCT02396381|76138527|FG001|COMPLETED|Overall Study||422||
60022563|NCT02396381|76138526|FG000|NOT COMPLETED|Overall Study||107||
60022564|NCT02396381|76138527|FG001|NOT COMPLETED|Overall Study||74||
60022565|NCT02532647|76138539|FG000|STARTED|Overall Study||32||
59611607|NCT01775904|75722585|FG000|NOT COMPLETED|Second Washout (7 Days)||0||
59914052|NCT03482011|76035036|FG006|COMPLETED|Maintenance Period (36 Weeks)||87||
59914053|NCT03482011|76035037|FG007|COMPLETED|Maintenance Period (36 Weeks)||123||
59914054|NCT03482011|76035030|FG000|NOT COMPLETED|Maintenance Period (36 Weeks)||0||
59914055|NCT03482011|76035031|FG001|NOT COMPLETED|Maintenance Period (36 Weeks)||0||
59914056|NCT03482011|76035032|FG002|NOT COMPLETED|Maintenance Period (36 Weeks)||1||
59914057|NCT03482011|76035033|FG003|NOT COMPLETED|Maintenance Period (36 Weeks)||4||
59914058|NCT03482011|76035034|FG004|NOT COMPLETED|Maintenance Period (36 Weeks)||5||
59914059|NCT03482011|76035035|FG005|NOT COMPLETED|Maintenance Period (36 Weeks)||4||
59914060|NCT03482011|76035036|FG006|NOT COMPLETED|Maintenance Period (36 Weeks)||4||
59507304|NCT02067273|75600510|FG000|NOT COMPLETED|Overall Study||0||
59507305|NCT02067273|75600511|FG001|NOT COMPLETED|Overall Study||3||
59507306|NCT02151253|75600517|FG000|STARTED|Overall Study||13||
59507307|NCT02151253|75600518|FG001|STARTED|Overall Study||15||
59914061|NCT03482011|76035037|FG007|NOT COMPLETED|Maintenance Period (36 Weeks)||17||
59914062|NCT03482011|76035030|FG000|STARTED|Follow-up Period (12 Weeks)|Participants were assigned to this arm during induction period.|0||
59914063|NCT03482011|76035031|FG001|STARTED|Follow-up Period (12 Weeks)|Participants were assigned to this arm during induction period.|0||
59914064|NCT03482011|76035032|FG002|STARTED|Follow-up Period (12 Weeks)||1||
59914065|NCT03482011|76035033|FG003|STARTED|Follow-up Period (12 Weeks)||10||
59914066|NCT03482011|76035034|FG004|STARTED|Follow-up Period (12 Weeks)||2||
59914067|NCT03482011|76035035|FG005|STARTED|Follow-up Period (12 Weeks)||4||
59914068|NCT03482011|76035036|FG006|STARTED|Follow-up Period (12 Weeks)||4||
59914069|NCT03482011|76035037|FG007|STARTED|Follow-up Period (12 Weeks)||21||
59914070|NCT03482011|76035030|FG000|COMPLETED|Follow-up Period (12 Weeks)||0||
59914071|NCT03482011|76035031|FG001|COMPLETED|Follow-up Period (12 Weeks)||0||
59914072|NCT03482011|76035032|FG002|COMPLETED|Follow-up Period (12 Weeks)||0||
59914073|NCT03482011|76035033|FG003|COMPLETED|Follow-up Period (12 Weeks)||5||
59914074|NCT03482011|76035034|FG004|COMPLETED|Follow-up Period (12 Weeks)||2||
59914075|NCT03482011|76035035|FG005|COMPLETED|Follow-up Period (12 Weeks)||3||
59914076|NCT03482011|76035036|FG006|COMPLETED|Follow-up Period (12 Weeks)||2||
59914077|NCT03482011|76035037|FG007|COMPLETED|Follow-up Period (12 Weeks)||4||
59914078|NCT03482011|76035030|FG000|NOT COMPLETED|Follow-up Period (12 Weeks)||0||
59914079|NCT03482011|76035031|FG001|NOT COMPLETED|Follow-up Period (12 Weeks)||0||
59914080|NCT03482011|76035032|FG002|NOT COMPLETED|Follow-up Period (12 Weeks)||1||
59914081|NCT03482011|76035033|FG003|NOT COMPLETED|Follow-up Period (12 Weeks)||5||
59914082|NCT03482011|76035034|FG004|NOT COMPLETED|Follow-up Period (12 Weeks)||0||
59914083|NCT03482011|76035035|FG005|NOT COMPLETED|Follow-up Period (12 Weeks)||1||
59914084|NCT03482011|76035036|FG006|NOT COMPLETED|Follow-up Period (12 Weeks)||2||
59914085|NCT03482011|76035037|FG007|NOT COMPLETED|Follow-up Period (12 Weeks)||17||
59914086|NCT03481309|76035068|FG000|STARTED|First Intervention (1 Day)||4||
59914087|NCT03481309|76035069|FG001|STARTED|First Intervention (1 Day)||3||
59914088|NCT03481309|76035070|FG002|STARTED|First Intervention (1 Day)||3||
59914089|NCT03481309|76035071|FG003|STARTED|First Intervention (1 Day)||3||
59914090|NCT03481309|76035072|FG004|STARTED|First Intervention (1 Day)||3||
59914091|NCT03481309|76035073|FG005|STARTED|First Intervention (1 Day)||3||
59914092|NCT03481309|76035068|FG000|COMPLETED|First Intervention (1 Day)||4||
59914093|NCT03481309|76035069|FG001|COMPLETED|First Intervention (1 Day)||3||
59914094|NCT03481309|76035070|FG002|COMPLETED|First Intervention (1 Day)||3||
59914095|NCT03481309|76035071|FG003|COMPLETED|First Intervention (1 Day)||3||
59914096|NCT03481309|76035072|FG004|COMPLETED|First Intervention (1 Day)||3||
59914097|NCT03481309|76035073|FG005|COMPLETED|First Intervention (1 Day)||3||
59914098|NCT03481309|76035068|FG000|NOT COMPLETED|First Intervention (1 Day)||0||
59914099|NCT03481309|76035069|FG001|NOT COMPLETED|First Intervention (1 Day)||0||
60022566|NCT02532647|76138540|FG001|STARTED|Overall Study||16||
60022567|NCT02532647|76138541|FG002|STARTED|Overall Study||31||
59507308|NCT02151253|75600517|FG000|COMPLETED|Overall Study||13||
59507309|NCT02151253|75600518|FG001|COMPLETED|Overall Study||15||
59507310|NCT02151253|75600517|FG000|NOT COMPLETED|Overall Study||0||
59507311|NCT02151253|75600518|FG001|NOT COMPLETED|Overall Study||0||
59914100|NCT03481309|76035070|FG002|NOT COMPLETED|First Intervention (1 Day)||0||
59914101|NCT03481309|76035071|FG003|NOT COMPLETED|First Intervention (1 Day)||0||
59914102|NCT03481309|76035072|FG004|NOT COMPLETED|First Intervention (1 Day)||0||
59914103|NCT03481309|76035073|FG005|NOT COMPLETED|First Intervention (1 Day)||0||
59914104|NCT03481309|76035068|FG000|STARTED|Washout (at Least 3 Days)||4||
59914105|NCT03481309|76035069|FG001|STARTED|Washout (at Least 3 Days)||3||
59914106|NCT03481309|76035070|FG002|STARTED|Washout (at Least 3 Days)||3||
59914107|NCT03481309|76035071|FG003|STARTED|Washout (at Least 3 Days)||3||
59914108|NCT03481309|76035072|FG004|STARTED|Washout (at Least 3 Days)||3||
59914109|NCT03481309|76035073|FG005|STARTED|Washout (at Least 3 Days)||3||
59914110|NCT03481309|76035068|FG000|COMPLETED|Washout (at Least 3 Days)||3||
59914111|NCT03481309|76035069|FG001|COMPLETED|Washout (at Least 3 Days)||3||
59914112|NCT03481309|76035070|FG002|COMPLETED|Washout (at Least 3 Days)||3||
59914113|NCT03481309|76035071|FG003|COMPLETED|Washout (at Least 3 Days)||3||
59914114|NCT03481309|76035072|FG004|COMPLETED|Washout (at Least 3 Days)||3||
59914115|NCT03481309|76035073|FG005|COMPLETED|Washout (at Least 3 Days)||3||
59914116|NCT03481309|76035068|FG000|NOT COMPLETED|Washout (at Least 3 Days)||1||
59914117|NCT03481309|76035069|FG001|NOT COMPLETED|Washout (at Least 3 Days)||0||
59914118|NCT03481309|76035070|FG002|NOT COMPLETED|Washout (at Least 3 Days)||0||
59914119|NCT03481309|76035071|FG003|NOT COMPLETED|Washout (at Least 3 Days)||0||
59914120|NCT03481309|76035072|FG004|NOT COMPLETED|Washout (at Least 3 Days)||0||
59914121|NCT03481309|76035073|FG005|NOT COMPLETED|Washout (at Least 3 Days)||0||
59914122|NCT03481309|76035068|FG000|STARTED|Second Intervention (1 Day)||3||
59914123|NCT03481309|76035069|FG001|STARTED|Second Intervention (1 Day)||3||
59914124|NCT03481309|76035070|FG002|STARTED|Second Intervention (1 Day)||3||
59914125|NCT03481309|76035071|FG003|STARTED|Second Intervention (1 Day)||3||
59914126|NCT03481309|76035072|FG004|STARTED|Second Intervention (1 Day)||3||
59914127|NCT03481309|76035073|FG005|STARTED|Second Intervention (1 Day)||3||
59914128|NCT03481309|76035068|FG000|COMPLETED|Second Intervention (1 Day)||3||
59914129|NCT03481309|76035069|FG001|COMPLETED|Second Intervention (1 Day)||3||
59914130|NCT03481309|76035070|FG002|COMPLETED|Second Intervention (1 Day)||3||
59914131|NCT03481309|76035071|FG003|COMPLETED|Second Intervention (1 Day)||3||
59914132|NCT03481309|76035072|FG004|COMPLETED|Second Intervention (1 Day)||3||
59914133|NCT03481309|76035073|FG005|COMPLETED|Second Intervention (1 Day)||3||
59914134|NCT03481309|76035068|FG000|NOT COMPLETED|Second Intervention (1 Day)||0||
59914135|NCT03481309|76035069|FG001|NOT COMPLETED|Second Intervention (1 Day)||0||
59914136|NCT03481309|76035070|FG002|NOT COMPLETED|Second Intervention (1 Day)||0||
59914137|NCT03481309|76035071|FG003|NOT COMPLETED|Second Intervention (1 Day)||0||
59914138|NCT03481309|76035072|FG004|NOT COMPLETED|Second Intervention (1 Day)||0||
59914139|NCT03481309|76035073|FG005|NOT COMPLETED|Second Intervention (1 Day)||0||
59914140|NCT03481309|76035068|FG000|STARTED|Washout (at Least 3 Days)||3||
59914141|NCT03481309|76035069|FG001|STARTED|Washout (at Least 3 Days)||3||
59914142|NCT03481309|76035070|FG002|STARTED|Washout (at Least 3 Days)||3||
59914143|NCT03481309|76035071|FG003|STARTED|Washout (at Least 3 Days)||3||
59914144|NCT03481309|76035072|FG004|STARTED|Washout (at Least 3 Days)||3||
59914145|NCT03481309|76035073|FG005|STARTED|Washout (at Least 3 Days)||3||
59914146|NCT03481309|76035068|FG000|COMPLETED|Washout (at Least 3 Days)||3||
59914147|NCT03481309|76035069|FG001|COMPLETED|Washout (at Least 3 Days)||3||
59914148|NCT03481309|76035070|FG002|COMPLETED|Washout (at Least 3 Days)||3||
59914149|NCT03481309|76035071|FG003|COMPLETED|Washout (at Least 3 Days)||3||
59914150|NCT03481309|76035072|FG004|COMPLETED|Washout (at Least 3 Days)||3||
59914151|NCT03481309|76035073|FG005|COMPLETED|Washout (at Least 3 Days)||3||
59914152|NCT03481309|76035068|FG000|NOT COMPLETED|Washout (at Least 3 Days)||0||
59914153|NCT03481309|76035069|FG001|NOT COMPLETED|Washout (at Least 3 Days)||0||
59914154|NCT03481309|76035070|FG002|NOT COMPLETED|Washout (at Least 3 Days)||0||
59914155|NCT03481309|76035071|FG003|NOT COMPLETED|Washout (at Least 3 Days)||0||
59914156|NCT03481309|76035072|FG004|NOT COMPLETED|Washout (at Least 3 Days)||0||
59914157|NCT03481309|76035073|FG005|NOT COMPLETED|Washout (at Least 3 Days)||0||
59914158|NCT03481309|76035068|FG000|STARTED|Third Intervention (1 Day)||3||
59914159|NCT03481309|76035069|FG001|STARTED|Third Intervention (1 Day)||3||
59914160|NCT03481309|76035070|FG002|STARTED|Third Intervention (1 Day)||3||
59914161|NCT03481309|76035071|FG003|STARTED|Third Intervention (1 Day)||3||
59914162|NCT03481309|76035072|FG004|STARTED|Third Intervention (1 Day)||3||
59914163|NCT03481309|76035073|FG005|STARTED|Third Intervention (1 Day)||3||
59914164|NCT03481309|76035068|FG000|COMPLETED|Third Intervention (1 Day)||3||
59914165|NCT03481309|76035069|FG001|COMPLETED|Third Intervention (1 Day)||3||
59914166|NCT03481309|76035070|FG002|COMPLETED|Third Intervention (1 Day)||3||
59914167|NCT03481309|76035071|FG003|COMPLETED|Third Intervention (1 Day)||3||
60022568|NCT02532647|76138539|FG000|Safety Population|Overall Study||31|Safety Population: all randomised patients who received any amount of trial drug|
60022569|NCT02532647|76138540|FG001|Safety Population|Overall Study||16|Safety Population: all randomised patients who received any amount of trial drug|
60022570|NCT02532647|76138541|FG002|Safety Population|Overall Study||30|Safety Population: all randomised patients who received any amount of trial drug|
60022571|NCT02532647|76138539|FG000|COMPLETED|Overall Study||31||
60022572|NCT02532647|76138540|FG001|COMPLETED|Overall Study||16||
60022573|NCT02532647|76138541|FG002|COMPLETED|Overall Study||30||
60022574|NCT02532647|76138539|FG000|NOT COMPLETED|Overall Study||1||
60022575|NCT02532647|76138540|FG001|NOT COMPLETED|Overall Study||0||
60022576|NCT02532647|76138541|FG002|NOT COMPLETED|Overall Study||1||
60022577|NCT02537015|76138549|FG000|STARTED|Overall Study||81||
60022578|NCT02537015|76138549|FG000|COMPLETED|Overall Study||75||
60022579|NCT02537015|76138549|FG000|NOT COMPLETED|Overall Study||6||
60022580|NCT02271945|76138555|FG000|STARTED|Overall Study||5||
60022581|NCT02271945|76138556|FG001|STARTED|Overall Study||5||
60022582|NCT02271945|76138555|FG000|COMPLETED|Overall Study||0||
60022583|NCT02271945|76138556|FG001|COMPLETED|Overall Study||0||
60022584|NCT02271945|76138555|FG000|NOT COMPLETED|Overall Study||5||
60022585|NCT02271945|76138556|FG001|NOT COMPLETED|Overall Study||5||
60022586|NCT01660763|76138564|FG000|STARTED|Overall Study||315||
60022587|NCT01660763|76138565|FG001|STARTED|Overall Study||104||
60022588|NCT01660763|76138564|FG000|COMPLETED|Overall Study||215||
60022589|NCT01660763|76138565|FG001|COMPLETED|Overall Study||43||
60022590|NCT01660763|76138564|FG000|NOT COMPLETED|Overall Study||100||
60022591|NCT01660763|76138565|FG001|NOT COMPLETED|Overall Study||61||
60022592|NCT01937117|76138571|FG000|STARTED|Overall Study||88||
60022593|NCT01937117|76138571|FG000|COMPLETED|Overall Study||75||
60022594|NCT01937117|76138571|FG000|NOT COMPLETED|Overall Study||13||
60022595|NCT02268045|76138577|FG000|STARTED|Overall Study||136||
60022596|NCT02268045|76138578|FG001|STARTED|Overall Study||136||
60022597|NCT02268045|76138577|FG000|COMPLETED|Overall Study||120||
60022598|NCT02268045|76138578|FG001|COMPLETED|Overall Study||116||
60022599|NCT02268045|76138577|FG000|NOT COMPLETED|Overall Study||16||
60022600|NCT02268045|76138578|FG001|NOT COMPLETED|Overall Study||20||
60022601|NCT02536781|76138588|FG000|STARTED|Overall Study||36||
60022602|NCT02536781|76138589|FG001|STARTED|Overall Study||34||
60022603|NCT02536781|76138588|FG000|COMPLETED|Overall Study||34||
60022604|NCT02536781|76138589|FG001|COMPLETED|Overall Study||34||
60022605|NCT02536781|76138588|FG000|NOT COMPLETED|Overall Study||2||
60022606|NCT02536781|76138589|FG001|NOT COMPLETED|Overall Study||0||
60022607|NCT02267187|76138595|FG000|STARTED|Overall Study||15||
60022608|NCT02267187|76138595|FG000|COMPLETED|Overall Study||10||
59914168|NCT03481309|76035072|FG004|COMPLETED|Third Intervention (1 Day)||3||
59914169|NCT03481309|76035073|FG005|COMPLETED|Third Intervention (1 Day)||3||
59914170|NCT03481309|76035068|FG000|NOT COMPLETED|Third Intervention (1 Day)||0||
59914171|NCT03481309|76035069|FG001|NOT COMPLETED|Third Intervention (1 Day)||0||
59914172|NCT03481309|76035070|FG002|NOT COMPLETED|Third Intervention (1 Day)||0||
59914173|NCT03481309|76035071|FG003|NOT COMPLETED|Third Intervention (1 Day)||0||
59914174|NCT03481309|76035072|FG004|NOT COMPLETED|Third Intervention (1 Day)||0||
59914175|NCT03481309|76035073|FG005|NOT COMPLETED|Third Intervention (1 Day)||0||
59914176|NCT03480841|76035081|FG000|STARTED|Overall Study||10||
59914177|NCT03480841|76035081|FG000|Time 1 Data Collection (T1)|Overall Study||10||
59914178|NCT03480841|76035081|FG000|LENA Baseline|Overall Study||10||
59914179|NCT03480841|76035081|FG000|LENA Time 1|Overall Study||10||
59914180|NCT03480841|76035081|FG000|LENA Time 2|Overall Study||10||
59914181|NCT03480841|76035081|FG000|LENA Time 3|Overall Study||10||
59914182|NCT03480841|76035081|FG000|LENA Time 4|Overall Study||9||
59914183|NCT03480841|76035081|FG000|LENA Time 5|Overall Study||8||
59914184|NCT03480841|76035081|FG000|Time 2 Data Collection (T2)|Overall Study||8||
59914185|NCT03480841|76035081|FG000|COMPLETED|Overall Study||8||
59914186|NCT03480841|76035081|FG000|NOT COMPLETED|Overall Study||2||
59914187|NCT02709538|76035088|FG000|STARTED|Overall Study||400||
59914188|NCT02709538|76035089|FG001|STARTED|Overall Study||100||
59914189|NCT02709538|76035090|FG002|STARTED|Overall Study||101||
59914190|NCT02709538|76035088|FG000|COMPLETED|Overall Study||287||
59914191|NCT02709538|76035089|FG001|COMPLETED|Overall Study||72||
59914192|NCT02709538|76035090|FG002|COMPLETED|Overall Study||81||
59914193|NCT02709538|76035088|FG000|NOT COMPLETED|Overall Study||113||
59914194|NCT02709538|76035089|FG001|NOT COMPLETED|Overall Study||28||
59914195|NCT02709538|76035090|FG002|NOT COMPLETED|Overall Study||20||
59914196|NCT03789318|76035103|FG000|STARTED|Overall Study||9||
59914197|NCT03789318|76035104|FG001|STARTED|Overall Study||9||
59914198|NCT03789318|76035105|FG002|STARTED|Overall Study||12||
59914199|NCT03789318|76035106|FG003|STARTED|Overall Study||12||
59914200|NCT03789318|76035107|FG004|STARTED|Overall Study||12||
59914201|NCT03789318|76035103|FG000|COMPLETED|Overall Study||9||
59914202|NCT03789318|76035104|FG001|COMPLETED|Overall Study||9||
59914203|NCT03789318|76035105|FG002|COMPLETED|Overall Study||9||
59914204|NCT03789318|76035106|FG003|COMPLETED|Overall Study||11||
59914205|NCT03789318|76035107|FG004|COMPLETED|Overall Study||12||
59914206|NCT03789318|76035103|FG000|NOT COMPLETED|Overall Study||0||
59914207|NCT03789318|76035104|FG001|NOT COMPLETED|Overall Study||0||
59914208|NCT03789318|76035105|FG002|NOT COMPLETED|Overall Study||3||
59914209|NCT03789318|76035106|FG003|NOT COMPLETED|Overall Study||1||
59914210|NCT03789318|76035107|FG004|NOT COMPLETED|Overall Study||0||
59914211|NCT03613662|76035119|FG000|STARTED|Overall Study||19||
59914212|NCT03613662|76035119|FG000|COMPLETED|Overall Study||19||
59914213|NCT03613662|76035119|FG000|NOT COMPLETED|Overall Study||0||
59914214|NCT00511134|76035125|FG000|STARTED|Overall Study||1||
59914215|NCT00511134|76035126|FG001|STARTED|Overall Study||3||
59914216|NCT00511134|76035125|FG000|COMPLETED|Overall Study||1||
59914217|NCT00511134|76035126|FG001|COMPLETED|Overall Study||1||
59914218|NCT00511134|76035125|FG000|NOT COMPLETED|Overall Study||0||
59914219|NCT00511134|76035126|FG001|NOT COMPLETED|Overall Study||2||
59914220|NCT01372384|76035132|FG000|STARTED|Overall Study||6||
59914221|NCT01372384|76035132|FG000|COMPLETED|Overall Study||3||
59914222|NCT01372384|76035132|FG000|NOT COMPLETED|Overall Study||3||
59914223|NCT03115476|76035139|FG000|STARTED|Main Trials (LP0084-119x)||407|Total number of subjects that started in Main Trials LP0084-1193, -1194, -1195, -1196 (LP0084-119x)|
59914224|NCT03115476|76035140|FG001|STARTED|Main Trials (LP0084-119x)||418|Total number of subjects that started in Main Trials LP0084-1193, -1194, -1195, -1196 (LP0084-119x)|
59914225|NCT03115476|76035141|FG002|STARTED|Main Trials (LP0084-119x)||409|Total number of subjects that started in Main Trials LP0084-1193, -1194, -1195, -1196 (LP0084-119x)|
59914226|NCT03115476|76035139|FG000|COMPLETED|Main Trials (LP0084-119x)||407||
59914227|NCT03115476|76035140|FG001|COMPLETED|Main Trials (LP0084-119x)||418||
59914228|NCT03115476|76035141|FG002|COMPLETED|Main Trials (LP0084-119x)||409||
60022609|NCT02267187|76138595|FG000|NOT COMPLETED|Overall Study||5||
60022610|NCT02532179|76138599|FG000|STARTED|Overall Study||12||
60022611|NCT02532179|76138599|FG000|COMPLETED|Overall Study||9||
60022612|NCT02532179|76138599|FG000|NOT COMPLETED|Overall Study||3||
60022613|NCT02409667|76138603|FG000|STARTED|Treatment Period 1, Baseline to Week 24||1647||
60022614|NCT02409667|76138604|FG001|STARTED|Treatment Period 1, Baseline to Week 24||0||
60022615|NCT02409667|76138605|FG002|STARTED|Treatment Period 1, Baseline to Week 24||0||
60022616|NCT02409667|76138606|FG003|STARTED|Treatment Period 1, Baseline to Week 24||0||
60022617|NCT02409667|76138607|FG004|STARTED|Treatment Period 1, Baseline to Week 24||0||
60022618|NCT02409667|76138603|FG000|COMPLETED|Treatment Period 1, Baseline to Week 24||1526||
60022619|NCT02409667|76138604|FG001|COMPLETED|Treatment Period 1, Baseline to Week 24||0||
60022620|NCT02409667|76138605|FG002|COMPLETED|Treatment Period 1, Baseline to Week 24||0||
60022621|NCT02409667|76138606|FG003|COMPLETED|Treatment Period 1, Baseline to Week 24||0||
60022622|NCT02409667|76138607|FG004|COMPLETED|Treatment Period 1, Baseline to Week 24||0||
60022623|NCT02409667|76138603|FG000|NOT COMPLETED|Treatment Period 1, Baseline to Week 24||121||
60022624|NCT02409667|76138604|FG001|NOT COMPLETED|Treatment Period 1, Baseline to Week 24||0||
60022625|NCT02409667|76138605|FG002|NOT COMPLETED|Treatment Period 1, Baseline to Week 24||0||
60022626|NCT02409667|76138606|FG003|NOT COMPLETED|Treatment Period 1, Baseline to Week 24||0||
60022627|NCT02409667|76138607|FG004|NOT COMPLETED|Treatment Period 1, Baseline to Week 24||0||
60022628|NCT02409667|76138603|FG000|STARTED|Treatment Period 2, Week 24 to Week 52)||0||
60022629|NCT02409667|76138604|FG001|STARTED|Treatment Period 2, Week 24 to Week 52)||644||
60022630|NCT02409667|76138605|FG002|STARTED|Treatment Period 2, Week 24 to Week 52)||662||
60022631|NCT02409667|76138606|FG003|STARTED|Treatment Period 2, Week 24 to Week 52)||114||
60022632|NCT02409667|76138607|FG004|STARTED|Treatment Period 2, Week 24 to Week 52)||93||
60022633|NCT02409667|76138603|FG000|COMPLETED|Treatment Period 2, Week 24 to Week 52)||0||
60022634|NCT02409667|76138604|FG001|COMPLETED|Treatment Period 2, Week 24 to Week 52)||621||
60022635|NCT02409667|76138605|FG002|COMPLETED|Treatment Period 2, Week 24 to Week 52)||641||
60022636|NCT02409667|76138606|FG003|COMPLETED|Treatment Period 2, Week 24 to Week 52)||106||
60022637|NCT02409667|76138607|FG004|COMPLETED|Treatment Period 2, Week 24 to Week 52)||90||
60022638|NCT02409667|76138603|FG000|NOT COMPLETED|Treatment Period 2, Week 24 to Week 52)||0||
60022639|NCT02409667|76138604|FG001|NOT COMPLETED|Treatment Period 2, Week 24 to Week 52)||23||
60022640|NCT02409667|76138605|FG002|NOT COMPLETED|Treatment Period 2, Week 24 to Week 52)||21||
60022641|NCT02409667|76138606|FG003|NOT COMPLETED|Treatment Period 2, Week 24 to Week 52)||8||
60022642|NCT02409667|76138607|FG004|NOT COMPLETED|Treatment Period 2, Week 24 to Week 52)||3||
60022643|NCT01641939|76138621|FG000|STARTED|Overall Study||117||
60022644|NCT01641939|76138622|FG001|STARTED|Overall Study||228||
60022645|NCT01641939|76138623|FG002|STARTED|Overall Study||70||
60022646|NCT01641939|76138621|FG000|Stage 1|Overall Study||37||
60022647|NCT01641939|76138622|FG001|Stage 1|Overall Study||75||
60022648|NCT01641939|76138623|FG002|Stage 1|Overall Study||70||
60022649|NCT01641939|76138621|FG000|Stage 2|Overall Study||80||
60022650|NCT01641939|76138622|FG001|Stage 2|Overall Study||153||
60022651|NCT01641939|76138623|FG002|Stage 2|Overall Study||0||
60022652|NCT01641939|76138621|FG000|COMPLETED|Overall Study||0||
60022653|NCT01641939|76138622|FG001|COMPLETED|Overall Study||0||
60022654|NCT01641939|76138623|FG002|COMPLETED|Overall Study||0||
60022655|NCT01641939|76138621|FG000|NOT COMPLETED|Overall Study||117||
60022656|NCT01641939|76138622|FG001|NOT COMPLETED|Overall Study||228||
60022657|NCT01641939|76138623|FG002|NOT COMPLETED|Overall Study||70||
60022658|NCT01641861|76138635|FG000|STARTED|Overall Study||246||
60022659|NCT01641861|76138636|FG001|STARTED|Overall Study||242||
60022660|NCT01641861|76138635|FG000|COMPLETED|Overall Study||211||
60022661|NCT01641861|76138636|FG001|COMPLETED|Overall Study||217||
60022662|NCT01641861|76138635|FG000|NOT COMPLETED|Overall Study||35||
60022663|NCT01641861|76138636|FG001|NOT COMPLETED|Overall Study||25||
60022664|NCT02409355|76138644|FG000|STARTED|Overall Study||4||
60022665|NCT02409355|76138645|FG001|STARTED|Overall Study||4||
60022666|NCT02409355|76138644|FG000|COMPLETED|Overall Study||0||
60022667|NCT02409355|76138645|FG001|COMPLETED|Overall Study||0||
60022668|NCT02409355|76138644|FG000|NOT COMPLETED|Overall Study||4||
60022669|NCT02409355|76138645|FG001|NOT COMPLETED|Overall Study||4||
60022670|NCT02408887|76138653|FG000|STARTED|Overall Study||8||
60022671|NCT02408887|76138654|FG001|STARTED|Overall Study||6||
60022672|NCT02408887|76138653|FG000|COMPLETED|Overall Study||7||
60022673|NCT02408887|76138654|FG001|COMPLETED|Overall Study||5||
60022674|NCT02408887|76138653|FG000|NOT COMPLETED|Overall Study||1||
60022675|NCT02408887|76138654|FG001|NOT COMPLETED|Overall Study||1||
60022676|NCT02266875|76138662|FG000|STARTED|Overall Study||40||
60022677|NCT02266875|76138663|FG001|STARTED|Overall Study||30||
60022678|NCT02266875|76138662|FG000|COMPLETED|Overall Study||29||
60022679|NCT02266875|76138663|FG001|COMPLETED|Overall Study||30||
60022680|NCT02266875|76138662|FG000|NOT COMPLETED|Overall Study||11||
60022681|NCT02266875|76138663|FG001|NOT COMPLETED|Overall Study||0||
60022682|NCT02438371|76138671|FG000|STARTED|Overall Study||24||
60022683|NCT02438371|76138672|FG001|STARTED|Overall Study||25||
60022684|NCT02438371|76138671|FG000|Received Intervention|Overall Study||24||
60022685|NCT02438371|76138672|FG001|Received Intervention|Overall Study||25||
60022686|NCT02438371|76138671|FG000|COMPLETED|Overall Study||20||
59914229|NCT03115476|76035139|FG000|NOT COMPLETED|Main Trials (LP0084-119x)||0||
59914230|NCT03115476|76035140|FG001|NOT COMPLETED|Main Trials (LP0084-119x)||0||
59914231|NCT03115476|76035141|FG002|NOT COMPLETED|Main Trials (LP0084-119x)||0||
59914232|NCT03115476|76035139|FG000|STARTED|LP0084-1369||191|"Number of subjects that continued into this extension trial LP0084-1369 from the Main trials"|
59914233|NCT03115476|76035140|FG001|STARTED|LP0084-1369||210|"Number of subjects that continued into this extension trial LP0084-1369 from the Main trials"|
59914234|NCT03115476|76035141|FG002|STARTED|LP0084-1369||162|"Number of subjects that continued into this extension trial LP0084-1369 from the Main trials"|
59914235|NCT03115476|76035139|FG000|COMPLETED|LP0084-1369|Trial was terminated by sponsor|0||
59914236|NCT03115476|76035140|FG001|COMPLETED|LP0084-1369|Trial was terminated by sponsor|0||
59914237|NCT03115476|76035141|FG002|COMPLETED|LP0084-1369|Trial was terminated by sponsor|0||
59914238|NCT03115476|76035139|FG000|NOT COMPLETED|LP0084-1369||191||
59758906|NCT00744861|75878245|FG001|STARTED|Feasibility Stage 1|Stage 1: Study phase to determine the feasibility of the study treatment and assessments|10||
59758907|NCT00744861|75878246|FG002|STARTED|Feasibility Stage 1|No subjects enrolled in Stage 1/Feasibility study|0||
59914239|NCT03115476|76035140|FG001|NOT COMPLETED|LP0084-1369||210||
59914240|NCT03115476|76035141|FG002|NOT COMPLETED|LP0084-1369||162||
59914241|NCT03480763|76035151|FG000|STARTED|Overall Study||327||
59914242|NCT03480763|76035152|FG001|STARTED|Overall Study||325||
59914243|NCT03480763|76035151|FG000|Vaccination 1 - (V114 or Prevnar 13™, Day 1)|Overall Study||326||
59914244|NCT03480763|76035152|FG001|Vaccination 1 - (V114 or Prevnar 13™, Day 1)|Overall Study||325||
59914245|NCT03480763|76035151|FG000|Vaccination 2 - (PNEUMOVAX™23, Month 12)|Overall Study||298||
59914246|NCT03480763|76035152|FG001|Vaccination 2 - (PNEUMOVAX™23, Month 12)|Overall Study||302||
59914247|NCT03480763|76035151|FG000|COMPLETED|Overall Study||303||
59914248|NCT03480763|76035152|FG001|COMPLETED|Overall Study||306||
59914249|NCT03480763|76035151|FG000|NOT COMPLETED|Overall Study||24||
59914250|NCT03480763|76035152|FG001|NOT COMPLETED|Overall Study||19||
59914251|NCT03123120|76035166|FG000|STARTED|Overall Study||8||
59914252|NCT03123120|76035167|FG001|STARTED|Overall Study||14||
59914253|NCT03123120|76035166|FG000|Safety Analysis Set (SAF)|Overall Study||7|1 patient who was randomized to placebo accidentally received one dose of Spesolimab and was analyzed in the Spesolimab group in the SAF|
59914254|NCT03123120|76035167|FG001|Safety Analysis Set (SAF)|Overall Study||15|1 patient who was randomized to placebo accidentally received one dose of Spesolimab and was analyzed in the Spesolimab group in the SAF|
59914255|NCT03123120|76035166|FG000|COMPLETED|Overall Study||8|Completed planned observation time.|
59914256|NCT03123120|76035167|FG001|COMPLETED|Overall Study||12|Completed planned observation time.|
59914257|NCT03123120|76035166|FG000|NOT COMPLETED|Overall Study||0||
59914258|NCT03123120|76035167|FG001|NOT COMPLETED|Overall Study||2||
59914259|NCT01319994|76035177|FG000|STARTED|Overall Study||26||
59914260|NCT01319994|76035178|FG001|STARTED|Overall Study||27||
59914261|NCT01319994|76035177|FG000|Abto Keep Appoinment Shedule|Overall Study||23||
59914262|NCT01319994|76035178|FG001|Abto Keep Appoinment Shedule|Overall Study||24||
59914263|NCT01319994|76035177|FG000|Tolerated at Least 1.7g/Day Dose|Overall Study||19||
59914264|NCT01319994|76035178|FG001|Tolerated at Least 1.7g/Day Dose|Overall Study||24||
59914265|NCT01319994|76035177|FG000|Glucocorticoid Dose as Inc Cri|Overall Study||19||
59914266|NCT01319994|76035178|FG001|Glucocorticoid Dose as Inc Cri|Overall Study||22||
59914267|NCT01319994|76035177|FG000|Did Not Develop Overt Diabetes|Overall Study||19||
59914268|NCT01319994|76035178|FG001|Did Not Develop Overt Diabetes|Overall Study||21||
59914269|NCT01319994|76035177|FG000|COMPLETED|Overall Study||19||
59914270|NCT01319994|76035178|FG001|COMPLETED|Overall Study||21||
59914271|NCT01319994|76035177|FG000|NOT COMPLETED|Overall Study||7||
59914272|NCT01319994|76035178|FG001|NOT COMPLETED|Overall Study||6||
59914273|NCT03208530|76035184|FG000|STARTED|Overall Study||75||
59914274|NCT03208530|76035184|FG000|COMPLETED|Overall Study||48||
59914275|NCT03208530|76035184|FG000|NOT COMPLETED|Overall Study||27||
59914276|NCT03453151|76035188|FG000|STARTED|Overall Study||19||
59758908|NCT00744861|75878247|FG003|STARTED|Feasibility Stage 1|No subjects enrolled in Stage 1/Feasibility study|0||
59758909|NCT00744861|75878244|FG000|COMPLETED|Feasibility Stage 1||7||
59758910|NCT00744861|75878245|FG001|COMPLETED|Feasibility Stage 1||8||
59758911|NCT00744861|75878246|FG002|COMPLETED|Feasibility Stage 1||0||
59758912|NCT00744861|75878247|FG003|COMPLETED|Feasibility Stage 1||0||
59758913|NCT00744861|75878244|FG000|NOT COMPLETED|Feasibility Stage 1||1||
59758914|NCT00744861|75878245|FG001|NOT COMPLETED|Feasibility Stage 1||2||
59758915|NCT00744861|75878246|FG002|NOT COMPLETED|Feasibility Stage 1||0||
59758916|NCT00744861|75878247|FG003|NOT COMPLETED|Feasibility Stage 1||0||
59758917|NCT00744861|75878244|FG000|STARTED|Pivotal Stage 2|No subjects enrolled in Stage 2 pivotal study phase|0||
59758918|NCT00744861|75878245|FG001|STARTED|Pivotal Stage 2|No subjects enrolled in Stage 2 pivotal study phase|0||
59758919|NCT00744861|75878246|FG002|STARTED|Pivotal Stage 2|Stage 2 pivotal study phase assessed safety and effectiveness of LIPUS treatment via Exospine device|154||
59758920|NCT00744861|75878247|FG003|STARTED|Pivotal Stage 2|Stage 2 pivotal study phase assessed safety and effectiveness of LIPUS treatment via Exospine device|156||
59758921|NCT00744861|75878244|FG000|COMPLETED|Pivotal Stage 2||0||
59914277|NCT03453151|76035188|FG000|COMPLETED|Overall Study||15||
59914278|NCT03453151|76035188|FG000|NOT COMPLETED|Overall Study||4||
59914279|NCT03452527|76035194|FG000|STARTED|Overall Study||7||
59914280|NCT03452527|76035195|FG001|STARTED|Overall Study||8||
59914281|NCT03452527|76035194|FG000|COMPLETED|Overall Study||4||
59914282|NCT03452527|76035195|FG001|COMPLETED|Overall Study||4||
59914283|NCT03452527|76035194|FG000|NOT COMPLETED|Overall Study||3||
59914284|NCT03452527|76035195|FG001|NOT COMPLETED|Overall Study||4||
59914285|NCT03028142|76035201|FG000|STARTED|Overall Study||5||
59914286|NCT03028142|76035202|FG001|STARTED|Overall Study||5||
59914287|NCT03028142|76035203|FG002|STARTED|Overall Study||6||
59914288|NCT03028142|76035204|FG003|STARTED|Overall Study||4||
59914289|NCT03028142|76035205|FG004|STARTED|Overall Study||6||
59914290|NCT03028142|76035206|FG005|STARTED|Overall Study||4||
59914291|NCT03028142|76035201|FG000|COMPLETED|Overall Study||4||
59914292|NCT03028142|76035202|FG001|COMPLETED|Overall Study||4||
59914293|NCT03028142|76035203|FG002|COMPLETED|Overall Study||6||
59914294|NCT03028142|76035204|FG003|COMPLETED|Overall Study||4||
59914295|NCT03028142|76035205|FG004|COMPLETED|Overall Study||5||
59914296|NCT03028142|76035206|FG005|COMPLETED|Overall Study||3||
59914297|NCT03028142|76035201|FG000|NOT COMPLETED|Overall Study||1||
59914298|NCT03028142|76035202|FG001|NOT COMPLETED|Overall Study||1||
59914299|NCT03028142|76035203|FG002|NOT COMPLETED|Overall Study||0||
59914300|NCT03028142|76035204|FG003|NOT COMPLETED|Overall Study||0||
59914301|NCT03028142|76035205|FG004|NOT COMPLETED|Overall Study||1||
59914302|NCT03028142|76035206|FG005|NOT COMPLETED|Overall Study||1||
59914303|NCT02708524|76035219|FG000|STARTED|Overall Study||139||
59914304|NCT02708524|76035220|FG001|STARTED|Overall Study||136||
59914305|NCT02708524|76035221|FG002|STARTED|Overall Study||137||
59914306|NCT02708524|76035222|FG003|STARTED|Overall Study||136||
59914307|NCT02708524|76035219|FG000|COMPLETED|Overall Study||135||
59914308|NCT02708524|76035220|FG001|COMPLETED|Overall Study||130||
59914309|NCT02708524|76035221|FG002|COMPLETED|Overall Study||134||
59914310|NCT02708524|76035222|FG003|COMPLETED|Overall Study||136||
59914311|NCT02708524|76035219|FG000|NOT COMPLETED|Overall Study||4||
59914312|NCT02708524|76035220|FG001|NOT COMPLETED|Overall Study||6||
59914313|NCT02708524|76035221|FG002|NOT COMPLETED|Overall Study||3||
59914314|NCT02708524|76035222|FG003|NOT COMPLETED|Overall Study||0||
59914315|NCT03418675|76035234|FG000|STARTED|Overall Study||40||
59914316|NCT03418675|76035235|FG001|STARTED|Overall Study||40||
59914317|NCT03418675|76035234|FG000|Completed All Baseline Measures|Overall Study||37||
59914318|NCT03418675|76035235|FG001|Completed All Baseline Measures|Overall Study||40||
59914319|NCT03418675|76035234|FG000|Completed One-post Randomization Visit|Overall Study||34||
59914320|NCT03418675|76035235|FG001|Completed One-post Randomization Visit|Overall Study||35||
59914321|NCT03418675|76035234|FG000|COMPLETED|Overall Study||25||
59914322|NCT03418675|76035235|FG001|COMPLETED|Overall Study||30||
59914323|NCT03418675|76035234|FG000|NOT COMPLETED|Overall Study||15||
59914324|NCT03418675|76035235|FG001|NOT COMPLETED|Overall Study||10||
59914325|NCT02653092|76035243|FG000|STARTED|Overall Study||26||
59914326|NCT02653092|76035244|FG001|STARTED|Overall Study||58||
59914327|NCT02653092|76035243|FG000|COMPLETED|Overall Study||13||
59914328|NCT02653092|76035244|FG001|COMPLETED|Overall Study||18||
59914329|NCT02653092|76035243|FG000|NOT COMPLETED|Overall Study||13||
59914330|NCT02653092|76035244|FG001|NOT COMPLETED|Overall Study||40||
59914331|NCT03417505|76035252|FG000|STARTED|First Lens Type (30 Days)||9||
59914332|NCT03417505|76035253|FG001|STARTED|First Lens Type (30 Days)||12||
59914333|NCT03417505|76035252|FG000|COMPLETED|First Lens Type (30 Days)||8||
59914334|NCT03417505|76035253|FG001|COMPLETED|First Lens Type (30 Days)||11||
59914335|NCT03417505|76035252|FG000|NOT COMPLETED|First Lens Type (30 Days)||1||
59914336|NCT03417505|76035253|FG001|NOT COMPLETED|First Lens Type (30 Days)||1||
59914337|NCT03417505|76035252|FG000|STARTED|Washout Period (7 Days)||8||
59914338|NCT03417505|76035253|FG001|STARTED|Washout Period (7 Days)||11||
59914339|NCT03417505|76035252|FG000|COMPLETED|Washout Period (7 Days)||8||
59914340|NCT03417505|76035253|FG001|COMPLETED|Washout Period (7 Days)||11||
59914341|NCT03417505|76035252|FG000|NOT COMPLETED|Washout Period (7 Days)||0||
59914342|NCT03417505|76035253|FG001|NOT COMPLETED|Washout Period (7 Days)||0||
59914343|NCT03417505|76035252|FG000|STARTED|Second Lens Type (30 Days)||8||
59914344|NCT03417505|76035253|FG001|STARTED|Second Lens Type (30 Days)||11||
59914345|NCT03417505|76035252|FG000|COMPLETED|Second Lens Type (30 Days)||8||
59914346|NCT03417505|76035253|FG001|COMPLETED|Second Lens Type (30 Days)||11||
59914347|NCT03417505|76035252|FG000|NOT COMPLETED|Second Lens Type (30 Days)||0||
59914348|NCT03417505|76035253|FG001|NOT COMPLETED|Second Lens Type (30 Days)||0||
59914349|NCT02953639|76035262|FG000|STARTED|Overall Study||81||
59914350|NCT02953639|76035263|FG001|STARTED|Overall Study||54||
59914351|NCT02953639|76035264|FG002|STARTED|Overall Study||78||
59914352|NCT02953639|76035262|FG000|COMPLETED|Overall Study||61||
59914353|NCT02953639|76035263|FG001|COMPLETED|Overall Study||40||
59914354|NCT02953639|76035264|FG002|COMPLETED|Overall Study||62||
59914355|NCT02953639|76035262|FG000|NOT COMPLETED|Overall Study||20||
59914356|NCT02953639|76035263|FG001|NOT COMPLETED|Overall Study||14||
59914357|NCT02953639|76035264|FG002|NOT COMPLETED|Overall Study||16||
59914358|NCT04147715|76035286|FG000|STARTED|Overall Study||12||
59914359|NCT04147715|76035287|FG001|STARTED|Overall Study||6||
59914360|NCT04147715|76035288|FG002|STARTED|Overall Study||6||
59914361|NCT04147715|76035289|FG003|STARTED|Overall Study||8||
59914362|NCT04147715|76035290|FG004|STARTED|Overall Study||6||
59914363|NCT04147715|76035291|FG005|STARTED|Overall Study||6||
60022687|NCT02438371|76138672|FG001|COMPLETED|Overall Study||22||
60022688|NCT02438371|76138671|FG000|NOT COMPLETED|Overall Study||4||
60022689|NCT02438371|76138672|FG001|NOT COMPLETED|Overall Study||3||
60022690|NCT02438137|76138680|FG000|STARTED|Overall Study||44||
60022691|NCT02438137|76138681|FG001|STARTED|Overall Study||21||
60022692|NCT02438137|76138680|FG000|COMPLETED|Overall Study||36||
60022693|NCT02438137|76138681|FG001|COMPLETED|Overall Study||15||
60022694|NCT02438137|76138680|FG000|NOT COMPLETED|Overall Study||8||
60022695|NCT02438137|76138681|FG001|NOT COMPLETED|Overall Study||6||
60022696|NCT02437903|76138689|FG000|STARTED|Overall Study||30||
60022697|NCT02437903|76138689|FG000|COMPLETED|Overall Study||25||
60022698|NCT02437903|76138689|FG000|NOT COMPLETED|Overall Study||5||
60022699|NCT02437513|76138694|FG000|STARTED|Overall Study||2||
60022700|NCT02437513|76138694|FG000|COMPLETED|Overall Study||0||
60022701|NCT02437513|76138694|FG000|NOT COMPLETED|Overall Study||2||
60022702|NCT02460991|76138700|FG000|STARTED|Overall Study||0||
60022703|NCT02460991|76138701|FG001|STARTED|Overall Study||2||
60022704|NCT02460991|76138700|FG000|COMPLETED|Overall Study||0||
60022705|NCT02460991|76138701|FG001|COMPLETED|Overall Study||0||
60022706|NCT02460991|76138700|FG000|NOT COMPLETED|Overall Study||0||
60022707|NCT02460991|76138701|FG001|NOT COMPLETED|Overall Study||2||
60022708|NCT02407249|76138712|FG000|STARTED|Overall Study||73||
60022709|NCT02407249|76138712|FG000|Treated|Overall Study||60||
60022710|NCT02407249|76138712|FG000|COMPLETED|Overall Study||47||
60022711|NCT02407249|76138712|FG000|NOT COMPLETED|Overall Study||26||
60022712|NCT02460679|76138716|FG000|STARTED|Overall Study||19||
60022713|NCT02460679|76138716|FG000|Received at Least 1 Dose of Study Drug|Overall Study||19||
60022714|NCT02460679|76138716|FG000|COMPLETED|Overall Study||14||
60022715|NCT02460679|76138716|FG000|NOT COMPLETED|Overall Study||5||
60022716|NCT02459899|76138724|FG000|STARTED|Overall Study||36||
60022717|NCT02459899|76138725|FG001|STARTED|Overall Study||35||
60022718|NCT02459899|76138726|FG002|STARTED|Overall Study||35||
60022719|NCT02459899|76138727|FG003|STARTED|Overall Study||35||
60022720|NCT02459899|76138724|FG000|COMPLETED|Overall Study||33||
60022721|NCT02459899|76138725|FG001|COMPLETED|Overall Study||29||
60022722|NCT02459899|76138726|FG002|COMPLETED|Overall Study||35||
60022723|NCT02459899|76138727|FG003|COMPLETED|Overall Study||33||
60022724|NCT02459899|76138724|FG000|NOT COMPLETED|Overall Study||3||
60022725|NCT02459899|76138725|FG001|NOT COMPLETED|Overall Study||6||
60022726|NCT02459899|76138726|FG002|NOT COMPLETED|Overall Study||0||
60022727|NCT02459899|76138727|FG003|NOT COMPLETED|Overall Study||2||
60022728|NCT02436889|76138739|FG000|STARTED|Overall Study||12||
60022729|NCT02436889|76138740|FG001|STARTED|Overall Study||11||
60022730|NCT02436889|76138739|FG000|COMPLETED|Overall Study||11||
60022731|NCT02436889|76138740|FG001|COMPLETED|Overall Study||10||
60022732|NCT02436889|76138739|FG000|NOT COMPLETED|Overall Study||1||
60022733|NCT02436889|76138740|FG001|NOT COMPLETED|Overall Study||1||
60022734|NCT02436811|76138749|FG000|STARTED|Overall Study||60||
60022735|NCT02436811|76138750|FG001|STARTED|Overall Study||60||
60022736|NCT02436811|76138751|FG002|STARTED|Overall Study||60||
60022737|NCT02436811|76138749|FG000|COMPLETED|Overall Study||58||
60022738|NCT02436811|76138750|FG001|COMPLETED|Overall Study||51||
60022739|NCT02436811|76138751|FG002|COMPLETED|Overall Study||53||
60022740|NCT02436811|76138749|FG000|NOT COMPLETED|Overall Study||2||
60022741|NCT02436811|76138750|FG001|NOT COMPLETED|Overall Study||9||
60022742|NCT02436811|76138751|FG002|NOT COMPLETED|Overall Study||7||
60022743|NCT02436577|76138765|FG000|STARTED|Overall Study||7||
60022744|NCT02436577|76138766|FG001|STARTED|Overall Study||7||
60022745|NCT02436577|76138767|FG002|STARTED|Overall Study||7||
60022746|NCT02436577|76138768|FG003|STARTED|Overall Study||7||
60022747|NCT02436577|76138769|FG004|STARTED|Overall Study||7||
60022748|NCT02436577|76138770|FG005|STARTED|Overall Study||7||
60022749|NCT02436577|76138765|FG000|COMPLETED|Overall Study||7||
60022750|NCT02436577|76138766|FG001|COMPLETED|Overall Study||6||
60022751|NCT02436577|76138767|FG002|COMPLETED|Overall Study||7||
60022752|NCT02436577|76138768|FG003|COMPLETED|Overall Study||7||
60022753|NCT02436577|76138769|FG004|COMPLETED|Overall Study||7||
60022754|NCT02436577|76138770|FG005|COMPLETED|Overall Study||7||
60022755|NCT02436577|76138765|FG000|NOT COMPLETED|Overall Study||0||
60022756|NCT02436577|76138766|FG001|NOT COMPLETED|Overall Study||1||
60022757|NCT02436577|76138767|FG002|NOT COMPLETED|Overall Study||0||
60022758|NCT02436577|76138768|FG003|NOT COMPLETED|Overall Study||0||
60022759|NCT02436577|76138769|FG004|NOT COMPLETED|Overall Study||0||
60022760|NCT02436577|76138770|FG005|NOT COMPLETED|Overall Study||0||
60022761|NCT02265705|76138780|FG000|STARTED|Treatment Period Week 0-24||145||
60022762|NCT02265705|76138781|FG001|STARTED|Treatment Period Week 0-24||145||
60022763|NCT02265705|76138782|FG002|STARTED|Treatment Period Week 0-24||0||
60022764|NCT02265705|76138783|FG003|STARTED|Treatment Period Week 0-24||0||
60022765|NCT02265705|76138784|FG004|STARTED|Treatment Period Week 0-24||0||
60022766|NCT02265705|76138785|FG005|STARTED|Treatment Period Week 0-24||0||
60022767|NCT02265705|76138786|FG006|STARTED|Treatment Period Week 0-24||0||
60022768|NCT02265705|76138780|FG000|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||145||
60022769|NCT02265705|76138781|FG001|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||145||
60022770|NCT02265705|76138782|FG002|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||0||
60022771|NCT02265705|76138783|FG003|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||0||
60022772|NCT02265705|76138784|FG004|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||0||
60022773|NCT02265705|76138785|FG005|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||0||
60022774|NCT02265705|76138786|FG006|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||0||
60022775|NCT02265705|76138780|FG000|Rescued|Treatment Period Week 0-24||59||
60022776|NCT02265705|76138781|FG001|Rescued|Treatment Period Week 0-24||17||
60022777|NCT02265705|76138782|FG002|Rescued|Treatment Period Week 0-24||0||
60022778|NCT02265705|76138783|FG003|Rescued|Treatment Period Week 0-24||0||
60022779|NCT02265705|76138784|FG004|Rescued|Treatment Period Week 0-24||0||
60022780|NCT02265705|76138785|FG005|Rescued|Treatment Period Week 0-24||0||
60022781|NCT02265705|76138786|FG006|Rescued|Treatment Period Week 0-24||0||
60022782|NCT02265705|76138780|FG000|COMPLETED|Treatment Period Week 0-24|"Completers include rescued participants."|133||
60022783|NCT02265705|76138781|FG001|COMPLETED|Treatment Period Week 0-24|"Completers include rescued participants."|136||
60022784|NCT02265705|76138782|FG002|COMPLETED|Treatment Period Week 0-24||0||
60022785|NCT02265705|76138783|FG003|COMPLETED|Treatment Period Week 0-24||0||
60022786|NCT02265705|76138784|FG004|COMPLETED|Treatment Period Week 0-24||0||
60022787|NCT02265705|76138785|FG005|COMPLETED|Treatment Period Week 0-24||0||
60022788|NCT02265705|76138786|FG006|COMPLETED|Treatment Period Week 0-24||0||
60022789|NCT02265705|76138780|FG000|NOT COMPLETED|Treatment Period Week 0-24||12||
60022790|NCT02265705|76138781|FG001|NOT COMPLETED|Treatment Period Week 0-24||9||
60022791|NCT02265705|76138782|FG002|NOT COMPLETED|Treatment Period Week 0-24||0||
60022792|NCT02265705|76138783|FG003|NOT COMPLETED|Treatment Period Week 0-24||0||
60022793|NCT02265705|76138784|FG004|NOT COMPLETED|Treatment Period Week 0-24||0||
60022794|NCT02265705|76138785|FG005|NOT COMPLETED|Treatment Period Week 0-24||0||
60022795|NCT02265705|76138786|FG006|NOT COMPLETED|Treatment Period Week 0-24||0||
60022796|NCT02265705|76138780|FG000|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0||
60022797|NCT02265705|76138781|FG001|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0||
60022798|NCT02265705|76138782|FG002|STARTED|Rescue Period|Participants who were determined to be nonresponders based on tender/swollen joint count.|77||
60022799|NCT02265705|76138783|FG003|STARTED|Rescue Period||0||
60022800|NCT02265705|76138784|FG004|STARTED|Rescue Period||0||
60022801|NCT02265705|76138785|FG005|STARTED|Rescue Period||0||
60022802|NCT02265705|76138786|FG006|STARTED|Rescue Period||0||
60022803|NCT02265705|76138780|FG000|COMPLETED|Rescue Period||0||
60022804|NCT02265705|76138781|FG001|COMPLETED|Rescue Period||0||
60022805|NCT02265705|76138782|FG002|COMPLETED|Rescue Period||74||
60022806|NCT02265705|76138783|FG003|COMPLETED|Rescue Period||0||
60022807|NCT02265705|76138784|FG004|COMPLETED|Rescue Period||0||
60022808|NCT02265705|76138785|FG005|COMPLETED|Rescue Period||0||
60022809|NCT02265705|76138786|FG006|COMPLETED|Rescue Period||0||
60022810|NCT02265705|76138780|FG000|NOT COMPLETED|Rescue Period||0||
60022811|NCT02265705|76138781|FG001|NOT COMPLETED|Rescue Period||0||
60022812|NCT02265705|76138782|FG002|NOT COMPLETED|Rescue Period||3||
60022813|NCT02265705|76138783|FG003|NOT COMPLETED|Rescue Period||0||
60022814|NCT02265705|76138784|FG004|NOT COMPLETED|Rescue Period||0||
60022815|NCT02265705|76138785|FG005|NOT COMPLETED|Rescue Period||0||
60022816|NCT02265705|76138786|FG006|NOT COMPLETED|Rescue Period||0||
60022817|NCT02265705|76138780|FG000|STARTED|Open Label Period||0||
60022818|NCT02265705|76138781|FG001|STARTED|Open Label Period||0||
60022819|NCT02265705|76138782|FG002|STARTED|Open Label Period||0||
60022820|NCT02265705|76138783|FG003|STARTED|Open Label Period|Completed Wk 24 w/o rescue Tx, switched to or remained on active Tx, and entered Open Label Period.|74||
60022821|NCT02265705|76138784|FG004|STARTED|Open Label Period|Completed Wk 24 w/o rescue Tx, switched to or remained on active Tx, and entered Open Label Period.|120||
60022822|NCT02265705|76138785|FG005|STARTED|Open Label Period||0||
60022823|NCT02265705|76138786|FG006|STARTED|Open Label Period||0||
60022824|NCT02265705|76138780|FG000|COMPLETED|Open Label Period||0||
60022825|NCT02265705|76138781|FG001|COMPLETED|Open Label Period||0||
60022826|NCT02265705|76138782|FG002|COMPLETED|Open Label Period||0||
60022827|NCT02265705|76138783|FG003|COMPLETED|Open Label Period||72||
60022828|NCT02265705|76138784|FG004|COMPLETED|Open Label Period||115||
60022829|NCT02265705|76138785|FG005|COMPLETED|Open Label Period||0||
60022830|NCT02265705|76138786|FG006|COMPLETED|Open Label Period||0||
60022831|NCT02265705|76138780|FG000|NOT COMPLETED|Open Label Period||0||
60022832|NCT02265705|76138781|FG001|NOT COMPLETED|Open Label Period||0||
60022833|NCT02265705|76138782|FG002|NOT COMPLETED|Open Label Period||0||
60022834|NCT02265705|76138783|FG003|NOT COMPLETED|Open Label Period||2||
60022835|NCT02265705|76138784|FG004|NOT COMPLETED|Open Label Period||5||
60022836|NCT02265705|76138785|FG005|NOT COMPLETED|Open Label Period||0||
60022837|NCT02265705|76138786|FG006|NOT COMPLETED|Open Label Period||0||
60022838|NCT02265705|76138780|FG000|STARTED|Follow-up Period||0||
60022839|NCT02265705|76138781|FG001|STARTED|Follow-up Period||0||
60022840|NCT02265705|76138782|FG002|STARTED|Follow-up Period||0||
60022841|NCT02265705|76138783|FG003|STARTED|Follow-up Period||0||
60022842|NCT02265705|76138784|FG004|STARTED|Follow-up Period||0||
60067787|NCT01973569|76182982|FG001|Discontinued Study Treatment|Overall Study||22||
59507312|NCT02151331|75600526|FG000|STARTED|Overall Study||77||
59507313|NCT02151331|75600527|FG001|STARTED|Overall Study||92||
59507314|NCT02151331|75600526|FG000|COMPLETED|Overall Study||45||
59507315|NCT02151331|75600527|FG001|COMPLETED|Overall Study||52||
59758922|NCT00744861|75878245|FG001|COMPLETED|Pivotal Stage 2||0||
59758923|NCT00744861|75878246|FG002|COMPLETED|Pivotal Stage 2||52||
59758924|NCT00744861|75878247|FG003|COMPLETED|Pivotal Stage 2||51||
59758925|NCT00744861|75878244|FG000|NOT COMPLETED|Pivotal Stage 2||0||
59758926|NCT00744861|75878245|FG001|NOT COMPLETED|Pivotal Stage 2||0||
59758927|NCT00744861|75878246|FG002|NOT COMPLETED|Pivotal Stage 2||102||
59758928|NCT00744861|75878247|FG003|NOT COMPLETED|Pivotal Stage 2||105||
59758929|NCT03969589|75878257|FG000|STARTED|Overall Study||20||
59758930|NCT03969589|75878258|FG001|STARTED|Overall Study||20||
59914364|NCT04147715|76035292|FG006|STARTED|Overall Study||6||
59914365|NCT04147715|76035293|FG007|STARTED|Overall Study||4||
59914366|NCT04147715|76035294|FG008|STARTED|Overall Study||8||
59914367|NCT04147715|76035295|FG009|STARTED|Overall Study||8||
59914368|NCT04147715|76035296|FG010|STARTED|Overall Study||14||
59914369|NCT04147715|76035297|FG011|STARTED|Overall Study||14||
59914370|NCT04147715|76035286|FG000|COMPLETED|Overall Study||12||
59914371|NCT04147715|76035287|FG001|COMPLETED|Overall Study||6||
59914372|NCT04147715|76035288|FG002|COMPLETED|Overall Study||6||
59914373|NCT04147715|76035289|FG003|COMPLETED|Overall Study||8||
59914374|NCT04147715|76035290|FG004|COMPLETED|Overall Study||6||
59914375|NCT04147715|76035291|FG005|COMPLETED|Overall Study||6||
59914376|NCT04147715|76035292|FG006|COMPLETED|Overall Study||6||
59914377|NCT04147715|76035293|FG007|COMPLETED|Overall Study||2||
59914378|NCT04147715|76035294|FG008|COMPLETED|Overall Study||7||
59758931|NCT03969589|75878257|FG000|COMPLETED|Overall Study||17||
59758932|NCT03969589|75878258|FG001|COMPLETED|Overall Study||17||
59758933|NCT03969589|75878257|FG000|NOT COMPLETED|Overall Study||3||
59758934|NCT03969589|75878258|FG001|NOT COMPLETED|Overall Study||3||
59758935|NCT00744627|75878266|FG000|STARTED|Overall Study||151||
59758936|NCT00744627|75878267|FG001|STARTED|Overall Study||150||
59758937|NCT00744627|75878266|FG000|Treated|Overall Study||150||
59758938|NCT00744627|75878267|FG001|Treated|Overall Study||150||
59758939|NCT00744627|75878266|FG000|COMPLETED|Overall Study||126||
59914379|NCT04147715|76035295|FG009|COMPLETED|Overall Study||8||
59914380|NCT04147715|76035296|FG010|COMPLETED|Overall Study||14||
59914381|NCT04147715|76035297|FG011|COMPLETED|Overall Study||14||
59914382|NCT04147715|76035286|FG000|NOT COMPLETED|Overall Study||0||
59914383|NCT04147715|76035287|FG001|NOT COMPLETED|Overall Study||0||
59914384|NCT04147715|76035288|FG002|NOT COMPLETED|Overall Study||0||
59914385|NCT04147715|76035289|FG003|NOT COMPLETED|Overall Study||0||
59914386|NCT04147715|76035290|FG004|NOT COMPLETED|Overall Study||0||
59758940|NCT00744627|75878267|FG001|COMPLETED|Overall Study||128||
59758941|NCT00744627|75878266|FG000|NOT COMPLETED|Overall Study||25||
59758942|NCT00744627|75878267|FG001|NOT COMPLETED|Overall Study||22||
59758943|NCT03959137|75878273|FG000|STARTED|Overall Study||215||
59914387|NCT04147715|76035291|FG005|NOT COMPLETED|Overall Study||0||
59914388|NCT04147715|76035292|FG006|NOT COMPLETED|Overall Study||0||
59914389|NCT04147715|76035293|FG007|NOT COMPLETED|Overall Study||2||
59914390|NCT04147715|76035294|FG008|NOT COMPLETED|Overall Study||1||
59914391|NCT04147715|76035295|FG009|NOT COMPLETED|Overall Study||0||
59914392|NCT04147715|76035296|FG010|NOT COMPLETED|Overall Study||0||
59914393|NCT04147715|76035297|FG011|NOT COMPLETED|Overall Study||0||
59914394|NCT00708526|76035371|FG000|STARTED|Wake up After Anesthesia||11||
59914395|NCT00708526|76035372|FG001|STARTED|Wake up After Anesthesia||11||
59914396|NCT00708526|76035371|FG000|COMPLETED|Wake up After Anesthesia||11||
59914397|NCT00708526|76035372|FG001|COMPLETED|Wake up After Anesthesia||11||
59914398|NCT00708526|76035371|FG000|NOT COMPLETED|Wake up After Anesthesia||0||
59914399|NCT00708526|76035372|FG001|NOT COMPLETED|Wake up After Anesthesia||0||
59914400|NCT00708526|76035371|FG000|STARTED|Return of Cognitive Function||11||
59914401|NCT00708526|76035372|FG001|STARTED|Return of Cognitive Function||11||
59914402|NCT00708526|76035371|FG000|COMPLETED|Return of Cognitive Function||11||
59914403|NCT00708526|76035372|FG001|COMPLETED|Return of Cognitive Function||11||
59914404|NCT00708526|76035371|FG000|NOT COMPLETED|Return of Cognitive Function||0||
59914405|NCT00708526|76035372|FG001|NOT COMPLETED|Return of Cognitive Function||0||
59914406|NCT02452554|76035384|FG000|STARTED|Overall Study||17||
59914407|NCT02452554|76035385|FG001|STARTED|Overall Study||17||
59914408|NCT02452554|76035386|FG002|STARTED|Overall Study||12||
59758944|NCT03959137|75878273|FG000|COMPLETED|Overall Study||209||
59914409|NCT02452554|76035387|FG003|STARTED|Overall Study||1||
59914410|NCT02452554|76035388|FG004|STARTED|Overall Study||5||
59914411|NCT02452554|76035389|FG005|STARTED|Overall Study||10||
59914412|NCT02452554|76035384|FG000|COMPLETED|Overall Study||0||
59914413|NCT02452554|76035385|FG001|COMPLETED|Overall Study||0||
59914414|NCT02452554|76035386|FG002|COMPLETED|Overall Study||1||
59914415|NCT02452554|76035387|FG003|COMPLETED|Overall Study||0||
59914416|NCT02452554|76035388|FG004|COMPLETED|Overall Study||0||
59914417|NCT02452554|76035389|FG005|COMPLETED|Overall Study||1||
59914418|NCT02452554|76035384|FG000|NOT COMPLETED|Overall Study||17||
59914419|NCT02452554|76035385|FG001|NOT COMPLETED|Overall Study||17||
59914420|NCT02452554|76035386|FG002|NOT COMPLETED|Overall Study||11||
59914421|NCT02452554|76035387|FG003|NOT COMPLETED|Overall Study||1||
59914422|NCT02452554|76035388|FG004|NOT COMPLETED|Overall Study||5||
59914423|NCT02452554|76035389|FG005|NOT COMPLETED|Overall Study||9||
59914424|NCT04009577|76035408|FG000|STARTED|Core Study||7||
59914425|NCT04009577|76035409|FG001|STARTED|Core Study||3||
59914426|NCT04009577|76035410|FG002|STARTED|Core Study||21||
59914427|NCT04009577|76035411|FG003|STARTED|Core Study||22||
59914428|NCT04009577|76035408|FG000|LEM5|Core Study||7||
59914429|NCT04009577|76035409|FG001|LEM5|Core Study||3||
59914430|NCT04009577|76035410|FG002|LEM5|Core Study||21||
59914431|NCT04009577|76035411|FG003|LEM5|Core Study||5||
59914432|NCT04009577|76035408|FG000|LEM10|Core Study||3||
59914433|NCT04009577|76035409|FG001|LEM10|Core Study||2||
59914434|NCT04009577|76035410|FG002|LEM10|Core Study||10||
59914435|NCT04009577|76035411|FG003|LEM10|Core Study||22||
59914436|NCT04009577|76035408|FG000|COMPLETED|Core Study||6||
59914437|NCT04009577|76035409|FG001|COMPLETED|Core Study||3||
59914438|NCT04009577|76035410|FG002|COMPLETED|Core Study||17||
59914439|NCT04009577|76035411|FG003|COMPLETED|Core Study||17||
59914440|NCT04009577|76035408|FG000|NOT COMPLETED|Core Study||1||
59914441|NCT04009577|76035409|FG001|NOT COMPLETED|Core Study||0||
59914442|NCT04009577|76035410|FG002|NOT COMPLETED|Core Study||4||
59914443|NCT04009577|76035411|FG003|NOT COMPLETED|Core Study||5||
59914444|NCT04009577|76035408|FG000|STARTED|Extension Phase||6|Participants who completed the Core Study had the option to participate in the Extension Phase|
59914445|NCT04009577|76035409|FG001|STARTED|Extension Phase||3|Participants who completed the Core Study had the option to participate in the Extension Phase|
59914446|NCT04009577|76035410|FG002|STARTED|Extension Phase||17|Participants who completed the Core Study had the option to participate in the Extension Phase|
59914447|NCT04009577|76035411|FG003|STARTED|Extension Phase||17|Participants who completed the Core Study had the option to participate in the Extension Phase|
59914448|NCT04009577|76035408|FG000|Treated|Extension Phase||6||
59914449|NCT04009577|76035409|FG001|Treated|Extension Phase||3||
59914450|NCT04009577|76035410|FG002|Treated|Extension Phase||15||
59914451|NCT04009577|76035411|FG003|Treated|Extension Phase||17||
59914452|NCT04009577|76035408|FG000|LEM5|Extension Phase||6||
59914453|NCT04009577|76035409|FG001|LEM5|Extension Phase||3||
59914454|NCT04009577|76035410|FG002|LEM5|Extension Phase||15||
59914455|NCT04009577|76035411|FG003|LEM5|Extension Phase||8||
59914456|NCT04009577|76035408|FG000|LEM10|Extension Phase||5||
59914457|NCT04009577|76035409|FG001|LEM10|Extension Phase||3||
59914458|NCT04009577|76035410|FG002|LEM10|Extension Phase||12||
59914459|NCT04009577|76035411|FG003|LEM10|Extension Phase||17||
59914460|NCT04009577|76035408|FG000|COMPLETED|Extension Phase||6||
59914461|NCT04009577|76035409|FG001|COMPLETED|Extension Phase||3||
59914462|NCT04009577|76035410|FG002|COMPLETED|Extension Phase||13||
59914463|NCT04009577|76035411|FG003|COMPLETED|Extension Phase||16||
59914464|NCT04009577|76035408|FG000|NOT COMPLETED|Extension Phase||0||
59758945|NCT03959137|75878273|FG000|NOT COMPLETED|Overall Study||6||
59914465|NCT04009577|76035409|FG001|NOT COMPLETED|Extension Phase||0||
59914466|NCT04009577|76035410|FG002|NOT COMPLETED|Extension Phase||4||
59914467|NCT04009577|76035411|FG003|NOT COMPLETED|Extension Phase||1||
59914468|NCT04146467|76035439|FG000|STARTED|Overall Study||17||
59914469|NCT04146467|76035440|FG001|STARTED|Overall Study||65||
59914470|NCT04146467|76035439|FG000|COMPLETED|Overall Study||17||
59914471|NCT04146467|76035440|FG001|COMPLETED|Overall Study||62||
59914472|NCT04146467|76035439|FG000|NOT COMPLETED|Overall Study||0||
59914473|NCT04146467|76035440|FG001|NOT COMPLETED|Overall Study||3||
59914474|NCT02705716|76035451|FG000|STARTED|Overall Study||72||
59914475|NCT02705716|76035452|FG001|STARTED|Overall Study||70||
59914476|NCT02705716|76035451|FG000|COMPLETED|Overall Study||68||
59914477|NCT02705716|76035452|FG001|COMPLETED|Overall Study||68||
59914478|NCT02705716|76035451|FG000|NOT COMPLETED|Overall Study||4||
59914479|NCT02705716|76035452|FG001|NOT COMPLETED|Overall Study||2||
59914480|NCT04138043|76035460|FG000|STARTED|Overall Study||2||
59914481|NCT04138043|76035461|FG001|STARTED|Overall Study||7||
59914482|NCT04138043|76035460|FG000|COMPLETED|Overall Study||2||
59914483|NCT04138043|76035461|FG001|COMPLETED|Overall Study||6||
59914484|NCT04138043|76035460|FG000|NOT COMPLETED|Overall Study||0||
59914485|NCT04138043|76035461|FG001|NOT COMPLETED|Overall Study||1||
59914486|NCT02417142|76035470|FG000|STARTED|Overall Study||35||
59914487|NCT02417142|76035471|FG001|STARTED|Overall Study||35||
59914488|NCT02417142|76035470|FG000|COMPLETED|Overall Study||19||
59914489|NCT02417142|76035471|FG001|COMPLETED|Overall Study||22||
59914490|NCT02417142|76035470|FG000|NOT COMPLETED|Overall Study||16||
59914491|NCT02417142|76035471|FG001|NOT COMPLETED|Overall Study||13||
59914492|NCT03443713|76035480|FG000|STARTED|Start up Visit (2 Hours)||8||
59914493|NCT03443713|76035481|FG001|STARTED|Start up Visit (2 Hours)||8||
59914494|NCT03443713|76035482|FG002|STARTED|Start up Visit (2 Hours)||9||
59914495|NCT03443713|76035480|FG000|COMPLETED|Start up Visit (2 Hours)||8||
59914496|NCT03443713|76035481|FG001|COMPLETED|Start up Visit (2 Hours)||8||
59914497|NCT03443713|76035482|FG002|COMPLETED|Start up Visit (2 Hours)||9||
59914498|NCT03443713|76035480|FG000|NOT COMPLETED|Start up Visit (2 Hours)||0||
59914499|NCT03443713|76035481|FG001|NOT COMPLETED|Start up Visit (2 Hours)||0||
59914500|NCT03443713|76035482|FG002|NOT COMPLETED|Start up Visit (2 Hours)||0||
59914501|NCT03443713|76035480|FG000|STARTED|First at Home Period (9-14 Days)||8||
59914502|NCT03443713|76035481|FG001|STARTED|First at Home Period (9-14 Days)||8||
59914503|NCT03443713|76035482|FG002|STARTED|First at Home Period (9-14 Days)||9||
59914504|NCT03443713|76035480|FG000|COMPLETED|First at Home Period (9-14 Days)||8||
59914505|NCT03443713|76035481|FG001|COMPLETED|First at Home Period (9-14 Days)||8||
59914506|NCT03443713|76035482|FG002|COMPLETED|First at Home Period (9-14 Days)||8||
59914507|NCT03443713|76035480|FG000|NOT COMPLETED|First at Home Period (9-14 Days)||0||
59914508|NCT03443713|76035481|FG001|NOT COMPLETED|First at Home Period (9-14 Days)||0||
59914509|NCT03443713|76035482|FG002|NOT COMPLETED|First at Home Period (9-14 Days)||1||
59914510|NCT03443713|76035480|FG000|STARTED|First Exercise Visit (1 Hour)||8||
59914511|NCT03443713|76035481|FG001|STARTED|First Exercise Visit (1 Hour)||8||
59914512|NCT03443713|76035482|FG002|STARTED|First Exercise Visit (1 Hour)||8||
59914513|NCT03443713|76035480|FG000|COMPLETED|First Exercise Visit (1 Hour)||8||
59914514|NCT03443713|76035481|FG001|COMPLETED|First Exercise Visit (1 Hour)||8||
59914515|NCT03443713|76035482|FG002|COMPLETED|First Exercise Visit (1 Hour)||8||
59914516|NCT03443713|76035480|FG000|NOT COMPLETED|First Exercise Visit (1 Hour)||0||
59914517|NCT03443713|76035481|FG001|NOT COMPLETED|First Exercise Visit (1 Hour)||0||
59914518|NCT03443713|76035482|FG002|NOT COMPLETED|First Exercise Visit (1 Hour)||0||
59914519|NCT03443713|76035480|FG000|STARTED|Dexcom Insertion Visit (30 Minutes)||8||
59914520|NCT03443713|76035481|FG001|STARTED|Dexcom Insertion Visit (30 Minutes)||8||
59914521|NCT03443713|76035482|FG002|STARTED|Dexcom Insertion Visit (30 Minutes)||8||
59914522|NCT03443713|76035480|FG000|COMPLETED|Dexcom Insertion Visit (30 Minutes)||8||
59914523|NCT03443713|76035481|FG001|COMPLETED|Dexcom Insertion Visit (30 Minutes)||8||
59914524|NCT03443713|76035482|FG002|COMPLETED|Dexcom Insertion Visit (30 Minutes)||8||
59914525|NCT03443713|76035480|FG000|NOT COMPLETED|Dexcom Insertion Visit (30 Minutes)||0||
59914526|NCT03443713|76035481|FG001|NOT COMPLETED|Dexcom Insertion Visit (30 Minutes)||0||
59914527|NCT03443713|76035482|FG002|NOT COMPLETED|Dexcom Insertion Visit (30 Minutes)||0||
59914528|NCT03443713|76035480|FG000|STARTED|Second at Home Period (2-11 Days)||8||
59914529|NCT03443713|76035481|FG001|STARTED|Second at Home Period (2-11 Days)||8||
59914530|NCT03443713|76035482|FG002|STARTED|Second at Home Period (2-11 Days)||8||
59914531|NCT03443713|76035480|FG000|COMPLETED|Second at Home Period (2-11 Days)||8||
59914532|NCT03443713|76035481|FG001|COMPLETED|Second at Home Period (2-11 Days)||8||
59914533|NCT03443713|76035482|FG002|COMPLETED|Second at Home Period (2-11 Days)||8||
59914534|NCT03443713|76035480|FG000|NOT COMPLETED|Second at Home Period (2-11 Days)||0||
59914535|NCT03443713|76035481|FG001|NOT COMPLETED|Second at Home Period (2-11 Days)||0||
59914536|NCT03443713|76035482|FG002|NOT COMPLETED|Second at Home Period (2-11 Days)||0||
59914537|NCT03443713|76035480|FG000|STARTED|Second Exercise Visit (1 Hour)||8||
59914538|NCT03443713|76035481|FG001|STARTED|Second Exercise Visit (1 Hour)||8||
59914539|NCT03443713|76035482|FG002|STARTED|Second Exercise Visit (1 Hour)||8||
59914540|NCT03443713|76035480|FG000|COMPLETED|Second Exercise Visit (1 Hour)||8||
59914541|NCT03443713|76035481|FG001|COMPLETED|Second Exercise Visit (1 Hour)||8||
59914542|NCT03443713|76035482|FG002|COMPLETED|Second Exercise Visit (1 Hour)||8||
59914543|NCT03443713|76035480|FG000|NOT COMPLETED|Second Exercise Visit (1 Hour)||0||
59914544|NCT03443713|76035481|FG001|NOT COMPLETED|Second Exercise Visit (1 Hour)||0||
59914545|NCT03443713|76035482|FG002|NOT COMPLETED|Second Exercise Visit (1 Hour)||0||
59914546|NCT03443713|76035480|FG000|STARTED|Third at Home Period (8-12 Days)||8||
59914547|NCT03443713|76035481|FG001|STARTED|Third at Home Period (8-12 Days)||8||
59914548|NCT03443713|76035482|FG002|STARTED|Third at Home Period (8-12 Days)||8||
59914549|NCT03443713|76035480|FG000|COMPLETED|Third at Home Period (8-12 Days)||8||
60022843|NCT02265705|76138785|FG005|STARTED|Follow-up Period|Participants from placebo who never rescued or switched and entered post-treatment follow-up period.|2||
60022844|NCT02265705|76138786|FG006|STARTED|Follow-up Period|Participants who ever took baricitinib and entered the post-treatment follow-up period.|58||
60022845|NCT02265705|76138780|FG000|COMPLETED|Follow-up Period||0||
60022846|NCT02265705|76138781|FG001|COMPLETED|Follow-up Period||0||
60022847|NCT02265705|76138782|FG002|COMPLETED|Follow-up Period||0||
60022848|NCT02265705|76138783|FG003|COMPLETED|Follow-up Period||0||
60022849|NCT02265705|76138784|FG004|COMPLETED|Follow-up Period||0||
60022850|NCT02265705|76138785|FG005|COMPLETED|Follow-up Period||1||
60022851|NCT02265705|76138786|FG006|COMPLETED|Follow-up Period||47||
60022852|NCT02265705|76138780|FG000|NOT COMPLETED|Follow-up Period||0||
60022853|NCT02265705|76138781|FG001|NOT COMPLETED|Follow-up Period||0||
60022854|NCT02265705|76138782|FG002|NOT COMPLETED|Follow-up Period||0||
60022855|NCT02265705|76138783|FG003|NOT COMPLETED|Follow-up Period||0||
60022856|NCT02265705|76138784|FG004|NOT COMPLETED|Follow-up Period||0||
60022857|NCT02265705|76138785|FG005|NOT COMPLETED|Follow-up Period||1||
60022858|NCT02265705|76138786|FG006|NOT COMPLETED|Follow-up Period||11||
60022859|NCT02459665|76138801|FG000|STARTED|Overall Study||17|Enrollment visit|
60022860|NCT02459665|76138802|FG001|STARTED|Overall Study||17|Enrollment visit|
60022861|NCT02459665|76138803|FG002|STARTED|Overall Study||17|Enrollment visit|
60022862|NCT02459665|76138804|FG003|STARTED|Overall Study||17|Enrollment visit|
60022863|NCT02459665|76138801|FG000|Day 7 Visit|Overall Study||17||
60022864|NCT02459665|76138802|FG001|Day 7 Visit|Overall Study||17||
60022865|NCT02459665|76138803|FG002|Day 7 Visit|Overall Study||17||
60022866|NCT02459665|76138804|FG003|Day 7 Visit|Overall Study||16||
60022867|NCT02459665|76138801|FG000|Month 1 Visit|Overall Study||17||
60022868|NCT02459665|76138802|FG001|Month 1 Visit|Overall Study||17||
60022869|NCT02459665|76138803|FG002|Month 1 Visit|Overall Study||17||
59758946|NCT00562627|75878280|FG000|STARTED|Overall Study||34||
59758947|NCT00562627|75878281|FG001|STARTED|Overall Study||34||
60022870|NCT02459665|76138804|FG003|Month 1 Visit|Overall Study||16||
60022871|NCT02459665|76138801|FG000|Month 2 Visit|Overall Study||17|Cessation of interventions|
60022872|NCT02459665|76138802|FG001|Month 2 Visit|Overall Study||16|Cessation of interventions|
60022873|NCT02459665|76138803|FG002|Month 2 Visit|Overall Study||17|Cessation of interventions|
59758948|NCT00562627|75878282|FG002|STARTED|Overall Study||34||
59758949|NCT00562627|75878280|FG000|COMPLETED|Overall Study||33||
59758950|NCT00562627|75878281|FG001|COMPLETED|Overall Study||33||
59758951|NCT00562627|75878282|FG002|COMPLETED|Overall Study||33||
59758952|NCT00562627|75878280|FG000|NOT COMPLETED|Overall Study||1||
59758953|NCT00562627|75878281|FG001|NOT COMPLETED|Overall Study||1||
59758954|NCT00562627|75878282|FG002|NOT COMPLETED|Overall Study||1||
60022874|NCT02459665|76138804|FG003|Month 2 Visit|Overall Study||16|Cessation of interventions|
60022875|NCT02459665|76138801|FG000|Month 6 Visit|Overall Study||17|Final study visit|
60022876|NCT02459665|76138802|FG001|Month 6 Visit|Overall Study||16|Final study visit|
60022877|NCT02459665|76138803|FG002|Month 6 Visit|Overall Study||16|Final study visit|
60022878|NCT02459665|76138804|FG003|Month 6 Visit|Overall Study||15|Final study visit|
60022879|NCT02459665|76138801|FG000|COMPLETED|Overall Study||17|Month 6|
60022880|NCT02459665|76138802|FG001|COMPLETED|Overall Study||16|Month 6|
60022881|NCT02459665|76138803|FG002|COMPLETED|Overall Study||16|Month 6|
60022882|NCT02459665|76138804|FG003|COMPLETED|Overall Study||15|Month 6|
60022883|NCT02459665|76138801|FG000|NOT COMPLETED|Overall Study||0||
60022884|NCT02459665|76138802|FG001|NOT COMPLETED|Overall Study||1||
60022885|NCT02459665|76138803|FG002|NOT COMPLETED|Overall Study||1||
60022886|NCT02459665|76138804|FG003|NOT COMPLETED|Overall Study||2||
60022887|NCT02265237|76138825|FG000|STARTED|As Enrolled (Overall Study)||59||
60022888|NCT02265237|76138826|FG001|STARTED|As Enrolled (Overall Study)||61||
60022889|NCT02265237|76138827|FG002|STARTED|As Enrolled (Overall Study)||61||
60022890|NCT02265237|76138828|FG003|STARTED|As Enrolled (Overall Study)||3||
60022891|NCT02265237|76138825|FG000|COMPLETED|As Enrolled (Overall Study)||54||
60022892|NCT02265237|76138826|FG001|COMPLETED|As Enrolled (Overall Study)||58||
60022893|NCT02265237|76138827|FG002|COMPLETED|As Enrolled (Overall Study)||51||
60022894|NCT02265237|76138828|FG003|COMPLETED|As Enrolled (Overall Study)||2||
60022895|NCT02265237|76138825|FG000|NOT COMPLETED|As Enrolled (Overall Study)||5||
60022896|NCT02265237|76138826|FG001|NOT COMPLETED|As Enrolled (Overall Study)||3||
60022897|NCT02265237|76138827|FG002|NOT COMPLETED|As Enrolled (Overall Study)||10||
60022898|NCT02265237|76138828|FG003|NOT COMPLETED|As Enrolled (Overall Study)||1||
60022899|NCT02265237|76138825|FG000|STARTED|As Treated (Overall Study)|One arm B subject received the drug for the duration for arm A and was included in arm A for safety.|60||
60022900|NCT02265237|76138826|FG001|STARTED|As Treated (Overall Study)|One arm B subject received the drug for the duration for arm A and was included in arm A for safety.|60||
60022901|NCT02265237|76138827|FG002|STARTED|As Treated (Overall Study)||61||
60022902|NCT02265237|76138828|FG003|STARTED|As Treated (Overall Study)||3||
60022903|NCT02265237|76138825|FG000|COMPLETED|As Treated (Overall Study)||55||
60022904|NCT02265237|76138826|FG001|COMPLETED|As Treated (Overall Study)||57||
60022905|NCT02265237|76138827|FG002|COMPLETED|As Treated (Overall Study)||51||
60022906|NCT02265237|76138828|FG003|COMPLETED|As Treated (Overall Study)||2||
60022907|NCT02265237|76138825|FG000|NOT COMPLETED|As Treated (Overall Study)||5||
60022908|NCT02265237|76138826|FG001|NOT COMPLETED|As Treated (Overall Study)||3||
60022909|NCT02265237|76138827|FG002|NOT COMPLETED|As Treated (Overall Study)||10||
60022910|NCT02265237|76138828|FG003|NOT COMPLETED|As Treated (Overall Study)||1||
60022911|NCT02263365|76138841|FG000|STARTED|Overall Study||22||
60022912|NCT02263365|76138842|FG001|STARTED|Overall Study||18||
60022913|NCT02263365|76138841|FG000|COMPLETED|Overall Study||0||
60022914|NCT02263365|76138842|FG001|COMPLETED|Overall Study||0||
60022915|NCT02263365|76138841|FG000|NOT COMPLETED|Overall Study||22||
60022916|NCT02263365|76138842|FG001|NOT COMPLETED|Overall Study||18||
60022917|NCT02261493|76138852|FG000|STARTED|Overall Study||156||
60022918|NCT02261493|76138853|FG001|STARTED|Overall Study||318||
60022919|NCT02261493|76138854|FG002|STARTED|Overall Study||313||
60022920|NCT02261493|76138852|FG000|COMPLETED|Overall Study||126||
60022921|NCT02261493|76138853|FG001|COMPLETED|Overall Study||271||
60022922|NCT02261493|76138854|FG002|COMPLETED|Overall Study||287||
60022923|NCT02261493|76138852|FG000|NOT COMPLETED|Overall Study||30||
60022924|NCT02261493|76138853|FG001|NOT COMPLETED|Overall Study||47||
60022925|NCT02261493|76138854|FG002|NOT COMPLETED|Overall Study||26||
60022926|NCT02260791|76138864|FG000|STARTED|Overall Study||366||
60022927|NCT02260791|76138865|FG001|STARTED|Overall Study||362||
60022928|NCT02260791|76138864|FG000|COMPLETED|Overall Study||333||
59611608|NCT01775904|75722585|FG000|STARTED|LY2886721 ODT (Water, Fed)||25||
60022929|NCT02260791|76138865|FG001|COMPLETED|Overall Study||328||
60022930|NCT02260791|76138864|FG000|NOT COMPLETED|Overall Study||33||
60022931|NCT02260791|76138865|FG001|NOT COMPLETED|Overall Study||34||
60022932|NCT02260635|76138873|FG000|STARTED|Double-Blind Treatment Period||27||
60022933|NCT02260635|76138874|FG001|STARTED|Double-Blind Treatment Period||27||
60022934|NCT02260635|76138873|FG000|Received at Least One Dose of Study Drug|Double-Blind Treatment Period||27||
60022935|NCT02260635|76138874|FG001|Received at Least One Dose of Study Drug|Double-Blind Treatment Period||26||
59611609|NCT01775904|75722585|FG000|Received at Least One Dose of Drug|LY2886721 ODT (Water, Fed)||25||
59611610|NCT01775904|75722585|FG000|COMPLETED|LY2886721 ODT (Water, Fed)||25||
59611611|NCT01775904|75722585|FG000|NOT COMPLETED|LY2886721 ODT (Water, Fed)||0||
59611612|NCT01775904|75722585|FG000|STARTED|Third Washout (7 Days)||25||
60022936|NCT02260635|76138873|FG000|COMPLETED|Double-Blind Treatment Period||26||
60022937|NCT02260635|76138874|FG001|COMPLETED|Double-Blind Treatment Period||25||
60022938|NCT02260635|76138873|FG000|NOT COMPLETED|Double-Blind Treatment Period||1||
60022939|NCT02260635|76138874|FG001|NOT COMPLETED|Double-Blind Treatment Period||2||
60022940|NCT02260635|76138873|FG000|STARTED|Open-Label Extension||26||
60022941|NCT02260635|76138874|FG001|STARTED|Open-Label Extension||25||
60022942|NCT02260635|76138873|FG000|Received at Least One Dose of Study Drug|Open-Label Extension||26||
60022943|NCT02260635|76138874|FG001|Received at Least One Dose of Study Drug|Open-Label Extension||25||
60022944|NCT02260635|76138873|FG000|COMPLETED|Open-Label Extension||0||
60022945|NCT02260635|76138874|FG001|COMPLETED|Open-Label Extension||0||
60022946|NCT02260635|76138873|FG000|NOT COMPLETED|Open-Label Extension||26||
60022947|NCT02260635|76138874|FG001|NOT COMPLETED|Open-Label Extension||25||
60022948|NCT02259231|76138889|FG000|STARTED|Overall Study||6||
60022949|NCT02259231|76138890|FG001|STARTED|Overall Study||6||
60022950|NCT02259231|76138891|FG002|STARTED|Overall Study||6||
60022951|NCT02259231|76138892|FG003|STARTED|Overall Study||6||
60022952|NCT02259231|76138893|FG004|STARTED|Overall Study||6||
60022953|NCT02259231|76138894|FG005|STARTED|Overall Study||6||
60022954|NCT02259231|76138895|FG006|STARTED|Overall Study||5||
60022955|NCT02259231|76138889|FG000|COMPLETED|Overall Study||0||
60022956|NCT02259231|76138890|FG001|COMPLETED|Overall Study||0||
60022957|NCT02259231|76138891|FG002|COMPLETED|Overall Study||0||
60022958|NCT02259231|76138892|FG003|COMPLETED|Overall Study||0||
60022959|NCT02259231|76138893|FG004|COMPLETED|Overall Study||0||
60022960|NCT02259231|76138894|FG005|COMPLETED|Overall Study||0||
60022961|NCT02259231|76138895|FG006|COMPLETED|Overall Study||0||
60022962|NCT02259231|76138889|FG000|NOT COMPLETED|Overall Study||6||
60022963|NCT02259231|76138890|FG001|NOT COMPLETED|Overall Study||6||
60022964|NCT02259231|76138891|FG002|NOT COMPLETED|Overall Study||6||
60022965|NCT02259231|76138892|FG003|NOT COMPLETED|Overall Study||6||
60022966|NCT02259231|76138893|FG004|NOT COMPLETED|Overall Study||6||
60022967|NCT02259231|76138894|FG005|NOT COMPLETED|Overall Study||6||
60022968|NCT02259231|76138895|FG006|NOT COMPLETED|Overall Study||5||
60022969|NCT02258529|76138911|FG000|STARTED|Overall Study||10||
60022970|NCT02258529|76138911|FG000|COMPLETED|Overall Study||0||
60022971|NCT02258529|76138911|FG000|NOT COMPLETED|Overall Study||10||
60022972|NCT02256969|76138918|FG000|STARTED|Overall Study||15||
60022973|NCT02256969|76138919|FG001|STARTED|Overall Study||15||
60022974|NCT02256969|76138920|FG002|STARTED|Overall Study||15||
60022975|NCT02256969|76138918|FG000|COMPLETED|Overall Study||13||
60022976|NCT02256969|76138919|FG001|COMPLETED|Overall Study||14||
60022977|NCT02256969|76138920|FG002|COMPLETED|Overall Study||14||
60022978|NCT02256969|76138918|FG000|NOT COMPLETED|Overall Study||2||
60022979|NCT02256969|76138919|FG001|NOT COMPLETED|Overall Study||1||
60022980|NCT02256969|76138920|FG002|NOT COMPLETED|Overall Study||1||
60022981|NCT02256891|76138930|FG000|STARTED|Overall Study||55||
60022982|NCT02256891|76138931|FG001|STARTED|Overall Study||42||
60022983|NCT02256891|76138930|FG000|COMPLETED|Overall Study||43||
60022984|NCT02256891|76138931|FG001|COMPLETED|Overall Study||29||
60022985|NCT02256891|76138930|FG000|NOT COMPLETED|Overall Study||12||
60022986|NCT02256891|76138931|FG001|NOT COMPLETED|Overall Study||13||
60022987|NCT02256267|76138939|FG000|STARTED|Period 1 (Day 1; Day 2 to Day 9 Washout)||24||
60022988|NCT02256267|76138939|FG000|Received at Least 1 Dose of LY2835219|Period 1 (Day 1; Day 2 to Day 9 Washout)||24||
60022989|NCT02256267|76138939|FG000|COMPLETED|Period 1 (Day 1; Day 2 to Day 9 Washout)||23||
60022990|NCT02256267|76138939|FG000|NOT COMPLETED|Period 1 (Day 1; Day 2 to Day 9 Washout)||1||
60022991|NCT02256267|76138939|FG000|STARTED|Period 2 (Day 1 to Day 6)||23||
60022992|NCT02256267|76138939|FG000|Received at Least 1 Dose of Rifampin|Period 2 (Day 1 to Day 6)||23||
60022993|NCT02256267|76138939|FG000|COMPLETED|Period 2 (Day 1 to Day 6)||23||
60022994|NCT02256267|76138939|FG000|NOT COMPLETED|Period 2 (Day 1 to Day 6)||0||
60022995|NCT02256267|76138939|FG000|STARTED|Period 2 (Day 7 to Day 14)||23||
60022996|NCT02256267|76138939|FG000|Received LY2835219 + Rifampin|Period 2 (Day 7 to Day 14)||23||
60022997|NCT02256267|76138939|FG000|COMPLETED|Period 2 (Day 7 to Day 14)||22||
60022998|NCT02256267|76138939|FG000|NOT COMPLETED|Period 2 (Day 7 to Day 14)||1||
60022999|NCT01641471|76138948|FG000|STARTED|Overall Study||58||
60023000|NCT01641471|76138949|FG001|STARTED|Overall Study||58||
60023001|NCT01641471|76138948|FG000|COMPLETED|Overall Study||35||
60023002|NCT01641471|76138949|FG001|COMPLETED|Overall Study||31||
60023003|NCT01641471|76138948|FG000|NOT COMPLETED|Overall Study||23||
60023004|NCT01641471|76138949|FG001|NOT COMPLETED|Overall Study||27||
60023005|NCT02255565|76138958|FG000|STARTED|Overall Study||9||
60023006|NCT02255565|76138959|FG001|STARTED|Overall Study||9||
60023007|NCT02255565|76138960|FG002|STARTED|Overall Study||9||
60023008|NCT02255565|76138958|FG000|COMPLETED|Overall Study||9||
60023009|NCT02255565|76138959|FG001|COMPLETED|Overall Study||8||
60023010|NCT02255565|76138960|FG002|COMPLETED|Overall Study||9||
60023011|NCT02255565|76138958|FG000|NOT COMPLETED|Overall Study||0||
60023012|NCT02255565|76138959|FG001|NOT COMPLETED|Overall Study||1||
60023013|NCT02255565|76138960|FG002|NOT COMPLETED|Overall Study||0||
60023014|NCT01640301|76139003|FG000|STARTED|Overall Study||13||
60023015|NCT01640301|76139004|FG001|STARTED|Overall Study||15||
60023016|NCT01640301|76139003|FG000|COMPLETED|Overall Study||13||
60023017|NCT01640301|76139004|FG001|COMPLETED|Overall Study||7||
60023018|NCT01640301|76139003|FG000|NOT COMPLETED|Overall Study||0||
60023019|NCT01640301|76139004|FG001|NOT COMPLETED|Overall Study||8||
60023020|NCT01642407|76139012|FG000|STARTED|Part 1 (Screening Till Week 16)||6||
60023021|NCT01642407|76139012|FG000|COMPLETED|Part 1 (Screening Till Week 16)||3||
60023022|NCT01642407|76139012|FG000|NOT COMPLETED|Part 1 (Screening Till Week 16)||3||
60023023|NCT01642407|76139012|FG000|STARTED|Part 2(Week17 to Maximum of 119.6 Weeks)||3||
60023024|NCT01642407|76139012|FG000|COMPLETED|Part 2(Week17 to Maximum of 119.6 Weeks)||1||
60023025|NCT01642407|76139012|FG000|NOT COMPLETED|Part 2(Week17 to Maximum of 119.6 Weeks)||2||
60023026|NCT02255097|76139016|FG000|STARTED|Overall Study||172||
60023027|NCT02255097|76139016|FG000|Treated|Overall Study||171||
60023028|NCT02255097|76139016|FG000|Received Second Course of Pembrolizumab|Overall Study||3||
60023029|NCT02255097|76139016|FG000|COMPLETED|Overall Study||0||
60023030|NCT02255097|76139016|FG000|NOT COMPLETED|Overall Study||172||
60023031|NCT02254551|76139021|FG000|STARTED|Dose Escalation||7||
60023032|NCT02254551|76139021|FG000|Cohort 1: LDE225 400mg|Dose Escalation|1 patient was found to be refractory to bortezomib and deemed ineligible.|7||
60023033|NCT02254551|76139021|FG000|Cohort 2: LDE225 600mg|Dose Escalation||0||
60023034|NCT02254551|76139021|FG000|Cohort 3: LDE225 800mg|Dose Escalation||0||
60023035|NCT02254551|76139021|FG000|COMPLETED|Dose Escalation|Due to toxicity and lack of efficacy, no other dose levels were examined.|4||
60023036|NCT02254551|76139021|FG000|NOT COMPLETED|Dose Escalation||3||
60023037|NCT02254551|76139021|FG000|STARTED|Expansion||0||
60023038|NCT02254551|76139021|FG000|COMPLETED|Expansion||0||
60023039|NCT02254551|76139021|FG000|NOT COMPLETED|Expansion||0||
60023040|NCT02254551|76139021|FG000|STARTED|Maintenance||0||
60023041|NCT02254551|76139021|FG000|COMPLETED|Maintenance||0||
60023042|NCT02254551|76139021|FG000|NOT COMPLETED|Maintenance||0||
59914550|NCT03443713|76035481|FG001|COMPLETED|Third at Home Period (8-12 Days)||8||
59914551|NCT03443713|76035482|FG002|COMPLETED|Third at Home Period (8-12 Days)||8||
59914552|NCT03443713|76035480|FG000|NOT COMPLETED|Third at Home Period (8-12 Days)||0||
59914553|NCT03443713|76035481|FG001|NOT COMPLETED|Third at Home Period (8-12 Days)||0||
59914554|NCT03443713|76035482|FG002|NOT COMPLETED|Third at Home Period (8-12 Days)||0||
59914555|NCT03443713|76035480|FG000|STARTED|Close-out Visit (30 Minutes)||8||
59914556|NCT03443713|76035481|FG001|STARTED|Close-out Visit (30 Minutes)||8||
59914557|NCT03443713|76035482|FG002|STARTED|Close-out Visit (30 Minutes)||8||
59914558|NCT03443713|76035480|FG000|COMPLETED|Close-out Visit (30 Minutes)||8||
59914559|NCT03443713|76035481|FG001|COMPLETED|Close-out Visit (30 Minutes)||8||
59914560|NCT03443713|76035482|FG002|COMPLETED|Close-out Visit (30 Minutes)||8||
59914561|NCT03443713|76035480|FG000|NOT COMPLETED|Close-out Visit (30 Minutes)||0||
59914562|NCT03443713|76035481|FG001|NOT COMPLETED|Close-out Visit (30 Minutes)||0||
59914563|NCT03443713|76035482|FG002|NOT COMPLETED|Close-out Visit (30 Minutes)||0||
59914564|NCT04133519|76035496|FG000|STARTED|Overall Study||188||
59914565|NCT04133519|76035497|FG001|STARTED|Overall Study||190||
59914566|NCT04133519|76035496|FG000|COMPLETED|Overall Study||182||
59914567|NCT04133519|76035497|FG001|COMPLETED|Overall Study||184||
59914568|NCT04133519|76035496|FG000|NOT COMPLETED|Overall Study||6||
59914569|NCT04133519|76035497|FG001|NOT COMPLETED|Overall Study||6||
59914570|NCT04007159|76035503|FG000|STARTED|Induction Phase||280||
59914571|NCT04007159|76035503|FG000|COMPLETED|Induction Phase||258||
59914572|NCT04007159|76035503|FG000|NOT COMPLETED|Induction Phase||22||
59914573|NCT04007159|76035503|FG000|STARTED|Rest Phase||258||
59914574|NCT04007159|76035503|FG000|COMPLETED|Rest Phase||258||
59914575|NCT04007159|76035503|FG000|NOT COMPLETED|Rest Phase||0||
59914576|NCT04007159|76035503|FG000|STARTED|Challenge Phase||258||
59914577|NCT04007159|76035503|FG000|COMPLETED|Challenge Phase||255||
59914578|NCT04007159|76035503|FG000|NOT COMPLETED|Challenge Phase||3||
59914579|NCT03119688|76035514|FG000|STARTED|Overall Study||48||
59914580|NCT03119688|76035514|FG000|COMPLETED|Overall Study||44||
59914581|NCT03119688|76035514|FG000|NOT COMPLETED|Overall Study||4||
59914582|NCT03389893|76035533|FG000|STARTED|Randomized Double Blind Period||46|The primary outcome was measured through Day 28, during the Randomized Double Blind Placebo Controlled (RDBPC) portion of the study.|
59914583|NCT03389893|76035534|FG001|STARTED|Randomized Double Blind Period||26|The primary outcome was measured through Day 28, during the Randomized Double Blind Placebo Controlled (RDBPC) portion of the study.|
59914584|NCT03389893|76035535|FG002|STARTED|Randomized Double Blind Period||0|The primary outcome was measured through Day 28, during the Randomized Double Blind Placebo Controlled (RDBPC) portion of the study.|
59914585|NCT03389893|76035536|FG003|STARTED|Randomized Double Blind Period||0|The primary outcome was measured through Day 28, during the Randomized Double Blind Placebo Controlled (RDBPC) portion of the study.|
59914586|NCT03389893|76035533|FG000|COMPLETED|Randomized Double Blind Period||45||
59914587|NCT03389893|76035534|FG001|COMPLETED|Randomized Double Blind Period||26||
59914588|NCT03389893|76035535|FG002|COMPLETED|Randomized Double Blind Period||0||
59914589|NCT03389893|76035536|FG003|COMPLETED|Randomized Double Blind Period||0||
59914590|NCT03389893|76035533|FG000|NOT COMPLETED|Randomized Double Blind Period||1||
59914591|NCT03389893|76035534|FG001|NOT COMPLETED|Randomized Double Blind Period||0||
59914592|NCT03389893|76035535|FG002|NOT COMPLETED|Randomized Double Blind Period||0||
59914593|NCT03389893|76035536|FG003|NOT COMPLETED|Randomized Double Blind Period||0||
59914594|NCT03389893|76035533|FG000|STARTED|Open Label Extension and Follow-Up||0||
59914595|NCT03389893|76035534|FG001|STARTED|Open Label Extension and Follow-Up||0||
59914596|NCT03389893|76035535|FG002|STARTED|Open Label Extension and Follow-Up||45||
59914597|NCT03389893|76035536|FG003|STARTED|Open Label Extension and Follow-Up||26||
59914598|NCT03389893|76035533|FG000|COMPLETED|Open Label Extension and Follow-Up||0|3 participants were lost to follow-up after Day 112|
59914599|NCT03389893|76035534|FG001|COMPLETED|Open Label Extension and Follow-Up||0|3 participants were lost to follow-up after Day 112|
59914600|NCT03389893|76035535|FG002|COMPLETED|Open Label Extension and Follow-Up||41|3 participants were lost to follow-up after Day 112|
59914601|NCT03389893|76035536|FG003|COMPLETED|Open Label Extension and Follow-Up||25|3 participants were lost to follow-up after Day 112|
59914602|NCT03389893|76035533|FG000|NOT COMPLETED|Open Label Extension and Follow-Up||0||
59914603|NCT03389893|76035534|FG001|NOT COMPLETED|Open Label Extension and Follow-Up||0||
59914604|NCT03389893|76035535|FG002|NOT COMPLETED|Open Label Extension and Follow-Up||4||
59914605|NCT03389893|76035536|FG003|NOT COMPLETED|Open Label Extension and Follow-Up||1||
59914606|NCT04128293|76035546|FG000|STARTED|Treatment Period 1 (1 Day)||4||
59914607|NCT04128293|76035547|FG001|STARTED|Treatment Period 1 (1 Day)||4||
59914608|NCT04128293|76035548|FG002|STARTED|Treatment Period 1 (1 Day)||4||
59914609|NCT04128293|76035549|FG003|STARTED|Treatment Period 1 (1 Day)||4||
59914610|NCT04128293|76035546|FG000|COMPLETED|Treatment Period 1 (1 Day)||4||
59914611|NCT04128293|76035547|FG001|COMPLETED|Treatment Period 1 (1 Day)||4||
59914612|NCT04128293|76035548|FG002|COMPLETED|Treatment Period 1 (1 Day)||4||
59914613|NCT04128293|76035549|FG003|COMPLETED|Treatment Period 1 (1 Day)||4||
59914614|NCT04128293|76035546|FG000|NOT COMPLETED|Treatment Period 1 (1 Day)||0||
59914615|NCT04128293|76035547|FG001|NOT COMPLETED|Treatment Period 1 (1 Day)||0||
59914616|NCT04128293|76035548|FG002|NOT COMPLETED|Treatment Period 1 (1 Day)||0||
59914617|NCT04128293|76035549|FG003|NOT COMPLETED|Treatment Period 1 (1 Day)||0||
59914618|NCT04128293|76035546|FG000|STARTED|Washout Period 1 (Up to 7 Days)||4||
59914619|NCT04128293|76035547|FG001|STARTED|Washout Period 1 (Up to 7 Days)||4||
59914620|NCT04128293|76035548|FG002|STARTED|Washout Period 1 (Up to 7 Days)||4||
59914621|NCT04128293|76035549|FG003|STARTED|Washout Period 1 (Up to 7 Days)||4||
59914622|NCT04128293|76035546|FG000|COMPLETED|Washout Period 1 (Up to 7 Days)||4||
59914623|NCT04128293|76035547|FG001|COMPLETED|Washout Period 1 (Up to 7 Days)||4||
59914624|NCT04128293|76035548|FG002|COMPLETED|Washout Period 1 (Up to 7 Days)||4||
59914625|NCT04128293|76035549|FG003|COMPLETED|Washout Period 1 (Up to 7 Days)||4||
59914626|NCT04128293|76035546|FG000|NOT COMPLETED|Washout Period 1 (Up to 7 Days)||0||
59914627|NCT04128293|76035547|FG001|NOT COMPLETED|Washout Period 1 (Up to 7 Days)||0||
59914628|NCT04128293|76035548|FG002|NOT COMPLETED|Washout Period 1 (Up to 7 Days)||0||
59914629|NCT04128293|76035549|FG003|NOT COMPLETED|Washout Period 1 (Up to 7 Days)||0||
59914630|NCT04128293|76035546|FG000|STARTED|Treatment Period 2 (1 Day)||4||
59914631|NCT04128293|76035547|FG001|STARTED|Treatment Period 2 (1 Day)||4||
59914632|NCT04128293|76035548|FG002|STARTED|Treatment Period 2 (1 Day)||4||
59914633|NCT04128293|76035549|FG003|STARTED|Treatment Period 2 (1 Day)||4||
59914634|NCT04128293|76035546|FG000|COMPLETED|Treatment Period 2 (1 Day)||4||
59914635|NCT04128293|76035547|FG001|COMPLETED|Treatment Period 2 (1 Day)||4||
59914636|NCT04128293|76035548|FG002|COMPLETED|Treatment Period 2 (1 Day)||4||
59914637|NCT04128293|76035549|FG003|COMPLETED|Treatment Period 2 (1 Day)||4||
59914638|NCT04128293|76035546|FG000|NOT COMPLETED|Treatment Period 2 (1 Day)||0||
59914639|NCT04128293|76035547|FG001|NOT COMPLETED|Treatment Period 2 (1 Day)||0||
59914640|NCT04128293|76035548|FG002|NOT COMPLETED|Treatment Period 2 (1 Day)||0||
59914641|NCT04128293|76035549|FG003|NOT COMPLETED|Treatment Period 2 (1 Day)||0||
59914642|NCT04128293|76035546|FG000|STARTED|Washout Period 2 (Up to 7 Days)||4||
59914643|NCT04128293|76035547|FG001|STARTED|Washout Period 2 (Up to 7 Days)||4||
59914644|NCT04128293|76035548|FG002|STARTED|Washout Period 2 (Up to 7 Days)||4||
59914645|NCT04128293|76035549|FG003|STARTED|Washout Period 2 (Up to 7 Days)||4||
59914646|NCT04128293|76035546|FG000|COMPLETED|Washout Period 2 (Up to 7 Days)||0||
59914647|NCT04128293|76035547|FG001|COMPLETED|Washout Period 2 (Up to 7 Days)||0||
59914648|NCT04128293|76035548|FG002|COMPLETED|Washout Period 2 (Up to 7 Days)||0||
59914649|NCT04128293|76035549|FG003|COMPLETED|Washout Period 2 (Up to 7 Days)||0||
59914650|NCT04128293|76035546|FG000|NOT COMPLETED|Washout Period 2 (Up to 7 Days)||4||
59914651|NCT04128293|76035547|FG001|NOT COMPLETED|Washout Period 2 (Up to 7 Days)||4||
59914652|NCT04128293|76035548|FG002|NOT COMPLETED|Washout Period 2 (Up to 7 Days)||4||
59914653|NCT04128293|76035549|FG003|NOT COMPLETED|Washout Period 2 (Up to 7 Days)||4||
59914654|NCT04128293|76035546|FG000|STARTED|Treatment Period 3 (1 Day)||0||
59914655|NCT04128293|76035547|FG001|STARTED|Treatment Period 3 (1 Day)||0||
59914656|NCT04128293|76035548|FG002|STARTED|Treatment Period 3 (1 Day)||0||
59914657|NCT04128293|76035549|FG003|STARTED|Treatment Period 3 (1 Day)||0||
59507316|NCT02151331|75600526|FG000|NOT COMPLETED|Overall Study||32||
59507317|NCT02151331|75600527|FG001|NOT COMPLETED|Overall Study||40||
59507318|NCT02067585|75600536|FG000|STARTED|Overall Study||16||
59507319|NCT02067585|75600537|FG001|STARTED|Overall Study||16||
59507320|NCT02067585|75600538|FG002|STARTED|Overall Study||16||
59507321|NCT02067585|75600536|FG000|COMPLETED|Overall Study||16||
59507322|NCT02067585|75600537|FG001|COMPLETED|Overall Study||16||
59914658|NCT04128293|76035546|FG000|COMPLETED|Treatment Period 3 (1 Day)||0||
59914659|NCT04128293|76035547|FG001|COMPLETED|Treatment Period 3 (1 Day)||0||
59914660|NCT04128293|76035548|FG002|COMPLETED|Treatment Period 3 (1 Day)||0||
59914661|NCT04128293|76035549|FG003|COMPLETED|Treatment Period 3 (1 Day)||0||
59914662|NCT04128293|76035546|FG000|NOT COMPLETED|Treatment Period 3 (1 Day)||0||
59914663|NCT04128293|76035547|FG001|NOT COMPLETED|Treatment Period 3 (1 Day)||0||
59914664|NCT04128293|76035548|FG002|NOT COMPLETED|Treatment Period 3 (1 Day)||0||
59914665|NCT04128293|76035549|FG003|NOT COMPLETED|Treatment Period 3 (1 Day)||0||
59914666|NCT04128293|76035546|FG000|STARTED|Washout Period 3 (Up to 7 Days)||0||
59914667|NCT04128293|76035547|FG001|STARTED|Washout Period 3 (Up to 7 Days)||0||
59914668|NCT04128293|76035548|FG002|STARTED|Washout Period 3 (Up to 7 Days)||0||
59914669|NCT04128293|76035549|FG003|STARTED|Washout Period 3 (Up to 7 Days)||0||
59914670|NCT04128293|76035546|FG000|COMPLETED|Washout Period 3 (Up to 7 Days)||0||
59914671|NCT04128293|76035547|FG001|COMPLETED|Washout Period 3 (Up to 7 Days)||0||
59914672|NCT04128293|76035548|FG002|COMPLETED|Washout Period 3 (Up to 7 Days)||0||
59914673|NCT04128293|76035549|FG003|COMPLETED|Washout Period 3 (Up to 7 Days)||0||
59914674|NCT04128293|76035546|FG000|NOT COMPLETED|Washout Period 3 (Up to 7 Days)||0||
59914675|NCT04128293|76035547|FG001|NOT COMPLETED|Washout Period 3 (Up to 7 Days)||0||
59914676|NCT04128293|76035548|FG002|NOT COMPLETED|Washout Period 3 (Up to 7 Days)||0||
59914677|NCT04128293|76035549|FG003|NOT COMPLETED|Washout Period 3 (Up to 7 Days)||0||
59507323|NCT02067585|75600538|FG002|COMPLETED|Overall Study||16||
59507324|NCT02067585|75600536|FG000|NOT COMPLETED|Overall Study||0||
59507325|NCT02067585|75600537|FG001|NOT COMPLETED|Overall Study||0||
59507326|NCT02067585|75600538|FG002|NOT COMPLETED|Overall Study||0||
59914678|NCT04128293|76035546|FG000|STARTED|Treatment Period 4 (1 Day)||0||
59914679|NCT04128293|76035547|FG001|STARTED|Treatment Period 4 (1 Day)||0||
59914680|NCT04128293|76035548|FG002|STARTED|Treatment Period 4 (1 Day)||0||
59914681|NCT04128293|76035549|FG003|STARTED|Treatment Period 4 (1 Day)||0||
59507327|NCT02308839|75600546|FG000|STARTED|Overall Study||181||
59507328|NCT02308839|75600546|FG000|COMPLETED|Overall Study||72||
59507329|NCT02308839|75600546|FG000|NOT COMPLETED|Overall Study||109||
59507330|NCT02314689|75600550|FG000|STARTED|Overall Study||4||
59507331|NCT02314689|75600550|FG000|COMPLETED|Overall Study|Target citrulline level reached with first 4 subjects enrolled at initial IV citrulline of 20 mg/kg|4||
59914682|NCT04128293|76035546|FG000|COMPLETED|Treatment Period 4 (1 Day)||0||
59914683|NCT04128293|76035547|FG001|COMPLETED|Treatment Period 4 (1 Day)||0||
59914684|NCT04128293|76035548|FG002|COMPLETED|Treatment Period 4 (1 Day)||0||
59914685|NCT04128293|76035549|FG003|COMPLETED|Treatment Period 4 (1 Day)||0||
59914686|NCT04128293|76035546|FG000|NOT COMPLETED|Treatment Period 4 (1 Day)||0||
59914687|NCT04128293|76035547|FG001|NOT COMPLETED|Treatment Period 4 (1 Day)||0||
59914688|NCT04128293|76035548|FG002|NOT COMPLETED|Treatment Period 4 (1 Day)||0||
59914689|NCT04128293|76035549|FG003|NOT COMPLETED|Treatment Period 4 (1 Day)||0||
59914690|NCT00787176|76035568|FG000|STARTED|Overall Study||69||
59914691|NCT00787176|76035569|FG001|STARTED|Overall Study||62||
59914692|NCT00787176|76035570|FG002|STARTED|Overall Study||60||
59914693|NCT00787176|76035571|FG003|STARTED|Overall Study||60||
59914694|NCT00787176|76035568|FG000|COMPLETED|Overall Study||62||
59914695|NCT00787176|76035569|FG001|COMPLETED|Overall Study||59||
59914696|NCT00787176|76035570|FG002|COMPLETED|Overall Study||54||
59914697|NCT00787176|76035571|FG003|COMPLETED|Overall Study||55||
59914698|NCT00787176|76035568|FG000|NOT COMPLETED|Overall Study||7||
59914699|NCT00787176|76035569|FG001|NOT COMPLETED|Overall Study||3||
59914700|NCT00787176|76035570|FG002|NOT COMPLETED|Overall Study||6||
59914701|NCT00787176|76035571|FG003|NOT COMPLETED|Overall Study||5||
59914702|NCT03691571|76035584|FG000|STARTED|Overall Study||31||
59914703|NCT03691571|76035585|FG001|STARTED|Overall Study||24||
59914704|NCT03691571|76035584|FG000|COMPLETED|Overall Study||22|Eleven patients withdrew from the study prior to completing the post-procedure EGD due to delays obtaining the EGD prior to discharge.|
59914705|NCT03691571|76035585|FG001|COMPLETED|Overall Study||22|Eleven patients withdrew from the study prior to completing the post-procedure EGD due to delays obtaining the EGD prior to discharge.|
59914706|NCT03691571|76035584|FG000|NOT COMPLETED|Overall Study||9||
59914707|NCT03691571|76035585|FG001|NOT COMPLETED|Overall Study||2||
59914708|NCT03113916|76035594|FG000|STARTED|Overall Study||99||
59914709|NCT03113916|76035595|FG001|STARTED|Overall Study||96||
59914710|NCT03113916|76035594|FG000|COMPLETED|Overall Study||88||
59914711|NCT03113916|76035595|FG001|COMPLETED|Overall Study||84||
59914712|NCT03113916|76035594|FG000|NOT COMPLETED|Overall Study||11||
59914713|NCT03113916|76035595|FG001|NOT COMPLETED|Overall Study||12||
59914714|NCT02925494|76035610|FG000|STARTED|Treatment Period||59||
59914715|NCT02925494|76035611|FG001|STARTED|Treatment Period||58||
59914716|NCT02925494|76035612|FG002|STARTED|Treatment Period||98||
59914717|NCT02925494|76035613|FG003|STARTED|Treatment Period||218||
59914718|NCT02925494|76035610|FG000|COMPLETED|Treatment Period||50||
59914719|NCT02925494|76035611|FG001|COMPLETED|Treatment Period||43||
59914720|NCT02925494|76035612|FG002|COMPLETED|Treatment Period||79||
59914721|NCT02925494|76035613|FG003|COMPLETED|Treatment Period||182||
59914722|NCT02925494|76035610|FG000|NOT COMPLETED|Treatment Period||9||
59914723|NCT02925494|76035611|FG001|NOT COMPLETED|Treatment Period||15||
59914724|NCT02925494|76035612|FG002|NOT COMPLETED|Treatment Period||19||
59914725|NCT02925494|76035613|FG003|NOT COMPLETED|Treatment Period||36||
59914726|NCT02925494|76035610|FG000|STARTED|Post-Treatment Follow-Up Period||54|Completed or prematurely discontinued the Treatment Period and entered the follow-up period.|
59914727|NCT02925494|76035611|FG001|STARTED|Post-Treatment Follow-Up Period||47|Completed or prematurely discontinued the Treatment Period and entered the follow-up period.|
59914728|NCT02925494|76035612|FG002|STARTED|Post-Treatment Follow-Up Period||88|Completed or prematurely discontinued the Treatment Period and entered the follow-up period.|
60023043|NCT01641237|76139028|FG000|STARTED|Period I||16||
60023044|NCT01641237|76139029|FG001|STARTED|Period I||16||
60023045|NCT01641237|76139030|FG002|STARTED|Period I||15||
60023046|NCT01641237|76139031|FG003|STARTED|Period I||15||
60023047|NCT01641237|76139028|FG000|COMPLETED|Period I||16||
60023048|NCT01641237|76139029|FG001|COMPLETED|Period I||16||
60023049|NCT01641237|76139030|FG002|COMPLETED|Period I||15||
60023050|NCT01641237|76139031|FG003|COMPLETED|Period I||15||
60023051|NCT01641237|76139028|FG000|NOT COMPLETED|Period I||0||
60023052|NCT01641237|76139029|FG001|NOT COMPLETED|Period I||0||
60023053|NCT01641237|76139030|FG002|NOT COMPLETED|Period I||0||
60023054|NCT01641237|76139031|FG003|NOT COMPLETED|Period I||0||
60023055|NCT01641237|76139028|FG000|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|15||
60023056|NCT01641237|76139029|FG001|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|16||
60023057|NCT01641237|76139030|FG002|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|16||
60023058|NCT01641237|76139031|FG003|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|15||
60023059|NCT01641237|76139028|FG000|COMPLETED|Period II||14||
60023060|NCT01641237|76139029|FG001|COMPLETED|Period II||16||
59914729|NCT02925494|76035613|FG003|STARTED|Post-Treatment Follow-Up Period||184|Completed or prematurely discontinued the Treatment Period and entered the follow-up period.|
59914730|NCT02925494|76035610|FG000|COMPLETED|Post-Treatment Follow-Up Period||40||
59914731|NCT02925494|76035611|FG001|COMPLETED|Post-Treatment Follow-Up Period||37||
59914732|NCT02925494|76035612|FG002|COMPLETED|Post-Treatment Follow-Up Period||64||
59914733|NCT02925494|76035613|FG003|COMPLETED|Post-Treatment Follow-Up Period||134||
59914734|NCT02925494|76035610|FG000|NOT COMPLETED|Post-Treatment Follow-Up Period||14||
59914735|NCT02925494|76035611|FG001|NOT COMPLETED|Post-Treatment Follow-Up Period||10||
59914736|NCT02925494|76035612|FG002|NOT COMPLETED|Post-Treatment Follow-Up Period||24||
59914737|NCT02925494|76035613|FG003|NOT COMPLETED|Post-Treatment Follow-Up Period||50||
60023061|NCT01641237|76139030|FG002|COMPLETED|Period II||16||
60023062|NCT01641237|76139031|FG003|COMPLETED|Period II||15||
60023063|NCT01641237|76139028|FG000|NOT COMPLETED|Period II||1||
60023064|NCT01641237|76139029|FG001|NOT COMPLETED|Period II||0||
60023065|NCT01641237|76139030|FG002|NOT COMPLETED|Period II||0||
60023066|NCT01641237|76139031|FG003|NOT COMPLETED|Period II||0||
60023067|NCT01641237|76139028|FG000|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|16||
60023068|NCT01641237|76139029|FG001|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|14||
60023069|NCT01641237|76139030|FG002|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|15||
60023070|NCT01641237|76139031|FG003|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|16||
60023071|NCT01641237|76139028|FG000|COMPLETED|Period III||15||
60023072|NCT01641237|76139029|FG001|COMPLETED|Period III||14||
59914738|NCT04006145|76035626|FG000|STARTED|Overall Study||23||
60023073|NCT01641237|76139030|FG002|COMPLETED|Period III||15||
60023074|NCT01641237|76139031|FG003|COMPLETED|Period III||16||
60023075|NCT01641237|76139028|FG000|NOT COMPLETED|Period III||1||
60023076|NCT01641237|76139029|FG001|NOT COMPLETED|Period III||0||
60023077|NCT01641237|76139030|FG002|NOT COMPLETED|Period III||0||
60023078|NCT01641237|76139031|FG003|NOT COMPLETED|Period III||0||
60023079|NCT01641237|76139028|FG000|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|15||
60023080|NCT01641237|76139029|FG001|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|15||
60023081|NCT01641237|76139030|FG002|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|15||
60023082|NCT01641237|76139031|FG003|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|15||
60023083|NCT01641237|76139028|FG000|COMPLETED|Period IV||15||
60023084|NCT01641237|76139029|FG001|COMPLETED|Period IV||15||
60023085|NCT01641237|76139030|FG002|COMPLETED|Period IV||15||
60023086|NCT01641237|76139031|FG003|COMPLETED|Period IV||15||
60023087|NCT01641237|76139028|FG000|NOT COMPLETED|Period IV||0||
60023088|NCT01641237|76139029|FG001|NOT COMPLETED|Period IV||0||
60023089|NCT01641237|76139030|FG002|NOT COMPLETED|Period IV||0||
60023090|NCT01641237|76139031|FG003|NOT COMPLETED|Period IV||0||
60023091|NCT01639833|76139043|FG000|STARTED|Overall Study||45||
60023092|NCT01639833|76139044|FG001|STARTED|Overall Study||45||
60023093|NCT01639833|76139043|FG000|COMPLETED|Overall Study||39||
60023094|NCT01639833|76139044|FG001|COMPLETED|Overall Study||41||
60023095|NCT01639833|76139043|FG000|NOT COMPLETED|Overall Study||6||
60023096|NCT01639833|76139044|FG001|NOT COMPLETED|Overall Study||4||
60023097|NCT01639131|76139050|FG000|STARTED|Overall Study||6||
60023098|NCT01639131|76139050|FG000|COMPLETED|Overall Study||0||
60023099|NCT01639131|76139050|FG000|NOT COMPLETED|Overall Study||6||
60023100|NCT01641159|76139056|FG000|STARTED|Overall Study||35||
60023101|NCT01641159|76139057|FG001|STARTED|Overall Study||27||
60023102|NCT01641159|76139056|FG000|COMPLETED|Overall Study||33||
60023103|NCT01641159|76139057|FG001|COMPLETED|Overall Study||25||
60023104|NCT01641159|76139056|FG000|NOT COMPLETED|Overall Study||2||
60023105|NCT01641159|76139057|FG001|NOT COMPLETED|Overall Study||2||
60023106|NCT01641081|76139063|FG000|STARTED|Period 1||18||
60023107|NCT01641081|76139064|FG001|STARTED|Period 1||18||
60023108|NCT01641081|76139065|FG002|STARTED|Period 1||15||
60023109|NCT01641081|76139066|FG003|STARTED|Period 1||22||
60023110|NCT01641081|76139067|FG004|STARTED|Period 1||17||
60023111|NCT01641081|76139068|FG005|STARTED|Period 1||19||
60023112|NCT01641081|76139069|FG006|STARTED|Period 1||19||
60023113|NCT01641081|76139070|FG007|STARTED|Period 1||17||
60023114|NCT01641081|76139071|FG008|STARTED|Period 1||15||
60023115|NCT01641081|76139072|FG009|STARTED|Period 1||14||
60023116|NCT01641081|76139063|FG000|COMPLETED|Period 1||17||
60023117|NCT01641081|76139064|FG001|COMPLETED|Period 1||18||
60023118|NCT01641081|76139065|FG002|COMPLETED|Period 1||15||
60023119|NCT01641081|76139066|FG003|COMPLETED|Period 1||22||
60023120|NCT01641081|76139067|FG004|COMPLETED|Period 1||16||
60023121|NCT01641081|76139068|FG005|COMPLETED|Period 1||19||
60023122|NCT01641081|76139069|FG006|COMPLETED|Period 1||18||
60023123|NCT01641081|76139070|FG007|COMPLETED|Period 1||14||
60023124|NCT01641081|76139071|FG008|COMPLETED|Period 1||15||
60023125|NCT01641081|76139072|FG009|COMPLETED|Period 1||14||
60023126|NCT01641081|76139063|FG000|NOT COMPLETED|Period 1||1||
60023127|NCT01641081|76139064|FG001|NOT COMPLETED|Period 1||0||
60023128|NCT01641081|76139065|FG002|NOT COMPLETED|Period 1||0||
60023129|NCT01641081|76139066|FG003|NOT COMPLETED|Period 1||0||
60023130|NCT01641081|76139067|FG004|NOT COMPLETED|Period 1||1||
60023131|NCT01641081|76139068|FG005|NOT COMPLETED|Period 1||0||
60023132|NCT01641081|76139069|FG006|NOT COMPLETED|Period 1||1||
60023133|NCT01641081|76139070|FG007|NOT COMPLETED|Period 1||3||
60023134|NCT01641081|76139071|FG008|NOT COMPLETED|Period 1||0||
60023135|NCT01641081|76139072|FG009|NOT COMPLETED|Period 1||0||
60023136|NCT01641081|76139063|FG000|STARTED|Period 2||17||
60023137|NCT01641081|76139064|FG001|STARTED|Period 2||18||
60023138|NCT01641081|76139065|FG002|STARTED|Period 2||15||
60023139|NCT01641081|76139066|FG003|STARTED|Period 2||22||
60023140|NCT01641081|76139067|FG004|STARTED|Period 2||16||
60023141|NCT01641081|76139068|FG005|STARTED|Period 2||19||
60023142|NCT01641081|76139069|FG006|STARTED|Period 2||18||
60023143|NCT01641081|76139070|FG007|STARTED|Period 2||14||
60023144|NCT01641081|76139071|FG008|STARTED|Period 2||15||
60023145|NCT01641081|76139072|FG009|STARTED|Period 2||14||
60023146|NCT01641081|76139063|FG000|COMPLETED|Period 2||16||
60023147|NCT01641081|76139064|FG001|COMPLETED|Period 2||18||
60023148|NCT01641081|76139065|FG002|COMPLETED|Period 2||15||
60023149|NCT01641081|76139066|FG003|COMPLETED|Period 2||21||
60023150|NCT01641081|76139067|FG004|COMPLETED|Period 2||16||
60023151|NCT01641081|76139068|FG005|COMPLETED|Period 2||18||
60023152|NCT01641081|76139069|FG006|COMPLETED|Period 2||16||
60023153|NCT01641081|76139070|FG007|COMPLETED|Period 2||14||
60023154|NCT01641081|76139071|FG008|COMPLETED|Period 2||15||
60023155|NCT01641081|76139072|FG009|COMPLETED|Period 2||14||
60023156|NCT01641081|76139063|FG000|NOT COMPLETED|Period 2||1||
60023157|NCT01641081|76139064|FG001|NOT COMPLETED|Period 2||0||
60023158|NCT01641081|76139065|FG002|NOT COMPLETED|Period 2||0||
60023159|NCT01641081|76139066|FG003|NOT COMPLETED|Period 2||1||
60023160|NCT01641081|76139067|FG004|NOT COMPLETED|Period 2||0||
60023161|NCT01641081|76139068|FG005|NOT COMPLETED|Period 2||1||
60023162|NCT01641081|76139069|FG006|NOT COMPLETED|Period 2||2||
60023163|NCT01641081|76139070|FG007|NOT COMPLETED|Period 2||0||
60023164|NCT01641081|76139071|FG008|NOT COMPLETED|Period 2||0||
60023165|NCT01641081|76139072|FG009|NOT COMPLETED|Period 2||0||
60023166|NCT01641081|76139063|FG000|STARTED|Period 3||16||
60023167|NCT01641081|76139064|FG001|STARTED|Period 3||18||
60023168|NCT01641081|76139065|FG002|STARTED|Period 3||15||
60023169|NCT01641081|76139066|FG003|STARTED|Period 3||21||
60023170|NCT01641081|76139067|FG004|STARTED|Period 3||16||
60023171|NCT01641081|76139068|FG005|STARTED|Period 3||18||
60023172|NCT01641081|76139069|FG006|STARTED|Period 3||16||
60023173|NCT01641081|76139070|FG007|STARTED|Period 3||14||
60023174|NCT01641081|76139071|FG008|STARTED|Period 3||15||
60023175|NCT01641081|76139072|FG009|STARTED|Period 3||14||
60023176|NCT01641081|76139063|FG000|COMPLETED|Period 3||16||
60023177|NCT01641081|76139064|FG001|COMPLETED|Period 3||18||
60023178|NCT01641081|76139065|FG002|COMPLETED|Period 3||14||
60023179|NCT01641081|76139066|FG003|COMPLETED|Period 3||21||
60023180|NCT01641081|76139067|FG004|COMPLETED|Period 3||16||
60023181|NCT01641081|76139068|FG005|COMPLETED|Period 3||18||
60023182|NCT01641081|76139069|FG006|COMPLETED|Period 3||16||
60023183|NCT01641081|76139070|FG007|COMPLETED|Period 3||14||
60023184|NCT01641081|76139071|FG008|COMPLETED|Period 3||14||
60023185|NCT01641081|76139072|FG009|COMPLETED|Period 3||14||
60023186|NCT01641081|76139063|FG000|NOT COMPLETED|Period 3||0||
60023187|NCT01641081|76139064|FG001|NOT COMPLETED|Period 3||0||
60023188|NCT01641081|76139065|FG002|NOT COMPLETED|Period 3||1||
60023189|NCT01641081|76139066|FG003|NOT COMPLETED|Period 3||0||
60023190|NCT01641081|76139067|FG004|NOT COMPLETED|Period 3||0||
60023191|NCT01641081|76139068|FG005|NOT COMPLETED|Period 3||0||
60023192|NCT01641081|76139069|FG006|NOT COMPLETED|Period 3||0||
60023193|NCT01641081|76139070|FG007|NOT COMPLETED|Period 3||0||
60023194|NCT01641081|76139071|FG008|NOT COMPLETED|Period 3||1||
60023195|NCT01641081|76139072|FG009|NOT COMPLETED|Period 3||0||
60023196|NCT01641081|76139063|FG000|STARTED|Period 4||16||
60023197|NCT01641081|76139064|FG001|STARTED|Period 4||18||
60023198|NCT01641081|76139065|FG002|STARTED|Period 4||14||
60023199|NCT01641081|76139066|FG003|STARTED|Period 4||21||
60023200|NCT01641081|76139067|FG004|STARTED|Period 4||16||
60023201|NCT01641081|76139068|FG005|STARTED|Period 4||18||
60023202|NCT01641081|76139069|FG006|STARTED|Period 4||16||
60023203|NCT01641081|76139070|FG007|STARTED|Period 4||14||
60023204|NCT01641081|76139071|FG008|STARTED|Period 4||14||
60023205|NCT01641081|76139072|FG009|STARTED|Period 4||14||
60023206|NCT01641081|76139063|FG000|COMPLETED|Period 4||16||
60023207|NCT01641081|76139064|FG001|COMPLETED|Period 4||17||
60023208|NCT01641081|76139065|FG002|COMPLETED|Period 4||14||
60023209|NCT01641081|76139066|FG003|COMPLETED|Period 4||20||
60023210|NCT01641081|76139067|FG004|COMPLETED|Period 4||16||
60023211|NCT01641081|76139068|FG005|COMPLETED|Period 4||18||
60023212|NCT01641081|76139069|FG006|COMPLETED|Period 4||16||
60023213|NCT01641081|76139070|FG007|COMPLETED|Period 4||14||
60023214|NCT01641081|76139071|FG008|COMPLETED|Period 4||14||
60023215|NCT01641081|76139072|FG009|COMPLETED|Period 4||14||
60023216|NCT01641081|76139063|FG000|NOT COMPLETED|Period 4||0||
60023217|NCT01641081|76139064|FG001|NOT COMPLETED|Period 4||1||
60023218|NCT01641081|76139065|FG002|NOT COMPLETED|Period 4||0||
60023219|NCT01641081|76139066|FG003|NOT COMPLETED|Period 4||1||
60023220|NCT01641081|76139067|FG004|NOT COMPLETED|Period 4||0||
60023221|NCT01641081|76139068|FG005|NOT COMPLETED|Period 4||0||
60023222|NCT01641081|76139069|FG006|NOT COMPLETED|Period 4||0||
60023223|NCT01641081|76139070|FG007|NOT COMPLETED|Period 4||0||
60023224|NCT01641081|76139071|FG008|NOT COMPLETED|Period 4||0||
60023225|NCT01641081|76139072|FG009|NOT COMPLETED|Period 4||0||
60023226|NCT01641081|76139063|FG000|STARTED|Period 5||16||
60023227|NCT01641081|76139064|FG001|STARTED|Period 5||17||
60023228|NCT01641081|76139065|FG002|STARTED|Period 5||14||
60023229|NCT01641081|76139066|FG003|STARTED|Period 5||20||
60023230|NCT01641081|76139067|FG004|STARTED|Period 5||16||
60023231|NCT01641081|76139068|FG005|STARTED|Period 5||18||
60023232|NCT01641081|76139069|FG006|STARTED|Period 5||16||
60023233|NCT01641081|76139070|FG007|STARTED|Period 5||14||
60023234|NCT01641081|76139071|FG008|STARTED|Period 5||14||
60023235|NCT01641081|76139072|FG009|STARTED|Period 5||14||
60023236|NCT01641081|76139063|FG000|COMPLETED|Period 5||16||
59507332|NCT02314689|75600550|FG000|NOT COMPLETED|Overall Study||0||
60023237|NCT01641081|76139064|FG001|COMPLETED|Period 5||17||
60023238|NCT01641081|76139065|FG002|COMPLETED|Period 5||12||
60023239|NCT01641081|76139066|FG003|COMPLETED|Period 5||20||
60023240|NCT01641081|76139067|FG004|COMPLETED|Period 5||16||
60023241|NCT01641081|76139068|FG005|COMPLETED|Period 5||18||
60023242|NCT01641081|76139069|FG006|COMPLETED|Period 5||16||
60023243|NCT01641081|76139070|FG007|COMPLETED|Period 5||14||
60023244|NCT01641081|76139071|FG008|COMPLETED|Period 5||14||
60023245|NCT01641081|76139072|FG009|COMPLETED|Period 5||14||
60023246|NCT01641081|76139063|FG000|NOT COMPLETED|Period 5||0||
60023247|NCT01641081|76139064|FG001|NOT COMPLETED|Period 5||0||
60023248|NCT01641081|76139065|FG002|NOT COMPLETED|Period 5||2||
60023249|NCT01641081|76139066|FG003|NOT COMPLETED|Period 5||0||
60023250|NCT01641081|76139067|FG004|NOT COMPLETED|Period 5||0||
60023251|NCT01641081|76139068|FG005|NOT COMPLETED|Period 5||0||
60023252|NCT01641081|76139069|FG006|NOT COMPLETED|Period 5||0||
60023253|NCT01641081|76139070|FG007|NOT COMPLETED|Period 5||0||
60023254|NCT01641081|76139071|FG008|NOT COMPLETED|Period 5||0||
60023255|NCT01641081|76139072|FG009|NOT COMPLETED|Period 5||0||
60023256|NCT01640925|76139086|FG000|STARTED|Overall Study||175||
60023257|NCT01640925|76139087|FG001|STARTED|Overall Study||175||
60023258|NCT01640925|76139086|FG000|COMPLETED|Overall Study||161||
60023259|NCT01640925|76139087|FG001|COMPLETED|Overall Study||164||
60023260|NCT01640925|76139086|FG000|NOT COMPLETED|Overall Study||14||
60023261|NCT01640925|76139087|FG001|NOT COMPLETED|Overall Study||11||
60023262|NCT01638429|76139093|FG000|STARTED|Overall Study||12||
60023263|NCT01638429|76139093|FG000|Pre-treatment Testing|Overall Study||11||
60023264|NCT01638429|76139093|FG000|Antibiotic Treatment|Overall Study||11||
60023265|NCT01638429|76139093|FG000|Post-treatment Testing|Overall Study||11||
60023266|NCT01638429|76139093|FG000|COMPLETED|Overall Study||11||
60023267|NCT01638429|76139093|FG000|NOT COMPLETED|Overall Study||1||
60023268|NCT01639755|76139101|FG000|STARTED|Overall Study||19||
60023269|NCT01639755|76139101|FG000|COMPLETED|Overall Study||0||
60023270|NCT01639755|76139101|FG000|NOT COMPLETED|Overall Study||19||
60023271|NCT01601535|76139111|FG000|STARTED|Phase 1||6||
60023272|NCT01601535|76139112|FG001|STARTED|Phase 1||6||
60023273|NCT01601535|76139113|FG002|STARTED|Phase 1||6||
60023274|NCT01601535|76139114|FG003|STARTED|Phase 1||4||
60023275|NCT01601535|76139115|FG004|STARTED|Phase 1||0||
59914739|NCT04006145|76035627|FG001|STARTED|Overall Study||24||
59914740|NCT04006145|76035626|FG000|Received Treatment|Overall Study||23||
59914741|NCT04006145|76035627|FG001|Received Treatment|Overall Study||24||
59914742|NCT04006145|76035626|FG000|COMPLETED|Overall Study||22||
59914743|NCT04006145|76035627|FG001|COMPLETED|Overall Study||21||
59914744|NCT04006145|76035626|FG000|NOT COMPLETED|Overall Study||1||
59914745|NCT04006145|76035627|FG001|NOT COMPLETED|Overall Study||3||
59914746|NCT03386773|76035635|FG000|STARTED|Overall Study||150||
59914747|NCT03386773|76035636|FG001|STARTED|Overall Study||150||
59914748|NCT03386773|76035635|FG000|COMPLETED|Overall Study||123||
59914749|NCT03386773|76035636|FG001|COMPLETED|Overall Study||115||
59914750|NCT03386773|76035635|FG000|NOT COMPLETED|Overall Study||27||
59914751|NCT03386773|76035636|FG001|NOT COMPLETED|Overall Study||35||
59914752|NCT04126343|76035648|FG000|STARTED|Overall Study||9||
59914753|NCT04126343|76035649|FG001|STARTED|Overall Study||9||
59914754|NCT04126343|76035650|FG002|STARTED|Overall Study||9||
59914755|NCT04126343|76035651|FG003|STARTED|Overall Study||9||
59914756|NCT04126343|76035652|FG004|STARTED|Overall Study||9||
59914757|NCT04126343|76035653|FG005|STARTED|Overall Study||9||
59914758|NCT04126343|76035648|FG000|Completed Padsevonil Period|Overall Study||9||
59914759|NCT04126343|76035649|FG001|Completed Padsevonil Period|Overall Study||9||
59914760|NCT04126343|76035650|FG002|Completed Padsevonil Period|Overall Study||9||
59914761|NCT04126343|76035651|FG003|Completed Padsevonil Period|Overall Study||7||
60023276|NCT01601535|76139116|FG005|STARTED|Phase 1||0||
60023277|NCT01601535|76139111|FG000|COMPLETED|Phase 1||0||
60023278|NCT01601535|76139112|FG001|COMPLETED|Phase 1||0||
60023279|NCT01601535|76139113|FG002|COMPLETED|Phase 1||1||
60023280|NCT01601535|76139114|FG003|COMPLETED|Phase 1||0||
60023281|NCT01601535|76139115|FG004|COMPLETED|Phase 1||0||
60023282|NCT01601535|76139116|FG005|COMPLETED|Phase 1||0||
59914762|NCT04126343|76035652|FG004|Completed Padsevonil Period|Overall Study||9||
59914763|NCT04126343|76035653|FG005|Completed Padsevonil Period|Overall Study||8||
59914764|NCT04126343|76035648|FG000|Completed Placebo Period|Overall Study||9||
59914765|NCT04126343|76035649|FG001|Completed Placebo Period|Overall Study||7||
59914766|NCT04126343|76035650|FG002|Completed Placebo Period|Overall Study||9||
59914767|NCT04126343|76035651|FG003|Completed Placebo Period|Overall Study||9||
59914768|NCT04126343|76035652|FG004|Completed Placebo Period|Overall Study||7||
60023283|NCT01601535|76139111|FG000|NOT COMPLETED|Phase 1||6||
60023284|NCT01601535|76139112|FG001|NOT COMPLETED|Phase 1||6||
60023285|NCT01601535|76139113|FG002|NOT COMPLETED|Phase 1||5||
60023286|NCT01601535|76139114|FG003|NOT COMPLETED|Phase 1||4||
60023287|NCT01601535|76139115|FG004|NOT COMPLETED|Phase 1||0||
59914769|NCT04126343|76035653|FG005|Completed Placebo Period|Overall Study||9||
59914770|NCT04126343|76035648|FG000|Completed Moxifloxacin Period|Overall Study||8||
59914771|NCT04126343|76035649|FG001|Completed Moxifloxacin Period|Overall Study||9||
59914772|NCT04126343|76035650|FG002|Completed Moxifloxacin Period|Overall Study||7||
60023288|NCT01601535|76139116|FG005|NOT COMPLETED|Phase 1||0||
60023289|NCT01601535|76139111|FG000|STARTED|Phase 2||0||
60023290|NCT01601535|76139112|FG001|STARTED|Phase 2||0||
60023291|NCT01601535|76139113|FG002|STARTED|Phase 2||0||
60023292|NCT01601535|76139114|FG003|STARTED|Phase 2||0||
60023293|NCT01601535|76139115|FG004|STARTED|Phase 2||20||
60023294|NCT01601535|76139116|FG005|STARTED|Phase 2||12||
60023295|NCT01601535|76139111|FG000|COMPLETED|Phase 2||0||
60023296|NCT01601535|76139112|FG001|COMPLETED|Phase 2||0||
60023297|NCT01601535|76139113|FG002|COMPLETED|Phase 2||0||
60023298|NCT01601535|76139114|FG003|COMPLETED|Phase 2||0||
60023299|NCT01601535|76139115|FG004|COMPLETED|Phase 2||1||
60023300|NCT01601535|76139116|FG005|COMPLETED|Phase 2||0||
60023301|NCT01601535|76139111|FG000|NOT COMPLETED|Phase 2||0||
60023302|NCT01601535|76139112|FG001|NOT COMPLETED|Phase 2||0||
60023303|NCT01601535|76139113|FG002|NOT COMPLETED|Phase 2||0||
60023304|NCT01601535|76139114|FG003|NOT COMPLETED|Phase 2||0||
60023305|NCT01601535|76139115|FG004|NOT COMPLETED|Phase 2||19||
60023306|NCT01601535|76139116|FG005|NOT COMPLETED|Phase 2||12||
60023307|NCT01638819|76139141|FG000|STARTED|Overall Study||15||
60023308|NCT01638819|76139142|FG001|STARTED|Overall Study||15||
60023309|NCT01638819|76139141|FG000|First Intervention (8 Weeks)|Overall Study||15||
60023310|NCT01638819|76139142|FG001|First Intervention (8 Weeks)|Overall Study||15||
60023311|NCT01638819|76139141|FG000|Second Intervention (24 Weeks)|Overall Study||14||
60023312|NCT01638819|76139142|FG001|Second Intervention (24 Weeks)|Overall Study||15||
60023313|NCT01638819|76139141|FG000|COMPLETED|Overall Study||14||
60023314|NCT01638819|76139142|FG001|COMPLETED|Overall Study||15||
60023315|NCT01638819|76139141|FG000|NOT COMPLETED|Overall Study||1||
60023316|NCT01638819|76139142|FG001|NOT COMPLETED|Overall Study||0||
60023317|NCT01363713|76139147|FG000|STARTED|Overall Study|Assessed for eligibility|130||
59914773|NCT04126343|76035651|FG003|Completed Moxifloxacin Period|Overall Study||9||
59914774|NCT04126343|76035652|FG004|Completed Moxifloxacin Period|Overall Study||9||
59914775|NCT04126343|76035653|FG005|Completed Moxifloxacin Period|Overall Study||9||
59914776|NCT04126343|76035648|FG000|COMPLETED|Overall Study||6||
59914777|NCT04126343|76035649|FG001|COMPLETED|Overall Study||5||
59914778|NCT04126343|76035650|FG002|COMPLETED|Overall Study||6||
59914779|NCT04126343|76035651|FG003|COMPLETED|Overall Study||5||
59914780|NCT04126343|76035652|FG004|COMPLETED|Overall Study||6||
59914781|NCT04126343|76035653|FG005|COMPLETED|Overall Study||5||
59914782|NCT04126343|76035648|FG000|NOT COMPLETED|Overall Study||3||
60023318|NCT01363713|76139147|FG000|ALLOCATED|Overall Study||130||
60023319|NCT01363713|76139147|FG000|COMPLETED|Overall Study|Analysed (n=130)|124||
60023320|NCT01363713|76139147|FG000|NOT COMPLETED|Overall Study||6||
60023321|NCT01637961|76139151|FG000|STARTED|Overall Study||23||
60023322|NCT01637961|76139151|FG000|COMPLETED|Overall Study|Eligible and treated patients.|21||
60023323|NCT01637961|76139151|FG000|NOT COMPLETED|Overall Study||2||
60023324|NCT04183335|76139163|FG000|STARTED|Overall Study||76||
60023325|NCT04183335|76139164|FG001|STARTED|Overall Study||75||
60023326|NCT04183335|76139163|FG000|Treated|Overall Study||75||
60023327|NCT04183335|76139164|FG001|Treated|Overall Study||75||
60023328|NCT04183335|76139163|FG000|COMPLETED|Overall Study||63||
60023329|NCT04183335|76139164|FG001|COMPLETED|Overall Study||72||
60023330|NCT04183335|76139163|FG000|NOT COMPLETED|Overall Study||13||
60023331|NCT04183335|76139164|FG001|NOT COMPLETED|Overall Study||3||
60023332|NCT04199793|76139172|FG000|STARTED|Overall Study||4||
60023333|NCT04199793|76139173|FG001|STARTED|Overall Study||4||
59914783|NCT04126343|76035649|FG001|NOT COMPLETED|Overall Study||4||
60023334|NCT04199793|76139172|FG000|COMPLETED|Overall Study||1||
60023335|NCT04199793|76139173|FG001|COMPLETED|Overall Study||1||
60023336|NCT04199793|76139172|FG000|NOT COMPLETED|Overall Study||3||
60023337|NCT04199793|76139173|FG001|NOT COMPLETED|Overall Study||3||
60023338|NCT04114539|76139179|FG000|STARTED|Overall Study||124||
60023339|NCT04114539|76139179|FG000|Safety Set (Treated)|Overall Study||121|The Safety Set included all participants who received at least one dose of study drug from the open labelled study.|
60023340|NCT04114539|76139179|FG000|Modified Intention-to-Treat Set|Overall Study||121|The Modified Intention-to-Treat (mITT) set included all participants who received at least one dose of study drug and had at least one post Baseline scoring of Yale Global Tic Severity Scale (YGTSS).|
60023341|NCT04114539|76139179|FG000|COMPLETED|Overall Study||80||
60023342|NCT04114539|76139179|FG000|NOT COMPLETED|Overall Study||44||
60023343|NCT01636947|76139185|FG000|STARTED|Overall Study||244||
60023344|NCT01636947|76139186|FG001|STARTED|Overall Study||250||
60023345|NCT01636947|76139185|FG000|Treated|Overall Study||242||
60023346|NCT01636947|76139186|FG001|Treated|Overall Study||248||
60023347|NCT01636947|76139185|FG000|COMPLETED|Overall Study||232||
59611613|NCT01775904|75722585|FG000|COMPLETED|Third Washout (7 Days)||25||
59611614|NCT01775904|75722585|FG000|NOT COMPLETED|Third Washout (7 Days)||0||
59611615|NCT01775904|75722585|FG000|STARTED|LY2886721 ODT (Water, Fasting)||25||
59611616|NCT01775904|75722585|FG000|Received at Least One Dose of Drug|LY2886721 ODT (Water, Fasting)|One participant was not dosed in this period due to an adverse event (AE).|24||
59611617|NCT01775904|75722585|FG000|COMPLETED|LY2886721 ODT (Water, Fasting)||24||
59611618|NCT01775904|75722585|FG000|NOT COMPLETED|LY2886721 ODT (Water, Fasting)||1||
59611619|NCT01775670|75722597|FG000|STARTED|Overall Study||1||
59611620|NCT01775670|75722598|FG001|STARTED|Overall Study||3||
59611621|NCT01775670|75722597|FG000|COMPLETED|Overall Study||0||
59914784|NCT04126343|76035650|FG002|NOT COMPLETED|Overall Study||3||
60023348|NCT01636947|76139186|FG001|COMPLETED|Overall Study||239||
60023349|NCT01636947|76139185|FG000|NOT COMPLETED|Overall Study||12||
60023350|NCT01636947|76139186|FG001|NOT COMPLETED|Overall Study||11||
60023351|NCT01635933|76139194|FG000|STARTED|Overall Study||178||
59914785|NCT04126343|76035651|FG003|NOT COMPLETED|Overall Study||4||
59914786|NCT04126343|76035652|FG004|NOT COMPLETED|Overall Study||3||
60023352|NCT01635933|76139195|FG001|STARTED|Overall Study||185||
60023353|NCT01635933|76139194|FG000|COMPLETED|Overall Study||176||
60023354|NCT01635933|76139195|FG001|COMPLETED|Overall Study||177||
60023355|NCT01635933|76139194|FG000|NOT COMPLETED|Overall Study||2||
60023356|NCT01635933|76139195|FG001|NOT COMPLETED|Overall Study||8||
60023357|NCT01635855|76139201|FG000|STARTED|Overall Study||117||
60023358|NCT01635855|76139201|FG000|COMPLETED|Overall Study||113||
60023359|NCT01635855|76139201|FG000|NOT COMPLETED|Overall Study||4||
60023360|NCT03052725|76139207|FG000|STARTED|Overall Study||194||
60023361|NCT03052725|76139208|FG001|STARTED|Overall Study||197||
60023362|NCT03052725|76139207|FG000|Safety Analysis Set|Overall Study||194|Enrolled and treated|
59611622|NCT01775670|75722598|FG001|COMPLETED|Overall Study||2||
59611623|NCT01775670|75722597|FG000|NOT COMPLETED|Overall Study||1||
60023363|NCT03052725|76139208|FG001|Safety Analysis Set|Overall Study||196|Enrolled and treated|
60023364|NCT03052725|76139207|FG000|COMPLETED|Overall Study||46|Completed treatment; due to study termination, the end of study visit was not conducted.|
60023365|NCT03052725|76139208|FG001|COMPLETED|Overall Study||47|Completed treatment; due to study termination, the end of study visit was not conducted.|
60023366|NCT03052725|76139207|FG000|NOT COMPLETED|Overall Study||148||
60023367|NCT03052725|76139208|FG001|NOT COMPLETED|Overall Study||150||
60023368|NCT02325531|76139217|FG000|STARTED|Overall Study|Data was collected at the clinic level, there was no data collected at the participant level|||9
60023369|NCT02325531|76139218|FG001|STARTED|Overall Study|Data was collected at the clinic level, there was no data collected at the participant level|||11
60023370|NCT02325531|76139219|FG002|STARTED|Overall Study|Data was collected at the clinic level, there was no data collected at the participant level|||9
60023371|NCT02325531|76139220|FG003|STARTED|Overall Study|Data was collected at the clinic level, there was no data collected at the participant level|||137
60023372|NCT02325531|76139217|FG000|COMPLETED|Overall Study|Data was collected at the clinic level, there was no data collected at the participant level|||9
60023373|NCT02325531|76139218|FG001|COMPLETED|Overall Study|Data was collected at the clinic level, there was no data collected at the participant level|||11
60023374|NCT02325531|76139219|FG002|COMPLETED|Overall Study|Data was collected at the clinic level, there was no data collected at the participant level|||7
60023375|NCT02325531|76139220|FG003|COMPLETED|Overall Study|Data was collected at the clinic level, there was no data collected at the participant level|||137
60023376|NCT02325531|76139217|FG000|NOT COMPLETED|Overall Study||||0
60023377|NCT02325531|76139218|FG001|NOT COMPLETED|Overall Study||||0
60023378|NCT02325531|76139219|FG002|NOT COMPLETED|Overall Study||||2
60023379|NCT02325531|76139220|FG003|NOT COMPLETED|Overall Study||||0
60023380|NCT01635153|76139232|FG000|STARTED|Overall Study||72||
60023381|NCT01635153|76139233|FG001|STARTED|Overall Study||79||
60023382|NCT01635153|76139232|FG000|COMPLETED|Overall Study||32||
60023383|NCT01635153|76139233|FG001|COMPLETED|Overall Study||36||
60023384|NCT01635153|76139232|FG000|NOT COMPLETED|Overall Study||40||
60023385|NCT01635153|76139233|FG001|NOT COMPLETED|Overall Study||43||
60023386|NCT01636713|76139242|FG000|STARTED|Overall Study||193||
60023387|NCT01636713|76139243|FG001|STARTED|Overall Study||194||
60023388|NCT01636713|76139244|FG002|STARTED|Overall Study||193||
60023389|NCT01636713|76139242|FG000|COMPLETED|Overall Study||161||
60023390|NCT01636713|76139243|FG001|COMPLETED|Overall Study||166||
60023391|NCT01636713|76139244|FG002|COMPLETED|Overall Study||170||
60023392|NCT01636713|76139242|FG000|NOT COMPLETED|Overall Study||32||
60023393|NCT01636713|76139243|FG001|NOT COMPLETED|Overall Study||28||
60023394|NCT01636713|76139244|FG002|NOT COMPLETED|Overall Study||23||
60023395|NCT01600053|76139252|FG000|STARTED|Overall Study||11||
60023396|NCT01600053|76139252|FG000|COMPLETED|Overall Study||0||
60023397|NCT01600053|76139252|FG000|NOT COMPLETED|Overall Study||11||
60023398|NCT01068249|76139256|FG000|STARTED|Overall Study||39||
60023399|NCT01068249|76139256|FG000|COMPLETED|Overall Study||35||
60023400|NCT01068249|76139256|FG000|NOT COMPLETED|Overall Study||4||
60023401|NCT01035099|76139262|FG000|STARTED|Overall Study||18||
60023402|NCT01035099|76139263|FG001|STARTED|Overall Study||22||
60023403|NCT01035099|76139262|FG000|COMPLETED|Overall Study||18||
60023404|NCT01035099|76139263|FG001|COMPLETED|Overall Study||22||
60023405|NCT01035099|76139262|FG000|NOT COMPLETED|Overall Study||0||
60023406|NCT01035099|76139263|FG001|NOT COMPLETED|Overall Study||0||
60023407|NCT02246673|76139275|FG000|STARTED|Overall Study||14||
60023408|NCT02246673|76139276|FG001|STARTED|Overall Study||12||
60023409|NCT02246673|76139277|FG002|STARTED|Overall Study||12||
60023410|NCT02246673|76139278|FG003|STARTED|Overall Study||14||
60023411|NCT02246673|76139279|FG004|STARTED|Overall Study||12||
60023412|NCT02246673|76139275|FG000|COMPLETED|Overall Study||13||
60023413|NCT02246673|76139276|FG001|COMPLETED|Overall Study||12||
60023414|NCT02246673|76139277|FG002|COMPLETED|Overall Study||12||
60023415|NCT02246673|76139278|FG003|COMPLETED|Overall Study||12||
60023416|NCT02246673|76139279|FG004|COMPLETED|Overall Study||11||
59611624|NCT01775670|75722598|FG001|NOT COMPLETED|Overall Study||1||
59611625|NCT01775124|75722606|FG000|STARTED|Core Period||168||
59611626|NCT01775124|75722607|FG001|STARTED|Core Period||166||
59611627|NCT01775124|75722606|FG000|Full Analysis Set|Core Period||167||
59611628|NCT01775124|75722607|FG001|Full Analysis Set|Core Period||166||
59611629|NCT01775124|75722606|FG000|Per Protocol Set|Core Period||157||
60023417|NCT02246673|76139275|FG000|NOT COMPLETED|Overall Study||1||
60023418|NCT02246673|76139276|FG001|NOT COMPLETED|Overall Study||0||
60023419|NCT02246673|76139277|FG002|NOT COMPLETED|Overall Study||0||
60023420|NCT02246673|76139278|FG003|NOT COMPLETED|Overall Study||2||
60023421|NCT02246673|76139279|FG004|NOT COMPLETED|Overall Study||1||
60023422|NCT03532425|76139323|FG000|STARTED|Overall Study||14||
60023423|NCT03532425|76139324|FG001|STARTED|Overall Study||14||
60023424|NCT03532425|76139323|FG000|COMPLETED|Overall Study||14||
60023425|NCT03532425|76139324|FG001|COMPLETED|Overall Study||13||
60023426|NCT03532425|76139323|FG000|NOT COMPLETED|Overall Study||0||
60023427|NCT03532425|76139324|FG001|NOT COMPLETED|Overall Study||1||
60023428|NCT03503877|76139330|FG000|STARTED|Overall Study||127||127
60023429|NCT03503877|76139331|FG001|STARTED|Overall Study||127||127
60023430|NCT03503877|76139330|FG000|COMPLETED|Overall Study||127||127
60023431|NCT03503877|76139331|FG001|COMPLETED|Overall Study||127||127
60023432|NCT03503877|76139330|FG000|NOT COMPLETED|Overall Study||0||0
60023433|NCT03503877|76139331|FG001|NOT COMPLETED|Overall Study||0||0
60023434|NCT02246439|76139341|FG000|STARTED|Overall Study|6 participants that enrolled in the study did not receive allocated intervention.|192|ITT Population (treated)|
60023435|NCT02246439|76139342|FG001|STARTED|Overall Study|3 participants that enrolled in the study did not receive allocated intervention.|129|ITT Population (treated)|
60023436|NCT02246439|76139341|FG000|Randomized|Overall Study||198||
60023437|NCT02246439|76139342|FG001|Randomized|Overall Study||132||
60023438|NCT02246439|76139341|FG000|COMPLETED|Overall Study||180||
60023439|NCT02246439|76139342|FG001|COMPLETED|Overall Study||118||
60023440|NCT02246439|76139341|FG000|NOT COMPLETED|Overall Study||12||
60023441|NCT02246439|76139342|FG001|NOT COMPLETED|Overall Study||11||
60023442|NCT02245737|76139351|FG000|STARTED|Overall Study||740||
60023443|NCT02245737|76139352|FG001|STARTED|Overall Study||739||
60023444|NCT02245737|76139353|FG002|STARTED|Overall Study||739||
60023445|NCT02245737|76139351|FG000|Received at Least 1 Dose of Study Drug|Overall Study||738||
60023446|NCT02245737|76139352|FG001|Received at Least 1 Dose of Study Drug|Overall Study||736||
60023447|NCT02245737|76139353|FG002|Received at Least 1 Dose of Study Drug|Overall Study||735||
60023448|NCT02245737|76139351|FG000|COMPLETED|Overall Study||187||
60023449|NCT02245737|76139352|FG001|COMPLETED|Overall Study||184||
60023450|NCT02245737|76139353|FG002|COMPLETED|Overall Study||168||
60023451|NCT02245737|76139351|FG000|NOT COMPLETED|Overall Study||553||
60023452|NCT02245737|76139352|FG001|NOT COMPLETED|Overall Study||555||
60023453|NCT02245737|76139353|FG002|NOT COMPLETED|Overall Study||571||
60023454|NCT02244957|76139365|FG000|STARTED|Overall Study||7||
60023455|NCT02244957|76139366|FG001|STARTED|Overall Study||16||
60023456|NCT02244957|76139365|FG000|COMPLETED|Overall Study||6||
60023457|NCT02244957|76139366|FG001|COMPLETED|Overall Study||16||
60023458|NCT02244957|76139365|FG000|NOT COMPLETED|Overall Study||1||
60023459|NCT02244957|76139366|FG001|NOT COMPLETED|Overall Study||0||
60023460|NCT02243865|76139376|FG000|STARTED|Overall Study||44||
60023461|NCT02243865|76139377|FG001|STARTED|Overall Study||43||
60023462|NCT02243865|76139376|FG000|COMPLETED|Overall Study||40||
60023463|NCT02243865|76139377|FG001|COMPLETED|Overall Study||38||
60023464|NCT02243865|76139376|FG000|NOT COMPLETED|Overall Study||4||
60023465|NCT02243865|76139377|FG001|NOT COMPLETED|Overall Study||5||
60023466|NCT02243631|76139387|FG000|STARTED|Overall Study||3||
60023467|NCT02243631|76139388|FG001|STARTED|Overall Study||5||
59507333|NCT02403999|75600557|FG000|STARTED|Overall Study||10||
60023468|NCT02243631|76139387|FG000|COMPLETED|Overall Study||3||
60023469|NCT02243631|76139388|FG001|COMPLETED|Overall Study||4||
60023470|NCT02243631|76139387|FG000|NOT COMPLETED|Overall Study||0||
60023471|NCT02243631|76139388|FG001|NOT COMPLETED|Overall Study||1||
60023472|NCT02242305|76139396|FG000|STARTED|Overall Study||151||
60023473|NCT02242305|76139397|FG001|STARTED|Overall Study||151||
60023474|NCT02242305|76139396|FG000|COMPLETED|Overall Study||145||
60023475|NCT02242305|76139397|FG001|COMPLETED|Overall Study||141||
60023476|NCT02242305|76139396|FG000|NOT COMPLETED|Overall Study||6||
60023477|NCT02242305|76139397|FG001|NOT COMPLETED|Overall Study||10||
60023478|NCT02240121|76139405|FG000|STARTED|Overall Study||40||
59507334|NCT02403999|75600558|FG001|STARTED|Overall Study||10||
59507335|NCT02403999|75600559|FG002|STARTED|Overall Study||11||
59507336|NCT02403999|75600557|FG000|COMPLETED|Overall Study||10||
60023479|NCT02240121|76139406|FG001|STARTED|Overall Study||40||
60023480|NCT02240121|76139405|FG000|COMPLETED|Overall Study||22||
59507337|NCT02403999|75600558|FG001|COMPLETED|Overall Study||10||
59507338|NCT02403999|75600559|FG002|COMPLETED|Overall Study||11||
59507339|NCT02403999|75600557|FG000|NOT COMPLETED|Overall Study||0||
60023481|NCT02240121|76139406|FG001|COMPLETED|Overall Study||20||
60023482|NCT02240121|76139405|FG000|NOT COMPLETED|Overall Study||18||
60023483|NCT02240121|76139406|FG001|NOT COMPLETED|Overall Study||20||
60023484|NCT02239263|76139412|FG000|STARTED|Overall Study||40||
60023485|NCT02239263|76139412|FG000|COMPLETED|Overall Study||34|6 subjects were programmed with the incorrect settings for testing and therefore were excluded from the final data set.|
60023486|NCT02239263|76139412|FG000|NOT COMPLETED|Overall Study||6||
60023487|NCT02238483|76139420|FG000|STARTED|Overall Study||108||108
60023488|NCT02238483|76139421|FG001|STARTED|Overall Study||105||105
60023489|NCT02238483|76139420|FG000|COMPLETED|Overall Study||93||93
60023490|NCT02238483|76139421|FG001|COMPLETED|Overall Study||91||91
60023491|NCT02238483|76139420|FG000|NOT COMPLETED|Overall Study||15||15
60023492|NCT02238483|76139421|FG001|NOT COMPLETED|Overall Study||14||14
60023493|NCT01632891|76139429|FG000|STARTED|Overall Study||26||
60023494|NCT01632891|76139430|FG001|STARTED|Overall Study||26||
60023495|NCT01632891|76139429|FG000|COMPLETED|Overall Study||25||
60023496|NCT01632891|76139430|FG001|COMPLETED|Overall Study||25||
60023497|NCT01632891|76139429|FG000|NOT COMPLETED|Overall Study||1||
60023498|NCT01632891|76139430|FG001|NOT COMPLETED|Overall Study||1||
59914787|NCT04126343|76035653|FG005|NOT COMPLETED|Overall Study||4||
59914788|NCT02952313|76035668|FG000|STARTED|Primary Endpoint||113||
59914789|NCT02952313|76035668|FG000|6 Months|Primary Endpoint||106||
59914790|NCT02952313|76035668|FG000|COMPLETED|Primary Endpoint||106||
59914791|NCT02952313|76035668|FG000|NOT COMPLETED|Primary Endpoint||7||
59914792|NCT02952313|76035668|FG000|STARTED|Long-term Follow-up||107|Participant with missed 6-month visit (primary endpoint) was included in later follow-up.|
59914793|NCT02952313|76035668|FG000|12-Month|Long-term Follow-up||93||
59914794|NCT02952313|76035668|FG000|18-Month|Long-term Follow-up||79||
60023499|NCT02208999|76139442|FG000|STARTED|Overall Study||106||
60023500|NCT02208999|76139442|FG000|COMPLETED|Overall Study||105||
60023501|NCT02208999|76139442|FG000|NOT COMPLETED|Overall Study||1||
60023502|NCT02208843|76139461|FG000|STARTED|Overall Study||60|Patients entered the study and all received at least 1 dose of afatinib|
60023503|NCT02208843|76139461|FG000|COMPLETED|Overall Study||0||
60023504|NCT02208843|76139461|FG000|NOT COMPLETED|Overall Study||60||
60023505|NCT02208063|76139467|FG000|STARTED|Overall Study||60|All Randomized|
60023506|NCT02208063|76139468|FG001|STARTED|Overall Study||61|All Randomized|
60023507|NCT02208063|76139467|FG000|Randomized and Treated|Overall Study||58||
60023508|NCT02208063|76139468|FG001|Randomized and Treated|Overall Study||60||
60023509|NCT02208063|76139467|FG000|Microbiological All Treated|Overall Study||47|Includes all subjects in the AT population who had a mono-microbial QBC positive for S. aureus.|
60023510|NCT02208063|76139468|FG001|Microbiological All Treated|Overall Study||52|Includes all subjects in the AT population who had a mono-microbial QBC positive for S. aureus.|
60023511|NCT02208063|76139467|FG000|COMPLETED|Overall Study||48||
60023512|NCT02208063|76139468|FG001|COMPLETED|Overall Study||50||
60023513|NCT02208063|76139467|FG000|NOT COMPLETED|Overall Study||12||
60023514|NCT02208063|76139468|FG001|NOT COMPLETED|Overall Study||11||
60023515|NCT02207907|76139476|FG000|STARTED|Overall Study||124||
60023516|NCT02207907|76139477|FG001|STARTED|Overall Study||123||
60023517|NCT02207907|76139476|FG000|COMPLETED|Overall Study||113||
60023518|NCT02207907|76139477|FG001|COMPLETED|Overall Study||115||
60023519|NCT02207907|76139476|FG000|NOT COMPLETED|Overall Study||11||
60023520|NCT02207907|76139477|FG001|NOT COMPLETED|Overall Study||8||
60023521|NCT02207829|76139486|FG000|STARTED|Overall Study||509||
60023522|NCT02207829|76139487|FG001|STARTED|Overall Study||508||
60023523|NCT02207829|76139486|FG000|COMPLETED|Overall Study||467||
60023524|NCT02207829|76139487|FG001|COMPLETED|Overall Study||474||
60023525|NCT02207829|76139486|FG000|NOT COMPLETED|Overall Study||42||
60023526|NCT02207829|76139487|FG001|NOT COMPLETED|Overall Study||34||
60023527|NCT02237157|76139493|FG000|STARTED|Gemcitabine, Local Delivery (Dose 1)||20||
60023528|NCT02237157|76139494|FG001|STARTED|Gemcitabine, Local Delivery (Dose 1)||0||
60023529|NCT02237157|76139495|FG002|STARTED|Gemcitabine, Local Delivery (Dose 1)||0||
60023530|NCT02237157|76139496|FG003|STARTED|Gemcitabine, Local Delivery (Dose 1)||0||
60023531|NCT02237157|76139493|FG000|COMPLETED|Gemcitabine, Local Delivery (Dose 1)||16||
60023532|NCT02237157|76139494|FG001|COMPLETED|Gemcitabine, Local Delivery (Dose 1)||0||
60023533|NCT02237157|76139495|FG002|COMPLETED|Gemcitabine, Local Delivery (Dose 1)||0||
60023534|NCT02237157|76139496|FG003|COMPLETED|Gemcitabine, Local Delivery (Dose 1)||0||
60023535|NCT02237157|76139493|FG000|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 1)||4||
60023536|NCT02237157|76139494|FG001|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 1)||0||
60023537|NCT02237157|76139495|FG002|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 1)||0||
60023538|NCT02237157|76139496|FG003|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 1)||0||
60023539|NCT02237157|76139493|FG000|STARTED|Gemcitabine, Local Delivery (Dose 2)||0||
60023540|NCT02237157|76139494|FG001|STARTED|Gemcitabine, Local Delivery (Dose 2)||15||
60023541|NCT02237157|76139495|FG002|STARTED|Gemcitabine, Local Delivery (Dose 2)||0||
60023542|NCT02237157|76139496|FG003|STARTED|Gemcitabine, Local Delivery (Dose 2)||0||
60023543|NCT02237157|76139493|FG000|COMPLETED|Gemcitabine, Local Delivery (Dose 2)||0||
60023544|NCT02237157|76139494|FG001|COMPLETED|Gemcitabine, Local Delivery (Dose 2)||15||
60023545|NCT02237157|76139495|FG002|COMPLETED|Gemcitabine, Local Delivery (Dose 2)||0||
60023546|NCT02237157|76139496|FG003|COMPLETED|Gemcitabine, Local Delivery (Dose 2)||0||
60023547|NCT02237157|76139493|FG000|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 2)||0||
60023548|NCT02237157|76139494|FG001|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 2)||0||
60023549|NCT02237157|76139495|FG002|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 2)||0||
60023550|NCT02237157|76139496|FG003|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 2)||0||
59914795|NCT02952313|76035668|FG000|COMPLETED|Long-term Follow-up||75||
59914796|NCT02952313|76035668|FG000|NOT COMPLETED|Long-term Follow-up||32||
60023551|NCT02237157|76139493|FG000|STARTED|Gemcitabine, Local Delivery (Dose 3)||0||
60023552|NCT02237157|76139494|FG001|STARTED|Gemcitabine, Local Delivery (Dose 3)||0||
60023553|NCT02237157|76139495|FG002|STARTED|Gemcitabine, Local Delivery (Dose 3)||11||
60023554|NCT02237157|76139496|FG003|STARTED|Gemcitabine, Local Delivery (Dose 3)||0||
60023555|NCT02237157|76139493|FG000|COMPLETED|Gemcitabine, Local Delivery (Dose 3)||0||
60023556|NCT02237157|76139494|FG001|COMPLETED|Gemcitabine, Local Delivery (Dose 3)||0||
60023557|NCT02237157|76139495|FG002|COMPLETED|Gemcitabine, Local Delivery (Dose 3)||11||
60023558|NCT02237157|76139496|FG003|COMPLETED|Gemcitabine, Local Delivery (Dose 3)||0||
60023559|NCT02237157|76139493|FG000|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 3)||0||
60023560|NCT02237157|76139494|FG001|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 3)||0||
60023561|NCT02237157|76139495|FG002|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 3)||0||
60023562|NCT02237157|76139496|FG003|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 3)||0||
60023563|NCT02237157|76139493|FG000|STARTED|Gemcitabine, Local Delivery (Dose 4)||0||
60023564|NCT02237157|76139494|FG001|STARTED|Gemcitabine, Local Delivery (Dose 4)||0||
60023565|NCT02237157|76139495|FG002|STARTED|Gemcitabine, Local Delivery (Dose 4)||0||
60023566|NCT02237157|76139496|FG003|STARTED|Gemcitabine, Local Delivery (Dose 4)||8||
60023567|NCT02237157|76139493|FG000|COMPLETED|Gemcitabine, Local Delivery (Dose 4)||0||
60023568|NCT02237157|76139494|FG001|COMPLETED|Gemcitabine, Local Delivery (Dose 4)||0||
60023569|NCT02237157|76139495|FG002|COMPLETED|Gemcitabine, Local Delivery (Dose 4)||0||
60023570|NCT02237157|76139496|FG003|COMPLETED|Gemcitabine, Local Delivery (Dose 4)||8||
60023571|NCT02237157|76139493|FG000|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 4)||0||
60023572|NCT02237157|76139494|FG001|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 4)||0||
60023573|NCT02237157|76139495|FG002|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 4)||0||
60023574|NCT02237157|76139496|FG003|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 4)||0||
60023575|NCT02237001|76139503|FG000|STARTED|Overall Study||30||
60023576|NCT02237001|76139503|FG000|6 Month Follow-up|Overall Study||27||
60023577|NCT02237001|76139503|FG000|12 Month Follow-up|Overall Study||21||
60023578|NCT02237001|76139503|FG000|24 Month Follow-up|Overall Study||19||
60023579|NCT02237001|76139503|FG000|COMPLETED|Overall Study||19||
60023580|NCT02237001|76139503|FG000|NOT COMPLETED|Overall Study||11||
60023581|NCT02236611|76139509|FG000|STARTED|Overall Study||516||
60023582|NCT02236611|76139510|FG001|STARTED|Overall Study||518||
60023583|NCT02236611|76139509|FG000|COMPLETED|Overall Study||490||
60023584|NCT02236611|76139510|FG001|COMPLETED|Overall Study||484||
60023585|NCT02236611|76139509|FG000|NOT COMPLETED|Overall Study||26||
60023586|NCT02236611|76139510|FG001|NOT COMPLETED|Overall Study||34||
60023587|NCT02234583|76139518|FG000|STARTED|Overall Study||847||
60023588|NCT02234583|76139519|FG001|STARTED|Overall Study||1241||
60023589|NCT02234583|76139518|FG000|COMPLETED|Overall Study||434||
60023590|NCT02234583|76139519|FG001|COMPLETED|Overall Study||685||
60023591|NCT02234583|76139518|FG000|NOT COMPLETED|Overall Study||413||
60023592|NCT02234583|76139519|FG001|NOT COMPLETED|Overall Study||556||
60023593|NCT03686397|76139533|FG000|STARTED|Overall Study||75|MITT Population|
60023594|NCT03686397|76139534|FG001|STARTED|Overall Study||35|MITT Population|
60023595|NCT03686397|76139533|FG000|COMPLETED|Overall Study||70||
60023596|NCT03686397|76139534|FG001|COMPLETED|Overall Study||27||
60023597|NCT03686397|76139533|FG000|NOT COMPLETED|Overall Study||5||
60023598|NCT03686397|76139534|FG001|NOT COMPLETED|Overall Study||8||
60023599|NCT02233803|76139540|FG000|STARTED|Treatment Period 1 (4-Wks)||100||
60023600|NCT02233803|76139541|FG001|STARTED|Treatment Period 1 (4-Wks)||99||
60023601|NCT02233803|76139540|FG000|COMPLETED|Treatment Period 1 (4-Wks)||97||
60023602|NCT02233803|76139541|FG001|COMPLETED|Treatment Period 1 (4-Wks)||95||
60023603|NCT02233803|76139540|FG000|NOT COMPLETED|Treatment Period 1 (4-Wks)||3||
60023604|NCT02233803|76139541|FG001|NOT COMPLETED|Treatment Period 1 (4-Wks)||4||
60023605|NCT02233803|76139540|FG000|STARTED|Washout Period (4-Wks)||97||
60023606|NCT02233803|76139541|FG001|STARTED|Washout Period (4-Wks)||95||
60023607|NCT02233803|76139540|FG000|COMPLETED|Washout Period (4-Wks)||95||
60023608|NCT02233803|76139541|FG001|COMPLETED|Washout Period (4-Wks)||93||
60023609|NCT02233803|76139540|FG000|NOT COMPLETED|Washout Period (4-Wks)||2||
60023610|NCT02233803|76139541|FG001|NOT COMPLETED|Washout Period (4-Wks)||2||
60023611|NCT02233803|76139540|FG000|STARTED|Treatment Period 2 (4-Wks)||95||
60023612|NCT02233803|76139541|FG001|STARTED|Treatment Period 2 (4-Wks)||93||
60023613|NCT02233803|76139540|FG000|COMPLETED|Treatment Period 2 (4-Wks)||93||
60023614|NCT02233803|76139541|FG001|COMPLETED|Treatment Period 2 (4-Wks)||91||
60023615|NCT02233803|76139540|FG000|NOT COMPLETED|Treatment Period 2 (4-Wks)||2||
60023616|NCT02233803|76139541|FG001|NOT COMPLETED|Treatment Period 2 (4-Wks)||2||
60023617|NCT02233647|76139549|FG000|STARTED|Overall Study||11||
60023618|NCT02233647|76139549|FG000|0 mg Cocaine With 0 mg Phendimetrazine|Overall Study||11||
60023619|NCT02233647|76139549|FG000|10 mg Cocaine With 0 mg Phendimetrazine|Overall Study||11||
60023620|NCT02233647|76139549|FG000|20 mg Cocaine With 0 mg Phendimetrazine|Overall Study||10||
60023621|NCT02233647|76139549|FG000|40 mg Cocaine With 0 mg Phendimetrazine|Overall Study||10||
60023622|NCT02233647|76139549|FG000|80 mg Cocaine With 0 mg Phendimetrazine|Overall Study||10||
60023623|NCT02233647|76139549|FG000|0 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10||
60023624|NCT02233647|76139549|FG000|10 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10||
60023625|NCT02233647|76139549|FG000|20 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10||
60023626|NCT02233647|76139549|FG000|40 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10||
60023627|NCT02233647|76139549|FG000|80 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10||
60023628|NCT02233647|76139549|FG000|0 mg Cocaine With 140 mg Phendimetrazine|Overall Study||10||
60023629|NCT02233647|76139549|FG000|10 mg Cocaine with140 mg Phendimetrazine|Overall Study||10||
60023630|NCT02233647|76139549|FG000|20 mg Cocaine with140 mg Phendimetrazine|Overall Study||10||
60023631|NCT02233647|76139549|FG000|40 mg Cocaine with140 mg Phendimetrazine|Overall Study||10||
60023632|NCT02233647|76139549|FG000|80 mg Cocaine with140 mg Phendimetrazine|Overall Study||10||
60023633|NCT02233647|76139549|FG000|0 mg Cocaine With 210 mg Phendimetrazine|Overall Study||10||
60023634|NCT02233647|76139549|FG000|10 mg Cocaine with210 mg Phendimetrazine|Overall Study||10||
60023635|NCT02233647|76139549|FG000|20 mg Cocaine with210 mg Phendimetrazine|Overall Study||10||
60023636|NCT02233647|76139549|FG000|40 mg Cocaine with210 mg Phendimetrazine|Overall Study||10||
60023637|NCT02233647|76139549|FG000|80 mg Cocaine with210 mg Phendimetrazine|Overall Study||10||
60023638|NCT02233647|76139549|FG000|COMPLETED|Overall Study||10||
60023639|NCT02233647|76139549|FG000|NOT COMPLETED|Overall Study||1||
60023640|NCT02233413|76139555|FG000|STARTED|Overall Study||35||
60023641|NCT02233413|76139556|FG001|STARTED|Overall Study||33||
60023642|NCT02233413|76139555|FG000|COMPLETED|Overall Study||24||
60023643|NCT02233413|76139556|FG001|COMPLETED|Overall Study||19||
60023644|NCT02233413|76139555|FG000|NOT COMPLETED|Overall Study||11||
60023645|NCT02233413|76139556|FG001|NOT COMPLETED|Overall Study||14||
60023646|NCT01632579|76139562|FG000|STARTED|Period 1 (First Intervention)||2||
60023647|NCT01632579|76139563|FG001|STARTED|Period 1 (First Intervention)||6||
60023648|NCT01632579|76139564|FG002|STARTED|Period 1 (First Intervention)||2||
60023649|NCT01632579|76139565|FG003|STARTED|Period 1 (First Intervention)||2||
60023650|NCT01632579|76139566|FG004|STARTED|Period 1 (First Intervention)||6||
60023651|NCT01632579|76139567|FG005|STARTED|Period 1 (First Intervention)||2||
60023652|NCT01632579|76139568|FG006|STARTED|Period 1 (First Intervention)||2||
60023653|NCT01632579|76139569|FG007|STARTED|Period 1 (First Intervention)||6||
59914797|NCT03119610|76035675|FG000|STARTED|Overall Study||13||
60023654|NCT01632579|76139570|FG008|STARTED|Period 1 (First Intervention)||2||
60023655|NCT01632579|76139562|FG000|Received at Least 1 Dose|Period 1 (First Intervention)||2||
60023656|NCT01632579|76139563|FG001|Received at Least 1 Dose|Period 1 (First Intervention)||6||
60023657|NCT01632579|76139564|FG002|Received at Least 1 Dose|Period 1 (First Intervention)||2||
60023658|NCT01632579|76139565|FG003|Received at Least 1 Dose|Period 1 (First Intervention)||2||
60023659|NCT01632579|76139566|FG004|Received at Least 1 Dose|Period 1 (First Intervention)||6||
60023660|NCT01632579|76139567|FG005|Received at Least 1 Dose|Period 1 (First Intervention)||2||
60023661|NCT01632579|76139568|FG006|Received at Least 1 Dose|Period 1 (First Intervention)||2||
60023662|NCT01632579|76139569|FG007|Received at Least 1 Dose|Period 1 (First Intervention)||6||
60023663|NCT01632579|76139570|FG008|Received at Least 1 Dose|Period 1 (First Intervention)||2||
59914798|NCT03119610|76035676|FG001|STARTED|Overall Study||10||
59914799|NCT03119610|76035675|FG000|COMPLETED|Overall Study||12||
59914800|NCT03119610|76035676|FG001|COMPLETED|Overall Study||9||
59914801|NCT03119610|76035675|FG000|NOT COMPLETED|Overall Study||1||
59914802|NCT03119610|76035676|FG001|NOT COMPLETED|Overall Study||1||
59914803|NCT04005755|76035682|FG000|STARTED|Overall Study||232||
59914804|NCT04005755|76035682|FG000|COMPLETED|Overall Study||215||
59914805|NCT04005755|76035682|FG000|NOT COMPLETED|Overall Study||17||
59914806|NCT03442777|76035689|FG000|STARTED|Overall Study|All participants received at least 1 dressing|542||
59914807|NCT03442777|76035690|FG001|STARTED|Overall Study|One participant received one Allevyn® Life dressing (wrong brand by mistake), besides 13 Mepilex® Border on sacrum, (0.2%) All participants received at least 1 dressing|545||
59914808|NCT03442777|76035691|FG002|STARTED|Overall Study|No participants received dressings|546||
60023664|NCT01632579|76139562|FG000|COMPLETED|Period 1 (First Intervention)||2||
60023665|NCT01632579|76139563|FG001|COMPLETED|Period 1 (First Intervention)||6||
60023666|NCT01632579|76139564|FG002|COMPLETED|Period 1 (First Intervention)||2||
60023667|NCT01632579|76139565|FG003|COMPLETED|Period 1 (First Intervention)||2||
60023668|NCT01632579|76139566|FG004|COMPLETED|Period 1 (First Intervention)||6||
60023669|NCT01632579|76139567|FG005|COMPLETED|Period 1 (First Intervention)||2||
60023670|NCT01632579|76139568|FG006|COMPLETED|Period 1 (First Intervention)||2||
60023671|NCT01632579|76139569|FG007|COMPLETED|Period 1 (First Intervention)||6||
60023672|NCT01632579|76139570|FG008|COMPLETED|Period 1 (First Intervention)||2||
60023673|NCT01632579|76139562|FG000|NOT COMPLETED|Period 1 (First Intervention)||0||
59914809|NCT03442777|76035689|FG000|COMPLETED|Overall Study||534|All participants completed the study however not all were included in the analysis.|
59914810|NCT03442777|76035690|FG001|COMPLETED|Overall Study||532|All participants completed the study however not all were included in the analysis.|
59914811|NCT03442777|76035691|FG002|COMPLETED|Overall Study||539|All participants completed the study however not all were included in the analysis.|
59914812|NCT03442777|76035689|FG000|NOT COMPLETED|Overall Study||8||
59914813|NCT03442777|76035690|FG001|NOT COMPLETED|Overall Study||13||
59914814|NCT03442777|76035691|FG002|NOT COMPLETED|Overall Study||7||
59914815|NCT03401749|76035700|FG000|STARTED|Overall Study||59||
59914816|NCT03401749|76035701|FG001|STARTED|Overall Study||67||
59914817|NCT03401749|76035702|FG002|STARTED|Overall Study||77||
59914818|NCT03401749|76035700|FG000|COMPLETED|Overall Study||39|"Completion was determined as patients who completed the 2 week, 6 week, and 3 month postoperative surgical site questionnaire. If patients did not complete all 3 post operative questionnaires, they were marked as lost to follow up. This does not suggest any adverse event occurred, simply that patients stopped coming to their postoperative clinical visits."|
59914819|NCT03401749|76035701|FG001|COMPLETED|Overall Study||51|"Completion was determined as patients who completed the 2 week, 6 week, and 3 month postoperative surgical site questionnaire. If patients did not complete all 3 post operative questionnaires, they were marked as lost to follow up. This does not suggest any adverse event occurred, simply that patients stopped coming to their postoperative clinical visits."|
59914820|NCT03401749|76035702|FG002|COMPLETED|Overall Study||51|"Completion was determined as patients who completed the 2 week, 6 week, and 3 month postoperative surgical site questionnaire. If patients did not complete all 3 post operative questionnaires, they were marked as lost to follow up. This does not suggest any adverse event occurred, simply that patients stopped coming to their postoperative clinical visits."|
59914821|NCT03401749|76035700|FG000|NOT COMPLETED|Overall Study||20||
59914822|NCT03401749|76035701|FG001|NOT COMPLETED|Overall Study||16||
59914823|NCT03401749|76035702|FG002|NOT COMPLETED|Overall Study||26||
59914824|NCT03029624|76035710|FG000|STARTED|Overall Study||46|Recruited|
59914825|NCT03029624|76035710|FG000|Primary Endpoint (3 Months)|Overall Study||44||
59914826|NCT03029624|76035710|FG000|COMPLETED|Overall Study||41||
59914827|NCT03029624|76035710|FG000|NOT COMPLETED|Overall Study||5||
59914828|NCT02952001|76035718|FG000|STARTED|Overall Study||28||
59914829|NCT02952001|76035719|FG001|STARTED|Overall Study||5||
59914830|NCT02952001|76035718|FG000|COMPLETED|Overall Study||14||
59914831|NCT02952001|76035719|FG001|COMPLETED|Overall Study||2||
59914832|NCT02952001|76035718|FG000|NOT COMPLETED|Overall Study||14||
59914833|NCT02952001|76035719|FG001|NOT COMPLETED|Overall Study||3||
59914834|NCT04123067|76035728|FG000|STARTED|Overall Study||0||
59914835|NCT04123067|76035729|FG001|STARTED|Overall Study||1||
59914836|NCT04123067|76035728|FG000|COMPLETED|Overall Study||0||
59914837|NCT04123067|76035729|FG001|COMPLETED|Overall Study||0||
59914838|NCT04123067|76035728|FG000|NOT COMPLETED|Overall Study||0||
59914839|NCT04123067|76035729|FG001|NOT COMPLETED|Overall Study||1||
59914840|NCT04117607|76035738|FG000|STARTED|Overall Study||3||
59914841|NCT04117607|76035739|FG001|STARTED|Overall Study||7||
59914842|NCT04117607|76035740|FG002|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0||
59914843|NCT04117607|76035741|FG003|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0||
59914844|NCT04117607|76035742|FG004|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0||
59914845|NCT04117607|76035743|FG005|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0||
59507340|NCT02403999|75600558|FG001|NOT COMPLETED|Overall Study||0||
59507341|NCT02403999|75600559|FG002|NOT COMPLETED|Overall Study||0||
59507342|NCT02405325|75600569|FG000|STARTED|Overall Study||267||
59507343|NCT02405325|75600570|FG001|STARTED|Overall Study||209||
59507344|NCT02405325|75600569|FG000|COMPLETED|Overall Study||203||
59507345|NCT02405325|75600570|FG001|COMPLETED|Overall Study||175||
59507346|NCT02405325|75600569|FG000|NOT COMPLETED|Overall Study||64||
59914846|NCT04117607|76035744|FG006|STARTED|Overall Study||4||
59914847|NCT04117607|76035745|FG007|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0||
59914848|NCT04117607|76035746|FG008|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0||
59914849|NCT04117607|76035747|FG009|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0||
59914850|NCT04117607|76035748|FG010|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0||
59914851|NCT04117607|76035749|FG011|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0||
59914852|NCT04117607|76035750|FG012|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0||
59914853|NCT04117607|76035751|FG013|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0||
59914854|NCT04117607|76035738|FG000|Received Study Product|Overall Study||3||
59914855|NCT04117607|76035739|FG001|Received Study Product|Overall Study||6||
59507347|NCT02405325|75600570|FG001|NOT COMPLETED|Overall Study||34||
59507348|NCT02069847|75600578|FG000|STARTED|Overall Study||22||
59507349|NCT02069847|75600579|FG001|STARTED|Overall Study||68||
59507350|NCT02069847|75600578|FG000|COMPLETED|Overall Study||22||
60023674|NCT01632579|76139563|FG001|NOT COMPLETED|Period 1 (First Intervention)||0||
60023675|NCT01632579|76139564|FG002|NOT COMPLETED|Period 1 (First Intervention)||0||
60023676|NCT01632579|76139565|FG003|NOT COMPLETED|Period 1 (First Intervention)||0||
60023677|NCT01632579|76139566|FG004|NOT COMPLETED|Period 1 (First Intervention)||0||
60023678|NCT01632579|76139567|FG005|NOT COMPLETED|Period 1 (First Intervention)||0||
60023679|NCT01632579|76139568|FG006|NOT COMPLETED|Period 1 (First Intervention)||0||
60023680|NCT01632579|76139569|FG007|NOT COMPLETED|Period 1 (First Intervention)||0||
60023681|NCT01632579|76139570|FG008|NOT COMPLETED|Period 1 (First Intervention)||0||
60023682|NCT01632579|76139562|FG000|STARTED|Washout Period||2||
60023683|NCT01632579|76139563|FG001|STARTED|Washout Period||6||
60023684|NCT01632579|76139564|FG002|STARTED|Washout Period||2||
60023685|NCT01632579|76139565|FG003|STARTED|Washout Period||2||
60023686|NCT01632579|76139566|FG004|STARTED|Washout Period||6||
60023687|NCT01632579|76139567|FG005|STARTED|Washout Period||2||
60023688|NCT01632579|76139568|FG006|STARTED|Washout Period||2||
60023689|NCT01632579|76139569|FG007|STARTED|Washout Period||6||
60023690|NCT01632579|76139570|FG008|STARTED|Washout Period||2||
60023691|NCT01632579|76139562|FG000|COMPLETED|Washout Period||1||
60023692|NCT01632579|76139563|FG001|COMPLETED|Washout Period||6||
60023693|NCT01632579|76139564|FG002|COMPLETED|Washout Period||2||
60023694|NCT01632579|76139565|FG003|COMPLETED|Washout Period||2||
60023695|NCT01632579|76139566|FG004|COMPLETED|Washout Period||6||
60023696|NCT01632579|76139567|FG005|COMPLETED|Washout Period||2||
60023697|NCT01632579|76139568|FG006|COMPLETED|Washout Period||2||
60023698|NCT01632579|76139569|FG007|COMPLETED|Washout Period||6||
60023699|NCT01632579|76139570|FG008|COMPLETED|Washout Period||2||
60023700|NCT01632579|76139562|FG000|NOT COMPLETED|Washout Period||1||
60023701|NCT01632579|76139563|FG001|NOT COMPLETED|Washout Period||0||
60023702|NCT01632579|76139564|FG002|NOT COMPLETED|Washout Period||0||
60023703|NCT01632579|76139565|FG003|NOT COMPLETED|Washout Period||0||
60023704|NCT01632579|76139566|FG004|NOT COMPLETED|Washout Period||0||
60023705|NCT01632579|76139567|FG005|NOT COMPLETED|Washout Period||0||
60023706|NCT01632579|76139568|FG006|NOT COMPLETED|Washout Period||0||
60023707|NCT01632579|76139569|FG007|NOT COMPLETED|Washout Period||0||
60023708|NCT01632579|76139570|FG008|NOT COMPLETED|Washout Period||0||
60023709|NCT01632579|76139562|FG000|STARTED|Period 2 (Second Intervention)||1||
60023710|NCT01632579|76139563|FG001|STARTED|Period 2 (Second Intervention)||6||
60023711|NCT01632579|76139564|FG002|STARTED|Period 2 (Second Intervention)||2||
60023712|NCT01632579|76139565|FG003|STARTED|Period 2 (Second Intervention)||2||
60023713|NCT01632579|76139566|FG004|STARTED|Period 2 (Second Intervention)||6||
60023714|NCT01632579|76139567|FG005|STARTED|Period 2 (Second Intervention)||2||
60023715|NCT01632579|76139568|FG006|STARTED|Period 2 (Second Intervention)||2||
60023716|NCT01632579|76139569|FG007|STARTED|Period 2 (Second Intervention)||6||
60023717|NCT01632579|76139570|FG008|STARTED|Period 2 (Second Intervention)||2||
60023718|NCT01632579|76139562|FG000|Received at Least 1 Dose|Period 2 (Second Intervention)||1||
60023719|NCT01632579|76139563|FG001|Received at Least 1 Dose|Period 2 (Second Intervention)||6||
60023720|NCT01632579|76139564|FG002|Received at Least 1 Dose|Period 2 (Second Intervention)||2||
60023721|NCT01632579|76139565|FG003|Received at Least 1 Dose|Period 2 (Second Intervention)||2||
60023722|NCT01632579|76139566|FG004|Received at Least 1 Dose|Period 2 (Second Intervention)||6||
60023723|NCT01632579|76139567|FG005|Received at Least 1 Dose|Period 2 (Second Intervention)||2||
60023724|NCT01632579|76139568|FG006|Received at Least 1 Dose|Period 2 (Second Intervention)||2||
60023725|NCT01632579|76139569|FG007|Received at Least 1 Dose|Period 2 (Second Intervention)||6||
60023726|NCT01632579|76139570|FG008|Received at Least 1 Dose|Period 2 (Second Intervention)||2||
60023727|NCT01632579|76139562|FG000|COMPLETED|Period 2 (Second Intervention)||0||
60023728|NCT01632579|76139563|FG001|COMPLETED|Period 2 (Second Intervention)||6||
60023729|NCT01632579|76139564|FG002|COMPLETED|Period 2 (Second Intervention)||2||
60023730|NCT01632579|76139565|FG003|COMPLETED|Period 2 (Second Intervention)||2||
60023731|NCT01632579|76139566|FG004|COMPLETED|Period 2 (Second Intervention)||6||
60023732|NCT01632579|76139567|FG005|COMPLETED|Period 2 (Second Intervention)||2||
60023733|NCT01632579|76139568|FG006|COMPLETED|Period 2 (Second Intervention)||2||
60023734|NCT01632579|76139569|FG007|COMPLETED|Period 2 (Second Intervention)||6||
60023735|NCT01632579|76139570|FG008|COMPLETED|Period 2 (Second Intervention)||2||
60023736|NCT01632579|76139562|FG000|NOT COMPLETED|Period 2 (Second Intervention)||1||
60023737|NCT01632579|76139563|FG001|NOT COMPLETED|Period 2 (Second Intervention)||0||
60023738|NCT01632579|76139564|FG002|NOT COMPLETED|Period 2 (Second Intervention)||0||
60023739|NCT01632579|76139565|FG003|NOT COMPLETED|Period 2 (Second Intervention)||0||
60023740|NCT01632579|76139566|FG004|NOT COMPLETED|Period 2 (Second Intervention)||0||
60023741|NCT01632579|76139567|FG005|NOT COMPLETED|Period 2 (Second Intervention)||0||
60023742|NCT01632579|76139568|FG006|NOT COMPLETED|Period 2 (Second Intervention)||0||
60023743|NCT01632579|76139569|FG007|NOT COMPLETED|Period 2 (Second Intervention)||0||
60023744|NCT01632579|76139570|FG008|NOT COMPLETED|Period 2 (Second Intervention)||0||
60023745|NCT01632579|76139562|FG000|STARTED|Washout Period||0||
60023746|NCT01632579|76139563|FG001|STARTED|Washout Period||6||
60023747|NCT01632579|76139564|FG002|STARTED|Washout Period||2||
59507351|NCT02069847|75600579|FG001|COMPLETED|Overall Study||68||
59507352|NCT02069847|75600578|FG000|NOT COMPLETED|Overall Study||0||
59507353|NCT02069847|75600579|FG001|NOT COMPLETED|Overall Study||0||
59507354|NCT02070237|75600586|FG000|STARTED|Overall Study||45||
59507355|NCT02070237|75600587|FG001|STARTED|Overall Study||45||
59758955|NCT00562159|75878292|FG000|STARTED|Overall Study||213||
59758956|NCT00562159|75878293|FG001|STARTED|Overall Study||225||
59758957|NCT00562159|75878292|FG000|COMPLETED|Overall Study||175||
59758958|NCT00562159|75878293|FG001|COMPLETED|Overall Study||192||
59758959|NCT00562159|75878292|FG000|NOT COMPLETED|Overall Study||38||
59758960|NCT00562159|75878293|FG001|NOT COMPLETED|Overall Study||33||
59758961|NCT04223778|75878302|FG000|STARTED|Overall Study||336||
59758962|NCT04223778|75878303|FG001|STARTED|Overall Study||336||
59758963|NCT04223778|75878302|FG000|COMPLETED|Overall Study||0||
59758964|NCT04223778|75878303|FG001|COMPLETED|Overall Study||0||
59914856|NCT04117607|76035740|FG002|Received Study Product|Overall Study||0||
59914857|NCT04117607|76035741|FG003|Received Study Product|Overall Study||0||
59914858|NCT04117607|76035742|FG004|Received Study Product|Overall Study||0||
59914859|NCT04117607|76035743|FG005|Received Study Product|Overall Study||0||
59914860|NCT04117607|76035744|FG006|Received Study Product|Overall Study||3||
59914861|NCT04117607|76035745|FG007|Received Study Product|Overall Study||0||
59914862|NCT04117607|76035746|FG008|Received Study Product|Overall Study||0||
59914863|NCT04117607|76035747|FG009|Received Study Product|Overall Study||0||
59914864|NCT04117607|76035748|FG010|Received Study Product|Overall Study||0||
59914865|NCT04117607|76035749|FG011|Received Study Product|Overall Study||0||
59914866|NCT04117607|76035750|FG012|Received Study Product|Overall Study||0||
59914867|NCT04117607|76035751|FG013|Received Study Product|Overall Study||0||
59507356|NCT02070237|75600586|FG000|COMPLETED|Overall Study||42||
59507357|NCT02070237|75600587|FG001|COMPLETED|Overall Study||42||
59507358|NCT02070237|75600586|FG000|NOT COMPLETED|Overall Study||3||
59507359|NCT02070237|75600587|FG001|NOT COMPLETED|Overall Study||3||
59758965|NCT04223778|75878302|FG000|NOT COMPLETED|Overall Study||336||
59758966|NCT04223778|75878303|FG001|NOT COMPLETED|Overall Study||336||
59914868|NCT04117607|76035738|FG000|Completed All PK Blood Draws|Overall Study||0||
59914869|NCT04117607|76035739|FG001|Completed All PK Blood Draws|Overall Study||6||
59914870|NCT04117607|76035740|FG002|Completed All PK Blood Draws|Overall Study||0||
59914871|NCT04117607|76035741|FG003|Completed All PK Blood Draws|Overall Study||0||
59914872|NCT04117607|76035742|FG004|Completed All PK Blood Draws|Overall Study||0||
59914873|NCT04117607|76035743|FG005|Completed All PK Blood Draws|Overall Study||0||
59914874|NCT04117607|76035744|FG006|Completed All PK Blood Draws|Overall Study||1||
59914875|NCT04117607|76035745|FG007|Completed All PK Blood Draws|Overall Study||0||
59914876|NCT04117607|76035746|FG008|Completed All PK Blood Draws|Overall Study||0||
59914877|NCT04117607|76035747|FG009|Completed All PK Blood Draws|Overall Study||0||
59914878|NCT04117607|76035748|FG010|Completed All PK Blood Draws|Overall Study||0||
59914879|NCT04117607|76035749|FG011|Completed All PK Blood Draws|Overall Study||0||
59914880|NCT04117607|76035750|FG012|Completed All PK Blood Draws|Overall Study||0||
59914881|NCT04117607|76035751|FG013|Completed All PK Blood Draws|Overall Study||0||
59914882|NCT04117607|76035738|FG000|COMPLETED|Overall Study||3||
59914883|NCT04117607|76035739|FG001|COMPLETED|Overall Study||6||
59914884|NCT04117607|76035740|FG002|COMPLETED|Overall Study||0||
59914885|NCT04117607|76035741|FG003|COMPLETED|Overall Study||0||
60023748|NCT01632579|76139565|FG003|STARTED|Washout Period||2||
60023749|NCT01632579|76139566|FG004|STARTED|Washout Period||6||
60023750|NCT01632579|76139567|FG005|STARTED|Washout Period||2||
60023751|NCT01632579|76139568|FG006|STARTED|Washout Period||2||
60023752|NCT01632579|76139569|FG007|STARTED|Washout Period||6||
60023753|NCT01632579|76139570|FG008|STARTED|Washout Period||2||
60023754|NCT01632579|76139562|FG000|COMPLETED|Washout Period||0||
60023755|NCT01632579|76139563|FG001|COMPLETED|Washout Period||6||
60023756|NCT01632579|76139564|FG002|COMPLETED|Washout Period||2||
60023757|NCT01632579|76139565|FG003|COMPLETED|Washout Period||2||
60023758|NCT01632579|76139566|FG004|COMPLETED|Washout Period||6||
60023759|NCT01632579|76139567|FG005|COMPLETED|Washout Period||2||
60023760|NCT01632579|76139568|FG006|COMPLETED|Washout Period||2||
60023761|NCT01632579|76139569|FG007|COMPLETED|Washout Period||6||
60023762|NCT01632579|76139570|FG008|COMPLETED|Washout Period||2||
60023763|NCT01632579|76139562|FG000|NOT COMPLETED|Washout Period||0||
60023764|NCT01632579|76139563|FG001|NOT COMPLETED|Washout Period||0||
60023765|NCT01632579|76139564|FG002|NOT COMPLETED|Washout Period||0||
60023766|NCT01632579|76139565|FG003|NOT COMPLETED|Washout Period||0||
60023767|NCT01632579|76139566|FG004|NOT COMPLETED|Washout Period||0||
60023768|NCT01632579|76139567|FG005|NOT COMPLETED|Washout Period||0||
60023769|NCT01632579|76139568|FG006|NOT COMPLETED|Washout Period||0||
60023770|NCT01632579|76139569|FG007|NOT COMPLETED|Washout Period||0||
60023771|NCT01632579|76139570|FG008|NOT COMPLETED|Washout Period||0||
60023772|NCT01632579|76139562|FG000|STARTED|Period 3 (Third Intervention)||0||
60023773|NCT01632579|76139563|FG001|STARTED|Period 3 (Third Intervention)||6||
60023774|NCT01632579|76139564|FG002|STARTED|Period 3 (Third Intervention)||2||
60023775|NCT01632579|76139565|FG003|STARTED|Period 3 (Third Intervention)||2||
60023776|NCT01632579|76139566|FG004|STARTED|Period 3 (Third Intervention)||6||
60023777|NCT01632579|76139567|FG005|STARTED|Period 3 (Third Intervention)||2||
60023778|NCT01632579|76139568|FG006|STARTED|Period 3 (Third Intervention)||2||
60023779|NCT01632579|76139569|FG007|STARTED|Period 3 (Third Intervention)||6||
60023780|NCT01632579|76139570|FG008|STARTED|Period 3 (Third Intervention)||2||
60023781|NCT01632579|76139562|FG000|Received at Least 1 Dose|Period 3 (Third Intervention)||0||
60023782|NCT01632579|76139563|FG001|Received at Least 1 Dose|Period 3 (Third Intervention)||6||
60023783|NCT01632579|76139564|FG002|Received at Least 1 Dose|Period 3 (Third Intervention)||2||
60023784|NCT01632579|76139565|FG003|Received at Least 1 Dose|Period 3 (Third Intervention)||2||
60023785|NCT01632579|76139566|FG004|Received at Least 1 Dose|Period 3 (Third Intervention)||6||
60023786|NCT01632579|76139567|FG005|Received at Least 1 Dose|Period 3 (Third Intervention)||2||
60023787|NCT01632579|76139568|FG006|Received at Least 1 Dose|Period 3 (Third Intervention)||2||
60023788|NCT01632579|76139569|FG007|Received at Least 1 Dose|Period 3 (Third Intervention)||6||
60023789|NCT01632579|76139570|FG008|Received at Least 1 Dose|Period 3 (Third Intervention)||2||
60023790|NCT01632579|76139562|FG000|COMPLETED|Period 3 (Third Intervention)||0||
60023791|NCT01632579|76139563|FG001|COMPLETED|Period 3 (Third Intervention)||6||
60023792|NCT01632579|76139564|FG002|COMPLETED|Period 3 (Third Intervention)||2||
60023793|NCT01632579|76139565|FG003|COMPLETED|Period 3 (Third Intervention)||2||
60023794|NCT01632579|76139566|FG004|COMPLETED|Period 3 (Third Intervention)||6||
60023795|NCT01632579|76139567|FG005|COMPLETED|Period 3 (Third Intervention)||2||
60023796|NCT01632579|76139568|FG006|COMPLETED|Period 3 (Third Intervention)||2||
60023797|NCT01632579|76139569|FG007|COMPLETED|Period 3 (Third Intervention)||6||
60023798|NCT01632579|76139570|FG008|COMPLETED|Period 3 (Third Intervention)||2||
60023799|NCT01632579|76139562|FG000|NOT COMPLETED|Period 3 (Third Intervention)||0||
60023800|NCT01632579|76139563|FG001|NOT COMPLETED|Period 3 (Third Intervention)||0||
60023801|NCT01632579|76139564|FG002|NOT COMPLETED|Period 3 (Third Intervention)||0||
60023802|NCT01632579|76139565|FG003|NOT COMPLETED|Period 3 (Third Intervention)||0||
60023803|NCT01632579|76139566|FG004|NOT COMPLETED|Period 3 (Third Intervention)||0||
60023804|NCT01632579|76139567|FG005|NOT COMPLETED|Period 3 (Third Intervention)||0||
60023805|NCT01632579|76139568|FG006|NOT COMPLETED|Period 3 (Third Intervention)||0||
60023806|NCT01632579|76139569|FG007|NOT COMPLETED|Period 3 (Third Intervention)||0||
60023807|NCT01632579|76139570|FG008|NOT COMPLETED|Period 3 (Third Intervention)||0||
60023808|NCT01632345|76139599|FG000|STARTED|Randomized Participants||41||
60023809|NCT01632345|76139600|FG001|STARTED|Randomized Participants||43||
60023810|NCT01632345|76139601|FG002|STARTED|Randomized Participants||42||
60023811|NCT01632345|76139602|FG003|STARTED|Randomized Participants||41||
59507360|NCT02406495|75600593|FG000|STARTED|Overall Study||40||
60023812|NCT01632345|76139603|FG004|STARTED|Randomized Participants||43||
60023813|NCT01632345|76139604|FG005|STARTED|Randomized Participants||66||
60023814|NCT01632345|76139605|FG006|STARTED|Randomized Participants||66||
60023815|NCT01632345|76139599|FG000|COMPLETED|Randomized Participants||41||
60023816|NCT01632345|76139600|FG001|COMPLETED|Randomized Participants||43||
60023817|NCT01632345|76139601|FG002|COMPLETED|Randomized Participants||42||
60023818|NCT01632345|76139602|FG003|COMPLETED|Randomized Participants||41||
60023819|NCT01632345|76139603|FG004|COMPLETED|Randomized Participants||43||
60023820|NCT01632345|76139604|FG005|COMPLETED|Randomized Participants||66||
60023821|NCT01632345|76139605|FG006|COMPLETED|Randomized Participants||66||
60023822|NCT01632345|76139599|FG000|NOT COMPLETED|Randomized Participants||0||
60023823|NCT01632345|76139600|FG001|NOT COMPLETED|Randomized Participants||0||
60023824|NCT01632345|76139601|FG002|NOT COMPLETED|Randomized Participants||0||
60023825|NCT01632345|76139602|FG003|NOT COMPLETED|Randomized Participants||0||
60023826|NCT01632345|76139603|FG004|NOT COMPLETED|Randomized Participants||0||
60023827|NCT01632345|76139604|FG005|NOT COMPLETED|Randomized Participants||0||
60023828|NCT01632345|76139605|FG006|NOT COMPLETED|Randomized Participants||0||
60023829|NCT01632345|76139599|FG000|STARTED|Treatment: Part I||41||
60023830|NCT01632345|76139600|FG001|STARTED|Treatment: Part I||43||
60023831|NCT01632345|76139601|FG002|STARTED|Treatment: Part I||42||
60023832|NCT01632345|76139602|FG003|STARTED|Treatment: Part I||41||
60023833|NCT01632345|76139603|FG004|STARTED|Treatment: Part I||43||
60023834|NCT01632345|76139604|FG005|STARTED|Treatment: Part I|Participants in Part II did not participate in Part I.|0||
60023835|NCT01632345|76139605|FG006|STARTED|Treatment: Part I|Participants in Part II did not participate in Part I.|0||
60023836|NCT01632345|76139599|FG000|Treated|Treatment: Part I||40||
60023837|NCT01632345|76139600|FG001|Treated|Treatment: Part I||43||
60023838|NCT01632345|76139601|FG002|Treated|Treatment: Part I||42||
60023839|NCT01632345|76139602|FG003|Treated|Treatment: Part I||41||
60023840|NCT01632345|76139603|FG004|Treated|Treatment: Part I||43||
60023841|NCT01632345|76139604|FG005|Treated|Treatment: Part I||0||
60023842|NCT01632345|76139605|FG006|Treated|Treatment: Part I||0||
60023843|NCT01632345|76139599|FG000|COMPLETED|Treatment: Part I||29||
60023844|NCT01632345|76139600|FG001|COMPLETED|Treatment: Part I||28||
60023845|NCT01632345|76139601|FG002|COMPLETED|Treatment: Part I||32||
60023846|NCT01632345|76139602|FG003|COMPLETED|Treatment: Part I||33||
60023847|NCT01632345|76139603|FG004|COMPLETED|Treatment: Part I||30||
60023848|NCT01632345|76139604|FG005|COMPLETED|Treatment: Part I||0||
60023849|NCT01632345|76139605|FG006|COMPLETED|Treatment: Part I||0||
60023850|NCT01632345|76139599|FG000|NOT COMPLETED|Treatment: Part I||12||
60023851|NCT01632345|76139600|FG001|NOT COMPLETED|Treatment: Part I||15||
60023852|NCT01632345|76139601|FG002|NOT COMPLETED|Treatment: Part I||10||
60023853|NCT01632345|76139602|FG003|NOT COMPLETED|Treatment: Part I||8||
60023854|NCT01632345|76139603|FG004|NOT COMPLETED|Treatment: Part I||13||
60023855|NCT01632345|76139604|FG005|NOT COMPLETED|Treatment: Part I||0||
60023856|NCT01632345|76139605|FG006|NOT COMPLETED|Treatment: Part I||0||
60023857|NCT01632345|76139599|FG000|STARTED|Treatment: Part II|Participants in Part I did not continue in Part II.|0||
60023858|NCT01632345|76139600|FG001|STARTED|Treatment: Part II|Participants in Part I did not continue in Part II.|0||
60023859|NCT01632345|76139601|FG002|STARTED|Treatment: Part II|Participants in Part I did not continue in Part II.|0||
60023860|NCT01632345|76139602|FG003|STARTED|Treatment: Part II|Participants in Part I did not continue in Part II.|0||
60023861|NCT01632345|76139603|FG004|STARTED|Treatment: Part II|Participants in Part I did not continue in Part II.|0||
60023862|NCT01632345|76139604|FG005|STARTED|Treatment: Part II|66 new participants enrolled at 100 mg dose in Part II.|66||
60023863|NCT01632345|76139605|FG006|STARTED|Treatment: Part II|66 new participants enrolled at efavirenz treatment in Part II.|66||
60023864|NCT01632345|76139599|FG000|Treated|Treatment: Part II||0||
60023865|NCT01632345|76139600|FG001|Treated|Treatment: Part II||0||
60023866|NCT01632345|76139601|FG002|Treated|Treatment: Part II||0||
60023867|NCT01632345|76139602|FG003|Treated|Treatment: Part II||0||
60023868|NCT01632345|76139603|FG004|Treated|Treatment: Part II||0||
60023869|NCT01632345|76139604|FG005|Treated|Treatment: Part II||66||
60023870|NCT01632345|76139605|FG006|Treated|Treatment: Part II||66||
60023871|NCT01632345|76139599|FG000|COMPLETED|Treatment: Part II||0||
60023872|NCT01632345|76139600|FG001|COMPLETED|Treatment: Part II||0||
60023873|NCT01632345|76139601|FG002|COMPLETED|Treatment: Part II||0||
60023874|NCT01632345|76139602|FG003|COMPLETED|Treatment: Part II||0||
60023875|NCT01632345|76139603|FG004|COMPLETED|Treatment: Part II||0||
60023876|NCT01632345|76139604|FG005|COMPLETED|Treatment: Part II||55||
60023877|NCT01632345|76139605|FG006|COMPLETED|Treatment: Part II||55||
60023878|NCT01632345|76139599|FG000|NOT COMPLETED|Treatment: Part II||0||
60023879|NCT01632345|76139600|FG001|NOT COMPLETED|Treatment: Part II||0||
60023880|NCT01632345|76139601|FG002|NOT COMPLETED|Treatment: Part II||0||
59914886|NCT04117607|76035742|FG004|COMPLETED|Overall Study||0||
59914887|NCT04117607|76035743|FG005|COMPLETED|Overall Study||0||
59914888|NCT04117607|76035744|FG006|COMPLETED|Overall Study||3||
59914889|NCT04117607|76035745|FG007|COMPLETED|Overall Study||0||
59914890|NCT04117607|76035746|FG008|COMPLETED|Overall Study||0||
59914891|NCT04117607|76035747|FG009|COMPLETED|Overall Study||0||
59914892|NCT04117607|76035748|FG010|COMPLETED|Overall Study||0||
59914893|NCT04117607|76035749|FG011|COMPLETED|Overall Study||0||
60023881|NCT01632345|76139602|FG003|NOT COMPLETED|Treatment: Part II||0||
60023882|NCT01632345|76139603|FG004|NOT COMPLETED|Treatment: Part II||0||
60023883|NCT01632345|76139604|FG005|NOT COMPLETED|Treatment: Part II||11||
60023884|NCT01632345|76139605|FG006|NOT COMPLETED|Treatment: Part II||11||
59914894|NCT04117607|76035750|FG012|COMPLETED|Overall Study||0||
59914895|NCT04117607|76035751|FG013|COMPLETED|Overall Study||0||
59914896|NCT04117607|76035738|FG000|NOT COMPLETED|Overall Study||0||
59914897|NCT04117607|76035739|FG001|NOT COMPLETED|Overall Study||1||
59914898|NCT04117607|76035740|FG002|NOT COMPLETED|Overall Study||0||
59914899|NCT04117607|76035741|FG003|NOT COMPLETED|Overall Study||0||
59914900|NCT04117607|76035742|FG004|NOT COMPLETED|Overall Study||0||
59914901|NCT04117607|76035743|FG005|NOT COMPLETED|Overall Study||0||
59914902|NCT04117607|76035744|FG006|NOT COMPLETED|Overall Study||1||
59914903|NCT04117607|76035745|FG007|NOT COMPLETED|Overall Study||0||
59914904|NCT04117607|76035746|FG008|NOT COMPLETED|Overall Study||0||
59914905|NCT04117607|76035747|FG009|NOT COMPLETED|Overall Study||0||
59914906|NCT04117607|76035748|FG010|NOT COMPLETED|Overall Study||0||
59914907|NCT04117607|76035749|FG011|NOT COMPLETED|Overall Study||0||
59914908|NCT04117607|76035750|FG012|NOT COMPLETED|Overall Study||0||
59914909|NCT04117607|76035751|FG013|NOT COMPLETED|Overall Study||0||
59914910|NCT04112303|76035767|FG000|STARTED|Overall Study||37||
59914911|NCT04112303|76035767|FG000|COMPLETED|Overall Study||36||
59914912|NCT04112303|76035767|FG000|NOT COMPLETED|Overall Study||1||
59914913|NCT03998189|76035773|FG000|STARTED|Overall Study||0||
59914914|NCT03998189|76035774|FG001|STARTED|Overall Study||1||
59914915|NCT03998189|76035773|FG000|COMPLETED|Overall Study||0||
59914916|NCT03998189|76035774|FG001|COMPLETED|Overall Study|Samples were collected but were not analyzed as the analysis would have been done once a proper batch of samples were collected. This did not occur as the study was found to no longer be feasible and was terminated.|0||
59914917|NCT03998189|76035773|FG000|NOT COMPLETED|Overall Study||0||
59914918|NCT03998189|76035774|FG001|NOT COMPLETED|Overall Study||1||
59914919|NCT04099277|76035780|FG000|STARTED|Overall Study||2||
59914920|NCT04099277|76035780|FG000|Received at Least 1 Dose of Study Drug|Overall Study||2||
59914921|NCT04099277|76035780|FG000|COMPLETED|Overall Study||0||
59914922|NCT04099277|76035780|FG000|NOT COMPLETED|Overall Study||2||
59914923|NCT03990389|76035786|FG000|STARTED|Overall Study||15||
59914924|NCT03990389|76035787|FG001|STARTED|Overall Study||16||
59914925|NCT03990389|76035786|FG000|COMPLETED|Overall Study||12||
59914926|NCT03990389|76035787|FG001|COMPLETED|Overall Study||16||
59914927|NCT03990389|76035786|FG000|NOT COMPLETED|Overall Study||3||
59914928|NCT03990389|76035787|FG001|NOT COMPLETED|Overall Study||0||
59914929|NCT03988907|76035795|FG000|STARTED|Overall Study||8||
59914930|NCT03988907|76035796|FG001|STARTED|Overall Study||27||
59914931|NCT03988907|76035795|FG000|COMPLETED|Overall Study||8||
59914932|NCT03988907|76035796|FG001|COMPLETED|Overall Study||26||
59914933|NCT03988907|76035795|FG000|NOT COMPLETED|Overall Study||0||
59914934|NCT03988907|76035796|FG001|NOT COMPLETED|Overall Study||1||
59914935|NCT03987191|76035810|FG000|STARTED|Overall Study||17||
59914936|NCT03987191|76035811|FG001|STARTED|Overall Study||15||
60023885|NCT02232243|76139623|FG000|STARTED|First Dose (200mg HCQ Twice Daily)||3||
60023886|NCT02232243|76139624|FG001|STARTED|First Dose (200mg HCQ Twice Daily)||0||
59914937|NCT03987191|76035810|FG000|Data Collected|Overall Study||17||
59914938|NCT03987191|76035811|FG001|Data Collected|Overall Study||13||
59914939|NCT03987191|76035810|FG000|COMPLETED|Overall Study||17||
59914940|NCT03987191|76035811|FG001|COMPLETED|Overall Study||13||
59914941|NCT03987191|76035810|FG000|NOT COMPLETED|Overall Study||0||
59914942|NCT03987191|76035811|FG001|NOT COMPLETED|Overall Study||2||
59914943|NCT04098809|76035819|FG000|STARTED|Overall Study||27||
59914944|NCT04098809|76035820|FG001|STARTED|Overall Study||25||
59914945|NCT04098809|76035819|FG000|COMPLETED|Overall Study||24||
59914946|NCT04098809|76035820|FG001|COMPLETED|Overall Study||21||
59914947|NCT04098809|76035819|FG000|NOT COMPLETED|Overall Study||3||
59914948|NCT04098809|76035820|FG001|NOT COMPLETED|Overall Study||4||
59914949|NCT03122184|76035828|FG000|STARTED|Overall Study||24||
59914950|NCT03122184|76035829|FG001|STARTED|Overall Study||23||
59914951|NCT03122184|76035828|FG000|COMPLETED|Overall Study||16||
59914952|NCT03122184|76035829|FG001|COMPLETED|Overall Study||17||
59914953|NCT03122184|76035828|FG000|NOT COMPLETED|Overall Study||8||
59914954|NCT03122184|76035829|FG001|NOT COMPLETED|Overall Study||6||
59914955|NCT04396106|76035839|FG000|STARTED|Overall Study||41||
59914956|NCT04396106|76035840|FG001|STARTED|Overall Study||40||
60023887|NCT02232243|76139625|FG002|STARTED|First Dose (200mg HCQ Twice Daily)||0||
60023888|NCT02232243|76139623|FG000|COMPLETED|First Dose (200mg HCQ Twice Daily)||3||
60023889|NCT02232243|76139624|FG001|COMPLETED|First Dose (200mg HCQ Twice Daily)||0||
60023890|NCT02232243|76139625|FG002|COMPLETED|First Dose (200mg HCQ Twice Daily)||0||
60023891|NCT02232243|76139623|FG000|NOT COMPLETED|First Dose (200mg HCQ Twice Daily)||0||
60023892|NCT02232243|76139624|FG001|NOT COMPLETED|First Dose (200mg HCQ Twice Daily)||0||
60023893|NCT02232243|76139625|FG002|NOT COMPLETED|First Dose (200mg HCQ Twice Daily)||0||
60023894|NCT02232243|76139623|FG000|STARTED|Second Dose (400mg HCQ Twice Daily)||0||
60023895|NCT02232243|76139624|FG001|STARTED|Second Dose (400mg HCQ Twice Daily)||4||
60023896|NCT02232243|76139625|FG002|STARTED|Second Dose (400mg HCQ Twice Daily)||0||
60023897|NCT02232243|76139623|FG000|COMPLETED|Second Dose (400mg HCQ Twice Daily)||0||
60023898|NCT02232243|76139624|FG001|COMPLETED|Second Dose (400mg HCQ Twice Daily)||3||
60023899|NCT02232243|76139625|FG002|COMPLETED|Second Dose (400mg HCQ Twice Daily)||0||
60023900|NCT02232243|76139623|FG000|NOT COMPLETED|Second Dose (400mg HCQ Twice Daily)||0||
60023901|NCT02232243|76139624|FG001|NOT COMPLETED|Second Dose (400mg HCQ Twice Daily)||1||
60023902|NCT02232243|76139625|FG002|NOT COMPLETED|Second Dose (400mg HCQ Twice Daily)||0||
60023903|NCT02232243|76139623|FG000|STARTED|Third Dose(200mg HCQ Twice Daily)||0||
60023904|NCT02232243|76139624|FG001|STARTED|Third Dose(200mg HCQ Twice Daily)||0||
60023905|NCT02232243|76139625|FG002|STARTED|Third Dose(200mg HCQ Twice Daily)||3||
60023906|NCT02232243|76139623|FG000|COMPLETED|Third Dose(200mg HCQ Twice Daily)||0||
60023907|NCT02232243|76139624|FG001|COMPLETED|Third Dose(200mg HCQ Twice Daily)||0||
60023908|NCT02232243|76139625|FG002|COMPLETED|Third Dose(200mg HCQ Twice Daily)||3||
60023909|NCT02232243|76139623|FG000|NOT COMPLETED|Third Dose(200mg HCQ Twice Daily)||0||
60023910|NCT02232243|76139624|FG001|NOT COMPLETED|Third Dose(200mg HCQ Twice Daily)||0||
60023911|NCT02232243|76139625|FG002|NOT COMPLETED|Third Dose(200mg HCQ Twice Daily)||0||
60023912|NCT02205333|76139643|FG000|STARTED|Overall Study||8||
60023913|NCT02205333|76139644|FG001|STARTED|Overall Study||6||
60023914|NCT02205333|76139645|FG002|STARTED|Overall Study||3||
60023915|NCT02205333|76139646|FG003|STARTED|Overall Study||7||
60023916|NCT02205333|76139647|FG004|STARTED|Overall Study||6||
60023917|NCT02205333|76139648|FG005|STARTED|Overall Study||7||
60023918|NCT02205333|76139649|FG006|STARTED|Overall Study||7||
60023919|NCT02205333|76139650|FG007|STARTED|Overall Study||3||
60023920|NCT02205333|76139651|FG008|STARTED|Overall Study||1||
60023921|NCT02205333|76139643|FG000|COMPLETED|Overall Study||2||
60023922|NCT02205333|76139644|FG001|COMPLETED|Overall Study||0||
60023923|NCT02205333|76139645|FG002|COMPLETED|Overall Study||1||
60023924|NCT02205333|76139646|FG003|COMPLETED|Overall Study||0||
60023925|NCT02205333|76139647|FG004|COMPLETED|Overall Study||1||
60023926|NCT02205333|76139648|FG005|COMPLETED|Overall Study||4||
60023927|NCT02205333|76139649|FG006|COMPLETED|Overall Study||2||
60023928|NCT02205333|76139650|FG007|COMPLETED|Overall Study||1||
60023929|NCT02205333|76139651|FG008|COMPLETED|Overall Study||1||
60023930|NCT02205333|76139643|FG000|NOT COMPLETED|Overall Study||6||
60023931|NCT02205333|76139644|FG001|NOT COMPLETED|Overall Study||6||
60023932|NCT02205333|76139645|FG002|NOT COMPLETED|Overall Study||2||
60023933|NCT02205333|76139646|FG003|NOT COMPLETED|Overall Study||7||
60023934|NCT02205333|76139647|FG004|NOT COMPLETED|Overall Study||5||
60023935|NCT02205333|76139648|FG005|NOT COMPLETED|Overall Study||3||
60023936|NCT02205333|76139649|FG006|NOT COMPLETED|Overall Study||5||
60023937|NCT02205333|76139650|FG007|NOT COMPLETED|Overall Study||2||
60023938|NCT02205333|76139651|FG008|NOT COMPLETED|Overall Study||0||
60023939|NCT02230683|76139671|FG000|STARTED|Overall Study||23||
60023940|NCT02230683|76139671|FG000|COMPLETED|Overall Study||22||
60023941|NCT02230683|76139671|FG000|NOT COMPLETED|Overall Study||1||
60023942|NCT02230527|76139683|FG000|STARTED|Overall Study||23||
60023943|NCT02230527|76139684|FG001|STARTED|Overall Study||23||
60023944|NCT02230527|76139683|FG000|COMPLETED|Overall Study||18||
60023945|NCT02230527|76139684|FG001|COMPLETED|Overall Study||21||
60023946|NCT02230527|76139683|FG000|NOT COMPLETED|Overall Study||5||
60023947|NCT02230527|76139684|FG001|NOT COMPLETED|Overall Study||2||
60023948|NCT02204319|76139690|FG000|STARTED|Overall Study||10||
60023949|NCT02204319|76139690|FG000|COMPLETED|Overall Study|3 did not complete study.|7||
60023950|NCT02204319|76139690|FG000|NOT COMPLETED|Overall Study||3||
60023951|NCT02204007|76139697|FG000|STARTED|Overall Study||18||
60023952|NCT02204007|76139698|FG001|STARTED|Overall Study||18||
60023953|NCT02204007|76139697|FG000|COMPLETED|Overall Study||17||
60023954|NCT02204007|76139698|FG001|COMPLETED|Overall Study||17||
60023955|NCT02204007|76139697|FG000|NOT COMPLETED|Overall Study||1||
60023956|NCT02204007|76139698|FG001|NOT COMPLETED|Overall Study||1||
60023957|NCT02203851|76139704|FG000|STARTED|Overall Study||110||
60023958|NCT02203851|76139704|FG000|COMPLETED|Overall Study||99||
60023959|NCT02203851|76139704|FG000|NOT COMPLETED|Overall Study||11||
60023960|NCT02228967|76139717|FG000|STARTED|Overall Study||403||
60023961|NCT02228967|76139718|FG001|STARTED|Overall Study||388||
60023962|NCT02228967|76139717|FG000|COMPLETED|Overall Study||244||
60023963|NCT02228967|76139718|FG001|COMPLETED|Overall Study||228||
60023964|NCT02228967|76139717|FG000|NOT COMPLETED|Overall Study||159||
60023965|NCT02228967|76139718|FG001|NOT COMPLETED|Overall Study||160||
60023966|NCT02227875|76139726|FG000|STARTED|Overall Study||277||
60023967|NCT02227875|76139727|FG001|STARTED|Overall Study||283||
60023968|NCT02227875|76139726|FG000|COMPLETED|Overall Study||240||
60023969|NCT02227875|76139727|FG001|COMPLETED|Overall Study||250||
60023970|NCT02227875|76139726|FG000|NOT COMPLETED|Overall Study||37||
60023971|NCT02227875|76139727|FG001|NOT COMPLETED|Overall Study||33||
60023972|NCT02203149|76139738|FG000|STARTED|Part 1||31||
60023973|NCT02203149|76139739|FG001|STARTED|Part 1||32||
60023974|NCT02203149|76139740|FG002|STARTED|Part 1||0||
60023975|NCT02203149|76139741|FG003|STARTED|Part 1||0||
60023976|NCT02203149|76139742|FG004|STARTED|Part 1||0||
60023977|NCT02203149|76139738|FG000|COMPLETED|Part 1||31||
60023978|NCT02203149|76139739|FG001|COMPLETED|Part 1||31||
60023979|NCT02203149|76139740|FG002|COMPLETED|Part 1||0||
60023980|NCT02203149|76139741|FG003|COMPLETED|Part 1||0||
60023981|NCT02203149|76139742|FG004|COMPLETED|Part 1||0||
60023982|NCT02203149|76139738|FG000|NOT COMPLETED|Part 1||0||
60023983|NCT02203149|76139739|FG001|NOT COMPLETED|Part 1||1||
60023984|NCT02203149|76139740|FG002|NOT COMPLETED|Part 1||0||
60023985|NCT02203149|76139741|FG003|NOT COMPLETED|Part 1||0||
60023986|NCT02203149|76139742|FG004|NOT COMPLETED|Part 1||0||
60023987|NCT02203149|76139738|FG000|STARTED|Part 2|Participants of Part 1 did not enter Part 2|0||
60023988|NCT02203149|76139739|FG001|STARTED|Part 2|Participants of Part 1 did not enter Part 2|0||
60023989|NCT02203149|76139740|FG002|STARTED|Part 2||227||
60023990|NCT02203149|76139741|FG003|STARTED|Part 2||74||
60023991|NCT02203149|76139742|FG004|STARTED|Part 2||35||
60023992|NCT02203149|76139738|FG000|Started Deferred Active Treatment|Part 2||0||
60023993|NCT02203149|76139739|FG001|Started Deferred Active Treatment|Part 2||0||
60023994|NCT02203149|76139740|FG002|Started Deferred Active Treatment|Part 2||0||
60023995|NCT02203149|76139741|FG003|Started Deferred Active Treatment|Part 2|1 participant in Deferred Treatment Arm receiving Placebo did not receive Deferred Active Treatment.|73||
60023996|NCT02203149|76139742|FG004|Started Deferred Active Treatment|Part 2||0||
60023997|NCT02203149|76139738|FG000|COMPLETED|Part 2||0||
60023998|NCT02203149|76139739|FG001|COMPLETED|Part 2||0||
60023999|NCT02203149|76139740|FG002|COMPLETED|Part 2||226||
60024000|NCT02203149|76139741|FG003|COMPLETED|Part 2||71||
60024001|NCT02203149|76139742|FG004|COMPLETED|Part 2||34||
60024002|NCT02203149|76139738|FG000|NOT COMPLETED|Part 2||0||
60024003|NCT02203149|76139739|FG001|NOT COMPLETED|Part 2||0||
60024004|NCT02203149|76139740|FG002|NOT COMPLETED|Part 2||1||
60024005|NCT02203149|76139741|FG003|NOT COMPLETED|Part 2||3||
60024006|NCT02203149|76139742|FG004|NOT COMPLETED|Part 2||1||
60024007|NCT02203071|76139766|FG000|STARTED|Overall Study||13||
60024008|NCT02203071|76139767|FG001|STARTED|Overall Study||6||
60024009|NCT02203071|76139766|FG000|COMPLETED|Overall Study||10||
60024010|NCT02203071|76139767|FG001|COMPLETED|Overall Study||5||
60024011|NCT02203071|76139766|FG000|NOT COMPLETED|Overall Study||3||
60024012|NCT02203071|76139767|FG001|NOT COMPLETED|Overall Study||1||
60024013|NCT02202837|76139775|FG000|STARTED|Overall Study||140||
60024014|NCT02202837|76139776|FG001|STARTED|Overall Study||17||
60024015|NCT02202837|76139775|FG000|COMPLETED|Overall Study||87||
60024016|NCT02202837|76139776|FG001|COMPLETED|Overall Study||12||
60024017|NCT02202837|76139775|FG000|NOT COMPLETED|Overall Study||53||
60024018|NCT02202837|76139776|FG001|NOT COMPLETED|Overall Study||5||
60024019|NCT02202759|76139785|FG000|STARTED|Overall Study||9||
60024020|NCT02202759|76139786|FG001|STARTED|Overall Study||15||
60024021|NCT02202759|76139787|FG002|STARTED|Overall Study||14||
60024022|NCT02202759|76139785|FG000|COMPLETED|Overall Study||0||
60024023|NCT02202759|76139786|FG001|COMPLETED|Overall Study||0||
60024024|NCT02202759|76139787|FG002|COMPLETED|Overall Study||0||
60024025|NCT02202759|76139785|FG000|NOT COMPLETED|Overall Study||9||
60024026|NCT02202759|76139786|FG001|NOT COMPLETED|Overall Study||15||
60024027|NCT02202759|76139787|FG002|NOT COMPLETED|Overall Study||14||
60024028|NCT02226549|76139796|FG000|STARTED|Overall Study||23||
60024029|NCT02226549|76139797|FG001|STARTED|Overall Study||24||
60024030|NCT02226549|76139796|FG000|COMPLETED|Overall Study||22||
60024031|NCT02226549|76139797|FG001|COMPLETED|Overall Study||23||
60024032|NCT02226549|76139796|FG000|NOT COMPLETED|Overall Study||1||
60024033|NCT02226549|76139797|FG001|NOT COMPLETED|Overall Study||1||
60024034|NCT02226003|76139806|FG000|STARTED|Overall Study||98||
60024035|NCT02226003|76139807|FG001|STARTED|Overall Study||96||
60024036|NCT02226003|76139808|FG002|STARTED|Overall Study||97||
60024037|NCT02226003|76139806|FG000|COMPLETED|Overall Study||96||
60024038|NCT02226003|76139807|FG001|COMPLETED|Overall Study||95||
60024039|NCT02226003|76139808|FG002|COMPLETED|Overall Study||91||
60024040|NCT02226003|76139806|FG000|NOT COMPLETED|Overall Study||2||
60024041|NCT02226003|76139807|FG001|NOT COMPLETED|Overall Study||1||
60024042|NCT02226003|76139808|FG002|NOT COMPLETED|Overall Study||6||
60024043|NCT02225223|76139818|FG000|STARTED|Overall Study||27||
60024044|NCT02225223|76139819|FG001|STARTED|Overall Study||8||
60024045|NCT02225223|76139818|FG000|COMPLETED|Overall Study||8||
60024046|NCT02225223|76139819|FG001|COMPLETED|Overall Study||3||
60024047|NCT02225223|76139818|FG000|NOT COMPLETED|Overall Study||19||
60024048|NCT02225223|76139819|FG001|NOT COMPLETED|Overall Study||5||
60024049|NCT01634139|76139828|FG000|STARTED|Overall Study||132||
60024050|NCT01634139|76139829|FG001|STARTED|Overall Study||136||
60024051|NCT01634139|76139830|FG002|STARTED|Overall Study||135||
60024052|NCT01634139|76139828|FG000|COMPLETED|Overall Study||122||
59914957|NCT04396106|76035841|FG002|STARTED|Overall Study||0||
59914958|NCT04396106|76035842|FG003|STARTED|Overall Study||2||
59914959|NCT04396106|76035839|FG000|COMPLETED|Overall Study||37||
60024053|NCT01634139|76139829|FG001|COMPLETED|Overall Study||130||
60024054|NCT01634139|76139830|FG002|COMPLETED|Overall Study||130||
60024055|NCT01634139|76139828|FG000|NOT COMPLETED|Overall Study||10||
60024056|NCT01634139|76139829|FG001|NOT COMPLETED|Overall Study||6||
60024057|NCT01634139|76139830|FG002|NOT COMPLETED|Overall Study||5||
60024058|NCT02224755|76139840|FG000|STARTED|Randomization to Device Implant|Patients in the Full Study Cohort (n=1028) who were randomized to HeartMate II|512||
59914960|NCT04396106|76035840|FG001|COMPLETED|Overall Study||37||
60024059|NCT02224755|76139841|FG001|STARTED|Randomization to Device Implant|Patients in the Full Study Cohort (n=1028) who were randomized to HeartMate 3|516||
60024060|NCT02224755|76139840|FG000|COMPLETED|Randomization to Device Implant|Patients who underwent HeartMate II LVAS implant|505||
60024061|NCT02224755|76139841|FG001|COMPLETED|Randomization to Device Implant|Patients who underwent HeartMate 3 LVAS implant|515||
60024062|NCT02224755|76139840|FG000|NOT COMPLETED|Randomization to Device Implant||7||
60024063|NCT02224755|76139841|FG001|NOT COMPLETED|Randomization to Device Implant||1||
60024064|NCT02224755|76139840|FG000|STARTED|Two Year Follow up Post-implant||505||
60024065|NCT02224755|76139841|FG001|STARTED|Two Year Follow up Post-implant||515||
60024066|NCT02224755|76139840|FG000|COMPLETED|Two Year Follow up Post-implant||247||
60024067|NCT02224755|76139841|FG001|COMPLETED|Two Year Follow up Post-implant||289||
60024068|NCT02224755|76139840|FG000|NOT COMPLETED|Two Year Follow up Post-implant||258||
60024069|NCT02224755|76139841|FG001|NOT COMPLETED|Two Year Follow up Post-implant||226||
60024070|NCT02404441|76139861|FG000|STARTED|Phase 1 Part||16||
60024071|NCT02404441|76139862|FG001|STARTED|Phase 1 Part||15||
60024072|NCT02404441|76139863|FG002|STARTED|Phase 1 Part||11||
60024073|NCT02404441|76139864|FG003|STARTED|Phase 1 Part||6||
60024074|NCT02404441|76139865|FG004|STARTED|Phase 1 Part||10||
60024075|NCT02404441|76139866|FG005|STARTED|Phase 1 Part||0||
60024076|NCT02404441|76139867|FG006|STARTED|Phase 1 Part||0||
60024077|NCT02404441|76139868|FG007|STARTED|Phase 1 Part||0||
60024078|NCT02404441|76139869|FG008|STARTED|Phase 1 Part||0||
59914961|NCT04396106|76035841|FG002|COMPLETED|Overall Study||0||
59914962|NCT04396106|76035842|FG003|COMPLETED|Overall Study||1||
59914963|NCT04396106|76035839|FG000|NOT COMPLETED|Overall Study||4||
59914964|NCT04396106|76035840|FG001|NOT COMPLETED|Overall Study||3||
59914965|NCT04396106|76035841|FG002|NOT COMPLETED|Overall Study||0||
59914966|NCT04396106|76035842|FG003|NOT COMPLETED|Overall Study||1||
60024079|NCT02404441|76139870|FG009|STARTED|Phase 1 Part||0||
60024080|NCT02404441|76139861|FG000|COMPLETED|Phase 1 Part||0|Completed = Treatment Discontinued|
60024081|NCT02404441|76139862|FG001|COMPLETED|Phase 1 Part||0|Completed = Treatment Discontinued|
60024082|NCT02404441|76139863|FG002|COMPLETED|Phase 1 Part||0|Completed = Treatment Discontinued|
59914967|NCT04091087|76035854|FG000|STARTED|Overall Study||33||
59914968|NCT04091087|76035855|FG001|STARTED|Overall Study||33||
59914969|NCT04091087|76035854|FG000|Treated|Overall Study||32||
59914970|NCT04091087|76035855|FG001|Treated|Overall Study||33||
59914971|NCT04091087|76035854|FG000|COMPLETED|Overall Study||23||
59914972|NCT04091087|76035855|FG001|COMPLETED|Overall Study||26||
59914973|NCT04091087|76035854|FG000|NOT COMPLETED|Overall Study||10||
59914974|NCT04091087|76035855|FG001|NOT COMPLETED|Overall Study||7||
59914975|NCT03046836|76035863|FG000|STARTED|Overall Study||100||
59914976|NCT03046836|76035864|FG001|STARTED|Overall Study||100||
59914977|NCT03046836|76035863|FG000|COMPLETED|Overall Study||100||
60024083|NCT02404441|76139864|FG003|COMPLETED|Phase 1 Part||0|Completed = Treatment Discontinued|
60024084|NCT02404441|76139865|FG004|COMPLETED|Phase 1 Part||0|Completed = Treatment Discontinued|
60024085|NCT02404441|76139866|FG005|COMPLETED|Phase 1 Part||0|Completed = Treatment Discontinued|
60024086|NCT02404441|76139867|FG006|COMPLETED|Phase 1 Part||0|Completed = Treatment Discontinued|
60024087|NCT02404441|76139868|FG007|COMPLETED|Phase 1 Part||0|Completed = Treatment Discontinued|
60024088|NCT02404441|76139869|FG008|COMPLETED|Phase 1 Part||0|Completed = Treatment Discontinued|
60024089|NCT02404441|76139870|FG009|COMPLETED|Phase 1 Part||0|Completed = Treatment Discontinued|
60024090|NCT02404441|76139861|FG000|NOT COMPLETED|Phase 1 Part||16||
60024091|NCT02404441|76139862|FG001|NOT COMPLETED|Phase 1 Part||15||
60024092|NCT02404441|76139863|FG002|NOT COMPLETED|Phase 1 Part||11||
60024093|NCT02404441|76139864|FG003|NOT COMPLETED|Phase 1 Part||6||
59758967|NCT00921557|75878312|FG000|STARTED|Weeks 0-48 (on Study Treatment)||17||
60024094|NCT02404441|76139865|FG004|NOT COMPLETED|Phase 1 Part||10||
60024095|NCT02404441|76139866|FG005|NOT COMPLETED|Phase 1 Part||0||
60024096|NCT02404441|76139867|FG006|NOT COMPLETED|Phase 1 Part||0||
60024097|NCT02404441|76139868|FG007|NOT COMPLETED|Phase 1 Part||0||
60024098|NCT02404441|76139869|FG008|NOT COMPLETED|Phase 1 Part||0||
60024099|NCT02404441|76139870|FG009|NOT COMPLETED|Phase 1 Part||0||
60024100|NCT02404441|76139861|FG000|STARTED|Phase 2 Part||0||
60024101|NCT02404441|76139862|FG001|STARTED|Phase 2 Part||0||
60024102|NCT02404441|76139863|FG002|STARTED|Phase 2 Part||0||
60024103|NCT02404441|76139864|FG003|STARTED|Phase 2 Part||0||
60024104|NCT02404441|76139865|FG004|STARTED|Phase 2 Part||0||
60024105|NCT02404441|76139866|FG005|STARTED|Phase 2 Part||59||
60024106|NCT02404441|76139867|FG006|STARTED|Phase 2 Part||61||
60024107|NCT02404441|76139868|FG007|STARTED|Phase 2 Part||40||
60024108|NCT02404441|76139869|FG008|STARTED|Phase 2 Part||59||
60024109|NCT02404441|76139870|FG009|STARTED|Phase 2 Part||42||
60024110|NCT02404441|76139861|FG000|Entered Post-treatment Follow-up|Phase 2 Part||0||
60024111|NCT02404441|76139862|FG001|Entered Post-treatment Follow-up|Phase 2 Part||0||
60024112|NCT02404441|76139863|FG002|Entered Post-treatment Follow-up|Phase 2 Part||0||
60024113|NCT02404441|76139864|FG003|Entered Post-treatment Follow-up|Phase 2 Part||0||
60024114|NCT02404441|76139865|FG004|Entered Post-treatment Follow-up|Phase 2 Part||0||
60024115|NCT02404441|76139866|FG005|Entered Post-treatment Follow-up|Phase 2 Part||2||
60024116|NCT02404441|76139867|FG006|Entered Post-treatment Follow-up|Phase 2 Part||6||
60024117|NCT02404441|76139868|FG007|Entered Post-treatment Follow-up|Phase 2 Part||1||
60024118|NCT02404441|76139869|FG008|Entered Post-treatment Follow-up|Phase 2 Part||6||
60024119|NCT02404441|76139870|FG009|Entered Post-treatment Follow-up|Phase 2 Part||1||
60024120|NCT02404441|76139861|FG000|No Longer Being Followed for Post-treatment Follow-up|Phase 2 Part||0||
60024121|NCT02404441|76139862|FG001|No Longer Being Followed for Post-treatment Follow-up|Phase 2 Part||0||
60024122|NCT02404441|76139863|FG002|No Longer Being Followed for Post-treatment Follow-up|Phase 2 Part||0||
60024123|NCT02404441|76139864|FG003|No Longer Being Followed for Post-treatment Follow-up|Phase 2 Part||0||
60024124|NCT02404441|76139865|FG004|No Longer Being Followed for Post-treatment Follow-up|Phase 2 Part||0||
60024125|NCT02404441|76139866|FG005|No Longer Being Followed for Post-treatment Follow-up|Phase 2 Part||2||
60024126|NCT02404441|76139867|FG006|No Longer Being Followed for Post-treatment Follow-up|Phase 2 Part||6||
60024127|NCT02404441|76139868|FG007|No Longer Being Followed for Post-treatment Follow-up|Phase 2 Part||1||
60024128|NCT02404441|76139869|FG008|No Longer Being Followed for Post-treatment Follow-up|Phase 2 Part||6||
59758968|NCT00921557|75878313|FG001|STARTED|Weeks 0-48 (on Study Treatment)||17||
59758969|NCT00921557|75878314|FG002|STARTED|Weeks 0-48 (on Study Treatment)||18||
59758970|NCT00921557|75878312|FG000|COMPLETED|Weeks 0-48 (on Study Treatment)|Completed 48 weeks|15||
59758971|NCT00921557|75878313|FG001|COMPLETED|Weeks 0-48 (on Study Treatment)|Completed 48 weeks|17||
59758972|NCT00921557|75878314|FG002|COMPLETED|Weeks 0-48 (on Study Treatment)|Completed 48 weeks|18||
59758973|NCT00921557|75878312|FG000|NOT COMPLETED|Weeks 0-48 (on Study Treatment)||2||
59758974|NCT00921557|75878313|FG001|NOT COMPLETED|Weeks 0-48 (on Study Treatment)||0||
59758975|NCT00921557|75878314|FG002|NOT COMPLETED|Weeks 0-48 (on Study Treatment)||0||
59758976|NCT00921557|75878312|FG000|STARTED|Weeks 48-96 (on Study Treatment)||15||
59758977|NCT00921557|75878313|FG001|STARTED|Weeks 48-96 (on Study Treatment)||17||
59758978|NCT00921557|75878314|FG002|STARTED|Weeks 48-96 (on Study Treatment)||18||
59758979|NCT00921557|75878312|FG000|COMPLETED|Weeks 48-96 (on Study Treatment)||15||
59758980|NCT00921557|75878313|FG001|COMPLETED|Weeks 48-96 (on Study Treatment)||16||
59758981|NCT00921557|75878314|FG002|COMPLETED|Weeks 48-96 (on Study Treatment)||17||
59914978|NCT03046836|76035864|FG001|COMPLETED|Overall Study||100||
59914979|NCT03046836|76035863|FG000|NOT COMPLETED|Overall Study||0||
59914980|NCT03046836|76035864|FG001|NOT COMPLETED|Overall Study||0||
59914981|NCT03400033|76035873|FG000|STARTED|Overall Study||270||
59914982|NCT03400033|76035874|FG001|STARTED|Overall Study||137||
59914983|NCT03400033|76035873|FG000|COMPLETED|Overall Study||269||
59914984|NCT03400033|76035874|FG001|COMPLETED|Overall Study||135||
59914985|NCT03400033|76035873|FG000|NOT COMPLETED|Overall Study||1||
59914986|NCT03400033|76035874|FG001|NOT COMPLETED|Overall Study||2||
60024129|NCT02404441|76139870|FG009|No Longer Being Followed for Post-treatment Follow-up|Phase 2 Part||1||
60024130|NCT02404441|76139861|FG000|Entered Survival Follow-up|Phase 2 Part||0||
60024131|NCT02404441|76139862|FG001|Entered Survival Follow-up|Phase 2 Part||0||
60024132|NCT02404441|76139863|FG002|Entered Survival Follow-up|Phase 2 Part||0||
60024133|NCT02404441|76139864|FG003|Entered Survival Follow-up|Phase 2 Part||0||
60024134|NCT02404441|76139865|FG004|Entered Survival Follow-up|Phase 2 Part||0||
60024135|NCT02404441|76139866|FG005|Entered Survival Follow-up|Phase 2 Part||38||
60024136|NCT02404441|76139867|FG006|Entered Survival Follow-up|Phase 2 Part||34||
60024137|NCT02404441|76139868|FG007|Entered Survival Follow-up|Phase 2 Part||26||
60024138|NCT02404441|76139869|FG008|Entered Survival Follow-up|Phase 2 Part||35||
60024139|NCT02404441|76139870|FG009|Entered Survival Follow-up|Phase 2 Part||25||
60024140|NCT02404441|76139861|FG000|COMPLETED|Phase 2 Part||0|Completed = Treatment Discontinued|
60024141|NCT02404441|76139862|FG001|COMPLETED|Phase 2 Part||0|Completed = Treatment Discontinued|
60024142|NCT02404441|76139863|FG002|COMPLETED|Phase 2 Part||0|Completed = Treatment Discontinued|
60024143|NCT02404441|76139864|FG003|COMPLETED|Phase 2 Part||0|Completed = Treatment Discontinued|
60024144|NCT02404441|76139865|FG004|COMPLETED|Phase 2 Part||0|Completed = Treatment Discontinued|
60024145|NCT02404441|76139866|FG005|COMPLETED|Phase 2 Part||0|Completed = Treatment Discontinued|
60024146|NCT02404441|76139867|FG006|COMPLETED|Phase 2 Part||0|Completed = Treatment Discontinued|
60024147|NCT02404441|76139868|FG007|COMPLETED|Phase 2 Part||0|Completed = Treatment Discontinued|
60024148|NCT02404441|76139869|FG008|COMPLETED|Phase 2 Part||0|Completed = Treatment Discontinued|
60024149|NCT02404441|76139870|FG009|COMPLETED|Phase 2 Part||0|Completed = Treatment Discontinued|
60024150|NCT02404441|76139861|FG000|NOT COMPLETED|Phase 2 Part||0||
60024151|NCT02404441|76139862|FG001|NOT COMPLETED|Phase 2 Part||0||
60024152|NCT02404441|76139863|FG002|NOT COMPLETED|Phase 2 Part||0||
60024153|NCT02404441|76139864|FG003|NOT COMPLETED|Phase 2 Part||0||
60024154|NCT02404441|76139865|FG004|NOT COMPLETED|Phase 2 Part||0||
60024155|NCT02404441|76139866|FG005|NOT COMPLETED|Phase 2 Part||59||
60024156|NCT02404441|76139867|FG006|NOT COMPLETED|Phase 2 Part||61||
60024157|NCT02404441|76139868|FG007|NOT COMPLETED|Phase 2 Part||40||
60024158|NCT02404441|76139869|FG008|NOT COMPLETED|Phase 2 Part||59||
60024159|NCT02404441|76139870|FG009|NOT COMPLETED|Phase 2 Part||42||
60024160|NCT02101281|76139916|FG000|STARTED|Overall Study||20||
60024161|NCT02101281|76139917|FG001|STARTED|Overall Study||20||
60024162|NCT02101281|76139916|FG000|COMPLETED|Overall Study||20||
60024163|NCT02101281|76139917|FG001|COMPLETED|Overall Study||19||
60024164|NCT02101281|76139916|FG000|NOT COMPLETED|Overall Study||0||
60024165|NCT02101281|76139917|FG001|NOT COMPLETED|Overall Study||1||
60024166|NCT02224599|76139929|FG000|STARTED|Overall Study||3||
60024167|NCT02224599|76139929|FG000|COMPLETED|Overall Study||1||
60024168|NCT02224599|76139929|FG000|NOT COMPLETED|Overall Study||2||
60024169|NCT02201901|76139936|FG000|STARTED|Overall Study||90||
60024170|NCT02201901|76139937|FG001|STARTED|Overall Study||88||
60024171|NCT02201901|76139938|FG002|STARTED|Overall Study||90||
60024172|NCT02201901|76139936|FG000|COMPLETED|Overall Study||75||
60024173|NCT02201901|76139937|FG001|COMPLETED|Overall Study||79||
60024174|NCT02201901|76139938|FG002|COMPLETED|Overall Study||77||
60024175|NCT02201901|76139936|FG000|NOT COMPLETED|Overall Study||15||
60024176|NCT02201901|76139937|FG001|NOT COMPLETED|Overall Study||9||
60024177|NCT02201901|76139938|FG002|NOT COMPLETED|Overall Study||13||
60024178|NCT02201277|76139949|FG000|STARTED|Overall Study|24 patients were consented but 1 patient had denali filter placed twice.|24||25
60024179|NCT02201277|76139950|FG001|STARTED|Overall Study|1 patient was withdrawn after signing consent due to physician preference for the option filter.|21||20
60024180|NCT02201277|76139949|FG000|Filter Retrieval|Overall Study||17||17
60024181|NCT02201277|76139950|FG001|Filter Retrieval|Overall Study||16||16
60024182|NCT02201277|76139949|FG000|Signed ICF But Did Not Enroll|Overall Study|Physician had preference for a specific filter so patient not randomized.|0||0
60024183|NCT02201277|76139950|FG001|Signed ICF But Did Not Enroll|Overall Study||1||1
60024184|NCT02201277|76139949|FG000|Filter Ruled to be Permanent|Overall Study||2||2
60024185|NCT02201277|76139950|FG001|Filter Ruled to be Permanent|Overall Study||2||2
60024186|NCT02201277|76139949|FG000|Lost to Follow up|Overall Study||2||2
60024187|NCT02201277|76139950|FG001|Lost to Follow up|Overall Study||1||1
60024188|NCT02201277|76139949|FG000|Death (Before Removal)|Overall Study||3|All cause mortality not related to the study devices.|3
60024189|NCT02201277|76139950|FG001|Death (Before Removal)|Overall Study||4|All cause mortality not related to the study devices.|4
60024190|NCT02201277|76139949|FG000|Complicated Retrieval|Overall Study||2|2 filters failed 1st attempts at retrieval then success.|2
60024191|NCT02201277|76139950|FG001|Complicated Retrieval|Overall Study||0|2 filters failed 1st attempts at retrieval then success.|0
60024192|NCT02201277|76139949|FG000|Failed Retrieval (Referred Elsewhere)|Overall Study||1||1
60024193|NCT02201277|76139950|FG001|Failed Retrieval (Referred Elsewhere)|Overall Study||0||0
60024194|NCT02201277|76139949|FG000|COMPLETED|Overall Study||17||18
60024195|NCT02201277|76139950|FG001|COMPLETED|Overall Study||16||16
60024196|NCT02201277|76139949|FG000|NOT COMPLETED|Overall Study||7||7
60024197|NCT02201277|76139950|FG001|NOT COMPLETED|Overall Study||5||4
60024198|NCT02224053|76139960|FG000|STARTED|AZD9291 and Omeprazole Co-administration||68||
60024199|NCT02224053|76139960|FG000|COMPLETED|AZD9291 and Omeprazole Co-administration||47||
60024200|NCT02224053|76139960|FG000|NOT COMPLETED|AZD9291 and Omeprazole Co-administration||21||
60024201|NCT02224053|76139960|FG000|STARTED|AZD9291 Alone||47||
60024202|NCT02224053|76139960|FG000|COMPLETED|AZD9291 Alone||47||
60024203|NCT02224053|76139960|FG000|NOT COMPLETED|AZD9291 Alone||0||
60024204|NCT02457793|76139972|FG000|STARTED|Overall Study||1||
60024205|NCT02457793|76139973|FG001|STARTED|Overall Study||5||
60024206|NCT02457793|76139974|FG002|STARTED|Overall Study||3||
60024207|NCT02457793|76139975|FG003|STARTED|Overall Study||5||
60024208|NCT02457793|76139976|FG004|STARTED|Overall Study||4||
60024209|NCT02457793|76139977|FG005|STARTED|Overall Study||6||
60024210|NCT02457793|76139972|FG000|COMPLETED|Overall Study||0||
60024211|NCT02457793|76139973|FG001|COMPLETED|Overall Study||1||
60024212|NCT02457793|76139974|FG002|COMPLETED|Overall Study||0||
60024213|NCT02457793|76139975|FG003|COMPLETED|Overall Study||0||
60024214|NCT02457793|76139976|FG004|COMPLETED|Overall Study||0||
60024215|NCT02457793|76139977|FG005|COMPLETED|Overall Study||0||
60024216|NCT02457793|76139972|FG000|NOT COMPLETED|Overall Study||1||
60024217|NCT02457793|76139973|FG001|NOT COMPLETED|Overall Study||4||
60024218|NCT02457793|76139974|FG002|NOT COMPLETED|Overall Study||3||
60024219|NCT02457793|76139975|FG003|NOT COMPLETED|Overall Study||5||
60024220|NCT02457793|76139976|FG004|NOT COMPLETED|Overall Study||4||
60024221|NCT02457793|76139977|FG005|NOT COMPLETED|Overall Study||6||
60024222|NCT01650259|76139994|FG000|STARTED|Overall Study|Started are the registered patients|2513||
60024223|NCT01650259|76139995|FG001|STARTED|Overall Study|Started are the registered patients|2363||
60024224|NCT01650259|76139994|FG000|COMPLETED|Overall Study||1470||
60024225|NCT01650259|76139995|FG001|COMPLETED|Overall Study||2128||
60024226|NCT01650259|76139994|FG000|NOT COMPLETED|Overall Study||1043||
60024227|NCT01650259|76139995|FG001|NOT COMPLETED|Overall Study||235||
60024228|NCT02434939|76140001|FG000|STARTED|Overall Study||120||
60024229|NCT02434939|76140002|FG001|STARTED|Overall Study||120||
60024230|NCT02434939|76140001|FG000|COMPLETED|Overall Study||83||
59758982|NCT00921557|75878312|FG000|NOT COMPLETED|Weeks 48-96 (on Study Treatment)||0||
59758983|NCT00921557|75878313|FG001|NOT COMPLETED|Weeks 48-96 (on Study Treatment)||1||
59758984|NCT00921557|75878314|FG002|NOT COMPLETED|Weeks 48-96 (on Study Treatment)||1||
59758985|NCT00921557|75878312|FG000|STARTED|Weeks 96-144 (Off Study Treatment)||15||
59758986|NCT00921557|75878313|FG001|STARTED|Weeks 96-144 (Off Study Treatment)||16||
59914987|NCT04089761|76035889|FG000|STARTED|"Run In Phase"||60||
59914988|NCT04089761|76035889|FG000|COMPLETED|"Run In Phase"||45||
59914989|NCT04089761|76035889|FG000|NOT COMPLETED|"Run In Phase"||15||
59914990|NCT04089761|76035889|FG000|STARTED|"Treatment Phase"||45||
59914991|NCT04089761|76035889|FG000|COMPLETED|"Treatment Phase"||39||
59914992|NCT04089761|76035889|FG000|NOT COMPLETED|"Treatment Phase"||6||
59914993|NCT04089761|76035889|FG000|STARTED|"Follow Up Phase (Optional)"|"Due to the COVID-19 pandemic, Only 27 participants were able to continue to the folllow Up phase"|27||
59914994|NCT04089761|76035889|FG000|COMPLETED|"Follow Up Phase (Optional)"||27||
59914995|NCT04089761|76035889|FG000|NOT COMPLETED|"Follow Up Phase (Optional)"||0||
59914996|NCT03118518|76035895|FG000|STARTED|Overall Study||108||
59914997|NCT03118518|76035896|FG001|STARTED|Overall Study||102||
59914998|NCT03118518|76035895|FG000|Subject Treated According to Randomization Assignment|Overall Study||104||
59914999|NCT03118518|76035896|FG001|Subject Treated According to Randomization Assignment|Overall Study||99||
59915000|NCT03118518|76035895|FG000|COMPLETED|Overall Study||102||
59915001|NCT03118518|76035896|FG001|COMPLETED|Overall Study||91||
59915002|NCT03118518|76035895|FG000|NOT COMPLETED|Overall Study||6||
59915003|NCT03118518|76035896|FG001|NOT COMPLETED|Overall Study||11||
59915004|NCT03984305|76035904|FG000|STARTED|Overall Study||23||
59915005|NCT03984305|76035905|FG001|STARTED|Overall Study||18||
59915006|NCT03984305|76035904|FG000|COMPLETED|Overall Study||0||
59915007|NCT03984305|76035905|FG001|COMPLETED|Overall Study||0||
59915008|NCT03984305|76035904|FG000|NOT COMPLETED|Overall Study||23||
59915009|NCT03984305|76035905|FG001|NOT COMPLETED|Overall Study||18||
60024231|NCT02434939|76140002|FG001|COMPLETED|Overall Study||71||
60024232|NCT02434939|76140001|FG000|NOT COMPLETED|Overall Study||37||
60024233|NCT02434939|76140002|FG001|NOT COMPLETED|Overall Study||49||
60024234|NCT02434471|76140009|FG000|STARTED|Overall Study||34||
60024235|NCT02434471|76140009|FG000|COMPLETED|Overall Study||25||
60024236|NCT02434471|76140009|FG000|NOT COMPLETED|Overall Study||9||
60024237|NCT02457637|76140014|FG000|STARTED|Recruitment|2600 is the number of inpatients who met our eligibility.|2600||
60024238|NCT02457637|76140014|FG000|COMPLETED|Recruitment|2361 patients were excluded according to our exclusion criteria,2600 patients remained.|2600||
60024239|NCT02457637|76140014|FG000|NOT COMPLETED|Recruitment||0||
60024240|NCT02457637|76140014|FG000|STARTED|28-Days Hospitalization and Observation||2600||
60024241|NCT02457637|76140014|FG000|Liver Transplantation|28-Days Hospitalization and Observation||124||
60024242|NCT02457637|76140014|FG000|Death|28-Days Hospitalization and Observation||74||
60024243|NCT02457637|76140014|FG000|COMPLETED|28-Days Hospitalization and Observation|Death and receiving Liver transplantation are two end points of our observation.|2600||
60024244|NCT02457637|76140014|FG000|NOT COMPLETED|28-Days Hospitalization and Observation||0||
60024245|NCT02457637|76140014|FG000|STARTED|Clinic or Telephone Follow-up||2600||
60024246|NCT02457637|76140014|FG000|One-year Liver Transplantation|Clinic or Telephone Follow-up||182||
60024247|NCT02457637|76140014|FG000|One-year Death|Clinic or Telephone Follow-up||475||
60024248|NCT02457637|76140014|FG000|COMPLETED|Clinic or Telephone Follow-up||2529||
60024249|NCT02457637|76140014|FG000|NOT COMPLETED|Clinic or Telephone Follow-up||71||
60024250|NCT02457325|76140021|FG000|STARTED|First Intervention (1 Day)||25||
60024251|NCT02457325|76140022|FG001|STARTED|First Intervention (1 Day)||25||
60024252|NCT02457325|76140021|FG000|COMPLETED|First Intervention (1 Day)||23||
60024253|NCT02457325|76140022|FG001|COMPLETED|First Intervention (1 Day)||23||
60024254|NCT02457325|76140021|FG000|NOT COMPLETED|First Intervention (1 Day)||2||
60024255|NCT02457325|76140022|FG001|NOT COMPLETED|First Intervention (1 Day)||2||
60024256|NCT02457325|76140021|FG000|STARTED|Washout (1-2 Months)||23||
60024257|NCT02457325|76140022|FG001|STARTED|Washout (1-2 Months)||23||
60024258|NCT02457325|76140021|FG000|COMPLETED|Washout (1-2 Months)||23||
60024259|NCT02457325|76140022|FG001|COMPLETED|Washout (1-2 Months)||23||
60024260|NCT02457325|76140021|FG000|NOT COMPLETED|Washout (1-2 Months)||0||
60024261|NCT02457325|76140022|FG001|NOT COMPLETED|Washout (1-2 Months)||0||
60024262|NCT02457325|76140021|FG000|STARTED|Second Intervention (1 Day)||23||
60024263|NCT02457325|76140022|FG001|STARTED|Second Intervention (1 Day)||23||
60024264|NCT02457325|76140021|FG000|COMPLETED|Second Intervention (1 Day)||23||
60024265|NCT02457325|76140022|FG001|COMPLETED|Second Intervention (1 Day)||23||
60024266|NCT02457325|76140021|FG000|NOT COMPLETED|Second Intervention (1 Day)||0||
60024267|NCT02457325|76140022|FG001|NOT COMPLETED|Second Intervention (1 Day)||0||
60024268|NCT02434081|76140028|FG000|STARTED|Overall Study|Only patients enrolled after protocol amendments 1 (n=43) and 2 (n=36) were analysed (concurrent CRT+Nivo). Patients who received CRT and sequentially Nivo (enrolled under original protocol (n=12) or protocol amendment 1 (n=3)) were not included in the analysis population.|79||
60024269|NCT02434081|76140028|FG000|COMPLETED|Overall Study||31||
60024270|NCT02434081|76140028|FG000|NOT COMPLETED|Overall Study||48||
60024271|NCT02222493|76140034|FG000|STARTED|Period 1: First Dose-Week 30 (Pre-dose)||324||
60024272|NCT02222493|76140035|FG001|STARTED|Period 1: First Dose-Week 30 (Pre-dose)||326||
60024273|NCT02222493|76140034|FG000|Received Treatment|Period 1: First Dose-Week 30 (Pre-dose)||323||
60024274|NCT02222493|76140035|FG001|Received Treatment|Period 1: First Dose-Week 30 (Pre-dose)||326||
60024275|NCT02222493|76140034|FG000|COMPLETED|Period 1: First Dose-Week 30 (Pre-dose)||280||
60024276|NCT02222493|76140035|FG001|COMPLETED|Period 1: First Dose-Week 30 (Pre-dose)||286||
60024277|NCT02222493|76140034|FG000|NOT COMPLETED|Period 1: First Dose-Week 30 (Pre-dose)||44||
60024278|NCT02222493|76140035|FG001|NOT COMPLETED|Period 1: First Dose-Week 30 (Pre-dose)||40||
60024279|NCT02222493|76140034|FG000|STARTED|Period 2: Week30 Dosing-Week54(Pre-dose)||423||
60024280|NCT02222493|76140035|FG001|STARTED|Period 2: Week30 Dosing-Week54(Pre-dose)||143||
60024281|NCT02222493|76140034|FG000|COMPLETED|Period 2: Week30 Dosing-Week54(Pre-dose)||380||
60024282|NCT02222493|76140035|FG001|COMPLETED|Period 2: Week30 Dosing-Week54(Pre-dose)||126||
60024283|NCT02222493|76140034|FG000|NOT COMPLETED|Period 2: Week30 Dosing-Week54(Pre-dose)||43||
60024284|NCT02222493|76140035|FG001|NOT COMPLETED|Period 2: Week30 Dosing-Week54(Pre-dose)||17||
60024285|NCT02222493|76140034|FG000|STARTED|Period 3: Week 54 Dosing-Week 78 Visit||505||
60024286|NCT02222493|76140035|FG001|STARTED|Period 3: Week 54 Dosing-Week 78 Visit||0||
60024287|NCT02222493|76140034|FG000|COMPLETED|Period 3: Week 54 Dosing-Week 78 Visit||474||
60024288|NCT02222493|76140035|FG001|COMPLETED|Period 3: Week 54 Dosing-Week 78 Visit||0||
60024289|NCT02222493|76140034|FG000|NOT COMPLETED|Period 3: Week 54 Dosing-Week 78 Visit||31||
60024290|NCT02222493|76140035|FG001|NOT COMPLETED|Period 3: Week 54 Dosing-Week 78 Visit||0||
60024291|NCT02433379|76140054|FG000|STARTED|Overall Study||1173||
60024292|NCT02433379|76140054|FG000|COMPLETED|Overall Study||852||
60024293|NCT02433379|76140054|FG000|NOT COMPLETED|Overall Study||321||
60024294|NCT02199795|76140062|FG000|STARTED|Overall Study||4||
60024295|NCT02199795|76140063|FG001|STARTED|Overall Study||3||
60024296|NCT02199795|76140062|FG000|COMPLETED|Overall Study||2||
60024297|NCT02199795|76140063|FG001|COMPLETED|Overall Study||3||
60024298|NCT02199795|76140062|FG000|NOT COMPLETED|Overall Study||2||
60024299|NCT02199795|76140063|FG001|NOT COMPLETED|Overall Study||0||
60024300|NCT02403817|76140071|FG000|STARTED|Overall Study||28||
60024301|NCT02403817|76140072|FG001|STARTED|Overall Study||2||
60024302|NCT02403817|76140071|FG000|COMPLETED|Overall Study||23||
60024303|NCT02403817|76140072|FG001|COMPLETED|Overall Study||2||
60024304|NCT02403817|76140071|FG000|NOT COMPLETED|Overall Study||5||
60024305|NCT02403817|76140072|FG001|NOT COMPLETED|Overall Study||0||
60024306|NCT02403271|76140078|FG000|STARTED|Period 1|All Phase 1b participants went on to participate in Phase 2.|7||
60024307|NCT02403271|76140079|FG001|STARTED|Period 1||0||
60024308|NCT02403271|76140078|FG000|COMPLETED|Period 1||6||
60024309|NCT02403271|76140079|FG001|COMPLETED|Period 1||0||
60024310|NCT02403271|76140078|FG000|NOT COMPLETED|Period 1||1||
60024311|NCT02403271|76140079|FG001|NOT COMPLETED|Period 1||0||
60024312|NCT02403271|76140078|FG000|STARTED|Period 2||0||
60024313|NCT02403271|76140079|FG001|STARTED|Period 2|Phase 2 includes all subjects who participated in Phase 1b.|124||
60024314|NCT02403271|76140078|FG000|COMPLETED|Period 2||0||
60024315|NCT02403271|76140079|FG001|COMPLETED|Period 2||0||
60024316|NCT02403271|76140078|FG000|NOT COMPLETED|Period 2||0||
60024317|NCT02403271|76140079|FG001|NOT COMPLETED|Period 2||124||
60024318|NCT02219685|76140087|FG000|STARTED|Blinded Treatment Phase||26||
60024319|NCT02219685|76140088|FG001|STARTED|Blinded Treatment Phase||14||
60024320|NCT02219685|76140087|FG000|COMPLETED|Blinded Treatment Phase||24||
60024321|NCT02219685|76140088|FG001|COMPLETED|Blinded Treatment Phase||14||
60024322|NCT02219685|76140087|FG000|NOT COMPLETED|Blinded Treatment Phase||2||
60024323|NCT02219685|76140088|FG001|NOT COMPLETED|Blinded Treatment Phase||0||
60024324|NCT02219685|76140087|FG000|STARTED|Open-Label (After Posttreatment Week 4)|Only participants from the Placebo arm were eligible to enroll in the Open-Label Phase.|0||
60024325|NCT02219685|76140088|FG001|STARTED|Open-Label (After Posttreatment Week 4)||14||
60024326|NCT02219685|76140087|FG000|COMPLETED|Open-Label (After Posttreatment Week 4)||0||
60024327|NCT02219685|76140088|FG001|COMPLETED|Open-Label (After Posttreatment Week 4)||14||
60024328|NCT02219685|76140087|FG000|NOT COMPLETED|Open-Label (After Posttreatment Week 4)||0||
60024329|NCT02219685|76140088|FG001|NOT COMPLETED|Open-Label (After Posttreatment Week 4)||0||
60024330|NCT02457247|76140100|FG000|STARTED|Period 1||68||
60024331|NCT02457247|76140101|FG001|STARTED|Period 1||70||
60024332|NCT02457247|76140102|FG002|STARTED|Period 1||68||
60024333|NCT02457247|76140103|FG003|STARTED|Period 1||70||
60024334|NCT02457247|76140100|FG000|COMPLETED|Period 1||66||
60024335|NCT02457247|76140101|FG001|COMPLETED|Period 1||68||
60024336|NCT02457247|76140102|FG002|COMPLETED|Period 1||68||
60024337|NCT02457247|76140103|FG003|COMPLETED|Period 1||70||
60024338|NCT02457247|76140100|FG000|NOT COMPLETED|Period 1||2||
60024339|NCT02457247|76140101|FG001|NOT COMPLETED|Period 1||2||
60024340|NCT02457247|76140102|FG002|NOT COMPLETED|Period 1||0||
60024341|NCT02457247|76140103|FG003|NOT COMPLETED|Period 1||0||
60024342|NCT02457247|76140100|FG000|STARTED|Period 2||66||
60024343|NCT02457247|76140101|FG001|STARTED|Period 2||68||
60024344|NCT02457247|76140102|FG002|STARTED|Period 2||68||
60024345|NCT02457247|76140103|FG003|STARTED|Period 2||70||
60024346|NCT02457247|76140100|FG000|COMPLETED|Period 2||64||
60024347|NCT02457247|76140101|FG001|COMPLETED|Period 2||65||
60024348|NCT02457247|76140102|FG002|COMPLETED|Period 2||68||
60024349|NCT02457247|76140103|FG003|COMPLETED|Period 2||70||
60024350|NCT02457247|76140100|FG000|NOT COMPLETED|Period 2||2||
60024351|NCT02457247|76140101|FG001|NOT COMPLETED|Period 2||3||
60024352|NCT02457247|76140102|FG002|NOT COMPLETED|Period 2||0||
60024353|NCT02457247|76140103|FG003|NOT COMPLETED|Period 2||0||
60024354|NCT02401867|76140119|FG000|STARTED|Enrolled||150||
60024355|NCT02401867|76140119|FG000|COMPLETED|Enrolled||150||
60024356|NCT02401867|76140119|FG000|NOT COMPLETED|Enrolled||0||
60024357|NCT02401867|76140119|FG000|STARTED|Specimen Collection||150||
60024358|NCT02401867|76140119|FG000|COMPLETED|Specimen Collection|Completed both vaginal self-swab and provider-collected cervical swab|140||
60024359|NCT02401867|76140119|FG000|NOT COMPLETED|Specimen Collection||10||
60024360|NCT02401867|76140119|FG000|STARTED|Analysis||140||
60024361|NCT02401867|76140119|FG000|COMPLETED|Analysis|Comparative analysis of vaginal HPV DNA results and cervical HPV DNA results|131||
60024362|NCT02401867|76140119|FG000|NOT COMPLETED|Analysis||9||
60024363|NCT02198235|76140127|FG000|STARTED|Overall Study||30||
60024364|NCT02198235|76140128|FG001|STARTED|Overall Study||30||
60024365|NCT02198235|76140129|FG002|STARTED|Overall Study||30||
60024366|NCT02198235|76140127|FG000|COMPLETED|Overall Study||27||
60024367|NCT02198235|76140128|FG001|COMPLETED|Overall Study||28||
60024368|NCT02198235|76140129|FG002|COMPLETED|Overall Study||28||
60024369|NCT02198235|76140127|FG000|NOT COMPLETED|Overall Study||3||
60024370|NCT02198235|76140128|FG001|NOT COMPLETED|Overall Study||2||
60024371|NCT02198235|76140129|FG002|NOT COMPLETED|Overall Study||2||
60024372|NCT02253147|76140137|FG000|STARTED|Overall Study||118||
60024373|NCT02253147|76140137|FG000|N Patients at W24 (Primary Outcome)|Overall Study||88||
60024374|NCT02253147|76140137|FG000|N Patients at W36|Overall Study||86||
60024375|NCT02253147|76140137|FG000|N Patients at W52|Overall Study||84||
60024376|NCT02253147|76140137|FG000|COMPLETED|Overall Study||71|N patients completed W64|
60024377|NCT02253147|76140137|FG000|NOT COMPLETED|Overall Study||47||
60024378|NCT02217501|76140145|FG000|STARTED|Overall Study||77||
60024379|NCT02217501|76140146|FG001|STARTED|Overall Study||82||
60024380|NCT02217501|76140145|FG000|COMPLETED|Overall Study||74||
60024381|NCT02217501|76140146|FG001|COMPLETED|Overall Study||78||
59758987|NCT00921557|75878314|FG002|STARTED|Weeks 96-144 (Off Study Treatment)||17||
59758988|NCT00921557|75878312|FG000|COMPLETED|Weeks 96-144 (Off Study Treatment)||12||
59758989|NCT00921557|75878313|FG001|COMPLETED|Weeks 96-144 (Off Study Treatment)||15||
59758990|NCT00921557|75878314|FG002|COMPLETED|Weeks 96-144 (Off Study Treatment)||16||
59758991|NCT00921557|75878312|FG000|NOT COMPLETED|Weeks 96-144 (Off Study Treatment)||3||
59758992|NCT00921557|75878313|FG001|NOT COMPLETED|Weeks 96-144 (Off Study Treatment)||1||
59758993|NCT00921557|75878314|FG002|NOT COMPLETED|Weeks 96-144 (Off Study Treatment)||1||
59758994|NCT00744471|75878331|FG000|STARTED|Overall Study||156||
59758995|NCT00744471|75878332|FG001|STARTED|Overall Study||156||
59758996|NCT00744471|75878333|FG002|STARTED|Overall Study||158||
59758997|NCT00744471|75878334|FG003|STARTED|Overall Study||157||
59758998|NCT00744471|75878331|FG000|Treated|Overall Study||155||
59758999|NCT00744471|75878332|FG001|Treated|Overall Study||155||
59759000|NCT00744471|75878333|FG002|Treated|Overall Study||154||
59759001|NCT00744471|75878334|FG003|Treated|Overall Study||157||
59759002|NCT00744471|75878331|FG000|COMPLETED|Overall Study||13||
59759003|NCT00744471|75878332|FG001|COMPLETED|Overall Study||11||
59759004|NCT00744471|75878333|FG002|COMPLETED|Overall Study||6||
59759005|NCT00744471|75878334|FG003|COMPLETED|Overall Study||9||
59759006|NCT00744471|75878331|FG000|NOT COMPLETED|Overall Study||143||
59759007|NCT00744471|75878332|FG001|NOT COMPLETED|Overall Study||145||
59759008|NCT00744471|75878333|FG002|NOT COMPLETED|Overall Study||152||
59759009|NCT00744471|75878334|FG003|NOT COMPLETED|Overall Study||148||
59759010|NCT00744237|75878347|FG000|STARTED|Overall Study||83||
59759011|NCT00744237|75878348|FG001|STARTED|Overall Study||73||
59759012|NCT00744237|75878349|FG002|STARTED|Overall Study||74||
59759013|NCT00744237|75878347|FG000|COMPLETED|Overall Study||56||
59759014|NCT00744237|75878348|FG001|COMPLETED|Overall Study||46||
59759015|NCT00744237|75878349|FG002|COMPLETED|Overall Study||59||
59759016|NCT00744237|75878347|FG000|NOT COMPLETED|Overall Study||27||
59759017|NCT00744237|75878348|FG001|NOT COMPLETED|Overall Study||27||
59759018|NCT00744237|75878349|FG002|NOT COMPLETED|Overall Study||15||
59759019|NCT00743145|75878357|FG000|STARTED|Overall Study||23||
59759020|NCT00743145|75878357|FG000|COMPLETED|Overall Study||19||
59759021|NCT00743145|75878357|FG000|NOT COMPLETED|Overall Study||4||
59759022|NCT00920855|75878374|FG000|STARTED|Overall Study||5||
59759023|NCT00920855|75878375|FG001|STARTED|Overall Study||4||
59759024|NCT00920855|75878376|FG002|STARTED|Overall Study||31||
59759025|NCT00920855|75878374|FG000|Safety and Efficacy Populations|Overall Study||5||
59759026|NCT00920855|75878375|FG001|Safety and Efficacy Populations|Overall Study||4||
59759027|NCT00920855|75878376|FG002|Safety and Efficacy Populations|Overall Study||31||
59759028|NCT00920855|75878374|FG000|COMPLETED|Overall Study|completed eight cycles of treatment|0||
59759029|NCT00920855|75878375|FG001|COMPLETED|Overall Study|completed eight cycles of treatment|1||
59759030|NCT00920855|75878376|FG002|COMPLETED|Overall Study|completed eight cycles of treatment|9||
59759031|NCT00920855|75878374|FG000|NOT COMPLETED|Overall Study||5||
59759032|NCT00920855|75878375|FG001|NOT COMPLETED|Overall Study||3||
59759033|NCT00920855|75878376|FG002|NOT COMPLETED|Overall Study||22||
59759034|NCT00742209|75878390|FG000|STARTED|Overall Study||129||
59759035|NCT00742209|75878391|FG001|STARTED|Overall Study||67||
59759036|NCT00742209|75878392|FG002|STARTED|Overall Study||134||
59759037|NCT00742209|75878393|FG003|STARTED|Overall Study||134||
59759038|NCT00742209|75878394|FG004|STARTED|Overall Study||62||
59759039|NCT00742209|75878390|FG000|COMPLETED|Overall Study||95||
59759040|NCT00742209|75878391|FG001|COMPLETED|Overall Study||49||
59759041|NCT00742209|75878392|FG002|COMPLETED|Overall Study||88||
59759042|NCT00742209|75878393|FG003|COMPLETED|Overall Study||97||
59759043|NCT00742209|75878394|FG004|COMPLETED|Overall Study||37||
59759044|NCT00742209|75878390|FG000|NOT COMPLETED|Overall Study||34||
59759045|NCT00742209|75878391|FG001|NOT COMPLETED|Overall Study||18||
59759046|NCT00742209|75878392|FG002|NOT COMPLETED|Overall Study||46||
59759047|NCT00742209|75878393|FG003|NOT COMPLETED|Overall Study||37||
59759048|NCT00742209|75878394|FG004|NOT COMPLETED|Overall Study||25||
59759049|NCT00741819|75878407|FG000|STARTED|Overall Study||73||
59759050|NCT00741819|75878407|FG000|COMPLETED|Overall Study||65||
59759051|NCT00741819|75878407|FG000|NOT COMPLETED|Overall Study||8||
59759052|NCT00924443|75878413|FG000|STARTED|Overall Study||69||
59759053|NCT00924443|75878413|FG000|Full Analysis Set (Received Study Drug)|Overall Study||66||
59759054|NCT00924443|75878413|FG000|COMPLETED|Overall Study||66||
59759055|NCT00924443|75878413|FG000|NOT COMPLETED|Overall Study||3||
59759056|NCT00924287|75878417|FG000|STARTED|Overall Study||1||
59759057|NCT00924287|75878417|FG000|COMPLETED|Overall Study||0||
59759058|NCT00924287|75878417|FG000|NOT COMPLETED|Overall Study||1||
59759059|NCT00923975|75878421|FG000|STARTED|Overall Study||51||
59759060|NCT00923975|75878421|FG000|COMPLETED|Overall Study|One subject did not meet inclusion criteria; the data was not used in analysis.|50||
59759061|NCT00923975|75878421|FG000|NOT COMPLETED|Overall Study||1||
59759062|NCT03728634|75878431|FG000|STARTED|Overall Study||6||
59759063|NCT03728634|75878432|FG001|STARTED|Overall Study||10||
59759064|NCT03728634|75878433|FG002|STARTED|Overall Study||10||
59759065|NCT03728634|75878434|FG003|STARTED|Overall Study||10||
60024382|NCT02217501|76140145|FG000|NOT COMPLETED|Overall Study||3||
60024383|NCT02217501|76140146|FG001|NOT COMPLETED|Overall Study||4||
60024384|NCT01649869|76140154|FG000|STARTED|Overall Study||18||
60024385|NCT01649869|76140155|FG001|STARTED|Overall Study||17||
60024386|NCT01649869|76140154|FG000|COMPLETED|Overall Study||16||
60024387|NCT01649869|76140155|FG001|COMPLETED|Overall Study||16||
60024388|NCT01649869|76140154|FG000|NOT COMPLETED|Overall Study||2||
60024389|NCT01649869|76140155|FG001|NOT COMPLETED|Overall Study||1||
60024390|NCT02197377|76140165|FG000|STARTED|Overall Study||30||
60024391|NCT02197377|76140166|FG001|STARTED|Overall Study||30||
60024392|NCT02197377|76140165|FG000|COMPLETED|Overall Study||30||
60024393|NCT02197377|76140166|FG001|COMPLETED|Overall Study||27||
60024394|NCT02197377|76140165|FG000|NOT COMPLETED|Overall Study||0||
60024395|NCT02197377|76140166|FG001|NOT COMPLETED|Overall Study||3||
60024396|NCT02400307|76140174|FG000|STARTED|Overall Study||11||
60024397|NCT02400307|76140175|FG001|STARTED|Overall Study||8||
60024398|NCT02400307|76140174|FG000|COMPLETED|Overall Study||10||
60024399|NCT02400307|76140175|FG001|COMPLETED|Overall Study||8||
60024400|NCT02400307|76140174|FG000|NOT COMPLETED|Overall Study||1||
60024401|NCT02400307|76140175|FG001|NOT COMPLETED|Overall Study||0||
60024402|NCT02196675|76140184|FG000|STARTED|Overall Study||27||
60024403|NCT02196675|76140185|FG001|STARTED|Overall Study||70||
60024404|NCT02196675|76140186|FG002|STARTED|Overall Study||8||
60024405|NCT02196675|76140184|FG000|COMPLETED|Overall Study||25||
60024406|NCT02196675|76140185|FG001|COMPLETED|Overall Study||68||
60024407|NCT02196675|76140186|FG002|COMPLETED|Overall Study||7||
60024408|NCT02196675|76140184|FG000|NOT COMPLETED|Overall Study||2||
59915010|NCT03397771|76035913|FG000|STARTED|Overall Study||53|Total number is reported as 84; data is reported for 82 subjects as 2 were randomisation errors.|
59915011|NCT03397771|76035914|FG001|STARTED|Overall Study||29|Total number is reported as 84; data is reported for 82 subjects as 2 were randomisation errors.|
59915012|NCT03397771|76035913|FG000|COMPLETED|Overall Study||45||
59915013|NCT03397771|76035914|FG001|COMPLETED|Overall Study||22||
59915014|NCT03397771|76035913|FG000|NOT COMPLETED|Overall Study||8||
59915015|NCT03397771|76035914|FG001|NOT COMPLETED|Overall Study||7||
59915016|NCT02876835|76035922|FG000|STARTED|Run-in Period: Placebo (Week-4 to Day 1)||1937||
59915017|NCT02876835|76035923|FG001|STARTED|Run-in Period: Placebo (Week-4 to Day 1)||1935||
59915018|NCT02876835|76035922|FG000|COMPLETED|Run-in Period: Placebo (Week-4 to Day 1)||1937||
59915019|NCT02876835|76035923|FG001|COMPLETED|Run-in Period: Placebo (Week-4 to Day 1)||1935||
60024409|NCT02196675|76140185|FG001|NOT COMPLETED|Overall Study||2||
60024410|NCT02196675|76140186|FG002|NOT COMPLETED|Overall Study||1||
60024411|NCT02399449|76140196|FG000|STARTED|Overall Study||25||
60024412|NCT02399449|76140197|FG001|STARTED|Overall Study||32||
60024413|NCT02399449|76140196|FG000|COMPLETED|Overall Study||22||
60024414|NCT02399449|76140197|FG001|COMPLETED|Overall Study||22||
60024415|NCT02399449|76140196|FG000|NOT COMPLETED|Overall Study||3||
60024416|NCT02399449|76140197|FG001|NOT COMPLETED|Overall Study||10||
60024417|NCT02217345|76140205|FG000|STARTED|Overall Study||27||
60024418|NCT02217345|76140206|FG001|STARTED|Overall Study||26||
60024419|NCT02217345|76140205|FG000|Baseline Data Available|Overall Study||26||
60024420|NCT02217345|76140206|FG001|Baseline Data Available|Overall Study||26||
60024421|NCT02217345|76140205|FG000|COMPLETED|Overall Study||20||
60024422|NCT02217345|76140206|FG001|COMPLETED|Overall Study||21||
60024423|NCT02217345|76140205|FG000|NOT COMPLETED|Overall Study||7||
60024424|NCT02217345|76140206|FG001|NOT COMPLETED|Overall Study||5||
60024425|NCT01652287|76140214|FG000|STARTED|Overall Study||31||
60024426|NCT01652287|76140215|FG001|STARTED|Overall Study||31||
60024427|NCT01652287|76140214|FG000|COMPLETED|Overall Study|• Did not receive allocated intervention (withdrew consent) (n=2)|29||
60024428|NCT01652287|76140215|FG001|COMPLETED|Overall Study||31||
60024429|NCT01652287|76140214|FG000|NOT COMPLETED|Overall Study||2||
60024430|NCT01652287|76140215|FG001|NOT COMPLETED|Overall Study||0||
60024431|NCT02251743|76140223|FG000|STARTED|Overall Study||85||
60024432|NCT02251743|76140224|FG001|STARTED|Overall Study||59||
60024433|NCT02251743|76140223|FG000|COMPLETED|Overall Study||84||
60024434|NCT02251743|76140224|FG001|COMPLETED|Overall Study||58||
60024435|NCT02251743|76140223|FG000|NOT COMPLETED|Overall Study||1||
60024436|NCT02251743|76140224|FG001|NOT COMPLETED|Overall Study||1||
60024437|NCT02428855|76140230|FG000|STARTED|Overall Study||8||
60024438|NCT02428855|76140230|FG000|COMPLETED|Overall Study||6||
60024439|NCT02428855|76140230|FG000|NOT COMPLETED|Overall Study||2||
60024440|NCT02428699|76140234|FG000|STARTED|Period 1||25||
60024441|NCT02428699|76140235|FG001|STARTED|Period 1||25||
60024442|NCT02428699|76140234|FG000|COMPLETED|Period 1||25||
60024443|NCT02428699|76140235|FG001|COMPLETED|Period 1||25||
60024444|NCT02428699|76140234|FG000|NOT COMPLETED|Period 1||0||
60024445|NCT02428699|76140235|FG001|NOT COMPLETED|Period 1||0||
60024446|NCT02428699|76140234|FG000|STARTED|Washout Period 1||25||
60024447|NCT02428699|76140235|FG001|STARTED|Washout Period 1||25||
60024448|NCT02428699|76140234|FG000|COMPLETED|Washout Period 1||24||
60024449|NCT02428699|76140235|FG001|COMPLETED|Washout Period 1||23||
60024450|NCT02428699|76140234|FG000|NOT COMPLETED|Washout Period 1||1||
60024451|NCT02428699|76140235|FG001|NOT COMPLETED|Washout Period 1||2||
60024452|NCT02428699|76140234|FG000|STARTED|Period 2||24||
60024453|NCT02428699|76140235|FG001|STARTED|Period 2||23||
60024454|NCT02428699|76140234|FG000|COMPLETED|Period 2||24||
60024455|NCT02428699|76140235|FG001|COMPLETED|Period 2||23||
60024456|NCT02428699|76140234|FG000|NOT COMPLETED|Period 2||0||
60024457|NCT02428699|76140235|FG001|NOT COMPLETED|Period 2||0||
60024458|NCT02428231|76140248|FG000|STARTED|Overall Study||30||
60024459|NCT02428231|76140249|FG001|STARTED|Overall Study||32||
60024460|NCT02428231|76140248|FG000|COMPLETED|Overall Study||17||
60024461|NCT02428231|76140249|FG001|COMPLETED|Overall Study||15||
60024462|NCT02428231|76140248|FG000|NOT COMPLETED|Overall Study||13||
60024463|NCT02428231|76140249|FG001|NOT COMPLETED|Overall Study||17||
60024464|NCT02397889|76140257|FG000|STARTED|Overall Study||15||
60024465|NCT02397889|76140258|FG001|STARTED|Overall Study||15||
60024466|NCT02397889|76140257|FG000|COMPLETED|Overall Study||14||
60024467|NCT02397889|76140258|FG001|COMPLETED|Overall Study||15||
60024468|NCT02397889|76140257|FG000|NOT COMPLETED|Overall Study||1||
60024469|NCT02397889|76140258|FG001|NOT COMPLETED|Overall Study||0||
60024470|NCT02397655|76140264|FG000|STARTED|Overall Study||12012||
60024471|NCT02397655|76140264|FG000|COMPLETED|Overall Study||10711||
60024472|NCT02397655|76140264|FG000|NOT COMPLETED|Overall Study||1301||
60024473|NCT02396953|76140271|FG000|STARTED|Overall Study||9||
60024474|NCT02396953|76140272|FG001|STARTED|Overall Study||9||
60024475|NCT02396953|76140273|FG002|STARTED|Overall Study||10||
60024476|NCT02396953|76140271|FG000|COMPLETED|Overall Study||5||
60024477|NCT02396953|76140272|FG001|COMPLETED|Overall Study||6||
60024478|NCT02396953|76140273|FG002|COMPLETED|Overall Study||7||
60024479|NCT02396953|76140271|FG000|NOT COMPLETED|Overall Study||4||
60024480|NCT02396953|76140272|FG001|NOT COMPLETED|Overall Study||3||
60024481|NCT02396953|76140273|FG002|NOT COMPLETED|Overall Study||3||
60024482|NCT02387983|76140288|FG000|STARTED|Overall Study||65||
60024483|NCT02387983|76140288|FG000|COMPLETED|Overall Study||58||
60024484|NCT02387983|76140288|FG000|NOT COMPLETED|Overall Study||7||
60024485|NCT02395627|76140295|FG000|STARTED|Overall Study||18||
60024486|NCT02395627|76140296|FG001|STARTED|Overall Study||16||
60024487|NCT02395627|76140297|FG002|STARTED|Overall Study||4||
60024488|NCT02395627|76140295|FG000|COMPLETED|Overall Study||15||
60024489|NCT02395627|76140296|FG001|COMPLETED|Overall Study||13||
60024490|NCT02395627|76140297|FG002|COMPLETED|Overall Study||4||
60024491|NCT02395627|76140295|FG000|NOT COMPLETED|Overall Study||3||
60024492|NCT02395627|76140296|FG001|NOT COMPLETED|Overall Study||3||
60024493|NCT02395627|76140297|FG002|NOT COMPLETED|Overall Study||0||
60024494|NCT02395471|76140309|FG000|STARTED|Overall Study||129||
60024495|NCT02395471|76140310|FG001|STARTED|Overall Study||62||
60024496|NCT02395471|76140309|FG000|COMPLETED|Overall Study||122||
60024497|NCT02395471|76140310|FG001|COMPLETED|Overall Study||59||
60024498|NCT02395471|76140309|FG000|NOT COMPLETED|Overall Study||7||
60024499|NCT02395471|76140310|FG001|NOT COMPLETED|Overall Study||3||
60024500|NCT02395081|76140328|FG000|STARTED|Overall Study||119||
60024501|NCT02395081|76140329|FG001|STARTED|Overall Study||121||
60024502|NCT02395081|76140330|FG002|STARTED|Overall Study||120||
60024503|NCT02395081|76140328|FG000|COMPLETED|Overall Study||112||
60024504|NCT02395081|76140329|FG001|COMPLETED|Overall Study||116||
60024505|NCT02395081|76140330|FG002|COMPLETED|Overall Study||116||
60024506|NCT02395081|76140328|FG000|NOT COMPLETED|Overall Study||7||
60024507|NCT02395081|76140329|FG001|NOT COMPLETED|Overall Study||5||
60024508|NCT02395081|76140330|FG002|NOT COMPLETED|Overall Study||4||
60024509|NCT02394925|76140341|FG000|STARTED|Overall Study||108||
60024510|NCT02394925|76140341|FG000|COMPLETED|Overall Study||79||
60024511|NCT02394925|76140341|FG000|NOT COMPLETED|Overall Study||29||
60024512|NCT02427607|76140345|FG000|STARTED|Overall Study||7||
60024513|NCT02427607|76140345|FG000|COMPLETED|Overall Study||6||
60024514|NCT02427607|76140345|FG000|NOT COMPLETED|Overall Study||1||
60024515|NCT02425111|76140349|FG000|STARTED|Part A: Treatment Period||101||
60024516|NCT02425111|76140349|FG000|COMPLETED|Part A: Treatment Period||78|Completed=Completed Study Drug|
60024517|NCT02425111|76140349|FG000|NOT COMPLETED|Part A: Treatment Period||23||
60024518|NCT02425111|76140349|FG000|STARTED|Part B: Treatment Extension Period||56||
60024519|NCT02425111|76140349|FG000|COMPLETED|Part B: Treatment Extension Period||46||
60024520|NCT02425111|76140349|FG000|NOT COMPLETED|Part B: Treatment Extension Period||10||
60024521|NCT02424565|76140354|FG000|STARTED|Period 1 (D0)||8||
60024522|NCT02424565|76140355|FG001|STARTED|Period 1 (D0)||7||
60024523|NCT02424565|76140354|FG000|COMPLETED|Period 1 (D0)||8||
60024524|NCT02424565|76140355|FG001|COMPLETED|Period 1 (D0)||6||
60024525|NCT02424565|76140354|FG000|NOT COMPLETED|Period 1 (D0)||0||
60024526|NCT02424565|76140355|FG001|NOT COMPLETED|Period 1 (D0)||1||
60024527|NCT02424565|76140354|FG000|STARTED|Washout Period||8||
60024528|NCT02424565|76140355|FG001|STARTED|Washout Period||6||
60024529|NCT02424565|76140354|FG000|COMPLETED|Washout Period||8||
60024530|NCT02424565|76140355|FG001|COMPLETED|Washout Period||6||
60024531|NCT02424565|76140354|FG000|NOT COMPLETED|Washout Period||0||
60024532|NCT02424565|76140355|FG001|NOT COMPLETED|Washout Period||0||
60024533|NCT02424565|76140354|FG000|STARTED|Period 2 (D3)||8||
60024534|NCT02424565|76140355|FG001|STARTED|Period 2 (D3)||6||
60024535|NCT02424565|76140354|FG000|COMPLETED|Period 2 (D3)||8||
60024536|NCT02424565|76140355|FG001|COMPLETED|Period 2 (D3)||6||
60024537|NCT02424565|76140354|FG000|NOT COMPLETED|Period 2 (D3)||0||
60024538|NCT02424565|76140355|FG001|NOT COMPLETED|Period 2 (D3)||0||
60024539|NCT02424253|76140363|FG000|STARTED|Overall Study||65||
60024540|NCT02424253|76140364|FG001|STARTED|Overall Study||33||
60024541|NCT02424253|76140363|FG000|COMPLETED|Overall Study||54||
60024542|NCT02424253|76140364|FG001|COMPLETED|Overall Study||24||
60024543|NCT02424253|76140363|FG000|NOT COMPLETED|Overall Study||11||
60024544|NCT02424253|76140364|FG001|NOT COMPLETED|Overall Study||9||
60024545|NCT02393755|76140372|FG000|STARTED|Overall Study||3||
60024546|NCT02393755|76140373|FG001|STARTED|Overall Study||39||
60024547|NCT02393755|76140372|FG000|COMPLETED|Overall Study||3||
60024548|NCT02393755|76140373|FG001|COMPLETED|Overall Study||32||
60024549|NCT02393755|76140372|FG000|NOT COMPLETED|Overall Study||0||
60024550|NCT02393755|76140373|FG001|NOT COMPLETED|Overall Study||7||
60024551|NCT02393209|76140380|FG000|STARTED|Overall Study||6||
60024552|NCT02393209|76140381|FG001|STARTED|Overall Study||8||
60024553|NCT02393209|76140382|FG002|STARTED|Overall Study||0||
60024554|NCT02393209|76140383|FG003|STARTED|Overall Study||0||
60024555|NCT02393209|76140380|FG000|COMPLETED|Overall Study||0||
60024556|NCT02393209|76140381|FG001|COMPLETED|Overall Study||0||
60024557|NCT02393209|76140382|FG002|COMPLETED|Overall Study||0||
60024558|NCT02393209|76140383|FG003|COMPLETED|Overall Study||0||
60024559|NCT02393209|76140380|FG000|NOT COMPLETED|Overall Study||6||
60024560|NCT02393209|76140381|FG001|NOT COMPLETED|Overall Study||8||
60024561|NCT02393209|76140382|FG002|NOT COMPLETED|Overall Study||0||
60024562|NCT02393209|76140383|FG003|NOT COMPLETED|Overall Study||0||
60024563|NCT02424097|76140394|FG000|STARTED|Overall Study||20||
60024564|NCT02424097|76140395|FG001|STARTED|Overall Study||20||
60024565|NCT02424097|76140394|FG000|COMPLETED|Overall Study||19||
60024566|NCT02424097|76140395|FG001|COMPLETED|Overall Study||18||
60024567|NCT02424097|76140394|FG000|NOT COMPLETED|Overall Study||1||
60024568|NCT02424097|76140395|FG001|NOT COMPLETED|Overall Study||2||
60024569|NCT02392507|76140401|FG000|STARTED|Induction Regimen||54||
60024570|NCT02392507|76140401|FG000|Received at Least 1 Dose of Study Drug|Induction Regimen||54||
60024571|NCT02392507|76140401|FG000|COMPLETED|Induction Regimen||47||
60024572|NCT02392507|76140401|FG000|NOT COMPLETED|Induction Regimen||7||
60024573|NCT02392507|76140401|FG000|STARTED|Maintenance Regimen|After induction regimen participants with disease response are eligible for maintenance regimen.|34||
60024574|NCT02392507|76140401|FG000|COMPLETED|Maintenance Regimen||32||
60024575|NCT02392507|76140401|FG000|NOT COMPLETED|Maintenance Regimen||2||
60024576|NCT02386345|76140410|FG000|STARTED|Overall Study||299||
60024577|NCT02386345|76140410|FG000|COMPLETED|Overall Study||197||
60024578|NCT02386345|76140410|FG000|NOT COMPLETED|Overall Study||102||
60024579|NCT01651117|76140418|FG000|STARTED|Overall Study||156||
60024580|NCT01651117|76140419|FG001|STARTED|Overall Study||205||
60024581|NCT01651117|76140420|FG002|STARTED|Overall Study||49||
60024582|NCT01651117|76140421|FG003|STARTED|Overall Study||70||
60024583|NCT01651117|76140418|FG000|COMPLETED|Overall Study||154||
60024584|NCT01651117|76140419|FG001|COMPLETED|Overall Study||202||
60024585|NCT01651117|76140420|FG002|COMPLETED|Overall Study||47||
60024586|NCT01651117|76140421|FG003|COMPLETED|Overall Study||68||
60024587|NCT01651117|76140418|FG000|NOT COMPLETED|Overall Study||2||
60024588|NCT01651117|76140419|FG001|NOT COMPLETED|Overall Study||3||
60024589|NCT01651117|76140420|FG002|NOT COMPLETED|Overall Study||2||
60024590|NCT01651117|76140421|FG003|NOT COMPLETED|Overall Study||2||
60024591|NCT02386189|76140436|FG000|STARTED|Overall Study||30||
60024592|NCT02386189|76140437|FG001|STARTED|Overall Study||33||
60024593|NCT02386189|76140436|FG000|COMPLETED|Overall Study||26||
60024594|NCT02386189|76140437|FG001|COMPLETED|Overall Study||30||
60024595|NCT02386189|76140436|FG000|NOT COMPLETED|Overall Study||4||
60024596|NCT02386189|76140437|FG001|NOT COMPLETED|Overall Study||3||
59507361|NCT02406495|75600593|FG000|COMPLETED|Overall Study||40||
60024597|NCT02385799|76140445|FG000|STARTED|Overall Study||26||
60024598|NCT02385799|76140446|FG001|STARTED|Overall Study||32||
60024599|NCT02385799|76140445|FG000|Completed End-of-Treatment Visit|Overall Study||21|Includes all subjects who returned for end-of-treatment study visit, including early terminations.|
60024600|NCT02385799|76140446|FG001|Completed End-of-Treatment Visit|Overall Study||26|Includes all subjects who returned for end-of-treatment study visit, including early terminations.|
60024601|NCT02385799|76140445|FG000|COMPLETED|Overall Study||21|Includes all subjects who completed 6-month treatment with study drug. Excludes early terminations.|
60024602|NCT02385799|76140446|FG001|COMPLETED|Overall Study||24|Includes all subjects who completed 6-month treatment with study drug. Excludes early terminations.|
60024603|NCT02385799|76140445|FG000|NOT COMPLETED|Overall Study||5||
60024604|NCT02385799|76140446|FG001|NOT COMPLETED|Overall Study||8||
60024605|NCT02422303|76140454|FG000|STARTED|Overall Study||6||
60024606|NCT02422303|76140455|FG001|STARTED|Overall Study||6||
60024607|NCT02422303|76140454|FG000|COMPLETED|Overall Study||5||
60024608|NCT02422303|76140455|FG001|COMPLETED|Overall Study||5||
60024609|NCT02422303|76140454|FG000|NOT COMPLETED|Overall Study||1||
60024610|NCT02422303|76140455|FG001|NOT COMPLETED|Overall Study||1||
60024611|NCT02392195|76140461|FG000|STARTED|Overall Study||10||
60024612|NCT02392195|76140461|FG000|COMPLETED|Overall Study||2||
60024613|NCT02392195|76140461|FG000|NOT COMPLETED|Overall Study||8||
60024614|NCT02391961|76140467|FG000|STARTED|First Intervention (4 Weeks)||10||
60024615|NCT02391961|76140468|FG001|STARTED|First Intervention (4 Weeks)||9||
60024616|NCT02391961|76140467|FG000|COMPLETED|First Intervention (4 Weeks)||8||
60024617|NCT02391961|76140468|FG001|COMPLETED|First Intervention (4 Weeks)||9||
60024618|NCT02391961|76140467|FG000|NOT COMPLETED|First Intervention (4 Weeks)||2||
60024619|NCT02391961|76140468|FG001|NOT COMPLETED|First Intervention (4 Weeks)||0||
60024620|NCT02391961|76140467|FG000|STARTED|Washout (2 Weeks)||8||
60024621|NCT02391961|76140468|FG001|STARTED|Washout (2 Weeks)||9||
60024622|NCT02391961|76140467|FG000|COMPLETED|Washout (2 Weeks)||7||
60024623|NCT02391961|76140468|FG001|COMPLETED|Washout (2 Weeks)||8||
60024624|NCT02391961|76140467|FG000|NOT COMPLETED|Washout (2 Weeks)||1||
60024625|NCT02391961|76140468|FG001|NOT COMPLETED|Washout (2 Weeks)||1||
60024626|NCT02391961|76140467|FG000|STARTED|Second Intervention (4 Weeks)||7||
60024627|NCT02391961|76140468|FG001|STARTED|Second Intervention (4 Weeks)||8||
60024628|NCT02391961|76140467|FG000|COMPLETED|Second Intervention (4 Weeks)||6||
60024629|NCT02391961|76140468|FG001|COMPLETED|Second Intervention (4 Weeks)||7||
60024630|NCT02391961|76140467|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||1||
60024631|NCT02391961|76140468|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||1||
60024632|NCT02384941|76140477|FG000|STARTED|Overall Study||268||
60024633|NCT02384941|76140478|FG001|STARTED|Overall Study||263||
60024634|NCT02384941|76140479|FG002|STARTED|Overall Study||262||
60024635|NCT02384941|76140477|FG000|COMPLETED|Overall Study||218||
60024636|NCT02384941|76140478|FG001|COMPLETED|Overall Study||228||
60024637|NCT02384941|76140479|FG002|COMPLETED|Overall Study||221||
60024638|NCT02384941|76140477|FG000|NOT COMPLETED|Overall Study||50||
60024639|NCT02384941|76140478|FG001|NOT COMPLETED|Overall Study||35||
60024640|NCT02384941|76140479|FG002|NOT COMPLETED|Overall Study||41||
60024641|NCT02384395|76140488|FG000|STARTED|Overall Study||40||
60024642|NCT02384395|76140488|FG000|Enrolled|Overall Study||40|Pending HLA and Hepatitis B results|
60024643|NCT02384395|76140488|FG000|Initiated Treatment|Overall Study||37||
60024644|NCT02384395|76140488|FG000|Completed Week 24|Overall Study||34||
60024645|NCT02384395|76140488|FG000|Completed Week 48|Overall Study||33||
60024646|NCT02384395|76140488|FG000|Completed Week 96|Overall Study||30|Two participants had data collected outside of Week 96 window|
60024647|NCT02384395|76140488|FG000|COMPLETED|Overall Study||30||
60024648|NCT02384395|76140488|FG000|NOT COMPLETED|Overall Study||10||
60024649|NCT02420353|76140494|FG000|STARTED|Overall Study||10||
60024650|NCT02420353|76140495|FG001|STARTED|Overall Study||10||
60024651|NCT02420353|76140494|FG000|Allocation to Intervention|Overall Study||10||
60024652|NCT02420353|76140495|FG001|Allocation to Intervention|Overall Study||10||
60024653|NCT02420353|76140494|FG000|COMPLETED|Overall Study||10||
60024654|NCT02420353|76140495|FG001|COMPLETED|Overall Study||9||
60024655|NCT02420353|76140494|FG000|NOT COMPLETED|Overall Study||0||
60024656|NCT02420353|76140495|FG001|NOT COMPLETED|Overall Study||1||
60024657|NCT02391337|76140503|FG000|STARTED|Baseline||80||
60024658|NCT02391337|76140504|FG001|STARTED|Baseline||81||
60024659|NCT02391337|76140503|FG000|COMPLETED|Baseline||80||
60024660|NCT02391337|76140504|FG001|COMPLETED|Baseline||81||
60024661|NCT02391337|76140503|FG000|NOT COMPLETED|Baseline||0||
60024662|NCT02391337|76140504|FG001|NOT COMPLETED|Baseline||0||
60024663|NCT02391337|76140503|FG000|STARTED|6 Months Follow-up||80||
60024664|NCT02391337|76140504|FG001|STARTED|6 Months Follow-up||81||
60024665|NCT02391337|76140503|FG000|COMPLETED|6 Months Follow-up||74||
60024666|NCT02391337|76140504|FG001|COMPLETED|6 Months Follow-up||76||
60024667|NCT02391337|76140503|FG000|NOT COMPLETED|6 Months Follow-up||6||
60024668|NCT02391337|76140504|FG001|NOT COMPLETED|6 Months Follow-up||5||
60024669|NCT02391337|76140503|FG000|STARTED|12 Months Follow-up||74||
60024670|NCT02391337|76140504|FG001|STARTED|12 Months Follow-up||76||
60024671|NCT02391337|76140503|FG000|COMPLETED|12 Months Follow-up||72||
60024672|NCT02391337|76140504|FG001|COMPLETED|12 Months Follow-up||73||
60024673|NCT02391337|76140503|FG000|NOT COMPLETED|12 Months Follow-up||2||
60024674|NCT02391337|76140504|FG001|NOT COMPLETED|12 Months Follow-up||3||
60024675|NCT02382991|76140512|FG000|STARTED|Overall Study||17||
60024676|NCT02382991|76140513|FG001|STARTED|Overall Study||18||
60024677|NCT02382991|76140512|FG000|COMPLETED|Overall Study||15||
60024678|NCT02382991|76140513|FG001|COMPLETED|Overall Study||15||
60024679|NCT02382991|76140512|FG000|NOT COMPLETED|Overall Study||2||
60024680|NCT02382991|76140513|FG001|NOT COMPLETED|Overall Study||3||
60024681|NCT02390557|76140521|FG000|STARTED|Wave 1||160||9
60024682|NCT02390557|76140522|FG001|STARTED|Wave 1||156||9
59611630|NCT01775124|75722607|FG001|Per Protocol Set|Core Period||155||
59915020|NCT02876835|76035922|FG000|NOT COMPLETED|Run-in Period: Placebo (Week-4 to Day 1)||0||
59611631|NCT01775124|75722606|FG000|Safety Set|Core Period|1 patient was mis-randomized & 1 patient discontinued due to AE. No treatment given|166||
59611632|NCT01775124|75722607|FG001|Safety Set|Core Period||166||
59611633|NCT01775124|75722606|FG000|COMPLETED|Core Period||157||
59611634|NCT01775124|75722607|FG001|COMPLETED|Core Period||156||
59611635|NCT01775124|75722606|FG000|NOT COMPLETED|Core Period||11||
59611636|NCT01775124|75722607|FG001|NOT COMPLETED|Core Period||10||
59611637|NCT01775124|75722606|FG000|STARTED|Extension Period||157||
59611638|NCT01775124|75722607|FG001|STARTED|Extension Period||156||
59611639|NCT01775124|75722606|FG000|COMPLETED|Extension Period||145||
59611640|NCT01775124|75722607|FG001|COMPLETED|Extension Period||138||
59611641|NCT01775124|75722606|FG000|NOT COMPLETED|Extension Period||12||
59611642|NCT01775124|75722607|FG001|NOT COMPLETED|Extension Period||18||
59611643|NCT01733316|75722614|FG000|STARTED|Cystagon® Phase||41||
59611644|NCT01733316|75722614|FG000|COMPLETED|Cystagon® Phase||41||
59611645|NCT01733316|75722614|FG000|NOT COMPLETED|Cystagon® Phase||0||
59611646|NCT01733316|75722614|FG000|STARTED|RP103 Phase||41||
59611647|NCT01733316|75722614|FG000|COMPLETED|RP103 Phase||40||
59611648|NCT01733316|75722614|FG000|NOT COMPLETED|RP103 Phase||1||
59611649|NCT01733316|75722614|FG000|STARTED|Long Term Extension Phase|Two participants did not enter the long term follow up period.|38||
59611650|NCT01733316|75722614|FG000|COMPLETED|Long Term Extension Phase||33||
59611651|NCT01733316|75722614|FG000|NOT COMPLETED|Long Term Extension Phase||5||
59611652|NCT01732926|75722627|FG000|STARTED|Overall Study||320||
59611653|NCT01732926|75722628|FG001|STARTED|Overall Study||155||
59759066|NCT03728634|75878435|FG004|STARTED|Overall Study||2||
59759067|NCT03728634|75878436|FG005|STARTED|Overall Study||9||
59915021|NCT02876835|76035923|FG001|NOT COMPLETED|Run-in Period: Placebo (Week-4 to Day 1)||0||
59915022|NCT02876835|76035922|FG000|STARTED|Treatment Period (51.1 Month)||1937||
59915023|NCT02876835|76035923|FG001|STARTED|Treatment Period (51.1 Month)||1935||
59915024|NCT02876835|76035922|FG000|COMPLETED|Treatment Period (51.1 Month)||1873||
59915025|NCT02876835|76035923|FG001|COMPLETED|Treatment Period (51.1 Month)||1870||
59915026|NCT02876835|76035922|FG000|NOT COMPLETED|Treatment Period (51.1 Month)||64||
59915027|NCT02876835|76035923|FG001|NOT COMPLETED|Treatment Period (51.1 Month)||65||
59759068|NCT03728634|75878431|FG000|COMPLETED|Overall Study||6||
59915028|NCT04086641|76035932|FG000|STARTED|Foot 1 (Two Week Utilization)||2||
59915029|NCT04086641|76035933|FG001|STARTED|Foot 1 (Two Week Utilization)||3||
59915030|NCT04086641|76035932|FG000|COMPLETED|Foot 1 (Two Week Utilization)||1||
59915031|NCT04086641|76035933|FG001|COMPLETED|Foot 1 (Two Week Utilization)||1||
59915032|NCT04086641|76035932|FG000|NOT COMPLETED|Foot 1 (Two Week Utilization)||1||
59915033|NCT04086641|76035933|FG001|NOT COMPLETED|Foot 1 (Two Week Utilization)||2||
59915034|NCT04086641|76035932|FG000|STARTED|Foot 2 (Two Week Utilization)||1||
59915035|NCT04086641|76035933|FG001|STARTED|Foot 2 (Two Week Utilization)||1||
59915036|NCT04086641|76035932|FG000|COMPLETED|Foot 2 (Two Week Utilization)||1||
59915037|NCT04086641|76035933|FG001|COMPLETED|Foot 2 (Two Week Utilization)||1||
59915038|NCT04086641|76035932|FG000|NOT COMPLETED|Foot 2 (Two Week Utilization)||0||
59915039|NCT04086641|76035933|FG001|NOT COMPLETED|Foot 2 (Two Week Utilization)||0||
59915040|NCT03503318|76035942|FG000|STARTED|Overall Study||181||
59915041|NCT03503318|76035943|FG001|STARTED|Overall Study||183||
59915042|NCT03503318|76035944|FG002|STARTED|Overall Study||180||
59915043|NCT03503318|76035942|FG000|Received at Least 1 Dose of Study Drug|Overall Study||179||
59915044|NCT03503318|76035943|FG001|Received at Least 1 Dose of Study Drug|Overall Study||183||
59915045|NCT03503318|76035944|FG002|Received at Least 1 Dose of Study Drug|Overall Study||180||
59915046|NCT03503318|76035942|FG000|COMPLETED|Overall Study||142||
59915047|NCT03503318|76035943|FG001|COMPLETED|Overall Study||144||
59915048|NCT03503318|76035944|FG002|COMPLETED|Overall Study||140||
59915049|NCT03503318|76035942|FG000|NOT COMPLETED|Overall Study||39||
59915050|NCT03503318|76035943|FG001|NOT COMPLETED|Overall Study||39||
59611654|NCT01732926|75722627|FG000|COMPLETED|Overall Study||53|Completed = reached primary efficacy endpoint of progressive disease or death|
59611655|NCT01732926|75722628|FG001|COMPLETED|Overall Study||45|Completed = reached primary efficacy endpoint of progressive disease or death|
59611656|NCT01732926|75722627|FG000|NOT COMPLETED|Overall Study||267||
59611657|NCT01732926|75722628|FG001|NOT COMPLETED|Overall Study||110||
59759069|NCT03728634|75878432|FG001|COMPLETED|Overall Study||10||
59759070|NCT03728634|75878433|FG002|COMPLETED|Overall Study||10||
59759071|NCT03728634|75878434|FG003|COMPLETED|Overall Study||10||
59759072|NCT03728634|75878435|FG004|COMPLETED|Overall Study||2||
59915051|NCT03503318|76035944|FG002|NOT COMPLETED|Overall Study||40||
59915052|NCT03396913|76035954|FG000|STARTED|Overall Study||43||
59915053|NCT03396913|76035955|FG001|STARTED|Overall Study||45||
59915054|NCT03396913|76035954|FG000|COMPLETED|Overall Study||43||
59611658|NCT01755858|75722636|FG000|STARTED|Overall Study||7||
59611659|NCT01755858|75722637|FG001|STARTED|Overall Study||9||
59611660|NCT01755858|75722636|FG000|COMPLETED|Overall Study||6||
59611661|NCT01755858|75722637|FG001|COMPLETED|Overall Study||8||
59611662|NCT01755858|75722636|FG000|NOT COMPLETED|Overall Study||1||
59611663|NCT01755858|75722637|FG001|NOT COMPLETED|Overall Study||1||
59611664|NCT01732770|75722647|FG000|STARTED|Overall Study||322||
59611665|NCT01732770|75722648|FG001|STARTED|Overall Study||321||
59611666|NCT01732770|75722647|FG000|Received Study Treatment|Overall Study||320||
59611667|NCT01732770|75722648|FG001|Received Study Treatment|Overall Study||320||
59611668|NCT01732770|75722647|FG000|COMPLETED|Overall Study||312||
59611669|NCT01732770|75722648|FG001|COMPLETED|Overall Study||313||
59611670|NCT01732770|75722647|FG000|NOT COMPLETED|Overall Study||10||
59611671|NCT01732770|75722648|FG001|NOT COMPLETED|Overall Study||8||
59611672|NCT01732692|75722656|FG000|STARTED|Overall Study||70||
59611673|NCT01732692|75722657|FG001|STARTED|Overall Study||70||
59611674|NCT01732692|75722656|FG000|COMPLETED|Overall Study||70||
59611675|NCT01732692|75722657|FG001|COMPLETED|Overall Study||69||
59611676|NCT01732692|75722656|FG000|NOT COMPLETED|Overall Study||0||
59611677|NCT01732692|75722657|FG001|NOT COMPLETED|Overall Study||1||
59611678|NCT01774968|75722665|FG000|STARTED|Overall Study||162||
59611679|NCT01774968|75722666|FG001|STARTED|Overall Study||163||
59611680|NCT01774968|75722665|FG000|Received at Least 1 Dose of Study Drug|Overall Study||162||
59611681|NCT01774968|75722666|FG001|Received at Least 1 Dose of Study Drug|Overall Study||161||
59611682|NCT01774968|75722665|FG000|COMPLETED|Overall Study||132||
59611683|NCT01774968|75722666|FG001|COMPLETED|Overall Study||128||
59611684|NCT01774968|75722665|FG000|NOT COMPLETED|Overall Study||30||
59611685|NCT01774968|75722666|FG001|NOT COMPLETED|Overall Study||35||
59611686|NCT01774344|75722674|FG000|STARTED|Overall Study||194||
59611687|NCT01774344|75722675|FG001|STARTED|Overall Study||379||
59611688|NCT01774344|75722674|FG000|Treated|Overall Study||193||
59611689|NCT01774344|75722675|FG001|Treated|Overall Study||374||
59611690|NCT01774344|75722674|FG000|Entered Survival FU|Overall Study||145||
59611691|NCT01774344|75722675|FG001|Entered Survival FU|Overall Study||291||
59611692|NCT01774344|75722674|FG000|COMPLETED|Overall Study||132||
59611693|NCT01774344|75722675|FG001|COMPLETED|Overall Study||258||
59611694|NCT01774344|75722674|FG000|NOT COMPLETED|Overall Study||62||
59611695|NCT01774344|75722675|FG001|NOT COMPLETED|Overall Study||121||
59611696|NCT01732536|75722683|FG000|STARTED|Overall Study||53||
59611697|NCT01732536|75722684|FG001|STARTED|Overall Study||47||
59611698|NCT01732536|75722683|FG000|COMPLETED|Overall Study||52||
59611699|NCT01732536|75722684|FG001|COMPLETED|Overall Study||46||
59611700|NCT01732536|75722683|FG000|NOT COMPLETED|Overall Study||1||
59611701|NCT01732536|75722684|FG001|NOT COMPLETED|Overall Study||1||
59611702|NCT01755702|75722693|FG000|STARTED|Period I||66||
59915055|NCT03396913|76035955|FG001|COMPLETED|Overall Study||39||
59915056|NCT03396913|76035954|FG000|NOT COMPLETED|Overall Study||0||
59915057|NCT03396913|76035955|FG001|NOT COMPLETED|Overall Study||6||
59611703|NCT01755702|75722693|FG000|Received Paracetamol|Period I||16||
59611704|NCT01755702|75722693|FG000|Received Placebo|Period I||17||
59611705|NCT01755702|75722693|FG000|Received Ibuprofen|Period I||16||
59611706|NCT01755702|75722693|FG000|Received Paracetamol/Caffeine|Period I||17||
59611707|NCT01755702|75722693|FG000|COMPLETED|Period I||66||
59611708|NCT01755702|75722693|FG000|NOT COMPLETED|Period I||0||
59611709|NCT01755702|75722693|FG000|STARTED|Wash Out Period I||66||
59611710|NCT01755702|75722693|FG000|COMPLETED|Wash Out Period I||63||
59611711|NCT01755702|75722693|FG000|NOT COMPLETED|Wash Out Period I||3||
59611712|NCT01755702|75722693|FG000|STARTED|Period II||63||
59611713|NCT01755702|75722693|FG000|Received Ibuprofen|Period II||11||
59611714|NCT01755702|75722693|FG000|Received Placebo|Period II||15||
59611715|NCT01755702|75722693|FG000|Received Paracetamol/Caffeine|Period II||20||
59611716|NCT01755702|75722693|FG000|Received Paracetamol|Period II||17||
59611717|NCT01755702|75722693|FG000|COMPLETED|Period II||63||
59915058|NCT03982433|76035961|FG000|STARTED|Overall Study||8||
59915059|NCT03982433|76035961|FG000|COMPLETED|Overall Study||7||
59611718|NCT01755702|75722693|FG000|NOT COMPLETED|Period II||0||
59611719|NCT01755702|75722693|FG000|STARTED|Washout Period II||63||
59611720|NCT01755702|75722693|FG000|COMPLETED|Washout Period II||58||
59611721|NCT01755702|75722693|FG000|NOT COMPLETED|Washout Period II||5||
59611722|NCT01755702|75722693|FG000|STARTED|Period III||58||
59611723|NCT01755702|75722693|FG000|Received Paracetamol|Period III||17||
59611724|NCT01755702|75722693|FG000|Received Placebo|Period III||13||
59611725|NCT01755702|75722693|FG000|Received Paracetamol/Caffeine|Period III||10||
59611726|NCT01755702|75722693|FG000|Received Ibuprofen|Period III||18||
59611727|NCT01755702|75722693|FG000|COMPLETED|Period III||58||
59611728|NCT01755702|75722693|FG000|NOT COMPLETED|Period III||0||
59611729|NCT01732458|75722707|FG000|STARTED|Overall Study||60||
59611730|NCT01732458|75722708|FG001|STARTED|Overall Study||58||
59611731|NCT01732458|75722709|FG002|STARTED|Overall Study||58||
59611732|NCT01732458|75722710|FG003|STARTED|Overall Study||52||
59611733|NCT01732458|75722707|FG000|Treated|Overall Study||57||
59611734|NCT01732458|75722708|FG001|Treated|Overall Study||55||
59915060|NCT03982433|76035961|FG000|NOT COMPLETED|Overall Study||1||
59611735|NCT01732458|75722709|FG002|Treated|Overall Study||56||
60024683|NCT02390557|76140523|FG002|STARTED|Wave 1||135||9
60024684|NCT02390557|76140521|FG000|COMPLETED|Wave 1||160||9
60024685|NCT02390557|76140522|FG001|COMPLETED|Wave 1||156||9
60024686|NCT02390557|76140523|FG002|COMPLETED|Wave 1||135||9
60024687|NCT02390557|76140521|FG000|NOT COMPLETED|Wave 1||0||0
60024688|NCT02390557|76140522|FG001|NOT COMPLETED|Wave 1||0||0
60024689|NCT02390557|76140523|FG002|NOT COMPLETED|Wave 1||0||0
60024690|NCT02390557|76140521|FG000|STARTED|Wave 2||160||9
60024691|NCT02390557|76140522|FG001|STARTED|Wave 2||156||9
60024692|NCT02390557|76140523|FG002|STARTED|Wave 2||135||9
60024693|NCT02390557|76140521|FG000|COMPLETED|Wave 2||88||9
60024694|NCT02390557|76140522|FG001|COMPLETED|Wave 2||115||9
60024695|NCT02390557|76140523|FG002|COMPLETED|Wave 2||112||9
60024696|NCT02390557|76140521|FG000|NOT COMPLETED|Wave 2||72||0
60024697|NCT02390557|76140522|FG001|NOT COMPLETED|Wave 2||41||0
60024698|NCT02390557|76140523|FG002|NOT COMPLETED|Wave 2||23||0
60024699|NCT01649791|76140531|FG000|STARTED|Overall Study||8||
60024700|NCT01649791|76140531|FG000|COMPLETED|Overall Study||5||
60024701|NCT01649791|76140531|FG000|NOT COMPLETED|Overall Study||3||
60024702|NCT01649557|76140538|FG000|STARTED|Overall Study||179||
60024703|NCT01649557|76140539|FG001|STARTED|Overall Study||41||
60024704|NCT01649557|76140540|FG002|STARTED|Overall Study||24||
60024705|NCT01649557|76140538|FG000|6-week Enrollers|Overall Study||159||
60024706|NCT01649557|76140539|FG001|6-week Enrollers|Overall Study||35||
60024707|NCT01649557|76140540|FG002|6-week Enrollers|Overall Study||22||
60024708|NCT01649557|76140538|FG000|52-week Enrollers|Overall Study||20||
60024709|NCT01649557|76140539|FG001|52-week Enrollers|Overall Study||6||
60024710|NCT01649557|76140540|FG002|52-week Enrollers|Overall Study||2||
60024711|NCT01649557|76140538|FG000|COMPLETED|Overall Study||135||
60024712|NCT01649557|76140539|FG001|COMPLETED|Overall Study||27||
60024713|NCT01649557|76140540|FG002|COMPLETED|Overall Study||15||
60024714|NCT01649557|76140538|FG000|NOT COMPLETED|Overall Study||44||
60024715|NCT01649557|76140539|FG001|NOT COMPLETED|Overall Study||14||
60024716|NCT01649557|76140540|FG002|NOT COMPLETED|Overall Study||9||
60024717|NCT02390245|76140548|FG000|STARTED|Phase I. Telemedicine Screening||906||
60024718|NCT02390245|76140549|FG001|STARTED|Phase I. Telemedicine Screening||0||
60024719|NCT02390245|76140550|FG002|STARTED|Phase I. Telemedicine Screening||0||
60024720|NCT02390245|76140548|FG000|COMPLETED|Phase I. Telemedicine Screening||906||
60024721|NCT02390245|76140549|FG001|COMPLETED|Phase I. Telemedicine Screening||0||
60024722|NCT02390245|76140550|FG002|COMPLETED|Phase I. Telemedicine Screening||0||
60024723|NCT02390245|76140548|FG000|NOT COMPLETED|Phase I. Telemedicine Screening||0||
60024724|NCT02390245|76140549|FG001|NOT COMPLETED|Phase I. Telemedicine Screening||0||
60024725|NCT02390245|76140550|FG002|NOT COMPLETED|Phase I. Telemedicine Screening||0||
60024726|NCT02390245|76140548|FG000|STARTED|Phase 2. Randomization Into 2 Groups|Remaining 355 participants from Phase I Telemedicine Screening had normal eye examinations requiring no further follow-up.|0||
60024727|NCT02390245|76140549|FG001|STARTED|Phase 2. Randomization Into 2 Groups||275||
60024728|NCT02390245|76140550|FG002|STARTED|Phase 2. Randomization Into 2 Groups||276||
60024729|NCT02390245|76140548|FG000|COMPLETED|Phase 2. Randomization Into 2 Groups||0||
59507362|NCT02406495|75600593|FG000|NOT COMPLETED|Overall Study||0||
60024730|NCT02390245|76140549|FG001|COMPLETED|Phase 2. Randomization Into 2 Groups||172||
60024731|NCT02390245|76140550|FG002|COMPLETED|Phase 2. Randomization Into 2 Groups||172||
60024732|NCT02390245|76140548|FG000|NOT COMPLETED|Phase 2. Randomization Into 2 Groups||0||
60024733|NCT02390245|76140549|FG001|NOT COMPLETED|Phase 2. Randomization Into 2 Groups||103||
60024734|NCT02390245|76140550|FG002|NOT COMPLETED|Phase 2. Randomization Into 2 Groups||104||
60024735|NCT02390245|76140548|FG000|STARTED|Phase 3. Ophthalmic Follow-up Adherence||0||
60024736|NCT02390245|76140549|FG001|STARTED|Phase 3. Ophthalmic Follow-up Adherence||172||
60024737|NCT02390245|76140550|FG002|STARTED|Phase 3. Ophthalmic Follow-up Adherence||172||
60024738|NCT02390245|76140548|FG000|COMPLETED|Phase 3. Ophthalmic Follow-up Adherence||0||
59507363|NCT02071095|75600608|FG000|STARTED|Overall Study||12||
59759073|NCT03728634|75878436|FG005|COMPLETED|Overall Study||9||
59759074|NCT03728634|75878431|FG000|NOT COMPLETED|Overall Study||0||
59759075|NCT03728634|75878432|FG001|NOT COMPLETED|Overall Study||0||
59759076|NCT03728634|75878433|FG002|NOT COMPLETED|Overall Study||0||
59759077|NCT03728634|75878434|FG003|NOT COMPLETED|Overall Study||0||
59759078|NCT03728634|75878435|FG004|NOT COMPLETED|Overall Study||0||
59759079|NCT03728634|75878436|FG005|NOT COMPLETED|Overall Study||0||
59759080|NCT00918203|75878457|FG000|STARTED|Treatment With or Without Olaratumab||70||
59759081|NCT00918203|75878458|FG001|STARTED|Treatment With or Without Olaratumab||67||
59759082|NCT00918203|75878459|FG002|STARTED|Treatment With or Without Olaratumab||0||
59759083|NCT00918203|75878457|FG000|Received at Least 1 Dose of Study Drug|Treatment With or Without Olaratumab||67||
59759084|NCT00918203|75878458|FG001|Received at Least 1 Dose of Study Drug|Treatment With or Without Olaratumab||64||
59915061|NCT03396835|76035965|FG000|STARTED|Overall Study||16||
59915062|NCT03396835|76035965|FG000|COMPLETED|Overall Study||14||
59915063|NCT03396835|76035965|FG000|NOT COMPLETED|Overall Study||2||
59915064|NCT03121950|76035971|FG000|STARTED|Overall Study||17||
59915065|NCT03121950|76035972|FG001|STARTED|Overall Study||3||
59915066|NCT03121950|76035971|FG000|COMPLETED|Overall Study||6||
59915067|NCT03121950|76035972|FG001|COMPLETED|Overall Study||1||
59915068|NCT03121950|76035971|FG000|NOT COMPLETED|Overall Study||11||
59915069|NCT03121950|76035972|FG001|NOT COMPLETED|Overall Study||2||
59915070|NCT03395353|76035980|FG000|STARTED|Overall Study||151||
59915071|NCT03395353|76035980|FG000|Received At Least 1 Dose of Study Drug|Overall Study||150||
59915072|NCT03395353|76035980|FG000|COMPLETED|Overall Study||64||
59915073|NCT03395353|76035980|FG000|NOT COMPLETED|Overall Study||87||
59915074|NCT04082663|76035988|FG000|STARTED|Overall Study||20||
59915075|NCT04082663|76035988|FG000|COMPLETED|Overall Study||13||
59915076|NCT04082663|76035988|FG000|NOT COMPLETED|Overall Study||7||
59915077|NCT03682367|76035994|FG000|STARTED|Overall Study||4||
59915078|NCT03682367|76035995|FG001|STARTED|Overall Study||4||
59915079|NCT03682367|76035994|FG000|COMPLETED|Overall Study|Withdrawn due to non-compliance|2||
59915080|NCT03682367|76035995|FG001|COMPLETED|Overall Study|Patients withdrawn due to confounding neuropathic pain or exited early from study.|0||
59915081|NCT03682367|76035994|FG000|NOT COMPLETED|Overall Study||2||
59915082|NCT03682367|76035995|FG001|NOT COMPLETED|Overall Study||4||
59915083|NCT03681353|76036001|FG000|STARTED|Overall Study||25||
59915084|NCT03681353|76036001|FG000|COMPLETED|Overall Study||18||
59915085|NCT03681353|76036001|FG000|NOT COMPLETED|Overall Study||7||
59915086|NCT03394885|76036005|FG000|STARTED|Overall Study||18||
59915087|NCT03394885|76036005|FG000|COMPLETED|Overall Study||3||
59915088|NCT03394885|76036005|FG000|NOT COMPLETED|Overall Study||15||
59915089|NCT02877927|76036011|FG000|STARTED|Overall Study||368||
59915090|NCT02877927|76036012|FG001|STARTED|Overall Study||367||
59915091|NCT02877927|76036011|FG000|COMPLETED|Overall Study||314||
59915092|NCT02877927|76036012|FG001|COMPLETED|Overall Study||310||
59915093|NCT02877927|76036011|FG000|NOT COMPLETED|Overall Study||54||
59915094|NCT02877927|76036012|FG001|NOT COMPLETED|Overall Study||57||
59915095|NCT02706886|76036027|FG000|STARTED|Part A: SAD Period||8||
59915096|NCT02706886|76036028|FG001|STARTED|Part A: SAD Period||6||
59915097|NCT02706886|76036029|FG002|STARTED|Part A: SAD Period||6||
59915098|NCT02706886|76036030|FG003|STARTED|Part A: SAD Period||6||
59915099|NCT02706886|76036031|FG004|STARTED|Part A: SAD Period||6||
59915100|NCT02706886|76036032|FG005|STARTED|Part A: SAD Period||0||
59915101|NCT02706886|76036033|FG006|STARTED|Part A: SAD Period||0||
59915102|NCT02706886|76036034|FG007|STARTED|Part A: SAD Period||0||
59915103|NCT02706886|76036035|FG008|STARTED|Part A: SAD Period||0||
59915104|NCT02706886|76036027|FG000|COMPLETED|Part A: SAD Period||8||
59915105|NCT02706886|76036028|FG001|COMPLETED|Part A: SAD Period||6||
59915106|NCT02706886|76036029|FG002|COMPLETED|Part A: SAD Period||6||
59915107|NCT02706886|76036030|FG003|COMPLETED|Part A: SAD Period||4||
59915108|NCT02706886|76036031|FG004|COMPLETED|Part A: SAD Period||6||
59915109|NCT02706886|76036032|FG005|COMPLETED|Part A: SAD Period||0||
59915110|NCT02706886|76036033|FG006|COMPLETED|Part A: SAD Period||0||
59915111|NCT02706886|76036034|FG007|COMPLETED|Part A: SAD Period||0||
59915112|NCT02706886|76036035|FG008|COMPLETED|Part A: SAD Period||0||
59915113|NCT02706886|76036027|FG000|NOT COMPLETED|Part A: SAD Period||0||
59915114|NCT02706886|76036028|FG001|NOT COMPLETED|Part A: SAD Period||0||
59915115|NCT02706886|76036029|FG002|NOT COMPLETED|Part A: SAD Period||0||
59915116|NCT02706886|76036030|FG003|NOT COMPLETED|Part A: SAD Period||2||
59915117|NCT02706886|76036031|FG004|NOT COMPLETED|Part A: SAD Period||0||
59915118|NCT02706886|76036032|FG005|NOT COMPLETED|Part A: SAD Period||0||
59915119|NCT02706886|76036033|FG006|NOT COMPLETED|Part A: SAD Period||0||
59915120|NCT02706886|76036034|FG007|NOT COMPLETED|Part A: SAD Period||0||
59915121|NCT02706886|76036035|FG008|NOT COMPLETED|Part A: SAD Period||0||
59915122|NCT02706886|76036027|FG000|STARTED|Part B: MAD Study Days 1-85||0||
59915123|NCT02706886|76036028|FG001|STARTED|Part B: MAD Study Days 1-85||0||
59915124|NCT02706886|76036029|FG002|STARTED|Part B: MAD Study Days 1-85||0||
59915125|NCT02706886|76036030|FG003|STARTED|Part B: MAD Study Days 1-85||0||
59915126|NCT02706886|76036031|FG004|STARTED|Part B: MAD Study Days 1-85||0||
59915127|NCT02706886|76036032|FG005|STARTED|Part B: MAD Study Days 1-85||3||
59915128|NCT02706886|76036033|FG006|STARTED|Part B: MAD Study Days 1-85||7||
60024739|NCT02390245|76140549|FG001|COMPLETED|Phase 3. Ophthalmic Follow-up Adherence||77||
60024740|NCT02390245|76140550|FG002|COMPLETED|Phase 3. Ophthalmic Follow-up Adherence||66||
60024741|NCT02390245|76140548|FG000|NOT COMPLETED|Phase 3. Ophthalmic Follow-up Adherence||0||
60024742|NCT02390245|76140549|FG001|NOT COMPLETED|Phase 3. Ophthalmic Follow-up Adherence||95||
60024743|NCT02390245|76140550|FG002|NOT COMPLETED|Phase 3. Ophthalmic Follow-up Adherence||106||
60024744|NCT02390167|76140559|FG000|STARTED|Overall Study||376||
60024745|NCT02390167|76140559|FG000|With Diabetes|Overall Study||333||
60024746|NCT02390167|76140559|FG000|Without Diabetes|Overall Study||43||
60024747|NCT02390167|76140559|FG000|COMPLETED|Overall Study||375||
60024748|NCT02390167|76140559|FG000|NOT COMPLETED|Overall Study||1||
60024749|NCT02347657|76140569|FG000|STARTED|Overall Study||259||
60024750|NCT02347657|76140570|FG001|STARTED|Overall Study||251||
60024751|NCT02347657|76140569|FG000|Treated|Overall Study||258||
60024752|NCT02347657|76140570|FG001|Treated|Overall Study||251||
60024753|NCT02347657|76140569|FG000|COMPLETED|Overall Study||241||
60024754|NCT02347657|76140570|FG001|COMPLETED|Overall Study||236||
60024755|NCT02347657|76140569|FG000|NOT COMPLETED|Overall Study||18||
60024756|NCT02347657|76140570|FG001|NOT COMPLETED|Overall Study||15||
60024757|NCT02347189|76140577|FG000|STARTED|Overall Study||39|Number of subjects consented|
60024758|NCT02347189|76140577|FG000|Catheterized|Overall Study||39|Number of subject catheterized with the intent of implant Melody TPV PB1016|
60024759|NCT02347189|76140577|FG000|Implanted|Overall Study||30|Number of subjects implanted with a Melody TPV PB1016|
60024760|NCT02347189|76140577|FG000|Implanted > 24 Hours|Overall Study||30|Number of subjects implanted successfully for at least 24 hours|
60024761|NCT02347189|76140577|FG000|COMPLETED|Overall Study||28|Number of subjects with evaluable data at 6 months|
60024762|NCT02347189|76140577|FG000|NOT COMPLETED|Overall Study||11||
60024763|NCT02382133|76140592|FG000|STARTED|Overall Study||43||
60024764|NCT02382133|76140592|FG000|COMPLETED|Overall Study||10||
60024765|NCT02382133|76140592|FG000|NOT COMPLETED|Overall Study||33||
60024766|NCT02346877|76140598|FG000|STARTED|Overall Study||19||
60024767|NCT02346877|76140599|FG001|STARTED|Overall Study||0||
60024768|NCT02346877|76140598|FG000|COMPLETED|Overall Study||0||
60024769|NCT02346877|76140599|FG001|COMPLETED|Overall Study||0||
60024770|NCT02346877|76140598|FG000|NOT COMPLETED|Overall Study||19||
60024771|NCT02346877|76140599|FG001|NOT COMPLETED|Overall Study||0||
60024772|NCT02346721|76140605|FG000|STARTED|Overall Study||111||
60024773|NCT02346721|76140605|FG000|COMPLETED|Overall Study||107||
60024774|NCT02346721|76140605|FG000|NOT COMPLETED|Overall Study||4||
60024775|NCT02389621|76140613|FG000|STARTED|Treatment Period||108||
60024776|NCT02389621|76140614|FG001|STARTED|Treatment Period||107||
60024777|NCT02389621|76140613|FG000|Received Study Drug|Treatment Period||107||
60024778|NCT02389621|76140614|FG001|Received Study Drug|Treatment Period||107||
60024779|NCT02389621|76140613|FG000|COMPLETED|Treatment Period||107||
60024780|NCT02389621|76140614|FG001|COMPLETED|Treatment Period||106||
60024781|NCT02389621|76140613|FG000|NOT COMPLETED|Treatment Period||1||
60024782|NCT02389621|76140614|FG001|NOT COMPLETED|Treatment Period||1||
60024783|NCT02389621|76140613|FG000|STARTED|Posttreatment Period||107||
60024784|NCT02389621|76140614|FG001|STARTED|Posttreatment Period||106||
60024785|NCT02389621|76140613|FG000|COMPLETED|Posttreatment Period||98||
60024786|NCT02389621|76140614|FG001|COMPLETED|Posttreatment Period||102||
60024787|NCT02389621|76140613|FG000|NOT COMPLETED|Posttreatment Period||9||
60024788|NCT02389621|76140614|FG001|NOT COMPLETED|Posttreatment Period||4||
60024789|NCT02388997|76140626|FG000|STARTED|Overall Study||15||
60024790|NCT02388997|76140627|FG001|STARTED|Overall Study||16||
60024791|NCT02388997|76140626|FG000|COMPLETED|Overall Study||12||
60024792|NCT02388997|76140627|FG001|COMPLETED|Overall Study||10||
60024793|NCT02388997|76140626|FG000|NOT COMPLETED|Overall Study||3||
60024794|NCT02388997|76140627|FG001|NOT COMPLETED|Overall Study||6||
60024795|NCT02388763|76140633|FG000|STARTED|Habitual, 10 Days of Wear||32||
60024796|NCT02388763|76140634|FG001|STARTED|Habitual, 10 Days of Wear||32||
60024797|NCT02388763|76140633|FG000|COMPLETED|Habitual, 10 Days of Wear||31||
60024798|NCT02388763|76140634|FG001|COMPLETED|Habitual, 10 Days of Wear||31||
60024799|NCT02388763|76140633|FG000|NOT COMPLETED|Habitual, 10 Days of Wear||1||
60024800|NCT02388763|76140634|FG001|NOT COMPLETED|Habitual, 10 Days of Wear||1||
60024801|NCT02388763|76140633|FG000|STARTED|Period 1, 10 Days of Wear||31||
60024802|NCT02388763|76140634|FG001|STARTED|Period 1, 10 Days of Wear||31||
60024803|NCT02388763|76140633|FG000|COMPLETED|Period 1, 10 Days of Wear||30||
60024804|NCT02388763|76140634|FG001|COMPLETED|Period 1, 10 Days of Wear||30||
60024805|NCT02388763|76140633|FG000|NOT COMPLETED|Period 1, 10 Days of Wear||1||
60024806|NCT02388763|76140634|FG001|NOT COMPLETED|Period 1, 10 Days of Wear||1||
60024807|NCT02388763|76140633|FG000|STARTED|Period 2, 10 Days of Wear||30||
60024808|NCT02388763|76140634|FG001|STARTED|Period 2, 10 Days of Wear||30||
60024809|NCT02388763|76140633|FG000|COMPLETED|Period 2, 10 Days of Wear||30||
60024810|NCT02388763|76140634|FG001|COMPLETED|Period 2, 10 Days of Wear||30||
60024811|NCT02388763|76140633|FG000|NOT COMPLETED|Period 2, 10 Days of Wear||0||
60024812|NCT02388763|76140634|FG001|NOT COMPLETED|Period 2, 10 Days of Wear||0||
60024813|NCT02388295|76140646|FG000|STARTED|Dose Escalation Week 1|Number randomized to treatment|19||
60024814|NCT02388295|76140647|FG001|STARTED|Dose Escalation Week 1|Number randomized to treatment|19||
60024815|NCT02388295|76140648|FG002|STARTED|Dose Escalation Week 1|Number randomized to treatment|20||
59759085|NCT00918203|75878459|FG002|Received at Least 1 Dose of Study Drug|Treatment With or Without Olaratumab||0||
59759086|NCT00918203|75878457|FG000|Death Due to Any Cause|Treatment With or Without Olaratumab||53||
59759087|NCT00918203|75878458|FG001|Death Due to Any Cause|Treatment With or Without Olaratumab||47||
59759088|NCT00918203|75878459|FG002|Death Due to Any Cause|Treatment With or Without Olaratumab||0||
59759089|NCT00918203|75878457|FG000|Alive/On Study at End/Off Treatment|Treatment With or Without Olaratumab||11||
59915129|NCT02706886|76036034|FG007|STARTED|Part B: MAD Study Days 1-85||7||
59915130|NCT02706886|76036035|FG008|STARTED|Part B: MAD Study Days 1-85||3||
59915131|NCT02706886|76036027|FG000|COMPLETED|Part B: MAD Study Days 1-85||0||
59915132|NCT02706886|76036028|FG001|COMPLETED|Part B: MAD Study Days 1-85||0||
59915133|NCT02706886|76036029|FG002|COMPLETED|Part B: MAD Study Days 1-85||0||
59915134|NCT02706886|76036030|FG003|COMPLETED|Part B: MAD Study Days 1-85||0||
59915135|NCT02706886|76036031|FG004|COMPLETED|Part B: MAD Study Days 1-85||0||
59915136|NCT02706886|76036032|FG005|COMPLETED|Part B: MAD Study Days 1-85||3||
59915137|NCT02706886|76036033|FG006|COMPLETED|Part B: MAD Study Days 1-85||7||
59915138|NCT02706886|76036034|FG007|COMPLETED|Part B: MAD Study Days 1-85||7||
59915139|NCT02706886|76036035|FG008|COMPLETED|Part B: MAD Study Days 1-85||3||
59915140|NCT02706886|76036027|FG000|NOT COMPLETED|Part B: MAD Study Days 1-85||0||
59915141|NCT02706886|76036028|FG001|NOT COMPLETED|Part B: MAD Study Days 1-85||0||
59915142|NCT02706886|76036029|FG002|NOT COMPLETED|Part B: MAD Study Days 1-85||0||
59915143|NCT02706886|76036030|FG003|NOT COMPLETED|Part B: MAD Study Days 1-85||0||
59915144|NCT02706886|76036031|FG004|NOT COMPLETED|Part B: MAD Study Days 1-85||0||
59915145|NCT02706886|76036032|FG005|NOT COMPLETED|Part B: MAD Study Days 1-85||0||
59915146|NCT02706886|76036033|FG006|NOT COMPLETED|Part B: MAD Study Days 1-85||0||
59915147|NCT02706886|76036034|FG007|NOT COMPLETED|Part B: MAD Study Days 1-85||0||
59915148|NCT02706886|76036035|FG008|NOT COMPLETED|Part B: MAD Study Days 1-85||0||
59915149|NCT02706886|76036027|FG000|STARTED|Part B: MAD Study Day 85-End of Study||0||
59915150|NCT02706886|76036028|FG001|STARTED|Part B: MAD Study Day 85-End of Study||0||
59915151|NCT02706886|76036029|FG002|STARTED|Part B: MAD Study Day 85-End of Study||0||
59915152|NCT02706886|76036030|FG003|STARTED|Part B: MAD Study Day 85-End of Study||0||
59915153|NCT02706886|76036031|FG004|STARTED|Part B: MAD Study Day 85-End of Study||0||
59915154|NCT02706886|76036032|FG005|STARTED|Part B: MAD Study Day 85-End of Study||0||
59915155|NCT02706886|76036033|FG006|STARTED|Part B: MAD Study Day 85-End of Study|One participant from the Part B: MAD: Placebo arm crossed over to this lumasiran arm.|8||
59915156|NCT02706886|76036034|FG007|STARTED|Part B: MAD Study Day 85-End of Study|One participant from the Part B: MAD: Placebo arm crossed over to this lumasiran arm.|8||
59915157|NCT02706886|76036035|FG008|STARTED|Part B: MAD Study Day 85-End of Study|One participant from the Part B: MAD: Placebo arm crossed over to this lumasiran arm.|4||
59915158|NCT02706886|76036027|FG000|COMPLETED|Part B: MAD Study Day 85-End of Study||0||
59915159|NCT02706886|76036028|FG001|COMPLETED|Part B: MAD Study Day 85-End of Study||0||
59915160|NCT02706886|76036029|FG002|COMPLETED|Part B: MAD Study Day 85-End of Study||0||
59915161|NCT02706886|76036030|FG003|COMPLETED|Part B: MAD Study Day 85-End of Study||0||
59915162|NCT02706886|76036031|FG004|COMPLETED|Part B: MAD Study Day 85-End of Study||0||
59915163|NCT02706886|76036032|FG005|COMPLETED|Part B: MAD Study Day 85-End of Study||0||
59915164|NCT02706886|76036033|FG006|COMPLETED|Part B: MAD Study Day 85-End of Study||8||
59915165|NCT02706886|76036034|FG007|COMPLETED|Part B: MAD Study Day 85-End of Study||8||
59915166|NCT02706886|76036035|FG008|COMPLETED|Part B: MAD Study Day 85-End of Study||4||
59915167|NCT02706886|76036027|FG000|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0||
59915168|NCT02706886|76036028|FG001|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0||
59915169|NCT02706886|76036029|FG002|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0||
59915170|NCT02706886|76036030|FG003|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0||
59915171|NCT02706886|76036031|FG004|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0||
59915172|NCT02706886|76036032|FG005|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0||
59915173|NCT02706886|76036033|FG006|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0||
59915174|NCT02706886|76036034|FG007|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0||
59915175|NCT02706886|76036035|FG008|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0||
59507364|NCT02071095|75600609|FG001|STARTED|Overall Study||3||
59759090|NCT00918203|75878458|FG001|Alive/On Study at End/Off Treatment|Treatment With or Without Olaratumab||10||
59759091|NCT00918203|75878459|FG002|Alive/On Study at End/Off Treatment|Treatment With or Without Olaratumab||0||
59759092|NCT00918203|75878457|FG000|COMPLETED|Treatment With or Without Olaratumab||64||
59759093|NCT00918203|75878458|FG001|COMPLETED|Treatment With or Without Olaratumab||57||
59762600|NCT03888235|75882411|FG001|NOT COMPLETED|Overall Study||1||
59915176|NCT02809131|76036080|FG000|STARTED|Overall Study||505||
60024816|NCT02388295|76140646|FG000|COMPLETED|Dose Escalation Week 1||17||
60024817|NCT02388295|76140647|FG001|COMPLETED|Dose Escalation Week 1||16||
60024818|NCT02388295|76140648|FG002|COMPLETED|Dose Escalation Week 1||18||
60024819|NCT02388295|76140646|FG000|NOT COMPLETED|Dose Escalation Week 1||2||
60024820|NCT02388295|76140647|FG001|NOT COMPLETED|Dose Escalation Week 1||3||
60024821|NCT02388295|76140648|FG002|NOT COMPLETED|Dose Escalation Week 1||2||
60024822|NCT02388295|76140646|FG000|STARTED|Dose Escalation Week 2||17||
60024823|NCT02388295|76140647|FG001|STARTED|Dose Escalation Week 2||16||
60024824|NCT02388295|76140648|FG002|STARTED|Dose Escalation Week 2||18||
60024825|NCT02388295|76140646|FG000|COMPLETED|Dose Escalation Week 2||16||
60024826|NCT02388295|76140647|FG001|COMPLETED|Dose Escalation Week 2||14||
60024827|NCT02388295|76140648|FG002|COMPLETED|Dose Escalation Week 2||17||
60024828|NCT02388295|76140646|FG000|NOT COMPLETED|Dose Escalation Week 2||1||
60024829|NCT02388295|76140647|FG001|NOT COMPLETED|Dose Escalation Week 2||2||
60024830|NCT02388295|76140648|FG002|NOT COMPLETED|Dose Escalation Week 2||1||
60024831|NCT02388295|76140646|FG000|STARTED|Treatment Weeks 3 to 12||16||
60024832|NCT02388295|76140647|FG001|STARTED|Treatment Weeks 3 to 12||14||
60024833|NCT02388295|76140648|FG002|STARTED|Treatment Weeks 3 to 12||17||
60024834|NCT02388295|76140646|FG000|COMPLETED|Treatment Weeks 3 to 12||15||
60024835|NCT02388295|76140647|FG001|COMPLETED|Treatment Weeks 3 to 12||13||
60024836|NCT02388295|76140648|FG002|COMPLETED|Treatment Weeks 3 to 12||17||
60024837|NCT02388295|76140646|FG000|NOT COMPLETED|Treatment Weeks 3 to 12||1||
60024838|NCT02388295|76140647|FG001|NOT COMPLETED|Treatment Weeks 3 to 12||1||
60024839|NCT02388295|76140648|FG002|NOT COMPLETED|Treatment Weeks 3 to 12||0||
60024840|NCT02345161|76140658|FG000|STARTED|Overall Study||911||
60024841|NCT02345161|76140659|FG001|STARTED|Overall Study||899||
60024842|NCT02345161|76140658|FG000|COMPLETED|Overall Study||866||
60024843|NCT02345161|76140659|FG001|COMPLETED|Overall Study||842||
60024844|NCT02345161|76140658|FG000|NOT COMPLETED|Overall Study||45||
60024845|NCT02345161|76140659|FG001|NOT COMPLETED|Overall Study||57||
60024846|NCT02251275|76140675|FG000|STARTED|Overall Study||506||
60024847|NCT02251275|76140676|FG001|STARTED|Overall Study||570||
60024848|NCT02251275|76140677|FG002|STARTED|Overall Study||718||
60024849|NCT02251275|76140678|FG003|STARTED|Overall Study|From trials 156-04-251 and 156-09-290|6||
60024850|NCT02251275|76140679|FG004|STARTED|Overall Study|From trials 156-04-251 and 156-09-290|3||
60024851|NCT02251275|76140675|FG000|Received at Least 1 Dose of Study Drug|Overall Study||505||
60024852|NCT02251275|76140676|FG001|Received at Least 1 Dose of Study Drug|Overall Study||569||
60024853|NCT02251275|76140677|FG002|Received at Least 1 Dose of Study Drug|Overall Study||717||
60024854|NCT02251275|76140678|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6||
60024855|NCT02251275|76140679|FG004|Received at Least 1 Dose of Study Drug|Overall Study||3||
60024856|NCT02251275|76140675|FG000|COMPLETED|Overall Study||434||
60024857|NCT02251275|76140676|FG001|COMPLETED|Overall Study||423||
60024858|NCT02251275|76140677|FG002|COMPLETED|Overall Study||624||
60024859|NCT02251275|76140678|FG003|COMPLETED|Overall Study||5||
60024860|NCT02251275|76140679|FG004|COMPLETED|Overall Study||2||
60024861|NCT02251275|76140675|FG000|NOT COMPLETED|Overall Study||72||
60024862|NCT02251275|76140676|FG001|NOT COMPLETED|Overall Study||147||
60024863|NCT02251275|76140677|FG002|NOT COMPLETED|Overall Study||94||
60024864|NCT02251275|76140678|FG003|NOT COMPLETED|Overall Study||1||
60024865|NCT02251275|76140679|FG004|NOT COMPLETED|Overall Study||1||
59507365|NCT02071095|75600608|FG000|COMPLETED|Overall Study||12||
60024866|NCT02379637|76140693|FG000|STARTED|Overall Study||35||
60024867|NCT02379637|76140694|FG001|STARTED|Overall Study||35||
60024868|NCT02379637|76140693|FG000|COMPLETED|Overall Study||33||
60024869|NCT02379637|76140694|FG001|COMPLETED|Overall Study||34||
60024870|NCT02379637|76140693|FG000|NOT COMPLETED|Overall Study||2||
60024871|NCT02379637|76140694|FG001|NOT COMPLETED|Overall Study||1||
60024872|NCT02195583|76140700|FG000|STARTED|Overall Study||62||
60024873|NCT02195583|76140700|FG000|Sodium Fluoride (1150 Ppm)|Overall Study|Discontinuations: 1 due to other reason in Period 5|57||
60024874|NCT02195583|76140700|FG000|Sodium Fluoride (0 Ppm)|Overall Study||59||
60024875|NCT02195583|76140700|FG000|Sodium Fluoride (1426 Ppm) + Zinc Base A|Overall Study|Discontinuations: 1 withdrawal of consent in Period 3 and 1 withdrawal of consent in Period 4|58||
60024876|NCT02195583|76140700|FG000|Sodium Fluoride (250 Ppm)|Overall Study||55||
60024877|NCT02195583|76140700|FG000|Sodium Fluoride (1426 Ppm)|Overall Study|Discontinuation:1 lost to follow up, 1 withdrawal of consent in Period 2, 1 other reason in Period 5|59||
60024878|NCT02195583|76140700|FG000|Sodium Fluoride (1426 Ppm) + Zinc Base B|Overall Study|Discontinuations: 1 withdrawal of consent in Period 2;1 adverse event each in Period 3 and Period 4|60||
60024879|NCT02195583|76140700|FG000|COMPLETED|Overall Study||53||
60024880|NCT02195583|76140700|FG000|NOT COMPLETED|Overall Study||9||
60024881|NCT02379091|76140719|FG000|STARTED|Overall Study||27||
60024882|NCT02379091|76140720|FG001|STARTED|Overall Study||28||
60024883|NCT02379091|76140721|FG002|STARTED|Overall Study||25||
60024884|NCT02379091|76140722|FG003|STARTED|Overall Study||28||
60024885|NCT02379091|76140719|FG000|Full Analysis Set|Overall Study|One participant was excluded because of data collection issues.|26||
60024886|NCT02379091|76140720|FG001|Full Analysis Set|Overall Study||28||
60024887|NCT02379091|76140721|FG002|Full Analysis Set|Overall Study|One participant was excluded because of data collection issues.|24||
60024888|NCT02379091|76140722|FG003|Full Analysis Set|Overall Study||28||
59507366|NCT02071095|75600609|FG001|COMPLETED|Overall Study||3||
60024889|NCT02379091|76140719|FG000|COMPLETED|Overall Study||15||
60024890|NCT02379091|76140720|FG001|COMPLETED|Overall Study||18||
60024891|NCT02379091|76140721|FG002|COMPLETED|Overall Study||18||
60024892|NCT02379091|76140722|FG003|COMPLETED|Overall Study||14||
60024893|NCT02379091|76140719|FG000|NOT COMPLETED|Overall Study||12||
60024894|NCT02379091|76140720|FG001|NOT COMPLETED|Overall Study||10||
60024895|NCT02379091|76140721|FG002|NOT COMPLETED|Overall Study||7||
60024896|NCT02379091|76140722|FG003|NOT COMPLETED|Overall Study||14||
60024897|NCT02378935|76140741|FG000|STARTED|Overall Study||34||
60024898|NCT02378935|76140742|FG001|STARTED|Overall Study||36||
60024899|NCT02378935|76140743|FG002|STARTED|Overall Study||33||
60024900|NCT02378935|76140744|FG003|STARTED|Overall Study||31||
60024901|NCT02378935|76140745|FG004|STARTED|Overall Study||31||
60024902|NCT02378935|76140746|FG005|STARTED|Overall Study||32||
60024903|NCT02378935|76140747|FG006|STARTED|Overall Study||8||
60024904|NCT02378935|76140741|FG000|COMPLETED|Overall Study||24||
60024905|NCT02378935|76140742|FG001|COMPLETED|Overall Study||36||
60024906|NCT02378935|76140743|FG002|COMPLETED|Overall Study||30||
60024907|NCT02378935|76140744|FG003|COMPLETED|Overall Study||25||
60024908|NCT02378935|76140745|FG004|COMPLETED|Overall Study||31||
60024909|NCT02378935|76140746|FG005|COMPLETED|Overall Study||32||
60024910|NCT02378935|76140747|FG006|COMPLETED|Overall Study||8||
60024911|NCT02378935|76140741|FG000|NOT COMPLETED|Overall Study||10||
59507367|NCT02071095|75600608|FG000|NOT COMPLETED|Overall Study||0||
59507368|NCT02071095|75600609|FG001|NOT COMPLETED|Overall Study||0||
59507369|NCT02406573|75600615|FG000|STARTED|Overall Study||30||
59507370|NCT02406573|75600615|FG000|COMPLETED|Overall Study||30||
60024912|NCT02378935|76140742|FG001|NOT COMPLETED|Overall Study||0||
60024913|NCT02378935|76140743|FG002|NOT COMPLETED|Overall Study||3||
60024914|NCT02378935|76140744|FG003|NOT COMPLETED|Overall Study||6||
60024915|NCT02378935|76140745|FG004|NOT COMPLETED|Overall Study||0||
60024916|NCT02378935|76140746|FG005|NOT COMPLETED|Overall Study||0||
60024917|NCT02378935|76140747|FG006|NOT COMPLETED|Overall Study||0||
60024918|NCT02250651|76140766|FG000|STARTED|Treatment Period 1 (Day 1 to Week 15)||176||
60024919|NCT02250651|76140767|FG001|STARTED|Treatment Period 1 (Day 1 to Week 15)||176||
60024920|NCT02250651|76140768|FG002|STARTED|Treatment Period 1 (Day 1 to Week 15)||176||
60024921|NCT02250651|76140766|FG000|Received Sham or Bimatoprost SR|Treatment Period 1 (Day 1 to Week 15)||176||
60024922|NCT02250651|76140767|FG001|Received Sham or Bimatoprost SR|Treatment Period 1 (Day 1 to Week 15)||175||
60024923|NCT02250651|76140768|FG002|Received Sham or Bimatoprost SR|Treatment Period 1 (Day 1 to Week 15)||173||
60024924|NCT02250651|76140766|FG000|COMPLETED|Treatment Period 1 (Day 1 to Week 15)||172||
60024925|NCT02250651|76140767|FG001|COMPLETED|Treatment Period 1 (Day 1 to Week 15)||170||
60024926|NCT02250651|76140768|FG002|COMPLETED|Treatment Period 1 (Day 1 to Week 15)||165||
60024927|NCT02250651|76140766|FG000|NOT COMPLETED|Treatment Period 1 (Day 1 to Week 15)||4||
60024928|NCT02250651|76140767|FG001|NOT COMPLETED|Treatment Period 1 (Day 1 to Week 15)||6||
60024929|NCT02250651|76140768|FG002|NOT COMPLETED|Treatment Period 1 (Day 1 to Week 15)||11||
60024930|NCT02250651|76140766|FG000|STARTED|Treatment Period 2 (Week 16 to Week 31)||165|Started=received administration (Sham or Bimatoprost SR) in the cycle|
60024931|NCT02250651|76140767|FG001|STARTED|Treatment Period 2 (Week 16 to Week 31)||168|Started=received administration (Sham or Bimatoprost SR) in the cycle|
60024932|NCT02250651|76140768|FG002|STARTED|Treatment Period 2 (Week 16 to Week 31)||165|Started=received administration (Sham or Bimatoprost SR) in the cycle|
60024933|NCT02250651|76140766|FG000|COMPLETED|Treatment Period 2 (Week 16 to Week 31)||159||
60024934|NCT02250651|76140767|FG001|COMPLETED|Treatment Period 2 (Week 16 to Week 31)||162||
60024935|NCT02250651|76140768|FG002|COMPLETED|Treatment Period 2 (Week 16 to Week 31)||160||
60024936|NCT02250651|76140766|FG000|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 31)||6||
60024937|NCT02250651|76140767|FG001|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 31)||6||
60024938|NCT02250651|76140768|FG002|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 31)||5||
60024939|NCT02250651|76140766|FG000|STARTED|Treatment Period 3 (Week 32 to Week 52)||147|Started=received administration (Sham or Bimatoprost SR) in the cycle|
60024940|NCT02250651|76140767|FG001|STARTED|Treatment Period 3 (Week 32 to Week 52)||156|Started=received administration (Sham or Bimatoprost SR) in the cycle|
60024941|NCT02250651|76140768|FG002|STARTED|Treatment Period 3 (Week 32 to Week 52)||159|Started=received administration (Sham or Bimatoprost SR) in the cycle|
60024942|NCT02250651|76140766|FG000|COMPLETED|Treatment Period 3 (Week 32 to Week 52)||138||
60024943|NCT02250651|76140767|FG001|COMPLETED|Treatment Period 3 (Week 32 to Week 52)||152||
60024944|NCT02250651|76140768|FG002|COMPLETED|Treatment Period 3 (Week 32 to Week 52)||154||
60024945|NCT02250651|76140766|FG000|NOT COMPLETED|Treatment Period 3 (Week 32 to Week 52)||9||
60024946|NCT02250651|76140767|FG001|NOT COMPLETED|Treatment Period 3 (Week 32 to Week 52)||4||
60024947|NCT02250651|76140768|FG002|NOT COMPLETED|Treatment Period 3 (Week 32 to Week 52)||5||
60024948|NCT02377921|76140778|FG000|STARTED|Overall Study||45||
60024949|NCT02377921|76140779|FG001|STARTED|Overall Study||44||
60024950|NCT02377921|76140778|FG000|COMPLETED|Overall Study||44||
60024951|NCT02377921|76140779|FG001|COMPLETED|Overall Study||43||
60024952|NCT02377921|76140778|FG000|NOT COMPLETED|Overall Study||1||
60024953|NCT02377921|76140779|FG001|NOT COMPLETED|Overall Study||1||
60024954|NCT02311153|76140787|FG000|STARTED|Overall Study||53||
60024955|NCT02311153|76140788|FG001|STARTED|Overall Study||49||
60024956|NCT02311153|76140787|FG000|COMPLETED|Overall Study||48||
60024957|NCT02311153|76140788|FG001|COMPLETED|Overall Study||42||
60024958|NCT02311153|76140787|FG000|NOT COMPLETED|Overall Study||5||
60024959|NCT02311153|76140788|FG001|NOT COMPLETED|Overall Study||7||
60024960|NCT02195427|76140796|FG000|STARTED|Overall Study||73||
60024961|NCT02195427|76140797|FG001|STARTED|Overall Study||74||
60024962|NCT02195427|76140796|FG000|N Patients at W24 (Primary Outcome)|Overall Study||67||
60024963|NCT02195427|76140797|FG001|N Patients at W24 (Primary Outcome)|Overall Study||62||
60024964|NCT02195427|76140796|FG000|N Patients at W36|Overall Study||65||
60024965|NCT02195427|76140797|FG001|N Patients at W36|Overall Study||59||
60024966|NCT02195427|76140796|FG000|N Patients at W52|Overall Study||63||
60024967|NCT02195427|76140797|FG001|N Patients at W52|Overall Study||56||
60024968|NCT02195427|76140796|FG000|COMPLETED|Overall Study||47|N patients completed W64|
60024969|NCT02195427|76140797|FG001|COMPLETED|Overall Study||47|N patients completed W64|
60024970|NCT02195427|76140796|FG000|NOT COMPLETED|Overall Study||26||
60024971|NCT02195427|76140797|FG001|NOT COMPLETED|Overall Study||27||
60024972|NCT02214225|76140810|FG000|STARTED|Overall Study||1741||
60024973|NCT02214225|76140811|FG001|STARTED|Overall Study||871||
60024974|NCT02214225|76140812|FG002|STARTED|Overall Study||872||
60024975|NCT02214225|76140810|FG000|COMPLETED|Overall Study||1686||
60024976|NCT02214225|76140811|FG001|COMPLETED|Overall Study||852||
60024977|NCT02214225|76140812|FG002|COMPLETED|Overall Study||850||
60024978|NCT02214225|76140810|FG000|NOT COMPLETED|Overall Study||55||
60024979|NCT02214225|76140811|FG001|NOT COMPLETED|Overall Study||19||
60024980|NCT02214225|76140812|FG002|NOT COMPLETED|Overall Study||22||
60024981|NCT02250183|76140843|FG000|STARTED|Overall Study||21||
60024982|NCT02250183|76140843|FG000|COMPLETED|Overall Study||13||
60024983|NCT02250183|76140843|FG000|NOT COMPLETED|Overall Study||8||
60024984|NCT02249949|76140850|FG000|STARTED|Overall Study||13||
60024985|NCT02249949|76140850|FG000|COMPLETED|Overall Study||11||
60024986|NCT02249949|76140850|FG000|NOT COMPLETED|Overall Study||2||
60024987|NCT02249091|76140856|FG000|STARTED|Overall Study||27||
60024988|NCT02249091|76140857|FG001|STARTED|Overall Study||15||
60024989|NCT02249091|76140856|FG000|COMPLETED|Overall Study||7||
60024990|NCT02249091|76140857|FG001|COMPLETED|Overall Study||2||
60024991|NCT02249091|76140856|FG000|NOT COMPLETED|Overall Study||20||
60024992|NCT02249091|76140857|FG001|NOT COMPLETED|Overall Study||13||
60024993|NCT02248857|76140866|FG000|STARTED|Baseline||157||
60024994|NCT02248857|76140867|FG001|STARTED|Baseline||168||
60024995|NCT02248857|76140868|FG002|STARTED|Baseline||127||
60024996|NCT02248857|76140866|FG000|COMPLETED|Baseline||157||
60024997|NCT02248857|76140867|FG001|COMPLETED|Baseline||168||
60024998|NCT02248857|76140868|FG002|COMPLETED|Baseline||127||
60024999|NCT02248857|76140866|FG000|NOT COMPLETED|Baseline||0||
60025000|NCT02248857|76140867|FG001|NOT COMPLETED|Baseline||0||
60025001|NCT02248857|76140868|FG002|NOT COMPLETED|Baseline||0||
60025002|NCT02248857|76140866|FG000|STARTED|3 Month||157||
60025003|NCT02248857|76140867|FG001|STARTED|3 Month||168||
60025004|NCT02248857|76140868|FG002|STARTED|3 Month||127||
60025005|NCT02248857|76140866|FG000|COMPLETED|3 Month||111||
60025006|NCT02248857|76140867|FG001|COMPLETED|3 Month||134||
60025007|NCT02248857|76140868|FG002|COMPLETED|3 Month||96||
60025008|NCT02248857|76140866|FG000|NOT COMPLETED|3 Month||46||
60025009|NCT02248857|76140867|FG001|NOT COMPLETED|3 Month||34||
60025010|NCT02248857|76140868|FG002|NOT COMPLETED|3 Month||31||
60025011|NCT02248857|76140866|FG000|STARTED|6 Month|157 baseline - 9 who withdrew = 148|148|Participants were still eligible for the 6 month if they did not complete the 3 month.|
60025012|NCT02248857|76140867|FG001|STARTED|6 Month|168 baseline - 3 who withdrew = 165|165|Participants were still eligible for the 6 month if they did not complete the 3 month.|
60025013|NCT02248857|76140868|FG002|STARTED|6 Month|127 baseline - 4 who withdrew = 123|123|Participants were still eligible for the 6 month if they did not complete the 3 month.|
60025014|NCT02248857|76140866|FG000|COMPLETED|6 Month||120||
60025015|NCT02248857|76140867|FG001|COMPLETED|6 Month||136||
60025016|NCT02248857|76140868|FG002|COMPLETED|6 Month||106||
60025017|NCT02248857|76140866|FG000|NOT COMPLETED|6 Month||28||
60025018|NCT02248857|76140867|FG001|NOT COMPLETED|6 Month||29||
60025019|NCT02248857|76140868|FG002|NOT COMPLETED|6 Month||17||
60025020|NCT02213055|76140878|FG000|STARTED|Overall Study||97||
60025021|NCT02213055|76140879|FG001|STARTED|Overall Study||0||
60025022|NCT02213055|76140878|FG000|COMPLETED|Overall Study||58||
60025023|NCT02213055|76140879|FG001|COMPLETED|Overall Study||0||
60025024|NCT02213055|76140878|FG000|NOT COMPLETED|Overall Study||39||
60025025|NCT02213055|76140879|FG001|NOT COMPLETED|Overall Study||0||
60025026|NCT02310763|76140888|FG000|STARTED|Period 1 (Weeks 1 to 48)||41||
60025027|NCT02310763|76140889|FG001|STARTED|Period 1 (Weeks 1 to 48)||39||
60025028|NCT02310763|76140890|FG002|STARTED|Period 1 (Weeks 1 to 48)||40||
60025029|NCT02310763|76140888|FG000|COMPLETED|Period 1 (Weeks 1 to 48)||38||
60025030|NCT02310763|76140889|FG001|COMPLETED|Period 1 (Weeks 1 to 48)||37||
60025031|NCT02310763|76140890|FG002|COMPLETED|Period 1 (Weeks 1 to 48)||38||
60025032|NCT02310763|76140888|FG000|NOT COMPLETED|Period 1 (Weeks 1 to 48)||3||
60025033|NCT02310763|76140889|FG001|NOT COMPLETED|Period 1 (Weeks 1 to 48)||2||
60025034|NCT02310763|76140890|FG002|NOT COMPLETED|Period 1 (Weeks 1 to 48)||2||
60025035|NCT02310763|76140888|FG000|STARTED|Period 2 (Weeks 49 to 96)||38||
60025036|NCT02310763|76140889|FG001|STARTED|Period 2 (Weeks 49 to 96)||37||
60025037|NCT02310763|76140890|FG002|STARTED|Period 2 (Weeks 49 to 96)||38||
60025038|NCT02310763|76140888|FG000|COMPLETED|Period 2 (Weeks 49 to 96)||22||
60025039|NCT02310763|76140889|FG001|COMPLETED|Period 2 (Weeks 49 to 96)||21||
60025040|NCT02310763|76140890|FG002|COMPLETED|Period 2 (Weeks 49 to 96)||22||
60025041|NCT02310763|76140888|FG000|NOT COMPLETED|Period 2 (Weeks 49 to 96)||16||
60025042|NCT02310763|76140889|FG001|NOT COMPLETED|Period 2 (Weeks 49 to 96)||16||
60025043|NCT02310763|76140890|FG002|NOT COMPLETED|Period 2 (Weeks 49 to 96)||16||
60025044|NCT02342743|76140916|FG000|STARTED|Baseline Period||73||
60025045|NCT02342743|76140916|FG000|COMPLETED|Baseline Period||58||
60025046|NCT02342743|76140916|FG000|NOT COMPLETED|Baseline Period||15||
60025047|NCT02342743|76140916|FG000|STARTED|Treatment Period|7 patients didn't meet inclusion criteria for treatment period, evaluated at the end of the baseline|58||
60025048|NCT02342743|76140916|FG000|COMPLETED|Treatment Period||47||
60025049|NCT02342743|76140916|FG000|NOT COMPLETED|Treatment Period||11||
60025050|NCT02377063|76140920|FG000|STARTED|Overall Study||25||
60025051|NCT02377063|76140920|FG000|COMPLETED|Overall Study||20||
60025052|NCT02377063|76140920|FG000|NOT COMPLETED|Overall Study||5||
60025053|NCT02309515|76140926|FG000|STARTED|Overall Study||5||
60025054|NCT02309515|76140927|FG001|STARTED|Overall Study||7||
60025055|NCT02309515|76140926|FG000|COMPLETED|Overall Study||5||
60025056|NCT02309515|76140927|FG001|COMPLETED|Overall Study||6||
60025057|NCT02309515|76140926|FG000|NOT COMPLETED|Overall Study||0||
60025058|NCT02309515|76140927|FG001|NOT COMPLETED|Overall Study||1||
60025059|NCT02309359|76140938|FG000|STARTED|Overall Study||69||
60025060|NCT02309359|76140939|FG001|STARTED|Overall Study||70||
60025061|NCT02309359|76140940|FG002|STARTED|Overall Study||68||
60025062|NCT02309359|76140941|FG003|STARTED|Overall Study||69||
60025063|NCT02309359|76140942|FG004|STARTED|Overall Study||69||
60025064|NCT02309359|76140938|FG000|COMPLETED|Overall Study||57||
60025065|NCT02309359|76140939|FG001|COMPLETED|Overall Study||62||
60025066|NCT02309359|76140940|FG002|COMPLETED|Overall Study||57||
60025067|NCT02309359|76140941|FG003|COMPLETED|Overall Study||57||
60025068|NCT02309359|76140942|FG004|COMPLETED|Overall Study||60||
60025069|NCT02309359|76140938|FG000|NOT COMPLETED|Overall Study||12||
60025070|NCT02309359|76140939|FG001|NOT COMPLETED|Overall Study||8||
60025071|NCT02309359|76140940|FG002|NOT COMPLETED|Overall Study||11||
60025072|NCT02309359|76140941|FG003|NOT COMPLETED|Overall Study||12||
60025073|NCT02309359|76140942|FG004|NOT COMPLETED|Overall Study||9||
60025074|NCT02247531|76140958|FG000|STARTED|Overall Study||321||
60025075|NCT02247531|76140959|FG001|STARTED|Overall Study||330||
60025076|NCT02247531|76140960|FG002|STARTED|Overall Study||324||
60025077|NCT02247531|76140958|FG000|COMPLETED|Overall Study||215||
60025078|NCT02247531|76140959|FG001|COMPLETED|Overall Study||205||
60025079|NCT02247531|76140960|FG002|COMPLETED|Overall Study||214||
60025080|NCT02247531|76140958|FG000|NOT COMPLETED|Overall Study||106||
60025081|NCT02247531|76140959|FG001|NOT COMPLETED|Overall Study||125||
60025082|NCT02247531|76140960|FG002|NOT COMPLETED|Overall Study||110||
60025083|NCT02375971|76140971|FG000|STARTED|Treatment (Day 1 - Baseline)||74|All randomized patients to whom treatment had been assigned (FAS)|
60025084|NCT02375971|76140972|FG001|STARTED|Treatment (Day 1 - Baseline)||77|All randomized patients to whom treatment had been assigned (FAS)|
60025085|NCT02375971|76140973|FG002|STARTED|Treatment (Day 1 - Baseline)||74|All randomized patients to whom treatment had been assigned (FAS)|
60025086|NCT02375971|76140971|FG000|Safety Set|Treatment (Day 1 - Baseline)||73|At least 1 application of investigational treatment and a 1 post baseline safety assessment|
60025087|NCT02375971|76140972|FG001|Safety Set|Treatment (Day 1 - Baseline)||76|At least 1 application of investigational treatment and a 1 post baseline safety assessment|
60025088|NCT02375971|76140973|FG002|Safety Set|Treatment (Day 1 - Baseline)||69|At least 1 application of investigational treatment and a 1 post baseline safety assessment|
60025089|NCT02375971|76140971|FG000|VEGF Set|Treatment (Day 1 - Baseline)||19|All patients who provided valid Vascular endothelial growth factor (VEGF) plasma samples|
60025090|NCT02375971|76140972|FG001|VEGF Set|Treatment (Day 1 - Baseline)||26|All patients who provided valid Vascular endothelial growth factor (VEGF) plasma samples|
60025091|NCT02375971|76140973|FG002|VEGF Set|Treatment (Day 1 - Baseline)||51|All patients who provided valid Vascular endothelial growth factor (VEGF) plasma samples|
60025092|NCT02375971|76140971|FG000|PK Set|Treatment (Day 1 - Baseline)||49|All patients who provided Pharmacokinetics (PK) serum samples|
60025093|NCT02375971|76140972|FG001|PK Set|Treatment (Day 1 - Baseline)||46|All patients who provided Pharmacokinetics (PK) serum samples|
60025094|NCT02375971|76140973|FG002|PK Set|Treatment (Day 1 - Baseline)||0|All patients who provided Pharmacokinetics (PK) serum samples|
59611736|NCT01732458|75722710|FG003|Treated|Overall Study||52||
59611737|NCT01732458|75722707|FG000|COMPLETED|Overall Study||57||
59611738|NCT01732458|75722708|FG001|COMPLETED|Overall Study||53||
59611739|NCT01732458|75722709|FG002|COMPLETED|Overall Study||55||
59611740|NCT01732458|75722710|FG003|COMPLETED|Overall Study||50||
59611741|NCT01732458|75722707|FG000|NOT COMPLETED|Overall Study||3||
60025095|NCT02375971|76140971|FG000|COMPLETED|Treatment (Day 1 - Baseline)||73|All patients who completed the treatment phase|
60025096|NCT02375971|76140972|FG001|COMPLETED|Treatment (Day 1 - Baseline)||76|All patients who completed the treatment phase|
60025097|NCT02375971|76140973|FG002|COMPLETED|Treatment (Day 1 - Baseline)||69|All patients who completed the treatment phase|
60025098|NCT02375971|76140971|FG000|NOT COMPLETED|Treatment (Day 1 - Baseline)||1||
60025099|NCT02375971|76140972|FG001|NOT COMPLETED|Treatment (Day 1 - Baseline)||1||
60025100|NCT02375971|76140973|FG002|NOT COMPLETED|Treatment (Day 1 - Baseline)||5||
60025101|NCT02375971|76140971|FG000|STARTED|Follow-Up Phase (up to Day 169)||73|All patients who started the follow-up phase|
60025102|NCT02375971|76140972|FG001|STARTED|Follow-Up Phase (up to Day 169)||76|All patients who started the follow-up phase|
60025103|NCT02375971|76140973|FG002|STARTED|Follow-Up Phase (up to Day 169)||69|All patients who started the follow-up phase|
60025104|NCT02375971|76140971|FG000|COMPLETED|Follow-Up Phase (up to Day 169)||66|All patients who completed the follow-up phase|
60025105|NCT02375971|76140972|FG001|COMPLETED|Follow-Up Phase (up to Day 169)||71|All patients who completed the follow-up phase|
60025106|NCT02375971|76140973|FG002|COMPLETED|Follow-Up Phase (up to Day 169)||64|All patients who completed the follow-up phase|
60025107|NCT02375971|76140971|FG000|NOT COMPLETED|Follow-Up Phase (up to Day 169)||7||
60025108|NCT02375971|76140972|FG001|NOT COMPLETED|Follow-Up Phase (up to Day 169)||5||
60025109|NCT02375971|76140973|FG002|NOT COMPLETED|Follow-Up Phase (up to Day 169)||5||
60025110|NCT02308735|76140985|FG000|STARTED|Overall Study||2||
60025111|NCT02308735|76140986|FG001|STARTED|Overall Study||0||
60025112|NCT02308735|76140987|FG002|STARTED|Overall Study||0||
60025113|NCT02308735|76140988|FG003|STARTED|Overall Study||2||
60025114|NCT02308735|76140985|FG000|COMPLETED|Overall Study||0||
60025115|NCT02308735|76140986|FG001|COMPLETED|Overall Study||0||
60025116|NCT02308735|76140987|FG002|COMPLETED|Overall Study||0||
60025117|NCT02308735|76140988|FG003|COMPLETED|Overall Study||0||
60025118|NCT02308735|76140985|FG000|NOT COMPLETED|Overall Study||2||
60025119|NCT02308735|76140986|FG001|NOT COMPLETED|Overall Study||0||
60025120|NCT02308735|76140987|FG002|NOT COMPLETED|Overall Study||0||
60025121|NCT02308735|76140988|FG003|NOT COMPLETED|Overall Study||2||
60025122|NCT02212197|76141001|FG000|STARTED|Overall Study||19||
60025123|NCT02212197|76141002|FG001|STARTED|Overall Study||15||
60025124|NCT02212197|76141003|FG002|STARTED|Overall Study||17||
59611742|NCT01732458|75722708|FG001|NOT COMPLETED|Overall Study||5||
59611743|NCT01732458|75722709|FG002|NOT COMPLETED|Overall Study||3||
59611744|NCT01732458|75722710|FG003|NOT COMPLETED|Overall Study||2||
59611745|NCT01731990|75722734|FG000|STARTED|Overall Study|"Started indicates Safety and Pharmacodynamics set ."|18||
59611746|NCT01731990|75722735|FG001|STARTED|Overall Study||20||
59611747|NCT01731990|75722734|FG000|COMPLETED|Overall Study||14||
59759094|NCT00918203|75878459|FG002|COMPLETED|Treatment With or Without Olaratumab||0||
59759095|NCT00918203|75878457|FG000|NOT COMPLETED|Treatment With or Without Olaratumab||6||
59759096|NCT00918203|75878458|FG001|NOT COMPLETED|Treatment With or Without Olaratumab||10||
59759097|NCT00918203|75878459|FG002|NOT COMPLETED|Treatment With or Without Olaratumab||0||
59759098|NCT00918203|75878457|FG000|STARTED|Crossover to Olaratumab Monotherapy||0||
59759099|NCT00918203|75878458|FG001|STARTED|Crossover to Olaratumab Monotherapy||0||
59759100|NCT00918203|75878459|FG002|STARTED|Crossover to Olaratumab Monotherapy|18 participants who had progressive disease crossed over to monotherapy.|18||
59759101|NCT00918203|75878457|FG000|COMPLETED|Crossover to Olaratumab Monotherapy||0||
59759102|NCT00918203|75878458|FG001|COMPLETED|Crossover to Olaratumab Monotherapy||0||
59759103|NCT00918203|75878459|FG002|COMPLETED|Crossover to Olaratumab Monotherapy||18||
59759104|NCT00918203|75878457|FG000|NOT COMPLETED|Crossover to Olaratumab Monotherapy||0||
59759105|NCT00918203|75878458|FG001|NOT COMPLETED|Crossover to Olaratumab Monotherapy||0||
59759106|NCT00918203|75878459|FG002|NOT COMPLETED|Crossover to Olaratumab Monotherapy||0||
59759107|NCT00918281|75878471|FG000|STARTED|Overall Study||70||
59759108|NCT00918281|75878471|FG000|COMPLETED|Overall Study||41||
59759109|NCT00918281|75878471|FG000|NOT COMPLETED|Overall Study||29||
59759110|NCT02770716|75878480|FG000|STARTED|Overall Study||199||
59759111|NCT02770716|75878481|FG001|STARTED|Overall Study||101||
59759112|NCT02770716|75878480|FG000|Intent to Treat (ITT)|Overall Study||199||
59759113|NCT02770716|75878481|FG001|Intent to Treat (ITT)|Overall Study||101||
59759114|NCT02770716|75878480|FG000|Safety Analysis Set (SAS)|Overall Study|One placebo participant received terlipressin as well, so is included in the terlipressin SAS|200||
59759115|NCT02770716|75878481|FG001|Safety Analysis Set (SAS)|Overall Study|One placebo participant did not receive any treatment, so was excluded from the SAS|99||
59759116|NCT02770716|75878480|FG000|Systemic Inflammatory Response Syndrome (SIRS) Subgroup|Overall Study||84|SIRS subgroup included all participants from the ITT population who met the SIRS criteria.|
59759117|NCT02770716|75878481|FG001|Systemic Inflammatory Response Syndrome (SIRS) Subgroup|Overall Study||48|SIRS subgroup included all participants from the ITT population who met the SIRS criteria.|
59759118|NCT02770716|75878480|FG000|COMPLETED|Overall Study|ITT Completed Study through Follow-up / Day 90 Visit|87||
59759119|NCT02770716|75878481|FG001|COMPLETED|Overall Study|ITT Completed Study through Follow-up / Day 90 Visit|52||
59759120|NCT02770716|75878480|FG000|NOT COMPLETED|Overall Study||112||
59759121|NCT02770716|75878481|FG001|NOT COMPLETED|Overall Study||49||
59759122|NCT00917579|75878487|FG000|STARTED|Period 1: 1st Intervention||39||
59759123|NCT00917579|75878488|FG001|STARTED|Period 1: 1st Intervention||37||
59759124|NCT00917579|75878487|FG000|COMPLETED|Period 1: 1st Intervention||39||
59759125|NCT00917579|75878488|FG001|COMPLETED|Period 1: 1st Intervention||37||
59759126|NCT00917579|75878487|FG000|NOT COMPLETED|Period 1: 1st Intervention||0||
59759127|NCT00917579|75878488|FG001|NOT COMPLETED|Period 1: 1st Intervention||0||
59759128|NCT00917579|75878487|FG000|STARTED|Washout >= 2 Weeks||39||
59759129|NCT00917579|75878488|FG001|STARTED|Washout >= 2 Weeks||37||
59759130|NCT00917579|75878487|FG000|COMPLETED|Washout >= 2 Weeks||37||
59759131|NCT00917579|75878488|FG001|COMPLETED|Washout >= 2 Weeks||37||
59759132|NCT00917579|75878487|FG000|NOT COMPLETED|Washout >= 2 Weeks||2||
59759133|NCT00917579|75878488|FG001|NOT COMPLETED|Washout >= 2 Weeks||0||
59759134|NCT00917579|75878487|FG000|STARTED|Period 2: 2nd Intervention||37||
59759135|NCT00917579|75878488|FG001|STARTED|Period 2: 2nd Intervention||37||
59759136|NCT00917579|75878487|FG000|COMPLETED|Period 2: 2nd Intervention||37||
59759137|NCT00917579|75878488|FG001|COMPLETED|Period 2: 2nd Intervention||37||
59759138|NCT00917579|75878487|FG000|NOT COMPLETED|Period 2: 2nd Intervention||0||
59759139|NCT00917579|75878488|FG001|NOT COMPLETED|Period 2: 2nd Intervention||0||
59759140|NCT00915551|75878496|FG000|STARTED|Overall Study||142||
59759141|NCT00915551|75878497|FG001|STARTED|Overall Study||136||
59759142|NCT00915551|75878496|FG000|COMPLETED|Overall Study||142||
59759143|NCT00915551|75878497|FG001|COMPLETED|Overall Study||135||
59759144|NCT00915551|75878496|FG000|NOT COMPLETED|Overall Study||0||
59759145|NCT00915551|75878497|FG001|NOT COMPLETED|Overall Study||1||
59759146|NCT00915473|75878505|FG000|STARTED|Screening||35||
59759147|NCT00915473|75878506|FG001|STARTED|Screening||35||
59759148|NCT00915473|75878505|FG000|COMPLETED|Screening||34||
59759149|NCT00915473|75878506|FG001|COMPLETED|Screening||35||
59759150|NCT00915473|75878505|FG000|NOT COMPLETED|Screening||1||
59759151|NCT00915473|75878506|FG001|NOT COMPLETED|Screening||0||
59759152|NCT00915473|75878505|FG000|STARTED|Injection||34||
59759153|NCT00915473|75878506|FG001|STARTED|Injection||35||
59759154|NCT00915473|75878505|FG000|COMPLETED|Injection||34||
59759155|NCT00915473|75878506|FG001|COMPLETED|Injection||35||
59759156|NCT00915473|75878505|FG000|NOT COMPLETED|Injection||0||
59759157|NCT00915473|75878506|FG001|NOT COMPLETED|Injection||0||
59759158|NCT00915473|75878505|FG000|STARTED|4-week Follow Up||34||
59759159|NCT00915473|75878506|FG001|STARTED|4-week Follow Up||35||
59759160|NCT00915473|75878505|FG000|COMPLETED|4-week Follow Up||33||
59759161|NCT00915473|75878506|FG001|COMPLETED|4-week Follow Up||30||
59759162|NCT00915473|75878505|FG000|NOT COMPLETED|4-week Follow Up||1||
60025125|NCT02212197|76141001|FG000|COMPLETED|Overall Study||18||
60025126|NCT02212197|76141002|FG001|COMPLETED|Overall Study||15||
60025127|NCT02212197|76141003|FG002|COMPLETED|Overall Study||17||
60025128|NCT02212197|76141001|FG000|NOT COMPLETED|Overall Study||1||
60025129|NCT02212197|76141002|FG001|NOT COMPLETED|Overall Study||0||
60025130|NCT02212197|76141003|FG002|NOT COMPLETED|Overall Study||0||
60025131|NCT02193165|76141014|FG000|STARTED|4 Week Product Use||40||
60025132|NCT02193165|76141015|FG001|STARTED|4 Week Product Use||40||
60025133|NCT02193165|76141016|FG002|STARTED|4 Week Product Use||40||
60025134|NCT02193165|76141014|FG000|COMPLETED|4 Week Product Use|1 subject failed to keep appointments and didn't return to clinical site|39||
60025135|NCT02193165|76141015|FG001|COMPLETED|4 Week Product Use|1 subject failed to keep appointments and didn't return to clinical site|39||
60025136|NCT02193165|76141016|FG002|COMPLETED|4 Week Product Use|1 subject failed to keep appointments and didn't return to clinical site|39||
60025137|NCT02193165|76141014|FG000|NOT COMPLETED|4 Week Product Use||1||
60025138|NCT02193165|76141015|FG001|NOT COMPLETED|4 Week Product Use||1||
60025139|NCT02193165|76141016|FG002|NOT COMPLETED|4 Week Product Use||1||
60025140|NCT02193165|76141014|FG000|STARTED|6 Week Product Use||39||
60025141|NCT02193165|76141015|FG001|STARTED|6 Week Product Use||39||
60025142|NCT02193165|76141016|FG002|STARTED|6 Week Product Use||39||
60025143|NCT02193165|76141014|FG000|COMPLETED|6 Week Product Use||39||
60025144|NCT02193165|76141015|FG001|COMPLETED|6 Week Product Use|1 subject failed to keep appointment time and didn't return to clinical site.|38||
60025145|NCT02193165|76141016|FG002|COMPLETED|6 Week Product Use||39||
60025146|NCT02193165|76141014|FG000|NOT COMPLETED|6 Week Product Use||0||
60025147|NCT02193165|76141015|FG001|NOT COMPLETED|6 Week Product Use||1||
60025148|NCT02193165|76141016|FG002|NOT COMPLETED|6 Week Product Use||0||
60025149|NCT01617460|76141024|FG000|STARTED|Overall Study||86||
60025150|NCT01617460|76141024|FG000|COMPLETED|Overall Study||46||
60025151|NCT01617460|76141024|FG000|NOT COMPLETED|Overall Study||40||
60025152|NCT01890148|76141028|FG000|STARTED|Overall Study||5||
60025153|NCT01890148|76141028|FG000|COMPLETED|Overall Study||4||
60025154|NCT01890148|76141028|FG000|NOT COMPLETED|Overall Study||1||
60025155|NCT01889602|76141035|FG000|STARTED|First Intervention||20||
60025156|NCT01889602|76141036|FG001|STARTED|First Intervention||20||
60025157|NCT01889602|76141037|FG002|STARTED|First Intervention||20||
60025158|NCT01889602|76141035|FG000|COMPLETED|First Intervention||19||
59507371|NCT02406573|75600615|FG000|NOT COMPLETED|Overall Study||0||
59507372|NCT02071173|75600619|FG000|STARTED|Overall Study||2244||
59507373|NCT02071173|75600619|FG000|Implanted/Attempted With a Study Device|Overall Study||2200|2045 with ACUITY X4 and RELIANCE 4-FRONT, 110 with ACUITY X4 only, 45 with RELIANCE 4-FRONT only|
59519012|NCT03587428|75612873|FG003|NOT COMPLETED|Period 2||0||
59519013|NCT03587428|75612874|FG004|NOT COMPLETED|Period 2||0||
60025159|NCT01889602|76141036|FG001|COMPLETED|First Intervention||17||
60025160|NCT01889602|76141037|FG002|COMPLETED|First Intervention||18||
60025161|NCT01889602|76141035|FG000|NOT COMPLETED|First Intervention||1||
60025162|NCT01889602|76141036|FG001|NOT COMPLETED|First Intervention||3||
60025163|NCT01889602|76141037|FG002|NOT COMPLETED|First Intervention||2||
60025164|NCT01889602|76141035|FG000|STARTED|First Washout Period of at Least 2 Weeks||19||
60025165|NCT01889602|76141036|FG001|STARTED|First Washout Period of at Least 2 Weeks||17||
60025166|NCT01889602|76141037|FG002|STARTED|First Washout Period of at Least 2 Weeks||18||
60025167|NCT01889602|76141035|FG000|COMPLETED|First Washout Period of at Least 2 Weeks||19||
60025168|NCT01889602|76141036|FG001|COMPLETED|First Washout Period of at Least 2 Weeks||17||
60025169|NCT01889602|76141037|FG002|COMPLETED|First Washout Period of at Least 2 Weeks||18||
60025170|NCT01889602|76141035|FG000|NOT COMPLETED|First Washout Period of at Least 2 Weeks||0||
60025171|NCT01889602|76141036|FG001|NOT COMPLETED|First Washout Period of at Least 2 Weeks||0||
60025172|NCT01889602|76141037|FG002|NOT COMPLETED|First Washout Period of at Least 2 Weeks||0||
60025173|NCT01889602|76141035|FG000|STARTED|Second Intervention||19||
60025174|NCT01889602|76141036|FG001|STARTED|Second Intervention||17||
60025175|NCT01889602|76141037|FG002|STARTED|Second Intervention||18||
60025176|NCT01889602|76141035|FG000|COMPLETED|Second Intervention||18||
60025177|NCT01889602|76141036|FG001|COMPLETED|Second Intervention||17||
60025178|NCT01889602|76141037|FG002|COMPLETED|Second Intervention||16||
60025179|NCT01889602|76141035|FG000|NOT COMPLETED|Second Intervention||1||
60025180|NCT01889602|76141036|FG001|NOT COMPLETED|Second Intervention||0||
60025181|NCT01889602|76141037|FG002|NOT COMPLETED|Second Intervention||2||
60025182|NCT01889602|76141035|FG000|STARTED|Second Washout Period of at Least 2 Week||18||
60025183|NCT01889602|76141036|FG001|STARTED|Second Washout Period of at Least 2 Week||17||
60025184|NCT01889602|76141037|FG002|STARTED|Second Washout Period of at Least 2 Week||16||
60025185|NCT01889602|76141035|FG000|COMPLETED|Second Washout Period of at Least 2 Week||18||
60025186|NCT01889602|76141036|FG001|COMPLETED|Second Washout Period of at Least 2 Week||17||
60025187|NCT01889602|76141037|FG002|COMPLETED|Second Washout Period of at Least 2 Week||16||
60025188|NCT01889602|76141035|FG000|NOT COMPLETED|Second Washout Period of at Least 2 Week||0||
60025189|NCT01889602|76141036|FG001|NOT COMPLETED|Second Washout Period of at Least 2 Week||0||
60025190|NCT01889602|76141037|FG002|NOT COMPLETED|Second Washout Period of at Least 2 Week||0||
60025191|NCT01889602|76141035|FG000|STARTED|Third Intervention||18||
60025192|NCT01889602|76141036|FG001|STARTED|Third Intervention||17||
60025193|NCT01889602|76141037|FG002|STARTED|Third Intervention||16||
60025194|NCT01889602|76141035|FG000|COMPLETED|Third Intervention||15||
60025195|NCT01889602|76141036|FG001|COMPLETED|Third Intervention||15||
60025196|NCT01889602|76141037|FG002|COMPLETED|Third Intervention||16||
60025197|NCT01889602|76141035|FG000|NOT COMPLETED|Third Intervention||3||
60025198|NCT01889602|76141036|FG001|NOT COMPLETED|Third Intervention||2||
60025199|NCT01889602|76141037|FG002|NOT COMPLETED|Third Intervention||0||
60025200|NCT01889602|76141035|FG000|STARTED|Third Washout Period of at Least 2 Weeks||15||
60025201|NCT01889602|76141036|FG001|STARTED|Third Washout Period of at Least 2 Weeks||15||
60025202|NCT01889602|76141037|FG002|STARTED|Third Washout Period of at Least 2 Weeks||16||
60025203|NCT01889602|76141035|FG000|COMPLETED|Third Washout Period of at Least 2 Weeks||15||
60025204|NCT01889602|76141036|FG001|COMPLETED|Third Washout Period of at Least 2 Weeks||15||
60025205|NCT01889602|76141037|FG002|COMPLETED|Third Washout Period of at Least 2 Weeks||16||
60025206|NCT01889602|76141035|FG000|NOT COMPLETED|Third Washout Period of at Least 2 Weeks||0||
60025207|NCT01889602|76141036|FG001|NOT COMPLETED|Third Washout Period of at Least 2 Weeks||0||
60025208|NCT01889602|76141037|FG002|NOT COMPLETED|Third Washout Period of at Least 2 Weeks||0||
60025209|NCT01935700|76141055|FG000|STARTED|Overall Study||14||
60025210|NCT01935700|76141056|FG001|STARTED|Overall Study||86||
60025211|NCT01935700|76141055|FG000|COMPLETED|Overall Study||9|The participant received more than 8 courses of colchicine management.|
60025212|NCT01935700|76141056|FG001|COMPLETED|Overall Study||86|The participant received more than 8 courses of colchicine management.|
60025213|NCT01935700|76141055|FG000|NOT COMPLETED|Overall Study||5||
60025214|NCT01935700|76141056|FG001|NOT COMPLETED|Overall Study||0||
60025215|NCT01618162|76141066|FG000|STARTED|Overall Study||289||
60025216|NCT01618162|76141067|FG001|STARTED|Overall Study||146||
60025217|NCT01618162|76141066|FG000|Exposed|Overall Study||288||
60025218|NCT01618162|76141067|FG001|Exposed|Overall Study||146||
60025219|NCT01618162|76141066|FG000|COMPLETED|Overall Study||251||
60025220|NCT01618162|76141067|FG001|COMPLETED|Overall Study||111||
60025221|NCT01618162|76141066|FG000|NOT COMPLETED|Overall Study||38||
60025222|NCT01618162|76141067|FG001|NOT COMPLETED|Overall Study||35||
60025223|NCT02193087|76141077|FG000|STARTED|Overall Study||199||
60025224|NCT02193087|76141078|FG001|STARTED|Overall Study||100||
60025225|NCT02193087|76141079|FG002|STARTED|Overall Study||100||
60025226|NCT02193087|76141080|FG003|STARTED|Overall Study||603||
60025227|NCT02193087|76141077|FG000|Received Vaccination|Overall Study||197||
60025228|NCT02193087|76141078|FG001|Received Vaccination|Overall Study||97||
60025229|NCT02193087|76141079|FG002|Received Vaccination|Overall Study||100||
60025230|NCT02193087|76141080|FG003|Received Vaccination|Overall Study||602||
60025231|NCT02193087|76141077|FG000|COMPLETED|Overall Study||162||
60025232|NCT02193087|76141078|FG001|COMPLETED|Overall Study||86||
60025233|NCT02193087|76141079|FG002|COMPLETED|Overall Study||93||
60025234|NCT02193087|76141080|FG003|COMPLETED|Overall Study||524||
60025235|NCT02193087|76141077|FG000|NOT COMPLETED|Overall Study||37||
60025236|NCT02193087|76141078|FG001|NOT COMPLETED|Overall Study||14||
60025237|NCT02193087|76141079|FG002|NOT COMPLETED|Overall Study||7||
60025238|NCT02193087|76141080|FG003|NOT COMPLETED|Overall Study||79||
60025239|NCT01617070|76141097|FG000|STARTED|LNAA (4 Weeks)||10||
60025240|NCT01617070|76141097|FG000|COMPLETED|LNAA (4 Weeks)||10||
60025241|NCT01617070|76141097|FG000|NOT COMPLETED|LNAA (4 Weeks)||0||
60025242|NCT01617070|76141097|FG000|STARTED|Washout (4 Weeks)||10||
60025243|NCT01617070|76141097|FG000|COMPLETED|Washout (4 Weeks)||10||
60025244|NCT01617070|76141097|FG000|NOT COMPLETED|Washout (4 Weeks)||0||
59611748|NCT01731990|75722735|FG001|COMPLETED|Overall Study||12||
60025245|NCT01617070|76141097|FG000|STARTED|BH4 Therapy (4 Weeks)||10||
60025246|NCT01617070|76141097|FG000|COMPLETED|BH4 Therapy (4 Weeks)||10||
60025247|NCT01617070|76141097|FG000|NOT COMPLETED|BH4 Therapy (4 Weeks)||0||
60025248|NCT01617070|76141097|FG000|STARTED|BH4 and LNAA (4 Weeks)||10||
60025249|NCT01617070|76141097|FG000|COMPLETED|BH4 and LNAA (4 Weeks)||9||
59611749|NCT01731990|75722734|FG000|NOT COMPLETED|Overall Study||4||
60025250|NCT01617070|76141097|FG000|NOT COMPLETED|BH4 and LNAA (4 Weeks)||1||
60025251|NCT02341417|76141110|FG000|STARTED|Overall Study||13||
60025252|NCT02341417|76141111|FG001|STARTED|Overall Study||14||
60025253|NCT02341417|76141112|FG002|STARTED|Overall Study||1||
60025254|NCT02341417|76141110|FG000|COMPLETED|Overall Study||11||
59611750|NCT01731990|75722735|FG001|NOT COMPLETED|Overall Study||8||
59611751|NCT01708902|75722748|FG000|STARTED|Overall Study||147||
59611752|NCT01708902|75722749|FG001|STARTED|Overall Study||145||
60025255|NCT02341417|76141111|FG001|COMPLETED|Overall Study||12||
60025256|NCT02341417|76141112|FG002|COMPLETED|Overall Study||0||
60025257|NCT02341417|76141110|FG000|NOT COMPLETED|Overall Study||2||
60025258|NCT02341417|76141111|FG001|NOT COMPLETED|Overall Study||2||
60025259|NCT02341417|76141112|FG002|NOT COMPLETED|Overall Study||1||
59611753|NCT01708902|75722750|FG002|STARTED|Overall Study||144||
60025260|NCT01888900|76141123|FG000|STARTED|Overall Study||22||
60025261|NCT01888900|76141124|FG001|STARTED|Overall Study||13||
60025262|NCT01888900|76141123|FG000|COMPLETED|Overall Study||22|2 failures were switched from DUAL treatment to QUAD treatment.|
60025263|NCT01888900|76141124|FG001|COMPLETED|Overall Study||11|2 failures were switched from DUAL treatment to QUAD treatment.|
60025264|NCT01888900|76141123|FG000|NOT COMPLETED|Overall Study||0||
60025265|NCT01888900|76141124|FG001|NOT COMPLETED|Overall Study||2||
60025266|NCT02340949|76141134|FG000|STARTED|Overall Study||115||
60025267|NCT02340949|76141135|FG001|STARTED|Overall Study||65||
60025268|NCT02340949|76141134|FG000|COMPLETED|Overall Study||99|Completed the treatment as per protocol|
60025269|NCT02340949|76141135|FG001|COMPLETED|Overall Study||61|Completed the treatment as per protocol|
60025270|NCT02340949|76141134|FG000|NOT COMPLETED|Overall Study||16||
60025271|NCT02340949|76141135|FG001|NOT COMPLETED|Overall Study||4||
60025272|NCT01646203|76141144|FG000|STARTED|Overall Study||2||
60025273|NCT01646203|76141145|FG001|STARTED|Overall Study||5||
60025274|NCT01646203|76141146|FG002|STARTED|Overall Study||7||
60025275|NCT01646203|76141144|FG000|Received at Least One Dose of Study Drug|Overall Study||2||
60025276|NCT01646203|76141145|FG001|Received at Least One Dose of Study Drug|Overall Study||5||
60025277|NCT01646203|76141146|FG002|Received at Least One Dose of Study Drug|Overall Study||7||
60025278|NCT01646203|76141144|FG000|COMPLETED|Overall Study||0||
60025279|NCT01646203|76141145|FG001|COMPLETED|Overall Study||3||
60025280|NCT01646203|76141146|FG002|COMPLETED|Overall Study||6||
60025281|NCT01646203|76141144|FG000|NOT COMPLETED|Overall Study||2||
60025282|NCT01646203|76141145|FG001|NOT COMPLETED|Overall Study||2||
60025283|NCT01646203|76141146|FG002|NOT COMPLETED|Overall Study||1||
60025284|NCT02375347|76141159|FG000|STARTED|Overall Study||13||
60025285|NCT02375347|76141159|FG000|COMPLETED|Overall Study||12||
60025286|NCT02375347|76141159|FG000|NOT COMPLETED|Overall Study||1||
60025287|NCT02374957|76141165|FG000|STARTED|Overall Study||11||
60025288|NCT02374957|76141166|FG001|STARTED|Overall Study||9||
60025289|NCT02374957|76141165|FG000|COMPLETED|Overall Study||10||
60025290|NCT02374957|76141166|FG001|COMPLETED|Overall Study||9||
60025291|NCT02374957|76141165|FG000|NOT COMPLETED|Overall Study||1||
60025292|NCT02374957|76141166|FG001|NOT COMPLETED|Overall Study||0||
60025293|NCT02374255|76141176|FG000|STARTED|Overall Study||155||
60025294|NCT02374255|76141177|FG001|STARTED|Overall Study||110||
60025295|NCT02374255|76141178|FG002|STARTED|Overall Study||11||
60025296|NCT02374255|76141179|FG003|STARTED|Overall Study||11||
60025297|NCT02374255|76141176|FG000|COMPLETED|Overall Study||153||
59611754|NCT01708902|75722751|FG003|STARTED|Overall Study||147||
59611755|NCT01708902|75722752|FG004|STARTED|Overall Study||147||
59611756|NCT01708902|75722753|FG005|STARTED|Overall Study||71||
60025298|NCT02374255|76141177|FG001|COMPLETED|Overall Study||110||
60025299|NCT02374255|76141178|FG002|COMPLETED|Overall Study||11||
60025300|NCT02374255|76141179|FG003|COMPLETED|Overall Study||11||
60025301|NCT02374255|76141176|FG000|NOT COMPLETED|Overall Study||2||
60025302|NCT02374255|76141177|FG001|NOT COMPLETED|Overall Study||0||
60025303|NCT02374255|76141178|FG002|NOT COMPLETED|Overall Study||0||
60025304|NCT02374255|76141179|FG003|NOT COMPLETED|Overall Study||0||
60025305|NCT02308033|76141197|FG000|STARTED|Overall Study||102||
60025306|NCT02308033|76141198|FG001|STARTED|Overall Study||102||
60025307|NCT02308033|76141197|FG000|COMPLETED|Overall Study||76||
60025308|NCT02308033|76141198|FG001|COMPLETED|Overall Study||83||
60025309|NCT02308033|76141197|FG000|NOT COMPLETED|Overall Study||26||
60025310|NCT02308033|76141198|FG001|NOT COMPLETED|Overall Study||19||
60025311|NCT02339155|76141206|FG000|STARTED|Overall Study||287|This includes Intent-to-treat population (ITT)|
60025312|NCT02339155|76141207|FG001|STARTED|Overall Study||286|This includes Intent-to-treat population (ITT)|
59611757|NCT01708902|75722754|FG006|STARTED|Overall Study||72||
59611758|NCT01708902|75722748|FG000|COMPLETED|Overall Study||130||
60025313|NCT02339155|76141206|FG000|Received Study Treatment|Overall Study||286||
60025314|NCT02339155|76141207|FG001|Received Study Treatment|Overall Study||280||
60025315|NCT02339155|76141206|FG000|COMPLETED|Overall Study||272||
60025316|NCT02339155|76141207|FG001|COMPLETED|Overall Study||265||
60025317|NCT02339155|76141206|FG000|NOT COMPLETED|Overall Study||15||
60025318|NCT02339155|76141207|FG001|NOT COMPLETED|Overall Study||21||
59611759|NCT01708902|75722749|FG001|COMPLETED|Overall Study||137||
59611760|NCT01708902|75722750|FG002|COMPLETED|Overall Study||127||
59611761|NCT01708902|75722751|FG003|COMPLETED|Overall Study||137||
59611762|NCT01708902|75722752|FG004|COMPLETED|Overall Study||131||
59611763|NCT01708902|75722753|FG005|COMPLETED|Overall Study||64||
59611764|NCT01708902|75722754|FG006|COMPLETED|Overall Study||65||
60025319|NCT02211261|76141226|FG000|STARTED|Overall Study||9||
60025320|NCT02211261|76141227|FG001|STARTED|Overall Study||6||
60025321|NCT02211261|76141228|FG002|STARTED|Overall Study||6||
60025322|NCT02211261|76141229|FG003|STARTED|Overall Study||6||
60025323|NCT02211261|76141230|FG004|STARTED|Overall Study||9||
60025324|NCT02211261|76141231|FG005|STARTED|Overall Study||2||
60025325|NCT02211261|76141232|FG006|STARTED|Overall Study||6||
60025326|NCT02211261|76141233|FG007|STARTED|Overall Study||8||
60025327|NCT02211261|76141234|FG008|STARTED|Overall Study||8||
60025328|NCT02211261|76141235|FG009|STARTED|Overall Study||16||
60025329|NCT02211261|76141236|FG010|STARTED|Overall Study||8||
60025330|NCT02211261|76141226|FG000|COMPLETED|Overall Study||9||
60025331|NCT02211261|76141227|FG001|COMPLETED|Overall Study||6||
60025332|NCT02211261|76141228|FG002|COMPLETED|Overall Study||5||
60025333|NCT02211261|76141229|FG003|COMPLETED|Overall Study||6||
60025334|NCT02211261|76141230|FG004|COMPLETED|Overall Study||7||
60025335|NCT02211261|76141231|FG005|COMPLETED|Overall Study||1||
60025336|NCT02211261|76141232|FG006|COMPLETED|Overall Study||6||
60025337|NCT02211261|76141233|FG007|COMPLETED|Overall Study||7||
60025338|NCT02211261|76141234|FG008|COMPLETED|Overall Study||8||
60025339|NCT02211261|76141235|FG009|COMPLETED|Overall Study||14||
60025340|NCT02211261|76141236|FG010|COMPLETED|Overall Study||8||
60025341|NCT02211261|76141226|FG000|NOT COMPLETED|Overall Study||0||
60025342|NCT02211261|76141227|FG001|NOT COMPLETED|Overall Study||0||
60025343|NCT02211261|76141228|FG002|NOT COMPLETED|Overall Study||1||
60025344|NCT02211261|76141229|FG003|NOT COMPLETED|Overall Study||0||
60025345|NCT02211261|76141230|FG004|NOT COMPLETED|Overall Study||2||
60025346|NCT02211261|76141231|FG005|NOT COMPLETED|Overall Study||1||
60025347|NCT02211261|76141232|FG006|NOT COMPLETED|Overall Study||0||
60025348|NCT02211261|76141233|FG007|NOT COMPLETED|Overall Study||1||
60025349|NCT02211261|76141234|FG008|NOT COMPLETED|Overall Study||0||
60025350|NCT02211261|76141235|FG009|NOT COMPLETED|Overall Study||2||
60025351|NCT02211261|76141236|FG010|NOT COMPLETED|Overall Study||0||
60025352|NCT02170077|76141272|FG000|STARTED|Overall Study||50||
60025353|NCT02170077|76141273|FG001|STARTED|Overall Study||47||
60025354|NCT02170077|76141274|FG002|STARTED|Overall Study||47||
60025355|NCT02170077|76141272|FG000|Intent to Treat (ITT) Population|Overall Study||50||
60025356|NCT02170077|76141273|FG001|Intent to Treat (ITT) Population|Overall Study||46||
60025357|NCT02170077|76141274|FG002|Intent to Treat (ITT) Population|Overall Study||47||
60025358|NCT02170077|76141272|FG000|COMPLETED|Overall Study||41||
60025359|NCT02170077|76141273|FG001|COMPLETED|Overall Study||34||
60025360|NCT02170077|76141274|FG002|COMPLETED|Overall Study||35||
60025361|NCT02170077|76141272|FG000|NOT COMPLETED|Overall Study||9||
60025362|NCT02170077|76141273|FG001|NOT COMPLETED|Overall Study||13||
60025363|NCT02170077|76141274|FG002|NOT COMPLETED|Overall Study||12||
60025364|NCT02210091|76141284|FG000|STARTED|Overall Study||32||
60025365|NCT02210091|76141285|FG001|STARTED|Overall Study||34||
60025366|NCT02210091|76141284|FG000|COMPLETED|Overall Study||32||
60025367|NCT02210091|76141285|FG001|COMPLETED|Overall Study||32||
60025368|NCT02210091|76141284|FG000|NOT COMPLETED|Overall Study||0||
60025369|NCT02210091|76141285|FG001|NOT COMPLETED|Overall Study||2||
60025370|NCT02338999|76141309|FG000|STARTED|First Intervention||39||
60025371|NCT02338999|76141310|FG001|STARTED|First Intervention||41||
60025372|NCT02338999|76141309|FG000|COMPLETED|First Intervention||36||
60025373|NCT02338999|76141310|FG001|COMPLETED|First Intervention||40||
60025374|NCT02338999|76141309|FG000|NOT COMPLETED|First Intervention||3||
60025375|NCT02338999|76141310|FG001|NOT COMPLETED|First Intervention||1||
60025376|NCT02338999|76141309|FG000|STARTED|Washout Period||36||
60025377|NCT02338999|76141310|FG001|STARTED|Washout Period||40||
60025378|NCT02338999|76141309|FG000|COMPLETED|Washout Period||36||
60025379|NCT02338999|76141310|FG001|COMPLETED|Washout Period||38||
60025380|NCT02338999|76141309|FG000|NOT COMPLETED|Washout Period||0||
60025381|NCT02338999|76141310|FG001|NOT COMPLETED|Washout Period||2||
60025382|NCT02338999|76141309|FG000|STARTED|Second Intervention||36||
60025383|NCT02338999|76141310|FG001|STARTED|Second Intervention||38||
60025384|NCT02338999|76141309|FG000|COMPLETED|Second Intervention||36||
60025385|NCT02338999|76141310|FG001|COMPLETED|Second Intervention||36||
60025386|NCT02338999|76141309|FG000|NOT COMPLETED|Second Intervention||0||
60025387|NCT02338999|76141310|FG001|NOT COMPLETED|Second Intervention||2||
60025388|NCT02169219|76141316|FG000|STARTED|Overall Study||20||
60025389|NCT02169219|76141316|FG000|COMPLETED|Overall Study||14||
60025390|NCT02169219|76141316|FG000|NOT COMPLETED|Overall Study||6||
60025391|NCT02191605|76141330|FG000|STARTED|Overall Study||15||
60025392|NCT02191605|76141331|FG001|STARTED|Overall Study||15||
60025393|NCT02191605|76141332|FG002|STARTED|Overall Study||15||
60025394|NCT02191605|76141333|FG003|STARTED|Overall Study||8||
59519014|NCT03587428|75612875|FG005|NOT COMPLETED|Period 2||0||
60025395|NCT02191605|76141334|FG004|STARTED|Overall Study||7||
60025396|NCT02191605|76141330|FG000|Completed Intervention Portion|Overall Study||15||
60025397|NCT02191605|76141331|FG001|Completed Intervention Portion|Overall Study||15||
60025398|NCT02191605|76141332|FG002|Completed Intervention Portion|Overall Study||15||
60025399|NCT02191605|76141333|FG003|Completed Intervention Portion|Overall Study||8||
60025400|NCT02191605|76141334|FG004|Completed Intervention Portion|Overall Study||7||
59507374|NCT02071173|75600619|FG000|RELIANCE 4-FRONT Endpoint Population|Overall Study|1507 with active fixation 4-FRONT lead, 37 with passive fixation 4-FRONT lead|1544|The first 1544 subjects implanted/attempted with 4-FRONT lead eligible for 4-FRONT endpoints|
59915177|NCT02809131|76036081|FG001|STARTED|Overall Study||505||
59915178|NCT02809131|76036080|FG000|COMPLETED|Overall Study||445||
59915179|NCT02809131|76036081|FG001|COMPLETED|Overall Study||445||
59915180|NCT02809131|76036080|FG000|NOT COMPLETED|Overall Study||60||
59915181|NCT02809131|76036081|FG001|NOT COMPLETED|Overall Study||60||
59915182|NCT04069715|76036089|FG000|STARTED|Overall Study||47||
59915183|NCT04069715|76036090|FG001|STARTED|Overall Study||48||
59915184|NCT04069715|76036089|FG000|COMPLETED|Overall Study||42||
59915185|NCT04069715|76036090|FG001|COMPLETED|Overall Study||43||
59915186|NCT04069715|76036089|FG000|NOT COMPLETED|Overall Study||5||
59915187|NCT04069715|76036090|FG001|NOT COMPLETED|Overall Study||5||
59915188|NCT03681119|76036098|FG000|STARTED|Overall Study||72||
59915189|NCT03681119|76036099|FG001|STARTED|Overall Study||11||
59915190|NCT03681119|76036098|FG000|COMPLETED|Overall Study||66||
59915191|NCT03681119|76036099|FG001|COMPLETED|Overall Study||11||
59915192|NCT03681119|76036098|FG000|NOT COMPLETED|Overall Study||6||
59915193|NCT03681119|76036099|FG001|NOT COMPLETED|Overall Study||0||
59915194|NCT03111108|76036105|FG000|STARTED|Overall Study||53||
59915195|NCT03111108|76036106|FG001|STARTED|Overall Study||64||
59915196|NCT03111108|76036105|FG000|COMPLETED|Overall Study||52||
59915197|NCT03111108|76036106|FG001|COMPLETED|Overall Study||63||
59915198|NCT03111108|76036105|FG000|NOT COMPLETED|Overall Study||1||
59915199|NCT03111108|76036106|FG001|NOT COMPLETED|Overall Study||1||
59915200|NCT03677375|76036112|FG000|STARTED|Overall Study||93||
59915201|NCT03677375|76036112|FG000|COMPLETED|Overall Study||81||
59915202|NCT03677375|76036112|FG000|NOT COMPLETED|Overall Study||12||
59915203|NCT00702520|76036118|FG000|STARTED|Base Study P05788 - Assigned Treatment||25||
59915204|NCT00702520|76036119|FG001|STARTED|Base Study P05788 - Assigned Treatment||25||
59915205|NCT00702520|76036120|FG002|STARTED|Base Study P05788 - Assigned Treatment||0||
59915206|NCT00702520|76036121|FG003|STARTED|Base Study P05788 - Assigned Treatment||0||
59915207|NCT00702520|76036118|FG000|Treated With Corifollitropin Alpha|Base Study P05788 - Assigned Treatment||25||
59915208|NCT00702520|76036119|FG001|Treated With Corifollitropin Alpha|Base Study P05788 - Assigned Treatment||24||
59915209|NCT00702520|76036120|FG002|Treated With Corifollitropin Alpha|Base Study P05788 - Assigned Treatment||0||
59915210|NCT00702520|76036121|FG003|Treated With Corifollitropin Alpha|Base Study P05788 - Assigned Treatment||0||
59915211|NCT00702520|76036118|FG000|Treated With hCG and Had Oocyte Pick-up|Base Study P05788 - Assigned Treatment||25||
59915212|NCT00702520|76036119|FG001|Treated With hCG and Had Oocyte Pick-up|Base Study P05788 - Assigned Treatment||24||
59915213|NCT00702520|76036120|FG002|Treated With hCG and Had Oocyte Pick-up|Base Study P05788 - Assigned Treatment||0||
59915214|NCT00702520|76036121|FG003|Treated With hCG and Had Oocyte Pick-up|Base Study P05788 - Assigned Treatment||0||
59915215|NCT00702520|76036118|FG000|COMPLETED|Base Study P05788 - Assigned Treatment||25||
59915216|NCT00702520|76036119|FG001|COMPLETED|Base Study P05788 - Assigned Treatment||24||
59915217|NCT00702520|76036120|FG002|COMPLETED|Base Study P05788 - Assigned Treatment||0||
59915218|NCT00702520|76036121|FG003|COMPLETED|Base Study P05788 - Assigned Treatment||0||
59915219|NCT00702520|76036118|FG000|NOT COMPLETED|Base Study P05788 - Assigned Treatment||0||
59915220|NCT00702520|76036119|FG001|NOT COMPLETED|Base Study P05788 - Assigned Treatment||1||
59915221|NCT00702520|76036120|FG002|NOT COMPLETED|Base Study P05788 - Assigned Treatment||0||
59915222|NCT00702520|76036121|FG003|NOT COMPLETED|Base Study P05788 - Assigned Treatment||0||
59915223|NCT00702520|76036118|FG000|STARTED|Base Study P05788 - Embryo Transfer||25||
59915224|NCT00702520|76036119|FG001|STARTED|Base Study P05788 - Embryo Transfer||24||
59915225|NCT00702520|76036120|FG002|STARTED|Base Study P05788 - Embryo Transfer||0||
59915226|NCT00702520|76036121|FG003|STARTED|Base Study P05788 - Embryo Transfer||0||
59915227|NCT00702520|76036118|FG000|Embryo Transfer|Base Study P05788 - Embryo Transfer||22||
59915228|NCT00702520|76036119|FG001|Embryo Transfer|Base Study P05788 - Embryo Transfer||18||
59915229|NCT00702520|76036120|FG002|Embryo Transfer|Base Study P05788 - Embryo Transfer||0||
59915230|NCT00702520|76036121|FG003|Embryo Transfer|Base Study P05788 - Embryo Transfer||0||
59915231|NCT00702520|76036118|FG000|COMPLETED|Base Study P05788 - Embryo Transfer||22||
59915232|NCT00702520|76036119|FG001|COMPLETED|Base Study P05788 - Embryo Transfer||18||
59915233|NCT00702520|76036120|FG002|COMPLETED|Base Study P05788 - Embryo Transfer||0||
59915234|NCT00702520|76036121|FG003|COMPLETED|Base Study P05788 - Embryo Transfer||0||
59915235|NCT00702520|76036118|FG000|NOT COMPLETED|Base Study P05788 - Embryo Transfer||3||
60025401|NCT02191605|76141330|FG000|COMPLETED|Overall Study||6|Completed postpartum follow-up|
60025402|NCT02191605|76141331|FG001|COMPLETED|Overall Study||11|Completed postpartum follow-up|
60025403|NCT02191605|76141332|FG002|COMPLETED|Overall Study||8|Completed postpartum follow-up|
60025404|NCT02191605|76141333|FG003|COMPLETED|Overall Study||5|Completed postpartum follow-up|
60025405|NCT02191605|76141334|FG004|COMPLETED|Overall Study||3|Completed postpartum follow-up|
60025406|NCT02191605|76141330|FG000|NOT COMPLETED|Overall Study||9||
60025407|NCT02191605|76141331|FG001|NOT COMPLETED|Overall Study||4||
60025408|NCT02191605|76141332|FG002|NOT COMPLETED|Overall Study||7||
60025409|NCT02191605|76141333|FG003|NOT COMPLETED|Overall Study||3||
60025410|NCT02191605|76141334|FG004|NOT COMPLETED|Overall Study||4||
60025411|NCT02191137|76141346|FG000|STARTED|Treatment||75||
60025412|NCT02191137|76141346|FG000|COMPLETED|Treatment||65||
60025413|NCT02191137|76141346|FG000|NOT COMPLETED|Treatment||10||
60025414|NCT02191137|76141346|FG000|STARTED|Follow-up||65||
60025415|NCT02191137|76141346|FG000|COMPLETED|Follow-up||60||
60025416|NCT02191137|76141346|FG000|NOT COMPLETED|Follow-up||5||
60025417|NCT02168439|76141352|FG000|STARTED|Overall Study||20||
60025418|NCT02168439|76141353|FG001|STARTED|Overall Study||20||
60025419|NCT02168439|76141352|FG000|COMPLETED|Overall Study||20||
60025420|NCT02168439|76141353|FG001|COMPLETED|Overall Study||18||
60025421|NCT02168439|76141352|FG000|NOT COMPLETED|Overall Study||0||
60025422|NCT02168439|76141353|FG001|NOT COMPLETED|Overall Study||2||
60025423|NCT02190591|76141361|FG000|STARTED|Overall Study||102||
60025424|NCT02190591|76141362|FG001|STARTED|Overall Study||102||
60025425|NCT02190591|76141361|FG000|COMPLETED|Overall Study||100||
60025426|NCT02190591|76141362|FG001|COMPLETED|Overall Study||91||
60025427|NCT02190591|76141361|FG000|NOT COMPLETED|Overall Study||2||
60025428|NCT02190591|76141362|FG001|NOT COMPLETED|Overall Study||11||
60025429|NCT02190435|76141370|FG000|STARTED|Overall Study||41||
60025430|NCT02190435|76141371|FG001|STARTED|Overall Study||24||
60025431|NCT02190435|76141370|FG000|COMPLETED|Overall Study||26||
60025432|NCT02190435|76141371|FG001|COMPLETED|Overall Study||24||
60025433|NCT02190435|76141370|FG000|NOT COMPLETED|Overall Study||15||
60025434|NCT02190435|76141371|FG001|NOT COMPLETED|Overall Study||0||
60025435|NCT02338843|76141379|FG000|STARTED|Overall Study||163|Discrepancy between enrollment and started numbers due to 23 pts who enrolled but were not treated.|
60025436|NCT02338843|76141380|FG001|STARTED|Overall Study||158|Discrepancy between enrollment and started numbers due to 23 pts who enrolled but were not treated.|
60025437|NCT02338843|76141379|FG000|COMPLETED|Overall Study||119||
60025438|NCT02338843|76141380|FG001|COMPLETED|Overall Study||100||
60025439|NCT02338843|76141379|FG000|NOT COMPLETED|Overall Study||44||
60025440|NCT02338843|76141380|FG001|NOT COMPLETED|Overall Study||58||
60025441|NCT02190279|76141389|FG000|STARTED|Overall Study||16||
60025442|NCT02190279|76141390|FG001|STARTED|Overall Study||69||
60025443|NCT02190279|76141391|FG002|STARTED|Overall Study||31||
60025444|NCT02190279|76141389|FG000|COMPLETED|Overall Study||13||
60025445|NCT02190279|76141390|FG001|COMPLETED|Overall Study||69||
60025446|NCT02190279|76141391|FG002|COMPLETED|Overall Study||28||
60025447|NCT02190279|76141389|FG000|NOT COMPLETED|Overall Study||3||
60025448|NCT02190279|76141390|FG001|NOT COMPLETED|Overall Study||0||
60025449|NCT02190279|76141391|FG002|NOT COMPLETED|Overall Study||3||
60025450|NCT02135445|76141403|FG000|STARTED|Overall Study||65||
60025451|NCT02135445|76141404|FG001|STARTED|Overall Study||38||
60025452|NCT02135445|76141403|FG000|COMPLETED|Overall Study||63||
60025453|NCT02135445|76141404|FG001|COMPLETED|Overall Study||38||
60025454|NCT02135445|76141403|FG000|NOT COMPLETED|Overall Study||2||
60025455|NCT02135445|76141404|FG001|NOT COMPLETED|Overall Study||0||
60025456|NCT02374099|76141412|FG000|STARTED|Overall Study||48||
60025457|NCT02374099|76141413|FG001|STARTED|Overall Study||49||
60025458|NCT02374099|76141412|FG000|Participants Treated|Overall Study|2 participants randomized, but not treated|46||
60025459|NCT02374099|76141413|FG001|Participants Treated|Overall Study|1 participant randomized, but not treated|48||
60025460|NCT02374099|76141412|FG000|COMPLETED|Overall Study||0||
60025461|NCT02374099|76141413|FG001|COMPLETED|Overall Study||0||
60025462|NCT02374099|76141412|FG000|NOT COMPLETED|Overall Study||48||
60025463|NCT02374099|76141413|FG001|NOT COMPLETED|Overall Study||49||
60025464|NCT02134977|76141419|FG000|STARTED|Overall Study||2816||
60025465|NCT02134977|76141419|FG000|COMPLETED|Overall Study||2714||
60025466|NCT02134977|76141419|FG000|NOT COMPLETED|Overall Study||102||
60025467|NCT02374021|76141425|FG000|STARTED|Overall Study||80||
60025468|NCT02374021|76141426|FG001|STARTED|Overall Study||79||
60025469|NCT02374021|76141425|FG000|COMPLETED|Overall Study||57||
60025470|NCT02374021|76141426|FG001|COMPLETED|Overall Study||58||
60025471|NCT02374021|76141425|FG000|NOT COMPLETED|Overall Study||23||
60025472|NCT02374021|76141426|FG001|NOT COMPLETED|Overall Study||21||
60025473|NCT02372383|76141434|FG000|STARTED|First Intervention (1 Day)||10||
60025474|NCT02372383|76141435|FG001|STARTED|First Intervention (1 Day)||11||
60025475|NCT02372383|76141436|FG002|STARTED|First Intervention (1 Day)||10||
60025476|NCT02372383|76141434|FG000|COMPLETED|First Intervention (1 Day)||10||
60025477|NCT02372383|76141435|FG001|COMPLETED|First Intervention (1 Day)||10||
60025478|NCT02372383|76141436|FG002|COMPLETED|First Intervention (1 Day)||10||
60025479|NCT02372383|76141434|FG000|NOT COMPLETED|First Intervention (1 Day)||0||
60025480|NCT02372383|76141435|FG001|NOT COMPLETED|First Intervention (1 Day)||1||
60025481|NCT02372383|76141436|FG002|NOT COMPLETED|First Intervention (1 Day)||0||
60025482|NCT02372383|76141434|FG000|STARTED|Washout (14 Days)||10||
60025483|NCT02372383|76141435|FG001|STARTED|Washout (14 Days)||10||
60025484|NCT02372383|76141436|FG002|STARTED|Washout (14 Days)||10||
60025485|NCT02372383|76141434|FG000|COMPLETED|Washout (14 Days)||10||
60025486|NCT02372383|76141435|FG001|COMPLETED|Washout (14 Days)||10||
60025487|NCT02372383|76141436|FG002|COMPLETED|Washout (14 Days)||10||
60025488|NCT02372383|76141434|FG000|NOT COMPLETED|Washout (14 Days)||0||
60025489|NCT02372383|76141435|FG001|NOT COMPLETED|Washout (14 Days)||0||
60025490|NCT02372383|76141436|FG002|NOT COMPLETED|Washout (14 Days)||0||
60025491|NCT02372383|76141434|FG000|STARTED|Second Intervention (1 Day)||10||
60025492|NCT02372383|76141435|FG001|STARTED|Second Intervention (1 Day)||10||
60025493|NCT02372383|76141436|FG002|STARTED|Second Intervention (1 Day)||10||
60025494|NCT02372383|76141434|FG000|COMPLETED|Second Intervention (1 Day)||10||
60025495|NCT02372383|76141435|FG001|COMPLETED|Second Intervention (1 Day)||10||
60025496|NCT02372383|76141436|FG002|COMPLETED|Second Intervention (1 Day)||10||
60025497|NCT02372383|76141434|FG000|NOT COMPLETED|Second Intervention (1 Day)||0||
60025498|NCT02372383|76141435|FG001|NOT COMPLETED|Second Intervention (1 Day)||0||
60025499|NCT02372383|76141436|FG002|NOT COMPLETED|Second Intervention (1 Day)||0||
60025500|NCT01648699|76141446|FG000|STARTED|Overall Study||20||
60025501|NCT01648699|76141446|FG000|COMPLETED|Overall Study||15||
60025502|NCT01648699|76141446|FG000|NOT COMPLETED|Overall Study||5||
60025503|NCT02134353|76141461|FG000|STARTED|Overall Study||209||
60025504|NCT02134353|76141462|FG001|STARTED|Overall Study||214||
60025505|NCT02134353|76141461|FG000|COMPLETED|Overall Study||183||
60025506|NCT02134353|76141462|FG001|COMPLETED|Overall Study||190||
60025507|NCT02134353|76141461|FG000|NOT COMPLETED|Overall Study||26||
60025508|NCT02134353|76141462|FG001|NOT COMPLETED|Overall Study||24||
60025509|NCT01646125|76141470|FG000|STARTED|Overall Study||31||
60025510|NCT01646125|76141471|FG001|STARTED|Overall Study||28||
60025511|NCT01646125|76141470|FG000|COMPLETED|Overall Study||0||
60025512|NCT01646125|76141471|FG001|COMPLETED|Overall Study||0||
60025513|NCT01646125|76141470|FG000|NOT COMPLETED|Overall Study||31||
60025514|NCT01646125|76141471|FG001|NOT COMPLETED|Overall Study||28||
60025515|NCT01362790|76141484|FG000|STARTED|Pilot Phase & Phase 2||11||
60025516|NCT01362790|76141485|FG001|STARTED|Pilot Phase & Phase 2||8||
60025517|NCT01362790|76141486|FG002|STARTED|Pilot Phase & Phase 2||7||
60025518|NCT01362790|76141487|FG003|STARTED|Pilot Phase & Phase 2||15||
60025519|NCT01362790|76141488|FG004|STARTED|Pilot Phase & Phase 2||0||
60025520|NCT01362790|76141489|FG005|STARTED|Pilot Phase & Phase 2||4||
60025521|NCT01362790|76141490|FG006|STARTED|Pilot Phase & Phase 2||0||
60025522|NCT01362790|76141484|FG000|COMPLETED|Pilot Phase & Phase 2||1||
59519015|NCT03587428|75612870|FG000|STARTED|Period 3||3||
59759163|NCT00915473|75878506|FG001|NOT COMPLETED|4-week Follow Up||5||
59759164|NCT00917501|75878514|FG000|STARTED|Overall Study||29||
59759165|NCT00917501|75878515|FG001|STARTED|Overall Study||26||
59759166|NCT00917501|75878514|FG000|COMPLETED|Overall Study||21||
59759167|NCT00917501|75878515|FG001|COMPLETED|Overall Study||21||
59759168|NCT00917501|75878514|FG000|NOT COMPLETED|Overall Study||8||
59759169|NCT00917501|75878515|FG001|NOT COMPLETED|Overall Study||5||
59759170|NCT04540952|75878523|FG000|STARTED|Overall Study||34||
59759171|NCT04540952|75878524|FG001|STARTED|Overall Study||34||
59759172|NCT04540952|75878523|FG000|COMPLETED|Overall Study||34||
59915236|NCT00702520|76036119|FG001|NOT COMPLETED|Base Study P05788 - Embryo Transfer||6||
59915237|NCT00702520|76036120|FG002|NOT COMPLETED|Base Study P05788 - Embryo Transfer||0||
59915238|NCT00702520|76036121|FG003|NOT COMPLETED|Base Study P05788 - Embryo Transfer||0||
59915239|NCT00702520|76036118|FG000|STARTED|Base Study P05788 - Follow-Up||22||
59915240|NCT00702520|76036119|FG001|STARTED|Base Study P05788 - Follow-Up||18||
59915241|NCT00702520|76036120|FG002|STARTED|Base Study P05788 - Follow-Up||0||
59915242|NCT00702520|76036121|FG003|STARTED|Base Study P05788 - Follow-Up||0||
59915243|NCT00702520|76036118|FG000|Ongoing Pregnancy at 10 Weeks|Base Study P05788 - Follow-Up||7||
59915244|NCT00702520|76036119|FG001|Ongoing Pregnancy at 10 Weeks|Base Study P05788 - Follow-Up||8||
59915245|NCT00702520|76036120|FG002|Ongoing Pregnancy at 10 Weeks|Base Study P05788 - Follow-Up||0||
60025523|NCT01362790|76141485|FG001|COMPLETED|Pilot Phase & Phase 2||0||
59759173|NCT04540952|75878524|FG001|COMPLETED|Overall Study||34||
59759174|NCT04540952|75878523|FG000|NOT COMPLETED|Overall Study||0||
59759175|NCT04540952|75878524|FG001|NOT COMPLETED|Overall Study||0||
59759176|NCT00917267|75878534|FG000|STARTED|Overall Study||346||
59759177|NCT00917267|75878535|FG001|STARTED|Overall Study||345||
59759178|NCT00917267|75878534|FG000|Intent to Treat (ITT)|Overall Study||340||
60025524|NCT01362790|76141486|FG002|COMPLETED|Pilot Phase & Phase 2||2||
60025525|NCT01362790|76141487|FG003|COMPLETED|Pilot Phase & Phase 2||1||
59759179|NCT00917267|75878535|FG001|Intent to Treat (ITT)|Overall Study||338||
60025526|NCT01362790|76141488|FG004|COMPLETED|Pilot Phase & Phase 2||0||
60025527|NCT01362790|76141489|FG005|COMPLETED|Pilot Phase & Phase 2||0||
60025528|NCT01362790|76141490|FG006|COMPLETED|Pilot Phase & Phase 2||0||
60025529|NCT01362790|76141484|FG000|NOT COMPLETED|Pilot Phase & Phase 2||10||
60025530|NCT01362790|76141485|FG001|NOT COMPLETED|Pilot Phase & Phase 2||8||
60025531|NCT01362790|76141486|FG002|NOT COMPLETED|Pilot Phase & Phase 2||5||
60025532|NCT01362790|76141487|FG003|NOT COMPLETED|Pilot Phase & Phase 2||14||
60025533|NCT01362790|76141488|FG004|NOT COMPLETED|Pilot Phase & Phase 2||0||
60025534|NCT01362790|76141489|FG005|NOT COMPLETED|Pilot Phase & Phase 2||4||
60025535|NCT01362790|76141490|FG006|NOT COMPLETED|Pilot Phase & Phase 2||0||
60025536|NCT01362790|76141484|FG000|STARTED|Dose De-escalation of Regimen A||0||
60025537|NCT01362790|76141485|FG001|STARTED|Dose De-escalation of Regimen A||0||
60025538|NCT01362790|76141486|FG002|STARTED|Dose De-escalation of Regimen A||0||
60025539|NCT01362790|76141487|FG003|STARTED|Dose De-escalation of Regimen A||0||
60025540|NCT01362790|76141488|FG004|STARTED|Dose De-escalation of Regimen A||8||
60025541|NCT01362790|76141489|FG005|STARTED|Dose De-escalation of Regimen A||0||
60025542|NCT01362790|76141490|FG006|STARTED|Dose De-escalation of Regimen A||0||
60025543|NCT01362790|76141484|FG000|COMPLETED|Dose De-escalation of Regimen A||0||
60025544|NCT01362790|76141485|FG001|COMPLETED|Dose De-escalation of Regimen A||0||
60025545|NCT01362790|76141486|FG002|COMPLETED|Dose De-escalation of Regimen A||0||
60025546|NCT01362790|76141487|FG003|COMPLETED|Dose De-escalation of Regimen A||0||
60025547|NCT01362790|76141488|FG004|COMPLETED|Dose De-escalation of Regimen A||2||
60025548|NCT01362790|76141489|FG005|COMPLETED|Dose De-escalation of Regimen A||0||
60025549|NCT01362790|76141490|FG006|COMPLETED|Dose De-escalation of Regimen A||0||
60025550|NCT01362790|76141484|FG000|NOT COMPLETED|Dose De-escalation of Regimen A||0||
60025551|NCT01362790|76141485|FG001|NOT COMPLETED|Dose De-escalation of Regimen A||0||
60025552|NCT01362790|76141486|FG002|NOT COMPLETED|Dose De-escalation of Regimen A||0||
60025553|NCT01362790|76141487|FG003|NOT COMPLETED|Dose De-escalation of Regimen A||0||
60025554|NCT01362790|76141488|FG004|NOT COMPLETED|Dose De-escalation of Regimen A||6||
60025555|NCT01362790|76141489|FG005|NOT COMPLETED|Dose De-escalation of Regimen A||0||
60025556|NCT01362790|76141490|FG006|NOT COMPLETED|Dose De-escalation of Regimen A||0||
60025557|NCT02167893|76141510|FG000|STARTED|Overall Study||11288||
60025558|NCT02167893|76141510|FG000|COMPLETED|Overall Study||11125||
60025559|NCT02167893|76141510|FG000|NOT COMPLETED|Overall Study||163||
60025560|NCT02167035|76141516|FG000|STARTED|Overall Study||21||
60025561|NCT02167035|76141517|FG001|STARTED|Overall Study||22||
60025562|NCT02167035|76141516|FG000|COMPLETED|Overall Study||16||
60025563|NCT02167035|76141517|FG001|COMPLETED|Overall Study||16||
60025564|NCT02167035|76141516|FG000|NOT COMPLETED|Overall Study||5||
60025565|NCT02167035|76141517|FG001|NOT COMPLETED|Overall Study||6||
60025566|NCT01615198|76141527|FG000|STARTED|Overall Study||296||
60025567|NCT01615198|76141528|FG001|STARTED|Overall Study||292||
60025568|NCT01615198|76141527|FG000|Full Analysis Set|Overall Study||296||
60025569|NCT01615198|76141528|FG001|Full Analysis Set|Overall Study||292||
60025570|NCT01615198|76141527|FG000|Ambulatory BP Monitoring (ABPM) Subset|Overall Study||154||
60025571|NCT01615198|76141528|FG001|Ambulatory BP Monitoring (ABPM) Subset|Overall Study||157||
60025572|NCT01615198|76141527|FG000|Safety Set|Overall Study||296||
60025573|NCT01615198|76141528|FG001|Safety Set|Overall Study||292||
60025574|NCT01615198|76141527|FG000|ABPM Dipper Status Subset|Overall Study||82||
60025575|NCT01615198|76141528|FG001|ABPM Dipper Status Subset|Overall Study||84||
60025576|NCT01615198|76141527|FG000|COMPLETED|Overall Study||272||
60025577|NCT01615198|76141528|FG001|COMPLETED|Overall Study||273||
60025578|NCT01615198|76141527|FG000|NOT COMPLETED|Overall Study||24||
60025579|NCT01615198|76141528|FG001|NOT COMPLETED|Overall Study||19||
60025580|NCT02337907|76141540|FG000|STARTED|Overall Study||55||
60025581|NCT02337907|76141541|FG001|STARTED|Overall Study||53||
60025582|NCT02337907|76141542|FG002|STARTED|Overall Study||55||
60025583|NCT02337907|76141543|FG003|STARTED|Overall Study||55||
60025584|NCT02337907|76141544|FG004|STARTED|Overall Study||106||
60025585|NCT02337907|76141545|FG005|STARTED|Overall Study||5||
60025586|NCT02337907|76141540|FG000|COMPLETED|Overall Study||51||
60025587|NCT02337907|76141541|FG001|COMPLETED|Overall Study||49||
60025588|NCT02337907|76141542|FG002|COMPLETED|Overall Study||54||
60025589|NCT02337907|76141543|FG003|COMPLETED|Overall Study||51||
60025590|NCT02337907|76141544|FG004|COMPLETED|Overall Study||96||
60025591|NCT02337907|76141545|FG005|COMPLETED|Overall Study||4||
60025592|NCT02337907|76141540|FG000|NOT COMPLETED|Overall Study||4||
60025593|NCT02337907|76141541|FG001|NOT COMPLETED|Overall Study||4||
60025594|NCT02337907|76141542|FG002|NOT COMPLETED|Overall Study||1||
60025595|NCT02337907|76141543|FG003|NOT COMPLETED|Overall Study||4||
60025596|NCT02337907|76141544|FG004|NOT COMPLETED|Overall Study||10||
59519016|NCT03587428|75612871|FG001|STARTED|Period 3||2||
60025597|NCT02337907|76141545|FG005|NOT COMPLETED|Overall Study||1||
60025598|NCT01913470|76141562|FG000|STARTED|Overall Study||5||
60025599|NCT01913470|76141563|FG001|STARTED|Overall Study||7||
60025600|NCT01913470|76141562|FG000|COMPLETED|Overall Study||5||
60025601|NCT01913470|76141563|FG001|COMPLETED|Overall Study||4||
60025602|NCT01913470|76141562|FG000|NOT COMPLETED|Overall Study||0||
60025603|NCT01913470|76141563|FG001|NOT COMPLETED|Overall Study||3||
60025604|NCT02372071|76141570|FG000|STARTED|Overall Study||111||
60025605|NCT02372071|76141570|FG000|COMPLETED|Overall Study||93||
60025606|NCT02372071|76141570|FG000|NOT COMPLETED|Overall Study||18||
60025607|NCT02337751|76141577|FG000|STARTED|Overall Study||95||
60025608|NCT02337751|76141578|FG001|STARTED|Overall Study||103||
60025609|NCT02337751|76141577|FG000|COMPLETED|Overall Study||84||
60025610|NCT02337751|76141578|FG001|COMPLETED|Overall Study||87||
60025611|NCT02337751|76141577|FG000|NOT COMPLETED|Overall Study||11||
60025612|NCT02337751|76141578|FG001|NOT COMPLETED|Overall Study||16||
60025613|NCT02166333|76141589|FG000|STARTED|Stage 1||262||
60025614|NCT02166333|76141590|FG001|STARTED|Stage 1||0||
60025615|NCT02166333|76141591|FG002|STARTED|Stage 1||130||
60025616|NCT02166333|76141592|FG003|STARTED|Stage 1||0||
60025617|NCT02166333|76141593|FG004|STARTED|Stage 1|Randomization to 2000 IU/d was stopped in February 2018 as part of planned dose-finding|68||
60025618|NCT02166333|76141594|FG005|STARTED|Stage 1|Randomization to 4000 IU/d was stopped in March 2018 as part of planned dose-finding|69||
60025619|NCT02166333|76141589|FG000|COMPLETED|Stage 1||242|In Stage 1, completed = started Stage 2|
60025620|NCT02166333|76141590|FG001|COMPLETED|Stage 1||0|In Stage 1, completed = started Stage 2|
60025621|NCT02166333|76141591|FG002|COMPLETED|Stage 1||122|In Stage 1, completed = started Stage 2|
60025622|NCT02166333|76141592|FG003|COMPLETED|Stage 1||0|In Stage 1, completed = started Stage 2|
60025623|NCT02166333|76141593|FG004|COMPLETED|Stage 1||59|In Stage 1, completed = started Stage 2|
60025624|NCT02166333|76141594|FG005|COMPLETED|Stage 1||63|In Stage 1, completed = started Stage 2|
60025625|NCT02166333|76141589|FG000|NOT COMPLETED|Stage 1||20||
60025626|NCT02166333|76141590|FG001|NOT COMPLETED|Stage 1||0||
60025627|NCT02166333|76141591|FG002|NOT COMPLETED|Stage 1||8||
60025628|NCT02166333|76141592|FG003|NOT COMPLETED|Stage 1||0||
60025629|NCT02166333|76141593|FG004|NOT COMPLETED|Stage 1||9||
60025630|NCT02166333|76141594|FG005|NOT COMPLETED|Stage 1||6||
60025631|NCT02166333|76141589|FG000|STARTED|Stage 2||242||
60025632|NCT02166333|76141590|FG001|STARTED|Stage 2||77||
60025633|NCT02166333|76141591|FG002|STARTED|Stage 2||122||
60025634|NCT02166333|76141592|FG003|STARTED|Stage 2||82||
60025635|NCT02166333|76141593|FG004|STARTED|Stage 2||59||
60025636|NCT02166333|76141594|FG005|STARTED|Stage 2||63||
60025637|NCT02166333|76141589|FG000|COMPLETED|Stage 2||35|In Stage 2, completed = participated in closeout (April-May 2019)|
60025638|NCT02166333|76141590|FG001|COMPLETED|Stage 2||71|In Stage 2, completed = participated in closeout (April-May 2019)|
60025639|NCT02166333|76141591|FG002|COMPLETED|Stage 2||47|In Stage 2, completed = participated in closeout (April-May 2019)|
60025640|NCT02166333|76141592|FG003|COMPLETED|Stage 2||73|In Stage 2, completed = participated in closeout (April-May 2019)|
60025641|NCT02166333|76141593|FG004|COMPLETED|Stage 2||2|In Stage 2, completed = participated in closeout (April-May 2019)|
60025642|NCT02166333|76141594|FG005|COMPLETED|Stage 2||4|In Stage 2, completed = participated in closeout (April-May 2019)|
60025643|NCT02166333|76141589|FG000|NOT COMPLETED|Stage 2||207||
60025644|NCT02166333|76141590|FG001|NOT COMPLETED|Stage 2||6||
60025645|NCT02166333|76141591|FG002|NOT COMPLETED|Stage 2||75||
60025646|NCT02166333|76141592|FG003|NOT COMPLETED|Stage 2||9||
60025647|NCT02166333|76141593|FG004|NOT COMPLETED|Stage 2||57||
60025648|NCT02166333|76141594|FG005|NOT COMPLETED|Stage 2||59||
60025649|NCT02132949|76141608|FG000|STARTED|Overall Study||199|ITT Population|
60025650|NCT02132949|76141609|FG001|STARTED|Overall Study|1 participant enrolled in Cohort B received Cohort A treatment (and was counted as part of Cohort B for efficacy).|201|ITT Population|
60025651|NCT02132949|76141608|FG000|Received Any Cohort A Study Treatment|Overall Study|1 participant withdrew prior to receiving any study drug.|198|Safety Population for Cohort A|
60025652|NCT02132949|76141609|FG001|Received Any Cohort A Study Treatment|Overall Study|1 participant enrolled in Cohort B received Cohort A treatment (and was counted as part of Cohort A for safety).|1|Safety Population for Cohort A|
60025653|NCT02132949|76141608|FG000|Received Any Cohort B Study Treatment|Overall Study||0|Safety Population for Cohort B|
60025654|NCT02132949|76141609|FG001|Received Any Cohort B Study Treatment|Overall Study|2 participants withdrew prior to receiving any study drug.|198|Safety Population for Cohort B|
60025655|NCT02132949|76141608|FG000|Underwent Surgery|Overall Study||187||
60025656|NCT02132949|76141609|FG001|Underwent Surgery|Overall Study||194||
60025657|NCT02132949|76141608|FG000|Completed Neoadjuvant Treatment (25 Weeks)|Overall Study||182||
60025658|NCT02132949|76141609|FG001|Completed Neoadjuvant Treatment (25 Weeks)|Overall Study||189||
60025659|NCT02132949|76141608|FG000|Started Adjuvant Treatment|Overall Study||181||
60025660|NCT02132949|76141609|FG001|Started Adjuvant Treatment|Overall Study|1 participant did not complete neoadjuvant treatment but started adjuvant treatment.|190||
60025661|NCT02132949|76141608|FG000|Completed Adjuvant Treatment (Up to 39 Weeks)|Overall Study||163||
60025662|NCT02132949|76141609|FG001|Completed Adjuvant Treatment (Up to 39 Weeks)|Overall Study||176||
60025663|NCT02132949|76141608|FG000|Started Treatment-Free Follow-Up (Up to 5 Years)|Overall Study||195|Includes participants who completed or discontinued neoadjuvant/adjuvant treatment.|
60025664|NCT02132949|76141609|FG001|Started Treatment-Free Follow-Up (Up to 5 Years)|Overall Study||195|Includes participants who completed or discontinued neoadjuvant/adjuvant treatment.|
60025665|NCT02132949|76141608|FG000|COMPLETED|Overall Study||158||
60025666|NCT02132949|76141609|FG001|COMPLETED|Overall Study||173||
60025667|NCT02132949|76141608|FG000|NOT COMPLETED|Overall Study||41||
60025668|NCT02132949|76141609|FG001|NOT COMPLETED|Overall Study||28||
60025669|NCT02165397|76141618|FG000|STARTED|Overall Study||75||
60025670|NCT02165397|76141619|FG001|STARTED|Overall Study||75||
60025671|NCT02165397|76141620|FG002|STARTED|Overall Study||31||
60025672|NCT02165397|76141618|FG000|COMPLETED|Overall Study||61|On-study until study termination by sponsor.|
60025673|NCT02165397|76141619|FG001|COMPLETED|Overall Study||56|On-study until study termination by sponsor.|
60025674|NCT02165397|76141620|FG002|COMPLETED|Overall Study||21|On-study until study termination by sponsor.|
60025675|NCT02165397|76141618|FG000|NOT COMPLETED|Overall Study||14||
60025676|NCT02165397|76141619|FG001|NOT COMPLETED|Overall Study||19||
60025677|NCT02165397|76141620|FG002|NOT COMPLETED|Overall Study||10||
60025678|NCT02132637|76141632|FG000|STARTED|Study Period 1||34||
60025679|NCT02132637|76141633|FG001|STARTED|Study Period 1||34||
60025680|NCT02132637|76141632|FG000|Received at Least One Dose of Study Drug|Study Period 1||34||
60025681|NCT02132637|76141633|FG001|Received at Least One Dose of Study Drug|Study Period 1||34||
60025682|NCT02132637|76141632|FG000|COMPLETED|Study Period 1||33||
60025683|NCT02132637|76141633|FG001|COMPLETED|Study Period 1||30||
60025684|NCT02132637|76141632|FG000|NOT COMPLETED|Study Period 1||1||
60025685|NCT02132637|76141633|FG001|NOT COMPLETED|Study Period 1||4||
60025686|NCT02132637|76141632|FG000|STARTED|Study Period 2 (Crossover)||33||
60025687|NCT02132637|76141633|FG001|STARTED|Study Period 2 (Crossover)||30||
60025688|NCT02132637|76141632|FG000|COMPLETED|Study Period 2 (Crossover)||31||
60025689|NCT02132637|76141633|FG001|COMPLETED|Study Period 2 (Crossover)||29||
60025690|NCT02132637|76141632|FG000|NOT COMPLETED|Study Period 2 (Crossover)||2||
60025691|NCT02132637|76141633|FG001|NOT COMPLETED|Study Period 2 (Crossover)||1||
60025692|NCT02164929|76141643|FG000|STARTED|Overall Study||4||
60025693|NCT02164929|76141644|FG001|STARTED|Overall Study||3||
60025694|NCT02164929|76141645|FG002|STARTED|Overall Study||5||
60025695|NCT02164929|76141646|FG003|STARTED|Overall Study||4||
60025696|NCT02164929|76141643|FG000|COMPLETED|Overall Study||3||
60025697|NCT02164929|76141644|FG001|COMPLETED|Overall Study||3||
60025698|NCT02164929|76141645|FG002|COMPLETED|Overall Study||4||
60025699|NCT02164929|76141646|FG003|COMPLETED|Overall Study||2||
60025700|NCT02164929|76141643|FG000|NOT COMPLETED|Overall Study||1||
60025701|NCT02164929|76141644|FG001|NOT COMPLETED|Overall Study||0||
60025702|NCT02164929|76141645|FG002|NOT COMPLETED|Overall Study||1||
60025703|NCT02164929|76141646|FG003|NOT COMPLETED|Overall Study||2||
60025704|NCT01888432|76141658|FG000|STARTED|12-month Analysis (FAS)||142||
60025705|NCT01888432|76141659|FG001|STARTED|12-month Analysis (FAS)||142||
60025706|NCT01888432|76141658|FG000|COMPLETED|12-month Analysis (FAS)||131||
60025707|NCT01888432|76141659|FG001|COMPLETED|12-month Analysis (FAS)||133||
60025708|NCT01888432|76141658|FG000|NOT COMPLETED|12-month Analysis (FAS)||11||
60025709|NCT01888432|76141659|FG001|NOT COMPLETED|12-month Analysis (FAS)||9||
60025710|NCT01888432|76141658|FG000|STARTED|24-month Analysis (FAS)||142||
60025711|NCT01888432|76141659|FG001|STARTED|24-month Analysis (FAS)||142||
60025712|NCT01888432|76141658|FG000|COMPLETED|24-month Analysis (FAS)||125||
60025713|NCT01888432|76141659|FG001|COMPLETED|24-month Analysis (FAS)||125||
59915246|NCT00702520|76036121|FG003|Ongoing Pregnancy at 10 Weeks|Base Study P05788 - Follow-Up||0||
59915247|NCT00702520|76036118|FG000|COMPLETED|Base Study P05788 - Follow-Up||7||
60025714|NCT01888432|76141658|FG000|NOT COMPLETED|24-month Analysis (FAS)||17||
60025715|NCT01888432|76141659|FG001|NOT COMPLETED|24-month Analysis (FAS)||17||
60025716|NCT01888432|76141658|FG000|STARTED|36-month Analysis (Extension)||13||
60025717|NCT01888432|76141659|FG001|STARTED|36-month Analysis (Extension)||5||
60025718|NCT01888432|76141658|FG000|COMPLETED|36-month Analysis (Extension)||12||
60025719|NCT01888432|76141659|FG001|COMPLETED|36-month Analysis (Extension)||5||
60025720|NCT01888432|76141658|FG000|NOT COMPLETED|36-month Analysis (Extension)||1||
60025721|NCT01888432|76141659|FG001|NOT COMPLETED|36-month Analysis (Extension)||0||
60025722|NCT02188719|76141671|FG000|STARTED|Overall Study||6||
59915248|NCT00702520|76036119|FG001|COMPLETED|Base Study P05788 - Follow-Up||8||
59915249|NCT00702520|76036120|FG002|COMPLETED|Base Study P05788 - Follow-Up||0||
59915250|NCT00702520|76036121|FG003|COMPLETED|Base Study P05788 - Follow-Up||0||
59915251|NCT00702520|76036118|FG000|NOT COMPLETED|Base Study P05788 - Follow-Up||15||
59915252|NCT00702520|76036119|FG001|NOT COMPLETED|Base Study P05788 - Follow-Up||10||
59915253|NCT00702520|76036120|FG002|NOT COMPLETED|Base Study P05788 - Follow-Up||0||
59915254|NCT00702520|76036121|FG003|NOT COMPLETED|Base Study P05788 - Follow-Up||0||
59915255|NCT00702520|76036118|FG000|STARTED|Follow-up Study P05783||7||
59915256|NCT00702520|76036119|FG001|STARTED|Follow-up Study P05783||8||
60025723|NCT02188719|76141672|FG001|STARTED|Overall Study||9||
60025724|NCT02188719|76141673|FG002|STARTED|Overall Study||0||
60025725|NCT02188719|76141674|FG003|STARTED|Overall Study||0||
60025726|NCT02188719|76141671|FG000|COMPLETED|Overall Study||6||
60025727|NCT02188719|76141672|FG001|COMPLETED|Overall Study||8||
60025728|NCT02188719|76141673|FG002|COMPLETED|Overall Study||0||
60025729|NCT02188719|76141674|FG003|COMPLETED|Overall Study||0||
60025730|NCT02188719|76141671|FG000|NOT COMPLETED|Overall Study||0||
60025731|NCT02188719|76141672|FG001|NOT COMPLETED|Overall Study||1||
60025732|NCT02188719|76141673|FG002|NOT COMPLETED|Overall Study||0||
60025733|NCT02188719|76141674|FG003|NOT COMPLETED|Overall Study||0||
60025734|NCT01934140|76141684|FG000|STARTED|Persistence Phase (Year 6-10)||235||
60025735|NCT01934140|76141685|FG001|STARTED|Persistence Phase (Year 6-10)||76||
60025736|NCT01934140|76141684|FG000|COMPLETED|Persistence Phase (Year 6-10)|Participants completed all persistence phase visits|152||
60025737|NCT01934140|76141685|FG001|COMPLETED|Persistence Phase (Year 6-10)|Participants completed all persistence phase visits|51||
60025738|NCT01934140|76141684|FG000|NOT COMPLETED|Persistence Phase (Year 6-10)||83||
60025739|NCT01934140|76141685|FG001|NOT COMPLETED|Persistence Phase (Year 6-10)||25||
60025740|NCT01934140|76141684|FG000|STARTED|Booster Phase (6 Months)|Eligible participants from persistence phase who provided consent, were enrolled in booster phase.|164||
60025741|NCT01934140|76141685|FG001|STARTED|Booster Phase (6 Months)|Eligible participants from persistence phase who provided consent, were enrolled in booster phase.|56||
60025742|NCT01934140|76141684|FG000|Vaccinated|Booster Phase (6 Months)||164||
60025743|NCT01934140|76141685|FG001|Vaccinated|Booster Phase (6 Months)||56||
60025744|NCT01934140|76141684|FG000|COMPLETED|Booster Phase (6 Months)||159||
60025745|NCT01934140|76141685|FG001|COMPLETED|Booster Phase (6 Months)||53||
60025746|NCT01934140|76141684|FG000|NOT COMPLETED|Booster Phase (6 Months)||5||
60025747|NCT01934140|76141685|FG001|NOT COMPLETED|Booster Phase (6 Months)||3||
60025748|NCT01933672|76141693|FG000|STARTED|Metformin Run-in Period||43||
60025749|NCT01933672|76141694|FG001|STARTED|Metformin Run-in Period||0||
60025750|NCT01933672|76141695|FG002|STARTED|Metformin Run-in Period||0||
60025751|NCT01933672|76141696|FG003|STARTED|Metformin Run-in Period||0||
60025752|NCT01933672|76141697|FG004|STARTED|Metformin Run-in Period||0||
60025753|NCT01933672|76141698|FG005|STARTED|Metformin Run-in Period||0||
60025754|NCT01933672|76141699|FG006|STARTED|Metformin Run-in Period||0||
60025755|NCT01933672|76141693|FG000|Received Treatment|Metformin Run-in Period||43||
60025756|NCT01933672|76141694|FG001|Received Treatment|Metformin Run-in Period||0||
60025757|NCT01933672|76141695|FG002|Received Treatment|Metformin Run-in Period||0||
60025758|NCT01933672|76141696|FG003|Received Treatment|Metformin Run-in Period||0||
60025759|NCT01933672|76141697|FG004|Received Treatment|Metformin Run-in Period||0||
60025760|NCT01933672|76141698|FG005|Received Treatment|Metformin Run-in Period||0||
60025761|NCT01933672|76141699|FG006|Received Treatment|Metformin Run-in Period||0||
60025762|NCT01933672|76141693|FG000|COMPLETED|Metformin Run-in Period||33||
60025763|NCT01933672|76141694|FG001|COMPLETED|Metformin Run-in Period||0||
60025764|NCT01933672|76141695|FG002|COMPLETED|Metformin Run-in Period||0||
60025765|NCT01933672|76141696|FG003|COMPLETED|Metformin Run-in Period||0||
60025766|NCT01933672|76141697|FG004|COMPLETED|Metformin Run-in Period||0||
60025767|NCT01933672|76141698|FG005|COMPLETED|Metformin Run-in Period||0||
60025768|NCT01933672|76141699|FG006|COMPLETED|Metformin Run-in Period||0||
60025769|NCT01933672|76141693|FG000|NOT COMPLETED|Metformin Run-in Period||10||
60025770|NCT01933672|76141694|FG001|NOT COMPLETED|Metformin Run-in Period||0||
60025771|NCT01933672|76141695|FG002|NOT COMPLETED|Metformin Run-in Period||0||
60025772|NCT01933672|76141696|FG003|NOT COMPLETED|Metformin Run-in Period||0||
60025773|NCT01933672|76141697|FG004|NOT COMPLETED|Metformin Run-in Period||0||
60025774|NCT01933672|76141698|FG005|NOT COMPLETED|Metformin Run-in Period||0||
60025775|NCT01933672|76141699|FG006|NOT COMPLETED|Metformin Run-in Period||0||
60025776|NCT01933672|76141693|FG000|STARTED|First Intervention Period (12-16 Days)||0||
60025777|NCT01933672|76141694|FG001|STARTED|First Intervention Period (12-16 Days)||7||
60025778|NCT01933672|76141695|FG002|STARTED|First Intervention Period (12-16 Days)||3||
60025779|NCT01933672|76141696|FG003|STARTED|First Intervention Period (12-16 Days)||5||
60025780|NCT01933672|76141697|FG004|STARTED|First Intervention Period (12-16 Days)||7||
60025781|NCT01933672|76141698|FG005|STARTED|First Intervention Period (12-16 Days)||5||
60025782|NCT01933672|76141699|FG006|STARTED|First Intervention Period (12-16 Days)||6||
60025783|NCT01933672|76141693|FG000|COMPLETED|First Intervention Period (12-16 Days)||0||
60025784|NCT01933672|76141694|FG001|COMPLETED|First Intervention Period (12-16 Days)||7||
60025785|NCT01933672|76141695|FG002|COMPLETED|First Intervention Period (12-16 Days)||2||
60025786|NCT01933672|76141696|FG003|COMPLETED|First Intervention Period (12-16 Days)||5||
60025787|NCT01933672|76141697|FG004|COMPLETED|First Intervention Period (12-16 Days)||6||
60025788|NCT01933672|76141698|FG005|COMPLETED|First Intervention Period (12-16 Days)||4||
60025789|NCT01933672|76141699|FG006|COMPLETED|First Intervention Period (12-16 Days)||6||
60025790|NCT01933672|76141693|FG000|NOT COMPLETED|First Intervention Period (12-16 Days)||0||
60025791|NCT01933672|76141694|FG001|NOT COMPLETED|First Intervention Period (12-16 Days)||0||
60025792|NCT01933672|76141695|FG002|NOT COMPLETED|First Intervention Period (12-16 Days)||1||
60025793|NCT01933672|76141696|FG003|NOT COMPLETED|First Intervention Period (12-16 Days)||0||
60025794|NCT01933672|76141697|FG004|NOT COMPLETED|First Intervention Period (12-16 Days)||1||
60025795|NCT01933672|76141698|FG005|NOT COMPLETED|First Intervention Period (12-16 Days)||1||
60025796|NCT01933672|76141699|FG006|NOT COMPLETED|First Intervention Period (12-16 Days)||0||
60025797|NCT01933672|76141693|FG000|STARTED|First Washout Period (7-14 Days)||0||
60025798|NCT01933672|76141694|FG001|STARTED|First Washout Period (7-14 Days)||7||
60025799|NCT01933672|76141695|FG002|STARTED|First Washout Period (7-14 Days)||2||
60025800|NCT01933672|76141696|FG003|STARTED|First Washout Period (7-14 Days)||5||
60025801|NCT01933672|76141697|FG004|STARTED|First Washout Period (7-14 Days)||6||
60025802|NCT01933672|76141698|FG005|STARTED|First Washout Period (7-14 Days)||4||
60025803|NCT01933672|76141699|FG006|STARTED|First Washout Period (7-14 Days)||6||
60025804|NCT01933672|76141693|FG000|COMPLETED|First Washout Period (7-14 Days)||0||
60025805|NCT01933672|76141694|FG001|COMPLETED|First Washout Period (7-14 Days)||7||
60025806|NCT01933672|76141695|FG002|COMPLETED|First Washout Period (7-14 Days)||2||
60025807|NCT01933672|76141696|FG003|COMPLETED|First Washout Period (7-14 Days)||5||
60025808|NCT01933672|76141697|FG004|COMPLETED|First Washout Period (7-14 Days)||6||
60025809|NCT01933672|76141698|FG005|COMPLETED|First Washout Period (7-14 Days)||4||
60025810|NCT01933672|76141699|FG006|COMPLETED|First Washout Period (7-14 Days)||6||
60025811|NCT01933672|76141693|FG000|NOT COMPLETED|First Washout Period (7-14 Days)||0||
60025812|NCT01933672|76141694|FG001|NOT COMPLETED|First Washout Period (7-14 Days)||0||
60025813|NCT01933672|76141695|FG002|NOT COMPLETED|First Washout Period (7-14 Days)||0||
60025814|NCT01933672|76141696|FG003|NOT COMPLETED|First Washout Period (7-14 Days)||0||
60025815|NCT01933672|76141697|FG004|NOT COMPLETED|First Washout Period (7-14 Days)||0||
59507375|NCT02071173|75600619|FG000|ACUITY X4 Endpoint Population|Overall Study|536 with ACUITY X4 Spiral lead, 228 with ACUITY X4 Straight lead|764|The first 764 subjects implanted/attempted with ACUITY X4 lead eligible for ACUITY X4 endpoints|
59507376|NCT02071173|75600619|FG000|COMPLETED|Overall Study|Follow-up is ongoing. Data as of 5-Feb-2020.|409||
60025816|NCT01933672|76141698|FG005|NOT COMPLETED|First Washout Period (7-14 Days)||0||
60025817|NCT01933672|76141699|FG006|NOT COMPLETED|First Washout Period (7-14 Days)||0||
60025818|NCT01933672|76141693|FG000|STARTED|Second Intervention Period (12-16 Days)||0||
60025819|NCT01933672|76141694|FG001|STARTED|Second Intervention Period (12-16 Days)||7||
60025820|NCT01933672|76141695|FG002|STARTED|Second Intervention Period (12-16 Days)||2||
60025821|NCT01933672|76141696|FG003|STARTED|Second Intervention Period (12-16 Days)||5||
60025822|NCT01933672|76141697|FG004|STARTED|Second Intervention Period (12-16 Days)||6||
60025823|NCT01933672|76141698|FG005|STARTED|Second Intervention Period (12-16 Days)||4||
60025824|NCT01933672|76141699|FG006|STARTED|Second Intervention Period (12-16 Days)||6||
60025825|NCT01933672|76141693|FG000|COMPLETED|Second Intervention Period (12-16 Days)||0||
60025826|NCT01933672|76141694|FG001|COMPLETED|Second Intervention Period (12-16 Days)||6||
60025827|NCT01933672|76141695|FG002|COMPLETED|Second Intervention Period (12-16 Days)||1||
60025828|NCT01933672|76141696|FG003|COMPLETED|Second Intervention Period (12-16 Days)||5||
60025829|NCT01933672|76141697|FG004|COMPLETED|Second Intervention Period (12-16 Days)||6||
60025830|NCT01933672|76141698|FG005|COMPLETED|Second Intervention Period (12-16 Days)||4||
60025831|NCT01933672|76141699|FG006|COMPLETED|Second Intervention Period (12-16 Days)||6||
60025832|NCT01933672|76141693|FG000|NOT COMPLETED|Second Intervention Period (12-16 Days)||0||
60025833|NCT01933672|76141694|FG001|NOT COMPLETED|Second Intervention Period (12-16 Days)||1||
59507377|NCT02071173|75600619|FG000|NOT COMPLETED|Overall Study||1835||
59507378|NCT02348359|75600628|FG000|STARTED|Overall Study||40||
59507379|NCT02348359|75600629|FG001|STARTED|Overall Study||39||
59507380|NCT02348359|75600630|FG002|STARTED|Overall Study||39||
59507381|NCT02348359|75600631|FG003|STARTED|Overall Study||39||
59507382|NCT02348359|75600628|FG000|COMPLETED|Overall Study||29||
60025834|NCT01933672|76141695|FG002|NOT COMPLETED|Second Intervention Period (12-16 Days)||1||
60025835|NCT01933672|76141696|FG003|NOT COMPLETED|Second Intervention Period (12-16 Days)||0||
60025836|NCT01933672|76141697|FG004|NOT COMPLETED|Second Intervention Period (12-16 Days)||0||
60025837|NCT01933672|76141698|FG005|NOT COMPLETED|Second Intervention Period (12-16 Days)||0||
60025838|NCT01933672|76141699|FG006|NOT COMPLETED|Second Intervention Period (12-16 Days)||0||
60025839|NCT01933672|76141693|FG000|STARTED|Second Washout Period (7-14 Days)||0||
60025840|NCT01933672|76141694|FG001|STARTED|Second Washout Period (7-14 Days)||6||
60025841|NCT01933672|76141695|FG002|STARTED|Second Washout Period (7-14 Days)||1||
60025842|NCT01933672|76141696|FG003|STARTED|Second Washout Period (7-14 Days)||5||
60025843|NCT01933672|76141697|FG004|STARTED|Second Washout Period (7-14 Days)||6||
60025844|NCT01933672|76141698|FG005|STARTED|Second Washout Period (7-14 Days)||4||
60025845|NCT01933672|76141699|FG006|STARTED|Second Washout Period (7-14 Days)||6||
60025846|NCT01933672|76141693|FG000|COMPLETED|Second Washout Period (7-14 Days)||0||
60025847|NCT01933672|76141694|FG001|COMPLETED|Second Washout Period (7-14 Days)||6||
60025848|NCT01933672|76141695|FG002|COMPLETED|Second Washout Period (7-14 Days)||1||
60025849|NCT01933672|76141696|FG003|COMPLETED|Second Washout Period (7-14 Days)||5||
60025850|NCT01933672|76141697|FG004|COMPLETED|Second Washout Period (7-14 Days)||6||
60025851|NCT01933672|76141698|FG005|COMPLETED|Second Washout Period (7-14 Days)||4||
60025852|NCT01933672|76141699|FG006|COMPLETED|Second Washout Period (7-14 Days)||6||
60025853|NCT01933672|76141693|FG000|NOT COMPLETED|Second Washout Period (7-14 Days)||0||
60025854|NCT01933672|76141694|FG001|NOT COMPLETED|Second Washout Period (7-14 Days)||0||
60025855|NCT01933672|76141695|FG002|NOT COMPLETED|Second Washout Period (7-14 Days)||0||
60025856|NCT01933672|76141696|FG003|NOT COMPLETED|Second Washout Period (7-14 Days)||0||
60025857|NCT01933672|76141697|FG004|NOT COMPLETED|Second Washout Period (7-14 Days)||0||
60025858|NCT01933672|76141698|FG005|NOT COMPLETED|Second Washout Period (7-14 Days)||0||
60025859|NCT01933672|76141699|FG006|NOT COMPLETED|Second Washout Period (7-14 Days)||0||
60025860|NCT01933672|76141693|FG000|STARTED|Third Intervention Period (12-16 Days)||0||
60025861|NCT01933672|76141694|FG001|STARTED|Third Intervention Period (12-16 Days)||6||
60025862|NCT01933672|76141695|FG002|STARTED|Third Intervention Period (12-16 Days)||1||
60025863|NCT01933672|76141696|FG003|STARTED|Third Intervention Period (12-16 Days)||5||
60025864|NCT01933672|76141697|FG004|STARTED|Third Intervention Period (12-16 Days)||6||
60025865|NCT01933672|76141698|FG005|STARTED|Third Intervention Period (12-16 Days)||4||
60025866|NCT01933672|76141699|FG006|STARTED|Third Intervention Period (12-16 Days)||6||
60025867|NCT01933672|76141693|FG000|COMPLETED|Third Intervention Period (12-16 Days)||0||
60025868|NCT01933672|76141694|FG001|COMPLETED|Third Intervention Period (12-16 Days)||5||
60025869|NCT01933672|76141695|FG002|COMPLETED|Third Intervention Period (12-16 Days)||1||
60025870|NCT01933672|76141696|FG003|COMPLETED|Third Intervention Period (12-16 Days)||4||
60025871|NCT01933672|76141697|FG004|COMPLETED|Third Intervention Period (12-16 Days)||6||
59507383|NCT02348359|75600629|FG001|COMPLETED|Overall Study||22||
59507384|NCT02348359|75600630|FG002|COMPLETED|Overall Study||25||
59507385|NCT02348359|75600631|FG003|COMPLETED|Overall Study||27||
59507386|NCT02348359|75600628|FG000|NOT COMPLETED|Overall Study||11||
59507387|NCT02348359|75600629|FG001|NOT COMPLETED|Overall Study||17||
60025872|NCT01933672|76141698|FG005|COMPLETED|Third Intervention Period (12-16 Days)||4||
60025873|NCT01933672|76141699|FG006|COMPLETED|Third Intervention Period (12-16 Days)||6||
60025874|NCT01933672|76141693|FG000|NOT COMPLETED|Third Intervention Period (12-16 Days)||0||
60025875|NCT01933672|76141694|FG001|NOT COMPLETED|Third Intervention Period (12-16 Days)||1||
60025876|NCT01933672|76141695|FG002|NOT COMPLETED|Third Intervention Period (12-16 Days)||0||
60025877|NCT01933672|76141696|FG003|NOT COMPLETED|Third Intervention Period (12-16 Days)||1||
60025878|NCT01933672|76141697|FG004|NOT COMPLETED|Third Intervention Period (12-16 Days)||0||
60025879|NCT01933672|76141698|FG005|NOT COMPLETED|Third Intervention Period (12-16 Days)||0||
60025880|NCT01933672|76141699|FG006|NOT COMPLETED|Third Intervention Period (12-16 Days)||0||
60025881|NCT02164539|76141718|FG000|STARTED|Treatment Phase A (4 Weeks)||41||
60025882|NCT02164539|76141719|FG001|STARTED|Treatment Phase A (4 Weeks)||42||
60025883|NCT02164539|76141720|FG002|STARTED|Treatment Phase A (4 Weeks)||40||
60025884|NCT02164539|76141721|FG003|STARTED|Treatment Phase A (4 Weeks)||46||
60025885|NCT02164539|76141722|FG004|STARTED|Treatment Phase A (4 Weeks)||85||
60025886|NCT02164539|76141723|FG005|STARTED|Treatment Phase A (4 Weeks)||84||
60025887|NCT02164539|76141724|FG006|STARTED|Treatment Phase A (4 Weeks)||0||
60025888|NCT02164539|76141718|FG000|COMPLETED|Treatment Phase A (4 Weeks)||39||
60025889|NCT02164539|76141719|FG001|COMPLETED|Treatment Phase A (4 Weeks)||42||
60025890|NCT02164539|76141720|FG002|COMPLETED|Treatment Phase A (4 Weeks)||39||
60025891|NCT02164539|76141721|FG003|COMPLETED|Treatment Phase A (4 Weeks)||44||
60025892|NCT02164539|76141722|FG004|COMPLETED|Treatment Phase A (4 Weeks)||82||
60025893|NCT02164539|76141723|FG005|COMPLETED|Treatment Phase A (4 Weeks)||83||
60025894|NCT02164539|76141724|FG006|COMPLETED|Treatment Phase A (4 Weeks)||0||
60025895|NCT02164539|76141718|FG000|NOT COMPLETED|Treatment Phase A (4 Weeks)||2||
60025896|NCT02164539|76141719|FG001|NOT COMPLETED|Treatment Phase A (4 Weeks)||0||
60025897|NCT02164539|76141720|FG002|NOT COMPLETED|Treatment Phase A (4 Weeks)||1||
60025898|NCT02164539|76141721|FG003|NOT COMPLETED|Treatment Phase A (4 Weeks)||2||
60025899|NCT02164539|76141722|FG004|NOT COMPLETED|Treatment Phase A (4 Weeks)||3||
60025900|NCT02164539|76141723|FG005|NOT COMPLETED|Treatment Phase A (4 Weeks)||1||
60025901|NCT02164539|76141724|FG006|NOT COMPLETED|Treatment Phase A (4 Weeks)||0||
60025902|NCT02164539|76141718|FG000|STARTED|Treatment Phase B (1 Week)||0||
60025903|NCT02164539|76141719|FG001|STARTED|Treatment Phase B (1 Week)||0||
60025904|NCT02164539|76141720|FG002|STARTED|Treatment Phase B (1 Week)||0||
60025905|NCT02164539|76141721|FG003|STARTED|Treatment Phase B (1 Week)||0||
60025906|NCT02164539|76141722|FG004|STARTED|Treatment Phase B (1 Week)||166||
60025907|NCT02164539|76141723|FG005|STARTED|Treatment Phase B (1 Week)||0||
60025908|NCT02164539|76141724|FG006|STARTED|Treatment Phase B (1 Week)||163||
60025909|NCT02164539|76141718|FG000|COMPLETED|Treatment Phase B (1 Week)||0||
60025910|NCT02164539|76141719|FG001|COMPLETED|Treatment Phase B (1 Week)||0||
60025911|NCT02164539|76141720|FG002|COMPLETED|Treatment Phase B (1 Week)||0||
60025912|NCT02164539|76141721|FG003|COMPLETED|Treatment Phase B (1 Week)||0||
60025913|NCT02164539|76141722|FG004|COMPLETED|Treatment Phase B (1 Week)||163||
60025914|NCT02164539|76141723|FG005|COMPLETED|Treatment Phase B (1 Week)||0||
60025915|NCT02164539|76141724|FG006|COMPLETED|Treatment Phase B (1 Week)||162||
60025916|NCT02164539|76141718|FG000|NOT COMPLETED|Treatment Phase B (1 Week)||0||
60025917|NCT02164539|76141719|FG001|NOT COMPLETED|Treatment Phase B (1 Week)||0||
60025918|NCT02164539|76141720|FG002|NOT COMPLETED|Treatment Phase B (1 Week)||0||
60025919|NCT02164539|76141721|FG003|NOT COMPLETED|Treatment Phase B (1 Week)||0||
60025920|NCT02164539|76141722|FG004|NOT COMPLETED|Treatment Phase B (1 Week)||3||
60025921|NCT02164539|76141723|FG005|NOT COMPLETED|Treatment Phase B (1 Week)||0||
60025922|NCT02164539|76141724|FG006|NOT COMPLETED|Treatment Phase B (1 Week)||1||
60025923|NCT02164539|76141718|FG000|STARTED|Treatment Phase C (1 Week)||79||
60025924|NCT02164539|76141719|FG001|STARTED|Treatment Phase C (1 Week)||0||
60025925|NCT02164539|76141720|FG002|STARTED|Treatment Phase C (1 Week)||0||
60025926|NCT02164539|76141721|FG003|STARTED|Treatment Phase C (1 Week)||0||
60025927|NCT02164539|76141722|FG004|STARTED|Treatment Phase C (1 Week)||84||
60025928|NCT02164539|76141723|FG005|STARTED|Treatment Phase C (1 Week)||82||
60025929|NCT02164539|76141724|FG006|STARTED|Treatment Phase C (1 Week)||80||
60025930|NCT02164539|76141718|FG000|COMPLETED|Treatment Phase C (1 Week)||78||
60025931|NCT02164539|76141719|FG001|COMPLETED|Treatment Phase C (1 Week)||0||
60025932|NCT02164539|76141720|FG002|COMPLETED|Treatment Phase C (1 Week)||0||
60025933|NCT02164539|76141721|FG003|COMPLETED|Treatment Phase C (1 Week)||0||
60025934|NCT02164539|76141722|FG004|COMPLETED|Treatment Phase C (1 Week)||84||
60025935|NCT02164539|76141723|FG005|COMPLETED|Treatment Phase C (1 Week)||82||
60025936|NCT02164539|76141724|FG006|COMPLETED|Treatment Phase C (1 Week)||78||
60025937|NCT02164539|76141718|FG000|NOT COMPLETED|Treatment Phase C (1 Week)||1||
60025938|NCT02164539|76141719|FG001|NOT COMPLETED|Treatment Phase C (1 Week)||0||
60025939|NCT02164539|76141720|FG002|NOT COMPLETED|Treatment Phase C (1 Week)||0||
60025940|NCT02164539|76141721|FG003|NOT COMPLETED|Treatment Phase C (1 Week)||0||
60025941|NCT02164539|76141722|FG004|NOT COMPLETED|Treatment Phase C (1 Week)||0||
60025942|NCT02164539|76141723|FG005|NOT COMPLETED|Treatment Phase C (1 Week)||0||
60025943|NCT02164539|76141724|FG006|NOT COMPLETED|Treatment Phase C (1 Week)||2||
60025944|NCT02188485|76141741|FG000|STARTED|Overall Study||32|Randomization|
60025945|NCT02188485|76141742|FG001|STARTED|Overall Study||30|Randomization|
60025946|NCT02188485|76141741|FG000|COMPLETED|Overall Study||30||
60025947|NCT02188485|76141742|FG001|COMPLETED|Overall Study||27||
60025948|NCT02188485|76141741|FG000|NOT COMPLETED|Overall Study||2||
60025949|NCT02188485|76141742|FG001|NOT COMPLETED|Overall Study||3||
59915257|NCT00702520|76036120|FG002|STARTED|Follow-up Study P05783|This is the number of infants born from mothers administered Corifollitropin alpha 100 ug.|8||
59915258|NCT00702520|76036121|FG003|STARTED|Follow-up Study P05783|This is the number of infants born from mothers administered Corifollitropin alpha 150 ug.|11||
59915259|NCT00702520|76036118|FG000|COMPLETED|Follow-up Study P05783||7||
59915260|NCT00702520|76036119|FG001|COMPLETED|Follow-up Study P05783||8||
59915261|NCT00702520|76036120|FG002|COMPLETED|Follow-up Study P05783||8||
59915262|NCT00702520|76036121|FG003|COMPLETED|Follow-up Study P05783||11||
59915263|NCT00702520|76036118|FG000|NOT COMPLETED|Follow-up Study P05783||0||
59915264|NCT00702520|76036119|FG001|NOT COMPLETED|Follow-up Study P05783||0||
59915265|NCT00702520|76036120|FG002|NOT COMPLETED|Follow-up Study P05783||0||
59915266|NCT00702520|76036121|FG003|NOT COMPLETED|Follow-up Study P05783||0||
59915267|NCT04067141|76036131|FG000|STARTED|First Intervention||35||
59915268|NCT04067141|76036132|FG001|STARTED|First Intervention||35||
59915269|NCT04067141|76036131|FG000|COMPLETED|First Intervention||35||
59915270|NCT04067141|76036132|FG001|COMPLETED|First Intervention||34||
59915271|NCT04067141|76036131|FG000|NOT COMPLETED|First Intervention||0||
59915272|NCT04067141|76036132|FG001|NOT COMPLETED|First Intervention||1||
59915273|NCT04067141|76036131|FG000|STARTED|Second Intervention|Unacceptable lens fit at dispense. One withdrawal by subject.|34||
59915274|NCT04067141|76036132|FG001|STARTED|Second Intervention|Unacceptable lens fit at dispense. One withdrawal by subject|33||
59915275|NCT04067141|76036131|FG000|COMPLETED|Second Intervention||34||
59915276|NCT04067141|76036132|FG001|COMPLETED|Second Intervention||31||
59915277|NCT04067141|76036131|FG000|NOT COMPLETED|Second Intervention||0||
59915278|NCT04067141|76036132|FG001|NOT COMPLETED|Second Intervention||2||
59915279|NCT02876601|76036142|FG000|STARTED|First Intervention (24 Hours)||8||
59915280|NCT02876601|76036143|FG001|STARTED|First Intervention (24 Hours)||8||
59915281|NCT02876601|76036144|FG002|STARTED|First Intervention (24 Hours)||2||
59915282|NCT02876601|76036145|FG003|STARTED|First Intervention (24 Hours)||2||
59915283|NCT02876601|76036142|FG000|COMPLETED|First Intervention (24 Hours)||8||
59915284|NCT02876601|76036143|FG001|COMPLETED|First Intervention (24 Hours)||8||
59915285|NCT02876601|76036144|FG002|COMPLETED|First Intervention (24 Hours)||2||
59915286|NCT02876601|76036145|FG003|COMPLETED|First Intervention (24 Hours)||2||
60025950|NCT02132247|76141750|FG000|STARTED|Overall Study||52||
60025951|NCT02132247|76141751|FG001|STARTED|Overall Study||52||
60025952|NCT02132247|76141750|FG000|COMPLETED|Overall Study||51||
60025953|NCT02132247|76141751|FG001|COMPLETED|Overall Study||52||
60025954|NCT02132247|76141750|FG000|NOT COMPLETED|Overall Study||1||
60025955|NCT02132247|76141751|FG001|NOT COMPLETED|Overall Study||0||
60025956|NCT01629381|76141759|FG000|STARTED|Overall Study||122||
60025957|NCT01629381|76141760|FG001|STARTED|Overall Study||119||
60025958|NCT01629381|76141759|FG000|COMPLETED|Overall Study||120||
60025959|NCT01629381|76141760|FG001|COMPLETED|Overall Study||114||
60025960|NCT01629381|76141759|FG000|NOT COMPLETED|Overall Study||2||
60025961|NCT01629381|76141760|FG001|NOT COMPLETED|Overall Study||5||
60025962|NCT02131311|76141770|FG000|STARTED|Overall Study||90||
60025963|NCT02131311|76141770|FG000|COMPLETED|Overall Study||86||
60025964|NCT02131311|76141770|FG000|NOT COMPLETED|Overall Study||4||
60025965|NCT01628913|76141777|FG000|STARTED|Overall Study||31||
60025966|NCT01628913|76141778|FG001|STARTED|Overall Study||31||
60025967|NCT01628913|76141777|FG000|COMPLETED|Overall Study||0||
60025968|NCT01628913|76141778|FG001|COMPLETED|Overall Study||0||
60025969|NCT01628913|76141777|FG000|NOT COMPLETED|Overall Study||31||
60025970|NCT01628913|76141778|FG001|NOT COMPLETED|Overall Study||31||
60025971|NCT02164383|76141786|FG000|STARTED|Overall Study||16||
60025972|NCT02164383|76141787|FG001|STARTED|Overall Study||14||
60025973|NCT02164383|76141786|FG000|COMPLETED|Overall Study||15||
60025974|NCT02164383|76141787|FG001|COMPLETED|Overall Study||14||
60025975|NCT02164383|76141786|FG000|NOT COMPLETED|Overall Study||1||
60025976|NCT02164383|76141787|FG001|NOT COMPLETED|Overall Study||0||
60025977|NCT02131233|76141795|FG000|STARTED|Overall Study|Enrolled participants|533||
60025978|NCT02131233|76141796|FG001|STARTED|Overall Study|Enrolled participants|269||
60025979|NCT02131233|76141795|FG000|Treated|Overall Study||531||
60025980|NCT02131233|76141796|FG001|Treated|Overall Study||266||
60025981|NCT02131233|76141795|FG000|COMPLETED|Overall Study|Completed to Week 96|467||
60025982|NCT02131233|76141796|FG001|COMPLETED|Overall Study|Completed to Week 96|227||
60025983|NCT02131233|76141795|FG000|NOT COMPLETED|Overall Study||66||
60025984|NCT02131233|76141796|FG001|NOT COMPLETED|Overall Study||42||
59915287|NCT02876601|76036142|FG000|NOT COMPLETED|First Intervention (24 Hours)||0||
59915288|NCT02876601|76036143|FG001|NOT COMPLETED|First Intervention (24 Hours)||0||
59915289|NCT02876601|76036144|FG002|NOT COMPLETED|First Intervention (24 Hours)||0||
59915290|NCT02876601|76036145|FG003|NOT COMPLETED|First Intervention (24 Hours)||0||
60025985|NCT02131155|76141804|FG000|STARTED|Overall Study|Started are treated patients.|25||
60025986|NCT02131155|76141805|FG001|STARTED|Overall Study|Started are treated patients.|11||
60067788|NCT01973569|76182983|FG002|Discontinued Study Treatment|Overall Study||15||
60025987|NCT02131155|76141804|FG000|COMPLETED|Overall Study|Completed are patients who completed study procedures as protocol requires.|0||
60025988|NCT02131155|76141805|FG001|COMPLETED|Overall Study|Completed are patients who completed study procedures as protocol requires.|0||
60025989|NCT02131155|76141804|FG000|NOT COMPLETED|Overall Study||25||
60025990|NCT02131155|76141805|FG001|NOT COMPLETED|Overall Study||11||
60025991|NCT01933594|76141817|FG000|STARTED|Overall Study||12||
60025992|NCT01933594|76141818|FG001|STARTED|Overall Study||12||
60025993|NCT01933594|76141819|FG002|STARTED|Overall Study||12||
60025994|NCT01933594|76141820|FG003|STARTED|Overall Study||7||
60025995|NCT01933594|76141821|FG004|STARTED|Overall Study||13||
60025996|NCT01933594|76141822|FG005|STARTED|Overall Study||3||
60025997|NCT01933594|76141817|FG000|COMPLETED|Overall Study||11||
60025998|NCT01933594|76141818|FG001|COMPLETED|Overall Study||12||
60025999|NCT01933594|76141819|FG002|COMPLETED|Overall Study||12||
60026000|NCT01933594|76141820|FG003|COMPLETED|Overall Study||7||
60026001|NCT01933594|76141821|FG004|COMPLETED|Overall Study||11||
60026002|NCT01933594|76141822|FG005|COMPLETED|Overall Study||3||
60026003|NCT01933594|76141817|FG000|NOT COMPLETED|Overall Study||1||
60026004|NCT01933594|76141818|FG001|NOT COMPLETED|Overall Study||0||
60026005|NCT01933594|76141819|FG002|NOT COMPLETED|Overall Study||0||
60026006|NCT01933594|76141820|FG003|NOT COMPLETED|Overall Study||0||
60026007|NCT01933594|76141821|FG004|NOT COMPLETED|Overall Study||2||
60026008|NCT01933594|76141822|FG005|NOT COMPLETED|Overall Study||0||
60026009|NCT01932970|76141840|FG000|STARTED|Overall Study|Includes all participants who enrolled into the washout period.|158||
60026010|NCT01932970|76141840|FG000|Received Treatment|Overall Study|Includes participants who completed the washout period and received etelcalcetide|148||
60026011|NCT01932970|76141840|FG000|COMPLETED|Overall Study||140||
60026012|NCT01932970|76141840|FG000|NOT COMPLETED|Overall Study||18||
60026013|NCT01912768|76141846|FG000|STARTED|Overall Study||239||
60026014|NCT01912768|76141847|FG001|STARTED|Overall Study||113||
60026015|NCT01912768|76141846|FG000|COMPLETED|Overall Study||229||
60026016|NCT01912768|76141847|FG001|COMPLETED|Overall Study||109||
60026017|NCT01912768|76141846|FG000|NOT COMPLETED|Overall Study||10||
60026018|NCT01912768|76141847|FG001|NOT COMPLETED|Overall Study||4||
60026019|NCT02305849|76141857|FG000|STARTED|Overall Study||175||
60026020|NCT02305849|76141858|FG001|STARTED|Overall Study||174||
60026021|NCT02305849|76141859|FG002|STARTED|Overall Study||85||
60026022|NCT02305849|76141860|FG003|STARTED|Overall Study||85||
60026023|NCT02305849|76141857|FG000|COMPLETED|Overall Study||148||
60026024|NCT02305849|76141858|FG001|COMPLETED|Overall Study||146||
60026025|NCT02305849|76141859|FG002|COMPLETED|Overall Study||67||
60026026|NCT02305849|76141860|FG003|COMPLETED|Overall Study||66||
60026027|NCT02305849|76141857|FG000|NOT COMPLETED|Overall Study||27||
60026028|NCT02305849|76141858|FG001|NOT COMPLETED|Overall Study||28||
60026029|NCT02305849|76141859|FG002|NOT COMPLETED|Overall Study||18||
60026030|NCT02305849|76141860|FG003|NOT COMPLETED|Overall Study||19||
60026031|NCT02371759|76141899|FG000|STARTED|Overall Study||32||
60026032|NCT02371759|76141900|FG001|STARTED|Overall Study||31||
60026033|NCT02371759|76141901|FG002|STARTED|Overall Study||33||
60026034|NCT02371759|76141902|FG003|STARTED|Overall Study||31||
60026035|NCT02371759|76141903|FG004|STARTED|Overall Study||27||
60026036|NCT02371759|76141904|FG005|STARTED|Overall Study||26||
60026037|NCT02371759|76141905|FG006|STARTED|Overall Study||25||
60026038|NCT02371759|76141906|FG007|STARTED|Overall Study||28||
60026039|NCT02371759|76141899|FG000|COMPLETED|Overall Study||29||
60026040|NCT02371759|76141900|FG001|COMPLETED|Overall Study||30||
60026041|NCT02371759|76141901|FG002|COMPLETED|Overall Study||32||
60026042|NCT02371759|76141902|FG003|COMPLETED|Overall Study||31||
60026043|NCT02371759|76141903|FG004|COMPLETED|Overall Study||24||
60026044|NCT02371759|76141904|FG005|COMPLETED|Overall Study||25||
60026045|NCT02371759|76141905|FG006|COMPLETED|Overall Study||25||
60026046|NCT02371759|76141906|FG007|COMPLETED|Overall Study||24||
60026047|NCT02371759|76141899|FG000|NOT COMPLETED|Overall Study||3||
60026048|NCT02371759|76141900|FG001|NOT COMPLETED|Overall Study||1||
60026049|NCT02371759|76141901|FG002|NOT COMPLETED|Overall Study||1||
60026050|NCT02371759|76141902|FG003|NOT COMPLETED|Overall Study||0||
60026051|NCT02371759|76141903|FG004|NOT COMPLETED|Overall Study||3||
60026052|NCT02371759|76141904|FG005|NOT COMPLETED|Overall Study||1||
60026053|NCT02371759|76141905|FG006|NOT COMPLETED|Overall Study||0||
60026054|NCT02371759|76141906|FG007|NOT COMPLETED|Overall Study||4||
60026055|NCT02531633|76141929|FG000|STARTED|Part A (52 Weeks)||42||
60026056|NCT02531633|76141930|FG001|STARTED|Part A (52 Weeks)||39||
60026057|NCT02531633|76141931|FG002|STARTED|Part A (52 Weeks)||26||
60026058|NCT02531633|76141932|FG003|STARTED|Part A (52 Weeks)||27||
60026059|NCT02531633|76141933|FG004|STARTED|Part A (52 Weeks)||27||
60026060|NCT02531633|76141934|FG005|STARTED|Part A (52 Weeks)||0||
60026061|NCT02531633|76141935|FG006|STARTED|Part A (52 Weeks)||0||
60026062|NCT02531633|76141936|FG007|STARTED|Part A (52 Weeks)||0||
60026063|NCT02531633|76141937|FG008|STARTED|Part A (52 Weeks)||0||
60026064|NCT02531633|76141938|FG009|STARTED|Part A (52 Weeks)||0||
60026065|NCT02531633|76141929|FG000|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||1|2 Participants completed Part A then withdrew. They are counted again in withdrawals|
60026066|NCT02531633|76141930|FG001|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0|2 Participants completed Part A then withdrew. They are counted again in withdrawals|
60026067|NCT02531633|76141931|FG002|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||1|2 Participants completed Part A then withdrew. They are counted again in withdrawals|
60026068|NCT02531633|76141932|FG003|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0|2 Participants completed Part A then withdrew. They are counted again in withdrawals|
60026069|NCT02531633|76141933|FG004|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0|2 Participants completed Part A then withdrew. They are counted again in withdrawals|
60026070|NCT02531633|76141934|FG005|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0|2 Participants completed Part A then withdrew. They are counted again in withdrawals|
60026071|NCT02531633|76141935|FG006|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0|2 Participants completed Part A then withdrew. They are counted again in withdrawals|
60026072|NCT02531633|76141936|FG007|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0|2 Participants completed Part A then withdrew. They are counted again in withdrawals|
60026073|NCT02531633|76141937|FG008|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0|2 Participants completed Part A then withdrew. They are counted again in withdrawals|
60026074|NCT02531633|76141938|FG009|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0|2 Participants completed Part A then withdrew. They are counted again in withdrawals|
60026075|NCT02531633|76141929|FG000|COMPLETED|Part A (52 Weeks)||8|Completed Part A and entered Part B|
60026076|NCT02531633|76141930|FG001|COMPLETED|Part A (52 Weeks)||5|Completed Part A and entered Part B|
60026077|NCT02531633|76141931|FG002|COMPLETED|Part A (52 Weeks)||4|Completed Part A and entered Part B|
60026078|NCT02531633|76141932|FG003|COMPLETED|Part A (52 Weeks)||5|Completed Part A and entered Part B|
60026079|NCT02531633|76141933|FG004|COMPLETED|Part A (52 Weeks)||4|Completed Part A and entered Part B|
60026080|NCT02531633|76141934|FG005|COMPLETED|Part A (52 Weeks)||0|Completed Part A and entered Part B|
60026081|NCT02531633|76141935|FG006|COMPLETED|Part A (52 Weeks)||0|Completed Part A and entered Part B|
60026082|NCT02531633|76141936|FG007|COMPLETED|Part A (52 Weeks)||0|Completed Part A and entered Part B|
60026083|NCT02531633|76141937|FG008|COMPLETED|Part A (52 Weeks)||0|Completed Part A and entered Part B|
60026084|NCT02531633|76141938|FG009|COMPLETED|Part A (52 Weeks)||0|Completed Part A and entered Part B|
60026085|NCT02531633|76141929|FG000|NOT COMPLETED|Part A (52 Weeks)||34||
60026086|NCT02531633|76141930|FG001|NOT COMPLETED|Part A (52 Weeks)||34||
60026087|NCT02531633|76141931|FG002|NOT COMPLETED|Part A (52 Weeks)||22||
60026088|NCT02531633|76141932|FG003|NOT COMPLETED|Part A (52 Weeks)||22||
60026089|NCT02531633|76141933|FG004|NOT COMPLETED|Part A (52 Weeks)||23||
60026090|NCT02531633|76141934|FG005|NOT COMPLETED|Part A (52 Weeks)||0||
60026091|NCT02531633|76141935|FG006|NOT COMPLETED|Part A (52 Weeks)||0||
60026092|NCT02531633|76141936|FG007|NOT COMPLETED|Part A (52 Weeks)||0||
60026093|NCT02531633|76141937|FG008|NOT COMPLETED|Part A (52 Weeks)||0||
60026094|NCT02531633|76141938|FG009|NOT COMPLETED|Part A (52 Weeks)||0||
60026095|NCT02531633|76141929|FG000|STARTED|Part B (104 Weeks)||0||
60026096|NCT02531633|76141930|FG001|STARTED|Part B (104 Weeks)||0||
60026097|NCT02531633|76141931|FG002|STARTED|Part B (104 Weeks)||0||
60026098|NCT02531633|76141932|FG003|STARTED|Part B (104 Weeks)||0||
60026099|NCT02531633|76141933|FG004|STARTED|Part B (104 Weeks)||0||
60026100|NCT02531633|76141934|FG005|STARTED|Part B (104 Weeks)||8||
60026101|NCT02531633|76141935|FG006|STARTED|Part B (104 Weeks)||5||
60026102|NCT02531633|76141936|FG007|STARTED|Part B (104 Weeks)||4||
60026103|NCT02531633|76141937|FG008|STARTED|Part B (104 Weeks)||5||
60026104|NCT02531633|76141938|FG009|STARTED|Part B (104 Weeks)||4||
60026105|NCT02531633|76141929|FG000|COMPLETED|Part B (104 Weeks)||0||
60026106|NCT02531633|76141930|FG001|COMPLETED|Part B (104 Weeks)||0||
60026107|NCT02531633|76141931|FG002|COMPLETED|Part B (104 Weeks)||0||
60026108|NCT02531633|76141932|FG003|COMPLETED|Part B (104 Weeks)||0||
60026109|NCT02531633|76141933|FG004|COMPLETED|Part B (104 Weeks)||0||
60026110|NCT02531633|76141934|FG005|COMPLETED|Part B (104 Weeks)||0||
60026111|NCT02531633|76141935|FG006|COMPLETED|Part B (104 Weeks)||0||
60026112|NCT02531633|76141936|FG007|COMPLETED|Part B (104 Weeks)||0||
60026113|NCT02531633|76141937|FG008|COMPLETED|Part B (104 Weeks)||0||
60026114|NCT02531633|76141938|FG009|COMPLETED|Part B (104 Weeks)||0||
60026115|NCT02531633|76141929|FG000|NOT COMPLETED|Part B (104 Weeks)||0||
60026116|NCT02531633|76141930|FG001|NOT COMPLETED|Part B (104 Weeks)||0||
60026117|NCT02531633|76141931|FG002|NOT COMPLETED|Part B (104 Weeks)||0||
60026118|NCT02531633|76141932|FG003|NOT COMPLETED|Part B (104 Weeks)||0||
60026119|NCT02531633|76141933|FG004|NOT COMPLETED|Part B (104 Weeks)||0||
60026120|NCT02531633|76141934|FG005|NOT COMPLETED|Part B (104 Weeks)||8||
60026121|NCT02531633|76141935|FG006|NOT COMPLETED|Part B (104 Weeks)||5||
60026122|NCT02531633|76141936|FG007|NOT COMPLETED|Part B (104 Weeks)||4||
60026123|NCT02531633|76141937|FG008|NOT COMPLETED|Part B (104 Weeks)||5||
60026124|NCT02531633|76141938|FG009|NOT COMPLETED|Part B (104 Weeks)||4||
60026125|NCT02536313|76141980|FG000|STARTED|Overall Study||24||
60026126|NCT02536313|76141981|FG001|STARTED|Overall Study||25||
60026127|NCT02536313|76141980|FG000|COMPLETED|Overall Study||24||
60026128|NCT02536313|76141981|FG001|COMPLETED|Overall Study||24||
60026129|NCT02536313|76141980|FG000|NOT COMPLETED|Overall Study||0||
60026130|NCT02536313|76141981|FG001|NOT COMPLETED|Overall Study||1||
60026131|NCT02187861|76141993|FG000|STARTED|Overall Study||9||
60026132|NCT02187861|76141994|FG001|STARTED|Overall Study||52||
60026133|NCT02187861|76141995|FG002|STARTED|Overall Study||51||
60026134|NCT02187861|76141996|FG003|STARTED|Overall Study||51||
60026135|NCT02187861|76141993|FG000|Treated|Overall Study||9||
60026136|NCT02187861|76141994|FG001|Treated|Overall Study||52||
60026137|NCT02187861|76141995|FG002|Treated|Overall Study||49||
60026138|NCT02187861|76141996|FG003|Treated|Overall Study||50||
60026139|NCT02187861|76141993|FG000|COMPLETED|Overall Study||3||
60026140|NCT02187861|76141994|FG001|COMPLETED|Overall Study||4||
60026141|NCT02187861|76141995|FG002|COMPLETED|Overall Study||19||
59507388|NCT02348359|75600630|FG002|NOT COMPLETED|Overall Study||14||
59507389|NCT02348359|75600631|FG003|NOT COMPLETED|Overall Study||12||
59507390|NCT02406885|75600643|FG000|STARTED|Overall Study||17||
59507391|NCT02406885|75600644|FG001|STARTED|Overall Study||16||
59507392|NCT02406885|75600643|FG000|COMPLETED|Overall Study||14||
60026142|NCT02187861|76141996|FG003|COMPLETED|Overall Study||19||
60026143|NCT02187861|76141993|FG000|NOT COMPLETED|Overall Study||6||
60026144|NCT02187861|76141994|FG001|NOT COMPLETED|Overall Study||48||
60026145|NCT02187861|76141995|FG002|NOT COMPLETED|Overall Study||32||
60026146|NCT02187861|76141996|FG003|NOT COMPLETED|Overall Study||32||
60026147|NCT02163993|76142011|FG000|STARTED|Treatment Period||138||
60026148|NCT02163993|76142012|FG001|STARTED|Treatment Period||68||
60026149|NCT02163993|76142013|FG002|STARTED|Treatment Period||68||
60026150|NCT02163993|76142014|FG003|STARTED|Treatment Period||71||
60026151|NCT02163993|76142015|FG004|STARTED|Treatment Period||69||
60026152|NCT02163993|76142011|FG000|Received at Least 1 Dose of Study Drug|Treatment Period||137||
60026153|NCT02163993|76142012|FG001|Received at Least 1 Dose of Study Drug|Treatment Period||68||
60026154|NCT02163993|76142013|FG002|Received at Least 1 Dose of Study Drug|Treatment Period||68||
60026155|NCT02163993|76142014|FG003|Received at Least 1 Dose of Study Drug|Treatment Period||70||
60026156|NCT02163993|76142015|FG004|Received at Least 1 Dose of Study Drug|Treatment Period||67||
60026157|NCT02163993|76142011|FG000|COMPLETED|Treatment Period||126||
60026158|NCT02163993|76142012|FG001|COMPLETED|Treatment Period||59||
60026159|NCT02163993|76142013|FG002|COMPLETED|Treatment Period||66||
60026160|NCT02163993|76142014|FG003|COMPLETED|Treatment Period||62||
60026161|NCT02163993|76142015|FG004|COMPLETED|Treatment Period||62||
60026162|NCT02163993|76142011|FG000|NOT COMPLETED|Treatment Period||12||
60026163|NCT02163993|76142012|FG001|NOT COMPLETED|Treatment Period||9||
60026164|NCT02163993|76142013|FG002|NOT COMPLETED|Treatment Period||2||
60026165|NCT02163993|76142014|FG003|NOT COMPLETED|Treatment Period||9||
60026166|NCT02163993|76142015|FG004|NOT COMPLETED|Treatment Period||7||
60026167|NCT02163993|76142011|FG000|STARTED|Post-treatment Period|One participant discontinued after Treatment Period. Did not enter into Post-treatment Period.|125||
60026168|NCT02163993|76142012|FG001|STARTED|Post-treatment Period|Participants who discontinued or completed the Treatment Period entered the Post-treatment period.|61||
60026169|NCT02163993|76142013|FG002|STARTED|Post-treatment Period||66||
60026170|NCT02163993|76142014|FG003|STARTED|Post-treatment Period|Participants who discontinued or completed the Treatment Period entered the Post-treatment period.|63||
60026171|NCT02163993|76142015|FG004|STARTED|Post-treatment Period|Participants who discontinued or completed the Treatment Period entered the Post-treatment period.|65||
60026172|NCT02163993|76142011|FG000|COMPLETED|Post-treatment Period||121||
60026173|NCT02163993|76142012|FG001|COMPLETED|Post-treatment Period||55||
60026174|NCT02163993|76142013|FG002|COMPLETED|Post-treatment Period||62||
60026175|NCT02163993|76142014|FG003|COMPLETED|Post-treatment Period||61||
60026176|NCT02163993|76142015|FG004|COMPLETED|Post-treatment Period||62||
60026177|NCT02163993|76142011|FG000|NOT COMPLETED|Post-treatment Period||4||
60026178|NCT02163993|76142012|FG001|NOT COMPLETED|Post-treatment Period||6||
60026179|NCT02163993|76142013|FG002|NOT COMPLETED|Post-treatment Period||4||
60026180|NCT02163993|76142014|FG003|NOT COMPLETED|Post-treatment Period||2||
60026181|NCT02163993|76142015|FG004|NOT COMPLETED|Post-treatment Period||3||
60026182|NCT02527421|76142038|FG000|STARTED|Overall Study||2||
60026183|NCT02527421|76142039|FG001|STARTED|Overall Study||1||
60026184|NCT02527421|76142038|FG000|COMPLETED|Overall Study||1||
60026185|NCT02527421|76142039|FG001|COMPLETED|Overall Study||1||
60026186|NCT02527421|76142038|FG000|NOT COMPLETED|Overall Study||1||
60026187|NCT02527421|76142039|FG001|NOT COMPLETED|Overall Study||0||
60026188|NCT02163915|76142050|FG000|STARTED|Overall Study||10||
60026189|NCT02163915|76142051|FG001|STARTED|Overall Study||8||
60026190|NCT02163915|76142052|FG002|STARTED|Overall Study||10||
60026191|NCT02163915|76142053|FG003|STARTED|Overall Study||9||
60026192|NCT02163915|76142054|FG004|STARTED|Overall Study||10||
60026193|NCT02163915|76142050|FG000|COMPLETED|Overall Study||7||
60026194|NCT02163915|76142051|FG001|COMPLETED|Overall Study||8||
60026195|NCT02163915|76142052|FG002|COMPLETED|Overall Study||8||
60026196|NCT02163915|76142053|FG003|COMPLETED|Overall Study||6||
60026197|NCT02163915|76142054|FG004|COMPLETED|Overall Study||6||
60026198|NCT02163915|76142050|FG000|NOT COMPLETED|Overall Study||3||
60026199|NCT02163915|76142051|FG001|NOT COMPLETED|Overall Study||0||
60026200|NCT02163915|76142052|FG002|NOT COMPLETED|Overall Study||2||
60026201|NCT02163915|76142053|FG003|NOT COMPLETED|Overall Study||3||
60026202|NCT02163915|76142054|FG004|NOT COMPLETED|Overall Study||4||
60026203|NCT02163759|76142073|FG000|STARTED|Overall Study||72||
60026204|NCT02163759|76142074|FG001|STARTED|Overall Study||142||
60026205|NCT02163759|76142075|FG002|STARTED|Overall Study||144||
60026206|NCT02163759|76142073|FG000|Completed Week 10|Overall Study||71||
60026207|NCT02163759|76142074|FG001|Completed Week 10|Overall Study||141||
60026208|NCT02163759|76142075|FG002|Completed Week 10|Overall Study||143||
60026209|NCT02163759|76142073|FG000|COMPLETED|Overall Study||71|Participants who rolled into open-label extension study or completed 12 weeks safety follow-up following treatment completion or discontinuation.|
60026210|NCT02163759|76142074|FG001|COMPLETED|Overall Study||137|Participants who rolled into open-label extension study or completed 12 weeks safety follow-up following treatment completion or discontinuation.|
60026211|NCT02163759|76142075|FG002|COMPLETED|Overall Study||141|Participants who rolled into open-label extension study or completed 12 weeks safety follow-up following treatment completion or discontinuation.|
60026212|NCT02163759|76142073|FG000|NOT COMPLETED|Overall Study||1||
60026213|NCT02163759|76142074|FG001|NOT COMPLETED|Overall Study||5||
60026214|NCT02163759|76142075|FG002|NOT COMPLETED|Overall Study||3||
60026215|NCT02371369|76142088|FG000|STARTED|Part 1||61||
60026216|NCT02371369|76142089|FG001|STARTED|Part 1||59||
60026217|NCT02371369|76142088|FG000|COMPLETED|Part 1||52||
60026218|NCT02371369|76142089|FG001|COMPLETED|Part 1||48||
60026219|NCT02371369|76142088|FG000|NOT COMPLETED|Part 1||9||
60026220|NCT02371369|76142089|FG001|NOT COMPLETED|Part 1||11||
60026221|NCT02371369|76142088|FG000|STARTED|Part 2|N=48; Only participants who were eligible to receive treatment in Part 2.|48||
60026222|NCT02371369|76142089|FG001|STARTED|Part 2|N=30; Only participants who were eligible to receive treatment in Part 2.|30||
60026223|NCT02371369|76142088|FG000|COMPLETED|Part 2||0||
60026224|NCT02371369|76142089|FG001|COMPLETED|Part 2||0||
60026225|NCT02371369|76142088|FG000|NOT COMPLETED|Part 2||48||
60026226|NCT02371369|76142089|FG001|NOT COMPLETED|Part 2||30||
60026227|NCT02187783|76142111|FG000|STARTED|Overall Study||106||
60026228|NCT02187783|76142111|FG000|Patients With Solid Tumors|Overall Study||105||
60026229|NCT02187783|76142111|FG000|COMPLETED|Overall Study||0||
60026230|NCT02187783|76142111|FG000|NOT COMPLETED|Overall Study||106||
60026231|NCT02337361|76142117|FG000|STARTED|Baseline Assessment||99||
60026232|NCT02337361|76142118|FG001|STARTED|Baseline Assessment||86||
60026233|NCT02337361|76142117|FG000|COMPLETED|Baseline Assessment||99||
60026234|NCT02337361|76142118|FG001|COMPLETED|Baseline Assessment||86||
60026235|NCT02337361|76142117|FG000|NOT COMPLETED|Baseline Assessment||0||
60026236|NCT02337361|76142118|FG001|NOT COMPLETED|Baseline Assessment||0||
60026237|NCT02337361|76142117|FG000|STARTED|3-month Follow-up||99||
60026238|NCT02337361|76142118|FG001|STARTED|3-month Follow-up||86||
60026239|NCT02337361|76142117|FG000|COMPLETED|3-month Follow-up||80||
60026240|NCT02337361|76142118|FG001|COMPLETED|3-month Follow-up||72||
60026241|NCT02337361|76142117|FG000|NOT COMPLETED|3-month Follow-up||19||
60026242|NCT02337361|76142118|FG001|NOT COMPLETED|3-month Follow-up||14||
60026243|NCT02337361|76142117|FG000|STARTED|6-month Follow-up||80||
60026244|NCT02337361|76142118|FG001|STARTED|6-month Follow-up||72||
60026245|NCT02337361|76142117|FG000|COMPLETED|6-month Follow-up||78||
60026246|NCT02337361|76142118|FG001|COMPLETED|6-month Follow-up||68||
60026247|NCT02337361|76142117|FG000|NOT COMPLETED|6-month Follow-up||2||
60026248|NCT02337361|76142118|FG001|NOT COMPLETED|6-month Follow-up||4||
60026249|NCT02336737|76142125|FG000|STARTED|Overall Study||160||
60026250|NCT02336737|76142125|FG000|COMPLETED|Overall Study||147||
60026251|NCT02336737|76142125|FG000|NOT COMPLETED|Overall Study||13||
60026252|NCT02130765|76142134|FG000|STARTED|Overall Study||11||
60026253|NCT02130765|76142135|FG001|STARTED|Overall Study||8||
60026254|NCT02130765|76142136|FG002|STARTED|Overall Study||26||
60026255|NCT02130765|76142137|FG003|STARTED|Overall Study||19||
60026256|NCT02130765|76142134|FG000|COMPLETED|Overall Study||7||
60026257|NCT02130765|76142135|FG001|COMPLETED|Overall Study||8||
60026258|NCT02130765|76142136|FG002|COMPLETED|Overall Study||26||
60026259|NCT02130765|76142137|FG003|COMPLETED|Overall Study||19||
60026260|NCT02130765|76142134|FG000|NOT COMPLETED|Overall Study||4||
60026261|NCT02130765|76142135|FG001|NOT COMPLETED|Overall Study||0||
60026262|NCT02130765|76142136|FG002|NOT COMPLETED|Overall Study||0||
60026263|NCT02130765|76142137|FG003|NOT COMPLETED|Overall Study||0||
60026264|NCT02305381|76142152|FG000|STARTED|Overall Study||132||
60026265|NCT02305381|76142153|FG001|STARTED|Overall Study||132||
60026266|NCT02305381|76142154|FG002|STARTED|Overall Study||133||
60026267|NCT02305381|76142152|FG000|Exposed|Overall Study||132||
60026268|NCT02305381|76142153|FG001|Exposed|Overall Study||131||
60026269|NCT02305381|76142154|FG002|Exposed|Overall Study||133||
60026270|NCT02305381|76142152|FG000|Premature Discontinuation of Treatment|Overall Study|Subjects who prematurely discontinued treatment were allowed to continue participation in the trial.|14||
60026271|NCT02305381|76142153|FG001|Premature Discontinuation of Treatment|Overall Study|Subjects who prematurely discontinued treatment were allowed to continue participation in the trial|16||
60026272|NCT02305381|76142154|FG002|Premature Discontinuation of Treatment|Overall Study|Subjects who prematurely discontinued treatment were allowed to continue participation in the trial.|13||
59507393|NCT02406885|75600644|FG001|COMPLETED|Overall Study||14||
59507394|NCT02406885|75600643|FG000|NOT COMPLETED|Overall Study||3||
59507395|NCT02406885|75600644|FG001|NOT COMPLETED|Overall Study||2||
59507396|NCT02407041|75600650|FG000|STARTED|Overall Study||5||
59507397|NCT02407041|75600650|FG000|COMPLETED|Overall Study||5||
59507398|NCT02407041|75600650|FG000|NOT COMPLETED|Overall Study||0||
59507399|NCT02341599|75600659|FG000|STARTED|Overall Study||8||
60026273|NCT02305381|76142152|FG000|COMPLETED|Overall Study|Subjects who completed the trial.|127||
60026274|NCT02305381|76142153|FG001|COMPLETED|Overall Study|Subjects who completed the trial.|127||
60026275|NCT02305381|76142154|FG002|COMPLETED|Overall Study|Subjects who completed the trial.|126||
60026276|NCT02305381|76142152|FG000|NOT COMPLETED|Overall Study||5||
60026277|NCT02305381|76142153|FG001|NOT COMPLETED|Overall Study||5||
60026278|NCT02305381|76142154|FG002|NOT COMPLETED|Overall Study||7||
60026279|NCT02336425|76142166|FG000|STARTED|Overall Study||2||
60026280|NCT02336425|76142167|FG001|STARTED|Overall Study||2||
60026281|NCT02336425|76142168|FG002|STARTED|Overall Study||3||
60026282|NCT02336425|76142169|FG003|STARTED|Overall Study||3||
60026283|NCT02336425|76142166|FG000|COMPLETED|Overall Study||0||
60026284|NCT02336425|76142167|FG001|COMPLETED|Overall Study||0||
60026285|NCT02336425|76142168|FG002|COMPLETED|Overall Study||0||
60026286|NCT02336425|76142169|FG003|COMPLETED|Overall Study||0||
60026287|NCT02336425|76142166|FG000|NOT COMPLETED|Overall Study||2||
60026288|NCT02336425|76142167|FG001|NOT COMPLETED|Overall Study||2||
60026289|NCT02336425|76142168|FG002|NOT COMPLETED|Overall Study||3||
60026290|NCT02336425|76142169|FG003|NOT COMPLETED|Overall Study||3||
60026291|NCT02163447|76142182|FG000|STARTED|Overall Study||106||
60026292|NCT02163447|76142183|FG001|STARTED|Overall Study||94||
60026293|NCT02163447|76142184|FG002|STARTED|Overall Study||100||
60026294|NCT02163447|76142182|FG000|Infants Born|Overall Study||101||
60026295|NCT02163447|76142183|FG001|Infants Born|Overall Study||93||
60026296|NCT02163447|76142184|FG002|Infants Born|Overall Study||100||
60026297|NCT02163447|76142182|FG000|COMPLETED|Overall Study||100||
59611765|NCT01708902|75722748|FG000|NOT COMPLETED|Overall Study||17||
59759180|NCT00917267|75878534|FG000|COMPLETED|Overall Study||307||
59759181|NCT00917267|75878535|FG001|COMPLETED|Overall Study||266||
59915291|NCT02876601|76036142|FG000|STARTED|Washout (Minimum of 6 Weeks)||8||
59915292|NCT02876601|76036143|FG001|STARTED|Washout (Minimum of 6 Weeks)||8||
59915293|NCT02876601|76036144|FG002|STARTED|Washout (Minimum of 6 Weeks)||2||
59915294|NCT02876601|76036145|FG003|STARTED|Washout (Minimum of 6 Weeks)||2||
59915295|NCT02876601|76036142|FG000|COMPLETED|Washout (Minimum of 6 Weeks)||8||
59915296|NCT02876601|76036143|FG001|COMPLETED|Washout (Minimum of 6 Weeks)||8||
59915297|NCT02876601|76036144|FG002|COMPLETED|Washout (Minimum of 6 Weeks)||1||
59915298|NCT02876601|76036145|FG003|COMPLETED|Washout (Minimum of 6 Weeks)||2||
59915299|NCT02876601|76036142|FG000|NOT COMPLETED|Washout (Minimum of 6 Weeks)||0||
59915300|NCT02876601|76036143|FG001|NOT COMPLETED|Washout (Minimum of 6 Weeks)||0||
59915301|NCT02876601|76036144|FG002|NOT COMPLETED|Washout (Minimum of 6 Weeks)||1||
59915302|NCT02876601|76036145|FG003|NOT COMPLETED|Washout (Minimum of 6 Weeks)||0||
59915303|NCT02876601|76036142|FG000|STARTED|Second Intervention (24 Hours)||8||
59915304|NCT02876601|76036143|FG001|STARTED|Second Intervention (24 Hours)||8||
59915305|NCT02876601|76036144|FG002|STARTED|Second Intervention (24 Hours)||1||
59915306|NCT02876601|76036145|FG003|STARTED|Second Intervention (24 Hours)||2||
59915307|NCT02876601|76036142|FG000|COMPLETED|Second Intervention (24 Hours)||8||
59915308|NCT02876601|76036143|FG001|COMPLETED|Second Intervention (24 Hours)||8||
59915309|NCT02876601|76036144|FG002|COMPLETED|Second Intervention (24 Hours)||1||
59915310|NCT02876601|76036145|FG003|COMPLETED|Second Intervention (24 Hours)||2||
59915311|NCT02876601|76036142|FG000|NOT COMPLETED|Second Intervention (24 Hours)||0||
59915312|NCT02876601|76036143|FG001|NOT COMPLETED|Second Intervention (24 Hours)||0||
59915313|NCT02876601|76036144|FG002|NOT COMPLETED|Second Intervention (24 Hours)||0||
59915314|NCT02876601|76036145|FG003|NOT COMPLETED|Second Intervention (24 Hours)||0||
59915315|NCT04054193|76036190|FG000|STARTED|Cycle 1||103||
59915316|NCT04054193|76036190|FG000|Treated (≥1 Dose)|Cycle 1||100||
59915317|NCT04054193|76036190|FG000|COMPLETED|Cycle 1||98||
59915318|NCT04054193|76036190|FG000|NOT COMPLETED|Cycle 1||5||
59951304|NCT03641287|76070233|FG000|NOT COMPLETED|Overall Study||3||
60026298|NCT02163447|76142183|FG001|COMPLETED|Overall Study||88||
60026299|NCT02163447|76142184|FG002|COMPLETED|Overall Study||97||
60026300|NCT02163447|76142182|FG000|NOT COMPLETED|Overall Study||6||
60026301|NCT02163447|76142183|FG001|NOT COMPLETED|Overall Study||6||
60026302|NCT02163447|76142184|FG002|NOT COMPLETED|Overall Study||3||
60026303|NCT02370667|76142205|FG000|STARTED|Overall Study||10||
60026304|NCT02370667|76142206|FG001|STARTED|Overall Study||11||
60026305|NCT02370667|76142207|FG002|STARTED|Overall Study||10||
60026306|NCT02370667|76142205|FG000|COMPLETED|Overall Study||10||
60026307|NCT02370667|76142206|FG001|COMPLETED|Overall Study||10||
60026308|NCT02370667|76142207|FG002|COMPLETED|Overall Study||10||
60026309|NCT02370667|76142205|FG000|NOT COMPLETED|Overall Study||0||
60026310|NCT02370667|76142206|FG001|NOT COMPLETED|Overall Study||1||
60026311|NCT02370667|76142207|FG002|NOT COMPLETED|Overall Study||0||
60026312|NCT02130297|76142215|FG000|STARTED|Overall Study||30||
60026313|NCT02130297|76142215|FG000|COMPLETED|Overall Study||26||
60026314|NCT02130297|76142215|FG000|NOT COMPLETED|Overall Study||4||
60026315|NCT01931956|76142223|FG000|STARTED|Overall Study||59||
60026316|NCT01931956|76142224|FG001|STARTED|Overall Study||7||
60026317|NCT01931956|76142225|FG002|STARTED|Overall Study||628||
60026318|NCT01931956|76142226|FG003|STARTED|Overall Study||271||
60026319|NCT01931956|76142223|FG000|COMPLETED|Overall Study||8||
60026320|NCT01931956|76142224|FG001|COMPLETED|Overall Study||0||
60026321|NCT01931956|76142225|FG002|COMPLETED|Overall Study||141||
60026322|NCT01931956|76142226|FG003|COMPLETED|Overall Study||138||
60026323|NCT01931956|76142223|FG000|NOT COMPLETED|Overall Study||51||
60026324|NCT01931956|76142224|FG001|NOT COMPLETED|Overall Study||7||
60026325|NCT01931956|76142225|FG002|NOT COMPLETED|Overall Study||487||
60026326|NCT01931956|76142226|FG003|NOT COMPLETED|Overall Study||133||
60026327|NCT01887418|76142252|FG000|STARTED|Overall Study||15||
60026328|NCT01887418|76142253|FG001|STARTED|Overall Study||14||
60026329|NCT01887418|76142254|FG002|STARTED|Overall Study||10||
60026330|NCT01887418|76142252|FG000|COMPLETED|Overall Study||15||
60026331|NCT01887418|76142253|FG001|COMPLETED|Overall Study||14||
60026332|NCT01887418|76142254|FG002|COMPLETED|Overall Study||9||
59759182|NCT00917267|75878534|FG000|NOT COMPLETED|Overall Study||39||
59759183|NCT00917267|75878535|FG001|NOT COMPLETED|Overall Study||79||
59759184|NCT00920699|75878548|FG000|STARTED|Overall Study||29||
59759185|NCT00920699|75878549|FG001|STARTED|Overall Study||30||
59759186|NCT00920699|75878550|FG002|STARTED|Overall Study||32||
59759187|NCT00920699|75878548|FG000|COMPLETED|Overall Study||27||
59759188|NCT00920699|75878549|FG001|COMPLETED|Overall Study||29||
60026333|NCT01887418|76142252|FG000|NOT COMPLETED|Overall Study||0||
60026334|NCT01887418|76142253|FG001|NOT COMPLETED|Overall Study||0||
60026335|NCT01887418|76142254|FG002|NOT COMPLETED|Overall Study||1||
60026336|NCT01886716|76142266|FG000|STARTED|Week 1||24||
60026337|NCT01886716|76142267|FG001|STARTED|Week 1||20||
60026338|NCT01886716|76142268|FG002|STARTED|Week 1||22||
60026339|NCT01886716|76142269|FG003|STARTED|Week 1||20||
60026340|NCT01886716|76142266|FG000|COMPLETED|Week 1||24||
60026341|NCT01886716|76142267|FG001|COMPLETED|Week 1||20||
60026342|NCT01886716|76142268|FG002|COMPLETED|Week 1||20||
60026343|NCT01886716|76142269|FG003|COMPLETED|Week 1||18||
60026344|NCT01886716|76142266|FG000|NOT COMPLETED|Week 1||0||
60026345|NCT01886716|76142267|FG001|NOT COMPLETED|Week 1||0||
60026346|NCT01886716|76142268|FG002|NOT COMPLETED|Week 1||2||
60026347|NCT01886716|76142269|FG003|NOT COMPLETED|Week 1||2||
60026348|NCT01886716|76142266|FG000|STARTED|Week 2||24||
60026349|NCT01886716|76142267|FG001|STARTED|Week 2||20||
60026350|NCT01886716|76142268|FG002|STARTED|Week 2||20||
60026351|NCT01886716|76142269|FG003|STARTED|Week 2||18||
59759189|NCT00920699|75878550|FG002|COMPLETED|Overall Study||28||
59759190|NCT00920699|75878548|FG000|NOT COMPLETED|Overall Study||2||
59759191|NCT00920699|75878549|FG001|NOT COMPLETED|Overall Study||1||
60026352|NCT01886716|76142266|FG000|COMPLETED|Week 2||21||
60026353|NCT01886716|76142267|FG001|COMPLETED|Week 2||18||
60026354|NCT01886716|76142268|FG002|COMPLETED|Week 2||19||
60026355|NCT01886716|76142269|FG003|COMPLETED|Week 2||15||
60026356|NCT01886716|76142266|FG000|NOT COMPLETED|Week 2||3||
60026357|NCT01886716|76142267|FG001|NOT COMPLETED|Week 2||2||
60026358|NCT01886716|76142268|FG002|NOT COMPLETED|Week 2||1||
59759192|NCT00920699|75878550|FG002|NOT COMPLETED|Overall Study||4||
59759193|NCT03462576|75878561|FG000|STARTED|Overall Study||46||
59759194|NCT03462576|75878562|FG001|STARTED|Overall Study||48||
59759195|NCT03462576|75878563|FG002|STARTED|Overall Study||45||
59759196|NCT03462576|75878561|FG000|COMPLETED|Overall Study||41||
60026359|NCT01886716|76142269|FG003|NOT COMPLETED|Week 2||3||
60026360|NCT01886716|76142266|FG000|STARTED|Week 3||21||
60026361|NCT01886716|76142267|FG001|STARTED|Week 3||18||
60026362|NCT01886716|76142268|FG002|STARTED|Week 3||19||
60026363|NCT01886716|76142269|FG003|STARTED|Week 3||15||
60026364|NCT01886716|76142266|FG000|COMPLETED|Week 3||20||
60026365|NCT01886716|76142267|FG001|COMPLETED|Week 3||17||
60026366|NCT01886716|76142268|FG002|COMPLETED|Week 3||19||
60026367|NCT01886716|76142269|FG003|COMPLETED|Week 3||14||
60026368|NCT01886716|76142266|FG000|NOT COMPLETED|Week 3||1||
60026369|NCT01886716|76142267|FG001|NOT COMPLETED|Week 3||1||
60026370|NCT01886716|76142268|FG002|NOT COMPLETED|Week 3||0||
60026371|NCT01886716|76142269|FG003|NOT COMPLETED|Week 3||1||
60026372|NCT01886716|76142266|FG000|STARTED|Week 4||20||
60026373|NCT01886716|76142267|FG001|STARTED|Week 4||17||
60026374|NCT01886716|76142268|FG002|STARTED|Week 4||19||
60026375|NCT01886716|76142269|FG003|STARTED|Week 4||14||
60026376|NCT01886716|76142266|FG000|COMPLETED|Week 4||20||
60026377|NCT01886716|76142267|FG001|COMPLETED|Week 4||17||
60026378|NCT01886716|76142268|FG002|COMPLETED|Week 4||19||
60026379|NCT01886716|76142269|FG003|COMPLETED|Week 4||14||
60026380|NCT01886716|76142266|FG000|NOT COMPLETED|Week 4||0||
60026381|NCT01886716|76142267|FG001|NOT COMPLETED|Week 4||0||
60026382|NCT01886716|76142268|FG002|NOT COMPLETED|Week 4||0||
60026383|NCT01886716|76142269|FG003|NOT COMPLETED|Week 4||0||
60026384|NCT01886716|76142266|FG000|STARTED|1-Week Post Follow-Up||20||
60026385|NCT01886716|76142267|FG001|STARTED|1-Week Post Follow-Up||17||
60026386|NCT01886716|76142268|FG002|STARTED|1-Week Post Follow-Up||19||
60026387|NCT01886716|76142269|FG003|STARTED|1-Week Post Follow-Up||14||
60026388|NCT01886716|76142266|FG000|COMPLETED|1-Week Post Follow-Up||20||
60026389|NCT01886716|76142267|FG001|COMPLETED|1-Week Post Follow-Up||17||
60026390|NCT01886716|76142268|FG002|COMPLETED|1-Week Post Follow-Up||19||
60026391|NCT01886716|76142269|FG003|COMPLETED|1-Week Post Follow-Up||14||
60026392|NCT01886716|76142266|FG000|NOT COMPLETED|1-Week Post Follow-Up||0||
60026393|NCT01886716|76142267|FG001|NOT COMPLETED|1-Week Post Follow-Up||0||
60026394|NCT01886716|76142268|FG002|NOT COMPLETED|1-Week Post Follow-Up||0||
60026395|NCT01886716|76142269|FG003|NOT COMPLETED|1-Week Post Follow-Up||0||
60026396|NCT01886716|76142266|FG000|STARTED|1-Month Post Follow-Up||20||
60026397|NCT01886716|76142267|FG001|STARTED|1-Month Post Follow-Up||17||
60026398|NCT01886716|76142268|FG002|STARTED|1-Month Post Follow-Up||19||
60026399|NCT01886716|76142269|FG003|STARTED|1-Month Post Follow-Up||14||
60026400|NCT01886716|76142266|FG000|COMPLETED|1-Month Post Follow-Up||20||
60026401|NCT01886716|76142267|FG001|COMPLETED|1-Month Post Follow-Up||17||
60026402|NCT01886716|76142268|FG002|COMPLETED|1-Month Post Follow-Up||19||
60026403|NCT01886716|76142269|FG003|COMPLETED|1-Month Post Follow-Up||14||
60026404|NCT01886716|76142266|FG000|NOT COMPLETED|1-Month Post Follow-Up||0||
60026405|NCT01886716|76142267|FG001|NOT COMPLETED|1-Month Post Follow-Up||0||
60026406|NCT01886716|76142268|FG002|NOT COMPLETED|1-Month Post Follow-Up||0||
60026407|NCT01886716|76142269|FG003|NOT COMPLETED|1-Month Post Follow-Up||0||
60026408|NCT01912612|76142281|FG000|STARTED|Overall Study||36||
60026409|NCT01912612|76142282|FG001|STARTED|Overall Study||40||
60026410|NCT01912612|76142283|FG002|STARTED|Overall Study||3||
60026411|NCT01912612|76142281|FG000|COMPLETED|Overall Study||31||
60026412|NCT01912612|76142282|FG001|COMPLETED|Overall Study||40||
60026413|NCT01912612|76142283|FG002|COMPLETED|Overall Study||0||
60026414|NCT01912612|76142281|FG000|NOT COMPLETED|Overall Study||5||
60026415|NCT01912612|76142282|FG001|NOT COMPLETED|Overall Study||0||
60026416|NCT01912612|76142283|FG002|NOT COMPLETED|Overall Study||3||
60026417|NCT02370511|76142292|FG000|STARTED|Overall Study||31||
60026418|NCT02370511|76142293|FG001|STARTED|Overall Study||30||
60026419|NCT02370511|76142294|FG002|STARTED|Overall Study||30||
60026420|NCT02370511|76142292|FG000|COMPLETED|Overall Study||19||
60026421|NCT02370511|76142293|FG001|COMPLETED|Overall Study||19||
60026422|NCT02370511|76142294|FG002|COMPLETED|Overall Study||29||
60026423|NCT02370511|76142292|FG000|NOT COMPLETED|Overall Study||12||
60026424|NCT02370511|76142293|FG001|NOT COMPLETED|Overall Study||11||
60026425|NCT02370511|76142294|FG002|NOT COMPLETED|Overall Study||1||
60026426|NCT02303041|76142304|FG000|STARTED|Overall Study||4||
60026427|NCT02303041|76142305|FG001|STARTED|Overall Study||6||
60026428|NCT02303041|76142304|FG000|COMPLETED|Overall Study||3||
60026429|NCT02303041|76142305|FG001|COMPLETED|Overall Study||4||
60026430|NCT02303041|76142304|FG000|NOT COMPLETED|Overall Study||1||
60026431|NCT02303041|76142305|FG001|NOT COMPLETED|Overall Study||2||
60026432|NCT02302807|76142313|FG000|STARTED|Overall Study||464||
60026433|NCT02302807|76142314|FG001|STARTED|Overall Study||467||
60026434|NCT02302807|76142313|FG000|Received Treatment|Overall Study||443||
60026435|NCT02302807|76142314|FG001|Received Treatment|Overall Study||459||
60026436|NCT02302807|76142313|FG000|COMPLETED|Overall Study|Participants still on chemotherapy were discontinued where that treatment was available locally.|0||
60026437|NCT02302807|76142314|FG001|COMPLETED|Overall Study|Participants still receiving atezolizumab had opportunity to continue treatment in extension study.|0||
60026438|NCT02302807|76142313|FG000|NOT COMPLETED|Overall Study||464||
60026439|NCT02302807|76142314|FG001|NOT COMPLETED|Overall Study||467||
60026440|NCT02335489|76142333|FG000|STARTED|Overall Study||10||
60026441|NCT02335489|76142333|FG000|Received Trial System|Overall Study||9||
60026442|NCT02335489|76142333|FG000|Receiving Permanent System|Overall Study||8||
60026443|NCT02335489|76142333|FG000|COMPLETED|Overall Study||0||
60026444|NCT02335489|76142333|FG000|NOT COMPLETED|Overall Study||10||
60026445|NCT02527343|76142339|FG000|STARTED|RT Period: Weeks 1 to 52||19||
60026446|NCT02527343|76142340|FG001|STARTED|RT Period: Weeks 1 to 52||21||
60026447|NCT02527343|76142341|FG002|STARTED|RT Period: Weeks 1 to 52||0||
60026448|NCT02527343|76142342|FG003|STARTED|RT Period: Weeks 1 to 52||0||
60026449|NCT02527343|76142343|FG004|STARTED|RT Period: Weeks 1 to 52||0||
60026450|NCT02527343|76142344|FG005|STARTED|RT Period: Weeks 1 to 52||0||
60026451|NCT02527343|76142339|FG000|COMPLETED|RT Period: Weeks 1 to 52||13||
60026452|NCT02527343|76142340|FG001|COMPLETED|RT Period: Weeks 1 to 52||14||
59611766|NCT01708902|75722749|FG001|NOT COMPLETED|Overall Study||8||
59611767|NCT01708902|75722750|FG002|NOT COMPLETED|Overall Study||17||
59915319|NCT04054193|76036190|FG000|STARTED|Cycles 2-3|Participation in Cycles 2-3 was optional after completing Cycle 1.|69||
59915320|NCT04054193|76036190|FG000|COMPLETED|Cycles 2-3||48|Completed Cycles 2 and 3|
59915321|NCT04054193|76036190|FG000|NOT COMPLETED|Cycles 2-3||21||
59915322|NCT03394027|76036198|FG000|STARTED|Overall Study||10||
59915323|NCT03394027|76036199|FG001|STARTED|Overall Study||6||
59915324|NCT03394027|76036200|FG002|STARTED|Overall Study||14||
59915325|NCT03394027|76036198|FG000|COMPLETED|Overall Study||7||
59915326|NCT03394027|76036199|FG001|COMPLETED|Overall Study||5||
59915327|NCT03394027|76036200|FG002|COMPLETED|Overall Study||10||
59915328|NCT03394027|76036198|FG000|NOT COMPLETED|Overall Study||3||
59915329|NCT03394027|76036199|FG001|NOT COMPLETED|Overall Study||1||
59915330|NCT03394027|76036200|FG002|NOT COMPLETED|Overall Study||4||
59915331|NCT03136107|76036226|FG000|STARTED|Overall Study||26||
59915332|NCT03136107|76036226|FG000|Test Product|Overall Study||26||
59915333|NCT03136107|76036226|FG000|Reference Product|Overall Study||26||
59915334|NCT03136107|76036226|FG000|Negative Control|Overall Study||26||
59915335|NCT03136107|76036226|FG000|COMPLETED|Overall Study||25||
59915336|NCT03136107|76036226|FG000|NOT COMPLETED|Overall Study||1||
59915337|NCT02916056|76036234|FG000|STARTED|Overall Study||297||
59915338|NCT02916056|76036234|FG000|COMPLETED|Overall Study||0||
59915339|NCT02916056|76036234|FG000|NOT COMPLETED|Overall Study||297||
59915340|NCT03384745|76036244|FG000|STARTED|Placebo Controlled Induction (W0 - W12)||52||
59915341|NCT03384745|76036245|FG001|STARTED|Placebo Controlled Induction (W0 - W12)||52||
59915342|NCT03384745|76036246|FG002|STARTED|Placebo Controlled Induction (W0 - W12)||53||
59915343|NCT03384745|76036247|FG003|STARTED|Placebo Controlled Induction (W0 - W12)||51||
59915344|NCT03384745|76036248|FG004|STARTED|Placebo Controlled Induction (W0 - W12)||52||
59915345|NCT03384745|76036249|FG005|STARTED|Placebo Controlled Induction (W0 - W12)||53||
59915346|NCT03384745|76036244|FG000|COMPLETED|Placebo Controlled Induction (W0 - W12)||52||
59915347|NCT03384745|76036245|FG001|COMPLETED|Placebo Controlled Induction (W0 - W12)||51||
59915348|NCT03384745|76036246|FG002|COMPLETED|Placebo Controlled Induction (W0 - W12)||50||
59915349|NCT03384745|76036247|FG003|COMPLETED|Placebo Controlled Induction (W0 - W12)||49||
59915350|NCT03384745|76036248|FG004|COMPLETED|Placebo Controlled Induction (W0 - W12)||49||
59915351|NCT03384745|76036249|FG005|COMPLETED|Placebo Controlled Induction (W0 - W12)||51||
59915352|NCT03384745|76036244|FG000|NOT COMPLETED|Placebo Controlled Induction (W0 - W12)||0||
59915353|NCT03384745|76036245|FG001|NOT COMPLETED|Placebo Controlled Induction (W0 - W12)||1||
59915354|NCT03384745|76036246|FG002|NOT COMPLETED|Placebo Controlled Induction (W0 - W12)||3||
59915355|NCT03384745|76036247|FG003|NOT COMPLETED|Placebo Controlled Induction (W0 - W12)||2||
59915356|NCT03384745|76036248|FG004|NOT COMPLETED|Placebo Controlled Induction (W0 - W12)||3||
59915357|NCT03384745|76036249|FG005|NOT COMPLETED|Placebo Controlled Induction (W0 - W12)||2||
59915358|NCT03384745|76036244|FG000|STARTED|Maintenance/Escalation (W12-W24)||52||
59915359|NCT03384745|76036245|FG001|STARTED|Maintenance/Escalation (W12-W24)||51||
59915360|NCT03384745|76036246|FG002|STARTED|Maintenance/Escalation (W12-W24)||50||
59915361|NCT03384745|76036247|FG003|STARTED|Maintenance/Escalation (W12-W24)||49||
59915362|NCT03384745|76036248|FG004|STARTED|Maintenance/Escalation (W12-W24)||49||
59915363|NCT03384745|76036249|FG005|STARTED|Maintenance/Escalation (W12-W24)||51||
59915364|NCT03384745|76036244|FG000|COMPLETED|Maintenance/Escalation (W12-W24)||52||
59915365|NCT03384745|76036245|FG001|COMPLETED|Maintenance/Escalation (W12-W24)||51||
59915366|NCT03384745|76036246|FG002|COMPLETED|Maintenance/Escalation (W12-W24)||49||
59915367|NCT03384745|76036247|FG003|COMPLETED|Maintenance/Escalation (W12-W24)||47||
59915368|NCT03384745|76036248|FG004|COMPLETED|Maintenance/Escalation (W12-W24)||47||
59915369|NCT03384745|76036249|FG005|COMPLETED|Maintenance/Escalation (W12-W24)||51||
59915370|NCT03384745|76036244|FG000|NOT COMPLETED|Maintenance/Escalation (W12-W24)||0||
59915371|NCT03384745|76036245|FG001|NOT COMPLETED|Maintenance/Escalation (W12-W24)||0||
59915372|NCT03384745|76036246|FG002|NOT COMPLETED|Maintenance/Escalation (W12-W24)||1||
59915373|NCT03384745|76036247|FG003|NOT COMPLETED|Maintenance/Escalation (W12-W24)||2||
59915374|NCT03384745|76036248|FG004|NOT COMPLETED|Maintenance/Escalation (W12-W24)||2||
59915375|NCT03384745|76036249|FG005|NOT COMPLETED|Maintenance/Escalation (W12-W24)||0||
59915376|NCT03384745|76036244|FG000|STARTED|Response Assess/Dose Hold (W24-W48)||52||
59915377|NCT03384745|76036245|FG001|STARTED|Response Assess/Dose Hold (W24-W48)||51||
59611768|NCT01708902|75722751|FG003|NOT COMPLETED|Overall Study||10||
59915378|NCT03384745|76036246|FG002|STARTED|Response Assess/Dose Hold (W24-W48)||49||
59915379|NCT03384745|76036247|FG003|STARTED|Response Assess/Dose Hold (W24-W48)||47||
59915380|NCT03384745|76036248|FG004|STARTED|Response Assess/Dose Hold (W24-W48)||47||
59915381|NCT03384745|76036249|FG005|STARTED|Response Assess/Dose Hold (W24-W48)||51||
59915382|NCT03384745|76036244|FG000|COMPLETED|Response Assess/Dose Hold (W24-W48)||51||
59915383|NCT03384745|76036245|FG001|COMPLETED|Response Assess/Dose Hold (W24-W48)||48||
59915384|NCT03384745|76036246|FG002|COMPLETED|Response Assess/Dose Hold (W24-W48)||45||
59915385|NCT03384745|76036247|FG003|COMPLETED|Response Assess/Dose Hold (W24-W48)||43||
59915386|NCT03384745|76036248|FG004|COMPLETED|Response Assess/Dose Hold (W24-W48)||46||
59915387|NCT03384745|76036249|FG005|COMPLETED|Response Assess/Dose Hold (W24-W48)||49||
59915388|NCT03384745|76036244|FG000|NOT COMPLETED|Response Assess/Dose Hold (W24-W48)||1||
60026453|NCT02527343|76142341|FG002|COMPLETED|RT Period: Weeks 1 to 52||0||
60026454|NCT02527343|76142342|FG003|COMPLETED|RT Period: Weeks 1 to 52||0||
60026455|NCT02527343|76142343|FG004|COMPLETED|RT Period: Weeks 1 to 52||0||
60026456|NCT02527343|76142344|FG005|COMPLETED|RT Period: Weeks 1 to 52||0||
60026457|NCT02527343|76142339|FG000|NOT COMPLETED|RT Period: Weeks 1 to 52||6||
60026458|NCT02527343|76142340|FG001|NOT COMPLETED|RT Period: Weeks 1 to 52||7||
60026459|NCT02527343|76142341|FG002|NOT COMPLETED|RT Period: Weeks 1 to 52||0||
60026460|NCT02527343|76142342|FG003|NOT COMPLETED|RT Period: Weeks 1 to 52||0||
60026461|NCT02527343|76142343|FG004|NOT COMPLETED|RT Period: Weeks 1 to 52||0||
60026462|NCT02527343|76142344|FG005|NOT COMPLETED|RT Period: Weeks 1 to 52||0||
60026463|NCT02527343|76142339|FG000|STARTED|RT Post Treatment Follow-up: Weeks 54-65||0||
60026464|NCT02527343|76142340|FG001|STARTED|RT Post Treatment Follow-up: Weeks 54-65||0||
60026465|NCT02527343|76142341|FG002|STARTED|RT Post Treatment Follow-up: Weeks 54-65|Only those participants who were entered in the 13-week post-treatment follow-up period after the randomized treatment period.|7||
60026466|NCT02527343|76142342|FG003|STARTED|RT Post Treatment Follow-up: Weeks 54-65|Only those participants who were entered in the 13-week post-treatment follow-up period after the randomized treatment period.|9||
60026467|NCT02527343|76142343|FG004|STARTED|RT Post Treatment Follow-up: Weeks 54-65||0||
60026468|NCT02527343|76142344|FG005|STARTED|RT Post Treatment Follow-up: Weeks 54-65||0||
60026469|NCT02527343|76142339|FG000|COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||0||
60026470|NCT02527343|76142340|FG001|COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||0||
60026471|NCT02527343|76142341|FG002|COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||6||
60026472|NCT02527343|76142342|FG003|COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||7||
60026473|NCT02527343|76142343|FG004|COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||0||
60026474|NCT02527343|76142344|FG005|COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||0||
60026475|NCT02527343|76142339|FG000|NOT COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||0||
60026476|NCT02527343|76142340|FG001|NOT COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||0||
60026477|NCT02527343|76142341|FG002|NOT COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||1||
60026478|NCT02527343|76142342|FG003|NOT COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||2||
60026479|NCT02527343|76142343|FG004|NOT COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||0||
60026480|NCT02527343|76142344|FG005|NOT COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||0||
60026481|NCT02527343|76142339|FG000|STARTED|OLE Period-Year 1: Week 53 to 104||0||
60026482|NCT02527343|76142340|FG001|STARTED|OLE Period-Year 1: Week 53 to 104||0||
60026483|NCT02527343|76142341|FG002|STARTED|OLE Period-Year 1: Week 53 to 104||0||
60026484|NCT02527343|76142342|FG003|STARTED|OLE Period-Year 1: Week 53 to 104||0||
60026485|NCT02527343|76142343|FG004|STARTED|OLE Period-Year 1: Week 53 to 104|Only those participants who were entered the in the OLE period (first OLE period) after the randomized treatment period.|12||
60026486|NCT02527343|76142344|FG005|STARTED|OLE Period-Year 1: Week 53 to 104|Only those participants who were entered the in the OLE period (first OLE period) after the randomized treatment period.|12||
60026487|NCT02527343|76142339|FG000|COMPLETED|OLE Period-Year 1: Week 53 to 104||0||
60026488|NCT02527343|76142340|FG001|COMPLETED|OLE Period-Year 1: Week 53 to 104||0||
60026489|NCT02527343|76142341|FG002|COMPLETED|OLE Period-Year 1: Week 53 to 104||0||
60026490|NCT02527343|76142342|FG003|COMPLETED|OLE Period-Year 1: Week 53 to 104||0||
60026491|NCT02527343|76142343|FG004|COMPLETED|OLE Period-Year 1: Week 53 to 104||1||
60026492|NCT02527343|76142344|FG005|COMPLETED|OLE Period-Year 1: Week 53 to 104||3||
60026493|NCT02527343|76142339|FG000|NOT COMPLETED|OLE Period-Year 1: Week 53 to 104||0||
60026494|NCT02527343|76142340|FG001|NOT COMPLETED|OLE Period-Year 1: Week 53 to 104||0||
60026495|NCT02527343|76142341|FG002|NOT COMPLETED|OLE Period-Year 1: Week 53 to 104||0||
60026496|NCT02527343|76142342|FG003|NOT COMPLETED|OLE Period-Year 1: Week 53 to 104||0||
60026497|NCT02527343|76142343|FG004|NOT COMPLETED|OLE Period-Year 1: Week 53 to 104||11||
60026498|NCT02527343|76142344|FG005|NOT COMPLETED|OLE Period-Year 1: Week 53 to 104||9||
60026499|NCT02527343|76142339|FG000|STARTED|OLE Period-Year 2: Week 105 to 156||0||
60026500|NCT02527343|76142340|FG001|STARTED|OLE Period-Year 2: Week 105 to 156||0||
60026501|NCT02527343|76142341|FG002|STARTED|OLE Period-Year 2: Week 105 to 156||0||
60026502|NCT02527343|76142342|FG003|STARTED|OLE Period-Year 2: Week 105 to 156||0||
60026503|NCT02527343|76142343|FG004|STARTED|OLE Period-Year 2: Week 105 to 156|Only those participants who were continuing the dosing for up to an additional 52 weeks in the second OLE period.|1||
60026504|NCT02527343|76142344|FG005|STARTED|OLE Period-Year 2: Week 105 to 156|Only those participants who were continuing the dosing for up to an additional 52 weeks in the second OLE period.|2||
60026505|NCT02527343|76142339|FG000|COMPLETED|OLE Period-Year 2: Week 105 to 156||0||
60026506|NCT02527343|76142340|FG001|COMPLETED|OLE Period-Year 2: Week 105 to 156||0||
60026507|NCT02527343|76142341|FG002|COMPLETED|OLE Period-Year 2: Week 105 to 156||0||
60026508|NCT02527343|76142342|FG003|COMPLETED|OLE Period-Year 2: Week 105 to 156||0||
60026509|NCT02527343|76142343|FG004|COMPLETED|OLE Period-Year 2: Week 105 to 156||0||
60026510|NCT02527343|76142344|FG005|COMPLETED|OLE Period-Year 2: Week 105 to 156||0||
60026511|NCT02527343|76142339|FG000|NOT COMPLETED|OLE Period-Year 2: Week 105 to 156||0||
60026512|NCT02527343|76142340|FG001|NOT COMPLETED|OLE Period-Year 2: Week 105 to 156||0||
60026513|NCT02527343|76142341|FG002|NOT COMPLETED|OLE Period-Year 2: Week 105 to 156||0||
60026514|NCT02527343|76142342|FG003|NOT COMPLETED|OLE Period-Year 2: Week 105 to 156||0||
60026515|NCT02527343|76142343|FG004|NOT COMPLETED|OLE Period-Year 2: Week 105 to 156||1||
60026516|NCT02527343|76142344|FG005|NOT COMPLETED|OLE Period-Year 2: Week 105 to 156||2||
60026517|NCT02527343|76142339|FG000|STARTED|PT Follow-up: Weeks 104 to 169||0||
60026518|NCT02527343|76142340|FG001|STARTED|PT Follow-up: Weeks 104 to 169||0||
60026519|NCT02527343|76142341|FG002|STARTED|PT Follow-up: Weeks 104 to 169||0||
60026520|NCT02527343|76142342|FG003|STARTED|PT Follow-up: Weeks 104 to 169||0||
60026521|NCT02527343|76142343|FG004|STARTED|PT Follow-up: Weeks 104 to 169|Participants who were entered in the post-treatment follow-up after the OLE Period.|12||
60026522|NCT02527343|76142344|FG005|STARTED|PT Follow-up: Weeks 104 to 169|Participants who were entered in the post-treatment follow-up after the OLE Period.|12||
60026523|NCT02527343|76142339|FG000|COMPLETED|PT Follow-up: Weeks 104 to 169||0||
60026524|NCT02527343|76142340|FG001|COMPLETED|PT Follow-up: Weeks 104 to 169||0||
60026525|NCT02527343|76142341|FG002|COMPLETED|PT Follow-up: Weeks 104 to 169||0||
60026526|NCT02527343|76142342|FG003|COMPLETED|PT Follow-up: Weeks 104 to 169||0||
60026527|NCT02527343|76142343|FG004|COMPLETED|PT Follow-up: Weeks 104 to 169||11||
60026528|NCT02527343|76142344|FG005|COMPLETED|PT Follow-up: Weeks 104 to 169||11||
60026529|NCT02527343|76142339|FG000|NOT COMPLETED|PT Follow-up: Weeks 104 to 169||0||
60026530|NCT02527343|76142340|FG001|NOT COMPLETED|PT Follow-up: Weeks 104 to 169||0||
60026531|NCT02527343|76142341|FG002|NOT COMPLETED|PT Follow-up: Weeks 104 to 169||0||
60026532|NCT02527343|76142342|FG003|NOT COMPLETED|PT Follow-up: Weeks 104 to 169||0||
60026533|NCT02527343|76142343|FG004|NOT COMPLETED|PT Follow-up: Weeks 104 to 169||1||
60026534|NCT02527343|76142344|FG005|NOT COMPLETED|PT Follow-up: Weeks 104 to 169||1||
60026535|NCT01931566|76142362|FG000|STARTED|Overall Study||433||
59759197|NCT03462576|75878562|FG001|COMPLETED|Overall Study||37||
60026536|NCT01931566|76142363|FG001|STARTED|Overall Study||1516||
60026537|NCT01931566|76142364|FG002|STARTED|Overall Study||1545||
60026538|NCT01931566|76142362|FG000|Treated|Overall Study||427||
60026539|NCT01931566|76142363|FG001|Treated|Overall Study||1507||
60026540|NCT01931566|76142364|FG002|Treated|Overall Study||1531||
60026541|NCT01931566|76142362|FG000|COMPLETED|Overall Study||4|Completed here refers to those participants who completed study drug.|
60026542|NCT01931566|76142363|FG001|COMPLETED|Overall Study||40|Completed here refers to those participants who completed study drug.|
60026543|NCT01931566|76142364|FG002|COMPLETED|Overall Study||39|Completed here refers to those participants who completed study drug.|
60026544|NCT01931566|76142362|FG000|NOT COMPLETED|Overall Study||429||
60026545|NCT01931566|76142363|FG001|NOT COMPLETED|Overall Study||1476||
60026546|NCT01931566|76142364|FG002|NOT COMPLETED|Overall Study||1506||
60026547|NCT01912456|76142375|FG000|STARTED|Period 1||22||
60026548|NCT01912456|76142376|FG001|STARTED|Period 1||23||
60026549|NCT01912456|76142377|FG002|STARTED|Period 1||23||
60026550|NCT01912456|76142378|FG003|STARTED|Period 1||22||
60026551|NCT01912456|76142375|FG000|COMPLETED|Period 1||20||
60026552|NCT01912456|76142376|FG001|COMPLETED|Period 1||22||
60026553|NCT01912456|76142377|FG002|COMPLETED|Period 1||21||
60026554|NCT01912456|76142378|FG003|COMPLETED|Period 1||19||
60026555|NCT01912456|76142375|FG000|NOT COMPLETED|Period 1||2||
60026556|NCT01912456|76142376|FG001|NOT COMPLETED|Period 1||1||
60026557|NCT01912456|76142377|FG002|NOT COMPLETED|Period 1||2||
60026558|NCT01912456|76142378|FG003|NOT COMPLETED|Period 1||3||
60026559|NCT01912456|76142375|FG000|STARTED|Period 2||20||
60026560|NCT01912456|76142376|FG001|STARTED|Period 2||22||
60026561|NCT01912456|76142377|FG002|STARTED|Period 2||21||
60026562|NCT01912456|76142378|FG003|STARTED|Period 2||19||
60026563|NCT01912456|76142375|FG000|COMPLETED|Period 2||20||
60026564|NCT01912456|76142376|FG001|COMPLETED|Period 2||20||
60026565|NCT01912456|76142377|FG002|COMPLETED|Period 2||21||
60026566|NCT01912456|76142378|FG003|COMPLETED|Period 2||18||
60026567|NCT01912456|76142375|FG000|NOT COMPLETED|Period 2||0||
60026568|NCT01912456|76142376|FG001|NOT COMPLETED|Period 2||2||
60026569|NCT01912456|76142377|FG002|NOT COMPLETED|Period 2||0||
60026570|NCT01912456|76142378|FG003|NOT COMPLETED|Period 2||1||
60026571|NCT01885936|76142390|FG000|STARTED|Overall Study||8||
60026572|NCT01885936|76142391|FG001|STARTED|Overall Study||5||
60026573|NCT01885936|76142390|FG000|COMPLETED|Overall Study||7||
60026574|NCT01885936|76142391|FG001|COMPLETED|Overall Study||5||
60026575|NCT01885936|76142390|FG000|NOT COMPLETED|Overall Study||1||
60026576|NCT01885936|76142391|FG001|NOT COMPLETED|Overall Study||0||
60026577|NCT01912222|76142400|FG000|STARTED|Part A: Pharmacokinetic Period||13||
60026578|NCT01912222|76142401|FG001|STARTED|Part A: Pharmacokinetic Period||15||
60026579|NCT01912222|76142402|FG002|STARTED|Part A: Pharmacokinetic Period||20||
60026580|NCT01912222|76142400|FG000|COMPLETED|Part A: Pharmacokinetic Period||12||
60026581|NCT01912222|76142401|FG001|COMPLETED|Part A: Pharmacokinetic Period||13||
60026582|NCT01912222|76142402|FG002|COMPLETED|Part A: Pharmacokinetic Period||18||
60026583|NCT01912222|76142400|FG000|NOT COMPLETED|Part A: Pharmacokinetic Period||1||
60026584|NCT01912222|76142401|FG001|NOT COMPLETED|Part A: Pharmacokinetic Period||2||
60026585|NCT01912222|76142402|FG002|NOT COMPLETED|Part A: Pharmacokinetic Period||2||
60026586|NCT01912222|76142400|FG000|STARTED|Part B: Treatment Period||13||
60026587|NCT01912222|76142401|FG001|STARTED|Part B: Treatment Period||15||
60026588|NCT01912222|76142402|FG002|STARTED|Part B: Treatment Period||20||
60026589|NCT01912222|76142400|FG000|COMPLETED|Part B: Treatment Period||0||
60026590|NCT01912222|76142401|FG001|COMPLETED|Part B: Treatment Period||0||
60026591|NCT01912222|76142402|FG002|COMPLETED|Part B: Treatment Period||0||
60026592|NCT01912222|76142400|FG000|NOT COMPLETED|Part B: Treatment Period||13||
60026593|NCT01912222|76142401|FG001|NOT COMPLETED|Part B: Treatment Period||15||
60026594|NCT01912222|76142402|FG002|NOT COMPLETED|Part B: Treatment Period||20||
60026595|NCT02525861|76142413|FG000|STARTED|Overall Study||18||
60026596|NCT02525861|76142414|FG001|STARTED|Overall Study||16||
60026597|NCT02525861|76142413|FG000|COMPLETED|Overall Study||17||
60026598|NCT02525861|76142414|FG001|COMPLETED|Overall Study||14||
60026599|NCT02525861|76142413|FG000|NOT COMPLETED|Overall Study||1||
60026600|NCT02525861|76142414|FG001|NOT COMPLETED|Overall Study||2||
60026601|NCT02524847|76142422|FG000|STARTED|Overall Study||29||
60026602|NCT02524847|76142422|FG000|Completed Treatment Up to Week 12|Overall Study||14|Includes participants who received ECP treatments up to and including Week 12|
60026603|NCT02524847|76142422|FG000|Started Second Line Treatment|Overall Study||5||
60026604|NCT02524847|76142422|FG000|COMPLETED|Overall Study||15||
60026605|NCT02524847|76142422|FG000|NOT COMPLETED|Overall Study||14||
60026606|NCT02525627|76142429|FG000|STARTED|Overall Study||16||
60026607|NCT02525627|76142430|FG001|STARTED|Overall Study||18||
60026608|NCT02525627|76142429|FG000|COMPLETED|Overall Study||2||
60026609|NCT02525627|76142430|FG001|COMPLETED|Overall Study||5||
60026610|NCT02525627|76142429|FG000|NOT COMPLETED|Overall Study||14||
60026611|NCT02525627|76142430|FG001|NOT COMPLETED|Overall Study||13||
60026612|NCT02129205|76142446|FG000|STARTED|Overall Study||2||
60026613|NCT02129205|76142447|FG001|STARTED|Overall Study||2||
60026614|NCT02129205|76142448|FG002|STARTED|Overall Study||2||
60026615|NCT02129205|76142449|FG003|STARTED|Overall Study||2||
60026616|NCT02129205|76142450|FG004|STARTED|Overall Study||7||
60026617|NCT02129205|76142451|FG005|STARTED|Overall Study||11||
60026618|NCT02129205|76142452|FG006|STARTED|Overall Study||6||
60026619|NCT02129205|76142453|FG007|STARTED|Overall Study||6||
60026620|NCT02129205|76142454|FG008|STARTED|Overall Study||2||
60026621|NCT02129205|76142455|FG009|STARTED|Overall Study||0||
60026622|NCT02129205|76142446|FG000|COMPLETED|Overall Study||1||
60026623|NCT02129205|76142447|FG001|COMPLETED|Overall Study||2||
60026624|NCT02129205|76142448|FG002|COMPLETED|Overall Study||2||
60026625|NCT02129205|76142449|FG003|COMPLETED|Overall Study||2||
59611769|NCT01708902|75722752|FG004|NOT COMPLETED|Overall Study||16||
59611770|NCT01708902|75722753|FG005|NOT COMPLETED|Overall Study||7||
59611771|NCT01708902|75722754|FG006|NOT COMPLETED|Overall Study||7||
59611772|NCT01755546|75722773|FG000|STARTED|Screened and Taper (Rollover and DeNovo)||304||
60026626|NCT02129205|76142450|FG004|COMPLETED|Overall Study||4||
60026627|NCT02129205|76142451|FG005|COMPLETED|Overall Study||7||
60026628|NCT02129205|76142452|FG006|COMPLETED|Overall Study||2||
60026629|NCT02129205|76142453|FG007|COMPLETED|Overall Study||4||
60026630|NCT02129205|76142454|FG008|COMPLETED|Overall Study||0||
60026631|NCT02129205|76142455|FG009|COMPLETED|Overall Study||0||
60026632|NCT02129205|76142446|FG000|NOT COMPLETED|Overall Study||1||
60026633|NCT02129205|76142447|FG001|NOT COMPLETED|Overall Study||0||
60026634|NCT02129205|76142448|FG002|NOT COMPLETED|Overall Study||0||
60026635|NCT02129205|76142449|FG003|NOT COMPLETED|Overall Study||0||
60026636|NCT02129205|76142450|FG004|NOT COMPLETED|Overall Study||3||
60026637|NCT02129205|76142451|FG005|NOT COMPLETED|Overall Study||4||
60026638|NCT02129205|76142452|FG006|NOT COMPLETED|Overall Study||4||
60026639|NCT02129205|76142453|FG007|NOT COMPLETED|Overall Study||2||
60026640|NCT02129205|76142454|FG008|NOT COMPLETED|Overall Study||2||
60026641|NCT02129205|76142455|FG009|NOT COMPLETED|Overall Study||0||
60026642|NCT02128269|76142479|FG000|STARTED|Treatment Period||9||
60026643|NCT02128269|76142479|FG000|COMPLETED|Treatment Period||7||
60026644|NCT02128269|76142479|FG000|NOT COMPLETED|Treatment Period||2||
60026645|NCT02128269|76142479|FG000|STARTED|Follow-up|All enrolled patients were followed for 12 weeks after their last infusion of ALXN1007.|9||
60026646|NCT02128269|76142479|FG000|COMPLETED|Follow-up||9||
60026647|NCT02128269|76142479|FG000|NOT COMPLETED|Follow-up||0||
60026648|NCT01626885|76142483|FG000|STARTED|Overall Study||42||
60026649|NCT01626885|76142483|FG000|COMPLETED|Overall Study||30||
60026650|NCT01626885|76142483|FG000|NOT COMPLETED|Overall Study||12||
60026651|NCT02524379|76142487|FG000|STARTED|Overall Study||3||
60026652|NCT02524379|76142487|FG000|COMPLETED|Overall Study||2||
60026653|NCT02524379|76142487|FG000|NOT COMPLETED|Overall Study||1||
60026654|NCT02524145|76142494|FG000|STARTED|Overall Study||15||
59613510|NCT01592292|75724648|FG001|STARTED|Overall Study||20||
60026655|NCT02524145|76142495|FG001|STARTED|Overall Study||15||
60026656|NCT02524145|76142496|FG002|STARTED|Overall Study||10||
60026657|NCT02524145|76142494|FG000|COMPLETED|Overall Study||13||
60026658|NCT02524145|76142495|FG001|COMPLETED|Overall Study||13||
60026659|NCT02524145|76142496|FG002|COMPLETED|Overall Study||7||
60026660|NCT02524145|76142494|FG000|NOT COMPLETED|Overall Study||2||
60026661|NCT02524145|76142495|FG001|NOT COMPLETED|Overall Study||2||
60026662|NCT02524145|76142496|FG002|NOT COMPLETED|Overall Study||3||
60026663|NCT01658813|76142504|FG000|STARTED|Overall Study||18||
60026664|NCT01658813|76142504|FG000|Eligible|Overall Study||18||
60026665|NCT01658813|76142504|FG000|Treated|Overall Study||18||
60026666|NCT01658813|76142504|FG000|COMPLETED|Overall Study||15||
60026667|NCT01658813|76142504|FG000|NOT COMPLETED|Overall Study||3||
60026668|NCT02187471|76142516|FG000|STARTED|Overall Study||325||
60026669|NCT02187471|76142517|FG001|STARTED|Overall Study||324||
60026670|NCT02187471|76142518|FG002|STARTED|Overall Study||326||
60026671|NCT02187471|76142519|FG003|STARTED|Overall Study||326||
60026672|NCT02187471|76142516|FG000|COMPLETED|Overall Study||249||
60026673|NCT02187471|76142517|FG001|COMPLETED|Overall Study||242||
60026674|NCT02187471|76142518|FG002|COMPLETED|Overall Study||240||
60026675|NCT02187471|76142519|FG003|COMPLETED|Overall Study||246||
60026676|NCT02187471|76142516|FG000|NOT COMPLETED|Overall Study||76||
60026677|NCT02187471|76142517|FG001|NOT COMPLETED|Overall Study||82||
60026678|NCT02187471|76142518|FG002|NOT COMPLETED|Overall Study||86||
60026679|NCT02187471|76142519|FG003|NOT COMPLETED|Overall Study||80||
60026680|NCT02525471|76142530|FG000|STARTED|Overall Study||24||
60026681|NCT02525471|76142530|FG000|Randomized/Treated|Overall Study||16||
60026682|NCT02525471|76142530|FG000|COMPLETED|Overall Study||13||
60026683|NCT02525471|76142530|FG000|NOT COMPLETED|Overall Study||11||
60026684|NCT01658735|76142538|FG000|STARTED|Overall Study||39||
60026685|NCT01658735|76142539|FG001|STARTED|Overall Study||36||
60026686|NCT01658735|76142540|FG002|STARTED|Overall Study||38||
60026687|NCT01658735|76142538|FG000|COMPLETED|Overall Study||34||
60026688|NCT01658735|76142539|FG001|COMPLETED|Overall Study||29||
60026689|NCT01658735|76142540|FG002|COMPLETED|Overall Study||34||
60026690|NCT01658735|76142538|FG000|NOT COMPLETED|Overall Study||5||
60026691|NCT01658735|76142539|FG001|NOT COMPLETED|Overall Study||7||
60026692|NCT01658735|76142540|FG002|NOT COMPLETED|Overall Study||4||
60026693|NCT02523599|76142550|FG000|STARTED|Overall Study||204||
60026694|NCT02523599|76142551|FG001|STARTED|Overall Study||101||
60026695|NCT02523599|76142550|FG000|Randomized But Not Treated|Overall Study||1||
60026696|NCT02523599|76142551|FG001|Randomized But Not Treated|Overall Study||0||
60026697|NCT02523599|76142550|FG000|COMPLETED|Overall Study||196||
60026698|NCT02523599|76142551|FG001|COMPLETED|Overall Study||100||
60026699|NCT02523599|76142550|FG000|NOT COMPLETED|Overall Study||8||
60026700|NCT02523599|76142551|FG001|NOT COMPLETED|Overall Study||1||
59507400|NCT02341599|75600660|FG001|STARTED|Overall Study||8||
60026701|NCT02187159|76142561|FG000|STARTED|Overall Study||318||
60026702|NCT02187159|76142562|FG001|STARTED|Overall Study||317||
60026703|NCT02187159|76142563|FG002|STARTED|Overall Study||318||
60026704|NCT02187159|76142564|FG003|STARTED|Overall Study||317||
60026705|NCT02187159|76142561|FG000|COMPLETED|Overall Study||249||
60026706|NCT02187159|76142562|FG001|COMPLETED|Overall Study||238||
60026707|NCT02187159|76142563|FG002|COMPLETED|Overall Study||241||
60026708|NCT02187159|76142564|FG003|COMPLETED|Overall Study||221||
60026709|NCT02187159|76142561|FG000|NOT COMPLETED|Overall Study||69||
60026710|NCT02187159|76142562|FG001|NOT COMPLETED|Overall Study||79||
60026711|NCT02187159|76142563|FG002|NOT COMPLETED|Overall Study||77||
60026712|NCT02187159|76142564|FG003|NOT COMPLETED|Overall Study||96||
60026713|NCT02335411|76142577|FG000|STARTED|Overall Study||259|First Course Pembrolizumab|
60026714|NCT02335411|76142578|FG001|STARTED|Overall Study||25|First Course Pembrolizumab|
60026715|NCT02335411|76142579|FG002|STARTED|Overall Study||31|First Course Pembrolizumab|
60026716|NCT02335411|76142577|FG000|Second Course Pembrolizumab|Overall Study||3||
60026717|NCT02335411|76142578|FG001|Second Course Pembrolizumab|Overall Study||1||
60026718|NCT02335411|76142579|FG002|Second Course Pembrolizumab|Overall Study||2||
60026719|NCT02335411|76142577|FG000|COMPLETED|Overall Study||0||
60026720|NCT02335411|76142578|FG001|COMPLETED|Overall Study||0||
60026721|NCT02335411|76142579|FG002|COMPLETED|Overall Study||0||
60026722|NCT02335411|76142577|FG000|NOT COMPLETED|Overall Study||259||
60026723|NCT02335411|76142578|FG001|NOT COMPLETED|Overall Study||25||
60026724|NCT02335411|76142579|FG002|NOT COMPLETED|Overall Study||31||
60026725|NCT02186301|76142593|FG000|STARTED|Overall Study||20||
60026726|NCT02186301|76142594|FG001|STARTED|Overall Study||30||
60026727|NCT02186301|76142595|FG002|STARTED|Overall Study||50||
60026728|NCT02186301|76142593|FG000|COMPLETED|Overall Study|Patients who are off study for any reason.|0||
60026729|NCT02186301|76142594|FG001|COMPLETED|Overall Study|Patients who are off study for any reason.|0||
60026730|NCT02186301|76142595|FG002|COMPLETED|Overall Study|Patients who are off study for any reason.|0||
60026731|NCT02186301|76142593|FG000|NOT COMPLETED|Overall Study||20||
60026732|NCT02186301|76142594|FG001|NOT COMPLETED|Overall Study||30||
60026733|NCT02186301|76142595|FG002|NOT COMPLETED|Overall Study||50||
60026734|NCT02186223|76142605|FG000|STARTED|Overall Study||172|(i.e., consented)|
60026735|NCT02186223|76142605|FG000|Device Placed|Overall Study||163||
60026736|NCT02186223|76142605|FG000|COMPLETED|Overall Study||151|(i.e., Device in place for at least 48 hours)|
60026737|NCT02186223|76142605|FG000|NOT COMPLETED|Overall Study||21||
60026738|NCT02163057|76142612|FG000|STARTED|Overall Study||6||
60026739|NCT02163057|76142613|FG001|STARTED|Overall Study||16||
60026740|NCT02163057|76142612|FG000|COMPLETED|Overall Study||3||
60026741|NCT02163057|76142613|FG001|COMPLETED|Overall Study||11||
60026742|NCT02163057|76142612|FG000|NOT COMPLETED|Overall Study||3||
60026743|NCT02163057|76142613|FG001|NOT COMPLETED|Overall Study||5||
60026744|NCT02185521|76142621|FG000|STARTED|Overall Study||127||
60026745|NCT02185521|76142621|FG000|COMPLETED|Overall Study||125||
60026746|NCT02185521|76142621|FG000|NOT COMPLETED|Overall Study||2||
60026747|NCT01599585|76142628|FG000|STARTED|Overall Study||62||
60026748|NCT01599585|76142629|FG001|STARTED|Overall Study||59||
60026749|NCT01599585|76142628|FG000|COMPLETED|Overall Study||40||
60026750|NCT01599585|76142629|FG001|COMPLETED|Overall Study||42||
60026751|NCT01599585|76142628|FG000|NOT COMPLETED|Overall Study||22||
60026752|NCT01599585|76142629|FG001|NOT COMPLETED|Overall Study||17||
60026753|NCT02185053|76142635|FG000|STARTED|Solifenacin Dose Escalation Phase||41||
60026754|NCT02185053|76142636|FG001|STARTED|Solifenacin Dose Escalation Phase||0||
60026755|NCT02185053|76142637|FG002|STARTED|Solifenacin Dose Escalation Phase||0||
60026756|NCT02185053|76142635|FG000|COMPLETED|Solifenacin Dose Escalation Phase||38||
60026757|NCT02185053|76142636|FG001|COMPLETED|Solifenacin Dose Escalation Phase||0||
60026758|NCT02185053|76142637|FG002|COMPLETED|Solifenacin Dose Escalation Phase||0||
60026759|NCT02185053|76142635|FG000|NOT COMPLETED|Solifenacin Dose Escalation Phase||3||
60026760|NCT02185053|76142636|FG001|NOT COMPLETED|Solifenacin Dose Escalation Phase||0||
60026761|NCT02185053|76142637|FG002|NOT COMPLETED|Solifenacin Dose Escalation Phase||0||
60026762|NCT02185053|76142635|FG000|STARTED|Donepezil Dose Escalation Phase||0||
60026763|NCT02185053|76142636|FG001|STARTED|Donepezil Dose Escalation Phase||38||
60026764|NCT02185053|76142637|FG002|STARTED|Donepezil Dose Escalation Phase||0||
60026765|NCT02185053|76142635|FG000|COMPLETED|Donepezil Dose Escalation Phase||0||
60026766|NCT02185053|76142636|FG001|COMPLETED|Donepezil Dose Escalation Phase||33||
60026767|NCT02185053|76142637|FG002|COMPLETED|Donepezil Dose Escalation Phase||0||
60026768|NCT02185053|76142635|FG000|NOT COMPLETED|Donepezil Dose Escalation Phase||0||
60026769|NCT02185053|76142636|FG001|NOT COMPLETED|Donepezil Dose Escalation Phase||5||
60026770|NCT02185053|76142637|FG002|NOT COMPLETED|Donepezil Dose Escalation Phase||0||
60026771|NCT02185053|76142635|FG000|STARTED|Donepezil Dose Maintenance Phase||0||
60026772|NCT02185053|76142636|FG001|STARTED|Donepezil Dose Maintenance Phase||0||
60026773|NCT02185053|76142637|FG002|STARTED|Donepezil Dose Maintenance Phase||33||
60026774|NCT02185053|76142635|FG000|COMPLETED|Donepezil Dose Maintenance Phase||0||
60026775|NCT02185053|76142636|FG001|COMPLETED|Donepezil Dose Maintenance Phase||0||
60026776|NCT02185053|76142637|FG002|COMPLETED|Donepezil Dose Maintenance Phase||30||
60026777|NCT02185053|76142635|FG000|NOT COMPLETED|Donepezil Dose Maintenance Phase||0||
60026778|NCT02185053|76142636|FG001|NOT COMPLETED|Donepezil Dose Maintenance Phase||0||
60026779|NCT02185053|76142637|FG002|NOT COMPLETED|Donepezil Dose Maintenance Phase||3||
60026780|NCT02161731|76142646|FG000|STARTED|Period 1 (Day -1 to Day 7 Predose)||24||
60026781|NCT02161731|76142647|FG001|STARTED|Period 1 (Day -1 to Day 7 Predose)||0||
60026782|NCT02161731|76142646|FG000|Received 1 Dose of Study Drug|Period 1 (Day -1 to Day 7 Predose)||24||
60026783|NCT02161731|76142647|FG001|Received 1 Dose of Study Drug|Period 1 (Day -1 to Day 7 Predose)||0||
60026784|NCT02161731|76142646|FG000|COMPLETED|Period 1 (Day -1 to Day 7 Predose)||24||
60026785|NCT02161731|76142647|FG001|COMPLETED|Period 1 (Day -1 to Day 7 Predose)||0||
60026786|NCT02161731|76142646|FG000|NOT COMPLETED|Period 1 (Day -1 to Day 7 Predose)||0||
60026787|NCT02161731|76142647|FG001|NOT COMPLETED|Period 1 (Day -1 to Day 7 Predose)||0||
60026788|NCT02161731|76142646|FG000|STARTED|Period 2 (Day 7 Dosing to Day 23)||0||
60026789|NCT02161731|76142647|FG001|STARTED|Period 2 (Day 7 Dosing to Day 23)||24||
60026790|NCT02161731|76142646|FG000|Received 1 Dose of Study Drug|Period 2 (Day 7 Dosing to Day 23)||0||
60026791|NCT02161731|76142647|FG001|Received 1 Dose of Study Drug|Period 2 (Day 7 Dosing to Day 23)||24||
60026792|NCT02161731|76142646|FG000|COMPLETED|Period 2 (Day 7 Dosing to Day 23)||0||
60026793|NCT02161731|76142647|FG001|COMPLETED|Period 2 (Day 7 Dosing to Day 23)||22||
60026794|NCT02161731|76142646|FG000|NOT COMPLETED|Period 2 (Day 7 Dosing to Day 23)||0||
60026795|NCT02161731|76142647|FG001|NOT COMPLETED|Period 2 (Day 7 Dosing to Day 23)||2||
60026796|NCT02124759|76142657|FG000|STARTED|Overall Study||6|Subjects gave informed consent to be screened for study.|
60026797|NCT02124759|76142658|FG001|STARTED|Overall Study||7|Subjects gave informed consent to be screened for study.|
60026798|NCT02124759|76142659|FG002|STARTED|Overall Study||7|Subjects gave informed consent to be screened for study.|
60026799|NCT02124759|76142657|FG000|Subjects Randomized to Intervention|Overall Study||4||
60026800|NCT02124759|76142658|FG001|Subjects Randomized to Intervention|Overall Study||5||
60026801|NCT02124759|76142659|FG002|Subjects Randomized to Intervention|Overall Study||4||
60026802|NCT02124759|76142657|FG000|Low Fat Diet|Overall Study|2 subjects did not complete and were withdrawn|4||
60026803|NCT02124759|76142658|FG001|Low Fat Diet|Overall Study||4||
60026804|NCT02124759|76142659|FG002|Low Fat Diet|Overall Study||4||
60026805|NCT02124759|76142657|FG000|High Fat Diet|Overall Study|1 subject did not complete|2||
60026806|NCT02124759|76142658|FG001|High Fat Diet|Overall Study|One subject withdrew (low fat diet had already been completed)|5||
60026807|NCT02124759|76142659|FG002|High Fat Diet|Overall Study|One subject withdrew and did not complete the low fat diet|4||
60026808|NCT02124759|76142657|FG000|COMPLETED|Overall Study||1||
60026809|NCT02124759|76142658|FG001|COMPLETED|Overall Study||4||
60026810|NCT02124759|76142659|FG002|COMPLETED|Overall Study||3||
60026811|NCT02124759|76142657|FG000|NOT COMPLETED|Overall Study||5||
60026812|NCT02124759|76142658|FG001|NOT COMPLETED|Overall Study||3||
60026813|NCT02124759|76142659|FG002|NOT COMPLETED|Overall Study||4||
60026814|NCT02302339|76142676|FG000|STARTED|Overall Study||62||
60026815|NCT02302339|76142677|FG001|STARTED|Overall Study||34||
60026816|NCT02302339|76142678|FG002|STARTED|Overall Study||29||
60026817|NCT02302339|76142679|FG003|STARTED|Overall Study||7||
60026818|NCT02302339|76142676|FG000|COMPLETED|Overall Study||61||
60026819|NCT02302339|76142677|FG001|COMPLETED|Overall Study||32||
60026820|NCT02302339|76142678|FG002|COMPLETED|Overall Study||28||
60026821|NCT02302339|76142679|FG003|COMPLETED|Overall Study||7||
60026822|NCT02302339|76142676|FG000|NOT COMPLETED|Overall Study||1||
60026823|NCT02302339|76142677|FG001|NOT COMPLETED|Overall Study||2||
60026824|NCT02302339|76142678|FG002|NOT COMPLETED|Overall Study||1||
60026825|NCT02302339|76142679|FG003|NOT COMPLETED|Overall Study||0||
60026826|NCT02161575|76142690|FG000|STARTED|Overall Study||103||
60026827|NCT02161575|76142690|FG000|Full Analysis Set (FAS) Population|Overall Study||100|received an application of study treatment and had a baseline and post-baseline assessment for CSRT|
60026828|NCT02161575|76142690|FG000|Safety (SAF) Population|Overall Study||100|received an application of study treatment and and had at least one post-baseline safety assessment|
60026829|NCT02161575|76142690|FG000|COMPLETED|Overall Study||92||
60026830|NCT02161575|76142690|FG000|NOT COMPLETED|Overall Study||11||
60026831|NCT02370121|76142696|FG000|STARTED|Overall Study||12||
60026832|NCT02370121|76142697|FG001|STARTED|Overall Study||12||
60026833|NCT02370121|76142696|FG000|COMPLETED|Overall Study|One patient did not complete the study due to early withdrawl|11||
60026834|NCT02370121|76142697|FG001|COMPLETED|Overall Study|One patient did not complete the study due to early withdrawl|11||
60026835|NCT02370121|76142696|FG000|NOT COMPLETED|Overall Study||1||
60026836|NCT02370121|76142697|FG001|NOT COMPLETED|Overall Study||1||
60026837|NCT02161185|76142703|FG000|STARTED|Test Dose Phase||7||
60026838|NCT02161185|76142703|FG000|COMPLETED|Test Dose Phase||7||
60026839|NCT02161185|76142703|FG000|NOT COMPLETED|Test Dose Phase||0||
60026840|NCT02161185|76142703|FG000|STARTED|Treatment Phase||7|6 of the 7 participants who entered Treatment Phase treated at least one seizure cluster|
60026841|NCT02161185|76142703|FG000|COMPLETED|Treatment Phase||0|Study discontinued due to poor enrollment|
60026842|NCT02161185|76142703|FG000|NOT COMPLETED|Treatment Phase||7||
60026843|NCT02159469|76142707|FG000|STARTED|Overall Study||150||
60026844|NCT02159469|76142707|FG000|Completed 12 Week|Overall Study||137||
60026845|NCT02159469|76142707|FG000|COMPLETED|Overall Study||97||
60026846|NCT02159469|76142707|FG000|NOT COMPLETED|Overall Study||53||
60026847|NCT02123511|76142714|FG000|STARTED|Overall Study||18||
60026848|NCT02123511|76142715|FG001|STARTED|Overall Study||16||
60026849|NCT02123511|76142714|FG000|Eligible Patients|Overall Study||17||
60026850|NCT02123511|76142715|FG001|Eligible Patients|Overall Study||15||
60026851|NCT02123511|76142714|FG000|COMPLETED|Overall Study||16|evaluable for Primary Endpoint (AUC for GRIX Sticky Saliva Total Score)|
60026852|NCT02123511|76142715|FG001|COMPLETED|Overall Study||12|evaluable for Primary Endpoint (AUC for GRIX Sticky Saliva Total Score)|
60026853|NCT02123511|76142714|FG000|NOT COMPLETED|Overall Study||2||
60026854|NCT02123511|76142715|FG001|NOT COMPLETED|Overall Study||4||
60026855|NCT02122887|76142723|FG000|STARTED|Overall Study||60||
60026856|NCT02122887|76142724|FG001|STARTED|Overall Study||41||
60026857|NCT02122887|76142723|FG000|COMPLETED|Overall Study||40||
60026858|NCT02122887|76142724|FG001|COMPLETED|Overall Study||39||
60026859|NCT02122887|76142723|FG000|NOT COMPLETED|Overall Study||20||
60026860|NCT02122887|76142724|FG001|NOT COMPLETED|Overall Study||2||
60026861|NCT02182947|76142730|FG000|STARTED|Overall Study||45||
60026862|NCT02182947|76142730|FG000|COMPLETED|Overall Study||27||
60026863|NCT02182947|76142730|FG000|NOT COMPLETED|Overall Study||18||
60026864|NCT02370043|76142734|FG000|STARTED|Overall Study||3||
60026865|NCT02370043|76142735|FG001|STARTED|Overall Study||3||
60026866|NCT02370043|76142736|FG002|STARTED|Overall Study||3||
60026867|NCT02370043|76142737|FG003|STARTED|Overall Study||3||
60026868|NCT02370043|76142738|FG004|STARTED|Overall Study||3||
60026869|NCT02370043|76142739|FG005|STARTED|Overall Study||4||
60026870|NCT02370043|76142734|FG000|COMPLETED|Overall Study||3||
60026871|NCT02370043|76142735|FG001|COMPLETED|Overall Study||3||
60026872|NCT02370043|76142736|FG002|COMPLETED|Overall Study||3||
60026873|NCT02370043|76142737|FG003|COMPLETED|Overall Study||3||
60026874|NCT02370043|76142738|FG004|COMPLETED|Overall Study||2||
60026875|NCT02370043|76142739|FG005|COMPLETED|Overall Study||3||
60026876|NCT02370043|76142734|FG000|NOT COMPLETED|Overall Study||0||
60026877|NCT02370043|76142735|FG001|NOT COMPLETED|Overall Study||0||
60026878|NCT02370043|76142736|FG002|NOT COMPLETED|Overall Study||0||
60026879|NCT02370043|76142737|FG003|NOT COMPLETED|Overall Study||0||
60026880|NCT02370043|76142738|FG004|NOT COMPLETED|Overall Study||1||
60026881|NCT02370043|76142739|FG005|NOT COMPLETED|Overall Study||1||
60026882|NCT02301403|76142769|FG000|STARTED|Overall Study||315||
60026883|NCT02301403|76142770|FG001|STARTED|Overall Study||308||
60026884|NCT02301403|76142769|FG000|COMPLETED|Overall Study||287||
59759198|NCT03462576|75878563|FG002|COMPLETED|Overall Study||37||
59915389|NCT03384745|76036245|FG001|NOT COMPLETED|Response Assess/Dose Hold (W24-W48)||3||
59915390|NCT03384745|76036246|FG002|NOT COMPLETED|Response Assess/Dose Hold (W24-W48)||4||
59915391|NCT03384745|76036247|FG003|NOT COMPLETED|Response Assess/Dose Hold (W24-W48)||4||
60026885|NCT02301403|76142770|FG001|COMPLETED|Overall Study||267||
60026886|NCT02301403|76142769|FG000|NOT COMPLETED|Overall Study||28||
60026887|NCT02301403|76142770|FG001|NOT COMPLETED|Overall Study||41||
60026888|NCT02301169|76142778|FG000|STARTED|Overall Study||21||
60026889|NCT02301169|76142779|FG001|STARTED|Overall Study||21||
60026890|NCT02301169|76142778|FG000|COMPLETED|Overall Study||20||
60026891|NCT02301169|76142779|FG001|COMPLETED|Overall Study||21||
60026892|NCT02301169|76142778|FG000|NOT COMPLETED|Overall Study||1||
60026893|NCT02301169|76142779|FG001|NOT COMPLETED|Overall Study||0||
60026894|NCT02333383|76142785|FG000|STARTED|Overall Study||201||
60026895|NCT02333383|76142785|FG000|COMPLETED|Overall Study||160||
59507401|NCT02341599|75600661|FG002|STARTED|Overall Study||8||
59759199|NCT03462576|75878561|FG000|NOT COMPLETED|Overall Study||5||
59915392|NCT03384745|76036248|FG004|NOT COMPLETED|Response Assess/Dose Hold (W24-W48)||1||
59915393|NCT03384745|76036249|FG005|NOT COMPLETED|Response Assess/Dose Hold (W24-W48)||2||
59915394|NCT03383887|76036269|FG000|STARTED|Overall Study||5||
59915395|NCT03383887|76036270|FG001|STARTED|Overall Study||6||
59915396|NCT03383887|76036269|FG000|COMPLETED|Overall Study||5||
59915397|NCT03383887|76036270|FG001|COMPLETED|Overall Study||5||
59915398|NCT03383887|76036269|FG000|NOT COMPLETED|Overall Study||0||
59915399|NCT03383887|76036270|FG001|NOT COMPLETED|Overall Study||1||
59915400|NCT03379753|76036278|FG000|STARTED|Overall Study||61||
60026896|NCT02333383|76142785|FG000|NOT COMPLETED|Overall Study||41||
60026897|NCT02332915|76142791|FG000|STARTED|Overall Study||18||
60026898|NCT02332915|76142792|FG001|STARTED|Overall Study||18||
60026899|NCT02332915|76142791|FG000|COMPLETED|Overall Study||12||
60026900|NCT02332915|76142792|FG001|COMPLETED|Overall Study||12||
60026901|NCT02332915|76142791|FG000|NOT COMPLETED|Overall Study||6||
60026902|NCT02332915|76142792|FG001|NOT COMPLETED|Overall Study||6||
60026903|NCT02369341|76142805|FG000|STARTED|Overall Study||63||
60026904|NCT02369341|76142806|FG001|STARTED|Overall Study||57||
60026905|NCT02369341|76142805|FG000|COMPLETED|Overall Study||62||
60026906|NCT02369341|76142806|FG001|COMPLETED|Overall Study||57||
60026907|NCT02369341|76142805|FG000|NOT COMPLETED|Overall Study||1||
59507402|NCT02341599|75600662|FG003|STARTED|Overall Study||8||
60026908|NCT02369341|76142806|FG001|NOT COMPLETED|Overall Study||0||
60026909|NCT02121795|76142818|FG000|STARTED|Double-Blind Phase||334||
60026910|NCT02121795|76142819|FG001|STARTED|Double-Blind Phase||334||
60026911|NCT02121795|76142818|FG000|Safety Analysis Set|Double-Blind Phase||333||
60026912|NCT02121795|76142819|FG001|Safety Analysis Set|Double-Blind Phase||330||
59507403|NCT02341599|75600663|FG004|STARTED|Overall Study||8||
59915401|NCT03379753|76036279|FG001|STARTED|Overall Study||71||
59915402|NCT03379753|76036278|FG000|COMPLETED|Overall Study||46||
59915403|NCT03379753|76036279|FG001|COMPLETED|Overall Study||46||
59915404|NCT03379753|76036278|FG000|NOT COMPLETED|Overall Study||15||
59915405|NCT03379753|76036279|FG001|NOT COMPLETED|Overall Study||25||
59915406|NCT03379675|76036288|FG000|STARTED|Overall Study||24||
59915407|NCT03379675|76036289|FG001|STARTED|Overall Study||24||
59915408|NCT03379675|76036290|FG002|STARTED|Overall Study||24||
59915409|NCT03379675|76036288|FG000|COMPLETED|Overall Study||20||
59915410|NCT03379675|76036289|FG001|COMPLETED|Overall Study||22||
59915411|NCT03379675|76036290|FG002|COMPLETED|Overall Study||22||
59915412|NCT03379675|76036288|FG000|NOT COMPLETED|Overall Study||4||
59915413|NCT03379675|76036289|FG001|NOT COMPLETED|Overall Study||2||
59915414|NCT03379675|76036290|FG002|NOT COMPLETED|Overall Study||2||
59915415|NCT02930889|76036298|FG000|STARTED|Overall Study||21||
59915416|NCT02930889|76036298|FG000|COMPLETED|Overall Study||5||
59915417|NCT02930889|76036298|FG000|NOT COMPLETED|Overall Study||16||
59915418|NCT02875977|76036304|FG000|STARTED|Overall Study||100||
59915419|NCT02875977|76036305|FG001|STARTED|Overall Study||100||
59915420|NCT02875977|76036304|FG000|COMPLETED|Overall Study||58||
59915421|NCT02875977|76036305|FG001|COMPLETED|Overall Study||71||
59915422|NCT02875977|76036304|FG000|NOT COMPLETED|Overall Study||42||
59915423|NCT02875977|76036305|FG001|NOT COMPLETED|Overall Study||29||
59915424|NCT04583592|76036313|FG000|STARTED|Overall Study||194||
59915425|NCT04583592|76036314|FG001|STARTED|Overall Study||101||
59915426|NCT04583592|76036313|FG000|COMPLETED|Overall Study||194||
59915427|NCT04583592|76036314|FG001|COMPLETED|Overall Study||100||
59915428|NCT04583592|76036313|FG000|NOT COMPLETED|Overall Study||0||
59915429|NCT04583592|76036314|FG001|NOT COMPLETED|Overall Study||1||
59915430|NCT02703532|76036324|FG000|STARTED|Overall Study||21||
59915431|NCT02703532|76036325|FG001|STARTED|Overall Study||11||
59915432|NCT02703532|76036326|FG002|STARTED|Overall Study||21||
59915433|NCT02703532|76036327|FG003|STARTED|Overall Study||11||
59915434|NCT02703532|76036324|FG000|COMPLETED|Overall Study||19||
59915435|NCT02703532|76036325|FG001|COMPLETED|Overall Study||10||
59915436|NCT02703532|76036326|FG002|COMPLETED|Overall Study||19||
59915437|NCT02703532|76036327|FG003|COMPLETED|Overall Study||10||
59915438|NCT02703532|76036324|FG000|NOT COMPLETED|Overall Study||2||
59915439|NCT02703532|76036325|FG001|NOT COMPLETED|Overall Study||1||
59915440|NCT02703532|76036326|FG002|NOT COMPLETED|Overall Study||2||
59915441|NCT02703532|76036327|FG003|NOT COMPLETED|Overall Study||1||
59915442|NCT03439670|76036343|FG000|STARTED|Overall Study||30||
59915443|NCT03439670|76036344|FG001|STARTED|Overall Study||30||
59915444|NCT03439670|76036345|FG002|STARTED|Overall Study||15||
59915445|NCT03439670|76036346|FG003|STARTED|Overall Study||16||
59915446|NCT03439670|76036347|FG004|STARTED|Overall Study||15||
59915447|NCT03439670|76036348|FG005|STARTED|Overall Study||15||
59915448|NCT03439670|76036343|FG000|COMPLETED|Overall Study||28||
59915449|NCT03439670|76036344|FG001|COMPLETED|Overall Study||26||
59915450|NCT03439670|76036345|FG002|COMPLETED|Overall Study||15||
59915451|NCT03439670|76036346|FG003|COMPLETED|Overall Study||15||
59915452|NCT03439670|76036347|FG004|COMPLETED|Overall Study||14||
59915453|NCT03439670|76036348|FG005|COMPLETED|Overall Study||14||
59915454|NCT03439670|76036343|FG000|NOT COMPLETED|Overall Study||2||
59915455|NCT03439670|76036344|FG001|NOT COMPLETED|Overall Study||4||
59915456|NCT03439670|76036345|FG002|NOT COMPLETED|Overall Study||0||
59915457|NCT03439670|76036346|FG003|NOT COMPLETED|Overall Study||1||
59915458|NCT03439670|76036347|FG004|NOT COMPLETED|Overall Study||1||
59915459|NCT03439670|76036348|FG005|NOT COMPLETED|Overall Study||1||
59915460|NCT02930343|76036360|FG000|STARTED|Overall Study||68||
59915461|NCT02930343|76036361|FG001|STARTED|Overall Study||68||
59915462|NCT02930343|76036360|FG000|COMPLETED|Overall Study||59||
59915463|NCT02930343|76036361|FG001|COMPLETED|Overall Study||61||
59915464|NCT02930343|76036360|FG000|NOT COMPLETED|Overall Study||9||
59915465|NCT02930343|76036361|FG001|NOT COMPLETED|Overall Study||7||
59915466|NCT02703454|76036369|FG000|STARTED|Overall Study||24||
59915467|NCT02703454|76036370|FG001|STARTED|Overall Study||27||
59915468|NCT02703454|76036369|FG000|Treated|Overall Study||23||
59915469|NCT02703454|76036370|FG001|Treated|Overall Study||24||
59915470|NCT02703454|76036369|FG000|COMPLETED|Overall Study||13||
59915471|NCT02703454|76036370|FG001|COMPLETED|Overall Study||11||
59915472|NCT02703454|76036369|FG000|NOT COMPLETED|Overall Study||11||
59915473|NCT02703454|76036370|FG001|NOT COMPLETED|Overall Study||16||
59915474|NCT03103542|76036376|FG000|STARTED|Overall Study|18 - screened 16 - enrolled|16||
59915475|NCT03103542|76036376|FG000|COMPLETED|Overall Study||9||
59915476|NCT03103542|76036376|FG000|NOT COMPLETED|Overall Study||7||
59915477|NCT01012167|76036384|FG000|STARTED|Overall Study||17||
59915478|NCT01012167|76036385|FG001|STARTED|Overall Study||20||
59915479|NCT01012167|76036386|FG002|STARTED|Overall Study||21||
59915480|NCT01012167|76036384|FG000|Withdrawn Prior to Study Drug Exposure|Overall Study||1||
59915481|NCT01012167|76036385|FG001|Withdrawn Prior to Study Drug Exposure|Overall Study||0||
59915482|NCT01012167|76036386|FG002|Withdrawn Prior to Study Drug Exposure|Overall Study||1||
59915483|NCT01012167|76036384|FG000|Exposed to Study Drug|Overall Study||16||
59951305|NCT03641287|76070234|FG001|NOT COMPLETED|Overall Study||0||
59915484|NCT01012167|76036385|FG001|Exposed to Study Drug|Overall Study||20||
59915485|NCT01012167|76036386|FG002|Exposed to Study Drug|Overall Study||20||
59915486|NCT01012167|76036384|FG000|COMPLETED|Overall Study||15||
60026913|NCT02121795|76142818|FG000|COMPLETED|Double-Blind Phase||296||
60026914|NCT02121795|76142819|FG001|COMPLETED|Double-Blind Phase||300||
60026915|NCT02121795|76142818|FG000|NOT COMPLETED|Double-Blind Phase||38||
60026916|NCT02121795|76142819|FG001|NOT COMPLETED|Double-Blind Phase||34||
60026917|NCT02121795|76142818|FG000|STARTED|Open-Label Phase|Not all participants entered the Open-Label Phase.|33||
60026918|NCT02121795|76142819|FG001|STARTED|Open-Label Phase|Not all participants entered the Open-Label Phase.|31||
60026919|NCT02121795|76142818|FG000|COMPLETED|Open-Label Phase||21||
60026920|NCT02121795|76142819|FG001|COMPLETED|Open-Label Phase||21||
60026921|NCT02121795|76142818|FG000|NOT COMPLETED|Open-Label Phase||12||
60026922|NCT02121795|76142819|FG001|NOT COMPLETED|Open-Label Phase||10||
60026923|NCT02158533|76142830|FG000|STARTED|Stage 1||265||
60026924|NCT02158533|76142831|FG001|STARTED|Stage 1||59||
60026925|NCT02158533|76142832|FG002|STARTED|Stage 1||60||
60026926|NCT02158533|76142833|FG003|STARTED|Stage 1||0||
60026927|NCT02158533|76142834|FG004|STARTED|Stage 1||0||
60026928|NCT02158533|76142835|FG005|STARTED|Stage 1||0||
60026929|NCT02158533|76142830|FG000|COMPLETED|Stage 1||251||
60026930|NCT02158533|76142831|FG001|COMPLETED|Stage 1||51||
60026931|NCT02158533|76142832|FG002|COMPLETED|Stage 1||52||
60026932|NCT02158533|76142833|FG003|COMPLETED|Stage 1||0||
60026933|NCT02158533|76142834|FG004|COMPLETED|Stage 1||0||
60026934|NCT02158533|76142835|FG005|COMPLETED|Stage 1||0||
60026935|NCT02158533|76142830|FG000|NOT COMPLETED|Stage 1||14||
60026936|NCT02158533|76142831|FG001|NOT COMPLETED|Stage 1||8||
60026937|NCT02158533|76142832|FG002|NOT COMPLETED|Stage 1||8||
60026938|NCT02158533|76142833|FG003|NOT COMPLETED|Stage 1||0||
60026939|NCT02158533|76142834|FG004|NOT COMPLETED|Stage 1||0||
60026940|NCT02158533|76142835|FG005|NOT COMPLETED|Stage 1||0||
60026941|NCT02158533|76142830|FG000|STARTED|Stage 2||0|Subjects randomized in Stage 2 are a subset of those randomized to placebo in Stage 1.|
60026942|NCT02158533|76142831|FG001|STARTED|Stage 2||0|Subjects randomized in Stage 2 are a subset of those randomized to placebo in Stage 1.|
60026943|NCT02158533|76142832|FG002|STARTED|Stage 2||0|Subjects randomized in Stage 2 are a subset of those randomized to placebo in Stage 1.|
59507404|NCT02341599|75600659|FG000|COMPLETED|Overall Study||8||
59507405|NCT02341599|75600660|FG001|COMPLETED|Overall Study||8||
59507406|NCT02341599|75600661|FG002|COMPLETED|Overall Study||8||
59915487|NCT01012167|76036385|FG001|COMPLETED|Overall Study||18||
59915488|NCT01012167|76036386|FG002|COMPLETED|Overall Study||17||
59915489|NCT01012167|76036384|FG000|NOT COMPLETED|Overall Study||2||
59915490|NCT01012167|76036385|FG001|NOT COMPLETED|Overall Study||2||
59915491|NCT01012167|76036386|FG002|NOT COMPLETED|Overall Study||4||
59915492|NCT03376321|76036403|FG000|STARTED|Overall Study||168||
59915493|NCT03376321|76036404|FG001|STARTED|Overall Study||166||
59915494|NCT03376321|76036403|FG000|Treated|Overall Study||163||
59915495|NCT03376321|76036404|FG001|Treated|Overall Study||163||
59915496|NCT03376321|76036403|FG000|COMPLETED|Overall Study||145||
59915497|NCT03376321|76036404|FG001|COMPLETED|Overall Study||141||
59915498|NCT03376321|76036403|FG000|NOT COMPLETED|Overall Study||23||
59915499|NCT03376321|76036404|FG001|NOT COMPLETED|Overall Study||25||
59915500|NCT03374995|76036412|FG000|STARTED|Overall Study||13||
59915501|NCT03374995|76036413|FG001|STARTED|Overall Study||12||
59915502|NCT03374995|76036412|FG000|COMPLETED|Overall Study||13||
59915503|NCT03374995|76036413|FG001|COMPLETED|Overall Study||11||
59915504|NCT03374995|76036412|FG000|NOT COMPLETED|Overall Study||0||
59915505|NCT03374995|76036413|FG001|NOT COMPLETED|Overall Study||1||
59915506|NCT02828982|76036419|FG000|STARTED|First Intervention (3 Weeks)||5||
60026944|NCT02158533|76142833|FG003|STARTED|Stage 2||56|Subjects randomized in Stage 2 are a subset of those randomized to placebo in Stage 1.|
60026945|NCT02158533|76142834|FG004|STARTED|Stage 2||56|Subjects randomized in Stage 2 are a subset of those randomized to placebo in Stage 1.|
60026946|NCT02158533|76142835|FG005|STARTED|Stage 2||56|Subjects randomized in Stage 2 are a subset of those randomized to placebo in Stage 1.|
60026947|NCT02158533|76142830|FG000|COMPLETED|Stage 2||0||
60026948|NCT02158533|76142831|FG001|COMPLETED|Stage 2||0||
60026949|NCT02158533|76142832|FG002|COMPLETED|Stage 2||0||
60026950|NCT02158533|76142833|FG003|COMPLETED|Stage 2||53||
60026951|NCT02158533|76142834|FG004|COMPLETED|Stage 2||52||
60026952|NCT02158533|76142835|FG005|COMPLETED|Stage 2||50||
60026953|NCT02158533|76142830|FG000|NOT COMPLETED|Stage 2||0||
60026954|NCT02158533|76142831|FG001|NOT COMPLETED|Stage 2||0||
60026955|NCT02158533|76142832|FG002|NOT COMPLETED|Stage 2||0||
60026956|NCT02158533|76142833|FG003|NOT COMPLETED|Stage 2||3||
60026957|NCT02158533|76142834|FG004|NOT COMPLETED|Stage 2||4||
60026958|NCT02158533|76142835|FG005|NOT COMPLETED|Stage 2||6||
59507407|NCT02341599|75600662|FG003|COMPLETED|Overall Study||8||
59507408|NCT02341599|75600663|FG004|COMPLETED|Overall Study||8||
59507409|NCT02341599|75600659|FG000|NOT COMPLETED|Overall Study||0||
59507410|NCT02341599|75600660|FG001|NOT COMPLETED|Overall Study||0||
59507411|NCT02341599|75600661|FG002|NOT COMPLETED|Overall Study||0||
60026959|NCT02120781|76142851|FG000|STARTED|Overall Study||15||
60026960|NCT02120781|76142852|FG001|STARTED|Overall Study||6||
60026961|NCT02120781|76142851|FG000|COMPLETED|Overall Study||11||
60026962|NCT02120781|76142852|FG001|COMPLETED|Overall Study||5||
60026963|NCT02120781|76142851|FG000|NOT COMPLETED|Overall Study||4||
60026964|NCT02120781|76142852|FG001|NOT COMPLETED|Overall Study||1||
60026965|NCT02120625|76142858|FG000|STARTED|Overall Study||8||
60026966|NCT02120625|76142858|FG000|COMPLETED|Overall Study||6||
60026967|NCT02120625|76142858|FG000|NOT COMPLETED|Overall Study||2||
60026968|NCT02120469|76142865|FG000|STARTED|Overall Study||13||
60026969|NCT02120469|76142866|FG001|STARTED|Overall Study||10||
60026970|NCT02120469|76142867|FG002|STARTED|Overall Study||4||
60026971|NCT02120469|76142865|FG000|COMPLETED|Overall Study||12||
60026972|NCT02120469|76142866|FG001|COMPLETED|Overall Study||10||
60026973|NCT02120469|76142867|FG002|COMPLETED|Overall Study||3||
60026974|NCT02120469|76142865|FG000|NOT COMPLETED|Overall Study||1||
60026975|NCT02120469|76142866|FG001|NOT COMPLETED|Overall Study||0||
60026976|NCT02120469|76142867|FG002|NOT COMPLETED|Overall Study||1||
60026977|NCT02157519|76142880|FG000|STARTED|Overall Study||91||
60026978|NCT02157519|76142881|FG001|STARTED|Overall Study||90||
60026979|NCT02157519|76142880|FG000|MEMScap Collected|Overall Study||84||
60026980|NCT02157519|76142881|FG001|MEMScap Collected|Overall Study||86||
60026981|NCT02157519|76142880|FG000|COMPLETED|Overall Study||80||
60026982|NCT02157519|76142881|FG001|COMPLETED|Overall Study||89||
60026983|NCT02157519|76142880|FG000|NOT COMPLETED|Overall Study||11||
60026984|NCT02157519|76142881|FG001|NOT COMPLETED|Overall Study||1||
60026985|NCT02180061|76142889|FG000|STARTED|Overall Study||34||
60026986|NCT02180061|76142890|FG001|STARTED|Overall Study||8||
60026987|NCT02180061|76142889|FG000|COMPLETED|Overall Study||9||
60026988|NCT02180061|76142890|FG001|COMPLETED|Overall Study||0||
60026989|NCT02180061|76142889|FG000|NOT COMPLETED|Overall Study||25||
60026990|NCT02180061|76142890|FG001|NOT COMPLETED|Overall Study||8||
60026991|NCT02179515|76142899|FG000|STARTED|Overall Study||3||
60026992|NCT02179515|76142900|FG001|STARTED|Overall Study||17||
60026993|NCT02179515|76142901|FG002|STARTED|Overall Study||18||
60026994|NCT02179515|76142899|FG000|COMPLETED|Overall Study||1||
60026995|NCT02179515|76142900|FG001|COMPLETED|Overall Study||1||
60026996|NCT02179515|76142901|FG002|COMPLETED|Overall Study||4||
60026997|NCT02179515|76142899|FG000|NOT COMPLETED|Overall Study||2||
60026998|NCT02179515|76142900|FG001|NOT COMPLETED|Overall Study||16||
60026999|NCT02179515|76142901|FG002|NOT COMPLETED|Overall Study||14||
60027000|NCT02120157|76142913|FG000|STARTED|Overall Study||32||
60027001|NCT02120157|76142913|FG000|Completed 180 Days|Overall Study||30||
60027002|NCT02120157|76142913|FG000|COMPLETED|Overall Study||24||
60027003|NCT02120157|76142913|FG000|NOT COMPLETED|Overall Study||8||
60027004|NCT02119299|76142919|FG000|STARTED|Overall Study||76||
60027005|NCT02119299|76142919|FG000|COMPLETED|Overall Study||67||
60027006|NCT02119299|76142919|FG000|NOT COMPLETED|Overall Study||9||
60027007|NCT02156271|76142925|FG000|STARTED|Overall Study||26||
60027008|NCT02156271|76142926|FG001|STARTED|Overall Study||13||
60027009|NCT02156271|76142925|FG000|COMPLETED|Overall Study||22||
60027010|NCT02156271|76142926|FG001|COMPLETED|Overall Study||10||
60027011|NCT02156271|76142925|FG000|NOT COMPLETED|Overall Study||4||
60027012|NCT02156271|76142926|FG001|NOT COMPLETED|Overall Study||3||
60027013|NCT01365455|76142935|FG000|STARTED|Induction Period||245||
60027014|NCT01365455|76142936|FG001|STARTED|Induction Period||245||
60027015|NCT01365455|76142937|FG002|STARTED|Induction Period||248||
60027016|NCT01365455|76142938|FG003|STARTED|Induction Period||0||
60027017|NCT01365455|76142939|FG004|STARTED|Induction Period||0||
60027018|NCT01365455|76142935|FG000|COMPLETED|Induction Period||230||
60027019|NCT01365455|76142936|FG001|COMPLETED|Induction Period||238||
60027020|NCT01365455|76142937|FG002|COMPLETED|Induction Period||232||
60027021|NCT01365455|76142938|FG003|COMPLETED|Induction Period||0||
60027022|NCT01365455|76142939|FG004|COMPLETED|Induction Period||0||
60027023|NCT01365455|76142935|FG000|NOT COMPLETED|Induction Period||15||
60027024|NCT01365455|76142936|FG001|NOT COMPLETED|Induction Period||7||
60027025|NCT01365455|76142937|FG002|NOT COMPLETED|Induction Period||16||
60027026|NCT01365455|76142938|FG003|NOT COMPLETED|Induction Period||0||
60027027|NCT01365455|76142939|FG004|NOT COMPLETED|Induction Period||0||
60027028|NCT01365455|76142935|FG000|STARTED|Maintenance Period||230||
60027029|NCT01365455|76142936|FG001|STARTED|Maintenance Period||238||
60027030|NCT01365455|76142937|FG002|STARTED|Maintenance Period||18||
60027031|NCT01365455|76142938|FG003|STARTED|Maintenance Period||109||
60027032|NCT01365455|76142939|FG004|STARTED|Maintenance Period||105||
60027033|NCT01365455|76142935|FG000|COMPLETED|Maintenance Period||201||
60027034|NCT01365455|76142936|FG001|COMPLETED|Maintenance Period||215||
60027035|NCT01365455|76142937|FG002|COMPLETED|Maintenance Period||15||
60027036|NCT01365455|76142938|FG003|COMPLETED|Maintenance Period||100||
60027037|NCT01365455|76142939|FG004|COMPLETED|Maintenance Period||92||
60027038|NCT01365455|76142935|FG000|NOT COMPLETED|Maintenance Period||29||
60027039|NCT01365455|76142936|FG001|NOT COMPLETED|Maintenance Period||23||
60027040|NCT01365455|76142937|FG002|NOT COMPLETED|Maintenance Period||3||
60027041|NCT01365455|76142938|FG003|NOT COMPLETED|Maintenance Period||9||
60027042|NCT01365455|76142939|FG004|NOT COMPLETED|Maintenance Period||13||
60027043|NCT01365455|76142935|FG000|STARTED|Follow-up Period||58||
60027044|NCT01365455|76142936|FG001|STARTED|Follow-up Period||47||
60027045|NCT01365455|76142937|FG002|STARTED|Follow-up Period||18||
60027046|NCT01365455|76142938|FG003|STARTED|Follow-up Period||0||
60027047|NCT01365455|76142939|FG004|STARTED|Follow-up Period||0||
60027048|NCT01365455|76142935|FG000|COMPLETED|Follow-up Period||58||
60027049|NCT01365455|76142936|FG001|COMPLETED|Follow-up Period||47||
60027050|NCT01365455|76142937|FG002|COMPLETED|Follow-up Period||18||
60027051|NCT01365455|76142938|FG003|COMPLETED|Follow-up Period||0||
60027052|NCT01365455|76142939|FG004|COMPLETED|Follow-up Period||0||
60027053|NCT01365455|76142935|FG000|NOT COMPLETED|Follow-up Period||0||
60027054|NCT01365455|76142936|FG001|NOT COMPLETED|Follow-up Period||0||
60027055|NCT01365455|76142937|FG002|NOT COMPLETED|Follow-up Period||0||
60027056|NCT01365455|76142938|FG003|NOT COMPLETED|Follow-up Period||0||
60027057|NCT01365455|76142939|FG004|NOT COMPLETED|Follow-up Period||0||
60027058|NCT02155881|76142959|FG000|STARTED|Overall Study||40||
60027059|NCT02155881|76142960|FG001|STARTED|Overall Study||40||
60027060|NCT02155881|76142959|FG000|COMPLETED|Overall Study||38||
60027061|NCT02155881|76142960|FG001|COMPLETED|Overall Study||36||
60027062|NCT02155881|76142959|FG000|NOT COMPLETED|Overall Study||2||
60027063|NCT02155881|76142960|FG001|NOT COMPLETED|Overall Study||4||
60027064|NCT01658579|76142970|FG000|STARTED|Treatment Period A||15||
60027065|NCT01658579|76142971|FG001|STARTED|Treatment Period A||15||
60027066|NCT01658579|76142972|FG002|STARTED|Treatment Period A||15||
60027067|NCT01658579|76142973|FG003|STARTED|Treatment Period A||14||
60027068|NCT01658579|76142970|FG000|COMPLETED|Treatment Period A||14||
60027069|NCT01658579|76142971|FG001|COMPLETED|Treatment Period A||15||
60027070|NCT01658579|76142972|FG002|COMPLETED|Treatment Period A||14||
60027071|NCT01658579|76142973|FG003|COMPLETED|Treatment Period A||13||
60027072|NCT01658579|76142970|FG000|NOT COMPLETED|Treatment Period A||1||
60027073|NCT01658579|76142971|FG001|NOT COMPLETED|Treatment Period A||0||
60027074|NCT01658579|76142972|FG002|NOT COMPLETED|Treatment Period A||1||
60027075|NCT01658579|76142973|FG003|NOT COMPLETED|Treatment Period A||1||
60027076|NCT01658579|76142970|FG000|STARTED|Treatment Period B||14||
60027077|NCT01658579|76142971|FG001|STARTED|Treatment Period B||15||
60027078|NCT01658579|76142972|FG002|STARTED|Treatment Period B||14||
60027079|NCT01658579|76142973|FG003|STARTED|Treatment Period B||13||
60027080|NCT01658579|76142970|FG000|COMPLETED|Treatment Period B||14||
60027081|NCT01658579|76142971|FG001|COMPLETED|Treatment Period B||15||
60027082|NCT01658579|76142972|FG002|COMPLETED|Treatment Period B||14||
60027083|NCT01658579|76142973|FG003|COMPLETED|Treatment Period B||12||
60027084|NCT01658579|76142970|FG000|NOT COMPLETED|Treatment Period B||0||
60027085|NCT01658579|76142971|FG001|NOT COMPLETED|Treatment Period B||0||
60027086|NCT01658579|76142972|FG002|NOT COMPLETED|Treatment Period B||0||
60027087|NCT01658579|76142973|FG003|NOT COMPLETED|Treatment Period B||1||
60027088|NCT02154087|76142979|FG000|STARTED|Overall Study||1||
60027089|NCT02154087|76142979|FG000|COMPLETED|Overall Study||0||
60027090|NCT02154087|76142979|FG000|NOT COMPLETED|Overall Study||1||
60027091|NCT02118597|76142983|FG000|STARTED|Overall Study||19||
60027092|NCT02118597|76142983|FG000|COMPLETED|Overall Study||3||
60027093|NCT02118597|76142983|FG000|NOT COMPLETED|Overall Study||16||
60027094|NCT01659125|76142987|FG000|STARTED|Overall Study||26||
60027095|NCT01659125|76142987|FG000|Initiated Treatment|Overall Study||24||
60027096|NCT01659125|76142987|FG000|Completed the Posttreatment Assessment|Overall Study||17||
60027097|NCT01659125|76142987|FG000|Completed 3-month Follow-up|Overall Study||16||
60027098|NCT01659125|76142987|FG000|Completed 6-month Follow-up|Overall Study||12||
60027099|NCT01659125|76142987|FG000|COMPLETED|Overall Study||12||
60027100|NCT01659125|76142987|FG000|NOT COMPLETED|Overall Study||14||
60027101|NCT01657253|76142993|FG000|STARTED|Overall Study||93||
59507412|NCT02341599|75600662|FG003|NOT COMPLETED|Overall Study||0||
60027102|NCT01657253|76142994|FG001|STARTED|Overall Study||90||
60027103|NCT01657253|76142993|FG000|COMPLETED|Overall Study||76||
60027104|NCT01657253|76142994|FG001|COMPLETED|Overall Study||72||
60027105|NCT01657253|76142993|FG000|NOT COMPLETED|Overall Study||17||
60027106|NCT01657253|76142994|FG001|NOT COMPLETED|Overall Study||18||
60027107|NCT02117427|76143003|FG000|STARTED|Overall Study||6||
60027108|NCT02117427|76143004|FG001|STARTED|Overall Study||5||
60027109|NCT02117427|76143005|FG002|STARTED|Overall Study||0||
60027110|NCT02117427|76143003|FG000|Run in Phase & Harvest|Overall Study||6||
60027111|NCT02117427|76143004|FG001|Run in Phase & Harvest|Overall Study||4||
60027112|NCT02117427|76143005|FG002|Run in Phase & Harvest|Overall Study||0||
60027113|NCT02117427|76143003|FG000|Implantation & Efficacy|Overall Study||6||
60027114|NCT02117427|76143004|FG001|Implantation & Efficacy|Overall Study||4||
59507413|NCT02341599|75600663|FG004|NOT COMPLETED|Overall Study||0||
60027115|NCT02117427|76143005|FG002|Implantation & Efficacy|Overall Study||0||
60027116|NCT02117427|76143003|FG000|Safety Follow-up|Overall Study||1||
60027117|NCT02117427|76143004|FG001|Safety Follow-up|Overall Study||0||
60027118|NCT02117427|76143005|FG002|Safety Follow-up|Overall Study||0||
60027119|NCT02117427|76143003|FG000|Long Term Safety Follow-up|Overall Study||1||
60027120|NCT02117427|76143004|FG001|Long Term Safety Follow-up|Overall Study||0||
60027121|NCT02117427|76143005|FG002|Long Term Safety Follow-up|Overall Study||0||
60027122|NCT02117427|76143003|FG000|COMPLETED|Overall Study||1||
60027123|NCT02117427|76143004|FG001|COMPLETED|Overall Study||0||
59759200|NCT03462576|75878562|FG001|NOT COMPLETED|Overall Study||11||
59759201|NCT03462576|75878563|FG002|NOT COMPLETED|Overall Study||8||
59759202|NCT00916721|75878573|FG000|STARTED|Overall Study||35||
60027124|NCT02117427|76143005|FG002|COMPLETED|Overall Study||0||
60027125|NCT02117427|76143003|FG000|NOT COMPLETED|Overall Study||5||
60027126|NCT02117427|76143004|FG001|NOT COMPLETED|Overall Study||5||
60027127|NCT02117427|76143005|FG002|NOT COMPLETED|Overall Study||0||
60027128|NCT02117349|76143013|FG000|STARTED|Overall Study||37||
60027129|NCT02117349|76143014|FG001|STARTED|Overall Study||18||
60027130|NCT02117349|76143013|FG000|Intent-to-treat Population|Overall Study||37|All randomized participants (group based on random assignment)|
60027131|NCT02117349|76143014|FG001|Intent-to-treat Population|Overall Study||18|All randomized participants (group based on random assignment)|
60027132|NCT02117349|76143013|FG000|Safety Population|Overall Study||36|Randomized participants exposed to study drug (group based on actual treatment received)|
60027133|NCT02117349|76143014|FG001|Safety Population|Overall Study||18|Randomized participants exposed to study drug (group based on actual treatment received)|
60027134|NCT02117349|76143013|FG000|Modified Intent-to-treat (mITT)|Overall Study||36|Randomized participants who received assigned study treatment and had no major protocol violations|
60027135|NCT02117349|76143014|FG001|Modified Intent-to-treat (mITT)|Overall Study||18|Randomized participants who received assigned study treatment and had no major protocol violations|
60027136|NCT02117349|76143013|FG000|COMPLETED|Overall Study||34||
60027137|NCT02117349|76143014|FG001|COMPLETED|Overall Study||17||
60027138|NCT02117349|76143013|FG000|NOT COMPLETED|Overall Study||3||
60027139|NCT02117349|76143014|FG001|NOT COMPLETED|Overall Study||1||
60027140|NCT01626495|76143020|FG000|STARTED|Overall Study|Number of enrolled subjects|73||
60027141|NCT01626495|76143020|FG000|Intervention|Overall Study||62||
60027142|NCT01626495|76143020|FG000|COMPLETED|Overall Study|Follow up phase completed as per protocol|21||
60027143|NCT01626495|76143020|FG000|NOT COMPLETED|Overall Study||52||
60027144|NCT02177175|76143026|FG000|STARTED|Overall Study||5||
60027145|NCT02177175|76143027|FG001|STARTED|Overall Study||6||
60027146|NCT02177175|76143026|FG000|COMPLETED|Overall Study||4||
60027147|NCT02177175|76143027|FG001|COMPLETED|Overall Study||6||
60027148|NCT02177175|76143026|FG000|NOT COMPLETED|Overall Study||1||
60027149|NCT02177175|76143027|FG001|NOT COMPLETED|Overall Study||0||
60027150|NCT02153073|76143033|FG000|STARTED|Overall Study||3084||
60027151|NCT02153073|76143033|FG000|COMPLETED|Overall Study||2786||
60027152|NCT02153073|76143033|FG000|NOT COMPLETED|Overall Study||298||
60027153|NCT01657877|76143037|FG000|STARTED|Overall Study||79||
60027154|NCT01657877|76143037|FG000|Received 500ppm Fluoride as SMFP+ 0% CSP|Overall Study|Discontinuations: 1 due to other reason in P2 and 1 protocol violation in P4|70||
60027155|NCT01657877|76143037|FG000|Received 1500ppm Fluoride as SMFP+5% CSP|Overall Study|Discontinuations:2 withdrawal of consent in period (P) 1; 1 AE in P2;1 protocol violation in P3 & P4|75||
60027156|NCT01657877|76143037|FG000|Received 0ppm Fluoride+ 5% CSP|Overall Study|Discontinuations: 1 protocol violation in P1 and P2 each and 1 withdrawal of consent in P1.|71||
60027157|NCT01657877|76143037|FG000|Received 0ppm Fluoride+ 0% CSP|Overall Study|Discontinuation: 1 in P4 due to other reasons|69||
60027158|NCT01657877|76143037|FG000|Received 1500ppm Fluoride as SMFP+0% CSP|Overall Study|Discontinuations: 1 protocol violation in P1 and 1 withdrawal of consent and AE in P3|71||
60027159|NCT01657877|76143037|FG000|COMPLETED|Overall Study||65||
60027160|NCT01657877|76143037|FG000|NOT COMPLETED|Overall Study||14||
60027161|NCT02175771|76143062|FG000|STARTED|Run-In Period (Pre-assignment)|Enrolled; two participants were enrolled but had no enrollment date in their records.|758||
60027162|NCT02175771|76143063|FG001|STARTED|Run-In Period (Pre-assignment)||0||
60027163|NCT02175771|76143064|FG002|STARTED|Run-In Period (Pre-assignment)||0||
60027164|NCT02175771|76143065|FG003|STARTED|Run-In Period (Pre-assignment)||0||
60027165|NCT02175771|76143066|FG004|STARTED|Run-In Period (Pre-assignment)||0||
60027166|NCT02175771|76143067|FG005|STARTED|Run-In Period (Pre-assignment)||0||
60027167|NCT02175771|76143068|FG006|STARTED|Run-In Period (Pre-assignment)||0||
60027168|NCT02175771|76143069|FG007|STARTED|Run-In Period (Pre-assignment)||0||
60027169|NCT02175771|76143070|FG008|STARTED|Run-In Period (Pre-assignment)||0||
60027170|NCT02175771|76143062|FG000|COMPLETED|Run-In Period (Pre-assignment)||674||
60027171|NCT02175771|76143063|FG001|COMPLETED|Run-In Period (Pre-assignment)||0||
60027172|NCT02175771|76143064|FG002|COMPLETED|Run-In Period (Pre-assignment)||0||
60027173|NCT02175771|76143065|FG003|COMPLETED|Run-In Period (Pre-assignment)||0||
60027174|NCT02175771|76143066|FG004|COMPLETED|Run-In Period (Pre-assignment)||0||
60027175|NCT02175771|76143067|FG005|COMPLETED|Run-In Period (Pre-assignment)||0||
60027176|NCT02175771|76143068|FG006|COMPLETED|Run-In Period (Pre-assignment)||0||
60027177|NCT02175771|76143069|FG007|COMPLETED|Run-In Period (Pre-assignment)||0||
60027178|NCT02175771|76143070|FG008|COMPLETED|Run-In Period (Pre-assignment)||0||
60027179|NCT02175771|76143062|FG000|NOT COMPLETED|Run-In Period (Pre-assignment)||84||
60067789|NCT01973569|76182981|FG000|Discontinued Study|Overall Study||23||
59759203|NCT00916721|75878574|FG001|STARTED|Overall Study||39||
59759204|NCT00916721|75878573|FG000|COMPLETED|Overall Study||25||
59759205|NCT00916721|75878574|FG001|COMPLETED|Overall Study||29||
59759206|NCT00916721|75878573|FG000|NOT COMPLETED|Overall Study||10||
59759207|NCT00916721|75878574|FG001|NOT COMPLETED|Overall Study||10||
60027180|NCT02175771|76143063|FG001|NOT COMPLETED|Run-In Period (Pre-assignment)||0||
60027181|NCT02175771|76143064|FG002|NOT COMPLETED|Run-In Period (Pre-assignment)||0||
60027182|NCT02175771|76143065|FG003|NOT COMPLETED|Run-In Period (Pre-assignment)||0||
60027183|NCT02175771|76143066|FG004|NOT COMPLETED|Run-In Period (Pre-assignment)||0||
60027184|NCT02175771|76143067|FG005|NOT COMPLETED|Run-In Period (Pre-assignment)||0||
60027185|NCT02175771|76143068|FG006|NOT COMPLETED|Run-In Period (Pre-assignment)||0||
60027186|NCT02175771|76143069|FG007|NOT COMPLETED|Run-In Period (Pre-assignment)||0||
60027187|NCT02175771|76143070|FG008|NOT COMPLETED|Run-In Period (Pre-assignment)||0||
60027188|NCT02175771|76143062|FG000|STARTED|Treatment Period||0||
60027189|NCT02175771|76143063|FG001|STARTED|Treatment Period||127||
60027190|NCT02175771|76143064|FG002|STARTED|Treatment Period||42||
60027191|NCT02175771|76143065|FG003|STARTED|Treatment Period||126||
60027192|NCT02175771|76143066|FG004|STARTED|Treatment Period||41||
60027193|NCT02175771|76143067|FG005|STARTED|Treatment Period||120||
60027194|NCT02175771|76143068|FG006|STARTED|Treatment Period||41||
60027195|NCT02175771|76143069|FG007|STARTED|Treatment Period||133||
60027196|NCT02175771|76143070|FG008|STARTED|Treatment Period||44||
60027197|NCT02175771|76143062|FG000|COMPLETED|Treatment Period||0||
60027198|NCT02175771|76143063|FG001|COMPLETED|Treatment Period||111||
60027199|NCT02175771|76143064|FG002|COMPLETED|Treatment Period||35||
60027200|NCT02175771|76143065|FG003|COMPLETED|Treatment Period||113||
60027201|NCT02175771|76143066|FG004|COMPLETED|Treatment Period||36||
60027202|NCT02175771|76143067|FG005|COMPLETED|Treatment Period||110||
60027203|NCT02175771|76143068|FG006|COMPLETED|Treatment Period||36||
60027204|NCT02175771|76143069|FG007|COMPLETED|Treatment Period||116||
60027205|NCT02175771|76143070|FG008|COMPLETED|Treatment Period||38||
60027206|NCT02175771|76143062|FG000|NOT COMPLETED|Treatment Period||0||
60027207|NCT02175771|76143063|FG001|NOT COMPLETED|Treatment Period||16||
60027208|NCT02175771|76143064|FG002|NOT COMPLETED|Treatment Period||7||
60027209|NCT02175771|76143065|FG003|NOT COMPLETED|Treatment Period||13||
60027210|NCT02175771|76143066|FG004|NOT COMPLETED|Treatment Period||5||
60027211|NCT02175771|76143067|FG005|NOT COMPLETED|Treatment Period||10||
60027212|NCT02175771|76143068|FG006|NOT COMPLETED|Treatment Period||5||
60027213|NCT02175771|76143069|FG007|NOT COMPLETED|Treatment Period||17||
60027214|NCT02175771|76143070|FG008|NOT COMPLETED|Treatment Period||6||
60027215|NCT01657799|76143091|FG000|STARTED|Overall Study||102||
60027216|NCT01657799|76143092|FG001|STARTED|Overall Study||103||
60027217|NCT01657799|76143093|FG002|STARTED|Overall Study||102||
60027218|NCT01657799|76143091|FG000|Received Treatment|Overall Study||101||
60027219|NCT01657799|76143092|FG001|Received Treatment|Overall Study||103||
60027220|NCT01657799|76143093|FG002|Received Treatment|Overall Study||102||
60027221|NCT01657799|76143091|FG000|COMPLETED|Overall Study||0||
60027222|NCT01657799|76143092|FG001|COMPLETED|Overall Study||0||
60027223|NCT01657799|76143093|FG002|COMPLETED|Overall Study||0||
60027224|NCT01657799|76143091|FG000|NOT COMPLETED|Overall Study||102||
60027225|NCT01657799|76143092|FG001|NOT COMPLETED|Overall Study||103||
60027226|NCT01657799|76143093|FG002|NOT COMPLETED|Overall Study||102||
60027227|NCT02116803|76143103|FG000|STARTED|Overall Study||10||
60027228|NCT02116803|76143104|FG001|STARTED|Overall Study||2||
60027229|NCT02116803|76143103|FG000|COMPLETED|Overall Study||0||
60027230|NCT02116803|76143104|FG001|COMPLETED|Overall Study||0||
60027231|NCT02116803|76143103|FG000|NOT COMPLETED|Overall Study||10||
60027232|NCT02116803|76143104|FG001|NOT COMPLETED|Overall Study||2||
60027233|NCT02115321|76143112|FG000|STARTED|Overall Study||30||
60027234|NCT02115321|76143113|FG001|STARTED|Overall Study||10||
60027235|NCT02115321|76143112|FG000|COMPLETED|Overall Study||29||
60027236|NCT02115321|76143113|FG001|COMPLETED|Overall Study||10||
60027237|NCT02115321|76143112|FG000|NOT COMPLETED|Overall Study||1||
60027238|NCT02115321|76143113|FG001|NOT COMPLETED|Overall Study||0||
60027239|NCT02367781|76143121|FG000|STARTED|Overall Study||483||
60027240|NCT02367781|76143122|FG001|STARTED|Overall Study||240||
60027241|NCT02367781|76143121|FG000|COMPLETED|Overall Study||0||
60027242|NCT02367781|76143122|FG001|COMPLETED|Overall Study||0||
60027243|NCT02367781|76143121|FG000|NOT COMPLETED|Overall Study||483||
60027244|NCT02367781|76143122|FG001|NOT COMPLETED|Overall Study||240||
60027245|NCT02152761|76143134|FG000|STARTED|Epoch: Treatment Epoch||75||
60027246|NCT02152761|76143135|FG001|STARTED|Epoch: Treatment Epoch||70||
60027247|NCT02152761|76143136|FG002|STARTED|Epoch: Treatment Epoch||34||
60027248|NCT02152761|76143137|FG003|STARTED|Epoch: Treatment Epoch||72||
60027249|NCT02152761|76143134|FG000|COMPLETED|Epoch: Treatment Epoch||64||
60027250|NCT02152761|76143135|FG001|COMPLETED|Epoch: Treatment Epoch||50||
60027251|NCT02152761|76143136|FG002|COMPLETED|Epoch: Treatment Epoch||29||
60027252|NCT02152761|76143137|FG003|COMPLETED|Epoch: Treatment Epoch||64||
60027253|NCT02152761|76143134|FG000|NOT COMPLETED|Epoch: Treatment Epoch||11||
60027254|NCT02152761|76143135|FG001|NOT COMPLETED|Epoch: Treatment Epoch||20||
60027255|NCT02152761|76143136|FG002|NOT COMPLETED|Epoch: Treatment Epoch||5||
60027256|NCT02152761|76143137|FG003|NOT COMPLETED|Epoch: Treatment Epoch||8||
60027257|NCT02152761|76143134|FG000|STARTED|Epoch: Post-treatment Follow-up Epoch||67||
60027258|NCT02152761|76143135|FG001|STARTED|Epoch: Post-treatment Follow-up Epoch||54||
60027259|NCT02152761|76143136|FG002|STARTED|Epoch: Post-treatment Follow-up Epoch||30||
60027260|NCT02152761|76143137|FG003|STARTED|Epoch: Post-treatment Follow-up Epoch||68||
60027261|NCT02152761|76143134|FG000|COMPLETED|Epoch: Post-treatment Follow-up Epoch||63||
60027262|NCT02152761|76143135|FG001|COMPLETED|Epoch: Post-treatment Follow-up Epoch||47||
60027263|NCT02152761|76143136|FG002|COMPLETED|Epoch: Post-treatment Follow-up Epoch||30||
60027264|NCT02152761|76143137|FG003|COMPLETED|Epoch: Post-treatment Follow-up Epoch||66||
60027265|NCT02152761|76143134|FG000|NOT COMPLETED|Epoch: Post-treatment Follow-up Epoch||4||
60027266|NCT02152761|76143135|FG001|NOT COMPLETED|Epoch: Post-treatment Follow-up Epoch||7||
60027267|NCT02152761|76143136|FG002|NOT COMPLETED|Epoch: Post-treatment Follow-up Epoch||0||
60027268|NCT02152761|76143137|FG003|NOT COMPLETED|Epoch: Post-treatment Follow-up Epoch||2||
60027269|NCT04242173|76143153|FG000|STARTED|Overall Study||3||
60027270|NCT04242173|76143153|FG000|COMPLETED|Overall Study||3||
60027271|NCT04242173|76143153|FG000|NOT COMPLETED|Overall Study||0||
60027272|NCT02152605|76143159|FG000|STARTED|Overall Study||248||
60027273|NCT02152605|76143160|FG001|STARTED|Overall Study||248||
60027274|NCT02152605|76143159|FG000|COMPLETED|Overall Study||229||
60027275|NCT02152605|76143160|FG001|COMPLETED|Overall Study||230||
60027276|NCT02152605|76143159|FG000|NOT COMPLETED|Overall Study||19||
60027277|NCT02152605|76143160|FG001|NOT COMPLETED|Overall Study||18||
60027278|NCT02152371|76143169|FG000|STARTED|Overall Study||150||
60027279|NCT02152371|76143170|FG001|STARTED|Overall Study||150||
60027280|NCT02152371|76143169|FG000|Received at Least 1 Dose of Study Drug.|Overall Study||150||
60027281|NCT02152371|76143170|FG001|Received at Least 1 Dose of Study Drug.|Overall Study||150||
60027282|NCT02152371|76143169|FG000|COMPLETED|Overall Study||138||
60027283|NCT02152371|76143170|FG001|COMPLETED|Overall Study||134||
60027284|NCT02152371|76143169|FG000|NOT COMPLETED|Overall Study||12||
60027285|NCT02152371|76143170|FG001|NOT COMPLETED|Overall Study||16||
60027286|NCT02332291|76143178|FG000|STARTED|Phase 1: Blinded Escitalopram or Placebo||63||
60027287|NCT02332291|76143179|FG001|STARTED|Phase 1: Blinded Escitalopram or Placebo||32||
60027288|NCT02332291|76143178|FG000|COMPLETED|Phase 1: Blinded Escitalopram or Placebo||59||
60027289|NCT02332291|76143179|FG001|COMPLETED|Phase 1: Blinded Escitalopram or Placebo||23||
60027290|NCT02332291|76143178|FG000|NOT COMPLETED|Phase 1: Blinded Escitalopram or Placebo||4||
60027291|NCT02332291|76143179|FG001|NOT COMPLETED|Phase 1: Blinded Escitalopram or Placebo||9||
60027292|NCT02332291|76143178|FG000|STARTED|Phase 2: Open-Label Bupropion||22||
60027293|NCT02332291|76143179|FG001|STARTED|Phase 2: Open-Label Bupropion||19||
60027294|NCT02332291|76143178|FG000|COMPLETED|Phase 2: Open-Label Bupropion||19||
60027295|NCT02332291|76143179|FG001|COMPLETED|Phase 2: Open-Label Bupropion||11||
60027296|NCT02332291|76143178|FG000|NOT COMPLETED|Phase 2: Open-Label Bupropion||3||
60027297|NCT02332291|76143179|FG001|NOT COMPLETED|Phase 2: Open-Label Bupropion||8||
60027298|NCT01656395|76143195|FG000|STARTED|Overall Study||60||
60027299|NCT01656395|76143196|FG001|STARTED|Overall Study||127||
60027300|NCT01656395|76143197|FG002|STARTED|Overall Study||142||
60027301|NCT01656395|76143198|FG003|STARTED|Overall Study||53||
60027302|NCT01656395|76143199|FG004|STARTED|Overall Study||60||
60027303|NCT01656395|76143200|FG005|STARTED|Overall Study||134||
60027304|NCT01656395|76143201|FG006|STARTED|Overall Study||0||
60027305|NCT01656395|76143202|FG007|STARTED|Overall Study||0||
60027306|NCT01656395|76143195|FG000|Treated Participants|Overall Study||58||
60027307|NCT01656395|76143196|FG001|Treated Participants|Overall Study||126||
60027308|NCT01656395|76143197|FG002|Treated Participants|Overall Study||135||
60027309|NCT01656395|76143198|FG003|Treated Participants|Overall Study||52||
60027310|NCT01656395|76143199|FG004|Treated Participants|Overall Study||60||
60027311|NCT01656395|76143200|FG005|Treated Participants|Overall Study||126||
60027312|NCT01656395|76143201|FG006|Treated Participants|Overall Study||0||
60027313|NCT01656395|76143202|FG007|Treated Participants|Overall Study||0||
60027314|NCT01656395|76143195|FG000|COMPLETED|Overall Study||43||
60027315|NCT01656395|76143196|FG001|COMPLETED|Overall Study||93||
60027316|NCT01656395|76143197|FG002|COMPLETED|Overall Study||106||
60027317|NCT01656395|76143198|FG003|COMPLETED|Overall Study||41||
60027318|NCT01656395|76143199|FG004|COMPLETED|Overall Study||46||
60027319|NCT01656395|76143200|FG005|COMPLETED|Overall Study||94||
60027320|NCT01656395|76143201|FG006|COMPLETED|Overall Study||0||
60027321|NCT01656395|76143202|FG007|COMPLETED|Overall Study||0||
59507414|NCT02408445|75600680|FG000|STARTED|Overall Study||10||
60027322|NCT01656395|76143195|FG000|NOT COMPLETED|Overall Study||17||
60027323|NCT01656395|76143196|FG001|NOT COMPLETED|Overall Study||34||
60027324|NCT01656395|76143197|FG002|NOT COMPLETED|Overall Study||36||
60027325|NCT01656395|76143198|FG003|NOT COMPLETED|Overall Study||12||
60027326|NCT01656395|76143199|FG004|NOT COMPLETED|Overall Study||14||
60027327|NCT01656395|76143200|FG005|NOT COMPLETED|Overall Study||40||
60027328|NCT01656395|76143201|FG006|NOT COMPLETED|Overall Study||0||
60027329|NCT01656395|76143202|FG007|NOT COMPLETED|Overall Study||0||
60027330|NCT02114931|76143218|FG000|STARTED|Overall Study||230||
60027331|NCT02114931|76143219|FG001|STARTED|Overall Study||237||
60027332|NCT02114931|76143218|FG000|Received Treatment|Overall Study|One participant was enrolled in error and did not receive treatment in the extension study|229||
60027333|NCT02114931|76143219|FG001|Received Treatment|Overall Study||237||
60027334|NCT02114931|76143218|FG000|COMPLETED|Overall Study||205||
60027335|NCT02114931|76143219|FG001|COMPLETED|Overall Study||207||
60027336|NCT02114931|76143218|FG000|NOT COMPLETED|Overall Study||25||
60027337|NCT02114931|76143219|FG001|NOT COMPLETED|Overall Study||30||
60027338|NCT01657019|76143225|FG000|STARTED|Overall Study||604||
60027339|NCT01657019|76143225|FG000|COMPLETED|Overall Study||369||
60027340|NCT01657019|76143225|FG000|NOT COMPLETED|Overall Study||235||
60027341|NCT02329327|76143231|FG000|STARTED|Overall Study||477||
60027342|NCT02329327|76143232|FG001|STARTED|Overall Study||2||
60027343|NCT02329327|76143231|FG000|Received At Least 1 Dose of Study Drug|Overall Study||477|Safety Population|
60027344|NCT02329327|76143232|FG001|Received At Least 1 Dose of Study Drug|Overall Study||2|Safety Population|
60027345|NCT02329327|76143231|FG000|Efficacy Population|Overall Study||347|All participants who received at least 1 dose of study drug and who met protocol-specified criteria for bleeding and anti-factor Xa (fXa) levels.|
60027346|NCT02329327|76143232|FG001|Efficacy Population|Overall Study||2|All participants who received at least 1 dose of study drug and who met protocol-specified criteria for bleeding and anti-factor Xa (fXa) levels.|
60027347|NCT02329327|76143231|FG000|Death|Overall Study||3|These deaths occurred during the follow-up period.|
60027348|NCT02329327|76143232|FG001|Death|Overall Study||0|These deaths occurred during the follow-up period.|
60027349|NCT02329327|76143231|FG000|COMPLETED|Overall Study||392||
60027350|NCT02329327|76143232|FG001|COMPLETED|Overall Study||2||
60027351|NCT02329327|76143231|FG000|NOT COMPLETED|Overall Study||85||
60027352|NCT02329327|76143232|FG001|NOT COMPLETED|Overall Study||0||
60027353|NCT02328937|76143251|FG000|STARTED|Period 1||7||
60027354|NCT02328937|76143252|FG001|STARTED|Period 1||6||
60027355|NCT02328937|76143253|FG002|STARTED|Period 1||7||
60027356|NCT02328937|76143254|FG003|STARTED|Period 1||6||
60027357|NCT02328937|76143255|FG004|STARTED|Period 1||6||
60027358|NCT02328937|76143256|FG005|STARTED|Period 1||6||
60027359|NCT02328937|76143251|FG000|COMPLETED|Period 1||7||
60027360|NCT02328937|76143252|FG001|COMPLETED|Period 1||6||
60027361|NCT02328937|76143253|FG002|COMPLETED|Period 1||7||
60027362|NCT02328937|76143254|FG003|COMPLETED|Period 1||5||
60027363|NCT02328937|76143255|FG004|COMPLETED|Period 1||6||
60027364|NCT02328937|76143256|FG005|COMPLETED|Period 1||6||
60027365|NCT02328937|76143251|FG000|NOT COMPLETED|Period 1||0||
60027366|NCT02328937|76143252|FG001|NOT COMPLETED|Period 1||0||
60027367|NCT02328937|76143253|FG002|NOT COMPLETED|Period 1||0||
60027368|NCT02328937|76143254|FG003|NOT COMPLETED|Period 1||1||
60027369|NCT02328937|76143255|FG004|NOT COMPLETED|Period 1||0||
60027370|NCT02328937|76143256|FG005|NOT COMPLETED|Period 1||0||
60027371|NCT02328937|76143251|FG000|STARTED|Period 2||7||
60027372|NCT02328937|76143252|FG001|STARTED|Period 2||6||
60027373|NCT02328937|76143253|FG002|STARTED|Period 2||7||
60027374|NCT02328937|76143254|FG003|STARTED|Period 2||5||
60027375|NCT02328937|76143255|FG004|STARTED|Period 2||6||
60027376|NCT02328937|76143256|FG005|STARTED|Period 2||6||
60027377|NCT02328937|76143251|FG000|COMPLETED|Period 2||7||
60027378|NCT02328937|76143252|FG001|COMPLETED|Period 2||6||
60027379|NCT02328937|76143253|FG002|COMPLETED|Period 2||6||
60027380|NCT02328937|76143254|FG003|COMPLETED|Period 2||5||
60027381|NCT02328937|76143255|FG004|COMPLETED|Period 2||6||
60027382|NCT02328937|76143256|FG005|COMPLETED|Period 2||6||
60027383|NCT02328937|76143251|FG000|NOT COMPLETED|Period 2||0||
60027384|NCT02328937|76143252|FG001|NOT COMPLETED|Period 2||0||
60027385|NCT02328937|76143253|FG002|NOT COMPLETED|Period 2||1||
60027386|NCT02328937|76143254|FG003|NOT COMPLETED|Period 2||0||
60027387|NCT02328937|76143255|FG004|NOT COMPLETED|Period 2||0||
60027388|NCT02328937|76143256|FG005|NOT COMPLETED|Period 2||0||
60027389|NCT02328937|76143251|FG000|STARTED|Period 3||7||
60027390|NCT02328937|76143252|FG001|STARTED|Period 3||6||
60027391|NCT02328937|76143253|FG002|STARTED|Period 3||6||
60027392|NCT02328937|76143254|FG003|STARTED|Period 3||5||
60027393|NCT02328937|76143255|FG004|STARTED|Period 3||6||
60027394|NCT02328937|76143256|FG005|STARTED|Period 3||6||
60027395|NCT02328937|76143251|FG000|COMPLETED|Period 3||7||
60027396|NCT02328937|76143252|FG001|COMPLETED|Period 3||6||
60027397|NCT02328937|76143253|FG002|COMPLETED|Period 3||6||
60027398|NCT02328937|76143254|FG003|COMPLETED|Period 3||5||
60027399|NCT02328937|76143255|FG004|COMPLETED|Period 3||6||
60027400|NCT02328937|76143256|FG005|COMPLETED|Period 3||6||
60027401|NCT02328937|76143251|FG000|NOT COMPLETED|Period 3||0||
60027402|NCT02328937|76143252|FG001|NOT COMPLETED|Period 3||0||
60027403|NCT02328937|76143253|FG002|NOT COMPLETED|Period 3||0||
60027404|NCT02328937|76143254|FG003|NOT COMPLETED|Period 3||0||
60027405|NCT02328937|76143255|FG004|NOT COMPLETED|Period 3||0||
60027406|NCT02328937|76143256|FG005|NOT COMPLETED|Period 3||0||
60027407|NCT02328547|76143266|FG000|STARTED|First Intervention (12 Weeks)||25||
60027408|NCT02328547|76143267|FG001|STARTED|First Intervention (12 Weeks)||23||
60027409|NCT02328547|76143266|FG000|COMPLETED|First Intervention (12 Weeks)||22||
60027410|NCT02328547|76143267|FG001|COMPLETED|First Intervention (12 Weeks)||23||
60027411|NCT02328547|76143266|FG000|NOT COMPLETED|First Intervention (12 Weeks)||3||
60027412|NCT02328547|76143267|FG001|NOT COMPLETED|First Intervention (12 Weeks)||0||
60027413|NCT02328547|76143266|FG000|STARTED|Second Intervention (12 Weeks)||22||
60027414|NCT02328547|76143267|FG001|STARTED|Second Intervention (12 Weeks)||23||
60027415|NCT02328547|76143266|FG000|COMPLETED|Second Intervention (12 Weeks)||22||
60027416|NCT02328547|76143267|FG001|COMPLETED|Second Intervention (12 Weeks)||23||
60027417|NCT02328547|76143266|FG000|NOT COMPLETED|Second Intervention (12 Weeks)||0||
60027418|NCT02328547|76143267|FG001|NOT COMPLETED|Second Intervention (12 Weeks)||0||
60027419|NCT02300311|76143281|FG000|STARTED|Overall Study||69||
60027420|NCT02300311|76143282|FG001|STARTED|Overall Study||69||
60027421|NCT02300311|76143281|FG000|COMPLETED|Overall Study||50||
60027422|NCT02300311|76143282|FG001|COMPLETED|Overall Study||69||
60027423|NCT02300311|76143281|FG000|NOT COMPLETED|Overall Study||19||
60027424|NCT02300311|76143282|FG001|NOT COMPLETED|Overall Study||0||
60027425|NCT04229381|76143288|FG000|STARTED|Overall Study||18||
60027426|NCT04229381|76143288|FG000|COMPLETED|Overall Study||18||
60027427|NCT04229381|76143288|FG000|NOT COMPLETED|Overall Study||0||
60027428|NCT02300233|76143295|FG000|STARTED|Overall Study||38||
60027429|NCT02300233|76143296|FG001|STARTED|Overall Study||25||
60027430|NCT02300233|76143297|FG002|STARTED|Overall Study||50||
60027431|NCT02300233|76143295|FG000|COMPLETED|Overall Study||34|Completed here refers to participants who completed the study treatment.|
60027432|NCT02300233|76143296|FG001|COMPLETED|Overall Study||24|Completed here refers to participants who completed the study treatment.|
60027433|NCT02300233|76143297|FG002|COMPLETED|Overall Study||27|Completed here refers to participants who completed the study treatment.|
60027434|NCT02300233|76143295|FG000|NOT COMPLETED|Overall Study||4||
60027435|NCT02300233|76143296|FG001|NOT COMPLETED|Overall Study||1||
60027436|NCT02300233|76143297|FG002|NOT COMPLETED|Overall Study||23||
60027437|NCT02175225|76143308|FG000|STARTED|Overall Study||145||
60027438|NCT02175225|76143309|FG001|STARTED|Overall Study||149||
60027439|NCT02175225|76143308|FG000|Initiated Study Drug|Overall Study|Subjects in whom study drug was not initiated are not subsequently followed per the protocol.|144||
60027440|NCT02175225|76143309|FG001|Initiated Study Drug|Overall Study|Subjects in whom study drug was not initiated are not subsequently followed per the protocol.|147||
60027441|NCT02175225|76143308|FG000|90 Day Outcome Obtained|Overall Study||140||
60027442|NCT02175225|76143309|FG001|90 Day Outcome Obtained|Overall Study||143||
60027443|NCT02175225|76143308|FG000|180 Day Outcome Obtained|Overall Study||135||
60027444|NCT02175225|76143309|FG001|180 Day Outcome Obtained|Overall Study||135||
60027445|NCT02175225|76143308|FG000|COMPLETED|Overall Study||137||
60027446|NCT02175225|76143309|FG001|COMPLETED|Overall Study||138||
60027447|NCT02175225|76143308|FG000|NOT COMPLETED|Overall Study||8||
60027448|NCT02175225|76143309|FG001|NOT COMPLETED|Overall Study||11||
60027449|NCT02299375|76143317|FG000|STARTED|Overall Study||94||
60027450|NCT02299375|76143318|FG001|STARTED|Overall Study||90||
60027451|NCT02299375|76143317|FG000|COMPLETED|Overall Study||14||
60027452|NCT02299375|76143318|FG001|COMPLETED|Overall Study||10||
60027453|NCT02299375|76143317|FG000|NOT COMPLETED|Overall Study||80||
60027454|NCT02299375|76143318|FG001|NOT COMPLETED|Overall Study||80||
60027455|NCT02151903|76143327|FG000|STARTED|Overall Study||3||
60027456|NCT02151903|76143328|FG001|STARTED|Overall Study||2||
60027457|NCT02151903|76143327|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3||
60027458|NCT02151903|76143328|FG001|Received at Least 1 Dose of Study Drug|Overall Study||2||
60027459|NCT02151903|76143327|FG000|COMPLETED|Overall Study||0||
60027460|NCT02151903|76143328|FG001|COMPLETED|Overall Study||1||
60027461|NCT02151903|76143327|FG000|NOT COMPLETED|Overall Study||3||
60027462|NCT02151903|76143328|FG001|NOT COMPLETED|Overall Study||1||
60027463|NCT02151591|76143336|FG000|STARTED|Overall Study||13||
60027464|NCT02151591|76143337|FG001|STARTED|Overall Study||13||
60027465|NCT02151591|76143336|FG000|COMPLETED|Overall Study||7||
60027466|NCT02151591|76143337|FG001|COMPLETED|Overall Study||10||
60027467|NCT02151591|76143336|FG000|NOT COMPLETED|Overall Study||6||
60027468|NCT02151591|76143337|FG001|NOT COMPLETED|Overall Study||3||
60027469|NCT02174523|76143345|FG000|STARTED|Overall Study||10||
60027470|NCT02174523|76143346|FG001|STARTED|Overall Study||4||
60027471|NCT02174523|76143345|FG000|COMPLETED|Overall Study||9||
60027472|NCT02174523|76143346|FG001|COMPLETED|Overall Study||4||
60027473|NCT02174523|76143345|FG000|NOT COMPLETED|Overall Study||1||
60027474|NCT02174523|76143346|FG001|NOT COMPLETED|Overall Study||0||
60027475|NCT02297815|76143353|FG000|STARTED|Overall Study||1604||
59611773|NCT01755546|75722773|FG000|COMPLETED|Screened and Taper (Rollover and DeNovo)||294||
60027476|NCT02297815|76143354|FG001|STARTED|Overall Study||868||
60027477|NCT02297815|76143353|FG000|5-10 Day Interview|Overall Study||1604||
60027478|NCT02297815|76143354|FG001|5-10 Day Interview|Overall Study||868||
60027479|NCT02297815|76143353|FG000|14-20 Day Interview|Overall Study||1368||
60027480|NCT02297815|76143354|FG001|14-20 Day Interview|Overall Study||728||
60027481|NCT02297815|76143353|FG000|COMPLETED|Overall Study||1368||
60027482|NCT02297815|76143354|FG001|COMPLETED|Overall Study||728||
60027483|NCT02297815|76143353|FG000|NOT COMPLETED|Overall Study||236||
60027484|NCT02297815|76143354|FG001|NOT COMPLETED|Overall Study||140||
60027485|NCT02114385|76143364|FG000|STARTED|Overall Study||249||
60027486|NCT02114385|76143365|FG001|STARTED|Overall Study||251||
60027487|NCT02114385|76143364|FG000|Vaccinated|Overall Study||249||
60027488|NCT02114385|76143365|FG001|Vaccinated|Overall Study||251||
60027489|NCT02114385|76143364|FG000|COMPLETED|Overall Study||246||
60027490|NCT02114385|76143365|FG001|COMPLETED|Overall Study||243||
60027491|NCT02114385|76143364|FG000|NOT COMPLETED|Overall Study||3||
60027492|NCT02114385|76143365|FG001|NOT COMPLETED|Overall Study||8||
60027493|NCT02114151|76143371|FG000|STARTED|Overall Study||103||
60027494|NCT02114151|76143371|FG000|COMPLETED|Overall Study||96||
60027495|NCT02114151|76143371|FG000|NOT COMPLETED|Overall Study||7||
60027496|NCT02297503|76143377|FG000|STARTED|Overall Study||30||
60027497|NCT02297503|76143378|FG001|STARTED|Overall Study||31||
60027498|NCT02297503|76143377|FG000|Initial Single Treatment|Overall Study||29||
60027499|NCT02297503|76143378|FG001|Initial Single Treatment|Overall Study||31||
60027500|NCT02297503|76143377|FG000|First Combined Treatment|Overall Study||28||
60027501|NCT02297503|76143378|FG001|First Combined Treatment|Overall Study||28||
59915507|NCT02828982|76036420|FG001|STARTED|First Intervention (3 Weeks)||7||
59915508|NCT02828982|76036419|FG000|Received Intervention|First Intervention (3 Weeks)||5||
59915509|NCT02828982|76036420|FG001|Received Intervention|First Intervention (3 Weeks)||7||
59915510|NCT02828982|76036419|FG000|COMPLETED|First Intervention (3 Weeks)||4||
59915511|NCT02828982|76036420|FG001|COMPLETED|First Intervention (3 Weeks)||6||
59915512|NCT02828982|76036419|FG000|NOT COMPLETED|First Intervention (3 Weeks)||1||
59507415|NCT02408445|75600681|FG001|STARTED|Overall Study||10||
59507416|NCT02408445|75600680|FG000|COMPLETED|Overall Study||10||
59915513|NCT02828982|76036420|FG001|NOT COMPLETED|First Intervention (3 Weeks)||1||
59915514|NCT02828982|76036419|FG000|STARTED|Second Intervention (3 Weeks)||4||
59915515|NCT02828982|76036420|FG001|STARTED|Second Intervention (3 Weeks)||6||
59915516|NCT02828982|76036419|FG000|Received Intervention|Second Intervention (3 Weeks)||4||
60027502|NCT02297503|76143377|FG000|Second Combined Treatment|Overall Study||28||
60027503|NCT02297503|76143378|FG001|Second Combined Treatment|Overall Study||28||
59507417|NCT02408445|75600681|FG001|COMPLETED|Overall Study||10||
59507418|NCT02408445|75600680|FG000|NOT COMPLETED|Overall Study||0||
60027504|NCT02297503|76143377|FG000|COMPLETED|Overall Study||28||
59507419|NCT02408445|75600681|FG001|NOT COMPLETED|Overall Study||0||
59507420|NCT02016885|75600691|FG000|STARTED|Overall Study||38||
59507421|NCT02016885|75600692|FG001|STARTED|Overall Study||40||
59507422|NCT02016885|75600693|FG002|STARTED|Overall Study||40||
60027505|NCT02297503|76143378|FG001|COMPLETED|Overall Study||27||
60027506|NCT02297503|76143377|FG000|NOT COMPLETED|Overall Study||2||
59915517|NCT02828982|76036420|FG001|Received Intervention|Second Intervention (3 Weeks)||6||
59915518|NCT02828982|76036419|FG000|COMPLETED|Second Intervention (3 Weeks)||4||
59915519|NCT02828982|76036420|FG001|COMPLETED|Second Intervention (3 Weeks)||6||
59915520|NCT02828982|76036419|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||0||
59915521|NCT02828982|76036420|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0||
59915522|NCT03133767|76036430|FG000|STARTED|Overall Study||79||
59915523|NCT03133767|76036431|FG001|STARTED|Overall Study||78||
59915524|NCT03133767|76036430|FG000|COMPLETED|Overall Study||41||
59915525|NCT03133767|76036431|FG001|COMPLETED|Overall Study||53||
59915526|NCT03133767|76036430|FG000|NOT COMPLETED|Overall Study||38||
59915527|NCT03133767|76036431|FG001|NOT COMPLETED|Overall Study||25||
59915528|NCT03391765|76036441|FG000|STARTED|Overall Study||51||
59915529|NCT03391765|76036442|FG001|STARTED|Overall Study||45||
59915530|NCT03391765|76036443|FG002|STARTED|Overall Study||23||
59915531|NCT03391765|76036444|FG003|STARTED|Overall Study||23||
59915532|NCT03391765|76036441|FG000|COMPLETED|Overall Study||0||
59915533|NCT03391765|76036442|FG001|COMPLETED|Overall Study||0||
59915534|NCT03391765|76036443|FG002|COMPLETED|Overall Study||0||
59915535|NCT03391765|76036444|FG003|COMPLETED|Overall Study||0||
59915536|NCT03391765|76036441|FG000|NOT COMPLETED|Overall Study||51||
59915537|NCT03391765|76036442|FG001|NOT COMPLETED|Overall Study||45||
59915538|NCT03391765|76036443|FG002|NOT COMPLETED|Overall Study||23||
59915539|NCT03391765|76036444|FG003|NOT COMPLETED|Overall Study||23||
59915540|NCT02802228|76036456|FG000|STARTED|Overall Study||20||
59915541|NCT02802228|76036457|FG001|STARTED|Overall Study||10||
59915542|NCT02802228|76036456|FG000|COMPLETED|Overall Study||15||
59915543|NCT02802228|76036457|FG001|COMPLETED|Overall Study||10||
59915544|NCT02802228|76036456|FG000|NOT COMPLETED|Overall Study||5||
59915545|NCT02802228|76036457|FG001|NOT COMPLETED|Overall Study||0||
59915546|NCT03130257|76036466|FG000|STARTED|Overall Study||172||
59915547|NCT03130257|76036467|FG001|STARTED|Overall Study||170||
59915548|NCT03130257|76036468|FG002|STARTED|Overall Study||168||
59915549|NCT03130257|76036466|FG000|COMPLETED|Overall Study||171||
59915550|NCT03130257|76036467|FG001|COMPLETED|Overall Study||170||
59915551|NCT03130257|76036468|FG002|COMPLETED|Overall Study||166||
59915552|NCT03130257|76036466|FG000|NOT COMPLETED|Overall Study||1||
59915553|NCT03130257|76036467|FG001|NOT COMPLETED|Overall Study||0||
59915554|NCT03130257|76036468|FG002|NOT COMPLETED|Overall Study||2||
59915555|NCT03674177|76036480|FG000|STARTED|Overall Study||124||
59915556|NCT03674177|76036481|FG001|STARTED|Overall Study||126||
59915557|NCT03674177|76036482|FG002|STARTED|Overall Study||126||
59915558|NCT03674177|76036483|FG003|STARTED|Overall Study||126||
59915559|NCT03674177|76036480|FG000|COMPLETED|Overall Study||122||
59915560|NCT03674177|76036481|FG001|COMPLETED|Overall Study||125||
59915561|NCT03674177|76036482|FG002|COMPLETED|Overall Study||126||
59915562|NCT03674177|76036483|FG003|COMPLETED|Overall Study||124||
59915563|NCT03674177|76036480|FG000|NOT COMPLETED|Overall Study||2||
59915564|NCT03674177|76036481|FG001|NOT COMPLETED|Overall Study||1||
59915565|NCT03674177|76036482|FG002|NOT COMPLETED|Overall Study||0||
59915566|NCT03674177|76036483|FG003|NOT COMPLETED|Overall Study||2||
59915567|NCT04380090|76036495|FG000|STARTED|Overall Study||76||
59915568|NCT04380090|76036496|FG001|STARTED|Overall Study||78||
59915569|NCT04380090|76036495|FG000|COMPLETED|Overall Study||60||
59915570|NCT04380090|76036496|FG001|COMPLETED|Overall Study||58||
59915571|NCT04380090|76036495|FG000|NOT COMPLETED|Overall Study||16||
59915572|NCT04380090|76036496|FG001|NOT COMPLETED|Overall Study||20||
59915573|NCT03354637|76036509|FG000|STARTED|Double-blind Period||43||
59915574|NCT03354637|76036510|FG001|STARTED|Double-blind Period||44||
59915575|NCT03354637|76036511|FG002|STARTED|Double-blind Period||42||
59915576|NCT03354637|76036509|FG000|COMPLETED|Double-blind Period||26||
59915577|NCT03354637|76036510|FG001|COMPLETED|Double-blind Period||31||
59915578|NCT03354637|76036511|FG002|COMPLETED|Double-blind Period||35||
59915579|NCT03354637|76036509|FG000|NOT COMPLETED|Double-blind Period||17||
59915580|NCT03354637|76036510|FG001|NOT COMPLETED|Double-blind Period||13||
59915581|NCT03354637|76036511|FG002|NOT COMPLETED|Double-blind Period||7||
59915582|NCT03354637|76036509|FG000|STARTED|Open Label Extension||0|Subjects entering the Open Label Extension period all received ATI-50002 0.46% Topical Solution.|
59915583|NCT03354637|76036510|FG001|STARTED|Open Label Extension||0|Subjects entering the Open Label Extension period all received ATI-50002 0.46% Topical Solution.|
59915584|NCT03354637|76036511|FG002|STARTED|Open Label Extension||61|Subjects entering the Open Label Extension period all received ATI-50002 0.46% Topical Solution.|
59915585|NCT03354637|76036509|FG000|COMPLETED|Open Label Extension||0||
59915586|NCT03354637|76036510|FG001|COMPLETED|Open Label Extension||0||
59915587|NCT03354637|76036511|FG002|COMPLETED|Open Label Extension||33||
59915588|NCT03354637|76036509|FG000|NOT COMPLETED|Open Label Extension||0||
59915589|NCT03354637|76036510|FG001|NOT COMPLETED|Open Label Extension||0||
59915590|NCT03354637|76036511|FG002|NOT COMPLETED|Open Label Extension||28||
59915591|NCT04053023|76036522|FG000|STARTED|Part A: Period 1 (Day 1 to Day 19)||19||
59915592|NCT04053023|76036523|FG001|STARTED|Part A: Period 1 (Day 1 to Day 19)||0||
59915593|NCT04053023|76036522|FG000|COMPLETED|Part A: Period 1 (Day 1 to Day 19)||19||
59915594|NCT04053023|76036523|FG001|COMPLETED|Part A: Period 1 (Day 1 to Day 19)||0||
59915595|NCT04053023|76036522|FG000|NOT COMPLETED|Part A: Period 1 (Day 1 to Day 19)||0||
60027507|NCT02297503|76143378|FG001|NOT COMPLETED|Overall Study||4||
60027508|NCT02113449|76143393|FG000|STARTED|Overall Study||147||
60027509|NCT02113449|76143393|FG000|COMPLETED|Overall Study||143||
60027510|NCT02113449|76143393|FG000|NOT COMPLETED|Overall Study||4||
60027511|NCT02366923|76143401|FG000|STARTED|Overall Study||28||
60027512|NCT02366923|76143401|FG000|COMPLETED|Overall Study||22||
60027513|NCT02366923|76143401|FG000|NOT COMPLETED|Overall Study||6||
60027514|NCT02326597|76143408|FG000|STARTED|Overall Study||60||
60027515|NCT02326597|76143409|FG001|STARTED|Overall Study||60||
60027516|NCT02326597|76143408|FG000|COMPLETED|Overall Study||18||
60027517|NCT02326597|76143409|FG001|COMPLETED|Overall Study||28||
60027518|NCT02326597|76143408|FG000|NOT COMPLETED|Overall Study||42||
60027519|NCT02326597|76143409|FG001|NOT COMPLETED|Overall Study||32||
60027520|NCT02366767|76143419|FG000|STARTED|Overall Study||11||
60027521|NCT02366767|76143420|FG001|STARTED|Overall Study||10||
60027522|NCT02366767|76143419|FG000|COMPLETED|Overall Study||10||
60027523|NCT02366767|76143420|FG001|COMPLETED|Overall Study||10||
60027524|NCT02366767|76143419|FG000|NOT COMPLETED|Overall Study||1||
60027525|NCT02366767|76143420|FG001|NOT COMPLETED|Overall Study||0||
60027526|NCT02150343|76143430|FG000|STARTED|Overall Study||180||
60027527|NCT02150343|76143431|FG001|STARTED|Overall Study||178||
60027528|NCT02150343|76143432|FG002|STARTED|Overall Study||178||
60027529|NCT02150343|76143433|FG003|STARTED|Overall Study||178||
60027530|NCT02150343|76143430|FG000|COMPLETED|Overall Study||159||
60027531|NCT02150343|76143431|FG001|COMPLETED|Overall Study||158||
60027532|NCT02150343|76143432|FG002|COMPLETED|Overall Study||166||
60027533|NCT02150343|76143433|FG003|COMPLETED|Overall Study||168||
60027534|NCT02150343|76143430|FG000|NOT COMPLETED|Overall Study||21||
60027535|NCT02150343|76143431|FG001|NOT COMPLETED|Overall Study||20||
60027536|NCT02150343|76143432|FG002|NOT COMPLETED|Overall Study||12||
60027537|NCT02150343|76143433|FG003|NOT COMPLETED|Overall Study||10||
60027538|NCT02149875|76143446|FG000|STARTED|Overall Study||27||
60027539|NCT02149875|76143447|FG001|STARTED|Overall Study||28||
60027540|NCT02149875|76143448|FG002|STARTED|Overall Study||29||
60027541|NCT02149875|76143446|FG000|COMPLETED|Overall Study||20||
60027542|NCT02149875|76143447|FG001|COMPLETED|Overall Study||20||
60027543|NCT02149875|76143448|FG002|COMPLETED|Overall Study||20||
60027544|NCT02149875|76143446|FG000|NOT COMPLETED|Overall Study||7||
60027545|NCT02149875|76143447|FG001|NOT COMPLETED|Overall Study||8||
60027546|NCT02149875|76143448|FG002|NOT COMPLETED|Overall Study||9||
60027547|NCT02112045|76143458|FG000|STARTED|Overall Study||45||
60027548|NCT02112045|76143459|FG001|STARTED|Overall Study||45||
60027549|NCT02112045|76143458|FG000|COMPLETED|Overall Study||44||
60027550|NCT02112045|76143459|FG001|COMPLETED|Overall Study||45||
60027551|NCT02112045|76143458|FG000|NOT COMPLETED|Overall Study||1||
60027552|NCT02112045|76143459|FG001|NOT COMPLETED|Overall Study||0||
60027553|NCT01629693|76143467|FG000|STARTED|Overall Study||193||
60027554|NCT01629693|76143468|FG001|STARTED|Overall Study||188||
60027555|NCT01629693|76143467|FG000|COMPLETED|Overall Study||188||
60027556|NCT01629693|76143468|FG001|COMPLETED|Overall Study||178||
60027557|NCT01629693|76143467|FG000|NOT COMPLETED|Overall Study||5||
60027558|NCT01629693|76143468|FG001|NOT COMPLETED|Overall Study||10||
60027559|NCT02147691|76143476|FG000|STARTED|Overall Study||10||
60027560|NCT02147691|76143477|FG001|STARTED|Overall Study||12||
60027561|NCT02147691|76143476|FG000|COMPLETED|Overall Study||6||
60027562|NCT02147691|76143477|FG001|COMPLETED|Overall Study||11||
60027563|NCT02147691|76143476|FG000|NOT COMPLETED|Overall Study||4||
60027564|NCT02147691|76143477|FG001|NOT COMPLETED|Overall Study||1||
60027565|NCT02111811|76143485|FG000|STARTED|Treatment Phase||139||
60027566|NCT02111811|76143486|FG001|STARTED|Treatment Phase||114||
60027567|NCT02111811|76143485|FG000|COMPLETED|Treatment Phase||115||
60027568|NCT02111811|76143486|FG001|COMPLETED|Treatment Phase||96||
60027569|NCT02111811|76143485|FG000|NOT COMPLETED|Treatment Phase||24||
60027570|NCT02111811|76143486|FG001|NOT COMPLETED|Treatment Phase||18||
60027571|NCT02111811|76143485|FG000|STARTED|Follow up Period (Aim 2)||139||
60027572|NCT02111811|76143486|FG001|STARTED|Follow up Period (Aim 2)|All subjects were approached for followup, 1 patient completed the 2nd followup and not the first.|114||
60027573|NCT02111811|76143485|FG000|COMPLETED|Follow up Period (Aim 2)||111||
60027574|NCT02111811|76143486|FG001|COMPLETED|Follow up Period (Aim 2)||97||
60027575|NCT02111811|76143485|FG000|NOT COMPLETED|Follow up Period (Aim 2)||28||
60027576|NCT02111811|76143486|FG001|NOT COMPLETED|Follow up Period (Aim 2)||17||
60027577|NCT01655693|76143495|FG000|STARTED|Overall Study||130||
60027578|NCT01655693|76143496|FG001|STARTED|Overall Study||133||
60027579|NCT01655693|76143497|FG002|STARTED|Overall Study||134||
60027580|NCT01655693|76143495|FG000|COMPLETED|Overall Study||4||
60027581|NCT01655693|76143496|FG001|COMPLETED|Overall Study||7||
60027582|NCT01655693|76143497|FG002|COMPLETED|Overall Study||4||
60027583|NCT01655693|76143495|FG000|NOT COMPLETED|Overall Study||126||
60027584|NCT01655693|76143496|FG001|NOT COMPLETED|Overall Study||126||
60027585|NCT01655693|76143497|FG002|NOT COMPLETED|Overall Study||130||
60027586|NCT01655381|76143515|FG000|STARTED|Overall Study||15||
60027587|NCT01655381|76143515|FG000|COMPLETED|Overall Study||12||
60027588|NCT01655381|76143515|FG000|NOT COMPLETED|Overall Study||3||
60027589|NCT01656161|76143520|FG000|STARTED|Overall Study|Intention to treat analysis set|120||
60027590|NCT01656161|76143520|FG000|Received Triptorelin at Day 1|Overall Study|Safety analysis set|120||
60027591|NCT01656161|76143520|FG000|Received Triptorelin at Day 169|Overall Study||115||
60027592|NCT01656161|76143520|FG000|COMPLETED|Overall Study|Per protocol analysis set|113||
60027593|NCT01656161|76143520|FG000|NOT COMPLETED|Overall Study||7||
60027594|NCT02111577|76143529|FG000|STARTED|Overall Study||787||
60027595|NCT02111577|76143530|FG001|STARTED|Overall Study||395||
60027596|NCT02111577|76143529|FG000|COMPLETED|Overall Study||188||
60027597|NCT02111577|76143530|FG001|COMPLETED|Overall Study||106||
60027598|NCT02111577|76143529|FG000|NOT COMPLETED|Overall Study||599||
60027599|NCT02111577|76143530|FG001|NOT COMPLETED|Overall Study||289||
60027600|NCT02170779|76143540|FG000|STARTED|Overall Study||20||
60027601|NCT02170779|76143541|FG001|STARTED|Overall Study||20||
60027602|NCT02170779|76143540|FG000|COMPLETED|Overall Study||19||
60027603|NCT02170779|76143541|FG001|COMPLETED|Overall Study||19||
60027604|NCT02170779|76143540|FG000|NOT COMPLETED|Overall Study||1||
60027605|NCT02170779|76143541|FG001|NOT COMPLETED|Overall Study||1||
60027606|NCT02147067|76143549|FG000|STARTED|Overall Study||13||
60027607|NCT02147067|76143550|FG001|STARTED|Overall Study||13||
60027608|NCT02147067|76143549|FG000|COMPLETED|Overall Study||11||
60027609|NCT02147067|76143550|FG001|COMPLETED|Overall Study||11||
60027610|NCT02147067|76143549|FG000|NOT COMPLETED|Overall Study||2||
60027611|NCT02147067|76143550|FG001|NOT COMPLETED|Overall Study||2||
60027612|NCT02170389|76143556|FG000|STARTED|Overall Study||5||
60027613|NCT02170389|76143556|FG000|COMPLETED|Overall Study||4||
60027614|NCT02170389|76143556|FG000|NOT COMPLETED|Overall Study||1||
60027615|NCT02146599|76143560|FG000|STARTED|Overall Study||301||
60027616|NCT02146599|76143560|FG000|COMPLETED|Overall Study||296||
60027617|NCT02146599|76143560|FG000|NOT COMPLETED|Overall Study||5||
60027618|NCT02146365|76143570|FG000|STARTED|Overall Study||49||
60027619|NCT02146365|76143571|FG001|STARTED|Overall Study||49||
60027620|NCT02146365|76143572|FG002|STARTED|Overall Study||50||
60027621|NCT02146365|76143573|FG003|STARTED|Overall Study||50||
60027622|NCT02146365|76143574|FG004|STARTED|Overall Study||24||
60027623|NCT02146365|76143575|FG005|STARTED|Overall Study||25||
60027624|NCT02146365|76143576|FG006|STARTED|Overall Study||25||
60027625|NCT02146365|76143577|FG007|STARTED|Overall Study||25||
60027626|NCT02146365|76143570|FG000|COMPLETED|Overall Study||45||
60027627|NCT02146365|76143571|FG001|COMPLETED|Overall Study||45||
60027628|NCT02146365|76143572|FG002|COMPLETED|Overall Study||43||
60027629|NCT02146365|76143573|FG003|COMPLETED|Overall Study||41||
60027630|NCT02146365|76143574|FG004|COMPLETED|Overall Study||22||
60027631|NCT02146365|76143575|FG005|COMPLETED|Overall Study||24||
60027632|NCT02146365|76143576|FG006|COMPLETED|Overall Study||25||
60027633|NCT02146365|76143577|FG007|COMPLETED|Overall Study||24||
60027634|NCT02146365|76143570|FG000|NOT COMPLETED|Overall Study||4||
60027635|NCT02146365|76143571|FG001|NOT COMPLETED|Overall Study||4||
60027636|NCT02146365|76143572|FG002|NOT COMPLETED|Overall Study||7||
60027637|NCT02146365|76143573|FG003|NOT COMPLETED|Overall Study||9||
60027638|NCT02146365|76143574|FG004|NOT COMPLETED|Overall Study||2||
60027639|NCT02146365|76143575|FG005|NOT COMPLETED|Overall Study||1||
60027640|NCT02146365|76143576|FG006|NOT COMPLETED|Overall Study||0||
60027641|NCT02146365|76143577|FG007|NOT COMPLETED|Overall Study||1||
60027642|NCT02146131|76143597|FG000|STARTED|Overall Study||170||
60027643|NCT02146131|76143598|FG001|STARTED|Overall Study||169||
60027644|NCT02146131|76143597|FG000|COMPLETED|Overall Study||109||
60027645|NCT02146131|76143598|FG001|COMPLETED|Overall Study||113||
60027646|NCT02146131|76143597|FG000|NOT COMPLETED|Overall Study||61||
60027647|NCT02146131|76143598|FG001|NOT COMPLETED|Overall Study||56||
60027648|NCT02107131|76143606|FG000|STARTED|Overall Study||20||
60027649|NCT02107131|76143607|FG001|STARTED|Overall Study||20||
60027650|NCT02107131|76143606|FG000|COMPLETED|Overall Study||12||
60027651|NCT02107131|76143607|FG001|COMPLETED|Overall Study||11||
60027652|NCT02107131|76143606|FG000|NOT COMPLETED|Overall Study||8||
60027653|NCT02107131|76143607|FG001|NOT COMPLETED|Overall Study||9||
60027654|NCT02106975|76143617|FG000|STARTED|Overall Study||84||
60027655|NCT02106975|76143618|FG001|STARTED|Overall Study||83||
60027656|NCT02106975|76143617|FG000|COMPLETED|Overall Study||59||
60027657|NCT02106975|76143618|FG001|COMPLETED|Overall Study||44||
60027658|NCT02106975|76143617|FG000|NOT COMPLETED|Overall Study||25||
60027659|NCT02106975|76143618|FG001|NOT COMPLETED|Overall Study||39||
60027660|NCT02145429|76143626|FG000|STARTED|Overall Study||91||
60027661|NCT02145429|76143627|FG001|STARTED|Overall Study||90||
60027662|NCT02145429|76143626|FG000|COMPLETED|Overall Study||75||
60027663|NCT02145429|76143627|FG001|COMPLETED|Overall Study||79||
60027664|NCT02145429|76143626|FG000|NOT COMPLETED|Overall Study||16||
60027665|NCT02145429|76143627|FG001|NOT COMPLETED|Overall Study||11||
60027666|NCT02144337|76143635|FG000|STARTED|Baseline 0 Months||8||
59611774|NCT01755546|75722773|FG000|NOT COMPLETED|Screened and Taper (Rollover and DeNovo)||10||
59611775|NCT01755546|75722773|FG000|STARTED|Titration Phase||294||
59611776|NCT01755546|75722773|FG000|COMPLETED|Titration Phase||224||
59915596|NCT04053023|76036523|FG001|NOT COMPLETED|Part A: Period 1 (Day 1 to Day 19)||0||
59915597|NCT04053023|76036522|FG000|STARTED|Part A: Period 2 (Day 20 to Day 38)||19||
59915598|NCT04053023|76036523|FG001|STARTED|Part A: Period 2 (Day 20 to Day 38)||0||
59915599|NCT04053023|76036522|FG000|COMPLETED|Part A: Period 2 (Day 20 to Day 38)||18||
59915600|NCT04053023|76036523|FG001|COMPLETED|Part A: Period 2 (Day 20 to Day 38)||0||
59915601|NCT04053023|76036522|FG000|NOT COMPLETED|Part A: Period 2 (Day 20 to Day 38)||1||
59915602|NCT04053023|76036523|FG001|NOT COMPLETED|Part A: Period 2 (Day 20 to Day 38)||0||
59915603|NCT04053023|76036522|FG000|STARTED|Part B: Period 1 (Day 1 to Day 19)||0||
59915604|NCT04053023|76036523|FG001|STARTED|Part B: Period 1 (Day 1 to Day 19)||0||
59915605|NCT04053023|76036522|FG000|COMPLETED|Part B: Period 1 (Day 1 to Day 19)||0||
59915606|NCT04053023|76036523|FG001|COMPLETED|Part B: Period 1 (Day 1 to Day 19)||0||
59915607|NCT04053023|76036522|FG000|NOT COMPLETED|Part B: Period 1 (Day 1 to Day 19)||0||
59915608|NCT04053023|76036523|FG001|NOT COMPLETED|Part B: Period 1 (Day 1 to Day 19)||0||
59915609|NCT04053023|76036522|FG000|STARTED|Part B: Period 2 (Day 20 to Day 38)||0||
59915610|NCT04053023|76036523|FG001|STARTED|Part B: Period 2 (Day 20 to Day 38)||0||
59915611|NCT04053023|76036522|FG000|COMPLETED|Part B: Period 2 (Day 20 to Day 38)||0||
59915612|NCT04053023|76036523|FG001|COMPLETED|Part B: Period 2 (Day 20 to Day 38)||0||
59915613|NCT04053023|76036522|FG000|NOT COMPLETED|Part B: Period 2 (Day 20 to Day 38)||0||
59915614|NCT04053023|76036523|FG001|NOT COMPLETED|Part B: Period 2 (Day 20 to Day 38)||0||
59915615|NCT03352453|76036535|FG000|STARTED|Overall Study||66||
59915616|NCT03352453|76036536|FG001|STARTED|Overall Study||72||
59915617|NCT03352453|76036535|FG000|COMPLETED|Overall Study||44||
59915618|NCT03352453|76036536|FG001|COMPLETED|Overall Study||40||
59915619|NCT03352453|76036535|FG000|NOT COMPLETED|Overall Study||22||
59915620|NCT03352453|76036536|FG001|NOT COMPLETED|Overall Study||32||
59915621|NCT03128931|76036542|FG000|STARTED|Overall Study||45||
59915622|NCT03128931|76036542|FG000|COMPLETED|Overall Study||41||
59915623|NCT03128931|76036542|FG000|NOT COMPLETED|Overall Study||4||
59915624|NCT03107052|76036549|FG000|STARTED|Overall Study||145|Intent-to-treat (ITT) analysis set: all participants enrolled for long-term safety evaluation|
59915625|NCT03107052|76036550|FG001|STARTED|Overall Study||60|Intent-to-treat (ITT) analysis set: all participants enrolled for long-term safety evaluation|
59915626|NCT03107052|76036551|FG002|STARTED|Overall Study||70|Intent-to-treat (ITT) analysis set: all participants enrolled for long-term safety evaluation|
59915627|NCT03107052|76036549|FG000|Safety Analysis Set|Overall Study|1 participant assigned to 225 mg monthly arm but received 675 mg quarterly after >12 weeks remission|144|All participants who received at least 1 dose of study drug|
59915628|NCT03107052|76036550|FG001|Safety Analysis Set|Overall Study||60|All participants who received at least 1 dose of study drug|
59915629|NCT03107052|76036551|FG002|Safety Analysis Set|Overall Study|1 participant assigned to 225 mg monthly arm but received 675 mg quarterly after >12 weeks remission|71|All participants who received at least 1 dose of study drug|
59915630|NCT03107052|76036549|FG000|COMPLETED|Overall Study||26||
59915631|NCT03107052|76036550|FG001|COMPLETED|Overall Study||14||
59915632|NCT03107052|76036551|FG002|COMPLETED|Overall Study||29||
59915633|NCT03107052|76036549|FG000|NOT COMPLETED|Overall Study||119||
59915634|NCT03107052|76036550|FG001|NOT COMPLETED|Overall Study||46||
59915635|NCT03107052|76036551|FG002|NOT COMPLETED|Overall Study||41||
59915636|NCT04050371|76036561|FG000|STARTED|Overall Study||24||
59915637|NCT04050371|76036562|FG001|STARTED|Overall Study||24||
59915638|NCT04050371|76036561|FG000|COMPLETED|Overall Study||23||
59915639|NCT04050371|76036562|FG001|COMPLETED|Overall Study||24||
59915640|NCT04050371|76036561|FG000|NOT COMPLETED|Overall Study||1||
59915641|NCT04050371|76036562|FG001|NOT COMPLETED|Overall Study||0||
59915642|NCT04447287|76036571|FG000|STARTED|Period 1: Run-in Period||23||
59915643|NCT04447287|76036572|FG001|STARTED|Period 1: Run-in Period||0||
59915644|NCT04447287|76036573|FG002|STARTED|Period 1: Run-in Period||0||
59915645|NCT04447287|76036571|FG000|COMPLETED|Period 1: Run-in Period||19||
59915646|NCT04447287|76036572|FG001|COMPLETED|Period 1: Run-in Period||0||
59915647|NCT04447287|76036573|FG002|COMPLETED|Period 1: Run-in Period||0||
59915648|NCT04447287|76036571|FG000|NOT COMPLETED|Period 1: Run-in Period||4||
59915649|NCT04447287|76036572|FG001|NOT COMPLETED|Period 1: Run-in Period||0||
59915650|NCT04447287|76036573|FG002|NOT COMPLETED|Period 1: Run-in Period||0||
59915651|NCT04447287|76036571|FG000|STARTED|Period 2: Investigational Period||1||
59915652|NCT04447287|76036572|FG001|STARTED|Period 2: Investigational Period||12||
59915653|NCT04447287|76036573|FG002|STARTED|Period 2: Investigational Period||6||
59915654|NCT04447287|76036571|FG000|COMPLETED|Period 2: Investigational Period||0||
59915655|NCT04447287|76036572|FG001|COMPLETED|Period 2: Investigational Period||12||
59915656|NCT04447287|76036573|FG002|COMPLETED|Period 2: Investigational Period||6||
59915657|NCT04447287|76036571|FG000|NOT COMPLETED|Period 2: Investigational Period||1||
59915658|NCT04447287|76036572|FG001|NOT COMPLETED|Period 2: Investigational Period||0||
59915659|NCT04447287|76036573|FG002|NOT COMPLETED|Period 2: Investigational Period||0||
59915660|NCT04447287|76036571|FG000|STARTED|Period 3: Down-Titration Period||0||
59915661|NCT04447287|76036572|FG001|STARTED|Period 3: Down-Titration Period||12||
59951306|NCT03524118|76070246|FG000|STARTED|Overall Study||8||
59611777|NCT01755546|75722773|FG000|NOT COMPLETED|Titration Phase||70||
60027667|NCT02144337|76143636|FG001|STARTED|Baseline 0 Months||5||
60027668|NCT02144337|76143635|FG000|COMPLETED|Baseline 0 Months||8||
60027669|NCT02144337|76143636|FG001|COMPLETED|Baseline 0 Months||5||
60027670|NCT02144337|76143635|FG000|NOT COMPLETED|Baseline 0 Months||0||
60027671|NCT02144337|76143636|FG001|NOT COMPLETED|Baseline 0 Months||0||
60027672|NCT02144337|76143635|FG000|STARTED|T2 Follow-up (Post-intervention)||8||
60027673|NCT02144337|76143636|FG001|STARTED|T2 Follow-up (Post-intervention)||5||
60027674|NCT02144337|76143635|FG000|COMPLETED|T2 Follow-up (Post-intervention)||4||
60027675|NCT02144337|76143636|FG001|COMPLETED|T2 Follow-up (Post-intervention)||4||
60027676|NCT02144337|76143635|FG000|NOT COMPLETED|T2 Follow-up (Post-intervention)||4||
60027677|NCT02144337|76143636|FG001|NOT COMPLETED|T2 Follow-up (Post-intervention)||1||
60027678|NCT02144337|76143635|FG000|STARTED|T3 Follow-up (3 Month Post-intervention)|Number not the same as number who completed previous period due to absence/loss of data at T2|8||
60027679|NCT02144337|76143636|FG001|STARTED|T3 Follow-up (3 Month Post-intervention)|Number not the same as number who completed previous period due to absence/loss of data at T2|5||
60027680|NCT02144337|76143635|FG000|COMPLETED|T3 Follow-up (3 Month Post-intervention)||5||
60027681|NCT02144337|76143636|FG001|COMPLETED|T3 Follow-up (3 Month Post-intervention)||5||
60027682|NCT02144337|76143635|FG000|NOT COMPLETED|T3 Follow-up (3 Month Post-intervention)||3||
60027683|NCT02144337|76143636|FG001|NOT COMPLETED|T3 Follow-up (3 Month Post-intervention)||0||
60027684|NCT02520011|76143646|FG000|STARTED|Overall Study||11||
60027685|NCT02520011|76143647|FG001|STARTED|Overall Study||79||
60027686|NCT02520011|76143648|FG002|STARTED|Overall Study||14||
60027687|NCT02520011|76143646|FG000|Stage 1|Overall Study||0||
60027688|NCT02520011|76143647|FG001|Stage 1|Overall Study||32||
60027689|NCT02520011|76143648|FG002|Stage 1|Overall Study||10||
60027690|NCT02520011|76143646|FG000|Stage 2|Overall Study||11||
60027691|NCT02520011|76143647|FG001|Stage 2|Overall Study||47||
60027692|NCT02520011|76143648|FG002|Stage 2|Overall Study||4||
60027693|NCT02520011|76143646|FG000|COMPLETED|Overall Study||6||
60027694|NCT02520011|76143647|FG001|COMPLETED|Overall Study||33||
60027695|NCT02520011|76143648|FG002|COMPLETED|Overall Study||5||
60027696|NCT02520011|76143646|FG000|NOT COMPLETED|Overall Study||5||
60027697|NCT02520011|76143647|FG001|NOT COMPLETED|Overall Study||46||
60027698|NCT02520011|76143648|FG002|NOT COMPLETED|Overall Study||9||
60027699|NCT02519231|76143663|FG000|STARTED|Overall Study||14||
60027700|NCT02519231|76143664|FG001|STARTED|Overall Study||14||
60027701|NCT02519231|76143663|FG000|COMPLETED|Overall Study|One was lost to follow up and never took the treatment. another never turned in bleeding diary.|12||
60027702|NCT02519231|76143664|FG001|COMPLETED|Overall Study|Six participants never turned in their bleeding diaries.|8||
60027703|NCT02519231|76143663|FG000|NOT COMPLETED|Overall Study||2||
60027704|NCT02519231|76143664|FG001|NOT COMPLETED|Overall Study||6||
60027705|NCT02106351|76143675|FG000|STARTED|Treatment Cycle 1||71||
60027706|NCT02106351|76143676|FG001|STARTED|Treatment Cycle 1||70||
60027707|NCT02106351|76143677|FG002|STARTED|Treatment Cycle 1||71||
60027708|NCT02106351|76143675|FG000|Received Treatment in TC 1|Treatment Cycle 1||70||
60027709|NCT02106351|76143676|FG001|Received Treatment in TC 1|Treatment Cycle 1||70||
60027710|NCT02106351|76143677|FG002|Received Treatment in TC 1|Treatment Cycle 1||70||
60027711|NCT02106351|76143675|FG000|COMPLETED|Treatment Cycle 1||66||
60027712|NCT02106351|76143676|FG001|COMPLETED|Treatment Cycle 1||67||
60027713|NCT02106351|76143677|FG002|COMPLETED|Treatment Cycle 1||67||
60027714|NCT02106351|76143675|FG000|NOT COMPLETED|Treatment Cycle 1||5||
60027715|NCT02106351|76143676|FG001|NOT COMPLETED|Treatment Cycle 1||3||
60027716|NCT02106351|76143677|FG002|NOT COMPLETED|Treatment Cycle 1||4||
60027717|NCT02106351|76143675|FG000|STARTED|Treatment Cycle 2|Subjects who received Dysport 2 U/kg in TC 1 were randomised to receive 8 or 16 U/kg in TCs 2-4.|0||
60027718|NCT02106351|76143676|FG001|STARTED|Treatment Cycle 2|Not all subjects who completed TC 1 required retreatment in TC 2.|88||
60027719|NCT02106351|76143677|FG002|STARTED|Treatment Cycle 2|Not all subjects who completed TC 1 required retreatment in TC 2.|90||
60027720|NCT02106351|76143675|FG000|COMPLETED|Treatment Cycle 2||0||
60027721|NCT02106351|76143676|FG001|COMPLETED|Treatment Cycle 2||83||
60027722|NCT02106351|76143677|FG002|COMPLETED|Treatment Cycle 2||87||
60027723|NCT02106351|76143675|FG000|NOT COMPLETED|Treatment Cycle 2||0||
60027724|NCT02106351|76143676|FG001|NOT COMPLETED|Treatment Cycle 2||5||
60027725|NCT02106351|76143677|FG002|NOT COMPLETED|Treatment Cycle 2||3||
60027726|NCT02106351|76143675|FG000|STARTED|Treatment Cycle 3||0||
60027727|NCT02106351|76143676|FG001|STARTED|Treatment Cycle 3|Not all subjects who completed TC 2 required retreatment in TC 3.|49||
60027728|NCT02106351|76143677|FG002|STARTED|Treatment Cycle 3|Not all subjects who completed TC 2 required retreatment in TC 3.|58||
60027729|NCT02106351|76143675|FG000|COMPLETED|Treatment Cycle 3||0||
60027730|NCT02106351|76143676|FG001|COMPLETED|Treatment Cycle 3||45||
60027731|NCT02106351|76143677|FG002|COMPLETED|Treatment Cycle 3||53||
60027732|NCT02106351|76143675|FG000|NOT COMPLETED|Treatment Cycle 3||0||
60027733|NCT02106351|76143676|FG001|NOT COMPLETED|Treatment Cycle 3||4||
60027734|NCT02106351|76143677|FG002|NOT COMPLETED|Treatment Cycle 3||5||
60027735|NCT02106351|76143675|FG000|STARTED|Treatment Cycle 4||0||
60027736|NCT02106351|76143676|FG001|STARTED|Treatment Cycle 4|Not all subjects who completed TC 3 required retreatment in TC 4.|22||
60027737|NCT02106351|76143677|FG002|STARTED|Treatment Cycle 4|Not all subjects who completed TC 3 required retreatment in TC 4.|33||
60027738|NCT02106351|76143675|FG000|COMPLETED|Treatment Cycle 4||0||
60027739|NCT02106351|76143676|FG001|COMPLETED|Treatment Cycle 4||21||
60027740|NCT02106351|76143677|FG002|COMPLETED|Treatment Cycle 4||31||
60027741|NCT02106351|76143675|FG000|NOT COMPLETED|Treatment Cycle 4||0||
60027742|NCT02106351|76143676|FG001|NOT COMPLETED|Treatment Cycle 4||1||
60027743|NCT02106351|76143677|FG002|NOT COMPLETED|Treatment Cycle 4||2||
60027744|NCT02143947|76143693|FG000|STARTED|Overall Study||36||
60027745|NCT02143947|76143694|FG001|STARTED|Overall Study||44||
60027746|NCT02143947|76143693|FG000|COMPLETED|Overall Study||32||
60027747|NCT02143947|76143694|FG001|COMPLETED|Overall Study||42||
60027748|NCT02143947|76143693|FG000|NOT COMPLETED|Overall Study||4||
60027749|NCT02143947|76143694|FG001|NOT COMPLETED|Overall Study||2||
60027750|NCT02075073|76143705|FG000|STARTED|Overall Study||36||
60027751|NCT02075073|76143706|FG001|STARTED|Overall Study||37||
60027752|NCT02075073|76143707|FG002|STARTED|Overall Study||36||
60027753|NCT02075073|76143705|FG000|COMPLETED|Overall Study||36||
60027754|NCT02075073|76143706|FG001|COMPLETED|Overall Study||36||
60027755|NCT02075073|76143707|FG002|COMPLETED|Overall Study||36||
60027756|NCT02075073|76143705|FG000|NOT COMPLETED|Overall Study||0||
60027757|NCT02075073|76143706|FG001|NOT COMPLETED|Overall Study||1||
60027758|NCT02075073|76143707|FG002|NOT COMPLETED|Overall Study||0||
60027759|NCT02074059|76143721|FG000|STARTED|Overall Study||8||
60027760|NCT02074059|76143722|FG001|STARTED|Overall Study||8||
60027761|NCT02074059|76143723|FG002|STARTED|Overall Study||8||
60027762|NCT02074059|76143724|FG003|STARTED|Overall Study||8||
60027763|NCT02074059|76143725|FG004|STARTED|Overall Study||8||
60027764|NCT02074059|76143726|FG005|STARTED|Overall Study||40||
60027765|NCT02074059|76143721|FG000|COMPLETED|Overall Study||8||
60027766|NCT02074059|76143722|FG001|COMPLETED|Overall Study||8||
60027767|NCT02074059|76143723|FG002|COMPLETED|Overall Study||8||
60027768|NCT02074059|76143724|FG003|COMPLETED|Overall Study||8||
60027769|NCT02074059|76143725|FG004|COMPLETED|Overall Study||7||
60027770|NCT02074059|76143726|FG005|COMPLETED|Overall Study||39||
60027771|NCT02074059|76143721|FG000|NOT COMPLETED|Overall Study||0||
60027772|NCT02074059|76143722|FG001|NOT COMPLETED|Overall Study||0||
60027773|NCT02074059|76143723|FG002|NOT COMPLETED|Overall Study||0||
60027774|NCT02074059|76143724|FG003|NOT COMPLETED|Overall Study||0||
60027775|NCT02074059|76143725|FG004|NOT COMPLETED|Overall Study||1||
60027776|NCT02074059|76143726|FG005|NOT COMPLETED|Overall Study||1||
60027777|NCT02143713|76143745|FG000|STARTED|Treatment Period (6 Months)||102||
60027778|NCT02143713|76143746|FG001|STARTED|Treatment Period (6 Months)||111||
60027779|NCT02143713|76143747|FG002|STARTED|Treatment Period (6 Months)||142||
60027780|NCT02143713|76143748|FG003|STARTED|Treatment Period (6 Months)||140||
60027781|NCT02143713|76143745|FG000|Received Elagolix|Treatment Period (6 Months)||102||
60027782|NCT02143713|76143746|FG001|Received Elagolix|Treatment Period (6 Months)||111||
60027783|NCT02143713|76143747|FG002|Received Elagolix|Treatment Period (6 Months)||142||
60027784|NCT02143713|76143748|FG003|Received Elagolix|Treatment Period (6 Months)||140||
60027785|NCT02143713|76143745|FG000|COMPLETED|Treatment Period (6 Months)||82||
60027786|NCT02143713|76143746|FG001|COMPLETED|Treatment Period (6 Months)||99||
60027787|NCT02143713|76143747|FG002|COMPLETED|Treatment Period (6 Months)||120||
60027788|NCT02143713|76143748|FG003|COMPLETED|Treatment Period (6 Months)||112||
59759208|NCT00915005|75878582|FG000|STARTED|Overall Study||105||
59759209|NCT00915005|75878583|FG001|STARTED|Overall Study||76||
59915662|NCT04447287|76036573|FG002|STARTED|Period 3: Down-Titration Period||6||
59915663|NCT04447287|76036571|FG000|COMPLETED|Period 3: Down-Titration Period||0||
59915664|NCT04447287|76036572|FG001|COMPLETED|Period 3: Down-Titration Period||12||
59915665|NCT04447287|76036573|FG002|COMPLETED|Period 3: Down-Titration Period||6||
60027789|NCT02143713|76143745|FG000|NOT COMPLETED|Treatment Period (6 Months)||20||
60027790|NCT02143713|76143746|FG001|NOT COMPLETED|Treatment Period (6 Months)||12||
60027791|NCT02143713|76143747|FG002|NOT COMPLETED|Treatment Period (6 Months)||22||
60027792|NCT02143713|76143748|FG003|NOT COMPLETED|Treatment Period (6 Months)||28||
60027793|NCT02143713|76143745|FG000|STARTED|Post-treatment Follow-up (12 Months)||85|Participants who completed the 6-month Treatment Period or prematurely discontinued could enter PTFU|
60027794|NCT02143713|76143746|FG001|STARTED|Post-treatment Follow-up (12 Months)||105|Participants who completed the 6-month Treatment Period or prematurely discontinued could enter PTFU|
60027795|NCT02143713|76143747|FG002|STARTED|Post-treatment Follow-up (12 Months)||125|Participants who completed the 6-month Treatment Period or prematurely discontinued could enter PTFU|
60027796|NCT02143713|76143748|FG003|STARTED|Post-treatment Follow-up (12 Months)||122|Participants who completed the 6-month Treatment Period or prematurely discontinued could enter PTFU|
60027797|NCT02143713|76143745|FG000|COMPLETED|Post-treatment Follow-up (12 Months)||73||
59611778|NCT01755546|75722773|FG000|STARTED|Long Term Treatment||224||
59759210|NCT00915005|75878582|FG000|COMPLETED|Overall Study||92||
59759211|NCT00915005|75878583|FG001|COMPLETED|Overall Study||57||
59759212|NCT00915005|75878582|FG000|NOT COMPLETED|Overall Study||13||
59915666|NCT04447287|76036571|FG000|NOT COMPLETED|Period 3: Down-Titration Period||0||
59915667|NCT04447287|76036572|FG001|NOT COMPLETED|Period 3: Down-Titration Period||0||
59915668|NCT04447287|76036573|FG002|NOT COMPLETED|Period 3: Down-Titration Period||0||
59915669|NCT01879319|76036594|FG000|STARTED|Overall Study||82||
59915670|NCT01879319|76036595|FG001|STARTED|Overall Study||82||
59915671|NCT01879319|76036594|FG000|Received Treatment|Overall Study||82||
59915672|NCT01879319|76036595|FG001|Received Treatment|Overall Study||82||
60027798|NCT02143713|76143746|FG001|COMPLETED|Post-treatment Follow-up (12 Months)||81||
60027799|NCT02143713|76143747|FG002|COMPLETED|Post-treatment Follow-up (12 Months)||96||
60027800|NCT02143713|76143748|FG003|COMPLETED|Post-treatment Follow-up (12 Months)||95||
60027801|NCT02143713|76143745|FG000|NOT COMPLETED|Post-treatment Follow-up (12 Months)||12||
60027802|NCT02143713|76143746|FG001|NOT COMPLETED|Post-treatment Follow-up (12 Months)||24||
60027803|NCT02143713|76143747|FG002|NOT COMPLETED|Post-treatment Follow-up (12 Months)||29||
60027804|NCT02143713|76143748|FG003|NOT COMPLETED|Post-treatment Follow-up (12 Months)||27||
60027805|NCT02519855|76143761|FG000|STARTED|Overall Study|Participants are included as treated|441||
60027806|NCT02519855|76143762|FG001|STARTED|Overall Study|Participants are included as treated|441||
60027807|NCT02519855|76143761|FG000|Vaccinated on Day 1|Overall Study||440||
60027808|NCT02519855|76143762|FG001|Vaccinated on Day 1|Overall Study||441||
60027809|NCT02519855|76143761|FG000|Vaccinated at Week 4|Overall Study||432||
60027810|NCT02519855|76143762|FG001|Vaccinated at Week 4|Overall Study||424||
60027811|NCT02519855|76143761|FG000|COMPLETED|Overall Study||438||
60027812|NCT02519855|76143762|FG001|COMPLETED|Overall Study||437||
60027813|NCT02519855|76143761|FG000|NOT COMPLETED|Overall Study||3||
60027814|NCT02519855|76143762|FG001|NOT COMPLETED|Overall Study||4||
60027815|NCT02142387|76143770|FG000|STARTED|Overall Study|Out-of-hospital cardiac arrest (OHCA) patients with presumed cardiac etiology.|2551||
60027816|NCT02142387|76143771|FG001|STARTED|Overall Study||16271||
60027817|NCT02142387|76143770|FG000|COMPLETED|Overall Study|Limited to the case where OHCA occurred in the private place.|1486||
60027818|NCT02142387|76143771|FG001|COMPLETED|Overall Study||8641||
60027819|NCT02142387|76143770|FG000|NOT COMPLETED|Overall Study||1065||
60027820|NCT02142387|76143771|FG001|NOT COMPLETED|Overall Study||7630||
60027821|NCT02518919|76143780|FG000|STARTED|Overall Study||21||
60027822|NCT02518919|76143781|FG001|STARTED|Overall Study||21||
60027823|NCT02518919|76143782|FG002|STARTED|Overall Study||21||
60027824|NCT02518919|76143780|FG000|COMPLETED|Overall Study||20||
59915673|NCT01879319|76036594|FG000|COMPLETED|Overall Study||80||
59915674|NCT01879319|76036595|FG001|COMPLETED|Overall Study||77||
59915675|NCT01879319|76036594|FG000|NOT COMPLETED|Overall Study||2||
59915676|NCT01879319|76036595|FG001|NOT COMPLETED|Overall Study||5||
59915677|NCT03102918|76036603|FG000|STARTED|Overall Study||5||
59915678|NCT03102918|76036604|FG001|STARTED|Overall Study||5||
60027825|NCT02518919|76143781|FG001|COMPLETED|Overall Study||20||
60027826|NCT02518919|76143782|FG002|COMPLETED|Overall Study||19||
60027827|NCT02518919|76143780|FG000|NOT COMPLETED|Overall Study||1||
60027828|NCT02518919|76143781|FG001|NOT COMPLETED|Overall Study||1||
60027829|NCT02518919|76143782|FG002|NOT COMPLETED|Overall Study||2||
60027830|NCT02518685|76143792|FG000|STARTED|Overall Study||213|Subjects randomized|
60027831|NCT02518685|76143793|FG001|STARTED|Overall Study||89|Subjects randomized|
60027832|NCT02518685|76143792|FG000|Safety Cohort|Overall Study|Randomized to and successfully received TPS (171) + Open-Label TPS-treated Subjects (32)|203|Ten subjects did not receive TPS|
60027833|NCT02518685|76143793|FG001|Safety Cohort|Overall Study||89|Ten subjects did not receive TPS|
60027834|NCT02518685|76143792|FG000|Randomized Cohort|Overall Study||181||
60027835|NCT02518685|76143793|FG001|Randomized Cohort|Overall Study||89||
60027836|NCT02518685|76143792|FG000|Enrolled|Overall Study|Includes 171 Successful device deployments, 10 unsuccessful delivery attempts and 32 Open-Label|213||
60027837|NCT02518685|76143793|FG001|Enrolled|Overall Study||89||
60027838|NCT02518685|76143792|FG000|Per Protocol Analysis|Overall Study|Three TPS-treated subjects were inadvertently unblinded, excluding them from efficacy analyses.|168||
60027839|NCT02518685|76143793|FG001|Per Protocol Analysis|Overall Study||89||
60027840|NCT02518685|76143792|FG000|COMPLETED|Overall Study|Randomized Completers (139) plus Open-Label Completers (25)|164|Completed 12-Month Visit|
60027841|NCT02518685|76143793|FG001|COMPLETED|Overall Study||79|Completed 12-Month Visit|
60027842|NCT02518685|76143792|FG000|NOT COMPLETED|Overall Study||49||
60027843|NCT02518685|76143793|FG001|NOT COMPLETED|Overall Study||10||
60027844|NCT02520089|76143802|FG000|STARTED|Overall Study||12||
60027845|NCT02520089|76143803|FG001|STARTED|Overall Study||11||
60027846|NCT02520089|76143802|FG000|COMPLETED|Overall Study||9||
60027847|NCT02520089|76143803|FG001|COMPLETED|Overall Study||7||
60027848|NCT02520089|76143802|FG000|NOT COMPLETED|Overall Study||3||
60027849|NCT02520089|76143803|FG001|NOT COMPLETED|Overall Study||4||
60027850|NCT02105961|76143812|FG000|STARTED|Overall Study||226||
60027851|NCT02105961|76143813|FG001|STARTED|Overall Study||223||
60027852|NCT02105961|76143814|FG002|STARTED|Overall Study||225||
60027853|NCT02105961|76143812|FG000|Completed Investigational Product (IP)|Overall Study||170||
60027854|NCT02105961|76143813|FG001|Completed Investigational Product (IP)|Overall Study||196||
60027855|NCT02105961|76143814|FG002|Completed Investigational Product (IP)|Overall Study||183||
60027856|NCT02105961|76143812|FG000|Not Completed IP|Overall Study||56||
60027857|NCT02105961|76143813|FG001|Not Completed IP|Overall Study||27||
60027858|NCT02105961|76143814|FG002|Not Completed IP|Overall Study||42||
60027859|NCT02105961|76143812|FG000|Withdrew IP Due to: Adverse Event|Overall Study||27||
60027860|NCT02105961|76143813|FG001|Withdrew IP Due to: Adverse Event|Overall Study||9||
60027861|NCT02105961|76143814|FG002|Withdrew IP Due to: Adverse Event|Overall Study||25||
60027862|NCT02105961|76143812|FG000|Withdrew IP Due to: Stopping Criteria|Overall Study||1||
60027863|NCT02105961|76143813|FG001|Withdrew IP Due to: Stopping Criteria|Overall Study||1||
60027864|NCT02105961|76143814|FG002|Withdrew IP Due to: Stopping Criteria|Overall Study||0||
60027865|NCT02105961|76143812|FG000|Withdrew IP Due to: Lack of Efficacy|Overall Study||6||
60027866|NCT02105961|76143813|FG001|Withdrew IP Due to: Lack of Efficacy|Overall Study||2||
59759213|NCT00915005|75878583|FG001|NOT COMPLETED|Overall Study||19||
59759214|NCT01143246|75878591|FG000|STARTED|Overall Study||97||
59759215|NCT01143246|75878592|FG001|STARTED|Overall Study||99||
59762601|NCT03888235|75882412|FG002|NOT COMPLETED|Overall Study||0||
59915679|NCT03102918|76036603|FG000|COMPLETED|Overall Study||4||
59915680|NCT03102918|76036604|FG001|COMPLETED|Overall Study||5||
59915681|NCT03102918|76036603|FG000|NOT COMPLETED|Overall Study||1||
59915682|NCT03102918|76036604|FG001|NOT COMPLETED|Overall Study||0||
59915683|NCT03128307|76036610|FG000|STARTED|Overall Study||604||
59915684|NCT03128307|76036610|FG000|COMPLETED|Overall Study||570||
59915685|NCT03128307|76036610|FG000|NOT COMPLETED|Overall Study||34||
59915686|NCT03102762|76036616|FG000|STARTED|Overall Study||35||
59915687|NCT03102762|76036617|FG001|STARTED|Overall Study||35||
60027867|NCT02105961|76143814|FG002|Withdrew IP Due to: Lack of Efficacy|Overall Study||2||
60027868|NCT02105961|76143812|FG000|Withdrew IP Due to: Protocol Deviation|Overall Study||2||
60027869|NCT02105961|76143813|FG001|Withdrew IP Due to: Protocol Deviation|Overall Study||0||
60027870|NCT02105961|76143814|FG002|Withdrew IP Due to: Protocol Deviation|Overall Study||1||
60027871|NCT02105961|76143812|FG000|Withdrew IP Due to: Lost to Follow-up|Overall Study||1||
60027872|NCT02105961|76143813|FG001|Withdrew IP Due to: Lost to Follow-up|Overall Study||1||
60027873|NCT02105961|76143814|FG002|Withdrew IP Due to: Lost to Follow-up|Overall Study||1||
60027874|NCT02105961|76143812|FG000|Withdrew IP Due to: Physician Decision|Overall Study||2||
60027875|NCT02105961|76143813|FG001|Withdrew IP Due to: Physician Decision|Overall Study||3||
60027876|NCT02105961|76143814|FG002|Withdrew IP Due to: Physician Decision|Overall Study||1||
60027877|NCT02105961|76143812|FG000|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||16||
60027878|NCT02105961|76143813|FG001|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||11||
60027879|NCT02105961|76143814|FG002|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||11||
60027880|NCT02105961|76143812|FG000|Withdrew IP Due to: Site Closed|Overall Study||1||
60027881|NCT02105961|76143813|FG001|Withdrew IP Due to: Site Closed|Overall Study||0||
60027882|NCT02105961|76143814|FG002|Withdrew IP Due to: Site Closed|Overall Study||1||
60027883|NCT02105961|76143812|FG000|COMPLETED|Overall Study||185||
60027884|NCT02105961|76143813|FG001|COMPLETED|Overall Study||206||
60027885|NCT02105961|76143814|FG002|COMPLETED|Overall Study||195||
60027886|NCT02105961|76143812|FG000|NOT COMPLETED|Overall Study||41||
60027887|NCT02105961|76143813|FG001|NOT COMPLETED|Overall Study||17||
60027888|NCT02105961|76143814|FG002|NOT COMPLETED|Overall Study||30||
60027889|NCT02141997|76143827|FG000|STARTED|Overall Study||56||
60027890|NCT02141997|76143828|FG001|STARTED|Overall Study||55||
60027891|NCT02141997|76143829|FG002|STARTED|Overall Study||56||
60027892|NCT02141997|76143830|FG003|STARTED|Overall Study||55||
60027893|NCT02141997|76143827|FG000|COMPLETED|Overall Study||53||
60027894|NCT02141997|76143828|FG001|COMPLETED|Overall Study||49||
60027895|NCT02141997|76143829|FG002|COMPLETED|Overall Study||53||
60027896|NCT02141997|76143830|FG003|COMPLETED|Overall Study||54||
60027897|NCT02141997|76143827|FG000|NOT COMPLETED|Overall Study||3||
60027898|NCT02141997|76143828|FG001|NOT COMPLETED|Overall Study||6||
60027899|NCT02141997|76143829|FG002|NOT COMPLETED|Overall Study||3||
60027900|NCT02141997|76143830|FG003|NOT COMPLETED|Overall Study||1||
60027901|NCT01628367|76143842|FG000|STARTED|Overall Study||16||
60027902|NCT01628367|76143843|FG001|STARTED|Overall Study||16||
60027903|NCT01628367|76143842|FG000|COMPLETED|Overall Study||15||
60027904|NCT01628367|76143843|FG001|COMPLETED|Overall Study||16||
60027905|NCT01628367|76143842|FG000|NOT COMPLETED|Overall Study||1||
60027906|NCT01628367|76143843|FG001|NOT COMPLETED|Overall Study||0||
60027907|NCT01627899|76143849|FG000|STARTED|Overall Study||5||
60027908|NCT01627899|76143849|FG000|COMPLETED|Overall Study||0||
60027909|NCT01627899|76143849|FG000|NOT COMPLETED|Overall Study||5||
60027910|NCT02519777|76143856|FG000|STARTED|Overall Study||63||
60027911|NCT02519777|76143857|FG001|STARTED|Overall Study||67||
60027912|NCT02519777|76143858|FG002|STARTED|Overall Study||61||
60027913|NCT02519777|76143856|FG000|COMPLETED|Overall Study||57||
60027914|NCT02519777|76143857|FG001|COMPLETED|Overall Study||59||
60027915|NCT02519777|76143858|FG002|COMPLETED|Overall Study||57||
60027916|NCT02519777|76143856|FG000|NOT COMPLETED|Overall Study||6||
60027917|NCT02519777|76143857|FG001|NOT COMPLETED|Overall Study||8||
60027918|NCT02519777|76143858|FG002|NOT COMPLETED|Overall Study||4||
60027919|NCT02515331|76143869|FG000|STARTED|Overall Study||17||
60027920|NCT02515331|76143870|FG001|STARTED|Overall Study||15||
60027921|NCT02515331|76143871|FG002|STARTED|Overall Study||32||
60027922|NCT02515331|76143869|FG000|Primary Pharmacodynamic Analysis Set|Overall Study||15||
60027923|NCT02515331|76143870|FG001|Primary Pharmacodynamic Analysis Set|Overall Study||14||
60027924|NCT02515331|76143871|FG002|Primary Pharmacodynamic Analysis Set|Overall Study||29||
60027925|NCT02515331|76143869|FG000|Pharmacokinetic (PK) Analysis Set|Overall Study||17||
60027926|NCT02515331|76143870|FG001|Pharmacokinetic (PK) Analysis Set|Overall Study||15||
60027927|NCT02515331|76143871|FG002|Pharmacokinetic (PK) Analysis Set|Overall Study||0||
60027928|NCT02515331|76143869|FG000|COMPLETED|Overall Study||15||
60027929|NCT02515331|76143870|FG001|COMPLETED|Overall Study||15||
60027930|NCT02515331|76143871|FG002|COMPLETED|Overall Study||28||
60027931|NCT02515331|76143869|FG000|NOT COMPLETED|Overall Study||2||
60027932|NCT02515331|76143870|FG001|NOT COMPLETED|Overall Study||0||
60027933|NCT02515331|76143871|FG002|NOT COMPLETED|Overall Study||4||
60027934|NCT02515097|76143881|FG000|STARTED|Overall Study||142||
60027935|NCT02515097|76143882|FG001|STARTED|Overall Study||71||
60027936|NCT02515097|76143881|FG000|Intent-to-Treat (ITT) Population|Overall Study||142|Participants who were randomized and dispensed study drug.|
60027937|NCT02515097|76143882|FG001|Intent-to-Treat (ITT) Population|Overall Study||71|Participants who were randomized and dispensed study drug.|
60027938|NCT02515097|76143881|FG000|Safety Population|Overall Study||142|Randomized participants with ≥1 confirmed dose of study drug and ≥1 post-Baseline safety assessment.|
60027939|NCT02515097|76143882|FG001|Safety Population|Overall Study||70|Randomized participants with ≥1 confirmed dose of study drug and ≥1 post-Baseline safety assessment.|
60027940|NCT02515097|76143881|FG000|COMPLETED|Overall Study||135||
60027941|NCT02515097|76143882|FG001|COMPLETED|Overall Study||65||
60027942|NCT02515097|76143881|FG000|NOT COMPLETED|Overall Study||7||
60027943|NCT02515097|76143882|FG001|NOT COMPLETED|Overall Study||6||
60027944|NCT02141295|76143891|FG000|STARTED|Overall Study||8||
60027945|NCT02141295|76143892|FG001|STARTED|Overall Study||94||
60027946|NCT02141295|76143893|FG002|STARTED|Overall Study||95||
60027947|NCT02141295|76143891|FG000|COMPLETED|Overall Study||2||
60027948|NCT02141295|76143892|FG001|COMPLETED|Overall Study||0||
60027949|NCT02141295|76143893|FG002|COMPLETED|Overall Study||0||
60027950|NCT02141295|76143891|FG000|NOT COMPLETED|Overall Study||6||
60027951|NCT02141295|76143892|FG001|NOT COMPLETED|Overall Study||94||
60027952|NCT02141295|76143893|FG002|NOT COMPLETED|Overall Study||95||
60027953|NCT02514551|76143905|FG000|STARTED|Overall Study||123||
60027954|NCT02514551|76143906|FG001|STARTED|Overall Study||122||
60027955|NCT02514551|76143905|FG000|Received at Least One Dose of Study Drug|Overall Study||123||
60027956|NCT02514551|76143906|FG001|Received at Least One Dose of Study Drug|Overall Study||120||
60027957|NCT02514551|76143905|FG000|COMPLETED|Overall Study||123||
60027958|NCT02514551|76143906|FG001|COMPLETED|Overall Study||119||
60027959|NCT02514551|76143905|FG000|NOT COMPLETED|Overall Study||0||
59611779|NCT01755546|75722773|FG000|COMPLETED|Long Term Treatment||103||
59611780|NCT01755546|75722773|FG000|NOT COMPLETED|Long Term Treatment||121||
59611781|NCT01755234|75722779|FG000|STARTED|Overall Study||45||
59611782|NCT01755234|75722780|FG001|STARTED|Overall Study||45||
59611783|NCT01755234|75722779|FG000|COMPLETED|Overall Study||30||
59611784|NCT01755234|75722780|FG001|COMPLETED|Overall Study||37||
60027960|NCT02514551|76143906|FG001|NOT COMPLETED|Overall Study||3||
60027961|NCT02141217|76143915|FG000|STARTED|Overall Study||234||
60027962|NCT02141217|76143916|FG001|STARTED|Overall Study||237||
60027963|NCT02141217|76143915|FG000|ITT Population-Randomized Treatment Arm|Overall Study||234||
60027964|NCT02141217|76143916|FG001|ITT Population-Randomized Treatment Arm|Overall Study||237||
60027965|NCT02141217|76143915|FG000|ITT Population-Actual Treatment Received|Overall Study||236||
60027966|NCT02141217|76143916|FG001|ITT Population-Actual Treatment Received|Overall Study||235||
60027967|NCT02141217|76143915|FG000|COMPLETED|Overall Study||223||
60027968|NCT02141217|76143916|FG001|COMPLETED|Overall Study||229||
60027969|NCT02141217|76143915|FG000|NOT COMPLETED|Overall Study||11||
60027970|NCT02141217|76143916|FG001|NOT COMPLETED|Overall Study||8||
60027971|NCT02138253|76143927|FG000|STARTED|Overall Study||41||
60027972|NCT02138253|76143928|FG001|STARTED|Overall Study||23||
60027973|NCT02138253|76143927|FG000|COMPLETED|Overall Study||32||
60027974|NCT02138253|76143928|FG001|COMPLETED|Overall Study||19||
60027975|NCT02138253|76143927|FG000|NOT COMPLETED|Overall Study||9||
60027976|NCT02138253|76143928|FG001|NOT COMPLETED|Overall Study||4||
60027977|NCT02514473|76143936|FG000|STARTED|Overall Study||101||
60027978|NCT02514473|76143937|FG001|STARTED|Overall Study||103||
60027979|NCT02514473|76143936|FG000|COMPLETED|Overall Study||98||
60027980|NCT02514473|76143937|FG001|COMPLETED|Overall Study||98||
60027981|NCT02514473|76143936|FG000|NOT COMPLETED|Overall Study||3||
60027982|NCT02514473|76143937|FG001|NOT COMPLETED|Overall Study||5||
60027983|NCT02513771|76143946|FG000|STARTED|Overall Study||45||
60027984|NCT02513771|76143947|FG001|STARTED|Overall Study||45||
60027985|NCT02513771|76143946|FG000|COMPLETED|Overall Study||43||
60027986|NCT02513771|76143947|FG001|COMPLETED|Overall Study||44||
60027987|NCT02513771|76143946|FG000|NOT COMPLETED|Overall Study||2||
60027988|NCT02513771|76143947|FG001|NOT COMPLETED|Overall Study||1||
60027989|NCT02104947|76143955|FG000|STARTED|Overall Study||301||
60027990|NCT02104947|76143956|FG001|STARTED|Overall Study||202||
60027991|NCT02104947|76143955|FG000|COMPLETED|Overall Study||222||
60027992|NCT02104947|76143956|FG001|COMPLETED|Overall Study||146||
60027993|NCT02104947|76143955|FG000|NOT COMPLETED|Overall Study||79||
60027994|NCT02104947|76143956|FG001|NOT COMPLETED|Overall Study||56||
60027995|NCT02513459|76143966|FG000|STARTED|Overall Study||65||
60027996|NCT02513459|76143966|FG000|COMPLETED|Overall Study||44||
60027997|NCT02513459|76143966|FG000|NOT COMPLETED|Overall Study||21||
59611785|NCT01755234|75722779|FG000|NOT COMPLETED|Overall Study||15||
59611786|NCT01755234|75722780|FG001|NOT COMPLETED|Overall Study||8||
60027998|NCT02104557|76143975|FG000|STARTED|Overall Study||362||
60027999|NCT02104557|76143975|FG000|Safety Population|Overall Study||337||
60028000|NCT02104557|76143975|FG000|COMPLETED|Overall Study||185||
60028001|NCT02104557|76143975|FG000|NOT COMPLETED|Overall Study||177||
60028002|NCT02069379|76143981|FG000|STARTED|Baseline Measurements||30||
60028003|NCT02069379|76143982|FG001|STARTED|Baseline Measurements||4||
59611787|NCT01731912|75722786|FG000|STARTED|Overall Study||16||
59611788|NCT01731912|75722786|FG000|COMPLETED|Overall Study||14||
59611789|NCT01731912|75722786|FG000|NOT COMPLETED|Overall Study||2||
59611790|NCT01731678|75722790|FG000|STARTED|Overall Study||39||
60028004|NCT02069379|76143983|FG002|STARTED|Baseline Measurements||2||
60028005|NCT02069379|76143984|FG003|STARTED|Baseline Measurements||6||
60028006|NCT02069379|76143981|FG000|Baseline Measurements Taken|Baseline Measurements||30||
60028007|NCT02069379|76143982|FG001|Baseline Measurements Taken|Baseline Measurements||4||
60028008|NCT02069379|76143983|FG002|Baseline Measurements Taken|Baseline Measurements||2||
60028009|NCT02069379|76143984|FG003|Baseline Measurements Taken|Baseline Measurements||6||
60028010|NCT02069379|76143981|FG000|COMPLETED|Baseline Measurements||27||
60028011|NCT02069379|76143982|FG001|COMPLETED|Baseline Measurements||4||
60028012|NCT02069379|76143983|FG002|COMPLETED|Baseline Measurements||2||
60028013|NCT02069379|76143984|FG003|COMPLETED|Baseline Measurements||4||
60028014|NCT02069379|76143981|FG000|NOT COMPLETED|Baseline Measurements||3||
60028015|NCT02069379|76143982|FG001|NOT COMPLETED|Baseline Measurements||0||
60028016|NCT02069379|76143983|FG002|NOT COMPLETED|Baseline Measurements||0||
60028017|NCT02069379|76143984|FG003|NOT COMPLETED|Baseline Measurements||2||
60028018|NCT02069379|76143981|FG000|STARTED|First Treatment Arm|Controls are not involved after initial baseline collection|0||
60028019|NCT02069379|76143982|FG001|STARTED|First Treatment Arm||4||
60028020|NCT02069379|76143983|FG002|STARTED|First Treatment Arm||2||
59915688|NCT03102762|76036616|FG000|COMPLETED|Overall Study||34||
59915689|NCT03102762|76036617|FG001|COMPLETED|Overall Study||35||
59915690|NCT03102762|76036616|FG000|NOT COMPLETED|Overall Study||1||
59915691|NCT03102762|76036617|FG001|NOT COMPLETED|Overall Study||0||
59915692|NCT01804296|76036624|FG000|STARTED|Overall Study||4||
59915693|NCT01804296|76036624|FG000|COMPLETED|Overall Study||4||
59915694|NCT01804296|76036624|FG000|NOT COMPLETED|Overall Study||0||
59915695|NCT01346475|76036630|FG000|STARTED|First Intervention||22||
59915696|NCT01346475|76036631|FG001|STARTED|First Intervention||28||
60028021|NCT02069379|76143984|FG003|STARTED|First Treatment Arm|Insulin resistant woman not randomized are not involved after initial baseline collection|0||
60028022|NCT02069379|76143981|FG000|COMPLETED|First Treatment Arm||0||
60028023|NCT02069379|76143982|FG001|COMPLETED|First Treatment Arm||3||
60028024|NCT02069379|76143983|FG002|COMPLETED|First Treatment Arm||1||
60028025|NCT02069379|76143984|FG003|COMPLETED|First Treatment Arm||0||
60028026|NCT02069379|76143981|FG000|NOT COMPLETED|First Treatment Arm||0||
60028027|NCT02069379|76143982|FG001|NOT COMPLETED|First Treatment Arm||1||
60028028|NCT02069379|76143983|FG002|NOT COMPLETED|First Treatment Arm||1||
60028029|NCT02069379|76143984|FG003|NOT COMPLETED|First Treatment Arm||0||
60028030|NCT02069379|76143981|FG000|STARTED|Washout Period (4 Weeks)|Controls are not involved after initial baseline collection|0||
60028031|NCT02069379|76143982|FG001|STARTED|Washout Period (4 Weeks)||3||
60028032|NCT02069379|76143983|FG002|STARTED|Washout Period (4 Weeks)||1||
60028033|NCT02069379|76143984|FG003|STARTED|Washout Period (4 Weeks)|Insulin resistant woman who were not randomized are not involved after initial baseline collection|0||
60028034|NCT02069379|76143981|FG000|COMPLETED|Washout Period (4 Weeks)||0||
60028035|NCT02069379|76143982|FG001|COMPLETED|Washout Period (4 Weeks)||1||
60028036|NCT02069379|76143983|FG002|COMPLETED|Washout Period (4 Weeks)||1||
60028037|NCT02069379|76143984|FG003|COMPLETED|Washout Period (4 Weeks)||0||
60028038|NCT02069379|76143981|FG000|NOT COMPLETED|Washout Period (4 Weeks)||0||
60028039|NCT02069379|76143982|FG001|NOT COMPLETED|Washout Period (4 Weeks)||2||
60028040|NCT02069379|76143983|FG002|NOT COMPLETED|Washout Period (4 Weeks)||0||
60028041|NCT02069379|76143984|FG003|NOT COMPLETED|Washout Period (4 Weeks)||0||
60028042|NCT02069379|76143981|FG000|STARTED|Second Treatment Arm|Controls are not involved after initial baseline collection|0||
60028043|NCT02069379|76143982|FG001|STARTED|Second Treatment Arm||1||
60028044|NCT02069379|76143983|FG002|STARTED|Second Treatment Arm||1||
60028045|NCT02069379|76143984|FG003|STARTED|Second Treatment Arm|Insulin resistant women who are not randomized are not involved after initial baseline collection|0||
60028046|NCT02069379|76143981|FG000|COMPLETED|Second Treatment Arm||0||
60028047|NCT02069379|76143982|FG001|COMPLETED|Second Treatment Arm||1||
60028048|NCT02069379|76143983|FG002|COMPLETED|Second Treatment Arm||0||
60028049|NCT02069379|76143984|FG003|COMPLETED|Second Treatment Arm||0||
60028050|NCT02069379|76143981|FG000|NOT COMPLETED|Second Treatment Arm||0||
60028051|NCT02069379|76143982|FG001|NOT COMPLETED|Second Treatment Arm||0||
60028052|NCT02069379|76143983|FG002|NOT COMPLETED|Second Treatment Arm||1||
60028053|NCT02069379|76143984|FG003|NOT COMPLETED|Second Treatment Arm||0||
60028054|NCT02511431|76144000|FG000|STARTED|Treatment||4||
60028055|NCT02511431|76144001|FG001|STARTED|Treatment||4||
60028056|NCT02511431|76144002|FG002|STARTED|Treatment||4||
60028057|NCT02511431|76144003|FG003|STARTED|Treatment||3||
59611791|NCT01731678|75722790|FG000|COMPLETED|Overall Study||32||
59915697|NCT01346475|76036630|FG000|COMPLETED|First Intervention||18||
59915698|NCT01346475|76036631|FG001|COMPLETED|First Intervention||25||
59915699|NCT01346475|76036630|FG000|NOT COMPLETED|First Intervention||4||
59915700|NCT01346475|76036631|FG001|NOT COMPLETED|First Intervention||3||
59915701|NCT01346475|76036630|FG000|STARTED|Second Intervention||18||
59915702|NCT01346475|76036631|FG001|STARTED|Second Intervention||25||
59915703|NCT01346475|76036630|FG000|COMPLETED|Second Intervention||18||
59915704|NCT01346475|76036631|FG001|COMPLETED|Second Intervention||25||
59915705|NCT01346475|76036630|FG000|NOT COMPLETED|Second Intervention||0||
60028058|NCT02511431|76144004|FG004|STARTED|Treatment||3||
60028059|NCT02511431|76144005|FG005|STARTED|Treatment||3||
60028060|NCT02511431|76144000|FG000|COMPLETED|Treatment||4||
60028061|NCT02511431|76144001|FG001|COMPLETED|Treatment||4||
60028062|NCT02511431|76144002|FG002|COMPLETED|Treatment||3||
60028063|NCT02511431|76144003|FG003|COMPLETED|Treatment||3||
60028064|NCT02511431|76144004|FG004|COMPLETED|Treatment||3||
60028065|NCT02511431|76144005|FG005|COMPLETED|Treatment||2||
59759216|NCT01143246|75878591|FG000|Intent to Treat (ITT)|Overall Study||97|All randomized participants who had at least one baseline assessment.|
59759217|NCT01143246|75878592|FG001|Intent to Treat (ITT)|Overall Study||99|All randomized participants who had at least one baseline assessment.|
60028066|NCT02511431|76144000|FG000|NOT COMPLETED|Treatment||0||
60028067|NCT02511431|76144001|FG001|NOT COMPLETED|Treatment||0||
60028068|NCT02511431|76144002|FG002|NOT COMPLETED|Treatment||1||
60028069|NCT02511431|76144003|FG003|NOT COMPLETED|Treatment||0||
60028070|NCT02511431|76144004|FG004|NOT COMPLETED|Treatment||0||
60028071|NCT02511431|76144005|FG005|NOT COMPLETED|Treatment||1||
60028072|NCT02511431|76144000|FG000|STARTED|Post-treatment Follow-up||4||
60028073|NCT02511431|76144001|FG001|STARTED|Post-treatment Follow-up||4||
60028074|NCT02511431|76144002|FG002|STARTED|Post-treatment Follow-up||3||
60028075|NCT02511431|76144003|FG003|STARTED|Post-treatment Follow-up||3||
60028076|NCT02511431|76144004|FG004|STARTED|Post-treatment Follow-up||3||
60028077|NCT02511431|76144005|FG005|STARTED|Post-treatment Follow-up||2||
60028078|NCT02511431|76144000|FG000|COMPLETED|Post-treatment Follow-up||4||
60028079|NCT02511431|76144001|FG001|COMPLETED|Post-treatment Follow-up||4||
60028080|NCT02511431|76144002|FG002|COMPLETED|Post-treatment Follow-up||3||
60028081|NCT02511431|76144003|FG003|COMPLETED|Post-treatment Follow-up||3||
60028082|NCT02511431|76144004|FG004|COMPLETED|Post-treatment Follow-up||3||
60028083|NCT02511431|76144005|FG005|COMPLETED|Post-treatment Follow-up||2||
60028084|NCT02511431|76144000|FG000|NOT COMPLETED|Post-treatment Follow-up||0||
60028085|NCT02511431|76144001|FG001|NOT COMPLETED|Post-treatment Follow-up||0||
60028086|NCT02511431|76144002|FG002|NOT COMPLETED|Post-treatment Follow-up||0||
60028087|NCT02511431|76144003|FG003|NOT COMPLETED|Post-treatment Follow-up||0||
60028088|NCT02511431|76144004|FG004|NOT COMPLETED|Post-treatment Follow-up||0||
60028089|NCT02511431|76144005|FG005|NOT COMPLETED|Post-treatment Follow-up||0||
60028090|NCT02137785|76144022|FG000|STARTED|Overall Study||135||
60028091|NCT02137785|76144023|FG001|STARTED|Overall Study||134||
60028092|NCT02137785|76144022|FG000|COMPLETED|Overall Study||132||
60028093|NCT02137785|76144023|FG001|COMPLETED|Overall Study||130||
60028094|NCT02137785|76144022|FG000|NOT COMPLETED|Overall Study||3||
60028095|NCT02137785|76144023|FG001|NOT COMPLETED|Overall Study||4||
60028096|NCT01655069|76144033|FG000|STARTED|Overall Study||61||
60028097|NCT01655069|76144034|FG001|STARTED|Overall Study||58||
60028098|NCT01655069|76144035|FG002|STARTED|Overall Study||14||
60028099|NCT01655069|76144036|FG003|STARTED|Overall Study||15||
60028100|NCT01655069|76144033|FG000|Safety Analysis Set (SAF)|Overall Study||61|SAF consisted of all participants with at least 1 dose of open-label solifenacin and safety data.|
60028101|NCT01655069|76144034|FG001|Safety Analysis Set (SAF)|Overall Study||57|SAF consisted of all participants with at least 1 dose of open-label solifenacin and safety data.|
60028102|NCT01655069|76144035|FG002|Safety Analysis Set (SAF)|Overall Study||14|SAF consisted of all participants with at least 1 dose of open-label solifenacin and safety data.|
60028103|NCT01655069|76144036|FG003|Safety Analysis Set (SAF)|Overall Study||15|SAF consisted of all participants with at least 1 dose of open-label solifenacin and safety data.|
60028104|NCT01655069|76144033|FG000|Full Analysis Set (FAS)|Overall Study||60|FAS consisted of all participants with at least 1 dose of open-label solifenacin and efficacy data.|
60028105|NCT01655069|76144034|FG001|Full Analysis Set (FAS)|Overall Study||57|FAS consisted of all participants with at least 1 dose of open-label solifenacin and efficacy data.|
60028106|NCT01655069|76144035|FG002|Full Analysis Set (FAS)|Overall Study||14|FAS consisted of all participants with at least 1 dose of open-label solifenacin and efficacy data.|
60028107|NCT01655069|76144036|FG003|Full Analysis Set (FAS)|Overall Study||15|FAS consisted of all participants with at least 1 dose of open-label solifenacin and efficacy data.|
60028108|NCT01655069|76144033|FG000|COMPLETED|Overall Study||53||
60028109|NCT01655069|76144034|FG001|COMPLETED|Overall Study||46||
60028110|NCT01655069|76144035|FG002|COMPLETED|Overall Study||12||
60028111|NCT01655069|76144036|FG003|COMPLETED|Overall Study||11||
60028112|NCT01655069|76144033|FG000|NOT COMPLETED|Overall Study||8||
60028113|NCT01655069|76144034|FG001|NOT COMPLETED|Overall Study||12||
60028114|NCT01655069|76144035|FG002|NOT COMPLETED|Overall Study||2||
60028115|NCT01655069|76144036|FG003|NOT COMPLETED|Overall Study||4||
60028116|NCT02068599|76144047|FG000|STARTED|Overall Study||130||
60028117|NCT02068599|76144048|FG001|STARTED|Overall Study||129||
60028118|NCT02068599|76144049|FG002|STARTED|Overall Study||130||
60028119|NCT02068599|76144047|FG000|Safety Analysis Set|Overall Study|One participant withdrew before taking any study drug.|129||
60028120|NCT02068599|76144048|FG001|Safety Analysis Set|Overall Study|One participant withdrew before taking any study drug.|128||
60028121|NCT02068599|76144049|FG002|Safety Analysis Set|Overall Study||130||
60028122|NCT02068599|76144047|FG000|Full Analysis Set|Overall Study||129||
60028123|NCT02068599|76144048|FG001|Full Analysis Set|Overall Study||128||
60028124|NCT02068599|76144049|FG002|Full Analysis Set|Overall Study||130||
60028125|NCT02068599|76144047|FG000|COMPLETED|Overall Study||119||
60028126|NCT02068599|76144048|FG001|COMPLETED|Overall Study||119||
60028127|NCT02068599|76144049|FG002|COMPLETED|Overall Study||117||
59915706|NCT01346475|76036631|FG001|NOT COMPLETED|Second Intervention||0||
59915707|NCT01338636|76036637|FG000|STARTED|Overall Study||30||
59915708|NCT01338636|76036637|FG000|COMPLETED|Overall Study||22||
59915709|NCT01338636|76036637|FG000|NOT COMPLETED|Overall Study||8||
59915710|NCT00322218|76036643|FG000|STARTED|Overall Study||34||
59915711|NCT00322218|76036644|FG001|STARTED|Overall Study||34||
59915712|NCT00322218|76036643|FG000|Per-Protocol Set|Overall Study||33||
59915713|NCT00322218|76036644|FG001|Per-Protocol Set|Overall Study||32||
59915714|NCT00322218|76036643|FG000|COMPLETED|Overall Study||31||
59915715|NCT00322218|76036644|FG001|COMPLETED|Overall Study||28||
59915716|NCT00322218|76036643|FG000|NOT COMPLETED|Overall Study||3||
59915717|NCT00322218|76036644|FG001|NOT COMPLETED|Overall Study||6||
59915718|NCT02873754|76036650|FG000|STARTED|Overall Study||11||
59915719|NCT02873754|76036650|FG000|COMPLETED|Overall Study||5||
59915720|NCT02873754|76036650|FG000|NOT COMPLETED|Overall Study||6||
59915721|NCT03287414|76036656|FG000|STARTED|Treatment Epoch||14||
59915722|NCT03287414|76036657|FG001|STARTED|Treatment Epoch||16||
59915723|NCT03287414|76036656|FG000|Treated|Treatment Epoch||13||
59915724|NCT03287414|76036657|FG001|Treated|Treatment Epoch||16||
59915725|NCT03287414|76036656|FG000|COMPLETED|Treatment Epoch||6||
59915726|NCT03287414|76036657|FG001|COMPLETED|Treatment Epoch||12||
59915727|NCT03287414|76036656|FG000|NOT COMPLETED|Treatment Epoch||8||
59915728|NCT03287414|76036657|FG001|NOT COMPLETED|Treatment Epoch||4||
59915729|NCT03287414|76036656|FG000|STARTED|PK/Safety Follow-up Epoch||7||
59915730|NCT03287414|76036657|FG001|STARTED|PK/Safety Follow-up Epoch||13||
59915731|NCT03287414|76036656|FG000|COMPLETED|PK/Safety Follow-up Epoch||7||
59915732|NCT03287414|76036657|FG001|COMPLETED|PK/Safety Follow-up Epoch||13||
59915733|NCT03287414|76036656|FG000|NOT COMPLETED|PK/Safety Follow-up Epoch||0||
59915734|NCT03287414|76036657|FG001|NOT COMPLETED|PK/Safety Follow-up Epoch||0||
59915735|NCT03287414|76036656|FG000|STARTED|PD/Safety Follow-up Epoch||7||
59915736|NCT03287414|76036657|FG001|STARTED|PD/Safety Follow-up Epoch||0||
59915737|NCT03287414|76036656|FG000|COMPLETED|PD/Safety Follow-up Epoch||5||
59915738|NCT03287414|76036657|FG001|COMPLETED|PD/Safety Follow-up Epoch||0||
59915739|NCT03287414|76036656|FG000|NOT COMPLETED|PD/Safety Follow-up Epoch||2||
59915740|NCT03287414|76036657|FG001|NOT COMPLETED|PD/Safety Follow-up Epoch||0||
59915741|NCT04203537|76036668|FG000|STARTED|Overall Study||6||
59915742|NCT04203537|76036669|FG001|STARTED|Overall Study||6||
59915743|NCT04203537|76036670|FG002|STARTED|Overall Study||6||
59915744|NCT04203537|76036671|FG003|STARTED|Overall Study||6||
59915745|NCT04203537|76036672|FG004|STARTED|Overall Study||54||
59915746|NCT04203537|76036673|FG005|STARTED|Overall Study||55||
59915747|NCT04203537|76036674|FG006|STARTED|Overall Study||60||
59915748|NCT04203537|76036668|FG000|COMPLETED|Overall Study||6||
59915749|NCT04203537|76036669|FG001|COMPLETED|Overall Study||6||
59915750|NCT04203537|76036670|FG002|COMPLETED|Overall Study||6||
59915751|NCT04203537|76036671|FG003|COMPLETED|Overall Study||6||
59915752|NCT04203537|76036672|FG004|COMPLETED|Overall Study||54||
59915753|NCT04203537|76036673|FG005|COMPLETED|Overall Study||55||
59915754|NCT04203537|76036674|FG006|COMPLETED|Overall Study||60||
59915755|NCT04203537|76036668|FG000|NOT COMPLETED|Overall Study||0||
59915756|NCT04203537|76036669|FG001|NOT COMPLETED|Overall Study||0||
59915757|NCT04203537|76036670|FG002|NOT COMPLETED|Overall Study||0||
59915758|NCT04203537|76036671|FG003|NOT COMPLETED|Overall Study||0||
59915759|NCT04203537|76036672|FG004|NOT COMPLETED|Overall Study||0||
59915760|NCT04203537|76036673|FG005|NOT COMPLETED|Overall Study||0||
59915761|NCT04203537|76036674|FG006|NOT COMPLETED|Overall Study||0||
59915762|NCT03101592|76036687|FG000|STARTED|Overall Study||3123||10
59915763|NCT03101592|76036688|FG001|STARTED|Overall Study||2896||10
59915764|NCT03101592|76036689|FG002|STARTED|Overall Study||3099||10
59915765|NCT03101592|76036687|FG000|COMPLETED|Overall Study||3012||10
59915766|NCT03101592|76036688|FG001|COMPLETED|Overall Study||2726||10
59915767|NCT03101592|76036689|FG002|COMPLETED|Overall Study||2981||10
59915768|NCT03101592|76036687|FG000|NOT COMPLETED|Overall Study||111||0
59915769|NCT03101592|76036688|FG001|NOT COMPLETED|Overall Study||170||0
59915770|NCT03101592|76036689|FG002|NOT COMPLETED|Overall Study||118||0
59915771|NCT04046939|76036707|FG000|STARTED|Screening Period||534||
59915772|NCT04046939|76036708|FG001|STARTED|Screening Period||0||
59915773|NCT04046939|76036709|FG002|STARTED|Screening Period||0||
59915774|NCT04046939|76036710|FG003|STARTED|Screening Period||0||
59915775|NCT04046939|76036707|FG000|Received Placebo During Run-In Period|Screening Period||144||
59915776|NCT04046939|76036708|FG001|Received Placebo During Run-In Period|Screening Period||0||
59915777|NCT04046939|76036709|FG002|Received Placebo During Run-In Period|Screening Period||0||
59915778|NCT04046939|76036710|FG003|Received Placebo During Run-In Period|Screening Period||0||
59915779|NCT04046939|76036707|FG000|COMPLETED|Screening Period||103||
59915780|NCT04046939|76036708|FG001|COMPLETED|Screening Period||0||
59915781|NCT04046939|76036709|FG002|COMPLETED|Screening Period||0||
59915782|NCT04046939|76036710|FG003|COMPLETED|Screening Period||0||
59915783|NCT04046939|76036707|FG000|NOT COMPLETED|Screening Period||431||
59915784|NCT04046939|76036708|FG001|NOT COMPLETED|Screening Period||0||
59915785|NCT04046939|76036709|FG002|NOT COMPLETED|Screening Period||0||
59915786|NCT04046939|76036710|FG003|NOT COMPLETED|Screening Period||0||
59915787|NCT04046939|76036707|FG000|STARTED|Primary Assessment Period||27||
60028128|NCT02068599|76144047|FG000|NOT COMPLETED|Overall Study||11||
60028129|NCT02068599|76144048|FG001|NOT COMPLETED|Overall Study||10||
60028130|NCT02068599|76144049|FG002|NOT COMPLETED|Overall Study||13||
60028131|NCT01654601|76144059|FG000|STARTED|1st Administration||14||
60028132|NCT01654601|76144060|FG001|STARTED|1st Administration||14||
60028133|NCT01654601|76144059|FG000|COMPLETED|1st Administration||12||
60028134|NCT01654601|76144060|FG001|COMPLETED|1st Administration||12||
59759218|NCT01143246|75878591|FG000|Safety Population (Treated Participants)|Overall Study||93|Eight participants did not receive treatment and were excluded from Safety Population.|
59915788|NCT04046939|76036708|FG001|STARTED|Primary Assessment Period||22||
59915789|NCT04046939|76036709|FG002|STARTED|Primary Assessment Period||26||
59915790|NCT04046939|76036710|FG003|STARTED|Primary Assessment Period||28||
59915791|NCT04046939|76036707|FG000|COMPLETED|Primary Assessment Period||25||
59915792|NCT04046939|76036708|FG001|COMPLETED|Primary Assessment Period||22||
59915793|NCT04046939|76036709|FG002|COMPLETED|Primary Assessment Period||24||
59915794|NCT04046939|76036710|FG003|COMPLETED|Primary Assessment Period||28||
59915795|NCT04046939|76036707|FG000|NOT COMPLETED|Primary Assessment Period||2||
59915796|NCT04046939|76036708|FG001|NOT COMPLETED|Primary Assessment Period||0||
59915797|NCT04046939|76036709|FG002|NOT COMPLETED|Primary Assessment Period||2||
59915798|NCT04046939|76036710|FG003|NOT COMPLETED|Primary Assessment Period||0||
59915799|NCT04046939|76036707|FG000|STARTED|Eosinophil Recovery Period||25||
59915800|NCT04046939|76036708|FG001|STARTED|Eosinophil Recovery Period||22||
59915801|NCT04046939|76036709|FG002|STARTED|Eosinophil Recovery Period||24||
59915802|NCT04046939|76036710|FG003|STARTED|Eosinophil Recovery Period||28||
59915803|NCT04046939|76036707|FG000|COMPLETED|Eosinophil Recovery Period||24||
59915804|NCT04046939|76036708|FG001|COMPLETED|Eosinophil Recovery Period||22||
59915805|NCT04046939|76036709|FG002|COMPLETED|Eosinophil Recovery Period||24||
59915806|NCT04046939|76036710|FG003|COMPLETED|Eosinophil Recovery Period||27||
59915807|NCT04046939|76036707|FG000|NOT COMPLETED|Eosinophil Recovery Period||1||
59915808|NCT04046939|76036708|FG001|NOT COMPLETED|Eosinophil Recovery Period||0||
59915809|NCT04046939|76036709|FG002|NOT COMPLETED|Eosinophil Recovery Period||0||
59915810|NCT04046939|76036710|FG003|NOT COMPLETED|Eosinophil Recovery Period||1||
59915811|NCT04042103|76036726|FG000|STARTED|Overall Study||21||
59915812|NCT04042103|76036726|FG000|COMPLETED|Overall Study||19||
59915813|NCT04042103|76036726|FG000|NOT COMPLETED|Overall Study||2||
59915814|NCT02955797|76036734|FG000|STARTED|Overall Study||306||
59915815|NCT02955797|76036735|FG001|STARTED|Overall Study||306||
59915816|NCT02955797|76036736|FG002|STARTED|Overall Study||203||
59915817|NCT02955797|76036737|FG003|STARTED|Overall Study||103||
59915818|NCT02955797|76036734|FG000|Safety Analysis Set (SafAS)|Overall Study||303|SafAS:participants who received at least 1 dose of study vaccine(s) & had any safety data available.|
59915819|NCT02955797|76036735|FG001|Safety Analysis Set (SafAS)|Overall Study||306|SafAS:participants who received at least 1 dose of study vaccine(s) & had any safety data available.|
59915820|NCT02955797|76036736|FG002|Safety Analysis Set (SafAS)|Overall Study||203|SafAS:participants who received at least 1 dose of study vaccine(s) & had any safety data available.|
59915821|NCT02955797|76036737|FG003|Safety Analysis Set (SafAS)|Overall Study||102|SafAS:participants who received at least 1 dose of study vaccine(s) & had any safety data available.|
59915822|NCT02955797|76036734|FG000|Per Protocol Analysis Set (PPAS)|Overall Study||293|Who had at least 1 dose of vaccine, valid post-vaccination serology data with no protocol deviation.|
59915823|NCT02955797|76036735|FG001|Per Protocol Analysis Set (PPAS)|Overall Study||296|Who had at least 1 dose of vaccine, valid post-vaccination serology data with no protocol deviation.|
59915824|NCT02955797|76036736|FG002|Per Protocol Analysis Set (PPAS)|Overall Study||198|Who had at least 1 dose of vaccine, valid post-vaccination serology data with no protocol deviation.|
59915825|NCT02955797|76036737|FG003|Per Protocol Analysis Set (PPAS)|Overall Study||99|Who had at least 1 dose of vaccine, valid post-vaccination serology data with no protocol deviation.|
59915826|NCT02955797|76036734|FG000|COMPLETED|Overall Study||303||
59915827|NCT02955797|76036735|FG001|COMPLETED|Overall Study||303||
59915828|NCT02955797|76036736|FG002|COMPLETED|Overall Study||203||
59915829|NCT02955797|76036737|FG003|COMPLETED|Overall Study||101||
59915830|NCT02955797|76036734|FG000|NOT COMPLETED|Overall Study||3||
59915831|NCT02955797|76036735|FG001|NOT COMPLETED|Overall Study||3||
59915832|NCT02955797|76036736|FG002|NOT COMPLETED|Overall Study||0||
59915833|NCT02955797|76036737|FG003|NOT COMPLETED|Overall Study||2||
59915834|NCT03101514|76036750|FG000|STARTED|Overall Study||53||
59915835|NCT03101514|76036750|FG000|COMPLETED|Overall Study||46||
59915836|NCT03101514|76036750|FG000|NOT COMPLETED|Overall Study||7||
59915837|NCT02702518|76036756|FG000|STARTED|Overall Study||29||
59915838|NCT02702518|76036757|FG001|STARTED|Overall Study||29||
59915839|NCT02702518|76036756|FG000|COMPLETED|Overall Study||26||
59915840|NCT02702518|76036757|FG001|COMPLETED|Overall Study||25||
59915841|NCT02702518|76036756|FG000|NOT COMPLETED|Overall Study||3||
59915842|NCT02702518|76036757|FG001|NOT COMPLETED|Overall Study||4||
60028135|NCT01654601|76144059|FG000|NOT COMPLETED|1st Administration||2||
60028136|NCT01654601|76144060|FG001|NOT COMPLETED|1st Administration||2||
60028137|NCT01654601|76144059|FG000|STARTED|2nd Administration||12||
60028138|NCT01654601|76144060|FG001|STARTED|2nd Administration||12||
60028139|NCT01654601|76144059|FG000|COMPLETED|2nd Administration||11||
60028140|NCT01654601|76144060|FG001|COMPLETED|2nd Administration||11||
60028141|NCT01654601|76144059|FG000|NOT COMPLETED|2nd Administration||1||
60028142|NCT01654601|76144060|FG001|NOT COMPLETED|2nd Administration||1||
60028143|NCT01654523|76144066|FG000|STARTED|Overall Study||20||
60028144|NCT01654523|76144066|FG000|COMPLETED|Overall Study||19||
60028145|NCT01654523|76144066|FG000|NOT COMPLETED|Overall Study||1||
59915843|NCT04039503|76036767|FG000|STARTED|Overall Study||116||
59915844|NCT04039503|76036768|FG001|STARTED|Overall Study||119||
59915845|NCT04039503|76036769|FG002|STARTED|Overall Study||120||
59915846|NCT04039503|76036770|FG003|STARTED|Overall Study||120||
59915847|NCT04039503|76036767|FG000|Received at Least One Dose of Study Drug|Overall Study||116||
59915848|NCT04039503|76036768|FG001|Received at Least One Dose of Study Drug|Overall Study||119||
59915849|NCT04039503|76036769|FG002|Received at Least One Dose of Study Drug|Overall Study||120||
60028146|NCT02508935|76144070|FG000|STARTED|Overall Study||23||
60028147|NCT02508935|76144070|FG000|COMPLETED|Overall Study||0||
60028148|NCT02508935|76144070|FG000|NOT COMPLETED|Overall Study||23||
60028149|NCT02508701|76144080|FG000|STARTED|Overall Study||9||
60028150|NCT02508701|76144081|FG001|STARTED|Overall Study||6||
60028151|NCT02508701|76144082|FG002|STARTED|Overall Study||5||
60028152|NCT02508701|76144083|FG003|STARTED|Overall Study||4||
60028153|NCT02508701|76144080|FG000|COMPLETED|Overall Study||0||
60028154|NCT02508701|76144081|FG001|COMPLETED|Overall Study||1||
60028155|NCT02508701|76144082|FG002|COMPLETED|Overall Study||0||
60028156|NCT02508701|76144083|FG003|COMPLETED|Overall Study||1||
60028157|NCT02508701|76144080|FG000|NOT COMPLETED|Overall Study||9||
60028158|NCT02508701|76144081|FG001|NOT COMPLETED|Overall Study||5||
60028159|NCT02508701|76144082|FG002|NOT COMPLETED|Overall Study||5||
60028160|NCT02508701|76144083|FG003|NOT COMPLETED|Overall Study||3||
60028161|NCT02507375|76144099|FG000|STARTED|Overall Study||6||
60028162|NCT02507375|76144100|FG001|STARTED|Overall Study|Two patients in cohort 2 did not begin treatment in Cycle 1 so were not included in the analysis set|9||
60028163|NCT02507375|76144099|FG000|Cycle 1|Overall Study||6||
60028164|NCT02507375|76144100|FG001|Cycle 1|Overall Study||9||
59915850|NCT04039503|76036770|FG003|Received at Least One Dose of Study Drug|Overall Study||120||
59915851|NCT04039503|76036767|FG000|COMPLETED|Overall Study||109||
59915852|NCT04039503|76036768|FG001|COMPLETED|Overall Study||115||
59915853|NCT04039503|76036769|FG002|COMPLETED|Overall Study||110||
59915854|NCT04039503|76036770|FG003|COMPLETED|Overall Study||117||
59915855|NCT04039503|76036767|FG000|NOT COMPLETED|Overall Study||7||
59915856|NCT04039503|76036768|FG001|NOT COMPLETED|Overall Study||4||
59915857|NCT04039503|76036769|FG002|NOT COMPLETED|Overall Study||10||
59915858|NCT04039503|76036770|FG003|NOT COMPLETED|Overall Study||3||
59915859|NCT02960516|76036788|FG000|STARTED|Overall Study||3||
59915860|NCT02960516|76036789|FG001|STARTED|Overall Study||8||
60028165|NCT02507375|76144099|FG000|Received Pertuzumab|Overall Study||6||
60028166|NCT02507375|76144100|FG001|Received Pertuzumab|Overall Study||6||
60028167|NCT02507375|76144099|FG000|Cycle 2|Overall Study||5||
60028168|NCT02507375|76144100|FG001|Cycle 2|Overall Study||5||
60028169|NCT02507375|76144099|FG000|Cycle 3|Overall Study||4||
60028170|NCT02507375|76144100|FG001|Cycle 3|Overall Study||5||
60028171|NCT02507375|76144099|FG000|Cycle 4|Overall Study||4||
60028172|NCT02507375|76144100|FG001|Cycle 4|Overall Study||2||
60028173|NCT02507375|76144099|FG000|Cycle 5|Overall Study||3||
60028174|NCT02507375|76144100|FG001|Cycle 5|Overall Study||1||
60028175|NCT02507375|76144099|FG000|Cycle 6|Overall Study||3||
60028176|NCT02507375|76144100|FG001|Cycle 6|Overall Study||1||
59915861|NCT02960516|76036790|FG002|STARTED|Overall Study||8||
59915862|NCT02960516|76036788|FG000|COMPLETED|Overall Study||3||
60028177|NCT02507375|76144099|FG000|Extension Period|Overall Study||2||
60028178|NCT02507375|76144100|FG001|Extension Period|Overall Study||1||
60028179|NCT02507375|76144099|FG000|COMPLETED|Overall Study||2||
60028180|NCT02507375|76144100|FG001|COMPLETED|Overall Study||1||
60028181|NCT02507375|76144099|FG000|NOT COMPLETED|Overall Study||4||
60028182|NCT02507375|76144100|FG001|NOT COMPLETED|Overall Study||8||
60028183|NCT02507219|76144110|FG000|STARTED|Overall Study||5||
60028184|NCT02507219|76144111|FG001|STARTED|Overall Study||4||
60028185|NCT02507219|76144112|FG002|STARTED|Overall Study||3||
60028186|NCT02507219|76144113|FG003|STARTED|Overall Study||3||
60028187|NCT02507219|76144114|FG004|STARTED|Overall Study||4||
60028188|NCT02507219|76144115|FG005|STARTED|Overall Study||3||
60028189|NCT02507219|76144110|FG000|COMPLETED|Overall Study||4||
60028190|NCT02507219|76144111|FG001|COMPLETED|Overall Study||4||
60028191|NCT02507219|76144112|FG002|COMPLETED|Overall Study||3||
60028192|NCT02507219|76144113|FG003|COMPLETED|Overall Study||3||
60028193|NCT02507219|76144114|FG004|COMPLETED|Overall Study||3||
60028194|NCT02507219|76144115|FG005|COMPLETED|Overall Study||3||
60028195|NCT02507219|76144110|FG000|NOT COMPLETED|Overall Study||1||
60028196|NCT02507219|76144111|FG001|NOT COMPLETED|Overall Study||0||
60028197|NCT02507219|76144112|FG002|NOT COMPLETED|Overall Study||0||
60028198|NCT02507219|76144113|FG003|NOT COMPLETED|Overall Study||0||
60028199|NCT02507219|76144114|FG004|NOT COMPLETED|Overall Study||1||
60028200|NCT02507219|76144115|FG005|NOT COMPLETED|Overall Study||0||
60028201|NCT02483975|76144125|FG000|STARTED|Overall Study||56||
60028202|NCT02483975|76144126|FG001|STARTED|Overall Study||55||
60028203|NCT02483975|76144125|FG000|COMPLETED|Overall Study||54||
60028204|NCT02483975|76144126|FG001|COMPLETED|Overall Study|Subject reported as not completed due to AE was discontinued due to exacerbation, was not an AE/SAE|53||
60028205|NCT02483975|76144125|FG000|NOT COMPLETED|Overall Study||2||
60028206|NCT02483975|76144126|FG001|NOT COMPLETED|Overall Study||2||
60028207|NCT02047227|76144137|FG000|STARTED|Overall Study||462||
60028208|NCT02047227|76144138|FG001|STARTED|Overall Study||477||
60028209|NCT02047227|76144137|FG000|Completed Ovarian Stimulation Phase|Overall Study||424||
60028210|NCT02047227|76144138|FG001|Completed Ovarian Stimulation Phase|Overall Study||440||
60028211|NCT02047227|76144137|FG000|COMPLETED|Overall Study||318||
60028212|NCT02047227|76144138|FG001|COMPLETED|Overall Study||347||
60028213|NCT02047227|76144137|FG000|NOT COMPLETED|Overall Study||144||
60028214|NCT02047227|76144138|FG001|NOT COMPLETED|Overall Study||130||
60028215|NCT02483585|76144146|FG000|STARTED|Double-blind Treatment Phase||291||
60028216|NCT02483585|76144147|FG001|STARTED|Double-blind Treatment Phase||286||
60028217|NCT02483585|76144146|FG000|Received Treatment|Double-blind Treatment Phase||289||
60028218|NCT02483585|76144147|FG001|Received Treatment|Double-blind Treatment Phase||283||
60028219|NCT02483585|76144146|FG000|COMPLETED|Double-blind Treatment Phase||275||
60028220|NCT02483585|76144147|FG001|COMPLETED|Double-blind Treatment Phase||271||
60028221|NCT02483585|76144146|FG000|NOT COMPLETED|Double-blind Treatment Phase||16||
60028222|NCT02483585|76144147|FG001|NOT COMPLETED|Double-blind Treatment Phase||15||
60028223|NCT02483585|76144146|FG000|STARTED|Open-label Treatment Phase|Five participants who completed the double-blind phase did not enter the open-label treatment phase|270||
60028224|NCT02483585|76144147|FG001|STARTED|Open-label Treatment Phase|Three participants who completed the double-blind phase did not enter the open-label treatment phase|268||
60028225|NCT02483585|76144146|FG000|COMPLETED|Open-label Treatment Phase||243||
60028226|NCT02483585|76144147|FG001|COMPLETED|Open-label Treatment Phase||243||
60028227|NCT02483585|76144146|FG000|NOT COMPLETED|Open-label Treatment Phase||27||
60028228|NCT02483585|76144147|FG001|NOT COMPLETED|Open-label Treatment Phase||25||
60028229|NCT02046993|76144159|FG000|STARTED|Overall Study||105||
60028230|NCT02046993|76144160|FG001|STARTED|Overall Study||105||
59759219|NCT01143246|75878592|FG001|Safety Population (Treated Participants)|Overall Study||95|Eight participants did not receive treatment and were excluded from Safety Population.|
60028231|NCT02046993|76144159|FG000|3rd Month|Overall Study||104||
60028232|NCT02046993|76144160|FG001|3rd Month|Overall Study||97||
60028233|NCT02046993|76144159|FG000|6th Month|Overall Study||102||
60028234|NCT02046993|76144160|FG001|6th Month|Overall Study||94||
60028235|NCT02046993|76144159|FG000|COMPLETED|Overall Study||102||
60028236|NCT02046993|76144160|FG001|COMPLETED|Overall Study||94||
60028237|NCT02046993|76144159|FG000|NOT COMPLETED|Overall Study||3||
60028238|NCT02046993|76144160|FG001|NOT COMPLETED|Overall Study||11||
60028239|NCT02101983|76144170|FG000|STARTED|Overall Study||5||
60028240|NCT02101983|76144171|FG001|STARTED|Overall Study||6||
60028241|NCT02101983|76144170|FG000|COMPLETED|Overall Study||4||
60028242|NCT02101983|76144171|FG001|COMPLETED|Overall Study||6||
60028243|NCT02101983|76144170|FG000|NOT COMPLETED|Overall Study||1||
60028244|NCT02101983|76144171|FG001|NOT COMPLETED|Overall Study||0||
60028245|NCT02482805|76144180|FG000|STARTED|Overall Study||26||
60028246|NCT02482805|76144181|FG001|STARTED|Overall Study||27||
60028247|NCT02482805|76144182|FG002|STARTED|Overall Study||20||
60028248|NCT02482805|76144180|FG000|COMPLETED|Overall Study||22||
60028249|NCT02482805|76144181|FG001|COMPLETED|Overall Study||23||
60028250|NCT02482805|76144182|FG002|COMPLETED|Overall Study||20||
60028251|NCT02482805|76144180|FG000|NOT COMPLETED|Overall Study||4||
60028252|NCT02482805|76144181|FG001|NOT COMPLETED|Overall Study||4||
60028253|NCT02482805|76144182|FG002|NOT COMPLETED|Overall Study||0||
59759220|NCT01143246|75878591|FG000|COMPLETED|Overall Study||52||
59759221|NCT01143246|75878592|FG001|COMPLETED|Overall Study||48||
59759222|NCT01143246|75878591|FG000|NOT COMPLETED|Overall Study||45||
60028254|NCT02503865|76144193|FG000|STARTED|Overall Study||70||
60028255|NCT02503865|76144194|FG001|STARTED|Overall Study||269||
60028256|NCT02503865|76144195|FG002|STARTED|Overall Study||66||
60028257|NCT02503865|76144193|FG000|COMPLETED|Overall Study||65||
60028258|NCT02503865|76144194|FG001|COMPLETED|Overall Study||222||
60028259|NCT02503865|76144195|FG002|COMPLETED|Overall Study||64||
60028260|NCT02503865|76144193|FG000|NOT COMPLETED|Overall Study||5||
60028261|NCT02503865|76144194|FG001|NOT COMPLETED|Overall Study||47||
60028262|NCT02503865|76144195|FG002|NOT COMPLETED|Overall Study||2||
60028263|NCT01623531|76144206|FG000|STARTED|Overall Study||31||
60028264|NCT01623531|76144207|FG001|STARTED|Overall Study||31||
60028265|NCT01623531|76144206|FG000|COMPLETED|Overall Study||27||
60028266|NCT01623531|76144207|FG001|COMPLETED|Overall Study||29||
60028267|NCT01623531|76144206|FG000|NOT COMPLETED|Overall Study||4||
60028268|NCT01623531|76144207|FG001|NOT COMPLETED|Overall Study||2||
60028269|NCT02503787|76144216|FG000|STARTED|Enrollment||64||
60028270|NCT02503787|76144216|FG000|COMPLETED|Enrollment||44||
60028271|NCT02503787|76144216|FG000|NOT COMPLETED|Enrollment||20||
60028272|NCT02503787|76144216|FG000|STARTED|Device Trial (HD Programming Trial)||44||
60028273|NCT02503787|76144216|FG000|COMPLETED|Device Trial (HD Programming Trial)||37||
60028274|NCT02503787|76144216|FG000|NOT COMPLETED|Device Trial (HD Programming Trial)||7||
60028275|NCT02503787|76144216|FG000|STARTED|Successful Trial (≥50% Pain Relief)||37||
60028276|NCT02503787|76144216|FG000|COMPLETED|Successful Trial (≥50% Pain Relief)||32||
60028277|NCT02503787|76144216|FG000|NOT COMPLETED|Successful Trial (≥50% Pain Relief)||5||
60028278|NCT02503787|76144216|FG000|STARTED|Implant to 3 Month Endpoint||32||
60028279|NCT02503787|76144216|FG000|COMPLETED|Implant to 3 Month Endpoint||29||
60028280|NCT02503787|76144216|FG000|NOT COMPLETED|Implant to 3 Month Endpoint||3||
60028281|NCT02482571|76144220|FG000|STARTED|Overall Study||25||
60028282|NCT02482571|76144220|FG000|COMPLETED|Overall Study||17||
60028283|NCT02482571|76144220|FG000|NOT COMPLETED|Overall Study||8||
60028284|NCT02481947|76144227|FG000|STARTED|Overall Study||230||
60028285|NCT02481947|76144228|FG001|STARTED|Overall Study||229||
60028286|NCT02481947|76144227|FG000|COMPLETED|Overall Study||184||
60028287|NCT02481947|76144228|FG001|COMPLETED|Overall Study||193||
60028288|NCT02481947|76144227|FG000|NOT COMPLETED|Overall Study||46||
60028289|NCT02481947|76144228|FG001|NOT COMPLETED|Overall Study||36||
60028290|NCT02503085|76144234|FG000|STARTED|Period 1||7||
60028291|NCT02503085|76144235|FG001|STARTED|Period 1||7||
60028292|NCT02503085|76144236|FG002|STARTED|Period 1||7||
59759223|NCT01143246|75878592|FG001|NOT COMPLETED|Overall Study||51||
59759224|NCT04654754|75878598|FG000|STARTED|LVN With T-piece and a Filter||12||
59759225|NCT04654754|75878598|FG000|COMPLETED|LVN With T-piece and a Filter||12||
59759226|NCT04654754|75878598|FG000|NOT COMPLETED|LVN With T-piece and a Filter||0||
60028293|NCT02503085|76144237|FG003|STARTED|Period 1||7||
60028294|NCT02503085|76144234|FG000|COMPLETED|Period 1||7||
60028295|NCT02503085|76144235|FG001|COMPLETED|Period 1||7||
60028296|NCT02503085|76144236|FG002|COMPLETED|Period 1||7||
60028297|NCT02503085|76144237|FG003|COMPLETED|Period 1||7||
60028298|NCT02503085|76144234|FG000|NOT COMPLETED|Period 1||0||
60028299|NCT02503085|76144235|FG001|NOT COMPLETED|Period 1||0||
60028300|NCT02503085|76144236|FG002|NOT COMPLETED|Period 1||0||
60028301|NCT02503085|76144237|FG003|NOT COMPLETED|Period 1||0||
60028302|NCT02503085|76144234|FG000|STARTED|Period 1: Washout (3 to 7 Days)||7||
60028303|NCT02503085|76144235|FG001|STARTED|Period 1: Washout (3 to 7 Days)||7||
59759227|NCT04654754|75878598|FG000|STARTED|High-flow High-humidity With Adapter||12||
59759228|NCT04654754|75878598|FG000|COMPLETED|High-flow High-humidity With Adapter||12||
60028304|NCT02503085|76144236|FG002|STARTED|Period 1: Washout (3 to 7 Days)||7||
60028305|NCT02503085|76144237|FG003|STARTED|Period 1: Washout (3 to 7 Days)||7||
60028306|NCT02503085|76144234|FG000|COMPLETED|Period 1: Washout (3 to 7 Days)||7||
60028307|NCT02503085|76144235|FG001|COMPLETED|Period 1: Washout (3 to 7 Days)||7||
60028308|NCT02503085|76144236|FG002|COMPLETED|Period 1: Washout (3 to 7 Days)||7||
59915863|NCT02960516|76036789|FG001|COMPLETED|Overall Study||8||
59915864|NCT02960516|76036790|FG002|COMPLETED|Overall Study||8||
59915865|NCT02960516|76036788|FG000|NOT COMPLETED|Overall Study||0||
59915866|NCT02960516|76036789|FG001|NOT COMPLETED|Overall Study||0||
59915867|NCT02960516|76036790|FG002|NOT COMPLETED|Overall Study||0||
59915868|NCT03131895|76036807|FG000|STARTED|Intervention Period 1 (2 Days)||28||
59915869|NCT03131895|76036808|FG001|STARTED|Intervention Period 1 (2 Days)||28||
59915870|NCT03131895|76036809|FG002|STARTED|Intervention Period 1 (2 Days)||30||
59915871|NCT03131895|76036810|FG003|STARTED|Intervention Period 1 (2 Days)||30||
59915872|NCT03131895|76036807|FG000|COMPLETED|Intervention Period 1 (2 Days)||28||
59915873|NCT03131895|76036808|FG001|COMPLETED|Intervention Period 1 (2 Days)||28||
59915874|NCT03131895|76036809|FG002|COMPLETED|Intervention Period 1 (2 Days)||30||
59915875|NCT03131895|76036810|FG003|COMPLETED|Intervention Period 1 (2 Days)||30||
59915876|NCT03131895|76036807|FG000|NOT COMPLETED|Intervention Period 1 (2 Days)||0||
59915877|NCT03131895|76036808|FG001|NOT COMPLETED|Intervention Period 1 (2 Days)||0||
59915878|NCT03131895|76036809|FG002|NOT COMPLETED|Intervention Period 1 (2 Days)||0||
59951307|NCT03524118|76070247|FG001|STARTED|Overall Study||31||
59951308|NCT03524118|76070248|FG002|STARTED|Overall Study||41||
59951309|NCT03524118|76070249|FG003|STARTED|Overall Study||32||
59951310|NCT03524118|76070250|FG004|STARTED|Overall Study||33||
59951311|NCT03524118|76070251|FG005|STARTED|Overall Study||38||
59951312|NCT03524118|76070246|FG000|Treated|Overall Study||8||
59951313|NCT03524118|76070247|FG001|Treated|Overall Study||31||
59951314|NCT03524118|76070248|FG002|Treated|Overall Study||40||
59951315|NCT03524118|76070249|FG003|Treated|Overall Study||32||
59951316|NCT03524118|76070250|FG004|Treated|Overall Study||32||
59951317|NCT03524118|76070251|FG005|Treated|Overall Study||38||
59951318|NCT03524118|76070246|FG000|Safety Analysis Population|Overall Study||6|Two participants who were randomized to the MK-1654 20 mg dose group actually received MK-1654 50 mg|
59951319|NCT03524118|76070247|FG001|Safety Analysis Population|Overall Study||33|Two participants who were randomized to the MK-1654 20 mg dose group actually received MK-1654 50 mg|
59951320|NCT03524118|76070248|FG002|Safety Analysis Population|Overall Study||40|Two participants who were randomized to the MK-1654 20 mg dose group actually received MK-1654 50 mg|
59951321|NCT03524118|76070249|FG003|Safety Analysis Population|Overall Study||32|Two participants who were randomized to the MK-1654 20 mg dose group actually received MK-1654 50 mg|
59951322|NCT03524118|76070250|FG004|Safety Analysis Population|Overall Study||32|Two participants who were randomized to the MK-1654 20 mg dose group actually received MK-1654 50 mg|
59951323|NCT03524118|76070251|FG005|Safety Analysis Population|Overall Study||38|Two participants who were randomized to the MK-1654 20 mg dose group actually received MK-1654 50 mg|
59951324|NCT03524118|76070246|FG000|COMPLETED|Overall Study||8||
59951325|NCT03524118|76070247|FG001|COMPLETED|Overall Study||29||
59951326|NCT03524118|76070248|FG002|COMPLETED|Overall Study||40||
59951327|NCT03524118|76070249|FG003|COMPLETED|Overall Study||31||
59951328|NCT03524118|76070250|FG004|COMPLETED|Overall Study||26||
59951329|NCT03524118|76070251|FG005|COMPLETED|Overall Study||37||
59951330|NCT03524118|76070246|FG000|NOT COMPLETED|Overall Study||0||
59951331|NCT03524118|76070247|FG001|NOT COMPLETED|Overall Study||2||
59951332|NCT03524118|76070248|FG002|NOT COMPLETED|Overall Study||1||
59951333|NCT03524118|76070249|FG003|NOT COMPLETED|Overall Study||1||
59951334|NCT03524118|76070250|FG004|NOT COMPLETED|Overall Study||7||
59951335|NCT03524118|76070251|FG005|NOT COMPLETED|Overall Study||1||
59951336|NCT03472586|76070265|FG000|STARTED|Overall Study||14||
59951337|NCT03472586|76070265|FG000|COMPLETED|Overall Study||1||
59951338|NCT03472586|76070265|FG000|NOT COMPLETED|Overall Study||13||
59951339|NCT03437265|76070269|FG000|STARTED|Overall Study||19||
59951340|NCT03437265|76070269|FG000|COMPLETED|Overall Study||13||
59951341|NCT03437265|76070269|FG000|NOT COMPLETED|Overall Study||6||
59951342|NCT03414424|76070275|FG000|STARTED|Overall Study||15||
59951343|NCT03414424|76070276|FG001|STARTED|Overall Study||15||
59951344|NCT03414424|76070275|FG000|COMPLETED|Overall Study||15||
59951345|NCT03414424|76070276|FG001|COMPLETED|Overall Study||12||
59951346|NCT03414424|76070275|FG000|NOT COMPLETED|Overall Study||0||
59951347|NCT03414424|76070276|FG001|NOT COMPLETED|Overall Study||3||
59951348|NCT03349476|76070282|FG000|STARTED|Overall Study||109||
59951349|NCT03349476|76070282|FG000|COMPLETED|Overall Study||106||
59951350|NCT03349476|76070282|FG000|NOT COMPLETED|Overall Study||3||
59951351|NCT03312634|76070288|FG000|STARTED|Overall Study||107||
59951352|NCT03312634|76070289|FG001|STARTED|Overall Study||114||
59951353|NCT03312634|76070288|FG000|COMPLETED|Overall Study||49||
59951354|NCT03312634|76070289|FG001|COMPLETED|Overall Study||33||
59951355|NCT03312634|76070288|FG000|NOT COMPLETED|Overall Study||58||
59951356|NCT03312634|76070289|FG001|NOT COMPLETED|Overall Study||81||
59951357|NCT03000569|76070298|FG000|STARTED|Overall Study||15||
59951358|NCT03000569|76070299|FG001|STARTED|Overall Study||14||
59951359|NCT03000569|76070298|FG000|COMPLETED|Overall Study||14||
59951360|NCT03000569|76070299|FG001|COMPLETED|Overall Study||14||
59951361|NCT03000569|76070298|FG000|NOT COMPLETED|Overall Study||1||
59951362|NCT03000569|76070299|FG001|NOT COMPLETED|Overall Study||0||
59951363|NCT02949921|76070315|FG000|STARTED|Overall Study||10||
60028309|NCT02503085|76144237|FG003|COMPLETED|Period 1: Washout (3 to 7 Days)||7||
60028310|NCT02503085|76144234|FG000|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0||
60028311|NCT02503085|76144235|FG001|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0||
60028312|NCT02503085|76144236|FG002|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0||
60028313|NCT02503085|76144237|FG003|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0||
60028314|NCT02503085|76144234|FG000|STARTED|Period 2||7||
60028315|NCT02503085|76144235|FG001|STARTED|Period 2||7||
60028316|NCT02503085|76144236|FG002|STARTED|Period 2||7||
60028317|NCT02503085|76144237|FG003|STARTED|Period 2||7||
60028318|NCT02503085|76144234|FG000|COMPLETED|Period 2||7||
60028319|NCT02503085|76144235|FG001|COMPLETED|Period 2||7||
60028320|NCT02503085|76144236|FG002|COMPLETED|Period 2||7||
60028321|NCT02503085|76144237|FG003|COMPLETED|Period 2||7||
60028322|NCT02503085|76144234|FG000|NOT COMPLETED|Period 2||0||
60028323|NCT02503085|76144235|FG001|NOT COMPLETED|Period 2||0||
60028324|NCT02503085|76144236|FG002|NOT COMPLETED|Period 2||0||
60028325|NCT02503085|76144237|FG003|NOT COMPLETED|Period 2||0||
60028326|NCT02503085|76144234|FG000|STARTED|Period 2: Washout (3 to 7 Days)||7||
60028327|NCT02503085|76144235|FG001|STARTED|Period 2: Washout (3 to 7 Days)||7||
60028328|NCT02503085|76144236|FG002|STARTED|Period 2: Washout (3 to 7 Days)||7||
60028329|NCT02503085|76144237|FG003|STARTED|Period 2: Washout (3 to 7 Days)||7||
60028330|NCT02503085|76144234|FG000|COMPLETED|Period 2: Washout (3 to 7 Days)||6||
60028331|NCT02503085|76144235|FG001|COMPLETED|Period 2: Washout (3 to 7 Days)||7||
60028332|NCT02503085|76144236|FG002|COMPLETED|Period 2: Washout (3 to 7 Days)||6||
60028333|NCT02503085|76144237|FG003|COMPLETED|Period 2: Washout (3 to 7 Days)||7||
60028334|NCT02503085|76144234|FG000|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||1||
60028335|NCT02503085|76144235|FG001|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0||
60028336|NCT02503085|76144236|FG002|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||1||
60028337|NCT02503085|76144237|FG003|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0||
60028338|NCT02503085|76144234|FG000|STARTED|Period 3||6||
60028339|NCT02503085|76144235|FG001|STARTED|Period 3||7||
60028340|NCT02503085|76144236|FG002|STARTED|Period 3||6||
60028341|NCT02503085|76144237|FG003|STARTED|Period 3||7||
60028342|NCT02503085|76144234|FG000|COMPLETED|Period 3||6||
60028343|NCT02503085|76144235|FG001|COMPLETED|Period 3||7||
60028344|NCT02503085|76144236|FG002|COMPLETED|Period 3||6||
60028345|NCT02503085|76144237|FG003|COMPLETED|Period 3||7||
60028346|NCT02503085|76144234|FG000|NOT COMPLETED|Period 3||0||
60028347|NCT02503085|76144235|FG001|NOT COMPLETED|Period 3||0||
60028348|NCT02503085|76144236|FG002|NOT COMPLETED|Period 3||0||
60028349|NCT02503085|76144237|FG003|NOT COMPLETED|Period 3||0||
60028350|NCT02503085|76144234|FG000|STARTED|Period 3: Washout (3 to 7 Days)||6||
60028351|NCT02503085|76144235|FG001|STARTED|Period 3: Washout (3 to 7 Days)||7||
60028352|NCT02503085|76144236|FG002|STARTED|Period 3: Washout (3 to 7 Days)||6||
60028353|NCT02503085|76144237|FG003|STARTED|Period 3: Washout (3 to 7 Days)||7||
60028354|NCT02503085|76144234|FG000|COMPLETED|Period 3: Washout (3 to 7 Days)||6||
60028355|NCT02503085|76144235|FG001|COMPLETED|Period 3: Washout (3 to 7 Days)||7||
60028356|NCT02503085|76144236|FG002|COMPLETED|Period 3: Washout (3 to 7 Days)||6||
60028357|NCT02503085|76144237|FG003|COMPLETED|Period 3: Washout (3 to 7 Days)||7||
60028358|NCT02503085|76144234|FG000|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0||
60028359|NCT02503085|76144235|FG001|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0||
60028360|NCT02503085|76144236|FG002|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0||
60028361|NCT02503085|76144237|FG003|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0||
60028362|NCT02503085|76144234|FG000|STARTED|Period 4||6||
60028363|NCT02503085|76144235|FG001|STARTED|Period 4||7||
60028364|NCT02503085|76144236|FG002|STARTED|Period 4||6||
60028365|NCT02503085|76144237|FG003|STARTED|Period 4||7||
60028366|NCT02503085|76144234|FG000|COMPLETED|Period 4||6||
60028367|NCT02503085|76144235|FG001|COMPLETED|Period 4||7||
60028368|NCT02503085|76144236|FG002|COMPLETED|Period 4||6||
60028369|NCT02503085|76144237|FG003|COMPLETED|Period 4||7||
60028370|NCT02503085|76144234|FG000|NOT COMPLETED|Period 4||0||
60028371|NCT02503085|76144235|FG001|NOT COMPLETED|Period 4||0||
60028372|NCT02503085|76144236|FG002|NOT COMPLETED|Period 4||0||
60028373|NCT02503085|76144237|FG003|NOT COMPLETED|Period 4||0||
60028374|NCT02481869|76144246|FG000|STARTED|Overall Study||5||
60028375|NCT02481869|76144247|FG001|STARTED|Overall Study||6||
60028376|NCT02481869|76144246|FG000|COMPLETED|Overall Study||0||
60028377|NCT02481869|76144247|FG001|COMPLETED|Overall Study||2||
60028378|NCT02481869|76144246|FG000|NOT COMPLETED|Overall Study||5||
60028379|NCT02481869|76144247|FG001|NOT COMPLETED|Overall Study||4||
60028380|NCT02502149|76144254|FG000|STARTED|PK1 Assessment Period||24||
60028381|NCT02502149|76144255|FG001|STARTED|PK1 Assessment Period||0||
60028382|NCT02502149|76144256|FG002|STARTED|PK1 Assessment Period||0||
60028383|NCT02502149|76144257|FG003|STARTED|PK1 Assessment Period||0||
60028384|NCT02502149|76144258|FG004|STARTED|PK1 Assessment Period||0||
60028385|NCT02502149|76144254|FG000|COMPLETED|PK1 Assessment Period||24||
60028386|NCT02502149|76144255|FG001|COMPLETED|PK1 Assessment Period||0||
60028387|NCT02502149|76144256|FG002|COMPLETED|PK1 Assessment Period||0||
60028388|NCT02502149|76144257|FG003|COMPLETED|PK1 Assessment Period||0||
60028389|NCT02502149|76144258|FG004|COMPLETED|PK1 Assessment Period||0||
60028390|NCT02502149|76144254|FG000|NOT COMPLETED|PK1 Assessment Period||0||
60028391|NCT02502149|76144255|FG001|NOT COMPLETED|PK1 Assessment Period||0||
60028392|NCT02502149|76144256|FG002|NOT COMPLETED|PK1 Assessment Period||0||
60028393|NCT02502149|76144257|FG003|NOT COMPLETED|PK1 Assessment Period||0||
60028394|NCT02502149|76144258|FG004|NOT COMPLETED|PK1 Assessment Period||0||
60028395|NCT02502149|76144254|FG000|STARTED|Intermediate||24||
60028396|NCT02502149|76144255|FG001|STARTED|Intermediate||0||
60028397|NCT02502149|76144256|FG002|STARTED|Intermediate||0||
60028398|NCT02502149|76144257|FG003|STARTED|Intermediate||0||
60028399|NCT02502149|76144258|FG004|STARTED|Intermediate||0||
60028400|NCT02502149|76144254|FG000|COMPLETED|Intermediate||23||
60028401|NCT02502149|76144255|FG001|COMPLETED|Intermediate||0||
60028402|NCT02502149|76144256|FG002|COMPLETED|Intermediate||0||
60028403|NCT02502149|76144257|FG003|COMPLETED|Intermediate||0||
60028404|NCT02502149|76144258|FG004|COMPLETED|Intermediate||0||
60028405|NCT02502149|76144254|FG000|NOT COMPLETED|Intermediate||1||
60028406|NCT02502149|76144255|FG001|NOT COMPLETED|Intermediate||0||
60028407|NCT02502149|76144256|FG002|NOT COMPLETED|Intermediate||0||
60028408|NCT02502149|76144257|FG003|NOT COMPLETED|Intermediate||0||
60028409|NCT02502149|76144258|FG004|NOT COMPLETED|Intermediate||0||
60028410|NCT02502149|76144254|FG000|STARTED|PK2 Assessment Period||0||
60028411|NCT02502149|76144255|FG001|STARTED|PK2 Assessment Period||11||
60028412|NCT02502149|76144256|FG002|STARTED|PK2 Assessment Period||12||
60028413|NCT02502149|76144257|FG003|STARTED|PK2 Assessment Period||0||
60028414|NCT02502149|76144258|FG004|STARTED|PK2 Assessment Period||0||
60028415|NCT02502149|76144254|FG000|COMPLETED|PK2 Assessment Period||0||
60028416|NCT02502149|76144255|FG001|COMPLETED|PK2 Assessment Period||11||
60028417|NCT02502149|76144256|FG002|COMPLETED|PK2 Assessment Period||12||
60028418|NCT02502149|76144257|FG003|COMPLETED|PK2 Assessment Period||0||
60028419|NCT02502149|76144258|FG004|COMPLETED|PK2 Assessment Period||0||
60028420|NCT02502149|76144254|FG000|NOT COMPLETED|PK2 Assessment Period||0||
60028421|NCT02502149|76144255|FG001|NOT COMPLETED|PK2 Assessment Period||0||
60028422|NCT02502149|76144256|FG002|NOT COMPLETED|PK2 Assessment Period||0||
60028423|NCT02502149|76144257|FG003|NOT COMPLETED|PK2 Assessment Period||0||
60028424|NCT02502149|76144258|FG004|NOT COMPLETED|PK2 Assessment Period||0||
60028425|NCT02502149|76144254|FG000|STARTED|Treatment Period||0||
60028426|NCT02502149|76144255|FG001|STARTED|Treatment Period||0||
60028427|NCT02502149|76144256|FG002|STARTED|Treatment Period||0||
60028428|NCT02502149|76144257|FG003|STARTED|Treatment Period||11||
60028429|NCT02502149|76144258|FG004|STARTED|Treatment Period||12||
60028430|NCT02502149|76144254|FG000|COMPLETED|Treatment Period||0||
60028431|NCT02502149|76144255|FG001|COMPLETED|Treatment Period||0||
60028432|NCT02502149|76144256|FG002|COMPLETED|Treatment Period||0||
60028433|NCT02502149|76144257|FG003|COMPLETED|Treatment Period||11||
60028434|NCT02502149|76144258|FG004|COMPLETED|Treatment Period||12||
60028435|NCT02502149|76144254|FG000|NOT COMPLETED|Treatment Period||0||
60028436|NCT02502149|76144255|FG001|NOT COMPLETED|Treatment Period||0||
60028437|NCT02502149|76144256|FG002|NOT COMPLETED|Treatment Period||0||
60028438|NCT02502149|76144257|FG003|NOT COMPLETED|Treatment Period||0||
60028439|NCT02502149|76144258|FG004|NOT COMPLETED|Treatment Period||0||
60028440|NCT02480621|76144277|FG000|STARTED|Randomization||44||
60028441|NCT02480621|76144278|FG001|STARTED|Randomization||40||
60028442|NCT02480621|76144277|FG000|COMPLETED|Randomization||43||
60028443|NCT02480621|76144278|FG001|COMPLETED|Randomization||39||
60028444|NCT02480621|76144277|FG000|NOT COMPLETED|Randomization||1||
60028445|NCT02480621|76144278|FG001|NOT COMPLETED|Randomization||1||
60028446|NCT02480621|76144277|FG000|STARTED|Follow Up||43||
60028447|NCT02480621|76144278|FG001|STARTED|Follow Up||39||
60028448|NCT02480621|76144277|FG000|COMPLETED|Follow Up||39||
60028449|NCT02480621|76144278|FG001|COMPLETED|Follow Up||37||
60028450|NCT02480621|76144277|FG000|NOT COMPLETED|Follow Up||4||
60028451|NCT02480621|76144278|FG001|NOT COMPLETED|Follow Up||2||
60028452|NCT02046603|76144286|FG000|STARTED|Overall Study||22||
60028453|NCT02046603|76144287|FG001|STARTED|Overall Study||140||
60028454|NCT02046603|76144286|FG000|Received at Least 1 Dose of Tocilizumab|Overall Study||21||
60028455|NCT02046603|76144287|FG001|Received at Least 1 Dose of Tocilizumab|Overall Study||140||
60028456|NCT02046603|76144286|FG000|COMPLETED|Overall Study||7||
60028457|NCT02046603|76144287|FG001|COMPLETED|Overall Study||65||
60028458|NCT02046603|76144286|FG000|NOT COMPLETED|Overall Study||15||
60028459|NCT02046603|76144287|FG001|NOT COMPLETED|Overall Study||75||
60028460|NCT01885078|76144302|FG000|STARTED|Treatment Period||451||
60028461|NCT01885078|76144303|FG001|STARTED|Treatment Period||1091||
60028462|NCT01885078|76144304|FG002|STARTED|Treatment Period||180||
60028463|NCT01885078|76144305|FG003|STARTED|Treatment Period||403||
60028464|NCT01885078|76144306|FG004|STARTED|Treatment Period||117||
60028465|NCT01885078|76144307|FG005|STARTED|Treatment Period||331||
60028466|NCT01885078|76144308|FG006|STARTED|Treatment Period||221||
60028467|NCT01885078|76144309|FG007|STARTED|Treatment Period||83||
60028468|NCT01885078|76144310|FG008|STARTED|Treatment Period||0||
60028469|NCT01885078|76144311|FG009|STARTED|Treatment Period||0||
60028470|NCT01885078|76144302|FG000|Received at Least Once Dose of Study Drug|Treatment Period||451||
60028471|NCT01885078|76144303|FG001|Received at Least Once Dose of Study Drug|Treatment Period||1090||
60028472|NCT01885078|76144304|FG002|Received at Least Once Dose of Study Drug|Treatment Period||180||
60028473|NCT01885078|76144305|FG003|Received at Least Once Dose of Study Drug|Treatment Period||403||
60028474|NCT01885078|76144306|FG004|Received at Least Once Dose of Study Drug|Treatment Period||117||
60028475|NCT01885078|76144307|FG005|Received at Least Once Dose of Study Drug|Treatment Period||331||
59507423|NCT02016885|75600694|FG003|STARTED|Overall Study||40||
59507424|NCT02016885|75600695|FG004|STARTED|Overall Study||40||
59507425|NCT02016885|75600691|FG000|COMPLETED|Overall Study||34||
60028476|NCT01885078|76144308|FG006|Received at Least Once Dose of Study Drug|Treatment Period||221||
60028477|NCT01885078|76144309|FG007|Received at Least Once Dose of Study Drug|Treatment Period||83||
60028478|NCT01885078|76144310|FG008|Received at Least Once Dose of Study Drug|Treatment Period||0||
60028479|NCT01885078|76144311|FG009|Received at Least Once Dose of Study Drug|Treatment Period||0||
60028480|NCT01885078|76144302|FG000|COMPLETED|Treatment Period||19||
60028481|NCT01885078|76144303|FG001|COMPLETED|Treatment Period||64||
60028482|NCT01885078|76144304|FG002|COMPLETED|Treatment Period||49||
60028483|NCT01885078|76144305|FG003|COMPLETED|Treatment Period||120||
60028484|NCT01885078|76144306|FG004|COMPLETED|Treatment Period||27||
60028485|NCT01885078|76144307|FG005|COMPLETED|Treatment Period||81||
60028486|NCT01885078|76144308|FG006|COMPLETED|Treatment Period||0||
60028487|NCT01885078|76144309|FG007|COMPLETED|Treatment Period||55||
60028488|NCT01885078|76144310|FG008|COMPLETED|Treatment Period||0||
60028489|NCT01885078|76144311|FG009|COMPLETED|Treatment Period||0||
60028490|NCT01885078|76144302|FG000|NOT COMPLETED|Treatment Period||432||
60028491|NCT01885078|76144303|FG001|NOT COMPLETED|Treatment Period||1027||
60028492|NCT01885078|76144304|FG002|NOT COMPLETED|Treatment Period||131||
60028493|NCT01885078|76144305|FG003|NOT COMPLETED|Treatment Period||283||
60028494|NCT01885078|76144306|FG004|NOT COMPLETED|Treatment Period||90||
60028495|NCT01885078|76144307|FG005|NOT COMPLETED|Treatment Period||250||
60028496|NCT01885078|76144308|FG006|NOT COMPLETED|Treatment Period||221||
60028497|NCT01885078|76144309|FG007|NOT COMPLETED|Treatment Period||28||
60028498|NCT01885078|76144310|FG008|NOT COMPLETED|Treatment Period||0||
60028499|NCT01885078|76144311|FG009|NOT COMPLETED|Treatment Period||0||
60028500|NCT01885078|76144302|FG000|STARTED|Step-down Period|Not all participants were eligible to enter the Step-Down Period.|0||
60028501|NCT01885078|76144303|FG001|STARTED|Step-down Period|Not all participants were eligible to enter the Step-Down Period.|0||
60028502|NCT01885078|76144304|FG002|STARTED|Step-down Period|Not all participants were eligible to enter the Step-Down Period.|0||
60028503|NCT01885078|76144305|FG003|STARTED|Step-down Period|Not all participants were eligible to enter the Step-Down Period.|0||
60028504|NCT01885078|76144306|FG004|STARTED|Step-down Period|Not all participants were eligible to enter the Step-Down Period.|0||
60028505|NCT01885078|76144307|FG005|STARTED|Step-down Period|Not all participants were eligible to enter the Step-Down Period.|0||
60028506|NCT01885078|76144308|FG006|STARTED|Step-down Period||0||
60028507|NCT01885078|76144309|FG007|STARTED|Step-down Period|Not all participants were eligible to enter the Step-Down Period.|0||
60028508|NCT01885078|76144310|FG008|STARTED|Step-down Period|Eligible participants were offered the option of participating in the Step-Down Period.|592||
60028509|NCT01885078|76144311|FG009|STARTED|Step-down Period|Eligible participants were offered the option of participating in the Step-Down Period.|594||
60028510|NCT01885078|76144302|FG000|Complete Through Week 96|Step-down Period||0||
60028511|NCT01885078|76144303|FG001|Complete Through Week 96|Step-down Period||0||
60028512|NCT01885078|76144304|FG002|Complete Through Week 96|Step-down Period||0||
60028513|NCT01885078|76144305|FG003|Complete Through Week 96|Step-down Period||0||
60028514|NCT01885078|76144306|FG004|Complete Through Week 96|Step-down Period||0||
60028515|NCT01885078|76144307|FG005|Complete Through Week 96|Step-down Period||0||
60028516|NCT01885078|76144308|FG006|Complete Through Week 96|Step-down Period||0||
60028517|NCT01885078|76144309|FG007|Complete Through Week 96|Step-down Period||0||
60028518|NCT01885078|76144310|FG008|Complete Through Week 96|Step-down Period||407||
60028519|NCT01885078|76144311|FG009|Complete Through Week 96|Step-down Period||455||
60028520|NCT01885078|76144302|FG000|COMPLETED|Step-down Period||0||
60028521|NCT01885078|76144303|FG001|COMPLETED|Step-down Period||0||
59507426|NCT02016885|75600692|FG001|COMPLETED|Overall Study||36||
59507427|NCT02016885|75600693|FG002|COMPLETED|Overall Study||39||
59507428|NCT02016885|75600694|FG003|COMPLETED|Overall Study||30||
59507429|NCT02016885|75600695|FG004|COMPLETED|Overall Study||39||
60028522|NCT01885078|76144304|FG002|COMPLETED|Step-down Period||0||
60028523|NCT01885078|76144305|FG003|COMPLETED|Step-down Period||0||
60028524|NCT01885078|76144306|FG004|COMPLETED|Step-down Period||0||
60028525|NCT01885078|76144307|FG005|COMPLETED|Step-down Period||0||
60028526|NCT01885078|76144308|FG006|COMPLETED|Step-down Period||0||
60028527|NCT01885078|76144309|FG007|COMPLETED|Step-down Period||0||
60028528|NCT01885078|76144310|FG008|COMPLETED|Step-down Period||523||
60028529|NCT01885078|76144311|FG009|COMPLETED|Step-down Period||533||
60028530|NCT01885078|76144302|FG000|NOT COMPLETED|Step-down Period||0||
60028531|NCT01885078|76144303|FG001|NOT COMPLETED|Step-down Period||0||
60028532|NCT01885078|76144304|FG002|NOT COMPLETED|Step-down Period||0||
60028533|NCT01885078|76144305|FG003|NOT COMPLETED|Step-down Period||0||
60028534|NCT01885078|76144306|FG004|NOT COMPLETED|Step-down Period||0||
60028535|NCT01885078|76144307|FG005|NOT COMPLETED|Step-down Period||0||
60028536|NCT01885078|76144308|FG006|NOT COMPLETED|Step-down Period||0||
60028537|NCT01885078|76144309|FG007|NOT COMPLETED|Step-down Period||0||
60028538|NCT01885078|76144310|FG008|NOT COMPLETED|Step-down Period||69||
60028539|NCT01885078|76144311|FG009|NOT COMPLETED|Step-down Period||61||
60028540|NCT02046369|76144334|FG000|STARTED|Overall Study||176||
60028541|NCT02046369|76144335|FG001|STARTED|Overall Study||174||
60028542|NCT02046369|76144334|FG000|COMPLETED|Overall Study||162||
60028543|NCT02046369|76144335|FG001|COMPLETED|Overall Study||156||
60028544|NCT02046369|76144334|FG000|NOT COMPLETED|Overall Study||14||
60028545|NCT02046369|76144335|FG001|NOT COMPLETED|Overall Study||18||
60028546|NCT02101359|76144343|FG000|STARTED|Overall Study||295||
60028547|NCT02101359|76144344|FG001|STARTED|Overall Study||296||
60028548|NCT02101359|76144343|FG000|COMPLETED|Overall Study||266||
60028549|NCT02101359|76144344|FG001|COMPLETED|Overall Study||277||
60028550|NCT02101359|76144343|FG000|NOT COMPLETED|Overall Study||29||
60028551|NCT02101359|76144344|FG001|NOT COMPLETED|Overall Study||19||
60028552|NCT02100969|76144350|FG000|STARTED|Overall Study||23||
60028553|NCT02100969|76144350|FG000|COMPLETED|Overall Study||22||
60028554|NCT02100969|76144350|FG000|NOT COMPLETED|Overall Study||1||
60028555|NCT01885000|76144357|FG000|STARTED|Overall Study||48||
60028556|NCT01885000|76144358|FG001|STARTED|Overall Study||44||
60028557|NCT01885000|76144357|FG000|COMPLETED|Overall Study||46||
60028558|NCT01885000|76144358|FG001|COMPLETED|Overall Study||42||
60028559|NCT01885000|76144357|FG000|NOT COMPLETED|Overall Study||2||
60028560|NCT01885000|76144358|FG001|NOT COMPLETED|Overall Study||2||
60028561|NCT01884688|76144364|FG000|STARTED|Overall Study||3||
60028562|NCT01884688|76144364|FG000|COMPLETED|Overall Study||1||
60028563|NCT01884688|76144364|FG000|NOT COMPLETED|Overall Study||2||
60028564|NCT01883362|76144370|FG000|STARTED|Treatment||30||
60028565|NCT01883362|76144371|FG001|STARTED|Treatment||30||
60028566|NCT01883362|76144370|FG000|COMPLETED|Treatment||14||
60028567|NCT01883362|76144371|FG001|COMPLETED|Treatment||16||
60028568|NCT01883362|76144370|FG000|NOT COMPLETED|Treatment||16||
60028569|NCT01883362|76144371|FG001|NOT COMPLETED|Treatment||14||
60028570|NCT01883362|76144370|FG000|STARTED|Post Treatment Follow-up||26||
60028571|NCT01883362|76144371|FG001|STARTED|Post Treatment Follow-up||27||
60028572|NCT01883362|76144370|FG000|COMPLETED|Post Treatment Follow-up||10||
60028573|NCT01883362|76144371|FG001|COMPLETED|Post Treatment Follow-up||13||
60028574|NCT01883362|76144370|FG000|NOT COMPLETED|Post Treatment Follow-up||16||
60028575|NCT01883362|76144371|FG001|NOT COMPLETED|Post Treatment Follow-up||14||
60028576|NCT02100813|76144389|FG000|STARTED|Overall Study||10||
60028577|NCT02100813|76144390|FG001|STARTED|Overall Study||11||
60028578|NCT02100813|76144391|FG002|STARTED|Overall Study||12||
60028579|NCT02100813|76144392|FG003|STARTED|Overall Study||12||
60028580|NCT02100813|76144393|FG004|STARTED|Overall Study||12||
60028581|NCT02100813|76144394|FG005|STARTED|Overall Study||32||
60028582|NCT02100813|76144395|FG006|STARTED|Overall Study||64||
60028583|NCT02100813|76144396|FG007|STARTED|Overall Study||67||
60028584|NCT02100813|76144389|FG000|COMPLETED|Overall Study||10||
60028585|NCT02100813|76144390|FG001|COMPLETED|Overall Study||11||
60028586|NCT02100813|76144391|FG002|COMPLETED|Overall Study||12||
60028587|NCT02100813|76144392|FG003|COMPLETED|Overall Study||12||
60028588|NCT02100813|76144393|FG004|COMPLETED|Overall Study||12||
60028589|NCT02100813|76144394|FG005|COMPLETED|Overall Study||32||
60028590|NCT02100813|76144395|FG006|COMPLETED|Overall Study||64||
60028591|NCT02100813|76144396|FG007|COMPLETED|Overall Study||66||
60028592|NCT02100813|76144389|FG000|NOT COMPLETED|Overall Study||0||
60028593|NCT02100813|76144390|FG001|NOT COMPLETED|Overall Study||0||
60028594|NCT02100813|76144391|FG002|NOT COMPLETED|Overall Study||0||
60028595|NCT02100813|76144392|FG003|NOT COMPLETED|Overall Study||0||
60028596|NCT02100813|76144393|FG004|NOT COMPLETED|Overall Study||0||
60028597|NCT02100813|76144394|FG005|NOT COMPLETED|Overall Study||0||
60028598|NCT02100813|76144395|FG006|NOT COMPLETED|Overall Study||0||
60028599|NCT02100813|76144396|FG007|NOT COMPLETED|Overall Study||1||
60028600|NCT04724967|76144414|FG000|STARTED|Overall Study||528||
60028601|NCT04724967|76144414|FG000|COMPLETED|Overall Study||528||
60028602|NCT04724967|76144414|FG000|NOT COMPLETED|Overall Study||0||
60028603|NCT01930162|76144418|FG000|STARTED|Overall Study||9||
60028604|NCT01930162|76144418|FG000|COMPLETED|Overall Study||4||
60028605|NCT01930162|76144418|FG000|NOT COMPLETED|Overall Study||5||
60028606|NCT02045979|76144426|FG000|STARTED|Overall Study|1 subject (not included to the 108) was randomized but did never take any study medication.|108||
60028607|NCT02045979|76144427|FG001|STARTED|Overall Study|1 subject (not included to the 108) was randomized but did never take any study medication..|108||
60028608|NCT02045979|76144428|FG002|STARTED|Overall Study|1 subject (not included to the 108) was randomized but did never take any study medication.|108||
60028609|NCT02045979|76144426|FG000|COMPLETED|Overall Study||106||
60028610|NCT02045979|76144427|FG001|COMPLETED|Overall Study||107||
60028611|NCT02045979|76144428|FG002|COMPLETED|Overall Study||107||
60028612|NCT02045979|76144426|FG000|NOT COMPLETED|Overall Study||2||
60028613|NCT02045979|76144427|FG001|NOT COMPLETED|Overall Study||1||
60028614|NCT02045979|76144428|FG002|NOT COMPLETED|Overall Study||1||
60028615|NCT01929226|76144438|FG000|STARTED|Overall Study||210||
60028616|NCT01929226|76144439|FG001|STARTED|Overall Study||70||
60028617|NCT01929226|76144438|FG000|COMPLETED|Overall Study||205||
60028618|NCT01929226|76144439|FG001|COMPLETED|Overall Study||69||
60028619|NCT01929226|76144438|FG000|NOT COMPLETED|Overall Study||5||
60028620|NCT01929226|76144439|FG001|NOT COMPLETED|Overall Study||1||
60028621|NCT02045433|76144446|FG000|STARTED|Overall Study||16||
60028622|NCT02045433|76144446|FG000|COMPLETED|Overall Study|Study was Prematurely ended due to toxicity|15||
60028623|NCT02045433|76144446|FG000|NOT COMPLETED|Overall Study||1||
60028624|NCT01911442|76144453|FG000|STARTED|Overall Study||49||
60028625|NCT01911442|76144454|FG001|STARTED|Overall Study||51||
60028626|NCT01911442|76144455|FG002|STARTED|Overall Study||50||
60028627|NCT01911442|76144453|FG000|COMPLETED|Overall Study||43||
60028628|NCT01911442|76144454|FG001|COMPLETED|Overall Study||47||
60028629|NCT01911442|76144455|FG002|COMPLETED|Overall Study||38||
60028630|NCT01911442|76144453|FG000|NOT COMPLETED|Overall Study||6||
60028631|NCT01911442|76144454|FG001|NOT COMPLETED|Overall Study||4||
60028632|NCT01911442|76144455|FG002|NOT COMPLETED|Overall Study||12||
60028633|NCT01928758|76144469|FG000|STARTED|Overall Study||94||
60028634|NCT01928758|76144470|FG001|STARTED|Overall Study||94||
60028635|NCT01928758|76144469|FG000|COMPLETED|Overall Study||69||
60028636|NCT01928758|76144470|FG001|COMPLETED|Overall Study||74||
60028637|NCT01928758|76144469|FG000|NOT COMPLETED|Overall Study||25||
60028638|NCT01928758|76144470|FG001|NOT COMPLETED|Overall Study||20||
60028639|NCT01910116|76144479|FG000|STARTED|Overall Study||110||
60028640|NCT01910116|76144480|FG001|STARTED|Overall Study||110||
60028641|NCT01910116|76144479|FG000|Week 4|Overall Study||106||
60028642|NCT01910116|76144480|FG001|Week 4|Overall Study||102||
60028643|NCT01910116|76144479|FG000|Week 8|Overall Study||98||
60028644|NCT01910116|76144480|FG001|Week 8|Overall Study||99||
60028645|NCT01910116|76144479|FG000|Week 12|Overall Study||97||
60028646|NCT01910116|76144480|FG001|Week 12|Overall Study||96||
60028647|NCT01910116|76144479|FG000|Week 16|Overall Study||96||
60028648|NCT01910116|76144480|FG001|Week 16|Overall Study||94||
60028649|NCT01910116|76144479|FG000|COMPLETED|Overall Study||96||
60028650|NCT01910116|76144480|FG001|COMPLETED|Overall Study||94||
60028651|NCT01910116|76144479|FG000|NOT COMPLETED|Overall Study||14||
60028652|NCT01910116|76144480|FG001|NOT COMPLETED|Overall Study||16||
60028653|NCT01614886|76144488|FG000|STARTED|Overall Study||107||
60028654|NCT01614886|76144489|FG001|STARTED|Overall Study||109||
60028655|NCT01614886|76144488|FG000|Safety Population (SAF)|Overall Study||107||
60028656|NCT01614886|76144489|FG001|Safety Population (SAF)|Overall Study||108||
60028657|NCT01614886|76144488|FG000|Full Analysis Set (FAS)|Overall Study||104||
60028658|NCT01614886|76144489|FG001|Full Analysis Set (FAS)|Overall Study||105||
60028659|NCT01614886|76144488|FG000|COMPLETED|Overall Study||87||
60028660|NCT01614886|76144489|FG001|COMPLETED|Overall Study||83||
60028661|NCT01614886|76144488|FG000|NOT COMPLETED|Overall Study||20||
60028662|NCT01614886|76144489|FG001|NOT COMPLETED|Overall Study||26||
60028663|NCT01880554|76144495|FG000|STARTED|Overall Study|Patients enrolled in the study|68||
60028664|NCT01880554|76144495|FG000|Population Eligible|Overall Study||58||
60028665|NCT01880554|76144495|FG000|Population Eligible and Assessable|Overall Study||54||
60028666|NCT01880554|76144495|FG000|COMPLETED|Overall Study|Patients eligible and assessable according to two-stage Simon's design (primary outcome)|52||
60028667|NCT01880554|76144495|FG000|NOT COMPLETED|Overall Study||16||
60028668|NCT02100657|76144503|FG000|STARTED|Cohort 1: Dose Level 1||8||
60028669|NCT02100657|76144504|FG001|STARTED|Cohort 1: Dose Level 1||0||
60028670|NCT02100657|76144505|FG002|STARTED|Cohort 1: Dose Level 1||0||
60028671|NCT02100657|76144503|FG000|COMPLETED|Cohort 1: Dose Level 1||0||
60028672|NCT02100657|76144504|FG001|COMPLETED|Cohort 1: Dose Level 1||0||
60028673|NCT02100657|76144505|FG002|COMPLETED|Cohort 1: Dose Level 1||0||
60028674|NCT02100657|76144503|FG000|NOT COMPLETED|Cohort 1: Dose Level 1||8||
60028675|NCT02100657|76144504|FG001|NOT COMPLETED|Cohort 1: Dose Level 1||0||
60028676|NCT02100657|76144505|FG002|NOT COMPLETED|Cohort 1: Dose Level 1||0||
60028677|NCT02100657|76144503|FG000|STARTED|Cohort 2: Dose Level 2||0||
60028678|NCT02100657|76144504|FG001|STARTED|Cohort 2: Dose Level 2||4||
60028679|NCT02100657|76144505|FG002|STARTED|Cohort 2: Dose Level 2||0||
60028680|NCT02100657|76144503|FG000|COMPLETED|Cohort 2: Dose Level 2||0||
60028681|NCT02100657|76144504|FG001|COMPLETED|Cohort 2: Dose Level 2||0||
60028682|NCT02100657|76144505|FG002|COMPLETED|Cohort 2: Dose Level 2||0||
60028683|NCT02100657|76144503|FG000|NOT COMPLETED|Cohort 2: Dose Level 2||0||
60028684|NCT02100657|76144504|FG001|NOT COMPLETED|Cohort 2: Dose Level 2||4||
60028685|NCT02100657|76144505|FG002|NOT COMPLETED|Cohort 2: Dose Level 2||0||
60028686|NCT02100657|76144503|FG000|STARTED|Cohort 3: Dose Level 3||0||
60028687|NCT02100657|76144504|FG001|STARTED|Cohort 3: Dose Level 3||0||
60028688|NCT02100657|76144505|FG002|STARTED|Cohort 3: Dose Level 3||27||
60028689|NCT02100657|76144503|FG000|COMPLETED|Cohort 3: Dose Level 3||0||
60028690|NCT02100657|76144504|FG001|COMPLETED|Cohort 3: Dose Level 3||0||
60028691|NCT02100657|76144505|FG002|COMPLETED|Cohort 3: Dose Level 3||0||
60028692|NCT02100657|76144503|FG000|NOT COMPLETED|Cohort 3: Dose Level 3||0||
60028693|NCT02100657|76144504|FG001|NOT COMPLETED|Cohort 3: Dose Level 3||0||
60028694|NCT02100657|76144505|FG002|NOT COMPLETED|Cohort 3: Dose Level 3||27||
60028695|NCT02067663|76144516|FG000|STARTED|Overall Study||68||
60028696|NCT02067663|76144517|FG001|STARTED|Overall Study||55||
60028697|NCT02067663|76144516|FG000|COMPLETED|Overall Study||55||
60028698|NCT02067663|76144517|FG001|COMPLETED|Overall Study||41||
60028699|NCT02067663|76144516|FG000|NOT COMPLETED|Overall Study||13||
60028700|NCT02067663|76144517|FG001|NOT COMPLETED|Overall Study||14||
60028701|NCT01909804|76144535|FG000|STARTED|Overall Study||26||
60028702|NCT01909804|76144536|FG001|STARTED|Overall Study||28||
60028703|NCT01909804|76144537|FG002|STARTED|Overall Study||27||
60028704|NCT01909804|76144538|FG003|STARTED|Overall Study||26||
60028705|NCT01909804|76144539|FG004|STARTED|Overall Study||26||
60028706|NCT01909804|76144540|FG005|STARTED|Overall Study||25||
60028707|NCT01909804|76144541|FG006|STARTED|Overall Study||27||
60028708|NCT01909804|76144542|FG007|STARTED|Overall Study||26||
60028709|NCT01909804|76144543|FG008|STARTED|Overall Study||27||
60028710|NCT01909804|76144544|FG009|STARTED|Overall Study||29||
60028711|NCT01909804|76144545|FG010|STARTED|Overall Study||27||
60028712|NCT01909804|76144546|FG011|STARTED|Overall Study||29||
60028713|NCT01909804|76144535|FG000|COMPLETED|Overall Study||22||
60028714|NCT01909804|76144536|FG001|COMPLETED|Overall Study||27||
59915879|NCT03131895|76036810|FG003|NOT COMPLETED|Intervention Period 1 (2 Days)||0||
59915880|NCT03131895|76036807|FG000|STARTED|Washout Period (at Least 5 Days)||28||
59915881|NCT03131895|76036808|FG001|STARTED|Washout Period (at Least 5 Days)||28||
59915882|NCT03131895|76036809|FG002|STARTED|Washout Period (at Least 5 Days)||30||
59915883|NCT03131895|76036810|FG003|STARTED|Washout Period (at Least 5 Days)||30||
59915884|NCT03131895|76036807|FG000|COMPLETED|Washout Period (at Least 5 Days)||27||
60028715|NCT01909804|76144537|FG002|COMPLETED|Overall Study||27||
60028716|NCT01909804|76144538|FG003|COMPLETED|Overall Study||26||
59915885|NCT03131895|76036808|FG001|COMPLETED|Washout Period (at Least 5 Days)||23||
59915886|NCT03131895|76036809|FG002|COMPLETED|Washout Period (at Least 5 Days)||26||
59915887|NCT03131895|76036810|FG003|COMPLETED|Washout Period (at Least 5 Days)||25||
59915888|NCT03131895|76036807|FG000|NOT COMPLETED|Washout Period (at Least 5 Days)||1||
59915889|NCT03131895|76036808|FG001|NOT COMPLETED|Washout Period (at Least 5 Days)||5||
59915890|NCT03131895|76036809|FG002|NOT COMPLETED|Washout Period (at Least 5 Days)||4||
59915891|NCT03131895|76036810|FG003|NOT COMPLETED|Washout Period (at Least 5 Days)||5||
59915892|NCT03131895|76036807|FG000|STARTED|Intervention Period 2 (2 Days)||27||
59915893|NCT03131895|76036808|FG001|STARTED|Intervention Period 2 (2 Days)||23||
59915894|NCT03131895|76036809|FG002|STARTED|Intervention Period 2 (2 Days)||26||
59915895|NCT03131895|76036810|FG003|STARTED|Intervention Period 2 (2 Days)||25||
60028717|NCT01909804|76144539|FG004|COMPLETED|Overall Study||18||
60028718|NCT01909804|76144540|FG005|COMPLETED|Overall Study||21||
60028719|NCT01909804|76144541|FG006|COMPLETED|Overall Study||25||
60028720|NCT01909804|76144542|FG007|COMPLETED|Overall Study||25||
60028721|NCT01909804|76144543|FG008|COMPLETED|Overall Study||27||
60028722|NCT01909804|76144544|FG009|COMPLETED|Overall Study||28||
60028723|NCT01909804|76144545|FG010|COMPLETED|Overall Study||26||
60028724|NCT01909804|76144546|FG011|COMPLETED|Overall Study||26||
60028725|NCT01909804|76144535|FG000|NOT COMPLETED|Overall Study||4||
60028726|NCT01909804|76144536|FG001|NOT COMPLETED|Overall Study||1||
59915896|NCT03131895|76036807|FG000|COMPLETED|Intervention Period 2 (2 Days)||26||
60028727|NCT01909804|76144537|FG002|NOT COMPLETED|Overall Study||0||
60028728|NCT01909804|76144538|FG003|NOT COMPLETED|Overall Study||0||
60028729|NCT01909804|76144539|FG004|NOT COMPLETED|Overall Study||8||
60028730|NCT01909804|76144540|FG005|NOT COMPLETED|Overall Study||4||
60028731|NCT01909804|76144541|FG006|NOT COMPLETED|Overall Study||2||
60028732|NCT01909804|76144542|FG007|NOT COMPLETED|Overall Study||1||
60028733|NCT01909804|76144543|FG008|NOT COMPLETED|Overall Study||0||
60028734|NCT01909804|76144544|FG009|NOT COMPLETED|Overall Study||1||
60028735|NCT01909804|76144545|FG010|NOT COMPLETED|Overall Study||1||
60028736|NCT01909804|76144546|FG011|NOT COMPLETED|Overall Study||3||
60028737|NCT01880086|76144570|FG000|STARTED|Overall Study||6||
59915897|NCT03131895|76036808|FG001|COMPLETED|Intervention Period 2 (2 Days)||22||
59915898|NCT03131895|76036809|FG002|COMPLETED|Intervention Period 2 (2 Days)||26||
59915899|NCT03131895|76036810|FG003|COMPLETED|Intervention Period 2 (2 Days)||25||
59915900|NCT03131895|76036807|FG000|NOT COMPLETED|Intervention Period 2 (2 Days)||1||
59915901|NCT03131895|76036808|FG001|NOT COMPLETED|Intervention Period 2 (2 Days)||1||
59915902|NCT03131895|76036809|FG002|NOT COMPLETED|Intervention Period 2 (2 Days)||0||
59915903|NCT03131895|76036810|FG003|NOT COMPLETED|Intervention Period 2 (2 Days)||0||
59915904|NCT04039919|76036825|FG000|STARTED|Treatment Period 1||7||
59915905|NCT04039919|76036826|FG001|STARTED|Treatment Period 1||6||
59915906|NCT04039919|76036827|FG002|STARTED|Treatment Period 1||5||
59915907|NCT04039919|76036828|FG003|STARTED|Treatment Period 1||6||
59915908|NCT04039919|76036829|FG004|STARTED|Treatment Period 1||16||
59915909|NCT04039919|76036825|FG000|COMPLETED|Treatment Period 1||6||
59915910|NCT04039919|76036826|FG001|COMPLETED|Treatment Period 1||6||
59915911|NCT04039919|76036827|FG002|COMPLETED|Treatment Period 1||5||
59915912|NCT04039919|76036828|FG003|COMPLETED|Treatment Period 1||6||
59915913|NCT04039919|76036829|FG004|COMPLETED|Treatment Period 1||0||
59915914|NCT04039919|76036825|FG000|NOT COMPLETED|Treatment Period 1||1||
59915915|NCT04039919|76036826|FG001|NOT COMPLETED|Treatment Period 1||0||
59915916|NCT04039919|76036827|FG002|NOT COMPLETED|Treatment Period 1||0||
59915917|NCT04039919|76036828|FG003|NOT COMPLETED|Treatment Period 1||0||
59915918|NCT04039919|76036829|FG004|NOT COMPLETED|Treatment Period 1||16||
59915919|NCT04039919|76036825|FG000|STARTED|Treatment Period 2||6||
59915920|NCT04039919|76036826|FG001|STARTED|Treatment Period 2||6||
59915921|NCT04039919|76036827|FG002|STARTED|Treatment Period 2||5||
59915922|NCT04039919|76036828|FG003|STARTED|Treatment Period 2||6||
59915923|NCT04039919|76036829|FG004|STARTED|Treatment Period 2||0||
59915924|NCT04039919|76036825|FG000|COMPLETED|Treatment Period 2||6||
59915925|NCT04039919|76036826|FG001|COMPLETED|Treatment Period 2||6||
59915926|NCT04039919|76036827|FG002|COMPLETED|Treatment Period 2||5||
59915927|NCT04039919|76036828|FG003|COMPLETED|Treatment Period 2||6||
59915928|NCT04039919|76036829|FG004|COMPLETED|Treatment Period 2||0||
59915929|NCT04039919|76036825|FG000|NOT COMPLETED|Treatment Period 2||0||
59915930|NCT04039919|76036826|FG001|NOT COMPLETED|Treatment Period 2||0||
59915931|NCT04039919|76036827|FG002|NOT COMPLETED|Treatment Period 2||0||
59915932|NCT04039919|76036828|FG003|NOT COMPLETED|Treatment Period 2||0||
59915933|NCT04039919|76036829|FG004|NOT COMPLETED|Treatment Period 2||0||
60028738|NCT01880086|76144571|FG001|STARTED|Overall Study||7||
59507430|NCT02016885|75600691|FG000|NOT COMPLETED|Overall Study||4||
59507431|NCT02016885|75600692|FG001|NOT COMPLETED|Overall Study||4||
59507432|NCT02016885|75600693|FG002|NOT COMPLETED|Overall Study||1||
59507433|NCT02016885|75600694|FG003|NOT COMPLETED|Overall Study||10||
59507434|NCT02016885|75600695|FG004|NOT COMPLETED|Overall Study||1||
59507435|NCT00802633|75600709|FG000|STARTED|Overall Study||40||
59507436|NCT00802633|75600710|FG001|STARTED|Overall Study||40||
59507437|NCT00802633|75600709|FG000|COMPLETED|Overall Study||40||
59507438|NCT00802633|75600710|FG001|COMPLETED|Overall Study||40||
59507439|NCT00802633|75600709|FG000|NOT COMPLETED|Overall Study||0||
59507440|NCT00802633|75600710|FG001|NOT COMPLETED|Overall Study||0||
59507441|NCT02016963|75600716|FG000|STARTED|Overall Study||20||
59507442|NCT02016963|75600716|FG000|COMPLETED|Overall Study||20||
59507443|NCT02016963|75600716|FG000|NOT COMPLETED|Overall Study||0||
59507444|NCT02018445|75600721|FG000|STARTED|Overall Study||36||
59507445|NCT02018445|75600721|FG000|COMPLETED|Overall Study||29||
59507446|NCT02018445|75600721|FG000|NOT COMPLETED|Overall Study||7||
59507447|NCT02342379|75600728|FG000|STARTED|Overall Study||35||
59507448|NCT02342379|75600728|FG000|COMPLETED|Overall Study||35||
59507449|NCT02342379|75600728|FG000|NOT COMPLETED|Overall Study||0||
59507450|NCT02019069|75600732|FG000|STARTED|Overall Study||11||
59507451|NCT02019069|75600732|FG000|COMPLETED|Overall Study||11||
59507452|NCT02019069|75600732|FG000|NOT COMPLETED|Overall Study||0||
59507453|NCT00821821|75600739|FG000|STARTED|Overall Study||12||
59507454|NCT00821821|75600740|FG001|STARTED|Overall Study||13||
59507455|NCT00821821|75600741|FG002|STARTED|Overall Study||11||
59507456|NCT00821821|75600739|FG000|COMPLETED|Overall Study||12||
59507457|NCT00821821|75600740|FG001|COMPLETED|Overall Study||13||
59507458|NCT00821821|75600741|FG002|COMPLETED|Overall Study||11||
59915934|NCT04039919|76036825|FG000|STARTED|Treatment Period 3||6||
59915935|NCT04039919|76036826|FG001|STARTED|Treatment Period 3||6||
59915936|NCT04039919|76036827|FG002|STARTED|Treatment Period 3||5||
59915937|NCT04039919|76036828|FG003|STARTED|Treatment Period 3||6||
59915938|NCT04039919|76036829|FG004|STARTED|Treatment Period 3||0||
59915939|NCT04039919|76036825|FG000|COMPLETED|Treatment Period 3||6||
60028739|NCT01880086|76144570|FG000|COMPLETED|Overall Study||5||
59507459|NCT00821821|75600739|FG000|NOT COMPLETED|Overall Study||0||
59507460|NCT00821821|75600740|FG001|NOT COMPLETED|Overall Study||0||
59507461|NCT00821821|75600741|FG002|NOT COMPLETED|Overall Study||0||
59507462|NCT02409459|75600753|FG000|STARTED|Overall Study||41||
59507463|NCT02409459|75600754|FG001|STARTED|Overall Study||40||
59507464|NCT02409459|75600753|FG000|COMPLETED|Overall Study||40||
59507465|NCT02409459|75600754|FG001|COMPLETED|Overall Study||39||
59507466|NCT02409459|75600753|FG000|NOT COMPLETED|Overall Study||1||
60028740|NCT01880086|76144571|FG001|COMPLETED|Overall Study||6||
60028741|NCT01880086|76144570|FG000|NOT COMPLETED|Overall Study||1||
60028742|NCT01880086|76144571|FG001|NOT COMPLETED|Overall Study||1||
60028743|NCT01879852|76144579|FG000|STARTED|Overall Study||14||
60028744|NCT01879852|76144580|FG001|STARTED|Overall Study||13||
60028745|NCT01879852|76144579|FG000|COMPLETED|Overall Study||12||
60028746|NCT01879852|76144580|FG001|COMPLETED|Overall Study||13||
60028747|NCT01879852|76144579|FG000|NOT COMPLETED|Overall Study||2||
60028748|NCT01879852|76144580|FG001|NOT COMPLETED|Overall Study||0||
60028749|NCT01879618|76144586|FG000|STARTED|Overall Study||152||
60028750|NCT01879618|76144586|FG000|COMPLETED|Overall Study||131||
60028751|NCT01879618|76144586|FG000|NOT COMPLETED|Overall Study||21||
60028752|NCT01926886|76144590|FG000|STARTED|Overall Study||102||
60028753|NCT01926886|76144591|FG001|STARTED|Overall Study|HCPs were not enrolled in the study. No baseline data were collected for these participants.|21||
60028754|NCT01926886|76144590|FG000|Received at Least 1 Dose of Study Drug|Overall Study||101||
60028755|NCT01926886|76144591|FG001|Received at Least 1 Dose of Study Drug|Overall Study|Partcipants were HCPs included for polling purposes. HCPs were not enrolled in the study.|0||
60028756|NCT01926886|76144590|FG000|COMPLETED|Overall Study||70||
60028757|NCT01926886|76144591|FG001|COMPLETED|Overall Study|Partcipants were HCPs included for polling purposes. HCPs were not enrolled in the study.|21||
60028758|NCT01926886|76144590|FG000|NOT COMPLETED|Overall Study||32||
60028759|NCT01926886|76144591|FG001|NOT COMPLETED|Overall Study||0||
60028760|NCT01909336|76144600|FG000|STARTED|Overall Study||53||
60028761|NCT01909336|76144601|FG001|STARTED|Overall Study||53||
60028762|NCT01909336|76144602|FG002|STARTED|Overall Study||55||
60028763|NCT01909336|76144600|FG000|COMPLETED|Overall Study||49||
60028764|NCT01909336|76144601|FG001|COMPLETED|Overall Study||50||
60028765|NCT01909336|76144602|FG002|COMPLETED|Overall Study||52||
60028766|NCT01909336|76144600|FG000|NOT COMPLETED|Overall Study||4||
60028767|NCT01909336|76144601|FG001|NOT COMPLETED|Overall Study||3||
60028768|NCT01909336|76144602|FG002|NOT COMPLETED|Overall Study||3||
60028769|NCT01926028|76144613|FG000|STARTED|Overall Study||85||
60028770|NCT01926028|76144614|FG001|STARTED|Overall Study||89||
60028771|NCT01926028|76144615|FG002|STARTED|Overall Study||14||
60028772|NCT01926028|76144613|FG000|COMPLETED|Overall Study||64||
60028773|NCT01926028|76144614|FG001|COMPLETED|Overall Study||67||
60028774|NCT01926028|76144615|FG002|COMPLETED|Overall Study||12||
60028775|NCT01926028|76144613|FG000|NOT COMPLETED|Overall Study||21||
60028776|NCT01926028|76144614|FG001|NOT COMPLETED|Overall Study||22||
60028777|NCT01926028|76144615|FG002|NOT COMPLETED|Overall Study||2||
60028778|NCT01925950|76144626|FG000|STARTED|Part 1||1||
60028779|NCT01925950|76144627|FG001|STARTED|Part 1||1||
60028780|NCT01925950|76144626|FG000|COMPLETED|Part 1||1||
60028781|NCT01925950|76144627|FG001|COMPLETED|Part 1||1||
60028782|NCT01925950|76144626|FG000|NOT COMPLETED|Part 1||0||
60028783|NCT01925950|76144627|FG001|NOT COMPLETED|Part 1||0||
60028784|NCT01925950|76144626|FG000|STARTED|Part 2||1||
60028785|NCT01925950|76144627|FG001|STARTED|Part 2|The 1 orBec subject completed Part 1 but did not meet the criteria of a CR to continue to Part 2|0||
59611792|NCT01731678|75722790|FG000|NOT COMPLETED|Overall Study||7||
59611793|NCT01731600|75722796|FG000|STARTED|Overall Study||34||
60028786|NCT01925950|76144626|FG000|COMPLETED|Part 2||0||
60028787|NCT01925950|76144627|FG001|COMPLETED|Part 2||0||
60028788|NCT01925950|76144626|FG000|NOT COMPLETED|Part 2||1||
60028789|NCT01925950|76144627|FG001|NOT COMPLETED|Part 2||0||
60028790|NCT01878292|76144636|FG000|STARTED|Randomized||174||
60028791|NCT01878292|76144637|FG001|STARTED|Randomized||175||
60028792|NCT01878292|76144638|FG002|STARTED|Randomized||180||
60028793|NCT01878292|76144636|FG000|COMPLETED|Randomized||171||
59611794|NCT01731600|75722797|FG001|STARTED|Overall Study||34||
59611795|NCT01731600|75722796|FG000|COMPLETED|Overall Study||28||
59611796|NCT01731600|75722797|FG001|COMPLETED|Overall Study||34||
60028794|NCT01878292|76144637|FG001|COMPLETED|Randomized||175||
60028795|NCT01878292|76144638|FG002|COMPLETED|Randomized||180||
60028796|NCT01878292|76144636|FG000|NOT COMPLETED|Randomized||3||
60028797|NCT01878292|76144637|FG001|NOT COMPLETED|Randomized||0||
60028798|NCT01878292|76144638|FG002|NOT COMPLETED|Randomized||0||
59611797|NCT01731600|75722796|FG000|NOT COMPLETED|Overall Study||6||
60028799|NCT01878292|76144636|FG000|STARTED|Double-blind Treatment Period||171||
59611798|NCT01731600|75722797|FG001|NOT COMPLETED|Overall Study||0||
60028800|NCT01878292|76144637|FG001|STARTED|Double-blind Treatment Period||175||
60028801|NCT01878292|76144638|FG002|STARTED|Double-blind Treatment Period||180||
60028802|NCT01878292|76144636|FG000|COMPLETED|Double-blind Treatment Period||142||
60028803|NCT01878292|76144637|FG001|COMPLETED|Double-blind Treatment Period||149||
60028804|NCT01878292|76144638|FG002|COMPLETED|Double-blind Treatment Period||161||
60067790|NCT01973569|76182982|FG001|Discontinued Study|Overall Study||22||
60067791|NCT01973569|76182983|FG002|Discontinued Study|Overall Study||15||
60067792|NCT01973569|76182981|FG000|COMPLETED|Overall Study||199||
60028805|NCT01878292|76144636|FG000|NOT COMPLETED|Double-blind Treatment Period||29||
60028806|NCT01878292|76144637|FG001|NOT COMPLETED|Double-blind Treatment Period||26||
60028807|NCT01878292|76144638|FG002|NOT COMPLETED|Double-blind Treatment Period||19||
60028808|NCT01878292|76144636|FG000|STARTED|Double-blind Down-Taper Period||127||
60028809|NCT01878292|76144637|FG001|STARTED|Double-blind Down-Taper Period||140||
60028810|NCT01878292|76144638|FG002|STARTED|Double-blind Down-Taper Period||146||
60028811|NCT01878292|76144636|FG000|COMPLETED|Double-blind Down-Taper Period||122||
60028812|NCT01878292|76144637|FG001|COMPLETED|Double-blind Down-Taper Period||132||
60028813|NCT01878292|76144638|FG002|COMPLETED|Double-blind Down-Taper Period||142||
60028814|NCT01878292|76144636|FG000|NOT COMPLETED|Double-blind Down-Taper Period||5||
60028815|NCT01878292|76144637|FG001|NOT COMPLETED|Double-blind Down-Taper Period||8||
60028816|NCT01878292|76144638|FG002|NOT COMPLETED|Double-blind Down-Taper Period||4||
60028817|NCT01908634|76144646|FG000|STARTED|Milk-based Strawberry Beverage With Meal||10||
60028818|NCT01908634|76144646|FG000|COMPLETED|Milk-based Strawberry Beverage With Meal||10|cross over design|
60028819|NCT01908634|76144646|FG000|NOT COMPLETED|Milk-based Strawberry Beverage With Meal||0||
60028820|NCT01908634|76144646|FG000|STARTED|Water-based Strawberry Beverage Wit Meal||10||
60028821|NCT01908634|76144646|FG000|COMPLETED|Water-based Strawberry Beverage Wit Meal||9||
60028822|NCT01908634|76144646|FG000|NOT COMPLETED|Water-based Strawberry Beverage Wit Meal||1||
60028823|NCT01908634|76144646|FG000|STARTED|Milk-based Strawberry Beverage w/o Meal||9||
60028824|NCT01908634|76144646|FG000|COMPLETED|Milk-based Strawberry Beverage w/o Meal||4||
59507467|NCT02409459|75600754|FG001|NOT COMPLETED|Overall Study||1||
59507468|NCT02409927|75600760|FG000|STARTED|Overall Study||10||
60028825|NCT01908634|76144646|FG000|NOT COMPLETED|Milk-based Strawberry Beverage w/o Meal||5||
60028826|NCT01908634|76144646|FG000|STARTED|Water-based Strawberry Beverage w/o Meal||4||
60028827|NCT01908634|76144646|FG000|COMPLETED|Water-based Strawberry Beverage w/o Meal||4||
60028828|NCT01908634|76144646|FG000|NOT COMPLETED|Water-based Strawberry Beverage w/o Meal||0||
60028829|NCT01878214|76144656|FG000|STARTED|Overall Study||223||
60028830|NCT01878214|76144657|FG001|STARTED|Overall Study||219||
60028831|NCT01878214|76144656|FG000|COMPLETED|Overall Study||170||
60028832|NCT01878214|76144657|FG001|COMPLETED|Overall Study||175||
60028833|NCT01878214|76144656|FG000|NOT COMPLETED|Overall Study||53||
60028834|NCT01878214|76144657|FG001|NOT COMPLETED|Overall Study||44||
60028835|NCT01907854|76144665|FG000|STARTED|Overall Study||203||
60028836|NCT01907854|76144666|FG001|STARTED|Overall Study||204||
60028837|NCT01907854|76144665|FG000|Exposed|Overall Study|One subject in lira arm was not exposed (Reason: withdrawal by subject)|202||
60028838|NCT01907854|76144666|FG001|Exposed|Overall Study||204||
60028839|NCT01907854|76144665|FG000|COMPLETED|Overall Study||187||
60028840|NCT01907854|76144666|FG001|COMPLETED|Overall Study||191||
60028841|NCT01907854|76144665|FG000|NOT COMPLETED|Overall Study||16||
60028842|NCT01907854|76144666|FG001|NOT COMPLETED|Overall Study||13||
60028843|NCT02480153|76144674|FG000|STARTED|Period 1: First Dose to Week 26 Pre-dose||297||
60028844|NCT02480153|76144675|FG001|STARTED|Period 1: First Dose to Week 26 Pre-dose||300||
60028845|NCT02480153|76144676|FG002|STARTED|Period 1: First Dose to Week 26 Pre-dose||0||
60028846|NCT02480153|76144674|FG000|Received Treatment|Period 1: First Dose to Week 26 Pre-dose||297||
60028847|NCT02480153|76144675|FG001|Received Treatment|Period 1: First Dose to Week 26 Pre-dose||299||
60028848|NCT02480153|76144676|FG002|Received Treatment|Period 1: First Dose to Week 26 Pre-dose||0||
60028849|NCT02480153|76144674|FG000|COMPLETED|Period 1: First Dose to Week 26 Pre-dose||293||
60028850|NCT02480153|76144675|FG001|COMPLETED|Period 1: First Dose to Week 26 Pre-dose||284||
60028851|NCT02480153|76144676|FG002|COMPLETED|Period 1: First Dose to Week 26 Pre-dose||0||
60028852|NCT02480153|76144674|FG000|NOT COMPLETED|Period 1: First Dose to Week 26 Pre-dose||4||
60028853|NCT02480153|76144675|FG001|NOT COMPLETED|Period 1: First Dose to Week 26 Pre-dose||16||
60028854|NCT02480153|76144676|FG002|NOT COMPLETED|Period 1: First Dose to Week 26 Pre-dose||0||
60028855|NCT02480153|76144674|FG000|STARTED|Period 2: Week 26 to Week 52 Pre-dose||283||
60028856|NCT02480153|76144675|FG001|STARTED|Period 2: Week 26 to Week 52 Pre-dose||135||
60028857|NCT02480153|76144676|FG002|STARTED|Period 2: Week 26 to Week 52 Pre-dose||134||
60028858|NCT02480153|76144674|FG000|Received Treatment|Period 2: Week 26 to Week 52 Pre-dose||283||
60028859|NCT02480153|76144675|FG001|Received Treatment|Period 2: Week 26 to Week 52 Pre-dose||135||
60028860|NCT02480153|76144676|FG002|Received Treatment|Period 2: Week 26 to Week 52 Pre-dose||133||
60028861|NCT02480153|76144674|FG000|COMPLETED|Period 2: Week 26 to Week 52 Pre-dose||263||
60028862|NCT02480153|76144675|FG001|COMPLETED|Period 2: Week 26 to Week 52 Pre-dose||122||
60028863|NCT02480153|76144676|FG002|COMPLETED|Period 2: Week 26 to Week 52 Pre-dose||127||
60028864|NCT02480153|76144674|FG000|NOT COMPLETED|Period 2: Week 26 to Week 52 Pre-dose||20||
60028865|NCT02480153|76144675|FG001|NOT COMPLETED|Period 2: Week 26 to Week 52 Pre-dose||13||
60028866|NCT02480153|76144676|FG002|NOT COMPLETED|Period 2: Week 26 to Week 52 Pre-dose||7||
60028867|NCT02480153|76144674|FG000|STARTED|Period 3: Week 52 Dosing to Week 78||259||
59507469|NCT02409927|75600760|FG000|COMPLETED|Overall Study||10||
60028868|NCT02480153|76144675|FG001|STARTED|Period 3: Week 52 Dosing to Week 78||121||
60028869|NCT02480153|76144676|FG002|STARTED|Period 3: Week 52 Dosing to Week 78||127||
60028870|NCT02480153|76144674|FG000|Received Treatment|Period 3: Week 52 Dosing to Week 78||258||
60028871|NCT02480153|76144675|FG001|Received Treatment|Period 3: Week 52 Dosing to Week 78||120||
59507470|NCT02409927|75600760|FG000|NOT COMPLETED|Overall Study||0||
60028872|NCT02480153|76144676|FG002|Received Treatment|Period 3: Week 52 Dosing to Week 78||127||
60028873|NCT02480153|76144674|FG000|COMPLETED|Period 3: Week 52 Dosing to Week 78||252||
60028874|NCT02480153|76144675|FG001|COMPLETED|Period 3: Week 52 Dosing to Week 78||118||
60028875|NCT02480153|76144676|FG002|COMPLETED|Period 3: Week 52 Dosing to Week 78||123||
60028876|NCT02480153|76144674|FG000|NOT COMPLETED|Period 3: Week 52 Dosing to Week 78||7||
60028877|NCT02480153|76144675|FG001|NOT COMPLETED|Period 3: Week 52 Dosing to Week 78||3||
60028878|NCT02480153|76144676|FG002|NOT COMPLETED|Period 3: Week 52 Dosing to Week 78||4||
60028879|NCT02500979|76144701|FG000|STARTED|Period 1||16|(Randomized Analysis Set)|
60028880|NCT02500979|76144702|FG001|STARTED|Period 1||17|(Randomized Analysis Set)|
60028881|NCT02500979|76144701|FG000|COMPLETED|Period 1||12|Number of subjects that entered Period 2|
60028882|NCT02500979|76144702|FG001|COMPLETED|Period 1||16|Number of subjects that entered Period 2|
60028883|NCT02500979|76144701|FG000|NOT COMPLETED|Period 1||4||
60028884|NCT02500979|76144702|FG001|NOT COMPLETED|Period 1||1||
60028885|NCT02500979|76144701|FG000|STARTED|Period 2||12|(Randomized Analysis Set)|
60028886|NCT02500979|76144702|FG001|STARTED|Period 2||16|(Randomized Analysis Set)|
60028887|NCT02500979|76144701|FG000|COMPLETED|Period 2||11|Completed Period 2|
60028888|NCT02500979|76144702|FG001|COMPLETED|Period 2||16|Completed Period 2|
60028889|NCT02500979|76144701|FG000|NOT COMPLETED|Period 2||1||
60028890|NCT02500979|76144702|FG001|NOT COMPLETED|Period 2||0||
60028891|NCT02500901|76144708|FG000|STARTED|Overall Study||2||
60028892|NCT02500901|76144708|FG000|COMPLETED|Overall Study||0||
60028893|NCT02500901|76144708|FG000|NOT COMPLETED|Overall Study||2||
60028894|NCT02479139|76144718|FG000|STARTED|Overall Study||27||
60028895|NCT02479139|76144719|FG001|STARTED|Overall Study||22||
60028896|NCT02479139|76144720|FG002|STARTED|Overall Study||28||
60028897|NCT02479139|76144721|FG003|STARTED|Overall Study||21||
60028898|NCT02479139|76144722|FG004|STARTED|Overall Study||22||
60028899|NCT02479139|76144723|FG005|STARTED|Overall Study||25||
60028900|NCT02479139|76144718|FG000|COMPLETED|Overall Study||19||
60028901|NCT02479139|76144719|FG001|COMPLETED|Overall Study||12||
60028902|NCT02479139|76144720|FG002|COMPLETED|Overall Study||21||
60028903|NCT02479139|76144721|FG003|COMPLETED|Overall Study||14||
60028904|NCT02479139|76144722|FG004|COMPLETED|Overall Study||17||
60028905|NCT02479139|76144723|FG005|COMPLETED|Overall Study||19||
60028906|NCT02479139|76144718|FG000|NOT COMPLETED|Overall Study||8||
60028907|NCT02479139|76144719|FG001|NOT COMPLETED|Overall Study||10||
60028908|NCT02479139|76144720|FG002|NOT COMPLETED|Overall Study||7||
60028909|NCT02479139|76144721|FG003|NOT COMPLETED|Overall Study||7||
60028910|NCT02479139|76144722|FG004|NOT COMPLETED|Overall Study||5||
60028911|NCT02479139|76144723|FG005|NOT COMPLETED|Overall Study||6||
60028912|NCT02478359|76144739|FG000|STARTED|Overall Study||1349||
60028913|NCT02478359|76144740|FG001|STARTED|Overall Study||1358||
60028914|NCT02478359|76144739|FG000|Intention-to-treat Population Month 12|Overall Study|Disenrolled from health plan: 106|1243||
60028915|NCT02478359|76144740|FG001|Intention-to-treat Population Month 12|Overall Study|Disenrolled from health plan: 65|1293||
60028916|NCT02478359|76144739|FG000|COMPLETED|Overall Study||1243||
60028917|NCT02478359|76144740|FG001|COMPLETED|Overall Study||1293||
60028918|NCT02478359|76144739|FG000|NOT COMPLETED|Overall Study||106||
60028919|NCT02478359|76144740|FG001|NOT COMPLETED|Overall Study||65||
60028920|NCT01877668|76144753|FG000|STARTED|Overall Study|Received treatment|107||
60028921|NCT01877668|76144754|FG001|STARTED|Overall Study|Received treatment|104||
60028922|NCT01877668|76144755|FG002|STARTED|Overall Study|Received treatment|106||
60028923|NCT01877668|76144756|FG003|STARTED|Overall Study|Received treatment|52||
60028924|NCT01877668|76144757|FG004|STARTED|Overall Study|Received treatment|53||
60028925|NCT01877668|76144753|FG000|COMPLETED|Overall Study||96||
60028926|NCT01877668|76144754|FG001|COMPLETED|Overall Study||96||
60028927|NCT01877668|76144755|FG002|COMPLETED|Overall Study||94||
60028928|NCT01877668|76144756|FG003|COMPLETED|Overall Study||44||
60028929|NCT01877668|76144757|FG004|COMPLETED|Overall Study||43||
60028930|NCT01877668|76144753|FG000|NOT COMPLETED|Overall Study||11||
60028931|NCT01877668|76144754|FG001|NOT COMPLETED|Overall Study||8||
60028932|NCT01877668|76144755|FG002|NOT COMPLETED|Overall Study||12||
60028933|NCT01877668|76144756|FG003|NOT COMPLETED|Overall Study||8||
60028934|NCT01877668|76144757|FG004|NOT COMPLETED|Overall Study||10||
60028935|NCT01877278|76144775|FG000|STARTED|Overall Study||33||
60028936|NCT01877278|76144776|FG001|STARTED|Overall Study||33||
60028937|NCT01877278|76144775|FG000|COMPLETED|Overall Study||30||
60028938|NCT01877278|76144776|FG001|COMPLETED|Overall Study||30||
60028939|NCT01877278|76144775|FG000|NOT COMPLETED|Overall Study||3||
60028940|NCT01877278|76144776|FG001|NOT COMPLETED|Overall Study||3||
60028941|NCT01906372|76144782|FG000|STARTED|Overall Study||12||
60028942|NCT01906372|76144782|FG000|Visit 7: Treatment Phase Completed|Overall Study||10||
60028943|NCT01906372|76144782|FG000|Visit 10: Follow up Phase Completed|Overall Study||8||
60028944|NCT01906372|76144782|FG000|COMPLETED|Overall Study||10||
60028945|NCT01906372|76144782|FG000|NOT COMPLETED|Overall Study||2||
60028946|NCT01925170|76144787|FG000|STARTED|Overall Study||1638||
60028947|NCT01925170|76144787|FG000|COMPLETED|Overall Study||1585||
60028948|NCT01925170|76144787|FG000|NOT COMPLETED|Overall Study||53||
60028949|NCT01925014|76144795|FG000|STARTED|Overall Study||1535||
60028950|NCT01925014|76144796|FG001|STARTED|Overall Study||1539||
60028951|NCT01925014|76144795|FG000|COMPLETED|Overall Study||1526||
60028952|NCT01925014|76144796|FG001|COMPLETED|Overall Study||1520||
60028953|NCT01925014|76144795|FG000|NOT COMPLETED|Overall Study||9||
60028954|NCT01925014|76144796|FG001|NOT COMPLETED|Overall Study||19||
60028955|NCT01876810|76144802|FG000|STARTED|Overall Study||14||
60028956|NCT01876810|76144803|FG001|STARTED|Overall Study||14||
60028957|NCT01876810|76144802|FG000|COMPLETED|Overall Study||14||
60028958|NCT01876810|76144803|FG001|COMPLETED|Overall Study||13||
60028959|NCT01876810|76144802|FG000|NOT COMPLETED|Overall Study||0||
60028960|NCT01876810|76144803|FG001|NOT COMPLETED|Overall Study||1||
60028961|NCT01876732|76144812|FG000|STARTED|Overall Study||132||
60028962|NCT01876732|76144812|FG000|COMPLETED|Overall Study||57||
60028963|NCT01876732|76144812|FG000|NOT COMPLETED|Overall Study||75||
60028964|NCT01905592|76144819|FG000|STARTED|Overall Study||71|Based on centrally confirmed intent-to-treat population|
60028965|NCT01905592|76144820|FG001|STARTED|Overall Study||135|Based on centrally confirmed intent-to-treat population|
60028966|NCT01905592|76144819|FG000|COMPLETED|Overall Study||0|Based on centrally confirmed intent-to-treat population|
60028967|NCT01905592|76144820|FG001|COMPLETED|Overall Study||0|Based on centrally confirmed intent-to-treat population|
60028968|NCT01905592|76144819|FG000|NOT COMPLETED|Overall Study||71||
60028969|NCT01905592|76144820|FG001|NOT COMPLETED|Overall Study||135||
60028970|NCT01876420|76144826|FG000|STARTED|Overall Study||60||
60028971|NCT01876420|76144826|FG000|COMPLETED|Overall Study||59||
60028972|NCT01876420|76144826|FG000|NOT COMPLETED|Overall Study||1||
60028973|NCT01875874|76144830|FG000|STARTED|Overall Study||8||
60028974|NCT01875874|76144830|FG000|COMPLETED|Overall Study||5||
60028975|NCT01875874|76144830|FG000|NOT COMPLETED|Overall Study||3||
60028976|NCT02500121|76144837|FG000|STARTED|Overall Study||53||
60028977|NCT02500121|76144838|FG001|STARTED|Overall Study||55||
60028978|NCT02500121|76144837|FG000|Crossover to Pembrolizumab|Overall Study|Only subjects that progressed on the control arm were eligible to participate in the crossover portion of the trial.|27||
60028979|NCT02500121|76144838|FG001|Crossover to Pembrolizumab|Overall Study|Not applicable for the experimental arm.|0||
60028980|NCT02500121|76144837|FG000|COMPLETED|Overall Study||26|All subjects that|
60028981|NCT02500121|76144838|FG001|COMPLETED|Overall Study||29|All subjects that|
60028982|NCT02500121|76144837|FG000|NOT COMPLETED|Overall Study||27||
60028983|NCT02500121|76144838|FG001|NOT COMPLETED|Overall Study||26||
60028984|NCT01875250|76144848|FG000|STARTED|Overall Study||19||
60028985|NCT01875250|76144849|FG001|STARTED|Overall Study||19||
60028986|NCT01875250|76144848|FG000|COMPLETED|Overall Study||17||
60028987|NCT01875250|76144849|FG001|COMPLETED|Overall Study||19||
60028988|NCT01875250|76144848|FG000|NOT COMPLETED|Overall Study||2||
60028989|NCT01875250|76144849|FG001|NOT COMPLETED|Overall Study||0||
60028990|NCT01904032|76144859|FG000|STARTED|Overall Study||64||
60028991|NCT01904032|76144860|FG001|STARTED|Overall Study||65||
60028992|NCT01904032|76144859|FG000|COMPLETED|Overall Study||57||
60028993|NCT01904032|76144860|FG001|COMPLETED|Overall Study||62||
60028994|NCT01904032|76144859|FG000|NOT COMPLETED|Overall Study||7||
60028995|NCT01904032|76144860|FG001|NOT COMPLETED|Overall Study||3||
60028996|NCT01903876|76144868|FG000|STARTED|Baseline to Post-Intervention Period||367||
60028997|NCT01903876|76144869|FG001|STARTED|Baseline to Post-Intervention Period||376||
60028998|NCT01903876|76144868|FG000|COMPLETED|Baseline to Post-Intervention Period||183||
60028999|NCT01903876|76144869|FG001|COMPLETED|Baseline to Post-Intervention Period||268||
60029000|NCT01903876|76144868|FG000|NOT COMPLETED|Baseline to Post-Intervention Period||184||
60029001|NCT01903876|76144869|FG001|NOT COMPLETED|Baseline to Post-Intervention Period||108||
60029002|NCT01903876|76144868|FG000|STARTED|Six-Month Follow-up Period||183||
60029003|NCT01903876|76144869|FG001|STARTED|Six-Month Follow-up Period||268||
60029004|NCT01903876|76144868|FG000|COMPLETED|Six-Month Follow-up Period||92||
60029005|NCT01903876|76144869|FG001|COMPLETED|Six-Month Follow-up Period||123||
60029006|NCT01903876|76144868|FG000|NOT COMPLETED|Six-Month Follow-up Period||91||
60029007|NCT01903876|76144869|FG001|NOT COMPLETED|Six-Month Follow-up Period||145||
60029008|NCT01921348|76144877|FG000|STARTED|Overall Study||9||
60029009|NCT01921348|76144878|FG001|STARTED|Overall Study||9||
60029010|NCT01921348|76144877|FG000|COMPLETED|Overall Study||8||
60029011|NCT01921348|76144878|FG001|COMPLETED|Overall Study||7||
60029012|NCT01921348|76144877|FG000|NOT COMPLETED|Overall Study||1||
60029013|NCT01921348|76144878|FG001|NOT COMPLETED|Overall Study||2||
60029014|NCT01921270|76144884|FG000|STARTED|Overall Study||18||
60029015|NCT01921270|76144884|FG000|COMPLETED|Overall Study||17||
60029016|NCT01921270|76144884|FG000|NOT COMPLETED|Overall Study||1||
60029017|NCT02325739|76144899|FG000|STARTED|Phase I Part||11||
60029018|NCT02325739|76144900|FG001|STARTED|Phase I Part||6||
60029019|NCT02325739|76144901|FG002|STARTED|Phase I Part||5||
60029020|NCT02325739|76144902|FG003|STARTED|Phase I Part||26||
60029021|NCT02325739|76144903|FG004|STARTED|Phase I Part||19||
60029022|NCT02325739|76144904|FG005|STARTED|Phase I Part||7||
60029023|NCT02325739|76144905|FG006|STARTED|Phase I Part||6||
60029024|NCT02325739|76144906|FG007|STARTED|Phase I Part||6||
60029025|NCT02325739|76144907|FG008|STARTED|Phase I Part||0||
60029026|NCT02325739|76144908|FG009|STARTED|Phase I Part||0||
60029027|NCT02325739|76144909|FG010|STARTED|Phase I Part||0||
60029028|NCT02325739|76144899|FG000|COMPLETED|Phase I Part||0||
60029029|NCT02325739|76144900|FG001|COMPLETED|Phase I Part||0||
60029030|NCT02325739|76144901|FG002|COMPLETED|Phase I Part||0||
60029031|NCT02325739|76144902|FG003|COMPLETED|Phase I Part||0||
60029032|NCT02325739|76144903|FG004|COMPLETED|Phase I Part||0||
60029033|NCT02325739|76144904|FG005|COMPLETED|Phase I Part||0||
60029034|NCT02325739|76144905|FG006|COMPLETED|Phase I Part||0||
60029035|NCT02325739|76144906|FG007|COMPLETED|Phase I Part||0||
60029036|NCT02325739|76144907|FG008|COMPLETED|Phase I Part||0||
60029037|NCT02325739|76144908|FG009|COMPLETED|Phase I Part||0||
60029038|NCT02325739|76144909|FG010|COMPLETED|Phase I Part||0||
60029039|NCT02325739|76144899|FG000|NOT COMPLETED|Phase I Part||11||
60029040|NCT02325739|76144900|FG001|NOT COMPLETED|Phase I Part||6||
60029041|NCT02325739|76144901|FG002|NOT COMPLETED|Phase I Part||5||
60029042|NCT02325739|76144902|FG003|NOT COMPLETED|Phase I Part||26||
60029043|NCT02325739|76144903|FG004|NOT COMPLETED|Phase I Part||19||
60029044|NCT02325739|76144904|FG005|NOT COMPLETED|Phase I Part||7||
60029045|NCT02325739|76144905|FG006|NOT COMPLETED|Phase I Part||6||
60029046|NCT02325739|76144906|FG007|NOT COMPLETED|Phase I Part||6||
60029047|NCT02325739|76144907|FG008|NOT COMPLETED|Phase I Part||0||
60029048|NCT02325739|76144908|FG009|NOT COMPLETED|Phase I Part||0||
59611799|NCT01730586|75722807|FG000|STARTED|Overall Study||34||
60029049|NCT02325739|76144909|FG010|NOT COMPLETED|Phase I Part||0||
60029050|NCT02325739|76144899|FG000|STARTED|Phase II Part||0||
60029051|NCT02325739|76144900|FG001|STARTED|Phase II Part||0||
60029052|NCT02325739|76144901|FG002|STARTED|Phase II Part||0||
60029053|NCT02325739|76144902|FG003|STARTED|Phase II Part||0||
60029054|NCT02325739|76144903|FG004|STARTED|Phase II Part||0||
60029055|NCT02325739|76144904|FG005|STARTED|Phase II Part||0||
60029056|NCT02325739|76144905|FG006|STARTED|Phase II Part||0||
60029057|NCT02325739|76144906|FG007|STARTED|Phase II Part||0||
60029058|NCT02325739|76144907|FG008|STARTED|Phase II Part||30||
60029059|NCT02325739|76144908|FG009|STARTED|Phase II Part||36||
60029060|NCT02325739|76144909|FG010|STARTED|Phase II Part||20||
60029061|NCT02325739|76144899|FG000|COMPLETED|Phase II Part||0||
60029062|NCT02325739|76144900|FG001|COMPLETED|Phase II Part||0||
60029063|NCT02325739|76144901|FG002|COMPLETED|Phase II Part||0||
60029064|NCT02325739|76144902|FG003|COMPLETED|Phase II Part||0||
60029065|NCT02325739|76144903|FG004|COMPLETED|Phase II Part||0||
60029066|NCT02325739|76144904|FG005|COMPLETED|Phase II Part||0||
60029067|NCT02325739|76144905|FG006|COMPLETED|Phase II Part||0||
60029068|NCT02325739|76144906|FG007|COMPLETED|Phase II Part||0||
60029069|NCT02325739|76144907|FG008|COMPLETED|Phase II Part||0||
60029070|NCT02325739|76144908|FG009|COMPLETED|Phase II Part||0||
60029071|NCT02325739|76144909|FG010|COMPLETED|Phase II Part||0||
60029072|NCT02325739|76144899|FG000|NOT COMPLETED|Phase II Part||0||
60029073|NCT02325739|76144900|FG001|NOT COMPLETED|Phase II Part||0||
60029074|NCT02325739|76144901|FG002|NOT COMPLETED|Phase II Part||0||
60029075|NCT02325739|76144902|FG003|NOT COMPLETED|Phase II Part||0||
60029076|NCT02325739|76144903|FG004|NOT COMPLETED|Phase II Part||0||
60029077|NCT02325739|76144904|FG005|NOT COMPLETED|Phase II Part||0||
60029078|NCT02325739|76144905|FG006|NOT COMPLETED|Phase II Part||0||
60029079|NCT02325739|76144906|FG007|NOT COMPLETED|Phase II Part||0||
60029080|NCT02325739|76144907|FG008|NOT COMPLETED|Phase II Part||30||
60029081|NCT02325739|76144908|FG009|NOT COMPLETED|Phase II Part||36||
60029082|NCT02325739|76144909|FG010|NOT COMPLETED|Phase II Part||20||
60029083|NCT01903720|76144954|FG000|STARTED|Overall Study||71||
60029084|NCT01903720|76144954|FG000|COMPLETED|Overall Study||59||
60029085|NCT01903720|76144954|FG000|NOT COMPLETED|Overall Study||12||
60029086|NCT02366689|76144961|FG000|STARTED|Overall Study||60||
60029087|NCT02366689|76144962|FG001|STARTED|Overall Study||58||
59611800|NCT01730586|75722807|FG000|COMPLETED|Overall Study||21||
59611801|NCT01730586|75722807|FG000|NOT COMPLETED|Overall Study||13||
60029088|NCT02366689|76144963|FG002|STARTED|Overall Study||61||
60029089|NCT02366689|76144961|FG000|COMPLETED|Overall Study||56||
60029090|NCT02366689|76144962|FG001|COMPLETED|Overall Study||55||
60029091|NCT02366689|76144963|FG002|COMPLETED|Overall Study||59||
60029092|NCT02366689|76144961|FG000|NOT COMPLETED|Overall Study||4||
60029093|NCT02366689|76144962|FG001|NOT COMPLETED|Overall Study||3||
60029094|NCT02366689|76144963|FG002|NOT COMPLETED|Overall Study||2||
60029095|NCT01903252|76144973|FG000|STARTED|Double-Blind Induction||409||
60029096|NCT01903252|76144974|FG001|STARTED|Double-Blind Induction||408||
60029097|NCT01903252|76144975|FG002|STARTED|Double-Blind Induction||0||
60029098|NCT01903252|76144976|FG003|STARTED|Double-Blind Induction||0||
60029099|NCT01903252|76144977|FG004|STARTED|Double-Blind Induction||0||
59611802|NCT01707030|75722815|FG000|STARTED|Overall Study||67||
60029100|NCT01903252|76144978|FG005|STARTED|Double-Blind Induction||0||
60029101|NCT01903252|76144973|FG000|COMPLETED|Double-Blind Induction||370||
60029102|NCT01903252|76144974|FG001|COMPLETED|Double-Blind Induction||367||
60029103|NCT01903252|76144975|FG002|COMPLETED|Double-Blind Induction||0||
59611803|NCT01707030|75722816|FG001|STARTED|Overall Study||71||
60029104|NCT01903252|76144976|FG003|COMPLETED|Double-Blind Induction||0||
60029105|NCT01903252|76144977|FG004|COMPLETED|Double-Blind Induction||0||
60029106|NCT01903252|76144978|FG005|COMPLETED|Double-Blind Induction||0||
60029107|NCT01903252|76144973|FG000|NOT COMPLETED|Double-Blind Induction||39||
60029108|NCT01903252|76144974|FG001|NOT COMPLETED|Double-Blind Induction||41||
59915940|NCT04039919|76036826|FG001|COMPLETED|Treatment Period 3||6||
59915941|NCT04039919|76036827|FG002|COMPLETED|Treatment Period 3||5||
59915942|NCT04039919|76036828|FG003|COMPLETED|Treatment Period 3||6||
59915943|NCT04039919|76036829|FG004|COMPLETED|Treatment Period 3||0||
59915944|NCT04039919|76036825|FG000|NOT COMPLETED|Treatment Period 3||0||
59915945|NCT04039919|76036826|FG001|NOT COMPLETED|Treatment Period 3||0||
59915946|NCT04039919|76036827|FG002|NOT COMPLETED|Treatment Period 3||0||
59915947|NCT04039919|76036828|FG003|NOT COMPLETED|Treatment Period 3||0||
59915948|NCT04039919|76036829|FG004|NOT COMPLETED|Treatment Period 3||0||
59915949|NCT04039919|76036825|FG000|STARTED|Treatment Period 4||6||
59915950|NCT04039919|76036826|FG001|STARTED|Treatment Period 4||6||
59915951|NCT04039919|76036827|FG002|STARTED|Treatment Period 4||5||
59915952|NCT04039919|76036828|FG003|STARTED|Treatment Period 4||6||
59915953|NCT04039919|76036829|FG004|STARTED|Treatment Period 4||0||
59915954|NCT04039919|76036825|FG000|COMPLETED|Treatment Period 4||6||
59915955|NCT04039919|76036826|FG001|COMPLETED|Treatment Period 4||6||
59915956|NCT04039919|76036827|FG002|COMPLETED|Treatment Period 4||5||
59915957|NCT04039919|76036828|FG003|COMPLETED|Treatment Period 4||6||
59915958|NCT04039919|76036829|FG004|COMPLETED|Treatment Period 4||0||
59915959|NCT04039919|76036825|FG000|NOT COMPLETED|Treatment Period 4||0||
59915960|NCT04039919|76036826|FG001|NOT COMPLETED|Treatment Period 4||0||
59915961|NCT04039919|76036827|FG002|NOT COMPLETED|Treatment Period 4||0||
59915962|NCT04039919|76036828|FG003|NOT COMPLETED|Treatment Period 4||0||
59915963|NCT04039919|76036829|FG004|NOT COMPLETED|Treatment Period 4||0||
59915964|NCT04039919|76036825|FG000|STARTED|Treatment Period 5||6||
59915965|NCT04039919|76036826|FG001|STARTED|Treatment Period 5||6||
59915966|NCT04039919|76036827|FG002|STARTED|Treatment Period 5||5||
59915967|NCT04039919|76036828|FG003|STARTED|Treatment Period 5||6||
59915968|NCT04039919|76036829|FG004|STARTED|Treatment Period 5||0||
59915969|NCT04039919|76036825|FG000|COMPLETED|Treatment Period 5||5||
59915970|NCT04039919|76036826|FG001|COMPLETED|Treatment Period 5||6||
59915971|NCT04039919|76036827|FG002|COMPLETED|Treatment Period 5||5||
59915972|NCT04039919|76036828|FG003|COMPLETED|Treatment Period 5||6||
59915973|NCT04039919|76036829|FG004|COMPLETED|Treatment Period 5||0||
59915974|NCT04039919|76036825|FG000|NOT COMPLETED|Treatment Period 5||1||
59915975|NCT04039919|76036826|FG001|NOT COMPLETED|Treatment Period 5||0||
59915976|NCT04039919|76036827|FG002|NOT COMPLETED|Treatment Period 5||0||
59915977|NCT04039919|76036828|FG003|NOT COMPLETED|Treatment Period 5||0||
59915978|NCT04039919|76036829|FG004|NOT COMPLETED|Treatment Period 5||0||
59915979|NCT04039919|76036825|FG000|STARTED|Treatment Period 6||5||
59915980|NCT04039919|76036826|FG001|STARTED|Treatment Period 6||6||
59915981|NCT04039919|76036827|FG002|STARTED|Treatment Period 6||5||
59915982|NCT04039919|76036828|FG003|STARTED|Treatment Period 6||6||
59915983|NCT04039919|76036829|FG004|STARTED|Treatment Period 6||0||
59915984|NCT04039919|76036825|FG000|COMPLETED|Treatment Period 6||5||
59915985|NCT04039919|76036826|FG001|COMPLETED|Treatment Period 6||6||
59915986|NCT04039919|76036827|FG002|COMPLETED|Treatment Period 6||5||
59915987|NCT04039919|76036828|FG003|COMPLETED|Treatment Period 6||6||
59915988|NCT04039919|76036829|FG004|COMPLETED|Treatment Period 6||0||
59915989|NCT04039919|76036825|FG000|NOT COMPLETED|Treatment Period 6||0||
59915990|NCT04039919|76036826|FG001|NOT COMPLETED|Treatment Period 6||0||
59915991|NCT04039919|76036827|FG002|NOT COMPLETED|Treatment Period 6||0||
59915992|NCT04039919|76036828|FG003|NOT COMPLETED|Treatment Period 6||0||
59915993|NCT04039919|76036829|FG004|NOT COMPLETED|Treatment Period 6||0||
59915994|NCT04035473|76036865|FG000|STARTED|Screening/Baseline||20||
59915995|NCT04035473|76036866|FG001|STARTED|Screening/Baseline||22||
59915996|NCT04035473|76036865|FG000|COMPLETED|Screening/Baseline||20||
59915997|NCT04035473|76036866|FG001|COMPLETED|Screening/Baseline||20||
59915998|NCT04035473|76036865|FG000|NOT COMPLETED|Screening/Baseline||0||
59915999|NCT04035473|76036866|FG001|NOT COMPLETED|Screening/Baseline||2||
59916000|NCT04035473|76036865|FG000|STARTED|Treatment Period 1||20||
59916001|NCT04035473|76036866|FG001|STARTED|Treatment Period 1||20||
59916002|NCT04035473|76036865|FG000|COMPLETED|Treatment Period 1||20||
59916003|NCT04035473|76036866|FG001|COMPLETED|Treatment Period 1||20||
59916004|NCT04035473|76036865|FG000|NOT COMPLETED|Treatment Period 1||0||
59916005|NCT04035473|76036866|FG001|NOT COMPLETED|Treatment Period 1||0||
59916006|NCT04035473|76036865|FG000|STARTED|Treatment Period 2|2 subjects withdrew before starting treatment period 2 due to diease progression and withdrawal from study treatment and procedure.|18||
59916007|NCT04035473|76036866|FG001|STARTED|Treatment Period 2|1 subject withdrew before starting treatment period 2 due to SAE and investigator's decision.|19||
59916008|NCT04035473|76036865|FG000|COMPLETED|Treatment Period 2||18||
59916009|NCT04035473|76036866|FG001|COMPLETED|Treatment Period 2||19||
59916010|NCT04035473|76036865|FG000|NOT COMPLETED|Treatment Period 2||0||
59916011|NCT04035473|76036866|FG001|NOT COMPLETED|Treatment Period 2||0||
59916012|NCT04035473|76036865|FG000|STARTED|Follow-up Period||18||
59916013|NCT04035473|76036866|FG001|STARTED|Follow-up Period||19||
59916014|NCT04035473|76036865|FG000|COMPLETED|Follow-up Period||16||
59916015|NCT04035473|76036866|FG001|COMPLETED|Follow-up Period||19||
59916016|NCT04035473|76036865|FG000|NOT COMPLETED|Follow-up Period||2||
59916017|NCT04035473|76036866|FG001|NOT COMPLETED|Follow-up Period||0||
59916018|NCT04032977|76036874|FG000|STARTED|Overall Study||80||
60029109|NCT01903252|76144975|FG002|NOT COMPLETED|Double-Blind Induction||0||
60029110|NCT01903252|76144976|FG003|NOT COMPLETED|Double-Blind Induction||0||
60029111|NCT01903252|76144977|FG004|NOT COMPLETED|Double-Blind Induction||0||
60029112|NCT01903252|76144978|FG005|NOT COMPLETED|Double-Blind Induction||0||
60029113|NCT01903252|76144973|FG000|STARTED|Extended Induction, Open-Label||0|This treatment arm was only used in Period 1, double-blind induction phase.|
60029114|NCT01903252|76144974|FG001|STARTED|Extended Induction, Open-Label|This treatment arm was only used in Period 1, double-blind induction phase.|0|This treatment arm was only used in Period 1, double-blind induction phase.|
60029115|NCT01903252|76144975|FG002|STARTED|Extended Induction, Open-Label|The subjects in this phase were non-responders at week 8 and discontinued the double-blind phase.|243|This treatment arm was only used in Period 1, double-blind induction phase.|
60029116|NCT01903252|76144976|FG003|STARTED|Extended Induction, Open-Label||0|This treatment arm was only used in Period 1, double-blind induction phase.|
59507471|NCT00816751|75600766|FG000|STARTED|Overall Study||45||
60029117|NCT01903252|76144977|FG004|STARTED|Extended Induction, Open-Label||0|This treatment arm was only used in Period 1, double-blind induction phase.|
60029118|NCT01903252|76144978|FG005|STARTED|Extended Induction, Open-Label||0|This treatment arm was only used in Period 1, double-blind induction phase.|
60029119|NCT01903252|76144973|FG000|COMPLETED|Extended Induction, Open-Label||0||
60029120|NCT01903252|76144974|FG001|COMPLETED|Extended Induction, Open-Label||0||
60029121|NCT01903252|76144975|FG002|COMPLETED|Extended Induction, Open-Label||220||
60029122|NCT01903252|76144976|FG003|COMPLETED|Extended Induction, Open-Label||0||
60029123|NCT01903252|76144977|FG004|COMPLETED|Extended Induction, Open-Label||0||
60029124|NCT01903252|76144978|FG005|COMPLETED|Extended Induction, Open-Label||0||
60029125|NCT01903252|76144973|FG000|NOT COMPLETED|Extended Induction, Open-Label||0||
60029126|NCT01903252|76144974|FG001|NOT COMPLETED|Extended Induction, Open-Label||0||
60029127|NCT01903252|76144975|FG002|NOT COMPLETED|Extended Induction, Open-Label||23||
60029128|NCT01903252|76144976|FG003|NOT COMPLETED|Extended Induction, Open-Label||0||
60029129|NCT01903252|76144977|FG004|NOT COMPLETED|Extended Induction, Open-Label||0||
60029130|NCT01903252|76144978|FG005|NOT COMPLETED|Extended Induction, Open-Label||0||
60029131|NCT01903252|76144973|FG000|STARTED|Maintenance, Open-Label||0|"All patients received TP05, three diffrent daily doses:~1.6g, 3.2g, 4.8g"|
60029132|NCT01903252|76144974|FG001|STARTED|Maintenance, Open-Label||0|"All patients received TP05, three diffrent daily doses:~1.6g, 3.2g, 4.8g"|
60029133|NCT01903252|76144975|FG002|STARTED|Maintenance, Open-Label|Period 2 (extended induction) is completed, subjects are newly allocated to Period 3, maintenance.|0|"All patients received TP05, three diffrent daily doses:~1.6g, 3.2g, 4.8g"|
60029134|NCT01903252|76144976|FG003|STARTED|Maintenance, Open-Label|This is period 3, Open-Label Maintenance following on from period 1, the double-blind induction.|202|"All patients received TP05, three diffrent daily doses:~1.6g, 3.2g, 4.8g"|
60029135|NCT01903252|76144977|FG004|STARTED|Maintenance, Open-Label|This is period 3, Open-Label Maintenance following on from period 1, the double-blind induction.|274|"All patients received TP05, three diffrent daily doses:~1.6g, 3.2g, 4.8g"|
60029136|NCT01903252|76144978|FG005|STARTED|Maintenance, Open-Label|This is period 3, Open-Label Maintenance following on from period 1, the double-blind induction.|199|"All patients received TP05, three diffrent daily doses:~1.6g, 3.2g, 4.8g"|
60029137|NCT01903252|76144973|FG000|COMPLETED|Maintenance, Open-Label||0||
60029138|NCT01903252|76144974|FG001|COMPLETED|Maintenance, Open-Label||0||
60029139|NCT01903252|76144975|FG002|COMPLETED|Maintenance, Open-Label||0||
60029140|NCT01903252|76144976|FG003|COMPLETED|Maintenance, Open-Label||196||
60029141|NCT01903252|76144977|FG004|COMPLETED|Maintenance, Open-Label||253||
60029142|NCT01903252|76144978|FG005|COMPLETED|Maintenance, Open-Label||181||
60029143|NCT01903252|76144973|FG000|NOT COMPLETED|Maintenance, Open-Label||0||
60029144|NCT01903252|76144974|FG001|NOT COMPLETED|Maintenance, Open-Label||0||
60029145|NCT01903252|76144975|FG002|NOT COMPLETED|Maintenance, Open-Label||0||
60029146|NCT01903252|76144976|FG003|NOT COMPLETED|Maintenance, Open-Label||6||
60029147|NCT01903252|76144977|FG004|NOT COMPLETED|Maintenance, Open-Label||21||
60029148|NCT01903252|76144978|FG005|NOT COMPLETED|Maintenance, Open-Label||18||
60029149|NCT01920958|76144996|FG000|STARTED|Overall Study||233||
60029150|NCT01920958|76144996|FG000|COMPLETED|Overall Study|Intent-to-Treat (ITT) Population|228||
60029151|NCT01920958|76144996|FG000|NOT COMPLETED|Overall Study||5||
60029152|NCT01613716|76145000|FG000|STARTED|Overall Study||30||
60029153|NCT01613716|76145000|FG000|COMPLETED|Overall Study||23||
60029154|NCT01613716|76145000|FG000|NOT COMPLETED|Overall Study||7||
60029155|NCT01872910|76145010|FG000|STARTED|Overall Study||30||
60029156|NCT01872910|76145011|FG001|STARTED|Overall Study||31||
60029157|NCT01872910|76145012|FG002|STARTED|Overall Study||30||
59507472|NCT00816751|75600767|FG001|STARTED|Overall Study||44||
60029158|NCT01872910|76145013|FG003|STARTED|Overall Study||15||
60029159|NCT01872910|76145014|FG004|STARTED|Overall Study||15||
60029160|NCT01872910|76145015|FG005|STARTED|Overall Study||3||
60029161|NCT01872910|76145010|FG000|Received Any Study Drug|Overall Study||30||
60029162|NCT01872910|76145011|FG001|Received Any Study Drug|Overall Study||31||
59507473|NCT00816751|75600766|FG000|COMPLETED|Overall Study||45||
59507474|NCT00816751|75600767|FG001|COMPLETED|Overall Study||44||
59916019|NCT04032977|76036875|FG001|STARTED|Overall Study||78||
59916020|NCT04032977|76036874|FG000|COMPLETED|Overall Study||71||
59916021|NCT04032977|76036875|FG001|COMPLETED|Overall Study||70||
59916022|NCT04032977|76036874|FG000|NOT COMPLETED|Overall Study||9||
59916023|NCT04032977|76036875|FG001|NOT COMPLETED|Overall Study||8||
59916024|NCT04030247|76036881|FG000|STARTED|Overall Study||50||
59916025|NCT04030247|76036881|FG000|COMPLETED|Overall Study||33||
59916026|NCT04030247|76036881|FG000|NOT COMPLETED|Overall Study||17||
59916027|NCT02915978|76036888|FG000|STARTED|Overall Study||15||
59916028|NCT02915978|76036889|FG001|STARTED|Overall Study||15||
60029163|NCT01872910|76145012|FG002|Received Any Study Drug|Overall Study||30||
60029164|NCT01872910|76145013|FG003|Received Any Study Drug|Overall Study||15||
60029165|NCT01872910|76145014|FG004|Received Any Study Drug|Overall Study||15||
60029166|NCT01872910|76145015|FG005|Received Any Study Drug|Overall Study||3||
60029167|NCT01872910|76145010|FG000|COMPLETED|Overall Study||28||
60029168|NCT01872910|76145011|FG001|COMPLETED|Overall Study||31||
60029169|NCT01872910|76145012|FG002|COMPLETED|Overall Study||28||
60029170|NCT01872910|76145013|FG003|COMPLETED|Overall Study||15||
60029171|NCT01872910|76145014|FG004|COMPLETED|Overall Study||15||
60029172|NCT01872910|76145015|FG005|COMPLETED|Overall Study||3||
60029173|NCT01872910|76145010|FG000|NOT COMPLETED|Overall Study||2||
60029174|NCT01872910|76145011|FG001|NOT COMPLETED|Overall Study||0||
60029175|NCT01872910|76145012|FG002|NOT COMPLETED|Overall Study||2||
60029176|NCT01872910|76145013|FG003|NOT COMPLETED|Overall Study||0||
60029177|NCT01872910|76145014|FG004|NOT COMPLETED|Overall Study||0||
60029178|NCT01872910|76145015|FG005|NOT COMPLETED|Overall Study||0||
60029179|NCT01920568|76145030|FG000|STARTED|Overall Study||326||
60029180|NCT01920568|76145031|FG001|STARTED|Overall Study||159||
60029181|NCT01920568|76145030|FG000|COMPLETED|Overall Study||175||
60029182|NCT01920568|76145031|FG001|COMPLETED|Overall Study||75||
60029183|NCT01920568|76145030|FG000|NOT COMPLETED|Overall Study||151||
60029184|NCT01920568|76145031|FG001|NOT COMPLETED|Overall Study||84||
60029185|NCT01902628|76145038|FG000|STARTED|Overall Study||437||
60029186|NCT01902628|76145038|FG000|COMPLETED|Overall Study||354||
60029187|NCT01902628|76145038|FG000|NOT COMPLETED|Overall Study||83||
60029188|NCT01920178|76145044|FG000|STARTED|Overall Study||5||
60029189|NCT01920178|76145045|FG001|STARTED|Overall Study||2||
60029190|NCT01920178|76145044|FG000|COMPLETED|Overall Study||3||
60029191|NCT01920178|76145045|FG001|COMPLETED|Overall Study||1||
60029192|NCT01920178|76145044|FG000|NOT COMPLETED|Overall Study||2||
60029193|NCT01920178|76145045|FG001|NOT COMPLETED|Overall Study||1||
60029194|NCT01901848|76145053|FG000|STARTED|Randomized and Treated||25||
60029195|NCT01901848|76145054|FG001|STARTED|Randomized and Treated||25||
60029196|NCT01901848|76145053|FG000|COMPLETED|Randomized and Treated|Ten cases were practice cases used to establish fidelity to CPT, and were removed from analyses.|22||
60029197|NCT01901848|76145054|FG001|COMPLETED|Randomized and Treated||19||
60029198|NCT01901848|76145053|FG000|NOT COMPLETED|Randomized and Treated||3||
60029199|NCT01901848|76145054|FG001|NOT COMPLETED|Randomized and Treated||6||
60029200|NCT01901848|76145053|FG000|STARTED|Removed From Analyses||22||
60029201|NCT01901848|76145054|FG001|STARTED|Removed From Analyses||19||
60029202|NCT01901848|76145053|FG000|COMPLETED|Removed From Analyses||12||
59507475|NCT00816751|75600766|FG000|NOT COMPLETED|Overall Study||0||
59507476|NCT00816751|75600767|FG001|NOT COMPLETED|Overall Study||0||
59507477|NCT00822523|75600776|FG000|STARTED|Overall Study||5||
59507478|NCT00822523|75600777|FG001|STARTED|Overall Study||4||
59916029|NCT02915978|76036890|FG002|STARTED|Overall Study||15||
59916030|NCT02915978|76036888|FG000|COMPLETED|Overall Study||13||
60029203|NCT01901848|76145054|FG001|COMPLETED|Removed From Analyses||19||
60029204|NCT01901848|76145053|FG000|NOT COMPLETED|Removed From Analyses||10||
60029205|NCT01901848|76145054|FG001|NOT COMPLETED|Removed From Analyses||0||
60029206|NCT01901614|76145062|FG000|STARTED|Overall Study||3||
60029207|NCT01901614|76145063|FG001|STARTED|Overall Study||2||
60029208|NCT01901614|76145062|FG000|COMPLETED|Overall Study||1||
60029209|NCT01901614|76145063|FG001|COMPLETED|Overall Study||1||
60029210|NCT01901614|76145062|FG000|NOT COMPLETED|Overall Study||2||
60029211|NCT01901614|76145063|FG001|NOT COMPLETED|Overall Study||1||
60029212|NCT01901302|76145071|FG000|STARTED|Overall Study||31||
60029213|NCT01901302|76145072|FG001|STARTED|Overall Study||30||
60029214|NCT01901302|76145071|FG000|Received at Least 1 Dose of Study Drug|Overall Study||31||
60029215|NCT01901302|76145072|FG001|Received at Least 1 Dose of Study Drug|Overall Study||30||
59507479|NCT00822523|75600778|FG002|STARTED|Overall Study||4||
59507480|NCT00822523|75600776|FG000|COMPLETED|Overall Study||5||
59916031|NCT02915978|76036889|FG001|COMPLETED|Overall Study||14||
60029216|NCT01901302|76145071|FG000|COMPLETED|Overall Study||4||
60029217|NCT01901302|76145072|FG001|COMPLETED|Overall Study||7||
60029218|NCT01901302|76145071|FG000|NOT COMPLETED|Overall Study||27||
60029219|NCT01901302|76145072|FG001|NOT COMPLETED|Overall Study||23||
60029220|NCT01919398|76145081|FG000|STARTED|Overall Study||3||
60029221|NCT01919398|76145082|FG001|STARTED|Overall Study||3||
60029222|NCT01919398|76145083|FG002|STARTED|Overall Study||13||
60029223|NCT01919398|76145081|FG000|Received at Least One Dose of Study Drug|Overall Study||3||
60029224|NCT01919398|76145082|FG001|Received at Least One Dose of Study Drug|Overall Study||3||
60029225|NCT01919398|76145083|FG002|Received at Least One Dose of Study Drug|Overall Study||13||
60029226|NCT01919398|76145081|FG000|COMPLETED|Overall Study||3||
60029227|NCT01919398|76145082|FG001|COMPLETED|Overall Study||3||
60029228|NCT01919398|76145083|FG002|COMPLETED|Overall Study||9||
60029229|NCT01919398|76145081|FG000|NOT COMPLETED|Overall Study||0||
60029230|NCT01919398|76145082|FG001|NOT COMPLETED|Overall Study||0||
60029231|NCT01919398|76145083|FG002|NOT COMPLETED|Overall Study||4||
60029232|NCT02500043|76145093|FG000|STARTED|Overall Study||337||
60029233|NCT02500043|76145094|FG001|STARTED|Overall Study||170||
60029234|NCT02500043|76145093|FG000|As-Treated (AT) Population|Overall Study||335|All participants who received at least 1 dose of study treatment.|
60029235|NCT02500043|76145094|FG001|As-Treated (AT) Population|Overall Study||168|All participants who received at least 1 dose of study treatment.|
60029236|NCT02500043|76145093|FG000|COMPLETED|Overall Study||0||
60029237|NCT02500043|76145094|FG001|COMPLETED|Overall Study||0||
60029238|NCT02500043|76145093|FG000|NOT COMPLETED|Overall Study||337||
60029239|NCT02500043|76145094|FG001|NOT COMPLETED|Overall Study||170||
60029240|NCT02499575|76145102|FG000|STARTED|Overall Study||1||
60029241|NCT02499575|76145103|FG001|STARTED|Overall Study||1||
60029242|NCT02499575|76145102|FG000|COMPLETED|Overall Study||1||
60029243|NCT02499575|76145103|FG001|COMPLETED|Overall Study||0||
60029244|NCT02499575|76145102|FG000|NOT COMPLETED|Overall Study||0||
60029245|NCT02499575|76145103|FG001|NOT COMPLETED|Overall Study||1||
60029246|NCT02065791|76145111|FG000|STARTED|Overall Study||2199||
60029247|NCT02065791|76145112|FG001|STARTED|Overall Study||2202||
60029248|NCT02065791|76145111|FG000|Treated|Overall Study||2197||
60029249|NCT02065791|76145112|FG001|Treated|Overall Study||2200||
60029250|NCT02065791|76145111|FG000|COMPLETED|Overall Study||2174||
60029251|NCT02065791|76145112|FG001|COMPLETED|Overall Study||2187||
60029252|NCT02065791|76145111|FG000|NOT COMPLETED|Overall Study||25||
60029253|NCT02065791|76145112|FG001|NOT COMPLETED|Overall Study||15||
60029254|NCT02499263|76145118|FG000|STARTED|Overall Study||146||
60029255|NCT02499263|76145118|FG000|COMPLETED|Overall Study||84||
60029256|NCT02499263|76145118|FG000|NOT COMPLETED|Overall Study||62||
60029257|NCT01654289|76145125|FG000|STARTED|Overall Study||138||
60029258|NCT01654289|76145126|FG001|STARTED|Overall Study||137||
60029259|NCT01654289|76145127|FG002|STARTED|Overall Study||138||
60029260|NCT01654289|76145125|FG000|COMPLETED|Overall Study||111||
60029261|NCT01654289|76145126|FG001|COMPLETED|Overall Study||109||
60029262|NCT01654289|76145127|FG002|COMPLETED|Overall Study||133||
60029263|NCT01654289|76145125|FG000|NOT COMPLETED|Overall Study||27||
60029264|NCT01654289|76145126|FG001|NOT COMPLETED|Overall Study||28||
60029265|NCT01654289|76145127|FG002|NOT COMPLETED|Overall Study||5||
60029266|NCT02499029|76145137|FG000|STARTED|Overall Study||18||
60029267|NCT02499029|76145138|FG001|STARTED|Overall Study||17||
60029268|NCT02499029|76145137|FG000|COMPLETED|Overall Study||13||
60029269|NCT02499029|76145138|FG001|COMPLETED|Overall Study||14||
60029270|NCT02499029|76145137|FG000|NOT COMPLETED|Overall Study||5||
60029271|NCT02499029|76145138|FG001|NOT COMPLETED|Overall Study||3||
60029272|NCT04968353|76145148|FG000|STARTED|Overall Study||20||20
60029273|NCT04968353|76145149|FG001|STARTED|Overall Study||15||15
60029274|NCT04968353|76145150|FG002|STARTED|Overall Study||16||16
60029275|NCT04968353|76145151|FG003|STARTED|Overall Study||22||23
60029276|NCT04968353|76145148|FG000|COMPLETED|Overall Study||19||19
60029277|NCT04968353|76145149|FG001|COMPLETED|Overall Study||15||15
60029278|NCT04968353|76145150|FG002|COMPLETED|Overall Study||14||14
60029279|NCT04968353|76145151|FG003|COMPLETED|Overall Study||22||23
60029280|NCT04968353|76145148|FG000|NOT COMPLETED|Overall Study||1||1
60029281|NCT04968353|76145149|FG001|NOT COMPLETED|Overall Study||0||0
60029282|NCT04968353|76145150|FG002|NOT COMPLETED|Overall Study||2||2
60029283|NCT04968353|76145151|FG003|NOT COMPLETED|Overall Study||0||0
60029284|NCT02065713|76145163|FG000|STARTED|Overall Study||23||
60029285|NCT02065713|76145164|FG001|STARTED|Overall Study||21||
60029286|NCT02065713|76145163|FG000|COMPLETED|Overall Study||22||
60029287|NCT02065713|76145164|FG001|COMPLETED|Overall Study||20||
60029288|NCT02065713|76145163|FG000|NOT COMPLETED|Overall Study||1||
60029289|NCT02065713|76145164|FG001|NOT COMPLETED|Overall Study||1||
60029290|NCT02497781|76145172|FG000|STARTED|Overall Study||68||
60029291|NCT02497781|76145173|FG001|STARTED|Overall Study||29||
60029292|NCT02497781|76145172|FG000|Treated|Overall Study||67||
60029293|NCT02497781|76145173|FG001|Treated|Overall Study||28||
60029294|NCT02497781|76145172|FG000|COMPLETED|Overall Study||64||
60029295|NCT02497781|76145173|FG001|COMPLETED|Overall Study||26||
60029296|NCT02497781|76145172|FG000|NOT COMPLETED|Overall Study||4||
60029297|NCT02497781|76145173|FG001|NOT COMPLETED|Overall Study||3||
60029298|NCT02497469|76145181|FG000|STARTED|Overall Study||386||
60029299|NCT02497469|76145182|FG001|STARTED|Overall Study||385||
60029300|NCT02497469|76145181|FG000|Safety Analysis Set|Overall Study||386|Participants who received at least one dose of study drug.|
60029301|NCT02497469|76145182|FG001|Safety Analysis Set|Overall Study||383|Participants who received at least one dose of study drug.|
60029302|NCT02497469|76145181|FG000|COMPLETED|Overall Study||217||
60029303|NCT02497469|76145182|FG001|COMPLETED|Overall Study||270||
60029304|NCT02497469|76145181|FG000|NOT COMPLETED|Overall Study||169||
60029305|NCT02497469|76145182|FG001|NOT COMPLETED|Overall Study||115||
60029306|NCT02497391|76145188|FG000|STARTED|Period 1 (14 Days)||16||
60029307|NCT02497391|76145189|FG001|STARTED|Period 1 (14 Days)||15||
60029308|NCT02497391|76145190|FG002|STARTED|Period 1 (14 Days)||16||
60029309|NCT02497391|76145191|FG003|STARTED|Period 1 (14 Days)||16||
60029310|NCT02497391|76145192|FG004|STARTED|Period 1 (14 Days)||16||
60029311|NCT02497391|76145193|FG005|STARTED|Period 1 (14 Days)||16||
60029312|NCT02497391|76145188|FG000|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||16||
60029313|NCT02497391|76145189|FG001|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||15||
60029314|NCT02497391|76145190|FG002|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||16||
60029315|NCT02497391|76145191|FG003|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||16||
60029316|NCT02497391|76145192|FG004|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||16||
60029317|NCT02497391|76145193|FG005|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||16||
60029318|NCT02497391|76145188|FG000|COMPLETED|Period 1 (14 Days)||16||
60029319|NCT02497391|76145189|FG001|COMPLETED|Period 1 (14 Days)||15||
60029320|NCT02497391|76145190|FG002|COMPLETED|Period 1 (14 Days)||16||
60029321|NCT02497391|76145191|FG003|COMPLETED|Period 1 (14 Days)||16||
60029322|NCT02497391|76145192|FG004|COMPLETED|Period 1 (14 Days)||16||
60029323|NCT02497391|76145193|FG005|COMPLETED|Period 1 (14 Days)||16||
60029324|NCT02497391|76145188|FG000|NOT COMPLETED|Period 1 (14 Days)||0||
60029325|NCT02497391|76145189|FG001|NOT COMPLETED|Period 1 (14 Days)||0||
60029326|NCT02497391|76145190|FG002|NOT COMPLETED|Period 1 (14 Days)||0||
60029327|NCT02497391|76145191|FG003|NOT COMPLETED|Period 1 (14 Days)||0||
59916032|NCT02915978|76036890|FG002|COMPLETED|Overall Study||15||
59916033|NCT02915978|76036888|FG000|NOT COMPLETED|Overall Study||2||
59916034|NCT02915978|76036889|FG001|NOT COMPLETED|Overall Study||1||
59916035|NCT02915978|76036890|FG002|NOT COMPLETED|Overall Study||0||
59916036|NCT02701192|76036898|FG000|STARTED|Overall Study||100||
59916037|NCT02701192|76036898|FG000|COMPLETED|Overall Study||94||
59916038|NCT02701192|76036898|FG000|NOT COMPLETED|Overall Study||6||
59916039|NCT03101358|76036906|FG000|STARTED|Overall Study||4||
59916040|NCT03101358|76036907|FG001|STARTED|Overall Study||3||
59916041|NCT03101358|76036908|FG002|STARTED|Overall Study||5||
59916042|NCT03101358|76036909|FG003|STARTED|Overall Study||11||
59916043|NCT03101358|76036906|FG000|Completed All Dosing|Overall Study||3||
59916044|NCT03101358|76036907|FG001|Completed All Dosing|Overall Study||3||
59916045|NCT03101358|76036908|FG002|Completed All Dosing|Overall Study||3||
60029328|NCT02497391|76145192|FG004|NOT COMPLETED|Period 1 (14 Days)||0||
59507481|NCT00822523|75600777|FG001|COMPLETED|Overall Study||4||
59507482|NCT00822523|75600778|FG002|COMPLETED|Overall Study||4||
59507483|NCT00822523|75600776|FG000|NOT COMPLETED|Overall Study||0||
59507484|NCT00822523|75600777|FG001|NOT COMPLETED|Overall Study||0||
59507485|NCT00822523|75600778|FG002|NOT COMPLETED|Overall Study||0||
59507486|NCT02410707|75600794|FG000|STARTED|Overall Study||43||
59507487|NCT02410707|75600794|FG000|COMPLETED|Overall Study||43||
59507488|NCT02410707|75600794|FG000|NOT COMPLETED|Overall Study||0||
59507489|NCT00822757|75600802|FG000|STARTED|Overall Study||41||
59507490|NCT00822757|75600803|FG001|STARTED|Overall Study||10||
59507491|NCT00822757|75600802|FG000|COMPLETED|Overall Study||41||
59507492|NCT00822757|75600803|FG001|COMPLETED|Overall Study||10||
59507493|NCT00822757|75600802|FG000|NOT COMPLETED|Overall Study||0||
59507494|NCT00822757|75600803|FG001|NOT COMPLETED|Overall Study||0||
59507495|NCT02343081|75600811|FG000|STARTED|First Intervention (Day 3)||8||
59507496|NCT02343081|75600812|FG001|STARTED|First Intervention (Day 3)||8||
59507497|NCT02343081|75600811|FG000|Received Intervention|First Intervention (Day 3)||8||
59507498|NCT02343081|75600812|FG001|Received Intervention|First Intervention (Day 3)||8||
59916046|NCT03101358|76036909|FG003|Completed All Dosing|Overall Study||10||
59916047|NCT03101358|76036906|FG000|COMPLETED|Overall Study||1||
59916048|NCT03101358|76036907|FG001|COMPLETED|Overall Study||3||
59916049|NCT03101358|76036908|FG002|COMPLETED|Overall Study||3||
59916050|NCT03101358|76036909|FG003|COMPLETED|Overall Study||5||
60029329|NCT02497391|76145193|FG005|NOT COMPLETED|Period 1 (14 Days)||0||
60029330|NCT02497391|76145188|FG000|STARTED|Period 2 (14 Days)||16||
60029331|NCT02497391|76145189|FG001|STARTED|Period 2 (14 Days)||15||
60029332|NCT02497391|76145190|FG002|STARTED|Period 2 (14 Days)||16||
60029333|NCT02497391|76145191|FG003|STARTED|Period 2 (14 Days)||16||
60029334|NCT02497391|76145192|FG004|STARTED|Period 2 (14 Days)||16||
60029335|NCT02497391|76145193|FG005|STARTED|Period 2 (14 Days)||16||
60029336|NCT02497391|76145188|FG000|COMPLETED|Period 2 (14 Days)||12||
60029337|NCT02497391|76145189|FG001|COMPLETED|Period 2 (14 Days)||14||
60029338|NCT02497391|76145190|FG002|COMPLETED|Period 2 (14 Days)||13||
60029339|NCT02497391|76145191|FG003|COMPLETED|Period 2 (14 Days)||13||
60029340|NCT02497391|76145192|FG004|COMPLETED|Period 2 (14 Days)||14||
60029341|NCT02497391|76145193|FG005|COMPLETED|Period 2 (14 Days)||13||
60029342|NCT02497391|76145188|FG000|NOT COMPLETED|Period 2 (14 Days)||4||
60029343|NCT02497391|76145189|FG001|NOT COMPLETED|Period 2 (14 Days)||1||
60029344|NCT02497391|76145190|FG002|NOT COMPLETED|Period 2 (14 Days)||3||
60029345|NCT02497391|76145191|FG003|NOT COMPLETED|Period 2 (14 Days)||3||
60029346|NCT02497391|76145192|FG004|NOT COMPLETED|Period 2 (14 Days)||2||
60029347|NCT02497391|76145193|FG005|NOT COMPLETED|Period 2 (14 Days)||3||
60029348|NCT02497391|76145188|FG000|STARTED|Period 3 (14 Days)||12||
60029349|NCT02497391|76145189|FG001|STARTED|Period 3 (14 Days)||14||
60029350|NCT02497391|76145190|FG002|STARTED|Period 3 (14 Days)||13||
60029351|NCT02497391|76145191|FG003|STARTED|Period 3 (14 Days)||13||
60029352|NCT02497391|76145192|FG004|STARTED|Period 3 (14 Days)||14||
60029353|NCT02497391|76145193|FG005|STARTED|Period 3 (14 Days)||13||
60029354|NCT02497391|76145188|FG000|COMPLETED|Period 3 (14 Days)||12||
60029355|NCT02497391|76145189|FG001|COMPLETED|Period 3 (14 Days)||13||
60029356|NCT02497391|76145190|FG002|COMPLETED|Period 3 (14 Days)||12||
60029357|NCT02497391|76145191|FG003|COMPLETED|Period 3 (14 Days)||13||
60029358|NCT02497391|76145192|FG004|COMPLETED|Period 3 (14 Days)||13||
60029359|NCT02497391|76145193|FG005|COMPLETED|Period 3 (14 Days)||13||
60029360|NCT02497391|76145188|FG000|NOT COMPLETED|Period 3 (14 Days)||0||
60029361|NCT02497391|76145189|FG001|NOT COMPLETED|Period 3 (14 Days)||1||
60029362|NCT02497391|76145190|FG002|NOT COMPLETED|Period 3 (14 Days)||1||
60029363|NCT02497391|76145191|FG003|NOT COMPLETED|Period 3 (14 Days)||0||
60029364|NCT02497391|76145192|FG004|NOT COMPLETED|Period 3 (14 Days)||1||
60029365|NCT02497391|76145193|FG005|NOT COMPLETED|Period 3 (14 Days)||0||
60029366|NCT02476175|76145201|FG000|STARTED|Overall Study||35||
60029367|NCT02476175|76145201|FG000|COMPLETED|Overall Study||33||
60029368|NCT02476175|76145201|FG000|NOT COMPLETED|Overall Study||2||
60029369|NCT02065557|76145208|FG000|STARTED|Induction Period||32||
60029370|NCT02065557|76145209|FG001|STARTED|Induction Period||51||
60029371|NCT02065557|76145210|FG002|STARTED|Induction Period||18||
60029372|NCT02065557|76145211|FG003|STARTED|Induction Period||0||
60029373|NCT02065557|76145212|FG004|STARTED|Induction Period||0||
60029374|NCT02065557|76145213|FG005|STARTED|Induction Period||0||
60029375|NCT02065557|76145208|FG000|Enrolled in Main Study|Induction Period||30||
60029376|NCT02065557|76145209|FG001|Enrolled in Main Study|Induction Period||47||
60029377|NCT02065557|76145210|FG002|Enrolled in Main Study|Induction Period||16||
60029378|NCT02065557|76145211|FG003|Enrolled in Main Study|Induction Period||0||
60029379|NCT02065557|76145212|FG004|Enrolled in Main Study|Induction Period||0||
60029380|NCT02065557|76145213|FG005|Enrolled in Main Study|Induction Period||0||
60029381|NCT02065557|76145208|FG000|Enrolled in Japan Sub-study|Induction Period||2||
60029382|NCT02065557|76145209|FG001|Enrolled in Japan Sub-study|Induction Period||4||
60029383|NCT02065557|76145210|FG002|Enrolled in Japan Sub-study|Induction Period||2||
60029384|NCT02065557|76145211|FG003|Enrolled in Japan Sub-study|Induction Period||0||
60029385|NCT02065557|76145212|FG004|Enrolled in Japan Sub-study|Induction Period||0||
60029386|NCT02065557|76145213|FG005|Enrolled in Japan Sub-study|Induction Period||0||
60029387|NCT02065557|76145208|FG000|COMPLETED|Induction Period||22||
60029388|NCT02065557|76145209|FG001|COMPLETED|Induction Period||43||
60029389|NCT02065557|76145210|FG002|COMPLETED|Induction Period||16||
60029390|NCT02065557|76145211|FG003|COMPLETED|Induction Period||0||
60029391|NCT02065557|76145212|FG004|COMPLETED|Induction Period||0||
60029392|NCT02065557|76145213|FG005|COMPLETED|Induction Period||0||
60029393|NCT02065557|76145208|FG000|NOT COMPLETED|Induction Period||10||
60029394|NCT02065557|76145209|FG001|NOT COMPLETED|Induction Period||8||
60029395|NCT02065557|76145210|FG002|NOT COMPLETED|Induction Period||2||
60029396|NCT02065557|76145211|FG003|NOT COMPLETED|Induction Period||0||
60029397|NCT02065557|76145212|FG004|NOT COMPLETED|Induction Period||0||
60029398|NCT02065557|76145213|FG005|NOT COMPLETED|Induction Period||0||
60029399|NCT02065557|76145208|FG000|STARTED|Maintenance Period||0||
60029400|NCT02065557|76145209|FG001|STARTED|Maintenance Period||0||
60029401|NCT02065557|76145210|FG002|STARTED|Maintenance Period||0||
60029402|NCT02065557|76145211|FG003|STARTED|Maintenance Period||12||
60029403|NCT02065557|76145212|FG004|STARTED|Maintenance Period||33||
60029404|NCT02065557|76145213|FG005|STARTED|Maintenance Period||36||
60029405|NCT02065557|76145208|FG000|COMPLETED|Maintenance Period||0|Completed Week 52|
60029406|NCT02065557|76145209|FG001|COMPLETED|Maintenance Period||0|Completed Week 52|
60029407|NCT02065557|76145210|FG002|COMPLETED|Maintenance Period||0|Completed Week 52|
60029408|NCT02065557|76145211|FG003|COMPLETED|Maintenance Period||11|Completed Week 52|
60029409|NCT02065557|76145212|FG004|COMPLETED|Maintenance Period||25|Completed Week 52|
60029410|NCT02065557|76145213|FG005|COMPLETED|Maintenance Period||32|Completed Week 52|
60029411|NCT02065557|76145208|FG000|NOT COMPLETED|Maintenance Period||0||
60029412|NCT02065557|76145209|FG001|NOT COMPLETED|Maintenance Period||0||
60029413|NCT02065557|76145210|FG002|NOT COMPLETED|Maintenance Period||0||
60029414|NCT02065557|76145211|FG003|NOT COMPLETED|Maintenance Period||1||
60029415|NCT02065557|76145212|FG004|NOT COMPLETED|Maintenance Period||8||
60029416|NCT02065557|76145213|FG005|NOT COMPLETED|Maintenance Period||4||
60029417|NCT02065245|76145245|FG000|STARTED|Infusion 1||5||
60029418|NCT02065245|76145246|FG001|STARTED|Infusion 1||5||
60029419|NCT02065245|76145247|FG002|STARTED|Infusion 1||5||
60029420|NCT02065245|76145248|FG003|STARTED|Infusion 1||10||
60029421|NCT02065245|76145249|FG004|STARTED|Infusion 1||10||
60029422|NCT02065245|76145250|FG005|STARTED|Infusion 1||10||
60029423|NCT02065245|76145251|FG006|STARTED|Infusion 1||20||
60029424|NCT02065245|76145245|FG000|COMPLETED|Infusion 1||5||
60029425|NCT02065245|76145246|FG001|COMPLETED|Infusion 1||5||
60029426|NCT02065245|76145247|FG002|COMPLETED|Infusion 1||4||
60029427|NCT02065245|76145248|FG003|COMPLETED|Infusion 1||10||
60029428|NCT02065245|76145249|FG004|COMPLETED|Infusion 1||9||
60029429|NCT02065245|76145250|FG005|COMPLETED|Infusion 1||10||
60029430|NCT02065245|76145251|FG006|COMPLETED|Infusion 1||19||
60029431|NCT02065245|76145245|FG000|NOT COMPLETED|Infusion 1||0||
60029432|NCT02065245|76145246|FG001|NOT COMPLETED|Infusion 1||0||
60029433|NCT02065245|76145247|FG002|NOT COMPLETED|Infusion 1||1||
60029434|NCT02065245|76145248|FG003|NOT COMPLETED|Infusion 1||0||
60029435|NCT02065245|76145249|FG004|NOT COMPLETED|Infusion 1||1||
60029436|NCT02065245|76145250|FG005|NOT COMPLETED|Infusion 1||0||
60029437|NCT02065245|76145251|FG006|NOT COMPLETED|Infusion 1||1||
60029438|NCT02065245|76145245|FG000|STARTED|Infusion 2||5||
60029439|NCT02065245|76145246|FG001|STARTED|Infusion 2||5||
60029440|NCT02065245|76145247|FG002|STARTED|Infusion 2||2||
60029441|NCT02065245|76145248|FG003|STARTED|Infusion 2||0||
60029442|NCT02065245|76145249|FG004|STARTED|Infusion 2||0||
60029443|NCT02065245|76145250|FG005|STARTED|Infusion 2||6||
60029444|NCT02065245|76145251|FG006|STARTED|Infusion 2||12||
60029445|NCT02065245|76145245|FG000|COMPLETED|Infusion 2||5||
60029446|NCT02065245|76145246|FG001|COMPLETED|Infusion 2||5||
60029447|NCT02065245|76145247|FG002|COMPLETED|Infusion 2||2||
60029448|NCT02065245|76145248|FG003|COMPLETED|Infusion 2||0||
60029449|NCT02065245|76145249|FG004|COMPLETED|Infusion 2||0||
60029450|NCT02065245|76145250|FG005|COMPLETED|Infusion 2||6||
60029451|NCT02065245|76145251|FG006|COMPLETED|Infusion 2||11||
60029452|NCT02065245|76145245|FG000|NOT COMPLETED|Infusion 2||0||
60029453|NCT02065245|76145246|FG001|NOT COMPLETED|Infusion 2||0||
60029454|NCT02065245|76145247|FG002|NOT COMPLETED|Infusion 2||0||
60029455|NCT02065245|76145248|FG003|NOT COMPLETED|Infusion 2||0||
60029456|NCT02065245|76145249|FG004|NOT COMPLETED|Infusion 2||0||
60029457|NCT02065245|76145250|FG005|NOT COMPLETED|Infusion 2||0||
59916051|NCT03101358|76036906|FG000|NOT COMPLETED|Overall Study||3||
59916052|NCT03101358|76036907|FG001|NOT COMPLETED|Overall Study||0||
59916053|NCT03101358|76036908|FG002|NOT COMPLETED|Overall Study||2||
59916054|NCT03101358|76036909|FG003|NOT COMPLETED|Overall Study||6||
59916055|NCT03657095|76036922|FG000|STARTED|Overall Study||59||
59916056|NCT03657095|76036923|FG001|STARTED|Overall Study||53||
59916057|NCT03657095|76036922|FG000|Received at Least 1 Dose of Study Drug|Overall Study||59||
59916058|NCT03657095|76036923|FG001|Received at Least 1 Dose of Study Drug|Overall Study||53||
59916059|NCT03657095|76036922|FG000|COMPLETED|Overall Study||0||
59916060|NCT03657095|76036923|FG001|COMPLETED|Overall Study||0||
59916061|NCT03657095|76036922|FG000|NOT COMPLETED|Overall Study||59||
59916062|NCT03657095|76036923|FG001|NOT COMPLETED|Overall Study||53||
59916063|NCT03100344|76036933|FG000|STARTED|Overall Study||57||
60029458|NCT02065245|76145251|FG006|NOT COMPLETED|Infusion 2||1||
60029459|NCT02065245|76145245|FG000|STARTED|Infusion 3||3||
60029460|NCT02065245|76145246|FG001|STARTED|Infusion 3||5||
60029461|NCT02065245|76145247|FG002|STARTED|Infusion 3||1||
60029462|NCT02065245|76145248|FG003|STARTED|Infusion 3||0||
60029463|NCT02065245|76145249|FG004|STARTED|Infusion 3||0||
60029464|NCT02065245|76145250|FG005|STARTED|Infusion 3||0||
60029465|NCT02065245|76145251|FG006|STARTED|Infusion 3||0||
59916064|NCT03100344|76036934|FG001|STARTED|Overall Study||55||
59916065|NCT03100344|76036935|FG002|STARTED|Overall Study||57||
59916066|NCT03100344|76036936|FG003|STARTED|Overall Study||57||
59916067|NCT03100344|76036933|FG000|COMPLETED|Overall Study||43||
59916068|NCT03100344|76036934|FG001|COMPLETED|Overall Study||44||
60029466|NCT02065245|76145245|FG000|COMPLETED|Infusion 3||2||
60029467|NCT02065245|76145246|FG001|COMPLETED|Infusion 3||4||
59916069|NCT03100344|76036935|FG002|COMPLETED|Overall Study||50||
60029468|NCT02065245|76145247|FG002|COMPLETED|Infusion 3||1||
60029469|NCT02065245|76145248|FG003|COMPLETED|Infusion 3||0||
60029470|NCT02065245|76145249|FG004|COMPLETED|Infusion 3||0||
60029471|NCT02065245|76145250|FG005|COMPLETED|Infusion 3||0||
60029472|NCT02065245|76145251|FG006|COMPLETED|Infusion 3||0||
60029473|NCT02065245|76145245|FG000|NOT COMPLETED|Infusion 3||1||
59916070|NCT03100344|76036936|FG003|COMPLETED|Overall Study||45||
60029474|NCT02065245|76145246|FG001|NOT COMPLETED|Infusion 3||1||
60029475|NCT02065245|76145247|FG002|NOT COMPLETED|Infusion 3||0||
60029476|NCT02065245|76145248|FG003|NOT COMPLETED|Infusion 3||0||
60029477|NCT02065245|76145249|FG004|NOT COMPLETED|Infusion 3||0||
60029478|NCT02065245|76145250|FG005|NOT COMPLETED|Infusion 3||0||
60029479|NCT02065245|76145251|FG006|NOT COMPLETED|Infusion 3||0||
60029480|NCT02065245|76145245|FG000|STARTED|Infusion 4||1||
60029481|NCT02065245|76145246|FG001|STARTED|Infusion 4||2||
60029482|NCT02065245|76145247|FG002|STARTED|Infusion 4||1||
60029483|NCT02065245|76145248|FG003|STARTED|Infusion 4||0||
60029484|NCT02065245|76145249|FG004|STARTED|Infusion 4||0||
60029485|NCT02065245|76145250|FG005|STARTED|Infusion 4||0||
60029486|NCT02065245|76145251|FG006|STARTED|Infusion 4||0||
60029487|NCT02065245|76145245|FG000|COMPLETED|Infusion 4||1||
60029488|NCT02065245|76145246|FG001|COMPLETED|Infusion 4||2||
60029489|NCT02065245|76145247|FG002|COMPLETED|Infusion 4||1||
60029490|NCT02065245|76145248|FG003|COMPLETED|Infusion 4||0||
60029491|NCT02065245|76145249|FG004|COMPLETED|Infusion 4||0||
60029492|NCT02065245|76145250|FG005|COMPLETED|Infusion 4||0||
60029493|NCT02065245|76145251|FG006|COMPLETED|Infusion 4||0||
60029494|NCT02065245|76145245|FG000|NOT COMPLETED|Infusion 4||0||
60029495|NCT02065245|76145246|FG001|NOT COMPLETED|Infusion 4||0||
60029496|NCT02065245|76145247|FG002|NOT COMPLETED|Infusion 4||0||
60029497|NCT02065245|76145248|FG003|NOT COMPLETED|Infusion 4||0||
60029498|NCT02065245|76145249|FG004|NOT COMPLETED|Infusion 4||0||
60029499|NCT02065245|76145250|FG005|NOT COMPLETED|Infusion 4||0||
60029500|NCT02065245|76145251|FG006|NOT COMPLETED|Infusion 4||0||
60029501|NCT02043015|76145267|FG000|STARTED|Overall Study||115||
60029502|NCT02043015|76145267|FG000|COMPLETED|Overall Study||87||
60029503|NCT02043015|76145267|FG000|NOT COMPLETED|Overall Study||28||
60029504|NCT02064231|76145273|FG000|STARTED|First Test Period (Test A or Test C)||14||
60029505|NCT02064231|76145274|FG001|STARTED|First Test Period (Test A or Test C)||12||
60029506|NCT02064231|76145275|FG002|STARTED|First Test Period (Test A or Test C)||1||
60029507|NCT02064231|76145276|FG003|STARTED|First Test Period (Test A or Test C)||1||
60029508|NCT02064231|76145273|FG000|COMPLETED|First Test Period (Test A or Test C)||7||
60029509|NCT02064231|76145274|FG001|COMPLETED|First Test Period (Test A or Test C)||8||
60029510|NCT02064231|76145275|FG002|COMPLETED|First Test Period (Test A or Test C)||0||
60029511|NCT02064231|76145276|FG003|COMPLETED|First Test Period (Test A or Test C)||1||
60029512|NCT02064231|76145273|FG000|NOT COMPLETED|First Test Period (Test A or Test C)||7||
60029513|NCT02064231|76145274|FG001|NOT COMPLETED|First Test Period (Test A or Test C)||4||
60029514|NCT02064231|76145275|FG002|NOT COMPLETED|First Test Period (Test A or Test C)||1||
60029515|NCT02064231|76145276|FG003|NOT COMPLETED|First Test Period (Test A or Test C)||0||
60029516|NCT02064231|76145273|FG000|STARTED|Second Test Period (Test B or Test D)||7||
60029517|NCT02064231|76145274|FG001|STARTED|Second Test Period (Test B or Test D)||8||
60029518|NCT02064231|76145275|FG002|STARTED|Second Test Period (Test B or Test D)||0||
60029519|NCT02064231|76145276|FG003|STARTED|Second Test Period (Test B or Test D)||1||
60029520|NCT02064231|76145273|FG000|COMPLETED|Second Test Period (Test B or Test D)||6||
60029521|NCT02064231|76145274|FG001|COMPLETED|Second Test Period (Test B or Test D)||7||
60029522|NCT02064231|76145275|FG002|COMPLETED|Second Test Period (Test B or Test D)||0||
60067793|NCT01973569|76182982|FG001|COMPLETED|Overall Study||200||
60029523|NCT02064231|76145276|FG003|COMPLETED|Second Test Period (Test B or Test D)||1||
60029524|NCT02064231|76145273|FG000|NOT COMPLETED|Second Test Period (Test B or Test D)||1||
60029525|NCT02064231|76145274|FG001|NOT COMPLETED|Second Test Period (Test B or Test D)||1||
60029526|NCT02064231|76145275|FG002|NOT COMPLETED|Second Test Period (Test B or Test D)||0||
60029527|NCT02064231|76145276|FG003|NOT COMPLETED|Second Test Period (Test B or Test D)||0||
60029528|NCT02064231|76145273|FG000|STARTED|Third Test Period (Own Product)|One subject who discontinued testing Test A proceeded to test Own product afterwards.|8||
60029529|NCT02064231|76145274|FG001|STARTED|Third Test Period (Own Product)|One subject who discontinued testing Test C proceeded to test Own product afterwards|8||
60029530|NCT02064231|76145275|FG002|STARTED|Third Test Period (Own Product)||0||
60029531|NCT02064231|76145276|FG003|STARTED|Third Test Period (Own Product)||1||
60029532|NCT02064231|76145273|FG000|COMPLETED|Third Test Period (Own Product)||8||
60029533|NCT02064231|76145274|FG001|COMPLETED|Third Test Period (Own Product)||8||
60029534|NCT02064231|76145275|FG002|COMPLETED|Third Test Period (Own Product)||0||
60029535|NCT02064231|76145276|FG003|COMPLETED|Third Test Period (Own Product)||1||
60029536|NCT02064231|76145273|FG000|NOT COMPLETED|Third Test Period (Own Product)||0||
60029537|NCT02064231|76145274|FG001|NOT COMPLETED|Third Test Period (Own Product)||0||
60029538|NCT02064231|76145275|FG002|NOT COMPLETED|Third Test Period (Own Product)||0||
60029539|NCT02064231|76145276|FG003|NOT COMPLETED|Third Test Period (Own Product)||0||
60029540|NCT02063217|76145291|FG000|STARTED|Overall Study||12||
60029541|NCT02063217|76145292|FG001|STARTED|Overall Study||12||
60029542|NCT02063217|76145293|FG002|STARTED|Overall Study||12||
60029543|NCT02063217|76145291|FG000|COMPLETED|Overall Study||11|All participants invited to repeat the study; enrollment totals include repeat participants.|
60029544|NCT02063217|76145292|FG001|COMPLETED|Overall Study||12|All participants invited to repeat the study; enrollment totals include repeat participants.|
60029545|NCT02063217|76145293|FG002|COMPLETED|Overall Study||12|All participants invited to repeat the study; enrollment totals include repeat participants.|
60029546|NCT02063217|76145291|FG000|NOT COMPLETED|Overall Study||1||
60029547|NCT02063217|76145292|FG001|NOT COMPLETED|Overall Study||0||
60029548|NCT02063217|76145293|FG002|NOT COMPLETED|Overall Study||0||
60029549|NCT02497001|76145305|FG000|STARTED|Overall Study||640||
60029550|NCT02497001|76145306|FG001|STARTED|Overall Study||627||
60029551|NCT02497001|76145307|FG002|STARTED|Overall Study||316||
60029552|NCT02497001|76145308|FG003|STARTED|Overall Study||319||
60029553|NCT02497001|76145305|FG000|COMPLETED|Overall Study||566||
60029554|NCT02497001|76145306|FG001|COMPLETED|Overall Study||524||
60029555|NCT02497001|76145307|FG002|COMPLETED|Overall Study||266||
60029556|NCT02497001|76145308|FG003|COMPLETED|Overall Study||278||
60029557|NCT02497001|76145305|FG000|NOT COMPLETED|Overall Study||74||
60029558|NCT02497001|76145306|FG001|NOT COMPLETED|Overall Study||103||
60029559|NCT02497001|76145307|FG002|NOT COMPLETED|Overall Study||50||
60029560|NCT02497001|76145308|FG003|NOT COMPLETED|Overall Study||41||
60029561|NCT02366143|76145324|FG000|STARTED|Overall Study||400||
60029562|NCT02366143|76145325|FG001|STARTED|Overall Study||400||
60029563|NCT02366143|76145326|FG002|STARTED|Overall Study||402||
60029564|NCT02366143|76145324|FG000|COMPLETED|Overall Study||0||
60029565|NCT02366143|76145325|FG001|COMPLETED|Overall Study||0||
60029566|NCT02366143|76145326|FG002|COMPLETED|Overall Study||0||
60029567|NCT02366143|76145324|FG000|NOT COMPLETED|Overall Study||400||
60029568|NCT02366143|76145325|FG001|NOT COMPLETED|Overall Study||400||
60029569|NCT02366143|76145326|FG002|NOT COMPLETED|Overall Study||402||
60029570|NCT02098395|76145342|FG000|STARTED|Overall Study||212||
60029571|NCT02098395|76145343|FG001|STARTED|Overall Study||209||
60029572|NCT02098395|76145344|FG002|STARTED|Overall Study||207||
60029573|NCT02098395|76145345|FG003|STARTED|Overall Study||207||
60029574|NCT02098395|76145342|FG000|Exposed|Overall Study||211||
60029575|NCT02098395|76145343|FG001|Exposed|Overall Study||209||
60029576|NCT02098395|76145344|FG002|Exposed|Overall Study||206||
60029577|NCT02098395|76145345|FG003|Exposed|Overall Study||206||
60029578|NCT02098395|76145342|FG000|COMPLETED|Overall Study||186||
60029579|NCT02098395|76145343|FG001|COMPLETED|Overall Study||177||
60029580|NCT02098395|76145344|FG002|COMPLETED|Overall Study||165||
60029581|NCT02098395|76145345|FG003|COMPLETED|Overall Study||180||
60029582|NCT02098395|76145342|FG000|NOT COMPLETED|Overall Study||26||
60029583|NCT02098395|76145343|FG001|NOT COMPLETED|Overall Study||32||
60029584|NCT02098395|76145344|FG002|NOT COMPLETED|Overall Study||42||
60029585|NCT02098395|76145345|FG003|NOT COMPLETED|Overall Study||27||
60029586|NCT02041923|76145357|FG000|STARTED|Overall Study||102||
60029587|NCT02041923|76145358|FG001|STARTED|Overall Study||96||
60029588|NCT02041923|76145357|FG000|COMPLETED|Overall Study||76||
60029589|NCT02041923|76145358|FG001|COMPLETED|Overall Study||66||
60029590|NCT02041923|76145357|FG000|NOT COMPLETED|Overall Study||26||
60029591|NCT02041923|76145358|FG001|NOT COMPLETED|Overall Study||30||
60029592|NCT02062437|76145366|FG000|STARTED|Overall Study|132 patients who undergone THR (July-Oct 2010), complying with in/exclusion criteria were identified|132||
60029593|NCT02062437|76145366|FG000|COMPLETED|Overall Study|80 patients were effectively enrolled, when coming back for their 2-year follow-up visit.|80||
60029594|NCT02062437|76145366|FG000|NOT COMPLETED|Overall Study||52||
60029595|NCT02365519|76145372|FG000|STARTED|Vehicle Run-In||213||
60029596|NCT02365519|76145373|FG001|STARTED|Vehicle Run-In||0||
60029597|NCT02365519|76145374|FG002|STARTED|Vehicle Run-In||0||
60029598|NCT02365519|76145372|FG000|COMPLETED|Vehicle Run-In||134||
60029599|NCT02365519|76145373|FG001|COMPLETED|Vehicle Run-In||0||
60029600|NCT02365519|76145374|FG002|COMPLETED|Vehicle Run-In||0||
60029601|NCT02365519|76145372|FG000|NOT COMPLETED|Vehicle Run-In||79||
60029602|NCT02365519|76145373|FG001|NOT COMPLETED|Vehicle Run-In||0||
60029603|NCT02365519|76145374|FG002|NOT COMPLETED|Vehicle Run-In||0||
60029604|NCT02365519|76145372|FG000|STARTED|Randomized and Treated||0||
60029605|NCT02365519|76145373|FG001|STARTED|Randomized and Treated||69||
60029606|NCT02365519|76145374|FG002|STARTED|Randomized and Treated||65||
60029607|NCT02365519|76145372|FG000|COMPLETED|Randomized and Treated||0||
60029608|NCT02365519|76145373|FG001|COMPLETED|Randomized and Treated||67||
60029609|NCT02365519|76145374|FG002|COMPLETED|Randomized and Treated||64||
60029610|NCT02365519|76145372|FG000|NOT COMPLETED|Randomized and Treated||0||
60029611|NCT02365519|76145373|FG001|NOT COMPLETED|Randomized and Treated||2||
60029612|NCT02365519|76145374|FG002|NOT COMPLETED|Randomized and Treated||1||
60029613|NCT02061813|76145383|FG000|STARTED|Overall Study||40||160
60029614|NCT02061813|76145383|FG000|Abametapir Lotion|Overall Study||40||40
60029615|NCT02061813|76145383|FG000|Vehicle Lotion|Overall Study||40||40
60029616|NCT02061813|76145383|FG000|Saline 0.9%|Overall Study||40||40
60029617|NCT02061813|76145383|FG000|SLS 0.2%|Overall Study||40||40
60029618|NCT02061813|76145383|FG000|COMPLETED|Overall Study||37||148
60029619|NCT02061813|76145383|FG000|NOT COMPLETED|Overall Study||3||12
60029620|NCT02096835|76145393|FG000|STARTED|Overall Study||53||
60029621|NCT02096835|76145394|FG001|STARTED|Overall Study||53||
60029622|NCT02096835|76145395|FG002|STARTED|Overall Study||51||
60029623|NCT02096835|76145393|FG000|COMPLETED|Overall Study||50||
60029624|NCT02096835|76145394|FG001|COMPLETED|Overall Study||53||
60029625|NCT02096835|76145395|FG002|COMPLETED|Overall Study||50||
60029626|NCT02096835|76145393|FG000|NOT COMPLETED|Overall Study||3||
60029627|NCT02096835|76145394|FG001|NOT COMPLETED|Overall Study||0||
60029628|NCT02096835|76145395|FG002|NOT COMPLETED|Overall Study||1||
60029629|NCT02294773|76145405|FG000|STARTED|Overall Study||7||
60029630|NCT02294773|76145406|FG001|STARTED|Overall Study||6||
60029631|NCT02294773|76145405|FG000|COMPLETED|Overall Study||7||
60029632|NCT02294773|76145406|FG001|COMPLETED|Overall Study||4||
60029633|NCT02294773|76145405|FG000|NOT COMPLETED|Overall Study||0||
60029634|NCT02294773|76145406|FG001|NOT COMPLETED|Overall Study||2||
60029635|NCT02365285|76145416|FG000|STARTED|Overall Study||7||
60029636|NCT02365285|76145417|FG001|STARTED|Overall Study||6||
60029637|NCT02365285|76145418|FG002|STARTED|Overall Study||7||
60029638|NCT02365285|76145419|FG003|STARTED|Overall Study||3||
60029639|NCT02365285|76145416|FG000|COMPLETED|Overall Study||7||
60029640|NCT02365285|76145417|FG001|COMPLETED|Overall Study||5||
60029641|NCT02365285|76145418|FG002|COMPLETED|Overall Study||6||
60029642|NCT02365285|76145419|FG003|COMPLETED|Overall Study||1||
60029643|NCT02365285|76145416|FG000|NOT COMPLETED|Overall Study||0||
60029644|NCT02365285|76145417|FG001|NOT COMPLETED|Overall Study||1||
60029645|NCT02365285|76145418|FG002|NOT COMPLETED|Overall Study||1||
60029646|NCT02365285|76145419|FG003|NOT COMPLETED|Overall Study||2||
60029647|NCT02041299|76145433|FG000|STARTED|Overall Study||152||
60029648|NCT02041299|76145434|FG001|STARTED|Overall Study|Two participants double-enrolled under different subject numbers so were each counted twice.|78||
60029649|NCT02041299|76145433|FG000|COMPLETED|Overall Study||106||
60029650|NCT02041299|76145434|FG001|COMPLETED|Overall Study||58||
60029651|NCT02041299|76145433|FG000|NOT COMPLETED|Overall Study||46||
60029652|NCT02041299|76145434|FG001|NOT COMPLETED|Overall Study||20||
60029653|NCT01645735|76145446|FG000|STARTED|Overall Study||32||
60029654|NCT01645735|76145447|FG001|STARTED|Overall Study||17||
60029655|NCT01645735|76145446|FG000|COMPLETED|Overall Study||28||
60029656|NCT01645735|76145447|FG001|COMPLETED|Overall Study||16||
60029657|NCT01645735|76145446|FG000|NOT COMPLETED|Overall Study||4||
60029658|NCT01645735|76145447|FG001|NOT COMPLETED|Overall Study||1||
60029659|NCT02365207|76145454|FG000|STARTED|Overall Study||6||
60029660|NCT02365207|76145454|FG000|COMPLETED|Overall Study||4||
60029661|NCT02365207|76145454|FG000|NOT COMPLETED|Overall Study||2||
60029662|NCT01645111|76145458|FG000|STARTED|Overall Study||50||
60029663|NCT01645111|76145458|FG000|COMPLETED|Overall Study||35||
60029664|NCT01645111|76145458|FG000|NOT COMPLETED|Overall Study||15||
60029665|NCT02364037|76145464|FG000|STARTED|Overall Study||502||
60029666|NCT02364037|76145465|FG001|STARTED|Overall Study||506||
60029667|NCT02364037|76145464|FG000|COMPLETED|Overall Study||458||
60029668|NCT02364037|76145465|FG001|COMPLETED|Overall Study||453||
60029669|NCT02364037|76145464|FG000|NOT COMPLETED|Overall Study||44||
60029670|NCT02364037|76145465|FG001|NOT COMPLETED|Overall Study||53||
60029671|NCT01919164|76145476|FG000|STARTED|Overall Study||108||
60029672|NCT01919164|76145477|FG001|STARTED|Overall Study||110||
60029673|NCT01919164|76145478|FG002|STARTED|Overall Study||111||
60029674|NCT01919164|76145479|FG003|STARTED|Overall Study||110||
60029675|NCT01919164|76145480|FG004|STARTED|Overall Study||110||
60029676|NCT01919164|76145476|FG000|Safety Analysis Set|Overall Study||107|Arm assignments for participants in Safety Set were based on actual treatment received.|
60067794|NCT01973569|76182983|FG002|COMPLETED|Overall Study||208||
60067795|NCT01973569|76182981|FG000|NOT COMPLETED|Overall Study||29||
60029677|NCT01919164|76145477|FG001|Safety Analysis Set|Overall Study|1 participant assigned to Placebo arm who inadvertently received 30 mcg was included in this arm.|109|Arm assignments for participants in Safety Set were based on actual treatment received.|
60029678|NCT01919164|76145478|FG002|Safety Analysis Set|Overall Study||111|Arm assignments for participants in Safety Set were based on actual treatment received.|
60029679|NCT01919164|76145479|FG003|Safety Analysis Set|Overall Study|1 participant in Sprifermin2 Cycles arm who inadvertently received 100 mcg was included in this arm.|111|Arm assignments for participants in Safety Set were based on actual treatment received.|
60029680|NCT01919164|76145480|FG004|Safety Analysis Set|Overall Study||109|Arm assignments for participants in Safety Set were based on actual treatment received.|
60029681|NCT01919164|76145476|FG000|COMPLETED|Overall Study||65||
60029682|NCT01919164|76145477|FG001|COMPLETED|Overall Study||80||
60029683|NCT01919164|76145478|FG002|COMPLETED|Overall Study||74||
60029684|NCT01919164|76145479|FG003|COMPLETED|Overall Study||82||
60029685|NCT01919164|76145480|FG004|COMPLETED|Overall Study||77||
60029686|NCT01919164|76145476|FG000|NOT COMPLETED|Overall Study||43||
60029687|NCT01919164|76145477|FG001|NOT COMPLETED|Overall Study||30||
60029688|NCT01919164|76145478|FG002|NOT COMPLETED|Overall Study||37||
60029689|NCT01919164|76145479|FG003|NOT COMPLETED|Overall Study||28||
60029690|NCT01919164|76145480|FG004|NOT COMPLETED|Overall Study||33||
60029691|NCT01901224|76145492|FG000|STARTED|Overall Study||2||
60029692|NCT01901224|76145492|FG000|COMPLETED|Overall Study||0||
60029693|NCT01901224|76145492|FG000|NOT COMPLETED|Overall Study||2||
60029694|NCT01901146|76145498|FG000|STARTED|Neoadjuvant Phase||364||
60029695|NCT01901146|76145499|FG001|STARTED|Neoadjuvant Phase||361||
60029696|NCT01901146|76145500|FG002|STARTED|Neoadjuvant Phase||0||
60029697|NCT01901146|76145501|FG003|STARTED|Neoadjuvant Phase||0||
60029698|NCT01901146|76145502|FG004|STARTED|Neoadjuvant Phase||0||
60029699|NCT01901146|76145498|FG000|COMPLETED|Neoadjuvant Phase|Indicates participants who completed surgery|358||
60029700|NCT01901146|76145499|FG001|COMPLETED|Neoadjuvant Phase|Indicates participants who completed surgery|347||
60029701|NCT01901146|76145500|FG002|COMPLETED|Neoadjuvant Phase||0||
60029702|NCT01901146|76145501|FG003|COMPLETED|Neoadjuvant Phase||0||
60029703|NCT01901146|76145502|FG004|COMPLETED|Neoadjuvant Phase||0||
60029704|NCT01901146|76145498|FG000|NOT COMPLETED|Neoadjuvant Phase||6||
60029705|NCT01901146|76145499|FG001|NOT COMPLETED|Neoadjuvant Phase||14||
60029706|NCT01901146|76145500|FG002|NOT COMPLETED|Neoadjuvant Phase||0||
60029707|NCT01901146|76145501|FG003|NOT COMPLETED|Neoadjuvant Phase||0||
60029708|NCT01901146|76145502|FG004|NOT COMPLETED|Neoadjuvant Phase||0||
60029709|NCT01901146|76145498|FG000|STARTED|Adjuvant Phase||0||
60029710|NCT01901146|76145499|FG001|STARTED|Adjuvant Phase||0||
60029711|NCT01901146|76145500|FG002|STARTED|Adjuvant Phase|Nine participants discontinued the study after surgery but before entering adjuvant phase.|349||
60029712|NCT01901146|76145501|FG003|STARTED|Adjuvant Phase|Two participants discontinued the study after surgery but before entering adjuvant phase.|171||
60029713|NCT01901146|76145502|FG004|STARTED|Adjuvant Phase|Three participants discontinued the study after surgery but before entering adjuvant phase.|171||
60029714|NCT01901146|76145498|FG000|COMPLETED|Adjuvant Phase||0||
60029715|NCT01901146|76145499|FG001|COMPLETED|Adjuvant Phase||0||
60029716|NCT01901146|76145500|FG002|COMPLETED|Adjuvant Phase||323||
60029717|NCT01901146|76145501|FG003|COMPLETED|Adjuvant Phase||164||
60029718|NCT01901146|76145502|FG004|COMPLETED|Adjuvant Phase||157||
60029719|NCT01901146|76145498|FG000|NOT COMPLETED|Adjuvant Phase||0||
60029720|NCT01901146|76145499|FG001|NOT COMPLETED|Adjuvant Phase||0||
60029721|NCT01901146|76145500|FG002|NOT COMPLETED|Adjuvant Phase||26||
60029722|NCT01901146|76145501|FG003|NOT COMPLETED|Adjuvant Phase||7||
60029723|NCT01901146|76145502|FG004|NOT COMPLETED|Adjuvant Phase||14||
60029724|NCT01644643|76145515|FG000|STARTED|Overall Study||15||
60029725|NCT01644643|76145516|FG001|STARTED|Overall Study||12||
60029726|NCT01644643|76145517|FG002|STARTED|Overall Study||153||
60029727|NCT01644643|76145518|FG003|STARTED|Overall Study||153||
60029728|NCT01644643|76145515|FG000|COMPLETED|Overall Study||13||
60029729|NCT01644643|76145516|FG001|COMPLETED|Overall Study||12||
60029730|NCT01644643|76145517|FG002|COMPLETED|Overall Study||148||
60029731|NCT01644643|76145518|FG003|COMPLETED|Overall Study||143||
60029732|NCT01644643|76145515|FG000|NOT COMPLETED|Overall Study||2||
60029733|NCT01644643|76145516|FG001|NOT COMPLETED|Overall Study||0||
60029734|NCT01644643|76145517|FG002|NOT COMPLETED|Overall Study||5||
60029735|NCT01644643|76145518|FG003|NOT COMPLETED|Overall Study||10||
60029736|NCT01864564|76145536|FG000|STARTED|Overall Study||480||
60029737|NCT01864564|76145537|FG001|STARTED|Overall Study||482||
60029738|NCT01864564|76145536|FG000|COMPLETED|Overall Study||443||
60029739|NCT01864564|76145537|FG001|COMPLETED|Overall Study||387||
60029740|NCT01864564|76145536|FG000|NOT COMPLETED|Overall Study||37||
60029741|NCT01864564|76145537|FG001|NOT COMPLETED|Overall Study||95||
60029742|NCT01864174|76145545|FG000|STARTED|Double Blind Treatment - All Treated||283||
60029743|NCT01864174|76145546|FG001|STARTED|Double Blind Treatment - All Treated||285||
60029744|NCT01864174|76145545|FG000|COMPLETED|Double Blind Treatment - All Treated||268||
60029745|NCT01864174|76145546|FG001|COMPLETED|Double Blind Treatment - All Treated||271||
60029746|NCT01864174|76145545|FG000|NOT COMPLETED|Double Blind Treatment - All Treated||15||
60029747|NCT01864174|76145546|FG001|NOT COMPLETED|Double Blind Treatment - All Treated||14||
60029748|NCT01864174|76145545|FG000|STARTED|Double Blind - Compliant Randomized||268||
60029749|NCT01864174|76145546|FG001|STARTED|Double Blind - Compliant Randomized||271||
60029750|NCT01864174|76145545|FG000|COMPLETED|Double Blind - Compliant Randomized||245||
60029751|NCT01864174|76145546|FG001|COMPLETED|Double Blind - Compliant Randomized||245||
60029752|NCT01864174|76145545|FG000|NOT COMPLETED|Double Blind - Compliant Randomized||23||
60029753|NCT01864174|76145546|FG001|NOT COMPLETED|Double Blind - Compliant Randomized||26||
60029754|NCT01864174|76145545|FG000|STARTED|Off Treatment Follow-Up||9||
60029755|NCT01864174|76145546|FG001|STARTED|Off Treatment Follow-Up||1||
60029756|NCT01864174|76145545|FG000|COMPLETED|Off Treatment Follow-Up||6||
59507499|NCT02343081|75600811|FG000|COMPLETED|First Intervention (Day 3)||8||
59507500|NCT02343081|75600812|FG001|COMPLETED|First Intervention (Day 3)||8||
59507501|NCT02343081|75600811|FG000|NOT COMPLETED|First Intervention (Day 3)||0||
59507502|NCT02343081|75600812|FG001|NOT COMPLETED|First Intervention (Day 3)||0||
59507503|NCT02343081|75600811|FG000|STARTED|Washout (10 Hours)||8||
59507504|NCT02343081|75600812|FG001|STARTED|Washout (10 Hours)||8||
59507505|NCT02343081|75600811|FG000|COMPLETED|Washout (10 Hours)||8||
59507506|NCT02343081|75600812|FG001|COMPLETED|Washout (10 Hours)||8||
59507507|NCT02343081|75600811|FG000|NOT COMPLETED|Washout (10 Hours)||0||
59507508|NCT02343081|75600812|FG001|NOT COMPLETED|Washout (10 Hours)||0||
59507509|NCT02343081|75600811|FG000|STARTED|Second Intervention (Day 4)||8||
59507510|NCT02343081|75600812|FG001|STARTED|Second Intervention (Day 4)||8||
59507511|NCT02343081|75600811|FG000|Received Intervention|Second Intervention (Day 4)||8||
59507512|NCT02343081|75600812|FG001|Received Intervention|Second Intervention (Day 4)||8||
59507513|NCT02343081|75600811|FG000|COMPLETED|Second Intervention (Day 4)||8||
59507514|NCT02343081|75600812|FG001|COMPLETED|Second Intervention (Day 4)||8||
59507515|NCT02343081|75600811|FG000|NOT COMPLETED|Second Intervention (Day 4)||0||
59507516|NCT02343081|75600812|FG001|NOT COMPLETED|Second Intervention (Day 4)||0||
59507517|NCT02343627|75600820|FG000|STARTED|Overall Study||35||
59507518|NCT02343627|75600821|FG001|STARTED|Overall Study||12||
59507519|NCT02343627|75600820|FG000|COMPLETED|Overall Study||23||
59507520|NCT02343627|75600821|FG001|COMPLETED|Overall Study||11||
59507521|NCT02343627|75600820|FG000|NOT COMPLETED|Overall Study||12||
59507522|NCT02343627|75600821|FG001|NOT COMPLETED|Overall Study||1||
59507523|NCT00823069|75600827|FG000|STARTED|Overall Study||60||
59507524|NCT00823069|75600827|FG000|COMPLETED|Overall Study||60||
60029757|NCT01864174|76145546|FG001|COMPLETED|Off Treatment Follow-Up||1||
60029758|NCT01864174|76145545|FG000|NOT COMPLETED|Off Treatment Follow-Up||3||
60029759|NCT01864174|76145546|FG001|NOT COMPLETED|Off Treatment Follow-Up||0||
59507525|NCT00823069|75600827|FG000|NOT COMPLETED|Overall Study||0||
60029760|NCT01900444|76145552|FG000|STARTED|Overall Study||119||
60029761|NCT01900444|76145552|FG000|COMPLETED|Overall Study||116||
60029762|NCT01900444|76145552|FG000|NOT COMPLETED|Overall Study||3||
60029763|NCT02294227|76145559|FG000|STARTED|Overall Study||114||
60029764|NCT02294227|76145560|FG001|STARTED|Overall Study||113||
60029765|NCT02294227|76145561|FG002|STARTED|Overall Study||114||
60029766|NCT02294227|76145559|FG000|COMPLETED|Overall Study||89|Completed Week 104|
60029767|NCT02294227|76145560|FG001|COMPLETED|Overall Study||88|Completed Week 104|
59507526|NCT00823303|75600836|FG000|STARTED|Overall Study||54||
59507527|NCT00823303|75600837|FG001|STARTED|Overall Study||56||
59507528|NCT00823303|75600836|FG000|COMPLETED|Overall Study||45||
59507529|NCT00823303|75600837|FG001|COMPLETED|Overall Study||45||
60029768|NCT02294227|76145561|FG002|COMPLETED|Overall Study||95|Completed Week 104|
60029769|NCT02294227|76145559|FG000|NOT COMPLETED|Overall Study||25||
60029770|NCT02294227|76145560|FG001|NOT COMPLETED|Overall Study||25||
59611804|NCT01707030|75722815|FG000|COMPLETED|Overall Study||56||
59611805|NCT01707030|75722816|FG001|COMPLETED|Overall Study||54||
60029771|NCT02294227|76145561|FG002|NOT COMPLETED|Overall Study||19||
60029772|NCT02496767|76145575|FG000|STARTED|Open-label Lead-in Phase||744||
60029773|NCT02496767|76145576|FG001|STARTED|Open-label Lead-in Phase||0||
60029774|NCT02496767|76145577|FG002|STARTED|Open-label Lead-in Phase||0||
60029775|NCT02496767|76145578|FG003|STARTED|Open-label Lead-in Phase||0||
60029776|NCT02496767|76145579|FG004|STARTED|Open-label Lead-in Phase||0||
60029777|NCT02496767|76145580|FG005|STARTED|Open-label Lead-in Phase||0||
60029778|NCT02496767|76145581|FG006|STARTED|Open-label Lead-in Phase||0||
60029779|NCT02496767|76145582|FG007|STARTED|Open-label Lead-in Phase||0||
60029780|NCT02496767|76145575|FG000|COMPLETED|Open-label Lead-in Phase||565||
60029781|NCT02496767|76145576|FG001|COMPLETED|Open-label Lead-in Phase||0||
60029782|NCT02496767|76145577|FG002|COMPLETED|Open-label Lead-in Phase||0||
59916071|NCT03100344|76036933|FG000|NOT COMPLETED|Overall Study||14||
59916072|NCT03100344|76036934|FG001|NOT COMPLETED|Overall Study||11||
59916073|NCT03100344|76036935|FG002|NOT COMPLETED|Overall Study||7||
59916074|NCT03100344|76036936|FG003|NOT COMPLETED|Overall Study||12||
59916075|NCT02951533|76036949|FG000|STARTED|Part I (Week 0 Through Week 24)||60||
59916076|NCT02951533|76036950|FG001|STARTED|Part I (Week 0 Through Week 24)||59||
59916077|NCT02951533|76036951|FG002|STARTED|Part I (Week 0 Through Week 24)||0||
59507530|NCT00823303|75600836|FG000|NOT COMPLETED|Overall Study||9||
59507531|NCT00823303|75600837|FG001|NOT COMPLETED|Overall Study||11||
59507532|NCT02344251|75600845|FG000|STARTED|Overall Study||20||
59507533|NCT02344251|75600846|FG001|STARTED|Overall Study||20||
59507534|NCT02344251|75600845|FG000|COMPLETED|Overall Study||20||
59507535|NCT02344251|75600846|FG001|COMPLETED|Overall Study||20||
59507536|NCT02344251|75600845|FG000|NOT COMPLETED|Overall Study||0||
59507537|NCT02344251|75600846|FG001|NOT COMPLETED|Overall Study||0||
59507538|NCT02344407|75600857|FG000|STARTED|Overall Study||500||
59507539|NCT02344407|75600858|FG001|STARTED|Overall Study||500||
59916078|NCT02951533|76036949|FG000|Treated|Part I (Week 0 Through Week 24)||60||
59916079|NCT02951533|76036950|FG001|Treated|Part I (Week 0 Through Week 24)||58||
59507540|NCT02344407|75600859|FG002|STARTED|Overall Study||500||
59611806|NCT01707030|75722815|FG000|NOT COMPLETED|Overall Study||11||
59611807|NCT01707030|75722816|FG001|NOT COMPLETED|Overall Study||17||
59507541|NCT02344407|75600857|FG000|COMPLETED|Overall Study||492||
59507542|NCT02344407|75600858|FG001|COMPLETED|Overall Study||491||
59611808|NCT01755156|75722828|FG000|STARTED|Phase A (Weeks 0-24)||201||
59611809|NCT01755156|75722829|FG001|STARTED|Phase A (Weeks 0-24)||201||
59611810|NCT01755156|75722828|FG000|COMPLETED|Phase A (Weeks 0-24)||184||
59611811|NCT01755156|75722829|FG001|COMPLETED|Phase A (Weeks 0-24)||177||
59611812|NCT01755156|75722828|FG000|NOT COMPLETED|Phase A (Weeks 0-24)||17||
59611813|NCT01755156|75722829|FG001|NOT COMPLETED|Phase A (Weeks 0-24)||24||
59611814|NCT01755156|75722828|FG000|STARTED|Phase B (Weeks 24-104)|1 participant who completed Phase A did not continue to Phase B.|183||
59611815|NCT01755156|75722829|FG001|STARTED|Phase B (Weeks 24-104)||177||
59611816|NCT01755156|75722828|FG000|COMPLETED|Phase B (Weeks 24-104)||144||
59916080|NCT02951533|76036951|FG002|Treated|Part I (Week 0 Through Week 24)||0||
59916081|NCT02951533|76036949|FG000|COMPLETED|Part I (Week 0 Through Week 24)||56||
59916082|NCT02951533|76036950|FG001|COMPLETED|Part I (Week 0 Through Week 24)||36||
60029783|NCT02496767|76145578|FG003|COMPLETED|Open-label Lead-in Phase||0||
60029784|NCT02496767|76145579|FG004|COMPLETED|Open-label Lead-in Phase||0||
60029785|NCT02496767|76145580|FG005|COMPLETED|Open-label Lead-in Phase||0||
60029786|NCT02496767|76145581|FG006|COMPLETED|Open-label Lead-in Phase||0||
60029787|NCT02496767|76145582|FG007|COMPLETED|Open-label Lead-in Phase||0||
59507543|NCT02344407|75600859|FG002|COMPLETED|Overall Study||494||
59507544|NCT02344407|75600857|FG000|NOT COMPLETED|Overall Study||8||
59507545|NCT02344407|75600858|FG001|NOT COMPLETED|Overall Study||9||
59507546|NCT02344407|75600859|FG002|NOT COMPLETED|Overall Study||6||
59507547|NCT00823459|75600867|FG000|STARTED|Overall Study||58||
59611817|NCT01755156|75722829|FG001|COMPLETED|Phase B (Weeks 24-104)||141||
59611818|NCT01755156|75722828|FG000|NOT COMPLETED|Phase B (Weeks 24-104)||39||
59611819|NCT01755156|75722829|FG001|NOT COMPLETED|Phase B (Weeks 24-104)||36||
59611820|NCT01754922|75722841|FG000|STARTED|Overall Study||32||
59611821|NCT01754922|75722842|FG001|STARTED|Overall Study||18||
59611822|NCT01754922|75722841|FG000|COMPLETED|Overall Study||32||
59611823|NCT01754922|75722842|FG001|COMPLETED|Overall Study||17||
59611824|NCT01754922|75722841|FG000|NOT COMPLETED|Overall Study||0||
59611825|NCT01754922|75722842|FG001|NOT COMPLETED|Overall Study||1||
59611826|NCT01754766|75722852|FG000|STARTED|Overall Study||31||
59611827|NCT01754766|75722853|FG001|STARTED|Overall Study||29||
59611828|NCT01754766|75722854|FG002|STARTED|Overall Study||30||
59611829|NCT01754766|75722852|FG000|COMPLETED|Overall Study||30||
59611830|NCT01754766|75722853|FG001|COMPLETED|Overall Study||28||
59611831|NCT01754766|75722854|FG002|COMPLETED|Overall Study||30||
59611832|NCT01754766|75722852|FG000|NOT COMPLETED|Overall Study||1||
59611833|NCT01754766|75722853|FG001|NOT COMPLETED|Overall Study||1||
59611834|NCT01754766|75722854|FG002|NOT COMPLETED|Overall Study||0||
59611835|NCT01754376|75722862|FG000|STARTED|Overall Study||6||
59611836|NCT01754376|75722862|FG000|Completed 2-week Lead in of Vemurafenib|Overall Study||6||
59611837|NCT01754376|75722862|FG000|COMPLETED|Overall Study||3||
59507548|NCT00823459|75600867|FG000|COMPLETED|Overall Study||58||
59507549|NCT00823459|75600867|FG000|NOT COMPLETED|Overall Study||0||
59507550|NCT02411565|75600874|FG000|STARTED|Overall Study||1||
59507551|NCT02411565|75600875|FG001|STARTED|Overall Study||2||
59507552|NCT02411565|75600874|FG000|COMPLETED|Overall Study||1||
59507553|NCT02411565|75600875|FG001|COMPLETED|Overall Study||2||
59507554|NCT02411565|75600874|FG000|NOT COMPLETED|Overall Study||0||
59507555|NCT02411565|75600875|FG001|NOT COMPLETED|Overall Study||0||
59507556|NCT02020785|75600883|FG000|STARTED|First Intervention (3 Weeks)||15||
59507557|NCT02020785|75600884|FG001|STARTED|First Intervention (3 Weeks)||16||
59507558|NCT02020785|75600883|FG000|COMPLETED|First Intervention (3 Weeks)||15||
59507559|NCT02020785|75600884|FG001|COMPLETED|First Intervention (3 Weeks)||16||
59507560|NCT02020785|75600883|FG000|NOT COMPLETED|First Intervention (3 Weeks)||0||
59759229|NCT04654754|75878598|FG000|NOT COMPLETED|High-flow High-humidity With Adapter||0||
59759230|NCT04654754|75878598|FG000|STARTED|LVN With Trach Collar||12||
59916083|NCT02951533|76036951|FG002|COMPLETED|Part I (Week 0 Through Week 24)||0||
59759231|NCT04654754|75878598|FG000|COMPLETED|LVN With Trach Collar||12||
59759232|NCT04654754|75878598|FG000|NOT COMPLETED|LVN With Trach Collar||0||
59759233|NCT04654754|75878598|FG000|STARTED|Venturi With Trach Collar||12||
59916084|NCT02951533|76036949|FG000|NOT COMPLETED|Part I (Week 0 Through Week 24)||4||
59916085|NCT02951533|76036950|FG001|NOT COMPLETED|Part I (Week 0 Through Week 24)||23||
59916086|NCT02951533|76036951|FG002|NOT COMPLETED|Part I (Week 0 Through Week 24)||0||
59916087|NCT02951533|76036949|FG000|STARTED|Part IIa (Week 24 Through Week 32)||56||
59916088|NCT02951533|76036950|FG001|STARTED|Part IIa (Week 24 Through Week 32)|1 participant did not sign informed consent form (ICF) for Study Part II but completed Study Part I.|35||
59916089|NCT02951533|76036951|FG002|STARTED|Part IIa (Week 24 Through Week 32)||0||
59916090|NCT02951533|76036949|FG000|PASI 75 Responder at Week 32|Part IIa (Week 24 Through Week 32)||54||
59916091|NCT02951533|76036950|FG001|PASI 75 Responder at Week 32|Part IIa (Week 24 Through Week 32)||14||
59916092|NCT02951533|76036951|FG002|PASI 75 Responder at Week 32|Part IIa (Week 24 Through Week 32)||0||
59916093|NCT02951533|76036949|FG000|PASI 75 Non-responder at Week 32|Part IIa (Week 24 Through Week 32)||1||
60029788|NCT02496767|76145575|FG000|NOT COMPLETED|Open-label Lead-in Phase||179||
60029789|NCT02496767|76145576|FG001|NOT COMPLETED|Open-label Lead-in Phase||0||
60029790|NCT02496767|76145577|FG002|NOT COMPLETED|Open-label Lead-in Phase||0||
60029791|NCT02496767|76145578|FG003|NOT COMPLETED|Open-label Lead-in Phase||0||
60029792|NCT02496767|76145579|FG004|NOT COMPLETED|Open-label Lead-in Phase||0||
60029793|NCT02496767|76145580|FG005|NOT COMPLETED|Open-label Lead-in Phase||0||
59759234|NCT04654754|75878598|FG000|COMPLETED|Venturi With Trach Collar||12||
59759235|NCT04654754|75878598|FG000|NOT COMPLETED|Venturi With Trach Collar||0||
59759236|NCT04654754|75878598|FG000|STARTED|High-flow High-humidity With Scavenger||12||
59759237|NCT04654754|75878598|FG000|COMPLETED|High-flow High-humidity With Scavenger||12||
59759238|NCT04654754|75878598|FG000|NOT COMPLETED|High-flow High-humidity With Scavenger||0||
59759239|NCT00561925|75878606|FG000|STARTED|14 Day Lead-In Period||1068||
59759240|NCT00561925|75878607|FG001|STARTED|14 Day Lead-In Period||0||
59759241|NCT00561925|75878608|FG002|STARTED|14 Day Lead-In Period||0||
59759242|NCT00561925|75878609|FG003|STARTED|14 Day Lead-In Period||0||
59759243|NCT00561925|75878610|FG004|STARTED|14 Day Lead-In Period||0||
59759244|NCT00561925|75878606|FG000|COMPLETED|14 Day Lead-In Period||1013||
59759245|NCT00561925|75878607|FG001|COMPLETED|14 Day Lead-In Period||0||
59759246|NCT00561925|75878608|FG002|COMPLETED|14 Day Lead-In Period||0||
59759247|NCT00561925|75878609|FG003|COMPLETED|14 Day Lead-In Period||0||
59759248|NCT00561925|75878610|FG004|COMPLETED|14 Day Lead-In Period||0||
59759249|NCT00561925|75878606|FG000|NOT COMPLETED|14 Day Lead-In Period||55||
59759250|NCT00561925|75878607|FG001|NOT COMPLETED|14 Day Lead-In Period||0||
59759251|NCT00561925|75878608|FG002|NOT COMPLETED|14 Day Lead-In Period||0||
59759252|NCT00561925|75878609|FG003|NOT COMPLETED|14 Day Lead-In Period||0||
59759253|NCT00561925|75878610|FG004|NOT COMPLETED|14 Day Lead-In Period||0||
59759254|NCT00561925|75878606|FG000|STARTED|144-week Double-blind, Double-dummy||0||
59759255|NCT00561925|75878607|FG001|STARTED|144-week Double-blind, Double-dummy||508||
59759256|NCT00561925|75878608|FG002|STARTED|144-week Double-blind, Double-dummy||505||
59759257|NCT00561925|75878609|FG003|STARTED|144-week Double-blind, Double-dummy||0||
59507561|NCT02020785|75600884|FG001|NOT COMPLETED|First Intervention (3 Weeks)||0||
59507562|NCT02020785|75600883|FG000|STARTED|Second Intervention (3 Weeks)||15||
59507563|NCT02020785|75600884|FG001|STARTED|Second Intervention (3 Weeks)||16||
59507564|NCT02020785|75600883|FG000|COMPLETED|Second Intervention (3 Weeks)||15||
59759258|NCT00561925|75878610|FG004|STARTED|144-week Double-blind, Double-dummy||0||
59507565|NCT02020785|75600884|FG001|COMPLETED|Second Intervention (3 Weeks)||16||
59507566|NCT02020785|75600883|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||0||
59507567|NCT02020785|75600884|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0||
59507568|NCT00825565|75600890|FG000|STARTED|Overall Study||8||
60029794|NCT02496767|76145581|FG006|NOT COMPLETED|Open-label Lead-in Phase||0||
60029795|NCT02496767|76145582|FG007|NOT COMPLETED|Open-label Lead-in Phase||0||
60029796|NCT02496767|76145575|FG000|STARTED|Double-blind, Placebo-controlled Phase||0||
60029797|NCT02496767|76145576|FG001|STARTED|Double-blind, Placebo-controlled Phase||188||
60029798|NCT02496767|76145577|FG002|STARTED|Double-blind, Placebo-controlled Phase||126||
60029799|NCT02496767|76145578|FG003|STARTED|Double-blind, Placebo-controlled Phase||126||
60029800|NCT02496767|76145579|FG004|STARTED|Double-blind, Placebo-controlled Phase||125||
60029801|NCT02496767|76145580|FG005|STARTED|Double-blind, Placebo-controlled Phase||0||
60029802|NCT02496767|76145581|FG006|STARTED|Double-blind, Placebo-controlled Phase||0||
60029803|NCT02496767|76145582|FG007|STARTED|Double-blind, Placebo-controlled Phase||0||
60029804|NCT02496767|76145575|FG000|COMPLETED|Double-blind, Placebo-controlled Phase||0||
60029805|NCT02496767|76145576|FG001|COMPLETED|Double-blind, Placebo-controlled Phase||132||
60029806|NCT02496767|76145577|FG002|COMPLETED|Double-blind, Placebo-controlled Phase||80||
60029807|NCT02496767|76145578|FG003|COMPLETED|Double-blind, Placebo-controlled Phase||65||
60029808|NCT02496767|76145579|FG004|COMPLETED|Double-blind, Placebo-controlled Phase||59||
60029809|NCT02496767|76145580|FG005|COMPLETED|Double-blind, Placebo-controlled Phase||0||
60029810|NCT02496767|76145581|FG006|COMPLETED|Double-blind, Placebo-controlled Phase||0||
60029811|NCT02496767|76145582|FG007|COMPLETED|Double-blind, Placebo-controlled Phase||0||
60029812|NCT02496767|76145575|FG000|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0||
60029813|NCT02496767|76145576|FG001|NOT COMPLETED|Double-blind, Placebo-controlled Phase||56||
59507569|NCT00825565|75600890|FG000|COMPLETED|Overall Study||8||
59507570|NCT00825565|75600890|FG000|NOT COMPLETED|Overall Study||0||
59507571|NCT02345031|75600902|FG000|STARTED|Overall Study||38||
59507572|NCT02345031|75600903|FG001|STARTED|Overall Study||40||
59507573|NCT02345031|75600902|FG000|COMPLETED|Overall Study||37||
59507574|NCT02345031|75600903|FG001|COMPLETED|Overall Study||39||
59507575|NCT02345031|75600902|FG000|NOT COMPLETED|Overall Study||1||
59507576|NCT02345031|75600903|FG001|NOT COMPLETED|Overall Study||1||
59507577|NCT00803647|75600911|FG000|STARTED|Overall Study||20||
59507578|NCT00803647|75600911|FG000|COMPLETED|Overall Study||20||
59507579|NCT00803647|75600911|FG000|NOT COMPLETED|Overall Study||0||
59507580|NCT00827983|75600917|FG000|STARTED|Overall Study|All randomised patients|339||
59507581|NCT00827983|75600918|FG001|STARTED|Overall Study|all randomised patients|344||
59507582|NCT00827983|75600917|FG000|COMPLETED|Overall Study|patients who performed the pregnancy test|321||
59507583|NCT00827983|75600918|FG001|COMPLETED|Overall Study|patients who performed the pregnancy test|328||
59507584|NCT00827983|75600917|FG000|NOT COMPLETED|Overall Study||18||
59507585|NCT00827983|75600918|FG001|NOT COMPLETED|Overall Study||16||
59507586|NCT02412501|75600924|FG000|STARTED|Overall Study||101||
59507587|NCT02412501|75600924|FG000|COMPLETED|Overall Study||101||
59507588|NCT02412501|75600924|FG000|NOT COMPLETED|Overall Study||0||
59507589|NCT02346903|75600929|FG000|STARTED|Overall Study||99||
59507590|NCT02346903|75600929|FG000|COMPLETED|Overall Study||99||
59507591|NCT02346903|75600929|FG000|NOT COMPLETED|Overall Study||0||
59507592|NCT00844051|75600935|FG000|STARTED|Overall Study||2087||
59507593|NCT00844051|75600936|FG001|STARTED|Overall Study||2368||
59507594|NCT00844051|75600935|FG000|COMPLETED|Overall Study||2087||
59507595|NCT00844051|75600936|FG001|COMPLETED|Overall Study||2368||
59507596|NCT00844051|75600935|FG000|NOT COMPLETED|Overall Study||0||
59507597|NCT00844051|75600936|FG001|NOT COMPLETED|Overall Study||0||
59507598|NCT02347605|75600948|FG000|STARTED|Overall Study||10||
59507599|NCT02347605|75600949|FG001|STARTED|Overall Study||10||
59507600|NCT02347605|75600950|FG002|STARTED|Overall Study||8||
59507601|NCT02347605|75600951|FG003|STARTED|Overall Study||10||
59507602|NCT02347605|75600952|FG004|STARTED|Overall Study||9||
59507603|NCT02347605|75600953|FG005|STARTED|Overall Study||9||
59507604|NCT02347605|75600948|FG000|Completed Lab 1|Overall Study||10||
59507605|NCT02347605|75600949|FG001|Completed Lab 1|Overall Study||10||
59507606|NCT02347605|75600950|FG002|Completed Lab 1|Overall Study||8||
59507607|NCT02347605|75600951|FG003|Completed Lab 1|Overall Study||10||
59507608|NCT02347605|75600952|FG004|Completed Lab 1|Overall Study||8||
60029814|NCT02496767|76145577|FG002|NOT COMPLETED|Double-blind, Placebo-controlled Phase||46||
59507609|NCT02347605|75600953|FG005|Completed Lab 1|Overall Study||9||
59507610|NCT02347605|75600948|FG000|Completed Lab 2|Overall Study||7||
59507611|NCT02347605|75600949|FG001|Completed Lab 2|Overall Study||7||
59507612|NCT02347605|75600950|FG002|Completed Lab 2|Overall Study||7||
59507613|NCT02347605|75600951|FG003|Completed Lab 2|Overall Study||7||
59507614|NCT02347605|75600952|FG004|Completed Lab 2|Overall Study||6||
59507615|NCT02347605|75600953|FG005|Completed Lab 2|Overall Study||8||
59507616|NCT02347605|75600948|FG000|COMPLETED|Overall Study||7|Completed lab 3 (and therefore the entire study)|
59507617|NCT02347605|75600949|FG001|COMPLETED|Overall Study||7|Completed lab 3 (and therefore the entire study)|
59507618|NCT02347605|75600950|FG002|COMPLETED|Overall Study||7|Completed lab 3 (and therefore the entire study)|
59507619|NCT02347605|75600951|FG003|COMPLETED|Overall Study||6|Completed lab 3 (and therefore the entire study)|
59507620|NCT02347605|75600952|FG004|COMPLETED|Overall Study||6|Completed lab 3 (and therefore the entire study)|
59507621|NCT02347605|75600953|FG005|COMPLETED|Overall Study||7|Completed lab 3 (and therefore the entire study)|
59507622|NCT02347605|75600948|FG000|NOT COMPLETED|Overall Study||3||
59507623|NCT02347605|75600949|FG001|NOT COMPLETED|Overall Study||3||
59507624|NCT02347605|75600950|FG002|NOT COMPLETED|Overall Study||1||
59916094|NCT02951533|76036950|FG001|PASI 75 Non-responder at Week 32|Part IIa (Week 24 Through Week 32)||20||
59507625|NCT02347605|75600951|FG003|NOT COMPLETED|Overall Study||4||
59507626|NCT02347605|75600952|FG004|NOT COMPLETED|Overall Study||3||
59507627|NCT02347605|75600953|FG005|NOT COMPLETED|Overall Study||2||
59507628|NCT02410161|75600963|FG000|STARTED|Overall Study||10||
59507629|NCT02410161|75600964|FG001|STARTED|Overall Study||10||
59507630|NCT02410161|75600963|FG000|COMPLETED|Overall Study||10||
59507631|NCT02410161|75600964|FG001|COMPLETED|Overall Study||10||
59507632|NCT02410161|75600963|FG000|NOT COMPLETED|Overall Study||0||
59507633|NCT02410161|75600964|FG001|NOT COMPLETED|Overall Study||0||
59507634|NCT02348619|75600970|FG000|STARTED|Titration Phase||174||
59507635|NCT02348619|75600971|FG001|STARTED|Titration Phase||0||
59507636|NCT02348619|75600970|FG000|COMPLETED|Titration Phase||157||
59507637|NCT02348619|75600971|FG001|COMPLETED|Titration Phase||0||
59507638|NCT02348619|75600970|FG000|NOT COMPLETED|Titration Phase||17||
59507639|NCT02348619|75600971|FG001|NOT COMPLETED|Titration Phase||0||
59507640|NCT02348619|75600970|FG000|STARTED|Stable-Dose Phase||157||
59507641|NCT02348619|75600971|FG001|STARTED|Stable-Dose Phase||0||
59507642|NCT02348619|75600970|FG000|COMPLETED|Stable-Dose Phase||124||
59507643|NCT02348619|75600971|FG001|COMPLETED|Stable-Dose Phase||0||
59507644|NCT02348619|75600970|FG000|NOT COMPLETED|Stable-Dose Phase||33||
59507645|NCT02348619|75600971|FG001|NOT COMPLETED|Stable-Dose Phase||0||
59507646|NCT02348619|75600970|FG000|STARTED|Double-Blind Withdrawal Phase||62||
59507647|NCT02348619|75600971|FG001|STARTED|Double-Blind Withdrawal Phase||62||
59507648|NCT02348619|75600970|FG000|COMPLETED|Double-Blind Withdrawal Phase||60||
59507649|NCT02348619|75600971|FG001|COMPLETED|Double-Blind Withdrawal Phase||62||
59507650|NCT02348619|75600970|FG000|NOT COMPLETED|Double-Blind Withdrawal Phase||2||
59507651|NCT02348619|75600971|FG001|NOT COMPLETED|Double-Blind Withdrawal Phase||0||
59507652|NCT02153671|75600979|FG000|STARTED|Overall Study||19||
59507653|NCT02153671|75600980|FG001|STARTED|Overall Study||24||
59507654|NCT02153671|75600979|FG000|COMPLETED|Overall Study||19||
59507655|NCT02153671|75600980|FG001|COMPLETED|Overall Study||24||
59507656|NCT02153671|75600979|FG000|NOT COMPLETED|Overall Study||0||
59611838|NCT01754376|75722862|FG000|NOT COMPLETED|Overall Study||3||
60029815|NCT02496767|76145578|FG003|NOT COMPLETED|Double-blind, Placebo-controlled Phase||61||
60029816|NCT02496767|76145579|FG004|NOT COMPLETED|Double-blind, Placebo-controlled Phase||66||
60029817|NCT02496767|76145580|FG005|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0||
60029818|NCT02496767|76145581|FG006|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0||
60029819|NCT02496767|76145582|FG007|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0||
60029820|NCT02496767|76145575|FG000|STARTED|Double-blind, Withdrawal Phase||0||
60029821|NCT02496767|76145576|FG001|STARTED|Double-blind, Withdrawal Phase||0||
60029822|NCT02496767|76145577|FG002|STARTED|Double-blind, Withdrawal Phase||0||
59916095|NCT02951533|76036951|FG002|PASI 75 Non-responder at Week 32|Part IIa (Week 24 Through Week 32)||0||
59916096|NCT02951533|76036949|FG000|COMPLETED|Part IIa (Week 24 Through Week 32)||55||
59916097|NCT02951533|76036950|FG001|COMPLETED|Part IIa (Week 24 Through Week 32)||34||
59916098|NCT02951533|76036951|FG002|COMPLETED|Part IIa (Week 24 Through Week 32)||0||
59916099|NCT02951533|76036949|FG000|NOT COMPLETED|Part IIa (Week 24 Through Week 32)||1||
59916100|NCT02951533|76036950|FG001|NOT COMPLETED|Part IIa (Week 24 Through Week 32)||1||
59916101|NCT02951533|76036951|FG002|NOT COMPLETED|Part IIa (Week 24 Through Week 32)||0||
59916102|NCT02951533|76036949|FG000|STARTED|Part IIb (Week 32 Through Week 56)||55||
60029823|NCT02496767|76145578|FG003|STARTED|Double-blind, Withdrawal Phase||0||
60029824|NCT02496767|76145579|FG004|STARTED|Double-blind, Withdrawal Phase||0||
60029825|NCT02496767|76145580|FG005|STARTED|Double-blind, Withdrawal Phase||132||
60029826|NCT02496767|76145581|FG006|STARTED|Double-blind, Withdrawal Phase||103||
60029827|NCT02496767|76145582|FG007|STARTED|Double-blind, Withdrawal Phase||101||
60029828|NCT02496767|76145575|FG000|COMPLETED|Double-blind, Withdrawal Phase||0||
60029829|NCT02496767|76145576|FG001|COMPLETED|Double-blind, Withdrawal Phase||0||
60029830|NCT02496767|76145577|FG002|COMPLETED|Double-blind, Withdrawal Phase||0||
60029831|NCT02496767|76145578|FG003|COMPLETED|Double-blind, Withdrawal Phase||0||
60029832|NCT02496767|76145579|FG004|COMPLETED|Double-blind, Withdrawal Phase||0||
60029833|NCT02496767|76145580|FG005|COMPLETED|Double-blind, Withdrawal Phase||126||
60029834|NCT02496767|76145581|FG006|COMPLETED|Double-blind, Withdrawal Phase||99||
60029835|NCT02496767|76145582|FG007|COMPLETED|Double-blind, Withdrawal Phase||96||
60029836|NCT02496767|76145575|FG000|NOT COMPLETED|Double-blind, Withdrawal Phase||0||
59951364|NCT02949921|76070316|FG001|STARTED|Overall Study||10||
59507657|NCT02153671|75600980|FG001|NOT COMPLETED|Overall Study||0||
59507658|NCT02413203|75600988|FG000|STARTED|Overall Study||10||
59507659|NCT02413203|75600989|FG001|STARTED|Overall Study||10||
59507660|NCT02413203|75600988|FG000|COMPLETED|Overall Study||10||
60029837|NCT02496767|76145576|FG001|NOT COMPLETED|Double-blind, Withdrawal Phase||0||
59951365|NCT02949921|76070315|FG000|COMPLETED|Overall Study||10||
60029838|NCT02496767|76145577|FG002|NOT COMPLETED|Double-blind, Withdrawal Phase||0||
60029839|NCT02496767|76145578|FG003|NOT COMPLETED|Double-blind, Withdrawal Phase||0||
60029840|NCT02496767|76145579|FG004|NOT COMPLETED|Double-blind, Withdrawal Phase||0||
60029841|NCT02496767|76145580|FG005|NOT COMPLETED|Double-blind, Withdrawal Phase||6||
60029842|NCT02496767|76145581|FG006|NOT COMPLETED|Double-blind, Withdrawal Phase||4||
60029843|NCT02496767|76145582|FG007|NOT COMPLETED|Double-blind, Withdrawal Phase||5||
60029844|NCT02496533|76145598|FG000|STARTED|Overall Study||105||
60029845|NCT02496533|76145599|FG001|STARTED|Overall Study||112||
60029846|NCT02496533|76145598|FG000|COMPLETED|Overall Study||102||
60029847|NCT02496533|76145599|FG001|COMPLETED|Overall Study||106||
60029848|NCT02496533|76145598|FG000|NOT COMPLETED|Overall Study||3||
60029849|NCT02496533|76145599|FG001|NOT COMPLETED|Overall Study||6||
60029850|NCT02496221|76145605|FG000|STARTED|Treatment Period 1 - 4 Days||10||
60029851|NCT02496221|76145606|FG001|STARTED|Treatment Period 1 - 4 Days||10||
60029852|NCT02496221|76145605|FG000|COMPLETED|Treatment Period 1 - 4 Days||10||
60029853|NCT02496221|76145606|FG001|COMPLETED|Treatment Period 1 - 4 Days||10||
60029854|NCT02496221|76145605|FG000|NOT COMPLETED|Treatment Period 1 - 4 Days||0||
60029855|NCT02496221|76145606|FG001|NOT COMPLETED|Treatment Period 1 - 4 Days||0||
60029856|NCT02496221|76145605|FG000|STARTED|Treatment Period 2 - 4 Days||10||
60029857|NCT02496221|76145606|FG001|STARTED|Treatment Period 2 - 4 Days||10||
60029858|NCT02496221|76145605|FG000|COMPLETED|Treatment Period 2 - 4 Days||8||
60029859|NCT02496221|76145606|FG001|COMPLETED|Treatment Period 2 - 4 Days||9||
59507661|NCT02413203|75600989|FG001|COMPLETED|Overall Study||10||
59507662|NCT02413203|75600988|FG000|NOT COMPLETED|Overall Study||0||
59507663|NCT02413203|75600989|FG001|NOT COMPLETED|Overall Study||0||
59507664|NCT02021955|75600998|FG000|STARTED|Step 0|Provider attrition=2; Provider addition=3; Patient discharges=14|210||30
59507665|NCT02021955|75600999|FG001|STARTED|Step 0|Provider attrition=0; Provider addition=0; Patient discharges=0|0||0
59507666|NCT02021955|75600998|FG000|COMPLETED|Step 0||210||30
60029860|NCT02496221|76145605|FG000|NOT COMPLETED|Treatment Period 2 - 4 Days||2||
60029861|NCT02496221|76145606|FG001|NOT COMPLETED|Treatment Period 2 - 4 Days||1||
60029862|NCT02475629|76145614|FG000|STARTED|Overall Study||40||
60029863|NCT02475629|76145614|FG000|COMPLETED|Overall Study||31||
60029864|NCT02475629|76145614|FG000|NOT COMPLETED|Overall Study||9||
60029865|NCT02475395|76145620|FG000|STARTED|Overall Study||258||
59507667|NCT02021955|75600999|FG001|COMPLETED|Step 0||0||0
59507668|NCT02021955|75600998|FG000|NOT COMPLETED|Step 0||0||0
59507669|NCT02021955|75600999|FG001|NOT COMPLETED|Step 0||0||0
59507670|NCT02021955|75600998|FG000|STARTED|Step 1|Provider attrition=20; Provider addition=2; Patient discharges=14|193||29
59507671|NCT02021955|75600999|FG001|STARTED|Step 1|Provider attrition=7; Provider addition=0; Patient discharges: 0|18||1
59507672|NCT02021955|75600998|FG000|COMPLETED|Step 1||193||29
59507673|NCT02021955|75600999|FG001|COMPLETED|Step 1||18||1
59507674|NCT02021955|75600998|FG000|NOT COMPLETED|Step 1||0||0
59507675|NCT02021955|75600999|FG001|NOT COMPLETED|Step 1||0||0
59507676|NCT02021955|75600998|FG000|STARTED|Step 2|Provider attrition=5; Provider addition=21; Patient discharges=12|165||28
59507677|NCT02021955|75600999|FG001|STARTED|Step 2|Provider attrition=2; Provider addition=5; Patient discharges=2|21||2
59507678|NCT02021955|75600998|FG000|COMPLETED|Step 2||165||28
59507679|NCT02021955|75600999|FG001|COMPLETED|Step 2||21||2
59507680|NCT02021955|75600998|FG000|NOT COMPLETED|Step 2||0||0
59507681|NCT02021955|75600999|FG001|NOT COMPLETED|Step 2||0||0
59507682|NCT02021955|75600998|FG000|STARTED|Step 3|Provider attrition=2; Provider addition=4; Patient discharges=5|175||27
59507683|NCT02021955|75600999|FG001|STARTED|Step 3|Provider attrition=0; Provider addition=3; Patient discharges=3|30||3
59507684|NCT02021955|75600998|FG000|COMPLETED|Step 3||175||27
59507685|NCT02021955|75600999|FG001|COMPLETED|Step 3||30||3
59507686|NCT02021955|75600998|FG000|NOT COMPLETED|Step 3||0||0
59507687|NCT02021955|75600999|FG001|NOT COMPLETED|Step 3||0||0
59507688|NCT02021955|75600998|FG000|STARTED|Step 4|Provider attrition=0; Provider addition=3; Patient discharges: 13|173||26
59507689|NCT02021955|75600999|FG001|STARTED|Step 4|Provider attrition=0; Provider addition=1; Patient discharges=0|37||4
59507690|NCT02021955|75600998|FG000|COMPLETED|Step 4||173||26
59507691|NCT02021955|75600999|FG001|COMPLETED|Step 4||37||4
59507692|NCT02021955|75600998|FG000|NOT COMPLETED|Step 4||0||0
59507693|NCT02021955|75600999|FG001|NOT COMPLETED|Step 4||0||0
59507694|NCT02021955|75600998|FG000|STARTED|Step 5|Provider attrition=3; Provider addition=0; Patient discharges=11|174||25
59507695|NCT02021955|75600999|FG001|STARTED|Step 5|Provider attrition=0; Provider addition=0; Patient discharges=2|40||5
60029866|NCT02475395|76145621|FG001|STARTED|Overall Study||14||
60029867|NCT02475395|76145620|FG000|COMPLETED|Overall Study||228||
60029868|NCT02475395|76145621|FG001|COMPLETED|Overall Study||11||
60029869|NCT02475395|76145620|FG000|NOT COMPLETED|Overall Study||30||
60029870|NCT02475395|76145621|FG001|NOT COMPLETED|Overall Study||3||
60029871|NCT01653743|76145629|FG000|STARTED|Overall Study||54||
60029872|NCT01653743|76145630|FG001|STARTED|Overall Study||27||
60029873|NCT01653743|76145629|FG000|COMPLETED|Overall Study||50||
60029874|NCT01653743|76145630|FG001|COMPLETED|Overall Study||27||
60029875|NCT01653743|76145629|FG000|NOT COMPLETED|Overall Study||4||
60029876|NCT01653743|76145630|FG001|NOT COMPLETED|Overall Study||0||
60029877|NCT02293993|76145640|FG000|STARTED|Course 1 (DLT Evaluation Period)||4||
60029878|NCT02293993|76145641|FG001|STARTED|Course 1 (DLT Evaluation Period)||6||
60029879|NCT02293993|76145642|FG002|STARTED|Course 1 (DLT Evaluation Period)||7||
60029880|NCT02293993|76145643|FG003|STARTED|Course 1 (DLT Evaluation Period)||4||
60029881|NCT02293993|76145640|FG000|COMPLETED|Course 1 (DLT Evaluation Period)||3||
60029882|NCT02293993|76145641|FG001|COMPLETED|Course 1 (DLT Evaluation Period)||6||
60029883|NCT02293993|76145642|FG002|COMPLETED|Course 1 (DLT Evaluation Period)||7||
60029884|NCT02293993|76145643|FG003|COMPLETED|Course 1 (DLT Evaluation Period)||3||
60029885|NCT02293993|76145640|FG000|NOT COMPLETED|Course 1 (DLT Evaluation Period)||1||
60029886|NCT02293993|76145641|FG001|NOT COMPLETED|Course 1 (DLT Evaluation Period)||0||
60029887|NCT02293993|76145642|FG002|NOT COMPLETED|Course 1 (DLT Evaluation Period)||0||
60029888|NCT02293993|76145643|FG003|NOT COMPLETED|Course 1 (DLT Evaluation Period)||1||
60029889|NCT02293993|76145640|FG000|STARTED|Course ≥2 (Extended Treatment Period)||2||
60029890|NCT02293993|76145641|FG001|STARTED|Course ≥2 (Extended Treatment Period)||5||
60029891|NCT02293993|76145642|FG002|STARTED|Course ≥2 (Extended Treatment Period)||6||
60029892|NCT02293993|76145643|FG003|STARTED|Course ≥2 (Extended Treatment Period)||3||
60029893|NCT02293993|76145640|FG000|COMPLETED|Course ≥2 (Extended Treatment Period)||0||
60029894|NCT02293993|76145641|FG001|COMPLETED|Course ≥2 (Extended Treatment Period)||0||
60029895|NCT02293993|76145642|FG002|COMPLETED|Course ≥2 (Extended Treatment Period)||1||
60029896|NCT02293993|76145643|FG003|COMPLETED|Course ≥2 (Extended Treatment Period)||2||
60029897|NCT02293993|76145640|FG000|NOT COMPLETED|Course ≥2 (Extended Treatment Period)||2||
60029898|NCT02293993|76145641|FG001|NOT COMPLETED|Course ≥2 (Extended Treatment Period)||5||
60029899|NCT02293993|76145642|FG002|NOT COMPLETED|Course ≥2 (Extended Treatment Period)||5||
60029900|NCT02293993|76145643|FG003|NOT COMPLETED|Course ≥2 (Extended Treatment Period)||1||
60029901|NCT02322775|76145663|FG000|STARTED|Overall Study||106||
60029902|NCT02322775|76145664|FG001|STARTED|Overall Study||105||
60029903|NCT02322775|76145663|FG000|COMPLETED|Overall Study||101||
60029904|NCT02322775|76145664|FG001|COMPLETED|Overall Study||99||
60029905|NCT02322775|76145663|FG000|NOT COMPLETED|Overall Study||5||
60029906|NCT02322775|76145664|FG001|NOT COMPLETED|Overall Study||6||
60029907|NCT02322229|76145670|FG000|STARTED|Overall Study||52||
60029908|NCT02322229|76145670|FG000|COMPLETED|Overall Study||50||
60029909|NCT02322229|76145670|FG000|NOT COMPLETED|Overall Study||2||
60029910|NCT02362789|76145677|FG000|STARTED|Run-in Phase (Week 0 to 16)||130||
60029911|NCT02362789|76145678|FG001|STARTED|Run-in Phase (Week 0 to 16)||0||
60029912|NCT02362789|76145679|FG002|STARTED|Run-in Phase (Week 0 to 16)||0||
60029913|NCT02362789|76145677|FG000|COMPLETED|Run-in Phase (Week 0 to 16)||128||
60029914|NCT02362789|76145678|FG001|COMPLETED|Run-in Phase (Week 0 to 16)||0||
60029915|NCT02362789|76145679|FG002|COMPLETED|Run-in Phase (Week 0 to 16)||0||
60029916|NCT02362789|76145677|FG000|NOT COMPLETED|Run-in Phase (Week 0 to 16)||2||
60029917|NCT02362789|76145678|FG001|NOT COMPLETED|Run-in Phase (Week 0 to 16)||0||
60029918|NCT02362789|76145679|FG002|NOT COMPLETED|Run-in Phase (Week 0 to 16)||0||
60029919|NCT02362789|76145677|FG000|STARTED|Randomized Withdrawal (Wk 16 to 32)|N/A. Run-in phase completed.|0||
60029920|NCT02362789|76145678|FG001|STARTED|Randomized Withdrawal (Wk 16 to 32)|Subjects achieving PASI reduction by 98-100% vs. baseline during Run-In|42||
60029921|NCT02362789|76145679|FG002|STARTED|Randomized Withdrawal (Wk 16 to 32)|Subjects achieving PASI reduction by 98-100% vs. baseline during Run-In|38||
60029922|NCT02362789|76145677|FG000|COMPLETED|Randomized Withdrawal (Wk 16 to 32)||0||
60029923|NCT02362789|76145678|FG001|COMPLETED|Randomized Withdrawal (Wk 16 to 32)||38||
60029924|NCT02362789|76145679|FG002|COMPLETED|Randomized Withdrawal (Wk 16 to 32)||26||
60029925|NCT02362789|76145677|FG000|NOT COMPLETED|Randomized Withdrawal (Wk 16 to 32)||0||
60029926|NCT02362789|76145678|FG001|NOT COMPLETED|Randomized Withdrawal (Wk 16 to 32)||4||
60029927|NCT02362789|76145679|FG002|NOT COMPLETED|Randomized Withdrawal (Wk 16 to 32)||12||
60029928|NCT01646827|76145688|FG000|STARTED|Overall Study||18||
60029929|NCT01646827|76145689|FG001|STARTED|Overall Study||19||
60029930|NCT01646827|76145688|FG000|COMPLETED|Overall Study||16||
60029931|NCT01646827|76145689|FG001|COMPLETED|Overall Study||14||
60029932|NCT01646827|76145688|FG000|NOT COMPLETED|Overall Study||2||
60029933|NCT01646827|76145689|FG001|NOT COMPLETED|Overall Study||5||
60029934|NCT02293837|76145699|FG000|STARTED|Overall Study||54||
60029935|NCT02293837|76145700|FG001|STARTED|Overall Study||27||
60029936|NCT02293837|76145701|FG002|STARTED|Overall Study|1 randomized adult was never treated|35||
60029937|NCT02293837|76145702|FG003|STARTED|Overall Study||20||
60029938|NCT02293837|76145699|FG000|COMPLETED|Overall Study||51||
60029939|NCT02293837|76145700|FG001|COMPLETED|Overall Study||23||
60029940|NCT02293837|76145701|FG002|COMPLETED|Overall Study||31||
60029941|NCT02293837|76145702|FG003|COMPLETED|Overall Study||19||
60029942|NCT02293837|76145699|FG000|NOT COMPLETED|Overall Study||3||
60029943|NCT02293837|76145700|FG001|NOT COMPLETED|Overall Study||4||
60029944|NCT02293837|76145701|FG002|NOT COMPLETED|Overall Study||4||
60029945|NCT02293837|76145702|FG003|NOT COMPLETED|Overall Study||1||
60029946|NCT02361307|76145718|FG000|STARTED|Overall Study||18||
60029947|NCT02361307|76145719|FG001|STARTED|Overall Study||18||
60029948|NCT02361307|76145718|FG000|COMPLETED|Overall Study||18||
60029949|NCT02361307|76145719|FG001|COMPLETED|Overall Study||17||
60029950|NCT02361307|76145718|FG000|NOT COMPLETED|Overall Study||0||
60029951|NCT02361307|76145719|FG001|NOT COMPLETED|Overall Study||1||
60029952|NCT02320903|76145728|FG000|STARTED|Overall Study||24||
60029953|NCT02320903|76145729|FG001|STARTED|Overall Study||32||
60029954|NCT02320903|76145730|FG002|STARTED|Overall Study||32||
60029955|NCT02320903|76145728|FG000|COMPLETED|Overall Study||16||
60029956|NCT02320903|76145729|FG001|COMPLETED|Overall Study||16||
60029957|NCT02320903|76145730|FG002|COMPLETED|Overall Study||16||
59916103|NCT02951533|76036950|FG001|STARTED|Part IIb (Week 32 Through Week 56)|Out of 34 participants in the FAE group, 14 PASI 75 responders remained on FAE treatment.|14||
59916104|NCT02951533|76036951|FG002|STARTED|Part IIb (Week 32 Through Week 56)|Out of 34 participants in FAE group, 20 PASI 75 non-responders switched to GUS group.|20||
59916105|NCT02951533|76036949|FG000|COMPLETED|Part IIb (Week 32 Through Week 56)||54||
59916106|NCT02951533|76036950|FG001|COMPLETED|Part IIb (Week 32 Through Week 56)||10||
59916107|NCT02951533|76036951|FG002|COMPLETED|Part IIb (Week 32 Through Week 56)||20||
59916108|NCT02951533|76036949|FG000|NOT COMPLETED|Part IIb (Week 32 Through Week 56)||1||
59916109|NCT02951533|76036950|FG001|NOT COMPLETED|Part IIb (Week 32 Through Week 56)||4||
59916110|NCT02951533|76036951|FG002|NOT COMPLETED|Part IIb (Week 32 Through Week 56)||0||
59916111|NCT02951533|76036949|FG000|STARTED|Part III (Week 64 Through Week 100)|18 participants were not eligible to enter Part III.|36||
60029958|NCT02320903|76145728|FG000|NOT COMPLETED|Overall Study||8||
60029959|NCT02320903|76145729|FG001|NOT COMPLETED|Overall Study||16||
60029960|NCT02320903|76145730|FG002|NOT COMPLETED|Overall Study||16||
60029961|NCT02320123|76145741|FG000|STARTED|Overall Study||10||
60029962|NCT02320123|76145742|FG001|STARTED|Overall Study||12||
60029963|NCT02320123|76145741|FG000|COMPLETED|Overall Study||0||
60029964|NCT02320123|76145742|FG001|COMPLETED|Overall Study||1||
60029965|NCT02320123|76145741|FG000|NOT COMPLETED|Overall Study||10||
60029966|NCT02320123|76145742|FG001|NOT COMPLETED|Overall Study||11||
60029967|NCT02360995|76145755|FG000|STARTED|Overall Study||43||
60029968|NCT02360995|76145756|FG001|STARTED|Overall Study||43||
60029969|NCT02360995|76145757|FG002|STARTED|Overall Study||43||
60029970|NCT02360995|76145755|FG000|COMPLETED|Overall Study||41||
60029971|NCT02360995|76145756|FG001|COMPLETED|Overall Study||42||
60029972|NCT02360995|76145757|FG002|COMPLETED|Overall Study||41||
60029973|NCT02360995|76145755|FG000|NOT COMPLETED|Overall Study||2||
60029974|NCT02360995|76145756|FG001|NOT COMPLETED|Overall Study||1||
60029975|NCT02360995|76145757|FG002|NOT COMPLETED|Overall Study||2||
60029976|NCT02360605|76145767|FG000|STARTED|Overall Study||311||
60029977|NCT02360605|76145768|FG001|STARTED|Overall Study||309||
60029978|NCT02360605|76145767|FG000|COMPLETED|Overall Study||300||
60029979|NCT02360605|76145768|FG001|COMPLETED|Overall Study||291||
60029980|NCT02360605|76145767|FG000|NOT COMPLETED|Overall Study||11||
60029981|NCT02360605|76145768|FG001|NOT COMPLETED|Overall Study||18||
60029982|NCT02360293|76145778|FG000|STARTED|Overall Study||178||
60029983|NCT02360293|76145779|FG001|STARTED|Overall Study||179||
60029984|NCT02360293|76145778|FG000|6month f/u Survey|Overall Study||110||
60029985|NCT02360293|76145779|FG001|6month f/u Survey|Overall Study||105||
60029986|NCT02360293|76145778|FG000|6month Physical Activity|Overall Study||122||
60029987|NCT02360293|76145779|FG001|6month Physical Activity|Overall Study||108||
60029988|NCT02360293|76145778|FG000|12month f/u Survey|Overall Study||102||
60029989|NCT02360293|76145779|FG001|12month f/u Survey|Overall Study||83||
60029990|NCT02360293|76145778|FG000|12month Physical Activity|Overall Study||68||
60029991|NCT02360293|76145779|FG001|12month Physical Activity|Overall Study||59||
60029992|NCT02360293|76145778|FG000|COMPLETED|Overall Study||102||
60029993|NCT02360293|76145779|FG001|COMPLETED|Overall Study||83||
60029994|NCT02360293|76145778|FG000|NOT COMPLETED|Overall Study||76||
60029995|NCT02360293|76145779|FG001|NOT COMPLETED|Overall Study||96||
60029996|NCT02359903|76145787|FG000|STARTED|Overall Study||45||
60029997|NCT02359903|76145788|FG001|STARTED|Overall Study||45||
60029998|NCT02359903|76145787|FG000|COMPLETED|Overall Study||45||
60029999|NCT02359903|76145788|FG001|COMPLETED|Overall Study||43||
60030000|NCT02359903|76145787|FG000|NOT COMPLETED|Overall Study||0||
60030001|NCT02359903|76145788|FG001|NOT COMPLETED|Overall Study||2||
60030002|NCT02291419|76145796|FG000|STARTED|Overall Study||1||
59507696|NCT02021955|75600998|FG000|COMPLETED|Step 5||174||25
59507697|NCT02021955|75600999|FG001|COMPLETED|Step 5||40||5
59507698|NCT02021955|75600998|FG000|NOT COMPLETED|Step 5||0||0
59507699|NCT02021955|75600999|FG001|NOT COMPLETED|Step 5||0||0
60030003|NCT02291419|76145797|FG001|STARTED|Overall Study||5||
60030004|NCT02291419|76145796|FG000|COMPLETED|Overall Study||0||
60030005|NCT02291419|76145797|FG001|COMPLETED|Overall Study||0||
60030006|NCT02291419|76145796|FG000|NOT COMPLETED|Overall Study||1||
60030007|NCT02291419|76145797|FG001|NOT COMPLETED|Overall Study||5||
60030008|NCT02319031|76145805|FG000|STARTED|Treatment Period||24||
60030009|NCT02319031|76145806|FG001|STARTED|Treatment Period||26||
60030010|NCT02319031|76145805|FG000|COMPLETED|Treatment Period||23||
60030011|NCT02319031|76145806|FG001|COMPLETED|Treatment Period||26||
60030012|NCT02319031|76145805|FG000|NOT COMPLETED|Treatment Period||1||
60030013|NCT02319031|76145806|FG001|NOT COMPLETED|Treatment Period||0||
60030014|NCT02319031|76145805|FG000|STARTED|Follow-Up Period||23||
60030015|NCT02319031|76145806|FG001|STARTED|Follow-Up Period||26||
60030016|NCT02319031|76145805|FG000|COMPLETED|Follow-Up Period||23||
60030017|NCT02319031|76145806|FG001|COMPLETED|Follow-Up Period||26||
60030018|NCT02319031|76145805|FG000|NOT COMPLETED|Follow-Up Period||0||
60030019|NCT02319031|76145806|FG001|NOT COMPLETED|Follow-Up Period||0||
60030020|NCT02318797|76145814|FG000|STARTED|Overall Study||516|# of individuals enrolled in each study arm|
60030021|NCT02318797|76145815|FG001|STARTED|Overall Study||713|# of individuals enrolled in each study arm|
60030022|NCT02318797|76145814|FG000|COMPLETED|Overall Study||428|# of individuals for whom we have at least one data element at the final data collection time point|
60030023|NCT02318797|76145815|FG001|COMPLETED|Overall Study||611|# of individuals for whom we have at least one data element at the final data collection time point|
60030024|NCT02318797|76145814|FG000|NOT COMPLETED|Overall Study||88||
60030025|NCT02318797|76145815|FG001|NOT COMPLETED|Overall Study||102||
60030026|NCT02359435|76145823|FG000|STARTED|Overall Study||220||
60030027|NCT02359435|76145824|FG001|STARTED|Overall Study||220||
60030028|NCT02359435|76145823|FG000|COMPLETED|Overall Study||216||
60030029|NCT02359435|76145824|FG001|COMPLETED|Overall Study||216||
60030030|NCT02359435|76145823|FG000|NOT COMPLETED|Overall Study||4||
60030031|NCT02359435|76145824|FG001|NOT COMPLETED|Overall Study||4||
60030032|NCT02318719|76145834|FG000|STARTED|Double-blind Phase||304||
60030033|NCT02318719|76145835|FG001|STARTED|Double-blind Phase||153||
60030034|NCT02318719|76145836|FG002|STARTED|Double-blind Phase||153||
60030035|NCT02318719|76145837|FG003|STARTED|Double-blind Phase||155||
60030036|NCT02318719|76145838|FG004|STARTED|Double-blind Phase||0||
60030037|NCT02318719|76145834|FG000|Did Not Receive Treatment|Double-blind Phase||1||
60030038|NCT02318719|76145835|FG001|Did Not Receive Treatment|Double-blind Phase||1||
60030039|NCT02318719|76145836|FG002|Did Not Receive Treatment|Double-blind Phase||0||
60030040|NCT02318719|76145837|FG003|Did Not Receive Treatment|Double-blind Phase||0||
60030041|NCT02318719|76145838|FG004|Did Not Receive Treatment|Double-blind Phase||0||
60030042|NCT02318719|76145834|FG000|COMPLETED|Double-blind Phase||266||
60030043|NCT02318719|76145835|FG001|COMPLETED|Double-blind Phase||137||
60030044|NCT02318719|76145836|FG002|COMPLETED|Double-blind Phase||128||
60030045|NCT02318719|76145837|FG003|COMPLETED|Double-blind Phase||140||
60030046|NCT02318719|76145838|FG004|COMPLETED|Double-blind Phase||0||
60030047|NCT02318719|76145834|FG000|NOT COMPLETED|Double-blind Phase||38||
60030048|NCT02318719|76145835|FG001|NOT COMPLETED|Double-blind Phase||16||
60030049|NCT02318719|76145836|FG002|NOT COMPLETED|Double-blind Phase||25||
60030050|NCT02318719|76145837|FG003|NOT COMPLETED|Double-blind Phase||15||
60030051|NCT02318719|76145838|FG004|NOT COMPLETED|Double-blind Phase||0||
60030052|NCT02318719|76145834|FG000|STARTED|Open-label Extension Phase||0||
60030053|NCT02318719|76145835|FG001|STARTED|Open-label Extension Phase||0||
60030054|NCT02318719|76145836|FG002|STARTED|Open-label Extension Phase||0||
60030055|NCT02318719|76145837|FG003|STARTED|Open-label Extension Phase||0||
59507700|NCT02021955|75600998|FG000|STARTED|Step 6|Provider attrition=0; Provider addition=2; Patient discharges=6|158||24
59507701|NCT02021955|75600999|FG001|STARTED|Step 6|Provider attrition=0; Provider addition=1; Patient discharges=1|53||6
59507702|NCT02021955|75600998|FG000|COMPLETED|Step 6||158||24
59507703|NCT02021955|75600999|FG001|COMPLETED|Step 6||53||6
59507704|NCT02021955|75600998|FG000|NOT COMPLETED|Step 6||0||0
59916112|NCT02951533|76036950|FG001|STARTED|Part III (Week 64 Through Week 100)|10 participants in the FAE group were not eligible to enter Part III.|0||
59916113|NCT02951533|76036951|FG002|STARTED|Part III (Week 64 Through Week 100)|8 participants were not eligible to enter Part III.|12||
59916114|NCT02951533|76036949|FG000|COMPLETED|Part III (Week 64 Through Week 100)||32||
59916115|NCT02951533|76036950|FG001|COMPLETED|Part III (Week 64 Through Week 100)||0||
59916116|NCT02951533|76036951|FG002|COMPLETED|Part III (Week 64 Through Week 100)||10||
59916117|NCT02951533|76036949|FG000|NOT COMPLETED|Part III (Week 64 Through Week 100)||4||
59916118|NCT02951533|76036950|FG001|NOT COMPLETED|Part III (Week 64 Through Week 100)||0||
59916119|NCT02951533|76036951|FG002|NOT COMPLETED|Part III (Week 64 Through Week 100)||2||
59916120|NCT02700412|76036968|FG000|STARTED|Overall Study||80||
59507705|NCT02021955|75600999|FG001|NOT COMPLETED|Step 6||0||0
59507706|NCT02021955|75600998|FG000|STARTED|Step 7|Provider attrition=0; Provider addition=2; Patient discharges=13|157||23
59519017|NCT03587428|75612872|FG002|STARTED|Period 3||3||
59916121|NCT02700412|76036968|FG000|COMPLETED|Overall Study||47||
59916122|NCT02700412|76036968|FG000|NOT COMPLETED|Overall Study||33||
59916123|NCT03665441|76036974|FG000|STARTED|Overall Study||255||
59916124|NCT03665441|76036975|FG001|STARTED|Overall Study||257||
59916125|NCT03665441|76036974|FG000|COMPLETED|Overall Study||216||
59916126|NCT03665441|76036975|FG001|COMPLETED|Overall Study||240||
59916127|NCT03665441|76036974|FG000|NOT COMPLETED|Overall Study||39||
59916128|NCT03665441|76036975|FG001|NOT COMPLETED|Overall Study||17||
59916129|NCT02699866|76036981|FG000|STARTED|Overall Study|First study centre initiation.|46||
59916130|NCT02699866|76036981|FG000|Included|Overall Study||41||
59916131|NCT02699866|76036981|FG000|COMPLETED|Overall Study|Last study centre close-out.|38||
59916132|NCT02699866|76036981|FG000|NOT COMPLETED|Overall Study||8||
59916133|NCT03663569|76036985|FG000|STARTED|Overall Study||4819||
59916134|NCT03663569|76036985|FG000|COMPLETED|Overall Study||4756||
59916135|NCT03663569|76036985|FG000|NOT COMPLETED|Overall Study||63||
59916136|NCT03596762|76036994|FG000|STARTED|Overall Study||47||
59916137|NCT03596762|76036995|FG001|STARTED|Overall Study||31||
59916138|NCT03596762|76036996|FG002|STARTED|Overall Study||17||
59916139|NCT03596762|76036997|FG003|STARTED|Overall Study||52||
59916140|NCT03596762|76036998|FG004|STARTED|Overall Study||52||
59916141|NCT03596762|76036994|FG000|COMPLETED|Overall Study||43||
59916142|NCT03596762|76036995|FG001|COMPLETED|Overall Study||30||
59916143|NCT03596762|76036996|FG002|COMPLETED|Overall Study||16||
59916144|NCT03596762|76036997|FG003|COMPLETED|Overall Study||51||
59916145|NCT03596762|76036998|FG004|COMPLETED|Overall Study||45||
59916146|NCT03596762|76036994|FG000|NOT COMPLETED|Overall Study||4||
59916147|NCT03596762|76036995|FG001|NOT COMPLETED|Overall Study||1||
59916148|NCT03596762|76036996|FG002|NOT COMPLETED|Overall Study||1||
59916149|NCT03596762|76036997|FG003|NOT COMPLETED|Overall Study||1||
59916150|NCT03596762|76036998|FG004|NOT COMPLETED|Overall Study||7||
59916151|NCT03663179|76037016|FG000|STARTED|Overall Study||18||
59916152|NCT03663179|76037017|FG001|STARTED|Overall Study||14||
59916153|NCT03663179|76037016|FG000|COMPLETED|Overall Study||14||
59916154|NCT03663179|76037017|FG001|COMPLETED|Overall Study||13||
59916155|NCT03663179|76037016|FG000|NOT COMPLETED|Overall Study||4||
59916156|NCT03663179|76037017|FG001|NOT COMPLETED|Overall Study||1||
59916157|NCT03662789|76037025|FG000|STARTED|Overall Study|Baseline|52||
59916158|NCT03662789|76037026|FG001|STARTED|Overall Study|Baseline|50||
59916159|NCT03662789|76037025|FG000|COMPLETED|Overall Study|Follow-up at 6 months|47||
59916160|NCT03662789|76037026|FG001|COMPLETED|Overall Study|Follow-up at 6 months|43||
59916161|NCT03662789|76037025|FG000|NOT COMPLETED|Overall Study||5||
59916162|NCT03662789|76037026|FG001|NOT COMPLETED|Overall Study||7||
60030056|NCT02318719|76145838|FG004|STARTED|Open-label Extension Phase|A portion of participants who completed the double-blind phase enrolled in the open-label extension.|239||
60030057|NCT02318719|76145834|FG000|COMPLETED|Open-label Extension Phase||0||
59507707|NCT02021955|75600999|FG001|STARTED|Step 7|Provider attrition=0; Provider addition=1; Patient discharges=2|57||7
59507708|NCT02021955|75600998|FG000|COMPLETED|Step 7||157||23
59507709|NCT02021955|75600999|FG001|COMPLETED|Step 7||57||7
59507710|NCT02021955|75600998|FG000|NOT COMPLETED|Step 7||0||0
59507711|NCT02021955|75600999|FG001|NOT COMPLETED|Step 7||0||0
59507712|NCT02021955|75600998|FG000|STARTED|Step 8|Provider attrition=1; Provider addition=0; Patient discharges=9|144||22
59507713|NCT02021955|75600999|FG001|STARTED|Step 8|Provider attrition=0; Provider addition=0; Patient discharges=11|73||8
59507714|NCT02021955|75600998|FG000|COMPLETED|Step 8||144||22
59507715|NCT02021955|75600999|FG001|COMPLETED|Step 8||73||8
59507716|NCT02021955|75600998|FG000|NOT COMPLETED|Step 8||0||0
59507717|NCT02021955|75600999|FG001|NOT COMPLETED|Step 8||0||0
59507718|NCT02021955|75600998|FG000|STARTED|Step 9|Provider attrition=2; Provider addition=1; Patient discharges=9|139||21
59507719|NCT02021955|75600999|FG001|STARTED|Step 9|Provider attrition=1; Provider addition=0; Patient discharges=8|77||9
59507720|NCT02021955|75600998|FG000|COMPLETED|Step 9||139||21
59507721|NCT02021955|75600999|FG001|COMPLETED|Step 9||77||9
59507722|NCT02021955|75600998|FG000|NOT COMPLETED|Step 9||0||0
59507723|NCT02021955|75600999|FG001|NOT COMPLETED|Step 9||0||0
59507724|NCT02021955|75600998|FG000|STARTED|Step 10|Provider attrition=0; Provider addition=1; Patient discharges: 8|135||20
59507725|NCT02021955|75600999|FG001|STARTED|Step 10|Provider attrition=1; Provider addition=0; Patient discharges=5|79||10
59507726|NCT02021955|75600998|FG000|COMPLETED|Step 10||135||20
59507727|NCT02021955|75600999|FG001|COMPLETED|Step 10||79||10
59507728|NCT02021955|75600998|FG000|NOT COMPLETED|Step 10||0||0
59507729|NCT02021955|75600999|FG001|NOT COMPLETED|Step 10||0||0
59507730|NCT02021955|75600998|FG000|STARTED|Step 11|Provider attrition=1; Provider addition=0; Patient discharges=11|126||19
59507731|NCT02021955|75600999|FG001|STARTED|Step 11|Provider attrition=2; Provider addition=2; Patient discharges=7|88||11
59507732|NCT02021955|75600998|FG000|COMPLETED|Step 11||126||19
59507733|NCT02021955|75600999|FG001|COMPLETED|Step 11||88||11
59507734|NCT02021955|75600998|FG000|NOT COMPLETED|Step 11||0||0
59507735|NCT02021955|75600999|FG001|NOT COMPLETED|Step 11||0||0
59507736|NCT02021955|75600998|FG000|STARTED|Step 12|Provider attrition=1; Provider addition=0; Patient discharges=3|123||18
59507737|NCT02021955|75600999|FG001|STARTED|Step 12|Provider attrition=0; Provider addition=2; Patient discharges=1|90||12
59507738|NCT02021955|75600998|FG000|COMPLETED|Step 12||123||18
59507739|NCT02021955|75600999|FG001|COMPLETED|Step 12||90||12
59507740|NCT02021955|75600998|FG000|NOT COMPLETED|Step 12||0||0
59507741|NCT02021955|75600999|FG001|NOT COMPLETED|Step 12||0||0
59507742|NCT02021955|75600998|FG000|STARTED|Step 13|Provider attrition=10; Provider addition=0; Patient discharges=4|118||17
59507743|NCT02021955|75600999|FG001|STARTED|Step 13|Provider attrition=4; Provider addition=0; Patient discharges=5|96||13
59507744|NCT02021955|75600998|FG000|COMPLETED|Step 13||118||17
59507745|NCT02021955|75600999|FG001|COMPLETED|Step 13||96||13
59507746|NCT02021955|75600998|FG000|NOT COMPLETED|Step 13||0||0
59507747|NCT02021955|75600999|FG001|NOT COMPLETED|Step 13||0||0
60030058|NCT02318719|76145835|FG001|COMPLETED|Open-label Extension Phase||0||
60030059|NCT02318719|76145836|FG002|COMPLETED|Open-label Extension Phase||0||
60030060|NCT02318719|76145837|FG003|COMPLETED|Open-label Extension Phase||0||
59507748|NCT02021955|75600998|FG000|STARTED|Step 14|Provider attrition=1; Provider addition=9; Patient discharges=7|105||16
59507749|NCT02021955|75600999|FG001|STARTED|Step 14|Provider attrition=7; Provider addition=11; Patient discharges=3|95||14
60030061|NCT02318719|76145838|FG004|COMPLETED|Open-label Extension Phase||184||
60030062|NCT02318719|76145834|FG000|NOT COMPLETED|Open-label Extension Phase||0||
60030063|NCT02318719|76145835|FG001|NOT COMPLETED|Open-label Extension Phase||0||
60030064|NCT02318719|76145836|FG002|NOT COMPLETED|Open-label Extension Phase||0||
60030065|NCT02318719|76145837|FG003|NOT COMPLETED|Open-label Extension Phase||0||
60030066|NCT02318719|76145838|FG004|NOT COMPLETED|Open-label Extension Phase||55||
60030067|NCT01870726|76145857|FG000|STARTED|Overall Study||5||
60030068|NCT01870726|76145858|FG001|STARTED|Overall Study||6||
60030069|NCT01870726|76145859|FG002|STARTED|Overall Study||4||
59507750|NCT02021955|75600998|FG000|COMPLETED|Step 14||105||16
59507751|NCT02021955|75600999|FG001|COMPLETED|Step 14||95||14
59507752|NCT02021955|75600998|FG000|NOT COMPLETED|Step 14||0||0
59507753|NCT02021955|75600999|FG001|NOT COMPLETED|Step 14||0||0
59507754|NCT02021955|75600998|FG000|STARTED|Step 15|Provider attrition=0; Provider addition=0; Patient discharges=4|110||15
59507755|NCT02021955|75600999|FG001|STARTED|Step 15|Provider attrition=0; Provider addition=5; Patient discharges=5|102||15
59507756|NCT02021955|75600998|FG000|COMPLETED|Step 15||110||15
59507757|NCT02021955|75600999|FG001|COMPLETED|Step 15||102||15
59507758|NCT02021955|75600998|FG000|NOT COMPLETED|Step 15||0||0
59507759|NCT02021955|75600999|FG001|NOT COMPLETED|Step 15||0||0
59507760|NCT02021955|75600998|FG000|STARTED|Step 16|Provider attrition=0; Provider addition=0; Patient discharges=2|103||14
59507761|NCT02021955|75600999|FG001|STARTED|Step 16|Provider attrition=0; Provider addition=3; Patient discharges=3|114||16
59507762|NCT02021955|75600998|FG000|COMPLETED|Step 16||103||14
59507763|NCT02021955|75600999|FG001|COMPLETED|Step 16||114||16
59507764|NCT02021955|75600998|FG000|NOT COMPLETED|Step 16||0||0
59507765|NCT02021955|75600999|FG001|NOT COMPLETED|Step 16||0||0
59507766|NCT02021955|75600998|FG000|STARTED|Step 17|Provider attrition=0; Provider addition=0; Patient discharges=8|99||13
59507767|NCT02021955|75600999|FG001|STARTED|Step 17|Provider attrition=0; Provider addition=0; Patient discharges=3|121||17
59507768|NCT02021955|75600998|FG000|COMPLETED|Step 17||99||13
59507769|NCT02021955|75600999|FG001|COMPLETED|Step 17||121||17
59507770|NCT02021955|75600998|FG000|NOT COMPLETED|Step 17||0||0
59507771|NCT02021955|75600999|FG001|NOT COMPLETED|Step 17||0||0
59507772|NCT02021955|75600998|FG000|STARTED|Step 18|Provider attrition=0; Provider addition=0; Patient discharges=6|96||12
59507773|NCT02021955|75600999|FG001|STARTED|Step 18|Provider attrition=0; Provider addition=0; Patient discharges=7|124||18
59507774|NCT02021955|75600998|FG000|COMPLETED|Step 18||96||12
59507775|NCT02021955|75600999|FG001|COMPLETED|Step 18||124||18
59507776|NCT02021955|75600998|FG000|NOT COMPLETED|Step 18||0||0
59507777|NCT02021955|75600999|FG001|NOT COMPLETED|Step 18||0||0
59507778|NCT02021955|75600998|FG000|STARTED|Step 19|Provider attrition=0; Provider addition=0; Patient discharges=5|94||11
59507779|NCT02021955|75600999|FG001|STARTED|Step 19|Provider attrition=0; Provider addition=0; Patient discharges=9|126||19
59507780|NCT02021955|75600998|FG000|COMPLETED|Step 19||94||11
60030070|NCT01870726|76145860|FG003|STARTED|Overall Study||6||
60030071|NCT01870726|76145861|FG004|STARTED|Overall Study||7||
59507781|NCT02021955|75600999|FG001|COMPLETED|Step 19||126||19
59507782|NCT02021955|75600998|FG000|NOT COMPLETED|Step 19||0||0
59507783|NCT02021955|75600999|FG001|NOT COMPLETED|Step 19||0||0
59519018|NCT03587428|75612873|FG003|STARTED|Period 3||3||
60030072|NCT01870726|76145862|FG005|STARTED|Overall Study||5||
60030073|NCT01870726|76145863|FG006|STARTED|Overall Study||10||
59507784|NCT02021955|75600998|FG000|STARTED|Step 20|Provider attrition=0; Provider addition=1; Patient discharges=9|92||10
59507785|NCT02021955|75600999|FG001|STARTED|Step 20|Provider attrition=0; Provider addition=1; Patient discharges=9|128||20
59611839|NCT01605396|75722869|FG000|STARTED|Overall Study||40||
59611840|NCT01605396|75722870|FG001|STARTED|Overall Study||40||
59611841|NCT01605396|75722869|FG000|Treated|Overall Study||39||
59507786|NCT02021955|75600998|FG000|COMPLETED|Step 20||92||10
59507787|NCT02021955|75600999|FG001|COMPLETED|Step 20||128||20
59507788|NCT02021955|75600998|FG000|NOT COMPLETED|Step 20||0||0
59507789|NCT02021955|75600999|FG001|NOT COMPLETED|Step 20||0||0
59507790|NCT02021955|75600998|FG000|STARTED|Step 21|Provider attrition=0; Provider addition=7; Patient discharges=1|88||9
59507791|NCT02021955|75600999|FG001|STARTED|Step 21|Provider attrition=0; Provider addition=12; Patient discharges=9|134||21
59507792|NCT02021955|75600998|FG000|COMPLETED|Step 21||88||9
59507793|NCT02021955|75600999|FG001|COMPLETED|Step 21||134||21
59507794|NCT02021955|75600998|FG000|NOT COMPLETED|Step 21||0||0
59507795|NCT02021955|75600999|FG001|NOT COMPLETED|Step 21||0||0
59507796|NCT02021955|75600998|FG000|STARTED|Step 22|Provider attrition=0; Provider addition=0; Patient discharges=8|89||8
59507797|NCT02021955|75600999|FG001|STARTED|Step 22|Provider attrition=0; Provider addition=3; Patient discharges=8|152||22
59507798|NCT02021955|75600998|FG000|COMPLETED|Step 22||89||8
59507799|NCT02021955|75600999|FG001|COMPLETED|Step 22||152||22
59507800|NCT02021955|75600998|FG000|NOT COMPLETED|Step 22||0||0
59507801|NCT02021955|75600999|FG001|NOT COMPLETED|Step 22||0||0
59507802|NCT02021955|75600998|FG000|STARTED|Step 23|Provider attrition=0; Provider addition=1; Patient discharges=3|69||7
59507803|NCT02021955|75600999|FG001|STARTED|Step 23|Provider attrition=0; Provider addition=0; Patient discharges=7|175||23
59507804|NCT02021955|75600998|FG000|COMPLETED|Step 23||69||7
59507805|NCT02021955|75600999|FG001|COMPLETED|Step 23||175||23
59507806|NCT02021955|75600998|FG000|NOT COMPLETED|Step 23||0||0
59507807|NCT02021955|75600999|FG001|NOT COMPLETED|Step 23||0||0
59507808|NCT02021955|75600998|FG000|STARTED|Step 24|Provider attrition=0; Provider addition=0; Patient discharges=4|62||6
59507809|NCT02021955|75600999|FG001|STARTED|Step 24|Provider attrition=1; Provider addition=1; Patient discharges=8|183||24
59507810|NCT02021955|75600998|FG000|COMPLETED|Step 24||62||6
59507811|NCT02021955|75600999|FG001|COMPLETED|Step 24||183||24
59507812|NCT02021955|75600998|FG000|NOT COMPLETED|Step 24||0||0
59507813|NCT02021955|75600999|FG001|NOT COMPLETED|Step 24||0||0
59507814|NCT02021955|75600998|FG000|STARTED|Step 25|Provider attrition=0; Provider addition=1; Patient discharges=0|37||5
59507815|NCT02021955|75600999|FG001|STARTED|Step 25|Provider attrition=1; Provider addition=0; Patient discharges=5|208||25
59611842|NCT01605396|75722870|FG001|Treated|Overall Study||40||
59507816|NCT02021955|75600998|FG000|COMPLETED|Step 25||37||5
59611843|NCT01605396|75722869|FG000|COMPLETED|Overall Study||0||
59611844|NCT01605396|75722870|FG001|COMPLETED|Overall Study||0||
59611845|NCT01605396|75722869|FG000|NOT COMPLETED|Overall Study||40||
59611846|NCT01605396|75722870|FG001|NOT COMPLETED|Overall Study||40||
59611847|NCT01730118|75722883|FG000|STARTED|Dose Escalation||6||
59611848|NCT01730118|75722884|FG001|STARTED|Dose Escalation||7||
59611849|NCT01730118|75722885|FG002|STARTED|Dose Escalation||6||
59611850|NCT01730118|75722886|FG003|STARTED|Dose Escalation||6||
59611851|NCT01730118|75722887|FG004|STARTED|Dose Escalation||0||
59507817|NCT02021955|75600999|FG001|COMPLETED|Step 25||208||25
59507818|NCT02021955|75600998|FG000|NOT COMPLETED|Step 25||0||0
59507819|NCT02021955|75600999|FG001|NOT COMPLETED|Step 25||0||0
59507820|NCT02021955|75600998|FG000|STARTED|Step 26|Provider attrition=0; Provider addition=0; Patient discharges=2|30||4
59507821|NCT02021955|75600999|FG001|STARTED|Step 26|Provider attrition=0; Provider addition=23; Patient discharges=9|215||26
59611852|NCT01730118|75722888|FG005|STARTED|Dose Escalation||0||
59507822|NCT02021955|75600998|FG000|COMPLETED|Step 26||30||4
59507823|NCT02021955|75600999|FG001|COMPLETED|Step 26||215||26
59507824|NCT02021955|75600998|FG000|NOT COMPLETED|Step 26||0||0
59507825|NCT02021955|75600999|FG001|NOT COMPLETED|Step 26||0||0
59611853|NCT01730118|75722889|FG006|STARTED|Dose Escalation||2||
59611854|NCT01730118|75722883|FG000|COMPLETED|Dose Escalation||0||
60030074|NCT01870726|76145857|FG000|COMPLETED|Overall Study||0||
60030075|NCT01870726|76145858|FG001|COMPLETED|Overall Study||0||
60030076|NCT01870726|76145859|FG002|COMPLETED|Overall Study||0||
59611855|NCT01730118|75722884|FG001|COMPLETED|Dose Escalation||0||
59611856|NCT01730118|75722885|FG002|COMPLETED|Dose Escalation||3||
59611857|NCT01730118|75722886|FG003|COMPLETED|Dose Escalation||0||
59611858|NCT01730118|75722887|FG004|COMPLETED|Dose Escalation||0||
59611859|NCT01730118|75722888|FG005|COMPLETED|Dose Escalation||0||
59611860|NCT01730118|75722889|FG006|COMPLETED|Dose Escalation||0||
59611861|NCT01730118|75722883|FG000|NOT COMPLETED|Dose Escalation||6||
59611862|NCT01730118|75722884|FG001|NOT COMPLETED|Dose Escalation||7||
59611863|NCT01730118|75722885|FG002|NOT COMPLETED|Dose Escalation||3||
59611864|NCT01730118|75722886|FG003|NOT COMPLETED|Dose Escalation||6||
59916163|NCT03658889|76037034|FG000|STARTED|Overall Study|Enrolled population|308||
59916164|NCT03658889|76037035|FG001|STARTED|Overall Study||69||
59916165|NCT03658889|76037034|FG000|COMPLETED|Overall Study|Analysis population|306||
59611865|NCT01730118|75722887|FG004|NOT COMPLETED|Dose Escalation||0||
59611866|NCT01730118|75722888|FG005|NOT COMPLETED|Dose Escalation||0||
59611867|NCT01730118|75722889|FG006|NOT COMPLETED|Dose Escalation||2||
59611868|NCT01730118|75722883|FG000|STARTED|Dose Expansion||0||
60030077|NCT01870726|76145860|FG003|COMPLETED|Overall Study||0||
60030078|NCT01870726|76145861|FG004|COMPLETED|Overall Study||0||
60030079|NCT01870726|76145862|FG005|COMPLETED|Overall Study||0||
60030080|NCT01870726|76145863|FG006|COMPLETED|Overall Study||0||
60030081|NCT01870726|76145857|FG000|NOT COMPLETED|Overall Study||5||
59916166|NCT03658889|76037035|FG001|COMPLETED|Overall Study||69||
59916167|NCT03658889|76037034|FG000|NOT COMPLETED|Overall Study||2||
60030082|NCT01870726|76145858|FG001|NOT COMPLETED|Overall Study||6||
60030083|NCT01870726|76145859|FG002|NOT COMPLETED|Overall Study||4||
60030084|NCT01870726|76145860|FG003|NOT COMPLETED|Overall Study||6||
60030085|NCT01870726|76145861|FG004|NOT COMPLETED|Overall Study||7||
60030086|NCT01870726|76145862|FG005|NOT COMPLETED|Overall Study||5||
59611869|NCT01730118|75722884|FG001|STARTED|Dose Expansion||0||
59611870|NCT01730118|75722885|FG002|STARTED|Dose Expansion||0||
59611871|NCT01730118|75722886|FG003|STARTED|Dose Expansion||0||
60030087|NCT01870726|76145863|FG006|NOT COMPLETED|Overall Study||10||
60030088|NCT01900054|76145888|FG000|STARTED|Overall Study||58||
60030089|NCT01900054|76145888|FG000|COMPLETED|Overall Study||56||
59507826|NCT02021955|75600998|FG000|STARTED|Step 27|Provider attrition=1; Provider addition=1; Patient discharges=0|25||3
59507827|NCT02021955|75600999|FG001|STARTED|Step 27|Provider attrition=1; Provider addition=4; Patient discharges=4|243||27
59507828|NCT02021955|75600998|FG000|COMPLETED|Step 27||25||3
59611872|NCT01730118|75722887|FG004|STARTED|Dose Expansion||3||
59611873|NCT01730118|75722888|FG005|STARTED|Dose Expansion||3||
59611874|NCT01730118|75722889|FG006|STARTED|Dose Expansion||0||
59611875|NCT01730118|75722883|FG000|COMPLETED|Dose Expansion||0||
59916168|NCT03658889|76037035|FG001|NOT COMPLETED|Overall Study||0||
59916169|NCT03655691|76037043|FG000|STARTED|Overall Study||26||
59916170|NCT03655691|76037044|FG001|STARTED|Overall Study||26||
59916171|NCT03655691|76037045|FG002|STARTED|Overall Study||27||
59916172|NCT03655691|76037043|FG000|COMPLETED|Overall Study||24||
59916173|NCT03655691|76037044|FG001|COMPLETED|Overall Study||23||
59916174|NCT03655691|76037045|FG002|COMPLETED|Overall Study||24||
59611876|NCT01730118|75722884|FG001|COMPLETED|Dose Expansion||0||
59611877|NCT01730118|75722885|FG002|COMPLETED|Dose Expansion||0||
59611878|NCT01730118|75722886|FG003|COMPLETED|Dose Expansion||0||
59611879|NCT01730118|75722887|FG004|COMPLETED|Dose Expansion||0||
59611880|NCT01730118|75722888|FG005|COMPLETED|Dose Expansion||0||
59611881|NCT01730118|75722889|FG006|COMPLETED|Dose Expansion||0||
59611882|NCT01730118|75722883|FG000|NOT COMPLETED|Dose Expansion||0||
59611883|NCT01730118|75722884|FG001|NOT COMPLETED|Dose Expansion||0||
59611884|NCT01730118|75722885|FG002|NOT COMPLETED|Dose Expansion||0||
59916175|NCT03655691|76037043|FG000|NOT COMPLETED|Overall Study||2||
59916176|NCT03655691|76037044|FG001|NOT COMPLETED|Overall Study||3||
60030090|NCT01900054|76145888|FG000|NOT COMPLETED|Overall Study||2||
60030091|NCT01612156|76145894|FG000|STARTED|Overall Study||42||
60030092|NCT01612156|76145895|FG001|STARTED|Overall Study||48||
60030093|NCT01612156|76145894|FG000|COMPLETED|Overall Study|Contraindication to urodynamics (urinary tract infection) diagnosed after randomization|40||
60030094|NCT01612156|76145895|FG001|COMPLETED|Overall Study||48||
60030095|NCT01612156|76145894|FG000|NOT COMPLETED|Overall Study||2||
60030096|NCT01612156|76145895|FG001|NOT COMPLETED|Overall Study||0||
59611885|NCT01730118|75722886|FG003|NOT COMPLETED|Dose Expansion||0||
59611886|NCT01730118|75722887|FG004|NOT COMPLETED|Dose Expansion||3||
59611887|NCT01730118|75722888|FG005|NOT COMPLETED|Dose Expansion||3||
59611888|NCT01730118|75722889|FG006|NOT COMPLETED|Dose Expansion||0||
59611889|NCT01730040|75722913|FG000|STARTED|Overall Study||57||
59611890|NCT01730040|75722914|FG001|STARTED|Overall Study||55||
59611891|NCT01730040|75722915|FG002|STARTED|Overall Study||57||
59611892|NCT01730040|75722916|FG003|STARTED|Overall Study||47||
59611893|NCT01730040|75722917|FG004|STARTED|Overall Study||45||
59611894|NCT01730040|75722918|FG005|STARTED|Overall Study||47||
59611895|NCT01730040|75722919|FG006|STARTED|Overall Study||47||
59611896|NCT01730040|75722913|FG000|Treated|Overall Study||57||
59611897|NCT01730040|75722914|FG001|Treated|Overall Study||55||
59916177|NCT03655691|76037045|FG002|NOT COMPLETED|Overall Study||3||
59916178|NCT03658811|76037053|FG000|STARTED|Overall Study||19||
59916179|NCT03658811|76037053|FG000|COMPLETED|Overall Study||16||
59916180|NCT03658811|76037053|FG000|NOT COMPLETED|Overall Study||3||
59916181|NCT03573206|76037057|FG000|STARTED|Overall Study||168||
59916182|NCT03573206|76037057|FG000|COMPLETED|Overall Study||168||
59916183|NCT03573206|76037057|FG000|NOT COMPLETED|Overall Study||0||
59916184|NCT03631355|76037063|FG000|STARTED|Overall Study||55||
59916185|NCT03631355|76037064|FG001|STARTED|Overall Study||55||
59916186|NCT03631355|76037063|FG000|COMPLETED|Overall Study||54||
59916187|NCT03631355|76037064|FG001|COMPLETED|Overall Study||53||
59916188|NCT03631355|76037063|FG000|NOT COMPLETED|Overall Study||1||
59916189|NCT03631355|76037064|FG001|NOT COMPLETED|Overall Study||2||
59916190|NCT03629249|76037073|FG000|STARTED|Overall Study||201|All patients who were randomized|
59916191|NCT03629249|76037074|FG001|STARTED|Overall Study||201|All patients who were randomized|
59916192|NCT03629249|76037075|FG002|STARTED|Overall Study||202|All patients who were randomized|
59916193|NCT03629249|76037073|FG000|Full Analysis Set (FAS)|Overall Study||201|All randomized patients who received at least one dose of study medication|
59916194|NCT03629249|76037074|FG001|Full Analysis Set (FAS)|Overall Study||200|All randomized patients who received at least one dose of study medication|
59916195|NCT03629249|76037075|FG002|Full Analysis Set (FAS)|Overall Study||201|All randomized patients who received at least one dose of study medication|
59916196|NCT03629249|76037073|FG000|Safety Set (SAF)|Overall Study||201|all patients who received at least one dose of double-blind study drug|
59916197|NCT03629249|76037074|FG001|Safety Set (SAF)|Overall Study||200|all patients who received at least one dose of double-blind study drug|
59916198|NCT03629249|76037075|FG002|Safety Set (SAF)|Overall Study||201|all patients who received at least one dose of double-blind study drug|
59916199|NCT03629249|76037073|FG000|COMPLETED|Overall Study||0||
59916200|NCT03629249|76037074|FG001|COMPLETED|Overall Study||0||
59916201|NCT03629249|76037075|FG002|COMPLETED|Overall Study||0||
59916202|NCT03629249|76037073|FG000|NOT COMPLETED|Overall Study||201||
59916203|NCT03629249|76037074|FG001|NOT COMPLETED|Overall Study||201||
59916204|NCT03629249|76037075|FG002|NOT COMPLETED|Overall Study||202||
59916205|NCT03628781|76037085|FG000|STARTED|Overall Study||85||
59916206|NCT03628781|76037086|FG001|STARTED|Overall Study||84||
59916207|NCT03628781|76037085|FG000|6-month Timepoint|Overall Study||63||
59916208|NCT03628781|76037086|FG001|6-month Timepoint|Overall Study||79||
59916209|NCT03628781|76037085|FG000|12-month Timepoint|Overall Study||53||
59916210|NCT03628781|76037086|FG001|12-month Timepoint|Overall Study||75||
59916211|NCT03628781|76037085|FG000|COMPLETED|Overall Study||53||
59916212|NCT03628781|76037086|FG001|COMPLETED|Overall Study||75||
59916213|NCT03628781|76037085|FG000|NOT COMPLETED|Overall Study||32||
59916214|NCT03628781|76037086|FG001|NOT COMPLETED|Overall Study||9||
59916215|NCT03371251|76037098|FG000|STARTED|Overall Study||7||
59916216|NCT03371251|76037099|FG001|STARTED|Overall Study||5||
59916217|NCT03371251|76037100|FG002|STARTED|Overall Study||9||
59916218|NCT03371251|76037101|FG003|STARTED|Overall Study||9||
59916219|NCT03371251|76037102|FG004|STARTED|Overall Study||37||
59916220|NCT03371251|76037103|FG005|STARTED|Overall Study||76||
59916221|NCT03371251|76037098|FG000|COMPLETED|Overall Study||5||
59916222|NCT03371251|76037099|FG001|COMPLETED|Overall Study||5||
59916223|NCT03371251|76037100|FG002|COMPLETED|Overall Study||8||
59916224|NCT03371251|76037101|FG003|COMPLETED|Overall Study||9||
59916225|NCT03371251|76037102|FG004|COMPLETED|Overall Study||30||
59916226|NCT03371251|76037103|FG005|COMPLETED|Overall Study||71||
59916227|NCT03371251|76037098|FG000|NOT COMPLETED|Overall Study||2||
59916228|NCT03371251|76037099|FG001|NOT COMPLETED|Overall Study||0||
59916229|NCT03371251|76037100|FG002|NOT COMPLETED|Overall Study||1||
59916230|NCT03371251|76037101|FG003|NOT COMPLETED|Overall Study||0||
59916231|NCT03371251|76037102|FG004|NOT COMPLETED|Overall Study||7||
59916232|NCT03371251|76037103|FG005|NOT COMPLETED|Overall Study||5||
59916233|NCT03370471|76037122|FG000|STARTED|Overall Study||23||
59916234|NCT03370471|76037123|FG001|STARTED|Overall Study||5||
59916235|NCT03370471|76037122|FG000|COMPLETED|Overall Study||16||
59916236|NCT03370471|76037123|FG001|COMPLETED|Overall Study||3||
59916237|NCT03370471|76037122|FG000|NOT COMPLETED|Overall Study||7||
59916238|NCT03370471|76037123|FG001|NOT COMPLETED|Overall Study||2||
59916239|NCT03349645|76037131|FG000|STARTED|Overall Study||94||
59916240|NCT03349645|76037131|FG000|COMPLETED|Overall Study||12||
59611898|NCT01730040|75722915|FG002|Treated|Overall Study||57||
59916241|NCT03349645|76037131|FG000|NOT COMPLETED|Overall Study||82||
60030097|NCT01899742|76145903|FG000|STARTED|Overall Study||247||
60030098|NCT01899742|76145904|FG001|STARTED|Overall Study||247||
60030099|NCT01899742|76145903|FG000|COMPLETED|Overall Study||230||
60030100|NCT01899742|76145904|FG001|COMPLETED|Overall Study||231||
60030101|NCT01899742|76145903|FG000|NOT COMPLETED|Overall Study||17||
60030102|NCT01899742|76145904|FG001|NOT COMPLETED|Overall Study||16||
60030103|NCT01615822|76145913|FG000|STARTED|Period 1||8||
60030104|NCT01615822|76145914|FG001|STARTED|Period 1||11||
60030105|NCT01615822|76145915|FG002|STARTED|Period 1||6||
60030106|NCT01615822|76145913|FG000|COMPLETED|Period 1||7||
60030107|NCT01615822|76145914|FG001|COMPLETED|Period 1||9||
60030108|NCT01615822|76145915|FG002|COMPLETED|Period 1||6||
60030109|NCT01615822|76145913|FG000|NOT COMPLETED|Period 1||1||
60030110|NCT01615822|76145914|FG001|NOT COMPLETED|Period 1||2||
60030111|NCT01615822|76145915|FG002|NOT COMPLETED|Period 1||0||
60030112|NCT01615822|76145913|FG000|STARTED|Period 2||7||
60030113|NCT01615822|76145914|FG001|STARTED|Period 2||9||
60030114|NCT01615822|76145915|FG002|STARTED|Period 2||6||
60030115|NCT01615822|76145913|FG000|COMPLETED|Period 2||7||
60030116|NCT01615822|76145914|FG001|COMPLETED|Period 2||8||
60030117|NCT01615822|76145915|FG002|COMPLETED|Period 2||4||
60030118|NCT01615822|76145913|FG000|NOT COMPLETED|Period 2||0||
60030119|NCT01615822|76145914|FG001|NOT COMPLETED|Period 2||1||
60030120|NCT01615822|76145915|FG002|NOT COMPLETED|Period 2||2||
60030121|NCT01898884|76145931|FG000|STARTED|Single Dose Period||8||
60030122|NCT01898884|76145932|FG001|STARTED|Single Dose Period||6||
60030123|NCT01898884|76145933|FG002|STARTED|Single Dose Period||6||
60030124|NCT01898884|76145934|FG003|STARTED|Single Dose Period||6||
60030125|NCT01898884|76145935|FG004|STARTED|Single Dose Period||6||
60030126|NCT01898884|76145936|FG005|STARTED|Single Dose Period||0||
60030127|NCT01898884|76145937|FG006|STARTED|Single Dose Period||0||
60030128|NCT01898884|76145938|FG007|STARTED|Single Dose Period||0||
60030129|NCT01898884|76145939|FG008|STARTED|Single Dose Period||0||
60030130|NCT01898884|76145931|FG000|COMPLETED|Single Dose Period||8||
60030131|NCT01898884|76145932|FG001|COMPLETED|Single Dose Period||6||
60030132|NCT01898884|76145933|FG002|COMPLETED|Single Dose Period||6||
60030133|NCT01898884|76145934|FG003|COMPLETED|Single Dose Period||6||
60030134|NCT01898884|76145935|FG004|COMPLETED|Single Dose Period||6||
60030135|NCT01898884|76145936|FG005|COMPLETED|Single Dose Period||0||
60030136|NCT01898884|76145937|FG006|COMPLETED|Single Dose Period||0||
60030137|NCT01898884|76145938|FG007|COMPLETED|Single Dose Period||0||
60030138|NCT01898884|76145939|FG008|COMPLETED|Single Dose Period||0||
60030139|NCT01898884|76145931|FG000|NOT COMPLETED|Single Dose Period||0||
60030140|NCT01898884|76145932|FG001|NOT COMPLETED|Single Dose Period||0||
59507829|NCT02021955|75600999|FG001|COMPLETED|Step 27||243||27
59507830|NCT02021955|75600998|FG000|NOT COMPLETED|Step 27||0||0
60030141|NCT01898884|76145933|FG002|NOT COMPLETED|Single Dose Period||0||
60030142|NCT01898884|76145934|FG003|NOT COMPLETED|Single Dose Period||0||
60030143|NCT01898884|76145935|FG004|NOT COMPLETED|Single Dose Period||0||
60030144|NCT01898884|76145936|FG005|NOT COMPLETED|Single Dose Period||0||
60030145|NCT01898884|76145937|FG006|NOT COMPLETED|Single Dose Period||0||
60030146|NCT01898884|76145938|FG007|NOT COMPLETED|Single Dose Period||0||
60030147|NCT01898884|76145939|FG008|NOT COMPLETED|Single Dose Period||0||
60030148|NCT01898884|76145931|FG000|STARTED|Multiple Dose Period||0||
60030149|NCT01898884|76145932|FG001|STARTED|Multiple Dose Period||0||
60030150|NCT01898884|76145933|FG002|STARTED|Multiple Dose Period||0||
60030151|NCT01898884|76145934|FG003|STARTED|Multiple Dose Period||0||
60030152|NCT01898884|76145935|FG004|STARTED|Multiple Dose Period||0||
60030153|NCT01898884|76145936|FG005|STARTED|Multiple Dose Period|Eligible participants who completed single dose treatment were randomized to multiple dose groups.|6||
60030154|NCT01898884|76145937|FG006|STARTED|Multiple Dose Period|Eligible participants who completed single dose treatment were randomized to multiple dose groups.|6||
60030155|NCT01898884|76145938|FG007|STARTED|Multiple Dose Period|Eligible participants who completed single dose treatment were randomized to multiple dose groups.|6||
60030156|NCT01898884|76145939|FG008|STARTED|Multiple Dose Period|Eligible participants who completed single dose treatment were randomized to multiple dose groups.|6||
60030157|NCT01898884|76145931|FG000|Treated|Multiple Dose Period||0||
60030158|NCT01898884|76145932|FG001|Treated|Multiple Dose Period||0||
60030159|NCT01898884|76145933|FG002|Treated|Multiple Dose Period||0||
60030160|NCT01898884|76145934|FG003|Treated|Multiple Dose Period||0||
60030161|NCT01898884|76145935|FG004|Treated|Multiple Dose Period||0||
60030162|NCT01898884|76145936|FG005|Treated|Multiple Dose Period||6||
60030163|NCT01898884|76145937|FG006|Treated|Multiple Dose Period||6||
60030164|NCT01898884|76145938|FG007|Treated|Multiple Dose Period||6||
60030165|NCT01898884|76145939|FG008|Treated|Multiple Dose Period||5||
60030166|NCT01898884|76145931|FG000|COMPLETED|Multiple Dose Period||0||
60030167|NCT01898884|76145932|FG001|COMPLETED|Multiple Dose Period||0||
60030168|NCT01898884|76145933|FG002|COMPLETED|Multiple Dose Period||0||
60030169|NCT01898884|76145934|FG003|COMPLETED|Multiple Dose Period||0||
60030170|NCT01898884|76145935|FG004|COMPLETED|Multiple Dose Period||0||
60030171|NCT01898884|76145936|FG005|COMPLETED|Multiple Dose Period||6||
60030172|NCT01898884|76145937|FG006|COMPLETED|Multiple Dose Period||5||
60030173|NCT01898884|76145938|FG007|COMPLETED|Multiple Dose Period||6||
60030174|NCT01898884|76145939|FG008|COMPLETED|Multiple Dose Period||5||
60030175|NCT01898884|76145931|FG000|NOT COMPLETED|Multiple Dose Period||0||
60030176|NCT01898884|76145932|FG001|NOT COMPLETED|Multiple Dose Period||0||
60030177|NCT01898884|76145933|FG002|NOT COMPLETED|Multiple Dose Period||0||
60030178|NCT01898884|76145934|FG003|NOT COMPLETED|Multiple Dose Period||0||
60030179|NCT01898884|76145935|FG004|NOT COMPLETED|Multiple Dose Period||0||
60030180|NCT01898884|76145936|FG005|NOT COMPLETED|Multiple Dose Period||0||
60030181|NCT01898884|76145937|FG006|NOT COMPLETED|Multiple Dose Period||1||
60030182|NCT01898884|76145938|FG007|NOT COMPLETED|Multiple Dose Period||0||
60030183|NCT01898884|76145939|FG008|NOT COMPLETED|Multiple Dose Period||1||
60030184|NCT01613326|76145977|FG000|STARTED|Overall Study||327||
60030185|NCT01613326|76145978|FG001|STARTED|Overall Study||330||
60030186|NCT01613326|76145977|FG000|COMPLETED|Overall Study||314||
60030187|NCT01613326|76145978|FG001|COMPLETED|Overall Study||316||
60030188|NCT01613326|76145977|FG000|NOT COMPLETED|Overall Study||13||
60030189|NCT01613326|76145978|FG001|NOT COMPLETED|Overall Study||14||
60030190|NCT01613248|76145990|FG000|STARTED|Overall Study||139||
60030191|NCT01613248|76145991|FG001|STARTED|Overall Study||138||
60030192|NCT01613248|76145992|FG002|STARTED|Overall Study||139||
60030193|NCT01613248|76145993|FG003|STARTED|Overall Study||139||
60030194|NCT01613248|76145994|FG004|STARTED|Overall Study||139||
60030195|NCT01613248|76145995|FG005|STARTED|Overall Study||140||
60030196|NCT01613248|76145990|FG000|COMPLETED|Overall Study||110||
60030197|NCT01613248|76145991|FG001|COMPLETED|Overall Study||104||
60030198|NCT01613248|76145992|FG002|COMPLETED|Overall Study||106||
60030199|NCT01613248|76145993|FG003|COMPLETED|Overall Study||101||
60030200|NCT01613248|76145994|FG004|COMPLETED|Overall Study||104||
60030201|NCT01613248|76145995|FG005|COMPLETED|Overall Study||102||
60030202|NCT01613248|76145990|FG000|NOT COMPLETED|Overall Study||29||
60030203|NCT01613248|76145991|FG001|NOT COMPLETED|Overall Study||34||
60030204|NCT01613248|76145992|FG002|NOT COMPLETED|Overall Study||33||
60030205|NCT01613248|76145993|FG003|NOT COMPLETED|Overall Study||38||
60030206|NCT01613248|76145994|FG004|NOT COMPLETED|Overall Study||35||
60030207|NCT01613248|76145995|FG005|NOT COMPLETED|Overall Study||38||
60030208|NCT01898806|76146009|FG000|STARTED|Overall Study||11||
60030209|NCT01898806|76146009|FG000|COMPLETED|Overall Study||8||
60030210|NCT01898806|76146009|FG000|NOT COMPLETED|Overall Study||3||
60030211|NCT02291029|76146019|FG000|STARTED|Overall Study||8||
60030212|NCT02291029|76146020|FG001|STARTED|Overall Study||4||
60030213|NCT02291029|76146021|FG002|STARTED|Overall Study||21||
60030214|NCT02291029|76146022|FG003|STARTED|Overall Study||11||
60030215|NCT02291029|76146023|FG004|STARTED|Overall Study||13||
60030216|NCT02291029|76146024|FG005|STARTED|Overall Study||12||
60030217|NCT02291029|76146019|FG000|COMPLETED|Overall Study||8||
60030218|NCT02291029|76146020|FG001|COMPLETED|Overall Study||3||
60030219|NCT02291029|76146021|FG002|COMPLETED|Overall Study||20||
60030220|NCT02291029|76146022|FG003|COMPLETED|Overall Study||11||
60030221|NCT02291029|76146023|FG004|COMPLETED|Overall Study||13||
60030222|NCT02291029|76146024|FG005|COMPLETED|Overall Study||12||
60030223|NCT02291029|76146019|FG000|NOT COMPLETED|Overall Study||0||
60030224|NCT02291029|76146020|FG001|NOT COMPLETED|Overall Study||1||
60030225|NCT02291029|76146021|FG002|NOT COMPLETED|Overall Study||1||
60030226|NCT02291029|76146022|FG003|NOT COMPLETED|Overall Study||0||
60030227|NCT02291029|76146023|FG004|NOT COMPLETED|Overall Study||0||
60030228|NCT02291029|76146024|FG005|NOT COMPLETED|Overall Study||0||
60030229|NCT02290873|76146041|FG000|STARTED|Overall Study||298||
60030230|NCT02290873|76146042|FG001|STARTED|Overall Study||60||
60030231|NCT02290873|76146043|FG002|STARTED|Overall Study||103||
60030232|NCT02290873|76146041|FG000|Modified Intention to Treat (mITT)|Overall Study||296|All ITT population who received at least 1 complete dose of study medication|
60030233|NCT02290873|76146042|FG001|Modified Intention to Treat (mITT)|Overall Study||60|All ITT population who received at least 1 complete dose of study medication|
60030234|NCT02290873|76146043|FG002|Modified Intention to Treat (mITT)|Overall Study||102|All ITT population who received at least 1 complete dose of study medication|
60030235|NCT02290873|76146041|FG000|Safety Population|Overall Study||296|All randomized patients who received any amount of study drug and were analyzed as treated|
60030236|NCT02290873|76146042|FG001|Safety Population|Overall Study||60|All randomized patients who received any amount of study drug and were analyzed as treated|
60030237|NCT02290873|76146043|FG002|Safety Population|Overall Study||102|All randomized patients who received any amount of study drug and were analyzed as treated|
60030238|NCT02290873|76146041|FG000|COMPLETED|Overall Study||296||
60030239|NCT02290873|76146042|FG001|COMPLETED|Overall Study||59||
60030240|NCT02290873|76146043|FG002|COMPLETED|Overall Study||101||
60030241|NCT02290873|76146041|FG000|NOT COMPLETED|Overall Study||2||
60030242|NCT02290873|76146042|FG001|NOT COMPLETED|Overall Study||1||
60030243|NCT02290873|76146043|FG002|NOT COMPLETED|Overall Study||2||
60030244|NCT02290405|76146054|FG000|STARTED|Overall Study||36||
60030245|NCT02290405|76146055|FG001|STARTED|Overall Study||53||
60030246|NCT02290405|76146054|FG000|COMPLETED|Overall Study||35||
60030247|NCT02290405|76146055|FG001|COMPLETED|Overall Study||53||
60030248|NCT02290405|76146054|FG000|NOT COMPLETED|Overall Study||1||
60030249|NCT02290405|76146055|FG001|NOT COMPLETED|Overall Study||0||
60030250|NCT02359045|76146063|FG000|STARTED|Overall Study||40||
60030251|NCT02359045|76146064|FG001|STARTED|Overall Study||42||
60030252|NCT02359045|76146063|FG000|COMPLETED|Overall Study||36||
60030253|NCT02359045|76146064|FG001|COMPLETED|Overall Study||39||
60030254|NCT02359045|76146063|FG000|NOT COMPLETED|Overall Study||4||
60030255|NCT02359045|76146064|FG001|NOT COMPLETED|Overall Study||3||
60030256|NCT02358343|76146085|FG000|STARTED|Screening Intervention|90 completed engagement interview|92||
60030257|NCT02358343|76146086|FG001|STARTED|Screening Intervention|89 completed control visit|92||
60030258|NCT02358343|76146087|FG002|STARTED|Screening Intervention||0||
60030259|NCT02358343|76146088|FG003|STARTED|Screening Intervention||0||
60030260|NCT02358343|76146089|FG004|STARTED|Screening Intervention||0||
60030261|NCT02358343|76146085|FG000|COMPLETED|Screening Intervention||86||
60030262|NCT02358343|76146086|FG001|COMPLETED|Screening Intervention||84||
60030263|NCT02358343|76146087|FG002|COMPLETED|Screening Intervention||0||
60030264|NCT02358343|76146088|FG003|COMPLETED|Screening Intervention||0||
60030265|NCT02358343|76146089|FG004|COMPLETED|Screening Intervention||0||
60030266|NCT02358343|76146085|FG000|NOT COMPLETED|Screening Intervention||6||
60030267|NCT02358343|76146086|FG001|NOT COMPLETED|Screening Intervention||8||
60030268|NCT02358343|76146087|FG002|NOT COMPLETED|Screening Intervention||0||
60030269|NCT02358343|76146088|FG003|NOT COMPLETED|Screening Intervention||0||
60030270|NCT02358343|76146089|FG004|NOT COMPLETED|Screening Intervention||0||
60030271|NCT02358343|76146085|FG000|STARTED|Comparative Efficacy Trial / Observation|Participants enrolled in screening intervention enrolled in comparative efficacy trial|0||
60030272|NCT02358343|76146086|FG001|STARTED|Comparative Efficacy Trial / Observation|Participants enrolled in screening intervention enrolled in comparative efficacy trial|0||
60030273|NCT02358343|76146087|FG002|STARTED|Comparative Efficacy Trial / Observation|44 completed treatment|60||
60030274|NCT02358343|76146088|FG003|STARTED|Comparative Efficacy Trial / Observation|47 completed treatment|60||
60030275|NCT02358343|76146089|FG004|STARTED|Comparative Efficacy Trial / Observation||20||
60030276|NCT02358343|76146085|FG000|COMPLETED|Comparative Efficacy Trial / Observation||0||
60030277|NCT02358343|76146086|FG001|COMPLETED|Comparative Efficacy Trial / Observation||0||
60030278|NCT02358343|76146087|FG002|COMPLETED|Comparative Efficacy Trial / Observation||55||
60030279|NCT02358343|76146088|FG003|COMPLETED|Comparative Efficacy Trial / Observation||58||
60030280|NCT02358343|76146089|FG004|COMPLETED|Comparative Efficacy Trial / Observation||18||
60030281|NCT02358343|76146085|FG000|NOT COMPLETED|Comparative Efficacy Trial / Observation||0||
60030282|NCT02358343|76146086|FG001|NOT COMPLETED|Comparative Efficacy Trial / Observation||0||
60030283|NCT02358343|76146087|FG002|NOT COMPLETED|Comparative Efficacy Trial / Observation||5||
60030284|NCT02358343|76146088|FG003|NOT COMPLETED|Comparative Efficacy Trial / Observation||2||
60030285|NCT02358343|76146089|FG004|NOT COMPLETED|Comparative Efficacy Trial / Observation||2||
60030286|NCT02356783|76146102|FG000|STARTED|Overall Study||16||
60030287|NCT02356783|76146103|FG001|STARTED|Overall Study||17||
60030288|NCT02356783|76146102|FG000|COMPLETED|Overall Study||15||
60030289|NCT02356783|76146103|FG001|COMPLETED|Overall Study||14||
60030290|NCT02356783|76146102|FG000|NOT COMPLETED|Overall Study||1||
60030291|NCT02356783|76146103|FG001|NOT COMPLETED|Overall Study||3||
60030292|NCT02289469|76146111|FG000|STARTED|Overall Study||250||
60030293|NCT02289469|76146112|FG001|STARTED|Overall Study||244||
60030294|NCT02289469|76146111|FG000|COMPLETED|Overall Study||244||
60030295|NCT02289469|76146112|FG001|COMPLETED|Overall Study||244||
60030296|NCT02289469|76146111|FG000|NOT COMPLETED|Overall Study||6||
60030297|NCT02289469|76146112|FG001|NOT COMPLETED|Overall Study||0||
60030298|NCT02318095|76146118|FG000|STARTED|Overall Study||40||
60030299|NCT02318095|76146118|FG000|COMPLETED|Overall Study||39||
60030300|NCT02318095|76146118|FG000|NOT COMPLETED|Overall Study||1||
60030301|NCT02317705|76146123|FG000|STARTED|Overall Study||48||
60030302|NCT02317705|76146123|FG000|Safety Population|Overall Study||44|All patients who received OTL38.|
60030303|NCT02317705|76146123|FG000|Modified Intent-to-Treat (mITT)|Overall Study||29|All patients who received OTL38, underwent cytoreductive surgery, were exposed to fluorescent light using the imaging system, and had at least one Folate Receptor-alpha positive target ovarian cancer lesion. Patients enrolled after protocol amendment 4 will not be included in the mITT population.|
60030304|NCT02317705|76146123|FG000|COMPLETED|Overall Study||43|Four subjects were screen failures and did not receive treatment; one subject who received treatment did not complete the study|
60030305|NCT02317705|76146123|FG000|NOT COMPLETED|Overall Study||5||
60030306|NCT02474069|76146127|FG000|STARTED|Selection Phase (SP)||772||
60030307|NCT02474069|76146128|FG001|STARTED|Selection Phase (SP)||0||
60030308|NCT02474069|76146129|FG002|STARTED|Selection Phase (SP)||0||
60030309|NCT02474069|76146127|FG000|COMPLETED|Selection Phase (SP)||749||
60030310|NCT02474069|76146128|FG001|COMPLETED|Selection Phase (SP)||0||
60030311|NCT02474069|76146129|FG002|COMPLETED|Selection Phase (SP)||0||
60030312|NCT02474069|76146127|FG000|NOT COMPLETED|Selection Phase (SP)||23||
60030313|NCT02474069|76146128|FG001|NOT COMPLETED|Selection Phase (SP)||0||
60030314|NCT02474069|76146129|FG002|NOT COMPLETED|Selection Phase (SP)||0||
60030315|NCT02474069|76146127|FG000|STARTED|Comparative Dosing Phase (CDP)||0||
60030316|NCT02474069|76146128|FG001|STARTED|Comparative Dosing Phase (CDP)||162||
60030317|NCT02474069|76146129|FG002|STARTED|Comparative Dosing Phase (CDP)||163||
60030318|NCT02474069|76146127|FG000|COMPLETED|Comparative Dosing Phase (CDP)||0||
60030319|NCT02474069|76146128|FG001|COMPLETED|Comparative Dosing Phase (CDP)||153||
60030320|NCT02474069|76146129|FG002|COMPLETED|Comparative Dosing Phase (CDP)||157||
60030321|NCT02474069|76146127|FG000|NOT COMPLETED|Comparative Dosing Phase (CDP)||0||
60030322|NCT02474069|76146128|FG001|NOT COMPLETED|Comparative Dosing Phase (CDP)||9||
60030323|NCT02474069|76146129|FG002|NOT COMPLETED|Comparative Dosing Phase (CDP)||6||
60030324|NCT02317627|76146142|FG000|STARTED|Overall Study||13||
60030325|NCT02317627|76146143|FG001|STARTED|Overall Study||13||
60030326|NCT02317627|76146144|FG002|STARTED|Overall Study||12||
60030327|NCT02317627|76146142|FG000|COMPLETED|Overall Study||11||
60030328|NCT02317627|76146143|FG001|COMPLETED|Overall Study||8||
60030329|NCT02317627|76146144|FG002|COMPLETED|Overall Study||8||
60030330|NCT02317627|76146142|FG000|NOT COMPLETED|Overall Study||2||
60030331|NCT02317627|76146143|FG001|NOT COMPLETED|Overall Study||5||
60030332|NCT02317627|76146144|FG002|NOT COMPLETED|Overall Study||4||
60030333|NCT02517905|76146160|FG000|STARTED|Overall Study||107||
60030334|NCT02517905|76146161|FG001|STARTED|Overall Study||59||
60030335|NCT02517905|76146160|FG000|COMPLETED|Overall Study||97||
60030336|NCT02517905|76146161|FG001|COMPLETED|Overall Study||57||
60030337|NCT02517905|76146160|FG000|NOT COMPLETED|Overall Study||10||
60030338|NCT02517905|76146161|FG001|NOT COMPLETED|Overall Study||2||
60030339|NCT02473913|76146169|FG000|STARTED|Overall Study||11||
60030340|NCT02473913|76146170|FG001|STARTED|Overall Study||11||
60030341|NCT02473913|76146169|FG000|COMPLETED|Overall Study||8||
60030342|NCT02473913|76146170|FG001|COMPLETED|Overall Study||8||
60030343|NCT02473913|76146169|FG000|NOT COMPLETED|Overall Study||3||
60030344|NCT02473913|76146170|FG001|NOT COMPLETED|Overall Study||3||
60030345|NCT02316847|76146178|FG000|STARTED|Overall Study||9||
60030346|NCT02316847|76146179|FG001|STARTED|Overall Study||99||
60030347|NCT02316847|76146178|FG000|COMPLETED|Overall Study||0||
60030348|NCT02316847|76146179|FG001|COMPLETED|Overall Study||13||
60030349|NCT02316847|76146178|FG000|NOT COMPLETED|Overall Study||9||
60030350|NCT02316847|76146179|FG001|NOT COMPLETED|Overall Study||86||
60030351|NCT02473523|76146187|FG000|STARTED|Overall Study||2||
60030352|NCT02473523|76146187|FG000|COMPLETED|Overall Study||0||
60030353|NCT02473523|76146187|FG000|NOT COMPLETED|Overall Study||2||
60030354|NCT02316769|76146193|FG000|STARTED|Overall Study||33||
60030355|NCT02316769|76146194|FG001|STARTED|Overall Study||33||
60030356|NCT02316769|76146193|FG000|COMPLETED|Overall Study||31||
60030357|NCT02316769|76146194|FG001|COMPLETED|Overall Study||33||
60030358|NCT02316769|76146193|FG000|NOT COMPLETED|Overall Study||2||
60030359|NCT02316769|76146194|FG001|NOT COMPLETED|Overall Study||0||
60030360|NCT02473445|76146200|FG000|STARTED|Overall Study||22||
60030361|NCT02473445|76146200|FG000|COMPLETED|Overall Study||0||
60030362|NCT02473445|76146200|FG000|NOT COMPLETED|Overall Study||22||
60030363|NCT02473367|76146204|FG000|STARTED|Period 1||20||
60030364|NCT02473367|76146204|FG000|COMPLETED|Period 1||20||
60030365|NCT02473367|76146204|FG000|NOT COMPLETED|Period 1||0||
60030366|NCT02473367|76146204|FG000|STARTED|Wait 1||20||
60030367|NCT02473367|76146204|FG000|COMPLETED|Wait 1||19||
60030368|NCT02473367|76146204|FG000|NOT COMPLETED|Wait 1||1||
60030369|NCT02473367|76146204|FG000|STARTED|Period 2||19||
60030370|NCT02473367|76146204|FG000|COMPLETED|Period 2||19||
60030371|NCT02473367|76146204|FG000|NOT COMPLETED|Period 2||0||
60030372|NCT02473367|76146204|FG000|STARTED|Wait 2||19||
60030373|NCT02473367|76146204|FG000|COMPLETED|Wait 2||19||
60030374|NCT02473367|76146204|FG000|NOT COMPLETED|Wait 2||0||
60030375|NCT02473367|76146204|FG000|STARTED|Period 3||19||
60030376|NCT02473367|76146204|FG000|COMPLETED|Period 3||19||
60030377|NCT02473367|76146204|FG000|NOT COMPLETED|Period 3||0||
60030378|NCT02473367|76146204|FG000|STARTED|Wait 3||19||
60030379|NCT02473367|76146204|FG000|COMPLETED|Wait 3||19||
60030380|NCT02473367|76146204|FG000|NOT COMPLETED|Wait 3||0||
60030381|NCT02473367|76146204|FG000|STARTED|Period 4||19||
60030382|NCT02473367|76146204|FG000|COMPLETED|Period 4||18||
60030383|NCT02473367|76146204|FG000|NOT COMPLETED|Period 4||1||
60030384|NCT02316613|76146214|FG000|STARTED|Overall Study||260||
60030385|NCT02316613|76146214|FG000|Safety Population|Overall Study||255||
60030386|NCT02316613|76146214|FG000|Overall Population|Overall Study||241||
60030387|NCT02316613|76146214|FG000|COMPLETED|Overall Study||156||
60030388|NCT02316613|76146214|FG000|NOT COMPLETED|Overall Study||104||
60030389|NCT02492165|76146233|FG000|STARTED|Overall Study||100||
60030390|NCT02492165|76146234|FG001|STARTED|Overall Study||60||
60030391|NCT02492165|76146235|FG002|STARTED|Overall Study||60||
60030392|NCT02492165|76146236|FG003|STARTED|Overall Study||30||
60030393|NCT02492165|76146233|FG000|COMPLETED|Overall Study||100||
60030394|NCT02492165|76146234|FG001|COMPLETED|Overall Study||59||
60030395|NCT02492165|76146235|FG002|COMPLETED|Overall Study||60||
60030396|NCT02492165|76146236|FG003|COMPLETED|Overall Study||30||
60030397|NCT02492165|76146233|FG000|NOT COMPLETED|Overall Study||0||
60030398|NCT02492165|76146234|FG001|NOT COMPLETED|Overall Study||1||
60030399|NCT02492165|76146235|FG002|NOT COMPLETED|Overall Study||0||
60030400|NCT02492165|76146236|FG003|NOT COMPLETED|Overall Study||0||
60030401|NCT02355691|76146248|FG000|STARTED|Overall Study||7||
60030402|NCT02355691|76146249|FG001|STARTED|Overall Study||9||
60030403|NCT02355691|76146248|FG000|1st Postop Visit|Overall Study||7||
60030404|NCT02355691|76146249|FG001|1st Postop Visit|Overall Study||9||
60030405|NCT02355691|76146248|FG000|2nd Postop Visit|Overall Study||7||
60030406|NCT02355691|76146249|FG001|2nd Postop Visit|Overall Study||9||
60030407|NCT02355691|76146248|FG000|COMPLETED|Overall Study||0||
60030408|NCT02355691|76146249|FG001|COMPLETED|Overall Study||0||
60030409|NCT02355691|76146248|FG000|NOT COMPLETED|Overall Study||7||
60030410|NCT02355691|76146249|FG001|NOT COMPLETED|Overall Study||9||
60030411|NCT02473289|76146257|FG000|STARTED|Overall Study||99||
60030412|NCT02473289|76146258|FG001|STARTED|Overall Study||94||
60030413|NCT02473289|76146257|FG000|COMPLETED|Overall Study||88||
60030414|NCT02473289|76146258|FG001|COMPLETED|Overall Study||81||
60030415|NCT02473289|76146257|FG000|NOT COMPLETED|Overall Study||11||
60030416|NCT02473289|76146258|FG001|NOT COMPLETED|Overall Study||13||
60030417|NCT02354599|76146270|FG000|STARTED|Overall Study||6||
60030418|NCT02354599|76146271|FG001|STARTED|Overall Study||6||
60030419|NCT02354599|76146272|FG002|STARTED|Overall Study||6||
60030420|NCT02354599|76146273|FG003|STARTED|Overall Study||6||
60030421|NCT02354599|76146274|FG004|STARTED|Overall Study||2||
60030422|NCT02354599|76146275|FG005|STARTED|Overall Study||6||
60030423|NCT02354599|76146270|FG000|COMPLETED|Overall Study||5||
60030424|NCT02354599|76146271|FG001|COMPLETED|Overall Study||5||
60030425|NCT02354599|76146272|FG002|COMPLETED|Overall Study||6||
60030426|NCT02354599|76146273|FG003|COMPLETED|Overall Study||6||
60030427|NCT02354599|76146274|FG004|COMPLETED|Overall Study||2||
60030428|NCT02354599|76146275|FG005|COMPLETED|Overall Study||5||
60030429|NCT02354599|76146270|FG000|NOT COMPLETED|Overall Study||1||
60030430|NCT02354599|76146271|FG001|NOT COMPLETED|Overall Study||1||
60030431|NCT02354599|76146272|FG002|NOT COMPLETED|Overall Study||0||
60030432|NCT02354599|76146273|FG003|NOT COMPLETED|Overall Study||0||
60030433|NCT02354599|76146274|FG004|NOT COMPLETED|Overall Study||0||
60030434|NCT02354599|76146275|FG005|NOT COMPLETED|Overall Study||1||
59611899|NCT01730040|75722916|FG003|Treated|Overall Study||47||
59611900|NCT01730040|75722917|FG004|Treated|Overall Study||45||
59916242|NCT03349333|76037135|FG000|STARTED|Overall Study||71||
59916243|NCT03349333|76037135|FG000|COMPLETED|Overall Study||0||
59916244|NCT03349333|76037135|FG000|NOT COMPLETED|Overall Study||71||
59916245|NCT03349099|76037141|FG000|STARTED|Overall Study||48||
59916246|NCT03349099|76037142|FG001|STARTED|Overall Study||47||
60030435|NCT02316223|76146298|FG000|STARTED|Overall Study||134||
59916247|NCT03349099|76037141|FG000|COMPLETED|Overall Study||44||
59916248|NCT03349099|76037142|FG001|COMPLETED|Overall Study||43||
59916249|NCT03349099|76037141|FG000|NOT COMPLETED|Overall Study||4||
59916250|NCT03349099|76037142|FG001|NOT COMPLETED|Overall Study||4||
59916251|NCT03348163|76037150|FG000|STARTED|Overall Study||12||
59916252|NCT03348163|76037151|FG001|STARTED|Overall Study||9||
59916253|NCT03348163|76037150|FG000|COMPLETED|Overall Study||10||
59916254|NCT03348163|76037151|FG001|COMPLETED|Overall Study||9||
59916255|NCT03348163|76037150|FG000|NOT COMPLETED|Overall Study||2||
59916256|NCT03348163|76037151|FG001|NOT COMPLETED|Overall Study||0||
59916257|NCT03347695|76037159|FG000|STARTED|Overall Study||20||
59916258|NCT03347695|76037160|FG001|STARTED|Overall Study||120||
59916259|NCT03347695|76037159|FG000|COMPLETED|Overall Study||20||
59916260|NCT03347695|76037160|FG001|COMPLETED|Overall Study||115||
59916261|NCT03347695|76037159|FG000|NOT COMPLETED|Overall Study||0||
59916262|NCT03347695|76037160|FG001|NOT COMPLETED|Overall Study||5||
59916263|NCT02892019|76037170|FG000|STARTED|Overall Study||41||
59916264|NCT02892019|76037171|FG001|STARTED|Overall Study||39||
59916265|NCT02892019|76037170|FG000|COMPLETED|Overall Study||40||
59916266|NCT02892019|76037171|FG001|COMPLETED|Overall Study||36||
59916267|NCT02892019|76037170|FG000|NOT COMPLETED|Overall Study||1||
59916268|NCT02892019|76037171|FG001|NOT COMPLETED|Overall Study||3||
60030436|NCT02316223|76146299|FG001|STARTED|Overall Study||133||
60030437|NCT02316223|76146300|FG002|STARTED|Overall Study||139||
60030438|NCT02316223|76146298|FG000|COMPLETED|Overall Study||90||
60030439|NCT02316223|76146299|FG001|COMPLETED|Overall Study||76||
60030440|NCT02316223|76146300|FG002|COMPLETED|Overall Study||95||
60030441|NCT02316223|76146298|FG000|NOT COMPLETED|Overall Study||44||
60030442|NCT02316223|76146299|FG001|NOT COMPLETED|Overall Study||57||
59611901|NCT01730040|75722918|FG005|Treated|Overall Study||46||
59611902|NCT01730040|75722919|FG006|Treated|Overall Study||47||
59916269|NCT03365791|76037177|FG000|STARTED|Overall Study||76||
59916270|NCT03365791|76037177|FG000|Full Analysis Set (FAS)|Overall Study||75|The FAS includes all participants who received at least one dose of study treatment and had at least one valid post-baseline efficacy assessment.|
59916271|NCT03365791|76037177|FG000|COMPLETED|Overall Study||4||
59916272|NCT03365791|76037177|FG000|NOT COMPLETED|Overall Study||72||
59916273|NCT03365011|76037184|FG000|STARTED|Overall Study||20||
59916274|NCT03365011|76037185|FG001|STARTED|Overall Study||20||
59916275|NCT03365011|76037184|FG000|COMPLETED|Overall Study||19||
60030443|NCT02316223|76146300|FG002|NOT COMPLETED|Overall Study||44||
60030444|NCT02286895|76146310|FG000|STARTED|Randomized and Vaccinated||300||
60030445|NCT02286895|76146311|FG001|STARTED|Randomized and Vaccinated||300||
60030446|NCT02286895|76146310|FG000|COMPLETED|Randomized and Vaccinated||300||
60030447|NCT02286895|76146311|FG001|COMPLETED|Randomized and Vaccinated||300||
60030448|NCT02286895|76146310|FG000|NOT COMPLETED|Randomized and Vaccinated||0||
60030449|NCT02286895|76146311|FG001|NOT COMPLETED|Randomized and Vaccinated||0||
60030450|NCT02286895|76146310|FG000|STARTED|Assessed for Measles Seroconversion||300||
60030451|NCT02286895|76146311|FG001|STARTED|Assessed for Measles Seroconversion||300||
60030452|NCT02286895|76146310|FG000|COMPLETED|Assessed for Measles Seroconversion||252||
59611903|NCT01730040|75722913|FG000|COMPLETED|Overall Study||44||
60030453|NCT02286895|76146311|FG001|COMPLETED|Assessed for Measles Seroconversion||261||
59916276|NCT03365011|76037185|FG001|COMPLETED|Overall Study||18||
59916277|NCT03365011|76037184|FG000|NOT COMPLETED|Overall Study||1||
59916278|NCT03365011|76037185|FG001|NOT COMPLETED|Overall Study||2||
59916279|NCT03627767|76037194|FG000|STARTED|Open-label (OL) Run-in Period (12 Weeks)||1235||
59916280|NCT03627767|76037195|FG001|STARTED|Open-label (OL) Run-in Period (12 Weeks)||0||
59916281|NCT03627767|76037196|FG002|STARTED|Open-label (OL) Run-in Period (12 Weeks)||0||
59916282|NCT03627767|76037197|FG003|STARTED|Open-label (OL) Run-in Period (12 Weeks)||0||
59916283|NCT03627767|76037198|FG004|STARTED|Open-label (OL) Run-in Period (12 Weeks)||0||
59916284|NCT03627767|76037194|FG000|Treated|Open-label (OL) Run-in Period (12 Weeks)||1233||
59916285|NCT03627767|76037195|FG001|Treated|Open-label (OL) Run-in Period (12 Weeks)||0||
59916286|NCT03627767|76037196|FG002|Treated|Open-label (OL) Run-in Period (12 Weeks)||0||
59916287|NCT03627767|76037197|FG003|Treated|Open-label (OL) Run-in Period (12 Weeks)||0||
59916288|NCT03627767|76037198|FG004|Treated|Open-label (OL) Run-in Period (12 Weeks)||0||
59916289|NCT03627767|76037194|FG000|COMPLETED|Open-label (OL) Run-in Period (12 Weeks)||798||
59916290|NCT03627767|76037195|FG001|COMPLETED|Open-label (OL) Run-in Period (12 Weeks)||0||
59916291|NCT03627767|76037196|FG002|COMPLETED|Open-label (OL) Run-in Period (12 Weeks)||0||
59916292|NCT03627767|76037197|FG003|COMPLETED|Open-label (OL) Run-in Period (12 Weeks)||0||
59916293|NCT03627767|76037198|FG004|COMPLETED|Open-label (OL) Run-in Period (12 Weeks)||0||
59916294|NCT03627767|76037194|FG000|NOT COMPLETED|Open-label (OL) Run-in Period (12 Weeks)||437||
59916295|NCT03627767|76037195|FG001|NOT COMPLETED|Open-label (OL) Run-in Period (12 Weeks)||0||
59916296|NCT03627767|76037196|FG002|NOT COMPLETED|Open-label (OL) Run-in Period (12 Weeks)||0||
59916297|NCT03627767|76037197|FG003|NOT COMPLETED|Open-label (OL) Run-in Period (12 Weeks)||0||
59916298|NCT03627767|76037198|FG004|NOT COMPLETED|Open-label (OL) Run-in Period (12 Weeks)||0||
59916299|NCT03627767|76037194|FG000|STARTED|Double-blind Treatment Period (40 Weeks)|Participants did not enter into the DB period.|0||
59916300|NCT03627767|76037195|FG001|STARTED|Double-blind Treatment Period (40 Weeks)|Participants who met the pre-defined criteria for DB.|267||
59916301|NCT03627767|76037196|FG002|STARTED|Double-blind Treatment Period (40 Weeks)|Participants who met the pre-defined criteria for DB.|265||
59916302|NCT03627767|76037197|FG003|STARTED|Double-blind Treatment Period (40 Weeks)|Participants who met the pre-defined criteria for DB.|266||
59916303|NCT03627767|76037198|FG004|STARTED|Double-blind Treatment Period (40 Weeks)||0||
59916304|NCT03627767|76037194|FG000|Participants Entered Rescue Period|Double-blind Treatment Period (40 Weeks)||0||
59916305|NCT03627767|76037195|FG001|Participants Entered Rescue Period|Double-blind Treatment Period (40 Weeks)||208||
59916306|NCT03627767|76037196|FG002|Participants Entered Rescue Period|Double-blind Treatment Period (40 Weeks)||109||
59916307|NCT03627767|76037197|FG003|Participants Entered Rescue Period|Double-blind Treatment Period (40 Weeks)||44||
59916308|NCT03627767|76037198|FG004|Participants Entered Rescue Period|Double-blind Treatment Period (40 Weeks)||0||
59916309|NCT03627767|76037194|FG000|Completed After Entering Rescue Period|Double-blind Treatment Period (40 Weeks)||0||
59916310|NCT03627767|76037195|FG001|Completed After Entering Rescue Period|Double-blind Treatment Period (40 Weeks)||201||
59916311|NCT03627767|76037196|FG002|Completed After Entering Rescue Period|Double-blind Treatment Period (40 Weeks)||99||
59916312|NCT03627767|76037197|FG003|Completed After Entering Rescue Period|Double-blind Treatment Period (40 Weeks)||41||
59916313|NCT03627767|76037198|FG004|Completed After Entering Rescue Period|Double-blind Treatment Period (40 Weeks)||0||
59916314|NCT03627767|76037194|FG000|Completed Without Entering Rescue Period|Double-blind Treatment Period (40 Weeks)||0||
59916315|NCT03627767|76037195|FG001|Completed Without Entering Rescue Period|Double-blind Treatment Period (40 Weeks)||43||
59916316|NCT03627767|76037196|FG002|Completed Without Entering Rescue Period|Double-blind Treatment Period (40 Weeks)||134||
59916317|NCT03627767|76037197|FG003|Completed Without Entering Rescue Period|Double-blind Treatment Period (40 Weeks)||187||
59916318|NCT03627767|76037198|FG004|Completed Without Entering Rescue Period|Double-blind Treatment Period (40 Weeks)||0||
59916319|NCT03627767|76037194|FG000|COMPLETED|Double-blind Treatment Period (40 Weeks)||0||
59916320|NCT03627767|76037195|FG001|COMPLETED|Double-blind Treatment Period (40 Weeks)|208 entered RP+43 completed study in DB period|251||
59916321|NCT03627767|76037196|FG002|COMPLETED|Double-blind Treatment Period (40 Weeks)|109 entered RP+134 completed study in DB period|243||
59916322|NCT03627767|76037197|FG003|COMPLETED|Double-blind Treatment Period (40 Weeks)|44 entered RP+187 completed study in DB period|231||
59916323|NCT03627767|76037198|FG004|COMPLETED|Double-blind Treatment Period (40 Weeks)||0||
59916324|NCT03627767|76037194|FG000|NOT COMPLETED|Double-blind Treatment Period (40 Weeks)||0||
59916325|NCT03627767|76037195|FG001|NOT COMPLETED|Double-blind Treatment Period (40 Weeks)||16||
59916326|NCT03627767|76037196|FG002|NOT COMPLETED|Double-blind Treatment Period (40 Weeks)||22||
59916327|NCT03627767|76037197|FG003|NOT COMPLETED|Double-blind Treatment Period (40 Weeks)||35||
59916328|NCT03627767|76037198|FG004|NOT COMPLETED|Double-blind Treatment Period (40 Weeks)||0||
59916329|NCT03627767|76037194|FG000|STARTED|Open-label Rescue Period (12 Weeks)||0||
59916330|NCT03627767|76037195|FG001|STARTED|Open-label Rescue Period (12 Weeks)|Participants did not enter into the OL- Rescue Period.|0||
59916331|NCT03627767|76037196|FG002|STARTED|Open-label Rescue Period (12 Weeks)|Participants did not enter into the OL- Rescue Period.|0||
59916332|NCT03627767|76037197|FG003|STARTED|Open-label Rescue Period (12 Weeks)|Participants did not enter into the OL- Rescue Period.|0||
59916333|NCT03627767|76037198|FG004|STARTED|Open-label Rescue Period (12 Weeks)|Participants who met the pre-defined criteria for OL- Rescue Period.|361||
59916334|NCT03627767|76037194|FG000|Met Protocol-defined Flare Criteria|Open-label Rescue Period (12 Weeks)||0||
59916335|NCT03627767|76037195|FG001|Met Protocol-defined Flare Criteria|Open-label Rescue Period (12 Weeks)||0||
60030454|NCT02286895|76146310|FG000|NOT COMPLETED|Assessed for Measles Seroconversion||48||
60030455|NCT02286895|76146311|FG001|NOT COMPLETED|Assessed for Measles Seroconversion||39||
60030456|NCT02472977|76146320|FG000|STARTED|Overall Study||6||
60030457|NCT02472977|76146321|FG001|STARTED|Overall Study||27||
60030458|NCT02472977|76146322|FG002|STARTED|Overall Study||8||
60030459|NCT02472977|76146320|FG000|COMPLETED|Overall Study||0||
60030460|NCT02472977|76146321|FG001|COMPLETED|Overall Study||0||
60030461|NCT02472977|76146322|FG002|COMPLETED|Overall Study||0||
60030462|NCT02472977|76146320|FG000|NOT COMPLETED|Overall Study||6||
60030463|NCT02472977|76146321|FG001|NOT COMPLETED|Overall Study||27||
60030464|NCT02472977|76146322|FG002|NOT COMPLETED|Overall Study||8||
60030465|NCT02060487|76146333|FG000|STARTED|Overall Study||129||
60030466|NCT02060487|76146334|FG001|STARTED|Overall Study||128||
60030467|NCT02060487|76146335|FG002|STARTED|Overall Study||128||
60030468|NCT02060487|76146333|FG000|COMPLETED|Overall Study||0||
60030469|NCT02060487|76146334|FG001|COMPLETED|Overall Study||0||
60030470|NCT02060487|76146335|FG002|COMPLETED|Overall Study||0||
60030471|NCT02060487|76146333|FG000|NOT COMPLETED|Overall Study||129||
60030472|NCT02060487|76146334|FG001|NOT COMPLETED|Overall Study||128||
60030473|NCT02060487|76146335|FG002|NOT COMPLETED|Overall Study||128||
60030474|NCT02059395|76146345|FG000|STARTED|Overall Study||22||
60030475|NCT02059395|76146346|FG001|STARTED|Overall Study||27||
60030476|NCT02059395|76146345|FG000|COMPLETED|Overall Study||20||
60030477|NCT02059395|76146346|FG001|COMPLETED|Overall Study||23||
60030478|NCT02059395|76146345|FG000|NOT COMPLETED|Overall Study||2||
60030479|NCT02059395|76146346|FG001|NOT COMPLETED|Overall Study||4||
60030480|NCT02059239|76146354|FG000|STARTED|Overall Study||18||
60030481|NCT02059239|76146355|FG001|STARTED|Overall Study||16||
60030482|NCT02059239|76146354|FG000|COMPLETED|Overall Study||16||
60030483|NCT02059239|76146355|FG001|COMPLETED|Overall Study||13||
59611904|NCT01730040|75722914|FG001|COMPLETED|Overall Study||40||
59611905|NCT01730040|75722915|FG002|COMPLETED|Overall Study||46||
59611906|NCT01730040|75722916|FG003|COMPLETED|Overall Study||39||
59916336|NCT03627767|76037196|FG002|Met Protocol-defined Flare Criteria|Open-label Rescue Period (12 Weeks)||0||
59916337|NCT03627767|76037197|FG003|Met Protocol-defined Flare Criteria|Open-label Rescue Period (12 Weeks)||0||
59916338|NCT03627767|76037198|FG004|Met Protocol-defined Flare Criteria|Open-label Rescue Period (12 Weeks)||351||
59916339|NCT03627767|76037194|FG000|COMPLETED|Open-label Rescue Period (12 Weeks)||0||
59916340|NCT03627767|76037195|FG001|COMPLETED|Open-label Rescue Period (12 Weeks)||0||
59916341|NCT03627767|76037196|FG002|COMPLETED|Open-label Rescue Period (12 Weeks)||0||
59916342|NCT03627767|76037197|FG003|COMPLETED|Open-label Rescue Period (12 Weeks)||0||
59916343|NCT03627767|76037198|FG004|COMPLETED|Open-label Rescue Period (12 Weeks)||341||
59916344|NCT03627767|76037194|FG000|NOT COMPLETED|Open-label Rescue Period (12 Weeks)||0||
60030484|NCT02059239|76146354|FG000|NOT COMPLETED|Overall Study||2||
60030485|NCT02059239|76146355|FG001|NOT COMPLETED|Overall Study||3||
60030486|NCT02059161|76146364|FG000|STARTED|Overall Study||245||
60030487|NCT02059161|76146365|FG001|STARTED|Overall Study||263||
60030488|NCT02059161|76146364|FG000|Treated|Overall Study||241||
60030489|NCT02059161|76146365|FG001|Treated|Overall Study||258||
60030490|NCT02059161|76146364|FG000|COMPLETED|Overall Study||196||
60030491|NCT02059161|76146365|FG001|COMPLETED|Overall Study||222||
60030492|NCT02059161|76146364|FG000|NOT COMPLETED|Overall Study||49||
60030493|NCT02059161|76146365|FG001|NOT COMPLETED|Overall Study||41||
60030494|NCT01897714|76146377|FG000|STARTED|Phase I (Dose Escalation)||4||
60030495|NCT01897714|76146378|FG001|STARTED|Phase I (Dose Escalation)||7||
60030496|NCT01897714|76146379|FG002|STARTED|Phase I (Dose Escalation)||6||
59951366|NCT02949921|76070316|FG001|COMPLETED|Overall Study||10||
60030497|NCT01897714|76146380|FG003|STARTED|Phase I (Dose Escalation)||6||
60030498|NCT01897714|76146381|FG004|STARTED|Phase I (Dose Escalation)||0||
60030499|NCT01897714|76146382|FG005|STARTED|Phase I (Dose Escalation)||0||
60030500|NCT01897714|76146377|FG000|COMPLETED|Phase I (Dose Escalation)||1|Completed 8 cycles or more of study drug.|
60030501|NCT01897714|76146378|FG001|COMPLETED|Phase I (Dose Escalation)||0|Completed 8 cycles or more of study drug.|
60030502|NCT01897714|76146379|FG002|COMPLETED|Phase I (Dose Escalation)||1|Completed 8 cycles or more of study drug.|
60030503|NCT01897714|76146380|FG003|COMPLETED|Phase I (Dose Escalation)||0|Completed 8 cycles or more of study drug.|
60030504|NCT01897714|76146381|FG004|COMPLETED|Phase I (Dose Escalation)||0|Completed 8 cycles or more of study drug.|
60030505|NCT01897714|76146382|FG005|COMPLETED|Phase I (Dose Escalation)||0|Completed 8 cycles or more of study drug.|
60030506|NCT01897714|76146377|FG000|NOT COMPLETED|Phase I (Dose Escalation)||3||
60030507|NCT01897714|76146378|FG001|NOT COMPLETED|Phase I (Dose Escalation)||7||
60030508|NCT01897714|76146379|FG002|NOT COMPLETED|Phase I (Dose Escalation)||5||
60030509|NCT01897714|76146380|FG003|NOT COMPLETED|Phase I (Dose Escalation)||6||
60030510|NCT01897714|76146381|FG004|NOT COMPLETED|Phase I (Dose Escalation)||0||
60030511|NCT01897714|76146382|FG005|NOT COMPLETED|Phase I (Dose Escalation)||0||
60030512|NCT01897714|76146377|FG000|STARTED|Phase II (MTD)||0||
60030513|NCT01897714|76146378|FG001|STARTED|Phase II (MTD)||0||
60030514|NCT01897714|76146379|FG002|STARTED|Phase II (MTD)||0||
60030515|NCT01897714|76146380|FG003|STARTED|Phase II (MTD)||0||
60030516|NCT01897714|76146381|FG004|STARTED|Phase II (MTD)|6 patients were entered from the Phase I: Melflufen 40 mg + Dexamethasone arm.|45||
60030517|NCT01897714|76146382|FG005|STARTED|Phase II (MTD)||13||
60030518|NCT01897714|76146377|FG000|COMPLETED|Phase II (MTD)||0||
60030519|NCT01897714|76146378|FG001|COMPLETED|Phase II (MTD)||0||
60030520|NCT01897714|76146379|FG002|COMPLETED|Phase II (MTD)||0||
59507831|NCT02021955|75600999|FG001|NOT COMPLETED|Step 27||0||0
59507832|NCT02021955|75600998|FG000|STARTED|Step 28|Provider attrition=0; Provider addition=2; Patient discharges=0|15||2
59507833|NCT02021955|75600999|FG001|STARTED|Step 28|Provider attrition=3; Provider addition=6; Patient discharges=6|256||28
59507834|NCT02021955|75600998|FG000|COMPLETED|Step 28||15||2
59507835|NCT02021955|75600999|FG001|COMPLETED|Step 28||256||28
60030521|NCT01897714|76146380|FG003|COMPLETED|Phase II (MTD)||0||
60030522|NCT01897714|76146381|FG004|COMPLETED|Phase II (MTD)||15||
60030523|NCT01897714|76146382|FG005|COMPLETED|Phase II (MTD)||2||
60030524|NCT01897714|76146377|FG000|NOT COMPLETED|Phase II (MTD)||0||
60030525|NCT01897714|76146378|FG001|NOT COMPLETED|Phase II (MTD)||0||
60030526|NCT01897714|76146379|FG002|NOT COMPLETED|Phase II (MTD)||0||
60030527|NCT01897714|76146380|FG003|NOT COMPLETED|Phase II (MTD)||0||
60030528|NCT01897714|76146381|FG004|NOT COMPLETED|Phase II (MTD)||30||
60030529|NCT01897714|76146382|FG005|NOT COMPLETED|Phase II (MTD)||11||
60030530|NCT01861522|76146400|FG000|STARTED|Overall Study||240||
60030531|NCT01861522|76146401|FG001|STARTED|Overall Study|One subject who did not receive any study drug was excluded from the FAS and the Safety Analysis Set|232||
60030532|NCT01861522|76146400|FG000|COMPLETED|Overall Study||237||
60030533|NCT01861522|76146401|FG001|COMPLETED|Overall Study||232||
60030534|NCT01861522|76146400|FG000|NOT COMPLETED|Overall Study||3||
60030535|NCT01861522|76146401|FG001|NOT COMPLETED|Overall Study||0||
60030536|NCT01860976|76146409|FG000|STARTED|Blinded Treatment||213||
60030537|NCT01860976|76146410|FG001|STARTED|Blinded Treatment||211||
60030538|NCT01860976|76146409|FG000|COMPLETED|Blinded Treatment||125|completed = participants who completed treatment period|
60030539|NCT01860976|76146410|FG001|COMPLETED|Blinded Treatment||98|completed = participants who completed treatment period|
60030540|NCT01860976|76146409|FG000|NOT COMPLETED|Blinded Treatment||88||
60030541|NCT01860976|76146410|FG001|NOT COMPLETED|Blinded Treatment||113||
60030542|NCT01860976|76146409|FG000|STARTED|Open-Label||197||
60030543|NCT01860976|76146410|FG001|STARTED|Open-Label||185||
60030544|NCT01860976|76146409|FG000|COMPLETED|Open-Label||169|completed = participants who completed the open label period|
60030545|NCT01860976|76146410|FG001|COMPLETED|Open-Label||166|completed = participants who completed the open label period|
60030546|NCT01860976|76146409|FG000|NOT COMPLETED|Open-Label||28||
60030547|NCT01860976|76146410|FG001|NOT COMPLETED|Open-Label||19||
60030548|NCT01860976|76146409|FG000|STARTED|Long Term Extension||106||
60030549|NCT01860976|76146410|FG001|STARTED|Long Term Extension||0||
59507836|NCT02021955|75600998|FG000|NOT COMPLETED|Step 28||0||0
59507837|NCT02021955|75600999|FG001|NOT COMPLETED|Step 28||0||0
59519019|NCT03587428|75612874|FG004|STARTED|Period 3||2||
59611907|NCT01730040|75722917|FG004|COMPLETED|Overall Study||39||
60030550|NCT01860976|76146409|FG000|COMPLETED|Long Term Extension||81|completed = completed long term extension period at the time of analysis|
60030551|NCT01860976|76146410|FG001|COMPLETED|Long Term Extension||0|completed = completed long term extension period at the time of analysis|
60030552|NCT01860976|76146409|FG000|NOT COMPLETED|Long Term Extension||25||
59916345|NCT03627767|76037195|FG001|NOT COMPLETED|Open-label Rescue Period (12 Weeks)||0||
59916346|NCT03627767|76037196|FG002|NOT COMPLETED|Open-label Rescue Period (12 Weeks)||0||
59916347|NCT03627767|76037197|FG003|NOT COMPLETED|Open-label Rescue Period (12 Weeks)||0||
59916348|NCT03627767|76037198|FG004|NOT COMPLETED|Open-label Rescue Period (12 Weeks)||20||
59916349|NCT03627065|76037209|FG000|STARTED|Overall Study||10||
59916350|NCT03627065|76037209|FG000|COMPLETED|Overall Study||7||
59916351|NCT03627065|76037209|FG000|NOT COMPLETED|Overall Study||3||
59916352|NCT02142738|76037215|FG000|STARTED|Overall Study||154||
59916353|NCT02142738|76037216|FG001|STARTED|Overall Study||151||
59916354|NCT02142738|76037215|FG000|Treated|Overall Study||154||
59916355|NCT02142738|76037216|FG001|Treated|Overall Study||150||
59916356|NCT02142738|76037215|FG000|Chemotherapy Switch to Pembrolizumab|Overall Study||0||
59916357|NCT02142738|76037216|FG001|Chemotherapy Switch to Pembrolizumab|Overall Study||83||
59916358|NCT02142738|76037215|FG000|Second Course Pembrolizumab|Overall Study||12||
59916359|NCT02142738|76037216|FG001|Second Course Pembrolizumab|Overall Study||1||
59916360|NCT02142738|76037215|FG000|COMPLETED|Overall Study||0||
59916361|NCT02142738|76037216|FG001|COMPLETED|Overall Study||0||
59916362|NCT02142738|76037215|FG000|NOT COMPLETED|Overall Study||154||
59916363|NCT02142738|76037216|FG001|NOT COMPLETED|Overall Study||151||
59916364|NCT03617861|76037227|FG000|STARTED|First Intervention (1 Day)||5||
59916365|NCT03617861|76037228|FG001|STARTED|First Intervention (1 Day)||5||
59916366|NCT03617861|76037229|FG002|STARTED|First Intervention (1 Day)||5||
59916367|NCT03617861|76037230|FG003|STARTED|First Intervention (1 Day)||5||
59916368|NCT03617861|76037227|FG000|COMPLETED|First Intervention (1 Day)||5||
59916369|NCT03617861|76037228|FG001|COMPLETED|First Intervention (1 Day)||5||
59916370|NCT03617861|76037229|FG002|COMPLETED|First Intervention (1 Day)||5||
59916371|NCT03617861|76037230|FG003|COMPLETED|First Intervention (1 Day)||5||
59916372|NCT03617861|76037227|FG000|NOT COMPLETED|First Intervention (1 Day)||0||
59916373|NCT03617861|76037228|FG001|NOT COMPLETED|First Intervention (1 Day)||0||
59916374|NCT03617861|76037229|FG002|NOT COMPLETED|First Intervention (1 Day)||0||
59916375|NCT03617861|76037230|FG003|NOT COMPLETED|First Intervention (1 Day)||0||
59916376|NCT03617861|76037227|FG000|STARTED|Washout (1 to 4 Weeks)||5||
59916377|NCT03617861|76037228|FG001|STARTED|Washout (1 to 4 Weeks)||5||
59916378|NCT03617861|76037229|FG002|STARTED|Washout (1 to 4 Weeks)||5||
59916379|NCT03617861|76037230|FG003|STARTED|Washout (1 to 4 Weeks)||5||
59916380|NCT03617861|76037227|FG000|COMPLETED|Washout (1 to 4 Weeks)||5||
59916381|NCT03617861|76037228|FG001|COMPLETED|Washout (1 to 4 Weeks)||5||
59916382|NCT03617861|76037229|FG002|COMPLETED|Washout (1 to 4 Weeks)||5||
59916383|NCT03617861|76037230|FG003|COMPLETED|Washout (1 to 4 Weeks)||5||
59916384|NCT03617861|76037227|FG000|NOT COMPLETED|Washout (1 to 4 Weeks)||0||
59916385|NCT03617861|76037228|FG001|NOT COMPLETED|Washout (1 to 4 Weeks)||0||
59916386|NCT03617861|76037229|FG002|NOT COMPLETED|Washout (1 to 4 Weeks)||0||
59916387|NCT03617861|76037230|FG003|NOT COMPLETED|Washout (1 to 4 Weeks)||0||
59916388|NCT03617861|76037227|FG000|STARTED|Second Intervention (1 Day)||5||
59916389|NCT03617861|76037228|FG001|STARTED|Second Intervention (1 Day)||5||
59916390|NCT03617861|76037229|FG002|STARTED|Second Intervention (1 Day)||5||
59916391|NCT03617861|76037230|FG003|STARTED|Second Intervention (1 Day)||5||
59916392|NCT03617861|76037227|FG000|COMPLETED|Second Intervention (1 Day)||5||
59916393|NCT03617861|76037228|FG001|COMPLETED|Second Intervention (1 Day)||5||
59916394|NCT03617861|76037229|FG002|COMPLETED|Second Intervention (1 Day)||4||
59916395|NCT03617861|76037230|FG003|COMPLETED|Second Intervention (1 Day)||5||
59916396|NCT03617861|76037227|FG000|NOT COMPLETED|Second Intervention (1 Day)||0||
59916397|NCT03617861|76037228|FG001|NOT COMPLETED|Second Intervention (1 Day)||0||
59916398|NCT03617861|76037229|FG002|NOT COMPLETED|Second Intervention (1 Day)||1||
59916399|NCT03617861|76037230|FG003|NOT COMPLETED|Second Intervention (1 Day)||0||
59916400|NCT03614975|76037242|FG000|STARTED|Overall Study||85||
59916401|NCT03614975|76037243|FG001|STARTED|Overall Study||81||
59916402|NCT03614975|76037242|FG000|COMPLETED|Overall Study||75||
59916403|NCT03614975|76037243|FG001|COMPLETED|Overall Study||73||
59916404|NCT03614975|76037242|FG000|NOT COMPLETED|Overall Study||10||
59916405|NCT03614975|76037243|FG001|NOT COMPLETED|Overall Study||8||
59916406|NCT03613649|76037261|FG000|STARTED|First Treatment||6||
59916407|NCT03613649|76037262|FG001|STARTED|First Treatment||6||
60030553|NCT01860976|76146410|FG001|NOT COMPLETED|Long Term Extension||0||
59916408|NCT03613649|76037263|FG002|STARTED|First Treatment||6||
59916409|NCT03613649|76037264|FG003|STARTED|First Treatment||6||
59916410|NCT03613649|76037265|FG004|STARTED|First Treatment||6||
59916411|NCT03613649|76037266|FG005|STARTED|First Treatment||6||
59916412|NCT03613649|76037267|FG006|STARTED|First Treatment||6||
59916413|NCT03613649|76037268|FG007|STARTED|First Treatment||6||
59916414|NCT03613649|76037269|FG008|STARTED|First Treatment||6||
59916415|NCT03613649|76037270|FG009|STARTED|First Treatment||6||
59916416|NCT03613649|76037271|FG010|STARTED|First Treatment||6||
59916417|NCT03613649|76037272|FG011|STARTED|First Treatment||6||
59916418|NCT03613649|76037261|FG000|Received Treatment|First Treatment||6||
59916419|NCT03613649|76037262|FG001|Received Treatment|First Treatment||6||
59916420|NCT03613649|76037263|FG002|Received Treatment|First Treatment||6||
59916421|NCT03613649|76037264|FG003|Received Treatment|First Treatment||6||
60030554|NCT01860040|76146421|FG000|STARTED|Overall Study|did not meet recruitment goal|1||
60030555|NCT01860040|76146422|FG001|STARTED|Overall Study|did not meet recruitment goal|0||
60030556|NCT01860040|76146421|FG000|COMPLETED|Overall Study|did not meet recruitment goal|0||
60030557|NCT01860040|76146422|FG001|COMPLETED|Overall Study|did not meet recruitment goal|0||
60030558|NCT01860040|76146421|FG000|NOT COMPLETED|Overall Study||1||
60030559|NCT01860040|76146422|FG001|NOT COMPLETED|Overall Study||0||
60030560|NCT01896934|76146427|FG000|STARTED|Overall Study||21||
60030561|NCT01896934|76146427|FG000|COMPLETED|Overall Study||19||
60030562|NCT01896934|76146427|FG000|NOT COMPLETED|Overall Study||2||
60030563|NCT02039505|76146434|FG000|STARTED|Induction Phase (Week 0 to Week 14)||82||
60030564|NCT02039505|76146435|FG001|STARTED|Induction Phase (Week 0 to Week 14)||164||
60030565|NCT02039505|76146436|FG002|STARTED|Induction Phase (Week 0 to Week 14)||46||
60030566|NCT02039505|76146437|FG003|STARTED|Induction Phase (Week 0 to Week 14)||0||
60030567|NCT02039505|76146438|FG004|STARTED|Induction Phase (Week 0 to Week 14)||0||
60030568|NCT02039505|76146439|FG005|STARTED|Induction Phase (Week 0 to Week 14)||0||
60030569|NCT02039505|76146440|FG006|STARTED|Induction Phase (Week 0 to Week 14)||0||
60030570|NCT02039505|76146434|FG000|COMPLETED|Induction Phase (Week 0 to Week 14)||78||
60030571|NCT02039505|76146435|FG001|COMPLETED|Induction Phase (Week 0 to Week 14)||155||
60030572|NCT02039505|76146436|FG002|COMPLETED|Induction Phase (Week 0 to Week 14)||36||
60030573|NCT02039505|76146437|FG003|COMPLETED|Induction Phase (Week 0 to Week 14)||0||
60030574|NCT02039505|76146438|FG004|COMPLETED|Induction Phase (Week 0 to Week 14)||0||
60030575|NCT02039505|76146439|FG005|COMPLETED|Induction Phase (Week 0 to Week 14)||0||
60030576|NCT02039505|76146440|FG006|COMPLETED|Induction Phase (Week 0 to Week 14)||0||
60030577|NCT02039505|76146434|FG000|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||4||
60030578|NCT02039505|76146435|FG001|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||9||
60030579|NCT02039505|76146436|FG002|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||10||
60030580|NCT02039505|76146437|FG003|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||0||
60030581|NCT02039505|76146438|FG004|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||0||
60030582|NCT02039505|76146439|FG005|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||0||
60030583|NCT02039505|76146440|FG006|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||0||
60030584|NCT02039505|76146434|FG000|STARTED|Maintenance Phase (Week 14 to Week 60)||0|Participants who achieved clinical response at Week 10 entered into the maintenance phase.|
60030585|NCT02039505|76146435|FG001|STARTED|Maintenance Phase (Week 14 to Week 60)||0|Participants who achieved clinical response at Week 10 entered into the maintenance phase.|
60030586|NCT02039505|76146436|FG002|STARTED|Maintenance Phase (Week 14 to Week 60)||0|Participants who achieved clinical response at Week 10 entered into the maintenance phase.|
60030587|NCT02039505|76146437|FG003|STARTED|Maintenance Phase (Week 14 to Week 60)||42|Participants who achieved clinical response at Week 10 entered into the maintenance phase.|
60030588|NCT02039505|76146438|FG004|STARTED|Maintenance Phase (Week 14 to Week 60)||41|Participants who achieved clinical response at Week 10 entered into the maintenance phase.|
60030589|NCT02039505|76146439|FG005|STARTED|Maintenance Phase (Week 14 to Week 60)||26|Participants who achieved clinical response at Week 10 entered into the maintenance phase.|
60030590|NCT02039505|76146440|FG006|STARTED|Maintenance Phase (Week 14 to Week 60)||0|Participants who achieved clinical response at Week 10 entered into the maintenance phase.|
60030591|NCT02039505|76146434|FG000|COMPLETED|Maintenance Phase (Week 14 to Week 60)||0||
60030592|NCT02039505|76146435|FG001|COMPLETED|Maintenance Phase (Week 14 to Week 60)||0||
60030593|NCT02039505|76146436|FG002|COMPLETED|Maintenance Phase (Week 14 to Week 60)||0||
60030594|NCT02039505|76146437|FG003|COMPLETED|Maintenance Phase (Week 14 to Week 60)||18||
60030595|NCT02039505|76146438|FG004|COMPLETED|Maintenance Phase (Week 14 to Week 60)||30||
60030596|NCT02039505|76146439|FG005|COMPLETED|Maintenance Phase (Week 14 to Week 60)||12||
60030597|NCT02039505|76146440|FG006|COMPLETED|Maintenance Phase (Week 14 to Week 60)||0||
60030598|NCT02039505|76146434|FG000|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||0||
60030599|NCT02039505|76146435|FG001|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||0||
60030600|NCT02039505|76146436|FG002|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||0||
59611908|NCT01730040|75722918|FG005|COMPLETED|Overall Study||40||
59611909|NCT01730040|75722919|FG006|COMPLETED|Overall Study||38||
59611910|NCT01730040|75722913|FG000|NOT COMPLETED|Overall Study||13||
59611911|NCT01730040|75722914|FG001|NOT COMPLETED|Overall Study||15||
59611912|NCT01730040|75722915|FG002|NOT COMPLETED|Overall Study||11||
59611913|NCT01730040|75722916|FG003|NOT COMPLETED|Overall Study||8||
59611914|NCT01730040|75722917|FG004|NOT COMPLETED|Overall Study||6||
59611915|NCT01730040|75722918|FG005|NOT COMPLETED|Overall Study||7||
59611916|NCT01730040|75722919|FG006|NOT COMPLETED|Overall Study||9||
59611917|NCT01706328|75722937|FG000|STARTED|2-week Run-in Period||993||
59611918|NCT01706328|75722938|FG001|STARTED|2-week Run-in Period||0||
59611919|NCT01706328|75722939|FG002|STARTED|2-week Run-in Period||0||
60030601|NCT02039505|76146437|FG003|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||24||
60030602|NCT02039505|76146438|FG004|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||11||
60030603|NCT02039505|76146439|FG005|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||14||
60030604|NCT02039505|76146440|FG006|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||0||
60030605|NCT02039505|76146434|FG000|STARTED|Open-Label (Week 10 up to Week 154)||0|33 out of 292 participants from induction/maintenance phase did not enter the open-label cohort.|
60030606|NCT02039505|76146435|FG001|STARTED|Open-Label (Week 10 up to Week 154)||0|33 out of 292 participants from induction/maintenance phase did not enter the open-label cohort.|
60030607|NCT02039505|76146436|FG002|STARTED|Open-Label (Week 10 up to Week 154)||0|33 out of 292 participants from induction/maintenance phase did not enter the open-label cohort.|
60030608|NCT02039505|76146437|FG003|STARTED|Open-Label (Week 10 up to Week 154)||0|33 out of 292 participants from induction/maintenance phase did not enter the open-label cohort.|
60030609|NCT02039505|76146438|FG004|STARTED|Open-Label (Week 10 up to Week 154)||0|33 out of 292 participants from induction/maintenance phase did not enter the open-label cohort.|
60030610|NCT02039505|76146439|FG005|STARTED|Open-Label (Week 10 up to Week 154)||0|33 out of 292 participants from induction/maintenance phase did not enter the open-label cohort.|
60067796|NCT01973569|76182982|FG001|NOT COMPLETED|Overall Study||25||
60067797|NCT01973569|76182983|FG002|NOT COMPLETED|Overall Study||18||
60067798|NCT01973491|76182991|FG000|STARTED|Baseline Control Period (8 Weeks)||37||
60067799|NCT01973491|76182991|FG000|COMPLETED|Baseline Control Period (8 Weeks)||19||
60067800|NCT01973491|76182991|FG000|NOT COMPLETED|Baseline Control Period (8 Weeks)||18||
60067801|NCT01973491|76182991|FG000|STARTED|Titration Period(4 Weeks)||19||
60067802|NCT01973491|76182991|FG000|COMPLETED|Titration Period(4 Weeks)||19||
60067803|NCT01973491|76182991|FG000|NOT COMPLETED|Titration Period(4 Weeks)||0||
60067804|NCT01973491|76182991|FG000|STARTED|Treatment Period (16 Weeks)||19||
60067805|NCT01973491|76182991|FG000|COMPLETED|Treatment Period (16 Weeks)||18||
60067806|NCT01973491|76182991|FG000|NOT COMPLETED|Treatment Period (16 Weeks)||1||
60067807|NCT01951586|76182997|FG000|STARTED|Overall Study||78||
60067808|NCT01951586|76182998|FG001|STARTED|Overall Study||148||
60030611|NCT02039505|76146440|FG006|STARTED|Open-Label (Week 10 up to Week 154)||259|33 out of 292 participants from induction/maintenance phase did not enter the open-label cohort.|
60030612|NCT02039505|76146434|FG000|COMPLETED|Open-Label (Week 10 up to Week 154)||0||
59507838|NCT02021955|75600998|FG000|STARTED|Step 29|Provider attrition=0; Provider addition=0; Patient discharges=0|10||1
59507839|NCT02021955|75600999|FG001|STARTED|Step 29|Provider attrition=1; Provider addition=2; Patient discharges=8|266||29
59507840|NCT02021955|75600998|FG000|COMPLETED|Step 29||10||1
59507841|NCT02021955|75600999|FG001|COMPLETED|Step 29||266||29
59507842|NCT02021955|75600998|FG000|NOT COMPLETED|Step 29||0||0
59507843|NCT02021955|75600999|FG001|NOT COMPLETED|Step 29||0||0
59507844|NCT02021955|75600998|FG000|STARTED|Step 30|Provider attrition=0; Provider addition=0; Patient discharges=0|0||0
59507845|NCT02021955|75600999|FG001|STARTED|Step 30|Provider attrition=0; Provider addition=1; Patient discharges=11|277||30
59507846|NCT02021955|75600998|FG000|COMPLETED|Step 30||0||0
59507847|NCT02021955|75600999|FG001|COMPLETED|Step 30||277||30
59507848|NCT02021955|75600998|FG000|NOT COMPLETED|Step 30||0||0
59507849|NCT02021955|75600999|FG001|NOT COMPLETED|Step 30||0||0
59507850|NCT00848185|75601008|FG000|STARTED|Overall Study||32||
59507851|NCT00848185|75601009|FG001|STARTED|Overall Study||32||
59507852|NCT00848185|75601010|FG002|STARTED|Overall Study||32||
59507853|NCT00848185|75601008|FG000|COMPLETED|Overall Study||32||
59507854|NCT00848185|75601009|FG001|COMPLETED|Overall Study||32||
59507855|NCT00848185|75601010|FG002|COMPLETED|Overall Study||32||
59507856|NCT00848185|75601008|FG000|NOT COMPLETED|Overall Study||0||
59507857|NCT00848185|75601009|FG001|NOT COMPLETED|Overall Study||0||
59507858|NCT00848185|75601010|FG002|NOT COMPLETED|Overall Study||0||
59507859|NCT02022111|75601020|FG000|STARTED|Overall Study||196||
59507860|NCT02022111|75601021|FG001|STARTED|Overall Study||208||
59507861|NCT02022111|75601020|FG000|COMPLETED|Overall Study||186||
59507862|NCT02022111|75601021|FG001|COMPLETED|Overall Study||193||
59507863|NCT02022111|75601020|FG000|NOT COMPLETED|Overall Study||10||
59507864|NCT02022111|75601021|FG001|NOT COMPLETED|Overall Study||15||
59507865|NCT02022735|75601029|FG000|STARTED|Overall Study||22||
59507866|NCT02022735|75601029|FG000|COMPLETED|Overall Study||22||
59507867|NCT02022735|75601029|FG000|NOT COMPLETED|Overall Study||0||
60030613|NCT02039505|76146435|FG001|COMPLETED|Open-Label (Week 10 up to Week 154)||0||
60030614|NCT02039505|76146436|FG002|COMPLETED|Open-Label (Week 10 up to Week 154)||0||
60030615|NCT02039505|76146437|FG003|COMPLETED|Open-Label (Week 10 up to Week 154)||0||
60030616|NCT02039505|76146438|FG004|COMPLETED|Open-Label (Week 10 up to Week 154)||0||
60030617|NCT02039505|76146439|FG005|COMPLETED|Open-Label (Week 10 up to Week 154)||0||
60030618|NCT02039505|76146440|FG006|COMPLETED|Open-Label (Week 10 up to Week 154)||188||
60030619|NCT02039505|76146434|FG000|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||0||
60030620|NCT02039505|76146435|FG001|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||0||
60030621|NCT02039505|76146436|FG002|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||0||
60030622|NCT02039505|76146437|FG003|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||0||
60030623|NCT02039505|76146438|FG004|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||0||
60030624|NCT02039505|76146439|FG005|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||0||
60030625|NCT02039505|76146440|FG006|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||71||
60030626|NCT02095197|76146462|FG000|STARTED|Overall Study||40||
60030627|NCT02095197|76146463|FG001|STARTED|Overall Study||39||
60030628|NCT02095197|76146462|FG000|COMPLETED|Overall Study||40||
60030629|NCT02095197|76146463|FG001|COMPLETED|Overall Study||36||
60030630|NCT02095197|76146462|FG000|NOT COMPLETED|Overall Study||0||
60030631|NCT02095197|76146463|FG001|NOT COMPLETED|Overall Study||3||
60030632|NCT02039427|76146473|FG000|STARTED|Overall Study||48||
60030633|NCT02039427|76146474|FG001|STARTED|Overall Study||48||
60030634|NCT02039427|76146475|FG002|STARTED|Overall Study||48||
60030635|NCT02039427|76146476|FG003|STARTED|Overall Study||48||
60030636|NCT02039427|76146473|FG000|COMPLETED|Overall Study||45||
60030637|NCT02039427|76146474|FG001|COMPLETED|Overall Study||47||
60030638|NCT02039427|76146475|FG002|COMPLETED|Overall Study||45||
60030639|NCT02039427|76146476|FG003|COMPLETED|Overall Study||43||
60030640|NCT02039427|76146473|FG000|NOT COMPLETED|Overall Study||3||
60030641|NCT02039427|76146474|FG001|NOT COMPLETED|Overall Study||1||
60030642|NCT02039427|76146475|FG002|NOT COMPLETED|Overall Study||3||
60030643|NCT02039427|76146476|FG003|NOT COMPLETED|Overall Study||5||
60030644|NCT02094885|76146492|FG000|STARTED|Overall Study||125||
60030645|NCT02094885|76146493|FG001|STARTED|Overall Study||127||
60030646|NCT02094885|76146492|FG000|COMPLETED|Overall Study||123||
60030647|NCT02094885|76146493|FG001|COMPLETED|Overall Study||122||
60030648|NCT02094885|76146492|FG000|NOT COMPLETED|Overall Study||2||
60030649|NCT02094885|76146493|FG001|NOT COMPLETED|Overall Study||5||
60030650|NCT01896856|76146505|FG000|STARTED|Overall Study||6||
60030651|NCT01896856|76146506|FG001|STARTED|Overall Study||3||
60030652|NCT01896856|76146507|FG002|STARTED|Overall Study||7||
60030653|NCT01896856|76146508|FG003|STARTED|Overall Study||6||
59507868|NCT02153983|75601045|FG000|STARTED|Overall Study||19||
59507869|NCT02153983|75601046|FG001|STARTED|Overall Study||21||
59507870|NCT02153983|75601047|FG002|STARTED|Overall Study||4||
60030654|NCT01896856|76146509|FG004|STARTED|Overall Study||62||
60030655|NCT01896856|76146510|FG005|STARTED|Overall Study||34||
60030656|NCT01896856|76146505|FG000|COMPLETED|Overall Study||6||
60030657|NCT01896856|76146506|FG001|COMPLETED|Overall Study||3||
60030658|NCT01896856|76146507|FG002|COMPLETED|Overall Study||6||
60030659|NCT01896856|76146508|FG003|COMPLETED|Overall Study||6||
60030660|NCT01896856|76146509|FG004|COMPLETED|Overall Study||62||
60030661|NCT01896856|76146510|FG005|COMPLETED|Overall Study||34||
60030662|NCT01896856|76146505|FG000|NOT COMPLETED|Overall Study||0||
60030663|NCT01896856|76146506|FG001|NOT COMPLETED|Overall Study||0||
60030664|NCT01896856|76146507|FG002|NOT COMPLETED|Overall Study||1||
60030665|NCT01896856|76146508|FG003|NOT COMPLETED|Overall Study||0||
60030666|NCT01896856|76146509|FG004|NOT COMPLETED|Overall Study||0||
60030667|NCT01896856|76146510|FG005|NOT COMPLETED|Overall Study||0||
60030668|NCT02038959|76146527|FG000|STARTED|Overall Study||98||
60030669|NCT02038959|76146528|FG001|STARTED|Overall Study||97||
60030670|NCT02038959|76146527|FG000|COMPLETED|Overall Study||92||
60030671|NCT02038959|76146528|FG001|COMPLETED|Overall Study||89||
60030672|NCT02038959|76146527|FG000|NOT COMPLETED|Overall Study||6||
60030673|NCT02038959|76146528|FG001|NOT COMPLETED|Overall Study||8||
60030674|NCT01896700|76146536|FG000|STARTED|Overall Study||12||
60030675|NCT01896700|76146537|FG001|STARTED|Overall Study||12||
60030676|NCT01896700|76146536|FG000|COMPLETED|Overall Study||8||
60030677|NCT01896700|76146537|FG001|COMPLETED|Overall Study||6||
60030678|NCT01896700|76146536|FG000|NOT COMPLETED|Overall Study||4||
60030679|NCT01896700|76146537|FG001|NOT COMPLETED|Overall Study||6||
60030680|NCT02352493|76146561|FG000|STARTED|Overall Study||8||
60030681|NCT02352493|76146562|FG001|STARTED|Overall Study||3||
60030682|NCT02352493|76146563|FG002|STARTED|Overall Study||3||
60030683|NCT02352493|76146564|FG003|STARTED|Overall Study||3||
60030684|NCT02352493|76146565|FG004|STARTED|Overall Study||3||
60030685|NCT02352493|76146566|FG005|STARTED|Overall Study||3||
60030686|NCT02352493|76146567|FG006|STARTED|Overall Study||3||
60030687|NCT02352493|76146568|FG007|STARTED|Overall Study||3||
60030688|NCT02352493|76146569|FG008|STARTED|Overall Study||3||
60030689|NCT02352493|76146570|FG009|STARTED|Overall Study||6||
60030690|NCT02352493|76146571|FG010|STARTED|Overall Study||3||
60030691|NCT02352493|76146572|FG011|STARTED|Overall Study||3||
60030692|NCT02352493|76146573|FG012|STARTED|Overall Study||3||
60030693|NCT02352493|76146574|FG013|STARTED|Overall Study||3||
60030694|NCT02352493|76146575|FG014|STARTED|Overall Study||3||
60030695|NCT02352493|76146576|FG015|STARTED|Overall Study||3||
60030696|NCT02352493|76146577|FG016|STARTED|Overall Study||3||
60030697|NCT02352493|76146578|FG017|STARTED|Overall Study||3||
60030698|NCT02352493|76146561|FG000|COMPLETED|Overall Study||8||
60030699|NCT02352493|76146562|FG001|COMPLETED|Overall Study||3||
60030700|NCT02352493|76146563|FG002|COMPLETED|Overall Study||3||
60030701|NCT02352493|76146564|FG003|COMPLETED|Overall Study||3||
60030702|NCT02352493|76146565|FG004|COMPLETED|Overall Study||3||
60030703|NCT02352493|76146566|FG005|COMPLETED|Overall Study||3||
60030704|NCT02352493|76146567|FG006|COMPLETED|Overall Study||2||
60030705|NCT02352493|76146568|FG007|COMPLETED|Overall Study||3||
60030706|NCT02352493|76146569|FG008|COMPLETED|Overall Study||1||
60030707|NCT02352493|76146570|FG009|COMPLETED|Overall Study||5||
60030708|NCT02352493|76146571|FG010|COMPLETED|Overall Study||3||
60030709|NCT02352493|76146572|FG011|COMPLETED|Overall Study||3||
60030710|NCT02352493|76146573|FG012|COMPLETED|Overall Study||2||
60030711|NCT02352493|76146574|FG013|COMPLETED|Overall Study||1||
60030712|NCT02352493|76146575|FG014|COMPLETED|Overall Study||2||
60030713|NCT02352493|76146576|FG015|COMPLETED|Overall Study||3||
60030714|NCT02352493|76146577|FG016|COMPLETED|Overall Study||3||
60030715|NCT02352493|76146578|FG017|COMPLETED|Overall Study||3||
60030716|NCT02352493|76146561|FG000|NOT COMPLETED|Overall Study||0||
60030717|NCT02352493|76146562|FG001|NOT COMPLETED|Overall Study||0||
59507871|NCT02153983|75601048|FG003|STARTED|Overall Study||13||
59507872|NCT02153983|75601049|FG004|STARTED|Overall Study||19||
59507873|NCT02153983|75601050|FG005|STARTED|Overall Study||1||
59507874|NCT02153983|75601045|FG000|COMPLETED|Overall Study||19||
60030718|NCT02352493|76146563|FG002|NOT COMPLETED|Overall Study||0||
60030719|NCT02352493|76146564|FG003|NOT COMPLETED|Overall Study||0||
60030720|NCT02352493|76146565|FG004|NOT COMPLETED|Overall Study||0||
60030721|NCT02352493|76146566|FG005|NOT COMPLETED|Overall Study||0||
60030722|NCT02352493|76146567|FG006|NOT COMPLETED|Overall Study||1||
60030723|NCT02352493|76146568|FG007|NOT COMPLETED|Overall Study||0||
60030724|NCT02352493|76146569|FG008|NOT COMPLETED|Overall Study||2||
60030725|NCT02352493|76146570|FG009|NOT COMPLETED|Overall Study||1||
60030726|NCT02352493|76146571|FG010|NOT COMPLETED|Overall Study||0||
60030727|NCT02352493|76146572|FG011|NOT COMPLETED|Overall Study||0||
60030728|NCT02352493|76146573|FG012|NOT COMPLETED|Overall Study||1||
60030729|NCT02352493|76146574|FG013|NOT COMPLETED|Overall Study||2||
60030730|NCT02352493|76146575|FG014|NOT COMPLETED|Overall Study||1||
59507875|NCT02153983|75601046|FG001|COMPLETED|Overall Study||18||
59507876|NCT02153983|75601047|FG002|COMPLETED|Overall Study||2||
59507877|NCT02153983|75601048|FG003|COMPLETED|Overall Study||13||
60030731|NCT02352493|76146576|FG015|NOT COMPLETED|Overall Study||0||
60030732|NCT02352493|76146577|FG016|NOT COMPLETED|Overall Study||0||
60030733|NCT02352493|76146578|FG017|NOT COMPLETED|Overall Study||0||
59507878|NCT02153983|75601049|FG004|COMPLETED|Overall Study||19||
60030734|NCT02286193|76146633|FG000|STARTED|Overall Study||622||
60030735|NCT02286193|76146633|FG000|COMPLETED|Overall Study||418||
60030736|NCT02286193|76146633|FG000|NOT COMPLETED|Overall Study||204||
60030737|NCT01896232|76146640|FG000|STARTED|Overall Study||343||
60030738|NCT01896232|76146641|FG001|STARTED|Overall Study||340||
60030739|NCT01896232|76146640|FG000|Received Treatment|Overall Study||341||
60030740|NCT01896232|76146641|FG001|Received Treatment|Overall Study||338||
60030741|NCT01896232|76146640|FG000|COMPLETED|Overall Study||294||
60030742|NCT01896232|76146641|FG001|COMPLETED|Overall Study||287||
60030743|NCT01896232|76146640|FG000|NOT COMPLETED|Overall Study||49||
60030744|NCT01896232|76146641|FG001|NOT COMPLETED|Overall Study||53||
60030745|NCT02460224|76146676|FG000|STARTED|Overall Study||17||
60030746|NCT02460224|76146677|FG001|STARTED|Overall Study||12||
60030747|NCT02460224|76146678|FG002|STARTED|Overall Study||6||
60030748|NCT02460224|76146679|FG003|STARTED|Overall Study||6||
60030749|NCT02460224|76146680|FG004|STARTED|Overall Study||6||
60030750|NCT02460224|76146681|FG005|STARTED|Overall Study||30||
60030751|NCT02460224|76146682|FG006|STARTED|Overall Study||30||
60030752|NCT02460224|76146683|FG007|STARTED|Overall Study||5||
60030753|NCT02460224|76146684|FG008|STARTED|Overall Study||6||
60030754|NCT02460224|76146685|FG009|STARTED|Overall Study||11||
60030755|NCT02460224|76146686|FG010|STARTED|Overall Study||5||
60030756|NCT02460224|76146687|FG011|STARTED|Overall Study||6||
60030757|NCT02460224|76146688|FG012|STARTED|Overall Study||6||
60030758|NCT02460224|76146689|FG013|STARTED|Overall Study||6||
60030759|NCT02460224|76146690|FG014|STARTED|Overall Study||5||
60030760|NCT02460224|76146691|FG015|STARTED|Overall Study||6||
60030761|NCT02460224|76146692|FG016|STARTED|Overall Study||20||
60030762|NCT02460224|76146693|FG017|STARTED|Overall Study||6||
60030763|NCT02460224|76146694|FG018|STARTED|Overall Study||12||
60030764|NCT02460224|76146695|FG019|STARTED|Overall Study||7||
60030765|NCT02460224|76146696|FG020|STARTED|Overall Study||6||
60030766|NCT02460224|76146697|FG021|STARTED|Overall Study||12||
60030767|NCT02460224|76146698|FG022|STARTED|Overall Study||6||
60030768|NCT02460224|76146699|FG023|STARTED|Overall Study||11||
60030769|NCT02460224|76146700|FG024|STARTED|Overall Study||6||
60030770|NCT02460224|76146701|FG025|STARTED|Overall Study||6||
60030771|NCT02460224|76146702|FG026|STARTED|Overall Study||121||
60030772|NCT02460224|76146703|FG027|STARTED|Overall Study||21||
60030773|NCT02460224|76146704|FG028|STARTED|Overall Study||93||
60030774|NCT02460224|76146676|FG000|Rest of the World Patients in the Dose Escalation Part|Overall Study||13||
60030775|NCT02460224|76146677|FG001|Rest of the World Patients in the Dose Escalation Part|Overall Study||12||
60030776|NCT02460224|76146678|FG002|Rest of the World Patients in the Dose Escalation Part|Overall Study||6||
60030777|NCT02460224|76146679|FG003|Rest of the World Patients in the Dose Escalation Part|Overall Study||6||
60030778|NCT02460224|76146680|FG004|Rest of the World Patients in the Dose Escalation Part|Overall Study||6||
60030779|NCT02460224|76146681|FG005|Rest of the World Patients in the Dose Escalation Part|Overall Study||25||
60030780|NCT02460224|76146682|FG006|Rest of the World Patients in the Dose Escalation Part|Overall Study||24||
60030781|NCT02460224|76146683|FG007|Rest of the World Patients in the Dose Escalation Part|Overall Study||5||
60030782|NCT02460224|76146684|FG008|Rest of the World Patients in the Dose Escalation Part|Overall Study||6||
60030783|NCT02460224|76146685|FG009|Rest of the World Patients in the Dose Escalation Part|Overall Study||11||
60030784|NCT02460224|76146686|FG010|Rest of the World Patients in the Dose Escalation Part|Overall Study||5||
60030785|NCT02460224|76146687|FG011|Rest of the World Patients in the Dose Escalation Part|Overall Study||6||
60030786|NCT02460224|76146688|FG012|Rest of the World Patients in the Dose Escalation Part|Overall Study||6||
60030787|NCT02460224|76146689|FG013|Rest of the World Patients in the Dose Escalation Part|Overall Study||6||
60030788|NCT02460224|76146690|FG014|Rest of the World Patients in the Dose Escalation Part|Overall Study||5||
60030789|NCT02460224|76146691|FG015|Rest of the World Patients in the Dose Escalation Part|Overall Study||6||
60030790|NCT02460224|76146692|FG016|Rest of the World Patients in the Dose Escalation Part|Overall Study||20||
60030791|NCT02460224|76146693|FG017|Rest of the World Patients in the Dose Escalation Part|Overall Study||6||
60030792|NCT02460224|76146694|FG018|Rest of the World Patients in the Dose Escalation Part|Overall Study||12||
60030793|NCT02460224|76146695|FG019|Rest of the World Patients in the Dose Escalation Part|Overall Study||7||
60030794|NCT02460224|76146696|FG020|Rest of the World Patients in the Dose Escalation Part|Overall Study||6||
60030795|NCT02460224|76146697|FG021|Rest of the World Patients in the Dose Escalation Part|Overall Study||12||
60030796|NCT02460224|76146698|FG022|Rest of the World Patients in the Dose Escalation Part|Overall Study||6||
60030797|NCT02460224|76146699|FG023|Rest of the World Patients in the Dose Escalation Part|Overall Study||11||
60030798|NCT02460224|76146700|FG024|Rest of the World Patients in the Dose Escalation Part|Overall Study||6||
60030799|NCT02460224|76146701|FG025|Rest of the World Patients in the Dose Escalation Part|Overall Study||6||
60030800|NCT02460224|76146702|FG026|Rest of the World Patients in the Dose Escalation Part|Overall Study||0||
60030801|NCT02460224|76146703|FG027|Rest of the World Patients in the Dose Escalation Part|Overall Study||0||
60030802|NCT02460224|76146704|FG028|Rest of the World Patients in the Dose Escalation Part|Overall Study||0||
60030803|NCT02460224|76146676|FG000|Japanese Patients in the Dose Escalation Part|Overall Study||4||
60030804|NCT02460224|76146677|FG001|Japanese Patients in the Dose Escalation Part|Overall Study||0||
60030805|NCT02460224|76146678|FG002|Japanese Patients in the Dose Escalation Part|Overall Study||0||
60030806|NCT02460224|76146679|FG003|Japanese Patients in the Dose Escalation Part|Overall Study||0||
60030807|NCT02460224|76146680|FG004|Japanese Patients in the Dose Escalation Part|Overall Study||0||
60030808|NCT02460224|76146681|FG005|Japanese Patients in the Dose Escalation Part|Overall Study||5||
60030809|NCT02460224|76146682|FG006|Japanese Patients in the Dose Escalation Part|Overall Study||6||
60030810|NCT02460224|76146683|FG007|Japanese Patients in the Dose Escalation Part|Overall Study||0||
60030811|NCT02460224|76146684|FG008|Japanese Patients in the Dose Escalation Part|Overall Study||0||
60030812|NCT02460224|76146685|FG009|Japanese Patients in the Dose Escalation Part|Overall Study||0||
60030813|NCT02460224|76146686|FG010|Japanese Patients in the Dose Escalation Part|Overall Study||0||
60030814|NCT02460224|76146687|FG011|Japanese Patients in the Dose Escalation Part|Overall Study||0||
60030815|NCT02460224|76146688|FG012|Japanese Patients in the Dose Escalation Part|Overall Study||0||
60030816|NCT02460224|76146689|FG013|Japanese Patients in the Dose Escalation Part|Overall Study||0||
60030817|NCT02460224|76146690|FG014|Japanese Patients in the Dose Escalation Part|Overall Study||0||
60030818|NCT02460224|76146691|FG015|Japanese Patients in the Dose Escalation Part|Overall Study||0||
60030819|NCT02460224|76146692|FG016|Japanese Patients in the Dose Escalation Part|Overall Study||0||
60030820|NCT02460224|76146693|FG017|Japanese Patients in the Dose Escalation Part|Overall Study||0||
60030821|NCT02460224|76146694|FG018|Japanese Patients in the Dose Escalation Part|Overall Study||0||
60030822|NCT02460224|76146695|FG019|Japanese Patients in the Dose Escalation Part|Overall Study||0||
60030823|NCT02460224|76146696|FG020|Japanese Patients in the Dose Escalation Part|Overall Study||0||
60030824|NCT02460224|76146697|FG021|Japanese Patients in the Dose Escalation Part|Overall Study||0||
60030825|NCT02460224|76146698|FG022|Japanese Patients in the Dose Escalation Part|Overall Study||0||
60030826|NCT02460224|76146699|FG023|Japanese Patients in the Dose Escalation Part|Overall Study||0||
60030827|NCT02460224|76146700|FG024|Japanese Patients in the Dose Escalation Part|Overall Study||0||
60030828|NCT02460224|76146701|FG025|Japanese Patients in the Dose Escalation Part|Overall Study||0||
60030829|NCT02460224|76146702|FG026|Japanese Patients in the Dose Escalation Part|Overall Study||0||
60030830|NCT02460224|76146703|FG027|Japanese Patients in the Dose Escalation Part|Overall Study||0||
60030831|NCT02460224|76146704|FG028|Japanese Patients in the Dose Escalation Part|Overall Study||0||
60030832|NCT02460224|76146676|FG000|COMPLETED|Overall Study||0||
60030833|NCT02460224|76146677|FG001|COMPLETED|Overall Study||0||
60030834|NCT02460224|76146678|FG002|COMPLETED|Overall Study||0||
60030835|NCT02460224|76146679|FG003|COMPLETED|Overall Study||0||
60030836|NCT02460224|76146680|FG004|COMPLETED|Overall Study||0||
60030837|NCT02460224|76146681|FG005|COMPLETED|Overall Study||0||
60030838|NCT02460224|76146682|FG006|COMPLETED|Overall Study||0||
60030839|NCT02460224|76146683|FG007|COMPLETED|Overall Study||0||
60030840|NCT02460224|76146684|FG008|COMPLETED|Overall Study||0||
60030841|NCT02460224|76146685|FG009|COMPLETED|Overall Study||0||
60030842|NCT02460224|76146686|FG010|COMPLETED|Overall Study||0||
60030843|NCT02460224|76146687|FG011|COMPLETED|Overall Study||0||
60030844|NCT02460224|76146688|FG012|COMPLETED|Overall Study||0||
60030845|NCT02460224|76146689|FG013|COMPLETED|Overall Study||0||
60030846|NCT02460224|76146690|FG014|COMPLETED|Overall Study||0||
60030847|NCT02460224|76146691|FG015|COMPLETED|Overall Study||0||
60030848|NCT02460224|76146692|FG016|COMPLETED|Overall Study||0||
60030849|NCT02460224|76146693|FG017|COMPLETED|Overall Study||0||
59611920|NCT01706328|75722937|FG000|COMPLETED|2-week Run-in Period||828||
59611921|NCT01706328|75722938|FG001|COMPLETED|2-week Run-in Period||0||
59611922|NCT01706328|75722939|FG002|COMPLETED|2-week Run-in Period||0||
59611923|NCT01706328|75722937|FG000|NOT COMPLETED|2-week Run-in Period||165||
60030850|NCT02460224|76146694|FG018|COMPLETED|Overall Study||0||
60030851|NCT02460224|76146695|FG019|COMPLETED|Overall Study||0||
60030852|NCT02460224|76146696|FG020|COMPLETED|Overall Study||0||
60030853|NCT02460224|76146697|FG021|COMPLETED|Overall Study||0||
60030854|NCT02460224|76146698|FG022|COMPLETED|Overall Study||0||
60030855|NCT02460224|76146699|FG023|COMPLETED|Overall Study||0||
60030856|NCT02460224|76146700|FG024|COMPLETED|Overall Study||0||
60030857|NCT02460224|76146701|FG025|COMPLETED|Overall Study||0||
60030858|NCT02460224|76146702|FG026|COMPLETED|Overall Study||0||
60030859|NCT02460224|76146703|FG027|COMPLETED|Overall Study||0||
60030860|NCT02460224|76146704|FG028|COMPLETED|Overall Study||0||
59611924|NCT01706328|75722938|FG001|NOT COMPLETED|2-week Run-in Period||0||
59611925|NCT01706328|75722939|FG002|NOT COMPLETED|2-week Run-in Period||0||
59611926|NCT01706328|75722937|FG000|STARTED|12-week Double-blind Treatment Period||0||
59611927|NCT01706328|75722938|FG001|STARTED|12-week Double-blind Treatment Period||412||
59611928|NCT01706328|75722939|FG002|STARTED|12-week Double-blind Treatment Period||416||
59611929|NCT01706328|75722937|FG000|COMPLETED|12-week Double-blind Treatment Period||0||
59611930|NCT01706328|75722938|FG001|COMPLETED|12-week Double-blind Treatment Period||366||
59611931|NCT01706328|75722939|FG002|COMPLETED|12-week Double-blind Treatment Period||371||
60030861|NCT02460224|76146676|FG000|NOT COMPLETED|Overall Study||17||
60030862|NCT02460224|76146677|FG001|NOT COMPLETED|Overall Study||12||
60030863|NCT02460224|76146678|FG002|NOT COMPLETED|Overall Study||6||
60030864|NCT02460224|76146679|FG003|NOT COMPLETED|Overall Study||6||
60030865|NCT02460224|76146680|FG004|NOT COMPLETED|Overall Study||6||
60030866|NCT02460224|76146681|FG005|NOT COMPLETED|Overall Study||30||
60030867|NCT02460224|76146682|FG006|NOT COMPLETED|Overall Study||30||
59916422|NCT03613649|76037265|FG004|Received Treatment|First Treatment||6||
59916423|NCT03613649|76037266|FG005|Received Treatment|First Treatment||6||
59916424|NCT03613649|76037267|FG006|Received Treatment|First Treatment||6||
59916425|NCT03613649|76037268|FG007|Received Treatment|First Treatment||6||
59916426|NCT03613649|76037269|FG008|Received Treatment|First Treatment||6||
59916427|NCT03613649|76037270|FG009|Received Treatment|First Treatment||6||
59916428|NCT03613649|76037271|FG010|Received Treatment|First Treatment||6||
59611932|NCT01706328|75722937|FG000|NOT COMPLETED|12-week Double-blind Treatment Period||0||
59611933|NCT01706328|75722938|FG001|NOT COMPLETED|12-week Double-blind Treatment Period||46||
59611934|NCT01706328|75722939|FG002|NOT COMPLETED|12-week Double-blind Treatment Period||45||
59916429|NCT03613649|76037272|FG011|Received Treatment|First Treatment||6||
59916430|NCT03613649|76037261|FG000|COMPLETED|First Treatment||6||
59916431|NCT03613649|76037262|FG001|COMPLETED|First Treatment||6||
59916432|NCT03613649|76037263|FG002|COMPLETED|First Treatment||6||
59916433|NCT03613649|76037264|FG003|COMPLETED|First Treatment||6||
59916434|NCT03613649|76037265|FG004|COMPLETED|First Treatment||6||
59916435|NCT03613649|76037266|FG005|COMPLETED|First Treatment||6||
59916436|NCT03613649|76037267|FG006|COMPLETED|First Treatment||6||
59916437|NCT03613649|76037268|FG007|COMPLETED|First Treatment||6||
59916438|NCT03613649|76037269|FG008|COMPLETED|First Treatment||6||
59916439|NCT03613649|76037270|FG009|COMPLETED|First Treatment||6||
59916440|NCT03613649|76037271|FG010|COMPLETED|First Treatment||6||
59916441|NCT03613649|76037272|FG011|COMPLETED|First Treatment||6||
59611935|NCT01753518|75722947|FG000|STARTED|Intention-to-Treat Analysis||110||
59916442|NCT03613649|76037261|FG000|NOT COMPLETED|First Treatment||0||
59916443|NCT03613649|76037262|FG001|NOT COMPLETED|First Treatment||0||
59916444|NCT03613649|76037263|FG002|NOT COMPLETED|First Treatment||0||
59916445|NCT03613649|76037264|FG003|NOT COMPLETED|First Treatment||0||
59916446|NCT03613649|76037265|FG004|NOT COMPLETED|First Treatment||0||
59916447|NCT03613649|76037266|FG005|NOT COMPLETED|First Treatment||0||
59916448|NCT03613649|76037267|FG006|NOT COMPLETED|First Treatment||0||
59916449|NCT03613649|76037268|FG007|NOT COMPLETED|First Treatment||0||
59916450|NCT03613649|76037269|FG008|NOT COMPLETED|First Treatment||0||
59916451|NCT03613649|76037270|FG009|NOT COMPLETED|First Treatment||0||
59916452|NCT03613649|76037271|FG010|NOT COMPLETED|First Treatment||0||
59916453|NCT03613649|76037272|FG011|NOT COMPLETED|First Treatment||0||
59916454|NCT03613649|76037261|FG000|STARTED|Second Treatment||6||
59916455|NCT03613649|76037262|FG001|STARTED|Second Treatment||6||
59916456|NCT03613649|76037263|FG002|STARTED|Second Treatment||6||
59916457|NCT03613649|76037264|FG003|STARTED|Second Treatment||6||
59916458|NCT03613649|76037265|FG004|STARTED|Second Treatment||6||
59916459|NCT03613649|76037266|FG005|STARTED|Second Treatment||6||
59916460|NCT03613649|76037267|FG006|STARTED|Second Treatment||6||
59916461|NCT03613649|76037268|FG007|STARTED|Second Treatment||6||
59916462|NCT03613649|76037269|FG008|STARTED|Second Treatment||6||
59916463|NCT03613649|76037270|FG009|STARTED|Second Treatment||6||
59916464|NCT03613649|76037271|FG010|STARTED|Second Treatment||6||
59916465|NCT03613649|76037272|FG011|STARTED|Second Treatment||6||
59916466|NCT03613649|76037261|FG000|Received Treatment|Second Treatment||6||
59916467|NCT03613649|76037262|FG001|Received Treatment|Second Treatment||6||
59916468|NCT03613649|76037263|FG002|Received Treatment|Second Treatment||6||
59916469|NCT03613649|76037264|FG003|Received Treatment|Second Treatment||6||
59916470|NCT03613649|76037265|FG004|Received Treatment|Second Treatment||6||
59916471|NCT03613649|76037266|FG005|Received Treatment|Second Treatment||6||
59916472|NCT03613649|76037267|FG006|Received Treatment|Second Treatment||6||
59916473|NCT03613649|76037268|FG007|Received Treatment|Second Treatment||6||
59916474|NCT03613649|76037269|FG008|Received Treatment|Second Treatment||6||
59916475|NCT03613649|76037270|FG009|Received Treatment|Second Treatment||6||
59916476|NCT03613649|76037271|FG010|Received Treatment|Second Treatment||6||
59916477|NCT03613649|76037272|FG011|Received Treatment|Second Treatment||6||
59916478|NCT03613649|76037261|FG000|COMPLETED|Second Treatment||6||
59916479|NCT03613649|76037262|FG001|COMPLETED|Second Treatment||6||
59916480|NCT03613649|76037263|FG002|COMPLETED|Second Treatment||5||
59916481|NCT03613649|76037264|FG003|COMPLETED|Second Treatment||6||
59916482|NCT03613649|76037265|FG004|COMPLETED|Second Treatment||5||
59916483|NCT03613649|76037266|FG005|COMPLETED|Second Treatment||6||
59916484|NCT03613649|76037267|FG006|COMPLETED|Second Treatment||6||
60030868|NCT02460224|76146683|FG007|NOT COMPLETED|Overall Study||5||
60030869|NCT02460224|76146684|FG008|NOT COMPLETED|Overall Study||6||
60030870|NCT02460224|76146685|FG009|NOT COMPLETED|Overall Study||11||
60030871|NCT02460224|76146686|FG010|NOT COMPLETED|Overall Study||5||
60030872|NCT02460224|76146687|FG011|NOT COMPLETED|Overall Study||6||
60030873|NCT02460224|76146688|FG012|NOT COMPLETED|Overall Study||6||
60030874|NCT02460224|76146689|FG013|NOT COMPLETED|Overall Study||6||
60030875|NCT02460224|76146690|FG014|NOT COMPLETED|Overall Study||5||
60030876|NCT02460224|76146691|FG015|NOT COMPLETED|Overall Study||6||
60030877|NCT02460224|76146692|FG016|NOT COMPLETED|Overall Study||20||
60030878|NCT02460224|76146693|FG017|NOT COMPLETED|Overall Study||6||
60030879|NCT02460224|76146694|FG018|NOT COMPLETED|Overall Study||12||
60030880|NCT02460224|76146695|FG019|NOT COMPLETED|Overall Study||7||
60030881|NCT02460224|76146696|FG020|NOT COMPLETED|Overall Study||6||
60030882|NCT02460224|76146697|FG021|NOT COMPLETED|Overall Study||12||
60030883|NCT02460224|76146698|FG022|NOT COMPLETED|Overall Study||6||
60030884|NCT02460224|76146699|FG023|NOT COMPLETED|Overall Study||11||
60030885|NCT02460224|76146700|FG024|NOT COMPLETED|Overall Study||6||
60030886|NCT02460224|76146701|FG025|NOT COMPLETED|Overall Study||6||
60030887|NCT02460224|76146702|FG026|NOT COMPLETED|Overall Study||121||
60030888|NCT02460224|76146703|FG027|NOT COMPLETED|Overall Study||21||
60030889|NCT02460224|76146704|FG028|NOT COMPLETED|Overall Study||93||
60030890|NCT02094573|76146778|FG000|STARTED|Overall Study||112||
60030891|NCT02094573|76146779|FG001|STARTED|Overall Study||110||
60030892|NCT02094573|76146778|FG000|Treated|Overall Study||109||
60030893|NCT02094573|76146779|FG001|Treated|Overall Study||110||
60030894|NCT02094573|76146778|FG000|COMPLETED|Overall Study||0|Completed = Participants who completed the treatment.|
60030895|NCT02094573|76146779|FG001|COMPLETED|Overall Study||0|Completed = Participants who completed the treatment.|
60030896|NCT02094573|76146778|FG000|NOT COMPLETED|Overall Study||112||
60030897|NCT02094573|76146779|FG001|NOT COMPLETED|Overall Study||110||
60030898|NCT01859494|76146785|FG000|STARTED|Overall Study||219||
60030899|NCT01859494|76146785|FG000|COMPLETED|Overall Study||218||
60030900|NCT01859494|76146785|FG000|NOT COMPLETED|Overall Study||1||
60030901|NCT01858636|76146789|FG000|STARTED|Overall Study|Subjects consented|235||
60030902|NCT01858636|76146789|FG000|Device Deployment|Overall Study||211||
60030903|NCT01858636|76146789|FG000|COMPLETED|Overall Study||207||
60030904|NCT01858636|76146789|FG000|NOT COMPLETED|Overall Study||28||
60030905|NCT02058849|76146796|FG000|STARTED|Overall Study||11||
60030906|NCT02058849|76146797|FG001|STARTED|Overall Study||2||
60030907|NCT02058849|76146796|FG000|COMPLETED|Overall Study||4||
60030908|NCT02058849|76146797|FG001|COMPLETED|Overall Study||1||
60030909|NCT02058849|76146796|FG000|NOT COMPLETED|Overall Study||7||
60030910|NCT02058849|76146797|FG001|NOT COMPLETED|Overall Study||1||
60030911|NCT01858558|76146805|FG000|STARTED|Overall Study||70||
60030912|NCT01858558|76146806|FG001|STARTED|Overall Study||31||
60030913|NCT01858558|76146805|FG000|COMPLETED|Overall Study||61||
60030914|NCT01858558|76146806|FG001|COMPLETED|Overall Study||29||
60030915|NCT01858558|76146805|FG000|NOT COMPLETED|Overall Study||9||
60030916|NCT01858558|76146806|FG001|NOT COMPLETED|Overall Study||2||
60030917|NCT02058537|76146812|FG000|STARTED|Overall Study||3||
60030918|NCT02058537|76146812|FG000|COMPLETED|Overall Study||2||
60030919|NCT02058537|76146812|FG000|NOT COMPLETED|Overall Study||1||
60030920|NCT01612000|76146820|FG000|STARTED|Overall Study||84||
60030921|NCT01612000|76146821|FG001|STARTED|Overall Study||86||
60030922|NCT01612000|76146822|FG002|STARTED|Overall Study||85||
60030923|NCT01612000|76146823|FG003|STARTED|Overall Study||86||
60030924|NCT01612000|76146820|FG000|COMPLETED|Overall Study||75||
60030925|NCT01612000|76146821|FG001|COMPLETED|Overall Study||81||
60030926|NCT01612000|76146822|FG002|COMPLETED|Overall Study||78||
60030927|NCT01612000|76146823|FG003|COMPLETED|Overall Study||76||
60030928|NCT01612000|76146820|FG000|NOT COMPLETED|Overall Study||9||
60030929|NCT01612000|76146821|FG001|NOT COMPLETED|Overall Study||5||
60030930|NCT01612000|76146822|FG002|NOT COMPLETED|Overall Study||7||
60030931|NCT01612000|76146823|FG003|NOT COMPLETED|Overall Study||10||
60030932|NCT01895608|76146837|FG000|STARTED|Overall Study||10||
60030933|NCT01895608|76146838|FG001|STARTED|Overall Study||7||
60030934|NCT01895608|76146839|FG002|STARTED|Overall Study||11||
60030935|NCT01895608|76146840|FG003|STARTED|Overall Study||6||
60030936|NCT01895608|76146837|FG000|COMPLETED|Overall Study||10||
60030937|NCT01895608|76146838|FG001|COMPLETED|Overall Study||6||
60030938|NCT01895608|76146839|FG002|COMPLETED|Overall Study||8||
60030939|NCT01895608|76146840|FG003|COMPLETED|Overall Study||6||
60030940|NCT01895608|76146837|FG000|NOT COMPLETED|Overall Study||0||
60030941|NCT01895608|76146838|FG001|NOT COMPLETED|Overall Study||1||
60030942|NCT01895608|76146839|FG002|NOT COMPLETED|Overall Study||3||
60030943|NCT01895608|76146840|FG003|NOT COMPLETED|Overall Study||0||
60030944|NCT02409680|76146852|FG000|STARTED|Overall Study||5990||
60030945|NCT02409680|76146853|FG001|STARTED|Overall Study||5986||
60030946|NCT02409680|76146852|FG000|Treated|Overall Study||5943||
60030947|NCT02409680|76146853|FG001|Treated|Overall Study||5936||
60030948|NCT02409680|76146852|FG000|Included in mITT Analysis|Overall Study||5787|A modified intention-to-treat (mITT) analysis was planned a priori for the primary and secondary outcomes to include only women who delivered at or after 20 weeks and were determined to be eligible after randomization. Numbers reported in the Outcomes section reflect available data and therefore do not always reflect the total population defined in the mITT.|
60030949|NCT02409680|76146853|FG001|Included in mITT Analysis|Overall Study||5771|A modified intention-to-treat (mITT) analysis was planned a priori for the primary and secondary outcomes to include only women who delivered at or after 20 weeks and were determined to be eligible after randomization. Numbers reported in the Outcomes section reflect available data and therefore do not always reflect the total population defined in the mITT.|
60030950|NCT02409680|76146852|FG000|COMPLETED|Overall Study||5975||
60030951|NCT02409680|76146853|FG001|COMPLETED|Overall Study||5956||
60030952|NCT02409680|76146852|FG000|NOT COMPLETED|Overall Study||15||
60030953|NCT02409680|76146853|FG001|NOT COMPLETED|Overall Study||30||
60030954|NCT01895452|76146861|FG000|STARTED|Overall Study||65||
60030955|NCT01895452|76146862|FG001|STARTED|Overall Study||226||
60030956|NCT01895452|76146861|FG000|COMPLETED|Overall Study||61||
60030957|NCT01895452|76146862|FG001|COMPLETED|Overall Study||198||
60030958|NCT01895452|76146861|FG000|NOT COMPLETED|Overall Study||4||
60030959|NCT01895452|76146862|FG001|NOT COMPLETED|Overall Study||28||
60030960|NCT02094417|76146872|FG000|STARTED|Overall Study||7||
60030961|NCT02094417|76146873|FG001|STARTED|Overall Study||9||
60030962|NCT02094417|76146874|FG002|STARTED|Overall Study||9||
60030963|NCT02094417|76146875|FG003|STARTED|Overall Study||10||
60030964|NCT02094417|76146872|FG000|COMPLETED|Overall Study||2||
60030965|NCT02094417|76146873|FG001|COMPLETED|Overall Study||1||
60030966|NCT02094417|76146874|FG002|COMPLETED|Overall Study||4||
60030967|NCT02094417|76146875|FG003|COMPLETED|Overall Study||3||
60030968|NCT02094417|76146872|FG000|NOT COMPLETED|Overall Study||5||
60030969|NCT02094417|76146873|FG001|NOT COMPLETED|Overall Study||8||
60030970|NCT02094417|76146874|FG002|NOT COMPLETED|Overall Study||5||
60030971|NCT02094417|76146875|FG003|NOT COMPLETED|Overall Study||7||
60030972|NCT01894984|76146887|FG000|STARTED|Overall Study||396||
60030973|NCT01894984|76146888|FG001|STARTED|Overall Study||244||
60030974|NCT01894984|76146887|FG000|COMPLETED|Overall Study||82||
60030975|NCT01894984|76146888|FG001|COMPLETED|Overall Study||69||
60030976|NCT01894984|76146887|FG000|NOT COMPLETED|Overall Study||314||
60030977|NCT01894984|76146888|FG001|NOT COMPLETED|Overall Study||175||
60030978|NCT02375672|76146894|FG000|STARTED|Overall Study||30||
60030979|NCT02375672|76146894|FG000|COMPLETED|Overall Study||10||
60030980|NCT02375672|76146894|FG000|NOT COMPLETED|Overall Study||20||
60030981|NCT01894516|76146902|FG000|STARTED|Period 1 (Baseline up to Week 12)||72||
60030982|NCT01894516|76146903|FG001|STARTED|Period 1 (Baseline up to Week 12)||72||
60030983|NCT01894516|76146904|FG002|STARTED|Period 1 (Baseline up to Week 12)||70||
60030984|NCT01894516|76146905|FG003|STARTED|Period 1 (Baseline up to Week 12)||69||
60030985|NCT01894516|76146902|FG000|COMPLETED|Period 1 (Baseline up to Week 12)||65||
60030986|NCT01894516|76146903|FG001|COMPLETED|Period 1 (Baseline up to Week 12)||67||
60030987|NCT01894516|76146904|FG002|COMPLETED|Period 1 (Baseline up to Week 12)||67||
60030988|NCT01894516|76146905|FG003|COMPLETED|Period 1 (Baseline up to Week 12)||66||
60030989|NCT01894516|76146902|FG000|NOT COMPLETED|Period 1 (Baseline up to Week 12)||7||
60030990|NCT01894516|76146903|FG001|NOT COMPLETED|Period 1 (Baseline up to Week 12)||5||
60030991|NCT01894516|76146904|FG002|NOT COMPLETED|Period 1 (Baseline up to Week 12)||3||
60030992|NCT01894516|76146905|FG003|NOT COMPLETED|Period 1 (Baseline up to Week 12)||3||
60030993|NCT01894516|76146902|FG000|STARTED|Period 2 (Week 13 to Week 24)|All participants from Placebo moved to 100 mg QD (65 participants) group.|0||
60030994|NCT01894516|76146903|FG001|STARTED|Period 2 (Week 13 to Week 24)|Nonresponders from 50 mg QD group moved to 100 mg QD group (15 participants).|52||
60030995|NCT01894516|76146904|FG002|STARTED|Period 2 (Week 13 to Week 24)|Nonresponders from Placebo(65 participants) and 50 mg QD (15 participants) moved to 100 mg QD group.|147||
60030996|NCT01894516|76146905|FG003|STARTED|Period 2 (Week 13 to Week 24)||66||
60030997|NCT01894516|76146902|FG000|COMPLETED|Period 2 (Week 13 to Week 24)||0||
60030998|NCT01894516|76146903|FG001|COMPLETED|Period 2 (Week 13 to Week 24)||50||
60030999|NCT01894516|76146904|FG002|COMPLETED|Period 2 (Week 13 to Week 24)||142||
60031000|NCT01894516|76146905|FG003|COMPLETED|Period 2 (Week 13 to Week 24)||65||
60031001|NCT01894516|76146902|FG000|NOT COMPLETED|Period 2 (Week 13 to Week 24)||0||
60031002|NCT01894516|76146903|FG001|NOT COMPLETED|Period 2 (Week 13 to Week 24)||2||
60031003|NCT01894516|76146904|FG002|NOT COMPLETED|Period 2 (Week 13 to Week 24)||5||
60031004|NCT01894516|76146905|FG003|NOT COMPLETED|Period 2 (Week 13 to Week 24)||1||
60031005|NCT02491463|76146923|FG000|STARTED|Overall Study||7||
60031006|NCT02491463|76146924|FG001|STARTED|Overall Study||31||
60031007|NCT02491463|76146925|FG002|STARTED|Overall Study||19||
59507879|NCT02153983|75601050|FG005|COMPLETED|Overall Study||1||
60031008|NCT02491463|76146926|FG003|STARTED|Overall Study||15||
60031009|NCT02491463|76146923|FG000|COMPLETED|Overall Study||5||
60031010|NCT02491463|76146924|FG001|COMPLETED|Overall Study||21||
60031011|NCT02491463|76146925|FG002|COMPLETED|Overall Study||15||
59507880|NCT02153983|75601045|FG000|NOT COMPLETED|Overall Study||0||
60031012|NCT02491463|76146926|FG003|COMPLETED|Overall Study||14||
60031013|NCT02491463|76146923|FG000|NOT COMPLETED|Overall Study||2||
59507881|NCT02153983|75601046|FG001|NOT COMPLETED|Overall Study||3||
59507882|NCT02153983|75601047|FG002|NOT COMPLETED|Overall Study||2||
60031014|NCT02491463|76146924|FG001|NOT COMPLETED|Overall Study||10||
60031015|NCT02491463|76146925|FG002|NOT COMPLETED|Overall Study||4||
60031016|NCT02491463|76146926|FG003|NOT COMPLETED|Overall Study||1||
60031017|NCT02038881|76146939|FG000|STARTED|Overall Study||27||
60031018|NCT02038881|76146940|FG001|STARTED|Overall Study||29||
60031019|NCT02038881|76146941|FG002|STARTED|Overall Study||31||
60031020|NCT02038881|76146939|FG000|COMPLETED|Overall Study||24||
60031021|NCT02038881|76146940|FG001|COMPLETED|Overall Study||29||
60031022|NCT02038881|76146941|FG002|COMPLETED|Overall Study||30||
60031023|NCT02038881|76146939|FG000|NOT COMPLETED|Overall Study||3||
60031024|NCT02038881|76146940|FG001|NOT COMPLETED|Overall Study||0||
60031025|NCT02038881|76146941|FG002|NOT COMPLETED|Overall Study||1||
60031026|NCT01857622|76146954|FG000|STARTED|Overall Study||50||
60031027|NCT01857622|76146955|FG001|STARTED|Overall Study||22||
60031028|NCT01857622|76146956|FG002|STARTED|Overall Study||21||
60031029|NCT01857622|76146954|FG000|COMPLETED|Overall Study||39||
60031030|NCT01857622|76146955|FG001|COMPLETED|Overall Study||21||
60031031|NCT01857622|76146956|FG002|COMPLETED|Overall Study||19||
60031032|NCT01857622|76146954|FG000|NOT COMPLETED|Overall Study||11||
60031033|NCT01857622|76146955|FG001|NOT COMPLETED|Overall Study||1||
60031034|NCT01857622|76146956|FG002|NOT COMPLETED|Overall Study||2||
60031035|NCT01857310|76146966|FG000|STARTED|Primary Analysis: Live Birth|Male partner|1185||
60031036|NCT01857310|76146967|FG001|STARTED|Primary Analysis: Live Birth|Male partner|1185||
60031037|NCT01857310|76146966|FG000|COMPLETED|Primary Analysis: Live Birth|Chart abstraction of whether live birth occurred|1185||
60031038|NCT01857310|76146967|FG001|COMPLETED|Primary Analysis: Live Birth|Chart abstraction of whether live birth occurred|1185||
60031039|NCT01857310|76146966|FG000|NOT COMPLETED|Primary Analysis: Live Birth||0||
60031040|NCT01857310|76146967|FG001|NOT COMPLETED|Primary Analysis: Live Birth||0||
60031041|NCT01857310|76146966|FG000|STARTED|Secondary Analysis: Semen Quality at 6m|Male partner|1185||
60031042|NCT01857310|76146967|FG001|STARTED|Secondary Analysis: Semen Quality at 6m|Male partner|1185||
60031043|NCT01857310|76146966|FG000|COMPLETED|Secondary Analysis: Semen Quality at 6m|Completed 6-month study visit|870||
60031044|NCT01857310|76146967|FG001|COMPLETED|Secondary Analysis: Semen Quality at 6m|Completed 6-month study visit|903||
60031045|NCT01857310|76146966|FG000|NOT COMPLETED|Secondary Analysis: Semen Quality at 6m||315||
60031046|NCT01857310|76146967|FG001|NOT COMPLETED|Secondary Analysis: Semen Quality at 6m||282||
60031047|NCT02472353|76146975|FG000|STARTED|Overall Study||14||
60031048|NCT02472353|76146976|FG001|STARTED|Overall Study||16||
60031049|NCT02472353|76146975|FG000|COMPLETED|Overall Study||10||
60031050|NCT02472353|76146976|FG001|COMPLETED|Overall Study||10||
60031051|NCT02472353|76146975|FG000|NOT COMPLETED|Overall Study||4||
60031052|NCT02472353|76146976|FG001|NOT COMPLETED|Overall Study||6||
60031053|NCT02491073|76146984|FG000|STARTED|Overall Study||37||
60031054|NCT02491073|76146985|FG001|STARTED|Overall Study||34||
60031055|NCT02491073|76146984|FG000|COMPLETED|Overall Study||36||
60031056|NCT02491073|76146985|FG001|COMPLETED|Overall Study||34||
60031057|NCT02491073|76146984|FG000|NOT COMPLETED|Overall Study||1||
60031058|NCT02491073|76146985|FG001|NOT COMPLETED|Overall Study||0||
60031059|NCT02314117|76147009|FG000|STARTED|Overall Study||326||
60031060|NCT02314117|76147010|FG001|STARTED|Overall Study||319||
60031061|NCT02314117|76147009|FG000|Received at Least One Dose of Study Drug|Overall Study||323||
60031062|NCT02314117|76147010|FG001|Received at Least One Dose of Study Drug|Overall Study||315||
60031063|NCT02314117|76147009|FG000|COMPLETED|Overall Study||314||
60031064|NCT02314117|76147010|FG001|COMPLETED|Overall Study||303||
60031065|NCT02314117|76147009|FG000|NOT COMPLETED|Overall Study||12||
60031066|NCT02314117|76147010|FG001|NOT COMPLETED|Overall Study||16||
60031067|NCT01893346|76147021|FG000|STARTED|Overall Study||11||
60031068|NCT01893346|76147022|FG001|STARTED|Overall Study||8||
60031069|NCT01893346|76147023|FG002|STARTED|Overall Study||8||
60031070|NCT01893346|76147024|FG003|STARTED|Overall Study||8||
60031071|NCT01893346|76147021|FG000|Patients Who Received Full Infusion|Overall Study||8||
60031072|NCT01893346|76147022|FG001|Patients Who Received Full Infusion|Overall Study||8||
60031073|NCT01893346|76147023|FG002|Patients Who Received Full Infusion|Overall Study||8||
60031074|NCT01893346|76147024|FG003|Patients Who Received Full Infusion|Overall Study||8||
60031075|NCT01893346|76147021|FG000|COMPLETED|Overall Study||8||
60031076|NCT01893346|76147022|FG001|COMPLETED|Overall Study||7||
60031077|NCT01893346|76147023|FG002|COMPLETED|Overall Study||8||
60031078|NCT01893346|76147024|FG003|COMPLETED|Overall Study||8||
60031079|NCT01893346|76147021|FG000|NOT COMPLETED|Overall Study||3||
60031080|NCT01893346|76147022|FG001|NOT COMPLETED|Overall Study||1||
60031081|NCT01893346|76147023|FG002|NOT COMPLETED|Overall Study||0||
60031082|NCT01893346|76147024|FG003|NOT COMPLETED|Overall Study||0||
60031083|NCT02490371|76147036|FG000|STARTED|Overall Study||12||
60031084|NCT02490371|76147037|FG001|STARTED|Overall Study||12||
60031085|NCT02490371|76147036|FG000|COMPLETED|Overall Study||11||
60031086|NCT02490371|76147037|FG001|COMPLETED|Overall Study||11||
60031087|NCT02490371|76147036|FG000|NOT COMPLETED|Overall Study||1||
60031088|NCT02490371|76147037|FG001|NOT COMPLETED|Overall Study||1||
60031089|NCT02058147|76147046|FG000|STARTED|Overall Study||469||
60031090|NCT02058147|76147047|FG001|STARTED|Overall Study||467||
60031091|NCT02058147|76147048|FG002|STARTED|Overall Study||234||
60031092|NCT02058147|76147046|FG000|Treated|Overall Study||469||
60031093|NCT02058147|76147047|FG001|Treated|Overall Study||467||
60031094|NCT02058147|76147048|FG002|Treated|Overall Study||233||
60031095|NCT02058147|76147046|FG000|COMPLETED|Overall Study||440||
60031096|NCT02058147|76147047|FG001|COMPLETED|Overall Study||440||
60031097|NCT02058147|76147048|FG002|COMPLETED|Overall Study||205||
60031098|NCT02058147|76147046|FG000|NOT COMPLETED|Overall Study||29||
60031099|NCT02058147|76147047|FG001|NOT COMPLETED|Overall Study||27||
60031100|NCT02058147|76147048|FG002|NOT COMPLETED|Overall Study||29||
60031101|NCT02489981|76147056|FG000|STARTED|Overall Study||340|Started patients in the safety set|
60031102|NCT02489981|76147056|FG000|COMPLETED|Overall Study||213||
60031103|NCT02489981|76147056|FG000|NOT COMPLETED|Overall Study||127||
60031104|NCT02471183|76147060|FG000|STARTED|Main Treatment Period||34||
60031105|NCT02471183|76147060|FG000|COMPLETED|Main Treatment Period||32||
60031106|NCT02471183|76147060|FG000|NOT COMPLETED|Main Treatment Period||2||
60031107|NCT02471183|76147060|FG000|STARTED|Extended Treatment Period||32||
60031108|NCT02471183|76147060|FG000|COMPLETED|Extended Treatment Period||31||
60031109|NCT02471183|76147060|FG000|NOT COMPLETED|Extended Treatment Period||1||
60031110|NCT01855828|76147064|FG000|STARTED|Overall Study||50||
60031111|NCT01855828|76147064|FG000|COMPLETED|Overall Study||48||
60031112|NCT01855828|76147064|FG000|NOT COMPLETED|Overall Study||2||
60031113|NCT02489279|76147075|FG000|STARTED|Overall Study||44||
60031114|NCT02489279|76147076|FG001|STARTED|Overall Study||41||
60031115|NCT02489279|76147075|FG000|COMPLETED|Overall Study||32||
60031116|NCT02489279|76147076|FG001|COMPLETED|Overall Study||31||
60031117|NCT02489279|76147075|FG000|NOT COMPLETED|Overall Study||12||
60031118|NCT02489279|76147076|FG001|NOT COMPLETED|Overall Study||10||
60031119|NCT02489045|76147082|FG000|STARTED|Overall Study||178||
60031120|NCT02489045|76147082|FG000|COMPLETED|Overall Study||125||
60031121|NCT02489045|76147082|FG000|NOT COMPLETED|Overall Study||53||
60031122|NCT02489045|76147082|FG000|STARTED|Follow-up|"Only subjects with portal hypertension in overall study were eligible to progress to follow-up"|21||
60031123|NCT02489045|76147082|FG000|COMPLETED|Follow-up||11||
60031124|NCT02489045|76147082|FG000|NOT COMPLETED|Follow-up||10||
60031125|NCT02488109|76147088|FG000|STARTED|Treatment in Hospital||60||
60031126|NCT02488109|76147089|FG001|STARTED|Treatment in Hospital||56||
60031127|NCT02488109|76147088|FG000|Received Treatment|Treatment in Hospital||60||
60031128|NCT02488109|76147089|FG001|Received Treatment|Treatment in Hospital||51||
60031129|NCT02488109|76147088|FG000|Included in mITT Analysis|Treatment in Hospital||60||
60031130|NCT02488109|76147089|FG001|Included in mITT Analysis|Treatment in Hospital||51||
60031131|NCT02488109|76147088|FG000|COMPLETED|Treatment in Hospital||60||
60031132|NCT02488109|76147089|FG001|COMPLETED|Treatment in Hospital||51||
60031133|NCT02488109|76147088|FG000|NOT COMPLETED|Treatment in Hospital||0||
60031134|NCT02488109|76147089|FG001|NOT COMPLETED|Treatment in Hospital||5||
60031135|NCT02488109|76147088|FG000|STARTED|12-month Follow-Up||60|Discharge from hospital|
60031136|NCT02488109|76147089|FG001|STARTED|12-month Follow-Up||51|Discharge from hospital|
60031137|NCT02488109|76147088|FG000|Included in mITT Analysis|12-month Follow-Up||60||
60031138|NCT02488109|76147089|FG001|Included in mITT Analysis|12-month Follow-Up||51||
60031139|NCT02488109|76147088|FG000|COMPLETED|12-month Follow-Up||56|Retained in trial through 12 months|
60031140|NCT02488109|76147089|FG001|COMPLETED|12-month Follow-Up||44|Retained in trial through 12 months|
60031141|NCT02488109|76147088|FG000|NOT COMPLETED|12-month Follow-Up||4||
60031142|NCT02488109|76147089|FG001|NOT COMPLETED|12-month Follow-Up||7||
60031143|NCT02351167|76147100|FG000|STARTED|Overall Study||275||
60031144|NCT02351167|76147101|FG001|STARTED|Overall Study||274||
60031145|NCT02351167|76147102|FG002|STARTED|Overall Study||273||
60031146|NCT02351167|76147100|FG000|COMPLETED|Overall Study||256||
60031147|NCT02351167|76147101|FG001|COMPLETED|Overall Study||256||
60031148|NCT02351167|76147102|FG002|COMPLETED|Overall Study||252||
60031149|NCT02351167|76147100|FG000|NOT COMPLETED|Overall Study||19||
60031150|NCT02351167|76147101|FG001|NOT COMPLETED|Overall Study||18||
60031151|NCT02351167|76147102|FG002|NOT COMPLETED|Overall Study||21||
60031152|NCT02350309|76147117|FG000|STARTED|Treatment Period 1 (2 Days)||12||
60031153|NCT02350309|76147118|FG001|STARTED|Treatment Period 1 (2 Days)||11||
60031154|NCT02350309|76147119|FG002|STARTED|Treatment Period 1 (2 Days)||11||
60031155|NCT02350309|76147120|FG003|STARTED|Treatment Period 1 (2 Days)||11||
60031156|NCT02350309|76147121|FG004|STARTED|Treatment Period 1 (2 Days)||12||
60031157|NCT02350309|76147122|FG005|STARTED|Treatment Period 1 (2 Days)||12||
60031158|NCT02350309|76147117|FG000|COMPLETED|Treatment Period 1 (2 Days)||12||
60031159|NCT02350309|76147118|FG001|COMPLETED|Treatment Period 1 (2 Days)||11||
60031160|NCT02350309|76147119|FG002|COMPLETED|Treatment Period 1 (2 Days)||10||
60031161|NCT02350309|76147120|FG003|COMPLETED|Treatment Period 1 (2 Days)||11||
60031162|NCT02350309|76147121|FG004|COMPLETED|Treatment Period 1 (2 Days)||12||
60031163|NCT02350309|76147122|FG005|COMPLETED|Treatment Period 1 (2 Days)||12||
60031164|NCT02350309|76147117|FG000|NOT COMPLETED|Treatment Period 1 (2 Days)||0||
60031165|NCT02350309|76147118|FG001|NOT COMPLETED|Treatment Period 1 (2 Days)||0||
60031166|NCT02350309|76147119|FG002|NOT COMPLETED|Treatment Period 1 (2 Days)||1||
60031167|NCT02350309|76147120|FG003|NOT COMPLETED|Treatment Period 1 (2 Days)||0||
60031168|NCT02350309|76147121|FG004|NOT COMPLETED|Treatment Period 1 (2 Days)||0||
60031169|NCT02350309|76147122|FG005|NOT COMPLETED|Treatment Period 1 (2 Days)||0||
60031170|NCT02350309|76147117|FG000|STARTED|Washout Period 1 (12-16 Days)||12||
60031171|NCT02350309|76147118|FG001|STARTED|Washout Period 1 (12-16 Days)||11||
60031172|NCT02350309|76147119|FG002|STARTED|Washout Period 1 (12-16 Days)||10||
60031173|NCT02350309|76147120|FG003|STARTED|Washout Period 1 (12-16 Days)||11||
60031174|NCT02350309|76147121|FG004|STARTED|Washout Period 1 (12-16 Days)||12||
60031175|NCT02350309|76147122|FG005|STARTED|Washout Period 1 (12-16 Days)||12||
60031176|NCT02350309|76147117|FG000|COMPLETED|Washout Period 1 (12-16 Days)||12||
60031177|NCT02350309|76147118|FG001|COMPLETED|Washout Period 1 (12-16 Days)||11||
60031178|NCT02350309|76147119|FG002|COMPLETED|Washout Period 1 (12-16 Days)||10||
60031179|NCT02350309|76147120|FG003|COMPLETED|Washout Period 1 (12-16 Days)||11||
60031180|NCT02350309|76147121|FG004|COMPLETED|Washout Period 1 (12-16 Days)||12||
60031181|NCT02350309|76147122|FG005|COMPLETED|Washout Period 1 (12-16 Days)||12||
60031182|NCT02350309|76147117|FG000|NOT COMPLETED|Washout Period 1 (12-16 Days)||0||
60031183|NCT02350309|76147118|FG001|NOT COMPLETED|Washout Period 1 (12-16 Days)||0||
60031184|NCT02350309|76147119|FG002|NOT COMPLETED|Washout Period 1 (12-16 Days)||0||
60031185|NCT02350309|76147120|FG003|NOT COMPLETED|Washout Period 1 (12-16 Days)||0||
60031186|NCT02350309|76147121|FG004|NOT COMPLETED|Washout Period 1 (12-16 Days)||0||
60031187|NCT02350309|76147122|FG005|NOT COMPLETED|Washout Period 1 (12-16 Days)||0||
60031188|NCT02350309|76147117|FG000|STARTED|Treatment Period 2 (2 Days)||12||
60031189|NCT02350309|76147118|FG001|STARTED|Treatment Period 2 (2 Days)||11||
60031190|NCT02350309|76147119|FG002|STARTED|Treatment Period 2 (2 Days)||10||
60031191|NCT02350309|76147120|FG003|STARTED|Treatment Period 2 (2 Days)||11||
60031192|NCT02350309|76147121|FG004|STARTED|Treatment Period 2 (2 Days)||12||
60031193|NCT02350309|76147122|FG005|STARTED|Treatment Period 2 (2 Days)||12||
60031194|NCT02350309|76147117|FG000|COMPLETED|Treatment Period 2 (2 Days)||12||
60031195|NCT02350309|76147118|FG001|COMPLETED|Treatment Period 2 (2 Days)||11||
60031196|NCT02350309|76147119|FG002|COMPLETED|Treatment Period 2 (2 Days)||10||
60031197|NCT02350309|76147120|FG003|COMPLETED|Treatment Period 2 (2 Days)||11||
60031198|NCT02350309|76147121|FG004|COMPLETED|Treatment Period 2 (2 Days)||12||
60031199|NCT02350309|76147122|FG005|COMPLETED|Treatment Period 2 (2 Days)||12||
60031200|NCT02350309|76147117|FG000|NOT COMPLETED|Treatment Period 2 (2 Days)||0||
60031201|NCT02350309|76147118|FG001|NOT COMPLETED|Treatment Period 2 (2 Days)||0||
60031202|NCT02350309|76147119|FG002|NOT COMPLETED|Treatment Period 2 (2 Days)||0||
60031203|NCT02350309|76147120|FG003|NOT COMPLETED|Treatment Period 2 (2 Days)||0||
60031204|NCT02350309|76147121|FG004|NOT COMPLETED|Treatment Period 2 (2 Days)||0||
60031205|NCT02350309|76147122|FG005|NOT COMPLETED|Treatment Period 2 (2 Days)||0||
60031206|NCT02350309|76147117|FG000|STARTED|Washout Period 2 (12-16 Days)||12||
60031207|NCT02350309|76147118|FG001|STARTED|Washout Period 2 (12-16 Days)||11||
60031208|NCT02350309|76147119|FG002|STARTED|Washout Period 2 (12-16 Days)||10||
60031209|NCT02350309|76147120|FG003|STARTED|Washout Period 2 (12-16 Days)||11||
60031210|NCT02350309|76147121|FG004|STARTED|Washout Period 2 (12-16 Days)||12||
60031211|NCT02350309|76147122|FG005|STARTED|Washout Period 2 (12-16 Days)||12||
60031212|NCT02350309|76147117|FG000|COMPLETED|Washout Period 2 (12-16 Days)||12||
60031213|NCT02350309|76147118|FG001|COMPLETED|Washout Period 2 (12-16 Days)||11||
60031214|NCT02350309|76147119|FG002|COMPLETED|Washout Period 2 (12-16 Days)||10||
60031215|NCT02350309|76147120|FG003|COMPLETED|Washout Period 2 (12-16 Days)||11||
60031216|NCT02350309|76147121|FG004|COMPLETED|Washout Period 2 (12-16 Days)||12||
60031217|NCT02350309|76147122|FG005|COMPLETED|Washout Period 2 (12-16 Days)||12||
60031218|NCT02350309|76147117|FG000|NOT COMPLETED|Washout Period 2 (12-16 Days)||0||
60031219|NCT02350309|76147118|FG001|NOT COMPLETED|Washout Period 2 (12-16 Days)||0||
60031220|NCT02350309|76147119|FG002|NOT COMPLETED|Washout Period 2 (12-16 Days)||0||
60031221|NCT02350309|76147120|FG003|NOT COMPLETED|Washout Period 2 (12-16 Days)||0||
60031222|NCT02350309|76147121|FG004|NOT COMPLETED|Washout Period 2 (12-16 Days)||0||
60031223|NCT02350309|76147122|FG005|NOT COMPLETED|Washout Period 2 (12-16 Days)||0||
60031224|NCT02350309|76147117|FG000|STARTED|Treatment Period 3 (2 Days)||12||
60031225|NCT02350309|76147118|FG001|STARTED|Treatment Period 3 (2 Days)||11||
60031226|NCT02350309|76147119|FG002|STARTED|Treatment Period 3 (2 Days)||10||
60031227|NCT02350309|76147120|FG003|STARTED|Treatment Period 3 (2 Days)||11||
60031228|NCT02350309|76147121|FG004|STARTED|Treatment Period 3 (2 Days)||12||
60031229|NCT02350309|76147122|FG005|STARTED|Treatment Period 3 (2 Days)||12||
60031230|NCT02350309|76147117|FG000|COMPLETED|Treatment Period 3 (2 Days)||12||
60031231|NCT02350309|76147118|FG001|COMPLETED|Treatment Period 3 (2 Days)||11||
60031232|NCT02350309|76147119|FG002|COMPLETED|Treatment Period 3 (2 Days)||10||
60031233|NCT02350309|76147120|FG003|COMPLETED|Treatment Period 3 (2 Days)||11||
60031234|NCT02350309|76147121|FG004|COMPLETED|Treatment Period 3 (2 Days)||12||
60031235|NCT02350309|76147122|FG005|COMPLETED|Treatment Period 3 (2 Days)||12||
60031236|NCT02350309|76147117|FG000|NOT COMPLETED|Treatment Period 3 (2 Days)||0||
60031237|NCT02350309|76147118|FG001|NOT COMPLETED|Treatment Period 3 (2 Days)||0||
60031238|NCT02350309|76147119|FG002|NOT COMPLETED|Treatment Period 3 (2 Days)||0||
60031239|NCT02350309|76147120|FG003|NOT COMPLETED|Treatment Period 3 (2 Days)||0||
60031240|NCT02350309|76147121|FG004|NOT COMPLETED|Treatment Period 3 (2 Days)||0||
60031241|NCT02350309|76147122|FG005|NOT COMPLETED|Treatment Period 3 (2 Days)||0||
60031242|NCT02350309|76147117|FG000|STARTED|Washout Period 3 (12-16 Days)||12||
60031243|NCT02350309|76147118|FG001|STARTED|Washout Period 3 (12-16 Days)||11||
60031244|NCT02350309|76147119|FG002|STARTED|Washout Period 3 (12-16 Days)||10||
60031245|NCT02350309|76147120|FG003|STARTED|Washout Period 3 (12-16 Days)||11||
60031246|NCT02350309|76147121|FG004|STARTED|Washout Period 3 (12-16 Days)||12||
60031247|NCT02350309|76147122|FG005|STARTED|Washout Period 3 (12-16 Days)||12||
60031248|NCT02350309|76147117|FG000|COMPLETED|Washout Period 3 (12-16 Days)||12||
60031249|NCT02350309|76147118|FG001|COMPLETED|Washout Period 3 (12-16 Days)||11||
60031250|NCT02350309|76147119|FG002|COMPLETED|Washout Period 3 (12-16 Days)||10||
60031251|NCT02350309|76147120|FG003|COMPLETED|Washout Period 3 (12-16 Days)||11||
60031252|NCT02350309|76147121|FG004|COMPLETED|Washout Period 3 (12-16 Days)||12||
60031253|NCT02350309|76147122|FG005|COMPLETED|Washout Period 3 (12-16 Days)||12||
60031254|NCT02350309|76147117|FG000|NOT COMPLETED|Washout Period 3 (12-16 Days)||0||
60031255|NCT02350309|76147118|FG001|NOT COMPLETED|Washout Period 3 (12-16 Days)||0||
60031256|NCT02350309|76147119|FG002|NOT COMPLETED|Washout Period 3 (12-16 Days)||0||
60031257|NCT02350309|76147120|FG003|NOT COMPLETED|Washout Period 3 (12-16 Days)||0||
60031258|NCT02350309|76147121|FG004|NOT COMPLETED|Washout Period 3 (12-16 Days)||0||
60031259|NCT02350309|76147122|FG005|NOT COMPLETED|Washout Period 3 (12-16 Days)||0||
60031260|NCT02350309|76147117|FG000|STARTED|Treatment Period 4 (2 Days)||12||
60031261|NCT02350309|76147118|FG001|STARTED|Treatment Period 4 (2 Days)||11||
60031262|NCT02350309|76147119|FG002|STARTED|Treatment Period 4 (2 Days)||10||
60031263|NCT02350309|76147120|FG003|STARTED|Treatment Period 4 (2 Days)||11||
60031264|NCT02350309|76147121|FG004|STARTED|Treatment Period 4 (2 Days)||12||
60031265|NCT02350309|76147122|FG005|STARTED|Treatment Period 4 (2 Days)||12||
60031266|NCT02350309|76147117|FG000|COMPLETED|Treatment Period 4 (2 Days)||12||
60031267|NCT02350309|76147118|FG001|COMPLETED|Treatment Period 4 (2 Days)||11||
60031268|NCT02350309|76147119|FG002|COMPLETED|Treatment Period 4 (2 Days)||10||
60031269|NCT02350309|76147120|FG003|COMPLETED|Treatment Period 4 (2 Days)||11||
60031270|NCT02350309|76147121|FG004|COMPLETED|Treatment Period 4 (2 Days)||12||
60031271|NCT02350309|76147122|FG005|COMPLETED|Treatment Period 4 (2 Days)||11||
60031272|NCT02350309|76147117|FG000|NOT COMPLETED|Treatment Period 4 (2 Days)||0||
60031273|NCT02350309|76147118|FG001|NOT COMPLETED|Treatment Period 4 (2 Days)||0||
60031274|NCT02350309|76147119|FG002|NOT COMPLETED|Treatment Period 4 (2 Days)||0||
60031275|NCT02350309|76147120|FG003|NOT COMPLETED|Treatment Period 4 (2 Days)||0||
60031276|NCT02350309|76147121|FG004|NOT COMPLETED|Treatment Period 4 (2 Days)||0||
60031277|NCT02350309|76147122|FG005|NOT COMPLETED|Treatment Period 4 (2 Days)||1||
60031278|NCT02038647|76147139|FG000|STARTED|Overall Study||89||
60031279|NCT02038647|76147140|FG001|STARTED|Overall Study||89||
60031280|NCT02038647|76147139|FG000|COMPLETED|Overall Study||0||
60031281|NCT02038647|76147140|FG001|COMPLETED|Overall Study||0||
60031282|NCT02038647|76147139|FG000|NOT COMPLETED|Overall Study||89||
60031283|NCT02038647|76147140|FG001|NOT COMPLETED|Overall Study||89||
60031284|NCT02058069|76147146|FG000|STARTED|Overall Study||100||
60031285|NCT02058069|76147146|FG000|COMPLETED|Overall Study||89||
60031286|NCT02058069|76147146|FG000|NOT COMPLETED|Overall Study||11||
60031287|NCT02057835|76147160|FG000|STARTED|Overall Study||8||
60031288|NCT02057835|76147161|FG001|STARTED|Overall Study||6||
60031289|NCT02057835|76147162|FG002|STARTED|Overall Study||6||
60031290|NCT02057835|76147163|FG003|STARTED|Overall Study||6||
60031291|NCT02057835|76147164|FG004|STARTED|Overall Study||6||
60031292|NCT02057835|76147165|FG005|STARTED|Overall Study||8||
60031293|NCT02057835|76147166|FG006|STARTED|Overall Study||6||
60031294|NCT02057835|76147167|FG007|STARTED|Overall Study||6||
60031295|NCT02057835|76147168|FG008|STARTED|Overall Study||6||
60031296|NCT02057835|76147169|FG009|STARTED|Overall Study||6||
60031297|NCT02057835|76147160|FG000|COMPLETED|Overall Study||8||
60031298|NCT02057835|76147161|FG001|COMPLETED|Overall Study||4||
60031299|NCT02057835|76147162|FG002|COMPLETED|Overall Study||6||
60031300|NCT02057835|76147163|FG003|COMPLETED|Overall Study||6||
60031301|NCT02057835|76147164|FG004|COMPLETED|Overall Study||6||
60031302|NCT02057835|76147165|FG005|COMPLETED|Overall Study||8||
60031303|NCT02057835|76147166|FG006|COMPLETED|Overall Study||6||
60031304|NCT02057835|76147167|FG007|COMPLETED|Overall Study||6||
60031305|NCT02057835|76147168|FG008|COMPLETED|Overall Study||6||
60031306|NCT02057835|76147169|FG009|COMPLETED|Overall Study||6||
60031307|NCT02057835|76147160|FG000|NOT COMPLETED|Overall Study||0||
60031308|NCT02057835|76147161|FG001|NOT COMPLETED|Overall Study||2||
60031309|NCT02057835|76147162|FG002|NOT COMPLETED|Overall Study||0||
60031310|NCT02057835|76147163|FG003|NOT COMPLETED|Overall Study||0||
60031311|NCT02057835|76147164|FG004|NOT COMPLETED|Overall Study||0||
60031312|NCT02057835|76147165|FG005|NOT COMPLETED|Overall Study||0||
60031313|NCT02057835|76147166|FG006|NOT COMPLETED|Overall Study||0||
60031314|NCT02057835|76147167|FG007|NOT COMPLETED|Overall Study||0||
60031315|NCT02057835|76147168|FG008|NOT COMPLETED|Overall Study||0||
60031316|NCT02057835|76147169|FG009|NOT COMPLETED|Overall Study||0||
60031317|NCT02057757|76147200|FG000|STARTED|Overall Study||131||
60031318|NCT02057757|76147201|FG001|STARTED|Overall Study||129||
60031319|NCT02057757|76147200|FG000|Intent to Treat|Overall Study||130||
60031320|NCT02057757|76147201|FG001|Intent to Treat|Overall Study||127||
60031321|NCT02057757|76147200|FG000|COMPLETED|Overall Study||117||
60031322|NCT02057757|76147201|FG001|COMPLETED|Overall Study||121||
60031323|NCT02057757|76147200|FG000|NOT COMPLETED|Overall Study||14||
60031324|NCT02057757|76147201|FG001|NOT COMPLETED|Overall Study||8||
60031325|NCT02037477|76147215|FG000|STARTED|Treatment Period 1||5||
60031326|NCT02037477|76147216|FG001|STARTED|Treatment Period 1||5||
60031327|NCT02037477|76147217|FG002|STARTED|Treatment Period 1||5||
60031328|NCT02037477|76147218|FG003|STARTED|Treatment Period 1||5||
60031329|NCT02037477|76147215|FG000|COMPLETED|Treatment Period 1||5||
60031330|NCT02037477|76147216|FG001|COMPLETED|Treatment Period 1||5||
60031331|NCT02037477|76147217|FG002|COMPLETED|Treatment Period 1||4||
60031332|NCT02037477|76147218|FG003|COMPLETED|Treatment Period 1||5||
60031333|NCT02037477|76147215|FG000|NOT COMPLETED|Treatment Period 1||0||
60031334|NCT02037477|76147216|FG001|NOT COMPLETED|Treatment Period 1||0||
60031335|NCT02037477|76147217|FG002|NOT COMPLETED|Treatment Period 1||1||
60031336|NCT02037477|76147218|FG003|NOT COMPLETED|Treatment Period 1||0||
60031337|NCT02037477|76147215|FG000|STARTED|Treatment Period 2||5||
60031338|NCT02037477|76147216|FG001|STARTED|Treatment Period 2||5||
60031339|NCT02037477|76147217|FG002|STARTED|Treatment Period 2||4||
60031340|NCT02037477|76147218|FG003|STARTED|Treatment Period 2||5||
60031341|NCT02037477|76147215|FG000|COMPLETED|Treatment Period 2||5||
60031342|NCT02037477|76147216|FG001|COMPLETED|Treatment Period 2||5||
60031343|NCT02037477|76147217|FG002|COMPLETED|Treatment Period 2||4||
60031344|NCT02037477|76147218|FG003|COMPLETED|Treatment Period 2||5||
60031345|NCT02037477|76147215|FG000|NOT COMPLETED|Treatment Period 2||0||
60031346|NCT02037477|76147216|FG001|NOT COMPLETED|Treatment Period 2||0||
60031347|NCT02037477|76147217|FG002|NOT COMPLETED|Treatment Period 2||0||
60031348|NCT02037477|76147218|FG003|NOT COMPLETED|Treatment Period 2||0||
59759259|NCT00561925|75878606|FG000|COMPLETED|144-week Double-blind, Double-dummy||0||
59507883|NCT02153983|75601048|FG003|NOT COMPLETED|Overall Study||0||
59507884|NCT02153983|75601049|FG004|NOT COMPLETED|Overall Study||0||
60031349|NCT02057523|76147228|FG000|STARTED|Overall Study||2||
60031350|NCT02057523|76147228|FG000|COMPLETED|Overall Study||0||
60031351|NCT02057523|76147228|FG000|NOT COMPLETED|Overall Study||2||
60031352|NCT02037165|76147237|FG000|STARTED|Period 1 (2 Days)|randomized subjects|5||
60031353|NCT02037165|76147238|FG001|STARTED|Period 1 (2 Days)|randomized subjects|5||
60031354|NCT02037165|76147239|FG002|STARTED|Period 1 (2 Days)|randomized subjects|5||
60031355|NCT02037165|76147240|FG003|STARTED|Period 1 (2 Days)|randomized subjects|5||
60031356|NCT02037165|76147241|FG004|STARTED|Period 1 (2 Days)|randomized subjects|5||
60031357|NCT02037165|76147237|FG000|COMPLETED|Period 1 (2 Days)||5||
60031358|NCT02037165|76147238|FG001|COMPLETED|Period 1 (2 Days)||5||
60031359|NCT02037165|76147239|FG002|COMPLETED|Period 1 (2 Days)||5||
60031360|NCT02037165|76147240|FG003|COMPLETED|Period 1 (2 Days)||5||
60031361|NCT02037165|76147241|FG004|COMPLETED|Period 1 (2 Days)||5||
60031362|NCT02037165|76147237|FG000|NOT COMPLETED|Period 1 (2 Days)||0||
60031363|NCT02037165|76147238|FG001|NOT COMPLETED|Period 1 (2 Days)||0||
60031364|NCT02037165|76147239|FG002|NOT COMPLETED|Period 1 (2 Days)||0||
60031365|NCT02037165|76147240|FG003|NOT COMPLETED|Period 1 (2 Days)||0||
60031366|NCT02037165|76147241|FG004|NOT COMPLETED|Period 1 (2 Days)||0||
60031367|NCT02037165|76147237|FG000|STARTED|Washout Period 1 (6 Days)||5||
60031368|NCT02037165|76147238|FG001|STARTED|Washout Period 1 (6 Days)||5||
60031369|NCT02037165|76147239|FG002|STARTED|Washout Period 1 (6 Days)||5||
60031370|NCT02037165|76147240|FG003|STARTED|Washout Period 1 (6 Days)||5||
60031371|NCT02037165|76147241|FG004|STARTED|Washout Period 1 (6 Days)||5||
60031372|NCT02037165|76147237|FG000|COMPLETED|Washout Period 1 (6 Days)||5||
60031373|NCT02037165|76147238|FG001|COMPLETED|Washout Period 1 (6 Days)||5||
60031374|NCT02037165|76147239|FG002|COMPLETED|Washout Period 1 (6 Days)||5||
60031375|NCT02037165|76147240|FG003|COMPLETED|Washout Period 1 (6 Days)||5||
60031376|NCT02037165|76147241|FG004|COMPLETED|Washout Period 1 (6 Days)||5||
60031377|NCT02037165|76147237|FG000|NOT COMPLETED|Washout Period 1 (6 Days)||0||
60031378|NCT02037165|76147238|FG001|NOT COMPLETED|Washout Period 1 (6 Days)||0||
60031379|NCT02037165|76147239|FG002|NOT COMPLETED|Washout Period 1 (6 Days)||0||
60031380|NCT02037165|76147240|FG003|NOT COMPLETED|Washout Period 1 (6 Days)||0||
60031381|NCT02037165|76147241|FG004|NOT COMPLETED|Washout Period 1 (6 Days)||0||
60031382|NCT02037165|76147237|FG000|STARTED|Period 2 (2 Days)||5||
60031383|NCT02037165|76147238|FG001|STARTED|Period 2 (2 Days)||5||
60031384|NCT02037165|76147239|FG002|STARTED|Period 2 (2 Days)||5||
60031385|NCT02037165|76147240|FG003|STARTED|Period 2 (2 Days)||5||
60031386|NCT02037165|76147241|FG004|STARTED|Period 2 (2 Days)||5||
60031387|NCT02037165|76147237|FG000|COMPLETED|Period 2 (2 Days)||5||
60031388|NCT02037165|76147238|FG001|COMPLETED|Period 2 (2 Days)||5||
60031389|NCT02037165|76147239|FG002|COMPLETED|Period 2 (2 Days)||5||
60031390|NCT02037165|76147240|FG003|COMPLETED|Period 2 (2 Days)||5||
60031391|NCT02037165|76147241|FG004|COMPLETED|Period 2 (2 Days)||5||
60031392|NCT02037165|76147237|FG000|NOT COMPLETED|Period 2 (2 Days)||0||
60031393|NCT02037165|76147238|FG001|NOT COMPLETED|Period 2 (2 Days)||0||
60031394|NCT02037165|76147239|FG002|NOT COMPLETED|Period 2 (2 Days)||0||
60031395|NCT02037165|76147240|FG003|NOT COMPLETED|Period 2 (2 Days)||0||
60031396|NCT02037165|76147241|FG004|NOT COMPLETED|Period 2 (2 Days)||0||
60031397|NCT02037165|76147237|FG000|STARTED|Washout Period 2 (6 Days)||5||
60031398|NCT02037165|76147238|FG001|STARTED|Washout Period 2 (6 Days)||5||
60031399|NCT02037165|76147239|FG002|STARTED|Washout Period 2 (6 Days)||5||
60031400|NCT02037165|76147240|FG003|STARTED|Washout Period 2 (6 Days)||5||
60031401|NCT02037165|76147241|FG004|STARTED|Washout Period 2 (6 Days)||5||
60031402|NCT02037165|76147237|FG000|COMPLETED|Washout Period 2 (6 Days)||5||
60031403|NCT02037165|76147238|FG001|COMPLETED|Washout Period 2 (6 Days)||5||
60031404|NCT02037165|76147239|FG002|COMPLETED|Washout Period 2 (6 Days)||5||
59916485|NCT03613649|76037268|FG007|COMPLETED|Second Treatment||6||
59916486|NCT03613649|76037269|FG008|COMPLETED|Second Treatment||6||
59916487|NCT03613649|76037270|FG009|COMPLETED|Second Treatment||6||
59916488|NCT03613649|76037271|FG010|COMPLETED|Second Treatment||6||
59916489|NCT03613649|76037272|FG011|COMPLETED|Second Treatment||6||
59916490|NCT03613649|76037261|FG000|NOT COMPLETED|Second Treatment||0||
59916491|NCT03613649|76037262|FG001|NOT COMPLETED|Second Treatment||0||
59916492|NCT03613649|76037263|FG002|NOT COMPLETED|Second Treatment||1||
59916493|NCT03613649|76037264|FG003|NOT COMPLETED|Second Treatment||0||
59916494|NCT03613649|76037265|FG004|NOT COMPLETED|Second Treatment||1||
59916495|NCT03613649|76037266|FG005|NOT COMPLETED|Second Treatment||0||
59916496|NCT03613649|76037267|FG006|NOT COMPLETED|Second Treatment||0||
59916497|NCT03613649|76037268|FG007|NOT COMPLETED|Second Treatment||0||
59916498|NCT03613649|76037269|FG008|NOT COMPLETED|Second Treatment||0||
59916499|NCT03613649|76037270|FG009|NOT COMPLETED|Second Treatment||0||
59916500|NCT03613649|76037271|FG010|NOT COMPLETED|Second Treatment||0||
59916501|NCT03613649|76037272|FG011|NOT COMPLETED|Second Treatment||0||
59916502|NCT03613649|76037261|FG000|STARTED|Third Treatment||6||
59916503|NCT03613649|76037262|FG001|STARTED|Third Treatment||6||
59916504|NCT03613649|76037263|FG002|STARTED|Third Treatment||5||
59916505|NCT03613649|76037264|FG003|STARTED|Third Treatment||6||
59916506|NCT03613649|76037265|FG004|STARTED|Third Treatment||5||
59916507|NCT03613649|76037266|FG005|STARTED|Third Treatment||6||
59916508|NCT03613649|76037267|FG006|STARTED|Third Treatment||6||
59916509|NCT03613649|76037268|FG007|STARTED|Third Treatment||6||
59916510|NCT03613649|76037269|FG008|STARTED|Third Treatment||6||
59916511|NCT03613649|76037270|FG009|STARTED|Third Treatment||6||
59916512|NCT03613649|76037271|FG010|STARTED|Third Treatment||6||
59916513|NCT03613649|76037272|FG011|STARTED|Third Treatment||6||
59916514|NCT03613649|76037261|FG000|Received Treatment|Third Treatment||6||
59916515|NCT03613649|76037262|FG001|Received Treatment|Third Treatment||6||
59916516|NCT03613649|76037263|FG002|Received Treatment|Third Treatment||5||
59916517|NCT03613649|76037264|FG003|Received Treatment|Third Treatment||6||
59916518|NCT03613649|76037265|FG004|Received Treatment|Third Treatment||5||
59916519|NCT03613649|76037266|FG005|Received Treatment|Third Treatment||6||
59916520|NCT03613649|76037267|FG006|Received Treatment|Third Treatment||5||
59916521|NCT03613649|76037268|FG007|Received Treatment|Third Treatment||6||
59916522|NCT03613649|76037269|FG008|Received Treatment|Third Treatment||6||
59916523|NCT03613649|76037270|FG009|Received Treatment|Third Treatment||6||
59916524|NCT03613649|76037271|FG010|Received Treatment|Third Treatment||6||
59916525|NCT03613649|76037272|FG011|Received Treatment|Third Treatment||6||
59916526|NCT03613649|76037261|FG000|COMPLETED|Third Treatment||6||
59916527|NCT03613649|76037262|FG001|COMPLETED|Third Treatment||6||
59916528|NCT03613649|76037263|FG002|COMPLETED|Third Treatment||5||
59916529|NCT03613649|76037264|FG003|COMPLETED|Third Treatment||6||
59916530|NCT03613649|76037265|FG004|COMPLETED|Third Treatment||4||
59916531|NCT03613649|76037266|FG005|COMPLETED|Third Treatment||6||
59916532|NCT03613649|76037267|FG006|COMPLETED|Third Treatment||5||
59916533|NCT03613649|76037268|FG007|COMPLETED|Third Treatment||6||
59916534|NCT03613649|76037269|FG008|COMPLETED|Third Treatment||6||
59916535|NCT03613649|76037270|FG009|COMPLETED|Third Treatment||6||
59916536|NCT03613649|76037271|FG010|COMPLETED|Third Treatment||6||
59916537|NCT03613649|76037272|FG011|COMPLETED|Third Treatment||4||
59916538|NCT03613649|76037261|FG000|NOT COMPLETED|Third Treatment||0||
59916539|NCT03613649|76037262|FG001|NOT COMPLETED|Third Treatment||0||
59916540|NCT03613649|76037263|FG002|NOT COMPLETED|Third Treatment||0||
59916541|NCT03613649|76037264|FG003|NOT COMPLETED|Third Treatment||0||
59916542|NCT03613649|76037265|FG004|NOT COMPLETED|Third Treatment||1||
59916543|NCT03613649|76037266|FG005|NOT COMPLETED|Third Treatment||0||
59916544|NCT03613649|76037267|FG006|NOT COMPLETED|Third Treatment||1||
59916545|NCT03613649|76037268|FG007|NOT COMPLETED|Third Treatment||0||
59916546|NCT03613649|76037269|FG008|NOT COMPLETED|Third Treatment||0||
59916547|NCT03613649|76037270|FG009|NOT COMPLETED|Third Treatment||0||
59916548|NCT03613649|76037271|FG010|NOT COMPLETED|Third Treatment||0||
59916549|NCT03613649|76037272|FG011|NOT COMPLETED|Third Treatment||2||
59916550|NCT03613649|76037261|FG000|STARTED|Fourth Treatment||6||
59916551|NCT03613649|76037262|FG001|STARTED|Fourth Treatment||6||
59916552|NCT03613649|76037263|FG002|STARTED|Fourth Treatment||5||
59916553|NCT03613649|76037264|FG003|STARTED|Fourth Treatment||6||
59916554|NCT03613649|76037265|FG004|STARTED|Fourth Treatment||4||
59916555|NCT03613649|76037266|FG005|STARTED|Fourth Treatment||6||
59916556|NCT03613649|76037267|FG006|STARTED|Fourth Treatment||5||
59916557|NCT03613649|76037268|FG007|STARTED|Fourth Treatment||6||
59916558|NCT03613649|76037269|FG008|STARTED|Fourth Treatment||6||
59916559|NCT03613649|76037270|FG009|STARTED|Fourth Treatment||6||
59916560|NCT03613649|76037271|FG010|STARTED|Fourth Treatment||6||
59916561|NCT03613649|76037272|FG011|STARTED|Fourth Treatment||4||
59916562|NCT03613649|76037261|FG000|Received Treatment|Fourth Treatment||5||
59916563|NCT03613649|76037262|FG001|Received Treatment|Fourth Treatment||6||
59916564|NCT03613649|76037263|FG002|Received Treatment|Fourth Treatment||5||
59916565|NCT03613649|76037264|FG003|Received Treatment|Fourth Treatment||6||
60031405|NCT02037165|76147240|FG003|COMPLETED|Washout Period 2 (6 Days)||5||
60031406|NCT02037165|76147241|FG004|COMPLETED|Washout Period 2 (6 Days)||5||
60031407|NCT02037165|76147237|FG000|NOT COMPLETED|Washout Period 2 (6 Days)||0||
60031408|NCT02037165|76147238|FG001|NOT COMPLETED|Washout Period 2 (6 Days)||0||
60031409|NCT02037165|76147239|FG002|NOT COMPLETED|Washout Period 2 (6 Days)||0||
60031410|NCT02037165|76147240|FG003|NOT COMPLETED|Washout Period 2 (6 Days)||0||
60031411|NCT02037165|76147241|FG004|NOT COMPLETED|Washout Period 2 (6 Days)||0||
60031412|NCT02037165|76147237|FG000|STARTED|Period 3 (2 Days)||5||
60031413|NCT02037165|76147238|FG001|STARTED|Period 3 (2 Days)||5||
60031414|NCT02037165|76147239|FG002|STARTED|Period 3 (2 Days)||5||
60031415|NCT02037165|76147240|FG003|STARTED|Period 3 (2 Days)||5||
60031416|NCT02037165|76147241|FG004|STARTED|Period 3 (2 Days)||5||
60031417|NCT02037165|76147237|FG000|COMPLETED|Period 3 (2 Days)||5||
60031418|NCT02037165|76147238|FG001|COMPLETED|Period 3 (2 Days)||5||
60031419|NCT02037165|76147239|FG002|COMPLETED|Period 3 (2 Days)||5||
60031420|NCT02037165|76147240|FG003|COMPLETED|Period 3 (2 Days)||5||
60031421|NCT02037165|76147241|FG004|COMPLETED|Period 3 (2 Days)||5||
60031422|NCT02037165|76147237|FG000|NOT COMPLETED|Period 3 (2 Days)||0||
60031423|NCT02037165|76147238|FG001|NOT COMPLETED|Period 3 (2 Days)||0||
60031424|NCT02037165|76147239|FG002|NOT COMPLETED|Period 3 (2 Days)||0||
60031425|NCT02037165|76147240|FG003|NOT COMPLETED|Period 3 (2 Days)||0||
60031426|NCT02037165|76147241|FG004|NOT COMPLETED|Period 3 (2 Days)||0||
60031427|NCT02037165|76147237|FG000|STARTED|Washout Period 3 (6 Days)||5||
60031428|NCT02037165|76147238|FG001|STARTED|Washout Period 3 (6 Days)||5||
60031429|NCT02037165|76147239|FG002|STARTED|Washout Period 3 (6 Days)||5||
60031430|NCT02037165|76147240|FG003|STARTED|Washout Period 3 (6 Days)||5||
60031431|NCT02037165|76147241|FG004|STARTED|Washout Period 3 (6 Days)||5||
60031432|NCT02037165|76147237|FG000|COMPLETED|Washout Period 3 (6 Days)||5||
60031433|NCT02037165|76147238|FG001|COMPLETED|Washout Period 3 (6 Days)||5||
60031434|NCT02037165|76147239|FG002|COMPLETED|Washout Period 3 (6 Days)||5||
60031435|NCT02037165|76147240|FG003|COMPLETED|Washout Period 3 (6 Days)||5||
60031436|NCT02037165|76147241|FG004|COMPLETED|Washout Period 3 (6 Days)||5||
60031437|NCT02037165|76147237|FG000|NOT COMPLETED|Washout Period 3 (6 Days)||0||
60031438|NCT02037165|76147238|FG001|NOT COMPLETED|Washout Period 3 (6 Days)||0||
60031439|NCT02037165|76147239|FG002|NOT COMPLETED|Washout Period 3 (6 Days)||0||
60031440|NCT02037165|76147240|FG003|NOT COMPLETED|Washout Period 3 (6 Days)||0||
60031441|NCT02037165|76147241|FG004|NOT COMPLETED|Washout Period 3 (6 Days)||0||
60031442|NCT02037165|76147237|FG000|STARTED|Period 4 (2 Days)||5||
60031443|NCT02037165|76147238|FG001|STARTED|Period 4 (2 Days)||5||
60031444|NCT02037165|76147239|FG002|STARTED|Period 4 (2 Days)||5||
60031445|NCT02037165|76147240|FG003|STARTED|Period 4 (2 Days)||5||
60031446|NCT02037165|76147241|FG004|STARTED|Period 4 (2 Days)||5||
60031447|NCT02037165|76147237|FG000|COMPLETED|Period 4 (2 Days)||5||
60031448|NCT02037165|76147238|FG001|COMPLETED|Period 4 (2 Days)||5||
60031449|NCT02037165|76147239|FG002|COMPLETED|Period 4 (2 Days)||5||
60031450|NCT02037165|76147240|FG003|COMPLETED|Period 4 (2 Days)||5||
60031451|NCT02037165|76147241|FG004|COMPLETED|Period 4 (2 Days)||5||
60031452|NCT02037165|76147237|FG000|NOT COMPLETED|Period 4 (2 Days)||0||
60031453|NCT02037165|76147238|FG001|NOT COMPLETED|Period 4 (2 Days)||0||
60031454|NCT02037165|76147239|FG002|NOT COMPLETED|Period 4 (2 Days)||0||
60031455|NCT02037165|76147240|FG003|NOT COMPLETED|Period 4 (2 Days)||0||
60031456|NCT02037165|76147241|FG004|NOT COMPLETED|Period 4 (2 Days)||0||
60031457|NCT02037165|76147237|FG000|STARTED|Washout Period 4 (6 Days)||5||
60031458|NCT02037165|76147238|FG001|STARTED|Washout Period 4 (6 Days)||5||
60031459|NCT02037165|76147239|FG002|STARTED|Washout Period 4 (6 Days)||5||
60031460|NCT02037165|76147240|FG003|STARTED|Washout Period 4 (6 Days)||5||
60031461|NCT02037165|76147241|FG004|STARTED|Washout Period 4 (6 Days)||5||
60031462|NCT02037165|76147237|FG000|COMPLETED|Washout Period 4 (6 Days)||5||
60031463|NCT02037165|76147238|FG001|COMPLETED|Washout Period 4 (6 Days)||5||
60031464|NCT02037165|76147239|FG002|COMPLETED|Washout Period 4 (6 Days)||5||
60031465|NCT02037165|76147240|FG003|COMPLETED|Washout Period 4 (6 Days)||5||
60031466|NCT02037165|76147241|FG004|COMPLETED|Washout Period 4 (6 Days)||4||
60031467|NCT02037165|76147237|FG000|NOT COMPLETED|Washout Period 4 (6 Days)||0||
60031468|NCT02037165|76147238|FG001|NOT COMPLETED|Washout Period 4 (6 Days)||0||
60031469|NCT02037165|76147239|FG002|NOT COMPLETED|Washout Period 4 (6 Days)||0||
60031470|NCT02037165|76147240|FG003|NOT COMPLETED|Washout Period 4 (6 Days)||0||
60031471|NCT02037165|76147241|FG004|NOT COMPLETED|Washout Period 4 (6 Days)||1||
60031472|NCT02037165|76147237|FG000|STARTED|Period 5 (2 Days)||5||
60031473|NCT02037165|76147238|FG001|STARTED|Period 5 (2 Days)||5||
60031474|NCT02037165|76147239|FG002|STARTED|Period 5 (2 Days)||5||
60031475|NCT02037165|76147240|FG003|STARTED|Period 5 (2 Days)||5||
60031476|NCT02037165|76147241|FG004|STARTED|Period 5 (2 Days)||4||
60031477|NCT02037165|76147237|FG000|COMPLETED|Period 5 (2 Days)||5||
60031478|NCT02037165|76147238|FG001|COMPLETED|Period 5 (2 Days)||5||
60031479|NCT02037165|76147239|FG002|COMPLETED|Period 5 (2 Days)||5||
60031480|NCT02037165|76147240|FG003|COMPLETED|Period 5 (2 Days)||5||
60031481|NCT02037165|76147241|FG004|COMPLETED|Period 5 (2 Days)||4||
60031482|NCT02037165|76147237|FG000|NOT COMPLETED|Period 5 (2 Days)||0||
60031483|NCT02037165|76147238|FG001|NOT COMPLETED|Period 5 (2 Days)||0||
60031484|NCT02037165|76147239|FG002|NOT COMPLETED|Period 5 (2 Days)||0||
60031485|NCT02037165|76147240|FG003|NOT COMPLETED|Period 5 (2 Days)||0||
60031486|NCT02037165|76147241|FG004|NOT COMPLETED|Period 5 (2 Days)||0||
60031487|NCT02470403|76147262|FG000|STARTED|Overall Study||44||
60031488|NCT02470403|76147263|FG001|STARTED|Overall Study||44||
60031489|NCT02470403|76147264|FG002|STARTED|Overall Study||40||
60031490|NCT02470403|76147265|FG003|STARTED|Overall Study||43||
60031491|NCT02470403|76147266|FG004|STARTED|Overall Study||10||
60031492|NCT02470403|76147262|FG000|Dysglycemic|Overall Study||24||
60031493|NCT02470403|76147263|FG001|Dysglycemic|Overall Study||24||
60031494|NCT02470403|76147264|FG002|Dysglycemic|Overall Study||20||
60031495|NCT02470403|76147265|FG003|Dysglycemic|Overall Study||20||
60031496|NCT02470403|76147266|FG004|Dysglycemic|Overall Study||5||
60031497|NCT02470403|76147262|FG000|Normoglycemic|Overall Study||20||
60031498|NCT02470403|76147263|FG001|Normoglycemic|Overall Study||20||
60031499|NCT02470403|76147264|FG002|Normoglycemic|Overall Study||20||
60031500|NCT02470403|76147265|FG003|Normoglycemic|Overall Study||23||
60031501|NCT02470403|76147266|FG004|Normoglycemic|Overall Study||5||
60031502|NCT02470403|76147262|FG000|COMPLETED|Overall Study||42||
60031503|NCT02470403|76147263|FG001|COMPLETED|Overall Study||43||
60031504|NCT02470403|76147264|FG002|COMPLETED|Overall Study||40||
60031505|NCT02470403|76147265|FG003|COMPLETED|Overall Study||39||
60031506|NCT02470403|76147266|FG004|COMPLETED|Overall Study||10||
60031507|NCT02470403|76147262|FG000|NOT COMPLETED|Overall Study||2||
60031508|NCT02470403|76147263|FG001|NOT COMPLETED|Overall Study||1||
60031509|NCT02470403|76147264|FG002|NOT COMPLETED|Overall Study||0||
60031510|NCT02470403|76147265|FG003|NOT COMPLETED|Overall Study||4||
60031511|NCT02470403|76147266|FG004|NOT COMPLETED|Overall Study||0||
60031512|NCT01855750|76147283|FG000|STARTED|Overall Study||419||
60031513|NCT01855750|76147284|FG001|STARTED|Overall Study||419||
60031514|NCT01855750|76147283|FG000|Treated|Overall Study|3 participants not treated:2 withdrew consent and 1 not treated per Sponsor/investigator's decision.|416||
60031515|NCT01855750|76147284|FG001|Treated|Overall Study|1 participant not treated: withdrew consent.|418||
60031516|NCT01855750|76147283|FG000|COMPLETED|Overall Study||0||
60031517|NCT01855750|76147284|FG001|COMPLETED|Overall Study||0||
60031518|NCT01855750|76147283|FG000|NOT COMPLETED|Overall Study||419||
60031519|NCT01855750|76147284|FG001|NOT COMPLETED|Overall Study||419||
60031520|NCT01855126|76147292|FG000|STARTED|First Intervention (8 Weeks)||24||
60031521|NCT01855126|76147293|FG001|STARTED|First Intervention (8 Weeks)||22||
60031522|NCT01855126|76147292|FG000|COMPLETED|First Intervention (8 Weeks)||20||
60031523|NCT01855126|76147293|FG001|COMPLETED|First Intervention (8 Weeks)||16||
60031524|NCT01855126|76147292|FG000|NOT COMPLETED|First Intervention (8 Weeks)||4||
60031525|NCT01855126|76147293|FG001|NOT COMPLETED|First Intervention (8 Weeks)||6||
60031526|NCT01855126|76147292|FG000|STARTED|Washout Period (2 Weeks)||20||
60031527|NCT01855126|76147293|FG001|STARTED|Washout Period (2 Weeks)||16||
60031528|NCT01855126|76147292|FG000|COMPLETED|Washout Period (2 Weeks)||20||
60031529|NCT01855126|76147293|FG001|COMPLETED|Washout Period (2 Weeks)||16||
60031530|NCT01855126|76147292|FG000|NOT COMPLETED|Washout Period (2 Weeks)||0||
60031531|NCT01855126|76147293|FG001|NOT COMPLETED|Washout Period (2 Weeks)||0||
60031532|NCT01855126|76147292|FG000|STARTED|Second Intervention (8 Weeks)||20||
60031533|NCT01855126|76147293|FG001|STARTED|Second Intervention (8 Weeks)||16||
60031534|NCT01855126|76147292|FG000|COMPLETED|Second Intervention (8 Weeks)||18||
60031535|NCT01855126|76147293|FG001|COMPLETED|Second Intervention (8 Weeks)||14||
60031536|NCT01855126|76147292|FG000|NOT COMPLETED|Second Intervention (8 Weeks)||2||
60031537|NCT01855126|76147293|FG001|NOT COMPLETED|Second Intervention (8 Weeks)||2||
60031538|NCT01622673|76147309|FG000|STARTED|Treatment Period 1||4||
60031539|NCT01622673|76147310|FG001|STARTED|Treatment Period 1||5||
60031540|NCT01622673|76147311|FG002|STARTED|Treatment Period 1||4||
60031541|NCT01622673|76147312|FG003|STARTED|Treatment Period 1||6||
60031542|NCT01622673|76147313|FG004|STARTED|Treatment Period 1||4||
60031543|NCT01622673|76147314|FG005|STARTED|Treatment Period 1||4||
60031544|NCT01622673|76147309|FG000|COMPLETED|Treatment Period 1||4||
60031545|NCT01622673|76147310|FG001|COMPLETED|Treatment Period 1||4||
60031546|NCT01622673|76147311|FG002|COMPLETED|Treatment Period 1||4||
60031547|NCT01622673|76147312|FG003|COMPLETED|Treatment Period 1||5||
60031548|NCT01622673|76147313|FG004|COMPLETED|Treatment Period 1||4||
60031549|NCT01622673|76147314|FG005|COMPLETED|Treatment Period 1||4||
60031550|NCT01622673|76147309|FG000|NOT COMPLETED|Treatment Period 1||0||
60031551|NCT01622673|76147310|FG001|NOT COMPLETED|Treatment Period 1||1||
60031552|NCT01622673|76147311|FG002|NOT COMPLETED|Treatment Period 1||0||
60031553|NCT01622673|76147312|FG003|NOT COMPLETED|Treatment Period 1||1||
60031554|NCT01622673|76147313|FG004|NOT COMPLETED|Treatment Period 1||0||
60031555|NCT01622673|76147314|FG005|NOT COMPLETED|Treatment Period 1||0||
60031556|NCT01622673|76147309|FG000|STARTED|Treatment Period 2||4||
60031557|NCT01622673|76147310|FG001|STARTED|Treatment Period 2||4||
60031558|NCT01622673|76147311|FG002|STARTED|Treatment Period 2||4||
60031559|NCT01622673|76147312|FG003|STARTED|Treatment Period 2||5||
60031560|NCT01622673|76147313|FG004|STARTED|Treatment Period 2||4||
60031561|NCT01622673|76147314|FG005|STARTED|Treatment Period 2||4||
60031562|NCT01622673|76147309|FG000|COMPLETED|Treatment Period 2||4||
60031563|NCT01622673|76147310|FG001|COMPLETED|Treatment Period 2||4||
60031564|NCT01622673|76147311|FG002|COMPLETED|Treatment Period 2||4||
60031565|NCT01622673|76147312|FG003|COMPLETED|Treatment Period 2||4||
60031566|NCT01622673|76147313|FG004|COMPLETED|Treatment Period 2||4||
60031567|NCT01622673|76147314|FG005|COMPLETED|Treatment Period 2||4||
60031568|NCT01622673|76147309|FG000|NOT COMPLETED|Treatment Period 2||0||
60031569|NCT01622673|76147310|FG001|NOT COMPLETED|Treatment Period 2||0||
60031570|NCT01622673|76147311|FG002|NOT COMPLETED|Treatment Period 2||0||
60031571|NCT01622673|76147312|FG003|NOT COMPLETED|Treatment Period 2||1||
60031572|NCT01622673|76147313|FG004|NOT COMPLETED|Treatment Period 2||0||
60031573|NCT01622673|76147314|FG005|NOT COMPLETED|Treatment Period 2||0||
60031574|NCT01622673|76147309|FG000|STARTED|Treatment Period 3||4||
60031575|NCT01622673|76147310|FG001|STARTED|Treatment Period 3||4||
60031576|NCT01622673|76147311|FG002|STARTED|Treatment Period 3||4||
60031577|NCT01622673|76147312|FG003|STARTED|Treatment Period 3||4||
60031578|NCT01622673|76147313|FG004|STARTED|Treatment Period 3||4||
60031579|NCT01622673|76147314|FG005|STARTED|Treatment Period 3||4||
60031580|NCT01622673|76147309|FG000|COMPLETED|Treatment Period 3||4||
60031581|NCT01622673|76147310|FG001|COMPLETED|Treatment Period 3||3||
60031582|NCT01622673|76147311|FG002|COMPLETED|Treatment Period 3||4||
60031583|NCT01622673|76147312|FG003|COMPLETED|Treatment Period 3||4||
60031584|NCT01622673|76147313|FG004|COMPLETED|Treatment Period 3||4||
60031585|NCT01622673|76147314|FG005|COMPLETED|Treatment Period 3||4||
60031586|NCT01622673|76147309|FG000|NOT COMPLETED|Treatment Period 3||0||
60031587|NCT01622673|76147310|FG001|NOT COMPLETED|Treatment Period 3||1||
60031588|NCT01622673|76147311|FG002|NOT COMPLETED|Treatment Period 3||0||
60031589|NCT01622673|76147312|FG003|NOT COMPLETED|Treatment Period 3||0||
60031590|NCT01622673|76147313|FG004|NOT COMPLETED|Treatment Period 3||0||
60031591|NCT01622673|76147314|FG005|NOT COMPLETED|Treatment Period 3||0||
60031592|NCT01622673|76147309|FG000|STARTED|Treatment Period 4||4||
60031593|NCT01622673|76147310|FG001|STARTED|Treatment Period 4||3||
60031594|NCT01622673|76147311|FG002|STARTED|Treatment Period 4||4||
60031595|NCT01622673|76147312|FG003|STARTED|Treatment Period 4||4||
60031596|NCT01622673|76147313|FG004|STARTED|Treatment Period 4||4||
60031597|NCT01622673|76147314|FG005|STARTED|Treatment Period 4||4||
60031598|NCT01622673|76147309|FG000|COMPLETED|Treatment Period 4||4||
60031599|NCT01622673|76147310|FG001|COMPLETED|Treatment Period 4||3||
60031600|NCT01622673|76147311|FG002|COMPLETED|Treatment Period 4||4||
60031601|NCT01622673|76147312|FG003|COMPLETED|Treatment Period 4||4||
60031602|NCT01622673|76147313|FG004|COMPLETED|Treatment Period 4||4||
60031603|NCT01622673|76147314|FG005|COMPLETED|Treatment Period 4||4||
60031604|NCT01622673|76147309|FG000|NOT COMPLETED|Treatment Period 4||0||
60031605|NCT01622673|76147310|FG001|NOT COMPLETED|Treatment Period 4||0||
60031606|NCT01622673|76147311|FG002|NOT COMPLETED|Treatment Period 4||0||
60031607|NCT01622673|76147312|FG003|NOT COMPLETED|Treatment Period 4||0||
60031608|NCT01622673|76147313|FG004|NOT COMPLETED|Treatment Period 4||0||
60031609|NCT01622673|76147314|FG005|NOT COMPLETED|Treatment Period 4||0||
60031610|NCT01622673|76147309|FG000|STARTED|Treatment Period 5||4||
60031611|NCT01622673|76147310|FG001|STARTED|Treatment Period 5||3||
60031612|NCT01622673|76147311|FG002|STARTED|Treatment Period 5||4||
60031613|NCT01622673|76147312|FG003|STARTED|Treatment Period 5||4||
60031614|NCT01622673|76147313|FG004|STARTED|Treatment Period 5||4||
60031615|NCT01622673|76147314|FG005|STARTED|Treatment Period 5||4||
60031616|NCT01622673|76147309|FG000|COMPLETED|Treatment Period 5||4||
60031617|NCT01622673|76147310|FG001|COMPLETED|Treatment Period 5||3||
60031618|NCT01622673|76147311|FG002|COMPLETED|Treatment Period 5||4||
60031619|NCT01622673|76147312|FG003|COMPLETED|Treatment Period 5||4||
60031620|NCT01622673|76147313|FG004|COMPLETED|Treatment Period 5||4||
60031621|NCT01622673|76147314|FG005|COMPLETED|Treatment Period 5||4||
60031622|NCT01622673|76147309|FG000|NOT COMPLETED|Treatment Period 5||0||
60031623|NCT01622673|76147310|FG001|NOT COMPLETED|Treatment Period 5||0||
60031624|NCT01622673|76147311|FG002|NOT COMPLETED|Treatment Period 5||0||
60031625|NCT01622673|76147312|FG003|NOT COMPLETED|Treatment Period 5||0||
60031626|NCT01622673|76147313|FG004|NOT COMPLETED|Treatment Period 5||0||
60031627|NCT01622673|76147314|FG005|NOT COMPLETED|Treatment Period 5||0||
60031628|NCT01855048|76147339|FG000|STARTED|Overall Study||9||
60031629|NCT01855048|76147340|FG001|STARTED|Overall Study||3||
60031630|NCT01855048|76147341|FG002|STARTED|Overall Study||6||
60031631|NCT01855048|76147342|FG003|STARTED|Overall Study||6||
60031632|NCT01855048|76147343|FG004|STARTED|Overall Study||6||
60031633|NCT01855048|76147344|FG005|STARTED|Overall Study||6||
60031634|NCT01855048|76147339|FG000|COMPLETED|Overall Study||9||
60031635|NCT01855048|76147340|FG001|COMPLETED|Overall Study||2||
60031636|NCT01855048|76147341|FG002|COMPLETED|Overall Study||6||
59611936|NCT01753518|75722948|FG001|STARTED|Intention-to-Treat Analysis||110||
59611937|NCT01753518|75722947|FG000|COMPLETED|Intention-to-Treat Analysis||103||
59611938|NCT01753518|75722948|FG001|COMPLETED|Intention-to-Treat Analysis||103||
59611939|NCT01753518|75722947|FG000|NOT COMPLETED|Intention-to-Treat Analysis||7||
59611940|NCT01753518|75722948|FG001|NOT COMPLETED|Intention-to-Treat Analysis||7||
59611941|NCT01753518|75722947|FG000|STARTED|Postpartum Follow-up||103||
59611942|NCT01753518|75722948|FG001|STARTED|Postpartum Follow-up||103||
59611943|NCT01753518|75722947|FG000|COMPLETED|Postpartum Follow-up||81||
59611944|NCT01753518|75722948|FG001|COMPLETED|Postpartum Follow-up||88||
59611945|NCT01753518|75722947|FG000|NOT COMPLETED|Postpartum Follow-up||22||
59611946|NCT01753518|75722948|FG001|NOT COMPLETED|Postpartum Follow-up||15||
59611947|NCT01706250|75722954|FG000|STARTED|Overall Study||20||
59611948|NCT01706250|75722954|FG000|COMPLETED|Overall Study||18||
59611949|NCT01706250|75722954|FG000|NOT COMPLETED|Overall Study||2||
59611950|NCT01729728|75722966|FG000|STARTED|Overall Study||21||
59611951|NCT01729728|75722967|FG001|STARTED|Overall Study||28||
59611952|NCT01729728|75722968|FG002|STARTED|Overall Study||17||
59611953|NCT01729728|75722966|FG000|COMPLETED|Overall Study||20||
59611954|NCT01729728|75722967|FG001|COMPLETED|Overall Study||22||
59611955|NCT01729728|75722968|FG002|COMPLETED|Overall Study||16||
59611956|NCT01729728|75722966|FG000|NOT COMPLETED|Overall Study||1||
59611957|NCT01729728|75722967|FG001|NOT COMPLETED|Overall Study||6||
59611958|NCT01729728|75722968|FG002|NOT COMPLETED|Overall Study||1||
59611959|NCT01729026|75723101|FG000|STARTED|Randomization to 3-month Follow-up||9||
59611960|NCT01729026|75723102|FG001|STARTED|Randomization to 3-month Follow-up||10||
59611961|NCT01729026|75723101|FG000|COMPLETED|Randomization to 3-month Follow-up||7||
59611962|NCT01729026|75723102|FG001|COMPLETED|Randomization to 3-month Follow-up||8||
59611963|NCT01729026|75723101|FG000|NOT COMPLETED|Randomization to 3-month Follow-up||2||
59611964|NCT01729026|75723102|FG001|NOT COMPLETED|Randomization to 3-month Follow-up||2||
59611965|NCT01729026|75723101|FG000|STARTED|3-month to 6-month (Final) Follow-up||7||
59611966|NCT01729026|75723102|FG001|STARTED|3-month to 6-month (Final) Follow-up||8||
59611967|NCT01729026|75723101|FG000|COMPLETED|3-month to 6-month (Final) Follow-up||6||
60031637|NCT01855048|76147342|FG003|COMPLETED|Overall Study||6||
60031638|NCT01855048|76147343|FG004|COMPLETED|Overall Study||5||
60031639|NCT01855048|76147344|FG005|COMPLETED|Overall Study||6||
60031640|NCT01855048|76147339|FG000|NOT COMPLETED|Overall Study||0||
60031641|NCT01855048|76147340|FG001|NOT COMPLETED|Overall Study||1||
60031642|NCT01855048|76147341|FG002|NOT COMPLETED|Overall Study||0||
60031643|NCT01855048|76147342|FG003|NOT COMPLETED|Overall Study||0||
60031644|NCT01855048|76147343|FG004|NOT COMPLETED|Overall Study||1||
60031645|NCT01855048|76147344|FG005|NOT COMPLETED|Overall Study||0||
60031646|NCT02469857|76147370|FG000|STARTED|Overall Study||143|As Treated (Safety) Analysis Set|
60031647|NCT02469857|76147371|FG001|STARTED|Overall Study||147|As Treated (Safety) Analysis Set|
60031648|NCT02469857|76147370|FG000|COMPLETED|Overall Study||118|As Treated (Safety) Analysis Set|
60031649|NCT02469857|76147371|FG001|COMPLETED|Overall Study||115|As Treated (Safety) Analysis Set|
60031650|NCT02469857|76147370|FG000|NOT COMPLETED|Overall Study||25||
60031651|NCT02469857|76147371|FG001|NOT COMPLETED|Overall Study||32||
60031652|NCT02036853|76147381|FG000|STARTED|Overall Study||6||
60031653|NCT02036853|76147382|FG001|STARTED|Overall Study||14||
60031654|NCT02036853|76147381|FG000|COMPLETED|Overall Study||6||
60031655|NCT02036853|76147382|FG001|COMPLETED|Overall Study||8||
59611968|NCT01729026|75723102|FG001|COMPLETED|3-month to 6-month (Final) Follow-up||6||
59611969|NCT01729026|75723101|FG000|NOT COMPLETED|3-month to 6-month (Final) Follow-up||1||
59611970|NCT01729026|75723102|FG001|NOT COMPLETED|3-month to 6-month (Final) Follow-up||2||
59611971|NCT01728792|75723116|FG000|STARTED|Overall Study||14||
59611972|NCT01728792|75723117|FG001|STARTED|Overall Study||16||
59611973|NCT01728792|75723118|FG002|STARTED|Overall Study||17||
59611974|NCT01728792|75723119|FG003|STARTED|Overall Study||17||
59611975|NCT01728792|75723120|FG004|STARTED|Overall Study||16||
59611976|NCT01728792|75723116|FG000|COMPLETED|Overall Study||11||
59611977|NCT01728792|75723117|FG001|COMPLETED|Overall Study||14||
59611978|NCT01728792|75723118|FG002|COMPLETED|Overall Study||13||
59611979|NCT01728792|75723119|FG003|COMPLETED|Overall Study||14||
59611980|NCT01728792|75723120|FG004|COMPLETED|Overall Study||16||
59611981|NCT01728792|75723116|FG000|NOT COMPLETED|Overall Study||3||
60031656|NCT02036853|76147381|FG000|NOT COMPLETED|Overall Study||0||
60031657|NCT02036853|76147382|FG001|NOT COMPLETED|Overall Study||6||
60031658|NCT02469623|76147388|FG000|STARTED|Overall Study||85||
60031659|NCT02469623|76147388|FG000|COMPLETED|Overall Study||72||
60031660|NCT02469623|76147388|FG000|NOT COMPLETED|Overall Study||13||
60031661|NCT02469077|76147395|FG000|STARTED|Pre Randomization - Pre Intervention||44|Order of preexercise intervention placebo/morphine/naloxone randomizedeach subject|
60031662|NCT02469077|76147396|FG001|STARTED|Pre Randomization - Pre Intervention||49|Order of preexercise intervention placebo/morphine/naloxone randomizedeach subject|
60031663|NCT02469077|76147395|FG000|Pre Intervention Placebo|Pre Randomization - Pre Intervention||44||
60031664|NCT02469077|76147396|FG001|Pre Intervention Placebo|Pre Randomization - Pre Intervention||49||
60031665|NCT02469077|76147395|FG000|Pre Intervention Morpine|Pre Randomization - Pre Intervention||44||
60031666|NCT02469077|76147396|FG001|Pre Intervention Morpine|Pre Randomization - Pre Intervention||49||
60031667|NCT02469077|76147395|FG000|Pre Intervention Naloxone|Pre Randomization - Pre Intervention||44||
60031668|NCT02469077|76147396|FG001|Pre Intervention Naloxone|Pre Randomization - Pre Intervention||49||
60031669|NCT02469077|76147395|FG000|COMPLETED|Pre Randomization - Pre Intervention||44||
60031670|NCT02469077|76147396|FG001|COMPLETED|Pre Randomization - Pre Intervention||49||
60031671|NCT02469077|76147395|FG000|NOT COMPLETED|Pre Randomization - Pre Intervention||0||
60031672|NCT02469077|76147396|FG001|NOT COMPLETED|Pre Randomization - Pre Intervention||0||
60031673|NCT02469077|76147395|FG000|STARTED|Post Randomization/Intervention Period||44||
60031674|NCT02469077|76147396|FG001|STARTED|Post Randomization/Intervention Period||49||
60031675|NCT02469077|76147395|FG000|COMPLETED|Post Randomization/Intervention Period||40||
60031676|NCT02469077|76147396|FG001|COMPLETED|Post Randomization/Intervention Period||45||
60031677|NCT02469077|76147395|FG000|NOT COMPLETED|Post Randomization/Intervention Period||4||
60031678|NCT02469077|76147396|FG001|NOT COMPLETED|Post Randomization/Intervention Period||4||
60031679|NCT02469077|76147395|FG000|STARTED|Post Intervention /Followup||40|Order ofpostexercise intervention assessmentwith placebo/morphine/naloxone randomized foreachsubject|
60031680|NCT02469077|76147396|FG001|STARTED|Post Intervention /Followup||45|Order ofpostexercise intervention assessmentwith placebo/morphine/naloxone randomized foreachsubject|
60031681|NCT02469077|76147395|FG000|Post Intervention Placebo|Post Intervention /Followup||39||
60031682|NCT02469077|76147396|FG001|Post Intervention Placebo|Post Intervention /Followup||45||
60031683|NCT02469077|76147395|FG000|Post Intervention Morphine|Post Intervention /Followup||40||
60031684|NCT02469077|76147396|FG001|Post Intervention Morphine|Post Intervention /Followup||45||
60031685|NCT02469077|76147395|FG000|Post Intervention Naloxone|Post Intervention /Followup||39||
60031686|NCT02469077|76147396|FG001|Post Intervention Naloxone|Post Intervention /Followup||44||
60031687|NCT02469077|76147395|FG000|COMPLETED|Post Intervention /Followup||38||
60031688|NCT02469077|76147396|FG001|COMPLETED|Post Intervention /Followup||44||
60031689|NCT02469077|76147395|FG000|NOT COMPLETED|Post Intervention /Followup||2||
60031690|NCT02469077|76147396|FG001|NOT COMPLETED|Post Intervention /Followup||1||
60031691|NCT02486627|76147408|FG000|STARTED|Overall Study||306||
60031692|NCT02486627|76147409|FG001|STARTED|Overall Study||303||
60031693|NCT02486627|76147408|FG000|COMPLETED|Overall Study||299||
60031694|NCT02486627|76147409|FG001|COMPLETED|Overall Study||294||
60031695|NCT02486627|76147408|FG000|NOT COMPLETED|Overall Study||7||
60031696|NCT02486627|76147409|FG001|NOT COMPLETED|Overall Study||9||
60031697|NCT01644565|76147415|FG000|STARTED|Overall Study||5||
60031698|NCT01644565|76147416|FG001|STARTED|Overall Study||5||
60031699|NCT01644565|76147417|FG002|STARTED|Overall Study||5||
60031700|NCT01644565|76147418|FG003|STARTED|Overall Study||5||
60031701|NCT01644565|76147419|FG004|STARTED|Overall Study||5||
60031702|NCT01644565|76147420|FG005|STARTED|Overall Study||7||
60031703|NCT01644565|76147421|FG006|STARTED|Overall Study||7||
60031704|NCT01644565|76147422|FG007|STARTED|Overall Study||10||
60031705|NCT01644565|76147423|FG008|STARTED|Overall Study||8||
60031706|NCT01644565|76147415|FG000|COMPLETED|Overall Study||4||
60031707|NCT01644565|76147416|FG001|COMPLETED|Overall Study||5||
60031708|NCT01644565|76147417|FG002|COMPLETED|Overall Study||5||
60031709|NCT01644565|76147418|FG003|COMPLETED|Overall Study||4||
60031710|NCT01644565|76147419|FG004|COMPLETED|Overall Study||4||
60031711|NCT01644565|76147420|FG005|COMPLETED|Overall Study||7||
60031712|NCT01644565|76147421|FG006|COMPLETED|Overall Study||7||
60031713|NCT01644565|76147422|FG007|COMPLETED|Overall Study||8||
60031714|NCT01644565|76147423|FG008|COMPLETED|Overall Study||7||
60031715|NCT01644565|76147415|FG000|NOT COMPLETED|Overall Study||1||
60031716|NCT01644565|76147416|FG001|NOT COMPLETED|Overall Study||0||
60031717|NCT01644565|76147417|FG002|NOT COMPLETED|Overall Study||0||
60031718|NCT01644565|76147418|FG003|NOT COMPLETED|Overall Study||1||
60031719|NCT01644565|76147419|FG004|NOT COMPLETED|Overall Study||1||
60031720|NCT01644565|76147420|FG005|NOT COMPLETED|Overall Study||0||
60031721|NCT01644565|76147421|FG006|NOT COMPLETED|Overall Study||0||
60031722|NCT01644565|76147422|FG007|NOT COMPLETED|Overall Study||2||
60031723|NCT01644565|76147423|FG008|NOT COMPLETED|Overall Study||1||
60031724|NCT02485925|76147443|FG000|STARTED|Overall Study||200|Patients who signed informed consent forms|
60031725|NCT02485925|76147443|FG000|Safety Population|Overall Study||200|All enrolled subjects who underwent insertion of the study catheter|
60031726|NCT02485925|76147443|FG000|Intent to Treat (ITT) Population|Overall Study||193|All enrolled subjects who met the inclusion/exclusion criteria and signed informed consent form|
60031727|NCT02485925|76147443|FG000|Per-Protocol Population|Overall Study||166|ITT subjects with 12 month primary efficacy data and insertion of the study catheter and ablation|
60031728|NCT02485925|76147443|FG000|COMPLETED|Overall Study||185||
60031729|NCT02485925|76147443|FG000|NOT COMPLETED|Overall Study||15||
60031730|NCT02282293|76147449|FG000|STARTED|Overall Study||100||
60031731|NCT02282293|76147450|FG001|STARTED|Overall Study||100||
60031732|NCT02282293|76147449|FG000|COMPLETED|Overall Study||97||
60031733|NCT02282293|76147450|FG001|COMPLETED|Overall Study||97||
60031734|NCT02282293|76147449|FG000|NOT COMPLETED|Overall Study||3||
60031735|NCT02282293|76147450|FG001|NOT COMPLETED|Overall Study||3||
59507885|NCT02153983|75601050|FG005|NOT COMPLETED|Overall Study||0||
60031736|NCT01854658|76147460|FG000|STARTED|Overall Study||439||
60031737|NCT01854658|76147461|FG001|STARTED|Overall Study||440||
60031738|NCT01854658|76147462|FG002|STARTED|Overall Study||512||
60031739|NCT01854658|76147463|FG003|STARTED|Overall Study||224||
59916566|NCT03613649|76037265|FG004|Received Treatment|Fourth Treatment||4||
59916567|NCT03613649|76037266|FG005|Received Treatment|Fourth Treatment||6||
59916568|NCT03613649|76037267|FG006|Received Treatment|Fourth Treatment||4||
59759260|NCT00561925|75878607|FG001|COMPLETED|144-week Double-blind, Double-dummy||358||
59916569|NCT03613649|76037268|FG007|Received Treatment|Fourth Treatment||6||
59916570|NCT03613649|76037269|FG008|Received Treatment|Fourth Treatment||6||
59916571|NCT03613649|76037270|FG009|Received Treatment|Fourth Treatment||6||
59916572|NCT03613649|76037271|FG010|Received Treatment|Fourth Treatment||6||
59916573|NCT03613649|76037272|FG011|Received Treatment|Fourth Treatment||4||
59916574|NCT03613649|76037261|FG000|COMPLETED|Fourth Treatment||5||
59916575|NCT03613649|76037262|FG001|COMPLETED|Fourth Treatment||6||
59916576|NCT03613649|76037263|FG002|COMPLETED|Fourth Treatment||5||
59916577|NCT03613649|76037264|FG003|COMPLETED|Fourth Treatment||6||
59916578|NCT03613649|76037265|FG004|COMPLETED|Fourth Treatment||3||
59916579|NCT03613649|76037266|FG005|COMPLETED|Fourth Treatment||6||
59916580|NCT03613649|76037267|FG006|COMPLETED|Fourth Treatment||4||
59916581|NCT03613649|76037268|FG007|COMPLETED|Fourth Treatment||6||
59916582|NCT03613649|76037269|FG008|COMPLETED|Fourth Treatment||6||
59916583|NCT03613649|76037270|FG009|COMPLETED|Fourth Treatment||6||
59916584|NCT03613649|76037271|FG010|COMPLETED|Fourth Treatment||6||
59916585|NCT03613649|76037272|FG011|COMPLETED|Fourth Treatment||4||
59916586|NCT03613649|76037261|FG000|NOT COMPLETED|Fourth Treatment||1||
59916587|NCT03613649|76037262|FG001|NOT COMPLETED|Fourth Treatment||0||
59916588|NCT03613649|76037263|FG002|NOT COMPLETED|Fourth Treatment||0||
59916589|NCT03613649|76037264|FG003|NOT COMPLETED|Fourth Treatment||0||
59916590|NCT03613649|76037265|FG004|NOT COMPLETED|Fourth Treatment||1||
59916591|NCT03613649|76037266|FG005|NOT COMPLETED|Fourth Treatment||0||
59916592|NCT03613649|76037267|FG006|NOT COMPLETED|Fourth Treatment||1||
59916593|NCT03613649|76037268|FG007|NOT COMPLETED|Fourth Treatment||0||
59916594|NCT03613649|76037269|FG008|NOT COMPLETED|Fourth Treatment||0||
59916595|NCT03613649|76037270|FG009|NOT COMPLETED|Fourth Treatment||0||
59916596|NCT03613649|76037271|FG010|NOT COMPLETED|Fourth Treatment||0||
59916597|NCT03613649|76037272|FG011|NOT COMPLETED|Fourth Treatment||0||
59916598|NCT03096288|76037294|FG000|STARTED|Overall Study||19||
59916599|NCT03096288|76037295|FG001|STARTED|Overall Study||18||
59916600|NCT03096288|76037296|FG002|STARTED|Overall Study||22||
59916601|NCT03096288|76037297|FG003|STARTED|Overall Study||25||
59916602|NCT03096288|76037294|FG000|COMPLETED|Overall Study||19||
59916603|NCT03096288|76037295|FG001|COMPLETED|Overall Study||17||
59916604|NCT03096288|76037296|FG002|COMPLETED|Overall Study||22||
59916605|NCT03096288|76037297|FG003|COMPLETED|Overall Study||24||
59916606|NCT03096288|76037294|FG000|NOT COMPLETED|Overall Study||0||
59916607|NCT03096288|76037295|FG001|NOT COMPLETED|Overall Study||1||
59916608|NCT03096288|76037296|FG002|NOT COMPLETED|Overall Study||0||
59916609|NCT03096288|76037297|FG003|NOT COMPLETED|Overall Study||1||
59916610|NCT03611075|76037316|FG000|STARTED|Overall Study||16||
59916611|NCT03611075|76037317|FG001|STARTED|Overall Study||15||
59916612|NCT03611075|76037318|FG002|STARTED|Overall Study||16||
59916613|NCT03611075|76037319|FG003|STARTED|Overall Study||17||
59916614|NCT03611075|76037320|FG004|STARTED|Overall Study||13||
59916615|NCT03611075|76037321|FG005|STARTED|Overall Study||18||
59916616|NCT03611075|76037322|FG006|STARTED|Overall Study||15||
59916617|NCT03611075|76037323|FG007|STARTED|Overall Study||17||
59916618|NCT03611075|76037324|FG008|STARTED|Overall Study||17||
59916619|NCT03611075|76037316|FG000|COMPLETED|Overall Study||15||
59916620|NCT03611075|76037317|FG001|COMPLETED|Overall Study||13||
59916621|NCT03611075|76037318|FG002|COMPLETED|Overall Study||14||
59916622|NCT03611075|76037319|FG003|COMPLETED|Overall Study||13||
59916623|NCT03611075|76037320|FG004|COMPLETED|Overall Study||13||
59916624|NCT03611075|76037321|FG005|COMPLETED|Overall Study||18||
59916625|NCT03611075|76037322|FG006|COMPLETED|Overall Study||13||
59916626|NCT03611075|76037323|FG007|COMPLETED|Overall Study||17||
59916627|NCT03611075|76037324|FG008|COMPLETED|Overall Study||17||
59916628|NCT03611075|76037316|FG000|NOT COMPLETED|Overall Study||1||
59916629|NCT03611075|76037317|FG001|NOT COMPLETED|Overall Study||2||
59916630|NCT03611075|76037318|FG002|NOT COMPLETED|Overall Study||2||
59916631|NCT03611075|76037319|FG003|NOT COMPLETED|Overall Study||4||
59916632|NCT03611075|76037320|FG004|NOT COMPLETED|Overall Study||0||
59916633|NCT03611075|76037321|FG005|NOT COMPLETED|Overall Study||0||
59916634|NCT03611075|76037322|FG006|NOT COMPLETED|Overall Study||2||
59916635|NCT03611075|76037323|FG007|NOT COMPLETED|Overall Study||0||
59916636|NCT03611075|76037324|FG008|NOT COMPLETED|Overall Study||0||
60031740|NCT01854658|76147460|FG000|COMPLETED|Overall Study||346||
60031741|NCT01854658|76147461|FG001|COMPLETED|Overall Study||365||
60031742|NCT01854658|76147462|FG002|COMPLETED|Overall Study||432||
60031743|NCT01854658|76147463|FG003|COMPLETED|Overall Study||165||
60031744|NCT01854658|76147460|FG000|NOT COMPLETED|Overall Study||93||
60031745|NCT01854658|76147461|FG001|NOT COMPLETED|Overall Study||75||
60031746|NCT01854658|76147462|FG002|NOT COMPLETED|Overall Study||80||
60031747|NCT01854658|76147463|FG003|NOT COMPLETED|Overall Study||59||
60031748|NCT01892020|76147473|FG000|STARTED|Period 1||81||
60031749|NCT01892020|76147474|FG001|STARTED|Period 1||80||
60031750|NCT01892020|76147473|FG000|COMPLETED|Period 1||78||
60031751|NCT01892020|76147474|FG001|COMPLETED|Period 1||74||
60031752|NCT01892020|76147473|FG000|NOT COMPLETED|Period 1||3||
60031753|NCT01892020|76147474|FG001|NOT COMPLETED|Period 1||6||
60031754|NCT01892020|76147473|FG000|STARTED|Period 2||78||
60031755|NCT01892020|76147474|FG001|STARTED|Period 2||74||
60031756|NCT01892020|76147473|FG000|COMPLETED|Period 2||77||
60031757|NCT01892020|76147474|FG001|COMPLETED|Period 2||74||
60031758|NCT01892020|76147473|FG000|NOT COMPLETED|Period 2||1||
60031759|NCT01892020|76147474|FG001|NOT COMPLETED|Period 2||0||
60031760|NCT02485691|76147482|FG000|STARTED|Overall Study||129||
60031761|NCT02485691|76147483|FG001|STARTED|Overall Study||126||
60031762|NCT02485691|76147482|FG000|Treated|Overall Study||126||
60031763|NCT02485691|76147483|FG001|Treated|Overall Study||124||
60031764|NCT02485691|76147482|FG000|COMPLETED|Overall Study||0||
60031765|NCT02485691|76147483|FG001|COMPLETED|Overall Study||0||
60031766|NCT02485691|76147482|FG000|NOT COMPLETED|Overall Study||129||
60031767|NCT02485691|76147483|FG001|NOT COMPLETED|Overall Study||126||
60031768|NCT02517515|76147492|FG000|STARTED|Overall Study||325||
60031769|NCT02517515|76147493|FG001|STARTED|Overall Study||325||
60031770|NCT02517515|76147492|FG000|COMPLETED|Overall Study||323||
60031771|NCT02517515|76147493|FG001|COMPLETED|Overall Study||323||
60031772|NCT02517515|76147492|FG000|NOT COMPLETED|Overall Study||2||
60031773|NCT02517515|76147493|FG001|NOT COMPLETED|Overall Study||2||
60031774|NCT02466659|76147502|FG000|STARTED|Overall Study||5||
60031775|NCT02466659|76147503|FG001|STARTED|Overall Study||3||
60031776|NCT02466659|76147502|FG000|COMPLETED|Overall Study||0||
60031777|NCT02466659|76147503|FG001|COMPLETED|Overall Study||1||
60031778|NCT02466659|76147502|FG000|NOT COMPLETED|Overall Study||5||
60031779|NCT02466659|76147503|FG001|NOT COMPLETED|Overall Study||2||
60031780|NCT01891864|76147511|FG000|STARTED|Treatment Period 1||264||
60031781|NCT01891864|76147512|FG001|STARTED|Treatment Period 1||267||
60031782|NCT01891864|76147513|FG002|STARTED|Treatment Period 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0||
60031783|NCT01891864|76147514|FG003|STARTED|Treatment Period 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0||
60031784|NCT01891864|76147515|FG004|STARTED|Treatment Period 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0||
60031785|NCT01891864|76147516|FG005|STARTED|Treatment Period 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0||
60031786|NCT01891864|76147511|FG000|COMPLETED|Treatment Period 1|6 patients discontinued after completion of Treatment Period 1 and did NOT start Treatment Period 2|256||
60031787|NCT01891864|76147512|FG001|COMPLETED|Treatment Period 1|8 patients discontinued after completion of Treatment Period 1 and did NOT start Treatment Period 2|255||
60031788|NCT01891864|76147513|FG002|COMPLETED|Treatment Period 1||0||
60031789|NCT01891864|76147514|FG003|COMPLETED|Treatment Period 1||0||
60031790|NCT01891864|76147515|FG004|COMPLETED|Treatment Period 1||0||
60031791|NCT01891864|76147516|FG005|COMPLETED|Treatment Period 1||0||
60031792|NCT01891864|76147511|FG000|NOT COMPLETED|Treatment Period 1||8||
60031793|NCT01891864|76147512|FG001|NOT COMPLETED|Treatment Period 1||12||
60031794|NCT01891864|76147513|FG002|NOT COMPLETED|Treatment Period 1||0||
60031795|NCT01891864|76147514|FG003|NOT COMPLETED|Treatment Period 1||0||
60031796|NCT01891864|76147515|FG004|NOT COMPLETED|Treatment Period 1||0||
60031797|NCT01891864|76147516|FG005|NOT COMPLETED|Treatment Period 1||0||
60031798|NCT01891864|76147511|FG000|STARTED|Treatment Period 2|Treatment arm applicable for Treatment Period 1 only (patients re-randomized in Treatment Period 2)|0||
60031799|NCT01891864|76147512|FG001|STARTED|Treatment Period 2|Treatment arm applicable for Treatment Period 1 only (patients re-randomized in Treatment Period 2)|0||
60031800|NCT01891864|76147513|FG002|STARTED|Treatment Period 2|"Part of the patients re-randomized from GP2015 Etanercept treatment arm in Treatment Period 1"|150||
60031801|NCT01891864|76147514|FG003|STARTED|Treatment Period 2|"Part of the patients re-randomized from Enbrel ® Etanercept treatment arm in Treatment Period 1"|151||
60031802|NCT01891864|76147515|FG004|STARTED|Treatment Period 2|"Part of the patients re-randomized from GP2015 Etanercept treatment arm in Treatment Period 1"|100||
60031803|NCT01891864|76147516|FG005|STARTED|Treatment Period 2|"Part of the patients re-randomized from Enbrel ® Etanercept treatment arm in Treatment Period 1"|96||
60031804|NCT01891864|76147511|FG000|COMPLETED|Treatment Period 2||0||
60031805|NCT01891864|76147512|FG001|COMPLETED|Treatment Period 2||0||
60031806|NCT01891864|76147513|FG002|COMPLETED|Treatment Period 2||143||
60031807|NCT01891864|76147514|FG003|COMPLETED|Treatment Period 2||142||
60031808|NCT01891864|76147515|FG004|COMPLETED|Treatment Period 2||96||
60031809|NCT01891864|76147516|FG005|COMPLETED|Treatment Period 2||91||
60031810|NCT01891864|76147511|FG000|NOT COMPLETED|Treatment Period 2||0||
60031811|NCT01891864|76147512|FG001|NOT COMPLETED|Treatment Period 2||0||
60031812|NCT01891864|76147513|FG002|NOT COMPLETED|Treatment Period 2||7||
60031813|NCT01891864|76147514|FG003|NOT COMPLETED|Treatment Period 2||9||
60031814|NCT01891864|76147515|FG004|NOT COMPLETED|Treatment Period 2||4||
60031815|NCT01891864|76147516|FG005|NOT COMPLETED|Treatment Period 2||5||
60031816|NCT01891864|76147511|FG000|STARTED|Extension Period||0||
60031817|NCT01891864|76147512|FG001|STARTED|Extension Period||0||
60031818|NCT01891864|76147513|FG002|STARTED|Extension Period|2 patients withdrew consent 1 patient lost to FU between Treatment Period 2 and the Extension period|140||
60031819|NCT01891864|76147514|FG003|STARTED|Extension Period||142||
60031820|NCT01891864|76147515|FG004|STARTED|Extension Period|1 patient discontinued between Treatment Period 2 and Extension Period due to lack of efficacy|95||
60031821|NCT01891864|76147516|FG005|STARTED|Extension Period|1 patient discontinued between Treatment Period 2 and Extension Period due to an adverse event|90||
60031822|NCT01891864|76147511|FG000|COMPLETED|Extension Period||0||
60031823|NCT01891864|76147512|FG001|COMPLETED|Extension Period||0||
60031824|NCT01891864|76147513|FG002|COMPLETED|Extension Period||132||
60031825|NCT01891864|76147514|FG003|COMPLETED|Extension Period||137||
60031826|NCT01891864|76147515|FG004|COMPLETED|Extension Period||88||
60031827|NCT01891864|76147516|FG005|COMPLETED|Extension Period||90||
60031828|NCT01891864|76147511|FG000|NOT COMPLETED|Extension Period||0||
60031829|NCT01891864|76147512|FG001|NOT COMPLETED|Extension Period||0||
60031830|NCT01891864|76147513|FG002|NOT COMPLETED|Extension Period||8||
60031831|NCT01891864|76147514|FG003|NOT COMPLETED|Extension Period||5||
60031832|NCT01891864|76147515|FG004|NOT COMPLETED|Extension Period||7||
60031833|NCT01891864|76147516|FG005|NOT COMPLETED|Extension Period||0||
60031834|NCT02485301|76147530|FG000|STARTED|Overall Study||1509|Out of 3024 subjects originally enrolled, only 3013 subjects received vaccination.|
60031835|NCT02485301|76147531|FG001|STARTED|Overall Study||1504|Out of 3024 subjects originally enrolled, only 3013 subjects received vaccination.|
60031836|NCT02485301|76147530|FG000|COMPLETED|Overall Study||1471||
60031837|NCT02485301|76147531|FG001|COMPLETED|Overall Study||1455||
60031838|NCT02485301|76147530|FG000|NOT COMPLETED|Overall Study||38||
60031839|NCT02485301|76147531|FG001|NOT COMPLETED|Overall Study||49||
60031840|NCT02484911|76147539|FG000|STARTED|Overall Study||60||
60031841|NCT02484911|76147540|FG001|STARTED|Overall Study||60||
60031842|NCT02484911|76147539|FG000|COMPLETED|Overall Study||56||
60031843|NCT02484911|76147540|FG001|COMPLETED|Overall Study||58||
60031844|NCT02484911|76147539|FG000|NOT COMPLETED|Overall Study||4||
60031845|NCT02484911|76147540|FG001|NOT COMPLETED|Overall Study||2||
60031846|NCT02466425|76147549|FG000|STARTED|Overall Study||132||
60031847|NCT02466425|76147550|FG001|STARTED|Overall Study||132||
60031848|NCT02466425|76147549|FG000|Treated|Overall Study||131||
60031849|NCT02466425|76147550|FG001|Treated|Overall Study||132||
60031850|NCT02466425|76147549|FG000|COMPLETED|Overall Study||118||
60031851|NCT02466425|76147550|FG001|COMPLETED|Overall Study||116||
60031852|NCT02466425|76147549|FG000|NOT COMPLETED|Overall Study||14||
60031853|NCT02466425|76147550|FG001|NOT COMPLETED|Overall Study||16||
60031854|NCT02451917|76147558|FG000|STARTED|First Intervention (24 Weeks)||16||
60031855|NCT02451917|76147559|FG001|STARTED|First Intervention (24 Weeks)||18||
60031856|NCT02451917|76147558|FG000|COMPLETED|First Intervention (24 Weeks)||14||
60031857|NCT02451917|76147559|FG001|COMPLETED|First Intervention (24 Weeks)||15||
60031858|NCT02451917|76147558|FG000|NOT COMPLETED|First Intervention (24 Weeks)||2||
60031859|NCT02451917|76147559|FG001|NOT COMPLETED|First Intervention (24 Weeks)||3||
60031860|NCT02451917|76147558|FG000|STARTED|Second Intervention (24 Weeks)||14||
60031861|NCT02451917|76147559|FG001|STARTED|Second Intervention (24 Weeks)||15||
60031862|NCT02451917|76147558|FG000|COMPLETED|Second Intervention (24 Weeks)||14||
60031863|NCT02451917|76147559|FG001|COMPLETED|Second Intervention (24 Weeks)||15||
60031864|NCT02451917|76147558|FG000|NOT COMPLETED|Second Intervention (24 Weeks)||0||
60031865|NCT02451917|76147559|FG001|NOT COMPLETED|Second Intervention (24 Weeks)||0||
60031866|NCT02349451|76147572|FG000|STARTED|Overall Study||24||
60031867|NCT02349451|76147573|FG001|STARTED|Overall Study||72||
60031868|NCT02349451|76147574|FG002|STARTED|Overall Study||71||
60031869|NCT02349451|76147575|FG003|STARTED|Overall Study||73||
60031870|NCT02349451|76147572|FG000|COMPLETED|Overall Study||24||
60031871|NCT02349451|76147573|FG001|COMPLETED|Overall Study||71||
60031872|NCT02349451|76147574|FG002|COMPLETED|Overall Study||69||
60031873|NCT02349451|76147575|FG003|COMPLETED|Overall Study||72||
60031874|NCT02349451|76147572|FG000|NOT COMPLETED|Overall Study||0||
60031875|NCT02349451|76147573|FG001|NOT COMPLETED|Overall Study||1||
60031876|NCT02349451|76147574|FG002|NOT COMPLETED|Overall Study||2||
60031877|NCT02349451|76147575|FG003|NOT COMPLETED|Overall Study||1||
60031878|NCT02409368|76147592|FG000|STARTED|Original Classification||173||
60031879|NCT02409368|76147593|FG001|STARTED|Original Classification||534||
59916637|NCT03095508|76037369|FG000|STARTED|Overall Study||114||
59916638|NCT03095508|76037370|FG001|STARTED|Overall Study||115||
59916639|NCT03095508|76037369|FG000|Per Protocol Population|Overall Study||112||
59916640|NCT03095508|76037370|FG001|Per Protocol Population|Overall Study||111||
59916641|NCT03095508|76037369|FG000|Safety Population|Overall Study||114||
59916642|NCT03095508|76037370|FG001|Safety Population|Overall Study||115||
59916643|NCT03095508|76037369|FG000|ITT Population|Overall Study||114||
59916644|NCT03095508|76037370|FG001|ITT Population|Overall Study||115||
59916645|NCT03095508|76037369|FG000|COMPLETED|Overall Study||114||
59916646|NCT03095508|76037370|FG001|COMPLETED|Overall Study||114||
59916647|NCT03095508|76037369|FG000|NOT COMPLETED|Overall Study||0||
59916648|NCT03095508|76037370|FG001|NOT COMPLETED|Overall Study||1||
59916649|NCT03607487|76037380|FG000|STARTED|Overall Study||9||
59916650|NCT03607487|76037381|FG001|STARTED|Overall Study||9||
59916651|NCT03607487|76037382|FG002|STARTED|Overall Study||9||
59916652|NCT03607487|76037383|FG003|STARTED|Overall Study||8||
59916653|NCT03607487|76037380|FG000|COMPLETED|Overall Study||7||
59916654|NCT03607487|76037381|FG001|COMPLETED|Overall Study||9||
59916655|NCT03607487|76037382|FG002|COMPLETED|Overall Study||9||
59916656|NCT03607487|76037383|FG003|COMPLETED|Overall Study||7||
59916657|NCT03607487|76037380|FG000|NOT COMPLETED|Overall Study||2||
59916658|NCT03607487|76037381|FG001|NOT COMPLETED|Overall Study||0||
59916659|NCT03607487|76037382|FG002|NOT COMPLETED|Overall Study||0||
59916660|NCT03607487|76037383|FG003|NOT COMPLETED|Overall Study||1||
59916661|NCT03605693|76037397|FG000|STARTED|Overall Study||5||
59916662|NCT03605693|76037398|FG001|STARTED|Overall Study||5||
59916663|NCT03605693|76037397|FG000|COMPLETED|Overall Study||0||
59916664|NCT03605693|76037398|FG001|COMPLETED|Overall Study||5||
59916665|NCT03605693|76037397|FG000|NOT COMPLETED|Overall Study||5||
59916666|NCT03605693|76037398|FG001|NOT COMPLETED|Overall Study||0||
59916667|NCT03605303|76037404|FG000|STARTED|Period 1||2||
59916668|NCT03605303|76037405|FG001|STARTED|Period 1||1||
59916669|NCT03605303|76037404|FG000|COMPLETED|Period 1||0||
59916670|NCT03605303|76037405|FG001|COMPLETED|Period 1||0||
59916671|NCT03605303|76037404|FG000|NOT COMPLETED|Period 1||2||
59916672|NCT03605303|76037405|FG001|NOT COMPLETED|Period 1||1||
59916673|NCT03605303|76037404|FG000|STARTED|Period 2||0||
59916674|NCT03605303|76037405|FG001|STARTED|Period 2||0||
59916675|NCT03605303|76037404|FG000|COMPLETED|Period 2||0||
59916676|NCT03605303|76037405|FG001|COMPLETED|Period 2||0||
59916677|NCT03605303|76037404|FG000|NOT COMPLETED|Period 2||0||
59916678|NCT03605303|76037405|FG001|NOT COMPLETED|Period 2||0||
59916679|NCT03604523|76037413|FG000|STARTED|Overall Study||5||
59916680|NCT03604523|76037414|FG001|STARTED|Overall Study||5||
59916681|NCT03604523|76037413|FG000|COMPLETED|Overall Study||4||
59916682|NCT03604523|76037414|FG001|COMPLETED|Overall Study||5||
59916683|NCT03604523|76037413|FG000|NOT COMPLETED|Overall Study||1||
59916684|NCT03604523|76037414|FG001|NOT COMPLETED|Overall Study||0||
59916685|NCT03602339|76037420|FG000|STARTED|Overall Study||157|Started period 1 (Gadoterate)|
59916686|NCT03602339|76037420|FG000|Completed Period 1 (Gadoterate)|Overall Study||155||
59916687|NCT03602339|76037420|FG000|Started Period 2 (Gadobutrol)|Overall Study||142||
59916688|NCT03602339|76037420|FG000|COMPLETED|Overall Study||142|Completed period 2 (Gadobutrol)|
59916689|NCT03602339|76037420|FG000|NOT COMPLETED|Overall Study||15||
59916690|NCT03653429|76037429|FG000|STARTED|Overall Study||49||
59916691|NCT03653429|76037430|FG001|STARTED|Overall Study||51||
59916692|NCT03653429|76037429|FG000|COMPLETED|Overall Study||45||
59916693|NCT03653429|76037430|FG001|COMPLETED|Overall Study||41||
59916694|NCT03653429|76037429|FG000|NOT COMPLETED|Overall Study||4||
59916695|NCT03653429|76037430|FG001|NOT COMPLETED|Overall Study||10||
59916696|NCT03601715|76037439|FG000|STARTED|First Intervention||7||
59916697|NCT03601715|76037440|FG001|STARTED|First Intervention||7||
59916698|NCT03601715|76037441|FG002|STARTED|First Intervention||6||
59916699|NCT03601715|76037439|FG000|COMPLETED|First Intervention||7||
59916700|NCT03601715|76037440|FG001|COMPLETED|First Intervention||7||
59916701|NCT03601715|76037441|FG002|COMPLETED|First Intervention||6||
59916702|NCT03601715|76037439|FG000|NOT COMPLETED|First Intervention||0||
59916703|NCT03601715|76037440|FG001|NOT COMPLETED|First Intervention||0||
59916704|NCT03601715|76037441|FG002|NOT COMPLETED|First Intervention||0||
59916705|NCT03601715|76037439|FG000|STARTED|Washout 1 (at Least 24 Hours)||7||
59916706|NCT03601715|76037440|FG001|STARTED|Washout 1 (at Least 24 Hours)||7||
59916707|NCT03601715|76037441|FG002|STARTED|Washout 1 (at Least 24 Hours)||6||
59916708|NCT03601715|76037439|FG000|COMPLETED|Washout 1 (at Least 24 Hours)||7||
59916709|NCT03601715|76037440|FG001|COMPLETED|Washout 1 (at Least 24 Hours)||7||
59916710|NCT03601715|76037441|FG002|COMPLETED|Washout 1 (at Least 24 Hours)||6||
59916711|NCT03601715|76037439|FG000|NOT COMPLETED|Washout 1 (at Least 24 Hours)||0||
59916712|NCT03601715|76037440|FG001|NOT COMPLETED|Washout 1 (at Least 24 Hours)||0||
60031880|NCT02409368|76147594|FG002|STARTED|Original Classification||103||
60031881|NCT02409368|76147595|FG003|STARTED|Original Classification||1||
60031882|NCT02409368|76147592|FG000|COMPLETED|Original Classification||173||
60031883|NCT02409368|76147593|FG001|COMPLETED|Original Classification||534||
60031884|NCT02409368|76147594|FG002|COMPLETED|Original Classification||103||
60031885|NCT02409368|76147595|FG003|COMPLETED|Original Classification||1||
60031886|NCT02409368|76147592|FG000|NOT COMPLETED|Original Classification||0||
60031887|NCT02409368|76147593|FG001|NOT COMPLETED|Original Classification||0||
60031888|NCT02409368|76147594|FG002|NOT COMPLETED|Original Classification||0||
60031889|NCT02409368|76147595|FG003|NOT COMPLETED|Original Classification||0||
60031890|NCT02409368|76147592|FG000|STARTED|ECOG Reclassification||172||
60031891|NCT02409368|76147593|FG001|STARTED|ECOG Reclassification||537||
60031892|NCT02409368|76147594|FG002|STARTED|ECOG Reclassification||102||
60031893|NCT02409368|76147595|FG003|STARTED|ECOG Reclassification||1||
60031894|NCT02409368|76147592|FG000|COMPLETED|ECOG Reclassification||0||
60031895|NCT02409368|76147593|FG001|COMPLETED|ECOG Reclassification||0||
60031896|NCT02409368|76147594|FG002|COMPLETED|ECOG Reclassification||0||
60031897|NCT02409368|76147595|FG003|COMPLETED|ECOG Reclassification||0||
60031898|NCT02409368|76147592|FG000|NOT COMPLETED|ECOG Reclassification||172||
60031899|NCT02409368|76147593|FG001|NOT COMPLETED|ECOG Reclassification||537||
60031900|NCT02409368|76147594|FG002|NOT COMPLETED|ECOG Reclassification||102||
60031901|NCT02409368|76147595|FG003|NOT COMPLETED|ECOG Reclassification||1||
60031902|NCT01853878|76147608|FG000|STARTED|Overall Study||86||
60031903|NCT01853878|76147609|FG001|STARTED|Overall Study||47||
60031904|NCT01853878|76147608|FG000|COMPLETED|Overall Study||23||
60031905|NCT01853878|76147609|FG001|COMPLETED|Overall Study||3||
60031906|NCT01853878|76147608|FG000|NOT COMPLETED|Overall Study||63||
60031907|NCT01853878|76147609|FG001|NOT COMPLETED|Overall Study||44||
60031908|NCT02342678|76147617|FG000|STARTED|Overall Study||28||
60031909|NCT02342678|76147618|FG001|STARTED|Overall Study||28||
60031910|NCT02342678|76147617|FG000|COMPLETED|Overall Study||27||
60031911|NCT02342678|76147618|FG001|COMPLETED|Overall Study||23||
60031912|NCT02342678|76147617|FG000|NOT COMPLETED|Overall Study||1||
60031913|NCT02342678|76147618|FG001|NOT COMPLETED|Overall Study||5||
60031914|NCT02342288|76147626|FG000|STARTED|Overall Study|16 patients were not randomized to either arm.|30||
60031915|NCT02342288|76147627|FG001|STARTED|Overall Study|various issues listed below caused removal of subjects|33||
60031916|NCT02342288|76147626|FG000|COMPLETED|Overall Study||25||
60031917|NCT02342288|76147627|FG001|COMPLETED|Overall Study||27||
60031918|NCT02342288|76147626|FG000|NOT COMPLETED|Overall Study||5||
60031919|NCT02342288|76147627|FG001|NOT COMPLETED|Overall Study||6||
60031920|NCT01853644|76147633|FG000|STARTED|Registration and Treatment Start||31||
60031921|NCT01853644|76147633|FG000|Registered|Registration and Treatment Start||31||
60031922|NCT01853644|76147633|FG000|Started Treatment|Registration and Treatment Start||30||
60031923|NCT01853644|76147633|FG000|COMPLETED|Registration and Treatment Start||30||
60031924|NCT01853644|76147633|FG000|NOT COMPLETED|Registration and Treatment Start||1||
60031925|NCT01853644|76147633|FG000|STARTED|Reached First Response/Complete 2 Cycles||30||
60031926|NCT01853644|76147633|FG000|COMPLETED|Reached First Response/Complete 2 Cycles||24||
60031927|NCT01853644|76147633|FG000|NOT COMPLETED|Reached First Response/Complete 2 Cycles||6||
60031928|NCT01853644|76147633|FG000|STARTED|Continued Treatment After First Response||24||
60031929|NCT01853644|76147633|FG000|COMPLETED|Continued Treatment After First Response||12||
60031930|NCT01853644|76147633|FG000|NOT COMPLETED|Continued Treatment After First Response||12||
60031931|NCT01853644|76147633|FG000|STARTED|Follow up for 3 Years or Until Death|All patients that are treated on the study go into the follow up period|30||
60031932|NCT01853644|76147633|FG000|COMPLETED|Follow up for 3 Years or Until Death||30|Memo released stating that no more data to be collected after 6.10.21 for remaining patients in follow up and study is considered complete. Last follow up data collected for last patient for the study was 5.11.21.|
60031933|NCT01853644|76147633|FG000|NOT COMPLETED|Follow up for 3 Years or Until Death||0||
60031934|NCT02374346|76147637|FG000|STARTED|Overall Study||494||
60031935|NCT02374346|76147637|FG000|COMPLETED|Overall Study||446||
60031936|NCT02374346|76147637|FG000|NOT COMPLETED|Overall Study||48||
60031937|NCT01853254|76147643|FG000|STARTED|Overall Study||272||
60031938|NCT01853254|76147643|FG000|COMPLETED|Overall Study||168||
60031939|NCT01853254|76147643|FG000|NOT COMPLETED|Overall Study||104||
60031940|NCT02373098|76147649|FG000|STARTED|Overall Study||66||
60031941|NCT02373098|76147650|FG001|STARTED|Overall Study||60||
60031942|NCT02373098|76147649|FG000|COMPLETED|Overall Study||54||
60031943|NCT02373098|76147650|FG001|COMPLETED|Overall Study||60||
60031944|NCT02373098|76147649|FG000|NOT COMPLETED|Overall Study||12||
60031945|NCT02373098|76147650|FG001|NOT COMPLETED|Overall Study||0||
60031946|NCT01853176|76147664|FG000|STARTED|Overall Study||4||
60031947|NCT01853176|76147665|FG001|STARTED|Overall Study||0||
60031948|NCT01853176|76147664|FG000|COMPLETED|Overall Study||0||
60031949|NCT01853176|76147665|FG001|COMPLETED|Overall Study||0||
60031950|NCT01853176|76147664|FG000|NOT COMPLETED|Overall Study||4||
60031951|NCT01853176|76147665|FG001|NOT COMPLETED|Overall Study||0||
60031952|NCT02372396|76147673|FG000|STARTED|Overall Study||17||
60031953|NCT02372396|76147674|FG001|STARTED|Overall Study||20||
60031954|NCT02372396|76147673|FG000|Began Intervention|Overall Study||14||
60031955|NCT02372396|76147674|FG001|Began Intervention|Overall Study||14||
60031956|NCT02372396|76147673|FG000|COMPLETED|Overall Study||10||
60031957|NCT02372396|76147674|FG001|COMPLETED|Overall Study||11||
60031958|NCT02372396|76147673|FG000|NOT COMPLETED|Overall Study||7||
60031959|NCT02372396|76147674|FG001|NOT COMPLETED|Overall Study||9||
60031960|NCT01835548|76147682|FG000|STARTED|Screening/Washout Period||0||
60031961|NCT01835548|76147683|FG001|STARTED|Screening/Washout Period||0||
60031962|NCT01835548|76147684|FG002|STARTED|Screening/Washout Period||87||
60031963|NCT01835548|76147682|FG000|COMPLETED|Screening/Washout Period||0||
59507886|NCT02348775|75601066|FG000|STARTED|Overall Study||8||
59507887|NCT02348775|75601067|FG001|STARTED|Overall Study||8||
59507888|NCT02348775|75601066|FG000|COMPLETED|Overall Study||8||
60031964|NCT01835548|76147683|FG001|COMPLETED|Screening/Washout Period||0||
60031965|NCT01835548|76147684|FG002|COMPLETED|Screening/Washout Period||87||
60031966|NCT01835548|76147682|FG000|NOT COMPLETED|Screening/Washout Period||0||
60031967|NCT01835548|76147683|FG001|NOT COMPLETED|Screening/Washout Period||0||
60031968|NCT01835548|76147684|FG002|NOT COMPLETED|Screening/Washout Period||0||
60031969|NCT01835548|76147682|FG000|STARTED|Dose Optimization Period||0||
60031970|NCT01835548|76147683|FG001|STARTED|Dose Optimization Period||0||
60031971|NCT01835548|76147684|FG002|STARTED|Dose Optimization Period||87||
60031972|NCT01835548|76147682|FG000|COMPLETED|Dose Optimization Period||0||
60031973|NCT01835548|76147683|FG001|COMPLETED|Dose Optimization Period||0||
60031974|NCT01835548|76147684|FG002|COMPLETED|Dose Optimization Period||85||
60031975|NCT01835548|76147682|FG000|NOT COMPLETED|Dose Optimization Period||0||
60031976|NCT01835548|76147683|FG001|NOT COMPLETED|Dose Optimization Period||0||
60031977|NCT01835548|76147684|FG002|NOT COMPLETED|Dose Optimization Period||2||
60031978|NCT01835548|76147682|FG000|STARTED|Dose Stabilization Period||0||
60031979|NCT01835548|76147683|FG001|STARTED|Dose Stabilization Period||0||
60031980|NCT01835548|76147684|FG002|STARTED|Dose Stabilization Period||85||
59507889|NCT02348775|75601067|FG001|COMPLETED|Overall Study||8||
59507890|NCT02348775|75601066|FG000|NOT COMPLETED|Overall Study||0||
60031981|NCT01835548|76147682|FG000|COMPLETED|Dose Stabilization Period||0||
60031982|NCT01835548|76147683|FG001|COMPLETED|Dose Stabilization Period||0||
60031983|NCT01835548|76147684|FG002|COMPLETED|Dose Stabilization Period||85||
60031984|NCT01835548|76147682|FG000|NOT COMPLETED|Dose Stabilization Period||0||
60031985|NCT01835548|76147683|FG001|NOT COMPLETED|Dose Stabilization Period||0||
60031986|NCT01835548|76147684|FG002|NOT COMPLETED|Dose Stabilization Period||0||
60031987|NCT01835548|76147682|FG000|STARTED|Double-Blind Treatment Period||44||
60031988|NCT01835548|76147683|FG001|STARTED|Double-Blind Treatment Period||41||
60031989|NCT01835548|76147684|FG002|STARTED|Double-Blind Treatment Period||0||
60031990|NCT01835548|76147682|FG000|COMPLETED|Double-Blind Treatment Period||44||
60031991|NCT01835548|76147683|FG001|COMPLETED|Double-Blind Treatment Period||39||
60031992|NCT01835548|76147684|FG002|COMPLETED|Double-Blind Treatment Period||0||
60031993|NCT01835548|76147682|FG000|NOT COMPLETED|Double-Blind Treatment Period||0||
60031994|NCT01835548|76147683|FG001|NOT COMPLETED|Double-Blind Treatment Period||2||
60031995|NCT01835548|76147684|FG002|NOT COMPLETED|Double-Blind Treatment Period||0||
60031996|NCT01852942|76147698|FG000|STARTED|Overall Study||25||
60031997|NCT01852942|76147699|FG001|STARTED|Overall Study||27||
60031998|NCT01852942|76147698|FG000|COMPLETED|Overall Study||20||
60031999|NCT01852942|76147699|FG001|COMPLETED|Overall Study||21||
60032000|NCT01852942|76147698|FG000|NOT COMPLETED|Overall Study||5||
60032001|NCT01852942|76147699|FG001|NOT COMPLETED|Overall Study||6||
60032002|NCT01852162|76147708|FG000|STARTED|Overall Study||18||
60032003|NCT01852162|76147709|FG001|STARTED|Overall Study||17||
60032004|NCT01852162|76147708|FG000|COMPLETED|Overall Study||14||
60032005|NCT01852162|76147709|FG001|COMPLETED|Overall Study||16||
60032006|NCT01852162|76147708|FG000|NOT COMPLETED|Overall Study||4||
60032007|NCT01852162|76147709|FG001|NOT COMPLETED|Overall Study||1||
60032008|NCT01835470|76147715|FG000|STARTED|Short Term Treatment Period (to Week 16)||20||
60032009|NCT01835470|76147715|FG000|COMPLETED|Short Term Treatment Period (to Week 16)||20||
60032010|NCT01835470|76147715|FG000|NOT COMPLETED|Short Term Treatment Period (to Week 16)||0||
60032011|NCT01835470|76147715|FG000|STARTED|Long Term Treatment Period||20||
60032012|NCT01835470|76147715|FG000|COMPLETED|Long Term Treatment Period|Completed LT period|16||
60032013|NCT01835470|76147715|FG000|NOT COMPLETED|Long Term Treatment Period||4||
60032014|NCT02451137|76147722|FG000|STARTED|Overall Study||1651||
60032015|NCT02451137|76147723|FG001|STARTED|Overall Study||1653||
60032016|NCT02451137|76147722|FG000|Treated|Overall Study||1632||
60032017|NCT02451137|76147723|FG001|Treated|Overall Study||1626||
60032018|NCT02451137|76147722|FG000|Safety Population|Overall Study|4 participants received Standard of Care instead of Toujeo.|1637|Randomized participants who received atleast 1 dose of drug analyzed according to treatment received|
60032019|NCT02451137|76147723|FG001|Safety Population|Overall Study|9 participants received Toujeo instead of Standard of Care.|1621|Randomized participants who received atleast 1 dose of drug analyzed according to treatment received|
60032020|NCT02451137|76147722|FG000|COMPLETED|Overall Study||1405|Completed 12 month on treatment period(time from 1st IMP intake upto last IMP + 1 day)|
60032021|NCT02451137|76147723|FG001|COMPLETED|Overall Study||1355|Completed 12 month on treatment period(time from 1st IMP intake upto last IMP + 1 day)|
60032022|NCT02451137|76147722|FG000|NOT COMPLETED|Overall Study||246||
60032023|NCT02451137|76147723|FG001|NOT COMPLETED|Overall Study||298||
59507891|NCT02348775|75601067|FG001|NOT COMPLETED|Overall Study||0||
59507892|NCT00828061|75601073|FG000|STARTED|Period 1||4||
59507893|NCT00828061|75601074|FG001|STARTED|Period 1||3||
59507894|NCT00828061|75601075|FG002|STARTED|Period 1||3||
59507895|NCT00828061|75601076|FG003|STARTED|Period 1||3||
59507896|NCT00828061|75601077|FG004|STARTED|Period 1||3||
60032024|NCT02372006|76147732|FG000|STARTED|Overall Study||8||
60032025|NCT02372006|76147733|FG001|STARTED|Overall Study||9||
60032026|NCT02372006|76147734|FG002|STARTED|Overall Study||39||
60032027|NCT02372006|76147732|FG000|COMPLETED|Overall Study||0||
60032028|NCT02372006|76147733|FG001|COMPLETED|Overall Study||0||
60032029|NCT02372006|76147734|FG002|COMPLETED|Overall Study||0||
60032030|NCT02372006|76147732|FG000|NOT COMPLETED|Overall Study||8||
60032031|NCT02372006|76147733|FG001|NOT COMPLETED|Overall Study||9||
60032032|NCT02372006|76147734|FG002|NOT COMPLETED|Overall Study||39||
60032033|NCT02406248|76147743|FG000|STARTED|Overall Study||108||
60032034|NCT02406248|76147743|FG000|COMPLETED|Overall Study||99||
60032035|NCT02406248|76147743|FG000|NOT COMPLETED|Overall Study||9||
60032036|NCT02450903|76147747|FG000|STARTED|Overall Study||20||
60032037|NCT02450903|76147747|FG000|Entered Post-treatment Effic. f/u Phase|Overall Study||4|Discontinued from treatment phase|
60032038|NCT02450903|76147747|FG000|Entered Survival Follow-up Phase|Overall Study||15|Discontinued from treatment phase|
60032039|NCT02450903|76147747|FG000|COMPLETED|Overall Study||0||
60032040|NCT02450903|76147747|FG000|NOT COMPLETED|Overall Study||20||
59611982|NCT01728792|75723117|FG001|NOT COMPLETED|Overall Study||2||
59611983|NCT01728792|75723118|FG002|NOT COMPLETED|Overall Study||4||
59611984|NCT01728792|75723119|FG003|NOT COMPLETED|Overall Study||3||
59611985|NCT01728792|75723120|FG004|NOT COMPLETED|Overall Study||0||
59611986|NCT01752036|75723132|FG000|STARTED|Overall Study||33||
59611987|NCT01752036|75723132|FG000|COMPLETED|Overall Study||31||
59611988|NCT01752036|75723132|FG000|NOT COMPLETED|Overall Study||2||
59611989|NCT01728324|75723140|FG000|STARTED|Termination of DBV||211||
59611990|NCT01728324|75723141|FG001|STARTED|Termination of DBV||213||
59611991|NCT01728324|75723142|FG002|STARTED|Termination of DBV||72||
59611992|NCT01728324|75723140|FG000|COMPLETED|Termination of DBV||173||
59611993|NCT01728324|75723141|FG001|COMPLETED|Termination of DBV||177||
59611994|NCT01728324|75723142|FG002|COMPLETED|Termination of DBV||58||
59611995|NCT01728324|75723140|FG000|NOT COMPLETED|Termination of DBV||38||
59611996|NCT01728324|75723141|FG001|NOT COMPLETED|Termination of DBV||36||
59611997|NCT01728324|75723142|FG002|NOT COMPLETED|Termination of DBV||14||
59611998|NCT01728324|75723140|FG000|STARTED|Termination of FDV||211||
59611999|NCT01728324|75723141|FG001|STARTED|Termination of FDV||213||
59612000|NCT01728324|75723142|FG002|STARTED|Termination of FDV||72||
59612001|NCT01728324|75723140|FG000|COMPLETED|Termination of FDV||173||
59612002|NCT01728324|75723141|FG001|COMPLETED|Termination of FDV||177||
59612003|NCT01728324|75723142|FG002|COMPLETED|Termination of FDV||58||
59612004|NCT01728324|75723140|FG000|NOT COMPLETED|Termination of FDV||38||
59612005|NCT01728324|75723141|FG001|NOT COMPLETED|Termination of FDV||36||
59612006|NCT01728324|75723142|FG002|NOT COMPLETED|Termination of FDV||14||
59612007|NCT01728324|75723140|FG000|STARTED|Termination of RBV||211||
59612008|NCT01728324|75723141|FG001|STARTED|Termination of RBV||213||
59612009|NCT01728324|75723142|FG002|STARTED|Termination of RBV||72||
59612010|NCT01728324|75723140|FG000|COMPLETED|Termination of RBV||172||
59612011|NCT01728324|75723141|FG001|COMPLETED|Termination of RBV||176||
59612012|NCT01728324|75723142|FG002|COMPLETED|Termination of RBV||57||
59612013|NCT01728324|75723140|FG000|NOT COMPLETED|Termination of RBV||39||
59612014|NCT01728324|75723141|FG001|NOT COMPLETED|Termination of RBV||37||
59612015|NCT01728324|75723142|FG002|NOT COMPLETED|Termination of RBV||15||
59612016|NCT01728246|75723154|FG000|STARTED|Overall Study||242||
59612017|NCT01728246|75723155|FG001|STARTED|Overall Study||231||
59612018|NCT01728246|75723154|FG000|COMPLETED|Overall Study||206||
59612019|NCT01728246|75723155|FG001|COMPLETED|Overall Study||195||
59612020|NCT01728246|75723154|FG000|NOT COMPLETED|Overall Study||36||
59612021|NCT01728246|75723155|FG001|NOT COMPLETED|Overall Study||36||
59612022|NCT01705236|75723161|FG000|STARTED|Overall Study||87||
59612023|NCT01705236|75723161|FG000|COMPLETED|Overall Study||60||
59612024|NCT01705236|75723161|FG000|NOT COMPLETED|Overall Study||27||
59612025|NCT01705080|75723168|FG000|STARTED|Overall Study||147||
59612026|NCT01705080|75723169|FG001|STARTED|Overall Study||101||
59507897|NCT00828061|75601078|FG005|STARTED|Period 1||3||
59507898|NCT00828061|75601073|FG000|COMPLETED|Period 1||4||
59507899|NCT00828061|75601074|FG001|COMPLETED|Period 1||3||
59507900|NCT00828061|75601075|FG002|COMPLETED|Period 1||3||
59507901|NCT00828061|75601076|FG003|COMPLETED|Period 1||3||
59507902|NCT00828061|75601077|FG004|COMPLETED|Period 1||3||
59612027|NCT01705080|75723170|FG002|STARTED|Overall Study||28||
59612028|NCT01705080|75723168|FG000|Renal Artery Ablation Procedure|Overall Study||147||
59612029|NCT01705080|75723169|FG001|Renal Artery Ablation Procedure|Overall Study||101||
59612030|NCT01705080|75723170|FG002|Renal Artery Ablation Procedure|Overall Study||28||
59612031|NCT01705080|75723168|FG000|Discharge Following Renal Artery Ablation Procedure|Overall Study||147||
59612032|NCT01705080|75723169|FG001|Discharge Following Renal Artery Ablation Procedure|Overall Study|Reason Not Completed: Withdrawal by Subject=1|100||
59612033|NCT01705080|75723170|FG002|Discharge Following Renal Artery Ablation Procedure|Overall Study||28||
59612034|NCT01705080|75723168|FG000|COMPLETED|Overall Study||72||
59507903|NCT00828061|75601078|FG005|COMPLETED|Period 1||3||
59507904|NCT00828061|75601073|FG000|NOT COMPLETED|Period 1||0||
59507905|NCT00828061|75601074|FG001|NOT COMPLETED|Period 1||0||
59507906|NCT00828061|75601075|FG002|NOT COMPLETED|Period 1||0||
59507907|NCT00828061|75601076|FG003|NOT COMPLETED|Period 1||0||
59507908|NCT00828061|75601077|FG004|NOT COMPLETED|Period 1||0||
59507909|NCT00828061|75601078|FG005|NOT COMPLETED|Period 1||0||
59507910|NCT00828061|75601073|FG000|STARTED|Period 2||4||
59507911|NCT00828061|75601074|FG001|STARTED|Period 2||3||
59507912|NCT00828061|75601075|FG002|STARTED|Period 2||3||
59612035|NCT01705080|75723169|FG001|COMPLETED|Overall Study||49||
59612036|NCT01705080|75723170|FG002|COMPLETED|Overall Study||12||
59612037|NCT01705080|75723168|FG000|NOT COMPLETED|Overall Study||75||
59612038|NCT01705080|75723169|FG001|NOT COMPLETED|Overall Study||52||
59612039|NCT01705080|75723170|FG002|NOT COMPLETED|Overall Study||16||
59612040|NCT01704846|75723180|FG000|STARTED|Treatment Period 1||30||
59612041|NCT01704846|75723181|FG001|STARTED|Treatment Period 1||30||
59612042|NCT01704846|75723180|FG000|COMPLETED|Treatment Period 1||30||
59612043|NCT01704846|75723181|FG001|COMPLETED|Treatment Period 1||30||
59612044|NCT01704846|75723180|FG000|NOT COMPLETED|Treatment Period 1||0||
59507913|NCT00828061|75601076|FG003|STARTED|Period 2||3||
59507914|NCT00828061|75601077|FG004|STARTED|Period 2||3||
59507915|NCT00828061|75601078|FG005|STARTED|Period 2||3||
60032041|NCT02371616|76147753|FG000|STARTED|Overall Study||150||
60032042|NCT02371616|76147754|FG001|STARTED|Overall Study||154||
60032043|NCT02371616|76147753|FG000|COMPLETED|Overall Study||146||
60032044|NCT02371616|76147754|FG001|COMPLETED|Overall Study||147||
60032045|NCT02371616|76147753|FG000|NOT COMPLETED|Overall Study||4||
60032046|NCT02371616|76147754|FG001|NOT COMPLETED|Overall Study||7||
60032047|NCT02370914|76147760|FG000|STARTED|Overall Study||84||
60032048|NCT02370914|76147760|FG000|COMPLETED|Overall Study||82||
60032049|NCT02370914|76147760|FG000|NOT COMPLETED|Overall Study||2||
60032050|NCT02370602|76147770|FG000|STARTED|Overall Study||1||
60032051|NCT02370602|76147771|FG001|STARTED|Overall Study||2||
60032052|NCT02370602|76147772|FG002|STARTED|Overall Study||2||
60032053|NCT02370602|76147773|FG003|STARTED|Overall Study||3||
60032054|NCT02370602|76147774|FG004|STARTED|Overall Study||3||
60032055|NCT02370602|76147775|FG005|STARTED|Overall Study||2||
60032056|NCT02370602|76147770|FG000|COMPLETED|Overall Study||0||
60032057|NCT02370602|76147771|FG001|COMPLETED|Overall Study||2||
60032058|NCT02370602|76147772|FG002|COMPLETED|Overall Study||2||
60032059|NCT02370602|76147773|FG003|COMPLETED|Overall Study||3||
60032060|NCT02370602|76147774|FG004|COMPLETED|Overall Study||3||
60032061|NCT02370602|76147775|FG005|COMPLETED|Overall Study||2||
60032062|NCT02370602|76147770|FG000|NOT COMPLETED|Overall Study||1||
60032063|NCT02370602|76147771|FG001|NOT COMPLETED|Overall Study||0||
60032064|NCT02370602|76147772|FG002|NOT COMPLETED|Overall Study||0||
60032065|NCT02370602|76147773|FG003|NOT COMPLETED|Overall Study||0||
60032066|NCT02370602|76147774|FG004|NOT COMPLETED|Overall Study||0||
60032067|NCT02370602|76147775|FG005|NOT COMPLETED|Overall Study||0||
60032068|NCT02370368|76147794|FG000|STARTED|Overall Study||14||
60032069|NCT02370368|76147795|FG001|STARTED|Overall Study||13||
60032070|NCT02370368|76147794|FG000|COMPLETED|Overall Study||8||
60032071|NCT02370368|76147795|FG001|COMPLETED|Overall Study||7||
60032072|NCT02370368|76147794|FG000|NOT COMPLETED|Overall Study||6||
60032073|NCT02370368|76147795|FG001|NOT COMPLETED|Overall Study||6||
60032074|NCT02340806|76147803|FG000|STARTED|Overall Study||108||
60032075|NCT02340806|76147804|FG001|STARTED|Overall Study||112||
60032076|NCT02340806|76147803|FG000|COMPLETED|Overall Study||102||
60032077|NCT02340806|76147804|FG001|COMPLETED|Overall Study||108||
60032078|NCT02340806|76147803|FG000|NOT COMPLETED|Overall Study||6||
60032079|NCT02340806|76147804|FG001|NOT COMPLETED|Overall Study||4||
60032080|NCT02338154|76147810|FG000|STARTED|Overall Study||516||
60032081|NCT02338154|76147810|FG000|Enrolled Cohort (Intent to Treat)|Overall Study||516||
60032082|NCT02338154|76147810|FG000|INTUITY (Study Valve Cohort)|Overall Study||493||
60032083|NCT02338154|76147810|FG000|COMPLETED|Overall Study||373||
60032084|NCT02338154|76147810|FG000|NOT COMPLETED|Overall Study||143||
60032085|NCT01835158|76147824|FG000|STARTED|Overall Study||79||
60032086|NCT01835158|76147825|FG001|STARTED|Overall Study||78||
60032087|NCT01835158|76147824|FG000|COMPLETED|Overall Study||78||
60032088|NCT01835158|76147825|FG001|COMPLETED|Overall Study||72||
60032089|NCT01835158|76147824|FG000|NOT COMPLETED|Overall Study||1||
60032090|NCT01835158|76147825|FG001|NOT COMPLETED|Overall Study||6||
60032091|NCT02337764|76147831|FG000|STARTED|Overall Study||222||
60032092|NCT02337764|76147831|FG000|COMPLETED|Overall Study||162||
60032093|NCT02337764|76147831|FG000|NOT COMPLETED|Overall Study||60||
60032094|NCT01834222|76147835|FG000|STARTED|Overall Study||659||
60032095|NCT01834222|76147835|FG000|Treated|Overall Study||658||
60032096|NCT01834222|76147835|FG000|COMPLETED|Overall Study||658||
60032097|NCT01834222|76147835|FG000|NOT COMPLETED|Overall Study||1||
60032098|NCT01833832|76147839|FG000|STARTED|Overall Study||11||
60032099|NCT01833832|76147839|FG000|COMPLETED|Overall Study||10||
60032100|NCT01833832|76147839|FG000|NOT COMPLETED|Overall Study||1||
60032101|NCT01833520|76147845|FG000|STARTED|Overall Study||3||
60032102|NCT01833520|76147846|FG001|STARTED|Overall Study||3||
60032103|NCT01833520|76147847|FG002|STARTED|Overall Study||9||
60032104|NCT01833520|76147848|FG003|STARTED|Overall Study||3||
60032105|NCT01833520|76147845|FG000|COMPLETED|Overall Study||0||
60032106|NCT01833520|76147846|FG001|COMPLETED|Overall Study||0||
60032107|NCT01833520|76147847|FG002|COMPLETED|Overall Study||1||
60032108|NCT01833520|76147848|FG003|COMPLETED|Overall Study||0||
60032109|NCT01833520|76147845|FG000|NOT COMPLETED|Overall Study||3||
60032110|NCT01833520|76147846|FG001|NOT COMPLETED|Overall Study||3||
60032111|NCT01833520|76147847|FG002|NOT COMPLETED|Overall Study||8||
60032112|NCT01833520|76147848|FG003|NOT COMPLETED|Overall Study||3||
60032113|NCT01850602|76147862|FG000|STARTED|Overall Study||108||
60032114|NCT01850602|76147863|FG001|STARTED|Overall Study||105||
60032115|NCT01850602|76147862|FG000|COMPLETED|Overall Study||94||
60032116|NCT01850602|76147863|FG001|COMPLETED|Overall Study||87||
60032117|NCT01850602|76147862|FG000|NOT COMPLETED|Overall Study||14||
60032118|NCT01850602|76147863|FG001|NOT COMPLETED|Overall Study||18||
60032119|NCT01832818|76147869|FG000|STARTED|Overall Study||14||
60032120|NCT01832818|76147869|FG000|COMPLETED|Overall Study||8||
60032121|NCT01832818|76147869|FG000|NOT COMPLETED|Overall Study||6||
60032122|NCT02405780|76147877|FG000|STARTED|Period I||216||
60032123|NCT02405780|76147878|FG001|STARTED|Period I||108||
60032124|NCT02405780|76147879|FG002|STARTED|Period I||108||
60032125|NCT02405780|76147880|FG003|STARTED|Period I||213||
60032126|NCT02405780|76147877|FG000|COMPLETED|Period I||189||
60032127|NCT02405780|76147878|FG001|COMPLETED|Period I||100||
60032128|NCT02405780|76147879|FG002|COMPLETED|Period I||93||
60032129|NCT02405780|76147880|FG003|COMPLETED|Period I||190||
60032130|NCT02405780|76147877|FG000|NOT COMPLETED|Period I||27||
60032131|NCT02405780|76147878|FG001|NOT COMPLETED|Period I||8||
60032132|NCT02405780|76147879|FG002|NOT COMPLETED|Period I||15||
60032133|NCT02405780|76147880|FG003|NOT COMPLETED|Period I||23||
60032134|NCT02405780|76147877|FG000|STARTED|Period II||189||
60032135|NCT02405780|76147878|FG001|STARTED|Period II||100||
60032136|NCT02405780|76147879|FG002|STARTED|Period II||93||
60032137|NCT02405780|76147880|FG003|STARTED|Period II||190||
60032138|NCT02405780|76147877|FG000|COMPLETED|Period II||174||
60032139|NCT02405780|76147878|FG001|COMPLETED|Period II||88||
60032140|NCT02405780|76147879|FG002|COMPLETED|Period II||81||
60032141|NCT02405780|76147880|FG003|COMPLETED|Period II||172||
60032142|NCT02405780|76147877|FG000|NOT COMPLETED|Period II||15||
60032143|NCT02405780|76147878|FG001|NOT COMPLETED|Period II||12||
60032144|NCT02405780|76147879|FG002|NOT COMPLETED|Period II||12||
60032145|NCT02405780|76147880|FG003|NOT COMPLETED|Period II||18||
60032146|NCT02369510|76147908|FG000|STARTED|Overall Study||23||
60032147|NCT02369510|76147909|FG001|STARTED|Overall Study||22||
60032148|NCT02369510|76147910|FG002|STARTED|Overall Study||23||
60032149|NCT02369510|76147908|FG000|COMPLETED|Overall Study||21||
60032150|NCT02369510|76147909|FG001|COMPLETED|Overall Study||19||
60032151|NCT02369510|76147910|FG002|COMPLETED|Overall Study||17||
60032152|NCT02369510|76147908|FG000|NOT COMPLETED|Overall Study||2||
60032153|NCT02369510|76147909|FG001|NOT COMPLETED|Overall Study||3||
60032154|NCT02369510|76147910|FG002|NOT COMPLETED|Overall Study||6||
60032155|NCT01650194|76147918|FG000|STARTED|Overall Study||60||
60032156|NCT01650194|76147918|FG000|Treated|Overall Study||60||
60032157|NCT01650194|76147918|FG000|COMPLETED|Overall Study||13||
60032158|NCT01650194|76147918|FG000|NOT COMPLETED|Overall Study||47||
60032159|NCT02367716|76147923|FG000|STARTED|Overall Study||121||
59612045|NCT01704846|75723181|FG001|NOT COMPLETED|Treatment Period 1||0||
59612046|NCT01704846|75723180|FG000|STARTED|Treatment Period 2||30||
59612047|NCT01704846|75723181|FG001|STARTED|Treatment Period 2||30||
59612048|NCT01704846|75723180|FG000|COMPLETED|Treatment Period 2||30||
59612049|NCT01704846|75723181|FG001|COMPLETED|Treatment Period 2||29||
60032160|NCT02367716|76147923|FG000|COMPLETED|Overall Study||120||
60032161|NCT02367716|76147923|FG000|NOT COMPLETED|Overall Study||1||
60032162|NCT02366936|76147928|FG000|STARTED|Overall Study||32||
60032163|NCT02366936|76147928|FG000|COMPLETED|Overall Study||24||
60032164|NCT02366936|76147928|FG000|NOT COMPLETED|Overall Study||8||
60032165|NCT01648166|76147934|FG000|STARTED|Overall Study||153||
60032166|NCT01648166|76147935|FG001|STARTED|Overall Study||367||
60032167|NCT01648166|76147934|FG000|COMPLETED|Overall Study||100||
60032168|NCT01648166|76147935|FG001|COMPLETED|Overall Study||267||
60032169|NCT01648166|76147934|FG000|NOT COMPLETED|Overall Study||53||
60032170|NCT01648166|76147935|FG001|NOT COMPLETED|Overall Study||100||
60032171|NCT02404220|76147945|FG000|STARTED|Overall Study||5||
60032172|NCT02404220|76147946|FG001|STARTED|Overall Study||8||
60032173|NCT02404220|76147947|FG002|STARTED|Overall Study||7||
59612050|NCT01704846|75723180|FG000|NOT COMPLETED|Treatment Period 2||0||
59612051|NCT01704846|75723181|FG001|NOT COMPLETED|Treatment Period 2||1||
59612052|NCT01704846|75723180|FG000|STARTED|Treatment Period 3||30||
59612053|NCT01704846|75723181|FG001|STARTED|Treatment Period 3||29||
59612054|NCT01704846|75723180|FG000|COMPLETED|Treatment Period 3||30||
59612055|NCT01704846|75723181|FG001|COMPLETED|Treatment Period 3||29||
59612056|NCT01704846|75723180|FG000|NOT COMPLETED|Treatment Period 3||0||
60032174|NCT02404220|76147948|FG003|STARTED|Overall Study||10||
60032175|NCT02404220|76147945|FG000|COMPLETED|Overall Study||0||
60032176|NCT02404220|76147946|FG001|COMPLETED|Overall Study||0||
60032177|NCT02404220|76147947|FG002|COMPLETED|Overall Study||0||
60032178|NCT02404220|76147948|FG003|COMPLETED|Overall Study||0||
60032179|NCT02404220|76147945|FG000|NOT COMPLETED|Overall Study||5||
60032180|NCT02404220|76147946|FG001|NOT COMPLETED|Overall Study||8||
60032181|NCT02404220|76147947|FG002|NOT COMPLETED|Overall Study||7||
60032182|NCT02404220|76147948|FG003|NOT COMPLETED|Overall Study||10||
60032183|NCT02335658|76147960|FG000|STARTED|Overall Study|97 subjects in Cohort 1 and 103 subjects in Cohort 2 started to receive DSP-5423P.|97||
60032184|NCT02335658|76147961|FG001|STARTED|Overall Study||103||
60032185|NCT02335658|76147960|FG000|COMPLETED|Overall Study|57 subjects in Cohort 1 and 59 subjects in Cohort 2 completed the study.|57||
60032186|NCT02335658|76147961|FG001|COMPLETED|Overall Study||59||
60032187|NCT02335658|76147960|FG000|NOT COMPLETED|Overall Study||40||
60032188|NCT02335658|76147961|FG001|NOT COMPLETED|Overall Study||44||
60032189|NCT02366468|76147971|FG000|STARTED|Overall Study||68|Randomized Safety Set|
60032190|NCT02366468|76147972|FG001|STARTED|Overall Study||67|Randomized Safety Set|
60032191|NCT02366468|76147971|FG000|Full Analysis Set (FAS)|Overall Study||67|Randomized patients who received study treatment and had post-baseline primary endpoint assessments|
60032192|NCT02366468|76147972|FG001|Full Analysis Set (FAS)|Overall Study||66|Randomized patients who received study treatment and had post-baseline primary endpoint assessments|
60032193|NCT02366468|76147971|FG000|Per Protocol Set (PPS)|Overall Study||62|All patients in the FAS who completed the trial without major protocol deviations|
60032194|NCT02366468|76147972|FG001|Per Protocol Set (PPS)|Overall Study||61|All patients in the FAS who completed the trial without major protocol deviations|
59759261|NCT00561925|75878608|FG002|COMPLETED|144-week Double-blind, Double-dummy||378||
59759262|NCT00561925|75878609|FG003|COMPLETED|144-week Double-blind, Double-dummy||0||
59759263|NCT00561925|75878610|FG004|COMPLETED|144-week Double-blind, Double-dummy||0||
59759264|NCT00561925|75878606|FG000|NOT COMPLETED|144-week Double-blind, Double-dummy||0||
59759265|NCT00561925|75878607|FG001|NOT COMPLETED|144-week Double-blind, Double-dummy||150||
59759266|NCT00561925|75878608|FG002|NOT COMPLETED|144-week Double-blind, Double-dummy||127||
59916713|NCT03601715|76037441|FG002|NOT COMPLETED|Washout 1 (at Least 24 Hours)||0||
59916714|NCT03601715|76037439|FG000|STARTED|Second Intervention||7||
59916715|NCT03601715|76037440|FG001|STARTED|Second Intervention||7||
59916716|NCT03601715|76037441|FG002|STARTED|Second Intervention||6||
59916717|NCT03601715|76037439|FG000|COMPLETED|Second Intervention||6||
59916718|NCT03601715|76037440|FG001|COMPLETED|Second Intervention||6||
59916719|NCT03601715|76037441|FG002|COMPLETED|Second Intervention||6||
59916720|NCT03601715|76037439|FG000|NOT COMPLETED|Second Intervention||1||
59916721|NCT03601715|76037440|FG001|NOT COMPLETED|Second Intervention||1||
59916722|NCT03601715|76037441|FG002|NOT COMPLETED|Second Intervention||0||
59916723|NCT03601715|76037439|FG000|STARTED|Wash Out 2 (at Least 24 Hours)||6||
59916724|NCT03601715|76037440|FG001|STARTED|Wash Out 2 (at Least 24 Hours)||6||
59916725|NCT03601715|76037441|FG002|STARTED|Wash Out 2 (at Least 24 Hours)||6||
59916726|NCT03601715|76037439|FG000|COMPLETED|Wash Out 2 (at Least 24 Hours)||6||
59916727|NCT03601715|76037440|FG001|COMPLETED|Wash Out 2 (at Least 24 Hours)||6||
59916728|NCT03601715|76037441|FG002|COMPLETED|Wash Out 2 (at Least 24 Hours)||6||
59916729|NCT03601715|76037439|FG000|NOT COMPLETED|Wash Out 2 (at Least 24 Hours)||0||
59916730|NCT03601715|76037440|FG001|NOT COMPLETED|Wash Out 2 (at Least 24 Hours)||0||
59916731|NCT03601715|76037441|FG002|NOT COMPLETED|Wash Out 2 (at Least 24 Hours)||0||
59916732|NCT03601715|76037439|FG000|STARTED|Third Intervention||6||
59916733|NCT03601715|76037440|FG001|STARTED|Third Intervention||6||
59916734|NCT03601715|76037441|FG002|STARTED|Third Intervention||6||
59916735|NCT03601715|76037439|FG000|COMPLETED|Third Intervention||6||
59916736|NCT03601715|76037440|FG001|COMPLETED|Third Intervention||6||
59916737|NCT03601715|76037441|FG002|COMPLETED|Third Intervention||6||
59916738|NCT03601715|76037439|FG000|NOT COMPLETED|Third Intervention||0||
59916739|NCT03601715|76037440|FG001|NOT COMPLETED|Third Intervention||0||
59916740|NCT03601715|76037441|FG002|NOT COMPLETED|Third Intervention||0||
59916741|NCT03735407|76037449|FG000|STARTED|Overall Study||40||
59916742|NCT03735407|76037449|FG000|COMPLETED|Overall Study||40||
59916743|NCT03735407|76037449|FG000|NOT COMPLETED|Overall Study||0||
59916744|NCT03594227|76037457|FG000|STARTED|Overall Study||23||
59916745|NCT03594227|76037458|FG001|STARTED|Overall Study||23||
59916746|NCT03594227|76037459|FG002|STARTED|Overall Study||22||
59916747|NCT03594227|76037460|FG003|STARTED|Overall Study||19||
59916748|NCT03594227|76037457|FG000|COMPLETED|Overall Study||18|Includes subjects with a SALT score after D155 occurring on or before the end of treatment date +10.|
59916749|NCT03594227|76037458|FG001|COMPLETED|Overall Study||19|Includes subjects with a SALT score after D155 occurring on or before the end of treatment date +10.|
59916750|NCT03594227|76037459|FG002|COMPLETED|Overall Study||19|Includes subjects with a SALT score after D155 occurring on or before the end of treatment date +10.|
59916751|NCT03594227|76037460|FG003|COMPLETED|Overall Study||14|Includes subjects with a SALT score after D155 occurring on or before the end of treatment date +10.|
59916752|NCT03594227|76037457|FG000|NOT COMPLETED|Overall Study||5||
59916753|NCT03594227|76037458|FG001|NOT COMPLETED|Overall Study||4||
59916754|NCT03594227|76037459|FG002|NOT COMPLETED|Overall Study||3||
59916755|NCT03594227|76037460|FG003|NOT COMPLETED|Overall Study||5||
59916756|NCT03098550|76037484|FG000|STARTED|Overall Study||41||
59916757|NCT03098550|76037485|FG001|STARTED|Overall Study||21||
59916758|NCT03098550|76037486|FG002|STARTED|Overall Study||43||
59916759|NCT03098550|76037484|FG000|COMPLETED|Overall Study||0||
59916760|NCT03098550|76037485|FG001|COMPLETED|Overall Study||1||
59916761|NCT03098550|76037486|FG002|COMPLETED|Overall Study||0||
59916762|NCT03098550|76037484|FG000|NOT COMPLETED|Overall Study||41||
59916763|NCT03098550|76037485|FG001|NOT COMPLETED|Overall Study||20||
59916764|NCT03098550|76037486|FG002|NOT COMPLETED|Overall Study||43||
59916765|NCT03095118|76037498|FG000|STARTED|Overall Study||12||
59916766|NCT03095118|76037498|FG000|COMPLETED|Overall Study||10||
59916767|NCT03095118|76037498|FG000|NOT COMPLETED|Overall Study||2||
59916768|NCT03594071|76037502|FG000|STARTED|Overall Study||294||309
59916769|NCT03594071|76037502|FG000|COMPLETED|Overall Study||289||304
59916770|NCT03594071|76037502|FG000|NOT COMPLETED|Overall Study||5||5
59916771|NCT02696902|76037509|FG000|STARTED|Overall Study||85||
59916772|NCT02696902|76037510|FG001|STARTED|Overall Study||16||
59916773|NCT02696902|76037511|FG002|STARTED|Overall Study||87||
59916774|NCT02696902|76037509|FG000|Treated|Overall Study||83||
59916775|NCT02696902|76037510|FG001|Treated|Overall Study||16||
59916776|NCT02696902|76037511|FG002|Treated|Overall Study||85||
59916777|NCT02696902|76037509|FG000|Intent-to-treat (ITT) Population|Overall Study||85||
59916778|NCT02696902|76037510|FG001|Intent-to-treat (ITT) Population|Overall Study||16||
59916779|NCT02696902|76037511|FG002|Intent-to-treat (ITT) Population|Overall Study||87||
59916780|NCT02696902|76037509|FG000|As-treated Population|Overall Study||83||
59916781|NCT02696902|76037510|FG001|As-treated Population|Overall Study||16||
59916782|NCT02696902|76037511|FG002|As-treated Population|Overall Study||85||
60032195|NCT02366468|76147971|FG000|COMPLETED|Overall Study||62||
60032196|NCT02366468|76147972|FG001|COMPLETED|Overall Study||58||
60032197|NCT02366468|76147971|FG000|NOT COMPLETED|Overall Study||6||
60032198|NCT02366468|76147972|FG001|NOT COMPLETED|Overall Study||9||
60032199|NCT02366312|76147980|FG000|STARTED|Overall Study||1||
60032200|NCT02366312|76147981|FG001|STARTED|Overall Study||1||
60032201|NCT02366312|76147980|FG000|COMPLETED|Overall Study||1||
60032202|NCT02366312|76147981|FG001|COMPLETED|Overall Study|The subject did not attend the 2-year post-treatment visit (last visit).|0||
60032203|NCT02366312|76147980|FG000|NOT COMPLETED|Overall Study||0||
60032204|NCT02366312|76147981|FG001|NOT COMPLETED|Overall Study||1||
60032205|NCT02335346|76147987|FG000|STARTED|Overall Study||93||
60032206|NCT02335346|76147987|FG000|Received At Least 1 Dose of Study Drug|Overall Study||93||
60032207|NCT02335346|76147987|FG000|COMPLETED|Overall Study||81||
60032208|NCT02335346|76147987|FG000|NOT COMPLETED|Overall Study||12||
60032209|NCT02403206|76147993|FG000|STARTED|Overall Study||194||
60032210|NCT02403206|76147994|FG001|STARTED|Overall Study||196||
60032211|NCT02403206|76147993|FG000|Treated Prior to Randomization|Overall Study||0||
60032212|NCT02403206|76147994|FG001|Treated Prior to Randomization|Overall Study||1||
60032213|NCT02403206|76147993|FG000|Randomized and Treated|Overall Study||188||
60032214|NCT02403206|76147994|FG001|Randomized and Treated|Overall Study||190||
60032215|NCT02403206|76147993|FG000|COMPLETED|Overall Study||183||
60032216|NCT02403206|76147994|FG001|COMPLETED|Overall Study||186||
60032217|NCT02403206|76147993|FG000|NOT COMPLETED|Overall Study||11||
60032218|NCT02403206|76147994|FG001|NOT COMPLETED|Overall Study||10||
60032219|NCT02333630|76148003|FG000|STARTED|Overall Study||100||
60032220|NCT02333630|76148004|FG001|STARTED|Overall Study||100||
60032221|NCT02333630|76148003|FG000|COMPLETED|Overall Study||95||
60032222|NCT02333630|76148004|FG001|COMPLETED|Overall Study||98||
60032223|NCT02333630|76148003|FG000|NOT COMPLETED|Overall Study||5||
60032224|NCT02333630|76148004|FG001|NOT COMPLETED|Overall Study||2||
60032225|NCT02401412|76148016|FG000|STARTED|Overall Study||89||
60032226|NCT02401412|76148017|FG001|STARTED|Overall Study||81||
60032227|NCT02401412|76148016|FG000|Received Study Device|Overall Study||89||
60032228|NCT02401412|76148017|FG001|Received Study Device|Overall Study||80||
60032229|NCT02401412|76148016|FG000|COMPLETED|Overall Study||59||
60032230|NCT02401412|76148017|FG001|COMPLETED|Overall Study||49||
60032231|NCT02401412|76148016|FG000|NOT COMPLETED|Overall Study||30||
60032232|NCT02401412|76148017|FG001|NOT COMPLETED|Overall Study||32||
60032233|NCT02365298|76148023|FG000|STARTED|Period 1||14||
60032234|NCT02365298|76148024|FG001|STARTED|Period 1||14||
60032235|NCT02365298|76148023|FG000|COMPLETED|Period 1||14||
60032236|NCT02365298|76148024|FG001|COMPLETED|Period 1||14||
60032237|NCT02365298|76148023|FG000|NOT COMPLETED|Period 1||0||
60032238|NCT02365298|76148024|FG001|NOT COMPLETED|Period 1||0||
60032239|NCT02365298|76148023|FG000|STARTED|Period 2||14||
60032240|NCT02365298|76148024|FG001|STARTED|Period 2||14||
60032241|NCT02365298|76148023|FG000|COMPLETED|Period 2||12||
60032242|NCT02365298|76148024|FG001|COMPLETED|Period 2||12||
60032243|NCT02365298|76148023|FG000|NOT COMPLETED|Period 2||2||
60032244|NCT02365298|76148024|FG001|NOT COMPLETED|Period 2||2||
60032245|NCT02365064|76148032|FG000|STARTED|Overall Study||31||
60032246|NCT02365064|76148033|FG001|STARTED|Overall Study||47||
60032247|NCT02365064|76148032|FG000|Included in ITT Analysis|Overall Study||29||
60032248|NCT02365064|76148033|FG001|Included in ITT Analysis|Overall Study||32||
60032249|NCT02365064|76148032|FG000|COMPLETED|Overall Study||21||
60032250|NCT02365064|76148033|FG001|COMPLETED|Overall Study||19||
60032251|NCT02365064|76148032|FG000|NOT COMPLETED|Overall Study||10||
60032252|NCT02365064|76148033|FG001|NOT COMPLETED|Overall Study||28||
60032253|NCT02401256|76148039|FG000|STARTED|Overall Study||70||
60032254|NCT02401256|76148039|FG000|Finished Phase 1|Overall Study||64||
60032255|NCT02401256|76148039|FG000|Finished Phase 2|Overall Study||58||
60032256|NCT02401256|76148039|FG000|Finished Phase 3|Overall Study||53||
60032257|NCT02401256|76148039|FG000|Analysed|Overall Study|Volunteers that completed at least until Phase 2 inpatient visit (Volunteers with Efavirenz PK data)|61||
60032258|NCT02401256|76148039|FG000|COMPLETED|Overall Study||53||
60032259|NCT02401256|76148039|FG000|NOT COMPLETED|Overall Study||17||
60032260|NCT02349295|76148048|FG000|STARTED|Double Blind Treatment (Week 0-24)||123||
60032261|NCT02349295|76148049|FG001|STARTED|Double Blind Treatment (Week 0-24)||122||
60032262|NCT02349295|76148050|FG002|STARTED|Double Blind Treatment (Week 0-24)||118||
60032263|NCT02349295|76148051|FG003|STARTED|Double Blind Treatment (Week 0-24)||0||
60032264|NCT02349295|76148052|FG004|STARTED|Double Blind Treatment (Week 0-24)||0||
60032265|NCT02349295|76148053|FG005|STARTED|Double Blind Treatment (Week 0-24)||0||
60032266|NCT02349295|76148054|FG006|STARTED|Double Blind Treatment (Week 0-24)||0||
60032267|NCT02349295|76148055|FG007|STARTED|Double Blind Treatment (Week 0-24)||0||
60032268|NCT02349295|76148056|FG008|STARTED|Double Blind Treatment (Week 0-24)||0||
60032269|NCT02349295|76148057|FG009|STARTED|Double Blind Treatment (Week 0-24)||0||
59612057|NCT01704846|75723181|FG001|NOT COMPLETED|Treatment Period 3||0||
59916783|NCT02696902|76037509|FG000|Modified Intent-to-treat (mITT) Population|Overall Study||83||
60032270|NCT02349295|76148058|FG010|STARTED|Double Blind Treatment (Week 0-24)||0||
60032271|NCT02349295|76148059|FG011|STARTED|Double Blind Treatment (Week 0-24)||0||
60032272|NCT02349295|76148060|FG012|STARTED|Double Blind Treatment (Week 0-24)||0||
60032273|NCT02349295|76148061|FG013|STARTED|Double Blind Treatment (Week 0-24)||0||
60032274|NCT02349295|76148048|FG000|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||123||
60032275|NCT02349295|76148049|FG001|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||122||
60032276|NCT02349295|76148050|FG002|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||118||
60032277|NCT02349295|76148051|FG003|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0||
60032278|NCT02349295|76148052|FG004|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0||
60032279|NCT02349295|76148053|FG005|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0||
60032280|NCT02349295|76148054|FG006|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0||
60032281|NCT02349295|76148055|FG007|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0||
60032282|NCT02349295|76148056|FG008|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0||
60032283|NCT02349295|76148057|FG009|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0||
60032284|NCT02349295|76148058|FG010|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0||
60032285|NCT02349295|76148059|FG011|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0||
60032286|NCT02349295|76148060|FG012|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0||
60032287|NCT02349295|76148061|FG013|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0||
60032288|NCT02349295|76148048|FG000|COMPLETED|Double Blind Treatment (Week 0-24)||109||
60032289|NCT02349295|76148049|FG001|COMPLETED|Double Blind Treatment (Week 0-24)||111||
60032290|NCT02349295|76148050|FG002|COMPLETED|Double Blind Treatment (Week 0-24)||94||
60032291|NCT02349295|76148051|FG003|COMPLETED|Double Blind Treatment (Week 0-24)||0||
60032292|NCT02349295|76148052|FG004|COMPLETED|Double Blind Treatment (Week 0-24)||0||
60032293|NCT02349295|76148053|FG005|COMPLETED|Double Blind Treatment (Week 0-24)||0||
60032294|NCT02349295|76148054|FG006|COMPLETED|Double Blind Treatment (Week 0-24)||0||
60032295|NCT02349295|76148055|FG007|COMPLETED|Double Blind Treatment (Week 0-24)||0||
60032296|NCT02349295|76148056|FG008|COMPLETED|Double Blind Treatment (Week 0-24)||0||
60032297|NCT02349295|76148057|FG009|COMPLETED|Double Blind Treatment (Week 0-24)||0||
60032298|NCT02349295|76148058|FG010|COMPLETED|Double Blind Treatment (Week 0-24)||0||
59916784|NCT02696902|76037510|FG001|Modified Intent-to-treat (mITT) Population|Overall Study||16||
59916785|NCT02696902|76037511|FG002|Modified Intent-to-treat (mITT) Population|Overall Study||85||
59916786|NCT02696902|76037509|FG000|COMPLETED|Overall Study||63||
59916787|NCT02696902|76037510|FG001|COMPLETED|Overall Study||12||
59916788|NCT02696902|76037511|FG002|COMPLETED|Overall Study||59||
59916789|NCT02696902|76037509|FG000|NOT COMPLETED|Overall Study||22||
59916790|NCT02696902|76037510|FG001|NOT COMPLETED|Overall Study||4||
59916791|NCT02696902|76037511|FG002|NOT COMPLETED|Overall Study||28||
59916792|NCT02694562|76037521|FG000|STARTED|Overall Study||20||
59916793|NCT02694562|76037521|FG000|COMPLETED|Overall Study||2||
59916794|NCT02694562|76037521|FG000|NOT COMPLETED|Overall Study||18||
59916795|NCT02874534|76037527|FG000|STARTED|Overall Study||31||
59916796|NCT02874534|76037528|FG001|STARTED|Overall Study||26||
59916797|NCT02874534|76037527|FG000|COMPLETED|Overall Study||23||
59916798|NCT02874534|76037528|FG001|COMPLETED|Overall Study||15||
59916799|NCT02874534|76037527|FG000|NOT COMPLETED|Overall Study||8||
59916800|NCT02874534|76037528|FG001|NOT COMPLETED|Overall Study||11||
59916801|NCT03097614|76037534|FG000|STARTED|Overall Study||57||
59916802|NCT03097614|76037534|FG000|COMPLETED|Overall Study||54||
59916803|NCT03097614|76037534|FG000|NOT COMPLETED|Overall Study||3||
59916804|NCT03364309|76037541|FG000|STARTED|Induction Period||88||
59916805|NCT03364309|76037542|FG001|STARTED|Induction Period||174||
59916806|NCT03364309|76037543|FG002|STARTED|Induction Period||176||
59916807|NCT03364309|76037544|FG003|STARTED|Induction Period||0||
59916808|NCT03364309|76037545|FG004|STARTED|Induction Period||0||
59916809|NCT03364309|76037546|FG005|STARTED|Induction Period||0||
60032299|NCT02349295|76148059|FG011|COMPLETED|Double Blind Treatment (Week 0-24)||0||
60032300|NCT02349295|76148060|FG012|COMPLETED|Double Blind Treatment (Week 0-24)||0||
60032301|NCT02349295|76148061|FG013|COMPLETED|Double Blind Treatment (Week 0-24)||0||
60032302|NCT02349295|76148048|FG000|NOT COMPLETED|Double Blind Treatment (Week 0-24)||14||
60032303|NCT02349295|76148049|FG001|NOT COMPLETED|Double Blind Treatment (Week 0-24)||11||
60032304|NCT02349295|76148050|FG002|NOT COMPLETED|Double Blind Treatment (Week 0-24)||24||
60032305|NCT02349295|76148051|FG003|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0||
59916810|NCT03364309|76037547|FG006|STARTED|Induction Period||0||
59916811|NCT03364309|76037548|FG007|STARTED|Induction Period||0||
59916812|NCT03364309|76037549|FG008|STARTED|Induction Period||0||
59916813|NCT03364309|76037550|FG009|STARTED|Induction Period||0||
60032306|NCT02349295|76148052|FG004|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0||
60032307|NCT02349295|76148053|FG005|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0||
60032308|NCT02349295|76148054|FG006|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0||
60032309|NCT02349295|76148055|FG007|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0||
60032310|NCT02349295|76148056|FG008|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0||
60032311|NCT02349295|76148057|FG009|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0||
60032312|NCT02349295|76148058|FG010|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0||
60032313|NCT02349295|76148059|FG011|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0||
60032314|NCT02349295|76148060|FG012|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0||
60032315|NCT02349295|76148061|FG013|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0||
60032316|NCT02349295|76148048|FG000|STARTED|IR (Week 16-24)|Only IR participants were included.|0||
60032317|NCT02349295|76148049|FG001|STARTED|IR (Week 16-24)|Only IR participants were included.|0||
60032318|NCT02349295|76148050|FG002|STARTED|IR (Week 16-24)|Only IR participants were included.|0||
60032319|NCT02349295|76148051|FG003|STARTED|IR (Week 16-24)|IR from ixekizumab 80 mg Q2W only.|17||
60032320|NCT02349295|76148052|FG004|STARTED|IR (Week 16-24)|IR from ixekizumab 80 mg Q4W only.|15||
60032321|NCT02349295|76148053|FG005|STARTED|IR (Week 16-24)|IR from placebo who re-randomized (1:1) to ixekizumab 80 mg Q2W.|16||
60032322|NCT02349295|76148054|FG006|STARTED|IR (Week 16-24)|IR from placebo who re-randomized (1:1) to ixekizumab 80 mg Q4W.|16||
60032323|NCT02349295|76148055|FG007|STARTED|IR (Week 16-24)||0||
60032324|NCT02349295|76148056|FG008|STARTED|IR (Week 16-24)||0||
60032325|NCT02349295|76148057|FG009|STARTED|IR (Week 16-24)||0||
60032326|NCT02349295|76148058|FG010|STARTED|IR (Week 16-24)||0||
60032327|NCT02349295|76148059|FG011|STARTED|IR (Week 16-24)||0||
60032328|NCT02349295|76148060|FG012|STARTED|IR (Week 16-24)||0||
60032329|NCT02349295|76148061|FG013|STARTED|IR (Week 16-24)||0||
60032330|NCT02349295|76148048|FG000|COMPLETED|IR (Week 16-24)||0||
59507916|NCT00828061|75601073|FG000|COMPLETED|Period 2||4||
59507917|NCT00828061|75601074|FG001|COMPLETED|Period 2||3||
59507918|NCT00828061|75601075|FG002|COMPLETED|Period 2||3||
59507919|NCT00828061|75601076|FG003|COMPLETED|Period 2||3||
59507920|NCT00828061|75601077|FG004|COMPLETED|Period 2||3||
59507921|NCT00828061|75601078|FG005|COMPLETED|Period 2||3||
59507922|NCT00828061|75601073|FG000|NOT COMPLETED|Period 2||0||
59759267|NCT00561925|75878609|FG003|NOT COMPLETED|144-week Double-blind, Double-dummy||0||
59762602|NCT00866307|75882443|FG000|STARTED|Induction||104||
59507923|NCT00828061|75601074|FG001|NOT COMPLETED|Period 2||0||
59507924|NCT00828061|75601075|FG002|NOT COMPLETED|Period 2||0||
59507925|NCT00828061|75601076|FG003|NOT COMPLETED|Period 2||0||
59612058|NCT01704846|75723180|FG000|STARTED|Treatment Period 4||30||
60032331|NCT02349295|76148049|FG001|COMPLETED|IR (Week 16-24)||0||
60032332|NCT02349295|76148050|FG002|COMPLETED|IR (Week 16-24)||0||
60032333|NCT02349295|76148051|FG003|COMPLETED|IR (Week 16-24)||16||
60032334|NCT02349295|76148052|FG004|COMPLETED|IR (Week 16-24)||15||
60032335|NCT02349295|76148053|FG005|COMPLETED|IR (Week 16-24)||16||
60032336|NCT02349295|76148054|FG006|COMPLETED|IR (Week 16-24)||16||
60032337|NCT02349295|76148055|FG007|COMPLETED|IR (Week 16-24)||0||
60032338|NCT02349295|76148056|FG008|COMPLETED|IR (Week 16-24)||0||
60032339|NCT02349295|76148057|FG009|COMPLETED|IR (Week 16-24)||0||
60032340|NCT02349295|76148058|FG010|COMPLETED|IR (Week 16-24)||0||
60032341|NCT02349295|76148059|FG011|COMPLETED|IR (Week 16-24)||0||
60032342|NCT02349295|76148060|FG012|COMPLETED|IR (Week 16-24)||0||
60032343|NCT02349295|76148061|FG013|COMPLETED|IR (Week 16-24)||0||
60032344|NCT02349295|76148048|FG000|NOT COMPLETED|IR (Week 16-24)||0||
60032345|NCT02349295|76148049|FG001|NOT COMPLETED|IR (Week 16-24)||0||
60032346|NCT02349295|76148050|FG002|NOT COMPLETED|IR (Week 16-24)||0||
60032347|NCT02349295|76148051|FG003|NOT COMPLETED|IR (Week 16-24)||1||
60032348|NCT02349295|76148052|FG004|NOT COMPLETED|IR (Week 16-24)||0||
60032349|NCT02349295|76148053|FG005|NOT COMPLETED|IR (Week 16-24)||0||
60032350|NCT02349295|76148054|FG006|NOT COMPLETED|IR (Week 16-24)||0||
60032351|NCT02349295|76148055|FG007|NOT COMPLETED|IR (Week 16-24)||0||
59507926|NCT00828061|75601077|FG004|NOT COMPLETED|Period 2||0||
59507927|NCT00828061|75601078|FG005|NOT COMPLETED|Period 2||0||
59507928|NCT00828061|75601073|FG000|STARTED|Period 3||4||
59507929|NCT00828061|75601074|FG001|STARTED|Period 3||3||
59507930|NCT00828061|75601075|FG002|STARTED|Period 3||3||
59507931|NCT00828061|75601076|FG003|STARTED|Period 3||3||
59507932|NCT00828061|75601077|FG004|STARTED|Period 3||3||
59507933|NCT00828061|75601078|FG005|STARTED|Period 3||3||
59507934|NCT00828061|75601073|FG000|COMPLETED|Period 3||4||
59507935|NCT00828061|75601074|FG001|COMPLETED|Period 3||3||
59507936|NCT00828061|75601075|FG002|COMPLETED|Period 3||3||
59507937|NCT00828061|75601076|FG003|COMPLETED|Period 3||3||
60032352|NCT02349295|76148056|FG008|NOT COMPLETED|IR (Week 16-24)||0||
60032353|NCT02349295|76148057|FG009|NOT COMPLETED|IR (Week 16-24)||0||
60032354|NCT02349295|76148058|FG010|NOT COMPLETED|IR (Week 16-24)||0||
60032355|NCT02349295|76148059|FG011|NOT COMPLETED|IR (Week 16-24)||0||
60032356|NCT02349295|76148060|FG012|NOT COMPLETED|IR (Week 16-24)||0||
60032357|NCT02349295|76148061|FG013|NOT COMPLETED|IR (Week 16-24)||0||
60032358|NCT02349295|76148048|FG000|STARTED|Long-Term Extension Period (Week 24-156)||0||
60032359|NCT02349295|76148049|FG001|STARTED|Long-Term Extension Period (Week 24-156)||0||
60032360|NCT02349295|76148050|FG002|STARTED|Long-Term Extension Period (Week 24-156)||0||
60032361|NCT02349295|76148051|FG003|STARTED|Long-Term Extension Period (Week 24-156)|Only included combined extension participants.|0||
60032362|NCT02349295|76148052|FG004|STARTED|Long-Term Extension Period (Week 24-156)|Only included combined extension participants.|0||
60032363|NCT02349295|76148053|FG005|STARTED|Long-Term Extension Period (Week 24-156)|Only included combined extension participants.|0||
60032364|NCT02349295|76148054|FG006|STARTED|Long-Term Extension Period (Week 24-156)|Only included combined extension participants.|0||
60032365|NCT02349295|76148055|FG007|STARTED|Long-Term Extension Period (Week 24-156)|IxeQ2W participants who entered the long-term extension period.|107||
60032366|NCT02349295|76148056|FG008|STARTED|Long-Term Extension Period (Week 24-156)|IxeQ4W participants who entered the long-term extension period.|111||
60032367|NCT02349295|76148057|FG009|STARTED|Long-Term Extension Period (Week 24-156)|Placebo/IxeQ2W participants who entered the long-term extension period.|46||
60032368|NCT02349295|76148058|FG010|STARTED|Long-Term Extension Period (Week 24-156)|Placebo/IxeQ4W participants who entered the long-term extension period.|46||
60032369|NCT02349295|76148059|FG011|STARTED|Long-Term Extension Period (Week 24-156)||0||
60032370|NCT02349295|76148060|FG012|STARTED|Long-Term Extension Period (Week 24-156)||0||
60032371|NCT02349295|76148061|FG013|STARTED|Long-Term Extension Period (Week 24-156)||0||
60032372|NCT02349295|76148048|FG000|COMPLETED|Long-Term Extension Period (Week 24-156)||0||
60032373|NCT02349295|76148049|FG001|COMPLETED|Long-Term Extension Period (Week 24-156)||0||
60032374|NCT02349295|76148050|FG002|COMPLETED|Long-Term Extension Period (Week 24-156)||0||
60032375|NCT02349295|76148051|FG003|COMPLETED|Long-Term Extension Period (Week 24-156)||0||
60032376|NCT02349295|76148052|FG004|COMPLETED|Long-Term Extension Period (Week 24-156)||0||
60032377|NCT02349295|76148053|FG005|COMPLETED|Long-Term Extension Period (Week 24-156)||0||
60032378|NCT02349295|76148054|FG006|COMPLETED|Long-Term Extension Period (Week 24-156)||0||
60032379|NCT02349295|76148055|FG007|COMPLETED|Long-Term Extension Period (Week 24-156)||55||
60032380|NCT02349295|76148056|FG008|COMPLETED|Long-Term Extension Period (Week 24-156)||70||
60032381|NCT02349295|76148057|FG009|COMPLETED|Long-Term Extension Period (Week 24-156)||20||
60032382|NCT02349295|76148058|FG010|COMPLETED|Long-Term Extension Period (Week 24-156)||23||
60032383|NCT02349295|76148059|FG011|COMPLETED|Long-Term Extension Period (Week 24-156)||0||
60032384|NCT02349295|76148060|FG012|COMPLETED|Long-Term Extension Period (Week 24-156)||0||
60032385|NCT02349295|76148061|FG013|COMPLETED|Long-Term Extension Period (Week 24-156)||0||
60032386|NCT02349295|76148048|FG000|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0||
60032387|NCT02349295|76148049|FG001|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0||
60032388|NCT02349295|76148050|FG002|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0||
60032389|NCT02349295|76148051|FG003|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0||
60032390|NCT02349295|76148052|FG004|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0||
60032391|NCT02349295|76148053|FG005|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0||
60032392|NCT02349295|76148054|FG006|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0||
60032393|NCT02349295|76148055|FG007|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||52||
60032394|NCT02349295|76148056|FG008|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||41||
60032395|NCT02349295|76148057|FG009|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||26||
60032396|NCT02349295|76148058|FG010|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||23||
60032397|NCT02349295|76148059|FG011|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0||
60032398|NCT02349295|76148060|FG012|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0||
60032399|NCT02349295|76148061|FG013|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0||
60032400|NCT02349295|76148048|FG000|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0||
60032401|NCT02349295|76148049|FG001|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0||
60032402|NCT02349295|76148050|FG002|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0||
60032403|NCT02349295|76148051|FG003|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0||
60032404|NCT02349295|76148052|FG004|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0||
60032405|NCT02349295|76148053|FG005|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0||
60032406|NCT02349295|76148054|FG006|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0||
60032407|NCT02349295|76148055|FG007|STARTED|Follow-Up Period (Up to 12-24 Weeks)|Only included post-treatment follow-up participants.|0||
60032408|NCT02349295|76148056|FG008|STARTED|Follow-Up Period (Up to 12-24 Weeks)|Only included post-treatment follow-up participants.|0||
60032409|NCT02349295|76148057|FG009|STARTED|Follow-Up Period (Up to 12-24 Weeks)|Only included post-treatment follow-up participants.|0||
60032410|NCT02349295|76148058|FG010|STARTED|Follow-Up Period (Up to 12-24 Weeks)|Only included post-treatment follow-up participants.|0||
60032411|NCT02349295|76148059|FG011|STARTED|Follow-Up Period (Up to 12-24 Weeks)|IxeQ2W participants who entered post-treatment follow-up.|142||
60032412|NCT02349295|76148060|FG012|STARTED|Follow-Up Period (Up to 12-24 Weeks)|IxeQ4W participants who entered post-treatment follow-up.|145||
60032413|NCT02349295|76148061|FG013|STARTED|Follow-Up Period (Up to 12-24 Weeks)|PBO participants who entered post-treatment follow-up.|17||
60032414|NCT02349295|76148048|FG000|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0||
60032415|NCT02349295|76148049|FG001|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0||
60032416|NCT02349295|76148050|FG002|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0||
60032417|NCT02349295|76148051|FG003|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0||
60032418|NCT02349295|76148052|FG004|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0||
60032419|NCT02349295|76148053|FG005|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0||
60032420|NCT02349295|76148054|FG006|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0||
60032421|NCT02349295|76148055|FG007|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0||
60032422|NCT02349295|76148056|FG008|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0||
60032423|NCT02349295|76148057|FG009|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0||
60032424|NCT02349295|76148058|FG010|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0||
60032425|NCT02349295|76148059|FG011|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||133||
60032426|NCT02349295|76148060|FG012|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||137||
60032427|NCT02349295|76148061|FG013|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||16||
60032428|NCT02349295|76148048|FG000|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0||
60032429|NCT02349295|76148049|FG001|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0||
60032430|NCT02349295|76148050|FG002|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0||
60032431|NCT02349295|76148051|FG003|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0||
60032432|NCT02349295|76148052|FG004|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0||
60032433|NCT02349295|76148053|FG005|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0||
60032434|NCT02349295|76148054|FG006|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0||
60032435|NCT02349295|76148055|FG007|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0||
60032436|NCT02349295|76148056|FG008|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0||
60032437|NCT02349295|76148057|FG009|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0||
60032438|NCT02349295|76148058|FG010|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0||
60032439|NCT02349295|76148059|FG011|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||9||
60032440|NCT02349295|76148060|FG012|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||8||
60032441|NCT02349295|76148061|FG013|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||1||
60032442|NCT02281357|76148088|FG000|STARTED|Overall Study||70||
60032443|NCT02281357|76148089|FG001|STARTED|Overall Study||70||
60032444|NCT02281357|76148088|FG000|COMPLETED|Overall Study||63|Patients who completed treatment and patients who discontinued treatment but completed the study.|
60032445|NCT02281357|76148089|FG001|COMPLETED|Overall Study||66|Patients who completed treatment and patients who discontinued treatment but completed the study.|
60032446|NCT02281357|76148088|FG000|NOT COMPLETED|Overall Study||7||
60032447|NCT02281357|76148089|FG001|NOT COMPLETED|Overall Study||4||
60032448|NCT02284243|76148097|FG000|STARTED|Overall Study||84||
60032449|NCT02284243|76148098|FG001|STARTED|Overall Study||84||
60032450|NCT02284243|76148097|FG000|COMPLETED|Overall Study||80||
60032451|NCT02284243|76148098|FG001|COMPLETED|Overall Study||81||
60032452|NCT02284243|76148097|FG000|NOT COMPLETED|Overall Study||4||
60032453|NCT02284243|76148098|FG001|NOT COMPLETED|Overall Study||3||
60032454|NCT02284009|76148106|FG000|STARTED|Overall Study||17||
60032455|NCT02284009|76148107|FG001|STARTED|Overall Study||50||
60032456|NCT02284009|76148106|FG000|COMPLETED|Overall Study||11||
60032457|NCT02284009|76148107|FG001|COMPLETED|Overall Study||40||
60032458|NCT02284009|76148106|FG000|NOT COMPLETED|Overall Study||6||
60032459|NCT02284009|76148107|FG001|NOT COMPLETED|Overall Study||10||
60032460|NCT02280499|76148115|FG000|STARTED|Overall Study||87||
60032461|NCT02280499|76148115|FG000|COMPLETED|Overall Study||26||
60032462|NCT02280499|76148115|FG000|NOT COMPLETED|Overall Study||61||
60032463|NCT02400476|76148125|FG000|STARTED|Overall Study||137||
60032464|NCT02400476|76148126|FG001|STARTED|Overall Study||64||
60032465|NCT02400476|76148127|FG002|STARTED|Overall Study||136||
60032466|NCT02400476|76148128|FG003|STARTED|Overall Study||104||
60032467|NCT02400476|76148129|FG004|STARTED|Overall Study||60||
60032468|NCT02400476|76148130|FG005|STARTED|Overall Study||62||
60032469|NCT02400476|76148125|FG000|COMPLETED|Overall Study||76||
60032470|NCT02400476|76148126|FG001|COMPLETED|Overall Study||52||
60032471|NCT02400476|76148127|FG002|COMPLETED|Overall Study||95||
60032472|NCT02400476|76148128|FG003|COMPLETED|Overall Study||74||
60032473|NCT02400476|76148129|FG004|COMPLETED|Overall Study||45||
60032474|NCT02400476|76148130|FG005|COMPLETED|Overall Study||46||
60032475|NCT02400476|76148125|FG000|NOT COMPLETED|Overall Study||61||
60032476|NCT02400476|76148126|FG001|NOT COMPLETED|Overall Study||12||
60032477|NCT02400476|76148127|FG002|NOT COMPLETED|Overall Study||41||
60032478|NCT02400476|76148128|FG003|NOT COMPLETED|Overall Study||30||
60032479|NCT02400476|76148129|FG004|NOT COMPLETED|Overall Study||15||
60032480|NCT02400476|76148130|FG005|NOT COMPLETED|Overall Study||16||
60032481|NCT02363738|76148146|FG000|STARTED|Overall Study||29||
60032482|NCT02363738|76148147|FG001|STARTED|Overall Study||31||
60032483|NCT02363738|76148146|FG000|COMPLETED|Overall Study||21||
60032484|NCT02363738|76148147|FG001|COMPLETED|Overall Study||26||
60032485|NCT02363738|76148146|FG000|NOT COMPLETED|Overall Study||8||
60032486|NCT02363738|76148147|FG001|NOT COMPLETED|Overall Study||5||
60032487|NCT02331680|76148156|FG000|STARTED|Overall Study||40||
60032488|NCT02331680|76148157|FG001|STARTED|Overall Study||40||
60032489|NCT02331680|76148158|FG002|STARTED|Overall Study||44||
60032490|NCT02331680|76148156|FG000|COMPLETED|Overall Study||34||
60032491|NCT02331680|76148157|FG001|COMPLETED|Overall Study||36||
60032492|NCT02331680|76148158|FG002|COMPLETED|Overall Study||29||
60032493|NCT02331680|76148156|FG000|NOT COMPLETED|Overall Study||6||
60032494|NCT02331680|76148157|FG001|NOT COMPLETED|Overall Study||4||
60032495|NCT02331680|76148158|FG002|NOT COMPLETED|Overall Study||15||
60032496|NCT02331446|76148170|FG000|STARTED|Overall Study||9||
60032497|NCT02331446|76148171|FG001|STARTED|Overall Study||11||
60032498|NCT02331446|76148172|FG002|STARTED|Overall Study||11||
60032499|NCT02331446|76148173|FG003|STARTED|Overall Study||11||
60032500|NCT02331446|76148170|FG000|COMPLETED|Overall Study||5||
60032501|NCT02331446|76148171|FG001|COMPLETED|Overall Study||6||
60032502|NCT02331446|76148172|FG002|COMPLETED|Overall Study||8||
60032503|NCT02331446|76148173|FG003|COMPLETED|Overall Study||8||
60032504|NCT02331446|76148170|FG000|NOT COMPLETED|Overall Study||4||
60032505|NCT02331446|76148171|FG001|NOT COMPLETED|Overall Study||5||
60032506|NCT02331446|76148172|FG002|NOT COMPLETED|Overall Study||3||
60032507|NCT02331446|76148173|FG003|NOT COMPLETED|Overall Study||3||
60032508|NCT02349061|76148185|FG000|STARTED|Main Study: PCP (Up to Week 24)||42||
60032509|NCT02349061|76148186|FG001|STARTED|Main Study: PCP (Up to Week 24)||60||
60032510|NCT02349061|76148187|FG002|STARTED|Main Study: PCP (Up to Week 24)||0||
60032511|NCT02349061|76148185|FG000|COMPLETED|Main Study: PCP (Up to Week 24)||33||
60032512|NCT02349061|76148186|FG001|COMPLETED|Main Study: PCP (Up to Week 24)||56||
60032513|NCT02349061|76148187|FG002|COMPLETED|Main Study: PCP (Up to Week 24)||0||
60032514|NCT02349061|76148185|FG000|NOT COMPLETED|Main Study: PCP (Up to Week 24)||9||
60032515|NCT02349061|76148186|FG001|NOT COMPLETED|Main Study: PCP (Up to Week 24)||4||
60032516|NCT02349061|76148187|FG002|NOT COMPLETED|Main Study: PCP (Up to Week 24)||0||
60032517|NCT02349061|76148185|FG000|STARTED|Main Study: Week 24 to 56||0||
60032518|NCT02349061|76148186|FG001|STARTED|Main Study: Week 24 to 56||56||
60032519|NCT02349061|76148187|FG002|STARTED|Main Study: Week 24 to 56||33||
60032520|NCT02349061|76148185|FG000|COMPLETED|Main Study: Week 24 to 56||0||
60032521|NCT02349061|76148186|FG001|COMPLETED|Main Study: Week 24 to 56||53||
60032522|NCT02349061|76148187|FG002|COMPLETED|Main Study: Week 24 to 56||30||
59762603|NCT00866307|75882444|FG001|STARTED|Induction||0||
60032523|NCT02349061|76148185|FG000|NOT COMPLETED|Main Study: Week 24 to 56||0||
60032524|NCT02349061|76148186|FG001|NOT COMPLETED|Main Study: Week 24 to 56||3||
60032525|NCT02349061|76148187|FG002|NOT COMPLETED|Main Study: Week 24 to 56||3||
60032526|NCT02349061|76148185|FG000|STARTED|Study Extension (Week 56 to Week 120)||0||
60032527|NCT02349061|76148186|FG001|STARTED|Study Extension (Week 56 to Week 120)|Who met study extension inclusion criteria received open-label ustekinumab SC through Week 104.|29||
60032528|NCT02349061|76148187|FG002|STARTED|Study Extension (Week 56 to Week 120)|Who met study extension inclusion criteria received open-label ustekinumab SC through Week 104.|17||
60032529|NCT02349061|76148185|FG000|COMPLETED|Study Extension (Week 56 to Week 120)||0||
60032530|NCT02349061|76148186|FG001|COMPLETED|Study Extension (Week 56 to Week 120)||24||
60032531|NCT02349061|76148187|FG002|COMPLETED|Study Extension (Week 56 to Week 120)||14||
60032532|NCT02349061|76148185|FG000|NOT COMPLETED|Study Extension (Week 56 to Week 120)||0||
60032533|NCT02349061|76148186|FG001|NOT COMPLETED|Study Extension (Week 56 to Week 120)||5||
60032534|NCT02349061|76148187|FG002|NOT COMPLETED|Study Extension (Week 56 to Week 120)||3||
60032535|NCT02331368|76148197|FG000|STARTED|Overall Study||32||
60032536|NCT02331368|76148197|FG000|COMPLETED|Overall Study||29||
60032537|NCT02331368|76148197|FG000|NOT COMPLETED|Overall Study||3||
60032538|NCT02362724|76148203|FG000|STARTED|Overall Study||59||
60032539|NCT02362724|76148204|FG001|STARTED|Overall Study||30||
60032540|NCT02362724|76148203|FG000|COMPLETED|Overall Study||53||
60032541|NCT02362724|76148204|FG001|COMPLETED|Overall Study||29||
60032542|NCT02362724|76148203|FG000|NOT COMPLETED|Overall Study||6||
60032543|NCT02362724|76148204|FG001|NOT COMPLETED|Overall Study||1||
60032544|NCT02362646|76148212|FG000|STARTED|Overall Study||106||
60032545|NCT02362646|76148213|FG001|STARTED|Overall Study||53||
60032546|NCT02362646|76148212|FG000|COMPLETED|Overall Study||68||
60032547|NCT02362646|76148213|FG001|COMPLETED|Overall Study||29||
60032548|NCT02362646|76148212|FG000|NOT COMPLETED|Overall Study||38||
60032549|NCT02362646|76148213|FG001|NOT COMPLETED|Overall Study||24||
60032550|NCT02280421|76148223|FG000|STARTED|First Intervention(2 Weeks)||12||
60032551|NCT02280421|76148224|FG001|STARTED|First Intervention(2 Weeks)||12||
60032552|NCT02280421|76148223|FG000|Received Intervention|First Intervention(2 Weeks)||12||
60032553|NCT02280421|76148224|FG001|Received Intervention|First Intervention(2 Weeks)||12||
60032554|NCT02280421|76148223|FG000|COMPLETED|First Intervention(2 Weeks)||12||
60032555|NCT02280421|76148224|FG001|COMPLETED|First Intervention(2 Weeks)||12||
60032556|NCT02280421|76148223|FG000|NOT COMPLETED|First Intervention(2 Weeks)||0||
60032557|NCT02280421|76148224|FG001|NOT COMPLETED|First Intervention(2 Weeks)||0||
60032558|NCT02280421|76148223|FG000|STARTED|Washout (2 Weeks)||12||
60032559|NCT02280421|76148224|FG001|STARTED|Washout (2 Weeks)||12||
60032560|NCT02280421|76148223|FG000|COMPLETED|Washout (2 Weeks)||11||
60032561|NCT02280421|76148224|FG001|COMPLETED|Washout (2 Weeks)||11||
60032562|NCT02280421|76148223|FG000|NOT COMPLETED|Washout (2 Weeks)||1||
60032563|NCT02280421|76148224|FG001|NOT COMPLETED|Washout (2 Weeks)||1||
60032564|NCT02280421|76148223|FG000|STARTED|Second Intervention(2 Weeks)||12||
60032565|NCT02280421|76148224|FG001|STARTED|Second Intervention(2 Weeks)||12||
60032566|NCT02280421|76148223|FG000|Received Intervention|Second Intervention(2 Weeks)||12||
60032567|NCT02280421|76148224|FG001|Received Intervention|Second Intervention(2 Weeks)||12||
60032568|NCT02280421|76148223|FG000|COMPLETED|Second Intervention(2 Weeks)||12||
60032569|NCT02280421|76148224|FG001|COMPLETED|Second Intervention(2 Weeks)||12||
60032570|NCT02280421|76148223|FG000|NOT COMPLETED|Second Intervention(2 Weeks)||0||
60032571|NCT02280421|76148224|FG001|NOT COMPLETED|Second Intervention(2 Weeks)||0||
60032572|NCT02362412|76148242|FG000|STARTED|Treatment Period II||9||
60032573|NCT02362412|76148243|FG001|STARTED|Treatment Period II||11||
60032574|NCT02362412|76148242|FG000|TREATED|Treatment Period II||9||
60032575|NCT02362412|76148243|FG001|TREATED|Treatment Period II||11||
60032576|NCT02362412|76148242|FG000|COMPLETED|Treatment Period II||9||
60032577|NCT02362412|76148243|FG001|COMPLETED|Treatment Period II||11||
60032578|NCT02362412|76148242|FG000|NOT COMPLETED|Treatment Period II||0||
60032579|NCT02362412|76148243|FG001|NOT COMPLETED|Treatment Period II||0||
60032580|NCT02362412|76148242|FG000|STARTED|Treatment Period III||9||
60032581|NCT02362412|76148243|FG001|STARTED|Treatment Period III||11||
60032582|NCT02362412|76148242|FG000|TREATED|Treatment Period III||9||
60032583|NCT02362412|76148243|FG001|TREATED|Treatment Period III||11||
60032584|NCT02362412|76148242|FG000|COMPLETED|Treatment Period III||9||
60032585|NCT02362412|76148243|FG001|COMPLETED|Treatment Period III||10||
60032586|NCT02362412|76148242|FG000|NOT COMPLETED|Treatment Period III||0||
60032587|NCT02362412|76148243|FG001|NOT COMPLETED|Treatment Period III||1||
60032588|NCT02280187|76148255|FG000|STARTED|Overall Study||400||
60032589|NCT02280187|76148255|FG000|COMPLETED|Overall Study||182||
60032590|NCT02280187|76148255|FG000|NOT COMPLETED|Overall Study||218||
60032591|NCT02347813|76148261|FG000|STARTED|First Intervention, 24 Weeks||6||
60032592|NCT02347813|76148262|FG001|STARTED|First Intervention, 24 Weeks||6||
60032593|NCT02347813|76148261|FG000|COMPLETED|First Intervention, 24 Weeks||4||
60032594|NCT02347813|76148262|FG001|COMPLETED|First Intervention, 24 Weeks||4||
60032595|NCT02347813|76148261|FG000|NOT COMPLETED|First Intervention, 24 Weeks||2||
60032596|NCT02347813|76148262|FG001|NOT COMPLETED|First Intervention, 24 Weeks||2||
60032597|NCT02347813|76148261|FG000|STARTED|Second Intervention, 24 Weeks||4||
60032598|NCT02347813|76148262|FG001|STARTED|Second Intervention, 24 Weeks||4||
60032599|NCT02347813|76148261|FG000|COMPLETED|Second Intervention, 24 Weeks||4||
60032600|NCT02347813|76148262|FG001|COMPLETED|Second Intervention, 24 Weeks||4||
60032601|NCT02347813|76148261|FG000|NOT COMPLETED|Second Intervention, 24 Weeks||0||
60032602|NCT02347813|76148262|FG001|NOT COMPLETED|Second Intervention, 24 Weeks||0||
59507938|NCT00828061|75601077|FG004|COMPLETED|Period 3||3||
59507939|NCT00828061|75601078|FG005|COMPLETED|Period 3||3||
59507940|NCT00828061|75601073|FG000|NOT COMPLETED|Period 3||0||
59507941|NCT00828061|75601074|FG001|NOT COMPLETED|Period 3||0||
59507942|NCT00828061|75601075|FG002|NOT COMPLETED|Period 3||0||
59507943|NCT00828061|75601076|FG003|NOT COMPLETED|Period 3||0||
59507944|NCT00828061|75601077|FG004|NOT COMPLETED|Period 3||0||
59507945|NCT00828061|75601078|FG005|NOT COMPLETED|Period 3||0||
59507946|NCT00849121|75601088|FG000|STARTED|Overall Study||8||
60032603|NCT02329730|76148272|FG000|STARTED|Overall Study||14||
60032604|NCT02329730|76148273|FG001|STARTED|Overall Study||14||
60032605|NCT02329730|76148274|FG002|STARTED|Overall Study||14||
60032606|NCT02329730|76148275|FG003|STARTED|Overall Study||14||
60032607|NCT02329730|76148276|FG004|STARTED|Overall Study||14||
59507947|NCT00849121|75601089|FG001|STARTED|Overall Study||9||
59507948|NCT00849121|75601088|FG000|COMPLETED|Overall Study||8||
59507949|NCT00849121|75601089|FG001|COMPLETED|Overall Study||9||
59507950|NCT00849121|75601088|FG000|NOT COMPLETED|Overall Study||0||
59507951|NCT00849121|75601089|FG001|NOT COMPLETED|Overall Study||0||
59507952|NCT02023125|75601097|FG000|STARTED|Period 1||9||
59507953|NCT02023125|75601098|FG001|STARTED|Period 1||9||
59507954|NCT02023125|75601099|FG002|STARTED|Period 1||24||
59507955|NCT02023125|75601097|FG000|COMPLETED|Period 1||9||
59916814|NCT03364309|76037551|FG010|STARTED|Induction Period||0||
60032608|NCT02329730|76148277|FG005|STARTED|Overall Study||14||
60032609|NCT02329730|76148278|FG006|STARTED|Overall Study||14||
59507956|NCT02023125|75601098|FG001|COMPLETED|Period 1||9||
59507957|NCT02023125|75601099|FG002|COMPLETED|Period 1||24||
59507958|NCT02023125|75601097|FG000|NOT COMPLETED|Period 1||0||
59916815|NCT03364309|76037552|FG011|STARTED|Induction Period||0||
59916816|NCT03364309|76037553|FG012|STARTED|Induction Period||0||
59916817|NCT03364309|76037554|FG013|STARTED|Induction Period||0||
59916818|NCT03364309|76037555|FG014|STARTED|Induction Period||0||
59916819|NCT03364309|76037556|FG015|STARTED|Induction Period||0||
59916820|NCT03364309|76037557|FG016|STARTED|Induction Period||0||
59916821|NCT03364309|76037558|FG017|STARTED|Induction Period||0||
59916822|NCT03364309|76037559|FG018|STARTED|Induction Period||0||
59916823|NCT03364309|76037541|FG000|Received at Least One Dose of Study Drug|Induction Period||88||
59916824|NCT03364309|76037542|FG001|Received at Least One Dose of Study Drug|Induction Period||174||
59916825|NCT03364309|76037543|FG002|Received at Least One Dose of Study Drug|Induction Period||176||
59916826|NCT03364309|76037544|FG003|Received at Least One Dose of Study Drug|Induction Period||0||
59916827|NCT03364309|76037545|FG004|Received at Least One Dose of Study Drug|Induction Period||0||
59916828|NCT03364309|76037546|FG005|Received at Least One Dose of Study Drug|Induction Period||0||
59916829|NCT03364309|76037547|FG006|Received at Least One Dose of Study Drug|Induction Period||0||
59916830|NCT03364309|76037548|FG007|Received at Least One Dose of Study Drug|Induction Period||0||
59916831|NCT03364309|76037549|FG008|Received at Least One Dose of Study Drug|Induction Period||0||
59916832|NCT03364309|76037550|FG009|Received at Least One Dose of Study Drug|Induction Period||0||
59916833|NCT03364309|76037551|FG010|Received at Least One Dose of Study Drug|Induction Period||0||
59916834|NCT03364309|76037552|FG011|Received at Least One Dose of Study Drug|Induction Period||0||
59916835|NCT03364309|76037553|FG012|Received at Least One Dose of Study Drug|Induction Period||0||
59916836|NCT03364309|76037554|FG013|Received at Least One Dose of Study Drug|Induction Period||0||
60032610|NCT02329730|76148279|FG007|STARTED|Overall Study||14||
60032611|NCT02329730|76148280|FG008|STARTED|Overall Study||8||
60032612|NCT02329730|76148281|FG009|STARTED|Overall Study||8||
59507959|NCT02023125|75601098|FG001|NOT COMPLETED|Period 1||0||
59507960|NCT02023125|75601099|FG002|NOT COMPLETED|Period 1||0||
59507961|NCT02023125|75601097|FG000|STARTED|Washout Period||9||
59507962|NCT02023125|75601098|FG001|STARTED|Washout Period||9||
59507963|NCT02023125|75601099|FG002|STARTED|Washout Period||24||
59507964|NCT02023125|75601097|FG000|COMPLETED|Washout Period||9||
59507965|NCT02023125|75601098|FG001|COMPLETED|Washout Period||9||
59916837|NCT03364309|76037555|FG014|Received at Least One Dose of Study Drug|Induction Period||0||
59507966|NCT02023125|75601099|FG002|COMPLETED|Washout Period||24||
59507967|NCT02023125|75601097|FG000|NOT COMPLETED|Washout Period||0||
59507968|NCT02023125|75601098|FG001|NOT COMPLETED|Washout Period||0||
59507969|NCT02023125|75601099|FG002|NOT COMPLETED|Washout Period||0||
59507970|NCT02023125|75601097|FG000|STARTED|Period 2||9||
59507971|NCT02023125|75601098|FG001|STARTED|Period 2||9||
59507972|NCT02023125|75601099|FG002|STARTED|Period 2||24||
59507973|NCT02023125|75601097|FG000|COMPLETED|Period 2||9||
59507974|NCT02023125|75601098|FG001|COMPLETED|Period 2||9||
59507975|NCT02023125|75601099|FG002|COMPLETED|Period 2||24||
59507976|NCT02023125|75601097|FG000|NOT COMPLETED|Period 2||0||
59507977|NCT02023125|75601098|FG001|NOT COMPLETED|Period 2||0||
59507978|NCT02023125|75601099|FG002|NOT COMPLETED|Period 2||0||
59507979|NCT00803959|75601113|FG000|STARTED|Overall Study||315||
59507980|NCT00803959|75601114|FG001|STARTED|Overall Study||315||
59507981|NCT00803959|75601113|FG000|ITT Analysis With Primary Outcome Data|Overall Study||266||
59507982|NCT00803959|75601114|FG001|ITT Analysis With Primary Outcome Data|Overall Study||272||
59507983|NCT00803959|75601113|FG000|COMPLETED|Overall Study|Because it is a non-inferiority trial, the PP analysis was the main analysis (n=259).|259||
59507984|NCT00803959|75601114|FG001|COMPLETED|Overall Study|Because it is a non-inferiority trial, the PP analysis was the main analysis (n=264).|264||
59507985|NCT00803959|75601113|FG000|NOT COMPLETED|Overall Study||56||
59507986|NCT00803959|75601114|FG001|NOT COMPLETED|Overall Study||51||
59507987|NCT02349477|75601122|FG000|STARTED|Overall Study||44||
59507988|NCT02349477|75601123|FG001|STARTED|Overall Study||46||
59507989|NCT02349477|75601122|FG000|COMPLETED|Overall Study||31||
59507990|NCT02349477|75601123|FG001|COMPLETED|Overall Study||28||
59507991|NCT02349477|75601122|FG000|NOT COMPLETED|Overall Study||13||
59507992|NCT02349477|75601123|FG001|NOT COMPLETED|Overall Study||18||
59507993|NCT00828295|75601135|FG000|STARTED|Overall Study||75||
59507994|NCT00828295|75601136|FG001|STARTED|Overall Study||75||
59507995|NCT00828295|75601135|FG000|COMPLETED|Overall Study||75||
59507996|NCT00828295|75601136|FG001|COMPLETED|Overall Study||75||
59507997|NCT00828295|75601135|FG000|NOT COMPLETED|Overall Study||0||
59507998|NCT00828295|75601136|FG001|NOT COMPLETED|Overall Study||0||
59507999|NCT00850603|75601147|FG000|STARTED|Overall Study||34||
59508000|NCT00850603|75601148|FG001|STARTED|Overall Study||34||
59508001|NCT00850603|75601149|FG002|STARTED|Overall Study||34||
59508002|NCT00850603|75601150|FG003|STARTED|Overall Study||34||
59508003|NCT00850603|75601151|FG004|STARTED|Overall Study||34||
59508004|NCT00850603|75601147|FG000|COMPLETED|Overall Study||34||
59508005|NCT00850603|75601148|FG001|COMPLETED|Overall Study||34||
59508006|NCT00850603|75601149|FG002|COMPLETED|Overall Study||34||
59508007|NCT00850603|75601150|FG003|COMPLETED|Overall Study||34||
59508008|NCT00850603|75601151|FG004|COMPLETED|Overall Study||34||
59508009|NCT00850603|75601147|FG000|NOT COMPLETED|Overall Study||0||
59508010|NCT00850603|75601148|FG001|NOT COMPLETED|Overall Study||0||
59508011|NCT00850603|75601149|FG002|NOT COMPLETED|Overall Study||0||
59508012|NCT00850603|75601150|FG003|NOT COMPLETED|Overall Study||0||
59508013|NCT00850603|75601151|FG004|NOT COMPLETED|Overall Study||0||
59508014|NCT02350569|75601163|FG000|STARTED|Main Study (LDV/SOF 4 Weeks)||16||
59508015|NCT02350569|75601163|FG000|COMPLETED|Main Study (LDV/SOF 4 Weeks)|1 participant discontinued treatment, but completed follow-up visits and study.|16||
59508016|NCT02350569|75601163|FG000|NOT COMPLETED|Main Study (LDV/SOF 4 Weeks)||0||
59508017|NCT02350569|75601163|FG000|STARTED|Retreatment (LDV/SOF 12 Weeks)|1 completed treatment (Main Study), experienced virologic failure, and entered Retreatment Phase|1||
59916838|NCT03364309|76037556|FG015|Received at Least One Dose of Study Drug|Induction Period||0||
59916839|NCT03364309|76037557|FG016|Received at Least One Dose of Study Drug|Induction Period||0||
59916840|NCT03364309|76037558|FG017|Received at Least One Dose of Study Drug|Induction Period||0||
59916841|NCT03364309|76037559|FG018|Received at Least One Dose of Study Drug|Induction Period||0||
59916842|NCT03364309|76037541|FG000|COMPLETED|Induction Period||82||
59916843|NCT03364309|76037542|FG001|COMPLETED|Induction Period||170||
59916844|NCT03364309|76037543|FG002|COMPLETED|Induction Period||175||
59916845|NCT03364309|76037544|FG003|COMPLETED|Induction Period||0||
59916846|NCT03364309|76037545|FG004|COMPLETED|Induction Period||0||
59916847|NCT03364309|76037546|FG005|COMPLETED|Induction Period||0||
59916848|NCT03364309|76037547|FG006|COMPLETED|Induction Period||0||
59916849|NCT03364309|76037548|FG007|COMPLETED|Induction Period||0||
59916850|NCT03364309|76037549|FG008|COMPLETED|Induction Period||0||
59508018|NCT02350569|75601163|FG000|COMPLETED|Retreatment (LDV/SOF 12 Weeks)||1||
59508019|NCT02350569|75601163|FG000|NOT COMPLETED|Retreatment (LDV/SOF 12 Weeks)||0||
59508020|NCT02023515|75601171|FG000|STARTED|Overall Study||24||
59508021|NCT02023515|75601172|FG001|STARTED|Overall Study||25||
59508022|NCT02023515|75601171|FG000|COMPLETED|Overall Study||23||
59508023|NCT02023515|75601172|FG001|COMPLETED|Overall Study||22||
59508024|NCT02023515|75601171|FG000|NOT COMPLETED|Overall Study||1||
59508025|NCT02023515|75601172|FG001|NOT COMPLETED|Overall Study||3||
59508026|NCT02350647|75601180|FG000|STARTED|Overall Study||32||
59508027|NCT02350647|75601181|FG001|STARTED|Overall Study||32||
59508028|NCT02350647|75601180|FG000|COMPLETED|Overall Study||26||
59508029|NCT02350647|75601181|FG001|COMPLETED|Overall Study||26||
59508030|NCT02350647|75601180|FG000|NOT COMPLETED|Overall Study||6||
59916851|NCT03364309|76037550|FG009|COMPLETED|Induction Period||0||
59508031|NCT02350647|75601181|FG001|NOT COMPLETED|Overall Study||6||
59508032|NCT02350881|75601187|FG000|STARTED|Overall Study|64 patients were included (6 bilateral)|64||
59508033|NCT02350881|75601187|FG000|COMPLETED|Overall Study|64 patients were completed (6 bilateral)|64||
59508034|NCT02350881|75601187|FG000|NOT COMPLETED|Overall Study||0||
59508035|NCT02023983|75601214|FG000|STARTED|Overall Study||76||
59508036|NCT02023983|75601215|FG001|STARTED|Overall Study||75||
59508037|NCT02023983|75601214|FG000|COMPLETED|Overall Study||76||
59508038|NCT02023983|75601215|FG001|COMPLETED|Overall Study||75||
59508039|NCT02023983|75601214|FG000|NOT COMPLETED|Overall Study||0||
59508040|NCT02023983|75601215|FG001|NOT COMPLETED|Overall Study||0||
59508041|NCT02351115|75601226|FG000|STARTED|Overall Study||1||
59508042|NCT02351115|75601227|FG001|STARTED|Overall Study||1||
59508043|NCT02351115|75601228|FG002|STARTED|Overall Study||1||
59508044|NCT02351115|75601229|FG003|STARTED|Overall Study||1||
59508045|NCT02351115|75601230|FG004|STARTED|Overall Study||1||
59508046|NCT02351115|75601226|FG000|COMPLETED|Overall Study||1||
59508047|NCT02351115|75601227|FG001|COMPLETED|Overall Study||1||
59508048|NCT02351115|75601228|FG002|COMPLETED|Overall Study||1||
59508049|NCT02351115|75601229|FG003|COMPLETED|Overall Study||1||
59508050|NCT02351115|75601230|FG004|COMPLETED|Overall Study||1||
59508051|NCT02351115|75601226|FG000|NOT COMPLETED|Overall Study||0||
59508052|NCT02351115|75601227|FG001|NOT COMPLETED|Overall Study||0||
59508053|NCT02351115|75601228|FG002|NOT COMPLETED|Overall Study||0||
59508054|NCT02351115|75601229|FG003|NOT COMPLETED|Overall Study||0||
59508055|NCT02351115|75601230|FG004|NOT COMPLETED|Overall Study||0||
59508056|NCT02351271|75601245|FG000|STARTED|Overall Study||68||
59508057|NCT02351271|75601246|FG001|STARTED|Overall Study||62||
59508058|NCT02351271|75601245|FG000|COMPLETED|Overall Study||68||
59508059|NCT02351271|75601246|FG001|COMPLETED|Overall Study||62||
59508060|NCT02351271|75601245|FG000|NOT COMPLETED|Overall Study||0||
59508061|NCT02351271|75601246|FG001|NOT COMPLETED|Overall Study||0||
59508062|NCT02025075|75601256|FG000|STARTED|Overall Study||16||
59508063|NCT02025075|75601257|FG001|STARTED|Overall Study||21||
59508064|NCT02025075|75601256|FG000|COMPLETED|Overall Study||16||
59508065|NCT02025075|75601257|FG001|COMPLETED|Overall Study||19||
59508066|NCT02025075|75601256|FG000|NOT COMPLETED|Overall Study||0||
59508067|NCT02025075|75601257|FG001|NOT COMPLETED|Overall Study||2||
59508068|NCT02351505|75601269|FG000|STARTED|Overall Study||1||
59508069|NCT02351505|75601269|FG000|COMPLETED|Overall Study||1||
59508070|NCT02351505|75601269|FG000|NOT COMPLETED|Overall Study||0||
59508071|NCT00242567|75601276|FG000|STARTED|Overall Study||259||
59508072|NCT00242567|75601277|FG001|STARTED|Overall Study||263||
59612059|NCT01704846|75723181|FG001|STARTED|Treatment Period 4||29||
59612060|NCT01704846|75723180|FG000|COMPLETED|Treatment Period 4||30||
59612061|NCT01704846|75723181|FG001|COMPLETED|Treatment Period 4||29||
59916852|NCT03364309|76037551|FG010|COMPLETED|Induction Period||0||
59916853|NCT03364309|76037552|FG011|COMPLETED|Induction Period||0||
59916854|NCT03364309|76037553|FG012|COMPLETED|Induction Period||0||
59508073|NCT00242567|75601276|FG000|Received at Least 1 Dose of Study Drug|Overall Study||259||
59508074|NCT00242567|75601277|FG001|Received at Least 1 Dose of Study Drug|Overall Study||72||
59612062|NCT01704846|75723180|FG000|NOT COMPLETED|Treatment Period 4||0||
59612063|NCT01704846|75723181|FG001|NOT COMPLETED|Treatment Period 4||0||
59612064|NCT01751802|75723189|FG000|STARTED|Overall Study||5||
59916855|NCT03364309|76037554|FG013|COMPLETED|Induction Period||0||
59508075|NCT00242567|75601276|FG000|Never Received Study Drug|Overall Study||0||
59508076|NCT00242567|75601277|FG001|Never Received Study Drug|Overall Study||191||
59508077|NCT00242567|75601276|FG000|COMPLETED|Overall Study||93||
59508078|NCT00242567|75601277|FG001|COMPLETED|Overall Study||123||
59508079|NCT00242567|75601276|FG000|NOT COMPLETED|Overall Study||166||
59508080|NCT00242567|75601277|FG001|NOT COMPLETED|Overall Study||140||
59508081|NCT00241631|75601287|FG000|STARTED|Run in (2 Weeks)||25||
59508082|NCT00241631|75601288|FG001|STARTED|Run in (2 Weeks)||24||
59508083|NCT00241631|75601287|FG000|COMPLETED|Run in (2 Weeks)||22||
59508084|NCT00241631|75601288|FG001|COMPLETED|Run in (2 Weeks)||21||
59508085|NCT00241631|75601287|FG000|NOT COMPLETED|Run in (2 Weeks)||3||
59508086|NCT00241631|75601288|FG001|NOT COMPLETED|Run in (2 Weeks)||3||
59508087|NCT00241631|75601287|FG000|STARTED|Phase 1 (4 Weeks)||22||
59508088|NCT00241631|75601288|FG001|STARTED|Phase 1 (4 Weeks)||21||
59612065|NCT01751802|75723190|FG001|STARTED|Overall Study||4||
59612066|NCT01751802|75723189|FG000|Completed Period 1|Overall Study||2||
59612067|NCT01751802|75723190|FG001|Completed Period 1|Overall Study||4||
59612068|NCT01751802|75723189|FG000|Completed Period 2|Overall Study||2||
59612069|NCT01751802|75723190|FG001|Completed Period 2|Overall Study||1||
59612070|NCT01751802|75723189|FG000|Completed Period 3|Overall Study||2||
59612071|NCT01751802|75723190|FG001|Completed Period 3|Overall Study||1||
59612072|NCT01751802|75723189|FG000|COMPLETED|Overall Study||1||
59612073|NCT01751802|75723190|FG001|COMPLETED|Overall Study||2||
59612074|NCT01751802|75723189|FG000|NOT COMPLETED|Overall Study||4||
59612075|NCT01751802|75723190|FG001|NOT COMPLETED|Overall Study||2||
59916856|NCT03364309|76037555|FG014|COMPLETED|Induction Period||0||
59508089|NCT00241631|75601287|FG000|COMPLETED|Phase 1 (4 Weeks)||14||
59508090|NCT00241631|75601288|FG001|COMPLETED|Phase 1 (4 Weeks)||16||
59508091|NCT00241631|75601287|FG000|NOT COMPLETED|Phase 1 (4 Weeks)||8||
59508092|NCT00241631|75601288|FG001|NOT COMPLETED|Phase 1 (4 Weeks)||5||
59508093|NCT00241631|75601287|FG000|STARTED|Wash Out (2 Weeks)||14||
59508094|NCT00241631|75601288|FG001|STARTED|Wash Out (2 Weeks)||16||
59508095|NCT00241631|75601287|FG000|COMPLETED|Wash Out (2 Weeks)||14||
59508096|NCT00241631|75601288|FG001|COMPLETED|Wash Out (2 Weeks)||16||
59508097|NCT00241631|75601287|FG000|NOT COMPLETED|Wash Out (2 Weeks)||0||
59508098|NCT00241631|75601288|FG001|NOT COMPLETED|Wash Out (2 Weeks)||0||
59759268|NCT00561925|75878610|FG004|NOT COMPLETED|144-week Double-blind, Double-dummy||0||
59759269|NCT00561925|75878606|FG000|STARTED|Open-Label Extension Period||0||
59508099|NCT00241631|75601287|FG000|STARTED|Phase 2 (4 Weeks)||14||
59508100|NCT00241631|75601288|FG001|STARTED|Phase 2 (4 Weeks)||16||
59508101|NCT00241631|75601287|FG000|COMPLETED|Phase 2 (4 Weeks)||14||
59508102|NCT00241631|75601288|FG001|COMPLETED|Phase 2 (4 Weeks)||16||
59508103|NCT00241631|75601287|FG000|NOT COMPLETED|Phase 2 (4 Weeks)||0||
59508104|NCT00241631|75601288|FG001|NOT COMPLETED|Phase 2 (4 Weeks)||0||
59508105|NCT02351739|75601296|FG000|STARTED|Overall Study||38||
59508106|NCT02351739|75601297|FG001|STARTED|Overall Study||40||
59508107|NCT02351739|75601296|FG000|Enrolled|Overall Study||38||
59508108|NCT02351739|75601297|FG001|Enrolled|Overall Study||40||
59508109|NCT02351739|75601296|FG000|Received Study Medication|Overall Study||35||
60032613|NCT02329730|76148282|FG010|STARTED|Overall Study||8||
60032614|NCT02329730|76148283|FG011|STARTED|Overall Study||8||
60032615|NCT02329730|76148272|FG000|COMPLETED|Overall Study||14||
59508110|NCT02351739|75601297|FG001|Received Study Medication|Overall Study||40||
59508111|NCT02351739|75601296|FG000|Discontinued Study|Overall Study||38||
59759270|NCT00561925|75878607|FG001|STARTED|Open-Label Extension Period||1||
59759271|NCT00561925|75878608|FG002|STARTED|Open-Label Extension Period||0||
59759272|NCT00561925|75878609|FG003|STARTED|Open-Label Extension Period||358||
59759273|NCT00561925|75878610|FG004|STARTED|Open-Label Extension Period||378||
59759274|NCT00561925|75878606|FG000|COMPLETED|Open-Label Extension Period||0||
59759275|NCT00561925|75878607|FG001|COMPLETED|Open-Label Extension Period||1||
59759276|NCT00561925|75878608|FG002|COMPLETED|Open-Label Extension Period||0||
59759277|NCT00561925|75878609|FG003|COMPLETED|Open-Label Extension Period||315||
59759278|NCT00561925|75878610|FG004|COMPLETED|Open-Label Extension Period||328||
59759279|NCT00561925|75878606|FG000|NOT COMPLETED|Open-Label Extension Period||0||
59759280|NCT00561925|75878607|FG001|NOT COMPLETED|Open-Label Extension Period||0||
59759281|NCT00561925|75878608|FG002|NOT COMPLETED|Open-Label Extension Period||0||
59759282|NCT00561925|75878609|FG003|NOT COMPLETED|Open-Label Extension Period||43||
59759283|NCT00561925|75878610|FG004|NOT COMPLETED|Open-Label Extension Period||50||
59759284|NCT00549445|75878630|FG000|STARTED|Overall Study||23||
59759285|NCT00549445|75878631|FG001|STARTED|Overall Study||30||
59759286|NCT00549445|75878630|FG000|COMPLETED|Overall Study||8||
60032616|NCT02329730|76148273|FG001|COMPLETED|Overall Study||14||
60032617|NCT02329730|76148274|FG002|COMPLETED|Overall Study||14||
60032618|NCT02329730|76148275|FG003|COMPLETED|Overall Study||14||
60032619|NCT02329730|76148276|FG004|COMPLETED|Overall Study||11||
60032620|NCT02329730|76148277|FG005|COMPLETED|Overall Study||12||
60032621|NCT02329730|76148278|FG006|COMPLETED|Overall Study||13||
60032622|NCT02329730|76148279|FG007|COMPLETED|Overall Study||13||
60032623|NCT02329730|76148280|FG008|COMPLETED|Overall Study||7||
60032624|NCT02329730|76148281|FG009|COMPLETED|Overall Study||7||
60032625|NCT02329730|76148282|FG010|COMPLETED|Overall Study||8||
59759287|NCT00549445|75878631|FG001|COMPLETED|Overall Study||13||
59759288|NCT00549445|75878630|FG000|NOT COMPLETED|Overall Study||15||
59759289|NCT00549445|75878631|FG001|NOT COMPLETED|Overall Study||17||
59759290|NCT00601107|75878641|FG000|STARTED|Overall Study|Randomized.|27||
59759291|NCT00601107|75878642|FG001|STARTED|Overall Study||31||
59759292|NCT00601107|75878643|FG002|STARTED|Overall Study||28||
59759293|NCT00601107|75878644|FG003|STARTED|Overall Study||25||
60032626|NCT02329730|76148283|FG011|COMPLETED|Overall Study||8||
59508112|NCT02351739|75601297|FG001|Discontinued Study|Overall Study||40||
59508113|NCT02351739|75601296|FG000|COMPLETED|Overall Study||0||
59508114|NCT02351739|75601297|FG001|COMPLETED|Overall Study||0||
59508115|NCT02351739|75601296|FG000|NOT COMPLETED|Overall Study||38||
59508116|NCT02351739|75601297|FG001|NOT COMPLETED|Overall Study||40||
60032627|NCT02329730|76148272|FG000|NOT COMPLETED|Overall Study||0||
60032628|NCT02329730|76148273|FG001|NOT COMPLETED|Overall Study||0||
59508117|NCT00240071|75601303|FG000|STARTED|Overall Study||30||
59508118|NCT00240071|75601303|FG000|COMPLETED|Overall Study|3 patients withdrew consent after 29, 5 and 3 1/2 months on study.|27||
59508119|NCT00240071|75601303|FG000|NOT COMPLETED|Overall Study||3||
59508120|NCT02352363|75601310|FG000|STARTED|Overall Study||278||
59508121|NCT02352363|75601311|FG001|STARTED|Overall Study||130||
59508122|NCT02352363|75601310|FG000|COMPLETED|Overall Study||271||
59508123|NCT02352363|75601311|FG001|COMPLETED|Overall Study||127||
59508124|NCT02352363|75601310|FG000|NOT COMPLETED|Overall Study||7||
59508125|NCT02352363|75601311|FG001|NOT COMPLETED|Overall Study||3||
59508126|NCT00765947|75601317|FG000|STARTED|Overall Study||256||
59508127|NCT00765947|75601317|FG000|COMPLETED|Overall Study||232||
59508128|NCT00765947|75601317|FG000|NOT COMPLETED|Overall Study||24||
59508129|NCT00766649|75601323|FG000|STARTED|Overall Study||11||
59508130|NCT00766649|75601323|FG000|COMPLETED|Overall Study||1||
59508131|NCT00766649|75601323|FG000|NOT COMPLETED|Overall Study||10||
60032629|NCT02329730|76148274|FG002|NOT COMPLETED|Overall Study||0||
60032630|NCT02329730|76148275|FG003|NOT COMPLETED|Overall Study||0||
60032631|NCT02329730|76148276|FG004|NOT COMPLETED|Overall Study||3||
60032632|NCT02329730|76148277|FG005|NOT COMPLETED|Overall Study||2||
60032633|NCT02329730|76148278|FG006|NOT COMPLETED|Overall Study||1||
60032634|NCT02329730|76148279|FG007|NOT COMPLETED|Overall Study||1||
60032635|NCT02329730|76148280|FG008|NOT COMPLETED|Overall Study||1||
60032636|NCT02329730|76148281|FG009|NOT COMPLETED|Overall Study||1||
60032637|NCT02329730|76148282|FG010|NOT COMPLETED|Overall Study||0||
60032638|NCT02329730|76148283|FG011|NOT COMPLETED|Overall Study||0||
60032639|NCT02328326|76148303|FG000|STARTED|Overall Study|3 participant dyads withdrew before 6-month follow up. 3 more care partners withdrew and 1 died.|246||
59508132|NCT02352831|75601329|FG000|STARTED|Overall Study||6||
59508133|NCT02352831|75601330|FG001|STARTED|Overall Study||10||
59508134|NCT02352831|75601329|FG000|COMPLETED|Overall Study||6||
59508135|NCT02352831|75601330|FG001|COMPLETED|Overall Study||10||
59508136|NCT02352831|75601329|FG000|NOT COMPLETED|Overall Study||0||
59508137|NCT02352831|75601330|FG001|NOT COMPLETED|Overall Study||0||
59508138|NCT00766727|75601338|FG000|STARTED|Overall Study||12||
59508139|NCT00766727|75601338|FG000|COMPLETED|Overall Study||9||
59508140|NCT00766727|75601338|FG000|NOT COMPLETED|Overall Study||3||
59508141|NCT02353299|75601344|FG000|STARTED|First Intervention (1 Night)||13||
59508142|NCT02353299|75601345|FG001|STARTED|First Intervention (1 Night)||13||
59508143|NCT02353299|75601346|FG002|STARTED|First Intervention (1 Night)||13||
59508144|NCT02353299|75601347|FG003|STARTED|First Intervention (1 Night)||13||
59508145|NCT02353299|75601344|FG000|COMPLETED|First Intervention (1 Night)||13||
59508146|NCT02353299|75601345|FG001|COMPLETED|First Intervention (1 Night)||13||
59508147|NCT02353299|75601346|FG002|COMPLETED|First Intervention (1 Night)||13||
59508148|NCT02353299|75601347|FG003|COMPLETED|First Intervention (1 Night)||13||
59508149|NCT02353299|75601344|FG000|NOT COMPLETED|First Intervention (1 Night)||0||
60032640|NCT02328326|76148304|FG001|STARTED|Overall Study|1 participant dyad withdrew from the study between assignment to control arm and 6-month follow up.|232||
60032641|NCT02328326|76148303|FG000|6-month Follow Up|Overall Study|We were unable to reach 15 participants. 1 patient died, 1 care partner withdrew before completion.|221||
60032642|NCT02328326|76148304|FG001|6-month Follow Up|Overall Study|We were unable to reach 9 participants. 1 patient died, 1 care partner withdrew before completion.|221||
60032643|NCT02328326|76148303|FG000|COMPLETED|Overall Study||224||
60032644|NCT02328326|76148304|FG001|COMPLETED|Overall Study||224||
60032645|NCT02328326|76148303|FG000|NOT COMPLETED|Overall Study||22||
60032646|NCT02328326|76148304|FG001|NOT COMPLETED|Overall Study||8||
60032647|NCT01649804|76148312|FG000|STARTED|Overall Study||12||
60032648|NCT01649804|76148312|FG000|COMPLETED|Overall Study||4||
60032649|NCT01649804|76148312|FG000|NOT COMPLETED|Overall Study||8||
60032650|NCT02397278|76148318|FG000|STARTED|Overall Study||7||
60032651|NCT02397278|76148319|FG001|STARTED|Overall Study||8||
59508150|NCT02353299|75601345|FG001|NOT COMPLETED|First Intervention (1 Night)||0||
59508151|NCT02353299|75601346|FG002|NOT COMPLETED|First Intervention (1 Night)||0||
59508152|NCT02353299|75601347|FG003|NOT COMPLETED|First Intervention (1 Night)||0||
59508153|NCT02353299|75601344|FG000|STARTED|Second Intervention (1 Night)||13||
59612076|NCT01704456|75723204|FG000|STARTED|Overall Study||67||
59612077|NCT01704456|75723205|FG001|STARTED|Overall Study||63||
59612078|NCT01704456|75723204|FG000|COMPLETED|Overall Study||59||
60032652|NCT02397278|76148318|FG000|COMPLETED|Overall Study||6||
60032653|NCT02397278|76148319|FG001|COMPLETED|Overall Study||5||
60032654|NCT02397278|76148318|FG000|NOT COMPLETED|Overall Study||1||
60032655|NCT02397278|76148319|FG001|NOT COMPLETED|Overall Study||3||
60032656|NCT02360228|76148328|FG000|STARTED|Overall Study||9||
60032657|NCT02360228|76148329|FG001|STARTED|Overall Study||8||
60032658|NCT02360228|76148330|FG002|STARTED|Overall Study||8||
60032659|NCT02360228|76148328|FG000|COMPLETED|Overall Study||8||
60032660|NCT02360228|76148329|FG001|COMPLETED|Overall Study||7||
60032661|NCT02360228|76148330|FG002|COMPLETED|Overall Study||7||
60032662|NCT02360228|76148328|FG000|NOT COMPLETED|Overall Study||1||
60032663|NCT02360228|76148329|FG001|NOT COMPLETED|Overall Study||1||
60032664|NCT02360228|76148330|FG002|NOT COMPLETED|Overall Study||1||
60032665|NCT02359994|76148340|FG000|STARTED|Overall Population Study||161|Enrolled and Randomized|
60032666|NCT02359994|76148341|FG001|STARTED|Overall Population Study||163|Enrolled and Randomized|
60032667|NCT02359994|76148340|FG000|Treated|Overall Population Study||160||
60032668|NCT02359994|76148341|FG001|Treated|Overall Population Study||162||
60032669|NCT02359994|76148340|FG000|COMPLETED|Overall Population Study||156||
60032670|NCT02359994|76148341|FG001|COMPLETED|Overall Population Study||155||
59508154|NCT02353299|75601345|FG001|STARTED|Second Intervention (1 Night)||13||
59508155|NCT02353299|75601346|FG002|STARTED|Second Intervention (1 Night)||13||
59508156|NCT02353299|75601347|FG003|STARTED|Second Intervention (1 Night)||13||
59508157|NCT02353299|75601344|FG000|COMPLETED|Second Intervention (1 Night)||13||
59508158|NCT02353299|75601345|FG001|COMPLETED|Second Intervention (1 Night)||13||
59508159|NCT02353299|75601346|FG002|COMPLETED|Second Intervention (1 Night)||13||
59612079|NCT01704456|75723205|FG001|COMPLETED|Overall Study||49||
59612080|NCT01704456|75723204|FG000|NOT COMPLETED|Overall Study||8||
59612081|NCT01704456|75723205|FG001|NOT COMPLETED|Overall Study||14||
59612082|NCT01703988|75723215|FG000|STARTED|Overall Study||8||
60032671|NCT02359994|76148340|FG000|NOT COMPLETED|Overall Population Study||5||
60032672|NCT02359994|76148341|FG001|NOT COMPLETED|Overall Population Study||8||
60032673|NCT02359994|76148340|FG000|STARTED|Extended Oncology 24-Month Survival|Oncology subjects in the PerClot group who completed either the 6 week or 3 month visit in the Overall Population Study.|85|Oncology subjects continued to be followed for an extended survival assessment at 24 months post-randomization after the 6 week or 3 month evaluation period in the Overall Population Study.|
60032674|NCT02359994|76148341|FG001|STARTED|Extended Oncology 24-Month Survival|Oncology subjects in the Arista group who completed either the 6 week or 3 month visit in the Overall Population Study.|93|Oncology subjects continued to be followed for an extended survival assessment at 24 months post-randomization after the 6 week or 3 month evaluation period in the Overall Population Study.|
60032675|NCT02359994|76148340|FG000|COMPLETED|Extended Oncology 24-Month Survival||65|Completed the 24-month visit.|
60032676|NCT02359994|76148341|FG001|COMPLETED|Extended Oncology 24-Month Survival||72|Completed the 24-month visit.|
60032677|NCT02359994|76148340|FG000|NOT COMPLETED|Extended Oncology 24-Month Survival||20||
60032678|NCT02359994|76148341|FG001|NOT COMPLETED|Extended Oncology 24-Month Survival||21||
60032679|NCT02326298|76148350|FG000|STARTED|Initial Period (Week 0 to Week 16)||51||
60032680|NCT02326298|76148351|FG001|STARTED|Initial Period (Week 0 to Week 16)||95||
60032681|NCT02326298|76148352|FG002|STARTED|Initial Period (Week 0 to Week 16)||88||
60032682|NCT02326298|76148353|FG003|STARTED|Initial Period (Week 0 to Week 16)||0||
60032683|NCT02326298|76148354|FG004|STARTED|Initial Period (Week 0 to Week 16)||0||
60032684|NCT02326298|76148355|FG005|STARTED|Initial Period (Week 0 to Week 16)||0||
60032685|NCT02326298|76148356|FG006|STARTED|Initial Period (Week 0 to Week 16)||0||
60032686|NCT02326298|76148357|FG007|STARTED|Initial Period (Week 0 to Week 16)||0||
60032687|NCT02326298|76148358|FG008|STARTED|Initial Period (Week 0 to Week 16)||0||
60032688|NCT02326298|76148359|FG009|STARTED|Initial Period (Week 0 to Week 16)||0||
60032689|NCT02326298|76148360|FG010|STARTED|Initial Period (Week 0 to Week 16)||0||
60032690|NCT02326298|76148361|FG011|STARTED|Initial Period (Week 0 to Week 16)||0||
60032691|NCT02326298|76148362|FG012|STARTED|Initial Period (Week 0 to Week 16)||0||
60032692|NCT02326298|76148363|FG013|STARTED|Initial Period (Week 0 to Week 16)||0||
60032693|NCT02326298|76148350|FG000|Completed Week 16|Initial Period (Week 0 to Week 16)||46||
60032694|NCT02326298|76148351|FG001|Completed Week 16|Initial Period (Week 0 to Week 16)||92||
60032695|NCT02326298|76148352|FG002|Completed Week 16|Initial Period (Week 0 to Week 16)||87||
60032696|NCT02326298|76148353|FG003|Completed Week 16|Initial Period (Week 0 to Week 16)||0||
60032697|NCT02326298|76148354|FG004|Completed Week 16|Initial Period (Week 0 to Week 16)||0||
60032698|NCT02326298|76148355|FG005|Completed Week 16|Initial Period (Week 0 to Week 16)||0||
59759294|NCT00601107|75878641|FG000|Treated|Overall Study||27||
59759295|NCT00601107|75878642|FG001|Treated|Overall Study||31||
60032699|NCT02326298|76148356|FG006|Completed Week 16|Initial Period (Week 0 to Week 16)||0||
60032700|NCT02326298|76148357|FG007|Completed Week 16|Initial Period (Week 0 to Week 16)||0||
60032701|NCT02326298|76148358|FG008|Completed Week 16|Initial Period (Week 0 to Week 16)||0||
60032702|NCT02326298|76148359|FG009|Completed Week 16|Initial Period (Week 0 to Week 16)||0||
60032703|NCT02326298|76148360|FG010|Completed Week 16|Initial Period (Week 0 to Week 16)||0||
59612083|NCT01703988|75723216|FG001|STARTED|Overall Study||8||
59612084|NCT01703988|75723217|FG002|STARTED|Overall Study||9||
59612085|NCT01703988|75723218|FG003|STARTED|Overall Study||9||
59612086|NCT01703988|75723215|FG000|COMPLETED|Overall Study||8||
59612087|NCT01703988|75723216|FG001|COMPLETED|Overall Study||8||
59612088|NCT01703988|75723217|FG002|COMPLETED|Overall Study||9||
59612089|NCT01703988|75723218|FG003|COMPLETED|Overall Study||8||
59612090|NCT01703988|75723215|FG000|NOT COMPLETED|Overall Study||0||
59612091|NCT01703988|75723216|FG001|NOT COMPLETED|Overall Study||0||
59612092|NCT01703988|75723217|FG002|NOT COMPLETED|Overall Study||0||
59612093|NCT01703988|75723218|FG003|NOT COMPLETED|Overall Study||1||
59612094|NCT01703832|75723231|FG000|STARTED|Overall Study||33||
59612095|NCT01703832|75723232|FG001|STARTED|Overall Study||32||
59612096|NCT01703832|75723231|FG000|COMPLETED|Overall Study||32||
59612097|NCT01703832|75723232|FG001|COMPLETED|Overall Study||32||
59612098|NCT01703832|75723231|FG000|NOT COMPLETED|Overall Study||1||
59759296|NCT00601107|75878643|FG002|Treated|Overall Study||28||
59759297|NCT00601107|75878644|FG003|Treated|Overall Study||25||
60032704|NCT02326298|76148361|FG011|Completed Week 16|Initial Period (Week 0 to Week 16)||0||
60032705|NCT02326298|76148362|FG012|Completed Week 16|Initial Period (Week 0 to Week 16)||0||
60032706|NCT02326298|76148363|FG013|Completed Week 16|Initial Period (Week 0 to Week 16)||0||
59612099|NCT01703832|75723232|FG001|NOT COMPLETED|Overall Study||0||
59612100|NCT01703286|75723238|FG000|STARTED|Period 1 Including Washout||7||
59612101|NCT01703286|75723239|FG001|STARTED|Period 1 Including Washout||7||
59612102|NCT01703286|75723240|FG002|STARTED|Period 1 Including Washout||7||
59612103|NCT01703286|75723241|FG003|STARTED|Period 1 Including Washout||7||
59612104|NCT01703286|75723242|FG004|STARTED|Period 1 Including Washout||7||
59612105|NCT01703286|75723243|FG005|STARTED|Period 1 Including Washout||7||
59759298|NCT00601107|75878641|FG000|COMPLETED|Overall Study||14||
59759299|NCT00601107|75878642|FG001|COMPLETED|Overall Study||22||
59759300|NCT00601107|75878643|FG002|COMPLETED|Overall Study||16||
59759301|NCT00601107|75878644|FG003|COMPLETED|Overall Study||13||
59759302|NCT00601107|75878641|FG000|NOT COMPLETED|Overall Study||13||
59759303|NCT00601107|75878642|FG001|NOT COMPLETED|Overall Study||9||
59612106|NCT01703286|75723238|FG000|COMPLETED|Period 1 Including Washout||7||
59612107|NCT01703286|75723239|FG001|COMPLETED|Period 1 Including Washout||7||
59612108|NCT01703286|75723240|FG002|COMPLETED|Period 1 Including Washout||7||
59759304|NCT00601107|75878643|FG002|NOT COMPLETED|Overall Study||12||
59759305|NCT00601107|75878644|FG003|NOT COMPLETED|Overall Study||12||
59759306|NCT00914927|75878661|FG000|STARTED|Overall Study||18||
59759307|NCT00914927|75878662|FG001|STARTED|Overall Study||16||
59916857|NCT03364309|76037556|FG015|COMPLETED|Induction Period||0||
59916858|NCT03364309|76037557|FG016|COMPLETED|Induction Period||0||
59916859|NCT03364309|76037558|FG017|COMPLETED|Induction Period||0||
59916860|NCT03364309|76037559|FG018|COMPLETED|Induction Period||0||
59916861|NCT03364309|76037541|FG000|NOT COMPLETED|Induction Period||6||
59916862|NCT03364309|76037542|FG001|NOT COMPLETED|Induction Period||4||
59916863|NCT03364309|76037543|FG002|NOT COMPLETED|Induction Period||1||
59916864|NCT03364309|76037544|FG003|NOT COMPLETED|Induction Period||0||
59916865|NCT03364309|76037545|FG004|NOT COMPLETED|Induction Period||0||
59916866|NCT03364309|76037546|FG005|NOT COMPLETED|Induction Period||0||
59916867|NCT03364309|76037547|FG006|NOT COMPLETED|Induction Period||0||
59916868|NCT03364309|76037548|FG007|NOT COMPLETED|Induction Period||0||
59916869|NCT03364309|76037549|FG008|NOT COMPLETED|Induction Period||0||
59916870|NCT03364309|76037550|FG009|NOT COMPLETED|Induction Period||0||
59916871|NCT03364309|76037551|FG010|NOT COMPLETED|Induction Period||0||
59916872|NCT03364309|76037552|FG011|NOT COMPLETED|Induction Period||0||
59916873|NCT03364309|76037553|FG012|NOT COMPLETED|Induction Period||0||
59916874|NCT03364309|76037554|FG013|NOT COMPLETED|Induction Period||0||
59916875|NCT03364309|76037555|FG014|NOT COMPLETED|Induction Period||0||
59916876|NCT03364309|76037556|FG015|NOT COMPLETED|Induction Period||0||
59916877|NCT03364309|76037557|FG016|NOT COMPLETED|Induction Period||0||
59916878|NCT03364309|76037558|FG017|NOT COMPLETED|Induction Period||0||
59916879|NCT03364309|76037559|FG018|NOT COMPLETED|Induction Period||0||
59916880|NCT03364309|76037541|FG000|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|0||
59916881|NCT03364309|76037542|FG001|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|0||
59916882|NCT03364309|76037543|FG002|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|0||
59916883|NCT03364309|76037544|FG003|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|47||
59916884|NCT03364309|76037545|FG004|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|92||
59916885|NCT03364309|76037546|FG005|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|50||
59916886|NCT03364309|76037547|FG006|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|100||
59916887|NCT03364309|76037548|FG007|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|3||
59916888|NCT03364309|76037549|FG008|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|79||
59916889|NCT03364309|76037550|FG009|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|31||
59916890|NCT03364309|76037551|FG010|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|23||
59916891|NCT03364309|76037552|FG011|STARTED|Maintenance Period||0||
59916892|NCT03364309|76037553|FG012|STARTED|Maintenance Period||0||
59916893|NCT03364309|76037554|FG013|STARTED|Maintenance Period||0||
59916894|NCT03364309|76037555|FG014|STARTED|Maintenance Period||0||
59916895|NCT03364309|76037556|FG015|STARTED|Maintenance Period||0||
59916896|NCT03364309|76037557|FG016|STARTED|Maintenance Period||0||
59916897|NCT03364309|76037558|FG017|STARTED|Maintenance Period||0||
59916898|NCT03364309|76037559|FG018|STARTED|Maintenance Period||0||
59916899|NCT03364309|76037541|FG000|Received at Least One Dose of Study Drug|Maintenance Period||0||
59916900|NCT03364309|76037542|FG001|Received at Least One Dose of Study Drug|Maintenance Period||0||
59916901|NCT03364309|76037543|FG002|Received at Least One Dose of Study Drug|Maintenance Period||0||
59916902|NCT03364309|76037544|FG003|Received at Least One Dose of Study Drug|Maintenance Period||47||
59916903|NCT03364309|76037545|FG004|Received at Least One Dose of Study Drug|Maintenance Period||92||
59916904|NCT03364309|76037546|FG005|Received at Least One Dose of Study Drug|Maintenance Period||50||
59916905|NCT03364309|76037547|FG006|Received at Least One Dose of Study Drug|Maintenance Period||100||
59916906|NCT03364309|76037548|FG007|Received at Least One Dose of Study Drug|Maintenance Period||3||
59759308|NCT00914927|75878663|FG002|STARTED|Overall Study||17||
59759309|NCT00914927|75878664|FG003|STARTED|Overall Study||16||
59759310|NCT00914927|75878665|FG004|STARTED|Overall Study||21||
59759311|NCT00914927|75878666|FG005|STARTED|Overall Study||21||
59916907|NCT03364309|76037549|FG008|Received at Least One Dose of Study Drug|Maintenance Period||79||
59916908|NCT03364309|76037550|FG009|Received at Least One Dose of Study Drug|Maintenance Period||31||
59759312|NCT00914927|75878667|FG006|STARTED|Overall Study||21||
59759313|NCT00914927|75878661|FG000|COMPLETED|Overall Study||16||
59759314|NCT00914927|75878662|FG001|COMPLETED|Overall Study||14||
59759315|NCT00914927|75878663|FG002|COMPLETED|Overall Study||17||
59759316|NCT00914927|75878664|FG003|COMPLETED|Overall Study||14||
59759317|NCT00914927|75878665|FG004|COMPLETED|Overall Study||19||
59759318|NCT00914927|75878666|FG005|COMPLETED|Overall Study||21||
59759319|NCT00914927|75878667|FG006|COMPLETED|Overall Study||21||
59759320|NCT00914927|75878661|FG000|NOT COMPLETED|Overall Study||2||
59759321|NCT00914927|75878662|FG001|NOT COMPLETED|Overall Study||2||
59612109|NCT01703286|75723241|FG003|COMPLETED|Period 1 Including Washout||6||
59612110|NCT01703286|75723242|FG004|COMPLETED|Period 1 Including Washout||7||
59612111|NCT01703286|75723243|FG005|COMPLETED|Period 1 Including Washout||6||
59612112|NCT01703286|75723238|FG000|NOT COMPLETED|Period 1 Including Washout||0||
59612113|NCT01703286|75723239|FG001|NOT COMPLETED|Period 1 Including Washout||0||
59612114|NCT01703286|75723240|FG002|NOT COMPLETED|Period 1 Including Washout||0||
59612115|NCT01703286|75723241|FG003|NOT COMPLETED|Period 1 Including Washout||1||
59612116|NCT01703286|75723242|FG004|NOT COMPLETED|Period 1 Including Washout||0||
59612117|NCT01703286|75723243|FG005|NOT COMPLETED|Period 1 Including Washout||1||
59612118|NCT01703286|75723238|FG000|STARTED|Period 2 Including Washout||7||
59612119|NCT01703286|75723239|FG001|STARTED|Period 2 Including Washout||7||
59612120|NCT01703286|75723240|FG002|STARTED|Period 2 Including Washout||7||
59612121|NCT01703286|75723241|FG003|STARTED|Period 2 Including Washout||6||
59612122|NCT01703286|75723242|FG004|STARTED|Period 2 Including Washout||7||
59612123|NCT01703286|75723243|FG005|STARTED|Period 2 Including Washout||6||
59612124|NCT01703286|75723238|FG000|COMPLETED|Period 2 Including Washout||7||
59612125|NCT01703286|75723239|FG001|COMPLETED|Period 2 Including Washout||7||
59612126|NCT01703286|75723240|FG002|COMPLETED|Period 2 Including Washout||7||
59612127|NCT01703286|75723241|FG003|COMPLETED|Period 2 Including Washout||5||
59612128|NCT01703286|75723242|FG004|COMPLETED|Period 2 Including Washout||7||
59612129|NCT01703286|75723243|FG005|COMPLETED|Period 2 Including Washout||6||
59612130|NCT01703286|75723238|FG000|NOT COMPLETED|Period 2 Including Washout||0||
59612131|NCT01703286|75723239|FG001|NOT COMPLETED|Period 2 Including Washout||0||
59612132|NCT01703286|75723240|FG002|NOT COMPLETED|Period 2 Including Washout||0||
59759322|NCT00914927|75878663|FG002|NOT COMPLETED|Overall Study||0||
59759323|NCT00914927|75878664|FG003|NOT COMPLETED|Overall Study||2||
59759324|NCT00914927|75878665|FG004|NOT COMPLETED|Overall Study||2||
59612133|NCT01703286|75723241|FG003|NOT COMPLETED|Period 2 Including Washout||1||
59612134|NCT01703286|75723242|FG004|NOT COMPLETED|Period 2 Including Washout||0||
59612135|NCT01703286|75723243|FG005|NOT COMPLETED|Period 2 Including Washout||0||
59612136|NCT01703286|75723238|FG000|STARTED|Period 3 Including Washout||7||
59612137|NCT01703286|75723239|FG001|STARTED|Period 3 Including Washout||7||
59612138|NCT01703286|75723240|FG002|STARTED|Period 3 Including Washout||7||
59612139|NCT01703286|75723241|FG003|STARTED|Period 3 Including Washout||5||
59612140|NCT01703286|75723242|FG004|STARTED|Period 3 Including Washout||7||
59612141|NCT01703286|75723243|FG005|STARTED|Period 3 Including Washout||6||
59612142|NCT01703286|75723238|FG000|COMPLETED|Period 3 Including Washout||7||
59612143|NCT01703286|75723239|FG001|COMPLETED|Period 3 Including Washout||7||
59612144|NCT01703286|75723240|FG002|COMPLETED|Period 3 Including Washout||7||
59612145|NCT01703286|75723241|FG003|COMPLETED|Period 3 Including Washout||5||
59612146|NCT01703286|75723242|FG004|COMPLETED|Period 3 Including Washout||7||
59612147|NCT01703286|75723243|FG005|COMPLETED|Period 3 Including Washout||6||
59612148|NCT01703286|75723238|FG000|NOT COMPLETED|Period 3 Including Washout||0||
59612149|NCT01703286|75723239|FG001|NOT COMPLETED|Period 3 Including Washout||0||
59612150|NCT01703286|75723240|FG002|NOT COMPLETED|Period 3 Including Washout||0||
59612151|NCT01703286|75723241|FG003|NOT COMPLETED|Period 3 Including Washout||0||
59612152|NCT01703286|75723242|FG004|NOT COMPLETED|Period 3 Including Washout||0||
59612153|NCT01703286|75723243|FG005|NOT COMPLETED|Period 3 Including Washout||0||
59612154|NCT01703208|75723256|FG000|STARTED|Overall Study||2100||
59612155|NCT01703208|75723257|FG001|STARTED|Overall Study||2102||
59612156|NCT01703208|75723256|FG000|Treated|Overall Study||2092||
59612157|NCT01703208|75723257|FG001|Treated|Overall Study||2100||
59612158|NCT01703208|75723256|FG000|COMPLETED|Overall Study||0||
59612159|NCT01703208|75723257|FG001|COMPLETED|Overall Study||0||
59612160|NCT01703208|75723256|FG000|NOT COMPLETED|Overall Study||2100||
59612161|NCT01703208|75723257|FG001|NOT COMPLETED|Overall Study||2102||
59612162|NCT01727700|75723266|FG000|STARTED|Overall Study||44||
59612163|NCT01727700|75723267|FG001|STARTED|Overall Study||45||
59612164|NCT01727700|75723268|FG002|STARTED|Overall Study||44||
59612165|NCT01727700|75723266|FG000|COMPLETED|Overall Study||42||
59612166|NCT01727700|75723267|FG001|COMPLETED|Overall Study||35||
59612167|NCT01727700|75723268|FG002|COMPLETED|Overall Study||42||
59612168|NCT01727700|75723266|FG000|NOT COMPLETED|Overall Study||2||
59612169|NCT01727700|75723267|FG001|NOT COMPLETED|Overall Study||10||
59612170|NCT01727700|75723268|FG002|NOT COMPLETED|Overall Study||2||
59612171|NCT01727154|75723276|FG000|STARTED|Overall Study||139||
59612172|NCT01727154|75723276|FG000|COMPLETED|Overall Study||80||
59612173|NCT01727154|75723276|FG000|NOT COMPLETED|Overall Study||59||
59612174|NCT01725750|75723282|FG000|STARTED|Overall Study||44||
59612175|NCT01725750|75723283|FG001|STARTED|Overall Study||44||
59612176|NCT01725750|75723282|FG000|COMPLETED|Overall Study||42||
59759325|NCT00914927|75878666|FG005|NOT COMPLETED|Overall Study||0||
59759326|NCT00914927|75878667|FG006|NOT COMPLETED|Overall Study||0||
59759327|NCT00914849|75878694|FG000|STARTED|Overall Study||34||
59759328|NCT00914849|75878695|FG001|STARTED|Overall Study||34||
59759329|NCT00914849|75878694|FG000|COMPLETED|Overall Study||33||
59759330|NCT00914849|75878695|FG001|COMPLETED|Overall Study||33||
59759331|NCT00914849|75878694|FG000|NOT COMPLETED|Overall Study||1||
59612177|NCT01725750|75723283|FG001|COMPLETED|Overall Study||34||
59612178|NCT01725750|75723282|FG000|NOT COMPLETED|Overall Study||2||
59612179|NCT01725750|75723283|FG001|NOT COMPLETED|Overall Study||10||
59612180|NCT01725282|75723295|FG000|STARTED|Overall Study||44||
59612181|NCT01725282|75723296|FG001|STARTED|Overall Study||44||
59612182|NCT01725282|75723297|FG002|STARTED|Overall Study||41||
59612183|NCT01725282|75723298|FG003|STARTED|Overall Study||43||
59612184|NCT01725282|75723295|FG000|COMPLETED|Overall Study||42||
59612185|NCT01725282|75723296|FG001|COMPLETED|Overall Study||39||
59612186|NCT01725282|75723297|FG002|COMPLETED|Overall Study||33||
59612187|NCT01725282|75723298|FG003|COMPLETED|Overall Study||36||
59916909|NCT03364309|76037551|FG010|Received at Least One Dose of Study Drug|Maintenance Period||23||
59916910|NCT03364309|76037552|FG011|Received at Least One Dose of Study Drug|Maintenance Period||0||
59916911|NCT03364309|76037553|FG012|Received at Least One Dose of Study Drug|Maintenance Period||0||
59916912|NCT03364309|76037554|FG013|Received at Least One Dose of Study Drug|Maintenance Period||0||
59916913|NCT03364309|76037555|FG014|Received at Least One Dose of Study Drug|Maintenance Period||0||
59916914|NCT03364309|76037556|FG015|Received at Least One Dose of Study Drug|Maintenance Period||0||
59916915|NCT03364309|76037557|FG016|Received at Least One Dose of Study Drug|Maintenance Period||0||
59916916|NCT03364309|76037558|FG017|Received at Least One Dose of Study Drug|Maintenance Period||0||
59916917|NCT03364309|76037559|FG018|Received at Least One Dose of Study Drug|Maintenance Period||0||
59916918|NCT03364309|76037541|FG000|COMPLETED|Maintenance Period||0||
59612188|NCT01725282|75723295|FG000|NOT COMPLETED|Overall Study||2||
59612189|NCT01725282|75723296|FG001|NOT COMPLETED|Overall Study||5||
59612190|NCT01725282|75723297|FG002|NOT COMPLETED|Overall Study||8||
59612191|NCT01725282|75723298|FG003|NOT COMPLETED|Overall Study||7||
59612192|NCT01725126|75723314|FG000|STARTED|Overall Study||4||
59612193|NCT01725126|75723315|FG001|STARTED|Overall Study||11||
59612194|NCT01725126|75723316|FG002|STARTED|Overall Study||6||
59612195|NCT01725126|75723317|FG003|STARTED|Overall Study||14||
59612196|NCT01725126|75723318|FG004|STARTED|Overall Study||6||
59612197|NCT01725126|75723319|FG005|STARTED|Overall Study||12||
59612198|NCT01725126|75723314|FG000|COMPLETED|Overall Study||4||
59612199|NCT01725126|75723315|FG001|COMPLETED|Overall Study||10||
59612200|NCT01725126|75723316|FG002|COMPLETED|Overall Study||6||
59612201|NCT01725126|75723317|FG003|COMPLETED|Overall Study||13||
59612202|NCT01725126|75723318|FG004|COMPLETED|Overall Study||6||
59612203|NCT01725126|75723319|FG005|COMPLETED|Overall Study||12||
59612204|NCT01725126|75723314|FG000|NOT COMPLETED|Overall Study||0||
59612205|NCT01725126|75723315|FG001|NOT COMPLETED|Overall Study||1||
59612206|NCT01725126|75723316|FG002|NOT COMPLETED|Overall Study||0||
59612207|NCT01725126|75723317|FG003|NOT COMPLETED|Overall Study||1||
59612208|NCT01725126|75723318|FG004|NOT COMPLETED|Overall Study||0||
59612209|NCT01725126|75723319|FG005|NOT COMPLETED|Overall Study||0||
59508160|NCT02353299|75601347|FG003|COMPLETED|Second Intervention (1 Night)||13||
59916919|NCT03364309|76037542|FG001|COMPLETED|Maintenance Period||0||
59916920|NCT03364309|76037543|FG002|COMPLETED|Maintenance Period||0||
59916921|NCT03364309|76037544|FG003|COMPLETED|Maintenance Period||3||
59916922|NCT03364309|76037545|FG004|COMPLETED|Maintenance Period||80||
59916923|NCT03364309|76037546|FG005|COMPLETED|Maintenance Period||4||
59916924|NCT03364309|76037547|FG006|COMPLETED|Maintenance Period||84||
59916925|NCT03364309|76037548|FG007|COMPLETED|Maintenance Period||1||
59916926|NCT03364309|76037549|FG008|COMPLETED|Maintenance Period||73||
59916927|NCT03364309|76037550|FG009|COMPLETED|Maintenance Period||27||
59916928|NCT03364309|76037551|FG010|COMPLETED|Maintenance Period||17||
59916929|NCT03364309|76037552|FG011|COMPLETED|Maintenance Period||0||
59508161|NCT02353299|75601344|FG000|NOT COMPLETED|Second Intervention (1 Night)||0||
59508162|NCT02353299|75601345|FG001|NOT COMPLETED|Second Intervention (1 Night)||0||
59916930|NCT03364309|76037553|FG012|COMPLETED|Maintenance Period||0||
59916931|NCT03364309|76037554|FG013|COMPLETED|Maintenance Period||0||
59508163|NCT02353299|75601346|FG002|NOT COMPLETED|Second Intervention (1 Night)||0||
59508164|NCT02353299|75601347|FG003|NOT COMPLETED|Second Intervention (1 Night)||0||
59508165|NCT02353299|75601344|FG000|STARTED|Third Intervention (1 Night)||13||
59508166|NCT02353299|75601345|FG001|STARTED|Third Intervention (1 Night)||13||
59508167|NCT02353299|75601346|FG002|STARTED|Third Intervention (1 Night)||13||
59612210|NCT01751724|75723344|FG000|STARTED|Overall Study||42||
59612211|NCT01751724|75723345|FG001|STARTED|Overall Study||44||
59612212|NCT01751724|75723344|FG000|COMPLETED|Overall Study||41||
59612213|NCT01751724|75723345|FG001|COMPLETED|Overall Study||42||
59612214|NCT01751724|75723344|FG000|NOT COMPLETED|Overall Study||1||
59508168|NCT02353299|75601347|FG003|STARTED|Third Intervention (1 Night)||13||
59508169|NCT02353299|75601344|FG000|COMPLETED|Third Intervention (1 Night)||13||
59508170|NCT02353299|75601345|FG001|COMPLETED|Third Intervention (1 Night)||13||
59508171|NCT02353299|75601346|FG002|COMPLETED|Third Intervention (1 Night)||13||
59508172|NCT02353299|75601347|FG003|COMPLETED|Third Intervention (1 Night)||13||
59612215|NCT01751724|75723345|FG001|NOT COMPLETED|Overall Study||2||
59612216|NCT01751646|75723353|FG000|STARTED|Overall Study||109||
59612217|NCT01751646|75723354|FG001|STARTED|Overall Study||105||
59612218|NCT01751646|75723353|FG000|COMPLETED|Overall Study||98||
59916932|NCT03364309|76037555|FG014|COMPLETED|Maintenance Period||0||
60032707|NCT02326298|76148350|FG000|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||46||
60032708|NCT02326298|76148351|FG001|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||92||
60032709|NCT02326298|76148352|FG002|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||85||
60032710|NCT02326298|76148353|FG003|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0||
60032711|NCT02326298|76148354|FG004|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0||
60032712|NCT02326298|76148355|FG005|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0||
60032713|NCT02326298|76148356|FG006|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0||
60032714|NCT02326298|76148357|FG007|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0||
60032715|NCT02326298|76148358|FG008|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0||
60032716|NCT02326298|76148359|FG009|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0||
60032717|NCT02326298|76148360|FG010|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0||
60032718|NCT02326298|76148361|FG011|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0||
60032719|NCT02326298|76148362|FG012|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0||
60032720|NCT02326298|76148363|FG013|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0||
60032721|NCT02326298|76148350|FG000|COMPLETED|Initial Period (Week 0 to Week 16)||46||
60032722|NCT02326298|76148351|FG001|COMPLETED|Initial Period (Week 0 to Week 16)||92||
60032723|NCT02326298|76148352|FG002|COMPLETED|Initial Period (Week 0 to Week 16)||85||
60032724|NCT02326298|76148353|FG003|COMPLETED|Initial Period (Week 0 to Week 16)||0||
60032725|NCT02326298|76148354|FG004|COMPLETED|Initial Period (Week 0 to Week 16)||0||
60032726|NCT02326298|76148355|FG005|COMPLETED|Initial Period (Week 0 to Week 16)||0||
60032727|NCT02326298|76148356|FG006|COMPLETED|Initial Period (Week 0 to Week 16)||0||
60032728|NCT02326298|76148357|FG007|COMPLETED|Initial Period (Week 0 to Week 16)||0||
60032729|NCT02326298|76148358|FG008|COMPLETED|Initial Period (Week 0 to Week 16)||0||
60032730|NCT02326298|76148359|FG009|COMPLETED|Initial Period (Week 0 to Week 16)||0||
60032731|NCT02326298|76148360|FG010|COMPLETED|Initial Period (Week 0 to Week 16)||0||
60032732|NCT02326298|76148361|FG011|COMPLETED|Initial Period (Week 0 to Week 16)||0||
60032733|NCT02326298|76148362|FG012|COMPLETED|Initial Period (Week 0 to Week 16)||0||
60032734|NCT02326298|76148363|FG013|COMPLETED|Initial Period (Week 0 to Week 16)||0||
60032735|NCT02326298|76148350|FG000|NOT COMPLETED|Initial Period (Week 0 to Week 16)||5||
60032736|NCT02326298|76148351|FG001|NOT COMPLETED|Initial Period (Week 0 to Week 16)||3||
60032737|NCT02326298|76148352|FG002|NOT COMPLETED|Initial Period (Week 0 to Week 16)||3||
60032738|NCT02326298|76148353|FG003|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0||
60032739|NCT02326298|76148354|FG004|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0||
60032740|NCT02326298|76148355|FG005|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0||
60032741|NCT02326298|76148356|FG006|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0||
60032742|NCT02326298|76148357|FG007|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0||
60032743|NCT02326298|76148358|FG008|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0||
60032744|NCT02326298|76148359|FG009|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0||
60032745|NCT02326298|76148360|FG010|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0||
60032746|NCT02326298|76148361|FG011|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0||
60032747|NCT02326298|76148362|FG012|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0||
60032748|NCT02326298|76148363|FG013|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0||
60032749|NCT02326298|76148350|FG000|STARTED|Maintenance Period (Week 16 to Week 48)||0||
60032750|NCT02326298|76148351|FG001|STARTED|Maintenance Period (Week 16 to Week 48)||0||
60032751|NCT02326298|76148352|FG002|STARTED|Maintenance Period (Week 16 to Week 48)||0||
60032752|NCT02326298|76148353|FG003|STARTED|Maintenance Period (Week 16 to Week 48)||3||
60032753|NCT02326298|76148354|FG004|STARTED|Maintenance Period (Week 16 to Week 48)||5||
60032754|NCT02326298|76148355|FG005|STARTED|Maintenance Period (Week 16 to Week 48)||74||
60032755|NCT02326298|76148356|FG006|STARTED|Maintenance Period (Week 16 to Week 48)||77||
60032756|NCT02326298|76148357|FG007|STARTED|Maintenance Period (Week 16 to Week 48)||38||
60032757|NCT02326298|76148358|FG008|STARTED|Maintenance Period (Week 16 to Week 48)||18||
60032758|NCT02326298|76148359|FG009|STARTED|Maintenance Period (Week 16 to Week 48)||8||
60032759|NCT02326298|76148360|FG010|STARTED|Maintenance Period (Week 16 to Week 48)||0||
60032760|NCT02326298|76148361|FG011|STARTED|Maintenance Period (Week 16 to Week 48)||0||
60032761|NCT02326298|76148362|FG012|STARTED|Maintenance Period (Week 16 to Week 48)||0||
60032762|NCT02326298|76148363|FG013|STARTED|Maintenance Period (Week 16 to Week 48)||0||
60032763|NCT02326298|76148350|FG000|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0||
60032764|NCT02326298|76148351|FG001|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0||
60032765|NCT02326298|76148352|FG002|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0||
60032766|NCT02326298|76148353|FG003|Completed Week 48|Maintenance Period (Week 16 to Week 48)||3||
60032767|NCT02326298|76148354|FG004|Completed Week 48|Maintenance Period (Week 16 to Week 48)||5||
60032768|NCT02326298|76148355|FG005|Completed Week 48|Maintenance Period (Week 16 to Week 48)||71||
60032769|NCT02326298|76148356|FG006|Completed Week 48|Maintenance Period (Week 16 to Week 48)||70||
60032770|NCT02326298|76148357|FG007|Completed Week 48|Maintenance Period (Week 16 to Week 48)||33||
60032771|NCT02326298|76148358|FG008|Completed Week 48|Maintenance Period (Week 16 to Week 48)||13||
60067809|NCT01951586|76182997|FG000|Received Study Drug|Overall Study||76||
60032772|NCT02326298|76148359|FG009|Completed Week 48|Maintenance Period (Week 16 to Week 48)||7||
60032773|NCT02326298|76148360|FG010|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0||
60032774|NCT02326298|76148361|FG011|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0||
60032775|NCT02326298|76148362|FG012|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0||
60032776|NCT02326298|76148363|FG013|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0||
60032777|NCT02326298|76148350|FG000|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0||
60032778|NCT02326298|76148351|FG001|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0||
59759332|NCT00914849|75878695|FG001|NOT COMPLETED|Overall Study||1||
60032779|NCT02326298|76148352|FG002|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0||
60032780|NCT02326298|76148353|FG003|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||3||
60032781|NCT02326298|76148354|FG004|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||5||
60032782|NCT02326298|76148355|FG005|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||69||
60032783|NCT02326298|76148356|FG006|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||70||
60032784|NCT02326298|76148357|FG007|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||33||
60032785|NCT02326298|76148358|FG008|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||13||
60032786|NCT02326298|76148359|FG009|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||7||
60032787|NCT02326298|76148360|FG010|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0||
60032788|NCT02326298|76148361|FG011|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0||
60032789|NCT02326298|76148362|FG012|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0||
60032790|NCT02326298|76148363|FG013|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0||
60032791|NCT02326298|76148350|FG000|COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
60032792|NCT02326298|76148351|FG001|COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
60032793|NCT02326298|76148352|FG002|COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
60032794|NCT02326298|76148353|FG003|COMPLETED|Maintenance Period (Week 16 to Week 48)||3||
60032795|NCT02326298|76148354|FG004|COMPLETED|Maintenance Period (Week 16 to Week 48)||5||
60032796|NCT02326298|76148355|FG005|COMPLETED|Maintenance Period (Week 16 to Week 48)||69||
60032797|NCT02326298|76148356|FG006|COMPLETED|Maintenance Period (Week 16 to Week 48)||70||
60032798|NCT02326298|76148357|FG007|COMPLETED|Maintenance Period (Week 16 to Week 48)||33||
60032799|NCT02326298|76148358|FG008|COMPLETED|Maintenance Period (Week 16 to Week 48)||13||
60032800|NCT02326298|76148359|FG009|COMPLETED|Maintenance Period (Week 16 to Week 48)||7||
60032801|NCT02326298|76148360|FG010|COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
60032802|NCT02326298|76148361|FG011|COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
60032803|NCT02326298|76148362|FG012|COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
60032804|NCT02326298|76148363|FG013|COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
60032805|NCT02326298|76148350|FG000|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
60032806|NCT02326298|76148351|FG001|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
60032807|NCT02326298|76148352|FG002|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
60032808|NCT02326298|76148353|FG003|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
60032809|NCT02326298|76148354|FG004|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
60032810|NCT02326298|76148355|FG005|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||5||
60032811|NCT02326298|76148356|FG006|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||7||
60032812|NCT02326298|76148357|FG007|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||5||
60032813|NCT02326298|76148358|FG008|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||5||
60032814|NCT02326298|76148359|FG009|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||1||
60032815|NCT02326298|76148360|FG010|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
60032816|NCT02326298|76148361|FG011|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
60032817|NCT02326298|76148362|FG012|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
60032818|NCT02326298|76148363|FG013|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
60032819|NCT02326298|76148350|FG000|STARTED|Open-label Period (Week 48 to Week 144)||0||
60032820|NCT02326298|76148351|FG001|STARTED|Open-label Period (Week 48 to Week 144)||0||
60032821|NCT02326298|76148352|FG002|STARTED|Open-label Period (Week 48 to Week 144)||0||
60032822|NCT02326298|76148353|FG003|STARTED|Open-label Period (Week 48 to Week 144)||0||
60032823|NCT02326298|76148354|FG004|STARTED|Open-label Period (Week 48 to Week 144)||0||
60032824|NCT02326298|76148355|FG005|STARTED|Open-label Period (Week 48 to Week 144)||0||
60032825|NCT02326298|76148356|FG006|STARTED|Open-label Period (Week 48 to Week 144)||0||
59759333|NCT00912743|75878703|FG000|STARTED|Overall Study||13||
60032826|NCT02326298|76148357|FG007|STARTED|Open-label Period (Week 48 to Week 144)||0||
60032827|NCT02326298|76148358|FG008|STARTED|Open-label Period (Week 48 to Week 144)||0||
60032828|NCT02326298|76148359|FG009|STARTED|Open-label Period (Week 48 to Week 144)||0||
60032829|NCT02326298|76148360|FG010|STARTED|Open-label Period (Week 48 to Week 144)||3||
60032830|NCT02326298|76148361|FG011|STARTED|Open-label Period (Week 48 to Week 144)||74||
59759334|NCT00912743|75878704|FG001|STARTED|Overall Study||20||
59759335|NCT00912743|75878703|FG000|COMPLETED|Overall Study||0||
59759336|NCT00912743|75878704|FG001|COMPLETED|Overall Study||0||
59759337|NCT00912743|75878703|FG000|NOT COMPLETED|Overall Study||13||
60032831|NCT02326298|76148362|FG012|STARTED|Open-label Period (Week 48 to Week 144)||70||
60032832|NCT02326298|76148363|FG013|STARTED|Open-label Period (Week 48 to Week 144)||53||
60032833|NCT02326298|76148350|FG000|COMPLETED|Open-label Period (Week 48 to Week 144)||0||
60032834|NCT02326298|76148351|FG001|COMPLETED|Open-label Period (Week 48 to Week 144)||0||
59612219|NCT01751646|75723354|FG001|COMPLETED|Overall Study||87||
59612220|NCT01751646|75723353|FG000|NOT COMPLETED|Overall Study||11||
59612221|NCT01751646|75723354|FG001|NOT COMPLETED|Overall Study||18||
59916933|NCT03364309|76037556|FG015|COMPLETED|Maintenance Period||0||
59916934|NCT03364309|76037557|FG016|COMPLETED|Maintenance Period||0||
59916935|NCT03364309|76037558|FG017|COMPLETED|Maintenance Period||0||
59916936|NCT03364309|76037559|FG018|COMPLETED|Maintenance Period||0||
59916937|NCT03364309|76037541|FG000|NOT COMPLETED|Maintenance Period||0||
59916938|NCT03364309|76037542|FG001|NOT COMPLETED|Maintenance Period||0||
59916939|NCT03364309|76037543|FG002|NOT COMPLETED|Maintenance Period||0||
59916940|NCT03364309|76037544|FG003|NOT COMPLETED|Maintenance Period||44||
59916941|NCT03364309|76037545|FG004|NOT COMPLETED|Maintenance Period||12||
59916942|NCT03364309|76037546|FG005|NOT COMPLETED|Maintenance Period||46||
59916943|NCT03364309|76037547|FG006|NOT COMPLETED|Maintenance Period||16||
59916944|NCT03364309|76037548|FG007|NOT COMPLETED|Maintenance Period||2||
59916945|NCT03364309|76037549|FG008|NOT COMPLETED|Maintenance Period||6||
59916946|NCT03364309|76037550|FG009|NOT COMPLETED|Maintenance Period||4||
59916947|NCT03364309|76037551|FG010|NOT COMPLETED|Maintenance Period||6||
59916948|NCT03364309|76037552|FG011|NOT COMPLETED|Maintenance Period||0||
59916949|NCT03364309|76037553|FG012|NOT COMPLETED|Maintenance Period||0||
59916950|NCT03364309|76037554|FG013|NOT COMPLETED|Maintenance Period||0||
59916951|NCT03364309|76037555|FG014|NOT COMPLETED|Maintenance Period||0||
59916952|NCT03364309|76037556|FG015|NOT COMPLETED|Maintenance Period||0||
59916953|NCT03364309|76037557|FG016|NOT COMPLETED|Maintenance Period||0||
59916954|NCT03364309|76037558|FG017|NOT COMPLETED|Maintenance Period||0||
59916955|NCT03364309|76037559|FG018|NOT COMPLETED|Maintenance Period||0||
59916956|NCT03364309|76037541|FG000|STARTED|Re-treatment (Maintenance) Period||0||
59916957|NCT03364309|76037542|FG001|STARTED|Re-treatment (Maintenance) Period||0||
59916958|NCT03364309|76037543|FG002|STARTED|Re-treatment (Maintenance) Period||0||
59916959|NCT03364309|76037544|FG003|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|0||
59916960|NCT03364309|76037545|FG004|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|0||
59916961|NCT03364309|76037546|FG005|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|0||
59916962|NCT03364309|76037547|FG006|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|0||
59916963|NCT03364309|76037548|FG007|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|0||
59916964|NCT03364309|76037549|FG008|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|0||
59916965|NCT03364309|76037550|FG009|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|0||
59916966|NCT03364309|76037551|FG010|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|0||
59916967|NCT03364309|76037552|FG011|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|2||
59916968|NCT03364309|76037553|FG012|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|43||
59916969|NCT03364309|76037554|FG013|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|7||
59916970|NCT03364309|76037555|FG014|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|45||
59916971|NCT03364309|76037556|FG015|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|10||
59916972|NCT03364309|76037557|FG016|STARTED|Re-treatment (Maintenance) Period||0||
59916973|NCT03364309|76037558|FG017|STARTED|Re-treatment (Maintenance) Period||0||
59916974|NCT03364309|76037559|FG018|STARTED|Re-treatment (Maintenance) Period||0||
59916975|NCT03364309|76037541|FG000|COMPLETED|Re-treatment (Maintenance) Period||0||
59916976|NCT03364309|76037542|FG001|COMPLETED|Re-treatment (Maintenance) Period||0||
59916977|NCT03364309|76037543|FG002|COMPLETED|Re-treatment (Maintenance) Period||0||
59916978|NCT03364309|76037544|FG003|COMPLETED|Re-treatment (Maintenance) Period||0||
59916979|NCT03364309|76037545|FG004|COMPLETED|Re-treatment (Maintenance) Period||0||
59916980|NCT03364309|76037546|FG005|COMPLETED|Re-treatment (Maintenance) Period||0||
59916981|NCT03364309|76037547|FG006|COMPLETED|Re-treatment (Maintenance) Period||0||
59916982|NCT03364309|76037548|FG007|COMPLETED|Re-treatment (Maintenance) Period||0||
59916983|NCT03364309|76037549|FG008|COMPLETED|Re-treatment (Maintenance) Period||0||
59916984|NCT03364309|76037550|FG009|COMPLETED|Re-treatment (Maintenance) Period||0||
59916985|NCT03364309|76037551|FG010|COMPLETED|Re-treatment (Maintenance) Period||0||
59916986|NCT03364309|76037552|FG011|COMPLETED|Re-treatment (Maintenance) Period||2||
59916987|NCT03364309|76037553|FG012|COMPLETED|Re-treatment (Maintenance) Period||42||
60032835|NCT02326298|76148352|FG002|COMPLETED|Open-label Period (Week 48 to Week 144)||0||
60032836|NCT02326298|76148353|FG003|COMPLETED|Open-label Period (Week 48 to Week 144)||0||
59612222|NCT01751568|75723367|FG000|STARTED|Overall Study||13||
59612223|NCT01751568|75723368|FG001|STARTED|Overall Study||14||
59612224|NCT01751568|75723369|FG002|STARTED|Overall Study||13||
59612225|NCT01751568|75723367|FG000|COMPLETED|Overall Study||12||
59612226|NCT01751568|75723368|FG001|COMPLETED|Overall Study||14||
59508173|NCT02353299|75601344|FG000|NOT COMPLETED|Third Intervention (1 Night)||0||
59916988|NCT03364309|76037554|FG013|COMPLETED|Re-treatment (Maintenance) Period||6||
59916989|NCT03364309|76037555|FG014|COMPLETED|Re-treatment (Maintenance) Period||43||
59916990|NCT03364309|76037556|FG015|COMPLETED|Re-treatment (Maintenance) Period||8||
59612227|NCT01751568|75723369|FG002|COMPLETED|Overall Study||13||
59612228|NCT01751568|75723367|FG000|NOT COMPLETED|Overall Study||1||
59612229|NCT01751568|75723368|FG001|NOT COMPLETED|Overall Study||0||
59612230|NCT01751568|75723369|FG002|NOT COMPLETED|Overall Study||0||
59612231|NCT01751412|75723377|FG000|STARTED|Overall Study||12||
59612232|NCT01751412|75723377|FG000|COMPLETED|Overall Study||11||
59916991|NCT03364309|76037557|FG016|COMPLETED|Re-treatment (Maintenance) Period||0||
59916992|NCT03364309|76037558|FG017|COMPLETED|Re-treatment (Maintenance) Period||0||
59916993|NCT03364309|76037559|FG018|COMPLETED|Re-treatment (Maintenance) Period||0||
59916994|NCT03364309|76037541|FG000|NOT COMPLETED|Re-treatment (Maintenance) Period||0||
59916995|NCT03364309|76037542|FG001|NOT COMPLETED|Re-treatment (Maintenance) Period||0||
59916996|NCT03364309|76037543|FG002|NOT COMPLETED|Re-treatment (Maintenance) Period||0||
59916997|NCT03364309|76037544|FG003|NOT COMPLETED|Re-treatment (Maintenance) Period||0||
59916998|NCT03364309|76037545|FG004|NOT COMPLETED|Re-treatment (Maintenance) Period||0||
59916999|NCT03364309|76037546|FG005|NOT COMPLETED|Re-treatment (Maintenance) Period||0||
59917000|NCT03364309|76037547|FG006|NOT COMPLETED|Re-treatment (Maintenance) Period||0||
59917001|NCT03364309|76037548|FG007|NOT COMPLETED|Re-treatment (Maintenance) Period||0||
59917002|NCT03364309|76037549|FG008|NOT COMPLETED|Re-treatment (Maintenance) Period||0||
59917003|NCT03364309|76037550|FG009|NOT COMPLETED|Re-treatment (Maintenance) Period||0||
59917004|NCT03364309|76037551|FG010|NOT COMPLETED|Re-treatment (Maintenance) Period||0||
59917005|NCT03364309|76037552|FG011|NOT COMPLETED|Re-treatment (Maintenance) Period||0||
59917006|NCT03364309|76037553|FG012|NOT COMPLETED|Re-treatment (Maintenance) Period||1||
59917007|NCT03364309|76037554|FG013|NOT COMPLETED|Re-treatment (Maintenance) Period||1||
59917008|NCT03364309|76037555|FG014|NOT COMPLETED|Re-treatment (Maintenance) Period||2||
59917009|NCT03364309|76037556|FG015|NOT COMPLETED|Re-treatment (Maintenance) Period||2||
59917010|NCT03364309|76037557|FG016|NOT COMPLETED|Re-treatment (Maintenance) Period||0||
59917011|NCT03364309|76037558|FG017|NOT COMPLETED|Re-treatment (Maintenance) Period||0||
59917012|NCT03364309|76037559|FG018|NOT COMPLETED|Re-treatment (Maintenance) Period||0||
59917013|NCT03364309|76037541|FG000|STARTED|Post-Treatment Followup Period||0||
59917014|NCT03364309|76037542|FG001|STARTED|Post-Treatment Followup Period||0||
59917015|NCT03364309|76037543|FG002|STARTED|Post-Treatment Followup Period||0||
59917016|NCT03364309|76037544|FG003|STARTED|Post-Treatment Followup Period||0||
59917017|NCT03364309|76037545|FG004|STARTED|Post-Treatment Followup Period||0||
59917018|NCT03364309|76037546|FG005|STARTED|Post-Treatment Followup Period||0||
59917019|NCT03364309|76037547|FG006|STARTED|Post-Treatment Followup Period||0||
59917020|NCT03364309|76037548|FG007|STARTED|Post-Treatment Followup Period||0||
59917021|NCT03364309|76037549|FG008|STARTED|Post-Treatment Followup Period||0||
59508174|NCT02353299|75601345|FG001|NOT COMPLETED|Third Intervention (1 Night)||0||
59508175|NCT02353299|75601346|FG002|NOT COMPLETED|Third Intervention (1 Night)||0||
59508176|NCT02353299|75601347|FG003|NOT COMPLETED|Third Intervention (1 Night)||0||
59508177|NCT02353299|75601344|FG000|STARTED|Fourth Intervention (1 Night)||13||
59508178|NCT02353299|75601345|FG001|STARTED|Fourth Intervention (1 Night)|One patient withdrawn from study prior to start of fourth intervention.|12||
59508179|NCT02353299|75601346|FG002|STARTED|Fourth Intervention (1 Night)||13||
59508180|NCT02353299|75601347|FG003|STARTED|Fourth Intervention (1 Night)||13||
59508181|NCT02353299|75601344|FG000|COMPLETED|Fourth Intervention (1 Night)||13||
59508182|NCT02353299|75601345|FG001|COMPLETED|Fourth Intervention (1 Night)||12||
59508183|NCT02353299|75601346|FG002|COMPLETED|Fourth Intervention (1 Night)||13||
59508184|NCT02353299|75601347|FG003|COMPLETED|Fourth Intervention (1 Night)||13||
59508185|NCT02353299|75601344|FG000|NOT COMPLETED|Fourth Intervention (1 Night)||0||
59508186|NCT02353299|75601345|FG001|NOT COMPLETED|Fourth Intervention (1 Night)||0||
59508187|NCT02353299|75601346|FG002|NOT COMPLETED|Fourth Intervention (1 Night)||0||
59508188|NCT02353299|75601347|FG003|NOT COMPLETED|Fourth Intervention (1 Night)||0||
59917022|NCT03364309|76037550|FG009|STARTED|Post-Treatment Followup Period||0||
59917023|NCT03364309|76037551|FG010|STARTED|Post-Treatment Followup Period||0||
59612233|NCT01751412|75723377|FG000|NOT COMPLETED|Overall Study||1||
59917024|NCT03364309|76037552|FG011|STARTED|Post-Treatment Followup Period|This period is to report for Follow-up Period participants.|0||
59917025|NCT03364309|76037553|FG012|STARTED|Post-Treatment Followup Period|This period is to report for Follow-up Period participants.|0||
59917026|NCT03364309|76037554|FG013|STARTED|Post-Treatment Followup Period|This period is to report for Follow-up Period participants.|0||
60032837|NCT02326298|76148354|FG004|COMPLETED|Open-label Period (Week 48 to Week 144)||0||
60032838|NCT02326298|76148355|FG005|COMPLETED|Open-label Period (Week 48 to Week 144)||0||
60032839|NCT02326298|76148356|FG006|COMPLETED|Open-label Period (Week 48 to Week 144)||0||
60032840|NCT02326298|76148357|FG007|COMPLETED|Open-label Period (Week 48 to Week 144)||0||
60032841|NCT02326298|76148358|FG008|COMPLETED|Open-label Period (Week 48 to Week 144)||0||
60032842|NCT02326298|76148359|FG009|COMPLETED|Open-label Period (Week 48 to Week 144)||0||
59508189|NCT00756977|75601367|FG000|STARTED|Overall Study||196||
59508190|NCT00756977|75601368|FG001|STARTED|Overall Study||198||
59508191|NCT00756977|75601367|FG000|COMPLETED|Overall Study||175||
59508192|NCT00756977|75601368|FG001|COMPLETED|Overall Study||187||
60032843|NCT02326298|76148360|FG010|COMPLETED|Open-label Period (Week 48 to Week 144)||3||
60032844|NCT02326298|76148361|FG011|COMPLETED|Open-label Period (Week 48 to Week 144)||54||
60032845|NCT02326298|76148362|FG012|COMPLETED|Open-label Period (Week 48 to Week 144)||51||
60032846|NCT02326298|76148363|FG013|COMPLETED|Open-label Period (Week 48 to Week 144)||44||
60032847|NCT02326298|76148350|FG000|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0||
60032848|NCT02326298|76148351|FG001|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0||
60032849|NCT02326298|76148352|FG002|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0||
60032850|NCT02326298|76148353|FG003|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0||
60032851|NCT02326298|76148354|FG004|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0||
60032852|NCT02326298|76148355|FG005|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0||
60032853|NCT02326298|76148356|FG006|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0||
60032854|NCT02326298|76148357|FG007|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0||
60032855|NCT02326298|76148358|FG008|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0||
60032856|NCT02326298|76148359|FG009|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0||
60032857|NCT02326298|76148360|FG010|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0||
60032858|NCT02326298|76148361|FG011|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||20||
60032859|NCT02326298|76148362|FG012|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||19||
60032860|NCT02326298|76148363|FG013|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||9||
60032861|NCT02396420|76148372|FG000|STARTED|Overall Study||2||
60032862|NCT02396420|76148372|FG000|1 Month Post PAE|Overall Study||2||
60032863|NCT02396420|76148372|FG000|3 Months Post PAE|Overall Study||2||
60032864|NCT02396420|76148372|FG000|6 Months Post PAE|Overall Study||2||
60032865|NCT02396420|76148372|FG000|COMPLETED|Overall Study||1|12 Months Post PAE|
60032866|NCT02396420|76148372|FG000|NOT COMPLETED|Overall Study||1||
60032867|NCT02279719|76148384|FG000|STARTED|Overall Study||5||
60032868|NCT02279719|76148385|FG001|STARTED|Overall Study||10||
60032869|NCT02279719|76148386|FG002|STARTED|Overall Study||4||
60032870|NCT02279719|76148387|FG003|STARTED|Overall Study||9||
60032871|NCT02279719|76148388|FG004|STARTED|Overall Study||28||
60032872|NCT02279719|76148389|FG005|STARTED|Overall Study||10||
60032873|NCT02279719|76148390|FG006|STARTED|Overall Study||31||
60032874|NCT02279719|76148384|FG000|COMPLETED|Overall Study||5||
60032875|NCT02279719|76148385|FG001|COMPLETED|Overall Study||10||
60032876|NCT02279719|76148386|FG002|COMPLETED|Overall Study||4||
60032877|NCT02279719|76148387|FG003|COMPLETED|Overall Study||9||
60032878|NCT02279719|76148388|FG004|COMPLETED|Overall Study||25||
60032879|NCT02279719|76148389|FG005|COMPLETED|Overall Study||10||
60032880|NCT02279719|76148390|FG006|COMPLETED|Overall Study||28||
59508193|NCT00756977|75601367|FG000|NOT COMPLETED|Overall Study||21||
60032881|NCT02279719|76148384|FG000|NOT COMPLETED|Overall Study||0||
60032882|NCT02279719|76148385|FG001|NOT COMPLETED|Overall Study||0||
60032883|NCT02279719|76148386|FG002|NOT COMPLETED|Overall Study||0||
60032884|NCT02279719|76148387|FG003|NOT COMPLETED|Overall Study||0||
60032885|NCT02279719|76148388|FG004|NOT COMPLETED|Overall Study||3||
60032886|NCT02279719|76148389|FG005|NOT COMPLETED|Overall Study||0||
60032887|NCT02279719|76148390|FG006|NOT COMPLETED|Overall Study||3||
60032888|NCT02279407|76148427|FG000|STARTED|Overall Study||22||
60032889|NCT02279407|76148428|FG001|STARTED|Overall Study||21||
60032890|NCT02279407|76148429|FG002|STARTED|Overall Study||20||
60032891|NCT02279407|76148430|FG003|STARTED|Overall Study||21||
60032892|NCT02279407|76148427|FG000|COMPLETED|Overall Study||20||
60032893|NCT02279407|76148428|FG001|COMPLETED|Overall Study||20||
60032894|NCT02279407|76148429|FG002|COMPLETED|Overall Study||15||
60032895|NCT02279407|76148430|FG003|COMPLETED|Overall Study||20||
60032896|NCT02279407|76148427|FG000|NOT COMPLETED|Overall Study||2||
60032897|NCT02279407|76148428|FG001|NOT COMPLETED|Overall Study||1||
60032898|NCT02279407|76148429|FG002|NOT COMPLETED|Overall Study||5||
60032899|NCT02279407|76148430|FG003|NOT COMPLETED|Overall Study||1||
59508194|NCT00756977|75601368|FG001|NOT COMPLETED|Overall Study||11||
59508195|NCT02027883|75601376|FG000|STARTED|Overall Study||50||
59508196|NCT02027883|75601377|FG001|STARTED|Overall Study||50||
59508197|NCT02027883|75601376|FG000|COMPLETED|Overall Study||50||
60032900|NCT02326220|76148442|FG000|STARTED|Double-blind Treatment Period|Out of 21 participants, 9 participants entered in open label treatment period|21||
59508198|NCT02027883|75601377|FG001|COMPLETED|Overall Study||50||
59508199|NCT02027883|75601376|FG000|NOT COMPLETED|Overall Study||0||
59508200|NCT02027883|75601377|FG001|NOT COMPLETED|Overall Study||0||
59508201|NCT00783965|75601389|FG000|STARTED|First Intervention (12 Months)||5||
60032901|NCT02326220|76148443|FG001|STARTED|Double-blind Treatment Period|Out of 41 participants, 20 participants entered in open label treatment period.|41||
60032902|NCT02326220|76148444|FG002|STARTED|Double-blind Treatment Period||0||
60032903|NCT02326220|76148442|FG000|COMPLETED|Double-blind Treatment Period||20||
60032904|NCT02326220|76148443|FG001|COMPLETED|Double-blind Treatment Period||37||
60032905|NCT02326220|76148444|FG002|COMPLETED|Double-blind Treatment Period||0||
60032906|NCT02326220|76148442|FG000|NOT COMPLETED|Double-blind Treatment Period||1||
60032907|NCT02326220|76148443|FG001|NOT COMPLETED|Double-blind Treatment Period||4||
60032908|NCT02326220|76148444|FG002|NOT COMPLETED|Double-blind Treatment Period||0||
60032909|NCT02326220|76148442|FG000|STARTED|Open-label Treatment Period||0|Open-label available to participants in a country in which alirocumab was not commercially available|
60032910|NCT02326220|76148443|FG001|STARTED|Open-label Treatment Period||0|Open-label available to participants in a country in which alirocumab was not commercially available|
60032911|NCT02326220|76148444|FG002|STARTED|Open-label Treatment Period|29 participants: 9 from Placebo and 20 from Alirocumab 150 mg arm entered in open-label period.|29|Open-label available to participants in a country in which alirocumab was not commercially available|
60032912|NCT02326220|76148442|FG000|COMPLETED|Open-label Treatment Period||0||
60032913|NCT02326220|76148443|FG001|COMPLETED|Open-label Treatment Period||0||
60032914|NCT02326220|76148444|FG002|COMPLETED|Open-label Treatment Period||27||
60032915|NCT02326220|76148442|FG000|NOT COMPLETED|Open-label Treatment Period||0||
60032916|NCT02326220|76148443|FG001|NOT COMPLETED|Open-label Treatment Period||0||
60032917|NCT02326220|76148444|FG002|NOT COMPLETED|Open-label Treatment Period||2||
60032918|NCT02279173|76148454|FG000|STARTED|Overall Study||203||
60032919|NCT02279173|76148454|FG000|Received Treatment|Overall Study||203||
60032920|NCT02279173|76148454|FG000|Enrolled Under Protocol Supplement|Overall Study||79||
60032921|NCT02279173|76148454|FG000|COMPLETED|Overall Study||109||
60032922|NCT02279173|76148454|FG000|NOT COMPLETED|Overall Study||94||
60032923|NCT02282917|76148460|FG000|STARTED|Overall Study||7||
60032924|NCT02282917|76148460|FG000|COMPLETED|Overall Study||5||
60032925|NCT02282917|76148460|FG000|NOT COMPLETED|Overall Study||2||
60032926|NCT02358668|76148467|FG000|STARTED|Overall Study||24||
60032927|NCT02358668|76148468|FG001|STARTED|Overall Study||24||
60032928|NCT02358668|76148469|FG002|STARTED|Overall Study||12||
60032929|NCT02358668|76148467|FG000|COMPLETED|Overall Study||22||
60032930|NCT02358668|76148468|FG001|COMPLETED|Overall Study||23||
60032931|NCT02358668|76148469|FG002|COMPLETED|Overall Study||12||
60032932|NCT02358668|76148467|FG000|NOT COMPLETED|Overall Study||2||
60032933|NCT02358668|76148468|FG001|NOT COMPLETED|Overall Study||1||
60032934|NCT02358668|76148469|FG002|NOT COMPLETED|Overall Study||0||
60032935|NCT02282605|76148480|FG000|STARTED|Overall Study||27||
60032936|NCT02282605|76148481|FG001|STARTED|Overall Study||12||
60032937|NCT02282605|76148482|FG002|STARTED|Overall Study||24||
60032938|NCT02282605|76148480|FG000|COMPLETED|Overall Study||24||
60032939|NCT02282605|76148481|FG001|COMPLETED|Overall Study||12||
60032940|NCT02282605|76148482|FG002|COMPLETED|Overall Study||24||
60032941|NCT02282605|76148480|FG000|NOT COMPLETED|Overall Study||3||
60032942|NCT02282605|76148481|FG001|NOT COMPLETED|Overall Study||0||
60032943|NCT02282605|76148482|FG002|NOT COMPLETED|Overall Study||0||
60032944|NCT02282527|76148492|FG000|STARTED|Overall Study||16||
60032945|NCT02282527|76148493|FG001|STARTED|Overall Study||16||
60032946|NCT02282527|76148492|FG000|COMPLETED|Overall Study||15||
60032947|NCT02282527|76148493|FG001|COMPLETED|Overall Study||15||
60032948|NCT02282527|76148492|FG000|NOT COMPLETED|Overall Study||1||
60032949|NCT02282527|76148493|FG001|NOT COMPLETED|Overall Study||1||
60032950|NCT02278939|76148504|FG000|STARTED|Overall Study||33||
60032951|NCT02278939|76148505|FG001|STARTED|Overall Study||34||
60032952|NCT02278939|76148504|FG000|COMPLETED|Overall Study||28||
60032953|NCT02278939|76148505|FG001|COMPLETED|Overall Study||33||
60032954|NCT02278939|76148504|FG000|NOT COMPLETED|Overall Study||5||
60032955|NCT02278939|76148505|FG001|NOT COMPLETED|Overall Study||1||
60032956|NCT02278471|76148513|FG000|STARTED|Overall Study||155||
60032957|NCT02278471|76148514|FG001|STARTED|Overall Study||148||
60032958|NCT02278471|76148513|FG000|COMPLETED|Overall Study||147||
60032959|NCT02278471|76148514|FG001|COMPLETED|Overall Study||128||
60032960|NCT02278471|76148513|FG000|NOT COMPLETED|Overall Study||8||
60032961|NCT02278471|76148514|FG001|NOT COMPLETED|Overall Study||20||
60032962|NCT02278003|76148523|FG000|STARTED|Overall Study||49||
60032963|NCT02278003|76148524|FG001|STARTED|Overall Study||20||
60032964|NCT02278003|76148523|FG000|COMPLETED|Overall Study||30||
60032965|NCT02278003|76148524|FG001|COMPLETED|Overall Study||20||
60032966|NCT02278003|76148523|FG000|NOT COMPLETED|Overall Study||19||
60032967|NCT02278003|76148524|FG001|NOT COMPLETED|Overall Study||0||
60032968|NCT02277769|76148533|FG000|STARTED|Overall Study||236||
60032969|NCT02277769|76148534|FG001|STARTED|Overall Study||233||
60032970|NCT02277769|76148535|FG002|STARTED|Overall Study||239||
59508202|NCT00783965|75601390|FG001|STARTED|First Intervention (12 Months)||29||
60032971|NCT02277769|76148533|FG000|Treated|Overall Study||235||
60032972|NCT02277769|76148534|FG001|Treated|Overall Study||233||
60032973|NCT02277769|76148535|FG002|Treated|Overall Study||239||
60032974|NCT02277769|76148533|FG000|Safety Population|Overall Study|1 participant received at least 1 injection of Dupilumab 300mg(analyzed in Dupilumab 300 mg q2w arm)|234||
60032975|NCT02277769|76148534|FG001|Safety Population|Overall Study|3 participants (1 [placebo] + 2 [Dupilumab 300 mg qw arm]) analyzed in Dupilumab 300 mg q2w arm|236||
60032976|NCT02277769|76148535|FG002|Safety Population|Overall Study|2 participants received fewer injections of Dupilumab 300 mg (analyzed in Dupilumab 300 mg q2w arm)|237||
60032977|NCT02277769|76148533|FG000|COMPLETED|Overall Study||190||
60032978|NCT02277769|76148534|FG001|COMPLETED|Overall Study||220||
60032979|NCT02277769|76148535|FG002|COMPLETED|Overall Study||221||
60032980|NCT02277769|76148533|FG000|NOT COMPLETED|Overall Study||46||
60032981|NCT02277769|76148534|FG001|NOT COMPLETED|Overall Study||13||
60032982|NCT02277769|76148535|FG002|NOT COMPLETED|Overall Study||18||
60032983|NCT01641991|76148547|FG000|STARTED|Overall Study||82||
60032984|NCT01641991|76148548|FG001|STARTED|Overall Study||82||
60032985|NCT01641991|76148549|FG002|STARTED|Overall Study||82||
60032986|NCT01641991|76148550|FG003|STARTED|Overall Study||82||
60032987|NCT01641991|76148547|FG000|COMPLETED|Overall Study||73||
60032988|NCT01641991|76148548|FG001|COMPLETED|Overall Study||74||
60032989|NCT01641991|76148549|FG002|COMPLETED|Overall Study||65||
60032990|NCT01641991|76148550|FG003|COMPLETED|Overall Study||66||
60032991|NCT01641991|76148547|FG000|NOT COMPLETED|Overall Study||9||
60032992|NCT01641991|76148548|FG001|NOT COMPLETED|Overall Study||8||
60032993|NCT01641991|76148549|FG002|NOT COMPLETED|Overall Study||17||
60032994|NCT01641991|76148550|FG003|NOT COMPLETED|Overall Study||16||
60032995|NCT02277691|76148563|FG000|STARTED|Overall Study||341||
60032996|NCT02277691|76148563|FG000|COMPLETED|Overall Study||295||
60032997|NCT02277691|76148563|FG000|NOT COMPLETED|Overall Study||46||
60032998|NCT02395172|76148569|FG000|STARTED|Overall Study||396||
60032999|NCT02395172|76148570|FG001|STARTED|Overall Study||396||
60033000|NCT02395172|76148569|FG000|Treated|Overall Study||393||
60033001|NCT02395172|76148570|FG001|Treated|Overall Study||365||
60033002|NCT02395172|76148569|FG000|COMPLETED|Overall Study||393||
60033003|NCT02395172|76148570|FG001|COMPLETED|Overall Study||365||
60033004|NCT02395172|76148569|FG000|NOT COMPLETED|Overall Study||3||
60033005|NCT02395172|76148570|FG001|NOT COMPLETED|Overall Study||31||
60033006|NCT02276053|76148576|FG000|STARTED|Overall Study||93||
60033007|NCT02276053|76148576|FG000|COMPLETED|Overall Study||79||
60033008|NCT02276053|76148576|FG000|NOT COMPLETED|Overall Study||14||
60033009|NCT02275819|76148583|FG000|STARTED|Overall Study||5||
60033010|NCT02275819|76148584|FG001|STARTED|Overall Study||6||
60033011|NCT02275819|76148583|FG000|COMPLETED|Overall Study||5||
60033012|NCT02275819|76148584|FG001|COMPLETED|Overall Study||5||
60033013|NCT02275819|76148583|FG000|NOT COMPLETED|Overall Study||0||
60033014|NCT02275819|76148584|FG001|NOT COMPLETED|Overall Study||1||
60033015|NCT02358044|76148592|FG000|STARTED|Overall Study||129||
60033016|NCT02358044|76148593|FG001|STARTED|Overall Study||128||
60033017|NCT02358044|76148592|FG000|Treated|Overall Study||129||
60033018|NCT02358044|76148593|FG001|Treated|Overall Study||126||
60033019|NCT02358044|76148592|FG000|COMPLETED|Overall Study|Completed = Completed Follow-up Week 24 (end of study)|127||
60033020|NCT02358044|76148593|FG001|COMPLETED|Overall Study|Completed = Completed Follow-up Week 24 (end of study)|121||
60033021|NCT02358044|76148592|FG000|NOT COMPLETED|Overall Study||2||
60033022|NCT02358044|76148593|FG001|NOT COMPLETED|Overall Study||7||
60033023|NCT02275117|76148604|FG000|STARTED|Overall Study||131||
60033024|NCT02275117|76148605|FG001|STARTED|Overall Study||133||
60033025|NCT02275117|76148606|FG002|STARTED|Overall Study||134||
60033026|NCT02275117|76148607|FG003|STARTED|Overall Study||133||
60033027|NCT02275117|76148608|FG004|STARTED|Overall Study||134||
60033028|NCT02275117|76148604|FG000|Randomized and Treated|Overall Study||120|3 participants received duplicate randomization, participants are summarized in first group assigned|
60033029|NCT02275117|76148605|FG001|Randomized and Treated|Overall Study||123|3 participants received duplicate randomization, participants are summarized in first group assigned|
60033030|NCT02275117|76148606|FG002|Randomized and Treated|Overall Study||122|3 participants received duplicate randomization, participants are summarized in first group assigned|
60033031|NCT02275117|76148607|FG003|Randomized and Treated|Overall Study||130|3 participants received duplicate randomization, participants are summarized in first group assigned|
60033032|NCT02275117|76148608|FG004|Randomized and Treated|Overall Study||121|3 participants received duplicate randomization, participants are summarized in first group assigned|
60033033|NCT02275117|76148604|FG000|COMPLETED|Overall Study||97||
60033034|NCT02275117|76148605|FG001|COMPLETED|Overall Study||96||
60033035|NCT02275117|76148606|FG002|COMPLETED|Overall Study||92||
60033036|NCT02275117|76148607|FG003|COMPLETED|Overall Study||100||
60033037|NCT02275117|76148608|FG004|COMPLETED|Overall Study||98||
60033038|NCT02275117|76148604|FG000|NOT COMPLETED|Overall Study||34||
60033039|NCT02275117|76148605|FG001|NOT COMPLETED|Overall Study||37||
60033040|NCT02275117|76148606|FG002|NOT COMPLETED|Overall Study||42||
60033041|NCT02275117|76148607|FG003|NOT COMPLETED|Overall Study||33||
60033042|NCT02275117|76148608|FG004|NOT COMPLETED|Overall Study||36||
60033043|NCT02274493|76148620|FG000|STARTED|Overall Study||15||
60033044|NCT02274493|76148620|FG000|COMPLETED|Overall Study||14||
60033045|NCT02274493|76148620|FG000|NOT COMPLETED|Overall Study||1||
60033046|NCT02273167|76148627|FG000|STARTED|Overall Study||283||
60033047|NCT02273167|76148628|FG001|STARTED|Overall Study||283||
60033048|NCT02273167|76148629|FG002|STARTED|Overall Study||283||
60033049|NCT02273167|76148627|FG000|COMPLETED|Overall Study||259||
60033050|NCT02273167|76148628|FG001|COMPLETED|Overall Study||260||
60033051|NCT02273167|76148629|FG002|COMPLETED|Overall Study||262||
60033052|NCT02273167|76148627|FG000|NOT COMPLETED|Overall Study||24||
60033053|NCT02273167|76148628|FG001|NOT COMPLETED|Overall Study||23||
60033054|NCT02273167|76148629|FG002|NOT COMPLETED|Overall Study||21||
60033055|NCT02272777|76148640|FG000|STARTED|Overall Study||112|All enrolled subjects were included in the Safety Set|
60033056|NCT02272777|76148641|FG001|STARTED|Overall Study||113|All enrolled subjects were included in the Safety Set|
60033057|NCT02272777|76148640|FG000|COMPLETED|Overall Study||108||
60033058|NCT02272777|76148641|FG001|COMPLETED|Overall Study||109||
60033059|NCT02272777|76148640|FG000|NOT COMPLETED|Overall Study||4||
60033060|NCT02272777|76148641|FG001|NOT COMPLETED|Overall Study||4||
60033061|NCT02357810|76148647|FG000|STARTED|Registered and Started Treatment||178||
60033062|NCT02357810|76148647|FG000|Signed Consent|Registered and Started Treatment||178||
60033063|NCT02357810|76148647|FG000|Registered to Study|Registered and Started Treatment||152||
60033064|NCT02357810|76148647|FG000|Initiated Treatment on Study|Registered and Started Treatment||151||
60033065|NCT02357810|76148647|FG000|COMPLETED|Registered and Started Treatment||151||
60033066|NCT02357810|76148647|FG000|NOT COMPLETED|Registered and Started Treatment||27||
60033067|NCT02357810|76148647|FG000|STARTED|Reached 12 Weeks Response||151||
60033068|NCT02357810|76148647|FG000|Completed 4 Weeks/1 Cycle|Reached 12 Weeks Response||151||
60033069|NCT02357810|76148647|FG000|Reached 6 Week Response|Reached 12 Weeks Response||129|Patients assessed as having progression at 6 weeks, discontinue study treatment per protocol.|
60033070|NCT02357810|76148647|FG000|Reached 12 Weeks/3 Cycles|Reached 12 Weeks Response||95||
60033071|NCT02357810|76148647|FG000|COMPLETED|Reached 12 Weeks Response||95||
60033072|NCT02357810|76148647|FG000|NOT COMPLETED|Reached 12 Weeks Response||56||
60033073|NCT02357810|76148647|FG000|STARTED|12 Week Response and Further Treatment||95||
60033074|NCT02357810|76148647|FG000|Assessed for 12 Week Response|12 Week Response and Further Treatment||95|Patients assessed as having progression at 12 weeks, discontinue study treatment per protocol.|
60033075|NCT02357810|76148647|FG000|Went on to be Treated After Response|12 Week Response and Further Treatment||73|Patients continue treatment until progressive disease, toxicity or patient withdrawal.|
60033076|NCT02357810|76148647|FG000|COMPLETED|12 Week Response and Further Treatment||73||
60033077|NCT02357810|76148647|FG000|NOT COMPLETED|12 Week Response and Further Treatment||22||
60033078|NCT02357810|76148647|FG000|STARTED|Follow-up at Treatment Discontinuation|All patients that receive at least one dose of study treatment go into follow up phase of the study.|151|Follow-up= 2yrs for patients with progression/5yrs for patients without progression, or until death or reach date 10.12.21|
60033079|NCT02357810|76148647|FG000|COMPLETED|Follow-up at Treatment Discontinuation||144||
60033080|NCT02357810|76148647|FG000|NOT COMPLETED|Follow-up at Treatment Discontinuation||7||
60033081|NCT02357576|76148653|FG000|STARTED|Treatment Period||12||
60033082|NCT02357576|76148654|FG001|STARTED|Treatment Period||9||
60033083|NCT02357576|76148653|FG000|COMPLETED|Treatment Period||12||
60033084|NCT02357576|76148654|FG001|COMPLETED|Treatment Period||7||
60033085|NCT02357576|76148653|FG000|NOT COMPLETED|Treatment Period||0||
60033086|NCT02357576|76148654|FG001|NOT COMPLETED|Treatment Period||2||
60033087|NCT02357576|76148653|FG000|STARTED|Neurodevelopmental Outcome Follow Up|1 patient exited the study after treatment completion and before returning for follow up visits.|11||
60033088|NCT02357576|76148654|FG001|STARTED|Neurodevelopmental Outcome Follow Up||7||
60033089|NCT02357576|76148653|FG000|COMPLETED|Neurodevelopmental Outcome Follow Up||6|Completed 24 Month Follow Up|
60033090|NCT02357576|76148654|FG001|COMPLETED|Neurodevelopmental Outcome Follow Up||2|Completed 24 Month Follow Up|
60033091|NCT02357576|76148653|FG000|NOT COMPLETED|Neurodevelopmental Outcome Follow Up||5||
60033092|NCT02357576|76148654|FG001|NOT COMPLETED|Neurodevelopmental Outcome Follow Up||5||
60033093|NCT01850446|76148662|FG000|STARTED|Overall Study||92||
60033094|NCT01850446|76148663|FG001|STARTED|Overall Study||92||
60033095|NCT01850446|76148662|FG000|COMPLETED|Overall Study||87||
60033096|NCT01850446|76148663|FG001|COMPLETED|Overall Study||90||
60033097|NCT01850446|76148662|FG000|NOT COMPLETED|Overall Study||5||
59917027|NCT03364309|76037555|FG014|STARTED|Post-Treatment Followup Period|This period is to report for Follow-up Period participants.|0||
59917028|NCT03364309|76037556|FG015|STARTED|Post-Treatment Followup Period|This period is to report for Follow-up Period participants.|0||
59917029|NCT03364309|76037557|FG016|STARTED|Post-Treatment Followup Period|This period is to report for Follow-up Period participants.|11||
59917030|NCT03364309|76037558|FG017|STARTED|Post-Treatment Followup Period|This period is to report for Follow-up Period participants.|375||
59917031|NCT03364309|76037559|FG018|STARTED|Post-Treatment Followup Period|This period is to report for Follow-up Period participants.|2||
59917032|NCT03364309|76037541|FG000|COMPLETED|Post-Treatment Followup Period||0||
59917033|NCT03364309|76037542|FG001|COMPLETED|Post-Treatment Followup Period||0||
59917034|NCT03364309|76037543|FG002|COMPLETED|Post-Treatment Followup Period||0||
60033098|NCT01850446|76148663|FG001|NOT COMPLETED|Overall Study||2||
60033099|NCT02465567|76148673|FG000|STARTED|Overall Study||2157||
60033100|NCT02465567|76148674|FG001|STARTED|Overall Study||2137||
60033101|NCT02465567|76148675|FG002|STARTED|Overall Study||2143||
60033102|NCT02465567|76148676|FG003|STARTED|Overall Study||2151||
60033103|NCT02465567|76148673|FG000|COMPLETED|Overall Study||1708||
60033104|NCT02465567|76148674|FG001|COMPLETED|Overall Study||1713||
60033105|NCT02465567|76148675|FG002|COMPLETED|Overall Study||1580||
60033106|NCT02465567|76148676|FG003|COMPLETED|Overall Study||1643||
60033107|NCT02465567|76148673|FG000|NOT COMPLETED|Overall Study||449||
60033108|NCT02465567|76148674|FG001|NOT COMPLETED|Overall Study||424||
60033109|NCT02465567|76148675|FG002|NOT COMPLETED|Overall Study||563||
60033110|NCT02465567|76148676|FG003|NOT COMPLETED|Overall Study||508||
60033111|NCT01644175|76148688|FG000|STARTED|Overall Study|Randomized|107||
60033112|NCT01644175|76148689|FG001|STARTED|Overall Study|Randomized|209||
60033113|NCT01644175|76148688|FG000|Treated|Overall Study||107||
60033114|NCT01644175|76148689|FG001|Treated|Overall Study||207||
60033115|NCT01644175|76148688|FG000|COMPLETED|Overall Study||75||
60033116|NCT01644175|76148689|FG001|COMPLETED|Overall Study||156||
60033117|NCT01644175|76148688|FG000|NOT COMPLETED|Overall Study||32||
60033118|NCT01644175|76148689|FG001|NOT COMPLETED|Overall Study||53||
60033119|NCT02357420|76148699|FG000|STARTED|Overall Study||104||
60033120|NCT02357420|76148700|FG001|STARTED|Overall Study||98||
60033121|NCT02357420|76148701|FG002|STARTED|Overall Study||109||
60033122|NCT02357420|76148702|FG003|STARTED|Overall Study||82||
60033123|NCT02357420|76148699|FG000|Full Analysis Set (FAS)|Overall Study||104||
60033124|NCT02357420|76148700|FG001|Full Analysis Set (FAS)|Overall Study||98||
60033125|NCT02357420|76148701|FG002|Full Analysis Set (FAS)|Overall Study||109||
60033126|NCT02357420|76148702|FG003|Full Analysis Set (FAS)|Overall Study|1 participant from safety set did not enter FAS.|81||
60033127|NCT02357420|76148699|FG000|COMPLETED|Overall Study|3 participants who discontinued prematurely were included in completed as they fulfilled Visit 8.|92||
60033128|NCT02357420|76148700|FG001|COMPLETED|Overall Study|1 participant who discontinued prematurely was included in completed as he/she fulfilled Visit 8.|86||
60033129|NCT02357420|76148701|FG002|COMPLETED|Overall Study|1 participant who discontinued prematurely was included in completed as he/she fulfilled Visit 8.|93||
60033130|NCT02357420|76148702|FG003|COMPLETED|Overall Study||63||
60033131|NCT02357420|76148699|FG000|NOT COMPLETED|Overall Study||12||
60033132|NCT02357420|76148700|FG001|NOT COMPLETED|Overall Study||12||
60033133|NCT02357420|76148701|FG002|NOT COMPLETED|Overall Study||16||
60033134|NCT02357420|76148702|FG003|NOT COMPLETED|Overall Study||19||
60033135|NCT01832038|76148712|FG000|STARTED|Overall Study||473||
60033136|NCT01832038|76148712|FG000|COMPLETED|Overall Study||238||
60033137|NCT01832038|76148712|FG000|NOT COMPLETED|Overall Study||235||
60033138|NCT01849588|76148717|FG000|STARTED|Overall Study||3||
60033139|NCT01849588|76148717|FG000|COMPLETED|Overall Study||0||
59508203|NCT00783965|75601389|FG000|COMPLETED|First Intervention (12 Months)||2||
59508204|NCT00783965|75601390|FG001|COMPLETED|First Intervention (12 Months)||25||
59508205|NCT00783965|75601389|FG000|NOT COMPLETED|First Intervention (12 Months)||3||
59759338|NCT00912743|75878704|FG001|NOT COMPLETED|Overall Study||20||
59759339|NCT00914459|75878712|FG000|STARTED|Overall Study||18||
59759340|NCT00914459|75878713|FG001|STARTED|Overall Study||19||
59759341|NCT00914459|75878712|FG000|COMPLETED|Overall Study||17||
59759342|NCT00914459|75878713|FG001|COMPLETED|Overall Study||18||
59759343|NCT00914459|75878712|FG000|NOT COMPLETED|Overall Study||1||
59759344|NCT00914459|75878713|FG001|NOT COMPLETED|Overall Study||1||
59759345|NCT00912509|75878723|FG000|STARTED|Overall Study||20||
59759346|NCT00912509|75878724|FG001|STARTED|Overall Study||10||
59759347|NCT00912509|75878723|FG000|COMPLETED|Overall Study||15||
59759348|NCT00912509|75878724|FG001|COMPLETED|Overall Study||7||
59917035|NCT03364309|76037544|FG003|COMPLETED|Post-Treatment Followup Period||0||
59917036|NCT03364309|76037545|FG004|COMPLETED|Post-Treatment Followup Period||0||
59917037|NCT03364309|76037546|FG005|COMPLETED|Post-Treatment Followup Period||0||
59917038|NCT03364309|76037547|FG006|COMPLETED|Post-Treatment Followup Period||0||
59917039|NCT03364309|76037548|FG007|COMPLETED|Post-Treatment Followup Period||0||
59917040|NCT03364309|76037549|FG008|COMPLETED|Post-Treatment Followup Period||0||
59917041|NCT03364309|76037550|FG009|COMPLETED|Post-Treatment Followup Period||0||
59917042|NCT03364309|76037551|FG010|COMPLETED|Post-Treatment Followup Period||0||
59917043|NCT03364309|76037552|FG011|COMPLETED|Post-Treatment Followup Period||0||
59917044|NCT03364309|76037553|FG012|COMPLETED|Post-Treatment Followup Period||0||
59917045|NCT03364309|76037554|FG013|COMPLETED|Post-Treatment Followup Period||0||
59917046|NCT03364309|76037555|FG014|COMPLETED|Post-Treatment Followup Period||0||
59917047|NCT03364309|76037556|FG015|COMPLETED|Post-Treatment Followup Period||0||
60033140|NCT01849588|76148717|FG000|NOT COMPLETED|Overall Study||3||
60033141|NCT02357342|76148723|FG000|STARTED|First 6 Months||20|15 subjects were still in study when it was extended; 13 subjects qualified for extension.|
59508206|NCT00783965|75601390|FG001|NOT COMPLETED|First Intervention (12 Months)||4||
59508207|NCT00783965|75601389|FG000|STARTED|Second Intervention (24 Months)||2||
59508208|NCT00783965|75601390|FG001|STARTED|Second Intervention (24 Months)||25||
59759349|NCT00912509|75878723|FG000|NOT COMPLETED|Overall Study||5||
59917048|NCT03364309|76037557|FG016|COMPLETED|Post-Treatment Followup Period||6||
59917049|NCT03364309|76037558|FG017|COMPLETED|Post-Treatment Followup Period||344||
60033142|NCT02357342|76148724|FG001|STARTED|First 6 Months||20|15 subjects were still in study when it was extended; 13 subjects qualified for extension.|
59759350|NCT00912509|75878724|FG001|NOT COMPLETED|Overall Study||3||
59759351|NCT02873598|75878734|FG000|STARTED|Overall Study||5||
60033143|NCT02357342|76148723|FG000|COMPLETED|First 6 Months|2 patients died. Neither deaths were study drug related.|18||
60033144|NCT02357342|76148724|FG001|COMPLETED|First 6 Months||20||
60033145|NCT02357342|76148723|FG000|NOT COMPLETED|First 6 Months||2||
60033146|NCT02357342|76148724|FG001|NOT COMPLETED|First 6 Months||0||
60033147|NCT02357342|76148723|FG000|STARTED|Extension Study||4||
60033148|NCT02357342|76148724|FG001|STARTED|Extension Study||9||
60033149|NCT02357342|76148723|FG000|COMPLETED|Extension Study||4||
60033150|NCT02357342|76148724|FG001|COMPLETED|Extension Study||9||
59508209|NCT00783965|75601389|FG000|COMPLETED|Second Intervention (24 Months)||2||
59508210|NCT00783965|75601390|FG001|COMPLETED|Second Intervention (24 Months)||16||
59759352|NCT02873598|75878735|FG001|STARTED|Overall Study||5||
59759353|NCT02873598|75878736|FG002|STARTED|Overall Study||4||
59759354|NCT02873598|75878734|FG000|COMPLETED|Overall Study||5||
59759355|NCT02873598|75878735|FG001|COMPLETED|Overall Study||5||
59759356|NCT02873598|75878736|FG002|COMPLETED|Overall Study||4||
59917050|NCT03364309|76037559|FG018|COMPLETED|Post-Treatment Followup Period||0||
59917051|NCT03364309|76037541|FG000|NOT COMPLETED|Post-Treatment Followup Period||0||
59917052|NCT03364309|76037542|FG001|NOT COMPLETED|Post-Treatment Followup Period||0||
59917053|NCT03364309|76037543|FG002|NOT COMPLETED|Post-Treatment Followup Period||0||
59917054|NCT03364309|76037544|FG003|NOT COMPLETED|Post-Treatment Followup Period||0||
59917055|NCT03364309|76037545|FG004|NOT COMPLETED|Post-Treatment Followup Period||0||
60033151|NCT02357342|76148723|FG000|NOT COMPLETED|Extension Study||0||
60033152|NCT02357342|76148724|FG001|NOT COMPLETED|Extension Study||0||
60033153|NCT02271529|76148730|FG000|STARTED|Overall Study||40||
60033154|NCT02271529|76148730|FG000|COMPLETED|Overall Study||39||
60033155|NCT02271529|76148730|FG000|NOT COMPLETED|Overall Study||1||
60033156|NCT02325518|76148736|FG000|STARTED|Overall Study||98||
60033157|NCT02325518|76148737|FG001|STARTED|Overall Study||103||
60033158|NCT02325518|76148736|FG000|Safety Set|Overall Study||98||
60033159|NCT02325518|76148737|FG001|Safety Set|Overall Study||103||
60033160|NCT02325518|76148736|FG000|Full Analysis Set (FAS)|Overall Study||98||
60033161|NCT02325518|76148737|FG001|Full Analysis Set (FAS)|Overall Study||101||
60033162|NCT02325518|76148736|FG000|Per Protocol Set (PPS)|Overall Study||92||
60033163|NCT02325518|76148737|FG001|Per Protocol Set (PPS)|Overall Study||97||
60033164|NCT02325518|76148736|FG000|COMPLETED|Overall Study||94||
60033165|NCT02325518|76148737|FG001|COMPLETED|Overall Study||100||
60033166|NCT02325518|76148736|FG000|NOT COMPLETED|Overall Study||4||
60033167|NCT02325518|76148737|FG001|NOT COMPLETED|Overall Study||3||
60033168|NCT02270983|76148747|FG000|STARTED|Overall Study||79||
60033169|NCT02270983|76148748|FG001|STARTED|Overall Study||87||
60033170|NCT02270983|76148749|FG002|STARTED|Overall Study||88||
60033171|NCT02270983|76148747|FG000|COMPLETED|Overall Study||70||
60033172|NCT02270983|76148748|FG001|COMPLETED|Overall Study||80||
60033173|NCT02270983|76148749|FG002|COMPLETED|Overall Study||76||
60033174|NCT02270983|76148747|FG000|NOT COMPLETED|Overall Study||9||
60033175|NCT02270983|76148748|FG001|NOT COMPLETED|Overall Study||7||
59917056|NCT03364309|76037546|FG005|NOT COMPLETED|Post-Treatment Followup Period||0||
59917057|NCT03364309|76037547|FG006|NOT COMPLETED|Post-Treatment Followup Period||0||
59917058|NCT03364309|76037548|FG007|NOT COMPLETED|Post-Treatment Followup Period||0||
59917059|NCT03364309|76037549|FG008|NOT COMPLETED|Post-Treatment Followup Period||0||
59759357|NCT02873598|75878734|FG000|NOT COMPLETED|Overall Study||0||
59917060|NCT03364309|76037550|FG009|NOT COMPLETED|Post-Treatment Followup Period||0||
59917061|NCT03364309|76037551|FG010|NOT COMPLETED|Post-Treatment Followup Period||0||
60033176|NCT02270983|76148749|FG002|NOT COMPLETED|Overall Study||12||
60033177|NCT02449889|76148760|FG000|STARTED|Overall Study||58||
60033178|NCT02449889|76148761|FG001|STARTED|Overall Study||58||
60033179|NCT02449889|76148762|FG002|STARTED|Overall Study||60||
60033180|NCT02449889|76148760|FG000|COMPLETED|Overall Study||57||
60033181|NCT02449889|76148761|FG001|COMPLETED|Overall Study||52||
60033182|NCT02449889|76148762|FG002|COMPLETED|Overall Study||59||
59759358|NCT02873598|75878735|FG001|NOT COMPLETED|Overall Study||0||
60033183|NCT02449889|76148760|FG000|NOT COMPLETED|Overall Study||1||
60033184|NCT02449889|76148761|FG001|NOT COMPLETED|Overall Study||6||
60033185|NCT02449889|76148762|FG002|NOT COMPLETED|Overall Study||1||
59508211|NCT00783965|75601389|FG000|NOT COMPLETED|Second Intervention (24 Months)||0||
59508212|NCT00783965|75601390|FG001|NOT COMPLETED|Second Intervention (24 Months)||9||
59508213|NCT02354859|75601398|FG000|STARTED|Overall Study||60|Treated, defined as randomized and started on study drug (IV gallium or placebo)|
59508214|NCT02354859|75601399|FG001|STARTED|Overall Study||59|Treated, defined as randomized and started on study drug (IV gallium or placebo)|
59508215|NCT02354859|75601398|FG000|COMPLETED|Overall Study||60|Completed last study visit (Day 56)|
59508216|NCT02354859|75601399|FG001|COMPLETED|Overall Study||57|Completed last study visit (Day 56)|
59508217|NCT02354859|75601398|FG000|NOT COMPLETED|Overall Study||0||
59508218|NCT02354859|75601399|FG001|NOT COMPLETED|Overall Study||2||
59508219|NCT02356107|75601405|FG000|STARTED|Overall Study||15||
59508220|NCT02356107|75601405|FG000|COMPLETED|Overall Study||12||
59508221|NCT02356107|75601405|FG000|NOT COMPLETED|Overall Study||3||
59508222|NCT00767507|75601413|FG000|STARTED|Overall Study||5||
59508223|NCT00767507|75601414|FG001|STARTED|Overall Study||6||
59508224|NCT00767507|75601415|FG002|STARTED|Overall Study||106||
59508225|NCT00767507|75601416|FG003|STARTED|Overall Study||104||
59508226|NCT00767507|75601413|FG000|COMPLETED|Overall Study||5||
59508227|NCT00767507|75601414|FG001|COMPLETED|Overall Study||6||
59508228|NCT00767507|75601415|FG002|COMPLETED|Overall Study||106||
59508229|NCT00767507|75601416|FG003|COMPLETED|Overall Study||101||
59508230|NCT00767507|75601413|FG000|NOT COMPLETED|Overall Study||0||
59508231|NCT00767507|75601414|FG001|NOT COMPLETED|Overall Study||0||
59508232|NCT00767507|75601415|FG002|NOT COMPLETED|Overall Study||0||
59508233|NCT00767507|75601416|FG003|NOT COMPLETED|Overall Study||3||
59508234|NCT02029755|75601436|FG000|STARTED|Overall Study||36||
59508235|NCT02029755|75601437|FG001|STARTED|Overall Study||36||
59508236|NCT02029755|75601438|FG002|STARTED|Overall Study||36||
59508237|NCT02029755|75601436|FG000|COMPLETED|Overall Study||36||
59508238|NCT02029755|75601437|FG001|COMPLETED|Overall Study||36||
59508239|NCT02029755|75601438|FG002|COMPLETED|Overall Study||36||
59508240|NCT02029755|75601436|FG000|NOT COMPLETED|Overall Study||0||
59508241|NCT02029755|75601437|FG001|NOT COMPLETED|Overall Study||0||
59508242|NCT02029755|75601438|FG002|NOT COMPLETED|Overall Study||0||
59508243|NCT02029911|75601446|FG000|STARTED|Overall Study|Treatment Attempted|60||
59508244|NCT02029911|75601446|FG000|Treated|Overall Study|Treatment Completed|60||
59508245|NCT02029911|75601446|FG000|COMPLETED|Overall Study|Completed 12 Month Follow-up|60||
59508246|NCT02029911|75601446|FG000|NOT COMPLETED|Overall Study||0||
59508247|NCT02357043|75601450|FG000|STARTED|Overall Study||368||
59508248|NCT02357043|75601450|FG000|COMPLETED|Overall Study||368||
59508249|NCT02357043|75601450|FG000|NOT COMPLETED|Overall Study||0||
59508250|NCT02031627|75601457|FG000|STARTED|Overall Study||7||
59508251|NCT02031627|75601458|FG001|STARTED|Overall Study||7||
59508252|NCT02031627|75601459|FG002|STARTED|Overall Study||7||
59508253|NCT02031627|75601457|FG000|COMPLETED|Overall Study||7||
59508254|NCT02031627|75601458|FG001|COMPLETED|Overall Study||7||
59508255|NCT02031627|75601459|FG002|COMPLETED|Overall Study||7||
59508256|NCT02031627|75601457|FG000|NOT COMPLETED|Overall Study||0||
59508257|NCT02031627|75601458|FG001|NOT COMPLETED|Overall Study||0||
59508258|NCT02031627|75601459|FG002|NOT COMPLETED|Overall Study||0||
59508259|NCT02358135|75601469|FG000|STARTED|Overall Study||150||
59508260|NCT02358135|75601470|FG001|STARTED|Overall Study||150||
59508261|NCT02358135|75601469|FG000|Randomized|Overall Study||148||
59508262|NCT02358135|75601470|FG001|Randomized|Overall Study||148||
59508263|NCT02358135|75601469|FG000|COMPLETED|Overall Study||135||
59508264|NCT02358135|75601470|FG001|COMPLETED|Overall Study||131||
59508265|NCT02358135|75601469|FG000|NOT COMPLETED|Overall Study||15||
59508266|NCT02358135|75601470|FG001|NOT COMPLETED|Overall Study||19||
59508267|NCT02032641|75601476|FG000|STARTED|Overall Study|18 Brows enrolled for evaluation|9||
59508268|NCT02032641|75601476|FG000|COMPLETED|Overall Study|16 brows completed study (half underwent treatment, half were control)|8||
59508269|NCT02032641|75601476|FG000|NOT COMPLETED|Overall Study||1||
59508270|NCT02312739|75601484|FG000|STARTED|Overall Study||36||
59508271|NCT02312739|75601485|FG001|STARTED|Overall Study||36||
59508272|NCT02312739|75601484|FG000|Withdrawn Prior to Procedure|Overall Study||6||
59508273|NCT02312739|75601485|FG001|Withdrawn Prior to Procedure|Overall Study||2||
59508274|NCT02312739|75601484|FG000|COMPLETED|Overall Study||30||
59508275|NCT02312739|75601485|FG001|COMPLETED|Overall Study||34||
59508276|NCT02312739|75601484|FG000|NOT COMPLETED|Overall Study||6||
59508277|NCT02312739|75601485|FG001|NOT COMPLETED|Overall Study||2||
59508278|NCT02351037|75601494|FG000|STARTED|Overall Study||7||
59508279|NCT02351037|75601495|FG001|STARTED|Overall Study||21||
59508280|NCT02351037|75601496|FG002|STARTED|Overall Study||8||
59508281|NCT02351037|75601494|FG000|COMPLETED|Overall Study||7||
59508282|NCT02351037|75601495|FG001|COMPLETED|Overall Study||21||
59508283|NCT02351037|75601496|FG002|COMPLETED|Overall Study||8||
59508284|NCT02351037|75601494|FG000|NOT COMPLETED|Overall Study||0||
59508285|NCT02351037|75601495|FG001|NOT COMPLETED|Overall Study||0||
59508286|NCT02351037|75601496|FG002|NOT COMPLETED|Overall Study||0||
59508287|NCT02358603|75601506|FG000|STARTED|Overall Study||40||
59508288|NCT02358603|75601507|FG001|STARTED|Overall Study||8||
59508289|NCT02358603|75601506|FG000|COMPLETED|Overall Study||40||
59508290|NCT02358603|75601507|FG001|COMPLETED|Overall Study||8||
59508291|NCT02358603|75601506|FG000|NOT COMPLETED|Overall Study||0||
59508292|NCT02358603|75601507|FG001|NOT COMPLETED|Overall Study||0||
59508293|NCT02359305|75601515|FG000|STARTED|Overall Study||34||
59508294|NCT02359305|75601516|FG001|STARTED|Overall Study||34||
59508295|NCT02359305|75601515|FG000|COMPLETED|Overall Study||34||
59508296|NCT02359305|75601516|FG001|COMPLETED|Overall Study||34||
59508297|NCT02359305|75601515|FG000|NOT COMPLETED|Overall Study||0||
59508298|NCT02359305|75601516|FG001|NOT COMPLETED|Overall Study||0||
59508299|NCT02360319|75601524|FG000|STARTED|Overall Study||255||
59508300|NCT02360319|75601525|FG001|STARTED|Overall Study||234||
59508301|NCT02360319|75601524|FG000|COMPLETED|Overall Study||167||
59508302|NCT02360319|75601525|FG001|COMPLETED|Overall Study||173||
59508303|NCT02360319|75601524|FG000|NOT COMPLETED|Overall Study||88||
59508304|NCT02360319|75601525|FG001|NOT COMPLETED|Overall Study||61||
59508305|NCT02360631|75601533|FG000|STARTED|Overall Study||300||
59508306|NCT02360631|75601534|FG001|STARTED|Overall Study||200||
59508307|NCT02360631|75601533|FG000|Week 12|Overall Study||249||
59508308|NCT02360631|75601534|FG001|Week 12|Overall Study||165||
59508309|NCT02360631|75601533|FG000|COMPLETED|Overall Study||267||
59508310|NCT02360631|75601534|FG001|COMPLETED|Overall Study||174||
59508311|NCT02360631|75601533|FG000|NOT COMPLETED|Overall Study||33||
59508312|NCT02360631|75601534|FG001|NOT COMPLETED|Overall Study||26||
59508313|NCT02033499|75601543|FG000|STARTED|Overall Study||152||
59508314|NCT02033499|75601544|FG001|STARTED|Overall Study||150||
59508315|NCT02033499|75601545|FG002|STARTED|Overall Study||148||
59508316|NCT02033499|75601543|FG000|COMPLETED|Overall Study||147||
59508317|NCT02033499|75601544|FG001|COMPLETED|Overall Study||142||
59508318|NCT02033499|75601545|FG002|COMPLETED|Overall Study||139||
59508319|NCT02033499|75601543|FG000|NOT COMPLETED|Overall Study||5||
59508320|NCT02033499|75601544|FG001|NOT COMPLETED|Overall Study||8||
59508321|NCT02033499|75601545|FG002|NOT COMPLETED|Overall Study||9||
59508322|NCT02362191|75601554|FG000|STARTED|Overall Study||5||
59508323|NCT02362191|75601554|FG000|COMPLETED|Overall Study||3||
59508324|NCT02362191|75601554|FG000|NOT COMPLETED|Overall Study||2||
59508325|NCT02363907|75601558|FG000|STARTED|Overall Study||30||
59508326|NCT02363907|75601558|FG000|COMPLETED|Overall Study||30||
59508327|NCT02363907|75601558|FG000|NOT COMPLETED|Overall Study||0||
59508328|NCT02366871|75601564|FG000|STARTED|Overall Study||204||
59508329|NCT02366871|75601565|FG001|STARTED|Overall Study||196||
59508330|NCT02366871|75601564|FG000|COMPLETED|Overall Study||204||
59508331|NCT02366871|75601565|FG001|COMPLETED|Overall Study||196||
59508332|NCT02366871|75601564|FG000|NOT COMPLETED|Overall Study||0||
59508333|NCT02366871|75601565|FG001|NOT COMPLETED|Overall Study||0||
59508334|NCT02036541|75601571|FG000|STARTED|Overall Study||65||
59508335|NCT02036541|75601571|FG000|Completed Endpoint Visit|Overall Study||54||
60033186|NCT01831804|76148779|FG000|STARTED|Overall Study||4||
59508336|NCT02036541|75601571|FG000|COMPLETED|Overall Study||49||
59508337|NCT02036541|75601571|FG000|NOT COMPLETED|Overall Study||16||
59508338|NCT02368431|75601577|FG000|STARTED|Overall Study||46||
59508339|NCT02368431|75601578|FG001|STARTED|Overall Study||46||
59508340|NCT02368431|75601577|FG000|COMPLETED|Overall Study||22||
59508341|NCT02368431|75601578|FG001|COMPLETED|Overall Study||27||
59508342|NCT02368431|75601577|FG000|NOT COMPLETED|Overall Study||24||
59508343|NCT02368431|75601578|FG001|NOT COMPLETED|Overall Study||19||
59508344|NCT00757601|75601584|FG000|STARTED|Period 1||2||
59508345|NCT00757601|75601585|FG001|STARTED|Period 1||2||
59508346|NCT00757601|75601586|FG002|STARTED|Period 1||2||
59508347|NCT00757601|75601587|FG003|STARTED|Period 1||2||
59508348|NCT00757601|75601588|FG004|STARTED|Period 1||2||
59508349|NCT00757601|75601589|FG005|STARTED|Period 1||2||
59508350|NCT00757601|75601590|FG006|STARTED|Period 1||2||
59508351|NCT00757601|75601591|FG007|STARTED|Period 1||2||
59508352|NCT00757601|75601592|FG008|STARTED|Period 1||2||
59508353|NCT00757601|75601593|FG009|STARTED|Period 1||2||
59508354|NCT00757601|75601594|FG010|STARTED|Period 1||2||
59508355|NCT00757601|75601595|FG011|STARTED|Period 1||3||
60033187|NCT01831804|76148780|FG001|STARTED|Overall Study||3||
60033188|NCT01831804|76148781|FG002|STARTED|Overall Study||9||
60033189|NCT01831804|76148782|FG003|STARTED|Overall Study||5||
60033190|NCT01831804|76148783|FG004|STARTED|Overall Study||5||
60033191|NCT01831804|76148784|FG005|STARTED|Overall Study||3||
59508356|NCT00757601|75601584|FG000|COMPLETED|Period 1||2||
59508357|NCT00757601|75601585|FG001|COMPLETED|Period 1||2||
59508358|NCT00757601|75601586|FG002|COMPLETED|Period 1||2||
59508359|NCT00757601|75601587|FG003|COMPLETED|Period 1||2||
59508360|NCT00757601|75601588|FG004|COMPLETED|Period 1||2||
59508361|NCT00757601|75601589|FG005|COMPLETED|Period 1||2||
59508362|NCT00757601|75601590|FG006|COMPLETED|Period 1||2||
59508363|NCT00757601|75601591|FG007|COMPLETED|Period 1||2||
59508364|NCT00757601|75601592|FG008|COMPLETED|Period 1||2||
59508365|NCT00757601|75601593|FG009|COMPLETED|Period 1||2||
59508366|NCT00757601|75601594|FG010|COMPLETED|Period 1||2||
59508367|NCT00757601|75601595|FG011|COMPLETED|Period 1||3||
59508368|NCT00757601|75601584|FG000|NOT COMPLETED|Period 1||0||
59508369|NCT00757601|75601585|FG001|NOT COMPLETED|Period 1||0||
59508370|NCT00757601|75601586|FG002|NOT COMPLETED|Period 1||0||
59508371|NCT00757601|75601587|FG003|NOT COMPLETED|Period 1||0||
59508372|NCT00757601|75601588|FG004|NOT COMPLETED|Period 1||0||
60033192|NCT01831804|76148785|FG006|STARTED|Overall Study||4||
59759359|NCT02873598|75878736|FG002|NOT COMPLETED|Overall Study||0||
59759360|NCT00913835|75878744|FG000|STARTED|Olara+Lip Dox and Lip Dox Monotherapy||63||
60033193|NCT01831804|76148786|FG007|STARTED|Overall Study||26||
59508373|NCT00757601|75601589|FG005|NOT COMPLETED|Period 1||0||
59508374|NCT00757601|75601590|FG006|NOT COMPLETED|Period 1||0||
59508375|NCT00757601|75601591|FG007|NOT COMPLETED|Period 1||0||
59508376|NCT00757601|75601592|FG008|NOT COMPLETED|Period 1||0||
59508377|NCT00757601|75601593|FG009|NOT COMPLETED|Period 1||0||
59508378|NCT00757601|75601594|FG010|NOT COMPLETED|Period 1||0||
59508379|NCT00757601|75601595|FG011|NOT COMPLETED|Period 1||0||
59508380|NCT00757601|75601584|FG000|STARTED|Period 2||2||
59508381|NCT00757601|75601585|FG001|STARTED|Period 2||2||
59508382|NCT00757601|75601586|FG002|STARTED|Period 2||2||
59508383|NCT00757601|75601587|FG003|STARTED|Period 2||2||
59759361|NCT00913835|75878745|FG001|STARTED|Olara+Lip Dox and Lip Dox Monotherapy||62||
59917062|NCT03364309|76037552|FG011|NOT COMPLETED|Post-Treatment Followup Period||0||
59917063|NCT03364309|76037553|FG012|NOT COMPLETED|Post-Treatment Followup Period||0||
59917064|NCT03364309|76037554|FG013|NOT COMPLETED|Post-Treatment Followup Period||0||
59917065|NCT03364309|76037555|FG014|NOT COMPLETED|Post-Treatment Followup Period||0||
59917066|NCT03364309|76037556|FG015|NOT COMPLETED|Post-Treatment Followup Period||0||
59917067|NCT03364309|76037557|FG016|NOT COMPLETED|Post-Treatment Followup Period||5||
59917068|NCT03364309|76037558|FG017|NOT COMPLETED|Post-Treatment Followup Period||31||
59917069|NCT03364309|76037559|FG018|NOT COMPLETED|Post-Treatment Followup Period||2||
59917070|NCT03334903|76037585|FG000|STARTED|Overall Study||39||
59917071|NCT03334903|76037586|FG001|STARTED|Overall Study||38||
59917072|NCT03334903|76037585|FG000|COMPLETED|Overall Study||35||
59917073|NCT03334903|76037586|FG001|COMPLETED|Overall Study||33||
59917074|NCT03334903|76037585|FG000|NOT COMPLETED|Overall Study||4||
59917075|NCT03334903|76037586|FG001|NOT COMPLETED|Overall Study||5||
59917076|NCT01353664|76037592|FG000|STARTED|Overall Study|Participants who received at least 1 dose of study drug.|19||
59917077|NCT01353664|76037592|FG000|COMPLETED|Overall Study|Completed = Number of participants who continued on Romidepsin treatment|0||
59917078|NCT01353664|76037592|FG000|NOT COMPLETED|Overall Study||19||
59917079|NCT02694328|76037598|FG000|STARTED|Overall Study||276||
59917080|NCT02694328|76037599|FG001|STARTED|Overall Study||274||
59917081|NCT02694328|76037598|FG000|COMPLETED|Overall Study||176||
59917082|NCT02694328|76037599|FG001|COMPLETED|Overall Study||176||
59759362|NCT00913835|75878744|FG000|Received Any Study Drug|Olara+Lip Dox and Lip Dox Monotherapy||62||
59917083|NCT02694328|76037598|FG000|NOT COMPLETED|Overall Study||100||
59917084|NCT02694328|76037599|FG001|NOT COMPLETED|Overall Study||98||
59508384|NCT00757601|75601588|FG004|STARTED|Period 2||2||
59508385|NCT00757601|75601589|FG005|STARTED|Period 2||2||
59917085|NCT03334747|76037614|FG000|STARTED|Treatment Phase||10|Randomized set (RAN)|
59917086|NCT03334747|76037615|FG001|STARTED|Treatment Phase||10|Randomized set (RAN)|
59917087|NCT03334747|76037616|FG002|STARTED|Treatment Phase||12|Randomized set (RAN)|
59951367|NCT02949921|76070315|FG000|NOT COMPLETED|Overall Study||0||
59951368|NCT02949921|76070316|FG001|NOT COMPLETED|Overall Study||0||
59951369|NCT02498132|76070325|FG000|STARTED|Overall Study||24||
59951370|NCT02498132|76070326|FG001|STARTED|Overall Study||19||
59951371|NCT02498132|76070327|FG002|STARTED|Overall Study||9||
59951372|NCT02498132|76070325|FG000|COMPLETED|Overall Study||22||
59951373|NCT02498132|76070326|FG001|COMPLETED|Overall Study||18||
59951374|NCT02498132|76070327|FG002|COMPLETED|Overall Study||9||
59951375|NCT02498132|76070325|FG000|NOT COMPLETED|Overall Study||2||
59951376|NCT02498132|76070326|FG001|NOT COMPLETED|Overall Study||1||
59951377|NCT02498132|76070327|FG002|NOT COMPLETED|Overall Study||0||
59951378|NCT02205359|76070337|FG000|STARTED|Overall Study||1810|Number of subjects following successful implant and randomization|
59951379|NCT02205359|76070338|FG001|STARTED|Overall Study||1807|Number of subjects following successful implant and randomization|
59951380|NCT02205359|76070337|FG000|COMPLETED|Overall Study||1117||
59951381|NCT02205359|76070338|FG001|COMPLETED|Overall Study||1096||
59951382|NCT02205359|76070337|FG000|NOT COMPLETED|Overall Study||693||
59951383|NCT02205359|76070338|FG001|NOT COMPLETED|Overall Study||711||
59951384|NCT02101775|76070348|FG000|STARTED|Overall Study||65||
59951385|NCT02101775|76070349|FG001|STARTED|Overall Study||34||
59951386|NCT02101775|76070350|FG002|STARTED|Overall Study||25||
59951387|NCT02101775|76070348|FG000|COMPLETED|Overall Study||61||
59951388|NCT02101775|76070349|FG001|COMPLETED|Overall Study||33||
59951389|NCT02101775|76070350|FG002|COMPLETED|Overall Study||25||
59951390|NCT02101775|76070348|FG000|NOT COMPLETED|Overall Study||4||
59951391|NCT02101775|76070349|FG001|NOT COMPLETED|Overall Study||1||
59951392|NCT02101775|76070350|FG002|NOT COMPLETED|Overall Study||0||
59951393|NCT01979536|76070366|FG000|STARTED|Overall Study||68||
59951394|NCT01979536|76070367|FG001|STARTED|Overall Study||69||
59951395|NCT01979536|76070366|FG000|COMPLETED|Overall Study||66||
59951396|NCT01979536|76070367|FG001|COMPLETED|Overall Study||61||
59951397|NCT01979536|76070366|FG000|NOT COMPLETED|Overall Study||2||
59951398|NCT01979536|76070367|FG001|NOT COMPLETED|Overall Study||8||
59951399|NCT01880723|76070379|FG000|STARTED|Overall Study||16||
59951400|NCT01880723|76070380|FG001|STARTED|Overall Study||16||
59951401|NCT01880723|76070379|FG000|COMPLETED|Overall Study||16||
60033194|NCT01831804|76148787|FG008|STARTED|Overall Study||4||
60033195|NCT01831804|76148779|FG000|COMPLETED|Overall Study||3||
60033196|NCT01831804|76148780|FG001|COMPLETED|Overall Study||1||
60033197|NCT01831804|76148781|FG002|COMPLETED|Overall Study||3||
60033198|NCT01831804|76148782|FG003|COMPLETED|Overall Study||5||
60033199|NCT01831804|76148783|FG004|COMPLETED|Overall Study||3||
60033200|NCT01831804|76148784|FG005|COMPLETED|Overall Study||3||
60033201|NCT01831804|76148785|FG006|COMPLETED|Overall Study||3||
60033202|NCT01831804|76148786|FG007|COMPLETED|Overall Study||23||
60033203|NCT01831804|76148787|FG008|COMPLETED|Overall Study||2||
60033204|NCT01831804|76148779|FG000|NOT COMPLETED|Overall Study||1||
60033205|NCT01831804|76148780|FG001|NOT COMPLETED|Overall Study||2||
60033206|NCT01831804|76148781|FG002|NOT COMPLETED|Overall Study||6||
60033207|NCT01831804|76148782|FG003|NOT COMPLETED|Overall Study||0||
60033208|NCT01831804|76148783|FG004|NOT COMPLETED|Overall Study||2||
60033209|NCT01831804|76148784|FG005|NOT COMPLETED|Overall Study||0||
60033210|NCT01831804|76148785|FG006|NOT COMPLETED|Overall Study||1||
60033211|NCT01831804|76148786|FG007|NOT COMPLETED|Overall Study||3||
60033212|NCT01831804|76148787|FG008|NOT COMPLETED|Overall Study||2||
60033213|NCT02270671|76148818|FG000|STARTED|Overall Study||64||
60033214|NCT02270671|76148819|FG001|STARTED|Overall Study||66||
60033215|NCT02270671|76148818|FG000|COMPLETED|Overall Study||59||
60033216|NCT02270671|76148819|FG001|COMPLETED|Overall Study||61||
60033217|NCT02270671|76148818|FG000|NOT COMPLETED|Overall Study||5||
60033218|NCT02270671|76148819|FG001|NOT COMPLETED|Overall Study||5||
60033219|NCT02324270|76148828|FG000|STARTED|Overall Study||218||
60033220|NCT02324270|76148829|FG001|STARTED|Overall Study||219||
60033221|NCT02324270|76148830|FG002|STARTED|Overall Study||221||
60033222|NCT02324270|76148828|FG000|Safety Population|Overall Study||214||
60033223|NCT02324270|76148829|FG001|Safety Population|Overall Study||216||
60033224|NCT02324270|76148830|FG002|Safety Population|Overall Study||217||
60033225|NCT02324270|76148828|FG000|mITT Population|Overall Study||214||
60033226|NCT02324270|76148829|FG001|mITT Population|Overall Study||216||
60033227|NCT02324270|76148830|FG002|mITT Population|Overall Study||217||
60033228|NCT02324270|76148828|FG000|PP Population|Overall Study||180||
60033229|NCT02324270|76148829|FG001|PP Population|Overall Study||177||
60033230|NCT02324270|76148830|FG002|PP Population|Overall Study||171||
60033231|NCT02324270|76148828|FG000|COMPLETED|Overall Study||213||
60033232|NCT02324270|76148829|FG001|COMPLETED|Overall Study||212||
60033233|NCT02324270|76148830|FG002|COMPLETED|Overall Study||216||
60033234|NCT02324270|76148828|FG000|NOT COMPLETED|Overall Study||5||
60033235|NCT02324270|76148829|FG001|NOT COMPLETED|Overall Study||7||
60033236|NCT02324270|76148830|FG002|NOT COMPLETED|Overall Study||5||
60033237|NCT02270515|76148838|FG000|STARTED|Intervention Period 1: 0-6 Months||175||
60033238|NCT02270515|76148838|FG000|COMPLETED|Intervention Period 1: 0-6 Months||159||
60033239|NCT02270515|76148838|FG000|NOT COMPLETED|Intervention Period 1: 0-6 Months||16||
60033240|NCT02270515|76148838|FG000|STARTED|Intervention Period 2: 6-12 Months||159||
60033241|NCT02270515|76148838|FG000|COMPLETED|Intervention Period 2: 6-12 Months||127||
60033242|NCT02270515|76148838|FG000|NOT COMPLETED|Intervention Period 2: 6-12 Months||32||
60033243|NCT02270515|76148838|FG000|STARTED|Intervention Period 3: 12-18 Months||127||
60033244|NCT02270515|76148838|FG000|COMPLETED|Intervention Period 3: 12-18 Months||103||
60033245|NCT02270515|76148838|FG000|NOT COMPLETED|Intervention Period 3: 12-18 Months||24||
60033246|NCT02448875|76148852|FG000|STARTED|Overall Study||60|Includes dose selection phase and expansion phase|
60033247|NCT02448875|76148853|FG001|STARTED|Overall Study||21|Includes dose selection phase and expansion phase|
60033248|NCT02448875|76148854|FG002|STARTED|Overall Study||61|Includes dose selection phase and expansion phase|
60033249|NCT02448875|76148852|FG000|Completed Dose Selection Phase|Overall Study||20||
60033250|NCT02448875|76148853|FG001|Completed Dose Selection Phase|Overall Study||21||
60033251|NCT02448875|76148854|FG002|Completed Dose Selection Phase|Overall Study||20||
60033252|NCT02448875|76148852|FG000|Full Analysis Set|Overall Study||60||
60033253|NCT02448875|76148853|FG001|Full Analysis Set|Overall Study||21||
60033254|NCT02448875|76148854|FG002|Full Analysis Set|Overall Study||61||
60033255|NCT02448875|76148852|FG000|Safety Analysis Set|Overall Study||60||
60033256|NCT02448875|76148853|FG001|Safety Analysis Set|Overall Study||21||
60033257|NCT02448875|76148854|FG002|Safety Analysis Set|Overall Study||61||
60033258|NCT02448875|76148852|FG000|COMPLETED|Overall Study||53|Completed expansion phase|
60033259|NCT02448875|76148853|FG001|COMPLETED|Overall Study||20|Completed expansion phase|
60033260|NCT02448875|76148854|FG002|COMPLETED|Overall Study||60|Completed expansion phase|
60033261|NCT02448875|76148852|FG000|NOT COMPLETED|Overall Study||7||
60033262|NCT02448875|76148853|FG001|NOT COMPLETED|Overall Study||1||
60033263|NCT02448875|76148854|FG002|NOT COMPLETED|Overall Study||1||
60033264|NCT01831726|76148865|FG000|STARTED|Overall Study||80||
60033265|NCT01831726|76148865|FG000|COMPLETED|Overall Study||0||
60033266|NCT01831726|76148865|FG000|NOT COMPLETED|Overall Study||80||
60033267|NCT01831258|76148869|FG000|STARTED|Overall Study||35||
60033268|NCT01831258|76148870|FG001|STARTED|Overall Study||35||
60033269|NCT01831258|76148869|FG000|COMPLETED|Overall Study||30||
60033270|NCT01831258|76148870|FG001|COMPLETED|Overall Study||32||
60033271|NCT01831258|76148869|FG000|NOT COMPLETED|Overall Study||5||
60033272|NCT01831258|76148870|FG001|NOT COMPLETED|Overall Study||3||
60033273|NCT01849276|76148878|FG000|STARTED|Registered to the Study||2||
60033274|NCT01849276|76148878|FG000|COMPLETED|Registered to the Study||2||
60033275|NCT01849276|76148878|FG000|NOT COMPLETED|Registered to the Study||0||
60033276|NCT01849276|76148878|FG000|STARTED|Completed Treatment||2||
60033277|NCT01849276|76148878|FG000|COMPLETED|Completed Treatment||2||
60033278|NCT01849276|76148878|FG000|NOT COMPLETED|Completed Treatment||0||
60033279|NCT01849276|76148878|FG000|STARTED|Followed for Survival for 5 Years||2||
60033280|NCT01849276|76148878|FG000|COMPLETED|Followed for Survival for 5 Years||0||
60033281|NCT01849276|76148878|FG000|NOT COMPLETED|Followed for Survival for 5 Years||2||
60033282|NCT02465489|76148882|FG000|STARTED|Overall Study||20||
60033283|NCT02465489|76148882|FG000|COMPLETED|Overall Study||15||
60033284|NCT02465489|76148882|FG000|NOT COMPLETED|Overall Study||5||
60033285|NCT01829464|76148897|FG000|STARTED|Overall Study||30||
60033286|NCT01829464|76148898|FG001|STARTED|Overall Study||31||
60033287|NCT01829464|76148899|FG002|STARTED|Overall Study||29||
60033288|NCT01829464|76148897|FG000|COMPLETED|Overall Study||2||
60033289|NCT01829464|76148898|FG001|COMPLETED|Overall Study||2||
60033290|NCT01829464|76148899|FG002|COMPLETED|Overall Study||3||
60033291|NCT01829464|76148897|FG000|NOT COMPLETED|Overall Study||28||
60033292|NCT01829464|76148898|FG001|NOT COMPLETED|Overall Study||29||
60033293|NCT01829464|76148899|FG002|NOT COMPLETED|Overall Study||26||
60033294|NCT01847092|76148909|FG000|STARTED|Overall Study||77||
60033295|NCT01847092|76148910|FG001|STARTED|Overall Study||77||
60033296|NCT01847092|76148909|FG000|COMPLETED|Overall Study||51||
60033297|NCT01847092|76148910|FG001|COMPLETED|Overall Study||66||
60033298|NCT01847092|76148909|FG000|NOT COMPLETED|Overall Study||26||
60033299|NCT01847092|76148910|FG001|NOT COMPLETED|Overall Study||11||
60033300|NCT01601821|76148918|FG000|STARTED|Overall Study||125||
60033301|NCT01601821|76148919|FG001|STARTED|Overall Study||120||
60033302|NCT01601821|76148918|FG000|COMPLETED|Overall Study||96||
60033303|NCT01601821|76148919|FG001|COMPLETED|Overall Study||91||
59508386|NCT00757601|75601590|FG006|STARTED|Period 2||2||
60033304|NCT01601821|76148918|FG000|NOT COMPLETED|Overall Study||29||
60033305|NCT01601821|76148919|FG001|NOT COMPLETED|Overall Study||29||
60033306|NCT02323646|76148928|FG000|STARTED|Treatment Course 1||14||
60033307|NCT02323646|76148929|FG001|STARTED|Treatment Course 1||13||
60033308|NCT02323646|76148930|FG002|STARTED|Treatment Course 1||15||
60033309|NCT02323646|76148928|FG000|COMPLETED|Treatment Course 1||11||
60033310|NCT02323646|76148929|FG001|COMPLETED|Treatment Course 1||10||
60033311|NCT02323646|76148930|FG002|COMPLETED|Treatment Course 1||12||
60033312|NCT02323646|76148928|FG000|NOT COMPLETED|Treatment Course 1||3||
60033313|NCT02323646|76148929|FG001|NOT COMPLETED|Treatment Course 1||3||
60033314|NCT02323646|76148930|FG002|NOT COMPLETED|Treatment Course 1||3||
60033315|NCT02323646|76148928|FG000|STARTED|Treatment Course 2||11||
60033316|NCT02323646|76148929|FG001|STARTED|Treatment Course 2||10||
60033317|NCT02323646|76148930|FG002|STARTED|Treatment Course 2||12||
60033318|NCT02323646|76148928|FG000|COMPLETED|Treatment Course 2||10||
60033319|NCT02323646|76148929|FG001|COMPLETED|Treatment Course 2||9||
60033320|NCT02323646|76148930|FG002|COMPLETED|Treatment Course 2||9||
60033321|NCT02323646|76148928|FG000|NOT COMPLETED|Treatment Course 2||1||
60033322|NCT02323646|76148929|FG001|NOT COMPLETED|Treatment Course 2||1||
60033323|NCT02323646|76148930|FG002|NOT COMPLETED|Treatment Course 2||3||
60033324|NCT01846624|76148938|FG000|STARTED|Overall Study||13||
60033325|NCT01846624|76148938|FG000|COMPLETED|Overall Study||12||
60033326|NCT01846624|76148938|FG000|NOT COMPLETED|Overall Study||1||
60033327|NCT01829230|76148944|FG000|STARTED|Overall Study||40||
60033328|NCT01829230|76148945|FG001|STARTED|Overall Study||42||
60033329|NCT01829230|76148944|FG000|COMPLETED|Overall Study||39||
60033330|NCT01829230|76148945|FG001|COMPLETED|Overall Study||38||
60033331|NCT01829230|76148944|FG000|NOT COMPLETED|Overall Study||1||
60033332|NCT01829230|76148945|FG001|NOT COMPLETED|Overall Study||4||
60033333|NCT02269657|76148951|FG000|STARTED|Overall Study||40||
60033334|NCT02269657|76148951|FG000|COMPLETED|Overall Study||37||
60033335|NCT02269657|76148951|FG000|NOT COMPLETED|Overall Study||3||
60033336|NCT02269423|76148961|FG000|STARTED|Overall Study||10||
60033337|NCT02269423|76148962|FG001|STARTED|Overall Study||10||
60033338|NCT02269423|76148963|FG002|STARTED|Overall Study||10||
60033339|NCT02269423|76148964|FG003|STARTED|Overall Study||9||
60033340|NCT02269423|76148961|FG000|COMPLETED|Overall Study||10||
60033341|NCT02269423|76148962|FG001|COMPLETED|Overall Study||9||
60033342|NCT02269423|76148963|FG002|COMPLETED|Overall Study||10||
59508387|NCT00757601|75601591|FG007|STARTED|Period 2||2||
59508388|NCT00757601|75601592|FG008|STARTED|Period 2||2||
59508389|NCT00757601|75601593|FG009|STARTED|Period 2||2||
60033343|NCT02269423|76148964|FG003|COMPLETED|Overall Study||8||
60033344|NCT02269423|76148961|FG000|NOT COMPLETED|Overall Study||0||
60033345|NCT02269423|76148962|FG001|NOT COMPLETED|Overall Study||1||
60033346|NCT02269423|76148963|FG002|NOT COMPLETED|Overall Study||0||
60033347|NCT02269423|76148964|FG003|NOT COMPLETED|Overall Study||1||
60033348|NCT01827670|76148976|FG000|STARTED|Overall Study||60||
60033349|NCT01827670|76148977|FG001|STARTED|Overall Study||59||
60033350|NCT01827670|76148976|FG000|COMPLETED|Overall Study||57||
60033351|NCT01827670|76148977|FG001|COMPLETED|Overall Study||56||
60033352|NCT01827670|76148976|FG000|NOT COMPLETED|Overall Study||3||
60033353|NCT01827670|76148977|FG001|NOT COMPLETED|Overall Study||3||
59917088|NCT03334747|76037617|FG003|STARTED|Treatment Phase||20|Randomized set (RAN)|
59917089|NCT03334747|76037618|FG004|STARTED|Treatment Phase||22|Randomized set (RAN)|
59917090|NCT03334747|76037619|FG005|STARTED|Treatment Phase||20|Randomized set (RAN)|
59917091|NCT03334747|76037620|FG006|STARTED|Treatment Phase||21|Randomized set (RAN)|
59917092|NCT03334747|76037621|FG007|STARTED|Treatment Phase||22|Randomized set (RAN)|
59917093|NCT03334747|76037622|FG008|STARTED|Treatment Phase||51|Randomized set (RAN)|
59917094|NCT03334747|76037614|FG000|COMPLETED|Treatment Phase||9||
59917095|NCT03334747|76037615|FG001|COMPLETED|Treatment Phase||10||
59917096|NCT03334747|76037616|FG002|COMPLETED|Treatment Phase||12||
59917097|NCT03334747|76037617|FG003|COMPLETED|Treatment Phase||20||
59917098|NCT03334747|76037618|FG004|COMPLETED|Treatment Phase||21||
59917099|NCT03334747|76037619|FG005|COMPLETED|Treatment Phase||19||
59917100|NCT03334747|76037620|FG006|COMPLETED|Treatment Phase||21||
59917101|NCT03334747|76037621|FG007|COMPLETED|Treatment Phase||22||
59917102|NCT03334747|76037622|FG008|COMPLETED|Treatment Phase||51||
59917103|NCT03334747|76037614|FG000|NOT COMPLETED|Treatment Phase||1||
59917104|NCT03334747|76037615|FG001|NOT COMPLETED|Treatment Phase||0||
59917105|NCT03334747|76037616|FG002|NOT COMPLETED|Treatment Phase||0||
59917106|NCT03334747|76037617|FG003|NOT COMPLETED|Treatment Phase||0||
59917107|NCT03334747|76037618|FG004|NOT COMPLETED|Treatment Phase||1||
59917108|NCT03334747|76037619|FG005|NOT COMPLETED|Treatment Phase||1||
59917109|NCT03334747|76037620|FG006|NOT COMPLETED|Treatment Phase||0||
59917110|NCT03334747|76037621|FG007|NOT COMPLETED|Treatment Phase||0||
59917111|NCT03334747|76037622|FG008|NOT COMPLETED|Treatment Phase||0||
59917112|NCT03334747|76037614|FG000|STARTED|Follow-Up Phase||9||
59917113|NCT03334747|76037615|FG001|STARTED|Follow-Up Phase||10||
59917114|NCT03334747|76037616|FG002|STARTED|Follow-Up Phase||12||
59917115|NCT03334747|76037617|FG003|STARTED|Follow-Up Phase||20||
59917116|NCT03334747|76037618|FG004|STARTED|Follow-Up Phase||21||
59917117|NCT03334747|76037619|FG005|STARTED|Follow-Up Phase||19||
59917118|NCT03334747|76037620|FG006|STARTED|Follow-Up Phase||21||
59917119|NCT03334747|76037621|FG007|STARTED|Follow-Up Phase||22||
59917120|NCT03334747|76037622|FG008|STARTED|Follow-Up Phase||51||
59917121|NCT03334747|76037614|FG000|COMPLETED|Follow-Up Phase||9||
59917122|NCT03334747|76037615|FG001|COMPLETED|Follow-Up Phase||10||
59917123|NCT03334747|76037616|FG002|COMPLETED|Follow-Up Phase||12||
59917124|NCT03334747|76037617|FG003|COMPLETED|Follow-Up Phase||20||
59917125|NCT03334747|76037618|FG004|COMPLETED|Follow-Up Phase||21||
59917126|NCT03334747|76037619|FG005|COMPLETED|Follow-Up Phase||19||
59917127|NCT03334747|76037620|FG006|COMPLETED|Follow-Up Phase||20||
59917128|NCT03334747|76037621|FG007|COMPLETED|Follow-Up Phase||22||
59917129|NCT03334747|76037622|FG008|COMPLETED|Follow-Up Phase||50||
59917130|NCT03334747|76037614|FG000|NOT COMPLETED|Follow-Up Phase||0||
59917131|NCT03334747|76037615|FG001|NOT COMPLETED|Follow-Up Phase||0||
59917132|NCT03334747|76037616|FG002|NOT COMPLETED|Follow-Up Phase||0||
59917133|NCT03334747|76037617|FG003|NOT COMPLETED|Follow-Up Phase||0||
59917134|NCT03334747|76037618|FG004|NOT COMPLETED|Follow-Up Phase||0||
59917135|NCT03334747|76037619|FG005|NOT COMPLETED|Follow-Up Phase||0||
59917136|NCT03334747|76037620|FG006|NOT COMPLETED|Follow-Up Phase||1||
59917137|NCT03334747|76037621|FG007|NOT COMPLETED|Follow-Up Phase||0||
59917138|NCT03334747|76037622|FG008|NOT COMPLETED|Follow-Up Phase||1||
59917139|NCT03346759|76037644|FG000|STARTED|Enrollment to Baseline Data Collected||15||
59917140|NCT03346759|76037645|FG001|STARTED|Enrollment to Baseline Data Collected||13||
59917141|NCT03346759|76037644|FG000|COMPLETED|Enrollment to Baseline Data Collected|Participants assigned to the Tampon A First arm who provided at least one vaginal microbiota sample.|13||
59917142|NCT03346759|76037645|FG001|COMPLETED|Enrollment to Baseline Data Collected|Participants assigned to the Tampon B First arm who provided at least one vaginal microbiota sample.|10||
59917143|NCT03346759|76037644|FG000|NOT COMPLETED|Enrollment to Baseline Data Collected||2||
59917144|NCT03346759|76037645|FG001|NOT COMPLETED|Enrollment to Baseline Data Collected||3||
59917145|NCT03346759|76037644|FG000|STARTED|First Menstrual Cycle||13||
59917146|NCT03346759|76037645|FG001|STARTED|First Menstrual Cycle||10||
59917147|NCT03346759|76037644|FG000|COMPLETED|First Menstrual Cycle||12||
59917148|NCT03346759|76037645|FG001|COMPLETED|First Menstrual Cycle||10||
59917149|NCT03346759|76037644|FG000|NOT COMPLETED|First Menstrual Cycle||1||
59917150|NCT03346759|76037645|FG001|NOT COMPLETED|First Menstrual Cycle||0||
59917151|NCT03346759|76037644|FG000|STARTED|Second Menstrual Cycle||12||
59917152|NCT03346759|76037645|FG001|STARTED|Second Menstrual Cycle||10||
59917153|NCT03346759|76037644|FG000|COMPLETED|Second Menstrual Cycle||11||
59917154|NCT03346759|76037645|FG001|COMPLETED|Second Menstrual Cycle||10||
59917155|NCT03346759|76037644|FG000|NOT COMPLETED|Second Menstrual Cycle||1||
59917156|NCT03346759|76037645|FG001|NOT COMPLETED|Second Menstrual Cycle||0||
59917157|NCT03346759|76037644|FG000|STARTED|Third Menstrual Cycle||11||
59917158|NCT03346759|76037645|FG001|STARTED|Third Menstrual Cycle||10||
59508390|NCT00757601|75601594|FG010|STARTED|Period 2||2||
59508391|NCT00757601|75601595|FG011|STARTED|Period 2||3||
59508392|NCT00757601|75601584|FG000|COMPLETED|Period 2||2||
59508393|NCT00757601|75601585|FG001|COMPLETED|Period 2||2||
59508394|NCT00757601|75601586|FG002|COMPLETED|Period 2||2||
59508395|NCT00757601|75601587|FG003|COMPLETED|Period 2||2||
59508396|NCT00757601|75601588|FG004|COMPLETED|Period 2||2||
59508397|NCT00757601|75601589|FG005|COMPLETED|Period 2||2||
59508398|NCT00757601|75601590|FG006|COMPLETED|Period 2||2||
59508399|NCT00757601|75601591|FG007|COMPLETED|Period 2||2||
59508400|NCT00757601|75601592|FG008|COMPLETED|Period 2||2||
59508401|NCT00757601|75601593|FG009|COMPLETED|Period 2||2||
59508402|NCT00757601|75601594|FG010|COMPLETED|Period 2||2||
60033354|NCT02267317|76148991|FG000|STARTED|Infusion1||8||
60033355|NCT02267317|76148992|FG001|STARTED|Infusion1||3||
60033356|NCT02267317|76148993|FG002|STARTED|Infusion1||1||
60033357|NCT02267317|76148994|FG003|STARTED|Infusion1||2||
60033358|NCT02267317|76148995|FG004|STARTED|Infusion1||0||
60033359|NCT02267317|76148996|FG005|STARTED|Infusion1||1||
60033360|NCT02267317|76148991|FG000|COMPLETED|Infusion1||8||
60033361|NCT02267317|76148992|FG001|COMPLETED|Infusion1||3||
60033362|NCT02267317|76148993|FG002|COMPLETED|Infusion1||1||
60033363|NCT02267317|76148994|FG003|COMPLETED|Infusion1||2||
60033364|NCT02267317|76148995|FG004|COMPLETED|Infusion1||0||
60033365|NCT02267317|76148996|FG005|COMPLETED|Infusion1||1||
60033366|NCT02267317|76148991|FG000|NOT COMPLETED|Infusion1||0||
60033367|NCT02267317|76148992|FG001|NOT COMPLETED|Infusion1||0||
60033368|NCT02267317|76148993|FG002|NOT COMPLETED|Infusion1||0||
60033369|NCT02267317|76148994|FG003|NOT COMPLETED|Infusion1||0||
60033370|NCT02267317|76148995|FG004|NOT COMPLETED|Infusion1||0||
60033371|NCT02267317|76148996|FG005|NOT COMPLETED|Infusion1||0||
60033372|NCT02267317|76148991|FG000|STARTED|Washout (3-4weeks Between Infusions)||8||
60033373|NCT02267317|76148992|FG001|STARTED|Washout (3-4weeks Between Infusions)||3||
60033374|NCT02267317|76148993|FG002|STARTED|Washout (3-4weeks Between Infusions)||1||
60033375|NCT02267317|76148994|FG003|STARTED|Washout (3-4weeks Between Infusions)||2||
60033376|NCT02267317|76148995|FG004|STARTED|Washout (3-4weeks Between Infusions)||0||
60033377|NCT02267317|76148996|FG005|STARTED|Washout (3-4weeks Between Infusions)||1||
60033378|NCT02267317|76148991|FG000|COMPLETED|Washout (3-4weeks Between Infusions)||6||
60033379|NCT02267317|76148992|FG001|COMPLETED|Washout (3-4weeks Between Infusions)||3||
60033380|NCT02267317|76148993|FG002|COMPLETED|Washout (3-4weeks Between Infusions)||1||
60033381|NCT02267317|76148994|FG003|COMPLETED|Washout (3-4weeks Between Infusions)||2||
60033382|NCT02267317|76148995|FG004|COMPLETED|Washout (3-4weeks Between Infusions)||0||
60033383|NCT02267317|76148996|FG005|COMPLETED|Washout (3-4weeks Between Infusions)||1||
60033384|NCT02267317|76148991|FG000|NOT COMPLETED|Washout (3-4weeks Between Infusions)||2||
60033385|NCT02267317|76148992|FG001|NOT COMPLETED|Washout (3-4weeks Between Infusions)||0||
60033386|NCT02267317|76148993|FG002|NOT COMPLETED|Washout (3-4weeks Between Infusions)||0||
60033387|NCT02267317|76148994|FG003|NOT COMPLETED|Washout (3-4weeks Between Infusions)||0||
60033388|NCT02267317|76148995|FG004|NOT COMPLETED|Washout (3-4weeks Between Infusions)||0||
59508403|NCT00757601|75601595|FG011|COMPLETED|Period 2|One participant discontinued the study after Period 2 and was replaced by another participant.|2||
59508404|NCT00757601|75601584|FG000|NOT COMPLETED|Period 2||0||
59508405|NCT00757601|75601585|FG001|NOT COMPLETED|Period 2||0||
59508406|NCT00757601|75601586|FG002|NOT COMPLETED|Period 2||0||
59917159|NCT03346759|76037644|FG000|COMPLETED|Third Menstrual Cycle||11||
59917160|NCT03346759|76037645|FG001|COMPLETED|Third Menstrual Cycle||10||
59917161|NCT03346759|76037644|FG000|NOT COMPLETED|Third Menstrual Cycle||0||
59917162|NCT03346759|76037645|FG001|NOT COMPLETED|Third Menstrual Cycle||0||
59917163|NCT03361423|76037654|FG000|STARTED|Overall Study||126||
59917164|NCT03361423|76037655|FG001|STARTED|Overall Study||126||
59917165|NCT03361423|76037654|FG000|COMPLETED|Overall Study||99||
59917166|NCT03361423|76037655|FG001|COMPLETED|Overall Study||103||
59917167|NCT03361423|76037654|FG000|NOT COMPLETED|Overall Study||27||
59917168|NCT03361423|76037655|FG001|NOT COMPLETED|Overall Study||23||
59917169|NCT02693002|76037663|FG000|STARTED|Overall Study||2||
59917170|NCT02693002|76037664|FG001|STARTED|Overall Study||2||
59917171|NCT02693002|76037663|FG000|COMPLETED|Overall Study||1||
60033389|NCT02267317|76148996|FG005|NOT COMPLETED|Washout (3-4weeks Between Infusions)||0||
60033390|NCT02267317|76148991|FG000|STARTED|Infusion2||6||
60033391|NCT02267317|76148992|FG001|STARTED|Infusion2||3||
60033392|NCT02267317|76148993|FG002|STARTED|Infusion2||1||
60033393|NCT02267317|76148994|FG003|STARTED|Infusion2||2||
60033394|NCT02267317|76148995|FG004|STARTED|Infusion2||0||
60033395|NCT02267317|76148996|FG005|STARTED|Infusion2||1||
60033396|NCT02267317|76148991|FG000|COMPLETED|Infusion2||6||
60033397|NCT02267317|76148992|FG001|COMPLETED|Infusion2||3||
60033398|NCT02267317|76148993|FG002|COMPLETED|Infusion2||1||
60033399|NCT02267317|76148994|FG003|COMPLETED|Infusion2||2||
59508407|NCT00757601|75601587|FG003|NOT COMPLETED|Period 2||0||
59508408|NCT00757601|75601588|FG004|NOT COMPLETED|Period 2||0||
59508409|NCT00757601|75601589|FG005|NOT COMPLETED|Period 2||0||
59508410|NCT00757601|75601590|FG006|NOT COMPLETED|Period 2||0||
60033400|NCT02267317|76148995|FG004|COMPLETED|Infusion2||0||
60033401|NCT02267317|76148996|FG005|COMPLETED|Infusion2||1||
60033402|NCT02267317|76148991|FG000|NOT COMPLETED|Infusion2||0||
60033403|NCT02267317|76148992|FG001|NOT COMPLETED|Infusion2||0||
60033404|NCT02267317|76148993|FG002|NOT COMPLETED|Infusion2||0||
60033405|NCT02267317|76148994|FG003|NOT COMPLETED|Infusion2||0||
60033406|NCT02267317|76148995|FG004|NOT COMPLETED|Infusion2||0||
60033407|NCT02267317|76148996|FG005|NOT COMPLETED|Infusion2||0||
60033408|NCT01844830|76149012|FG000|STARTED|Overall Study||60||
60033409|NCT01844830|76149013|FG001|STARTED|Overall Study||30||
60033410|NCT01844830|76149012|FG000|100 µL Dose|Overall Study||16||
60033411|NCT01844830|76149013|FG001|100 µL Dose|Overall Study||8||
60033412|NCT01844830|76149012|FG000|200 µL Dose|Overall Study||24||
60033413|NCT01844830|76149013|FG001|200 µL Dose|Overall Study||12||
60033414|NCT01844830|76149012|FG000|400 µL Dose|Overall Study||20||
60033415|NCT01844830|76149013|FG001|400 µL Dose|Overall Study||10||
60033416|NCT01844830|76149012|FG000|COMPLETED|Overall Study||59|1 patient in the Kovacaine Mist 200 µL dose group did not finish the study.|
60033417|NCT01844830|76149013|FG001|COMPLETED|Overall Study||30|1 patient in the Kovacaine Mist 200 µL dose group did not finish the study.|
60033418|NCT01844830|76149012|FG000|NOT COMPLETED|Overall Study||1||
60033419|NCT01844830|76149013|FG001|NOT COMPLETED|Overall Study||0||
60033420|NCT01827592|76149022|FG000|STARTED|Overall Study|Randomized patients.|126||
60033421|NCT01827592|76149023|FG001|STARTED|Overall Study|Randomized patients.|126||
60033422|NCT01827592|76149024|FG002|STARTED|Overall Study|Randomized patients.|124||
60033423|NCT01827592|76149022|FG000|Safety Analysis Set|Overall Study|1 patient withdrew consent before getting the treatment.|125||
60033424|NCT01827592|76149023|FG001|Safety Analysis Set|Overall Study||126||
60033425|NCT01827592|76149024|FG002|Safety Analysis Set|Overall Study||124||
60033426|NCT01827592|76149022|FG000|COMPLETED|Overall Study||52||
60033427|NCT01827592|76149023|FG001|COMPLETED|Overall Study||46||
60033428|NCT01827592|76149024|FG002|COMPLETED|Overall Study||48||
60033429|NCT01827592|76149022|FG000|NOT COMPLETED|Overall Study||74||
60033430|NCT01827592|76149023|FG001|NOT COMPLETED|Overall Study||80||
60033431|NCT01827592|76149024|FG002|NOT COMPLETED|Overall Study||76||
60033432|NCT02323334|76149042|FG000|STARTED|Period 1||4||
60033433|NCT02323334|76149043|FG001|STARTED|Period 1||4||
60033434|NCT02323334|76149044|FG002|STARTED|Period 1||4||
60033435|NCT02323334|76149045|FG003|STARTED|Period 1||4||
60033436|NCT02323334|76149046|FG004|STARTED|Period 1||4||
60033437|NCT02323334|76149047|FG005|STARTED|Period 1||4||
60033438|NCT02323334|76149048|FG006|STARTED|Period 1||6||
59508411|NCT00757601|75601591|FG007|NOT COMPLETED|Period 2||0||
59508412|NCT00757601|75601592|FG008|NOT COMPLETED|Period 2||0||
59508413|NCT00757601|75601593|FG009|NOT COMPLETED|Period 2||0||
59508414|NCT00757601|75601594|FG010|NOT COMPLETED|Period 2||0||
59508415|NCT00757601|75601595|FG011|NOT COMPLETED|Period 2||1||
59508416|NCT00757601|75601584|FG000|STARTED|Period 3||2||
59508417|NCT00757601|75601585|FG001|STARTED|Period 3||2||
59508418|NCT00757601|75601586|FG002|STARTED|Period 3||2||
59508419|NCT00757601|75601587|FG003|STARTED|Period 3||2||
59508420|NCT00757601|75601588|FG004|STARTED|Period 3||2||
59508421|NCT00757601|75601589|FG005|STARTED|Period 3||2||
59508422|NCT00757601|75601590|FG006|STARTED|Period 3||2||
59508423|NCT00757601|75601591|FG007|STARTED|Period 3||2||
59508424|NCT00757601|75601592|FG008|STARTED|Period 3||2||
59508425|NCT00757601|75601593|FG009|STARTED|Period 3||2||
60033439|NCT02323334|76149049|FG007|STARTED|Period 1||6||
60033440|NCT02323334|76149050|FG008|STARTED|Period 1||5||
60033441|NCT02323334|76149051|FG009|STARTED|Period 1||7||
60033442|NCT02323334|76149052|FG010|STARTED|Period 1||5||
60033443|NCT02323334|76149053|FG011|STARTED|Period 1||3||
60033444|NCT02323334|76149054|FG012|STARTED|Period 1||9||
60033445|NCT02323334|76149055|FG013|STARTED|Period 1||9||
60033446|NCT02323334|76149056|FG014|STARTED|Period 1||9||
60033447|NCT02323334|76149057|FG015|STARTED|Period 1||9||
60033448|NCT02323334|76149058|FG016|STARTED|Period 1||2||
60033449|NCT02323334|76149042|FG000|Received at Least One Dose of Study Drug|Period 1||4||
60033450|NCT02323334|76149043|FG001|Received at Least One Dose of Study Drug|Period 1||4||
60033451|NCT02323334|76149044|FG002|Received at Least One Dose of Study Drug|Period 1||4||
60033452|NCT02323334|76149045|FG003|Received at Least One Dose of Study Drug|Period 1||4||
60033453|NCT02323334|76149046|FG004|Received at Least One Dose of Study Drug|Period 1||4||
60033454|NCT02323334|76149047|FG005|Received at Least One Dose of Study Drug|Period 1||4||
60033455|NCT02323334|76149048|FG006|Received at Least One Dose of Study Drug|Period 1||6||
59508426|NCT00757601|75601594|FG010|STARTED|Period 3||2||
60033456|NCT02323334|76149049|FG007|Received at Least One Dose of Study Drug|Period 1||6||
60033457|NCT02323334|76149050|FG008|Received at Least One Dose of Study Drug|Period 1||5||
60067810|NCT01951586|76182998|FG001|Received Study Drug|Overall Study||145||
60067811|NCT01951586|76182997|FG000|COMPLETED|Overall Study||0||
60067812|NCT01951586|76182998|FG001|COMPLETED|Overall Study||0||
60067813|NCT01951586|76182997|FG000|NOT COMPLETED|Overall Study||78||
60067814|NCT01951586|76182998|FG001|NOT COMPLETED|Overall Study||148||
60067815|NCT01785849|76183007|FG000|STARTED|Overall Study||254||
60067816|NCT01785849|76183008|FG001|STARTED|Overall Study||254||
60067817|NCT01785849|76183007|FG000|Received Treatment|Overall Study||254||
60067818|NCT01785849|76183008|FG001|Received Treatment|Overall Study||251||
60067819|NCT01785849|76183007|FG000|COMPLETED|Overall Study||193||
60067820|NCT01785849|76183008|FG001|COMPLETED|Overall Study||220||
60033458|NCT02323334|76149051|FG009|Received at Least One Dose of Study Drug|Period 1||7||
60033459|NCT02323334|76149052|FG010|Received at Least One Dose of Study Drug|Period 1||5||
60033460|NCT02323334|76149053|FG011|Received at Least One Dose of Study Drug|Period 1||3||
60033461|NCT02323334|76149054|FG012|Received at Least One Dose of Study Drug|Period 1||9||
60033462|NCT02323334|76149055|FG013|Received at Least One Dose of Study Drug|Period 1||9||
60033463|NCT02323334|76149056|FG014|Received at Least One Dose of Study Drug|Period 1||9||
60033464|NCT02323334|76149057|FG015|Received at Least One Dose of Study Drug|Period 1||9||
60033465|NCT02323334|76149058|FG016|Received at Least One Dose of Study Drug|Period 1||2||
60033466|NCT02323334|76149042|FG000|COMPLETED|Period 1||4||
60033467|NCT02323334|76149043|FG001|COMPLETED|Period 1||4||
60033468|NCT02323334|76149044|FG002|COMPLETED|Period 1||4||
60033469|NCT02323334|76149045|FG003|COMPLETED|Period 1||4||
60033470|NCT02323334|76149046|FG004|COMPLETED|Period 1||4||
60033471|NCT02323334|76149047|FG005|COMPLETED|Period 1||4||
60033472|NCT02323334|76149048|FG006|COMPLETED|Period 1||6||
60033473|NCT02323334|76149049|FG007|COMPLETED|Period 1||6||
60033474|NCT02323334|76149050|FG008|COMPLETED|Period 1||5||
60033475|NCT02323334|76149051|FG009|COMPLETED|Period 1||7||
60033476|NCT02323334|76149052|FG010|COMPLETED|Period 1||5||
60033477|NCT02323334|76149053|FG011|COMPLETED|Period 1||3||
60033478|NCT02323334|76149054|FG012|COMPLETED|Period 1||9||
60033479|NCT02323334|76149055|FG013|COMPLETED|Period 1||9||
60033480|NCT02323334|76149056|FG014|COMPLETED|Period 1||9||
60033481|NCT02323334|76149057|FG015|COMPLETED|Period 1||9||
60033482|NCT02323334|76149058|FG016|COMPLETED|Period 1||2||
60033483|NCT02323334|76149042|FG000|NOT COMPLETED|Period 1||0||
60033484|NCT02323334|76149043|FG001|NOT COMPLETED|Period 1||0||
60033485|NCT02323334|76149044|FG002|NOT COMPLETED|Period 1||0||
60033486|NCT02323334|76149045|FG003|NOT COMPLETED|Period 1||0||
60033487|NCT02323334|76149046|FG004|NOT COMPLETED|Period 1||0||
60033488|NCT02323334|76149047|FG005|NOT COMPLETED|Period 1||0||
60033489|NCT02323334|76149048|FG006|NOT COMPLETED|Period 1||0||
60033490|NCT02323334|76149049|FG007|NOT COMPLETED|Period 1||0||
60033491|NCT02323334|76149050|FG008|NOT COMPLETED|Period 1||0||
60033492|NCT02323334|76149051|FG009|NOT COMPLETED|Period 1||0||
60033493|NCT02323334|76149052|FG010|NOT COMPLETED|Period 1||0||
60033494|NCT02323334|76149053|FG011|NOT COMPLETED|Period 1||0||
60033495|NCT02323334|76149054|FG012|NOT COMPLETED|Period 1||0||
60033496|NCT02323334|76149055|FG013|NOT COMPLETED|Period 1||0||
60033497|NCT02323334|76149056|FG014|NOT COMPLETED|Period 1||0||
60033498|NCT02323334|76149057|FG015|NOT COMPLETED|Period 1||0||
60033499|NCT02323334|76149058|FG016|NOT COMPLETED|Period 1||0||
60033500|NCT02323334|76149042|FG000|STARTED|Period 2||4||
60033501|NCT02323334|76149043|FG001|STARTED|Period 2||4||
60033502|NCT02323334|76149044|FG002|STARTED|Period 2||4||
60033503|NCT02323334|76149045|FG003|STARTED|Period 2||4||
60033504|NCT02323334|76149046|FG004|STARTED|Period 2||4||
60033505|NCT02323334|76149047|FG005|STARTED|Period 2||4||
60033506|NCT02323334|76149048|FG006|STARTED|Period 2||6||
60033507|NCT02323334|76149049|FG007|STARTED|Period 2||6||
60033508|NCT02323334|76149050|FG008|STARTED|Period 2|Part B was a single period conducted in parallel to Part A and received last dose in Period 1.|0||
60033509|NCT02323334|76149051|FG009|STARTED|Period 2|Part B was a single period conducted in parallel to Part A and received last dose in Period 1.|0||
60033510|NCT02323334|76149052|FG010|STARTED|Period 2|Part B was a single period conducted in parallel to Part A and received last dose in Period 1.|0||
60033511|NCT02323334|76149053|FG011|STARTED|Period 2|Part B was a single period conducted in parallel to Part A and received last dose in Period 1.|0||
60033512|NCT02323334|76149054|FG012|STARTED|Period 2|Part C was a single period conducted in parallel to Part A and received last dose in Period 1.|0||
60033513|NCT02323334|76149055|FG013|STARTED|Period 2|Part C was a single period conducted in parallel to Part A and received last dose in Period 1.|0||
60033514|NCT02323334|76149056|FG014|STARTED|Period 2|Part C was a single period conducted in parallel to Part A and received last dose in Period 1.|0||
60033515|NCT02323334|76149057|FG015|STARTED|Period 2|Part C was a single period conducted in parallel to Part A and received last dose in Period 1.|0||
60033516|NCT02323334|76149058|FG016|STARTED|Period 2|Part D was a single period conducted in parallel to Part A and received last dose in Period 1.|0||
60033517|NCT02323334|76149042|FG000|COMPLETED|Period 2||4||
60033518|NCT02323334|76149043|FG001|COMPLETED|Period 2||4||
60033519|NCT02323334|76149044|FG002|COMPLETED|Period 2||4||
60033520|NCT02323334|76149045|FG003|COMPLETED|Period 2||4||
60033521|NCT02323334|76149046|FG004|COMPLETED|Period 2||4||
60033522|NCT02323334|76149047|FG005|COMPLETED|Period 2||4||
60033523|NCT02323334|76149048|FG006|COMPLETED|Period 2||6||
60033524|NCT02323334|76149049|FG007|COMPLETED|Period 2||6||
60033525|NCT02323334|76149050|FG008|COMPLETED|Period 2||0||
60033526|NCT02323334|76149051|FG009|COMPLETED|Period 2||0||
60033527|NCT02323334|76149052|FG010|COMPLETED|Period 2||0||
60033528|NCT02323334|76149053|FG011|COMPLETED|Period 2||0||
60033529|NCT02323334|76149054|FG012|COMPLETED|Period 2||0||
60033530|NCT02323334|76149055|FG013|COMPLETED|Period 2||0||
60033531|NCT02323334|76149056|FG014|COMPLETED|Period 2||0||
60033532|NCT02323334|76149057|FG015|COMPLETED|Period 2||0||
60033533|NCT02323334|76149058|FG016|COMPLETED|Period 2||0||
60033534|NCT02323334|76149042|FG000|NOT COMPLETED|Period 2||0||
60033535|NCT02323334|76149043|FG001|NOT COMPLETED|Period 2||0||
60033536|NCT02323334|76149044|FG002|NOT COMPLETED|Period 2||0||
60033537|NCT02323334|76149045|FG003|NOT COMPLETED|Period 2||0||
60033538|NCT02323334|76149046|FG004|NOT COMPLETED|Period 2||0||
60033539|NCT02323334|76149047|FG005|NOT COMPLETED|Period 2||0||
60033540|NCT02323334|76149048|FG006|NOT COMPLETED|Period 2||0||
60033541|NCT02323334|76149049|FG007|NOT COMPLETED|Period 2||0||
60033542|NCT02323334|76149050|FG008|NOT COMPLETED|Period 2||0||
60033543|NCT02323334|76149051|FG009|NOT COMPLETED|Period 2||0||
60033544|NCT02323334|76149052|FG010|NOT COMPLETED|Period 2||0||
60033545|NCT02323334|76149053|FG011|NOT COMPLETED|Period 2||0||
60033546|NCT02323334|76149054|FG012|NOT COMPLETED|Period 2||0||
60033547|NCT02323334|76149055|FG013|NOT COMPLETED|Period 2||0||
60033548|NCT02323334|76149056|FG014|NOT COMPLETED|Period 2||0||
60033549|NCT02323334|76149057|FG015|NOT COMPLETED|Period 2||0||
60033550|NCT02323334|76149058|FG016|NOT COMPLETED|Period 2||0||
60033551|NCT02323334|76149042|FG000|STARTED|Period 3||4||
60033552|NCT02323334|76149043|FG001|STARTED|Period 3||4||
60033553|NCT02323334|76149044|FG002|STARTED|Period 3||4||
60033554|NCT02323334|76149045|FG003|STARTED|Period 3||4||
60033555|NCT02323334|76149046|FG004|STARTED|Period 3||4||
60033556|NCT02323334|76149047|FG005|STARTED|Period 3||4||
60033557|NCT02323334|76149048|FG006|STARTED|Period 3|Part A Cohort 3 Food Effect participated in Period 1 and Period 2 only.|0||
60033558|NCT02323334|76149049|FG007|STARTED|Period 3|Part A Cohort 3 Food Effect participated in Period 1 and Period 2 only.|0||
60033559|NCT02323334|76149050|FG008|STARTED|Period 3||0||
60033560|NCT02323334|76149051|FG009|STARTED|Period 3||0||
60033561|NCT02323334|76149052|FG010|STARTED|Period 3||0||
59917172|NCT02693002|76037664|FG001|COMPLETED|Overall Study||2||
59917173|NCT02693002|76037663|FG000|NOT COMPLETED|Overall Study||1||
59917174|NCT02693002|76037664|FG001|NOT COMPLETED|Overall Study||0||
59917175|NCT03093870|76037673|FG000|STARTED|Overall Study||24||
59917176|NCT03093870|76037674|FG001|STARTED|Overall Study||64||
59917177|NCT03093870|76037675|FG002|STARTED|Overall Study||63||
59917178|NCT03093870|76037673|FG000|COMPLETED|Overall Study||0||
59917179|NCT03093870|76037674|FG001|COMPLETED|Overall Study||23||
59917180|NCT03093870|76037675|FG002|COMPLETED|Overall Study||22||
59917181|NCT03093870|76037673|FG000|NOT COMPLETED|Overall Study||24||
60033562|NCT02323334|76149053|FG011|STARTED|Period 3||0||
60033563|NCT02323334|76149054|FG012|STARTED|Period 3||0||
60033564|NCT02323334|76149055|FG013|STARTED|Period 3||0||
60033565|NCT02323334|76149056|FG014|STARTED|Period 3||0||
60033566|NCT02323334|76149057|FG015|STARTED|Period 3||0||
60033567|NCT02323334|76149058|FG016|STARTED|Period 3||0||
60033568|NCT02323334|76149042|FG000|COMPLETED|Period 3||3||
60033569|NCT02323334|76149043|FG001|COMPLETED|Period 3||4||
60033570|NCT02323334|76149044|FG002|COMPLETED|Period 3||3||
60033571|NCT02323334|76149045|FG003|COMPLETED|Period 3||4||
60033572|NCT02323334|76149046|FG004|COMPLETED|Period 3||4||
60033573|NCT02323334|76149047|FG005|COMPLETED|Period 3||4||
59917182|NCT03093870|76037674|FG001|NOT COMPLETED|Overall Study||41||
59917183|NCT03093870|76037675|FG002|NOT COMPLETED|Overall Study||41||
59917184|NCT02558634|76037683|FG000|STARTED|Blinded: First Intervention (3 Months)||4||
59917185|NCT02558634|76037684|FG001|STARTED|Blinded: First Intervention (3 Months)||2||
59917186|NCT02558634|76037683|FG000|COMPLETED|Blinded: First Intervention (3 Months)||4||
59917187|NCT02558634|76037684|FG001|COMPLETED|Blinded: First Intervention (3 Months)||2||
59917188|NCT02558634|76037683|FG000|NOT COMPLETED|Blinded: First Intervention (3 Months)||0||
60033574|NCT02323334|76149048|FG006|COMPLETED|Period 3||0||
60033575|NCT02323334|76149049|FG007|COMPLETED|Period 3||0||
60033576|NCT02323334|76149050|FG008|COMPLETED|Period 3||0||
60033577|NCT02323334|76149051|FG009|COMPLETED|Period 3||0||
60033578|NCT02323334|76149052|FG010|COMPLETED|Period 3||0||
60033579|NCT02323334|76149053|FG011|COMPLETED|Period 3||0||
60033580|NCT02323334|76149054|FG012|COMPLETED|Period 3||0||
60033581|NCT02323334|76149055|FG013|COMPLETED|Period 3||0||
60033582|NCT02323334|76149056|FG014|COMPLETED|Period 3||0||
60033583|NCT02323334|76149057|FG015|COMPLETED|Period 3||0||
60033584|NCT02323334|76149058|FG016|COMPLETED|Period 3||0||
60033585|NCT02323334|76149042|FG000|NOT COMPLETED|Period 3||1||
60033586|NCT02323334|76149043|FG001|NOT COMPLETED|Period 3||0||
59508427|NCT00757601|75601595|FG011|STARTED|Period 3||2||
59508428|NCT00757601|75601584|FG000|COMPLETED|Period 3||2||
59508429|NCT00757601|75601585|FG001|COMPLETED|Period 3||2||
59917189|NCT02558634|76037684|FG001|NOT COMPLETED|Blinded: First Intervention (3 Months)||0||
59917190|NCT02558634|76037683|FG000|STARTED|Blinded: Second Intervention (3 Months)||4||
59917191|NCT02558634|76037684|FG001|STARTED|Blinded: Second Intervention (3 Months)||2||
59917192|NCT02558634|76037683|FG000|COMPLETED|Blinded: Second Intervention (3 Months)|Assessed after 2 weeks - 1 participant requested to have their DBS 'on'|3||
59917193|NCT02558634|76037684|FG001|COMPLETED|Blinded: Second Intervention (3 Months)||2||
59917194|NCT02558634|76037683|FG000|NOT COMPLETED|Blinded: Second Intervention (3 Months)||1||
59508430|NCT00757601|75601586|FG002|COMPLETED|Period 3||2||
59508431|NCT00757601|75601587|FG003|COMPLETED|Period 3||2||
59917195|NCT02558634|76037684|FG001|NOT COMPLETED|Blinded: Second Intervention (3 Months)||0||
59917196|NCT02558634|76037683|FG000|STARTED|Unblinded: DBS on (6 Months)||4||
59917197|NCT02558634|76037684|FG001|STARTED|Unblinded: DBS on (6 Months)||2||
60033587|NCT02323334|76149044|FG002|NOT COMPLETED|Period 3||1||
60033588|NCT02323334|76149045|FG003|NOT COMPLETED|Period 3||0||
60033589|NCT02323334|76149046|FG004|NOT COMPLETED|Period 3||0||
60033590|NCT02323334|76149047|FG005|NOT COMPLETED|Period 3||0||
60033591|NCT02323334|76149048|FG006|NOT COMPLETED|Period 3||0||
60033592|NCT02323334|76149049|FG007|NOT COMPLETED|Period 3||0||
60033593|NCT02323334|76149050|FG008|NOT COMPLETED|Period 3||0||
59759363|NCT00913835|75878745|FG001|Received Any Study Drug|Olara+Lip Dox and Lip Dox Monotherapy||61||
59759364|NCT00913835|75878744|FG000|COMPLETED|Olara+Lip Dox and Lip Dox Monotherapy||55||
59759365|NCT00913835|75878745|FG001|COMPLETED|Olara+Lip Dox and Lip Dox Monotherapy||55||
59759366|NCT00913835|75878744|FG000|NOT COMPLETED|Olara+Lip Dox and Lip Dox Monotherapy||8||
59759367|NCT00913835|75878745|FG001|NOT COMPLETED|Olara+Lip Dox and Lip Dox Monotherapy||7||
59759368|NCT00913835|75878744|FG000|STARTED|Lip Dox: Olaratumab Monotherapy||0||
60033594|NCT02323334|76149051|FG009|NOT COMPLETED|Period 3||0||
60033595|NCT02323334|76149052|FG010|NOT COMPLETED|Period 3||0||
59917198|NCT02558634|76037683|FG000|COMPLETED|Unblinded: DBS on (6 Months)||4||
59917199|NCT02558634|76037684|FG001|COMPLETED|Unblinded: DBS on (6 Months)||2||
59917200|NCT02558634|76037683|FG000|NOT COMPLETED|Unblinded: DBS on (6 Months)||0||
60033596|NCT02323334|76149053|FG011|NOT COMPLETED|Period 3||0||
60033597|NCT02323334|76149054|FG012|NOT COMPLETED|Period 3||0||
60033598|NCT02323334|76149055|FG013|NOT COMPLETED|Period 3||0||
59508432|NCT00757601|75601588|FG004|COMPLETED|Period 3||2||
59508433|NCT00757601|75601589|FG005|COMPLETED|Period 3||2||
59508434|NCT00757601|75601590|FG006|COMPLETED|Period 3||2||
59508435|NCT00757601|75601591|FG007|COMPLETED|Period 3||2||
59508436|NCT00757601|75601592|FG008|COMPLETED|Period 3||2||
59508437|NCT00757601|75601593|FG009|COMPLETED|Period 3||2||
59508438|NCT00757601|75601594|FG010|COMPLETED|Period 3||2||
59508439|NCT00757601|75601595|FG011|COMPLETED|Period 3||2||
59508440|NCT00757601|75601584|FG000|NOT COMPLETED|Period 3||0||
59759369|NCT00913835|75878745|FG001|STARTED|Lip Dox: Olaratumab Monotherapy||28||
59759370|NCT00913835|75878744|FG000|Received at Least 1 Dose of Study Drug|Lip Dox: Olaratumab Monotherapy||0||
59759371|NCT00913835|75878745|FG001|Received at Least 1 Dose of Study Drug|Lip Dox: Olaratumab Monotherapy||28||
59759372|NCT00913835|75878744|FG000|COMPLETED|Lip Dox: Olaratumab Monotherapy||0||
59759373|NCT00913835|75878745|FG001|COMPLETED|Lip Dox: Olaratumab Monotherapy||25||
59508441|NCT00757601|75601585|FG001|NOT COMPLETED|Period 3||0||
59508442|NCT00757601|75601586|FG002|NOT COMPLETED|Period 3||0||
59508443|NCT00757601|75601587|FG003|NOT COMPLETED|Period 3||0||
59508444|NCT00757601|75601588|FG004|NOT COMPLETED|Period 3||0||
59612234|NCT01751178|75723384|FG000|STARTED|Overall Study||108||
59917201|NCT02558634|76037684|FG001|NOT COMPLETED|Unblinded: DBS on (6 Months)||0||
59917202|NCT03346057|76037698|FG000|STARTED|Overall Study||111||
60033599|NCT02323334|76149056|FG014|NOT COMPLETED|Period 3||0||
60033600|NCT02323334|76149057|FG015|NOT COMPLETED|Period 3||0||
60033601|NCT02323334|76149058|FG016|NOT COMPLETED|Period 3||0||
60033602|NCT02323334|76149042|FG000|STARTED|Period 4||3||
60033603|NCT02323334|76149043|FG001|STARTED|Period 4||4||
60033604|NCT02323334|76149044|FG002|STARTED|Period 4||3||
60033605|NCT02323334|76149045|FG003|STARTED|Period 4||4||
60033606|NCT02323334|76149046|FG004|STARTED|Period 4||4||
59508445|NCT00757601|75601589|FG005|NOT COMPLETED|Period 3||0||
59508446|NCT00757601|75601590|FG006|NOT COMPLETED|Period 3||0||
60033607|NCT02323334|76149047|FG005|STARTED|Period 4||4||
60033608|NCT02323334|76149048|FG006|STARTED|Period 4||0||
60033609|NCT02323334|76149049|FG007|STARTED|Period 4||0||
60033610|NCT02323334|76149050|FG008|STARTED|Period 4||0||
60033611|NCT02323334|76149051|FG009|STARTED|Period 4||0||
60033612|NCT02323334|76149052|FG010|STARTED|Period 4||0||
60033613|NCT02323334|76149053|FG011|STARTED|Period 4||0||
60033614|NCT02323334|76149054|FG012|STARTED|Period 4||0||
60033615|NCT02323334|76149055|FG013|STARTED|Period 4||0||
60033616|NCT02323334|76149056|FG014|STARTED|Period 4||0||
60033617|NCT02323334|76149057|FG015|STARTED|Period 4||0||
60033618|NCT02323334|76149058|FG016|STARTED|Period 4||0||
60033619|NCT02323334|76149042|FG000|COMPLETED|Period 4||3||
60033620|NCT02323334|76149043|FG001|COMPLETED|Period 4||4||
60033621|NCT02323334|76149044|FG002|COMPLETED|Period 4||3||
60033622|NCT02323334|76149045|FG003|COMPLETED|Period 4||4||
60033623|NCT02323334|76149046|FG004|COMPLETED|Period 4||4||
60033624|NCT02323334|76149047|FG005|COMPLETED|Period 4||4||
60033625|NCT02323334|76149048|FG006|COMPLETED|Period 4||0||
60033626|NCT02323334|76149049|FG007|COMPLETED|Period 4||0||
60033627|NCT02323334|76149050|FG008|COMPLETED|Period 4||0||
60033628|NCT02323334|76149051|FG009|COMPLETED|Period 4||0||
60033629|NCT02323334|76149052|FG010|COMPLETED|Period 4||0||
60033630|NCT02323334|76149053|FG011|COMPLETED|Period 4||0||
60033631|NCT02323334|76149054|FG012|COMPLETED|Period 4||0||
60033632|NCT02323334|76149055|FG013|COMPLETED|Period 4||0||
60033633|NCT02323334|76149056|FG014|COMPLETED|Period 4||0||
60033634|NCT02323334|76149057|FG015|COMPLETED|Period 4||0||
60033635|NCT02323334|76149058|FG016|COMPLETED|Period 4||0||
60033636|NCT02323334|76149042|FG000|NOT COMPLETED|Period 4||0||
60033637|NCT02323334|76149043|FG001|NOT COMPLETED|Period 4||0||
60033638|NCT02323334|76149044|FG002|NOT COMPLETED|Period 4||0||
60033639|NCT02323334|76149045|FG003|NOT COMPLETED|Period 4||0||
60033640|NCT02323334|76149046|FG004|NOT COMPLETED|Period 4||0||
60033641|NCT02323334|76149047|FG005|NOT COMPLETED|Period 4||0||
60033642|NCT02323334|76149048|FG006|NOT COMPLETED|Period 4||0||
60033643|NCT02323334|76149049|FG007|NOT COMPLETED|Period 4||0||
60033644|NCT02323334|76149050|FG008|NOT COMPLETED|Period 4||0||
60033645|NCT02323334|76149051|FG009|NOT COMPLETED|Period 4||0||
60033646|NCT02323334|76149052|FG010|NOT COMPLETED|Period 4||0||
60033647|NCT02323334|76149053|FG011|NOT COMPLETED|Period 4||0||
60033648|NCT02323334|76149054|FG012|NOT COMPLETED|Period 4||0||
60033649|NCT02323334|76149055|FG013|NOT COMPLETED|Period 4||0||
60033650|NCT02323334|76149056|FG014|NOT COMPLETED|Period 4||0||
60033651|NCT02323334|76149057|FG015|NOT COMPLETED|Period 4||0||
60033652|NCT02323334|76149058|FG016|NOT COMPLETED|Period 4||0||
60033653|NCT02448719|76149131|FG000|STARTED|Overall Study||12||
60033654|NCT02448719|76149132|FG001|STARTED|Overall Study||6||
60033655|NCT02448719|76149133|FG002|STARTED|Overall Study||6||
60033656|NCT02448719|76149134|FG003|STARTED|Overall Study||6||
60033657|NCT02448719|76149135|FG004|STARTED|Overall Study||6||
60033658|NCT02448719|76149136|FG005|STARTED|Overall Study||6||
60033659|NCT02448719|76149137|FG006|STARTED|Overall Study||6||
60033660|NCT02448719|76149138|FG007|STARTED|Overall Study||6||
60033661|NCT02448719|76149139|FG008|STARTED|Overall Study||6||
60033662|NCT02448719|76149140|FG009|STARTED|Overall Study||6||
60033663|NCT02448719|76149141|FG010|STARTED|Overall Study||6||
60033664|NCT02448719|76149131|FG000|COMPLETED|Overall Study||12||
60033665|NCT02448719|76149132|FG001|COMPLETED|Overall Study||6||
60033666|NCT02448719|76149133|FG002|COMPLETED|Overall Study||6||
60033667|NCT02448719|76149134|FG003|COMPLETED|Overall Study||6||
60033668|NCT02448719|76149135|FG004|COMPLETED|Overall Study||5||
60033669|NCT02448719|76149136|FG005|COMPLETED|Overall Study||6||
60033670|NCT02448719|76149137|FG006|COMPLETED|Overall Study||6||
60033671|NCT02448719|76149138|FG007|COMPLETED|Overall Study||6||
60033672|NCT02448719|76149139|FG008|COMPLETED|Overall Study||6||
60033673|NCT02448719|76149140|FG009|COMPLETED|Overall Study||6||
60033674|NCT02448719|76149141|FG010|COMPLETED|Overall Study||6||
60033675|NCT02448719|76149131|FG000|NOT COMPLETED|Overall Study||0||
60033676|NCT02448719|76149132|FG001|NOT COMPLETED|Overall Study||0||
60033677|NCT02448719|76149133|FG002|NOT COMPLETED|Overall Study||0||
60033678|NCT02448719|76149134|FG003|NOT COMPLETED|Overall Study||0||
60033679|NCT02448719|76149135|FG004|NOT COMPLETED|Overall Study||1||
60033680|NCT02448719|76149136|FG005|NOT COMPLETED|Overall Study||0||
60033681|NCT02448719|76149137|FG006|NOT COMPLETED|Overall Study||0||
60033682|NCT02448719|76149138|FG007|NOT COMPLETED|Overall Study||0||
60033683|NCT02448719|76149139|FG008|NOT COMPLETED|Overall Study||0||
60033684|NCT02448719|76149140|FG009|NOT COMPLETED|Overall Study||0||
60033685|NCT02448719|76149141|FG010|NOT COMPLETED|Overall Study||0||
60033686|NCT02322866|76149204|FG000|STARTED|Overall Study||515||
60033687|NCT02322866|76149205|FG001|STARTED|Overall Study||519||
60033688|NCT02322866|76149204|FG000|COMPLETED|Overall Study||444||
60033689|NCT02322866|76149205|FG001|COMPLETED|Overall Study||433||
60033690|NCT02322866|76149204|FG000|NOT COMPLETED|Overall Study||71||
60033691|NCT02322866|76149205|FG001|NOT COMPLETED|Overall Study||86||
60033692|NCT01640353|76149211|FG000|STARTED|Overall Study||194||
60033693|NCT01640353|76149211|FG000|Treated|Overall Study||172||
60033694|NCT01640353|76149211|FG000|Month 1|Overall Study||171||
60033695|NCT01640353|76149211|FG000|Month 3|Overall Study||169||
60033696|NCT01640353|76149211|FG000|Month 6|Overall Study||168||
60033697|NCT01640353|76149211|FG000|Month 12|Overall Study||160||
60033698|NCT01640353|76149211|FG000|Month 18|Overall Study||150||
60033699|NCT01640353|76149211|FG000|COMPLETED|Overall Study||149||
60033700|NCT01640353|76149211|FG000|NOT COMPLETED|Overall Study||45||
60033701|NCT02463071|76149218|FG000|STARTED|Overall Study||152||
60033702|NCT02463071|76149219|FG001|STARTED|Overall Study||154||
60033703|NCT02463071|76149220|FG002|STARTED|Overall Study||77||
60033704|NCT02463071|76149218|FG000|COMPLETED|Overall Study||140||
59917203|NCT03346057|76037699|FG001|STARTED|Overall Study||112||
59917204|NCT03346057|76037700|FG002|STARTED|Overall Study||68||
59917205|NCT03346057|76037701|FG003|STARTED|Overall Study||53||
59917206|NCT03346057|76037698|FG000|Treated|Overall Study||105||
60033705|NCT02463071|76149219|FG001|COMPLETED|Overall Study||138||
60033706|NCT02463071|76149220|FG002|COMPLETED|Overall Study||71||
60033707|NCT02463071|76149218|FG000|NOT COMPLETED|Overall Study||12||
60033708|NCT02463071|76149219|FG001|NOT COMPLETED|Overall Study||16||
60033709|NCT02463071|76149220|FG002|NOT COMPLETED|Overall Study||6||
60033710|NCT02266381|76149231|FG000|STARTED|Overall Study||150||
60033711|NCT02266381|76149232|FG001|STARTED|Overall Study||150||
60033712|NCT02266381|76149233|FG002|STARTED|Overall Study||150||
60033713|NCT02266381|76149231|FG000|COMPLETED|Overall Study||147||
60033714|NCT02266381|76149232|FG001|COMPLETED|Overall Study||145||
60033715|NCT02266381|76149233|FG002|COMPLETED|Overall Study||146||
60033716|NCT02266381|76149231|FG000|NOT COMPLETED|Overall Study||3||
60033717|NCT02266381|76149232|FG001|NOT COMPLETED|Overall Study||5||
60033718|NCT02266381|76149233|FG002|NOT COMPLETED|Overall Study||4||
60033719|NCT01827046|76149245|FG000|STARTED|Overall Study||250||
60033720|NCT01827046|76149246|FG001|STARTED|Overall Study||249||
59917207|NCT03346057|76037699|FG001|Treated|Overall Study||107||
59917208|NCT03346057|76037700|FG002|Treated|Overall Study||68||
60033721|NCT01827046|76149245|FG000|COMPLETED|Overall Study||249||
60033722|NCT01827046|76149246|FG001|COMPLETED|Overall Study||240||
60033723|NCT01827046|76149245|FG000|NOT COMPLETED|Overall Study||1||
60033724|NCT01827046|76149246|FG001|NOT COMPLETED|Overall Study||9||
60033725|NCT02356562|76149254|FG000|STARTED|Overall Study||22||
60033726|NCT02356562|76149255|FG001|STARTED|Overall Study||7||
60033727|NCT02356562|76149254|FG000|COMPLETED|Overall Study||20||
59508447|NCT00757601|75601591|FG007|NOT COMPLETED|Period 3||0||
59508448|NCT00757601|75601592|FG008|NOT COMPLETED|Period 3||0||
59508449|NCT00757601|75601593|FG009|NOT COMPLETED|Period 3||0||
59508450|NCT00757601|75601594|FG010|NOT COMPLETED|Period 3||0||
59508451|NCT00757601|75601595|FG011|NOT COMPLETED|Period 3||0||
59508452|NCT00757601|75601584|FG000|STARTED|Period 4||2||
59508453|NCT00757601|75601585|FG001|STARTED|Period 4||2||
59508454|NCT00757601|75601586|FG002|STARTED|Period 4||2||
59508455|NCT00757601|75601587|FG003|STARTED|Period 4||2||
59508456|NCT00757601|75601588|FG004|STARTED|Period 4||2||
59508457|NCT00757601|75601589|FG005|STARTED|Period 4||2||
59508458|NCT00757601|75601590|FG006|STARTED|Period 4||2||
59508459|NCT00757601|75601591|FG007|STARTED|Period 4||2||
59508460|NCT00757601|75601592|FG008|STARTED|Period 4||2||
59508461|NCT00757601|75601593|FG009|STARTED|Period 4||2||
59508462|NCT00757601|75601594|FG010|STARTED|Period 4||2||
59508463|NCT00757601|75601595|FG011|STARTED|Period 4||2||
59508464|NCT00757601|75601584|FG000|COMPLETED|Period 4||2||
59759374|NCT00913835|75878744|FG000|NOT COMPLETED|Lip Dox: Olaratumab Monotherapy||0||
59917209|NCT03346057|76037701|FG003|Treated|Overall Study||51||
59508465|NCT00757601|75601585|FG001|COMPLETED|Period 4||2||
59508466|NCT00757601|75601586|FG002|COMPLETED|Period 4||2||
59508467|NCT00757601|75601587|FG003|COMPLETED|Period 4||2||
59508468|NCT00757601|75601588|FG004|COMPLETED|Period 4||2||
59508469|NCT00757601|75601589|FG005|COMPLETED|Period 4||2||
59759375|NCT00913835|75878745|FG001|NOT COMPLETED|Lip Dox: Olaratumab Monotherapy||3||
59759376|NCT04238429|75878760|FG000|STARTED|Overall Study||43||
59917210|NCT03346057|76037698|FG000|COMPLETED|Overall Study||104||
59917211|NCT03346057|76037699|FG001|COMPLETED|Overall Study||104||
59917212|NCT03346057|76037700|FG002|COMPLETED|Overall Study||67||
59917213|NCT03346057|76037701|FG003|COMPLETED|Overall Study||51||
60033728|NCT02356562|76149255|FG001|COMPLETED|Overall Study||6||
60033729|NCT02356562|76149254|FG000|NOT COMPLETED|Overall Study||2||
60033730|NCT02356562|76149255|FG001|NOT COMPLETED|Overall Study||1||
60033731|NCT02448563|76149266|FG000|STARTED|Overall Study|Randomized after completing Visit 2|32||
60033732|NCT02448563|76149267|FG001|STARTED|Overall Study|Randomized after completing Visit 2|30||
60033733|NCT02448563|76149266|FG000|COMPLETED|Overall Study||16||
60033734|NCT02448563|76149267|FG001|COMPLETED|Overall Study||19||
60033735|NCT02448563|76149266|FG000|NOT COMPLETED|Overall Study||16||
60033736|NCT02448563|76149267|FG001|NOT COMPLETED|Overall Study||11||
60033737|NCT02266225|76149277|FG000|STARTED|Overall Study||48||
60033738|NCT02266225|76149277|FG000|Enrolled in Intervention|Overall Study||44||
60033739|NCT02266225|76149277|FG000|COMPLETED|Overall Study||32||
60033740|NCT02266225|76149277|FG000|NOT COMPLETED|Overall Study||16||
60033741|NCT02354690|76149282|FG000|STARTED|Overall Study||13||
60033742|NCT02354690|76149282|FG000|COMPLETED|Overall Study||12||
60033743|NCT02354690|76149282|FG000|NOT COMPLETED|Overall Study||1||
60033744|NCT02354222|76149288|FG000|STARTED|Overall Study||77||
60033745|NCT02354222|76149289|FG001|STARTED|Overall Study||77||
60033746|NCT02354222|76149288|FG000|COMPLETED|Overall Study||73||
60033747|NCT02354222|76149289|FG001|COMPLETED|Overall Study||66||
60033748|NCT02354222|76149288|FG000|NOT COMPLETED|Overall Study||4||
60033749|NCT02354222|76149289|FG001|NOT COMPLETED|Overall Study||11||
60033750|NCT02353442|76149297|FG000|STARTED|Overall Study||28||
60033751|NCT02353442|76149298|FG001|STARTED|Overall Study||31||
60033752|NCT02353442|76149297|FG000|COMPLETED|Overall Study||25||
60033753|NCT02353442|76149298|FG001|COMPLETED|Overall Study||27||
60033754|NCT02353442|76149297|FG000|NOT COMPLETED|Overall Study||3||
60033755|NCT02353442|76149298|FG001|NOT COMPLETED|Overall Study||4||
60033756|NCT02351960|76149306|FG000|STARTED|Overall Study||208||
60033757|NCT02351960|76149307|FG001|STARTED|Overall Study||88||
60033758|NCT02351960|76149306|FG000|COMPLETED|Overall Study||197||
60033759|NCT02351960|76149307|FG001|COMPLETED|Overall Study||76||
60033760|NCT02351960|76149306|FG000|NOT COMPLETED|Overall Study||11||
60033761|NCT02351960|76149307|FG001|NOT COMPLETED|Overall Study||12||
60033762|NCT02351180|76149316|FG000|STARTED|Overall Study||8||
60033763|NCT02351180|76149317|FG001|STARTED|Overall Study||8||
60033764|NCT02351180|76149316|FG000|COMPLETED|Overall Study||7||
60033765|NCT02351180|76149317|FG001|COMPLETED|Overall Study||8||
60033766|NCT02351180|76149316|FG000|NOT COMPLETED|Overall Study||1||
60033767|NCT02351180|76149317|FG001|NOT COMPLETED|Overall Study||0||
60033768|NCT02350478|76149325|FG000|STARTED|Overall Study||25||
60033769|NCT02350478|76149326|FG001|STARTED|Overall Study||24||
60033770|NCT02350478|76149325|FG000|COMPLETED|Overall Study||20||
60033771|NCT02350478|76149326|FG001|COMPLETED|Overall Study||23||
60033772|NCT02350478|76149325|FG000|NOT COMPLETED|Overall Study||5||
60033773|NCT02350478|76149326|FG001|NOT COMPLETED|Overall Study||1||
60033774|NCT02349542|76149332|FG000|STARTED|Overall Study||20||
60033775|NCT02349542|76149332|FG000|COMPLETED|Overall Study||15|Patients were withdrawn from the study if they did not schedule surgery or canceled their surgery.|
60033776|NCT02349542|76149332|FG000|NOT COMPLETED|Overall Study||5||
60033777|NCT02321930|76149336|FG000|STARTED|Overall Study||25||
60033778|NCT02321930|76149336|FG000|COMPLETED|Overall Study||24||
60033779|NCT02321930|76149336|FG000|NOT COMPLETED|Overall Study||1||
60033780|NCT01647542|76149343|FG000|STARTED|Overall Study||131||
60033781|NCT01647542|76149344|FG001|STARTED|Overall Study||131||
60033782|NCT01647542|76149345|FG002|STARTED|Overall Study||131||
60033783|NCT01647542|76149343|FG000|COMPLETED|Overall Study||55||
60033784|NCT01647542|76149344|FG001|COMPLETED|Overall Study||58||
60033785|NCT01647542|76149345|FG002|COMPLETED|Overall Study||59||
60033786|NCT01647542|76149343|FG000|NOT COMPLETED|Overall Study||76||
60033787|NCT01647542|76149344|FG001|NOT COMPLETED|Overall Study||73||
60033788|NCT01647542|76149345|FG002|NOT COMPLETED|Overall Study||72||
60033789|NCT02321462|76149355|FG000|STARTED|Overall Study||147|Patients randomized to each arm|
60033790|NCT02321462|76149356|FG001|STARTED|Overall Study||149|Patients randomized to each arm|
60033791|NCT02321462|76149355|FG000|ITT Population|Overall Study||146|Patients assessed according to their randomised treatment, regardless of treatment they received|
60033792|NCT02321462|76149356|FG001|ITT Population|Overall Study||148|Patients assessed according to their randomised treatment, regardless of treatment they received|
60033793|NCT02321462|76149355|FG000|Treated Patients|Overall Study||147|Patients assessed according to actual treatment they received (See Limitations and Caveats section)|
60033794|NCT02321462|76149356|FG001|Treated Patients|Overall Study||147|Patients assessed according to actual treatment they received (See Limitations and Caveats section)|
60033795|NCT02321462|76149355|FG000|Safety Population|Overall Study||147|Patients assessed according to actual treatment they received (See Limitations and Caveats section)|
60033796|NCT02321462|76149356|FG001|Safety Population|Overall Study||147|Patients assessed according to actual treatment they received (See Limitations and Caveats section)|
60033797|NCT02321462|76149355|FG000|COMPLETED|Overall Study||141||
60033798|NCT02321462|76149356|FG001|COMPLETED|Overall Study||146||
60033799|NCT02321462|76149355|FG000|NOT COMPLETED|Overall Study||6||
60033800|NCT02321462|76149356|FG001|NOT COMPLETED|Overall Study||3||
60033801|NCT02391584|76149365|FG000|STARTED|Primary Endpoint (6-weeks)||31||
60033802|NCT02391584|76149366|FG001|STARTED|Primary Endpoint (6-weeks)||29||
60033803|NCT02391584|76149365|FG000|COMPLETED|Primary Endpoint (6-weeks)||29||
60033804|NCT02391584|76149366|FG001|COMPLETED|Primary Endpoint (6-weeks)||27||
60033805|NCT02391584|76149365|FG000|NOT COMPLETED|Primary Endpoint (6-weeks)||2||
60033806|NCT02391584|76149366|FG001|NOT COMPLETED|Primary Endpoint (6-weeks)||2||
60033807|NCT02391584|76149365|FG000|STARTED|3 Month|Includes 30 balloon dilation and 23 crossover participants|53|Control participants crossed over to balloon dilation or exited the study after the 6-week visit.|
60033808|NCT02391584|76149366|FG001|STARTED|3 Month|23 Crossover participants are included in balloon dilation arm for remainder of study visits.|0|Control participants crossed over to balloon dilation or exited the study after the 6-week visit.|
60033809|NCT02391584|76149365|FG000|COMPLETED|3 Month||52||
60033810|NCT02391584|76149366|FG001|COMPLETED|3 Month||0||
60033811|NCT02391584|76149365|FG000|NOT COMPLETED|3 Month||1||
60033812|NCT02391584|76149366|FG001|NOT COMPLETED|3 Month||0||
60033813|NCT02391584|76149365|FG000|STARTED|6 Month||52||
60033814|NCT02391584|76149366|FG001|STARTED|6 Month||0||
60033815|NCT02391584|76149365|FG000|COMPLETED|6 Month||51||
60033816|NCT02391584|76149366|FG001|COMPLETED|6 Month||0||
60033817|NCT02391584|76149365|FG000|NOT COMPLETED|6 Month||1||
60033818|NCT02391584|76149366|FG001|NOT COMPLETED|6 Month||0||
60033819|NCT02391584|76149365|FG000|STARTED|12 Month (End of Study)||51||
60033820|NCT02391584|76149366|FG001|STARTED|12 Month (End of Study)||0||
60033821|NCT02391584|76149365|FG000|COMPLETED|12 Month (End of Study)||49||
60033822|NCT02391584|76149366|FG001|COMPLETED|12 Month (End of Study)||0||
60033823|NCT02391584|76149365|FG000|NOT COMPLETED|12 Month (End of Study)||2||
60033824|NCT02391584|76149366|FG001|NOT COMPLETED|12 Month (End of Study)||0||
60033825|NCT02266147|76149379|FG000|STARTED|PART 1: Dose Escalation||3||
60033826|NCT02266147|76149380|FG001|STARTED|PART 1: Dose Escalation||3||
60033827|NCT02266147|76149381|FG002|STARTED|PART 1: Dose Escalation||3||
60033828|NCT02266147|76149382|FG003|STARTED|PART 1: Dose Escalation||4||
60033829|NCT02266147|76149379|FG000|COMPLETED|PART 1: Dose Escalation||2||
60033830|NCT02266147|76149380|FG001|COMPLETED|PART 1: Dose Escalation||0||
60033831|NCT02266147|76149381|FG002|COMPLETED|PART 1: Dose Escalation||0||
60033832|NCT02266147|76149382|FG003|COMPLETED|PART 1: Dose Escalation||0||
60033833|NCT02266147|76149379|FG000|NOT COMPLETED|PART 1: Dose Escalation||1||
60033834|NCT02266147|76149380|FG001|NOT COMPLETED|PART 1: Dose Escalation||3||
60033835|NCT02266147|76149381|FG002|NOT COMPLETED|PART 1: Dose Escalation||3||
60033836|NCT02266147|76149382|FG003|NOT COMPLETED|PART 1: Dose Escalation||4||
60033837|NCT02266147|76149379|FG000|STARTED|PART 2: Dose Expansion|Participants were enrolled separately from Part 1; sponsor terminated the trial early during Part 2.|7|Sponsor terminated the trial early during Part 2 and participants should be counted once per row.|
60033838|NCT02266147|76149380|FG001|STARTED|PART 2: Dose Expansion|No new participants were enrolled and sponsor terminated the trial early during Part 2.|0|Sponsor terminated the trial early during Part 2 and participants should be counted once per row.|
60033839|NCT02266147|76149381|FG002|STARTED|PART 2: Dose Expansion|No new participants were enrolled and sponsor terminated the trial early during Part 2.|0|Sponsor terminated the trial early during Part 2 and participants should be counted once per row.|
60033840|NCT02266147|76149382|FG003|STARTED|PART 2: Dose Expansion|Participants were enrolled separately from Part 1; sponsor terminated the trial early during Part 2.|9|Sponsor terminated the trial early during Part 2 and participants should be counted once per row.|
60033841|NCT02266147|76149379|FG000|COMPLETED|PART 2: Dose Expansion||0||
60033842|NCT02266147|76149380|FG001|COMPLETED|PART 2: Dose Expansion||0||
60033843|NCT02266147|76149381|FG002|COMPLETED|PART 2: Dose Expansion||0||
60033844|NCT02266147|76149382|FG003|COMPLETED|PART 2: Dose Expansion||0||
60033845|NCT02266147|76149379|FG000|NOT COMPLETED|PART 2: Dose Expansion||7||
60033846|NCT02266147|76149380|FG001|NOT COMPLETED|PART 2: Dose Expansion||0||
60033847|NCT02266147|76149381|FG002|NOT COMPLETED|PART 2: Dose Expansion||0||
60033848|NCT02266147|76149382|FG003|NOT COMPLETED|PART 2: Dose Expansion||9||
60033849|NCT02264977|76149394|FG000|STARTED|Overall Study||9||
60033850|NCT02264977|76149394|FG000|COMPLETED|Overall Study||4||
60033851|NCT02264977|76149394|FG000|NOT COMPLETED|Overall Study||5||
60033852|NCT02264821|76149401|FG000|STARTED|Overall Study|Double Blind|64||
60033853|NCT02264821|76149402|FG001|STARTED|Overall Study|Double Blind|64||
60033854|NCT02264821|76149403|FG002|STARTED|Overall Study|Double Blind|64||
60033855|NCT02264821|76149401|FG000|COMPLETED|Overall Study||63||
60033856|NCT02264821|76149402|FG001|COMPLETED|Overall Study||61||
59759377|NCT04238429|75878761|FG001|STARTED|Overall Study||43||
59759378|NCT04238429|75878760|FG000|COMPLETED|Overall Study||40||
59759379|NCT04238429|75878761|FG001|COMPLETED|Overall Study||41||
59759380|NCT04238429|75878760|FG000|NOT COMPLETED|Overall Study||3||
59759381|NCT04238429|75878761|FG001|NOT COMPLETED|Overall Study||2||
59759382|NCT00913523|75878770|FG000|STARTED|Overall Study||162||
59759383|NCT00913523|75878771|FG001|STARTED|Overall Study||159||
59759384|NCT00913523|75878772|FG002|STARTED|Overall Study||161||
59759385|NCT00913523|75878770|FG000|COMPLETED|Overall Study||144||
59759386|NCT00913523|75878771|FG001|COMPLETED|Overall Study||143||
59759387|NCT00913523|75878772|FG002|COMPLETED|Overall Study||147||
59759388|NCT00913523|75878770|FG000|NOT COMPLETED|Overall Study||18||
60033857|NCT02264821|76149403|FG002|COMPLETED|Overall Study||58||
60033858|NCT02264821|76149401|FG000|NOT COMPLETED|Overall Study||1||
60033859|NCT02264821|76149402|FG001|NOT COMPLETED|Overall Study||3||
60033860|NCT02264821|76149403|FG002|NOT COMPLETED|Overall Study||6||
60033861|NCT02261467|76149413|FG000|STARTED|Overall Study||101||
60033862|NCT02261467|76149414|FG001|STARTED|Overall Study||290||
60033863|NCT02261467|76149413|FG000|COMPLETED|Overall Study||80||
59759389|NCT00913523|75878771|FG001|NOT COMPLETED|Overall Study||16||
59917214|NCT03346057|76037698|FG000|NOT COMPLETED|Overall Study||7||
59917215|NCT03346057|76037699|FG001|NOT COMPLETED|Overall Study||8||
59917216|NCT03346057|76037700|FG002|NOT COMPLETED|Overall Study||1||
59917217|NCT03346057|76037701|FG003|NOT COMPLETED|Overall Study||2||
59917218|NCT03345979|76037713|FG000|STARTED|Overall Study||99||
59917219|NCT03345979|76037714|FG001|STARTED|Overall Study||101||
59917220|NCT03345979|76037713|FG000|COMPLETED|Overall Study||56||
59917221|NCT03345979|76037714|FG001|COMPLETED|Overall Study||43||
59917222|NCT03345979|76037713|FG000|NOT COMPLETED|Overall Study||43||
60033864|NCT02261467|76149414|FG001|COMPLETED|Overall Study||253||
60033865|NCT02261467|76149413|FG000|NOT COMPLETED|Overall Study||21||
60033866|NCT02261467|76149414|FG001|NOT COMPLETED|Overall Study||37||
59759390|NCT00913523|75878772|FG002|NOT COMPLETED|Overall Study||14||
59759391|NCT00912197|75878782|FG000|STARTED|Overall Study||15||
59759392|NCT00912197|75878783|FG001|STARTED|Overall Study||13||
60033867|NCT01643473|76149422|FG000|STARTED|Overall Study||21||
60033868|NCT01643473|76149423|FG001|STARTED|Overall Study||21||
60033869|NCT01643473|76149422|FG000|COMPLETED|Overall Study||20||
59508470|NCT00757601|75601590|FG006|COMPLETED|Period 4||2||
59508471|NCT00757601|75601591|FG007|COMPLETED|Period 4||2||
59508472|NCT00757601|75601592|FG008|COMPLETED|Period 4||2||
59508473|NCT00757601|75601593|FG009|COMPLETED|Period 4|One participant discontinued after receiving the 230 mg dose of MK1006 and was not replaced|1||
59508474|NCT00757601|75601594|FG010|COMPLETED|Period 4||2||
59508475|NCT00757601|75601595|FG011|COMPLETED|Period 4|Replacement participant discontinued after receiving placebo to 230mg MK1006 and was not replaced|1||
59508476|NCT00757601|75601584|FG000|NOT COMPLETED|Period 4||0||
59508477|NCT00757601|75601585|FG001|NOT COMPLETED|Period 4||0||
59508478|NCT00757601|75601586|FG002|NOT COMPLETED|Period 4||0||
60033870|NCT01643473|76149423|FG001|COMPLETED|Overall Study||21||
60033871|NCT01643473|76149422|FG000|NOT COMPLETED|Overall Study||1||
60033872|NCT01643473|76149423|FG001|NOT COMPLETED|Overall Study||0||
60033873|NCT02320058|76149431|FG000|STARTED|Overall Study||101||
60033874|NCT02320058|76149432|FG001|STARTED|Overall Study||18||
60033875|NCT02320058|76149431|FG000|COMPLETED|Overall Study||59||
60033876|NCT02320058|76149432|FG001|COMPLETED|Overall Study||5||
60033877|NCT02320058|76149431|FG000|NOT COMPLETED|Overall Study||42||
60033878|NCT02320058|76149432|FG001|NOT COMPLETED|Overall Study||13||
60033879|NCT02319668|76149440|FG000|STARTED|Overall Study||19||
60033880|NCT02319668|76149441|FG001|STARTED|Overall Study||19||
60033881|NCT02319668|76149440|FG000|COMPLETED|Overall Study||19||
60033882|NCT02319668|76149441|FG001|COMPLETED|Overall Study||17||
60033883|NCT02319668|76149440|FG000|NOT COMPLETED|Overall Study||0||
60033884|NCT02319668|76149441|FG001|NOT COMPLETED|Overall Study||2||
60033885|NCT02092467|76149453|FG000|STARTED|Overall Study||1457||
60033886|NCT02092467|76149454|FG001|STARTED|Overall Study||1457||
60033887|NCT02092467|76149455|FG002|STARTED|Overall Study||1458||
60033888|NCT02092467|76149453|FG000|Treated|Overall Study||1455||
60033889|NCT02092467|76149454|FG001|Treated|Overall Study||1456||
60033890|NCT02092467|76149455|FG002|Treated|Overall Study||1451||
60033891|NCT02092467|76149453|FG000|COMPLETED|Overall Study||1053||
60033892|NCT02092467|76149454|FG001|COMPLETED|Overall Study||998||
60033893|NCT02092467|76149455|FG002|COMPLETED|Overall Study||1060||
60033894|NCT02092467|76149453|FG000|NOT COMPLETED|Overall Study||404||
60033895|NCT02092467|76149454|FG001|NOT COMPLETED|Overall Study||459||
60033896|NCT02092467|76149455|FG002|NOT COMPLETED|Overall Study||398||
60033897|NCT02462759|76149467|FG000|STARTED|Part 1: Double Blind||7||
60033898|NCT02462759|76149468|FG001|STARTED|Part 1: Double Blind||14||
60033899|NCT02462759|76149469|FG002|STARTED|Part 1: Double Blind||0||
60033900|NCT02462759|76149467|FG000|COMPLETED|Part 1: Double Blind||6||
60033901|NCT02462759|76149468|FG001|COMPLETED|Part 1: Double Blind||14||
60033902|NCT02462759|76149469|FG002|COMPLETED|Part 1: Double Blind||0||
60033903|NCT02462759|76149467|FG000|NOT COMPLETED|Part 1: Double Blind||1||
60033904|NCT02462759|76149468|FG001|NOT COMPLETED|Part 1: Double Blind||0||
60033905|NCT02462759|76149469|FG002|NOT COMPLETED|Part 1: Double Blind||0||
60033906|NCT02462759|76149467|FG000|STARTED|Part 2: Open-Label Phase||0||
60033907|NCT02462759|76149468|FG001|STARTED|Part 2: Open-Label Phase||0||
60033908|NCT02462759|76149469|FG002|STARTED|Part 2: Open-Label Phase||20||
59508479|NCT00757601|75601587|FG003|NOT COMPLETED|Period 4||0||
59508480|NCT00757601|75601588|FG004|NOT COMPLETED|Period 4||0||
59508481|NCT00757601|75601589|FG005|NOT COMPLETED|Period 4||0||
59508482|NCT00757601|75601590|FG006|NOT COMPLETED|Period 4||0||
60033909|NCT02462759|76149467|FG000|COMPLETED|Part 2: Open-Label Phase||0||
60033910|NCT02462759|76149468|FG001|COMPLETED|Part 2: Open-Label Phase||0||
60033911|NCT02462759|76149469|FG002|COMPLETED|Part 2: Open-Label Phase||20||
60033912|NCT02462759|76149467|FG000|NOT COMPLETED|Part 2: Open-Label Phase||0||
60033913|NCT02462759|76149468|FG001|NOT COMPLETED|Part 2: Open-Label Phase||0||
60033914|NCT02462759|76149469|FG002|NOT COMPLETED|Part 2: Open-Label Phase||0||
60033915|NCT02349386|76149484|FG000|STARTED|24-Week Double-Blind Main Study||9||
60033916|NCT02349386|76149485|FG001|STARTED|24-Week Double-Blind Main Study||8||
60033917|NCT02349386|76149486|FG002|STARTED|24-Week Double-Blind Main Study||9||
60033918|NCT02349386|76149487|FG003|STARTED|24-Week Double-Blind Main Study||8||
60033919|NCT02349386|76149484|FG000|COMPLETED|24-Week Double-Blind Main Study||3||
60033920|NCT02349386|76149485|FG001|COMPLETED|24-Week Double-Blind Main Study||2||
60033921|NCT02349386|76149486|FG002|COMPLETED|24-Week Double-Blind Main Study||4||
59508483|NCT00757601|75601591|FG007|NOT COMPLETED|Period 4||0||
59508484|NCT00757601|75601592|FG008|NOT COMPLETED|Period 4||0||
59508485|NCT00757601|75601593|FG009|NOT COMPLETED|Period 4||1||
59508486|NCT00757601|75601594|FG010|NOT COMPLETED|Period 4||0||
60033922|NCT02349386|76149487|FG003|COMPLETED|24-Week Double-Blind Main Study||0||
60033923|NCT02349386|76149484|FG000|NOT COMPLETED|24-Week Double-Blind Main Study||6||
60033924|NCT02349386|76149485|FG001|NOT COMPLETED|24-Week Double-Blind Main Study||6||
60033925|NCT02349386|76149486|FG002|NOT COMPLETED|24-Week Double-Blind Main Study||5||
60033926|NCT02349386|76149487|FG003|NOT COMPLETED|24-Week Double-Blind Main Study||8||
60033927|NCT02349386|76149484|FG000|STARTED|28-Week Double-Blind Optional Extension||3||
60033928|NCT02349386|76149485|FG001|STARTED|28-Week Double-Blind Optional Extension||2||
60033929|NCT02349386|76149486|FG002|STARTED|28-Week Double-Blind Optional Extension||4||
60033930|NCT02349386|76149487|FG003|STARTED|28-Week Double-Blind Optional Extension||0||
60033931|NCT02349386|76149484|FG000|COMPLETED|28-Week Double-Blind Optional Extension||1||
60033932|NCT02349386|76149485|FG001|COMPLETED|28-Week Double-Blind Optional Extension||2||
60033933|NCT02349386|76149486|FG002|COMPLETED|28-Week Double-Blind Optional Extension||1||
60033934|NCT02349386|76149487|FG003|COMPLETED|28-Week Double-Blind Optional Extension||0||
60033935|NCT02349386|76149484|FG000|NOT COMPLETED|28-Week Double-Blind Optional Extension||2||
60033936|NCT02349386|76149485|FG001|NOT COMPLETED|28-Week Double-Blind Optional Extension||0||
60033937|NCT02349386|76149486|FG002|NOT COMPLETED|28-Week Double-Blind Optional Extension||3||
60033938|NCT02349386|76149487|FG003|NOT COMPLETED|28-Week Double-Blind Optional Extension||0||
60033939|NCT02036775|76149497|FG000|STARTED|Treatment Period 1 (6 Days)||4||
60033940|NCT02036775|76149498|FG001|STARTED|Treatment Period 1 (6 Days)||4||
60033941|NCT02036775|76149499|FG002|STARTED|Treatment Period 1 (6 Days)||4||
60033942|NCT02036775|76149500|FG003|STARTED|Treatment Period 1 (6 Days)||4||
60033943|NCT02036775|76149501|FG004|STARTED|Treatment Period 1 (6 Days)||4||
60033944|NCT02036775|76149502|FG005|STARTED|Treatment Period 1 (6 Days)||4||
60033945|NCT02036775|76149497|FG000|COMPLETED|Treatment Period 1 (6 Days)||4||
60033946|NCT02036775|76149498|FG001|COMPLETED|Treatment Period 1 (6 Days)||4||
60033947|NCT02036775|76149499|FG002|COMPLETED|Treatment Period 1 (6 Days)||4||
60033948|NCT02036775|76149500|FG003|COMPLETED|Treatment Period 1 (6 Days)||4||
60033949|NCT02036775|76149501|FG004|COMPLETED|Treatment Period 1 (6 Days)||4||
60033950|NCT02036775|76149502|FG005|COMPLETED|Treatment Period 1 (6 Days)||4||
60033951|NCT02036775|76149497|FG000|NOT COMPLETED|Treatment Period 1 (6 Days)||0||
60033952|NCT02036775|76149498|FG001|NOT COMPLETED|Treatment Period 1 (6 Days)||0||
60033953|NCT02036775|76149499|FG002|NOT COMPLETED|Treatment Period 1 (6 Days)||0||
60033954|NCT02036775|76149500|FG003|NOT COMPLETED|Treatment Period 1 (6 Days)||0||
60033955|NCT02036775|76149501|FG004|NOT COMPLETED|Treatment Period 1 (6 Days)||0||
60033956|NCT02036775|76149502|FG005|NOT COMPLETED|Treatment Period 1 (6 Days)||0||
60033957|NCT02036775|76149497|FG000|STARTED|Treatment Period 2 (6 Days)||4||
60033958|NCT02036775|76149498|FG001|STARTED|Treatment Period 2 (6 Days)||4||
60033959|NCT02036775|76149499|FG002|STARTED|Treatment Period 2 (6 Days)||4||
60033960|NCT02036775|76149500|FG003|STARTED|Treatment Period 2 (6 Days)||4||
60033961|NCT02036775|76149501|FG004|STARTED|Treatment Period 2 (6 Days)||4||
60033962|NCT02036775|76149502|FG005|STARTED|Treatment Period 2 (6 Days)||4||
60033963|NCT02036775|76149497|FG000|COMPLETED|Treatment Period 2 (6 Days)||4||
60033964|NCT02036775|76149498|FG001|COMPLETED|Treatment Period 2 (6 Days)||4||
60033965|NCT02036775|76149499|FG002|COMPLETED|Treatment Period 2 (6 Days)||4||
60033966|NCT02036775|76149500|FG003|COMPLETED|Treatment Period 2 (6 Days)||4||
60033967|NCT02036775|76149501|FG004|COMPLETED|Treatment Period 2 (6 Days)||4||
60033968|NCT02036775|76149502|FG005|COMPLETED|Treatment Period 2 (6 Days)||3||
60033969|NCT02036775|76149497|FG000|NOT COMPLETED|Treatment Period 2 (6 Days)||0||
60033970|NCT02036775|76149498|FG001|NOT COMPLETED|Treatment Period 2 (6 Days)||0||
60033971|NCT02036775|76149499|FG002|NOT COMPLETED|Treatment Period 2 (6 Days)||0||
60033972|NCT02036775|76149500|FG003|NOT COMPLETED|Treatment Period 2 (6 Days)||0||
60033973|NCT02036775|76149501|FG004|NOT COMPLETED|Treatment Period 2 (6 Days)||0||
60033974|NCT02036775|76149502|FG005|NOT COMPLETED|Treatment Period 2 (6 Days)||1||
60033975|NCT02036775|76149497|FG000|STARTED|Treatment Period 3 (6 Days)||4||
60033976|NCT02036775|76149498|FG001|STARTED|Treatment Period 3 (6 Days)||4||
60033977|NCT02036775|76149499|FG002|STARTED|Treatment Period 3 (6 Days)||4||
60033978|NCT02036775|76149500|FG003|STARTED|Treatment Period 3 (6 Days)||4||
60033979|NCT02036775|76149501|FG004|STARTED|Treatment Period 3 (6 Days)||4||
60033980|NCT02036775|76149502|FG005|STARTED|Treatment Period 3 (6 Days)||3||
60033981|NCT02036775|76149497|FG000|COMPLETED|Treatment Period 3 (6 Days)||4||
60033982|NCT02036775|76149498|FG001|COMPLETED|Treatment Period 3 (6 Days)||4||
60033983|NCT02036775|76149499|FG002|COMPLETED|Treatment Period 3 (6 Days)||4||
60033984|NCT02036775|76149500|FG003|COMPLETED|Treatment Period 3 (6 Days)||4||
60033985|NCT02036775|76149501|FG004|COMPLETED|Treatment Period 3 (6 Days)||4||
60033986|NCT02036775|76149502|FG005|COMPLETED|Treatment Period 3 (6 Days)||3||
60033987|NCT02036775|76149497|FG000|NOT COMPLETED|Treatment Period 3 (6 Days)||0||
60033988|NCT02036775|76149498|FG001|NOT COMPLETED|Treatment Period 3 (6 Days)||0||
60033989|NCT02036775|76149499|FG002|NOT COMPLETED|Treatment Period 3 (6 Days)||0||
60033990|NCT02036775|76149500|FG003|NOT COMPLETED|Treatment Period 3 (6 Days)||0||
60033991|NCT02036775|76149501|FG004|NOT COMPLETED|Treatment Period 3 (6 Days)||0||
60033992|NCT02036775|76149502|FG005|NOT COMPLETED|Treatment Period 3 (6 Days)||0||
60033993|NCT02092389|76149510|FG000|STARTED|Overall Study||10||
60033994|NCT02092389|76149510|FG000|COMPLETED|Overall Study||4||
60033995|NCT02092389|76149510|FG000|NOT COMPLETED|Overall Study||6||
60033996|NCT02034591|76149514|FG000|STARTED|Overall Study||4||
60033997|NCT02034591|76149515|FG001|STARTED|Overall Study||3||
60033998|NCT02034591|76149516|FG002|STARTED|Overall Study||4||
60033999|NCT02034591|76149517|FG003|STARTED|Overall Study||3||
60034000|NCT02034591|76149518|FG004|STARTED|Overall Study||4||
60034001|NCT02034591|76149519|FG005|STARTED|Overall Study||3||
60034002|NCT02034591|76149514|FG000|COMPLETED|Overall Study||4||
60034003|NCT02034591|76149515|FG001|COMPLETED|Overall Study||3||
60034004|NCT02034591|76149516|FG002|COMPLETED|Overall Study||4||
60034005|NCT02034591|76149517|FG003|COMPLETED|Overall Study||3||
60034006|NCT02034591|76149518|FG004|COMPLETED|Overall Study||3||
60034007|NCT02034591|76149519|FG005|COMPLETED|Overall Study||3||
60034008|NCT02034591|76149514|FG000|NOT COMPLETED|Overall Study||0||
60034009|NCT02034591|76149515|FG001|NOT COMPLETED|Overall Study||0||
60034010|NCT02034591|76149516|FG002|NOT COMPLETED|Overall Study||0||
60034011|NCT02034591|76149517|FG003|NOT COMPLETED|Overall Study||0||
60034012|NCT02034591|76149518|FG004|NOT COMPLETED|Overall Study||1||
60034013|NCT02034591|76149519|FG005|NOT COMPLETED|Overall Study||0||
60034014|NCT02391116|76149528|FG000|STARTED|Treatment||67||
60034015|NCT02391116|76149528|FG000|Included in Per Protocol Set|Treatment||40||
60034016|NCT02391116|76149528|FG000|COMPLETED|Treatment|Reasons for completion in this period included death (2), PD (50) and lack of efficacy (1)|53||
60034017|NCT02391116|76149528|FG000|NOT COMPLETED|Treatment||14||
60034018|NCT02391116|76149528|FG000|STARTED|Safety Follow-up|This period excludes 2 deaths on treatment and 9 participants entering active follow-up|56||
60034019|NCT02391116|76149528|FG000|COMPLETED|Safety Follow-up|14 participants were considered completed due to death|43||
60034020|NCT02391116|76149528|FG000|NOT COMPLETED|Safety Follow-up||13||
60034021|NCT02391116|76149528|FG000|STARTED|Active Follow-up|This period incorporates safety follow-up with radiological|9||
60034022|NCT02391116|76149528|FG000|COMPLETED|Active Follow-up|Reasons for completion in this period included death (2) and PD (4)|6||
60034023|NCT02391116|76149528|FG000|NOT COMPLETED|Active Follow-up||3||
60034024|NCT02391116|76149528|FG000|STARTED|Survival Follow-up|21 participants discontinued from treatment didn't enter due to withdrawal by subject (3) and death|46||
60034025|NCT02391116|76149528|FG000|COMPLETED|Survival Follow-up|Reason for completed in this period included death (35) and clinical endpoint reached (7)|42||
60034026|NCT02391116|76149528|FG000|NOT COMPLETED|Survival Follow-up||4||
60034027|NCT02091921|76149539|FG000|STARTED|Overall Study||53||
59508487|NCT00757601|75601595|FG011|NOT COMPLETED|Period 4||1||
59508488|NCT00757601|75601584|FG000|STARTED|Period 5||2||
59508489|NCT00757601|75601585|FG001|STARTED|Period 5||2||
59508490|NCT00757601|75601586|FG002|STARTED|Period 5||2||
59508491|NCT00757601|75601587|FG003|STARTED|Period 5||2||
59508492|NCT00757601|75601588|FG004|STARTED|Period 5||2||
59508493|NCT00757601|75601589|FG005|STARTED|Period 5||2||
60034028|NCT02091921|76149539|FG000|COMPLETED|Overall Study||50||
60034029|NCT02091921|76149539|FG000|NOT COMPLETED|Overall Study||3||
60034030|NCT02447081|76149546|FG000|STARTED|Overall Study||1088||
60034031|NCT02447081|76149546|FG000|COMPLETED|Overall Study||864||
60034032|NCT02447081|76149546|FG000|NOT COMPLETED|Overall Study||224||
60034033|NCT02391038|76149550|FG000|STARTED|Overall Study||3||
60034034|NCT02391038|76149551|FG001|STARTED|Overall Study||3||
60034035|NCT02391038|76149552|FG002|STARTED|Overall Study||6||
60034036|NCT02391038|76149550|FG000|COMPLETED|Overall Study||0||
60034037|NCT02391038|76149551|FG001|COMPLETED|Overall Study||0||
60034038|NCT02391038|76149552|FG002|COMPLETED|Overall Study||0||
60034039|NCT02391038|76149550|FG000|NOT COMPLETED|Overall Study||3||
60034040|NCT02391038|76149551|FG001|NOT COMPLETED|Overall Study||3||
60034041|NCT02391038|76149552|FG002|NOT COMPLETED|Overall Study||6||
60034042|NCT02260921|76149563|FG000|STARTED|Overall Study||121||
60034043|NCT02260921|76149564|FG001|STARTED|Overall Study||59||
60034044|NCT02260921|76149563|FG000|Per-Protocol Population|Overall Study||112||
60034045|NCT02260921|76149564|FG001|Per-Protocol Population|Overall Study||56||
60034046|NCT02260921|76149563|FG000|COMPLETED|Overall Study||107||
60034047|NCT02260921|76149564|FG001|COMPLETED|Overall Study||55||
60034048|NCT02260921|76149563|FG000|NOT COMPLETED|Overall Study||14||
60034049|NCT02260921|76149564|FG001|NOT COMPLETED|Overall Study||4||
60034050|NCT02462603|76149570|FG000|STARTED|Overall Study||44||
59508494|NCT00757601|75601590|FG006|STARTED|Period 5||2||
59508495|NCT00757601|75601591|FG007|STARTED|Period 5||2||
59508496|NCT00757601|75601592|FG008|STARTED|Period 5||2||
59508497|NCT00757601|75601593|FG009|STARTED|Period 5||1||
59508498|NCT00757601|75601594|FG010|STARTED|Period 5||2||
60034051|NCT02462603|76149570|FG000|Received at Least 1 Dose of Study Drug|Overall Study||41||
60034052|NCT02462603|76149570|FG000|EITT Population|Overall Study||40|participant who received at least 1 dose of PTC589 and had a minimum of Month 3 assessment.|
60034053|NCT02462603|76149570|FG000|COMPLETED|Overall Study||40||
60034054|NCT02462603|76149570|FG000|NOT COMPLETED|Overall Study||4||
60034055|NCT02034513|76149576|FG000|STARTED|Overall Study||249||
60034056|NCT02034513|76149577|FG001|STARTED|Overall Study||252||
60034057|NCT02034513|76149576|FG000|Exposed|Overall Study||249||
60034058|NCT02034513|76149577|FG001|Exposed|Overall Study||251||
60034059|NCT02034513|76149576|FG000|COMPLETED|Overall Study||200||
60034060|NCT02034513|76149577|FG001|COMPLETED|Overall Study||195||
60034061|NCT02034513|76149576|FG000|NOT COMPLETED|Overall Study||49||
60034062|NCT02034513|76149577|FG001|NOT COMPLETED|Overall Study||57||
59508499|NCT00757601|75601595|FG011|STARTED|Period 5||1||
60034063|NCT02348840|76149589|FG000|STARTED|Overall Study||23||
60034064|NCT02348840|76149590|FG001|STARTED|Overall Study||21||
60034065|NCT02348840|76149591|FG002|STARTED|Overall Study||425||
60034066|NCT02348840|76149592|FG003|STARTED|Overall Study||374||
60034067|NCT02348840|76149589|FG000|COMPLETED|Overall Study||21||
59508500|NCT00757601|75601584|FG000|COMPLETED|Period 5||2||
59508501|NCT00757601|75601585|FG001|COMPLETED|Period 5||2||
59508502|NCT00757601|75601586|FG002|COMPLETED|Period 5||2||
59508503|NCT00757601|75601587|FG003|COMPLETED|Period 5||2||
60034068|NCT02348840|76149590|FG001|COMPLETED|Overall Study||20||
60034069|NCT02348840|76149591|FG002|COMPLETED|Overall Study||425||
60034070|NCT02348840|76149592|FG003|COMPLETED|Overall Study||374||
60034071|NCT02348840|76149589|FG000|NOT COMPLETED|Overall Study||2||
60034072|NCT02348840|76149590|FG001|NOT COMPLETED|Overall Study||1||
60034073|NCT02348840|76149591|FG002|NOT COMPLETED|Overall Study||0||
60034074|NCT02348840|76149592|FG003|NOT COMPLETED|Overall Study||0||
60034075|NCT02462057|76149607|FG000|STARTED|Overall Study||791||
60034076|NCT02462057|76149608|FG001|STARTED|Overall Study||793||
60034077|NCT02462057|76149609|FG002|STARTED|Overall Study||812||
60034078|NCT02462057|76149610|FG003|STARTED|Overall Study||752||
60034079|NCT02462057|76149611|FG004|STARTED|Overall Study||758||
60034080|NCT02462057|76149607|FG000|COMPLETED|Overall Study||737||
60034081|NCT02462057|76149608|FG001|COMPLETED|Overall Study||753||
60034082|NCT02462057|76149609|FG002|COMPLETED|Overall Study||766||
60034083|NCT02462057|76149610|FG003|COMPLETED|Overall Study||701||
60034084|NCT02462057|76149611|FG004|COMPLETED|Overall Study||708||
60034085|NCT02462057|76149607|FG000|NOT COMPLETED|Overall Study||54||
60034086|NCT02462057|76149608|FG001|NOT COMPLETED|Overall Study||40||
60034087|NCT02462057|76149609|FG002|NOT COMPLETED|Overall Study||46||
60034088|NCT02462057|76149610|FG003|NOT COMPLETED|Overall Study||51||
60034089|NCT02462057|76149611|FG004|NOT COMPLETED|Overall Study||50||
60034090|NCT02461745|76149625|FG000|STARTED|Overall Study||130||
60034091|NCT02461745|76149626|FG001|STARTED|Overall Study||70||
60034092|NCT02461745|76149625|FG000|COMPLETED|Overall Study||116||
60034093|NCT02461745|76149626|FG001|COMPLETED|Overall Study||66||
60034094|NCT02461745|76149625|FG000|NOT COMPLETED|Overall Study||14||
60034095|NCT02461745|76149626|FG001|NOT COMPLETED|Overall Study||4||
60034096|NCT02034435|76149636|FG000|STARTED|Overall Study||13||
60034097|NCT02034435|76149637|FG001|STARTED|Overall Study||15||
60034098|NCT02034435|76149638|FG002|STARTED|Overall Study||7||
60034099|NCT02034435|76149639|FG003|STARTED|Overall Study||9||
60034100|NCT02034435|76149636|FG000|Aim 1|Overall Study||13||
60034101|NCT02034435|76149637|FG001|Aim 1|Overall Study||15||
60034102|NCT02034435|76149638|FG002|Aim 1|Overall Study||0||
60034103|NCT02034435|76149639|FG003|Aim 1|Overall Study||0||
60034104|NCT02034435|76149636|FG000|Aim 2|Overall Study||0||
60034105|NCT02034435|76149637|FG001|Aim 2|Overall Study||0||
60034106|NCT02034435|76149638|FG002|Aim 2|Overall Study||7||
60034107|NCT02034435|76149639|FG003|Aim 2|Overall Study||9||
60034108|NCT02034435|76149636|FG000|COMPLETED|Overall Study||11||
60034109|NCT02034435|76149637|FG001|COMPLETED|Overall Study||13||
60034110|NCT02034435|76149638|FG002|COMPLETED|Overall Study||7||
60034111|NCT02034435|76149639|FG003|COMPLETED|Overall Study||8||
60034112|NCT02034435|76149636|FG000|NOT COMPLETED|Overall Study||2||
60034113|NCT02034435|76149637|FG001|NOT COMPLETED|Overall Study||2||
60034114|NCT02034435|76149638|FG002|NOT COMPLETED|Overall Study||0||
60034115|NCT02034435|76149639|FG003|NOT COMPLETED|Overall Study||1||
60034116|NCT02033889|76149652|FG000|STARTED|Overall Study||209||
60034117|NCT02033889|76149653|FG001|STARTED|Overall Study||207||
60034118|NCT02033889|76149654|FG002|STARTED|Overall Study||205||
60034119|NCT02033889|76149652|FG000|COMPLETED|Overall Study||175||
59612235|NCT01751178|75723385|FG001|STARTED|Overall Study||109||
59612236|NCT01751178|75723386|FG002|STARTED|Overall Study||107||
59612237|NCT01751178|75723384|FG000|COMPLETED|Overall Study||105||
59612238|NCT01751178|75723385|FG001|COMPLETED|Overall Study||109||
60034120|NCT02033889|76149653|FG001|COMPLETED|Overall Study||187||
60034121|NCT02033889|76149654|FG002|COMPLETED|Overall Study||180||
60034122|NCT02033889|76149652|FG000|NOT COMPLETED|Overall Study||34||
60034123|NCT02033889|76149653|FG001|NOT COMPLETED|Overall Study||20||
60034124|NCT02033889|76149654|FG002|NOT COMPLETED|Overall Study||25||
60034125|NCT02447003|76149664|FG000|STARTED|Overall Study||170||
60034126|NCT02447003|76149665|FG001|STARTED|Overall Study||84||
60034127|NCT02447003|76149664|FG000|COMPLETED|Overall Study||0||
60034128|NCT02447003|76149665|FG001|COMPLETED|Overall Study||0||
60034129|NCT02447003|76149664|FG000|NOT COMPLETED|Overall Study||170||
60034130|NCT02447003|76149665|FG001|NOT COMPLETED|Overall Study||84||
60034131|NCT01844284|76149675|FG000|STARTED|Overall Study|Intent-to-treat (ITT) population|266||
60034132|NCT01844284|76149676|FG001|STARTED|Overall Study|Intent-to-treat (ITT) population|134||
60034133|NCT01844284|76149675|FG000|COMPLETED|Overall Study||254||
60034134|NCT01844284|76149676|FG001|COMPLETED|Overall Study||127||
60034135|NCT01844284|76149675|FG000|NOT COMPLETED|Overall Study||12||
60034136|NCT01844284|76149676|FG001|NOT COMPLETED|Overall Study||7||
60034137|NCT02054715|76149684|FG000|STARTED|Baseline/Follow-up 1||219||
60034138|NCT02054715|76149685|FG001|STARTED|Baseline/Follow-up 1||199||
60034139|NCT02054715|76149684|FG000|COMPLETED|Baseline/Follow-up 1||211||
60034140|NCT02054715|76149685|FG001|COMPLETED|Baseline/Follow-up 1||192||
60034141|NCT02054715|76149684|FG000|NOT COMPLETED|Baseline/Follow-up 1||8||
60034142|NCT02054715|76149685|FG001|NOT COMPLETED|Baseline/Follow-up 1||7||
59612239|NCT01751178|75723386|FG002|COMPLETED|Overall Study||105||
60034143|NCT02054715|76149684|FG000|STARTED|Follow-up 2||211||
60034144|NCT02054715|76149685|FG001|STARTED|Follow-up 2||192||
60034145|NCT02054715|76149684|FG000|COMPLETED|Follow-up 2||192||
60034146|NCT02054715|76149685|FG001|COMPLETED|Follow-up 2||173||
60034147|NCT02054715|76149684|FG000|NOT COMPLETED|Follow-up 2||19||
60034148|NCT02054715|76149685|FG001|NOT COMPLETED|Follow-up 2||19||
60034149|NCT02446769|76149691|FG000|STARTED|Screening Period||18||
60034150|NCT02446769|76149692|FG001|STARTED|Screening Period||0||
60034151|NCT02446769|76149693|FG002|STARTED|Screening Period||0||
60034152|NCT02446769|76149691|FG000|COMPLETED|Screening Period||7||
60034153|NCT02446769|76149692|FG001|COMPLETED|Screening Period||0||
60034154|NCT02446769|76149693|FG002|COMPLETED|Screening Period||0||
60034155|NCT02446769|76149691|FG000|NOT COMPLETED|Screening Period||11||
60034156|NCT02446769|76149692|FG001|NOT COMPLETED|Screening Period||0||
60034157|NCT02446769|76149693|FG002|NOT COMPLETED|Screening Period||0||
60034158|NCT02446769|76149691|FG000|STARTED|Study Period||0||
60034159|NCT02446769|76149692|FG001|STARTED|Study Period||4||
60034160|NCT02446769|76149693|FG002|STARTED|Study Period||3||
60034161|NCT02446769|76149691|FG000|COMPLETED|Study Period||0||
60034162|NCT02446769|76149692|FG001|COMPLETED|Study Period||2||
60034163|NCT02446769|76149693|FG002|COMPLETED|Study Period||3||
59508504|NCT00757601|75601588|FG004|COMPLETED|Period 5||2||
59508505|NCT00757601|75601589|FG005|COMPLETED|Period 5||2||
59508506|NCT00757601|75601590|FG006|COMPLETED|Period 5||2||
59508507|NCT00757601|75601591|FG007|COMPLETED|Period 5||2||
59508508|NCT00757601|75601592|FG008|COMPLETED|Period 5||2||
59508509|NCT00757601|75601593|FG009|COMPLETED|Period 5||1||
59508510|NCT00757601|75601594|FG010|COMPLETED|Period 5||2||
59508511|NCT00757601|75601595|FG011|COMPLETED|Period 5||1||
59508512|NCT00757601|75601584|FG000|NOT COMPLETED|Period 5||0||
59612240|NCT01751178|75723384|FG000|NOT COMPLETED|Overall Study||3||
60034164|NCT02446769|76149691|FG000|NOT COMPLETED|Study Period||0||
60034165|NCT02446769|76149692|FG001|NOT COMPLETED|Study Period||2||
60034166|NCT02446769|76149693|FG002|NOT COMPLETED|Study Period||0||
60034167|NCT02420093|76149702|FG000|STARTED|Overall Study||9||
60034168|NCT02420093|76149703|FG001|STARTED|Overall Study||8||
60034169|NCT02420093|76149702|FG000|COMPLETED|Overall Study||8||
60034170|NCT02420093|76149703|FG001|COMPLETED|Overall Study||7||
60034171|NCT02420093|76149702|FG000|NOT COMPLETED|Overall Study||1||
60034172|NCT02420093|76149703|FG001|NOT COMPLETED|Overall Study||1||
60034173|NCT02419937|76149711|FG000|STARTED|Overall Study||12||
60034174|NCT02419937|76149712|FG001|STARTED|Overall Study||16||
60034175|NCT02419937|76149711|FG000|COMPLETED|Overall Study||11||
60034176|NCT02419937|76149712|FG001|COMPLETED|Overall Study||16||
59508513|NCT00757601|75601585|FG001|NOT COMPLETED|Period 5||0||
59612241|NCT01751178|75723385|FG001|NOT COMPLETED|Overall Study||0||
60034177|NCT02419937|76149711|FG000|NOT COMPLETED|Overall Study||1||
60034178|NCT02419937|76149712|FG001|NOT COMPLETED|Overall Study||0||
60034179|NCT02054481|76149722|FG000|STARTED|Overall Study||43||
60034180|NCT02054481|76149723|FG001|STARTED|Overall Study||41||
60034181|NCT02054481|76149724|FG002|STARTED|Overall Study||42||
60034182|NCT02054481|76149725|FG003|STARTED|Overall Study||40||
60034183|NCT02054481|76149722|FG000|COMPLETED|Overall Study||39||
59508514|NCT00757601|75601586|FG002|NOT COMPLETED|Period 5||0||
59508515|NCT00757601|75601587|FG003|NOT COMPLETED|Period 5||0||
59508516|NCT00757601|75601588|FG004|NOT COMPLETED|Period 5||0||
59508517|NCT00757601|75601589|FG005|NOT COMPLETED|Period 5||0||
59508518|NCT00757601|75601590|FG006|NOT COMPLETED|Period 5||0||
59612242|NCT01751178|75723386|FG002|NOT COMPLETED|Overall Study||2||
60034184|NCT02054481|76149723|FG001|COMPLETED|Overall Study||39||
60034185|NCT02054481|76149724|FG002|COMPLETED|Overall Study||40||
60034186|NCT02054481|76149725|FG003|COMPLETED|Overall Study||39||
60034187|NCT02054481|76149722|FG000|NOT COMPLETED|Overall Study||4||
60034188|NCT02054481|76149723|FG001|NOT COMPLETED|Overall Study||2||
60034189|NCT02054481|76149724|FG002|NOT COMPLETED|Overall Study||2||
60034190|NCT02054481|76149725|FG003|NOT COMPLETED|Overall Study||1||
60034191|NCT01610752|76149739|FG000|STARTED|Overall Study||18||
60034192|NCT01610752|76149740|FG001|STARTED|Overall Study||19||
60034193|NCT01610752|76149741|FG002|STARTED|Overall Study||17||
60034194|NCT01610752|76149739|FG000|COMPLETED|Overall Study||18||
60034195|NCT01610752|76149740|FG001|COMPLETED|Overall Study||19||
60034196|NCT01610752|76149741|FG002|COMPLETED|Overall Study||13||
60034197|NCT01610752|76149739|FG000|NOT COMPLETED|Overall Study||0||
60034198|NCT01610752|76149740|FG001|NOT COMPLETED|Overall Study||0||
60034199|NCT01610752|76149741|FG002|NOT COMPLETED|Overall Study||4||
60034200|NCT02054325|76149751|FG000|STARTED|Overall Study||51||
60034201|NCT02054325|76149752|FG001|STARTED|Overall Study||55||
60034202|NCT02054325|76149751|FG000|COMPLETED|Overall Study||43||
60034203|NCT02054325|76149752|FG001|COMPLETED|Overall Study||50||
59508519|NCT00757601|75601591|FG007|NOT COMPLETED|Period 5||0||
59508520|NCT00757601|75601592|FG008|NOT COMPLETED|Period 5||0||
59508521|NCT00757601|75601593|FG009|NOT COMPLETED|Period 5||0||
59508522|NCT00757601|75601594|FG010|NOT COMPLETED|Period 5||0||
59508523|NCT00757601|75601595|FG011|NOT COMPLETED|Period 5||0||
59612243|NCT01606254|75723402|FG000|STARTED|Overall Study||14||
60034204|NCT02054325|76149751|FG000|NOT COMPLETED|Overall Study||8||
60034205|NCT02054325|76149752|FG001|NOT COMPLETED|Overall Study||5||
60034206|NCT02446691|76149758|FG000|STARTED|Overall Study||128||
60034207|NCT02446691|76149758|FG000|COMPLETED|Overall Study||117||
60034208|NCT02446691|76149758|FG000|NOT COMPLETED|Overall Study||11||
60034209|NCT02091375|76149764|FG000|STARTED|Overall Study||61||
60034210|NCT02091375|76149765|FG001|STARTED|Overall Study||59||
60034211|NCT02091375|76149764|FG000|Safety Analysis Set|Overall Study||61|All randomized participants who received at least 1 dose of investigational medicinal product (IMP)|
60034212|NCT02091375|76149765|FG001|Safety Analysis Set|Overall Study||59|All randomized participants who received at least 1 dose of investigational medicinal product (IMP)|
60034213|NCT02091375|76149764|FG000|Intention to Treat (ITT) Analysis Set|Overall Study||61|All participants in the Part B Safety Analysis Set who had post-baseline efficacy data|
60034214|NCT02091375|76149765|FG001|Intention to Treat (ITT) Analysis Set|Overall Study||59|All participants in the Part B Safety Analysis Set who had post-baseline efficacy data|
60034215|NCT02091375|76149764|FG000|COMPLETED|Overall Study||52||
60034216|NCT02091375|76149765|FG001|COMPLETED|Overall Study||56||
60034217|NCT02091375|76149764|FG000|NOT COMPLETED|Overall Study||9||
60034218|NCT02091375|76149765|FG001|NOT COMPLETED|Overall Study||3||
60034219|NCT02032875|76149773|FG000|STARTED|Treatment Period||53||
60034220|NCT02032875|76149774|FG001|STARTED|Treatment Period||60||
60034221|NCT02032875|76149773|FG000|COMPLETED|Treatment Period||52||
60034222|NCT02032875|76149774|FG001|COMPLETED|Treatment Period||56||
60034223|NCT02032875|76149773|FG000|NOT COMPLETED|Treatment Period||1||
60034224|NCT02032875|76149774|FG001|NOT COMPLETED|Treatment Period||4||
60034225|NCT02032875|76149773|FG000|STARTED|Follow-up Period|Out of 53 participants who entered the treatment period, all 53 continued in the follow-up period.|53||
60034226|NCT02032875|76149774|FG001|STARTED|Follow-up Period|Of 60 participants in treatment period, 57 continued in follow-up, 3 entered treatment extension.|57||
60034227|NCT02032875|76149773|FG000|COMPLETED|Follow-up Period||50||
60034228|NCT02032875|76149774|FG001|COMPLETED|Follow-up Period||46||
60034229|NCT02032875|76149773|FG000|NOT COMPLETED|Follow-up Period||3||
60034230|NCT02032875|76149774|FG001|NOT COMPLETED|Follow-up Period||11||
60034231|NCT02032407|76149781|FG000|STARTED|Overall Study||68||
60034232|NCT02032407|76149781|FG000|COMPLETED|Overall Study||63||
60034233|NCT02032407|76149781|FG000|NOT COMPLETED|Overall Study||5||
60034234|NCT04689867|76149785|FG000|STARTED|Overall Study||5||
60034235|NCT04689867|76149785|FG000|COMPLETED|Overall Study||5||
60034236|NCT04689867|76149785|FG000|NOT COMPLETED|Overall Study||0||
60034237|NCT01843972|76149799|FG000|STARTED|Overall Study||13||
60034238|NCT01843972|76149800|FG001|STARTED|Overall Study||6||
60034239|NCT01843972|76149801|FG002|STARTED|Overall Study||5||
60034240|NCT01843972|76149802|FG003|STARTED|Overall Study||6||
60034241|NCT01843972|76149803|FG004|STARTED|Overall Study||6||
60034242|NCT01843972|76149804|FG005|STARTED|Overall Study||6||
60034243|NCT01843972|76149805|FG006|STARTED|Overall Study||5||
60034244|NCT01843972|76149806|FG007|STARTED|Overall Study||5||
60034245|NCT01843972|76149807|FG008|STARTED|Overall Study||17||
60034246|NCT01843972|76149808|FG009|STARTED|Overall Study||12||
60034247|NCT01843972|76149799|FG000|COMPLETED|Overall Study||13||
60034248|NCT01843972|76149800|FG001|COMPLETED|Overall Study||6||
60034249|NCT01843972|76149801|FG002|COMPLETED|Overall Study||5||
60034250|NCT01843972|76149802|FG003|COMPLETED|Overall Study||6||
60034251|NCT01843972|76149803|FG004|COMPLETED|Overall Study||5||
60034252|NCT01843972|76149804|FG005|COMPLETED|Overall Study||6||
60034253|NCT01843972|76149805|FG006|COMPLETED|Overall Study||5||
60034254|NCT01843972|76149806|FG007|COMPLETED|Overall Study||5||
60034255|NCT01843972|76149807|FG008|COMPLETED|Overall Study||17||
60034256|NCT01843972|76149808|FG009|COMPLETED|Overall Study||12||
60034257|NCT01843972|76149799|FG000|NOT COMPLETED|Overall Study||0||
60034258|NCT01843972|76149800|FG001|NOT COMPLETED|Overall Study||0||
60034259|NCT01843972|76149801|FG002|NOT COMPLETED|Overall Study||0||
60034260|NCT01843972|76149802|FG003|NOT COMPLETED|Overall Study||0||
60034261|NCT01843972|76149803|FG004|NOT COMPLETED|Overall Study||1||
60034262|NCT01843972|76149804|FG005|NOT COMPLETED|Overall Study||0||
60034263|NCT01843972|76149805|FG006|NOT COMPLETED|Overall Study||0||
60034264|NCT01843972|76149806|FG007|NOT COMPLETED|Overall Study||0||
60034265|NCT01843972|76149807|FG008|NOT COMPLETED|Overall Study||0||
60034266|NCT01843972|76149808|FG009|NOT COMPLETED|Overall Study||0||
60034267|NCT01826422|76149846|FG000|STARTED|Overall Study||18||
60034268|NCT01826422|76149847|FG001|STARTED|Overall Study||22||
60034269|NCT01826422|76149846|FG000|COMPLETED|Overall Study||17||
60034270|NCT01826422|76149847|FG001|COMPLETED|Overall Study||19||
60034271|NCT01826422|76149846|FG000|NOT COMPLETED|Overall Study||1||
60034272|NCT01826422|76149847|FG001|NOT COMPLETED|Overall Study||3||
60034273|NCT01843660|76149853|FG000|STARTED|Overall Study||1059||
60034274|NCT01843660|76149853|FG000|COMPLETED|Overall Study||1029||
60034275|NCT01843660|76149853|FG000|NOT COMPLETED|Overall Study||30||
60034276|NCT02090283|76149860|FG000|STARTED|Overall Study||17||
60034277|NCT02090283|76149861|FG001|STARTED|Overall Study||15||
60034278|NCT02090283|76149862|FG002|STARTED|Overall Study||10||
60034279|NCT02090283|76149860|FG000|Received At Least 1 Dose Of Study Drug|Overall Study||17||
60034280|NCT02090283|76149861|FG001|Received At Least 1 Dose Of Study Drug|Overall Study||15||
60034281|NCT02090283|76149862|FG002|Received At Least 1 Dose Of Study Drug|Overall Study||10||
60034282|NCT02090283|76149860|FG000|COMPLETED|Overall Study||0||
60034283|NCT02090283|76149861|FG001|COMPLETED|Overall Study||0||
60034284|NCT02090283|76149862|FG002|COMPLETED|Overall Study||0||
60034285|NCT02090283|76149860|FG000|NOT COMPLETED|Overall Study||17||
59917223|NCT03345979|76037714|FG001|NOT COMPLETED|Overall Study||58||
59917224|NCT02696434|76037722|FG000|STARTED|Overall Study||50||
59917225|NCT02696434|76037723|FG001|STARTED|Overall Study||51||
59917226|NCT02696434|76037722|FG000|COMPLETED|Overall Study||28||
59917227|NCT02696434|76037723|FG001|COMPLETED|Overall Study||33||
59917228|NCT02696434|76037722|FG000|NOT COMPLETED|Overall Study||22||
59612244|NCT01606254|75723403|FG001|STARTED|Overall Study||14||
59612245|NCT01606254|75723404|FG002|STARTED|Overall Study||14||
59917229|NCT02696434|76037723|FG001|NOT COMPLETED|Overall Study||18||
59917230|NCT03345901|76037729|FG000|STARTED|Overall Study||18||
59917231|NCT03345901|76037729|FG000|COMPLETED|Overall Study||0||
59917232|NCT03345901|76037729|FG000|NOT COMPLETED|Overall Study||18||
59917233|NCT02950831|76037734|FG000|STARTED|Overall Study||27||
59917234|NCT02950831|76037734|FG000|Complete Trial|Overall Study||26||
59917235|NCT02950831|76037734|FG000|Permanent Implant|Overall Study||20||
59917236|NCT02950831|76037734|FG000|4 Week Follow up|Overall Study||20||
59917237|NCT02950831|76037734|FG000|8 Weeks Follow up|Overall Study||19||
59917238|NCT02950831|76037734|FG000|COMPLETED|Overall Study||18||
59917239|NCT02950831|76037734|FG000|NOT COMPLETED|Overall Study||9||
59917240|NCT03593681|76037738|FG000|STARTED|Overall Study||150||
59917241|NCT03593681|76037738|FG000|COMPLETED|Overall Study||115||
59917242|NCT03593681|76037738|FG000|NOT COMPLETED|Overall Study||35||
59917243|NCT03592745|76037761|FG000|STARTED|Overall Study||18||
59917244|NCT03592745|76037762|FG001|STARTED|Overall Study||18||
59917245|NCT03592745|76037761|FG000|COMPLETED|Overall Study||15||
59917246|NCT03592745|76037762|FG001|COMPLETED|Overall Study||15||
59917247|NCT03592745|76037761|FG000|NOT COMPLETED|Overall Study||3||
59917248|NCT03592745|76037762|FG001|NOT COMPLETED|Overall Study||3||
59917249|NCT03592277|76037770|FG000|STARTED|Overall Study||60||
59917250|NCT03592277|76037771|FG001|STARTED|Overall Study||60||
59917251|NCT03592277|76037770|FG000|Powered For|Overall Study||60||
59917252|NCT03592277|76037771|FG001|Powered For|Overall Study||60||
59917253|NCT03592277|76037770|FG000|COMPLETED|Overall Study||54||
59917254|NCT03592277|76037771|FG001|COMPLETED|Overall Study||52||
59917255|NCT03592277|76037770|FG000|NOT COMPLETED|Overall Study||6||
59917256|NCT03592277|76037771|FG001|NOT COMPLETED|Overall Study||8||
59917257|NCT03401112|76037782|FG000|STARTED|Overall Study||15||
59917258|NCT03401112|76037783|FG001|STARTED|Overall Study||26||
59917259|NCT03401112|76037784|FG002|STARTED|Overall Study||22||
59917260|NCT03401112|76037785|FG003|STARTED|Overall Study||27||
59917261|NCT03401112|76037786|FG004|STARTED|Overall Study||10||
59917262|NCT03401112|76037782|FG000|Received at Least 1 Dose of Study Drug|Overall Study||12||
59612246|NCT01606254|75723405|FG003|STARTED|Overall Study||14||
59612247|NCT01606254|75723402|FG000|COMPLETED|Overall Study||12||
59612248|NCT01606254|75723403|FG001|COMPLETED|Overall Study||10||
59612249|NCT01606254|75723404|FG002|COMPLETED|Overall Study||14||
59612250|NCT01606254|75723405|FG003|COMPLETED|Overall Study||11||
59612251|NCT01606254|75723402|FG000|NOT COMPLETED|Overall Study||2||
59612252|NCT01606254|75723403|FG001|NOT COMPLETED|Overall Study||4||
59612253|NCT01606254|75723404|FG002|NOT COMPLETED|Overall Study||0||
59612254|NCT01606254|75723405|FG003|NOT COMPLETED|Overall Study||3||
59612255|NCT01750242|75723415|FG000|STARTED|Overall Study||23||
59917263|NCT03401112|76037783|FG001|Received at Least 1 Dose of Study Drug|Overall Study||26||
59917264|NCT03401112|76037784|FG002|Received at Least 1 Dose of Study Drug|Overall Study||20||
59917265|NCT03401112|76037785|FG003|Received at Least 1 Dose of Study Drug|Overall Study||25||
59917266|NCT03401112|76037786|FG004|Received at Least 1 Dose of Study Drug|Overall Study||10||
59917267|NCT03401112|76037782|FG000|COMPLETED|Overall Study||10||
59917268|NCT03401112|76037783|FG001|COMPLETED|Overall Study||19||
59917269|NCT03401112|76037784|FG002|COMPLETED|Overall Study||11||
59612256|NCT01750242|75723415|FG000|Readable Images|Overall Study|Subjects with readable images were analyzed and there were 3 subjects with unreadable images.|20||
59612257|NCT01750242|75723415|FG000|COMPLETED|Overall Study||20||
59612258|NCT01750242|75723415|FG000|NOT COMPLETED|Overall Study||3||
59612259|NCT01723254|75723428|FG000|STARTED|Overall Study||6||
59612260|NCT01723254|75723429|FG001|STARTED|Overall Study||21||
59612261|NCT01723254|75723430|FG002|STARTED|Overall Study||20||
59612262|NCT01723254|75723431|FG003|STARTED|Overall Study||20||
59917270|NCT03401112|76037785|FG003|COMPLETED|Overall Study||21||
59917271|NCT03401112|76037786|FG004|COMPLETED|Overall Study||10||
59917272|NCT03401112|76037782|FG000|NOT COMPLETED|Overall Study||5||
59917273|NCT03401112|76037783|FG001|NOT COMPLETED|Overall Study||7||
59917274|NCT03401112|76037784|FG002|NOT COMPLETED|Overall Study||11||
59508524|NCT02037555|75601627|FG000|STARTED|Overall Study||213||
59508525|NCT02037555|75601628|FG001|STARTED|Overall Study||212||
59917275|NCT03401112|76037785|FG003|NOT COMPLETED|Overall Study||6||
59917276|NCT03401112|76037786|FG004|NOT COMPLETED|Overall Study||0||
59917277|NCT02697916|76037815|FG000|STARTED|Overall Study||7540||
59917278|NCT02697916|76037816|FG001|STARTED|Overall Study||7536||
59917279|NCT02697916|76037815|FG000|COMPLETED|Overall Study||6962||
59917280|NCT02697916|76037816|FG001|COMPLETED|Overall Study||6828||
59917281|NCT02697916|76037815|FG000|NOT COMPLETED|Overall Study||578||
59917282|NCT02697916|76037816|FG001|NOT COMPLETED|Overall Study||708||
59917283|NCT01871220|76037824|FG000|STARTED|Overall Study||29||
60034286|NCT02090283|76149861|FG001|NOT COMPLETED|Overall Study||15||
60034287|NCT02090283|76149862|FG002|NOT COMPLETED|Overall Study||10||
60034288|NCT02032173|76149870|FG000|STARTED|Overall Study||31||
60034289|NCT02032173|76149870|FG000|Included Population - Main Group|Overall Study||31|Included population with evaluable patients at specific time points|
60034290|NCT02032173|76149870|FG000|Rescue Group|Overall Study|1 participant moved to Rescue Group at M6 and trial discontinued before any data was collected.|1|Participants who did not meet the pre-defined criteria were moved to Rescue Group|
60034291|NCT02032173|76149870|FG000|COMPLETED|Overall Study||0||
59759393|NCT00912197|75878782|FG000|COMPLETED|Overall Study||12||
59759394|NCT00912197|75878783|FG001|COMPLETED|Overall Study||10||
59759395|NCT00912197|75878782|FG000|NOT COMPLETED|Overall Study||3||
59508526|NCT02037555|75601627|FG000|Dosed|Overall Study||201|Reported for Safety Results|
59508527|NCT02037555|75601628|FG001|Dosed|Overall Study||198|Reported for Safety Results|
59508528|NCT02037555|75601627|FG000|Dosed and Operated On|Overall Study||200|Reported for Efficacy Results|
59508529|NCT02037555|75601628|FG001|Dosed and Operated On|Overall Study||196|Reported for Efficacy Results|
59508530|NCT02037555|75601627|FG000|COMPLETED|Overall Study||190||
59759396|NCT00912197|75878783|FG001|NOT COMPLETED|Overall Study||3||
60034292|NCT02032173|76149870|FG000|NOT COMPLETED|Overall Study||31||
60034293|NCT02031471|76149874|FG000|STARTED|24 Week Treatment Period||57||
60034294|NCT02031471|76149874|FG000|COMPLETED|24 Week Treatment Period||46||
60034295|NCT02031471|76149874|FG000|NOT COMPLETED|24 Week Treatment Period||11||
60034296|NCT02031471|76149874|FG000|STARTED|Long Term Extension (LTE) Period|Only participants who achieved at least a moderate EULAR response at Week 24 entered the LTE Period.|39||
60034297|NCT02031471|76149874|FG000|COMPLETED|Long Term Extension (LTE) Period||37||
60034298|NCT02031471|76149874|FG000|NOT COMPLETED|Long Term Extension (LTE) Period||2||
60034299|NCT02461589|76149888|FG000|STARTED|Overall Study||64||
60034300|NCT02461589|76149889|FG001|STARTED|Overall Study||63||
60034301|NCT02461589|76149890|FG002|STARTED|Overall Study||65||
60034302|NCT02461589|76149891|FG003|STARTED|Overall Study||63||
59759397|NCT00910247|75878791|FG000|STARTED|Overall Study||274||
59759398|NCT00910247|75878791|FG000|COMPLETED|Overall Study||205||
59759399|NCT00910247|75878791|FG000|NOT COMPLETED|Overall Study||69||
59759400|NCT00659334|75878802|FG000|STARTED|Overall Study||46||
60034303|NCT02461589|76149892|FG004|STARTED|Overall Study||64||
60034304|NCT02461589|76149893|FG005|STARTED|Overall Study||64||
60034305|NCT02461589|76149894|FG006|STARTED|Overall Study||64||
60034306|NCT02461589|76149895|FG007|STARTED|Overall Study||65||
60034307|NCT02461589|76149896|FG008|STARTED|Overall Study||129||
60034308|NCT02461589|76149897|FG009|STARTED|Overall Study||65||
60034309|NCT02461589|76149888|FG000|Exposed|Overall Study||64||
60034310|NCT02461589|76149889|FG001|Exposed|Overall Study||63||
60034311|NCT02461589|76149890|FG002|Exposed|Overall Study||65||
60034312|NCT02461589|76149891|FG003|Exposed|Overall Study||63||
60034313|NCT02461589|76149892|FG004|Exposed|Overall Study||64||
59508531|NCT02037555|75601628|FG001|COMPLETED|Overall Study||191||
59508532|NCT02037555|75601627|FG000|NOT COMPLETED|Overall Study||23||
59508533|NCT02037555|75601628|FG001|NOT COMPLETED|Overall Study||21||
59508534|NCT02369211|75601636|FG000|STARTED|Overall Study||43||
59508535|NCT02369211|75601637|FG001|STARTED|Overall Study||43||
59759401|NCT00659334|75878803|FG001|STARTED|Overall Study||41||
60034314|NCT02461589|76149893|FG005|Exposed|Overall Study||64||
60034315|NCT02461589|76149894|FG006|Exposed|Overall Study||64||
59759402|NCT00659334|75878804|FG002|STARTED|Overall Study||5||
60034316|NCT02461589|76149895|FG007|Exposed|Overall Study||65||
60034317|NCT02461589|76149896|FG008|Exposed|Overall Study||129||
59759403|NCT00659334|75878805|FG003|STARTED|Overall Study||2||
59759404|NCT00659334|75878806|FG004|STARTED|Overall Study||1||
59917284|NCT01871220|76037825|FG001|STARTED|Overall Study||32||
59917285|NCT01871220|76037824|FG000|COMPLETED|Overall Study||25||
59917286|NCT01871220|76037825|FG001|COMPLETED|Overall Study||29||
59917287|NCT01871220|76037824|FG000|NOT COMPLETED|Overall Study||4||
59917288|NCT01871220|76037825|FG001|NOT COMPLETED|Overall Study||3||
59917289|NCT03359473|76037835|FG000|STARTED|Overall Study||23||
59917290|NCT03359473|76037836|FG001|STARTED|Overall Study||24||
59917291|NCT03359473|76037837|FG002|STARTED|Overall Study||24||
59917292|NCT03359473|76037838|FG003|STARTED|Overall Study||25||
59917293|NCT03359473|76037835|FG000|COMPLETED|Overall Study||21||
59917294|NCT03359473|76037836|FG001|COMPLETED|Overall Study||18||
59917295|NCT03359473|76037837|FG002|COMPLETED|Overall Study||18||
59917296|NCT03359473|76037838|FG003|COMPLETED|Overall Study||20||
59917297|NCT03359473|76037835|FG000|NOT COMPLETED|Overall Study||2||
60034318|NCT02461589|76149897|FG009|Exposed|Overall Study||64||
60034319|NCT02461589|76149888|FG000|COMPLETED|Overall Study||58||
60034320|NCT02461589|76149889|FG001|COMPLETED|Overall Study||61||
60034321|NCT02461589|76149890|FG002|COMPLETED|Overall Study||60||
60034322|NCT02461589|76149891|FG003|COMPLETED|Overall Study||58||
59508536|NCT02369211|75601636|FG000|COMPLETED|Overall Study||43||
59508537|NCT02369211|75601637|FG001|COMPLETED|Overall Study||41||
59508538|NCT02369211|75601636|FG000|NOT COMPLETED|Overall Study||0||
59508539|NCT02369211|75601637|FG001|NOT COMPLETED|Overall Study||2||
59508540|NCT00759161|75601643|FG000|STARTED|Overall Study||35||
59508541|NCT00759161|75601643|FG000|COMPLETED|Overall Study||35||
60034323|NCT02461589|76149892|FG004|COMPLETED|Overall Study||62||
60034324|NCT02461589|76149893|FG005|COMPLETED|Overall Study||61||
60034325|NCT02461589|76149894|FG006|COMPLETED|Overall Study||58||
60034326|NCT02461589|76149895|FG007|COMPLETED|Overall Study||60||
60034327|NCT02461589|76149896|FG008|COMPLETED|Overall Study||123||
60034328|NCT02461589|76149897|FG009|COMPLETED|Overall Study||60||
59508542|NCT00759161|75601643|FG000|NOT COMPLETED|Overall Study||0||
59508543|NCT02038023|75601650|FG000|STARTED|Overall Study||74||
59508544|NCT02038023|75601650|FG000|COMPLETED|Overall Study||73||
59508545|NCT02038023|75601650|FG000|NOT COMPLETED|Overall Study||1||
59508546|NCT02038179|75601656|FG000|STARTED|Phase 1 (4 Weeks)||52||
59508547|NCT02038179|75601657|FG001|STARTED|Phase 1 (4 Weeks)||47||
59508548|NCT02038179|75601656|FG000|COMPLETED|Phase 1 (4 Weeks)||48||
59508549|NCT02038179|75601657|FG001|COMPLETED|Phase 1 (4 Weeks)||42||
59508550|NCT02038179|75601656|FG000|NOT COMPLETED|Phase 1 (4 Weeks)||4||
59508551|NCT02038179|75601657|FG001|NOT COMPLETED|Phase 1 (4 Weeks)||5||
59508552|NCT02038179|75601656|FG000|STARTED|Washout (2-4 Weeks)||48||
59508553|NCT02038179|75601657|FG001|STARTED|Washout (2-4 Weeks)||42||
59508554|NCT02038179|75601656|FG000|COMPLETED|Washout (2-4 Weeks)||46||
59508555|NCT02038179|75601657|FG001|COMPLETED|Washout (2-4 Weeks)||40||
59508556|NCT02038179|75601656|FG000|NOT COMPLETED|Washout (2-4 Weeks)||2||
59508557|NCT02038179|75601657|FG001|NOT COMPLETED|Washout (2-4 Weeks)||2||
59508558|NCT02038179|75601656|FG000|STARTED|Phase 2 (4 Weeks)||46||
59508559|NCT02038179|75601657|FG001|STARTED|Phase 2 (4 Weeks)||40||
60034329|NCT02461589|76149888|FG000|NOT COMPLETED|Overall Study||6||
60034330|NCT02461589|76149889|FG001|NOT COMPLETED|Overall Study||2||
60034331|NCT02461589|76149890|FG002|NOT COMPLETED|Overall Study||5||
60034332|NCT02461589|76149891|FG003|NOT COMPLETED|Overall Study||5||
60034333|NCT02461589|76149892|FG004|NOT COMPLETED|Overall Study||2||
60034334|NCT02461589|76149893|FG005|NOT COMPLETED|Overall Study||3||
60034335|NCT02461589|76149894|FG006|NOT COMPLETED|Overall Study||6||
60034336|NCT02461589|76149895|FG007|NOT COMPLETED|Overall Study||5||
60034337|NCT02461589|76149896|FG008|NOT COMPLETED|Overall Study||6||
60034338|NCT02461589|76149897|FG009|NOT COMPLETED|Overall Study||5||
60034339|NCT02089737|76149919|FG000|STARTED|Overall Study||3091||
60034340|NCT02089737|76149919|FG000|COMPLETED|Overall Study||3085||
60034341|NCT02089737|76149919|FG000|NOT COMPLETED|Overall Study||6||
60034342|NCT02460575|76149926|FG000|STARTED|Overall Study||40||
59508560|NCT02038179|75601656|FG000|COMPLETED|Phase 2 (4 Weeks)||44||
59508561|NCT02038179|75601657|FG001|COMPLETED|Phase 2 (4 Weeks)||38||
60034343|NCT02460575|76149927|FG001|STARTED|Overall Study||20||
60034344|NCT02460575|76149926|FG000|COMPLETED|Overall Study||39||
60034345|NCT02460575|76149927|FG001|COMPLETED|Overall Study||20||
60034346|NCT02460575|76149926|FG000|NOT COMPLETED|Overall Study||1||
60034347|NCT02460575|76149927|FG001|NOT COMPLETED|Overall Study||0||
60034348|NCT02089347|76149935|FG000|STARTED|Overall Study||356||
60034349|NCT02089347|76149936|FG001|STARTED|Overall Study||178||
60034350|NCT02089347|76149935|FG000|COMPLETED|Overall Study||355||
60034351|NCT02089347|76149936|FG001|COMPLETED|Overall Study||178||
60034352|NCT02089347|76149935|FG000|NOT COMPLETED|Overall Study||1||
60034353|NCT02089347|76149936|FG001|NOT COMPLETED|Overall Study||0||
60034354|NCT02445755|76149942|FG000|STARTED|Overall Study|Neonates will be tested with 3 transcutaneous (TcB) devices +/-30 minutes of routine bilirubin labs|113||
60034355|NCT02445755|76149942|FG000|COMPLETED|Overall Study||100||
59508562|NCT02038179|75601656|FG000|NOT COMPLETED|Phase 2 (4 Weeks)||2||
59508563|NCT02038179|75601657|FG001|NOT COMPLETED|Phase 2 (4 Weeks)||2||
60034356|NCT02445755|76149942|FG000|NOT COMPLETED|Overall Study||13||
60034357|NCT02419469|76149949|FG000|STARTED|Overall Study||1||
60034358|NCT02419469|76149949|FG000|COMPLETED|Overall Study||0||
59508564|NCT00768287|75601663|FG000|STARTED|Pharmacokinetic Study||16||
59508565|NCT00768287|75601664|FG001|STARTED|Pharmacokinetic Study||16||
59508566|NCT00768287|75601665|FG002|STARTED|Pharmacokinetic Study||0||
59508567|NCT00768287|75601666|FG003|STARTED|Pharmacokinetic Study||0||
59508568|NCT00768287|75601667|FG004|STARTED|Pharmacokinetic Study||0||
59508569|NCT00768287|75601668|FG005|STARTED|Pharmacokinetic Study||0||
59508570|NCT00768287|75601663|FG000|COMPLETED|Pharmacokinetic Study||16||
59508571|NCT00768287|75601664|FG001|COMPLETED|Pharmacokinetic Study||16||
59508572|NCT00768287|75601665|FG002|COMPLETED|Pharmacokinetic Study||0||
59508573|NCT00768287|75601666|FG003|COMPLETED|Pharmacokinetic Study||0||
59508574|NCT00768287|75601667|FG004|COMPLETED|Pharmacokinetic Study||0||
59508575|NCT00768287|75601668|FG005|COMPLETED|Pharmacokinetic Study||0||
59508576|NCT00768287|75601663|FG000|NOT COMPLETED|Pharmacokinetic Study||0||
59508577|NCT00768287|75601664|FG001|NOT COMPLETED|Pharmacokinetic Study||0||
59508578|NCT00768287|75601665|FG002|NOT COMPLETED|Pharmacokinetic Study||0||
59508579|NCT00768287|75601666|FG003|NOT COMPLETED|Pharmacokinetic Study||0||
59508580|NCT00768287|75601667|FG004|NOT COMPLETED|Pharmacokinetic Study||0||
59508581|NCT00768287|75601668|FG005|NOT COMPLETED|Pharmacokinetic Study||0||
60034359|NCT02419469|76149949|FG000|NOT COMPLETED|Overall Study||1||
60034360|NCT02419313|76149953|FG000|STARTED|First Intervention||18||
60034361|NCT02419313|76149954|FG001|STARTED|First Intervention||15||
60034362|NCT02419313|76149953|FG000|COMPLETED|First Intervention||16||
60034363|NCT02419313|76149954|FG001|COMPLETED|First Intervention||15||
60034364|NCT02419313|76149953|FG000|NOT COMPLETED|First Intervention||2||
60034365|NCT02419313|76149954|FG001|NOT COMPLETED|First Intervention||0||
60034366|NCT02419313|76149953|FG000|STARTED|Second Intervention||16||
60034367|NCT02419313|76149954|FG001|STARTED|Second Intervention||15||
60034368|NCT02419313|76149953|FG000|COMPLETED|Second Intervention||15||
60034369|NCT02419313|76149954|FG001|COMPLETED|Second Intervention||15||
60034370|NCT02419313|76149953|FG000|NOT COMPLETED|Second Intervention||1||
60034371|NCT02419313|76149954|FG001|NOT COMPLETED|Second Intervention||0||
60034372|NCT02419001|76149962|FG000|STARTED|Period 1- Ceftriaxone Without SYN-004||6||
60034373|NCT02419001|76149963|FG001|STARTED|Period 1- Ceftriaxone Without SYN-004||5||
60034374|NCT02419001|76149962|FG000|COMPLETED|Period 1- Ceftriaxone Without SYN-004|The Adverse Event (AE) was with ceftriaxone, not with Investigational Product (IP)|5||
60034375|NCT02419001|76149963|FG001|COMPLETED|Period 1- Ceftriaxone Without SYN-004||5||
60034376|NCT02419001|76149962|FG000|NOT COMPLETED|Period 1- Ceftriaxone Without SYN-004||1||
60034377|NCT02419001|76149963|FG001|NOT COMPLETED|Period 1- Ceftriaxone Without SYN-004||0||
60034378|NCT02419001|76149962|FG000|STARTED|Period 2- Ceftriaxone With SYN-004||5||
60034379|NCT02419001|76149963|FG001|STARTED|Period 2- Ceftriaxone With SYN-004||5||
60034380|NCT02419001|76149962|FG000|COMPLETED|Period 2- Ceftriaxone With SYN-004||5||
60034381|NCT02419001|76149963|FG001|COMPLETED|Period 2- Ceftriaxone With SYN-004||5||
60034382|NCT02419001|76149962|FG000|NOT COMPLETED|Period 2- Ceftriaxone With SYN-004||0||
60034383|NCT02419001|76149963|FG001|NOT COMPLETED|Period 2- Ceftriaxone With SYN-004||0||
60034384|NCT02031237|76149971|FG000|STARTED|Overall Study||14||
60034385|NCT02031237|76149972|FG001|STARTED|Overall Study||35||
60034386|NCT02031237|76149973|FG002|STARTED|Overall Study||3||
60034387|NCT02031237|76149971|FG000|COMPLETED|Overall Study||9||
60034388|NCT02031237|76149972|FG001|COMPLETED|Overall Study||21||
59508582|NCT00768287|75601663|FG000|STARTED|Repeat Pharmacokinetic Study||0||
59508583|NCT00768287|75601664|FG001|STARTED|Repeat Pharmacokinetic Study||0||
59508584|NCT00768287|75601665|FG002|STARTED|Repeat Pharmacokinetic Study|Eight subjects were part of the IB1001 first group; 6 were from the nonacog alfa first group.|14||
59508585|NCT00768287|75601666|FG003|STARTED|Repeat Pharmacokinetic Study||0||
59508586|NCT00768287|75601667|FG004|STARTED|Repeat Pharmacokinetic Study||0||
59508587|NCT00768287|75601668|FG005|STARTED|Repeat Pharmacokinetic Study||0||
59508588|NCT00768287|75601663|FG000|COMPLETED|Repeat Pharmacokinetic Study||0||
59508589|NCT00768287|75601664|FG001|COMPLETED|Repeat Pharmacokinetic Study||0||
59508590|NCT00768287|75601665|FG002|COMPLETED|Repeat Pharmacokinetic Study||14||
59508591|NCT00768287|75601666|FG003|COMPLETED|Repeat Pharmacokinetic Study||0||
60034389|NCT02031237|76149973|FG002|COMPLETED|Overall Study||0||
60034390|NCT02031237|76149971|FG000|NOT COMPLETED|Overall Study||5||
60034391|NCT02031237|76149972|FG001|NOT COMPLETED|Overall Study||14||
60034392|NCT02031237|76149973|FG002|NOT COMPLETED|Overall Study||3||
60034393|NCT02088957|76149980|FG000|STARTED|Overall Study||1||
60034394|NCT02088957|76149981|FG001|STARTED|Overall Study||0||
60034395|NCT02088957|76149980|FG000|COMPLETED|Overall Study||0||
60034396|NCT02088957|76149981|FG001|COMPLETED|Overall Study||0||
60034397|NCT02088957|76149980|FG000|NOT COMPLETED|Overall Study||1||
60034398|NCT02088957|76149981|FG001|NOT COMPLETED|Overall Study||0||
60034399|NCT02418845|76149989|FG000|STARTED|Overall Study||125||
60034400|NCT02418845|76149990|FG001|STARTED|Overall Study||64||
60034401|NCT02418845|76149989|FG000|COMPLETED|Overall Study||109||
59508592|NCT00768287|75601667|FG004|COMPLETED|Repeat Pharmacokinetic Study||0||
59508593|NCT00768287|75601668|FG005|COMPLETED|Repeat Pharmacokinetic Study||0||
60034402|NCT02418845|76149990|FG001|COMPLETED|Overall Study||52||
60034403|NCT02418845|76149989|FG000|NOT COMPLETED|Overall Study||16||
60034404|NCT02418845|76149990|FG001|NOT COMPLETED|Overall Study||12||
60034405|NCT02088177|76149996|FG000|STARTED|Overall Study||12||
59508594|NCT00768287|75601663|FG000|NOT COMPLETED|Repeat Pharmacokinetic Study||0||
59508595|NCT00768287|75601664|FG001|NOT COMPLETED|Repeat Pharmacokinetic Study||0||
59508596|NCT00768287|75601665|FG002|NOT COMPLETED|Repeat Pharmacokinetic Study||0||
59508597|NCT00768287|75601666|FG003|NOT COMPLETED|Repeat Pharmacokinetic Study||0||
59508598|NCT00768287|75601667|FG004|NOT COMPLETED|Repeat Pharmacokinetic Study||0||
59508599|NCT00768287|75601668|FG005|NOT COMPLETED|Repeat Pharmacokinetic Study||0||
59519020|NCT03587428|75612875|FG005|STARTED|Period 3||2||
59519021|NCT03587428|75612870|FG000|COMPLETED|Period 3||3||
59917298|NCT03359473|76037836|FG001|NOT COMPLETED|Overall Study||6||
59917299|NCT03359473|76037837|FG002|NOT COMPLETED|Overall Study||6||
59917300|NCT03359473|76037838|FG003|NOT COMPLETED|Overall Study||5||
59917301|NCT03589469|76037851|FG000|STARTED|Overall Study||145||
59917302|NCT03589469|76037851|FG000|Participants Received Treatment|Overall Study||145||
59917303|NCT03589469|76037851|FG000|COMPLETED|Overall Study||11||
59917304|NCT03589469|76037851|FG000|NOT COMPLETED|Overall Study||134||
59917305|NCT03359395|76037857|FG000|STARTED|First Intervention A / B||49||
59917306|NCT03359395|76037858|FG001|STARTED|First Intervention A / B||50||
59917307|NCT03359395|76037857|FG000|COMPLETED|First Intervention A / B||46||
59917308|NCT03359395|76037858|FG001|COMPLETED|First Intervention A / B||47||
59917309|NCT03359395|76037857|FG000|NOT COMPLETED|First Intervention A / B||3||
59917310|NCT03359395|76037858|FG001|NOT COMPLETED|First Intervention A / B||3||
59917311|NCT03359395|76037857|FG000|STARTED|Second Intervention B/A||46||
59917312|NCT03359395|76037858|FG001|STARTED|Second Intervention B/A||47||
59917313|NCT03359395|76037857|FG000|COMPLETED|Second Intervention B/A||43||
59917314|NCT03359395|76037858|FG001|COMPLETED|Second Intervention B/A||44||
59917315|NCT03359395|76037857|FG000|NOT COMPLETED|Second Intervention B/A||3||
59917316|NCT03359395|76037858|FG001|NOT COMPLETED|Second Intervention B/A||3||
59917317|NCT03586427|76037869|FG000|STARTED|Overall Study||48||
59917318|NCT03586427|76037870|FG001|STARTED|Overall Study||50||
59917319|NCT03586427|76037871|FG002|STARTED|Overall Study||52||
59917320|NCT03586427|76037872|FG003|STARTED|Overall Study||50||
59917321|NCT03586427|76037873|FG004|STARTED|Overall Study||51||
59917322|NCT03586427|76037869|FG000|COMPLETED|Overall Study||48||
59917323|NCT03586427|76037870|FG001|COMPLETED|Overall Study||46||
59917324|NCT03586427|76037871|FG002|COMPLETED|Overall Study||46||
59917325|NCT03586427|76037872|FG003|COMPLETED|Overall Study||46||
59917326|NCT03586427|76037873|FG004|COMPLETED|Overall Study||46||
59917327|NCT03586427|76037869|FG000|NOT COMPLETED|Overall Study||0||
59917328|NCT03586427|76037870|FG001|NOT COMPLETED|Overall Study||4||
59917329|NCT03586427|76037871|FG002|NOT COMPLETED|Overall Study||6||
59917330|NCT03586427|76037872|FG003|NOT COMPLETED|Overall Study||4||
59917331|NCT03586427|76037873|FG004|NOT COMPLETED|Overall Study||5||
59917332|NCT03648983|76037890|FG000|STARTED|Overall Study||95||
59917333|NCT03648983|76037890|FG000|COMPLETED|Overall Study||0||
59917334|NCT03648983|76037890|FG000|NOT COMPLETED|Overall Study||95||
59917335|NCT02695420|76037899|FG000|STARTED|Overall Study||21||
59917336|NCT02695420|76037900|FG001|STARTED|Overall Study||21||
59917337|NCT02695420|76037901|FG002|STARTED|Overall Study||19||
59917338|NCT02695420|76037902|FG003|STARTED|Overall Study||20||
59917339|NCT02695420|76037899|FG000|COMPLETED|Overall Study||21||
59917340|NCT02695420|76037900|FG001|COMPLETED|Overall Study||20||
59917341|NCT02695420|76037901|FG002|COMPLETED|Overall Study||19||
59917342|NCT02695420|76037902|FG003|COMPLETED|Overall Study||20||
59917343|NCT02695420|76037899|FG000|NOT COMPLETED|Overall Study||0||
59917344|NCT02695420|76037900|FG001|NOT COMPLETED|Overall Study||1||
59917345|NCT02695420|76037901|FG002|NOT COMPLETED|Overall Study||0||
59917346|NCT02695420|76037902|FG003|NOT COMPLETED|Overall Study||0||
59917347|NCT03358147|76037920|FG000|STARTED|Overall Study||235|6 subjects were excluded due to overlapping IP exposure|
59917348|NCT03358147|76037921|FG001|STARTED|Overall Study||240|6 subjects were excluded due to overlapping IP exposure|
59917349|NCT03358147|76037922|FG002|STARTED|Overall Study||240|6 subjects were excluded due to overlapping IP exposure|
59917350|NCT03358147|76037923|FG003|STARTED|Overall Study||237|6 subjects were excluded due to overlapping IP exposure|
59917351|NCT03358147|76037924|FG004|STARTED|Overall Study||119|6 subjects were excluded due to overlapping IP exposure|
59917352|NCT03358147|76037920|FG000|COMPLETED|Overall Study||201||
59917353|NCT03358147|76037921|FG001|COMPLETED|Overall Study||201||
59917354|NCT03358147|76037922|FG002|COMPLETED|Overall Study||206||
59917355|NCT03358147|76037923|FG003|COMPLETED|Overall Study||201||
59917356|NCT03358147|76037924|FG004|COMPLETED|Overall Study||105||
59917357|NCT03358147|76037920|FG000|NOT COMPLETED|Overall Study||34||
59917358|NCT03358147|76037921|FG001|NOT COMPLETED|Overall Study||39||
59917359|NCT03358147|76037922|FG002|NOT COMPLETED|Overall Study||34||
59917360|NCT03358147|76037923|FG003|NOT COMPLETED|Overall Study||36||
59917361|NCT03358147|76037924|FG004|NOT COMPLETED|Overall Study||14||
59917362|NCT03093402|76037940|FG000|STARTED|Overall Study||27||
59917363|NCT03093402|76037941|FG001|STARTED|Overall Study||28||
59917364|NCT03093402|76037942|FG002|STARTED|Overall Study||26||
59917365|NCT03093402|76037943|FG003|STARTED|Overall Study||28||
59917366|NCT03093402|76037940|FG000|COMPLETED|Overall Study||20||
59917367|NCT03093402|76037941|FG001|COMPLETED|Overall Study||23||
59917368|NCT03093402|76037942|FG002|COMPLETED|Overall Study||24||
59917369|NCT03093402|76037943|FG003|COMPLETED|Overall Study||24||
59508600|NCT00768287|75601663|FG000|STARTED|Treatment Study||0|29 subjects enrolled from PK study; 4 from Surgery Substudy; 35 directly into Treatment study.|
59508601|NCT00768287|75601664|FG001|STARTED|Treatment Study||0|29 subjects enrolled from PK study; 4 from Surgery Substudy; 35 directly into Treatment study.|
59508602|NCT00768287|75601665|FG002|STARTED|Treatment Study||0|29 subjects enrolled from PK study; 4 from Surgery Substudy; 35 directly into Treatment study.|
59508603|NCT00768287|75601666|FG003|STARTED|Treatment Study|1 subject was not assigned a regimen at the start of the study.|58|29 subjects enrolled from PK study; 4 from Surgery Substudy; 35 directly into Treatment study.|
59508604|NCT00768287|75601667|FG004|STARTED|Treatment Study|1 subject was not assigned a regimen at the start of the study.|9|29 subjects enrolled from PK study; 4 from Surgery Substudy; 35 directly into Treatment study.|
59508605|NCT00768287|75601668|FG005|STARTED|Treatment Study||0|29 subjects enrolled from PK study; 4 from Surgery Substudy; 35 directly into Treatment study.|
59508606|NCT00768287|75601663|FG000|Treated|Treatment Study||0||
59508607|NCT00768287|75601664|FG001|Treated|Treatment Study||0||
59508608|NCT00768287|75601665|FG002|Treated|Treatment Study||0||
59508609|NCT00768287|75601666|FG003|Treated|Treatment Study|Subjects could switch treatment regimens. 3 subjects switched from On Demand to Prophylaxis.|61||
59519022|NCT03587428|75612871|FG001|COMPLETED|Period 3||2||
59917370|NCT03093402|76037940|FG000|NOT COMPLETED|Overall Study||7||
59917371|NCT03093402|76037941|FG001|NOT COMPLETED|Overall Study||5||
59917372|NCT03093402|76037942|FG002|NOT COMPLETED|Overall Study||2||
59917373|NCT03093402|76037943|FG003|NOT COMPLETED|Overall Study||4||
59917374|NCT03585959|76037953|FG000|STARTED|Overall Study||50||
59917375|NCT03585959|76037953|FG000|COMPLETED|Overall Study||47||
59917376|NCT03585959|76037953|FG000|NOT COMPLETED|Overall Study||3||
59917377|NCT03584789|76037962|FG000|STARTED|Overall Study||1739||17
59917378|NCT03584789|76037963|FG001|STARTED|Overall Study||2297||16
59917379|NCT03584789|76037964|FG002|STARTED|Overall Study||1686||17
59917380|NCT03584789|76037962|FG000|COMPLETED|Overall Study||1720||16
59917381|NCT03584789|76037963|FG001|COMPLETED|Overall Study||2269||14
59917382|NCT03584789|76037964|FG002|COMPLETED|Overall Study||1660||13
59917383|NCT03584789|76037962|FG000|NOT COMPLETED|Overall Study||19||1
59917384|NCT03584789|76037963|FG001|NOT COMPLETED|Overall Study||28||2
59917385|NCT03584789|76037964|FG002|NOT COMPLETED|Overall Study||26||4
59917386|NCT03343639|76037974|FG000|STARTED|Overall Study||102||
59917387|NCT03343639|76037975|FG001|STARTED|Overall Study||102||
59917388|NCT03343639|76037974|FG000|COMPLETED|Overall Study||88||
59917389|NCT03343639|76037975|FG001|COMPLETED|Overall Study||90||
59917390|NCT03343639|76037974|FG000|NOT COMPLETED|Overall Study||14||
59917391|NCT03343639|76037975|FG001|NOT COMPLETED|Overall Study||12||
59917392|NCT03647267|76037983|FG000|STARTED|Overall Study||24||24
59917393|NCT03647267|76037984|FG001|STARTED|Overall Study||22||22
59917394|NCT03647267|76037983|FG000|COMPLETED|Overall Study||23||23
59917395|NCT03647267|76037984|FG001|COMPLETED|Overall Study||22||22
59917396|NCT03647267|76037983|FG000|NOT COMPLETED|Overall Study||1||1
59917397|NCT03647267|76037984|FG001|NOT COMPLETED|Overall Study||0||0
59917398|NCT03356977|76037992|FG000|STARTED|Overall Study||137||
59917399|NCT03356977|76037992|FG000|COMPLETED|Overall Study||132||
59917400|NCT03356977|76037992|FG000|NOT COMPLETED|Overall Study||5||
59917401|NCT02690974|76037996|FG000|STARTED|Overall Study||302|All enrolled patients to whom treatment had been assigned (FAS)|
59917402|NCT02690974|76037996|FG000|COMPLETED|Overall Study||262||
59917403|NCT02690974|76037996|FG000|NOT COMPLETED|Overall Study||40||
59917404|NCT03093324|76038002|FG000|STARTED|Overall Study||254|All enrolled participants.|
59917405|NCT03093324|76038003|FG001|STARTED|Overall Study||252|All enrolled participants.|
59917406|NCT03093324|76038002|FG000|Safety Population|Overall Study||253|All enrolled participants who received at least one dose of study drug.|
59917407|NCT03093324|76038003|FG001|Safety Population|Overall Study||251|All enrolled participants who received at least one dose of study drug.|
59917408|NCT03093324|76038002|FG000|COMPLETED|Overall Study||245||
59917409|NCT03093324|76038003|FG001|COMPLETED|Overall Study||233||
59917410|NCT03093324|76038002|FG000|NOT COMPLETED|Overall Study||9||
59917411|NCT03093324|76038003|FG001|NOT COMPLETED|Overall Study||19||
59917412|NCT03584009|76038011|FG000|STARTED|Overall Study||51||
59917413|NCT03584009|76038012|FG001|STARTED|Overall Study||52||
59917414|NCT03584009|76038011|FG000|COMPLETED|Overall Study||0||
59917415|NCT03584009|76038012|FG001|COMPLETED|Overall Study||0||
59917416|NCT03584009|76038011|FG000|NOT COMPLETED|Overall Study||51||
59917417|NCT03584009|76038012|FG001|NOT COMPLETED|Overall Study||52||
59917418|NCT04167462|76038023|FG000|STARTED|Overall Study||146|Started=treated|
59917419|NCT04167462|76038024|FG001|STARTED|Overall Study||74|Started=treated|
59917420|NCT04167462|76038023|FG000|COMPLETED|Overall Study||132||
59917421|NCT04167462|76038024|FG001|COMPLETED|Overall Study||64||
59917422|NCT04167462|76038023|FG000|NOT COMPLETED|Overall Study||14||
59759405|NCT00659334|75878807|FG005|STARTED|Overall Study||0||
59917423|NCT04167462|76038024|FG001|NOT COMPLETED|Overall Study||10||
59917424|NCT03583385|76038031|FG000|STARTED|Treatment Period 1||24||
59917425|NCT03583385|76038032|FG001|STARTED|Treatment Period 1||24||
59917426|NCT03583385|76038031|FG000|COMPLETED|Treatment Period 1||23||
59917427|NCT03583385|76038032|FG001|COMPLETED|Treatment Period 1||23||
59917428|NCT03583385|76038031|FG000|NOT COMPLETED|Treatment Period 1||1||
59917429|NCT03583385|76038032|FG001|NOT COMPLETED|Treatment Period 1||1||
59917430|NCT03583385|76038031|FG000|STARTED|Treatment Period 2|Of 46 participants who completed period 1, 45 entered period2 & 1 participant didn't attend period2.|22||
59917431|NCT03583385|76038032|FG001|STARTED|Treatment Period 2||23||
59917432|NCT03583385|76038031|FG000|COMPLETED|Treatment Period 2||21||
59917433|NCT03583385|76038032|FG001|COMPLETED|Treatment Period 2||23||
59917434|NCT03583385|76038031|FG000|NOT COMPLETED|Treatment Period 2||1||
59917435|NCT03583385|76038032|FG001|NOT COMPLETED|Treatment Period 2||0||
59917436|NCT04350372|76038038|FG000|STARTED|Overall Study||16||
59917437|NCT04350372|76038038|FG000|COMPLETED|Overall Study||15||
59917438|NCT04350372|76038038|FG000|NOT COMPLETED|Overall Study||1||
59917439|NCT02949973|76038042|FG000|STARTED|Overall Study||10||
59917440|NCT02949973|76038042|FG000|COMPLETED|Overall Study||9||
59917441|NCT02949973|76038042|FG000|NOT COMPLETED|Overall Study||1||
59917442|NCT02948959|76038048|FG000|STARTED|52 Weeks Treatment Period||135|Randomized.|
59917443|NCT02948959|76038049|FG001|STARTED|52 Weeks Treatment Period||273|Randomized.|
59917444|NCT02948959|76038048|FG000|Treated|52 Weeks Treatment Period||135||
59917445|NCT02948959|76038049|FG001|Treated|52 Weeks Treatment Period||270||
59917446|NCT02948959|76038048|FG000|Safety Population|52 Weeks Treatment Period|1 participant randomized to placebo received dupilumab; counted in dupilumab arm for safety analysis.|134|Participants who actually received at least 1 dose or part of a dose of investigational medicinal product (IMP), analyzed according to the treatment actually received.|
59917447|NCT02948959|76038049|FG001|Safety Population|52 Weeks Treatment Period|1 participant randomized to placebo received dupilumab; counted in dupilumab arm for safety analysis.|271|Participants who actually received at least 1 dose or part of a dose of investigational medicinal product (IMP), analyzed according to the treatment actually received.|
59917448|NCT02948959|76038048|FG000|Type 2 Inflammatory Asthma Phenotype Population|52 Weeks Treatment Period||114|Randomized participants with baseline blood eosinophils >=150 cells per microliter or baseline fractional exhaled nitric oxide (FeNO) >=20 parts per billion (ppb).|
59917449|NCT02948959|76038049|FG001|Type 2 Inflammatory Asthma Phenotype Population|52 Weeks Treatment Period||236|Randomized participants with baseline blood eosinophils >=150 cells per microliter or baseline fractional exhaled nitric oxide (FeNO) >=20 parts per billion (ppb).|
59917450|NCT02948959|76038048|FG000|Baseline Blood Eosinophils Count >=300 Cells Per Microlitre Population|52 Weeks Treatment Period||84|Randomized participants with baseline blood eosinophil count >=300 cells per microliter.|
59917451|NCT02948959|76038049|FG001|Baseline Blood Eosinophils Count >=300 Cells Per Microlitre Population|52 Weeks Treatment Period||175|Randomized participants with baseline blood eosinophil count >=300 cells per microliter.|
59917452|NCT02948959|76038048|FG000|COMPLETED|52 Weeks Treatment Period||130||
59917453|NCT02948959|76038049|FG001|COMPLETED|52 Weeks Treatment Period||248||
59917454|NCT02948959|76038048|FG000|NOT COMPLETED|52 Weeks Treatment Period||5||
59917455|NCT02948959|76038049|FG001|NOT COMPLETED|52 Weeks Treatment Period||25||
59917456|NCT02948959|76038048|FG000|STARTED|12 Weeks Follow-up Period||9|Only participants who completed treatment, did not continue to 1-year long-term open-label extension study (LTS14424; NCT03560466) entered Period 2 (12-week posttreatment follow-up period).|
59917457|NCT02948959|76038049|FG001|STARTED|12 Weeks Follow-up Period||31|Only participants who completed treatment, did not continue to 1-year long-term open-label extension study (LTS14424; NCT03560466) entered Period 2 (12-week posttreatment follow-up period).|
59917458|NCT02948959|76038048|FG000|COMPLETED|12 Weeks Follow-up Period||4||
59917459|NCT02948959|76038049|FG001|COMPLETED|12 Weeks Follow-up Period||19||
59917460|NCT02948959|76038048|FG000|NOT COMPLETED|12 Weeks Follow-up Period||5||
59917461|NCT02948959|76038049|FG001|NOT COMPLETED|12 Weeks Follow-up Period||12||
59917462|NCT03582215|76038071|FG000|STARTED|Overall Study||6||
59917463|NCT03582215|76038072|FG001|STARTED|Overall Study||6||
59917464|NCT03582215|76038073|FG002|STARTED|Overall Study||6||
59917465|NCT03582215|76038074|FG003|STARTED|Overall Study||6||
59917466|NCT03582215|76038075|FG004|STARTED|Overall Study||12||
59917467|NCT03582215|76038076|FG005|STARTED|Overall Study||12||
59917468|NCT03582215|76038077|FG006|STARTED|Overall Study||12||
60034406|NCT02088177|76149996|FG000|COMPLETED|Overall Study||9||
60034407|NCT02088177|76149996|FG000|NOT COMPLETED|Overall Study||3||
60034408|NCT02030535|76150000|FG000|STARTED|Treatment Period 1 (1 Day)||53||
60034409|NCT02030535|76150000|FG000|COMPLETED|Treatment Period 1 (1 Day)||53||
60034410|NCT02030535|76150000|FG000|NOT COMPLETED|Treatment Period 1 (1 Day)||0||
60034411|NCT02030535|76150000|FG000|STARTED|Washout Period 1 (21 Days)||53||
60034412|NCT02030535|76150000|FG000|COMPLETED|Washout Period 1 (21 Days)||52||
60034413|NCT02030535|76150000|FG000|NOT COMPLETED|Washout Period 1 (21 Days)||1||
60034414|NCT02030535|76150000|FG000|STARTED|Treatment Period 2 (1 Day)||52||
60034415|NCT02030535|76150000|FG000|COMPLETED|Treatment Period 2 (1 Day)||52||
60034416|NCT02030535|76150000|FG000|NOT COMPLETED|Treatment Period 2 (1 Day)||0||
60034417|NCT02030535|76150000|FG000|STARTED|Washout Period 2 (21 Days)||52||
60034418|NCT02030535|76150000|FG000|COMPLETED|Washout Period 2 (21 Days)||52||
60034419|NCT02030535|76150000|FG000|NOT COMPLETED|Washout Period 2 (21 Days)||0||
60034420|NCT02030535|76150000|FG000|STARTED|Treatment Period 3 (1 Day)||52||
60034421|NCT02030535|76150000|FG000|COMPLETED|Treatment Period 3 (1 Day)||52||
60034422|NCT02030535|76150000|FG000|NOT COMPLETED|Treatment Period 3 (1 Day)||0||
60034423|NCT02029989|76150016|FG000|STARTED|Overall Study|A subject was given the same ID# as withdrawn subject (ID # counted twice) causing N=61 discrepancy.|61||
60034424|NCT02029989|76150017|FG001|STARTED|Overall Study||60||
60034425|NCT02029989|76150016|FG000|COMPLETED|Overall Study||45||
60034426|NCT02029989|76150017|FG001|COMPLETED|Overall Study||49||
60034427|NCT02029989|76150016|FG000|NOT COMPLETED|Overall Study||16||
59917469|NCT03582215|76038078|FG007|STARTED|Overall Study||12||
59917470|NCT03582215|76038071|FG000|COMPLETED|Overall Study||5||
59917471|NCT03582215|76038072|FG001|COMPLETED|Overall Study||6||
59917472|NCT03582215|76038073|FG002|COMPLETED|Overall Study||6||
59917473|NCT03582215|76038074|FG003|COMPLETED|Overall Study||6||
59917474|NCT03582215|76038075|FG004|COMPLETED|Overall Study||12||
59917475|NCT03582215|76038076|FG005|COMPLETED|Overall Study||12||
59917476|NCT03582215|76038077|FG006|COMPLETED|Overall Study||10||
59917477|NCT03582215|76038078|FG007|COMPLETED|Overall Study||10||
59917478|NCT03582215|76038071|FG000|NOT COMPLETED|Overall Study||1||
59917479|NCT03582215|76038072|FG001|NOT COMPLETED|Overall Study||0||
59917480|NCT03582215|76038073|FG002|NOT COMPLETED|Overall Study||0||
59917481|NCT03582215|76038074|FG003|NOT COMPLETED|Overall Study||0||
59917482|NCT03582215|76038075|FG004|NOT COMPLETED|Overall Study||0||
59917483|NCT03582215|76038076|FG005|NOT COMPLETED|Overall Study||0||
59917484|NCT03582215|76038077|FG006|NOT COMPLETED|Overall Study||2||
59917485|NCT03582215|76038078|FG007|NOT COMPLETED|Overall Study||2||
59917486|NCT03089580|76038107|FG000|STARTED|Overall Study||14||28
59917487|NCT03089580|76038107|FG000|COMPLETED|Overall Study||12||24
59917488|NCT03089580|76038107|FG000|NOT COMPLETED|Overall Study||2||4
60034428|NCT02029989|76150017|FG001|NOT COMPLETED|Overall Study||11||
60034429|NCT02048241|76150025|FG000|STARTED|Overall Study||5||
60034430|NCT02048241|76150026|FG001|STARTED|Overall Study||6||
60034431|NCT02048241|76150025|FG000|COMPLETED|Overall Study||5||
60034432|NCT02048241|76150026|FG001|COMPLETED|Overall Study||5||
60034433|NCT02048241|76150025|FG000|NOT COMPLETED|Overall Study||0||
60034434|NCT02048241|76150026|FG001|NOT COMPLETED|Overall Study||1||
60034435|NCT02087943|76150035|FG000|STARTED|Placebo-Controlled Phase Week 0-12||64||
59917489|NCT03645395|76038117|FG000|STARTED|Part 1 (Up to 6 Months)||3||
59917490|NCT03645395|76038118|FG001|STARTED|Part 1 (Up to 6 Months)||3||
59917491|NCT03645395|76038119|FG002|STARTED|Part 1 (Up to 6 Months)||3||
59917492|NCT03645395|76038120|FG003|STARTED|Part 1 (Up to 6 Months)||0||
60034436|NCT02087943|76150036|FG001|STARTED|Placebo-Controlled Phase Week 0-12||58||
59917493|NCT03645395|76038117|FG000|COMPLETED|Part 1 (Up to 6 Months)||1||
60034437|NCT02087943|76150037|FG002|STARTED|Placebo-Controlled Phase Week 0-12||63||
60034438|NCT02087943|76150038|FG003|STARTED|Placebo-Controlled Phase Week 0-12||0||
60034439|NCT02087943|76150039|FG004|STARTED|Placebo-Controlled Phase Week 0-12||0||
60034440|NCT02087943|76150035|FG000|Safety Population|Placebo-Controlled Phase Week 0-12|Includes all participants who received at least one dose of study drug.|64||
60034441|NCT02087943|76150036|FG001|Safety Population|Placebo-Controlled Phase Week 0-12|Includes all participants who received at least one dose of study drug.|58||
60034442|NCT02087943|76150037|FG002|Safety Population|Placebo-Controlled Phase Week 0-12|Includes all participants who received at least one dose of study drug.|63||
60034443|NCT02087943|76150038|FG003|Safety Population|Placebo-Controlled Phase Week 0-12||0||
60034444|NCT02087943|76150039|FG004|Safety Population|Placebo-Controlled Phase Week 0-12||0||
60034445|NCT02087943|76150035|FG000|COMPLETED|Placebo-Controlled Phase Week 0-12|3 participants who completed week 12 did not enter the active treatment phase.|50||
60034446|NCT02087943|76150036|FG001|COMPLETED|Placebo-Controlled Phase Week 0-12||46||
60034447|NCT02087943|76150037|FG002|COMPLETED|Placebo-Controlled Phase Week 0-12|1 participant who completed week 12 did not enter the active treatment phase.|50||
60034448|NCT02087943|76150038|FG003|COMPLETED|Placebo-Controlled Phase Week 0-12||0||
60034449|NCT02087943|76150039|FG004|COMPLETED|Placebo-Controlled Phase Week 0-12||0||
60034450|NCT02087943|76150035|FG000|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||14||
60034451|NCT02087943|76150036|FG001|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||12||
60034452|NCT02087943|76150037|FG002|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||13||
60034453|NCT02087943|76150038|FG003|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||0||
60034454|NCT02087943|76150039|FG004|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||0||
60034455|NCT02087943|76150035|FG000|STARTED|Active Treatment Phase Week 12-24||0||
60034456|NCT02087943|76150036|FG001|STARTED|Active Treatment Phase Week 12-24||46||
60034457|NCT02087943|76150037|FG002|STARTED|Active Treatment Phase Week 12-24||49||
60034458|NCT02087943|76150038|FG003|STARTED|Active Treatment Phase Week 12-24||24||
60034459|NCT02087943|76150039|FG004|STARTED|Active Treatment Phase Week 12-24||23||
60034460|NCT02087943|76150035|FG000|COMPLETED|Active Treatment Phase Week 12-24||0||
60034461|NCT02087943|76150036|FG001|COMPLETED|Active Treatment Phase Week 12-24||42||
60034462|NCT02087943|76150037|FG002|COMPLETED|Active Treatment Phase Week 12-24||44||
60034463|NCT02087943|76150038|FG003|COMPLETED|Active Treatment Phase Week 12-24||22||
60034464|NCT02087943|76150039|FG004|COMPLETED|Active Treatment Phase Week 12-24||21||
60034465|NCT02087943|76150035|FG000|NOT COMPLETED|Active Treatment Phase Week 12-24||0||
60034466|NCT02087943|76150036|FG001|NOT COMPLETED|Active Treatment Phase Week 12-24||4||
60034467|NCT02087943|76150037|FG002|NOT COMPLETED|Active Treatment Phase Week 12-24||5||
60034468|NCT02087943|76150038|FG003|NOT COMPLETED|Active Treatment Phase Week 12-24||2||
60034469|NCT02087943|76150039|FG004|NOT COMPLETED|Active Treatment Phase Week 12-24||2||
60034470|NCT02087943|76150035|FG000|STARTED|Observational Follow-up Phase Week 24-30||0||
60034471|NCT02087943|76150036|FG001|STARTED|Observational Follow-up Phase Week 24-30||46||
60034472|NCT02087943|76150037|FG002|STARTED|Observational Follow-up Phase Week 24-30||48||
60034473|NCT02087943|76150038|FG003|STARTED|Observational Follow-up Phase Week 24-30||24||
60034474|NCT02087943|76150039|FG004|STARTED|Observational Follow-up Phase Week 24-30||23||
60034475|NCT02087943|76150035|FG000|COMPLETED|Observational Follow-up Phase Week 24-30||0||
60034476|NCT02087943|76150036|FG001|COMPLETED|Observational Follow-up Phase Week 24-30||46||
60034477|NCT02087943|76150037|FG002|COMPLETED|Observational Follow-up Phase Week 24-30||45||
60034478|NCT02087943|76150038|FG003|COMPLETED|Observational Follow-up Phase Week 24-30||23||
60034479|NCT02087943|76150039|FG004|COMPLETED|Observational Follow-up Phase Week 24-30||22||
60034480|NCT02087943|76150035|FG000|NOT COMPLETED|Observational Follow-up Phase Week 24-30||0||
60034481|NCT02087943|76150036|FG001|NOT COMPLETED|Observational Follow-up Phase Week 24-30||0||
60034482|NCT02087943|76150037|FG002|NOT COMPLETED|Observational Follow-up Phase Week 24-30||3||
60034483|NCT02087943|76150038|FG003|NOT COMPLETED|Observational Follow-up Phase Week 24-30||1||
60034484|NCT02087943|76150039|FG004|NOT COMPLETED|Observational Follow-up Phase Week 24-30||1||
60034485|NCT02029521|76150053|FG000|STARTED|Overall Study||24||
60034486|NCT02029521|76150054|FG001|STARTED|Overall Study||23||
60034487|NCT02029521|76150053|FG000|COMPLETED|Overall Study||22||
60034488|NCT02029521|76150054|FG001|COMPLETED|Overall Study||22||
60034489|NCT02029521|76150053|FG000|NOT COMPLETED|Overall Study||2||
60034490|NCT02029521|76150054|FG001|NOT COMPLETED|Overall Study||1||
60034491|NCT04685811|76150063|FG000|STARTED|Overall Study||16||
60034492|NCT04685811|76150063|FG000|COMPLETED|Overall Study||16||
60034493|NCT04685811|76150063|FG000|NOT COMPLETED|Overall Study||0||
60034494|NCT02443883|76150075|FG000|STARTED|Overall Study||40||
60034495|NCT02443883|76150076|FG001|STARTED|Overall Study||42||
60034496|NCT02443883|76150077|FG002|STARTED|Overall Study||41||
60034497|NCT02443883|76150078|FG003|STARTED|Overall Study||41||
60034498|NCT02443883|76150075|FG000|Received at Least One Dose of Study Drug|Overall Study||38||
59508610|NCT00768287|75601667|FG004|Treated|Treatment Study|Subjects could switch treatment regimens. 3 subjects switched from Prophylaxis to On Demand.|12||
59508611|NCT00768287|75601668|FG005|Treated|Treatment Study||0||
59508612|NCT00768287|75601663|FG000|COMPLETED|Treatment Study||0||
59508613|NCT00768287|75601664|FG001|COMPLETED|Treatment Study||0||
60034499|NCT02443883|76150076|FG001|Received at Least One Dose of Study Drug|Overall Study||42||
60034500|NCT02443883|76150077|FG002|Received at Least One Dose of Study Drug|Overall Study||41||
59917494|NCT03645395|76038118|FG001|COMPLETED|Part 1 (Up to 6 Months)||0||
59917495|NCT03645395|76038119|FG002|COMPLETED|Part 1 (Up to 6 Months)||0||
59917496|NCT03645395|76038120|FG003|COMPLETED|Part 1 (Up to 6 Months)||0||
59917497|NCT03645395|76038117|FG000|NOT COMPLETED|Part 1 (Up to 6 Months)||2||
59917498|NCT03645395|76038118|FG001|NOT COMPLETED|Part 1 (Up to 6 Months)||3||
59917499|NCT03645395|76038119|FG002|NOT COMPLETED|Part 1 (Up to 6 Months)||3||
59917500|NCT03645395|76038120|FG003|NOT COMPLETED|Part 1 (Up to 6 Months)||0||
59917501|NCT03645395|76038117|FG000|STARTED|Part 2 (Up to 6 Months)||0||
59917502|NCT03645395|76038118|FG001|STARTED|Part 2 (Up to 6 Months)||0||
59917503|NCT03645395|76038119|FG002|STARTED|Part 2 (Up to 6 Months)||0||
59917504|NCT03645395|76038120|FG003|STARTED|Part 2 (Up to 6 Months)||0||
59917505|NCT03645395|76038117|FG000|COMPLETED|Part 2 (Up to 6 Months)||0||
59917506|NCT03645395|76038118|FG001|COMPLETED|Part 2 (Up to 6 Months)||0||
59759406|NCT00659334|75878808|FG006|STARTED|Overall Study||21||
59759407|NCT00659334|75878802|FG000|COMPLETED|Overall Study|8 Screen failures|38||
59759408|NCT00659334|75878803|FG001|COMPLETED|Overall Study|5 Screen failures|36||
59759409|NCT00659334|75878804|FG002|COMPLETED|Overall Study||5||
59759410|NCT00659334|75878805|FG003|COMPLETED|Overall Study||2||
59759411|NCT00659334|75878806|FG004|COMPLETED|Overall Study||1||
59759412|NCT00659334|75878807|FG005|COMPLETED|Overall Study||0||
59759413|NCT00659334|75878808|FG006|COMPLETED|Overall Study|1 screen failure|20||
59917507|NCT03645395|76038119|FG002|COMPLETED|Part 2 (Up to 6 Months)||0||
59917508|NCT03645395|76038120|FG003|COMPLETED|Part 2 (Up to 6 Months)||0||
59917509|NCT03645395|76038117|FG000|NOT COMPLETED|Part 2 (Up to 6 Months)||0||
59917510|NCT03645395|76038118|FG001|NOT COMPLETED|Part 2 (Up to 6 Months)||0||
59917511|NCT03645395|76038119|FG002|NOT COMPLETED|Part 2 (Up to 6 Months)||0||
59917512|NCT03645395|76038120|FG003|NOT COMPLETED|Part 2 (Up to 6 Months)||0||
59917513|NCT03342469|76038133|FG000|STARTED|Overall Study||9||
59917514|NCT03342469|76038134|FG001|STARTED|Overall Study||9||
59917515|NCT03342469|76038135|FG002|STARTED|Overall Study||3||
59917516|NCT03342469|76038136|FG003|STARTED|Overall Study||8||
59917517|NCT03342469|76038133|FG000|COMPLETED|Overall Study||9||
59917518|NCT03342469|76038134|FG001|COMPLETED|Overall Study||8||
59917519|NCT03342469|76038135|FG002|COMPLETED|Overall Study||3||
59917520|NCT03342469|76038136|FG003|COMPLETED|Overall Study||8||
59917521|NCT03342469|76038133|FG000|NOT COMPLETED|Overall Study||0||
59917522|NCT03342469|76038134|FG001|NOT COMPLETED|Overall Study||1||
59917523|NCT03342469|76038135|FG002|NOT COMPLETED|Overall Study||0||
59917524|NCT03342469|76038136|FG003|NOT COMPLETED|Overall Study||0||
59917525|NCT03581825|76038147|FG000|STARTED|Period 1||31||
59917526|NCT03581825|76038148|FG001|STARTED|Period 1||31||
59917527|NCT03581825|76038147|FG000|COMPLETED|Period 1||30||
59917528|NCT03581825|76038148|FG001|COMPLETED|Period 1||31||
59917529|NCT03581825|76038147|FG000|NOT COMPLETED|Period 1||1||
59917530|NCT03581825|76038148|FG001|NOT COMPLETED|Period 1||0||
59917531|NCT03581825|76038147|FG000|STARTED|Period 2||30||
59917532|NCT03581825|76038148|FG001|STARTED|Period 2||31||
59917533|NCT03581825|76038147|FG000|COMPLETED|Period 2||30||
59917534|NCT03581825|76038148|FG001|COMPLETED|Period 2||30||
59917535|NCT03581825|76038147|FG000|NOT COMPLETED|Period 2||0||
59917536|NCT03581825|76038148|FG001|NOT COMPLETED|Period 2||1||
59917537|NCT03342001|76038154|FG000|STARTED|Overall Study||11||
59917538|NCT03342001|76038154|FG000|COMPLETED|Overall Study||9||
59917539|NCT03342001|76038154|FG000|NOT COMPLETED|Overall Study||2||
59917540|NCT03341923|76038158|FG000|STARTED|Period 1, First 14 Days of Wear||67||
59759414|NCT00659334|75878802|FG000|NOT COMPLETED|Overall Study||8||
59759415|NCT00659334|75878803|FG001|NOT COMPLETED|Overall Study||5||
59917541|NCT03341923|76038159|FG001|STARTED|Period 1, First 14 Days of Wear||67||
59917542|NCT03341923|76038158|FG000|COMPLETED|Period 1, First 14 Days of Wear||67||
59917543|NCT03341923|76038159|FG001|COMPLETED|Period 1, First 14 Days of Wear||67||
59917544|NCT03341923|76038158|FG000|NOT COMPLETED|Period 1, First 14 Days of Wear||0||
59917545|NCT03341923|76038159|FG001|NOT COMPLETED|Period 1, First 14 Days of Wear||0||
59917546|NCT03341923|76038158|FG000|STARTED|Period 2, Second 14 Days of Wear||67||
59917547|NCT03341923|76038159|FG001|STARTED|Period 2, Second 14 Days of Wear|Subject completed Period 1 but was discontinued before starting Period 2.|66||
59917548|NCT03341923|76038158|FG000|COMPLETED|Period 2, Second 14 Days of Wear||67||
59917549|NCT03341923|76038159|FG001|COMPLETED|Period 2, Second 14 Days of Wear||65||
59917550|NCT03341923|76038158|FG000|NOT COMPLETED|Period 2, Second 14 Days of Wear||0||
59917551|NCT03341923|76038159|FG001|NOT COMPLETED|Period 2, Second 14 Days of Wear||1||
59917552|NCT03579719|76038167|FG000|STARTED|Overall Study||15||
59917553|NCT03579719|76038167|FG000|COMPLETED|Overall Study||14||
59917554|NCT03579719|76038167|FG000|NOT COMPLETED|Overall Study||1||
60034501|NCT02443883|76150078|FG003|Received at Least One Dose of Study Drug|Overall Study||40||
60034502|NCT02443883|76150075|FG000|COMPLETED|Overall Study||34||
60034503|NCT02443883|76150076|FG001|COMPLETED|Overall Study||38||
60034504|NCT02443883|76150077|FG002|COMPLETED|Overall Study||40||
60034505|NCT02443883|76150078|FG003|COMPLETED|Overall Study||36||
60034506|NCT02443883|76150075|FG000|NOT COMPLETED|Overall Study||6||
60034507|NCT02443883|76150076|FG001|NOT COMPLETED|Overall Study||4||
60034508|NCT02443883|76150077|FG002|NOT COMPLETED|Overall Study||1||
60034509|NCT02443883|76150078|FG003|NOT COMPLETED|Overall Study||5||
60034510|NCT02460263|76150088|FG000|STARTED|In-Center Period||30||
60034511|NCT02460263|76150088|FG000|COMPLETED|In-Center Period||30||
60034512|NCT02460263|76150088|FG000|NOT COMPLETED|In-Center Period||0||
60034513|NCT02460263|76150088|FG000|STARTED|Transition Period||30||
60034514|NCT02460263|76150088|FG000|COMPLETED|Transition Period||28||
60034515|NCT02460263|76150088|FG000|NOT COMPLETED|Transition Period||2||
60034516|NCT02460263|76150088|FG000|STARTED|In-Home Period||28||
60034517|NCT02460263|76150088|FG000|COMPLETED|In-Home Period||28||
60034518|NCT02460263|76150088|FG000|NOT COMPLETED|In-Home Period||0||
60034519|NCT02443805|76150098|FG000|STARTED|Overall Study||802||
60034520|NCT02443805|76150099|FG001|STARTED|Overall Study||805||
60034521|NCT02443805|76150098|FG000|COMPLETED|Overall Study||589||
60034522|NCT02443805|76150099|FG001|COMPLETED|Overall Study||678||
60034523|NCT02443805|76150098|FG000|NOT COMPLETED|Overall Study||213||
60034524|NCT02443805|76150099|FG001|NOT COMPLETED|Overall Study||127||
59917555|NCT03341533|76038173|FG000|STARTED|Overall Study||72||
59917556|NCT03341533|76038174|FG001|STARTED|Overall Study||70||
59917557|NCT03341533|76038173|FG000|COMPLETED|Overall Study||69||
59917558|NCT03341533|76038174|FG001|COMPLETED|Overall Study||68||
59917559|NCT03341533|76038173|FG000|NOT COMPLETED|Overall Study||3||
59917560|NCT03341533|76038174|FG001|NOT COMPLETED|Overall Study||2||
59917561|NCT02688088|76038180|FG000|STARTED|Single Dose Drug Cocktail - Period 1||44||
59917562|NCT02688088|76038181|FG001|STARTED|Single Dose Drug Cocktail - Period 1||0||
60034525|NCT01652885|76150105|FG000|STARTED|Overall Study||23||
60034526|NCT01652885|76150105|FG000|COMPLETED|Overall Study||22||
60034527|NCT01652885|76150105|FG000|NOT COMPLETED|Overall Study||1||
60034528|NCT02459951|76150109|FG000|STARTED|Overall Study||10||
60034529|NCT02459951|76150109|FG000|COMPLETED|Overall Study||9||
60034530|NCT02459951|76150109|FG000|NOT COMPLETED|Overall Study||1||
60034531|NCT02087241|76150118|FG000|STARTED|Overall Study||3||
60034532|NCT02087241|76150119|FG001|STARTED|Overall Study||3||
60034533|NCT02087241|76150120|FG002|STARTED|Overall Study||1||
60034534|NCT02087241|76150121|FG003|STARTED|Overall Study||7||
60034535|NCT02087241|76150118|FG000|COMPLETED|Overall Study||0||
60034536|NCT02087241|76150119|FG001|COMPLETED|Overall Study||0||
60034537|NCT02087241|76150120|FG002|COMPLETED|Overall Study||0||
60034538|NCT02087241|76150121|FG003|COMPLETED|Overall Study||0||
60034539|NCT02087241|76150118|FG000|NOT COMPLETED|Overall Study||3||
60034540|NCT02087241|76150119|FG001|NOT COMPLETED|Overall Study||3||
60034541|NCT02087241|76150120|FG002|NOT COMPLETED|Overall Study||1||
60034542|NCT02087241|76150121|FG003|NOT COMPLETED|Overall Study||7||
60034543|NCT02087085|76150137|FG000|STARTED|Overall Study||154||
60034544|NCT02087085|76150138|FG001|STARTED|Overall Study||156||
60034545|NCT02087085|76150137|FG000|COMPLETED|Overall Study||34||
60034546|NCT02087085|76150138|FG001|COMPLETED|Overall Study||40||
60034547|NCT02087085|76150137|FG000|NOT COMPLETED|Overall Study||120||
60034548|NCT02087085|76150138|FG001|NOT COMPLETED|Overall Study||116||
60034549|NCT02443337|76150146|FG000|STARTED|Overall Study||15||
60034550|NCT02443337|76150147|FG001|STARTED|Overall Study||16||
59612263|NCT01723254|75723432|FG004|STARTED|Overall Study||20||
59917563|NCT02688088|76038182|FG002|STARTED|Single Dose Drug Cocktail - Period 1||0||
59917564|NCT02688088|76038183|FG003|STARTED|Single Dose Drug Cocktail - Period 1||0||
59917565|NCT02688088|76038184|FG004|STARTED|Single Dose Drug Cocktail - Period 1||0||
60034551|NCT02443337|76150146|FG000|Received at Least One Dose of Study Drug|Overall Study||15||
60034552|NCT02443337|76150147|FG001|Received at Least One Dose of Study Drug|Overall Study||16||
60034553|NCT02443337|76150146|FG000|COMPLETED|Overall Study||10||
60034554|NCT02443337|76150147|FG001|COMPLETED|Overall Study||14||
60034555|NCT02443337|76150146|FG000|NOT COMPLETED|Overall Study||5||
60034556|NCT02443337|76150147|FG001|NOT COMPLETED|Overall Study||2||
60034557|NCT02443103|76150158|FG000|STARTED|Overall Study||4||
60034558|NCT02443103|76150158|FG000|COMPLETED|Overall Study||1||
60034559|NCT02443103|76150158|FG000|NOT COMPLETED|Overall Study||3||
60034560|NCT02022657|76150162|FG000|STARTED|Overall Study||10||
60034561|NCT02022657|76150163|FG001|STARTED|Overall Study||8||
60034562|NCT02022657|76150164|FG002|STARTED|Overall Study||9||
60034563|NCT02022657|76150165|FG003|STARTED|Overall Study||8||
60034564|NCT02022657|76150166|FG004|STARTED|Overall Study||8||
60034565|NCT02022657|76150167|FG005|STARTED|Overall Study||9||
59612264|NCT01723254|75723433|FG005|STARTED|Overall Study||20||
60034566|NCT02022657|76150162|FG000|COMPLETED|Overall Study||8||
60034567|NCT02022657|76150163|FG001|COMPLETED|Overall Study||8||
60034568|NCT02022657|76150164|FG002|COMPLETED|Overall Study||8||
60034569|NCT02022657|76150165|FG003|COMPLETED|Overall Study||8||
59508614|NCT00768287|75601665|FG002|COMPLETED|Treatment Study||0||
59508615|NCT00768287|75601666|FG003|COMPLETED|Treatment Study||58||
59508616|NCT00768287|75601667|FG004|COMPLETED|Treatment Study||9||
59508617|NCT00768287|75601668|FG005|COMPLETED|Treatment Study||0||
60034570|NCT02022657|76150166|FG004|COMPLETED|Overall Study||8||
60034571|NCT02022657|76150167|FG005|COMPLETED|Overall Study||8||
60034572|NCT02022657|76150162|FG000|NOT COMPLETED|Overall Study||2||
60034573|NCT02022657|76150163|FG001|NOT COMPLETED|Overall Study||0||
60034574|NCT02022657|76150164|FG002|NOT COMPLETED|Overall Study||1||
60034575|NCT02022657|76150165|FG003|NOT COMPLETED|Overall Study||0||
60034576|NCT02022657|76150166|FG004|NOT COMPLETED|Overall Study||0||
60034577|NCT02022657|76150167|FG005|NOT COMPLETED|Overall Study||1||
60034578|NCT02418455|76150173|FG000|STARTED|48-Week Treatment Period||8||
60034579|NCT02418455|76150173|FG000|Emergency IND (eIND)|48-Week Treatment Period||1|Previously treated with UX003 under eIND application; did not complete the 48-Week Treatment Period.|
60034580|NCT02418455|76150173|FG000|COMPLETED|48-Week Treatment Period||7||
60034581|NCT02418455|76150173|FG000|NOT COMPLETED|48-Week Treatment Period||1||
60034582|NCT02418455|76150173|FG000|STARTED|Continuation Period||7||
60034583|NCT02418455|76150173|FG000|COMPLETED|Continuation Period||0||
60034584|NCT02418455|76150173|FG000|NOT COMPLETED|Continuation Period||7||
60034585|NCT02417753|76150179|FG000|STARTED|Overall Study||1||
60034586|NCT02417753|76150179|FG000|COMPLETED|Overall Study||0||
60034587|NCT02417753|76150179|FG000|NOT COMPLETED|Overall Study||1||
60034588|NCT02417441|76150185|FG000|STARTED|Overall Study||645||
60034589|NCT02417441|76150186|FG001|STARTED|Overall Study||325||
60034590|NCT02417441|76150185|FG000|COMPLETED|Overall Study||593||
60034591|NCT02417441|76150186|FG001|COMPLETED|Overall Study||306||
60034592|NCT02417441|76150185|FG000|NOT COMPLETED|Overall Study||52||
60034593|NCT02417441|76150186|FG001|NOT COMPLETED|Overall Study||19||
60034594|NCT02021643|76150199|FG000|STARTED|Overall Study||156||
60034595|NCT02021643|76150200|FG001|STARTED|Overall Study||290||
60034596|NCT02021643|76150201|FG002|STARTED|Overall Study||11||
60034597|NCT02021643|76150202|FG003|STARTED|Overall Study||230||
60034598|NCT02021643|76150199|FG000|COMPLETED|Overall Study||147||
60034599|NCT02021643|76150200|FG001|COMPLETED|Overall Study||280||
60034600|NCT02021643|76150201|FG002|COMPLETED|Overall Study||11||
60034601|NCT02021643|76150202|FG003|COMPLETED|Overall Study||218||
60034602|NCT02021643|76150199|FG000|NOT COMPLETED|Overall Study||9||
60034603|NCT02021643|76150200|FG001|NOT COMPLETED|Overall Study||10||
60034604|NCT02021643|76150201|FG002|NOT COMPLETED|Overall Study||0||
60034605|NCT02021643|76150202|FG003|NOT COMPLETED|Overall Study||12||
60034606|NCT02415959|76150223|FG000|STARTED|Overall Study||14||
60034607|NCT02415959|76150224|FG001|STARTED|Overall Study||14||
60034608|NCT02415959|76150225|FG002|STARTED|Overall Study||14||
60034609|NCT02415959|76150226|FG003|STARTED|Overall Study||14||
60034610|NCT02415959|76150227|FG004|STARTED|Overall Study||14||
60034611|NCT02415959|76150223|FG000|COMPLETED|Overall Study||14||
60034612|NCT02415959|76150224|FG001|COMPLETED|Overall Study||13||
60034613|NCT02415959|76150225|FG002|COMPLETED|Overall Study||14||
60034614|NCT02415959|76150226|FG003|COMPLETED|Overall Study||13||
60034615|NCT02415959|76150227|FG004|COMPLETED|Overall Study||14||
60034616|NCT02415959|76150223|FG000|NOT COMPLETED|Overall Study||0||
60034617|NCT02415959|76150224|FG001|NOT COMPLETED|Overall Study||1||
60034618|NCT02415959|76150225|FG002|NOT COMPLETED|Overall Study||0||
60034619|NCT02415959|76150226|FG003|NOT COMPLETED|Overall Study||1||
60034620|NCT02415959|76150227|FG004|NOT COMPLETED|Overall Study||0||
60034621|NCT02021565|76150241|FG000|STARTED|Baseline Through Intervention||72||
60034622|NCT02021565|76150242|FG001|STARTED|Baseline Through Intervention||54||
60034623|NCT02021565|76150241|FG000|Caregivers|Baseline Through Intervention||36||
60034624|NCT02021565|76150242|FG001|Caregivers|Baseline Through Intervention||27||
60034625|NCT02021565|76150241|FG000|Care Recipients|Baseline Through Intervention||36||
60034626|NCT02021565|76150242|FG001|Care Recipients|Baseline Through Intervention||27||
59508618|NCT00768287|75601663|FG000|NOT COMPLETED|Treatment Study||0||
59508619|NCT00768287|75601664|FG001|NOT COMPLETED|Treatment Study||0||
59508620|NCT00768287|75601665|FG002|NOT COMPLETED|Treatment Study||0||
59508621|NCT00768287|75601666|FG003|NOT COMPLETED|Treatment Study||0||
59508622|NCT00768287|75601667|FG004|NOT COMPLETED|Treatment Study||0||
59508623|NCT00768287|75601668|FG005|NOT COMPLETED|Treatment Study||0||
60034627|NCT02021565|76150241|FG000|COMPLETED|Baseline Through Intervention||60||
60034628|NCT02021565|76150242|FG001|COMPLETED|Baseline Through Intervention||36||
60034629|NCT02021565|76150241|FG000|NOT COMPLETED|Baseline Through Intervention||12||
59519023|NCT03587428|75612872|FG002|COMPLETED|Period 3||3||
60034630|NCT02021565|76150242|FG001|NOT COMPLETED|Baseline Through Intervention||18||
60034631|NCT02021565|76150241|FG000|STARTED|3-month Follow-up||60||
60034632|NCT02021565|76150242|FG001|STARTED|3-month Follow-up||36||
60034633|NCT02021565|76150241|FG000|Caregivers|3-month Follow-up||30||
60034634|NCT02021565|76150242|FG001|Caregivers|3-month Follow-up||18||
60034635|NCT02021565|76150241|FG000|Care Recipients|3-month Follow-up||30||
60034636|NCT02021565|76150242|FG001|Care Recipients|3-month Follow-up||18||
60034637|NCT02021565|76150241|FG000|COMPLETED|3-month Follow-up||50||
60034638|NCT02021565|76150242|FG001|COMPLETED|3-month Follow-up||34||
60034639|NCT02021565|76150241|FG000|NOT COMPLETED|3-month Follow-up||10||
59508624|NCT00768287|75601663|FG000|STARTED|Surgical Sub-study||0|Four subjects came from prophylaxis, 3 from on demand, 10 enrolled directly into Surgical Substudy.|
59508625|NCT00768287|75601664|FG001|STARTED|Surgical Sub-study||0|Four subjects came from prophylaxis, 3 from on demand, 10 enrolled directly into Surgical Substudy.|
59508626|NCT00768287|75601665|FG002|STARTED|Surgical Sub-study||0|Four subjects came from prophylaxis, 3 from on demand, 10 enrolled directly into Surgical Substudy.|
59508627|NCT00768287|75601666|FG003|STARTED|Surgical Sub-study||0|Four subjects came from prophylaxis, 3 from on demand, 10 enrolled directly into Surgical Substudy.|
59508628|NCT00768287|75601667|FG004|STARTED|Surgical Sub-study||0|Four subjects came from prophylaxis, 3 from on demand, 10 enrolled directly into Surgical Substudy.|
59508629|NCT00768287|75601668|FG005|STARTED|Surgical Sub-study|1 female subject was excluded from the efficacy analysis. She was included in the safety population.|17|Four subjects came from prophylaxis, 3 from on demand, 10 enrolled directly into Surgical Substudy.|
59759416|NCT00659334|75878804|FG002|NOT COMPLETED|Overall Study||0||
59759417|NCT00659334|75878805|FG003|NOT COMPLETED|Overall Study||0||
59759418|NCT00659334|75878806|FG004|NOT COMPLETED|Overall Study||0||
59917566|NCT02688088|76038180|FG000|Received One Dose of Drug Cocktail|Single Dose Drug Cocktail - Period 1||44||
59917567|NCT02688088|76038181|FG001|Received One Dose of Drug Cocktail|Single Dose Drug Cocktail - Period 1||0||
60034640|NCT02021565|76150242|FG001|NOT COMPLETED|3-month Follow-up||2||
60034641|NCT02021331|76150252|FG000|STARTED|Overall Study||2||
60034642|NCT02021331|76150253|FG001|STARTED|Overall Study||3||
60034643|NCT02021331|76150252|FG000|COMPLETED|Overall Study||2||
60034644|NCT02021331|76150253|FG001|COMPLETED|Overall Study||1||
60034645|NCT02021331|76150252|FG000|NOT COMPLETED|Overall Study||0||
60034646|NCT02021331|76150253|FG001|NOT COMPLETED|Overall Study||2||
60034647|NCT02085135|76150261|FG000|STARTED|Overall Study||34||
60034648|NCT02085135|76150262|FG001|STARTED|Overall Study||32||
60034649|NCT02085135|76150261|FG000|COMPLETED|Overall Study||23||
60034650|NCT02085135|76150262|FG001|COMPLETED|Overall Study||23||
60034651|NCT02085135|76150261|FG000|NOT COMPLETED|Overall Study||11||
60034652|NCT02085135|76150262|FG001|NOT COMPLETED|Overall Study||9||
60034653|NCT02441309|76150271|FG000|STARTED|Overall Study||3||
60034654|NCT02441309|76150272|FG001|STARTED|Overall Study||2||
60034655|NCT02441309|76150273|FG002|STARTED|Overall Study||3||
60034656|NCT02441309|76150271|FG000|Received Allocated Intervention|Overall Study||1||
60034657|NCT02441309|76150272|FG001|Received Allocated Intervention|Overall Study||2||
60034658|NCT02441309|76150273|FG002|Received Allocated Intervention|Overall Study||3||
60034659|NCT02441309|76150271|FG000|COMPLETED|Overall Study||0||
60034660|NCT02441309|76150272|FG001|COMPLETED|Overall Study||0||
60034661|NCT02441309|76150273|FG002|COMPLETED|Overall Study||0||
60034662|NCT02441309|76150271|FG000|NOT COMPLETED|Overall Study||3||
60034663|NCT02441309|76150272|FG001|NOT COMPLETED|Overall Study||2||
60034664|NCT02441309|76150273|FG002|NOT COMPLETED|Overall Study||3||
60034665|NCT02027025|76150287|FG000|STARTED|Overall Study||48||
60034666|NCT02027025|76150288|FG001|STARTED|Overall Study||47||
60034667|NCT02027025|76150289|FG002|STARTED|Overall Study||47||
60034668|NCT02027025|76150287|FG000|COMPLETED|Overall Study||47||
60034669|NCT02027025|76150288|FG001|COMPLETED|Overall Study||42||
60034670|NCT02027025|76150289|FG002|COMPLETED|Overall Study||46||
60034671|NCT02027025|76150287|FG000|NOT COMPLETED|Overall Study||1||
60034672|NCT02027025|76150288|FG001|NOT COMPLETED|Overall Study||5||
60034673|NCT02027025|76150289|FG002|NOT COMPLETED|Overall Study||1||
60034674|NCT01652729|76150311|FG000|STARTED|Overall Study|One subject was enrolled twice at different sites. He was randomized to exenatide at both sites.|182||
60034675|NCT01652729|76150312|FG001|STARTED|Overall Study||122||
60034676|NCT01652729|76150313|FG002|STARTED|Overall Study||61||
59917568|NCT02688088|76038182|FG002|Received One Dose of Drug Cocktail|Single Dose Drug Cocktail - Period 1||0||
59917569|NCT02688088|76038183|FG003|Received One Dose of Drug Cocktail|Single Dose Drug Cocktail - Period 1||0||
59917570|NCT02688088|76038184|FG004|Received One Dose of Drug Cocktail|Single Dose Drug Cocktail - Period 1||0||
59917571|NCT02688088|76038180|FG000|COMPLETED|Single Dose Drug Cocktail - Period 1||44||
59917572|NCT02688088|76038181|FG001|COMPLETED|Single Dose Drug Cocktail - Period 1||0||
59917573|NCT02688088|76038182|FG002|COMPLETED|Single Dose Drug Cocktail - Period 1||0||
59917574|NCT02688088|76038183|FG003|COMPLETED|Single Dose Drug Cocktail - Period 1||0||
59917575|NCT02688088|76038184|FG004|COMPLETED|Single Dose Drug Cocktail - Period 1||0||
60034677|NCT01652729|76150311|FG000|Modified Intent-to-Treat|Overall Study|All randomized subjects who received at least one dose of study drug.|181||
60034678|NCT01652729|76150312|FG001|Modified Intent-to-Treat|Overall Study||122||
60034679|NCT01652729|76150313|FG002|Modified Intent-to-Treat|Overall Study||61||
60034680|NCT01652729|76150311|FG000|Treated|Overall Study|All subjects who received at least one dose of study medication even if not randomized.|181||
60034681|NCT01652729|76150312|FG001|Treated|Overall Study||122||
60034682|NCT01652729|76150313|FG002|Treated|Overall Study||61||
60034683|NCT01652729|76150311|FG000|Evaluable|Overall Study|Subjects who completed study procedures to Week 24 or beyond and had adequate study drug exposure|143||
60034684|NCT01652729|76150312|FG001|Evaluable|Overall Study||91||
60034685|NCT01652729|76150313|FG002|Evaluable|Overall Study||43||
60034686|NCT01652729|76150311|FG000|Meal Test Subjects|Overall Study||60||
60034687|NCT01652729|76150312|FG001|Meal Test Subjects|Overall Study||41||
60034688|NCT01652729|76150313|FG002|Meal Test Subjects|Overall Study||20||
60034689|NCT01652729|76150311|FG000|Meal Test Evaluable|Overall Study|ITT subjects who ate >=75% of meal and did not miss 2-hour postprandial glucose measures at V3 and 8|44||
60034690|NCT01652729|76150312|FG001|Meal Test Evaluable|Overall Study||31||
60034691|NCT01652729|76150313|FG002|Meal Test Evaluable|Overall Study||15||
60034692|NCT01652729|76150311|FG000|COMPLETED|Overall Study|The double-enrolled subject's reasons for withdrawal were LTFU and PV. Only PV is shown below.|155||
60034693|NCT01652729|76150312|FG001|COMPLETED|Overall Study||109||
60034694|NCT01652729|76150313|FG002|COMPLETED|Overall Study||47||
60034695|NCT01652729|76150311|FG000|NOT COMPLETED|Overall Study||27||
60034696|NCT01652729|76150312|FG001|NOT COMPLETED|Overall Study||13||
60034697|NCT01652729|76150313|FG002|NOT COMPLETED|Overall Study||14||
60034698|NCT02083965|76150323|FG000|STARTED|PK Period 1||10||
60034699|NCT02083965|76150324|FG001|STARTED|PK Period 1||9||
60034700|NCT02083965|76150323|FG000|COMPLETED|PK Period 1||10||
60034701|NCT02083965|76150324|FG001|COMPLETED|PK Period 1||9||
60034702|NCT02083965|76150323|FG000|NOT COMPLETED|PK Period 1||0||
60034703|NCT02083965|76150324|FG001|NOT COMPLETED|PK Period 1||0||
60034704|NCT02083965|76150323|FG000|STARTED|Washout Period||10||
60034705|NCT02083965|76150324|FG001|STARTED|Washout Period||9||
60034706|NCT02083965|76150323|FG000|COMPLETED|Washout Period||10||
60034707|NCT02083965|76150324|FG001|COMPLETED|Washout Period||9||
60034708|NCT02083965|76150323|FG000|NOT COMPLETED|Washout Period||0||
60034709|NCT02083965|76150324|FG001|NOT COMPLETED|Washout Period||0||
60034710|NCT02083965|76150323|FG000|STARTED|PK Period 2||10||
59508630|NCT00768287|75601663|FG000|COMPLETED|Surgical Sub-study||0||
59508631|NCT00768287|75601664|FG001|COMPLETED|Surgical Sub-study||0||
59508632|NCT00768287|75601665|FG002|COMPLETED|Surgical Sub-study||0||
59508633|NCT00768287|75601666|FG003|COMPLETED|Surgical Sub-study||0||
59508634|NCT00768287|75601667|FG004|COMPLETED|Surgical Sub-study||0||
59508635|NCT00768287|75601668|FG005|COMPLETED|Surgical Sub-study||17||
59508636|NCT00768287|75601663|FG000|NOT COMPLETED|Surgical Sub-study||0||
59508637|NCT00768287|75601664|FG001|NOT COMPLETED|Surgical Sub-study||0||
59508638|NCT00768287|75601665|FG002|NOT COMPLETED|Surgical Sub-study||0||
59508639|NCT00768287|75601666|FG003|NOT COMPLETED|Surgical Sub-study||0||
59508640|NCT00768287|75601667|FG004|NOT COMPLETED|Surgical Sub-study||0||
60034711|NCT02083965|76150324|FG001|STARTED|PK Period 2||9||
60034712|NCT02083965|76150323|FG000|COMPLETED|PK Period 2||10||
60034713|NCT02083965|76150324|FG001|COMPLETED|PK Period 2||9||
60034714|NCT02083965|76150323|FG000|NOT COMPLETED|PK Period 2||0||
60034715|NCT02083965|76150324|FG001|NOT COMPLETED|PK Period 2||0||
60034716|NCT02083965|76150323|FG000|STARTED|Treatment Period||10||
60034717|NCT02083965|76150324|FG001|STARTED|Treatment Period|1 participant completed PK period 1 and 2, then chose to withdraw and did not enter treatment period|8||
60034718|NCT02083965|76150323|FG000|COMPLETED|Treatment Period||9||
60034719|NCT02083965|76150324|FG001|COMPLETED|Treatment Period||8||
59508641|NCT00768287|75601668|FG005|NOT COMPLETED|Surgical Sub-study||0||
60034720|NCT02083965|76150323|FG000|NOT COMPLETED|Treatment Period||1||
60034721|NCT02083965|76150324|FG001|NOT COMPLETED|Treatment Period||0||
60034722|NCT02438813|76150332|FG000|STARTED|Overall Study||1029||
60034723|NCT02438813|76150332|FG000|Received Treatment for SMF|Overall Study||676||
60034724|NCT02438813|76150332|FG000|Did Not ReceiveTreatment for SMF|Overall Study||353||
59508648|NCT00768521|75601689|FG000|STARTED|Period 1||9||
59508649|NCT00768521|75601690|FG001|STARTED|Period 1||11||
59508650|NCT00768521|75601689|FG000|COMPLETED|Period 1||9||
60034725|NCT02438813|76150332|FG000|COMPLETED|Overall Study||504||
60034726|NCT02438813|76150332|FG000|NOT COMPLETED|Overall Study||525||
60034727|NCT02437409|76150346|FG000|STARTED|Overall Study|Eventually 100 evaluable patients, attrition rate of 15%|115||
60034728|NCT02437409|76150346|FG000|COMPLETED|Overall Study|In total 100 patients fulfilled the in-and exclusion criteria,15 patients were excluded/discontinued|100||
60034729|NCT02437409|76150346|FG000|NOT COMPLETED|Overall Study||15||
60034730|NCT02459093|76150353|FG000|STARTED|Overall Study||275||
60034731|NCT02459093|76150354|FG001|STARTED|Overall Study||275||
60034732|NCT02459093|76150353|FG000|COMPLETED|Overall Study||263|Received treatment and completed 30 day follow-up|
60034733|NCT02459093|76150354|FG001|COMPLETED|Overall Study||257|Received treatment and completed 30 day follow-up|
60034734|NCT02459093|76150353|FG000|NOT COMPLETED|Overall Study||12||
60034735|NCT02459093|76150354|FG001|NOT COMPLETED|Overall Study||18||
60034736|NCT02458469|76150360|FG000|STARTED|First Intervention (2 Weeks)||3||
60034737|NCT02458469|76150361|FG001|STARTED|First Intervention (2 Weeks)||2||
60034738|NCT02458469|76150362|FG002|STARTED|First Intervention (2 Weeks)||3||
60034739|NCT02458469|76150363|FG003|STARTED|First Intervention (2 Weeks)||0||
60034740|NCT02458469|76150364|FG004|STARTED|First Intervention (2 Weeks)||1||
60034741|NCT02458469|76150365|FG005|STARTED|First Intervention (2 Weeks)||2||
60034742|NCT02458469|76150360|FG000|COMPLETED|First Intervention (2 Weeks)||2||
60034743|NCT02458469|76150361|FG001|COMPLETED|First Intervention (2 Weeks)||2||
59508651|NCT00768521|75601690|FG001|COMPLETED|Period 1||11||
60034744|NCT02458469|76150362|FG002|COMPLETED|First Intervention (2 Weeks)||2||
60034745|NCT02458469|76150363|FG003|COMPLETED|First Intervention (2 Weeks)||0||
60034746|NCT02458469|76150364|FG004|COMPLETED|First Intervention (2 Weeks)||1||
60034747|NCT02458469|76150365|FG005|COMPLETED|First Intervention (2 Weeks)||2||
60034748|NCT02458469|76150360|FG000|NOT COMPLETED|First Intervention (2 Weeks)||1||
60034749|NCT02458469|76150361|FG001|NOT COMPLETED|First Intervention (2 Weeks)||0||
60034750|NCT02458469|76150362|FG002|NOT COMPLETED|First Intervention (2 Weeks)||1||
60034751|NCT02458469|76150363|FG003|NOT COMPLETED|First Intervention (2 Weeks)||0||
60034752|NCT02458469|76150364|FG004|NOT COMPLETED|First Intervention (2 Weeks)||0||
60034753|NCT02458469|76150365|FG005|NOT COMPLETED|First Intervention (2 Weeks)||0||
60034754|NCT02458469|76150360|FG000|STARTED|First Washout (2 Weeks)||2||
60034755|NCT02458469|76150361|FG001|STARTED|First Washout (2 Weeks)||2||
60034756|NCT02458469|76150362|FG002|STARTED|First Washout (2 Weeks)||2||
60034757|NCT02458469|76150363|FG003|STARTED|First Washout (2 Weeks)||0||
60034758|NCT02458469|76150364|FG004|STARTED|First Washout (2 Weeks)||1||
60034759|NCT02458469|76150365|FG005|STARTED|First Washout (2 Weeks)||2||
60034760|NCT02458469|76150360|FG000|COMPLETED|First Washout (2 Weeks)||2||
60034761|NCT02458469|76150361|FG001|COMPLETED|First Washout (2 Weeks)||2||
60034762|NCT02458469|76150362|FG002|COMPLETED|First Washout (2 Weeks)||2||
60034763|NCT02458469|76150363|FG003|COMPLETED|First Washout (2 Weeks)||0||
60034764|NCT02458469|76150364|FG004|COMPLETED|First Washout (2 Weeks)||1||
60034765|NCT02458469|76150365|FG005|COMPLETED|First Washout (2 Weeks)||2||
60034766|NCT02458469|76150360|FG000|NOT COMPLETED|First Washout (2 Weeks)||0||
60034767|NCT02458469|76150361|FG001|NOT COMPLETED|First Washout (2 Weeks)||0||
60034768|NCT02458469|76150362|FG002|NOT COMPLETED|First Washout (2 Weeks)||0||
60034769|NCT02458469|76150363|FG003|NOT COMPLETED|First Washout (2 Weeks)||0||
60034770|NCT02458469|76150364|FG004|NOT COMPLETED|First Washout (2 Weeks)||0||
60034771|NCT02458469|76150365|FG005|NOT COMPLETED|First Washout (2 Weeks)||0||
60034772|NCT02458469|76150360|FG000|STARTED|Second Intervention (2 Weeks)||2||
60034773|NCT02458469|76150361|FG001|STARTED|Second Intervention (2 Weeks)||2||
60034774|NCT02458469|76150362|FG002|STARTED|Second Intervention (2 Weeks)||2||
60034775|NCT02458469|76150363|FG003|STARTED|Second Intervention (2 Weeks)||0||
60034776|NCT02458469|76150364|FG004|STARTED|Second Intervention (2 Weeks)||1||
60034777|NCT02458469|76150365|FG005|STARTED|Second Intervention (2 Weeks)||2||
60034778|NCT02458469|76150360|FG000|COMPLETED|Second Intervention (2 Weeks)||2||
60034779|NCT02458469|76150361|FG001|COMPLETED|Second Intervention (2 Weeks)||2||
60034780|NCT02458469|76150362|FG002|COMPLETED|Second Intervention (2 Weeks)||2||
60034781|NCT02458469|76150363|FG003|COMPLETED|Second Intervention (2 Weeks)||0||
60034782|NCT02458469|76150364|FG004|COMPLETED|Second Intervention (2 Weeks)||1||
60034783|NCT02458469|76150365|FG005|COMPLETED|Second Intervention (2 Weeks)||1||
60034784|NCT02458469|76150360|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||0||
60034785|NCT02458469|76150361|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||0||
60034786|NCT02458469|76150362|FG002|NOT COMPLETED|Second Intervention (2 Weeks)||0||
60034787|NCT02458469|76150363|FG003|NOT COMPLETED|Second Intervention (2 Weeks)||0||
60034788|NCT02458469|76150364|FG004|NOT COMPLETED|Second Intervention (2 Weeks)||0||
60034789|NCT02458469|76150365|FG005|NOT COMPLETED|Second Intervention (2 Weeks)||1||
60034790|NCT02458469|76150360|FG000|STARTED|Second Washout (2 Weeks)||2||
60034791|NCT02458469|76150361|FG001|STARTED|Second Washout (2 Weeks)||2||
60034792|NCT02458469|76150362|FG002|STARTED|Second Washout (2 Weeks)||2||
60034793|NCT02458469|76150363|FG003|STARTED|Second Washout (2 Weeks)||0||
60034794|NCT02458469|76150364|FG004|STARTED|Second Washout (2 Weeks)||1||
60034795|NCT02458469|76150365|FG005|STARTED|Second Washout (2 Weeks)||1||
60034796|NCT02458469|76150360|FG000|COMPLETED|Second Washout (2 Weeks)||2||
60034797|NCT02458469|76150361|FG001|COMPLETED|Second Washout (2 Weeks)||2||
60034798|NCT02458469|76150362|FG002|COMPLETED|Second Washout (2 Weeks)||2||
60034799|NCT02458469|76150363|FG003|COMPLETED|Second Washout (2 Weeks)||0||
60034800|NCT02458469|76150364|FG004|COMPLETED|Second Washout (2 Weeks)||1||
60034801|NCT02458469|76150365|FG005|COMPLETED|Second Washout (2 Weeks)||1||
60034802|NCT02458469|76150360|FG000|NOT COMPLETED|Second Washout (2 Weeks)||0||
60034803|NCT02458469|76150361|FG001|NOT COMPLETED|Second Washout (2 Weeks)||0||
60034804|NCT02458469|76150362|FG002|NOT COMPLETED|Second Washout (2 Weeks)||0||
60034805|NCT02458469|76150363|FG003|NOT COMPLETED|Second Washout (2 Weeks)||0||
60034806|NCT02458469|76150364|FG004|NOT COMPLETED|Second Washout (2 Weeks)||0||
60034807|NCT02458469|76150365|FG005|NOT COMPLETED|Second Washout (2 Weeks)||0||
60034808|NCT02458469|76150360|FG000|STARTED|Third Intervention (2 Weeks)||2||
60034809|NCT02458469|76150361|FG001|STARTED|Third Intervention (2 Weeks)||2||
60034810|NCT02458469|76150362|FG002|STARTED|Third Intervention (2 Weeks)||2||
60034811|NCT02458469|76150363|FG003|STARTED|Third Intervention (2 Weeks)||0||
60034812|NCT02458469|76150364|FG004|STARTED|Third Intervention (2 Weeks)||1||
60034813|NCT02458469|76150365|FG005|STARTED|Third Intervention (2 Weeks)||1||
60034814|NCT02458469|76150360|FG000|COMPLETED|Third Intervention (2 Weeks)||2||
60034815|NCT02458469|76150361|FG001|COMPLETED|Third Intervention (2 Weeks)||2||
60034816|NCT02458469|76150362|FG002|COMPLETED|Third Intervention (2 Weeks)||2||
60034817|NCT02458469|76150363|FG003|COMPLETED|Third Intervention (2 Weeks)||0||
60034818|NCT02458469|76150364|FG004|COMPLETED|Third Intervention (2 Weeks)||1||
60034819|NCT02458469|76150365|FG005|COMPLETED|Third Intervention (2 Weeks)||1||
59508652|NCT00768521|75601689|FG000|NOT COMPLETED|Period 1||0||
59508653|NCT00768521|75601690|FG001|NOT COMPLETED|Period 1||0||
59508654|NCT00768521|75601689|FG000|STARTED|Period 2||9||
59508655|NCT00768521|75601690|FG001|STARTED|Period 2||11||
59508656|NCT00768521|75601689|FG000|COMPLETED|Period 2||9||
59508657|NCT00768521|75601690|FG001|COMPLETED|Period 2||11||
59508658|NCT00768521|75601689|FG000|NOT COMPLETED|Period 2||0||
59508659|NCT00768521|75601690|FG001|NOT COMPLETED|Period 2||0||
59508660|NCT02038569|75601696|FG000|STARTED|Overall Study||107||
59508661|NCT02038569|75601696|FG000|COMPLETED|Overall Study||102||
59508662|NCT02038569|75601696|FG000|NOT COMPLETED|Overall Study||5||
59508663|NCT00768599|75601704|FG000|STARTED|Overall Study||45||
59508664|NCT00768599|75601705|FG001|STARTED|Overall Study||43||
59508665|NCT00768599|75601706|FG002|STARTED|Overall Study||47||
59508666|NCT00768599|75601704|FG000|COMPLETED|Overall Study||34||
59508667|NCT00768599|75601705|FG001|COMPLETED|Overall Study||27||
59508668|NCT00768599|75601706|FG002|COMPLETED|Overall Study||35||
59612265|NCT01723254|75723434|FG006|STARTED|Overall Study||20||
59917576|NCT02688088|76038180|FG000|NOT COMPLETED|Single Dose Drug Cocktail - Period 1||0||
59917577|NCT02688088|76038181|FG001|NOT COMPLETED|Single Dose Drug Cocktail - Period 1||0||
59917578|NCT02688088|76038182|FG002|NOT COMPLETED|Single Dose Drug Cocktail - Period 1||0||
59917579|NCT02688088|76038183|FG003|NOT COMPLETED|Single Dose Drug Cocktail - Period 1||0||
59917580|NCT02688088|76038184|FG004|NOT COMPLETED|Single Dose Drug Cocktail - Period 1||0||
59917581|NCT02688088|76038180|FG000|STARTED|Abemaciclib + Drug Cocktail - Period 2|Participants received Drug Cocktail in Period 1 only.|0||
59917582|NCT02688088|76038181|FG001|STARTED|Abemaciclib + Drug Cocktail - Period 2|Participants entered Period 2 to receive Abemaciclib on Days 1 to 12 and Drug Cocktail on Day 8.|44||
59917583|NCT02688088|76038182|FG002|STARTED|Abemaciclib + Drug Cocktail - Period 2||0||
59917584|NCT02688088|76038183|FG003|STARTED|Abemaciclib + Drug Cocktail - Period 2||0||
59917585|NCT02688088|76038184|FG004|STARTED|Abemaciclib + Drug Cocktail - Period 2||0||
59917586|NCT02688088|76038180|FG000|Received at Least One Dose of Study Drug|Abemaciclib + Drug Cocktail - Period 2||0||
59917587|NCT02688088|76038181|FG001|Received at Least One Dose of Study Drug|Abemaciclib + Drug Cocktail - Period 2||42||
59917588|NCT02688088|76038182|FG002|Received at Least One Dose of Study Drug|Abemaciclib + Drug Cocktail - Period 2||0||
59917589|NCT02688088|76038183|FG003|Received at Least One Dose of Study Drug|Abemaciclib + Drug Cocktail - Period 2||0||
59917590|NCT02688088|76038184|FG004|Received at Least One Dose of Study Drug|Abemaciclib + Drug Cocktail - Period 2||0||
59917591|NCT02688088|76038180|FG000|COMPLETED|Abemaciclib + Drug Cocktail - Period 2||0||
59917592|NCT02688088|76038181|FG001|COMPLETED|Abemaciclib + Drug Cocktail - Period 2||37||
59917593|NCT02688088|76038182|FG002|COMPLETED|Abemaciclib + Drug Cocktail - Period 2||0||
59917594|NCT02688088|76038183|FG003|COMPLETED|Abemaciclib + Drug Cocktail - Period 2||0||
59917595|NCT02688088|76038184|FG004|COMPLETED|Abemaciclib + Drug Cocktail - Period 2||0||
59917596|NCT02688088|76038180|FG000|NOT COMPLETED|Abemaciclib + Drug Cocktail - Period 2||0||
59917597|NCT02688088|76038181|FG001|NOT COMPLETED|Abemaciclib + Drug Cocktail - Period 2||7||
59917598|NCT02688088|76038182|FG002|NOT COMPLETED|Abemaciclib + Drug Cocktail - Period 2||0||
59917599|NCT02688088|76038183|FG003|NOT COMPLETED|Abemaciclib + Drug Cocktail - Period 2||0||
59917600|NCT02688088|76038184|FG004|NOT COMPLETED|Abemaciclib + Drug Cocktail - Period 2||0||
59917601|NCT02688088|76038180|FG000|STARTED|Abemaciclib Days 13 to 28 - Period 3||0||
59917602|NCT02688088|76038181|FG001|STARTED|Abemaciclib Days 13 to 28 - Period 3|Participants completed Period 2.|0||
59917603|NCT02688088|76038182|FG002|STARTED|Abemaciclib Days 13 to 28 - Period 3|Participants continue Abemaciclib in Period 3.|37||
59917604|NCT02688088|76038183|FG003|STARTED|Abemaciclib Days 13 to 28 - Period 3||0||
59917605|NCT02688088|76038184|FG004|STARTED|Abemaciclib Days 13 to 28 - Period 3||0||
59917606|NCT02688088|76038180|FG000|Received at Least One Dose of Study Drug|Abemaciclib Days 13 to 28 - Period 3||0||
59917607|NCT02688088|76038181|FG001|Received at Least One Dose of Study Drug|Abemaciclib Days 13 to 28 - Period 3||0||
59917608|NCT02688088|76038182|FG002|Received at Least One Dose of Study Drug|Abemaciclib Days 13 to 28 - Period 3||36||
59917609|NCT02688088|76038183|FG003|Received at Least One Dose of Study Drug|Abemaciclib Days 13 to 28 - Period 3||0||
59951402|NCT01880723|76070380|FG001|COMPLETED|Overall Study||16||
59508669|NCT00768599|75601704|FG000|NOT COMPLETED|Overall Study||11||
59508670|NCT00768599|75601705|FG001|NOT COMPLETED|Overall Study||16||
59612266|NCT01723254|75723435|FG007|STARTED|Overall Study||63||
59612267|NCT01723254|75723428|FG000|COMPLETED|Overall Study||5||
59612268|NCT01723254|75723429|FG001|COMPLETED|Overall Study||18||
59612269|NCT01723254|75723430|FG002|COMPLETED|Overall Study||17||
59508671|NCT00768599|75601706|FG002|NOT COMPLETED|Overall Study||12||
59508672|NCT02370693|75601717|FG000|STARTED|Overall Study||3||
59508673|NCT02370693|75601718|FG001|STARTED|Overall Study||4||
59508674|NCT02370693|75601717|FG000|COMPLETED|Overall Study||2||
59508675|NCT02370693|75601718|FG001|COMPLETED|Overall Study||3||
59508676|NCT02370693|75601717|FG000|NOT COMPLETED|Overall Study||1||
59508677|NCT02370693|75601718|FG001|NOT COMPLETED|Overall Study||1||
59508678|NCT02039115|75601726|FG000|STARTED|Overall Study||1||
59508679|NCT02039115|75601727|FG001|STARTED|Overall Study||0||
59508680|NCT02039115|75601726|FG000|COMPLETED|Overall Study||1||
59508681|NCT02039115|75601727|FG001|COMPLETED|Overall Study||0||
59508682|NCT02039115|75601726|FG000|NOT COMPLETED|Overall Study||0||
59508683|NCT02039115|75601727|FG001|NOT COMPLETED|Overall Study||0||
60034820|NCT02458469|76150360|FG000|NOT COMPLETED|Third Intervention (2 Weeks)||0||
60034821|NCT02458469|76150361|FG001|NOT COMPLETED|Third Intervention (2 Weeks)||0||
60034822|NCT02458469|76150362|FG002|NOT COMPLETED|Third Intervention (2 Weeks)||0||
60034823|NCT02458469|76150363|FG003|NOT COMPLETED|Third Intervention (2 Weeks)||0||
60034824|NCT02458469|76150364|FG004|NOT COMPLETED|Third Intervention (2 Weeks)||0||
60034825|NCT02458469|76150365|FG005|NOT COMPLETED|Third Intervention (2 Weeks)||0||
60034826|NCT01843348|76150376|FG000|STARTED|Overall Study||205||
60034827|NCT01843348|76150377|FG001|STARTED|Overall Study||208||
60034828|NCT01843348|76150378|FG002|STARTED|Overall Study||199||
60034829|NCT01843348|76150376|FG000|Safety Analysis Set (SAS)|Overall Study|One participant received TAC + Certican in error - analyzed with TAC + Certican arm|204||
60034830|NCT01843348|76150377|FG001|Safety Analysis Set (SAS)|Overall Study|Two participants received TAC + Certican in other arms in errorr - analyzed with TAC + Certican arm|210||
60034831|NCT01843348|76150378|FG002|Safety Analysis Set (SAS)|Overall Study|One participant received TAC + Certican in error - analyzed with TAC + Certican arm|198||
60034832|NCT01843348|76150376|FG000|Full Analysis Set (FAS)|Overall Study|Participants in the FAS received at least one dose of study drug|205||
60034833|NCT01843348|76150377|FG001|Full Analysis Set (FAS)|Overall Study|Participants in the FAS received at least one dose of study drug|208||
60034834|NCT01843348|76150378|FG002|Full Analysis Set (FAS)|Overall Study|Participants in the FAS received at least one dose of study drug|199||
60034835|NCT01843348|76150376|FG000|Per Protocol Set (PPS)|Overall Study|Participants in the FAS without major protocol deviations|147||
60034836|NCT01843348|76150377|FG001|Per Protocol Set (PPS)|Overall Study|Participants in the FAS without major protocol deviations|111||
60034837|NCT01843348|76150378|FG002|Per Protocol Set (PPS)|Overall Study|Participants in the FAS without major protocol deviations|80||
60034838|NCT01843348|76150376|FG000|COMPLETED|Overall Study||182||
60034839|NCT01843348|76150377|FG001|COMPLETED|Overall Study||168||
60034840|NCT01843348|76150378|FG002|COMPLETED|Overall Study||158||
60034841|NCT01843348|76150376|FG000|NOT COMPLETED|Overall Study||23||
60034842|NCT01843348|76150377|FG001|NOT COMPLETED|Overall Study||40||
60034843|NCT01843348|76150378|FG002|NOT COMPLETED|Overall Study||41||
60034844|NCT01843192|76150391|FG000|STARTED|Overall Study||26||
60034845|NCT01843192|76150392|FG001|STARTED|Overall Study||34||
60034846|NCT01843192|76150393|FG002|STARTED|Overall Study||11||
60034847|NCT01843192|76150391|FG000|COMPLETED|Overall Study||24||
60034848|NCT01843192|76150392|FG001|COMPLETED|Overall Study||28||
60034849|NCT01843192|76150393|FG002|COMPLETED|Overall Study||9||
60034850|NCT01843192|76150391|FG000|NOT COMPLETED|Overall Study||2||
60034851|NCT01843192|76150392|FG001|NOT COMPLETED|Overall Study||6||
60034852|NCT01843192|76150393|FG002|NOT COMPLETED|Overall Study||2||
60034853|NCT01825876|76150401|FG000|STARTED|Period 1||17||
60034854|NCT01825876|76150402|FG001|STARTED|Period 1||0||
60034855|NCT01825876|76150401|FG000|Received 1 Dose of Study Drug|Period 1||17||
60034856|NCT01825876|76150402|FG001|Received 1 Dose of Study Drug|Period 1||0||
60034857|NCT01825876|76150401|FG000|COMPLETED|Period 1||17||
60034858|NCT01825876|76150402|FG001|COMPLETED|Period 1||0||
60034859|NCT01825876|76150401|FG000|NOT COMPLETED|Period 1||0||
60034860|NCT01825876|76150402|FG001|NOT COMPLETED|Period 1||0||
60034861|NCT01825876|76150401|FG000|STARTED|Period 2|Participants received a different treatment in Period 2.|0||
60034862|NCT01825876|76150402|FG001|STARTED|Period 2|Participants received a different treatment in Period 1.|17||
60034863|NCT01825876|76150401|FG000|Received 1 Dose of Study Drug|Period 2||0||
60034864|NCT01825876|76150402|FG001|Received 1 Dose of Study Drug|Period 2||17||
60034865|NCT01825876|76150401|FG000|COMPLETED|Period 2||0||
60034866|NCT01825876|76150402|FG001|COMPLETED|Period 2||16||
60034867|NCT01825876|76150401|FG000|NOT COMPLETED|Period 2||0||
60034868|NCT01825876|76150402|FG001|NOT COMPLETED|Period 2||1||
60034869|NCT01842958|76150413|FG000|STARTED|Overall Study||25||
59508684|NCT00759473|75601738|FG000|STARTED|Overall Study||10||
60034870|NCT01842958|76150414|FG001|STARTED|Overall Study||25||
60034871|NCT01842958|76150413|FG000|Randomized|Overall Study|One subject was randomized to 3.3 mm implant, but received the 4.1 mm implant.|25||
60034872|NCT01842958|76150414|FG001|Randomized|Overall Study||25||
60034873|NCT01842958|76150413|FG000|COMPLETED|Overall Study||24||
60034874|NCT01842958|76150414|FG001|COMPLETED|Overall Study||24||
60034875|NCT01842958|76150413|FG000|NOT COMPLETED|Overall Study||1||
60034876|NCT01842958|76150414|FG001|NOT COMPLETED|Overall Study||1||
60034877|NCT02413229|76150428|FG000|STARTED|Overall Study||25||
60034878|NCT02413229|76150429|FG001|STARTED|Overall Study||12||
60034879|NCT02413229|76150430|FG002|STARTED|Overall Study||26||
60034880|NCT02413229|76150431|FG003|STARTED|Overall Study||12||
60034881|NCT02413229|76150432|FG004|STARTED|Overall Study||24||
60034882|NCT02413229|76150433|FG005|STARTED|Overall Study||12||
60034883|NCT02413229|76150434|FG006|STARTED|Overall Study||25||
60034884|NCT02413229|76150435|FG007|STARTED|Overall Study||15||
60034885|NCT02413229|76150428|FG000|COMPLETED|Overall Study||24||
60034886|NCT02413229|76150429|FG001|COMPLETED|Overall Study||11||
60034887|NCT02413229|76150430|FG002|COMPLETED|Overall Study||25||
60034888|NCT02413229|76150431|FG003|COMPLETED|Overall Study||11||
60034889|NCT02413229|76150432|FG004|COMPLETED|Overall Study||21||
60034890|NCT02413229|76150433|FG005|COMPLETED|Overall Study||12||
60034891|NCT02413229|76150434|FG006|COMPLETED|Overall Study||25||
60034892|NCT02413229|76150435|FG007|COMPLETED|Overall Study||11||
60034893|NCT02413229|76150428|FG000|NOT COMPLETED|Overall Study||1||
60034894|NCT02413229|76150429|FG001|NOT COMPLETED|Overall Study||1||
60034895|NCT02413229|76150430|FG002|NOT COMPLETED|Overall Study||1||
60034896|NCT02413229|76150431|FG003|NOT COMPLETED|Overall Study||1||
60034897|NCT02413229|76150432|FG004|NOT COMPLETED|Overall Study||3||
60034898|NCT02413229|76150433|FG005|NOT COMPLETED|Overall Study||0||
60034899|NCT02413229|76150434|FG006|NOT COMPLETED|Overall Study||0||
60034900|NCT02413229|76150435|FG007|NOT COMPLETED|Overall Study||4||
60034901|NCT01825798|76150455|FG000|STARTED|Overall Study||32||
60034902|NCT01825798|76150456|FG001|STARTED|Overall Study||28||
60034903|NCT01825798|76150455|FG000|COMPLETED|Overall Study||30||
60034904|NCT01825798|76150456|FG001|COMPLETED|Overall Study||23||
60034905|NCT01825798|76150455|FG000|NOT COMPLETED|Overall Study||2||
60034906|NCT01825798|76150456|FG001|NOT COMPLETED|Overall Study||5||
60034907|NCT01824472|76150465|FG000|STARTED|Overall Study||17||
60034908|NCT01824472|76150466|FG001|STARTED|Overall Study||13||
60034909|NCT01824472|76150467|FG002|STARTED|Overall Study||15||
60034910|NCT01824472|76150465|FG000|COMPLETED|Overall Study||16||
59508685|NCT00759473|75601739|FG001|STARTED|Overall Study||10||
59508686|NCT00759473|75601740|FG002|STARTED|Overall Study||12||
59508687|NCT00759473|75601741|FG003|STARTED|Overall Study||23||
59508688|NCT00759473|75601742|FG004|STARTED|Overall Study||24||
59508689|NCT00759473|75601738|FG000|COMPLETED|Overall Study||10||
59508690|NCT00759473|75601739|FG001|COMPLETED|Overall Study||10||
59508691|NCT00759473|75601740|FG002|COMPLETED|Overall Study||12||
60034911|NCT01824472|76150466|FG001|COMPLETED|Overall Study||6||
60034912|NCT01824472|76150467|FG002|COMPLETED|Overall Study||11||
60034913|NCT01824472|76150465|FG000|NOT COMPLETED|Overall Study||1||
60034914|NCT01824472|76150466|FG001|NOT COMPLETED|Overall Study||7||
60034915|NCT01824472|76150467|FG002|NOT COMPLETED|Overall Study||4||
60034916|NCT02412761|76150475|FG000|STARTED|First Intervention (2 Weeks)||5||
60034917|NCT02412761|76150476|FG001|STARTED|First Intervention (2 Weeks)||6||
60034918|NCT02412761|76150477|FG002|STARTED|First Intervention (2 Weeks)||5||
60034919|NCT02412761|76150478|FG003|STARTED|First Intervention (2 Weeks)||8||
60034920|NCT02412761|76150479|FG004|STARTED|First Intervention (2 Weeks)||4||
60034921|NCT02412761|76150480|FG005|STARTED|First Intervention (2 Weeks)||7||
60034922|NCT02412761|76150475|FG000|COMPLETED|First Intervention (2 Weeks)||5||
59759419|NCT00659334|75878807|FG005|NOT COMPLETED|Overall Study||0||
60034923|NCT02412761|76150476|FG001|COMPLETED|First Intervention (2 Weeks)||5||
60034924|NCT02412761|76150477|FG002|COMPLETED|First Intervention (2 Weeks)||4||
60034925|NCT02412761|76150478|FG003|COMPLETED|First Intervention (2 Weeks)||8||
60034926|NCT02412761|76150479|FG004|COMPLETED|First Intervention (2 Weeks)||4||
60034927|NCT02412761|76150480|FG005|COMPLETED|First Intervention (2 Weeks)||6||
60034928|NCT02412761|76150475|FG000|NOT COMPLETED|First Intervention (2 Weeks)||0||
60034929|NCT02412761|76150476|FG001|NOT COMPLETED|First Intervention (2 Weeks)||1||
60034930|NCT02412761|76150477|FG002|NOT COMPLETED|First Intervention (2 Weeks)||1||
60034931|NCT02412761|76150478|FG003|NOT COMPLETED|First Intervention (2 Weeks)||0||
60034932|NCT02412761|76150479|FG004|NOT COMPLETED|First Intervention (2 Weeks)||0||
60034933|NCT02412761|76150480|FG005|NOT COMPLETED|First Intervention (2 Weeks)||1||
60034934|NCT02412761|76150475|FG000|STARTED|Second Intervention (2 Weeks)||5||
59508692|NCT00759473|75601741|FG003|COMPLETED|Overall Study||23||
59508693|NCT00759473|75601742|FG004|COMPLETED|Overall Study||24||
59508694|NCT00759473|75601738|FG000|NOT COMPLETED|Overall Study||0||
59508695|NCT00759473|75601739|FG001|NOT COMPLETED|Overall Study||0||
59508696|NCT00759473|75601740|FG002|NOT COMPLETED|Overall Study||0||
59508697|NCT00759473|75601741|FG003|NOT COMPLETED|Overall Study||0||
59508698|NCT00759473|75601742|FG004|NOT COMPLETED|Overall Study||0||
59759420|NCT00659334|75878808|FG006|NOT COMPLETED|Overall Study||1||
60034935|NCT02412761|76150476|FG001|STARTED|Second Intervention (2 Weeks)||5||
60034936|NCT02412761|76150477|FG002|STARTED|Second Intervention (2 Weeks)||4||
60034937|NCT02412761|76150478|FG003|STARTED|Second Intervention (2 Weeks)||8||
60034938|NCT02412761|76150479|FG004|STARTED|Second Intervention (2 Weeks)||4||
60034939|NCT02412761|76150480|FG005|STARTED|Second Intervention (2 Weeks)||6||
60034940|NCT02412761|76150475|FG000|COMPLETED|Second Intervention (2 Weeks)||5||
60034941|NCT02412761|76150476|FG001|COMPLETED|Second Intervention (2 Weeks)||5||
60034942|NCT02412761|76150477|FG002|COMPLETED|Second Intervention (2 Weeks)||4||
60034943|NCT02412761|76150478|FG003|COMPLETED|Second Intervention (2 Weeks)||8||
60034944|NCT02412761|76150479|FG004|COMPLETED|Second Intervention (2 Weeks)||4||
60034945|NCT02412761|76150480|FG005|COMPLETED|Second Intervention (2 Weeks)||6||
60034946|NCT02412761|76150475|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||0||
60034947|NCT02412761|76150476|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||0||
60034948|NCT02412761|76150477|FG002|NOT COMPLETED|Second Intervention (2 Weeks)||0||
60034949|NCT02412761|76150478|FG003|NOT COMPLETED|Second Intervention (2 Weeks)||0||
59508699|NCT02371395|75601754|FG000|STARTED|Overall Study||1000||
59508700|NCT02371395|75601754|FG000|COMPLETED|Overall Study||1000||
59759421|NCT02084160|75878824|FG000|STARTED|Overall Study||579||
60034950|NCT02412761|76150479|FG004|NOT COMPLETED|Second Intervention (2 Weeks)||0||
60034951|NCT02412761|76150480|FG005|NOT COMPLETED|Second Intervention (2 Weeks)||0||
60034952|NCT02412761|76150475|FG000|STARTED|Third Intervention (2 Weeks)||5||
60034953|NCT02412761|76150476|FG001|STARTED|Third Intervention (2 Weeks)||5||
60034954|NCT02412761|76150477|FG002|STARTED|Third Intervention (2 Weeks)||4||
60034955|NCT02412761|76150478|FG003|STARTED|Third Intervention (2 Weeks)||8||
60034956|NCT02412761|76150479|FG004|STARTED|Third Intervention (2 Weeks)||4||
60034957|NCT02412761|76150480|FG005|STARTED|Third Intervention (2 Weeks)||6||
60034958|NCT02412761|76150475|FG000|COMPLETED|Third Intervention (2 Weeks)||5||
60034959|NCT02412761|76150476|FG001|COMPLETED|Third Intervention (2 Weeks)||5||
60034960|NCT02412761|76150477|FG002|COMPLETED|Third Intervention (2 Weeks)||4||
60034961|NCT02412761|76150478|FG003|COMPLETED|Third Intervention (2 Weeks)||8||
60034962|NCT02412761|76150479|FG004|COMPLETED|Third Intervention (2 Weeks)||4||
60034963|NCT02412761|76150480|FG005|COMPLETED|Third Intervention (2 Weeks)||6||
60034964|NCT02412761|76150475|FG000|NOT COMPLETED|Third Intervention (2 Weeks)||0||
60034965|NCT02412761|76150476|FG001|NOT COMPLETED|Third Intervention (2 Weeks)||0||
60034966|NCT02412761|76150477|FG002|NOT COMPLETED|Third Intervention (2 Weeks)||0||
60034967|NCT02412761|76150478|FG003|NOT COMPLETED|Third Intervention (2 Weeks)||0||
60034968|NCT02412761|76150479|FG004|NOT COMPLETED|Third Intervention (2 Weeks)||0||
60034969|NCT02412761|76150480|FG005|NOT COMPLETED|Third Intervention (2 Weeks)||0||
60034970|NCT01842334|76150490|FG000|STARTED|Overall Study||5||
60034971|NCT01842334|76150491|FG001|STARTED|Overall Study||7||
60034972|NCT01842334|76150490|FG000|COMPLETED|Overall Study||2||
60034973|NCT01842334|76150491|FG001|COMPLETED|Overall Study||3||
60034974|NCT01842334|76150490|FG000|NOT COMPLETED|Overall Study||3||
60034975|NCT01842334|76150491|FG001|NOT COMPLETED|Overall Study||4||
60034976|NCT02457611|76150497|FG000|STARTED|Overall Study||26||
60034977|NCT02457611|76150497|FG000|COMPLETED|Overall Study||23||
60034978|NCT02457611|76150497|FG000|NOT COMPLETED|Overall Study||3||
60034979|NCT02457065|76150503|FG000|STARTED|Overall Study||27||
60034980|NCT02457065|76150504|FG001|STARTED|Overall Study||27||
60034981|NCT02457065|76150503|FG000|COMPLETED|Overall Study||18||
60034982|NCT02457065|76150504|FG001|COMPLETED|Overall Study||16||
60034983|NCT02457065|76150503|FG000|NOT COMPLETED|Overall Study||9||
60034984|NCT02457065|76150504|FG001|NOT COMPLETED|Overall Study||11||
60034985|NCT02083653|76150513|FG000|STARTED|Overall Study||83||
60034986|NCT02083653|76150514|FG001|STARTED|Overall Study||86||
60034987|NCT02083653|76150515|FG002|STARTED|Overall Study||85||
60034988|NCT02083653|76150513|FG000|COMPLETED|Overall Study||1||
60034989|NCT02083653|76150514|FG001|COMPLETED|Overall Study||1||
60034990|NCT02083653|76150515|FG002|COMPLETED|Overall Study||1||
60034991|NCT02083653|76150513|FG000|NOT COMPLETED|Overall Study||82||
60034992|NCT02083653|76150514|FG001|NOT COMPLETED|Overall Study||85||
60034993|NCT02083653|76150515|FG002|NOT COMPLETED|Overall Study||84||
60034994|NCT02436239|76150527|FG000|STARTED|Open-Lable Treatment Period||122||
60034995|NCT02436239|76150528|FG001|STARTED|Open-Lable Treatment Period||131||
60034996|NCT02436239|76150529|FG002|STARTED|Open-Lable Treatment Period||65||
60034997|NCT02436239|76150530|FG003|STARTED|Open-Lable Treatment Period||12||
60034998|NCT02436239|76150527|FG000|COMPLETED|Open-Lable Treatment Period||89||
60034999|NCT02436239|76150528|FG001|COMPLETED|Open-Lable Treatment Period||97||
60035000|NCT02436239|76150529|FG002|COMPLETED|Open-Lable Treatment Period||38||
60035001|NCT02436239|76150530|FG003|COMPLETED|Open-Lable Treatment Period||7||
60035002|NCT02436239|76150527|FG000|NOT COMPLETED|Open-Lable Treatment Period||33||
60035003|NCT02436239|76150528|FG001|NOT COMPLETED|Open-Lable Treatment Period||34||
60035004|NCT02436239|76150529|FG002|NOT COMPLETED|Open-Lable Treatment Period||27||
60035005|NCT02436239|76150530|FG003|NOT COMPLETED|Open-Lable Treatment Period||5||
60035006|NCT02436239|76150527|FG000|STARTED|Down-Taper Period|Enrollment permitted for participants who had not completed previous open-label treatment period.|90||
60035007|NCT02436239|76150528|FG001|STARTED|Down-Taper Period|Enrollment permitted for participants who had not completed previous open-label treatment period.|103||
60035008|NCT02436239|76150529|FG002|STARTED|Down-Taper Period|Enrollment permitted for participants who had not completed previous open-label treatment period.|44||
60035009|NCT02436239|76150530|FG003|STARTED|Down-Taper Period|One participant who completed the open-label treatment period did not enter the down-taper period.|6||
60035010|NCT02436239|76150527|FG000|COMPLETED|Down-Taper Period||86||
60035011|NCT02436239|76150528|FG001|COMPLETED|Down-Taper Period||99||
60035012|NCT02436239|76150529|FG002|COMPLETED|Down-Taper Period||43||
60035013|NCT02436239|76150530|FG003|COMPLETED|Down-Taper Period||4||
60035014|NCT02436239|76150527|FG000|NOT COMPLETED|Down-Taper Period||4||
60035015|NCT02436239|76150528|FG001|NOT COMPLETED|Down-Taper Period||4||
60035016|NCT02436239|76150529|FG002|NOT COMPLETED|Down-Taper Period||1||
60035017|NCT02436239|76150530|FG003|NOT COMPLETED|Down-Taper Period||2||
60035018|NCT02026011|76150542|FG000|STARTED|Allocation 1 (First Set of Medication)||46||
60035019|NCT02026011|76150543|FG001|STARTED|Allocation 1 (First Set of Medication)||41||
60035020|NCT02026011|76150542|FG000|COMPLETED|Allocation 1 (First Set of Medication)||38||
60035021|NCT02026011|76150543|FG001|COMPLETED|Allocation 1 (First Set of Medication)||39||
60035022|NCT02026011|76150542|FG000|NOT COMPLETED|Allocation 1 (First Set of Medication)||8||
60035023|NCT02026011|76150543|FG001|NOT COMPLETED|Allocation 1 (First Set of Medication)||2||
60035024|NCT02026011|76150542|FG000|STARTED|Allocation 2 (Second Set of Medication)||38||
60035025|NCT02026011|76150543|FG001|STARTED|Allocation 2 (Second Set of Medication)||37||
60035026|NCT02026011|76150542|FG000|COMPLETED|Allocation 2 (Second Set of Medication)||37||
60035027|NCT02026011|76150543|FG001|COMPLETED|Allocation 2 (Second Set of Medication)||35||
60035028|NCT02026011|76150542|FG000|NOT COMPLETED|Allocation 2 (Second Set of Medication)||1||
60035029|NCT02026011|76150543|FG001|NOT COMPLETED|Allocation 2 (Second Set of Medication)||2||
60035030|NCT02436005|76150552|FG000|STARTED|First Intervention||12||
60035031|NCT02436005|76150553|FG001|STARTED|First Intervention||13||
60035032|NCT02436005|76150552|FG000|COMPLETED|First Intervention||12||
59508701|NCT02371395|75601754|FG000|NOT COMPLETED|Overall Study||0||
59508702|NCT00759707|75601758|FG000|STARTED|Overall Study||19||
59508703|NCT00759707|75601758|FG000|COMPLETED|Overall Study||19||
59508704|NCT00759707|75601758|FG000|NOT COMPLETED|Overall Study||0||
59508705|NCT02039817|75601764|FG000|STARTED|Overall Study||8||
59508706|NCT02039817|75601765|FG001|STARTED|Overall Study||8||
59508707|NCT02039817|75601764|FG000|COMPLETED|Overall Study||8||
59508708|NCT02039817|75601765|FG001|COMPLETED|Overall Study||8||
59508709|NCT02039817|75601764|FG000|NOT COMPLETED|Overall Study||0||
59508710|NCT02039817|75601765|FG001|NOT COMPLETED|Overall Study||0||
59508711|NCT02371785|75601770|FG000|STARTED|Overall Study||20||
59508712|NCT02371785|75601770|FG000|COMPLETED|Overall Study||20||
59508713|NCT02371785|75601770|FG000|NOT COMPLETED|Overall Study||0||
59508714|NCT00770861|75601782|FG000|STARTED|Overall Study||141||
59508715|NCT00770861|75601783|FG001|STARTED|Overall Study||136||
59508716|NCT00770861|75601782|FG000|COMPLETED|Overall Study||131||
59508717|NCT00770861|75601783|FG001|COMPLETED|Overall Study||120||
59508718|NCT00770861|75601782|FG000|NOT COMPLETED|Overall Study||10||
59508719|NCT00770861|75601783|FG001|NOT COMPLETED|Overall Study||16||
59508720|NCT00787241|75601792|FG000|STARTED|Overall Study||261||
59508721|NCT00787241|75601793|FG001|STARTED|Overall Study||143||
59508722|NCT00787241|75601794|FG002|STARTED|Overall Study||41||
59508723|NCT00787241|75601792|FG000|COMPLETED|Overall Study||261||
59508724|NCT00787241|75601793|FG001|COMPLETED|Overall Study||143||
59508725|NCT00787241|75601794|FG002|COMPLETED|Overall Study||41||
59508726|NCT00787241|75601792|FG000|NOT COMPLETED|Overall Study||0||
59508727|NCT00787241|75601793|FG001|NOT COMPLETED|Overall Study||0||
59508728|NCT00787241|75601794|FG002|NOT COMPLETED|Overall Study||0||
59508729|NCT02041221|75601808|FG000|STARTED|Part 1||6||
59508730|NCT02041221|75601809|FG001|STARTED|Part 1||6||
59508731|NCT02041221|75601810|FG002|STARTED|Part 1||6||
59508732|NCT02041221|75601811|FG003|STARTED|Part 1||6||
59917610|NCT02688088|76038184|FG004|Received at Least One Dose of Study Drug|Abemaciclib Days 13 to 28 - Period 3||0||
59917611|NCT02688088|76038180|FG000|COMPLETED|Abemaciclib Days 13 to 28 - Period 3||0||
59917612|NCT02688088|76038181|FG001|COMPLETED|Abemaciclib Days 13 to 28 - Period 3||0||
59917613|NCT02688088|76038182|FG002|COMPLETED|Abemaciclib Days 13 to 28 - Period 3||29||
59917614|NCT02688088|76038183|FG003|COMPLETED|Abemaciclib Days 13 to 28 - Period 3||0||
59917615|NCT02688088|76038184|FG004|COMPLETED|Abemaciclib Days 13 to 28 - Period 3||0||
59917616|NCT02688088|76038180|FG000|NOT COMPLETED|Abemaciclib Days 13 to 28 - Period 3||0||
59917617|NCT02688088|76038181|FG001|NOT COMPLETED|Abemaciclib Days 13 to 28 - Period 3||0||
59917618|NCT02688088|76038182|FG002|NOT COMPLETED|Abemaciclib Days 13 to 28 - Period 3||8||
59917619|NCT02688088|76038183|FG003|NOT COMPLETED|Abemaciclib Days 13 to 28 - Period 3||0||
59917620|NCT02688088|76038184|FG004|NOT COMPLETED|Abemaciclib Days 13 to 28 - Period 3||0||
59917621|NCT02688088|76038180|FG000|STARTED|Abemaciclib Days 1 to 28 - Period 4||0||
59917622|NCT02688088|76038181|FG001|STARTED|Abemaciclib Days 1 to 28 - Period 4||0||
59917623|NCT02688088|76038182|FG002|STARTED|Abemaciclib Days 1 to 28 - Period 4|Participants completed Abemaciclib Period 3.|0||
59917624|NCT02688088|76038183|FG003|STARTED|Abemaciclib Days 1 to 28 - Period 4|Participants continued to receive Abemaciclib in Period 4.|29||
59917625|NCT02688088|76038184|FG004|STARTED|Abemaciclib Days 1 to 28 - Period 4||0||
59917626|NCT02688088|76038180|FG000|COMPLETED|Abemaciclib Days 1 to 28 - Period 4||0||
59917627|NCT02688088|76038181|FG001|COMPLETED|Abemaciclib Days 1 to 28 - Period 4||0||
59917628|NCT02688088|76038182|FG002|COMPLETED|Abemaciclib Days 1 to 28 - Period 4||0||
59917629|NCT02688088|76038183|FG003|COMPLETED|Abemaciclib Days 1 to 28 - Period 4||21||
59917630|NCT02688088|76038184|FG004|COMPLETED|Abemaciclib Days 1 to 28 - Period 4||0||
59917631|NCT02688088|76038180|FG000|NOT COMPLETED|Abemaciclib Days 1 to 28 - Period 4||0||
59917632|NCT02688088|76038181|FG001|NOT COMPLETED|Abemaciclib Days 1 to 28 - Period 4||0||
60035033|NCT02436005|76150553|FG001|COMPLETED|First Intervention||13||
59508733|NCT02041221|75601812|FG004|STARTED|Part 1||6||
59508734|NCT02041221|75601813|FG005|STARTED|Part 1||10||
59508735|NCT02041221|75601808|FG000|COMPLETED|Part 1||6||
59508736|NCT02041221|75601809|FG001|COMPLETED|Part 1||6||
59508737|NCT02041221|75601810|FG002|COMPLETED|Part 1||6||
60035034|NCT02436005|76150552|FG000|NOT COMPLETED|First Intervention||0||
60035035|NCT02436005|76150553|FG001|NOT COMPLETED|First Intervention||0||
59508738|NCT02041221|75601811|FG003|COMPLETED|Part 1||6||
59508739|NCT02041221|75601812|FG004|COMPLETED|Part 1||6||
59508740|NCT02041221|75601813|FG005|COMPLETED|Part 1||10||
59508741|NCT02041221|75601808|FG000|NOT COMPLETED|Part 1||0||
59508742|NCT02041221|75601809|FG001|NOT COMPLETED|Part 1||0||
59508743|NCT02041221|75601810|FG002|NOT COMPLETED|Part 1||0||
60035036|NCT02436005|76150552|FG000|STARTED|Second Intervention||12||
60035037|NCT02436005|76150553|FG001|STARTED|Second Intervention||13||
60035038|NCT02436005|76150552|FG000|COMPLETED|Second Intervention||12||
60035039|NCT02436005|76150553|FG001|COMPLETED|Second Intervention||12||
60035040|NCT02436005|76150552|FG000|NOT COMPLETED|Second Intervention||0||
60035041|NCT02436005|76150553|FG001|NOT COMPLETED|Second Intervention||1||
60035042|NCT02456909|76150561|FG000|STARTED|Overall Study||88||
60035043|NCT02456909|76150562|FG001|STARTED|Overall Study||88||
60035044|NCT02456909|76150561|FG000|COMPLETED|Overall Study||64||
60035045|NCT02456909|76150562|FG001|COMPLETED|Overall Study||61||
60035046|NCT02456909|76150561|FG000|NOT COMPLETED|Overall Study||24||
60035047|NCT02456909|76150562|FG001|NOT COMPLETED|Overall Study||27||
60035048|NCT02025621|76150570|FG000|STARTED|Overall Study||442||
60035049|NCT02025621|76150571|FG001|STARTED|Overall Study||440||
60035050|NCT02025621|76150570|FG000|COMPLETED|Overall Study||428||
60035051|NCT02025621|76150571|FG001|COMPLETED|Overall Study||421||
60035052|NCT02025621|76150570|FG000|NOT COMPLETED|Overall Study||14||
60035053|NCT02025621|76150571|FG001|NOT COMPLETED|Overall Study||19||
60035054|NCT02020941|76150577|FG000|STARTED|Overall Study||10||
60035055|NCT02020941|76150577|FG000|COMPLETED|Overall Study||2||
60035056|NCT02020941|76150577|FG000|NOT COMPLETED|Overall Study||8||
60035057|NCT02024529|76150583|FG000|STARTED|Overall Study||269||
60035058|NCT02024529|76150584|FG001|STARTED|Overall Study||269||
60035059|NCT02024529|76150583|FG000|COMPLETED|Overall Study||256||
60035060|NCT02024529|76150584|FG001|COMPLETED|Overall Study||244||
60035061|NCT02024529|76150583|FG000|NOT COMPLETED|Overall Study||13||
60035062|NCT02024529|76150584|FG001|NOT COMPLETED|Overall Study||25||
60035063|NCT02020863|76150592|FG000|STARTED|Overall Study||40||
60035064|NCT02020863|76150592|FG000|COMPLETED|Overall Study||35||
60035065|NCT02020863|76150592|FG000|NOT COMPLETED|Overall Study||5||
60035066|NCT01824394|76150599|FG000|STARTED|Overall Study||174|Patients who signed informed consent forms|
60035067|NCT01824394|76150600|FG001|STARTED|Overall Study||169|Patients who signed informed consent forms|
60035068|NCT01824394|76150601|FG002|STARTED|Overall Study||125|Patients who signed informed consent forms|
60035069|NCT01824394|76150599|FG000|Intent to Treat Population|Overall Study||151|Intent-to-Treat (ITT) population include randomized patients who have the ablation catheter inserted|
60035070|NCT01824394|76150600|FG001|Intent to Treat Population|Overall Study||149|Intent-to-Treat (ITT) population include randomized patients who have the ablation catheter inserted|
60035071|NCT01824394|76150601|FG002|Intent to Treat Population|Overall Study|Calibration Roll-in patients are not included in the ITT|0|Intent-to-Treat (ITT) population include randomized patients who have the ablation catheter inserted|
60035072|NCT01824394|76150599|FG000|Safety Population|Overall Study||151|Safety Population includes those patients who have the ablation catheter inserted|
60035073|NCT01824394|76150600|FG001|Safety Population|Overall Study||149|Safety Population includes those patients who have the ablation catheter inserted|
60035074|NCT01824394|76150601|FG002|Safety Population|Overall Study|Calibration Roll-in patients are included in the safety population|104|Safety Population includes those patients who have the ablation catheter inserted|
60035075|NCT01824394|76150599|FG000|Per-Protocol Population|Overall Study||150|Includes ITT patients who have undergone RF ablation and are in compliance with study protocol|
60035076|NCT01824394|76150600|FG001|Per-Protocol Population|Overall Study||148|Includes ITT patients who have undergone RF ablation and are in compliance with study protocol|
60035077|NCT01824394|76150601|FG002|Per-Protocol Population|Overall Study|Calibration Roll-in patients are not included in the per protocol population|0|Includes ITT patients who have undergone RF ablation and are in compliance with study protocol|
60035078|NCT01824394|76150599|FG000|COMPLETED|Overall Study||55|All enrolled subjects who underwent insertion of the study catheter|
60035079|NCT01824394|76150600|FG001|COMPLETED|Overall Study||53|All enrolled subjects who underwent insertion of the study catheter|
60035080|NCT01824394|76150601|FG002|COMPLETED|Overall Study||51|All enrolled subjects who underwent insertion of the study catheter|
60035081|NCT01824394|76150599|FG000|NOT COMPLETED|Overall Study||119||
60035082|NCT01824394|76150600|FG001|NOT COMPLETED|Overall Study||116||
60035083|NCT01824394|76150601|FG002|NOT COMPLETED|Overall Study||74||
60035084|NCT01823536|76150615|FG000|STARTED|Overall Study||73||
60035085|NCT01823536|76150616|FG001|STARTED|Overall Study||103||
60035086|NCT01823536|76150617|FG002|STARTED|Overall Study||120||
60035087|NCT01823536|76150618|FG003|STARTED|Overall Study||66||
60035088|NCT01823536|76150619|FG004|STARTED|Overall Study||101||
60035089|NCT01823536|76150620|FG005|STARTED|Overall Study||2||
60035090|NCT01823536|76150615|FG000|COMPLETED|Overall Study||71||
60035091|NCT01823536|76150616|FG001|COMPLETED|Overall Study||101||
60035092|NCT01823536|76150617|FG002|COMPLETED|Overall Study||119||
60035093|NCT01823536|76150618|FG003|COMPLETED|Overall Study||64||
60035094|NCT01823536|76150619|FG004|COMPLETED|Overall Study||99||
60035095|NCT01823536|76150620|FG005|COMPLETED|Overall Study||2||
60035096|NCT01823536|76150615|FG000|NOT COMPLETED|Overall Study||2||
60035097|NCT01823536|76150616|FG001|NOT COMPLETED|Overall Study||2||
60035098|NCT01823536|76150617|FG002|NOT COMPLETED|Overall Study||1||
60035099|NCT01823536|76150618|FG003|NOT COMPLETED|Overall Study||2||
60035100|NCT01823536|76150619|FG004|NOT COMPLETED|Overall Study||2||
60035101|NCT01823536|76150620|FG005|NOT COMPLETED|Overall Study||0||
60035102|NCT01841554|76150633|FG000|STARTED|Overall Study||61||
60035103|NCT01841554|76150633|FG000|Implanted|Overall Study||60||
60035104|NCT01841554|76150633|FG000|1 Year Follow Up|Overall Study||42||
60035105|NCT01841554|76150633|FG000|COMPLETED|Overall Study||42||
60035106|NCT01841554|76150633|FG000|NOT COMPLETED|Overall Study||19||
60035107|NCT01823224|76150639|FG000|STARTED|Overall Study||34||
60035108|NCT01823224|76150640|FG001|STARTED|Overall Study||33||
60035109|NCT01823224|76150639|FG000|COMPLETED|Overall Study||28||
60035110|NCT01823224|76150640|FG001|COMPLETED|Overall Study||22||
60035111|NCT01823224|76150639|FG000|NOT COMPLETED|Overall Study||6||
60035112|NCT01823224|76150640|FG001|NOT COMPLETED|Overall Study||11||
60035113|NCT01840228|76150650|FG000|STARTED|Overall Study||19||
60035114|NCT01840228|76150651|FG001|STARTED|Overall Study||19||
60035115|NCT01840228|76150650|FG000|COMPLETED|Overall Study||18||
60035116|NCT01840228|76150651|FG001|COMPLETED|Overall Study||18||
60035117|NCT01840228|76150650|FG000|NOT COMPLETED|Overall Study||1||
60035118|NCT01840228|76150651|FG001|NOT COMPLETED|Overall Study||1||
60035119|NCT01839916|76150661|FG000|STARTED|Overall Study||77||
60035120|NCT01839916|76150661|FG000|COMPLETED|Overall Study||36||
59762604|NCT00866307|75882445|FG002|STARTED|Induction||0||
60035121|NCT01839916|76150661|FG000|NOT COMPLETED|Overall Study||41||
60035122|NCT01823146|76150667|FG000|STARTED|Overall Study||55||
60035123|NCT01823146|76150668|FG001|STARTED|Overall Study||51||
60035124|NCT01823146|76150667|FG000|COMPLETED|Overall Study||53||
60035125|NCT01823146|76150668|FG001|COMPLETED|Overall Study||49||
60035126|NCT01823146|76150667|FG000|NOT COMPLETED|Overall Study||2||
60035127|NCT01823146|76150668|FG001|NOT COMPLETED|Overall Study||2||
60035128|NCT02083185|76150677|FG000|STARTED|Overall Study||56||
60035129|NCT02083185|76150678|FG001|STARTED|Overall Study||56||
60035130|NCT02083185|76150679|FG002|STARTED|Overall Study||24||
60035131|NCT02083185|76150677|FG000|Safety Population|Overall Study||56||
60035132|NCT02083185|76150678|FG001|Safety Population|Overall Study||54||
60035133|NCT02083185|76150679|FG002|Safety Population|Overall Study||24||
60035134|NCT02083185|76150677|FG000|COMPLETED|Overall Study||36||
60035135|NCT02083185|76150678|FG001|COMPLETED|Overall Study||27||
60035136|NCT02083185|76150679|FG002|COMPLETED|Overall Study||17||
60035137|NCT02083185|76150677|FG000|NOT COMPLETED|Overall Study||20||
60035138|NCT02083185|76150678|FG001|NOT COMPLETED|Overall Study||29||
60035139|NCT02083185|76150679|FG002|NOT COMPLETED|Overall Study||7||
60035140|NCT02019927|76150693|FG000|STARTED|Overall Study||46||
60035141|NCT02019927|76150694|FG001|STARTED|Overall Study||23||
60035142|NCT02019927|76150695|FG002|STARTED|Overall Study||9||
60035143|NCT02019927|76150696|FG003|STARTED|Overall Study||5||
60035144|NCT02019927|76150697|FG004|STARTED|Overall Study||10||
60035145|NCT02019927|76150698|FG005|STARTED|Overall Study||4||
60035146|NCT02019927|76150693|FG000|COMPLETED|Overall Study||44||
60035147|NCT02019927|76150694|FG001|COMPLETED|Overall Study||19||
60035148|NCT02019927|76150695|FG002|COMPLETED|Overall Study||8||
60035149|NCT02019927|76150696|FG003|COMPLETED|Overall Study||3||
60035150|NCT02019927|76150697|FG004|COMPLETED|Overall Study||7||
60035151|NCT02019927|76150698|FG005|COMPLETED|Overall Study||3||
60035152|NCT02019927|76150693|FG000|NOT COMPLETED|Overall Study||2||
60035153|NCT02019927|76150694|FG001|NOT COMPLETED|Overall Study||4||
60035154|NCT02019927|76150695|FG002|NOT COMPLETED|Overall Study||1||
60035155|NCT02019927|76150696|FG003|NOT COMPLETED|Overall Study||2||
60035156|NCT02019927|76150697|FG004|NOT COMPLETED|Overall Study||3||
60035157|NCT02019927|76150698|FG005|NOT COMPLETED|Overall Study||1||
60035158|NCT02412371|76150722|FG000|STARTED|Overall Study||7||
60035159|NCT02412371|76150723|FG001|STARTED|Overall Study||9||
60035160|NCT02412371|76150724|FG002|STARTED|Overall Study||7||
60035161|NCT02412371|76150725|FG003|STARTED|Overall Study||8||
60035162|NCT02412371|76150726|FG004|STARTED|Overall Study||12||
60035163|NCT02412371|76150727|FG005|STARTED|Overall Study||5||
60035164|NCT02412371|76150722|FG000|COMPLETED|Overall Study||0|Completed indicates participants remaining on study.|
60035165|NCT02412371|76150723|FG001|COMPLETED|Overall Study||0|Completed indicates participants remaining on study.|
60035166|NCT02412371|76150724|FG002|COMPLETED|Overall Study||0|Completed indicates participants remaining on study.|
60035167|NCT02412371|76150725|FG003|COMPLETED|Overall Study||0|Completed indicates participants remaining on study.|
60035168|NCT02412371|76150726|FG004|COMPLETED|Overall Study||0|Completed indicates participants remaining on study.|
60035169|NCT02412371|76150727|FG005|COMPLETED|Overall Study||0|Completed indicates participants remaining on study.|
60035170|NCT02412371|76150722|FG000|NOT COMPLETED|Overall Study||7||
60035171|NCT02412371|76150723|FG001|NOT COMPLETED|Overall Study||9||
60035172|NCT02412371|76150724|FG002|NOT COMPLETED|Overall Study||7||
60035173|NCT02412371|76150725|FG003|NOT COMPLETED|Overall Study||8||
60035174|NCT02412371|76150726|FG004|NOT COMPLETED|Overall Study||12||
60035175|NCT02412371|76150727|FG005|NOT COMPLETED|Overall Study||5||
60035176|NCT02411747|76150744|FG000|STARTED|Overall Study||16||
60035177|NCT02411747|76150745|FG001|STARTED|Overall Study||16||
60035178|NCT02411747|76150744|FG000|Simulation Training Completed|Overall Study||16||
60035179|NCT02411747|76150745|FG001|Simulation Training Completed|Overall Study||16||
60035180|NCT02411747|76150744|FG000|COMPLETED|Overall Study||13||
60035181|NCT02411747|76150745|FG001|COMPLETED|Overall Study||12||
60035182|NCT02411747|76150744|FG000|NOT COMPLETED|Overall Study||3||
60035183|NCT02411747|76150745|FG001|NOT COMPLETED|Overall Study||4||
60035184|NCT01822756|76150756|FG000|STARTED|Overall Study||16||
60035185|NCT01822756|76150757|FG001|STARTED|Overall Study||4||
60035186|NCT01822756|76150758|FG002|STARTED|Overall Study||10||
60035187|NCT01822756|76150759|FG003|STARTED|Overall Study||4||
60035188|NCT01822756|76150760|FG004|STARTED|Overall Study||8||
60035189|NCT01822756|76150756|FG000|Discontinued From the Study|Overall Study||16||
60035190|NCT01822756|76150757|FG001|Discontinued From the Study|Overall Study||4||
60035191|NCT01822756|76150758|FG002|Discontinued From the Study|Overall Study||10||
60035192|NCT01822756|76150759|FG003|Discontinued From the Study|Overall Study||4||
60035193|NCT01822756|76150760|FG004|Discontinued From the Study|Overall Study||7||
60035194|NCT01822756|76150756|FG000|COMPLETED|Overall Study||0||
60035195|NCT01822756|76150757|FG001|COMPLETED|Overall Study||0||
60035196|NCT01822756|76150758|FG002|COMPLETED|Overall Study||0||
60035197|NCT01822756|76150759|FG003|COMPLETED|Overall Study||0||
60035198|NCT01822756|76150760|FG004|COMPLETED|Overall Study||1||
60035199|NCT01822756|76150756|FG000|NOT COMPLETED|Overall Study||16||
60035200|NCT01822756|76150757|FG001|NOT COMPLETED|Overall Study||4||
60035201|NCT01822756|76150758|FG002|NOT COMPLETED|Overall Study||10||
60035202|NCT01822756|76150759|FG003|NOT COMPLETED|Overall Study||4||
60035203|NCT01822756|76150760|FG004|NOT COMPLETED|Overall Study||7||
60035204|NCT01822678|76150775|FG000|STARTED|Overall Study||57||
60035205|NCT01822678|76150776|FG001|STARTED|Overall Study||64||
60035206|NCT01822678|76150777|FG002|STARTED|Overall Study||40||
60035207|NCT01822678|76150775|FG000|Treated|Overall Study||57||
60035208|NCT01822678|76150776|FG001|Treated|Overall Study||64||
60035209|NCT01822678|76150777|FG002|Treated|Overall Study||40||
60035210|NCT01822678|76150775|FG000|Safety Population|Overall Study||57||
60035211|NCT01822678|76150776|FG001|Safety Population|Overall Study||64||
60035212|NCT01822678|76150777|FG002|Safety Population|Overall Study||40||
60035213|NCT01822678|76150775|FG000|Intention-to-Treat Population (ITT)|Overall Study||57||
60035214|NCT01822678|76150776|FG001|Intention-to-Treat Population (ITT)|Overall Study|1 patient was excluded from the ITT population because he did not have post baseline efficacy data|63||
60035215|NCT01822678|76150777|FG002|Intention-to-Treat Population (ITT)|Overall Study||40||
60035216|NCT01822678|76150775|FG000|Per Protocol Population|Overall Study||45||
60035217|NCT01822678|76150776|FG001|Per Protocol Population|Overall Study||52||
60035218|NCT01822678|76150777|FG002|Per Protocol Population|Overall Study||34||
60035219|NCT01822678|76150775|FG000|COMPLETED|Overall Study||45||
60035220|NCT01822678|76150776|FG001|COMPLETED|Overall Study||49||
60035221|NCT01822678|76150777|FG002|COMPLETED|Overall Study||29||
60035222|NCT01822678|76150775|FG000|NOT COMPLETED|Overall Study||12||
60035223|NCT01822678|76150776|FG001|NOT COMPLETED|Overall Study||15||
60035224|NCT01822678|76150777|FG002|NOT COMPLETED|Overall Study||11||
60035225|NCT01822366|76150789|FG000|STARTED|Overall Study||320||
60035226|NCT01822366|76150790|FG001|STARTED|Overall Study||320||
60035227|NCT01822366|76150791|FG002|STARTED|Overall Study||320||
60035228|NCT01822366|76150792|FG003|STARTED|Overall Study||320||
60035229|NCT01822366|76150789|FG000|COMPLETED|Overall Study||315||
60035230|NCT01822366|76150790|FG001|COMPLETED|Overall Study||298||
60035231|NCT01822366|76150791|FG002|COMPLETED|Overall Study||315||
59508744|NCT02041221|75601811|FG003|NOT COMPLETED|Part 1||0||
60035232|NCT01822366|76150792|FG003|COMPLETED|Overall Study||298||
59508745|NCT02041221|75601812|FG004|NOT COMPLETED|Part 1||0||
59508746|NCT02041221|75601813|FG005|NOT COMPLETED|Part 1||0||
60035233|NCT01822366|76150789|FG000|NOT COMPLETED|Overall Study||5||
60035234|NCT01822366|76150790|FG001|NOT COMPLETED|Overall Study||22||
60035235|NCT01822366|76150791|FG002|NOT COMPLETED|Overall Study||5||
60035236|NCT01822366|76150792|FG003|NOT COMPLETED|Overall Study||22||
60035237|NCT01838590|76150824|FG000|STARTED|Overall Study||52||
60035238|NCT01838590|76150825|FG001|STARTED|Overall Study||51||
60035239|NCT01838590|76150824|FG000|COMPLETED|Overall Study||40||
60035240|NCT01838590|76150825|FG001|COMPLETED|Overall Study||46||
60035241|NCT01838590|76150824|FG000|NOT COMPLETED|Overall Study||12||
60035242|NCT01838590|76150825|FG001|NOT COMPLETED|Overall Study||5||
60035243|NCT01611454|76150837|FG000|STARTED|Overall Study||58||
60035244|NCT01611454|76150838|FG001|STARTED|Overall Study||48||
60035245|NCT01611454|76150837|FG000|COMPLETED|Overall Study||40||
60035246|NCT01611454|76150838|FG001|COMPLETED|Overall Study||38||
60035247|NCT01611454|76150837|FG000|NOT COMPLETED|Overall Study||18||
60035248|NCT01611454|76150838|FG001|NOT COMPLETED|Overall Study||10||
60035249|NCT01611298|76150848|FG000|STARTED|Overall Study||7||
60035250|NCT01611298|76150848|FG000|COMPLETED|Overall Study||5||
60035251|NCT01611298|76150848|FG000|NOT COMPLETED|Overall Study||2||
60035252|NCT01822132|76150854|FG000|STARTED|Overall Study||25||
60035253|NCT01822132|76150855|FG001|STARTED|Overall Study||27||
60035254|NCT01822132|76150854|FG000|COMPLETED|Overall Study||21||
60035255|NCT01822132|76150855|FG001|COMPLETED|Overall Study||25||
60035256|NCT01822132|76150854|FG000|NOT COMPLETED|Overall Study||4||
60035257|NCT01822132|76150855|FG001|NOT COMPLETED|Overall Study||2||
60035258|NCT01821898|76150869|FG000|STARTED|Overall Study||2||
60035259|NCT01821898|76150870|FG001|STARTED|Overall Study||1||
60035260|NCT01821898|76150869|FG000|COMPLETED|Overall Study||0||
60035261|NCT01821898|76150870|FG001|COMPLETED|Overall Study||0||
60035262|NCT01821898|76150869|FG000|NOT COMPLETED|Overall Study||2||
60035263|NCT01821898|76150870|FG001|NOT COMPLETED|Overall Study||1||
60035264|NCT02411591|76150880|FG000|STARTED|Overall Study||3||
60035265|NCT02411591|76150881|FG001|STARTED|Overall Study||57||
60035266|NCT02411591|76150882|FG002|STARTED|Overall Study||6||
60035267|NCT02411591|76150880|FG000|Part A|Overall Study||3||
60035268|NCT02411591|76150881|FG001|Part A|Overall Study||6||
60035269|NCT02411591|76150882|FG002|Part A|Overall Study||6||
60035270|NCT02411591|76150880|FG000|Expansion Cohort Part B|Overall Study||0||
60035271|NCT02411591|76150881|FG001|Expansion Cohort Part B|Overall Study||51||
60035272|NCT02411591|76150882|FG002|Expansion Cohort Part B|Overall Study||0||
60035273|NCT02411591|76150880|FG000|Progressive Disease|Overall Study||3||
60035274|NCT02411591|76150881|FG001|Progressive Disease|Overall Study||42||
60035275|NCT02411591|76150882|FG002|Progressive Disease|Overall Study||3||
60035276|NCT02411591|76150880|FG000|Death|Overall Study||0||
60035277|NCT02411591|76150881|FG001|Death|Overall Study||2||
60035278|NCT02411591|76150882|FG002|Death|Overall Study||0||
60035279|NCT02411591|76150880|FG000|COMPLETED|Overall Study||3||
60035280|NCT02411591|76150881|FG001|COMPLETED|Overall Study||47||
60035281|NCT02411591|76150882|FG002|COMPLETED|Overall Study||3||
60035282|NCT02411591|76150880|FG000|NOT COMPLETED|Overall Study||0||
60035283|NCT02411591|76150881|FG001|NOT COMPLETED|Overall Study||10||
60035284|NCT02411591|76150882|FG002|NOT COMPLETED|Overall Study||3||
60035285|NCT02454959|76150898|FG000|STARTED|Overall Study||79||
60035286|NCT02454959|76150898|FG000|GFF MDI (PT003) With Aerochamber|Overall Study||73||
60035287|NCT02454959|76150898|FG000|GFF MDI (PT003) Without Aerochamber|Overall Study||77||
60035288|NCT02454959|76150898|FG000|COMPLETED|Overall Study||70||
60035289|NCT02454959|76150898|FG000|NOT COMPLETED|Overall Study||9||
60035290|NCT01821118|76150906|FG000|STARTED|Overall Study||24||
60035291|NCT01821118|76150907|FG001|STARTED|Overall Study||12||
60035292|NCT01821118|76150906|FG000|COMPLETED|Overall Study||24||
60035293|NCT01821118|76150907|FG001|COMPLETED|Overall Study||11||
60035294|NCT01821118|76150906|FG000|NOT COMPLETED|Overall Study||0||
60035295|NCT01821118|76150907|FG001|NOT COMPLETED|Overall Study||1||
60035296|NCT01650779|76150913|FG000|STARTED|Overall Study||15||
60035297|NCT01650779|76150913|FG000|COMPLETED|Overall Study||14||
60035298|NCT01650779|76150913|FG000|NOT COMPLETED|Overall Study||1||
60035299|NCT02411201|76150917|FG000|STARTED|Overall Study||51||
60035300|NCT02411201|76150917|FG000|COMPLETED|Overall Study||45||
60035301|NCT02411201|76150917|FG000|NOT COMPLETED|Overall Study||6||
60035302|NCT01838044|76150925|FG000|STARTED|Overall Study||89||
60035303|NCT01838044|76150926|FG001|STARTED|Overall Study||91||
60035304|NCT01838044|76150925|FG000|COMPLETED|Overall Study||81||
60035305|NCT01838044|76150926|FG001|COMPLETED|Overall Study||75||
60035306|NCT01838044|76150925|FG000|NOT COMPLETED|Overall Study||8||
60035307|NCT01838044|76150926|FG001|NOT COMPLETED|Overall Study||16||
60035308|NCT02410811|76150937|FG000|STARTED|Overall Study||5||
60035309|NCT02410811|76150938|FG001|STARTED|Overall Study||10||
60035310|NCT02410811|76150939|FG002|STARTED|Overall Study||11||
60035311|NCT02410811|76150940|FG003|STARTED|Overall Study||7||
60035312|NCT02410811|76150937|FG000|COMPLETED|Overall Study||5||
60035313|NCT02410811|76150938|FG001|COMPLETED|Overall Study||10||
60035314|NCT02410811|76150939|FG002|COMPLETED|Overall Study||10||
60035315|NCT02410811|76150940|FG003|COMPLETED|Overall Study||7||
60035316|NCT02410811|76150937|FG000|NOT COMPLETED|Overall Study||0||
60035317|NCT02410811|76150938|FG001|NOT COMPLETED|Overall Study||0||
60035318|NCT02410811|76150939|FG002|NOT COMPLETED|Overall Study||1||
60035319|NCT02410811|76150940|FG003|NOT COMPLETED|Overall Study||0||
60035320|NCT02435381|76150950|FG000|STARTED|Overall Study||5||
60035321|NCT02435381|76150951|FG001|STARTED|Overall Study||6||
60035322|NCT02435381|76150950|FG000|COMPLETED|Overall Study||3||
60035323|NCT02435381|76150951|FG001|COMPLETED|Overall Study||5||
60035324|NCT02435381|76150950|FG000|NOT COMPLETED|Overall Study||2||
60035325|NCT02435381|76150951|FG001|NOT COMPLETED|Overall Study||1||
60035326|NCT01837966|76150967|FG000|STARTED|Overall Study||47||
60035327|NCT01837966|76150968|FG001|STARTED|Overall Study||46||
60035328|NCT01837966|76150967|FG000|COMPLETED|Overall Study||45||
60035329|NCT01837966|76150968|FG001|COMPLETED|Overall Study||45||
60035330|NCT01837966|76150967|FG000|NOT COMPLETED|Overall Study||2||
60035331|NCT01837966|76150968|FG001|NOT COMPLETED|Overall Study||1||
60035332|NCT02435147|76150974|FG000|STARTED|Overall Study||86||
59508747|NCT02041221|75601808|FG000|STARTED|Part 2||6||
59508748|NCT02041221|75601809|FG001|STARTED|Part 2||6||
59508749|NCT02041221|75601810|FG002|STARTED|Part 2||6||
59508750|NCT02041221|75601811|FG003|STARTED|Part 2|Part 1 data fields are by default copied in Part 2. There is no dose 4 and 5 actually.|0||
59508751|NCT02041221|75601812|FG004|STARTED|Part 2|Part 1 data fields are by default copied in Part 2. There is no dose 4 and 5 actually|0||
59508752|NCT02041221|75601813|FG005|STARTED|Part 2||6||
59508753|NCT02041221|75601808|FG000|COMPLETED|Part 2||6||
59508754|NCT02041221|75601809|FG001|COMPLETED|Part 2||6||
59508755|NCT02041221|75601810|FG002|COMPLETED|Part 2||5||
59508756|NCT02041221|75601811|FG003|COMPLETED|Part 2|Part 1 data fields are by default copied in Part 2. There is no dose 4 and 5 actually|0||
59508757|NCT02041221|75601812|FG004|COMPLETED|Part 2|Part 1 data fields are by default copied in Part 2. There is no dose 4 and 5 actually|0||
59508758|NCT02041221|75601813|FG005|COMPLETED|Part 2||6||
59508759|NCT02041221|75601808|FG000|NOT COMPLETED|Part 2||0||
59508760|NCT02041221|75601809|FG001|NOT COMPLETED|Part 2||0||
60035333|NCT02435147|76150974|FG000|COMPLETED|Overall Study||75||
60035334|NCT02435147|76150974|FG000|NOT COMPLETED|Overall Study||11||
60035335|NCT02435069|76150978|FG000|STARTED|Preoperative Baseline Phase||5||
60035336|NCT02435069|76150979|FG001|STARTED|Preoperative Baseline Phase||0||
60035337|NCT02435069|76150980|FG002|STARTED|Preoperative Baseline Phase||0||
60035338|NCT02435069|76150981|FG003|STARTED|Preoperative Baseline Phase||0||
60035339|NCT02435069|76150982|FG004|STARTED|Preoperative Baseline Phase||0||
60035340|NCT02435069|76150978|FG000|COMPLETED|Preoperative Baseline Phase||5||
60035341|NCT02435069|76150979|FG001|COMPLETED|Preoperative Baseline Phase||0||
60035342|NCT02435069|76150980|FG002|COMPLETED|Preoperative Baseline Phase||0||
60035343|NCT02435069|76150981|FG003|COMPLETED|Preoperative Baseline Phase||0||
60035344|NCT02435069|76150982|FG004|COMPLETED|Preoperative Baseline Phase||0||
60035345|NCT02435069|76150978|FG000|NOT COMPLETED|Preoperative Baseline Phase||0||
60035346|NCT02435069|76150979|FG001|NOT COMPLETED|Preoperative Baseline Phase||0||
60035347|NCT02435069|76150980|FG002|NOT COMPLETED|Preoperative Baseline Phase||0||
60035348|NCT02435069|76150981|FG003|NOT COMPLETED|Preoperative Baseline Phase||0||
60035349|NCT02435069|76150982|FG004|NOT COMPLETED|Preoperative Baseline Phase||0||
60035350|NCT02435069|76150978|FG000|STARTED|Dose Response - First Intervention||0||
60035351|NCT02435069|76150979|FG001|STARTED|Dose Response - First Intervention||3||
60035352|NCT02435069|76150980|FG002|STARTED|Dose Response - First Intervention||2||
60035353|NCT02435069|76150981|FG003|STARTED|Dose Response - First Intervention||0||
60035354|NCT02435069|76150982|FG004|STARTED|Dose Response - First Intervention||0||
60035355|NCT02435069|76150978|FG000|COMPLETED|Dose Response - First Intervention||0||
60035356|NCT02435069|76150979|FG001|COMPLETED|Dose Response - First Intervention||2||
60035357|NCT02435069|76150980|FG002|COMPLETED|Dose Response - First Intervention||1||
60035358|NCT02435069|76150981|FG003|COMPLETED|Dose Response - First Intervention||0||
60035359|NCT02435069|76150982|FG004|COMPLETED|Dose Response - First Intervention||0||
60035360|NCT02435069|76150978|FG000|NOT COMPLETED|Dose Response - First Intervention||0||
60035361|NCT02435069|76150979|FG001|NOT COMPLETED|Dose Response - First Intervention||1||
60035362|NCT02435069|76150980|FG002|NOT COMPLETED|Dose Response - First Intervention||1||
60035363|NCT02435069|76150981|FG003|NOT COMPLETED|Dose Response - First Intervention||0||
59508761|NCT02041221|75601810|FG002|NOT COMPLETED|Part 2||1||
59508762|NCT02041221|75601811|FG003|NOT COMPLETED|Part 2||0||
59508763|NCT02041221|75601812|FG004|NOT COMPLETED|Part 2||0||
59508764|NCT02041221|75601813|FG005|NOT COMPLETED|Part 2||0||
59508765|NCT02041377|75601827|FG000|STARTED|Overall Study||134||
59508766|NCT02041377|75601827|FG000|COMPLETED|Overall Study||134||
59508767|NCT02041377|75601827|FG000|NOT COMPLETED|Overall Study||0||
59508768|NCT00787943|75601831|FG000|STARTED|Overall Study||10||
60035364|NCT02435069|76150982|FG004|NOT COMPLETED|Dose Response - First Intervention||0||
60035365|NCT02435069|76150978|FG000|STARTED|Effectiveness - Second Intervention||0||
60035366|NCT02435069|76150979|FG001|STARTED|Effectiveness - Second Intervention||0||
60035367|NCT02435069|76150980|FG002|STARTED|Effectiveness - Second Intervention||0||
60035368|NCT02435069|76150981|FG003|STARTED|Effectiveness - Second Intervention||1||
60035369|NCT02435069|76150982|FG004|STARTED|Effectiveness - Second Intervention||1||
59917633|NCT02688088|76038182|FG002|NOT COMPLETED|Abemaciclib Days 1 to 28 - Period 4||0||
60035370|NCT02435069|76150978|FG000|COMPLETED|Effectiveness - Second Intervention||0||
60035371|NCT02435069|76150979|FG001|COMPLETED|Effectiveness - Second Intervention||0||
60035372|NCT02435069|76150980|FG002|COMPLETED|Effectiveness - Second Intervention||0||
60035373|NCT02435069|76150981|FG003|COMPLETED|Effectiveness - Second Intervention||1||
60035374|NCT02435069|76150982|FG004|COMPLETED|Effectiveness - Second Intervention||0||
60035375|NCT02435069|76150978|FG000|NOT COMPLETED|Effectiveness - Second Intervention||0||
60035376|NCT02435069|76150979|FG001|NOT COMPLETED|Effectiveness - Second Intervention||0||
60035377|NCT02435069|76150980|FG002|NOT COMPLETED|Effectiveness - Second Intervention||0||
60035378|NCT02435069|76150981|FG003|NOT COMPLETED|Effectiveness - Second Intervention||0||
60035379|NCT02435069|76150982|FG004|NOT COMPLETED|Effectiveness - Second Intervention||1||
60035380|NCT02454101|76151004|FG000|STARTED|Overall Study||150||
60035381|NCT02454101|76151005|FG001|STARTED|Overall Study||150||
60035382|NCT02454101|76151004|FG000|COMPLETED|Overall Study||145||
60035383|NCT02454101|76151005|FG001|COMPLETED|Overall Study||143||
60035384|NCT02454101|76151004|FG000|NOT COMPLETED|Overall Study||5||
60035385|NCT02454101|76151005|FG001|NOT COMPLETED|Overall Study||7||
60035386|NCT02409719|76151013|FG000|STARTED|Overall Study||31|Each milestone corresponds to the time of evaluation.|
60035387|NCT02409719|76151014|FG001|STARTED|Overall Study||45|Each milestone corresponds to the time of evaluation.|
60035388|NCT02409719|76151013|FG000|2 Weeks|Overall Study||28||
60035389|NCT02409719|76151014|FG001|2 Weeks|Overall Study||42||
60035390|NCT02409719|76151013|FG000|4 Weeks|Overall Study||28||
60035391|NCT02409719|76151014|FG001|4 Weeks|Overall Study||42||
60035392|NCT02409719|76151013|FG000|6 Weeks|Overall Study||28||
60035393|NCT02409719|76151014|FG001|6 Weeks|Overall Study||42||
60035394|NCT02409719|76151013|FG000|3 Months|Overall Study||28||
60035395|NCT02409719|76151014|FG001|3 Months|Overall Study||42||
60035396|NCT02409719|76151013|FG000|6 Months|Overall Study||28||
60035397|NCT02409719|76151014|FG001|6 Months|Overall Study||42||
60035398|NCT02409719|76151013|FG000|12 Months|Overall Study||28||
60035399|NCT02409719|76151014|FG001|12 Months|Overall Study||42||
60035400|NCT02409719|76151013|FG000|COMPLETED|Overall Study||28||
60035401|NCT02409719|76151014|FG001|COMPLETED|Overall Study||42||
60035402|NCT02409719|76151013|FG000|NOT COMPLETED|Overall Study||3||
60035403|NCT02409719|76151014|FG001|NOT COMPLETED|Overall Study||3||
60035404|NCT01820572|76151022|FG000|STARTED|Randomization||223|= Participants Randomized|
60035405|NCT01820572|76151023|FG001|STARTED|Randomization||223|= Participants Randomized|
60035406|NCT01820572|76151022|FG000|COMPLETED|Randomization||221|= Participants Treated|
60035407|NCT01820572|76151023|FG001|COMPLETED|Randomization||222|= Participants Treated|
60035408|NCT01820572|76151022|FG000|NOT COMPLETED|Randomization||2||
60035409|NCT01820572|76151023|FG001|NOT COMPLETED|Randomization||1||
60035410|NCT01820572|76151022|FG000|STARTED|Treatment Period||221|= participants treated|
60035411|NCT01820572|76151023|FG001|STARTED|Treatment Period||222|= participants treated|
60035412|NCT01820572|76151022|FG000|COMPLETED|Treatment Period||195|= participants completing treatment|
60035413|NCT01820572|76151023|FG001|COMPLETED|Treatment Period||186|= participants completing treatment|
60035414|NCT01820572|76151022|FG000|NOT COMPLETED|Treatment Period||26||
59917634|NCT02688088|76038183|FG003|NOT COMPLETED|Abemaciclib Days 1 to 28 - Period 4||8||
59917635|NCT02688088|76038184|FG004|NOT COMPLETED|Abemaciclib Days 1 to 28 - Period 4||0||
59917636|NCT02688088|76038180|FG000|STARTED|Abemaciclib Safety Extension Period||0||
59917637|NCT02688088|76038181|FG001|STARTED|Abemaciclib Safety Extension Period||0||
59917638|NCT02688088|76038182|FG002|STARTED|Abemaciclib Safety Extension Period||0||
59917639|NCT02688088|76038183|FG003|STARTED|Abemaciclib Safety Extension Period|Participants completed Period 4.|0||
59917640|NCT02688088|76038184|FG004|STARTED|Abemaciclib Safety Extension Period|Participants had option of continuing Abemaciclib in Safety Extension Period.|18||
59917641|NCT02688088|76038180|FG000|Received at Least One Dose of Study Drug|Abemaciclib Safety Extension Period||0||
59917642|NCT02688088|76038181|FG001|Received at Least One Dose of Study Drug|Abemaciclib Safety Extension Period||0||
59951403|NCT01880723|76070379|FG000|NOT COMPLETED|Overall Study||0||
60035415|NCT01820572|76151023|FG001|NOT COMPLETED|Treatment Period||36||
60035416|NCT01820260|76151043|FG000|STARTED|Phase 1 (Part 1)||3||
60035417|NCT01820260|76151044|FG001|STARTED|Phase 1 (Part 1)||12||
60035418|NCT01820260|76151045|FG002|STARTED|Phase 1 (Part 1)||10||
60035419|NCT01820260|76151046|FG003|STARTED|Phase 1 (Part 1)||12||
60035420|NCT01820260|76151047|FG004|STARTED|Phase 1 (Part 1)||12||
60035421|NCT01820260|76151048|FG005|STARTED|Phase 1 (Part 1)||10||
60035422|NCT01820260|76151049|FG006|STARTED|Phase 1 (Part 1)||12||
60035423|NCT01820260|76151050|FG007|STARTED|Phase 1 (Part 1)||11||
60035424|NCT01820260|76151051|FG008|STARTED|Phase 1 (Part 1)||0||
60035425|NCT01820260|76151052|FG009|STARTED|Phase 1 (Part 1)||0||
60035426|NCT01820260|76151053|FG010|STARTED|Phase 1 (Part 1)||0||
60035427|NCT01820260|76151054|FG011|STARTED|Phase 1 (Part 1)||0||
60035428|NCT01820260|76151055|FG012|STARTED|Phase 1 (Part 1)||0||
60035429|NCT01820260|76151056|FG013|STARTED|Phase 1 (Part 1)||0||
60035430|NCT01820260|76151043|FG000|COMPLETED|Phase 1 (Part 1)||3||
60035431|NCT01820260|76151044|FG001|COMPLETED|Phase 1 (Part 1)||12||
60035432|NCT01820260|76151045|FG002|COMPLETED|Phase 1 (Part 1)||10||
60035433|NCT01820260|76151046|FG003|COMPLETED|Phase 1 (Part 1)||12||
60035434|NCT01820260|76151047|FG004|COMPLETED|Phase 1 (Part 1)||12||
60035435|NCT01820260|76151048|FG005|COMPLETED|Phase 1 (Part 1)||10||
60035436|NCT01820260|76151049|FG006|COMPLETED|Phase 1 (Part 1)||11||
60035437|NCT01820260|76151050|FG007|COMPLETED|Phase 1 (Part 1)||11||
60035438|NCT01820260|76151051|FG008|COMPLETED|Phase 1 (Part 1)||0||
60035439|NCT01820260|76151052|FG009|COMPLETED|Phase 1 (Part 1)||0||
60035440|NCT01820260|76151053|FG010|COMPLETED|Phase 1 (Part 1)||0||
60035441|NCT01820260|76151054|FG011|COMPLETED|Phase 1 (Part 1)||0||
60035442|NCT01820260|76151055|FG012|COMPLETED|Phase 1 (Part 1)||0||
60035443|NCT01820260|76151056|FG013|COMPLETED|Phase 1 (Part 1)||0||
60035444|NCT01820260|76151043|FG000|NOT COMPLETED|Phase 1 (Part 1)||0||
60035445|NCT01820260|76151044|FG001|NOT COMPLETED|Phase 1 (Part 1)||0||
60035446|NCT01820260|76151045|FG002|NOT COMPLETED|Phase 1 (Part 1)||0||
60035447|NCT01820260|76151046|FG003|NOT COMPLETED|Phase 1 (Part 1)||0||
60035448|NCT01820260|76151047|FG004|NOT COMPLETED|Phase 1 (Part 1)||0||
60035449|NCT01820260|76151048|FG005|NOT COMPLETED|Phase 1 (Part 1)||0||
60035450|NCT01820260|76151049|FG006|NOT COMPLETED|Phase 1 (Part 1)||1||
60035451|NCT01820260|76151050|FG007|NOT COMPLETED|Phase 1 (Part 1)||0||
60035452|NCT01820260|76151051|FG008|NOT COMPLETED|Phase 1 (Part 1)||0||
60035453|NCT01820260|76151052|FG009|NOT COMPLETED|Phase 1 (Part 1)||0||
60035454|NCT01820260|76151053|FG010|NOT COMPLETED|Phase 1 (Part 1)||0||
60035455|NCT01820260|76151054|FG011|NOT COMPLETED|Phase 1 (Part 1)||0||
60035456|NCT01820260|76151055|FG012|NOT COMPLETED|Phase 1 (Part 1)||0||
60035457|NCT01820260|76151056|FG013|NOT COMPLETED|Phase 1 (Part 1)||0||
60035458|NCT01820260|76151043|FG000|STARTED|Phase 2 (Part 2)||0||
60035459|NCT01820260|76151044|FG001|STARTED|Phase 2 (Part 2)||0||
60035460|NCT01820260|76151045|FG002|STARTED|Phase 2 (Part 2)||0||
60035461|NCT01820260|76151046|FG003|STARTED|Phase 2 (Part 2)||0||
60035462|NCT01820260|76151047|FG004|STARTED|Phase 2 (Part 2)||0||
60035463|NCT01820260|76151048|FG005|STARTED|Phase 2 (Part 2)||0||
60035464|NCT01820260|76151049|FG006|STARTED|Phase 2 (Part 2)||0||
60035465|NCT01820260|76151050|FG007|STARTED|Phase 2 (Part 2)||0||
60035466|NCT01820260|76151051|FG008|STARTED|Phase 2 (Part 2)||64||
60035467|NCT01820260|76151052|FG009|STARTED|Phase 2 (Part 2)||62||
60035468|NCT01820260|76151053|FG010|STARTED|Phase 2 (Part 2)||61||
60035469|NCT01820260|76151054|FG011|STARTED|Phase 2 (Part 2)||64||
60035470|NCT01820260|76151055|FG012|STARTED|Phase 2 (Part 2)||31||
60035471|NCT01820260|76151056|FG013|STARTED|Phase 2 (Part 2)||31||
60035472|NCT01820260|76151043|FG000|COMPLETED|Phase 2 (Part 2)||0||
60035473|NCT01820260|76151044|FG001|COMPLETED|Phase 2 (Part 2)||0||
60035474|NCT01820260|76151045|FG002|COMPLETED|Phase 2 (Part 2)||0||
60035475|NCT01820260|76151046|FG003|COMPLETED|Phase 2 (Part 2)||0||
60035476|NCT01820260|76151047|FG004|COMPLETED|Phase 2 (Part 2)||0||
60035477|NCT01820260|76151048|FG005|COMPLETED|Phase 2 (Part 2)||0||
60035478|NCT01820260|76151049|FG006|COMPLETED|Phase 2 (Part 2)||0||
60035479|NCT01820260|76151050|FG007|COMPLETED|Phase 2 (Part 2)||0||
60035480|NCT01820260|76151051|FG008|COMPLETED|Phase 2 (Part 2)||64||
60035481|NCT01820260|76151052|FG009|COMPLETED|Phase 2 (Part 2)||61||
60035482|NCT01820260|76151053|FG010|COMPLETED|Phase 2 (Part 2)||61||
60035483|NCT01820260|76151054|FG011|COMPLETED|Phase 2 (Part 2)||64||
60035484|NCT01820260|76151055|FG012|COMPLETED|Phase 2 (Part 2)||31||
60035485|NCT01820260|76151056|FG013|COMPLETED|Phase 2 (Part 2)||31||
60035486|NCT01820260|76151043|FG000|NOT COMPLETED|Phase 2 (Part 2)||0||
60035487|NCT01820260|76151044|FG001|NOT COMPLETED|Phase 2 (Part 2)||0||
60035488|NCT01820260|76151045|FG002|NOT COMPLETED|Phase 2 (Part 2)||0||
60035489|NCT01820260|76151046|FG003|NOT COMPLETED|Phase 2 (Part 2)||0||
60035490|NCT01820260|76151047|FG004|NOT COMPLETED|Phase 2 (Part 2)||0||
60035491|NCT01820260|76151048|FG005|NOT COMPLETED|Phase 2 (Part 2)||0||
60035492|NCT01820260|76151049|FG006|NOT COMPLETED|Phase 2 (Part 2)||0||
60035493|NCT01820260|76151050|FG007|NOT COMPLETED|Phase 2 (Part 2)||0||
60035494|NCT01820260|76151051|FG008|NOT COMPLETED|Phase 2 (Part 2)||0||
60035495|NCT01820260|76151052|FG009|NOT COMPLETED|Phase 2 (Part 2)||1||
60035496|NCT01820260|76151053|FG010|NOT COMPLETED|Phase 2 (Part 2)||0||
60035497|NCT01820260|76151054|FG011|NOT COMPLETED|Phase 2 (Part 2)||0||
60035498|NCT01820260|76151055|FG012|NOT COMPLETED|Phase 2 (Part 2)||0||
60035499|NCT01820260|76151056|FG013|NOT COMPLETED|Phase 2 (Part 2)||0||
60035500|NCT01610596|76151094|FG000|STARTED|Overall Study||36||
60035501|NCT01610596|76151095|FG001|STARTED|Overall Study||36||
60035502|NCT01610596|76151094|FG000|COMPLETED|Overall Study||36||
60035503|NCT01610596|76151095|FG001|COMPLETED|Overall Study||35||
59508769|NCT00787943|75601831|FG000|COMPLETED|Overall Study||10||
59508770|NCT00787943|75601831|FG000|NOT COMPLETED|Overall Study||0||
59508771|NCT00771173|75601841|FG000|STARTED|Overall Study||129||
60035504|NCT01610596|76151094|FG000|NOT COMPLETED|Overall Study||0||
60035505|NCT01610596|76151095|FG001|NOT COMPLETED|Overall Study||1||
60035506|NCT01818700|76151101|FG000|STARTED|Overall Study|The No. of enrolled patients|245||
60035507|NCT01818700|76151101|FG000|Safety Set|Overall Study|4 subjects were not study drug administered.|241||
60035508|NCT01818700|76151101|FG000|FAS Set|Overall Study|31 subjects excluded from FAS due to no assessment of primary efficacy(26) and IC/EC violation(5).|210||
60035509|NCT01818700|76151101|FG000|PP Set|Overall Study|105 subjects excluded from PP set due to various reasons.|105||
59508772|NCT00771173|75601842|FG001|STARTED|Overall Study||129||
59508773|NCT00771173|75601841|FG000|COMPLETED|Overall Study||107||
59508774|NCT00771173|75601842|FG001|COMPLETED|Overall Study||112||
59508775|NCT00771173|75601841|FG000|NOT COMPLETED|Overall Study||22||
59508776|NCT00771173|75601842|FG001|NOT COMPLETED|Overall Study||17||
59508777|NCT02377947|75601848|FG000|STARTED|Overall Study||50||
59508778|NCT02377947|75601848|FG000|COMPLETED|Overall Study||50||
59508779|NCT02377947|75601848|FG000|NOT COMPLETED|Overall Study||0||
59508780|NCT02044419|75601855|FG000|STARTED|First Intervention||11||
59508781|NCT02044419|75601856|FG001|STARTED|First Intervention||10||
59508782|NCT02044419|75601857|FG002|STARTED|First Intervention||11||
60035510|NCT01818700|76151101|FG000|COMPLETED|Overall Study|104 subjects dropped out this study prior to study completion.|141||
60035511|NCT01818700|76151101|FG000|NOT COMPLETED|Overall Study||104||
60035512|NCT01817764|76151109|FG000|STARTED|Overall Study||353||
60035513|NCT01817764|76151110|FG001|STARTED|Overall Study||353||
60035514|NCT01817764|76151109|FG000|COMPLETED|Overall Study||319||
60035515|NCT01817764|76151110|FG001|COMPLETED|Overall Study||315||
60035516|NCT01817764|76151109|FG000|NOT COMPLETED|Overall Study||34||
60035517|NCT01817764|76151110|FG001|NOT COMPLETED|Overall Study||38||
60035518|NCT01803880|76151119|FG000|STARTED|Overall Study||19||
60035519|NCT01803880|76151120|FG001|STARTED|Overall Study||28||
60035520|NCT01803880|76151121|FG002|STARTED|Overall Study||29||
60035521|NCT01803880|76151119|FG000|COMPLETED|Overall Study||13||
60035522|NCT01803880|76151120|FG001|COMPLETED|Overall Study||18||
60035523|NCT01803880|76151121|FG002|COMPLETED|Overall Study||14||
60035524|NCT01803880|76151119|FG000|NOT COMPLETED|Overall Study||6||
60035525|NCT01803880|76151120|FG001|NOT COMPLETED|Overall Study||10||
60035526|NCT01803880|76151121|FG002|NOT COMPLETED|Overall Study||15||
60035527|NCT01803646|76151133|FG000|STARTED|Overall Study||204||
60035528|NCT01803646|76151134|FG001|STARTED|Overall Study||139||
60035529|NCT01803646|76151133|FG000|COMPLETED|Overall Study||187||
60035530|NCT01803646|76151134|FG001|COMPLETED|Overall Study||129||
60035531|NCT01803646|76151133|FG000|NOT COMPLETED|Overall Study||17||
60035532|NCT01803646|76151134|FG001|NOT COMPLETED|Overall Study||10||
60035533|NCT01817530|76151148|FG000|STARTED|Overall Study||65|randomized and treated|
59508783|NCT02044419|75601855|FG000|COMPLETED|First Intervention||11||
59508784|NCT02044419|75601856|FG001|COMPLETED|First Intervention||9||
59508785|NCT02044419|75601857|FG002|COMPLETED|First Intervention||10||
59508786|NCT02044419|75601855|FG000|NOT COMPLETED|First Intervention||0||
60035534|NCT01817530|76151149|FG001|STARTED|Overall Study||65|randomized and treated|
60035535|NCT01817530|76151150|FG002|STARTED|Overall Study||64|randomized and treated|
60035536|NCT01817530|76151151|FG003|STARTED|Overall Study||65|randomized and treated|
59508787|NCT02044419|75601856|FG001|NOT COMPLETED|First Intervention||1||
59508788|NCT02044419|75601857|FG002|NOT COMPLETED|First Intervention||1||
59508789|NCT02044419|75601855|FG000|STARTED|Second Intervention||11||
59508790|NCT02044419|75601856|FG001|STARTED|Second Intervention||9||
59508791|NCT02044419|75601857|FG002|STARTED|Second Intervention||10||
59508792|NCT02044419|75601855|FG000|COMPLETED|Second Intervention||11||
60035537|NCT01817530|76151152|FG004|STARTED|Overall Study||78|randomized and treated|
60035538|NCT01817530|76151153|FG005|STARTED|Overall Study||77|randomized and treated|
60035539|NCT01817530|76151154|FG006|STARTED|Overall Study||76|randomized and treated|
60035540|NCT01817530|76151155|FG007|STARTED|Overall Study||77|randomized and treated|
60035541|NCT01817530|76151148|FG000|COMPLETED|Overall Study||50||
60035542|NCT01817530|76151149|FG001|COMPLETED|Overall Study||52||
60035543|NCT01817530|76151150|FG002|COMPLETED|Overall Study||53||
60035544|NCT01817530|76151151|FG003|COMPLETED|Overall Study||52||
59508793|NCT02044419|75601856|FG001|COMPLETED|Second Intervention||9||
59508794|NCT02044419|75601857|FG002|COMPLETED|Second Intervention||10||
59508795|NCT02044419|75601855|FG000|NOT COMPLETED|Second Intervention||0||
59508796|NCT02044419|75601856|FG001|NOT COMPLETED|Second Intervention||0||
59508797|NCT02044419|75601857|FG002|NOT COMPLETED|Second Intervention||0||
59508798|NCT02044419|75601855|FG000|STARTED|Third Intervention||11||
59508799|NCT02044419|75601856|FG001|STARTED|Third Intervention||9||
59508800|NCT02044419|75601857|FG002|STARTED|Third Intervention||10||
59508801|NCT02044419|75601855|FG000|COMPLETED|Third Intervention||11||
59508802|NCT02044419|75601856|FG001|COMPLETED|Third Intervention||9||
59508803|NCT02044419|75601857|FG002|COMPLETED|Third Intervention||10||
59917643|NCT02688088|76038182|FG002|Received at Least One Dose of Study Drug|Abemaciclib Safety Extension Period||0||
59917644|NCT02688088|76038183|FG003|Received at Least One Dose of Study Drug|Abemaciclib Safety Extension Period||0||
59917645|NCT02688088|76038184|FG004|Received at Least One Dose of Study Drug|Abemaciclib Safety Extension Period||18||
59917646|NCT02688088|76038180|FG000|COMPLETED|Abemaciclib Safety Extension Period||0||
59917647|NCT02688088|76038181|FG001|COMPLETED|Abemaciclib Safety Extension Period||0||
59917648|NCT02688088|76038182|FG002|COMPLETED|Abemaciclib Safety Extension Period||0||
59917649|NCT02688088|76038183|FG003|COMPLETED|Abemaciclib Safety Extension Period||0||
59917650|NCT02688088|76038184|FG004|COMPLETED|Abemaciclib Safety Extension Period||0||
59917651|NCT02688088|76038180|FG000|NOT COMPLETED|Abemaciclib Safety Extension Period||0||
59917652|NCT02688088|76038181|FG001|NOT COMPLETED|Abemaciclib Safety Extension Period||0||
59917653|NCT02688088|76038182|FG002|NOT COMPLETED|Abemaciclib Safety Extension Period||0||
59917654|NCT02688088|76038183|FG003|NOT COMPLETED|Abemaciclib Safety Extension Period||0||
59917655|NCT02688088|76038184|FG004|NOT COMPLETED|Abemaciclib Safety Extension Period||18||
59917656|NCT03641651|76038209|FG000|STARTED|Overall Study||15||
59917657|NCT03641651|76038209|FG000|COMPLETED|Overall Study||14||
59917658|NCT03641651|76038209|FG000|NOT COMPLETED|Overall Study||1||
59917659|NCT03341299|76038213|FG000|STARTED|Period 1||9||
59917660|NCT03341299|76038214|FG001|STARTED|Period 1||9||
59917661|NCT03341299|76038215|FG002|STARTED|Period 1||9||
59917662|NCT03341299|76038216|FG003|STARTED|Period 1||9||
59917663|NCT03341299|76038213|FG000|COMPLETED|Period 1||9||
59917664|NCT03341299|76038214|FG001|COMPLETED|Period 1||9||
59917665|NCT03341299|76038215|FG002|COMPLETED|Period 1||9||
59917666|NCT03341299|76038216|FG003|COMPLETED|Period 1||9||
59917667|NCT03341299|76038213|FG000|NOT COMPLETED|Period 1||0||
59917668|NCT03341299|76038214|FG001|NOT COMPLETED|Period 1||0||
59917669|NCT03341299|76038215|FG002|NOT COMPLETED|Period 1||0||
59917670|NCT03341299|76038216|FG003|NOT COMPLETED|Period 1||0||
59917671|NCT03341299|76038213|FG000|STARTED|Washout (A Minimum of 21 Hours)||9||
59917672|NCT03341299|76038214|FG001|STARTED|Washout (A Minimum of 21 Hours)||9||
59917673|NCT03341299|76038215|FG002|STARTED|Washout (A Minimum of 21 Hours)||9||
59917674|NCT03341299|76038216|FG003|STARTED|Washout (A Minimum of 21 Hours)||9||
59917675|NCT03341299|76038213|FG000|COMPLETED|Washout (A Minimum of 21 Hours)||9||
59917676|NCT03341299|76038214|FG001|COMPLETED|Washout (A Minimum of 21 Hours)||9||
59917677|NCT03341299|76038215|FG002|COMPLETED|Washout (A Minimum of 21 Hours)||8||
59917678|NCT03341299|76038216|FG003|COMPLETED|Washout (A Minimum of 21 Hours)||9||
59917679|NCT03341299|76038213|FG000|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0||
59917680|NCT03341299|76038214|FG001|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0||
59917681|NCT03341299|76038215|FG002|NOT COMPLETED|Washout (A Minimum of 21 Hours)||1||
59917682|NCT03341299|76038216|FG003|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0||
59917683|NCT03341299|76038213|FG000|STARTED|Period 2||9||
59917684|NCT03341299|76038214|FG001|STARTED|Period 2||9||
59917685|NCT03341299|76038215|FG002|STARTED|Period 2||8||
59917686|NCT03341299|76038216|FG003|STARTED|Period 2||9||
59917687|NCT03341299|76038213|FG000|COMPLETED|Period 2||9||
59917688|NCT03341299|76038214|FG001|COMPLETED|Period 2||9||
59917689|NCT03341299|76038215|FG002|COMPLETED|Period 2||8||
59917690|NCT03341299|76038216|FG003|COMPLETED|Period 2||9||
59917691|NCT03341299|76038213|FG000|NOT COMPLETED|Period 2||0||
59917692|NCT03341299|76038214|FG001|NOT COMPLETED|Period 2||0||
59917693|NCT03341299|76038215|FG002|NOT COMPLETED|Period 2||0||
59917694|NCT03341299|76038216|FG003|NOT COMPLETED|Period 2||0||
59917695|NCT03341299|76038213|FG000|STARTED|Washout (A Minimum of 21 Hours)||9||
59508804|NCT02044419|75601855|FG000|NOT COMPLETED|Third Intervention||0||
59917696|NCT03341299|76038214|FG001|STARTED|Washout (A Minimum of 21 Hours)||9||
59917697|NCT03341299|76038215|FG002|STARTED|Washout (A Minimum of 21 Hours)||8||
59917698|NCT03341299|76038216|FG003|STARTED|Washout (A Minimum of 21 Hours)||9||
60035545|NCT01817530|76151152|FG004|COMPLETED|Overall Study||67||
60035546|NCT01817530|76151153|FG005|COMPLETED|Overall Study||58||
59508805|NCT02044419|75601856|FG001|NOT COMPLETED|Third Intervention||0||
59612270|NCT01723254|75723431|FG003|COMPLETED|Overall Study||18||
59917699|NCT03341299|76038213|FG000|COMPLETED|Washout (A Minimum of 21 Hours)||9||
59917700|NCT03341299|76038214|FG001|COMPLETED|Washout (A Minimum of 21 Hours)||9||
59917701|NCT03341299|76038215|FG002|COMPLETED|Washout (A Minimum of 21 Hours)||8||
59917702|NCT03341299|76038216|FG003|COMPLETED|Washout (A Minimum of 21 Hours)||9||
59917703|NCT03341299|76038213|FG000|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0||
59917704|NCT03341299|76038214|FG001|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0||
60035547|NCT01817530|76151154|FG006|COMPLETED|Overall Study||53||
60035548|NCT01817530|76151155|FG007|COMPLETED|Overall Study||53||
60035549|NCT01817530|76151148|FG000|NOT COMPLETED|Overall Study||15||
60035550|NCT01817530|76151149|FG001|NOT COMPLETED|Overall Study||13||
60035551|NCT01817530|76151150|FG002|NOT COMPLETED|Overall Study||11||
60035552|NCT01817530|76151151|FG003|NOT COMPLETED|Overall Study||13||
60035553|NCT01817530|76151152|FG004|NOT COMPLETED|Overall Study||11||
60035554|NCT01817530|76151153|FG005|NOT COMPLETED|Overall Study||19||
60035555|NCT01817530|76151154|FG006|NOT COMPLETED|Overall Study||23||
60035556|NCT01817530|76151155|FG007|NOT COMPLETED|Overall Study||24||
60035557|NCT01816984|76151173|FG000|STARTED|Overall Study||12||
60035558|NCT01816984|76151173|FG000|COMPLETED|Overall Study||11||
60035559|NCT01816984|76151173|FG000|NOT COMPLETED|Overall Study||1||
60035560|NCT01816906|76151179|FG000|STARTED|Six Months||41||
60035561|NCT01816906|76151180|FG001|STARTED|Six Months||41||
60035562|NCT01816906|76151179|FG000|COMPLETED|Six Months||20||
60035563|NCT01816906|76151180|FG001|COMPLETED|Six Months||19||
60035564|NCT01816906|76151179|FG000|NOT COMPLETED|Six Months||21||
60035565|NCT01816906|76151180|FG001|NOT COMPLETED|Six Months||22||
60035566|NCT01816906|76151179|FG000|STARTED|12 Months||20||
60035567|NCT01816906|76151180|FG001|STARTED|12 Months||19||
60035568|NCT01816906|76151179|FG000|COMPLETED|12 Months||16||
60035569|NCT01816906|76151180|FG001|COMPLETED|12 Months||14||
60035570|NCT01816906|76151179|FG000|NOT COMPLETED|12 Months||4||
60035571|NCT01816906|76151180|FG001|NOT COMPLETED|12 Months||5||
60035572|NCT01816594|76151189|FG000|STARTED|Overall Study||25||
60035573|NCT01816594|76151190|FG001|STARTED|Overall Study||25||
60035574|NCT01816594|76151189|FG000|Randomized to the wt Cohort|Overall Study|wt = PIK3CA wild-type|21||
60035575|NCT01816594|76151190|FG001|Randomized to the wt Cohort|Overall Study|wt = PIK3CA wild-type|21||
60035576|NCT01816594|76151189|FG000|Randomized to the mt Cohort|Overall Study|mt = PIK3CA mutant|4||
60035577|NCT01816594|76151190|FG001|Randomized to the mt Cohort|Overall Study|mt = PIK3CA mutant|4||
60035578|NCT01816594|76151189|FG000|COMPLETED|Overall Study||14||
60035579|NCT01816594|76151190|FG001|COMPLETED|Overall Study||23||
60035580|NCT01816594|76151189|FG000|NOT COMPLETED|Overall Study||11||
60035581|NCT01816594|76151190|FG001|NOT COMPLETED|Overall Study||2||
60035582|NCT01802320|76151202|FG000|STARTED|Overall Study||18||
60035583|NCT01802320|76151202|FG000|COMPLETED|Overall Study||16||
60035584|NCT01802320|76151202|FG000|NOT COMPLETED|Overall Study||2||
60035585|NCT02453711|76151215|FG000|STARTED|Overall Study||103||
60035586|NCT02453711|76151216|FG001|STARTED|Overall Study||102||
60035587|NCT02453711|76151217|FG002|STARTED|Overall Study||103||
59612271|NCT01723254|75723432|FG004|COMPLETED|Overall Study||18||
59612272|NCT01723254|75723433|FG005|COMPLETED|Overall Study||18||
59612273|NCT01723254|75723434|FG006|COMPLETED|Overall Study||19||
60035588|NCT02453711|76151218|FG003|STARTED|Overall Study||103||
60035589|NCT02453711|76151219|FG004|STARTED|Overall Study||102||
60035590|NCT02453711|76151220|FG005|STARTED|Overall Study||102||
59612274|NCT01723254|75723435|FG007|COMPLETED|Overall Study||60||
60035591|NCT02453711|76151221|FG006|STARTED|Overall Study||103||
60035592|NCT02453711|76151222|FG007|STARTED|Overall Study||103||
60035593|NCT02453711|76151223|FG008|STARTED|Overall Study||136||
60035594|NCT02453711|76151215|FG000|Full Analysis Set|Overall Study||103||
60035595|NCT02453711|76151216|FG001|Full Analysis Set|Overall Study||102||
60035596|NCT02453711|76151217|FG002|Full Analysis Set|Overall Study||103||
59612275|NCT01723254|75723428|FG000|NOT COMPLETED|Overall Study||1||
59612276|NCT01723254|75723429|FG001|NOT COMPLETED|Overall Study||3||
60035597|NCT02453711|76151218|FG003|Full Analysis Set|Overall Study||103||
60035598|NCT02453711|76151219|FG004|Full Analysis Set|Overall Study||102||
60035599|NCT02453711|76151220|FG005|Full Analysis Set|Overall Study||102||
60035600|NCT02453711|76151221|FG006|Full Analysis Set|Overall Study||103||
60035601|NCT02453711|76151222|FG007|Full Analysis Set|Overall Study||103||
60035602|NCT02453711|76151223|FG008|Full Analysis Set|Overall Study||136||
60035603|NCT02453711|76151215|FG000|Safety Analysis Set|Overall Study||103||
60035604|NCT02453711|76151216|FG001|Safety Analysis Set|Overall Study||102||
60035605|NCT02453711|76151217|FG002|Safety Analysis Set|Overall Study||103||
60035606|NCT02453711|76151218|FG003|Safety Analysis Set|Overall Study||103||
60035607|NCT02453711|76151219|FG004|Safety Analysis Set|Overall Study||102||
60035608|NCT02453711|76151220|FG005|Safety Analysis Set|Overall Study||102||
60035609|NCT02453711|76151221|FG006|Safety Analysis Set|Overall Study||103||
60035610|NCT02453711|76151222|FG007|Safety Analysis Set|Overall Study||103||
60035611|NCT02453711|76151223|FG008|Safety Analysis Set|Overall Study||136||
60035612|NCT02453711|76151215|FG000|COMPLETED|Overall Study||92||
60035613|NCT02453711|76151216|FG001|COMPLETED|Overall Study||95||
60035614|NCT02453711|76151217|FG002|COMPLETED|Overall Study||94||
60035615|NCT02453711|76151218|FG003|COMPLETED|Overall Study||96||
60035616|NCT02453711|76151219|FG004|COMPLETED|Overall Study||100||
60035617|NCT02453711|76151220|FG005|COMPLETED|Overall Study||96||
60035618|NCT02453711|76151221|FG006|COMPLETED|Overall Study||100||
60035619|NCT02453711|76151222|FG007|COMPLETED|Overall Study||96||
60035620|NCT02453711|76151223|FG008|COMPLETED|Overall Study||123||
60035621|NCT02453711|76151215|FG000|NOT COMPLETED|Overall Study||11||
60035622|NCT02453711|76151216|FG001|NOT COMPLETED|Overall Study||7||
60035623|NCT02453711|76151217|FG002|NOT COMPLETED|Overall Study||9||
60035624|NCT02453711|76151218|FG003|NOT COMPLETED|Overall Study||7||
60035625|NCT02453711|76151219|FG004|NOT COMPLETED|Overall Study||2||
60035626|NCT02453711|76151220|FG005|NOT COMPLETED|Overall Study||6||
60035627|NCT02453711|76151221|FG006|NOT COMPLETED|Overall Study||3||
60035628|NCT02453711|76151222|FG007|NOT COMPLETED|Overall Study||7||
60035629|NCT02453711|76151223|FG008|NOT COMPLETED|Overall Study||13||
60035630|NCT02453555|76151245|FG000|STARTED|24-week Double-blind Treatment Period|Started are treated subjects.|182||
60035631|NCT02453555|76151246|FG001|STARTED|24-week Double-blind Treatment Period|Started are treated subjects.|93||
60035632|NCT02453555|76151247|FG002|STARTED|24-week Double-blind Treatment Period|This reporting group is not applicable in this period.|0||
60035633|NCT02453555|76151248|FG003|STARTED|24-week Double-blind Treatment Period|This reporting group is not applicable in this period.|0||
60035634|NCT02453555|76151249|FG004|STARTED|24-week Double-blind Treatment Period|This reporting group is not applicable in this period.|0||
60035635|NCT02453555|76151250|FG005|STARTED|24-week Double-blind Treatment Period|This reporting group is not applicable in this period.|0||
60035636|NCT02453555|76151245|FG000|COMPLETED|24-week Double-blind Treatment Period||177||
60035637|NCT02453555|76151246|FG001|COMPLETED|24-week Double-blind Treatment Period||86||
60035638|NCT02453555|76151247|FG002|COMPLETED|24-week Double-blind Treatment Period||0||
60035639|NCT02453555|76151248|FG003|COMPLETED|24-week Double-blind Treatment Period||0||
60035640|NCT02453555|76151249|FG004|COMPLETED|24-week Double-blind Treatment Period||0||
60035641|NCT02453555|76151250|FG005|COMPLETED|24-week Double-blind Treatment Period||0||
60035642|NCT02453555|76151245|FG000|NOT COMPLETED|24-week Double-blind Treatment Period||5||
60035643|NCT02453555|76151246|FG001|NOT COMPLETED|24-week Double-blind Treatment Period||7||
60035644|NCT02453555|76151247|FG002|NOT COMPLETED|24-week Double-blind Treatment Period||0||
60035645|NCT02453555|76151248|FG003|NOT COMPLETED|24-week Double-blind Treatment Period||0||
60035646|NCT02453555|76151249|FG004|NOT COMPLETED|24-week Double-blind Treatment Period||0||
60035647|NCT02453555|76151250|FG005|NOT COMPLETED|24-week Double-blind Treatment Period||0||
59759422|NCT02084160|75878824|FG000|COMPLETED|Overall Study||579|579 patient records were reviewed for follow up events, only a small portion had events to report|
59759423|NCT02084160|75878824|FG000|NOT COMPLETED|Overall Study||0||
59759424|NCT00910091|75878830|FG000|STARTED|Pre-assignment||36||
59759425|NCT00910091|75878831|FG001|STARTED|Pre-assignment||37||
59759426|NCT00910091|75878830|FG000|COMPLETED|Pre-assignment||36||
59759427|NCT00910091|75878831|FG001|COMPLETED|Pre-assignment||35||
59759428|NCT00910091|75878830|FG000|NOT COMPLETED|Pre-assignment||0||
59759429|NCT00910091|75878831|FG001|NOT COMPLETED|Pre-assignment||2||
59759430|NCT00910091|75878830|FG000|STARTED|Treatment and Survival||36||
59759431|NCT00910091|75878831|FG001|STARTED|Treatment and Survival||35||
60035648|NCT02453555|76151245|FG000|STARTED|Extension Period|This reporting group is not applicable in this period.|0||
60035649|NCT02453555|76151246|FG001|STARTED|Extension Period|This reporting group is not applicable in this period.|0||
60035650|NCT02453555|76151247|FG002|STARTED|Extension Period||126||
60035651|NCT02453555|76151248|FG003|STARTED|Extension Period||51||
59759432|NCT00910091|75878830|FG000|COMPLETED|Treatment and Survival||32||
59759433|NCT00910091|75878831|FG001|COMPLETED|Treatment and Survival||31||
59759434|NCT00910091|75878830|FG000|NOT COMPLETED|Treatment and Survival||4||
59759435|NCT00910091|75878831|FG001|NOT COMPLETED|Treatment and Survival||4||
59759436|NCT00909857|75878840|FG000|STARTED|Overall Study||253||
59759437|NCT00909857|75878841|FG001|STARTED|Overall Study||254||
59759438|NCT00909857|75878840|FG000|Treated|Overall Study||234||
59759439|NCT00909857|75878841|FG001|Treated|Overall Study||230||
60035652|NCT02453555|76151249|FG004|STARTED|Extension Period||80||
60035653|NCT02453555|76151250|FG005|STARTED|Extension Period||6||
60035654|NCT02453555|76151245|FG000|COMPLETED|Extension Period||0||
60035655|NCT02453555|76151246|FG001|COMPLETED|Extension Period||0||
60035656|NCT02453555|76151247|FG002|COMPLETED|Extension Period||123||
60035657|NCT02453555|76151248|FG003|COMPLETED|Extension Period||49||
60035658|NCT02453555|76151249|FG004|COMPLETED|Extension Period||79||
60035659|NCT02453555|76151250|FG005|COMPLETED|Extension Period||5||
60035660|NCT02453555|76151245|FG000|NOT COMPLETED|Extension Period||0||
60035661|NCT02453555|76151246|FG001|NOT COMPLETED|Extension Period||0||
60035662|NCT02453555|76151247|FG002|NOT COMPLETED|Extension Period||3||
60035663|NCT02453555|76151248|FG003|NOT COMPLETED|Extension Period||2||
60035664|NCT02453555|76151249|FG004|NOT COMPLETED|Extension Period||1||
60035665|NCT02453555|76151250|FG005|NOT COMPLETED|Extension Period||1||
60035666|NCT02453321|76151263|FG000|STARTED|Overall Study||20||
60035667|NCT02453321|76151264|FG001|STARTED|Overall Study||21||
60035668|NCT02453321|76151265|FG002|STARTED|Overall Study||21||
60035669|NCT02453321|76151263|FG000|COMPLETED|Overall Study||19||
60035670|NCT02453321|76151264|FG001|COMPLETED|Overall Study||19||
60035671|NCT02453321|76151265|FG002|COMPLETED|Overall Study||19||
60035672|NCT02453321|76151263|FG000|NOT COMPLETED|Overall Study||1||
60035673|NCT02453321|76151264|FG001|NOT COMPLETED|Overall Study||2||
60035674|NCT02453321|76151265|FG002|NOT COMPLETED|Overall Study||2||
60035675|NCT01610284|76151278|FG000|STARTED|Randomization Phase||576|All randomized patients (FAS)|
60035676|NCT01610284|76151279|FG001|STARTED|Randomization Phase||571|All randomized patients (FAS)|
60035677|NCT01610284|76151278|FG000|Safety Set (SS)|Randomization Phase||573|At least 1 dose of study treatment and a 1 post baseline safety assessment|
60035678|NCT01610284|76151279|FG001|Safety Set (SS)|Randomization Phase||570|At least 1 dose of study treatment and a 1 post baseline safety assessment|
60035679|NCT01610284|76151278|FG000|COMPLETED|Randomization Phase||574|Randomized and treated|
60035680|NCT01610284|76151279|FG001|COMPLETED|Randomization Phase||569|Randomized and treated|
60035681|NCT01610284|76151278|FG000|NOT COMPLETED|Randomization Phase||2||
60035682|NCT01610284|76151279|FG001|NOT COMPLETED|Randomization Phase||2||
60035683|NCT01610284|76151278|FG000|STARTED|Treatment Phase||574|All patients in FAS that were treated|
60035684|NCT01610284|76151279|FG001|STARTED|Treatment Phase||569|All patients in FAS that were treated|
60035685|NCT01610284|76151278|FG000|BKM120 Pharmacokinetic Analysis Set|Treatment Phase||93|At least one dose of Buparlisib and 1 evaluable buparlisib concentration measurement|
60035686|NCT01610284|76151279|FG001|BKM120 Pharmacokinetic Analysis Set|Treatment Phase||0|At least one dose of Buparlisib and 1 evaluable buparlisib concentration measurement|
60035687|NCT01610284|76151278|FG000|Full Pharmacokinetic Analysis Set (FPAS)|Treatment Phase||35|A subset of the patients in the Buparlisib PAS|
60035688|NCT01610284|76151279|FG001|Full Pharmacokinetic Analysis Set (FPAS)|Treatment Phase||0|A subset of the patients in the Buparlisib PAS|
60035689|NCT01610284|76151278|FG000|COMPLETED|Treatment Phase||0||
60035690|NCT01610284|76151279|FG001|COMPLETED|Treatment Phase||0||
60035691|NCT01610284|76151278|FG000|NOT COMPLETED|Treatment Phase||574||
60035692|NCT01610284|76151279|FG001|NOT COMPLETED|Treatment Phase||569||
60035693|NCT01610284|76151278|FG000|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|89|All patients who discontinued treatment and entered Post-Treatment Efficacy Follow-Up Phase|
60035694|NCT01610284|76151279|FG001|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|29|All patients who discontinued treatment and entered Post-Treatment Efficacy Follow-Up Phase|
60035695|NCT01610284|76151278|FG000|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0||
60035696|NCT01610284|76151279|FG001|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0||
60035697|NCT01610284|76151278|FG000|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||89||
60035698|NCT01610284|76151279|FG001|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||29||
60035699|NCT02452463|76151288|FG000|STARTED|Overall Study||5||
60035700|NCT02452463|76151289|FG001|STARTED|Overall Study||3||
59508806|NCT02044419|75601857|FG002|NOT COMPLETED|Third Intervention||0||
59508807|NCT02045277|75601869|FG000|STARTED|Overall Study||59||
59508808|NCT02045277|75601870|FG001|STARTED|Overall Study||63||
59508809|NCT02045277|75601871|FG002|STARTED|Overall Study||59||
60035701|NCT02452463|76151290|FG002|STARTED|Overall Study|"No participants were enrolled in the Arm III (Nintedanib, Durvalumab) Arm."|0||
60035702|NCT02452463|76151288|FG000|COMPLETED|Overall Study||3||
60035703|NCT02452463|76151289|FG001|COMPLETED|Overall Study||1||
60035704|NCT02452463|76151290|FG002|COMPLETED|Overall Study||0||
60035705|NCT02452463|76151288|FG000|NOT COMPLETED|Overall Study||2||
60035706|NCT02452463|76151289|FG001|NOT COMPLETED|Overall Study||2||
60035707|NCT02452463|76151290|FG002|NOT COMPLETED|Overall Study||0||
60035708|NCT02432105|76151301|FG000|STARTED|Overall Study||164||
59508810|NCT02045277|75601872|FG003|STARTED|Overall Study||31||
60035709|NCT02432105|76151302|FG001|STARTED|Overall Study||110||
60035710|NCT02432105|76151303|FG002|STARTED|Overall Study||111||
60035711|NCT02432105|76151301|FG000|COMPLETED|Overall Study||162||
60035712|NCT02432105|76151302|FG001|COMPLETED|Overall Study||108||
60035713|NCT02432105|76151303|FG002|COMPLETED|Overall Study||108||
60035714|NCT02432105|76151301|FG000|NOT COMPLETED|Overall Study||2||
60035715|NCT02432105|76151302|FG001|NOT COMPLETED|Overall Study||2||
60035716|NCT02432105|76151303|FG002|NOT COMPLETED|Overall Study||3||
59508811|NCT02045277|75601869|FG000|COMPLETED|Overall Study||55||
59612277|NCT01723254|75723430|FG002|NOT COMPLETED|Overall Study||3||
60035717|NCT02431793|76151315|FG000|STARTED|Overall Study||202||
60035718|NCT02431793|76151316|FG001|STARTED|Overall Study||243||
60035719|NCT02431793|76151317|FG002|STARTED|Overall Study||207||
60035720|NCT02431793|76151315|FG000|Completed T1 (3-5 Days Post Enrollment)|Overall Study||136||
60035721|NCT02431793|76151316|FG001|Completed T1 (3-5 Days Post Enrollment)|Overall Study||180||
60035722|NCT02431793|76151317|FG002|Completed T1 (3-5 Days Post Enrollment)|Overall Study||143||
60035723|NCT02431793|76151315|FG000|Completed T2 (7-14 Days Post Enrollment)|Overall Study||95||
60035724|NCT02431793|76151316|FG001|Completed T2 (7-14 Days Post Enrollment)|Overall Study||141||
60035725|NCT02431793|76151317|FG002|Completed T2 (7-14 Days Post Enrollment)|Overall Study||107||
60035726|NCT02431793|76151315|FG000|Completed T3 (30 Days Post Enrollment)|Overall Study||85||
60035727|NCT02431793|76151316|FG001|Completed T3 (30 Days Post Enrollment)|Overall Study||113||
60035728|NCT02431793|76151317|FG002|Completed T3 (30 Days Post Enrollment)|Overall Study||93||
60035729|NCT02431793|76151315|FG000|COMPLETED|Overall Study||83||
60035730|NCT02431793|76151316|FG001|COMPLETED|Overall Study||109||
60035731|NCT02431793|76151317|FG002|COMPLETED|Overall Study||90||
60035732|NCT02431793|76151315|FG000|NOT COMPLETED|Overall Study||119||
60035733|NCT02431793|76151316|FG001|NOT COMPLETED|Overall Study||134||
60035734|NCT02431793|76151317|FG002|NOT COMPLETED|Overall Study||117||
60035735|NCT01801930|76151329|FG000|STARTED|Overall Study||6||
60035736|NCT01801930|76151330|FG001|STARTED|Overall Study||6||
60035737|NCT01801930|76151331|FG002|STARTED|Overall Study||6||
60035738|NCT01801930|76151332|FG003|STARTED|Overall Study||6||
60035739|NCT01801930|76151329|FG000|COMPLETED|Overall Study||0||
60035740|NCT01801930|76151330|FG001|COMPLETED|Overall Study||0||
60035741|NCT01801930|76151331|FG002|COMPLETED|Overall Study||0||
60035742|NCT01801930|76151332|FG003|COMPLETED|Overall Study||0||
60035743|NCT01801930|76151329|FG000|NOT COMPLETED|Overall Study||6||
60035744|NCT01801930|76151330|FG001|NOT COMPLETED|Overall Study||6||
60035745|NCT01801930|76151331|FG002|NOT COMPLETED|Overall Study||6||
60035746|NCT01801930|76151332|FG003|NOT COMPLETED|Overall Study||6||
60035747|NCT01610206|76151344|FG000|STARTED|Overall Study||73||
60035748|NCT01610206|76151345|FG001|STARTED|Overall Study||75||
60035749|NCT01610206|76151344|FG000|COMPLETED|Overall Study||63||
60035750|NCT01610206|76151345|FG001|COMPLETED|Overall Study||45||
60035751|NCT01610206|76151344|FG000|NOT COMPLETED|Overall Study||10||
60035752|NCT01610206|76151345|FG001|NOT COMPLETED|Overall Study||30||
60035753|NCT01816048|76151351|FG000|STARTED|Overall Study||8||
60035754|NCT01816048|76151351|FG000|COMPLETED|Overall Study||2||
60035755|NCT01816048|76151351|FG000|NOT COMPLETED|Overall Study||6||
60035756|NCT01612858|76151358|FG000|STARTED|Overall Study||16||
60035757|NCT01612858|76151359|FG001|STARTED|Overall Study||4||
60035758|NCT01612858|76151358|FG000|COMPLETED|Overall Study||11||
60035759|NCT01612858|76151359|FG001|COMPLETED|Overall Study||3||
60035760|NCT01612858|76151358|FG000|NOT COMPLETED|Overall Study||5||
60035761|NCT01612858|76151359|FG001|NOT COMPLETED|Overall Study||1||
60035762|NCT01612780|76151365|FG000|STARTED|Overall Study||82||
60035763|NCT01612780|76151365|FG000|COMPLETED|Overall Study||76||
60035764|NCT01612780|76151365|FG000|NOT COMPLETED|Overall Study||6||
60035765|NCT01612702|76151371|FG000|STARTED|Overall Study||146||
60035766|NCT01612702|76151372|FG001|STARTED|Overall Study||145||
60035767|NCT01612702|76151371|FG000|COMPLETED|Overall Study||135||
60035768|NCT01612702|76151372|FG001|COMPLETED|Overall Study||134||
60035769|NCT01612702|76151371|FG000|NOT COMPLETED|Overall Study||11||
60035770|NCT01612702|76151372|FG001|NOT COMPLETED|Overall Study||11||
60035771|NCT02431559|76151382|FG000|STARTED|Overall Study||3||
60035772|NCT02431559|76151383|FG001|STARTED|Overall Study||4||
60035773|NCT02431559|76151384|FG002|STARTED|Overall Study||6||
60035774|NCT02431559|76151385|FG003|STARTED|Overall Study||40||
60035775|NCT02431559|76151382|FG000|COMPLETED|Overall Study||1|Completed 12 cycles of study treatment|
60035776|NCT02431559|76151383|FG001|COMPLETED|Overall Study||1|Completed 12 cycles of study treatment|
60035777|NCT02431559|76151384|FG002|COMPLETED|Overall Study||2|Completed 12 cycles of study treatment|
60035778|NCT02431559|76151385|FG003|COMPLETED|Overall Study||9|Completed 12 cycles of study treatment|
60035779|NCT02431559|76151382|FG000|NOT COMPLETED|Overall Study||2||
60035780|NCT02431559|76151383|FG001|NOT COMPLETED|Overall Study||3||
60035781|NCT02431559|76151384|FG002|NOT COMPLETED|Overall Study||4||
60035782|NCT02431559|76151385|FG003|NOT COMPLETED|Overall Study||31||
60035783|NCT02388269|76151399|FG000|STARTED|Overall Study||41|Run-in period|
60035784|NCT02388269|76151400|FG001|STARTED|Overall Study||40|Run-in period|
60035785|NCT02388269|76151401|FG002|STARTED|Overall Study||10|Run-in period|
60035786|NCT02388269|76151399|FG000|Randomised Period|Overall Study||41||
60035787|NCT02388269|76151400|FG001|Randomised Period|Overall Study||40||
60035788|NCT02388269|76151401|FG002|Randomised Period|Overall Study||0||
60035789|NCT02388269|76151399|FG000|Open Label|Overall Study||37||
60035790|NCT02388269|76151400|FG001|Open Label|Overall Study||38||
60035791|NCT02388269|76151401|FG002|Open Label|Overall Study||0||
60035792|NCT02388269|76151399|FG000|COMPLETED|Overall Study||32|completed = run-in + randomised + open label periods|
60035793|NCT02388269|76151400|FG001|COMPLETED|Overall Study||38|completed = run-in + randomised + open label periods|
60035794|NCT02388269|76151401|FG002|COMPLETED|Overall Study||0|completed = run-in + randomised + open label periods|
60035795|NCT02388269|76151399|FG000|NOT COMPLETED|Overall Study||9||
60035796|NCT02388269|76151400|FG001|NOT COMPLETED|Overall Study||2||
60035797|NCT02388269|76151401|FG002|NOT COMPLETED|Overall Study||10||
60035798|NCT01652573|76151427|FG000|STARTED|Overall Study||10||
60035799|NCT01652573|76151428|FG001|STARTED|Overall Study||11||
60035800|NCT01652573|76151427|FG000|COMPLETED|Overall Study||10||
60035801|NCT01652573|76151428|FG001|COMPLETED|Overall Study||10||
60035802|NCT01652573|76151427|FG000|NOT COMPLETED|Overall Study||0||
60035803|NCT01652573|76151428|FG001|NOT COMPLETED|Overall Study||1||
60035804|NCT02388191|76151436|FG000|STARTED|Overall Study||59||
60035805|NCT02388191|76151437|FG001|STARTED|Overall Study||60||
60035806|NCT02388191|76151436|FG000|COMPLETED|Overall Study||58||
60035807|NCT02388191|76151437|FG001|COMPLETED|Overall Study||60||
60035808|NCT02388191|76151436|FG000|NOT COMPLETED|Overall Study||1||
60035809|NCT02388191|76151437|FG001|NOT COMPLETED|Overall Study||0||
60035810|NCT01815736|76151445|FG000|STARTED|Randomized Treatment Phase-Up to Week 96||963||
60035811|NCT01815736|76151446|FG001|STARTED|Randomized Treatment Phase-Up to Week 96||480||
60035812|NCT01815736|76151445|FG000|COMPLETED|Randomized Treatment Phase-Up to Week 96||914||
60035813|NCT01815736|76151446|FG001|COMPLETED|Randomized Treatment Phase-Up to Week 96||445||
60035814|NCT01815736|76151445|FG000|NOT COMPLETED|Randomized Treatment Phase-Up to Week 96||49||
60035815|NCT01815736|76151446|FG001|NOT COMPLETED|Randomized Treatment Phase-Up to Week 96||35||
60035816|NCT01815736|76151445|FG000|STARTED|Extension Treatment Phase- After Week 96|9 participants who completed the Randomized Treatment Phase did not continue in the Extension E/C/F/TAF Treatment Phase.|905||
60035817|NCT01815736|76151446|FG001|STARTED|Extension Treatment Phase- After Week 96|21 participants who completed the Randomized Treatment Phase did not continue in the Extension E/C/F/TAF Treatment Phase.|424||
60035818|NCT01815736|76151445|FG000|COMPLETED|Extension Treatment Phase- After Week 96||854||
60035819|NCT01815736|76151446|FG001|COMPLETED|Extension Treatment Phase- After Week 96||398||
60035820|NCT01815736|76151445|FG000|NOT COMPLETED|Extension Treatment Phase- After Week 96||51||
60035821|NCT01815736|76151446|FG001|NOT COMPLETED|Extension Treatment Phase- After Week 96||26||
60035822|NCT01651949|76151457|FG000|STARTED|Overall Study||1106||
60035823|NCT01651949|76151458|FG001|STARTED|Overall Study||1101||
60035824|NCT01651949|76151459|FG002|STARTED|Overall Study||313||
60035825|NCT01651949|76151457|FG000|Vaccination 1|Overall Study||1103||
60035826|NCT01651949|76151458|FG001|Vaccination 1|Overall Study||1099||
60035827|NCT01651949|76151459|FG002|Vaccination 1|Overall Study||313||
60035828|NCT01651949|76151457|FG000|Vaccination 2|Overall Study||1089||
60035829|NCT01651949|76151458|FG001|Vaccination 2|Overall Study||1069||
60035830|NCT01651949|76151459|FG002|Vaccination 2|Overall Study||298||
60035831|NCT01651949|76151457|FG000|Vaccination 3|Overall Study||1067||
60035832|NCT01651949|76151458|FG001|Vaccination 3|Overall Study||1037||
60035833|NCT01651949|76151459|FG002|Vaccination 3|Overall Study||291||
60035834|NCT01651949|76151457|FG000|COMPLETED|Overall Study||1053||
60035835|NCT01651949|76151458|FG001|COMPLETED|Overall Study||1015||
60035836|NCT01651949|76151459|FG002|COMPLETED|Overall Study||282||
60035837|NCT01651949|76151457|FG000|NOT COMPLETED|Overall Study||53||
60035838|NCT01651949|76151458|FG001|NOT COMPLETED|Overall Study||86||
60035839|NCT01651949|76151459|FG002|NOT COMPLETED|Overall Study||31||
60035840|NCT02387957|76151470|FG000|STARTED|Overall Study||21||
60035841|NCT02387957|76151471|FG001|STARTED|Overall Study||21||
60035842|NCT02387957|76151472|FG002|STARTED|Overall Study||21||
60035843|NCT02387957|76151470|FG000|COMPLETED|Overall Study|The study was discontinued|0||
60035844|NCT02387957|76151471|FG001|COMPLETED|Overall Study|The study was discontinued|0||
60035845|NCT02387957|76151472|FG002|COMPLETED|Overall Study|The study was discontinued|1||
60035846|NCT02387957|76151470|FG000|NOT COMPLETED|Overall Study||21||
60035847|NCT02387957|76151471|FG001|NOT COMPLETED|Overall Study||21||
60035848|NCT02387957|76151472|FG002|NOT COMPLETED|Overall Study||20||
60035849|NCT01800916|76151480|FG000|STARTED|Test Period 1 (1 Week)||7||
60035850|NCT01800916|76151481|FG001|STARTED|Test Period 1 (1 Week)||7||
60035851|NCT01800916|76151482|FG002|STARTED|Test Period 1 (1 Week)||7||
60035852|NCT01800916|76151483|FG003|STARTED|Test Period 1 (1 Week)||7||
60035853|NCT01800916|76151484|FG004|STARTED|Test Period 1 (1 Week)||8||
60035854|NCT01800916|76151485|FG005|STARTED|Test Period 1 (1 Week)||7||
60035855|NCT01800916|76151486|FG006|STARTED|Test Period 1 (1 Week)||7||
60035856|NCT01800916|76151487|FG007|STARTED|Test Period 1 (1 Week)||7||
60035857|NCT01800916|76151488|FG008|STARTED|Test Period 1 (1 Week)||7||
60035858|NCT01800916|76151480|FG000|COMPLETED|Test Period 1 (1 Week)||7||
60035859|NCT01800916|76151481|FG001|COMPLETED|Test Period 1 (1 Week)||7||
60035860|NCT01800916|76151482|FG002|COMPLETED|Test Period 1 (1 Week)||7||
60035861|NCT01800916|76151483|FG003|COMPLETED|Test Period 1 (1 Week)||6||
60035862|NCT01800916|76151484|FG004|COMPLETED|Test Period 1 (1 Week)||7||
60035863|NCT01800916|76151485|FG005|COMPLETED|Test Period 1 (1 Week)||7||
60035864|NCT01800916|76151486|FG006|COMPLETED|Test Period 1 (1 Week)||7||
60035865|NCT01800916|76151487|FG007|COMPLETED|Test Period 1 (1 Week)||7||
60035866|NCT01800916|76151488|FG008|COMPLETED|Test Period 1 (1 Week)||7||
60035867|NCT01800916|76151480|FG000|NOT COMPLETED|Test Period 1 (1 Week)||0||
60035868|NCT01800916|76151481|FG001|NOT COMPLETED|Test Period 1 (1 Week)||0||
60035869|NCT01800916|76151482|FG002|NOT COMPLETED|Test Period 1 (1 Week)||0||
60035870|NCT01800916|76151483|FG003|NOT COMPLETED|Test Period 1 (1 Week)||1||
60035871|NCT01800916|76151484|FG004|NOT COMPLETED|Test Period 1 (1 Week)||1||
60035872|NCT01800916|76151485|FG005|NOT COMPLETED|Test Period 1 (1 Week)||0||
60035873|NCT01800916|76151486|FG006|NOT COMPLETED|Test Period 1 (1 Week)||0||
60035874|NCT01800916|76151487|FG007|NOT COMPLETED|Test Period 1 (1 Week)||0||
60035875|NCT01800916|76151488|FG008|NOT COMPLETED|Test Period 1 (1 Week)||0||
60035876|NCT01800916|76151480|FG000|STARTED|Test Period 2 (1 Week)||7||
60035877|NCT01800916|76151481|FG001|STARTED|Test Period 2 (1 Week)||7||
60035878|NCT01800916|76151482|FG002|STARTED|Test Period 2 (1 Week)||7||
60035879|NCT01800916|76151483|FG003|STARTED|Test Period 2 (1 Week)||6||
60035880|NCT01800916|76151484|FG004|STARTED|Test Period 2 (1 Week)||7||
60035881|NCT01800916|76151485|FG005|STARTED|Test Period 2 (1 Week)||7||
60035882|NCT01800916|76151486|FG006|STARTED|Test Period 2 (1 Week)||7||
60035883|NCT01800916|76151487|FG007|STARTED|Test Period 2 (1 Week)||7||
60035884|NCT01800916|76151488|FG008|STARTED|Test Period 2 (1 Week)||7||
60035885|NCT01800916|76151480|FG000|COMPLETED|Test Period 2 (1 Week)||7||
60035886|NCT01800916|76151481|FG001|COMPLETED|Test Period 2 (1 Week)||7||
60035887|NCT01800916|76151482|FG002|COMPLETED|Test Period 2 (1 Week)||7||
60035888|NCT01800916|76151483|FG003|COMPLETED|Test Period 2 (1 Week)||6||
60035889|NCT01800916|76151484|FG004|COMPLETED|Test Period 2 (1 Week)||7||
60035890|NCT01800916|76151485|FG005|COMPLETED|Test Period 2 (1 Week)||7||
60035891|NCT01800916|76151486|FG006|COMPLETED|Test Period 2 (1 Week)||7||
60035892|NCT01800916|76151487|FG007|COMPLETED|Test Period 2 (1 Week)||7||
60035893|NCT01800916|76151488|FG008|COMPLETED|Test Period 2 (1 Week)||7||
60035894|NCT01800916|76151480|FG000|NOT COMPLETED|Test Period 2 (1 Week)||0||
60035895|NCT01800916|76151481|FG001|NOT COMPLETED|Test Period 2 (1 Week)||0||
60035896|NCT01800916|76151482|FG002|NOT COMPLETED|Test Period 2 (1 Week)||0||
60035897|NCT01800916|76151483|FG003|NOT COMPLETED|Test Period 2 (1 Week)||0||
60035898|NCT01800916|76151484|FG004|NOT COMPLETED|Test Period 2 (1 Week)||0||
60035899|NCT01800916|76151485|FG005|NOT COMPLETED|Test Period 2 (1 Week)||0||
60035900|NCT01800916|76151486|FG006|NOT COMPLETED|Test Period 2 (1 Week)||0||
60035901|NCT01800916|76151487|FG007|NOT COMPLETED|Test Period 2 (1 Week)||0||
60035902|NCT01800916|76151488|FG008|NOT COMPLETED|Test Period 2 (1 Week)||0||
60035903|NCT01800916|76151480|FG000|STARTED|Test Period 3 (1 Week)||7||
60035904|NCT01800916|76151481|FG001|STARTED|Test Period 3 (1 Week)||7||
60035905|NCT01800916|76151482|FG002|STARTED|Test Period 3 (1 Week)||7||
60035906|NCT01800916|76151483|FG003|STARTED|Test Period 3 (1 Week)||6||
60035907|NCT01800916|76151484|FG004|STARTED|Test Period 3 (1 Week)||7||
60035908|NCT01800916|76151485|FG005|STARTED|Test Period 3 (1 Week)||7||
60035909|NCT01800916|76151486|FG006|STARTED|Test Period 3 (1 Week)||7||
60035910|NCT01800916|76151487|FG007|STARTED|Test Period 3 (1 Week)||7||
60035911|NCT01800916|76151488|FG008|STARTED|Test Period 3 (1 Week)||7||
60035912|NCT01800916|76151480|FG000|COMPLETED|Test Period 3 (1 Week)||7||
60035913|NCT01800916|76151481|FG001|COMPLETED|Test Period 3 (1 Week)||7||
60035914|NCT01800916|76151482|FG002|COMPLETED|Test Period 3 (1 Week)||7||
60035915|NCT01800916|76151483|FG003|COMPLETED|Test Period 3 (1 Week)||6||
59508812|NCT02045277|75601870|FG001|COMPLETED|Overall Study||62||
59508813|NCT02045277|75601871|FG002|COMPLETED|Overall Study||47||
59508814|NCT02045277|75601872|FG003|COMPLETED|Overall Study||29||
59508815|NCT02045277|75601869|FG000|NOT COMPLETED|Overall Study||4||
59508816|NCT02045277|75601870|FG001|NOT COMPLETED|Overall Study||1||
59508817|NCT02045277|75601871|FG002|NOT COMPLETED|Overall Study||12||
59508818|NCT02045277|75601872|FG003|NOT COMPLETED|Overall Study||2||
59508819|NCT02045511|75601884|FG000|STARTED|Overall Study||8||
59508820|NCT02045511|75601885|FG001|STARTED|Overall Study||7||
59508821|NCT02045511|75601884|FG000|COMPLETED|Overall Study||8||
59508822|NCT02045511|75601885|FG001|COMPLETED|Overall Study||7||
59508823|NCT02045511|75601884|FG000|NOT COMPLETED|Overall Study||0||
60035916|NCT01800916|76151484|FG004|COMPLETED|Test Period 3 (1 Week)||7||
60035917|NCT01800916|76151485|FG005|COMPLETED|Test Period 3 (1 Week)||7||
60035918|NCT01800916|76151486|FG006|COMPLETED|Test Period 3 (1 Week)||7||
60035919|NCT01800916|76151487|FG007|COMPLETED|Test Period 3 (1 Week)||7||
60035920|NCT01800916|76151488|FG008|COMPLETED|Test Period 3 (1 Week)||7||
60035921|NCT01800916|76151480|FG000|NOT COMPLETED|Test Period 3 (1 Week)||0||
60035922|NCT01800916|76151481|FG001|NOT COMPLETED|Test Period 3 (1 Week)||0||
60035923|NCT01800916|76151482|FG002|NOT COMPLETED|Test Period 3 (1 Week)||0||
60035924|NCT01800916|76151483|FG003|NOT COMPLETED|Test Period 3 (1 Week)||0||
60035925|NCT01800916|76151484|FG004|NOT COMPLETED|Test Period 3 (1 Week)||0||
60035926|NCT01800916|76151485|FG005|NOT COMPLETED|Test Period 3 (1 Week)||0||
60035927|NCT01800916|76151486|FG006|NOT COMPLETED|Test Period 3 (1 Week)||0||
60035928|NCT01800916|76151487|FG007|NOT COMPLETED|Test Period 3 (1 Week)||0||
60035929|NCT01800916|76151488|FG008|NOT COMPLETED|Test Period 3 (1 Week)||0||
60035930|NCT01800058|76151498|FG000|STARTED|Overall Study||66||
60035931|NCT01800058|76151498|FG000|COMPLETED|Overall Study||65||
60035932|NCT01800058|76151498|FG000|NOT COMPLETED|Overall Study||1||
60035933|NCT01815580|76151505|FG000|STARTED|Overall Study||110||
60035934|NCT01815580|76151506|FG001|STARTED|Overall Study||115||
60035935|NCT01815580|76151505|FG000|COMPLETED|Overall Study||98||
60035936|NCT01815580|76151506|FG001|COMPLETED|Overall Study||100||
60035937|NCT01815580|76151505|FG000|NOT COMPLETED|Overall Study||12||
60035938|NCT01815580|76151506|FG001|NOT COMPLETED|Overall Study||15||
60035939|NCT01799590|76151520|FG000|STARTED|Overall Study||111||
60035940|NCT01799590|76151521|FG001|STARTED|Overall Study||94||
60035941|NCT01799590|76151522|FG002|STARTED|Overall Study||91||
60035942|NCT01799590|76151520|FG000|COMPLETED|Overall Study||85||
60035943|NCT01799590|76151521|FG001|COMPLETED|Overall Study||78||
60035944|NCT01799590|76151522|FG002|COMPLETED|Overall Study||77||
60035945|NCT01799590|76151520|FG000|NOT COMPLETED|Overall Study||26||
60035946|NCT01799590|76151521|FG001|NOT COMPLETED|Overall Study||16||
60035947|NCT01799590|76151522|FG002|NOT COMPLETED|Overall Study||14||
60035948|NCT01815424|76151533|FG000|STARTED|Week 0 to 16||90||
60035949|NCT01815424|76151534|FG001|STARTED|Week 0 to 16||88||
59508824|NCT02045511|75601885|FG001|NOT COMPLETED|Overall Study||0||
59508825|NCT02378025|75601893|FG000|STARTED|Overall Study||39||
59508826|NCT02378025|75601894|FG001|STARTED|Overall Study||36||
59508827|NCT02378025|75601893|FG000|COMPLETED|Overall Study||26||
59508828|NCT02378025|75601894|FG001|COMPLETED|Overall Study||15||
59508829|NCT02378025|75601893|FG000|NOT COMPLETED|Overall Study||13||
59508830|NCT02378025|75601894|FG001|NOT COMPLETED|Overall Study||21||
59508831|NCT00771407|75601902|FG000|STARTED|Overall Study||60||
59508832|NCT00771407|75601903|FG001|STARTED|Overall Study||60||
59508833|NCT00771407|75601902|FG000|COMPLETED|Overall Study||40||
59508834|NCT00771407|75601903|FG001|COMPLETED|Overall Study||35||
59508835|NCT00771407|75601902|FG000|NOT COMPLETED|Overall Study||20||
59508836|NCT00771407|75601903|FG001|NOT COMPLETED|Overall Study||25||
59508837|NCT02379117|75601911|FG000|STARTED|Overall Study||30||
60035950|NCT01815424|76151535|FG002|STARTED|Week 0 to 16||88||
60035951|NCT01815424|76151536|FG003|STARTED|Week 0 to 16||0||
60035952|NCT01815424|76151537|FG004|STARTED|Week 0 to 16||0||
59508838|NCT02379117|75601912|FG001|STARTED|Overall Study||31||
59508839|NCT02379117|75601911|FG000|COMPLETED|Overall Study||30||
59508840|NCT02379117|75601912|FG001|COMPLETED|Overall Study||31||
59508841|NCT02379117|75601911|FG000|NOT COMPLETED|Overall Study||0||
59508842|NCT02379117|75601912|FG001|NOT COMPLETED|Overall Study||0||
59508843|NCT00788255|75601918|FG000|STARTED|Overall Study||25||
59508844|NCT00788255|75601918|FG000|Oxytocin Infusion 1: 22.5 μU/mL|Overall Study||25||
59508845|NCT00788255|75601918|FG000|Oxytocin Infusion 2: 30.1μU/mL|Overall Study||25||
60035953|NCT01815424|76151533|FG000|COMPLETED|Week 0 to 16||83||
60035954|NCT01815424|76151534|FG001|COMPLETED|Week 0 to 16||84||
59508846|NCT00788255|75601918|FG000|Oxytocin Infusion 3: 32.9μU/mL|Overall Study||25||
60035955|NCT01815424|76151535|FG002|COMPLETED|Week 0 to 16||77||
60035956|NCT01815424|76151536|FG003|COMPLETED|Week 0 to 16||0||
60035957|NCT01815424|76151537|FG004|COMPLETED|Week 0 to 16||0||
60035958|NCT01815424|76151533|FG000|NOT COMPLETED|Week 0 to 16||7||
60035959|NCT01815424|76151534|FG001|NOT COMPLETED|Week 0 to 16||4||
60035960|NCT01815424|76151535|FG002|NOT COMPLETED|Week 0 to 16||11||
60035961|NCT01815424|76151536|FG003|NOT COMPLETED|Week 0 to 16||0||
60035962|NCT01815424|76151537|FG004|NOT COMPLETED|Week 0 to 16||0||
60035963|NCT01815424|76151533|FG000|STARTED|Week 16 to 52||83||
60035964|NCT01815424|76151534|FG001|STARTED|Week 16 to 52||84||
60035965|NCT01815424|76151535|FG002|STARTED|Week 16 to 52||0||
60035966|NCT01815424|76151536|FG003|STARTED|Week 16 to 52||38||
60035967|NCT01815424|76151537|FG004|STARTED|Week 16 to 52||39||
60035968|NCT01815424|76151533|FG000|COMPLETED|Week 16 to 52||81||
60035969|NCT01815424|76151534|FG001|COMPLETED|Week 16 to 52||79||
60035970|NCT01815424|76151535|FG002|COMPLETED|Week 16 to 52||0||
60035971|NCT01815424|76151536|FG003|COMPLETED|Week 16 to 52||35||
60035972|NCT01815424|76151537|FG004|COMPLETED|Week 16 to 52||36||
60035973|NCT01815424|76151533|FG000|NOT COMPLETED|Week 16 to 52||2||
60035974|NCT01815424|76151534|FG001|NOT COMPLETED|Week 16 to 52||5||
60035975|NCT01815424|76151535|FG002|NOT COMPLETED|Week 16 to 52||0||
60035976|NCT01815424|76151536|FG003|NOT COMPLETED|Week 16 to 52||3||
60035977|NCT01815424|76151537|FG004|NOT COMPLETED|Week 16 to 52||3||
60035978|NCT02431247|76151552|FG000|STARTED|BL to EOE-Test and BL to Switch- Control||362||
60035979|NCT02431247|76151553|FG001|STARTED|BL to EOE-Test and BL to Switch- Control||363||
60035980|NCT02431247|76151554|FG002|STARTED|BL to EOE-Test and BL to Switch- Control||0||
60035981|NCT02431247|76151552|FG000|COMPLETED|BL to EOE-Test and BL to Switch- Control||296||
60035982|NCT02431247|76151553|FG001|COMPLETED|BL to EOE-Test and BL to Switch- Control||322||
60035983|NCT02431247|76151554|FG002|COMPLETED|BL to EOE-Test and BL to Switch- Control||0||
60035984|NCT02431247|76151552|FG000|NOT COMPLETED|BL to EOE-Test and BL to Switch- Control||66||
60035985|NCT02431247|76151553|FG001|NOT COMPLETED|BL to EOE-Test and BL to Switch- Control||41||
60035986|NCT02431247|76151554|FG002|NOT COMPLETED|BL to EOE-Test and BL to Switch- Control||0||
60035987|NCT02431247|76151552|FG000|STARTED|Switch to D/C/F/TAF (Until EOE)||0||
60035988|NCT02431247|76151553|FG001|STARTED|Switch to D/C/F/TAF (Until EOE)|322 participants from DRV/COBI+ FTC/TDF (Control) group switched to D/C/F/TAF (Test) Group|0||
60035989|NCT02431247|76151554|FG002|STARTED|Switch to D/C/F/TAF (Until EOE)|322 participants from DRV/COBI+ FTC/TDF (Control) group switched to D/C/F/TAF (Test) Group|322||
60035990|NCT02431247|76151552|FG000|COMPLETED|Switch to D/C/F/TAF (Until EOE)||0||
60035991|NCT02431247|76151553|FG001|COMPLETED|Switch to D/C/F/TAF (Until EOE)||0||
60035992|NCT02431247|76151554|FG002|COMPLETED|Switch to D/C/F/TAF (Until EOE)||289||
60035993|NCT02431247|76151552|FG000|NOT COMPLETED|Switch to D/C/F/TAF (Until EOE)||0||
60035994|NCT02431247|76151553|FG001|NOT COMPLETED|Switch to D/C/F/TAF (Until EOE)||0||
60035995|NCT02431247|76151554|FG002|NOT COMPLETED|Switch to D/C/F/TAF (Until EOE)||33||
60035996|NCT01814878|76151568|FG000|STARTED|Overall Study||162||
60035997|NCT01814878|76151569|FG001|STARTED|Overall Study||158||
60035998|NCT01814878|76151568|FG000|COMPLETED|Overall Study||116||
60035999|NCT01814878|76151569|FG001|COMPLETED|Overall Study||128||
60036000|NCT01814878|76151568|FG000|NOT COMPLETED|Overall Study||46||
60036001|NCT01814878|76151569|FG001|NOT COMPLETED|Overall Study||30||
60036002|NCT02407457|76151577|FG000|STARTED|Baseline||235||
60036003|NCT02407457|76151578|FG001|STARTED|Baseline||220||
60036004|NCT02407457|76151577|FG000|COMPLETED|Baseline||235||
60036005|NCT02407457|76151578|FG001|COMPLETED|Baseline||220||
60036006|NCT02407457|76151577|FG000|NOT COMPLETED|Baseline||0||
60036007|NCT02407457|76151578|FG001|NOT COMPLETED|Baseline||0||
60036008|NCT02407457|76151577|FG000|STARTED|1 Month||235||
60036009|NCT02407457|76151578|FG001|STARTED|1 Month||220||
60036010|NCT02407457|76151577|FG000|COMPLETED|1 Month||229||
60036011|NCT02407457|76151578|FG001|COMPLETED|1 Month||213||
60036012|NCT02407457|76151577|FG000|NOT COMPLETED|1 Month||6||
60036013|NCT02407457|76151578|FG001|NOT COMPLETED|1 Month||7||
60036014|NCT02407457|76151577|FG000|STARTED|6-Month||231||
60036015|NCT02407457|76151578|FG001|STARTED|6-Month||219||
60036016|NCT02407457|76151577|FG000|COMPLETED|6-Month||211||
60036017|NCT02407457|76151578|FG001|COMPLETED|6-Month||194||
60036018|NCT02407457|76151577|FG000|NOT COMPLETED|6-Month||20||
60036019|NCT02407457|76151578|FG001|NOT COMPLETED|6-Month||25||
60036020|NCT02407457|76151577|FG000|STARTED|1 Year||227||
60036021|NCT02407457|76151578|FG001|STARTED|1 Year||208||
60036022|NCT02407457|76151577|FG000|COMPLETED|1 Year||194||
60036023|NCT02407457|76151578|FG001|COMPLETED|1 Year||180||
60036024|NCT02407457|76151577|FG000|NOT COMPLETED|1 Year||33||
60036025|NCT02407457|76151578|FG001|NOT COMPLETED|1 Year||28||
60036026|NCT02407457|76151577|FG000|STARTED|2-year||218||
60036027|NCT02407457|76151578|FG001|STARTED|2-year||194||
60036028|NCT02407457|76151577|FG000|COMPLETED|2-year||184||
60036029|NCT02407457|76151578|FG001|COMPLETED|2-year||159||
60036030|NCT02407457|76151577|FG000|NOT COMPLETED|2-year||34||
60036031|NCT02407457|76151578|FG001|NOT COMPLETED|2-year||35||
60036032|NCT02407457|76151577|FG000|STARTED|3-year||198||
60036033|NCT02407457|76151578|FG001|STARTED|3-year||175||
60036034|NCT02407457|76151577|FG000|COMPLETED|3-year||156||
60036035|NCT02407457|76151578|FG001|COMPLETED|3-year||137||
60036036|NCT02407457|76151577|FG000|NOT COMPLETED|3-year||42||
60036037|NCT02407457|76151578|FG001|NOT COMPLETED|3-year||38||
60036038|NCT02407457|76151577|FG000|STARTED|4-year||181||
60036039|NCT02407457|76151578|FG001|STARTED|4-year||156||
60036040|NCT02407457|76151577|FG000|COMPLETED|4-year||100||
60036041|NCT02407457|76151578|FG001|COMPLETED|4-year||95||
60036042|NCT02407457|76151577|FG000|NOT COMPLETED|4-year||81||
60036043|NCT02407457|76151578|FG001|NOT COMPLETED|4-year||61||
60036044|NCT02407457|76151577|FG000|STARTED|5-year||123||
60036045|NCT02407457|76151578|FG001|STARTED|5-year||113||
60036046|NCT02407457|76151577|FG000|COMPLETED|5-year|Due to the time frame of the study - subjects have not passed 5-year.|31||
60036047|NCT02407457|76151578|FG001|COMPLETED|5-year||36||
60036048|NCT02407457|76151577|FG000|NOT COMPLETED|5-year||92||
60036049|NCT02407457|76151578|FG001|NOT COMPLETED|5-year||77||
60036050|NCT01814800|76151584|FG000|STARTED|Overall Study||59||
60036051|NCT01814800|76151584|FG000|COMPLETED|Overall Study||54||
60036052|NCT01814800|76151584|FG000|NOT COMPLETED|Overall Study||5||
60036053|NCT01814332|76151590|FG000|STARTED|Overall Study||63||
60036054|NCT01814332|76151591|FG001|STARTED|Overall Study||65||
60036055|NCT01814332|76151590|FG000|COMPLETED|Overall Study||47||
60036056|NCT01814332|76151591|FG001|COMPLETED|Overall Study||49||
60036057|NCT01814332|76151590|FG000|NOT COMPLETED|Overall Study||16||
60036058|NCT01814332|76151591|FG001|NOT COMPLETED|Overall Study||16||
60036059|NCT02407223|76151600|FG000|STARTED|Overall Study||116||
60036060|NCT02407223|76151601|FG001|STARTED|Overall Study||118||
60036061|NCT02407223|76151602|FG002|STARTED|Overall Study||122||
60036062|NCT02407223|76151600|FG000|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|22||
60036063|NCT02407223|76151601|FG001|Early Escape at Week 16|Overall Study||0||
60036064|NCT02407223|76151602|FG002|Early Escape at Week 16|Overall Study||0||
60036065|NCT02407223|76151600|FG000|Cross Over at Week 24|Overall Study|Study discontinuation/completion reported under randomization group|60||
60036066|NCT02407223|76151601|FG001|Cross Over at Week 24|Overall Study||0||
60036067|NCT02407223|76151602|FG002|Cross Over at Week 24|Overall Study||0||
60036068|NCT02407223|76151600|FG000|Qualified Re-randomization at Week 52|Overall Study||0||
60036069|NCT02407223|76151601|FG001|Qualified Re-randomization at Week 52|Overall Study||3||
60036070|NCT02407223|76151602|FG002|Qualified Re-randomization at Week 52|Overall Study||2||
60036071|NCT02407223|76151600|FG000|COMPLETED|Overall Study||0||
60036072|NCT02407223|76151601|FG001|COMPLETED|Overall Study||0||
60036073|NCT02407223|76151602|FG002|COMPLETED|Overall Study||0||
60036074|NCT02407223|76151600|FG000|NOT COMPLETED|Overall Study||116||
60036075|NCT02407223|76151601|FG001|NOT COMPLETED|Overall Study||118||
60036076|NCT02407223|76151602|FG002|NOT COMPLETED|Overall Study||122||
60036077|NCT01797562|76151612|FG000|STARTED|Overall Study||116||
60036078|NCT01797562|76151612|FG000|COMPLETED|Overall Study||111||
60036079|NCT01797562|76151612|FG000|NOT COMPLETED|Overall Study||5||
60036080|NCT01813474|76151620|FG000|STARTED|Overall Study||4||
60036081|NCT01813474|76151621|FG001|STARTED|Overall Study||7||
60036082|NCT01813474|76151622|FG002|STARTED|Overall Study||12||
60036083|NCT01813474|76151620|FG000|COMPLETED|Overall Study|ongoing study at final data cut off|1||
60036084|NCT01813474|76151621|FG001|COMPLETED|Overall Study||0||
60036085|NCT01813474|76151622|FG002|COMPLETED|Overall Study|ongoing study at final data cut off|1||
60036086|NCT01813474|76151620|FG000|NOT COMPLETED|Overall Study||3||
60036087|NCT01813474|76151621|FG001|NOT COMPLETED|Overall Study||7||
60036088|NCT01813474|76151622|FG002|NOT COMPLETED|Overall Study||11||
60036089|NCT01868542|76151633|FG000|STARTED|Overall Study||23||
60036090|NCT01868542|76151634|FG001|STARTED|Overall Study||23||
60036091|NCT01868542|76151633|FG000|COMPLETED|Overall Study||23||
60036092|NCT01868542|76151634|FG001|COMPLETED|Overall Study||21||
60036093|NCT01868542|76151633|FG000|NOT COMPLETED|Overall Study||0||
59612278|NCT01723254|75723431|FG003|NOT COMPLETED|Overall Study||2||
59508847|NCT00788255|75601918|FG000|Oxytocin: 0 μU/mL|Overall Study||25||
59508848|NCT00788255|75601918|FG000|COMPLETED|Overall Study||25||
59508849|NCT00788255|75601918|FG000|NOT COMPLETED|Overall Study||0||
59508850|NCT02379195|75601925|FG000|STARTED|Overall Study||12||
59508851|NCT02379195|75601925|FG000|COMPLETED|Overall Study||12||
59508852|NCT02379195|75601925|FG000|NOT COMPLETED|Overall Study||0||
59508853|NCT02379273|75601929|FG000|STARTED|Overall Study||35||
59508854|NCT02379273|75601929|FG000|COMPLETED|Overall Study|Completed 5 years postactivation.|35||
59508855|NCT02379273|75601929|FG000|NOT COMPLETED|Overall Study||0||
59508856|NCT02382705|75601933|FG000|STARTED|Overall Study||57||
59508857|NCT02382705|75601933|FG000|COMPLETED|Overall Study||33||
59508858|NCT02382705|75601933|FG000|NOT COMPLETED|Overall Study||24||
59508859|NCT00771875|75601940|FG000|STARTED|Overall Study||10||
59612279|NCT01723254|75723432|FG004|NOT COMPLETED|Overall Study||2||
59917705|NCT03341299|76038215|FG002|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0||
59508860|NCT00771875|75601941|FG001|STARTED|Overall Study||10||
59508861|NCT00771875|75601942|FG002|STARTED|Overall Study||10||
59612280|NCT01723254|75723433|FG005|NOT COMPLETED|Overall Study||2||
59612281|NCT01723254|75723434|FG006|NOT COMPLETED|Overall Study||1||
59917706|NCT03341299|76038216|FG003|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0||
59917707|NCT03341299|76038213|FG000|STARTED|Period 3||9||
59917708|NCT03341299|76038214|FG001|STARTED|Period 3||9||
59917709|NCT03341299|76038215|FG002|STARTED|Period 3||8||
59917710|NCT03341299|76038216|FG003|STARTED|Period 3||9||
59917711|NCT03341299|76038213|FG000|COMPLETED|Period 3||9||
59917712|NCT03341299|76038214|FG001|COMPLETED|Period 3||9||
59917713|NCT03341299|76038215|FG002|COMPLETED|Period 3||8||
59917714|NCT03341299|76038216|FG003|COMPLETED|Period 3||9||
59917715|NCT03341299|76038213|FG000|NOT COMPLETED|Period 3||0||
60036094|NCT01868542|76151634|FG001|NOT COMPLETED|Overall Study||2||
60036095|NCT01797094|76151642|FG000|STARTED|Overall Study||48||
60036096|NCT01797094|76151643|FG001|STARTED|Overall Study||53||
60036097|NCT01797094|76151642|FG000|COMPLETED|Overall Study||42||
60036098|NCT01797094|76151643|FG001|COMPLETED|Overall Study||51||
60036099|NCT01797094|76151642|FG000|NOT COMPLETED|Overall Study||6||
60036100|NCT01797094|76151643|FG001|NOT COMPLETED|Overall Study||2||
60036101|NCT02383589|76151651|FG000|STARTED|Treatment Period||67||
60036102|NCT02383589|76151652|FG001|STARTED|Treatment Period||68||
60036103|NCT02383589|76151651|FG000|COMPLETED|Treatment Period||66|Completed the 52-week treatment period and entered safety follow up (SFU)|
60036104|NCT02383589|76151652|FG001|COMPLETED|Treatment Period||58|Completed the 52-week treatment period and entered safety follow up (SFU)|
60036105|NCT02383589|76151651|FG000|NOT COMPLETED|Treatment Period||1||
60036106|NCT02383589|76151652|FG001|NOT COMPLETED|Treatment Period||10||
60036107|NCT02383589|76151651|FG000|STARTED|Safety Follow-up (SFU)||66||
60036108|NCT02383589|76151652|FG001|STARTED|Safety Follow-up (SFU)||58||
60036109|NCT02383589|76151651|FG000|COMPLETED|Safety Follow-up (SFU)||59||
59612282|NCT01723254|75723435|FG007|NOT COMPLETED|Overall Study||3||
59612283|NCT01722162|75723455|FG000|STARTED|Overall Study||23||
59612284|NCT01722162|75723456|FG001|STARTED|Overall Study||24||
60036110|NCT02383589|76151652|FG001|COMPLETED|Safety Follow-up (SFU)||53||
60036111|NCT02383589|76151651|FG000|NOT COMPLETED|Safety Follow-up (SFU)||7||
60036112|NCT02383589|76151652|FG001|NOT COMPLETED|Safety Follow-up (SFU)||5||
60036113|NCT01810432|76151660|FG000|STARTED|Period 1||20||
60036114|NCT01810432|76151661|FG001|STARTED|Period 1||20||
60036115|NCT01810432|76151660|FG000|Received at Least 1 Dose of Study Drug|Period 1||20||
60036116|NCT01810432|76151661|FG001|Received at Least 1 Dose of Study Drug|Period 1||20||
60036117|NCT01810432|76151660|FG000|COMPLETED|Period 1||20||
60036118|NCT01810432|76151661|FG001|COMPLETED|Period 1||20||
60036119|NCT01810432|76151660|FG000|NOT COMPLETED|Period 1||0||
60036120|NCT01810432|76151661|FG001|NOT COMPLETED|Period 1||0||
60036121|NCT01810432|76151660|FG000|STARTED|Washout||20||
60036122|NCT01810432|76151661|FG001|STARTED|Washout||20||
60036123|NCT01810432|76151660|FG000|COMPLETED|Washout||19||
60036124|NCT01810432|76151661|FG001|COMPLETED|Washout||19||
60036125|NCT01810432|76151660|FG000|NOT COMPLETED|Washout||1||
60036126|NCT01810432|76151661|FG001|NOT COMPLETED|Washout||1||
60036127|NCT01810432|76151660|FG000|STARTED|Period 2||19||
59612285|NCT01722162|75723455|FG000|COMPLETED|Overall Study||18||
59612286|NCT01722162|75723456|FG001|COMPLETED|Overall Study||18||
59612287|NCT01722162|75723455|FG000|NOT COMPLETED|Overall Study||5||
59612288|NCT01722162|75723456|FG001|NOT COMPLETED|Overall Study||6||
59612289|NCT01721772|75723464|FG000|STARTED|Pre-Treatment||210|Randomized|
59612290|NCT01721772|75723465|FG001|STARTED|Pre-Treatment||208|Randomized|
59612291|NCT01721772|75723464|FG000|COMPLETED|Pre-Treatment||206|Moving to the treatment period|
59612292|NCT01721772|75723465|FG001|COMPLETED|Pre-Treatment||205|Moving to the treatment period|
60036128|NCT01810432|76151661|FG001|STARTED|Period 2||19||
60036129|NCT01810432|76151660|FG000|Received at Least 1 Dose of Study Drug|Period 2||19||
60036130|NCT01810432|76151661|FG001|Received at Least 1 Dose of Study Drug|Period 2||19||
60036131|NCT01810432|76151660|FG000|COMPLETED|Period 2||15||
60036132|NCT01810432|76151661|FG001|COMPLETED|Period 2||17||
60036133|NCT01810432|76151660|FG000|NOT COMPLETED|Period 2||4||
60036134|NCT01810432|76151661|FG001|NOT COMPLETED|Period 2||2||
60036135|NCT01796860|76151667|FG000|STARTED|Overall Study||10||
60036136|NCT01796860|76151667|FG000|COMPLETED|Overall Study||7||
60036137|NCT01796860|76151667|FG000|NOT COMPLETED|Overall Study||3||
60036138|NCT01796548|76151671|FG000|STARTED|Overall Study||17||
60036139|NCT01796548|76151671|FG000|Treated|Overall Study||15||
60036140|NCT01796548|76151671|FG000|COMPLETED|Overall Study||14||
60036141|NCT01796548|76151671|FG000|NOT COMPLETED|Overall Study||3||
60036142|NCT02406677|76151677|FG000|STARTED|Overall Study||6436|Total Patients Enrolled|
60036143|NCT02406677|76151678|FG001|STARTED|Overall Study||4565|Total Patients Enrolled|
60036144|NCT02406677|76151677|FG000|COMPLETED|Overall Study||6135||
60036145|NCT02406677|76151678|FG001|COMPLETED|Overall Study||3967||
60036146|NCT02406677|76151677|FG000|NOT COMPLETED|Overall Study||301||
60036147|NCT02406677|76151678|FG001|NOT COMPLETED|Overall Study||598||
60036148|NCT02404805|76151694|FG000|STARTED|Overall Study||5||
60036149|NCT02404805|76151695|FG001|STARTED|Overall Study||3||
60036150|NCT02404805|76151696|FG002|STARTED|Overall Study||5||
60036151|NCT02404805|76151697|FG003|STARTED|Overall Study||5||
60036152|NCT02404805|76151698|FG004|STARTED|Overall Study||3||
60036153|NCT02404805|76151699|FG005|STARTED|Overall Study||4||
60036154|NCT02404805|76151694|FG000|COMPLETED|Overall Study||4||
60036155|NCT02404805|76151695|FG001|COMPLETED|Overall Study||3||
60036156|NCT02404805|76151696|FG002|COMPLETED|Overall Study||5||
60036157|NCT02404805|76151697|FG003|COMPLETED|Overall Study||5||
60036158|NCT02404805|76151698|FG004|COMPLETED|Overall Study||3||
60036159|NCT02404805|76151699|FG005|COMPLETED|Overall Study||4||
60036160|NCT02404805|76151694|FG000|NOT COMPLETED|Overall Study||1||
60036161|NCT02404805|76151695|FG001|NOT COMPLETED|Overall Study||0||
60036162|NCT02404805|76151696|FG002|NOT COMPLETED|Overall Study||0||
60036163|NCT02404805|76151697|FG003|NOT COMPLETED|Overall Study||0||
60036164|NCT02404805|76151698|FG004|NOT COMPLETED|Overall Study||0||
60036165|NCT02404805|76151699|FG005|NOT COMPLETED|Overall Study||0||
60036166|NCT02430311|76151710|FG000|STARTED|Part A||20||
60036167|NCT02430311|76151711|FG001|STARTED|Part A||16||
60036168|NCT02430311|76151710|FG000|Received Olaparib|Part A||20||
60036169|NCT02430311|76151711|FG001|Received Olaparib|Part A||16||
59508862|NCT00771875|75601940|FG000|COMPLETED|Overall Study||10||
59508863|NCT00771875|75601941|FG001|COMPLETED|Overall Study||9||
60036170|NCT02430311|76151710|FG000|Received Paclitaxel|Part A|Cohort 1 patients are planned to receive olaparib monotherapy|0||
60036171|NCT02430311|76151711|FG001|Received Paclitaxel|Part A||16||
60036172|NCT02430311|76151710|FG000|COMPLETED|Part A||19||
60036173|NCT02430311|76151711|FG001|COMPLETED|Part A||15||
60036174|NCT02430311|76151710|FG000|NOT COMPLETED|Part A||1||
60036175|NCT02430311|76151711|FG001|NOT COMPLETED|Part A||1||
60036176|NCT02430311|76151710|FG000|STARTED|Part B||19||
60036177|NCT02430311|76151711|FG001|STARTED|Part B||15||
60036178|NCT02430311|76151710|FG000|Received Olaparib|Part B||19||
60036179|NCT02430311|76151711|FG001|Received Olaparib|Part B||15||
60036180|NCT02430311|76151710|FG000|Received Paclitaxel|Part B|Cohort 1 patients are planned to receive olaparib monotherapy|0||
60036181|NCT02430311|76151711|FG001|Received Paclitaxel|Part B||14||
60036182|NCT02430311|76151710|FG000|COMPLETED|Part B||9||
60036183|NCT02430311|76151711|FG001|COMPLETED|Part B||7||
60036184|NCT02430311|76151710|FG000|NOT COMPLETED|Part B||10||
60036185|NCT02430311|76151711|FG001|NOT COMPLETED|Part B||8||
60036186|NCT02404649|76151728|FG000|STARTED|Overall Study||17||
60036187|NCT02404649|76151729|FG001|STARTED|Overall Study||16||
60036188|NCT02404649|76151728|FG000|COMPLETED|Overall Study||16||
60036189|NCT02404649|76151729|FG001|COMPLETED|Overall Study||14||
60036190|NCT02404649|76151728|FG000|NOT COMPLETED|Overall Study||1||
60036191|NCT02404649|76151729|FG001|NOT COMPLETED|Overall Study||2||
60036192|NCT02383355|76151737|FG000|STARTED|Overall Study||19||
60036193|NCT02383355|76151738|FG001|STARTED|Overall Study||21||
60036194|NCT02383355|76151737|FG000|COMPLETED|Overall Study||17||
60036195|NCT02383355|76151738|FG001|COMPLETED|Overall Study||21||
60036196|NCT02383355|76151737|FG000|NOT COMPLETED|Overall Study||2||
60036197|NCT02383355|76151738|FG001|NOT COMPLETED|Overall Study||0||
60036198|NCT02381795|76151744|FG000|STARTED|Overall Study||10||
60036199|NCT02381795|76151744|FG000|COMPLETED|Overall Study||7||
60036200|NCT02381795|76151744|FG000|NOT COMPLETED|Overall Study||3||
60036201|NCT02404493|76151750|FG000|STARTED|Overall Study||17||
60036202|NCT02404493|76151751|FG001|STARTED|Overall Study||6||
60036203|NCT02404493|76151750|FG000|COMPLETED|Overall Study||16||
60036204|NCT02404493|76151751|FG001|COMPLETED|Overall Study||5||
60036205|NCT02404493|76151750|FG000|NOT COMPLETED|Overall Study||1||
60036206|NCT02404493|76151751|FG001|NOT COMPLETED|Overall Study||1||
60036207|NCT02380859|76151759|FG000|STARTED|Overall Study||19||
60036208|NCT02380859|76151760|FG001|STARTED|Overall Study||13||
60036209|NCT02380859|76151759|FG000|COMPLETED|Overall Study||17||
59508864|NCT00771875|75601942|FG002|COMPLETED|Overall Study||10||
59508865|NCT00771875|75601940|FG000|NOT COMPLETED|Overall Study||0||
59508866|NCT00771875|75601941|FG001|NOT COMPLETED|Overall Study||1||
60036210|NCT02380859|76151760|FG001|COMPLETED|Overall Study||13||
60036211|NCT02380859|76151759|FG000|NOT COMPLETED|Overall Study||2||
60036212|NCT02380859|76151760|FG001|NOT COMPLETED|Overall Study||0||
60036213|NCT02380703|76151768|FG000|STARTED|Overall Study||114|This is the number of PWD assigned to each arm.|
60036214|NCT02380703|76151769|FG001|STARTED|Overall Study||114|This is the number of PWD assigned to each arm.|
60036215|NCT02380703|76151768|FG000|Month 3|Overall Study||104|This is the number of PWD who reached the Month 3 assessment window.|
60036216|NCT02380703|76151769|FG001|Month 3|Overall Study||109|This is the number of PWD who reached the Month 3 assessment window.|
60036217|NCT02380703|76151768|FG000|Month 6|Overall Study||102|This is the number of PWD who reached the Month 6 assessment window.|
60036218|NCT02380703|76151769|FG001|Month 6|Overall Study||107|This is the number of PWD who reached the Month 6 assessment window.|
60036219|NCT02380703|76151768|FG000|Month 12|Overall Study||99|This is the number of PWD who reached the Month 12 assessment window.|
60036220|NCT02380703|76151769|FG001|Month 12|Overall Study||100|This is the number of PWD who reached the Month 12 assessment window.|
60036221|NCT02380703|76151768|FG000|COMPLETED|Overall Study||78|This is the number of PWD who completed the Month 12 assessment.|
60036222|NCT02380703|76151769|FG001|COMPLETED|Overall Study||78|This is the number of PWD who completed the Month 12 assessment.|
60036223|NCT02380703|76151768|FG000|NOT COMPLETED|Overall Study||36||
60036224|NCT02380703|76151769|FG001|NOT COMPLETED|Overall Study||36||
60036225|NCT02379923|76151775|FG000|STARTED|Overall Study||163||
60036226|NCT02379923|76151775|FG000|COMPLETED|Overall Study||158||
60036227|NCT02379923|76151775|FG000|NOT COMPLETED|Overall Study||5||
60036228|NCT02379221|76151782|FG000|STARTED|Overall Study||49||
60036229|NCT02379221|76151782|FG000|COMPLETED|Overall Study||48||
60036230|NCT02379221|76151782|FG000|NOT COMPLETED|Overall Study||1||
60036231|NCT02404103|76151793|FG000|STARTED|Overall Study||14||
60036232|NCT02404103|76151794|FG001|STARTED|Overall Study||12||
60036233|NCT02404103|76151793|FG000|COMPLETED|Overall Study||10||
60036234|NCT02404103|76151794|FG001|COMPLETED|Overall Study||9||
60036235|NCT02404103|76151793|FG000|NOT COMPLETED|Overall Study||4||
60036236|NCT02404103|76151794|FG001|NOT COMPLETED|Overall Study||3||
60036237|NCT02404025|76151810|FG000|STARTED|Overall Study||10||
60036238|NCT02404025|76151810|FG000|COMPLETED|Overall Study||6||
60036239|NCT02404025|76151810|FG000|NOT COMPLETED|Overall Study||4||
60036240|NCT02377817|76151816|FG000|STARTED|Overall Study||13||
60036241|NCT02377817|76151817|FG001|STARTED|Overall Study||10||
60036242|NCT02377817|76151816|FG000|COMPLETED|Overall Study||10||
60036243|NCT02377817|76151817|FG001|COMPLETED|Overall Study||10||
60036244|NCT02377817|76151816|FG000|NOT COMPLETED|Overall Study||3||
60036245|NCT02377817|76151817|FG001|NOT COMPLETED|Overall Study||0||
60036246|NCT02403635|76151825|FG000|STARTED|Overall Study||27||
60036247|NCT02403635|76151825|FG000|Screening (28 Days)|Overall Study||27||
60036248|NCT02403635|76151825|FG000|Received the First Dose|Overall Study||18||
60036249|NCT02403635|76151825|FG000|COMPLETED|Overall Study||18||
60036250|NCT02403635|76151825|FG000|NOT COMPLETED|Overall Study||9||
60036251|NCT02402933|76151845|FG000|STARTED|Overall Study||26||
60036252|NCT02402933|76151845|FG000|Received at Least One Dose of Study Drug|Overall Study||22||
59508867|NCT00771875|75601942|FG002|NOT COMPLETED|Overall Study||0||
59508868|NCT02046525|75601952|FG000|STARTED|Overall Study||5||
59508869|NCT02046525|75601953|FG001|STARTED|Overall Study||5||
59508870|NCT02046525|75601952|FG000|COMPLETED|Overall Study||5||
59508871|NCT02046525|75601953|FG001|COMPLETED|Overall Study||5||
59508872|NCT02046525|75601952|FG000|NOT COMPLETED|Overall Study||0||
59508873|NCT02046525|75601953|FG001|NOT COMPLETED|Overall Study||0||
59508874|NCT02047305|75601959|FG000|STARTED|Overall Study||96||
59508875|NCT02047305|75601959|FG000|COMPLETED|Overall Study||96||
59508876|NCT02047305|75601959|FG000|NOT COMPLETED|Overall Study||0||
59508877|NCT00760019|75601965|FG000|STARTED|Overall Study||15||
59508878|NCT00760019|75601966|FG001|STARTED|Overall Study||15||
59508879|NCT00760019|75601967|FG002|STARTED|Overall Study||14||
59508880|NCT00760019|75601968|FG003|STARTED|Overall Study||14||
60036253|NCT02402933|76151845|FG000|COMPLETED|Overall Study||12||
60036254|NCT02402933|76151845|FG000|NOT COMPLETED|Overall Study||14||
60036255|NCT01796470|76151854|FG000|STARTED|Overall Study||35||
60036256|NCT01796470|76151855|FG001|STARTED|Overall Study||14||
60036257|NCT01796470|76151856|FG002|STARTED|Overall Study||6||
60036258|NCT01796470|76151857|FG003|STARTED|Overall Study||3||
60036259|NCT01796470|76151858|FG004|STARTED|Overall Study||8||
60036260|NCT01796470|76151854|FG000|Entospletinib Monotherapy|Overall Study||4|Participants who received monotherapy when combination therapy was discontinued.|
60036261|NCT01796470|76151855|FG001|Entospletinib Monotherapy|Overall Study||4|Participants who received monotherapy when combination therapy was discontinued.|
60036262|NCT01796470|76151856|FG002|Entospletinib Monotherapy|Overall Study||0|Participants who received monotherapy when combination therapy was discontinued.|
60036263|NCT01796470|76151857|FG003|Entospletinib Monotherapy|Overall Study||0|Participants who received monotherapy when combination therapy was discontinued.|
60036264|NCT01796470|76151858|FG004|Entospletinib Monotherapy|Overall Study||0|Participants who received monotherapy when combination therapy was discontinued.|
60036265|NCT01796470|76151854|FG000|COMPLETED|Overall Study||0||
60036266|NCT01796470|76151855|FG001|COMPLETED|Overall Study||0||
59508881|NCT00760019|75601965|FG000|COMPLETED|Overall Study||15||
59508882|NCT00760019|75601966|FG001|COMPLETED|Overall Study||15||
59508883|NCT00760019|75601967|FG002|COMPLETED|Overall Study||14||
59508884|NCT00760019|75601968|FG003|COMPLETED|Overall Study||14||
59508885|NCT00760019|75601965|FG000|NOT COMPLETED|Overall Study||0||
59508886|NCT00760019|75601966|FG001|NOT COMPLETED|Overall Study||0||
59508887|NCT00760019|75601967|FG002|NOT COMPLETED|Overall Study||0||
60036267|NCT01796470|76151856|FG002|COMPLETED|Overall Study||0||
60036268|NCT01796470|76151857|FG003|COMPLETED|Overall Study||0||
60036269|NCT01796470|76151858|FG004|COMPLETED|Overall Study||0||
60036270|NCT01796470|76151854|FG000|NOT COMPLETED|Overall Study||35||
60036271|NCT01796470|76151855|FG001|NOT COMPLETED|Overall Study||14||
60036272|NCT01796470|76151856|FG002|NOT COMPLETED|Overall Study||6||
60036273|NCT01796470|76151857|FG003|NOT COMPLETED|Overall Study||3||
60036274|NCT01796470|76151858|FG004|NOT COMPLETED|Overall Study||8||
60036275|NCT01868074|76151876|FG000|STARTED|Overall Study||36||
60036276|NCT01868074|76151877|FG001|STARTED|Overall Study||36||
60036277|NCT01868074|76151876|FG000|COMPLETED|Overall Study||29||
60036278|NCT01868074|76151877|FG001|COMPLETED|Overall Study||32||
60036279|NCT01868074|76151876|FG000|NOT COMPLETED|Overall Study||7||
60036280|NCT01868074|76151877|FG001|NOT COMPLETED|Overall Study||4||
60036281|NCT01810042|76151883|FG000|STARTED|Overall Study||49||
60036282|NCT01810042|76151883|FG000|COMPLETED|Overall Study||39||
60036283|NCT01810042|76151883|FG000|NOT COMPLETED|Overall Study||10||
60036284|NCT02424539|76151890|FG000|STARTED|Overall Study||120||
60036285|NCT02424539|76151891|FG001|STARTED|Overall Study||119||
60036286|NCT02424539|76151892|FG002|STARTED|Overall Study||119||
60036287|NCT02424539|76151890|FG000|COMPLETED|Overall Study||106||
60036288|NCT02424539|76151891|FG001|COMPLETED|Overall Study||111||
60036289|NCT02424539|76151892|FG002|COMPLETED|Overall Study||111||
60036290|NCT02424539|76151890|FG000|NOT COMPLETED|Overall Study||14||
60036291|NCT02424539|76151891|FG001|NOT COMPLETED|Overall Study||8||
60036292|NCT02424539|76151892|FG002|NOT COMPLETED|Overall Study||8||
60036293|NCT01809262|76151900|FG000|STARTED|Period 1 (First Dose + Washout)||4||
60036294|NCT01809262|76151901|FG001|STARTED|Period 1 (First Dose + Washout)||4||
60036295|NCT01809262|76151902|FG002|STARTED|Period 1 (First Dose + Washout)||4||
60036296|NCT01809262|76151903|FG003|STARTED|Period 1 (First Dose + Washout)||3||
60036297|NCT01809262|76151904|FG004|STARTED|Period 1 (First Dose + Washout)||4||
60036298|NCT01809262|76151905|FG005|STARTED|Period 1 (First Dose + Washout)||3||
60036299|NCT01809262|76151906|FG006|STARTED|Period 1 (First Dose + Washout)||3||
60036300|NCT01809262|76151907|FG007|STARTED|Period 1 (First Dose + Washout)||4||
60036301|NCT01809262|76151908|FG008|STARTED|Period 1 (First Dose + Washout)||3||
60036302|NCT01809262|76151909|FG009|STARTED|Period 1 (First Dose + Washout)||4||
60036303|NCT01809262|76151900|FG000|COMPLETED|Period 1 (First Dose + Washout)||4||
60036304|NCT01809262|76151901|FG001|COMPLETED|Period 1 (First Dose + Washout)||4||
60036305|NCT01809262|76151902|FG002|COMPLETED|Period 1 (First Dose + Washout)||4||
60036306|NCT01809262|76151903|FG003|COMPLETED|Period 1 (First Dose + Washout)||3||
60036307|NCT01809262|76151904|FG004|COMPLETED|Period 1 (First Dose + Washout)||3||
60036308|NCT01809262|76151905|FG005|COMPLETED|Period 1 (First Dose + Washout)||3||
60036309|NCT01809262|76151906|FG006|COMPLETED|Period 1 (First Dose + Washout)||3||
60036310|NCT01809262|76151907|FG007|COMPLETED|Period 1 (First Dose + Washout)||4||
60036311|NCT01809262|76151908|FG008|COMPLETED|Period 1 (First Dose + Washout)||3||
60036312|NCT01809262|76151909|FG009|COMPLETED|Period 1 (First Dose + Washout)||4||
60036313|NCT01809262|76151900|FG000|NOT COMPLETED|Period 1 (First Dose + Washout)||0||
60036314|NCT01809262|76151901|FG001|NOT COMPLETED|Period 1 (First Dose + Washout)||0||
60036315|NCT01809262|76151902|FG002|NOT COMPLETED|Period 1 (First Dose + Washout)||0||
60036316|NCT01809262|76151903|FG003|NOT COMPLETED|Period 1 (First Dose + Washout)||0||
60036317|NCT01809262|76151904|FG004|NOT COMPLETED|Period 1 (First Dose + Washout)||1||
60036318|NCT01809262|76151905|FG005|NOT COMPLETED|Period 1 (First Dose + Washout)||0||
60036319|NCT01809262|76151906|FG006|NOT COMPLETED|Period 1 (First Dose + Washout)||0||
60036320|NCT01809262|76151907|FG007|NOT COMPLETED|Period 1 (First Dose + Washout)||0||
60036321|NCT01809262|76151908|FG008|NOT COMPLETED|Period 1 (First Dose + Washout)||0||
60036322|NCT01809262|76151909|FG009|NOT COMPLETED|Period 1 (First Dose + Washout)||0||
60036323|NCT01809262|76151900|FG000|STARTED|Period 2 (Second Dose + Washout)||4||
60036324|NCT01809262|76151901|FG001|STARTED|Period 2 (Second Dose + Washout)||4||
60036325|NCT01809262|76151902|FG002|STARTED|Period 2 (Second Dose + Washout)||4||
60036326|NCT01809262|76151903|FG003|STARTED|Period 2 (Second Dose + Washout)||3||
60036327|NCT01809262|76151904|FG004|STARTED|Period 2 (Second Dose + Washout)||3||
59508888|NCT00760019|75601968|FG003|NOT COMPLETED|Overall Study||0||
60036328|NCT01809262|76151905|FG005|STARTED|Period 2 (Second Dose + Washout)||3||
60036329|NCT01809262|76151906|FG006|STARTED|Period 2 (Second Dose + Washout)||3||
60036330|NCT01809262|76151907|FG007|STARTED|Period 2 (Second Dose + Washout)||4||
60036331|NCT01809262|76151908|FG008|STARTED|Period 2 (Second Dose + Washout)||3||
60036332|NCT01809262|76151909|FG009|STARTED|Period 2 (Second Dose + Washout)||4||
60036333|NCT01809262|76151900|FG000|COMPLETED|Period 2 (Second Dose + Washout)||4||
60036334|NCT01809262|76151901|FG001|COMPLETED|Period 2 (Second Dose + Washout)||4||
59508889|NCT02383719|75601974|FG000|STARTED|Overall Study||18||
60036335|NCT01809262|76151902|FG002|COMPLETED|Period 2 (Second Dose + Washout)||4||
60036336|NCT01809262|76151903|FG003|COMPLETED|Period 2 (Second Dose + Washout)||3||
60036337|NCT01809262|76151904|FG004|COMPLETED|Period 2 (Second Dose + Washout)||3||
60036338|NCT01809262|76151905|FG005|COMPLETED|Period 2 (Second Dose + Washout)||3||
60036339|NCT01809262|76151906|FG006|COMPLETED|Period 2 (Second Dose + Washout)||3||
60036340|NCT01809262|76151907|FG007|COMPLETED|Period 2 (Second Dose + Washout)||4||
59508890|NCT02383719|75601974|FG000|COMPLETED|Overall Study||18||
60036341|NCT01809262|76151908|FG008|COMPLETED|Period 2 (Second Dose + Washout)||3||
60036342|NCT01809262|76151909|FG009|COMPLETED|Period 2 (Second Dose + Washout)||4||
59508891|NCT02383719|75601974|FG000|NOT COMPLETED|Overall Study||0||
59508892|NCT00789113|75601978|FG000|STARTED|Overall Study||12||
60036343|NCT01809262|76151900|FG000|NOT COMPLETED|Period 2 (Second Dose + Washout)||0||
60067821|NCT01785849|76183007|FG000|NOT COMPLETED|Overall Study||61||
59508893|NCT00789113|75601978|FG000|COMPLETED|Overall Study||12||
59508894|NCT00789113|75601978|FG000|NOT COMPLETED|Overall Study||0||
59508895|NCT02386605|75601985|FG000|STARTED|Overall Study||41||
59508896|NCT02386605|75601986|FG001|STARTED|Overall Study||38||
59508897|NCT02386605|75601985|FG000|COMPLETED|Overall Study||34||
59508898|NCT02386605|75601986|FG001|COMPLETED|Overall Study||28||
59508899|NCT02386605|75601985|FG000|NOT COMPLETED|Overall Study||7||
59508900|NCT02386605|75601986|FG001|NOT COMPLETED|Overall Study||10||
59508901|NCT02387853|75601992|FG000|STARTED|Overall Study||106||
59508902|NCT02387853|75601992|FG000|COMPLETED|Overall Study||103||
59508903|NCT02387853|75601992|FG000|NOT COMPLETED|Overall Study||3||
59508904|NCT02145299|75601998|FG000|STARTED|Overall Study||6||
59508905|NCT02145299|75601999|FG001|STARTED|Overall Study||2||
59508906|NCT02145299|75601998|FG000|COMPLETED|Overall Study||6||
59508907|NCT02145299|75601999|FG001|COMPLETED|Overall Study||2||
59508908|NCT02145299|75601998|FG000|NOT COMPLETED|Overall Study||0||
59508909|NCT02145299|75601999|FG001|NOT COMPLETED|Overall Study||0||
59508910|NCT02051595|75602005|FG000|STARTED|Overall Study||25||
59508911|NCT02051595|75602005|FG000|COMPLETED|Overall Study||25||
59508912|NCT02051595|75602005|FG000|NOT COMPLETED|Overall Study||0||
59508913|NCT02146001|75602011|FG000|STARTED|Overall Study||19||
59508914|NCT02146001|75602012|FG001|STARTED|Overall Study||19||
59508915|NCT02146001|75602011|FG000|COMPLETED|Overall Study||19||
59508916|NCT02146001|75602012|FG001|COMPLETED|Overall Study||19||
59508917|NCT02146001|75602011|FG000|NOT COMPLETED|Overall Study||0||
59508918|NCT02146001|75602012|FG001|NOT COMPLETED|Overall Study||0||
59508919|NCT02313597|75602020|FG000|STARTED|Overall Study||40||
59508920|NCT02313597|75602021|FG001|STARTED|Overall Study||40||
59508921|NCT02313597|75602020|FG000|COMPLETED|Overall Study||40||
59508922|NCT02313597|75602021|FG001|COMPLETED|Overall Study||40||
59508923|NCT02313597|75602020|FG000|NOT COMPLETED|Overall Study||0||
59508924|NCT02313597|75602021|FG001|NOT COMPLETED|Overall Study||0||
59508925|NCT02388321|75602029|FG000|STARTED|Overall Study||11||
59508926|NCT02388321|75602030|FG001|STARTED|Overall Study||11||
59508927|NCT02388321|75602029|FG000|COMPLETED|Overall Study||11||
59508928|NCT02388321|75602030|FG001|COMPLETED|Overall Study||11||
59508929|NCT02388321|75602029|FG000|NOT COMPLETED|Overall Study||0||
59508930|NCT02388321|75602030|FG001|NOT COMPLETED|Overall Study||0||
59508931|NCT02313675|75602040|FG000|STARTED|Overall Study||11||
59508932|NCT02313675|75602041|FG001|STARTED|Overall Study||11||
59508933|NCT02313675|75602042|FG002|STARTED|Overall Study||11||
59508934|NCT02313675|75602043|FG003|STARTED|Overall Study||11||
59508935|NCT02313675|75602040|FG000|COMPLETED|Overall Study||11||
59508936|NCT02313675|75602041|FG001|COMPLETED|Overall Study||11||
59508937|NCT02313675|75602042|FG002|COMPLETED|Overall Study||11||
59508938|NCT02313675|75602043|FG003|COMPLETED|Overall Study||11||
59508939|NCT02313675|75602040|FG000|NOT COMPLETED|Overall Study||0||
59508940|NCT02313675|75602041|FG001|NOT COMPLETED|Overall Study||0||
59917716|NCT03341299|76038214|FG001|NOT COMPLETED|Period 3||0||
59508941|NCT02313675|75602042|FG002|NOT COMPLETED|Overall Study||0||
59508942|NCT02313675|75602043|FG003|NOT COMPLETED|Overall Study||0||
59508943|NCT02388633|75602053|FG000|STARTED|Overall Study||8||
59508944|NCT02388633|75602053|FG000|COMPLETED|Overall Study||8||
59917717|NCT03341299|76038215|FG002|NOT COMPLETED|Period 3||0||
59917718|NCT03341299|76038216|FG003|NOT COMPLETED|Period 3||0||
59917719|NCT03341299|76038213|FG000|STARTED|Washout (A Minimum of 21 Hours)||9||
59917720|NCT03341299|76038214|FG001|STARTED|Washout (A Minimum of 21 Hours)||9||
59508945|NCT02388633|75602053|FG000|NOT COMPLETED|Overall Study||0||
59508946|NCT02389101|75602057|FG000|STARTED|Overall Study||21||
59508947|NCT02389101|75602057|FG000|COMPLETED|Overall Study||21||
59508948|NCT02389101|75602057|FG000|NOT COMPLETED|Overall Study||0||
59508949|NCT02389725|75602063|FG000|STARTED|Overall Study||59||
59508950|NCT02389725|75602064|FG001|STARTED|Overall Study||60||
59508951|NCT02389725|75602063|FG000|COMPLETED|Overall Study||59||
59508952|NCT02389725|75602064|FG001|COMPLETED|Overall Study||60||
59508953|NCT02389725|75602063|FG000|NOT COMPLETED|Overall Study||0||
59508954|NCT02389725|75602064|FG001|NOT COMPLETED|Overall Study||0||
59508955|NCT02389881|75602079|FG000|STARTED|Overall Study||6||
59508956|NCT02389881|75602080|FG001|STARTED|Overall Study||6||
59508957|NCT02389881|75602081|FG002|STARTED|Overall Study||6||
59508958|NCT02389881|75602082|FG003|STARTED|Overall Study||6||
59508959|NCT02389881|75602083|FG004|STARTED|Overall Study||6||
59917721|NCT03341299|76038215|FG002|STARTED|Washout (A Minimum of 21 Hours)||8||
59917722|NCT03341299|76038216|FG003|STARTED|Washout (A Minimum of 21 Hours)||9||
60036344|NCT01809262|76151901|FG001|NOT COMPLETED|Period 2 (Second Dose + Washout)||0||
60036345|NCT01809262|76151902|FG002|NOT COMPLETED|Period 2 (Second Dose + Washout)||0||
60036346|NCT01809262|76151903|FG003|NOT COMPLETED|Period 2 (Second Dose + Washout)||0||
60036347|NCT01809262|76151904|FG004|NOT COMPLETED|Period 2 (Second Dose + Washout)||0||
59508960|NCT02389881|75602084|FG005|STARTED|Overall Study||8||
59508961|NCT02389881|75602085|FG006|STARTED|Overall Study||2||
59508962|NCT02389881|75602079|FG000|COMPLETED|Overall Study||6||
59508963|NCT02389881|75602080|FG001|COMPLETED|Overall Study||6||
59508964|NCT02389881|75602081|FG002|COMPLETED|Overall Study||6||
59508965|NCT02389881|75602082|FG003|COMPLETED|Overall Study||6||
60036348|NCT01809262|76151905|FG005|NOT COMPLETED|Period 2 (Second Dose + Washout)||0||
60036349|NCT01809262|76151906|FG006|NOT COMPLETED|Period 2 (Second Dose + Washout)||0||
60036350|NCT01809262|76151907|FG007|NOT COMPLETED|Period 2 (Second Dose + Washout)||0||
60036351|NCT01809262|76151908|FG008|NOT COMPLETED|Period 2 (Second Dose + Washout)||0||
60036352|NCT01809262|76151909|FG009|NOT COMPLETED|Period 2 (Second Dose + Washout)||0||
60036353|NCT01809262|76151900|FG000|STARTED|Period 3 (Third Dose + Washout)||4||
60036354|NCT01809262|76151901|FG001|STARTED|Period 3 (Third Dose + Washout)||4||
60036355|NCT01809262|76151902|FG002|STARTED|Period 3 (Third Dose + Washout)||4||
60036356|NCT01809262|76151903|FG003|STARTED|Period 3 (Third Dose + Washout)||3||
59508966|NCT02389881|75602083|FG004|COMPLETED|Overall Study||6||
59508967|NCT02389881|75602084|FG005|COMPLETED|Overall Study||8||
59508968|NCT02389881|75602085|FG006|COMPLETED|Overall Study||2||
60036357|NCT01809262|76151904|FG004|STARTED|Period 3 (Third Dose + Washout)||3||
60036358|NCT01809262|76151905|FG005|STARTED|Period 3 (Third Dose + Washout)||3||
60036359|NCT01809262|76151906|FG006|STARTED|Period 3 (Third Dose + Washout)||3||
60036360|NCT01809262|76151907|FG007|STARTED|Period 3 (Third Dose + Washout)||4||
60036361|NCT01809262|76151908|FG008|STARTED|Period 3 (Third Dose + Washout)||3||
60036362|NCT01809262|76151909|FG009|STARTED|Period 3 (Third Dose + Washout)||4||
60036363|NCT01809262|76151900|FG000|COMPLETED|Period 3 (Third Dose + Washout)||4||
60036364|NCT01809262|76151901|FG001|COMPLETED|Period 3 (Third Dose + Washout)||3||
60036365|NCT01809262|76151902|FG002|COMPLETED|Period 3 (Third Dose + Washout)||4||
60036366|NCT01809262|76151903|FG003|COMPLETED|Period 3 (Third Dose + Washout)||3||
60036367|NCT01809262|76151904|FG004|COMPLETED|Period 3 (Third Dose + Washout)||3||
60036368|NCT01809262|76151905|FG005|COMPLETED|Period 3 (Third Dose + Washout)||3||
60036369|NCT01809262|76151906|FG006|COMPLETED|Period 3 (Third Dose + Washout)||3||
60036370|NCT01809262|76151907|FG007|COMPLETED|Period 3 (Third Dose + Washout)||4||
60036371|NCT01809262|76151908|FG008|COMPLETED|Period 3 (Third Dose + Washout)||3||
60036372|NCT01809262|76151909|FG009|COMPLETED|Period 3 (Third Dose + Washout)||4||
60036373|NCT01809262|76151900|FG000|NOT COMPLETED|Period 3 (Third Dose + Washout)||0||
60036374|NCT01809262|76151901|FG001|NOT COMPLETED|Period 3 (Third Dose + Washout)||1||
60036375|NCT01809262|76151902|FG002|NOT COMPLETED|Period 3 (Third Dose + Washout)||0||
60036376|NCT01809262|76151903|FG003|NOT COMPLETED|Period 3 (Third Dose + Washout)||0||
59508969|NCT02389881|75602079|FG000|NOT COMPLETED|Overall Study||0||
59508970|NCT02389881|75602080|FG001|NOT COMPLETED|Overall Study||0||
59508971|NCT02389881|75602081|FG002|NOT COMPLETED|Overall Study||0||
60036377|NCT01809262|76151904|FG004|NOT COMPLETED|Period 3 (Third Dose + Washout)||0||
60036378|NCT01809262|76151905|FG005|NOT COMPLETED|Period 3 (Third Dose + Washout)||0||
60036379|NCT01809262|76151906|FG006|NOT COMPLETED|Period 3 (Third Dose + Washout)||0||
60036380|NCT01809262|76151907|FG007|NOT COMPLETED|Period 3 (Third Dose + Washout)||0||
60036381|NCT01809262|76151908|FG008|NOT COMPLETED|Period 3 (Third Dose + Washout)||0||
60036382|NCT01809262|76151909|FG009|NOT COMPLETED|Period 3 (Third Dose + Washout)||0||
60036383|NCT01809262|76151900|FG000|STARTED|Period 4 (Fourth Dose + Washout)||4||
60036384|NCT01809262|76151901|FG001|STARTED|Period 4 (Fourth Dose + Washout)||3||
60036385|NCT01809262|76151902|FG002|STARTED|Period 4 (Fourth Dose + Washout)||4||
60036386|NCT01809262|76151903|FG003|STARTED|Period 4 (Fourth Dose + Washout)||3||
60036387|NCT01809262|76151904|FG004|STARTED|Period 4 (Fourth Dose + Washout)||3||
60036388|NCT01809262|76151905|FG005|STARTED|Period 4 (Fourth Dose + Washout)||3||
60036389|NCT01809262|76151906|FG006|STARTED|Period 4 (Fourth Dose + Washout)||3||
60036390|NCT01809262|76151907|FG007|STARTED|Period 4 (Fourth Dose + Washout)||4||
60036391|NCT01809262|76151908|FG008|STARTED|Period 4 (Fourth Dose + Washout)||3||
59508972|NCT02389881|75602082|FG003|NOT COMPLETED|Overall Study||0||
59508973|NCT02389881|75602083|FG004|NOT COMPLETED|Overall Study||0||
60036392|NCT01809262|76151909|FG009|STARTED|Period 4 (Fourth Dose + Washout)||4||
60036393|NCT01809262|76151900|FG000|COMPLETED|Period 4 (Fourth Dose + Washout)||4||
60036394|NCT01809262|76151901|FG001|COMPLETED|Period 4 (Fourth Dose + Washout)||3||
60036395|NCT01809262|76151902|FG002|COMPLETED|Period 4 (Fourth Dose + Washout)||4||
60036396|NCT01809262|76151903|FG003|COMPLETED|Period 4 (Fourth Dose + Washout)||3||
60036397|NCT01809262|76151904|FG004|COMPLETED|Period 4 (Fourth Dose + Washout)||3||
60036398|NCT01809262|76151905|FG005|COMPLETED|Period 4 (Fourth Dose + Washout)||3||
60036399|NCT01809262|76151906|FG006|COMPLETED|Period 4 (Fourth Dose + Washout)||3||
60036400|NCT01809262|76151907|FG007|COMPLETED|Period 4 (Fourth Dose + Washout)||4||
60036401|NCT01809262|76151908|FG008|COMPLETED|Period 4 (Fourth Dose + Washout)||3||
60036402|NCT01809262|76151909|FG009|COMPLETED|Period 4 (Fourth Dose + Washout)||4||
60036403|NCT01809262|76151900|FG000|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0||
60036404|NCT01809262|76151901|FG001|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0||
60036405|NCT01809262|76151902|FG002|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0||
60036406|NCT01809262|76151903|FG003|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0||
60036407|NCT01809262|76151904|FG004|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0||
60036408|NCT01809262|76151905|FG005|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0||
60036409|NCT01809262|76151906|FG006|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0||
60036410|NCT01809262|76151907|FG007|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0||
60036411|NCT01809262|76151908|FG008|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0||
60036412|NCT01809262|76151909|FG009|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0||
60036413|NCT01809262|76151900|FG000|STARTED|Period 5 (Fifth Dose + Washout)||4||
60036414|NCT01809262|76151901|FG001|STARTED|Period 5 (Fifth Dose + Washout)||3||
60036415|NCT01809262|76151902|FG002|STARTED|Period 5 (Fifth Dose + Washout)||4||
60036416|NCT01809262|76151903|FG003|STARTED|Period 5 (Fifth Dose + Washout)||3||
60036417|NCT01809262|76151904|FG004|STARTED|Period 5 (Fifth Dose + Washout)||3||
60036418|NCT01809262|76151905|FG005|STARTED|Period 5 (Fifth Dose + Washout)||3||
60036419|NCT01809262|76151906|FG006|STARTED|Period 5 (Fifth Dose + Washout)||3||
60036420|NCT01809262|76151907|FG007|STARTED|Period 5 (Fifth Dose + Washout)||4||
60036421|NCT01809262|76151908|FG008|STARTED|Period 5 (Fifth Dose + Washout)||3||
60036422|NCT01809262|76151909|FG009|STARTED|Period 5 (Fifth Dose + Washout)||4||
60036423|NCT01809262|76151900|FG000|COMPLETED|Period 5 (Fifth Dose + Washout)||4||
60036424|NCT01809262|76151901|FG001|COMPLETED|Period 5 (Fifth Dose + Washout)||3||
60036425|NCT01809262|76151902|FG002|COMPLETED|Period 5 (Fifth Dose + Washout)||4||
60036426|NCT01809262|76151903|FG003|COMPLETED|Period 5 (Fifth Dose + Washout)||3||
60036427|NCT01809262|76151904|FG004|COMPLETED|Period 5 (Fifth Dose + Washout)||3||
60036428|NCT01809262|76151905|FG005|COMPLETED|Period 5 (Fifth Dose + Washout)||3||
60036429|NCT01809262|76151906|FG006|COMPLETED|Period 5 (Fifth Dose + Washout)||3||
60036430|NCT01809262|76151907|FG007|COMPLETED|Period 5 (Fifth Dose + Washout)||4||
60036431|NCT01809262|76151908|FG008|COMPLETED|Period 5 (Fifth Dose + Washout)||3||
60036432|NCT01809262|76151909|FG009|COMPLETED|Period 5 (Fifth Dose + Washout)||4||
60036433|NCT01809262|76151900|FG000|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0||
60036434|NCT01809262|76151901|FG001|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0||
60036435|NCT01809262|76151902|FG002|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0||
60036436|NCT01809262|76151903|FG003|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0||
60036437|NCT01809262|76151904|FG004|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0||
60036438|NCT01809262|76151905|FG005|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0||
60036439|NCT01809262|76151906|FG006|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0||
60036440|NCT01809262|76151907|FG007|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0||
60036441|NCT01809262|76151908|FG008|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0||
60036442|NCT01809262|76151909|FG009|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0||
60036443|NCT01808248|76151923|FG000|STARTED|Overall Study||47||
60036444|NCT01808248|76151923|FG000|Completed Posttreatment Week 12 Visit|Overall Study||45||
60036445|NCT01808248|76151923|FG000|COMPLETED|Overall Study||42||
60036446|NCT01808248|76151923|FG000|NOT COMPLETED|Overall Study||5||
60036447|NCT02424383|76151929|FG000|STARTED|Overall Study||1005||
60036448|NCT02424383|76151929|FG000|Per-Protocol Population|Overall Study||966||
60036449|NCT02424383|76151929|FG000|COMPLETED|Overall Study||629||
60036450|NCT02424383|76151929|FG000|NOT COMPLETED|Overall Study||376||
60036451|NCT01867294|76151937|FG000|STARTED|Overall Study||9||
60036452|NCT01867294|76151938|FG001|STARTED|Overall Study||10||
60036453|NCT01867294|76151939|FG002|STARTED|Overall Study||0||
60036454|NCT01867294|76151940|FG003|STARTED|Overall Study||0||
60036455|NCT01867294|76151937|FG000|COMPLETED|Overall Study||8||
60036456|NCT01867294|76151938|FG001|COMPLETED|Overall Study||9||
60036457|NCT01867294|76151939|FG002|COMPLETED|Overall Study||0||
60036458|NCT01867294|76151940|FG003|COMPLETED|Overall Study||0||
60036459|NCT01867294|76151937|FG000|NOT COMPLETED|Overall Study||1||
60036460|NCT01867294|76151938|FG001|NOT COMPLETED|Overall Study||1||
60036461|NCT01867294|76151939|FG002|NOT COMPLETED|Overall Study||0||
60036462|NCT01867294|76151940|FG003|NOT COMPLETED|Overall Study||0||
60036463|NCT02424149|76151950|FG000|STARTED|Overall Study||54||
60036464|NCT02424149|76151951|FG001|STARTED|Overall Study||53||
60036465|NCT02424149|76151950|FG000|COMPLETED|Overall Study||52||
60036466|NCT02424149|76151951|FG001|COMPLETED|Overall Study||52||
60036467|NCT02424149|76151950|FG000|NOT COMPLETED|Overall Study||2||
60036468|NCT02424149|76151951|FG001|NOT COMPLETED|Overall Study||1||
60036469|NCT02423291|76151957|FG000|STARTED|Overall Study|Patients enrolled|15||
60036470|NCT02423291|76151957|FG000|COMPLETED|Overall Study|Patients that have completed therapy|0||
60036471|NCT02423291|76151957|FG000|NOT COMPLETED|Overall Study||15||
60036472|NCT02401529|76151963|FG000|STARTED|Overall Study||59||
60036473|NCT02401529|76151964|FG001|STARTED|Overall Study||57||
60036474|NCT02401529|76151963|FG000|COMPLETED|Overall Study||50||
60036475|NCT02401529|76151964|FG001|COMPLETED|Overall Study||50||
60036476|NCT02401529|76151963|FG000|NOT COMPLETED|Overall Study||9||
60036477|NCT02401529|76151964|FG001|NOT COMPLETED|Overall Study||7||
60036478|NCT01867216|76151978|FG000|STARTED|Overall Study||16||
60036479|NCT01867216|76151979|FG001|STARTED|Overall Study||8||
60036480|NCT01867216|76151980|FG002|STARTED|Overall Study||8||
60036481|NCT01867216|76151981|FG003|STARTED|Overall Study||8||
60036482|NCT01867216|76151982|FG004|STARTED|Overall Study||9||
60036483|NCT01867216|76151983|FG005|STARTED|Overall Study||8||
59759440|NCT00909857|75878840|FG000|COMPLETED|Overall Study||217||
60036484|NCT01867216|76151984|FG006|STARTED|Overall Study||9||
60036485|NCT01867216|76151978|FG000|Received Study Drug|Overall Study||14||
60036486|NCT01867216|76151979|FG001|Received Study Drug|Overall Study||8||
60036487|NCT01867216|76151980|FG002|Received Study Drug|Overall Study||8||
60036488|NCT01867216|76151981|FG003|Received Study Drug|Overall Study||8||
60036489|NCT01867216|76151982|FG004|Received Study Drug|Overall Study||9||
60036490|NCT01867216|76151983|FG005|Received Study Drug|Overall Study||8||
60036491|NCT01867216|76151984|FG006|Received Study Drug|Overall Study||9||
60036492|NCT01867216|76151978|FG000|COMPLETED|Overall Study||12||
60036493|NCT01867216|76151979|FG001|COMPLETED|Overall Study||8||
60036494|NCT01867216|76151980|FG002|COMPLETED|Overall Study||8||
60036495|NCT01867216|76151981|FG003|COMPLETED|Overall Study||8||
60036496|NCT01867216|76151982|FG004|COMPLETED|Overall Study||8||
60036497|NCT01867216|76151983|FG005|COMPLETED|Overall Study||8||
60036498|NCT01867216|76151984|FG006|COMPLETED|Overall Study||8||
60036499|NCT01867216|76151978|FG000|NOT COMPLETED|Overall Study||4||
60036500|NCT01867216|76151979|FG001|NOT COMPLETED|Overall Study||0||
60036501|NCT01867216|76151980|FG002|NOT COMPLETED|Overall Study||0||
60036502|NCT01867216|76151981|FG003|NOT COMPLETED|Overall Study||0||
60036503|NCT01867216|76151982|FG004|NOT COMPLETED|Overall Study||1||
60036504|NCT01867216|76151983|FG005|NOT COMPLETED|Overall Study||0||
60036505|NCT01867216|76151984|FG006|NOT COMPLETED|Overall Study||1||
60036506|NCT01866826|76152006|FG000|STARTED|Phase I -Initial Randomization - 4 Weeks||23||
60036507|NCT01866826|76152007|FG001|STARTED|Phase I -Initial Randomization - 4 Weeks||23||
60036508|NCT01866826|76152006|FG000|COMPLETED|Phase I -Initial Randomization - 4 Weeks||22||
60036509|NCT01866826|76152007|FG001|COMPLETED|Phase I -Initial Randomization - 4 Weeks||23||
60036510|NCT01866826|76152006|FG000|NOT COMPLETED|Phase I -Initial Randomization - 4 Weeks||1||
60036511|NCT01866826|76152007|FG001|NOT COMPLETED|Phase I -Initial Randomization - 4 Weeks||0||
60036512|NCT01866826|76152006|FG000|STARTED|Wash-Out Period - 4 -6 Weeks||22||
60036513|NCT01866826|76152007|FG001|STARTED|Wash-Out Period - 4 -6 Weeks||23||
60036514|NCT01866826|76152006|FG000|COMPLETED|Wash-Out Period - 4 -6 Weeks||22||
60036515|NCT01866826|76152007|FG001|COMPLETED|Wash-Out Period - 4 -6 Weeks||20||
60036516|NCT01866826|76152006|FG000|NOT COMPLETED|Wash-Out Period - 4 -6 Weeks||0||
60036517|NCT01866826|76152007|FG001|NOT COMPLETED|Wash-Out Period - 4 -6 Weeks||3||
60036518|NCT01866826|76152006|FG000|STARTED|Second Intervention - 4 Weeks||22||
60036519|NCT01866826|76152007|FG001|STARTED|Second Intervention - 4 Weeks||20||
60036520|NCT01866826|76152006|FG000|COMPLETED|Second Intervention - 4 Weeks||22||
59759441|NCT00909857|75878841|FG001|COMPLETED|Overall Study||209||
59759442|NCT00909857|75878840|FG000|NOT COMPLETED|Overall Study||36||
59759443|NCT00909857|75878841|FG001|NOT COMPLETED|Overall Study||45||
59759444|NCT00911807|75878850|FG000|STARTED|Overall Study||72||
59759445|NCT00911807|75878851|FG001|STARTED|Overall Study||70||
59759446|NCT00911807|75878852|FG002|STARTED|Overall Study||75||
59759447|NCT00911807|75878850|FG000|COMPLETED|Overall Study||55||
59759448|NCT00911807|75878851|FG001|COMPLETED|Overall Study||52||
59759449|NCT00911807|75878852|FG002|COMPLETED|Overall Study||52||
59759450|NCT00911807|75878850|FG000|NOT COMPLETED|Overall Study||17||
59759451|NCT00911807|75878851|FG001|NOT COMPLETED|Overall Study||18||
59759452|NCT00911807|75878852|FG002|NOT COMPLETED|Overall Study||23||
59759453|NCT03812588|75878864|FG000|STARTED|Overall Study||5||
59759454|NCT03812588|75878865|FG001|STARTED|Overall Study||7||
59759455|NCT03812588|75878866|FG002|STARTED|Overall Study||5||
60036521|NCT01866826|76152007|FG001|COMPLETED|Second Intervention - 4 Weeks||20||
60036522|NCT01866826|76152006|FG000|NOT COMPLETED|Second Intervention - 4 Weeks||0||
60036523|NCT01866826|76152007|FG001|NOT COMPLETED|Second Intervention - 4 Weeks||0||
59508974|NCT02389881|75602084|FG005|NOT COMPLETED|Overall Study||0||
59508975|NCT02389881|75602085|FG006|NOT COMPLETED|Overall Study||0||
59508976|NCT02389959|75602103|FG000|STARTED|Overall Study||20||
60036524|NCT04584970|76152015|FG000|STARTED|Overall Study||11||
60036525|NCT04584970|76152016|FG001|STARTED|Overall Study||12||
60036526|NCT04584970|76152015|FG000|COMPLETED|Overall Study||10||
60036527|NCT04584970|76152016|FG001|COMPLETED|Overall Study||9||
60036528|NCT04584970|76152015|FG000|NOT COMPLETED|Overall Study||1||
60036529|NCT04584970|76152016|FG001|NOT COMPLETED|Overall Study||3||
60036530|NCT01791244|76152024|FG000|STARTED|Overall Study||46||
60036531|NCT01791244|76152025|FG001|STARTED|Overall Study||47||
60036532|NCT01791244|76152024|FG000|Intent to Treat (ITT)|Overall Study||38||
59508977|NCT02389959|75602104|FG001|STARTED|Overall Study||20||
59508978|NCT02389959|75602103|FG000|COMPLETED|Overall Study||18||
59508979|NCT02389959|75602104|FG001|COMPLETED|Overall Study||19||
59508980|NCT02389959|75602103|FG000|NOT COMPLETED|Overall Study||2||
60036533|NCT01791244|76152025|FG001|Intent to Treat (ITT)|Overall Study||39||
60036534|NCT01791244|76152024|FG000|COMPLETED|Overall Study||31||
60036535|NCT01791244|76152025|FG001|COMPLETED|Overall Study||29||
60036536|NCT01791244|76152024|FG000|NOT COMPLETED|Overall Study||15||
60036537|NCT01791244|76152025|FG001|NOT COMPLETED|Overall Study||18||
60036538|NCT01865812|76152033|FG000|STARTED|Primary Treatment Phase||27|One participant was thought to have been incorrectly dispensed 5-mg OCA during the PTP. This participant was not included in the ITT population and this participant's data was not included in any of the analyses.|
60036539|NCT01865812|76152034|FG001|STARTED|Primary Treatment Phase||0|One participant was thought to have been incorrectly dispensed 5-mg OCA during the PTP. This participant was not included in the ITT population and this participant's data was not included in any of the analyses.|
60036540|NCT01865812|76152033|FG000|Received at Least 1 Dose of Study Drug|Primary Treatment Phase||27|One participant was thought to have been incorrectly dispensed 5-mg OCA during the PTP. This participant was not included in the ITT population and this participant's data was not included in any of the analyses.|
60036541|NCT01865812|76152034|FG001|Received at Least 1 Dose of Study Drug|Primary Treatment Phase||0|One participant was thought to have been incorrectly dispensed 5-mg OCA during the PTP. This participant was not included in the ITT population and this participant's data was not included in any of the analyses.|
60036542|NCT01865812|76152033|FG000|COMPLETED|Primary Treatment Phase||25||
60036543|NCT01865812|76152034|FG001|COMPLETED|Primary Treatment Phase||0||
60036544|NCT01865812|76152033|FG000|NOT COMPLETED|Primary Treatment Phase||2||
60036545|NCT01865812|76152034|FG001|NOT COMPLETED|Primary Treatment Phase||0||
60036546|NCT01865812|76152033|FG000|STARTED|Long-term Safety Extension Phase|Only eligible participants who completed the PTP phase enrolled in the LTSE phase.|0|Only eligible participants who completed the PTP phase enrolled in the LTSE phase.|
60036547|NCT01865812|76152034|FG001|STARTED|Long-term Safety Extension Phase|Only eligible participants who completed the PTP phase enrolled in the LTSE phase.|21|Only eligible participants who completed the PTP phase enrolled in the LTSE phase.|
60036548|NCT01865812|76152033|FG000|Received at Least 1 Dose of Study Drug|Long-term Safety Extension Phase||0||
60036549|NCT01865812|76152034|FG001|Received at Least 1 Dose of Study Drug|Long-term Safety Extension Phase||21||
60036550|NCT01865812|76152033|FG000|COMPLETED|Long-term Safety Extension Phase||0||
60036551|NCT01865812|76152034|FG001|COMPLETED|Long-term Safety Extension Phase||15||
60036552|NCT01865812|76152033|FG000|NOT COMPLETED|Long-term Safety Extension Phase||0||
60036553|NCT01865812|76152034|FG001|NOT COMPLETED|Long-term Safety Extension Phase||6||
60036554|NCT01808092|76152043|FG000|STARTED|Overall Study||409||
60036555|NCT01808092|76152044|FG001|STARTED|Overall Study||408||
60036556|NCT01808092|76152043|FG000|COMPLETED|Overall Study||355||
60036557|NCT01808092|76152044|FG001|COMPLETED|Overall Study||363||
60036558|NCT01808092|76152043|FG000|NOT COMPLETED|Overall Study||54||
60036559|NCT01808092|76152044|FG001|NOT COMPLETED|Overall Study||45||
60036560|NCT01774084|76152052|FG000|STARTED|Overall Study||11||
60036561|NCT01774084|76152053|FG001|STARTED|Overall Study||12||
60036562|NCT01774084|76152052|FG000|COMPLETED|Overall Study||10||
60036563|NCT01774084|76152053|FG001|COMPLETED|Overall Study||12||
60036564|NCT01774084|76152052|FG000|NOT COMPLETED|Overall Study||1||
60036565|NCT01774084|76152053|FG001|NOT COMPLETED|Overall Study||0||
60036566|NCT01807234|76152065|FG000|STARTED|Overall Study||12||
60036567|NCT01807234|76152066|FG001|STARTED|Overall Study||12||
59508981|NCT02389959|75602104|FG001|NOT COMPLETED|Overall Study||1||
59508982|NCT00775931|75602112|FG000|STARTED|Overall Study||6||
59508983|NCT00775931|75602113|FG001|STARTED|Overall Study||1||
59508984|NCT00775931|75602112|FG000|COMPLETED|Overall Study||6||
59508985|NCT00775931|75602113|FG001|COMPLETED|Overall Study||1||
59612293|NCT01721772|75723464|FG000|NOT COMPLETED|Pre-Treatment||4||
59508986|NCT00775931|75602112|FG000|NOT COMPLETED|Overall Study||0||
59508987|NCT00775931|75602113|FG001|NOT COMPLETED|Overall Study||0||
59612294|NCT01721772|75723465|FG001|NOT COMPLETED|Pre-Treatment||3||
59508988|NCT02148107|75602122|FG000|STARTED|Overall Study||8||
59508989|NCT02148107|75602123|FG001|STARTED|Overall Study||7||
59508990|NCT02148107|75602124|FG002|STARTED|Overall Study||3||
59508991|NCT02148107|75602122|FG000|COMPLETED|Overall Study||8||
59612295|NCT01721772|75723464|FG000|STARTED|Treatment||206|Treated|
59508992|NCT02148107|75602123|FG001|COMPLETED|Overall Study||7||
59508993|NCT02148107|75602124|FG002|COMPLETED|Overall Study||3||
59612296|NCT01721772|75723465|FG001|STARTED|Treatment||205|Treated|
60036568|NCT01807234|76152067|FG002|STARTED|Overall Study||12||
60036569|NCT01807234|76152068|FG003|STARTED|Overall Study||12||
60036570|NCT01807234|76152069|FG004|STARTED|Overall Study||12||
60036571|NCT01807234|76152070|FG005|STARTED|Overall Study||12||
60036572|NCT01807234|76152065|FG000|Randomized, But Did Not Take Drug|Overall Study||3||
60036573|NCT01807234|76152066|FG001|Randomized, But Did Not Take Drug|Overall Study||5||
60036574|NCT01807234|76152067|FG002|Randomized, But Did Not Take Drug|Overall Study||2||
60036575|NCT01807234|76152068|FG003|Randomized, But Did Not Take Drug|Overall Study||1||
60036576|NCT01807234|76152069|FG004|Randomized, But Did Not Take Drug|Overall Study||4||
60036577|NCT01807234|76152070|FG005|Randomized, But Did Not Take Drug|Overall Study||3||
60036578|NCT01807234|76152065|FG000|Completed Only 1 Attack|Overall Study||2||
60036579|NCT01807234|76152066|FG001|Completed Only 1 Attack|Overall Study||1||
60036580|NCT01807234|76152067|FG002|Completed Only 1 Attack|Overall Study||0||
60036581|NCT01807234|76152068|FG003|Completed Only 1 Attack|Overall Study||1||
60036582|NCT01807234|76152069|FG004|Completed Only 1 Attack|Overall Study||0||
60036583|NCT01807234|76152070|FG005|Completed Only 1 Attack|Overall Study||1||
60036584|NCT01807234|76152065|FG000|COMPLETED|Overall Study||7||
60036585|NCT01807234|76152066|FG001|COMPLETED|Overall Study||6||
60036586|NCT01807234|76152067|FG002|COMPLETED|Overall Study||10||
60036587|NCT01807234|76152068|FG003|COMPLETED|Overall Study||10||
60036588|NCT01807234|76152069|FG004|COMPLETED|Overall Study||8||
60036589|NCT01807234|76152070|FG005|COMPLETED|Overall Study||8||
60036590|NCT01807234|76152065|FG000|NOT COMPLETED|Overall Study||5||
60036591|NCT01807234|76152066|FG001|NOT COMPLETED|Overall Study||6||
60036592|NCT01807234|76152067|FG002|NOT COMPLETED|Overall Study||2||
60036593|NCT01807234|76152068|FG003|NOT COMPLETED|Overall Study||2||
60036594|NCT01807234|76152069|FG004|NOT COMPLETED|Overall Study||4||
60036595|NCT01807234|76152070|FG005|NOT COMPLETED|Overall Study||4||
60036596|NCT01790932|76152080|FG000|STARTED|Overall Study||50||
60036597|NCT01790932|76152080|FG000|COMPLETED|Overall Study||0|Given treatment duration is not fixed, all participants are considered as 'Non Completed'.|
60036598|NCT01790932|76152080|FG000|NOT COMPLETED|Overall Study||50||
60036599|NCT02377427|76152086|FG000|STARTED|Part A (Up to Week 20)||26||
60036600|NCT02377427|76152087|FG001|STARTED|Part A (Up to Week 20)||10||
60036601|NCT02377427|76152088|FG002|STARTED|Part A (Up to Week 20)||0||
60036602|NCT02377427|76152089|FG003|STARTED|Part A (Up to Week 20)||0||
60036603|NCT02377427|76152090|FG004|STARTED|Part A (Up to Week 20)||0||
59759456|NCT03812588|75878867|FG003|STARTED|Overall Study||8||
59759457|NCT03812588|75878864|FG000|COMPLETED|Overall Study||3||
59759458|NCT03812588|75878865|FG001|COMPLETED|Overall Study||5||
59759459|NCT03812588|75878866|FG002|COMPLETED|Overall Study||3||
59759460|NCT03812588|75878867|FG003|COMPLETED|Overall Study||8||
59759461|NCT03812588|75878864|FG000|NOT COMPLETED|Overall Study||2||
60036604|NCT02377427|76152086|FG000|COMPLETED|Part A (Up to Week 20)||22||
60036605|NCT02377427|76152087|FG001|COMPLETED|Part A (Up to Week 20)||10||
60036606|NCT02377427|76152088|FG002|COMPLETED|Part A (Up to Week 20)||0||
60036607|NCT02377427|76152089|FG003|COMPLETED|Part A (Up to Week 20)||0||
60036608|NCT02377427|76152090|FG004|COMPLETED|Part A (Up to Week 20)||0||
60036609|NCT02377427|76152086|FG000|NOT COMPLETED|Part A (Up to Week 20)||4||
60036610|NCT02377427|76152087|FG001|NOT COMPLETED|Part A (Up to Week 20)||0||
60036611|NCT02377427|76152088|FG002|NOT COMPLETED|Part A (Up to Week 20)||0||
60036612|NCT02377427|76152089|FG003|NOT COMPLETED|Part A (Up to Week 20)||0||
60036613|NCT02377427|76152090|FG004|NOT COMPLETED|Part A (Up to Week 20)||0||
60036614|NCT02377427|76152086|FG000|STARTED|Part B (From Week 20 and up to Week 80)||0||
60036615|NCT02377427|76152087|FG001|STARTED|Part B (From Week 20 and up to Week 80)||0||
60036616|NCT02377427|76152088|FG002|STARTED|Part B (From Week 20 and up to Week 80)|Two participants of PartA chose not to continue in PartB;4 shifted to PartB Mepolizumab 40/100mg arm|16||
60036617|NCT02377427|76152089|FG003|STARTED|Part B (From Week 20 and up to Week 80)||10||
60036618|NCT02377427|76152090|FG004|STARTED|Part B (From Week 20 and up to Week 80)||4||
60036619|NCT02377427|76152086|FG000|COMPLETED|Part B (From Week 20 and up to Week 80)||0||
60036620|NCT02377427|76152087|FG001|COMPLETED|Part B (From Week 20 and up to Week 80)||0||
60036621|NCT02377427|76152088|FG002|COMPLETED|Part B (From Week 20 and up to Week 80)||15||
60036622|NCT02377427|76152089|FG003|COMPLETED|Part B (From Week 20 and up to Week 80)||10||
60036623|NCT02377427|76152090|FG004|COMPLETED|Part B (From Week 20 and up to Week 80)||4||
60036624|NCT02377427|76152086|FG000|NOT COMPLETED|Part B (From Week 20 and up to Week 80)||0||
60036625|NCT02377427|76152087|FG001|NOT COMPLETED|Part B (From Week 20 and up to Week 80)||0||
60036626|NCT02377427|76152088|FG002|NOT COMPLETED|Part B (From Week 20 and up to Week 80)||1||
60036627|NCT02377427|76152089|FG003|NOT COMPLETED|Part B (From Week 20 and up to Week 80)||0||
60036628|NCT02377427|76152090|FG004|NOT COMPLETED|Part B (From Week 20 and up to Week 80)||0||
60036629|NCT02421887|76152105|FG000|STARTED|Overall Study||85||
60036630|NCT02421887|76152106|FG001|STARTED|Overall Study||86||
60036631|NCT02421887|76152105|FG000|COMPLETED|Overall Study||68||
59759462|NCT03812588|75878865|FG001|NOT COMPLETED|Overall Study||2||
59759463|NCT03812588|75878866|FG002|NOT COMPLETED|Overall Study||2||
59759464|NCT03812588|75878867|FG003|NOT COMPLETED|Overall Study||0||
59759465|NCT04287920|75878879|FG000|STARTED|Overall Study||6||
59759466|NCT04287920|75878880|FG001|STARTED|Overall Study||6||
59759467|NCT04287920|75878879|FG000|COMPLETED|Overall Study||5||
60036632|NCT02421887|76152106|FG001|COMPLETED|Overall Study||77||
60036633|NCT02421887|76152105|FG000|NOT COMPLETED|Overall Study||17||
60036634|NCT02421887|76152106|FG001|NOT COMPLETED|Overall Study||9||
60036635|NCT01609582|76152114|FG000|STARTED|Overall Study||1603||
60036636|NCT01609582|76152115|FG001|STARTED|Overall Study||1604||
60036637|NCT01609582|76152114|FG000|Treated|Overall Study||1603||
60036638|NCT01609582|76152115|FG001|Treated|Overall Study||1601||
60036639|NCT01609582|76152114|FG000|COMPLETED|Overall Study||0||
60036640|NCT01609582|76152115|FG001|COMPLETED|Overall Study||0||
60036641|NCT01609582|76152114|FG000|NOT COMPLETED|Overall Study||1603||
60036642|NCT01609582|76152115|FG001|NOT COMPLETED|Overall Study||1604||
60036643|NCT01789606|76152123|FG000|STARTED|Overall Study||251||
60036644|NCT01789606|76152124|FG001|STARTED|Overall Study||832||
60036645|NCT01789606|76152123|FG000|COMPLETED|Overall Study||228||
60036646|NCT01789606|76152124|FG001|COMPLETED|Overall Study||382||
60036647|NCT01789606|76152123|FG000|NOT COMPLETED|Overall Study||23||
60036648|NCT01789606|76152124|FG001|NOT COMPLETED|Overall Study||450||
60036649|NCT01788358|76152129|FG000|STARTED|Overall Study||508||
60036650|NCT01788358|76152129|FG000|Treated|Overall Study||508||
60036651|NCT01788358|76152129|FG000|Completed Week 28|Overall Study||417||
60036652|NCT01788358|76152129|FG000|Entered Extension to Week 52|Overall Study|Only the first 200 subjects who completed Week 28 visit, continued treatment up to 52 weeks.|200||
60036653|NCT01788358|76152129|FG000|Completed Week 52|Overall Study||193||
60036654|NCT01788358|76152129|FG000|COMPLETED|Overall Study|217 subjects completed the study at Week 28 while the remaining 193 subjects completed at Week 52|410||
60036655|NCT01788358|76152129|FG000|NOT COMPLETED|Overall Study||98||
60036656|NCT01773226|76152133|FG000|STARTED|Overall Study||11||
60036657|NCT01773226|76152133|FG000|COMPLETED|Overall Study|Withdrawal of one subject after one-month assessment due to persistent OA symptoms|10||
60036658|NCT01773226|76152133|FG000|NOT COMPLETED|Overall Study||1||
60036659|NCT01773070|76152137|FG000|STARTED|Overall Study||478||
60036660|NCT01773070|76152137|FG000|COMPLETED|Overall Study||397||
60036661|NCT01773070|76152137|FG000|NOT COMPLETED|Overall Study||81||
60036662|NCT01772368|76152141|FG000|STARTED|Overall Study||72||
60036663|NCT01772368|76152141|FG000|Received Fp MDPI 100 mcg|Overall Study||67||
60036664|NCT01772368|76152141|FG000|Received FS MDPI 100/6.25 mcg|Overall Study||68||
60036665|NCT01772368|76152141|FG000|Received FS MDPI 100/12.5mcg|Overall Study||69||
60036666|NCT01772368|76152141|FG000|Received FS MDPI 100/25 mcg|Overall Study||67||
59508994|NCT02148107|75602122|FG000|NOT COMPLETED|Overall Study||0||
59508995|NCT02148107|75602123|FG001|NOT COMPLETED|Overall Study||0||
59508996|NCT02148107|75602124|FG002|NOT COMPLETED|Overall Study||0||
59508997|NCT02052141|75602134|FG000|STARTED|Intervention Period 1||5||
59508998|NCT02052141|75602135|FG001|STARTED|Intervention Period 1||7||
59508999|NCT02052141|75602134|FG000|COMPLETED|Intervention Period 1||5||
59509000|NCT02052141|75602135|FG001|COMPLETED|Intervention Period 1||7||
59509001|NCT02052141|75602134|FG000|NOT COMPLETED|Intervention Period 1||0||
59759468|NCT04287920|75878880|FG001|COMPLETED|Overall Study||2||
60036667|NCT01772368|76152141|FG000|Received FS MDPI 100/50 mcg|Overall Study||68||
60036668|NCT01772368|76152141|FG000|Received Advair Diskus 100/50 mcg|Overall Study||66||
60036669|NCT01772368|76152141|FG000|COMPLETED|Overall Study||65||
60036670|NCT01772368|76152141|FG000|NOT COMPLETED|Overall Study||7||
60036671|NCT01788046|76152159|FG000|STARTED|Overall Study||260||
60036672|NCT01788046|76152160|FG001|STARTED|Overall Study||255||
60036673|NCT01788046|76152159|FG000|Received Treatment|Overall Study||259||
60036674|NCT01788046|76152160|FG001|Received Treatment|Overall Study||252||
60036675|NCT01788046|76152159|FG000|COMPLETED|Overall Study||204||
60036676|NCT01788046|76152160|FG001|COMPLETED|Overall Study||218||
60036677|NCT01788046|76152159|FG000|NOT COMPLETED|Overall Study||56||
59509002|NCT02052141|75602135|FG001|NOT COMPLETED|Intervention Period 1||0||
59509003|NCT02052141|75602134|FG000|STARTED|Intervention Period 2||5||
59509004|NCT02052141|75602135|FG001|STARTED|Intervention Period 2||7||
59509005|NCT02052141|75602134|FG000|COMPLETED|Intervention Period 2||5||
60036678|NCT01788046|76152160|FG001|NOT COMPLETED|Overall Study||37||
60036679|NCT01806298|76152166|FG000|STARTED|Overall Study||78||
60036680|NCT01806298|76152166|FG000|COMPLETED|Overall Study||68||
60036681|NCT01806298|76152166|FG000|NOT COMPLETED|Overall Study||10||
60036682|NCT01772134|76152173|FG000|STARTED|Overall Study|These participants were randomized but did not all receive study treatment.|207||
60036683|NCT01772134|76152174|FG001|STARTED|Overall Study|These participants were randomized but did not all receive study treatment.|204||
60036684|NCT01772134|76152175|FG002|STARTED|Overall Study|These participants were randomized but did not all receive study treatment.|206||
60036685|NCT01772134|76152173|FG000|Received Randomized Study Medication|Overall Study||205||
60036686|NCT01772134|76152174|FG001|Received Randomized Study Medication|Overall Study||204||
59509006|NCT02052141|75602135|FG001|COMPLETED|Intervention Period 2||7||
59509007|NCT02052141|75602134|FG000|NOT COMPLETED|Intervention Period 2||0||
59509008|NCT02052141|75602135|FG001|NOT COMPLETED|Intervention Period 2||0||
59509009|NCT02391987|75602143|FG000|STARTED|Overall Study||54||
59509010|NCT02391987|75602144|FG001|STARTED|Overall Study||58||
59509011|NCT02391987|75602143|FG000|COMPLETED|Overall Study||54||
59509012|NCT02391987|75602144|FG001|COMPLETED|Overall Study||58||
59509013|NCT02391987|75602143|FG000|NOT COMPLETED|Overall Study||0||
59509014|NCT02391987|75602144|FG001|NOT COMPLETED|Overall Study||0||
59509015|NCT00777179|75602152|FG000|STARTED|Overall Study|Number of participants for intent-to-treat (ITT) set population|75||
59509016|NCT00777179|75602153|FG001|STARTED|Overall Study|Number of participants for intent-to-treat (ITT) set population|42||
59509017|NCT00777179|75602152|FG000|COMPLETED|Overall Study|All participants' data within ITT set were included for final result.|75||
59509018|NCT00777179|75602153|FG001|COMPLETED|Overall Study|All participants' data within ITT set were included for final result.|42||
59509019|NCT00777179|75602152|FG000|NOT COMPLETED|Overall Study||0||
59509020|NCT00777179|75602153|FG001|NOT COMPLETED|Overall Study||0||
59509021|NCT02392767|75602161|FG000|STARTED|Overall Study||12||
59509022|NCT02392767|75602162|FG001|STARTED|Overall Study||13||
59509023|NCT02392767|75602161|FG000|COMPLETED|Overall Study||12||
59509024|NCT02392767|75602162|FG001|COMPLETED|Overall Study||13||
59509025|NCT02392767|75602161|FG000|NOT COMPLETED|Overall Study||0||
59509026|NCT02392767|75602162|FG001|NOT COMPLETED|Overall Study||0||
59509027|NCT02394951|75602172|FG000|STARTED|Period I||12||
59509028|NCT02394951|75602173|FG001|STARTED|Period I||14||
59509029|NCT02394951|75602172|FG000|COMPLETED|Period I||11||
59509030|NCT02394951|75602173|FG001|COMPLETED|Period I||13||
59509031|NCT02394951|75602172|FG000|NOT COMPLETED|Period I||1||
59509032|NCT02394951|75602173|FG001|NOT COMPLETED|Period I||1||
59509033|NCT02394951|75602172|FG000|STARTED|Period II||11||
59509034|NCT02394951|75602173|FG001|STARTED|Period II||13||
59509035|NCT02394951|75602172|FG000|COMPLETED|Period II||11||
59509036|NCT02394951|75602173|FG001|COMPLETED|Period II||9||
59509037|NCT02394951|75602172|FG000|NOT COMPLETED|Period II||0||
59509038|NCT02394951|75602173|FG001|NOT COMPLETED|Period II||4||
59509039|NCT02056431|75602181|FG000|STARTED|Overall Study||604||
59509040|NCT02056431|75602182|FG001|STARTED|Overall Study||666||
59509041|NCT02056431|75602181|FG000|COMPLETED|Overall Study||560||
59509042|NCT02056431|75602182|FG001|COMPLETED|Overall Study||619||
59509043|NCT02056431|75602181|FG000|NOT COMPLETED|Overall Study||44||
59509044|NCT02056431|75602182|FG001|NOT COMPLETED|Overall Study||47||
59509045|NCT00795275|75602192|FG000|STARTED|Overall Study||11||
59917723|NCT03341299|76038213|FG000|COMPLETED|Washout (A Minimum of 21 Hours)||9||
59917724|NCT03341299|76038214|FG001|COMPLETED|Washout (A Minimum of 21 Hours)||9||
59917725|NCT03341299|76038215|FG002|COMPLETED|Washout (A Minimum of 21 Hours)||8||
59509046|NCT00795275|75602193|FG001|STARTED|Overall Study||15||
59509047|NCT00795275|75602192|FG000|COMPLETED|Overall Study||10||
59509048|NCT00795275|75602193|FG001|COMPLETED|Overall Study||13||
59509049|NCT00795275|75602192|FG000|NOT COMPLETED|Overall Study||1||
59509050|NCT00795275|75602193|FG001|NOT COMPLETED|Overall Study||2||
59509051|NCT00777335|75602203|FG000|STARTED|Overall Study||2||
59509052|NCT00777335|75602204|FG001|STARTED|Overall Study||2||
59509053|NCT00777335|75602203|FG000|COMPLETED|Overall Study||2||
59509054|NCT00777335|75602204|FG001|COMPLETED|Overall Study||2||
59509055|NCT00777335|75602203|FG000|NOT COMPLETED|Overall Study||0||
59509056|NCT00777335|75602204|FG001|NOT COMPLETED|Overall Study||0||
59509057|NCT00790673|75602214|FG000|STARTED|Overall Study||6||
59509058|NCT00790673|75602215|FG001|STARTED|Overall Study||6||
59509059|NCT00790673|75602216|FG002|STARTED|Overall Study||12||
59509060|NCT00790673|75602217|FG003|STARTED|Overall Study||8||
59509061|NCT00790673|75602214|FG000|COMPLETED|Overall Study||6||
59509062|NCT00790673|75602215|FG001|COMPLETED|Overall Study||6||
59509063|NCT00790673|75602216|FG002|COMPLETED|Overall Study||12||
59509064|NCT00790673|75602217|FG003|COMPLETED|Overall Study||8||
59509065|NCT00790673|75602214|FG000|NOT COMPLETED|Overall Study||0||
59509066|NCT00790673|75602215|FG001|NOT COMPLETED|Overall Study||0||
59509067|NCT00790673|75602216|FG002|NOT COMPLETED|Overall Study||0||
59509068|NCT00790673|75602217|FG003|NOT COMPLETED|Overall Study||0||
59509069|NCT00791219|75602230|FG000|STARTED|Overall Study||24||
59917726|NCT03341299|76038216|FG003|COMPLETED|Washout (A Minimum of 21 Hours)||9||
59509070|NCT00791219|75602231|FG001|STARTED|Overall Study||76||
59509071|NCT00791219|75602232|FG002|STARTED|Overall Study||75||
59509072|NCT00791219|75602230|FG000|COMPLETED|Overall Study||19||
59509073|NCT00791219|75602231|FG001|COMPLETED|Overall Study||60||
59509074|NCT00791219|75602232|FG002|COMPLETED|Overall Study||61||
59509075|NCT00791219|75602230|FG000|NOT COMPLETED|Overall Study||5||
59509076|NCT00791219|75602231|FG001|NOT COMPLETED|Overall Study||16||
59509077|NCT00791219|75602232|FG002|NOT COMPLETED|Overall Study||14||
59509078|NCT00797459|75602240|FG000|STARTED|Overall Study||60||
59509079|NCT00797459|75602240|FG000|COMPLETED|Overall Study||60||
59509080|NCT00797459|75602240|FG000|NOT COMPLETED|Overall Study||0||
59509081|NCT00810095|75602248|FG000|STARTED|Overall Study||40||
59509082|NCT00810095|75602248|FG000|COMPLETED|Overall Study||40||
59509083|NCT00810095|75602248|FG000|NOT COMPLETED|Overall Study||0||
59509084|NCT00792077|75602252|FG000|STARTED|Overall Study||6||
59509085|NCT00792077|75602252|FG000|Day 15+/- 3 Days|Overall Study||6||
59509086|NCT00792077|75602252|FG000|Day 29+/-3 Days|Overall Study||6||
59509087|NCT00792077|75602252|FG000|Day 43+/-3 Days|Overall Study||6||
59509088|NCT00792077|75602252|FG000|Day 57+/-3 Days|Overall Study||6||
59509089|NCT00792077|75602252|FG000|COMPLETED|Overall Study||6||
59509090|NCT00792077|75602252|FG000|NOT COMPLETED|Overall Study||0||
59509091|NCT00799643|75602258|FG000|STARTED|Overall Study||140||
59509092|NCT00799643|75602259|FG001|STARTED|Overall Study||146||
59509093|NCT00799643|75602258|FG000|COMPLETED|Overall Study||115||
59509094|NCT00799643|75602259|FG001|COMPLETED|Overall Study||119||
59509095|NCT00799643|75602258|FG000|NOT COMPLETED|Overall Study||25||
59509096|NCT00799643|75602259|FG001|NOT COMPLETED|Overall Study||27||
59509097|NCT00800345|75602266|FG000|STARTED|Overall Study||33||
59509098|NCT00800345|75602266|FG000|COMPLETED|Overall Study||33||
59509099|NCT00800345|75602266|FG000|NOT COMPLETED|Overall Study||0||
59509100|NCT03782103|75602270|FG000|STARTED|Overall Study||156||72
59509101|NCT03782103|75602270|FG000|ZP|Overall Study||156||72
59509102|NCT03782103|75602270|FG000|CP|Overall Study||156||72
59509103|NCT03782103|75602270|FG000|Vehicle|Overall Study||156||72
59509104|NCT03782103|75602270|FG000|COMPLETED|Overall Study||156||72
59509105|NCT03782103|75602270|FG000|NOT COMPLETED|Overall Study||0||0
59509106|NCT00810719|75602282|FG000|STARTED|Overall Study||30||
59509107|NCT00810719|75602282|FG000|COMPLETED|Overall Study||30||
59509108|NCT00810719|75602282|FG000|NOT COMPLETED|Overall Study||0||
59509109|NCT03761277|75602286|FG000|STARTED|Enrollment to Implant||93||
59509110|NCT03761277|75602286|FG000|Intrathecal Trial|Enrollment to Implant||72||
59509111|NCT03761277|75602286|FG000|COMPLETED|Enrollment to Implant||52||
59509112|NCT03761277|75602286|FG000|NOT COMPLETED|Enrollment to Implant||41||
59509113|NCT03761277|75602286|FG000|STARTED|Post-Implant to 6 Months||52||
59509114|NCT03761277|75602286|FG000|COMPLETED|Post-Implant to 6 Months||47||
59509115|NCT03761277|75602286|FG000|NOT COMPLETED|Post-Implant to 6 Months||5||
59509116|NCT03761277|75602286|FG000|STARTED|6 Months to 12 Months||47||
59509117|NCT03761277|75602286|FG000|COMPLETED|6 Months to 12 Months||19||
59509118|NCT03761277|75602286|FG000|NOT COMPLETED|6 Months to 12 Months||28||
59509119|NCT00810797|75602290|FG000|STARTED|Overall Study||36||
59509120|NCT00810797|75602290|FG000|COMPLETED|Overall Study||36||
59509121|NCT00810797|75602290|FG000|NOT COMPLETED|Overall Study||0||
59509122|NCT00801827|75602294|FG000|STARTED|Overall Study|2 others consented but due to scheduling did not complete|5||
59509123|NCT00801827|75602294|FG000|COMPLETED|Overall Study||5||
59509124|NCT00801827|75602294|FG000|NOT COMPLETED|Overall Study||0||
59509125|NCT00802685|75602300|FG000|STARTED|Overall Study||54||
59509126|NCT00802685|75602301|FG001|STARTED|Overall Study||51||
59509127|NCT00802685|75602300|FG000|COMPLETED|Overall Study||54||
59509128|NCT00802685|75602301|FG001|COMPLETED|Overall Study||51||
59509129|NCT00802685|75602300|FG000|NOT COMPLETED|Overall Study||0||
59509130|NCT00802685|75602301|FG001|NOT COMPLETED|Overall Study||0||
59509131|NCT00802919|75602309|FG000|STARTED|Overall Study||45||
59509132|NCT00802919|75602310|FG001|STARTED|Overall Study||46||
59509133|NCT00802919|75602309|FG000|COMPLETED|Overall Study||42||
59509134|NCT00802919|75602310|FG001|COMPLETED|Overall Study||45||
59509135|NCT00802919|75602309|FG000|NOT COMPLETED|Overall Study||3||
59509136|NCT00802919|75602310|FG001|NOT COMPLETED|Overall Study||1||
59509137|NCT00802997|75602319|FG000|STARTED|Baseline to 3 Months||34||
59509138|NCT00802997|75602320|FG001|STARTED|Baseline to 3 Months||17||
59509139|NCT00802997|75602319|FG000|COMPLETED|Baseline to 3 Months||34||
59509140|NCT00802997|75602320|FG001|COMPLETED|Baseline to 3 Months||17||
59509141|NCT00802997|75602319|FG000|NOT COMPLETED|Baseline to 3 Months||0||
59509142|NCT00802997|75602320|FG001|NOT COMPLETED|Baseline to 3 Months||0||
59509143|NCT00802997|75602319|FG000|STARTED|3 Months to 6 Months||34||
59509144|NCT00802997|75602320|FG001|STARTED|3 Months to 6 Months|Sham subjects unblinded at 3 Months. None continued in sham group.|0||
59509145|NCT00802997|75602319|FG000|COMPLETED|3 Months to 6 Months||27||
59509146|NCT00802997|75602320|FG001|COMPLETED|3 Months to 6 Months|Sham subjects unblinded at 3 Months. None continued in sham group.|0||
59509147|NCT00802997|75602319|FG000|NOT COMPLETED|3 Months to 6 Months||7||
59509148|NCT00802997|75602320|FG001|NOT COMPLETED|3 Months to 6 Months||0||
59509149|NCT00802997|75602319|FG000|STARTED|6 Month to 9 Months||27||
59509150|NCT00802997|75602320|FG001|STARTED|6 Month to 9 Months|Sham subjects unblinded at 3 Months. None continued in sham group.|0||
59917727|NCT03341299|76038213|FG000|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0||
59917728|NCT03341299|76038214|FG001|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0||
59917729|NCT03341299|76038215|FG002|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0||
59509151|NCT00802997|75602319|FG000|COMPLETED|6 Month to 9 Months||25||
59917730|NCT03341299|76038216|FG003|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0||
59917731|NCT03341299|76038213|FG000|STARTED|Period 4||9||
59917732|NCT03341299|76038214|FG001|STARTED|Period 4||9||
59917733|NCT03341299|76038215|FG002|STARTED|Period 4||8||
59917734|NCT03341299|76038216|FG003|STARTED|Period 4||9||
59917735|NCT03341299|76038213|FG000|COMPLETED|Period 4||9||
59917736|NCT03341299|76038214|FG001|COMPLETED|Period 4||9||
59917737|NCT03341299|76038215|FG002|COMPLETED|Period 4||8||
59917738|NCT03341299|76038216|FG003|COMPLETED|Period 4||9||
59917739|NCT03341299|76038213|FG000|NOT COMPLETED|Period 4||0||
59917740|NCT03341299|76038214|FG001|NOT COMPLETED|Period 4||0||
59917741|NCT03341299|76038215|FG002|NOT COMPLETED|Period 4||0||
59917742|NCT03341299|76038216|FG003|NOT COMPLETED|Period 4||0||
59917743|NCT02949271|76038230|FG000|STARTED|Overall Study||90||
59917744|NCT02949271|76038231|FG001|STARTED|Overall Study||89||
59917745|NCT02949271|76038230|FG000|COMPLETED|Overall Study||61||
59917746|NCT02949271|76038231|FG001|COMPLETED|Overall Study||59||
59917747|NCT02949271|76038230|FG000|NOT COMPLETED|Overall Study||29||
59917748|NCT02949271|76038231|FG001|NOT COMPLETED|Overall Study||30||
59917749|NCT03640559|76038239|FG000|STARTED|Overall Study||25||
59917750|NCT03640559|76038240|FG001|STARTED|Overall Study||25||
59917751|NCT03640559|76038239|FG000|COMPLETED|Overall Study||23||
59917752|NCT03640559|76038240|FG001|COMPLETED|Overall Study||24||
59917753|NCT03640559|76038239|FG000|NOT COMPLETED|Overall Study||2||
59917754|NCT03640559|76038240|FG001|NOT COMPLETED|Overall Study||1||
59917755|NCT03339583|76038248|FG000|STARTED|First Intervention (14 Days)||19||
59917756|NCT03339583|76038249|FG001|STARTED|First Intervention (14 Days)||23||
59917757|NCT03339583|76038248|FG000|COMPLETED|First Intervention (14 Days)||18||
59917758|NCT03339583|76038249|FG001|COMPLETED|First Intervention (14 Days)||23||
59917759|NCT03339583|76038248|FG000|NOT COMPLETED|First Intervention (14 Days)||1||
59917760|NCT03339583|76038249|FG001|NOT COMPLETED|First Intervention (14 Days)||0||
59917761|NCT03339583|76038248|FG000|STARTED|Washout (14 Days)||18||
59917762|NCT03339583|76038249|FG001|STARTED|Washout (14 Days)||23||
59917763|NCT03339583|76038248|FG000|COMPLETED|Washout (14 Days)||18||
59917764|NCT03339583|76038249|FG001|COMPLETED|Washout (14 Days)||23||
59917765|NCT03339583|76038248|FG000|NOT COMPLETED|Washout (14 Days)||0||
59917766|NCT03339583|76038249|FG001|NOT COMPLETED|Washout (14 Days)||0||
59917767|NCT03339583|76038248|FG000|STARTED|Second Intervention (14 Days)||18||
59917768|NCT03339583|76038249|FG001|STARTED|Second Intervention (14 Days)||23||
59917769|NCT03339583|76038248|FG000|COMPLETED|Second Intervention (14 Days)||18||
59917770|NCT03339583|76038249|FG001|COMPLETED|Second Intervention (14 Days)||21||
59917771|NCT03339583|76038248|FG000|NOT COMPLETED|Second Intervention (14 Days)||0||
59917772|NCT03339583|76038249|FG001|NOT COMPLETED|Second Intervention (14 Days)||2||
59917773|NCT03339583|76038248|FG000|STARTED|Follow-up (14 Days)||18||
59917774|NCT03339583|76038249|FG001|STARTED|Follow-up (14 Days)||21||
59917775|NCT03339583|76038248|FG000|COMPLETED|Follow-up (14 Days)||12||
59917776|NCT03339583|76038249|FG001|COMPLETED|Follow-up (14 Days)||18||
59917777|NCT03339583|76038248|FG000|NOT COMPLETED|Follow-up (14 Days)||6||
59917778|NCT03339583|76038249|FG001|NOT COMPLETED|Follow-up (14 Days)||3||
59917779|NCT03639779|76038257|FG000|STARTED|Overall Study||5||10
59917780|NCT03639779|76038257|FG000|Baseline|Overall Study||5||10
59917781|NCT03639779|76038257|FG000|Month 1|Overall Study||5||10
59917782|NCT03639779|76038257|FG000|Month 2|Overall Study||4||8
59917783|NCT03639779|76038257|FG000|Month 3|Overall Study||4||8
59917784|NCT03639779|76038257|FG000|COMPLETED|Overall Study||4||8
59917785|NCT03639779|76038257|FG000|NOT COMPLETED|Overall Study||1||2
59917786|NCT03575975|76038266|FG000|STARTED|Overall Study||4||
59917787|NCT03575975|76038267|FG001|STARTED|Overall Study||5||
59917788|NCT03575975|76038268|FG002|STARTED|Overall Study||0||
59917789|NCT03575975|76038266|FG000|COMPLETED|Overall Study||3||
59917790|NCT03575975|76038267|FG001|COMPLETED|Overall Study||5||
59917791|NCT03575975|76038268|FG002|COMPLETED|Overall Study||0||
59917792|NCT03575975|76038266|FG000|NOT COMPLETED|Overall Study||1||
60036687|NCT01772134|76152175|FG002|Received Randomized Study Medication|Overall Study||205||
60036688|NCT01772134|76152173|FG000|COMPLETED|Overall Study||178||
60036689|NCT01772134|76152174|FG001|COMPLETED|Overall Study||190||
59917793|NCT03575975|76038267|FG001|NOT COMPLETED|Overall Study||0||
60036690|NCT01772134|76152175|FG002|COMPLETED|Overall Study||184||
59917794|NCT03575975|76038268|FG002|NOT COMPLETED|Overall Study||0||
59917795|NCT03636893|76038276|FG000|STARTED|Overall Study||40||
59917796|NCT03636893|76038277|FG001|STARTED|Overall Study||34||
59917797|NCT03636893|76038276|FG000|COMPLETED|Overall Study||31||
59917798|NCT03636893|76038277|FG001|COMPLETED|Overall Study||24||
59509152|NCT00802997|75602320|FG001|COMPLETED|6 Month to 9 Months|Sham subjects unblinded at 3 Months. None continued in sham group.|0||
59509153|NCT00802997|75602319|FG000|NOT COMPLETED|6 Month to 9 Months||2||
59509154|NCT00802997|75602320|FG001|NOT COMPLETED|6 Month to 9 Months||0||
59509155|NCT00803543|75602328|FG000|STARTED|Overall Study||69||
59509156|NCT00803543|75602329|FG001|STARTED|Overall Study||34||
59509157|NCT00803543|75602328|FG000|COMPLETED|Overall Study||45||
59917799|NCT03636893|76038276|FG000|NOT COMPLETED|Overall Study||9||
59917800|NCT03636893|76038277|FG001|NOT COMPLETED|Overall Study||10||
59917801|NCT01353586|76038285|FG000|STARTED|Overall Study||167||
59917802|NCT01353586|76038286|FG001|STARTED|Overall Study||19||
59917803|NCT01353586|76038285|FG000|Participated in Workflow Phase|Overall Study||20||
59917804|NCT01353586|76038286|FG001|Participated in Workflow Phase|Overall Study||0||
59917805|NCT01353586|76038285|FG000|Participated in Roll-in Phase|Overall Study||22||
59917806|NCT01353586|76038286|FG001|Participated in Roll-in Phase|Overall Study||0||
59917807|NCT01353586|76038285|FG000|Participated in SNA Substudy|Overall Study||19||
59917808|NCT01353586|76038286|FG001|Participated in SNA Substudy|Overall Study||19||
59917809|NCT01353586|76038285|FG000|COMPLETED|Overall Study||160||
59917810|NCT01353586|76038286|FG001|COMPLETED|Overall Study||17||
59917811|NCT01353586|76038285|FG000|NOT COMPLETED|Overall Study||7||
59917812|NCT01353586|76038286|FG001|NOT COMPLETED|Overall Study||2||
59917813|NCT03091920|76038298|FG000|STARTED|Overall Study||6||
59917814|NCT03091920|76038299|FG001|STARTED|Overall Study||10||
59917815|NCT03091920|76038300|FG002|STARTED|Overall Study||10||
59917816|NCT03091920|76038298|FG000|COMPLETED|Overall Study||6||
59917817|NCT03091920|76038299|FG001|COMPLETED|Overall Study||9||
59917818|NCT03091920|76038300|FG002|COMPLETED|Overall Study||10||
59917819|NCT03091920|76038298|FG000|NOT COMPLETED|Overall Study||0||
59917820|NCT03091920|76038299|FG001|NOT COMPLETED|Overall Study||1||
59917821|NCT03091920|76038300|FG002|NOT COMPLETED|Overall Study||0||
59917822|NCT03338569|76038316|FG000|STARTED|Overall Study||64||
59917823|NCT03338569|76038317|FG001|STARTED|Overall Study||61||
59917824|NCT03338569|76038316|FG000|COMPLETED|Overall Study||56||
59917825|NCT03338569|76038317|FG001|COMPLETED|Overall Study||56||
59917826|NCT03338569|76038316|FG000|NOT COMPLETED|Overall Study||8||
59917827|NCT03338569|76038317|FG001|NOT COMPLETED|Overall Study||5||
59917828|NCT03338023|76038325|FG000|STARTED|Overall Study||137||
59917829|NCT03338023|76038326|FG001|STARTED|Overall Study||135||
59917830|NCT03338023|76038325|FG000|Received at Least One Dose of Study Drug|Overall Study||137||
59917831|NCT03338023|76038326|FG001|Received at Least One Dose of Study Drug|Overall Study||135||
59917832|NCT03338023|76038325|FG000|COMPLETED|Overall Study||128||
59917833|NCT03338023|76038326|FG001|COMPLETED|Overall Study||125||
59917834|NCT03338023|76038325|FG000|NOT COMPLETED|Overall Study||9||
59917835|NCT03338023|76038326|FG001|NOT COMPLETED|Overall Study||10||
59917836|NCT03337477|76038334|FG000|STARTED|Overall Study||33|Randomized|
59917837|NCT03337477|76038335|FG001|STARTED|Overall Study||37|Randomized|
59917838|NCT03337477|76038334|FG000|COMPLETED|Overall Study||22||
59917839|NCT03337477|76038335|FG001|COMPLETED|Overall Study||24||
59917840|NCT03337477|76038334|FG000|NOT COMPLETED|Overall Study||11||
59917841|NCT03337477|76038335|FG001|NOT COMPLETED|Overall Study||13||
59917842|NCT02687542|76038348|FG000|STARTED|Overall Study||23||
59917843|NCT02687542|76038349|FG001|STARTED|Overall Study||13||
59917844|NCT02687542|76038350|FG002|STARTED|Overall Study||15||
59917845|NCT02687542|76038351|FG003|STARTED|Overall Study||13||
59917846|NCT02687542|76038352|FG004|STARTED|Overall Study||44||
59917847|NCT02687542|76038348|FG000|COMPLETED|Overall Study||15||
59917848|NCT02687542|76038349|FG001|COMPLETED|Overall Study||1||
59917849|NCT02687542|76038350|FG002|COMPLETED|Overall Study||1||
59509158|NCT00803543|75602329|FG001|COMPLETED|Overall Study||22||
59509159|NCT00803543|75602328|FG000|NOT COMPLETED|Overall Study||24||
59917850|NCT02687542|76038351|FG003|COMPLETED|Overall Study||3||
59917851|NCT02687542|76038352|FG004|COMPLETED|Overall Study||24||
59917852|NCT02687542|76038348|FG000|NOT COMPLETED|Overall Study||8||
59917853|NCT02687542|76038349|FG001|NOT COMPLETED|Overall Study||12||
59917854|NCT02687542|76038350|FG002|NOT COMPLETED|Overall Study||14||
59917855|NCT02687542|76038351|FG003|NOT COMPLETED|Overall Study||10||
59917856|NCT02687542|76038352|FG004|NOT COMPLETED|Overall Study||20||
59917857|NCT03336619|76038366|FG000|STARTED|Overall Study||515||
59509160|NCT00803543|75602329|FG001|NOT COMPLETED|Overall Study||12||
59509161|NCT04099641|75602337|FG000|STARTED|Overall Study||61||
59509162|NCT04099641|75602338|FG001|STARTED|Overall Study||19||
59917858|NCT03336619|76038367|FG001|STARTED|Overall Study||515||
59917859|NCT03336619|76038366|FG000|Positive for Influenza by RT-PCR at Baseline (Intent-to-treat Infected [ITTI] Population)|Overall Study||314||
59509163|NCT04099641|75602337|FG000|Safety Population|Overall Study||61||
59509164|NCT04099641|75602338|FG001|Safety Population|Overall Study||19||
59509165|NCT04099641|75602337|FG000|DLT-evaluable Population|Overall Study||3||
59509166|NCT04099641|75602338|FG001|DLT-evaluable Population|Overall Study||0||
59509167|NCT04099641|75602337|FG000|Efficacy Population|Overall Study||61||
59509168|NCT04099641|75602338|FG001|Efficacy Population|Overall Study||19||
59509169|NCT04099641|75602337|FG000|COMPLETED|Overall Study||12||
59509170|NCT04099641|75602338|FG001|COMPLETED|Overall Study||7||
59509171|NCT04099641|75602337|FG000|NOT COMPLETED|Overall Study||49||
59509172|NCT04099641|75602338|FG001|NOT COMPLETED|Overall Study||12||
59509173|NCT00803777|75602344|FG000|STARTED|Overall Study||147||
59509174|NCT00803777|75602344|FG000|COMPLETED|Overall Study||147||
59509175|NCT00803777|75602344|FG000|NOT COMPLETED|Overall Study||0||
59509176|NCT02152085|75602350|FG000|STARTED|Overall Study||14||
59509177|NCT02152085|75602351|FG001|STARTED|Overall Study||15||
59509178|NCT02152085|75602350|FG000|COMPLETED|Overall Study||13||
60036691|NCT01772134|76152173|FG000|NOT COMPLETED|Overall Study||29||
60036692|NCT01772134|76152174|FG001|NOT COMPLETED|Overall Study||14||
60036693|NCT01772134|76152175|FG002|NOT COMPLETED|Overall Study||22||
60036694|NCT01994889|76152186|FG000|STARTED|Overall Study||88||
60036695|NCT01994889|76152187|FG001|STARTED|Overall Study||176||
60036696|NCT01994889|76152188|FG002|STARTED|Overall Study||177||
60036697|NCT01994889|76152186|FG000|COMPLETED|Overall Study||60||
60036698|NCT01994889|76152187|FG001|COMPLETED|Overall Study||113||
60036699|NCT01994889|76152188|FG002|COMPLETED|Overall Study||85||
60036700|NCT01994889|76152186|FG000|NOT COMPLETED|Overall Study||28||
60036701|NCT01994889|76152187|FG001|NOT COMPLETED|Overall Study||63||
60036702|NCT01994889|76152188|FG002|NOT COMPLETED|Overall Study||92||
60036703|NCT02082483|76152197|FG000|STARTED|Overall Study||71||
60036704|NCT02082483|76152198|FG001|STARTED|Overall Study||73||
60036705|NCT02082483|76152197|FG000|COMPLETED|Overall Study||65||
60036706|NCT02082483|76152198|FG001|COMPLETED|Overall Study||67||
60036707|NCT02082483|76152197|FG000|NOT COMPLETED|Overall Study||6||
60036708|NCT02082483|76152198|FG001|NOT COMPLETED|Overall Study||6||
60036709|NCT02017899|76152211|FG000|STARTED|Overall Study||8||
60036710|NCT02017899|76152212|FG001|STARTED|Overall Study||9||
60036711|NCT02017899|76152213|FG002|STARTED|Overall Study||8||
60036712|NCT02017899|76152214|FG003|STARTED|Overall Study||8||
60036713|NCT02017899|76152215|FG004|STARTED|Overall Study||9||
60036714|NCT02017899|76152216|FG005|STARTED|Overall Study||8||
60036715|NCT02017899|76152211|FG000|COMPLETED|Overall Study||8||
60036716|NCT02017899|76152212|FG001|COMPLETED|Overall Study||9||
60036717|NCT02017899|76152213|FG002|COMPLETED|Overall Study||8||
60036718|NCT02017899|76152214|FG003|COMPLETED|Overall Study||7||
60036719|NCT02017899|76152215|FG004|COMPLETED|Overall Study||8||
60036720|NCT02017899|76152216|FG005|COMPLETED|Overall Study||8||
60036721|NCT02017899|76152211|FG000|NOT COMPLETED|Overall Study||0||
60036722|NCT02017899|76152212|FG001|NOT COMPLETED|Overall Study||0||
60036723|NCT02017899|76152213|FG002|NOT COMPLETED|Overall Study||0||
60036724|NCT02017899|76152214|FG003|NOT COMPLETED|Overall Study||1||
60036725|NCT02017899|76152215|FG004|NOT COMPLETED|Overall Study||1||
60036726|NCT02017899|76152216|FG005|NOT COMPLETED|Overall Study||0||
60036727|NCT01993329|76152236|FG000|STARTED|Period 1||3||
60036728|NCT01993329|76152237|FG001|STARTED|Period 1||4||
60036729|NCT01993329|76152238|FG002|STARTED|Period 1||3||
60036730|NCT01993329|76152239|FG003|STARTED|Period 1||3||
60036731|NCT01993329|76152240|FG004|STARTED|Period 1||3||
59509179|NCT02152085|75602351|FG001|COMPLETED|Overall Study||14||
59509180|NCT02152085|75602350|FG000|NOT COMPLETED|Overall Study||1||
59509181|NCT02152085|75602351|FG001|NOT COMPLETED|Overall Study||1||
59509182|NCT00805493|75602360|FG000|STARTED|Overall Study||3||
60036732|NCT01993329|76152241|FG005|STARTED|Period 1||4||
60036733|NCT01993329|76152236|FG000|COMPLETED|Period 1||3||
60036734|NCT01993329|76152237|FG001|COMPLETED|Period 1||4||
60036735|NCT01993329|76152238|FG002|COMPLETED|Period 1||3||
60036736|NCT01993329|76152239|FG003|COMPLETED|Period 1||3||
60036737|NCT01993329|76152240|FG004|COMPLETED|Period 1||3||
60036738|NCT01993329|76152241|FG005|COMPLETED|Period 1||4||
59509183|NCT00805493|75602361|FG001|STARTED|Overall Study||2||
59509184|NCT00805493|75602362|FG002|STARTED|Overall Study||1||
59509185|NCT00805493|75602360|FG000|COMPLETED|Overall Study||1||
59509186|NCT00805493|75602361|FG001|COMPLETED|Overall Study||2||
59509187|NCT00805493|75602362|FG002|COMPLETED|Overall Study||0||
59509188|NCT00805493|75602360|FG000|NOT COMPLETED|Overall Study||2||
59509189|NCT00805493|75602361|FG001|NOT COMPLETED|Overall Study||0||
59509190|NCT00805493|75602362|FG002|NOT COMPLETED|Overall Study||1||
59509191|NCT00807209|75602376|FG000|STARTED|Overall Study||1||
59509192|NCT00807209|75602377|FG001|STARTED|Overall Study||1||
59509193|NCT00807209|75602378|FG002|STARTED|Overall Study||1||
60036739|NCT01993329|76152236|FG000|NOT COMPLETED|Period 1||0||
60036740|NCT01993329|76152237|FG001|NOT COMPLETED|Period 1||0||
60036741|NCT01993329|76152238|FG002|NOT COMPLETED|Period 1||0||
60036742|NCT01993329|76152239|FG003|NOT COMPLETED|Period 1||0||
60036743|NCT01993329|76152240|FG004|NOT COMPLETED|Period 1||0||
60036744|NCT01993329|76152241|FG005|NOT COMPLETED|Period 1||0||
60036745|NCT01993329|76152236|FG000|STARTED|Wash-out||3||
60036746|NCT01993329|76152237|FG001|STARTED|Wash-out||4||
60036747|NCT01993329|76152238|FG002|STARTED|Wash-out||3||
60036748|NCT01993329|76152239|FG003|STARTED|Wash-out||3||
60036749|NCT01993329|76152240|FG004|STARTED|Wash-out||3||
60036750|NCT01993329|76152241|FG005|STARTED|Wash-out||4||
60036751|NCT01993329|76152236|FG000|COMPLETED|Wash-out||3||
60036752|NCT01993329|76152237|FG001|COMPLETED|Wash-out||4||
60036753|NCT01993329|76152238|FG002|COMPLETED|Wash-out||3||
60036754|NCT01993329|76152239|FG003|COMPLETED|Wash-out||3||
60036755|NCT01993329|76152240|FG004|COMPLETED|Wash-out||3||
60036756|NCT01993329|76152241|FG005|COMPLETED|Wash-out||4||
60036757|NCT01993329|76152236|FG000|NOT COMPLETED|Wash-out||0||
60036758|NCT01993329|76152237|FG001|NOT COMPLETED|Wash-out||0||
60036759|NCT01993329|76152238|FG002|NOT COMPLETED|Wash-out||0||
60036760|NCT01993329|76152239|FG003|NOT COMPLETED|Wash-out||0||
59509194|NCT00807209|75602376|FG000|COMPLETED|Overall Study||1||
59509195|NCT00807209|75602377|FG001|COMPLETED|Overall Study||1||
59509196|NCT00807209|75602378|FG002|COMPLETED|Overall Study||1||
59509197|NCT00807209|75602376|FG000|NOT COMPLETED|Overall Study||0||
60036761|NCT01993329|76152240|FG004|NOT COMPLETED|Wash-out||0||
60036762|NCT01993329|76152241|FG005|NOT COMPLETED|Wash-out||0||
60036763|NCT01993329|76152236|FG000|STARTED|Period 2||3||
60036764|NCT01993329|76152237|FG001|STARTED|Period 2||4||
60036765|NCT01993329|76152238|FG002|STARTED|Period 2||3||
60036766|NCT01993329|76152239|FG003|STARTED|Period 2||3||
60036767|NCT01993329|76152240|FG004|STARTED|Period 2||3||
60036768|NCT01993329|76152241|FG005|STARTED|Period 2||4||
60036769|NCT01993329|76152236|FG000|COMPLETED|Period 2||3||
60036770|NCT01993329|76152237|FG001|COMPLETED|Period 2||4||
60036771|NCT01993329|76152238|FG002|COMPLETED|Period 2||3||
60036772|NCT01993329|76152239|FG003|COMPLETED|Period 2||3||
60036773|NCT01993329|76152240|FG004|COMPLETED|Period 2||3||
60036774|NCT01993329|76152241|FG005|COMPLETED|Period 2||3||
60036775|NCT01993329|76152236|FG000|NOT COMPLETED|Period 2||0||
60036776|NCT01993329|76152237|FG001|NOT COMPLETED|Period 2||0||
60036777|NCT01993329|76152238|FG002|NOT COMPLETED|Period 2||0||
60036778|NCT01993329|76152239|FG003|NOT COMPLETED|Period 2||0||
60036779|NCT01993329|76152240|FG004|NOT COMPLETED|Period 2||0||
60036780|NCT01993329|76152241|FG005|NOT COMPLETED|Period 2||1||
60036781|NCT01993329|76152236|FG000|STARTED|Wash-out||3||
60036782|NCT01993329|76152237|FG001|STARTED|Wash-out||4||
60036783|NCT01993329|76152238|FG002|STARTED|Wash-out||3||
60036784|NCT01993329|76152239|FG003|STARTED|Wash-out||3||
60036785|NCT01993329|76152240|FG004|STARTED|Wash-out||3||
60036786|NCT01993329|76152241|FG005|STARTED|Wash-out||3||
60036787|NCT01993329|76152236|FG000|COMPLETED|Wash-out||3||
60036788|NCT01993329|76152237|FG001|COMPLETED|Wash-out||3||
60036789|NCT01993329|76152238|FG002|COMPLETED|Wash-out||3||
60036790|NCT01993329|76152239|FG003|COMPLETED|Wash-out||3||
60036791|NCT01993329|76152240|FG004|COMPLETED|Wash-out||3||
60036792|NCT01993329|76152241|FG005|COMPLETED|Wash-out||3||
60036793|NCT01993329|76152236|FG000|NOT COMPLETED|Wash-out||0||
60036794|NCT01993329|76152237|FG001|NOT COMPLETED|Wash-out||1||
60036795|NCT01993329|76152238|FG002|NOT COMPLETED|Wash-out||0||
60036796|NCT01993329|76152239|FG003|NOT COMPLETED|Wash-out||0||
60036797|NCT01993329|76152240|FG004|NOT COMPLETED|Wash-out||0||
60036798|NCT01993329|76152241|FG005|NOT COMPLETED|Wash-out||0||
60036799|NCT01993329|76152236|FG000|STARTED|Period 3||3||
60036800|NCT01993329|76152237|FG001|STARTED|Period 3||3||
60036801|NCT01993329|76152238|FG002|STARTED|Period 3||3||
60036802|NCT01993329|76152239|FG003|STARTED|Period 3||3||
60036803|NCT01993329|76152240|FG004|STARTED|Period 3||3||
59509198|NCT00807209|75602377|FG001|NOT COMPLETED|Overall Study||0||
59509199|NCT00807209|75602378|FG002|NOT COMPLETED|Overall Study||0||
60036804|NCT01993329|76152241|FG005|STARTED|Period 3||3||
59509200|NCT00807989|75602388|FG000|STARTED|Overall Study||107||
60036805|NCT01993329|76152236|FG000|COMPLETED|Period 3||3||
60036806|NCT01993329|76152237|FG001|COMPLETED|Period 3||3||
60036807|NCT01993329|76152238|FG002|COMPLETED|Period 3||3||
60036808|NCT01993329|76152239|FG003|COMPLETED|Period 3||3||
60036809|NCT01993329|76152240|FG004|COMPLETED|Period 3||3||
60036810|NCT01993329|76152241|FG005|COMPLETED|Period 3||3||
60036811|NCT01993329|76152236|FG000|NOT COMPLETED|Period 3||0||
60036812|NCT01993329|76152237|FG001|NOT COMPLETED|Period 3||0||
60036813|NCT01993329|76152238|FG002|NOT COMPLETED|Period 3||0||
60036814|NCT01993329|76152239|FG003|NOT COMPLETED|Period 3||0||
59509201|NCT00807989|75602389|FG001|STARTED|Overall Study||100||
59509202|NCT00807989|75602388|FG000|COMPLETED|Overall Study||104||
59509203|NCT00807989|75602389|FG001|COMPLETED|Overall Study||98||
60036815|NCT01993329|76152240|FG004|NOT COMPLETED|Period 3||0||
60036816|NCT01993329|76152241|FG005|NOT COMPLETED|Period 3||0||
60036817|NCT02016183|76152253|FG000|STARTED|Overall Study||3222||
60036818|NCT02016183|76152253|FG000|COMPLETED|Overall Study||3157||
60036819|NCT02016183|76152253|FG000|NOT COMPLETED|Overall Study||65||
60036820|NCT02377349|76152259|FG000|STARTED|Overall Study||341||
60036821|NCT02377349|76152260|FG001|STARTED|Overall Study||346||
60036822|NCT02377349|76152259|FG000|COMPLETED|Overall Study||325||
60036823|NCT02377349|76152260|FG001|COMPLETED|Overall Study||335||
60036824|NCT02377349|76152259|FG000|NOT COMPLETED|Overall Study||16||
60036825|NCT02377349|76152260|FG001|NOT COMPLETED|Overall Study||11||
60036826|NCT02421419|76152278|FG000|STARTED|Overall Study||6||
60036827|NCT02421419|76152279|FG001|STARTED|Overall Study||11||
60036828|NCT02421419|76152280|FG002|STARTED|Overall Study||9||
60036829|NCT02421419|76152278|FG000|COMPLETED|Overall Study||6||
60036830|NCT02421419|76152279|FG001|COMPLETED|Overall Study||11||
60036831|NCT02421419|76152280|FG002|COMPLETED|Overall Study||8||
60036832|NCT02421419|76152278|FG000|NOT COMPLETED|Overall Study||0||
60036833|NCT02421419|76152279|FG001|NOT COMPLETED|Overall Study||0||
59759469|NCT04287920|75878879|FG000|NOT COMPLETED|Overall Study||1||
59759470|NCT04287920|75878880|FG001|NOT COMPLETED|Overall Study||4||
59759471|NCT00909779|75878888|FG000|STARTED|Overall Study||421||
59759472|NCT00909779|75878889|FG001|STARTED|Overall Study||420||
59917860|NCT03336619|76038367|FG001|Positive for Influenza by RT-PCR at Baseline (Intent-to-treat Infected [ITTI] Population)|Overall Study||306||
59917861|NCT03336619|76038366|FG000|COMPLETED|Overall Study||301||
59612297|NCT01721772|75723464|FG000|COMPLETED|Treatment||0||
59612298|NCT01721772|75723465|FG001|COMPLETED|Treatment||0||
59612299|NCT01721772|75723464|FG000|NOT COMPLETED|Treatment||206||
59612300|NCT01721772|75723465|FG001|NOT COMPLETED|Treatment||205||
59612301|NCT01702428|75723475|FG000|STARTED|Overall Study||1239||
60036834|NCT02421419|76152280|FG002|NOT COMPLETED|Overall Study||1||
60036835|NCT02016105|76152290|FG000|STARTED|TREATMENT PERIOD 1||231||
60036836|NCT02016105|76152291|FG001|STARTED|TREATMENT PERIOD 1||234||
60036837|NCT02016105|76152292|FG002|STARTED|TREATMENT PERIOD 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0||
60036838|NCT02016105|76152293|FG003|STARTED|TREATMENT PERIOD 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0||
60036839|NCT02016105|76152294|FG004|STARTED|TREATMENT PERIOD 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0||
60036840|NCT02016105|76152295|FG005|STARTED|TREATMENT PERIOD 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0||
60036841|NCT02016105|76152290|FG000|COMPLETED|TREATMENT PERIOD 1|12 patients did not proceed into Treatment Period 2|201||
60036842|NCT02016105|76152291|FG001|COMPLETED|TREATMENT PERIOD 1|11 patients did not proceed into Treatment Period 2|201||
60036843|NCT02016105|76152292|FG002|COMPLETED|TREATMENT PERIOD 1||0||
60036844|NCT02016105|76152293|FG003|COMPLETED|TREATMENT PERIOD 1||0||
59759473|NCT00909779|75878888|FG000|COMPLETED|Overall Study|All subjects but 47 were followed for 12 months/until death (whichever was earlier).|211||
59759474|NCT00909779|75878889|FG001|COMPLETED|Overall Study|All subjects but 42 were followed for 12 months/until death (whichever was earlier).|255||
59759475|NCT00909779|75878888|FG000|NOT COMPLETED|Overall Study||210||
59759476|NCT00909779|75878889|FG001|NOT COMPLETED|Overall Study||165||
59759477|NCT00910871|75878897|FG000|STARTED|Overall Study||233||
59759478|NCT00910871|75878897|FG000|COMPLETED|Overall Study||179||
59759479|NCT00910871|75878897|FG000|NOT COMPLETED|Overall Study||54||
59759480|NCT04067843|75878903|FG000|STARTED|Overall Study||10||
59759481|NCT04067843|75878904|FG001|STARTED|Overall Study||10||
59759482|NCT04067843|75878903|FG000|COMPLETED|Overall Study||10||
60036845|NCT02016105|76152294|FG004|COMPLETED|TREATMENT PERIOD 1||0||
60036846|NCT02016105|76152295|FG005|COMPLETED|TREATMENT PERIOD 1||0||
60036847|NCT02016105|76152290|FG000|NOT COMPLETED|TREATMENT PERIOD 1||30||
60036848|NCT02016105|76152291|FG001|NOT COMPLETED|TREATMENT PERIOD 1||33||
60036849|NCT02016105|76152292|FG002|NOT COMPLETED|TREATMENT PERIOD 1||0||
60036850|NCT02016105|76152293|FG003|NOT COMPLETED|TREATMENT PERIOD 1||0||
60036851|NCT02016105|76152294|FG004|NOT COMPLETED|TREATMENT PERIOD 1||0||
60036852|NCT02016105|76152295|FG005|NOT COMPLETED|TREATMENT PERIOD 1||0||
60036853|NCT02016105|76152290|FG000|STARTED|TREATMENT PERIOD 2|Treatment arm applicable for Treatment Period 1 only (patients re-randomized in Treatment Period 2)|0||
59612302|NCT01702428|75723476|FG001|STARTED|Overall Study||1232||
59612303|NCT01702428|75723477|FG002|STARTED|Overall Study||1243||
59917862|NCT03336619|76038367|FG001|COMPLETED|Overall Study||290||
59917863|NCT03336619|76038366|FG000|NOT COMPLETED|Overall Study||214||
59917864|NCT03336619|76038367|FG001|NOT COMPLETED|Overall Study||225||
59917865|NCT03639558|76038378|FG000|STARTED|Overall Study||52||
59917866|NCT03639558|76038379|FG001|STARTED|Overall Study||48||
59917867|NCT03639558|76038378|FG000|COMPLETED|Overall Study||51||
59917868|NCT03639558|76038379|FG001|COMPLETED|Overall Study||43||
59917869|NCT03639558|76038378|FG000|NOT COMPLETED|Overall Study||1||
59917870|NCT03639558|76038379|FG001|NOT COMPLETED|Overall Study||5||
59917871|NCT01353508|76038389|FG000|STARTED|Period 1 - First Intervention (7 Days)||8||
59917872|NCT01353508|76038390|FG001|STARTED|Period 1 - First Intervention (7 Days)||8||
59917873|NCT01353508|76038391|FG002|STARTED|Period 1 - First Intervention (7 Days)||8||
59917874|NCT01353508|76038392|FG003|STARTED|Period 1 - First Intervention (7 Days)||8||
59917875|NCT01353508|76038389|FG000|COMPLETED|Period 1 - First Intervention (7 Days)||8||
59917876|NCT01353508|76038390|FG001|COMPLETED|Period 1 - First Intervention (7 Days)||8||
59951404|NCT01880723|76070380|FG001|NOT COMPLETED|Overall Study||0||
59509204|NCT00807989|75602388|FG000|NOT COMPLETED|Overall Study||3||
59509205|NCT00807989|75602389|FG001|NOT COMPLETED|Overall Study||2||
59509206|NCT00843479|75602397|FG000|STARTED|Overall Study||12||
59509207|NCT00843479|75602398|FG001|STARTED|Overall Study||12||
59509208|NCT00843479|75602397|FG000|COMPLETED|Overall Study||12||
59509209|NCT00843479|75602398|FG001|COMPLETED|Overall Study||12||
59509210|NCT00843479|75602397|FG000|NOT COMPLETED|Overall Study||0||
59509211|NCT00843479|75602398|FG001|NOT COMPLETED|Overall Study||0||
59509212|NCT00843713|75602408|FG000|STARTED|Overall Study||30||
59509213|NCT00843713|75602409|FG001|STARTED|Overall Study||26||
59509214|NCT00843713|75602408|FG000|COMPLETED|Overall Study||30||
59509215|NCT00843713|75602409|FG001|COMPLETED|Overall Study||26||
59509216|NCT00843713|75602408|FG000|NOT COMPLETED|Overall Study||0||
59509217|NCT00843713|75602409|FG001|NOT COMPLETED|Overall Study||0||
59509218|NCT00845039|75602417|FG000|STARTED|Overall Study||2||
59509219|NCT00845039|75602418|FG001|STARTED|Overall Study||2||
59509220|NCT00845039|75602417|FG000|Received at Least 1 Dose of Study Drug|Overall Study||2||
59509221|NCT00845039|75602418|FG001|Received at Least 1 Dose of Study Drug|Overall Study||2||
59509222|NCT00845039|75602417|FG000|COMPLETED|Overall Study||2||
59509223|NCT00845039|75602418|FG001|COMPLETED|Overall Study||2||
59509224|NCT00845039|75602417|FG000|NOT COMPLETED|Overall Study||0||
59509225|NCT00845039|75602418|FG001|NOT COMPLETED|Overall Study||0||
59509226|NCT00845195|75602428|FG000|STARTED|Overall Study||75||
59509227|NCT00845195|75602429|FG001|STARTED|Overall Study||75||
59509228|NCT00845195|75602428|FG000|COMPLETED|Overall Study||75||
59509229|NCT00845195|75602429|FG001|COMPLETED|Overall Study||75||
59509230|NCT00845195|75602428|FG000|NOT COMPLETED|Overall Study||0||
59509231|NCT00845195|75602429|FG001|NOT COMPLETED|Overall Study||0||
59509232|NCT00845507|75602437|FG000|STARTED|Overall Study||24||
59509233|NCT00845507|75602438|FG001|STARTED|Overall Study||30||
59509234|NCT00845507|75602437|FG000|COMPLETED|Overall Study||22||
59509235|NCT00845507|75602438|FG001|COMPLETED|Overall Study||29||
59509236|NCT00845507|75602437|FG000|NOT COMPLETED|Overall Study||2||
59509237|NCT00845507|75602438|FG001|NOT COMPLETED|Overall Study||1||
59509238|NCT00845663|75602446|FG000|STARTED|Overall Study||49||
59509239|NCT00845663|75602447|FG001|STARTED|Overall Study||49||
59509240|NCT00845663|75602446|FG000|COMPLETED|Overall Study||49||
59509241|NCT00845663|75602447|FG001|COMPLETED|Overall Study||49||
59509242|NCT00845663|75602446|FG000|NOT COMPLETED|Overall Study||0||
59509243|NCT00845663|75602447|FG001|NOT COMPLETED|Overall Study||0||
59509244|NCT02871934|75602455|FG000|STARTED|Overall Study||193||
59509245|NCT02871934|75602456|FG001|STARTED|Overall Study||215||
59509246|NCT02871934|75602455|FG000|COMPLETED|Overall Study||193||
59509247|NCT02871934|75602456|FG001|COMPLETED|Overall Study||215||
59509248|NCT02871934|75602455|FG000|NOT COMPLETED|Overall Study||0||
59509249|NCT02871934|75602456|FG001|NOT COMPLETED|Overall Study||0||
59509250|NCT03123393|75602464|FG000|STARTED|Overall Study||24||
59509251|NCT03123393|75602465|FG001|STARTED|Overall Study||25||
60036854|NCT02016105|76152291|FG001|STARTED|TREATMENT PERIOD 2|Treatment arm applicable for Treatment Period 1 only (patients re-randomized in Treatment Period 2)|0||
60036855|NCT02016105|76152292|FG002|STARTED|TREATMENT PERIOD 2|"Patients re-randomized from Humira ® adalimumab treatment arm in Treatment Period 1"|63||
59509252|NCT03123393|75602464|FG000|COMPLETED|Overall Study||3||
59509253|NCT03123393|75602465|FG001|COMPLETED|Overall Study||2||
59509254|NCT03123393|75602464|FG000|NOT COMPLETED|Overall Study||21||
59509255|NCT03123393|75602465|FG001|NOT COMPLETED|Overall Study||23||
59509256|NCT00848237|75602471|FG000|STARTED|Overall Study||5521||
59509257|NCT00848237|75602471|FG000|COMPLETED|Overall Study||4982||
59509258|NCT00848237|75602471|FG000|NOT COMPLETED|Overall Study||539||
59509259|NCT02589808|75602475|FG000|STARTED|Overall Study||76||
59509260|NCT02589808|75602475|FG000|COMPLETED|Overall Study||76||
59509261|NCT02589808|75602475|FG000|NOT COMPLETED|Overall Study||0||
59509262|NCT02591056|75602479|FG000|STARTED|Overall Study||27||
60036856|NCT02016105|76152293|FG003|STARTED|TREATMENT PERIOD 2|"Patients re-randomized from Humira ® adalimumab treatment arm in Treatment Period 1"|127||
59509263|NCT02591056|75602479|FG000|COMPLETED|Overall Study||27||
59509264|NCT02591056|75602479|FG000|NOT COMPLETED|Overall Study||0||
59509265|NCT02593006|75602486|FG000|STARTED|Overall Study||257||
59509266|NCT02593006|75602487|FG001|STARTED|Overall Study||100||
59509267|NCT02593006|75602488|FG002|STARTED|Overall Study||43||
59509268|NCT02593006|75602486|FG000|COMPLETED|Overall Study||250||
59509269|NCT02593006|75602487|FG001|COMPLETED|Overall Study||93||
59509270|NCT02593006|75602488|FG002|COMPLETED|Overall Study||38||
59509271|NCT02593006|75602486|FG000|NOT COMPLETED|Overall Study||7||
59509272|NCT02593006|75602487|FG001|NOT COMPLETED|Overall Study||7||
59509273|NCT02593006|75602488|FG002|NOT COMPLETED|Overall Study||5||
59509274|NCT00814697|75602497|FG000|STARTED|Overall Study||12||
59509275|NCT00814697|75602497|FG000|COMPLETED|Overall Study||12||
59509276|NCT00814697|75602497|FG000|NOT COMPLETED|Overall Study||0||
59509277|NCT00814775|75602503|FG000|STARTED|Overall Study||23||
59509278|NCT00814775|75602504|FG001|STARTED|Overall Study||20||
59509279|NCT00814775|75602503|FG000|COMPLETED|Overall Study||23||
59509280|NCT00814775|75602504|FG001|COMPLETED|Overall Study||20||
59509281|NCT00814775|75602503|FG000|NOT COMPLETED|Overall Study||0||
59509282|NCT00814775|75602504|FG001|NOT COMPLETED|Overall Study||0||
59509283|NCT02593396|75602512|FG000|STARTED|Overall Study||40||
59509284|NCT02593396|75602513|FG001|STARTED|Overall Study||40||
59509285|NCT02593396|75602512|FG000|At Least Done One Efficacy Assessment|Overall Study||36|At least one efficacy assessment after the baseline visit.|
59509286|NCT02593396|75602513|FG001|At Least Done One Efficacy Assessment|Overall Study||36|At least one efficacy assessment after the baseline visit.|
59509287|NCT02593396|75602512|FG000|COMPLETED|Overall Study||25||
59509288|NCT02593396|75602513|FG001|COMPLETED|Overall Study||26||
59509289|NCT02593396|75602512|FG000|NOT COMPLETED|Overall Study||15||
59509290|NCT02593396|75602513|FG001|NOT COMPLETED|Overall Study||14||
59509291|NCT02593630|75602519|FG000|STARTED|Overall Study||54||
59509292|NCT02593630|75602519|FG000|COMPLETED|Overall Study||53||
59509293|NCT02593630|75602519|FG000|NOT COMPLETED|Overall Study||1||
60036857|NCT02016105|76152294|FG004|STARTED|TREATMENT PERIOD 2|"Patients re-randomized from GP2017 adalimumab treatment arm in Treatment Period 1"|63||
60036858|NCT02016105|76152295|FG005|STARTED|TREATMENT PERIOD 2|"Patients re-randomized from GP2017 adalimumab treatment arm in Treatment Period 1"|126||
60036859|NCT02016105|76152290|FG000|COMPLETED|TREATMENT PERIOD 2||0||
60036860|NCT02016105|76152291|FG001|COMPLETED|TREATMENT PERIOD 2||0||
60036861|NCT02016105|76152292|FG002|COMPLETED|TREATMENT PERIOD 2||57||
60036862|NCT02016105|76152293|FG003|COMPLETED|TREATMENT PERIOD 2||116||
60036863|NCT02016105|76152294|FG004|COMPLETED|TREATMENT PERIOD 2||59||
60036864|NCT02016105|76152295|FG005|COMPLETED|TREATMENT PERIOD 2||112||
60036865|NCT02016105|76152290|FG000|NOT COMPLETED|TREATMENT PERIOD 2||0||
60036866|NCT02016105|76152291|FG001|NOT COMPLETED|TREATMENT PERIOD 2||0||
60036867|NCT02016105|76152292|FG002|NOT COMPLETED|TREATMENT PERIOD 2||6||
60036868|NCT02016105|76152293|FG003|NOT COMPLETED|TREATMENT PERIOD 2||11||
60036869|NCT02016105|76152294|FG004|NOT COMPLETED|TREATMENT PERIOD 2||4||
60036870|NCT02016105|76152295|FG005|NOT COMPLETED|TREATMENT PERIOD 2||14||
60036871|NCT02016105|76152290|FG000|STARTED|EXTENSION PERIOD||0||
60036872|NCT02016105|76152291|FG001|STARTED|EXTENSION PERIOD||0||
60036873|NCT02016105|76152292|FG002|STARTED|EXTENSION PERIOD|5 patients did not proceed from Treatment Period 2 into Extension Period|52||
60036874|NCT02016105|76152293|FG003|STARTED|EXTENSION PERIOD|7 patients did not proceed from Treatment Period 2 into Extension Period|109||
60036875|NCT02016105|76152294|FG004|STARTED|EXTENSION PERIOD|3 patients did not proceed from Treatment Period 2 into Extension Period|56||
60036876|NCT02016105|76152295|FG005|STARTED|EXTENSION PERIOD|6 patients did not proceed from Treatment Period 2 into Extension Period|106||
60036877|NCT02016105|76152290|FG000|COMPLETED|EXTENSION PERIOD||0||
60036878|NCT02016105|76152291|FG001|COMPLETED|EXTENSION PERIOD||0||
60036879|NCT02016105|76152292|FG002|COMPLETED|EXTENSION PERIOD||47||
60036880|NCT02016105|76152293|FG003|COMPLETED|EXTENSION PERIOD||104||
60036881|NCT02016105|76152294|FG004|COMPLETED|EXTENSION PERIOD||50||
60036882|NCT02016105|76152295|FG005|COMPLETED|EXTENSION PERIOD||100||
60036883|NCT02016105|76152290|FG000|NOT COMPLETED|EXTENSION PERIOD||0||
60036884|NCT02016105|76152291|FG001|NOT COMPLETED|EXTENSION PERIOD||0||
60036885|NCT02016105|76152292|FG002|NOT COMPLETED|EXTENSION PERIOD||5||
60036886|NCT02016105|76152293|FG003|NOT COMPLETED|EXTENSION PERIOD||5||
60036887|NCT02016105|76152294|FG004|NOT COMPLETED|EXTENSION PERIOD||6||
60036888|NCT02016105|76152295|FG005|NOT COMPLETED|EXTENSION PERIOD||6||
60036889|NCT02400905|76152309|FG000|STARTED|Overall Study||271||
60036890|NCT02400905|76152309|FG000|30-Days Follow-up|Overall Study||268||
60036891|NCT02400905|76152309|FG000|12-Months Follow-up|Overall Study||256||
60036892|NCT02400905|76152309|FG000|24-Months Follow-up|Overall Study||225||
60036893|NCT02400905|76152309|FG000|36 Months-Follow-up|Overall Study||208||
59509294|NCT00848783|75602527|FG000|STARTED|Overall Study||4||
59509295|NCT00848783|75602528|FG001|STARTED|Overall Study||3||
59509296|NCT00848783|75602529|FG002|STARTED|Overall Study||1||
59509297|NCT00848783|75602527|FG000|COMPLETED|Overall Study||1||
60036894|NCT02400905|76152309|FG000|COMPLETED|Overall Study||208||
60036895|NCT02400905|76152309|FG000|NOT COMPLETED|Overall Study||63||
59509298|NCT00848783|75602528|FG001|COMPLETED|Overall Study||1||
59509299|NCT00848783|75602529|FG002|COMPLETED|Overall Study||1||
59509300|NCT00848783|75602527|FG000|NOT COMPLETED|Overall Study||3||
59509301|NCT00848783|75602528|FG001|NOT COMPLETED|Overall Study||2||
59509302|NCT00848783|75602529|FG002|NOT COMPLETED|Overall Study||0||
59509303|NCT00849251|75602536|FG000|STARTED|Overall Study||6||
59509304|NCT00849251|75602537|FG001|STARTED|Overall Study||25||
59509305|NCT00849251|75602536|FG000|COMPLETED|Overall Study||5||
59509306|NCT00849251|75602537|FG001|COMPLETED|Overall Study||24||
60036896|NCT02400749|76152316|FG000|STARTED|Week 0 -16||50||
59509307|NCT00849251|75602536|FG000|NOT COMPLETED|Overall Study||1||
59509308|NCT00849251|75602537|FG001|NOT COMPLETED|Overall Study||1||
59509309|NCT00850031|75602543|FG000|STARTED|Overall Study||118||
59509310|NCT00850031|75602543|FG000|COMPLETED|Overall Study||101||
59509311|NCT00850031|75602543|FG000|NOT COMPLETED|Overall Study||17||
59509312|NCT02153099|75602554|FG000|STARTED|Overall Study||6||
59509313|NCT02153099|75602555|FG001|STARTED|Overall Study||6||
59509314|NCT02153099|75602556|FG002|STARTED|Overall Study||6||
59509315|NCT02153099|75602557|FG003|STARTED|Overall Study||6||
59509316|NCT02153099|75602558|FG004|STARTED|Overall Study||6||
60036897|NCT02400749|76152317|FG001|STARTED|Week 0 -16||50||
60036898|NCT02400749|76152316|FG000|COMPLETED|Week 0 -16||39||
60036899|NCT02400749|76152317|FG001|COMPLETED|Week 0 -16||44||
60036900|NCT02400749|76152316|FG000|NOT COMPLETED|Week 0 -16||11||
60036901|NCT02400749|76152317|FG001|NOT COMPLETED|Week 0 -16||6||
60036902|NCT02400749|76152316|FG000|STARTED|Week 17 - 32||39||
60036903|NCT02400749|76152317|FG001|STARTED|Week 17 - 32||44||
60036904|NCT02400749|76152316|FG000|COMPLETED|Week 17 - 32||34||
60036905|NCT02400749|76152317|FG001|COMPLETED|Week 17 - 32||41||
60036906|NCT02400749|76152316|FG000|NOT COMPLETED|Week 17 - 32||5||
60036907|NCT02400749|76152317|FG001|NOT COMPLETED|Week 17 - 32||3||
60036908|NCT02420327|76152323|FG000|STARTED|Overall Study||43||
60036909|NCT02420327|76152323|FG000|COMPLETED|Overall Study||27||
60036910|NCT02420327|76152323|FG000|NOT COMPLETED|Overall Study||16||
60036911|NCT02374853|76152335|FG000|STARTED|Overall Study||517||
60036912|NCT02374853|76152336|FG001|STARTED|Overall Study||520||
60036913|NCT02374853|76152335|FG000|COMPLETED|Overall Study||512||
60036914|NCT02374853|76152336|FG001|COMPLETED|Overall Study||509||
60036915|NCT02374853|76152335|FG000|NOT COMPLETED|Overall Study||5||
60036916|NCT02374853|76152336|FG001|NOT COMPLETED|Overall Study||11||
60036917|NCT02015793|76152344|FG000|STARTED|Overall Study||15||
60036918|NCT02015793|76152345|FG001|STARTED|Overall Study||15||
60036919|NCT02015793|76152344|FG000|Completed Double-Blind Period|Overall Study||14||
60036920|NCT02015793|76152345|FG001|Completed Double-Blind Period|Overall Study||14||
60036921|NCT02015793|76152344|FG000|Entered Open-label Extension Period|Overall Study||13||
60036922|NCT02015793|76152345|FG001|Entered Open-label Extension Period|Overall Study||14||
60036923|NCT02015793|76152344|FG000|COMPLETED|Overall Study||11||
60036924|NCT02015793|76152345|FG001|COMPLETED|Overall Study||11||
59509317|NCT02153099|75602559|FG005|STARTED|Overall Study||6||
60036925|NCT02015793|76152344|FG000|NOT COMPLETED|Overall Study||4||
60036926|NCT02015793|76152345|FG001|NOT COMPLETED|Overall Study||4||
60036927|NCT02347631|76152359|FG000|STARTED|Washout 1 (1 Month)||61||
60036928|NCT02347631|76152360|FG001|STARTED|Washout 1 (1 Month)||57||
60036929|NCT02347631|76152359|FG000|COMPLETED|Washout 1 (1 Month)||61||
60036930|NCT02347631|76152360|FG001|COMPLETED|Washout 1 (1 Month)||57||
60036931|NCT02347631|76152359|FG000|NOT COMPLETED|Washout 1 (1 Month)||0||
60036932|NCT02347631|76152360|FG001|NOT COMPLETED|Washout 1 (1 Month)||0||
60036933|NCT02347631|76152359|FG000|STARTED|First Intervention (2 Months)||61||
60036934|NCT02347631|76152360|FG001|STARTED|First Intervention (2 Months)||57||
60036935|NCT02347631|76152359|FG000|COMPLETED|First Intervention (2 Months)||54||
60036936|NCT02347631|76152360|FG001|COMPLETED|First Intervention (2 Months)||51||
60036937|NCT02347631|76152359|FG000|NOT COMPLETED|First Intervention (2 Months)||7||
60036938|NCT02347631|76152360|FG001|NOT COMPLETED|First Intervention (2 Months)||6||
60036939|NCT02347631|76152359|FG000|STARTED|Washout 2 (1 Month)||54||
60036940|NCT02347631|76152360|FG001|STARTED|Washout 2 (1 Month)||51||
60036941|NCT02347631|76152359|FG000|COMPLETED|Washout 2 (1 Month)||52||
60036942|NCT02347631|76152360|FG001|COMPLETED|Washout 2 (1 Month)||48||
60036943|NCT02347631|76152359|FG000|NOT COMPLETED|Washout 2 (1 Month)||2||
60036944|NCT02347631|76152360|FG001|NOT COMPLETED|Washout 2 (1 Month)||3||
60036945|NCT02347631|76152359|FG000|STARTED|Second Intervention (2 Months)||52||
60036946|NCT02347631|76152360|FG001|STARTED|Second Intervention (2 Months)||48||
60036947|NCT02347631|76152359|FG000|COMPLETED|Second Intervention (2 Months)||39||
60036948|NCT02347631|76152360|FG001|COMPLETED|Second Intervention (2 Months)||44||
60036949|NCT02347631|76152359|FG000|NOT COMPLETED|Second Intervention (2 Months)||13||
60036950|NCT02347631|76152360|FG001|NOT COMPLETED|Second Intervention (2 Months)||4||
60036951|NCT02015637|76152370|FG000|STARTED|Overall Study||306||
60036952|NCT02015637|76152371|FG001|STARTED|Overall Study||154||
60036953|NCT02015637|76152370|FG000|COMPLETED|Overall Study||298||
60036954|NCT02015637|76152371|FG001|COMPLETED|Overall Study||149||
60036955|NCT02015637|76152370|FG000|NOT COMPLETED|Overall Study||8||
59509318|NCT02153099|75602560|FG006|STARTED|Overall Study||12||
59509319|NCT02153099|75602554|FG000|COMPLETED|Overall Study||6||
60036956|NCT02015637|76152371|FG001|NOT COMPLETED|Overall Study||5||
60036957|NCT02347085|76152377|FG000|STARTED|Overall Study||43||
59509320|NCT02153099|75602555|FG001|COMPLETED|Overall Study||6||
59509321|NCT02153099|75602556|FG002|COMPLETED|Overall Study||6||
60036958|NCT02347085|76152377|FG000|GFF MDI 14.4/9.6 µg|Overall Study||40||
60036959|NCT02347085|76152377|FG000|Placebo MDI|Overall Study||40||
60036960|NCT02347085|76152377|FG000|COMPLETED|Overall Study||33||
60036961|NCT02347085|76152377|FG000|NOT COMPLETED|Overall Study||10||
60036962|NCT02374463|76152385|FG000|STARTED|Overall Study||15||
60036963|NCT02374463|76152386|FG001|STARTED|Overall Study||12||
59509322|NCT02153099|75602557|FG003|COMPLETED|Overall Study||6||
59509323|NCT02153099|75602558|FG004|COMPLETED|Overall Study||6||
59509324|NCT02153099|75602559|FG005|COMPLETED|Overall Study||6||
59509325|NCT02153099|75602560|FG006|COMPLETED|Overall Study||12||
59509326|NCT02153099|75602554|FG000|NOT COMPLETED|Overall Study||0||
59509327|NCT02153099|75602555|FG001|NOT COMPLETED|Overall Study||0||
59509328|NCT02153099|75602556|FG002|NOT COMPLETED|Overall Study||0||
59509329|NCT02153099|75602557|FG003|NOT COMPLETED|Overall Study||0||
59509330|NCT02153099|75602558|FG004|NOT COMPLETED|Overall Study||0||
59509331|NCT02153099|75602559|FG005|NOT COMPLETED|Overall Study||0||
59509332|NCT02153099|75602560|FG006|NOT COMPLETED|Overall Study||0||
59509333|NCT00850889|75602576|FG000|STARTED|Overall Study||32||
59509334|NCT00850889|75602576|FG000|COMPLETED|Overall Study||32||
59509335|NCT00850889|75602576|FG000|NOT COMPLETED|Overall Study||0||
59509336|NCT00851279|75602583|FG000|STARTED|Overall Study||53||
60036964|NCT02374463|76152385|FG000|COMPLETED|Overall Study||12||
60036965|NCT02374463|76152386|FG001|COMPLETED|Overall Study||9||
60036966|NCT02374463|76152385|FG000|NOT COMPLETED|Overall Study||3||
60036967|NCT02374463|76152386|FG001|NOT COMPLETED|Overall Study||3||
60036968|NCT02015481|76152393|FG000|STARTED|Overall Study||25||
60036969|NCT02015481|76152393|FG000|COMPLETED|Overall Study||24||
60036970|NCT02015481|76152393|FG000|NOT COMPLETED|Overall Study||1||
60036971|NCT02374307|76152400|FG000|STARTED|3-months Follow-up||77||
60036972|NCT02374307|76152401|FG001|STARTED|3-months Follow-up||78||
60036973|NCT02374307|76152400|FG000|COMPLETED|3-months Follow-up||69||
60036974|NCT02374307|76152401|FG001|COMPLETED|3-months Follow-up||69||
60036975|NCT02374307|76152400|FG000|NOT COMPLETED|3-months Follow-up||8||
60036976|NCT02374307|76152401|FG001|NOT COMPLETED|3-months Follow-up||9||
60036977|NCT02374307|76152400|FG000|STARTED|6-months Follow-up|5 subjects missed the first follow-up, but continued the study and were assessed at 6 months.|74||
60036978|NCT02374307|76152401|FG001|STARTED|6-months Follow-up|1 subject missed the first follow-up, but continued the study and was assessed at 6 months.|70||
60036979|NCT02374307|76152400|FG000|COMPLETED|6-months Follow-up||71||
60036980|NCT02374307|76152401|FG001|COMPLETED|6-months Follow-up||64||
60036981|NCT02374307|76152400|FG000|NOT COMPLETED|6-months Follow-up||3||
60036982|NCT02374307|76152401|FG001|NOT COMPLETED|6-months Follow-up||6||
60036983|NCT02397473|76152409|FG000|STARTED|Treatment Phase||57||
60036984|NCT02397473|76152410|FG001|STARTED|Treatment Phase||52||
60036985|NCT02397473|76152409|FG000|Received at Least One Dose of Study Drug|Treatment Phase||57||
60036986|NCT02397473|76152410|FG001|Received at Least One Dose of Study Drug|Treatment Phase||49||
60036987|NCT02397473|76152409|FG000|COMPLETED|Treatment Phase||45||
60036988|NCT02397473|76152410|FG001|COMPLETED|Treatment Phase||45||
60036989|NCT02397473|76152409|FG000|NOT COMPLETED|Treatment Phase||12||
60036990|NCT02397473|76152410|FG001|NOT COMPLETED|Treatment Phase||7||
60036991|NCT02397473|76152409|FG000|STARTED|Post Treatment Follow-up Phase|Participants who discontinued treatment period had an option to enter post treatment phase.|50||
60036992|NCT02397473|76152410|FG001|STARTED|Post Treatment Follow-up Phase||47||
60036993|NCT02397473|76152409|FG000|COMPLETED|Post Treatment Follow-up Phase||47||
60036994|NCT02397473|76152410|FG001|COMPLETED|Post Treatment Follow-up Phase||45||
60036995|NCT02397473|76152409|FG000|NOT COMPLETED|Post Treatment Follow-up Phase||3||
60036996|NCT02397473|76152410|FG001|NOT COMPLETED|Post Treatment Follow-up Phase||2||
60036997|NCT02344745|76152421|FG000|STARTED|Overall Study||40||
60036998|NCT02344745|76152422|FG001|STARTED|Overall Study||40||
60036999|NCT02344745|76152421|FG000|COMPLETED|Overall Study||38||
60037000|NCT02344745|76152422|FG001|COMPLETED|Overall Study||40||
60037001|NCT02344745|76152421|FG000|NOT COMPLETED|Overall Study||2||
59509337|NCT00851279|75602583|FG000|COMPLETED|Overall Study||53||
59509338|NCT00851279|75602583|FG000|NOT COMPLETED|Overall Study||0||
59509339|NCT00851357|75602590|FG000|STARTED|Overall Study||1200||
59509340|NCT00851357|75602591|FG001|STARTED|Overall Study||1201||
59509341|NCT00851357|75602592|FG002|STARTED|Overall Study||1799||
59509342|NCT00851357|75602590|FG000|COMPLETED|Overall Study||1200||
59509343|NCT00851357|75602591|FG001|COMPLETED|Overall Study||1201||
59509344|NCT00851357|75602592|FG002|COMPLETED|Overall Study||1799||
60037002|NCT02344745|76152422|FG001|NOT COMPLETED|Overall Study||0||
60037003|NCT02370641|76152430|FG000|STARTED|Overall Study||18||
60037004|NCT02370641|76152431|FG001|STARTED|Overall Study||8||
60037005|NCT02370641|76152430|FG000|COMPLETED|Overall Study||14||
60037006|NCT02370641|76152431|FG001|COMPLETED|Overall Study||6||
60037007|NCT02370641|76152430|FG000|NOT COMPLETED|Overall Study||4||
60037008|NCT02370641|76152431|FG001|NOT COMPLETED|Overall Study||2||
60037009|NCT01621191|76152437|FG000|STARTED|Overall Study||149||
60037010|NCT01621191|76152437|FG000|Received at Least 1 Dose of Study Drug|Overall Study||149||
60037011|NCT01621191|76152437|FG000|Had at Least 1 Post-Baseline Observation|Overall Study||148||
59509345|NCT00851357|75602590|FG000|NOT COMPLETED|Overall Study||0||
60037012|NCT01621191|76152437|FG000|COMPLETED|Overall Study||124||
60037013|NCT01621191|76152437|FG000|NOT COMPLETED|Overall Study||25||
59509346|NCT00851357|75602591|FG001|NOT COMPLETED|Overall Study||0||
59509347|NCT00851357|75602592|FG002|NOT COMPLETED|Overall Study||0||
59509348|NCT00815087|75602602|FG000|STARTED|Overall Study||10||
59509349|NCT00815087|75602603|FG001|STARTED|Overall Study||10||
59509350|NCT00815087|75602602|FG000|COMPLETED|Overall Study||10||
59509351|NCT00815087|75602603|FG001|COMPLETED|Overall Study||10||
59509352|NCT00815087|75602602|FG000|NOT COMPLETED|Overall Study||0||
59509353|NCT00815087|75602603|FG001|NOT COMPLETED|Overall Study||0||
59509354|NCT02856269|75602611|FG000|STARTED|Overall Study||25||
59509355|NCT02856269|75602612|FG001|STARTED|Overall Study||27||
60037014|NCT02343263|76152445|FG000|STARTED|Overall Study|Study closed due for administrative reasons|5||
60037015|NCT02343263|76152446|FG001|STARTED|Overall Study||3||
60037016|NCT02343263|76152447|FG002|STARTED|Overall Study||1||
60037017|NCT02343263|76152445|FG000|COMPLETED|Overall Study|Study closed due for administrative reasons|0|Study closed due for administrative reasons|
60037018|NCT02343263|76152446|FG001|COMPLETED|Overall Study||0|Study closed due for administrative reasons|
60037019|NCT02343263|76152447|FG002|COMPLETED|Overall Study||0|Study closed due for administrative reasons|
60037020|NCT02343263|76152445|FG000|NOT COMPLETED|Overall Study||5||
60037021|NCT02343263|76152446|FG001|NOT COMPLETED|Overall Study||3||
60037022|NCT02343263|76152447|FG002|NOT COMPLETED|Overall Study||1||
60037023|NCT02081859|76152461|FG000|STARTED|Overall Study||150||
60037024|NCT02081859|76152462|FG001|STARTED|Overall Study||150||
60037025|NCT02081859|76152461|FG000|COMPLETED|Overall Study||116||
60037026|NCT02081859|76152462|FG001|COMPLETED|Overall Study||119||
60037027|NCT02081859|76152461|FG000|NOT COMPLETED|Overall Study||34||
60037028|NCT02081859|76152462|FG001|NOT COMPLETED|Overall Study||31||
60037029|NCT02342639|76152470|FG000|STARTED|Overall Study||19||
60037030|NCT02342639|76152471|FG001|STARTED|Overall Study||19||
60037031|NCT02342639|76152470|FG000|COMPLETED|Overall Study||17||
60037032|NCT02342639|76152471|FG001|COMPLETED|Overall Study||14||
60037033|NCT02342639|76152470|FG000|NOT COMPLETED|Overall Study||2||
60037034|NCT02342639|76152471|FG001|NOT COMPLETED|Overall Study||5||
60037035|NCT01625091|76152481|FG000|STARTED|Intervention||96||
60037036|NCT01625091|76152482|FG001|STARTED|Intervention||98||
60037037|NCT01625091|76152481|FG000|2 Months|Intervention||90||
60037038|NCT01625091|76152482|FG001|2 Months|Intervention||93||
60037039|NCT01625091|76152481|FG000|4 Months|Intervention||85||
60037040|NCT01625091|76152482|FG001|4 Months|Intervention||87||
60037041|NCT01625091|76152481|FG000|COMPLETED|Intervention||85||
60037042|NCT01625091|76152482|FG001|COMPLETED|Intervention||87||
60037043|NCT01625091|76152481|FG000|NOT COMPLETED|Intervention||11||
60037044|NCT01625091|76152482|FG001|NOT COMPLETED|Intervention||11||
60037045|NCT01625091|76152481|FG000|STARTED|Post-intervention||85||
60037046|NCT01625091|76152482|FG001|STARTED|Post-intervention||87||
60037047|NCT01625091|76152481|FG000|7 Months|Post-intervention||81||
60037048|NCT01625091|76152482|FG001|7 Months|Post-intervention||85||
60037049|NCT01625091|76152481|FG000|COMPLETED|Post-intervention||81||
60037050|NCT01625091|76152482|FG001|COMPLETED|Post-intervention||85||
60037051|NCT01625091|76152481|FG000|NOT COMPLETED|Post-intervention||4||
60037052|NCT01625091|76152482|FG001|NOT COMPLETED|Post-intervention||2||
60037053|NCT02396849|76152490|FG000|STARTED|Overall Study||29||
60037054|NCT02396849|76152491|FG001|STARTED|Overall Study||30||
60037055|NCT02396849|76152490|FG000|COMPLETED|Overall Study||27||
60037056|NCT02396849|76152491|FG001|COMPLETED|Overall Study||28||
60037057|NCT02396849|76152490|FG000|NOT COMPLETED|Overall Study||2||
60037058|NCT02396849|76152491|FG001|NOT COMPLETED|Overall Study||2||
60037059|NCT02370251|76152499|FG000|STARTED|Overall Study||63||
60037060|NCT02370251|76152499|FG000|COMPLETED|Overall Study||52||
60037061|NCT02370251|76152499|FG000|NOT COMPLETED|Overall Study||11||
60037062|NCT02396537|76152505|FG000|STARTED|Overall Study||40||
60037063|NCT02396537|76152506|FG001|STARTED|Overall Study||37||
60037064|NCT02396537|76152505|FG000|COMPLETED|Overall Study||40||
60037065|NCT02396537|76152506|FG001|COMPLETED|Overall Study||36||
60037066|NCT02396537|76152505|FG000|NOT COMPLETED|Overall Study||0||
60037067|NCT02396537|76152506|FG001|NOT COMPLETED|Overall Study||1||
60037068|NCT02342171|76152514|FG000|STARTED|Overall Study||99||
60037069|NCT02342171|76152515|FG001|STARTED|Overall Study||507||
60037070|NCT02342171|76152514|FG000|COMPLETED|Overall Study||84||
60037071|NCT02342171|76152515|FG001|COMPLETED|Overall Study||418||
60037072|NCT02342171|76152514|FG000|NOT COMPLETED|Overall Study||15||
60037073|NCT02342171|76152515|FG001|NOT COMPLETED|Overall Study||89||
60037074|NCT01624467|76152520|FG000|STARTED|Overall Study||75||
60037075|NCT01624467|76152520|FG000|Received at Least One Dose of Study Drug|Overall Study||75||
60037076|NCT01624467|76152520|FG000|COMPLETED|Overall Study||44||
60037077|NCT01624467|76152520|FG000|NOT COMPLETED|Overall Study||31||
60037078|NCT01624233|76152526|FG000|STARTED|Period 2 - Induction||91||
59759483|NCT04067843|75878904|FG001|COMPLETED|Overall Study||10||
59759484|NCT04067843|75878903|FG000|NOT COMPLETED|Overall Study||0||
59759485|NCT04067843|75878904|FG001|NOT COMPLETED|Overall Study||0||
59917877|NCT01353508|76038391|FG002|COMPLETED|Period 1 - First Intervention (7 Days)||8||
59917878|NCT01353508|76038392|FG003|COMPLETED|Period 1 - First Intervention (7 Days)||7||
59917879|NCT01353508|76038389|FG000|NOT COMPLETED|Period 1 - First Intervention (7 Days)||0||
59917880|NCT01353508|76038390|FG001|NOT COMPLETED|Period 1 - First Intervention (7 Days)||0||
59917881|NCT01353508|76038391|FG002|NOT COMPLETED|Period 1 - First Intervention (7 Days)||0||
59917882|NCT01353508|76038392|FG003|NOT COMPLETED|Period 1 - First Intervention (7 Days)||1||
59917883|NCT01353508|76038389|FG000|STARTED|Period 2 - Second Intervention (7 Days)||8||
59917884|NCT01353508|76038390|FG001|STARTED|Period 2 - Second Intervention (7 Days)||8||
59917885|NCT01353508|76038391|FG002|STARTED|Period 2 - Second Intervention (7 Days)||8||
59917886|NCT01353508|76038392|FG003|STARTED|Period 2 - Second Intervention (7 Days)||7||
59917887|NCT01353508|76038389|FG000|COMPLETED|Period 2 - Second Intervention (7 Days)||7||
59917888|NCT01353508|76038390|FG001|COMPLETED|Period 2 - Second Intervention (7 Days)||8||
59917889|NCT01353508|76038391|FG002|COMPLETED|Period 2 - Second Intervention (7 Days)||8||
59917890|NCT01353508|76038392|FG003|COMPLETED|Period 2 - Second Intervention (7 Days)||7||
59917891|NCT01353508|76038389|FG000|NOT COMPLETED|Period 2 - Second Intervention (7 Days)||1||
59917892|NCT01353508|76038390|FG001|NOT COMPLETED|Period 2 - Second Intervention (7 Days)||0||
59917893|NCT01353508|76038391|FG002|NOT COMPLETED|Period 2 - Second Intervention (7 Days)||0||
59917894|NCT01353508|76038392|FG003|NOT COMPLETED|Period 2 - Second Intervention (7 Days)||0||
59917895|NCT03636269|76038404|FG000|STARTED|Period 1: Double-blind Phase||235||
59917896|NCT03636269|76038405|FG001|STARTED|Period 1: Double-blind Phase||236||
59917897|NCT03636269|76038406|FG002|STARTED|Period 1: Double-blind Phase||0||
59917898|NCT03636269|76038404|FG000|COMPLETED|Period 1: Double-blind Phase||206||
59917899|NCT03636269|76038405|FG001|COMPLETED|Period 1: Double-blind Phase||223||
59917900|NCT03636269|76038406|FG002|COMPLETED|Period 1: Double-blind Phase||0||
59917901|NCT03636269|76038404|FG000|NOT COMPLETED|Period 1: Double-blind Phase||29||
59917902|NCT03636269|76038405|FG001|NOT COMPLETED|Period 1: Double-blind Phase||13||
59917903|NCT03636269|76038406|FG002|NOT COMPLETED|Period 1: Double-blind Phase||0||
59917904|NCT03636269|76038404|FG000|STARTED|Period 2: Open-label Phase||0||
59917905|NCT03636269|76038405|FG001|STARTED|Period 2: Open-label Phase||0||
59917906|NCT03636269|76038406|FG002|STARTED|Period 2: Open-label Phase||399||
59917907|NCT03636269|76038404|FG000|COMPLETED|Period 2: Open-label Phase||0||
59917908|NCT03636269|76038405|FG001|COMPLETED|Period 2: Open-label Phase||0||
59917909|NCT03636269|76038406|FG002|COMPLETED|Period 2: Open-label Phase||5||
59917910|NCT03636269|76038404|FG000|NOT COMPLETED|Period 2: Open-label Phase||0||
59917911|NCT03636269|76038405|FG001|NOT COMPLETED|Period 2: Open-label Phase||0||
59917912|NCT03636269|76038406|FG002|NOT COMPLETED|Period 2: Open-label Phase||394||
59917913|NCT02685202|76038415|FG000|STARTED|Overall Study||9||
59917914|NCT02685202|76038415|FG000|COMPLETED|Overall Study||0||
59917915|NCT02685202|76038415|FG000|NOT COMPLETED|Overall Study||9||
60037079|NCT01624233|76152526|FG000|Received at Least 1 Dose of Study Drug|Period 2 - Induction||91||
59759486|NCT02631941|75878922|FG000|STARTED|Overall Study||9||
59759487|NCT02631941|75878923|FG001|STARTED|Overall Study||10||
59759488|NCT02631941|75878924|FG002|STARTED|Overall Study||9||
59759489|NCT02631941|75878925|FG003|STARTED|Overall Study||9||
59759490|NCT02631941|75878926|FG004|STARTED|Overall Study||9||
59759491|NCT02631941|75878927|FG005|STARTED|Overall Study||8||
59759492|NCT02631941|75878928|FG006|STARTED|Overall Study||9||
59759493|NCT02631941|75878929|FG007|STARTED|Overall Study||9||
59759494|NCT02631941|75878930|FG008|STARTED|Overall Study||10||
59759495|NCT02631941|75878931|FG009|STARTED|Overall Study||9||
59759496|NCT02631941|75878922|FG000|A|Overall Study||9||
59759497|NCT02631941|75878923|FG001|A|Overall Study||8||
59759498|NCT02631941|75878924|FG002|A|Overall Study||9||
59759499|NCT02631941|75878925|FG003|A|Overall Study||9||
59759500|NCT02631941|75878926|FG004|A|Overall Study||9||
59759501|NCT02631941|75878927|FG005|A|Overall Study||8||
59759502|NCT02631941|75878928|FG006|A|Overall Study||9||
59759503|NCT02631941|75878929|FG007|A|Overall Study||9||
59759504|NCT02631941|75878930|FG008|A|Overall Study||9||
59759505|NCT02631941|75878931|FG009|A|Overall Study||9||
59759506|NCT02631941|75878922|FG000|B1|Overall Study||9||
59917916|NCT03087786|76038421|FG000|STARTED|Overall Study||50||
59917917|NCT03087786|76038422|FG001|STARTED|Overall Study||50||
59917918|NCT03087786|76038421|FG000|COMPLETED|Overall Study||48||
59917919|NCT03087786|76038422|FG001|COMPLETED|Overall Study||50||
59917920|NCT03087786|76038421|FG000|NOT COMPLETED|Overall Study||2||
59917921|NCT03087786|76038422|FG001|NOT COMPLETED|Overall Study||0||
59917922|NCT03635957|76038428|FG000|STARTED|Run-In Period||15||
60037080|NCT01624233|76152526|FG000|Erythrodermic Psoriasis (Ps)|Period 2 - Induction||8||
59759507|NCT02631941|75878923|FG001|B1|Overall Study||10||
59759508|NCT02631941|75878924|FG002|B1|Overall Study||9||
59759509|NCT02631941|75878925|FG003|B1|Overall Study||9||
59759510|NCT02631941|75878926|FG004|B1|Overall Study||8||
59759511|NCT02631941|75878927|FG005|B1|Overall Study||8||
59759512|NCT02631941|75878928|FG006|B1|Overall Study||9||
59759513|NCT02631941|75878929|FG007|B1|Overall Study||9||
59759514|NCT02631941|75878930|FG008|B1|Overall Study||10||
59917923|NCT03635957|76038428|FG000|COMPLETED|Run-In Period||14||
59917924|NCT03635957|76038428|FG000|NOT COMPLETED|Run-In Period||1||
60037081|NCT01624233|76152526|FG000|Pustular Ps|Period 2 - Induction||5||
60037082|NCT01624233|76152526|FG000|Plaque Ps|Period 2 - Induction||78||
60037083|NCT01624233|76152526|FG000|COMPLETED|Period 2 - Induction||90||
60037084|NCT01624233|76152526|FG000|NOT COMPLETED|Period 2 - Induction||1||
60037085|NCT01624233|76152526|FG000|STARTED|Period 3 - Maintenance||90||
60037086|NCT01624233|76152526|FG000|Received at Least 1 Dose of Study Drug|Period 3 - Maintenance||90||
60037087|NCT01624233|76152526|FG000|COMPLETED|Period 3 - Maintenance||83||
60037088|NCT01624233|76152526|FG000|NOT COMPLETED|Period 3 - Maintenance||7||
60037089|NCT01624233|76152526|FG000|STARTED|Period 4 - Drug Free Period|Only responders in participants with plaque Ps moved to the Drug Free Period 4.|70||
60037090|NCT01624233|76152526|FG000|Adverse Event|Period 4 - Drug Free Period|1 participant who discontinued due to adverse event is included in the participants who relapsed.|1||
60037091|NCT01624233|76152526|FG000|Physician Decision|Period 4 - Drug Free Period|1 participant who discontinued due to physician decision is included in the participants relapsed.|1||
60037092|NCT01624233|76152526|FG000|COMPLETED|Period 4 - Drug Free Period||9||
60037093|NCT01624233|76152526|FG000|NOT COMPLETED|Period 4 - Drug Free Period||61||
60037094|NCT01624233|76152526|FG000|STARTED|Period 5 - Retreatment Period|Period 5 included (participants with erythrodermic Ps or pustular Ps) or Period 4 completers.|80||
60037095|NCT01624233|76152526|FG000|COMPLETED|Period 5 - Retreatment Period||70||
60037096|NCT01624233|76152526|FG000|NOT COMPLETED|Period 5 - Retreatment Period||10||
60037097|NCT01624233|76152526|FG000|STARTED|Period 6: Follow-up|Period 6 included participants received a dose of drug and exhibited the required neutrophil count.|88||
60037098|NCT01624233|76152526|FG000|COMPLETED|Period 6: Follow-up||79||
60037099|NCT01624233|76152526|FG000|NOT COMPLETED|Period 6: Follow-up||9||
60037100|NCT01993017|76152537|FG000|STARTED|Overall Study||499||
59509356|NCT02856269|75602611|FG000|COMPLETED|Overall Study||24||
59509357|NCT02856269|75602612|FG001|COMPLETED|Overall Study||24||
59509358|NCT02856269|75602611|FG000|NOT COMPLETED|Overall Study||1||
59509359|NCT02856269|75602612|FG001|NOT COMPLETED|Overall Study||3||
59509360|NCT00852137|75602620|FG000|STARTED|Overall Study||13||
59509361|NCT00852137|75602621|FG001|STARTED|Overall Study||3||
59917925|NCT03635957|76038428|FG000|STARTED|Pegloticase + IMM Period||14||
59917926|NCT03635957|76038428|FG000|Completed Study at 24 Weeks-Amendment 1|Pegloticase + IMM Period||1||
59917927|NCT03635957|76038428|FG000|Completed Study at 52 Weeks-Amendment 2|Pegloticase + IMM Period||10||
59917928|NCT03635957|76038428|FG000|Discontinued Study Treatment Early|Pegloticase + IMM Period||5||
59917929|NCT03635957|76038428|FG000|Had 3-Month Follow-up|Pegloticase + IMM Period||7||
59917930|NCT03635957|76038428|FG000|Had 6-Month Follow-up|Pegloticase + IMM Period||6||
59917931|NCT03635957|76038428|FG000|COMPLETED|Pegloticase + IMM Period||11|1 participant completed study under Amend. 1 at Week 24. Amend. 2 extended the study to 52 weeks.|
59917932|NCT03635957|76038428|FG000|NOT COMPLETED|Pegloticase + IMM Period||3||
59917933|NCT01353274|76038433|FG000|STARTED|Overall Study||1157||
59917934|NCT01353274|76038433|FG000|COMPLETED|Overall Study||1129||
59917935|NCT01353274|76038433|FG000|NOT COMPLETED|Overall Study||28||
59917936|NCT02690194|76038440|FG000|STARTED|Overall Study||17||
59917937|NCT02690194|76038441|FG001|STARTED|Overall Study||18||
59917938|NCT02690194|76038442|FG002|STARTED|Overall Study||19||
59917939|NCT02690194|76038440|FG000|COMPLETED|Overall Study||16||
59917940|NCT02690194|76038441|FG001|COMPLETED|Overall Study||14||
59917941|NCT02690194|76038442|FG002|COMPLETED|Overall Study||19||
59917942|NCT02690194|76038440|FG000|NOT COMPLETED|Overall Study||1||
59917943|NCT02690194|76038441|FG001|NOT COMPLETED|Overall Study||4||
59917944|NCT02690194|76038442|FG002|NOT COMPLETED|Overall Study||0||
59917945|NCT02684344|76038452|FG000|STARTED|Overall Study||1||
59917946|NCT02684344|76038453|FG001|STARTED|Overall Study||4||
59917947|NCT02684344|76038452|FG000|COMPLETED|Overall Study||1||
59917948|NCT02684344|76038453|FG001|COMPLETED|Overall Study||3||
59917949|NCT02684344|76038452|FG000|NOT COMPLETED|Overall Study||0||
59917950|NCT02684344|76038453|FG001|NOT COMPLETED|Overall Study||1||
59917951|NCT02683876|76038461|FG000|STARTED|Overall Study||17||
59917952|NCT02683876|76038462|FG001|STARTED|Overall Study||22||
59917953|NCT02683876|76038461|FG000|COMPLETED|Overall Study||15||
59917954|NCT02683876|76038462|FG001|COMPLETED|Overall Study||22||
59917955|NCT02683876|76038461|FG000|NOT COMPLETED|Overall Study||2||
59917956|NCT02683876|76038462|FG001|NOT COMPLETED|Overall Study||0||
59917957|NCT03974100|76038472|FG000|STARTED|TP1 - Day 1 to Week 52||263||
59509362|NCT00852137|75602620|FG000|COMPLETED|Overall Study||13||
59509363|NCT00852137|75602621|FG001|COMPLETED|Overall Study||3||
59509364|NCT00852137|75602620|FG000|NOT COMPLETED|Overall Study||0||
59509365|NCT00852137|75602621|FG001|NOT COMPLETED|Overall Study||0||
59509366|NCT00852527|75602627|FG000|STARTED|Overall Study||196||
59509367|NCT00852527|75602628|FG001|STARTED|Overall Study||242||
59509368|NCT00852527|75602627|FG000|COMPLETED|Overall Study||196||
59509369|NCT00852527|75602628|FG001|COMPLETED|Overall Study||242||
59509370|NCT00852527|75602627|FG000|NOT COMPLETED|Overall Study||0||
59509371|NCT00852527|75602628|FG001|NOT COMPLETED|Overall Study||0||
60037101|NCT01993017|76152538|FG001|STARTED|Overall Study||501||
60037102|NCT01993017|76152539|FG002|STARTED|Overall Study||500||
60037103|NCT01993017|76152537|FG000|COMPLETED|Overall Study||393||
60037104|NCT01993017|76152538|FG001|COMPLETED|Overall Study||411||
60037105|NCT01993017|76152539|FG002|COMPLETED|Overall Study||421||
60037106|NCT01993017|76152537|FG000|NOT COMPLETED|Overall Study||106||
60037107|NCT01993017|76152538|FG001|NOT COMPLETED|Overall Study||90||
60037108|NCT01993017|76152539|FG002|NOT COMPLETED|Overall Study||79||
60037109|NCT01992549|76152548|FG000|STARTED|Overall Study||48||
60037110|NCT01992549|76152548|FG000|SAF Population|Overall Study||48|SAF population = study population of patients in safety analysis|
60037111|NCT01992549|76152548|FG000|ITT Population|Overall Study||47|ITT population = intent-to-treat population|
60037112|NCT01992549|76152548|FG000|PROPH Population|Overall Study||47|PROPH population = study population of patients receiving prophylaxis|
60037113|NCT01992549|76152548|FG000|BLEED Population|Overall Study||29|BLEED population = study population of Bleeding Events (BEs)|
60037114|NCT01992549|76152548|FG000|SURG Population|Overall Study||3|SURG population = study population of patients undergoing surgery treated with Human-cl rhFVIII|
59509372|NCT00852761|75602635|FG000|STARTED|Overall Study||17||
59509373|NCT00852761|75602636|FG001|STARTED|Overall Study||17||
59509374|NCT00852761|75602635|FG000|COMPLETED|Overall Study||17||
59509375|NCT00852761|75602636|FG001|COMPLETED|Overall Study||17||
59509376|NCT00852761|75602635|FG000|NOT COMPLETED|Overall Study||0||
60037115|NCT01992549|76152548|FG000|COMPLETED|Overall Study||44||
60037116|NCT01992549|76152548|FG000|NOT COMPLETED|Overall Study||4||
60037117|NCT01992159|76152562|FG000|STARTED|Overall Study||63||
60037118|NCT01992159|76152563|FG001|STARTED|Overall Study||63||
60037119|NCT01992159|76152564|FG002|STARTED|Overall Study||63||
60037120|NCT01992159|76152565|FG003|STARTED|Overall Study||63||
60037121|NCT01992159|76152562|FG000|Received Treatment|Overall Study||63||
60037122|NCT01992159|76152563|FG001|Received Treatment|Overall Study||63||
60037123|NCT01992159|76152564|FG002|Received Treatment|Overall Study||63||
60037124|NCT01992159|76152565|FG003|Received Treatment|Overall Study||63||
60037125|NCT01992159|76152562|FG000|Completed First 12 Months of Study|Overall Study||59||
60037126|NCT01992159|76152563|FG001|Completed First 12 Months of Study|Overall Study||56||
60037127|NCT01992159|76152564|FG002|Completed First 12 Months of Study|Overall Study||63||
60037128|NCT01992159|76152565|FG003|Completed First 12 Months of Study|Overall Study||59||
60037129|NCT01992159|76152562|FG000|COMPLETED|Overall Study||59||
60037130|NCT01992159|76152563|FG001|COMPLETED|Overall Study||55||
60037131|NCT01992159|76152564|FG002|COMPLETED|Overall Study||62||
60037132|NCT01992159|76152565|FG003|COMPLETED|Overall Study||59||
60037133|NCT01992159|76152562|FG000|NOT COMPLETED|Overall Study||4||
60037134|NCT01992159|76152563|FG001|NOT COMPLETED|Overall Study||8||
60037135|NCT01992159|76152564|FG002|NOT COMPLETED|Overall Study||1||
60037136|NCT01992159|76152565|FG003|NOT COMPLETED|Overall Study||4||
60037137|NCT01988493|76152580|FG000|STARTED|Overall Study||7||
60037138|NCT01988493|76152581|FG001|STARTED|Overall Study||14||
60037139|NCT01988493|76152582|FG002|STARTED|Overall Study||6||
60037140|NCT01988493|76152583|FG003|STARTED|Overall Study||45||
60037141|NCT01988493|76152584|FG004|STARTED|Overall Study||45||
60037142|NCT01988493|76152580|FG000|Treated|Overall Study||7||
60037143|NCT01988493|76152581|FG001|Treated|Overall Study||14||
60037144|NCT01988493|76152582|FG002|Treated|Overall Study||6||
60037145|NCT01988493|76152583|FG003|Treated|Overall Study||45||
60037146|NCT01988493|76152584|FG004|Treated|Overall Study||44||
60037147|NCT01988493|76152580|FG000|Safety Population|Overall Study||7||
60037148|NCT01988493|76152581|FG001|Safety Population|Overall Study||14||
60037149|NCT01988493|76152582|FG002|Safety Population|Overall Study||6||
60037150|NCT01988493|76152583|FG003|Safety Population|Overall Study||45||
60037151|NCT01988493|76152584|FG004|Safety Population|Overall Study||44||
60037152|NCT01988493|76152580|FG000|COMPLETED|Overall Study||7||
60037153|NCT01988493|76152581|FG001|COMPLETED|Overall Study||14||
59509377|NCT00852761|75602636|FG001|NOT COMPLETED|Overall Study||0||
59509378|NCT00854087|75602644|FG000|STARTED|Overall Study||59||
59509379|NCT00854087|75602645|FG001|STARTED|Overall Study||59||
59509380|NCT00854087|75602644|FG000|COMPLETED|Overall Study||40||
60037154|NCT01988493|76152582|FG002|COMPLETED|Overall Study||6||
60037155|NCT01988493|76152583|FG003|COMPLETED|Overall Study||45||
60037156|NCT01988493|76152584|FG004|COMPLETED|Overall Study||44||
60037157|NCT01988493|76152580|FG000|NOT COMPLETED|Overall Study||0||
60037158|NCT01988493|76152581|FG001|NOT COMPLETED|Overall Study||0||
60037159|NCT01988493|76152582|FG002|NOT COMPLETED|Overall Study||0||
60037160|NCT01988493|76152583|FG003|NOT COMPLETED|Overall Study||0||
60037161|NCT01988493|76152584|FG004|NOT COMPLETED|Overall Study||1||
60037162|NCT02081079|76152600|FG000|STARTED|Overall Study||44||
60037163|NCT02081079|76152601|FG001|STARTED|Overall Study||41||
60037164|NCT02081079|76152600|FG000|COMPLETED|Overall Study||40||
60037165|NCT02081079|76152601|FG001|COMPLETED|Overall Study||39||
60037166|NCT02081079|76152600|FG000|NOT COMPLETED|Overall Study||4||
60037167|NCT02081079|76152601|FG001|NOT COMPLETED|Overall Study||2||
60037168|NCT02081001|76152613|FG000|STARTED|Overall Study||2||
60037169|NCT02081001|76152614|FG001|STARTED|Overall Study||1||
60037170|NCT02081001|76152615|FG002|STARTED|Overall Study||2||
60037171|NCT02081001|76152616|FG003|STARTED|Overall Study||1||
60037172|NCT02081001|76152617|FG004|STARTED|Overall Study||3||
60037173|NCT02081001|76152618|FG005|STARTED|Overall Study||1||
60037174|NCT02081001|76152619|FG006|STARTED|Overall Study||2||
60037175|NCT02081001|76152620|FG007|STARTED|Overall Study||1||
60037176|NCT02081001|76152621|FG008|STARTED|Overall Study||2||
60037177|NCT02081001|76152622|FG009|STARTED|Overall Study||1||
60037178|NCT02081001|76152623|FG010|STARTED|Overall Study||2||
60037179|NCT02081001|76152624|FG011|STARTED|Overall Study||1||
60037180|NCT02081001|76152613|FG000|COMPLETED|Overall Study||2||
59759515|NCT02631941|75878931|FG009|B1|Overall Study||9||
60037181|NCT02081001|76152614|FG001|COMPLETED|Overall Study||1||
60037182|NCT02081001|76152615|FG002|COMPLETED|Overall Study||2||
60037183|NCT02081001|76152616|FG003|COMPLETED|Overall Study||1||
60037184|NCT02081001|76152617|FG004|COMPLETED|Overall Study||2||
60037185|NCT02081001|76152618|FG005|COMPLETED|Overall Study||1||
60037186|NCT02081001|76152619|FG006|COMPLETED|Overall Study||2||
60037187|NCT02081001|76152620|FG007|COMPLETED|Overall Study||1||
60037188|NCT02081001|76152621|FG008|COMPLETED|Overall Study||2||
59612304|NCT01702428|75723478|FG003|STARTED|Overall Study||1289||
59612305|NCT01702428|75723475|FG000|COMPLETED|Overall Study||1175||
59612306|NCT01702428|75723476|FG001|COMPLETED|Overall Study||1162||
59612307|NCT01702428|75723477|FG002|COMPLETED|Overall Study||1190||
59612308|NCT01702428|75723478|FG003|COMPLETED|Overall Study||1232||
59612309|NCT01702428|75723475|FG000|NOT COMPLETED|Overall Study||64||
59612310|NCT01702428|75723476|FG001|NOT COMPLETED|Overall Study||70||
59612311|NCT01702428|75723477|FG002|NOT COMPLETED|Overall Study||53||
59612312|NCT01702428|75723478|FG003|NOT COMPLETED|Overall Study||57||
59612313|NCT01701258|75723499|FG000|STARTED|Assessment and Scheduling||153|153 individuals were enrolled in the study. 96 were eligible after the screening visit.|
59612314|NCT01701258|75723500|FG001|STARTED|Assessment and Scheduling||0|153 individuals were enrolled in the study. 96 were eligible after the screening visit.|
59612315|NCT01701258|75723501|FG002|STARTED|Assessment and Scheduling||0|153 individuals were enrolled in the study. 96 were eligible after the screening visit.|
59612316|NCT01701258|75723502|FG003|STARTED|Assessment and Scheduling||0|153 individuals were enrolled in the study. 96 were eligible after the screening visit.|
59612317|NCT01701258|75723503|FG004|STARTED|Assessment and Scheduling||0|153 individuals were enrolled in the study. 96 were eligible after the screening visit.|
59612318|NCT01701258|75723504|FG005|STARTED|Assessment and Scheduling||0|153 individuals were enrolled in the study. 96 were eligible after the screening visit.|
59612319|NCT01701258|75723505|FG006|STARTED|Assessment and Scheduling||0|153 individuals were enrolled in the study. 96 were eligible after the screening visit.|
59612320|NCT01701258|75723506|FG007|STARTED|Assessment and Scheduling||0|153 individuals were enrolled in the study. 96 were eligible after the screening visit.|
59612321|NCT01701258|75723507|FG008|STARTED|Assessment and Scheduling||0|153 individuals were enrolled in the study. 96 were eligible after the screening visit.|
59612322|NCT01701258|75723508|FG009|STARTED|Assessment and Scheduling||0|153 individuals were enrolled in the study. 96 were eligible after the screening visit.|
59612323|NCT01701258|75723509|FG010|STARTED|Assessment and Scheduling||0|153 individuals were enrolled in the study. 96 were eligible after the screening visit.|
59612324|NCT01701258|75723510|FG011|STARTED|Assessment and Scheduling||0|153 individuals were enrolled in the study. 96 were eligible after the screening visit.|
59612325|NCT01701258|75723511|FG012|STARTED|Assessment and Scheduling||0|153 individuals were enrolled in the study. 96 were eligible after the screening visit.|
59612326|NCT01701258|75723499|FG000|Eligible After Screening Visit|Assessment and Scheduling||96|96 participants were eligible after the screening visit. These were our baseline participants.|
59612327|NCT01701258|75723500|FG001|Eligible After Screening Visit|Assessment and Scheduling||0|96 participants were eligible after the screening visit. These were our baseline participants.|
59613511|NCT01592292|75724649|FG002|STARTED|Overall Study||13||
59759516|NCT02631941|75878922|FG000|B2|Overall Study||9||
59759517|NCT02631941|75878923|FG001|B2|Overall Study||8||
59759518|NCT02631941|75878924|FG002|B2|Overall Study||9||
59759519|NCT02631941|75878925|FG003|B2|Overall Study||9||
59759520|NCT02631941|75878926|FG004|B2|Overall Study||9||
59759521|NCT02631941|75878927|FG005|B2|Overall Study||8||
59759522|NCT02631941|75878928|FG006|B2|Overall Study||9||
59759523|NCT02631941|75878929|FG007|B2|Overall Study||9||
59759524|NCT02631941|75878930|FG008|B2|Overall Study||9||
59759525|NCT02631941|75878931|FG009|B2|Overall Study||9||
59759526|NCT02631941|75878922|FG000|C|Overall Study||9||
59759527|NCT02631941|75878923|FG001|C|Overall Study||8||
59759528|NCT02631941|75878924|FG002|C|Overall Study||9||
59759529|NCT02631941|75878925|FG003|C|Overall Study||9||
59759530|NCT02631941|75878926|FG004|C|Overall Study||8||
59759531|NCT02631941|75878927|FG005|C|Overall Study||8||
59759532|NCT02631941|75878928|FG006|C|Overall Study||9||
59759533|NCT02631941|75878929|FG007|C|Overall Study||8||
60037189|NCT02081001|76152622|FG009|COMPLETED|Overall Study||1||
60037190|NCT02081001|76152623|FG010|COMPLETED|Overall Study||2||
60037191|NCT02081001|76152624|FG011|COMPLETED|Overall Study||1||
60037192|NCT02081001|76152613|FG000|NOT COMPLETED|Overall Study||0||
60037193|NCT02081001|76152614|FG001|NOT COMPLETED|Overall Study||0||
60037194|NCT02081001|76152615|FG002|NOT COMPLETED|Overall Study||0||
60037195|NCT02081001|76152616|FG003|NOT COMPLETED|Overall Study||0||
60037196|NCT02081001|76152617|FG004|NOT COMPLETED|Overall Study||1||
60037197|NCT02081001|76152618|FG005|NOT COMPLETED|Overall Study||0||
60037198|NCT02081001|76152619|FG006|NOT COMPLETED|Overall Study||0||
60037199|NCT02081001|76152620|FG007|NOT COMPLETED|Overall Study||0||
60037200|NCT02081001|76152621|FG008|NOT COMPLETED|Overall Study||0||
59509381|NCT00854087|75602645|FG001|COMPLETED|Overall Study||40||
59509382|NCT00854087|75602644|FG000|NOT COMPLETED|Overall Study||19||
59509383|NCT00854087|75602645|FG001|NOT COMPLETED|Overall Study||19||
59509384|NCT02487797|75602653|FG000|STARTED|Overall Study||502||
59509385|NCT02487797|75602654|FG001|STARTED|Overall Study||501||
59509386|NCT02487797|75602653|FG000|COMPLETED|Overall Study||502||
59509387|NCT02487797|75602654|FG001|COMPLETED|Overall Study||501||
59509388|NCT02487797|75602653|FG000|NOT COMPLETED|Overall Study||0||
59509389|NCT02487797|75602654|FG001|NOT COMPLETED|Overall Study||0||
59509390|NCT00855413|75602660|FG000|STARTED|Overall Study||15||
59509391|NCT00855413|75602660|FG000|COMPLETED|Overall Study||15||
59509392|NCT00855413|75602660|FG000|NOT COMPLETED|Overall Study||0||
59509393|NCT00856739|75602667|FG000|STARTED|Overall Study||70||
59509394|NCT00856739|75602668|FG001|STARTED|Overall Study||52||
59509395|NCT00856739|75602669|FG002|STARTED|Overall Study||55||
59509396|NCT00856739|75602667|FG000|COMPLETED|Overall Study||70||
59509397|NCT00856739|75602668|FG001|COMPLETED|Overall Study||52||
59509398|NCT00856739|75602669|FG002|COMPLETED|Overall Study||55||
59509399|NCT00856739|75602667|FG000|NOT COMPLETED|Overall Study||0||
59509400|NCT00856739|75602668|FG001|NOT COMPLETED|Overall Study||0||
59509401|NCT00856739|75602669|FG002|NOT COMPLETED|Overall Study||0||
59509402|NCT00816101|75602683|FG000|STARTED|Overall Study||13||
59509403|NCT00816101|75602684|FG001|STARTED|Overall Study||8||
59509404|NCT00816101|75602685|FG002|STARTED|Overall Study||5||
59509405|NCT00816101|75602683|FG000|COMPLETED|Overall Study||13||
59509406|NCT00816101|75602684|FG001|COMPLETED|Overall Study||8||
59509407|NCT00816101|75602685|FG002|COMPLETED|Overall Study||5||
59509408|NCT00816101|75602683|FG000|NOT COMPLETED|Overall Study||0||
59509409|NCT00816101|75602684|FG001|NOT COMPLETED|Overall Study||0||
59509410|NCT00816101|75602685|FG002|NOT COMPLETED|Overall Study||0||
59509411|NCT00818363|75602695|FG000|STARTED|Overall Study||40||
59509412|NCT00818363|75602696|FG001|STARTED|Overall Study||20||
59509413|NCT00818363|75602695|FG000|COMPLETED|Overall Study||40||
59509414|NCT00818363|75602696|FG001|COMPLETED|Overall Study||19||
59509415|NCT00818363|75602695|FG000|NOT COMPLETED|Overall Study||0||
59509416|NCT00818363|75602696|FG001|NOT COMPLETED|Overall Study||1||
59509417|NCT00828841|75602705|FG000|STARTED|Overall Study||235||
59509418|NCT00828841|75602706|FG001|STARTED|Overall Study||236||
59509419|NCT00828841|75602707|FG002|STARTED|Overall Study||130||
59509420|NCT00828841|75602705|FG000|COMPLETED|Overall Study||231||
59509421|NCT00828841|75602706|FG001|COMPLETED|Overall Study||232||
59509422|NCT00828841|75602707|FG002|COMPLETED|Overall Study||126||
59509423|NCT00828841|75602705|FG000|NOT COMPLETED|Overall Study||4||
59509424|NCT00828841|75602706|FG001|NOT COMPLETED|Overall Study||4||
59509425|NCT00828841|75602707|FG002|NOT COMPLETED|Overall Study||4||
60037201|NCT02081001|76152622|FG009|NOT COMPLETED|Overall Study||0||
60037202|NCT02081001|76152623|FG010|NOT COMPLETED|Overall Study||0||
60037203|NCT02081001|76152624|FG011|NOT COMPLETED|Overall Study||0||
60037204|NCT02080221|76152635|FG000|STARTED|Overall Study||50||
60037205|NCT02080221|76152635|FG000|COMPLETED|Overall Study||48||
60037206|NCT02080221|76152635|FG000|NOT COMPLETED|Overall Study||2||
60037207|NCT02079909|76152642|FG000|STARTED|Overall Study||158||
59509426|NCT00858689|75602717|FG000|STARTED|Overall Study||20||
59509427|NCT00858689|75602717|FG000|COMPLETED|Overall Study||19||
59509428|NCT00858689|75602717|FG000|NOT COMPLETED|Overall Study||1||
59509429|NCT00830791|75602727|FG000|STARTED|Overall Study||8||
60037208|NCT02079909|76152643|FG001|STARTED|Overall Study||166||
60037209|NCT02079909|76152644|FG002|STARTED|Overall Study||158||
60037210|NCT02079909|76152642|FG000|COMPLETED|Overall Study||120||
60037211|NCT02079909|76152643|FG001|COMPLETED|Overall Study||117||
59509430|NCT00830791|75602728|FG001|STARTED|Overall Study||8||
59509431|NCT00830791|75602729|FG002|STARTED|Overall Study||8||
59509432|NCT00830791|75602730|FG003|STARTED|Overall Study||8||
59509433|NCT00830791|75602731|FG004|STARTED|Overall Study||0||
59509434|NCT00830791|75602732|FG005|STARTED|Overall Study||0||
59509435|NCT00830791|75602727|FG000|COMPLETED|Overall Study||8||
59509436|NCT00830791|75602728|FG001|COMPLETED|Overall Study||8||
59509437|NCT00830791|75602729|FG002|COMPLETED|Overall Study||8||
60037212|NCT02079909|76152644|FG002|COMPLETED|Overall Study||140||
59917958|NCT03974100|76038473|FG001|STARTED|TP1 - Day 1 to Week 52||264||
60037213|NCT02079909|76152642|FG000|NOT COMPLETED|Overall Study||38||
60037214|NCT02079909|76152643|FG001|NOT COMPLETED|Overall Study||49||
60037215|NCT02079909|76152644|FG002|NOT COMPLETED|Overall Study||18||
60037216|NCT02014467|76152654|FG000|STARTED|Overall Study||365||
60037217|NCT02014467|76152655|FG001|STARTED|Overall Study||119||
60037218|NCT02014467|76152654|FG000|COMPLETED|Overall Study||340||
60037219|NCT02014467|76152655|FG001|COMPLETED|Overall Study||112||
60037220|NCT02014467|76152654|FG000|NOT COMPLETED|Overall Study||25||
60037221|NCT02014467|76152655|FG001|NOT COMPLETED|Overall Study||7||
60037222|NCT02013765|76152661|FG000|STARTED|Overall Study||5||
60037223|NCT02013765|76152661|FG000|COMPLETED|Overall Study||4||
60037224|NCT02013765|76152661|FG000|NOT COMPLETED|Overall Study||1||
60037225|NCT02013687|76152669|FG000|STARTED|Overall Study||6||
60037226|NCT02013687|76152670|FG001|STARTED|Overall Study||6||
60037227|NCT02013687|76152671|FG002|STARTED|Overall Study||16||
60037228|NCT02013687|76152672|FG003|STARTED|Overall Study||16||
60037229|NCT02013687|76152669|FG000|COMPLETED|Overall Study||6||
60037230|NCT02013687|76152670|FG001|COMPLETED|Overall Study||6||
60037231|NCT02013687|76152671|FG002|COMPLETED|Overall Study||14||
60037232|NCT02013687|76152672|FG003|COMPLETED|Overall Study||14||
60037233|NCT02013687|76152669|FG000|NOT COMPLETED|Overall Study||0||
60037234|NCT02013687|76152670|FG001|NOT COMPLETED|Overall Study||0||
60037235|NCT02013687|76152671|FG002|NOT COMPLETED|Overall Study||2||
59917959|NCT03974100|76038474|FG002|STARTED|TP1 - Day 1 to Week 52||0||
59917960|NCT03974100|76038475|FG003|STARTED|TP1 - Day 1 to Week 52||0||
59917961|NCT03974100|76038476|FG004|STARTED|TP1 - Day 1 to Week 52||0||
59917962|NCT03974100|76038472|FG000|Per-Protocol Set (PPS)|TP1 - Day 1 to Week 52||233||
59917963|NCT03974100|76038473|FG001|Per-Protocol Set (PPS)|TP1 - Day 1 to Week 52||230||
59917964|NCT03974100|76038474|FG002|Per-Protocol Set (PPS)|TP1 - Day 1 to Week 52||0||
59917965|NCT03974100|76038475|FG003|Per-Protocol Set (PPS)|TP1 - Day 1 to Week 52||0||
59917966|NCT03974100|76038476|FG004|Per-Protocol Set (PPS)|TP1 - Day 1 to Week 52||0||
59917967|NCT03974100|76038472|FG000|TP1 Full Analysis Set (TP1 FAS)|TP1 - Day 1 to Week 52||255||
59917968|NCT03974100|76038473|FG001|TP1 Full Analysis Set (TP1 FAS)|TP1 - Day 1 to Week 52||257||
59917969|NCT03974100|76038474|FG002|TP1 Full Analysis Set (TP1 FAS)|TP1 - Day 1 to Week 52||0||
59917970|NCT03974100|76038475|FG003|TP1 Full Analysis Set (TP1 FAS)|TP1 - Day 1 to Week 52||0||
59917971|NCT03974100|76038476|FG004|TP1 Full Analysis Set (TP1 FAS)|TP1 - Day 1 to Week 52||0||
59917972|NCT03974100|76038472|FG000|Pharmacodynamic Analysis Set (PDS)|TP1 - Day 1 to Week 52||228||
59917973|NCT03974100|76038473|FG001|Pharmacodynamic Analysis Set (PDS)|TP1 - Day 1 to Week 52||213||
59917974|NCT03974100|76038474|FG002|Pharmacodynamic Analysis Set (PDS)|TP1 - Day 1 to Week 52||0||
59917975|NCT03974100|76038475|FG003|Pharmacodynamic Analysis Set (PDS)|TP1 - Day 1 to Week 52||0||
59917976|NCT03974100|76038476|FG004|Pharmacodynamic Analysis Set (PDS)|TP1 - Day 1 to Week 52||0||
59917977|NCT03974100|76038472|FG000|Pharmacokinetic Analysis Set (PKS)|TP1 - Day 1 to Week 52||260||
59917978|NCT03974100|76038473|FG001|Pharmacokinetic Analysis Set (PKS)|TP1 - Day 1 to Week 52||258||
59917979|NCT03974100|76038474|FG002|Pharmacokinetic Analysis Set (PKS)|TP1 - Day 1 to Week 52||0||
59917980|NCT03974100|76038475|FG003|Pharmacokinetic Analysis Set (PKS)|TP1 - Day 1 to Week 52||0||
59917981|NCT03974100|76038476|FG004|Pharmacokinetic Analysis Set (PKS)|TP1 - Day 1 to Week 52||0||
60037236|NCT02013687|76152672|FG003|NOT COMPLETED|Overall Study||2||
60037237|NCT02013609|76152686|FG000|STARTED|Overall Study|One participant out of 48 participants enrolled had discontinued before receiving study medication.|47||
60037238|NCT02013609|76152686|FG000|COMPLETED|Overall Study||29||
60037239|NCT02013609|76152686|FG000|NOT COMPLETED|Overall Study||18||
60037240|NCT01988337|76152690|FG000|STARTED|Overall Study||56||130
60037241|NCT01988337|76152690|FG000|Intervention (at Baseline)|Overall Study|"Received Resin Infiltration Treatment: 56 participants, 65 lesions~Received Resin Mock (Control) Treatment: 56 participants, 65 lesions"|56||130
59917982|NCT03974100|76038472|FG000|TP1 Safety Analysis Set|TP1 - Day 1 to Week 52||263||
60067822|NCT01785849|76183008|FG001|NOT COMPLETED|Overall Study||34||
60067823|NCT01756833|76183016|FG000|STARTED|Overall Study||133||
59917983|NCT03974100|76038473|FG001|TP1 Safety Analysis Set|TP1 - Day 1 to Week 52||264||
59917984|NCT03974100|76038474|FG002|TP1 Safety Analysis Set|TP1 - Day 1 to Week 52||0||
59509438|NCT00830791|75602730|FG003|COMPLETED|Overall Study||8||
59509439|NCT00830791|75602731|FG004|COMPLETED|Overall Study||0||
59509440|NCT00830791|75602732|FG005|COMPLETED|Overall Study||0||
59509441|NCT00830791|75602727|FG000|NOT COMPLETED|Overall Study||0||
59509442|NCT00830791|75602728|FG001|NOT COMPLETED|Overall Study||0||
59509443|NCT00830791|75602729|FG002|NOT COMPLETED|Overall Study||0||
59509444|NCT00830791|75602730|FG003|NOT COMPLETED|Overall Study||0||
59509445|NCT00830791|75602731|FG004|NOT COMPLETED|Overall Study||0||
59509446|NCT00830791|75602732|FG005|NOT COMPLETED|Overall Study||0||
59509447|NCT00820235|75602748|FG000|STARTED|Overall Study||48||48
59509448|NCT00820235|75602749|FG001|STARTED|Overall Study||49||49
59509449|NCT00820235|75602750|FG002|STARTED|Overall Study||44||44
59917985|NCT03974100|76038475|FG003|TP1 Safety Analysis Set|TP1 - Day 1 to Week 52||0||
59917986|NCT03974100|76038476|FG004|TP1 Safety Analysis Set|TP1 - Day 1 to Week 52||0||
59917987|NCT03974100|76038472|FG000|COMPLETED|TP1 - Day 1 to Week 52||253||
59917988|NCT03974100|76038473|FG001|COMPLETED|TP1 - Day 1 to Week 52||249||
59917989|NCT03974100|76038474|FG002|COMPLETED|TP1 - Day 1 to Week 52||0||
59917990|NCT03974100|76038475|FG003|COMPLETED|TP1 - Day 1 to Week 52||0||
59917991|NCT03974100|76038476|FG004|COMPLETED|TP1 - Day 1 to Week 52||0||
59917992|NCT03974100|76038472|FG000|NOT COMPLETED|TP1 - Day 1 to Week 52||10||
59917993|NCT03974100|76038473|FG001|NOT COMPLETED|TP1 - Day 1 to Week 52||15||
59917994|NCT03974100|76038474|FG002|NOT COMPLETED|TP1 - Day 1 to Week 52||0||
59917995|NCT03974100|76038475|FG003|NOT COMPLETED|TP1 - Day 1 to Week 52||0||
59917996|NCT03974100|76038476|FG004|NOT COMPLETED|TP1 - Day 1 to Week 52||0||
59917997|NCT03974100|76038472|FG000|STARTED|TP2- Week 52 to Week 78||0||
59917998|NCT03974100|76038473|FG001|STARTED|TP2- Week 52 to Week 78||0||
59917999|NCT03974100|76038474|FG002|STARTED|TP2- Week 52 to Week 78||253||
60037242|NCT01988337|76152690|FG000|6 Months Follow up|Overall Study|"Followed up of those that received Resin Infiltration Treatment: 43 participants, 51 lesions~Followed up of those that received Resin Mock (Control) Treatment: 43 participants, 51 lesions"|43||102
60037243|NCT01988337|76152690|FG000|12 Months Follow up|Overall Study|"Followed up of those that received Resin Infiltration Treatment: 43 participants, 51 lesions~Followed up of those that received Resin Mock (Control) Treatment: 43 participants, 51 lesions"|43||102
60037244|NCT01988337|76152690|FG000|COMPLETED|Overall Study||0|36 month follow up was expected for completion.|0
60037245|NCT01988337|76152690|FG000|NOT COMPLETED|Overall Study||56||130
60037246|NCT02013531|76152696|FG000|STARTED|Overall Study||37||
60037247|NCT02013531|76152696|FG000|COMPLETED|Overall Study||32||
60037248|NCT02013531|76152696|FG000|NOT COMPLETED|Overall Study||5||
60037249|NCT01988103|76152703|FG000|STARTED|Placebo-Controlled Phase Week 0-16||84||
60037250|NCT01988103|76152704|FG001|STARTED|Placebo-Controlled Phase Week 0-16||85||
60037251|NCT01988103|76152705|FG002|STARTED|Placebo-Controlled Phase Week 0-16||85||
60037252|NCT01988103|76152706|FG003|STARTED|Placebo-Controlled Phase Week 0-16||0||
60067824|NCT01756833|76183017|FG001|STARTED|Overall Study||128||
59509450|NCT00820235|75602748|FG000|COMPLETED|Overall Study||33||33
59509451|NCT00820235|75602749|FG001|COMPLETED|Overall Study||28||28
59509452|NCT00820235|75602750|FG002|COMPLETED|Overall Study||27||27
59509453|NCT00820235|75602748|FG000|NOT COMPLETED|Overall Study||15||15
59918000|NCT03974100|76038475|FG003|STARTED|TP2- Week 52 to Week 78||125||
59509454|NCT00820235|75602749|FG001|NOT COMPLETED|Overall Study||21||21
59509455|NCT00820235|75602750|FG002|NOT COMPLETED|Overall Study||17||17
59509456|NCT00821795|75602760|FG000|STARTED|Overall Study||50||
59509457|NCT00821795|75602761|FG001|STARTED|Overall Study||64||
59509458|NCT00821795|75602760|FG000|COMPLETED|Overall Study||44||
59509459|NCT00821795|75602761|FG001|COMPLETED|Overall Study||60||
59509460|NCT00821795|75602760|FG000|NOT COMPLETED|Overall Study||6||
59509461|NCT00821795|75602761|FG001|NOT COMPLETED|Overall Study||4||
59509462|NCT00833365|75602769|FG000|STARTED|Overall Study||9||
59509463|NCT00833365|75602770|FG001|STARTED|Overall Study||6||
59509464|NCT00833365|75602769|FG000|COMPLETED|Overall Study||9||
59509465|NCT00833365|75602770|FG001|COMPLETED|Overall Study||6||
59509466|NCT00833365|75602769|FG000|NOT COMPLETED|Overall Study||0||
59509467|NCT00833365|75602770|FG001|NOT COMPLETED|Overall Study||0||
59509468|NCT00821951|75602776|FG000|STARTED|Overall Study||17||
59509469|NCT00821951|75602776|FG000|COMPLETED|Overall Study||12||
59509470|NCT00821951|75602776|FG000|NOT COMPLETED|Overall Study||5||
59509471|NCT00852631|75602780|FG000|STARTED|Overall Study||28||
59509472|NCT00852631|75602780|FG000|COMPLETED|Overall Study||17||
59509473|NCT00852631|75602780|FG000|NOT COMPLETED|Overall Study||11||
59509474|NCT00860015|75602784|FG000|STARTED|Overall Study||12||
59509475|NCT00860015|75602784|FG000|COMPLETED|Overall Study||12||
60037253|NCT01988103|76152707|FG004|STARTED|Placebo-Controlled Phase Week 0-16||0||
60037254|NCT01988103|76152703|FG000|COMPLETED|Placebo-Controlled Phase Week 0-16||72||
60037255|NCT01988103|76152704|FG001|COMPLETED|Placebo-Controlled Phase Week 0-16||69||
60037256|NCT01988103|76152705|FG002|COMPLETED|Placebo-Controlled Phase Week 0-16||76||
60037257|NCT01988103|76152706|FG003|COMPLETED|Placebo-Controlled Phase Week 0-16||0||
60037258|NCT01988103|76152707|FG004|COMPLETED|Placebo-Controlled Phase Week 0-16||0||
60037259|NCT01988103|76152703|FG000|NOT COMPLETED|Placebo-Controlled Phase Week 0-16||12||
60037260|NCT01988103|76152704|FG001|NOT COMPLETED|Placebo-Controlled Phase Week 0-16||16||
60037261|NCT01988103|76152705|FG002|NOT COMPLETED|Placebo-Controlled Phase Week 0-16||9||
60037262|NCT01988103|76152706|FG003|NOT COMPLETED|Placebo-Controlled Phase Week 0-16||0||
60037263|NCT01988103|76152707|FG004|NOT COMPLETED|Placebo-Controlled Phase Week 0-16||0||
60037264|NCT01988103|76152703|FG000|STARTED|Active Treatment Phase (Weeks 16-68)||0||
60037265|NCT01988103|76152704|FG001|STARTED|Active Treatment Phase (Weeks 16-68)||69||
60037266|NCT01988103|76152705|FG002|STARTED|Active Treatment Phase (Weeks 16-68)||76||
60037267|NCT01988103|76152706|FG003|STARTED|Active Treatment Phase (Weeks 16-68)||36||
60037268|NCT01988103|76152707|FG004|STARTED|Active Treatment Phase (Weeks 16-68)||35||
60037269|NCT01988103|76152703|FG000|COMPLETED|Active Treatment Phase (Weeks 16-68)||0||
60037270|NCT01988103|76152704|FG001|COMPLETED|Active Treatment Phase (Weeks 16-68)||56||
60037271|NCT01988103|76152705|FG002|COMPLETED|Active Treatment Phase (Weeks 16-68)||65||
60037272|NCT01988103|76152706|FG003|COMPLETED|Active Treatment Phase (Weeks 16-68)||33||
60037273|NCT01988103|76152707|FG004|COMPLETED|Active Treatment Phase (Weeks 16-68)||30||
60037274|NCT01988103|76152703|FG000|NOT COMPLETED|Active Treatment Phase (Weeks 16-68)||0||
60037275|NCT01988103|76152704|FG001|NOT COMPLETED|Active Treatment Phase (Weeks 16-68)||13||
60037276|NCT01988103|76152705|FG002|NOT COMPLETED|Active Treatment Phase (Weeks 16-68)||11||
60037277|NCT01988103|76152706|FG003|NOT COMPLETED|Active Treatment Phase (Weeks 16-68)||3||
59509476|NCT00860015|75602784|FG000|NOT COMPLETED|Overall Study||0||
59509477|NCT00853333|75602791|FG000|STARTED|Overall Study||28||
59509478|NCT00853333|75602792|FG001|STARTED|Overall Study||27||
59509479|NCT00853333|75602793|FG002|STARTED|Overall Study||31||
59509480|NCT00853333|75602791|FG000|COMPLETED|Overall Study||28||
59759534|NCT02631941|75878930|FG008|C|Overall Study||9||
59759535|NCT02631941|75878931|FG009|C|Overall Study||9||
60037278|NCT01988103|76152707|FG004|NOT COMPLETED|Active Treatment Phase (Weeks 16-68)||5||
59509481|NCT00853333|75602792|FG001|COMPLETED|Overall Study||27||
59509482|NCT00853333|75602793|FG002|COMPLETED|Overall Study||31||
59509483|NCT00853333|75602791|FG000|NOT COMPLETED|Overall Study||0||
59509484|NCT00853333|75602792|FG001|NOT COMPLETED|Overall Study||0||
59509485|NCT00853333|75602793|FG002|NOT COMPLETED|Overall Study||0||
59509486|NCT00853645|75602801|FG000|STARTED|Overall Study||6||
59509487|NCT00853645|75602801|FG000|COMPLETED|Overall Study||6||
59509488|NCT00853645|75602801|FG000|NOT COMPLETED|Overall Study||0||
59509489|NCT00822107|75602805|FG000|STARTED|Overall Study||5||
59509490|NCT00822107|75602805|FG000|COMPLETED|Overall Study||5||
59509491|NCT00822107|75602805|FG000|NOT COMPLETED|Overall Study||0||
59759536|NCT02631941|75878922|FG000|D|Overall Study||9||
59759537|NCT02631941|75878923|FG001|D|Overall Study||8||
60037279|NCT01988103|76152703|FG000|STARTED|Observational Follow-up Phase||12||
60037280|NCT01988103|76152704|FG001|STARTED|Observational Follow-up Phase||82||
59509492|NCT00833443|75602811|FG000|STARTED|Overall Study||41||
59509493|NCT00833443|75602812|FG001|STARTED|Overall Study||43||
59509494|NCT00833443|75602811|FG000|COMPLETED|Overall Study||21||
59509495|NCT00833443|75602812|FG001|COMPLETED|Overall Study||15||
59759538|NCT02631941|75878924|FG002|D|Overall Study||9||
59509496|NCT00833443|75602811|FG000|NOT COMPLETED|Overall Study||20||
59509497|NCT00833443|75602812|FG001|NOT COMPLETED|Overall Study||28||
59509498|NCT00822185|75602825|FG000|STARTED|Overall Study||6||
59509499|NCT00822185|75602826|FG001|STARTED|Overall Study||6||
59509500|NCT00822185|75602827|FG002|STARTED|Overall Study||6||
59509501|NCT00822185|75602828|FG003|STARTED|Overall Study||6||
59509502|NCT00822185|75602829|FG004|STARTED|Overall Study||8||
59509503|NCT00822185|75602825|FG000|COMPLETED|Overall Study||6||
59509504|NCT00822185|75602826|FG001|COMPLETED|Overall Study||6||
59509505|NCT00822185|75602827|FG002|COMPLETED|Overall Study||6||
59509506|NCT00822185|75602828|FG003|COMPLETED|Overall Study||6||
60037281|NCT01988103|76152705|FG002|STARTED|Observational Follow-up Phase||83||
60037282|NCT01988103|76152706|FG003|STARTED|Observational Follow-up Phase||36||
60037283|NCT01988103|76152707|FG004|STARTED|Observational Follow-up Phase||33||
60037284|NCT01988103|76152703|FG000|COMPLETED|Observational Follow-up Phase||12||
60037285|NCT01988103|76152704|FG001|COMPLETED|Observational Follow-up Phase||79||
60037286|NCT01988103|76152705|FG002|COMPLETED|Observational Follow-up Phase||82||
60037287|NCT01988103|76152706|FG003|COMPLETED|Observational Follow-up Phase||36||
60037288|NCT01988103|76152707|FG004|COMPLETED|Observational Follow-up Phase||33||
60037289|NCT01988103|76152703|FG000|NOT COMPLETED|Observational Follow-up Phase||0||
60037290|NCT01988103|76152704|FG001|NOT COMPLETED|Observational Follow-up Phase||3||
60037291|NCT01988103|76152705|FG002|NOT COMPLETED|Observational Follow-up Phase||1||
60037292|NCT01988103|76152706|FG003|NOT COMPLETED|Observational Follow-up Phase||0||
60037293|NCT01988103|76152707|FG004|NOT COMPLETED|Observational Follow-up Phase||0||
60037294|NCT02013375|76152722|FG000|STARTED|Overall Study||2||
60037295|NCT02013375|76152722|FG000|COMPLETED|Overall Study||0|Both subjects did not engraft|
60037296|NCT02013375|76152722|FG000|NOT COMPLETED|Overall Study||2||
60037297|NCT02079519|76152727|FG000|STARTED|Overall Study||10||
60037298|NCT02079519|76152727|FG000|COMPLETED|Overall Study||0||
60037299|NCT02079519|76152727|FG000|NOT COMPLETED|Overall Study||10||
60037300|NCT01987557|76152734|FG000|STARTED|Overall Study||16||
60037301|NCT01987557|76152735|FG001|STARTED|Overall Study||16||
60037302|NCT01987557|76152736|FG002|STARTED|Overall Study||16||
60037303|NCT01987557|76152734|FG000|COMPLETED|Overall Study||13||
60037304|NCT01987557|76152735|FG001|COMPLETED|Overall Study||13||
60037305|NCT01987557|76152736|FG002|COMPLETED|Overall Study||13||
60037306|NCT01987557|76152734|FG000|NOT COMPLETED|Overall Study||3||
60037307|NCT01987557|76152735|FG001|NOT COMPLETED|Overall Study||3||
59509507|NCT00822185|75602829|FG004|COMPLETED|Overall Study||8||
59509508|NCT00822185|75602825|FG000|NOT COMPLETED|Overall Study||0||
59509509|NCT00822185|75602826|FG001|NOT COMPLETED|Overall Study||0||
60037308|NCT01987557|76152736|FG002|NOT COMPLETED|Overall Study||3||
60037309|NCT02078817|76152744|FG000|STARTED|Overall Study||14||
60037310|NCT02078817|76152744|FG000|COMPLETED|Overall Study||13||
60037311|NCT02078817|76152744|FG000|NOT COMPLETED|Overall Study||1||
60037312|NCT02011893|76152748|FG000|STARTED|Enrollment to Randomization||173||
60037313|NCT02011893|76152749|FG001|STARTED|Enrollment to Randomization||0||
59509510|NCT00822185|75602827|FG002|NOT COMPLETED|Overall Study||0||
59509511|NCT00822185|75602828|FG003|NOT COMPLETED|Overall Study||0||
60037314|NCT02011893|76152750|FG002|STARTED|Enrollment to Randomization||0||
60037315|NCT02011893|76152748|FG000|Baseline|Enrollment to Randomization||141||
60037316|NCT02011893|76152749|FG001|Baseline|Enrollment to Randomization||0||
60037317|NCT02011893|76152750|FG002|Baseline|Enrollment to Randomization||0||
60037318|NCT02011893|76152748|FG000|Trial Stimulation Implant|Enrollment to Randomization||121||
60037319|NCT02011893|76152749|FG001|Trial Stimulation Implant|Enrollment to Randomization||0||
60037320|NCT02011893|76152750|FG002|Trial Stimulation Implant|Enrollment to Randomization||0||
60037321|NCT02011893|76152748|FG000|Permanent Stimulation Implant|Enrollment to Randomization||101||
60037322|NCT02011893|76152749|FG001|Permanent Stimulation Implant|Enrollment to Randomization||0||
60037323|NCT02011893|76152750|FG002|Permanent Stimulation Implant|Enrollment to Randomization||0||
59509512|NCT00822185|75602829|FG004|NOT COMPLETED|Overall Study||0||
59509513|NCT00835003|75602843|FG000|STARTED|Overall Study||636||
59509514|NCT00835003|75602844|FG001|STARTED|Overall Study||638||
59509515|NCT00835003|75602843|FG000|COMPLETED|Overall Study||636||
59509516|NCT00835003|75602844|FG001|COMPLETED|Overall Study||638||
60037324|NCT02011893|76152748|FG000|Randomization|Enrollment to Randomization||100||
60037325|NCT02011893|76152749|FG001|Randomization|Enrollment to Randomization||0||
59509517|NCT00835003|75602843|FG000|NOT COMPLETED|Overall Study||0||
60037326|NCT02011893|76152750|FG002|Randomization|Enrollment to Randomization||0||
60037327|NCT02011893|76152748|FG000|COMPLETED|Enrollment to Randomization||100||
60037328|NCT02011893|76152749|FG001|COMPLETED|Enrollment to Randomization||0||
60037329|NCT02011893|76152750|FG002|COMPLETED|Enrollment to Randomization||0||
60037330|NCT02011893|76152748|FG000|NOT COMPLETED|Enrollment to Randomization||73||
59509518|NCT00835003|75602844|FG001|NOT COMPLETED|Overall Study||0||
59509519|NCT00860171|75602850|FG000|STARTED|Overall Study||16||
59509520|NCT00860171|75602850|FG000|COMPLETED|Overall Study||16||
60037331|NCT02011893|76152749|FG001|NOT COMPLETED|Enrollment to Randomization||0||
60037332|NCT02011893|76152750|FG002|NOT COMPLETED|Enrollment to Randomization||0||
60037333|NCT02011893|76152748|FG000|STARTED|Period 1 (Randomization to 12 Weeks)||0||
60037334|NCT02011893|76152749|FG001|STARTED|Period 1 (Randomization to 12 Weeks)||45||
60037335|NCT02011893|76152750|FG002|STARTED|Period 1 (Randomization to 12 Weeks)||55||
60037336|NCT02011893|76152748|FG000|6 Week Follow-up|Period 1 (Randomization to 12 Weeks)||0||
60037337|NCT02011893|76152749|FG001|6 Week Follow-up|Period 1 (Randomization to 12 Weeks)||45||
60037338|NCT02011893|76152750|FG002|6 Week Follow-up|Period 1 (Randomization to 12 Weeks)||52||
60037339|NCT02011893|76152748|FG000|12 Week Follow-up|Period 1 (Randomization to 12 Weeks)||0||
60037340|NCT02011893|76152749|FG001|12 Week Follow-up|Period 1 (Randomization to 12 Weeks)||45||
60037341|NCT02011893|76152750|FG002|12 Week Follow-up|Period 1 (Randomization to 12 Weeks)||52||
60037342|NCT02011893|76152748|FG000|COMPLETED|Period 1 (Randomization to 12 Weeks)||0||
60037343|NCT02011893|76152749|FG001|COMPLETED|Period 1 (Randomization to 12 Weeks)||45||
60037344|NCT02011893|76152750|FG002|COMPLETED|Period 1 (Randomization to 12 Weeks)||52||
60037345|NCT02011893|76152748|FG000|NOT COMPLETED|Period 1 (Randomization to 12 Weeks)||0||
60037346|NCT02011893|76152749|FG001|NOT COMPLETED|Period 1 (Randomization to 12 Weeks)||0||
60037347|NCT02011893|76152750|FG002|NOT COMPLETED|Period 1 (Randomization to 12 Weeks)||3||
60037348|NCT02011893|76152748|FG000|STARTED|Period 2 (12 Weeks to 24 Weeks)||0||
60037349|NCT02011893|76152749|FG001|STARTED|Period 2 (12 Weeks to 24 Weeks)||45||
60037350|NCT02011893|76152750|FG002|STARTED|Period 2 (12 Weeks to 24 Weeks)||52||
60037351|NCT02011893|76152748|FG000|18 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||0||
60037352|NCT02011893|76152749|FG001|18 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||44||
60037353|NCT02011893|76152750|FG002|18 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||51||
60037354|NCT02011893|76152748|FG000|24 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||0||
60037355|NCT02011893|76152749|FG001|24 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||45||
60037356|NCT02011893|76152750|FG002|24 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||51||
60037357|NCT02011893|76152748|FG000|COMPLETED|Period 2 (12 Weeks to 24 Weeks)||0||
60037358|NCT02011893|76152749|FG001|COMPLETED|Period 2 (12 Weeks to 24 Weeks)||45||
60037359|NCT02011893|76152750|FG002|COMPLETED|Period 2 (12 Weeks to 24 Weeks)||51||
60037360|NCT02011893|76152748|FG000|NOT COMPLETED|Period 2 (12 Weeks to 24 Weeks)||0||
60037361|NCT02011893|76152749|FG001|NOT COMPLETED|Period 2 (12 Weeks to 24 Weeks)||0||
60037362|NCT02011893|76152750|FG002|NOT COMPLETED|Period 2 (12 Weeks to 24 Weeks)||1||
60037363|NCT02011113|76152755|FG000|STARTED|Overall Study||36||
60037364|NCT02011113|76152755|FG000|COMPLETED|Overall Study|Completed = participants with progressive disease were considered as completed.|0||
59509521|NCT00860171|75602850|FG000|NOT COMPLETED|Overall Study||0||
59509522|NCT00860795|75602856|FG000|STARTED|Overall Study||10||
59509523|NCT00860795|75602857|FG001|STARTED|Overall Study||10||
59509524|NCT00860795|75602856|FG000|Number to Complete Study Medication|Overall Study||9||
59509525|NCT00860795|75602857|FG001|Number to Complete Study Medication|Overall Study||10||
59918001|NCT03974100|76038476|FG004|STARTED|TP2- Week 52 to Week 78||124||
59918002|NCT03974100|76038472|FG000|TP2 Full Analysis Set (TP2 FAS)|TP2- Week 52 to Week 78||0||
59918003|NCT03974100|76038473|FG001|TP2 Full Analysis Set (TP2 FAS)|TP2- Week 52 to Week 78||0||
59918004|NCT03974100|76038474|FG002|TP2 Full Analysis Set (TP2 FAS)|TP2- Week 52 to Week 78||253||
59918005|NCT03974100|76038475|FG003|TP2 Full Analysis Set (TP2 FAS)|TP2- Week 52 to Week 78||124||
59918006|NCT03974100|76038476|FG004|TP2 Full Analysis Set (TP2 FAS)|TP2- Week 52 to Week 78||124||
59918007|NCT03974100|76038472|FG000|TP2 Safety Analysis Set|TP2- Week 52 to Week 78||0||
59918008|NCT03974100|76038473|FG001|TP2 Safety Analysis Set|TP2- Week 52 to Week 78||0||
59918009|NCT03974100|76038474|FG002|TP2 Safety Analysis Set|TP2- Week 52 to Week 78||253||
59918010|NCT03974100|76038475|FG003|TP2 Safety Analysis Set|TP2- Week 52 to Week 78||125||
59918011|NCT03974100|76038476|FG004|TP2 Safety Analysis Set|TP2- Week 52 to Week 78||124||
59918012|NCT03974100|76038472|FG000|COMPLETED|TP2- Week 52 to Week 78||0||
59918013|NCT03974100|76038473|FG001|COMPLETED|TP2- Week 52 to Week 78||0||
59918014|NCT03974100|76038474|FG002|COMPLETED|TP2- Week 52 to Week 78||253||
59918015|NCT03974100|76038475|FG003|COMPLETED|TP2- Week 52 to Week 78||123||
59918016|NCT03974100|76038476|FG004|COMPLETED|TP2- Week 52 to Week 78||124||
59918017|NCT03974100|76038472|FG000|NOT COMPLETED|TP2- Week 52 to Week 78||0||
59918018|NCT03974100|76038473|FG001|NOT COMPLETED|TP2- Week 52 to Week 78||0||
59918019|NCT03974100|76038474|FG002|NOT COMPLETED|TP2- Week 52 to Week 78||0||
59918020|NCT03974100|76038475|FG003|NOT COMPLETED|TP2- Week 52 to Week 78||2||
59918021|NCT03974100|76038476|FG004|NOT COMPLETED|TP2- Week 52 to Week 78||0||
59918022|NCT02689804|76038490|FG000|STARTED|Overall Study||18||
60037365|NCT02011113|76152755|FG000|NOT COMPLETED|Overall Study||36||
60037366|NCT01807156|76152760|FG000|STARTED|Overall Study||7||
60037367|NCT01807156|76152760|FG000|COMPLETED|Overall Study||6||
60037368|NCT01807156|76152760|FG000|NOT COMPLETED|Overall Study||1||
60037369|NCT01987479|76152764|FG000|STARTED|Overall Study||150||
60037370|NCT01987479|76152764|FG000|COMPLETED|Overall Study||133||
60037371|NCT01987479|76152764|FG000|NOT COMPLETED|Overall Study||17||
60037372|NCT01620489|76152770|FG000|STARTED|Overall Study||140||
59509526|NCT00860795|75602856|FG000|COMPLETED|Overall Study|One participant discontinued study medication on day 5, but completed safety evaluations|10||
59509527|NCT00860795|75602857|FG001|COMPLETED|Overall Study||10||
59918023|NCT02689804|76038491|FG001|STARTED|Overall Study||16||
59918024|NCT02689804|76038490|FG000|COMPLETED|Overall Study||16||
60037373|NCT01620489|76152771|FG001|STARTED|Overall Study||139||
60037374|NCT01620489|76152770|FG000|Exposed|Overall Study||140||
60037375|NCT01620489|76152771|FG001|Exposed|Overall Study|2 subjects did not take trial product|137||
60037376|NCT01620489|76152770|FG000|COMPLETED|Overall Study||105||
60037377|NCT01620489|76152771|FG001|COMPLETED|Overall Study|2 subjects did not take trial product|105||
60037378|NCT01620489|76152770|FG000|NOT COMPLETED|Overall Study||35||
60037379|NCT01620489|76152771|FG001|NOT COMPLETED|Overall Study||34||
60037380|NCT02076165|76152779|FG000|STARTED|Overall Study||74||
60037381|NCT02076165|76152780|FG001|STARTED|Overall Study||75||
60037382|NCT02076165|76152779|FG000|COMPLETED|Overall Study||66||
60037383|NCT02076165|76152780|FG001|COMPLETED|Overall Study||69||
60037384|NCT02076165|76152779|FG000|NOT COMPLETED|Overall Study||8||
60037385|NCT02076165|76152780|FG001|NOT COMPLETED|Overall Study||6||
60037386|NCT01620255|76152791|FG000|STARTED|Overall Study||73||
60037387|NCT01620255|76152792|FG001|STARTED|Overall Study||71||
60037388|NCT01620255|76152793|FG002|STARTED|Overall Study||70||
60037389|NCT01620255|76152794|FG003|STARTED|Overall Study||73||
60037390|NCT01620255|76152795|FG004|STARTED|Overall Study||70||
60037391|NCT01620255|76152791|FG000|Treated|Overall Study||73||
60037392|NCT01620255|76152792|FG001|Treated|Overall Study||71||
60037393|NCT01620255|76152793|FG002|Treated|Overall Study||70||
60037394|NCT01620255|76152794|FG003|Treated|Overall Study||73||
60037395|NCT01620255|76152795|FG004|Treated|Overall Study||70||
60037396|NCT01620255|76152791|FG000|COMPLETED|Overall Study||69||
60037397|NCT01620255|76152792|FG001|COMPLETED|Overall Study||65||
60037398|NCT01620255|76152793|FG002|COMPLETED|Overall Study||68||
60037399|NCT01620255|76152794|FG003|COMPLETED|Overall Study||70||
60037400|NCT01620255|76152795|FG004|COMPLETED|Overall Study||64||
60037401|NCT01620255|76152791|FG000|NOT COMPLETED|Overall Study||4||
60037402|NCT01620255|76152792|FG001|NOT COMPLETED|Overall Study||6||
60037403|NCT01620255|76152793|FG002|NOT COMPLETED|Overall Study||2||
60037404|NCT01620255|76152794|FG003|NOT COMPLETED|Overall Study||3||
60037405|NCT01620255|76152795|FG004|NOT COMPLETED|Overall Study||6||
60037406|NCT02010567|76152812|FG000|STARTED|Overall Study||3||
60037407|NCT02010567|76152813|FG001|STARTED|Overall Study||6||
60037408|NCT02010567|76152814|FG002|STARTED|Overall Study||14||
60037409|NCT02010567|76152815|FG003|STARTED|Overall Study||3||
60037410|NCT02010567|76152816|FG004|STARTED|Overall Study||6||
60037411|NCT02010567|76152812|FG000|COMPLETED|Overall Study||3||
60037412|NCT02010567|76152813|FG001|COMPLETED|Overall Study||6||
60037413|NCT02010567|76152814|FG002|COMPLETED|Overall Study||13||
59759539|NCT02631941|75878925|FG003|D|Overall Study||9||
60037414|NCT02010567|76152815|FG003|COMPLETED|Overall Study||3||
60037415|NCT02010567|76152816|FG004|COMPLETED|Overall Study||5||
60037416|NCT02010567|76152812|FG000|NOT COMPLETED|Overall Study||0||
60037417|NCT02010567|76152813|FG001|NOT COMPLETED|Overall Study||0||
60037418|NCT02010567|76152814|FG002|NOT COMPLETED|Overall Study||1||
60037419|NCT02010567|76152815|FG003|NOT COMPLETED|Overall Study||0||
60037420|NCT02010567|76152816|FG004|NOT COMPLETED|Overall Study||1||
60037421|NCT01806064|76152831|FG000|STARTED|Overall Study||3||
60037422|NCT01806064|76152832|FG001|STARTED|Overall Study||15||
60037423|NCT01806064|76152833|FG002|STARTED|Overall Study||5||
60037424|NCT01806064|76152834|FG003|STARTED|Overall Study||75||
60037425|NCT01806064|76152835|FG004|STARTED|Overall Study||75||
60037426|NCT01806064|76152831|FG000|COMPLETED|Overall Study||3||
60037427|NCT01806064|76152832|FG001|COMPLETED|Overall Study||15||
60037428|NCT01806064|76152833|FG002|COMPLETED|Overall Study||5||
60037429|NCT01806064|76152834|FG003|COMPLETED|Overall Study||74||
60037430|NCT01806064|76152835|FG004|COMPLETED|Overall Study||73||
60037431|NCT01806064|76152831|FG000|NOT COMPLETED|Overall Study||0||
60037432|NCT01806064|76152832|FG001|NOT COMPLETED|Overall Study||0||
60037433|NCT01806064|76152833|FG002|NOT COMPLETED|Overall Study||0||
60037434|NCT01806064|76152834|FG003|NOT COMPLETED|Overall Study||1||
60037435|NCT01806064|76152835|FG004|NOT COMPLETED|Overall Study||2||
60037436|NCT01804582|76152853|FG000|STARTED|Overall Study||177||
60037437|NCT01804582|76152854|FG001|STARTED|Overall Study||173||
60037438|NCT01804582|76152853|FG000|COMPLETED|Overall Study||128||
60037439|NCT01804582|76152854|FG001|COMPLETED|Overall Study||117||
60037440|NCT01804582|76152853|FG000|NOT COMPLETED|Overall Study||49||
60037441|NCT01804582|76152854|FG001|NOT COMPLETED|Overall Study||56||
60037442|NCT01787188|76152864|FG000|STARTED|Overall Study||139||
60037443|NCT01787188|76152865|FG001|STARTED|Overall Study||130||
60037444|NCT01787188|76152866|FG002|STARTED|Overall Study||134||
60037445|NCT01787188|76152864|FG000|COMPLETED|Overall Study||122||
60037446|NCT01787188|76152865|FG001|COMPLETED|Overall Study||112||
59759540|NCT02631941|75878926|FG004|D|Overall Study||8||
59759541|NCT02631941|75878927|FG005|D|Overall Study||8||
59759542|NCT02631941|75878928|FG006|D|Overall Study||9||
60037447|NCT01787188|76152866|FG002|COMPLETED|Overall Study||116||
60037448|NCT01787188|76152864|FG000|NOT COMPLETED|Overall Study||17||
60037449|NCT01787188|76152865|FG001|NOT COMPLETED|Overall Study||18||
60037450|NCT01787188|76152866|FG002|NOT COMPLETED|Overall Study||18||
60037451|NCT01787032|76152880|FG000|STARTED|Overall Study||3||
60037452|NCT01787032|76152881|FG001|STARTED|Overall Study||3||
60037453|NCT01787032|76152882|FG002|STARTED|Overall Study||3||
60037454|NCT01787032|76152883|FG003|STARTED|Overall Study||3||
60037455|NCT01787032|76152884|FG004|STARTED|Overall Study||4||
60037456|NCT01787032|76152885|FG005|STARTED|Overall Study||4||
60037457|NCT01787032|76152880|FG000|Received R|Overall Study||3||
60037458|NCT01787032|76152881|FG001|Received R|Overall Study||3||
60037459|NCT01787032|76152882|FG002|Received R|Overall Study||3||
60037460|NCT01787032|76152883|FG003|Received R|Overall Study||3||
60037461|NCT01787032|76152884|FG004|Received R|Overall Study||4||
60037462|NCT01787032|76152885|FG005|Received R|Overall Study||3||
59612328|NCT01701258|75723501|FG002|Eligible After Screening Visit|Assessment and Scheduling||0|96 participants were eligible after the screening visit. These were our baseline participants.|
60037463|NCT01787032|76152880|FG000|Received T1|Overall Study||3||
60037464|NCT01787032|76152881|FG001|Received T1|Overall Study||3||
60037465|NCT01787032|76152882|FG002|Received T1|Overall Study||3||
60037466|NCT01787032|76152883|FG003|Received T1|Overall Study||3||
60037467|NCT01787032|76152884|FG004|Received T1|Overall Study||3||
60037468|NCT01787032|76152885|FG005|Received T1|Overall Study||4||
60037469|NCT01787032|76152880|FG000|Received T2|Overall Study||3||
60037470|NCT01787032|76152881|FG001|Received T2|Overall Study||3||
60037471|NCT01787032|76152882|FG002|Received T2|Overall Study||3||
60037472|NCT01787032|76152883|FG003|Received T2|Overall Study||3||
60037473|NCT01787032|76152884|FG004|Received T2|Overall Study||4||
60037474|NCT01787032|76152885|FG005|Received T2|Overall Study||4||
60037475|NCT01787032|76152880|FG000|COMPLETED|Overall Study||3||
60037476|NCT01787032|76152881|FG001|COMPLETED|Overall Study||3||
60037477|NCT01787032|76152882|FG002|COMPLETED|Overall Study||3||
60037478|NCT01787032|76152883|FG003|COMPLETED|Overall Study||3||
60037479|NCT01787032|76152884|FG004|COMPLETED|Overall Study||3||
60037480|NCT01787032|76152885|FG005|COMPLETED|Overall Study||3||
60037481|NCT01787032|76152880|FG000|NOT COMPLETED|Overall Study||0||
60037482|NCT01787032|76152881|FG001|NOT COMPLETED|Overall Study||0||
60037483|NCT01787032|76152882|FG002|NOT COMPLETED|Overall Study||0||
60037484|NCT01787032|76152883|FG003|NOT COMPLETED|Overall Study||0||
60037485|NCT01787032|76152884|FG004|NOT COMPLETED|Overall Study||1||
60037486|NCT01787032|76152885|FG005|NOT COMPLETED|Overall Study||1||
59918025|NCT02689804|76038491|FG001|COMPLETED|Overall Study||16||
59918026|NCT02689804|76038490|FG000|NOT COMPLETED|Overall Study||2||
59918027|NCT02689804|76038491|FG001|NOT COMPLETED|Overall Study||0||
59918028|NCT02946931|76038500|FG000|STARTED|Overall Study||1402|Treated with Prizbind®|
59918029|NCT02946931|76038500|FG000|Case Report Forms (CRFs) Collected|Overall Study||814||
59918030|NCT02946931|76038500|FG000|CRFs Valid|Overall Study||813||
59918031|NCT02946931|76038500|FG000|COMPLETED|Overall Study||571||
59918032|NCT02946931|76038500|FG000|NOT COMPLETED|Overall Study||831||
59918033|NCT02689492|76038504|FG000|STARTED|Overall Study||401||
59918034|NCT02689492|76038504|FG000|COMPLETED|Overall Study||315||
59918035|NCT02689492|76038504|FG000|NOT COMPLETED|Overall Study||86||
59918036|NCT04353271|76038513|FG000|STARTED|Overall Study||1||
59918037|NCT04353271|76038514|FG001|STARTED|Overall Study||2||
59918038|NCT04353271|76038513|FG000|COMPLETED|Overall Study||1||
59918039|NCT04353271|76038514|FG001|COMPLETED|Overall Study||1||
59918040|NCT04353271|76038513|FG000|NOT COMPLETED|Overall Study||0||
59918041|NCT04353271|76038514|FG001|NOT COMPLETED|Overall Study||1||
59918042|NCT01374568|76038522|FG000|STARTED|Overall Study||2||
59918043|NCT01374568|76038523|FG001|STARTED|Overall Study||3||
60037487|NCT01737268|76152895|FG000|STARTED|Overall Study||20||
60037488|NCT01737268|76152895|FG000|Treated|Overall Study||20||
60037489|NCT01737268|76152895|FG000|COMPLETED|Overall Study||11||
60037490|NCT01737268|76152895|FG000|NOT COMPLETED|Overall Study||9||
60037491|NCT01769404|76152900|FG000|STARTED|Treatment Period 1||12||
60037492|NCT01769404|76152901|FG001|STARTED|Treatment Period 1||13||
60037493|NCT01769404|76152900|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 1||9||
59613512|NCT01592292|75724650|FG003|STARTED|Overall Study||11||
59918044|NCT01374568|76038522|FG000|COMPLETED|Overall Study||2||
59918045|NCT01374568|76038523|FG001|COMPLETED|Overall Study||1||
59918046|NCT01374568|76038522|FG000|NOT COMPLETED|Overall Study||0||
59918047|NCT01374568|76038523|FG001|NOT COMPLETED|Overall Study||2||
59918048|NCT02682784|76038533|FG000|STARTED|Overall Study||40||
59918049|NCT02682784|76038534|FG001|STARTED|Overall Study||37||
59918050|NCT02682784|76038535|FG002|STARTED|Overall Study||29||
59918051|NCT02682784|76038536|FG003|STARTED|Overall Study||32||
59918052|NCT02682784|76038533|FG000|COMPLETED|Overall Study||39||
59918053|NCT02682784|76038534|FG001|COMPLETED|Overall Study||35||
60037494|NCT01769404|76152901|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 1||13||
60037495|NCT01769404|76152900|FG000|COMPLETED|Treatment Period 1||7||
60037496|NCT01769404|76152901|FG001|COMPLETED|Treatment Period 1||13||
60037497|NCT01769404|76152900|FG000|NOT COMPLETED|Treatment Period 1||5||
60037498|NCT01769404|76152901|FG001|NOT COMPLETED|Treatment Period 1||0||
60037499|NCT01769404|76152900|FG000|STARTED|Treatment Period 2||7||
60037500|NCT01769404|76152901|FG001|STARTED|Treatment Period 2||13||
60037501|NCT01769404|76152900|FG000|COMPLETED|Treatment Period 2||0||
60037502|NCT01769404|76152901|FG001|COMPLETED|Treatment Period 2||13||
60037503|NCT01769404|76152900|FG000|NOT COMPLETED|Treatment Period 2||7||
59918054|NCT02682784|76038535|FG002|COMPLETED|Overall Study||27||
59918055|NCT02682784|76038536|FG003|COMPLETED|Overall Study||29||
59918056|NCT02682784|76038533|FG000|NOT COMPLETED|Overall Study||1||
59918057|NCT02682784|76038534|FG001|NOT COMPLETED|Overall Study||2||
59918058|NCT02682784|76038535|FG002|NOT COMPLETED|Overall Study||2||
59918059|NCT02682784|76038536|FG003|NOT COMPLETED|Overall Study||3||
59918060|NCT03387852|76038550|FG000|STARTED|Overall Study||74|Randomized|
59918061|NCT03387852|76038551|FG001|STARTED|Overall Study||73|Randomized|
59918062|NCT03387852|76038552|FG002|STARTED|Overall Study||74|Randomized|
59918063|NCT03387852|76038553|FG003|STARTED|Overall Study||75|Randomized|
59918064|NCT03387852|76038550|FG000|Treated|Overall Study||74||
59918065|NCT03387852|76038551|FG001|Treated|Overall Study||73||
59918066|NCT03387852|76038552|FG002|Treated|Overall Study||74||
60037504|NCT01769404|76152901|FG001|NOT COMPLETED|Treatment Period 2||0||
60037505|NCT01769326|76152913|FG000|STARTED|Overall Study||11||
60037506|NCT01769326|76152914|FG001|STARTED|Overall Study||12||
60037507|NCT01769326|76152915|FG002|STARTED|Overall Study||9||
60037508|NCT01769326|76152916|FG003|STARTED|Overall Study||8||
60037509|NCT01769326|76152913|FG000|COMPLETED|Overall Study||9||
60037510|NCT01769326|76152914|FG001|COMPLETED|Overall Study||8||
60037511|NCT01769326|76152915|FG002|COMPLETED|Overall Study||8||
60037512|NCT01769326|76152916|FG003|COMPLETED|Overall Study||8||
60037513|NCT01769326|76152913|FG000|NOT COMPLETED|Overall Study||2||
60037514|NCT01769326|76152914|FG001|NOT COMPLETED|Overall Study||4||
60037515|NCT01769326|76152915|FG002|NOT COMPLETED|Overall Study||1||
60037516|NCT01769326|76152916|FG003|NOT COMPLETED|Overall Study||0||
60037517|NCT01786564|76152926|FG000|STARTED|Overall Study||120||
59612329|NCT01701258|75723502|FG003|Eligible After Screening Visit|Assessment and Scheduling||0|96 participants were eligible after the screening visit. These were our baseline participants.|
59612330|NCT01701258|75723503|FG004|Eligible After Screening Visit|Assessment and Scheduling||0|96 participants were eligible after the screening visit. These were our baseline participants.|
59918067|NCT03387852|76038553|FG003|Treated|Overall Study||74||
59918068|NCT03387852|76038550|FG000|COMPLETED|Overall Study||41||
59918069|NCT03387852|76038551|FG001|COMPLETED|Overall Study||55||
59918070|NCT03387852|76038552|FG002|COMPLETED|Overall Study||47||
60037518|NCT01786564|76152926|FG000|COMPLETED|Overall Study||56||
60037519|NCT01786564|76152926|FG000|NOT COMPLETED|Overall Study||64||
60037520|NCT01786330|76152932|FG000|STARTED|Overall Study||30||
60037521|NCT01786330|76152933|FG001|STARTED|Overall Study||30||
60037522|NCT01786330|76152932|FG000|COMPLETED|Overall Study||29||
60037523|NCT01786330|76152933|FG001|COMPLETED|Overall Study||27||
60037524|NCT01786330|76152932|FG000|NOT COMPLETED|Overall Study||1||
60037525|NCT01786330|76152933|FG001|NOT COMPLETED|Overall Study||3||
60037526|NCT01786174|76152941|FG000|STARTED|Overall Study||18||
60037527|NCT01786174|76152942|FG001|STARTED|Overall Study||10||
60037528|NCT01786174|76152941|FG000|Randomized|Overall Study||19||
60037529|NCT01786174|76152942|FG001|Randomized|Overall Study||11||
60037530|NCT01786174|76152941|FG000|COMPLETED|Overall Study||16||
60037531|NCT01786174|76152942|FG001|COMPLETED|Overall Study||10||
60037532|NCT01786174|76152941|FG000|NOT COMPLETED|Overall Study||2||
60037533|NCT01786174|76152942|FG001|NOT COMPLETED|Overall Study||0||
60037534|NCT01736566|76152953|FG000|STARTED|Main Study||51||
60037535|NCT01736566|76152954|FG001|STARTED|Main Study||50||
59612331|NCT01701258|75723504|FG005|Eligible After Screening Visit|Assessment and Scheduling||0|96 participants were eligible after the screening visit. These were our baseline participants.|
59612332|NCT01701258|75723505|FG006|Eligible After Screening Visit|Assessment and Scheduling||0|96 participants were eligible after the screening visit. These were our baseline participants.|
59613513|NCT01592292|75724647|FG000|Intention to Treat (ITT) Set|Overall Study|Excluding primary effect evaluation omission.|34||
59759543|NCT02631941|75878929|FG007|D|Overall Study||9||
59918071|NCT03387852|76038553|FG003|COMPLETED|Overall Study||56||
59918072|NCT03387852|76038550|FG000|NOT COMPLETED|Overall Study||33||
59918073|NCT03387852|76038551|FG001|NOT COMPLETED|Overall Study||18||
59918074|NCT03387852|76038552|FG002|NOT COMPLETED|Overall Study||27||
59918075|NCT03387852|76038553|FG003|NOT COMPLETED|Overall Study||19||
59918076|NCT02679274|76038566|FG000|STARTED|Overall Study||2|One (1) subject withdrew after consent, and randomization but before study testing started.|
59918077|NCT02679274|76038567|FG001|STARTED|Overall Study||1|One (1) subject withdrew after consent, and randomization but before study testing started.|
59918078|NCT02679274|76038566|FG000|COMPLETED|Overall Study||1||
59918079|NCT02679274|76038567|FG001|COMPLETED|Overall Study||1||
59918080|NCT02679274|76038566|FG000|NOT COMPLETED|Overall Study||1||
59918081|NCT02679274|76038567|FG001|NOT COMPLETED|Overall Study||0||
59918082|NCT04969861|76038575|FG000|STARTED|Overall Study||1||
59918083|NCT04969861|76038576|FG001|STARTED|Overall Study||0||
59918084|NCT04969861|76038575|FG000|COMPLETED|Overall Study||0||
59918085|NCT04969861|76038576|FG001|COMPLETED|Overall Study||0||
59918086|NCT04969861|76038575|FG000|NOT COMPLETED|Overall Study||1||
60037536|NCT01736566|76152955|FG002|STARTED|Main Study||50||
60037537|NCT01736566|76152956|FG003|STARTED|Main Study||52||
60037538|NCT01736566|76152957|FG004|STARTED|Main Study||10||
60037539|NCT01736566|76152953|FG000|COMPLETED|Main Study||50||
60037540|NCT01736566|76152954|FG001|COMPLETED|Main Study||50||
60037541|NCT01736566|76152955|FG002|COMPLETED|Main Study||49||
60037542|NCT01736566|76152956|FG003|COMPLETED|Main Study||51||
60037543|NCT01736566|76152957|FG004|COMPLETED|Main Study||6||
60037544|NCT01736566|76152953|FG000|NOT COMPLETED|Main Study||1||
60037545|NCT01736566|76152954|FG001|NOT COMPLETED|Main Study||0||
60037546|NCT01736566|76152955|FG002|NOT COMPLETED|Main Study||1||
60037547|NCT01736566|76152956|FG003|NOT COMPLETED|Main Study||1||
60037548|NCT01736566|76152957|FG004|NOT COMPLETED|Main Study||4||
60037549|NCT01736566|76152953|FG000|STARTED|Long Term Follow-up||42||
60037550|NCT01736566|76152954|FG001|STARTED|Long Term Follow-up||0||
60037551|NCT01736566|76152955|FG002|STARTED|Long Term Follow-up||49||
60037552|NCT01736566|76152956|FG003|STARTED|Long Term Follow-up||0||
60037553|NCT01736566|76152957|FG004|STARTED|Long Term Follow-up||1||
60037554|NCT01736566|76152953|FG000|COMPLETED|Long Term Follow-up||0||
60037555|NCT01736566|76152954|FG001|COMPLETED|Long Term Follow-up||0||
60037556|NCT01736566|76152955|FG002|COMPLETED|Long Term Follow-up||0||
60037557|NCT01736566|76152956|FG003|COMPLETED|Long Term Follow-up||0||
60037558|NCT01736566|76152957|FG004|COMPLETED|Long Term Follow-up||0||
60037559|NCT01736566|76152953|FG000|NOT COMPLETED|Long Term Follow-up||42||
60037560|NCT01736566|76152954|FG001|NOT COMPLETED|Long Term Follow-up||0||
60037561|NCT01736566|76152955|FG002|NOT COMPLETED|Long Term Follow-up||49||
60037562|NCT01736566|76152956|FG003|NOT COMPLETED|Long Term Follow-up||0||
60037563|NCT01736566|76152957|FG004|NOT COMPLETED|Long Term Follow-up||1||
60037564|NCT01768858|76152982|FG000|STARTED|Overall Study||96||
60037565|NCT01768858|76152982|FG000|COMPLETED|Overall Study||74||
60037566|NCT01768858|76152982|FG000|NOT COMPLETED|Overall Study||22||
59509528|NCT00860795|75602856|FG000|NOT COMPLETED|Overall Study||0||
59509529|NCT00860795|75602857|FG001|NOT COMPLETED|Overall Study||0||
59509530|NCT00823043|75602863|FG000|STARTED|Overall Study||64||
59509531|NCT00823043|75602864|FG001|STARTED|Overall Study||39||
59509532|NCT00823043|75602863|FG000|COMPLETED|Overall Study||64||
59509533|NCT00823043|75602864|FG001|COMPLETED|Overall Study||39||
59509534|NCT00823043|75602863|FG000|NOT COMPLETED|Overall Study||0||
59509535|NCT00823043|75602864|FG001|NOT COMPLETED|Overall Study||0||
59509536|NCT00861263|75602869|FG000|STARTED|Overall Study||193||
59509537|NCT00861263|75602869|FG000|COMPLETED|Overall Study||193||
59509538|NCT00861263|75602869|FG000|NOT COMPLETED|Overall Study||0||
59509539|NCT00862745|75602875|FG000|STARTED|Randomized Control Trial||322||
59509540|NCT00862745|75602876|FG001|STARTED|Randomized Control Trial||323||
59509541|NCT00862745|75602875|FG000|COMPLETED|Randomized Control Trial||284||
59509542|NCT00862745|75602876|FG001|COMPLETED|Randomized Control Trial||284||
59509543|NCT00862745|75602875|FG000|NOT COMPLETED|Randomized Control Trial||38||
59509544|NCT00862745|75602876|FG001|NOT COMPLETED|Randomized Control Trial||39||
59509545|NCT00862745|75602875|FG000|STARTED|Open-label Follow-up|19 participants elected not to enter the open-label portion of the study after completing the RCT.|268||
59509546|NCT00862745|75602876|FG001|STARTED|Open-label Follow-up|10 participants elected not to enter the open-label portion of the study after completing the RCT.|274||
59509547|NCT00862745|75602875|FG000|COMPLETED|Open-label Follow-up||229||
59509548|NCT00862745|75602876|FG001|COMPLETED|Open-label Follow-up||225||
59509549|NCT00862745|75602875|FG000|NOT COMPLETED|Open-label Follow-up||39||
59509550|NCT00862745|75602876|FG001|NOT COMPLETED|Open-label Follow-up||49||
59509551|NCT02150759|75602884|FG000|STARTED|Overall Study||23||
59612333|NCT01701258|75723506|FG007|Eligible After Screening Visit|Assessment and Scheduling||0|96 participants were eligible after the screening visit. These were our baseline participants.|
60037567|NCT01736254|76152986|FG000|STARTED|Period 1 (Day 1)||24||
60037568|NCT01736254|76152986|FG000|Received at Least One Dose of Study Drug|Period 1 (Day 1)||24||
60037569|NCT01736254|76152986|FG000|COMPLETED|Period 1 (Day 1)||24||
60037570|NCT01736254|76152986|FG000|NOT COMPLETED|Period 1 (Day 1)||0||
60037571|NCT01736254|76152986|FG000|STARTED|Period 2 (Days 2 to 12)||24||
60037572|NCT01736254|76152986|FG000|COMPLETED|Period 2 (Days 2 to 12)||21||
60037573|NCT01736254|76152986|FG000|NOT COMPLETED|Period 2 (Days 2 to 12)||3||
60037574|NCT01736254|76152986|FG000|STARTED|Period 3 (Days 13 to 23)||21||
60037575|NCT01736254|76152986|FG000|COMPLETED|Period 3 (Days 13 to 23)||20||
60037576|NCT01736254|76152986|FG000|NOT COMPLETED|Period 3 (Days 13 to 23)||1||
60037577|NCT01767376|76152997|FG000|STARTED|Overall Study||231||
60037578|NCT01767376|76152998|FG001|STARTED|Overall Study||228||
59509552|NCT02150759|75602885|FG001|STARTED|Overall Study||23||
59509553|NCT02150759|75602884|FG000|COMPLETED|Overall Study||22||
59509554|NCT02150759|75602885|FG001|COMPLETED|Overall Study||21||
59509555|NCT02150759|75602884|FG000|NOT COMPLETED|Overall Study||1||
59509556|NCT02150759|75602885|FG001|NOT COMPLETED|Overall Study||2||
59509557|NCT02150837|75602893|FG000|STARTED|Overall Study|87 Charts were screened with 25 screen failures due to exclusion criteria.|62||
59509558|NCT02150837|75602894|FG001|STARTED|Overall Study|478 charts were screened with 168 screen failures due to exclusion criteria.|310||
59509559|NCT02150837|75602893|FG000|COMPLETED|Overall Study|There was no predefined study period to complete. 37 remained through the 12 wk primary endpoint.|37||
59613514|NCT01592292|75724648|FG001|Intention to Treat (ITT) Set|Overall Study||13||
59759544|NCT02631941|75878930|FG008|D|Overall Study||9||
59759545|NCT02631941|75878931|FG009|D|Overall Study||9||
60037579|NCT01767376|76152999|FG002|STARTED|Overall Study||232||
60037580|NCT01767376|76152997|FG000|COMPLETED|Overall Study||227||
60037581|NCT01767376|76152998|FG001|COMPLETED|Overall Study||225||
60037582|NCT01767376|76152999|FG002|COMPLETED|Overall Study||232||
60037583|NCT01767376|76152997|FG000|NOT COMPLETED|Overall Study||4||
59509560|NCT02150837|75602894|FG001|COMPLETED|Overall Study|There was no predefined study period to complete. 185 remained through the 12 wk primary endpoint.|185||
59509561|NCT02150837|75602893|FG000|NOT COMPLETED|Overall Study||25||
60037584|NCT01767376|76152998|FG001|NOT COMPLETED|Overall Study||3||
60037585|NCT01767376|76152999|FG002|NOT COMPLETED|Overall Study||0||
60037586|NCT01767142|76153009|FG000|STARTED|Overall Study|Each subject was treated on a single thigh. therefore the number of units is 40.|40||40
60037587|NCT01767142|76153009|FG000|COMPLETED|Overall Study||37||37
60037588|NCT01767142|76153009|FG000|NOT COMPLETED|Overall Study||3||3
60037589|NCT01785628|76153015|FG000|STARTED|Overall Study||15||
60037590|NCT01785628|76153016|FG001|STARTED|Overall Study||15||
60037591|NCT01785628|76153015|FG000|COMPLETED|Overall Study||13||
60037592|NCT01785628|76153016|FG001|COMPLETED|Overall Study||12||
60037593|NCT01785628|76153015|FG000|NOT COMPLETED|Overall Study||2||
60037594|NCT01785628|76153016|FG001|NOT COMPLETED|Overall Study||3||
60037595|NCT01785472|76153025|FG000|STARTED|Overall Study||479||
60037596|NCT01785472|76153026|FG001|STARTED|Overall Study||473||
60037597|NCT01785472|76153027|FG002|STARTED|Overall Study||486||
60037598|NCT01785472|76153025|FG000|Full Analysis Set (FAS)|Overall Study||479||
60037599|NCT01785472|76153026|FG001|Full Analysis Set (FAS)|Overall Study||472||
60037600|NCT01785472|76153027|FG002|Full Analysis Set (FAS)|Overall Study||484||
60037601|NCT01785472|76153025|FG000|Safety Set (SAF)|Overall Study||478||
60037602|NCT01785472|76153026|FG001|Safety Set (SAF)|Overall Study||472||
60037603|NCT01785472|76153027|FG002|Safety Set (SAF)|Overall Study||484||
60037604|NCT01785472|76153025|FG000|COMPLETED|Overall Study||455||
60037605|NCT01785472|76153026|FG001|COMPLETED|Overall Study||454||
60037606|NCT01785472|76153027|FG002|COMPLETED|Overall Study||464||
60037607|NCT01785472|76153025|FG000|NOT COMPLETED|Overall Study||24||
60037608|NCT01785472|76153026|FG001|NOT COMPLETED|Overall Study||19||
60037609|NCT01785472|76153027|FG002|NOT COMPLETED|Overall Study||22||
60037610|NCT01785160|76153037|FG000|STARTED|Treatment Period 1: Raltegravir||25||
60037611|NCT01785160|76153037|FG000|COMPLETED|Treatment Period 1: Raltegravir||24||
60037612|NCT01785160|76153037|FG000|NOT COMPLETED|Treatment Period 1: Raltegravir||1||
60037613|NCT01785160|76153037|FG000|STARTED|Washout Period of at Least 7 Days||24||
60037614|NCT01785160|76153037|FG000|COMPLETED|Washout Period of at Least 7 Days||23||
60037615|NCT01785160|76153037|FG000|NOT COMPLETED|Washout Period of at Least 7 Days||1||
60037616|NCT01785160|76153037|FG000|STARTED|Treatment Period 2: Raltegravir + Faldap||23||
60037617|NCT01785160|76153037|FG000|COMPLETED|Treatment Period 2: Raltegravir + Faldap||23||
60037618|NCT01785160|76153037|FG000|NOT COMPLETED|Treatment Period 2: Raltegravir + Faldap||0||
60037619|NCT01736176|76153043|FG000|STARTED|Overall Study|Enrolled participants who underwent the PEG-J placement procedure|39||
60037620|NCT01736176|76153043|FG000|Received LCIG|Overall Study||38||
60037621|NCT01736176|76153043|FG000|COMPLETED|Overall Study||28||
60037622|NCT01736176|76153043|FG000|NOT COMPLETED|Overall Study||11||
60037623|NCT01735630|76153053|FG000|STARTED|Overall Study||175||
59509562|NCT02150837|75602894|FG001|NOT COMPLETED|Overall Study||125||
59509563|NCT00857545|75602902|FG000|STARTED|Overall Study||86||
59509564|NCT00857545|75602903|FG001|STARTED|Overall Study||85||
59509565|NCT00857545|75602902|FG000|COMPLETED|Overall Study|Enrolled and randomized participants.|86||
59509566|NCT00857545|75602903|FG001|COMPLETED|Overall Study||85||
59509567|NCT00857545|75602902|FG000|NOT COMPLETED|Overall Study||0||
59509568|NCT00857545|75602903|FG001|NOT COMPLETED|Overall Study||0||
59509569|NCT00826007|75602911|FG000|STARTED|Overall Study|Retrospective review|308||
60037624|NCT01735630|76153054|FG001|STARTED|Overall Study||175||
60037625|NCT01735630|76153053|FG000|COMPLETED|Overall Study||157||
60037626|NCT01735630|76153054|FG001|COMPLETED|Overall Study||157||
60037627|NCT01735630|76153053|FG000|NOT COMPLETED|Overall Study||18||
60037628|NCT01735630|76153054|FG001|NOT COMPLETED|Overall Study||18||
60037629|NCT01735396|76153060|FG000|STARTED|Overall Study||11||
60037630|NCT01735396|76153060|FG000|COMPLETED|Overall Study||10||
60037631|NCT01735396|76153060|FG000|NOT COMPLETED|Overall Study||1||
60037632|NCT01766206|76153064|FG000|STARTED|Overall Study||3939|Among 3939 subjects, 15 are in the ≥ 56 age category (outside the range defined as per the protocol)|
60037633|NCT01766206|76153064|FG000|COMPLETED|Overall Study||3888||
60037634|NCT01766206|76153064|FG000|NOT COMPLETED|Overall Study||51||
60037635|NCT01734850|76153071|FG000|STARTED|Overall Study||4||
60037636|NCT01734850|76153072|FG001|STARTED|Overall Study||4||
60037637|NCT01734850|76153073|FG002|STARTED|Overall Study||5||
60037638|NCT01734850|76153071|FG000|COMPLETED|Overall Study||1||
60037639|NCT01734850|76153072|FG001|COMPLETED|Overall Study||2||
59509570|NCT00826007|75602912|FG001|STARTED|Overall Study||279||
60037640|NCT01734850|76153073|FG002|COMPLETED|Overall Study||1||
60037641|NCT01734850|76153071|FG000|NOT COMPLETED|Overall Study||3||
60037642|NCT01734850|76153072|FG001|NOT COMPLETED|Overall Study||2||
60037643|NCT01734850|76153073|FG002|NOT COMPLETED|Overall Study||4||
60037644|NCT01766050|76153084|FG000|STARTED|Overall Study||22||
59509571|NCT00826007|75602911|FG000|COMPLETED|Overall Study|Retrospective review|308||
60037645|NCT01766050|76153084|FG000|COMPLETED|Overall Study||18||
60037646|NCT01766050|76153084|FG000|NOT COMPLETED|Overall Study||4||
60037647|NCT02341625|76153112|FG000|STARTED|Overall Study||2||
60037648|NCT02341625|76153113|FG001|STARTED|Overall Study||2||
60037649|NCT02341625|76153114|FG002|STARTED|Overall Study||3||
59612334|NCT01701258|75723507|FG008|Eligible After Screening Visit|Assessment and Scheduling||0|96 participants were eligible after the screening visit. These were our baseline participants.|
60037650|NCT02341625|76153115|FG003|STARTED|Overall Study||8||
60037651|NCT02341625|76153116|FG004|STARTED|Overall Study||8||
60037652|NCT02341625|76153117|FG005|STARTED|Overall Study||10||
60037653|NCT02341625|76153118|FG006|STARTED|Overall Study||51||
60037654|NCT02341625|76153119|FG007|STARTED|Overall Study||8||
60037655|NCT02341625|76153120|FG008|STARTED|Overall Study||4||
60037656|NCT02341625|76153121|FG009|STARTED|Overall Study||30||
60037657|NCT02341625|76153112|FG000|COMPLETED|Overall Study||0||
60037658|NCT02341625|76153113|FG001|COMPLETED|Overall Study||0||
60037659|NCT02341625|76153114|FG002|COMPLETED|Overall Study||0||
60037660|NCT02341625|76153115|FG003|COMPLETED|Overall Study||0||
60037661|NCT02341625|76153116|FG004|COMPLETED|Overall Study||0||
60037662|NCT02341625|76153117|FG005|COMPLETED|Overall Study||0||
60037663|NCT02341625|76153118|FG006|COMPLETED|Overall Study||0||
60037664|NCT02341625|76153119|FG007|COMPLETED|Overall Study||0||
60037665|NCT02341625|76153120|FG008|COMPLETED|Overall Study||0||
60037666|NCT02341625|76153121|FG009|COMPLETED|Overall Study||0||
60037667|NCT02341625|76153112|FG000|NOT COMPLETED|Overall Study||2||
60037668|NCT02341625|76153113|FG001|NOT COMPLETED|Overall Study||2||
60037669|NCT02341625|76153114|FG002|NOT COMPLETED|Overall Study||3||
60037670|NCT02341625|76153115|FG003|NOT COMPLETED|Overall Study||8||
60037671|NCT02341625|76153116|FG004|NOT COMPLETED|Overall Study||8||
60037672|NCT02341625|76153117|FG005|NOT COMPLETED|Overall Study||10||
60037673|NCT02341625|76153118|FG006|NOT COMPLETED|Overall Study||51||
60037674|NCT02341625|76153119|FG007|NOT COMPLETED|Overall Study||8||
60037675|NCT02341625|76153120|FG008|NOT COMPLETED|Overall Study||4||
60037676|NCT02341625|76153121|FG009|NOT COMPLETED|Overall Study||30||
60037677|NCT02370095|76153168|FG000|STARTED|Overall Study||10||
60037678|NCT02370095|76153169|FG001|STARTED|Overall Study||4||
60037679|NCT02370095|76153168|FG000|COMPLETED|Overall Study||10||
60037680|NCT02370095|76153169|FG001|COMPLETED|Overall Study||3||
60037681|NCT02370095|76153168|FG000|NOT COMPLETED|Overall Study||0||
60037682|NCT02370095|76153169|FG001|NOT COMPLETED|Overall Study||1||
60037683|NCT01783678|76153181|FG000|STARTED|Overall Study||19||
60037684|NCT01783678|76153182|FG001|STARTED|Overall Study||112||
60037685|NCT01783678|76153183|FG002|STARTED|Overall Study||6||
60037686|NCT01783678|76153184|FG003|STARTED|Overall Study||58||
60037687|NCT01783678|76153185|FG004|STARTED|Overall Study||49||
60037688|NCT01783678|76153186|FG005|STARTED|Overall Study||31||
60037689|NCT01783678|76153181|FG000|COMPLETED|Overall Study||17||
60037690|NCT01783678|76153182|FG001|COMPLETED|Overall Study||94||
60037691|NCT01783678|76153183|FG002|COMPLETED|Overall Study||5||
60037692|NCT01783678|76153184|FG003|COMPLETED|Overall Study||50||
60037693|NCT01783678|76153185|FG004|COMPLETED|Overall Study||42||
60037694|NCT01783678|76153186|FG005|COMPLETED|Overall Study||26||
60037695|NCT01783678|76153181|FG000|NOT COMPLETED|Overall Study||2||
60037696|NCT01783678|76153182|FG001|NOT COMPLETED|Overall Study||18||
60037697|NCT01783678|76153183|FG002|NOT COMPLETED|Overall Study||1||
60037698|NCT01783678|76153184|FG003|NOT COMPLETED|Overall Study||8||
60037699|NCT01783678|76153185|FG004|NOT COMPLETED|Overall Study||7||
60037700|NCT01783678|76153186|FG005|NOT COMPLETED|Overall Study||5||
60037701|NCT01734772|76153203|FG000|STARTED|Overall Study||24||
60037702|NCT01734772|76153204|FG001|STARTED|Overall Study||24||
60037703|NCT01734772|76153203|FG000|COMPLETED|Overall Study||23||
60037704|NCT01734772|76153204|FG001|COMPLETED|Overall Study||21||
60037705|NCT01734772|76153203|FG000|NOT COMPLETED|Overall Study||1||
60037706|NCT01734772|76153204|FG001|NOT COMPLETED|Overall Study||3||
60037707|NCT02340221|76153218|FG000|STARTED|Overall Study||214||
60037708|NCT02340221|76153219|FG001|STARTED|Overall Study||417||
60037709|NCT02340221|76153218|FG000|COMPLETED|Overall Study||0||
60037710|NCT02340221|76153219|FG001|COMPLETED|Overall Study||0||
59612335|NCT01701258|75723508|FG009|Eligible After Screening Visit|Assessment and Scheduling||0|96 participants were eligible after the screening visit. These were our baseline participants.|
59612336|NCT01701258|75723509|FG010|Eligible After Screening Visit|Assessment and Scheduling||0|96 participants were eligible after the screening visit. These were our baseline participants.|
59612337|NCT01701258|75723510|FG011|Eligible After Screening Visit|Assessment and Scheduling||0|96 participants were eligible after the screening visit. These were our baseline participants.|
59612338|NCT01701258|75723511|FG012|Eligible After Screening Visit|Assessment and Scheduling||0|96 participants were eligible after the screening visit. These were our baseline participants.|
59759546|NCT02631941|75878922|FG000|COMPLETED|Overall Study||9||
60037711|NCT02340221|76153218|FG000|NOT COMPLETED|Overall Study||214||
60037712|NCT02340221|76153219|FG001|NOT COMPLETED|Overall Study||417||
60037713|NCT02395133|76153230|FG000|STARTED|Overall Study||83|Full Analysis Set (FAS) included all randomized participants|
60037714|NCT02395133|76153231|FG001|STARTED|Overall Study||84|Full Analysis Set (FAS) included all randomized participants|
60037715|NCT02395133|76153232|FG002|STARTED|Overall Study||86|Full Analysis Set (FAS) included all randomized participants|
60037716|NCT02395133|76153233|FG003|STARTED|Overall Study||169|Full Analysis Set (FAS) included all randomized participants|
60037717|NCT02395133|76153230|FG000|COMPLETED|Overall Study||69||
60037718|NCT02395133|76153231|FG001|COMPLETED|Overall Study||75||
60037719|NCT02395133|76153232|FG002|COMPLETED|Overall Study||76||
60037720|NCT02395133|76153233|FG003|COMPLETED|Overall Study||155||
60037721|NCT02395133|76153230|FG000|NOT COMPLETED|Overall Study||14||
60037722|NCT02395133|76153231|FG001|NOT COMPLETED|Overall Study||9||
60037723|NCT02395133|76153232|FG002|NOT COMPLETED|Overall Study||10||
60037724|NCT02395133|76153233|FG003|NOT COMPLETED|Overall Study||14||
60037725|NCT02395055|76153245|FG000|STARTED|Overall Study||47||
60037726|NCT02395055|76153246|FG001|STARTED|Overall Study||47||
60037727|NCT02395055|76153245|FG000|COMPLETED|Overall Study||40||
60037728|NCT02395055|76153246|FG001|COMPLETED|Overall Study||44||
60037729|NCT02395055|76153245|FG000|NOT COMPLETED|Overall Study||7||
60037730|NCT02395055|76153246|FG001|NOT COMPLETED|Overall Study||3||
60037731|NCT02369159|76153254|FG000|STARTED|Overall Study||114||
60037732|NCT02369159|76153255|FG001|STARTED|Overall Study||23||
60037733|NCT02369159|76153254|FG000|ITT Population|Overall Study||114|Intend-to-treat (ITT) population included all randomized subjects|
60037734|NCT02369159|76153255|FG001|ITT Population|Overall Study||23|Intend-to-treat (ITT) population included all randomized subjects|
60037735|NCT02369159|76153254|FG000|Safety Population|Overall Study||107|Safety Population included all randomized subjects who received ≥ 1 partial dose of peramivir or oseltamivir.|
60037736|NCT02369159|76153255|FG001|Safety Population|Overall Study||23|Safety Population included all randomized subjects who received ≥ 1 partial dose of peramivir or oseltamivir.|
60037737|NCT02369159|76153254|FG000|ITTI Population|Overall Study||81|Intent-to-treat-infected (ITTI) population included all subjects who were enrolled, treated, and had influenza confirmed by RT-PCR.|
60037738|NCT02369159|76153255|FG001|ITTI Population|Overall Study||16|Intent-to-treat-infected (ITTI) population included all subjects who were enrolled, treated, and had influenza confirmed by RT-PCR.|
60037739|NCT02369159|76153254|FG000|E-R Population|Overall Study||80|Exposure-response (E-R) Population included all subjects in the ITTI population who had a quantifiable peramivir concentration on Day 1 and had ≥ 1 post-baseline effectiveness assessment.|
60037740|NCT02369159|76153255|FG001|E-R Population|Overall Study|Milestone only applied to Peramivir group|0|Exposure-response (E-R) Population included all subjects in the ITTI population who had a quantifiable peramivir concentration on Day 1 and had ≥ 1 post-baseline effectiveness assessment.|
60037741|NCT02369159|76153254|FG000|COMPLETED|Overall Study||106||
60037742|NCT02369159|76153255|FG001|COMPLETED|Overall Study||21||
60037743|NCT02369159|76153254|FG000|NOT COMPLETED|Overall Study||8||
60037744|NCT02369159|76153255|FG001|NOT COMPLETED|Overall Study||2||
60037745|NCT02368691|76153272|FG000|STARTED|Overall Study|32 subjects were enrolled and received at least one dose of study drug|32||
60037746|NCT02368691|76153272|FG000|COMPLETED|Overall Study||0||
60037747|NCT02368691|76153272|FG000|NOT COMPLETED|Overall Study||32||
60037748|NCT02394665|76153279|FG000|STARTED|Overall Study||1||
60037749|NCT02394665|76153280|FG001|STARTED|Overall Study||0||
60037750|NCT02394665|76153281|FG002|STARTED|Overall Study||0||
60037751|NCT02394665|76153279|FG000|COMPLETED|Overall Study||0||
60037752|NCT02394665|76153280|FG001|COMPLETED|Overall Study||0||
60037753|NCT02394665|76153281|FG002|COMPLETED|Overall Study||0||
60037754|NCT02394665|76153279|FG000|NOT COMPLETED|Overall Study||1||
60037755|NCT02394665|76153280|FG001|NOT COMPLETED|Overall Study||0||
60037756|NCT02394665|76153281|FG002|NOT COMPLETED|Overall Study||0||
60037757|NCT02367911|76153291|FG000|STARTED|Overall Study||71||
60037758|NCT02367911|76153292|FG001|STARTED|Overall Study||73||
60037759|NCT02367911|76153291|FG000|COMPLETED|Overall Study||66||
60037760|NCT02367911|76153292|FG001|COMPLETED|Overall Study||69||
60037761|NCT02367911|76153291|FG000|NOT COMPLETED|Overall Study||5||
60037762|NCT02367911|76153292|FG001|NOT COMPLETED|Overall Study||4||
60037763|NCT02339285|76153301|FG000|STARTED|Overall Study||10|All randomized participants included in analysis. Intent-to-treat; last observation carried forward.|
60037764|NCT02339285|76153302|FG001|STARTED|Overall Study||11|All randomized participants included in analysis. Intent-to-treat; last observation carried forward.|
60037765|NCT02339285|76153303|FG002|STARTED|Overall Study||11|All randomized participants included in analysis. Intent-to-treat; last observation carried forward.|
60037766|NCT02339285|76153301|FG000|Completed Intervention|Overall Study||10|Number of participants that completed 5 days of stimulation.|
60037767|NCT02339285|76153302|FG001|Completed Intervention|Overall Study||10|Number of participants that completed 5 days of stimulation.|
60037768|NCT02339285|76153303|FG002|Completed Intervention|Overall Study||10|Number of participants that completed 5 days of stimulation.|
60037769|NCT02339285|76153301|FG000|2 Week Follow-up|Overall Study||9|Number of participants that attended the follow-up visit 2 weeks after completion of intervention.|
60037770|NCT02339285|76153302|FG001|2 Week Follow-up|Overall Study||10|Number of participants that attended the follow-up visit 2 weeks after completion of intervention.|
60037771|NCT02339285|76153303|FG002|2 Week Follow-up|Overall Study||10|Number of participants that attended the follow-up visit 2 weeks after completion of intervention.|
60037772|NCT02339285|76153301|FG000|4 Week Follow-up Visit|Overall Study||9|Number of participants that attended the follow-up visit 4 weeks after completion of intervention.|
60037773|NCT02339285|76153302|FG001|4 Week Follow-up Visit|Overall Study||8|Number of participants that attended the follow-up visit 4 weeks after completion of intervention.|
60037774|NCT02339285|76153303|FG002|4 Week Follow-up Visit|Overall Study||9|Number of participants that attended the follow-up visit 4 weeks after completion of intervention.|
60037775|NCT02339285|76153301|FG000|COMPLETED|Overall Study||9|Number of participants that completed all sessions.|
60037776|NCT02339285|76153302|FG001|COMPLETED|Overall Study||8|Number of participants that completed all sessions.|
60037777|NCT02339285|76153303|FG002|COMPLETED|Overall Study||9|Number of participants that completed all sessions.|
60037778|NCT02339285|76153301|FG000|NOT COMPLETED|Overall Study||1||
60037779|NCT02339285|76153302|FG001|NOT COMPLETED|Overall Study||3||
60037780|NCT02339285|76153303|FG002|NOT COMPLETED|Overall Study||2||
60037781|NCT02367833|76153314|FG000|STARTED|Overall Study||9||
60037782|NCT02367833|76153315|FG001|STARTED|Overall Study||9||
60037783|NCT02367833|76153316|FG002|STARTED|Overall Study||8||
60037784|NCT02367833|76153314|FG000|COMPLETED|Overall Study||8||
60037785|NCT02367833|76153315|FG001|COMPLETED|Overall Study||8||
60037786|NCT02367833|76153316|FG002|COMPLETED|Overall Study||8||
60037787|NCT02367833|76153314|FG000|NOT COMPLETED|Overall Study||1||
60037788|NCT02367833|76153315|FG001|NOT COMPLETED|Overall Study||1||
60037789|NCT02367833|76153316|FG002|NOT COMPLETED|Overall Study||0||
60037790|NCT02367521|76153326|FG000|STARTED|Overall Study||17||
60037791|NCT02367521|76153327|FG001|STARTED|Overall Study||17||
60037792|NCT02367521|76153326|FG000|COMPLETED|Overall Study||13||
60037793|NCT02367521|76153327|FG001|COMPLETED|Overall Study||17||
60037794|NCT02367521|76153326|FG000|NOT COMPLETED|Overall Study||4||
60037795|NCT02367521|76153327|FG001|NOT COMPLETED|Overall Study||0||
60037796|NCT02338193|76153336|FG000|STARTED|Overall Study||20||
60037797|NCT02338193|76153337|FG001|STARTED|Overall Study||21||
60037798|NCT02338193|76153338|FG002|STARTED|Overall Study||25||
60037799|NCT02338193|76153336|FG000|COMPLETED|Overall Study||17||
60037800|NCT02338193|76153337|FG001|COMPLETED|Overall Study||17||
60037801|NCT02338193|76153338|FG002|COMPLETED|Overall Study||15||
59509572|NCT00826007|75602912|FG001|COMPLETED|Overall Study||279||
59509573|NCT00826007|75602911|FG000|NOT COMPLETED|Overall Study||0||
59509574|NCT00826007|75602912|FG001|NOT COMPLETED|Overall Study||0||
59509575|NCT00835159|75602919|FG000|STARTED|Overall Study||11||
59509576|NCT00835159|75602920|FG001|STARTED|Overall Study||17||
59509577|NCT00835159|75602919|FG000|COMPLETED|Overall Study||11||
60037802|NCT02338193|76153336|FG000|NOT COMPLETED|Overall Study||3||
60037803|NCT02338193|76153337|FG001|NOT COMPLETED|Overall Study||4||
60037804|NCT02338193|76153338|FG002|NOT COMPLETED|Overall Study||10||
60037805|NCT01783444|76153349|FG000|STARTED|Treatment Phase||104|All randomized subjects (FAS)|
60037806|NCT01783444|76153350|FG001|STARTED|Treatment Phase||103|All randomized subjects (FAS)|
60037807|NCT01783444|76153351|FG002|STARTED|Treatment Phase||102|All randomized subjects (FAS)|
60037808|NCT01783444|76153349|FG000|Safety Set|Treatment Phase||104|At least 1 dose of study treatment and a 1 post baseline safety assessment|
60037809|NCT01783444|76153350|FG001|Safety Set|Treatment Phase||103|At least 1 dose of study treatment and a 1 post baseline safety assessment|
59509578|NCT00835159|75602920|FG001|COMPLETED|Overall Study||17||
59509579|NCT00835159|75602919|FG000|NOT COMPLETED|Overall Study||0||
59509580|NCT00835159|75602920|FG001|NOT COMPLETED|Overall Study||0||
59509581|NCT00827099|75602926|FG000|STARTED|Overall Study||5||
59509582|NCT00827099|75602926|FG000|COMPLETED|Overall Study||5||
59509583|NCT00827099|75602926|FG000|NOT COMPLETED|Overall Study||0||
59509584|NCT02617888|75602933|FG000|STARTED|Overall Study||50||
59509585|NCT02617888|75602934|FG001|STARTED|Overall Study||51||
59509586|NCT02617888|75602935|FG002|STARTED|Overall Study||127||
59509587|NCT02617888|75602933|FG000|COMPLETED|Overall Study|Incomplete due to inadequate double-strand DNA break sample.|49||
59509588|NCT02617888|75602934|FG001|COMPLETED|Overall Study|Incomplete due to inadequate double-strand DNA break samples.|44||
59509589|NCT02617888|75602935|FG002|COMPLETED|Overall Study||127||
59509590|NCT02617888|75602933|FG000|NOT COMPLETED|Overall Study||1||
59509591|NCT02617888|75602934|FG001|NOT COMPLETED|Overall Study||7||
59509592|NCT02617888|75602935|FG002|NOT COMPLETED|Overall Study||0||
59509593|NCT02618512|75602942|FG000|STARTED|Overall Study||3||
59509594|NCT02618512|75602942|FG000|COMPLETED|Overall Study||3||
59509595|NCT02618512|75602942|FG000|NOT COMPLETED|Overall Study||0||
59509596|NCT00857857|75602946|FG000|STARTED|Overall Study||24||
59509597|NCT00857857|75602946|FG000|COMPLETED|Overall Study||24||
59509598|NCT00857857|75602946|FG000|NOT COMPLETED|Overall Study||0||
59509599|NCT02622178|75602961|FG000|STARTED|Overall Study||42||
59509600|NCT02622178|75602962|FG001|STARTED|Overall Study||45||
59509601|NCT02622178|75602963|FG002|STARTED|Overall Study||49||
59509602|NCT02622178|75602961|FG000|COMPLETED|Overall Study||42||
59509603|NCT02622178|75602962|FG001|COMPLETED|Overall Study||45||
59509604|NCT02622178|75602963|FG002|COMPLETED|Overall Study||49||
59509605|NCT02622178|75602961|FG000|NOT COMPLETED|Overall Study||0||
59509606|NCT02622178|75602962|FG001|NOT COMPLETED|Overall Study||0||
60037810|NCT01783444|76153351|FG002|Safety Set|Treatment Phase||102|At least 1 dose of study treatment and a 1 post baseline safety assessment|
60037811|NCT01783444|76153349|FG000|COMPLETED|Treatment Phase||0||
60037812|NCT01783444|76153350|FG001|COMPLETED|Treatment Phase||0||
60037813|NCT01783444|76153351|FG002|COMPLETED|Treatment Phase||0||
60037814|NCT01783444|76153349|FG000|NOT COMPLETED|Treatment Phase||104||
59509607|NCT02622178|75602963|FG002|NOT COMPLETED|Overall Study||0||
59509608|NCT02623348|75602974|FG000|STARTED|Overall Study||30||
59509609|NCT02623348|75602975|FG001|STARTED|Overall Study||30||
59509610|NCT02623348|75602974|FG000|3-month Assessment|Overall Study||27||
59509611|NCT02623348|75602975|FG001|3-month Assessment|Overall Study||26||
59509612|NCT02623348|75602974|FG000|COMPLETED|Overall Study||27||
59509613|NCT02623348|75602975|FG001|COMPLETED|Overall Study||28||
60037815|NCT01783444|76153350|FG001|NOT COMPLETED|Treatment Phase||103||
60037816|NCT01783444|76153351|FG002|NOT COMPLETED|Treatment Phase||102||
60067825|NCT01756833|76183016|FG000|COMPLETED|Overall Study||129||
60067826|NCT01756833|76183017|FG001|COMPLETED|Overall Study||125||
59509614|NCT02623348|75602974|FG000|NOT COMPLETED|Overall Study||3||
59509615|NCT02623348|75602975|FG001|NOT COMPLETED|Overall Study||2||
59509616|NCT02625298|75602983|FG000|STARTED|Overall Study||11||
59509617|NCT02625298|75602984|FG001|STARTED|Overall Study||13||
59509618|NCT02625298|75602983|FG000|COMPLETED|Overall Study||10||
59509619|NCT02625298|75602984|FG001|COMPLETED|Overall Study||13||
59509620|NCT02625298|75602983|FG000|NOT COMPLETED|Overall Study||1||
59509621|NCT02625298|75602984|FG001|NOT COMPLETED|Overall Study||0||
59509622|NCT02625844|75602992|FG000|STARTED|Overall Study||110||
59509623|NCT02625844|75602992|FG000|COMPLETED|Overall Study||110||
59509624|NCT02625844|75602992|FG000|NOT COMPLETED|Overall Study||0||
59509625|NCT00858013|75602998|FG000|STARTED|Overall Study||46||
59509626|NCT00858013|75602999|FG001|STARTED|Overall Study||42||
59509627|NCT00858013|75602998|FG000|COMPLETED|Overall Study||24||
59509628|NCT00858013|75602999|FG001|COMPLETED|Overall Study||23||
59509629|NCT00858013|75602998|FG000|NOT COMPLETED|Overall Study||22||
59612339|NCT01701258|75723499|FG000|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||68|68 out of the 96 eligible participants completed the MRI.|
59918087|NCT04969861|76038576|FG001|NOT COMPLETED|Overall Study||0||
60037817|NCT01783444|76153349|FG000|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Follow-Up Phase|96|All patients who discontinued treatment and entered Post-Treatment Efficacy Follow-Up Phase|
60037818|NCT01783444|76153350|FG001|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Follow-Up Phase|93|All patients who discontinued treatment and entered Post-Treatment Efficacy Follow-Up Phase|
60037819|NCT01783444|76153351|FG002|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Follow-Up Phase|91|All patients who discontinued treatment and entered Post-Treatment Efficacy Follow-Up Phase|
60037820|NCT01783444|76153349|FG000|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0||
60037821|NCT01783444|76153350|FG001|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0||
60037822|NCT01783444|76153351|FG002|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0||
60037823|NCT01783444|76153349|FG000|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||96||
60037824|NCT01783444|76153350|FG001|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||93||
60037825|NCT01783444|76153351|FG002|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||91||
60037826|NCT02367131|76153360|FG000|STARTED|Overall Study|Started are the treated patients|423||
60037827|NCT02367131|76153360|FG000|COMPLETED|Overall Study||201||
60037828|NCT02367131|76153360|FG000|NOT COMPLETED|Overall Study||222||
60037829|NCT02394275|76153364|FG000|STARTED|Overall Study||140||
60037830|NCT02394275|76153364|FG000|Safety Population|Overall Study||133||
60037831|NCT02394275|76153364|FG000|Evaluable at 13 Weeks|Overall Study||133||
59509630|NCT00858013|75602999|FG001|NOT COMPLETED|Overall Study||19||
59509631|NCT02626156|75603009|FG000|STARTED|Baseline (Visit 1 to Visit 2)||29||
59509632|NCT02626156|75603010|FG001|STARTED|Baseline (Visit 1 to Visit 2)||29||
59509633|NCT02626156|75603011|FG002|STARTED|Baseline (Visit 1 to Visit 2)||42||
59509634|NCT02626156|75603012|FG003|STARTED|Baseline (Visit 1 to Visit 2)||40||
59509635|NCT02626156|75603009|FG000|COMPLETED|Baseline (Visit 1 to Visit 2)||23||
59509636|NCT02626156|75603010|FG001|COMPLETED|Baseline (Visit 1 to Visit 2)||22||
59509637|NCT02626156|75603011|FG002|COMPLETED|Baseline (Visit 1 to Visit 2)||37||
59509638|NCT02626156|75603012|FG003|COMPLETED|Baseline (Visit 1 to Visit 2)||35||
59509639|NCT02626156|75603009|FG000|NOT COMPLETED|Baseline (Visit 1 to Visit 2)||6||
59509640|NCT02626156|75603010|FG001|NOT COMPLETED|Baseline (Visit 1 to Visit 2)||7||
59509641|NCT02626156|75603011|FG002|NOT COMPLETED|Baseline (Visit 1 to Visit 2)||5||
59509642|NCT02626156|75603012|FG003|NOT COMPLETED|Baseline (Visit 1 to Visit 2)||5||
59509643|NCT02626156|75603009|FG000|STARTED|Study Visit 3||23||
59612340|NCT01701258|75723500|FG001|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0|68 out of the 96 eligible participants completed the MRI.|
59759547|NCT02631941|75878923|FG001|COMPLETED|Overall Study||8||
59918088|NCT02678416|76038584|FG000|STARTED|Part 1||12||
59918089|NCT02678416|76038584|FG000|Safety Population|Part 1||12||
59918090|NCT02678416|76038584|FG000|Modified Intent to Treat (mITT)|Part 1||12||
59918091|NCT02678416|76038584|FG000|Per Protocol Population|Part 1||8||
59918092|NCT02678416|76038584|FG000|COMPLETED|Part 1||11||
59918093|NCT02678416|76038584|FG000|NOT COMPLETED|Part 1||1||
59918094|NCT02678416|76038584|FG000|STARTED|Part 2|Part 2 enrolled all new participants|67||
59918095|NCT02678416|76038584|FG000|Treated (Safety Population)|Part 2||66|One participant was randomized but not treated.|
59918096|NCT02678416|76038584|FG000|Modified Intent to Treat Population|Part 2||66||
59918097|NCT02678416|76038584|FG000|Pharmacokinetic Population|Part 2||65||
60037832|NCT02394275|76153364|FG000|COMPLETED|Overall Study||111||
60037833|NCT02394275|76153364|FG000|NOT COMPLETED|Overall Study||29||
60037834|NCT01608724|76153369|FG000|STARTED|Overall Study|One patient was excluded because the Informed Consent Form was destroyed by site staff by mistake.|1423||
60037835|NCT01608724|76153369|FG000|Treated|Overall Study||1361||
60037836|NCT01608724|76153369|FG000|COMPLETED|Overall Study||1180||
60037837|NCT01608724|76153369|FG000|NOT COMPLETED|Overall Study||243||
60037838|NCT02366195|76153373|FG000|STARTED|Overall Study||112||
60037839|NCT02366195|76153373|FG000|Received Study Drug|Overall Study||111||
60037840|NCT02366195|76153373|FG000|COMPLETED|Overall Study||58||
60037841|NCT02366195|76153373|FG000|NOT COMPLETED|Overall Study||54||
60037842|NCT02364947|76153380|FG000|STARTED|Overall Study||248||
60037843|NCT02364947|76153381|FG001|STARTED|Overall Study||184||
60037844|NCT02364947|76153382|FG002|STARTED|Overall Study||245||
60037845|NCT02364947|76153380|FG000|COMPLETED|Overall Study||189||
60037846|NCT02364947|76153381|FG001|COMPLETED|Overall Study||139||
60037847|NCT02364947|76153382|FG002|COMPLETED|Overall Study||219||
60037848|NCT02364947|76153380|FG000|NOT COMPLETED|Overall Study||59||
60037849|NCT02364947|76153381|FG001|NOT COMPLETED|Overall Study||45||
60037850|NCT02364947|76153382|FG002|NOT COMPLETED|Overall Study||26||
60037851|NCT02392481|76153394|FG000|STARTED|Overall Study||10||
60037852|NCT02392481|76153395|FG001|STARTED|Overall Study||12||
60037853|NCT02392481|76153396|FG002|STARTED|Overall Study||20||
60037854|NCT02392481|76153397|FG003|STARTED|Overall Study||27||
60037855|NCT02392481|76153394|FG000|COMPLETED|Overall Study||10||
60037856|NCT02392481|76153395|FG001|COMPLETED|Overall Study||12||
60037857|NCT02392481|76153396|FG002|COMPLETED|Overall Study||18||
60037858|NCT02392481|76153397|FG003|COMPLETED|Overall Study||25||
59509644|NCT02626156|75603010|FG001|STARTED|Study Visit 3||22||
59509645|NCT02626156|75603011|FG002|STARTED|Study Visit 3||37||
59509646|NCT02626156|75603012|FG003|STARTED|Study Visit 3||35||
59509647|NCT02626156|75603009|FG000|COMPLETED|Study Visit 3||15||
59509648|NCT02626156|75603010|FG001|COMPLETED|Study Visit 3||17||
59509649|NCT02626156|75603011|FG002|COMPLETED|Study Visit 3||33||
59509650|NCT02626156|75603012|FG003|COMPLETED|Study Visit 3||33||
59509651|NCT02626156|75603009|FG000|NOT COMPLETED|Study Visit 3||8||
59509652|NCT02626156|75603010|FG001|NOT COMPLETED|Study Visit 3||5||
59509653|NCT02626156|75603011|FG002|NOT COMPLETED|Study Visit 3||4||
59509654|NCT02626156|75603012|FG003|NOT COMPLETED|Study Visit 3||2||
59509655|NCT02626156|75603009|FG000|STARTED|Study Visit 4||15||
59509656|NCT02626156|75603010|FG001|STARTED|Study Visit 4||17||
59509657|NCT02626156|75603011|FG002|STARTED|Study Visit 4||33||
59509658|NCT02626156|75603012|FG003|STARTED|Study Visit 4||33||
59509659|NCT02626156|75603009|FG000|COMPLETED|Study Visit 4||12||
59509660|NCT02626156|75603010|FG001|COMPLETED|Study Visit 4||15||
59509661|NCT02626156|75603011|FG002|COMPLETED|Study Visit 4||24||
59509662|NCT02626156|75603012|FG003|COMPLETED|Study Visit 4||28||
59509663|NCT02626156|75603009|FG000|NOT COMPLETED|Study Visit 4||3||
59509664|NCT02626156|75603010|FG001|NOT COMPLETED|Study Visit 4||2||
59509665|NCT02626156|75603011|FG002|NOT COMPLETED|Study Visit 4||9||
59509666|NCT02626156|75603012|FG003|NOT COMPLETED|Study Visit 4||5||
59509667|NCT00835861|75603030|FG000|STARTED|Overall Study||15||
59509668|NCT00835861|75603031|FG001|STARTED|Overall Study||16||
59509669|NCT00835861|75603030|FG000|COMPLETED|Overall Study||14||
59509670|NCT00835861|75603031|FG001|COMPLETED|Overall Study||14||
59509671|NCT00835861|75603030|FG000|NOT COMPLETED|Overall Study||1||
59509672|NCT00835861|75603031|FG001|NOT COMPLETED|Overall Study||2||
59509673|NCT02627794|75603037|FG000|STARTED|Overall Study||3||6
59509674|NCT02627794|75603037|FG000|COMPLETED|Overall Study||3||6
59759548|NCT02631941|75878924|FG002|COMPLETED|Overall Study||9||
60037859|NCT02392481|76153394|FG000|NOT COMPLETED|Overall Study||0||
60037860|NCT02392481|76153395|FG001|NOT COMPLETED|Overall Study||0||
60037861|NCT02392481|76153396|FG002|NOT COMPLETED|Overall Study||2||
60037862|NCT02392481|76153397|FG003|NOT COMPLETED|Overall Study||2||
60037863|NCT02392403|76153407|FG000|STARTED|Overall Study||45||
60037864|NCT02392403|76153407|FG000|COMPLETED|Overall Study||42||
60037865|NCT02392403|76153407|FG000|NOT COMPLETED|Overall Study||3||
60037866|NCT02392247|76153411|FG000|STARTED|Overall Study||52||
60037867|NCT02392247|76153411|FG000|COMPLETED|Overall Study||50||
60037868|NCT02392247|76153411|FG000|NOT COMPLETED|Overall Study||2||
59509675|NCT02627794|75603037|FG000|NOT COMPLETED|Overall Study||0||0
59509676|NCT00804973|75603047|FG000|STARTED|Overall Study||40||
59509677|NCT00804973|75603048|FG001|STARTED|Overall Study||40||
59509678|NCT00804973|75603049|FG002|STARTED|Overall Study||40||
59509679|NCT00804973|75603047|FG000|Received at Least 1 Dose of Study Drug|Overall Study||40||
59509680|NCT00804973|75603048|FG001|Received at Least 1 Dose of Study Drug|Overall Study||40||
59509681|NCT00804973|75603049|FG002|Received at Least 1 Dose of Study Drug|Overall Study||40||
59509682|NCT00804973|75603047|FG000|COMPLETED|Overall Study||40||
59509683|NCT00804973|75603048|FG001|COMPLETED|Overall Study||40||
59509684|NCT00804973|75603049|FG002|COMPLETED|Overall Study||40||
60037869|NCT02337725|76153417|FG000|STARTED|Overall Study||126||
60037870|NCT02337725|76153418|FG001|STARTED|Overall Study||118||
60037871|NCT02337725|76153417|FG000|COMPLETED|Overall Study||100||
60037872|NCT02337725|76153418|FG001|COMPLETED|Overall Study||110||
60037873|NCT02337725|76153417|FG000|NOT COMPLETED|Overall Study||26||
60037874|NCT02337725|76153418|FG001|NOT COMPLETED|Overall Study||8||
60037875|NCT02337491|76153426|FG000|STARTED|Overall Study||50||
59509685|NCT00804973|75603047|FG000|NOT COMPLETED|Overall Study||0||
59509686|NCT00804973|75603048|FG001|NOT COMPLETED|Overall Study||0||
59918098|NCT02678416|76038584|FG000|Per Protocol Population|Part 2||64||
59918099|NCT02678416|76038584|FG000|COMPLETED|Part 2||64||
59918100|NCT02678416|76038584|FG000|NOT COMPLETED|Part 2||3||
59918101|NCT02680834|76038604|FG000|STARTED|Overall Study||26||
59918102|NCT02680834|76038605|FG001|STARTED|Overall Study||30||
60037876|NCT02337491|76153427|FG001|STARTED|Overall Study||30||
60037877|NCT02337491|76153426|FG000|COMPLETED|Overall Study||0||
60037878|NCT02337491|76153427|FG001|COMPLETED|Overall Study||0||
60037879|NCT02337491|76153426|FG000|NOT COMPLETED|Overall Study||50||
60037880|NCT02337491|76153427|FG001|NOT COMPLETED|Overall Study||30||
60037881|NCT01765582|76153437|FG000|STARTED|Overall Study||93||
60037882|NCT01765582|76153438|FG001|STARTED|Overall Study||92||
60037883|NCT01765582|76153439|FG002|STARTED|Overall Study||95||
60037884|NCT01765582|76153437|FG000|COMPLETED|Overall Study||0||
60037885|NCT01765582|76153438|FG001|COMPLETED|Overall Study||0||
60037886|NCT01765582|76153439|FG002|COMPLETED|Overall Study||0||
60037887|NCT01765582|76153437|FG000|NOT COMPLETED|Overall Study||93||
60037888|NCT01765582|76153438|FG001|NOT COMPLETED|Overall Study||92||
60037889|NCT01765582|76153439|FG002|NOT COMPLETED|Overall Study||95||
60037890|NCT01649375|76153451|FG000|STARTED|Up to Week 16||73||
60037891|NCT01649375|76153452|FG001|STARTED|Up to Week 16||72||
60037892|NCT01649375|76153453|FG002|STARTED|Up to Week 16||74||
60037893|NCT01649375|76153454|FG003|STARTED|Up to Week 16||0||
60037894|NCT01649375|76153455|FG004|STARTED|Up to Week 16||0||
60037895|NCT01649375|76153451|FG000|COMPLETED|Up to Week 16||68||
60037896|NCT01649375|76153452|FG001|COMPLETED|Up to Week 16||66||
60037897|NCT01649375|76153453|FG002|COMPLETED|Up to Week 16||66||
60037898|NCT01649375|76153454|FG003|COMPLETED|Up to Week 16||0||
60037899|NCT01649375|76153455|FG004|COMPLETED|Up to Week 16||0||
60037900|NCT01649375|76153451|FG000|NOT COMPLETED|Up to Week 16||5||
60037901|NCT01649375|76153452|FG001|NOT COMPLETED|Up to Week 16||6||
59918103|NCT02680834|76038604|FG000|COMPLETED|Overall Study||15||
59918104|NCT02680834|76038605|FG001|COMPLETED|Overall Study||27||
59918105|NCT02680834|76038604|FG000|NOT COMPLETED|Overall Study||11||
59918106|NCT02680834|76038605|FG001|NOT COMPLETED|Overall Study||3||
60037902|NCT01649375|76153453|FG002|NOT COMPLETED|Up to Week 16||8||
60037903|NCT01649375|76153454|FG003|NOT COMPLETED|Up to Week 16||0||
60037904|NCT01649375|76153455|FG004|NOT COMPLETED|Up to Week 16||0||
60037905|NCT01649375|76153451|FG000|STARTED|Week 16 up to Week 260||68||
60037906|NCT01649375|76153452|FG001|STARTED|Week 16 up to Week 260||66||
60037907|NCT01649375|76153453|FG002|STARTED|Week 16 up to Week 260||0||
60037908|NCT01649375|76153454|FG003|STARTED|Week 16 up to Week 260||32||
60037909|NCT01649375|76153455|FG004|STARTED|Week 16 up to Week 260||34||
60037910|NCT01649375|76153451|FG000|COMPLETED|Week 16 up to Week 260||48||
60037911|NCT01649375|76153452|FG001|COMPLETED|Week 16 up to Week 260||53||
60037912|NCT01649375|76153453|FG002|COMPLETED|Week 16 up to Week 260||0||
60037913|NCT01649375|76153454|FG003|COMPLETED|Week 16 up to Week 260||20||
60037914|NCT01649375|76153455|FG004|COMPLETED|Week 16 up to Week 260||29||
60037915|NCT01649375|76153451|FG000|NOT COMPLETED|Week 16 up to Week 260||20||
60037916|NCT01649375|76153452|FG001|NOT COMPLETED|Week 16 up to Week 260||13||
60037917|NCT01649375|76153453|FG002|NOT COMPLETED|Week 16 up to Week 260||0||
60037918|NCT01649375|76153454|FG003|NOT COMPLETED|Week 16 up to Week 260||12||
60037919|NCT01649375|76153455|FG004|NOT COMPLETED|Week 16 up to Week 260||5||
60037920|NCT02336555|76153465|FG000|STARTED|Treatment Period 1 (28 Days)||18||
60037921|NCT02336555|76153466|FG001|STARTED|Treatment Period 1 (28 Days)||17||
60037922|NCT02336555|76153465|FG000|COMPLETED|Treatment Period 1 (28 Days)||16||
60037923|NCT02336555|76153466|FG001|COMPLETED|Treatment Period 1 (28 Days)||16||
60037924|NCT02336555|76153465|FG000|NOT COMPLETED|Treatment Period 1 (28 Days)||2||
60037925|NCT02336555|76153466|FG001|NOT COMPLETED|Treatment Period 1 (28 Days)||1||
60037926|NCT02336555|76153465|FG000|STARTED|Treatment Period 2 (28 Days)||16||
60037927|NCT02336555|76153466|FG001|STARTED|Treatment Period 2 (28 Days)||16||
60037928|NCT02336555|76153465|FG000|COMPLETED|Treatment Period 2 (28 Days)||16||
60037929|NCT02336555|76153466|FG001|COMPLETED|Treatment Period 2 (28 Days)||15||
60037930|NCT02336555|76153465|FG000|NOT COMPLETED|Treatment Period 2 (28 Days)||0||
60037931|NCT02336555|76153466|FG001|NOT COMPLETED|Treatment Period 2 (28 Days)||1||
60037932|NCT01648283|76153472|FG000|STARTED|Overall Study||78||
60037933|NCT01648283|76153472|FG000|COMPLETED|Overall Study||64||
60037934|NCT01648283|76153472|FG000|NOT COMPLETED|Overall Study||14||
60037935|NCT01649297|76153483|FG000|STARTED|Overall Study|randomised|219||
60037936|NCT01649297|76153484|FG001|STARTED|Overall Study|randomised|218||
60037937|NCT01649297|76153485|FG002|STARTED|Overall Study|randomised|219||
60037938|NCT01649297|76153486|FG003|STARTED|Overall Study|randomised|220||
60037939|NCT01649297|76153487|FG004|STARTED|Overall Study|randomised|107||
60037940|NCT01649297|76153483|FG000|COMPLETED|Overall Study||205||
60037941|NCT01649297|76153484|FG001|COMPLETED|Overall Study||205||
60037942|NCT01649297|76153485|FG002|COMPLETED|Overall Study||202||
60037943|NCT01649297|76153486|FG003|COMPLETED|Overall Study||201||
60037944|NCT01649297|76153487|FG004|COMPLETED|Overall Study||103||
60037945|NCT01649297|76153483|FG000|NOT COMPLETED|Overall Study||14||
60037946|NCT01649297|76153484|FG001|NOT COMPLETED|Overall Study||13||
60037947|NCT01649297|76153485|FG002|NOT COMPLETED|Overall Study||17||
60037948|NCT01649297|76153486|FG003|NOT COMPLETED|Overall Study||19||
60037949|NCT01649297|76153487|FG004|NOT COMPLETED|Overall Study||4||
60037950|NCT01648205|76153499|FG000|STARTED|Placebo||25|ECG data were available at 1 months in 21 of 25 subjects: one subject withdrew from the study and second subject got pregnant and was withdrawn, two other subjects still participating in the study did not have ECGs done (which was a protocol violation).|
60037951|NCT01648205|76153499|FG000|COMPLETED|Placebo||21||
60037952|NCT01648205|76153499|FG000|NOT COMPLETED|Placebo||4||
60037953|NCT01648205|76153499|FG000|STARTED|Ranolazine||23|ECG data were available at 1 months in 21 of 25 subjects: one subject withdrew from the study and second subject got pregnant and was withdrawn, two other subjects still participating in the study did not have ECGs done (which was a protocol violation) but they still participated in the period 2. This is why period 2 was started by 23 patients.|
60037954|NCT01648205|76153499|FG000|COMPLETED|Ranolazine||18||
60037955|NCT01648205|76153499|FG000|NOT COMPLETED|Ranolazine||5||
60037956|NCT02362451|76153509|FG000|STARTED|Overall Study||6||
60037957|NCT02362451|76153510|FG001|STARTED|Overall Study||1||
60037958|NCT02362451|76153509|FG000|COMPLETED|Overall Study||2||
60037959|NCT02362451|76153510|FG001|COMPLETED|Overall Study||0||
60037960|NCT02362451|76153509|FG000|NOT COMPLETED|Overall Study||4||
60037961|NCT02362451|76153510|FG001|NOT COMPLETED|Overall Study||1||
60037962|NCT01734382|76153519|FG000|STARTED|Part 1||19||
60037963|NCT01734382|76153520|FG001|STARTED|Part 1||0||
60037964|NCT01734382|76153521|FG002|STARTED|Part 1||0||
60037965|NCT01734382|76153519|FG000|COMPLETED|Part 1||17||
60037966|NCT01734382|76153520|FG001|COMPLETED|Part 1||0||
60037967|NCT01734382|76153521|FG002|COMPLETED|Part 1||0||
60037968|NCT01734382|76153519|FG000|NOT COMPLETED|Part 1||2||
60037969|NCT01734382|76153520|FG001|NOT COMPLETED|Part 1||0||
60037970|NCT01734382|76153521|FG002|NOT COMPLETED|Part 1||0||
60037971|NCT01734382|76153519|FG000|STARTED|Part 2||0||
60037972|NCT01734382|76153520|FG001|STARTED|Part 2||7||
60037973|NCT01734382|76153521|FG002|STARTED|Part 2||15||
60037974|NCT01734382|76153519|FG000|COMPLETED|Part 2||0||
60037975|NCT01734382|76153520|FG001|COMPLETED|Part 2||5||
60037976|NCT01734382|76153521|FG002|COMPLETED|Part 2||8||
60037977|NCT01734382|76153519|FG000|NOT COMPLETED|Part 2||0||
60037978|NCT01734382|76153520|FG001|NOT COMPLETED|Part 2||2||
60037979|NCT01734382|76153521|FG002|NOT COMPLETED|Part 2||7||
60037980|NCT02391311|76153535|FG000|STARTED|Overall Study||21||
60037981|NCT02391311|76153536|FG001|STARTED|Overall Study||21||
60037982|NCT02391311|76153535|FG000|COMPLETED|Overall Study||18||
60037983|NCT02391311|76153536|FG001|COMPLETED|Overall Study||19||
60037984|NCT02391311|76153535|FG000|NOT COMPLETED|Overall Study||3||
60037985|NCT02391311|76153536|FG001|NOT COMPLETED|Overall Study||2||
60037986|NCT01765426|76153546|FG000|STARTED|Overall Study||18||
60037987|NCT01765426|76153547|FG001|STARTED|Overall Study||17||
60037988|NCT01765426|76153548|FG002|STARTED|Overall Study||17||
60037989|NCT01765426|76153549|FG003|STARTED|Overall Study||15||
60037990|NCT01765426|76153546|FG000|Completed All Vaccinations|Overall Study||17||
60037991|NCT01765426|76153547|FG001|Completed All Vaccinations|Overall Study||16||
60037992|NCT01765426|76153548|FG002|Completed All Vaccinations|Overall Study||17||
60037993|NCT01765426|76153549|FG003|Completed All Vaccinations|Overall Study||15||
60037994|NCT01765426|76153546|FG000|COMPLETED|Overall Study||18||
60037995|NCT01765426|76153547|FG001|COMPLETED|Overall Study||16||
60037996|NCT01765426|76153548|FG002|COMPLETED|Overall Study||17||
60037997|NCT01765426|76153549|FG003|COMPLETED|Overall Study||15||
60037998|NCT01765426|76153546|FG000|NOT COMPLETED|Overall Study||0||
60037999|NCT01765426|76153547|FG001|NOT COMPLETED|Overall Study||1||
60038000|NCT01765426|76153548|FG002|NOT COMPLETED|Overall Study||0||
60038001|NCT01765426|76153549|FG003|NOT COMPLETED|Overall Study||0||
60038002|NCT01765270|76153561|FG000|STARTED|Overall Study||5||
60038003|NCT01765270|76153562|FG001|STARTED|Overall Study||7||
60038004|NCT01765270|76153561|FG000|COMPLETED|Overall Study||4||
60038005|NCT01765270|76153562|FG001|COMPLETED|Overall Study||6||
60038006|NCT01765270|76153561|FG000|NOT COMPLETED|Overall Study||1||
60038007|NCT01765270|76153562|FG001|NOT COMPLETED|Overall Study||1||
60038008|NCT01733758|76153573|FG000|STARTED|Overall Study||77||
60038009|NCT01733758|76153574|FG001|STARTED|Overall Study||160||
60038010|NCT01733758|76153575|FG002|STARTED|Overall Study||150||
60038011|NCT01733758|76153576|FG003|STARTED|Overall Study||103||
60038012|NCT01733758|76153573|FG000|COMPLETED|Overall Study||62||
60038013|NCT01733758|76153574|FG001|COMPLETED|Overall Study||148||
60038014|NCT01733758|76153575|FG002|COMPLETED|Overall Study||135||
60038015|NCT01733758|76153576|FG003|COMPLETED|Overall Study||95||
60038016|NCT01733758|76153573|FG000|NOT COMPLETED|Overall Study||15||
60038017|NCT01733758|76153574|FG001|NOT COMPLETED|Overall Study||12||
60038018|NCT01733758|76153575|FG002|NOT COMPLETED|Overall Study||15||
60038019|NCT01733758|76153576|FG003|NOT COMPLETED|Overall Study||8||
60038020|NCT01607554|76153588|FG000|STARTED|Overall Study||2||
60038021|NCT01607554|76153588|FG000|COMPLETED|Overall Study||0||
60038022|NCT01607554|76153588|FG000|NOT COMPLETED|Overall Study||2||
60038023|NCT01607476|76153595|FG000|STARTED|Overall Study||25||
60038024|NCT01607476|76153596|FG001|STARTED|Overall Study||30||
60038025|NCT01607476|76153597|FG002|STARTED|Overall Study||33||
60038026|NCT01607476|76153595|FG000|COMPLETED|Overall Study||24||
60038027|NCT01607476|76153596|FG001|COMPLETED|Overall Study||30||
60038028|NCT01607476|76153597|FG002|COMPLETED|Overall Study||30||
60038029|NCT01607476|76153595|FG000|NOT COMPLETED|Overall Study||1||
60038030|NCT01607476|76153596|FG001|NOT COMPLETED|Overall Study||0||
60038031|NCT01607476|76153597|FG002|NOT COMPLETED|Overall Study||3||
60038032|NCT01765192|76153607|FG000|STARTED|Treatment Period 1||32||
60038033|NCT01765192|76153608|FG001|STARTED|Treatment Period 1||32||
60038034|NCT01765192|76153607|FG000|COMPLETED|Treatment Period 1||32||
60038035|NCT01765192|76153608|FG001|COMPLETED|Treatment Period 1||31||
60038036|NCT01765192|76153607|FG000|NOT COMPLETED|Treatment Period 1||0||
60038037|NCT01765192|76153608|FG001|NOT COMPLETED|Treatment Period 1||1||
60038038|NCT01765192|76153607|FG000|STARTED|Washout Period||32||
59509687|NCT00804973|75603049|FG002|NOT COMPLETED|Overall Study||0||
59509688|NCT02628106|75603057|FG000|STARTED|Overall Study||21||
59509689|NCT02628106|75603057|FG000|COMPLETED|Overall Study||21||
59509690|NCT02628106|75603057|FG000|NOT COMPLETED|Overall Study||0||
59509691|NCT02628964|75603063|FG000|STARTED|Overall Study||50||
60038039|NCT01765192|76153608|FG001|STARTED|Washout Period||31||
60038040|NCT01765192|76153607|FG000|COMPLETED|Washout Period||30||
60038041|NCT01765192|76153608|FG001|COMPLETED|Washout Period||30||
60038042|NCT01765192|76153607|FG000|NOT COMPLETED|Washout Period||2||
60038043|NCT01765192|76153608|FG001|NOT COMPLETED|Washout Period||1||
60038044|NCT01765192|76153607|FG000|STARTED|Treatment Period 2||30||
60038045|NCT01765192|76153608|FG001|STARTED|Treatment Period 2||30||
60038046|NCT01765192|76153607|FG000|COMPLETED|Treatment Period 2||30||
60038047|NCT01765192|76153608|FG001|COMPLETED|Treatment Period 2||28||
60038048|NCT01765192|76153607|FG000|NOT COMPLETED|Treatment Period 2||0||
60038049|NCT01765192|76153608|FG001|NOT COMPLETED|Treatment Period 2||2||
60038050|NCT01765192|76153607|FG000|STARTED|End of Treatment Period 2 to Final Visit||30||
60038051|NCT01765192|76153608|FG001|STARTED|End of Treatment Period 2 to Final Visit||28||
60038052|NCT01765192|76153607|FG000|COMPLETED|End of Treatment Period 2 to Final Visit||30||
60038053|NCT01765192|76153608|FG001|COMPLETED|End of Treatment Period 2 to Final Visit||27||
60038054|NCT01765192|76153607|FG000|NOT COMPLETED|End of Treatment Period 2 to Final Visit||0||
60038055|NCT01765192|76153608|FG001|NOT COMPLETED|End of Treatment Period 2 to Final Visit||1||
60038056|NCT01733680|76153616|FG000|STARTED|Overall Study||2||
60038057|NCT01733680|76153617|FG001|STARTED|Overall Study||1||
60038058|NCT01733680|76153616|FG000|COMPLETED|Overall Study||2||
60038059|NCT01733680|76153617|FG001|COMPLETED|Overall Study||0||
60038060|NCT01733680|76153616|FG000|NOT COMPLETED|Overall Study||0||
60038061|NCT01733680|76153617|FG001|NOT COMPLETED|Overall Study||1||
60038062|NCT02336165|76153632|FG000|STARTED|Overall Study||40||
60038063|NCT02336165|76153633|FG001|STARTED|Overall Study||31||
60038064|NCT02336165|76153634|FG002|STARTED|Overall Study||33||
60038065|NCT02336165|76153635|FG003|STARTED|Overall Study||33||
60038066|NCT02336165|76153636|FG004|STARTED|Overall Study||22||
60038067|NCT02336165|76153632|FG000|COMPLETED|Overall Study||6||
60038068|NCT02336165|76153633|FG001|COMPLETED|Overall Study||6||
60038069|NCT02336165|76153634|FG002|COMPLETED|Overall Study||2||
60038070|NCT02336165|76153635|FG003|COMPLETED|Overall Study||2||
60038071|NCT02336165|76153636|FG004|COMPLETED|Overall Study||0||
60038072|NCT02336165|76153632|FG000|NOT COMPLETED|Overall Study||34||
60038073|NCT02336165|76153633|FG001|NOT COMPLETED|Overall Study||25||
59509692|NCT02628964|75603064|FG001|STARTED|Overall Study||50||
60038074|NCT02336165|76153634|FG002|NOT COMPLETED|Overall Study||31||
60038075|NCT02336165|76153635|FG003|NOT COMPLETED|Overall Study||31||
60038076|NCT02336165|76153636|FG004|NOT COMPLETED|Overall Study||22||
60038077|NCT02360111|76153652|FG000|STARTED|Overall Study||3||
60038078|NCT02360111|76153652|FG000|COMPLETED|Overall Study||1||
60038079|NCT02360111|76153652|FG000|NOT COMPLETED|Overall Study||2||
60038080|NCT02334683|76153658|FG000|STARTED|First 12 Week Period||10||
59509693|NCT02628964|75603063|FG000|COMPLETED|Overall Study||50||
60038081|NCT02334683|76153659|FG001|STARTED|First 12 Week Period||10||
60038082|NCT02334683|76153658|FG000|COMPLETED|First 12 Week Period||9||
60038083|NCT02334683|76153659|FG001|COMPLETED|First 12 Week Period||10||
60038084|NCT02334683|76153658|FG000|NOT COMPLETED|First 12 Week Period||1||
60038085|NCT02334683|76153659|FG001|NOT COMPLETED|First 12 Week Period||0||
60038086|NCT02334683|76153658|FG000|STARTED|Second 12 Week Period||9||
60038087|NCT02334683|76153659|FG001|STARTED|Second 12 Week Period||10||
60038088|NCT02334683|76153658|FG000|COMPLETED|Second 12 Week Period||9||
60038089|NCT02334683|76153659|FG001|COMPLETED|Second 12 Week Period||9||
60038090|NCT02334683|76153658|FG000|NOT COMPLETED|Second 12 Week Period||0||
60038091|NCT02334683|76153659|FG001|NOT COMPLETED|Second 12 Week Period||1||
60038092|NCT02319044|76153668|FG000|STARTED|Overall Study||133||
60038093|NCT02319044|76153669|FG001|STARTED|Overall Study||67||
60038094|NCT02319044|76153670|FG002|STARTED|Overall Study||67||
60038095|NCT02319044|76153668|FG000|COMPLETED|Overall Study||11||
60038096|NCT02319044|76153669|FG001|COMPLETED|Overall Study||7||
60038097|NCT02319044|76153670|FG002|COMPLETED|Overall Study||0||
60038098|NCT02319044|76153668|FG000|NOT COMPLETED|Overall Study||122||
60038099|NCT02319044|76153669|FG001|NOT COMPLETED|Overall Study||60||
60038100|NCT02319044|76153670|FG002|NOT COMPLETED|Overall Study||67||
60038101|NCT01649765|76153681|FG000|STARTED|Overall Study||40||
60038102|NCT01649765|76153682|FG001|STARTED|Overall Study||53||
60038103|NCT01649765|76153681|FG000|COMPLETED|Overall Study||31||
60038104|NCT01649765|76153682|FG001|COMPLETED|Overall Study||45||
60038105|NCT01649765|76153681|FG000|NOT COMPLETED|Overall Study||9||
60038106|NCT01649765|76153682|FG001|NOT COMPLETED|Overall Study||8||
60038107|NCT02317562|76153689|FG000|STARTED|Overall Study||19||
60038108|NCT02317562|76153689|FG000|COMPLETED|Overall Study||5||
60038109|NCT02317562|76153689|FG000|NOT COMPLETED|Overall Study||14||
60038110|NCT02317016|76153693|FG000|STARTED|Part A: Day 1-3 (Rosuvastatin Alone)||44||
60038111|NCT02317016|76153693|FG000|COMPLETED|Part A: Day 1-3 (Rosuvastatin Alone)||44||
60038112|NCT02317016|76153693|FG000|NOT COMPLETED|Part A: Day 1-3 (Rosuvastatin Alone)||0||
60038113|NCT02317016|76153693|FG000|STARTED|Part A: Day 4-31 (AZD9291 Alone)||44||
60038114|NCT02317016|76153693|FG000|COMPLETED|Part A: Day 4-31 (AZD9291 Alone)||43||
60038115|NCT02317016|76153693|FG000|NOT COMPLETED|Part A: Day 4-31 (AZD9291 Alone)||1||
60038116|NCT02317016|76153693|FG000|STARTED|Part A: Day 32-34 (Rosuvastatin+AZD9291)||43||
60038117|NCT02317016|76153693|FG000|COMPLETED|Part A: Day 32-34 (Rosuvastatin+AZD9291)||41||
60038118|NCT02317016|76153693|FG000|NOT COMPLETED|Part A: Day 32-34 (Rosuvastatin+AZD9291)||2||
60038119|NCT02317016|76153693|FG000|STARTED|Part B: Day 35 to End Part B (AZD9291)|41 completed Part A + 1 entered Part B without completing Part A (due to AE) = 42 started Part B|42||
60038120|NCT02317016|76153693|FG000|COMPLETED|Part B: Day 35 to End Part B (AZD9291)||11||
60038121|NCT02317016|76153693|FG000|NOT COMPLETED|Part B: Day 35 to End Part B (AZD9291)||31||
60038122|NCT02311478|76153701|FG000|STARTED|Overall Study||79||
60038123|NCT02311478|76153701|FG000|IUD Insertion|Overall Study||78||
60038124|NCT02311478|76153701|FG000|COMPLETED|Overall Study||72||
60038125|NCT02311478|76153701|FG000|NOT COMPLETED|Overall Study||7||
60038126|NCT02388932|76153706|FG000|STARTED|Overall Study||3||
60038127|NCT02388932|76153706|FG000|COMPLETED|Overall Study||2||
60038128|NCT02388932|76153706|FG000|NOT COMPLETED|Overall Study||1||
60038129|NCT02388776|76153711|FG000|STARTED|Overall Study||2||
60038130|NCT02388776|76153711|FG000|COMPLETED|Overall Study||0||
60038131|NCT02388776|76153711|FG000|NOT COMPLETED|Overall Study||2||
60038132|NCT02316548|76153718|FG000|STARTED|Overall Study|Randomized|6||
60038133|NCT02316548|76153719|FG001|STARTED|Overall Study|Randomized|7||
60038134|NCT02316548|76153718|FG000|Eligible Population|Overall Study||6||
60038135|NCT02316548|76153719|FG001|Eligible Population|Overall Study||6||
60038136|NCT02316548|76153718|FG000|Eligible With Disease Assessment|Overall Study||4||
60038137|NCT02316548|76153719|FG001|Eligible With Disease Assessment|Overall Study||1||
60038138|NCT02316548|76153718|FG000|Eligible With Adverse Event Data|Overall Study||4||
60038139|NCT02316548|76153719|FG001|Eligible With Adverse Event Data|Overall Study||2||
59509694|NCT02628964|75603064|FG001|COMPLETED|Overall Study||49||
59509695|NCT02628964|75603063|FG000|NOT COMPLETED|Overall Study||0||
60038140|NCT02316548|76153718|FG000|COMPLETED|Overall Study|Eligible patients on study until study termination|6||
60038141|NCT02316548|76153719|FG001|COMPLETED|Overall Study|Eligible patients on study until study termination|6||
59509696|NCT02628964|75603064|FG001|NOT COMPLETED|Overall Study||1||
59509697|NCT00836017|75603070|FG000|STARTED|Overall Study||1046||
59509698|NCT00836017|75603070|FG000|COMPLETED|Overall Study||502||
60038142|NCT02316548|76153718|FG000|NOT COMPLETED|Overall Study||0||
60038143|NCT02316548|76153719|FG001|NOT COMPLETED|Overall Study||1||
60038144|NCT02281760|76153725|FG000|STARTED|Overall Study||6||
60038145|NCT02281760|76153725|FG000|COMPLETED|Overall Study||5||
60038146|NCT02281760|76153725|FG000|NOT COMPLETED|Overall Study||1||
59509699|NCT00836017|75603070|FG000|NOT COMPLETED|Overall Study||544||
59509700|NCT02629354|75603076|FG000|STARTED|Period 1||18||
60038147|NCT02390531|76153737|FG000|STARTED|Overall Study||11||
60038148|NCT02390531|76153738|FG001|STARTED|Overall Study||16||
60038149|NCT02390531|76153739|FG002|STARTED|Overall Study||24||
60038150|NCT02390531|76153740|FG003|STARTED|Overall Study||10||
60038151|NCT02390531|76153741|FG004|STARTED|Overall Study||14||
59509701|NCT02629354|75603077|FG001|STARTED|Period 1||18||
60038152|NCT02390531|76153742|FG005|STARTED|Overall Study||9||
60038153|NCT02390531|76153743|FG006|STARTED|Overall Study||12||
60038154|NCT02390531|76153744|FG007|STARTED|Overall Study||24||
60038155|NCT02390531|76153737|FG000|COMPLETED|Overall Study||11||
60038156|NCT02390531|76153738|FG001|COMPLETED|Overall Study||14||
60038157|NCT02390531|76153739|FG002|COMPLETED|Overall Study||24||
60038158|NCT02390531|76153740|FG003|COMPLETED|Overall Study||9||
60038159|NCT02390531|76153741|FG004|COMPLETED|Overall Study||13||
60038160|NCT02390531|76153742|FG005|COMPLETED|Overall Study||9||
60038161|NCT02390531|76153743|FG006|COMPLETED|Overall Study||10||
60038162|NCT02390531|76153744|FG007|COMPLETED|Overall Study||23||
60038163|NCT02390531|76153737|FG000|NOT COMPLETED|Overall Study||0||
60038164|NCT02390531|76153738|FG001|NOT COMPLETED|Overall Study||2||
60038165|NCT02390531|76153739|FG002|NOT COMPLETED|Overall Study||0||
60038166|NCT02390531|76153740|FG003|NOT COMPLETED|Overall Study||1||
60038167|NCT02390531|76153741|FG004|NOT COMPLETED|Overall Study||1||
60038168|NCT02390531|76153742|FG005|NOT COMPLETED|Overall Study||0||
60038169|NCT02390531|76153743|FG006|NOT COMPLETED|Overall Study||2||
60038170|NCT02390531|76153744|FG007|NOT COMPLETED|Overall Study||1||
60038171|NCT02390219|76153780|FG000|STARTED|Overall Study||46||
60038172|NCT02390219|76153780|FG000|COMPLETED|Overall Study||33||
60038173|NCT02390219|76153780|FG000|NOT COMPLETED|Overall Study||13||
60038174|NCT02334215|76153787|FG000|STARTED|Overall Study||75||
60038175|NCT02334215|76153788|FG001|STARTED|Overall Study||74||
60038176|NCT02334215|76153789|FG002|STARTED|Overall Study||76||
60038177|NCT02334215|76153787|FG000|COMPLETED|Overall Study||68|Number of participants that had at least one urine test conducted|
60038178|NCT02334215|76153788|FG001|COMPLETED|Overall Study||68|Number of participants that had at least one urine test conducted|
60038179|NCT02334215|76153789|FG002|COMPLETED|Overall Study||61|Number of participants that had at least one urine test conducted|
60038180|NCT02334215|76153787|FG000|NOT COMPLETED|Overall Study||7||
60038181|NCT02334215|76153788|FG001|NOT COMPLETED|Overall Study||6||
60038182|NCT02334215|76153789|FG002|NOT COMPLETED|Overall Study||15||
60038183|NCT02359877|76153801|FG000|STARTED|Overall Study||34||
60038184|NCT02359877|76153802|FG001|STARTED|Overall Study||6||
60038185|NCT02359877|76153803|FG002|STARTED|Overall Study||6||
60038186|NCT02359877|76153804|FG003|STARTED|Overall Study||14||
60038187|NCT02359877|76153801|FG000|COMPLETED|Overall Study||33||
60038188|NCT02359877|76153802|FG001|COMPLETED|Overall Study||6||
60038189|NCT02359877|76153803|FG002|COMPLETED|Overall Study||6||
60038190|NCT02359877|76153804|FG003|COMPLETED|Overall Study||11||
60038191|NCT02359877|76153801|FG000|NOT COMPLETED|Overall Study||1||
60038192|NCT02359877|76153802|FG001|NOT COMPLETED|Overall Study||0||
60038193|NCT02359877|76153803|FG002|NOT COMPLETED|Overall Study||0||
60038194|NCT02359877|76153804|FG003|NOT COMPLETED|Overall Study||3||
60038195|NCT02389829|76153834|FG000|STARTED|Overall Study||64||
60038196|NCT02389829|76153835|FG001|STARTED|Overall Study||63||
60038197|NCT02389829|76153834|FG000|COMPLETED|Overall Study||64||
60038198|NCT02389829|76153835|FG001|COMPLETED|Overall Study||62||
60038199|NCT02389829|76153834|FG000|NOT COMPLETED|Overall Study||0||
60038200|NCT02389829|76153835|FG001|NOT COMPLETED|Overall Study||1||
60038201|NCT02358863|76153841|FG000|STARTED|Overall Study||13||
60038202|NCT02358863|76153841|FG000|COMPLETED|Overall Study||10||
60038203|NCT02358863|76153841|FG000|NOT COMPLETED|Overall Study||3||
60038204|NCT02358473|76153845|FG000|STARTED|Overall Study||13||
60038205|NCT02358473|76153845|FG000|COMPLETED|Overall Study||0||
60038206|NCT02358473|76153845|FG000|NOT COMPLETED|Overall Study||13||
59759549|NCT02631941|75878925|FG003|COMPLETED|Overall Study||9||
59759550|NCT02631941|75878926|FG004|COMPLETED|Overall Study||8||
60038207|NCT02357459|76153852|FG000|STARTED|Overall Study||161||
60038208|NCT02357459|76153853|FG001|STARTED|Overall Study||163||
60038209|NCT02357459|76153854|FG002|STARTED|Overall Study||162||
60038210|NCT02357459|76153852|FG000|COMPLETED|Overall Study||144||
60038211|NCT02357459|76153853|FG001|COMPLETED|Overall Study||149||
60038212|NCT02357459|76153854|FG002|COMPLETED|Overall Study||150||
60038213|NCT02357459|76153852|FG000|NOT COMPLETED|Overall Study||17||
60038214|NCT02357459|76153853|FG001|NOT COMPLETED|Overall Study||14||
60038215|NCT02357459|76153854|FG002|NOT COMPLETED|Overall Study||12||
60038216|NCT02332889|76153865|FG000|STARTED|Overall Study||1||
59759551|NCT02631941|75878927|FG005|COMPLETED|Overall Study||8||
60038217|NCT02332889|76153865|FG000|COMPLETED|Overall Study||0||
59759552|NCT02631941|75878928|FG006|COMPLETED|Overall Study||9||
59759553|NCT02631941|75878929|FG007|COMPLETED|Overall Study||8||
60038218|NCT02332889|76153865|FG000|NOT COMPLETED|Overall Study||1||
60038219|NCT02357147|76153871|FG000|STARTED|Combination Treatment Phase||52||
60038220|NCT02357147|76153872|FG001|STARTED|Combination Treatment Phase||56||
60038221|NCT02357147|76153871|FG000|Treated|Combination Treatment Phase||52||
60038222|NCT02357147|76153872|FG001|Treated|Combination Treatment Phase||54||
60038223|NCT02357147|76153871|FG000|COMPLETED|Combination Treatment Phase||26||
60038224|NCT02357147|76153872|FG001|COMPLETED|Combination Treatment Phase||29||
60038225|NCT02357147|76153871|FG000|NOT COMPLETED|Combination Treatment Phase||26||
60038226|NCT02357147|76153872|FG001|NOT COMPLETED|Combination Treatment Phase||27||
59918107|NCT03343704|76038613|FG000|STARTED|Overall Study||13||
59918108|NCT03343704|76038614|FG001|STARTED|Overall Study||6||
59918109|NCT03343704|76038613|FG000|COMPLETED|Overall Study||12||
59918110|NCT03343704|76038614|FG001|COMPLETED|Overall Study||4||
59918111|NCT03343704|76038613|FG000|NOT COMPLETED|Overall Study||1||
59918112|NCT03343704|76038614|FG001|NOT COMPLETED|Overall Study||2||
59918113|NCT02680756|76038624|FG000|STARTED|Overall Study||125||
59918114|NCT02680756|76038625|FG001|STARTED|Overall Study||125||
59918115|NCT02680756|76038624|FG000|Received Treatment|Overall Study||127|3 pts randomised to IV were given FM instead in error. Some pts in each arm were not treated.|
59918116|NCT02680756|76038625|FG001|Received Treatment|Overall Study||120|3 pts randomised to IV were given FM instead in error. Some pts in each arm were not treated.|
59918117|NCT02680756|76038624|FG000|COMPLETED|Overall Study||93||
59918118|NCT02680756|76038625|FG001|COMPLETED|Overall Study||106||
59918119|NCT02680756|76038624|FG000|NOT COMPLETED|Overall Study||32||
59918120|NCT02680756|76038625|FG001|NOT COMPLETED|Overall Study||19||
59918121|NCT03086460|76038631|FG000|STARTED|Study Participants||67|"Due to an error in the randomization system during the trial, some patients received the same treatment in several treatment intervals. The error was recognized after the database lock and unblinding. Patients were analyzed according to the treatments assigned by the Interactive Response Technology (IRT) system.~For statistical analyses as randomized corresponds to as actually allocated by the IRT that was used for efficacy analyses not according to those which were originally planned."|
59918122|NCT03086460|76038631|FG000|Treatment A|Study Participants||39|Number of patients who received Treatment A.|
59918123|NCT03086460|76038631|FG000|Treatment B|Study Participants||35|Number of patients who received Treatment B.|
59918124|NCT03086460|76038631|FG000|Treatment C|Study Participants||37|Number of patients who received Treatment C.|
60038227|NCT02357147|76153871|FG000|STARTED|Maintenance Treatment Phase||26||
60038228|NCT02357147|76153872|FG001|STARTED|Maintenance Treatment Phase||29||
60038229|NCT02357147|76153871|FG000|Treated|Maintenance Treatment Phase||25||
59918125|NCT03086460|76038631|FG000|Treatment D|Study Participants||40|Number of patients who received Treatment D.|
59918126|NCT03086460|76038631|FG000|Treatment E|Study Participants||40|Number of patients who received Treatment E.|
59918127|NCT03086460|76038631|FG000|Treatment F|Study Participants||41|Number of patients who received Treatment F.|
59918128|NCT03086460|76038631|FG000|COMPLETED|Study Participants||58|"Patients who received the same treatment during two treatment intervals were considered twice in the corresponding group (once for each treatment interval).~The table above presents the number of patients receiving each treatment in at least one treatment interval."|
59918129|NCT03086460|76038631|FG000|NOT COMPLETED|Study Participants||9||
59918130|NCT03086460|76038631|FG000|STARTED|Treatment A||39||
59918131|NCT03086460|76038631|FG000|COMPLETED|Treatment A||35||
59918132|NCT03086460|76038631|FG000|NOT COMPLETED|Treatment A||4||
59918133|NCT03086460|76038631|FG000|STARTED|Treatment B||35||
60038230|NCT02357147|76153872|FG001|Treated|Maintenance Treatment Phase||29||
60038231|NCT02357147|76153871|FG000|COMPLETED|Maintenance Treatment Phase||0||
60038232|NCT02357147|76153872|FG001|COMPLETED|Maintenance Treatment Phase||0||
60038233|NCT02357147|76153871|FG000|NOT COMPLETED|Maintenance Treatment Phase||26||
60038234|NCT02357147|76153872|FG001|NOT COMPLETED|Maintenance Treatment Phase||29||
60038235|NCT02356211|76153884|FG000|STARTED|Overall Study||57||
60038236|NCT02356211|76153885|FG001|STARTED|Overall Study||52||
60038237|NCT02356211|76153884|FG000|COMPLETED|Overall Study||54||
60038238|NCT02356211|76153885|FG001|COMPLETED|Overall Study||42||
60038239|NCT02356211|76153884|FG000|NOT COMPLETED|Overall Study||3||
60038240|NCT02356211|76153885|FG001|NOT COMPLETED|Overall Study||10||
60038241|NCT02332655|76153891|FG000|STARTED|Overall Study||5||
60038242|NCT02332655|76153891|FG000|COMPLETED|Overall Study||4||
60038243|NCT02332655|76153891|FG000|NOT COMPLETED|Overall Study||1||
60038244|NCT02388737|76153898|FG000|STARTED|Overall Study||235||
60038245|NCT02388737|76153899|FG001|STARTED|Overall Study||226||
60038246|NCT02388737|76153900|FG002|STARTED|Overall Study||242||
60038247|NCT02388737|76153898|FG000|COMPLETED|Overall Study||181||
60038248|NCT02388737|76153899|FG001|COMPLETED|Overall Study||166||
60038249|NCT02388737|76153900|FG002|COMPLETED|Overall Study||180||
60038250|NCT02388737|76153898|FG000|NOT COMPLETED|Overall Study||54||
60038251|NCT02388737|76153899|FG001|NOT COMPLETED|Overall Study||60||
60038252|NCT02388737|76153900|FG002|NOT COMPLETED|Overall Study||62||
60038253|NCT02355743|76153908|FG000|STARTED|Overall Study||8||
60038254|NCT02355743|76153908|FG000|COMPLETED|Overall Study||6||
60038255|NCT02355743|76153908|FG000|NOT COMPLETED|Overall Study||2||
60038256|NCT02388347|76153917|FG000|STARTED|Overall Study||8||
60038257|NCT02388347|76153918|FG001|STARTED|Overall Study||6||
60038258|NCT02388347|76153919|FG002|STARTED|Overall Study||6||
60038259|NCT02388347|76153920|FG003|STARTED|Overall Study||6||
60038260|NCT02388347|76153921|FG004|STARTED|Overall Study||6||
60038261|NCT02388347|76153917|FG000|COMPLETED|Overall Study||8||
60038262|NCT02388347|76153918|FG001|COMPLETED|Overall Study||6||
60038263|NCT02388347|76153919|FG002|COMPLETED|Overall Study||5||
60038264|NCT02388347|76153920|FG003|COMPLETED|Overall Study||6||
60038265|NCT02388347|76153921|FG004|COMPLETED|Overall Study||6||
60038266|NCT02388347|76153917|FG000|NOT COMPLETED|Overall Study||0||
60038267|NCT02388347|76153918|FG001|NOT COMPLETED|Overall Study||0||
60038268|NCT02388347|76153919|FG002|NOT COMPLETED|Overall Study||1||
60038269|NCT02388347|76153920|FG003|NOT COMPLETED|Overall Study||0||
60038270|NCT02388347|76153921|FG004|NOT COMPLETED|Overall Study||0||
60038271|NCT02355665|76153939|FG000|STARTED|Overall Study||601||
60038272|NCT02355665|76153940|FG001|STARTED|Overall Study||597||
60038273|NCT02355665|76153939|FG000|COMPLETED|Overall Study||352||
60038274|NCT02355665|76153940|FG001|COMPLETED|Overall Study||365||
60038275|NCT02355665|76153939|FG000|NOT COMPLETED|Overall Study||249||
60038276|NCT02355665|76153940|FG001|NOT COMPLETED|Overall Study||232||
60038277|NCT02010255|76153960|FG000|STARTED|Overall Study||28||
60038278|NCT02010255|76153961|FG001|STARTED|Overall Study||28||
60038279|NCT02010255|76153962|FG002|STARTED|Overall Study||25||
60038280|NCT02010255|76153963|FG003|STARTED|Overall Study||26||
60038281|NCT02010255|76153964|FG004|STARTED|Overall Study||52||
60038282|NCT02010255|76153965|FG005|STARTED|Overall Study||49||
60038283|NCT02010255|76153966|FG006|STARTED|Overall Study||34||
60038284|NCT02010255|76153967|FG007|STARTED|Overall Study||33||
60038285|NCT02010255|76153968|FG008|STARTED|Overall Study||22||
60038286|NCT02010255|76153969|FG009|STARTED|Overall Study||23||
60038287|NCT02010255|76153970|FG010|STARTED|Overall Study||3||
60038288|NCT02010255|76153971|FG011|STARTED|Overall Study||5||
60038289|NCT02010255|76153972|FG012|STARTED|Overall Study||3||
60038290|NCT02010255|76153973|FG013|STARTED|Overall Study||3||
60038291|NCT02010255|76153960|FG000|COMPLETED|Overall Study||22||
60038292|NCT02010255|76153961|FG001|COMPLETED|Overall Study||26||
60038293|NCT02010255|76153962|FG002|COMPLETED|Overall Study||18||
60038294|NCT02010255|76153963|FG003|COMPLETED|Overall Study||20||
60038295|NCT02010255|76153964|FG004|COMPLETED|Overall Study||48||
60038296|NCT02010255|76153965|FG005|COMPLETED|Overall Study||49||
60038297|NCT02010255|76153966|FG006|COMPLETED|Overall Study||33||
60038298|NCT02010255|76153967|FG007|COMPLETED|Overall Study||32||
60038299|NCT02010255|76153968|FG008|COMPLETED|Overall Study||21||
60038300|NCT02010255|76153969|FG009|COMPLETED|Overall Study||23||
60038301|NCT02010255|76153970|FG010|COMPLETED|Overall Study||1||
60038302|NCT02010255|76153971|FG011|COMPLETED|Overall Study||4||
60038303|NCT02010255|76153972|FG012|COMPLETED|Overall Study||3||
60038304|NCT02010255|76153973|FG013|COMPLETED|Overall Study||2||
60038305|NCT02010255|76153960|FG000|NOT COMPLETED|Overall Study||6||
60038306|NCT02010255|76153961|FG001|NOT COMPLETED|Overall Study||2||
60038307|NCT02010255|76153962|FG002|NOT COMPLETED|Overall Study||7||
59509702|NCT02629354|75603076|FG000|COMPLETED|Period 1||18||
59509703|NCT02629354|75603077|FG001|COMPLETED|Period 1||18||
59509704|NCT02629354|75603076|FG000|NOT COMPLETED|Period 1||0||
59509705|NCT02629354|75603077|FG001|NOT COMPLETED|Period 1||0||
59509706|NCT02629354|75603076|FG000|STARTED|Washout Period||18||
59509707|NCT02629354|75603077|FG001|STARTED|Washout Period||18||
59509708|NCT02629354|75603076|FG000|COMPLETED|Washout Period||18||
60038308|NCT02010255|76153963|FG003|NOT COMPLETED|Overall Study||6||
60038309|NCT02010255|76153964|FG004|NOT COMPLETED|Overall Study||4||
60038310|NCT02010255|76153965|FG005|NOT COMPLETED|Overall Study||0||
60038311|NCT02010255|76153966|FG006|NOT COMPLETED|Overall Study||1||
60038312|NCT02010255|76153967|FG007|NOT COMPLETED|Overall Study||1||
60038313|NCT02010255|76153968|FG008|NOT COMPLETED|Overall Study||1||
60038314|NCT02010255|76153969|FG009|NOT COMPLETED|Overall Study||0||
60038315|NCT02010255|76153970|FG010|NOT COMPLETED|Overall Study||2||
60038316|NCT02010255|76153971|FG011|NOT COMPLETED|Overall Study||1||
59509709|NCT02629354|75603077|FG001|COMPLETED|Washout Period||18||
59509710|NCT02629354|75603076|FG000|NOT COMPLETED|Washout Period||0||
59509711|NCT02629354|75603077|FG001|NOT COMPLETED|Washout Period||0||
59509712|NCT02629354|75603076|FG000|STARTED|Period 2||18||
59509713|NCT02629354|75603077|FG001|STARTED|Period 2||18||
59509714|NCT02629354|75603076|FG000|COMPLETED|Period 2||18||
60038317|NCT02010255|76153972|FG012|NOT COMPLETED|Overall Study||0||
60038318|NCT02010255|76153973|FG013|NOT COMPLETED|Overall Study||1||
60038319|NCT02354417|76154028|FG000|STARTED|Overall Study||3||
60038320|NCT02354417|76154028|FG000|COMPLETED|Overall Study||2||
60038321|NCT02354417|76154028|FG000|NOT COMPLETED|Overall Study||1||
60038322|NCT02332187|76154034|FG000|STARTED|Overall Study||5||
60038323|NCT02332187|76154035|FG001|STARTED|Overall Study||10||
60038324|NCT02332187|76154034|FG000|COMPLETED|Overall Study||3||
60038325|NCT02332187|76154035|FG001|COMPLETED|Overall Study||7||
59509715|NCT02629354|75603077|FG001|COMPLETED|Period 2||18||
59509716|NCT02629354|75603076|FG000|NOT COMPLETED|Period 2||0||
60038326|NCT02332187|76154034|FG000|NOT COMPLETED|Overall Study||2||
60038327|NCT02332187|76154035|FG001|NOT COMPLETED|Overall Study||3||
60038328|NCT02330549|76154043|FG000|STARTED|Overall Study||20||
59509717|NCT02629354|75603077|FG001|NOT COMPLETED|Period 2||0||
59509718|NCT02629354|75603076|FG000|STARTED|Follow-up||18||
59509719|NCT02629354|75603077|FG001|STARTED|Follow-up||18||
60038329|NCT02330549|76154044|FG001|STARTED|Overall Study||25||
60038330|NCT02330549|76154043|FG000|COMPLETED|Overall Study||16||
60038331|NCT02330549|76154044|FG001|COMPLETED|Overall Study||24||
60038332|NCT02330549|76154043|FG000|NOT COMPLETED|Overall Study||4||
60038333|NCT02330549|76154044|FG001|NOT COMPLETED|Overall Study||1||
60038334|NCT02009865|76154052|FG000|STARTED|Overall Study||81||
60038335|NCT02009865|76154053|FG001|STARTED|Overall Study||81||
60038336|NCT02009865|76154052|FG000|COMPLETED|Overall Study||80||
60038337|NCT02009865|76154053|FG001|COMPLETED|Overall Study||76||
60038338|NCT02009865|76154052|FG000|NOT COMPLETED|Overall Study||1||
60038339|NCT02009865|76154053|FG001|NOT COMPLETED|Overall Study||5||
60038340|NCT01620177|76154059|FG000|STARTED|Overall Study||98||
60038341|NCT01620177|76154059|FG000|COMPLETED|Overall Study||19||
60038342|NCT01620177|76154059|FG000|NOT COMPLETED|Overall Study||79||
60038343|NCT02075541|76154078|FG000|STARTED|Overall Study||73||
60038344|NCT02075541|76154079|FG001|STARTED|Overall Study||72||
60038345|NCT02075541|76154078|FG000|COMPLETED|Overall Study||69||
60038346|NCT02075541|76154079|FG001|COMPLETED|Overall Study||64||
60038347|NCT02075541|76154078|FG000|NOT COMPLETED|Overall Study||4||
60038348|NCT02075541|76154079|FG001|NOT COMPLETED|Overall Study||8||
60038349|NCT02330081|76154085|FG000|STARTED|Overall Study||22||
60038350|NCT02330081|76154085|FG000|COMPLETED|Overall Study||14||
60038351|NCT02330081|76154085|FG000|NOT COMPLETED|Overall Study||8||
60038352|NCT01986855|76154095|FG000|STARTED|Overall Study||158||
60038353|NCT01986855|76154096|FG001|STARTED|Overall Study||156||
60038354|NCT01986855|76154097|FG002|STARTED|Overall Study||154||
59509720|NCT02629354|75603076|FG000|COMPLETED|Follow-up||18||
59509721|NCT02629354|75603077|FG001|COMPLETED|Follow-up||18||
59509722|NCT02629354|75603076|FG000|NOT COMPLETED|Follow-up||0||
59509723|NCT02629354|75603077|FG001|NOT COMPLETED|Follow-up||0||
59509724|NCT02834247|75603087|FG000|STARTED|Dose Escalation Phase||8||
59509725|NCT02834247|75603088|FG001|STARTED|Dose Escalation Phase||11||
59509726|NCT02834247|75603089|FG002|STARTED|Dose Escalation Phase||5||
59509727|NCT02834247|75603090|FG003|STARTED|Dose Escalation Phase||0||
59612341|NCT01701258|75723501|FG002|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0|68 out of the 96 eligible participants completed the MRI.|
60038355|NCT01986855|76154095|FG000|Treated|Overall Study||158||
60038356|NCT01986855|76154096|FG001|Treated|Overall Study||155||
60038357|NCT01986855|76154097|FG002|Treated|Overall Study||154||
60038358|NCT01986855|76154095|FG000|COMPLETED|Overall Study||145||
60038359|NCT01986855|76154096|FG001|COMPLETED|Overall Study||142||
60038360|NCT01986855|76154097|FG002|COMPLETED|Overall Study||143||
60038361|NCT01986855|76154095|FG000|NOT COMPLETED|Overall Study||13||
60038362|NCT01986855|76154096|FG001|NOT COMPLETED|Overall Study||14||
60038363|NCT01986855|76154097|FG002|NOT COMPLETED|Overall Study||11||
60038364|NCT02075463|76154105|FG000|STARTED|Overall Study||15||
60038365|NCT02075463|76154105|FG000|COMPLETED|Overall Study||7||
60038366|NCT02075463|76154105|FG000|NOT COMPLETED|Overall Study||8||
60038367|NCT02353871|76154112|FG000|STARTED|Overall Study|Randomised.|125||
60038368|NCT02353871|76154113|FG001|STARTED|Overall Study|Randomised. Included a subject who was randomised by mistake (excluded from mITT population).|60||
60038369|NCT02353871|76154112|FG000|COMPLETED|Overall Study||122||
60038370|NCT02353871|76154113|FG001|COMPLETED|Overall Study||51||
60038371|NCT02353871|76154112|FG000|NOT COMPLETED|Overall Study||3||
60038372|NCT02353871|76154113|FG001|NOT COMPLETED|Overall Study||9||
60038373|NCT02009397|76154119|FG000|STARTED|Overall Study||26||
60038374|NCT02009397|76154119|FG000|COMPLETED|Overall Study||6||
60038375|NCT02009397|76154119|FG000|NOT COMPLETED|Overall Study||20||
60038376|NCT02312219|76154125|FG000|STARTED|Overall Study||13||
60038377|NCT02312219|76154126|FG001|STARTED|Overall Study||22||
60038378|NCT02312219|76154125|FG000|COMPLETED|Overall Study||12||
60038379|NCT02312219|76154126|FG001|COMPLETED|Overall Study||16||
59509728|NCT02834247|75603087|FG000|COMPLETED|Dose Escalation Phase||0||
59509729|NCT02834247|75603088|FG001|COMPLETED|Dose Escalation Phase||0||
59509730|NCT02834247|75603089|FG002|COMPLETED|Dose Escalation Phase||0||
59509731|NCT02834247|75603090|FG003|COMPLETED|Dose Escalation Phase||0||
59612342|NCT01701258|75723502|FG003|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0|68 out of the 96 eligible participants completed the MRI.|
59613515|NCT01592292|75724649|FG002|Intention to Treat (ITT) Set|Overall Study||10||
60038380|NCT02312219|76154125|FG000|NOT COMPLETED|Overall Study||1||
60038381|NCT02312219|76154126|FG001|NOT COMPLETED|Overall Study||6||
60038382|NCT01986231|76154132|FG000|STARTED|Overall Study||12||
60038383|NCT01986231|76154132|FG000|COMPLETED|Overall Study||11||
60038384|NCT01986231|76154132|FG000|NOT COMPLETED|Overall Study||1||
60038385|NCT02312063|76154138|FG000|STARTED|Overall Study||23||
60038386|NCT02312063|76154139|FG001|STARTED|Overall Study||25||
60038387|NCT02312063|76154138|FG000|COMPLETED|Overall Study||23||
60038388|NCT02312063|76154139|FG001|COMPLETED|Overall Study||24||
60038389|NCT02312063|76154138|FG000|NOT COMPLETED|Overall Study||0||
60038390|NCT02312063|76154139|FG001|NOT COMPLETED|Overall Study||1||
60038391|NCT02353169|76154150|FG000|STARTED|Overall Study||15||
60038392|NCT02353169|76154151|FG001|STARTED|Overall Study||18||
59759554|NCT02631941|75878930|FG008|COMPLETED|Overall Study||9||
60038393|NCT02353169|76154152|FG002|STARTED|Overall Study||16||
60038394|NCT02353169|76154153|FG003|STARTED|Overall Study||15||
60038395|NCT02353169|76154150|FG000|COMPLETED|Overall Study||12||
60038396|NCT02353169|76154151|FG001|COMPLETED|Overall Study||12||
60038397|NCT02353169|76154152|FG002|COMPLETED|Overall Study||12||
60038398|NCT02353169|76154153|FG003|COMPLETED|Overall Study||12||
60038399|NCT02353169|76154150|FG000|NOT COMPLETED|Overall Study||3||
60038400|NCT02353169|76154151|FG001|NOT COMPLETED|Overall Study||6||
60038401|NCT02353169|76154152|FG002|NOT COMPLETED|Overall Study||4||
60038402|NCT02353169|76154153|FG003|NOT COMPLETED|Overall Study||3||
60038403|NCT02009163|76154163|FG000|STARTED|Open-label Period (Non-randomized)||418||
60038404|NCT02009163|76154164|FG001|STARTED|Open-label Period (Non-randomized)||0||
60038405|NCT02009163|76154165|FG002|STARTED|Open-label Period (Non-randomized)||0||
60038406|NCT02009163|76154163|FG000|COMPLETED|Open-label Period (Non-randomized)||275||
60038407|NCT02009163|76154164|FG001|COMPLETED|Open-label Period (Non-randomized)||0||
60038408|NCT02009163|76154165|FG002|COMPLETED|Open-label Period (Non-randomized)||0||
60038409|NCT02009163|76154163|FG000|NOT COMPLETED|Open-label Period (Non-randomized)||143||
60038410|NCT02009163|76154164|FG001|NOT COMPLETED|Open-label Period (Non-randomized)||0||
60038411|NCT02009163|76154165|FG002|NOT COMPLETED|Open-label Period (Non-randomized)||0||
60038412|NCT02009163|76154163|FG000|STARTED|Randomized-withdrawal Period|The open-label treatment group is not an arm of the randomized-withdrawal period.|0||
60038413|NCT02009163|76154164|FG001|STARTED|Randomized-withdrawal Period|The total who started the Placebo and SPD489 arms equals those who completed the open-label period.|138||
60038414|NCT02009163|76154165|FG002|STARTED|Randomized-withdrawal Period|The total who started the Placebo and SPD489 arms equals those who completed the open-label period.|137||
60038415|NCT02009163|76154163|FG000|COMPLETED|Randomized-withdrawal Period||0||
60038416|NCT02009163|76154164|FG001|COMPLETED|Randomized-withdrawal Period||50||
60038417|NCT02009163|76154165|FG002|COMPLETED|Randomized-withdrawal Period||102||
60038418|NCT02009163|76154163|FG000|NOT COMPLETED|Randomized-withdrawal Period||0||
60038419|NCT02009163|76154164|FG001|NOT COMPLETED|Randomized-withdrawal Period||88||
60038420|NCT02009163|76154165|FG002|NOT COMPLETED|Randomized-withdrawal Period||35||
60038421|NCT01983969|76154178|FG000|STARTED|Overall Study||37||
60038422|NCT01983969|76154179|FG001|STARTED|Overall Study||19||
60038423|NCT01983969|76154180|FG002|STARTED|Overall Study||5||
60038424|NCT01983969|76154178|FG000|COMPLETED|Overall Study||37||
60038425|NCT01983969|76154179|FG001|COMPLETED|Overall Study||18||
60038426|NCT01983969|76154180|FG002|COMPLETED|Overall Study||5||
60038427|NCT01983969|76154178|FG000|NOT COMPLETED|Overall Study||0||
60038428|NCT01983969|76154179|FG001|NOT COMPLETED|Overall Study||1||
60038429|NCT01983969|76154180|FG002|NOT COMPLETED|Overall Study||0||
60038430|NCT02008773|76154196|FG000|STARTED|Overall Study||40||
60038431|NCT02008773|76154197|FG001|STARTED|Overall Study||34||
60038432|NCT02008773|76154198|FG002|STARTED|Overall Study||46||
60038433|NCT02008773|76154199|FG003|STARTED|Overall Study||50||
60038434|NCT02008773|76154196|FG000|COMPLETED|Overall Study||27||
60038435|NCT02008773|76154197|FG001|COMPLETED|Overall Study||25||
60038436|NCT02008773|76154198|FG002|COMPLETED|Overall Study||32||
60038437|NCT02008773|76154199|FG003|COMPLETED|Overall Study||38||
60038438|NCT02008773|76154196|FG000|NOT COMPLETED|Overall Study||13||
60038439|NCT02008773|76154197|FG001|NOT COMPLETED|Overall Study||9||
60038440|NCT02008773|76154198|FG002|NOT COMPLETED|Overall Study||14||
60038441|NCT02008773|76154199|FG003|NOT COMPLETED|Overall Study||12||
59612343|NCT01701258|75723503|FG004|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0|68 out of the 96 eligible participants completed the MRI.|
59612344|NCT01701258|75723504|FG005|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0|68 out of the 96 eligible participants completed the MRI.|
59612345|NCT01701258|75723505|FG006|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0|68 out of the 96 eligible participants completed the MRI.|
59612346|NCT01701258|75723506|FG007|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0|68 out of the 96 eligible participants completed the MRI.|
59612347|NCT01701258|75723507|FG008|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0|68 out of the 96 eligible participants completed the MRI.|
59759555|NCT02631941|75878931|FG009|COMPLETED|Overall Study||9||
59759556|NCT02631941|75878922|FG000|NOT COMPLETED|Overall Study||0||
60038442|NCT02257567|76154218|FG000|STARTED|Overall Study||6||
60038443|NCT02257567|76154219|FG001|STARTED|Overall Study||6||
60038444|NCT02257567|76154220|FG002|STARTED|Overall Study||6||
60038445|NCT02257567|76154221|FG003|STARTED|Overall Study||6||
60038446|NCT02257567|76154222|FG004|STARTED|Overall Study||39||
60038447|NCT02257567|76154223|FG005|STARTED|Overall Study||41||
60038448|NCT02257567|76154224|FG006|STARTED|Overall Study||40||
60038449|NCT02257567|76154225|FG007|STARTED|Overall Study||40||
60038450|NCT02257567|76154226|FG008|STARTED|Overall Study||20||
60038451|NCT02257567|76154227|FG009|STARTED|Overall Study||21||
60038452|NCT02257567|76154228|FG010|STARTED|Overall Study||106||
60038453|NCT02257567|76154218|FG000|Safety Population|Overall Study||6|Safety population was defined as all participants who have received at least one dose of study medication.|
60038454|NCT02257567|76154219|FG001|Safety Population|Overall Study||6|Safety population was defined as all participants who have received at least one dose of study medication.|
60038455|NCT02257567|76154220|FG002|Safety Population|Overall Study||6|Safety population was defined as all participants who have received at least one dose of study medication.|
60038456|NCT02257567|76154221|FG003|Safety Population|Overall Study||6|Safety population was defined as all participants who have received at least one dose of study medication.|
60038457|NCT02257567|76154222|FG004|Safety Population|Overall Study||38|Safety population was defined as all participants who have received at least one dose of study medication.|
60038458|NCT02257567|76154223|FG005|Safety Population|Overall Study||41|Safety population was defined as all participants who have received at least one dose of study medication.|
60038459|NCT02257567|76154224|FG006|Safety Population|Overall Study||39|Safety population was defined as all participants who have received at least one dose of study medication.|
60038460|NCT02257567|76154225|FG007|Safety Population|Overall Study||39|Safety population was defined as all participants who have received at least one dose of study medication.|
60038461|NCT02257567|76154226|FG008|Safety Population|Overall Study||20|Safety population was defined as all participants who have received at least one dose of study medication.|
60038462|NCT02257567|76154227|FG009|Safety Population|Overall Study||20|Safety population was defined as all participants who have received at least one dose of study medication.|
60038463|NCT02257567|76154228|FG010|Safety Population|Overall Study||106|Safety population was defined as all participants who have received at least one dose of study medication.|
60038464|NCT02257567|76154218|FG000|COMPLETED|Overall Study||4||
60038465|NCT02257567|76154219|FG001|COMPLETED|Overall Study||4||
60038466|NCT02257567|76154220|FG002|COMPLETED|Overall Study||2||
60038467|NCT02257567|76154221|FG003|COMPLETED|Overall Study||1||
60038468|NCT02257567|76154222|FG004|COMPLETED|Overall Study||20||
60038469|NCT02257567|76154223|FG005|COMPLETED|Overall Study||22||
60038470|NCT02257567|76154224|FG006|COMPLETED|Overall Study||6||
60038471|NCT02257567|76154225|FG007|COMPLETED|Overall Study||2||
60038472|NCT02257567|76154226|FG008|COMPLETED|Overall Study||16||
60038473|NCT02257567|76154227|FG009|COMPLETED|Overall Study||0||
60038474|NCT02257567|76154228|FG010|COMPLETED|Overall Study||30||
60038475|NCT02257567|76154218|FG000|NOT COMPLETED|Overall Study||2||
60038476|NCT02257567|76154219|FG001|NOT COMPLETED|Overall Study||2||
60038477|NCT02257567|76154220|FG002|NOT COMPLETED|Overall Study||4||
60038478|NCT02257567|76154221|FG003|NOT COMPLETED|Overall Study||5||
60038479|NCT02257567|76154222|FG004|NOT COMPLETED|Overall Study||19||
60038480|NCT02257567|76154223|FG005|NOT COMPLETED|Overall Study||19||
60038481|NCT02257567|76154224|FG006|NOT COMPLETED|Overall Study||34||
60038482|NCT02257567|76154225|FG007|NOT COMPLETED|Overall Study||38||
60038483|NCT02257567|76154226|FG008|NOT COMPLETED|Overall Study||4||
60038484|NCT02257567|76154227|FG009|NOT COMPLETED|Overall Study||21||
60038485|NCT02257567|76154228|FG010|NOT COMPLETED|Overall Study||76||
60038486|NCT01642615|76154285|FG000|STARTED|Open Label Maintenance Phase||63||
60038487|NCT01642615|76154286|FG001|STARTED|Open Label Maintenance Phase||0||
60038488|NCT01642615|76154287|FG002|STARTED|Open Label Maintenance Phase||0||
60038489|NCT01642615|76154285|FG000|Safety Analysis Set|Open Label Maintenance Phase||62||
60038490|NCT01642615|76154286|FG001|Safety Analysis Set|Open Label Maintenance Phase||0||
60038491|NCT01642615|76154287|FG002|Safety Analysis Set|Open Label Maintenance Phase||0||
60038492|NCT01642615|76154285|FG000|COMPLETED|Open Label Maintenance Phase||58||
60038493|NCT01642615|76154286|FG001|COMPLETED|Open Label Maintenance Phase||0||
60038494|NCT01642615|76154287|FG002|COMPLETED|Open Label Maintenance Phase||0||
60038495|NCT01642615|76154285|FG000|NOT COMPLETED|Open Label Maintenance Phase||5||
60038496|NCT01642615|76154286|FG001|NOT COMPLETED|Open Label Maintenance Phase||0||
60038497|NCT01642615|76154287|FG002|NOT COMPLETED|Open Label Maintenance Phase||0||
60038498|NCT01642615|76154285|FG000|STARTED|Double Blind Maintenance Phase||0||
60038499|NCT01642615|76154286|FG001|STARTED|Double Blind Maintenance Phase||25||
60038500|NCT01642615|76154287|FG002|STARTED|Double Blind Maintenance Phase||26||
60038501|NCT01642615|76154285|FG000|COMPLETED|Double Blind Maintenance Phase||0||
60038502|NCT01642615|76154286|FG001|COMPLETED|Double Blind Maintenance Phase||18||
60038503|NCT01642615|76154287|FG002|COMPLETED|Double Blind Maintenance Phase||20||
60038504|NCT01642615|76154285|FG000|NOT COMPLETED|Double Blind Maintenance Phase||0||
60038505|NCT01642615|76154286|FG001|NOT COMPLETED|Double Blind Maintenance Phase||7||
60038506|NCT01642615|76154287|FG002|NOT COMPLETED|Double Blind Maintenance Phase||6||
60038507|NCT02311361|76154299|FG000|STARTED|Overall Study||14||
60038508|NCT02311361|76154300|FG001|STARTED|Overall Study||11||
60038509|NCT02311361|76154301|FG002|STARTED|Overall Study||19||
60038510|NCT02311361|76154302|FG003|STARTED|Overall Study||21||
60038511|NCT02311361|76154299|FG000|Received Radiation Therapy Only|Overall Study||0||
60038512|NCT02311361|76154300|FG001|Received Radiation Therapy Only|Overall Study||1||
60038513|NCT02311361|76154301|FG002|Received Radiation Therapy Only|Overall Study||1||
60038514|NCT02311361|76154302|FG003|Received Radiation Therapy Only|Overall Study||1||
60038515|NCT02311361|76154299|FG000|COMPLETED|Overall Study||14||
60038516|NCT02311361|76154300|FG001|COMPLETED|Overall Study||10||
60038517|NCT02311361|76154301|FG002|COMPLETED|Overall Study||19||
60038518|NCT02311361|76154302|FG003|COMPLETED|Overall Study||20||
60038519|NCT02311361|76154299|FG000|NOT COMPLETED|Overall Study||0||
60038520|NCT02311361|76154300|FG001|NOT COMPLETED|Overall Study||1||
60038521|NCT02311361|76154301|FG002|NOT COMPLETED|Overall Study||0||
60038522|NCT02311361|76154302|FG003|NOT COMPLETED|Overall Study||1||
60038523|NCT02352779|76154319|FG000|STARTED|Overall Study||37||
60038524|NCT02352779|76154320|FG001|STARTED|Overall Study||36||
60038525|NCT02352779|76154321|FG002|STARTED|Overall Study||35||
60038526|NCT02352779|76154319|FG000|COMPLETED|Overall Study||29||
60038527|NCT02352779|76154320|FG001|COMPLETED|Overall Study||35||
60038528|NCT02352779|76154321|FG002|COMPLETED|Overall Study||33||
60038529|NCT02352779|76154319|FG000|NOT COMPLETED|Overall Study||8||
60038530|NCT02352779|76154320|FG001|NOT COMPLETED|Overall Study||1||
60038531|NCT02352779|76154321|FG002|NOT COMPLETED|Overall Study||2||
60038532|NCT02257489|76154338|FG000|STARTED|Overall Study||6||
60038533|NCT02257489|76154339|FG001|STARTED|Overall Study||6||
60038534|NCT02257489|76154340|FG002|STARTED|Overall Study||6||
60038535|NCT02257489|76154341|FG003|STARTED|Overall Study||6||
60038536|NCT02257489|76154342|FG004|STARTED|Overall Study||6||
60038537|NCT02257489|76154343|FG005|STARTED|Overall Study||6||
60038538|NCT02257489|76154344|FG006|STARTED|Overall Study||6||
60038539|NCT02257489|76154345|FG007|STARTED|Overall Study||10||
60038540|NCT02257489|76154346|FG008|STARTED|Overall Study||6||
60038541|NCT02257489|76154338|FG000|COMPLETED|Overall Study||6||
60038542|NCT02257489|76154339|FG001|COMPLETED|Overall Study||6||
60038543|NCT02257489|76154340|FG002|COMPLETED|Overall Study||6||
60038544|NCT02257489|76154341|FG003|COMPLETED|Overall Study||5||
60038545|NCT02257489|76154342|FG004|COMPLETED|Overall Study||6||
60038546|NCT02257489|76154343|FG005|COMPLETED|Overall Study||6||
60038547|NCT02257489|76154344|FG006|COMPLETED|Overall Study||6||
60038548|NCT02257489|76154345|FG007|COMPLETED|Overall Study||10||
60038549|NCT02257489|76154346|FG008|COMPLETED|Overall Study||6||
60038550|NCT02257489|76154338|FG000|NOT COMPLETED|Overall Study||0||
59509732|NCT02834247|75603087|FG000|NOT COMPLETED|Dose Escalation Phase||8||
59509733|NCT02834247|75603088|FG001|NOT COMPLETED|Dose Escalation Phase||11||
59509734|NCT02834247|75603089|FG002|NOT COMPLETED|Dose Escalation Phase||5||
59509735|NCT02834247|75603090|FG003|NOT COMPLETED|Dose Escalation Phase||0||
59509736|NCT02834247|75603087|FG000|STARTED|Dose Expansion Phase||0||
60038551|NCT02257489|76154339|FG001|NOT COMPLETED|Overall Study||0||
60038552|NCT02257489|76154340|FG002|NOT COMPLETED|Overall Study||0||
60038553|NCT02257489|76154341|FG003|NOT COMPLETED|Overall Study||1||
60038554|NCT02257489|76154342|FG004|NOT COMPLETED|Overall Study||0||
60038555|NCT02257489|76154343|FG005|NOT COMPLETED|Overall Study||0||
60038556|NCT02257489|76154344|FG006|NOT COMPLETED|Overall Study||0||
60038557|NCT02257489|76154345|FG007|NOT COMPLETED|Overall Study||0||
60038558|NCT02257489|76154346|FG008|NOT COMPLETED|Overall Study||0||
60038559|NCT02329223|76154369|FG000|STARTED|Overall Study||73||
60038560|NCT02329223|76154370|FG001|STARTED|Overall Study||71||
60038561|NCT02329223|76154371|FG002|STARTED|Overall Study||74||
59509737|NCT02834247|75603088|FG001|STARTED|Dose Expansion Phase||0||
59509738|NCT02834247|75603089|FG002|STARTED|Dose Expansion Phase||0||
59509739|NCT02834247|75603090|FG003|STARTED|Dose Expansion Phase||17||
59509740|NCT02834247|75603087|FG000|COMPLETED|Dose Expansion Phase||0||
60038562|NCT02329223|76154369|FG000|Full Analysis Set|Overall Study||73||
60038563|NCT02329223|76154370|FG001|Full Analysis Set|Overall Study||70||
60038564|NCT02329223|76154371|FG002|Full Analysis Set|Overall Study||74||
60038565|NCT02329223|76154369|FG000|Safety Set|Overall Study||73||
60038566|NCT02329223|76154370|FG001|Safety Set|Overall Study||71||
60038567|NCT02329223|76154371|FG002|Safety Set|Overall Study||74||
60038568|NCT02329223|76154369|FG000|COMPLETED|Overall Study||72||
60038569|NCT02329223|76154370|FG001|COMPLETED|Overall Study||68||
60038570|NCT02329223|76154371|FG002|COMPLETED|Overall Study||68||
60038571|NCT02329223|76154369|FG000|NOT COMPLETED|Overall Study||1||
60038572|NCT02329223|76154370|FG001|NOT COMPLETED|Overall Study||3||
60038573|NCT02329223|76154371|FG002|NOT COMPLETED|Overall Study||6||
60038574|NCT01641601|76154381|FG000|STARTED|Overall Study||3||
59509741|NCT02834247|75603088|FG001|COMPLETED|Dose Expansion Phase||0||
59509742|NCT02834247|75603089|FG002|COMPLETED|Dose Expansion Phase||0||
60038575|NCT01641601|76154382|FG001|STARTED|Overall Study||5||
60038576|NCT01641601|76154381|FG000|COMPLETED|Overall Study|Study discontinued prior to data collection.|0||
60038577|NCT01641601|76154382|FG001|COMPLETED|Overall Study|Study discontinued prior to data collection.|0||
60038578|NCT01641601|76154381|FG000|NOT COMPLETED|Overall Study||3||
60038579|NCT01641601|76154382|FG001|NOT COMPLETED|Overall Study||5||
60038580|NCT02350127|76154390|FG000|STARTED|4-Month Assessment||44||
60038581|NCT02350127|76154391|FG001|STARTED|4-Month Assessment||44||
60038582|NCT02350127|76154390|FG000|Completed Baseline|4-Month Assessment|Withdrew prior to baseline due to time constraints (n=1) and lack of interest (n=1)|42||
60038583|NCT02350127|76154391|FG001|Completed Baseline|4-Month Assessment|Withdrew prior to baseline due to health issue (n=1)|43||
60038584|NCT02350127|76154390|FG000|COMPLETED|4-Month Assessment||33||
60038585|NCT02350127|76154391|FG001|COMPLETED|4-Month Assessment||35||
60038586|NCT02350127|76154390|FG000|NOT COMPLETED|4-Month Assessment||11||
60038587|NCT02350127|76154391|FG001|NOT COMPLETED|4-Month Assessment||9||
60038588|NCT02350127|76154390|FG000|STARTED|8-Month Assessment||33||
60038589|NCT02350127|76154391|FG001|STARTED|8-Month Assessment||35||
60038590|NCT02350127|76154390|FG000|COMPLETED|8-Month Assessment||27||
60038591|NCT02350127|76154391|FG001|COMPLETED|8-Month Assessment||26||
60038592|NCT02350127|76154390|FG000|NOT COMPLETED|8-Month Assessment||6||
60038593|NCT02350127|76154391|FG001|NOT COMPLETED|8-Month Assessment||9||
60038594|NCT02256553|76154398|FG000|STARTED|Period I||102||
60038595|NCT02256553|76154398|FG000|COMPLETED|Period I||96||
60038596|NCT02256553|76154398|FG000|NOT COMPLETED|Period I||6||
60038597|NCT02256553|76154398|FG000|STARTED|Period II||96||
60038598|NCT02256553|76154398|FG000|COMPLETED|Period II||94||
60038599|NCT02256553|76154398|FG000|NOT COMPLETED|Period II||2||
60038600|NCT02256553|76154398|FG000|STARTED|Period III||94||
60038601|NCT02256553|76154398|FG000|COMPLETED|Period III||91||
60038602|NCT02256553|76154398|FG000|NOT COMPLETED|Period III||3||
60038603|NCT02349425|76154408|FG000|STARTED|Period 1||15||
60038604|NCT02349425|76154409|FG001|STARTED|Period 1||14||
60038605|NCT02349425|76154410|FG002|STARTED|Period 1||15||
60038606|NCT02349425|76154411|FG003|STARTED|Period 1||15||
60038607|NCT02349425|76154408|FG000|COMPLETED|Period 1||14||
60038608|NCT02349425|76154409|FG001|COMPLETED|Period 1||13||
60038609|NCT02349425|76154410|FG002|COMPLETED|Period 1||15||
60038610|NCT02349425|76154411|FG003|COMPLETED|Period 1||15||
60038611|NCT02349425|76154408|FG000|NOT COMPLETED|Period 1||1||
60038612|NCT02349425|76154409|FG001|NOT COMPLETED|Period 1||1||
60038613|NCT02349425|76154410|FG002|NOT COMPLETED|Period 1||0||
60038614|NCT02349425|76154411|FG003|NOT COMPLETED|Period 1||0||
60038615|NCT02349425|76154408|FG000|STARTED|Period 2||14||
60038616|NCT02349425|76154409|FG001|STARTED|Period 2||13||
60038617|NCT02349425|76154410|FG002|STARTED|Period 2||15||
60038618|NCT02349425|76154411|FG003|STARTED|Period 2||15||
60038619|NCT02349425|76154408|FG000|COMPLETED|Period 2||14||
60038620|NCT02349425|76154409|FG001|COMPLETED|Period 2||12||
60038621|NCT02349425|76154410|FG002|COMPLETED|Period 2||14||
60038622|NCT02349425|76154411|FG003|COMPLETED|Period 2||15||
60038623|NCT02349425|76154408|FG000|NOT COMPLETED|Period 2||0||
60038624|NCT02349425|76154409|FG001|NOT COMPLETED|Period 2||1||
60038625|NCT02349425|76154410|FG002|NOT COMPLETED|Period 2||1||
60038626|NCT02349425|76154411|FG003|NOT COMPLETED|Period 2||0||
60038627|NCT02310581|76154453|FG000|STARTED|Overall Study||9||
60038628|NCT02310581|76154454|FG001|STARTED|Overall Study||11||
60038629|NCT02310581|76154455|FG002|STARTED|Overall Study||10||
60038630|NCT02310581|76154456|FG003|STARTED|Overall Study||10||
60038631|NCT02310581|76154453|FG000|COMPLETED|Overall Study||6||
60038632|NCT02310581|76154454|FG001|COMPLETED|Overall Study||9||
59509743|NCT02834247|75603090|FG003|COMPLETED|Dose Expansion Phase||0||
59509744|NCT02834247|75603087|FG000|NOT COMPLETED|Dose Expansion Phase||0||
59509745|NCT02834247|75603088|FG001|NOT COMPLETED|Dose Expansion Phase||0||
59509746|NCT02834247|75603089|FG002|NOT COMPLETED|Dose Expansion Phase||0||
60038633|NCT02310581|76154455|FG002|COMPLETED|Overall Study||9||
60038634|NCT02310581|76154456|FG003|COMPLETED|Overall Study||9||
60038635|NCT02310581|76154453|FG000|NOT COMPLETED|Overall Study||3||
60038636|NCT02310581|76154454|FG001|NOT COMPLETED|Overall Study||2||
60038637|NCT02310581|76154455|FG002|NOT COMPLETED|Overall Study||1||
60038638|NCT02310581|76154456|FG003|NOT COMPLETED|Overall Study||1||
60038639|NCT02309723|76154469|FG000|STARTED|Overall Study||129||
60038640|NCT02309723|76154470|FG001|STARTED|Overall Study||128||
60038641|NCT02309723|76154471|FG002|STARTED|Overall Study||129||
60038642|NCT02309723|76154469|FG000|COMPLETED|Overall Study||105||
60038643|NCT02309723|76154470|FG001|COMPLETED|Overall Study||105||
60038644|NCT02309723|76154471|FG002|COMPLETED|Overall Study||105||
60038645|NCT02309723|76154469|FG000|NOT COMPLETED|Overall Study||24||
60038646|NCT02309723|76154470|FG001|NOT COMPLETED|Overall Study||23||
59509747|NCT02834247|75603090|FG003|NOT COMPLETED|Dose Expansion Phase||17||
60038647|NCT02309723|76154471|FG002|NOT COMPLETED|Overall Study||24||
60038648|NCT02309411|76154482|FG000|STARTED|Overall Study||25||
60038649|NCT02309411|76154483|FG001|STARTED|Overall Study||15||
60038650|NCT02309411|76154484|FG002|STARTED|Overall Study||6||
60038651|NCT02309411|76154482|FG000|COMPLETED|Overall Study||23||
60038652|NCT02309411|76154483|FG001|COMPLETED|Overall Study||14||
60038653|NCT02309411|76154484|FG002|COMPLETED|Overall Study||6||
60038654|NCT02309411|76154482|FG000|NOT COMPLETED|Overall Study||2||
60038655|NCT02309411|76154483|FG001|NOT COMPLETED|Overall Study||1||
60038656|NCT02309411|76154484|FG002|NOT COMPLETED|Overall Study||0||
60038657|NCT02008227|76154493|FG000|STARTED|Overall Study||612||
60038658|NCT02008227|76154494|FG001|STARTED|Overall Study||613||
60038659|NCT02008227|76154493|FG000|Treated|Overall Study||579||
60038660|NCT02008227|76154494|FG001|Treated|Overall Study||608||
60038661|NCT02008227|76154493|FG000|COMPLETED|Overall Study||0||
60038662|NCT02008227|76154494|FG001|COMPLETED|Overall Study||0||
60038663|NCT02008227|76154493|FG000|NOT COMPLETED|Overall Study||612||
60038664|NCT02008227|76154494|FG001|NOT COMPLETED|Overall Study||613||
60038665|NCT02006979|76154503|FG000|STARTED|Overall Study||14||
60038666|NCT02006979|76154504|FG001|STARTED|Overall Study||13||
60038667|NCT02006979|76154503|FG000|COMPLETED|Overall Study||13||
60038668|NCT02006979|76154504|FG001|COMPLETED|Overall Study||11||
60038669|NCT02006979|76154503|FG000|NOT COMPLETED|Overall Study||1||
60038670|NCT02006979|76154504|FG001|NOT COMPLETED|Overall Study||2||
60038671|NCT02348723|76154512|FG000|STARTED|Overall Study||338||
60038672|NCT02348723|76154513|FG001|STARTED|Overall Study||338||
60038673|NCT02348723|76154512|FG000|COMPLETED|Overall Study||310||
60038674|NCT02348723|76154513|FG001|COMPLETED|Overall Study||312||
60038675|NCT02348723|76154512|FG000|NOT COMPLETED|Overall Study||28||
60038676|NCT02348723|76154513|FG001|NOT COMPLETED|Overall Study||26||
60038677|NCT01967277|76154521|FG000|STARTED|Overall Study||22||
60038678|NCT01967277|76154522|FG001|STARTED|Overall Study||22||
60038679|NCT01967277|76154521|FG000|COMPLETED|Overall Study||21||
60038680|NCT01967277|76154522|FG001|COMPLETED|Overall Study||19||
60038681|NCT01967277|76154521|FG000|NOT COMPLETED|Overall Study||1||
60038682|NCT01967277|76154522|FG001|NOT COMPLETED|Overall Study||3||
60038683|NCT02326883|76154531|FG000|STARTED|Overall Study||6314||
60038684|NCT02326883|76154532|FG001|STARTED|Overall Study||6312||
60038685|NCT02326883|76154533|FG002|STARTED|Overall Study||6256||
60038686|NCT02326883|76154531|FG000|COMPLETED|Overall Study||6230||
60038687|NCT02326883|76154532|FG001|COMPLETED|Overall Study||6227||
60038688|NCT02326883|76154533|FG002|COMPLETED|Overall Study||6187||
60038689|NCT02326883|76154531|FG000|NOT COMPLETED|Overall Study||84||
60038690|NCT02326883|76154532|FG001|NOT COMPLETED|Overall Study||85||
60038691|NCT02326883|76154533|FG002|NOT COMPLETED|Overall Study||69||
60038692|NCT02006667|76154541|FG000|STARTED|Overall Study||13||
60038693|NCT02006667|76154541|FG000|COMPLETED|Overall Study||7||
60038694|NCT02006667|76154541|FG000|NOT COMPLETED|Overall Study||6||
60038695|NCT01983111|76154547|FG000|STARTED|Overall Study||70||
60038696|NCT01983111|76154548|FG001|STARTED|Overall Study||66||
59509748|NCT00859027|75603104|FG000|STARTED|Overall Study||25||
59509749|NCT00859027|75603105|FG001|STARTED|Overall Study||25||
59509750|NCT00859027|75603104|FG000|COMPLETED|Overall Study||20||
59509751|NCT00859027|75603105|FG001|COMPLETED|Overall Study||20||
59509752|NCT00859027|75603104|FG000|NOT COMPLETED|Overall Study||5||
59509753|NCT00859027|75603105|FG001|NOT COMPLETED|Overall Study||5||
59759557|NCT02631941|75878923|FG001|NOT COMPLETED|Overall Study||2||
60038697|NCT01983111|76154547|FG000|COMPLETED|Overall Study||58||
60038698|NCT01983111|76154548|FG001|COMPLETED|Overall Study||59||
60038699|NCT01983111|76154547|FG000|NOT COMPLETED|Overall Study||12||
60038700|NCT01983111|76154548|FG001|NOT COMPLETED|Overall Study||7||
60038701|NCT02348489|76154556|FG000|STARTED|Overall Study||408||
60038702|NCT02348489|76154557|FG001|STARTED|Overall Study||407||
60038703|NCT02348489|76154556|FG000|COMPLETED|Overall Study||55||
60038704|NCT02348489|76154557|FG001|COMPLETED|Overall Study||40||
60038705|NCT02348489|76154556|FG000|NOT COMPLETED|Overall Study||353||
59759558|NCT02631941|75878924|FG002|NOT COMPLETED|Overall Study||0||
60038706|NCT02348489|76154557|FG001|NOT COMPLETED|Overall Study||367||
60038707|NCT02309099|76154567|FG000|STARTED|Overall Study||7||
60038708|NCT02309099|76154568|FG001|STARTED|Overall Study||3||
60038709|NCT02309099|76154567|FG000|Cochlear Implantation|Overall Study||7|Cochlear implantation following initial surgical procedure (schannoma resection or labyrinthectomy)|
60038710|NCT02309099|76154568|FG001|Cochlear Implantation|Overall Study||3|Cochlear implantation following initial surgical procedure (schannoma resection or labyrinthectomy)|
60038711|NCT02309099|76154567|FG000|Initial Activation|Overall Study||7|Initial activation of cochlear implant (2-4 weeks following surgical procedure/implantation)|
60038712|NCT02309099|76154568|FG001|Initial Activation|Overall Study||3|Initial activation of cochlear implant (2-4 weeks following surgical procedure/implantation)|
60038713|NCT02309099|76154567|FG000|Cochlear Implant Use/Follow-Up|Overall Study|5 participants completed cochlear implant use/follow-up (2 did not complete due to adverse event)|5|Device use over the initial 12 months following initial activation (1-month to 12-months)|
60038714|NCT02309099|76154568|FG001|Cochlear Implant Use/Follow-Up|Overall Study||3|Device use over the initial 12 months following initial activation (1-month to 12-months)|
59509754|NCT02630992|75603111|FG000|STARTED|Overall Study||112||
59509755|NCT02630992|75603111|FG000|COMPLETED|Overall Study||99||
59509756|NCT02630992|75603111|FG000|NOT COMPLETED|Overall Study||13||
59509757|NCT00836407|75603117|FG000|STARTED|Overall Study||15||
59509758|NCT00836407|75603118|FG001|STARTED|Overall Study||15||
59509759|NCT00836407|75603117|FG000|COMPLETED|Overall Study||4||
59509760|NCT00836407|75603118|FG001|COMPLETED|Overall Study||7||
60038715|NCT02309099|76154567|FG000|COMPLETED|Overall Study|5 participants completed the study (2 did not complete due to adverse event)|5||
60038716|NCT02309099|76154568|FG001|COMPLETED|Overall Study||3||
60038717|NCT02309099|76154567|FG000|NOT COMPLETED|Overall Study||2||
60038718|NCT02309099|76154568|FG001|NOT COMPLETED|Overall Study||0||
60038719|NCT01966107|76154576|FG000|STARTED|Overall Study||1812||
60038720|NCT01966107|76154577|FG001|STARTED|Overall Study||1818||
60038721|NCT01966107|76154576|FG000|Full Analysis Set|Overall Study||1791|Subjects included in full analysis set (FAS)|
60038722|NCT01966107|76154577|FG001|Full Analysis Set|Overall Study||1798|Subjects included in full analysis set (FAS)|
60038723|NCT01966107|76154576|FG000|COMPLETED|Overall Study||1010|Subjects who remained on treatment through this time point|
60038724|NCT01966107|76154577|FG001|COMPLETED|Overall Study||937|Subjects who remained on treatment through this time point|
60038725|NCT01966107|76154576|FG000|NOT COMPLETED|Overall Study||802||
60038726|NCT01966107|76154577|FG001|NOT COMPLETED|Overall Study||881||
60038727|NCT02347943|76154586|FG000|STARTED|Overall Study||140||
60038728|NCT02347943|76154587|FG001|STARTED|Overall Study||67||
60038729|NCT02347943|76154588|FG002|STARTED|Overall Study||45||
60038730|NCT02347943|76154586|FG000|COMPLETED|Overall Study||0||
60038731|NCT02347943|76154587|FG001|COMPLETED|Overall Study||0||
60038732|NCT02347943|76154588|FG002|COMPLETED|Overall Study||0||
60038733|NCT02347943|76154586|FG000|NOT COMPLETED|Overall Study||140||
60038734|NCT02347943|76154587|FG001|NOT COMPLETED|Overall Study||67||
60038735|NCT02347943|76154588|FG002|NOT COMPLETED|Overall Study||45||
60038736|NCT01982331|76154598|FG000|STARTED|Received Vaccination 1||28||
60038737|NCT01982331|76154599|FG001|STARTED|Received Vaccination 1||10||
60038738|NCT01982331|76154598|FG000|COMPLETED|Received Vaccination 1||28||
60038739|NCT01982331|76154599|FG001|COMPLETED|Received Vaccination 1||10||
60038740|NCT01982331|76154598|FG000|NOT COMPLETED|Received Vaccination 1||0||
60038741|NCT01982331|76154599|FG001|NOT COMPLETED|Received Vaccination 1||0||
60038742|NCT01982331|76154598|FG000|STARTED|Received Vaccination 2||28||
60038743|NCT01982331|76154599|FG001|STARTED|Received Vaccination 2||10||
60038744|NCT01982331|76154598|FG000|COMPLETED|Received Vaccination 2||27||
60038745|NCT01982331|76154599|FG001|COMPLETED|Received Vaccination 2||7||
60038746|NCT01982331|76154598|FG000|NOT COMPLETED|Received Vaccination 2||1||
60038747|NCT01982331|76154599|FG001|NOT COMPLETED|Received Vaccination 2||3||
60038748|NCT01982331|76154598|FG000|STARTED|Completed Study (Day 112)||27||
60038749|NCT01982331|76154599|FG001|STARTED|Completed Study (Day 112)||7||
60038750|NCT01982331|76154598|FG000|COMPLETED|Completed Study (Day 112)||25||
60038751|NCT01982331|76154599|FG001|COMPLETED|Completed Study (Day 112)||7||
60038752|NCT01982331|76154598|FG000|NOT COMPLETED|Completed Study (Day 112)||2||
60038753|NCT01982331|76154599|FG001|NOT COMPLETED|Completed Study (Day 112)||0||
60038754|NCT02326025|76154607|FG000|STARTED|Overall Study||25||
60038755|NCT02326025|76154608|FG001|STARTED|Overall Study||24||
60038756|NCT02326025|76154607|FG000|Received at Least 1 Dose of Study Drug|Overall Study||25||
60038757|NCT02326025|76154608|FG001|Received at Least 1 Dose of Study Drug|Overall Study||24||
60038758|NCT02326025|76154607|FG000|COMPLETED|Overall Study||20||
60038759|NCT02326025|76154608|FG001|COMPLETED|Overall Study||19||
60038760|NCT02326025|76154607|FG000|NOT COMPLETED|Overall Study||5||
60038761|NCT02326025|76154608|FG001|NOT COMPLETED|Overall Study||5||
60038762|NCT01619865|76154627|FG000|STARTED|Overall Study||223||
60038763|NCT01619865|76154627|FG000|COMPLETED|Overall Study||219||
60038764|NCT01619865|76154627|FG000|NOT COMPLETED|Overall Study||4||
60038765|NCT02006121|76154634|FG000|STARTED|Double Blind Phase||54||
60038766|NCT02006121|76154635|FG001|STARTED|Double Blind Phase||53||
60038767|NCT02006121|76154634|FG000|COMPLETED|Double Blind Phase|Early switching to open label: 1 for lack of efficacy, 1 could not tolerate 3 mg/hour minimum rate|42||
60038768|NCT02006121|76154635|FG001|COMPLETED|Double Blind Phase|16 placebo-treated patients early switched to open label phase due to lack of efficacy|29||
60038769|NCT02006121|76154634|FG000|NOT COMPLETED|Double Blind Phase||12||
60038770|NCT02006121|76154635|FG001|NOT COMPLETED|Double Blind Phase||24||
60038771|NCT02006121|76154634|FG000|STARTED|Open Label Phase|From Apo: 38 completers and 2 early switched; From Placebo: 28 completers and 16 early switched|84||
60038772|NCT02006121|76154635|FG001|STARTED|Open Label Phase|No patients received placebo in the open label phase|0||
60038773|NCT02006121|76154634|FG000|COMPLETED|Open Label Phase|30 who continued on apomorphine from blinded phase, 29 who switched to apomorphine from placebo|59||
60038774|NCT02006121|76154635|FG001|COMPLETED|Open Label Phase||0||
60038775|NCT02006121|76154634|FG000|NOT COMPLETED|Open Label Phase||25||
60038776|NCT02006121|76154635|FG001|NOT COMPLETED|Open Label Phase||0||
59509761|NCT00836407|75603117|FG000|NOT COMPLETED|Overall Study||11||
59509762|NCT00836407|75603118|FG001|NOT COMPLETED|Overall Study||8||
59509763|NCT02631772|75603126|FG000|STARTED|Overall Study||16||
59509764|NCT02631772|75603127|FG001|STARTED|Overall Study||16||
60038777|NCT02005887|76154647|FG000|STARTED|Overall Study||26||
59509765|NCT02631772|75603126|FG000|COMPLETED|Overall Study||16||
59509766|NCT02631772|75603127|FG001|COMPLETED|Overall Study||16||
59509767|NCT02631772|75603126|FG000|NOT COMPLETED|Overall Study||0||
59509768|NCT02631772|75603127|FG001|NOT COMPLETED|Overall Study||0||
59509769|NCT02633488|75603135|FG000|STARTED|Overall Study||6||
60038778|NCT02005887|76154648|FG001|STARTED|Overall Study||25||
60038779|NCT02005887|76154647|FG000|COMPLETED|Overall Study||26||
60038780|NCT02005887|76154648|FG001|COMPLETED|Overall Study||23||
60038781|NCT02005887|76154647|FG000|NOT COMPLETED|Overall Study||0||
60038782|NCT02005887|76154648|FG001|NOT COMPLETED|Overall Study||2||
60038783|NCT01982253|76154657|FG000|STARTED|Overall Study||2||
60038784|NCT01982253|76154658|FG001|STARTED|Overall Study||4||
60038785|NCT01982253|76154659|FG002|STARTED|Overall Study||4||
60038786|NCT01982253|76154657|FG000|COMPLETED|Overall Study||0||
60038787|NCT01982253|76154658|FG001|COMPLETED|Overall Study||0||
60038788|NCT01982253|76154659|FG002|COMPLETED|Overall Study||0||
60038789|NCT01982253|76154657|FG000|NOT COMPLETED|Overall Study||2||
60038790|NCT01982253|76154658|FG001|NOT COMPLETED|Overall Study||4||
60038791|NCT01982253|76154659|FG002|NOT COMPLETED|Overall Study||4||
60038792|NCT01619787|76154669|FG000|STARTED|Overall Study||217||
60038793|NCT01619787|76154669|FG000|COMPLETED|Overall Study||212||
60038794|NCT01619787|76154669|FG000|NOT COMPLETED|Overall Study||5||
60038795|NCT01981473|76154678|FG000|STARTED|Overall Study||202||
60038796|NCT01981473|76154679|FG001|STARTED|Overall Study||199||
60038797|NCT01981473|76154680|FG002|STARTED|Overall Study||204||
60038798|NCT01981473|76154678|FG000|COMPLETED|Overall Study||200||
60038799|NCT01981473|76154679|FG001|COMPLETED|Overall Study||199||
60038800|NCT01981473|76154680|FG002|COMPLETED|Overall Study||196||
60038801|NCT01981473|76154678|FG000|NOT COMPLETED|Overall Study||2||
60038802|NCT01981473|76154679|FG001|NOT COMPLETED|Overall Study||0||
60038803|NCT01981473|76154680|FG002|NOT COMPLETED|Overall Study||8||
60038804|NCT02005029|76154693|FG000|STARTED|First Intervention (1 Day)||5||
60038805|NCT02005029|76154694|FG001|STARTED|First Intervention (1 Day)||5||
60038806|NCT02005029|76154693|FG000|COMPLETED|First Intervention (1 Day)||4||
60038807|NCT02005029|76154694|FG001|COMPLETED|First Intervention (1 Day)||5||
60038808|NCT02005029|76154693|FG000|NOT COMPLETED|First Intervention (1 Day)||1||
60038809|NCT02005029|76154694|FG001|NOT COMPLETED|First Intervention (1 Day)||0||
60038810|NCT02005029|76154693|FG000|STARTED|Washout (2 Weeks)||4||
60038811|NCT02005029|76154694|FG001|STARTED|Washout (2 Weeks)||5||
60038812|NCT02005029|76154693|FG000|COMPLETED|Washout (2 Weeks)||4||
60038813|NCT02005029|76154694|FG001|COMPLETED|Washout (2 Weeks)||5||
60038814|NCT02005029|76154693|FG000|NOT COMPLETED|Washout (2 Weeks)||0||
60038815|NCT02005029|76154694|FG001|NOT COMPLETED|Washout (2 Weeks)||0||
60038816|NCT02005029|76154693|FG000|STARTED|Second Intervention (1 Day)||4||
60038817|NCT02005029|76154694|FG001|STARTED|Second Intervention (1 Day)||5||
60038818|NCT02005029|76154693|FG000|COMPLETED|Second Intervention (1 Day)||4||
60038819|NCT02005029|76154694|FG001|COMPLETED|Second Intervention (1 Day)||5||
60038820|NCT02005029|76154693|FG000|NOT COMPLETED|Second Intervention (1 Day)||0||
60038821|NCT02005029|76154694|FG001|NOT COMPLETED|Second Intervention (1 Day)||0||
60038822|NCT02325791|76154722|FG000|STARTED|Overall Study||23||
60038823|NCT02325791|76154723|FG001|STARTED|Overall Study||383||
60038824|NCT02325791|76154724|FG002|STARTED|Overall Study||385||
60038825|NCT02325791|76154725|FG003|STARTED|Overall Study||381||
60038826|NCT02325791|76154722|FG000|COMPLETED|Overall Study||23||
60038827|NCT02325791|76154723|FG001|COMPLETED|Overall Study||358||
60038828|NCT02325791|76154724|FG002|COMPLETED|Overall Study||360||
60038829|NCT02325791|76154725|FG003|COMPLETED|Overall Study||355||
60038830|NCT02325791|76154722|FG000|NOT COMPLETED|Overall Study||0||
60038831|NCT02325791|76154723|FG001|NOT COMPLETED|Overall Study||25||
60038832|NCT02325791|76154724|FG002|NOT COMPLETED|Overall Study||25||
60038833|NCT02325791|76154725|FG003|NOT COMPLETED|Overall Study||26||
60038834|NCT02004873|76154738|FG000|STARTED|Overall Study|Micra Implant Attempt|725||
60038835|NCT02004873|76154738|FG000|Micra Implant Success|Overall Study||719||
60038836|NCT02004873|76154738|FG000|COMPLETED|Overall Study|6-Month Follow-up|301||
60038837|NCT02004873|76154738|FG000|NOT COMPLETED|Overall Study||424||
60038838|NCT02347787|76154747|FG000|STARTED|6 Month Follow-Up||288||
60038839|NCT02347787|76154748|FG001|STARTED|6 Month Follow-Up||304||
60038840|NCT02347787|76154747|FG000|COMPLETED|6 Month Follow-Up||222||
59509770|NCT02633488|75603136|FG001|STARTED|Overall Study||5||
59509771|NCT02633488|75603135|FG000|COMPLETED|Overall Study||6||
59509772|NCT02633488|75603136|FG001|COMPLETED|Overall Study||5||
59509773|NCT02633488|75603135|FG000|NOT COMPLETED|Overall Study||0||
60038841|NCT02347787|76154748|FG001|COMPLETED|6 Month Follow-Up||248||
60038842|NCT02347787|76154747|FG000|NOT COMPLETED|6 Month Follow-Up||66||
60038843|NCT02347787|76154748|FG001|NOT COMPLETED|6 Month Follow-Up||56||
60038844|NCT02347787|76154747|FG000|STARTED|9 Month Follow-Up||288||
60038845|NCT02347787|76154748|FG001|STARTED|9 Month Follow-Up||304||
60038846|NCT02347787|76154747|FG000|COMPLETED|9 Month Follow-Up||227||
60038847|NCT02347787|76154748|FG001|COMPLETED|9 Month Follow-Up||233||
60038848|NCT02347787|76154747|FG000|NOT COMPLETED|9 Month Follow-Up||61||
60038849|NCT02347787|76154748|FG001|NOT COMPLETED|9 Month Follow-Up||71||
60038850|NCT01979835|76154759|FG000|STARTED|Primary Outcome SA Measurment||1030||
60038851|NCT01979835|76154759|FG000|COMPLETED|Primary Outcome SA Measurment||1012||
60038852|NCT01979835|76154759|FG000|NOT COMPLETED|Primary Outcome SA Measurment||18||
60038853|NCT01979835|76154759|FG000|STARTED|Follow-up||1012||
60038854|NCT01979835|76154759|FG000|COMPLETED|Follow-up||980||
60038855|NCT01979835|76154759|FG000|NOT COMPLETED|Follow-up||32||
60038856|NCT02282345|76154765|FG000|STARTED|Overall Study||13||
60038857|NCT02282345|76154766|FG001|STARTED|Overall Study||20||
60038858|NCT02282345|76154765|FG000|COMPLETED|Overall Study||13||
60038859|NCT02282345|76154766|FG001|COMPLETED|Overall Study||19||
60038860|NCT02282345|76154765|FG000|NOT COMPLETED|Overall Study||0||
60038861|NCT02282345|76154766|FG001|NOT COMPLETED|Overall Study||1||
60038862|NCT01732822|76154777|FG000|STARTED|Overall Study||6930||
60038863|NCT01732822|76154778|FG001|STARTED|Overall Study||6955||
60038864|NCT01732822|76154777|FG000|COMPLETED|Overall Study|Includes patients who did not withdraw informed consent prior to the PACD|6807||
60038865|NCT01732822|76154778|FG001|COMPLETED|Overall Study|Includes patients who did not withdraw informed consent prior to the PACD|6842||
60038866|NCT01732822|76154777|FG000|NOT COMPLETED|Overall Study||123||
60038867|NCT01732822|76154778|FG001|NOT COMPLETED|Overall Study||113||
60038868|NCT02004093|76154808|FG000|STARTED|Overall Study|Includes 1 participant who was randomized to chemotherapy group but received pertuzumab+chemotherapy|75||
60038869|NCT02004093|76154809|FG001|STARTED|Overall Study||74||
60038870|NCT02004093|76154808|FG000|COMPLETED|Overall Study||1||
60038871|NCT02004093|76154809|FG001|COMPLETED|Overall Study||1||
60038872|NCT02004093|76154808|FG000|NOT COMPLETED|Overall Study||74||
60038873|NCT02004093|76154809|FG001|NOT COMPLETED|Overall Study||73||
60038874|NCT01641367|76154824|FG000|STARTED|Cohorts||287|Participants were followed on step 1/2 until 48 weeks after the last participant enrolled to Step 1.|
60038875|NCT01641367|76154825|FG001|STARTED|Cohorts||74|Participants were followed on step 1/2 until 48 weeks after the last participant enrolled to Step 1.|
60038876|NCT01641367|76154826|FG002|STARTED|Cohorts||72|Participants were followed on step 1/2 until 48 weeks after the last participant enrolled to Step 1.|
60038877|NCT01641367|76154827|FG003|STARTED|Cohorts||8|Participants were followed on step 1/2 until 48 weeks after the last participant enrolled to Step 1.|
60038878|NCT01641367|76154828|FG004|STARTED|Cohorts||70|Participants were followed on step 1/2 until 48 weeks after the last participant enrolled to Step 1.|
60038879|NCT01641367|76154829|FG005|STARTED|Cohorts||34|Participants were followed on step 1/2 until 48 weeks after the last participant enrolled to Step 1.|
60038880|NCT01641367|76154830|FG006|STARTED|Cohorts||0|Participants were followed on step 1/2 until 48 weeks after the last participant enrolled to Step 1.|
60038881|NCT01641367|76154831|FG007|STARTED|Cohorts||0|Participants were followed on step 1/2 until 48 weeks after the last participant enrolled to Step 1.|
60038882|NCT01641367|76154824|FG000|Followed 72 Weeks on Step 1/2|Cohorts||211||
60038883|NCT01641367|76154825|FG001|Followed 72 Weeks on Step 1/2|Cohorts||60||
60038884|NCT01641367|76154826|FG002|Followed 72 Weeks on Step 1/2|Cohorts||60||
60038885|NCT01641367|76154827|FG003|Followed 72 Weeks on Step 1/2|Cohorts||6||
60038886|NCT01641367|76154828|FG004|Followed 72 Weeks on Step 1/2|Cohorts||52||
60038887|NCT01641367|76154829|FG005|Followed 72 Weeks on Step 1/2|Cohorts||30||
60038888|NCT01641367|76154830|FG006|Followed 72 Weeks on Step 1/2|Cohorts||0||
60038889|NCT01641367|76154831|FG007|Followed 72 Weeks on Step 1/2|Cohorts||0||
59918134|NCT03086460|76038631|FG000|COMPLETED|Treatment B||35||
59918135|NCT03086460|76038631|FG000|NOT COMPLETED|Treatment B||0||
59918136|NCT03086460|76038631|FG000|STARTED|Treatment C||37||
59918137|NCT03086460|76038631|FG000|COMPLETED|Treatment C||35||
59918138|NCT03086460|76038631|FG000|NOT COMPLETED|Treatment C||2||
59918139|NCT03086460|76038631|FG000|STARTED|Treatment D||40||
59918140|NCT03086460|76038631|FG000|COMPLETED|Treatment D||40||
59918141|NCT03086460|76038631|FG000|NOT COMPLETED|Treatment D||0||
59918142|NCT03086460|76038631|FG000|STARTED|Treatment E||40||
59918143|NCT03086460|76038631|FG000|COMPLETED|Treatment E||36||
59918144|NCT03086460|76038631|FG000|NOT COMPLETED|Treatment E||4||
59918145|NCT03086460|76038631|FG000|STARTED|Treatment F||41||
59918146|NCT03086460|76038631|FG000|COMPLETED|Treatment F||41||
59918147|NCT03086460|76038631|FG000|NOT COMPLETED|Treatment F||0||
59918148|NCT02674490|76038648|FG000|STARTED|Overall Study||30|Randomized|
59918149|NCT02674490|76038649|FG001|STARTED|Overall Study||28|Randomized|
59918150|NCT02674490|76038648|FG000|Received at Least One Treatment Session (Modified Intent-to-treat Sample)|Overall Study||26||
59918151|NCT02674490|76038649|FG001|Received at Least One Treatment Session (Modified Intent-to-treat Sample)|Overall Study||25||
60038890|NCT01641367|76154824|FG000|COMPLETED|Cohorts||253|Completed the study = participant must have had the last step 1/2 visit between 22NOV2016-13FEB2017|
60038891|NCT01641367|76154825|FG001|COMPLETED|Cohorts||73|Completed the study = participant must have had the last step 1/2 visit between 22NOV2016-13FEB2017|
60038892|NCT01641367|76154826|FG002|COMPLETED|Cohorts||68|Completed the study = participant must have had the last step 1/2 visit between 22NOV2016-13FEB2017|
60038893|NCT01641367|76154827|FG003|COMPLETED|Cohorts||8|Completed the study = participant must have had the last step 1/2 visit between 22NOV2016-13FEB2017|
60038894|NCT01641367|76154828|FG004|COMPLETED|Cohorts||67|Completed the study = participant must have had the last step 1/2 visit between 22NOV2016-13FEB2017|
60038895|NCT01641367|76154829|FG005|COMPLETED|Cohorts||33|Completed the study = participant must have had the last step 1/2 visit between 22NOV2016-13FEB2017|
60038896|NCT01641367|76154830|FG006|COMPLETED|Cohorts||0|Completed the study = participant must have had the last step 1/2 visit between 22NOV2016-13FEB2017|
60038897|NCT01641367|76154831|FG007|COMPLETED|Cohorts||0|Completed the study = participant must have had the last step 1/2 visit between 22NOV2016-13FEB2017|
60038898|NCT01641367|76154824|FG000|NOT COMPLETED|Cohorts||34||
60038899|NCT01641367|76154825|FG001|NOT COMPLETED|Cohorts||1||
60038900|NCT01641367|76154826|FG002|NOT COMPLETED|Cohorts||4||
60038901|NCT01641367|76154827|FG003|NOT COMPLETED|Cohorts||0||
60038902|NCT01641367|76154828|FG004|NOT COMPLETED|Cohorts||3||
60038903|NCT01641367|76154829|FG005|NOT COMPLETED|Cohorts||1||
60038904|NCT01641367|76154830|FG006|NOT COMPLETED|Cohorts||0||
60038905|NCT01641367|76154831|FG007|NOT COMPLETED|Cohorts||0||
60038906|NCT01641367|76154824|FG000|STARTED|Randomized Adherence Intervention||0|Participants were followed on step 1/2 until 48 weeks after the last participant enrolled to Step 1.|
60038907|NCT01641367|76154825|FG001|STARTED|Randomized Adherence Intervention||0|Participants were followed on step 1/2 until 48 weeks after the last participant enrolled to Step 1.|
60038908|NCT01641367|76154826|FG002|STARTED|Randomized Adherence Intervention||0|Participants were followed on step 1/2 until 48 weeks after the last participant enrolled to Step 1.|
60038909|NCT01641367|76154827|FG003|STARTED|Randomized Adherence Intervention||0|Participants were followed on step 1/2 until 48 weeks after the last participant enrolled to Step 1.|
60038910|NCT01641367|76154828|FG004|STARTED|Randomized Adherence Intervention||0|Participants were followed on step 1/2 until 48 weeks after the last participant enrolled to Step 1.|
60038911|NCT01641367|76154829|FG005|STARTED|Randomized Adherence Intervention||0|Participants were followed on step 1/2 until 48 weeks after the last participant enrolled to Step 1.|
60038912|NCT01641367|76154830|FG006|STARTED|Randomized Adherence Intervention||257|Participants were followed on step 1/2 until 48 weeks after the last participant enrolled to Step 1.|
60038913|NCT01641367|76154831|FG007|STARTED|Randomized Adherence Intervention||264|Participants were followed on step 1/2 until 48 weeks after the last participant enrolled to Step 1.|
60038914|NCT01641367|76154824|FG000|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||0||
60038915|NCT01641367|76154825|FG001|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||0||
60038916|NCT01641367|76154826|FG002|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||0||
60038917|NCT01641367|76154827|FG003|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||0||
60038918|NCT01641367|76154828|FG004|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||0||
60038919|NCT01641367|76154829|FG005|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||0||
60038920|NCT01641367|76154830|FG006|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||196||
59509774|NCT02633488|75603136|FG001|NOT COMPLETED|Overall Study||0||
59509775|NCT00859339|75603142|FG000|STARTED|Overall Study||9||
59509776|NCT00859339|75603142|FG000|COMPLETED|Overall Study||9||
59509777|NCT00859339|75603142|FG000|NOT COMPLETED|Overall Study||0||
59509778|NCT00859495|75603146|FG000|STARTED|Overall Study||9||
59509779|NCT00859495|75603146|FG000|COMPLETED|Overall Study||9||
59509780|NCT00859495|75603146|FG000|NOT COMPLETED|Overall Study||0||
59509781|NCT00859651|75603152|FG000|STARTED|Overall Study||18||
59509782|NCT00859651|75603153|FG001|STARTED|Overall Study||22||
59509783|NCT00859651|75603152|FG000|COMPLETED|Overall Study||18||
59509784|NCT00859651|75603153|FG001|COMPLETED|Overall Study||22||
59509785|NCT00859651|75603152|FG000|NOT COMPLETED|Overall Study||0||
59509786|NCT00859651|75603153|FG001|NOT COMPLETED|Overall Study||0||
59509787|NCT02633956|75603163|FG000|STARTED|Overall Study||20||
59509788|NCT02633956|75603164|FG001|STARTED|Overall Study||21||
59509789|NCT02633956|75603165|FG002|STARTED|Overall Study||22||
59509790|NCT02633956|75603166|FG003|STARTED|Overall Study||21||
59509791|NCT02633956|75603163|FG000|COMPLETED|Overall Study||19||
59509792|NCT02633956|75603164|FG001|COMPLETED|Overall Study||19||
59509793|NCT02633956|75603165|FG002|COMPLETED|Overall Study||20||
59509794|NCT02633956|75603166|FG003|COMPLETED|Overall Study||21||
59509795|NCT02633956|75603163|FG000|NOT COMPLETED|Overall Study||1||
59509796|NCT02633956|75603164|FG001|NOT COMPLETED|Overall Study||2||
59509797|NCT02633956|75603165|FG002|NOT COMPLETED|Overall Study||2||
59509798|NCT02633956|75603166|FG003|NOT COMPLETED|Overall Study||0||
59509799|NCT00836641|75603182|FG000|STARTED|Overall Study||36||
59509800|NCT00836641|75603183|FG001|STARTED|Overall Study||34||
59509801|NCT00836641|75603182|FG000|COMPLETED|Overall Study||36||
59509802|NCT00836641|75603183|FG001|COMPLETED|Overall Study||34||
59509803|NCT00836641|75603182|FG000|NOT COMPLETED|Overall Study||0||
59509804|NCT00836641|75603183|FG001|NOT COMPLETED|Overall Study||0||
59509805|NCT00806221|75603188|FG000|STARTED|Overall Study||22||
59509806|NCT00806221|75603188|FG000|COMPLETED|Overall Study||20||
59509807|NCT00806221|75603188|FG000|NOT COMPLETED|Overall Study||2||
60038921|NCT01641367|76154831|FG007|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||202||
60038922|NCT01641367|76154824|FG000|COMPLETED|Randomized Adherence Intervention||0|Completed the study = participant must have had the last step 1/2 visit between 22NOV2016-13FEB2017|
60038923|NCT01641367|76154825|FG001|COMPLETED|Randomized Adherence Intervention||0|Completed the study = participant must have had the last step 1/2 visit between 22NOV2016-13FEB2017|
60038924|NCT01641367|76154826|FG002|COMPLETED|Randomized Adherence Intervention||0|Completed the study = participant must have had the last step 1/2 visit between 22NOV2016-13FEB2017|
60038925|NCT01641367|76154827|FG003|COMPLETED|Randomized Adherence Intervention||0|Completed the study = participant must have had the last step 1/2 visit between 22NOV2016-13FEB2017|
60038926|NCT01641367|76154828|FG004|COMPLETED|Randomized Adherence Intervention||0|Completed the study = participant must have had the last step 1/2 visit between 22NOV2016-13FEB2017|
60038927|NCT01641367|76154829|FG005|COMPLETED|Randomized Adherence Intervention||0|Completed the study = participant must have had the last step 1/2 visit between 22NOV2016-13FEB2017|
60038928|NCT01641367|76154830|FG006|COMPLETED|Randomized Adherence Intervention||238|Completed the study = participant must have had the last step 1/2 visit between 22NOV2016-13FEB2017|
60038929|NCT01641367|76154831|FG007|COMPLETED|Randomized Adherence Intervention||240|Completed the study = participant must have had the last step 1/2 visit between 22NOV2016-13FEB2017|
60038930|NCT01641367|76154824|FG000|NOT COMPLETED|Randomized Adherence Intervention||0||
60038931|NCT01641367|76154825|FG001|NOT COMPLETED|Randomized Adherence Intervention||0||
60038932|NCT01641367|76154826|FG002|NOT COMPLETED|Randomized Adherence Intervention||0||
60038933|NCT01641367|76154827|FG003|NOT COMPLETED|Randomized Adherence Intervention||0||
60038934|NCT01641367|76154828|FG004|NOT COMPLETED|Randomized Adherence Intervention||0||
60038935|NCT01641367|76154829|FG005|NOT COMPLETED|Randomized Adherence Intervention||0||
60038936|NCT01641367|76154830|FG006|NOT COMPLETED|Randomized Adherence Intervention||19||
60038937|NCT01641367|76154831|FG007|NOT COMPLETED|Randomized Adherence Intervention||24||
60038938|NCT02325713|76154870|FG000|STARTED|Intervention Period 1 (2 Days)||2||
60038939|NCT02325713|76154871|FG001|STARTED|Intervention Period 1 (2 Days)||2||
60038940|NCT02325713|76154872|FG002|STARTED|Intervention Period 1 (2 Days)||2||
60038941|NCT02325713|76154873|FG003|STARTED|Intervention Period 1 (2 Days)||2||
60038942|NCT02325713|76154874|FG004|STARTED|Intervention Period 1 (2 Days)||2||
60038943|NCT02325713|76154875|FG005|STARTED|Intervention Period 1 (2 Days)||2||
60038944|NCT02325713|76154876|FG006|STARTED|Intervention Period 1 (2 Days)||2||
60038945|NCT02325713|76154877|FG007|STARTED|Intervention Period 1 (2 Days)||2||
60038946|NCT02325713|76154878|FG008|STARTED|Intervention Period 1 (2 Days)||2||
60038947|NCT02325713|76154879|FG009|STARTED|Intervention Period 1 (2 Days)||2||
60038948|NCT02325713|76154880|FG010|STARTED|Intervention Period 1 (2 Days)||2||
60038949|NCT02325713|76154881|FG011|STARTED|Intervention Period 1 (2 Days)||2||
60038950|NCT02325713|76154882|FG012|STARTED|Intervention Period 1 (2 Days)||2||
60038951|NCT02325713|76154883|FG013|STARTED|Intervention Period 1 (2 Days)||2||
60038952|NCT02325713|76154884|FG014|STARTED|Intervention Period 1 (2 Days)||2||
60038953|NCT02325713|76154885|FG015|STARTED|Intervention Period 1 (2 Days)||2||
60038954|NCT02325713|76154870|FG000|COMPLETED|Intervention Period 1 (2 Days)||2||
60038955|NCT02325713|76154871|FG001|COMPLETED|Intervention Period 1 (2 Days)||2||
60038956|NCT02325713|76154872|FG002|COMPLETED|Intervention Period 1 (2 Days)||2||
60038957|NCT02325713|76154873|FG003|COMPLETED|Intervention Period 1 (2 Days)||2||
60038958|NCT02325713|76154874|FG004|COMPLETED|Intervention Period 1 (2 Days)||2||
60038959|NCT02325713|76154875|FG005|COMPLETED|Intervention Period 1 (2 Days)||2||
60038960|NCT02325713|76154876|FG006|COMPLETED|Intervention Period 1 (2 Days)||2||
60038961|NCT02325713|76154877|FG007|COMPLETED|Intervention Period 1 (2 Days)||2||
60038962|NCT02325713|76154878|FG008|COMPLETED|Intervention Period 1 (2 Days)||2||
60038963|NCT02325713|76154879|FG009|COMPLETED|Intervention Period 1 (2 Days)||2||
60038964|NCT02325713|76154880|FG010|COMPLETED|Intervention Period 1 (2 Days)||1||
60038965|NCT02325713|76154881|FG011|COMPLETED|Intervention Period 1 (2 Days)||2||
60038966|NCT02325713|76154882|FG012|COMPLETED|Intervention Period 1 (2 Days)||2||
60038967|NCT02325713|76154883|FG013|COMPLETED|Intervention Period 1 (2 Days)||2||
60038968|NCT02325713|76154884|FG014|COMPLETED|Intervention Period 1 (2 Days)||2||
60038969|NCT02325713|76154885|FG015|COMPLETED|Intervention Period 1 (2 Days)||2||
60038970|NCT02325713|76154870|FG000|NOT COMPLETED|Intervention Period 1 (2 Days)||0||
60038971|NCT02325713|76154871|FG001|NOT COMPLETED|Intervention Period 1 (2 Days)||0||
60038972|NCT02325713|76154872|FG002|NOT COMPLETED|Intervention Period 1 (2 Days)||0||
60038973|NCT02325713|76154873|FG003|NOT COMPLETED|Intervention Period 1 (2 Days)||0||
60038974|NCT02325713|76154874|FG004|NOT COMPLETED|Intervention Period 1 (2 Days)||0||
60038975|NCT02325713|76154875|FG005|NOT COMPLETED|Intervention Period 1 (2 Days)||0||
60038976|NCT02325713|76154876|FG006|NOT COMPLETED|Intervention Period 1 (2 Days)||0||
60038977|NCT02325713|76154877|FG007|NOT COMPLETED|Intervention Period 1 (2 Days)||0||
60038978|NCT02325713|76154878|FG008|NOT COMPLETED|Intervention Period 1 (2 Days)||0||
60038979|NCT02325713|76154879|FG009|NOT COMPLETED|Intervention Period 1 (2 Days)||0||
60038980|NCT02325713|76154880|FG010|NOT COMPLETED|Intervention Period 1 (2 Days)||1||
60038981|NCT02325713|76154881|FG011|NOT COMPLETED|Intervention Period 1 (2 Days)||0||
60038982|NCT02325713|76154882|FG012|NOT COMPLETED|Intervention Period 1 (2 Days)||0||
60038983|NCT02325713|76154883|FG013|NOT COMPLETED|Intervention Period 1 (2 Days)||0||
60038984|NCT02325713|76154884|FG014|NOT COMPLETED|Intervention Period 1 (2 Days)||0||
60038985|NCT02325713|76154885|FG015|NOT COMPLETED|Intervention Period 1 (2 Days)||0||
60067827|NCT01756833|76183016|FG000|NOT COMPLETED|Overall Study||4||
60038986|NCT02325713|76154870|FG000|STARTED|Intervention Period 2 (2 Days)||2||
60038987|NCT02325713|76154871|FG001|STARTED|Intervention Period 2 (2 Days)||2||
60038988|NCT02325713|76154872|FG002|STARTED|Intervention Period 2 (2 Days)||2||
60038989|NCT02325713|76154873|FG003|STARTED|Intervention Period 2 (2 Days)||2||
60038990|NCT02325713|76154874|FG004|STARTED|Intervention Period 2 (2 Days)||2||
60038991|NCT02325713|76154875|FG005|STARTED|Intervention Period 2 (2 Days)||2||
60038992|NCT02325713|76154876|FG006|STARTED|Intervention Period 2 (2 Days)||2||
60038993|NCT02325713|76154877|FG007|STARTED|Intervention Period 2 (2 Days)||2||
60038994|NCT02325713|76154878|FG008|STARTED|Intervention Period 2 (2 Days)||2||
60038995|NCT02325713|76154879|FG009|STARTED|Intervention Period 2 (2 Days)||2||
60038996|NCT02325713|76154880|FG010|STARTED|Intervention Period 2 (2 Days)||1||
60038997|NCT02325713|76154881|FG011|STARTED|Intervention Period 2 (2 Days)||2||
60038998|NCT02325713|76154882|FG012|STARTED|Intervention Period 2 (2 Days)||2||
60038999|NCT02325713|76154883|FG013|STARTED|Intervention Period 2 (2 Days)||2||
60039000|NCT02325713|76154884|FG014|STARTED|Intervention Period 2 (2 Days)||2||
60039001|NCT02325713|76154885|FG015|STARTED|Intervention Period 2 (2 Days)||2||
60039002|NCT02325713|76154870|FG000|COMPLETED|Intervention Period 2 (2 Days)||1||
60039003|NCT02325713|76154871|FG001|COMPLETED|Intervention Period 2 (2 Days)||2||
60039004|NCT02325713|76154872|FG002|COMPLETED|Intervention Period 2 (2 Days)||2||
60039005|NCT02325713|76154873|FG003|COMPLETED|Intervention Period 2 (2 Days)||2||
60039006|NCT02325713|76154874|FG004|COMPLETED|Intervention Period 2 (2 Days)||2||
60039007|NCT02325713|76154875|FG005|COMPLETED|Intervention Period 2 (2 Days)||2||
60039008|NCT02325713|76154876|FG006|COMPLETED|Intervention Period 2 (2 Days)||2||
60039009|NCT02325713|76154877|FG007|COMPLETED|Intervention Period 2 (2 Days)||2||
60039010|NCT02325713|76154878|FG008|COMPLETED|Intervention Period 2 (2 Days)||2||
60039011|NCT02325713|76154879|FG009|COMPLETED|Intervention Period 2 (2 Days)||2||
60039012|NCT02325713|76154880|FG010|COMPLETED|Intervention Period 2 (2 Days)||1||
60039013|NCT02325713|76154881|FG011|COMPLETED|Intervention Period 2 (2 Days)||2||
60039014|NCT02325713|76154882|FG012|COMPLETED|Intervention Period 2 (2 Days)||2||
60039015|NCT02325713|76154883|FG013|COMPLETED|Intervention Period 2 (2 Days)||2||
60039016|NCT02325713|76154884|FG014|COMPLETED|Intervention Period 2 (2 Days)||2||
60039017|NCT02325713|76154885|FG015|COMPLETED|Intervention Period 2 (2 Days)||2||
60039018|NCT02325713|76154870|FG000|NOT COMPLETED|Intervention Period 2 (2 Days)||1||
60039019|NCT02325713|76154871|FG001|NOT COMPLETED|Intervention Period 2 (2 Days)||0||
60039020|NCT02325713|76154872|FG002|NOT COMPLETED|Intervention Period 2 (2 Days)||0||
60039021|NCT02325713|76154873|FG003|NOT COMPLETED|Intervention Period 2 (2 Days)||0||
60039022|NCT02325713|76154874|FG004|NOT COMPLETED|Intervention Period 2 (2 Days)||0||
60039023|NCT02325713|76154875|FG005|NOT COMPLETED|Intervention Period 2 (2 Days)||0||
60039024|NCT02325713|76154876|FG006|NOT COMPLETED|Intervention Period 2 (2 Days)||0||
60039025|NCT02325713|76154877|FG007|NOT COMPLETED|Intervention Period 2 (2 Days)||0||
60039026|NCT02325713|76154878|FG008|NOT COMPLETED|Intervention Period 2 (2 Days)||0||
60039027|NCT02325713|76154879|FG009|NOT COMPLETED|Intervention Period 2 (2 Days)||0||
60039028|NCT02325713|76154880|FG010|NOT COMPLETED|Intervention Period 2 (2 Days)||0||
60039029|NCT02325713|76154881|FG011|NOT COMPLETED|Intervention Period 2 (2 Days)||0||
60039030|NCT02325713|76154882|FG012|NOT COMPLETED|Intervention Period 2 (2 Days)||0||
60039031|NCT02325713|76154883|FG013|NOT COMPLETED|Intervention Period 2 (2 Days)||0||
60039032|NCT02325713|76154884|FG014|NOT COMPLETED|Intervention Period 2 (2 Days)||0||
60039033|NCT02325713|76154885|FG015|NOT COMPLETED|Intervention Period 2 (2 Days)||0||
60039034|NCT02325713|76154870|FG000|STARTED|Intervention Period 3 (2 Days)||1||
60039035|NCT02325713|76154871|FG001|STARTED|Intervention Period 3 (2 Days)||2||
60039036|NCT02325713|76154872|FG002|STARTED|Intervention Period 3 (2 Days)||2||
60039037|NCT02325713|76154873|FG003|STARTED|Intervention Period 3 (2 Days)||2||
60039038|NCT02325713|76154874|FG004|STARTED|Intervention Period 3 (2 Days)||2||
60039039|NCT02325713|76154875|FG005|STARTED|Intervention Period 3 (2 Days)||2||
60039040|NCT02325713|76154876|FG006|STARTED|Intervention Period 3 (2 Days)||2||
60039041|NCT02325713|76154877|FG007|STARTED|Intervention Period 3 (2 Days)||2||
60039042|NCT02325713|76154878|FG008|STARTED|Intervention Period 3 (2 Days)||2||
60039043|NCT02325713|76154879|FG009|STARTED|Intervention Period 3 (2 Days)||2||
60039044|NCT02325713|76154880|FG010|STARTED|Intervention Period 3 (2 Days)||1||
60039045|NCT02325713|76154881|FG011|STARTED|Intervention Period 3 (2 Days)||2||
60039046|NCT02325713|76154882|FG012|STARTED|Intervention Period 3 (2 Days)||2||
60039047|NCT02325713|76154883|FG013|STARTED|Intervention Period 3 (2 Days)||2||
60039048|NCT02325713|76154884|FG014|STARTED|Intervention Period 3 (2 Days)||2||
60039049|NCT02325713|76154885|FG015|STARTED|Intervention Period 3 (2 Days)||2||
60039050|NCT02325713|76154870|FG000|COMPLETED|Intervention Period 3 (2 Days)||1||
60039051|NCT02325713|76154871|FG001|COMPLETED|Intervention Period 3 (2 Days)||2||
60039052|NCT02325713|76154872|FG002|COMPLETED|Intervention Period 3 (2 Days)||2||
60039053|NCT02325713|76154873|FG003|COMPLETED|Intervention Period 3 (2 Days)||2||
60039054|NCT02325713|76154874|FG004|COMPLETED|Intervention Period 3 (2 Days)||2||
60039055|NCT02325713|76154875|FG005|COMPLETED|Intervention Period 3 (2 Days)||2||
60039056|NCT02325713|76154876|FG006|COMPLETED|Intervention Period 3 (2 Days)||2||
60039057|NCT02325713|76154877|FG007|COMPLETED|Intervention Period 3 (2 Days)||2||
60039058|NCT02325713|76154878|FG008|COMPLETED|Intervention Period 3 (2 Days)||2||
60039059|NCT02325713|76154879|FG009|COMPLETED|Intervention Period 3 (2 Days)||1||
60039060|NCT02325713|76154880|FG010|COMPLETED|Intervention Period 3 (2 Days)||1||
60039061|NCT02325713|76154881|FG011|COMPLETED|Intervention Period 3 (2 Days)||2||
60039062|NCT02325713|76154882|FG012|COMPLETED|Intervention Period 3 (2 Days)||2||
60039063|NCT02325713|76154883|FG013|COMPLETED|Intervention Period 3 (2 Days)||2||
60039064|NCT02325713|76154884|FG014|COMPLETED|Intervention Period 3 (2 Days)||2||
60039065|NCT02325713|76154885|FG015|COMPLETED|Intervention Period 3 (2 Days)||2||
60039066|NCT02325713|76154870|FG000|NOT COMPLETED|Intervention Period 3 (2 Days)||0||
60039067|NCT02325713|76154871|FG001|NOT COMPLETED|Intervention Period 3 (2 Days)||0||
60039068|NCT02325713|76154872|FG002|NOT COMPLETED|Intervention Period 3 (2 Days)||0||
60039069|NCT02325713|76154873|FG003|NOT COMPLETED|Intervention Period 3 (2 Days)||0||
60039070|NCT02325713|76154874|FG004|NOT COMPLETED|Intervention Period 3 (2 Days)||0||
60039071|NCT02325713|76154875|FG005|NOT COMPLETED|Intervention Period 3 (2 Days)||0||
59509808|NCT02634814|75603195|FG000|STARTED|Overall Study||32||
59509809|NCT02634814|75603196|FG001|STARTED|Overall Study||29||
59509810|NCT02634814|75603197|FG002|STARTED|Overall Study||29||
59509811|NCT02634814|75603195|FG000|COMPLETED|Overall Study||30||
60039072|NCT02325713|76154876|FG006|NOT COMPLETED|Intervention Period 3 (2 Days)||0||
60039073|NCT02325713|76154877|FG007|NOT COMPLETED|Intervention Period 3 (2 Days)||0||
60039074|NCT02325713|76154878|FG008|NOT COMPLETED|Intervention Period 3 (2 Days)||0||
60039075|NCT02325713|76154879|FG009|NOT COMPLETED|Intervention Period 3 (2 Days)||1||
60039076|NCT02325713|76154880|FG010|NOT COMPLETED|Intervention Period 3 (2 Days)||0||
60039077|NCT02325713|76154881|FG011|NOT COMPLETED|Intervention Period 3 (2 Days)||0||
60039078|NCT02325713|76154882|FG012|NOT COMPLETED|Intervention Period 3 (2 Days)||0||
60039079|NCT02325713|76154883|FG013|NOT COMPLETED|Intervention Period 3 (2 Days)||0||
60039080|NCT02325713|76154884|FG014|NOT COMPLETED|Intervention Period 3 (2 Days)||0||
60039081|NCT02325713|76154885|FG015|NOT COMPLETED|Intervention Period 3 (2 Days)||0||
60039082|NCT02325713|76154870|FG000|STARTED|Intervention Period 4 (2 Days)||1||
60039083|NCT02325713|76154871|FG001|STARTED|Intervention Period 4 (2 Days)||2||
60039084|NCT02325713|76154872|FG002|STARTED|Intervention Period 4 (2 Days)||2||
60039085|NCT02325713|76154873|FG003|STARTED|Intervention Period 4 (2 Days)||2||
60039086|NCT02325713|76154874|FG004|STARTED|Intervention Period 4 (2 Days)||2||
60039087|NCT02325713|76154875|FG005|STARTED|Intervention Period 4 (2 Days)||2||
60039088|NCT02325713|76154876|FG006|STARTED|Intervention Period 4 (2 Days)||2||
60039089|NCT02325713|76154877|FG007|STARTED|Intervention Period 4 (2 Days)||2||
60039090|NCT02325713|76154878|FG008|STARTED|Intervention Period 4 (2 Days)||2||
60039091|NCT02325713|76154879|FG009|STARTED|Intervention Period 4 (2 Days)||1||
60039092|NCT02325713|76154880|FG010|STARTED|Intervention Period 4 (2 Days)||1||
60039093|NCT02325713|76154881|FG011|STARTED|Intervention Period 4 (2 Days)||2||
60039094|NCT02325713|76154882|FG012|STARTED|Intervention Period 4 (2 Days)||2||
60039095|NCT02325713|76154883|FG013|STARTED|Intervention Period 4 (2 Days)||2||
60039096|NCT02325713|76154884|FG014|STARTED|Intervention Period 4 (2 Days)||2||
60039097|NCT02325713|76154885|FG015|STARTED|Intervention Period 4 (2 Days)||2||
60039098|NCT02325713|76154870|FG000|COMPLETED|Intervention Period 4 (2 Days)||1||
60039099|NCT02325713|76154871|FG001|COMPLETED|Intervention Period 4 (2 Days)||2||
60039100|NCT02325713|76154872|FG002|COMPLETED|Intervention Period 4 (2 Days)||2||
60039101|NCT02325713|76154873|FG003|COMPLETED|Intervention Period 4 (2 Days)||2||
60039102|NCT02325713|76154874|FG004|COMPLETED|Intervention Period 4 (2 Days)||2||
60039103|NCT02325713|76154875|FG005|COMPLETED|Intervention Period 4 (2 Days)||2||
60039104|NCT02325713|76154876|FG006|COMPLETED|Intervention Period 4 (2 Days)||2||
60039105|NCT02325713|76154877|FG007|COMPLETED|Intervention Period 4 (2 Days)||2||
60039106|NCT02325713|76154878|FG008|COMPLETED|Intervention Period 4 (2 Days)||2||
59509812|NCT02634814|75603196|FG001|COMPLETED|Overall Study||23||
59509813|NCT02634814|75603197|FG002|COMPLETED|Overall Study||29||
59509814|NCT02634814|75603195|FG000|NOT COMPLETED|Overall Study||2||
59509815|NCT02634814|75603196|FG001|NOT COMPLETED|Overall Study||6||
60039107|NCT02325713|76154879|FG009|COMPLETED|Intervention Period 4 (2 Days)||1||
60039108|NCT02325713|76154880|FG010|COMPLETED|Intervention Period 4 (2 Days)||1||
60039109|NCT02325713|76154881|FG011|COMPLETED|Intervention Period 4 (2 Days)||2||
60039110|NCT02325713|76154882|FG012|COMPLETED|Intervention Period 4 (2 Days)||2||
60039111|NCT02325713|76154883|FG013|COMPLETED|Intervention Period 4 (2 Days)||2||
60039112|NCT02325713|76154884|FG014|COMPLETED|Intervention Period 4 (2 Days)||2||
60039113|NCT02325713|76154885|FG015|COMPLETED|Intervention Period 4 (2 Days)||2||
60039114|NCT02325713|76154870|FG000|NOT COMPLETED|Intervention Period 4 (2 Days)||0||
60039115|NCT02325713|76154871|FG001|NOT COMPLETED|Intervention Period 4 (2 Days)||0||
60039116|NCT02325713|76154872|FG002|NOT COMPLETED|Intervention Period 4 (2 Days)||0||
60039117|NCT02325713|76154873|FG003|NOT COMPLETED|Intervention Period 4 (2 Days)||0||
59509816|NCT02634814|75603197|FG002|NOT COMPLETED|Overall Study||0||
59509817|NCT02635828|75603205|FG000|STARTED|Overall Study||54||
59509818|NCT02635828|75603205|FG000|COMPLETED|Overall Study||40||
59509819|NCT02635828|75603205|FG000|NOT COMPLETED|Overall Study||14||
59509820|NCT00836719|75603209|FG000|STARTED|Overall Study||10||
59509821|NCT00836719|75603209|FG000|COMPLETED|Overall Study||10||
60039118|NCT02325713|76154874|FG004|NOT COMPLETED|Intervention Period 4 (2 Days)||0||
60039119|NCT02325713|76154875|FG005|NOT COMPLETED|Intervention Period 4 (2 Days)||0||
60039120|NCT02325713|76154876|FG006|NOT COMPLETED|Intervention Period 4 (2 Days)||0||
59918152|NCT02674490|76038648|FG000|COMPLETED|Overall Study||25|Completed 1 week follow-up|
59918153|NCT02674490|76038649|FG001|COMPLETED|Overall Study||21|Completed 1 week follow-up|
59918154|NCT02674490|76038648|FG000|NOT COMPLETED|Overall Study||5||
59918155|NCT02674490|76038649|FG001|NOT COMPLETED|Overall Study||7||
59918156|NCT02677714|76038657|FG000|STARTED|Overall Study||12|All enrolled patients who were dosed were included in both the full analysis set (FAS) and the safety set|
59918157|NCT02677714|76038658|FG001|STARTED|Overall Study||2|All enrolled patients who were dosed were included in both the full analysis set (FAS) and the safety set|
59918158|NCT02677714|76038657|FG000|COMPLETED|Overall Study||10||
59918159|NCT02677714|76038658|FG001|COMPLETED|Overall Study||2||
59918160|NCT02677714|76038657|FG000|NOT COMPLETED|Overall Study||2||
59918161|NCT02677714|76038658|FG001|NOT COMPLETED|Overall Study||0||
59918162|NCT02677324|76038664|FG000|STARTED|Overall Study||33||
59918163|NCT02677324|76038664|FG000|COMPLETED|Overall Study||21||
59918164|NCT02677324|76038664|FG000|NOT COMPLETED|Overall Study||12||
59918165|NCT01971008|76038672|FG000|STARTED|Overall Study||6||
59918166|NCT01971008|76038673|FG001|STARTED|Overall Study||9||
59918167|NCT01971008|76038672|FG000|COMPLETED|Overall Study||4||
59918168|NCT01971008|76038673|FG001|COMPLETED|Overall Study||8||
59918169|NCT01971008|76038672|FG000|NOT COMPLETED|Overall Study||2||
59918170|NCT01971008|76038673|FG001|NOT COMPLETED|Overall Study||1||
59918171|NCT01374178|76038682|FG000|STARTED|Period 1 (up to 24 Hours After Dosing)||11||
59918172|NCT01374178|76038683|FG001|STARTED|Period 1 (up to 24 Hours After Dosing)||5||
59918173|NCT01374178|76038682|FG000|Received at Least 1 Dose of LY2963016|Period 1 (up to 24 Hours After Dosing)||11||
59918174|NCT01374178|76038683|FG001|Received at Least 1 Dose of LY2963016|Period 1 (up to 24 Hours After Dosing)||5||
59918175|NCT01374178|76038682|FG000|COMPLETED|Period 1 (up to 24 Hours After Dosing)||11||
59918176|NCT01374178|76038683|FG001|COMPLETED|Period 1 (up to 24 Hours After Dosing)||5||
59918177|NCT01374178|76038682|FG000|NOT COMPLETED|Period 1 (up to 24 Hours After Dosing)||0||
59918178|NCT01374178|76038683|FG001|NOT COMPLETED|Period 1 (up to 24 Hours After Dosing)||0||
59918179|NCT01374178|76038682|FG000|STARTED|Washout Period of at Least 7 Days||11||
59918180|NCT01374178|76038683|FG001|STARTED|Washout Period of at Least 7 Days||5||
59918181|NCT01374178|76038682|FG000|COMPLETED|Washout Period of at Least 7 Days||10||
59918182|NCT01374178|76038683|FG001|COMPLETED|Washout Period of at Least 7 Days||5||
59918183|NCT01374178|76038682|FG000|NOT COMPLETED|Washout Period of at Least 7 Days||1||
59918184|NCT01374178|76038683|FG001|NOT COMPLETED|Washout Period of at Least 7 Days||0||
59918185|NCT01374178|76038682|FG000|STARTED|Period 2 (up to 24 Hours After Dosing)||10||
59918186|NCT01374178|76038683|FG001|STARTED|Period 2 (up to 24 Hours After Dosing)||5||
59918187|NCT01374178|76038682|FG000|COMPLETED|Period 2 (up to 24 Hours After Dosing)||8||
59918188|NCT01374178|76038683|FG001|COMPLETED|Period 2 (up to 24 Hours After Dosing)||5||
59918189|NCT01374178|76038682|FG000|NOT COMPLETED|Period 2 (up to 24 Hours After Dosing)||2||
59918190|NCT01374178|76038683|FG001|NOT COMPLETED|Period 2 (up to 24 Hours After Dosing)||0||
59918191|NCT03025542|76038691|FG000|STARTED|Overall Study||32||
59918192|NCT03025542|76038692|FG001|STARTED|Overall Study||17||
59918193|NCT03025542|76038691|FG000|COMPLETED|Overall Study||30||
59918194|NCT03025542|76038692|FG001|COMPLETED|Overall Study||15||
59918195|NCT03025542|76038691|FG000|NOT COMPLETED|Overall Study||2||
59918196|NCT03025542|76038692|FG001|NOT COMPLETED|Overall Study||2||
59918197|NCT03022370|76038706|FG000|STARTED|Overall Study||677||
59918198|NCT03022370|76038707|FG001|STARTED|Overall Study||674||
59918199|NCT03022370|76038706|FG000|COMPLETED|Overall Study||497||
59918200|NCT03022370|76038707|FG001|COMPLETED|Overall Study||553||
59918201|NCT03022370|76038706|FG000|NOT COMPLETED|Overall Study||180||
59918202|NCT03022370|76038707|FG001|NOT COMPLETED|Overall Study||121||
59918203|NCT03021668|76038719|FG000|STARTED|Overall Study||62||
59918204|NCT03021668|76038720|FG001|STARTED|Overall Study||62||
59918205|NCT03021668|76038719|FG000|COMPLETED|Overall Study||62||
59918206|NCT03021668|76038720|FG001|COMPLETED|Overall Study||61||
59918207|NCT03021668|76038719|FG000|NOT COMPLETED|Overall Study||0||
59918208|NCT03021668|76038720|FG001|NOT COMPLETED|Overall Study||1||
59918209|NCT03020888|76038726|FG000|STARTED|Overall Study||120||
59918210|NCT03020888|76038726|FG000|COMPLETED|Overall Study||107||
59918211|NCT03020888|76038726|FG000|NOT COMPLETED|Overall Study||13||
59918212|NCT02250300|76038734|FG000|STARTED|Dose Escalation 3.0 mg Phase||0||
59918213|NCT02250300|76038735|FG001|STARTED|Dose Escalation 3.0 mg Phase||0||
59918214|NCT02250300|76038736|FG002|STARTED|Dose Escalation 3.0 mg Phase||3||
59918215|NCT02250300|76038737|FG003|STARTED|Dose Escalation 3.0 mg Phase||0||
59918216|NCT02250300|76038734|FG000|COMPLETED|Dose Escalation 3.0 mg Phase||0||
59918217|NCT02250300|76038735|FG001|COMPLETED|Dose Escalation 3.0 mg Phase||0||
59918218|NCT02250300|76038736|FG002|COMPLETED|Dose Escalation 3.0 mg Phase||3||
59918219|NCT02250300|76038737|FG003|COMPLETED|Dose Escalation 3.0 mg Phase||0||
59918220|NCT02250300|76038734|FG000|NOT COMPLETED|Dose Escalation 3.0 mg Phase||0||
59918221|NCT02250300|76038735|FG001|NOT COMPLETED|Dose Escalation 3.0 mg Phase||0||
59918222|NCT02250300|76038736|FG002|NOT COMPLETED|Dose Escalation 3.0 mg Phase||0||
59951405|NCT01798992|76070390|FG000|STARTED|Overall Study||4||
60039121|NCT02325713|76154877|FG007|NOT COMPLETED|Intervention Period 4 (2 Days)||0||
60039122|NCT02325713|76154878|FG008|NOT COMPLETED|Intervention Period 4 (2 Days)||0||
60039123|NCT02325713|76154879|FG009|NOT COMPLETED|Intervention Period 4 (2 Days)||0||
59918223|NCT02250300|76038737|FG003|NOT COMPLETED|Dose Escalation 3.0 mg Phase||0||
59918224|NCT02250300|76038734|FG000|STARTED|Dose Escalation 4.0 mg Phase||0||
60039124|NCT02325713|76154880|FG010|NOT COMPLETED|Intervention Period 4 (2 Days)||0||
60039125|NCT02325713|76154881|FG011|NOT COMPLETED|Intervention Period 4 (2 Days)||0||
60039126|NCT02325713|76154882|FG012|NOT COMPLETED|Intervention Period 4 (2 Days)||0||
60039127|NCT02325713|76154883|FG013|NOT COMPLETED|Intervention Period 4 (2 Days)||0||
60039128|NCT02325713|76154884|FG014|NOT COMPLETED|Intervention Period 4 (2 Days)||0||
60039129|NCT02325713|76154885|FG015|NOT COMPLETED|Intervention Period 4 (2 Days)||0||
60039130|NCT02325401|76154900|FG000|STARTED|Overall Study||6||
60039131|NCT02325401|76154901|FG001|STARTED|Overall Study||9||
60039132|NCT02325401|76154902|FG002|STARTED|Overall Study||5||
59509822|NCT00836719|75603209|FG000|NOT COMPLETED|Overall Study||0||
59509823|NCT02638168|75603213|FG000|STARTED|Overall Study||3|This was with-in subject trial|
59509824|NCT02638168|75603214|FG001|STARTED|Overall Study||0|This was with-in subject trial|
59509825|NCT02638168|75603213|FG000|COMPLETED|Overall Study||3||
59509826|NCT02638168|75603214|FG001|COMPLETED|Overall Study||0||
59509827|NCT02638168|75603213|FG000|NOT COMPLETED|Overall Study||0||
59509828|NCT02638168|75603214|FG001|NOT COMPLETED|Overall Study||0||
59918225|NCT02250300|76038735|FG001|STARTED|Dose Escalation 4.0 mg Phase||0||
59918226|NCT02250300|76038736|FG002|STARTED|Dose Escalation 4.0 mg Phase|This cohort was involved only in the 3.0 mg dose escalation phase and were not involved in subsequent phases of the study.|0||
59918227|NCT02250300|76038737|FG003|STARTED|Dose Escalation 4.0 mg Phase|This cohort was involved only in the 4.0 mg dose escalation phase and were not involved in prior or subsequent phases of the study.|3||
59918228|NCT02250300|76038734|FG000|COMPLETED|Dose Escalation 4.0 mg Phase||0||
59918229|NCT02250300|76038735|FG001|COMPLETED|Dose Escalation 4.0 mg Phase||0||
59918230|NCT02250300|76038736|FG002|COMPLETED|Dose Escalation 4.0 mg Phase||0||
59918231|NCT02250300|76038737|FG003|COMPLETED|Dose Escalation 4.0 mg Phase||3||
59918232|NCT02250300|76038734|FG000|NOT COMPLETED|Dose Escalation 4.0 mg Phase||0||
59918233|NCT02250300|76038735|FG001|NOT COMPLETED|Dose Escalation 4.0 mg Phase||0||
59918234|NCT02250300|76038736|FG002|NOT COMPLETED|Dose Escalation 4.0 mg Phase||0||
59918235|NCT02250300|76038737|FG003|NOT COMPLETED|Dose Escalation 4.0 mg Phase||0||
60039133|NCT02325401|76154900|FG000|COMPLETED|Overall Study||6||
60039134|NCT02325401|76154901|FG001|COMPLETED|Overall Study||8||
60039135|NCT02325401|76154902|FG002|COMPLETED|Overall Study||4||
60039136|NCT02325401|76154900|FG000|NOT COMPLETED|Overall Study||0||
60039137|NCT02325401|76154901|FG001|NOT COMPLETED|Overall Study||1||
60039138|NCT02325401|76154902|FG002|NOT COMPLETED|Overall Study||1||
60039139|NCT02324699|76154916|FG000|STARTED|Overall Study||1||
60039140|NCT02324699|76154916|FG000|COMPLETED|Overall Study||0||
59509829|NCT00837031|75603218|FG000|STARTED|Overall Study||72||
59509830|NCT00837031|75603218|FG000|COMPLETED|Overall Study||72||
59509831|NCT00837031|75603218|FG000|NOT COMPLETED|Overall Study||0||
59509832|NCT02639494|75603222|FG000|STARTED|Overall Study||20||
59509833|NCT02639494|75603222|FG000|COMPLETED|Overall Study||20||
59509834|NCT02639494|75603222|FG000|NOT COMPLETED|Overall Study||0||
59509835|NCT02154763|75603228|FG000|STARTED|Overall Study||60||
60039141|NCT02324699|76154916|FG000|NOT COMPLETED|Overall Study||1||
60039142|NCT01764256|76154924|FG000|STARTED|Received All Vaccinations||12||
60039143|NCT01764256|76154925|FG001|STARTED|Received All Vaccinations||12||
60039144|NCT01764256|76154926|FG002|STARTED|Received All Vaccinations||12||
60039145|NCT01764256|76154927|FG003|STARTED|Received All Vaccinations||12||
60039146|NCT01764256|76154924|FG000|COMPLETED|Received All Vaccinations||10||
60039147|NCT01764256|76154925|FG001|COMPLETED|Received All Vaccinations||11||
60039148|NCT01764256|76154926|FG002|COMPLETED|Received All Vaccinations||11||
60039149|NCT01764256|76154927|FG003|COMPLETED|Received All Vaccinations||12||
60039150|NCT01764256|76154924|FG000|NOT COMPLETED|Received All Vaccinations||2||
60039151|NCT01764256|76154925|FG001|NOT COMPLETED|Received All Vaccinations||1||
60039152|NCT01764256|76154926|FG002|NOT COMPLETED|Received All Vaccinations||1||
60039153|NCT01764256|76154927|FG003|NOT COMPLETED|Received All Vaccinations||0||
60039154|NCT01764256|76154924|FG000|STARTED|Completed Study||10||
60039155|NCT01764256|76154925|FG001|STARTED|Completed Study||11||
60039156|NCT01764256|76154926|FG002|STARTED|Completed Study||11||
60039157|NCT01764256|76154927|FG003|STARTED|Completed Study||12||
60039158|NCT01764256|76154924|FG000|COMPLETED|Completed Study||10||
60039159|NCT01764256|76154925|FG001|COMPLETED|Completed Study||11||
60039160|NCT01764256|76154926|FG002|COMPLETED|Completed Study||11||
60039161|NCT01764256|76154927|FG003|COMPLETED|Completed Study||11||
60039162|NCT01764256|76154924|FG000|NOT COMPLETED|Completed Study||0||
60039163|NCT01764256|76154925|FG001|NOT COMPLETED|Completed Study||0||
60039164|NCT01764256|76154926|FG002|NOT COMPLETED|Completed Study||0||
60039165|NCT01764256|76154927|FG003|NOT COMPLETED|Completed Study||1||
60039166|NCT01979523|76154943|FG000|STARTED|Overall Study||21||
60039167|NCT01979523|76154944|FG001|STARTED|Overall Study||21||
60039168|NCT01979523|76154943|FG000|COMPLETED|Overall Study||20||
60039169|NCT01979523|76154944|FG001|COMPLETED|Overall Study||21||
60039170|NCT01979523|76154943|FG000|NOT COMPLETED|Overall Study||1||
60039171|NCT01979523|76154944|FG001|NOT COMPLETED|Overall Study||0||
60039172|NCT02255461|76154956|FG000|STARTED|Overall Study||3||
60039173|NCT02255461|76154957|FG001|STARTED|Overall Study||12||
60039174|NCT02255461|76154958|FG002|STARTED|Overall Study||6||
60039175|NCT02255461|76154959|FG003|STARTED|Overall Study||4||
60039176|NCT02255461|76154960|FG004|STARTED|Overall Study||10||
60039177|NCT02255461|76154956|FG000|COMPLETED|Overall Study||3||
60039178|NCT02255461|76154957|FG001|COMPLETED|Overall Study||10||
60039179|NCT02255461|76154958|FG002|COMPLETED|Overall Study||5||
60039180|NCT02255461|76154959|FG003|COMPLETED|Overall Study||4||
60039181|NCT02255461|76154960|FG004|COMPLETED|Overall Study||8||
60039182|NCT02255461|76154956|FG000|NOT COMPLETED|Overall Study||0||
60039183|NCT02255461|76154957|FG001|NOT COMPLETED|Overall Study||2||
60039184|NCT02255461|76154958|FG002|NOT COMPLETED|Overall Study||1||
60039185|NCT02255461|76154959|FG003|NOT COMPLETED|Overall Study||0||
60039186|NCT02255461|76154960|FG004|NOT COMPLETED|Overall Study||2||
60039187|NCT01764022|76154979|FG000|STARTED|Overall Study||115||
60039188|NCT01764022|76154980|FG001|STARTED|Overall Study||110||
60039189|NCT01764022|76154979|FG000|Received at Least 1 Dose of Study Drug|Overall Study||113||
60039190|NCT01764022|76154980|FG001|Received at Least 1 Dose of Study Drug|Overall Study||110||
60039191|NCT01764022|76154979|FG000|COMPLETED|Overall Study||107|Received 6 cycles of therapy during main period of the study or had disease progression|
60039192|NCT01764022|76154980|FG001|COMPLETED|Overall Study||96|Received 6 cycles of therapy during main period of the study or had disease progression|
60039193|NCT01764022|76154979|FG000|NOT COMPLETED|Overall Study||8||
60039194|NCT01764022|76154980|FG001|NOT COMPLETED|Overall Study||14||
60039195|NCT02003391|76154990|FG000|STARTED|Overall Study||81||
60039196|NCT02003391|76154991|FG001|STARTED|Overall Study||75||
60039197|NCT02003391|76154990|FG000|Safety Population|Overall Study||81||
59509836|NCT02154763|75603229|FG001|STARTED|Overall Study||60||
59509837|NCT02154763|75603228|FG000|COMPLETED|Overall Study||46||
60039198|NCT02003391|76154991|FG001|Safety Population|Overall Study||75||
60039199|NCT02003391|76154990|FG000|Intent to Treat Population|Overall Study||78||
60039200|NCT02003391|76154991|FG001|Intent to Treat Population|Overall Study||73||
60039201|NCT02003391|76154990|FG000|COMPLETED|Overall Study||78||
60039202|NCT02003391|76154991|FG001|COMPLETED|Overall Study||73||
60039203|NCT02003391|76154990|FG000|NOT COMPLETED|Overall Study||3||
59509838|NCT02154763|75603229|FG001|COMPLETED|Overall Study||46||
59509839|NCT02154763|75603228|FG000|NOT COMPLETED|Overall Study||14||
59509840|NCT02154763|75603229|FG001|NOT COMPLETED|Overall Study||14||
60039204|NCT02003391|76154991|FG001|NOT COMPLETED|Overall Study||2||
60039205|NCT02254681|76154997|FG000|STARTED|Overall Study||6||
60039206|NCT02254681|76154997|FG000|COMPLETED|Overall Study||0||
60039207|NCT02254681|76154997|FG000|NOT COMPLETED|Overall Study||6||
60039208|NCT01965327|76155002|FG000|STARTED|Overall Study||12||
60039209|NCT01965327|76155002|FG000|COMPLETED|Overall Study|Prior to completion, 2 subjects were withdrawn by the PI for failure to adhere to study protocol.|10||
60039210|NCT01965327|76155002|FG000|NOT COMPLETED|Overall Study||2||
60039211|NCT02002689|76155006|FG000|STARTED|Overall Study||10||
60039212|NCT02002689|76155006|FG000|COMPLETED|Overall Study||0||
60039213|NCT02002689|76155006|FG000|NOT COMPLETED|Overall Study||10||
60039214|NCT01639729|76155010|FG000|STARTED|Overall Study||4||
60039215|NCT01639729|76155011|FG001|STARTED|Overall Study||4||
60039216|NCT01639729|76155012|FG002|STARTED|Overall Study||4||
60039217|NCT01639729|76155013|FG003|STARTED|Overall Study||5||
60039218|NCT01639729|76155014|FG004|STARTED|Overall Study||4||
60039219|NCT01639729|76155015|FG005|STARTED|Overall Study||4||
60039220|NCT01639729|76155010|FG000|COMPLETED|Overall Study||3||
60039221|NCT01639729|76155011|FG001|COMPLETED|Overall Study||4||
60039222|NCT01639729|76155012|FG002|COMPLETED|Overall Study||3||
60039223|NCT01639729|76155013|FG003|COMPLETED|Overall Study||4||
60039224|NCT01639729|76155014|FG004|COMPLETED|Overall Study||4||
60039225|NCT01639729|76155015|FG005|COMPLETED|Overall Study||4||
60039226|NCT01639729|76155010|FG000|NOT COMPLETED|Overall Study||1||
60039227|NCT01639729|76155011|FG001|NOT COMPLETED|Overall Study||0||
60039228|NCT01639729|76155012|FG002|NOT COMPLETED|Overall Study||1||
59509841|NCT02639884|75603237|FG000|STARTED|Overall Study||51||
59509842|NCT02639884|75603237|FG000|COMPLETED|Overall Study||47||
59509843|NCT02639884|75603237|FG000|NOT COMPLETED|Overall Study||4||
59509844|NCT02641522|75603242|FG000|STARTED|Overall Study||10||
59509845|NCT02641522|75603242|FG000|COMPLETED|Overall Study||10||
59509846|NCT02641522|75603242|FG000|NOT COMPLETED|Overall Study||0||
59509847|NCT00840307|75603246|FG000|STARTED|Overall Study||20||
60039229|NCT01639729|76155013|FG003|NOT COMPLETED|Overall Study||1||
60039230|NCT01639729|76155014|FG004|NOT COMPLETED|Overall Study||0||
60039231|NCT01639729|76155015|FG005|NOT COMPLETED|Overall Study||0||
60039232|NCT02002533|76155027|FG000|STARTED|Overall Study||34||
60039233|NCT02002533|76155028|FG001|STARTED|Overall Study||37||
60039234|NCT02002533|76155027|FG000|COMPLETED|Overall Study||28||
60039235|NCT02002533|76155028|FG001|COMPLETED|Overall Study||19||
60039236|NCT02002533|76155027|FG000|NOT COMPLETED|Overall Study||6||
60039237|NCT02002533|76155028|FG001|NOT COMPLETED|Overall Study||18||
60039238|NCT02002221|76155037|FG000|STARTED|Overall Study||78||
60039239|NCT02002221|76155038|FG001|STARTED|Overall Study||78||
60039240|NCT02002221|76155037|FG000|COMPLETED|Overall Study||76||
60039241|NCT02002221|76155038|FG001|COMPLETED|Overall Study||75||
60039242|NCT02002221|76155037|FG000|NOT COMPLETED|Overall Study||2||
60039243|NCT02002221|76155038|FG001|NOT COMPLETED|Overall Study||3||
60039244|NCT01639495|76155044|FG000|STARTED|Overall Study|Patients who signed the informed consent.|148||
60039245|NCT01639495|76155044|FG000|Safety Cohort|Overall Study||144|Safety population includes those enrolled subjects who underwent insertion of the study catheter.|
60039246|NCT01639495|76155044|FG000|Primary Effectiveness Cohort|Overall Study||138|Safety cohort subjects meeting eligibility criteria & receiving radiofrequency (RF) ablation for AF|
60039247|NCT01639495|76155044|FG000|COMPLETED|Overall Study||132||
60039248|NCT01639495|76155044|FG000|NOT COMPLETED|Overall Study||16||
60039249|NCT02001987|76155048|FG000|STARTED|Core Study Period (24 Weeks)||139||
60039250|NCT02001987|76155048|FG000|COMPLETED|Core Study Period (24 Weeks)||116||
60039251|NCT02001987|76155048|FG000|NOT COMPLETED|Core Study Period (24 Weeks)||23||
60039252|NCT02001987|76155048|FG000|STARTED|LTE Period (52 Weeks)||116||
60039253|NCT02001987|76155048|FG000|COMPLETED|LTE Period (52 Weeks)||107||
60039254|NCT02001987|76155048|FG000|NOT COMPLETED|LTE Period (52 Weeks)||9||
59509848|NCT00840307|75603246|FG000|COMPLETED|Overall Study||16||
59509849|NCT00840307|75603246|FG000|NOT COMPLETED|Overall Study||4||
59509850|NCT02641834|75603252|FG000|STARTED|Overall Study||60||
59509851|NCT02641834|75603253|FG001|STARTED|Overall Study||58||
60039255|NCT01363765|76155059|FG000|STARTED|Overall Study|This is number of participants enrolled, each with one sample submitted to Xpert in intervention arm|18322||
60039256|NCT01363765|76155060|FG001|STARTED|Overall Study|This is number of participants enrolled, each with one sample considered in baseline arm.|16436||
60039257|NCT01363765|76155059|FG000|COMPLETED|Overall Study|Excluded were duplicates, non-residents, missing age, unavailability of system (smears done instead)|12522||
60039258|NCT01363765|76155060|FG001|COMPLETED|Overall Study|Samples contributing to observation arm. Excluded were duplicates, non-residents, missing age.|11705||
60039259|NCT01363765|76155059|FG000|NOT COMPLETED|Overall Study||5800||
60039260|NCT01363765|76155060|FG001|NOT COMPLETED|Overall Study||4731||
60039261|NCT02001051|76155070|FG000|STARTED|Overall Study||2||
60039262|NCT02001051|76155071|FG001|STARTED|Overall Study||2||
60039263|NCT02001051|76155070|FG000|COMPLETED|Overall Study||2||
60039264|NCT02001051|76155071|FG001|COMPLETED|Overall Study||1||
59509852|NCT02641834|75603252|FG000|COMPLETED|Overall Study||50||
59509853|NCT02641834|75603253|FG001|COMPLETED|Overall Study||50||
60039265|NCT02001051|76155070|FG000|NOT COMPLETED|Overall Study||0||
60039266|NCT02001051|76155071|FG001|NOT COMPLETED|Overall Study||1||
60039267|NCT01763164|76155079|FG000|STARTED|Treatment Phase||269||
60039268|NCT01763164|76155080|FG001|STARTED|Treatment Phase||133||
60039269|NCT01763164|76155079|FG000|Treated/Safety Set|Treatment Phase||269||
60039270|NCT01763164|76155080|FG001|Treated/Safety Set|Treatment Phase||114||
60039271|NCT01763164|76155079|FG000|Full Analysis Set|Treatment Phase||269||
59509854|NCT02641834|75603252|FG000|NOT COMPLETED|Overall Study||10||
59509855|NCT02641834|75603253|FG001|NOT COMPLETED|Overall Study||8||
59509856|NCT00861601|75603263|FG000|STARTED|Overall Study||12||
59509857|NCT00861601|75603264|FG001|STARTED|Overall Study||14||
60039272|NCT01763164|76155080|FG001|Full Analysis Set|Treatment Phase||133||
60039273|NCT01763164|76155079|FG000|COMPLETED|Treatment Phase||0||
60039274|NCT01763164|76155080|FG001|COMPLETED|Treatment Phase||0||
60039275|NCT01763164|76155079|FG000|NOT COMPLETED|Treatment Phase||269||
60039276|NCT01763164|76155080|FG001|NOT COMPLETED|Treatment Phase||133||
60039277|NCT01763164|76155079|FG000|STARTED|Follow up Phase|Participants were followed up after completion or discontinuation of treatment.|200||
60039278|NCT01763164|76155080|FG001|STARTED|Follow up Phase|Participants were followed up after completion or discontinuation of treatment.|78||
60039279|NCT01763164|76155079|FG000|COMPLETED|Follow up Phase||3||
60039280|NCT01763164|76155080|FG001|COMPLETED|Follow up Phase||3||
60039281|NCT01763164|76155079|FG000|NOT COMPLETED|Follow up Phase||197||
60039282|NCT01763164|76155080|FG001|NOT COMPLETED|Follow up Phase||75||
60039283|NCT01782742|76155088|FG000|STARTED|Double-blind Treatment Phase||16||
60039284|NCT01782742|76155089|FG001|STARTED|Double-blind Treatment Phase||4||
60039285|NCT01782742|76155088|FG000|COMPLETED|Double-blind Treatment Phase||15||
60039286|NCT01782742|76155089|FG001|COMPLETED|Double-blind Treatment Phase||4||
60039287|NCT01782742|76155088|FG000|NOT COMPLETED|Double-blind Treatment Phase||1||
60039288|NCT01782742|76155089|FG001|NOT COMPLETED|Double-blind Treatment Phase||0||
60039289|NCT01782742|76155088|FG000|STARTED|Open Label Phase||19||
60039290|NCT01782742|76155089|FG001|STARTED|Open Label Phase||0||
60039291|NCT01782742|76155088|FG000|COMPLETED|Open Label Phase||19||
60039292|NCT01782742|76155089|FG001|COMPLETED|Open Label Phase||0||
60039293|NCT01782742|76155088|FG000|NOT COMPLETED|Open Label Phase||0||
60039294|NCT01782742|76155089|FG001|NOT COMPLETED|Open Label Phase||0||
60039295|NCT01782664|76155103|FG000|STARTED|Overall Study||14||
60039296|NCT01782664|76155104|FG001|STARTED|Overall Study||15||
60039297|NCT01782664|76155105|FG002|STARTED|Overall Study||16||
60039298|NCT01782664|76155106|FG003|STARTED|Overall Study||14||
60039299|NCT01782664|76155107|FG004|STARTED|Overall Study||6||
60039300|NCT01782664|76155108|FG005|STARTED|Overall Study||2||
60039301|NCT01782664|76155103|FG000|COMPLETED|Overall Study||8||
60039302|NCT01782664|76155104|FG001|COMPLETED|Overall Study||10||
60039303|NCT01782664|76155105|FG002|COMPLETED|Overall Study||12||
60039304|NCT01782664|76155106|FG003|COMPLETED|Overall Study||9||
60039305|NCT01782664|76155107|FG004|COMPLETED|Overall Study||6||
60039306|NCT01782664|76155108|FG005|COMPLETED|Overall Study||2||
60039307|NCT01782664|76155103|FG000|NOT COMPLETED|Overall Study||6||
60039308|NCT01782664|76155104|FG001|NOT COMPLETED|Overall Study||5||
60039309|NCT01782664|76155105|FG002|NOT COMPLETED|Overall Study||4||
60039310|NCT01782664|76155106|FG003|NOT COMPLETED|Overall Study||5||
60039311|NCT01782664|76155107|FG004|NOT COMPLETED|Overall Study||0||
60039312|NCT01782664|76155108|FG005|NOT COMPLETED|Overall Study||0||
60039313|NCT01732588|76155125|FG000|STARTED|First Intervention (7 Days)||4||
60039314|NCT01732588|76155126|FG001|STARTED|First Intervention (7 Days)||3||
60039315|NCT01732588|76155127|FG002|STARTED|First Intervention (7 Days)||4||
60039316|NCT01732588|76155125|FG000|COMPLETED|First Intervention (7 Days)||4||
60039317|NCT01732588|76155126|FG001|COMPLETED|First Intervention (7 Days)||2||
60039318|NCT01732588|76155127|FG002|COMPLETED|First Intervention (7 Days)||4||
60039319|NCT01732588|76155125|FG000|NOT COMPLETED|First Intervention (7 Days)||0||
60039320|NCT01732588|76155126|FG001|NOT COMPLETED|First Intervention (7 Days)||1||
60039321|NCT01732588|76155127|FG002|NOT COMPLETED|First Intervention (7 Days)||0||
60039322|NCT01732588|76155125|FG000|STARTED|Second Intervention (7 Days)||4||
60039323|NCT01732588|76155126|FG001|STARTED|Second Intervention (7 Days)||2||
60039324|NCT01732588|76155127|FG002|STARTED|Second Intervention (7 Days)||4||
60039325|NCT01732588|76155125|FG000|COMPLETED|Second Intervention (7 Days)||4||
60039326|NCT01732588|76155126|FG001|COMPLETED|Second Intervention (7 Days)||2||
60039327|NCT01732588|76155127|FG002|COMPLETED|Second Intervention (7 Days)||4||
60039328|NCT01732588|76155125|FG000|NOT COMPLETED|Second Intervention (7 Days)||0||
60039329|NCT01732588|76155126|FG001|NOT COMPLETED|Second Intervention (7 Days)||0||
59509858|NCT00861601|75603265|FG002|STARTED|Overall Study||12||
59509859|NCT00861601|75603263|FG000|COMPLETED|Overall Study||12||
60039330|NCT01732588|76155127|FG002|NOT COMPLETED|Second Intervention (7 Days)||0||
60039331|NCT01732588|76155125|FG000|STARTED|Third Intervention (7 Days)||4||
60039332|NCT01732588|76155126|FG001|STARTED|Third Intervention (7 Days)||2||
60039333|NCT01732588|76155127|FG002|STARTED|Third Intervention (7 Days)||4||
60039334|NCT01732588|76155125|FG000|COMPLETED|Third Intervention (7 Days)||4||
60039335|NCT01732588|76155126|FG001|COMPLETED|Third Intervention (7 Days)||2||
59509860|NCT00861601|75603264|FG001|COMPLETED|Overall Study||14||
59509861|NCT00861601|75603265|FG002|COMPLETED|Overall Study||12||
60039336|NCT01732588|76155127|FG002|COMPLETED|Third Intervention (7 Days)||4||
60039337|NCT01732588|76155125|FG000|NOT COMPLETED|Third Intervention (7 Days)||0||
60039338|NCT01732588|76155126|FG001|NOT COMPLETED|Third Intervention (7 Days)||0||
60039339|NCT01732588|76155127|FG002|NOT COMPLETED|Third Intervention (7 Days)||0||
60039340|NCT01781962|76155135|FG000|STARTED|Overall Study||206||
60039341|NCT01781962|76155135|FG000|COMPLETED|Overall Study||201||
60039342|NCT01781962|76155135|FG000|NOT COMPLETED|Overall Study||5||
60039343|NCT01639339|76155141|FG000|STARTED|Double-blind Period (Up to Week 104)||224||
60039344|NCT01639339|76155142|FG001|STARTED|Double-blind Period (Up to Week 104)||224||
60039345|NCT01639339|76155141|FG000|COMPLETED|Double-blind Period (Up to Week 104)||170||
60039346|NCT01639339|76155142|FG001|COMPLETED|Double-blind Period (Up to Week 104)||186||
60039347|NCT01639339|76155141|FG000|NOT COMPLETED|Double-blind Period (Up to Week 104)||54||
60039348|NCT01639339|76155142|FG001|NOT COMPLETED|Double-blind Period (Up to Week 104)||38||
60039349|NCT01639339|76155141|FG000|STARTED|Open-label Period (Up to Week 28)|Of the 356 participants who completed the double-blind period, 279 were eligible for open-label treatment. As enrolling into the open-label period was optional, only 257 participants enrolled, of whom 255 started open-label treatment.|123||
60039350|NCT01639339|76155142|FG001|STARTED|Open-label Period (Up to Week 28)||132||
60039351|NCT01639339|76155141|FG000|COMPLETED|Open-label Period (Up to Week 28)||122||
60039352|NCT01639339|76155142|FG001|COMPLETED|Open-label Period (Up to Week 28)||124||
60039353|NCT01639339|76155141|FG000|NOT COMPLETED|Open-label Period (Up to Week 28)||1||
60039354|NCT01639339|76155142|FG001|NOT COMPLETED|Open-label Period (Up to Week 28)||8||
60039355|NCT02000817|76155156|FG000|STARTED|Overall Study||6||
60039356|NCT02000817|76155157|FG001|STARTED|Overall Study||9||
60039357|NCT02000817|76155158|FG002|STARTED|Overall Study||8||
60039358|NCT02000817|76155159|FG003|STARTED|Overall Study||7||
60039359|NCT02000817|76155156|FG000|COMPLETED|Overall Study||4||
60039360|NCT02000817|76155157|FG001|COMPLETED|Overall Study||8||
60039361|NCT02000817|76155158|FG002|COMPLETED|Overall Study||7||
60039362|NCT02000817|76155159|FG003|COMPLETED|Overall Study||7||
60039363|NCT02000817|76155156|FG000|NOT COMPLETED|Overall Study||2||
60039364|NCT02000817|76155157|FG001|NOT COMPLETED|Overall Study||1||
60039365|NCT02000817|76155158|FG002|NOT COMPLETED|Overall Study||1||
60039366|NCT02000817|76155159|FG003|NOT COMPLETED|Overall Study||0||
60039367|NCT01641133|76155175|FG000|STARTED|Overall Study||97||
60039368|NCT01641133|76155176|FG001|STARTED|Overall Study||99||
60039369|NCT01641133|76155177|FG002|STARTED|Overall Study||98||
60039370|NCT01641133|76155175|FG000|COMPLETED|Overall Study||87||
60039371|NCT01641133|76155176|FG001|COMPLETED|Overall Study||90||
60039372|NCT01641133|76155177|FG002|COMPLETED|Overall Study||90||
60039373|NCT01641133|76155175|FG000|NOT COMPLETED|Overall Study||10||
60039374|NCT01641133|76155176|FG001|NOT COMPLETED|Overall Study||9||
60039375|NCT01641133|76155177|FG002|NOT COMPLETED|Overall Study||8||
60039376|NCT02000427|76155185|FG000|STARTED|Overall Study||45||
60039377|NCT02000427|76155185|FG000|COMPLETED|Overall Study|Indicates participants ongoing in study as of the data cut-off date of 20 May 2015.|23||
60039378|NCT02000427|76155185|FG000|NOT COMPLETED|Overall Study||22||
60039379|NCT01600885|76155189|FG000|STARTED|First Period||10||
60039380|NCT01600885|76155190|FG001|STARTED|First Period||9||
60039381|NCT01600885|76155189|FG000|COMPLETED|First Period||8||
60039382|NCT01600885|76155190|FG001|COMPLETED|First Period||8||
60039383|NCT01600885|76155189|FG000|NOT COMPLETED|First Period||2||
60039384|NCT01600885|76155190|FG001|NOT COMPLETED|First Period||1||
60039385|NCT01600885|76155189|FG000|STARTED|Wash Out Period||8||
60039386|NCT01600885|76155190|FG001|STARTED|Wash Out Period||8||
60039387|NCT01600885|76155189|FG000|COMPLETED|Wash Out Period||8||
60039388|NCT01600885|76155190|FG001|COMPLETED|Wash Out Period||8||
60039389|NCT01600885|76155189|FG000|NOT COMPLETED|Wash Out Period||0||
60039390|NCT01600885|76155190|FG001|NOT COMPLETED|Wash Out Period||0||
60039391|NCT01600885|76155189|FG000|STARTED|Second Period||8||
60039392|NCT01600885|76155190|FG001|STARTED|Second Period||8||
60039393|NCT01600885|76155189|FG000|COMPLETED|Second Period||8||
60039394|NCT01600885|76155190|FG001|COMPLETED|Second Period||8||
60039395|NCT01600885|76155189|FG000|NOT COMPLETED|Second Period||0||
60039396|NCT01600885|76155190|FG001|NOT COMPLETED|Second Period||0||
60039397|NCT01732510|76155203|FG000|STARTED|Overall Study||9||
60039398|NCT01732510|76155204|FG001|STARTED|Overall Study||9||
60039399|NCT01732510|76155205|FG002|STARTED|Overall Study||8||
60039400|NCT01732510|76155206|FG003|STARTED|Overall Study||10||
60039401|NCT01732510|76155207|FG004|STARTED|Overall Study||8||
60039402|NCT01732510|76155208|FG005|STARTED|Overall Study||13||
60039403|NCT01732510|76155209|FG006|STARTED|Overall Study||8||
60039404|NCT01732510|76155203|FG000|COMPLETED|Overall Study||8||
60039405|NCT01732510|76155204|FG001|COMPLETED|Overall Study||4||
60039406|NCT01732510|76155205|FG002|COMPLETED|Overall Study||4||
60039407|NCT01732510|76155206|FG003|COMPLETED|Overall Study||5||
60039408|NCT01732510|76155207|FG004|COMPLETED|Overall Study||3||
60039409|NCT01732510|76155208|FG005|COMPLETED|Overall Study||0||
60039410|NCT01732510|76155209|FG006|COMPLETED|Overall Study||0||
60039411|NCT01732510|76155203|FG000|NOT COMPLETED|Overall Study||1||
60039412|NCT01732510|76155204|FG001|NOT COMPLETED|Overall Study||5||
60039413|NCT01732510|76155205|FG002|NOT COMPLETED|Overall Study||4||
60039414|NCT01732510|76155206|FG003|NOT COMPLETED|Overall Study||5||
59509862|NCT00861601|75603263|FG000|NOT COMPLETED|Overall Study||0||
59509863|NCT00861601|75603264|FG001|NOT COMPLETED|Overall Study||0||
59509864|NCT00861601|75603265|FG002|NOT COMPLETED|Overall Study||0||
59918236|NCT02250300|76038734|FG000|STARTED|Expansion Phase|This expansion cohort involved a new group of subjects using the 4.0 mg dose.|25||
59918237|NCT02250300|76038735|FG001|STARTED|Expansion Phase|This expansion cohort involved a new group of subjects using the 4.0 mg dose.|26||
59918238|NCT02250300|76038736|FG002|STARTED|Expansion Phase||0||
59918239|NCT02250300|76038737|FG003|STARTED|Expansion Phase|This cohort was involved only in the 4.0 mg dose escalation phase and was not involved in expansion phase of the study.|0||
59918240|NCT02250300|76038734|FG000|COMPLETED|Expansion Phase||19||
59918241|NCT02250300|76038735|FG001|COMPLETED|Expansion Phase||19||
59918242|NCT02250300|76038736|FG002|COMPLETED|Expansion Phase||0||
59918243|NCT02250300|76038737|FG003|COMPLETED|Expansion Phase||0||
59918244|NCT02250300|76038734|FG000|NOT COMPLETED|Expansion Phase||6||
59918245|NCT02250300|76038735|FG001|NOT COMPLETED|Expansion Phase||7||
59918246|NCT02250300|76038736|FG002|NOT COMPLETED|Expansion Phase||0||
59918247|NCT02250300|76038737|FG003|NOT COMPLETED|Expansion Phase||0||
59918248|NCT03020966|76038750|FG000|STARTED|Overall Study||77||
59918249|NCT03020966|76038751|FG001|STARTED|Overall Study||77||
59918250|NCT03020966|76038750|FG000|COMPLETED|Overall Study||75||
59918251|NCT03020966|76038751|FG001|COMPLETED|Overall Study||77||
59918252|NCT03020966|76038750|FG000|NOT COMPLETED|Overall Study||2||
59918253|NCT03020966|76038751|FG001|NOT COMPLETED|Overall Study||0||
59918254|NCT03020576|76038759|FG000|STARTED|Overall Study||15||
59918255|NCT03020576|76038760|FG001|STARTED|Overall Study||16||
59918256|NCT03020576|76038759|FG000|COMPLETED|Overall Study||14||
59918257|NCT03020576|76038760|FG001|COMPLETED|Overall Study||14||
59918258|NCT03020576|76038759|FG000|NOT COMPLETED|Overall Study||1||
59918259|NCT03020576|76038760|FG001|NOT COMPLETED|Overall Study||2||
59918260|NCT03017612|76038766|FG000|STARTED|Overall Study||13||
59918261|NCT03017612|76038766|FG000|COMPLETED|Overall Study||11||
59918262|NCT03017612|76038766|FG000|NOT COMPLETED|Overall Study||2||
59918263|NCT03635099|76038778|FG000|STARTED|Period 1||20||
59918264|NCT03635099|76038779|FG001|STARTED|Period 1||40||
59918265|NCT03635099|76038780|FG002|STARTED|Period 1||39||
59918266|NCT03635099|76038781|FG003|STARTED|Period 1||39||
59918267|NCT03635099|76038782|FG004|STARTED|Period 1||40||
59918268|NCT03635099|76038783|FG005|STARTED|Period 1||10||
59918269|NCT03635099|76038784|FG006|STARTED|Period 1||44||
59918270|NCT03635099|76038785|FG007|STARTED|Period 1||42||
59918271|NCT03635099|76038778|FG000|Full Analysis Set (FAS)|Period 1||20||
59918272|NCT03635099|76038779|FG001|Full Analysis Set (FAS)|Period 1||40||
59918273|NCT03635099|76038780|FG002|Full Analysis Set (FAS)|Period 1||39||
59918274|NCT03635099|76038781|FG003|Full Analysis Set (FAS)|Period 1||39||
59918275|NCT03635099|76038782|FG004|Full Analysis Set (FAS)|Period 1||40||
59918276|NCT03635099|76038783|FG005|Full Analysis Set (FAS)|Period 1||10||
59918277|NCT03635099|76038784|FG006|Full Analysis Set (FAS)|Period 1||43||
59918278|NCT03635099|76038785|FG007|Full Analysis Set (FAS)|Period 1||42||
59918279|NCT03635099|76038778|FG000|COMPLETED|Period 1||16|Completed period 1: completed 12 weeks of treatment.|
59918280|NCT03635099|76038779|FG001|COMPLETED|Period 1||37|Completed period 1: completed 12 weeks of treatment.|
59918281|NCT03635099|76038780|FG002|COMPLETED|Period 1||31|Completed period 1: completed 12 weeks of treatment.|
59918282|NCT03635099|76038781|FG003|COMPLETED|Period 1||34|Completed period 1: completed 12 weeks of treatment.|
59918283|NCT03635099|76038782|FG004|COMPLETED|Period 1||37|Completed period 1: completed 12 weeks of treatment.|
59918284|NCT03635099|76038783|FG005|COMPLETED|Period 1||9|Completed period 1: completed 12 weeks of treatment.|
59918285|NCT03635099|76038784|FG006|COMPLETED|Period 1||40|Completed period 1: completed 12 weeks of treatment.|
59918286|NCT03635099|76038785|FG007|COMPLETED|Period 1||40|Completed period 1: completed 12 weeks of treatment.|
59918287|NCT03635099|76038778|FG000|NOT COMPLETED|Period 1||4||
59918288|NCT03635099|76038779|FG001|NOT COMPLETED|Period 1||3||
59918289|NCT03635099|76038780|FG002|NOT COMPLETED|Period 1||8||
59918290|NCT03635099|76038781|FG003|NOT COMPLETED|Period 1||5||
59918291|NCT03635099|76038782|FG004|NOT COMPLETED|Period 1||3||
59918292|NCT03635099|76038783|FG005|NOT COMPLETED|Period 1||1||
59918293|NCT03635099|76038784|FG006|NOT COMPLETED|Period 1||4||
59918294|NCT03635099|76038785|FG007|NOT COMPLETED|Period 1||2||
59918295|NCT03635099|76038778|FG000|STARTED|Not Eligible for Period 2||16||
59918296|NCT03635099|76038779|FG001|STARTED|Not Eligible for Period 2||37||
59918297|NCT03635099|76038780|FG002|STARTED|Not Eligible for Period 2||31||
59918298|NCT03635099|76038781|FG003|STARTED|Not Eligible for Period 2||34||
59918299|NCT03635099|76038782|FG004|STARTED|Not Eligible for Period 2||37||
59918300|NCT03635099|76038783|FG005|STARTED|Not Eligible for Period 2||9||
59918301|NCT03635099|76038784|FG006|STARTED|Not Eligible for Period 2||40||
59918302|NCT03635099|76038785|FG007|STARTED|Not Eligible for Period 2||40||
59918303|NCT03635099|76038778|FG000|COMPLETED|Not Eligible for Period 2||15|Completed subjects moved to period 2. Not completed did not move to period 2.|
59918304|NCT03635099|76038779|FG001|COMPLETED|Not Eligible for Period 2||37|Completed subjects moved to period 2. Not completed did not move to period 2.|
59918305|NCT03635099|76038780|FG002|COMPLETED|Not Eligible for Period 2||31|Completed subjects moved to period 2. Not completed did not move to period 2.|
59951406|NCT01798992|76070391|FG001|STARTED|Overall Study||19||
60039415|NCT01732510|76155207|FG004|NOT COMPLETED|Overall Study||5||
60039416|NCT01732510|76155208|FG005|NOT COMPLETED|Overall Study||13||
59918306|NCT03635099|76038781|FG003|COMPLETED|Not Eligible for Period 2||33|Completed subjects moved to period 2. Not completed did not move to period 2.|
59918307|NCT03635099|76038782|FG004|COMPLETED|Not Eligible for Period 2||37|Completed subjects moved to period 2. Not completed did not move to period 2.|
59918308|NCT03635099|76038783|FG005|COMPLETED|Not Eligible for Period 2||0|Completed subjects moved to period 2. Not completed did not move to period 2.|
59918309|NCT03635099|76038784|FG006|COMPLETED|Not Eligible for Period 2||0|Completed subjects moved to period 2. Not completed did not move to period 2.|
59918310|NCT03635099|76038785|FG007|COMPLETED|Not Eligible for Period 2||0|Completed subjects moved to period 2. Not completed did not move to period 2.|
59918311|NCT03635099|76038778|FG000|NOT COMPLETED|Not Eligible for Period 2||1||
59918312|NCT03635099|76038779|FG001|NOT COMPLETED|Not Eligible for Period 2||0||
59918313|NCT03635099|76038780|FG002|NOT COMPLETED|Not Eligible for Period 2||0||
59918314|NCT03635099|76038781|FG003|NOT COMPLETED|Not Eligible for Period 2||1||
60039417|NCT01732510|76155209|FG006|NOT COMPLETED|Overall Study||8||
60039418|NCT01637077|76155230|FG000|STARTED|Overall Study||23||
59612348|NCT01701258|75723508|FG009|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0|68 out of the 96 eligible participants completed the MRI.|
59612349|NCT01701258|75723509|FG010|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0|68 out of the 96 eligible participants completed the MRI.|
59612350|NCT01701258|75723510|FG011|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0|68 out of the 96 eligible participants completed the MRI.|
59612351|NCT01701258|75723511|FG012|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0|68 out of the 96 eligible participants completed the MRI.|
59612352|NCT01701258|75723499|FG000|Returned for PET (Session 3)|Assessment and Scheduling||73|73 /96 eligible completed the PET. They didn't need to complete the the MRI to complete the PET.|
59612353|NCT01701258|75723500|FG001|Returned for PET (Session 3)|Assessment and Scheduling||0|73 /96 eligible completed the PET. They didn't need to complete the the MRI to complete the PET.|
59612354|NCT01701258|75723501|FG002|Returned for PET (Session 3)|Assessment and Scheduling||0|73 /96 eligible completed the PET. They didn't need to complete the the MRI to complete the PET.|
59612355|NCT01701258|75723502|FG003|Returned for PET (Session 3)|Assessment and Scheduling||0|73 /96 eligible completed the PET. They didn't need to complete the the MRI to complete the PET.|
59612356|NCT01701258|75723503|FG004|Returned for PET (Session 3)|Assessment and Scheduling||0|73 /96 eligible completed the PET. They didn't need to complete the the MRI to complete the PET.|
59612357|NCT01701258|75723504|FG005|Returned for PET (Session 3)|Assessment and Scheduling||0|73 /96 eligible completed the PET. They didn't need to complete the the MRI to complete the PET.|
59612358|NCT01701258|75723505|FG006|Returned for PET (Session 3)|Assessment and Scheduling||0|73 /96 eligible completed the PET. They didn't need to complete the the MRI to complete the PET.|
59612359|NCT01701258|75723506|FG007|Returned for PET (Session 3)|Assessment and Scheduling||0|73 /96 eligible completed the PET. They didn't need to complete the the MRI to complete the PET.|
59612360|NCT01701258|75723507|FG008|Returned for PET (Session 3)|Assessment and Scheduling||0|73 /96 eligible completed the PET. They didn't need to complete the the MRI to complete the PET.|
59612361|NCT01701258|75723508|FG009|Returned for PET (Session 3)|Assessment and Scheduling||0|73 /96 eligible completed the PET. They didn't need to complete the the MRI to complete the PET.|
59759559|NCT02631941|75878925|FG003|NOT COMPLETED|Overall Study||0||
59759560|NCT02631941|75878926|FG004|NOT COMPLETED|Overall Study||1||
59759561|NCT02631941|75878927|FG005|NOT COMPLETED|Overall Study||0||
59759562|NCT02631941|75878928|FG006|NOT COMPLETED|Overall Study||0||
59759563|NCT02631941|75878929|FG007|NOT COMPLETED|Overall Study||1||
59759564|NCT02631941|75878930|FG008|NOT COMPLETED|Overall Study||1||
59759565|NCT02631941|75878931|FG009|NOT COMPLETED|Overall Study||0||
59759566|NCT00908375|75878943|FG000|STARTED|Overall Study||20||
59759567|NCT00908375|75878944|FG001|STARTED|Overall Study||19||
59759568|NCT00908375|75878943|FG000|COMPLETED|Overall Study||10||
59759569|NCT00908375|75878944|FG001|COMPLETED|Overall Study||9||
59759570|NCT00908375|75878943|FG000|NOT COMPLETED|Overall Study||10||
59759571|NCT00908375|75878944|FG001|NOT COMPLETED|Overall Study||10||
59759572|NCT00909389|75878950|FG000|STARTED|Overall Study||4748||
59759573|NCT00909389|75878950|FG000|COMPLETED|Overall Study||4615||
59759574|NCT00909389|75878950|FG000|NOT COMPLETED|Overall Study||133||
59759575|NCT00910715|75878957|FG000|STARTED|Overall Study||108||
59759576|NCT00910715|75878958|FG001|STARTED|Overall Study||117||
60039419|NCT01637077|76155231|FG001|STARTED|Overall Study||23||
60039420|NCT01637077|76155230|FG000|COMPLETED|Overall Study||19||
60039421|NCT01637077|76155231|FG001|COMPLETED|Overall Study||22||
60039422|NCT01637077|76155230|FG000|NOT COMPLETED|Overall Study||4||
59612362|NCT01701258|75723509|FG010|Returned for PET (Session 3)|Assessment and Scheduling||0|73 /96 eligible completed the PET. They didn't need to complete the the MRI to complete the PET.|
59612363|NCT01701258|75723510|FG011|Returned for PET (Session 3)|Assessment and Scheduling||0|73 /96 eligible completed the PET. They didn't need to complete the the MRI to complete the PET.|
59613516|NCT01592292|75724650|FG003|Intention to Treat (ITT) Set|Overall Study||8||
59759577|NCT00910715|75878959|FG002|STARTED|Overall Study||81||
59759578|NCT00910715|75878957|FG000|COMPLETED|Overall Study||86||
59759579|NCT00910715|75878958|FG001|COMPLETED|Overall Study||91||
59759580|NCT00910715|75878959|FG002|COMPLETED|Overall Study||81||
59759581|NCT00910715|75878957|FG000|NOT COMPLETED|Overall Study||22||
59759582|NCT00910715|75878958|FG001|NOT COMPLETED|Overall Study||26||
60039423|NCT01637077|76155231|FG001|NOT COMPLETED|Overall Study||1||
60039424|NCT02308163|76155241|FG000|STARTED|Overall Study||104||
60039425|NCT02308163|76155242|FG001|STARTED|Overall Study||102||
60039426|NCT02308163|76155243|FG002|STARTED|Overall Study||50||
60039427|NCT02308163|76155244|FG003|STARTED|Overall Study||52||
60039428|NCT02308163|76155245|FG004|STARTED|Overall Study||201||
60039429|NCT02308163|76155241|FG000|COMPLETED|Overall Study||73||
60039430|NCT02308163|76155242|FG001|COMPLETED|Overall Study||84||
59509865|NCT02641912|75603278|FG000|STARTED|Overall Study||53||
59509866|NCT02641912|75603279|FG001|STARTED|Overall Study||47||
59509867|NCT02641912|75603278|FG000|COMPLETED|Overall Study||53||
59509868|NCT02641912|75603279|FG001|COMPLETED|Overall Study||47||
59509869|NCT02641912|75603278|FG000|NOT COMPLETED|Overall Study||0||
59509870|NCT02641912|75603279|FG001|NOT COMPLETED|Overall Study||0||
59509871|NCT00861913|75603289|FG000|STARTED|Overall Study||13||
59612364|NCT01701258|75723511|FG012|Returned for PET (Session 3)|Assessment and Scheduling||0|73 /96 eligible completed the PET. They didn't need to complete the the MRI to complete the PET.|
59612365|NCT01701258|75723499|FG000|Returned for EEG (Session 4)|Assessment and Scheduling||66|66/96 completed the EEG. Participants did at least two sessions after the screening visit.|
59612366|NCT01701258|75723500|FG001|Returned for EEG (Session 4)|Assessment and Scheduling||0|66/96 completed the EEG. Participants did at least two sessions after the screening visit.|
59612367|NCT01701258|75723501|FG002|Returned for EEG (Session 4)|Assessment and Scheduling||0|66/96 completed the EEG. Participants did at least two sessions after the screening visit.|
59612368|NCT01701258|75723502|FG003|Returned for EEG (Session 4)|Assessment and Scheduling||0|66/96 completed the EEG. Participants did at least two sessions after the screening visit.|
59612369|NCT01701258|75723503|FG004|Returned for EEG (Session 4)|Assessment and Scheduling||0|66/96 completed the EEG. Participants did at least two sessions after the screening visit.|
59759583|NCT00910715|75878959|FG002|NOT COMPLETED|Overall Study||0||
59759584|NCT03690674|75878969|FG000|STARTED|Overall Study||35||
59759585|NCT03690674|75878970|FG001|STARTED|Overall Study||35||
59759586|NCT03690674|75878969|FG000|COMPLETED|Overall Study||32||
59759587|NCT03690674|75878970|FG001|COMPLETED|Overall Study||32||
59759588|NCT03690674|75878969|FG000|NOT COMPLETED|Overall Study||3||
59759589|NCT03690674|75878970|FG001|NOT COMPLETED|Overall Study||3||
59918315|NCT03635099|76038782|FG004|NOT COMPLETED|Not Eligible for Period 2||0||
59918316|NCT03635099|76038783|FG005|NOT COMPLETED|Not Eligible for Period 2||9||
59918317|NCT03635099|76038784|FG006|NOT COMPLETED|Not Eligible for Period 2||40||
59918318|NCT03635099|76038785|FG007|NOT COMPLETED|Not Eligible for Period 2||40||
59918319|NCT03635099|76038778|FG000|STARTED|Eligible for Period 2||15||
59918320|NCT03635099|76038779|FG001|STARTED|Eligible for Period 2||37||
59918321|NCT03635099|76038780|FG002|STARTED|Eligible for Period 2||31||
59918322|NCT03635099|76038781|FG003|STARTED|Eligible for Period 2||33||
59918323|NCT03635099|76038782|FG004|STARTED|Eligible for Period 2||37||
59918324|NCT03635099|76038783|FG005|STARTED|Eligible for Period 2||0||
60039431|NCT02308163|76155243|FG002|COMPLETED|Overall Study||36||
60039432|NCT02308163|76155244|FG003|COMPLETED|Overall Study||39||
60039433|NCT02308163|76155245|FG004|COMPLETED|Overall Study||167||
60039434|NCT02308163|76155241|FG000|NOT COMPLETED|Overall Study||31||
60039435|NCT02308163|76155242|FG001|NOT COMPLETED|Overall Study||18||
60039436|NCT02308163|76155243|FG002|NOT COMPLETED|Overall Study||14||
60039437|NCT02308163|76155244|FG003|NOT COMPLETED|Overall Study||13||
59509872|NCT00861913|75603289|FG000|COMPLETED|Overall Study||13||
59509873|NCT00861913|75603289|FG000|NOT COMPLETED|Overall Study||0||
59509874|NCT00862537|75603293|FG000|STARTED|Overall Study||18||
59509875|NCT00862537|75603293|FG000|COMPLETED|Overall Study||11||
59762605|NCT00866307|75882443|FG000|COMPLETED|Induction||84||
59918325|NCT03635099|76038784|FG006|STARTED|Eligible for Period 2||0||
59918326|NCT03635099|76038785|FG007|STARTED|Eligible for Period 2||0||
60039438|NCT02308163|76155245|FG004|NOT COMPLETED|Overall Study||34||
60039439|NCT01999335|76155277|FG000|STARTED|Overall Study||3||
59918327|NCT03635099|76038778|FG000|Switching Patients|Eligible for Period 2|Switched to the 'BI 200 mg' dose group.|15|Non-responding patients in dose groups were switched at the end of period 1 to a higher dose group.|
59918328|NCT03635099|76038779|FG001|Switching Patients|Eligible for Period 2|Switched to the 'BI 50 mg' dose group.|35|Non-responding patients in dose groups were switched at the end of period 1 to a higher dose group.|
59918329|NCT03635099|76038780|FG002|Switching Patients|Eligible for Period 2|Switched to the 'BI 100 mg' dose group.|21|Non-responding patients in dose groups were switched at the end of period 1 to a higher dose group.|
59509876|NCT00862537|75603293|FG000|NOT COMPLETED|Overall Study||7||
59951407|NCT01798992|76070392|FG002|STARTED|Overall Study||16||
59951408|NCT01798992|76070393|FG003|STARTED|Overall Study||17||
60039440|NCT01999335|76155278|FG001|STARTED|Overall Study||1||
60039441|NCT01999335|76155279|FG002|STARTED|Overall Study||7||
59509877|NCT00863551|75603297|FG000|STARTED|Overall Study||12||
59509878|NCT00863551|75603297|FG000|COMPLETED|Overall Study||12||
59509879|NCT00863551|75603297|FG000|NOT COMPLETED|Overall Study||0||
59509880|NCT02642536|75603303|FG000|STARTED|Overall Study||21||
59759590|NCT03207776|75878979|FG000|STARTED|Overall Study||2479|All patients with the diagnosis were to receive the intervention|
59759591|NCT03207776|75878980|FG001|STARTED|Overall Study||2353|All patients with the diagnosis were to receive the intervention|
59759592|NCT03207776|75878979|FG000|COMPLETED|Overall Study||2479||
59759593|NCT03207776|75878980|FG001|COMPLETED|Overall Study||2353||
59918330|NCT03635099|76038781|FG003|Switching Patients|Eligible for Period 2|Switched to the 'BI 200 mg' dose group.|25|Non-responding patients in dose groups were switched at the end of period 1 to a higher dose group.|
59918331|NCT03635099|76038782|FG004|Switching Patients|Eligible for Period 2||0|Non-responding patients in dose groups were switched at the end of period 1 to a higher dose group.|
60039442|NCT01999335|76155280|FG003|STARTED|Overall Study||10||
59759594|NCT03207776|75878979|FG000|NOT COMPLETED|Overall Study||0||
59918332|NCT03635099|76038783|FG005|Switching Patients|Eligible for Period 2||0|Non-responding patients in dose groups were switched at the end of period 1 to a higher dose group.|
59918333|NCT03635099|76038784|FG006|Switching Patients|Eligible for Period 2||0|Non-responding patients in dose groups were switched at the end of period 1 to a higher dose group.|
60039443|NCT01999335|76155281|FG004|STARTED|Overall Study||12||
60039444|NCT01999335|76155277|FG000|Received Study Treatment|Overall Study||3||
60039445|NCT01999335|76155278|FG001|Received Study Treatment|Overall Study||1||
60039446|NCT01999335|76155279|FG002|Received Study Treatment|Overall Study||7||
60039447|NCT01999335|76155280|FG003|Received Study Treatment|Overall Study||10||
60039448|NCT01999335|76155281|FG004|Received Study Treatment|Overall Study||10||
60039449|NCT01999335|76155277|FG000|COMPLETED|Overall Study||3||
60039450|NCT01999335|76155278|FG001|COMPLETED|Overall Study||1||
60039451|NCT01999335|76155279|FG002|COMPLETED|Overall Study||7||
60039452|NCT01999335|76155280|FG003|COMPLETED|Overall Study||10||
60039453|NCT01999335|76155281|FG004|COMPLETED|Overall Study||10||
60039454|NCT01999335|76155277|FG000|NOT COMPLETED|Overall Study||0||
59918334|NCT03635099|76038785|FG007|Switching Patients|Eligible for Period 2||0|Non-responding patients in dose groups were switched at the end of period 1 to a higher dose group.|
59951409|NCT01798992|76070390|FG000|COMPLETED|Overall Study||4||
60039455|NCT01999335|76155278|FG001|NOT COMPLETED|Overall Study||0||
60039456|NCT01999335|76155279|FG002|NOT COMPLETED|Overall Study||0||
60039457|NCT01999335|76155280|FG003|NOT COMPLETED|Overall Study||0||
60039458|NCT01999335|76155281|FG004|NOT COMPLETED|Overall Study||2||
60039459|NCT01978119|76155296|FG000|STARTED|Treatment Period 1 (12 Weeks)||40||
60039460|NCT01978119|76155297|FG001|STARTED|Treatment Period 1 (12 Weeks)||42||
60039461|NCT01978119|76155296|FG000|COMPLETED|Treatment Period 1 (12 Weeks)||38||
60039462|NCT01978119|76155297|FG001|COMPLETED|Treatment Period 1 (12 Weeks)||42||
60039463|NCT01978119|76155296|FG000|NOT COMPLETED|Treatment Period 1 (12 Weeks)||2||
60039464|NCT01978119|76155297|FG001|NOT COMPLETED|Treatment Period 1 (12 Weeks)||0||
60039465|NCT01978119|76155296|FG000|STARTED|Washout Period 1 (3 Weeks)||38||
60039466|NCT01978119|76155297|FG001|STARTED|Washout Period 1 (3 Weeks)||42||
60039467|NCT01978119|76155296|FG000|COMPLETED|Washout Period 1 (3 Weeks)||38||
60039468|NCT01978119|76155297|FG001|COMPLETED|Washout Period 1 (3 Weeks)||42||
60039469|NCT01978119|76155296|FG000|NOT COMPLETED|Washout Period 1 (3 Weeks)||0||
60039470|NCT01978119|76155297|FG001|NOT COMPLETED|Washout Period 1 (3 Weeks)||0||
60039471|NCT01978119|76155296|FG000|STARTED|Treatment Period 2 (12 Weeks)||38||
60039472|NCT01978119|76155297|FG001|STARTED|Treatment Period 2 (12 Weeks)||42||
60039473|NCT01978119|76155296|FG000|COMPLETED|Treatment Period 2 (12 Weeks)||38||
60039474|NCT01978119|76155297|FG001|COMPLETED|Treatment Period 2 (12 Weeks)||40||
60039475|NCT01978119|76155296|FG000|NOT COMPLETED|Treatment Period 2 (12 Weeks)||0||
60039476|NCT01978119|76155297|FG001|NOT COMPLETED|Treatment Period 2 (12 Weeks)||2||
60039477|NCT01999179|76155303|FG000|STARTED|Overall Study||27||
60039478|NCT01999179|76155303|FG000|COMPLETED|Overall Study||20||
60039479|NCT01999179|76155303|FG000|NOT COMPLETED|Overall Study||7||
60039480|NCT01977729|76155307|FG000|STARTED|Overall Study||1||
60039481|NCT01977729|76155307|FG000|COMPLETED|Overall Study||0||
60039482|NCT01977729|76155307|FG000|NOT COMPLETED|Overall Study||1||
60039483|NCT01998477|76155315|FG000|STARTED|Overall Study||282||
60039484|NCT01998477|76155316|FG001|STARTED|Overall Study||148||
60039485|NCT01998477|76155315|FG000|COMPLETED|Overall Study||272||
60039486|NCT01998477|76155316|FG001|COMPLETED|Overall Study||143||
60039487|NCT01998477|76155315|FG000|NOT COMPLETED|Overall Study||10||
60039488|NCT01998477|76155316|FG001|NOT COMPLETED|Overall Study||5||
60039489|NCT01998399|76155349|FG000|STARTED|Overall Study||12||
60039490|NCT01998399|76155350|FG001|STARTED|Overall Study||13||
60039491|NCT01998399|76155349|FG000|COMPLETED|Overall Study||4||
60039492|NCT01998399|76155350|FG001|COMPLETED|Overall Study||4||
60039493|NCT01998399|76155349|FG000|NOT COMPLETED|Overall Study||8||
60039494|NCT01998399|76155350|FG001|NOT COMPLETED|Overall Study||9||
60039495|NCT01781572|76155367|FG000|STARTED|MEK162 45mg BID+LEE011 200mg||16||
60039496|NCT01781572|76155368|FG001|STARTED|MEK162 45mg BID+LEE011 200mg||6||
59509881|NCT02642536|75603304|FG001|STARTED|Overall Study||23||
59509882|NCT02642536|75603303|FG000|COMPLETED|Overall Study||19||
59509883|NCT02642536|75603304|FG001|COMPLETED|Overall Study||18||
60039497|NCT01781572|76155369|FG002|STARTED|MEK162 45mg BID+LEE011 200mg||41||
59509884|NCT02642536|75603303|FG000|NOT COMPLETED|Overall Study||2||
60039498|NCT01781572|76155367|FG000|COMPLETED|MEK162 45mg BID+LEE011 200mg||0||
60039499|NCT01781572|76155368|FG001|COMPLETED|MEK162 45mg BID+LEE011 200mg||0||
60039500|NCT01781572|76155369|FG002|COMPLETED|MEK162 45mg BID+LEE011 200mg||0||
60039501|NCT01781572|76155367|FG000|NOT COMPLETED|MEK162 45mg BID+LEE011 200mg||16||
60039502|NCT01781572|76155368|FG001|NOT COMPLETED|MEK162 45mg BID+LEE011 200mg||6||
60039503|NCT01781572|76155369|FG002|NOT COMPLETED|MEK162 45mg BID+LEE011 200mg||41||
59509885|NCT02642536|75603304|FG001|NOT COMPLETED|Overall Study||5||
59918335|NCT03635099|76038778|FG000|Non Switching Patients|Eligible for Period 2||0|Patients stayed in initially randomized treatment group.|
59918336|NCT03635099|76038779|FG001|Non Switching Patients|Eligible for Period 2||2|Patients stayed in initially randomized treatment group.|
59918337|NCT03635099|76038780|FG002|Non Switching Patients|Eligible for Period 2||10|Patients stayed in initially randomized treatment group.|
59918338|NCT03635099|76038781|FG003|Non Switching Patients|Eligible for Period 2||8|Patients stayed in initially randomized treatment group.|
59918339|NCT03635099|76038782|FG004|Non Switching Patients|Eligible for Period 2||37|Patients stayed in initially randomized treatment group.|
59918340|NCT03635099|76038783|FG005|Non Switching Patients|Eligible for Period 2||0|Patients stayed in initially randomized treatment group.|
59918341|NCT03635099|76038784|FG006|Non Switching Patients|Eligible for Period 2||0|Patients stayed in initially randomized treatment group.|
59918342|NCT03635099|76038785|FG007|Non Switching Patients|Eligible for Period 2||0|Patients stayed in initially randomized treatment group.|
59918343|NCT03635099|76038778|FG000|COMPLETED|Eligible for Period 2||0||
59918344|NCT03635099|76038779|FG001|COMPLETED|Eligible for Period 2||2||
60039504|NCT01781572|76155367|FG000|STARTED|MEK162 45mg BID+LEE011 250mg||3||
60039505|NCT01781572|76155368|FG001|STARTED|MEK162 45mg BID+LEE011 250mg||0||
60039506|NCT01781572|76155369|FG002|STARTED|MEK162 45mg BID+LEE011 250mg||0||
60039507|NCT01781572|76155367|FG000|COMPLETED|MEK162 45mg BID+LEE011 250mg||0||
60039508|NCT01781572|76155368|FG001|COMPLETED|MEK162 45mg BID+LEE011 250mg||0||
60039509|NCT01781572|76155369|FG002|COMPLETED|MEK162 45mg BID+LEE011 250mg||0||
60039510|NCT01781572|76155367|FG000|NOT COMPLETED|MEK162 45mg BID+LEE011 250mg||3||
60039511|NCT01781572|76155368|FG001|NOT COMPLETED|MEK162 45mg BID+LEE011 250mg||0||
60039512|NCT01781572|76155369|FG002|NOT COMPLETED|MEK162 45mg BID+LEE011 250mg||0||
60039513|NCT01781572|76155367|FG000|STARTED|MEK162 30mg BID+LEE011 300mg||4||
60039514|NCT01781572|76155368|FG001|STARTED|MEK162 30mg BID+LEE011 300mg||2||
60039515|NCT01781572|76155369|FG002|STARTED|MEK162 30mg BID+LEE011 300mg||0||
60039516|NCT01781572|76155367|FG000|COMPLETED|MEK162 30mg BID+LEE011 300mg||0||
60039517|NCT01781572|76155368|FG001|COMPLETED|MEK162 30mg BID+LEE011 300mg||0||
60039518|NCT01781572|76155369|FG002|COMPLETED|MEK162 30mg BID+LEE011 300mg||0||
60039519|NCT01781572|76155367|FG000|NOT COMPLETED|MEK162 30mg BID+LEE011 300mg||4||
60039520|NCT01781572|76155368|FG001|NOT COMPLETED|MEK162 30mg BID+LEE011 300mg||2||
60039521|NCT01781572|76155369|FG002|NOT COMPLETED|MEK162 30mg BID+LEE011 300mg||0||
60039522|NCT01781572|76155367|FG000|STARTED|MEK162 45mg BID+LEE011 300mg||6||
60039523|NCT01781572|76155368|FG001|STARTED|MEK162 45mg BID+LEE011 300mg||4||
60039524|NCT01781572|76155369|FG002|STARTED|MEK162 45mg BID+LEE011 300mg||0||
60039525|NCT01781572|76155367|FG000|COMPLETED|MEK162 45mg BID+LEE011 300mg||0||
60039526|NCT01781572|76155368|FG001|COMPLETED|MEK162 45mg BID+LEE011 300mg||0||
60039527|NCT01781572|76155369|FG002|COMPLETED|MEK162 45mg BID+LEE011 300mg||0||
60039528|NCT01781572|76155367|FG000|NOT COMPLETED|MEK162 45mg BID+LEE011 300mg||6||
60039529|NCT01781572|76155368|FG001|NOT COMPLETED|MEK162 45mg BID+LEE011 300mg||4||
60039530|NCT01781572|76155369|FG002|NOT COMPLETED|MEK162 45mg BID+LEE011 300mg||0||
60039531|NCT01781572|76155367|FG000|STARTED|MEK162 30mg LEE011 200mg||0||
60039532|NCT01781572|76155368|FG001|STARTED|MEK162 30mg LEE011 200mg||5||
60039533|NCT01781572|76155369|FG002|STARTED|MEK162 30mg LEE011 200mg||0||
60039534|NCT01781572|76155367|FG000|COMPLETED|MEK162 30mg LEE011 200mg||0||
60039535|NCT01781572|76155368|FG001|COMPLETED|MEK162 30mg LEE011 200mg||0||
60039536|NCT01781572|76155369|FG002|COMPLETED|MEK162 30mg LEE011 200mg||0||
60039537|NCT01781572|76155367|FG000|NOT COMPLETED|MEK162 30mg LEE011 200mg||0||
60039538|NCT01781572|76155368|FG001|NOT COMPLETED|MEK162 30mg LEE011 200mg||5||
60039539|NCT01781572|76155369|FG002|NOT COMPLETED|MEK162 30mg LEE011 200mg||0||
60039540|NCT01781572|76155367|FG000|STARTED|MEK162 45mg LEE011 450mg||0||
60039541|NCT01781572|76155368|FG001|STARTED|MEK162 45mg LEE011 450mg||9||
60039542|NCT01781572|76155369|FG002|STARTED|MEK162 45mg LEE011 450mg||0||
60039543|NCT01781572|76155367|FG000|COMPLETED|MEK162 45mg LEE011 450mg||0||
60039544|NCT01781572|76155368|FG001|COMPLETED|MEK162 45mg LEE011 450mg||0||
60039545|NCT01781572|76155369|FG002|COMPLETED|MEK162 45mg LEE011 450mg||0||
60039546|NCT01781572|76155367|FG000|NOT COMPLETED|MEK162 45mg LEE011 450mg||0||
60039547|NCT01781572|76155368|FG001|NOT COMPLETED|MEK162 45mg LEE011 450mg||9||
59509886|NCT02620774|75603312|FG000|STARTED|Overall Study||10||
59918345|NCT03635099|76038780|FG002|COMPLETED|Eligible for Period 2||10||
59918346|NCT03635099|76038781|FG003|COMPLETED|Eligible for Period 2||8||
59918347|NCT03635099|76038782|FG004|COMPLETED|Eligible for Period 2||37||
59918348|NCT03635099|76038783|FG005|COMPLETED|Eligible for Period 2||0||
59918349|NCT03635099|76038784|FG006|COMPLETED|Eligible for Period 2||0||
59918350|NCT03635099|76038785|FG007|COMPLETED|Eligible for Period 2||0||
59918351|NCT03635099|76038778|FG000|NOT COMPLETED|Eligible for Period 2||15||
59918352|NCT03635099|76038779|FG001|NOT COMPLETED|Eligible for Period 2||35||
59918353|NCT03635099|76038780|FG002|NOT COMPLETED|Eligible for Period 2||21||
59918354|NCT03635099|76038781|FG003|NOT COMPLETED|Eligible for Period 2||25||
59918355|NCT03635099|76038782|FG004|NOT COMPLETED|Eligible for Period 2||0||
59918356|NCT03635099|76038783|FG005|NOT COMPLETED|Eligible for Period 2||0||
59918357|NCT03635099|76038784|FG006|NOT COMPLETED|Eligible for Period 2||0||
59918358|NCT03635099|76038785|FG007|NOT COMPLETED|Eligible for Period 2||0||
59918359|NCT03635099|76038778|FG000|STARTED|Period 2||0||
59918360|NCT03635099|76038779|FG001|STARTED|Period 2||2||
59918361|NCT03635099|76038780|FG002|STARTED|Period 2|"Combination of period 1 dose groups: BI 50 mg and switched patients from dose Group BI 25 mg"|45||
59918362|NCT03635099|76038781|FG003|STARTED|Period 2|"Combination of period 1 dose groups: BI 100 mg and switched patients from dose Group BI 50 mg"|29||
59918363|NCT03635099|76038782|FG004|STARTED|Period 2|"Combination of period 1: BI 200mg, switched patients from dose Group BI 100 mg and Placebo."|77||
59918364|NCT03635099|76038783|FG005|STARTED|Period 2||0||
59918365|NCT03635099|76038784|FG006|STARTED|Period 2||0||
59918366|NCT03635099|76038785|FG007|STARTED|Period 2||0||
59918367|NCT03635099|76038778|FG000|COMPLETED|Period 2||0||
59918368|NCT03635099|76038779|FG001|COMPLETED|Period 2||2||
59918369|NCT03635099|76038780|FG002|COMPLETED|Period 2||36||
59918370|NCT03635099|76038781|FG003|COMPLETED|Period 2||25||
59918371|NCT03635099|76038782|FG004|COMPLETED|Period 2||65||
59918372|NCT03635099|76038783|FG005|COMPLETED|Period 2||0||
59918373|NCT03635099|76038784|FG006|COMPLETED|Period 2||0||
59918374|NCT03635099|76038785|FG007|COMPLETED|Period 2||0||
59918375|NCT03635099|76038778|FG000|NOT COMPLETED|Period 2||0||
59918376|NCT03635099|76038779|FG001|NOT COMPLETED|Period 2||0||
59918377|NCT03635099|76038780|FG002|NOT COMPLETED|Period 2||9||
59918378|NCT03635099|76038781|FG003|NOT COMPLETED|Period 2||4||
59918379|NCT03635099|76038782|FG004|NOT COMPLETED|Period 2||12||
59918380|NCT03635099|76038783|FG005|NOT COMPLETED|Period 2||0||
59509887|NCT02620774|75603313|FG001|STARTED|Overall Study||6||
59509888|NCT02620774|75603312|FG000|COMPLETED|Overall Study||10||
59918381|NCT03635099|76038784|FG006|NOT COMPLETED|Period 2||0||
60039548|NCT01781572|76155369|FG002|NOT COMPLETED|MEK162 45mg LEE011 450mg||0||
60039549|NCT01781572|76155367|FG000|STARTED|MEK162 45mg LEE011 600mg||0||
60039550|NCT01781572|76155368|FG001|STARTED|MEK162 45mg LEE011 600mg||6||
60039551|NCT01781572|76155369|FG002|STARTED|MEK162 45mg LEE011 600mg||0||
60039552|NCT01781572|76155367|FG000|COMPLETED|MEK162 45mg LEE011 600mg||0||
59918382|NCT03635099|76038785|FG007|NOT COMPLETED|Period 2||0||
59918383|NCT02108652|76038811|FG000|STARTED|Overall Study||310||
59918384|NCT02108652|76038811|FG000|COMPLETED|Overall Study||0||
59918385|NCT02108652|76038811|FG000|NOT COMPLETED|Overall Study||310||
59918386|NCT03634085|76038817|FG000|STARTED|Overall Study||8||
59918387|NCT03634085|76038818|FG001|STARTED|Overall Study||8||
59918388|NCT03634085|76038817|FG000|Period 1|Overall Study|8 subjects started BDM2-50 mg and 8 subjects completed BDM2-50 mg including matching placebo.|8||
59918389|NCT03634085|76038818|FG001|Period 1|Overall Study|8 subjects started BDM2 - 150mg and 8 subjects completed BDM2 - 150 mg including matching placebo|8||
59918390|NCT03634085|76038817|FG000|Period 2|Overall Study|8 subjects started BDM2 - 450 mg and 7 subjects completed BDM2 - 450 mg (drop out; 1 active)|8||
59918391|NCT03634085|76038818|FG001|Period 2|Overall Study|8 subjects started BDM2 - 900 mg fasted and 8 subjects completed BDM2 - 900 mg fasted|8||
59918392|NCT03634085|76038817|FG000|Period 3|Overall Study|8 subjects started BDM2 - 1800 mg and 7 subjects completed BDM2 - 1800 mg (drop out; 1 active)|8||
59918393|NCT03634085|76038818|FG001|Period 3|Overall Study|8 subjects started and 6 subjects completed BDM2 - 900 mg fed (dropout; 1 active 1 placebo)|8||
59918394|NCT03634085|76038817|FG000|Period 4|Overall Study|8 subjects started BDM2 - 3100 mg and 7 subjects completed BDM2 - 3100 mg (drop out; 1 active)|8||
60039553|NCT01781572|76155368|FG001|COMPLETED|MEK162 45mg LEE011 600mg||0||
60039554|NCT01781572|76155369|FG002|COMPLETED|MEK162 45mg LEE011 600mg||0||
60039555|NCT01781572|76155367|FG000|NOT COMPLETED|MEK162 45mg LEE011 600mg||0||
60039556|NCT01781572|76155368|FG001|NOT COMPLETED|MEK162 45mg LEE011 600mg||6||
60039557|NCT01781572|76155369|FG002|NOT COMPLETED|MEK162 45mg LEE011 600mg||0||
60039558|NCT01998243|76155400|FG000|STARTED|Overall Study||42||
60039559|NCT01998243|76155401|FG001|STARTED|Overall Study||39||
60039560|NCT01998243|76155400|FG000|COMPLETED|Overall Study||34||
60039561|NCT01998243|76155401|FG001|COMPLETED|Overall Study||32||
60039562|NCT01998243|76155400|FG000|NOT COMPLETED|Overall Study||8||
60039563|NCT01998243|76155401|FG001|NOT COMPLETED|Overall Study||7||
60039564|NCT01977573|76155413|FG000|STARTED|Overall Study||136||
60039565|NCT01977573|76155414|FG001|STARTED|Overall Study||44||
60039566|NCT01977573|76155415|FG002|STARTED|Overall Study||36||
60039567|NCT01977573|76155416|FG003|STARTED|Overall Study||36||
60039568|NCT01977573|76155413|FG000|COMPLETED|Overall Study||116||
60039569|NCT01977573|76155414|FG001|COMPLETED|Overall Study||41||
60039570|NCT01977573|76155415|FG002|COMPLETED|Overall Study||32||
60039571|NCT01977573|76155416|FG003|COMPLETED|Overall Study||33||
60039572|NCT01977573|76155413|FG000|NOT COMPLETED|Overall Study||20||
60039573|NCT01977573|76155414|FG001|NOT COMPLETED|Overall Study||3||
60039574|NCT01977573|76155415|FG002|NOT COMPLETED|Overall Study||4||
60039575|NCT01977573|76155416|FG003|NOT COMPLETED|Overall Study||3||
60039576|NCT01963767|76155429|FG000|STARTED|Overall Study||58||
60039577|NCT01963767|76155430|FG001|STARTED|Overall Study||55||
60039578|NCT01963767|76155429|FG000|COMPLETED|Overall Study||52||
60039579|NCT01963767|76155430|FG001|COMPLETED|Overall Study||53||
60039580|NCT01963767|76155429|FG000|NOT COMPLETED|Overall Study||6||
60039581|NCT01963767|76155430|FG001|NOT COMPLETED|Overall Study||2||
60039582|NCT01731886|76155438|FG000|STARTED|Overall Study||31||
60039583|NCT01731886|76155439|FG001|STARTED|Overall Study||29||
60039584|NCT01731886|76155438|FG000|COMPLETED|Overall Study||29||
60039585|NCT01731886|76155439|FG001|COMPLETED|Overall Study||28||
60039586|NCT01731886|76155438|FG000|NOT COMPLETED|Overall Study||2||
60039587|NCT01731886|76155439|FG001|NOT COMPLETED|Overall Study||1||
60039588|NCT01759420|76155446|FG000|STARTED|Overall Study||28||
60039589|NCT01759420|76155446|FG000|COMPLETED|Overall Study||22||
60039590|NCT01759420|76155446|FG000|NOT COMPLETED|Overall Study||6||
60039591|NCT01781026|76155450|FG000|STARTED|Overall Study||2||
60039592|NCT01781026|76155450|FG000|COMPLETED|Overall Study||0||
60039593|NCT01781026|76155450|FG000|NOT COMPLETED|Overall Study||2||
60039594|NCT01607398|76155456|FG000|STARTED|Overall Study||28||
60039595|NCT01607398|76155457|FG001|STARTED|Overall Study||28||
60039596|NCT01607398|76155456|FG000|COMPLETED|Overall Study||26||
60039597|NCT01607398|76155457|FG001|COMPLETED|Overall Study||26||
60039598|NCT01607398|76155456|FG000|NOT COMPLETED|Overall Study||2||
60039599|NCT01607398|76155457|FG001|NOT COMPLETED|Overall Study||2||
60039600|NCT01779856|76155463|FG000|STARTED|Overall Study||81||
60039601|NCT01779856|76155463|FG000|COMPLETED|Overall Study||57||
60039602|NCT01779856|76155463|FG000|NOT COMPLETED|Overall Study||24||
60039603|NCT01729156|76155477|FG000|STARTED|Overall Study||12||
60039604|NCT01729156|76155478|FG001|STARTED|Overall Study||12||
60039605|NCT01729156|76155479|FG002|STARTED|Overall Study||12||
60039606|NCT01729156|76155477|FG000|COMPLETED|Overall Study||11||
60039607|NCT01729156|76155478|FG001|COMPLETED|Overall Study||12||
60039608|NCT01729156|76155479|FG002|COMPLETED|Overall Study||12||
60039609|NCT01729156|76155477|FG000|NOT COMPLETED|Overall Study||1||
60039610|NCT01729156|76155478|FG001|NOT COMPLETED|Overall Study||0||
60039611|NCT01729156|76155479|FG002|NOT COMPLETED|Overall Study||0||
60039612|NCT01779700|76155490|FG000|STARTED|Overall Study||18||
60039613|NCT01779700|76155491|FG001|STARTED|Overall Study||22||
60039614|NCT01779700|76155490|FG000|COMPLETED|Overall Study||14||
60039615|NCT01779700|76155491|FG001|COMPLETED|Overall Study||17||
60039616|NCT01779700|76155490|FG000|NOT COMPLETED|Overall Study||4||
60039617|NCT01779700|76155491|FG001|NOT COMPLETED|Overall Study||5||
60039618|NCT01778530|76155497|FG000|STARTED|Overall Study||2||
60039619|NCT01778530|76155497|FG000|COMPLETED|Overall Study||0||
60039620|NCT01778530|76155497|FG000|NOT COMPLETED|Overall Study||2||
60039621|NCT01778062|76155503|FG000|STARTED|Overall Study||68||
60039622|NCT01778062|76155504|FG001|STARTED|Overall Study||68||
60039623|NCT01778062|76155503|FG000|Safety Set|Overall Study||68||
60039624|NCT01778062|76155504|FG001|Safety Set|Overall Study||68||
60039625|NCT01778062|76155503|FG000|Intent to Treat (ITT)|Overall Study||68||
60039626|NCT01778062|76155504|FG001|Intent to Treat (ITT)|Overall Study|One failed to perform primary efficacy evaluation and was excluded, 135 were included in the ITT set|67||
60039627|NCT01778062|76155503|FG000|COMPLETED|Overall Study||62||
60039628|NCT01778062|76155504|FG001|COMPLETED|Overall Study||57||
60039629|NCT01778062|76155503|FG000|NOT COMPLETED|Overall Study||6||
60039630|NCT01778062|76155504|FG001|NOT COMPLETED|Overall Study||11||
60039631|NCT01759264|76155510|FG000|STARTED|Overall Study||101||
60039632|NCT01759264|76155510|FG000|COMPLETED|Overall Study||91||
60039633|NCT01759264|76155510|FG000|NOT COMPLETED|Overall Study||10||
60039634|NCT01757704|76155517|FG000|STARTED|Overall Study|One patient was excluded at start of surgery due to opening of the pleurae during sternotomy.|11||
60067828|NCT01756833|76183017|FG001|NOT COMPLETED|Overall Study||3||
60039635|NCT01757704|76155518|FG001|STARTED|Overall Study|Two patients excluded intraoperatively due to failure to obtain TCD signals and one due to adhesion.|13||
60039636|NCT01757704|76155517|FG000|COMPLETED|Overall Study||10||
60039637|NCT01757704|76155518|FG001|COMPLETED|Overall Study||10||
60039638|NCT01757704|76155517|FG000|NOT COMPLETED|Overall Study||1||
60039639|NCT01757704|76155518|FG001|NOT COMPLETED|Overall Study||3||
60039640|NCT01757392|76155524|FG000|STARTED|Overall Study||39|Number of participants who were screened|
60039641|NCT01757392|76155524|FG000|COMPLETED|Overall Study||35|Number of participants who received at least one wart injection|
60039642|NCT01757392|76155524|FG000|NOT COMPLETED|Overall Study||4||
60039643|NCT01756846|76155530|FG000|STARTED|Overall Study||1833||
60039644|NCT01756846|76155531|FG001|STARTED|Overall Study||1833||
60039645|NCT01756846|76155530|FG000|COMPLETED|Overall Study||1827||
60039646|NCT01756846|76155531|FG001|COMPLETED|Overall Study||1821||
60039647|NCT01756846|76155530|FG000|NOT COMPLETED|Overall Study||6||
60039648|NCT01756846|76155531|FG001|NOT COMPLETED|Overall Study||12||
60039649|NCT01963611|76155542|FG000|STARTED|Overall Study||51||
60039650|NCT01963611|76155543|FG001|STARTED|Overall Study||49||
60039651|NCT01963611|76155544|FG002|STARTED|Overall Study||52||
60039652|NCT01963611|76155545|FG003|STARTED|Overall Study||52||
60039653|NCT01963611|76155546|FG004|STARTED|Overall Study||51||
60039654|NCT01963611|76155542|FG000|Safety Analysis Set|Overall Study||51||
60039655|NCT01963611|76155543|FG001|Safety Analysis Set|Overall Study||49||
60039656|NCT01963611|76155544|FG002|Safety Analysis Set|Overall Study||52||
60039657|NCT01963611|76155545|FG003|Safety Analysis Set|Overall Study||52||
60039658|NCT01963611|76155546|FG004|Safety Analysis Set|Overall Study||50||
60039659|NCT01963611|76155542|FG000|COMPLETED|Overall Study||0||
60039660|NCT01963611|76155543|FG001|COMPLETED|Overall Study||0||
60039661|NCT01963611|76155544|FG002|COMPLETED|Overall Study||0||
60039662|NCT01963611|76155545|FG003|COMPLETED|Overall Study||0||
60039663|NCT01963611|76155546|FG004|COMPLETED|Overall Study||0||
60039664|NCT01963611|76155542|FG000|NOT COMPLETED|Overall Study||51||
60039665|NCT01963611|76155543|FG001|NOT COMPLETED|Overall Study||49||
60039666|NCT01963611|76155544|FG002|NOT COMPLETED|Overall Study||52||
60039667|NCT01963611|76155545|FG003|NOT COMPLETED|Overall Study||52||
60039668|NCT01963611|76155546|FG004|NOT COMPLETED|Overall Study||51||
60039669|NCT01975701|76155559|FG000|STARTED|Overall Study||26||
60039670|NCT01975701|76155559|FG000|COMPLETED|Overall Study||1||
60039671|NCT01975701|76155559|FG000|NOT COMPLETED|Overall Study||25||
60039672|NCT01962987|76155566|FG000|STARTED|Overall Study||190||
60039673|NCT01962987|76155567|FG001|STARTED|Overall Study||191||
60039674|NCT01962987|76155568|FG002|STARTED|Overall Study||95||
60039675|NCT01962987|76155566|FG000|COMPLETED|Overall Study||160||
60039676|NCT01962987|76155567|FG001|COMPLETED|Overall Study||163||
60039677|NCT01962987|76155568|FG002|COMPLETED|Overall Study||83||
60039678|NCT01962987|76155566|FG000|NOT COMPLETED|Overall Study||30||
60039679|NCT01962987|76155567|FG001|NOT COMPLETED|Overall Study||28||
60039680|NCT01962987|76155568|FG002|NOT COMPLETED|Overall Study||12||
60039681|NCT01962441|76155579|FG000|STARTED|Randomized Period||200||
60039682|NCT01962441|76155580|FG001|STARTED|Randomized Period||201||
60039683|NCT01962441|76155581|FG002|STARTED|Randomized Period||200||
60039684|NCT01962441|76155579|FG000|COMPLETED|Randomized Period||190||
60039685|NCT01962441|76155580|FG001|COMPLETED|Randomized Period||190||
60039686|NCT01962441|76155581|FG002|COMPLETED|Randomized Period||189||
60039687|NCT01962441|76155579|FG000|NOT COMPLETED|Randomized Period||10||
60039688|NCT01962441|76155580|FG001|NOT COMPLETED|Randomized Period||11||
60039689|NCT01962441|76155581|FG002|NOT COMPLETED|Randomized Period||11||
60039690|NCT01962441|76155579|FG000|STARTED|Retreatment Substudy|20 participants who experienced virologic failure enrolled into the Retreatment Substudy.|20||
60039691|NCT01962441|76155580|FG001|STARTED|Retreatment Substudy|10 participants who experienced virologic failure enrolled into the Retreatment Substudy.|10||
60039692|NCT01962441|76155581|FG002|STARTED|Retreatment Substudy|Participants in the SOF+RBV+Peg-IFN group were not eligible to enroll in the Retreatment Substudy.|0||
60039693|NCT01962441|76155579|FG000|COMPLETED|Retreatment Substudy||18||
60039694|NCT01962441|76155580|FG001|COMPLETED|Retreatment Substudy||10||
60039695|NCT01962441|76155581|FG002|COMPLETED|Retreatment Substudy||0||
60039696|NCT01962441|76155579|FG000|NOT COMPLETED|Retreatment Substudy||2||
60039697|NCT01962441|76155580|FG001|NOT COMPLETED|Retreatment Substudy||0||
60039698|NCT01962441|76155581|FG002|NOT COMPLETED|Retreatment Substudy||0||
60039699|NCT01638013|76155593|FG000|STARTED|Overall Study||201||
60039700|NCT01638013|76155594|FG001|STARTED|Overall Study||225||
60039701|NCT01638013|76155595|FG002|STARTED|Overall Study||417||
60039702|NCT01638013|76155593|FG000|COMPLETED|Overall Study||70||
60039703|NCT01638013|76155594|FG001|COMPLETED|Overall Study||147||
60039704|NCT01638013|76155595|FG002|COMPLETED|Overall Study||296||
60039705|NCT01638013|76155593|FG000|NOT COMPLETED|Overall Study||131||
60039706|NCT01638013|76155594|FG001|NOT COMPLETED|Overall Study||78||
60039707|NCT01638013|76155595|FG002|NOT COMPLETED|Overall Study||121||
60039708|NCT01637623|76155610|FG000|STARTED|Overall Study||29||
60039709|NCT01637623|76155611|FG001|STARTED|Overall Study||30||
60039710|NCT01637623|76155612|FG002|STARTED|Overall Study||28||
60039711|NCT01637623|76155610|FG000|Received Intervention|Overall Study||28||
60039712|NCT01637623|76155611|FG001|Received Intervention|Overall Study||30||
60039713|NCT01637623|76155612|FG002|Received Intervention|Overall Study||27||
60039714|NCT01637623|76155610|FG000|Did Not Receive Intervention|Overall Study||1||
60039715|NCT01637623|76155611|FG001|Did Not Receive Intervention|Overall Study||0||
60039716|NCT01637623|76155612|FG002|Did Not Receive Intervention|Overall Study||1||
60039717|NCT01637623|76155610|FG000|Analyzed|Overall Study||28|baseline characteristics data is for the 86 participants analyzed|
60039718|NCT01637623|76155611|FG001|Analyzed|Overall Study||30|baseline characteristics data is for the 86 participants analyzed|
60039719|NCT01637623|76155612|FG002|Analyzed|Overall Study||28|baseline characteristics data is for the 86 participants analyzed|
60039720|NCT01637623|76155610|FG000|COMPLETED|Overall Study||28||
60039721|NCT01637623|76155611|FG001|COMPLETED|Overall Study||30||
60039722|NCT01637623|76155612|FG002|COMPLETED|Overall Study||25||
60039723|NCT01637623|76155610|FG000|NOT COMPLETED|Overall Study||1||
60039724|NCT01637623|76155611|FG001|NOT COMPLETED|Overall Study||0||
60039725|NCT01637623|76155612|FG002|NOT COMPLETED|Overall Study||3||
60039726|NCT01962207|76155624|FG000|STARTED|Persistence Phase (5 Years)||76||
60039727|NCT01962207|76155625|FG001|STARTED|Persistence Phase (5 Years)||23||
60039728|NCT01962207|76155626|FG002|STARTED|Persistence Phase (5 Years)||115||
60039729|NCT01962207|76155627|FG003|STARTED|Persistence Phase (5 Years)||29||
60039730|NCT01962207|76155624|FG000|COMPLETED|Persistence Phase (5 Years)||47||
60039731|NCT01962207|76155625|FG001|COMPLETED|Persistence Phase (5 Years)||10||
60039732|NCT01962207|76155626|FG002|COMPLETED|Persistence Phase (5 Years)||71||
60039733|NCT01962207|76155627|FG003|COMPLETED|Persistence Phase (5 Years)||17||
60039734|NCT01962207|76155624|FG000|NOT COMPLETED|Persistence Phase (5 Years)||29||
60039735|NCT01962207|76155625|FG001|NOT COMPLETED|Persistence Phase (5 Years)||13||
60039736|NCT01962207|76155626|FG002|NOT COMPLETED|Persistence Phase (5 Years)||44||
60039737|NCT01962207|76155627|FG003|NOT COMPLETED|Persistence Phase (5 Years)||12||
60039738|NCT01962207|76155624|FG000|STARTED|Booster Phase (6 Months)|Eligible participants from persistence phase who provided consent to get enrolled in booster phase.|67||
60039739|NCT01962207|76155625|FG001|STARTED|Booster Phase (6 Months)|Eligible participants from persistence phase who provided consent to get enrolled in booster phase.|16||
60039740|NCT01962207|76155626|FG002|STARTED|Booster Phase (6 Months)|Eligible participants from persistence phase who provided consent to get enrolled in booster phase.|77||
60039741|NCT01962207|76155627|FG003|STARTED|Booster Phase (6 Months)|Eligible participants from persistence phase who provided consent to get enrolled in booster phase.|21||
60039742|NCT01962207|76155624|FG000|COMPLETED|Booster Phase (6 Months)||67||
60039743|NCT01962207|76155625|FG001|COMPLETED|Booster Phase (6 Months)||16||
60039744|NCT01962207|76155626|FG002|COMPLETED|Booster Phase (6 Months)||77||
59918395|NCT03634085|76038818|FG001|Period 4|Overall Study|this period is not applicable for Cohort B|0||
59918396|NCT03634085|76038817|FG000|COMPLETED|Overall Study|1 subject dropped out due to car accident|7||
59918397|NCT03634085|76038818|FG001|COMPLETED|Overall Study|"1 subject dropped out due to personal emergency~1 subject dropped out due to personal circumstances"|6||
59918398|NCT03634085|76038817|FG000|NOT COMPLETED|Overall Study||1||
60039745|NCT01962207|76155627|FG003|COMPLETED|Booster Phase (6 Months)||21||
60039746|NCT01962207|76155624|FG000|NOT COMPLETED|Booster Phase (6 Months)||0||
60039747|NCT01962207|76155625|FG001|NOT COMPLETED|Booster Phase (6 Months)||0||
60039748|NCT01962207|76155626|FG002|NOT COMPLETED|Booster Phase (6 Months)||0||
60039749|NCT01962207|76155627|FG003|NOT COMPLETED|Booster Phase (6 Months)||0||
60039750|NCT01995825|76155643|FG000|STARTED|Overall Study||18||
60039751|NCT01995825|76155644|FG001|STARTED|Overall Study||17||
60039752|NCT01995825|76155643|FG000|COMPLETED|Overall Study||17||
60039753|NCT01995825|76155644|FG001|COMPLETED|Overall Study||17||
60039754|NCT01995825|76155643|FG000|NOT COMPLETED|Overall Study||1||
60039755|NCT01995825|76155644|FG001|NOT COMPLETED|Overall Study||0||
60039756|NCT01995357|76155650|FG000|STARTED|Period 1||4||
60039757|NCT01995357|76155651|FG001|STARTED|Period 1||3||
60039758|NCT01995357|76155652|FG002|STARTED|Period 1||4||
60039759|NCT01995357|76155653|FG003|STARTED|Period 1||3||
60039760|NCT01995357|76155654|FG004|STARTED|Period 1||4||
60039761|NCT01995357|76155655|FG005|STARTED|Period 1||4||
60039762|NCT01995357|76155650|FG000|COMPLETED|Period 1||4||
60039763|NCT01995357|76155651|FG001|COMPLETED|Period 1||3||
59509889|NCT02620774|75603313|FG001|COMPLETED|Overall Study||6||
59509890|NCT02620774|75603312|FG000|NOT COMPLETED|Overall Study||0||
59918399|NCT03634085|76038818|FG001|NOT COMPLETED|Overall Study||2||
59918400|NCT02676778|76038834|FG000|STARTED|Overall Study||17||
60039764|NCT01995357|76155652|FG002|COMPLETED|Period 1||4||
60039765|NCT01995357|76155653|FG003|COMPLETED|Period 1||3||
60039766|NCT01995357|76155654|FG004|COMPLETED|Period 1||4||
60039767|NCT01995357|76155655|FG005|COMPLETED|Period 1||4||
60039768|NCT01995357|76155650|FG000|NOT COMPLETED|Period 1||0||
60039769|NCT01995357|76155651|FG001|NOT COMPLETED|Period 1||0||
60039770|NCT01995357|76155652|FG002|NOT COMPLETED|Period 1||0||
60039771|NCT01995357|76155653|FG003|NOT COMPLETED|Period 1||0||
59918401|NCT02676778|76038835|FG001|STARTED|Overall Study||19||
59918402|NCT02676778|76038836|FG002|STARTED|Overall Study||1||
59918403|NCT02676778|76038834|FG000|COMPLETED|Overall Study||0||
59918404|NCT02676778|76038835|FG001|COMPLETED|Overall Study||7||
59918405|NCT02676778|76038836|FG002|COMPLETED|Overall Study||0||
59918406|NCT02676778|76038834|FG000|NOT COMPLETED|Overall Study||17||
59509891|NCT02620774|75603313|FG001|NOT COMPLETED|Overall Study||0||
59509892|NCT02643004|75603319|FG000|STARTED|First Intervention (One Week)||35||
59509893|NCT02643004|75603320|FG001|STARTED|First Intervention (One Week)||35||
59509894|NCT02643004|75603319|FG000|COMPLETED|First Intervention (One Week)||35||
59509895|NCT02643004|75603320|FG001|COMPLETED|First Intervention (One Week)||35||
59509896|NCT02643004|75603319|FG000|NOT COMPLETED|First Intervention (One Week)||0||
59509897|NCT02643004|75603320|FG001|NOT COMPLETED|First Intervention (One Week)||0||
59509898|NCT02643004|75603319|FG000|STARTED|Second Intervention (One Week)||35||
59509899|NCT02643004|75603320|FG001|STARTED|Second Intervention (One Week)||35||
59509900|NCT02643004|75603319|FG000|COMPLETED|Second Intervention (One Week)||35||
59509901|NCT02643004|75603320|FG001|COMPLETED|Second Intervention (One Week)||35||
59509902|NCT02643004|75603319|FG000|NOT COMPLETED|Second Intervention (One Week)||0||
59509903|NCT02643004|75603320|FG001|NOT COMPLETED|Second Intervention (One Week)||0||
59509904|NCT00865969|75603326|FG000|STARTED|Overall Study||129||
59509905|NCT00865969|75603326|FG000|COMPLETED|Overall Study||129||
59509906|NCT00865969|75603326|FG000|NOT COMPLETED|Overall Study||0||
59509907|NCT00866749|75603330|FG000|STARTED|Overall Study||120||
59509908|NCT00866749|75603330|FG000|COMPLETED|Overall Study||120||
59509909|NCT00866749|75603330|FG000|NOT COMPLETED|Overall Study||0||
59509910|NCT00866905|75603334|FG000|STARTED|Overall Study||168||
59509911|NCT00866905|75603334|FG000|COMPLETED|Overall Study||135||
59509912|NCT00866905|75603334|FG000|NOT COMPLETED|Overall Study||33||
59509913|NCT00867139|75603343|FG000|STARTED|Overall Study||2||
59509914|NCT00867139|75603344|FG001|STARTED|Overall Study||1||
59509915|NCT00867139|75603345|FG002|STARTED|Overall Study||4||
59509916|NCT00867139|75603343|FG000|COMPLETED|Overall Study||2||
59509917|NCT00867139|75603344|FG001|COMPLETED|Overall Study||1||
59509918|NCT00867139|75603345|FG002|COMPLETED|Overall Study|One open-labeled patient withdrew on day 5.|3||
59509919|NCT00867139|75603343|FG000|NOT COMPLETED|Overall Study||0||
59509920|NCT00867139|75603344|FG001|NOT COMPLETED|Overall Study||0||
59509921|NCT00867139|75603345|FG002|NOT COMPLETED|Overall Study||1||
59509922|NCT00867217|75603363|FG000|STARTED|Overall Study||80||
59509923|NCT00867217|75603364|FG001|STARTED|Overall Study||80||
59509924|NCT00867217|75603363|FG000|COMPLETED|Overall Study||77||
59509925|NCT00867217|75603364|FG001|COMPLETED|Overall Study||70||
59509926|NCT00867217|75603363|FG000|NOT COMPLETED|Overall Study||3||
59509927|NCT00867217|75603364|FG001|NOT COMPLETED|Overall Study||10||
59509928|NCT00867451|75603372|FG000|STARTED|Overall Study||4||
59509929|NCT00867451|75603373|FG001|STARTED|Overall Study||4||
59509930|NCT00867451|75603372|FG000|COMPLETED|Overall Study||4||
59509931|NCT00867451|75603373|FG001|COMPLETED|Overall Study||4||
59509932|NCT00867451|75603372|FG000|NOT COMPLETED|Overall Study||0||
59509933|NCT00867451|75603373|FG001|NOT COMPLETED|Overall Study||0||
59509934|NCT00867529|75603383|FG000|STARTED|Overall Study||63||
59509935|NCT00867529|75603383|FG000|COMPLETED|Overall Study||63||
59509936|NCT00867529|75603383|FG000|NOT COMPLETED|Overall Study||0||
59509937|NCT00889915|75603391|FG000|STARTED|Overall Study||37||
59509938|NCT00889915|75603392|FG001|STARTED|Overall Study||76||
59509939|NCT00889915|75603393|FG002|STARTED|Overall Study||67||
59509940|NCT00889915|75603394|FG003|STARTED|Overall Study||48||
59612370|NCT01701258|75723504|FG005|Returned for EEG (Session 4)|Assessment and Scheduling||0|66/96 completed the EEG. Participants did at least two sessions after the screening visit.|
59509941|NCT00889915|75603391|FG000|COMPLETED|Overall Study||35||
59509942|NCT00889915|75603392|FG001|COMPLETED|Overall Study||71||
59509943|NCT00889915|75603393|FG002|COMPLETED|Overall Study||54||
59509944|NCT00889915|75603394|FG003|COMPLETED|Overall Study||40||
59509945|NCT00889915|75603391|FG000|NOT COMPLETED|Overall Study||2||
59509946|NCT00889915|75603392|FG001|NOT COMPLETED|Overall Study||5||
59509947|NCT00889915|75603393|FG002|NOT COMPLETED|Overall Study||13||
59509948|NCT00889915|75603394|FG003|NOT COMPLETED|Overall Study||8||
59509949|NCT00841087|75603406|FG000|STARTED|Overall Study||33||
59509950|NCT00841087|75603407|FG001|STARTED|Overall Study||32||
59509951|NCT00841087|75603406|FG000|COMPLETED|Overall Study||33||
59509952|NCT00841087|75603407|FG001|COMPLETED|Overall Study||32||
59509953|NCT00841087|75603406|FG000|NOT COMPLETED|Overall Study||0||
59509954|NCT00841087|75603407|FG001|NOT COMPLETED|Overall Study||0||
59509955|NCT02685436|75603413|FG000|STARTED|Overall Study|the overall studied group|52||
59509956|NCT02685436|75603413|FG000|COMPLETED|Overall Study|GERD positive patients by either combined MII-pH or esophageal biopsy|38||
59509957|NCT02685436|75603413|FG000|NOT COMPLETED|Overall Study||14||
59509958|NCT00841555|75603420|FG000|STARTED|Overall Study||3||
59509959|NCT00841555|75603421|FG001|STARTED|Overall Study||3||
59509960|NCT00841555|75603422|FG002|STARTED|Overall Study||3||
59509961|NCT00841555|75603420|FG000|COMPLETED|Overall Study||3||
59509962|NCT00841555|75603421|FG001|COMPLETED|Overall Study||3||
59509963|NCT00841555|75603422|FG002|COMPLETED|Overall Study||3||
59509964|NCT00841555|75603420|FG000|NOT COMPLETED|Overall Study||0||
59509965|NCT00841555|75603421|FG001|NOT COMPLETED|Overall Study||0||
59509966|NCT00841555|75603422|FG002|NOT COMPLETED|Overall Study||0||
59509967|NCT02686138|75603430|FG000|STARTED|Overall Study||293||
59509968|NCT02686138|75603431|FG001|STARTED|Overall Study||300||
59509969|NCT02686138|75603430|FG000|COMPLETED|Overall Study||219||
59509970|NCT02686138|75603431|FG001|COMPLETED|Overall Study||235||
59509971|NCT02686138|75603430|FG000|NOT COMPLETED|Overall Study||74||
59509972|NCT02686138|75603431|FG001|NOT COMPLETED|Overall Study||65||
60039772|NCT01995357|76155654|FG004|NOT COMPLETED|Period 1||0||
60039773|NCT01995357|76155655|FG005|NOT COMPLETED|Period 1||0||
60039774|NCT01995357|76155650|FG000|STARTED|Period 2||4||
60039775|NCT01995357|76155651|FG001|STARTED|Period 2||3||
60039776|NCT01995357|76155652|FG002|STARTED|Period 2||4||
60039777|NCT01995357|76155653|FG003|STARTED|Period 2||3||
60039778|NCT01995357|76155654|FG004|STARTED|Period 2||4||
60039779|NCT01995357|76155655|FG005|STARTED|Period 2||4||
60039780|NCT01995357|76155650|FG000|COMPLETED|Period 2||4||
60039781|NCT01995357|76155651|FG001|COMPLETED|Period 2||3||
60039782|NCT01995357|76155652|FG002|COMPLETED|Period 2||4||
60039783|NCT01995357|76155653|FG003|COMPLETED|Period 2||3||
60039784|NCT01995357|76155654|FG004|COMPLETED|Period 2||4||
60039785|NCT01995357|76155655|FG005|COMPLETED|Period 2||4||
60039786|NCT01995357|76155650|FG000|NOT COMPLETED|Period 2||0||
60039787|NCT01995357|76155651|FG001|NOT COMPLETED|Period 2||0||
60039788|NCT01995357|76155652|FG002|NOT COMPLETED|Period 2||0||
60039789|NCT01995357|76155653|FG003|NOT COMPLETED|Period 2||0||
60039790|NCT01995357|76155654|FG004|NOT COMPLETED|Period 2||0||
60039791|NCT01995357|76155655|FG005|NOT COMPLETED|Period 2||0||
60039792|NCT01995357|76155650|FG000|STARTED|Period 3||4||
60039793|NCT01995357|76155651|FG001|STARTED|Period 3||3||
60039794|NCT01995357|76155652|FG002|STARTED|Period 3||4||
60039795|NCT01995357|76155653|FG003|STARTED|Period 3||3||
60039796|NCT01995357|76155654|FG004|STARTED|Period 3||4||
60039797|NCT01995357|76155655|FG005|STARTED|Period 3||4||
60039798|NCT01995357|76155650|FG000|COMPLETED|Period 3||4||
60039799|NCT01995357|76155651|FG001|COMPLETED|Period 3||3||
60039800|NCT01995357|76155652|FG002|COMPLETED|Period 3||4||
60039801|NCT01995357|76155653|FG003|COMPLETED|Period 3||3||
60039802|NCT01995357|76155654|FG004|COMPLETED|Period 3||4||
60039803|NCT01995357|76155655|FG005|COMPLETED|Period 3||4||
60039804|NCT01995357|76155650|FG000|NOT COMPLETED|Period 3||0||
60039805|NCT01995357|76155651|FG001|NOT COMPLETED|Period 3||0||
60039806|NCT01995357|76155652|FG002|NOT COMPLETED|Period 3||0||
60039807|NCT01995357|76155653|FG003|NOT COMPLETED|Period 3||0||
60039808|NCT01995357|76155654|FG004|NOT COMPLETED|Period 3||0||
60039809|NCT01995357|76155655|FG005|NOT COMPLETED|Period 3||0||
60039810|NCT01995357|76155650|FG000|STARTED|Period 4||4||
60039811|NCT01995357|76155651|FG001|STARTED|Period 4||3||
60039812|NCT01995357|76155652|FG002|STARTED|Period 4|The subject who did not complete period 5, erroneously used product A when B should have been used.|4||
60039813|NCT01995357|76155653|FG003|STARTED|Period 4||3||
60039814|NCT01995357|76155654|FG004|STARTED|Period 4||4||
60039815|NCT01995357|76155655|FG005|STARTED|Period 4||4||
60039816|NCT01995357|76155650|FG000|COMPLETED|Period 4||4||
60039817|NCT01995357|76155651|FG001|COMPLETED|Period 4||3||
60039818|NCT01995357|76155652|FG002|COMPLETED|Period 4||4||
60039819|NCT01995357|76155653|FG003|COMPLETED|Period 4||3||
60039820|NCT01995357|76155654|FG004|COMPLETED|Period 4||4||
60039821|NCT01995357|76155655|FG005|COMPLETED|Period 4||4||
59918407|NCT02676778|76038835|FG001|NOT COMPLETED|Overall Study||12||
59918408|NCT02676778|76038836|FG002|NOT COMPLETED|Overall Study||1||
59918409|NCT02946385|76038851|FG000|STARTED|Overall Study||126||
60039822|NCT01995357|76155650|FG000|NOT COMPLETED|Period 4||0||
60039823|NCT01995357|76155651|FG001|NOT COMPLETED|Period 4||0||
60039824|NCT01995357|76155652|FG002|NOT COMPLETED|Period 4||0||
60039825|NCT01995357|76155653|FG003|NOT COMPLETED|Period 4||0||
60039826|NCT01995357|76155654|FG004|NOT COMPLETED|Period 4||0||
60039827|NCT01995357|76155655|FG005|NOT COMPLETED|Period 4||0||
60039828|NCT01995357|76155650|FG000|STARTED|Period 5|The two discontinued subjects tested zero planned B products in period 5.|4||
60039829|NCT01995357|76155651|FG001|STARTED|Period 5||3||
60039830|NCT01995357|76155652|FG002|STARTED|Period 5||4||
60039831|NCT01995357|76155653|FG003|STARTED|Period 5||3||
60039832|NCT01995357|76155654|FG004|STARTED|Period 5|1 subject terminated due to an adverse event. Subject counted as completed as some B products tested|4||
60039833|NCT01995357|76155655|FG005|STARTED|Period 5||4||
59918410|NCT02946385|76038852|FG001|STARTED|Overall Study||127||
59918411|NCT02946385|76038853|FG002|STARTED|Overall Study||99||
59918412|NCT02946385|76038854|FG003|STARTED|Overall Study||74||
59918413|NCT02946385|76038855|FG004|STARTED|Overall Study||101||
59918414|NCT02946385|76038856|FG005|STARTED|Overall Study||77||
59918415|NCT02946385|76038851|FG000|COMPLETED|Overall Study||126||
60039834|NCT01995357|76155650|FG000|COMPLETED|Period 5||2||
60039835|NCT01995357|76155651|FG001|COMPLETED|Period 5||3||
60039836|NCT01995357|76155652|FG002|COMPLETED|Period 5||3||
59918416|NCT02946385|76038852|FG001|COMPLETED|Overall Study||127||
59918417|NCT02946385|76038853|FG002|COMPLETED|Overall Study||96||
59918418|NCT02946385|76038854|FG003|COMPLETED|Overall Study||74||
59918419|NCT02946385|76038855|FG004|COMPLETED|Overall Study||99||
60039837|NCT01995357|76155653|FG003|COMPLETED|Period 5||3||
60039838|NCT01995357|76155654|FG004|COMPLETED|Period 5||4||
60039839|NCT01995357|76155655|FG005|COMPLETED|Period 5||4||
60039840|NCT01995357|76155650|FG000|NOT COMPLETED|Period 5||2||
60039841|NCT01995357|76155651|FG001|NOT COMPLETED|Period 5||0||
60039842|NCT01995357|76155652|FG002|NOT COMPLETED|Period 5||1||
60039843|NCT01995357|76155653|FG003|NOT COMPLETED|Period 5||0||
60039844|NCT01995357|76155654|FG004|NOT COMPLETED|Period 5||0||
60039845|NCT01995357|76155655|FG005|NOT COMPLETED|Period 5||0||
60039846|NCT01638559|76155671|FG000|STARTED|Overall Study||88||
60039847|NCT01638559|76155671|FG000|COMPLETED|Overall Study|Completion through the time of the primary endpoint (outcome).|85||
60039848|NCT01638559|76155671|FG000|NOT COMPLETED|Overall Study||3||
60039849|NCT01756300|76155686|FG000|STARTED|Overall Study|Subjects underwent renal denervation treatment with the study catheter.|35||
60039850|NCT01756300|76155686|FG000|COMPLETED|Overall Study|Subjects with follow up available at 12 months|33||
60039851|NCT01756300|76155686|FG000|NOT COMPLETED|Overall Study||2||
60039852|NCT01995201|76155709|FG000|STARTED|From Baseline Until Week 24||74||
60039853|NCT01995201|76155710|FG001|STARTED|From Baseline Until Week 24||327||
60039854|NCT01995201|76155711|FG002|STARTED|From Baseline Until Week 24||0||
60039855|NCT01995201|76155712|FG003|STARTED|From Baseline Until Week 24||0||
60039856|NCT01995201|76155713|FG004|STARTED|From Baseline Until Week 24||0||
60039857|NCT01995201|76155714|FG005|STARTED|From Baseline Until Week 24||0||
60039858|NCT01995201|76155715|FG006|STARTED|From Baseline Until Week 24||0||
60039859|NCT01995201|76155709|FG000|COMPLETED|From Baseline Until Week 24||64||
60039860|NCT01995201|76155710|FG001|COMPLETED|From Baseline Until Week 24||281||
60039861|NCT01995201|76155711|FG002|COMPLETED|From Baseline Until Week 24||0||
60039862|NCT01995201|76155712|FG003|COMPLETED|From Baseline Until Week 24||0||
60039863|NCT01995201|76155713|FG004|COMPLETED|From Baseline Until Week 24||0||
60039864|NCT01995201|76155714|FG005|COMPLETED|From Baseline Until Week 24||0||
60039865|NCT01995201|76155715|FG006|COMPLETED|From Baseline Until Week 24||0||
60039866|NCT01995201|76155709|FG000|NOT COMPLETED|From Baseline Until Week 24||10||
60039867|NCT01995201|76155710|FG001|NOT COMPLETED|From Baseline Until Week 24||46||
60039868|NCT01995201|76155711|FG002|NOT COMPLETED|From Baseline Until Week 24||0||
60039869|NCT01995201|76155712|FG003|NOT COMPLETED|From Baseline Until Week 24||0||
60039870|NCT01995201|76155713|FG004|NOT COMPLETED|From Baseline Until Week 24||0||
60039871|NCT01995201|76155714|FG005|NOT COMPLETED|From Baseline Until Week 24||0||
60039872|NCT01995201|76155715|FG006|NOT COMPLETED|From Baseline Until Week 24||0||
60039873|NCT01995201|76155709|FG000|STARTED|From Week 24 Until Week 48||0||
60039874|NCT01995201|76155710|FG001|STARTED|From Week 24 Until Week 48||0||
60039875|NCT01995201|76155711|FG002|STARTED|From Week 24 Until Week 48||89||
60039876|NCT01995201|76155712|FG003|STARTED|From Week 24 Until Week 48||90||
60039877|NCT01995201|76155713|FG004|STARTED|From Week 24 Until Week 48||95||
60039878|NCT01995201|76155714|FG005|STARTED|From Week 24 Until Week 48||67||
60039879|NCT01995201|76155715|FG006|STARTED|From Week 24 Until Week 48||2||
60039880|NCT01995201|76155709|FG000|COMPLETED|From Week 24 Until Week 48||0||
60039881|NCT01995201|76155710|FG001|COMPLETED|From Week 24 Until Week 48||0||
60039882|NCT01995201|76155711|FG002|COMPLETED|From Week 24 Until Week 48||84||
60039883|NCT01995201|76155712|FG003|COMPLETED|From Week 24 Until Week 48||89||
60039884|NCT01995201|76155713|FG004|COMPLETED|From Week 24 Until Week 48||89||
60039885|NCT01995201|76155714|FG005|COMPLETED|From Week 24 Until Week 48||59||
60039886|NCT01995201|76155715|FG006|COMPLETED|From Week 24 Until Week 48||0||
60039887|NCT01995201|76155709|FG000|NOT COMPLETED|From Week 24 Until Week 48||0||
60039888|NCT01995201|76155710|FG001|NOT COMPLETED|From Week 24 Until Week 48||0||
60039889|NCT01995201|76155711|FG002|NOT COMPLETED|From Week 24 Until Week 48||5||
60039890|NCT01995201|76155712|FG003|NOT COMPLETED|From Week 24 Until Week 48||1||
60039891|NCT01995201|76155713|FG004|NOT COMPLETED|From Week 24 Until Week 48||6||
60039892|NCT01995201|76155714|FG005|NOT COMPLETED|From Week 24 Until Week 48||8||
60039893|NCT01995201|76155715|FG006|NOT COMPLETED|From Week 24 Until Week 48||2||
60039894|NCT01728454|76155739|FG000|STARTED|Stage 1 and 2||17||
60039895|NCT01728454|76155740|FG001|STARTED|Stage 1 and 2||20||
60039896|NCT01728454|76155741|FG002|STARTED|Stage 1 and 2||23||
60039897|NCT01728454|76155739|FG000|COMPLETED|Stage 1 and 2||12||
60039898|NCT01728454|76155740|FG001|COMPLETED|Stage 1 and 2||16||
60039899|NCT01728454|76155741|FG002|COMPLETED|Stage 1 and 2||19||
60039900|NCT01728454|76155739|FG000|NOT COMPLETED|Stage 1 and 2||5||
60039901|NCT01728454|76155740|FG001|NOT COMPLETED|Stage 1 and 2||4||
60039902|NCT01728454|76155741|FG002|NOT COMPLETED|Stage 1 and 2||4||
60039903|NCT01728454|76155739|FG000|STARTED|Stage 3|Eligible participants who opted to participate in Stage 3.|6||
60039904|NCT01728454|76155740|FG001|STARTED|Stage 3|Eligible participants who opted to participate in Stage 3.|5||
60039905|NCT01728454|76155741|FG002|STARTED|Stage 3|Eligible participants who opted to participate in Stage 3.|11||
60039906|NCT01728454|76155739|FG000|COMPLETED|Stage 3||3||
60039907|NCT01728454|76155740|FG001|COMPLETED|Stage 3||1||
60039908|NCT01728454|76155741|FG002|COMPLETED|Stage 3||7||
60039909|NCT01728454|76155739|FG000|NOT COMPLETED|Stage 3||3||
60039910|NCT01728454|76155740|FG001|NOT COMPLETED|Stage 3||4||
60039911|NCT01728454|76155741|FG002|NOT COMPLETED|Stage 3||4||
60039912|NCT01636687|76155755|FG000|STARTED|Induction Period||61||
60039913|NCT01636687|76155756|FG001|STARTED|Induction Period||60||
60039914|NCT01636687|76155757|FG002|STARTED|Induction Period||0||
60039915|NCT01636687|76155758|FG003|STARTED|Induction Period||0||
60039916|NCT01636687|76155759|FG004|STARTED|Induction Period||61||
60039917|NCT01636687|76155755|FG000|COMPLETED|Induction Period||58||
60039918|NCT01636687|76155756|FG001|COMPLETED|Induction Period||60||
60039919|NCT01636687|76155757|FG002|COMPLETED|Induction Period||0||
60039920|NCT01636687|76155758|FG003|COMPLETED|Induction Period||0||
60039921|NCT01636687|76155759|FG004|COMPLETED|Induction Period||59||
60039922|NCT01636687|76155755|FG000|NOT COMPLETED|Induction Period||3||
60039923|NCT01636687|76155756|FG001|NOT COMPLETED|Induction Period||0||
60039924|NCT01636687|76155757|FG002|NOT COMPLETED|Induction Period||0||
60039925|NCT01636687|76155758|FG003|NOT COMPLETED|Induction Period||0||
60039926|NCT01636687|76155759|FG004|NOT COMPLETED|Induction Period||2||
60039927|NCT01636687|76155755|FG000|STARTED|Maintenance Period||58||
60039928|NCT01636687|76155756|FG001|STARTED|Maintenance Period||60||
60039929|NCT01636687|76155757|FG002|STARTED|Maintenance Period||28||
60039930|NCT01636687|76155758|FG003|STARTED|Maintenance Period||28||
60039931|NCT01636687|76155759|FG004|STARTED|Maintenance Period||3||
60039932|NCT01636687|76155755|FG000|COMPLETED|Maintenance Period||50||
60039933|NCT01636687|76155756|FG001|COMPLETED|Maintenance Period||58||
60039934|NCT01636687|76155757|FG002|COMPLETED|Maintenance Period||26||
60039935|NCT01636687|76155758|FG003|COMPLETED|Maintenance Period||28||
60039936|NCT01636687|76155759|FG004|COMPLETED|Maintenance Period||1||
60039937|NCT01636687|76155755|FG000|NOT COMPLETED|Maintenance Period||8||
60039938|NCT01636687|76155756|FG001|NOT COMPLETED|Maintenance Period||2||
60039939|NCT01636687|76155757|FG002|NOT COMPLETED|Maintenance Period||2||
60039940|NCT01636687|76155758|FG003|NOT COMPLETED|Maintenance Period||0||
60039941|NCT01636687|76155759|FG004|NOT COMPLETED|Maintenance Period||2||
60039942|NCT01636687|76155755|FG000|STARTED|Extension Period||47||
60039943|NCT01636687|76155756|FG001|STARTED|Extension Period||54||
60039944|NCT01636687|76155757|FG002|STARTED|Extension Period||25||
60039945|NCT01636687|76155758|FG003|STARTED|Extension Period||28||
60039946|NCT01636687|76155759|FG004|STARTED|Extension Period||0||
60039947|NCT01636687|76155755|FG000|COMPLETED|Extension Period||0||
60039948|NCT01636687|76155756|FG001|COMPLETED|Extension Period||0||
59918420|NCT02946385|76038856|FG005|COMPLETED|Overall Study||76||
60039949|NCT01636687|76155757|FG002|COMPLETED|Extension Period||0||
60039950|NCT01636687|76155758|FG003|COMPLETED|Extension Period||0||
60039951|NCT01636687|76155759|FG004|COMPLETED|Extension Period||0||
60039952|NCT01636687|76155755|FG000|NOT COMPLETED|Extension Period||47||
60039953|NCT01636687|76155756|FG001|NOT COMPLETED|Extension Period||54||
60039954|NCT01636687|76155757|FG002|NOT COMPLETED|Extension Period||25||
60039955|NCT01636687|76155758|FG003|NOT COMPLETED|Extension Period||28||
60039956|NCT01636687|76155759|FG004|NOT COMPLETED|Extension Period||0||
60039957|NCT01636687|76155755|FG000|STARTED|Follow-up Period||38||
60039958|NCT01636687|76155756|FG001|STARTED|Follow-up Period||45||
60039959|NCT01636687|76155757|FG002|STARTED|Follow-up Period||21||
60039960|NCT01636687|76155758|FG003|STARTED|Follow-up Period||20||
59918421|NCT02946385|76038851|FG000|NOT COMPLETED|Overall Study||0||
59918422|NCT02946385|76038852|FG001|NOT COMPLETED|Overall Study||0||
59918423|NCT02946385|76038853|FG002|NOT COMPLETED|Overall Study||3||
59918424|NCT02946385|76038854|FG003|NOT COMPLETED|Overall Study||0||
59918425|NCT02946385|76038855|FG004|NOT COMPLETED|Overall Study||2||
59918426|NCT02946385|76038856|FG005|NOT COMPLETED|Overall Study||1||
59918427|NCT02694718|76038876|FG000|STARTED|Overall Study||60||
59918428|NCT02694718|76038876|FG000|COMPLETED|Overall Study||58||
59918429|NCT02694718|76038876|FG000|NOT COMPLETED|Overall Study||2||
59918430|NCT02944513|76038882|FG000|STARTED|Overall Study||35||
59918431|NCT02944513|76038883|FG001|STARTED|Overall Study||33||
59918432|NCT02944513|76038882|FG000|COMPLETED|Overall Study||31||
59918433|NCT02944513|76038883|FG001|COMPLETED|Overall Study||32||
59918434|NCT02944513|76038882|FG000|NOT COMPLETED|Overall Study||4||
59918435|NCT02944513|76038883|FG001|NOT COMPLETED|Overall Study||1||
59918436|NCT04762537|76038891|FG000|STARTED|Step 1 (Weeks 0-14)||14||1
59918437|NCT04762537|76038892|FG001|STARTED|Step 1 (Weeks 0-14)||14||1
59918438|NCT04762537|76038893|FG002|STARTED|Step 1 (Weeks 0-14)||6||1
59918439|NCT04762537|76038894|FG003|STARTED|Step 1 (Weeks 0-14)||25||1
59918440|NCT04762537|76038895|FG004|STARTED|Step 1 (Weeks 0-14)||15||1
59918441|NCT04762537|76038896|FG005|STARTED|Step 1 (Weeks 0-14)||8||1
59918442|NCT04762537|76038891|FG000|COMPLETED|Step 1 (Weeks 0-14)||7||1
59918443|NCT04762537|76038892|FG001|COMPLETED|Step 1 (Weeks 0-14)||6||1
59918444|NCT04762537|76038893|FG002|COMPLETED|Step 1 (Weeks 0-14)||1||1
60039961|NCT01636687|76155759|FG004|STARTED|Follow-up Period||2||
60039962|NCT01636687|76155755|FG000|COMPLETED|Follow-up Period||37||
60039963|NCT01636687|76155756|FG001|COMPLETED|Follow-up Period||45||
60039964|NCT01636687|76155757|FG002|COMPLETED|Follow-up Period||21||
60039965|NCT01636687|76155758|FG003|COMPLETED|Follow-up Period||20||
60039966|NCT01636687|76155759|FG004|COMPLETED|Follow-up Period||1||
60039967|NCT01636687|76155755|FG000|NOT COMPLETED|Follow-up Period||1||
60039968|NCT01636687|76155756|FG001|NOT COMPLETED|Follow-up Period||0||
60039969|NCT01636687|76155757|FG002|NOT COMPLETED|Follow-up Period||0||
60039970|NCT01636687|76155758|FG003|NOT COMPLETED|Follow-up Period||0||
60039971|NCT01636687|76155759|FG004|NOT COMPLETED|Follow-up Period||1||
60039972|NCT01634659|76155779|FG000|STARTED|Period 1 - First 8 Days of Wear||155||
60039973|NCT01634659|76155780|FG001|STARTED|Period 1 - First 8 Days of Wear||158||
59509973|NCT00842023|75603439|FG000|STARTED|Overall Study||45||
59509974|NCT00842023|75603440|FG001|STARTED|Overall Study||44||
60039974|NCT01634659|76155779|FG000|COMPLETED|Period 1 - First 8 Days of Wear||155||
60039975|NCT01634659|76155780|FG001|COMPLETED|Period 1 - First 8 Days of Wear||158||
60039976|NCT01634659|76155779|FG000|NOT COMPLETED|Period 1 - First 8 Days of Wear||0||
60039977|NCT01634659|76155780|FG001|NOT COMPLETED|Period 1 - First 8 Days of Wear||0||
60039978|NCT01634659|76155779|FG000|STARTED|Period 2 - Second 8 Days of Wear||155||
60039979|NCT01634659|76155780|FG001|STARTED|Period 2 - Second 8 Days of Wear||158||
60039980|NCT01634659|76155779|FG000|COMPLETED|Period 2 - Second 8 Days of Wear||152||
59509975|NCT00842023|75603439|FG000|COMPLETED|Overall Study||45||
59918445|NCT04762537|76038894|FG003|COMPLETED|Step 1 (Weeks 0-14)||6||1
59918446|NCT04762537|76038895|FG004|COMPLETED|Step 1 (Weeks 0-14)||12||1
59918447|NCT04762537|76038896|FG005|COMPLETED|Step 1 (Weeks 0-14)||1||1
59918448|NCT04762537|76038891|FG000|NOT COMPLETED|Step 1 (Weeks 0-14)||7||0
59918449|NCT04762537|76038892|FG001|NOT COMPLETED|Step 1 (Weeks 0-14)||8||0
59918450|NCT04762537|76038893|FG002|NOT COMPLETED|Step 1 (Weeks 0-14)||5||0
59918451|NCT04762537|76038894|FG003|NOT COMPLETED|Step 1 (Weeks 0-14)||19||0
59918452|NCT04762537|76038895|FG004|NOT COMPLETED|Step 1 (Weeks 0-14)||3||0
59918453|NCT04762537|76038896|FG005|NOT COMPLETED|Step 1 (Weeks 0-14)||7||0
59918454|NCT04762537|76038891|FG000|STARTED|Step 2 (Weeks 14-28)||7||1
59918455|NCT04762537|76038892|FG001|STARTED|Step 2 (Weeks 14-28)||25||1
59918456|NCT04762537|76038893|FG002|STARTED|Step 2 (Weeks 14-28)||9||1
59918457|NCT04762537|76038894|FG003|STARTED|Step 2 (Weeks 14-28)||24||1
59918458|NCT04762537|76038895|FG004|STARTED|Step 2 (Weeks 14-28)||13||1
59918459|NCT04762537|76038896|FG005|STARTED|Step 2 (Weeks 14-28)||6||1
59918460|NCT04762537|76038891|FG000|COMPLETED|Step 2 (Weeks 14-28)||4||1
59918461|NCT04762537|76038892|FG001|COMPLETED|Step 2 (Weeks 14-28)||19||1
59918462|NCT04762537|76038893|FG002|COMPLETED|Step 2 (Weeks 14-28)||5||1
59918463|NCT04762537|76038894|FG003|COMPLETED|Step 2 (Weeks 14-28)||7||1
59918464|NCT04762537|76038895|FG004|COMPLETED|Step 2 (Weeks 14-28)||7||1
59918465|NCT04762537|76038896|FG005|COMPLETED|Step 2 (Weeks 14-28)||3||1
59918466|NCT04762537|76038891|FG000|NOT COMPLETED|Step 2 (Weeks 14-28)||3||0
59918467|NCT04762537|76038892|FG001|NOT COMPLETED|Step 2 (Weeks 14-28)||6||0
59918468|NCT04762537|76038893|FG002|NOT COMPLETED|Step 2 (Weeks 14-28)||4||0
59918469|NCT04762537|76038894|FG003|NOT COMPLETED|Step 2 (Weeks 14-28)||17||0
59918470|NCT04762537|76038895|FG004|NOT COMPLETED|Step 2 (Weeks 14-28)||6||0
59918471|NCT04762537|76038896|FG005|NOT COMPLETED|Step 2 (Weeks 14-28)||3||0
59918472|NCT04762537|76038891|FG000|STARTED|Step 3 (Weeks 28-42)||10||1
59918473|NCT04762537|76038892|FG001|STARTED|Step 3 (Weeks 28-42)||23||1
59918474|NCT04762537|76038893|FG002|STARTED|Step 3 (Weeks 28-42)||12||1
59918475|NCT04762537|76038894|FG003|STARTED|Step 3 (Weeks 28-42)||15||1
59918476|NCT04762537|76038895|FG004|STARTED|Step 3 (Weeks 28-42)||13||1
59918477|NCT04762537|76038896|FG005|STARTED|Step 3 (Weeks 28-42)||7||1
59918478|NCT04762537|76038891|FG000|COMPLETED|Step 3 (Weeks 28-42)||2||1
59918479|NCT04762537|76038892|FG001|COMPLETED|Step 3 (Weeks 28-42)||14||1
60039981|NCT01634659|76155780|FG001|COMPLETED|Period 2 - Second 8 Days of Wear||158||
59509976|NCT00842023|75603440|FG001|COMPLETED|Overall Study||44||
59509977|NCT00842023|75603439|FG000|NOT COMPLETED|Overall Study||0||
59509978|NCT00842023|75603440|FG001|NOT COMPLETED|Overall Study||0||
59509979|NCT00868309|75603451|FG000|STARTED|Overall Study||6||
59509980|NCT00868309|75603452|FG001|STARTED|Overall Study||6||
59509981|NCT00868309|75603451|FG000|COMPLETED|Overall Study||6||
59509982|NCT00868309|75603452|FG001|COMPLETED|Overall Study||6||
59509983|NCT00868309|75603451|FG000|NOT COMPLETED|Overall Study||0||
59509984|NCT00868309|75603452|FG001|NOT COMPLETED|Overall Study||0||
59509985|NCT02693704|75603462|FG000|STARTED|Overall Study||10||
59509986|NCT02693704|75603463|FG001|STARTED|Overall Study||10||
59509987|NCT02693704|75603464|FG002|STARTED|Overall Study||10||
59509988|NCT02693704|75603465|FG003|STARTED|Overall Study||10||
59918480|NCT04762537|76038893|FG002|COMPLETED|Step 3 (Weeks 28-42)||9||1
59918481|NCT04762537|76038894|FG003|COMPLETED|Step 3 (Weeks 28-42)||5||1
59918482|NCT04762537|76038895|FG004|COMPLETED|Step 3 (Weeks 28-42)||4||1
59918483|NCT04762537|76038896|FG005|COMPLETED|Step 3 (Weeks 28-42)||3||1
59918484|NCT04762537|76038891|FG000|NOT COMPLETED|Step 3 (Weeks 28-42)||8||0
59918485|NCT04762537|76038892|FG001|NOT COMPLETED|Step 3 (Weeks 28-42)||9||0
59918486|NCT04762537|76038893|FG002|NOT COMPLETED|Step 3 (Weeks 28-42)||3||0
59918487|NCT04762537|76038894|FG003|NOT COMPLETED|Step 3 (Weeks 28-42)||10||0
59918488|NCT04762537|76038895|FG004|NOT COMPLETED|Step 3 (Weeks 28-42)||9||0
59918489|NCT04762537|76038896|FG005|NOT COMPLETED|Step 3 (Weeks 28-42)||4||0
59918490|NCT04762537|76038891|FG000|STARTED|Step 4 (Weeks 42-56)||15||1
60039982|NCT01634659|76155779|FG000|NOT COMPLETED|Period 2 - Second 8 Days of Wear||3||
60039983|NCT01634659|76155780|FG001|NOT COMPLETED|Period 2 - Second 8 Days of Wear||0||
60039984|NCT04875065|76155786|FG000|STARTED|Overall Study||10||
60039985|NCT04875065|76155786|FG000|COMPLETED|Overall Study||8||
59509989|NCT02693704|75603462|FG000|COMPLETED|Overall Study||10||
59509990|NCT02693704|75603463|FG001|COMPLETED|Overall Study||10||
59509991|NCT02693704|75603464|FG002|COMPLETED|Overall Study||10||
60039986|NCT04875065|76155786|FG000|NOT COMPLETED|Overall Study||2||
60039987|NCT04863248|76155792|FG000|STARTED|Overall Study||4||
60039988|NCT04863248|76155793|FG001|STARTED|Overall Study||3||
60039989|NCT04863248|76155792|FG000|COMPLETED|Overall Study||0||
60039990|NCT04863248|76155793|FG001|COMPLETED|Overall Study||0||
60039991|NCT04863248|76155792|FG000|NOT COMPLETED|Overall Study||4||
60039992|NCT04863248|76155793|FG001|NOT COMPLETED|Overall Study||3||
60039993|NCT04285229|76155801|FG000|STARTED|Double-Blind Treatment Period||73||
60039994|NCT04285229|76155802|FG001|STARTED|Double-Blind Treatment Period||74||
60039995|NCT04285229|76155803|FG002|STARTED|Double-Blind Treatment Period||0||
60039996|NCT04285229|76155804|FG003|STARTED|Double-Blind Treatment Period||0||
60039997|NCT04285229|76155805|FG004|STARTED|Double-Blind Treatment Period||0||
60039998|NCT04285229|76155806|FG005|STARTED|Double-Blind Treatment Period||0||
60039999|NCT04285229|76155801|FG000|Received at Least One Dose of Study Drug|Double-Blind Treatment Period||73||
60040000|NCT04285229|76155802|FG001|Received at Least One Dose of Study Drug|Double-Blind Treatment Period||74||
60040001|NCT04285229|76155803|FG002|Received at Least One Dose of Study Drug|Double-Blind Treatment Period||0||
60040002|NCT04285229|76155804|FG003|Received at Least One Dose of Study Drug|Double-Blind Treatment Period||0||
60040003|NCT04285229|76155805|FG004|Received at Least One Dose of Study Drug|Double-Blind Treatment Period||0||
60040004|NCT04285229|76155806|FG005|Received at Least One Dose of Study Drug|Double-Blind Treatment Period||0||
60040005|NCT04285229|76155801|FG000|COMPLETED|Double-Blind Treatment Period||71||
60040006|NCT04285229|76155802|FG001|COMPLETED|Double-Blind Treatment Period||74||
60040007|NCT04285229|76155803|FG002|COMPLETED|Double-Blind Treatment Period||0||
60040008|NCT04285229|76155804|FG003|COMPLETED|Double-Blind Treatment Period||0||
60040009|NCT04285229|76155805|FG004|COMPLETED|Double-Blind Treatment Period||0||
60040010|NCT04285229|76155806|FG005|COMPLETED|Double-Blind Treatment Period||0||
60040011|NCT04285229|76155801|FG000|NOT COMPLETED|Double-Blind Treatment Period||2||
60040012|NCT04285229|76155802|FG001|NOT COMPLETED|Double-Blind Treatment Period||0||
60040013|NCT04285229|76155803|FG002|NOT COMPLETED|Double-Blind Treatment Period||0||
60040014|NCT04285229|76155804|FG003|NOT COMPLETED|Double-Blind Treatment Period||0||
60040015|NCT04285229|76155805|FG004|NOT COMPLETED|Double-Blind Treatment Period||0||
60040016|NCT04285229|76155806|FG005|NOT COMPLETED|Double-Blind Treatment Period||0||
60040017|NCT04285229|76155801|FG000|STARTED|Extended Treatment Period|Double-blind treatment period arm.|0||
60040018|NCT04285229|76155802|FG001|STARTED|Extended Treatment Period|Double-blind treatment period arm.|0||
60040019|NCT04285229|76155803|FG002|STARTED|Extended Treatment Period|Participants from the double-blind treatment period who entered the extended treatment period.|70||
60040020|NCT04285229|76155804|FG003|STARTED|Extended Treatment Period|Participants from the double-blind treatment period who entered the extended treatment period.|72||
60040021|NCT04285229|76155805|FG004|STARTED|Extended Treatment Period||0||
60040022|NCT04285229|76155806|FG005|STARTED|Extended Treatment Period||0||
60040023|NCT04285229|76155801|FG000|COMPLETED|Extended Treatment Period||0||
60040024|NCT04285229|76155802|FG001|COMPLETED|Extended Treatment Period||0||
60040025|NCT04285229|76155803|FG002|COMPLETED|Extended Treatment Period||69||
60040026|NCT04285229|76155804|FG003|COMPLETED|Extended Treatment Period||64||
60040027|NCT04285229|76155805|FG004|COMPLETED|Extended Treatment Period||0||
60040028|NCT04285229|76155806|FG005|COMPLETED|Extended Treatment Period||0||
60040029|NCT04285229|76155801|FG000|NOT COMPLETED|Extended Treatment Period||0||
60040030|NCT04285229|76155802|FG001|NOT COMPLETED|Extended Treatment Period||0||
60040031|NCT04285229|76155803|FG002|NOT COMPLETED|Extended Treatment Period||1||
60040032|NCT04285229|76155804|FG003|NOT COMPLETED|Extended Treatment Period||8||
60040033|NCT04285229|76155805|FG004|NOT COMPLETED|Extended Treatment Period||0||
60040034|NCT04285229|76155806|FG005|NOT COMPLETED|Extended Treatment Period||0||
60040035|NCT04285229|76155801|FG000|STARTED|Follow-up Period||0||
60040036|NCT04285229|76155802|FG001|STARTED|Follow-up Period||0||
60040037|NCT04285229|76155803|FG002|STARTED|Follow-up Period|Extended treatment period arm.|0||
60040038|NCT04285229|76155804|FG003|STARTED|Follow-up Period|Extended treatment period arm.|0||
60040039|NCT04285229|76155805|FG004|STARTED|Follow-up Period|Participants from the double-blind or the extended treatment periods who entered the follow-up period.|1||
60040040|NCT04285229|76155806|FG005|STARTED|Follow-up Period|Participants from the double-blind or the extended treatment periods who entered the follow-up period.|135||
60040041|NCT04285229|76155801|FG000|COMPLETED|Follow-up Period||0||
60040042|NCT04285229|76155802|FG001|COMPLETED|Follow-up Period||0||
60040043|NCT04285229|76155803|FG002|COMPLETED|Follow-up Period||0||
60040044|NCT04285229|76155804|FG003|COMPLETED|Follow-up Period||0||
60040045|NCT04285229|76155805|FG004|COMPLETED|Follow-up Period||0||
60040046|NCT04285229|76155806|FG005|COMPLETED|Follow-up Period||123||
60040047|NCT04285229|76155801|FG000|NOT COMPLETED|Follow-up Period||0||
60040048|NCT04285229|76155802|FG001|NOT COMPLETED|Follow-up Period||0||
60040049|NCT04285229|76155803|FG002|NOT COMPLETED|Follow-up Period||0||
60040050|NCT04285229|76155804|FG003|NOT COMPLETED|Follow-up Period||0||
60040051|NCT04285229|76155805|FG004|NOT COMPLETED|Follow-up Period||1||
60040052|NCT04285229|76155806|FG005|NOT COMPLETED|Follow-up Period||12||
60040053|NCT04263454|76155823|FG000|STARTED|Overall Study||16||
60040054|NCT04263454|76155824|FG001|STARTED|Overall Study||20||
60040055|NCT04263454|76155823|FG000|COMPLETED|Overall Study||13||
60040056|NCT04263454|76155824|FG001|COMPLETED|Overall Study||12||
60040057|NCT04263454|76155823|FG000|NOT COMPLETED|Overall Study||3||
60040058|NCT04263454|76155824|FG001|NOT COMPLETED|Overall Study||8||
60067829|NCT01617967|76183029|FG000|STARTED|Overall Study||4||
60040059|NCT04155463|76155834|FG000|STARTED|First Intervention (1 Week)||20||
60040060|NCT04155463|76155835|FG001|STARTED|First Intervention (1 Week)||20||
60040061|NCT04155463|76155834|FG000|COMPLETED|First Intervention (1 Week)||20||
60040062|NCT04155463|76155835|FG001|COMPLETED|First Intervention (1 Week)||19||
60040063|NCT04155463|76155834|FG000|NOT COMPLETED|First Intervention (1 Week)||0||
60040064|NCT04155463|76155835|FG001|NOT COMPLETED|First Intervention (1 Week)||1||
60040065|NCT04155463|76155834|FG000|STARTED|Washout (1 Day)||20||
60040066|NCT04155463|76155835|FG001|STARTED|Washout (1 Day)||19||
60040067|NCT04155463|76155834|FG000|COMPLETED|Washout (1 Day)||20||
60040068|NCT04155463|76155835|FG001|COMPLETED|Washout (1 Day)||19||
60040069|NCT04155463|76155834|FG000|NOT COMPLETED|Washout (1 Day)||0||
60040070|NCT04155463|76155835|FG001|NOT COMPLETED|Washout (1 Day)||0||
60040071|NCT04155463|76155834|FG000|STARTED|Second Intervention (1 Week)||20||
60040072|NCT04155463|76155835|FG001|STARTED|Second Intervention (1 Week)||19||
60040073|NCT04155463|76155834|FG000|COMPLETED|Second Intervention (1 Week)||20||
60040074|NCT04155463|76155835|FG001|COMPLETED|Second Intervention (1 Week)||19||
60040075|NCT04155463|76155834|FG000|NOT COMPLETED|Second Intervention (1 Week)||0||
60040076|NCT04155463|76155835|FG001|NOT COMPLETED|Second Intervention (1 Week)||0||
60040077|NCT04056611|76155841|FG000|STARTED|Overall Study||3||
60040078|NCT04056611|76155841|FG000|COMPLETED|Overall Study||2||
60040079|NCT04056611|76155841|FG000|NOT COMPLETED|Overall Study||1||
60040080|NCT04001803|76155845|FG000|STARTED|Intervention Phase (Up to Month 12)||115||
60040081|NCT04001803|76155845|FG000|COMPLETED|Intervention Phase (Up to Month 12)||102||
60040082|NCT04001803|76155845|FG000|NOT COMPLETED|Intervention Phase (Up to Month 12)||13||
60040083|NCT04001803|76155845|FG000|STARTED|Extension Phase (From Months 13 to 30)|1 participant completed Intervention Phase but did not enter the Extension Phase (Participant Relocated)|101||
60040084|NCT04001803|76155845|FG000|COMPLETED|Extension Phase (From Months 13 to 30)||95||
60040085|NCT04001803|76155845|FG000|NOT COMPLETED|Extension Phase (From Months 13 to 30)||6||
60040086|NCT04001803|76155845|FG000|STARTED|Long-term Follow-up Phase(Up to Week 52)|85 participants who completed the Extension Phase did not enter Long-term follow-up Phase as they transitioned off CAB LA + RPV LA regimen to commercial available CAB LA + RPV LA.|10||
60040087|NCT04001803|76155845|FG000|COMPLETED|Long-term Follow-up Phase(Up to Week 52)||7||
60040088|NCT04001803|76155845|FG000|NOT COMPLETED|Long-term Follow-up Phase(Up to Week 52)||3||
60040089|NCT03768427|76155854|FG000|STARTED|Overall Study||88||
60040090|NCT03768427|76155855|FG001|STARTED|Overall Study||89||
60040091|NCT03768427|76155856|FG002|STARTED|Overall Study||137||
60040092|NCT03768427|76155857|FG003|STARTED|Overall Study||140||
60040093|NCT03768427|76155854|FG000|COMPLETED|Overall Study||76||
60040094|NCT03768427|76155855|FG001|COMPLETED|Overall Study||85||
60040095|NCT03768427|76155856|FG002|COMPLETED|Overall Study||126||
60040096|NCT03768427|76155857|FG003|COMPLETED|Overall Study||129||
60040097|NCT03768427|76155854|FG000|NOT COMPLETED|Overall Study||12||
60040098|NCT03768427|76155855|FG001|NOT COMPLETED|Overall Study||4||
60040099|NCT03768427|76155856|FG002|NOT COMPLETED|Overall Study||11||
60040100|NCT03768427|76155857|FG003|NOT COMPLETED|Overall Study||11||
60040101|NCT03724149|76155867|FG000|STARTED|Overall Study||10||
60040102|NCT03724149|76155867|FG000|COMPLETED|Overall Study||10||
60040103|NCT03724149|76155867|FG000|NOT COMPLETED|Overall Study||0||
59509992|NCT02693704|75603465|FG003|COMPLETED|Overall Study||10||
59509993|NCT02693704|75603462|FG000|NOT COMPLETED|Overall Study||0||
59509994|NCT02693704|75603463|FG001|NOT COMPLETED|Overall Study||0||
59509995|NCT02693704|75603464|FG002|NOT COMPLETED|Overall Study||0||
59509996|NCT02693704|75603465|FG003|NOT COMPLETED|Overall Study||0||
60040104|NCT03595228|76155871|FG000|STARTED|Overall Study||29||
60040105|NCT03595228|76155871|FG000|COMPLETED|Overall Study||10||
60040106|NCT03595228|76155871|FG000|NOT COMPLETED|Overall Study||19||
60040107|NCT03572933|76155877|FG000|STARTED|Overall Study||51||
60040108|NCT03572933|76155878|FG001|STARTED|Overall Study||50||
60040109|NCT03572933|76155877|FG000|COMPLETED|Overall Study||47||
60040110|NCT03572933|76155878|FG001|COMPLETED|Overall Study||48||
60040111|NCT03572933|76155877|FG000|NOT COMPLETED|Overall Study||4||
60040112|NCT03572933|76155878|FG001|NOT COMPLETED|Overall Study||2||
60040113|NCT03558152|76155889|FG000|STARTED|Overall Study||22||
60040114|NCT03558152|76155890|FG001|STARTED|Overall Study||21||
60040115|NCT03558152|76155891|FG002|STARTED|Overall Study||21||
60040116|NCT03558152|76155892|FG003|STARTED|Overall Study||23||
60040117|NCT03558152|76155893|FG004|STARTED|Overall Study||22||
60040118|NCT03558152|76155894|FG005|STARTED|Overall Study||21||
60040119|NCT03558152|76155895|FG006|STARTED|Overall Study||43||
60040120|NCT03558152|76155896|FG007|STARTED|Overall Study||22||
60040121|NCT03558152|76155889|FG000|COMPLETED|Overall Study||7||
60040122|NCT03558152|76155890|FG001|COMPLETED|Overall Study||6||
60040123|NCT03558152|76155891|FG002|COMPLETED|Overall Study||8||
60040124|NCT03558152|76155892|FG003|COMPLETED|Overall Study||8||
60040125|NCT03558152|76155893|FG004|COMPLETED|Overall Study||3||
60040126|NCT03558152|76155894|FG005|COMPLETED|Overall Study||7||
60040127|NCT03558152|76155895|FG006|COMPLETED|Overall Study||21||
60040128|NCT03558152|76155896|FG007|COMPLETED|Overall Study||6||
60040129|NCT03558152|76155889|FG000|NOT COMPLETED|Overall Study||15||
60040130|NCT03558152|76155890|FG001|NOT COMPLETED|Overall Study||15||
59509997|NCT02696200|75603477|FG000|STARTED|Overall Study||32||
59509998|NCT02696200|75603478|FG001|STARTED|Overall Study||30||
60040131|NCT03558152|76155891|FG002|NOT COMPLETED|Overall Study||13||
60040132|NCT03558152|76155892|FG003|NOT COMPLETED|Overall Study||15||
60040133|NCT03558152|76155893|FG004|NOT COMPLETED|Overall Study||19||
60040134|NCT03558152|76155894|FG005|NOT COMPLETED|Overall Study||14||
60040135|NCT03558152|76155895|FG006|NOT COMPLETED|Overall Study||22||
60040136|NCT03558152|76155896|FG007|NOT COMPLETED|Overall Study||16||
60040137|NCT03482141|76155930|FG000|STARTED|Overall Study||316||
60040138|NCT03482141|76155930|FG000|COMPLETED|Overall Study||316||
60040139|NCT03482141|76155930|FG000|NOT COMPLETED|Overall Study||0||
60040140|NCT03461406|76155936|FG000|STARTED|Overall Study||95||
60040141|NCT03461406|76155937|FG001|STARTED|Overall Study||91||
60040142|NCT03461406|76155936|FG000|Parenchymous Surgery|Overall Study|Participants who underwent parenchymous surgery were included.|46||
60040143|NCT03461406|76155937|FG001|Parenchymous Surgery|Overall Study|Participants who underwent parenchymous surgery were included.|43||
60040144|NCT03461406|76155936|FG000|Soft Tissue Surgery|Overall Study|Participants who underwent soft tissue surgery were included.|45||
60040145|NCT03461406|76155937|FG001|Soft Tissue Surgery|Overall Study|Participants who underwent soft tissue surgery were included.|44||
60040146|NCT03461406|76155936|FG000|Safety Population|Overall Study||91|Safety population included all participants who received any amount of IP.|
60040147|NCT03461406|76155937|FG001|Safety Population|Overall Study||87|Safety population included all participants who received any amount of IP.|
60040148|NCT03461406|76155936|FG000|COMPLETED|Overall Study||87||
60040149|NCT03461406|76155937|FG001|COMPLETED|Overall Study||84||
60040150|NCT03461406|76155936|FG000|NOT COMPLETED|Overall Study||8||
60040151|NCT03461406|76155937|FG001|NOT COMPLETED|Overall Study||7||
60040152|NCT03431974|76155945|FG000|STARTED|Overall Study||11||
60040153|NCT03431974|76155946|FG001|STARTED|Overall Study||8||
60040154|NCT03431974|76155945|FG000|COMPLETED|Overall Study||8||
60040155|NCT03431974|76155946|FG001|COMPLETED|Overall Study||6||
60040156|NCT03431974|76155945|FG000|NOT COMPLETED|Overall Study||3||
60040157|NCT03431974|76155946|FG001|NOT COMPLETED|Overall Study||2||
60040158|NCT03408899|76155952|FG000|STARTED|PC-1005 Gel: 4 mL Dose||13||
60040159|NCT03408899|76155952|FG000|COMPLETED|PC-1005 Gel: 4 mL Dose||12||
60040160|NCT03408899|76155952|FG000|NOT COMPLETED|PC-1005 Gel: 4 mL Dose||1||
59509999|NCT02696200|75603477|FG000|COMPLETED|Overall Study||32||
59510000|NCT02696200|75603478|FG001|COMPLETED|Overall Study||30||
60040161|NCT03408899|76155952|FG000|STARTED|PC-1005 Gel: 16 mL Dose||12||
60040162|NCT03408899|76155952|FG000|COMPLETED|PC-1005 Gel: 16 mL Dose||12||
60040163|NCT03408899|76155952|FG000|NOT COMPLETED|PC-1005 Gel: 16 mL Dose||0||
60040164|NCT03408899|76155952|FG000|STARTED|PC-1005 Gel: 32 mL Dose||12||
60040165|NCT03408899|76155952|FG000|COMPLETED|PC-1005 Gel: 32 mL Dose||12||
60040166|NCT03408899|76155952|FG000|NOT COMPLETED|PC-1005 Gel: 32 mL Dose||0||
60040167|NCT02915744|76155963|FG000|STARTED|Overall Study||92||
60040168|NCT02915744|76155964|FG001|STARTED|Overall Study||86||
60040169|NCT02915744|76155963|FG000|COMPLETED|Overall Study||13||
60040170|NCT02915744|76155964|FG001|COMPLETED|Overall Study||9||
60040171|NCT02915744|76155963|FG000|NOT COMPLETED|Overall Study||79||
60040172|NCT02915744|76155964|FG001|NOT COMPLETED|Overall Study||77||
60040173|NCT02528643|76155973|FG000|STARTED|DB (Median Duration up to 14.65 Months)||55||
60040174|NCT02528643|76155974|FG001|STARTED|DB (Median Duration up to 14.65 Months)||110||
60040175|NCT02528643|76155973|FG000|Treated|DB (Median Duration up to 14.65 Months)||55||
60040176|NCT02528643|76155974|FG001|Treated|DB (Median Duration up to 14.65 Months)||107||
60040177|NCT02528643|76155973|FG000|COMPLETED|DB (Median Duration up to 14.65 Months)||0||
60040178|NCT02528643|76155974|FG001|COMPLETED|DB (Median Duration up to 14.65 Months)||0||
60040179|NCT02528643|76155973|FG000|NOT COMPLETED|DB (Median Duration up to 14.65 Months)||55||
60040180|NCT02528643|76155974|FG001|NOT COMPLETED|DB (Median Duration up to 14.65 Months)||110||
60040181|NCT02528643|76155973|FG000|STARTED|OL (Median Duration up to 27.56 Months)||0||
60040182|NCT02528643|76155974|FG001|STARTED|OL (Median Duration up to 27.56 Months)||1||
60040183|NCT02528643|76155973|FG000|COMPLETED|OL (Median Duration up to 27.56 Months)||0||
60040184|NCT02528643|76155974|FG001|COMPLETED|OL (Median Duration up to 27.56 Months)||0||
60040185|NCT02528643|76155973|FG000|NOT COMPLETED|OL (Median Duration up to 27.56 Months)||0||
60040186|NCT02528643|76155974|FG001|NOT COMPLETED|OL (Median Duration up to 27.56 Months)||1||
60040187|NCT02506933|76155984|FG000|STARTED|Overall Study||51||
59510001|NCT02696200|75603477|FG000|NOT COMPLETED|Overall Study||0||
59510002|NCT02696200|75603478|FG001|NOT COMPLETED|Overall Study||0||
59510003|NCT02697214|75603488|FG000|STARTED|Overall Study||26|Each subject wore standard EKG, Polar H7 and 2 wrist monitoring devices|26
59510004|NCT02697214|75603489|FG001|STARTED|Overall Study||25|Each subject wore standard EKG, Polar H7 and 2 wrist monitoring devices|25
60040188|NCT02506933|76155985|FG001|STARTED|Overall Study||51||
60040189|NCT02506933|76155984|FG000|COMPLETED|Overall Study||51||
60040190|NCT02506933|76155985|FG001|COMPLETED|Overall Study||51||
59510005|NCT02697214|75603490|FG002|STARTED|Overall Study||25|Each subject wore standard EKG, Polar H7 and 2 wrist monitoring devices|25
59510006|NCT02697214|75603491|FG003|STARTED|Overall Study||24|Each subject wore standard EKG, Polar H7 and 2 wrist monitoring devices|24
59510007|NCT02697214|75603492|FG004|STARTED|Overall Study||50|Each subject wore standard EKG, Polar H7 and 2 wrist monitoring devices|50
59510008|NCT02697214|75603493|FG005|STARTED|Overall Study||50|Each subject wore standard EKG, Polar H7 and 2 wrist monitoring devices|50
59510009|NCT02697214|75603488|FG000|Heart Rate at 2mph|Overall Study||26||26
59510010|NCT02697214|75603489|FG001|Heart Rate at 2mph|Overall Study||25||25
59510011|NCT02697214|75603490|FG002|Heart Rate at 2mph|Overall Study||25||25
59759595|NCT03207776|75878980|FG001|NOT COMPLETED|Overall Study||0||
59918491|NCT04762537|76038892|FG001|STARTED|Step 4 (Weeks 42-56)||32||1
59918492|NCT04762537|76038893|FG002|STARTED|Step 4 (Weeks 42-56)||4||1
59918493|NCT04762537|76038894|FG003|STARTED|Step 4 (Weeks 42-56)||23||1
59918494|NCT04762537|76038895|FG004|STARTED|Step 4 (Weeks 42-56)||18||1
59918495|NCT04762537|76038896|FG005|STARTED|Step 4 (Weeks 42-56)||12||1
59918496|NCT04762537|76038891|FG000|COMPLETED|Step 4 (Weeks 42-56)||11||1
59918497|NCT04762537|76038892|FG001|COMPLETED|Step 4 (Weeks 42-56)||19||1
59918498|NCT04762537|76038893|FG002|COMPLETED|Step 4 (Weeks 42-56)||2||1
59918499|NCT04762537|76038894|FG003|COMPLETED|Step 4 (Weeks 42-56)||14||1
59918500|NCT04762537|76038895|FG004|COMPLETED|Step 4 (Weeks 42-56)||8||1
59918501|NCT04762537|76038896|FG005|COMPLETED|Step 4 (Weeks 42-56)||1||1
59918502|NCT04762537|76038891|FG000|NOT COMPLETED|Step 4 (Weeks 42-56)||4||0
59918503|NCT04762537|76038892|FG001|NOT COMPLETED|Step 4 (Weeks 42-56)||13||0
59918504|NCT04762537|76038893|FG002|NOT COMPLETED|Step 4 (Weeks 42-56)||2||0
60040191|NCT02506933|76155984|FG000|NOT COMPLETED|Overall Study||0||
60040192|NCT02506933|76155985|FG001|NOT COMPLETED|Overall Study||0||
60040193|NCT02409810|76155991|FG000|STARTED|Overall Study||20||
60040194|NCT02409810|76155991|FG000|COMPLETED|Overall Study||19||
60040195|NCT02409810|76155991|FG000|NOT COMPLETED|Overall Study||1||
60040196|NCT02175680|76155995|FG000|STARTED|Overall Study||43||
60040197|NCT02175680|76155995|FG000|COMPLETED|Overall Study||41||
60040198|NCT02175680|76155995|FG000|NOT COMPLETED|Overall Study||2||
60040199|NCT01983462|76156009|FG000|STARTED|Overall Study||11||
60040200|NCT01983462|76156010|FG001|STARTED|Overall Study||11||
60040201|NCT01983462|76156011|FG002|STARTED|Overall Study||11||
60040202|NCT01983462|76156009|FG000|COMPLETED|Overall Study||10||
60040203|NCT01983462|76156010|FG001|COMPLETED|Overall Study||11||
60040204|NCT01983462|76156011|FG002|COMPLETED|Overall Study||11||
60040205|NCT01983462|76156009|FG000|NOT COMPLETED|Overall Study||1||
60040206|NCT01983462|76156010|FG001|NOT COMPLETED|Overall Study||0||
60040207|NCT01983462|76156011|FG002|NOT COMPLETED|Overall Study||0||
60040208|NCT01779375|76156021|FG000|STARTED|Overall Study||47||
60040209|NCT01779375|76156022|FG001|STARTED|Overall Study||44||
60040210|NCT01779375|76156021|FG000|COMPLETED|Overall Study||45||
60040211|NCT01779375|76156022|FG001|COMPLETED|Overall Study||41||
60040212|NCT01779375|76156021|FG000|NOT COMPLETED|Overall Study||2||
60040213|NCT01779375|76156022|FG001|NOT COMPLETED|Overall Study||3||
60040214|NCT01559935|76156030|FG000|STARTED|Car Phase||72||
60040215|NCT01559935|76156030|FG000|COMPLETED|Car Phase||58||
60040216|NCT01559935|76156030|FG000|NOT COMPLETED|Car Phase||14||
60040217|NCT01559935|76156030|FG000|STARTED|BiRD Phase||58||
60040218|NCT01559935|76156030|FG000|COMPLETED|BiRD Phase||54||
60040219|NCT01559935|76156030|FG000|NOT COMPLETED|BiRD Phase||4||
60040220|NCT01559935|76156030|FG000|STARTED|Maintenance Phase||54||
60040221|NCT01559935|76156030|FG000|COMPLETED|Maintenance Phase||0||
60040222|NCT01559935|76156030|FG000|NOT COMPLETED|Maintenance Phase||54||
60040223|NCT00981058|76156036|FG000|STARTED|Overall Study||545||
60040224|NCT00981058|76156037|FG001|STARTED|Overall Study||548||
60040225|NCT00981058|76156036|FG000|Received at Least 1 Dose of Study Drug|Overall Study||538||
59510012|NCT02697214|75603491|FG003|Heart Rate at 2mph|Overall Study||24||24
59510013|NCT02697214|75603492|FG004|Heart Rate at 2mph|Overall Study||50||50
59510014|NCT02697214|75603493|FG005|Heart Rate at 2mph|Overall Study||50||50
59510015|NCT02697214|75603488|FG000|Heart Rate at 3mph|Overall Study||26||26
59510016|NCT02697214|75603489|FG001|Heart Rate at 3mph|Overall Study||25||25
59510017|NCT02697214|75603490|FG002|Heart Rate at 3mph|Overall Study||25||25
59510018|NCT02697214|75603491|FG003|Heart Rate at 3mph|Overall Study||24||24
59510019|NCT02697214|75603492|FG004|Heart Rate at 3mph|Overall Study||50||50
59510020|NCT02697214|75603493|FG005|Heart Rate at 3mph|Overall Study||50||50
59510021|NCT02697214|75603488|FG000|Heart Rate at 4mph|Overall Study||26||26
59510022|NCT02697214|75603489|FG001|Heart Rate at 4mph|Overall Study||25||25
59510023|NCT02697214|75603490|FG002|Heart Rate at 4mph|Overall Study||25||25
59510024|NCT02697214|75603491|FG003|Heart Rate at 4mph|Overall Study||24||24
59510025|NCT02697214|75603492|FG004|Heart Rate at 4mph|Overall Study||50||50
59510026|NCT02697214|75603493|FG005|Heart Rate at 4mph|Overall Study||50||50
59510027|NCT02697214|75603488|FG000|Heart Rate at 6mph|Overall Study||26||26
59510028|NCT02697214|75603489|FG001|Heart Rate at 6mph|Overall Study||25||25
59510029|NCT02697214|75603490|FG002|Heart Rate at 6mph|Overall Study||25||25
59510030|NCT02697214|75603491|FG003|Heart Rate at 6mph|Overall Study||24||24
59510031|NCT02697214|75603492|FG004|Heart Rate at 6mph|Overall Study||50||50
59510032|NCT02697214|75603493|FG005|Heart Rate at 6mph|Overall Study||50||50
59510033|NCT02697214|75603488|FG000|COMPLETED|Overall Study||26||26
59510034|NCT02697214|75603489|FG001|COMPLETED|Overall Study||25||25
59510035|NCT02697214|75603490|FG002|COMPLETED|Overall Study||25||25
59510036|NCT02697214|75603491|FG003|COMPLETED|Overall Study||24||24
59510037|NCT02697214|75603492|FG004|COMPLETED|Overall Study||50||50
59510038|NCT02697214|75603493|FG005|COMPLETED|Overall Study||50||50
59510039|NCT02697214|75603488|FG000|NOT COMPLETED|Overall Study||0||0
59510040|NCT02697214|75603489|FG001|NOT COMPLETED|Overall Study||0||0
59510041|NCT02697214|75603490|FG002|NOT COMPLETED|Overall Study||0||0
59510042|NCT02697214|75603491|FG003|NOT COMPLETED|Overall Study||0||0
59510043|NCT02697214|75603492|FG004|NOT COMPLETED|Overall Study||0||0
59510044|NCT02697214|75603493|FG005|NOT COMPLETED|Overall Study||0||0
59510045|NCT02697292|75603505|FG000|STARTED|Overall Study||9||
59510046|NCT02697292|75603506|FG001|STARTED|Overall Study||8||
59510047|NCT02697292|75603505|FG000|COMPLETED|Overall Study||9||
59510048|NCT02697292|75603506|FG001|COMPLETED|Overall Study||8||
59510049|NCT02697292|75603505|FG000|NOT COMPLETED|Overall Study||0||
59510050|NCT02697292|75603506|FG001|NOT COMPLETED|Overall Study||0||
59510051|NCT02699632|75603513|FG000|STARTED|Overall Study||360||
59510052|NCT02699632|75603513|FG000|COMPLETED|Overall Study||358||
59510053|NCT02699632|75603513|FG000|NOT COMPLETED|Overall Study||2||
59510054|NCT00842335|75603520|FG000|STARTED|Overall Study||18||
59510055|NCT00842335|75603520|FG000|COMPLETED|Overall Study||18||
59510056|NCT00842335|75603520|FG000|NOT COMPLETED|Overall Study||0||
59510057|NCT02700334|75603528|FG000|STARTED|Overall Study||12||
59510058|NCT02700334|75603529|FG001|STARTED|Overall Study||12||
59510059|NCT02700334|75603528|FG000|COMPLETED|Overall Study||12||
59510060|NCT02700334|75603529|FG001|COMPLETED|Overall Study||12||
59510061|NCT02700334|75603528|FG000|NOT COMPLETED|Overall Study||0||
59510062|NCT02700334|75603529|FG001|NOT COMPLETED|Overall Study||0||
59510063|NCT00868699|75603538|FG000|STARTED|Overall Study||170||
59510064|NCT00868699|75603539|FG001|STARTED|Overall Study||169||
59510065|NCT00868699|75603540|FG002|STARTED|Overall Study||166||
59510066|NCT00868699|75603538|FG000|Intent-to-Treat Population|Overall Study||162||
59510067|NCT00868699|75603539|FG001|Intent-to-Treat Population|Overall Study||162||
59510068|NCT00868699|75603540|FG002|Intent-to-Treat Population|Overall Study||161||
59510069|NCT00868699|75603538|FG000|Safety Population|Overall Study||168||
59510070|NCT00868699|75603539|FG001|Safety Population|Overall Study||167||
59510071|NCT00868699|75603540|FG002|Safety Population|Overall Study||164||
59510072|NCT00868699|75603538|FG000|COMPLETED|Overall Study||127||
59510073|NCT00868699|75603539|FG001|COMPLETED|Overall Study||124||
59510074|NCT00868699|75603540|FG002|COMPLETED|Overall Study||123||
59510075|NCT00868699|75603538|FG000|NOT COMPLETED|Overall Study||43||
59510076|NCT00868699|75603539|FG001|NOT COMPLETED|Overall Study||45||
59510077|NCT00868699|75603540|FG002|NOT COMPLETED|Overall Study||43||
59510078|NCT02701270|75603548|FG000|STARTED|First Intervention at Visit 1||2||
59510079|NCT02701270|75603549|FG001|STARTED|First Intervention at Visit 1||3||
59510080|NCT02701270|75603550|FG002|STARTED|First Intervention at Visit 1||3||
59510081|NCT02701270|75603551|FG003|STARTED|First Intervention at Visit 1||3||
59510082|NCT02701270|75603548|FG000|COMPLETED|First Intervention at Visit 1||2||
59510083|NCT02701270|75603549|FG001|COMPLETED|First Intervention at Visit 1||3||
59510084|NCT02701270|75603550|FG002|COMPLETED|First Intervention at Visit 1||3||
59510085|NCT02701270|75603551|FG003|COMPLETED|First Intervention at Visit 1||3||
59510086|NCT02701270|75603548|FG000|NOT COMPLETED|First Intervention at Visit 1||0||
59510087|NCT02701270|75603549|FG001|NOT COMPLETED|First Intervention at Visit 1||0||
59510088|NCT02701270|75603550|FG002|NOT COMPLETED|First Intervention at Visit 1||0||
59510089|NCT02701270|75603551|FG003|NOT COMPLETED|First Intervention at Visit 1||0||
59510090|NCT02701270|75603548|FG000|STARTED|Second Intervention at Visit 2||2||
59918505|NCT04762537|76038894|FG003|NOT COMPLETED|Step 4 (Weeks 42-56)||9||0
60040226|NCT00981058|76156037|FG001|Received at Least 1 Dose of Study Drug|Overall Study||541||
60040227|NCT00981058|76156036|FG000|Death Due to Any Cause|Overall Study||418||
60040228|NCT00981058|76156037|FG001|Death Due to Any Cause|Overall Study||442||
60040229|NCT00981058|76156036|FG000|COMPLETED|Overall Study||425||
60040230|NCT00981058|76156037|FG001|COMPLETED|Overall Study||451||
60040231|NCT00981058|76156036|FG000|NOT COMPLETED|Overall Study||120||
60040232|NCT00981058|76156037|FG001|NOT COMPLETED|Overall Study||97||
60040233|NCT00565851|76156051|FG000|STARTED|Surgical Assignment||316||
60040234|NCT00565851|76156052|FG001|STARTED|Surgical Assignment||456||
60040235|NCT00565851|76156053|FG002|STARTED|Surgical Assignment||33||
60040236|NCT00565851|76156054|FG003|STARTED|Surgical Assignment||165||
60040237|NCT00565851|76156055|FG004|STARTED|Surgical Assignment||6||
60040238|NCT00565851|76156056|FG005|STARTED|Surgical Assignment||34||
60040239|NCT00565851|76156057|FG006|STARTED|Surgical Assignment||5||
60040240|NCT00565851|76156058|FG007|STARTED|Surgical Assignment||37||
60040241|NCT00565851|76156051|FG000|Randomized - Yes Surgery|Surgical Assignment||0||
60040242|NCT00565851|76156052|FG001|Randomized - Yes Surgery|Surgical Assignment||0||
60040243|NCT00565851|76156053|FG002|Randomized - Yes Surgery|Surgical Assignment||33||
60040244|NCT00565851|76156054|FG003|Randomized - Yes Surgery|Surgical Assignment||165||
60040245|NCT00565851|76156055|FG004|Randomized - Yes Surgery|Surgical Assignment||0||
60040246|NCT00565851|76156056|FG005|Randomized - Yes Surgery|Surgical Assignment||0||
60040247|NCT00565851|76156057|FG006|Randomized - Yes Surgery|Surgical Assignment||5||
60040248|NCT00565851|76156058|FG007|Randomized - Yes Surgery|Surgical Assignment||37||
60040249|NCT00565851|76156051|FG000|Randomized - no Surgery|Surgical Assignment||33||
60040250|NCT00565851|76156052|FG001|Randomized - no Surgery|Surgical Assignment||172||
60040251|NCT00565851|76156053|FG002|Randomized - no Surgery|Surgical Assignment||0||
60040252|NCT00565851|76156054|FG003|Randomized - no Surgery|Surgical Assignment||0||
60040253|NCT00565851|76156055|FG004|Randomized - no Surgery|Surgical Assignment||6||
60040254|NCT00565851|76156056|FG005|Randomized - no Surgery|Surgical Assignment||34||
60040255|NCT00565851|76156057|FG006|Randomized - no Surgery|Surgical Assignment||0||
60040256|NCT00565851|76156058|FG007|Randomized - no Surgery|Surgical Assignment||0||
60040257|NCT00565851|76156051|FG000|Not Surgical Candidate|Surgical Assignment||283||
60040258|NCT00565851|76156052|FG001|Not Surgical Candidate|Surgical Assignment||284||
60067830|NCT01617967|76183030|FG001|STARTED|Overall Study||3||
59918506|NCT04762537|76038895|FG004|NOT COMPLETED|Step 4 (Weeks 42-56)||10||0
59918507|NCT04762537|76038896|FG005|NOT COMPLETED|Step 4 (Weeks 42-56)||11||0
59918508|NCT04762537|76038891|FG000|STARTED|Step 5 (Weeks 56-70)||6||1
59918509|NCT04762537|76038892|FG001|STARTED|Step 5 (Weeks 56-70)||13||1
59918510|NCT04762537|76038893|FG002|STARTED|Step 5 (Weeks 56-70)||5||1
59918511|NCT04762537|76038894|FG003|STARTED|Step 5 (Weeks 56-70)||12||1
59918512|NCT04762537|76038895|FG004|STARTED|Step 5 (Weeks 56-70)||24||1
59918513|NCT04762537|76038896|FG005|STARTED|Step 5 (Weeks 56-70)||5||1
59918514|NCT04762537|76038891|FG000|COMPLETED|Step 5 (Weeks 56-70)||4||1
59918515|NCT04762537|76038892|FG001|COMPLETED|Step 5 (Weeks 56-70)||10||1
59918516|NCT04762537|76038893|FG002|COMPLETED|Step 5 (Weeks 56-70)||3||1
59918517|NCT04762537|76038894|FG003|COMPLETED|Step 5 (Weeks 56-70)||11||1
59918518|NCT04762537|76038895|FG004|COMPLETED|Step 5 (Weeks 56-70)||12||1
59918519|NCT04762537|76038896|FG005|COMPLETED|Step 5 (Weeks 56-70)||1||1
59918520|NCT04762537|76038891|FG000|NOT COMPLETED|Step 5 (Weeks 56-70)||2||0
59918521|NCT04762537|76038892|FG001|NOT COMPLETED|Step 5 (Weeks 56-70)||3||0
59918522|NCT04762537|76038893|FG002|NOT COMPLETED|Step 5 (Weeks 56-70)||2||0
59918523|NCT04762537|76038894|FG003|NOT COMPLETED|Step 5 (Weeks 56-70)||1||0
59918524|NCT04762537|76038895|FG004|NOT COMPLETED|Step 5 (Weeks 56-70)||12||0
59918525|NCT04762537|76038896|FG005|NOT COMPLETED|Step 5 (Weeks 56-70)||4||0
59918526|NCT04138615|76038902|FG000|STARTED|Overall Study||19||
59918527|NCT04138615|76038903|FG001|STARTED|Overall Study||25||
59918528|NCT04138615|76038902|FG000|COMPLETED|Overall Study||14||
59918529|NCT04138615|76038903|FG001|COMPLETED|Overall Study||16||
59918530|NCT04138615|76038902|FG000|NOT COMPLETED|Overall Study||5||
59918531|NCT04138615|76038903|FG001|NOT COMPLETED|Overall Study||9||
59918532|NCT03018938|76038911|FG000|STARTED|Overall Study||404||
59918533|NCT03018938|76038912|FG001|STARTED|Overall Study||410||
59918534|NCT03018938|76038911|FG000|Received at Least 1 Dose of Study Drug|Overall Study||404||
59918535|NCT03018938|76038912|FG001|Received at Least 1 Dose of Study Drug|Overall Study||410||
59918536|NCT03018938|76038911|FG000|COMPLETED|Overall Study||338||
59918537|NCT03018938|76038912|FG001|COMPLETED|Overall Study||325||
59918538|NCT03018938|76038911|FG000|NOT COMPLETED|Overall Study||66||
59918539|NCT03018938|76038912|FG001|NOT COMPLETED|Overall Study||85||
59918540|NCT02943577|76038920|FG000|STARTED|Overall Study||209||
59918541|NCT02943577|76038921|FG001|STARTED|Overall Study||206||
59918542|NCT02943577|76038920|FG000|COMPLETED|Overall Study||204||
59918543|NCT02943577|76038921|FG001|COMPLETED|Overall Study||201||
59918544|NCT02943577|76038920|FG000|NOT COMPLETED|Overall Study||5||
59918545|NCT02943577|76038921|FG001|NOT COMPLETED|Overall Study||5||
59918546|NCT03016598|76038929|FG000|STARTED|Overall Study||18||
59918547|NCT03016598|76038930|FG001|STARTED|Overall Study||22||
59918548|NCT03016598|76038929|FG000|COMPLETED|Overall Study||18||
59918549|NCT03016598|76038930|FG001|COMPLETED|Overall Study||20||
59918550|NCT03016598|76038929|FG000|NOT COMPLETED|Overall Study||0||
59918551|NCT03016598|76038930|FG001|NOT COMPLETED|Overall Study||2||
59918552|NCT03017846|76038936|FG000|STARTED|Overall Study||30||
59918553|NCT03017846|76038936|FG000|COMPLETED|Overall Study||25||
59918554|NCT03017846|76038936|FG000|NOT COMPLETED|Overall Study||5||
59918555|NCT03014180|76038942|FG000|STARTED|Overall Study||60||
59918556|NCT03014180|76038942|FG000|COMPLETED|Overall Study||58||
59918557|NCT03014180|76038942|FG000|NOT COMPLETED|Overall Study||2||
59918558|NCT03011840|76038952|FG000|STARTED|Overall Study||232||
59918559|NCT03011840|76038953|FG001|STARTED|Overall Study||217||
59918560|NCT03011840|76038952|FG000|COMPLETED|Overall Study||232||
59918561|NCT03011840|76038953|FG001|COMPLETED|Overall Study||196||
59918562|NCT03011840|76038952|FG000|NOT COMPLETED|Overall Study||0||
59918563|NCT03011840|76038953|FG001|NOT COMPLETED|Overall Study||21||
59918564|NCT02942485|76038961|FG000|STARTED|Overall Study||7||
59918565|NCT02942485|76038962|FG001|STARTED|Overall Study||1||
59918566|NCT02942485|76038961|FG000|COMPLETED|Overall Study||6||
59918567|NCT02942485|76038962|FG001|COMPLETED|Overall Study||1||
59918568|NCT02942485|76038961|FG000|NOT COMPLETED|Overall Study||1||
59918569|NCT02942485|76038962|FG001|NOT COMPLETED|Overall Study||0||
59918570|NCT02942407|76038970|FG000|STARTED|Overall Study||82||
59918571|NCT02942407|76038971|FG001|STARTED|Overall Study||72||
59918572|NCT02942407|76038970|FG000|COMPLETED|Overall Study||56||
59918573|NCT02942407|76038971|FG001|COMPLETED|Overall Study||48||
59918574|NCT02942407|76038970|FG000|NOT COMPLETED|Overall Study||26||
59918575|NCT02942407|76038971|FG001|NOT COMPLETED|Overall Study||24||
59918576|NCT03009344|76038985|FG000|STARTED|Overall Study||7||
59918577|NCT03009344|76038985|FG000|COMPLETED|Overall Study||0||
59918578|NCT03009344|76038985|FG000|NOT COMPLETED|Overall Study||7||
59918579|NCT03322423|76038989|FG000|STARTED|Period 1||38||
59918580|NCT03322423|76038990|FG001|STARTED|Period 1||40||
59918581|NCT03322423|76038989|FG000|COMPLETED|Period 1||36||
59918582|NCT03322423|76038990|FG001|COMPLETED|Period 1||38||
59918583|NCT03322423|76038989|FG000|NOT COMPLETED|Period 1||2||
59918584|NCT03322423|76038990|FG001|NOT COMPLETED|Period 1||2||
59918585|NCT03322423|76038989|FG000|STARTED|Period 2||36||
59918586|NCT03322423|76038990|FG001|STARTED|Period 2||38||
59918587|NCT03322423|76038989|FG000|COMPLETED|Period 2||35||
59918588|NCT03322423|76038990|FG001|COMPLETED|Period 2||36||
59918589|NCT03322423|76038989|FG000|NOT COMPLETED|Period 2||1||
59918590|NCT03322423|76038990|FG001|NOT COMPLETED|Period 2||2||
59918591|NCT03007472|76038996|FG000|STARTED|Overall Study||96||
59918592|NCT03007472|76038996|FG000|COMPLETED|Overall Study||91||
59918593|NCT03007472|76038996|FG000|NOT COMPLETED|Overall Study||5||
60040259|NCT00565851|76156053|FG002|Not Surgical Candidate|Surgical Assignment||0||
60040260|NCT00565851|76156054|FG003|Not Surgical Candidate|Surgical Assignment||0||
60040261|NCT00565851|76156055|FG004|Not Surgical Candidate|Surgical Assignment||0||
60040262|NCT00565851|76156056|FG005|Not Surgical Candidate|Surgical Assignment||0||
60040263|NCT00565851|76156057|FG006|Not Surgical Candidate|Surgical Assignment||0||
60040264|NCT00565851|76156058|FG007|Not Surgical Candidate|Surgical Assignment||0||
60040265|NCT00565851|76156051|FG000|COMPLETED|Surgical Assignment||313|Includes participants who followed through with surgical assignment|
60040266|NCT00565851|76156052|FG001|COMPLETED|Surgical Assignment||454|Includes participants who followed through with surgical assignment|
60040267|NCT00565851|76156053|FG002|COMPLETED|Surgical Assignment||31|Includes participants who followed through with surgical assignment|
60040268|NCT00565851|76156054|FG003|COMPLETED|Surgical Assignment||154|Includes participants who followed through with surgical assignment|
60040269|NCT00565851|76156055|FG004|COMPLETED|Surgical Assignment||6|Includes participants who followed through with surgical assignment|
60040270|NCT00565851|76156056|FG005|COMPLETED|Surgical Assignment||34|Includes participants who followed through with surgical assignment|
60040271|NCT00565851|76156057|FG006|COMPLETED|Surgical Assignment||5|Includes participants who followed through with surgical assignment|
60040272|NCT00565851|76156058|FG007|COMPLETED|Surgical Assignment||35|Includes participants who followed through with surgical assignment|
60040273|NCT00565851|76156051|FG000|NOT COMPLETED|Surgical Assignment||3||
60040274|NCT00565851|76156052|FG001|NOT COMPLETED|Surgical Assignment||2||
60040275|NCT00565851|76156053|FG002|NOT COMPLETED|Surgical Assignment||2||
60040276|NCT00565851|76156054|FG003|NOT COMPLETED|Surgical Assignment||11||
60040277|NCT00565851|76156055|FG004|NOT COMPLETED|Surgical Assignment||0||
60040278|NCT00565851|76156056|FG005|NOT COMPLETED|Surgical Assignment||0||
60040279|NCT00565851|76156057|FG006|NOT COMPLETED|Surgical Assignment||0||
60040280|NCT00565851|76156058|FG007|NOT COMPLETED|Surgical Assignment||2||
60040281|NCT00565851|76156051|FG000|STARTED|Chemotherapy Assignment||316||
60040282|NCT00565851|76156052|FG001|STARTED|Chemotherapy Assignment||456||
60040283|NCT00565851|76156053|FG002|STARTED|Chemotherapy Assignment||33||
60040284|NCT00565851|76156054|FG003|STARTED|Chemotherapy Assignment||165||
59510091|NCT02701270|75603549|FG001|STARTED|Second Intervention at Visit 2||3||
59510092|NCT02701270|75603550|FG002|STARTED|Second Intervention at Visit 2||3||
59510093|NCT02701270|75603551|FG003|STARTED|Second Intervention at Visit 2||3||
59510094|NCT02701270|75603548|FG000|COMPLETED|Second Intervention at Visit 2||2||
59510095|NCT02701270|75603549|FG001|COMPLETED|Second Intervention at Visit 2||3||
59510096|NCT02701270|75603550|FG002|COMPLETED|Second Intervention at Visit 2||3||
59510097|NCT02701270|75603551|FG003|COMPLETED|Second Intervention at Visit 2||3||
59510098|NCT02701270|75603548|FG000|NOT COMPLETED|Second Intervention at Visit 2||0||
59510099|NCT02701270|75603549|FG001|NOT COMPLETED|Second Intervention at Visit 2||0||
59510100|NCT02701270|75603550|FG002|NOT COMPLETED|Second Intervention at Visit 2||0||
59510101|NCT02701270|75603551|FG003|NOT COMPLETED|Second Intervention at Visit 2||0||
59510102|NCT02701270|75603548|FG000|STARTED|Third Intervention at Visit 3||2||
59510103|NCT02701270|75603549|FG001|STARTED|Third Intervention at Visit 3||3||
59510104|NCT02701270|75603550|FG002|STARTED|Third Intervention at Visit 3||3||
59918594|NCT03321721|76039003|FG000|STARTED|Overall Study||4||
59918595|NCT03321721|76039004|FG001|STARTED|Overall Study||10||
59918596|NCT03321721|76039005|FG002|STARTED|Overall Study||12||
59918597|NCT03321721|76039003|FG000|COMPLETED|Overall Study||0||
59918598|NCT03321721|76039004|FG001|COMPLETED|Overall Study||2||
59918599|NCT03321721|76039005|FG002|COMPLETED|Overall Study||1||
59918600|NCT03321721|76039003|FG000|NOT COMPLETED|Overall Study||4||
59918601|NCT03321721|76039004|FG001|NOT COMPLETED|Overall Study||8||
59918602|NCT03321721|76039005|FG002|NOT COMPLETED|Overall Study||11||
59918603|NCT03015116|76039017|FG000|STARTED|Overall Study||38||
59918604|NCT03015116|76039018|FG001|STARTED|Overall Study||38||
59918605|NCT03015116|76039019|FG002|STARTED|Overall Study||38||
59918606|NCT03015116|76039017|FG000|COMPLETED|Overall Study||31||
59918607|NCT03015116|76039018|FG001|COMPLETED|Overall Study||36||
59918608|NCT03015116|76039019|FG002|COMPLETED|Overall Study||36||
59918609|NCT03015116|76039017|FG000|NOT COMPLETED|Overall Study||7||
59918610|NCT03015116|76039018|FG001|NOT COMPLETED|Overall Study||2||
60040285|NCT00565851|76156055|FG004|STARTED|Chemotherapy Assignment||6||
60040286|NCT00565851|76156056|FG005|STARTED|Chemotherapy Assignment||34||
60040287|NCT00565851|76156057|FG006|STARTED|Chemotherapy Assignment||5||
60040288|NCT00565851|76156058|FG007|STARTED|Chemotherapy Assignment||37||
60040289|NCT00565851|76156051|FG000|Randomized to Chemo|Chemotherapy Assignment||310||
59918611|NCT03015116|76039019|FG002|NOT COMPLETED|Overall Study||2||
59918612|NCT03006458|76039029|FG000|STARTED|First Intervention||14||
59918613|NCT03006458|76039030|FG001|STARTED|First Intervention||10||
59918614|NCT03006458|76039029|FG000|COMPLETED|First Intervention||14||
59918615|NCT03006458|76039030|FG001|COMPLETED|First Intervention||7||
59918616|NCT03006458|76039029|FG000|NOT COMPLETED|First Intervention||0||
60040290|NCT00565851|76156052|FG001|Randomized to Chemo|Chemotherapy Assignment||311||
60040291|NCT00565851|76156053|FG002|Randomized to Chemo|Chemotherapy Assignment||27||
60040292|NCT00565851|76156054|FG003|Randomized to Chemo|Chemotherapy Assignment||26||
60040293|NCT00565851|76156055|FG004|Randomized to Chemo|Chemotherapy Assignment||0||
60040294|NCT00565851|76156056|FG005|Randomized to Chemo|Chemotherapy Assignment||0||
59918617|NCT03006458|76039030|FG001|NOT COMPLETED|First Intervention||3||
59918618|NCT03006458|76039029|FG000|STARTED|Second Intervention||14||
60040295|NCT00565851|76156057|FG006|Randomized to Chemo|Chemotherapy Assignment||0||
60040296|NCT00565851|76156058|FG007|Randomized to Chemo|Chemotherapy Assignment||0||
60040297|NCT00565851|76156051|FG000|Pre-specified Chemo|Chemotherapy Assignment||6||
60040298|NCT00565851|76156052|FG001|Pre-specified Chemo|Chemotherapy Assignment||145||
60040299|NCT00565851|76156053|FG002|Pre-specified Chemo|Chemotherapy Assignment||6||
60040300|NCT00565851|76156054|FG003|Pre-specified Chemo|Chemotherapy Assignment||139||
60040301|NCT00565851|76156055|FG004|Pre-specified Chemo|Chemotherapy Assignment||6||
60040302|NCT00565851|76156056|FG005|Pre-specified Chemo|Chemotherapy Assignment||34||
60040303|NCT00565851|76156057|FG006|Pre-specified Chemo|Chemotherapy Assignment||5||
60040304|NCT00565851|76156058|FG007|Pre-specified Chemo|Chemotherapy Assignment||37||
60040305|NCT00565851|76156051|FG000|COMPLETED|Chemotherapy Assignment||307||
60040306|NCT00565851|76156052|FG001|COMPLETED|Chemotherapy Assignment||433||
60040307|NCT00565851|76156053|FG002|COMPLETED|Chemotherapy Assignment||30||
60040308|NCT00565851|76156054|FG003|COMPLETED|Chemotherapy Assignment||129||
60040309|NCT00565851|76156055|FG004|COMPLETED|Chemotherapy Assignment||6||
60040310|NCT00565851|76156056|FG005|COMPLETED|Chemotherapy Assignment||31||
60040311|NCT00565851|76156057|FG006|COMPLETED|Chemotherapy Assignment||5||
60040312|NCT00565851|76156058|FG007|COMPLETED|Chemotherapy Assignment||34||
60040313|NCT00565851|76156051|FG000|NOT COMPLETED|Chemotherapy Assignment||9||
60040314|NCT00565851|76156052|FG001|NOT COMPLETED|Chemotherapy Assignment||23||
60040315|NCT00565851|76156053|FG002|NOT COMPLETED|Chemotherapy Assignment||3||
60040316|NCT00565851|76156054|FG003|NOT COMPLETED|Chemotherapy Assignment||36||
60040317|NCT00565851|76156055|FG004|NOT COMPLETED|Chemotherapy Assignment||0||
60040318|NCT00565851|76156056|FG005|NOT COMPLETED|Chemotherapy Assignment||3||
60040319|NCT00565851|76156057|FG006|NOT COMPLETED|Chemotherapy Assignment||0||
60040320|NCT00565851|76156058|FG007|NOT COMPLETED|Chemotherapy Assignment||3||
60040321|NCT00305227|76156082|FG000|STARTED|Overall Study||50||
60040322|NCT00305227|76156083|FG001|STARTED|Overall Study||50||
60040323|NCT00305227|76156082|FG000|COMPLETED|Overall Study|with at least 8 weeks of observation|43||
60040324|NCT00305227|76156083|FG001|COMPLETED|Overall Study|with at least 8 weeks of observation|44||
60040325|NCT00305227|76156082|FG000|NOT COMPLETED|Overall Study||7||
60040326|NCT00305227|76156083|FG001|NOT COMPLETED|Overall Study||6||
60040327|NCT01599793|76156091|FG000|STARTED|Overall Study||19||
60040328|NCT01599793|76156091|FG000|COMPLETED|Overall Study||17||
60040329|NCT01599793|76156091|FG000|NOT COMPLETED|Overall Study||2||
60040330|NCT02805517|76156095|FG000|STARTED|Overall Study||6||
60040331|NCT02805517|76156095|FG000|COMPLETED|Overall Study||6||
60040332|NCT02805517|76156095|FG000|NOT COMPLETED|Overall Study||0||
60040333|NCT01755598|76156106|FG000|STARTED|Overall Study||1786||
60040334|NCT01755598|76156107|FG001|STARTED|Overall Study||1787||
60040335|NCT01755598|76156106|FG000|COMPLETED|Overall Study||1521||
60040336|NCT01755598|76156107|FG001|COMPLETED|Overall Study||1504||
60040337|NCT01755598|76156106|FG000|NOT COMPLETED|Overall Study||265||
60040338|NCT01755598|76156107|FG001|NOT COMPLETED|Overall Study||283||
60040339|NCT01606306|76156119|FG000|STARTED|Overall Study||50||
60040340|NCT01606306|76156120|FG001|STARTED|Overall Study||49||
60040341|NCT01606306|76156121|FG002|STARTED|Overall Study||51||
60040342|NCT01606306|76156122|FG003|STARTED|Overall Study||51||
59918619|NCT03006458|76039030|FG001|STARTED|Second Intervention||10||
59918620|NCT03006458|76039029|FG000|COMPLETED|Second Intervention||14||
59918621|NCT03006458|76039030|FG001|COMPLETED|Second Intervention||10||
59918622|NCT03006458|76039029|FG000|NOT COMPLETED|Second Intervention||0||
59918623|NCT03006458|76039030|FG001|NOT COMPLETED|Second Intervention||0||
60040343|NCT01606306|76156123|FG004|STARTED|Overall Study||52||
60040344|NCT01606306|76156124|FG005|STARTED|Overall Study||47||
60040345|NCT01606306|76156119|FG000|Completed First Treatment Period|Overall Study||43||
60040346|NCT01606306|76156120|FG001|Completed First Treatment Period|Overall Study||47||
60040347|NCT01606306|76156121|FG002|Completed First Treatment Period|Overall Study||47||
60040348|NCT01606306|76156122|FG003|Completed First Treatment Period|Overall Study||45||
60040349|NCT01606306|76156123|FG004|Completed First Treatment Period|Overall Study||47||
60040350|NCT01606306|76156124|FG005|Completed First Treatment Period|Overall Study||44||
60040351|NCT01606306|76156119|FG000|Completed Second Treatment Period|Overall Study||41||
60040352|NCT01606306|76156120|FG001|Completed Second Treatment Period|Overall Study||38||
60040353|NCT01606306|76156121|FG002|Completed Second Treatment Period|Overall Study||43||
60040354|NCT01606306|76156122|FG003|Completed Second Treatment Period|Overall Study||44||
60040355|NCT01606306|76156123|FG004|Completed Second Treatment Period|Overall Study||46||
60040356|NCT01606306|76156124|FG005|Completed Second Treatment Period|Overall Study||41||
60040357|NCT01606306|76156119|FG000|Completed Third Treatment Period|Overall Study||35||
60040358|NCT01606306|76156120|FG001|Completed Third Treatment Period|Overall Study||39||
60040359|NCT01606306|76156121|FG002|Completed Third Treatment Period|Overall Study||37||
60040360|NCT01606306|76156122|FG003|Completed Third Treatment Period|Overall Study||38||
60040361|NCT01606306|76156123|FG004|Completed Third Treatment Period|Overall Study||41||
60040362|NCT01606306|76156124|FG005|Completed Third Treatment Period|Overall Study||36||
60040363|NCT01606306|76156119|FG000|COMPLETED|Overall Study||35||
60040364|NCT01606306|76156120|FG001|COMPLETED|Overall Study||39||
60040365|NCT01606306|76156121|FG002|COMPLETED|Overall Study||37||
60040366|NCT01606306|76156122|FG003|COMPLETED|Overall Study||38||
60040367|NCT01606306|76156123|FG004|COMPLETED|Overall Study||41||
60040368|NCT01606306|76156124|FG005|COMPLETED|Overall Study||36||
60040369|NCT01606306|76156119|FG000|NOT COMPLETED|Overall Study||15||
60040370|NCT01606306|76156120|FG001|NOT COMPLETED|Overall Study||10||
60040371|NCT01606306|76156121|FG002|NOT COMPLETED|Overall Study||14||
60040372|NCT01606306|76156122|FG003|NOT COMPLETED|Overall Study||13||
60040373|NCT01606306|76156123|FG004|NOT COMPLETED|Overall Study||11||
60040374|NCT01606306|76156124|FG005|NOT COMPLETED|Overall Study||11||
60040375|NCT01754194|76156132|FG000|STARTED|Overall Study||169||
60040376|NCT01754194|76156133|FG001|STARTED|Overall Study||124||
60040377|NCT01754194|76156132|FG000|COMPLETED|Overall Study||117||
60040378|NCT01754194|76156133|FG001|COMPLETED|Overall Study||97||
60040379|NCT01754194|76156132|FG000|NOT COMPLETED|Overall Study||52||
60040380|NCT01754194|76156133|FG001|NOT COMPLETED|Overall Study||27||
60040381|NCT01753570|76156144|FG000|STARTED|Overall Study||30||
60040382|NCT01753570|76156145|FG001|STARTED|Overall Study||30||
60040383|NCT01753570|76156146|FG002|STARTED|Overall Study||14||
60040384|NCT01753570|76156144|FG000|COMPLETED|Overall Study||28||
60040385|NCT01753570|76156145|FG001|COMPLETED|Overall Study||25||
60040386|NCT01753570|76156146|FG002|COMPLETED|Overall Study||13||
60040387|NCT01753570|76156144|FG000|NOT COMPLETED|Overall Study||2||
60040388|NCT01753570|76156145|FG001|NOT COMPLETED|Overall Study||5||
60040389|NCT01753570|76156146|FG002|NOT COMPLETED|Overall Study||1||
60040390|NCT01753336|76156155|FG000|STARTED|Overall Study||112||
60040391|NCT01753336|76156155|FG000|Cycle 1|Overall Study||112||
60040392|NCT01753336|76156155|FG000|Cycle 2|Overall Study||98||
60040393|NCT01753336|76156155|FG000|Cycle 3|Overall Study||93||
60040394|NCT01753336|76156155|FG000|COMPLETED|Overall Study||92||
60040395|NCT01753336|76156155|FG000|NOT COMPLETED|Overall Study||20||
60040396|NCT01777282|76156164|FG000|STARTED|Overall Study||120||
60040397|NCT01777282|76156165|FG001|STARTED|Overall Study||67||
60040398|NCT01777282|76156166|FG002|STARTED|Overall Study||65||
60040399|NCT01777282|76156167|FG003|STARTED|Overall Study||61||
60040400|NCT01777282|76156168|FG004|STARTED|Overall Study||61||
60040401|NCT01777282|76156164|FG000|Completing Treatment Period|Overall Study||109||
60040402|NCT01777282|76156165|FG001|Completing Treatment Period|Overall Study||63||
60040403|NCT01777282|76156166|FG002|Completing Treatment Period|Overall Study||59||
60040404|NCT01777282|76156167|FG003|Completing Treatment Period|Overall Study||59||
60040405|NCT01777282|76156168|FG004|Completing Treatment Period|Overall Study||54||
60040406|NCT01777282|76156164|FG000|Completing Follow-up Period|Overall Study||109||
60040407|NCT01777282|76156165|FG001|Completing Follow-up Period|Overall Study||63||
60040408|NCT01777282|76156166|FG002|Completing Follow-up Period|Overall Study||59||
60040409|NCT01777282|76156167|FG003|Completing Follow-up Period|Overall Study||59||
60040410|NCT01777282|76156168|FG004|Completing Follow-up Period|Overall Study||54||
60040411|NCT01777282|76156164|FG000|COMPLETED|Overall Study||109||
60040412|NCT01777282|76156165|FG001|COMPLETED|Overall Study||63||
60040413|NCT01777282|76156166|FG002|COMPLETED|Overall Study||59||
60040414|NCT01777282|76156167|FG003|COMPLETED|Overall Study||59||
60040415|NCT01777282|76156168|FG004|COMPLETED|Overall Study||54||
60040416|NCT01777282|76156164|FG000|NOT COMPLETED|Overall Study||11||
60040417|NCT01777282|76156165|FG001|NOT COMPLETED|Overall Study||4||
60040418|NCT01777282|76156166|FG002|NOT COMPLETED|Overall Study||6||
59510105|NCT02701270|75603551|FG003|STARTED|Third Intervention at Visit 3||3||
60040419|NCT01777282|76156167|FG003|NOT COMPLETED|Overall Study||2||
60040420|NCT01777282|76156168|FG004|NOT COMPLETED|Overall Study||7||
59519024|NCT03587428|75612873|FG003|COMPLETED|Period 3||3||
60040421|NCT01975389|76156182|FG000|STARTED|Overall Study||5283||
60040422|NCT01975389|76156183|FG001|STARTED|Overall Study||5281||
60040423|NCT01975389|76156182|FG000|Treated|Overall Study||5279||
60040424|NCT01975389|76156183|FG001|Treated|Overall Study||5276||
60040425|NCT01975389|76156182|FG000|COMPLETED|Overall Study||5031||
60040426|NCT01975389|76156183|FG001|COMPLETED|Overall Study||5045||
60040427|NCT01975389|76156182|FG000|NOT COMPLETED|Overall Study||252||
60040428|NCT01975389|76156183|FG001|NOT COMPLETED|Overall Study||236||
60040429|NCT01974141|76156191|FG000|STARTED|Overall Study||1044||
60040430|NCT01974141|76156192|FG001|STARTED|Overall Study||1058||
60040431|NCT01974141|76156191|FG000|COMPLETED|Overall Study||948||
60040432|NCT01974141|76156192|FG001|COMPLETED|Overall Study||976||
60040433|NCT01974141|76156191|FG000|NOT COMPLETED|Overall Study||96||
60040434|NCT01974141|76156192|FG001|NOT COMPLETED|Overall Study||82||
60040435|NCT01945593|76156202|FG000|STARTED|Overall Study||3||
60040436|NCT01945593|76156203|FG001|STARTED|Overall Study||64||
60040437|NCT01945593|76156204|FG002|STARTED|Overall Study||26||
60040438|NCT01945593|76156205|FG003|STARTED|Overall Study||125||
60040439|NCT01945593|76156202|FG000|COMPLETED|Overall Study||3||
60040440|NCT01945593|76156203|FG001|COMPLETED|Overall Study||56||
60040441|NCT01945593|76156204|FG002|COMPLETED|Overall Study||23||
60040442|NCT01945593|76156205|FG003|COMPLETED|Overall Study||105||
60040443|NCT01945593|76156202|FG000|NOT COMPLETED|Overall Study||0||
60040444|NCT01945593|76156203|FG001|NOT COMPLETED|Overall Study||8||
60040445|NCT01945593|76156204|FG002|NOT COMPLETED|Overall Study||3||
60040446|NCT01945593|76156205|FG003|NOT COMPLETED|Overall Study||20||
60040447|NCT01945281|76156222|FG000|STARTED|Overall Study||34||
60040448|NCT01945281|76156223|FG001|STARTED|Overall Study||17||
60040449|NCT01945281|76156222|FG000|Treated|Overall Study||33||
60040450|NCT01945281|76156223|FG001|Treated|Overall Study||16||
60040451|NCT01945281|76156222|FG000|COMPLETED|Overall Study||28||
60040452|NCT01945281|76156223|FG001|COMPLETED|Overall Study||13||
60040453|NCT01945281|76156222|FG000|NOT COMPLETED|Overall Study||6||
60040454|NCT01945281|76156223|FG001|NOT COMPLETED|Overall Study||4||
60040455|NCT01961349|76156232|FG000|STARTED|Overall Study||54||
60040456|NCT01961349|76156233|FG001|STARTED|Overall Study||107||
60040457|NCT01961349|76156234|FG002|STARTED|Overall Study||111||
60040458|NCT01961349|76156232|FG000|COMPLETED|Overall Study||51||
60040459|NCT01961349|76156233|FG001|COMPLETED|Overall Study||101||
60040460|NCT01961349|76156234|FG002|COMPLETED|Overall Study||109||
60040461|NCT01961349|76156232|FG000|NOT COMPLETED|Overall Study||3||
60040462|NCT01961349|76156233|FG001|NOT COMPLETED|Overall Study||6||
60040463|NCT01961349|76156234|FG002|NOT COMPLETED|Overall Study||2||
60040464|NCT01973595|76156246|FG000|STARTED|Intervention Phase 1||15||
60040465|NCT01973595|76156247|FG001|STARTED|Intervention Phase 1||14||
60040466|NCT01973595|76156248|FG002|STARTED|Intervention Phase 1||15||
60040467|NCT01973595|76156249|FG003|STARTED|Intervention Phase 1||14||
60040468|NCT01973595|76156246|FG000|COMPLETED|Intervention Phase 1||15||
60040469|NCT01973595|76156247|FG001|COMPLETED|Intervention Phase 1||14||
60040470|NCT01973595|76156248|FG002|COMPLETED|Intervention Phase 1||15||
60040471|NCT01973595|76156249|FG003|COMPLETED|Intervention Phase 1||14||
60040472|NCT01973595|76156246|FG000|NOT COMPLETED|Intervention Phase 1||0||
60040473|NCT01973595|76156247|FG001|NOT COMPLETED|Intervention Phase 1||0||
60040474|NCT01973595|76156248|FG002|NOT COMPLETED|Intervention Phase 1||0||
60040475|NCT01973595|76156249|FG003|NOT COMPLETED|Intervention Phase 1||0||
60040476|NCT01973595|76156246|FG000|STARTED|Washout||15||
60040477|NCT01973595|76156247|FG001|STARTED|Washout||14||
60040478|NCT01973595|76156248|FG002|STARTED|Washout||15||
60040479|NCT01973595|76156249|FG003|STARTED|Washout||14||
60040480|NCT01973595|76156246|FG000|COMPLETED|Washout||14||
60040481|NCT01973595|76156247|FG001|COMPLETED|Washout||14||
60040482|NCT01973595|76156248|FG002|COMPLETED|Washout||14||
60040483|NCT01973595|76156249|FG003|COMPLETED|Washout||14||
60040484|NCT01973595|76156246|FG000|NOT COMPLETED|Washout||1||
60040485|NCT01973595|76156247|FG001|NOT COMPLETED|Washout||0||
60040486|NCT01973595|76156248|FG002|NOT COMPLETED|Washout||1||
60040487|NCT01973595|76156249|FG003|NOT COMPLETED|Washout||0||
60040488|NCT01973595|76156246|FG000|STARTED|Intervention Phase 2||14||
60040489|NCT01973595|76156247|FG001|STARTED|Intervention Phase 2||14||
60040490|NCT01973595|76156248|FG002|STARTED|Intervention Phase 2||14||
60040491|NCT01973595|76156249|FG003|STARTED|Intervention Phase 2||14||
60040492|NCT01973595|76156246|FG000|COMPLETED|Intervention Phase 2||14||
60040493|NCT01973595|76156247|FG001|COMPLETED|Intervention Phase 2||14||
60040494|NCT01973595|76156248|FG002|COMPLETED|Intervention Phase 2||14||
60040495|NCT01973595|76156249|FG003|COMPLETED|Intervention Phase 2||14||
60040496|NCT01973595|76156246|FG000|NOT COMPLETED|Intervention Phase 2||0||
60040497|NCT01973595|76156247|FG001|NOT COMPLETED|Intervention Phase 2||0||
60040498|NCT01973595|76156248|FG002|NOT COMPLETED|Intervention Phase 2||0||
60040499|NCT01973595|76156249|FG003|NOT COMPLETED|Intervention Phase 2||0||
60040500|NCT01944969|76156260|FG000|STARTED|Overall Study||26||
60040501|NCT01944969|76156260|FG000|COMPLETED|Overall Study||0||
60040502|NCT01944969|76156260|FG000|NOT COMPLETED|Overall Study||26||
60040503|NCT01961115|76156269|FG000|STARTED|Overall Study||2||
60040504|NCT01961115|76156270|FG001|STARTED|Overall Study||0||
60040505|NCT01961115|76156271|FG002|STARTED|Overall Study||9||
60040506|NCT01961115|76156269|FG000|COMPLETED|Overall Study||0|The protocol called for 12 patients to be enrolled. After 3 years and 4 months only 11 pts enrolled.|
60040507|NCT01961115|76156270|FG001|COMPLETED|Overall Study||0|The protocol called for 12 patients to be enrolled. After 3 years and 4 months only 11 pts enrolled.|
60040508|NCT01961115|76156271|FG002|COMPLETED|Overall Study||5|The protocol called for 12 patients to be enrolled. After 3 years and 4 months only 11 pts enrolled.|
60040509|NCT01961115|76156269|FG000|NOT COMPLETED|Overall Study||2||
60040510|NCT01961115|76156270|FG001|NOT COMPLETED|Overall Study||0||
60040511|NCT01961115|76156271|FG002|NOT COMPLETED|Overall Study||4||
60040512|NCT01973439|76156279|FG000|STARTED|Overall Study||23||
60040513|NCT01973439|76156279|FG000|Two Evaluable PK Days|Overall Study|18 Children had two evaluable PK days|18||
60040514|NCT01973439|76156279|FG000|One Evaluable PK Day Only|Overall Study|5 children had only one evaluable PK day.|5||
60040515|NCT01973439|76156279|FG000|COMPLETED|Overall Study||18||
60040516|NCT01973439|76156279|FG000|NOT COMPLETED|Overall Study||5||
60040517|NCT01973283|76156283|FG000|STARTED|Overall Study||100||
59510106|NCT02701270|75603548|FG000|COMPLETED|Third Intervention at Visit 3||2||
59510107|NCT02701270|75603549|FG001|COMPLETED|Third Intervention at Visit 3||3||
60040518|NCT01973283|76156283|FG000|COMPLETED|Overall Study||96||
60040519|NCT01973283|76156283|FG000|NOT COMPLETED|Overall Study||4||
60040520|NCT01943799|76156293|FG000|STARTED|Overall Study||27||
60040521|NCT01943799|76156294|FG001|STARTED|Overall Study||50||
60040522|NCT01943799|76156295|FG002|STARTED|Overall Study|1 participant was randomized to OAV + GS-4774 2 YU but received OAV + GS-4774 10 YU.|51||
60040523|NCT01943799|76156296|FG003|STARTED|Overall Study||50||
60040524|NCT01943799|76156293|FG000|COMPLETED|Overall Study||22||
60040525|NCT01943799|76156294|FG001|COMPLETED|Overall Study||47||
60040526|NCT01943799|76156295|FG002|COMPLETED|Overall Study||49||
60040527|NCT01943799|76156296|FG003|COMPLETED|Overall Study||50||
60040528|NCT01943799|76156293|FG000|NOT COMPLETED|Overall Study||5||
60040529|NCT01943799|76156294|FG001|NOT COMPLETED|Overall Study||3||
60040530|NCT01943799|76156295|FG002|NOT COMPLETED|Overall Study||2||
60040531|NCT01943799|76156296|FG003|NOT COMPLETED|Overall Study||0||
60040532|NCT01972659|76156308|FG000|STARTED|Overall Study||40||
60040533|NCT01972659|76156309|FG001|STARTED|Overall Study||40||
60040534|NCT01972659|76156308|FG000|COMPLETED|Overall Study||36||
60040535|NCT01972659|76156309|FG001|COMPLETED|Overall Study||37||
60040536|NCT01972659|76156308|FG000|NOT COMPLETED|Overall Study||4||
60040537|NCT01972659|76156309|FG001|NOT COMPLETED|Overall Study||3||
60040538|NCT01971723|76156317|FG000|STARTED|Overall Study||16||
60040539|NCT01971723|76156318|FG001|STARTED|Overall Study||16||
60040540|NCT01971723|76156317|FG000|COMPLETED|Overall Study||14||
60040541|NCT01971723|76156318|FG001|COMPLETED|Overall Study||13||
60040542|NCT01971723|76156317|FG000|NOT COMPLETED|Overall Study||2||
60040543|NCT01971723|76156318|FG001|NOT COMPLETED|Overall Study||3||
60040544|NCT01942785|76156324|FG000|STARTED|Overall Study||54||
60040545|NCT01942785|76156324|FG000|COMPLETED|Overall Study||50||
60040546|NCT01942785|76156324|FG000|NOT COMPLETED|Overall Study||4||
60040547|NCT01774786|76156332|FG000|STARTED|Overall Study||388|Intent-to-Treat (ITT) population|
60040548|NCT01774786|76156333|FG001|STARTED|Overall Study||392|Intent-to-Treat (ITT) population|
60040549|NCT01774786|76156332|FG000|Did Not Receive Any Study Treatment|Overall Study|2 patients found ineligible after enrollment and 2 patients died before treatment.|4||
60040550|NCT01774786|76156333|FG001|Did Not Receive Any Study Treatment|Overall Study|All 3 patients found ineligible for the study after enrollment and before treatment.|3||
60040551|NCT01774786|76156332|FG000|Received at Least One Dose of Pertuzumab|Overall Study||384|Pertuzumab Safety Population|
60040552|NCT01774786|76156333|FG001|Received at Least One Dose of Pertuzumab|Overall Study|One participant randomized to placebo arm received 1 dose of pertuzumab by error.|1|Pertuzumab Safety Population|
60040553|NCT01774786|76156332|FG000|Received Placebo (No Pertuzumab)|Overall Study||0|Placebo Safety Population|
60040554|NCT01774786|76156333|FG001|Received Placebo (No Pertuzumab)|Overall Study||388|Placebo Safety Population|
60040555|NCT01774786|76156332|FG000|COMPLETED|Overall Study||60||
59510108|NCT02701270|75603550|FG002|COMPLETED|Third Intervention at Visit 3||3||
59510109|NCT02701270|75603551|FG003|COMPLETED|Third Intervention at Visit 3||3||
59510110|NCT02701270|75603548|FG000|NOT COMPLETED|Third Intervention at Visit 3||0||
59510111|NCT02701270|75603549|FG001|NOT COMPLETED|Third Intervention at Visit 3||0||
59510112|NCT02701270|75603550|FG002|NOT COMPLETED|Third Intervention at Visit 3||0||
59510113|NCT02701270|75603551|FG003|NOT COMPLETED|Third Intervention at Visit 3||0||
59510114|NCT02701270|75603548|FG000|STARTED|Fourth Intervention at Visit 4||2||
59510115|NCT02701270|75603549|FG001|STARTED|Fourth Intervention at Visit 4||3||
59510116|NCT02701270|75603550|FG002|STARTED|Fourth Intervention at Visit 4||3||
59510117|NCT02701270|75603551|FG003|STARTED|Fourth Intervention at Visit 4||3||
59510118|NCT02701270|75603548|FG000|COMPLETED|Fourth Intervention at Visit 4||2||
59510119|NCT02701270|75603549|FG001|COMPLETED|Fourth Intervention at Visit 4||3||
59510120|NCT02701270|75603550|FG002|COMPLETED|Fourth Intervention at Visit 4||3||
59510121|NCT02701270|75603551|FG003|COMPLETED|Fourth Intervention at Visit 4||3||
59510122|NCT02701270|75603548|FG000|NOT COMPLETED|Fourth Intervention at Visit 4||0||
59510123|NCT02701270|75603549|FG001|NOT COMPLETED|Fourth Intervention at Visit 4||0||
59510124|NCT02701270|75603550|FG002|NOT COMPLETED|Fourth Intervention at Visit 4||0||
59510125|NCT02701270|75603551|FG003|NOT COMPLETED|Fourth Intervention at Visit 4||0||
59510126|NCT02701582|75603564|FG000|STARTED|Overall Study||35||
59510127|NCT02701582|75603565|FG001|STARTED|Overall Study||33||
59510128|NCT02701582|75603564|FG000|COMPLETED|Overall Study||33||
59510129|NCT02701582|75603565|FG001|COMPLETED|Overall Study||33||
59510130|NCT02701582|75603564|FG000|NOT COMPLETED|Overall Study||2||
59510131|NCT02701582|75603565|FG001|NOT COMPLETED|Overall Study||0||
59510132|NCT00869167|75603575|FG000|STARTED|Overall Study||2||
59510133|NCT00869167|75603576|FG001|STARTED|Overall Study||1||
59510134|NCT00869167|75603575|FG000|COMPLETED|Overall Study||2||
59510135|NCT00869167|75603576|FG001|COMPLETED|Overall Study||0||
59510136|NCT00869167|75603575|FG000|NOT COMPLETED|Overall Study||0||
59510137|NCT00869167|75603576|FG001|NOT COMPLETED|Overall Study||1||
59510138|NCT00843349|75603588|FG000|STARTED|Overall Study||11||
59510139|NCT00843349|75603589|FG001|STARTED|Overall Study||11||
59510140|NCT00843349|75603590|FG002|STARTED|Overall Study||10||
59510141|NCT00843349|75603591|FG003|STARTED|Overall Study||11||
60040556|NCT01774786|76156333|FG001|COMPLETED|Overall Study||46||
59510142|NCT00843349|75603588|FG000|COMPLETED|Overall Study||8||
59510143|NCT00843349|75603589|FG001|COMPLETED|Overall Study||11||
59510144|NCT00843349|75603590|FG002|COMPLETED|Overall Study||10||
59510145|NCT00843349|75603591|FG003|COMPLETED|Overall Study||10||
59510146|NCT00843349|75603588|FG000|NOT COMPLETED|Overall Study||3||
60040557|NCT01774786|76156332|FG000|NOT COMPLETED|Overall Study||328||
59510147|NCT00843349|75603589|FG001|NOT COMPLETED|Overall Study||0||
59510148|NCT00843349|75603590|FG002|NOT COMPLETED|Overall Study||0||
59510149|NCT00843349|75603591|FG003|NOT COMPLETED|Overall Study||1||
59510150|NCT00869791|75603601|FG000|STARTED|Period 1 Treatment for 7 Days||14||
59510151|NCT00869791|75603602|FG001|STARTED|Period 1 Treatment for 7 Days||13||
59510152|NCT00869791|75603601|FG000|COMPLETED|Period 1 Treatment for 7 Days||14||
59510153|NCT00869791|75603602|FG001|COMPLETED|Period 1 Treatment for 7 Days||13||
59510154|NCT00869791|75603601|FG000|NOT COMPLETED|Period 1 Treatment for 7 Days||0||
59510155|NCT00869791|75603602|FG001|NOT COMPLETED|Period 1 Treatment for 7 Days||0||
59510156|NCT00869791|75603601|FG000|STARTED|Period 2 Treatment for 7 Days||14||
59510157|NCT00869791|75603602|FG001|STARTED|Period 2 Treatment for 7 Days||13||
59510158|NCT00869791|75603601|FG000|COMPLETED|Period 2 Treatment for 7 Days||14||
59510159|NCT00869791|75603602|FG001|COMPLETED|Period 2 Treatment for 7 Days||13||
59510160|NCT00869791|75603601|FG000|NOT COMPLETED|Period 2 Treatment for 7 Days||0||
59510161|NCT00869791|75603602|FG001|NOT COMPLETED|Period 2 Treatment for 7 Days||0||
59510162|NCT02704702|75603614|FG000|STARTED|Overall Study||6||
59510163|NCT02704702|75603615|FG001|STARTED|Overall Study||6||
59510164|NCT02704702|75603616|FG002|STARTED|Overall Study||6||
59510165|NCT02704702|75603617|FG003|STARTED|Overall Study||6||
59510166|NCT02704702|75603618|FG004|STARTED|Overall Study||6||
59510167|NCT02704702|75603619|FG005|STARTED|Overall Study||6||
59510168|NCT02704702|75603614|FG000|COMPLETED|Overall Study||5||
59510169|NCT02704702|75603615|FG001|COMPLETED|Overall Study||6||
59510170|NCT02704702|75603616|FG002|COMPLETED|Overall Study||6||
59510171|NCT02704702|75603617|FG003|COMPLETED|Overall Study||5||
59510172|NCT02704702|75603618|FG004|COMPLETED|Overall Study||4||
59510173|NCT02704702|75603619|FG005|COMPLETED|Overall Study||4||
59510174|NCT02704702|75603614|FG000|NOT COMPLETED|Overall Study||1||
59510175|NCT02704702|75603615|FG001|NOT COMPLETED|Overall Study||0||
59510176|NCT02704702|75603616|FG002|NOT COMPLETED|Overall Study||0||
59510177|NCT02704702|75603617|FG003|NOT COMPLETED|Overall Study||1||
59510178|NCT02704702|75603618|FG004|NOT COMPLETED|Overall Study||2||
59510179|NCT02704702|75603619|FG005|NOT COMPLETED|Overall Study||2||
59510180|NCT00869947|75603639|FG000|STARTED|Overall Study||8||
59510181|NCT00869947|75603640|FG001|STARTED|Overall Study||8||
59510182|NCT00869947|75603639|FG000|COMPLETED|Overall Study||8||
59510183|NCT00869947|75603640|FG001|COMPLETED|Overall Study||8||
59510184|NCT00869947|75603639|FG000|NOT COMPLETED|Overall Study||0||
59510185|NCT00869947|75603640|FG001|NOT COMPLETED|Overall Study||0||
59510186|NCT02707432|75603650|FG000|STARTED|Overall Study||72||
59510187|NCT02707432|75603651|FG001|STARTED|Overall Study||71||
59510188|NCT02707432|75603650|FG000|COMPLETED|Overall Study||57||
59510189|NCT02707432|75603651|FG001|COMPLETED|Overall Study||51||
59510190|NCT02707432|75603650|FG000|NOT COMPLETED|Overall Study||15||
59510191|NCT02707432|75603651|FG001|NOT COMPLETED|Overall Study||20||
59510192|NCT02708212|75603659|FG000|STARTED|Overall Study||60||
59510193|NCT02708212|75603660|FG001|STARTED|Overall Study||60||
59510194|NCT02708212|75603659|FG000|COMPLETED|Overall Study||60||
59510195|NCT02708212|75603660|FG001|COMPLETED|Overall Study||60||
59510196|NCT02708212|75603659|FG000|NOT COMPLETED|Overall Study||0||
59510197|NCT02708212|75603660|FG001|NOT COMPLETED|Overall Study||0||
59510198|NCT00871819|75603670|FG000|STARTED|Overall Study||20||
59510199|NCT00871819|75603670|FG000|COMPLETED|Overall Study||20||
59510200|NCT00871819|75603670|FG000|NOT COMPLETED|Overall Study||0||
59510201|NCT02708290|75603676|FG000|STARTED|Overall Study||1009||
59510202|NCT02708290|75603677|FG001|STARTED|Overall Study||1009||
59510203|NCT02708290|75603676|FG000|COMPLETED|Overall Study||1009||
59510204|NCT02708290|75603677|FG001|COMPLETED|Overall Study||1009||
59510205|NCT02708290|75603676|FG000|NOT COMPLETED|Overall Study||0||
59510206|NCT02708290|75603677|FG001|NOT COMPLETED|Overall Study||0||
59759596|NCT02855060|75878988|FG000|STARTED|Overall Study||22||
59510207|NCT00895531|75603685|FG000|STARTED|Overall Study||38||
59510208|NCT00895531|75603686|FG001|STARTED|Overall Study||37||
59510209|NCT00895531|75603685|FG000|COMPLETED|Overall Study||38||
59510210|NCT00895531|75603686|FG001|COMPLETED|Overall Study||37||
59510211|NCT00895531|75603685|FG000|NOT COMPLETED|Overall Study||0||
59510212|NCT00895531|75603686|FG001|NOT COMPLETED|Overall Study||0||
59510213|NCT02709694|75603692|FG000|STARTED|Overall Study||33||
59510214|NCT02709694|75603692|FG000|Any Back Pain|Overall Study||19||
59510215|NCT02709694|75603692|FG000|No Back Pain|Overall Study||14||
59510216|NCT02709694|75603692|FG000|MRI Showing Presence of Sacroiliitis|Overall Study||4||
59510217|NCT02709694|75603692|FG000|MRI Not Showing Sacroiliitis|Overall Study||29||
59510218|NCT02709694|75603692|FG000|Classified as Having Inflammatory Back Pain by the ASAS Criteria|Overall Study||6||
59510219|NCT02709694|75603692|FG000|Not Classified as Having Inflammatory Back Pain by the ASAS Criteria|Overall Study||25||
59510220|NCT02709694|75603692|FG000|Having Bone Marrow Edema Seen in MRI|Overall Study||33||
59510221|NCT02709694|75603692|FG000|Having Erosion (a Structural Lesion) Seen in MRI|Overall Study||33||
59510222|NCT02709694|75603692|FG000|Having Fat Metaplasia Seen in MRI|Overall Study||33||
59510223|NCT02709694|75603692|FG000|Having Backfill (Type of Structural Lesion) Seen in MRI|Overall Study||33||
59510224|NCT02709694|75603692|FG000|Having Ankylosis Seen in MRI|Overall Study||33||
59510225|NCT02709694|75603692|FG000|COMPLETED|Overall Study||33||
59510226|NCT02709694|75603692|FG000|NOT COMPLETED|Overall Study||0||
59510227|NCT00872833|75603706|FG000|STARTED|Overall Study||15||
59510228|NCT00872833|75603707|FG001|STARTED|Overall Study||17||
59510229|NCT00872833|75603706|FG000|COMPLETED|Overall Study||15||
59510230|NCT00872833|75603707|FG001|COMPLETED|Overall Study||17||
59510231|NCT00872833|75603706|FG000|NOT COMPLETED|Overall Study||0||
59510232|NCT00872833|75603707|FG001|NOT COMPLETED|Overall Study||0||
59510233|NCT02710240|75603716|FG000|STARTED|Overall Study||336||
59510234|NCT02710240|75603716|FG000|COMPLETED|Overall Study||336||
59510235|NCT02710240|75603716|FG000|NOT COMPLETED|Overall Study||0||
59510236|NCT02710630|75603725|FG000|STARTED|Period 1||7||
59612371|NCT01701258|75723505|FG006|Returned for EEG (Session 4)|Assessment and Scheduling||0|66/96 completed the EEG. Participants did at least two sessions after the screening visit.|
59612372|NCT01701258|75723506|FG007|Returned for EEG (Session 4)|Assessment and Scheduling||0|66/96 completed the EEG. Participants did at least two sessions after the screening visit.|
59612373|NCT01701258|75723507|FG008|Returned for EEG (Session 4)|Assessment and Scheduling||0|66/96 completed the EEG. Participants did at least two sessions after the screening visit.|
59918624|NCT03320941|76039041|FG000|STARTED|Overall Study||19||
59918625|NCT03320941|76039042|FG001|STARTED|Overall Study||19||
59918626|NCT03320941|76039043|FG002|STARTED|Overall Study||28||
59918627|NCT03320941|76039044|FG003|STARTED|Overall Study||31||
59918628|NCT03320941|76039045|FG004|STARTED|Overall Study||29||
59918629|NCT03320941|76039041|FG000|COMPLETED|Overall Study||19||
59918630|NCT03320941|76039042|FG001|COMPLETED|Overall Study||19||
59918631|NCT03320941|76039043|FG002|COMPLETED|Overall Study||28||
59918632|NCT03320941|76039044|FG003|COMPLETED|Overall Study||30||
59918633|NCT03320941|76039045|FG004|COMPLETED|Overall Study||29||
59918634|NCT03320941|76039041|FG000|NOT COMPLETED|Overall Study||0||
59759597|NCT02855060|75878989|FG001|STARTED|Overall Study||28||
59759598|NCT02855060|75878988|FG000|COMPLETED|Overall Study||20||
59918635|NCT03320941|76039042|FG001|NOT COMPLETED|Overall Study||0||
60040558|NCT01774786|76156333|FG001|NOT COMPLETED|Overall Study||346||
60040559|NCT01960725|76156341|FG000|STARTED|Overall Study||33||
60040560|NCT01960725|76156342|FG001|STARTED|Overall Study||33||
60040561|NCT01960725|76156341|FG000|Received First Vaccine|Overall Study||33||
60040562|NCT01960725|76156342|FG001|Received First Vaccine|Overall Study||33||
60040563|NCT01960725|76156341|FG000|Recieved Second Vaccine|Overall Study||33||
60040564|NCT01960725|76156342|FG001|Recieved Second Vaccine|Overall Study||33||
60040565|NCT01960725|76156341|FG000|Received Third Vaccine|Overall Study||32||
60040566|NCT01960725|76156342|FG001|Received Third Vaccine|Overall Study||32||
60040567|NCT01960725|76156341|FG000|COMPLETED|Overall Study||27|Immunogenicity data completed|
60040568|NCT01960725|76156342|FG001|COMPLETED|Overall Study||28|Immunogenicity data completed|
60040569|NCT01960725|76156341|FG000|NOT COMPLETED|Overall Study||6||
60040570|NCT01960725|76156342|FG001|NOT COMPLETED|Overall Study||5||
60040571|NCT01942161|76156351|FG000|STARTED|Overall Study||35||
60040572|NCT01942161|76156352|FG001|STARTED|Overall Study||30||
60040573|NCT01942161|76156353|FG002|STARTED|Overall Study||41||
60040574|NCT01942161|76156351|FG000|COMPLETED|Overall Study||27||
60040575|NCT01942161|76156352|FG001|COMPLETED|Overall Study||24||
60040576|NCT01942161|76156353|FG002|COMPLETED|Overall Study||35||
60040577|NCT01942161|76156351|FG000|NOT COMPLETED|Overall Study||8||
60040578|NCT01942161|76156352|FG001|NOT COMPLETED|Overall Study||6||
60040579|NCT01942161|76156353|FG002|NOT COMPLETED|Overall Study||6||
60040580|NCT01971645|76156364|FG000|STARTED|Overall Study||25||
60040581|NCT01971645|76156365|FG001|STARTED|Overall Study||27||
60040582|NCT01971645|76156366|FG002|STARTED|Overall Study||25||
60040583|NCT01971645|76156364|FG000|COMPLETED|Overall Study||23||
60040584|NCT01971645|76156365|FG001|COMPLETED|Overall Study||27||
60040585|NCT01971645|76156366|FG002|COMPLETED|Overall Study||23||
59510237|NCT02710630|75603726|FG001|STARTED|Period 1||7||
59510238|NCT02710630|75603727|FG002|STARTED|Period 1||7||
59510239|NCT02710630|75603728|FG003|STARTED|Period 1||7||
59510240|NCT02710630|75603729|FG004|STARTED|Period 1||7||
59510241|NCT02710630|75603725|FG000|COMPLETED|Period 1||7||
59510242|NCT02710630|75603726|FG001|COMPLETED|Period 1||7||
59510243|NCT02710630|75603727|FG002|COMPLETED|Period 1||7||
59510244|NCT02710630|75603728|FG003|COMPLETED|Period 1||7||
59612374|NCT01701258|75723508|FG009|Returned for EEG (Session 4)|Assessment and Scheduling||0|66/96 completed the EEG. Participants did at least two sessions after the screening visit.|
59612375|NCT01701258|75723509|FG010|Returned for EEG (Session 4)|Assessment and Scheduling||0|66/96 completed the EEG. Participants did at least two sessions after the screening visit.|
59759599|NCT02855060|75878989|FG001|COMPLETED|Overall Study||23||
59918636|NCT03320941|76039043|FG002|NOT COMPLETED|Overall Study||0||
59918637|NCT03320941|76039044|FG003|NOT COMPLETED|Overall Study||1||
59918638|NCT03320941|76039045|FG004|NOT COMPLETED|Overall Study||0||
59918639|NCT03005288|76039059|FG000|STARTED|Overall Study||39|All the participants who were assigned a randomization number.|
59918640|NCT03005288|76039060|FG001|STARTED|Overall Study||39|All the participants who were assigned a randomization number.|
59918641|NCT03005288|76039059|FG000|Safety Analysis Set|Overall Study||37|All subjects that received any study drug.|
59951410|NCT01798992|76070391|FG001|COMPLETED|Overall Study||17||
60040586|NCT01971645|76156364|FG000|NOT COMPLETED|Overall Study||2||
60040587|NCT01971645|76156365|FG001|NOT COMPLETED|Overall Study||0||
60040588|NCT01971645|76156366|FG002|NOT COMPLETED|Overall Study||2||
60040589|NCT01941537|76156376|FG000|STARTED|Overall Study||40||
60040590|NCT01941537|76156377|FG001|STARTED|Overall Study||20||
60040591|NCT01941537|76156376|FG000|COMPLETED|Overall Study||36||
60040592|NCT01941537|76156377|FG001|COMPLETED|Overall Study||17||
60040593|NCT01941537|76156376|FG000|NOT COMPLETED|Overall Study||4||
59510245|NCT02710630|75603729|FG004|COMPLETED|Period 1||7||
59918642|NCT03005288|76039060|FG001|Safety Analysis Set|Overall Study||38|All subjects that received any study drug.|
59918643|NCT03005288|76039059|FG000|Pharmacokinetics (PK) Analysis Set|Overall Study|One subject was excluded due to a protocol deviation.|36|All subjects who received any study drug and experienced no protocol deviations.|
59918644|NCT03005288|76039060|FG001|Pharmacokinetics (PK) Analysis Set|Overall Study|PK samples were only obtained and evaluated for subjects treated with BYM338.|0|All subjects who received any study drug and experienced no protocol deviations.|
59918645|NCT03005288|76039059|FG000|Pharmacodynamics (PD) Analysis Set|Overall Study|One subject was excluded due to a protocol deviation.|36|All subjects who received any study drug and experienced no protocol deviations.|
59918646|NCT03005288|76039060|FG001|Pharmacodynamics (PD) Analysis Set|Overall Study|Two subjects were excluded due to protocol deviations.|36|All subjects who received any study drug and experienced no protocol deviations.|
59918647|NCT03005288|76039059|FG000|COMPLETED|Overall Study||27||
59918648|NCT03005288|76039060|FG001|COMPLETED|Overall Study||31||
59918649|NCT03005288|76039059|FG000|NOT COMPLETED|Overall Study||12||
59918650|NCT03005288|76039060|FG001|NOT COMPLETED|Overall Study||8||
59918651|NCT03003494|76039066|FG000|STARTED|Overall Study||306||
59918652|NCT03003494|76039066|FG000|COMPLETED|Overall Study||278||
59918653|NCT03003494|76039066|FG000|NOT COMPLETED|Overall Study||28||
59918654|NCT03559699|76039070|FG000|STARTED|Overall Study||27||
59918655|NCT03559699|76039070|FG000|COMPLETED|Overall Study||20||
59918656|NCT03559699|76039070|FG000|NOT COMPLETED|Overall Study||7||
59918657|NCT03085758|76039077|FG000|STARTED|Overall Study||72||
59918658|NCT03085758|76039078|FG001|STARTED|Overall Study||77||
59918659|NCT03085758|76039079|FG002|STARTED|Overall Study||152||
59918660|NCT03085758|76039077|FG000|COMPLETED|Overall Study||43||
59918661|NCT03085758|76039078|FG001|COMPLETED|Overall Study||49||
59918662|NCT03085758|76039079|FG002|COMPLETED|Overall Study||96||
59918663|NCT03085758|76039077|FG000|NOT COMPLETED|Overall Study||29||
59918664|NCT03085758|76039078|FG001|NOT COMPLETED|Overall Study||28||
59918665|NCT03085758|76039079|FG002|NOT COMPLETED|Overall Study||56||
59918666|NCT02573233|76039093|FG000|STARTED|Overall Study||22||
59918667|NCT02573233|76039094|FG001|STARTED|Overall Study||20||
59918668|NCT02573233|76039093|FG000|COMPLETED|Overall Study||22||
59918669|NCT02573233|76039094|FG001|COMPLETED|Overall Study||20||
59918670|NCT02573233|76039093|FG000|NOT COMPLETED|Overall Study||0||
59918671|NCT02573233|76039094|FG001|NOT COMPLETED|Overall Study||0||
59918672|NCT03935880|76039103|FG000|STARTED|Overall Study||9||
59918673|NCT03935880|76039104|FG001|STARTED|Overall Study||11||
59918674|NCT03935880|76039103|FG000|Completed Surgery|Overall Study||9||
59918675|NCT03935880|76039104|FG001|Completed Surgery|Overall Study||10||
59918676|NCT03935880|76039103|FG000|COMPLETED|Overall Study||9||
59918677|NCT03935880|76039104|FG001|COMPLETED|Overall Study||10||
59918678|NCT03935880|76039103|FG000|NOT COMPLETED|Overall Study||0||
59918679|NCT03935880|76039104|FG001|NOT COMPLETED|Overall Study||1||
59918680|NCT03315793|76039112|FG000|STARTED|Overall Study||75||
59918681|NCT03315793|76039113|FG001|STARTED|Overall Study||74||
59918682|NCT03315793|76039112|FG000|Received at Least 1 Dose of Study Drug|Overall Study||75||
59918683|NCT03315793|76039113|FG001|Received at Least 1 Dose of Study Drug|Overall Study||74||
59918684|NCT03315793|76039112|FG000|COMPLETED|Overall Study||70||
59918685|NCT03315793|76039113|FG001|COMPLETED|Overall Study||71||
59918686|NCT03315793|76039112|FG000|NOT COMPLETED|Overall Study||5||
59918687|NCT03315793|76039113|FG001|NOT COMPLETED|Overall Study||3||
59918688|NCT02676466|76039129|FG000|STARTED|Overall Study||109||
59918689|NCT02676466|76039130|FG001|STARTED|Overall Study||71||
59918690|NCT02676466|76039131|FG002|STARTED|Overall Study||26||
59918691|NCT02676466|76039132|FG003|STARTED|Overall Study||17||
59918692|NCT02676466|76039133|FG004|STARTED|Overall Study||26||
59918693|NCT02676466|76039134|FG005|STARTED|Overall Study||13||
59918694|NCT02676466|76039135|FG006|STARTED|Overall Study||13||
59918695|NCT02676466|76039136|FG007|STARTED|Overall Study||14||
59918696|NCT02676466|76039129|FG000|COMPLETED|Overall Study||105|Recruitment was completed June 22, 2017 and follow-up completed June 22, 2018 in all cells.|
59918697|NCT02676466|76039130|FG001|COMPLETED|Overall Study||66|Recruitment was completed June 22, 2017 and follow-up completed June 22, 2018 in all cells.|
59918698|NCT02676466|76039131|FG002|COMPLETED|Overall Study||24|Recruitment was completed June 22, 2017 and follow-up completed June 22, 2018 in all cells.|
59918699|NCT02676466|76039132|FG003|COMPLETED|Overall Study||17|Recruitment was completed June 22, 2017 and follow-up completed June 22, 2018 in all cells.|
59918700|NCT02676466|76039133|FG004|COMPLETED|Overall Study||23|Recruitment was completed June 22, 2017 and follow-up completed June 22, 2018 in all cells.|
59918701|NCT02676466|76039134|FG005|COMPLETED|Overall Study||12|Recruitment was completed June 22, 2017 and follow-up completed June 22, 2018 in all cells.|
59918702|NCT02676466|76039135|FG006|COMPLETED|Overall Study||12|Recruitment was completed June 22, 2017 and follow-up completed June 22, 2018 in all cells.|
59918703|NCT02676466|76039136|FG007|COMPLETED|Overall Study||13|Recruitment was completed June 22, 2017 and follow-up completed June 22, 2018 in all cells.|
59918704|NCT02676466|76039129|FG000|NOT COMPLETED|Overall Study||4||
59918705|NCT02676466|76039130|FG001|NOT COMPLETED|Overall Study||5||
59918706|NCT02676466|76039131|FG002|NOT COMPLETED|Overall Study||2||
59918707|NCT02676466|76039132|FG003|NOT COMPLETED|Overall Study||0||
59918708|NCT02676466|76039133|FG004|NOT COMPLETED|Overall Study||3||
59918709|NCT02676466|76039134|FG005|NOT COMPLETED|Overall Study||1||
59918710|NCT02676466|76039135|FG006|NOT COMPLETED|Overall Study||1||
59510246|NCT02710630|75603725|FG000|NOT COMPLETED|Period 1||0||
59510247|NCT02710630|75603726|FG001|NOT COMPLETED|Period 1||0||
60040594|NCT01941537|76156377|FG001|NOT COMPLETED|Overall Study||3||
60040595|NCT01971567|76156386|FG000|STARTED|Overall Study||56||
60040596|NCT01971567|76156387|FG001|STARTED|Overall Study||51||
60040597|NCT01971567|76156386|FG000|COMPLETED|Overall Study||52||
60040598|NCT01971567|76156387|FG001|COMPLETED|Overall Study||49||
60040599|NCT01971567|76156386|FG000|NOT COMPLETED|Overall Study||4||
60040600|NCT01971567|76156387|FG001|NOT COMPLETED|Overall Study||2||
60040601|NCT01960413|76156395|FG000|STARTED|Overall Study||24||
60040602|NCT01960413|76156396|FG001|STARTED|Overall Study||22||
60040603|NCT01960413|76156395|FG000|COMPLETED|Overall Study||20||
60040604|NCT01960413|76156396|FG001|COMPLETED|Overall Study||21||
60040605|NCT01960413|76156395|FG000|NOT COMPLETED|Overall Study||4||
60040606|NCT01960413|76156396|FG001|NOT COMPLETED|Overall Study||1||
60040607|NCT01970475|76156404|FG000|STARTED|Overall Study||264||
60040608|NCT01970475|76156405|FG001|STARTED|Overall Study||262||
60040609|NCT01970475|76156404|FG000|COMPLETED|Overall Study||243||
60040610|NCT01970475|76156405|FG001|COMPLETED|Overall Study||251||
60040611|NCT01970475|76156404|FG000|NOT COMPLETED|Overall Study||21||
60040612|NCT01970475|76156405|FG001|NOT COMPLETED|Overall Study||11||
60040613|NCT01939977|76156413|FG000|STARTED|Overall Study||46||
60040614|NCT01939977|76156414|FG001|STARTED|Overall Study|48 patients randomized but 1 did not meet inclusion criteria. 47 patients analyzed.|48||
60040615|NCT01939977|76156413|FG000|COMPLETED|Overall Study||37||
60040616|NCT01939977|76156414|FG001|COMPLETED|Overall Study||41||
60040617|NCT01939977|76156413|FG000|NOT COMPLETED|Overall Study||9||
60040618|NCT01939977|76156414|FG001|NOT COMPLETED|Overall Study||7||
60040619|NCT01939899|76156425|FG000|STARTED|Lead-in Dose Finding Phase||3||
60040620|NCT01939899|76156426|FG001|STARTED|Lead-in Dose Finding Phase||7||
60040621|NCT01939899|76156427|FG002|STARTED|Lead-in Dose Finding Phase||6||
60040622|NCT01939899|76156428|FG003|STARTED|Lead-in Dose Finding Phase||0||
60040623|NCT01939899|76156429|FG004|STARTED|Lead-in Dose Finding Phase||0||
60040624|NCT01939899|76156425|FG000|COMPLETED|Lead-in Dose Finding Phase||1||
60040625|NCT01939899|76156426|FG001|COMPLETED|Lead-in Dose Finding Phase||0||
60040626|NCT01939899|76156427|FG002|COMPLETED|Lead-in Dose Finding Phase||1||
60040627|NCT01939899|76156428|FG003|COMPLETED|Lead-in Dose Finding Phase||0||
60040628|NCT01939899|76156429|FG004|COMPLETED|Lead-in Dose Finding Phase||0||
60040629|NCT01939899|76156425|FG000|NOT COMPLETED|Lead-in Dose Finding Phase||2||
60040630|NCT01939899|76156426|FG001|NOT COMPLETED|Lead-in Dose Finding Phase||7||
60040631|NCT01939899|76156427|FG002|NOT COMPLETED|Lead-in Dose Finding Phase||5||
60040632|NCT01939899|76156428|FG003|NOT COMPLETED|Lead-in Dose Finding Phase||0||
60040633|NCT01939899|76156429|FG004|NOT COMPLETED|Lead-in Dose Finding Phase||0||
60040634|NCT01939899|76156425|FG000|STARTED|Phase 2||0||
60040635|NCT01939899|76156426|FG001|STARTED|Phase 2||0||
60040636|NCT01939899|76156427|FG002|STARTED|Phase 2||0||
60040637|NCT01939899|76156428|FG003|STARTED|Phase 2||12||
60040638|NCT01939899|76156429|FG004|STARTED|Phase 2||1||
60040639|NCT01939899|76156425|FG000|COMPLETED|Phase 2||0||
60040640|NCT01939899|76156426|FG001|COMPLETED|Phase 2||0||
60040641|NCT01939899|76156427|FG002|COMPLETED|Phase 2||0||
60040642|NCT01939899|76156428|FG003|COMPLETED|Phase 2||1||
60040643|NCT01939899|76156429|FG004|COMPLETED|Phase 2||0||
60040644|NCT01939899|76156425|FG000|NOT COMPLETED|Phase 2||0||
60040645|NCT01939899|76156426|FG001|NOT COMPLETED|Phase 2||0||
60040646|NCT01939899|76156427|FG002|NOT COMPLETED|Phase 2||0||
60040647|NCT01939899|76156428|FG003|NOT COMPLETED|Phase 2||11||
60040648|NCT01939899|76156429|FG004|NOT COMPLETED|Phase 2||1||
60040649|NCT01970397|76156449|FG000|STARTED|Overall Study||69||
60040650|NCT01970397|76156450|FG001|STARTED|Overall Study||69||
60040651|NCT01970397|76156449|FG000|COMPLETED|Overall Study||67||
60040652|NCT01970397|76156450|FG001|COMPLETED|Overall Study||64||
60040653|NCT01970397|76156449|FG000|NOT COMPLETED|Overall Study||2||
60040654|NCT01970397|76156450|FG001|NOT COMPLETED|Overall Study||5||
60040655|NCT01970241|76156458|FG000|STARTED|Overall Study||46||
60040656|NCT01970241|76156459|FG001|STARTED|Overall Study||39||
59510248|NCT02710630|75603727|FG002|NOT COMPLETED|Period 1||0||
60040657|NCT01970241|76156458|FG000|COMPLETED|Overall Study||29||
60040658|NCT01970241|76156459|FG001|COMPLETED|Overall Study||31||
60040659|NCT01970241|76156458|FG000|NOT COMPLETED|Overall Study||17||
60040660|NCT01970241|76156459|FG001|NOT COMPLETED|Overall Study||8||
60040661|NCT01939353|76156467|FG000|STARTED|Placebo Run-in (1 Week)||45||
60040662|NCT01939353|76156467|FG000|COMPLETED|Placebo Run-in (1 Week)||41||
60040663|NCT01939353|76156467|FG000|NOT COMPLETED|Placebo Run-in (1 Week)||4||
59510249|NCT02710630|75603728|FG003|NOT COMPLETED|Period 1||0||
59510250|NCT02710630|75603729|FG004|NOT COMPLETED|Period 1||0||
60040664|NCT01939353|76156467|FG000|STARTED|CTN SR Treatment Phase (4 Weeks)||41||
59510251|NCT02710630|75603725|FG000|STARTED|Period 2||7||
60040665|NCT01939353|76156467|FG000|COMPLETED|CTN SR Treatment Phase (4 Weeks)||37||
60040666|NCT01939353|76156467|FG000|NOT COMPLETED|CTN SR Treatment Phase (4 Weeks)||4||
59510252|NCT02710630|75603726|FG001|STARTED|Period 2||7||
59510253|NCT02710630|75603727|FG002|STARTED|Period 2||7||
60040667|NCT01970007|76156471|FG000|STARTED|Overall Study||243||
60040668|NCT01970007|76156471|FG000|COMPLETED|Overall Study||188||
60040669|NCT01970007|76156471|FG000|NOT COMPLETED|Overall Study||55||
60040670|NCT01728376|76156481|FG000|STARTED|Overall Study||22||
59510254|NCT02710630|75603728|FG003|STARTED|Period 2||7||
59510255|NCT02710630|75603729|FG004|STARTED|Period 2||7||
59510256|NCT02710630|75603725|FG000|Not Treated|Period 2||1||
59918711|NCT02676466|76039136|FG007|NOT COMPLETED|Overall Study||1||
59918712|NCT03633695|76039160|FG000|STARTED|Overall Study||343||686
59918713|NCT03633695|76039161|FG001|STARTED|Overall Study||110||220
59918714|NCT03633695|76039160|FG000|Astigmatism Group 1 (IC-8™ IOL Group)|Overall Study||273||546
59918715|NCT03633695|76039161|FG001|Astigmatism Group 1 (IC-8™ IOL Group)|Overall Study||0||0
59918716|NCT03633695|76039160|FG000|Astigmatism Group 2 (IC-8™ IOL Group)|Overall Study||70||140
59918717|NCT03633695|76039161|FG001|Astigmatism Group 2 (IC-8™ IOL Group)|Overall Study||0||0
59918718|NCT03633695|76039160|FG000|Astigmatism Group 1 (Control Group)|Overall Study||0||0
59918719|NCT03633695|76039161|FG001|Astigmatism Group 1 (Control Group)|Overall Study||91||182
59918720|NCT03633695|76039160|FG000|Astigmatism Group 2 (Control Group)|Overall Study||0||0
59918721|NCT03633695|76039161|FG001|Astigmatism Group 2 (Control Group)|Overall Study||19||38
59918722|NCT03633695|76039160|FG000|COMPLETED|Overall Study||331||662
59918723|NCT03633695|76039161|FG001|COMPLETED|Overall Study||101||202
59918724|NCT03633695|76039160|FG000|NOT COMPLETED|Overall Study||12||24
59918725|NCT03633695|76039161|FG001|NOT COMPLETED|Overall Study||9||18
59918726|NCT03314233|76039183|FG000|STARTED|Overall Study|21 mothers provided informed consent for participation in the trial.|21||
59918727|NCT03314233|76039183|FG000|COMPLETED|Overall Study|20 mothers who had provided informed consent met eligibility criteria at time of delivery.|20||
59918728|NCT03314233|76039183|FG000|NOT COMPLETED|Overall Study||1||
59918729|NCT02675998|76039191|FG000|STARTED|8-Week Treatment Period||74||
59918730|NCT02675998|76039192|FG001|STARTED|8-Week Treatment Period||73||
59918731|NCT02675998|76039193|FG002|STARTED|8-Week Treatment Period||72||
59918732|NCT02675998|76039194|FG003|STARTED|8-Week Treatment Period||0||
59918733|NCT02675998|76039191|FG000|COMPLETED|8-Week Treatment Period||57||
59918734|NCT02675998|76039192|FG001|COMPLETED|8-Week Treatment Period||54||
59918735|NCT02675998|76039193|FG002|COMPLETED|8-Week Treatment Period||53||
59918736|NCT02675998|76039194|FG003|COMPLETED|8-Week Treatment Period||0||
59918737|NCT02675998|76039191|FG000|NOT COMPLETED|8-Week Treatment Period||17||
59918738|NCT02675998|76039192|FG001|NOT COMPLETED|8-Week Treatment Period||19||
59918739|NCT02675998|76039193|FG002|NOT COMPLETED|8-Week Treatment Period||19||
59918740|NCT02675998|76039194|FG003|NOT COMPLETED|8-Week Treatment Period||0||
59918741|NCT02675998|76039191|FG000|STARTED|4-Week Randomized Withdrawal Period||25|The number of patients in combined tenapanor groups is less since half were re-randomized to Placebo|
59918742|NCT02675998|76039192|FG001|STARTED|4-Week Randomized Withdrawal Period||23|The number of patients in combined tenapanor groups is less since half were re-randomized to Placebo|
59918743|NCT02675998|76039193|FG002|STARTED|4-Week Randomized Withdrawal Period||34|The number of patients in combined tenapanor groups is less since half were re-randomized to Placebo|
59918744|NCT02675998|76039194|FG003|STARTED|4-Week Randomized Withdrawal Period||82|The number of patients in combined tenapanor groups is less since half were re-randomized to Placebo|
59918745|NCT02675998|76039191|FG000|COMPLETED|4-Week Randomized Withdrawal Period||24||
59918746|NCT02675998|76039192|FG001|COMPLETED|4-Week Randomized Withdrawal Period||22||
59918747|NCT02675998|76039193|FG002|COMPLETED|4-Week Randomized Withdrawal Period||32||
59918748|NCT02675998|76039194|FG003|COMPLETED|4-Week Randomized Withdrawal Period||74||
59918749|NCT02675998|76039191|FG000|NOT COMPLETED|4-Week Randomized Withdrawal Period||1||
59918750|NCT02675998|76039192|FG001|NOT COMPLETED|4-Week Randomized Withdrawal Period||1||
59918751|NCT02675998|76039193|FG002|NOT COMPLETED|4-Week Randomized Withdrawal Period||2||
59918752|NCT02675998|76039194|FG003|NOT COMPLETED|4-Week Randomized Withdrawal Period||8||
59918753|NCT04588519|76039204|FG000|STARTED|Overall Study||8||
59918754|NCT04588519|76039204|FG000|COMPLETED|Overall Study||8||
59918755|NCT04588519|76039204|FG000|NOT COMPLETED|Overall Study||0||
59918756|NCT02674204|76039210|FG000|STARTED|Overall Study||1||
59918757|NCT02674204|76039211|FG001|STARTED|Overall Study||1||
59918758|NCT02674204|76039210|FG000|COMPLETED|Overall Study||0||
59918759|NCT02674204|76039211|FG001|COMPLETED|Overall Study||1||
59918760|NCT02674204|76039210|FG000|NOT COMPLETED|Overall Study||1||
59918761|NCT02674204|76039211|FG001|NOT COMPLETED|Overall Study||0||
59918762|NCT02941627|76039217|FG000|STARTED|Overall Study|Among 53 patients enrolled: 1 passed away after the informed consent completion, 1 was not implanted for surgical failure, and 1 for cholesteatoma discovered during surgical procedure. This last patient was included in safety analysis as defined in the protocol. Therefore, among 53 patients enrolled 51 were evaluated for safety outcomes, and 50 were successfully implanted and complete the study.|53||
59918763|NCT02941627|76039217|FG000|Clinical Safety on Overall Participants|Overall Study||51||
59918764|NCT02941627|76039217|FG000|Clinical Efficiency on English Speaking Participants|Overall Study|Among the 50 patients successfully implanted 33 English speaking participant complete speech performance measure.|33||
59918765|NCT02941627|76039217|FG000|COMPLETED|Overall Study||50||
59918766|NCT02941627|76039217|FG000|NOT COMPLETED|Overall Study||3||
59918767|NCT03521934|76039229|FG000|STARTED|Overall Study||608||
59918768|NCT03521934|76039230|FG001|STARTED|Overall Study||614||
59918769|NCT03521934|76039229|FG000|Randomized and Treated|Overall Study||605||
59510257|NCT02710630|75603726|FG001|Not Treated|Period 2||0||
59510258|NCT02710630|75603727|FG002|Not Treated|Period 2||0||
59510259|NCT02710630|75603728|FG003|Not Treated|Period 2||0||
59510260|NCT02710630|75603729|FG004|Not Treated|Period 2||0||
59759600|NCT02855060|75878988|FG000|NOT COMPLETED|Overall Study||2||
59759601|NCT02855060|75878989|FG001|NOT COMPLETED|Overall Study||5||
59759602|NCT01959464|75878997|FG000|STARTED|Overall Study||10||
59759603|NCT01959464|75878998|FG001|STARTED|Overall Study||10||
59759604|NCT01959464|75878997|FG000|COMPLETED|Overall Study||9||
59759605|NCT01959464|75878998|FG001|COMPLETED|Overall Study||10||
59759606|NCT01959464|75878997|FG000|NOT COMPLETED|Overall Study||1||
59759607|NCT01959464|75878998|FG001|NOT COMPLETED|Overall Study||0||
59759608|NCT00782288|75879007|FG000|STARTED|Overall Study||8||
59759609|NCT00782288|75879008|FG001|STARTED|Overall Study||8||
59918770|NCT03521934|76039230|FG001|Randomized and Treated|Overall Study||611||
59918771|NCT03521934|76039229|FG000|COMPLETED|Overall Study||0||
59918772|NCT03521934|76039230|FG001|COMPLETED|Overall Study||0||
59918773|NCT03521934|76039229|FG000|NOT COMPLETED|Overall Study||608||
59918774|NCT03521934|76039230|FG001|NOT COMPLETED|Overall Study||614||
59918775|NCT03434353|76039241|FG000|STARTED|Overall Study||30||
59918776|NCT03434353|76039242|FG001|STARTED|Overall Study||12||
59918777|NCT03434353|76039243|FG002|STARTED|Overall Study||30||
59918778|NCT03434353|76039244|FG003|STARTED|Overall Study||21||
59918779|NCT03434353|76039245|FG004|STARTED|Overall Study||30||
59918780|NCT03434353|76039241|FG000|COMPLETED|Overall Study||16||
59918781|NCT03434353|76039242|FG001|COMPLETED|Overall Study||9||
59918782|NCT03434353|76039243|FG002|COMPLETED|Overall Study||16||
59918783|NCT03434353|76039244|FG003|COMPLETED|Overall Study||18||
59918784|NCT03434353|76039245|FG004|COMPLETED|Overall Study||12||
59918785|NCT03434353|76039241|FG000|NOT COMPLETED|Overall Study||14||
59918786|NCT03434353|76039242|FG001|NOT COMPLETED|Overall Study||3||
59918787|NCT03434353|76039243|FG002|NOT COMPLETED|Overall Study||14||
59918788|NCT03434353|76039244|FG003|NOT COMPLETED|Overall Study||3||
59918789|NCT03434353|76039245|FG004|NOT COMPLETED|Overall Study||18||
59918790|NCT02914184|76039261|FG000|STARTED|Overall Study||400||
59918791|NCT02914184|76039262|FG001|STARTED|Overall Study||396||
59918792|NCT02914184|76039263|FG002|STARTED|Overall Study||402||
59918793|NCT02914184|76039264|FG003|STARTED|Overall Study||402||
59918794|NCT02914184|76039261|FG000|COMPLETED|Overall Study||386||
59918795|NCT02914184|76039262|FG001|COMPLETED|Overall Study||383||
59918796|NCT02914184|76039263|FG002|COMPLETED|Overall Study||385||
59918797|NCT02914184|76039264|FG003|COMPLETED|Overall Study||391||
59918798|NCT02914184|76039261|FG000|NOT COMPLETED|Overall Study||14||
59918799|NCT02914184|76039262|FG001|NOT COMPLETED|Overall Study||13||
59918800|NCT02914184|76039263|FG002|NOT COMPLETED|Overall Study||17||
59918801|NCT02914184|76039264|FG003|NOT COMPLETED|Overall Study||11||
59759610|NCT00782288|75879009|FG002|STARTED|Overall Study||8||
59759611|NCT00782288|75879007|FG000|COMPLETED|Overall Study||8||
59759612|NCT00782288|75879008|FG001|COMPLETED|Overall Study||8||
59759613|NCT00782288|75879009|FG002|COMPLETED|Overall Study||8||
59759614|NCT00782288|75879007|FG000|NOT COMPLETED|Overall Study||0||
59759615|NCT00782288|75879008|FG001|NOT COMPLETED|Overall Study||0||
59759616|NCT00782288|75879009|FG002|NOT COMPLETED|Overall Study||0||
59759617|NCT00600483|75879021|FG000|STARTED|Overall Study||753||
59759618|NCT00600483|75879022|FG001|STARTED|Overall Study||749||
59759619|NCT00600483|75879021|FG000|COMPLETED|Overall Study||717||
59759620|NCT00600483|75879022|FG001|COMPLETED|Overall Study||702||
59759621|NCT00600483|75879021|FG000|NOT COMPLETED|Overall Study||36||
59759622|NCT00600483|75879022|FG001|NOT COMPLETED|Overall Study||47||
59759623|NCT00600171|75879034|FG000|STARTED|Overall Study||102||
59759624|NCT00600171|75879035|FG001|STARTED|Overall Study||101||
59759625|NCT00600171|75879036|FG002|STARTED|Overall Study||101||
59759626|NCT00600171|75879037|FG003|STARTED|Overall Study||100||
59759627|NCT00600171|75879038|FG004|STARTED|Overall Study||101||
59759628|NCT00600171|75879039|FG005|STARTED|Overall Study||102||
59759629|NCT00600171|75879034|FG000|COMPLETED|Overall Study||86||
59759630|NCT00600171|75879035|FG001|COMPLETED|Overall Study||84||
59759631|NCT00600171|75879036|FG002|COMPLETED|Overall Study||91||
59759632|NCT00600171|75879037|FG003|COMPLETED|Overall Study||88||
59759633|NCT00600171|75879038|FG004|COMPLETED|Overall Study||93||
59759634|NCT00600171|75879039|FG005|COMPLETED|Overall Study||97||
59918802|NCT03633227|76039278|FG000|STARTED|Double Blind (DB), up to Week 48||12||
59918803|NCT03633227|76039279|FG001|STARTED|Double Blind (DB), up to Week 48||10||
59918804|NCT03633227|76039278|FG000|COMPLETED|Double Blind (DB), up to Week 48||4||
59918805|NCT03633227|76039279|FG001|COMPLETED|Double Blind (DB), up to Week 48||6||
59918806|NCT03633227|76039278|FG000|NOT COMPLETED|Double Blind (DB), up to Week 48||8||
59918807|NCT03633227|76039279|FG001|NOT COMPLETED|Double Blind (DB), up to Week 48||4||
59918808|NCT03633227|76039278|FG000|STARTED|DB Extension, Week 48 up to 3 Years||4||
59918809|NCT03633227|76039279|FG001|STARTED|DB Extension, Week 48 up to 3 Years||6||
59918810|NCT03633227|76039278|FG000|COMPLETED|DB Extension, Week 48 up to 3 Years||0||
59918811|NCT03633227|76039279|FG001|COMPLETED|DB Extension, Week 48 up to 3 Years||0||
59918812|NCT03633227|76039278|FG000|NOT COMPLETED|DB Extension, Week 48 up to 3 Years||4||
59918813|NCT03633227|76039279|FG001|NOT COMPLETED|DB Extension, Week 48 up to 3 Years||6||
59759635|NCT00600171|75879034|FG000|NOT COMPLETED|Overall Study||16||
59510261|NCT02710630|75603725|FG000|COMPLETED|Period 2||7||
59510262|NCT02710630|75603726|FG001|COMPLETED|Period 2||7||
59510263|NCT02710630|75603727|FG002|COMPLETED|Period 2||7||
59510264|NCT02710630|75603728|FG003|COMPLETED|Period 2||7||
59510265|NCT02710630|75603729|FG004|COMPLETED|Period 2||7||
59510266|NCT02710630|75603725|FG000|NOT COMPLETED|Period 2||0||
59510267|NCT02710630|75603726|FG001|NOT COMPLETED|Period 2||0||
59510268|NCT02710630|75603727|FG002|NOT COMPLETED|Period 2||0||
59510269|NCT02710630|75603728|FG003|NOT COMPLETED|Period 2||0||
59510270|NCT02710630|75603729|FG004|NOT COMPLETED|Period 2||0||
59510271|NCT02710630|75603725|FG000|STARTED|Period 3||7||
59510272|NCT02710630|75603726|FG001|STARTED|Period 3||7||
59510273|NCT02710630|75603727|FG002|STARTED|Period 3||7||
59510274|NCT02710630|75603728|FG003|STARTED|Period 3||7||
59510275|NCT02710630|75603729|FG004|STARTED|Period 3||7||
59510276|NCT02710630|75603725|FG000|COMPLETED|Period 3||7||
59510277|NCT02710630|75603726|FG001|COMPLETED|Period 3||7||
59510278|NCT02710630|75603727|FG002|COMPLETED|Period 3||7||
59510279|NCT02710630|75603728|FG003|COMPLETED|Period 3||7||
59510280|NCT02710630|75603729|FG004|COMPLETED|Period 3||7||
59510281|NCT02710630|75603725|FG000|NOT COMPLETED|Period 3||0||
59510282|NCT02710630|75603726|FG001|NOT COMPLETED|Period 3||0||
59510283|NCT02710630|75603727|FG002|NOT COMPLETED|Period 3||0||
59510284|NCT02710630|75603728|FG003|NOT COMPLETED|Period 3||0||
59510285|NCT02710630|75603729|FG004|NOT COMPLETED|Period 3||0||
59510286|NCT02710630|75603725|FG000|STARTED|Period 4||7||
59510287|NCT02710630|75603726|FG001|STARTED|Period 4||7||
59510288|NCT02710630|75603727|FG002|STARTED|Period 4||7||
59759636|NCT00600171|75879035|FG001|NOT COMPLETED|Overall Study||17||
59759637|NCT00600171|75879036|FG002|NOT COMPLETED|Overall Study||10||
59918814|NCT02913326|76039292|FG000|STARTED|Overall Study||60||
59918815|NCT02913326|76039293|FG001|STARTED|Overall Study||60||
59918816|NCT02913326|76039292|FG000|COMPLETED|Overall Study||59||
59918817|NCT02913326|76039293|FG001|COMPLETED|Overall Study||58||
59918818|NCT02913326|76039292|FG000|NOT COMPLETED|Overall Study||1||
59918819|NCT02913326|76039293|FG001|NOT COMPLETED|Overall Study||2||
59918820|NCT02912468|76039301|FG000|STARTED|Overall Study||133||
59918821|NCT02912468|76039302|FG001|STARTED|Overall Study||143||
59918822|NCT02912468|76039301|FG000|Treated|Overall Study||133||
59918823|NCT02912468|76039302|FG001|Treated|Overall Study||142||
59918824|NCT02912468|76039301|FG000|Safety Population|Overall Study||132|1 participant of placebo arm received 1 dose of dupilumab: counted in dupilumab for safety analysis.|
59918825|NCT02912468|76039302|FG001|Safety Population|Overall Study||143|1 participant of placebo arm received 1 dose of dupilumab: counted in dupilumab for safety analysis.|
59510289|NCT02710630|75603728|FG003|STARTED|Period 4||7||
59918826|NCT02912468|76039301|FG000|COMPLETED|Overall Study||124||
59918827|NCT02912468|76039302|FG001|COMPLETED|Overall Study||138||
59918828|NCT02912468|76039301|FG000|NOT COMPLETED|Overall Study||9||
59918829|NCT02912468|76039302|FG001|NOT COMPLETED|Overall Study||5||
59918830|NCT04438499|76039309|FG000|STARTED|Overall Study|31 participants represent the sensitivity analysis (intent to treat) population. Since there was a lack of efficacy in one participant which was determined to be due to anatomical factors (catheterization was unsuccessful), one additional participant was enrolled to meet the minimum requirement of 30 primary analysis population participants.|31|Sensitivity (Intent to Treat) Population|
59510290|NCT02710630|75603729|FG004|STARTED|Period 4||7||
59510291|NCT02710630|75603725|FG000|COMPLETED|Period 4||7||
59510292|NCT02710630|75603726|FG001|COMPLETED|Period 4||7||
59510293|NCT02710630|75603727|FG002|COMPLETED|Period 4||7||
59510294|NCT02710630|75603728|FG003|COMPLETED|Period 4||7||
59510295|NCT02710630|75603729|FG004|COMPLETED|Period 4||7||
59510296|NCT02710630|75603725|FG000|NOT COMPLETED|Period 4||0||
59510297|NCT02710630|75603726|FG001|NOT COMPLETED|Period 4||0||
59510298|NCT02710630|75603727|FG002|NOT COMPLETED|Period 4||0||
59918831|NCT04438499|76039309|FG000|COMPLETED|Overall Study|29 of 31 participants completed the study. One enrolled participant did not complete the study due to anatomical factors preventing catheterization and this participant was replaced to meet the minimum required 30 primary analysis population participants. A second enrolled participant did not complete the study due to a device deficiency and failure of the catheter during the procedure.|29||
59918832|NCT04438499|76039309|FG000|NOT COMPLETED|Overall Study||2||
59918833|NCT00002874|76039315|FG000|STARTED|Overall Study||421||
59918834|NCT00002874|76039316|FG001|STARTED|Overall Study||419||
59918835|NCT00002874|76039315|FG000|COMPLETED|Overall Study||376|Subjects with data available for the primary analysis are considered to have completed the study.|
59510299|NCT02710630|75603728|FG003|NOT COMPLETED|Period 4||0||
59510300|NCT02710630|75603729|FG004|NOT COMPLETED|Period 4||0||
59510301|NCT02710630|75603725|FG000|STARTED|Period 5||7||
59510302|NCT02710630|75603726|FG001|STARTED|Period 5||7||
59510303|NCT02710630|75603727|FG002|STARTED|Period 5||7||
59510304|NCT02710630|75603728|FG003|STARTED|Period 5||7||
60040671|NCT01728376|76156482|FG001|STARTED|Overall Study||11||
60040672|NCT01728376|76156483|FG002|STARTED|Overall Study||19||
60040673|NCT01728376|76156484|FG003|STARTED|Overall Study||9||
60040674|NCT01728376|76156485|FG004|STARTED|Overall Study||14||
60040675|NCT01728376|76156486|FG005|STARTED|Overall Study||7||
60040676|NCT01728376|76156481|FG000|Treated|Overall Study||22||
60040677|NCT01728376|76156482|FG001|Treated|Overall Study||10||
60040678|NCT01728376|76156483|FG002|Treated|Overall Study||19||
60040679|NCT01728376|76156484|FG003|Treated|Overall Study||9||
60040680|NCT01728376|76156485|FG004|Treated|Overall Study||14||
60040681|NCT01728376|76156486|FG005|Treated|Overall Study||7||
60040682|NCT01728376|76156481|FG000|COMPLETED|Overall Study||18||
60040683|NCT01728376|76156482|FG001|COMPLETED|Overall Study||9||
60040684|NCT01728376|76156483|FG002|COMPLETED|Overall Study||17||
60040685|NCT01728376|76156484|FG003|COMPLETED|Overall Study||7||
60040686|NCT01728376|76156485|FG004|COMPLETED|Overall Study||12||
60040687|NCT01728376|76156486|FG005|COMPLETED|Overall Study||5||
60040688|NCT01728376|76156481|FG000|NOT COMPLETED|Overall Study||4||
60040689|NCT01728376|76156482|FG001|NOT COMPLETED|Overall Study||2||
60040690|NCT01728376|76156483|FG002|NOT COMPLETED|Overall Study||2||
60040691|NCT01728376|76156484|FG003|NOT COMPLETED|Overall Study||2||
60040692|NCT01728376|76156485|FG004|NOT COMPLETED|Overall Study||2||
60040693|NCT01728376|76156486|FG005|NOT COMPLETED|Overall Study||2||
60040694|NCT01708174|76156503|FG000|STARTED|Treatment Period||2||
60040695|NCT01708174|76156504|FG001|STARTED|Treatment Period||16||
60040696|NCT01708174|76156505|FG002|STARTED|Treatment Period||4||
60040697|NCT01708174|76156503|FG000|Pharmacokinetic Analysis Set|Treatment Period||2||
60040698|NCT01708174|76156504|FG001|Pharmacokinetic Analysis Set|Treatment Period||13||
60040699|NCT01708174|76156505|FG002|Pharmacokinetic Analysis Set|Treatment Period||0||
60040700|NCT01708174|76156503|FG000|COMPLETED|Treatment Period||1||
60040701|NCT01708174|76156504|FG001|COMPLETED|Treatment Period||14||
60040702|NCT01708174|76156505|FG002|COMPLETED|Treatment Period||3||
60040703|NCT01708174|76156503|FG000|NOT COMPLETED|Treatment Period||1||
60040704|NCT01708174|76156504|FG001|NOT COMPLETED|Treatment Period||2||
60040705|NCT01708174|76156505|FG002|NOT COMPLETED|Treatment Period||1||
60040706|NCT01708174|76156503|FG000|STARTED|Survival Follow-up||1||
60040707|NCT01708174|76156504|FG001|STARTED|Survival Follow-up||10||
60040708|NCT01708174|76156505|FG002|STARTED|Survival Follow-up||0||
60040709|NCT01708174|76156503|FG000|COMPLETED|Survival Follow-up||1||
60040710|NCT01708174|76156504|FG001|COMPLETED|Survival Follow-up||10||
60040711|NCT01708174|76156505|FG002|COMPLETED|Survival Follow-up||0||
60040712|NCT01708174|76156503|FG000|NOT COMPLETED|Survival Follow-up||0||
60040713|NCT01708174|76156504|FG001|NOT COMPLETED|Survival Follow-up||0||
60040714|NCT01708174|76156505|FG002|NOT COMPLETED|Survival Follow-up||0||
60040715|NCT01605916|76156519|FG000|STARTED|Overall Study||4||
60040716|NCT01605916|76156520|FG001|STARTED|Overall Study||4||
60040717|NCT01605916|76156521|FG002|STARTED|Overall Study||4||
60040718|NCT01605916|76156522|FG003|STARTED|Overall Study||6||
60040719|NCT01605916|76156523|FG004|STARTED|Overall Study||7||
60040720|NCT01605916|76156519|FG000|COMPLETED|Overall Study||0||
60040721|NCT01605916|76156520|FG001|COMPLETED|Overall Study||0||
60040722|NCT01605916|76156521|FG002|COMPLETED|Overall Study|Subject ongoing the study at data cut off|1||
59510305|NCT02710630|75603729|FG004|STARTED|Period 5||7||
59510306|NCT02710630|75603725|FG000|COMPLETED|Period 5||7||
60040723|NCT01605916|76156522|FG003|COMPLETED|Overall Study||0||
60040724|NCT01605916|76156523|FG004|COMPLETED|Overall Study|Subject ongoing the study at data cut off|1||
60040725|NCT01605916|76156519|FG000|NOT COMPLETED|Overall Study||4||
60040726|NCT01605916|76156520|FG001|NOT COMPLETED|Overall Study||4||
60040727|NCT01605916|76156521|FG002|NOT COMPLETED|Overall Study||3||
60040728|NCT01605916|76156522|FG003|NOT COMPLETED|Overall Study||6||
60040729|NCT01605916|76156523|FG004|NOT COMPLETED|Overall Study||6||
60040730|NCT01635283|76156536|FG000|STARTED|Overall Study||5||
60040731|NCT01635283|76156536|FG000|COMPLETED|Overall Study||1||
60040732|NCT01635283|76156536|FG000|NOT COMPLETED|Overall Study||4||
60040733|NCT01707004|76156543|FG000|STARTED|Overall Study||20||
60040734|NCT01707004|76156543|FG000|COMPLETED|Overall Study|3 participants were not eligible to proceed to Bone Marrow Transplant due to significant infections.|17||
60040735|NCT01707004|76156543|FG000|NOT COMPLETED|Overall Study||3||
60040736|NCT01939197|76156555|FG000|STARTED|Overall Study||31||
59510307|NCT02710630|75603726|FG001|COMPLETED|Period 5||7||
59510308|NCT02710630|75603727|FG002|COMPLETED|Period 5||7||
59510309|NCT02710630|75603728|FG003|COMPLETED|Period 5||7||
60040737|NCT01939197|76156556|FG001|STARTED|Overall Study||32||
60040738|NCT01939197|76156557|FG002|STARTED|Overall Study||10||
60040739|NCT01939197|76156558|FG003|STARTED|Overall Study||12||
60040740|NCT01939197|76156559|FG004|STARTED|Overall Study||200||
60040741|NCT01939197|76156560|FG005|STARTED|Overall Study||5||
60040742|NCT01939197|76156561|FG006|STARTED|Overall Study||28||
60040743|NCT01939197|76156555|FG000|COMPLETED|Overall Study||30||
60040744|NCT01939197|76156556|FG001|COMPLETED|Overall Study||31||
60040745|NCT01939197|76156557|FG002|COMPLETED|Overall Study||10||
60040746|NCT01939197|76156558|FG003|COMPLETED|Overall Study||11||
60040747|NCT01939197|76156559|FG004|COMPLETED|Overall Study||196||
60040748|NCT01939197|76156560|FG005|COMPLETED|Overall Study||4||
60040749|NCT01939197|76156561|FG006|COMPLETED|Overall Study||26||
60040750|NCT01939197|76156555|FG000|NOT COMPLETED|Overall Study||1||
60040751|NCT01939197|76156556|FG001|NOT COMPLETED|Overall Study||1||
60040752|NCT01939197|76156557|FG002|NOT COMPLETED|Overall Study||0||
60040753|NCT01939197|76156558|FG003|NOT COMPLETED|Overall Study||1||
60040754|NCT01939197|76156559|FG004|NOT COMPLETED|Overall Study||4||
60040755|NCT01939197|76156560|FG005|NOT COMPLETED|Overall Study||1||
60040756|NCT01939197|76156561|FG006|NOT COMPLETED|Overall Study||2||
60040757|NCT01969851|76156594|FG000|STARTED|Overall Study||10||
60040758|NCT01969851|76156595|FG001|STARTED|Overall Study||24||
60040759|NCT01969851|76156596|FG002|STARTED|Overall Study||21||
60040760|NCT01969851|76156594|FG000|COMPLETED|Overall Study||9||
60040761|NCT01969851|76156595|FG001|COMPLETED|Overall Study||21||
60040762|NCT01969851|76156596|FG002|COMPLETED|Overall Study||14||
60040763|NCT01969851|76156594|FG000|NOT COMPLETED|Overall Study||1||
60040764|NCT01969851|76156595|FG001|NOT COMPLETED|Overall Study||3||
60040765|NCT01969851|76156596|FG002|NOT COMPLETED|Overall Study||7||
60040766|NCT01938573|76156604|FG000|STARTED|Overall Study||15||
60040767|NCT01938573|76156605|FG001|STARTED|Overall Study||6||
60040768|NCT01938573|76156604|FG000|COMPLETED|Overall Study||13||
60040769|NCT01938573|76156605|FG001|COMPLETED|Overall Study||6||
60040770|NCT01938573|76156604|FG000|NOT COMPLETED|Overall Study||2||
60040771|NCT01938573|76156605|FG001|NOT COMPLETED|Overall Study||0||
60040772|NCT01937871|76156613|FG000|STARTED|Overall Study||361||
59510310|NCT02710630|75603729|FG004|COMPLETED|Period 5||7||
59510311|NCT02710630|75603725|FG000|NOT COMPLETED|Period 5||0||
59510312|NCT02710630|75603726|FG001|NOT COMPLETED|Period 5||0||
59510313|NCT02710630|75603727|FG002|NOT COMPLETED|Period 5||0||
59918836|NCT00002874|76039316|FG001|COMPLETED|Overall Study||384|Subjects with data available for the primary analysis are considered to have completed the study.|
59918837|NCT00002874|76039315|FG000|NOT COMPLETED|Overall Study||45||
59918838|NCT00002874|76039316|FG001|NOT COMPLETED|Overall Study||35||
59918839|NCT03001076|76039324|FG000|STARTED|Overall Study||88||
59918840|NCT03001076|76039325|FG001|STARTED|Overall Study||181||
59918841|NCT03001076|76039324|FG000|COMPLETED|Overall Study||81||
59918842|NCT03001076|76039325|FG001|COMPLETED|Overall Study||176||
59918843|NCT03001076|76039324|FG000|NOT COMPLETED|Overall Study||7||
59918844|NCT03001076|76039325|FG001|NOT COMPLETED|Overall Study||5||
59918845|NCT03555305|76039331|FG000|STARTED|Period 1||29||
59918846|NCT03555305|76039332|FG001|STARTED|Period 1||29||
59918847|NCT03555305|76039331|FG000|Received at Least 1 Dose of Study Drug|Period 1||29||
59918848|NCT03555305|76039332|FG001|Received at Least 1 Dose of Study Drug|Period 1||29||
59918849|NCT03555305|76039331|FG000|COMPLETED|Period 1||29||
59918850|NCT03555305|76039332|FG001|COMPLETED|Period 1||27||
59918851|NCT03555305|76039331|FG000|NOT COMPLETED|Period 1||0||
59918852|NCT03555305|76039332|FG001|NOT COMPLETED|Period 1||2||
59918853|NCT03555305|76039331|FG000|STARTED|Period 2||29||
59918854|NCT03555305|76039332|FG001|STARTED|Period 2||27||
59918855|NCT03555305|76039331|FG000|COMPLETED|Period 2||29||
59918856|NCT03555305|76039332|FG001|COMPLETED|Period 2||27||
59918857|NCT03555305|76039331|FG000|NOT COMPLETED|Period 2||0||
59918858|NCT03555305|76039332|FG001|NOT COMPLETED|Period 2||0||
59918859|NCT03553823|76039340|FG000|STARTED|Overall Study||20||
59918860|NCT03553823|76039341|FG001|STARTED|Overall Study||20||
59918861|NCT03553823|76039340|FG000|COMPLETED|Overall Study||20||
60040773|NCT01937871|76156614|FG001|STARTED|Overall Study||363||
60040774|NCT01937871|76156615|FG002|STARTED|Overall Study||185||
60040775|NCT01937871|76156613|FG000|Received at Least One Dose of Study Drug|Overall Study||361||
60040776|NCT01937871|76156614|FG001|Received at Least One Dose of Study Drug|Overall Study||362||
60040777|NCT01937871|76156615|FG002|Received at Least One Dose of Study Drug|Overall Study||185||
60040778|NCT01937871|76156613|FG000|COMPLETED|Overall Study||337||
60040779|NCT01937871|76156614|FG001|COMPLETED|Overall Study||346||
60040780|NCT01937871|76156615|FG002|COMPLETED|Overall Study||174||
60040781|NCT01937871|76156613|FG000|NOT COMPLETED|Overall Study||24||
60040782|NCT01937871|76156614|FG001|NOT COMPLETED|Overall Study||17||
60040783|NCT01937871|76156615|FG002|NOT COMPLETED|Overall Study||11||
60040784|NCT01269463|76156626|FG000|STARTED|First Intervention||13||
60040785|NCT01269463|76156627|FG001|STARTED|First Intervention||13||
60040786|NCT01269463|76156626|FG000|COMPLETED|First Intervention||11||
60040787|NCT01269463|76156627|FG001|COMPLETED|First Intervention||11||
60040788|NCT01269463|76156626|FG000|NOT COMPLETED|First Intervention||2||
60040789|NCT01269463|76156627|FG001|NOT COMPLETED|First Intervention||2||
60040790|NCT01269463|76156626|FG000|STARTED|Second Intervention||11||
60040791|NCT01269463|76156627|FG001|STARTED|Second Intervention||11||
60040792|NCT01269463|76156626|FG000|COMPLETED|Second Intervention||11||
60040793|NCT01269463|76156627|FG001|COMPLETED|Second Intervention||11||
60040794|NCT01269463|76156626|FG000|NOT COMPLETED|Second Intervention||0||
60040795|NCT01269463|76156627|FG001|NOT COMPLETED|Second Intervention||0||
60040796|NCT01269463|76156626|FG000|STARTED|Third Intervention||11||
60040797|NCT01269463|76156627|FG001|STARTED|Third Intervention||11||
60040798|NCT01269463|76156626|FG000|COMPLETED|Third Intervention||11||
60040799|NCT01269463|76156627|FG001|COMPLETED|Third Intervention||11||
60040800|NCT01269463|76156626|FG000|NOT COMPLETED|Third Intervention||0||
60040801|NCT01269463|76156627|FG001|NOT COMPLETED|Third Intervention||0||
60040802|NCT02539459|76156634|FG000|STARTED|Overall Study||20||
60040803|NCT02539459|76156634|FG000|COMPLETED|Overall Study||18||
60040804|NCT02539459|76156634|FG000|NOT COMPLETED|Overall Study||2||
60040805|NCT01706926|76156642|FG000|STARTED|Overall Study||81||
60040806|NCT01706926|76156643|FG001|STARTED|Overall Study||81||
60040807|NCT01706926|76156644|FG002|STARTED|Overall Study||85||
60040808|NCT01706926|76156645|FG003|STARTED|Overall Study||79||
60040809|NCT01706926|76156642|FG000|COMPLETED|Overall Study||75||
60040810|NCT01706926|76156643|FG001|COMPLETED|Overall Study||77||
60040811|NCT01706926|76156644|FG002|COMPLETED|Overall Study||79||
60040812|NCT01706926|76156645|FG003|COMPLETED|Overall Study||74||
60040813|NCT01706926|76156642|FG000|NOT COMPLETED|Overall Study||6||
60040814|NCT01706926|76156643|FG001|NOT COMPLETED|Overall Study||4||
60040815|NCT01706926|76156644|FG002|NOT COMPLETED|Overall Study||6||
60040816|NCT01706926|76156645|FG003|NOT COMPLETED|Overall Study||5||
60040817|NCT01634113|76156661|FG000|STARTED|Overall Study||34||
60040818|NCT01634113|76156662|FG001|STARTED|Overall Study||36||
60040819|NCT01634113|76156663|FG002|STARTED|Overall Study||32||
60040820|NCT01634113|76156661|FG000|COMPLETED|Overall Study||34||
60040821|NCT01634113|76156662|FG001|COMPLETED|Overall Study||36||
60040822|NCT01634113|76156663|FG002|COMPLETED|Overall Study||31||
60040823|NCT01634113|76156661|FG000|NOT COMPLETED|Overall Study||0||
60040824|NCT01634113|76156662|FG001|NOT COMPLETED|Overall Study||0||
60040825|NCT01634113|76156663|FG002|NOT COMPLETED|Overall Study||1||
60040826|NCT01706770|76156673|FG000|STARTED|Overall Study||33||
60040827|NCT01706770|76156674|FG001|STARTED|Overall Study||17||
60040828|NCT01706770|76156673|FG000|COMPLETED|Overall Study||31||
60040829|NCT01706770|76156674|FG001|COMPLETED|Overall Study||17||
60040830|NCT01706770|76156673|FG000|NOT COMPLETED|Overall Study||2||
60040831|NCT01706770|76156674|FG001|NOT COMPLETED|Overall Study||0||
60040832|NCT01937715|76156685|FG000|STARTED|Overall Study||3||
60040833|NCT01937715|76156686|FG001|STARTED|Overall Study||4||
60040834|NCT01937715|76156687|FG002|STARTED|Overall Study||3||
60040835|NCT01937715|76156688|FG003|STARTED|Overall Study||5||
60040836|NCT01937715|76156689|FG004|STARTED|Overall Study||3||
60040837|NCT01937715|76156685|FG000|COMPLETED|Overall Study||3||
60040838|NCT01937715|76156686|FG001|COMPLETED|Overall Study||3||
60040839|NCT01937715|76156687|FG002|COMPLETED|Overall Study||3||
60040840|NCT01937715|76156688|FG003|COMPLETED|Overall Study||1||
60040841|NCT01937715|76156689|FG004|COMPLETED|Overall Study||1||
60040842|NCT01937715|76156685|FG000|NOT COMPLETED|Overall Study||0||
60040843|NCT01937715|76156686|FG001|NOT COMPLETED|Overall Study||1||
60040844|NCT01937715|76156687|FG002|NOT COMPLETED|Overall Study||0||
60040845|NCT01937715|76156688|FG003|NOT COMPLETED|Overall Study||4||
60040846|NCT01937715|76156689|FG004|NOT COMPLETED|Overall Study||2||
60040847|NCT01937559|76156704|FG000|STARTED|Overall Study||61||
60040848|NCT01937559|76156705|FG001|STARTED|Overall Study||61||
60040849|NCT01937559|76156706|FG002|STARTED|Overall Study||66||
60040850|NCT01937559|76156704|FG000|COMPLETED|Overall Study||50||
60040851|NCT01937559|76156705|FG001|COMPLETED|Overall Study||50||
60040852|NCT01937559|76156706|FG002|COMPLETED|Overall Study||66||
60040853|NCT01937559|76156704|FG000|NOT COMPLETED|Overall Study||11||
60040854|NCT01937559|76156705|FG001|NOT COMPLETED|Overall Study||11||
60040855|NCT01937559|76156706|FG002|NOT COMPLETED|Overall Study||0||
60040856|NCT01960257|76156718|FG000|STARTED|Stage 1 (1-3 Weeks)||77||
60040857|NCT01960257|76156719|FG001|STARTED|Stage 1 (1-3 Weeks)||0||
60040858|NCT01960257|76156720|FG002|STARTED|Stage 1 (1-3 Weeks)||0||
60040859|NCT01960257|76156718|FG000|COMPLETED|Stage 1 (1-3 Weeks)||61||
60040860|NCT01960257|76156719|FG001|COMPLETED|Stage 1 (1-3 Weeks)||0||
60040861|NCT01960257|76156720|FG002|COMPLETED|Stage 1 (1-3 Weeks)||0||
60040862|NCT01960257|76156718|FG000|NOT COMPLETED|Stage 1 (1-3 Weeks)||16||
60040863|NCT01960257|76156719|FG001|NOT COMPLETED|Stage 1 (1-3 Weeks)||0||
60040864|NCT01960257|76156720|FG002|NOT COMPLETED|Stage 1 (1-3 Weeks)||0||
60040865|NCT01960257|76156718|FG000|STARTED|Stage 2(1-4 Months, Not to Exceed 12wks)||0||
60040866|NCT01960257|76156719|FG001|STARTED|Stage 2(1-4 Months, Not to Exceed 12wks)||41||
60040867|NCT01960257|76156720|FG002|STARTED|Stage 2(1-4 Months, Not to Exceed 12wks)||20||
59918862|NCT03553823|76039341|FG001|COMPLETED|Overall Study||19||
59918863|NCT03553823|76039340|FG000|NOT COMPLETED|Overall Study||0||
59918864|NCT03553823|76039341|FG001|NOT COMPLETED|Overall Study||1||
60040868|NCT01960257|76156718|FG000|COMPLETED|Stage 2(1-4 Months, Not to Exceed 12wks)||0||
59510314|NCT02710630|75603728|FG003|NOT COMPLETED|Period 5||0||
59510315|NCT02710630|75603729|FG004|NOT COMPLETED|Period 5||0||
59510316|NCT02710630|75603725|FG000|STARTED|Period 6||7||
59510317|NCT02710630|75603726|FG001|STARTED|Period 6||7||
59510318|NCT02710630|75603727|FG002|STARTED|Period 6||7||
59510319|NCT02710630|75603728|FG003|STARTED|Period 6||7||
59510320|NCT02710630|75603729|FG004|STARTED|Period 6||7||
59510321|NCT02710630|75603725|FG000|COMPLETED|Period 6||7||
59510322|NCT02710630|75603726|FG001|COMPLETED|Period 6||7||
59918865|NCT03000686|76039349|FG000|STARTED|Part 1, Period 1 (1 Day)||5||
59918866|NCT03000686|76039350|FG001|STARTED|Part 1, Period 1 (1 Day)||6||
59918867|NCT03000686|76039351|FG002|STARTED|Part 1, Period 1 (1 Day)||0||
59918868|NCT03000686|76039352|FG003|STARTED|Part 1, Period 1 (1 Day)||0||
59918869|NCT03000686|76039349|FG000|COMPLETED|Part 1, Period 1 (1 Day)||5||
59918870|NCT03000686|76039350|FG001|COMPLETED|Part 1, Period 1 (1 Day)||5||
59918871|NCT03000686|76039351|FG002|COMPLETED|Part 1, Period 1 (1 Day)||0||
59918872|NCT03000686|76039352|FG003|COMPLETED|Part 1, Period 1 (1 Day)||0||
59918873|NCT03000686|76039349|FG000|NOT COMPLETED|Part 1, Period 1 (1 Day)||0||
59918874|NCT03000686|76039350|FG001|NOT COMPLETED|Part 1, Period 1 (1 Day)||1||
59918875|NCT03000686|76039351|FG002|NOT COMPLETED|Part 1, Period 1 (1 Day)||0||
59918876|NCT03000686|76039352|FG003|NOT COMPLETED|Part 1, Period 1 (1 Day)||0||
59918877|NCT03000686|76039349|FG000|STARTED|Part 1, Wash-out (Up to 14 Days)||5||
59918878|NCT03000686|76039350|FG001|STARTED|Part 1, Wash-out (Up to 14 Days)||5||
59918879|NCT03000686|76039351|FG002|STARTED|Part 1, Wash-out (Up to 14 Days)||0||
59918880|NCT03000686|76039352|FG003|STARTED|Part 1, Wash-out (Up to 14 Days)||0||
59918881|NCT03000686|76039349|FG000|COMPLETED|Part 1, Wash-out (Up to 14 Days)||5||
59918882|NCT03000686|76039350|FG001|COMPLETED|Part 1, Wash-out (Up to 14 Days)||5||
59918883|NCT03000686|76039351|FG002|COMPLETED|Part 1, Wash-out (Up to 14 Days)||0||
59918884|NCT03000686|76039352|FG003|COMPLETED|Part 1, Wash-out (Up to 14 Days)||0||
59918885|NCT03000686|76039349|FG000|NOT COMPLETED|Part 1, Wash-out (Up to 14 Days)||0||
59918886|NCT03000686|76039350|FG001|NOT COMPLETED|Part 1, Wash-out (Up to 14 Days)||0||
59918887|NCT03000686|76039351|FG002|NOT COMPLETED|Part 1, Wash-out (Up to 14 Days)||0||
59918888|NCT03000686|76039352|FG003|NOT COMPLETED|Part 1, Wash-out (Up to 14 Days)||0||
59918889|NCT03000686|76039349|FG000|STARTED|Part 1, Period 2 (1 Day)||5||
59918890|NCT03000686|76039350|FG001|STARTED|Part 1, Period 2 (1 Day)||5||
59918891|NCT03000686|76039351|FG002|STARTED|Part 1, Period 2 (1 Day)||0||
59918892|NCT03000686|76039352|FG003|STARTED|Part 1, Period 2 (1 Day)||0||
59918893|NCT03000686|76039349|FG000|COMPLETED|Part 1, Period 2 (1 Day)||5||
59918894|NCT03000686|76039350|FG001|COMPLETED|Part 1, Period 2 (1 Day)||5||
59918895|NCT03000686|76039351|FG002|COMPLETED|Part 1, Period 2 (1 Day)||0||
59918896|NCT03000686|76039352|FG003|COMPLETED|Part 1, Period 2 (1 Day)||0||
59918897|NCT03000686|76039349|FG000|NOT COMPLETED|Part 1, Period 2 (1 Day)||0||
59918898|NCT03000686|76039350|FG001|NOT COMPLETED|Part 1, Period 2 (1 Day)||0||
59918899|NCT03000686|76039351|FG002|NOT COMPLETED|Part 1, Period 2 (1 Day)||0||
59918900|NCT03000686|76039352|FG003|NOT COMPLETED|Part 1, Period 2 (1 Day)||0||
59918901|NCT03000686|76039349|FG000|STARTED|Part 2, Period 1 (1 Day)||0||
59918902|NCT03000686|76039350|FG001|STARTED|Part 2, Period 1 (1 Day)||0||
59918903|NCT03000686|76039351|FG002|STARTED|Part 2, Period 1 (1 Day)||3||
59918904|NCT03000686|76039352|FG003|STARTED|Part 2, Period 1 (1 Day)||3||
59918905|NCT03000686|76039349|FG000|COMPLETED|Part 2, Period 1 (1 Day)||0||
59918906|NCT03000686|76039350|FG001|COMPLETED|Part 2, Period 1 (1 Day)||0||
59918907|NCT03000686|76039351|FG002|COMPLETED|Part 2, Period 1 (1 Day)||3||
59918908|NCT03000686|76039352|FG003|COMPLETED|Part 2, Period 1 (1 Day)||3||
59918909|NCT03000686|76039349|FG000|NOT COMPLETED|Part 2, Period 1 (1 Day)||0||
59918910|NCT03000686|76039350|FG001|NOT COMPLETED|Part 2, Period 1 (1 Day)||0||
59918911|NCT03000686|76039351|FG002|NOT COMPLETED|Part 2, Period 1 (1 Day)||0||
59918912|NCT03000686|76039352|FG003|NOT COMPLETED|Part 2, Period 1 (1 Day)||0||
59918913|NCT03000686|76039349|FG000|STARTED|Part 2, Wash-out (Up to 14 Days)||0||
59918914|NCT03000686|76039350|FG001|STARTED|Part 2, Wash-out (Up to 14 Days)||0||
59918915|NCT03000686|76039351|FG002|STARTED|Part 2, Wash-out (Up to 14 Days)||3||
59918916|NCT03000686|76039352|FG003|STARTED|Part 2, Wash-out (Up to 14 Days)||3||
59918917|NCT03000686|76039349|FG000|COMPLETED|Part 2, Wash-out (Up to 14 Days)||0||
59918918|NCT03000686|76039350|FG001|COMPLETED|Part 2, Wash-out (Up to 14 Days)||0||
59510323|NCT02710630|75603727|FG002|COMPLETED|Period 6||7||
59510324|NCT02710630|75603728|FG003|COMPLETED|Period 6||7||
59918919|NCT03000686|76039351|FG002|COMPLETED|Part 2, Wash-out (Up to 14 Days)||3||
59918920|NCT03000686|76039352|FG003|COMPLETED|Part 2, Wash-out (Up to 14 Days)||3||
59918921|NCT03000686|76039349|FG000|NOT COMPLETED|Part 2, Wash-out (Up to 14 Days)||0||
59918922|NCT03000686|76039350|FG001|NOT COMPLETED|Part 2, Wash-out (Up to 14 Days)||0||
59918923|NCT03000686|76039351|FG002|NOT COMPLETED|Part 2, Wash-out (Up to 14 Days)||0||
59918924|NCT03000686|76039352|FG003|NOT COMPLETED|Part 2, Wash-out (Up to 14 Days)||0||
59510325|NCT02710630|75603729|FG004|COMPLETED|Period 6||7||
59510326|NCT02710630|75603725|FG000|NOT COMPLETED|Period 6||0||
60040869|NCT01960257|76156719|FG001|COMPLETED|Stage 2(1-4 Months, Not to Exceed 12wks)||41||
60040870|NCT01960257|76156720|FG002|COMPLETED|Stage 2(1-4 Months, Not to Exceed 12wks)||20||
60040871|NCT01960257|76156718|FG000|NOT COMPLETED|Stage 2(1-4 Months, Not to Exceed 12wks)||0||
60040872|NCT01960257|76156719|FG001|NOT COMPLETED|Stage 2(1-4 Months, Not to Exceed 12wks)||0||
60040873|NCT01960257|76156720|FG002|NOT COMPLETED|Stage 2(1-4 Months, Not to Exceed 12wks)||0||
60040874|NCT01918371|76156732|FG000|STARTED|Overall Study||166||
60040875|NCT01918371|76156733|FG001|STARTED|Overall Study||157||
60040876|NCT01918371|76156732|FG000|Participants With Complete Data|Overall Study||165||
60040877|NCT01918371|76156733|FG001|Participants With Complete Data|Overall Study||156||
60040878|NCT01918371|76156732|FG000|COMPLETED|Overall Study||165||
60040879|NCT01918371|76156733|FG001|COMPLETED|Overall Study||156||
60040880|NCT01918371|76156732|FG000|NOT COMPLETED|Overall Study||1||
60040881|NCT01918371|76156733|FG001|NOT COMPLETED|Overall Study||1||
60040882|NCT01917747|76156741|FG000|STARTED|Overall Study||60||
60040883|NCT01917747|76156742|FG001|STARTED|Overall Study||46||
60040884|NCT01917747|76156741|FG000|COMPLETED|Overall Study||41||
60040885|NCT01917747|76156742|FG001|COMPLETED|Overall Study||35||
60040886|NCT01917747|76156741|FG000|NOT COMPLETED|Overall Study||19||
60040887|NCT01917747|76156742|FG001|NOT COMPLETED|Overall Study||11||
60040888|NCT01597791|76156754|FG000|STARTED|Overall Study||28||
60040889|NCT01597791|76156755|FG001|STARTED|Overall Study||28||
60040890|NCT01597791|76156754|FG000|COMPLETED|Overall Study||20||
60040891|NCT01597791|76156755|FG001|COMPLETED|Overall Study||18||
60040892|NCT01597791|76156754|FG000|NOT COMPLETED|Overall Study||8||
60040893|NCT01597791|76156755|FG001|NOT COMPLETED|Overall Study||10||
60040894|NCT01916967|76156764|FG000|STARTED|Overall Study||80||
60040895|NCT01916967|76156765|FG001|STARTED|Overall Study||79||
60040896|NCT01916967|76156766|FG002|STARTED|Overall Study||80||
60040897|NCT01916967|76156764|FG000|COMPLETED|Overall Study||80||
60040898|NCT01916967|76156765|FG001|COMPLETED|Overall Study||78||
60040899|NCT01916967|76156766|FG002|COMPLETED|Overall Study||71||
60040900|NCT01916967|76156764|FG000|NOT COMPLETED|Overall Study||0||
60040901|NCT01916967|76156765|FG001|NOT COMPLETED|Overall Study||1||
60040902|NCT01916967|76156766|FG002|NOT COMPLETED|Overall Study||9||
60040903|NCT01936623|76156778|FG000|STARTED|Overall Study||40||
60040904|NCT01936623|76156779|FG001|STARTED|Overall Study||40||
60040905|NCT01936623|76156778|FG000|COMPLETED|Overall Study||40||
60040906|NCT01936623|76156779|FG001|COMPLETED|Overall Study||35||
60040907|NCT01936623|76156778|FG000|NOT COMPLETED|Overall Study||0||
60040908|NCT01936623|76156779|FG001|NOT COMPLETED|Overall Study||5||
60040909|NCT01959243|76156787|FG000|STARTED|Overall Study||337||
60040910|NCT01959243|76156788|FG001|STARTED|Overall Study||170||
60040911|NCT01959243|76156787|FG000|Received at Least 1 Dose of Study Drug|Overall Study||337||
60040912|NCT01959243|76156788|FG001|Received at Least 1 Dose of Study Drug|Overall Study||170||
60040913|NCT01959243|76156787|FG000|COMPLETED|Overall Study||324||
60040914|NCT01959243|76156788|FG001|COMPLETED|Overall Study||166||
60040915|NCT01959243|76156787|FG000|NOT COMPLETED|Overall Study||13||
60040916|NCT01959243|76156788|FG001|NOT COMPLETED|Overall Study||4||
60040917|NCT01959165|76156798|FG000|STARTED|Overall Study||13||
60040918|NCT01959165|76156799|FG001|STARTED|Overall Study|1 patient discontinued the study without any treatment out of 11 patients.|11||
60040919|NCT01959165|76156800|FG002|STARTED|Overall Study||12||
60040920|NCT01959165|76156801|FG003|STARTED|Overall Study||9||
60040921|NCT01959165|76156798|FG000|COMPLETED|Overall Study||12|completed patients number in double blind period|
60040922|NCT01959165|76156799|FG001|COMPLETED|Overall Study||10|completed patients number in double blind period|
60040923|NCT01959165|76156800|FG002|COMPLETED|Overall Study||12|completed patients number in double blind period|
60040924|NCT01959165|76156801|FG003|COMPLETED|Overall Study||7|completed patients number in double blind period|
60040925|NCT01959165|76156798|FG000|NOT COMPLETED|Overall Study||1||
60040926|NCT01959165|76156799|FG001|NOT COMPLETED|Overall Study||1||
60040927|NCT01959165|76156800|FG002|NOT COMPLETED|Overall Study||0||
60040928|NCT01959165|76156801|FG003|NOT COMPLETED|Overall Study||2||
60040929|NCT01916109|76156811|FG000|STARTED|Overall Study||4||
60040930|NCT01916109|76156811|FG000|COMPLETED|Overall Study||3||
60040931|NCT01916109|76156811|FG000|NOT COMPLETED|Overall Study||1||
60040932|NCT01915095|76156822|FG000|STARTED|Overall Study||10||
60040933|NCT01915095|76156823|FG001|STARTED|Overall Study||10||
60040934|NCT01915095|76156824|FG002|STARTED|Overall Study||5||
60040935|NCT01915095|76156825|FG003|STARTED|Overall Study||8||
60040936|NCT01915095|76156826|FG004|STARTED|Overall Study||9||
60040937|NCT01915095|76156822|FG000|SCI|Overall Study||5||
60040938|NCT01915095|76156823|FG001|SCI|Overall Study||5||
60040939|NCT01915095|76156824|FG002|SCI|Overall Study||5||
60040940|NCT01915095|76156825|FG003|SCI|Overall Study||8||
60040941|NCT01915095|76156826|FG004|SCI|Overall Study||9||
60040942|NCT01915095|76156822|FG000|Control|Overall Study||5||
60040943|NCT01915095|76156823|FG001|Control|Overall Study||5||
60040944|NCT01915095|76156824|FG002|Control|Overall Study||0||
60040945|NCT01915095|76156825|FG003|Control|Overall Study||0||
60040946|NCT01915095|76156826|FG004|Control|Overall Study||0||
60040947|NCT01915095|76156822|FG000|COMPLETED|Overall Study||10||
60040948|NCT01915095|76156823|FG001|COMPLETED|Overall Study||10||
60040949|NCT01915095|76156824|FG002|COMPLETED|Overall Study||5||
59510327|NCT02710630|75603726|FG001|NOT COMPLETED|Period 6||0||
59510328|NCT02710630|75603727|FG002|NOT COMPLETED|Period 6||0||
59510329|NCT02710630|75603728|FG003|NOT COMPLETED|Period 6||0||
59510330|NCT02710630|75603729|FG004|NOT COMPLETED|Period 6||0||
59510331|NCT02715076|75603749|FG000|STARTED|Overall Study||48||
59510332|NCT02715076|75603750|FG001|STARTED|Overall Study||50||
59612376|NCT01701258|75723510|FG011|Returned for EEG (Session 4)|Assessment and Scheduling||0|66/96 completed the EEG. Participants did at least two sessions after the screening visit.|
59612377|NCT01701258|75723511|FG012|Returned for EEG (Session 4)|Assessment and Scheduling||0|66/96 completed the EEG. Participants did at least two sessions after the screening visit.|
59759638|NCT00600171|75879037|FG003|NOT COMPLETED|Overall Study||12||
59510333|NCT02715076|75603751|FG002|STARTED|Overall Study||49||
59510334|NCT02715076|75603752|FG003|STARTED|Overall Study||50||
59510335|NCT02715076|75603753|FG004|STARTED|Overall Study||47||
59510336|NCT02715076|75603754|FG005|STARTED|Overall Study||48||
59612378|NCT01701258|75723499|FG000|COMPLETED|Assessment and Scheduling||70|Participants completed the study if they completed the screening session and two imaging sessions.|
59612379|NCT01701258|75723500|FG001|COMPLETED|Assessment and Scheduling||0|Participants completed the study if they completed the screening session and two imaging sessions.|
59759639|NCT00600171|75879038|FG004|NOT COMPLETED|Overall Study||8||
59759640|NCT00600171|75879039|FG005|NOT COMPLETED|Overall Study||5||
59759641|NCT04035668|75879058|FG000|STARTED|Overall Study||24||
59759642|NCT04035668|75879059|FG001|STARTED|Overall Study||25||
59759643|NCT04035668|75879060|FG002|STARTED|Overall Study||24||
59759644|NCT04035668|75879058|FG000|COMPLETED|Overall Study||17||
59759645|NCT04035668|75879059|FG001|COMPLETED|Overall Study||17||
59759646|NCT04035668|75879060|FG002|COMPLETED|Overall Study||21||
59759647|NCT04035668|75879058|FG000|NOT COMPLETED|Overall Study||7||
59759648|NCT04035668|75879059|FG001|NOT COMPLETED|Overall Study||8||
59759649|NCT04035668|75879060|FG002|NOT COMPLETED|Overall Study||3||
59759650|NCT00605150|75879074|FG000|STARTED|Overall Study|11 started|11||
59759651|NCT00605150|75879074|FG000|COMPLETED|Overall Study||10||
59759652|NCT00605150|75879074|FG000|NOT COMPLETED|Overall Study||1||
59759653|NCT00885495|75879080|FG000|STARTED|Overall Study||8||
59759654|NCT00885495|75879081|FG001|STARTED|Overall Study||9||
59759655|NCT00885495|75879080|FG000|COMPLETED|Overall Study||6||
59759656|NCT00885495|75879081|FG001|COMPLETED|Overall Study||6||
59759657|NCT00885495|75879080|FG000|NOT COMPLETED|Overall Study||2||
59759658|NCT00885495|75879081|FG001|NOT COMPLETED|Overall Study||3||
59759659|NCT00885105|75879094|FG000|STARTED|Overall Study||112||
59759660|NCT00885105|75879095|FG001|STARTED|Overall Study||130||
59759661|NCT00885105|75879094|FG000|COMPLETED|Overall Study||111||
59759662|NCT00885105|75879095|FG001|COMPLETED|Overall Study||120||
59759663|NCT00885105|75879094|FG000|NOT COMPLETED|Overall Study||1||
59759664|NCT00885105|75879095|FG001|NOT COMPLETED|Overall Study||10||
59759665|NCT03945188|75879103|FG000|STARTED|Overall Study||289||
59759666|NCT03945188|75879104|FG001|STARTED|Overall Study||144||
59759667|NCT03945188|75879103|FG000|COMPLETED|Overall Study||161||
59759668|NCT03945188|75879104|FG001|COMPLETED|Overall Study||46||
59759669|NCT03945188|75879103|FG000|NOT COMPLETED|Overall Study||128||
59759670|NCT03945188|75879104|FG001|NOT COMPLETED|Overall Study||98||
59759671|NCT00884949|75879110|FG000|STARTED|Weeks 1-12: 0.1 mg/kg/Week||20||
59759672|NCT00884949|75879110|FG000|COMPLETED|Weeks 1-12: 0.1 mg/kg/Week||18||
59759673|NCT00884949|75879110|FG000|NOT COMPLETED|Weeks 1-12: 0.1 mg/kg/Week||2||
59759674|NCT00884949|75879110|FG000|STARTED|Weeks 13-24: 1.0 mg/kg/Week||18||
59759675|NCT00884949|75879110|FG000|COMPLETED|Weeks 13-24: 1.0 mg/kg/Week||18||
59759676|NCT00884949|75879110|FG000|NOT COMPLETED|Weeks 13-24: 1.0 mg/kg/Week||0||
59759677|NCT00884949|75879110|FG000|STARTED|Weeks 25-36: 2.0 mg/kg/Week||18||
59759678|NCT00884949|75879110|FG000|COMPLETED|Weeks 25-36: 2.0 mg/kg/Week||18||
59759679|NCT00884949|75879110|FG000|NOT COMPLETED|Weeks 25-36: 2.0 mg/kg/Week||0||
59759680|NCT00884949|75879110|FG000|STARTED|Continuation Period||18||
59759681|NCT00884949|75879110|FG000|COMPLETED|Continuation Period||18||
59759682|NCT00884949|75879110|FG000|NOT COMPLETED|Continuation Period||0||
59759683|NCT00884793|75879123|FG000|STARTED|Overall Study||8||
59759684|NCT00884793|75879123|FG000|COMPLETED|Overall Study||7||
59759685|NCT00884793|75879123|FG000|NOT COMPLETED|Overall Study||1||
59759686|NCT00884325|75879129|FG000|STARTED|Overall Study||20||
59759687|NCT00884325|75879130|FG001|STARTED|Overall Study||20||
59759688|NCT00884325|75879129|FG000|COMPLETED|Overall Study||17||
59759689|NCT00884325|75879130|FG001|COMPLETED|Overall Study||16||
59759690|NCT00884325|75879129|FG000|NOT COMPLETED|Overall Study||3||
59759691|NCT00884325|75879130|FG001|NOT COMPLETED|Overall Study||4||
59759692|NCT00883779|75879138|FG000|STARTED|Primary Study Treatment Phase||225||
59759693|NCT00883779|75879139|FG001|STARTED|Primary Study Treatment Phase||226||
59510337|NCT02715076|75603749|FG000|COMPLETED|Overall Study||48||
59759694|NCT00883779|75879138|FG000|COMPLETED|Primary Study Treatment Phase||120||
59759695|NCT00883779|75879139|FG001|COMPLETED|Primary Study Treatment Phase||140||
59759696|NCT00883779|75879138|FG000|NOT COMPLETED|Primary Study Treatment Phase||105||
59759697|NCT00883779|75879139|FG001|NOT COMPLETED|Primary Study Treatment Phase||86||
59759698|NCT00883779|75879138|FG000|STARTED|Post-Study Treatment Phase||112||
59759699|NCT00883779|75879139|FG001|STARTED|Post-Study Treatment Phase||135||
59759700|NCT00883779|75879138|FG000|COMPLETED|Post-Study Treatment Phase||0||
60040950|NCT01915095|76156825|FG003|COMPLETED|Overall Study||4||
60040951|NCT01915095|76156826|FG004|COMPLETED|Overall Study||3||
60040952|NCT01915095|76156822|FG000|NOT COMPLETED|Overall Study||0||
60040953|NCT01915095|76156823|FG001|NOT COMPLETED|Overall Study||0||
60040954|NCT01915095|76156824|FG002|NOT COMPLETED|Overall Study||0||
60040955|NCT01915095|76156825|FG003|NOT COMPLETED|Overall Study||4||
60040956|NCT01915095|76156826|FG004|NOT COMPLETED|Overall Study||6||
60040957|NCT01958619|76156851|FG000|STARTED|Overall Study||15||
60040958|NCT01958619|76156852|FG001|STARTED|Overall Study||14||
60040959|NCT01958619|76156853|FG002|STARTED|Overall Study||14||
60040960|NCT01958619|76156854|FG003|STARTED|Overall Study||12||
60040961|NCT01958619|76156851|FG000|COMPLETED|Overall Study||13||
60040962|NCT01958619|76156852|FG001|COMPLETED|Overall Study||14||
60040963|NCT01958619|76156853|FG002|COMPLETED|Overall Study||13||
60040964|NCT01958619|76156854|FG003|COMPLETED|Overall Study||12||
60040965|NCT01958619|76156851|FG000|NOT COMPLETED|Overall Study||2||
59510338|NCT02715076|75603750|FG001|COMPLETED|Overall Study||50||
59510339|NCT02715076|75603751|FG002|COMPLETED|Overall Study||49||
59510340|NCT02715076|75603752|FG003|COMPLETED|Overall Study||50||
59510341|NCT02715076|75603753|FG004|COMPLETED|Overall Study||47||
59918925|NCT03000686|76039349|FG000|STARTED|Part 2, Period 2 (1 Day)||0||
59918926|NCT03000686|76039350|FG001|STARTED|Part 2, Period 2 (1 Day)||0||
59918927|NCT03000686|76039351|FG002|STARTED|Part 2, Period 2 (1 Day)||3||
60040966|NCT01958619|76156852|FG001|NOT COMPLETED|Overall Study||0||
60040967|NCT01958619|76156853|FG002|NOT COMPLETED|Overall Study||1||
60040968|NCT01958619|76156854|FG003|NOT COMPLETED|Overall Study||0||
60040969|NCT01752634|76156870|FG000|STARTED|Up to Week 24 (Primary Analysis)||99||
60040970|NCT01752634|76156871|FG001|STARTED|Up to Week 24 (Primary Analysis)||100||
60040971|NCT01752634|76156872|FG002|STARTED|Up to Week 24 (Primary Analysis)||100||
60040972|NCT01752634|76156873|FG003|STARTED|Up to Week 24 (Primary Analysis)||43||
60040973|NCT01752634|76156874|FG004|STARTED|Up to Week 24 (Primary Analysis)||45||
59918928|NCT03000686|76039352|FG003|STARTED|Part 2, Period 2 (1 Day)||3||
59918929|NCT03000686|76039349|FG000|COMPLETED|Part 2, Period 2 (1 Day)||0||
59918930|NCT03000686|76039350|FG001|COMPLETED|Part 2, Period 2 (1 Day)||0||
59918931|NCT03000686|76039351|FG002|COMPLETED|Part 2, Period 2 (1 Day)||3||
59918932|NCT03000686|76039352|FG003|COMPLETED|Part 2, Period 2 (1 Day)||3||
59918933|NCT03000686|76039349|FG000|NOT COMPLETED|Part 2, Period 2 (1 Day)||0||
59918934|NCT03000686|76039350|FG001|NOT COMPLETED|Part 2, Period 2 (1 Day)||0||
59918935|NCT03000686|76039351|FG002|NOT COMPLETED|Part 2, Period 2 (1 Day)||0||
59918936|NCT03000686|76039352|FG003|NOT COMPLETED|Part 2, Period 2 (1 Day)||0||
59918937|NCT04701138|76039364|FG000|STARTED|Overall Study||24||
59918938|NCT04701138|76039364|FG000|COMPLETED|Overall Study||23||
59918939|NCT04701138|76039364|FG000|NOT COMPLETED|Overall Study||1||
59918940|NCT02493660|76039370|FG000|STARTED|Overall Study|ITT|93||
59918941|NCT02493660|76039371|FG001|STARTED|Overall Study|ITT|91||
59918942|NCT02493660|76039370|FG000|COMPLETED|Overall Study||83||
59918943|NCT02493660|76039371|FG001|COMPLETED|Overall Study|Investigator requested subject be discontinued prior to any post-procedure efficacy assessments.|79||
59918944|NCT02493660|76039370|FG000|NOT COMPLETED|Overall Study||10||
59918945|NCT02493660|76039371|FG001|NOT COMPLETED|Overall Study||12||
59918946|NCT03552029|76039381|FG000|STARTED|Overall Study||4||
59918947|NCT03552029|76039382|FG001|STARTED|Overall Study||6||
59918948|NCT03552029|76039381|FG000|COMPLETED|Overall Study||0||
59918949|NCT03552029|76039382|FG001|COMPLETED|Overall Study||0||
59918950|NCT03552029|76039381|FG000|NOT COMPLETED|Overall Study||4||
59918951|NCT03552029|76039382|FG001|NOT COMPLETED|Overall Study||6||
59918952|NCT05395104|76039388|FG000|STARTED|Overall Study||14||
59918953|NCT05395104|76039388|FG000|Received At Least 1 Dose Of Study Drug|Overall Study||14|Safety Analysis Population|
59918954|NCT05395104|76039388|FG000|COMPLETED|Overall Study||12||
59918955|NCT05395104|76039388|FG000|NOT COMPLETED|Overall Study||2||
59918956|NCT05327491|76039394|FG000|STARTED|Periods 1 & 2||73||
60040974|NCT01752634|76156875|FG005|STARTED|Up to Week 24 (Primary Analysis)||10||
60040975|NCT01752634|76156870|FG000|COMPLETED|Up to Week 24 (Primary Analysis)||93||
60040976|NCT01752634|76156871|FG001|COMPLETED|Up to Week 24 (Primary Analysis)||95||
60040977|NCT01752634|76156872|FG002|COMPLETED|Up to Week 24 (Primary Analysis)||97||
60040978|NCT01752634|76156873|FG003|COMPLETED|Up to Week 24 (Primary Analysis)||43||
60040979|NCT01752634|76156874|FG004|COMPLETED|Up to Week 24 (Primary Analysis)||45||
60040980|NCT01752634|76156875|FG005|COMPLETED|Up to Week 24 (Primary Analysis)||0||
60040981|NCT01752634|76156870|FG000|NOT COMPLETED|Up to Week 24 (Primary Analysis)||6||
59510342|NCT02715076|75603754|FG005|COMPLETED|Overall Study||48||
59510343|NCT02715076|75603749|FG000|NOT COMPLETED|Overall Study||0||
59510344|NCT02715076|75603750|FG001|NOT COMPLETED|Overall Study||0||
59510345|NCT02715076|75603751|FG002|NOT COMPLETED|Overall Study||0||
59510346|NCT02715076|75603752|FG003|NOT COMPLETED|Overall Study||0||
59510347|NCT02715076|75603753|FG004|NOT COMPLETED|Overall Study||0||
59510348|NCT02715076|75603754|FG005|NOT COMPLETED|Overall Study||0||
59918957|NCT05327491|76039395|FG001|STARTED|Periods 1 & 2||73||
59918958|NCT05327491|76039396|FG002|STARTED|Periods 1 & 2||0||
59918959|NCT05327491|76039397|FG003|STARTED|Periods 1 & 2||0||
59918960|NCT05327491|76039394|FG000|Received at Least 1 Dose|Periods 1 & 2||73||
59918961|NCT05327491|76039395|FG001|Received at Least 1 Dose|Periods 1 & 2||73||
60040982|NCT01752634|76156871|FG001|NOT COMPLETED|Up to Week 24 (Primary Analysis)||5||
60040983|NCT01752634|76156872|FG002|NOT COMPLETED|Up to Week 24 (Primary Analysis)||3||
60040984|NCT01752634|76156873|FG003|NOT COMPLETED|Up to Week 24 (Primary Analysis)||0||
60040985|NCT01752634|76156874|FG004|NOT COMPLETED|Up to Week 24 (Primary Analysis)||0||
60040986|NCT01752634|76156875|FG005|NOT COMPLETED|Up to Week 24 (Primary Analysis)||10||
60040987|NCT01752634|76156870|FG000|STARTED|Week 24 to Week 260||93||
60040988|NCT01752634|76156871|FG001|STARTED|Week 24 to Week 260||95||
60040989|NCT01752634|76156872|FG002|STARTED|Week 24 to Week 260||97||
60040990|NCT01752634|76156873|FG003|STARTED|Week 24 to Week 260||43||
60040991|NCT01752634|76156874|FG004|STARTED|Week 24 to Week 260||45||
60040992|NCT01752634|76156875|FG005|STARTED|Week 24 to Week 260||0||
60040993|NCT01752634|76156870|FG000|COMPLETED|Week 24 to Week 260||59||
60040994|NCT01752634|76156871|FG001|COMPLETED|Week 24 to Week 260||65||
60040995|NCT01752634|76156872|FG002|COMPLETED|Week 24 to Week 260||64||
60040996|NCT01752634|76156873|FG003|COMPLETED|Week 24 to Week 260||29||
60040997|NCT01752634|76156874|FG004|COMPLETED|Week 24 to Week 260||31||
59759701|NCT00883779|75879139|FG001|COMPLETED|Post-Study Treatment Phase||0||
59759702|NCT00883779|75879138|FG000|NOT COMPLETED|Post-Study Treatment Phase||112||
59759703|NCT00883779|75879139|FG001|NOT COMPLETED|Post-Study Treatment Phase||135||
59759704|NCT00883779|75879138|FG000|STARTED|Off-study Phase||209||
59759705|NCT00883779|75879139|FG001|STARTED|Off-study Phase||202||
59759706|NCT00883779|75879138|FG000|COMPLETED|Off-study Phase||0||
59759707|NCT00883779|75879139|FG001|COMPLETED|Off-study Phase||0||
59759708|NCT00883779|75879138|FG000|NOT COMPLETED|Off-study Phase||209||
59759709|NCT00883779|75879139|FG001|NOT COMPLETED|Off-study Phase||202||
59759710|NCT04159701|75879147|FG000|STARTED|Period 1: Treatment Period||39||
59759711|NCT04159701|75879148|FG001|STARTED|Period 1: Treatment Period||13||
59759712|NCT04159701|75879147|FG000|Received at Least One Dose of Study Drug|Period 1: Treatment Period||39||
59759713|NCT04159701|75879148|FG001|Received at Least One Dose of Study Drug|Period 1: Treatment Period||13||
59759714|NCT04159701|75879147|FG000|COMPLETED|Period 1: Treatment Period||31||
59510349|NCT00873457|75603768|FG000|STARTED|Overall Study||16||
59510350|NCT00873457|75603768|FG000|COMPLETED|Overall Study||16||
59510351|NCT00873457|75603768|FG000|NOT COMPLETED|Overall Study||0||
60040998|NCT01752634|76156875|FG005|COMPLETED|Week 24 to Week 260||0||
60040999|NCT01752634|76156870|FG000|NOT COMPLETED|Week 24 to Week 260||34||
59510352|NCT02715700|75603772|FG000|STARTED|Overall Study||14||
59510353|NCT02715700|75603772|FG000|COMPLETED|Overall Study||14||
59510354|NCT02715700|75603772|FG000|NOT COMPLETED|Overall Study||0||
59510355|NCT00875329|75603780|FG000|STARTED|Overall Study||97||
59510356|NCT00875329|75603780|FG000|COMPLETED|Overall Study||97||
59510357|NCT00875329|75603780|FG000|NOT COMPLETED|Overall Study||0||
59510358|NCT02716324|75603786|FG000|STARTED|Overall Study||149||
59510359|NCT02716324|75603787|FG001|STARTED|Overall Study||154||
59510360|NCT02716324|75603786|FG000|COMPLETED|Overall Study||130||
59510361|NCT02716324|75603787|FG001|COMPLETED|Overall Study||143||
59510362|NCT02716324|75603786|FG000|NOT COMPLETED|Overall Study||19||
59510363|NCT02716324|75603787|FG001|NOT COMPLETED|Overall Study||11||
59510364|NCT00875641|75603796|FG000|STARTED|Overall Study||57931||
59510365|NCT00875641|75603797|FG001|STARTED|Overall Study||173384||
59510366|NCT00875641|75603798|FG002|STARTED|Overall Study||159344||
59510367|NCT00875641|75603796|FG000|COMPLETED|Overall Study||57931||
59510368|NCT00875641|75603797|FG001|COMPLETED|Overall Study||173384||
59510369|NCT00875641|75603798|FG002|COMPLETED|Overall Study||159344||
59510370|NCT00875641|75603796|FG000|NOT COMPLETED|Overall Study||0||
59510371|NCT00875641|75603797|FG001|NOT COMPLETED|Overall Study||0||
59510372|NCT00875641|75603798|FG002|NOT COMPLETED|Overall Study||0||
59510373|NCT00895921|75603808|FG000|STARTED|Overall Study||15||
59759715|NCT04159701|75879148|FG001|COMPLETED|Period 1: Treatment Period||12||
59759716|NCT04159701|75879147|FG000|NOT COMPLETED|Period 1: Treatment Period||8||
59759717|NCT04159701|75879148|FG001|NOT COMPLETED|Period 1: Treatment Period||1||
59759718|NCT04159701|75879147|FG000|STARTED|Washout Period||31||
59510374|NCT00895921|75603809|FG001|STARTED|Overall Study||15||
59510375|NCT00895921|75603808|FG000|COMPLETED|Overall Study||15||
59510376|NCT00895921|75603809|FG001|COMPLETED|Overall Study||15||
59759719|NCT04159701|75879148|FG001|STARTED|Washout Period||12||
59759720|NCT04159701|75879147|FG000|COMPLETED|Washout Period||18||
59759721|NCT04159701|75879148|FG001|COMPLETED|Washout Period||8||
60041000|NCT01752634|76156871|FG001|NOT COMPLETED|Week 24 to Week 260||30||
60041001|NCT01752634|76156872|FG002|NOT COMPLETED|Week 24 to Week 260||33||
60041002|NCT01752634|76156873|FG003|NOT COMPLETED|Week 24 to Week 260||14||
60041003|NCT01752634|76156874|FG004|NOT COMPLETED|Week 24 to Week 260||14||
60041004|NCT01752634|76156875|FG005|NOT COMPLETED|Week 24 to Week 260||0||
60041005|NCT01726270|76156885|FG000|STARTED|Part 1, Self-Selection Phase||689||
60041006|NCT01726270|76156885|FG000|COMPLETED|Part 1, Self-Selection Phase||679||
59510377|NCT00895921|75603808|FG000|NOT COMPLETED|Overall Study||0||
59510378|NCT00895921|75603809|FG001|NOT COMPLETED|Overall Study||0||
59510379|NCT02716714|75603817|FG000|STARTED|Overall Study||67||
59510380|NCT02716714|75603818|FG001|STARTED|Overall Study||10||
59510381|NCT02716714|75603817|FG000|COMPLETED|Overall Study||55||
59510382|NCT02716714|75603818|FG001|COMPLETED|Overall Study||8||
59510383|NCT02716714|75603817|FG000|NOT COMPLETED|Overall Study||12||
60041007|NCT01726270|76156885|FG000|NOT COMPLETED|Part 1, Self-Selection Phase||10||
60041008|NCT01726270|76156885|FG000|STARTED|Eligibility for Part 2|No. of subjects potentially eligible for Part 2|389||
60041009|NCT01726270|76156885|FG000|COMPLETED|Eligibility for Part 2||369||
60041010|NCT01726270|76156885|FG000|NOT COMPLETED|Eligibility for Part 2||20||
60041011|NCT01726270|76156885|FG000|STARTED|Part 2, Actual-Use Phase|20 subjects were eligible for Part 2 but did not enter Part 2|369||
60041012|NCT01726270|76156885|FG000|COMPLETED|Part 2, Actual-Use Phase||330||
60041013|NCT01726270|76156885|FG000|NOT COMPLETED|Part 2, Actual-Use Phase||39||
60041014|NCT01914393|76156894|FG000|STARTED|Overall Study||271||
60041015|NCT01914393|76156895|FG001|STARTED|Overall Study||125||
60041016|NCT01914393|76156896|FG002|STARTED|Overall Study||306||
60041017|NCT01914393|76156894|FG000|COMPLETED|Overall Study||156||
60041018|NCT01914393|76156895|FG001|COMPLETED|Overall Study||54||
60041019|NCT01914393|76156896|FG002|COMPLETED|Overall Study||168||
60041020|NCT01914393|76156894|FG000|NOT COMPLETED|Overall Study||115||
60041021|NCT01914393|76156895|FG001|NOT COMPLETED|Overall Study||71||
60041022|NCT01914393|76156896|FG002|NOT COMPLETED|Overall Study||138||
60041023|NCT01931865|76156908|FG000|STARTED|Overall Study||12||
60041024|NCT01931865|76156908|FG000|COMPLETED|Overall Study||8||
60041025|NCT01931865|76156908|FG000|NOT COMPLETED|Overall Study||4||
60041026|NCT01617447|76156915|FG000|STARTED|Overall Study||47||
60041027|NCT01617447|76156916|FG001|STARTED|Overall Study||45||
60041028|NCT01617447|76156915|FG000|COMPLETED|Overall Study||47||
60041029|NCT01617447|76156916|FG001|COMPLETED|Overall Study||42||
60041030|NCT01617447|76156915|FG000|NOT COMPLETED|Overall Study||0||
60041031|NCT01617447|76156916|FG001|NOT COMPLETED|Overall Study||3||
60041032|NCT00432679|76156924|FG000|STARTED|Overall Study||74||
60041033|NCT00432679|76156925|FG001|STARTED|Overall Study||75||
60041034|NCT00432679|76156924|FG000|COMPLETED|Overall Study||69||
60041035|NCT00432679|76156925|FG001|COMPLETED|Overall Study||72||
60041036|NCT00432679|76156924|FG000|NOT COMPLETED|Overall Study||5||
60041037|NCT00432679|76156925|FG001|NOT COMPLETED|Overall Study||3||
60041038|NCT01600105|76156933|FG000|STARTED|Total Participants||255||
60041039|NCT01600105|76156934|FG001|STARTED|Total Participants||21||
60041040|NCT01600105|76156933|FG000|COMPLETED|Total Participants||214||
60041041|NCT01600105|76156934|FG001|COMPLETED|Total Participants||11||
60041042|NCT01600105|76156933|FG000|NOT COMPLETED|Total Participants||41||
60041043|NCT01600105|76156934|FG001|NOT COMPLETED|Total Participants||10||
60041044|NCT01600105|76156933|FG000|STARTED|Sub Study I||19||
60041045|NCT01600105|76156934|FG001|STARTED|Sub Study I||21||
60041046|NCT01600105|76156933|FG000|COMPLETED|Sub Study I||19||
60041047|NCT01600105|76156934|FG001|COMPLETED|Sub Study I||11||
60041048|NCT01600105|76156933|FG000|NOT COMPLETED|Sub Study I||0||
60041049|NCT01600105|76156934|FG001|NOT COMPLETED|Sub Study I||10||
60041050|NCT01600105|76156933|FG000|STARTED|Sub Study II||65||
60041051|NCT01600105|76156934|FG001|STARTED|Sub Study II||0||
60041052|NCT01600105|76156933|FG000|COMPLETED|Sub Study II||60||
60041053|NCT01600105|76156934|FG001|COMPLETED|Sub Study II||0||
60041054|NCT01600105|76156933|FG000|NOT COMPLETED|Sub Study II||5||
60041055|NCT01600105|76156934|FG001|NOT COMPLETED|Sub Study II||0||
60041056|NCT01600105|76156933|FG000|STARTED|Sub Study III||39||
60041057|NCT01600105|76156934|FG001|STARTED|Sub Study III||0||
60041058|NCT01600105|76156933|FG000|COMPLETED|Sub Study III||34||
60041059|NCT01600105|76156934|FG001|COMPLETED|Sub Study III||0||
60041060|NCT01600105|76156933|FG000|NOT COMPLETED|Sub Study III||5||
60041061|NCT01600105|76156934|FG001|NOT COMPLETED|Sub Study III||0||
60041062|NCT01600105|76156933|FG000|STARTED|Sub Study IV||41||
60041063|NCT01600105|76156934|FG001|STARTED|Sub Study IV||8||
60041064|NCT01600105|76156933|FG000|COMPLETED|Sub Study IV||41||
60041065|NCT01600105|76156934|FG001|COMPLETED|Sub Study IV||8||
60041066|NCT01600105|76156933|FG000|NOT COMPLETED|Sub Study IV||0||
60041067|NCT01600105|76156934|FG001|NOT COMPLETED|Sub Study IV||0||
60041068|NCT01600105|76156933|FG000|STARTED|Sub Study V||52||
60041069|NCT01600105|76156934|FG001|STARTED|Sub Study V||0||
60041070|NCT01600105|76156933|FG000|COMPLETED|Sub Study V||50||
60041071|NCT01600105|76156934|FG001|COMPLETED|Sub Study V||0||
60041072|NCT01600105|76156933|FG000|NOT COMPLETED|Sub Study V||2||
60041073|NCT01600105|76156934|FG001|NOT COMPLETED|Sub Study V||0||
60041074|NCT02246647|76156946|FG000|STARTED|Overall Study||19||
60041075|NCT02246647|76156947|FG001|STARTED|Overall Study||20||
60041076|NCT02246647|76156946|FG000|COMPLETED|Overall Study||18|2 subjects (1 in Healthy Volunteers and 1 in IBS-C) would count as screen failures & hence withdrawn|
60041077|NCT02246647|76156947|FG001|COMPLETED|Overall Study||19|2 subjects (1 in Healthy Volunteers and 1 in IBS-C) would count as screen failures & hence withdrawn|
60041078|NCT02246647|76156946|FG000|NOT COMPLETED|Overall Study||1||
60041079|NCT02246647|76156947|FG001|NOT COMPLETED|Overall Study||1||
60041080|NCT01933113|76156967|FG000|STARTED|Overall Study||3||
60041081|NCT01933113|76156967|FG000|COMPLETED|Overall Study||2||
60041082|NCT01933113|76156967|FG000|NOT COMPLETED|Overall Study||1||
60041083|NCT02244619|76156973|FG000|STARTED|Overall Study||249||
60041084|NCT02244619|76156974|FG001|STARTED|Overall Study||266||
60041085|NCT02244619|76156973|FG000|COMPLETED|Overall Study||241||
60041086|NCT02244619|76156974|FG001|COMPLETED|Overall Study||245||
60041087|NCT02244619|76156973|FG000|NOT COMPLETED|Overall Study||8||
60041088|NCT02244619|76156974|FG001|NOT COMPLETED|Overall Study||21||
60041089|NCT02243371|76156982|FG000|STARTED|Overall Study||51||
60041090|NCT02243371|76156983|FG001|STARTED|Overall Study||42||
60041091|NCT02243371|76156982|FG000|COMPLETED|Overall Study||14||
60041092|NCT02243371|76156983|FG001|COMPLETED|Overall Study||10||
60041093|NCT02243371|76156982|FG000|NOT COMPLETED|Overall Study||37||
60041094|NCT02243371|76156983|FG001|NOT COMPLETED|Overall Study||32||
60041095|NCT01931475|76156991|FG000|STARTED|Period 1: Double-Blind Treatment Phase||205||
60041096|NCT01931475|76156992|FG001|STARTED|Period 1: Double-Blind Treatment Phase||202||
60041097|NCT01931475|76156991|FG000|Received at Least 1 Dose of Study Drug|Period 1: Double-Blind Treatment Phase||199||
60041098|NCT01931475|76156992|FG001|Received at Least 1 Dose of Study Drug|Period 1: Double-Blind Treatment Phase||198||
60041099|NCT01931475|76156991|FG000|COMPLETED|Period 1: Double-Blind Treatment Phase||166||
60041100|NCT01931475|76156992|FG001|COMPLETED|Period 1: Double-Blind Treatment Phase||176||
60041101|NCT01931475|76156991|FG000|NOT COMPLETED|Period 1: Double-Blind Treatment Phase||39||
60041102|NCT01931475|76156992|FG001|NOT COMPLETED|Period 1: Double-Blind Treatment Phase||26||
60041103|NCT01931475|76156991|FG000|STARTED|Period 2: Extension Treatment Phase||166||
60041104|NCT01931475|76156992|FG001|STARTED|Period 2: Extension Treatment Phase||176||
60041105|NCT01931475|76156991|FG000|Received at Least 1 Dose of Study Drug|Period 2: Extension Treatment Phase||166||
60041106|NCT01931475|76156992|FG001|Received at Least 1 Dose of Study Drug|Period 2: Extension Treatment Phase||175||
60041107|NCT01931475|76156991|FG000|COMPLETED|Period 2: Extension Treatment Phase||162||
60041108|NCT01931475|76156992|FG001|COMPLETED|Period 2: Extension Treatment Phase||157||
60041109|NCT01931475|76156991|FG000|NOT COMPLETED|Period 2: Extension Treatment Phase||4||
60041110|NCT01931475|76156992|FG001|NOT COMPLETED|Period 2: Extension Treatment Phase||19||
60041111|NCT01931397|76157003|FG000|STARTED|Overall Study||30||
60041112|NCT01931397|76157003|FG000|COMPLETED|Overall Study||19||
60041113|NCT01931397|76157003|FG000|NOT COMPLETED|Overall Study||11||
60041114|NCT01929993|76157013|FG000|STARTED|Overall Study||82||
60041115|NCT01929993|76157014|FG001|STARTED|Overall Study||82||
60041116|NCT01929993|76157013|FG000|COMPLETED|Overall Study||52||
60041117|NCT01929993|76157014|FG001|COMPLETED|Overall Study||54||
60041118|NCT01929993|76157013|FG000|NOT COMPLETED|Overall Study||30||
60041119|NCT01929993|76157014|FG001|NOT COMPLETED|Overall Study||28||
60041120|NCT01912599|76157022|FG000|STARTED|Overall Study||20||
60041121|NCT01912599|76157023|FG001|STARTED|Overall Study||16||
60041122|NCT01912599|76157022|FG000|COMPLETED|Overall Study||20||
60041123|NCT01912599|76157023|FG001|COMPLETED|Overall Study||15||
60041124|NCT01912599|76157022|FG000|NOT COMPLETED|Overall Study||0||
60041125|NCT01912599|76157023|FG001|NOT COMPLETED|Overall Study||1||
60041126|NCT01929681|76157031|FG000|STARTED|Overall Study||28||
60041127|NCT01929681|76157032|FG001|STARTED|Overall Study||25||
60041128|NCT01929681|76157031|FG000|COMPLETED|Overall Study||26||
60041129|NCT01929681|76157032|FG001|COMPLETED|Overall Study||24||
60041130|NCT01929681|76157031|FG000|NOT COMPLETED|Overall Study||2||
60041131|NCT01929681|76157032|FG001|NOT COMPLETED|Overall Study||1||
60041132|NCT01646177|76157042|FG000|STARTED|Blinded Induction Dosing (Week 0-12)||193||
60041133|NCT01646177|76157043|FG001|STARTED|Blinded Induction Dosing (Week 0-12)||382||
60041134|NCT01646177|76157044|FG002|STARTED|Blinded Induction Dosing (Week 0-12)||386||
60041135|NCT01646177|76157045|FG003|STARTED|Blinded Induction Dosing (Week 0-12)||385||
60041136|NCT01646177|76157046|FG004|STARTED|Blinded Induction Dosing (Week 0-12)||0||
60041137|NCT01646177|76157047|FG005|STARTED|Blinded Induction Dosing (Week 0-12)||0||
60041138|NCT01646177|76157048|FG006|STARTED|Blinded Induction Dosing (Week 0-12)||0||
60041139|NCT01646177|76157049|FG007|STARTED|Blinded Induction Dosing (Week 0-12)||0||
60041140|NCT01646177|76157050|FG008|STARTED|Blinded Induction Dosing (Week 0-12)||0||
60041141|NCT01646177|76157051|FG009|STARTED|Blinded Induction Dosing (Week 0-12)||0||
60041142|NCT01646177|76157052|FG010|STARTED|Blinded Induction Dosing (Week 0-12)||0||
59510384|NCT02716714|75603818|FG001|NOT COMPLETED|Overall Study||2||
59510385|NCT02719366|75603828|FG000|STARTED|First Intervention||6||
59510386|NCT02719366|75603829|FG001|STARTED|First Intervention||6||
59510387|NCT02719366|75603828|FG000|COMPLETED|First Intervention||6||
59510388|NCT02719366|75603829|FG001|COMPLETED|First Intervention||6||
59510389|NCT02719366|75603828|FG000|NOT COMPLETED|First Intervention||0||
59510390|NCT02719366|75603829|FG001|NOT COMPLETED|First Intervention||0||
59510391|NCT02719366|75603828|FG000|STARTED|Second Intervention||6||
59510392|NCT02719366|75603829|FG001|STARTED|Second Intervention||6||
59510393|NCT02719366|75603828|FG000|COMPLETED|Second Intervention||6||
60041143|NCT01646177|76157053|FG011|STARTED|Blinded Induction Dosing (Week 0-12)||0||
60041144|NCT01646177|76157042|FG000|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||193||
60041145|NCT01646177|76157043|FG001|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||382||
59510394|NCT02719366|75603829|FG001|COMPLETED|Second Intervention||6||
59510395|NCT02719366|75603828|FG000|NOT COMPLETED|Second Intervention||0||
60041146|NCT01646177|76157044|FG002|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||382||
60041147|NCT01646177|76157045|FG003|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||384||
60041148|NCT01646177|76157046|FG004|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0||
60041149|NCT01646177|76157047|FG005|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0||
60041150|NCT01646177|76157048|FG006|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0||
60041151|NCT01646177|76157049|FG007|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0||
60041152|NCT01646177|76157050|FG008|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0||
60041153|NCT01646177|76157051|FG009|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0||
60041154|NCT01646177|76157052|FG010|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0||
60041155|NCT01646177|76157053|FG011|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0||
60041156|NCT01646177|76157042|FG000|COMPLETED|Blinded Induction Dosing (Week 0-12)||183||
60041157|NCT01646177|76157043|FG001|COMPLETED|Blinded Induction Dosing (Week 0-12)||369||
60041158|NCT01646177|76157044|FG002|COMPLETED|Blinded Induction Dosing (Week 0-12)||360||
60041159|NCT01646177|76157045|FG003|COMPLETED|Blinded Induction Dosing (Week 0-12)||363||
60041160|NCT01646177|76157046|FG004|COMPLETED|Blinded Induction Dosing (Week 0-12)||0||
60041161|NCT01646177|76157047|FG005|COMPLETED|Blinded Induction Dosing (Week 0-12)||0||
60041162|NCT01646177|76157048|FG006|COMPLETED|Blinded Induction Dosing (Week 0-12)||0||
60041163|NCT01646177|76157049|FG007|COMPLETED|Blinded Induction Dosing (Week 0-12)||0||
60041164|NCT01646177|76157050|FG008|COMPLETED|Blinded Induction Dosing (Week 0-12)||0||
60041165|NCT01646177|76157051|FG009|COMPLETED|Blinded Induction Dosing (Week 0-12)||0||
60041166|NCT01646177|76157052|FG010|COMPLETED|Blinded Induction Dosing (Week 0-12)||0||
60041167|NCT01646177|76157053|FG011|COMPLETED|Blinded Induction Dosing (Week 0-12)||0||
60041168|NCT01646177|76157042|FG000|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||10||
60041169|NCT01646177|76157043|FG001|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||13||
60041170|NCT01646177|76157044|FG002|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||26||
60041171|NCT01646177|76157045|FG003|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||22||
60041172|NCT01646177|76157046|FG004|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0||
60041173|NCT01646177|76157047|FG005|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0||
60041174|NCT01646177|76157048|FG006|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0||
60041175|NCT01646177|76157049|FG007|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0||
60041176|NCT01646177|76157050|FG008|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0||
60041177|NCT01646177|76157051|FG009|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0||
60041178|NCT01646177|76157052|FG010|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0||
60041179|NCT01646177|76157053|FG011|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0||
60041180|NCT01646177|76157042|FG000|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|0||
60041181|NCT01646177|76157043|FG001|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|0||
60041182|NCT01646177|76157044|FG002|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|0||
60041183|NCT01646177|76157045|FG003|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|0||
60041184|NCT01646177|76157046|FG004|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|183||
60041185|NCT01646177|76157047|FG005|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|369||
60041186|NCT01646177|76157048|FG006|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|360||
60041187|NCT01646177|76157049|FG007|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|362||
60041188|NCT01646177|76157050|FG008|STARTED|Long-Term Extension Period (Week 12-264)||0||
60041189|NCT01646177|76157051|FG009|STARTED|Long-Term Extension Period (Week 12-264)||0||
60041190|NCT01646177|76157052|FG010|STARTED|Long-Term Extension Period (Week 12-264)||0||
60041191|NCT01646177|76157053|FG011|STARTED|Long-Term Extension Period (Week 12-264)||0||
60041192|NCT01646177|76157042|FG000|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0||
60041193|NCT01646177|76157043|FG001|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0||
60041194|NCT01646177|76157044|FG002|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0||
60041195|NCT01646177|76157045|FG003|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0||
60041196|NCT01646177|76157046|FG004|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||183||
60041197|NCT01646177|76157047|FG005|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||369||
60041198|NCT01646177|76157048|FG006|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||360||
60041199|NCT01646177|76157049|FG007|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||362||
60041200|NCT01646177|76157050|FG008|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0||
60041201|NCT01646177|76157051|FG009|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0||
60041202|NCT01646177|76157052|FG010|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0||
60041203|NCT01646177|76157053|FG011|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0||
60041204|NCT01646177|76157042|FG000|COMPLETED|Long-Term Extension Period (Week 12-264)||0||
60041205|NCT01646177|76157043|FG001|COMPLETED|Long-Term Extension Period (Week 12-264)||0||
60041206|NCT01646177|76157044|FG002|COMPLETED|Long-Term Extension Period (Week 12-264)||0||
60041207|NCT01646177|76157045|FG003|COMPLETED|Long-Term Extension Period (Week 12-264)||0||
60041208|NCT01646177|76157046|FG004|COMPLETED|Long-Term Extension Period (Week 12-264)||135||
60041209|NCT01646177|76157047|FG005|COMPLETED|Long-Term Extension Period (Week 12-264)||256||
59510396|NCT02719366|75603829|FG001|NOT COMPLETED|Second Intervention||0||
59510397|NCT02720224|75603836|FG000|STARTED|Overall Study||6||
59510398|NCT02720224|75603836|FG000|COMPLETED|Overall Study||6||
59510399|NCT02720224|75603836|FG000|NOT COMPLETED|Overall Study||0||
59510400|NCT02722330|75603840|FG000|STARTED|Overall Study||23||
59510401|NCT02722330|75603840|FG000|COMPLETED|Overall Study||23||
59510402|NCT02722330|75603840|FG000|NOT COMPLETED|Overall Study||0||
59510403|NCT00881647|75603846|FG000|STARTED|Overall Study||29||
59510404|NCT00881647|75603847|FG001|STARTED|Overall Study||16||
59510405|NCT00881647|75603846|FG000|COMPLETED|Overall Study||27||
59510406|NCT00881647|75603847|FG001|COMPLETED|Overall Study||15||
60041210|NCT01646177|76157048|FG006|COMPLETED|Long-Term Extension Period (Week 12-264)||244||
60041211|NCT01646177|76157049|FG007|COMPLETED|Long-Term Extension Period (Week 12-264)||255||
60041212|NCT01646177|76157050|FG008|COMPLETED|Long-Term Extension Period (Week 12-264)||0||
60041213|NCT01646177|76157051|FG009|COMPLETED|Long-Term Extension Period (Week 12-264)||0||
60041214|NCT01646177|76157052|FG010|COMPLETED|Long-Term Extension Period (Week 12-264)||0||
60041215|NCT01646177|76157053|FG011|COMPLETED|Long-Term Extension Period (Week 12-264)||0||
60041216|NCT01646177|76157042|FG000|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0||
60041217|NCT01646177|76157043|FG001|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0||
60041218|NCT01646177|76157044|FG002|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0||
60041219|NCT01646177|76157045|FG003|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0||
60041220|NCT01646177|76157046|FG004|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||48||
60041221|NCT01646177|76157047|FG005|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||113||
60041222|NCT01646177|76157048|FG006|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||116||
60041223|NCT01646177|76157049|FG007|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||107||
60041224|NCT01646177|76157050|FG008|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0||
60041225|NCT01646177|76157051|FG009|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0||
60041226|NCT01646177|76157052|FG010|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0||
60041227|NCT01646177|76157053|FG011|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0||
60041228|NCT01646177|76157042|FG000|STARTED|Follow-Up Period (Minimum of 12 Weeks)||0||
60041229|NCT01646177|76157043|FG001|STARTED|Follow-Up Period (Minimum of 12 Weeks)||0||
60041230|NCT01646177|76157044|FG002|STARTED|Follow-Up Period (Minimum of 12 Weeks)||0||
60041231|NCT01646177|76157045|FG003|STARTED|Follow-Up Period (Minimum of 12 Weeks)||0||
60041232|NCT01646177|76157046|FG004|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|0||
60041233|NCT01646177|76157047|FG005|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|0||
60041234|NCT01646177|76157048|FG006|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|0||
60041235|NCT01646177|76157049|FG007|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|0||
60041236|NCT01646177|76157050|FG008|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|157||
60041237|NCT01646177|76157051|FG009|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|309||
60041238|NCT01646177|76157052|FG010|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|305||
60041239|NCT01646177|76157053|FG011|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|313||
60041240|NCT01646177|76157042|FG000|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0||
60041241|NCT01646177|76157043|FG001|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0||
59510407|NCT00881647|75603846|FG000|NOT COMPLETED|Overall Study||2||
59510408|NCT00881647|75603847|FG001|NOT COMPLETED|Overall Study||1||
59510409|NCT00882661|75603856|FG000|STARTED|Investigational Training||89||
59510410|NCT00882661|75603857|FG001|STARTED|Investigational Training||0||
59510411|NCT00882661|75603856|FG000|COMPLETED|Investigational Training||79||
59510412|NCT00882661|75603857|FG001|COMPLETED|Investigational Training||0||
59510413|NCT00882661|75603856|FG000|NOT COMPLETED|Investigational Training||10||
59510414|NCT00882661|75603857|FG001|NOT COMPLETED|Investigational Training||0||
59510415|NCT00882661|75603856|FG000|STARTED|Treatment||151||
59510416|NCT00882661|75603857|FG001|STARTED|Treatment||140||
59510417|NCT00882661|75603856|FG000|COMPLETED|Treatment||141||
59510418|NCT00882661|75603857|FG001|COMPLETED|Treatment||114||
59510419|NCT00882661|75603856|FG000|NOT COMPLETED|Treatment||10||
59510420|NCT00882661|75603857|FG001|NOT COMPLETED|Treatment||26||
59510421|NCT00883675|75603865|FG000|STARTED|Overall Study||133||
60041242|NCT01646177|76157044|FG002|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0||
60041243|NCT01646177|76157045|FG003|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0||
60041244|NCT01646177|76157046|FG004|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0||
60041245|NCT01646177|76157047|FG005|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0||
60041246|NCT01646177|76157048|FG006|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0||
60041247|NCT01646177|76157049|FG007|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0||
60041248|NCT01646177|76157050|FG008|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||157||
60041249|NCT01646177|76157051|FG009|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||309||
60041250|NCT01646177|76157052|FG010|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||305||
60041251|NCT01646177|76157053|FG011|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||313||
60041252|NCT01646177|76157042|FG000|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0||
60041253|NCT01646177|76157043|FG001|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0||
60041254|NCT01646177|76157044|FG002|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0||
60041255|NCT01646177|76157045|FG003|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0||
60041256|NCT01646177|76157046|FG004|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0||
60041257|NCT01646177|76157047|FG005|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0||
60041258|NCT01646177|76157048|FG006|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0||
60041259|NCT01646177|76157049|FG007|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0||
60041260|NCT01646177|76157050|FG008|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||126||
60041261|NCT01646177|76157051|FG009|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||233||
60041262|NCT01646177|76157052|FG010|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||225||
60041263|NCT01646177|76157053|FG011|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||230||
60041264|NCT01646177|76157042|FG000|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0||
60041265|NCT01646177|76157043|FG001|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0||
60041266|NCT01646177|76157044|FG002|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0||
59510422|NCT00883675|75603865|FG000|COMPLETED|Overall Study||133||
59510423|NCT00883675|75603865|FG000|NOT COMPLETED|Overall Study||0||
59510424|NCT00884065|75603871|FG000|STARTED|Overall Study||25||
59510425|NCT00884065|75603872|FG001|STARTED|Overall Study||25||
59510426|NCT00884065|75603871|FG000|COMPLETED|Overall Study||25||
60041267|NCT01646177|76157045|FG003|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0||
60041268|NCT01646177|76157046|FG004|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0||
60041269|NCT01646177|76157047|FG005|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0||
60041270|NCT01646177|76157048|FG006|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0||
60041271|NCT01646177|76157049|FG007|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0||
60041272|NCT01646177|76157050|FG008|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||31||
60041273|NCT01646177|76157051|FG009|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||76||
60041274|NCT01646177|76157052|FG010|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||80||
60041275|NCT01646177|76157053|FG011|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||83||
60041276|NCT01912287|76157076|FG000|STARTED|Overall Study||93||
60041277|NCT01912287|76157077|FG001|STARTED|Overall Study||90||
60041278|NCT01912287|76157078|FG002|STARTED|Overall Study||43||
60041279|NCT01912287|76157076|FG000|COMPLETED|Overall Study||60||
60041280|NCT01912287|76157077|FG001|COMPLETED|Overall Study||67||
60041281|NCT01912287|76157078|FG002|COMPLETED|Overall Study||28||
60041282|NCT01912287|76157076|FG000|NOT COMPLETED|Overall Study||33||
60041283|NCT01912287|76157077|FG001|NOT COMPLETED|Overall Study||23||
60041284|NCT01912287|76157078|FG002|NOT COMPLETED|Overall Study||15||
60041285|NCT01929135|76157088|FG000|STARTED|Overall Study||19||
60041286|NCT01929135|76157089|FG001|STARTED|Overall Study||19||
60041287|NCT01929135|76157088|FG000|COMPLETED|Overall Study||18||
60041288|NCT01929135|76157089|FG001|COMPLETED|Overall Study||18||
60041289|NCT01929135|76157088|FG000|NOT COMPLETED|Overall Study||1||
60041290|NCT01929135|76157089|FG001|NOT COMPLETED|Overall Study||1||
59510427|NCT00884065|75603872|FG001|COMPLETED|Overall Study||25||
59510428|NCT00884065|75603871|FG000|NOT COMPLETED|Overall Study||0||
59510429|NCT00884065|75603872|FG001|NOT COMPLETED|Overall Study||0||
59510430|NCT02722408|75603878|FG000|STARTED|Overall Study||8||
59510431|NCT02722408|75603878|FG000|COMPLETED|Overall Study||8||
59510432|NCT02722408|75603878|FG000|NOT COMPLETED|Overall Study||0||
59510433|NCT00884611|75603884|FG000|STARTED|Overall Study||20||
59510434|NCT00884611|75603884|FG000|Enrolled, Not Treated|Overall Study||1||
60041291|NCT01911819|76157100|FG000|STARTED|Overall Study||10||10
59510435|NCT00884611|75603884|FG000|COMPLETED|Overall Study||19||
60041292|NCT01911819|76157101|FG001|STARTED|Overall Study|One of 10 sinuses was replaced to another sinus due to infection.|11||11
60041293|NCT01911819|76157102|FG002|STARTED|Overall Study||10||10
60041294|NCT01911819|76157100|FG000|COMPLETED|Overall Study||9||9
60041295|NCT01911819|76157101|FG001|COMPLETED|Overall Study||9||9
60041296|NCT01911819|76157102|FG002|COMPLETED|Overall Study||10||10
60041297|NCT01911819|76157100|FG000|NOT COMPLETED|Overall Study||1||1
60041298|NCT01911819|76157101|FG001|NOT COMPLETED|Overall Study||2||2
60041299|NCT01911819|76157102|FG002|NOT COMPLETED|Overall Study||0||0
60041300|NCT02280863|76157112|FG000|STARTED|Android Platform||8||
60041301|NCT02280863|76157113|FG001|STARTED|Android Platform||0||
60041302|NCT02280863|76157112|FG000|COMPLETED|Android Platform||8||
60041303|NCT02280863|76157113|FG001|COMPLETED|Android Platform||0||
60041304|NCT02280863|76157112|FG000|NOT COMPLETED|Android Platform||0||
60041305|NCT02280863|76157113|FG001|NOT COMPLETED|Android Platform||0||
60041306|NCT02280863|76157112|FG000|STARTED|Integrated Platform|One additional participant was enrolled for part 2.|9||
60041307|NCT02280863|76157113|FG001|STARTED|Integrated Platform||15||
60041308|NCT02280863|76157112|FG000|COMPLETED|Integrated Platform||9||
60041309|NCT02280863|76157113|FG001|COMPLETED|Integrated Platform||14||
60041310|NCT02280863|76157112|FG000|NOT COMPLETED|Integrated Platform||0||
60041311|NCT02280863|76157113|FG001|NOT COMPLETED|Integrated Platform||1||
60041312|NCT01911429|76157126|FG000|STARTED|Overall Study||108||
60041313|NCT01911429|76157127|FG001|STARTED|Overall Study|Subjects received lurasidone 40/mg day from Days 1-3, and 80mg/day from days 4 to Week 6 visit|106||
60041314|NCT01911429|76157128|FG002|STARTED|Overall Study|one subject randomized to Placebo group was never dosed for study medication, making the total 112|113||
60041315|NCT01911429|76157126|FG000|COMPLETED|Overall Study||96||
60041316|NCT01911429|76157127|FG001|COMPLETED|Overall Study||96||
60041317|NCT01911429|76157128|FG002|COMPLETED|Overall Study||93||
60041318|NCT01911429|76157126|FG000|NOT COMPLETED|Overall Study||12||
60041319|NCT01911429|76157127|FG001|NOT COMPLETED|Overall Study||10||
60041320|NCT01911429|76157128|FG002|NOT COMPLETED|Overall Study||20||
60041321|NCT02324465|76157138|FG000|STARTED|Overall Study||18||
60041322|NCT02324465|76157139|FG001|STARTED|Overall Study||22||
60041323|NCT02324465|76157138|FG000|COMPLETED|Overall Study||18||
60041324|NCT02324465|76157139|FG001|COMPLETED|Overall Study||21||
60041325|NCT02324465|76157138|FG000|NOT COMPLETED|Overall Study||0||
59918962|NCT05327491|76039396|FG002|Received at Least 1 Dose|Periods 1 & 2||0||
59918963|NCT05327491|76039397|FG003|Received at Least 1 Dose|Periods 1 & 2||0||
59918964|NCT05327491|76039394|FG000|COMPLETED|Periods 1 & 2||72||
60041326|NCT02324465|76157139|FG001|NOT COMPLETED|Overall Study||1||
60041327|NCT02324153|76157147|FG000|STARTED|Overall Study||41||
60041328|NCT02324153|76157148|FG001|STARTED|Overall Study||39||
60041329|NCT02324153|76157147|FG000|COMPLETED|Overall Study||33||
60041330|NCT02324153|76157148|FG001|COMPLETED|Overall Study||38||
60041331|NCT02324153|76157147|FG000|NOT COMPLETED|Overall Study||8||
60041332|NCT02324153|76157148|FG001|NOT COMPLETED|Overall Study||1||
60041333|NCT02280473|76157156|FG000|STARTED|Overall Study||94||
60041334|NCT02280473|76157157|FG001|STARTED|Overall Study||94||
60041335|NCT02280473|76157156|FG000|COMPLETED|Overall Study||93||
60041336|NCT02280473|76157157|FG001|COMPLETED|Overall Study||91||
60041337|NCT02280473|76157156|FG000|NOT COMPLETED|Overall Study||1||
60041338|NCT02280473|76157157|FG001|NOT COMPLETED|Overall Study||3||
60041339|NCT01911273|76157165|FG000|STARTED|Overall Study||1||
60041340|NCT01911273|76157166|FG001|STARTED|Overall Study||2||
60041341|NCT01911273|76157165|FG000|COMPLETED|Overall Study||0||
60041342|NCT01911273|76157166|FG001|COMPLETED|Overall Study||0||
60041343|NCT01911273|76157165|FG000|NOT COMPLETED|Overall Study||1||
60041344|NCT01911273|76157166|FG001|NOT COMPLETED|Overall Study||2||
60041345|NCT02308007|76157175|FG000|STARTED|Overall Study||159||
60041346|NCT02308007|76157176|FG001|STARTED|Overall Study||159||
60041347|NCT02308007|76157177|FG002|STARTED|Overall Study||157||
60041348|NCT02308007|76157175|FG000|COMPLETED|Overall Study||83||
60041349|NCT02308007|76157176|FG001|COMPLETED|Overall Study||84||
60041350|NCT02308007|76157177|FG002|COMPLETED|Overall Study||82||
60041351|NCT02308007|76157175|FG000|NOT COMPLETED|Overall Study||76||
60041352|NCT02308007|76157176|FG001|NOT COMPLETED|Overall Study||75||
60041353|NCT02308007|76157177|FG002|NOT COMPLETED|Overall Study||75||
60041354|NCT02278367|76157187|FG000|STARTED|Overall Study||69||
60041355|NCT02278367|76157188|FG001|STARTED|Overall Study||110||
59918965|NCT05327491|76039395|FG001|COMPLETED|Periods 1 & 2||72||
59918966|NCT05327491|76039396|FG002|COMPLETED|Periods 1 & 2||0||
59918967|NCT05327491|76039397|FG003|COMPLETED|Periods 1 & 2||0||
59918968|NCT05327491|76039394|FG000|NOT COMPLETED|Periods 1 & 2||1||
60041356|NCT02278367|76157187|FG000|COMPLETED|Overall Study||59||
60041357|NCT02278367|76157188|FG001|COMPLETED|Overall Study||110||
60041358|NCT02278367|76157187|FG000|NOT COMPLETED|Overall Study||10||
60041359|NCT02278367|76157188|FG001|NOT COMPLETED|Overall Study||0||
60041360|NCT01910181|76157194|FG000|STARTED|Overall Study||46||
60041361|NCT01910181|76157194|FG000|PK Cohort|Overall Study||20||
60041362|NCT01910181|76157194|FG000|Expansion Cohort|Overall Study||26||
60041363|NCT01910181|76157194|FG000|COMPLETED|Overall Study||0||
60041364|NCT01910181|76157194|FG000|NOT COMPLETED|Overall Study||46||
60041365|NCT01957215|76157201|FG000|STARTED|Overall Study||135||
60041366|NCT01957215|76157202|FG001|STARTED|Overall Study||135||
59918969|NCT05327491|76039395|FG001|NOT COMPLETED|Periods 1 & 2||1||
59918970|NCT05327491|76039396|FG002|NOT COMPLETED|Periods 1 & 2||0||
60041367|NCT01957215|76157201|FG000|COMPLETED|Overall Study||122||
60041368|NCT01957215|76157202|FG001|COMPLETED|Overall Study||123||
60041369|NCT01957215|76157201|FG000|NOT COMPLETED|Overall Study||13||
60041370|NCT01957215|76157202|FG001|NOT COMPLETED|Overall Study||12||
60041371|NCT02322749|76157212|FG000|STARTED|Period 1||8||
59918971|NCT05327491|76039397|FG003|NOT COMPLETED|Periods 1 & 2||0||
59918972|NCT05327491|76039394|FG000|STARTED|Period 3 (Food Effect Substudy)||0||
60041372|NCT02322749|76157213|FG001|STARTED|Period 1||8||
60041373|NCT02322749|76157214|FG002|STARTED|Period 1||8||
60041374|NCT02322749|76157215|FG003|STARTED|Period 1||8||
60041375|NCT02322749|76157216|FG004|STARTED|Period 1||8||
60041376|NCT02322749|76157217|FG005|STARTED|Period 1||8||
60041377|NCT02322749|76157212|FG000|COMPLETED|Period 1||8||
60041378|NCT02322749|76157213|FG001|COMPLETED|Period 1||8||
60041379|NCT02322749|76157214|FG002|COMPLETED|Period 1||8||
60041380|NCT02322749|76157215|FG003|COMPLETED|Period 1||8||
60041381|NCT02322749|76157216|FG004|COMPLETED|Period 1||8||
60041382|NCT02322749|76157217|FG005|COMPLETED|Period 1||8||
60041383|NCT02322749|76157212|FG000|NOT COMPLETED|Period 1||0||
60041384|NCT02322749|76157213|FG001|NOT COMPLETED|Period 1||0||
60041385|NCT02322749|76157214|FG002|NOT COMPLETED|Period 1||0||
60041386|NCT02322749|76157215|FG003|NOT COMPLETED|Period 1||0||
60041387|NCT02322749|76157216|FG004|NOT COMPLETED|Period 1||0||
60041388|NCT02322749|76157217|FG005|NOT COMPLETED|Period 1||0||
60041389|NCT02322749|76157212|FG000|STARTED|Period 2||8||
60041390|NCT02322749|76157213|FG001|STARTED|Period 2||8||
60041391|NCT02322749|76157214|FG002|STARTED|Period 2||8||
60041392|NCT02322749|76157215|FG003|STARTED|Period 2||8||
60041393|NCT02322749|76157216|FG004|STARTED|Period 2||8||
60041394|NCT02322749|76157217|FG005|STARTED|Period 2||8||
60041395|NCT02322749|76157212|FG000|COMPLETED|Period 2||8||
60041396|NCT02322749|76157213|FG001|COMPLETED|Period 2||8||
60041397|NCT02322749|76157214|FG002|COMPLETED|Period 2||8||
60041398|NCT02322749|76157215|FG003|COMPLETED|Period 2||6||
60041399|NCT02322749|76157216|FG004|COMPLETED|Period 2||8||
60041400|NCT02322749|76157217|FG005|COMPLETED|Period 2||8||
60041401|NCT02322749|76157212|FG000|NOT COMPLETED|Period 2||0||
60041402|NCT02322749|76157213|FG001|NOT COMPLETED|Period 2||0||
60041403|NCT02322749|76157214|FG002|NOT COMPLETED|Period 2||0||
60041404|NCT02322749|76157215|FG003|NOT COMPLETED|Period 2||2||
60041405|NCT02322749|76157216|FG004|NOT COMPLETED|Period 2||0||
60041406|NCT02322749|76157217|FG005|NOT COMPLETED|Period 2||0||
60041407|NCT02322749|76157212|FG000|STARTED|Period 3||8||
60041408|NCT02322749|76157213|FG001|STARTED|Period 3||8||
60041409|NCT02322749|76157214|FG002|STARTED|Period 3||8||
60041410|NCT02322749|76157215|FG003|STARTED|Period 3||6||
60041411|NCT02322749|76157216|FG004|STARTED|Period 3||8||
60041412|NCT02322749|76157217|FG005|STARTED|Period 3||8||
60041413|NCT02322749|76157212|FG000|COMPLETED|Period 3||8||
60041414|NCT02322749|76157213|FG001|COMPLETED|Period 3||8||
60041415|NCT02322749|76157214|FG002|COMPLETED|Period 3||7||
60041416|NCT02322749|76157215|FG003|COMPLETED|Period 3||6||
60041417|NCT02322749|76157216|FG004|COMPLETED|Period 3||8||
60041418|NCT02322749|76157217|FG005|COMPLETED|Period 3||8||
60041419|NCT02322749|76157212|FG000|NOT COMPLETED|Period 3||0||
60041420|NCT02322749|76157213|FG001|NOT COMPLETED|Period 3||0||
60041421|NCT02322749|76157214|FG002|NOT COMPLETED|Period 3||1||
60041422|NCT02322749|76157215|FG003|NOT COMPLETED|Period 3||0||
60041423|NCT02322749|76157216|FG004|NOT COMPLETED|Period 3||0||
60041424|NCT02322749|76157217|FG005|NOT COMPLETED|Period 3||0||
60041425|NCT01957137|76157226|FG000|STARTED|Randomized Portion||30||
60041426|NCT01957137|76157226|FG000|Continuous Stimulation|Randomized Portion|Subjects received continuous stimulation for approximately 4 weeks.|29||
60041427|NCT01957137|76157226|FG000|Cycling Parameter #1|Randomized Portion|Subjects received Cycling Parameter #1 for approximately 4 weeks.|30||
60041428|NCT01957137|76157226|FG000|Cycling Parameter #2|Randomized Portion|Subjects received Cycling Parameter #2 for approximately 4 weeks.|28||
60041429|NCT01957137|76157226|FG000|Cycling Parameter #3|Randomized Portion|Subjects received Cycling Parameter #3 for approximately 4 weeks.|28||
60041430|NCT01957137|76157226|FG000|COMPLETED|Randomized Portion||28||
60041431|NCT01957137|76157226|FG000|NOT COMPLETED|Randomized Portion||2||
60041432|NCT01957137|76157226|FG000|STARTED|No Stimulation|Following randomized portion, all subjects went through no stimulation for approximately 4 weeks.|28||
60041433|NCT01957137|76157226|FG000|COMPLETED|No Stimulation||28||
60041434|NCT01957137|76157226|FG000|NOT COMPLETED|No Stimulation||0||
60041435|NCT01928433|76157241|FG000|STARTED|Overall Study||76||
60041436|NCT01928433|76157242|FG001|STARTED|Overall Study||75||
60041437|NCT01928433|76157243|FG002|STARTED|Overall Study||74||
60041438|NCT01928433|76157241|FG000|COMPLETED|Overall Study||56||
60041439|NCT01928433|76157242|FG001|COMPLETED|Overall Study||54||
60041440|NCT01928433|76157243|FG002|COMPLETED|Overall Study||46||
60041441|NCT01928433|76157241|FG000|NOT COMPLETED|Overall Study||20||
60041442|NCT01928433|76157242|FG001|NOT COMPLETED|Overall Study||21||
60041443|NCT01928433|76157243|FG002|NOT COMPLETED|Overall Study||28||
60041444|NCT02322281|76157257|FG000|STARTED|Overall Study||53||
60041445|NCT02322281|76157258|FG001|STARTED|Overall Study||22||
60041446|NCT02322281|76157259|FG002|STARTED|Overall Study||74||
60041447|NCT02322281|76157257|FG000|Crossed Over to Rociletinib 500 mg BID|Overall Study||0||
60041448|NCT02322281|76157258|FG001|Crossed Over to Rociletinib 500 mg BID|Overall Study||0||
60041449|NCT02322281|76157259|FG002|Crossed Over to Rociletinib 500 mg BID|Overall Study||36||
60041450|NCT02322281|76157257|FG000|Crossed Over to Rociletinib 625 mg BID|Overall Study||0||
60041451|NCT02322281|76157258|FG001|Crossed Over to Rociletinib 625 mg BID|Overall Study||0||
60041452|NCT02322281|76157259|FG002|Crossed Over to Rociletinib 625 mg BID|Overall Study||3||
60041453|NCT02322281|76157257|FG000|COMPLETED|Overall Study|Patients who are off study for any reason.|0||
60041454|NCT02322281|76157258|FG001|COMPLETED|Overall Study|Patients who are off study for any reason.|0||
60041455|NCT02322281|76157259|FG002|COMPLETED|Overall Study|Patients who are off study for any reason.|0||
60041456|NCT02322281|76157257|FG000|NOT COMPLETED|Overall Study||53||
60041457|NCT02322281|76157258|FG001|NOT COMPLETED|Overall Study||22||
60041458|NCT02322281|76157259|FG002|NOT COMPLETED|Overall Study||74||
60041459|NCT02322125|76157269|FG000|STARTED|Overall Study||12||
60041460|NCT02322125|76157269|FG000|COMPLETED|Overall Study||10||
60041461|NCT02322125|76157269|FG000|NOT COMPLETED|Overall Study||2||
60041462|NCT02243293|76157290|FG000|STARTED|Overall Study||25||
60041463|NCT02243293|76157291|FG001|STARTED|Overall Study||24||
60041464|NCT02243293|76157292|FG002|STARTED|Overall Study||25||
60041465|NCT02243293|76157293|FG003|STARTED|Overall Study||30||
60041466|NCT02243293|76157294|FG004|STARTED|Overall Study||31||
60041467|NCT02243293|76157295|FG005|STARTED|Overall Study||31||
60041468|NCT02243293|76157296|FG006|STARTED|Overall Study||30||
60041469|NCT02243293|76157297|FG007|STARTED|Overall Study||0||
60041470|NCT02243293|76157298|FG008|STARTED|Overall Study||0||
60041471|NCT02243293|76157299|FG009|STARTED|Overall Study||55||
60041472|NCT02243293|76157300|FG010|STARTED|Overall Study||0||
60041473|NCT02243293|76157301|FG011|STARTED|Overall Study||53||
60041474|NCT02243293|76157302|FG012|STARTED|Overall Study||0||
60041475|NCT02243293|76157303|FG013|STARTED|Overall Study||0||
60041476|NCT02243293|76157304|FG014|STARTED|Overall Study||28||
60041477|NCT02243293|76157305|FG015|STARTED|Overall Study||27||
60041478|NCT02243293|76157306|FG016|STARTED|Overall Study||40||
60041479|NCT02243293|76157307|FG017|STARTED|Overall Study||22||
60041480|NCT02243293|76157308|FG018|STARTED|Overall Study||22||
60041481|NCT02243293|76157309|FG019|STARTED|Overall Study||48||
60041482|NCT02243293|76157310|FG020|STARTED|Overall Study||145||
60041483|NCT02243293|76157311|FG021|STARTED|Overall Study||58||
60041484|NCT02243293|76157290|FG000|COMPLETED|Overall Study||23||
60041485|NCT02243293|76157291|FG001|COMPLETED|Overall Study||23||
60041486|NCT02243293|76157292|FG002|COMPLETED|Overall Study||24||
60041487|NCT02243293|76157293|FG003|COMPLETED|Overall Study||29||
60041488|NCT02243293|76157294|FG004|COMPLETED|Overall Study||30||
60041489|NCT02243293|76157295|FG005|COMPLETED|Overall Study||31||
60041490|NCT02243293|76157296|FG006|COMPLETED|Overall Study||27||
60041491|NCT02243293|76157297|FG007|COMPLETED|Overall Study||0||
60041492|NCT02243293|76157298|FG008|COMPLETED|Overall Study||0||
60041493|NCT02243293|76157299|FG009|COMPLETED|Overall Study||53||
60041494|NCT02243293|76157300|FG010|COMPLETED|Overall Study||0||
60041495|NCT02243293|76157301|FG011|COMPLETED|Overall Study||50||
60041496|NCT02243293|76157302|FG012|COMPLETED|Overall Study||0||
60041497|NCT02243293|76157303|FG013|COMPLETED|Overall Study||0||
60041498|NCT02243293|76157304|FG014|COMPLETED|Overall Study||27||
60041499|NCT02243293|76157305|FG015|COMPLETED|Overall Study||26||
60041500|NCT02243293|76157306|FG016|COMPLETED|Overall Study||37||
60041501|NCT02243293|76157307|FG017|COMPLETED|Overall Study||21||
60041502|NCT02243293|76157308|FG018|COMPLETED|Overall Study||22||
60041503|NCT02243293|76157309|FG019|COMPLETED|Overall Study||47||
60041504|NCT02243293|76157310|FG020|COMPLETED|Overall Study||143||
60041505|NCT02243293|76157311|FG021|COMPLETED|Overall Study||55||
60041506|NCT02243293|76157290|FG000|NOT COMPLETED|Overall Study||2||
60041507|NCT02243293|76157291|FG001|NOT COMPLETED|Overall Study||1||
60041508|NCT02243293|76157292|FG002|NOT COMPLETED|Overall Study||1||
60041509|NCT02243293|76157293|FG003|NOT COMPLETED|Overall Study||1||
60041510|NCT02243293|76157294|FG004|NOT COMPLETED|Overall Study||1||
60041511|NCT02243293|76157295|FG005|NOT COMPLETED|Overall Study||0||
60041512|NCT02243293|76157296|FG006|NOT COMPLETED|Overall Study||3||
60041513|NCT02243293|76157297|FG007|NOT COMPLETED|Overall Study||0||
60041514|NCT02243293|76157298|FG008|NOT COMPLETED|Overall Study||0||
60041515|NCT02243293|76157299|FG009|NOT COMPLETED|Overall Study||2||
60041516|NCT02243293|76157300|FG010|NOT COMPLETED|Overall Study||0||
60041517|NCT02243293|76157301|FG011|NOT COMPLETED|Overall Study||3||
60041518|NCT02243293|76157302|FG012|NOT COMPLETED|Overall Study||0||
60041519|NCT02243293|76157303|FG013|NOT COMPLETED|Overall Study||0||
60041520|NCT02243293|76157304|FG014|NOT COMPLETED|Overall Study||1||
60041521|NCT02243293|76157305|FG015|NOT COMPLETED|Overall Study||1||
60041522|NCT02243293|76157306|FG016|NOT COMPLETED|Overall Study||3||
60041523|NCT02243293|76157307|FG017|NOT COMPLETED|Overall Study||1||
60041524|NCT02243293|76157308|FG018|NOT COMPLETED|Overall Study||0||
60041525|NCT02243293|76157309|FG019|NOT COMPLETED|Overall Study||1||
60041526|NCT02243293|76157310|FG020|NOT COMPLETED|Overall Study||2||
60041527|NCT02243293|76157311|FG021|NOT COMPLETED|Overall Study||3||
60041528|NCT02322047|76157352|FG000|STARTED|Overall Study||8||
60041529|NCT02322047|76157353|FG001|STARTED|Overall Study||7||
60041530|NCT02322047|76157354|FG002|STARTED|Overall Study||7||
60041531|NCT02322047|76157355|FG003|STARTED|Overall Study||9||
60041532|NCT02322047|76157352|FG000|COMPLETED|Overall Study||6||
60041533|NCT02322047|76157353|FG001|COMPLETED|Overall Study||6||
60041534|NCT02322047|76157354|FG002|COMPLETED|Overall Study||6||
60041535|NCT02322047|76157355|FG003|COMPLETED|Overall Study||7||
60041536|NCT02322047|76157352|FG000|NOT COMPLETED|Overall Study||2||
60041537|NCT02322047|76157353|FG001|NOT COMPLETED|Overall Study||1||
60041538|NCT02322047|76157354|FG002|NOT COMPLETED|Overall Study||1||
60041539|NCT02322047|76157355|FG003|NOT COMPLETED|Overall Study||2||
60041540|NCT02254291|76157368|FG000|STARTED|Overall Study||103||
60041541|NCT02254291|76157369|FG001|STARTED|Overall Study||102||
60041542|NCT02254291|76157370|FG002|STARTED|Overall Study||103||
60041543|NCT02254291|76157368|FG000|Exposed|Overall Study||103||
60041544|NCT02254291|76157369|FG001|Exposed|Overall Study||102||
60041545|NCT02254291|76157370|FG002|Exposed|Overall Study||103||
60041546|NCT02254291|76157368|FG000|COMPLETED|Overall Study||103||
60041547|NCT02254291|76157369|FG001|COMPLETED|Overall Study||99||
60041548|NCT02254291|76157370|FG002|COMPLETED|Overall Study||101||
60041549|NCT02254291|76157368|FG000|NOT COMPLETED|Overall Study||0||
60041550|NCT02254291|76157369|FG001|NOT COMPLETED|Overall Study||3||
60041551|NCT02254291|76157370|FG002|NOT COMPLETED|Overall Study||2||
60041552|NCT02253433|76157380|FG000|STARTED|Overall Study||130||
60041553|NCT02253433|76157381|FG001|STARTED|Overall Study||134||
60041554|NCT02253433|76157380|FG000|COMPLETED|Overall Study||114||
60041555|NCT02253433|76157381|FG001|COMPLETED|Overall Study||79||
60041556|NCT02253433|76157380|FG000|NOT COMPLETED|Overall Study||16||
60041557|NCT02253433|76157381|FG001|NOT COMPLETED|Overall Study||55||
60041558|NCT02242981|76157388|FG000|STARTED|Overall Study||6||
60041559|NCT02242981|76157388|FG000|Received Study Drug|Overall Study||6||
60041560|NCT02242981|76157388|FG000|COMPLETED|Overall Study||5||
60041561|NCT02242981|76157388|FG000|NOT COMPLETED|Overall Study||1||
60041562|NCT02277743|76157395|FG000|STARTED|Overall Study||224||
60041563|NCT02277743|76157396|FG001|STARTED|Overall Study||224||
60041564|NCT02277743|76157397|FG002|STARTED|Overall Study||223||
60041565|NCT02277743|76157395|FG000|Treated|Overall Study||223||
60041566|NCT02277743|76157396|FG001|Treated|Overall Study||223||
60041567|NCT02277743|76157397|FG002|Treated|Overall Study||223||
60041568|NCT02277743|76157395|FG000|Safety Population|Overall Study|1 participant received at least 1 injection of Dupilumab 300mg(analyzed in Dupilumab 300 mg q2w arm)|222||
60041569|NCT02277743|76157396|FG001|Safety Population|Overall Study|6 participants (1 [placebo] + 5 [Dupilumab 300 mg qw arm]) analyzed in Dupilumab 300 mg q2w arm|229||
60041570|NCT02277743|76157397|FG002|Safety Population|Overall Study|5 participants received fewer injections of Dupilumab 300 mg (analyzed in Dupilumab 300 mg q2w arm)|218||
60041571|NCT02277743|76157395|FG000|COMPLETED|Overall Study||184||
60041572|NCT02277743|76157396|FG001|COMPLETED|Overall Study||208||
60041573|NCT02277743|76157397|FG002|COMPLETED|Overall Study||197||
60041574|NCT02277743|76157395|FG000|NOT COMPLETED|Overall Study||40||
60041575|NCT02277743|76157396|FG001|NOT COMPLETED|Overall Study||16||
60041576|NCT02277743|76157397|FG002|NOT COMPLETED|Overall Study||26||
60041577|NCT02242903|76157412|FG000|STARTED|Overall Study||12||
60041578|NCT02242903|76157413|FG001|STARTED|Overall Study||6||
60041579|NCT02242903|76157414|FG002|STARTED|Overall Study||6||
60041580|NCT02242903|76157415|FG003|STARTED|Overall Study||6||
60041581|NCT02242903|76157416|FG004|STARTED|Overall Study||6||
60041582|NCT02242903|76157417|FG005|STARTED|Overall Study||6||
60041583|NCT02242903|76157418|FG006|STARTED|Overall Study||6||
60041584|NCT02242903|76157412|FG000|Received at Least One Dose of Study Drug|Overall Study||12||
60041585|NCT02242903|76157413|FG001|Received at Least One Dose of Study Drug|Overall Study||6||
60041586|NCT02242903|76157414|FG002|Received at Least One Dose of Study Drug|Overall Study||6||
60041587|NCT02242903|76157415|FG003|Received at Least One Dose of Study Drug|Overall Study||6||
60041588|NCT02242903|76157416|FG004|Received at Least One Dose of Study Drug|Overall Study||6||
60041589|NCT02242903|76157417|FG005|Received at Least One Dose of Study Drug|Overall Study||6||
60041590|NCT02242903|76157418|FG006|Received at Least One Dose of Study Drug|Overall Study||6||
60041591|NCT02242903|76157412|FG000|COMPLETED|Overall Study||11||
60041592|NCT02242903|76157413|FG001|COMPLETED|Overall Study||6||
60041593|NCT02242903|76157414|FG002|COMPLETED|Overall Study||6||
60041594|NCT02242903|76157415|FG003|COMPLETED|Overall Study||6||
60041595|NCT02242903|76157416|FG004|COMPLETED|Overall Study||6||
60041596|NCT02242903|76157417|FG005|COMPLETED|Overall Study||6||
60041597|NCT02242903|76157418|FG006|COMPLETED|Overall Study||6||
60041598|NCT02242903|76157412|FG000|NOT COMPLETED|Overall Study||1||
60041599|NCT02242903|76157413|FG001|NOT COMPLETED|Overall Study||0||
60041600|NCT02242903|76157414|FG002|NOT COMPLETED|Overall Study||0||
60041601|NCT02242903|76157415|FG003|NOT COMPLETED|Overall Study||0||
60041602|NCT02242903|76157416|FG004|NOT COMPLETED|Overall Study||0||
60041603|NCT02242903|76157417|FG005|NOT COMPLETED|Overall Study||0||
60041604|NCT02242903|76157418|FG006|NOT COMPLETED|Overall Study||0||
60041605|NCT02320721|76157442|FG000|STARTED|Overall Study||508||
60041606|NCT02320721|76157443|FG001|STARTED|Overall Study||506||
60041607|NCT02320721|76157442|FG000|Treated (Safety Population)|Overall Study||508||
60041608|NCT02320721|76157443|FG001|Treated (Safety Population)|Overall Study||505||
60041609|NCT02320721|76157442|FG000|COMPLETED|Overall Study||481||
60041610|NCT02320721|76157443|FG001|COMPLETED|Overall Study||472||
60041611|NCT02320721|76157442|FG000|NOT COMPLETED|Overall Study||27||
60041612|NCT02320721|76157443|FG001|NOT COMPLETED|Overall Study||34||
60041613|NCT02320487|76157449|FG000|STARTED|Overall Study||102||
60041614|NCT02320487|76157449|FG000|COMPLETED|Overall Study|Completed = completed the 6-cycle Treatment Period.|81||
60041615|NCT02320487|76157449|FG000|NOT COMPLETED|Overall Study||21||
60041616|NCT02277119|76157456|FG000|STARTED|Overall Study||58||
60041617|NCT02277119|76157457|FG001|STARTED|Overall Study||24||
60041618|NCT02277119|76157458|FG002|STARTED|Overall Study||27||
60041619|NCT02277119|76157456|FG000|COMPLETED|Overall Study||55||
60041620|NCT02277119|76157457|FG001|COMPLETED|Overall Study||20||
60041621|NCT02277119|76157458|FG002|COMPLETED|Overall Study||19||
60041622|NCT02277119|76157456|FG000|NOT COMPLETED|Overall Study||3||
60041623|NCT02277119|76157457|FG001|NOT COMPLETED|Overall Study||4||
60041624|NCT02277119|76157458|FG002|NOT COMPLETED|Overall Study||8||
60041625|NCT02320253|76157469|FG000|STARTED|Overall Study||69||
60041626|NCT02320253|76157470|FG001|STARTED|Overall Study||70||
60041627|NCT02320253|76157471|FG002|STARTED|Overall Study||72||
60041628|NCT02320253|76157469|FG000|COMPLETED|Overall Study||63||
60041629|NCT02320253|76157470|FG001|COMPLETED|Overall Study||68||
60041630|NCT02320253|76157471|FG002|COMPLETED|Overall Study||70||
60041631|NCT02320253|76157469|FG000|NOT COMPLETED|Overall Study||6||
60041632|NCT02320253|76157470|FG001|NOT COMPLETED|Overall Study||2||
60041633|NCT02320253|76157471|FG002|NOT COMPLETED|Overall Study||2||
60041634|NCT02276807|76157481|FG000|STARTED|Overall Study||68||
60041635|NCT02276807|76157482|FG001|STARTED|Overall Study||72||
59510436|NCT00884611|75603884|FG000|NOT COMPLETED|Overall Study||1||
59510437|NCT00891319|75603896|FG000|STARTED|Overall Study||40||
59510438|NCT00891319|75603897|FG001|STARTED|Overall Study||40||
59510439|NCT00891319|75603896|FG000|COMPLETED|Overall Study||32||
59510440|NCT00891319|75603897|FG001|COMPLETED|Overall Study||40||
59510441|NCT00891319|75603896|FG000|NOT COMPLETED|Overall Study||8||
59510442|NCT00891319|75603897|FG001|NOT COMPLETED|Overall Study||0||
59510443|NCT00885079|75603905|FG000|STARTED|Overall Study||93||
59510444|NCT00885079|75603906|FG001|STARTED|Overall Study||95||
60041636|NCT02276807|76157481|FG000|12-week Assessment|Overall Study||57|Participant completed the main outcome measure, but may not have completed all required measures.|
60041637|NCT02276807|76157482|FG001|12-week Assessment|Overall Study||63|Participant completed the main outcome measure, but may not have completed all required measures.|
60041638|NCT02276807|76157481|FG000|COMPLETED|Overall Study||50|Participant completed the main outcome measure, but may not have completed all required measures.|
60041639|NCT02276807|76157482|FG001|COMPLETED|Overall Study||55|Participant completed the main outcome measure, but may not have completed all required measures.|
59510445|NCT00885079|75603905|FG000|COMPLETED|Overall Study||91||
59510446|NCT00885079|75603906|FG001|COMPLETED|Overall Study||91||
59510447|NCT00885079|75603905|FG000|NOT COMPLETED|Overall Study||2||
59510448|NCT00885079|75603906|FG001|NOT COMPLETED|Overall Study||4||
59510449|NCT00896779|75603914|FG000|STARTED|Overall Study||8||
59510450|NCT00896779|75603915|FG001|STARTED|Overall Study||12||
59510451|NCT00896779|75603914|FG000|COMPLETED|Overall Study||8||
59510452|NCT00896779|75603915|FG001|COMPLETED|Overall Study||11||
59510453|NCT00896779|75603914|FG000|NOT COMPLETED|Overall Study||0||
59510454|NCT00896779|75603915|FG001|NOT COMPLETED|Overall Study||1||
59510455|NCT02726620|75603923|FG000|STARTED|Historic Cohort - Three Years||17463||
59510456|NCT02726620|75603924|FG001|STARTED|Historic Cohort - Three Years||0||
59510457|NCT02726620|75603923|FG000|MAP < 65 mmHg: Primary Analysis|Historic Cohort - Three Years||15624|Per study protocol only patients with any MAP < 65 mmHg will be included in the primary analysis.|
59510458|NCT02726620|75603924|FG001|MAP < 65 mmHg: Primary Analysis|Historic Cohort - Three Years||0|Per study protocol only patients with any MAP < 65 mmHg will be included in the primary analysis.|
59510459|NCT02726620|75603923|FG000|COMPLETED|Historic Cohort - Three Years||17463||
59510460|NCT02726620|75603924|FG001|COMPLETED|Historic Cohort - Three Years||0||
59510461|NCT02726620|75603923|FG000|NOT COMPLETED|Historic Cohort - Three Years||0||
59510462|NCT02726620|75603924|FG001|NOT COMPLETED|Historic Cohort - Three Years||0||
59510463|NCT02726620|75603923|FG000|STARTED|Month 1: Attending Randomization||0||
59510464|NCT02726620|75603924|FG001|STARTED|Month 1: Attending Randomization||485||
59510465|NCT02726620|75603923|FG000|MAP < 65 mmHg: Primary Analysis|Month 1: Attending Randomization||0|Per study protocol only patients with any MAP < 65 mmHg will be included in the primary analysis.|
59510466|NCT02726620|75603924|FG001|MAP < 65 mmHg: Primary Analysis|Month 1: Attending Randomization||432|Per study protocol only patients with any MAP < 65 mmHg will be included in the primary analysis.|
59510467|NCT02726620|75603923|FG000|Correct IOH Notifications|Month 1: Attending Randomization||0|The decision support notifications log matches the actual occurrens of intraoperative hypotension.|
59612380|NCT01701258|75723501|FG002|COMPLETED|Assessment and Scheduling||0|Participants completed the study if they completed the screening session and two imaging sessions.|
59510468|NCT02726620|75603924|FG001|Correct IOH Notifications|Month 1: Attending Randomization||313|The decision support notifications log matches the actual occurrens of intraoperative hypotension.|
59510469|NCT02726620|75603923|FG000|COMPLETED|Month 1: Attending Randomization||0||
59510470|NCT02726620|75603924|FG001|COMPLETED|Month 1: Attending Randomization||485||
59510471|NCT02726620|75603923|FG000|NOT COMPLETED|Month 1: Attending Randomization||0||
59510472|NCT02726620|75603924|FG001|NOT COMPLETED|Month 1: Attending Randomization||0||
59510473|NCT02726620|75603923|FG000|STARTED|Months 2-3: In-room Providers Randomized||0||
60041640|NCT02276807|76157481|FG000|NOT COMPLETED|Overall Study||18||
60041641|NCT02276807|76157482|FG001|NOT COMPLETED|Overall Study||17||
60041642|NCT02252965|76157490|FG000|STARTED|Overall Study||267||
60041643|NCT02252965|76157491|FG001|STARTED|Overall Study||265||
60041644|NCT02252965|76157490|FG000|Safety Population|Overall Study|Out of 261, 12 subjects intolerant to the Metformin IR switched to Metformin XR group.|261||
60041645|NCT02252965|76157491|FG001|Safety Population|Overall Study||264||
60041646|NCT02252965|76157490|FG000|COMPLETED|Overall Study||227||
60041647|NCT02252965|76157491|FG001|COMPLETED|Overall Study||222||
59510474|NCT02726620|75603924|FG001|STARTED|Months 2-3: In-room Providers Randomized||1253||
59510475|NCT02726620|75603923|FG000|MAP < 65 mmHg: Primary Analysis|Months 2-3: In-room Providers Randomized||0|Per study protocol only patients with any MAP < 65 mmHg will be included in the primary analysis.|
59510476|NCT02726620|75603924|FG001|MAP < 65 mmHg: Primary Analysis|Months 2-3: In-room Providers Randomized||1103|Per study protocol only patients with any MAP < 65 mmHg will be included in the primary analysis.|
59510477|NCT02726620|75603923|FG000|Correct IOH Notifications|Months 2-3: In-room Providers Randomized||0|The decision support notifications log matches the actual occurrens of intraoperative hypotension.|
59510478|NCT02726620|75603924|FG001|Correct IOH Notifications|Months 2-3: In-room Providers Randomized||825|The decision support notifications log matches the actual occurrens of intraoperative hypotension.|
59510479|NCT02726620|75603923|FG000|COMPLETED|Months 2-3: In-room Providers Randomized||0||
60041648|NCT02252965|76157490|FG000|NOT COMPLETED|Overall Study||40||
60041649|NCT02252965|76157491|FG001|NOT COMPLETED|Overall Study||43||
60041650|NCT02242435|76157501|FG000|STARTED|Overall Study||172||
60041651|NCT02242435|76157502|FG001|STARTED|Overall Study||170||
60041652|NCT02242435|76157501|FG000|COMPLETED|Overall Study||152||
60041653|NCT02242435|76157502|FG001|COMPLETED|Overall Study||154||
60041654|NCT02242435|76157501|FG000|NOT COMPLETED|Overall Study||20||
60041655|NCT02242435|76157502|FG001|NOT COMPLETED|Overall Study||16||
60041656|NCT02251717|76157510|FG000|STARTED|Overall Study||57||
60041657|NCT02251717|76157511|FG001|STARTED|Overall Study||57||
60041658|NCT02251717|76157510|FG000|COMPLETED|Overall Study||56||
60041659|NCT02251717|76157511|FG001|COMPLETED|Overall Study||56||
60041660|NCT02251717|76157510|FG000|NOT COMPLETED|Overall Study||1||
60041661|NCT02251717|76157511|FG001|NOT COMPLETED|Overall Study||1||
60041662|NCT02242201|76157520|FG000|STARTED|Overall Study||55||
60041663|NCT02242201|76157521|FG001|STARTED|Overall Study||55||
60041664|NCT02242201|76157522|FG002|STARTED|Overall Study||55||
60041665|NCT02242201|76157520|FG000|COMPLETED|Overall Study||51||
60041666|NCT02242201|76157521|FG001|COMPLETED|Overall Study||54||
60041667|NCT02242201|76157522|FG002|COMPLETED|Overall Study||54||
60041668|NCT02242201|76157520|FG000|NOT COMPLETED|Overall Study||4||
59510480|NCT02726620|75603924|FG001|COMPLETED|Months 2-3: In-room Providers Randomized||1253||
59510481|NCT02726620|75603923|FG000|NOT COMPLETED|Months 2-3: In-room Providers Randomized||0||
59510482|NCT02726620|75603924|FG001|NOT COMPLETED|Months 2-3: In-room Providers Randomized||0||
60041669|NCT02242201|76157521|FG001|NOT COMPLETED|Overall Study||1||
60041670|NCT02242201|76157522|FG002|NOT COMPLETED|Overall Study||1||
60041671|NCT02242045|76157530|FG000|STARTED|Overall Study||6||
60041672|NCT02242045|76157530|FG000|COMPLETED|Overall Study||0||
60041673|NCT02242045|76157530|FG000|NOT COMPLETED|Overall Study||6||
60041674|NCT02241889|76157534|FG000|STARTED|Overall Study||4||
60041675|NCT02241889|76157535|FG001|STARTED|Overall Study||4||
60041676|NCT02241889|76157536|FG002|STARTED|Overall Study||3||
60041677|NCT02241889|76157537|FG003|STARTED|Overall Study||3||
60041678|NCT02241889|76157538|FG004|STARTED|Overall Study||5||
60041679|NCT02241889|76157539|FG005|STARTED|Overall Study||4||
60041680|NCT02241889|76157534|FG000|COMPLETED|Overall Study||4||
60041681|NCT02241889|76157535|FG001|COMPLETED|Overall Study||4||
60041682|NCT02241889|76157536|FG002|COMPLETED|Overall Study||2||
60041683|NCT02241889|76157537|FG003|COMPLETED|Overall Study||3||
60041684|NCT02241889|76157538|FG004|COMPLETED|Overall Study||5||
60041685|NCT02241889|76157539|FG005|COMPLETED|Overall Study||3||
60041686|NCT02241889|76157534|FG000|NOT COMPLETED|Overall Study||0||
59510483|NCT02726620|75603923|FG000|STARTED|Through End of Study: All Interventions||0||
60041687|NCT02241889|76157535|FG001|NOT COMPLETED|Overall Study||0||
60041688|NCT02241889|76157536|FG002|NOT COMPLETED|Overall Study||1||
60041689|NCT02241889|76157537|FG003|NOT COMPLETED|Overall Study||0||
60041690|NCT02241889|76157538|FG004|NOT COMPLETED|Overall Study||0||
60041691|NCT02241889|76157539|FG005|NOT COMPLETED|Overall Study||1||
60041692|NCT02241733|76157549|FG000|STARTED|Overall Study||40||
60041693|NCT02241733|76157550|FG001|STARTED|Overall Study||40||
60041694|NCT02241733|76157549|FG000|COMPLETED|Overall Study||25||
60041695|NCT02241733|76157550|FG001|COMPLETED|Overall Study||30||
60041696|NCT02241733|76157549|FG000|NOT COMPLETED|Overall Study||15||
60041697|NCT02241733|76157550|FG001|NOT COMPLETED|Overall Study||10||
60041698|NCT02241343|76157556|FG000|STARTED|Overall Study||1||
60041699|NCT02241343|76157556|FG000|COMPLETED|Overall Study||0||
60041700|NCT02241343|76157556|FG000|NOT COMPLETED|Overall Study||1||
60041701|NCT02241187|76157561|FG000|STARTED|Overall Study||2||
60041702|NCT02241187|76157561|FG000|COMPLETED|Overall Study||0||
60041703|NCT02241187|76157561|FG000|NOT COMPLETED|Overall Study||2||
60041704|NCT02249767|76157568|FG000|STARTED|Overall Study||230||
60041705|NCT02249767|76157569|FG001|STARTED|Overall Study||229||
60041706|NCT02249767|76157570|FG002|STARTED|Overall Study||115||
60041707|NCT02249767|76157568|FG000|COMPLETED|Overall Study||222||
60041708|NCT02249767|76157569|FG001|COMPLETED|Overall Study||220||
60041709|NCT02249767|76157570|FG002|COMPLETED|Overall Study||107||
60041710|NCT02249767|76157568|FG000|NOT COMPLETED|Overall Study||8||
60041711|NCT02249767|76157569|FG001|NOT COMPLETED|Overall Study||9||
60041712|NCT02249767|76157570|FG002|NOT COMPLETED|Overall Study||8||
60041713|NCT02239939|76157580|FG000|STARTED|Overall Study||20||
60041714|NCT02239939|76157581|FG001|STARTED|Overall Study||17||
60041715|NCT02239939|76157580|FG000|COMPLETED|Overall Study||18||
60041716|NCT02239939|76157581|FG001|COMPLETED|Overall Study||15||
60041717|NCT02239939|76157580|FG000|NOT COMPLETED|Overall Study||2||
60041718|NCT02239939|76157581|FG001|NOT COMPLETED|Overall Study||2||
60041719|NCT02248675|76157591|FG000|STARTED|Overall Study||26||
60041720|NCT02248675|76157592|FG001|STARTED|Overall Study||28||
60041721|NCT02248675|76157591|FG000|COMPLETED|Overall Study||23||
60041722|NCT02248675|76157592|FG001|COMPLETED|Overall Study||27||
60041723|NCT02248675|76157591|FG000|NOT COMPLETED|Overall Study||3||
60041724|NCT02248675|76157592|FG001|NOT COMPLETED|Overall Study||1||
60041725|NCT02238379|76157600|FG000|STARTED|Overall Study||12||
60041726|NCT02238379|76157601|FG001|STARTED|Overall Study||14||
60041727|NCT02238379|76157600|FG000|COMPLETED|Overall Study||11||
60041728|NCT02238379|76157601|FG001|COMPLETED|Overall Study||14||
60041729|NCT02238379|76157600|FG000|NOT COMPLETED|Overall Study||1||
60041730|NCT02238379|76157601|FG001|NOT COMPLETED|Overall Study||0||
60041731|NCT02238067|76157607|FG000|STARTED|Overall Study||196||
60041732|NCT02238067|76157607|FG000|COMPLETED|Overall Study||151||
60041733|NCT02238067|76157607|FG000|NOT COMPLETED|Overall Study||45||
60041734|NCT02237911|76157614|FG000|STARTED|Overall Study||96||
60041735|NCT02237911|76157615|FG001|STARTED|Overall Study||96||
60041736|NCT02237911|76157616|FG002|STARTED|Overall Study||48||
60041737|NCT02237911|76157614|FG000|3 Months|Overall Study||90||
60041738|NCT02237911|76157615|FG001|3 Months|Overall Study||87||
60041739|NCT02237911|76157616|FG002|3 Months|Overall Study||44||
60041740|NCT02237911|76157614|FG000|6 Months|Overall Study||89||
60041741|NCT02237911|76157615|FG001|6 Months|Overall Study||88||
60041742|NCT02237911|76157616|FG002|6 Months|Overall Study||45||
60041743|NCT02237911|76157614|FG000|COMPLETED|Overall Study||89||
60041744|NCT02237911|76157615|FG001|COMPLETED|Overall Study||88||
60041745|NCT02237911|76157616|FG002|COMPLETED|Overall Study||45||
60041746|NCT02237911|76157614|FG000|NOT COMPLETED|Overall Study||7||
60041747|NCT02237911|76157615|FG001|NOT COMPLETED|Overall Study||8||
60041748|NCT02237911|76157616|FG002|NOT COMPLETED|Overall Study||3||
59510484|NCT02726620|75603924|FG001|STARTED|Through End of Study: All Interventions||3234||
59510485|NCT02726620|75603923|FG000|MAP < 65 mmHg: Primary Analysis|Through End of Study: All Interventions||0|Per study protocol only patients with any MAP < 65 mmHg will be included in the primary analysis.|
59510486|NCT02726620|75603924|FG001|MAP < 65 mmHg: Primary Analysis|Through End of Study: All Interventions||2793|Per study protocol only patients with any MAP < 65 mmHg will be included in the primary analysis.|
59510487|NCT02726620|75603923|FG000|Correct IOH Notifications|Through End of Study: All Interventions||0|The decision support notifications log matches the actual occurrens of intraoperative hypotension.|
59510488|NCT02726620|75603924|FG001|Correct IOH Notifications|Through End of Study: All Interventions||2072|The decision support notifications log matches the actual occurrens of intraoperative hypotension.|
59510489|NCT02726620|75603923|FG000|COMPLETED|Through End of Study: All Interventions||0||
59510490|NCT02726620|75603924|FG001|COMPLETED|Through End of Study: All Interventions||3234||
59510491|NCT02726620|75603923|FG000|NOT COMPLETED|Through End of Study: All Interventions||0||
59510492|NCT02726620|75603924|FG001|NOT COMPLETED|Through End of Study: All Interventions||0||
60041749|NCT02234479|76157626|FG000|STARTED|Overall Study||16||
60041750|NCT02234479|76157627|FG001|STARTED|Overall Study||18||
60041751|NCT02234479|76157626|FG000|COMPLETED|Overall Study||15||
60041752|NCT02234479|76157627|FG001|COMPLETED|Overall Study||15||
60041753|NCT02234479|76157626|FG000|NOT COMPLETED|Overall Study||1||
60041754|NCT02234479|76157627|FG001|NOT COMPLETED|Overall Study||3||
59510493|NCT00887575|75603930|FG000|STARTED|Phase I||6||
59510494|NCT00887575|75603931|FG001|STARTED|Phase I||6||
59510495|NCT00887575|75603932|FG002|STARTED|Phase I||3||
59510496|NCT00887575|75603930|FG000|COMPLETED|Phase I||6||
59510497|NCT00887575|75603931|FG001|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0||
59510498|NCT00887575|75603932|FG002|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0||
59510499|NCT00887575|75603930|FG000|NOT COMPLETED|Phase I||0||
59510500|NCT00887575|75603931|FG001|NOT COMPLETED|Phase I||6||
60041755|NCT02207491|76157635|FG000|STARTED|Overall Study||202||
60041756|NCT02207491|76157636|FG001|STARTED|Overall Study||209||
60041757|NCT02207491|76157635|FG000|COMPLETED|Overall Study||171||
60041758|NCT02207491|76157636|FG001|COMPLETED|Overall Study||196||
60041759|NCT02207491|76157635|FG000|NOT COMPLETED|Overall Study||31||
60041760|NCT02207491|76157636|FG001|NOT COMPLETED|Overall Study||13||
60041761|NCT02315066|76157656|FG000|STARTED|Overall Study||2||
60041762|NCT02315066|76157657|FG001|STARTED|Overall Study||10||
59510501|NCT00887575|75603932|FG002|NOT COMPLETED|Phase I||3||
59519025|NCT03587428|75612874|FG004|COMPLETED|Period 3||2||
59759722|NCT04159701|75879147|FG000|NOT COMPLETED|Washout Period||13||
60041763|NCT02315066|76157658|FG002|STARTED|Overall Study||11||
60041764|NCT02315066|76157659|FG003|STARTED|Overall Study||12||
60041765|NCT02315066|76157660|FG004|STARTED|Overall Study||13||
60041766|NCT02315066|76157661|FG005|STARTED|Overall Study||4||
60041767|NCT02315066|76157662|FG006|STARTED|Overall Study||16||
60041768|NCT02315066|76157663|FG007|STARTED|Overall Study||19||
60041769|NCT02315066|76157664|FG008|STARTED|Overall Study||11||
60041770|NCT02315066|76157665|FG009|STARTED|Overall Study||12||
60041771|NCT02315066|76157666|FG010|STARTED|Overall Study||12||
60041772|NCT02315066|76157667|FG011|STARTED|Overall Study||11||
60041773|NCT02315066|76157668|FG012|STARTED|Overall Study||11||
60041774|NCT02315066|76157669|FG013|STARTED|Overall Study||30||
60041775|NCT02315066|76157656|FG000|COMPLETED|Overall Study||0||
60041776|NCT02315066|76157657|FG001|COMPLETED|Overall Study||0||
60041777|NCT02315066|76157658|FG002|COMPLETED|Overall Study||2||
60041778|NCT02315066|76157659|FG003|COMPLETED|Overall Study||1||
60041779|NCT02315066|76157660|FG004|COMPLETED|Overall Study||2||
60041780|NCT02315066|76157661|FG005|COMPLETED|Overall Study||1||
60041781|NCT02315066|76157662|FG006|COMPLETED|Overall Study||3||
60041782|NCT02315066|76157663|FG007|COMPLETED|Overall Study||5||
60041783|NCT02315066|76157664|FG008|COMPLETED|Overall Study||0||
60041784|NCT02315066|76157665|FG009|COMPLETED|Overall Study||1||
60041785|NCT02315066|76157666|FG010|COMPLETED|Overall Study||0||
60041786|NCT02315066|76157667|FG011|COMPLETED|Overall Study||0||
60041787|NCT02315066|76157668|FG012|COMPLETED|Overall Study||1||
60041788|NCT02315066|76157669|FG013|COMPLETED|Overall Study||0||
60041789|NCT02315066|76157656|FG000|NOT COMPLETED|Overall Study||2||
60041790|NCT02315066|76157657|FG001|NOT COMPLETED|Overall Study||10||
60041791|NCT02315066|76157658|FG002|NOT COMPLETED|Overall Study||9||
60041792|NCT02315066|76157659|FG003|NOT COMPLETED|Overall Study||11||
60041793|NCT02315066|76157660|FG004|NOT COMPLETED|Overall Study||11||
60041794|NCT02315066|76157661|FG005|NOT COMPLETED|Overall Study||3||
60041795|NCT02315066|76157662|FG006|NOT COMPLETED|Overall Study||13||
60041796|NCT02315066|76157663|FG007|NOT COMPLETED|Overall Study||14||
60041797|NCT02315066|76157664|FG008|NOT COMPLETED|Overall Study||11||
60041798|NCT02315066|76157665|FG009|NOT COMPLETED|Overall Study||11||
60041799|NCT02315066|76157666|FG010|NOT COMPLETED|Overall Study||12||
60041800|NCT02315066|76157667|FG011|NOT COMPLETED|Overall Study||11||
60041801|NCT02315066|76157668|FG012|NOT COMPLETED|Overall Study||10||
60041802|NCT02315066|76157669|FG013|NOT COMPLETED|Overall Study||30||
60041803|NCT02207413|76157705|FG000|STARTED|Overall Study||60||
60041804|NCT02207413|76157706|FG001|STARTED|Overall Study||60||
60041805|NCT02207413|76157707|FG002|STARTED|Overall Study||410||
60041806|NCT02207413|76157708|FG003|STARTED|Overall Study||411||
60041807|NCT02207413|76157709|FG004|STARTED|Overall Study||466||
60041808|NCT02207413|76157710|FG005|STARTED|Overall Study||474||
60041809|NCT02207413|76157705|FG000|COMPLETED|Overall Study||59||
60041810|NCT02207413|76157706|FG001|COMPLETED|Overall Study||60||
60041811|NCT02207413|76157707|FG002|COMPLETED|Overall Study|Primed subjects: 309; Unprimed subjects: 101|410||
60041812|NCT02207413|76157708|FG003|COMPLETED|Overall Study|Primed subjects: 312; Unprimed subjects: 98|410||
60041813|NCT02207413|76157709|FG004|COMPLETED|Overall Study|Primed subjects: 40; Unprimed subjects: 419|459||
60041814|NCT02207413|76157710|FG005|COMPLETED|Overall Study|Primed subjects: 41; Unprimed subjects: 420|461||
60041815|NCT02207413|76157705|FG000|NOT COMPLETED|Overall Study||1||
60041816|NCT02207413|76157706|FG001|NOT COMPLETED|Overall Study||0||
60041817|NCT02207413|76157707|FG002|NOT COMPLETED|Overall Study||0||
60041818|NCT02207413|76157708|FG003|NOT COMPLETED|Overall Study||1||
60041819|NCT02207413|76157709|FG004|NOT COMPLETED|Overall Study||7||
60041820|NCT02207413|76157710|FG005|NOT COMPLETED|Overall Study||13||
60041821|NCT02309372|76157732|FG000|STARTED|Overall Study||27||
60041822|NCT02309372|76157733|FG001|STARTED|Overall Study||27||
60041823|NCT02309372|76157732|FG000|COMPLETED|Overall Study||24||
60041824|NCT02309372|76157733|FG001|COMPLETED|Overall Study||25||
60041825|NCT02309372|76157732|FG000|NOT COMPLETED|Overall Study||3||
60041826|NCT02309372|76157733|FG001|NOT COMPLETED|Overall Study||2||
60041827|NCT02276027|76157743|FG000|STARTED|Overall Study||2||
60041828|NCT02276027|76157744|FG001|STARTED|Overall Study||16||
60041829|NCT02276027|76157745|FG002|STARTED|Overall Study||26||
60041830|NCT02276027|76157746|FG003|STARTED|Overall Study||22||
60041831|NCT02276027|76157743|FG000|COMPLETED|Overall Study||0||
60041832|NCT02276027|76157744|FG001|COMPLETED|Overall Study||0||
60041833|NCT02276027|76157745|FG002|COMPLETED|Overall Study||6||
60041834|NCT02276027|76157746|FG003|COMPLETED|Overall Study||0||
60041835|NCT02276027|76157743|FG000|NOT COMPLETED|Overall Study||2||
60041836|NCT02276027|76157744|FG001|NOT COMPLETED|Overall Study||16||
60041837|NCT02276027|76157745|FG002|NOT COMPLETED|Overall Study||20||
60041838|NCT02276027|76157746|FG003|NOT COMPLETED|Overall Study||22||
60041839|NCT02309294|76157756|FG000|STARTED|Overall Study||43||
60041840|NCT02309294|76157756|FG000|COMPLETED|Overall Study||41||
60041841|NCT02309294|76157756|FG000|NOT COMPLETED|Overall Study||2||
60041842|NCT02233543|76157760|FG000|STARTED|Period 1||22||
60041843|NCT02233543|76157761|FG001|STARTED|Period 1||16||
60041844|NCT02233543|76157760|FG000|COMPLETED|Period 1||19||
60041845|NCT02233543|76157761|FG001|COMPLETED|Period 1||13||
60041846|NCT02233543|76157760|FG000|NOT COMPLETED|Period 1||3||
60041847|NCT02233543|76157761|FG001|NOT COMPLETED|Period 1||3||
60041848|NCT02233543|76157760|FG000|STARTED|Period 2||19||
60041849|NCT02233543|76157761|FG001|STARTED|Period 2||13||
60041850|NCT02233543|76157760|FG000|COMPLETED|Period 2|1 participant erroneously received QVA149 during both periods.|17||
60041851|NCT02233543|76157761|FG001|COMPLETED|Period 2||12||
60041852|NCT02233543|76157760|FG000|NOT COMPLETED|Period 2||2||
60041853|NCT02233543|76157761|FG001|NOT COMPLETED|Period 2||1||
60041854|NCT02309138|76157769|FG000|STARTED|Overall Study||460||
60041855|NCT02309138|76157770|FG001|STARTED|Overall Study||461||
60041856|NCT02309138|76157769|FG000|COMPLETED|Overall Study||412||
60041857|NCT02309138|76157770|FG001|COMPLETED|Overall Study||443||
60041858|NCT02309138|76157769|FG000|NOT COMPLETED|Overall Study||48||
60041859|NCT02309138|76157770|FG001|NOT COMPLETED|Overall Study||18||
60041860|NCT02233309|76157786|FG000|STARTED|Overall Study||36||
60041861|NCT02233309|76157786|FG000|COMPLETED|Overall Study||31||
60041862|NCT02233309|76157786|FG000|NOT COMPLETED|Overall Study||5||
60041863|NCT02204917|76157790|FG000|STARTED|Overall Study||31||
60041864|NCT02204917|76157790|FG000|COMPLETED|Overall Study||30||
60041865|NCT02204917|76157790|FG000|NOT COMPLETED|Overall Study||1||
60041866|NCT02280044|76157799|FG000|STARTED|Overall Study||15||
60041867|NCT02280044|76157800|FG001|STARTED|Overall Study||15||
60041868|NCT02280044|76157799|FG000|COMPLETED|Overall Study||15||
60041869|NCT02280044|76157800|FG001|COMPLETED|Overall Study||13||
60041870|NCT02280044|76157799|FG000|NOT COMPLETED|Overall Study||0||
60041871|NCT02280044|76157800|FG001|NOT COMPLETED|Overall Study||2||
60041872|NCT02308748|76157806|FG000|STARTED|Period 1||2||
60041873|NCT02308748|76157807|FG001|STARTED|Period 1||2||
60041874|NCT02308748|76157808|FG002|STARTED|Period 1||2||
60041875|NCT02308748|76157809|FG003|STARTED|Period 1||2||
60041876|NCT02308748|76157810|FG004|STARTED|Period 1||2||
60041877|NCT02308748|76157811|FG005|STARTED|Period 1||3||
60041878|NCT02308748|76157812|FG006|STARTED|Period 1||2||
60041879|NCT02308748|76157813|FG007|STARTED|Period 1||2||
60041880|NCT02308748|76157814|FG008|STARTED|Period 1||2||
60041881|NCT02308748|76157815|FG009|STARTED|Period 1||3||
60041882|NCT02308748|76157806|FG000|COMPLETED|Period 1||2||
60041883|NCT02308748|76157807|FG001|COMPLETED|Period 1||2||
60041884|NCT02308748|76157808|FG002|COMPLETED|Period 1|One subject withdraw consent before starting Period 2|1||
60041885|NCT02308748|76157809|FG003|COMPLETED|Period 1||2||
60041886|NCT02308748|76157810|FG004|COMPLETED|Period 1||2||
60041887|NCT02308748|76157811|FG005|COMPLETED|Period 1||3||
60041888|NCT02308748|76157812|FG006|COMPLETED|Period 1||2||
60041889|NCT02308748|76157813|FG007|COMPLETED|Period 1||2||
60041890|NCT02308748|76157814|FG008|COMPLETED|Period 1||2||
60041891|NCT02308748|76157815|FG009|COMPLETED|Period 1||3||
60041892|NCT02308748|76157806|FG000|NOT COMPLETED|Period 1||0||
60041893|NCT02308748|76157807|FG001|NOT COMPLETED|Period 1||0||
60041894|NCT02308748|76157808|FG002|NOT COMPLETED|Period 1||1||
60041895|NCT02308748|76157809|FG003|NOT COMPLETED|Period 1||0||
60041896|NCT02308748|76157810|FG004|NOT COMPLETED|Period 1||0||
60041897|NCT02308748|76157811|FG005|NOT COMPLETED|Period 1||0||
60041898|NCT02308748|76157812|FG006|NOT COMPLETED|Period 1||0||
60041899|NCT02308748|76157813|FG007|NOT COMPLETED|Period 1||0||
60041900|NCT02308748|76157814|FG008|NOT COMPLETED|Period 1||0||
60041901|NCT02308748|76157815|FG009|NOT COMPLETED|Period 1||0||
60041902|NCT02308748|76157806|FG000|STARTED|Period 2||2||
60041903|NCT02308748|76157807|FG001|STARTED|Period 2||2||
60041904|NCT02308748|76157808|FG002|STARTED|Period 2||1||
60041905|NCT02308748|76157809|FG003|STARTED|Period 2||2||
60041906|NCT02308748|76157810|FG004|STARTED|Period 2||2||
59759723|NCT04159701|75879148|FG001|NOT COMPLETED|Washout Period||4||
60041907|NCT02308748|76157811|FG005|STARTED|Period 2||3||
60041908|NCT02308748|76157812|FG006|STARTED|Period 2||2||
60041909|NCT02308748|76157813|FG007|STARTED|Period 2||2||
60041910|NCT02308748|76157814|FG008|STARTED|Period 2||2||
60041911|NCT02308748|76157815|FG009|STARTED|Period 2||3||
60041912|NCT02308748|76157806|FG000|COMPLETED|Period 2||2||
60041913|NCT02308748|76157807|FG001|COMPLETED|Period 2||2||
60041914|NCT02308748|76157808|FG002|COMPLETED|Period 2||1||
60041915|NCT02308748|76157809|FG003|COMPLETED|Period 2||2||
60041916|NCT02308748|76157810|FG004|COMPLETED|Period 2||2||
60041917|NCT02308748|76157811|FG005|COMPLETED|Period 2||3||
60041918|NCT02308748|76157812|FG006|COMPLETED|Period 2||2||
60041919|NCT02308748|76157813|FG007|COMPLETED|Period 2||1||
60041920|NCT02308748|76157814|FG008|COMPLETED|Period 2||2||
60041921|NCT02308748|76157815|FG009|COMPLETED|Period 2||3||
60041922|NCT02308748|76157806|FG000|NOT COMPLETED|Period 2||0||
60041923|NCT02308748|76157807|FG001|NOT COMPLETED|Period 2||0||
60041924|NCT02308748|76157808|FG002|NOT COMPLETED|Period 2||0||
60041925|NCT02308748|76157809|FG003|NOT COMPLETED|Period 2||0||
60041926|NCT02308748|76157810|FG004|NOT COMPLETED|Period 2||0||
60041927|NCT02308748|76157811|FG005|NOT COMPLETED|Period 2||0||
59759724|NCT04159701|75879147|FG000|STARTED|Period 2: Treatment Period (Crossover)||18||
60041928|NCT02308748|76157812|FG006|NOT COMPLETED|Period 2||0||
60041929|NCT02308748|76157813|FG007|NOT COMPLETED|Period 2||1||
60041930|NCT02308748|76157814|FG008|NOT COMPLETED|Period 2||0||
60041931|NCT02308748|76157815|FG009|NOT COMPLETED|Period 2||0||
60041932|NCT02308748|76157806|FG000|STARTED|Period 3||2||
60041933|NCT02308748|76157807|FG001|STARTED|Period 3||2||
60041934|NCT02308748|76157808|FG002|STARTED|Period 3||1||
60041935|NCT02308748|76157809|FG003|STARTED|Period 3||2||
60041936|NCT02308748|76157810|FG004|STARTED|Period 3||2||
60041937|NCT02308748|76157811|FG005|STARTED|Period 3||3||
60041938|NCT02308748|76157812|FG006|STARTED|Period 3||2||
60041939|NCT02308748|76157813|FG007|STARTED|Period 3||1||
60041940|NCT02308748|76157814|FG008|STARTED|Period 3||2||
60041941|NCT02308748|76157815|FG009|STARTED|Period 3||3||
60041942|NCT02308748|76157806|FG000|COMPLETED|Period 3||2||
60041943|NCT02308748|76157807|FG001|COMPLETED|Period 3||2||
60041944|NCT02308748|76157808|FG002|COMPLETED|Period 3||1||
60041945|NCT02308748|76157809|FG003|COMPLETED|Period 3||2||
60041946|NCT02308748|76157810|FG004|COMPLETED|Period 3||2||
60041947|NCT02308748|76157811|FG005|COMPLETED|Period 3||3||
60041948|NCT02308748|76157812|FG006|COMPLETED|Period 3||2||
60041949|NCT02308748|76157813|FG007|COMPLETED|Period 3||1||
60041950|NCT02308748|76157814|FG008|COMPLETED|Period 3||2||
60041951|NCT02308748|76157815|FG009|COMPLETED|Period 3||2||
60041952|NCT02308748|76157806|FG000|NOT COMPLETED|Period 3||0||
60041953|NCT02308748|76157807|FG001|NOT COMPLETED|Period 3||0||
60041954|NCT02308748|76157808|FG002|NOT COMPLETED|Period 3||0||
60041955|NCT02308748|76157809|FG003|NOT COMPLETED|Period 3||0||
60041956|NCT02308748|76157810|FG004|NOT COMPLETED|Period 3||0||
60041957|NCT02308748|76157811|FG005|NOT COMPLETED|Period 3||0||
60041958|NCT02308748|76157812|FG006|NOT COMPLETED|Period 3||0||
60041959|NCT02308748|76157813|FG007|NOT COMPLETED|Period 3||0||
60041960|NCT02308748|76157814|FG008|NOT COMPLETED|Period 3||0||
60041961|NCT02308748|76157815|FG009|NOT COMPLETED|Period 3||1||
60041962|NCT02308748|76157806|FG000|STARTED|Period 4||2||
60041963|NCT02308748|76157807|FG001|STARTED|Period 4||2||
60041964|NCT02308748|76157808|FG002|STARTED|Period 4||1||
60041965|NCT02308748|76157809|FG003|STARTED|Period 4||2||
60041966|NCT02308748|76157810|FG004|STARTED|Period 4||2||
60041967|NCT02308748|76157811|FG005|STARTED|Period 4||3||
60041968|NCT02308748|76157812|FG006|STARTED|Period 4||2||
60041969|NCT02308748|76157813|FG007|STARTED|Period 4||1||
60041970|NCT02308748|76157814|FG008|STARTED|Period 4||2||
60041971|NCT02308748|76157815|FG009|STARTED|Period 4||2||
60041972|NCT02308748|76157806|FG000|COMPLETED|Period 4||2||
60041973|NCT02308748|76157807|FG001|COMPLETED|Period 4||2||
60041974|NCT02308748|76157808|FG002|COMPLETED|Period 4||1||
60041975|NCT02308748|76157809|FG003|COMPLETED|Period 4||2||
60041976|NCT02308748|76157810|FG004|COMPLETED|Period 4||2||
60041977|NCT02308748|76157811|FG005|COMPLETED|Period 4||3||
60041978|NCT02308748|76157812|FG006|COMPLETED|Period 4||2||
60041979|NCT02308748|76157813|FG007|COMPLETED|Period 4||1||
60041980|NCT02308748|76157814|FG008|COMPLETED|Period 4||2||
60041981|NCT02308748|76157815|FG009|COMPLETED|Period 4||2||
60041982|NCT02308748|76157806|FG000|NOT COMPLETED|Period 4||0||
60041983|NCT02308748|76157807|FG001|NOT COMPLETED|Period 4||0||
60041984|NCT02308748|76157808|FG002|NOT COMPLETED|Period 4||0||
60041985|NCT02308748|76157809|FG003|NOT COMPLETED|Period 4||0||
60041986|NCT02308748|76157810|FG004|NOT COMPLETED|Period 4||0||
60041987|NCT02308748|76157811|FG005|NOT COMPLETED|Period 4||0||
60041988|NCT02308748|76157812|FG006|NOT COMPLETED|Period 4||0||
60041989|NCT02308748|76157813|FG007|NOT COMPLETED|Period 4||0||
60041990|NCT02308748|76157814|FG008|NOT COMPLETED|Period 4||0||
60041991|NCT02308748|76157815|FG009|NOT COMPLETED|Period 4||0||
60041992|NCT02308748|76157806|FG000|STARTED|Period 5||2||
60041993|NCT02308748|76157807|FG001|STARTED|Period 5||2||
60041994|NCT02308748|76157808|FG002|STARTED|Period 5||1||
60041995|NCT02308748|76157809|FG003|STARTED|Period 5||2||
60041996|NCT02308748|76157810|FG004|STARTED|Period 5||2||
60041997|NCT02308748|76157811|FG005|STARTED|Period 5||3||
60041998|NCT02308748|76157812|FG006|STARTED|Period 5||2||
60041999|NCT02308748|76157813|FG007|STARTED|Period 5||1||
60042000|NCT02308748|76157814|FG008|STARTED|Period 5||2||
60042001|NCT02308748|76157815|FG009|STARTED|Period 5||2||
60042002|NCT02308748|76157806|FG000|COMPLETED|Period 5||1||
60042003|NCT02308748|76157807|FG001|COMPLETED|Period 5||2||
60042004|NCT02308748|76157808|FG002|COMPLETED|Period 5||1||
60042005|NCT02308748|76157809|FG003|COMPLETED|Period 5||2||
60042006|NCT02308748|76157810|FG004|COMPLETED|Period 5||2||
60042007|NCT02308748|76157811|FG005|COMPLETED|Period 5||3||
60042008|NCT02308748|76157812|FG006|COMPLETED|Period 5||2||
60042009|NCT02308748|76157813|FG007|COMPLETED|Period 5||1||
60042010|NCT02308748|76157814|FG008|COMPLETED|Period 5||1||
60042011|NCT02308748|76157815|FG009|COMPLETED|Period 5||2||
60042012|NCT02308748|76157806|FG000|NOT COMPLETED|Period 5||1||
60042013|NCT02308748|76157807|FG001|NOT COMPLETED|Period 5||0||
60042014|NCT02308748|76157808|FG002|NOT COMPLETED|Period 5||0||
60042015|NCT02308748|76157809|FG003|NOT COMPLETED|Period 5||0||
60042016|NCT02308748|76157810|FG004|NOT COMPLETED|Period 5||0||
60042017|NCT02308748|76157811|FG005|NOT COMPLETED|Period 5||0||
60042018|NCT02308748|76157812|FG006|NOT COMPLETED|Period 5||0||
60042019|NCT02308748|76157813|FG007|NOT COMPLETED|Period 5||0||
60042020|NCT02308748|76157814|FG008|NOT COMPLETED|Period 5||1||
60042021|NCT02308748|76157815|FG009|NOT COMPLETED|Period 5||0||
60042022|NCT01646216|76157829|FG000|STARTED|Overall Study||17||
60042023|NCT01646216|76157830|FG001|STARTED|Overall Study||17||
60042024|NCT01646216|76157829|FG000|COMPLETED|Overall Study||6||
60042025|NCT01646216|76157830|FG001|COMPLETED|Overall Study||4||
60042026|NCT01646216|76157829|FG000|NOT COMPLETED|Overall Study||11||
60042027|NCT01646216|76157830|FG001|NOT COMPLETED|Overall Study||13||
60042028|NCT02308124|76157843|FG000|STARTED|Overall Study||29||
60042029|NCT02308124|76157844|FG001|STARTED|Overall Study||29||
60042030|NCT02308124|76157845|FG002|STARTED|Overall Study||29||
60042031|NCT02308124|76157843|FG000|COMPLETED|Overall Study||23||
60042032|NCT02308124|76157844|FG001|COMPLETED|Overall Study||21||
60042033|NCT02308124|76157845|FG002|COMPLETED|Overall Study||21||
60042034|NCT02308124|76157843|FG000|NOT COMPLETED|Overall Study||6||
60042035|NCT02308124|76157844|FG001|NOT COMPLETED|Overall Study||8||
60042036|NCT02308124|76157845|FG002|NOT COMPLETED|Overall Study||8||
60042037|NCT02232061|76157853|FG000|STARTED|Overall Study||6||
60042038|NCT02232061|76157853|FG000|COMPLETED|Overall Study||4||
60042039|NCT02232061|76157853|FG000|NOT COMPLETED|Overall Study||2||
60042040|NCT02275481|76157859|FG000|STARTED|Overall Study||32||
60042041|NCT02275481|76157860|FG001|STARTED|Overall Study||34||
60042042|NCT02275481|76157859|FG000|COMPLETED|Overall Study||23||
60042043|NCT02275481|76157860|FG001|COMPLETED|Overall Study||31||
60042044|NCT02275481|76157859|FG000|NOT COMPLETED|Overall Study||9||
60042045|NCT02275481|76157860|FG001|NOT COMPLETED|Overall Study||3||
60042046|NCT02204449|76157868|FG000|STARTED|Overall Study||46||
60042047|NCT02204449|76157869|FG001|STARTED|Overall Study||48||
60042048|NCT02204449|76157868|FG000|COMPLETED|Overall Study||39||
60042049|NCT02204449|76157869|FG001|COMPLETED|Overall Study||37||
60042050|NCT02204449|76157868|FG000|NOT COMPLETED|Overall Study||7||
59510502|NCT00887575|75603930|FG000|STARTED|Phase II - Neoadjuvant Therapy|Includes patients treated at MTD during Phase I, 39 additional patients enrolled, 4 were not treated|41||
59510503|NCT00887575|75603931|FG001|STARTED|Phase II - Neoadjuvant Therapy||0||
59510504|NCT00887575|75603932|FG002|STARTED|Phase II - Neoadjuvant Therapy||0||
59510505|NCT00887575|75603930|FG000|COMPLETED|Phase II - Neoadjuvant Therapy||16||
59510506|NCT00887575|75603931|FG001|COMPLETED|Phase II - Neoadjuvant Therapy||0||
59759725|NCT04159701|75879148|FG001|STARTED|Period 2: Treatment Period (Crossover)||8||
59759726|NCT04159701|75879147|FG000|COMPLETED|Period 2: Treatment Period (Crossover)||18||
59759727|NCT04159701|75879148|FG001|COMPLETED|Period 2: Treatment Period (Crossover)||5||
59759728|NCT04159701|75879147|FG000|NOT COMPLETED|Period 2: Treatment Period (Crossover)||0||
59759729|NCT04159701|75879148|FG001|NOT COMPLETED|Period 2: Treatment Period (Crossover)||3||
59759730|NCT04159701|75879147|FG000|STARTED|Post-treatment Follow-up|All participants who received study drug could move to post-treatment follow-up.|29||
59759731|NCT04159701|75879148|FG001|STARTED|Post-treatment Follow-up|All participants who received study drug could move to post-treatment follow-up.|9||
59759732|NCT04159701|75879147|FG000|COMPLETED|Post-treatment Follow-up||19||
59759733|NCT04159701|75879148|FG001|COMPLETED|Post-treatment Follow-up||6||
59918973|NCT05327491|76039395|FG001|STARTED|Period 3 (Food Effect Substudy)||0||
59918974|NCT05327491|76039396|FG002|STARTED|Period 3 (Food Effect Substudy)||7||
59918975|NCT05327491|76039397|FG003|STARTED|Period 3 (Food Effect Substudy)||7||
59918976|NCT05327491|76039394|FG000|COMPLETED|Period 3 (Food Effect Substudy)||0||
59918977|NCT05327491|76039395|FG001|COMPLETED|Period 3 (Food Effect Substudy)||0||
59918978|NCT05327491|76039396|FG002|COMPLETED|Period 3 (Food Effect Substudy)||7||
59918979|NCT05327491|76039397|FG003|COMPLETED|Period 3 (Food Effect Substudy)||7||
59918980|NCT05327491|76039394|FG000|NOT COMPLETED|Period 3 (Food Effect Substudy)||0||
59918981|NCT05327491|76039395|FG001|NOT COMPLETED|Period 3 (Food Effect Substudy)||0||
59918982|NCT05327491|76039396|FG002|NOT COMPLETED|Period 3 (Food Effect Substudy)||0||
59918983|NCT05327491|76039397|FG003|NOT COMPLETED|Period 3 (Food Effect Substudy)||0||
59918984|NCT05320029|76039408|FG000|STARTED|Overall Study||82||
59918985|NCT05320029|76039409|FG001|STARTED|Overall Study||82||
59918986|NCT05320029|76039408|FG000|COMPLETED|Overall Study||80||
59918987|NCT05320029|76039409|FG001|COMPLETED|Overall Study||80||
59918988|NCT05320029|76039408|FG000|NOT COMPLETED|Overall Study||2||
59510507|NCT00887575|75603932|FG002|COMPLETED|Phase II - Neoadjuvant Therapy||0||
59510508|NCT00887575|75603930|FG000|NOT COMPLETED|Phase II - Neoadjuvant Therapy||25||
59759734|NCT04159701|75879147|FG000|NOT COMPLETED|Post-treatment Follow-up||10||
59918989|NCT05320029|76039409|FG001|NOT COMPLETED|Overall Study||2||
60042051|NCT02204449|76157869|FG001|NOT COMPLETED|Overall Study||11||
60042052|NCT02308046|76157877|FG000|STARTED|Overall Study||107||
60042053|NCT02308046|76157878|FG001|STARTED|Overall Study||105||
60042054|NCT02308046|76157877|FG000|COMPLETED|Overall Study||73||
60042055|NCT02308046|76157878|FG001|COMPLETED|Overall Study||67||
60042056|NCT02308046|76157877|FG000|NOT COMPLETED|Overall Study||34||
60042057|NCT02308046|76157878|FG001|NOT COMPLETED|Overall Study||38||
60042058|NCT02318693|76157886|FG000|STARTED|Overall Study||26||
60042059|NCT02318693|76157887|FG001|STARTED|Overall Study||27||
60042060|NCT02318693|76157886|FG000|Treated|Overall Study||26||
60042061|NCT02318693|76157887|FG001|Treated|Overall Study|1 randomized participant did not receive treatment.|26||
60042062|NCT02318693|76157886|FG000|COMPLETED|Overall Study||26||
60042063|NCT02318693|76157887|FG001|COMPLETED|Overall Study||26||
60042064|NCT02318693|76157886|FG000|NOT COMPLETED|Overall Study||0||
60042065|NCT02318693|76157887|FG001|NOT COMPLETED|Overall Study||1||
60042066|NCT02230891|76157896|FG000|STARTED|Baseline||21||
60042067|NCT02230891|76157897|FG001|STARTED|Baseline||18||
60042068|NCT02230891|76157898|FG002|STARTED|Baseline||19||
60042069|NCT02230891|76157896|FG000|COMPLETED|Baseline||21||
60042070|NCT02230891|76157897|FG001|COMPLETED|Baseline||17||
60042071|NCT02230891|76157898|FG002|COMPLETED|Baseline||18||
60042072|NCT02230891|76157896|FG000|NOT COMPLETED|Baseline||0||
60042073|NCT02230891|76157897|FG001|NOT COMPLETED|Baseline||1||
60042074|NCT02230891|76157898|FG002|NOT COMPLETED|Baseline||1||
60042075|NCT02230891|76157896|FG000|STARTED|2 Week||21||
60042076|NCT02230891|76157897|FG001|STARTED|2 Week||17||
60042077|NCT02230891|76157898|FG002|STARTED|2 Week|No week 2 for subjects in usual care|0||
60042078|NCT02230891|76157896|FG000|COMPLETED|2 Week||18||
60042079|NCT02230891|76157897|FG001|COMPLETED|2 Week||15||
60042080|NCT02230891|76157898|FG002|COMPLETED|2 Week|No week 2 for subjects in usual care|0||
60042081|NCT02230891|76157896|FG000|NOT COMPLETED|2 Week||3||
60042082|NCT02230891|76157897|FG001|NOT COMPLETED|2 Week||2||
60042083|NCT02230891|76157898|FG002|NOT COMPLETED|2 Week||0||
60042084|NCT02230891|76157896|FG000|STARTED|6 Month||18||
60042085|NCT02230891|76157897|FG001|STARTED|6 Month||15||
60042086|NCT02230891|76157898|FG002|STARTED|6 Month||18||
60042087|NCT02230891|76157896|FG000|COMPLETED|6 Month||17||
60042088|NCT02230891|76157897|FG001|COMPLETED|6 Month||12||
60042089|NCT02230891|76157898|FG002|COMPLETED|6 Month||17||
60042090|NCT02230891|76157896|FG000|NOT COMPLETED|6 Month||1||
60042091|NCT02230891|76157897|FG001|NOT COMPLETED|6 Month||3||
60042092|NCT02230891|76157898|FG002|NOT COMPLETED|6 Month||1||
60042093|NCT02230891|76157896|FG000|STARTED|12 Month||17||
60042094|NCT02230891|76157897|FG001|STARTED|12 Month||12||
60042095|NCT02230891|76157898|FG002|STARTED|12 Month||17||
60042096|NCT02230891|76157896|FG000|COMPLETED|12 Month||16||
60042097|NCT02230891|76157897|FG001|COMPLETED|12 Month||9||
60042098|NCT02230891|76157898|FG002|COMPLETED|12 Month||17||
60042099|NCT02230891|76157896|FG000|NOT COMPLETED|12 Month||1||
60042100|NCT02230891|76157897|FG001|NOT COMPLETED|12 Month||3||
60042101|NCT02230891|76157898|FG002|NOT COMPLETED|12 Month||0||
60042102|NCT02230891|76157896|FG000|STARTED|18 Month End of Study||16||
60042103|NCT02230891|76157897|FG001|STARTED|18 Month End of Study||9||
60042104|NCT02230891|76157898|FG002|STARTED|18 Month End of Study||17||
60042105|NCT02230891|76157896|FG000|COMPLETED|18 Month End of Study||15||
60042106|NCT02230891|76157897|FG001|COMPLETED|18 Month End of Study||9||
60042107|NCT02230891|76157898|FG002|COMPLETED|18 Month End of Study||16||
60042108|NCT02230891|76157896|FG000|NOT COMPLETED|18 Month End of Study||1||
60042109|NCT02230891|76157897|FG001|NOT COMPLETED|18 Month End of Study||0||
60042110|NCT02230891|76157898|FG002|NOT COMPLETED|18 Month End of Study||1||
60042111|NCT01646138|76157913|FG000|STARTED|Overall Study||5||
60042112|NCT01646138|76157914|FG001|STARTED|Overall Study||4||
60042113|NCT01646138|76157915|FG002|STARTED|Overall Study||5||
60042114|NCT01646138|76157916|FG003|STARTED|Overall Study||19||
60042115|NCT01646138|76157917|FG004|STARTED|Overall Study||15||
60042116|NCT01646138|76157913|FG000|COMPLETED|Overall Study||5||
60042117|NCT01646138|76157914|FG001|COMPLETED|Overall Study||4||
60042118|NCT01646138|76157915|FG002|COMPLETED|Overall Study||5||
60042119|NCT01646138|76157916|FG003|COMPLETED|Overall Study||19||
60042120|NCT01646138|76157917|FG004|COMPLETED|Overall Study||13||
60042121|NCT01646138|76157913|FG000|NOT COMPLETED|Overall Study||0||
60042122|NCT01646138|76157914|FG001|NOT COMPLETED|Overall Study||0||
60042123|NCT01646138|76157915|FG002|NOT COMPLETED|Overall Study||0||
60042124|NCT01646138|76157916|FG003|NOT COMPLETED|Overall Study||0||
60042125|NCT01646138|76157917|FG004|NOT COMPLETED|Overall Study||2||
60042126|NCT02204371|76157929|FG000|STARTED|Overall Study||7||
60042127|NCT02204371|76157929|FG000|COMPLETED|Overall Study||6||
60042128|NCT02204371|76157929|FG000|NOT COMPLETED|Overall Study||1||
60042129|NCT02274857|76157935|FG000|STARTED|Overall Study||179||
60042130|NCT02274857|76157936|FG001|STARTED|Overall Study||171||
60042131|NCT02274857|76157935|FG000|Completed Per Protocol|Overall Study||102|Per protocol are subjects in ITT group who completed all follow-ups with no major deviations.|
60042132|NCT02274857|76157936|FG001|Completed Per Protocol|Overall Study||114|Per protocol are subjects in ITT group who completed all follow-ups with no major deviations.|
60042133|NCT02274857|76157935|FG000|COMPLETED|Overall Study||159||
60042134|NCT02274857|76157936|FG001|COMPLETED|Overall Study||165||
60042135|NCT02274857|76157935|FG000|NOT COMPLETED|Overall Study||20||
60042136|NCT02274857|76157936|FG001|NOT COMPLETED|Overall Study||6||
60042137|NCT02302859|76157945|FG000|STARTED|Overall Study||2||
60042138|NCT02302859|76157946|FG001|STARTED|Overall Study||6||
60042139|NCT02302859|76157945|FG000|COMPLETED|Overall Study||1||
60042140|NCT02302859|76157946|FG001|COMPLETED|Overall Study||4||
60042141|NCT02302859|76157945|FG000|NOT COMPLETED|Overall Study||1||
60042142|NCT02302859|76157946|FG001|NOT COMPLETED|Overall Study||2||
60042143|NCT02274311|76157952|FG000|STARTED|Three Months of Clomiphene Treatment||16||
60042144|NCT02274311|76157952|FG000|COMPLETED|Three Months of Clomiphene Treatment||16||
60042145|NCT02274311|76157952|FG000|NOT COMPLETED|Three Months of Clomiphene Treatment||0||
60042146|NCT02274311|76157952|FG000|STARTED|Three Months of Clomiphene Wash-out||16||
60042147|NCT02274311|76157952|FG000|COMPLETED|Three Months of Clomiphene Wash-out||15||
59759735|NCT04159701|75879148|FG001|NOT COMPLETED|Post-treatment Follow-up||3||
59759736|NCT00880269|75879160|FG000|STARTED|Overall Study||32||
59759737|NCT00880269|75879161|FG001|STARTED|Overall Study||27||
60042148|NCT02274311|76157952|FG000|NOT COMPLETED|Three Months of Clomiphene Wash-out||1||
60042149|NCT02316353|76157960|FG000|STARTED|Overall Study|7 subjects assigned to the CSL830 (40) Arm, were titrated up to the 60 IU/kg arm during the study|63||
60042150|NCT02316353|76157961|FG001|STARTED|Overall Study||63||
60042151|NCT02316353|76157960|FG000|COMPLETED|Overall Study||55||
60042152|NCT02316353|76157961|FG001|COMPLETED|Overall Study||55||
60042153|NCT02316353|76157960|FG000|NOT COMPLETED|Overall Study||8||
60042154|NCT02316353|76157961|FG001|NOT COMPLETED|Overall Study||8||
60042155|NCT02273141|76157972|FG000|STARTED|Overall Study||257||
60042156|NCT02273141|76157973|FG001|STARTED|Overall Study||258||
60042157|NCT02273141|76157972|FG000|COMPLETED|Overall Study||240||
60042158|NCT02273141|76157973|FG001|COMPLETED|Overall Study||233||
60042159|NCT02273141|76157972|FG000|NOT COMPLETED|Overall Study||17||
60042160|NCT02273141|76157973|FG001|NOT COMPLETED|Overall Study||25||
60042161|NCT02314052|76157979|FG000|STARTED|Cycle One||3||
60042162|NCT02314052|76157980|FG001|STARTED|Cycle One||3||
60042163|NCT02314052|76157981|FG002|STARTED|Cycle One||3||
60042164|NCT02314052|76157982|FG003|STARTED|Cycle One||3||
60042165|NCT02314052|76157983|FG004|STARTED|Cycle One||6||
60042166|NCT02314052|76157984|FG005|STARTED|Cycle One||3||
60042167|NCT02314052|76157979|FG000|COMPLETED|Cycle One||3||
60042168|NCT02314052|76157980|FG001|COMPLETED|Cycle One||3||
60042169|NCT02314052|76157981|FG002|COMPLETED|Cycle One||3||
60042170|NCT02314052|76157982|FG003|COMPLETED|Cycle One||2||
60042171|NCT02314052|76157983|FG004|COMPLETED|Cycle One||6||
60042172|NCT02314052|76157984|FG005|COMPLETED|Cycle One||3||
60042173|NCT02314052|76157979|FG000|NOT COMPLETED|Cycle One||0||
60042174|NCT02314052|76157980|FG001|NOT COMPLETED|Cycle One||0||
60042175|NCT02314052|76157981|FG002|NOT COMPLETED|Cycle One||0||
60042176|NCT02314052|76157982|FG003|NOT COMPLETED|Cycle One||1||
59510509|NCT00887575|75603931|FG001|NOT COMPLETED|Phase II - Neoadjuvant Therapy||0||
59510510|NCT00887575|75603932|FG002|NOT COMPLETED|Phase II - Neoadjuvant Therapy||0||
59519026|NCT03587428|75612875|FG005|COMPLETED|Period 3||2||
59759738|NCT00880269|75879160|FG000|Discontinued Treatment|Overall Study||32||
59759739|NCT00880269|75879161|FG001|Discontinued Treatment|Overall Study||27||
59918990|NCT05299892|76039415|FG000|STARTED|Overall Study||36||
59918991|NCT05299892|76039415|FG000|COMPLETED|Overall Study||34||
59918992|NCT05299892|76039415|FG000|NOT COMPLETED|Overall Study||2||
59918993|NCT04983940|76039420|FG000|STARTED|Overall Study||41||
59918994|NCT04983940|76039420|FG000|COMPLETED|Overall Study||25||
59918995|NCT04983940|76039420|FG000|NOT COMPLETED|Overall Study||16||
59918996|NCT04966910|76039428|FG000|STARTED|Baseline||22||2
59918997|NCT04966910|76039429|FG001|STARTED|Baseline||18||2
59918998|NCT04966910|76039430|FG002|STARTED|Baseline||2||2
59918999|NCT04966910|76039431|FG003|STARTED|Baseline||2||2
59919000|NCT04966910|76039428|FG000|COMPLETED|Baseline||22||2
59919001|NCT04966910|76039429|FG001|COMPLETED|Baseline||18||2
59919002|NCT04966910|76039430|FG002|COMPLETED|Baseline||1||1
60042177|NCT02314052|76157983|FG004|NOT COMPLETED|Cycle One||0||
60042178|NCT02314052|76157984|FG005|NOT COMPLETED|Cycle One||0||
60042179|NCT02314052|76157979|FG000|STARTED|Cycle Two||3||
60042180|NCT02314052|76157980|FG001|STARTED|Cycle Two||3||
60042181|NCT02314052|76157981|FG002|STARTED|Cycle Two||3||
60042182|NCT02314052|76157982|FG003|STARTED|Cycle Two||2||
60042183|NCT02314052|76157983|FG004|STARTED|Cycle Two||6||
60042184|NCT02314052|76157984|FG005|STARTED|Cycle Two||3||
60042185|NCT02314052|76157979|FG000|COMPLETED|Cycle Two||3||
60042186|NCT02314052|76157980|FG001|COMPLETED|Cycle Two||2||
60042187|NCT02314052|76157981|FG002|COMPLETED|Cycle Two||2||
59759740|NCT00880269|75879160|FG000|COMPLETED|Overall Study||0||
59919003|NCT04966910|76039431|FG003|COMPLETED|Baseline||2||2
59919004|NCT04966910|76039428|FG000|NOT COMPLETED|Baseline||0||0
60042188|NCT02314052|76157982|FG003|COMPLETED|Cycle Two||1||
60042189|NCT02314052|76157983|FG004|COMPLETED|Cycle Two||2||
60042190|NCT02314052|76157984|FG005|COMPLETED|Cycle Two||3||
60042191|NCT02314052|76157979|FG000|NOT COMPLETED|Cycle Two||0||
60042192|NCT02314052|76157980|FG001|NOT COMPLETED|Cycle Two||1||
60042193|NCT02314052|76157981|FG002|NOT COMPLETED|Cycle Two||1||
60042194|NCT02314052|76157982|FG003|NOT COMPLETED|Cycle Two||1||
60042195|NCT02314052|76157983|FG004|NOT COMPLETED|Cycle Two||4||
60042196|NCT02314052|76157984|FG005|NOT COMPLETED|Cycle Two||0||
60042197|NCT02314052|76157979|FG000|STARTED|Cycle Three||3||
60042198|NCT02314052|76157980|FG001|STARTED|Cycle Three||2||
60042199|NCT02314052|76157981|FG002|STARTED|Cycle Three||2||
60042200|NCT02314052|76157982|FG003|STARTED|Cycle Three||1||
60042201|NCT02314052|76157983|FG004|STARTED|Cycle Three||2||
60042202|NCT02314052|76157984|FG005|STARTED|Cycle Three||3||
60042203|NCT02314052|76157979|FG000|COMPLETED|Cycle Three||3||
59510511|NCT00887575|75603930|FG000|STARTED|Phase II - Maintenance Therapy|Pts who completed 6 cycles of Neoadjuvant Therapy & underwent surgery were eligible for maintenance|8||
59510512|NCT00887575|75603931|FG001|STARTED|Phase II - Maintenance Therapy||0||
59510513|NCT00887575|75603932|FG002|STARTED|Phase II - Maintenance Therapy||0||
59510514|NCT00887575|75603930|FG000|COMPLETED|Phase II - Maintenance Therapy||6||
60042204|NCT02314052|76157980|FG001|COMPLETED|Cycle Three|1 of 2 completers in cohort 2 (subject 02-005) only completed 1 of 2 infusions during this cycle|2||
60042205|NCT02314052|76157981|FG002|COMPLETED|Cycle Three||2||
60042206|NCT02314052|76157982|FG003|COMPLETED|Cycle Three||1||
60042207|NCT02314052|76157983|FG004|COMPLETED|Cycle Three||2||
60042208|NCT02314052|76157984|FG005|COMPLETED|Cycle Three||3||
60042209|NCT02314052|76157979|FG000|NOT COMPLETED|Cycle Three||0||
60042210|NCT02314052|76157980|FG001|NOT COMPLETED|Cycle Three||0||
60042211|NCT02314052|76157981|FG002|NOT COMPLETED|Cycle Three||0||
60042212|NCT02314052|76157982|FG003|NOT COMPLETED|Cycle Three||0||
60042213|NCT02314052|76157983|FG004|NOT COMPLETED|Cycle Three||0||
60042214|NCT02314052|76157984|FG005|NOT COMPLETED|Cycle Three||0||
60042215|NCT02314052|76157979|FG000|STARTED|Cycle Four||3||
60042216|NCT02314052|76157980|FG001|STARTED|Cycle Four||2||
60042217|NCT02314052|76157981|FG002|STARTED|Cycle Four||2||
60042218|NCT02314052|76157982|FG003|STARTED|Cycle Four||1||
60042219|NCT02314052|76157983|FG004|STARTED|Cycle Four||2||
60042220|NCT02314052|76157984|FG005|STARTED|Cycle Four||3||
60042221|NCT02314052|76157979|FG000|COMPLETED|Cycle Four||0||
60042222|NCT02314052|76157980|FG001|COMPLETED|Cycle Four||2||
59612381|NCT01701258|75723502|FG003|COMPLETED|Assessment and Scheduling||0|Participants completed the study if they completed the screening session and two imaging sessions.|
60042223|NCT02314052|76157981|FG002|COMPLETED|Cycle Four||1||
60042224|NCT02314052|76157982|FG003|COMPLETED|Cycle Four||0||
60042225|NCT02314052|76157983|FG004|COMPLETED|Cycle Four||2||
60042226|NCT02314052|76157984|FG005|COMPLETED|Cycle Four||0||
59510515|NCT00887575|75603931|FG001|COMPLETED|Phase II - Maintenance Therapy||0||
59510516|NCT00887575|75603932|FG002|COMPLETED|Phase II - Maintenance Therapy||0||
59510517|NCT00887575|75603930|FG000|NOT COMPLETED|Phase II - Maintenance Therapy||2||
59510518|NCT00887575|75603931|FG001|NOT COMPLETED|Phase II - Maintenance Therapy||0||
59612382|NCT01701258|75723503|FG004|COMPLETED|Assessment and Scheduling||0|Participants completed the study if they completed the screening session and two imaging sessions.|
59612383|NCT01701258|75723504|FG005|COMPLETED|Assessment and Scheduling||0|Participants completed the study if they completed the screening session and two imaging sessions.|
59612384|NCT01701258|75723505|FG006|COMPLETED|Assessment and Scheduling||0|Participants completed the study if they completed the screening session and two imaging sessions.|
59612385|NCT01701258|75723506|FG007|COMPLETED|Assessment and Scheduling||0|Participants completed the study if they completed the screening session and two imaging sessions.|
59612386|NCT01701258|75723507|FG008|COMPLETED|Assessment and Scheduling||0|Participants completed the study if they completed the screening session and two imaging sessions.|
59612387|NCT01701258|75723508|FG009|COMPLETED|Assessment and Scheduling||0|Participants completed the study if they completed the screening session and two imaging sessions.|
59612388|NCT01701258|75723509|FG010|COMPLETED|Assessment and Scheduling||0|Participants completed the study if they completed the screening session and two imaging sessions.|
59759741|NCT00880269|75879161|FG001|COMPLETED|Overall Study||0||
59919005|NCT04966910|76039429|FG001|NOT COMPLETED|Baseline||0||0
59919006|NCT04966910|76039430|FG002|NOT COMPLETED|Baseline||1||1
59919007|NCT04966910|76039431|FG003|NOT COMPLETED|Baseline||0||0
59919008|NCT04966910|76039428|FG000|STARTED|4-Week Follow-Up||22|All enrolled participants at baseline were considered to start the 4-week follow-up time period.|2
59919009|NCT04966910|76039429|FG001|STARTED|4-Week Follow-Up||18|All enrolled participants at baseline were considered to start the 4-week follow-up time period.|2
59919010|NCT04966910|76039430|FG002|STARTED|4-Week Follow-Up|Clinicians did not receive 4 week timepoint surveys|0|All enrolled participants at baseline were considered to start the 4-week follow-up time period.|0
59919011|NCT04966910|76039431|FG003|STARTED|4-Week Follow-Up|Clinicians did not receive 4 week timepoint surveys|0|All enrolled participants at baseline were considered to start the 4-week follow-up time period.|0
59919012|NCT04966910|76039428|FG000|COMPLETED|4-Week Follow-Up||17||2
59919013|NCT04966910|76039429|FG001|COMPLETED|4-Week Follow-Up||14||2
59919014|NCT04966910|76039430|FG002|COMPLETED|4-Week Follow-Up||0||0
59919015|NCT04966910|76039431|FG003|COMPLETED|4-Week Follow-Up||0||0
59919016|NCT04966910|76039428|FG000|NOT COMPLETED|4-Week Follow-Up||5||0
59919017|NCT04966910|76039429|FG001|NOT COMPLETED|4-Week Follow-Up||4||0
59919018|NCT04966910|76039430|FG002|NOT COMPLETED|4-Week Follow-Up||0||0
59919019|NCT04966910|76039431|FG003|NOT COMPLETED|4-Week Follow-Up||0||0
59951411|NCT01798992|76070392|FG002|COMPLETED|Overall Study||14||
59951412|NCT01798992|76070393|FG003|COMPLETED|Overall Study||16||
60042227|NCT02314052|76157979|FG000|NOT COMPLETED|Cycle Four||3||
60042228|NCT02314052|76157980|FG001|NOT COMPLETED|Cycle Four||0||
60042229|NCT02314052|76157981|FG002|NOT COMPLETED|Cycle Four||1||
60042230|NCT02314052|76157982|FG003|NOT COMPLETED|Cycle Four||1||
60042231|NCT02314052|76157983|FG004|NOT COMPLETED|Cycle Four||0||
59510519|NCT00887575|75603932|FG002|NOT COMPLETED|Phase II - Maintenance Therapy||0||
59510520|NCT00887653|75603937|FG000|STARTED|Overall Study||20||
60042232|NCT02314052|76157984|FG005|NOT COMPLETED|Cycle Four||3||
59510521|NCT00887653|75603937|FG000|COMPLETED|Overall Study||20||
60042233|NCT02314052|76157979|FG000|STARTED|Cycle Five||0||
60042234|NCT02314052|76157980|FG001|STARTED|Cycle Five||2||
60042235|NCT02314052|76157981|FG002|STARTED|Cycle Five||1||
60042236|NCT02314052|76157982|FG003|STARTED|Cycle Five|subject missed cycle four but returned for cycle 5|1||
60042237|NCT02314052|76157983|FG004|STARTED|Cycle Five||2||
60042238|NCT02314052|76157984|FG005|STARTED|Cycle Five||0||
60042239|NCT02314052|76157979|FG000|COMPLETED|Cycle Five||0||
60042240|NCT02314052|76157980|FG001|COMPLETED|Cycle Five||0||
60042241|NCT02314052|76157981|FG002|COMPLETED|Cycle Five||0||
60042242|NCT02314052|76157982|FG003|COMPLETED|Cycle Five|subject missed cycle four but returned for cycle 5|1||
60042243|NCT02314052|76157983|FG004|COMPLETED|Cycle Five||2||
60042244|NCT02314052|76157984|FG005|COMPLETED|Cycle Five||0||
60042245|NCT02314052|76157979|FG000|NOT COMPLETED|Cycle Five||0||
60042246|NCT02314052|76157980|FG001|NOT COMPLETED|Cycle Five||2||
60042247|NCT02314052|76157981|FG002|NOT COMPLETED|Cycle Five||1||
60042248|NCT02314052|76157982|FG003|NOT COMPLETED|Cycle Five||0||
60042249|NCT02314052|76157983|FG004|NOT COMPLETED|Cycle Five||0||
60042250|NCT02314052|76157984|FG005|NOT COMPLETED|Cycle Five||0||
60042251|NCT02314052|76157979|FG000|STARTED|Cycles 6 -10.5||0||
60042252|NCT02314052|76157980|FG001|STARTED|Cycles 6 -10.5||0||
60042253|NCT02314052|76157981|FG002|STARTED|Cycles 6 -10.5||0||
60042254|NCT02314052|76157982|FG003|STARTED|Cycles 6 -10.5||1||
60042255|NCT02314052|76157983|FG004|STARTED|Cycles 6 -10.5||2||
60042256|NCT02314052|76157984|FG005|STARTED|Cycles 6 -10.5||0||
60042257|NCT02314052|76157979|FG000|COMPLETED|Cycles 6 -10.5||0||
60042258|NCT02314052|76157980|FG001|COMPLETED|Cycles 6 -10.5||0||
60042259|NCT02314052|76157981|FG002|COMPLETED|Cycles 6 -10.5||0||
60042260|NCT02314052|76157982|FG003|COMPLETED|Cycles 6 -10.5||1||
60042261|NCT02314052|76157983|FG004|COMPLETED|Cycles 6 -10.5|Subject 02-014 only completed 1 of 2 doses in cycle 6|2||
60042262|NCT02314052|76157984|FG005|COMPLETED|Cycles 6 -10.5||0||
60042263|NCT02314052|76157979|FG000|NOT COMPLETED|Cycles 6 -10.5||0||
60042264|NCT02314052|76157980|FG001|NOT COMPLETED|Cycles 6 -10.5||0||
60042265|NCT02314052|76157981|FG002|NOT COMPLETED|Cycles 6 -10.5||0||
60042266|NCT02314052|76157982|FG003|NOT COMPLETED|Cycles 6 -10.5||0||
60042267|NCT02314052|76157983|FG004|NOT COMPLETED|Cycles 6 -10.5||0||
60042268|NCT02314052|76157984|FG005|NOT COMPLETED|Cycles 6 -10.5||0||
60042269|NCT02279732|76158000|FG000|STARTED|Overall Study||98|Started = Participants treated with double blind therapy|
60042270|NCT02279732|76158001|FG001|STARTED|Overall Study||106|Started = Participants treated with double blind therapy|
60042271|NCT02279732|76158000|FG000|COMPLETED|Overall Study||0|Completed|
60042272|NCT02279732|76158001|FG001|COMPLETED|Overall Study||0|Completed|
60042273|NCT02279732|76158000|FG000|NOT COMPLETED|Overall Study||98||
60042274|NCT02279732|76158001|FG001|NOT COMPLETED|Overall Study||106||
60042275|NCT02279498|76158009|FG000|STARTED|Overall Study||65||
60042276|NCT02279498|76158010|FG001|STARTED|Overall Study||63||
60042277|NCT02279498|76158009|FG000|COMPLETED|Overall Study||47||
60042278|NCT02279498|76158010|FG001|COMPLETED|Overall Study||59||
60042279|NCT02279498|76158009|FG000|NOT COMPLETED|Overall Study||18||
60042280|NCT02279498|76158010|FG001|NOT COMPLETED|Overall Study||4||
60042281|NCT02307266|76158020|FG000|STARTED|Overall Study||33||
60042282|NCT02307266|76158021|FG001|STARTED|Overall Study||33||
59510522|NCT00887653|75603937|FG000|NOT COMPLETED|Overall Study||0||
59510523|NCT00887965|75603941|FG000|STARTED|Overall Study||15||
59510524|NCT00887965|75603941|FG000|COMPLETED|Overall Study||15||
59510525|NCT00887965|75603941|FG000|NOT COMPLETED|Overall Study||0||
59510526|NCT02729038|75603949|FG000|STARTED|Part 1 (Up to 44 Days)||8||
59510527|NCT02729038|75603950|FG001|STARTED|Part 1 (Up to 44 Days)||8||
59510528|NCT02729038|75603951|FG002|STARTED|Part 1 (Up to 44 Days)||8||
59510529|NCT02729038|75603952|FG003|STARTED|Part 1 (Up to 44 Days)||0||
59510530|NCT02729038|75603949|FG000|COMPLETED|Part 1 (Up to 44 Days)||8||
59510531|NCT02729038|75603950|FG001|COMPLETED|Part 1 (Up to 44 Days)||8||
60042283|NCT02307266|76158022|FG002|STARTED|Overall Study||31||
60042284|NCT02307266|76158020|FG000|COMPLETED|Overall Study||25||
60042285|NCT02307266|76158021|FG001|COMPLETED|Overall Study||32||
60042286|NCT02307266|76158022|FG002|COMPLETED|Overall Study||25||
60042287|NCT02307266|76158020|FG000|NOT COMPLETED|Overall Study||8||
60042288|NCT02307266|76158021|FG001|NOT COMPLETED|Overall Study||1||
60042289|NCT02307266|76158022|FG002|NOT COMPLETED|Overall Study||6||
60042290|NCT02279420|76158030|FG000|STARTED|Overall Study||73||
60042291|NCT02279420|76158030|FG000|COMPLETED|Overall Study||50||
60042292|NCT02279420|76158030|FG000|NOT COMPLETED|Overall Study||23||
60042293|NCT02278952|76158034|FG000|STARTED|Overall Study|The number of biopsy procedures performed during the time the patient was enrolled in the study.|50||225
60042294|NCT02278952|76158034|FG000|COMPLETED|Overall Study|The number of biopsy samples assayed during the time the patient was enrolled in the study.|44||117
59510532|NCT02729038|75603951|FG002|COMPLETED|Part 1 (Up to 44 Days)||8||
59510533|NCT02729038|75603952|FG003|COMPLETED|Part 1 (Up to 44 Days)||0||
59510534|NCT02729038|75603949|FG000|NOT COMPLETED|Part 1 (Up to 44 Days)||0||
59510535|NCT02729038|75603950|FG001|NOT COMPLETED|Part 1 (Up to 44 Days)||0||
59510536|NCT02729038|75603951|FG002|NOT COMPLETED|Part 1 (Up to 44 Days)||0||
59510537|NCT02729038|75603952|FG003|NOT COMPLETED|Part 1 (Up to 44 Days)||0||
59510538|NCT02729038|75603949|FG000|STARTED|Part 2 (Up to 50 Days)||0||
59510539|NCT02729038|75603950|FG001|STARTED|Part 2 (Up to 50 Days)||0||
59510540|NCT02729038|75603951|FG002|STARTED|Part 2 (Up to 50 Days)||0||
60042295|NCT02278952|76158034|FG000|NOT COMPLETED|Overall Study||6||108
59510541|NCT02729038|75603952|FG003|STARTED|Part 2 (Up to 50 Days)||8||
59510542|NCT02729038|75603949|FG000|COMPLETED|Part 2 (Up to 50 Days)||0||
59510543|NCT02729038|75603950|FG001|COMPLETED|Part 2 (Up to 50 Days)||0||
59510544|NCT02729038|75603951|FG002|COMPLETED|Part 2 (Up to 50 Days)||0||
60042296|NCT02278328|76158044|FG000|STARTED|Neuropsych Screening||10||
60042297|NCT02278328|76158045|FG001|STARTED|Neuropsych Screening||7||
60042298|NCT02278328|76158046|FG002|STARTED|Neuropsych Screening||8||
60042299|NCT02278328|76158044|FG000|COMPLETED|Neuropsych Screening||9||
60042300|NCT02278328|76158045|FG001|COMPLETED|Neuropsych Screening||6||
60042301|NCT02278328|76158046|FG002|COMPLETED|Neuropsych Screening||6||
60042302|NCT02278328|76158044|FG000|NOT COMPLETED|Neuropsych Screening||1||
60042303|NCT02278328|76158045|FG001|NOT COMPLETED|Neuropsych Screening||1||
60042304|NCT02278328|76158046|FG002|NOT COMPLETED|Neuropsych Screening||2||
60042305|NCT02278328|76158044|FG000|STARTED|First Intervention (1 Day)||9||
60042306|NCT02278328|76158045|FG001|STARTED|First Intervention (1 Day)||6||
60042307|NCT02278328|76158046|FG002|STARTED|First Intervention (1 Day)||6||
60042308|NCT02278328|76158044|FG000|COMPLETED|First Intervention (1 Day)||9||
60042309|NCT02278328|76158045|FG001|COMPLETED|First Intervention (1 Day)||6||
60042310|NCT02278328|76158046|FG002|COMPLETED|First Intervention (1 Day)||6||
60042311|NCT02278328|76158044|FG000|NOT COMPLETED|First Intervention (1 Day)||0||
60042312|NCT02278328|76158045|FG001|NOT COMPLETED|First Intervention (1 Day)||0||
60042313|NCT02278328|76158046|FG002|NOT COMPLETED|First Intervention (1 Day)||0||
60042314|NCT02278328|76158044|FG000|STARTED|Washout (1 Week)||9||
60042315|NCT02278328|76158045|FG001|STARTED|Washout (1 Week)||6||
60042316|NCT02278328|76158046|FG002|STARTED|Washout (1 Week)||6||
60042317|NCT02278328|76158044|FG000|COMPLETED|Washout (1 Week)||9||
60042318|NCT02278328|76158045|FG001|COMPLETED|Washout (1 Week)||6||
60042319|NCT02278328|76158046|FG002|COMPLETED|Washout (1 Week)||6||
60042320|NCT02278328|76158044|FG000|NOT COMPLETED|Washout (1 Week)||0||
60042321|NCT02278328|76158045|FG001|NOT COMPLETED|Washout (1 Week)||0||
60042322|NCT02278328|76158046|FG002|NOT COMPLETED|Washout (1 Week)||0||
60042323|NCT02278328|76158044|FG000|STARTED|Second Intervention (1 Day)||9||
60042324|NCT02278328|76158045|FG001|STARTED|Second Intervention (1 Day)||6||
60042325|NCT02278328|76158046|FG002|STARTED|Second Intervention (1 Day)||6||
60042326|NCT02278328|76158044|FG000|COMPLETED|Second Intervention (1 Day)||9||
60042327|NCT02278328|76158045|FG001|COMPLETED|Second Intervention (1 Day)||6||
60042328|NCT02278328|76158046|FG002|COMPLETED|Second Intervention (1 Day)||6||
60042329|NCT02278328|76158044|FG000|NOT COMPLETED|Second Intervention (1 Day)||0||
60042330|NCT02278328|76158045|FG001|NOT COMPLETED|Second Intervention (1 Day)||0||
60042331|NCT02278328|76158046|FG002|NOT COMPLETED|Second Intervention (1 Day)||0||
60042332|NCT02278328|76158044|FG000|STARTED|Second Washout (1 Week)||9||
60042333|NCT02278328|76158045|FG001|STARTED|Second Washout (1 Week)||6||
60042334|NCT02278328|76158046|FG002|STARTED|Second Washout (1 Week)||6||
60042335|NCT02278328|76158044|FG000|COMPLETED|Second Washout (1 Week)||9||
60042336|NCT02278328|76158045|FG001|COMPLETED|Second Washout (1 Week)||6||
60042337|NCT02278328|76158046|FG002|COMPLETED|Second Washout (1 Week)||6||
60042338|NCT02278328|76158044|FG000|NOT COMPLETED|Second Washout (1 Week)||0||
60042339|NCT02278328|76158045|FG001|NOT COMPLETED|Second Washout (1 Week)||0||
60042340|NCT02278328|76158046|FG002|NOT COMPLETED|Second Washout (1 Week)||0||
60042341|NCT02278328|76158044|FG000|STARTED|Third Intervention (1 Day)||9||
60042342|NCT02278328|76158045|FG001|STARTED|Third Intervention (1 Day)||6||
60042343|NCT02278328|76158046|FG002|STARTED|Third Intervention (1 Day)||6||
60042344|NCT02278328|76158044|FG000|COMPLETED|Third Intervention (1 Day)||9||
60042345|NCT02278328|76158045|FG001|COMPLETED|Third Intervention (1 Day)||6||
60042346|NCT02278328|76158046|FG002|COMPLETED|Third Intervention (1 Day)||6||
60042347|NCT02278328|76158044|FG000|NOT COMPLETED|Third Intervention (1 Day)||0||
60042348|NCT02278328|76158045|FG001|NOT COMPLETED|Third Intervention (1 Day)||0||
60042349|NCT02278328|76158046|FG002|NOT COMPLETED|Third Intervention (1 Day)||0||
60042350|NCT02278328|76158044|FG000|STARTED|Third Washout (1 Week)||9||
60042351|NCT02278328|76158045|FG001|STARTED|Third Washout (1 Week)||6||
60042352|NCT02278328|76158046|FG002|STARTED|Third Washout (1 Week)||6||
60042353|NCT02278328|76158044|FG000|COMPLETED|Third Washout (1 Week)||9||
60042354|NCT02278328|76158045|FG001|COMPLETED|Third Washout (1 Week)||6||
59510545|NCT02729038|75603952|FG003|COMPLETED|Part 2 (Up to 50 Days)||8||
60042355|NCT02278328|76158046|FG002|COMPLETED|Third Washout (1 Week)||6||
60042356|NCT02278328|76158044|FG000|NOT COMPLETED|Third Washout (1 Week)||0||
60042357|NCT02278328|76158045|FG001|NOT COMPLETED|Third Washout (1 Week)||0||
60042358|NCT02278328|76158046|FG002|NOT COMPLETED|Third Washout (1 Week)||0||
60042359|NCT02314637|76158054|FG000|STARTED|Overall Study||151||
60042360|NCT02314637|76158055|FG001|STARTED|Overall Study||89||
59510546|NCT02729038|75603949|FG000|NOT COMPLETED|Part 2 (Up to 50 Days)||0||
60042361|NCT02314637|76158054|FG000|COMPLETED|Overall Study||135||
60042362|NCT02314637|76158055|FG001|COMPLETED|Overall Study||75||
60042363|NCT02314637|76158054|FG000|NOT COMPLETED|Overall Study||16||
60042364|NCT02314637|76158055|FG001|NOT COMPLETED|Overall Study||14||
60042365|NCT01646645|76158061|FG000|STARTED|Overall Study||58||
60042366|NCT01646645|76158061|FG000|COMPLETED|Overall Study||28||
59510547|NCT02729038|75603950|FG001|NOT COMPLETED|Part 2 (Up to 50 Days)||0||
60042367|NCT01646645|76158061|FG000|NOT COMPLETED|Overall Study||30||
60042368|NCT02272985|76158065|FG000|STARTED|Overall Study||15||
60042369|NCT02272985|76158065|FG000|COMPLETED|Overall Study||12||
60042370|NCT02272985|76158065|FG000|NOT COMPLETED|Overall Study||3||
60042371|NCT01644149|76158072|FG000|STARTED|Overall Study||43||
60042372|NCT01644149|76158073|FG001|STARTED|Overall Study||40||
60042373|NCT01644149|76158072|FG000|COMPLETED|Overall Study|One subject discontinued prior to vaccination. 28 day serum samples not obtained from 3 subjects.|39||
60042374|NCT01644149|76158073|FG001|COMPLETED|Overall Study|28 day serum samples were not obtained from one NS subject.|39||
60042375|NCT01644149|76158072|FG000|NOT COMPLETED|Overall Study||4||
60042376|NCT01644149|76158073|FG001|NOT COMPLETED|Overall Study||1||
60042377|NCT02313233|76158082|FG000|STARTED|Overall Study||20||
60042378|NCT02313233|76158083|FG001|STARTED|Overall Study||21||
60042379|NCT02313233|76158082|FG000|COMPLETED|Overall Study||18||
60042380|NCT02313233|76158083|FG001|COMPLETED|Overall Study||18||
60042381|NCT02313233|76158082|FG000|NOT COMPLETED|Overall Study||2||
60042382|NCT02313233|76158083|FG001|NOT COMPLETED|Overall Study||3||
60042383|NCT02313155|76158093|FG000|STARTED|Overall Study||55||
60042384|NCT02313155|76158094|FG001|STARTED|Overall Study||55||
60042385|NCT02313155|76158093|FG000|COMPLETED|Overall Study||55||
60042386|NCT02313155|76158094|FG001|COMPLETED|Overall Study||54||
60042387|NCT02313155|76158093|FG000|NOT COMPLETED|Overall Study||0||
60042388|NCT02313155|76158094|FG001|NOT COMPLETED|Overall Study||1||
60042389|NCT02204293|76158102|FG000|STARTED|Core Study Part I||19||
60042390|NCT02204293|76158103|FG001|STARTED|Core Study Part I||17||
60042391|NCT02204293|76158104|FG002|STARTED|Core Study Part I||0||
60042392|NCT02204293|76158105|FG003|STARTED|Core Study Part I||0||
60042393|NCT02204293|76158106|FG004|STARTED|Core Study Part I||0||
60042394|NCT02204293|76158107|FG005|STARTED|Core Study Part I||0||
60042395|NCT02204293|76158102|FG000|Intention-to-treat Population|Core Study Part I|One participant left the study before treatment was started.|18||
60042396|NCT02204293|76158103|FG001|Intention-to-treat Population|Core Study Part I||17||
60042397|NCT02204293|76158104|FG002|Intention-to-treat Population|Core Study Part I||0||
60042398|NCT02204293|76158105|FG003|Intention-to-treat Population|Core Study Part I||0||
60042399|NCT02204293|76158106|FG004|Intention-to-treat Population|Core Study Part I||0||
60042400|NCT02204293|76158107|FG005|Intention-to-treat Population|Core Study Part I||0||
60042401|NCT02204293|76158102|FG000|Safety Population|Core Study Part I|2 participants from placebo arm received canakinumab at Week 4, included in Safety population.|20||
60042402|NCT02204293|76158103|FG001|Safety Population|Core Study Part I||15||
60042403|NCT02204293|76158104|FG002|Safety Population|Core Study Part I||0||
60042404|NCT02204293|76158105|FG003|Safety Population|Core Study Part I||0||
60042405|NCT02204293|76158106|FG004|Safety Population|Core Study Part I||0||
60042406|NCT02204293|76158107|FG005|Safety Population|Core Study Part I||0||
60042407|NCT02204293|76158102|FG000|COMPLETED|Core Study Part I||17||
60042408|NCT02204293|76158103|FG001|COMPLETED|Core Study Part I||14||
60042409|NCT02204293|76158104|FG002|COMPLETED|Core Study Part I||0||
60042410|NCT02204293|76158105|FG003|COMPLETED|Core Study Part I||0||
60042411|NCT02204293|76158106|FG004|COMPLETED|Core Study Part I||0||
60042412|NCT02204293|76158107|FG005|COMPLETED|Core Study Part I||0||
60042413|NCT02204293|76158102|FG000|NOT COMPLETED|Core Study Part I||2||
60042414|NCT02204293|76158103|FG001|NOT COMPLETED|Core Study Part I||3||
60042415|NCT02204293|76158104|FG002|NOT COMPLETED|Core Study Part I||0||
60042416|NCT02204293|76158105|FG003|NOT COMPLETED|Core Study Part I||0||
60042417|NCT02204293|76158106|FG004|NOT COMPLETED|Core Study Part I||0||
60042418|NCT02204293|76158107|FG005|NOT COMPLETED|Core Study Part I||0||
60042419|NCT02204293|76158102|FG000|STARTED|Core Study Part 2|Participants who achieved response at Week 12, entered Part II.|0||
60042420|NCT02204293|76158103|FG001|STARTED|Core Study Part 2||0||
60042421|NCT02204293|76158104|FG002|STARTED|Core Study Part 2|Participants who achieved response at Week 12, entered Part II.|12||
60042422|NCT02204293|76158105|FG003|STARTED|Core Study Part 2||4||
60042423|NCT02204293|76158106|FG004|STARTED|Core Study Part 2||7||
60042424|NCT02204293|76158107|FG005|STARTED|Core Study Part 2||0||
60042425|NCT02204293|76158102|FG000|Safety Population|Core Study Part 2||0||
60042426|NCT02204293|76158103|FG001|Safety Population|Core Study Part 2||0||
60042427|NCT02204293|76158104|FG002|Safety Population|Core Study Part 2|Included 2 participants from placebo arm who received canakinumab at Week 4.|14||
60042428|NCT02204293|76158105|FG003|Safety Population|Core Study Part 2||2||
60042429|NCT02204293|76158106|FG004|Safety Population|Core Study Part 2||7||
60042430|NCT02204293|76158107|FG005|Safety Population|Core Study Part 2||0||
60042431|NCT02204293|76158102|FG000|COMPLETED|Core Study Part 2||0||
60042432|NCT02204293|76158103|FG001|COMPLETED|Core Study Part 2||0||
60042433|NCT02204293|76158104|FG002|COMPLETED|Core Study Part 2||12||
60042434|NCT02204293|76158105|FG003|COMPLETED|Core Study Part 2||4||
60042435|NCT02204293|76158106|FG004|COMPLETED|Core Study Part 2||7||
60042436|NCT02204293|76158107|FG005|COMPLETED|Core Study Part 2||0||
60042437|NCT02204293|76158102|FG000|NOT COMPLETED|Core Study Part 2||0||
60042438|NCT02204293|76158103|FG001|NOT COMPLETED|Core Study Part 2||0||
60042439|NCT02204293|76158104|FG002|NOT COMPLETED|Core Study Part 2||0||
60042440|NCT02204293|76158105|FG003|NOT COMPLETED|Core Study Part 2||0||
60042441|NCT02204293|76158106|FG004|NOT COMPLETED|Core Study Part 2||0||
60042442|NCT02204293|76158107|FG005|NOT COMPLETED|Core Study Part 2||0||
60042443|NCT02204293|76158102|FG000|STARTED|LTE Phase||0|Participants who achieved remission entered LTE Phase.|
60042444|NCT02204293|76158103|FG001|STARTED|LTE Phase||0|Participants who achieved remission entered LTE Phase.|
60042445|NCT02204293|76158104|FG002|STARTED|LTE Phase||0|Participants who achieved remission entered LTE Phase.|
60042446|NCT02204293|76158105|FG003|STARTED|LTE Phase||0|Participants who achieved remission entered LTE Phase.|
60042447|NCT02204293|76158106|FG004|STARTED|LTE Phase||0|Participants who achieved remission entered LTE Phase.|
60042448|NCT02204293|76158107|FG005|STARTED|LTE Phase||7|Participants who achieved remission entered LTE Phase.|
60042449|NCT02204293|76158102|FG000|COMPLETED|LTE Phase||0||
60042450|NCT02204293|76158103|FG001|COMPLETED|LTE Phase||0||
60042451|NCT02204293|76158104|FG002|COMPLETED|LTE Phase||0||
60042452|NCT02204293|76158105|FG003|COMPLETED|LTE Phase||0||
60042453|NCT02204293|76158106|FG004|COMPLETED|LTE Phase||0||
60042454|NCT02204293|76158107|FG005|COMPLETED|LTE Phase||0||
60042455|NCT02204293|76158102|FG000|NOT COMPLETED|LTE Phase||0||
60042456|NCT02204293|76158103|FG001|NOT COMPLETED|LTE Phase||0||
60042457|NCT02204293|76158104|FG002|NOT COMPLETED|LTE Phase||0||
60042458|NCT02204293|76158105|FG003|NOT COMPLETED|LTE Phase||0||
60042459|NCT02204293|76158106|FG004|NOT COMPLETED|LTE Phase||0||
59510548|NCT02729038|75603951|FG002|NOT COMPLETED|Part 2 (Up to 50 Days)||0||
59510549|NCT02729038|75603952|FG003|NOT COMPLETED|Part 2 (Up to 50 Days)||0||
59510550|NCT00888511|75603969|FG000|STARTED|Overall Study||15||
60042460|NCT02204293|76158107|FG005|NOT COMPLETED|LTE Phase||7||
60042461|NCT02304926|76158123|FG000|STARTED|Overall Study||22||
60042462|NCT02304926|76158124|FG001|STARTED|Overall Study||20||
60042463|NCT02304926|76158123|FG000|COMPLETED|Overall Study||20||
60042464|NCT02304926|76158124|FG001|COMPLETED|Overall Study||19||
60042465|NCT02304926|76158123|FG000|NOT COMPLETED|Overall Study||2||
60042466|NCT02304926|76158124|FG001|NOT COMPLETED|Overall Study||1||
60042467|NCT01646255|76158134|FG000|STARTED|Overall Study||172||
60042468|NCT01646255|76158135|FG001|STARTED|Overall Study||174||
60042469|NCT01646255|76158134|FG000|COMPLETED|Overall Study||151||
60042470|NCT01646255|76158135|FG001|COMPLETED|Overall Study||160||
60042471|NCT01646255|76158134|FG000|NOT COMPLETED|Overall Study||21||
60042472|NCT01646255|76158135|FG001|NOT COMPLETED|Overall Study||14||
60042473|NCT02304380|76158148|FG000|STARTED|Pediatric Claims Data Analysis (Aim 3)||0||
60042474|NCT02304380|76158149|FG001|STARTED|Pediatric Claims Data Analysis (Aim 3)||0||
60042475|NCT02304380|76158150|FG002|STARTED|Pediatric Claims Data Analysis (Aim 3)||0||
60042476|NCT02304380|76158151|FG003|STARTED|Pediatric Claims Data Analysis (Aim 3)||0||
60042477|NCT02304380|76158152|FG004|STARTED|Pediatric Claims Data Analysis (Aim 3)||17356||
60042478|NCT02304380|76158153|FG005|STARTED|Pediatric Claims Data Analysis (Aim 3)||47026||
60042479|NCT02304380|76158148|FG000|COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0||
60042480|NCT02304380|76158149|FG001|COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0||
60042481|NCT02304380|76158150|FG002|COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0||
60042482|NCT02304380|76158151|FG003|COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0||
60042483|NCT02304380|76158152|FG004|COMPLETED|Pediatric Claims Data Analysis (Aim 3)|2,096 Caregivers of the 17,356 claims were included in the Caregiver Survey.|17356||
60042484|NCT02304380|76158153|FG005|COMPLETED|Pediatric Claims Data Analysis (Aim 3)|Not included in any other portion of the study.|47026||
60042485|NCT02304380|76158148|FG000|NOT COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0||
60042486|NCT02304380|76158149|FG001|NOT COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0||
60042487|NCT02304380|76158150|FG002|NOT COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0||
60042488|NCT02304380|76158151|FG003|NOT COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0||
60042489|NCT02304380|76158152|FG004|NOT COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0||
60042490|NCT02304380|76158153|FG005|NOT COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0||
60042491|NCT02304380|76158148|FG000|STARTED|Pediatric Adult Caregiver Survey (Aim 2)||0||
60042492|NCT02304380|76158149|FG001|STARTED|Pediatric Adult Caregiver Survey (Aim 2)||0||
60042493|NCT02304380|76158150|FG002|STARTED|Pediatric Adult Caregiver Survey (Aim 2)||0||
60042494|NCT02304380|76158151|FG003|STARTED|Pediatric Adult Caregiver Survey (Aim 2)||2096||
60042495|NCT02304380|76158152|FG004|STARTED|Pediatric Adult Caregiver Survey (Aim 2)||0||
60042496|NCT02304380|76158153|FG005|STARTED|Pediatric Adult Caregiver Survey (Aim 2)||0||
60042497|NCT02304380|76158148|FG000|COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0||
60042498|NCT02304380|76158149|FG001|COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0||
60042499|NCT02304380|76158150|FG002|COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0||
60042500|NCT02304380|76158151|FG003|COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)|68 Caregivers/Patients of the 2,062 surveyed were included in the Interviews and Focus Group .|2062||
60042501|NCT02304380|76158152|FG004|COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0||
60042502|NCT02304380|76158153|FG005|COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0||
60042503|NCT02304380|76158148|FG000|NOT COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0||
60042504|NCT02304380|76158149|FG001|NOT COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0||
60042505|NCT02304380|76158150|FG002|NOT COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0||
60042506|NCT02304380|76158151|FG003|NOT COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||34||
60042507|NCT02304380|76158152|FG004|NOT COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0||
60042508|NCT02304380|76158153|FG005|NOT COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0||
60042509|NCT02304380|76158148|FG000|STARTED|Interviews & Focus Groups (Aim 1)||0||
60042510|NCT02304380|76158149|FG001|STARTED|Interviews & Focus Groups (Aim 1)||35||
59510551|NCT00888511|75603969|FG000|COMPLETED|Overall Study||15||
59510552|NCT00888511|75603969|FG000|NOT COMPLETED|Overall Study||0||
59510553|NCT02730988|75603975|FG000|STARTED|Overall Study||47||
59510554|NCT02730988|75603976|FG001|STARTED|Overall Study||49||
59510555|NCT02730988|75603975|FG000|COMPLETED|Overall Study||43||
59510556|NCT02730988|75603976|FG001|COMPLETED|Overall Study||39||
59510557|NCT02730988|75603975|FG000|NOT COMPLETED|Overall Study||4||
59510558|NCT02730988|75603976|FG001|NOT COMPLETED|Overall Study||10||
59510559|NCT02731300|75603984|FG000|STARTED|Overall Study||15||
59510560|NCT02731300|75603985|FG001|STARTED|Overall Study||7||
59510561|NCT02731300|75603984|FG000|COMPLETED|Overall Study||15||
59510562|NCT02731300|75603985|FG001|COMPLETED|Overall Study||7||
59510563|NCT02731300|75603984|FG000|NOT COMPLETED|Overall Study||0||
59510564|NCT02731300|75603985|FG001|NOT COMPLETED|Overall Study||0||
59510565|NCT00888979|75603991|FG000|STARTED|Overall Study||10||
59510566|NCT00888979|75603991|FG000|Received the Inhaler/Counseling|Overall Study||8||
59510567|NCT00888979|75603991|FG000|COMPLETED|Overall Study||6||
59510568|NCT00888979|75603991|FG000|NOT COMPLETED|Overall Study||4||
59510569|NCT02734498|75603998|FG000|STARTED|Overall Study||2||
59510570|NCT02734498|75603999|FG001|STARTED|Overall Study||0||
59510571|NCT02734498|75604000|FG002|STARTED|Overall Study||0||
59510572|NCT02734498|75603998|FG000|COMPLETED|Overall Study||2||
59510573|NCT02734498|75603999|FG001|COMPLETED|Overall Study||0||
59510574|NCT02734498|75604000|FG002|COMPLETED|Overall Study||0||
59510575|NCT02734498|75603998|FG000|NOT COMPLETED|Overall Study||0||
59510576|NCT02734498|75603999|FG001|NOT COMPLETED|Overall Study||0||
59510577|NCT02734498|75604000|FG002|NOT COMPLETED|Overall Study||0||
59510578|NCT02734576|75604008|FG000|STARTED|Overall Study||10||
59510579|NCT02734576|75604008|FG000|COMPLETED|Overall Study||10||
59510580|NCT02734576|75604008|FG000|NOT COMPLETED|Overall Study||0||
59510581|NCT02737072|75604015|FG000|STARTED|Overall Study||3||
59510582|NCT02737072|75604016|FG001|STARTED|Overall Study||3||
59510583|NCT02737072|75604017|FG002|STARTED|Overall Study||3||
59510584|NCT02737072|75604015|FG000|Received at Least One Dose of Drug|Overall Study||3||
59510585|NCT02737072|75604016|FG001|Received at Least One Dose of Drug|Overall Study||3||
59510586|NCT02737072|75604017|FG002|Received at Least One Dose of Drug|Overall Study||3||
59510587|NCT02737072|75604015|FG000|COMPLETED|Overall Study||3||
59510588|NCT02737072|75604016|FG001|COMPLETED|Overall Study||3||
59510589|NCT02737072|75604017|FG002|COMPLETED|Overall Study||3||
59510590|NCT02737072|75604015|FG000|NOT COMPLETED|Overall Study||0||
59510591|NCT02737072|75604016|FG001|NOT COMPLETED|Overall Study||0||
59510592|NCT02737072|75604017|FG002|NOT COMPLETED|Overall Study||0||
59510593|NCT02722564|75604029|FG000|STARTED|Overall Study||55||
59510594|NCT02722564|75604029|FG000|COMPLETED|Overall Study||55||
59510595|NCT02722564|75604029|FG000|NOT COMPLETED|Overall Study||0||
59510596|NCT00904345|75604033|FG000|STARTED|Overall Study||21||
59510597|NCT00904345|75604033|FG000|Stopped or Modified Treatment Due to Toxicity|Overall Study||3||
59510598|NCT00904345|75604033|FG000|COMPLETED|Overall Study||18|18 completed treatment with RT + Cetuximab|
59510599|NCT00904345|75604033|FG000|NOT COMPLETED|Overall Study||3||
59510600|NCT00904813|75604042|FG000|STARTED|Overall Study||129||
59612389|NCT01701258|75723510|FG011|COMPLETED|Assessment and Scheduling||0|Participants completed the study if they completed the screening session and two imaging sessions.|
59759742|NCT00880269|75879160|FG000|NOT COMPLETED|Overall Study||32||
59759743|NCT00880269|75879161|FG001|NOT COMPLETED|Overall Study||27||
59759744|NCT00880191|75879169|FG000|STARTED|Overall Study||207||
59919020|NCT04966910|76039428|FG000|STARTED|9-Week Follow-Up||22|All enrolled participants at baseline were considered to start the 9-week follow-up time period. Participants were not required to complete the 4-week follow-up to start and be considered for the 9-week follow-up.|2
59919021|NCT04966910|76039429|FG001|STARTED|9-Week Follow-Up||18|All enrolled participants at baseline were considered to start the 9-week follow-up time period. Participants were not required to complete the 4-week follow-up to start and be considered for the 9-week follow-up.|2
59919022|NCT04966910|76039430|FG002|STARTED|9-Week Follow-Up|Clinicians did not receive a 4 week survey, therefore the number of participants who started this period is not the same as the number who completed the previous period.|2|All enrolled participants at baseline were considered to start the 9-week follow-up time period. Participants were not required to complete the 4-week follow-up to start and be considered for the 9-week follow-up.|2
59951413|NCT01798992|76070390|FG000|NOT COMPLETED|Overall Study||0||
59510601|NCT00904813|75604043|FG001|STARTED|Overall Study||128||
59510602|NCT00904813|75604044|FG002|STARTED|Overall Study||128||
59510603|NCT00904813|75604045|FG003|STARTED|Overall Study||228||
59510604|NCT00904813|75604046|FG004|STARTED|Overall Study||227||
59510605|NCT00904813|75604042|FG000|COMPLETED|Overall Study||129||
59510606|NCT00904813|75604043|FG001|COMPLETED|Overall Study||128||
59510607|NCT00904813|75604044|FG002|COMPLETED|Overall Study||128||
59510608|NCT00904813|75604045|FG003|COMPLETED|Overall Study||228||
59510609|NCT00904813|75604046|FG004|COMPLETED|Overall Study||227||
59510610|NCT00904813|75604042|FG000|NOT COMPLETED|Overall Study||0||
59510611|NCT00904813|75604043|FG001|NOT COMPLETED|Overall Study||0||
59510612|NCT00904813|75604044|FG002|NOT COMPLETED|Overall Study||0||
59510613|NCT00904813|75604045|FG003|NOT COMPLETED|Overall Study||0||
59510614|NCT00904813|75604046|FG004|NOT COMPLETED|Overall Study||0||
59510615|NCT03617926|75604071|FG000|STARTED|Overall Study||35||
59510616|NCT03617926|75604072|FG001|STARTED|Overall Study||35||
59510617|NCT03617926|75604071|FG000|COMPLETED|Overall Study||35||
59510618|NCT03617926|75604072|FG001|COMPLETED|Overall Study||35||
59510619|NCT03617926|75604071|FG000|NOT COMPLETED|Overall Study||0||
59510620|NCT03617926|75604072|FG001|NOT COMPLETED|Overall Study||0||
59510621|NCT02470312|75604085|FG000|STARTED|Overall Study||147||
59510622|NCT02470312|75604086|FG001|STARTED|Overall Study||431||
59510623|NCT02470312|75604085|FG000|COMPLETED|Overall Study||142||
59510624|NCT02470312|75604086|FG001|COMPLETED|Overall Study||419||
59510625|NCT02470312|75604085|FG000|NOT COMPLETED|Overall Study||5||
59510626|NCT02470312|75604086|FG001|NOT COMPLETED|Overall Study||12||
59510627|NCT02470390|75604094|FG000|STARTED|Overall Study||6||
59510628|NCT02470390|75604095|FG001|STARTED|Overall Study||7||
59510629|NCT02470390|75604094|FG000|COMPLETED|Overall Study||6||
59510630|NCT02470390|75604095|FG001|COMPLETED|Overall Study||6||
59510631|NCT02470390|75604094|FG000|NOT COMPLETED|Overall Study||0||
59510632|NCT02470390|75604095|FG001|NOT COMPLETED|Overall Study||1||
59510633|NCT02471326|75604103|FG000|STARTED|Overall Study||10||
59510634|NCT02471326|75604103|FG000|COMPLETED|Overall Study||9||
59510635|NCT02471326|75604103|FG000|NOT COMPLETED|Overall Study||1||
59510636|NCT02472262|75604110|FG000|STARTED|Overall Study||117||
59510637|NCT02472262|75604111|FG001|STARTED|Overall Study||120||
59510638|NCT02472262|75604112|FG002|STARTED|Overall Study||118||
59510639|NCT02472262|75604110|FG000|COMPLETED|Overall Study||99||
59510640|NCT02472262|75604111|FG001|COMPLETED|Overall Study||99||
59510641|NCT02472262|75604112|FG002|COMPLETED|Overall Study||93||
59510642|NCT02472262|75604110|FG000|NOT COMPLETED|Overall Study||18||
59510643|NCT02472262|75604111|FG001|NOT COMPLETED|Overall Study||21||
59510644|NCT02472262|75604112|FG002|NOT COMPLETED|Overall Study||25||
59510645|NCT00901225|75604120|FG000|STARTED|Overall Study||21||
59510646|NCT00901225|75604120|FG000|COMPLETED|Overall Study||20||
59510647|NCT00901225|75604120|FG000|NOT COMPLETED|Overall Study||1||
59510648|NCT02472730|75604126|FG000|STARTED|Overall Study||110||
59510649|NCT02472730|75604127|FG001|STARTED|Overall Study||109||
59510650|NCT02472730|75604126|FG000|COMPLETED|Overall Study||101||
59510651|NCT02472730|75604127|FG001|COMPLETED|Overall Study||102||
59510652|NCT02472730|75604126|FG000|NOT COMPLETED|Overall Study||9||
59510653|NCT02472730|75604127|FG001|NOT COMPLETED|Overall Study||7||
59510654|NCT02475070|75604135|FG000|STARTED|Overall Study||17||
59510655|NCT02475070|75604136|FG001|STARTED|Overall Study||11||
59510656|NCT02475070|75604135|FG000|COMPLETED|Overall Study||17||
59510657|NCT02475070|75604136|FG001|COMPLETED|Overall Study||11||
59510658|NCT02475070|75604135|FG000|NOT COMPLETED|Overall Study||0||
59510659|NCT02475070|75604136|FG001|NOT COMPLETED|Overall Study||0||
59510660|NCT00902161|75604145|FG000|STARTED|Pre-study Washout/Propanolol Run-in||0||
59510661|NCT00902161|75604146|FG001|STARTED|Pre-study Washout/Propanolol Run-in||0||
59510662|NCT00902161|75604147|FG002|STARTED|Pre-study Washout/Propanolol Run-in||22||
59510663|NCT00902161|75604145|FG000|COMPLETED|Pre-study Washout/Propanolol Run-in||0||
59510664|NCT00902161|75604146|FG001|COMPLETED|Pre-study Washout/Propanolol Run-in||0||
59510665|NCT00902161|75604147|FG002|COMPLETED|Pre-study Washout/Propanolol Run-in||22||
59510666|NCT00902161|75604145|FG000|NOT COMPLETED|Pre-study Washout/Propanolol Run-in||0||
59510667|NCT00902161|75604146|FG001|NOT COMPLETED|Pre-study Washout/Propanolol Run-in||0||
59510668|NCT00902161|75604147|FG002|NOT COMPLETED|Pre-study Washout/Propanolol Run-in||0||
59510669|NCT00902161|75604145|FG000|STARTED|Period 1||12||
59510670|NCT00902161|75604146|FG001|STARTED|Period 1||10||
59510671|NCT00902161|75604147|FG002|STARTED|Period 1||0||
59510672|NCT00902161|75604145|FG000|COMPLETED|Period 1||12||
59510673|NCT00902161|75604146|FG001|COMPLETED|Period 1||10||
59510674|NCT00902161|75604147|FG002|COMPLETED|Period 1||0||
59510675|NCT00902161|75604145|FG000|NOT COMPLETED|Period 1||0||
59510676|NCT00902161|75604146|FG001|NOT COMPLETED|Period 1||0||
59510677|NCT00902161|75604147|FG002|NOT COMPLETED|Period 1||0||
59510678|NCT00902161|75604145|FG000|STARTED|Post-clamp Washout||0||
59510679|NCT00902161|75604146|FG001|STARTED|Post-clamp Washout||0||
59510680|NCT00902161|75604147|FG002|STARTED|Post-clamp Washout||22||
59510681|NCT00902161|75604145|FG000|COMPLETED|Post-clamp Washout||0||
59510682|NCT00902161|75604146|FG001|COMPLETED|Post-clamp Washout||0||
59510683|NCT00902161|75604147|FG002|COMPLETED|Post-clamp Washout|2 participants discontinued washout and were replaced; 1 due to an AE and 1 due to lack of efficacy|22||
59510684|NCT00902161|75604145|FG000|NOT COMPLETED|Post-clamp Washout||0||
59510685|NCT00902161|75604146|FG001|NOT COMPLETED|Post-clamp Washout||0||
59510686|NCT00902161|75604147|FG002|NOT COMPLETED|Post-clamp Washout||0||
59510687|NCT00902161|75604145|FG000|STARTED|Period 2||8||
59510688|NCT00902161|75604146|FG001|STARTED|Period 2||9||
59510689|NCT00902161|75604147|FG002|STARTED|Period 2||0||
59510690|NCT00902161|75604145|FG000|COMPLETED|Period 2|2 participants discontinued and were replaced; 1 due to protocol deviation and 1 withdrew consent|8||
59510691|NCT00902161|75604146|FG001|COMPLETED|Period 2||9||
59510692|NCT00902161|75604147|FG002|COMPLETED|Period 2||0||
59510693|NCT00902161|75604145|FG000|NOT COMPLETED|Period 2||0||
59510694|NCT00902161|75604146|FG001|NOT COMPLETED|Period 2||0||
59510695|NCT00902161|75604147|FG002|NOT COMPLETED|Period 2||0||
59510696|NCT02478580|75604159|FG000|STARTED|Overall Study||34||
59510697|NCT02478580|75604160|FG001|STARTED|Overall Study||33||
59510698|NCT02478580|75604159|FG000|COMPLETED|Overall Study||34||
59510699|NCT02478580|75604160|FG001|COMPLETED|Overall Study||33||
59510700|NCT02478580|75604159|FG000|NOT COMPLETED|Overall Study||0||
59510701|NCT02478580|75604160|FG001|NOT COMPLETED|Overall Study||0||
59510702|NCT02480920|75604168|FG000|STARTED|Overall Study||2738||
59510703|NCT02480920|75604168|FG000|COMPLETED|Overall Study||2738||
59510704|NCT02480920|75604168|FG000|NOT COMPLETED|Overall Study||0||
59510705|NCT02480998|75604174|FG000|STARTED|Overall Study||56||
59510706|NCT02480998|75604175|FG001|STARTED|Overall Study||28||
59510707|NCT02480998|75604174|FG000|COMPLETED|Overall Study||56||
59510708|NCT02480998|75604175|FG001|COMPLETED|Overall Study||28||
59510709|NCT02480998|75604174|FG000|NOT COMPLETED|Overall Study||0||
59510710|NCT02480998|75604175|FG001|NOT COMPLETED|Overall Study||0||
59510711|NCT03218995|75604183|FG000|STARTED|Overall Study||15||
59510712|NCT03218995|75604183|FG000|Received at Least 1 Dose of Study Drug|Overall Study||15||
59510713|NCT03218995|75604183|FG000|COMPLETED|Overall Study||15||
59510714|NCT03218995|75604183|FG000|NOT COMPLETED|Overall Study||0||
59510715|NCT00905125|75604191|FG000|STARTED|Overall Study||46||
59510716|NCT00905125|75604192|FG001|STARTED|Overall Study||56||
59510717|NCT00905125|75604191|FG000|COMPLETED|Overall Study||42||
59510718|NCT00905125|75604192|FG001|COMPLETED|Overall Study||53||
59510719|NCT00905125|75604191|FG000|NOT COMPLETED|Overall Study||4||
59510720|NCT00905125|75604192|FG001|NOT COMPLETED|Overall Study||3||
59510721|NCT00905827|75604201|FG000|STARTED|Overall Study||70||
59510722|NCT00905827|75604202|FG001|STARTED|Overall Study||69||
59510723|NCT00905827|75604203|FG002|STARTED|Overall Study||73||
59510724|NCT00905827|75604201|FG000|COMPLETED|Overall Study||70||
59510725|NCT00905827|75604202|FG001|COMPLETED|Overall Study||69||
59510726|NCT00905827|75604203|FG002|COMPLETED|Overall Study||73||
59510727|NCT00905827|75604201|FG000|NOT COMPLETED|Overall Study||0||
59510728|NCT00905827|75604202|FG001|NOT COMPLETED|Overall Study||0||
59510729|NCT00905827|75604203|FG002|NOT COMPLETED|Overall Study||0||
59510730|NCT03219073|75604211|FG000|STARTED|Overall Study||0||
59510731|NCT03219073|75604212|FG001|STARTED|Overall Study||1||
59510732|NCT03219073|75604211|FG000|COMPLETED|Overall Study||0||
59510733|NCT03219073|75604212|FG001|COMPLETED|Overall Study||1||
59510734|NCT03219073|75604211|FG000|NOT COMPLETED|Overall Study||0||
59510735|NCT03219073|75604212|FG001|NOT COMPLETED|Overall Study||0||
59510736|NCT00894127|75604217|FG000|STARTED|Overall Study||128||
59510737|NCT00894127|75604217|FG000|COMPLETED|Overall Study||128||
59510738|NCT00894127|75604217|FG000|NOT COMPLETED|Overall Study||0||
59510739|NCT03216499|75604221|FG000|STARTED|Overall Study||24||
59510740|NCT03216499|75604221|FG000|COMPLETED|Overall Study||24||
59510741|NCT03216499|75604221|FG000|NOT COMPLETED|Overall Study||0||
59510742|NCT02484898|75604225|FG000|STARTED|Overall Study||200||
59510743|NCT02484898|75604225|FG000|COMPLETED|Overall Study||182||
59510744|NCT02484898|75604225|FG000|NOT COMPLETED|Overall Study||18||
59510745|NCT02485834|75604229|FG000|STARTED|Overall Study||3|Randomized|
59510746|NCT02485834|75604230|FG001|STARTED|Overall Study||2|Randomized|
59510747|NCT02485834|75604229|FG000|COMPLETED|Overall Study||3||
59510748|NCT02485834|75604230|FG001|COMPLETED|Overall Study||2||
59510749|NCT02485834|75604229|FG000|NOT COMPLETED|Overall Study||0||
59510750|NCT02485834|75604230|FG001|NOT COMPLETED|Overall Study||0||
59510751|NCT01954966|75604237|FG000|STARTED|Overall Study||34||
59510752|NCT01954966|75604238|FG001|STARTED|Overall Study||32||
59510753|NCT01954966|75604237|FG000|Completed Week 1 of Intervention (Drug Assigned to Receive First)|Overall Study||30||
59510754|NCT01954966|75604238|FG001|Completed Week 1 of Intervention (Drug Assigned to Receive First)|Overall Study||30||
59510755|NCT01954966|75604237|FG000|Started Phase 2 After Washout Period (1-2 Week for Males, 1-3 Month for Females)|Overall Study||30||
59510756|NCT01954966|75604238|FG001|Started Phase 2 After Washout Period (1-2 Week for Males, 1-3 Month for Females)|Overall Study||30||
59510757|NCT01954966|75604237|FG000|Completed Week 2 of Intervention (Drug Assigned to Receive Second)|Overall Study||24||
59510758|NCT01954966|75604238|FG001|Completed Week 2 of Intervention (Drug Assigned to Receive Second)|Overall Study||28||
59510759|NCT01954966|75604237|FG000|COMPLETED|Overall Study||24||
59510760|NCT01954966|75604238|FG001|COMPLETED|Overall Study||28||
59510761|NCT01954966|75604237|FG000|NOT COMPLETED|Overall Study||10||
59510762|NCT01954966|75604238|FG001|NOT COMPLETED|Overall Study||4||
59510763|NCT02485912|75604246|FG000|STARTED|Overall Study||20||
59510764|NCT02485912|75604247|FG001|STARTED|Overall Study||20||
59510765|NCT02485912|75604246|FG000|COMPLETED|Overall Study||20||
59510766|NCT02485912|75604247|FG001|COMPLETED|Overall Study||20||
59510767|NCT02485912|75604246|FG000|NOT COMPLETED|Overall Study||0||
59510768|NCT02485912|75604247|FG001|NOT COMPLETED|Overall Study||0||
59510769|NCT02488018|75604253|FG000|STARTED|Overall Study||10||
59510770|NCT02488018|75604253|FG000|COMPLETED|Overall Study||10||
59510771|NCT02488018|75604253|FG000|NOT COMPLETED|Overall Study||0||
59510772|NCT00908791|75604257|FG000|STARTED|Overall Study||24||
59510773|NCT00908791|75604257|FG000|COMPLETED|Overall Study||24||
59510774|NCT00908791|75604257|FG000|NOT COMPLETED|Overall Study||0||
59510775|NCT02489110|75604272|FG000|STARTED|Overall Study||75||
59510776|NCT02489110|75604273|FG001|STARTED|Overall Study||75||
59510777|NCT02489110|75604272|FG000|COMPLETED|Overall Study||48||
59510778|NCT02489110|75604273|FG001|COMPLETED|Overall Study||50||
59510779|NCT02489110|75604272|FG000|NOT COMPLETED|Overall Study||27||
59510780|NCT02489110|75604273|FG001|NOT COMPLETED|Overall Study||25||
59510781|NCT02489734|75604281|FG000|STARTED|Overall Study||56||
59510782|NCT02489734|75604282|FG001|STARTED|Overall Study||53||
59919023|NCT04966910|76039431|FG003|STARTED|9-Week Follow-Up|Clinicians did not receive a 4 week survey, therefore the number of participants who started this period is not the same as the number who completed the previous period.|2|All enrolled participants at baseline were considered to start the 9-week follow-up time period. Participants were not required to complete the 4-week follow-up to start and be considered for the 9-week follow-up.|2
59919024|NCT04966910|76039428|FG000|COMPLETED|9-Week Follow-Up||19||2
59919025|NCT04966910|76039429|FG001|COMPLETED|9-Week Follow-Up||17||2
59919026|NCT04966910|76039430|FG002|COMPLETED|9-Week Follow-Up||2||2
59919027|NCT04966910|76039431|FG003|COMPLETED|9-Week Follow-Up||0||0
59919028|NCT04966910|76039428|FG000|NOT COMPLETED|9-Week Follow-Up||3||0
60042511|NCT02304380|76158150|FG002|STARTED|Interviews & Focus Groups (Aim 1)||33||
59510783|NCT02489734|75604281|FG000|COMPLETED|Overall Study||39||
59510784|NCT02489734|75604282|FG001|COMPLETED|Overall Study||53||
59510785|NCT02489734|75604281|FG000|NOT COMPLETED|Overall Study||17||
59510786|NCT02489734|75604282|FG001|NOT COMPLETED|Overall Study||0||
59919029|NCT04966910|76039429|FG001|NOT COMPLETED|9-Week Follow-Up||1||0
59919030|NCT04966910|76039430|FG002|NOT COMPLETED|9-Week Follow-Up||0||0
59919031|NCT04966910|76039431|FG003|NOT COMPLETED|9-Week Follow-Up||2||2
60042512|NCT02304380|76158151|FG003|STARTED|Interviews & Focus Groups (Aim 1)||0||
60042513|NCT02304380|76158152|FG004|STARTED|Interviews & Focus Groups (Aim 1)||0||
60042514|NCT02304380|76158153|FG005|STARTED|Interviews & Focus Groups (Aim 1)||0||
60042515|NCT02304380|76158148|FG000|COMPLETED|Interviews & Focus Groups (Aim 1)||0||
60042516|NCT02304380|76158149|FG001|COMPLETED|Interviews & Focus Groups (Aim 1)||35||
60042517|NCT02304380|76158150|FG002|COMPLETED|Interviews & Focus Groups (Aim 1)||33||
60042518|NCT02304380|76158151|FG003|COMPLETED|Interviews & Focus Groups (Aim 1)||0||
60042519|NCT02304380|76158152|FG004|COMPLETED|Interviews & Focus Groups (Aim 1)||0||
60042520|NCT02304380|76158153|FG005|COMPLETED|Interviews & Focus Groups (Aim 1)||0||
60042521|NCT02304380|76158148|FG000|NOT COMPLETED|Interviews & Focus Groups (Aim 1)||0||
60042522|NCT02304380|76158149|FG001|NOT COMPLETED|Interviews & Focus Groups (Aim 1)||0||
60042523|NCT02304380|76158150|FG002|NOT COMPLETED|Interviews & Focus Groups (Aim 1)||0||
60042524|NCT02304380|76158151|FG003|NOT COMPLETED|Interviews & Focus Groups (Aim 1)||0||
60042525|NCT02304380|76158152|FG004|NOT COMPLETED|Interviews & Focus Groups (Aim 1)||0||
60042526|NCT02304380|76158153|FG005|NOT COMPLETED|Interviews & Focus Groups (Aim 1)||0||
60042527|NCT02304380|76158148|FG000|STARTED|ACO Stakeholder Interviews (Aim 1)||24||
60042528|NCT02304380|76158149|FG001|STARTED|ACO Stakeholder Interviews (Aim 1)||0||
60042529|NCT02304380|76158150|FG002|STARTED|ACO Stakeholder Interviews (Aim 1)||0||
60042530|NCT02304380|76158151|FG003|STARTED|ACO Stakeholder Interviews (Aim 1)||0||
60042531|NCT02304380|76158152|FG004|STARTED|ACO Stakeholder Interviews (Aim 1)||0||
60042532|NCT02304380|76158153|FG005|STARTED|ACO Stakeholder Interviews (Aim 1)||0||
60042533|NCT02304380|76158148|FG000|COMPLETED|ACO Stakeholder Interviews (Aim 1)||24||
60042534|NCT02304380|76158149|FG001|COMPLETED|ACO Stakeholder Interviews (Aim 1)||0||
60042535|NCT02304380|76158150|FG002|COMPLETED|ACO Stakeholder Interviews (Aim 1)||0||
60042536|NCT02304380|76158151|FG003|COMPLETED|ACO Stakeholder Interviews (Aim 1)||0||
60042537|NCT02304380|76158152|FG004|COMPLETED|ACO Stakeholder Interviews (Aim 1)||0||
60042538|NCT02304380|76158153|FG005|COMPLETED|ACO Stakeholder Interviews (Aim 1)||0||
60042539|NCT02304380|76158148|FG000|NOT COMPLETED|ACO Stakeholder Interviews (Aim 1)||0||
60042540|NCT02304380|76158149|FG001|NOT COMPLETED|ACO Stakeholder Interviews (Aim 1)||0||
60042541|NCT02304380|76158150|FG002|NOT COMPLETED|ACO Stakeholder Interviews (Aim 1)||0||
60042542|NCT02304380|76158151|FG003|NOT COMPLETED|ACO Stakeholder Interviews (Aim 1)||0||
60042543|NCT02304380|76158152|FG004|NOT COMPLETED|ACO Stakeholder Interviews (Aim 1)||0||
60042544|NCT02304380|76158153|FG005|NOT COMPLETED|ACO Stakeholder Interviews (Aim 1)||0||
60042545|NCT02203591|76158175|FG000|STARTED|Overall Study||343||343
60042546|NCT02203591|76158176|FG001|STARTED|Overall Study||344||344
60042547|NCT02203591|76158177|FG002|STARTED|Overall Study||347||347
60042548|NCT02203591|76158178|FG003|STARTED|Overall Study||104||104
60042549|NCT02203591|76158179|FG004|STARTED|Overall Study||242||242
60042550|NCT02203591|76158180|FG005|STARTED|Overall Study||244||244
60042551|NCT02203591|76158181|FG006|STARTED|Overall Study||248||248
60042552|NCT02203591|76158182|FG007|STARTED|Overall Study||74||74
60042553|NCT02203591|76158175|FG000|COMPLETED|Overall Study||196||196
60042554|NCT02203591|76158176|FG001|COMPLETED|Overall Study||202||202
60042555|NCT02203591|76158177|FG002|COMPLETED|Overall Study||196||196
60042556|NCT02203591|76158178|FG003|COMPLETED|Overall Study||59||59
60042557|NCT02203591|76158179|FG004|COMPLETED|Overall Study||208||208
60042558|NCT02203591|76158180|FG005|COMPLETED|Overall Study||209||209
60042559|NCT02203591|76158181|FG006|COMPLETED|Overall Study||219||219
60042560|NCT02203591|76158182|FG007|COMPLETED|Overall Study||61||61
60042561|NCT02203591|76158175|FG000|NOT COMPLETED|Overall Study||147||147
60042562|NCT02203591|76158176|FG001|NOT COMPLETED|Overall Study||142||142
60042563|NCT02203591|76158177|FG002|NOT COMPLETED|Overall Study||151||151
60042564|NCT02203591|76158178|FG003|NOT COMPLETED|Overall Study||45||45
60042565|NCT02203591|76158179|FG004|NOT COMPLETED|Overall Study||34||34
59510787|NCT02490670|75604290|FG000|STARTED|Period 1 (19 Days)||14||
59510788|NCT02490670|75604291|FG001|STARTED|Period 1 (19 Days)||14||
59510789|NCT02490670|75604290|FG000|COMPLETED|Period 1 (19 Days)||14||
59510790|NCT02490670|75604291|FG001|COMPLETED|Period 1 (19 Days)||14||
59510791|NCT02490670|75604290|FG000|NOT COMPLETED|Period 1 (19 Days)||0||
59510792|NCT02490670|75604291|FG001|NOT COMPLETED|Period 1 (19 Days)||0||
59510793|NCT02490670|75604290|FG000|STARTED|Washout Period (7 Days)||14||
59510794|NCT02490670|75604291|FG001|STARTED|Washout Period (7 Days)||14||
59510795|NCT02490670|75604290|FG000|COMPLETED|Washout Period (7 Days)||14||
59510796|NCT02490670|75604291|FG001|COMPLETED|Washout Period (7 Days)||14||
59510797|NCT02490670|75604290|FG000|NOT COMPLETED|Washout Period (7 Days)||0||
59510798|NCT02490670|75604291|FG001|NOT COMPLETED|Washout Period (7 Days)||0||
59510799|NCT02490670|75604290|FG000|STARTED|Period 2 (19 Days)||14||
59510800|NCT02490670|75604291|FG001|STARTED|Period 2 (19 Days)||14||
59510801|NCT02490670|75604290|FG000|COMPLETED|Period 2 (19 Days)||14||
59510802|NCT02490670|75604291|FG001|COMPLETED|Period 2 (19 Days)||14||
59510803|NCT02490670|75604290|FG000|NOT COMPLETED|Period 2 (19 Days)||0||
59510804|NCT02490670|75604291|FG001|NOT COMPLETED|Period 2 (19 Days)||0||
59510805|NCT00908947|75604297|FG000|STARTED|Overall Study||173||
59510806|NCT00908947|75604297|FG000|COMPLETED|Overall Study||83||
59510807|NCT00908947|75604297|FG000|NOT COMPLETED|Overall Study||90||
59510808|NCT02492854|75604304|FG000|STARTED|Overall Study||5||
59510809|NCT02492854|75604305|FG001|STARTED|Overall Study||3||
59510810|NCT02492854|75604304|FG000|COMPLETED|Overall Study||5||
59510811|NCT02492854|75604305|FG001|COMPLETED|Overall Study||3||
59510812|NCT02492854|75604304|FG000|NOT COMPLETED|Overall Study||0||
59510813|NCT02492854|75604305|FG001|NOT COMPLETED|Overall Study||0||
59510814|NCT02493088|75604311|FG000|STARTED|Overall Study||11||
59510815|NCT02493088|75604311|FG000|COMPLETED|Overall Study||11||
59510816|NCT02493088|75604311|FG000|NOT COMPLETED|Overall Study||0||
59510817|NCT02494102|75604317|FG000|STARTED|Overall Study||42||
59510818|NCT02494102|75604318|FG001|STARTED|Overall Study||47||
59510819|NCT02494102|75604317|FG000|COMPLETED|Overall Study||42||
59510820|NCT02494102|75604318|FG001|COMPLETED|Overall Study||47||
59510821|NCT02494102|75604317|FG000|NOT COMPLETED|Overall Study||0||
59510822|NCT02494102|75604318|FG001|NOT COMPLETED|Overall Study||0||
59510823|NCT00894517|75604326|FG000|STARTED|Overall Study||30||
60042566|NCT02203591|76158180|FG005|NOT COMPLETED|Overall Study||35||35
60042567|NCT02203591|76158181|FG006|NOT COMPLETED|Overall Study||29||29
60042568|NCT02203591|76158182|FG007|NOT COMPLETED|Overall Study||13||13
60042569|NCT01642277|76158206|FG000|STARTED|Overall Study||74||
60042570|NCT01642277|76158207|FG001|STARTED|Overall Study||60||
60042571|NCT01642277|76158206|FG000|COMPLETED|Overall Study||50||
60042572|NCT01642277|76158207|FG001|COMPLETED|Overall Study||60||
60042573|NCT01642277|76158206|FG000|NOT COMPLETED|Overall Study||24||
60042574|NCT01642277|76158207|FG001|NOT COMPLETED|Overall Study||0||
60042575|NCT02230189|76158217|FG000|STARTED|Overall Study||22||
60042576|NCT02230189|76158218|FG001|STARTED|Overall Study||2||
60042577|NCT02230189|76158219|FG002|STARTED|Overall Study||4||
60042578|NCT02230189|76158217|FG000|COMPLETED|Overall Study||17||
60042579|NCT02230189|76158218|FG001|COMPLETED|Overall Study||2||
60042580|NCT02230189|76158219|FG002|COMPLETED|Overall Study||3||
60042581|NCT02230189|76158217|FG000|NOT COMPLETED|Overall Study||5||
60042582|NCT02230189|76158218|FG001|NOT COMPLETED|Overall Study||0||
60042583|NCT02230189|76158219|FG002|NOT COMPLETED|Overall Study||1||
60042584|NCT02304302|76158230|FG000|STARTED|Overall Study||79||
60042585|NCT02304302|76158231|FG001|STARTED|Overall Study||81||
60042586|NCT02304302|76158230|FG000|COMPLETED|Overall Study||76||
60042587|NCT02304302|76158231|FG001|COMPLETED|Overall Study||73||
60042588|NCT02304302|76158230|FG000|NOT COMPLETED|Overall Study||3||
60042589|NCT02304302|76158231|FG001|NOT COMPLETED|Overall Study||8||
60042590|NCT02276612|76158243|FG000|STARTED|Overall Study||50||
60042591|NCT02276612|76158244|FG001|STARTED|Overall Study||10||
60042592|NCT02276612|76158243|FG000|COMPLETED|Overall Study||46||
60042593|NCT02276612|76158244|FG001|COMPLETED|Overall Study||10||
60042594|NCT02276612|76158243|FG000|NOT COMPLETED|Overall Study||4||
60042595|NCT02276612|76158244|FG001|NOT COMPLETED|Overall Study||0||
60042596|NCT02301143|76158250|FG000|STARTED|Induction Period||107|Participants enrolled.|
60042597|NCT02301143|76158251|FG001|STARTED|Induction Period||0|Participants enrolled.|
60042598|NCT02301143|76158250|FG000|COMPLETED|Induction Period||62||
59510824|NCT00894517|75604327|FG001|STARTED|Overall Study||31||
59510825|NCT00894517|75604326|FG000|COMPLETED|Overall Study||28||
59510826|NCT00894517|75604327|FG001|COMPLETED|Overall Study||26||
59510827|NCT00894517|75604326|FG000|NOT COMPLETED|Overall Study||2||
59510828|NCT00894517|75604327|FG001|NOT COMPLETED|Overall Study||5||
59510829|NCT02494180|75604335|FG000|STARTED|Overall Study||85||
59510830|NCT02494180|75604336|FG001|STARTED|Overall Study||85||
59510831|NCT02494180|75604335|FG000|COMPLETED|Overall Study||85||
59510832|NCT02494180|75604336|FG001|COMPLETED|Overall Study||85||
59510833|NCT02494180|75604335|FG000|NOT COMPLETED|Overall Study||0||
60042599|NCT02301143|76158251|FG001|COMPLETED|Induction Period||0||
60042600|NCT02301143|76158250|FG000|NOT COMPLETED|Induction Period||45||
60042601|NCT02301143|76158251|FG001|NOT COMPLETED|Induction Period||0||
60042602|NCT02301143|76158250|FG000|STARTED|Investigator's Choice||0||
60042603|NCT02301143|76158251|FG001|STARTED|Investigator's Choice|12 participants continued nab-Paclitaxel/Gemcitabine; 18 started chemoradiation;17 underwent surgery|47||
59510834|NCT02494180|75604336|FG001|NOT COMPLETED|Overall Study||0||
59510835|NCT02494336|75604344|FG000|STARTED|Overall Study||24||
59510836|NCT02494336|75604345|FG001|STARTED|Overall Study||24||
59510837|NCT02494336|75604344|FG000|COMPLETED|Overall Study||24||
59510838|NCT02494336|75604345|FG001|COMPLETED|Overall Study||24||
59510839|NCT02494336|75604344|FG000|NOT COMPLETED|Overall Study||0||
59510840|NCT02494336|75604345|FG001|NOT COMPLETED|Overall Study||0||
59612390|NCT01701258|75723511|FG012|COMPLETED|Assessment and Scheduling||0|Participants completed the study if they completed the screening session and two imaging sessions.|
59612391|NCT01701258|75723499|FG000|NOT COMPLETED|Assessment and Scheduling||83||
59612392|NCT01701258|75723500|FG001|NOT COMPLETED|Assessment and Scheduling||0||
59919032|NCT04900038|76039447|FG000|STARTED|Overall Study||22||
59919033|NCT04900038|76039448|FG001|STARTED|Overall Study||20||
59919034|NCT04900038|76039449|FG002|STARTED|Overall Study||22||
59919035|NCT04900038|76039450|FG003|STARTED|Overall Study||21||
59919036|NCT04900038|76039447|FG000|COMPLETED|Overall Study||2||
59919037|NCT04900038|76039448|FG001|COMPLETED|Overall Study||3||
59919038|NCT04900038|76039449|FG002|COMPLETED|Overall Study||2||
59919039|NCT04900038|76039450|FG003|COMPLETED|Overall Study||3||
59919040|NCT04900038|76039447|FG000|NOT COMPLETED|Overall Study||20||
59919041|NCT04900038|76039448|FG001|NOT COMPLETED|Overall Study||17||
59919042|NCT04900038|76039449|FG002|NOT COMPLETED|Overall Study||20||
59919043|NCT04900038|76039450|FG003|NOT COMPLETED|Overall Study||18||
59919044|NCT04880642|76039462|FG000|STARTED|Randomization||136||
59919045|NCT04880642|76039463|FG001|STARTED|Randomization||136||
59919046|NCT04880642|76039462|FG000|COMPLETED|Randomization||134||
59919047|NCT04880642|76039463|FG001|COMPLETED|Randomization||133||
59919048|NCT04880642|76039462|FG000|NOT COMPLETED|Randomization||2||
59919049|NCT04880642|76039463|FG001|NOT COMPLETED|Randomization||3||
59919050|NCT04880642|76039462|FG000|STARTED|Treatment Period||134||
59919051|NCT04880642|76039463|FG001|STARTED|Treatment Period||133||
59919052|NCT04880642|76039462|FG000|COMPLETED|Treatment Period||122||
59919053|NCT04880642|76039463|FG001|COMPLETED|Treatment Period||121||
59919054|NCT04880642|76039462|FG000|NOT COMPLETED|Treatment Period||12||
59919055|NCT04880642|76039463|FG001|NOT COMPLETED|Treatment Period||12||
59919056|NCT04880642|76039462|FG000|STARTED|Follow-up||122|A total of 8 subjects (5 subjects in the C21 group and 3 subjects in the placebo group) discontinued treatment but continued to participate in the trial.|
59919057|NCT04880642|76039463|FG001|STARTED|Follow-up||121|A total of 8 subjects (5 subjects in the C21 group and 3 subjects in the placebo group) discontinued treatment but continued to participate in the trial.|
59919058|NCT04880642|76039462|FG000|COMPLETED|Follow-up||117||
59919059|NCT04880642|76039463|FG001|COMPLETED|Follow-up||118||
59919060|NCT04880642|76039462|FG000|NOT COMPLETED|Follow-up||5||
59919061|NCT04880642|76039463|FG001|NOT COMPLETED|Follow-up||3||
59919062|NCT04578535|76039475|FG000|STARTED|Overall Study||8||
59919063|NCT04578535|76039476|FG001|STARTED|Overall Study||8||
59919064|NCT04578535|76039477|FG002|STARTED|Overall Study||8||
59919065|NCT04578535|76039478|FG003|STARTED|Overall Study||9||
59919066|NCT04578535|76039479|FG004|STARTED|Overall Study||8||
59919067|NCT04578535|76039480|FG005|STARTED|Overall Study||10||
59919068|NCT04578535|76039475|FG000|COMPLETED|Overall Study||6||
59919069|NCT04578535|76039476|FG001|COMPLETED|Overall Study||8||
59919070|NCT04578535|76039477|FG002|COMPLETED|Overall Study||8||
59919071|NCT04578535|76039478|FG003|COMPLETED|Overall Study||7||
59919072|NCT04578535|76039479|FG004|COMPLETED|Overall Study||6||
59919073|NCT04578535|76039480|FG005|COMPLETED|Overall Study||3||
59919074|NCT04578535|76039475|FG000|NOT COMPLETED|Overall Study||2||
59919075|NCT04578535|76039476|FG001|NOT COMPLETED|Overall Study||0||
59919076|NCT04578535|76039477|FG002|NOT COMPLETED|Overall Study||0||
59919077|NCT04578535|76039478|FG003|NOT COMPLETED|Overall Study||2||
59919078|NCT04578535|76039479|FG004|NOT COMPLETED|Overall Study||2||
59919079|NCT04578535|76039480|FG005|NOT COMPLETED|Overall Study||7||
59919080|NCT04574362|76039500|FG000|STARTED|Overall Study||716||
59919081|NCT04574362|76039501|FG001|STARTED|Overall Study||715||
59919082|NCT04574362|76039500|FG000|Treated|Overall Study||668||
59919083|NCT04574362|76039501|FG001|Treated|Overall Study||674||
59919084|NCT04574362|76039500|FG000|COMPLETED|Overall Study||709||
59919085|NCT04574362|76039501|FG001|COMPLETED|Overall Study||704||
59919086|NCT04574362|76039500|FG000|NOT COMPLETED|Overall Study||7||
59919087|NCT04574362|76039501|FG001|NOT COMPLETED|Overall Study||11||
59919088|NCT04470908|76039507|FG000|STARTED|Zanubrutinib on Day 1||13||
59919089|NCT04470908|76039507|FG000|COMPLETED|Zanubrutinib on Day 1||13||
59919090|NCT04470908|76039507|FG000|NOT COMPLETED|Zanubrutinib on Day 1||0||
59919091|NCT04470908|76039507|FG000|STARTED|Rifabutin on Days 3 to 10||13||
59919092|NCT04470908|76039507|FG000|COMPLETED|Rifabutin on Days 3 to 10||13||
59919093|NCT04470908|76039507|FG000|NOT COMPLETED|Rifabutin on Days 3 to 10||0||
59919094|NCT04470908|76039507|FG000|STARTED|Zanubrutinib + Rifabutin on Day 11||13||
59510841|NCT01839331|75604355|FG000|STARTED|Overall Study||83||83
59510842|NCT01839331|75604356|FG001|STARTED|Overall Study||83||83
59510843|NCT01839331|75604357|FG002|STARTED|Overall Study||82||82
59510844|NCT01839331|75604358|FG003|STARTED|Overall Study||81||81
59510845|NCT01839331|75604355|FG000|Week 6|Overall Study||83||83
59759745|NCT00880191|75879170|FG001|STARTED|Overall Study||206||
59919095|NCT04470908|76039507|FG000|COMPLETED|Zanubrutinib + Rifabutin on Day 11||12||
59919096|NCT04470908|76039507|FG000|NOT COMPLETED|Zanubrutinib + Rifabutin on Day 11||1||
59919097|NCT04399837|76039521|FG000|STARTED|Overall Study||31||
59919098|NCT04399837|76039522|FG001|STARTED|Overall Study||31||
59919099|NCT04399837|76039523|FG002|STARTED|Overall Study||31||
59919100|NCT04399837|76039524|FG003|STARTED|Overall Study||30||
59919101|NCT04399837|76039521|FG000|COMPLETED|Overall Study||30|Completed trial|
59919102|NCT04399837|76039522|FG001|COMPLETED|Overall Study||27|Completed trial|
59919103|NCT04399837|76039523|FG002|COMPLETED|Overall Study||28|Completed trial|
60042604|NCT02301143|76158250|FG000|COMPLETED|Investigator's Choice||0||
60042605|NCT02301143|76158251|FG001|COMPLETED|Investigator's Choice|3 participants completed nab-Paclitaxel+Gemcitabine,18 completed chemoradiation,16 had surgery.|37||
60042606|NCT02301143|76158250|FG000|NOT COMPLETED|Investigator's Choice||0||
60042607|NCT02301143|76158251|FG001|NOT COMPLETED|Investigator's Choice||10||
60042608|NCT02276222|76158264|FG000|STARTED|Overall Study||621||
60042609|NCT02276222|76158265|FG001|STARTED|Overall Study||466||
60042610|NCT02276222|76158264|FG000|COMPLETED|Overall Study|one subject withdrew at randomization due to a pre-treatment event prior to being dosed|436||
60042611|NCT02276222|76158265|FG001|COMPLETED|Overall Study||402||
60042612|NCT02276222|76158264|FG000|NOT COMPLETED|Overall Study||185||
60042613|NCT02276222|76158265|FG001|NOT COMPLETED|Overall Study||64||
60042614|NCT02275364|76158271|FG000|STARTED|Period 1||14||
60042615|NCT02275364|76158272|FG001|STARTED|Period 1||14||
60042616|NCT02275364|76158271|FG000|COMPLETED|Period 1||12||
60042617|NCT02275364|76158272|FG001|COMPLETED|Period 1||14||
60042618|NCT02275364|76158271|FG000|NOT COMPLETED|Period 1||2||
60042619|NCT02275364|76158272|FG001|NOT COMPLETED|Period 1||0||
60042620|NCT02275364|76158271|FG000|STARTED|Washout Period 1||12||
60042621|NCT02275364|76158272|FG001|STARTED|Washout Period 1||14||
60042622|NCT02275364|76158271|FG000|COMPLETED|Washout Period 1||12||
60042623|NCT02275364|76158272|FG001|COMPLETED|Washout Period 1||14||
60042624|NCT02275364|76158271|FG000|NOT COMPLETED|Washout Period 1||0||
60042625|NCT02275364|76158272|FG001|NOT COMPLETED|Washout Period 1||0||
60042626|NCT02275364|76158271|FG000|STARTED|Period 2||12||
60042627|NCT02275364|76158272|FG001|STARTED|Period 2||14||
60042628|NCT02275364|76158271|FG000|COMPLETED|Period 2||12||
60042629|NCT02275364|76158272|FG001|COMPLETED|Period 2||14||
60042630|NCT02275364|76158271|FG000|NOT COMPLETED|Period 2||0||
60042631|NCT02275364|76158272|FG001|NOT COMPLETED|Period 2||0||
60042632|NCT02275364|76158271|FG000|STARTED|Washout Period 2||12||
60042633|NCT02275364|76158272|FG001|STARTED|Washout Period 2||14||
60042634|NCT02275364|76158271|FG000|COMPLETED|Washout Period 2||12||
60042635|NCT02275364|76158272|FG001|COMPLETED|Washout Period 2||14||
60042636|NCT02275364|76158271|FG000|NOT COMPLETED|Washout Period 2||0||
60042637|NCT02275364|76158272|FG001|NOT COMPLETED|Washout Period 2||0||
60042638|NCT02275364|76158271|FG000|STARTED|Period 3||12||
60042639|NCT02275364|76158272|FG001|STARTED|Period 3||14||
60042640|NCT02275364|76158271|FG000|COMPLETED|Period 3||12||
60042641|NCT02275364|76158272|FG001|COMPLETED|Period 3||14||
60042642|NCT02275364|76158271|FG000|NOT COMPLETED|Period 3||0||
60042643|NCT02275364|76158272|FG001|NOT COMPLETED|Period 3||0||
60042644|NCT02275364|76158271|FG000|STARTED|Period 4||12||
60042645|NCT02275364|76158272|FG001|STARTED|Period 4||14||
60042646|NCT02275364|76158271|FG000|COMPLETED|Period 4||12||
60042647|NCT02275364|76158272|FG001|COMPLETED|Period 4||14||
60042648|NCT02275364|76158271|FG000|NOT COMPLETED|Period 4||0||
60042649|NCT02275364|76158272|FG001|NOT COMPLETED|Period 4||0||
60042650|NCT02275052|76158289|FG000|STARTED|Period 1: Treatment Period 1 (12 Weeks)||99||
60042651|NCT02275052|76158290|FG001|STARTED|Period 1: Treatment Period 1 (12 Weeks)||99||
60042652|NCT02275052|76158291|FG002|STARTED|Period 1: Treatment Period 1 (12 Weeks)||0||
60042653|NCT02275052|76158292|FG003|STARTED|Period 1: Treatment Period 1 (12 Weeks)||0||
60042654|NCT02275052|76158289|FG000|COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||90||
60042655|NCT02275052|76158290|FG001|COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||93||
60042656|NCT02275052|76158291|FG002|COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||0||
60042657|NCT02275052|76158292|FG003|COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||0||
60042658|NCT02275052|76158289|FG000|NOT COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||9||
60042659|NCT02275052|76158290|FG001|NOT COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||6||
60042660|NCT02275052|76158291|FG002|NOT COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||0||
59951414|NCT01798992|76070391|FG001|NOT COMPLETED|Overall Study||2||
60042661|NCT02275052|76158292|FG003|NOT COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||0||
60042662|NCT02275052|76158289|FG000|STARTED|Washout Period (12-17 Days)||90||
60042663|NCT02275052|76158290|FG001|STARTED|Washout Period (12-17 Days)||93||
60042664|NCT02275052|76158291|FG002|STARTED|Washout Period (12-17 Days)||0||
60042665|NCT02275052|76158292|FG003|STARTED|Washout Period (12-17 Days)||0||
60042666|NCT02275052|76158289|FG000|COMPLETED|Washout Period (12-17 Days)||86||
60042667|NCT02275052|76158290|FG001|COMPLETED|Washout Period (12-17 Days)||93||
60042668|NCT02275052|76158291|FG002|COMPLETED|Washout Period (12-17 Days)||0||
60042669|NCT02275052|76158292|FG003|COMPLETED|Washout Period (12-17 Days)||0||
60042670|NCT02275052|76158289|FG000|NOT COMPLETED|Washout Period (12-17 Days)||4||
60042671|NCT02275052|76158290|FG001|NOT COMPLETED|Washout Period (12-17 Days)||0||
60042672|NCT02275052|76158291|FG002|NOT COMPLETED|Washout Period (12-17 Days)||0||
60042673|NCT02275052|76158292|FG003|NOT COMPLETED|Washout Period (12-17 Days)||0||
60042674|NCT02275052|76158289|FG000|STARTED|Period 2: Treatment Period 2 (12 Weeks)||0||
60042675|NCT02275052|76158290|FG001|STARTED|Period 2: Treatment Period 2 (12 Weeks)||0||
60042676|NCT02275052|76158291|FG002|STARTED|Period 2: Treatment Period 2 (12 Weeks)||93||
60042677|NCT02275052|76158292|FG003|STARTED|Period 2: Treatment Period 2 (12 Weeks)||86||
60042678|NCT02275052|76158289|FG000|COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||0||
60042679|NCT02275052|76158290|FG001|COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||0||
60042680|NCT02275052|76158291|FG002|COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||88||
60042681|NCT02275052|76158292|FG003|COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||72||
60042682|NCT02275052|76158289|FG000|NOT COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||0||
60042683|NCT02275052|76158290|FG001|NOT COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||0||
60042684|NCT02275052|76158291|FG002|NOT COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||5||
60042685|NCT02275052|76158292|FG003|NOT COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||14||
60042686|NCT02274038|76158298|FG000|STARTED|Overall Study||3||
60042687|NCT02274038|76158298|FG000|COMPLETED|Overall Study||2||
60042688|NCT02274038|76158298|FG000|NOT COMPLETED|Overall Study||1||
60042689|NCT02300558|76158304|FG000|STARTED|Single Blind Phase (24 Weeks)||41||
60042690|NCT02300558|76158304|FG000|COMPLETED|Single Blind Phase (24 Weeks)||35||
60042691|NCT02300558|76158304|FG000|NOT COMPLETED|Single Blind Phase (24 Weeks)||6||
60042692|NCT02300558|76158304|FG000|STARTED|Open-Label (OL) Extension Phase||32|3 participants completed the single-blind phase (24 weeks) but did not continue to OL Extension.|
60042693|NCT02300558|76158304|FG000|COMPLETED|Open-Label (OL) Extension Phase||0||
60042694|NCT02300558|76158304|FG000|NOT COMPLETED|Open-Label (OL) Extension Phase||32||
60042695|NCT02273960|76158316|FG000|STARTED|Short Term Period||5||
60042696|NCT02273960|76158317|FG001|STARTED|Short Term Period||6||
60042697|NCT02273960|76158318|FG002|STARTED|Short Term Period||5||
60042698|NCT02273960|76158319|FG003|STARTED|Short Term Period||10||
60042699|NCT02273960|76158316|FG000|COMPLETED|Short Term Period||0|Completed = Entering Long Term Extension|
60042700|NCT02273960|76158317|FG001|COMPLETED|Short Term Period||0|Completed = Entering Long Term Extension|
60042701|NCT02273960|76158318|FG002|COMPLETED|Short Term Period||1|Completed = Entering Long Term Extension|
60042702|NCT02273960|76158319|FG003|COMPLETED|Short Term Period||4|Completed = Entering Long Term Extension|
60042703|NCT02273960|76158316|FG000|NOT COMPLETED|Short Term Period||5||
60042704|NCT02273960|76158317|FG001|NOT COMPLETED|Short Term Period||6||
60042705|NCT02273960|76158318|FG002|NOT COMPLETED|Short Term Period||4||
59510846|NCT01839331|75604356|FG001|Week 6|Overall Study||83||83
59510847|NCT01839331|75604357|FG002|Week 6|Overall Study||82||82
59510848|NCT01839331|75604358|FG003|Week 6|Overall Study||81||81
59510849|NCT01839331|75604355|FG000|COMPLETED|Overall Study||79||79
59510850|NCT01839331|75604356|FG001|COMPLETED|Overall Study||77||77
59510851|NCT01839331|75604357|FG002|COMPLETED|Overall Study||77||77
59510852|NCT01839331|75604358|FG003|COMPLETED|Overall Study||76||76
59510853|NCT01839331|75604355|FG000|NOT COMPLETED|Overall Study||4||4
59510854|NCT01839331|75604356|FG001|NOT COMPLETED|Overall Study||6||6
59510855|NCT01839331|75604357|FG002|NOT COMPLETED|Overall Study||5||5
59510856|NCT01839331|75604358|FG003|NOT COMPLETED|Overall Study||5||5
59510857|NCT02495038|75604377|FG000|STARTED|Overall Study||27||
59510858|NCT02495038|75604378|FG001|STARTED|Overall Study||27||
59510859|NCT02495038|75604379|FG002|STARTED|Overall Study||27||
59510860|NCT02495038|75604377|FG000|COMPLETED|Overall Study||27||
59510861|NCT02495038|75604378|FG001|COMPLETED|Overall Study||27||
59510862|NCT02495038|75604379|FG002|COMPLETED|Overall Study||27||
59510863|NCT02495038|75604377|FG000|NOT COMPLETED|Overall Study||0||
59510864|NCT02495038|75604378|FG001|NOT COMPLETED|Overall Study||0||
59510865|NCT02495038|75604379|FG002|NOT COMPLETED|Overall Study||0||
59510866|NCT02501590|75604389|FG000|STARTED|Overall Study||13||
59510867|NCT02501590|75604390|FG001|STARTED|Overall Study||35||
59510868|NCT02501590|75604389|FG000|COMPLETED|Overall Study||13||
59510869|NCT02501590|75604390|FG001|COMPLETED|Overall Study||35||
59510870|NCT02501590|75604389|FG000|NOT COMPLETED|Overall Study||0||
59510871|NCT02501590|75604390|FG001|NOT COMPLETED|Overall Study||0||
59510872|NCT02503852|75604400|FG000|STARTED|Overall Study||16||
59510873|NCT02503852|75604401|FG001|STARTED|Overall Study||22||
59510874|NCT02503852|75604402|FG002|STARTED|Overall Study||24||
59510875|NCT02503852|75604403|FG003|STARTED|Overall Study||9||
59510876|NCT02503852|75604400|FG000|COMPLETED|Overall Study||12||
59510877|NCT02503852|75604401|FG001|COMPLETED|Overall Study||19||
59510878|NCT02503852|75604402|FG002|COMPLETED|Overall Study||21||
59510879|NCT02503852|75604403|FG003|COMPLETED|Overall Study||8||
59510880|NCT02503852|75604400|FG000|NOT COMPLETED|Overall Study||4||
59510881|NCT02503852|75604401|FG001|NOT COMPLETED|Overall Study||3||
59510882|NCT02503852|75604402|FG002|NOT COMPLETED|Overall Study||3||
59510883|NCT02503852|75604403|FG003|NOT COMPLETED|Overall Study||1||
59510884|NCT02504554|75604415|FG000|STARTED|Overall Study|1 participant was switched from the oral group to the rectal group due to nausea/vomiting.|12||
59510885|NCT02504554|75604416|FG001|STARTED|Overall Study||6||
59510886|NCT02504554|75604415|FG000|COMPLETED|Overall Study||12||
59510887|NCT02504554|75604416|FG001|COMPLETED|Overall Study||6||
60042706|NCT02273960|76158319|FG003|NOT COMPLETED|Short Term Period||6||
60042707|NCT02273960|76158316|FG000|STARTED|Long Term Extension||0||
60042708|NCT02273960|76158317|FG001|STARTED|Long Term Extension||0||
60042709|NCT02273960|76158318|FG002|STARTED|Long Term Extension||1||
60042710|NCT02273960|76158319|FG003|STARTED|Long Term Extension||4||
60042711|NCT02273960|76158316|FG000|COMPLETED|Long Term Extension||0||
60042712|NCT02273960|76158317|FG001|COMPLETED|Long Term Extension||0||
60042713|NCT02273960|76158318|FG002|COMPLETED|Long Term Extension||1||
60042714|NCT02273960|76158319|FG003|COMPLETED|Long Term Extension||3||
60042715|NCT02273960|76158316|FG000|NOT COMPLETED|Long Term Extension||0||
60042716|NCT02273960|76158317|FG001|NOT COMPLETED|Long Term Extension||0||
60042717|NCT02273960|76158318|FG002|NOT COMPLETED|Long Term Extension||0||
60042718|NCT02273960|76158319|FG003|NOT COMPLETED|Long Term Extension||1||
60042719|NCT01646021|76158331|FG000|STARTED|Overall Study||139||
59510888|NCT02504554|75604415|FG000|NOT COMPLETED|Overall Study||0||
59510889|NCT02504554|75604416|FG001|NOT COMPLETED|Overall Study||0||
59510890|NCT00914485|75604422|FG000|STARTED|Overall Study||369||
59510891|NCT00914485|75604422|FG000|COMPLETED|Overall Study||369||
59510892|NCT00914485|75604422|FG000|NOT COMPLETED|Overall Study||0||
59510893|NCT02506114|75604429|FG000|STARTED|Overall Study||5||
59510894|NCT02506114|75604430|FG001|STARTED|Overall Study||4||
59510895|NCT02506114|75604431|FG002|STARTED|Overall Study||6||
59510896|NCT02506114|75604429|FG000|COMPLETED|Overall Study||5||
59510897|NCT02506114|75604430|FG001|COMPLETED|Overall Study||4||
59510898|NCT02506114|75604431|FG002|COMPLETED|Overall Study||6||
59510899|NCT02506114|75604429|FG000|NOT COMPLETED|Overall Study||0||
59510900|NCT02506114|75604430|FG001|NOT COMPLETED|Overall Study||0||
59510901|NCT02506114|75604431|FG002|NOT COMPLETED|Overall Study||0||
59510902|NCT00915031|75604441|FG000|STARTED|Overall Study||714||
59510903|NCT00915031|75604442|FG001|STARTED|Overall Study||24||
59510904|NCT00915031|75604441|FG000|COMPLETED|Overall Study||714||
59510905|NCT00915031|75604442|FG001|COMPLETED|Overall Study||24||
59510906|NCT00915031|75604441|FG000|NOT COMPLETED|Overall Study||0||
59510907|NCT00915031|75604442|FG001|NOT COMPLETED|Overall Study||0||
59510908|NCT02506660|75604449|FG000|STARTED|Overall Study||64||
59510909|NCT02506660|75604450|FG001|STARTED|Overall Study||64||
59510910|NCT02506660|75604449|FG000|COMPLETED|Overall Study||62||
59510911|NCT02506660|75604450|FG001|COMPLETED|Overall Study||63||
59510912|NCT02506660|75604449|FG000|NOT COMPLETED|Overall Study||2||
59510913|NCT02506660|75604450|FG001|NOT COMPLETED|Overall Study||1||
59510914|NCT02509624|75604460|FG000|STARTED|Overall Study||10||
60042720|NCT01646021|76158332|FG001|STARTED|Overall Study||141||
60042721|NCT01646021|76158331|FG000|Treated|Overall Study||139||
60042722|NCT01646021|76158332|FG001|Treated|Overall Study||139||
60042723|NCT01646021|76158331|FG000|COMPLETED|Overall Study||0||
60042724|NCT01646021|76158332|FG001|COMPLETED|Overall Study||0||
60042725|NCT01646021|76158331|FG000|NOT COMPLETED|Overall Study||139||
59510915|NCT02509624|75604461|FG001|STARTED|Overall Study||10||
59510916|NCT02509624|75604462|FG002|STARTED|Overall Study||10||
59510917|NCT02509624|75604463|FG003|STARTED|Overall Study||22||
59510918|NCT02509624|75604460|FG000|COMPLETED|Overall Study||10||
59510919|NCT02509624|75604461|FG001|COMPLETED|Overall Study||10||
59510920|NCT02509624|75604462|FG002|COMPLETED|Overall Study||10||
59510921|NCT02509624|75604463|FG003|COMPLETED|Overall Study||22||
59510922|NCT02509624|75604460|FG000|NOT COMPLETED|Overall Study||0||
59510923|NCT02509624|75604461|FG001|NOT COMPLETED|Overall Study||0||
59510924|NCT02509624|75604462|FG002|NOT COMPLETED|Overall Study||0||
59510925|NCT02509624|75604463|FG003|NOT COMPLETED|Overall Study||0||
59510926|NCT02509936|75604478|FG000|STARTED|Overall Study||163||
59510927|NCT02509936|75604479|FG001|STARTED|Overall Study||161||
59510928|NCT02509936|75604478|FG000|COMPLETED|Overall Study||151||
59510929|NCT02509936|75604479|FG001|COMPLETED|Overall Study||145||
59510930|NCT02509936|75604478|FG000|NOT COMPLETED|Overall Study||12||
59510931|NCT02509936|75604479|FG001|NOT COMPLETED|Overall Study||16||
59510932|NCT00912301|75604488|FG000|STARTED|Overall Study||11||
59510933|NCT00912301|75604489|FG001|STARTED|Overall Study||12||
59510934|NCT00912301|75604490|FG002|STARTED|Overall Study||13||
59510935|NCT00912301|75604488|FG000|COMPLETED|Overall Study||11||
59510936|NCT00912301|75604489|FG001|COMPLETED|Overall Study||12||
59510937|NCT00912301|75604490|FG002|COMPLETED|Overall Study||13||
59510938|NCT00912301|75604488|FG000|NOT COMPLETED|Overall Study||0||
59510939|NCT00912301|75604489|FG001|NOT COMPLETED|Overall Study||0||
59510940|NCT00912301|75604490|FG002|NOT COMPLETED|Overall Study||0||
59510941|NCT02512276|75604500|FG000|STARTED|Overall Study||2038||
59510942|NCT02512276|75604501|FG001|STARTED|Overall Study||2040||
59510943|NCT02512276|75604500|FG000|COMPLETED|Overall Study||2030||
59510944|NCT02512276|75604501|FG001|COMPLETED|Overall Study||2029||
59510945|NCT02512276|75604500|FG000|NOT COMPLETED|Overall Study||8||
60042726|NCT01646021|76158332|FG001|NOT COMPLETED|Overall Study||141||
60042727|NCT01750918|76158349|FG000|STARTED|Overall Study||3|All patients who were treated with at least one dose of the study drug at the time of the final analysis.|
60042728|NCT01750918|76158350|FG001|STARTED|Overall Study||4|All patients who were treated with at least one dose of the study drug at the time of the final analysis.|
60042729|NCT01750918|76158351|FG002|STARTED|Overall Study||36|All patients who were treated with at least one dose of the study drug at the time of the final analysis.|
60042730|NCT01750918|76158352|FG003|STARTED|Overall Study||50|All patients who were treated with at least one dose of the study drug at the time of the final analysis.|
60042731|NCT01750918|76158353|FG004|STARTED|Overall Study||13|All patients who were treated with at least one dose of the study drug at the time of the final analysis.|
60042732|NCT01750918|76158354|FG005|STARTED|Overall Study||20|All patients who were treated with at least one dose of the study drug at the time of the final analysis.|
60042733|NCT01750918|76158355|FG006|STARTED|Overall Study||20|All patients who were treated with at least one dose of the study drug at the time of the final analysis.|
60042734|NCT01750918|76158356|FG007|STARTED|Overall Study||20|All patients who were treated with at least one dose of the study drug at the time of the final analysis.|
60042735|NCT01750918|76158349|FG000|Pharmacokinetic Population|Overall Study||3|All patients in the All Treated Population for whom a PK sample was obtained and analyzed.|
60042736|NCT01750918|76158350|FG001|Pharmacokinetic Population|Overall Study||4|All patients in the All Treated Population for whom a PK sample was obtained and analyzed.|
60042737|NCT01750918|76158351|FG002|Pharmacokinetic Population|Overall Study||35|All patients in the All Treated Population for whom a PK sample was obtained and analyzed.|
60042738|NCT01750918|76158352|FG003|Pharmacokinetic Population|Overall Study||48|All patients in the All Treated Population for whom a PK sample was obtained and analyzed.|
60042739|NCT01750918|76158353|FG004|Pharmacokinetic Population|Overall Study||12|All patients in the All Treated Population for whom a PK sample was obtained and analyzed.|
60042740|NCT01750918|76158354|FG005|Pharmacokinetic Population|Overall Study||19|All patients in the All Treated Population for whom a PK sample was obtained and analyzed.|
60042741|NCT01750918|76158355|FG006|Pharmacokinetic Population|Overall Study||18|All patients in the All Treated Population for whom a PK sample was obtained and analyzed.|
60042742|NCT01750918|76158356|FG007|Pharmacokinetic Population|Overall Study||20|All patients in the All Treated Population for whom a PK sample was obtained and analyzed.|
60042743|NCT01750918|76158349|FG000|Biomarker Population|Overall Study||3|All patients in the All Treated Population whom a tumor biopsy/tissue was obtained and analyzed.|
60042744|NCT01750918|76158350|FG001|Biomarker Population|Overall Study||4|All patients in the All Treated Population whom a tumor biopsy/tissue was obtained and analyzed.|
60042745|NCT01750918|76158351|FG002|Biomarker Population|Overall Study||36|All patients in the All Treated Population whom a tumor biopsy/tissue was obtained and analyzed.|
60042746|NCT01750918|76158352|FG003|Biomarker Population|Overall Study||50|All patients in the All Treated Population whom a tumor biopsy/tissue was obtained and analyzed.|
60042747|NCT01750918|76158353|FG004|Biomarker Population|Overall Study||13|All patients in the All Treated Population whom a tumor biopsy/tissue was obtained and analyzed.|
60042748|NCT01750918|76158354|FG005|Biomarker Population|Overall Study||17|All patients in the All Treated Population whom a tumor biopsy/tissue was obtained and analyzed.|
60042749|NCT01750918|76158355|FG006|Biomarker Population|Overall Study||19|All patients in the All Treated Population whom a tumor biopsy/tissue was obtained and analyzed.|
60042750|NCT01750918|76158356|FG007|Biomarker Population|Overall Study||20|All patients in the All Treated Population whom a tumor biopsy/tissue was obtained and analyzed.|
60042751|NCT01750918|76158349|FG000|Crossover Population|Overall Study||0|Subset of patients in double combination who crossed over to triplet combination.|
60042752|NCT01750918|76158350|FG001|Crossover Population|Overall Study||0|Subset of patients in double combination who crossed over to triplet combination.|
60042753|NCT01750918|76158351|FG002|Crossover Population|Overall Study||0|Subset of patients in double combination who crossed over to triplet combination.|
60042754|NCT01750918|76158352|FG003|Crossover Population|Overall Study||0|Subset of patients in double combination who crossed over to triplet combination.|
60042755|NCT01750918|76158353|FG004|Crossover Population|Overall Study||4|Subset of patients in double combination who crossed over to triplet combination.|
60042756|NCT01750918|76158354|FG005|Crossover Population|Overall Study||2|Subset of patients in double combination who crossed over to triplet combination.|
60042757|NCT01750918|76158355|FG006|Crossover Population|Overall Study||5|Subset of patients in double combination who crossed over to triplet combination.|
60042758|NCT01750918|76158356|FG007|Crossover Population|Overall Study||5|Subset of patients in double combination who crossed over to triplet combination.|
60042759|NCT01750918|76158349|FG000|COMPLETED|Overall Study||3||
59510946|NCT02512276|75604501|FG001|NOT COMPLETED|Overall Study||11||
59510947|NCT00915499|75604509|FG000|STARTED|Overall Study||33||
59510948|NCT00915499|75604510|FG001|STARTED|Overall Study||33||
60042760|NCT01750918|76158350|FG001|COMPLETED|Overall Study||4||
60042761|NCT01750918|76158351|FG002|COMPLETED|Overall Study||28||
60042762|NCT01750918|76158352|FG003|COMPLETED|Overall Study||44||
60042763|NCT01750918|76158353|FG004|COMPLETED|Overall Study||12||
60042764|NCT01750918|76158354|FG005|COMPLETED|Overall Study||17||
60042765|NCT01750918|76158355|FG006|COMPLETED|Overall Study||17||
60042766|NCT01750918|76158356|FG007|COMPLETED|Overall Study||16||
60042767|NCT01750918|76158349|FG000|NOT COMPLETED|Overall Study||0||
60042768|NCT01750918|76158350|FG001|NOT COMPLETED|Overall Study||0||
60042769|NCT01750918|76158351|FG002|NOT COMPLETED|Overall Study||8||
60042770|NCT01750918|76158352|FG003|NOT COMPLETED|Overall Study||6||
60042771|NCT01750918|76158353|FG004|NOT COMPLETED|Overall Study||1||
60042772|NCT01750918|76158354|FG005|NOT COMPLETED|Overall Study||3||
60042773|NCT01750918|76158355|FG006|NOT COMPLETED|Overall Study||3||
59510949|NCT00915499|75604509|FG000|COMPLETED|Overall Study||29||
59510950|NCT00915499|75604510|FG001|COMPLETED|Overall Study||31||
59510951|NCT00915499|75604509|FG000|NOT COMPLETED|Overall Study||4||
59510952|NCT00915499|75604510|FG001|NOT COMPLETED|Overall Study||2||
59510953|NCT02512900|75604518|FG000|STARTED|Overall Study||11||
59510954|NCT02512900|75604519|FG001|STARTED|Overall Study||10||
59762606|NCT00866307|75882444|FG001|COMPLETED|Induction||0||
60042774|NCT01750918|76158356|FG007|NOT COMPLETED|Overall Study||4||
60042775|NCT02300987|76158388|FG000|STARTED|Primary Phase : Prior to Cross-over||8||
60042776|NCT02300987|76158389|FG001|STARTED|Primary Phase : Prior to Cross-over||2||
60042777|NCT02300987|76158388|FG000|COMPLETED|Primary Phase : Prior to Cross-over||2||
60042778|NCT02300987|76158389|FG001|COMPLETED|Primary Phase : Prior to Cross-over||0||
60042779|NCT02300987|76158388|FG000|NOT COMPLETED|Primary Phase : Prior to Cross-over||6||
60042780|NCT02300987|76158389|FG001|NOT COMPLETED|Primary Phase : Prior to Cross-over||2||
60042781|NCT02300987|76158388|FG000|STARTED|Secondary Phase : Cross-over to LEE011||1||
60042782|NCT02300987|76158389|FG001|STARTED|Secondary Phase : Cross-over to LEE011||2||
60042783|NCT02300987|76158388|FG000|COMPLETED|Secondary Phase : Cross-over to LEE011||0||
60042784|NCT02300987|76158389|FG001|COMPLETED|Secondary Phase : Cross-over to LEE011||1||
60042785|NCT02300987|76158388|FG000|NOT COMPLETED|Secondary Phase : Cross-over to LEE011||1||
60042786|NCT02300987|76158389|FG001|NOT COMPLETED|Secondary Phase : Cross-over to LEE011||1||
60042787|NCT01750840|76158396|FG000|STARTED|Overall Study||8||
60042788|NCT01750840|76158396|FG000|COMPLETED|Overall Study||4||
60042789|NCT01750840|76158396|FG000|NOT COMPLETED|Overall Study||4||
60042790|NCT01606228|76158401|FG000|STARTED|Overall Study||188||
60042791|NCT01606228|76158401|FG000|COMPLETED|Overall Study||159||
60042792|NCT01606228|76158401|FG000|NOT COMPLETED|Overall Study||29||
60042793|NCT01706536|76158410|FG000|STARTED|Overall Study||57||
60042794|NCT01706536|76158411|FG001|STARTED|Overall Study||55||
60042795|NCT01706536|76158412|FG002|STARTED|Overall Study||54||
60042796|NCT01706536|76158413|FG003|STARTED|Overall Study||57||
60042797|NCT01706536|76158414|FG004|STARTED|Overall Study||59||
60042798|NCT01706536|76158410|FG000|COMPLETED|Overall Study||53||
60042799|NCT01706536|76158411|FG001|COMPLETED|Overall Study||51||
60042800|NCT01706536|76158412|FG002|COMPLETED|Overall Study||49||
60042801|NCT01706536|76158413|FG003|COMPLETED|Overall Study||53||
60042802|NCT01706536|76158414|FG004|COMPLETED|Overall Study||57||
60042803|NCT01706536|76158410|FG000|NOT COMPLETED|Overall Study||4||
60042804|NCT01706536|76158411|FG001|NOT COMPLETED|Overall Study||4||
60042805|NCT01706536|76158412|FG002|NOT COMPLETED|Overall Study||5||
60042806|NCT01706536|76158413|FG003|NOT COMPLETED|Overall Study||4||
60042807|NCT01706536|76158414|FG004|NOT COMPLETED|Overall Study||2||
60042808|NCT02269943|76158429|FG000|STARTED|Treatment Period||6||
60042809|NCT02269943|76158430|FG001|STARTED|Treatment Period||30||
60042810|NCT02269943|76158429|FG000|Investigational Product (IP) Stopped|Treatment Period||6|IP stopped due to disease progression, consent withdrawal, AE, discontinued at physician's decision|
60042811|NCT02269943|76158430|FG001|Investigational Product (IP) Stopped|Treatment Period||30|IP stopped due to disease progression, consent withdrawal, AE, discontinued at physician's decision|
60042812|NCT02269943|76158429|FG000|COMPLETED|Treatment Period|Not applicable according to the study design|0||
60042813|NCT02269943|76158430|FG001|COMPLETED|Treatment Period|Not applicable according to the study design|0||
60042814|NCT02269943|76158429|FG000|NOT COMPLETED|Treatment Period||6||
60042815|NCT02269943|76158430|FG001|NOT COMPLETED|Treatment Period||30||
60042816|NCT02269943|76158429|FG000|STARTED|Follow-Up Survival Period||5||
60042817|NCT02269943|76158430|FG001|STARTED|Follow-Up Survival Period||26||
60042818|NCT02269943|76158429|FG000|COMPLETED|Follow-Up Survival Period|Not applicable according to the study design.|0||
60042819|NCT02269943|76158430|FG001|COMPLETED|Follow-Up Survival Period|Not applicable according to the study design.|0||
60042820|NCT02269943|76158429|FG000|NOT COMPLETED|Follow-Up Survival Period||5||
60042821|NCT02269943|76158430|FG001|NOT COMPLETED|Follow-Up Survival Period||26||
60042822|NCT01706458|76158438|FG000|STARTED|Overall Study||9||
60042823|NCT01706458|76158439|FG001|STARTED|Overall Study||9||
60042824|NCT01706458|76158438|FG000|COMPLETED|Overall Study||6||
60042825|NCT01706458|76158439|FG001|COMPLETED|Overall Study||5||
60042826|NCT01706458|76158438|FG000|NOT COMPLETED|Overall Study||3||
60042827|NCT01706458|76158439|FG001|NOT COMPLETED|Overall Study||4||
60042828|NCT02269787|76158447|FG000|STARTED|Overall Study||148||
60042829|NCT02269787|76158448|FG001|STARTED|Overall Study||150||
60042830|NCT02269787|76158447|FG000|COMPLETED|Overall Study||126||
60042831|NCT02269787|76158448|FG001|COMPLETED|Overall Study||140||
60042832|NCT02269787|76158447|FG000|NOT COMPLETED|Overall Study||22||
60042833|NCT02269787|76158448|FG001|NOT COMPLETED|Overall Study||10||
60042834|NCT01605370|76158456|FG000|STARTED|Overall Study||1||
60042835|NCT01605370|76158457|FG001|STARTED|Overall Study||0||
60042836|NCT01605370|76158456|FG000|COMPLETED|Overall Study||0||
60042837|NCT01605370|76158457|FG001|COMPLETED|Overall Study||0||
60042838|NCT01605370|76158456|FG000|NOT COMPLETED|Overall Study||1||
60042839|NCT01605370|76158457|FG001|NOT COMPLETED|Overall Study||0||
60042840|NCT02269709|76158463|FG000|STARTED|Time of Enrollment||21||
60042841|NCT02269709|76158463|FG000|COMPLETED|Time of Enrollment||18|Three patients withdrew before the start of the study.|
60042842|NCT02269709|76158463|FG000|NOT COMPLETED|Time of Enrollment||3||
60042843|NCT02269709|76158463|FG000|STARTED|Follow-up #1 (24-72 Hours Post-surgery)||18||
60042844|NCT02269709|76158463|FG000|COMPLETED|Follow-up #1 (24-72 Hours Post-surgery)||17||
60042845|NCT02269709|76158463|FG000|NOT COMPLETED|Follow-up #1 (24-72 Hours Post-surgery)||1||
60042846|NCT02269709|76158463|FG000|STARTED|Prior to Hospital Discharge||17||
60042847|NCT02269709|76158463|FG000|COMPLETED|Prior to Hospital Discharge||17||
60042848|NCT02269709|76158463|FG000|NOT COMPLETED|Prior to Hospital Discharge||0||
60042849|NCT02269709|76158463|FG000|STARTED|Six Month Follow-up||17||
60042850|NCT02269709|76158463|FG000|COMPLETED|Six Month Follow-up||5||
60042851|NCT02269709|76158463|FG000|NOT COMPLETED|Six Month Follow-up||12||
60042852|NCT02269475|76158470|FG000|STARTED|Overall Study||868||
60042853|NCT02269475|76158471|FG001|STARTED|Overall Study||433||
60042854|NCT02269475|76158470|FG000|Received IP (Safety Population)|Overall Study||868||
60042855|NCT02269475|76158471|FG001|Received IP (Safety Population)|Overall Study||433||
60042856|NCT02269475|76158470|FG000|Per Protocol Population|Overall Study||849||
60042857|NCT02269475|76158471|FG001|Per Protocol Population|Overall Study||430||
60042858|NCT02269475|76158470|FG000|COMPLETED|Overall Study||865||
60042859|NCT02269475|76158471|FG001|COMPLETED|Overall Study||432||
60042860|NCT02269475|76158470|FG000|NOT COMPLETED|Overall Study||3||
60042861|NCT02269475|76158471|FG001|NOT COMPLETED|Overall Study||1||
60042862|NCT01605136|76158480|FG000|STARTED|Study Period||48||
60042863|NCT01605136|76158481|FG001|STARTED|Study Period||45||
60042864|NCT01605136|76158480|FG000|COMPLETED|Study Period||45||
60042865|NCT01605136|76158481|FG001|COMPLETED|Study Period||42||
60042866|NCT01605136|76158480|FG000|NOT COMPLETED|Study Period||3||
60042867|NCT01605136|76158481|FG001|NOT COMPLETED|Study Period||3||
60042868|NCT01605136|76158480|FG000|STARTED|Safety Follow-Up Period||45||
60042869|NCT01605136|76158481|FG001|STARTED|Safety Follow-Up Period||42||
60042870|NCT01605136|76158480|FG000|COMPLETED|Safety Follow-Up Period||44||
60042871|NCT01605136|76158481|FG001|COMPLETED|Safety Follow-Up Period||40||
60042872|NCT01605136|76158480|FG000|NOT COMPLETED|Safety Follow-Up Period||1||
60042873|NCT01605136|76158481|FG001|NOT COMPLETED|Safety Follow-Up Period||2||
60042874|NCT01706146|76158487|FG000|STARTED|Overall Study||59||
60042875|NCT01706146|76158487|FG000|COMPLETED|Overall Study|1 pt developed permanent AF; 1 pt needed dual antiplatelet therapy; 3 possible TIA; 1 withdraw|53||
60042876|NCT01706146|76158487|FG000|NOT COMPLETED|Overall Study||6||
60042877|NCT02269241|76158491|FG000|STARTED|Overall Study||1552||
60042878|NCT02269241|76158491|FG000|COMPLETED|Overall Study||352||
60042879|NCT02269241|76158491|FG000|NOT COMPLETED|Overall Study||1200||
60042880|NCT01750684|76158498|FG000|STARTED|Overall Study||6||
60042881|NCT01750684|76158499|FG001|STARTED|Overall Study||7||
60042882|NCT01750684|76158498|FG000|COMPLETED|Overall Study||4||
60042883|NCT01750684|76158499|FG001|COMPLETED|Overall Study||5||
60042884|NCT01750684|76158498|FG000|NOT COMPLETED|Overall Study||2||
60042885|NCT01750684|76158499|FG001|NOT COMPLETED|Overall Study||2||
60042886|NCT01750294|76158506|FG000|STARTED|Overall Study||14||
60042887|NCT01750294|76158506|FG000|COMPLETED|Overall Study||12||
60042888|NCT01750294|76158506|FG000|NOT COMPLETED|Overall Study||2||
60042889|NCT01749982|76158514|FG000|STARTED|Overall Study||15||
60042890|NCT01749982|76158515|FG001|STARTED|Overall Study||15||
60042891|NCT01749982|76158516|FG002|STARTED|Overall Study||15||
60042892|NCT01749982|76158517|FG003|STARTED|Overall Study||15||
60042893|NCT01749982|76158514|FG000|COMPLETED|Overall Study||15||
60042894|NCT01749982|76158515|FG001|COMPLETED|Overall Study||15||
60042895|NCT01749982|76158516|FG002|COMPLETED|Overall Study||15||
60042896|NCT01749982|76158517|FG003|COMPLETED|Overall Study||12||
60042897|NCT01749982|76158514|FG000|NOT COMPLETED|Overall Study||0||
59612393|NCT01701258|75723501|FG002|NOT COMPLETED|Assessment and Scheduling||0||
60042898|NCT01749982|76158515|FG001|NOT COMPLETED|Overall Study||0||
60042899|NCT01749982|76158516|FG002|NOT COMPLETED|Overall Study||0||
60042900|NCT01749982|76158517|FG003|NOT COMPLETED|Overall Study||3||
60042901|NCT02269163|76158529|FG000|STARTED|Overall Study||50||
60042902|NCT02269163|76158530|FG001|STARTED|Overall Study||25||
60042903|NCT02269163|76158529|FG000|COMPLETED|Overall Study||47||
60042904|NCT02269163|76158530|FG001|COMPLETED|Overall Study||18||
60042905|NCT02269163|76158529|FG000|NOT COMPLETED|Overall Study||3||
60042906|NCT02269163|76158530|FG001|NOT COMPLETED|Overall Study||7||
60042907|NCT01749826|76158540|FG000|STARTED|Overall Study||20||
60042908|NCT01749826|76158541|FG001|STARTED|Overall Study||0||
60042909|NCT01749826|76158540|FG000|COMPLETED|Overall Study||0||
60042910|NCT01749826|76158541|FG001|COMPLETED|Overall Study||0||
60042911|NCT01749826|76158540|FG000|NOT COMPLETED|Overall Study||20||
60042912|NCT01749826|76158541|FG001|NOT COMPLETED|Overall Study||0||
60042913|NCT02300129|76158547|FG000|STARTED|Period 1 Session 1 (Day 1)||11||
60042914|NCT02300129|76158548|FG001|STARTED|Period 1 Session 1 (Day 1)||5||
60042915|NCT02300129|76158549|FG002|STARTED|Period 1 Session 1 (Day 1)||7||
60042916|NCT02300129|76158550|FG003|STARTED|Period 1 Session 1 (Day 1)||11||
60042917|NCT02300129|76158547|FG000|COMPLETED|Period 1 Session 1 (Day 1)||11||
60042918|NCT02300129|76158548|FG001|COMPLETED|Period 1 Session 1 (Day 1)||5||
60042919|NCT02300129|76158549|FG002|COMPLETED|Period 1 Session 1 (Day 1)||7||
60042920|NCT02300129|76158550|FG003|COMPLETED|Period 1 Session 1 (Day 1)||11||
60042921|NCT02300129|76158547|FG000|NOT COMPLETED|Period 1 Session 1 (Day 1)||0||
60042922|NCT02300129|76158548|FG001|NOT COMPLETED|Period 1 Session 1 (Day 1)||0||
60042923|NCT02300129|76158549|FG002|NOT COMPLETED|Period 1 Session 1 (Day 1)||0||
60042924|NCT02300129|76158550|FG003|NOT COMPLETED|Period 1 Session 1 (Day 1)||0||
60042925|NCT02300129|76158547|FG000|STARTED|Period 1 Session 2 (Day 3)||11||
60042926|NCT02300129|76158548|FG001|STARTED|Period 1 Session 2 (Day 3)|Withdrawal consent of 1 subject between Day 1 and Day 3|5||
60042927|NCT02300129|76158549|FG002|STARTED|Period 1 Session 2 (Day 3)||7||
60042928|NCT02300129|76158550|FG003|STARTED|Period 1 Session 2 (Day 3)||11||
60042929|NCT02300129|76158547|FG000|COMPLETED|Period 1 Session 2 (Day 3)||11||
60042930|NCT02300129|76158548|FG001|COMPLETED|Period 1 Session 2 (Day 3)||4||
60042931|NCT02300129|76158549|FG002|COMPLETED|Period 1 Session 2 (Day 3)||7||
60042932|NCT02300129|76158550|FG003|COMPLETED|Period 1 Session 2 (Day 3)||11||
60042933|NCT02300129|76158547|FG000|NOT COMPLETED|Period 1 Session 2 (Day 3)||0||
60042934|NCT02300129|76158548|FG001|NOT COMPLETED|Period 1 Session 2 (Day 3)||1||
60042935|NCT02300129|76158549|FG002|NOT COMPLETED|Period 1 Session 2 (Day 3)||0||
60042936|NCT02300129|76158550|FG003|NOT COMPLETED|Period 1 Session 2 (Day 3)||0||
60042937|NCT02300129|76158547|FG000|STARTED|Period 1 Session 3 (Day 5)||11||
60042938|NCT02300129|76158548|FG001|STARTED|Period 1 Session 3 (Day 5)||4||
60042939|NCT02300129|76158549|FG002|STARTED|Period 1 Session 3 (Day 5)||7||
60042940|NCT02300129|76158550|FG003|STARTED|Period 1 Session 3 (Day 5)||11||
60042941|NCT02300129|76158547|FG000|COMPLETED|Period 1 Session 3 (Day 5)||11||
60042942|NCT02300129|76158548|FG001|COMPLETED|Period 1 Session 3 (Day 5)||4||
60042943|NCT02300129|76158549|FG002|COMPLETED|Period 1 Session 3 (Day 5)||7||
60042944|NCT02300129|76158550|FG003|COMPLETED|Period 1 Session 3 (Day 5)||11||
60042945|NCT02300129|76158547|FG000|NOT COMPLETED|Period 1 Session 3 (Day 5)||0||
60042946|NCT02300129|76158548|FG001|NOT COMPLETED|Period 1 Session 3 (Day 5)||0||
60042947|NCT02300129|76158549|FG002|NOT COMPLETED|Period 1 Session 3 (Day 5)||0||
60042948|NCT02300129|76158550|FG003|NOT COMPLETED|Period 1 Session 3 (Day 5)||0||
60042949|NCT02300129|76158547|FG000|STARTED|Period 2 Treatment 1 (2 Weeks)||11||
60042950|NCT02300129|76158548|FG001|STARTED|Period 2 Treatment 1 (2 Weeks)||4||
60042951|NCT02300129|76158549|FG002|STARTED|Period 2 Treatment 1 (2 Weeks)||7||
60042952|NCT02300129|76158550|FG003|STARTED|Period 2 Treatment 1 (2 Weeks)|Withdrawal consent of 1 subject between the Period 1 and Period 2|11||
60042953|NCT02300129|76158547|FG000|COMPLETED|Period 2 Treatment 1 (2 Weeks)||10||
60042954|NCT02300129|76158548|FG001|COMPLETED|Period 2 Treatment 1 (2 Weeks)||4||
60042955|NCT02300129|76158549|FG002|COMPLETED|Period 2 Treatment 1 (2 Weeks)||7||
60042956|NCT02300129|76158550|FG003|COMPLETED|Period 2 Treatment 1 (2 Weeks)||10||
60042957|NCT02300129|76158547|FG000|NOT COMPLETED|Period 2 Treatment 1 (2 Weeks)||1||
60042958|NCT02300129|76158548|FG001|NOT COMPLETED|Period 2 Treatment 1 (2 Weeks)||0||
60042959|NCT02300129|76158549|FG002|NOT COMPLETED|Period 2 Treatment 1 (2 Weeks)||0||
60042960|NCT02300129|76158550|FG003|NOT COMPLETED|Period 2 Treatment 1 (2 Weeks)||1||
60042961|NCT02300129|76158547|FG000|STARTED|Period 2 Treatment 2 (2 Weeks)||10||
60042962|NCT02300129|76158548|FG001|STARTED|Period 2 Treatment 2 (2 Weeks)||4||
60042963|NCT02300129|76158549|FG002|STARTED|Period 2 Treatment 2 (2 Weeks)||7||
60042964|NCT02300129|76158550|FG003|STARTED|Period 2 Treatment 2 (2 Weeks)||10||
60042965|NCT02300129|76158547|FG000|COMPLETED|Period 2 Treatment 2 (2 Weeks)||10||
60042966|NCT02300129|76158548|FG001|COMPLETED|Period 2 Treatment 2 (2 Weeks)||4||
60042967|NCT02300129|76158549|FG002|COMPLETED|Period 2 Treatment 2 (2 Weeks)||7||
60042968|NCT02300129|76158550|FG003|COMPLETED|Period 2 Treatment 2 (2 Weeks)||10||
60042969|NCT02300129|76158547|FG000|NOT COMPLETED|Period 2 Treatment 2 (2 Weeks)||0||
60042970|NCT02300129|76158548|FG001|NOT COMPLETED|Period 2 Treatment 2 (2 Weeks)||0||
60042971|NCT02300129|76158549|FG002|NOT COMPLETED|Period 2 Treatment 2 (2 Weeks)||0||
59510955|NCT02512900|75604518|FG000|COMPLETED|Overall Study||11||
59510956|NCT02512900|75604519|FG001|COMPLETED|Overall Study||10||
60042972|NCT02300129|76158550|FG003|NOT COMPLETED|Period 2 Treatment 2 (2 Weeks)||0||
60042973|NCT02267135|76158562|FG000|STARTED|Period 1 (Randomized Set)||51||
60042974|NCT02267135|76158563|FG001|STARTED|Period 1 (Randomized Set)||51||
60042975|NCT02267135|76158562|FG000|COMPLETED|Period 1 (Randomized Set)||50||
60042976|NCT02267135|76158563|FG001|COMPLETED|Period 1 (Randomized Set)||47||
60042977|NCT02267135|76158562|FG000|NOT COMPLETED|Period 1 (Randomized Set)||1||
60042978|NCT02267135|76158563|FG001|NOT COMPLETED|Period 1 (Randomized Set)||4||
60042979|NCT02267135|76158562|FG000|STARTED|Period 2 (Randomized Set)||50||
60042980|NCT02267135|76158563|FG001|STARTED|Period 2 (Randomized Set)||47||
60042981|NCT02267135|76158562|FG000|COMPLETED|Period 2 (Randomized Set)||46||
60042982|NCT02267135|76158563|FG001|COMPLETED|Period 2 (Randomized Set)||46||
60042983|NCT02267135|76158562|FG000|NOT COMPLETED|Period 2 (Randomized Set)||4||
60042984|NCT02267135|76158563|FG001|NOT COMPLETED|Period 2 (Randomized Set)||1||
60042985|NCT02299427|76158574|FG000|STARTED|Overall Study||35||
60042986|NCT02299427|76158575|FG001|STARTED|Overall Study||34||
60042987|NCT02299427|76158574|FG000|COMPLETED|Overall Study||12||
60042988|NCT02299427|76158575|FG001|COMPLETED|Overall Study||31||
60042989|NCT02299427|76158574|FG000|NOT COMPLETED|Overall Study||23||
60042990|NCT02299427|76158575|FG001|NOT COMPLETED|Overall Study||3||
60042991|NCT01724866|76158585|FG000|STARTED|Overall Study||39||
60042992|NCT01724866|76158586|FG001|STARTED|Overall Study||37||
60042993|NCT01724866|76158587|FG002|STARTED|Overall Study||36||
60042994|NCT01724866|76158588|FG003|STARTED|Overall Study||36||
60042995|NCT01724866|76158585|FG000|Evaluable Population|Overall Study||39|The Evaluable Population included all randomized participants who had received either SPI-2012 or pegfilgrastim and had completed Cycle 1.|
60042996|NCT01724866|76158586|FG001|Evaluable Population|Overall Study||36|The Evaluable Population included all randomized participants who had received either SPI-2012 or pegfilgrastim and had completed Cycle 1.|
60042997|NCT01724866|76158587|FG002|Evaluable Population|Overall Study||36|The Evaluable Population included all randomized participants who had received either SPI-2012 or pegfilgrastim and had completed Cycle 1.|
60042998|NCT01724866|76158588|FG003|Evaluable Population|Overall Study||36|The Evaluable Population included all randomized participants who had received either SPI-2012 or pegfilgrastim and had completed Cycle 1.|
60042999|NCT01724866|76158585|FG000|COMPLETED|Overall Study||38||
60043000|NCT01724866|76158586|FG001|COMPLETED|Overall Study||32||
60043001|NCT01724866|76158587|FG002|COMPLETED|Overall Study||33||
60043002|NCT01724866|76158588|FG003|COMPLETED|Overall Study||35||
60043003|NCT01724866|76158585|FG000|NOT COMPLETED|Overall Study||1||
60043004|NCT01724866|76158586|FG001|NOT COMPLETED|Overall Study||5||
60043005|NCT01724866|76158587|FG002|NOT COMPLETED|Overall Study||3||
60043006|NCT01724866|76158588|FG003|NOT COMPLETED|Overall Study||1||
60043007|NCT02266433|76158600|FG000|STARTED|Overall Study||127||
60043008|NCT02266433|76158601|FG001|STARTED|Overall Study||118||
60043009|NCT02266433|76158600|FG000|COMPLETED|Overall Study||68||
60043010|NCT02266433|76158601|FG001|COMPLETED|Overall Study||65||
60043011|NCT02266433|76158600|FG000|NOT COMPLETED|Overall Study||59||
60043012|NCT02266433|76158601|FG001|NOT COMPLETED|Overall Study||53||
60043013|NCT01748890|76158608|FG000|STARTED|Overall Study||4||
60043014|NCT01748890|76158608|FG000|COMPLETED|Overall Study|Insufficient recruitment for analysis|0||
60043015|NCT01748890|76158608|FG000|NOT COMPLETED|Overall Study||4||
60043016|NCT01747876|76158615|FG000|STARTED|Overall Study||5||
60043017|NCT01747876|76158616|FG001|STARTED|Overall Study||15||
60043018|NCT01747876|76158617|FG002|STARTED|Overall Study||12||
60043019|NCT01747876|76158615|FG000|COMPLETED|Overall Study||0||
60043020|NCT01747876|76158616|FG001|COMPLETED|Overall Study||0||
60043021|NCT01747876|76158617|FG002|COMPLETED|Overall Study||0||
60043022|NCT01747876|76158615|FG000|NOT COMPLETED|Overall Study||5||
60043023|NCT01747876|76158616|FG001|NOT COMPLETED|Overall Study||15||
60043024|NCT01747876|76158617|FG002|NOT COMPLETED|Overall Study||12||
60043025|NCT02273726|76158630|FG000|STARTED|Overall Study||370||
60043026|NCT02273726|76158631|FG001|STARTED|Overall Study||371||
60043027|NCT02273726|76158630|FG000|Received at Least 1 Dose of Study Drug|Overall Study||370||
60043028|NCT02273726|76158631|FG001|Received at Least 1 Dose of Study Drug|Overall Study||370||
60043029|NCT02273726|76158630|FG000|COMPLETED|Overall Study||127||
59510957|NCT02512900|75604518|FG000|NOT COMPLETED|Overall Study||0||
60043030|NCT02273726|76158631|FG001|COMPLETED|Overall Study||183||
60043031|NCT02273726|76158630|FG000|NOT COMPLETED|Overall Study||243||
60043032|NCT02273726|76158631|FG001|NOT COMPLETED|Overall Study||188||
60043033|NCT01723228|76158639|FG000|STARTED|Overall Study||86||
60043034|NCT01723228|76158640|FG001|STARTED|Overall Study||84||
59510958|NCT02512900|75604519|FG001|NOT COMPLETED|Overall Study||0||
60043035|NCT01723228|76158639|FG000|COMPLETED|Overall Study||78||
60043036|NCT01723228|76158640|FG001|COMPLETED|Overall Study||73||
60043037|NCT01723228|76158639|FG000|NOT COMPLETED|Overall Study||8||
60043038|NCT01723228|76158640|FG001|NOT COMPLETED|Overall Study||11||
60043039|NCT02273180|76158648|FG000|STARTED|Overall Study||253||
60043040|NCT02273180|76158649|FG001|STARTED|Overall Study||254||
60043041|NCT02273180|76158648|FG000|Treated|Overall Study||252||
60043042|NCT02273180|76158649|FG001|Treated|Overall Study||254||
60043043|NCT02273180|76158648|FG000|COMPLETED|Overall Study||226||
60043044|NCT02273180|76158649|FG001|COMPLETED|Overall Study||235||
60043045|NCT02273180|76158648|FG000|NOT COMPLETED|Overall Study||27||
60043046|NCT02273180|76158649|FG001|NOT COMPLETED|Overall Study||19||
60043047|NCT01746862|76158657|FG000|STARTED|Overall Study||60||
60043048|NCT01746862|76158658|FG001|STARTED|Overall Study||30||
60043049|NCT01746862|76158657|FG000|Treated|Overall Study||59||
60043050|NCT01746862|76158658|FG001|Treated|Overall Study||30||
60043051|NCT01746862|76158657|FG000|COMPLETED|Overall Study||52||
60043052|NCT01746862|76158658|FG001|COMPLETED|Overall Study||27||
60043053|NCT01746862|76158657|FG000|NOT COMPLETED|Overall Study||8||
60043054|NCT01746862|76158658|FG001|NOT COMPLETED|Overall Study||3||
60043055|NCT01745848|76158665|FG000|STARTED|Overall Study||26||
60043056|NCT01745848|76158665|FG000|COMPLETED|Overall Study||20||
60043057|NCT01745848|76158665|FG000|NOT COMPLETED|Overall Study||6||
60043058|NCT01745380|76158671|FG000|STARTED|Overall Study||100||
60043059|NCT01745380|76158672|FG001|STARTED|Overall Study||50||
60043060|NCT01745380|76158671|FG000|COMPLETED|Overall Study||99||
60043061|NCT01745380|76158672|FG001|COMPLETED|Overall Study||49||
60043062|NCT01745380|76158671|FG000|NOT COMPLETED|Overall Study||1||
60043063|NCT01745380|76158672|FG001|NOT COMPLETED|Overall Study||1||
60043064|NCT01745146|76158680|FG000|STARTED|Overall Study||30||
60043065|NCT01745146|76158681|FG001|STARTED|Overall Study||60||
60043066|NCT01745146|76158680|FG000|Allocation to Intervention|Overall Study||30||
60043067|NCT01745146|76158681|FG001|Allocation to Intervention|Overall Study||60||
60043068|NCT01745146|76158680|FG000|Primary Outcome Assessment|Overall Study||27||
60043069|NCT01745146|76158681|FG001|Primary Outcome Assessment|Overall Study||57||
60043070|NCT01745146|76158680|FG000|Analysis|Overall Study||27||
60043071|NCT01745146|76158681|FG001|Analysis|Overall Study||57||
60043072|NCT01745146|76158680|FG000|COMPLETED|Overall Study||27||
60043073|NCT01745146|76158681|FG001|COMPLETED|Overall Study||57||
60043074|NCT01745146|76158680|FG000|NOT COMPLETED|Overall Study||3||
60043075|NCT01745146|76158681|FG001|NOT COMPLETED|Overall Study||3||
60043076|NCT02203513|76158693|FG000|STARTED|Overall Study||22||
60043077|NCT02203513|76158694|FG001|STARTED|Overall Study||29||
60043078|NCT02203513|76158695|FG002|STARTED|Overall Study||9||
60043079|NCT02203513|76158696|FG003|STARTED|Overall Study||2||
60043080|NCT02203513|76158697|FG004|STARTED|Overall Study||49||
60043081|NCT02203513|76158693|FG000|COMPLETED|Overall Study||16||
60043082|NCT02203513|76158694|FG001|COMPLETED|Overall Study||21||
60043083|NCT02203513|76158695|FG002|COMPLETED|Overall Study||6||
60043084|NCT02203513|76158696|FG003|COMPLETED|Overall Study||1||
60043085|NCT02203513|76158697|FG004|COMPLETED|Overall Study||43||
60043086|NCT02203513|76158693|FG000|NOT COMPLETED|Overall Study||6||
60043087|NCT02203513|76158694|FG001|NOT COMPLETED|Overall Study||8||
60043088|NCT02203513|76158695|FG002|NOT COMPLETED|Overall Study||3||
60043089|NCT02203513|76158696|FG003|NOT COMPLETED|Overall Study||1||
60043090|NCT02203513|76158697|FG004|NOT COMPLETED|Overall Study||6||
60043091|NCT02299934|76158711|FG000|STARTED|Overall Study||13||
60043092|NCT02299934|76158711|FG000|COMPLETED|Overall Study||0||
60043093|NCT02299934|76158711|FG000|NOT COMPLETED|Overall Study||13||
60043094|NCT01703260|76158718|FG000|STARTED|Overall Study||7||
60043095|NCT01703260|76158719|FG001|STARTED|Overall Study||7||
60043096|NCT01703260|76158720|FG002|STARTED|Overall Study||6||
60043097|NCT01703260|76158718|FG000|COMPLETED|Overall Study||4||
60043098|NCT01703260|76158719|FG001|COMPLETED|Overall Study||3||
60043099|NCT01703260|76158720|FG002|COMPLETED|Overall Study||3||
60043100|NCT01703260|76158718|FG000|NOT COMPLETED|Overall Study||3||
60043101|NCT01703260|76158719|FG001|NOT COMPLETED|Overall Study||4||
60043102|NCT01703260|76158720|FG002|NOT COMPLETED|Overall Study||3||
60043103|NCT02203357|76158731|FG000|STARTED|Overall Study||117||
60043104|NCT02203357|76158732|FG001|STARTED|Overall Study||111||
60043105|NCT02203357|76158733|FG002|STARTED|Overall Study||125||
60043106|NCT02203357|76158731|FG000|mon7/2/3|Overall Study||114|mon 7 for 0-1-6 group, mon 2 for 0-1 group, mon 3 for 0-2 group|
60043107|NCT02203357|76158732|FG001|mon7/2/3|Overall Study||110|mon 7 for 0-1-6 group, mon 2 for 0-1 group, mon 3 for 0-2 group|
60043108|NCT02203357|76158733|FG002|mon7/2/3|Overall Study||124|mon 7 for 0-1-6 group, mon 2 for 0-1 group, mon 3 for 0-2 group|
60043109|NCT02203357|76158731|FG000|mon12|Overall Study||113||
60043110|NCT02203357|76158732|FG001|mon12|Overall Study||101||
60043111|NCT02203357|76158733|FG002|mon12|Overall Study||122||
59612394|NCT01701258|75723502|FG003|NOT COMPLETED|Assessment and Scheduling||0||
60043112|NCT02203357|76158731|FG000|mon24|Overall Study||59||
60043113|NCT02203357|76158732|FG001|mon24|Overall Study||45||
60043114|NCT02203357|76158733|FG002|mon24|Overall Study||55||
60043115|NCT02203357|76158731|FG000|COMPLETED|Overall Study||59||
60043116|NCT02203357|76158732|FG001|COMPLETED|Overall Study||45||
60043117|NCT02203357|76158733|FG002|COMPLETED|Overall Study||55||
60043118|NCT02203357|76158731|FG000|NOT COMPLETED|Overall Study||58||
60043119|NCT02203357|76158732|FG001|NOT COMPLETED|Overall Study||66||
60043120|NCT02203357|76158733|FG002|NOT COMPLETED|Overall Study||70||
60043121|NCT02299388|76158746|FG000|STARTED|Overall Study||6||
60043122|NCT02299388|76158747|FG001|STARTED|Overall Study||5||
60043123|NCT02299388|76158746|FG000|COMPLETED|Overall Study||6||
60043124|NCT02299388|76158747|FG001|COMPLETED|Overall Study||4||
60043125|NCT02299388|76158746|FG000|NOT COMPLETED|Overall Study||0||
60043126|NCT02299388|76158747|FG001|NOT COMPLETED|Overall Study||1||
60043127|NCT02202577|76158755|FG000|STARTED|Overall Study||461||
59612395|NCT01701258|75723503|FG004|NOT COMPLETED|Assessment and Scheduling||0||
60043128|NCT02202577|76158756|FG001|STARTED|Overall Study||471||
60043129|NCT02202577|76158755|FG000|COMPLETED|Overall Study||448||
60043130|NCT02202577|76158756|FG001|COMPLETED|Overall Study||452||
60043131|NCT02202577|76158755|FG000|NOT COMPLETED|Overall Study||13||
60043132|NCT02202577|76158756|FG001|NOT COMPLETED|Overall Study||19||
60043133|NCT02299076|76158764|FG000|STARTED|Overall Study||230||
60043134|NCT02299076|76158765|FG001|STARTED|Overall Study||226||
60043135|NCT02299076|76158764|FG000|COMPLETED|Overall Study||210||
60043136|NCT02299076|76158765|FG001|COMPLETED|Overall Study||212||
60043137|NCT02299076|76158764|FG000|NOT COMPLETED|Overall Study||20||
60043138|NCT02299076|76158765|FG001|NOT COMPLETED|Overall Study||14||
60043139|NCT01723072|76158773|FG000|STARTED|Overall Study|28-week treatment period and 8-week follow-up period|44||
60043140|NCT01723072|76158774|FG001|STARTED|Overall Study|28-week treatment period and 8-week follow-up period|47||
60043141|NCT01723072|76158773|FG000|COMPLETED|Overall Study||33||
60043142|NCT01723072|76158774|FG001|COMPLETED|Overall Study||26||
60043143|NCT01723072|76158773|FG000|NOT COMPLETED|Overall Study||11||
60043144|NCT01723072|76158774|FG001|NOT COMPLETED|Overall Study||21||
60043145|NCT01722994|76158782|FG000|STARTED|Overall Study||49||
60043146|NCT01722994|76158783|FG001|STARTED|Overall Study||48||
60043147|NCT01722994|76158782|FG000|COMPLETED|Overall Study||24||
60043148|NCT01722994|76158783|FG001|COMPLETED|Overall Study||31||
60043149|NCT01722994|76158782|FG000|NOT COMPLETED|Overall Study||25||
60043150|NCT01722994|76158783|FG001|NOT COMPLETED|Overall Study||17||
60043151|NCT02228395|76158791|FG000|STARTED|First Intervention Period||3||
60043152|NCT02228395|76158792|FG001|STARTED|First Intervention Period||3||
60043153|NCT02228395|76158793|FG002|STARTED|First Intervention Period||3||
60043154|NCT02228395|76158791|FG000|COMPLETED|First Intervention Period||2||
60043155|NCT02228395|76158792|FG001|COMPLETED|First Intervention Period||2||
59510959|NCT02513212|75604528|FG000|STARTED|Overall Study||12||
59510960|NCT02513212|75604529|FG001|STARTED|Overall Study||12||
60043156|NCT02228395|76158793|FG002|COMPLETED|First Intervention Period||2||
60043157|NCT02228395|76158791|FG000|NOT COMPLETED|First Intervention Period||1||
60043158|NCT02228395|76158792|FG001|NOT COMPLETED|First Intervention Period||1||
60043159|NCT02228395|76158793|FG002|NOT COMPLETED|First Intervention Period||1||
60043160|NCT02228395|76158791|FG000|STARTED|Washout Period (at Least 10 Days)|One participant discontinued in the First Intervention Period and was replaced.|3||
60043161|NCT02228395|76158792|FG001|STARTED|Washout Period (at Least 10 Days)|One participant discontinued in the First Intervention Period and was replaced.|3||
60043162|NCT02228395|76158793|FG002|STARTED|Washout Period (at Least 10 Days)|One participant discontinued in the First Intervention Period and was replaced.|3||
60043163|NCT02228395|76158791|FG000|COMPLETED|Washout Period (at Least 10 Days)||3||
60043164|NCT02228395|76158792|FG001|COMPLETED|Washout Period (at Least 10 Days)||3||
60043165|NCT02228395|76158793|FG002|COMPLETED|Washout Period (at Least 10 Days)||3||
60043166|NCT02228395|76158791|FG000|NOT COMPLETED|Washout Period (at Least 10 Days)||0||
60043167|NCT02228395|76158792|FG001|NOT COMPLETED|Washout Period (at Least 10 Days)||0||
60043168|NCT02228395|76158793|FG002|NOT COMPLETED|Washout Period (at Least 10 Days)||0||
60043169|NCT02228395|76158791|FG000|STARTED|Second Intervention Period||3||
60043170|NCT02228395|76158792|FG001|STARTED|Second Intervention Period||3||
60043171|NCT02228395|76158793|FG002|STARTED|Second Intervention Period||3||
60043172|NCT02228395|76158791|FG000|COMPLETED|Second Intervention Period||3||
60043173|NCT02228395|76158792|FG001|COMPLETED|Second Intervention Period||3||
60043174|NCT02228395|76158793|FG002|COMPLETED|Second Intervention Period||3||
60043175|NCT02228395|76158791|FG000|NOT COMPLETED|Second Intervention Period||0||
60043176|NCT02228395|76158792|FG001|NOT COMPLETED|Second Intervention Period||0||
60043177|NCT02228395|76158793|FG002|NOT COMPLETED|Second Intervention Period||0||
60043178|NCT02228395|76158791|FG000|STARTED|Washout Period (at Least 10 Days)||3||
60043179|NCT02228395|76158792|FG001|STARTED|Washout Period (at Least 10 Days)||3||
60043180|NCT02228395|76158793|FG002|STARTED|Washout Period (at Least 10 Days)||3||
60043181|NCT02228395|76158791|FG000|COMPLETED|Washout Period (at Least 10 Days)||3||
60043182|NCT02228395|76158792|FG001|COMPLETED|Washout Period (at Least 10 Days)||3||
60043183|NCT02228395|76158793|FG002|COMPLETED|Washout Period (at Least 10 Days)||3||
60043184|NCT02228395|76158791|FG000|NOT COMPLETED|Washout Period (at Least 10 Days)||0||
60043185|NCT02228395|76158792|FG001|NOT COMPLETED|Washout Period (at Least 10 Days)||0||
60043186|NCT02228395|76158793|FG002|NOT COMPLETED|Washout Period (at Least 10 Days)||0||
60043187|NCT02228395|76158791|FG000|STARTED|Third Intervention Period||3||
60043188|NCT02228395|76158792|FG001|STARTED|Third Intervention Period||3||
60043189|NCT02228395|76158793|FG002|STARTED|Third Intervention Period||3||
60043190|NCT02228395|76158791|FG000|COMPLETED|Third Intervention Period||3||
60043191|NCT02228395|76158792|FG001|COMPLETED|Third Intervention Period||3||
59510961|NCT02513212|75604528|FG000|COMPLETED|Overall Study||11||
59510962|NCT02513212|75604529|FG001|COMPLETED|Overall Study||12||
59510963|NCT02513212|75604528|FG000|NOT COMPLETED|Overall Study||1||
59510964|NCT02513212|75604529|FG001|NOT COMPLETED|Overall Study||0||
59510965|NCT02513446|75604537|FG000|STARTED|Period 1||8||
60043192|NCT02228395|76158793|FG002|COMPLETED|Third Intervention Period||3||
60043193|NCT02228395|76158791|FG000|NOT COMPLETED|Third Intervention Period||0||
60043194|NCT02228395|76158792|FG001|NOT COMPLETED|Third Intervention Period||0||
60043195|NCT02228395|76158793|FG002|NOT COMPLETED|Third Intervention Period||0||
60043196|NCT02170051|76158805|FG000|STARTED|Overall Study||26||
60043197|NCT02170051|76158806|FG001|STARTED|Overall Study||29||
60043198|NCT02170051|76158805|FG000|Tested at Mid-point|Overall Study||13||
60043199|NCT02170051|76158806|FG001|Tested at Mid-point|Overall Study||18||
60043200|NCT02170051|76158805|FG000|Tested at Post-treatment|Overall Study||15||
59510966|NCT02513446|75604538|FG001|STARTED|Period 1||8||
59510967|NCT02513446|75604537|FG000|COMPLETED|Period 1||8||
60043201|NCT02170051|76158806|FG001|Tested at Post-treatment|Overall Study||16||
60043202|NCT02170051|76158805|FG000|COMPLETED|Overall Study||15|Tested at 6-month follow-up|
60043203|NCT02170051|76158806|FG001|COMPLETED|Overall Study||16|Tested at 6-month follow-up|
60043204|NCT02170051|76158805|FG000|NOT COMPLETED|Overall Study||11||
60043205|NCT02170051|76158806|FG001|NOT COMPLETED|Overall Study||13||
60043206|NCT02169739|76158814|FG000|STARTED|Overall Study||2||
60043207|NCT02169739|76158815|FG001|STARTED|Overall Study||4||
60043208|NCT02169739|76158814|FG000|COMPLETED|Overall Study||2||
60043209|NCT02169739|76158815|FG001|COMPLETED|Overall Study||0||
60043210|NCT02169739|76158814|FG000|NOT COMPLETED|Overall Study||0||
60043211|NCT02169739|76158815|FG001|NOT COMPLETED|Overall Study||4||
60043212|NCT02169505|76158822|FG000|STARTED|Overall Study||2||
60043213|NCT02169505|76158822|FG000|COMPLETED|Overall Study||1||
60043214|NCT02169505|76158822|FG000|NOT COMPLETED|Overall Study||1||
60043215|NCT01909791|76158829|FG000|STARTED|Overall Study||226||
60043216|NCT01909791|76158830|FG001|STARTED|Overall Study||240||
60043217|NCT01909791|76158831|FG002|STARTED|Overall Study||236||
60043218|NCT01909791|76158829|FG000|COMPLETED|Overall Study||205||
60043219|NCT01909791|76158830|FG001|COMPLETED|Overall Study||212||
60043220|NCT01909791|76158831|FG002|COMPLETED|Overall Study||208||
60043221|NCT01909791|76158829|FG000|NOT COMPLETED|Overall Study||21||
60043222|NCT01909791|76158830|FG001|NOT COMPLETED|Overall Study||28||
60043223|NCT01909791|76158831|FG002|NOT COMPLETED|Overall Study||28||
60043224|NCT02202499|76158847|FG000|STARTED|Overall Study||21||
60043225|NCT02202499|76158848|FG001|STARTED|Overall Study||20||
60043226|NCT02202499|76158849|FG002|STARTED|Overall Study||21||
60043227|NCT02202499|76158847|FG000|COMPLETED|Overall Study||19||
60043228|NCT02202499|76158848|FG001|COMPLETED|Overall Study||20||
60043229|NCT02202499|76158849|FG002|COMPLETED|Overall Study||19||
60043230|NCT02202499|76158847|FG000|NOT COMPLETED|Overall Study||2||
60043231|NCT02202499|76158848|FG001|NOT COMPLETED|Overall Study||0||
60043232|NCT02202499|76158849|FG002|NOT COMPLETED|Overall Study||2||
60043233|NCT02202109|76158864|FG000|STARTED|Overall Study||302||
60043234|NCT02202109|76158865|FG001|STARTED|Overall Study||300||
60043235|NCT02202109|76158864|FG000|COMPLETED|Overall Study||212||
60043236|NCT02202109|76158865|FG001|COMPLETED|Overall Study||213||
60043237|NCT02202109|76158864|FG000|NOT COMPLETED|Overall Study||90||
60043238|NCT02202109|76158865|FG001|NOT COMPLETED|Overall Study||87||
60043239|NCT02227849|76158871|FG000|STARTED|Overall Study||71||
60043240|NCT02227849|76158871|FG000|COMPLETED|Overall Study||63||
60043241|NCT02227849|76158871|FG000|NOT COMPLETED|Overall Study||8||
60043242|NCT01927497|76158877|FG000|STARTED|Overall Study||50||
60043243|NCT01927497|76158878|FG001|STARTED|Overall Study||54||
60043244|NCT01927497|76158877|FG000|COMPLETED|Overall Study||48||
60043245|NCT01927497|76158878|FG001|COMPLETED|Overall Study||53||
60043246|NCT01927497|76158877|FG000|NOT COMPLETED|Overall Study||2||
60043247|NCT01927497|76158878|FG001|NOT COMPLETED|Overall Study||1||
60043248|NCT02169271|76158886|FG000|STARTED|Overall Study||49||
60043249|NCT02169271|76158887|FG001|STARTED|Overall Study||49||
60043250|NCT02169271|76158886|FG000|COMPLETED|Overall Study||48||
60043251|NCT02169271|76158887|FG001|COMPLETED|Overall Study||47||
60043252|NCT02169271|76158886|FG000|NOT COMPLETED|Overall Study||1||
60043253|NCT02169271|76158887|FG001|NOT COMPLETED|Overall Study||2||
60043254|NCT02202031|76158895|FG000|STARTED|Overall Study||82||
60043255|NCT02202031|76158896|FG001|STARTED|Overall Study||79||
60043256|NCT02202031|76158895|FG000|COMPLETED|Overall Study||77||
60043257|NCT02202031|76158896|FG001|COMPLETED|Overall Study||74||
60043258|NCT02202031|76158895|FG000|NOT COMPLETED|Overall Study||5||
60043259|NCT02202031|76158896|FG001|NOT COMPLETED|Overall Study||5||
60043260|NCT01644188|76158904|FG000|STARTED|Overall Study|Randomized|479||
60043261|NCT01644188|76158905|FG001|STARTED|Overall Study|Randomized|241||
60043262|NCT01644188|76158904|FG000|Treated|Overall Study||479||
60043263|NCT01644188|76158905|FG001|Treated|Overall Study||241||
60043264|NCT01644188|76158904|FG000|COMPLETED|Overall Study||357||
60043265|NCT01644188|76158905|FG001|COMPLETED|Overall Study||166||
60043266|NCT01644188|76158904|FG000|NOT COMPLETED|Overall Study||122||
60043267|NCT01644188|76158905|FG001|NOT COMPLETED|Overall Study||75||
60043268|NCT02201953|76158913|FG000|STARTED|Overall Study||278||
60043269|NCT02201953|76158914|FG001|STARTED|Overall Study||280||
60043270|NCT02201953|76158913|FG000|COMPLETED|Overall Study||258||
60043271|NCT02201953|76158914|FG001|COMPLETED|Overall Study||224||
60043272|NCT02201953|76158913|FG000|NOT COMPLETED|Overall Study||20||
60043273|NCT02201953|76158914|FG001|NOT COMPLETED|Overall Study||56||
60043274|NCT02271854|76158920|FG000|STARTED|Overall Study||102||
60043275|NCT02271854|76158920|FG000|COMPLETED|Overall Study||98||
60043276|NCT02271854|76158920|FG000|NOT COMPLETED|Overall Study||4||
60043277|NCT02296892|76158928|FG000|STARTED|Overall Study||310||
60043278|NCT02296892|76158929|FG001|STARTED|Overall Study||63||
60043279|NCT02296892|76158930|FG002|STARTED|Overall Study||73||
60043280|NCT02296892|76158928|FG000|Safety Population|Overall Study||303|All randomized patients who received any amount of the trial drug and were analyzed as treated|
60043281|NCT02296892|76158929|FG001|Safety Population|Overall Study||59|All randomized patients who received any amount of the trial drug and were analyzed as treated|
60043282|NCT02296892|76158930|FG002|Safety Population|Overall Study||69|All randomized patients who received any amount of the trial drug and were analyzed as treated|
60043283|NCT02296892|76158928|FG000|Complete Trial Treatment Period|Overall Study||303||
60043284|NCT02296892|76158929|FG001|Complete Trial Treatment Period|Overall Study||59||
60043285|NCT02296892|76158930|FG002|Complete Trial Treatment Period|Overall Study||69||
60043286|NCT02296892|76158928|FG000|COMPLETED|Overall Study||298||
60043287|NCT02296892|76158929|FG001|COMPLETED|Overall Study||59||
60043288|NCT02296892|76158930|FG002|COMPLETED|Overall Study||68||
60043289|NCT02296892|76158928|FG000|NOT COMPLETED|Overall Study||12||
60043290|NCT02296892|76158929|FG001|NOT COMPLETED|Overall Study||4||
60043291|NCT02296892|76158930|FG002|NOT COMPLETED|Overall Study||5||
60043292|NCT02270684|76158940|FG000|STARTED|Overall Study||1||
60043293|NCT02270684|76158941|FG001|STARTED|Overall Study||3||
60043294|NCT02270684|76158940|FG000|COMPLETED|Overall Study||0||
60043295|NCT02270684|76158941|FG001|COMPLETED|Overall Study||0||
60043296|NCT02270684|76158940|FG000|NOT COMPLETED|Overall Study||1||
60043297|NCT02270684|76158941|FG001|NOT COMPLETED|Overall Study||3||
60043298|NCT02168803|76158950|FG000|STARTED|Overall Study||30||
60043299|NCT02168803|76158951|FG001|STARTED|Overall Study||32||
60043300|NCT02168803|76158952|FG002|STARTED|Overall Study||39||
60043301|NCT02168803|76158950|FG000|Received at Least 1 Dose of Study Drug|Overall Study||30||
59510968|NCT02513446|75604538|FG001|COMPLETED|Period 1||8||
59510969|NCT02513446|75604537|FG000|NOT COMPLETED|Period 1||0||
59510970|NCT02513446|75604538|FG001|NOT COMPLETED|Period 1||0||
59510971|NCT02513446|75604537|FG000|STARTED|Washout Period of 10 Days||8||
59510972|NCT02513446|75604538|FG001|STARTED|Washout Period of 10 Days||8||
59510973|NCT02513446|75604537|FG000|COMPLETED|Washout Period of 10 Days||8||
59510974|NCT02513446|75604538|FG001|COMPLETED|Washout Period of 10 Days||8||
59612396|NCT01701258|75723504|FG005|NOT COMPLETED|Assessment and Scheduling||0||
59612397|NCT01701258|75723505|FG006|NOT COMPLETED|Assessment and Scheduling||0||
59612398|NCT01701258|75723506|FG007|NOT COMPLETED|Assessment and Scheduling||0||
59612399|NCT01701258|75723507|FG008|NOT COMPLETED|Assessment and Scheduling||0||
59612400|NCT01701258|75723508|FG009|NOT COMPLETED|Assessment and Scheduling||0||
59919104|NCT04399837|76039524|FG003|COMPLETED|Overall Study||26|Completed trial|
59919105|NCT04399837|76039521|FG000|NOT COMPLETED|Overall Study||1||
59919106|NCT04399837|76039522|FG001|NOT COMPLETED|Overall Study||4||
59919107|NCT04399837|76039523|FG002|NOT COMPLETED|Overall Study||3||
59919108|NCT04399837|76039524|FG003|NOT COMPLETED|Overall Study||4||
60043302|NCT02168803|76158951|FG001|Received at Least 1 Dose of Study Drug|Overall Study||32||
60043303|NCT02168803|76158952|FG002|Received at Least 1 Dose of Study Drug|Overall Study||39||
60043304|NCT02168803|76158950|FG000|COMPLETED|Overall Study||28||
60043305|NCT02168803|76158951|FG001|COMPLETED|Overall Study||29||
60043306|NCT02168803|76158952|FG002|COMPLETED|Overall Study||33||
60043307|NCT02168803|76158950|FG000|NOT COMPLETED|Overall Study||2||
60043308|NCT02168803|76158951|FG001|NOT COMPLETED|Overall Study||3||
60043309|NCT02168803|76158952|FG002|NOT COMPLETED|Overall Study||6||
60043310|NCT02201329|76158967|FG000|STARTED|Overall Study||5||
60043311|NCT02201329|76158967|FG000|COMPLETED|Overall Study||0||
59510975|NCT02513446|75604537|FG000|NOT COMPLETED|Washout Period of 10 Days||0||
59510976|NCT02513446|75604538|FG001|NOT COMPLETED|Washout Period of 10 Days||0||
59510977|NCT02513446|75604537|FG000|STARTED|Period 2||8||
59510978|NCT02513446|75604538|FG001|STARTED|Period 2||8||
59510979|NCT02513446|75604537|FG000|COMPLETED|Period 2||8||
59510980|NCT02513446|75604538|FG001|COMPLETED|Period 2||8||
59510981|NCT02513446|75604537|FG000|NOT COMPLETED|Period 2||0||
59510982|NCT02513446|75604538|FG001|NOT COMPLETED|Period 2||0||
59510983|NCT00864383|75604548|FG000|STARTED|Per- Protocol||640||
59510984|NCT00864383|75604549|FG001|STARTED|Per- Protocol||655||
59510985|NCT00864383|75604550|FG002|STARTED|Per- Protocol||636||
59510986|NCT00864383|75604548|FG000|COMPLETED|Per- Protocol||510||
59510987|NCT00864383|75604549|FG001|COMPLETED|Per- Protocol||514||
59919109|NCT04365413|76039540|FG000|STARTED|Overall Study||45||
59919110|NCT04365413|76039540|FG000|COMPLETED|Overall Study||45||
59919111|NCT04365413|76039540|FG000|NOT COMPLETED|Overall Study||0||
60043312|NCT02201329|76158967|FG000|NOT COMPLETED|Overall Study||5||
60043313|NCT01927419|76158973|FG000|STARTED|Pre-Treatment Period||95||
60043314|NCT01927419|76158974|FG001|STARTED|Pre-Treatment Period||47||
60043315|NCT01927419|76158973|FG000|COMPLETED|Pre-Treatment Period||94||
60043316|NCT01927419|76158974|FG001|COMPLETED|Pre-Treatment Period||46||
60043317|NCT01927419|76158973|FG000|NOT COMPLETED|Pre-Treatment Period||1||
59510988|NCT00864383|75604550|FG002|COMPLETED|Per- Protocol||524||
59612401|NCT01701258|75723509|FG010|NOT COMPLETED|Assessment and Scheduling||0||
59919112|NCT04364269|76039547|FG000|STARTED|Overall Study||9||
59919113|NCT04364269|76039548|FG001|STARTED|Overall Study||12||
60043318|NCT01927419|76158974|FG001|NOT COMPLETED|Pre-Treatment Period||1||
60043319|NCT01927419|76158973|FG000|STARTED|Treatment Period||94||
59510989|NCT00864383|75604548|FG000|NOT COMPLETED|Per- Protocol||130||
59510990|NCT00864383|75604549|FG001|NOT COMPLETED|Per- Protocol||141||
59510991|NCT00864383|75604550|FG002|NOT COMPLETED|Per- Protocol||112||
59510992|NCT00864383|75604548|FG000|STARTED|Modified Intent to Treat||640||
59510993|NCT00864383|75604549|FG001|STARTED|Modified Intent to Treat||655||
59510994|NCT00864383|75604550|FG002|STARTED|Modified Intent to Treat||636||
59919114|NCT04364269|76039549|FG002|STARTED|Overall Study||4||
60043320|NCT01927419|76158974|FG001|STARTED|Treatment Period||46||
60043321|NCT01927419|76158973|FG000|COMPLETED|Treatment Period||0||
60043322|NCT01927419|76158974|FG001|COMPLETED|Treatment Period||0||
60043323|NCT01927419|76158973|FG000|NOT COMPLETED|Treatment Period||94||
60043324|NCT01927419|76158974|FG001|NOT COMPLETED|Treatment Period||46||
60043325|NCT02168491|76158980|FG000|STARTED|Overall Study||9||
60043326|NCT02168491|76158980|FG000|COMPLETED|Overall Study||8||
60043327|NCT02168491|76158980|FG000|NOT COMPLETED|Overall Study||1||
60043328|NCT02225743|76158984|FG000|STARTED|Overall Study||120||
60043329|NCT02225743|76158984|FG000|COMPLETED|Overall Study|18 patients chose not to participate on the day of surgery.|102||
60043330|NCT02225743|76158984|FG000|NOT COMPLETED|Overall Study||18||
60043331|NCT01721746|76158990|FG000|STARTED|Pre-Treatment||272|Started = Randomized|
60043332|NCT01721746|76158991|FG001|STARTED|Pre-Treatment||133|Started = Randomized|
60043333|NCT01721746|76158990|FG000|COMPLETED|Pre-Treatment||268|Completed = Received Treatment|
60043334|NCT01721746|76158991|FG001|COMPLETED|Pre-Treatment||102|Completed = Received Treatment|
60043335|NCT01721746|76158990|FG000|NOT COMPLETED|Pre-Treatment||4||
60043336|NCT01721746|76158991|FG001|NOT COMPLETED|Pre-Treatment||31||
60043337|NCT01721746|76158990|FG000|STARTED|Treatment||268|Started = Received treatment|
59919115|NCT04364269|76039547|FG000|COMPLETED|Overall Study||8||
59919116|NCT04364269|76039548|FG001|COMPLETED|Overall Study||11||
59919117|NCT04364269|76039549|FG002|COMPLETED|Overall Study||4||
59919118|NCT04364269|76039547|FG000|NOT COMPLETED|Overall Study||1||
59919119|NCT04364269|76039548|FG001|NOT COMPLETED|Overall Study||1||
59919120|NCT04364269|76039549|FG002|NOT COMPLETED|Overall Study||0||
59919121|NCT04299048|76039557|FG000|STARTED|Overall Study||11||
59919122|NCT04299048|76039557|FG000|Treated|Overall Study||10||
60043338|NCT01721746|76158991|FG001|STARTED|Treatment||102|Started = Received treatment|
60043339|NCT01721746|76158990|FG000|COMPLETED|Treatment||0|Completed = Completed treatment|
60043340|NCT01721746|76158991|FG001|COMPLETED|Treatment||0|Completed = Completed treatment|
60043341|NCT01721746|76158990|FG000|NOT COMPLETED|Treatment||268||
60043342|NCT01721746|76158991|FG001|NOT COMPLETED|Treatment||102||
59919123|NCT04299048|76039557|FG000|COMPLETED|Overall Study||7||
59919124|NCT04299048|76039557|FG000|NOT COMPLETED|Overall Study||4||
59919125|NCT04152200|76039563|FG000|STARTED|Primary Analysis Period||6||
59919126|NCT04152200|76039564|FG001|STARTED|Primary Analysis Period||15||
59919127|NCT04152200|76039563|FG000|COMPLETED|Primary Analysis Period||6||
59919128|NCT04152200|76039564|FG001|COMPLETED|Primary Analysis Period||15||
59919129|NCT04152200|76039563|FG000|NOT COMPLETED|Primary Analysis Period||0||
59919130|NCT04152200|76039564|FG001|NOT COMPLETED|Primary Analysis Period||0||
59919131|NCT04152200|76039563|FG000|STARTED|Long-term Extension Period||6||
59919132|NCT04152200|76039564|FG001|STARTED|Long-term Extension Period||15||
59919133|NCT04152200|76039563|FG000|COMPLETED|Long-term Extension Period||0||
59919134|NCT04152200|76039564|FG001|COMPLETED|Long-term Extension Period||0||
59919135|NCT04152200|76039563|FG000|NOT COMPLETED|Long-term Extension Period||6||
59919136|NCT04152200|76039564|FG001|NOT COMPLETED|Long-term Extension Period||15||
59919137|NCT04134091|76039575|FG000|STARTED|Overall Study||18||
59919138|NCT04134091|76039576|FG001|STARTED|Overall Study||19||
59919139|NCT04134091|76039577|FG002|STARTED|Overall Study||19||
59919140|NCT04134091|76039575|FG000|Completed Week 12|Overall Study||18||
59919141|NCT04134091|76039576|FG001|Completed Week 12|Overall Study||19||
59919142|NCT04134091|76039577|FG002|Completed Week 12|Overall Study||18||
59919143|NCT04134091|76039575|FG000|COMPLETED|Overall Study|Completed Week 36|18||
60043343|NCT02225665|76159000|FG000|STARTED|Overall Study||3||
60043344|NCT02225665|76159001|FG001|STARTED|Overall Study||5||
60043345|NCT02225665|76159000|FG000|COMPLETED|Overall Study||2||
60043346|NCT02225665|76159001|FG001|COMPLETED|Overall Study||4||
60043347|NCT02225665|76159000|FG000|NOT COMPLETED|Overall Study||1||
60043348|NCT02225665|76159001|FG001|NOT COMPLETED|Overall Study||1||
60043349|NCT01721200|76159009|FG000|STARTED|Overall Study||62||
60043350|NCT01721200|76159010|FG001|STARTED|Overall Study||63||
60043351|NCT01721200|76159009|FG000|Completed 2 Week Follow-up|Overall Study||60||
60043352|NCT01721200|76159010|FG001|Completed 2 Week Follow-up|Overall Study||61||
60043353|NCT01721200|76159009|FG000|COMPLETED|Overall Study||59||
60043354|NCT01721200|76159010|FG001|COMPLETED|Overall Study||58||
60043355|NCT01721200|76159009|FG000|NOT COMPLETED|Overall Study||3||
59919144|NCT04134091|76039576|FG001|COMPLETED|Overall Study|Completed Week 36|17||
59919145|NCT04134091|76039577|FG002|COMPLETED|Overall Study|Completed Week 36|17||
59919146|NCT04134091|76039575|FG000|NOT COMPLETED|Overall Study||0||
59919147|NCT04134091|76039576|FG001|NOT COMPLETED|Overall Study||2||
59919148|NCT04134091|76039577|FG002|NOT COMPLETED|Overall Study||2||
59919149|NCT04115644|76039588|FG000|STARTED|Overall Study||26||
59919150|NCT04115644|76039589|FG001|STARTED|Overall Study||30||
59919151|NCT04115644|76039590|FG002|STARTED|Overall Study||26||
59919152|NCT04115644|76039588|FG000|COMPLETED|Overall Study||26||
59919153|NCT04115644|76039589|FG001|COMPLETED|Overall Study||30||
59919154|NCT04115644|76039590|FG002|COMPLETED|Overall Study||25||
59919155|NCT04115644|76039588|FG000|NOT COMPLETED|Overall Study||0||
59919156|NCT04115644|76039589|FG001|NOT COMPLETED|Overall Study||0||
59919157|NCT04115644|76039590|FG002|NOT COMPLETED|Overall Study||1||
59919158|NCT03905694|76039598|FG000|STARTED|Primary Analysis Period||18||
59919159|NCT03905694|76039598|FG000|COMPLETED|Primary Analysis Period||18||
59919160|NCT03905694|76039598|FG000|NOT COMPLETED|Primary Analysis Period||0||
59510995|NCT00864383|75604548|FG000|COMPLETED|Modified Intent to Treat||555||
59510996|NCT00864383|75604549|FG001|COMPLETED|Modified Intent to Treat||568||
59510997|NCT00864383|75604550|FG002|COMPLETED|Modified Intent to Treat||551||
59510998|NCT00864383|75604548|FG000|NOT COMPLETED|Modified Intent to Treat||85||
59510999|NCT00864383|75604549|FG001|NOT COMPLETED|Modified Intent to Treat||87||
59511000|NCT00864383|75604550|FG002|NOT COMPLETED|Modified Intent to Treat||85||
59511001|NCT02514070|75604560|FG000|STARTED|Weeks 0 to Week 6||19||
59511002|NCT02514070|75604561|FG001|STARTED|Weeks 0 to Week 6||20||
59511003|NCT02514070|75604560|FG000|COMPLETED|Weeks 0 to Week 6||17||
59511004|NCT02514070|75604561|FG001|COMPLETED|Weeks 0 to Week 6||16||
59511005|NCT02514070|75604560|FG000|NOT COMPLETED|Weeks 0 to Week 6||2||
59511006|NCT02514070|75604561|FG001|NOT COMPLETED|Weeks 0 to Week 6||4||
59511007|NCT02514070|75604560|FG000|STARTED|Week 6 to Week 14 - Washout Period||17||
59511008|NCT02514070|75604561|FG001|STARTED|Week 6 to Week 14 - Washout Period||16||
59511009|NCT02514070|75604560|FG000|COMPLETED|Week 6 to Week 14 - Washout Period||17||
59511010|NCT02514070|75604561|FG001|COMPLETED|Week 6 to Week 14 - Washout Period||16||
59511011|NCT02514070|75604560|FG000|NOT COMPLETED|Week 6 to Week 14 - Washout Period||0||
59511012|NCT02514070|75604561|FG001|NOT COMPLETED|Week 6 to Week 14 - Washout Period||0||
59511013|NCT02514070|75604560|FG000|STARTED|Week 14 to Week 20||17||
59511014|NCT02514070|75604561|FG001|STARTED|Week 14 to Week 20||16||
59511015|NCT02514070|75604560|FG000|COMPLETED|Week 14 to Week 20||16||
59511016|NCT02514070|75604561|FG001|COMPLETED|Week 14 to Week 20||14||
59511017|NCT02514070|75604560|FG000|NOT COMPLETED|Week 14 to Week 20||1||
59511018|NCT02514070|75604561|FG001|NOT COMPLETED|Week 14 to Week 20||2||
59511019|NCT00864539|75604577|FG000|STARTED|Overall Study||104||
59511020|NCT00864539|75604578|FG001|STARTED|Overall Study||95||
59511021|NCT00864539|75604579|FG002|STARTED|Overall Study||102||
59511022|NCT00864539|75604580|FG003|STARTED|Overall Study||96||
59511023|NCT00864539|75604581|FG004|STARTED|Overall Study||103||
59511024|NCT00864539|75604582|FG005|STARTED|Overall Study||85||
59511025|NCT00864539|75604577|FG000|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|95||
59511026|NCT00864539|75604578|FG001|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|72||
59511027|NCT00864539|75604579|FG002|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|92||
59511028|NCT00864539|75604580|FG003|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|89||
59511029|NCT00864539|75604581|FG004|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|81||
59511030|NCT00864539|75604582|FG005|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|71||
59511031|NCT00864539|75604577|FG000|NOT COMPLETED|Overall Study||9||
59511032|NCT00864539|75604578|FG001|NOT COMPLETED|Overall Study||23||
59511033|NCT00864539|75604579|FG002|NOT COMPLETED|Overall Study||10||
59919161|NCT03905694|76039598|FG000|STARTED|Long-term Extension Period||18||
59919162|NCT03905694|76039598|FG000|COMPLETED|Long-term Extension Period||0||
59511034|NCT00864539|75604580|FG003|NOT COMPLETED|Overall Study||7||
59511035|NCT00864539|75604581|FG004|NOT COMPLETED|Overall Study||22||
59919163|NCT03905694|76039598|FG000|NOT COMPLETED|Long-term Extension Period||18||
59919164|NCT03681184|76039604|FG000|STARTED|6-Month Double-Blind Period||13||
59919165|NCT03681184|76039605|FG001|STARTED|6-Month Double-Blind Period||26||
59919166|NCT03681184|76039604|FG000|COMPLETED|6-Month Double-Blind Period||13||
59919167|NCT03681184|76039605|FG001|COMPLETED|6-Month Double-Blind Period||25||
59919168|NCT03681184|76039604|FG000|NOT COMPLETED|6-Month Double-Blind Period||0||
59612402|NCT01701258|75723510|FG011|NOT COMPLETED|Assessment and Scheduling||0||
59612403|NCT01701258|75723511|FG012|NOT COMPLETED|Assessment and Scheduling||0||
59612404|NCT01701258|75723499|FG000|STARTED|Drug+fMRI (Session 2)||0|Eligible participants after the screening session were invited to participate in this session.|
59612405|NCT01701258|75723500|FG001|STARTED|Drug+fMRI (Session 2)||0|Eligible participants after the screening session were invited to participate in this session.|
59612406|NCT01701258|75723501|FG002|STARTED|Drug+fMRI (Session 2)||11|Eligible participants after the screening session were invited to participate in this session.|
59612407|NCT01701258|75723502|FG003|STARTED|Drug+fMRI (Session 2)||11|Eligible participants after the screening session were invited to participate in this session.|
59612408|NCT01701258|75723503|FG004|STARTED|Drug+fMRI (Session 2)||0|Eligible participants after the screening session were invited to participate in this session.|
59612409|NCT01701258|75723504|FG005|STARTED|Drug+fMRI (Session 2)||9|Eligible participants after the screening session were invited to participate in this session.|
59612410|NCT01701258|75723505|FG006|STARTED|Drug+fMRI (Session 2)||8|Eligible participants after the screening session were invited to participate in this session.|
59612411|NCT01701258|75723506|FG007|STARTED|Drug+fMRI (Session 2)||0|Eligible participants after the screening session were invited to participate in this session.|
59612412|NCT01701258|75723507|FG008|STARTED|Drug+fMRI (Session 2)||6|Eligible participants after the screening session were invited to participate in this session.|
59612413|NCT01701258|75723508|FG009|STARTED|Drug+fMRI (Session 2)||6|Eligible participants after the screening session were invited to participate in this session.|
59612414|NCT01701258|75723509|FG010|STARTED|Drug+fMRI (Session 2)||0|Eligible participants after the screening session were invited to participate in this session.|
59612415|NCT01701258|75723510|FG011|STARTED|Drug+fMRI (Session 2)||10|Eligible participants after the screening session were invited to participate in this session.|
59612416|NCT01701258|75723511|FG012|STARTED|Drug+fMRI (Session 2)||7|Eligible participants after the screening session were invited to participate in this session.|
59612417|NCT01701258|75723499|FG000|Received Drug Challenge|Drug+fMRI (Session 2)||0|Not all participants that were eligible completed the MRI.|
59612418|NCT01701258|75723500|FG001|Received Drug Challenge|Drug+fMRI (Session 2)||0|Not all participants that were eligible completed the MRI.|
59612419|NCT01701258|75723501|FG002|Received Drug Challenge|Drug+fMRI (Session 2)||11|Not all participants that were eligible completed the MRI.|
59612420|NCT01701258|75723502|FG003|Received Drug Challenge|Drug+fMRI (Session 2)||11|Not all participants that were eligible completed the MRI.|
59612421|NCT01701258|75723503|FG004|Received Drug Challenge|Drug+fMRI (Session 2)||0|Not all participants that were eligible completed the MRI.|
59612422|NCT01701258|75723504|FG005|Received Drug Challenge|Drug+fMRI (Session 2)||9|Not all participants that were eligible completed the MRI.|
59612423|NCT01701258|75723505|FG006|Received Drug Challenge|Drug+fMRI (Session 2)||8|Not all participants that were eligible completed the MRI.|
59612424|NCT01701258|75723506|FG007|Received Drug Challenge|Drug+fMRI (Session 2)||0|Not all participants that were eligible completed the MRI.|
59612425|NCT01701258|75723507|FG008|Received Drug Challenge|Drug+fMRI (Session 2)||6|Not all participants that were eligible completed the MRI.|
59612426|NCT01701258|75723508|FG009|Received Drug Challenge|Drug+fMRI (Session 2)||6|Not all participants that were eligible completed the MRI.|
59612427|NCT01701258|75723509|FG010|Received Drug Challenge|Drug+fMRI (Session 2)||0|Not all participants that were eligible completed the MRI.|
59612428|NCT01701258|75723510|FG011|Received Drug Challenge|Drug+fMRI (Session 2)||10|Not all participants that were eligible completed the MRI.|
59612429|NCT01701258|75723511|FG012|Received Drug Challenge|Drug+fMRI (Session 2)||7|Not all participants that were eligible completed the MRI.|
59612430|NCT01701258|75723499|FG000|COMPLETED|Drug+fMRI (Session 2)||0||
60043356|NCT01721200|76159010|FG001|NOT COMPLETED|Overall Study||5||
60043357|NCT02225587|76159023|FG000|STARTED|Overall Study||200|Received Vaccination 1|
60043358|NCT02225587|76159024|FG001|STARTED|Overall Study||200|Received Vaccination 1|
60043359|NCT02225587|76159023|FG000|Vaccination 2|Overall Study||188|Received Vaccination 2|
59612431|NCT01701258|75723500|FG001|COMPLETED|Drug+fMRI (Session 2)||0||
59919169|NCT03681184|76039605|FG001|NOT COMPLETED|6-Month Double-Blind Period||1||
59919170|NCT03681184|76039604|FG000|STARTED|3-Month Blinded Extension Period||13||
59919171|NCT03681184|76039605|FG001|STARTED|3-Month Blinded Extension Period|1 participant discontinued study drug and entered safety follow up after the DB period.|24||
59919172|NCT03681184|76039604|FG000|COMPLETED|3-Month Blinded Extension Period||1||
59612432|NCT01701258|75723501|FG002|COMPLETED|Drug+fMRI (Session 2)||11||
59612433|NCT01701258|75723502|FG003|COMPLETED|Drug+fMRI (Session 2)||11||
59612434|NCT01701258|75723503|FG004|COMPLETED|Drug+fMRI (Session 2)||0||
59612435|NCT01701258|75723504|FG005|COMPLETED|Drug+fMRI (Session 2)||9||
59612436|NCT01701258|75723505|FG006|COMPLETED|Drug+fMRI (Session 2)||8||
59612437|NCT01701258|75723506|FG007|COMPLETED|Drug+fMRI (Session 2)||0||
59612438|NCT01701258|75723507|FG008|COMPLETED|Drug+fMRI (Session 2)||6||
59919173|NCT03681184|76039605|FG001|COMPLETED|3-Month Blinded Extension Period||1||
59919174|NCT03681184|76039604|FG000|NOT COMPLETED|3-Month Blinded Extension Period||12||
59919175|NCT03681184|76039605|FG001|NOT COMPLETED|3-Month Blinded Extension Period||23||
59919176|NCT03681184|76039604|FG000|STARTED|Open-Label Extension Period||1||
59919177|NCT03681184|76039605|FG001|STARTED|Open-Label Extension Period||1||
59919178|NCT03681184|76039604|FG000|COMPLETED|Open-Label Extension Period||0||
59919179|NCT03681184|76039605|FG001|COMPLETED|Open-Label Extension Period||0||
59919180|NCT03681184|76039604|FG000|NOT COMPLETED|Open-Label Extension Period||1||
59919181|NCT03681184|76039605|FG001|NOT COMPLETED|Open-Label Extension Period||1||
59919182|NCT03673462|76039613|FG000|STARTED|Overall Study||2099||
60043360|NCT02225587|76159024|FG001|Vaccination 2|Overall Study||185|Received Vaccination 2|
60043361|NCT02225587|76159023|FG000|Vaccination 3|Overall Study||172|Received Vaccination 3|
60043362|NCT02225587|76159024|FG001|Vaccination 3|Overall Study||164|Received Vaccination 3|
60043363|NCT02225587|76159023|FG000|COMPLETED|Overall Study||172||
60043364|NCT02225587|76159024|FG001|COMPLETED|Overall Study||162||
60043365|NCT02225587|76159023|FG000|NOT COMPLETED|Overall Study||28||
60043366|NCT02225587|76159024|FG001|NOT COMPLETED|Overall Study||38||
60043367|NCT02296424|76159032|FG000|STARTED|Part 1|16 patients immediately went into Part II|84||
60043368|NCT02296424|76159033|FG001|STARTED|Part 1||98||
60043369|NCT02296424|76159034|FG002|STARTED|Part 1||0||
60043370|NCT02296424|76159035|FG003|STARTED|Part 1||0||
60043371|NCT02296424|76159032|FG000|COMPLETED|Part 1||61||
60043372|NCT02296424|76159033|FG001|COMPLETED|Part 1||65||
60043373|NCT02296424|76159034|FG002|COMPLETED|Part 1||0||
60043374|NCT02296424|76159035|FG003|COMPLETED|Part 1||0||
59511036|NCT00864539|75604582|FG005|NOT COMPLETED|Overall Study||14||
59511037|NCT00827255|75604596|FG000|STARTED|Overall Study||35||
59511038|NCT00827255|75604596|FG000|COMPLETED|Overall Study||35||
59511039|NCT00827255|75604596|FG000|NOT COMPLETED|Overall Study||0||
59511040|NCT02153489|75604600|FG000|STARTED|Period 1||15||
59511041|NCT02153489|75604601|FG001|STARTED|Period 1||15||
59511042|NCT02153489|75604600|FG000|COMPLETED|Period 1||15||
59511043|NCT02153489|75604601|FG001|COMPLETED|Period 1||15||
59511044|NCT02153489|75604600|FG000|NOT COMPLETED|Period 1||0||
59511045|NCT02153489|75604601|FG001|NOT COMPLETED|Period 1||0||
59511046|NCT02153489|75604600|FG000|STARTED|Period 2||15||
59511047|NCT02153489|75604601|FG001|STARTED|Period 2||15||
59511048|NCT02153489|75604600|FG000|COMPLETED|Period 2||15||
59511049|NCT02153489|75604601|FG001|COMPLETED|Period 2||15||
59511050|NCT02153489|75604600|FG000|NOT COMPLETED|Period 2||0||
59511051|NCT02153489|75604601|FG001|NOT COMPLETED|Period 2||0||
59511052|NCT00866879|75604609|FG000|STARTED|Overall Study||90||
59511053|NCT00866879|75604610|FG001|STARTED|Overall Study||185||
59511054|NCT00866879|75604609|FG000|COMPLETED|Overall Study||90||
59511055|NCT00866879|75604610|FG001|COMPLETED|Overall Study||185||
59511056|NCT00866879|75604609|FG000|NOT COMPLETED|Overall Study||0||
59511057|NCT00866879|75604610|FG001|NOT COMPLETED|Overall Study||0||
59511058|NCT02153723|75604616|FG000|STARTED|Overall Study||10||
59511059|NCT02153723|75604616|FG000|COMPLETED|Overall Study||10||
60043375|NCT02296424|76159032|FG000|NOT COMPLETED|Part 1||23||
60043376|NCT02296424|76159033|FG001|NOT COMPLETED|Part 1||33||
60043377|NCT02296424|76159034|FG002|NOT COMPLETED|Part 1||0||
60043378|NCT02296424|76159035|FG003|NOT COMPLETED|Part 1||0||
60043379|NCT02296424|76159032|FG000|STARTED|Part 2||0||
60043380|NCT02296424|76159033|FG001|STARTED|Part 2||0||
60043381|NCT02296424|76159034|FG002|STARTED|Part 2||38||
60043382|NCT02296424|76159035|FG003|STARTED|Part 2||37||
60043383|NCT02296424|76159032|FG000|COMPLETED|Part 2||0||
60043384|NCT02296424|76159033|FG001|COMPLETED|Part 2||0||
60043385|NCT02296424|76159034|FG002|COMPLETED|Part 2||35||
60043386|NCT02296424|76159035|FG003|COMPLETED|Part 2||37||
60043387|NCT02296424|76159032|FG000|NOT COMPLETED|Part 2||0||
60043388|NCT02296424|76159033|FG001|NOT COMPLETED|Part 2||0||
60043389|NCT02296424|76159034|FG002|NOT COMPLETED|Part 2||3||
60043390|NCT02296424|76159035|FG003|NOT COMPLETED|Part 2||0||
60043391|NCT02296190|76159049|FG000|STARTED|Overall Study||35||
60043392|NCT02296190|76159050|FG001|STARTED|Overall Study||41||
60043393|NCT02296190|76159051|FG002|STARTED|Overall Study||35||
60043394|NCT02296190|76159052|FG003|STARTED|Overall Study||43||
60043395|NCT02296190|76159053|FG004|STARTED|Overall Study||36||
59511060|NCT02153723|75604616|FG000|NOT COMPLETED|Overall Study||0||
59511061|NCT00828191|75604622|FG000|STARTED|Overall Study|Randomized patients|400||
60043396|NCT02296190|76159054|FG005|STARTED|Overall Study||9||
60043397|NCT02296190|76159049|FG000|COMPLETED|Overall Study||21||
60043398|NCT02296190|76159050|FG001|COMPLETED|Overall Study||20||
59511062|NCT00828191|75604623|FG001|STARTED|Overall Study|Randomized patients|400||
60043399|NCT02296190|76159051|FG002|COMPLETED|Overall Study||23||
60043400|NCT02296190|76159052|FG003|COMPLETED|Overall Study||20||
60043401|NCT02296190|76159053|FG004|COMPLETED|Overall Study||20||
60043402|NCT02296190|76159054|FG005|COMPLETED|Overall Study||9||
60043403|NCT02296190|76159049|FG000|NOT COMPLETED|Overall Study||14||
60043404|NCT02296190|76159050|FG001|NOT COMPLETED|Overall Study||21||
60043405|NCT02296190|76159051|FG002|NOT COMPLETED|Overall Study||12||
60043406|NCT02296190|76159052|FG003|NOT COMPLETED|Overall Study||23||
60043407|NCT02296190|76159053|FG004|NOT COMPLETED|Overall Study||16||
60043408|NCT02296190|76159054|FG005|NOT COMPLETED|Overall Study||0||
60043409|NCT02296112|76159067|FG000|STARTED|Overall Study||9||
60043410|NCT02296112|76159067|FG000|COMPLETED|Overall Study||0||
60043411|NCT02296112|76159067|FG000|NOT COMPLETED|Overall Study||9||
60043412|NCT02295644|76159080|FG000|STARTED|Overall Study|All groups were randomly allocated to subjects upon the start of their individual trials|7||
60043413|NCT02295644|76159081|FG001|STARTED|Overall Study|All groups were randomly allocated to subjects upon the start of their individual trials|7||
60043414|NCT02295644|76159082|FG002|STARTED|Overall Study|All groups were randomly allocated to subjects upon the start of their individual trials|7||
60043415|NCT02295644|76159083|FG003|STARTED|Overall Study|All groups were randomly allocated to subjects upon the start of their individual trials|7||
60043416|NCT02295644|76159080|FG000|COMPLETED|Overall Study||7||
60043417|NCT02295644|76159081|FG001|COMPLETED|Overall Study||7||
60043418|NCT02295644|76159082|FG002|COMPLETED|Overall Study||6||
60043419|NCT02295644|76159083|FG003|COMPLETED|Overall Study||5||
60043420|NCT02295644|76159080|FG000|NOT COMPLETED|Overall Study||0||
60043421|NCT02295644|76159081|FG001|NOT COMPLETED|Overall Study||0||
60043422|NCT02295644|76159082|FG002|NOT COMPLETED|Overall Study||1||
60043423|NCT02295644|76159083|FG003|NOT COMPLETED|Overall Study||2||
60043424|NCT02269670|76159093|FG000|STARTED|Overall Study||3||
60043425|NCT02269670|76159093|FG000|COMPLETED|Overall Study||0||
60043426|NCT02269670|76159093|FG000|NOT COMPLETED|Overall Study||3||
60043427|NCT02225353|76159100|FG000|STARTED|Overall Study||91||
60043428|NCT02225353|76159101|FG001|STARTED|Overall Study||90||
60043429|NCT02225353|76159102|FG002|STARTED|Overall Study||90||
60043430|NCT02225353|76159100|FG000|COMPLETED|Overall Study||87||
60043431|NCT02225353|76159101|FG001|COMPLETED|Overall Study||84||
60043432|NCT02225353|76159102|FG002|COMPLETED|Overall Study||75||
60043433|NCT02225353|76159100|FG000|NOT COMPLETED|Overall Study||4||
60043434|NCT02225353|76159101|FG001|NOT COMPLETED|Overall Study||6||
60043435|NCT02225353|76159102|FG002|NOT COMPLETED|Overall Study||15||
60043436|NCT01641926|76159117|FG000|STARTED|Overall Study||143||
60043437|NCT01641926|76159118|FG001|STARTED|Overall Study||145||
60043438|NCT01641926|76159119|FG002|STARTED|Overall Study||57||
60043439|NCT01641926|76159120|FG003|STARTED|Overall Study||57||
60043440|NCT01641926|76159117|FG000|Treated (All Participants as Treated)|Overall Study||142||
60043441|NCT01641926|76159118|FG001|Treated (All Participants as Treated)|Overall Study||144||
60043442|NCT01641926|76159119|FG002|Treated (All Participants as Treated)|Overall Study||56||
60043443|NCT01641926|76159120|FG003|Treated (All Participants as Treated)|Overall Study||57||
60043444|NCT01641926|76159117|FG000|COMPLETED|Overall Study||115||
60043445|NCT01641926|76159118|FG001|COMPLETED|Overall Study||130||
60043446|NCT01641926|76159119|FG002|COMPLETED|Overall Study||46||
60043447|NCT01641926|76159120|FG003|COMPLETED|Overall Study||53||
60043448|NCT01641926|76159117|FG000|NOT COMPLETED|Overall Study||28||
60043449|NCT01641926|76159118|FG001|NOT COMPLETED|Overall Study||15||
60043450|NCT01641926|76159119|FG002|NOT COMPLETED|Overall Study||11||
60043451|NCT01641926|76159120|FG003|NOT COMPLETED|Overall Study||4||
60043452|NCT02295020|76159132|FG000|STARTED|Overall Study||20||
60043453|NCT02295020|76159133|FG001|STARTED|Overall Study||20||
60043454|NCT02295020|76159132|FG000|COMPLETED|Overall Study||17||
60043455|NCT02295020|76159133|FG001|COMPLETED|Overall Study||17||
60043456|NCT02295020|76159132|FG000|NOT COMPLETED|Overall Study||3||
60043457|NCT02295020|76159133|FG001|NOT COMPLETED|Overall Study||3||
60043458|NCT02200939|76159147|FG000|STARTED|Overall Study||33||
60043459|NCT02200939|76159148|FG001|STARTED|Overall Study||115||
60043460|NCT02200939|76159147|FG000|COMPLETED|Overall Study||31||
60043461|NCT02200939|76159148|FG001|COMPLETED|Overall Study||104||
60043462|NCT02200939|76159147|FG000|NOT COMPLETED|Overall Study||2||
60043463|NCT02200939|76159148|FG001|NOT COMPLETED|Overall Study||11||
60043464|NCT02294786|76159160|FG000|STARTED|Overall Study||30||
60043465|NCT02294786|76159161|FG001|STARTED|Overall Study||32||
60043466|NCT02294786|76159160|FG000|Safety Population|Overall Study|One subject randomized to Octreotide received only 0.1 mg dose.|29|All randomized subjects who received at least one dose of study treatment.|
60043467|NCT02294786|76159161|FG001|Safety Population|Overall Study|The subject was included in the No-Octreotide arm.|33|All randomized subjects who received at least one dose of study treatment.|
60043468|NCT02294786|76159160|FG000|ITT Population|Overall Study||30|All randomized subjects regardless of whether or not treatment was administered.|
60043469|NCT02294786|76159161|FG001|ITT Population|Overall Study||32|All randomized subjects regardless of whether or not treatment was administered.|
60043470|NCT02294786|76159160|FG000|COMPLETED|Overall Study||19||
60043471|NCT02294786|76159161|FG001|COMPLETED|Overall Study||18||
60043472|NCT02294786|76159160|FG000|NOT COMPLETED|Overall Study||11||
60043473|NCT02294786|76159161|FG001|NOT COMPLETED|Overall Study||14||
60043474|NCT02269124|76159170|FG000|STARTED|Overall Study||21|Completion of each of the six survey rounds is defined here as completing at least one of the five surveys for the given time point.|
60067831|NCT01617967|76183031|FG002|STARTED|Overall Study||3||
60043475|NCT02269124|76159171|FG001|STARTED|Overall Study||16|Completion of each of the six survey rounds is defined here as completing at least one of the five surveys for the given time point.|
60043476|NCT02269124|76159170|FG000|Completed Survey Round 1 (Arm 1, 0 Weeks)|Overall Study||20|Survey Round 1 was administered 0 weeks into the study, corresponding to the beginning of the first treatment arm. Round 1 represents the first of six survey rounds overall.|
60043477|NCT02269124|76159171|FG001|Completed Survey Round 1 (Arm 1, 0 Weeks)|Overall Study||14|Survey Round 1 was administered 0 weeks into the study, corresponding to the beginning of the first treatment arm. Round 1 represents the first of six survey rounds overall.|
60043478|NCT02269124|76159170|FG000|Completed Survey Round 2 (Arm 1, 6 Weeks)|Overall Study||17|Survey Round 2 was administered 6 weeks into the study, corresponding to the halfway point within the first treatment arm. Round 2 represents the second of six survey rounds overall.|
60043479|NCT02269124|76159171|FG001|Completed Survey Round 2 (Arm 1, 6 Weeks)|Overall Study||13|Survey Round 2 was administered 6 weeks into the study, corresponding to the halfway point within the first treatment arm. Round 2 represents the second of six survey rounds overall.|
60043480|NCT02269124|76159170|FG000|Completed Survey Round 3 (Arm 1, 12 Weeks)|Overall Study||17|Survey Round 3 was administered 12 weeks into the study, corresponding to the last measures during the first treatment arm. Survey Round 3 was administered shortly before the subject had ended the first treatment arm, while Survey Round 4 was administered shortly after the subject initiated the second treatment arm. Round 3 represents the third of six survey rounds overall.|
60043481|NCT02269124|76159171|FG001|Completed Survey Round 3 (Arm 1, 12 Weeks)|Overall Study||11|Survey Round 3 was administered 12 weeks into the study, corresponding to the last measures during the first treatment arm. Survey Round 3 was administered shortly before the subject had ended the first treatment arm, while Survey Round 4 was administered shortly after the subject initiated the second treatment arm. Round 3 represents the third of six survey rounds overall.|
60043482|NCT02269124|76159170|FG000|Completed Survey Round 4 (Arm 2, 12 Weeks)|Overall Study||11|Survey Round 4 was administered 12 weeks into the study, corresponding to the first measures during the second treatment arm. Survey Round 4 was administered shortly after the subject had initiated the second treatment arm, while Survey Round 3 was administered shortly before the subject ended the first treatment arm. Round 4 represents the fourth of six survey rounds overall.|
60043483|NCT02269124|76159171|FG001|Completed Survey Round 4 (Arm 2, 12 Weeks)|Overall Study||8|Survey Round 4 was administered 12 weeks into the study, corresponding to the first measures during the second treatment arm. Survey Round 4 was administered shortly after the subject had initiated the second treatment arm, while Survey Round 3 was administered shortly before the subject ended the first treatment arm. Round 4 represents the fourth of six survey rounds overall.|
60043484|NCT02269124|76159170|FG000|Completed Survey Round 5 (Arm 2, 18 Weeks)|Overall Study||16|Survey Round 5 was administered 18 weeks into the study, corresponding to the halfway point within the second treatment arm. Round 5 represents the fifth of six survey rounds overall.|
60043485|NCT02269124|76159171|FG001|Completed Survey Round 5 (Arm 2, 18 Weeks)|Overall Study||10|Survey Round 5 was administered 18 weeks into the study, corresponding to the halfway point within the second treatment arm. Round 5 represents the fifth of six survey rounds overall.|
60043486|NCT02269124|76159170|FG000|Completed Survey Round 6 (Arm 2, 24 Weeks)|Overall Study||14|Survey Round 6 was administered 24 weeks into the study, corresponding to the last measures in the second treatment arm. Round 6 represents the sixth of six survey rounds overall.|
60043487|NCT02269124|76159171|FG001|Completed Survey Round 6 (Arm 2, 24 Weeks)|Overall Study||10|Survey Round 6 was administered 24 weeks into the study, corresponding to the last measures in the second treatment arm. Round 6 represents the sixth of six survey rounds overall.|
60043488|NCT02269124|76159170|FG000|COMPLETED|Overall Study|One participant from the Conventional Measures Only First arm did not return any surveys, nor did their parent/guardian or teacher, and were deemed lost to follow-up.|20|Overall completion is defined here as completing at least one survey.|
60043489|NCT02269124|76159171|FG001|COMPLETED|Overall Study|Two participants from the Conventional measures + Hearing Aid First arm withdrew from the study prior to the second arm because they did not wish to stop using the hearing aid.|14|Overall completion is defined here as completing at least one survey.|
60043490|NCT02269124|76159170|FG000|NOT COMPLETED|Overall Study||1||
60043491|NCT02269124|76159171|FG001|NOT COMPLETED|Overall Study||2||
60043492|NCT01927341|76159183|FG000|STARTED|Phase 1b||10||
60043493|NCT01927341|76159184|FG001|STARTED|Phase 1b||0||
60043494|NCT01927341|76159185|FG002|STARTED|Phase 1b||0||
59759746|NCT00880191|75879169|FG000|Available for Primary Endpoint Analysis|Overall Study||207||
60043495|NCT01927341|76159186|FG003|STARTED|Phase 1b||0||
60043496|NCT01927341|76159187|FG004|STARTED|Phase 1b||0||
60043497|NCT01927341|76159183|FG000|COMPLETED|Phase 1b||0||
60043498|NCT01927341|76159184|FG001|COMPLETED|Phase 1b||0||
60043499|NCT01927341|76159185|FG002|COMPLETED|Phase 1b||0||
60043500|NCT01927341|76159186|FG003|COMPLETED|Phase 1b||0||
60043501|NCT01927341|76159187|FG004|COMPLETED|Phase 1b||0||
60043502|NCT01927341|76159183|FG000|NOT COMPLETED|Phase 1b||10||
60043503|NCT01927341|76159184|FG001|NOT COMPLETED|Phase 1b||0||
60043504|NCT01927341|76159185|FG002|NOT COMPLETED|Phase 1b||0||
60043505|NCT01927341|76159186|FG003|NOT COMPLETED|Phase 1b||0||
60043506|NCT01927341|76159187|FG004|NOT COMPLETED|Phase 1b||0||
59511063|NCT00828191|75604622|FG000|COMPLETED|Overall Study|Patients with at least one embryo transferred.|392||
59511064|NCT00828191|75604623|FG001|COMPLETED|Overall Study|Patients with at least one embryo transferred.|390||
59511065|NCT00828191|75604622|FG000|NOT COMPLETED|Overall Study||8||
59511066|NCT00828191|75604623|FG001|NOT COMPLETED|Overall Study||10||
59511067|NCT00867659|75604629|FG000|STARTED|Overall Study|October 2009|20||
59511068|NCT00867659|75604629|FG000|COMPLETED|Overall Study|January 2010|20||
59511069|NCT00867659|75604629|FG000|NOT COMPLETED|Overall Study||0||
59511070|NCT00912925|75604636|FG000|STARTED|Overall Study||23||
59511071|NCT00912925|75604637|FG001|STARTED|Overall Study||22||
59511072|NCT00912925|75604636|FG000|COMPLETED|Overall Study||23||
59511073|NCT00912925|75604637|FG001|COMPLETED|Overall Study||22||
59511074|NCT00912925|75604636|FG000|NOT COMPLETED|Overall Study||0||
59511075|NCT00912925|75604637|FG001|NOT COMPLETED|Overall Study||0||
60043507|NCT01927341|76159183|FG000|STARTED|Phase 2||0||
60043508|NCT01927341|76159184|FG001|STARTED|Phase 2|Participants of phase 2 enrolled after enrollment of participants of phase 1b.|15||
60043509|NCT01927341|76159185|FG002|STARTED|Phase 2|Participants of phase 2 enrolled after enrollment of participants of phase 1b.|5||
60043510|NCT01927341|76159186|FG003|STARTED|Phase 2|Participants of phase 2 enrolled after enrollment of participants of phase 1b.|15||
60043511|NCT01927341|76159187|FG004|STARTED|Phase 2|Participants of phase 2 enrolled after enrollment of participants of phase 1b.|8||
60043512|NCT01927341|76159183|FG000|COMPLETED|Phase 2||0||
60043513|NCT01927341|76159184|FG001|COMPLETED|Phase 2||0||
60043514|NCT01927341|76159185|FG002|COMPLETED|Phase 2||0||
60043515|NCT01927341|76159186|FG003|COMPLETED|Phase 2||0||
60043516|NCT01927341|76159187|FG004|COMPLETED|Phase 2||0||
60043517|NCT01927341|76159183|FG000|NOT COMPLETED|Phase 2||0||
60043518|NCT01927341|76159184|FG001|NOT COMPLETED|Phase 2||15||
60043519|NCT01927341|76159185|FG002|NOT COMPLETED|Phase 2||5||
60043520|NCT01927341|76159186|FG003|NOT COMPLETED|Phase 2||15||
60043521|NCT01927341|76159187|FG004|NOT COMPLETED|Phase 2||8||
60043522|NCT02294474|76159205|FG000|STARTED|Overall Study||253||
60043523|NCT02294474|76159206|FG001|STARTED|Overall Study||252||
60043524|NCT02294474|76159205|FG000|COMPLETED|Overall Study||228||
60043525|NCT02294474|76159206|FG001|COMPLETED|Overall Study||230||
60043526|NCT02294474|76159205|FG000|NOT COMPLETED|Overall Study||25||
60043527|NCT02294474|76159206|FG001|NOT COMPLETED|Overall Study||22||
60043528|NCT02168101|76159216|FG000|STARTED|Overall Study||3||
60043529|NCT02168101|76159217|FG001|STARTED|Overall Study||3||
60043530|NCT02168101|76159218|FG002|STARTED|Overall Study||3||
60043531|NCT02168101|76159216|FG000|COMPLETED|Overall Study||1||
60043532|NCT02168101|76159217|FG001|COMPLETED|Overall Study||1||
60043533|NCT02168101|76159218|FG002|COMPLETED|Overall Study||2||
60043534|NCT02168101|76159216|FG000|NOT COMPLETED|Overall Study||2||
60043535|NCT02168101|76159217|FG001|NOT COMPLETED|Overall Study||2||
60043536|NCT02168101|76159218|FG002|NOT COMPLETED|Overall Study||1||
60043537|NCT02298179|76159239|FG000|STARTED|Overall Study||24||
60043538|NCT02298179|76159240|FG001|STARTED|Overall Study||24||
60043539|NCT02298179|76159241|FG002|STARTED|Overall Study||24||
60043540|NCT02298179|76159242|FG003|STARTED|Overall Study||24||
60043541|NCT02298179|76159243|FG004|STARTED|Overall Study||24||
60043542|NCT02298179|76159244|FG005|STARTED|Overall Study||24||
60043543|NCT02298179|76159245|FG006|STARTED|Overall Study||24||
60043544|NCT02298179|76159246|FG007|STARTED|Overall Study||24||
60043545|NCT02298179|76159247|FG008|STARTED|Overall Study||24||
60043546|NCT02298179|76159248|FG009|STARTED|Overall Study||24||
60043547|NCT02298179|76159249|FG010|STARTED|Overall Study||24||
60043548|NCT02298179|76159250|FG011|STARTED|Overall Study||24||
60043549|NCT02298179|76159239|FG000|COMPLETED|Overall Study||24||
60043550|NCT02298179|76159240|FG001|COMPLETED|Overall Study||24||
60043551|NCT02298179|76159241|FG002|COMPLETED|Overall Study||23||
60043552|NCT02298179|76159242|FG003|COMPLETED|Overall Study||24||
60043553|NCT02298179|76159243|FG004|COMPLETED|Overall Study||24||
60043554|NCT02298179|76159244|FG005|COMPLETED|Overall Study||24||
60043555|NCT02298179|76159245|FG006|COMPLETED|Overall Study||24||
60043556|NCT02298179|76159246|FG007|COMPLETED|Overall Study||23||
60043557|NCT02298179|76159247|FG008|COMPLETED|Overall Study||24||
60043558|NCT02298179|76159248|FG009|COMPLETED|Overall Study||24||
60043559|NCT02298179|76159249|FG010|COMPLETED|Overall Study||24||
60043560|NCT02298179|76159250|FG011|COMPLETED|Overall Study||24||
60043561|NCT02298179|76159239|FG000|NOT COMPLETED|Overall Study||0||
60043562|NCT02298179|76159240|FG001|NOT COMPLETED|Overall Study||0||
60043563|NCT02298179|76159241|FG002|NOT COMPLETED|Overall Study||1||
60043564|NCT02298179|76159242|FG003|NOT COMPLETED|Overall Study||0||
59511076|NCT00828347|75604645|FG000|STARTED|Overall Study||12||
59511077|NCT00828347|75604646|FG001|STARTED|Overall Study||11||
59511078|NCT00828347|75604645|FG000|COMPLETED|Overall Study||12||
59511079|NCT00828347|75604646|FG001|COMPLETED|Overall Study||11||
59511080|NCT00828347|75604645|FG000|NOT COMPLETED|Overall Study||0||
59511081|NCT00828347|75604646|FG001|NOT COMPLETED|Overall Study||0||
59511082|NCT00829049|75604654|FG000|STARTED|Overall Study||77||
60043565|NCT02298179|76159243|FG004|NOT COMPLETED|Overall Study||0||
60043566|NCT02298179|76159244|FG005|NOT COMPLETED|Overall Study||0||
60043567|NCT02298179|76159245|FG006|NOT COMPLETED|Overall Study||0||
60043568|NCT02298179|76159246|FG007|NOT COMPLETED|Overall Study||1||
60043569|NCT02298179|76159247|FG008|NOT COMPLETED|Overall Study||0||
60043570|NCT02298179|76159248|FG009|NOT COMPLETED|Overall Study||0||
60043571|NCT02298179|76159249|FG010|NOT COMPLETED|Overall Study||0||
60043572|NCT02298179|76159250|FG011|NOT COMPLETED|Overall Study||0||
60043573|NCT02298023|76159279|FG000|STARTED|Overall Study||8||
60043574|NCT02298023|76159280|FG001|STARTED|Overall Study||8||
60043575|NCT02298023|76159281|FG002|STARTED|Overall Study||8||
60043576|NCT02298023|76159279|FG000|Intervention|Overall Study|Withdrawal by participant before intervention.|7||
60043577|NCT02298023|76159280|FG001|Intervention|Overall Study||8||
59759747|NCT00880191|75879170|FG001|Available for Primary Endpoint Analysis|Overall Study||206||
59759748|NCT00880191|75879169|FG000|COMPLETED|Overall Study||194||
59759749|NCT00880191|75879170|FG001|COMPLETED|Overall Study||198||
59759750|NCT00880191|75879169|FG000|NOT COMPLETED|Overall Study||13||
60043578|NCT02298023|76159281|FG002|Intervention|Overall Study||8||
60043579|NCT02298023|76159279|FG000|COMPLETED|Overall Study||7||
60043580|NCT02298023|76159280|FG001|COMPLETED|Overall Study||8||
60043581|NCT02298023|76159281|FG002|COMPLETED|Overall Study||8||
60043582|NCT02298023|76159279|FG000|NOT COMPLETED|Overall Study||1||
60043583|NCT02298023|76159280|FG001|NOT COMPLETED|Overall Study||0||
60043584|NCT02298023|76159281|FG002|NOT COMPLETED|Overall Study||0||
60043585|NCT02296931|76159294|FG000|STARTED|Overall Study||10||
60043586|NCT02296931|76159295|FG001|STARTED|Overall Study||24||
60043587|NCT02296931|76159294|FG000|COMPLETED|Overall Study||10||
60043588|NCT02296931|76159295|FG001|COMPLETED|Overall Study||22||
60043589|NCT02296931|76159294|FG000|NOT COMPLETED|Overall Study||0||
60043590|NCT02296931|76159295|FG001|NOT COMPLETED|Overall Study||2||
60043591|NCT02166697|76159301|FG000|STARTED|Overall Study||14151||
60043592|NCT02166697|76159301|FG000|COMPLETED|Overall Study||13804||
60043593|NCT02166697|76159301|FG000|NOT COMPLETED|Overall Study||347||
60043594|NCT01909479|76159307|FG000|STARTED|From Baseline to Week 26||135||
60043595|NCT01909479|76159308|FG001|STARTED|From Baseline to Week 26||67||
60043596|NCT01909479|76159307|FG000|COMPLETED|From Baseline to Week 26||129||
60043597|NCT01909479|76159308|FG001|COMPLETED|From Baseline to Week 26||58||
60043598|NCT01909479|76159307|FG000|NOT COMPLETED|From Baseline to Week 26||6||
60043599|NCT01909479|76159308|FG001|NOT COMPLETED|From Baseline to Week 26||9||
60043600|NCT01909479|76159307|FG000|STARTED|26 - 52 Weeks||128|One patient withdrew consent after completing Period 1|
60043601|NCT01909479|76159308|FG001|STARTED|26 - 52 Weeks||58|One patient withdrew consent after completing Period 1|
60043602|NCT01909479|76159307|FG000|COMPLETED|26 - 52 Weeks||125||
60043603|NCT01909479|76159308|FG001|COMPLETED|26 - 52 Weeks||56||
60043604|NCT01909479|76159307|FG000|NOT COMPLETED|26 - 52 Weeks||3||
60043605|NCT01909479|76159308|FG001|NOT COMPLETED|26 - 52 Weeks||2||
60043606|NCT01909479|76159307|FG000|STARTED|52 Weeks to End of Study|Not all of the participants that completed the previous period continued on in the study|111||
60043607|NCT01909479|76159308|FG001|STARTED|52 Weeks to End of Study|Not all of the participants that completed the previous period continued on in the study|50||
60043608|NCT01909479|76159307|FG000|COMPLETED|52 Weeks to End of Study||83||
60043609|NCT01909479|76159308|FG001|COMPLETED|52 Weeks to End of Study||35||
60043610|NCT01909479|76159307|FG000|NOT COMPLETED|52 Weeks to End of Study||28||
60043611|NCT01909479|76159308|FG001|NOT COMPLETED|52 Weeks to End of Study||15||
60043612|NCT01955733|76159321|FG000|STARTED|Period 1||33||
60043613|NCT01955733|76159322|FG001|STARTED|Period 1||29||
60043614|NCT01955733|76159323|FG002|STARTED|Period 1||29||
60043615|NCT01955733|76159321|FG000|COMPLETED|Period 1||32||
60043616|NCT01955733|76159322|FG001|COMPLETED|Period 1||29||
60043617|NCT01955733|76159323|FG002|COMPLETED|Period 1||29||
60043618|NCT01955733|76159321|FG000|NOT COMPLETED|Period 1||1||
60043619|NCT01955733|76159322|FG001|NOT COMPLETED|Period 1||0||
60043620|NCT01955733|76159323|FG002|NOT COMPLETED|Period 1||0||
60043621|NCT01955733|76159321|FG000|STARTED|Period 2||32||
60043622|NCT01955733|76159322|FG001|STARTED|Period 2||29||
60043623|NCT01955733|76159323|FG002|STARTED|Period 2||29||
60043624|NCT01955733|76159321|FG000|COMPLETED|Period 2||20||
60043625|NCT01955733|76159322|FG001|COMPLETED|Period 2||10||
60043626|NCT01955733|76159323|FG002|COMPLETED|Period 2||8||
60043627|NCT01955733|76159321|FG000|NOT COMPLETED|Period 2||12||
60043628|NCT01955733|76159322|FG001|NOT COMPLETED|Period 2||19||
60043629|NCT01955733|76159323|FG002|NOT COMPLETED|Period 2||21||
60043630|NCT02197897|76159331|FG000|STARTED|Overall Study||15||
60043631|NCT02197897|76159331|FG000|COMPLETED|Overall Study||14||
60043632|NCT02197897|76159331|FG000|NOT COMPLETED|Overall Study||1||
60043633|NCT02223793|76159338|FG000|STARTED|Overall Study||185||
60043634|NCT02223793|76159339|FG001|STARTED|Overall Study||199||
60043635|NCT02223793|76159340|FG002|STARTED|Overall Study||198||
60043636|NCT02223793|76159338|FG000|COMPLETED|Overall Study||168||
59759751|NCT00880191|75879170|FG001|NOT COMPLETED|Overall Study||8||
59759752|NCT00597519|75879176|FG000|STARTED|Overall Study||28||
59759753|NCT00597519|75879176|FG000|COMPLETED|Overall Study||27||
59919183|NCT03673462|76039614|FG001|STARTED|Overall Study||698||
59919184|NCT03673462|76039613|FG000|Safety Analysis Set (SafAS)|Overall Study||2080|Safety Analysis Set (SafAS) included all participants who had received at least one dose of the study vaccines and had any safety data available.|
59919185|NCT03673462|76039614|FG001|Safety Analysis Set (SafAS)|Overall Study||697|Safety Analysis Set (SafAS) included all participants who had received at least one dose of the study vaccines and had any safety data available.|
59919186|NCT03673462|76039613|FG000|Vaccinated at 2 Months|Overall Study||2080||
59919187|NCT03673462|76039614|FG001|Vaccinated at 2 Months|Overall Study||695||
60043637|NCT02223793|76159339|FG001|COMPLETED|Overall Study||190||
60043638|NCT02223793|76159340|FG002|COMPLETED|Overall Study||185||
60043639|NCT02223793|76159338|FG000|NOT COMPLETED|Overall Study||17||
60043640|NCT02223793|76159339|FG001|NOT COMPLETED|Overall Study||9||
60043641|NCT02223793|76159340|FG002|NOT COMPLETED|Overall Study||13||
60043642|NCT01926015|76159350|FG000|STARTED|Overall Study|Participants who passed all entry criteria and who were randomized into the study|96||
60043643|NCT01926015|76159351|FG001|STARTED|Overall Study|Participants who passed all entry criteria and who were randomized into the study|96||
60043644|NCT01926015|76159350|FG000|Received >=1 Vaccination|Overall Study||94||
60043645|NCT01926015|76159351|FG001|Received >=1 Vaccination|Overall Study||96||
60043646|NCT01926015|76159350|FG000|COMPLETED|Overall Study||94||
60043647|NCT01926015|76159351|FG001|COMPLETED|Overall Study||95||
60043648|NCT01926015|76159350|FG000|NOT COMPLETED|Overall Study||2||
60043649|NCT01926015|76159351|FG001|NOT COMPLETED|Overall Study||1||
60043650|NCT02223715|76159357|FG000|STARTED|Overall Study||600||
60043651|NCT02223715|76159357|FG000|COMPLETED|Overall Study||496||
60043652|NCT02223715|76159357|FG000|NOT COMPLETED|Overall Study||104||
60043653|NCT02196259|76159367|FG000|STARTED|Overall Study||3||
60043654|NCT02196259|76159368|FG001|STARTED|Overall Study||7||
60043655|NCT02196259|76159369|FG002|STARTED|Overall Study||3||
60043656|NCT02196259|76159367|FG000|COMPLETED|Overall Study||3||
60043657|NCT02196259|76159368|FG001|COMPLETED|Overall Study||4||
60043658|NCT02196259|76159369|FG002|COMPLETED|Overall Study||2||
60043659|NCT02196259|76159367|FG000|NOT COMPLETED|Overall Study||0||
60043660|NCT02196259|76159368|FG001|NOT COMPLETED|Overall Study||3||
60043661|NCT02196259|76159369|FG002|NOT COMPLETED|Overall Study||1||
60043662|NCT02294396|76159380|FG000|STARTED|Overall Study||167||
60043663|NCT02294396|76159381|FG001|STARTED|Overall Study||161||
60043664|NCT02294396|76159382|FG002|STARTED|Overall Study||161||
60043665|NCT02294396|76159383|FG003|STARTED|Overall Study||160||
60043666|NCT02294396|76159380|FG000|COMPLETED|Overall Study||127||
60043667|NCT02294396|76159381|FG001|COMPLETED|Overall Study||128||
60043668|NCT02294396|76159382|FG002|COMPLETED|Overall Study||126||
60043669|NCT02294396|76159383|FG003|COMPLETED|Overall Study||123||
60043670|NCT02294396|76159380|FG000|NOT COMPLETED|Overall Study||40||
60043671|NCT02294396|76159381|FG001|NOT COMPLETED|Overall Study||33||
60043672|NCT02294396|76159382|FG002|NOT COMPLETED|Overall Study||35||
60043673|NCT02294396|76159383|FG003|NOT COMPLETED|Overall Study||37||
60043674|NCT01721044|76159396|FG000|STARTED|Treatment Period||176||
60043675|NCT01721044|76159397|FG001|STARTED|Treatment Period|Randomized to 4mg (N=11) but received 2mg due to moderate renal impairment were included in 4mg arm|174||
60043676|NCT01721044|76159398|FG002|STARTED|Treatment Period||177||
60043677|NCT01721044|76159396|FG000|Rescue Week 16-24|Treatment Period||56||
60043678|NCT01721044|76159397|FG001|Rescue Week 16-24|Treatment Period||38||
60043679|NCT01721044|76159398|FG002|Rescue Week 16-24|Treatment Period||33||
60043680|NCT01721044|76159396|FG000|COMPLETED|Treatment Period||144||
60043681|NCT01721044|76159397|FG001|COMPLETED|Treatment Period||157||
60043682|NCT01721044|76159398|FG002|COMPLETED|Treatment Period||158||
60043683|NCT01721044|76159396|FG000|NOT COMPLETED|Treatment Period||32||
60043684|NCT01721044|76159397|FG001|NOT COMPLETED|Treatment Period||17||
60043685|NCT01721044|76159398|FG002|NOT COMPLETED|Treatment Period||19||
60043686|NCT01721044|76159396|FG000|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|19||
60043687|NCT01721044|76159397|FG001|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|9||
60043688|NCT01721044|76159398|FG002|STARTED|Follow Up|Participants from treatment and rescue who entered the post-treatment follow-up period.|20||
60043689|NCT01721044|76159396|FG000|COMPLETED|Follow Up||19||
60043690|NCT01721044|76159397|FG001|COMPLETED|Follow Up||9||
60043691|NCT01721044|76159398|FG002|COMPLETED|Follow Up||20||
60043692|NCT01721044|76159396|FG000|NOT COMPLETED|Follow Up||0||
60043693|NCT01721044|76159397|FG001|NOT COMPLETED|Follow Up||0||
60043694|NCT01721044|76159398|FG002|NOT COMPLETED|Follow Up||0||
60043695|NCT02164981|76159420|FG000|STARTED|Started||23||
60043696|NCT02164981|76159421|FG001|STARTED|Started||19||
60043697|NCT02164981|76159422|FG002|STARTED|Started||18||
60043698|NCT02164981|76159420|FG000|COMPLETED|Started||18|These subjects moved onto the Phase 1|
60043699|NCT02164981|76159421|FG001|COMPLETED|Started||16|These subjects moved onto the Phase 1|
60043700|NCT02164981|76159422|FG002|COMPLETED|Started||18|These subjects moved onto the Phase 1|
60043701|NCT02164981|76159420|FG000|NOT COMPLETED|Started||5||
60043702|NCT02164981|76159421|FG001|NOT COMPLETED|Started||3||
60043703|NCT02164981|76159422|FG002|NOT COMPLETED|Started||0||
60043704|NCT02164981|76159420|FG000|STARTED|Phase 1 (Day 0 - Day 14)||18||
60043705|NCT02164981|76159421|FG001|STARTED|Phase 1 (Day 0 - Day 14)||16||
60043706|NCT02164981|76159422|FG002|STARTED|Phase 1 (Day 0 - Day 14)||18||
60043707|NCT02164981|76159420|FG000|COMPLETED|Phase 1 (Day 0 - Day 14)||18||
60043708|NCT02164981|76159421|FG001|COMPLETED|Phase 1 (Day 0 - Day 14)||14||
60043709|NCT02164981|76159422|FG002|COMPLETED|Phase 1 (Day 0 - Day 14)||18||
60043710|NCT02164981|76159420|FG000|NOT COMPLETED|Phase 1 (Day 0 - Day 14)||0||
60043711|NCT02164981|76159421|FG001|NOT COMPLETED|Phase 1 (Day 0 - Day 14)||2||
60043712|NCT02164981|76159422|FG002|NOT COMPLETED|Phase 1 (Day 0 - Day 14)||0||
60043713|NCT02164981|76159420|FG000|STARTED|Phase 2 (Day 14 - Day 28)||18||
60043714|NCT02164981|76159421|FG001|STARTED|Phase 2 (Day 14 - Day 28)||14||
60043715|NCT02164981|76159422|FG002|STARTED|Phase 2 (Day 14 - Day 28)||18||
60043716|NCT02164981|76159420|FG000|COMPLETED|Phase 2 (Day 14 - Day 28)||16||
60043717|NCT02164981|76159421|FG001|COMPLETED|Phase 2 (Day 14 - Day 28)||12||
60043718|NCT02164981|76159422|FG002|COMPLETED|Phase 2 (Day 14 - Day 28)||18||
60043719|NCT02164981|76159420|FG000|NOT COMPLETED|Phase 2 (Day 14 - Day 28)||2||
60043720|NCT02164981|76159421|FG001|NOT COMPLETED|Phase 2 (Day 14 - Day 28)||2||
60043721|NCT02164981|76159422|FG002|NOT COMPLETED|Phase 2 (Day 14 - Day 28)||0||
60043722|NCT02195869|76159443|FG000|STARTED|Overall Study|Phase 1b: 6 patients, 420 mg, no DLT observed. Phase 2: 42 patients, 420 mg|42||
60043723|NCT02195869|76159443|FG000|All-Treated Population|Overall Study||42||
60043724|NCT02195869|76159443|FG000|COMPLETED|Overall Study||0||
60043725|NCT02195869|76159443|FG000|NOT COMPLETED|Overall Study||42||
60043726|NCT01908699|76159452|FG000|STARTED|Overall Study||137|Started = Randomized|
60043727|NCT01908699|76159453|FG001|STARTED|Overall Study||136|Started = Randomized|
60043728|NCT01908699|76159452|FG000|Received at Least 1 Dose of Study Drug|Overall Study||136||
60043729|NCT01908699|76159453|FG001|Received at Least 1 Dose of Study Drug|Overall Study||135||
60043730|NCT01908699|76159452|FG000|COMPLETED|Overall Study||62||
60043731|NCT01908699|76159453|FG001|COMPLETED|Overall Study||58||
60043732|NCT01908699|76159452|FG000|NOT COMPLETED|Overall Study||75||
60043733|NCT01908699|76159453|FG001|NOT COMPLETED|Overall Study||78||
60043734|NCT01599637|76159462|FG000|STARTED|Overall Study|" started indicates randomized safety, pharmacodynamics and pharmocokinetics set"|20||
60043735|NCT01599637|76159463|FG001|STARTED|Overall Study||10||
60043736|NCT01599637|76159464|FG002|STARTED|Overall Study||10||
60043737|NCT01599637|76159462|FG000|COMPLETED|Overall Study||19||
59511083|NCT00829049|75604655|FG001|STARTED|Overall Study||88||
59511084|NCT00829049|75604654|FG000|COMPLETED|Overall Study||60||
59511085|NCT00829049|75604655|FG001|COMPLETED|Overall Study||68||
59511086|NCT00829049|75604654|FG000|NOT COMPLETED|Overall Study||17||
59511087|NCT00829049|75604655|FG001|NOT COMPLETED|Overall Study||20||
59511088|NCT00868751|75604661|FG000|STARTED|Overall Study||1||
59511089|NCT00868751|75604661|FG000|COMPLETED|Overall Study||0||
59511090|NCT00868751|75604661|FG000|NOT COMPLETED|Overall Study||1||
59511091|NCT00913003|75604667|FG000|STARTED|Overall Study||11||
59511092|NCT00913003|75604668|FG001|STARTED|Overall Study||11||
59511093|NCT00913003|75604667|FG000|COMPLETED|Overall Study||11||
59511094|NCT00913003|75604668|FG001|COMPLETED|Overall Study||11||
59511095|NCT00913003|75604667|FG000|NOT COMPLETED|Overall Study||0||
59511096|NCT00913003|75604668|FG001|NOT COMPLETED|Overall Study||0||
59511097|NCT00869141|75604676|FG000|STARTED|Overall Study||26||
59511098|NCT00869141|75604677|FG001|STARTED|Overall Study||26||
59511099|NCT00869141|75604676|FG000|COMPLETED|Overall Study||26||
59511100|NCT00869141|75604677|FG001|COMPLETED|Overall Study||26||
59511101|NCT00869141|75604676|FG000|NOT COMPLETED|Overall Study||0||
59511102|NCT00869141|75604677|FG001|NOT COMPLETED|Overall Study||0||
59511103|NCT00829985|75604687|FG000|STARTED|Overall Study||28||
59511104|NCT00829985|75604688|FG001|STARTED|Overall Study||26||
59511105|NCT00829985|75604687|FG000|COMPLETED|Overall Study||19||
59511106|NCT00829985|75604688|FG001|COMPLETED|Overall Study||22||
59511107|NCT00829985|75604687|FG000|NOT COMPLETED|Overall Study||9||
59511108|NCT00829985|75604688|FG001|NOT COMPLETED|Overall Study||4||
59511109|NCT01606176|75604696|FG000|STARTED|Overall Study||36||
59511110|NCT01606176|75604697|FG001|STARTED|Overall Study||34||
59511111|NCT01606176|75604696|FG000|COMPLETED|Overall Study||32||
59511112|NCT01606176|75604697|FG001|COMPLETED|Overall Study||31||
59511113|NCT01606176|75604696|FG000|NOT COMPLETED|Overall Study||4||
59511114|NCT01606176|75604697|FG001|NOT COMPLETED|Overall Study||3||
59511115|NCT00913081|75604703|FG000|STARTED|Quercetin 500 mg + Niacin 500 mg (1day)||17||
59511116|NCT00913081|75604703|FG000|COMPLETED|Quercetin 500 mg + Niacin 500 mg (1day)||17||
59511117|NCT00913081|75604703|FG000|NOT COMPLETED|Quercetin 500 mg + Niacin 500 mg (1day)||0||
59511118|NCT00913081|75604703|FG000|STARTED|Washout #1 (7 Days)||17||
59511119|NCT00913081|75604703|FG000|COMPLETED|Washout #1 (7 Days)||17||
59511120|NCT00913081|75604703|FG000|NOT COMPLETED|Washout #1 (7 Days)||0||
59511121|NCT00913081|75604703|FG000|STARTED|Quercetin 1000 mg + Niacin 500 mg (1day)||17||
59511122|NCT00913081|75604703|FG000|COMPLETED|Quercetin 1000 mg + Niacin 500 mg (1day)||17||
59511123|NCT00913081|75604703|FG000|NOT COMPLETED|Quercetin 1000 mg + Niacin 500 mg (1day)||0||
59511124|NCT00913081|75604703|FG000|STARTED|Washout #2 (7 Days)||17||
59511125|NCT00913081|75604703|FG000|COMPLETED|Washout #2 (7 Days)||17||
59511126|NCT00913081|75604703|FG000|NOT COMPLETED|Washout #2 (7 Days)||0||
59511127|NCT00913081|75604703|FG000|STARTED|Quercetin 2000 mg + Niacin 500 mg (1day)||17||
59511128|NCT00913081|75604703|FG000|COMPLETED|Quercetin 2000 mg + Niacin 500 mg (1day)||17||
59612439|NCT01701258|75723508|FG009|COMPLETED|Drug+fMRI (Session 2)||6||
59511129|NCT00913081|75604703|FG000|NOT COMPLETED|Quercetin 2000 mg + Niacin 500 mg (1day)||0||
59612440|NCT01701258|75723509|FG010|COMPLETED|Drug+fMRI (Session 2)||0||
59612441|NCT01701258|75723510|FG011|COMPLETED|Drug+fMRI (Session 2)||10||
59511130|NCT00913081|75604703|FG000|STARTED|Washout #3 (7days)||17||
59511131|NCT00913081|75604703|FG000|COMPLETED|Washout #3 (7days)||17||
59511132|NCT00913081|75604703|FG000|NOT COMPLETED|Washout #3 (7days)||0||
59511133|NCT00913081|75604703|FG000|STARTED|Placebo + Niacin 500 mg (1day)||17||
59612442|NCT01701258|75723511|FG012|COMPLETED|Drug+fMRI (Session 2)||7||
60043738|NCT01599637|76159463|FG001|COMPLETED|Overall Study||8||
60043739|NCT01599637|76159464|FG002|COMPLETED|Overall Study||10||
60043740|NCT01599637|76159462|FG000|NOT COMPLETED|Overall Study||1||
60043741|NCT01599637|76159463|FG001|NOT COMPLETED|Overall Study||2||
60043742|NCT01599637|76159464|FG002|NOT COMPLETED|Overall Study||0||
60043743|NCT02264639|76159479|FG000|STARTED|Overall Study|Subjects in this arm participated in Cohort 1 only.|2||
59612443|NCT01701258|75723499|FG000|NOT COMPLETED|Drug+fMRI (Session 2)||0||
59511134|NCT00913081|75604703|FG000|COMPLETED|Placebo + Niacin 500 mg (1day)||17||
59511135|NCT00913081|75604703|FG000|NOT COMPLETED|Placebo + Niacin 500 mg (1day)||0||
59511136|NCT04077424|75604716|FG000|STARTED|Overall Study||2||
59511137|NCT04077424|75604717|FG001|STARTED|Overall Study||2||
59511138|NCT04077424|75604718|FG002|STARTED|Overall Study||6||
59919188|NCT03673462|76039613|FG000|Vaccinated at 4 Months|Overall Study||2005||
59919189|NCT03673462|76039614|FG001|Vaccinated at 4 Months|Overall Study||663||
60043744|NCT02264639|76159480|FG001|STARTED|Overall Study|Subject in this arm participated in Cohort 2 only.|1||
60043745|NCT02264639|76159481|FG002|STARTED|Overall Study|Subject in this arm participated in Cohorts 2, 3 and 4.|1||
60043746|NCT02264639|76159482|FG003|STARTED|Overall Study|Subject in this arm participated in Cohorts 3 and 4; single-dose phase was not applicable.|1||
60043747|NCT02264639|76159483|FG004|STARTED|Overall Study|Subjects in this arm participated in Cohort 4 only; single-dose phase was not applicable.|4||
60043748|NCT02264639|76159479|FG000|COMPLETED|Overall Study||0|Completed the study (with reference to the last cohort in which a subject participated).|
60043749|NCT02264639|76159480|FG001|COMPLETED|Overall Study||1|Completed the study (with reference to the last cohort in which a subject participated).|
60043750|NCT02264639|76159481|FG002|COMPLETED|Overall Study||0|Completed the study (with reference to the last cohort in which a subject participated).|
60043751|NCT02264639|76159482|FG003|COMPLETED|Overall Study||1|Completed the study (with reference to the last cohort in which a subject participated).|
60043752|NCT02264639|76159483|FG004|COMPLETED|Overall Study||3|Completed the study (with reference to the last cohort in which a subject participated).|
59511139|NCT04077424|75604716|FG000|COMPLETED|Overall Study||2||
59511140|NCT04077424|75604717|FG001|COMPLETED|Overall Study||2||
59511141|NCT04077424|75604718|FG002|COMPLETED|Overall Study||6||
59511142|NCT04077424|75604716|FG000|NOT COMPLETED|Overall Study||0||
59511143|NCT04077424|75604717|FG001|NOT COMPLETED|Overall Study||0||
59919190|NCT03673462|76039613|FG000|Vaccinated at 6 Months|Overall Study||1951||
59919191|NCT03673462|76039614|FG001|Vaccinated at 6 Months|Overall Study||648||
59919192|NCT03673462|76039613|FG000|Vaccinated at 12 Months|Overall Study||1838||
59919193|NCT03673462|76039614|FG001|Vaccinated at 12 Months|Overall Study||623||
59919194|NCT03673462|76039613|FG000|COMPLETED|Overall Study||1799||
59919195|NCT03673462|76039614|FG001|COMPLETED|Overall Study||611||
59919196|NCT03673462|76039613|FG000|NOT COMPLETED|Overall Study||300||
59919197|NCT03673462|76039614|FG001|NOT COMPLETED|Overall Study||87||
59919198|NCT03432364|76039623|FG000|STARTED|Primary (ST-400 Infusion up to Week 52 )||5||
59919199|NCT03432364|76039623|FG000|COMPLETED|Primary (ST-400 Infusion up to Week 52 )||5||
59919200|NCT03432364|76039623|FG000|NOT COMPLETED|Primary (ST-400 Infusion up to Week 52 )||0||
59919201|NCT03432364|76039623|FG000|STARTED|Follow Up (Weeks 52-156 Post Infusion)||5||
59919202|NCT03432364|76039623|FG000|COMPLETED|Follow Up (Weeks 52-156 Post Infusion)||4||
59919203|NCT03432364|76039623|FG000|NOT COMPLETED|Follow Up (Weeks 52-156 Post Infusion)||1||
59919204|NCT03307785|76039639|FG000|STARTED|Part A: Up to 28.5 Months||16||
59919205|NCT03307785|76039640|FG001|STARTED|Part A: Up to 28.5 Months||6||
59919206|NCT03307785|76039641|FG002|STARTED|Part A: Up to 28.5 Months||0||
59919207|NCT03307785|76039642|FG003|STARTED|Part A: Up to 28.5 Months||0||
59919208|NCT03307785|76039643|FG004|STARTED|Part A: Up to 28.5 Months||0||
59919209|NCT03307785|76039644|FG005|STARTED|Part A: Up to 28.5 Months||0||
59919210|NCT03307785|76039645|FG006|STARTED|Part A: Up to 28.5 Months||0||
59919211|NCT03307785|76039646|FG007|STARTED|Part A: Up to 28.5 Months||0||
59919212|NCT03307785|76039647|FG008|STARTED|Part A: Up to 28.5 Months||0||
59919213|NCT03307785|76039648|FG009|STARTED|Part A: Up to 28.5 Months||0||
59919214|NCT03307785|76039649|FG010|STARTED|Part A: Up to 28.5 Months||0||
59919215|NCT03307785|76039639|FG000|COMPLETED|Part A: Up to 28.5 Months||0||
59919216|NCT03307785|76039640|FG001|COMPLETED|Part A: Up to 28.5 Months||0||
59919217|NCT03307785|76039641|FG002|COMPLETED|Part A: Up to 28.5 Months||0||
59919218|NCT03307785|76039642|FG003|COMPLETED|Part A: Up to 28.5 Months||0||
59919219|NCT03307785|76039643|FG004|COMPLETED|Part A: Up to 28.5 Months||0||
59919220|NCT03307785|76039644|FG005|COMPLETED|Part A: Up to 28.5 Months||0||
59919221|NCT03307785|76039645|FG006|COMPLETED|Part A: Up to 28.5 Months||0||
59919222|NCT03307785|76039646|FG007|COMPLETED|Part A: Up to 28.5 Months||0||
59919223|NCT03307785|76039647|FG008|COMPLETED|Part A: Up to 28.5 Months||0||
59919224|NCT03307785|76039648|FG009|COMPLETED|Part A: Up to 28.5 Months||0||
59919225|NCT03307785|76039649|FG010|COMPLETED|Part A: Up to 28.5 Months||0||
59919226|NCT03307785|76039639|FG000|NOT COMPLETED|Part A: Up to 28.5 Months||16||
59919227|NCT03307785|76039640|FG001|NOT COMPLETED|Part A: Up to 28.5 Months||6||
59919228|NCT03307785|76039641|FG002|NOT COMPLETED|Part A: Up to 28.5 Months||0||
59919229|NCT03307785|76039642|FG003|NOT COMPLETED|Part A: Up to 28.5 Months||0||
59919230|NCT03307785|76039643|FG004|NOT COMPLETED|Part A: Up to 28.5 Months||0||
59919231|NCT03307785|76039644|FG005|NOT COMPLETED|Part A: Up to 28.5 Months||0||
59919232|NCT03307785|76039645|FG006|NOT COMPLETED|Part A: Up to 28.5 Months||0||
59511144|NCT04077424|75604718|FG002|NOT COMPLETED|Overall Study||0||
59511145|NCT00869375|75604728|FG000|STARTED|Overall Study||3||
59919233|NCT03307785|76039646|FG007|NOT COMPLETED|Part A: Up to 28.5 Months||0||
59511146|NCT00869375|75604729|FG001|STARTED|Overall Study||3||
59511147|NCT00869375|75604728|FG000|COMPLETED|Overall Study||3||
59511148|NCT00869375|75604729|FG001|COMPLETED|Overall Study||3||
59511149|NCT00869375|75604728|FG000|NOT COMPLETED|Overall Study||0||
60043753|NCT02264639|76159479|FG000|NOT COMPLETED|Overall Study||2||
60043754|NCT02264639|76159480|FG001|NOT COMPLETED|Overall Study||0||
60043755|NCT02264639|76159481|FG002|NOT COMPLETED|Overall Study||1||
60043756|NCT02264639|76159482|FG003|NOT COMPLETED|Overall Study||0||
60043757|NCT02264639|76159483|FG004|NOT COMPLETED|Overall Study||1||
60043758|NCT01363011|76159500|FG000|STARTED|Main Study||33||
60043759|NCT01363011|76159501|FG001|STARTED|Main Study||73||
60043760|NCT01363011|76159500|FG000|COMPLETED|Main Study||29||
60043761|NCT01363011|76159501|FG001|COMPLETED|Main Study||64||
60043762|NCT01363011|76159500|FG000|NOT COMPLETED|Main Study||4||
60043763|NCT01363011|76159501|FG001|NOT COMPLETED|Main Study||9||
60043764|NCT01363011|76159500|FG000|STARTED|Extension Phase|11 participants who completed the main study did not enroll into the extension phase.|18||
60043765|NCT01363011|76159501|FG001|STARTED|Extension Phase|15 participants who completed the main study did not enroll into the extension phase.|49||
60043766|NCT01363011|76159500|FG000|COMPLETED|Extension Phase||13||
60043767|NCT01363011|76159501|FG001|COMPLETED|Extension Phase||41||
60043768|NCT01363011|76159500|FG000|NOT COMPLETED|Extension Phase||5||
60043769|NCT01363011|76159501|FG001|NOT COMPLETED|Extension Phase||8||
60043770|NCT02263547|76159507|FG000|STARTED|Overall Study||14||
60043771|NCT02263547|76159507|FG000|COMPLETED|Overall Study||11||
60043772|NCT02263547|76159507|FG000|NOT COMPLETED|Overall Study||3||
60043773|NCT01925703|76159511|FG000|STARTED|Overall Study||13||
60043774|NCT01925703|76159511|FG000|Dosing Regimen Completed|Overall Study||12||
60043775|NCT01925703|76159511|FG000|Full Iron Repletion Achieved|Overall Study||11||
60043776|NCT01925703|76159511|FG000|Follow-up Completed|Overall Study||9||
60043777|NCT01925703|76159511|FG000|COMPLETED|Overall Study||9||
60043778|NCT01925703|76159511|FG000|NOT COMPLETED|Overall Study||4||
60043779|NCT01617681|76159519|FG000|STARTED|Period 1 Double Blind||32||
60043780|NCT01617681|76159520|FG001|STARTED|Period 1 Double Blind||31||
60043781|NCT01617681|76159521|FG002|STARTED|Period 1 Double Blind||33||
60043782|NCT01617681|76159522|FG003|STARTED|Period 1 Double Blind||31||
60043783|NCT01617681|76159523|FG004|STARTED|Period 1 Double Blind||0||
60043784|NCT01617681|76159519|FG000|Full Analysis Set (FAS)|Period 1 Double Blind||31||
60043785|NCT01617681|76159520|FG001|Full Analysis Set (FAS)|Period 1 Double Blind||31||
60043786|NCT01617681|76159521|FG002|Full Analysis Set (FAS)|Period 1 Double Blind||33||
60043787|NCT01617681|76159522|FG003|Full Analysis Set (FAS)|Period 1 Double Blind||31||
60043788|NCT01617681|76159523|FG004|Full Analysis Set (FAS)|Period 1 Double Blind||0||
60043789|NCT01617681|76159519|FG000|COMPLETED|Period 1 Double Blind||29||
60043790|NCT01617681|76159520|FG001|COMPLETED|Period 1 Double Blind||30||
60043791|NCT01617681|76159521|FG002|COMPLETED|Period 1 Double Blind||32||
60043792|NCT01617681|76159522|FG003|COMPLETED|Period 1 Double Blind||29||
60043793|NCT01617681|76159523|FG004|COMPLETED|Period 1 Double Blind||0||
60043794|NCT01617681|76159519|FG000|NOT COMPLETED|Period 1 Double Blind||3||
60043795|NCT01617681|76159520|FG001|NOT COMPLETED|Period 1 Double Blind||1||
60043796|NCT01617681|76159521|FG002|NOT COMPLETED|Period 1 Double Blind||1||
60043797|NCT01617681|76159522|FG003|NOT COMPLETED|Period 1 Double Blind||2||
60043798|NCT01617681|76159523|FG004|NOT COMPLETED|Period 1 Double Blind||0||
60043799|NCT01617681|76159519|FG000|STARTED|Period 2 Open Label||0||
60043800|NCT01617681|76159520|FG001|STARTED|Period 2 Open Label||0||
60043801|NCT01617681|76159521|FG002|STARTED|Period 2 Open Label||0||
60043802|NCT01617681|76159522|FG003|STARTED|Period 2 Open Label||0||
60043803|NCT01617681|76159523|FG004|STARTED|Period 2 Open Label||120||
60043804|NCT01617681|76159519|FG000|COMPLETED|Period 2 Open Label||0||
60043805|NCT01617681|76159520|FG001|COMPLETED|Period 2 Open Label||0||
60043806|NCT01617681|76159521|FG002|COMPLETED|Period 2 Open Label||0||
60043807|NCT01617681|76159522|FG003|COMPLETED|Period 2 Open Label||0||
60043808|NCT01617681|76159523|FG004|COMPLETED|Period 2 Open Label||114||
60043809|NCT01617681|76159519|FG000|NOT COMPLETED|Period 2 Open Label||0||
60043810|NCT01617681|76159520|FG001|NOT COMPLETED|Period 2 Open Label||0||
60043811|NCT01617681|76159521|FG002|NOT COMPLETED|Period 2 Open Label||0||
60043812|NCT01617681|76159522|FG003|NOT COMPLETED|Period 2 Open Label||0||
60043813|NCT01617681|76159523|FG004|NOT COMPLETED|Period 2 Open Label||6||
60043814|NCT02263079|76159535|FG000|STARTED|Overall Study||26||
60043815|NCT02263079|76159536|FG001|STARTED|Overall Study||33||
60043816|NCT02263079|76159537|FG002|STARTED|Overall Study||3||
60043817|NCT02263079|76159535|FG000|COMPLETED|Overall Study||23||
60043818|NCT02263079|76159536|FG001|COMPLETED|Overall Study||25||
60043819|NCT02263079|76159537|FG002|COMPLETED|Overall Study|Completed study but not included in the analysis|3||
60043820|NCT02263079|76159535|FG000|NOT COMPLETED|Overall Study||3||
60043821|NCT02263079|76159536|FG001|NOT COMPLETED|Overall Study||8||
60043822|NCT02263079|76159537|FG002|NOT COMPLETED|Overall Study||0||
60043823|NCT02295995|76159547|FG000|STARTED|Overall Study||36||
60043824|NCT02295995|76159548|FG001|STARTED|Overall Study||18||
60043825|NCT02295995|76159547|FG000|COMPLETED|Overall Study||31||
60043826|NCT02295995|76159548|FG001|COMPLETED|Overall Study||17||
60043827|NCT02295995|76159547|FG000|NOT COMPLETED|Overall Study||5||
60043828|NCT02295995|76159548|FG001|NOT COMPLETED|Overall Study||1||
60043829|NCT02294981|76159555|FG000|STARTED|Overall Study||4||
60043830|NCT02294981|76159555|FG000|COMPLETED|Overall Study||3||
60043831|NCT02294981|76159555|FG000|NOT COMPLETED|Overall Study||1||
60043832|NCT02262377|76159561|FG000|STARTED|Overall Study||80||
60043833|NCT02262377|76159562|FG001|STARTED|Overall Study||79||
60043834|NCT02262377|76159561|FG000|COMPLETED|Overall Study||68||
60043835|NCT02262377|76159562|FG001|COMPLETED|Overall Study||73||
60043836|NCT02262377|76159561|FG000|NOT COMPLETED|Overall Study||12||
60043837|NCT02262377|76159562|FG001|NOT COMPLETED|Overall Study||6||
60043838|NCT02260817|76159571|FG000|STARTED|Overall Study||14||
60043839|NCT02260817|76159572|FG001|STARTED|Overall Study||95||
60043840|NCT02260817|76159571|FG000|COMPLETED|Overall Study||14||
60043841|NCT02260817|76159572|FG001|COMPLETED|Overall Study||58||
60043842|NCT02260817|76159571|FG000|NOT COMPLETED|Overall Study||0||
60043843|NCT02260817|76159572|FG001|NOT COMPLETED|Overall Study||37||
60043844|NCT01642589|76159580|FG000|STARTED|Overall Study||200||
60043845|NCT01642589|76159581|FG001|STARTED|Overall Study||100||
60043846|NCT01642589|76159580|FG000|COMPLETED|Overall Study||199||
60043847|NCT01642589|76159581|FG001|COMPLETED|Overall Study||99||
60043848|NCT01642589|76159580|FG000|NOT COMPLETED|Overall Study||1||
60043849|NCT01642589|76159581|FG001|NOT COMPLETED|Overall Study||1||
60043850|NCT02268812|76159591|FG000|STARTED|Overall Study||77||
60043851|NCT02268812|76159592|FG001|STARTED|Overall Study||72||
60043852|NCT02268812|76159593|FG002|STARTED|Overall Study||30||
60043853|NCT02268812|76159594|FG003|STARTED|Overall Study||40||
60043854|NCT02268812|76159591|FG000|COMPLETED|Overall Study||61||
60043855|NCT02268812|76159592|FG001|COMPLETED|Overall Study||40||
60043856|NCT02268812|76159593|FG002|COMPLETED|Overall Study||21||
60043857|NCT02268812|76159594|FG003|COMPLETED|Overall Study||26||
60043858|NCT02268812|76159591|FG000|NOT COMPLETED|Overall Study||16||
60043859|NCT02268812|76159592|FG001|NOT COMPLETED|Overall Study||32||
60043860|NCT02268812|76159593|FG002|NOT COMPLETED|Overall Study||9||
60043861|NCT02268812|76159594|FG003|NOT COMPLETED|Overall Study||14||
60043862|NCT01954251|76159606|FG000|STARTED|Overall Study||413||
60043863|NCT01954251|76159607|FG001|STARTED|Overall Study||415||
60043864|NCT01954251|76159606|FG000|COMPLETED|Overall Study||400||
60043865|NCT01954251|76159607|FG001|COMPLETED|Overall Study||396||
60043866|NCT01954251|76159606|FG000|NOT COMPLETED|Overall Study||13||
60043867|NCT01954251|76159607|FG001|NOT COMPLETED|Overall Study||19||
60043868|NCT01644617|76159617|FG000|STARTED|Overall Study||42||
60043869|NCT01644617|76159618|FG001|STARTED|Overall Study||41||
60043870|NCT01644617|76159619|FG002|STARTED|Overall Study||41||
60043871|NCT01644617|76159617|FG000|COMPLETED|Overall Study||36||
60043872|NCT01644617|76159618|FG001|COMPLETED|Overall Study||36||
60043873|NCT01644617|76159619|FG002|COMPLETED|Overall Study||34||
60043874|NCT01644617|76159617|FG000|NOT COMPLETED|Overall Study||6||
60043875|NCT01644617|76159618|FG001|NOT COMPLETED|Overall Study||5||
60043876|NCT01644617|76159619|FG002|NOT COMPLETED|Overall Study||7||
60043877|NCT02294318|76159629|FG000|STARTED|Overall Study||24||
60043878|NCT02294318|76159630|FG001|STARTED|Overall Study||23||
60043879|NCT02294318|76159629|FG000|COMPLETED|Overall Study||21||
60043880|NCT02294318|76159630|FG001|COMPLETED|Overall Study||21||
60043881|NCT02294318|76159629|FG000|NOT COMPLETED|Overall Study||3||
60043882|NCT02294318|76159630|FG001|NOT COMPLETED|Overall Study||2||
60043883|NCT02293499|76159639|FG000|STARTED|Baseline - Enrollment||152||
60043884|NCT02293499|76159640|FG001|STARTED|Baseline - Enrollment||168||
60043885|NCT02293499|76159641|FG002|STARTED|Baseline - Enrollment||51||
60043886|NCT02293499|76159639|FG000|COMPLETED|Baseline - Enrollment||152||
60043887|NCT02293499|76159640|FG001|COMPLETED|Baseline - Enrollment||168||
60043888|NCT02293499|76159641|FG002|COMPLETED|Baseline - Enrollment||51||
60043889|NCT02293499|76159639|FG000|NOT COMPLETED|Baseline - Enrollment||0||
60043890|NCT02293499|76159640|FG001|NOT COMPLETED|Baseline - Enrollment||0||
60043891|NCT02293499|76159641|FG002|NOT COMPLETED|Baseline - Enrollment||0||
60043892|NCT02293499|76159639|FG000|STARTED|Training - Peer Leaders Only|Participant number carried over from previous time point.|0|Only the Peer leader arm of this study participated in this time point by study design.|
60043893|NCT02293499|76159640|FG001|STARTED|Training - Peer Leaders Only|Participant number carried over from previous time point.|0|Only the Peer leader arm of this study participated in this time point by study design.|
60043894|NCT02293499|76159641|FG002|STARTED|Training - Peer Leaders Only||51|Only the Peer leader arm of this study participated in this time point by study design.|
60043895|NCT02293499|76159639|FG000|COMPLETED|Training - Peer Leaders Only||0||
60043896|NCT02293499|76159640|FG001|COMPLETED|Training - Peer Leaders Only||0||
60043897|NCT02293499|76159641|FG002|COMPLETED|Training - Peer Leaders Only||41||
60043898|NCT02293499|76159639|FG000|NOT COMPLETED|Training - Peer Leaders Only||0||
60043899|NCT02293499|76159640|FG001|NOT COMPLETED|Training - Peer Leaders Only||0||
60043900|NCT02293499|76159641|FG002|NOT COMPLETED|Training - Peer Leaders Only||10||
60043901|NCT02293499|76159639|FG000|STARTED|Intervention - Camp|By design, they did not participate in the previous period.|152||
59511150|NCT00869375|75604729|FG001|NOT COMPLETED|Overall Study||0||
60043902|NCT02293499|76159640|FG001|STARTED|Intervention - Camp|By design, they did not participate in the previous period.|168||
60043903|NCT02293499|76159641|FG002|STARTED|Intervention - Camp||41||
60043904|NCT02293499|76159639|FG000|COMPLETED|Intervention - Camp||125||
60043905|NCT02293499|76159640|FG001|COMPLETED|Intervention - Camp||134||
60043906|NCT02293499|76159641|FG002|COMPLETED|Intervention - Camp||35||
60043907|NCT02293499|76159639|FG000|NOT COMPLETED|Intervention - Camp||27||
60043908|NCT02293499|76159640|FG001|NOT COMPLETED|Intervention - Camp||34||
60043909|NCT02293499|76159641|FG002|NOT COMPLETED|Intervention - Camp||6||
59511151|NCT00869609|75604739|FG000|STARTED|Overall Study||31||
59511152|NCT00869609|75604740|FG001|STARTED|Overall Study||29||
59511153|NCT00869609|75604739|FG000|COMPLETED|Overall Study||25||
59511154|NCT00869609|75604740|FG001|COMPLETED|Overall Study||26||
59511155|NCT00869609|75604739|FG000|NOT COMPLETED|Overall Study||6||
59511156|NCT00869609|75604740|FG001|NOT COMPLETED|Overall Study||3||
59511157|NCT01603368|75604748|FG000|STARTED|Overall Study||68||
59511158|NCT01603368|75604749|FG001|STARTED|Overall Study||66||
59511159|NCT01603368|75604748|FG000|COMPLETED|Overall Study||68||
59511160|NCT01603368|75604749|FG001|COMPLETED|Overall Study||66||
59511161|NCT01603368|75604748|FG000|NOT COMPLETED|Overall Study||0||
59511162|NCT01603368|75604749|FG001|NOT COMPLETED|Overall Study||0||
59511163|NCT00832637|75604755|FG000|STARTED|Overall Study||33||
59511164|NCT00832637|75604755|FG000|COMPLETED|Overall Study||33||
59511165|NCT00832637|75604755|FG000|NOT COMPLETED|Overall Study||0||
59511166|NCT00918229|75604759|FG000|STARTED|Overall Study||24||
59511167|NCT00918229|75604759|FG000|COMPLETED|Overall Study||24||
59511168|NCT00918229|75604759|FG000|NOT COMPLETED|Overall Study||0||
59511169|NCT01663896|75604763|FG000|STARTED|Overall Study||418||
59511170|NCT01663896|75604763|FG000|COMPLETED|Overall Study||375||
59511171|NCT01663896|75604763|FG000|NOT COMPLETED|Overall Study||43||
59511172|NCT00915655|75604768|FG000|STARTED|Overall Study||12||
59511173|NCT00915655|75604768|FG000|COMPLETED|Overall Study|'Completed' represents patients who have not discontinued at time of cut-off for Week 24 analysis|12||
59511174|NCT00915655|75604768|FG000|NOT COMPLETED|Overall Study||0||
59511175|NCT00870467|75604774|FG000|STARTED|Double-blind||171||
59511176|NCT00870467|75604775|FG001|STARTED|Double-blind||163||
59511177|NCT00870467|75604776|FG002|STARTED|Double-blind||0||
59511178|NCT00870467|75604777|FG003|STARTED|Double-blind||0||
59511179|NCT00870467|75604778|FG004|STARTED|Double-blind||0||
59511180|NCT00870467|75604779|FG005|STARTED|Double-blind||0||
59511181|NCT00870467|75604774|FG000|COMPLETED|Double-blind|10 participants who completed 26 weeks received open-label adalimumab 40 mg eow as rescue therapy|155||
59511182|NCT00870467|75604775|FG001|COMPLETED|Double-blind|24 participants who completed 26 weeks received open-label adalimumab 40 mg eow as rescue therapy|151||
59511183|NCT00870467|75604776|FG002|COMPLETED|Double-blind||0||
59511184|NCT00870467|75604777|FG003|COMPLETED|Double-blind||0||
59511185|NCT00870467|75604778|FG004|COMPLETED|Double-blind||0||
59511186|NCT00870467|75604779|FG005|COMPLETED|Double-blind||0||
59511187|NCT00870467|75604774|FG000|NOT COMPLETED|Double-blind||16||
59511188|NCT00870467|75604775|FG001|NOT COMPLETED|Double-blind||12||
59511189|NCT00870467|75604776|FG002|NOT COMPLETED|Double-blind||0||
59511190|NCT00870467|75604777|FG003|NOT COMPLETED|Double-blind||0||
59511191|NCT00870467|75604778|FG004|NOT COMPLETED|Double-blind||0||
59511192|NCT00870467|75604779|FG005|NOT COMPLETED|Double-blind||0||
59511193|NCT00870467|75604774|FG000|STARTED|Open-label||0||
60043910|NCT02293499|76159639|FG000|STARTED|3 Month Follow Up||149||
60043911|NCT02293499|76159640|FG001|STARTED|3 Month Follow Up||162||
60043912|NCT02293499|76159641|FG002|STARTED|3 Month Follow Up||39||
60043913|NCT02293499|76159639|FG000|COMPLETED|3 Month Follow Up||134||
60043914|NCT02293499|76159640|FG001|COMPLETED|3 Month Follow Up||147||
60043915|NCT02293499|76159641|FG002|COMPLETED|3 Month Follow Up||29||
60043916|NCT02293499|76159639|FG000|NOT COMPLETED|3 Month Follow Up||15||
60043917|NCT02293499|76159640|FG001|NOT COMPLETED|3 Month Follow Up||15||
59511194|NCT00870467|75604775|FG001|STARTED|Open-label||0||
59511195|NCT00870467|75604776|FG002|STARTED|Open-label||145||
59511196|NCT00870467|75604777|FG003|STARTED|Open-label||127||
59511197|NCT00870467|75604778|FG004|STARTED|Open-label||10||
59511198|NCT00870467|75604779|FG005|STARTED|Open-label||24||
59511199|NCT00870467|75604774|FG000|COMPLETED|Open-label||0||
59511200|NCT00870467|75604775|FG001|COMPLETED|Open-label||0||
59511201|NCT00870467|75604776|FG002|COMPLETED|Open-label||132||
59511202|NCT00870467|75604777|FG003|COMPLETED|Open-label||120||
59511203|NCT00870467|75604778|FG004|COMPLETED|Open-label||5||
59511204|NCT00870467|75604779|FG005|COMPLETED|Open-label||21||
59511205|NCT00870467|75604774|FG000|NOT COMPLETED|Open-label||0||
59511206|NCT00870467|75604775|FG001|NOT COMPLETED|Open-label||0||
59511207|NCT00870467|75604776|FG002|NOT COMPLETED|Open-label||13||
59511208|NCT00870467|75604777|FG003|NOT COMPLETED|Open-label||7||
59511209|NCT00870467|75604778|FG004|NOT COMPLETED|Open-label||5||
60043918|NCT02293499|76159641|FG002|NOT COMPLETED|3 Month Follow Up||10||
60043919|NCT02293499|76159639|FG000|STARTED|6 Month Follow Up||148||
59511210|NCT00870467|75604779|FG005|NOT COMPLETED|Open-label||3||
59511211|NCT05209932|75604793|FG000|STARTED|Overall Study|Study participation began February 15th for both treatment group and waitlist control. We had rolling treatment groups and rolling control groups (each Friday for 4 weeks we started a new group). We then put off starting any more cohorts late March (2020) when COVID started getting bad. We did rolling posttests too for each cohort. The waitlist control groups were given access to the program approx. 15 weeks after their cohort started. We finished data collection August 31, 2021.|140||
60043920|NCT02293499|76159640|FG001|STARTED|6 Month Follow Up||162||
60043921|NCT02293499|76159641|FG002|STARTED|6 Month Follow Up||35||
60043922|NCT02293499|76159639|FG000|COMPLETED|6 Month Follow Up||131||
59511212|NCT05209932|75604794|FG001|STARTED|Overall Study|Study participation began February 15th for both treatment group and waitlist control. We had rolling treatment groups and rolling control groups (each Friday for 4 weeks we started a new group). We delayed starting new cohorts when COVID started getting bad. We did rolling posttests too for each cohort. The waitlist control groups were given access to the program approx. 15 weeks after their cohort started. Data collection completed August 31, 2021.|93||
59511213|NCT05209932|75604793|FG000|Completed All or Partial Units|Overall Study|Completed 10 units - 42.0% (N=34) Completed 5-9 units - 8.6% (N=7) Completed 1-4 units- 19.8% (N=16) Completed 0 units - 29.6% (N=24)|57||
59511214|NCT05209932|75604794|FG001|Completed All or Partial Units|Overall Study|Completed 10 units- NA Completed 5-9 units -NA Completed 1-4 units- NA Completed 0 units - NA|93||
59511215|NCT05209932|75604793|FG000|COMPLETED|Overall Study|N= 81 parents and N=59 children|140||
59511216|NCT05209932|75604794|FG001|COMPLETED|Overall Study|N = 50 parents and N = 43 children|93||
59511217|NCT05209932|75604793|FG000|NOT COMPLETED|Overall Study||0||
59511218|NCT05209932|75604794|FG001|NOT COMPLETED|Overall Study||0||
59511219|NCT00870545|75604803|FG000|STARTED|Overall Study||86||
59511220|NCT00870545|75604803|FG000|COMPLETED|Overall Study||69||
59511221|NCT00870545|75604803|FG000|NOT COMPLETED|Overall Study||17||
59511222|NCT00872027|75604809|FG000|STARTED|Overall Study||7||
59511223|NCT00872027|75604810|FG001|STARTED|Overall Study||8||
59511224|NCT00872027|75604809|FG000|COMPLETED|Overall Study||7||
59511225|NCT00872027|75604810|FG001|COMPLETED|Overall Study||8||
59511226|NCT00872027|75604809|FG000|NOT COMPLETED|Overall Study||0||
59511227|NCT00872027|75604810|FG001|NOT COMPLETED|Overall Study||0||
59511228|NCT02576652|75604816|FG000|STARTED|Overall Study||6||
59511229|NCT02576652|75604816|FG000|COMPLETED|Overall Study||4||
59511230|NCT02576652|75604816|FG000|NOT COMPLETED|Overall Study||2||
59511231|NCT00872339|75604823|FG000|STARTED|Overall Study||201||
59511232|NCT00872339|75604824|FG001|STARTED|Overall Study||14||
59511233|NCT00872339|75604825|FG002|STARTED|Overall Study||37||
59511234|NCT00872339|75604823|FG000|COMPLETED|Overall Study||201||
59511235|NCT00872339|75604824|FG001|COMPLETED|Overall Study||14||
59511236|NCT00872339|75604825|FG002|COMPLETED|Overall Study||37||
59511237|NCT00872339|75604823|FG000|NOT COMPLETED|Overall Study||0||
59511238|NCT00872339|75604824|FG001|NOT COMPLETED|Overall Study||0||
59511239|NCT00872339|75604825|FG002|NOT COMPLETED|Overall Study||0||
59511240|NCT00872729|75604833|FG000|STARTED|Overall Study||9||
59511241|NCT00872729|75604833|FG000|COMPLETED|Overall Study||9||
59511242|NCT00872729|75604833|FG000|NOT COMPLETED|Overall Study||0||
59511243|NCT00832871|75604859|FG000|STARTED|Overall Study||4||
59511244|NCT00832871|75604859|FG000|COMPLETED|Overall Study||4||
59511245|NCT00832871|75604859|FG000|NOT COMPLETED|Overall Study||0||
59511246|NCT03070600|75604865|FG000|STARTED|Overall Study||2250||
59511247|NCT03070600|75604866|FG001|STARTED|Overall Study||2197||
59511248|NCT03070600|75604865|FG000|COMPLETED|Overall Study||2156||
59511249|NCT03070600|75604866|FG001|COMPLETED|Overall Study||2032||
59511250|NCT03070600|75604865|FG000|NOT COMPLETED|Overall Study||94||
59511251|NCT03070600|75604866|FG001|NOT COMPLETED|Overall Study||165||
59511252|NCT00873821|75604880|FG000|STARTED|Overall Study||22||
59511253|NCT00873821|75604881|FG001|STARTED|Overall Study||22||
59511254|NCT00873821|75604880|FG000|COMPLETED|Overall Study||22||
59511255|NCT00873821|75604881|FG001|COMPLETED|Overall Study||22||
59511256|NCT00873821|75604880|FG000|NOT COMPLETED|Overall Study||0||
59511257|NCT00873821|75604881|FG001|NOT COMPLETED|Overall Study||0||
59511258|NCT00212134|75604889|FG000|STARTED|Phase 1 (to Age 1 Year)||57||
59511259|NCT00212134|75604890|FG001|STARTED|Phase 1 (to Age 1 Year)||57||
59511260|NCT00212134|75604889|FG000|Complete First Endpoint at 1 Year|Phase 1 (to Age 1 Year)||57||
59511261|NCT00212134|75604890|FG001|Complete First Endpoint at 1 Year|Phase 1 (to Age 1 Year)||57||
59511262|NCT00212134|75604889|FG000|COMPLETED|Phase 1 (to Age 1 Year)|Age 1 data collection visit|57||
59511263|NCT00212134|75604890|FG001|COMPLETED|Phase 1 (to Age 1 Year)|Age 1 data collection visit|57||
59511264|NCT00212134|75604889|FG000|NOT COMPLETED|Phase 1 (to Age 1 Year)||0||
59511265|NCT00212134|75604890|FG001|NOT COMPLETED|Phase 1 (to Age 1 Year)||0||
59511266|NCT00212134|75604889|FG000|STARTED|Phase 2 (Age 1 Year to Age 5 Years)|Visual acuity assessment at Age 4.5 Years and final visit at Age 5 Years.|57||
59511267|NCT00212134|75604890|FG001|STARTED|Phase 2 (Age 1 Year to Age 5 Years)|Visual acuity assessment at Age 4.5 Years and final visit at Age 5 Years.|57||
59511268|NCT00212134|75604889|FG000|COMPLETED|Phase 2 (Age 1 Year to Age 5 Years)||57||
59511269|NCT00212134|75604890|FG001|COMPLETED|Phase 2 (Age 1 Year to Age 5 Years)|Patient lost to follow-up.|56||
59511270|NCT00212134|75604889|FG000|NOT COMPLETED|Phase 2 (Age 1 Year to Age 5 Years)||0||
59511271|NCT00212134|75604890|FG001|NOT COMPLETED|Phase 2 (Age 1 Year to Age 5 Years)||1||
59511272|NCT00212134|75604889|FG000|STARTED|Phase 3 (Age 10 Years)||57||
59511273|NCT00212134|75604890|FG001|STARTED|Phase 3 (Age 10 Years)||56||
59511274|NCT00212134|75604889|FG000|COMPLETED|Phase 3 (Age 10 Years)||55||
59511275|NCT00212134|75604890|FG001|COMPLETED|Phase 3 (Age 10 Years)||55||
59511276|NCT00212134|75604889|FG000|NOT COMPLETED|Phase 3 (Age 10 Years)||2||
59511277|NCT00212134|75604890|FG001|NOT COMPLETED|Phase 3 (Age 10 Years)||1||
59511278|NCT02575950|75604900|FG000|STARTED|Overall Study||3||
59511279|NCT02575950|75604901|FG001|STARTED|Overall Study||6||
59511280|NCT02575950|75604902|FG002|STARTED|Overall Study||6||
59511281|NCT02575950|75604903|FG003|STARTED|Overall Study||25||
59511282|NCT02575950|75604900|FG000|COMPLETED|Overall Study||3||
59511283|NCT02575950|75604901|FG001|COMPLETED|Overall Study||5||
59511284|NCT02575950|75604902|FG002|COMPLETED|Overall Study||6||
59511285|NCT02575950|75604903|FG003|COMPLETED|Overall Study||20||
59511286|NCT02575950|75604900|FG000|NOT COMPLETED|Overall Study||0||
59511287|NCT02575950|75604901|FG001|NOT COMPLETED|Overall Study||1||
59511288|NCT02575950|75604902|FG002|NOT COMPLETED|Overall Study||0||
59511289|NCT02575950|75604903|FG003|NOT COMPLETED|Overall Study||5||
59511290|NCT00913627|75604915|FG000|STARTED|Overall Study||29||
59511291|NCT00913627|75604916|FG001|STARTED|Overall Study||53||
59511292|NCT00913627|75604917|FG002|STARTED|Overall Study||56||
59511293|NCT00913627|75604918|FG003|STARTED|Overall Study||58||
59511294|NCT00913627|75604915|FG000|COMPLETED|Overall Study||29||
59511295|NCT00913627|75604916|FG001|COMPLETED|Overall Study||53||
59511296|NCT00913627|75604917|FG002|COMPLETED|Overall Study||56||
59511297|NCT00913627|75604918|FG003|COMPLETED|Overall Study||58||
59511298|NCT00913627|75604915|FG000|NOT COMPLETED|Overall Study||0||
59511299|NCT00913627|75604916|FG001|NOT COMPLETED|Overall Study||0||
59511300|NCT00913627|75604917|FG002|NOT COMPLETED|Overall Study||0||
59511301|NCT00913627|75604918|FG003|NOT COMPLETED|Overall Study||0||
59511302|NCT04142034|75604930|FG000|STARTED|Recruitment Period||535||
59511303|NCT04142034|75604931|FG001|STARTED|Recruitment Period||23||
59511304|NCT04142034|75604932|FG002|STARTED|Recruitment Period||0||
59511305|NCT04142034|75604933|FG003|STARTED|Recruitment Period||0||
59511306|NCT04142034|75604930|FG000|COMPLETED|Recruitment Period|The recruitment period included a hiatus in recruitment due to the pandemic|99||
59511307|NCT04142034|75604931|FG001|COMPLETED|Recruitment Period|The recruitment period included a hiatus in recruitment due to the pandemic|5||
59511308|NCT04142034|75604932|FG002|COMPLETED|Recruitment Period|the intervention arm is only relevant during period 2|0||
59511309|NCT04142034|75604933|FG003|COMPLETED|Recruitment Period|intervention arm is only relevant in period 2|0||
59511310|NCT04142034|75604930|FG000|NOT COMPLETED|Recruitment Period||436||
59511311|NCT04142034|75604931|FG001|NOT COMPLETED|Recruitment Period||18||
59511312|NCT04142034|75604932|FG002|NOT COMPLETED|Recruitment Period||0||
59511313|NCT04142034|75604933|FG003|NOT COMPLETED|Recruitment Period||0||
59511314|NCT04142034|75604930|FG000|STARTED|Intervention Period|Recruitment method is only relevant in period 1|0||
59511315|NCT04142034|75604931|FG001|STARTED|Intervention Period|Recruitment method is only relevant in period 1|0||
59511316|NCT04142034|75604932|FG002|STARTED|Intervention Period|There were 104 participants recruited into the intervention part of the study; half were randomized to the iAmHealthy + newsletter behavioral intervention.|52||
59511317|NCT04142034|75604933|FG003|STARTED|Intervention Period|There were 104 participants recruited into the intervention part of the study; half were randomized to the Newsletter intervention.|52||
59511318|NCT04142034|75604930|FG000|COMPLETED|Intervention Period||0||
59511319|NCT04142034|75604931|FG001|COMPLETED|Intervention Period||0||
59511320|NCT04142034|75604932|FG002|COMPLETED|Intervention Period||45||
59511321|NCT04142034|75604933|FG003|COMPLETED|Intervention Period||50||
59511322|NCT04142034|75604930|FG000|NOT COMPLETED|Intervention Period||0||
59511323|NCT04142034|75604931|FG001|NOT COMPLETED|Intervention Period||0||
59511324|NCT04142034|75604932|FG002|NOT COMPLETED|Intervention Period||7||
59511325|NCT04142034|75604933|FG003|NOT COMPLETED|Intervention Period||2||
59511326|NCT02738086|75604943|FG000|STARTED|Overall Study||16||
59511327|NCT02738086|75604944|FG001|STARTED|Overall Study||15||
59511328|NCT02738086|75604943|FG000|COMPLETED|Overall Study||14||
59511329|NCT02738086|75604944|FG001|COMPLETED|Overall Study||13||
59511330|NCT02738086|75604943|FG000|NOT COMPLETED|Overall Study||2||
59511331|NCT02738086|75604944|FG001|NOT COMPLETED|Overall Study||2||
59511332|NCT00877877|75604953|FG000|STARTED|Year 5||397||
59511333|NCT00877877|75604953|FG000|COMPLETED|Year 5||397||
59511334|NCT00877877|75604953|FG000|NOT COMPLETED|Year 5||0||
59511335|NCT00877877|75604953|FG000|STARTED|Year 6||529||
59511336|NCT00877877|75604953|FG000|COMPLETED|Year 6||529||
59511337|NCT00877877|75604953|FG000|NOT COMPLETED|Year 6||0||
59511338|NCT00877877|75604953|FG000|STARTED|Year 7||523||
59511339|NCT00877877|75604953|FG000|COMPLETED|Year 7||523||
59511340|NCT00877877|75604953|FG000|NOT COMPLETED|Year 7||0||
59511341|NCT00877877|75604953|FG000|STARTED|Year 8||522||
59511342|NCT00877877|75604953|FG000|COMPLETED|Year 8||522||
59511343|NCT00877877|75604953|FG000|NOT COMPLETED|Year 8||0||
59511344|NCT00877877|75604953|FG000|STARTED|Year 9||507||
59511345|NCT00877877|75604953|FG000|COMPLETED|Year 9||507||
59511346|NCT00877877|75604953|FG000|NOT COMPLETED|Year 9||0||
59511347|NCT00877877|75604953|FG000|STARTED|Year 10||495||
59511348|NCT00877877|75604953|FG000|COMPLETED|Year 10||495||
59511349|NCT00877877|75604953|FG000|NOT COMPLETED|Year 10||0||
59511350|NCT02739100|75604962|FG000|STARTED|Overall Study||13||
59511351|NCT02739100|75604962|FG000|Triferic 2 Micromolar Via Hemodialysate|Overall Study||13||
59511352|NCT02739100|75604962|FG000|Triferic 6.6 mg IV Predialyzer|Overall Study||13||
59511353|NCT02739100|75604962|FG000|Triferic 6.6. mg IV Post-dialyzer|Overall Study||13||
59511354|NCT02739100|75604962|FG000|COMPLETED|Overall Study||13||
59511355|NCT02739100|75604962|FG000|NOT COMPLETED|Overall Study||0||
59612444|NCT01701258|75723500|FG001|NOT COMPLETED|Drug+fMRI (Session 2)||0||
59511356|NCT02740504|75604970|FG000|STARTED|Overall Study||20||
59511357|NCT02740504|75604970|FG000|COMPLETED|Overall Study||20||
59511358|NCT02740504|75604970|FG000|NOT COMPLETED|Overall Study||0||
59511359|NCT02740582|75604976|FG000|STARTED|First Intervention||29||
59511360|NCT02740582|75604977|FG001|STARTED|First Intervention||33||
60043923|NCT02293499|76159640|FG001|COMPLETED|6 Month Follow Up||135||
60043924|NCT02293499|76159641|FG002|COMPLETED|6 Month Follow Up||28||
60043925|NCT02293499|76159639|FG000|NOT COMPLETED|6 Month Follow Up||17||
60043926|NCT02293499|76159640|FG001|NOT COMPLETED|6 Month Follow Up||27||
60043927|NCT02293499|76159641|FG002|NOT COMPLETED|6 Month Follow Up||7||
60043928|NCT02293499|76159639|FG000|STARTED|9 Month Follow Up||148||
60043929|NCT02293499|76159640|FG001|STARTED|9 Month Follow Up||162||
60043930|NCT02293499|76159641|FG002|STARTED|9 Month Follow Up||34||
60043931|NCT02293499|76159639|FG000|COMPLETED|9 Month Follow Up||122||
60043932|NCT02293499|76159640|FG001|COMPLETED|9 Month Follow Up||134||
60043933|NCT02293499|76159641|FG002|COMPLETED|9 Month Follow Up||30||
60043934|NCT02293499|76159639|FG000|NOT COMPLETED|9 Month Follow Up||26||
60043935|NCT02293499|76159640|FG001|NOT COMPLETED|9 Month Follow Up||28||
60043936|NCT02293499|76159641|FG002|NOT COMPLETED|9 Month Follow Up||4||
60043937|NCT02293499|76159639|FG000|STARTED|12 Month Follow Up||146||
60043938|NCT02293499|76159640|FG001|STARTED|12 Month Follow Up||162||
60043939|NCT02293499|76159641|FG002|STARTED|12 Month Follow Up||34||
60043940|NCT02293499|76159639|FG000|COMPLETED|12 Month Follow Up||120||
60043941|NCT02293499|76159640|FG001|COMPLETED|12 Month Follow Up||136||
60043942|NCT02293499|76159641|FG002|COMPLETED|12 Month Follow Up||28||
60043943|NCT02293499|76159639|FG000|NOT COMPLETED|12 Month Follow Up||26||
60043944|NCT02293499|76159640|FG001|NOT COMPLETED|12 Month Follow Up||26||
60043945|NCT02293499|76159641|FG002|NOT COMPLETED|12 Month Follow Up||6||
60043946|NCT02293499|76159639|FG000|STARTED|15 Month Follow Up||146||
60043947|NCT02293499|76159640|FG001|STARTED|15 Month Follow Up||161||
60043948|NCT02293499|76159641|FG002|STARTED|15 Month Follow Up||34||
60043949|NCT02293499|76159639|FG000|COMPLETED|15 Month Follow Up||124||
60043950|NCT02293499|76159640|FG001|COMPLETED|15 Month Follow Up||139||
60043951|NCT02293499|76159641|FG002|COMPLETED|15 Month Follow Up||27||
60043952|NCT02293499|76159639|FG000|NOT COMPLETED|15 Month Follow Up||22||
60043953|NCT02293499|76159640|FG001|NOT COMPLETED|15 Month Follow Up||22||
60043954|NCT02293499|76159641|FG002|NOT COMPLETED|15 Month Follow Up||7||
60043955|NCT02257385|76159652|FG000|STARTED|Overall Study||482||
60043956|NCT02257385|76159653|FG001|STARTED|Overall Study||479||
60043957|NCT02257385|76159652|FG000|COMPLETED|Overall Study||460||
60043958|NCT02257385|76159653|FG001|COMPLETED|Overall Study||457||
60043959|NCT02257385|76159652|FG000|NOT COMPLETED|Overall Study||22||
60043960|NCT02257385|76159653|FG001|NOT COMPLETED|Overall Study||22||
60043961|NCT01629667|76159662|FG000|STARTED|Overall Study||59||
60043962|NCT01629667|76159663|FG001|STARTED|Overall Study||58||
60043963|NCT01629667|76159664|FG002|STARTED|Overall Study||59||
60043964|NCT01629667|76159662|FG000|Randomized and Treated|Overall Study||57||
60043965|NCT01629667|76159663|FG001|Randomized and Treated|Overall Study||57||
60043966|NCT01629667|76159664|FG002|Randomized and Treated|Overall Study||59||
60043967|NCT01629667|76159662|FG000|COMPLETED|Overall Study||12||
60043968|NCT01629667|76159663|FG001|COMPLETED|Overall Study||17||
60043969|NCT01629667|76159664|FG002|COMPLETED|Overall Study||14||
60043970|NCT01629667|76159662|FG000|NOT COMPLETED|Overall Study||47||
60043971|NCT01629667|76159663|FG001|NOT COMPLETED|Overall Study||41||
60043972|NCT01629667|76159664|FG002|NOT COMPLETED|Overall Study||45||
60043973|NCT01645280|76159679|FG000|STARTED|Overall Study|16 participants in placebo group early escaped to receive Ustekinmab; included in safety population.|55||
60043974|NCT01645280|76159680|FG001|STARTED|Overall Study||54||
60043975|NCT01645280|76159681|FG002|STARTED|Overall Study||55||
60043976|NCT01645280|76159682|FG003|STARTED|Overall Study||54||
60043977|NCT01645280|76159683|FG004|STARTED|Overall Study||55||
60043978|NCT01645280|76159679|FG000|COMPLETED|Overall Study||49||
60043979|NCT01645280|76159680|FG001|COMPLETED|Overall Study||51||
60043980|NCT01645280|76159681|FG002|COMPLETED|Overall Study||49||
60043981|NCT01645280|76159682|FG003|COMPLETED|Overall Study||48||
60043982|NCT01645280|76159683|FG004|COMPLETED|Overall Study||47||
60043983|NCT01645280|76159679|FG000|NOT COMPLETED|Overall Study||6||
60043984|NCT01645280|76159680|FG001|NOT COMPLETED|Overall Study||3||
60043985|NCT01645280|76159681|FG002|NOT COMPLETED|Overall Study||6||
60043986|NCT01645280|76159682|FG003|NOT COMPLETED|Overall Study||6||
60043987|NCT01645280|76159683|FG004|NOT COMPLETED|Overall Study||8||
60043988|NCT02256917|76159696|FG000|STARTED|Pharmacokinetic (PK) Evaluation Phase||58||
60043989|NCT02256917|76159696|FG000|COMPLETED|Pharmacokinetic (PK) Evaluation Phase||58||
60043990|NCT02256917|76159696|FG000|NOT COMPLETED|Pharmacokinetic (PK) Evaluation Phase||0||
60043991|NCT02256917|76159696|FG000|STARTED|Prophylactic Treatment Phase I||57||
60043992|NCT02256917|76159696|FG000|COMPLETED|Prophylactic Treatment Phase I||56||
60043993|NCT02256917|76159696|FG000|NOT COMPLETED|Prophylactic Treatment Phase I||1||
60043994|NCT02256917|76159696|FG000|STARTED|Prophylactic Treatment Phase II||56||
60043995|NCT02256917|76159696|FG000|COMPLETED|Prophylactic Treatment Phase II||52||
60043996|NCT02256917|76159696|FG000|NOT COMPLETED|Prophylactic Treatment Phase II||4||
60043997|NCT01629589|76159709|FG000|STARTED|Overall Study||212||
60043998|NCT01629589|76159710|FG001|STARTED|Overall Study||211||
60043999|NCT01629589|76159709|FG000|COMPLETED|Overall Study|A participant received the Boostrix vaccine. Study data reported for the Boostrix vaccine group.|204||
60044000|NCT01629589|76159710|FG001|COMPLETED|Overall Study||204||
60044001|NCT01629589|76159709|FG000|NOT COMPLETED|Overall Study||8||
60044002|NCT01629589|76159710|FG001|NOT COMPLETED|Overall Study||7||
60044003|NCT02256839|76159718|FG000|STARTED|Overall Study||53||
60044004|NCT02256839|76159719|FG001|STARTED|Overall Study||215||
60044005|NCT02256839|76159718|FG000|COMPLETED|Overall Study||51||
60044006|NCT02256839|76159719|FG001|COMPLETED|Overall Study||212||
60044007|NCT02256839|76159718|FG000|NOT COMPLETED|Overall Study||2||
60044008|NCT02256839|76159719|FG001|NOT COMPLETED|Overall Study||3||
60044009|NCT02220907|76159725|FG000|STARTED|Overall Study||153||
60044010|NCT02220907|76159725|FG000|COMPLETED|Overall Study||142||
60044011|NCT02220907|76159725|FG000|NOT COMPLETED|Overall Study||11||
60044012|NCT02255981|76159729|FG000|STARTED|Overall Study|Both eyes of each patient were included except 2 that not were treatable|33||64
60044013|NCT02255981|76159729|FG000|COMPLETED|Overall Study|2 eyes of the final 29 subjects were excluded.|29||56
60044014|NCT02255981|76159729|FG000|NOT COMPLETED|Overall Study||4||8
60044015|NCT01601873|76159741|FG000|STARTED|Overall Study||50||
60044016|NCT01601873|76159742|FG001|STARTED|Overall Study||47||
60044017|NCT01601873|76159741|FG000|COMPLETED|Overall Study||48||
60044018|NCT01601873|76159742|FG001|COMPLETED|Overall Study||44||
60044019|NCT01601873|76159741|FG000|NOT COMPLETED|Overall Study||2||
60044020|NCT01601873|76159742|FG001|NOT COMPLETED|Overall Study||3||
60044021|NCT02194933|76159750|FG000|STARTED|Overall Study||19||
60044022|NCT02194933|76159751|FG001|STARTED|Overall Study||19||
60044023|NCT02194933|76159750|FG000|COMPLETED|Overall Study||16||
60044024|NCT02194933|76159751|FG001|COMPLETED|Overall Study||10||
60044025|NCT02194933|76159750|FG000|NOT COMPLETED|Overall Study||3||
60044026|NCT02194933|76159751|FG001|NOT COMPLETED|Overall Study||9||
60044027|NCT01644890|76159761|FG000|STARTED|Overall Study||218||
60044028|NCT01644890|76159762|FG001|STARTED|Overall Study||218||
60044029|NCT01644890|76159761|FG000|COMPLETED|Overall Study||2||
60044030|NCT01644890|76159762|FG001|COMPLETED|Overall Study||3||
60044031|NCT01644890|76159761|FG000|NOT COMPLETED|Overall Study||216||
60044032|NCT01644890|76159762|FG001|NOT COMPLETED|Overall Study||215||
60044033|NCT01628965|76159768|FG000|STARTED|Overall Study||143||
60044034|NCT01628965|76159768|FG000|COMPLETED|Overall Study||94||
60044035|NCT01628965|76159768|FG000|NOT COMPLETED|Overall Study||49||
60044036|NCT01644734|76159772|FG000|STARTED|Overall Study|Patients with documentation of treatment.|1282||
60044037|NCT01644734|76159772|FG000|COMPLETED|Overall Study||1016||
60044038|NCT01644734|76159772|FG000|NOT COMPLETED|Overall Study||266||
60044039|NCT02255279|76159778|FG000|STARTED|Overall Study||144||
60044040|NCT02255279|76159779|FG001|STARTED|Overall Study||143||
60044041|NCT02255279|76159778|FG000|COMPLETED|Overall Study||139||
60044042|NCT02255279|76159779|FG001|COMPLETED|Overall Study||134||
60044043|NCT02255279|76159778|FG000|NOT COMPLETED|Overall Study||5||
60044044|NCT02255279|76159779|FG001|NOT COMPLETED|Overall Study||9||
60044045|NCT01643798|76159799|FG000|STARTED|Pretreatment 1 and Stimulation||7||
60044046|NCT01643798|76159800|FG001|STARTED|Pretreatment 1 and Stimulation||8||
60044047|NCT01643798|76159799|FG000|COMPLETED|Pretreatment 1 and Stimulation||6||
60044048|NCT01643798|76159800|FG001|COMPLETED|Pretreatment 1 and Stimulation||8||
60044049|NCT01643798|76159799|FG000|NOT COMPLETED|Pretreatment 1 and Stimulation||1||
60044050|NCT01643798|76159800|FG001|NOT COMPLETED|Pretreatment 1 and Stimulation||0||
60044051|NCT01643798|76159799|FG000|STARTED|Pretreatment 2 and Stimulation||6||
60044052|NCT01643798|76159800|FG001|STARTED|Pretreatment 2 and Stimulation||8||
60044053|NCT01643798|76159799|FG000|COMPLETED|Pretreatment 2 and Stimulation||6||
60044054|NCT01643798|76159800|FG001|COMPLETED|Pretreatment 2 and Stimulation||8||
60044055|NCT01643798|76159799|FG000|NOT COMPLETED|Pretreatment 2 and Stimulation||0||
60044056|NCT01643798|76159800|FG001|NOT COMPLETED|Pretreatment 2 and Stimulation||0||
60044057|NCT02194699|76159813|FG000|STARTED|Randomised||428||
60044058|NCT02194699|76159814|FG001|STARTED|Randomised||428||
60044059|NCT02194699|76159813|FG000|COMPLETED|Randomised||420||
60044060|NCT02194699|76159814|FG001|COMPLETED|Randomised||417||
60044061|NCT02194699|76159813|FG000|NOT COMPLETED|Randomised||8||
60044062|NCT02194699|76159814|FG001|NOT COMPLETED|Randomised||11||
60044063|NCT02194699|76159813|FG000|STARTED|With Potential to Receive 52 Weeks of IP|Includes all patients randomised with the potential to receive 52 weeks of IP and receiving any IP.|420||
60044064|NCT02194699|76159814|FG001|STARTED|With Potential to Receive 52 Weeks of IP|Includes all patients randomised with the potential to receive 52 weeks of IP and receiving any IP.|417||
60044065|NCT02194699|76159813|FG000|COMPLETED|With Potential to Receive 52 Weeks of IP||370||
60044066|NCT02194699|76159814|FG001|COMPLETED|With Potential to Receive 52 Weeks of IP||365||
60044067|NCT02194699|76159813|FG000|NOT COMPLETED|With Potential to Receive 52 Weeks of IP||50||
60044068|NCT02194699|76159814|FG001|NOT COMPLETED|With Potential to Receive 52 Weeks of IP||52||
60044069|NCT02293538|76159830|FG000|STARTED|Overall Study||73||
60044070|NCT02293538|76159831|FG001|STARTED|Overall Study||71||
60044071|NCT02293538|76159830|FG000|COMPLETED|Overall Study||72||
60044072|NCT02293538|76159831|FG001|COMPLETED|Overall Study||69||
60044073|NCT02293538|76159830|FG000|NOT COMPLETED|Overall Study||1||
60044074|NCT02293538|76159831|FG001|NOT COMPLETED|Overall Study||2||
60044075|NCT02194621|76159841|FG000|STARTED|Overall Study||43||
60044076|NCT02194621|76159842|FG001|STARTED|Overall Study||42||
60044077|NCT02194621|76159843|FG002|STARTED|Overall Study||43||
60044078|NCT02194621|76159841|FG000|COMPLETED|Overall Study||37||
60044079|NCT02194621|76159842|FG001|COMPLETED|Overall Study||36||
60044080|NCT02194621|76159843|FG002|COMPLETED|Overall Study||34||
60044081|NCT02194621|76159841|FG000|NOT COMPLETED|Overall Study||6||
60044082|NCT02194621|76159842|FG001|NOT COMPLETED|Overall Study||6||
60044083|NCT02194621|76159843|FG002|NOT COMPLETED|Overall Study||9||
60044084|NCT02220205|76159853|FG000|STARTED|Overall Study||30||
60044085|NCT02220205|76159854|FG001|STARTED|Overall Study||30||
60044086|NCT02220205|76159853|FG000|COMPLETED|Overall Study||29||
60044087|NCT02220205|76159854|FG001|COMPLETED|Overall Study||30||
60044088|NCT02220205|76159853|FG000|NOT COMPLETED|Overall Study||1||
60044089|NCT02220205|76159854|FG001|NOT COMPLETED|Overall Study||0||
60044090|NCT02266706|76159869|FG000|STARTED|Overall Study||6||
60044091|NCT02266706|76159870|FG001|STARTED|Overall Study||7||
60044092|NCT02266706|76159871|FG002|STARTED|Overall Study||4||
60044093|NCT02266706|76159872|FG003|STARTED|Overall Study||4||
60044094|NCT02266706|76159873|FG004|STARTED|Overall Study||1||
60044095|NCT02266706|76159874|FG005|STARTED|Overall Study||7||
60044096|NCT02266706|76159875|FG006|STARTED|Overall Study||8||
60044097|NCT02266706|76159876|FG007|STARTED|Overall Study||2||
60044098|NCT02266706|76159877|FG008|STARTED|Overall Study||4||
60044099|NCT02266706|76159869|FG000|Treated|Overall Study||6||
60044100|NCT02266706|76159870|FG001|Treated|Overall Study||6||
60044101|NCT02266706|76159871|FG002|Treated|Overall Study||3||
60044102|NCT02266706|76159872|FG003|Treated|Overall Study||3||
60044103|NCT02266706|76159873|FG004|Treated|Overall Study||1||
60044104|NCT02266706|76159874|FG005|Treated|Overall Study||5||
60044105|NCT02266706|76159875|FG006|Treated|Overall Study||7||
60044106|NCT02266706|76159876|FG007|Treated|Overall Study||2||
60044107|NCT02266706|76159877|FG008|Treated|Overall Study||4||
60044108|NCT02266706|76159869|FG000|COMPLETED|Overall Study||6||
60044109|NCT02266706|76159870|FG001|COMPLETED|Overall Study||6||
60044110|NCT02266706|76159871|FG002|COMPLETED|Overall Study||3||
60044111|NCT02266706|76159872|FG003|COMPLETED|Overall Study||3||
60044112|NCT02266706|76159873|FG004|COMPLETED|Overall Study||1||
60044113|NCT02266706|76159874|FG005|COMPLETED|Overall Study||5||
60044114|NCT02266706|76159875|FG006|COMPLETED|Overall Study||7||
60044115|NCT02266706|76159876|FG007|COMPLETED|Overall Study||2||
60044116|NCT02266706|76159877|FG008|COMPLETED|Overall Study||4||
60044117|NCT02266706|76159869|FG000|NOT COMPLETED|Overall Study||0||
60044118|NCT02266706|76159870|FG001|NOT COMPLETED|Overall Study||1||
60044119|NCT02266706|76159871|FG002|NOT COMPLETED|Overall Study||1||
60044120|NCT02266706|76159872|FG003|NOT COMPLETED|Overall Study||1||
60044121|NCT02266706|76159873|FG004|NOT COMPLETED|Overall Study||0||
60044122|NCT02266706|76159874|FG005|NOT COMPLETED|Overall Study||2||
60044123|NCT02266706|76159875|FG006|NOT COMPLETED|Overall Study||1||
60044124|NCT02266706|76159876|FG007|NOT COMPLETED|Overall Study||0||
60044125|NCT02266706|76159877|FG008|NOT COMPLETED|Overall Study||0||
60044126|NCT02293460|76159897|FG000|STARTED|Overall Study||43||
60044127|NCT02293460|76159897|FG000|COMPLETED|Overall Study||37||
60044128|NCT02293460|76159897|FG000|NOT COMPLETED|Overall Study||6||
60044129|NCT02266004|76159901|FG000|STARTED|Overall Study||9||
60044130|NCT02266004|76159901|FG000|COMPLETED|Overall Study||7||
60044131|NCT02266004|76159901|FG000|NOT COMPLETED|Overall Study||2||
60044132|NCT02292719|76159911|FG000|STARTED|Overall Study||9||
60044133|NCT02292719|76159912|FG001|STARTED|Overall Study||11||
60044134|NCT02292719|76159913|FG002|STARTED|Overall Study||10||
60044135|NCT02292719|76159914|FG003|STARTED|Overall Study||9||
60044136|NCT02292719|76159915|FG004|STARTED|Overall Study||21||
59612445|NCT01701258|75723501|FG002|NOT COMPLETED|Drug+fMRI (Session 2)||0||
60044137|NCT02292719|76159916|FG005|STARTED|Overall Study||10||
60044138|NCT02292719|76159911|FG000|COMPLETED|Overall Study||9||
60044139|NCT02292719|76159912|FG001|COMPLETED|Overall Study||11||
60044140|NCT02292719|76159913|FG002|COMPLETED|Overall Study||9||
60044141|NCT02292719|76159914|FG003|COMPLETED|Overall Study||8||
60044142|NCT02292719|76159915|FG004|COMPLETED|Overall Study||20||
60044143|NCT02292719|76159916|FG005|COMPLETED|Overall Study||10||
60044144|NCT02292719|76159911|FG000|NOT COMPLETED|Overall Study||0||
60044145|NCT02292719|76159912|FG001|NOT COMPLETED|Overall Study||0||
60044146|NCT02292719|76159913|FG002|NOT COMPLETED|Overall Study||1||
60044147|NCT02292719|76159914|FG003|NOT COMPLETED|Overall Study||1||
60044148|NCT02292719|76159915|FG004|NOT COMPLETED|Overall Study||1||
60044149|NCT02292719|76159916|FG005|NOT COMPLETED|Overall Study||0||
60044150|NCT02291861|76159934|FG000|STARTED|Overall Study||74||
60044151|NCT02291861|76159935|FG001|STARTED|Overall Study||75||
60044152|NCT02291861|76159936|FG002|STARTED|Overall Study||74||
60044153|NCT02291861|76159937|FG003|STARTED|Overall Study||75||
60044154|NCT02291861|76159934|FG000|Safety Population|Overall Study||72||
60044155|NCT02291861|76159935|FG001|Safety Population|Overall Study||74||
60044156|NCT02291861|76159936|FG002|Safety Population|Overall Study||73||
60044157|NCT02291861|76159937|FG003|Safety Population|Overall Study||74||
60044158|NCT02291861|76159934|FG000|Modified Intent to Treat Pop (mITT)|Overall Study||58||
60044159|NCT02291861|76159935|FG001|Modified Intent to Treat Pop (mITT)|Overall Study||60||
60044160|NCT02291861|76159936|FG002|Modified Intent to Treat Pop (mITT)|Overall Study||49||
60044161|NCT02291861|76159937|FG003|Modified Intent to Treat Pop (mITT)|Overall Study||55||
60044162|NCT02291861|76159934|FG000|COMPLETED|Overall Study||67||
60044163|NCT02291861|76159935|FG001|COMPLETED|Overall Study||67||
60044164|NCT02291861|76159936|FG002|COMPLETED|Overall Study||65||
60044165|NCT02291861|76159937|FG003|COMPLETED|Overall Study||65||
60044166|NCT02291861|76159934|FG000|NOT COMPLETED|Overall Study||7||
60044167|NCT02291861|76159935|FG001|NOT COMPLETED|Overall Study||8||
60044168|NCT02291861|76159936|FG002|NOT COMPLETED|Overall Study||9||
60044169|NCT02291861|76159937|FG003|NOT COMPLETED|Overall Study||10||
60044170|NCT02291549|76159949|FG000|STARTED|Overall Study||201||
60044171|NCT02291549|76159950|FG001|STARTED|Overall Study||99||
60044172|NCT02291549|76159949|FG000|COMPLETED|Overall Study||200||
60044173|NCT02291549|76159950|FG001|COMPLETED|Overall Study||98||
60044174|NCT02291549|76159949|FG000|NOT COMPLETED|Overall Study||1||
60044175|NCT02291549|76159950|FG001|NOT COMPLETED|Overall Study||1||
60044176|NCT02264990|76159960|FG000|STARTED|Overall Study||297||
60044177|NCT02264990|76159961|FG001|STARTED|Overall Study||298||
60044178|NCT02264990|76159960|FG000|Received Treatment|Overall Study||288||
60044179|NCT02264990|76159961|FG001|Received Treatment|Overall Study||293||
60044180|NCT02264990|76159960|FG000|Received Maintenance Therapy|Overall Study||148||
60044181|NCT02264990|76159961|FG001|Received Maintenance Therapy|Overall Study||123||
60044182|NCT02264990|76159960|FG000|COMPLETED|Overall Study||37||
60044183|NCT02264990|76159961|FG001|COMPLETED|Overall Study||39||
60044184|NCT02264990|76159960|FG000|NOT COMPLETED|Overall Study||260||
60044185|NCT02264990|76159961|FG001|NOT COMPLETED|Overall Study||259||
60044186|NCT02291237|76159970|FG000|STARTED|Overall Study||86||
60044187|NCT02291237|76159971|FG001|STARTED|Overall Study||86||
60044188|NCT02291237|76159970|FG000|COMPLETED|Overall Study||0||
60044189|NCT02291237|76159971|FG001|COMPLETED|Overall Study||0||
60044190|NCT02291237|76159970|FG000|NOT COMPLETED|Overall Study||86||
60044191|NCT02291237|76159971|FG001|NOT COMPLETED|Overall Study||86||
60044192|NCT02292446|76159977|FG000|STARTED|Overall Study||161||
60044193|NCT02292446|76159977|FG000|COMPLETED|Overall Study||141||
60044194|NCT02292446|76159977|FG000|NOT COMPLETED|Overall Study||20||
60044195|NCT02290925|76159986|FG000|STARTED|First Period of Three Months||62||
60044196|NCT02290925|76159987|FG001|STARTED|First Period of Three Months||71||
60044197|NCT02290925|76159986|FG000|COMPLETED|First Period of Three Months||58||
60044198|NCT02290925|76159987|FG001|COMPLETED|First Period of Three Months||69||
60044199|NCT02290925|76159986|FG000|NOT COMPLETED|First Period of Three Months||4||
60044200|NCT02290925|76159987|FG001|NOT COMPLETED|First Period of Three Months||2||
60044201|NCT02290925|76159986|FG000|STARTED|Second Period of 3 Months||58||
60044202|NCT02290925|76159987|FG001|STARTED|Second Period of 3 Months||69||
60044203|NCT02290925|76159986|FG000|COMPLETED|Second Period of 3 Months||57||
60044204|NCT02290925|76159987|FG001|COMPLETED|Second Period of 3 Months||65||
60044205|NCT02290925|76159986|FG000|NOT COMPLETED|Second Period of 3 Months||1||
60044206|NCT02290925|76159987|FG001|NOT COMPLETED|Second Period of 3 Months||4||
60044207|NCT02290691|76159997|FG000|STARTED|Overall Study||496||
60044208|NCT02290691|76159998|FG001|STARTED|Overall Study||488||
60044209|NCT02290691|76159997|FG000|COMPLETED|Overall Study||488||
60044210|NCT02290691|76159998|FG001|COMPLETED|Overall Study||479||
60044211|NCT02290691|76159997|FG000|NOT COMPLETED|Overall Study||8||
60044212|NCT02290691|76159998|FG001|NOT COMPLETED|Overall Study||9||
60044213|NCT02292212|76160004|FG000|STARTED|Pre-ViE Phase||17||
60044214|NCT02292212|76160004|FG000|COMPLETED|Pre-ViE Phase||17||
60044215|NCT02292212|76160004|FG000|NOT COMPLETED|Pre-ViE Phase||0||
60044216|NCT02292212|76160004|FG000|STARTED|ViE Phase||17||
60044217|NCT02292212|76160004|FG000|COMPLETED|ViE Phase||14||
60044218|NCT02292212|76160004|FG000|NOT COMPLETED|ViE Phase||3||
60044219|NCT02292212|76160004|FG000|STARTED|Post-ViE Phase||14||
60044220|NCT02292212|76160004|FG000|COMPLETED|Post-ViE Phase||14||
60044221|NCT02292212|76160004|FG000|NOT COMPLETED|Post-ViE Phase||0||
60044222|NCT02291510|76160019|FG000|STARTED|Overall Study||5||
60044223|NCT02291510|76160020|FG001|STARTED|Overall Study||5||
60044224|NCT02291510|76160021|FG002|STARTED|Overall Study||5||
60044225|NCT02291510|76160022|FG003|STARTED|Overall Study||5||
60044226|NCT02291510|76160019|FG000|Completed Treatment A|Overall Study||5||
60044227|NCT02291510|76160020|FG001|Completed Treatment A|Overall Study||5||
60044228|NCT02291510|76160021|FG002|Completed Treatment A|Overall Study||5||
60044229|NCT02291510|76160022|FG003|Completed Treatment A|Overall Study||5||
60044230|NCT02291510|76160019|FG000|Completed Treatment B|Overall Study||5||
60044231|NCT02291510|76160020|FG001|Completed Treatment B|Overall Study||5||
60044232|NCT02291510|76160021|FG002|Completed Treatment B|Overall Study||5||
60044233|NCT02291510|76160022|FG003|Completed Treatment B|Overall Study||4||
60044234|NCT02291510|76160019|FG000|Completed Treatment C|Overall Study||5||
60044235|NCT02291510|76160020|FG001|Completed Treatment C|Overall Study||5||
60044236|NCT02291510|76160021|FG002|Completed Treatment C|Overall Study||5||
60044237|NCT02291510|76160022|FG003|Completed Treatment C|Overall Study||4||
60044238|NCT02291510|76160019|FG000|Completed Treatment D|Overall Study||5||
60044239|NCT02291510|76160020|FG001|Completed Treatment D|Overall Study||5||
60044240|NCT02291510|76160021|FG002|Completed Treatment D|Overall Study||5||
60044241|NCT02291510|76160022|FG003|Completed Treatment D|Overall Study||5||
60044242|NCT02291510|76160019|FG000|COMPLETED|Overall Study||5||
60044243|NCT02291510|76160020|FG001|COMPLETED|Overall Study||5||
60044244|NCT02291510|76160021|FG002|COMPLETED|Overall Study||5||
60044245|NCT02291510|76160022|FG003|COMPLETED|Overall Study||4||
60044246|NCT02291510|76160019|FG000|NOT COMPLETED|Overall Study||0||
60044247|NCT02291510|76160020|FG001|NOT COMPLETED|Overall Study||0||
60044248|NCT02291510|76160021|FG002|NOT COMPLETED|Overall Study||0||
60044249|NCT02291510|76160022|FG003|NOT COMPLETED|Overall Study||1||
60044250|NCT02290223|76160034|FG000|STARTED|Baseline||189||
60044251|NCT02290223|76160035|FG001|STARTED|Baseline||187||
60044252|NCT02290223|76160034|FG000|COMPLETED|Baseline||189||
60044253|NCT02290223|76160035|FG001|COMPLETED|Baseline||187||
60044254|NCT02290223|76160034|FG000|NOT COMPLETED|Baseline||0||
60044255|NCT02290223|76160035|FG001|NOT COMPLETED|Baseline||0||
60044256|NCT02290223|76160034|FG000|STARTED|6 Months||189||
60044257|NCT02290223|76160035|FG001|STARTED|6 Months||187||
60044258|NCT02290223|76160034|FG000|COMPLETED|6 Months||173||
60044259|NCT02290223|76160035|FG001|COMPLETED|6 Months||181||
59511361|NCT02740582|75604976|FG000|COMPLETED|First Intervention||24||
59511362|NCT02740582|75604977|FG001|COMPLETED|First Intervention||31||
60044260|NCT02290223|76160034|FG000|NOT COMPLETED|6 Months||16||
60044261|NCT02290223|76160035|FG001|NOT COMPLETED|6 Months||6||
60044262|NCT02290223|76160034|FG000|STARTED|12 Months|All participants were contacted at 12 mo, unless deceased or withdrawn (n=7).|182||
60044263|NCT02290223|76160035|FG001|STARTED|12 Months|All participants were contacted at 12 mo, unless deceased or withdrawn (n=0).|187||
60044264|NCT02290223|76160034|FG000|COMPLETED|12 Months||166||
60044265|NCT02290223|76160035|FG001|COMPLETED|12 Months||176||
60044266|NCT02290223|76160034|FG000|NOT COMPLETED|12 Months||16||
60044267|NCT02290223|76160035|FG001|NOT COMPLETED|12 Months||11||
60044268|NCT02289833|76160043|FG000|STARTED|Overall Study||29||
60044269|NCT02289833|76160044|FG001|STARTED|Overall Study||20||
60044270|NCT02289833|76160043|FG000|COMPLETED|Overall Study||2||
60044271|NCT02289833|76160044|FG001|COMPLETED|Overall Study||3||
60044272|NCT02289833|76160043|FG000|NOT COMPLETED|Overall Study||27||
60044273|NCT02289833|76160044|FG001|NOT COMPLETED|Overall Study||17||
60044274|NCT01702558|76160057|FG000|STARTED|Overall Study||7||
60044275|NCT01702558|76160058|FG001|STARTED|Overall Study||5||
60044276|NCT01702558|76160059|FG002|STARTED|Overall Study||6||
60044277|NCT01702558|76160060|FG003|STARTED|Overall Study||81||
60044278|NCT01702558|76160061|FG004|STARTED|Overall Study||80||
60044279|NCT01702558|76160057|FG000|COMPLETED|Overall Study||3||
60044280|NCT01702558|76160058|FG001|COMPLETED|Overall Study||1||
60044281|NCT01702558|76160059|FG002|COMPLETED|Overall Study||1||
60044282|NCT01702558|76160060|FG003|COMPLETED|Overall Study||34||
60044283|NCT01702558|76160061|FG004|COMPLETED|Overall Study||38||
60044284|NCT01702558|76160057|FG000|NOT COMPLETED|Overall Study||4||
60044285|NCT01702558|76160058|FG001|NOT COMPLETED|Overall Study||4||
60044286|NCT01702558|76160059|FG002|NOT COMPLETED|Overall Study||5||
60044287|NCT01702558|76160060|FG003|NOT COMPLETED|Overall Study||47||
60044288|NCT01702558|76160061|FG004|NOT COMPLETED|Overall Study||42||
60044289|NCT02287883|76160076|FG000|STARTED|Overall Study||1081||
60044290|NCT02287883|76160077|FG001|STARTED|Overall Study||1095||
60044291|NCT02287883|76160076|FG000|One-year Follow-up Survey|Overall Study||622||
60044292|NCT02287883|76160077|FG001|One-year Follow-up Survey|Overall Study||669||
60044293|NCT02287883|76160076|FG000|COMPLETED|Overall Study||622||
60044294|NCT02287883|76160077|FG001|COMPLETED|Overall Study||669||
60044295|NCT02287883|76160076|FG000|NOT COMPLETED|Overall Study||459||
60044296|NCT02287883|76160077|FG001|NOT COMPLETED|Overall Study||426||
60044297|NCT01743040|76160083|FG000|STARTED|Overall Study||1014||
60044298|NCT01743040|76160083|FG000|CADence Testing|Overall Study||1013||
60044299|NCT01743040|76160083|FG000|Nuclear Stress Test|Overall Study||992||
60044300|NCT01743040|76160083|FG000|CT and/or Standard Angiogram|Overall Study||785||
60044301|NCT01743040|76160083|FG000|COMPLETED|Overall Study||785||
60044302|NCT01743040|76160083|FG000|NOT COMPLETED|Overall Study||229||
59511363|NCT02740582|75604976|FG000|NOT COMPLETED|First Intervention||5||
60044303|NCT02194465|76160094|FG000|STARTED|Overall Study||51||
60044304|NCT02194465|76160095|FG001|STARTED|Overall Study||50||
60044305|NCT02194465|76160096|FG002|STARTED|Overall Study||52||
60044306|NCT02194465|76160097|FG003|STARTED|Overall Study||49||
60044307|NCT02194465|76160098|FG004|STARTED|Overall Study||51||
60044308|NCT02194465|76160099|FG005|STARTED|Overall Study||25||
59511364|NCT02740582|75604977|FG001|NOT COMPLETED|First Intervention||2||
59511365|NCT02740582|75604976|FG000|STARTED|Washout||24||
59511366|NCT02740582|75604977|FG001|STARTED|Washout||31||
59511367|NCT02740582|75604976|FG000|COMPLETED|Washout||24||
60044309|NCT02194465|76160100|FG006|STARTED|Overall Study||26||
60044310|NCT02194465|76160094|FG000|Received at Least 1 Dose of Study Drug|Overall Study||51||
60044311|NCT02194465|76160095|FG001|Received at Least 1 Dose of Study Drug|Overall Study||50||
60044312|NCT02194465|76160096|FG002|Received at Least 1 Dose of Study Drug|Overall Study||51||
60044313|NCT02194465|76160097|FG003|Received at Least 1 Dose of Study Drug|Overall Study||49||
60044314|NCT02194465|76160098|FG004|Received at Least 1 Dose of Study Drug|Overall Study||51||
60044315|NCT02194465|76160099|FG005|Received at Least 1 Dose of Study Drug|Overall Study||25||
60044316|NCT02194465|76160100|FG006|Received at Least 1 Dose of Study Drug|Overall Study||26||
60044317|NCT02194465|76160094|FG000|COMPLETED|Overall Study||42||
60044318|NCT02194465|76160095|FG001|COMPLETED|Overall Study||43||
60044319|NCT02194465|76160096|FG002|COMPLETED|Overall Study||44||
60044320|NCT02194465|76160097|FG003|COMPLETED|Overall Study||41||
60044321|NCT02194465|76160098|FG004|COMPLETED|Overall Study||42||
60044322|NCT02194465|76160099|FG005|COMPLETED|Overall Study||21||
60044323|NCT02194465|76160100|FG006|COMPLETED|Overall Study||24||
60044324|NCT02194465|76160094|FG000|NOT COMPLETED|Overall Study||9||
60044325|NCT02194465|76160095|FG001|NOT COMPLETED|Overall Study||7||
60044326|NCT02194465|76160096|FG002|NOT COMPLETED|Overall Study||8||
60044327|NCT02194465|76160097|FG003|NOT COMPLETED|Overall Study||8||
60044328|NCT02194465|76160098|FG004|NOT COMPLETED|Overall Study||9||
60044329|NCT02194465|76160099|FG005|NOT COMPLETED|Overall Study||4||
60044330|NCT02194465|76160100|FG006|NOT COMPLETED|Overall Study||2||
60044331|NCT02287025|76160122|FG000|STARTED|Overall Study||12||6
60044332|NCT02287025|76160123|FG001|STARTED|Overall Study||11||4
60044333|NCT02287025|76160122|FG000|COMPLETED|Overall Study||2||6
60044334|NCT02287025|76160123|FG001|COMPLETED|Overall Study||2||4
60044335|NCT02287025|76160122|FG000|NOT COMPLETED|Overall Study||10||0
60044336|NCT02287025|76160123|FG001|NOT COMPLETED|Overall Study||9||0
60044337|NCT01720264|76160127|FG000|STARTED|Transplant With Sitagliptin for 15 Days||15||
60044338|NCT01720264|76160127|FG000|COMPLETED|Transplant With Sitagliptin for 15 Days||14||
60044339|NCT01720264|76160127|FG000|NOT COMPLETED|Transplant With Sitagliptin for 15 Days||1||
60044340|NCT01720264|76160127|FG000|STARTED|Post-transplant (Day 16) to 1 Year||14||
60044341|NCT01720264|76160127|FG000|COMPLETED|Post-transplant (Day 16) to 1 Year||2||
60044342|NCT01720264|76160127|FG000|NOT COMPLETED|Post-transplant (Day 16) to 1 Year||12||
60044343|NCT01702246|76160131|FG000|STARTED|Overall Study||24||
60044344|NCT01702246|76160131|FG000|COMPLETED|Overall Study||19||
60044345|NCT01702246|76160131|FG000|NOT COMPLETED|Overall Study||5||
60044346|NCT01631227|76160140|FG000|STARTED|Overall Study||333||
60044347|NCT01631227|76160141|FG001|STARTED|Overall Study||332||
60044348|NCT01631227|76160140|FG000|Safety Subject Sample|Overall Study|1 patient was randomized by mistake and never received study medication.|332||
60044349|NCT01631227|76160141|FG001|Safety Subject Sample|Overall Study||332||
60044350|NCT01631227|76160140|FG000|Full Analysis Set Population|Overall Study|2 patients not eligible for the Full Analysis Set due to missing post-baseline efficacy measurement|330||
60044351|NCT01631227|76160141|FG001|Full Analysis Set Population|Overall Study|1 patient not eligible for the Full Analysis Set due to missing post-baseline efficacy measurement|331||
59759754|NCT00597519|75879176|FG000|NOT COMPLETED|Overall Study||1||
59759755|NCT00879333|75879182|FG000|STARTED|Overall Study||439||
59759756|NCT00879333|75879183|FG001|STARTED|Overall Study||217||
60044352|NCT01631227|76160140|FG000|COMPLETED|Overall Study||303||
60044353|NCT01631227|76160141|FG001|COMPLETED|Overall Study||310||
60044354|NCT01631227|76160140|FG000|NOT COMPLETED|Overall Study||30||
60044355|NCT01631227|76160141|FG001|NOT COMPLETED|Overall Study||22||
60044356|NCT01719172|76160147|FG000|STARTED|Overall Study||30||
60044357|NCT01719172|76160147|FG000|COMPLETED|Overall Study||28||
60044358|NCT01719172|76160147|FG000|NOT COMPLETED|Overall Study||2||
60044359|NCT02286947|76160151|FG000|STARTED|Overall Study||24||
60044360|NCT02286947|76160151|FG000|COMPLETED|Overall Study||22||
60044361|NCT02286947|76160151|FG000|NOT COMPLETED|Overall Study||2||
60044362|NCT02286713|76160159|FG000|STARTED|One Week Follow-Up||259||
60044363|NCT02286713|76160160|FG001|STARTED|One Week Follow-Up||257||
60044364|NCT02286713|76160159|FG000|COMPLETED|One Week Follow-Up||235||
60044365|NCT02286713|76160160|FG001|COMPLETED|One Week Follow-Up||233||
60044366|NCT02286713|76160159|FG000|NOT COMPLETED|One Week Follow-Up||24||
60044367|NCT02286713|76160160|FG001|NOT COMPLETED|One Week Follow-Up||24||
60044368|NCT02286713|76160159|FG000|STARTED|Three Month Follow-Up||252||
60044369|NCT02286713|76160160|FG001|STARTED|Three Month Follow-Up||254||
60044370|NCT02286713|76160159|FG000|COMPLETED|Three Month Follow-Up||224||
60044371|NCT02286713|76160160|FG001|COMPLETED|Three Month Follow-Up||228||
60044372|NCT02286713|76160159|FG000|NOT COMPLETED|Three Month Follow-Up||28||
60044373|NCT02286713|76160160|FG001|NOT COMPLETED|Three Month Follow-Up||26||
60044374|NCT02286713|76160159|FG000|STARTED|Six Month Follow-Up||250||
60044375|NCT02286713|76160160|FG001|STARTED|Six Month Follow-Up||252||
60044376|NCT02286713|76160159|FG000|COMPLETED|Six Month Follow-Up||218||
60044377|NCT02286713|76160160|FG001|COMPLETED|Six Month Follow-Up||225||
60044378|NCT02286713|76160159|FG000|NOT COMPLETED|Six Month Follow-Up||32||
59759757|NCT00879333|75879182|FG000|Discontinued Study Treatment|Overall Study||428||
59759758|NCT00879333|75879183|FG001|Discontinued Study Treatment|Overall Study||217||
59759759|NCT00879333|75879182|FG000|COMPLETED|Overall Study|Completed=Patients Still on Treatment; At data cutoff final analysis, 11 patients were on treatment|11||
59759760|NCT00879333|75879183|FG001|COMPLETED|Overall Study||0||
59759761|NCT00879333|75879182|FG000|NOT COMPLETED|Overall Study||428||
59759762|NCT00879333|75879183|FG001|NOT COMPLETED|Overall Study||217||
59759763|NCT03481556|75879195|FG000|STARTED|Overall Study||15||
59759764|NCT03481556|75879196|FG001|STARTED|Overall Study||8||
60044379|NCT02286713|76160160|FG001|NOT COMPLETED|Six Month Follow-Up||27||
60044380|NCT02285855|76160168|FG000|STARTED|Overall Study||16||
60044381|NCT02285855|76160169|FG001|STARTED|Overall Study||2||
60044382|NCT02285855|76160168|FG000|Randomized|Overall Study||16||
60044383|NCT02285855|76160169|FG001|Randomized|Overall Study||2||
60044384|NCT02285855|76160168|FG000|COMPLETED|Overall Study||14||
60044385|NCT02285855|76160169|FG001|COMPLETED|Overall Study||1||
60044386|NCT02285855|76160168|FG000|NOT COMPLETED|Overall Study||2||
60044387|NCT02285855|76160169|FG001|NOT COMPLETED|Overall Study||1||
60044388|NCT02285777|76160177|FG000|STARTED|Overall Study||95||
60044389|NCT02285777|76160178|FG001|STARTED|Overall Study||94||
60044390|NCT02285777|76160177|FG000|COMPLETED|Overall Study||90||
60044391|NCT02285777|76160178|FG001|COMPLETED|Overall Study||91||
60044392|NCT02285777|76160177|FG000|NOT COMPLETED|Overall Study||5||
60044393|NCT02285777|76160178|FG001|NOT COMPLETED|Overall Study||3||
60044394|NCT02285153|76160186|FG000|STARTED|Overall Study||7||
60044395|NCT02285153|76160187|FG001|STARTED|Overall Study||8||
60044396|NCT02285153|76160186|FG000|COMPLETED|Overall Study||6||
60044397|NCT02285153|76160187|FG001|COMPLETED|Overall Study||8||
60044398|NCT02285153|76160186|FG000|NOT COMPLETED|Overall Study||1||
60044399|NCT02285153|76160187|FG001|NOT COMPLETED|Overall Study||0||
60044400|NCT02284373|76160196|FG000|STARTED|Overall Study||5||
60044401|NCT02284373|76160197|FG001|STARTED|Overall Study||5||
60044402|NCT02284373|76160198|FG002|STARTED|Overall Study||29||
60044403|NCT02284373|76160196|FG000|COMPLETED|Overall Study||5||
60044404|NCT02284373|76160197|FG001|COMPLETED|Overall Study||2||
60044405|NCT02284373|76160198|FG002|COMPLETED|Overall Study||29||
60044406|NCT02284373|76160196|FG000|NOT COMPLETED|Overall Study||0||
60044407|NCT02284373|76160197|FG001|NOT COMPLETED|Overall Study||3||
60044408|NCT02284373|76160198|FG002|NOT COMPLETED|Overall Study||0||
60044409|NCT01632241|76160208|FG000|STARTED|Double-blinded (Up to Week 52)||165||
60044410|NCT01632241|76160209|FG001|STARTED|Double-blinded (Up to Week 52)||331||
60044411|NCT01632241|76160208|FG000|COMPLETED|Double-blinded (Up to Week 52)||121||
60044412|NCT01632241|76160209|FG001|COMPLETED|Double-blinded (Up to Week 52)||252||
60044413|NCT01632241|76160208|FG000|NOT COMPLETED|Double-blinded (Up to Week 52)||44||
60044414|NCT01632241|76160209|FG001|NOT COMPLETED|Double-blinded (Up to Week 52)||79||
60044415|NCT01632241|76160208|FG000|STARTED|Open-label (Week 52 to Week 76)|As the OL phase was optional, participants did not choose to enter the OL Phase.|117||
60044416|NCT01632241|76160209|FG001|STARTED|Open-label (Week 52 to Week 76)|As the OL phase was optional, participants did not choose to enter the OL Phase.|242||
60044417|NCT01632241|76160208|FG000|COMPLETED|Open-label (Week 52 to Week 76)||107||
60044418|NCT01632241|76160209|FG001|COMPLETED|Open-label (Week 52 to Week 76)||220||
60044419|NCT01632241|76160208|FG000|NOT COMPLETED|Open-label (Week 52 to Week 76)||10||
60044420|NCT01632241|76160209|FG001|NOT COMPLETED|Open-label (Week 52 to Week 76)||22||
60044421|NCT02263508|76160224|FG000|STARTED|Overall Study||21||
60044422|NCT02263508|76160225|FG001|STARTED|Overall Study||346||
60044423|NCT02263508|76160226|FG002|STARTED|Overall Study||346||
60044424|NCT02263508|76160224|FG000|Received Talimogene Laherparepvec/Placebo|Overall Study||21||
60044425|NCT02263508|76160225|FG001|Received Talimogene Laherparepvec/Placebo|Overall Study||345||
60044426|NCT02263508|76160226|FG002|Received Talimogene Laherparepvec/Placebo|Overall Study||343||
60044427|NCT02263508|76160224|FG000|Received Pembrolizumab|Overall Study||21||
60044428|NCT02263508|76160225|FG001|Received Pembrolizumab|Overall Study||345||
60044429|NCT02263508|76160226|FG002|Received Pembrolizumab|Overall Study||343||
60044430|NCT02263508|76160224|FG000|COMPLETED|Overall Study||0||
60044431|NCT02263508|76160225|FG001|COMPLETED|Overall Study||0||
60044432|NCT02263508|76160226|FG002|COMPLETED|Overall Study||0||
60044433|NCT02263508|76160224|FG000|NOT COMPLETED|Overall Study||21||
60044434|NCT02263508|76160225|FG001|NOT COMPLETED|Overall Study||346||
60044435|NCT02263508|76160226|FG002|NOT COMPLETED|Overall Study||346||
60044436|NCT02291432|76160237|FG000|STARTED|Overall Study||25||
60044437|NCT02291432|76160237|FG000|Muscle Biopsy|Overall Study||25||
60044438|NCT02291432|76160237|FG000|AMDC Injection|Overall Study||23||
60044439|NCT02291432|76160237|FG000|1-Month Follow Up|Overall Study||23||
60044440|NCT02291432|76160237|FG000|3-Month Follow Up|Overall Study||23||
60044441|NCT02291432|76160237|FG000|6-Month Follow Up|Overall Study||23||
60044442|NCT02291432|76160237|FG000|12-Month Follow Up|Overall Study||23||
60044443|NCT02291432|76160237|FG000|COMPLETED|Overall Study||23||
60044444|NCT02291432|76160237|FG000|NOT COMPLETED|Overall Study||2||
60044445|NCT02290340|76160245|FG000|STARTED|Overall Study||18||
60044446|NCT02290340|76160246|FG001|STARTED|Overall Study||8||
60044447|NCT02290340|76160247|FG002|STARTED|Overall Study||31||
60044448|NCT02290340|76160248|FG003|STARTED|Overall Study||32||
60044449|NCT02290340|76160245|FG000|COMPLETED|Overall Study||16||
60044450|NCT02290340|76160246|FG001|COMPLETED|Overall Study||8||
60044451|NCT02290340|76160247|FG002|COMPLETED|Overall Study||31||
60044452|NCT02290340|76160248|FG003|COMPLETED|Overall Study||30||
59759765|NCT03481556|75879197|FG002|STARTED|Overall Study||6||
59759766|NCT03481556|75879198|FG003|STARTED|Overall Study||27||
59759767|NCT03481556|75879195|FG000|COMPLETED|Overall Study||0||
59759768|NCT03481556|75879196|FG001|COMPLETED|Overall Study||1||
59759769|NCT03481556|75879197|FG002|COMPLETED|Overall Study||1||
59759770|NCT03481556|75879198|FG003|COMPLETED|Overall Study||2||
60044453|NCT02290340|76160245|FG000|NOT COMPLETED|Overall Study||2||
60044454|NCT02290340|76160246|FG001|NOT COMPLETED|Overall Study||0||
60044455|NCT02290340|76160247|FG002|NOT COMPLETED|Overall Study||0||
60044456|NCT02290340|76160248|FG003|NOT COMPLETED|Overall Study||2||
60044457|NCT02290028|76160261|FG000|STARTED|Overall Study||2226||
60044458|NCT02290028|76160261|FG000|COMPLETED|Overall Study||0||
60044459|NCT02290028|76160261|FG000|NOT COMPLETED|Overall Study||2226||
60044460|NCT01741792|76160271|FG000|STARTED|Overall Study|3 participants were not considered evaluable and were replaced as specified in the protocol.|9||
60044461|NCT01741792|76160272|FG001|STARTED|Overall Study|Cohort 2 was closed to enrollment on recommendation of the data monitoring committee|2||
60044462|NCT01741792|76160273|FG002|STARTED|Overall Study||14||
60044463|NCT01741792|76160271|FG000|Efficacy Set|Overall Study|Completed > 7 days of infusion on the highest intended dose level or discontinued due to progression|7||
60044464|NCT01741792|76160272|FG001|Efficacy Set|Overall Study|Completed > 7 days of infusion on the highest intended dose level or discontinued due to progression|1||
60044465|NCT01741792|76160273|FG002|Efficacy Set|Overall Study|Completed > 7 days of infusion on the highest intended dose level or discontinued due to progression|13||
60044466|NCT01741792|76160271|FG000|COMPLETED|Overall Study||3||
60044467|NCT01741792|76160272|FG001|COMPLETED|Overall Study||1||
60044468|NCT01741792|76160273|FG002|COMPLETED|Overall Study||2||
60044469|NCT01741792|76160271|FG000|NOT COMPLETED|Overall Study||6||
60044470|NCT01741792|76160272|FG001|NOT COMPLETED|Overall Study||1||
60044471|NCT01741792|76160273|FG002|NOT COMPLETED|Overall Study||12||
60044472|NCT02289950|76160289|FG000|STARTED|Overall Study||142|214|
60044473|NCT02289950|76160290|FG001|STARTED|Overall Study||72|214|
60044474|NCT02289950|76160289|FG000|Treated|Overall Study|1 participant randomized to placebo group but was treated with farletuzumab, and was analyzed in the farletuzumab group in safety analysis set.|140||
60044475|NCT02289950|76160290|FG001|Treated|Overall Study||71||
60044476|NCT02289950|76160289|FG000|COMPLETED|Overall Study||0||
60044477|NCT02289950|76160290|FG001|COMPLETED|Overall Study||0||
60044478|NCT02289950|76160289|FG000|NOT COMPLETED|Overall Study||142||
60044479|NCT02289950|76160290|FG001|NOT COMPLETED|Overall Study||72||
60044480|NCT01741012|76160296|FG000|STARTED|Overall Study||37||
60044481|NCT01741012|76160296|FG000|COMPLETED|Overall Study||34||
60044482|NCT01741012|76160296|FG000|NOT COMPLETED|Overall Study||3||
60044483|NCT02288312|76160304|FG000|STARTED|Overall Study||6||
60044484|NCT02288312|76160305|FG001|STARTED|Overall Study||6||
60044485|NCT02288312|76160306|FG002|STARTED|Overall Study||6||
60044486|NCT02288312|76160304|FG000|COMPLETED|Overall Study||5||
60044487|NCT02288312|76160305|FG001|COMPLETED|Overall Study||6||
60044488|NCT02288312|76160306|FG002|COMPLETED|Overall Study||6||
60044489|NCT02288312|76160304|FG000|NOT COMPLETED|Overall Study||1||
60044490|NCT02288312|76160305|FG001|NOT COMPLETED|Overall Study||0||
60044491|NCT02288312|76160306|FG002|NOT COMPLETED|Overall Study||0||
60044492|NCT01740388|76160316|FG000|STARTED|Overall Study||64||
60044493|NCT01740388|76160317|FG001|STARTED|Overall Study||72||
60044494|NCT01740388|76160316|FG000|COMPLETED|Overall Study||18||
60044495|NCT01740388|76160317|FG001|COMPLETED|Overall Study||28||
60044496|NCT01740388|76160316|FG000|NOT COMPLETED|Overall Study||46||
60044497|NCT01740388|76160317|FG001|NOT COMPLETED|Overall Study||44||
60044498|NCT01740154|76160323|FG000|STARTED|Overall Study||13||
60044499|NCT01740154|76160323|FG000|COMPLETED|Overall Study||12||
60044500|NCT01740154|76160323|FG000|NOT COMPLETED|Overall Study||1||
60044501|NCT02287922|76160331|FG000|STARTED|Overall Study||62||
60044502|NCT02287922|76160332|FG001|STARTED|Overall Study||62||
60044503|NCT02287922|76160333|FG002|STARTED|Overall Study||63||
60044504|NCT02287922|76160334|FG003|STARTED|Overall Study||64||
60044505|NCT02287922|76160331|FG000|COMPLETED|Overall Study||59||
60044506|NCT02287922|76160332|FG001|COMPLETED|Overall Study||60||
60044507|NCT02287922|76160333|FG002|COMPLETED|Overall Study||56||
60044508|NCT02287922|76160334|FG003|COMPLETED|Overall Study||57||
60044509|NCT02287922|76160331|FG000|NOT COMPLETED|Overall Study||3||
60044510|NCT02287922|76160332|FG001|NOT COMPLETED|Overall Study||2||
60044511|NCT02287922|76160333|FG002|NOT COMPLETED|Overall Study||7||
60044512|NCT02287922|76160334|FG003|NOT COMPLETED|Overall Study||7||
60044513|NCT02287610|76160345|FG000|STARTED|Overall Study||64||
60044514|NCT02287610|76160345|FG000|Per Protocol Follow-Up|Overall Study||56||
60044515|NCT02287610|76160345|FG000|COMPLETED|Overall Study||48||
60044516|NCT02287610|76160345|FG000|NOT COMPLETED|Overall Study||16||
60044517|NCT02262728|76160351|FG000|STARTED|Treatment Period (12 Weeks)||19||
60044518|NCT02262728|76160352|FG001|STARTED|Treatment Period (12 Weeks)||21||
60044519|NCT02262728|76160351|FG000|COMPLETED|Treatment Period (12 Weeks)|Participants who completed continued follow-up phase.|19||
60044520|NCT02262728|76160352|FG001|COMPLETED|Treatment Period (12 Weeks)|Participants who completed continued follow-up phase.|21||
60044521|NCT02262728|76160351|FG000|NOT COMPLETED|Treatment Period (12 Weeks)||0||
60044522|NCT02262728|76160352|FG001|NOT COMPLETED|Treatment Period (12 Weeks)||0||
60044523|NCT02262728|76160351|FG000|STARTED|Follow-up Phase (3 Years)||19||
60044524|NCT02262728|76160352|FG001|STARTED|Follow-up Phase (3 Years)||21||
60044525|NCT02262728|76160351|FG000|COMPLETED|Follow-up Phase (3 Years)||15||
60044526|NCT02262728|76160352|FG001|COMPLETED|Follow-up Phase (3 Years)||18||
60044527|NCT02262728|76160351|FG000|NOT COMPLETED|Follow-up Phase (3 Years)||4||
60044528|NCT02262728|76160352|FG001|NOT COMPLETED|Follow-up Phase (3 Years)||3||
60044529|NCT02262260|76160360|FG000|STARTED|Overall Study||45||
60044530|NCT02262260|76160361|FG001|STARTED|Overall Study||42||
60044531|NCT02262260|76160360|FG000|COMPLETED|Overall Study||34||
60044532|NCT02262260|76160361|FG001|COMPLETED|Overall Study||32||
60044533|NCT02262260|76160360|FG000|NOT COMPLETED|Overall Study||11||
60044534|NCT02262260|76160361|FG001|NOT COMPLETED|Overall Study||10||
60044535|NCT02285270|76160367|FG000|STARTED|Overall Study||10||
60044536|NCT02285270|76160367|FG000|COMPLETED|Overall Study||5||
60044537|NCT02285270|76160367|FG000|NOT COMPLETED|Overall Study||5||
60044538|NCT01717768|76160381|FG000|STARTED|Part 1 (Duration of 15 Days)||17||
60044539|NCT01717768|76160382|FG001|STARTED|Part 1 (Duration of 15 Days)||17||
60044540|NCT01717768|76160383|FG002|STARTED|Part 1 (Duration of 15 Days)||0||
60044541|NCT01717768|76160384|FG003|STARTED|Part 1 (Duration of 15 Days)||0||
60044542|NCT01717768|76160385|FG004|STARTED|Part 1 (Duration of 15 Days)||0||
60044543|NCT01717768|76160386|FG005|STARTED|Part 1 (Duration of 15 Days)||0||
60044544|NCT01717768|76160387|FG006|STARTED|Part 1 (Duration of 15 Days)||0||
60044545|NCT01717768|76160388|FG007|STARTED|Part 1 (Duration of 15 Days)||0||
60044546|NCT01717768|76160389|FG008|STARTED|Part 1 (Duration of 15 Days)||0||
60044547|NCT01717768|76160390|FG009|STARTED|Part 1 (Duration of 15 Days)||0||
60044548|NCT01717768|76160391|FG010|STARTED|Part 1 (Duration of 15 Days)||0||
60044549|NCT01717768|76160392|FG011|STARTED|Part 1 (Duration of 15 Days)||0||
60044550|NCT01717768|76160381|FG000|COMPLETED|Part 1 (Duration of 15 Days)||17||
60044551|NCT01717768|76160382|FG001|COMPLETED|Part 1 (Duration of 15 Days)||16||
60044552|NCT01717768|76160383|FG002|COMPLETED|Part 1 (Duration of 15 Days)||0||
60044553|NCT01717768|76160384|FG003|COMPLETED|Part 1 (Duration of 15 Days)||0||
60044554|NCT01717768|76160385|FG004|COMPLETED|Part 1 (Duration of 15 Days)||0||
60044555|NCT01717768|76160386|FG005|COMPLETED|Part 1 (Duration of 15 Days)||0||
60044556|NCT01717768|76160387|FG006|COMPLETED|Part 1 (Duration of 15 Days)||0||
60044557|NCT01717768|76160388|FG007|COMPLETED|Part 1 (Duration of 15 Days)||0||
60044558|NCT01717768|76160389|FG008|COMPLETED|Part 1 (Duration of 15 Days)||0||
60044559|NCT01717768|76160390|FG009|COMPLETED|Part 1 (Duration of 15 Days)||0||
60044560|NCT01717768|76160391|FG010|COMPLETED|Part 1 (Duration of 15 Days)||0||
60044561|NCT01717768|76160392|FG011|COMPLETED|Part 1 (Duration of 15 Days)||0||
60044562|NCT01717768|76160381|FG000|NOT COMPLETED|Part 1 (Duration of 15 Days)||0||
60044563|NCT01717768|76160382|FG001|NOT COMPLETED|Part 1 (Duration of 15 Days)||1||
60044564|NCT01717768|76160383|FG002|NOT COMPLETED|Part 1 (Duration of 15 Days)||0||
60044565|NCT01717768|76160384|FG003|NOT COMPLETED|Part 1 (Duration of 15 Days)||0||
60044566|NCT01717768|76160385|FG004|NOT COMPLETED|Part 1 (Duration of 15 Days)||0||
60044567|NCT01717768|76160386|FG005|NOT COMPLETED|Part 1 (Duration of 15 Days)||0||
60044568|NCT01717768|76160387|FG006|NOT COMPLETED|Part 1 (Duration of 15 Days)||0||
60044569|NCT01717768|76160388|FG007|NOT COMPLETED|Part 1 (Duration of 15 Days)||0||
60044570|NCT01717768|76160389|FG008|NOT COMPLETED|Part 1 (Duration of 15 Days)||0||
60044571|NCT01717768|76160390|FG009|NOT COMPLETED|Part 1 (Duration of 15 Days)||0||
60044572|NCT01717768|76160391|FG010|NOT COMPLETED|Part 1 (Duration of 15 Days)||0||
60044573|NCT01717768|76160392|FG011|NOT COMPLETED|Part 1 (Duration of 15 Days)||0||
60044574|NCT01717768|76160381|FG000|STARTED|Part 2 (Duration of 15 Days)||0||
60044575|NCT01717768|76160382|FG001|STARTED|Part 2 (Duration of 15 Days)||0||
60044576|NCT01717768|76160383|FG002|STARTED|Part 2 (Duration of 15 Days)||17||
60044577|NCT01717768|76160384|FG003|STARTED|Part 2 (Duration of 15 Days)||0||
60044578|NCT01717768|76160385|FG004|STARTED|Part 2 (Duration of 15 Days)||0||
60044579|NCT01717768|76160386|FG005|STARTED|Part 2 (Duration of 15 Days)||0||
60044580|NCT01717768|76160387|FG006|STARTED|Part 2 (Duration of 15 Days)||0||
60044581|NCT01717768|76160388|FG007|STARTED|Part 2 (Duration of 15 Days)||0||
60044582|NCT01717768|76160389|FG008|STARTED|Part 2 (Duration of 15 Days)||0||
60044583|NCT01717768|76160390|FG009|STARTED|Part 2 (Duration of 15 Days)||0||
60044584|NCT01717768|76160391|FG010|STARTED|Part 2 (Duration of 15 Days)||0||
60044585|NCT01717768|76160392|FG011|STARTED|Part 2 (Duration of 15 Days)||0||
60044586|NCT01717768|76160381|FG000|COMPLETED|Part 2 (Duration of 15 Days)||0||
60044587|NCT01717768|76160382|FG001|COMPLETED|Part 2 (Duration of 15 Days)||0||
60044588|NCT01717768|76160383|FG002|COMPLETED|Part 2 (Duration of 15 Days)||17||
60044589|NCT01717768|76160384|FG003|COMPLETED|Part 2 (Duration of 15 Days)||0||
60044590|NCT01717768|76160385|FG004|COMPLETED|Part 2 (Duration of 15 Days)||0||
60044591|NCT01717768|76160386|FG005|COMPLETED|Part 2 (Duration of 15 Days)||0||
60044592|NCT01717768|76160387|FG006|COMPLETED|Part 2 (Duration of 15 Days)||0||
60044593|NCT01717768|76160388|FG007|COMPLETED|Part 2 (Duration of 15 Days)||0||
60044594|NCT01717768|76160389|FG008|COMPLETED|Part 2 (Duration of 15 Days)||0||
60044595|NCT01717768|76160390|FG009|COMPLETED|Part 2 (Duration of 15 Days)||0||
60044596|NCT01717768|76160391|FG010|COMPLETED|Part 2 (Duration of 15 Days)||0||
60044597|NCT01717768|76160392|FG011|COMPLETED|Part 2 (Duration of 15 Days)||0||
60044598|NCT01717768|76160381|FG000|NOT COMPLETED|Part 2 (Duration of 15 Days)||0||
60044599|NCT01717768|76160382|FG001|NOT COMPLETED|Part 2 (Duration of 15 Days)||0||
60044600|NCT01717768|76160383|FG002|NOT COMPLETED|Part 2 (Duration of 15 Days)||0||
60044601|NCT01717768|76160384|FG003|NOT COMPLETED|Part 2 (Duration of 15 Days)||0||
60044602|NCT01717768|76160385|FG004|NOT COMPLETED|Part 2 (Duration of 15 Days)||0||
60044603|NCT01717768|76160386|FG005|NOT COMPLETED|Part 2 (Duration of 15 Days)||0||
60044604|NCT01717768|76160387|FG006|NOT COMPLETED|Part 2 (Duration of 15 Days)||0||
60044605|NCT01717768|76160388|FG007|NOT COMPLETED|Part 2 (Duration of 15 Days)||0||
60044606|NCT01717768|76160389|FG008|NOT COMPLETED|Part 2 (Duration of 15 Days)||0||
60044607|NCT01717768|76160390|FG009|NOT COMPLETED|Part 2 (Duration of 15 Days)||0||
60044608|NCT01717768|76160391|FG010|NOT COMPLETED|Part 2 (Duration of 15 Days)||0||
60044609|NCT01717768|76160392|FG011|NOT COMPLETED|Part 2 (Duration of 15 Days)||0||
60044610|NCT01717768|76160381|FG000|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0||
60044611|NCT01717768|76160382|FG001|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0||
60044612|NCT01717768|76160383|FG002|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0||
60044613|NCT01717768|76160384|FG003|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||4||
60044614|NCT01717768|76160385|FG004|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||5||
60044615|NCT01717768|76160386|FG005|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||5||
60044616|NCT01717768|76160387|FG006|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0||
60044617|NCT01717768|76160388|FG007|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0||
60044618|NCT01717768|76160389|FG008|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0||
60044619|NCT01717768|76160390|FG009|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0||
60044620|NCT01717768|76160391|FG010|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0||
60044621|NCT01717768|76160392|FG011|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0||
60044622|NCT01717768|76160381|FG000|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0||
60044623|NCT01717768|76160382|FG001|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0||
60044624|NCT01717768|76160383|FG002|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0||
60044625|NCT01717768|76160384|FG003|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||4||
60044626|NCT01717768|76160385|FG004|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||5||
60044627|NCT01717768|76160386|FG005|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||5||
60044628|NCT01717768|76160387|FG006|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0||
60044629|NCT01717768|76160388|FG007|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0||
60044630|NCT01717768|76160389|FG008|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0||
60044631|NCT01717768|76160390|FG009|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0||
60044632|NCT01717768|76160391|FG010|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0||
60044633|NCT01717768|76160392|FG011|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0||
60044634|NCT01717768|76160381|FG000|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0||
60044635|NCT01717768|76160382|FG001|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0||
60044636|NCT01717768|76160383|FG002|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0||
60044637|NCT01717768|76160384|FG003|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0||
60044638|NCT01717768|76160385|FG004|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0||
60044639|NCT01717768|76160386|FG005|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0||
60044640|NCT01717768|76160387|FG006|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0||
60044641|NCT01717768|76160388|FG007|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0||
60044642|NCT01717768|76160389|FG008|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0||
60044643|NCT01717768|76160390|FG009|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0||
60044644|NCT01717768|76160391|FG010|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0||
60044645|NCT01717768|76160392|FG011|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0||
60044646|NCT01717768|76160381|FG000|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0||
60044647|NCT01717768|76160382|FG001|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0||
60044648|NCT01717768|76160383|FG002|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0||
60044649|NCT01717768|76160384|FG003|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||4||
60044650|NCT01717768|76160385|FG004|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||5||
60044651|NCT01717768|76160386|FG005|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||5||
60044652|NCT01717768|76160387|FG006|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0||
60044653|NCT01717768|76160388|FG007|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0||
60044654|NCT01717768|76160389|FG008|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0||
60044655|NCT01717768|76160390|FG009|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0||
60044656|NCT01717768|76160391|FG010|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0||
60044657|NCT01717768|76160392|FG011|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0||
60044658|NCT01717768|76160381|FG000|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0||
60044659|NCT01717768|76160382|FG001|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0||
60044660|NCT01717768|76160383|FG002|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0||
60044661|NCT01717768|76160384|FG003|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||4||
60044662|NCT01717768|76160385|FG004|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||5||
60044663|NCT01717768|76160386|FG005|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||5||
60044664|NCT01717768|76160387|FG006|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0||
60044665|NCT01717768|76160388|FG007|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0||
60044666|NCT01717768|76160389|FG008|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0||
60044667|NCT01717768|76160390|FG009|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0||
60044668|NCT01717768|76160391|FG010|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0||
60044669|NCT01717768|76160392|FG011|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0||
60044670|NCT01717768|76160381|FG000|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0||
60044671|NCT01717768|76160382|FG001|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0||
60044672|NCT01717768|76160383|FG002|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0||
60044673|NCT01717768|76160384|FG003|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0||
60044674|NCT01717768|76160385|FG004|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0||
60044675|NCT01717768|76160386|FG005|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0||
60044676|NCT01717768|76160387|FG006|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0||
60044677|NCT01717768|76160388|FG007|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0||
60044678|NCT01717768|76160389|FG008|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0||
60044679|NCT01717768|76160390|FG009|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0||
60044680|NCT01717768|76160391|FG010|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0||
60044681|NCT01717768|76160392|FG011|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0||
60044682|NCT01717768|76160381|FG000|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0||
60044683|NCT01717768|76160382|FG001|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0||
60044684|NCT01717768|76160383|FG002|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0||
60044685|NCT01717768|76160384|FG003|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||4||
60044686|NCT01717768|76160385|FG004|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||5||
60044687|NCT01717768|76160386|FG005|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||5||
60044688|NCT01717768|76160387|FG006|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0||
60044689|NCT01717768|76160388|FG007|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0||
60044690|NCT01717768|76160389|FG008|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0||
60044691|NCT01717768|76160390|FG009|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0||
60044692|NCT01717768|76160391|FG010|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0||
60044693|NCT01717768|76160392|FG011|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0||
60044694|NCT01717768|76160381|FG000|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0||
60044695|NCT01717768|76160382|FG001|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0||
60044696|NCT01717768|76160383|FG002|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0||
60044697|NCT01717768|76160384|FG003|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||4||
60044698|NCT01717768|76160385|FG004|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||5||
60044699|NCT01717768|76160386|FG005|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||5||
60044700|NCT01717768|76160387|FG006|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0||
60044701|NCT01717768|76160388|FG007|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0||
60044702|NCT01717768|76160389|FG008|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0||
60044703|NCT01717768|76160390|FG009|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0||
60044704|NCT01717768|76160391|FG010|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0||
60044705|NCT01717768|76160392|FG011|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0||
60044706|NCT01717768|76160381|FG000|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0||
60044707|NCT01717768|76160382|FG001|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0||
60044708|NCT01717768|76160383|FG002|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0||
60044709|NCT01717768|76160384|FG003|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0||
60044710|NCT01717768|76160385|FG004|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0||
60044711|NCT01717768|76160386|FG005|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0||
60044712|NCT01717768|76160387|FG006|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0||
60044713|NCT01717768|76160388|FG007|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0||
60044714|NCT01717768|76160389|FG008|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0||
60044715|NCT01717768|76160390|FG009|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0||
60044716|NCT01717768|76160391|FG010|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0||
60044717|NCT01717768|76160392|FG011|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0||
60044718|NCT01717768|76160381|FG000|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0||
60044719|NCT01717768|76160382|FG001|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0||
60044720|NCT01717768|76160383|FG002|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0||
60044721|NCT01717768|76160384|FG003|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0||
60044722|NCT01717768|76160385|FG004|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0||
60044723|NCT01717768|76160386|FG005|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0||
60044724|NCT01717768|76160387|FG006|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||17||
60044725|NCT01717768|76160388|FG007|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0||
60044726|NCT01717768|76160389|FG008|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||16||
60044727|NCT01717768|76160390|FG009|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0||
60044728|NCT01717768|76160391|FG010|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||16||
60044729|NCT01717768|76160392|FG011|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||16||
60044730|NCT01717768|76160381|FG000|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0||
60044731|NCT01717768|76160382|FG001|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0||
60044732|NCT01717768|76160383|FG002|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0||
60044733|NCT01717768|76160384|FG003|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0||
60044734|NCT01717768|76160385|FG004|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0||
60044735|NCT01717768|76160386|FG005|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0||
60044736|NCT01717768|76160387|FG006|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||17||
60044737|NCT01717768|76160388|FG007|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0||
60044738|NCT01717768|76160389|FG008|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||16||
60044739|NCT01717768|76160390|FG009|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0||
60044740|NCT01717768|76160391|FG010|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||16||
60044741|NCT01717768|76160392|FG011|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||15||
60044742|NCT01717768|76160381|FG000|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0||
60044743|NCT01717768|76160382|FG001|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0||
60044744|NCT01717768|76160383|FG002|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0||
60044745|NCT01717768|76160384|FG003|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0||
60044746|NCT01717768|76160385|FG004|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0||
59511368|NCT02740582|75604977|FG001|COMPLETED|Washout||31||
60044747|NCT01717768|76160386|FG005|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0||
60044748|NCT01717768|76160387|FG006|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0||
60044749|NCT01717768|76160388|FG007|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0||
60044750|NCT01717768|76160389|FG008|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0||
60044751|NCT01717768|76160390|FG009|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0||
60044752|NCT01717768|76160391|FG010|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0||
60044753|NCT01717768|76160392|FG011|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||1||
60044754|NCT01717768|76160381|FG000|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0||
60044755|NCT01717768|76160382|FG001|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0||
60044756|NCT01717768|76160383|FG002|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0||
60044757|NCT01717768|76160384|FG003|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0||
60044758|NCT01717768|76160385|FG004|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0||
60044759|NCT01717768|76160386|FG005|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0||
60044760|NCT01717768|76160387|FG006|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0||
60044761|NCT01717768|76160388|FG007|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||17||
60044762|NCT01717768|76160389|FG008|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0||
60044763|NCT01717768|76160390|FG009|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||16||
60044764|NCT01717768|76160391|FG010|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0||
60044765|NCT01717768|76160392|FG011|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0||
60044766|NCT01717768|76160381|FG000|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0||
60044767|NCT01717768|76160382|FG001|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0||
60044768|NCT01717768|76160383|FG002|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0||
60044769|NCT01717768|76160384|FG003|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0||
60044770|NCT01717768|76160385|FG004|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0||
60044771|NCT01717768|76160386|FG005|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0||
60044772|NCT01717768|76160387|FG006|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0||
60044773|NCT01717768|76160388|FG007|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||15||
60044774|NCT01717768|76160389|FG008|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0||
60044775|NCT01717768|76160390|FG009|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||15||
60044776|NCT01717768|76160391|FG010|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0||
60044777|NCT01717768|76160392|FG011|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0||
60044778|NCT01717768|76160381|FG000|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0||
60044779|NCT01717768|76160382|FG001|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0||
60044780|NCT01717768|76160383|FG002|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0||
60044781|NCT01717768|76160384|FG003|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0||
60044782|NCT01717768|76160385|FG004|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0||
60044783|NCT01717768|76160386|FG005|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0||
60044784|NCT01717768|76160387|FG006|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0||
60044785|NCT01717768|76160388|FG007|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||2||
60044786|NCT01717768|76160389|FG008|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0||
60044787|NCT01717768|76160390|FG009|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||1||
60044788|NCT01717768|76160391|FG010|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0||
60044789|NCT01717768|76160392|FG011|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0||
60044790|NCT02260934|76160420|FG000|STARTED|Overall Study||22||
60044791|NCT02260934|76160421|FG001|STARTED|Overall Study||21||
60044792|NCT02260934|76160420|FG000|COMPLETED|Overall Study|At primary outcome timepoint: Ten participants engaged in ongoing scheduled study visits.|19||
60044793|NCT02260934|76160421|FG001|COMPLETED|Overall Study|At primary outcome timepoint: Eleven participants engaged in ongoing scheduled study visits.|17||
60044794|NCT02260934|76160420|FG000|NOT COMPLETED|Overall Study||3||
60044795|NCT02260934|76160421|FG001|NOT COMPLETED|Overall Study||4||
59511369|NCT02740582|75604976|FG000|NOT COMPLETED|Washout||0||
59511370|NCT02740582|75604977|FG001|NOT COMPLETED|Washout||0||
59511371|NCT02740582|75604976|FG000|STARTED|Second Intervention||24||
60044796|NCT02260388|76160438|FG000|STARTED|Overall Study||134||
60044797|NCT02260388|76160439|FG001|STARTED|Overall Study||126||
60044798|NCT02260388|76160440|FG002|STARTED|Overall Study||73||
60044799|NCT02260388|76160441|FG003|STARTED|Overall Study||69||
60044800|NCT02260388|76160438|FG000|COMPLETED|Overall Study||132||
60044801|NCT02260388|76160439|FG001|COMPLETED|Overall Study||118||
60044802|NCT02260388|76160440|FG002|COMPLETED|Overall Study||70||
60044803|NCT02260388|76160441|FG003|COMPLETED|Overall Study||65||
59511372|NCT02740582|75604977|FG001|STARTED|Second Intervention||31||
59511373|NCT02740582|75604976|FG000|COMPLETED|Second Intervention||23||
59511374|NCT02740582|75604977|FG001|COMPLETED|Second Intervention||28||
60044804|NCT02260388|76160438|FG000|NOT COMPLETED|Overall Study||2||
60044805|NCT02260388|76160439|FG001|NOT COMPLETED|Overall Study||8||
60044806|NCT02260388|76160440|FG002|NOT COMPLETED|Overall Study||3||
60044807|NCT02260388|76160441|FG003|NOT COMPLETED|Overall Study||4||
60044808|NCT02260154|76160451|FG000|STARTED|Overall Study||220||
60044809|NCT02260154|76160451|FG000|COMPLETED|Overall Study||218||
60044810|NCT02260154|76160451|FG000|NOT COMPLETED|Overall Study||2||
60044811|NCT02284178|76160458|FG000|STARTED|Overall Study||255||
60044812|NCT02284178|76160459|FG001|STARTED|Overall Study||258||
60044813|NCT02284178|76160458|FG000|COMPLETED|Overall Study||206||
60044814|NCT02284178|76160459|FG001|COMPLETED|Overall Study||204||
60044815|NCT02284178|76160458|FG000|NOT COMPLETED|Overall Study||49||
59511375|NCT02740582|75604976|FG000|NOT COMPLETED|Second Intervention||1||
59511376|NCT02740582|75604977|FG001|NOT COMPLETED|Second Intervention||3||
59511377|NCT01049581|75604985|FG000|STARTED|Overall Study||13||
60044816|NCT02284178|76160459|FG001|NOT COMPLETED|Overall Study||54||
60044817|NCT01643408|76160465|FG000|STARTED|Overall Study||30||
60044818|NCT01643408|76160465|FG000|COMPLETED|Overall Study||16||
60044819|NCT01643408|76160465|FG000|NOT COMPLETED|Overall Study||14||
60044820|NCT02283788|76160473|FG000|STARTED|Overall Study||17||
60044821|NCT02283788|76160474|FG001|STARTED|Overall Study||17||
60044822|NCT02283788|76160475|FG002|STARTED|Overall Study||17||
60044823|NCT02283788|76160476|FG003|STARTED|Overall Study||16||
60044824|NCT02283788|76160473|FG000|COMPLETED|Overall Study||16||
60044825|NCT02283788|76160474|FG001|COMPLETED|Overall Study||13||
60044826|NCT02283788|76160475|FG002|COMPLETED|Overall Study||12||
60044827|NCT02283788|76160476|FG003|COMPLETED|Overall Study||14||
60044828|NCT02283788|76160473|FG000|NOT COMPLETED|Overall Study||1||
60044829|NCT02283788|76160474|FG001|NOT COMPLETED|Overall Study||4||
60044830|NCT02283788|76160475|FG002|NOT COMPLETED|Overall Study||5||
60044831|NCT02283788|76160476|FG003|NOT COMPLETED|Overall Study||2||
60044832|NCT01739764|76160489|FG000|STARTED|Overall Study||29||
60044833|NCT01739764|76160490|FG001|STARTED|Overall Study||40||
60044834|NCT01739764|76160491|FG002|STARTED|Overall Study||146||
60044835|NCT01739764|76160489|FG000|COMPLETED|Overall Study||3||
60044836|NCT01739764|76160490|FG001|COMPLETED|Overall Study||4||
60044837|NCT01739764|76160491|FG002|COMPLETED|Overall Study||20||
60044838|NCT01739764|76160489|FG000|NOT COMPLETED|Overall Study||26||
60044839|NCT01739764|76160490|FG001|NOT COMPLETED|Overall Study||36||
60044840|NCT01739764|76160491|FG002|NOT COMPLETED|Overall Study||126||
60044841|NCT01700530|76160502|FG000|STARTED|Overall Study||9||
60044842|NCT01700530|76160503|FG001|STARTED|Overall Study||21||
60044843|NCT01700530|76160504|FG002|STARTED|Overall Study||20||
60044844|NCT01700530|76160502|FG000|COMPLETED|Overall Study||9||
60044845|NCT01700530|76160503|FG001|COMPLETED|Overall Study||18||
60044846|NCT01700530|76160504|FG002|COMPLETED|Overall Study||19||
60044847|NCT01700530|76160502|FG000|NOT COMPLETED|Overall Study||0||
60044848|NCT01700530|76160503|FG001|NOT COMPLETED|Overall Study||3||
60044849|NCT01700530|76160504|FG002|NOT COMPLETED|Overall Study||1||
59511378|NCT01049581|75604986|FG001|STARTED|Overall Study||14||
59511379|NCT01049581|75604985|FG000|COMPLETED|Overall Study||11||
59511380|NCT01049581|75604986|FG001|COMPLETED|Overall Study||13||
60044850|NCT01700140|76160515|FG000|STARTED|Overall Study||61||
60044851|NCT01700140|76160516|FG001|STARTED|Overall Study||66||
59511381|NCT01049581|75604985|FG000|NOT COMPLETED|Overall Study||2||
59511382|NCT01049581|75604986|FG001|NOT COMPLETED|Overall Study||1||
59511383|NCT02740660|75604997|FG000|STARTED|Overall Study||6||
59511384|NCT02740660|75604998|FG001|STARTED|Overall Study||6||
59511385|NCT02740660|75604997|FG000|COMPLETED|Overall Study||6||
59511386|NCT02740660|75604998|FG001|COMPLETED|Overall Study||6||
60044852|NCT01700140|76160517|FG002|STARTED|Overall Study||62||
60044853|NCT01700140|76160515|FG000|COMPLETED|Overall Study||55||
60044854|NCT01700140|76160516|FG001|COMPLETED|Overall Study||57||
60044855|NCT01700140|76160517|FG002|COMPLETED|Overall Study||61||
60044856|NCT01700140|76160515|FG000|NOT COMPLETED|Overall Study||6||
60044857|NCT01700140|76160516|FG001|NOT COMPLETED|Overall Study||9||
60044858|NCT01700140|76160517|FG002|NOT COMPLETED|Overall Study||1||
60044859|NCT01717456|76160530|FG000|STARTED|End of Treatment||11||
60044860|NCT01717456|76160531|FG001|STARTED|End of Treatment||8||
60044861|NCT01717456|76160530|FG000|COMPLETED|End of Treatment||11||
60044862|NCT01717456|76160531|FG001|COMPLETED|End of Treatment||6||
60044863|NCT01717456|76160530|FG000|NOT COMPLETED|End of Treatment||0||
60044864|NCT01717456|76160531|FG001|NOT COMPLETED|End of Treatment||2||
60044865|NCT01717456|76160530|FG000|STARTED|Follow-Up 6 Months After End of Tx||11||
60044866|NCT01717456|76160531|FG001|STARTED|Follow-Up 6 Months After End of Tx||6||
60044867|NCT01717456|76160530|FG000|COMPLETED|Follow-Up 6 Months After End of Tx||7||
60044868|NCT01717456|76160531|FG001|COMPLETED|Follow-Up 6 Months After End of Tx||2||
60044869|NCT01717456|76160530|FG000|NOT COMPLETED|Follow-Up 6 Months After End of Tx||4||
60044870|NCT01717456|76160531|FG001|NOT COMPLETED|Follow-Up 6 Months After End of Tx||4||
60044871|NCT01699750|76160540|FG000|STARTED|Overall Study||34||
60044872|NCT01699750|76160541|FG001|STARTED|Overall Study||36||
60044873|NCT01699750|76160540|FG000|COMPLETED|Overall Study||34||
60044874|NCT01699750|76160541|FG001|COMPLETED|Overall Study||33||
60044875|NCT01699750|76160540|FG000|NOT COMPLETED|Overall Study||0||
60044876|NCT01699750|76160541|FG001|NOT COMPLETED|Overall Study||3||
60044877|NCT01716754|76160555|FG000|STARTED|Overall Study||199||
60044878|NCT01716754|76160556|FG001|STARTED|Overall Study||40||
60044879|NCT01716754|76160557|FG002|STARTED|Overall Study||135||
60044880|NCT01716754|76160558|FG003|STARTED|Overall Study||97||
60044881|NCT01716754|76160555|FG000|FAS|Overall Study||199||
60044882|NCT01716754|76160556|FG001|FAS|Overall Study||40||
60044883|NCT01716754|76160557|FG002|FAS|Overall Study||131||
60044884|NCT01716754|76160558|FG003|FAS|Overall Study||96||
60044885|NCT01716754|76160555|FG000|Safety Set|Overall Study||199||
60044886|NCT01716754|76160556|FG001|Safety Set|Overall Study||40||
60044887|NCT01716754|76160557|FG002|Safety Set|Overall Study||131||
60044888|NCT01716754|76160558|FG003|Safety Set|Overall Study||96||
60044889|NCT01716754|76160555|FG000|COMPLETED|Overall Study||188||
60044890|NCT01716754|76160556|FG001|COMPLETED|Overall Study||36||
60044891|NCT01716754|76160557|FG002|COMPLETED|Overall Study||121||
60044892|NCT01716754|76160558|FG003|COMPLETED|Overall Study||89||
60044893|NCT01716754|76160555|FG000|NOT COMPLETED|Overall Study||11||
60044894|NCT01716754|76160556|FG001|NOT COMPLETED|Overall Study||4||
60044895|NCT01716754|76160557|FG002|NOT COMPLETED|Overall Study||14||
60044896|NCT01716754|76160558|FG003|NOT COMPLETED|Overall Study||8||
60044897|NCT01698814|76160569|FG000|STARTED|Overall Study||331||
60044898|NCT01698814|76160570|FG001|STARTED|Overall Study||169||
60044899|NCT01698814|76160569|FG000|COMPLETED|Overall Study||329||
60044900|NCT01698814|76160570|FG001|COMPLETED|Overall Study||166||
60044901|NCT01698814|76160569|FG000|NOT COMPLETED|Overall Study||2||
60044902|NCT01698814|76160570|FG001|NOT COMPLETED|Overall Study||3||
60044903|NCT01738984|76160578|FG000|STARTED|Overall Study||250||
60044904|NCT01738984|76160579|FG001|STARTED|Overall Study||249||
60044905|NCT01738984|76160578|FG000|COMPLETED|Overall Study||186||
60044906|NCT01738984|76160579|FG001|COMPLETED|Overall Study||210||
60044907|NCT01738984|76160578|FG000|NOT COMPLETED|Overall Study||64||
60044908|NCT01738984|76160579|FG001|NOT COMPLETED|Overall Study||39||
60044909|NCT01738594|76160588|FG000|STARTED|Registration and Treatment Start||0||
60044910|NCT01738594|76160589|FG001|STARTED|Registration and Treatment Start||3||
60044911|NCT01738594|76160590|FG002|STARTED|Registration and Treatment Start||0||
60044912|NCT01738594|76160591|FG003|STARTED|Registration and Treatment Start||0||
60044913|NCT01738594|76160592|FG004|STARTED|Registration and Treatment Start||1||
60044914|NCT01738594|76160593|FG005|STARTED|Registration and Treatment Start||3||
60044915|NCT01738594|76160594|FG006|STARTED|Registration and Treatment Start||0||
60044916|NCT01738594|76160595|FG007|STARTED|Registration and Treatment Start||0||
60044917|NCT01738594|76160588|FG000|Registered to Study|Registration and Treatment Start||0||
60044918|NCT01738594|76160589|FG001|Registered to Study|Registration and Treatment Start||3||
60044919|NCT01738594|76160590|FG002|Registered to Study|Registration and Treatment Start||0||
60044920|NCT01738594|76160591|FG003|Registered to Study|Registration and Treatment Start||0||
60044921|NCT01738594|76160592|FG004|Registered to Study|Registration and Treatment Start||1||
60044922|NCT01738594|76160593|FG005|Registered to Study|Registration and Treatment Start||3||
60044923|NCT01738594|76160594|FG006|Registered to Study|Registration and Treatment Start||0||
60044924|NCT01738594|76160595|FG007|Registered to Study|Registration and Treatment Start||0||
60044925|NCT01738594|76160588|FG000|Treatment Started|Registration and Treatment Start||0||
60044926|NCT01738594|76160589|FG001|Treatment Started|Registration and Treatment Start||2||
60044927|NCT01738594|76160590|FG002|Treatment Started|Registration and Treatment Start||0||
60044928|NCT01738594|76160591|FG003|Treatment Started|Registration and Treatment Start||0||
60044929|NCT01738594|76160592|FG004|Treatment Started|Registration and Treatment Start||1||
60044930|NCT01738594|76160593|FG005|Treatment Started|Registration and Treatment Start||3||
60044931|NCT01738594|76160594|FG006|Treatment Started|Registration and Treatment Start||0||
60044932|NCT01738594|76160595|FG007|Treatment Started|Registration and Treatment Start||0||
60044933|NCT01738594|76160588|FG000|COMPLETED|Registration and Treatment Start||0||
60044934|NCT01738594|76160589|FG001|COMPLETED|Registration and Treatment Start||2||
60044935|NCT01738594|76160590|FG002|COMPLETED|Registration and Treatment Start||0||
60044936|NCT01738594|76160591|FG003|COMPLETED|Registration and Treatment Start||0||
60044937|NCT01738594|76160592|FG004|COMPLETED|Registration and Treatment Start||1||
60044938|NCT01738594|76160593|FG005|COMPLETED|Registration and Treatment Start||3||
60044939|NCT01738594|76160594|FG006|COMPLETED|Registration and Treatment Start||0||
60044940|NCT01738594|76160595|FG007|COMPLETED|Registration and Treatment Start||0||
60044941|NCT01738594|76160588|FG000|NOT COMPLETED|Registration and Treatment Start||0||
60044942|NCT01738594|76160589|FG001|NOT COMPLETED|Registration and Treatment Start||1||
60044943|NCT01738594|76160590|FG002|NOT COMPLETED|Registration and Treatment Start||0||
60044944|NCT01738594|76160591|FG003|NOT COMPLETED|Registration and Treatment Start||0||
60044945|NCT01738594|76160592|FG004|NOT COMPLETED|Registration and Treatment Start||0||
60044946|NCT01738594|76160593|FG005|NOT COMPLETED|Registration and Treatment Start||0||
60044947|NCT01738594|76160594|FG006|NOT COMPLETED|Registration and Treatment Start||0||
60044948|NCT01738594|76160595|FG007|NOT COMPLETED|Registration and Treatment Start||0||
60044949|NCT01738594|76160588|FG000|STARTED|Completed 2 Cycles/Reached 1st Response||0||
60044950|NCT01738594|76160589|FG001|STARTED|Completed 2 Cycles/Reached 1st Response||2||
60044951|NCT01738594|76160590|FG002|STARTED|Completed 2 Cycles/Reached 1st Response||0||
60044952|NCT01738594|76160591|FG003|STARTED|Completed 2 Cycles/Reached 1st Response||0||
60044953|NCT01738594|76160592|FG004|STARTED|Completed 2 Cycles/Reached 1st Response||1||
60044954|NCT01738594|76160593|FG005|STARTED|Completed 2 Cycles/Reached 1st Response||3||
60044955|NCT01738594|76160594|FG006|STARTED|Completed 2 Cycles/Reached 1st Response||0||
60044956|NCT01738594|76160595|FG007|STARTED|Completed 2 Cycles/Reached 1st Response||0||
60044957|NCT01738594|76160588|FG000|COMPLETED|Completed 2 Cycles/Reached 1st Response||0||
60044958|NCT01738594|76160589|FG001|COMPLETED|Completed 2 Cycles/Reached 1st Response||2||
60044959|NCT01738594|76160590|FG002|COMPLETED|Completed 2 Cycles/Reached 1st Response||0||
60044960|NCT01738594|76160591|FG003|COMPLETED|Completed 2 Cycles/Reached 1st Response||0||
60044961|NCT01738594|76160592|FG004|COMPLETED|Completed 2 Cycles/Reached 1st Response||1||
60044962|NCT01738594|76160593|FG005|COMPLETED|Completed 2 Cycles/Reached 1st Response||2||
60044963|NCT01738594|76160594|FG006|COMPLETED|Completed 2 Cycles/Reached 1st Response||0||
60044964|NCT01738594|76160595|FG007|COMPLETED|Completed 2 Cycles/Reached 1st Response||0||
60044965|NCT01738594|76160588|FG000|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0||
60044966|NCT01738594|76160589|FG001|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0||
60044967|NCT01738594|76160590|FG002|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0||
60044968|NCT01738594|76160591|FG003|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0||
60044969|NCT01738594|76160592|FG004|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0||
60044970|NCT01738594|76160593|FG005|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||1||
60044971|NCT01738594|76160594|FG006|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0||
60044972|NCT01738594|76160595|FG007|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0||
60044973|NCT01738594|76160588|FG000|STARTED|Completed 4 Cycles of Treatment||0||
60044974|NCT01738594|76160589|FG001|STARTED|Completed 4 Cycles of Treatment||2||
60044975|NCT01738594|76160590|FG002|STARTED|Completed 4 Cycles of Treatment||0||
60044976|NCT01738594|76160591|FG003|STARTED|Completed 4 Cycles of Treatment||0||
60044977|NCT01738594|76160592|FG004|STARTED|Completed 4 Cycles of Treatment||1||
60044978|NCT01738594|76160593|FG005|STARTED|Completed 4 Cycles of Treatment||2||
60044979|NCT01738594|76160594|FG006|STARTED|Completed 4 Cycles of Treatment||0||
60044980|NCT01738594|76160595|FG007|STARTED|Completed 4 Cycles of Treatment||0||
60044981|NCT01738594|76160588|FG000|COMPLETED|Completed 4 Cycles of Treatment||0||
60044982|NCT01738594|76160589|FG001|COMPLETED|Completed 4 Cycles of Treatment||0||
60044983|NCT01738594|76160590|FG002|COMPLETED|Completed 4 Cycles of Treatment||0||
60044984|NCT01738594|76160591|FG003|COMPLETED|Completed 4 Cycles of Treatment||0||
60044985|NCT01738594|76160592|FG004|COMPLETED|Completed 4 Cycles of Treatment||1||
60044986|NCT01738594|76160593|FG005|COMPLETED|Completed 4 Cycles of Treatment||1||
60044987|NCT01738594|76160594|FG006|COMPLETED|Completed 4 Cycles of Treatment||0||
60044988|NCT01738594|76160595|FG007|COMPLETED|Completed 4 Cycles of Treatment||0||
60044989|NCT01738594|76160588|FG000|NOT COMPLETED|Completed 4 Cycles of Treatment||0||
60044990|NCT01738594|76160589|FG001|NOT COMPLETED|Completed 4 Cycles of Treatment||2||
60044991|NCT01738594|76160590|FG002|NOT COMPLETED|Completed 4 Cycles of Treatment||0||
60044992|NCT01738594|76160591|FG003|NOT COMPLETED|Completed 4 Cycles of Treatment||0||
60044993|NCT01738594|76160592|FG004|NOT COMPLETED|Completed 4 Cycles of Treatment||0||
60044994|NCT01738594|76160593|FG005|NOT COMPLETED|Completed 4 Cycles of Treatment||1||
60044995|NCT01738594|76160594|FG006|NOT COMPLETED|Completed 4 Cycles of Treatment||0||
60044996|NCT01738594|76160595|FG007|NOT COMPLETED|Completed 4 Cycles of Treatment||0||
60044997|NCT01738594|76160588|FG000|STARTED|Went on to Continue Treatment Cycle 5||0||
60044998|NCT01738594|76160589|FG001|STARTED|Went on to Continue Treatment Cycle 5||0||
60044999|NCT01738594|76160590|FG002|STARTED|Went on to Continue Treatment Cycle 5||0||
60045000|NCT01738594|76160591|FG003|STARTED|Went on to Continue Treatment Cycle 5||0||
60045001|NCT01738594|76160592|FG004|STARTED|Went on to Continue Treatment Cycle 5||1||
60045002|NCT01738594|76160593|FG005|STARTED|Went on to Continue Treatment Cycle 5||1||
60045003|NCT01738594|76160594|FG006|STARTED|Went on to Continue Treatment Cycle 5||0||
60045004|NCT01738594|76160595|FG007|STARTED|Went on to Continue Treatment Cycle 5||0||
60045005|NCT01738594|76160588|FG000|COMPLETED|Went on to Continue Treatment Cycle 5||0||
60045006|NCT01738594|76160589|FG001|COMPLETED|Went on to Continue Treatment Cycle 5||0||
60045007|NCT01738594|76160590|FG002|COMPLETED|Went on to Continue Treatment Cycle 5||0||
60045008|NCT01738594|76160591|FG003|COMPLETED|Went on to Continue Treatment Cycle 5||0||
60045009|NCT01738594|76160592|FG004|COMPLETED|Went on to Continue Treatment Cycle 5||0||
60045010|NCT01738594|76160593|FG005|COMPLETED|Went on to Continue Treatment Cycle 5||0||
60045011|NCT01738594|76160594|FG006|COMPLETED|Went on to Continue Treatment Cycle 5||0||
60045012|NCT01738594|76160595|FG007|COMPLETED|Went on to Continue Treatment Cycle 5||0||
60045013|NCT01738594|76160588|FG000|NOT COMPLETED|Went on to Continue Treatment Cycle 5||0||
60045014|NCT01738594|76160589|FG001|NOT COMPLETED|Went on to Continue Treatment Cycle 5||0||
60045015|NCT01738594|76160590|FG002|NOT COMPLETED|Went on to Continue Treatment Cycle 5||0||
60045016|NCT01738594|76160591|FG003|NOT COMPLETED|Went on to Continue Treatment Cycle 5||0||
60045017|NCT01738594|76160592|FG004|NOT COMPLETED|Went on to Continue Treatment Cycle 5||1||
60045018|NCT01738594|76160593|FG005|NOT COMPLETED|Went on to Continue Treatment Cycle 5||1||
60045019|NCT01738594|76160594|FG006|NOT COMPLETED|Went on to Continue Treatment Cycle 5||0||
59511387|NCT02740660|75604997|FG000|NOT COMPLETED|Overall Study||0||
59511388|NCT02740660|75604998|FG001|NOT COMPLETED|Overall Study||0||
59511389|NCT02571972|75605004|FG000|STARTED|Overall Study|2 patients signed consent but withdrew from the study prior to using dorzolamide-timolol drops.|14||
59511390|NCT02571972|75605004|FG000|COMPLETED|Overall Study||10||
59511391|NCT02571972|75605004|FG000|NOT COMPLETED|Overall Study||4||
59511392|NCT00842075|75605010|FG000|STARTED|Overall Study||5||
59511393|NCT00842075|75605011|FG001|STARTED|Overall Study||5||
59511394|NCT00842075|75605010|FG000|COMPLETED|Overall Study||5||
59511395|NCT00842075|75605011|FG001|COMPLETED|Overall Study||5||
59511396|NCT00842075|75605010|FG000|NOT COMPLETED|Overall Study||0||
59511397|NCT00842075|75605011|FG001|NOT COMPLETED|Overall Study||0||
59511398|NCT00879359|75605017|FG000|STARTED|Overall Study||15||
59511399|NCT00879359|75605017|FG000|COMPLETED|Overall Study||15||
59511400|NCT00879359|75605017|FG000|NOT COMPLETED|Overall Study||0||
59511401|NCT00880919|75605025|FG000|STARTED|Overall Study||33||
59919234|NCT03307785|76039647|FG008|NOT COMPLETED|Part A: Up to 28.5 Months||0||
59919235|NCT03307785|76039648|FG009|NOT COMPLETED|Part A: Up to 28.5 Months||0||
59919236|NCT03307785|76039649|FG010|NOT COMPLETED|Part A: Up to 28.5 Months||0||
59919237|NCT03307785|76039639|FG000|STARTED|Part B: Up to 28.5 Months||0||
59919238|NCT03307785|76039640|FG001|STARTED|Part B: Up to 28.5 Months||0||
59511402|NCT00880919|75605026|FG001|STARTED|Overall Study||33||
59511403|NCT00880919|75605027|FG002|STARTED|Overall Study||29||
59511404|NCT00880919|75605025|FG000|COMPLETED|Overall Study||18||
59511405|NCT00880919|75605026|FG001|COMPLETED|Overall Study||19||
59511406|NCT00880919|75605027|FG002|COMPLETED|Overall Study||23||
59511407|NCT00880919|75605025|FG000|NOT COMPLETED|Overall Study||15||
59511408|NCT00880919|75605026|FG001|NOT COMPLETED|Overall Study||14||
59511409|NCT00880919|75605027|FG002|NOT COMPLETED|Overall Study||6||
59511410|NCT02741284|75605040|FG000|STARTED|Overall Study||57||
59511411|NCT02741284|75605041|FG001|STARTED|Overall Study||57||
59511412|NCT02741284|75605040|FG000|COMPLETED|Overall Study||51||
59511413|NCT02741284|75605041|FG001|COMPLETED|Overall Study||48||
59511414|NCT02741284|75605040|FG000|NOT COMPLETED|Overall Study||6||
59511415|NCT02741284|75605041|FG001|NOT COMPLETED|Overall Study||9||
59511416|NCT00880997|75605052|FG000|STARTED|Overall Study||9||
59511417|NCT00880997|75605053|FG001|STARTED|Overall Study||8||
59511418|NCT00880997|75605054|FG002|STARTED|Overall Study||13||
59511419|NCT00880997|75605052|FG000|COMPLETED|Overall Study||6||
59919239|NCT03307785|76039641|FG002|STARTED|Part B: Up to 28.5 Months||14||
59919240|NCT03307785|76039642|FG003|STARTED|Part B: Up to 28.5 Months||0||
59919241|NCT03307785|76039643|FG004|STARTED|Part B: Up to 28.5 Months||0||
59919242|NCT03307785|76039644|FG005|STARTED|Part B: Up to 28.5 Months||0||
59919243|NCT03307785|76039645|FG006|STARTED|Part B: Up to 28.5 Months||0||
59919244|NCT03307785|76039646|FG007|STARTED|Part B: Up to 28.5 Months||0||
60045020|NCT01738594|76160595|FG007|NOT COMPLETED|Went on to Continue Treatment Cycle 5||0||
60045021|NCT01738594|76160588|FG000|STARTED|Follow up for 1 Year||0|All patients that receive treatment on study go into the follow up period|
60045022|NCT01738594|76160589|FG001|STARTED|Follow up for 1 Year||2|All patients that receive treatment on study go into the follow up period|
60045023|NCT01738594|76160590|FG002|STARTED|Follow up for 1 Year||0|All patients that receive treatment on study go into the follow up period|
60045024|NCT01738594|76160591|FG003|STARTED|Follow up for 1 Year||0|All patients that receive treatment on study go into the follow up period|
60045025|NCT01738594|76160592|FG004|STARTED|Follow up for 1 Year||1|All patients that receive treatment on study go into the follow up period|
60045026|NCT01738594|76160593|FG005|STARTED|Follow up for 1 Year||3|All patients that receive treatment on study go into the follow up period|
60045027|NCT01738594|76160594|FG006|STARTED|Follow up for 1 Year||0|All patients that receive treatment on study go into the follow up period|
60045028|NCT01738594|76160595|FG007|STARTED|Follow up for 1 Year||0|All patients that receive treatment on study go into the follow up period|
60045029|NCT01738594|76160588|FG000|COMPLETED|Follow up for 1 Year||0||
60045030|NCT01738594|76160589|FG001|COMPLETED|Follow up for 1 Year||2||
60045031|NCT01738594|76160590|FG002|COMPLETED|Follow up for 1 Year||0||
60045032|NCT01738594|76160591|FG003|COMPLETED|Follow up for 1 Year||0||
60045033|NCT01738594|76160592|FG004|COMPLETED|Follow up for 1 Year||1||
60045034|NCT01738594|76160593|FG005|COMPLETED|Follow up for 1 Year||0||
60045035|NCT01738594|76160594|FG006|COMPLETED|Follow up for 1 Year||0||
60045036|NCT01738594|76160595|FG007|COMPLETED|Follow up for 1 Year||0||
60045037|NCT01738594|76160588|FG000|NOT COMPLETED|Follow up for 1 Year||0||
60045038|NCT01738594|76160589|FG001|NOT COMPLETED|Follow up for 1 Year||0||
60045039|NCT01738594|76160590|FG002|NOT COMPLETED|Follow up for 1 Year||0||
60045040|NCT01738594|76160591|FG003|NOT COMPLETED|Follow up for 1 Year||0||
60045041|NCT01738594|76160592|FG004|NOT COMPLETED|Follow up for 1 Year||0||
60045042|NCT01738594|76160593|FG005|NOT COMPLETED|Follow up for 1 Year||3||
60045043|NCT01738594|76160594|FG006|NOT COMPLETED|Follow up for 1 Year||0||
60045044|NCT01738594|76160595|FG007|NOT COMPLETED|Follow up for 1 Year||0||
60045045|NCT01738438|76160605|FG000|STARTED|Overall Study||35||
60045046|NCT01738438|76160605|FG000|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0||
60045047|NCT01738438|76160605|FG000|NOT COMPLETED|Overall Study||35||
60045048|NCT01716520|76160609|FG000|STARTED|Treatment Period 1 (14 Days)||31||
60045049|NCT01716520|76160610|FG001|STARTED|Treatment Period 1 (14 Days)||30||
59919245|NCT03307785|76039647|FG008|STARTED|Part B: Up to 28.5 Months||0||
59919246|NCT03307785|76039648|FG009|STARTED|Part B: Up to 28.5 Months||0||
59919247|NCT03307785|76039649|FG010|STARTED|Part B: Up to 28.5 Months||0||
59919248|NCT03307785|76039639|FG000|COMPLETED|Part B: Up to 28.5 Months||0||
59919249|NCT03307785|76039640|FG001|COMPLETED|Part B: Up to 28.5 Months||0||
59919250|NCT03307785|76039641|FG002|COMPLETED|Part B: Up to 28.5 Months||0||
59919251|NCT03307785|76039642|FG003|COMPLETED|Part B: Up to 28.5 Months||0||
59919252|NCT03307785|76039643|FG004|COMPLETED|Part B: Up to 28.5 Months||0||
59919253|NCT03307785|76039644|FG005|COMPLETED|Part B: Up to 28.5 Months||0||
59919254|NCT03307785|76039645|FG006|COMPLETED|Part B: Up to 28.5 Months||0||
59919255|NCT03307785|76039646|FG007|COMPLETED|Part B: Up to 28.5 Months||0||
59919256|NCT03307785|76039647|FG008|COMPLETED|Part B: Up to 28.5 Months||0||
59919257|NCT03307785|76039648|FG009|COMPLETED|Part B: Up to 28.5 Months||0||
59919258|NCT03307785|76039649|FG010|COMPLETED|Part B: Up to 28.5 Months||0||
59919259|NCT03307785|76039639|FG000|NOT COMPLETED|Part B: Up to 28.5 Months||0||
59919260|NCT03307785|76039640|FG001|NOT COMPLETED|Part B: Up to 28.5 Months||0||
59919261|NCT03307785|76039641|FG002|NOT COMPLETED|Part B: Up to 28.5 Months||14||
59919262|NCT03307785|76039642|FG003|NOT COMPLETED|Part B: Up to 28.5 Months||0||
59919263|NCT03307785|76039643|FG004|NOT COMPLETED|Part B: Up to 28.5 Months||0||
59919264|NCT03307785|76039644|FG005|NOT COMPLETED|Part B: Up to 28.5 Months||0||
59919265|NCT03307785|76039645|FG006|NOT COMPLETED|Part B: Up to 28.5 Months||0||
59919266|NCT03307785|76039646|FG007|NOT COMPLETED|Part B: Up to 28.5 Months||0||
59919267|NCT03307785|76039647|FG008|NOT COMPLETED|Part B: Up to 28.5 Months||0||
59919268|NCT03307785|76039648|FG009|NOT COMPLETED|Part B: Up to 28.5 Months||0||
59919269|NCT03307785|76039649|FG010|NOT COMPLETED|Part B: Up to 28.5 Months||0||
59919270|NCT03307785|76039639|FG000|STARTED|Part C: Up to 22.5 Months||0||
59919271|NCT03307785|76039640|FG001|STARTED|Part C: Up to 22.5 Months||0||
59919272|NCT03307785|76039641|FG002|STARTED|Part C: Up to 22.5 Months||0||
59919273|NCT03307785|76039642|FG003|STARTED|Part C: Up to 22.5 Months||6||
59919274|NCT03307785|76039643|FG004|STARTED|Part C: Up to 22.5 Months||7||
59919275|NCT03307785|76039644|FG005|STARTED|Part C: Up to 22.5 Months||0||
59919276|NCT03307785|76039645|FG006|STARTED|Part C: Up to 22.5 Months||0||
59919277|NCT03307785|76039646|FG007|STARTED|Part C: Up to 22.5 Months||0||
59919278|NCT03307785|76039647|FG008|STARTED|Part C: Up to 22.5 Months||0||
59919279|NCT03307785|76039648|FG009|STARTED|Part C: Up to 22.5 Months||0||
59919280|NCT03307785|76039649|FG010|STARTED|Part C: Up to 22.5 Months||0||
59919281|NCT03307785|76039639|FG000|COMPLETED|Part C: Up to 22.5 Months||0||
59919282|NCT03307785|76039640|FG001|COMPLETED|Part C: Up to 22.5 Months||0||
59919283|NCT03307785|76039641|FG002|COMPLETED|Part C: Up to 22.5 Months||0||
59919284|NCT03307785|76039642|FG003|COMPLETED|Part C: Up to 22.5 Months||0||
59919285|NCT03307785|76039643|FG004|COMPLETED|Part C: Up to 22.5 Months||0||
59919286|NCT03307785|76039644|FG005|COMPLETED|Part C: Up to 22.5 Months||0||
60045050|NCT01716520|76160611|FG002|STARTED|Treatment Period 1 (14 Days)||30||
60045051|NCT01716520|76160612|FG003|STARTED|Treatment Period 1 (14 Days)||30||
60045052|NCT01716520|76160613|FG004|STARTED|Treatment Period 1 (14 Days)||31||
60045053|NCT01716520|76160614|FG005|STARTED|Treatment Period 1 (14 Days)||30||
59919287|NCT03307785|76039645|FG006|COMPLETED|Part C: Up to 22.5 Months||0||
60045054|NCT01716520|76160609|FG000|COMPLETED|Treatment Period 1 (14 Days)||29||
60045055|NCT01716520|76160610|FG001|COMPLETED|Treatment Period 1 (14 Days)||29||
60045056|NCT01716520|76160611|FG002|COMPLETED|Treatment Period 1 (14 Days)||28||
60045057|NCT01716520|76160612|FG003|COMPLETED|Treatment Period 1 (14 Days)||29||
60045058|NCT01716520|76160613|FG004|COMPLETED|Treatment Period 1 (14 Days)||31||
60045059|NCT01716520|76160614|FG005|COMPLETED|Treatment Period 1 (14 Days)||29||
60045060|NCT01716520|76160609|FG000|NOT COMPLETED|Treatment Period 1 (14 Days)||2||
60045061|NCT01716520|76160610|FG001|NOT COMPLETED|Treatment Period 1 (14 Days)||1||
60045062|NCT01716520|76160611|FG002|NOT COMPLETED|Treatment Period 1 (14 Days)||2||
60045063|NCT01716520|76160612|FG003|NOT COMPLETED|Treatment Period 1 (14 Days)||1||
60045064|NCT01716520|76160613|FG004|NOT COMPLETED|Treatment Period 1 (14 Days)||0||
60045065|NCT01716520|76160614|FG005|NOT COMPLETED|Treatment Period 1 (14 Days)||1||
60045066|NCT01716520|76160609|FG000|STARTED|Washout Period 1 (10 to 14 Days)||29||
60045067|NCT01716520|76160610|FG001|STARTED|Washout Period 1 (10 to 14 Days)||29||
59919288|NCT03307785|76039646|FG007|COMPLETED|Part C: Up to 22.5 Months||0||
59919289|NCT03307785|76039647|FG008|COMPLETED|Part C: Up to 22.5 Months||0||
59919290|NCT03307785|76039648|FG009|COMPLETED|Part C: Up to 22.5 Months||0||
59919291|NCT03307785|76039649|FG010|COMPLETED|Part C: Up to 22.5 Months||0||
59919292|NCT03307785|76039639|FG000|NOT COMPLETED|Part C: Up to 22.5 Months||0||
59919293|NCT03307785|76039640|FG001|NOT COMPLETED|Part C: Up to 22.5 Months||0||
59919294|NCT03307785|76039641|FG002|NOT COMPLETED|Part C: Up to 22.5 Months||0||
59919295|NCT03307785|76039642|FG003|NOT COMPLETED|Part C: Up to 22.5 Months||6||
59919296|NCT03307785|76039643|FG004|NOT COMPLETED|Part C: Up to 22.5 Months||7||
59919297|NCT03307785|76039644|FG005|NOT COMPLETED|Part C: Up to 22.5 Months||0||
59919298|NCT03307785|76039645|FG006|NOT COMPLETED|Part C: Up to 22.5 Months||0||
59919299|NCT03307785|76039646|FG007|NOT COMPLETED|Part C: Up to 22.5 Months||0||
59919300|NCT03307785|76039647|FG008|NOT COMPLETED|Part C: Up to 22.5 Months||0||
59919301|NCT03307785|76039648|FG009|NOT COMPLETED|Part C: Up to 22.5 Months||0||
59919302|NCT03307785|76039649|FG010|NOT COMPLETED|Part C: Up to 22.5 Months||0||
59919303|NCT03307785|76039639|FG000|STARTED|Part D: Up to 9.5 Months||0||
59919304|NCT03307785|76039640|FG001|STARTED|Part D: Up to 9.5 Months||0||
59919305|NCT03307785|76039641|FG002|STARTED|Part D: Up to 9.5 Months||0||
59919306|NCT03307785|76039642|FG003|STARTED|Part D: Up to 9.5 Months||0||
59919307|NCT03307785|76039643|FG004|STARTED|Part D: Up to 9.5 Months||0||
59919308|NCT03307785|76039644|FG005|STARTED|Part D: Up to 9.5 Months||6||
59919309|NCT03307785|76039645|FG006|STARTED|Part D: Up to 9.5 Months||0||
59919310|NCT03307785|76039646|FG007|STARTED|Part D: Up to 9.5 Months||0||
59919311|NCT03307785|76039647|FG008|STARTED|Part D: Up to 9.5 Months||0||
59919312|NCT03307785|76039648|FG009|STARTED|Part D: Up to 9.5 Months||0||
59919313|NCT03307785|76039649|FG010|STARTED|Part D: Up to 9.5 Months||0||
59919314|NCT03307785|76039639|FG000|COMPLETED|Part D: Up to 9.5 Months||0||
59919315|NCT03307785|76039640|FG001|COMPLETED|Part D: Up to 9.5 Months||0||
59919316|NCT03307785|76039641|FG002|COMPLETED|Part D: Up to 9.5 Months||0||
60045068|NCT01716520|76160611|FG002|STARTED|Washout Period 1 (10 to 14 Days)||28||
60045069|NCT01716520|76160612|FG003|STARTED|Washout Period 1 (10 to 14 Days)||29||
60045070|NCT01716520|76160613|FG004|STARTED|Washout Period 1 (10 to 14 Days)||31||
60045071|NCT01716520|76160614|FG005|STARTED|Washout Period 1 (10 to 14 Days)||29||
60045072|NCT01716520|76160609|FG000|COMPLETED|Washout Period 1 (10 to 14 Days)||29||
60045073|NCT01716520|76160610|FG001|COMPLETED|Washout Period 1 (10 to 14 Days)||28||
60045074|NCT01716520|76160611|FG002|COMPLETED|Washout Period 1 (10 to 14 Days)||27||
60045075|NCT01716520|76160612|FG003|COMPLETED|Washout Period 1 (10 to 14 Days)||29||
60045076|NCT01716520|76160613|FG004|COMPLETED|Washout Period 1 (10 to 14 Days)||31||
60045077|NCT01716520|76160614|FG005|COMPLETED|Washout Period 1 (10 to 14 Days)||27||
60045078|NCT01716520|76160609|FG000|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0||
60045079|NCT01716520|76160610|FG001|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||1||
60045080|NCT01716520|76160611|FG002|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||1||
60045081|NCT01716520|76160612|FG003|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0||
60045082|NCT01716520|76160613|FG004|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0||
60045083|NCT01716520|76160614|FG005|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||2||
60045084|NCT01716520|76160609|FG000|STARTED|Treatment Period 2 (14 Days)||29||
60045085|NCT01716520|76160610|FG001|STARTED|Treatment Period 2 (14 Days)||28||
60045086|NCT01716520|76160611|FG002|STARTED|Treatment Period 2 (14 Days)||27||
60045087|NCT01716520|76160612|FG003|STARTED|Treatment Period 2 (14 Days)||29||
60045088|NCT01716520|76160613|FG004|STARTED|Treatment Period 2 (14 Days)||31||
60045089|NCT01716520|76160614|FG005|STARTED|Treatment Period 2 (14 Days)||27||
60045090|NCT01716520|76160609|FG000|COMPLETED|Treatment Period 2 (14 Days)||29||
60045091|NCT01716520|76160610|FG001|COMPLETED|Treatment Period 2 (14 Days)||28||
60045092|NCT01716520|76160611|FG002|COMPLETED|Treatment Period 2 (14 Days)||27||
60045093|NCT01716520|76160612|FG003|COMPLETED|Treatment Period 2 (14 Days)||28||
60045094|NCT01716520|76160613|FG004|COMPLETED|Treatment Period 2 (14 Days)||29||
59612446|NCT01701258|75723502|FG003|NOT COMPLETED|Drug+fMRI (Session 2)||0||
59612447|NCT01701258|75723503|FG004|NOT COMPLETED|Drug+fMRI (Session 2)||0||
59612448|NCT01701258|75723504|FG005|NOT COMPLETED|Drug+fMRI (Session 2)||0||
59612449|NCT01701258|75723505|FG006|NOT COMPLETED|Drug+fMRI (Session 2)||0||
59612450|NCT01701258|75723506|FG007|NOT COMPLETED|Drug+fMRI (Session 2)||0||
60045095|NCT01716520|76160614|FG005|COMPLETED|Treatment Period 2 (14 Days)||27||
60045096|NCT01716520|76160609|FG000|NOT COMPLETED|Treatment Period 2 (14 Days)||0||
60045097|NCT01716520|76160610|FG001|NOT COMPLETED|Treatment Period 2 (14 Days)||0||
59612451|NCT01701258|75723507|FG008|NOT COMPLETED|Drug+fMRI (Session 2)||0||
59612452|NCT01701258|75723508|FG009|NOT COMPLETED|Drug+fMRI (Session 2)||0||
59612453|NCT01701258|75723509|FG010|NOT COMPLETED|Drug+fMRI (Session 2)||0||
59612454|NCT01701258|75723510|FG011|NOT COMPLETED|Drug+fMRI (Session 2)||0||
59612455|NCT01701258|75723511|FG012|NOT COMPLETED|Drug+fMRI (Session 2)||0||
59612456|NCT01701258|75723499|FG000|STARTED|PET (Session 3)||0|Not all participants that were eligible or completed the MRI completed the PET.|
59612457|NCT01701258|75723500|FG001|STARTED|PET (Session 3)||20|Not all participants that were eligible or completed the MRI completed the PET.|
59612458|NCT01701258|75723501|FG002|STARTED|PET (Session 3)||0|Not all participants that were eligible or completed the MRI completed the PET.|
59612459|NCT01701258|75723502|FG003|STARTED|PET (Session 3)||0|Not all participants that were eligible or completed the MRI completed the PET.|
59612460|NCT01701258|75723503|FG004|STARTED|PET (Session 3)||16|Not all participants that were eligible or completed the MRI completed the PET.|
59612461|NCT01701258|75723504|FG005|STARTED|PET (Session 3)||0|Not all participants that were eligible or completed the MRI completed the PET.|
59759771|NCT03481556|75879195|FG000|NOT COMPLETED|Overall Study||15||
59919317|NCT03307785|76039642|FG003|COMPLETED|Part D: Up to 9.5 Months||0||
59919318|NCT03307785|76039643|FG004|COMPLETED|Part D: Up to 9.5 Months||0||
59919319|NCT03307785|76039644|FG005|COMPLETED|Part D: Up to 9.5 Months||3||
59919320|NCT03307785|76039645|FG006|COMPLETED|Part D: Up to 9.5 Months||0||
59919321|NCT03307785|76039646|FG007|COMPLETED|Part D: Up to 9.5 Months||0||
59919322|NCT03307785|76039647|FG008|COMPLETED|Part D: Up to 9.5 Months||0||
59919323|NCT03307785|76039648|FG009|COMPLETED|Part D: Up to 9.5 Months||0||
59919324|NCT03307785|76039649|FG010|COMPLETED|Part D: Up to 9.5 Months||0||
59919325|NCT03307785|76039639|FG000|NOT COMPLETED|Part D: Up to 9.5 Months||0||
59919326|NCT03307785|76039640|FG001|NOT COMPLETED|Part D: Up to 9.5 Months||0||
59919327|NCT03307785|76039641|FG002|NOT COMPLETED|Part D: Up to 9.5 Months||0||
59919328|NCT03307785|76039642|FG003|NOT COMPLETED|Part D: Up to 9.5 Months||0||
59919329|NCT03307785|76039643|FG004|NOT COMPLETED|Part D: Up to 9.5 Months||0||
59919330|NCT03307785|76039644|FG005|NOT COMPLETED|Part D: Up to 9.5 Months||3||
59919331|NCT03307785|76039645|FG006|NOT COMPLETED|Part D: Up to 9.5 Months||0||
59919332|NCT03307785|76039646|FG007|NOT COMPLETED|Part D: Up to 9.5 Months||0||
59919333|NCT03307785|76039647|FG008|NOT COMPLETED|Part D: Up to 9.5 Months||0||
59919334|NCT03307785|76039648|FG009|NOT COMPLETED|Part D: Up to 9.5 Months||0||
59919335|NCT03307785|76039649|FG010|NOT COMPLETED|Part D: Up to 9.5 Months||0||
59919336|NCT03307785|76039639|FG000|STARTED|Part E: Up to 4.4 Months||0||
59919337|NCT03307785|76039640|FG001|STARTED|Part E: Up to 4.4 Months||0||
59919338|NCT03307785|76039641|FG002|STARTED|Part E: Up to 4.4 Months||0||
59919339|NCT03307785|76039642|FG003|STARTED|Part E: Up to 4.4 Months||0||
59919340|NCT03307785|76039643|FG004|STARTED|Part E: Up to 4.4 Months||0||
59919341|NCT03307785|76039644|FG005|STARTED|Part E: Up to 4.4 Months||0||
59919342|NCT03307785|76039645|FG006|STARTED|Part E: Up to 4.4 Months||2||
59919343|NCT03307785|76039646|FG007|STARTED|Part E: Up to 4.4 Months||0||
59919344|NCT03307785|76039647|FG008|STARTED|Part E: Up to 4.4 Months||0||
59919345|NCT03307785|76039648|FG009|STARTED|Part E: Up to 4.4 Months||0||
59919346|NCT03307785|76039649|FG010|STARTED|Part E: Up to 4.4 Months||0||
59919347|NCT03307785|76039639|FG000|COMPLETED|Part E: Up to 4.4 Months||0||
59919348|NCT03307785|76039640|FG001|COMPLETED|Part E: Up to 4.4 Months||0||
59919349|NCT03307785|76039641|FG002|COMPLETED|Part E: Up to 4.4 Months||0||
59919350|NCT03307785|76039642|FG003|COMPLETED|Part E: Up to 4.4 Months||0||
59919351|NCT03307785|76039643|FG004|COMPLETED|Part E: Up to 4.4 Months||0||
59919352|NCT03307785|76039644|FG005|COMPLETED|Part E: Up to 4.4 Months||0||
59919353|NCT03307785|76039645|FG006|COMPLETED|Part E: Up to 4.4 Months||0||
59919354|NCT03307785|76039646|FG007|COMPLETED|Part E: Up to 4.4 Months||0||
59919355|NCT03307785|76039647|FG008|COMPLETED|Part E: Up to 4.4 Months||0||
59919356|NCT03307785|76039648|FG009|COMPLETED|Part E: Up to 4.4 Months||0||
59919357|NCT03307785|76039649|FG010|COMPLETED|Part E: Up to 4.4 Months||0||
59919358|NCT03307785|76039639|FG000|NOT COMPLETED|Part E: Up to 4.4 Months||0||
59919359|NCT03307785|76039640|FG001|NOT COMPLETED|Part E: Up to 4.4 Months||0||
59919360|NCT03307785|76039641|FG002|NOT COMPLETED|Part E: Up to 4.4 Months||0||
59919361|NCT03307785|76039642|FG003|NOT COMPLETED|Part E: Up to 4.4 Months||0||
59919362|NCT03307785|76039643|FG004|NOT COMPLETED|Part E: Up to 4.4 Months||0||
59919363|NCT03307785|76039644|FG005|NOT COMPLETED|Part E: Up to 4.4 Months||0||
60045098|NCT01716520|76160611|FG002|NOT COMPLETED|Treatment Period 2 (14 Days)||0||
60045099|NCT01716520|76160612|FG003|NOT COMPLETED|Treatment Period 2 (14 Days)||1||
60045100|NCT01716520|76160613|FG004|NOT COMPLETED|Treatment Period 2 (14 Days)||2||
60045101|NCT01716520|76160614|FG005|NOT COMPLETED|Treatment Period 2 (14 Days)||0||
60045102|NCT01716520|76160609|FG000|STARTED|Washout Period 2 (10 to 14 Days)||29||
60045103|NCT01716520|76160610|FG001|STARTED|Washout Period 2 (10 to 14 Days)||28||
60045104|NCT01716520|76160611|FG002|STARTED|Washout Period 2 (10 to 14 Days)||27||
60045105|NCT01716520|76160612|FG003|STARTED|Washout Period 2 (10 to 14 Days)||28||
60045106|NCT01716520|76160613|FG004|STARTED|Washout Period 2 (10 to 14 Days)||29||
60045107|NCT01716520|76160614|FG005|STARTED|Washout Period 2 (10 to 14 Days)||27||
60045108|NCT01716520|76160609|FG000|COMPLETED|Washout Period 2 (10 to 14 Days)||27||
60045109|NCT01716520|76160610|FG001|COMPLETED|Washout Period 2 (10 to 14 Days)||27||
60045110|NCT01716520|76160611|FG002|COMPLETED|Washout Period 2 (10 to 14 Days)||26||
60045111|NCT01716520|76160612|FG003|COMPLETED|Washout Period 2 (10 to 14 Days)||28||
60045112|NCT01716520|76160613|FG004|COMPLETED|Washout Period 2 (10 to 14 Days)||29||
60045113|NCT01716520|76160614|FG005|COMPLETED|Washout Period 2 (10 to 14 Days)||25||
60045114|NCT01716520|76160609|FG000|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||2||
60045115|NCT01716520|76160610|FG001|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||1||
60045116|NCT01716520|76160611|FG002|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||1||
60045117|NCT01716520|76160612|FG003|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0||
60045118|NCT01716520|76160613|FG004|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0||
60045119|NCT01716520|76160614|FG005|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||2||
60045120|NCT01716520|76160609|FG000|STARTED|Treatment Period 3 (14 Days)||27||
60045121|NCT01716520|76160610|FG001|STARTED|Treatment Period 3 (14 Days)||27||
60045122|NCT01716520|76160611|FG002|STARTED|Treatment Period 3 (14 Days)||26||
60045123|NCT01716520|76160612|FG003|STARTED|Treatment Period 3 (14 Days)||28||
60045124|NCT01716520|76160613|FG004|STARTED|Treatment Period 3 (14 Days)||29||
60045125|NCT01716520|76160614|FG005|STARTED|Treatment Period 3 (14 Days)||25||
60045126|NCT01716520|76160609|FG000|COMPLETED|Treatment Period 3 (14 Days)||27||
60045127|NCT01716520|76160610|FG001|COMPLETED|Treatment Period 3 (14 Days)||27||
60045128|NCT01716520|76160611|FG002|COMPLETED|Treatment Period 3 (14 Days)||25||
60045129|NCT01716520|76160612|FG003|COMPLETED|Treatment Period 3 (14 Days)||28||
59759772|NCT03481556|75879196|FG001|NOT COMPLETED|Overall Study||7||
59919364|NCT03307785|76039645|FG006|NOT COMPLETED|Part E: Up to 4.4 Months||2||
59919365|NCT03307785|76039646|FG007|NOT COMPLETED|Part E: Up to 4.4 Months||0||
59919366|NCT03307785|76039647|FG008|NOT COMPLETED|Part E: Up to 4.4 Months||0||
59919367|NCT03307785|76039648|FG009|NOT COMPLETED|Part E: Up to 4.4 Months||0||
59919368|NCT03307785|76039649|FG010|NOT COMPLETED|Part E: Up to 4.4 Months||0||
59919369|NCT03307785|76039639|FG000|STARTED|Part F: Up to 3.5 Months||0||
59919370|NCT03307785|76039640|FG001|STARTED|Part F: Up to 3.5 Months||0||
59919371|NCT03307785|76039641|FG002|STARTED|Part F: Up to 3.5 Months||0||
59919372|NCT03307785|76039642|FG003|STARTED|Part F: Up to 3.5 Months||0||
59919373|NCT03307785|76039643|FG004|STARTED|Part F: Up to 3.5 Months||0||
59919374|NCT03307785|76039644|FG005|STARTED|Part F: Up to 3.5 Months||0||
59919375|NCT03307785|76039645|FG006|STARTED|Part F: Up to 3.5 Months||0||
59919376|NCT03307785|76039646|FG007|STARTED|Part F: Up to 3.5 Months||1||
59919377|NCT03307785|76039647|FG008|STARTED|Part F: Up to 3.5 Months||0||
59919378|NCT03307785|76039648|FG009|STARTED|Part F: Up to 3.5 Months||0||
59919379|NCT03307785|76039649|FG010|STARTED|Part F: Up to 3.5 Months||0||
59919380|NCT03307785|76039639|FG000|COMPLETED|Part F: Up to 3.5 Months||0||
59919381|NCT03307785|76039640|FG001|COMPLETED|Part F: Up to 3.5 Months||0||
59919382|NCT03307785|76039641|FG002|COMPLETED|Part F: Up to 3.5 Months||0||
59919383|NCT03307785|76039642|FG003|COMPLETED|Part F: Up to 3.5 Months||0||
59919384|NCT03307785|76039643|FG004|COMPLETED|Part F: Up to 3.5 Months||0||
59919385|NCT03307785|76039644|FG005|COMPLETED|Part F: Up to 3.5 Months||0||
59919386|NCT03307785|76039645|FG006|COMPLETED|Part F: Up to 3.5 Months||0||
59919387|NCT03307785|76039646|FG007|COMPLETED|Part F: Up to 3.5 Months||0||
59919388|NCT03307785|76039647|FG008|COMPLETED|Part F: Up to 3.5 Months||0||
59919389|NCT03307785|76039648|FG009|COMPLETED|Part F: Up to 3.5 Months||0||
59919390|NCT03307785|76039649|FG010|COMPLETED|Part F: Up to 3.5 Months||0||
59919391|NCT03307785|76039639|FG000|NOT COMPLETED|Part F: Up to 3.5 Months||0||
59919392|NCT03307785|76039640|FG001|NOT COMPLETED|Part F: Up to 3.5 Months||0||
59919393|NCT03307785|76039641|FG002|NOT COMPLETED|Part F: Up to 3.5 Months||0||
59919394|NCT03307785|76039642|FG003|NOT COMPLETED|Part F: Up to 3.5 Months||0||
59919395|NCT03307785|76039643|FG004|NOT COMPLETED|Part F: Up to 3.5 Months||0||
59919396|NCT03307785|76039644|FG005|NOT COMPLETED|Part F: Up to 3.5 Months||0||
59919397|NCT03307785|76039645|FG006|NOT COMPLETED|Part F: Up to 3.5 Months||0||
59919398|NCT03307785|76039646|FG007|NOT COMPLETED|Part F: Up to 3.5 Months||1||
59951415|NCT01798992|76070392|FG002|NOT COMPLETED|Overall Study||2||
60045130|NCT01716520|76160613|FG004|COMPLETED|Treatment Period 3 (14 Days)||29||
60045131|NCT01716520|76160614|FG005|COMPLETED|Treatment Period 3 (14 Days)||23||
60045132|NCT01716520|76160609|FG000|NOT COMPLETED|Treatment Period 3 (14 Days)||0||
60045133|NCT01716520|76160610|FG001|NOT COMPLETED|Treatment Period 3 (14 Days)||0||
60045134|NCT01716520|76160611|FG002|NOT COMPLETED|Treatment Period 3 (14 Days)||1||
60045135|NCT01716520|76160612|FG003|NOT COMPLETED|Treatment Period 3 (14 Days)||0||
60045136|NCT01716520|76160613|FG004|NOT COMPLETED|Treatment Period 3 (14 Days)||0||
60045137|NCT01716520|76160614|FG005|NOT COMPLETED|Treatment Period 3 (14 Days)||2||
60045138|NCT01698268|76160624|FG000|STARTED|Overall Study||25||
60045139|NCT01698268|76160625|FG001|STARTED|Overall Study||25||
60045140|NCT01698268|76160624|FG000|COMPLETED|Overall Study||23||
60045141|NCT01698268|76160625|FG001|COMPLETED|Overall Study||24||
59511420|NCT00880997|75605053|FG001|COMPLETED|Overall Study||6||
59511421|NCT00880997|75605054|FG002|COMPLETED|Overall Study||5||
59511422|NCT00880997|75605052|FG000|NOT COMPLETED|Overall Study||3||
59759773|NCT03481556|75879197|FG002|NOT COMPLETED|Overall Study||5||
59919399|NCT03307785|76039647|FG008|NOT COMPLETED|Part F: Up to 3.5 Months||0||
59919400|NCT03307785|76039648|FG009|NOT COMPLETED|Part F: Up to 3.5 Months||0||
59919401|NCT03307785|76039649|FG010|NOT COMPLETED|Part F: Up to 3.5 Months||0||
59919402|NCT03307785|76039639|FG000|STARTED|Part G: Up to 24 Months||0||
59919403|NCT03307785|76039640|FG001|STARTED|Part G: Up to 24 Months||0||
59919404|NCT03307785|76039641|FG002|STARTED|Part G: Up to 24 Months||0||
59919405|NCT03307785|76039642|FG003|STARTED|Part G: Up to 24 Months||0||
59919406|NCT03307785|76039643|FG004|STARTED|Part G: Up to 24 Months||0||
59919407|NCT03307785|76039644|FG005|STARTED|Part G: Up to 24 Months||0||
59919408|NCT03307785|76039645|FG006|STARTED|Part G: Up to 24 Months||0||
59919409|NCT03307785|76039646|FG007|STARTED|Part G: Up to 24 Months||0||
59919410|NCT03307785|76039647|FG008|STARTED|Part G: Up to 24 Months||0||
59919411|NCT03307785|76039648|FG009|STARTED|Part G: Up to 24 Months||0||
59919412|NCT03307785|76039649|FG010|STARTED|Part G: Up to 24 Months||0||
59919413|NCT03307785|76039639|FG000|COMPLETED|Part G: Up to 24 Months||0||
59919414|NCT03307785|76039640|FG001|COMPLETED|Part G: Up to 24 Months||0||
59919415|NCT03307785|76039641|FG002|COMPLETED|Part G: Up to 24 Months||0||
59919416|NCT03307785|76039642|FG003|COMPLETED|Part G: Up to 24 Months||0||
59919417|NCT03307785|76039643|FG004|COMPLETED|Part G: Up to 24 Months||0||
59919418|NCT03307785|76039644|FG005|COMPLETED|Part G: Up to 24 Months||0||
59919419|NCT03307785|76039645|FG006|COMPLETED|Part G: Up to 24 Months||0||
59919420|NCT03307785|76039646|FG007|COMPLETED|Part G: Up to 24 Months||0||
59919421|NCT03307785|76039647|FG008|COMPLETED|Part G: Up to 24 Months||0||
59919422|NCT03307785|76039648|FG009|COMPLETED|Part G: Up to 24 Months||0||
59919423|NCT03307785|76039649|FG010|COMPLETED|Part G: Up to 24 Months||0||
59919424|NCT03307785|76039639|FG000|NOT COMPLETED|Part G: Up to 24 Months||0||
59919425|NCT03307785|76039640|FG001|NOT COMPLETED|Part G: Up to 24 Months||0||
59919426|NCT03307785|76039641|FG002|NOT COMPLETED|Part G: Up to 24 Months||0||
59919427|NCT03307785|76039642|FG003|NOT COMPLETED|Part G: Up to 24 Months||0||
59919428|NCT03307785|76039643|FG004|NOT COMPLETED|Part G: Up to 24 Months||0||
59919429|NCT03307785|76039644|FG005|NOT COMPLETED|Part G: Up to 24 Months||0||
59919430|NCT03307785|76039645|FG006|NOT COMPLETED|Part G: Up to 24 Months||0||
59919431|NCT03307785|76039646|FG007|NOT COMPLETED|Part G: Up to 24 Months||0||
59919432|NCT03307785|76039647|FG008|NOT COMPLETED|Part G: Up to 24 Months||0||
59919433|NCT03307785|76039648|FG009|NOT COMPLETED|Part G: Up to 24 Months||0||
59919434|NCT03307785|76039649|FG010|NOT COMPLETED|Part G: Up to 24 Months||0||
59919435|NCT03307785|76039639|FG000|STARTED|Part H: Up to 24 Months||0||
59919436|NCT03307785|76039640|FG001|STARTED|Part H: Up to 24 Months||0||
59919437|NCT03307785|76039641|FG002|STARTED|Part H: Up to 24 Months||0||
59919438|NCT03307785|76039642|FG003|STARTED|Part H: Up to 24 Months||0||
59919439|NCT03307785|76039643|FG004|STARTED|Part H: Up to 24 Months||0||
59919440|NCT03307785|76039644|FG005|STARTED|Part H: Up to 24 Months||0||
59919441|NCT03307785|76039645|FG006|STARTED|Part H: Up to 24 Months||0||
59919442|NCT03307785|76039646|FG007|STARTED|Part H: Up to 24 Months||0||
59919443|NCT03307785|76039647|FG008|STARTED|Part H: Up to 24 Months||0||
59919444|NCT03307785|76039648|FG009|STARTED|Part H: Up to 24 Months||0||
59919445|NCT03307785|76039649|FG010|STARTED|Part H: Up to 24 Months||0||
59919446|NCT03307785|76039639|FG000|COMPLETED|Part H: Up to 24 Months||0||
59919447|NCT03307785|76039640|FG001|COMPLETED|Part H: Up to 24 Months||0||
59919448|NCT03307785|76039641|FG002|COMPLETED|Part H: Up to 24 Months||0||
59919449|NCT03307785|76039642|FG003|COMPLETED|Part H: Up to 24 Months||0||
59919450|NCT03307785|76039643|FG004|COMPLETED|Part H: Up to 24 Months||0||
59919451|NCT03307785|76039644|FG005|COMPLETED|Part H: Up to 24 Months||0||
59919452|NCT03307785|76039645|FG006|COMPLETED|Part H: Up to 24 Months||0||
59919453|NCT03307785|76039646|FG007|COMPLETED|Part H: Up to 24 Months||0||
59919454|NCT03307785|76039647|FG008|COMPLETED|Part H: Up to 24 Months||0||
59919455|NCT03307785|76039648|FG009|COMPLETED|Part H: Up to 24 Months||0||
59919456|NCT03307785|76039649|FG010|COMPLETED|Part H: Up to 24 Months||0||
59919457|NCT03307785|76039639|FG000|NOT COMPLETED|Part H: Up to 24 Months||0||
59919458|NCT03307785|76039640|FG001|NOT COMPLETED|Part H: Up to 24 Months||0||
59919459|NCT03307785|76039641|FG002|NOT COMPLETED|Part H: Up to 24 Months||0||
59919460|NCT03307785|76039642|FG003|NOT COMPLETED|Part H: Up to 24 Months||0||
59919461|NCT03307785|76039643|FG004|NOT COMPLETED|Part H: Up to 24 Months||0||
59919462|NCT03307785|76039644|FG005|NOT COMPLETED|Part H: Up to 24 Months||0||
59919463|NCT03307785|76039645|FG006|NOT COMPLETED|Part H: Up to 24 Months||0||
59919464|NCT03307785|76039646|FG007|NOT COMPLETED|Part H: Up to 24 Months||0||
59511423|NCT00880997|75605053|FG001|NOT COMPLETED|Overall Study||2||
59511424|NCT00880997|75605054|FG002|NOT COMPLETED|Overall Study||8||
59511425|NCT00881465|75605064|FG000|STARTED|Overall Study||16||
59759774|NCT03481556|75879198|FG003|NOT COMPLETED|Overall Study||25||
59919465|NCT03307785|76039647|FG008|NOT COMPLETED|Part H: Up to 24 Months||0||
59919466|NCT03307785|76039648|FG009|NOT COMPLETED|Part H: Up to 24 Months||0||
59919467|NCT03307785|76039649|FG010|NOT COMPLETED|Part H: Up to 24 Months||0||
59919468|NCT03307785|76039639|FG000|STARTED|Part I: Up to 24 Months||0||
60045142|NCT01698268|76160624|FG000|NOT COMPLETED|Overall Study||2||
60045143|NCT01698268|76160625|FG001|NOT COMPLETED|Overall Study||1||
60045144|NCT01697956|76160633|FG000|STARTED|Overall Study|enrolled and randomized|67||
60045145|NCT01697956|76160634|FG001|STARTED|Overall Study|enrolled and randomized|32||
60045146|NCT01697956|76160633|FG000|Per Protocol Population|Overall Study||66||
60045147|NCT01697956|76160634|FG001|Per Protocol Population|Overall Study||31||
60045148|NCT01697956|76160633|FG000|COMPLETED|Overall Study||66||
60045149|NCT01697956|76160634|FG001|COMPLETED|Overall Study||31||
60045150|NCT01697956|76160633|FG000|NOT COMPLETED|Overall Study||1||
60045151|NCT01697956|76160634|FG001|NOT COMPLETED|Overall Study||1||
60045152|NCT01697800|76160648|FG000|STARTED|Overall Study||15||
60045153|NCT01697800|76160649|FG001|STARTED|Overall Study||25||
60045154|NCT01697800|76160648|FG000|COMPLETED|Overall Study||15||
60045155|NCT01697800|76160649|FG001|COMPLETED|Overall Study||24||
60045156|NCT01697800|76160648|FG000|NOT COMPLETED|Overall Study||0||
60045157|NCT01697800|76160649|FG001|NOT COMPLETED|Overall Study||1||
60045158|NCT01644500|76160658|FG000|STARTED|Overall Study||244||
60045159|NCT01644500|76160659|FG001|STARTED|Overall Study||248||
60045160|NCT01644500|76160660|FG002|STARTED|Overall Study||245||
60045161|NCT01644500|76160658|FG000|Received at Least One Dose of Study Drug|Overall Study||244||
60045162|NCT01644500|76160659|FG001|Received at Least One Dose of Study Drug|Overall Study||248||
60045163|NCT01644500|76160660|FG002|Received at Least One Dose of Study Drug|Overall Study||243||
60045164|NCT01644500|76160658|FG000|Modified Intent-to-treat Population|Overall Study||239||
60045165|NCT01644500|76160659|FG001|Modified Intent-to-treat Population|Overall Study||239||
60045166|NCT01644500|76160660|FG002|Modified Intent-to-treat Population|Overall Study||242||
60045167|NCT01644500|76160658|FG000|COMPLETED|Overall Study||222||
60045168|NCT01644500|76160659|FG001|COMPLETED|Overall Study||224||
59919469|NCT03307785|76039640|FG001|STARTED|Part I: Up to 24 Months||0||
59919470|NCT03307785|76039641|FG002|STARTED|Part I: Up to 24 Months||0||
59919471|NCT03307785|76039642|FG003|STARTED|Part I: Up to 24 Months||0||
60045169|NCT01644500|76160660|FG002|COMPLETED|Overall Study||230||
60045170|NCT01644500|76160658|FG000|NOT COMPLETED|Overall Study||22||
60045171|NCT01644500|76160659|FG001|NOT COMPLETED|Overall Study||24||
60045172|NCT01644500|76160660|FG002|NOT COMPLETED|Overall Study||15||
60045173|NCT01604824|76160672|FG000|STARTED|Double-blind (DB) Period||6||
60045174|NCT01604824|76160673|FG001|STARTED|Double-blind (DB) Period||7||
60045175|NCT01604824|76160674|FG002|STARTED|Double-blind (DB) Period||5||
59759775|NCT00596427|75879216|FG000|STARTED|Overall Study||30||
59759776|NCT00596427|75879217|FG001|STARTED|Overall Study||30||
59919472|NCT03307785|76039643|FG004|STARTED|Part I: Up to 24 Months||0||
59919473|NCT03307785|76039644|FG005|STARTED|Part I: Up to 24 Months||0||
59919474|NCT03307785|76039645|FG006|STARTED|Part I: Up to 24 Months||0||
59919475|NCT03307785|76039646|FG007|STARTED|Part I: Up to 24 Months||0||
59919476|NCT03307785|76039647|FG008|STARTED|Part I: Up to 24 Months||0||
59919477|NCT03307785|76039648|FG009|STARTED|Part I: Up to 24 Months||0||
59919478|NCT03307785|76039649|FG010|STARTED|Part I: Up to 24 Months||0||
59919479|NCT03307785|76039639|FG000|COMPLETED|Part I: Up to 24 Months||0||
59919480|NCT03307785|76039640|FG001|COMPLETED|Part I: Up to 24 Months||0||
59919481|NCT03307785|76039641|FG002|COMPLETED|Part I: Up to 24 Months||0||
59919482|NCT03307785|76039642|FG003|COMPLETED|Part I: Up to 24 Months||0||
59919483|NCT03307785|76039643|FG004|COMPLETED|Part I: Up to 24 Months||0||
59919484|NCT03307785|76039644|FG005|COMPLETED|Part I: Up to 24 Months||0||
59919485|NCT03307785|76039645|FG006|COMPLETED|Part I: Up to 24 Months||0||
59919486|NCT03307785|76039646|FG007|COMPLETED|Part I: Up to 24 Months||0||
59919487|NCT03307785|76039647|FG008|COMPLETED|Part I: Up to 24 Months||0||
59919488|NCT03307785|76039648|FG009|COMPLETED|Part I: Up to 24 Months||0||
59919489|NCT03307785|76039649|FG010|COMPLETED|Part I: Up to 24 Months||0||
59919490|NCT03307785|76039639|FG000|NOT COMPLETED|Part I: Up to 24 Months||0||
59919491|NCT03307785|76039640|FG001|NOT COMPLETED|Part I: Up to 24 Months||0||
60045176|NCT01604824|76160675|FG003|STARTED|Double-blind (DB) Period||5||
60045177|NCT01604824|76160676|FG004|STARTED|Double-blind (DB) Period||0||
60045178|NCT01604824|76160677|FG005|STARTED|Double-blind (DB) Period||0||
60045179|NCT01604824|76160672|FG000|Completed DB Period (Day 99)|Double-blind (DB) Period||6||
60045180|NCT01604824|76160673|FG001|Completed DB Period (Day 99)|Double-blind (DB) Period||7||
60045181|NCT01604824|76160674|FG002|Completed DB Period (Day 99)|Double-blind (DB) Period||5||
59759777|NCT00596427|75879216|FG000|COMPLETED|Overall Study||26||
60045182|NCT01604824|76160675|FG003|Completed DB Period (Day 99)|Double-blind (DB) Period||5||
60045183|NCT01604824|76160676|FG004|Completed DB Period (Day 99)|Double-blind (DB) Period||0||
60045184|NCT01604824|76160677|FG005|Completed DB Period (Day 99)|Double-blind (DB) Period||0||
60045185|NCT01604824|76160672|FG000|Completed DB Follow-up (Day 155)|Double-blind (DB) Period||6||
60045186|NCT01604824|76160673|FG001|Completed DB Follow-up (Day 155)|Double-blind (DB) Period||7||
60045187|NCT01604824|76160674|FG002|Completed DB Follow-up (Day 155)|Double-blind (DB) Period||5||
60045188|NCT01604824|76160675|FG003|Completed DB Follow-up (Day 155)|Double-blind (DB) Period||5||
60045189|NCT01604824|76160676|FG004|Completed DB Follow-up (Day 155)|Double-blind (DB) Period||0||
60045190|NCT01604824|76160677|FG005|Completed DB Follow-up (Day 155)|Double-blind (DB) Period||0||
60045191|NCT01604824|76160672|FG000|COMPLETED|Double-blind (DB) Period||6||
60045192|NCT01604824|76160673|FG001|COMPLETED|Double-blind (DB) Period||7||
60045193|NCT01604824|76160674|FG002|COMPLETED|Double-blind (DB) Period||5||
60045194|NCT01604824|76160675|FG003|COMPLETED|Double-blind (DB) Period||5||
60045195|NCT01604824|76160676|FG004|COMPLETED|Double-blind (DB) Period||0||
60045196|NCT01604824|76160677|FG005|COMPLETED|Double-blind (DB) Period||0||
60045197|NCT01604824|76160672|FG000|NOT COMPLETED|Double-blind (DB) Period||0||
60045198|NCT01604824|76160673|FG001|NOT COMPLETED|Double-blind (DB) Period||0||
60045199|NCT01604824|76160674|FG002|NOT COMPLETED|Double-blind (DB) Period||0||
60045200|NCT01604824|76160675|FG003|NOT COMPLETED|Double-blind (DB) Period||0||
60045201|NCT01604824|76160676|FG004|NOT COMPLETED|Double-blind (DB) Period||0||
60045202|NCT01604824|76160677|FG005|NOT COMPLETED|Double-blind (DB) Period||0||
59759778|NCT00596427|75879217|FG001|COMPLETED|Overall Study||28||
59759779|NCT00596427|75879216|FG000|NOT COMPLETED|Overall Study||4||
60045203|NCT01604824|76160672|FG000|STARTED|Open-label Extension (OLE) Period||0||
60045204|NCT01604824|76160673|FG001|STARTED|Open-label Extension (OLE) Period||0||
60045205|NCT01604824|76160674|FG002|STARTED|Open-label Extension (OLE) Period||0||
60045206|NCT01604824|76160675|FG003|STARTED|Open-label Extension (OLE) Period||0||
60045207|NCT01604824|76160676|FG004|STARTED|Open-label Extension (OLE) Period|Completed DB Period (Day 99)|13||
60045208|NCT01604824|76160677|FG005|STARTED|Open-label Extension (OLE) Period|Completed DB follow-up (Day 155)|10||
60045209|NCT01604824|76160672|FG000|Started Open-label Extension Period|Open-label Extension (OLE) Period||0||
60045210|NCT01604824|76160673|FG001|Started Open-label Extension Period|Open-label Extension (OLE) Period||0||
60045211|NCT01604824|76160674|FG002|Started Open-label Extension Period|Open-label Extension (OLE) Period||0||
60045212|NCT01604824|76160675|FG003|Started Open-label Extension Period|Open-label Extension (OLE) Period||0||
60045213|NCT01604824|76160676|FG004|Started Open-label Extension Period|Open-label Extension (OLE) Period|Two subjects chose not to enter OLE period|11||
60045214|NCT01604824|76160677|FG005|Started Open-label Extension Period|Open-label Extension (OLE) Period||10||
60045215|NCT01604824|76160672|FG000|Completed Study|Open-label Extension (OLE) Period||0||
60045216|NCT01604824|76160673|FG001|Completed Study|Open-label Extension (OLE) Period||0||
60045217|NCT01604824|76160674|FG002|Completed Study|Open-label Extension (OLE) Period||0||
60045218|NCT01604824|76160675|FG003|Completed Study|Open-label Extension (OLE) Period||0||
60045219|NCT01604824|76160676|FG004|Completed Study|Open-label Extension (OLE) Period||10||
60045220|NCT01604824|76160677|FG005|Completed Study|Open-label Extension (OLE) Period||10||
60045221|NCT01604824|76160672|FG000|COMPLETED|Open-label Extension (OLE) Period||0||
60045222|NCT01604824|76160673|FG001|COMPLETED|Open-label Extension (OLE) Period||0||
60045223|NCT01604824|76160674|FG002|COMPLETED|Open-label Extension (OLE) Period||0||
60045224|NCT01604824|76160675|FG003|COMPLETED|Open-label Extension (OLE) Period||0||
60045225|NCT01604824|76160676|FG004|COMPLETED|Open-label Extension (OLE) Period||10||
60045226|NCT01604824|76160677|FG005|COMPLETED|Open-label Extension (OLE) Period||10||
60045227|NCT01604824|76160672|FG000|NOT COMPLETED|Open-label Extension (OLE) Period||0||
60045228|NCT01604824|76160673|FG001|NOT COMPLETED|Open-label Extension (OLE) Period||0||
60045229|NCT01604824|76160674|FG002|NOT COMPLETED|Open-label Extension (OLE) Period||0||
60045230|NCT01604824|76160675|FG003|NOT COMPLETED|Open-label Extension (OLE) Period||0||
60045231|NCT01604824|76160676|FG004|NOT COMPLETED|Open-label Extension (OLE) Period||3||
60045232|NCT01604824|76160677|FG005|NOT COMPLETED|Open-label Extension (OLE) Period||0||
60045233|NCT01716052|76160691|FG000|STARTED|Overall Study||1||
60045234|NCT01716052|76160692|FG001|STARTED|Overall Study||1||
60045235|NCT01716052|76160691|FG000|COMPLETED|Overall Study||0||
60045236|NCT01716052|76160692|FG001|COMPLETED|Overall Study||0||
60045237|NCT01716052|76160691|FG000|NOT COMPLETED|Overall Study||1||
60045238|NCT01716052|76160692|FG001|NOT COMPLETED|Overall Study||1||
60045239|NCT01641692|76160698|FG000|STARTED|Treatment Period 1||42||
60045240|NCT01641692|76160699|FG001|STARTED|Treatment Period 1||45||
60045241|NCT01641692|76160700|FG002|STARTED|Treatment Period 1||51||
60045242|NCT01641692|76160701|FG003|STARTED|Treatment Period 1||41||
60045243|NCT01641692|76160702|FG004|STARTED|Treatment Period 1||43||
60045244|NCT01641692|76160703|FG005|STARTED|Treatment Period 1||39||
60045245|NCT01641692|76160704|FG006|STARTED|Treatment Period 1||38||
60045246|NCT01641692|76160705|FG007|STARTED|Treatment Period 1||51||
60045247|NCT01641692|76160698|FG000|COMPLETED|Treatment Period 1||40||
60045248|NCT01641692|76160699|FG001|COMPLETED|Treatment Period 1||45||
60045249|NCT01641692|76160700|FG002|COMPLETED|Treatment Period 1||50||
60045250|NCT01641692|76160701|FG003|COMPLETED|Treatment Period 1||41||
60045251|NCT01641692|76160702|FG004|COMPLETED|Treatment Period 1||39||
60045252|NCT01641692|76160703|FG005|COMPLETED|Treatment Period 1||37||
60045253|NCT01641692|76160704|FG006|COMPLETED|Treatment Period 1||38||
60045254|NCT01641692|76160705|FG007|COMPLETED|Treatment Period 1||48||
60045255|NCT01641692|76160698|FG000|NOT COMPLETED|Treatment Period 1||2||
60045256|NCT01641692|76160699|FG001|NOT COMPLETED|Treatment Period 1||0||
59759780|NCT00596427|75879217|FG001|NOT COMPLETED|Overall Study||2||
59759781|NCT02732210|75879226|FG000|STARTED|Overall Study||303||
59759782|NCT02732210|75879227|FG001|STARTED|Overall Study||632||
60045257|NCT01641692|76160700|FG002|NOT COMPLETED|Treatment Period 1||1||
60045258|NCT01641692|76160701|FG003|NOT COMPLETED|Treatment Period 1||0||
60045259|NCT01641692|76160702|FG004|NOT COMPLETED|Treatment Period 1||4||
60045260|NCT01641692|76160703|FG005|NOT COMPLETED|Treatment Period 1||2||
60045261|NCT01641692|76160704|FG006|NOT COMPLETED|Treatment Period 1||0||
60045262|NCT01641692|76160705|FG007|NOT COMPLETED|Treatment Period 1||3||
60045263|NCT01641692|76160698|FG000|STARTED|Washout Period 1 (12-14 Days)||40||
60045264|NCT01641692|76160699|FG001|STARTED|Washout Period 1 (12-14 Days)||45||
60045265|NCT01641692|76160700|FG002|STARTED|Washout Period 1 (12-14 Days)||50||
60045266|NCT01641692|76160701|FG003|STARTED|Washout Period 1 (12-14 Days)||41||
60045267|NCT01641692|76160702|FG004|STARTED|Washout Period 1 (12-14 Days)||39||
60045268|NCT01641692|76160703|FG005|STARTED|Washout Period 1 (12-14 Days)||37||
60045269|NCT01641692|76160704|FG006|STARTED|Washout Period 1 (12-14 Days)||38||
60045270|NCT01641692|76160705|FG007|STARTED|Washout Period 1 (12-14 Days)||48||
60045271|NCT01641692|76160698|FG000|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|36||
59759783|NCT02732210|75879226|FG000|COMPLETED|Overall Study||218||
60045272|NCT01641692|76160699|FG001|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|44||
60045273|NCT01641692|76160700|FG002|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|47||
60045274|NCT01641692|76160701|FG003|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|39||
60045275|NCT01641692|76160702|FG004|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|35||
60045276|NCT01641692|76160703|FG005|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|37||
60045277|NCT01641692|76160704|FG006|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|36||
60045278|NCT01641692|76160705|FG007|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|47||
60045279|NCT01641692|76160698|FG000|NOT COMPLETED|Washout Period 1 (12-14 Days)||4||
60045280|NCT01641692|76160699|FG001|NOT COMPLETED|Washout Period 1 (12-14 Days)||1||
60045281|NCT01641692|76160700|FG002|NOT COMPLETED|Washout Period 1 (12-14 Days)||3||
60045282|NCT01641692|76160701|FG003|NOT COMPLETED|Washout Period 1 (12-14 Days)||2||
60045283|NCT01641692|76160702|FG004|NOT COMPLETED|Washout Period 1 (12-14 Days)||4||
60045284|NCT01641692|76160703|FG005|NOT COMPLETED|Washout Period 1 (12-14 Days)||0||
60045285|NCT01641692|76160704|FG006|NOT COMPLETED|Washout Period 1 (12-14 Days)||2||
60045286|NCT01641692|76160705|FG007|NOT COMPLETED|Washout Period 1 (12-14 Days)||1||
60045287|NCT01641692|76160698|FG000|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|33||
60045288|NCT01641692|76160699|FG001|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|46||
60067832|NCT01617967|76183032|FG003|STARTED|Overall Study||7||
60067833|NCT01617967|76183033|FG004|STARTED|Overall Study||3||
60067834|NCT01617967|76183034|FG005|STARTED|Overall Study||9||
60067835|NCT01617967|76183029|FG000|COMPLETED|Overall Study||3||
60067836|NCT01617967|76183030|FG001|COMPLETED|Overall Study||3||
60067837|NCT01617967|76183031|FG002|COMPLETED|Overall Study||3||
60067838|NCT01617967|76183032|FG003|COMPLETED|Overall Study||6||
60067839|NCT01617967|76183033|FG004|COMPLETED|Overall Study||3||
60067840|NCT01617967|76183034|FG005|COMPLETED|Overall Study||8||
60067841|NCT01617967|76183029|FG000|NOT COMPLETED|Overall Study||1||
60067842|NCT01617967|76183030|FG001|NOT COMPLETED|Overall Study||0||
60045289|NCT01641692|76160700|FG002|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|40||
60045290|NCT01641692|76160701|FG003|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|41||
60045291|NCT01641692|76160702|FG004|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|37||
60045292|NCT01641692|76160703|FG005|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|45||
60045293|NCT01641692|76160704|FG006|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|43||
60045294|NCT01641692|76160705|FG007|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|36||
60045295|NCT01641692|76160698|FG000|COMPLETED|Treatment Period 2||30||
60045296|NCT01641692|76160699|FG001|COMPLETED|Treatment Period 2||46||
59759784|NCT02732210|75879227|FG001|COMPLETED|Overall Study||338||
59759785|NCT02732210|75879226|FG000|NOT COMPLETED|Overall Study||85||
59759786|NCT02732210|75879227|FG001|NOT COMPLETED|Overall Study||294||
59759787|NCT00595959|75879233|FG000|STARTED|Overall Study||65||
59759788|NCT00595959|75879233|FG000|COMPLETED|Overall Study||63||
59759789|NCT00595959|75879233|FG000|NOT COMPLETED|Overall Study||2||
59759790|NCT03104192|75879241|FG000|STARTED|Overall Study||9||
59759791|NCT03104192|75879242|FG001|STARTED|Overall Study||27||
59759792|NCT03104192|75879243|FG002|STARTED|Overall Study||16||
59759793|NCT03104192|75879244|FG003|STARTED|Overall Study||17||
59759794|NCT03104192|75879241|FG000|COMPLETED|Overall Study||9||
59759795|NCT03104192|75879242|FG001|COMPLETED|Overall Study||23||
59759796|NCT03104192|75879243|FG002|COMPLETED|Overall Study||14||
59759797|NCT03104192|75879244|FG003|COMPLETED|Overall Study||14||
59759798|NCT03104192|75879241|FG000|NOT COMPLETED|Overall Study||0||
59759799|NCT03104192|75879242|FG001|NOT COMPLETED|Overall Study||4||
59759800|NCT03104192|75879243|FG002|NOT COMPLETED|Overall Study||2||
59759801|NCT03104192|75879244|FG003|NOT COMPLETED|Overall Study||3||
59759802|NCT03930446|75879262|FG000|STARTED|Overall Study||40||
59759803|NCT03930446|75879263|FG001|STARTED|Overall Study||40||
59759804|NCT03930446|75879262|FG000|COMPLETED|Overall Study||40||
59759805|NCT03930446|75879263|FG001|COMPLETED|Overall Study||40||
59759806|NCT03930446|75879262|FG000|NOT COMPLETED|Overall Study||0||
59759807|NCT03930446|75879263|FG001|NOT COMPLETED|Overall Study||0||
59759808|NCT00436748|75879271|FG000|STARTED|Overall Study||59||
59759809|NCT00436748|75879272|FG001|STARTED|Overall Study||57||
59759810|NCT00436748|75879271|FG000|Received Treatment|Overall Study||58||
59759811|NCT00436748|75879272|FG001|Received Treatment|Overall Study||56||
59759812|NCT00436748|75879271|FG000|COMPLETED|Overall Study||48||
59759813|NCT00436748|75879272|FG001|COMPLETED|Overall Study||45||
59759814|NCT00436748|75879271|FG000|NOT COMPLETED|Overall Study||11||
59759815|NCT00436748|75879272|FG001|NOT COMPLETED|Overall Study||12||
59759816|NCT02703272|75879282|FG000|STARTED|Overall Study||11||
59759817|NCT02703272|75879283|FG001|STARTED|Overall Study||10||
60045297|NCT01641692|76160700|FG002|COMPLETED|Treatment Period 2||40||
59759818|NCT02703272|75879284|FG002|STARTED|Overall Study||35||
59759819|NCT02703272|75879285|FG003|STARTED|Overall Study||16||
59759820|NCT02703272|75879282|FG000|COMPLETED|Overall Study||0||
59759821|NCT02703272|75879283|FG001|COMPLETED|Overall Study||0||
59759822|NCT02703272|75879284|FG002|COMPLETED|Overall Study||0||
59759823|NCT02703272|75879285|FG003|COMPLETED|Overall Study||0||
59759824|NCT02703272|75879282|FG000|NOT COMPLETED|Overall Study||11||
59759825|NCT02703272|75879283|FG001|NOT COMPLETED|Overall Study||10||
59759826|NCT02703272|75879284|FG002|NOT COMPLETED|Overall Study||35||
59759827|NCT02703272|75879285|FG003|NOT COMPLETED|Overall Study||16||
59759828|NCT02022566|75879315|FG000|STARTED|Overall Study||227||
59759829|NCT02022566|75879316|FG001|STARTED|Overall Study||90||
59759830|NCT02022566|75879315|FG000|COMPLETED|Overall Study||169||
59759831|NCT02022566|75879316|FG001|COMPLETED|Overall Study||49||
59759832|NCT02022566|75879315|FG000|NOT COMPLETED|Overall Study||58||
59759833|NCT02022566|75879316|FG001|NOT COMPLETED|Overall Study||41||
59759834|NCT02568215|75879325|FG000|STARTED|Overall Study||637|Enrollment is concurrent with receiving the first infusion (safety analyses)|
59759835|NCT02568215|75879326|FG001|STARTED|Overall Study||642|Enrollment is concurrent with receiving the first infusion (safety analyses)|
59759836|NCT02568215|75879327|FG002|STARTED|Overall Study||645|Enrollment is concurrent with receiving the first infusion (safety analyses)|
59759837|NCT02568215|75879325|FG000|Modified Intent-to-treat Population|Overall Study||637|Participants excluded from MITT if HIV positive at enrollment or randomized/enrolled more than once (efficacy analyses)|
59762607|NCT00866307|75882445|FG002|COMPLETED|Induction||0||
59762608|NCT00866307|75882443|FG000|NOT COMPLETED|Induction||20||
59511426|NCT00881465|75605065|FG001|STARTED|Overall Study||15||
59511427|NCT00881465|75605064|FG000|COMPLETED|Overall Study||14||
59511428|NCT00881465|75605065|FG001|COMPLETED|Overall Study||15||
59511429|NCT00881465|75605064|FG000|NOT COMPLETED|Overall Study||2||
59511430|NCT00881465|75605065|FG001|NOT COMPLETED|Overall Study||0||
59511431|NCT00883103|75605073|FG000|STARTED|Overall Study||69||
59511432|NCT00883103|75605074|FG001|STARTED|Overall Study||68||
59511433|NCT00883103|75605073|FG000|COMPLETED|Overall Study||69||
59511434|NCT00883103|75605074|FG001|COMPLETED|Overall Study||68||
59511435|NCT00883103|75605073|FG000|NOT COMPLETED|Overall Study||0||
59511436|NCT00883103|75605074|FG001|NOT COMPLETED|Overall Study||0||
59511437|NCT02742532|75605082|FG000|STARTED|Overall Study||31||
59511438|NCT02742532|75605083|FG001|STARTED|Overall Study||32||
59511439|NCT02742532|75605082|FG000|COMPLETED|Overall Study||28||
59511440|NCT02742532|75605083|FG001|COMPLETED|Overall Study||31||
59511441|NCT02742532|75605082|FG000|NOT COMPLETED|Overall Study||3||
59511442|NCT02742532|75605083|FG001|NOT COMPLETED|Overall Study||1||
59511443|NCT02740114|75605091|FG000|STARTED|Overall Study||54||
59511444|NCT02740114|75605092|FG001|STARTED|Overall Study||48||
59511445|NCT02740114|75605091|FG000|COMPLETED|Overall Study||54||
59511446|NCT02740114|75605092|FG001|COMPLETED|Overall Study||48||
59511447|NCT02740114|75605091|FG000|NOT COMPLETED|Overall Study||0||
59511448|NCT02740114|75605092|FG001|NOT COMPLETED|Overall Study||0||
59511449|NCT02166905|75605102|FG000|STARTED|Overall Study||7||
59511450|NCT02166905|75605103|FG001|STARTED|Overall Study||16||
59511451|NCT02166905|75605104|FG002|STARTED|Overall Study||15||
59511452|NCT02166905|75605105|FG003|STARTED|Overall Study||2||
59511453|NCT02166905|75605102|FG000|COMPLETED|Overall Study||6||
59511454|NCT02166905|75605103|FG001|COMPLETED|Overall Study||16||
59511455|NCT02166905|75605104|FG002|COMPLETED|Overall Study||15||
59511456|NCT02166905|75605105|FG003|COMPLETED|Overall Study||2||
59511457|NCT02166905|75605102|FG000|NOT COMPLETED|Overall Study||1||
59511458|NCT02166905|75605103|FG001|NOT COMPLETED|Overall Study||0||
59511459|NCT02166905|75605104|FG002|NOT COMPLETED|Overall Study||0||
59511460|NCT02166905|75605105|FG003|NOT COMPLETED|Overall Study||0||
59511461|NCT02743078|75605119|FG000|STARTED|Overall Study||3||
59511462|NCT02743078|75605119|FG000|Eligible Populaton|Overall Study||3||
59511463|NCT02743078|75605119|FG000|Eligible With Six-month Follow-up Data|Overall Study||3||
59511464|NCT02743078|75605119|FG000|COMPLETED|Overall Study||3|Participants contributing data to results are considered to have completed the study|
59511465|NCT02743078|75605119|FG000|NOT COMPLETED|Overall Study||0||
59511466|NCT00890981|75605125|FG000|STARTED|Overall Study||39||
59511467|NCT00890981|75605126|FG001|STARTED|Overall Study||40||
59511468|NCT00890981|75605125|FG000|COMPLETED|Overall Study||39||
59511469|NCT00890981|75605126|FG001|COMPLETED|Overall Study||40||
59511470|NCT00890981|75605125|FG000|NOT COMPLETED|Overall Study||0||
59511471|NCT00890981|75605126|FG001|NOT COMPLETED|Overall Study||0||
59511472|NCT02743312|75605134|FG000|STARTED|Overall Study||3||
59511473|NCT02743312|75605135|FG001|STARTED|Overall Study||2||
59511474|NCT02743312|75605134|FG000|COMPLETED|Overall Study||3||
59511475|NCT02743312|75605135|FG001|COMPLETED|Overall Study||2||
59511476|NCT02743312|75605134|FG000|NOT COMPLETED|Overall Study||0||
59511477|NCT02743312|75605135|FG001|NOT COMPLETED|Overall Study||0||
59511478|NCT01501955|75605152|FG000|STARTED|Overall Study||11||
59511479|NCT01501955|75605153|FG001|STARTED|Overall Study||9||
59511480|NCT01501955|75605152|FG000|Surgery|Overall Study||11||
59511481|NCT01501955|75605153|FG001|Surgery|Overall Study||9||
59511482|NCT01501955|75605152|FG000|6 Weeks Postop|Overall Study|1 patient withdrew on own request|10||
59511483|NCT01501955|75605153|FG001|6 Weeks Postop|Overall Study||9||
59511484|NCT01501955|75605152|FG000|1 Year Postop|Overall Study|1 patient terminated due to stem revision|9||
59511485|NCT01501955|75605153|FG001|1 Year Postop|Overall Study|2 patients terminated due to stem revision|7||
59511486|NCT01501955|75605152|FG000|2 Years Postop|Overall Study||9||
59511487|NCT01501955|75605153|FG001|2 Years Postop|Overall Study|1 patient terminated due to stem revision|6||
59511488|NCT01501955|75605152|FG000|COMPLETED|Overall Study||9|Primary endpoint at 2 years postop. All active patients will be followed further until 10 years.|
59511489|NCT01501955|75605153|FG001|COMPLETED|Overall Study||6|Primary endpoint at 2 years postop. All active patients will be followed further until 10 years.|
59511490|NCT01501955|75605152|FG000|NOT COMPLETED|Overall Study||2||
59511491|NCT01501955|75605153|FG001|NOT COMPLETED|Overall Study||3||
59511492|NCT02743702|75605161|FG000|STARTED|Overall Study||11||
59511493|NCT02743702|75605162|FG001|STARTED|Overall Study||10||
59511494|NCT02743702|75605161|FG000|COMPLETED|Overall Study||11||
59511495|NCT02743702|75605162|FG001|COMPLETED|Overall Study||10||
59511496|NCT02743702|75605161|FG000|NOT COMPLETED|Overall Study||0||
59511497|NCT02743702|75605162|FG001|NOT COMPLETED|Overall Study||0||
59511498|NCT00883415|75605168|FG000|STARTED|Overall Study||20||
59511499|NCT00883415|75605168|FG000|COMPLETED|Overall Study||18||
59511500|NCT00883415|75605168|FG000|NOT COMPLETED|Overall Study||2||
59511501|NCT02743936|75605174|FG000|STARTED|Overall Study||32||
59511502|NCT02743936|75605175|FG001|STARTED|Overall Study||32||
59511503|NCT02743936|75605174|FG000|COMPLETED|Overall Study||32||
59511504|NCT02743936|75605175|FG001|COMPLETED|Overall Study||32||
59511505|NCT02743936|75605174|FG000|NOT COMPLETED|Overall Study||0||
59511506|NCT02743936|75605175|FG001|NOT COMPLETED|Overall Study||0||
59511507|NCT00842231|75605181|FG000|STARTED|Overall Study||40||
59511508|NCT00842231|75605181|FG000|COMPLETED|Overall Study||40||
59511509|NCT00842231|75605181|FG000|NOT COMPLETED|Overall Study||0||
59511510|NCT00884585|75605187|FG000|STARTED|Double-Masked Phase (Day 1-Month 3)||89||
59511511|NCT00884585|75605188|FG001|STARTED|Double-Masked Phase (Day 1-Month 3)||87||
59511512|NCT00884585|75605187|FG000|COMPLETED|Double-Masked Phase (Day 1-Month 3)||79||
59511513|NCT00884585|75605188|FG001|COMPLETED|Double-Masked Phase (Day 1-Month 3)|All placebo patients who completed the double-masked phase received COS in the open-label phase.|83||
59511514|NCT00884585|75605187|FG000|NOT COMPLETED|Double-Masked Phase (Day 1-Month 3)||10||
59511515|NCT00884585|75605188|FG001|NOT COMPLETED|Double-Masked Phase (Day 1-Month 3)||4||
59511516|NCT00884585|75605187|FG000|STARTED|Open-Label Phase (Months 3-9)|All patients who completed the double-masked phase received COS in the open-label phase.|162||
59511517|NCT00884585|75605188|FG001|STARTED|Open-Label Phase (Months 3-9)|All placebo patients who completed the double-masked phase received COS in the open-label phase.|0||
59511518|NCT00884585|75605187|FG000|COMPLETED|Open-Label Phase (Months 3-9)||147||
59759838|NCT02568215|75879326|FG001|Modified Intent-to-treat Population|Overall Study||642|Participants excluded from MITT if HIV positive at enrollment or randomized/enrolled more than once (efficacy analyses)|
59759839|NCT02568215|75879327|FG002|Modified Intent-to-treat Population|Overall Study||645|Participants excluded from MITT if HIV positive at enrollment or randomized/enrolled more than once (efficacy analyses)|
59511519|NCT00884585|75605188|FG001|COMPLETED|Open-Label Phase (Months 3-9)||0||
59511520|NCT00884585|75605187|FG000|NOT COMPLETED|Open-Label Phase (Months 3-9)||15||
59511521|NCT00884585|75605188|FG001|NOT COMPLETED|Open-Label Phase (Months 3-9)||0||
59511522|NCT00884585|75605187|FG000|STARTED|Open-Label Maintenance (Months 9-12)||147||
59511523|NCT00884585|75605188|FG001|STARTED|Open-Label Maintenance (Months 9-12)||0||
59511524|NCT00884585|75605187|FG000|COMPLETED|Open-Label Maintenance (Months 9-12)||144||
59511525|NCT00884585|75605188|FG001|COMPLETED|Open-Label Maintenance (Months 9-12)||0||
59511526|NCT00884585|75605187|FG000|NOT COMPLETED|Open-Label Maintenance (Months 9-12)||3||
59511527|NCT00884585|75605188|FG001|NOT COMPLETED|Open-Label Maintenance (Months 9-12)||0||
59511528|NCT00884897|75605196|FG000|STARTED|Overall Study||13||
59511529|NCT00884897|75605197|FG001|STARTED|Overall Study||15||
59511530|NCT00884897|75605196|FG000|COMPLETED|Overall Study||13||
59511531|NCT00884897|75605197|FG001|COMPLETED|Overall Study||15||
59511532|NCT00884897|75605196|FG000|NOT COMPLETED|Overall Study||0||
59511533|NCT00884897|75605197|FG001|NOT COMPLETED|Overall Study||0||
59511534|NCT02753842|75605209|FG000|STARTED|First Follow-Up (Set of Condoms)||85||
59511535|NCT02753842|75605210|FG001|STARTED|First Follow-Up (Set of Condoms)||84||
59511536|NCT02753842|75605211|FG002|STARTED|First Follow-Up (Set of Condoms)||85||
59511537|NCT02753842|75605212|FG003|STARTED|First Follow-Up (Set of Condoms)||83||
59511538|NCT02753842|75605213|FG004|STARTED|First Follow-Up (Set of Condoms)||83||
59511539|NCT02753842|75605214|FG005|STARTED|First Follow-Up (Set of Condoms)||84||
59511540|NCT02753842|75605209|FG000|COMPLETED|First Follow-Up (Set of Condoms)||75||
59511541|NCT02753842|75605210|FG001|COMPLETED|First Follow-Up (Set of Condoms)||76||
59511542|NCT02753842|75605211|FG002|COMPLETED|First Follow-Up (Set of Condoms)||76||
59511543|NCT02753842|75605212|FG003|COMPLETED|First Follow-Up (Set of Condoms)||81||
59511544|NCT02753842|75605213|FG004|COMPLETED|First Follow-Up (Set of Condoms)||76||
59511545|NCT02753842|75605214|FG005|COMPLETED|First Follow-Up (Set of Condoms)||79||
59511546|NCT02753842|75605209|FG000|NOT COMPLETED|First Follow-Up (Set of Condoms)||10||
59511547|NCT02753842|75605210|FG001|NOT COMPLETED|First Follow-Up (Set of Condoms)||8||
59511548|NCT02753842|75605211|FG002|NOT COMPLETED|First Follow-Up (Set of Condoms)||9||
59511549|NCT02753842|75605212|FG003|NOT COMPLETED|First Follow-Up (Set of Condoms)||2||
59511550|NCT02753842|75605213|FG004|NOT COMPLETED|First Follow-Up (Set of Condoms)||7||
59511551|NCT02753842|75605214|FG005|NOT COMPLETED|First Follow-Up (Set of Condoms)||5||
59759840|NCT02568215|75879325|FG000|COMPLETED|Overall Study||558||
59759841|NCT02568215|75879326|FG001|COMPLETED|Overall Study||562||
59759842|NCT02568215|75879327|FG002|COMPLETED|Overall Study||555||
59759843|NCT02568215|75879325|FG000|NOT COMPLETED|Overall Study||79||
59759844|NCT02568215|75879326|FG001|NOT COMPLETED|Overall Study||80||
59759845|NCT02568215|75879327|FG002|NOT COMPLETED|Overall Study||90||
59511552|NCT02753842|75605209|FG000|STARTED|Second Follow-Up (Set of Condoms)||75||
59511553|NCT02753842|75605210|FG001|STARTED|Second Follow-Up (Set of Condoms)||76||
59759846|NCT03293498|75879343|FG000|STARTED|Overall Study||109||
59759847|NCT03293498|75879344|FG001|STARTED|Overall Study||111||
59759848|NCT03293498|75879345|FG002|STARTED|Overall Study||110||
59511554|NCT02753842|75605211|FG002|STARTED|Second Follow-Up (Set of Condoms)||76||
59511555|NCT02753842|75605212|FG003|STARTED|Second Follow-Up (Set of Condoms)||81||
59511556|NCT02753842|75605213|FG004|STARTED|Second Follow-Up (Set of Condoms)||76||
59511557|NCT02753842|75605214|FG005|STARTED|Second Follow-Up (Set of Condoms)||79||
59511558|NCT02753842|75605209|FG000|COMPLETED|Second Follow-Up (Set of Condoms)||71||
59511559|NCT02753842|75605210|FG001|COMPLETED|Second Follow-Up (Set of Condoms)||71||
59511560|NCT02753842|75605211|FG002|COMPLETED|Second Follow-Up (Set of Condoms)||71||
59511561|NCT02753842|75605212|FG003|COMPLETED|Second Follow-Up (Set of Condoms)||76||
59511562|NCT02753842|75605213|FG004|COMPLETED|Second Follow-Up (Set of Condoms)||75||
59511563|NCT02753842|75605214|FG005|COMPLETED|Second Follow-Up (Set of Condoms)||72||
59511564|NCT02753842|75605209|FG000|NOT COMPLETED|Second Follow-Up (Set of Condoms)||4||
59511565|NCT02753842|75605210|FG001|NOT COMPLETED|Second Follow-Up (Set of Condoms)||5||
59511566|NCT02753842|75605211|FG002|NOT COMPLETED|Second Follow-Up (Set of Condoms)||5||
59511567|NCT02753842|75605212|FG003|NOT COMPLETED|Second Follow-Up (Set of Condoms)||5||
59511568|NCT02753842|75605213|FG004|NOT COMPLETED|Second Follow-Up (Set of Condoms)||1||
59511569|NCT02753842|75605214|FG005|NOT COMPLETED|Second Follow-Up (Set of Condoms)||7||
59511570|NCT02753842|75605209|FG000|STARTED|Third Follow-Up (Set of Condoms)||71||
59511571|NCT02753842|75605210|FG001|STARTED|Third Follow-Up (Set of Condoms)||71||
59511572|NCT02753842|75605211|FG002|STARTED|Third Follow-Up (Set of Condoms)||71||
59511573|NCT02753842|75605212|FG003|STARTED|Third Follow-Up (Set of Condoms)||76||
59511574|NCT02753842|75605213|FG004|STARTED|Third Follow-Up (Set of Condoms)||75||
59511575|NCT02753842|75605214|FG005|STARTED|Third Follow-Up (Set of Condoms)||72||
59511576|NCT02753842|75605209|FG000|COMPLETED|Third Follow-Up (Set of Condoms)||65||
59511577|NCT02753842|75605210|FG001|COMPLETED|Third Follow-Up (Set of Condoms)||66||
59511578|NCT02753842|75605211|FG002|COMPLETED|Third Follow-Up (Set of Condoms)||68||
59511579|NCT02753842|75605212|FG003|COMPLETED|Third Follow-Up (Set of Condoms)||70||
59511580|NCT02753842|75605213|FG004|COMPLETED|Third Follow-Up (Set of Condoms)||71||
59511581|NCT02753842|75605214|FG005|COMPLETED|Third Follow-Up (Set of Condoms)||69||
60045298|NCT01641692|76160701|FG003|COMPLETED|Treatment Period 2||41||
60045299|NCT01641692|76160702|FG004|COMPLETED|Treatment Period 2||37||
60045300|NCT01641692|76160703|FG005|COMPLETED|Treatment Period 2||43||
60045301|NCT01641692|76160704|FG006|COMPLETED|Treatment Period 2||43||
60045302|NCT01641692|76160705|FG007|COMPLETED|Treatment Period 2||35||
60045303|NCT01641692|76160698|FG000|NOT COMPLETED|Treatment Period 2||3||
60045304|NCT01641692|76160699|FG001|NOT COMPLETED|Treatment Period 2||0||
60045305|NCT01641692|76160700|FG002|NOT COMPLETED|Treatment Period 2||0||
60045306|NCT01641692|76160701|FG003|NOT COMPLETED|Treatment Period 2||0||
60045307|NCT01641692|76160702|FG004|NOT COMPLETED|Treatment Period 2||0||
60045308|NCT01641692|76160703|FG005|NOT COMPLETED|Treatment Period 2||2||
60045309|NCT01641692|76160704|FG006|NOT COMPLETED|Treatment Period 2||0||
60045310|NCT01641692|76160705|FG007|NOT COMPLETED|Treatment Period 2||1||
60045311|NCT01641692|76160698|FG000|STARTED|Washout Period 2 (12-14 Days)||30||
60045312|NCT01641692|76160699|FG001|STARTED|Washout Period 2 (12-14 Days)||46||
60045313|NCT01641692|76160700|FG002|STARTED|Washout Period 2 (12-14 Days)||40||
60045314|NCT01641692|76160701|FG003|STARTED|Washout Period 2 (12-14 Days)||41||
60045315|NCT01641692|76160702|FG004|STARTED|Washout Period 2 (12-14 Days)||37||
60045316|NCT01641692|76160703|FG005|STARTED|Washout Period 2 (12-14 Days)||43||
60045317|NCT01641692|76160704|FG006|STARTED|Washout Period 2 (12-14 Days)||43||
60045318|NCT01641692|76160705|FG007|STARTED|Washout Period 2 (12-14 Days)||35||
60045319|NCT01641692|76160698|FG000|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|30||
60045320|NCT01641692|76160699|FG001|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|46||
60045321|NCT01641692|76160700|FG002|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|39||
60045322|NCT01641692|76160701|FG003|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|41||
60045323|NCT01641692|76160702|FG004|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|34||
60045324|NCT01641692|76160703|FG005|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|42||
60045325|NCT01641692|76160704|FG006|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|42||
59511582|NCT02753842|75605209|FG000|NOT COMPLETED|Third Follow-Up (Set of Condoms)||6||
59759849|NCT03293498|75879343|FG000|COMPLETED|Overall Study||109||
60045326|NCT01641692|76160705|FG007|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|34||
60045327|NCT01641692|76160698|FG000|NOT COMPLETED|Washout Period 2 (12-14 Days)||0||
60045328|NCT01641692|76160699|FG001|NOT COMPLETED|Washout Period 2 (12-14 Days)||0||
60045329|NCT01641692|76160700|FG002|NOT COMPLETED|Washout Period 2 (12-14 Days)||1||
60045330|NCT01641692|76160701|FG003|NOT COMPLETED|Washout Period 2 (12-14 Days)||0||
60045331|NCT01641692|76160702|FG004|NOT COMPLETED|Washout Period 2 (12-14 Days)||3||
60045332|NCT01641692|76160703|FG005|NOT COMPLETED|Washout Period 2 (12-14 Days)||1||
60045333|NCT01641692|76160704|FG006|NOT COMPLETED|Washout Period 2 (12-14 Days)||1||
59511583|NCT02753842|75605210|FG001|NOT COMPLETED|Third Follow-Up (Set of Condoms)||5||
59511584|NCT02753842|75605211|FG002|NOT COMPLETED|Third Follow-Up (Set of Condoms)||3||
59759850|NCT03293498|75879344|FG001|COMPLETED|Overall Study||111||
59759851|NCT03293498|75879345|FG002|COMPLETED|Overall Study||110||
59759852|NCT03293498|75879343|FG000|NOT COMPLETED|Overall Study||0||
59759853|NCT03293498|75879344|FG001|NOT COMPLETED|Overall Study||0||
59759854|NCT03293498|75879345|FG002|NOT COMPLETED|Overall Study||0||
59759855|NCT01831076|75879355|FG000|STARTED|Overall Study||31||
59759856|NCT01831076|75879356|FG001|STARTED|Overall Study||5||
59919492|NCT03307785|76039641|FG002|NOT COMPLETED|Part I: Up to 24 Months||0||
59919493|NCT03307785|76039642|FG003|NOT COMPLETED|Part I: Up to 24 Months||0||
59919494|NCT03307785|76039643|FG004|NOT COMPLETED|Part I: Up to 24 Months||0||
59919495|NCT03307785|76039644|FG005|NOT COMPLETED|Part I: Up to 24 Months||0||
59919496|NCT03307785|76039645|FG006|NOT COMPLETED|Part I: Up to 24 Months||0||
59919497|NCT03307785|76039646|FG007|NOT COMPLETED|Part I: Up to 24 Months||0||
59919498|NCT03307785|76039647|FG008|NOT COMPLETED|Part I: Up to 24 Months||0||
59919499|NCT03307785|76039648|FG009|NOT COMPLETED|Part I: Up to 24 Months||0||
60045334|NCT01641692|76160705|FG007|NOT COMPLETED|Washout Period 2 (12-14 Days)||1||
60045335|NCT01641692|76160698|FG000|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|43||
59759857|NCT01831076|75879355|FG000|COMPLETED|Overall Study||30||
59759858|NCT01831076|75879356|FG001|COMPLETED|Overall Study||4||
59759859|NCT01831076|75879355|FG000|NOT COMPLETED|Overall Study||1||
59759860|NCT01831076|75879356|FG001|NOT COMPLETED|Overall Study||1||
59759861|NCT00908141|75879364|FG000|STARTED|Overall Study||8||
59919500|NCT03307785|76039649|FG010|NOT COMPLETED|Part I: Up to 24 Months||0||
59919501|NCT03199040|76039672|FG000|STARTED|Overall Study||9||
59919502|NCT03199040|76039673|FG001|STARTED|Overall Study||9||
59919503|NCT03199040|76039672|FG000|COMPLETED|Overall Study||5||
59919504|NCT03199040|76039673|FG001|COMPLETED|Overall Study||8||
59919505|NCT03199040|76039672|FG000|NOT COMPLETED|Overall Study||4||
59919506|NCT03199040|76039673|FG001|NOT COMPLETED|Overall Study||1||
59919507|NCT03072238|76039681|FG000|STARTED|Overall Study||554||
59919508|NCT03072238|76039682|FG001|STARTED|Overall Study||547||
59919509|NCT03072238|76039681|FG000|COMPLETED|Overall Study||0||
59919510|NCT03072238|76039682|FG001|COMPLETED|Overall Study||0||
59919511|NCT03072238|76039681|FG000|NOT COMPLETED|Overall Study||554||
59919512|NCT03072238|76039682|FG001|NOT COMPLETED|Overall Study||547||
59919513|NCT02970318|76039691|FG000|STARTED|Overall for Arm A & Main for Arm B||155||
59919514|NCT02970318|76039692|FG001|STARTED|Overall for Arm A & Main for Arm B||155||
59919515|NCT02970318|76039693|FG002|STARTED|Overall for Arm A & Main for Arm B||0||
59919516|NCT02970318|76039694|FG003|STARTED|Overall for Arm A & Main for Arm B||0||
59919517|NCT02970318|76039691|FG000|Arm B Treatment= Idelalisib Plus Rituximab|Overall for Arm A & Main for Arm B||0||
59919518|NCT02970318|76039692|FG001|Arm B Treatment= Idelalisib Plus Rituximab|Overall for Arm A & Main for Arm B||119||
59919519|NCT02970318|76039693|FG002|Arm B Treatment= Idelalisib Plus Rituximab|Overall for Arm A & Main for Arm B||0||
59919520|NCT02970318|76039694|FG003|Arm B Treatment= Idelalisib Plus Rituximab|Overall for Arm A & Main for Arm B||0||
59919521|NCT02970318|76039691|FG000|Arm B Treatment = Bendamustine Plus Rituximab|Overall for Arm A & Main for Arm B||0||
59919522|NCT02970318|76039692|FG001|Arm B Treatment = Bendamustine Plus Rituximab|Overall for Arm A & Main for Arm B||36||
59919523|NCT02970318|76039693|FG002|Arm B Treatment = Bendamustine Plus Rituximab|Overall for Arm A & Main for Arm B||0||
59919524|NCT02970318|76039694|FG003|Arm B Treatment = Bendamustine Plus Rituximab|Overall for Arm A & Main for Arm B||0||
59919525|NCT02970318|76039691|FG000|Completed|Overall for Arm A & Main for Arm B||0|Completed study treatment at final DCO (03Sep2021)|
59919526|NCT02970318|76039692|FG001|Completed|Overall for Arm A & Main for Arm B|This subject received 1st dose of study drug on 11Nov2011, completed study treatment on 14MAR2019, never crossed over, and and died 11 months after completing study treatment on 15Feb2020.|1|Completed study treatment at final DCO (03Sep2021)|
59919527|NCT02970318|76039693|FG002|Completed|Overall for Arm A & Main for Arm B||0|Completed study treatment at final DCO (03Sep2021)|
59919528|NCT02970318|76039694|FG003|Completed|Overall for Arm A & Main for Arm B||0|Completed study treatment at final DCO (03Sep2021)|
59919529|NCT02970318|76039691|FG000|Completed|Overall for Arm A & Main for Arm B||99|Patients ongoing treatment at final DCO (03Sep2021)|
60045336|NCT01641692|76160699|FG001|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|33||
60045337|NCT01641692|76160700|FG002|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|38||
60045338|NCT01641692|76160701|FG003|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|42||
60045339|NCT01641692|76160702|FG004|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|40||
60045340|NCT01641692|76160703|FG005|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|39||
60045341|NCT01641692|76160704|FG006|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|35||
59612462|NCT01701258|75723505|FG006|STARTED|PET (Session 3)||0|Not all participants that were eligible or completed the MRI completed the PET.|
59759862|NCT00908141|75879365|FG001|STARTED|Overall Study||9||
59612463|NCT01701258|75723506|FG007|STARTED|PET (Session 3)||19|Not all participants that were eligible or completed the MRI completed the PET.|
59612464|NCT01701258|75723507|FG008|STARTED|PET (Session 3)||0|Not all participants that were eligible or completed the MRI completed the PET.|
59612465|NCT01701258|75723508|FG009|STARTED|PET (Session 3)||0|Not all participants that were eligible or completed the MRI completed the PET.|
59612466|NCT01701258|75723509|FG010|STARTED|PET (Session 3)||18|Not all participants that were eligible or completed the MRI completed the PET.|
59612467|NCT01701258|75723510|FG011|STARTED|PET (Session 3)||0|Not all participants that were eligible or completed the MRI completed the PET.|
59612468|NCT01701258|75723511|FG012|STARTED|PET (Session 3)||0|Not all participants that were eligible or completed the MRI completed the PET.|
59612469|NCT01701258|75723499|FG000|COMPLETED|PET (Session 3)||0||
59612470|NCT01701258|75723500|FG001|COMPLETED|PET (Session 3)||20||
59612471|NCT01701258|75723501|FG002|COMPLETED|PET (Session 3)||0||
59612472|NCT01701258|75723502|FG003|COMPLETED|PET (Session 3)||0||
59612473|NCT01701258|75723503|FG004|COMPLETED|PET (Session 3)||16||
59612474|NCT01701258|75723504|FG005|COMPLETED|PET (Session 3)||0||
59612475|NCT01701258|75723505|FG006|COMPLETED|PET (Session 3)||0||
59612476|NCT01701258|75723506|FG007|COMPLETED|PET (Session 3)||19||
59612477|NCT01701258|75723507|FG008|COMPLETED|PET (Session 3)||0||
59612478|NCT01701258|75723508|FG009|COMPLETED|PET (Session 3)||0||
59612479|NCT01701258|75723509|FG010|COMPLETED|PET (Session 3)||18||
59612480|NCT01701258|75723510|FG011|COMPLETED|PET (Session 3)||0||
59612481|NCT01701258|75723511|FG012|COMPLETED|PET (Session 3)||0||
59612482|NCT01701258|75723499|FG000|NOT COMPLETED|PET (Session 3)||0||
60045342|NCT01641692|76160705|FG007|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|38||
60045343|NCT01641692|76160698|FG000|COMPLETED|Treatment Period 3||43||
60045344|NCT01641692|76160699|FG001|COMPLETED|Treatment Period 3||32||
60045345|NCT01641692|76160700|FG002|COMPLETED|Treatment Period 3||37||
60045346|NCT01641692|76160701|FG003|COMPLETED|Treatment Period 3||42||
60045347|NCT01641692|76160702|FG004|COMPLETED|Treatment Period 3||40||
60045348|NCT01641692|76160703|FG005|COMPLETED|Treatment Period 3||39||
60045349|NCT01641692|76160704|FG006|COMPLETED|Treatment Period 3||33||
60045350|NCT01641692|76160705|FG007|COMPLETED|Treatment Period 3||38||
60045351|NCT01641692|76160698|FG000|NOT COMPLETED|Treatment Period 3||0||
60045352|NCT01641692|76160699|FG001|NOT COMPLETED|Treatment Period 3||1||
60045353|NCT01641692|76160700|FG002|NOT COMPLETED|Treatment Period 3||1||
60045354|NCT01641692|76160701|FG003|NOT COMPLETED|Treatment Period 3||0||
60045355|NCT01641692|76160702|FG004|NOT COMPLETED|Treatment Period 3||0||
60045356|NCT01641692|76160703|FG005|NOT COMPLETED|Treatment Period 3||0||
60045357|NCT01641692|76160704|FG006|NOT COMPLETED|Treatment Period 3||2||
60045358|NCT01641692|76160705|FG007|NOT COMPLETED|Treatment Period 3||0||
60045359|NCT01641692|76160698|FG000|STARTED|Washout Period 3 or Follow-up||43||
60045360|NCT01641692|76160699|FG001|STARTED|Washout Period 3 or Follow-up||32||
60045361|NCT01641692|76160700|FG002|STARTED|Washout Period 3 or Follow-up||37||
60045362|NCT01641692|76160701|FG003|STARTED|Washout Period 3 or Follow-up||42||
60045363|NCT01641692|76160702|FG004|STARTED|Washout Period 3 or Follow-up||40||
60045364|NCT01641692|76160703|FG005|STARTED|Washout Period 3 or Follow-up||39||
60045365|NCT01641692|76160704|FG006|STARTED|Washout Period 3 or Follow-up||33||
60045366|NCT01641692|76160705|FG007|STARTED|Washout Period 3 or Follow-up||38||
60045367|NCT01641692|76160698|FG000|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|42||
60045368|NCT01641692|76160699|FG001|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|32||
60045369|NCT01641692|76160700|FG002|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|36||
60045370|NCT01641692|76160701|FG003|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|41||
60045371|NCT01641692|76160702|FG004|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|40||
60045372|NCT01641692|76160703|FG005|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|37||
60045373|NCT01641692|76160704|FG006|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|32||
60045374|NCT01641692|76160705|FG007|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|38||
60045375|NCT01641692|76160698|FG000|NOT COMPLETED|Washout Period 3 or Follow-up||1||
60045376|NCT01641692|76160699|FG001|NOT COMPLETED|Washout Period 3 or Follow-up||0||
60045377|NCT01641692|76160700|FG002|NOT COMPLETED|Washout Period 3 or Follow-up||1||
60045378|NCT01641692|76160701|FG003|NOT COMPLETED|Washout Period 3 or Follow-up||1||
60045379|NCT01641692|76160702|FG004|NOT COMPLETED|Washout Period 3 or Follow-up||0||
60045380|NCT01641692|76160703|FG005|NOT COMPLETED|Washout Period 3 or Follow-up||2||
60045381|NCT01641692|76160704|FG006|NOT COMPLETED|Washout Period 3 or Follow-up||1||
60045382|NCT01641692|76160705|FG007|NOT COMPLETED|Washout Period 3 or Follow-up||0||
60045383|NCT01682512|76160727|FG000|STARTED|Overall Study||116||
60045384|NCT01682512|76160728|FG001|STARTED|Overall Study||111||
60045385|NCT01682512|76160729|FG002|STARTED|Overall Study||66||
60045386|NCT01682512|76160727|FG000|Randomized in Part-I|Overall Study||66||
60045387|NCT01682512|76160728|FG001|Randomized in Part-I|Overall Study||65||
60045388|NCT01682512|76160729|FG002|Randomized in Part-I|Overall Study||66||
60045389|NCT01682512|76160727|FG000|Randomized in Part-II|Overall Study||50||
60045390|NCT01682512|76160728|FG001|Randomized in Part-II|Overall Study||46||
60045391|NCT01682512|76160729|FG002|Randomized in Part-II|Overall Study||0||
60045392|NCT01682512|76160727|FG000|COMPLETED|Overall Study||44||
60045393|NCT01682512|76160728|FG001|COMPLETED|Overall Study||40||
60045394|NCT01682512|76160729|FG002|COMPLETED|Overall Study||48||
60045395|NCT01682512|76160727|FG000|NOT COMPLETED|Overall Study||72||
60045396|NCT01682512|76160728|FG001|NOT COMPLETED|Overall Study||71||
60045397|NCT01682512|76160729|FG002|NOT COMPLETED|Overall Study||18||
60045398|NCT02256488|76160741|FG000|STARTED|Overall Study||387||
60045399|NCT02256488|76160742|FG001|STARTED|Overall Study||392||
60045400|NCT02256488|76160743|FG002|STARTED|Overall Study||392||
60045401|NCT02256488|76160744|FG003|STARTED|Overall Study||390||
60045402|NCT02256488|76160741|FG000|COMPLETED|Overall Study||379||
60045403|NCT02256488|76160742|FG001|COMPLETED|Overall Study||386||
60045404|NCT02256488|76160743|FG002|COMPLETED|Overall Study||382||
60045405|NCT02256488|76160744|FG003|COMPLETED|Overall Study||384||
60045406|NCT02256488|76160741|FG000|NOT COMPLETED|Overall Study||8||
60045407|NCT02256488|76160742|FG001|NOT COMPLETED|Overall Study||6||
60045408|NCT02256488|76160743|FG002|NOT COMPLETED|Overall Study||10||
60045409|NCT02256488|76160744|FG003|NOT COMPLETED|Overall Study||6||
60045410|NCT01715896|76160757|FG000|STARTED|Overall Study||68||
60045411|NCT01715896|76160758|FG001|STARTED|Overall Study||70||
60045412|NCT01715896|76160757|FG000|COMPLETED|Overall Study||65||
60045413|NCT01715896|76160758|FG001|COMPLETED|Overall Study||59||
60045414|NCT01715896|76160757|FG000|NOT COMPLETED|Overall Study||3||
60045415|NCT01715896|76160758|FG001|NOT COMPLETED|Overall Study||11||
60045416|NCT02255552|76160767|FG000|STARTED|Overall Study||79||
60045417|NCT02255552|76160768|FG001|STARTED|Overall Study||30||
60045418|NCT02255552|76160767|FG000|COMPLETED|Overall Study||78||
60045419|NCT02255552|76160768|FG001|COMPLETED|Overall Study||15||
60045420|NCT02255552|76160767|FG000|NOT COMPLETED|Overall Study||1||
60045421|NCT02255552|76160768|FG001|NOT COMPLETED|Overall Study||15||
60045422|NCT01714726|76160776|FG000|STARTED|Double-Blinded Induction Period||60||
60045423|NCT01714726|76160777|FG001|STARTED|Double-Blinded Induction Period||59||
60045424|NCT01714726|76160778|FG002|STARTED|Double-Blinded Induction Period||0||
60045425|NCT01714726|76160779|FG003|STARTED|Double-Blinded Induction Period||0||
60045426|NCT01714726|76160776|FG000|COMPLETED|Double-Blinded Induction Period||52||
60045427|NCT01714726|76160777|FG001|COMPLETED|Double-Blinded Induction Period||52||
60045428|NCT01714726|76160778|FG002|COMPLETED|Double-Blinded Induction Period||0||
60045429|NCT01714726|76160779|FG003|COMPLETED|Double-Blinded Induction Period||0||
60045430|NCT01714726|76160776|FG000|NOT COMPLETED|Double-Blinded Induction Period||8||
60045431|NCT01714726|76160777|FG001|NOT COMPLETED|Double-Blinded Induction Period||7||
60045432|NCT01714726|76160778|FG002|NOT COMPLETED|Double-Blinded Induction Period||0||
60045433|NCT01714726|76160779|FG003|NOT COMPLETED|Double-Blinded Induction Period||0||
60045434|NCT01714726|76160776|FG000|STARTED|Open-Label Period||0||
60045435|NCT01714726|76160777|FG001|STARTED|Open-Label Period||0||
60045436|NCT01714726|76160778|FG002|STARTED|Open-Label Period||52||
60045437|NCT01714726|76160779|FG003|STARTED|Open-Label Period||52||
60045438|NCT01714726|76160776|FG000|COMPLETED|Open-Label Period||0||
60045439|NCT01714726|76160777|FG001|COMPLETED|Open-Label Period||0||
60045440|NCT01714726|76160778|FG002|COMPLETED|Open-Label Period||33||
60045441|NCT01714726|76160779|FG003|COMPLETED|Open-Label Period||24||
60045442|NCT01714726|76160776|FG000|NOT COMPLETED|Open-Label Period||0||
60045443|NCT01714726|76160777|FG001|NOT COMPLETED|Open-Label Period||0||
60045444|NCT01714726|76160778|FG002|NOT COMPLETED|Open-Label Period||19||
60045445|NCT01714726|76160779|FG003|NOT COMPLETED|Open-Label Period||28||
60045446|NCT02255474|76160792|FG000|STARTED|Overall Study||98||98
60045447|NCT02255474|76160793|FG001|STARTED|Overall Study||98||98
60045448|NCT02255474|76160794|FG002|STARTED|Overall Study||98||98
60045449|NCT02255474|76160792|FG000|COMPLETED|Overall Study||96||96
60045450|NCT02255474|76160793|FG001|COMPLETED|Overall Study||96||96
60045451|NCT02255474|76160794|FG002|COMPLETED|Overall Study||95||95
60045452|NCT02255474|76160792|FG000|NOT COMPLETED|Overall Study||2||2
60045453|NCT02255474|76160793|FG001|NOT COMPLETED|Overall Study||2||2
60045454|NCT02255474|76160794|FG002|NOT COMPLETED|Overall Study||3||3
60045455|NCT02254772|76160803|FG000|STARTED|Overall Study||9||
60045456|NCT02254772|76160803|FG000|COMPLETED|Overall Study||7||
60045457|NCT02254772|76160803|FG000|NOT COMPLETED|Overall Study||2||
60045458|NCT02254460|76160807|FG000|STARTED|Overall Study||13||
60045459|NCT02254460|76160808|FG001|STARTED|Overall Study||12||
60045460|NCT02254460|76160807|FG000|COMPLETED|Overall Study||12||
60045461|NCT02254460|76160808|FG001|COMPLETED|Overall Study||12||
60045462|NCT02254460|76160807|FG000|NOT COMPLETED|Overall Study||1||
60045463|NCT02254460|76160808|FG001|NOT COMPLETED|Overall Study||0||
60045464|NCT01682044|76160814|FG000|STARTED|Overall Study||20||
60045465|NCT01682044|76160814|FG000|COMPLETED|Overall Study||16||
60045466|NCT01682044|76160814|FG000|NOT COMPLETED|Overall Study||4||
60045467|NCT01696942|76160820|FG000|STARTED|Overall Study||5||
60045468|NCT01696942|76160821|FG001|STARTED|Overall Study||5||
60045469|NCT01696942|76160820|FG000|COMPLETED|Overall Study||3||
60045470|NCT01696942|76160821|FG001|COMPLETED|Overall Study||2||
60045471|NCT01696942|76160820|FG000|NOT COMPLETED|Overall Study||2||
60045472|NCT01696942|76160821|FG001|NOT COMPLETED|Overall Study||3||
60045473|NCT01640366|76160827|FG000|STARTED|Overall Study||200||
60045474|NCT01640366|76160827|FG000|Day 21 Follow-up|Overall Study||185||
59759863|NCT00908141|75879364|FG000|COMPLETED|Overall Study||8||
59759864|NCT00908141|75879365|FG001|COMPLETED|Overall Study||8||
59759865|NCT00908141|75879364|FG000|NOT COMPLETED|Overall Study||0||
59759866|NCT00908141|75879365|FG001|NOT COMPLETED|Overall Study||1||
59759867|NCT00906347|75879373|FG000|STARTED|Randomized||176||
59759868|NCT00906347|75879374|FG001|STARTED|Randomized||174||
59759869|NCT00906347|75879373|FG000|COMPLETED|Randomized||176||
59759870|NCT00906347|75879374|FG001|COMPLETED|Randomized||174||
59759871|NCT00906347|75879373|FG000|NOT COMPLETED|Randomized||0||
59759872|NCT00906347|75879374|FG001|NOT COMPLETED|Randomized||0||
59759873|NCT00906347|75879373|FG000|STARTED|Received Study Drug||176||
59759874|NCT00906347|75879374|FG001|STARTED|Received Study Drug||174||
59759875|NCT00906347|75879373|FG000|COMPLETED|Received Study Drug||136||
59759876|NCT00906347|75879374|FG001|COMPLETED|Received Study Drug||143||
59759877|NCT00906347|75879373|FG000|NOT COMPLETED|Received Study Drug||40||
59759878|NCT00906347|75879374|FG001|NOT COMPLETED|Received Study Drug||31||
59759879|NCT00906035|75879383|FG000|STARTED|Overall Study||8||
59759880|NCT00906035|75879384|FG001|STARTED|Overall Study||9||
59759881|NCT00906035|75879385|FG002|STARTED|Overall Study||8||
59759882|NCT00906035|75879383|FG000|COMPLETED|Overall Study|One Drop-Out; SAE day before Visit 1 and One subject Withrew prior to visit 1|6||
59759883|NCT00906035|75879384|FG001|COMPLETED|Overall Study|2 subjects Withdrew after Visit 1 and 1 subject Withdrew shortly after Visit 1due to an AE|6||
59759884|NCT00906035|75879385|FG002|COMPLETED|Overall Study||8||
59759885|NCT00906035|75879383|FG000|NOT COMPLETED|Overall Study||2||
59759886|NCT00906035|75879384|FG001|NOT COMPLETED|Overall Study||3||
59759887|NCT00906035|75879385|FG002|NOT COMPLETED|Overall Study||0||
59759888|NCT00905489|75879393|FG000|STARTED|Pharmaco-kinetic (PK) Phase||85||
59759889|NCT00905489|75879393|FG000|COMPLETED|Pharmaco-kinetic (PK) Phase||80||
59759890|NCT00905489|75879393|FG000|NOT COMPLETED|Pharmaco-kinetic (PK) Phase||5||
59759891|NCT00905489|75879393|FG000|STARTED|Optional Extension Phase (OEP)|Includes only subjects who chose to continue trt with nevirapine XR after completing the PK phase.|40||
59759892|NCT00905489|75879393|FG000|COMPLETED|Optional Extension Phase (OEP)||39||
59759893|NCT00905489|75879393|FG000|NOT COMPLETED|Optional Extension Phase (OEP)||1||
59759894|NCT02704754|75879404|FG000|STARTED|Overall Study||21||
59759895|NCT02704754|75879405|FG001|STARTED|Overall Study||20||
59759896|NCT02704754|75879404|FG000|COMPLETED|Overall Study||18||
59759897|NCT02704754|75879405|FG001|COMPLETED|Overall Study||19||
59759898|NCT02704754|75879404|FG000|NOT COMPLETED|Overall Study||3||
59759899|NCT02704754|75879405|FG001|NOT COMPLETED|Overall Study||1||
59759900|NCT03170882|75879413|FG000|STARTED|Overall Study||49||
59759901|NCT03170882|75879414|FG001|STARTED|Overall Study||73||
59759902|NCT03170882|75879413|FG000|Treated: Safety Population|Overall Study||47|Safety Population included all participants who received at least 1 dose of any study drug.|
59759903|NCT03170882|75879414|FG001|Treated: Safety Population|Overall Study||72|Safety Population included all participants who received at least 1 dose of any study drug.|
59759904|NCT03170882|75879413|FG000|ITT PRO Population|Overall Study||45|Intent-to-Treat Patient Reported Outcomes (ITT PRO) Population included participants with a measurement at study entry and at least one post study entry measurement for at least 1 subscale on all 3 questionnaires (EORTC QLQ-C30, EORTC QLQ-MY20 and EQ-5D-5L).|
59759905|NCT03170882|75879414|FG001|ITT PRO Population|Overall Study||70|Intent-to-Treat Patient Reported Outcomes (ITT PRO) Population included participants with a measurement at study entry and at least one post study entry measurement for at least 1 subscale on all 3 questionnaires (EORTC QLQ-C30, EORTC QLQ-MY20 and EQ-5D-5L).|
59759906|NCT03170882|75879413|FG000|COMPLETED|Overall Study||0||
59759907|NCT03170882|75879414|FG001|COMPLETED|Overall Study||0||
59759908|NCT03170882|75879413|FG000|NOT COMPLETED|Overall Study||49||
59759909|NCT03170882|75879414|FG001|NOT COMPLETED|Overall Study||73||
59759910|NCT00907517|75879425|FG000|STARTED|Overall Study||3||
59759911|NCT00907517|75879426|FG001|STARTED|Overall Study||3||
59759912|NCT00907517|75879427|FG002|STARTED|Overall Study||6||
59759913|NCT00907517|75879428|FG003|STARTED|Overall Study||6||
59759914|NCT00907517|75879429|FG004|STARTED|Overall Study||6||
59759915|NCT00907517|75879425|FG000|COMPLETED|Overall Study||0||
59759916|NCT00907517|75879426|FG001|COMPLETED|Overall Study||0||
59759917|NCT00907517|75879427|FG002|COMPLETED|Overall Study||2||
59759918|NCT00907517|75879428|FG003|COMPLETED|Overall Study||2||
60045475|NCT01640366|76160827|FG000|Day 42 Follow-up|Overall Study||177||
60045476|NCT01640366|76160827|FG000|Day 90 Follow-up|Overall Study||178||
60045477|NCT01640366|76160827|FG000|COMPLETED|Overall Study||178||
60045478|NCT01640366|76160827|FG000|NOT COMPLETED|Overall Study||22||
60045479|NCT01640288|76160835|FG000|STARTED|Overall Study||100||
60045480|NCT01640288|76160836|FG001|STARTED|Overall Study||71||
60045481|NCT01640288|76160835|FG000|Received Allocated Intervention|Overall Study|74 rec'd the gas (inc. 4 images were not obtained due to equipment failure = 70)|70||
60045482|NCT01640288|76160836|FG001|Received Allocated Intervention|Overall Study|53 rec'd the gas (exc. 1 images not obtained due to equipment failure, 4 poor images = 48 )|48||
60045483|NCT01640288|76160835|FG000|Did Not Receive Allocated Intervention|Overall Study||26||
60045484|NCT01640288|76160836|FG001|Did Not Receive Allocated Intervention|Overall Study||18||
60045485|NCT01640288|76160835|FG000|COMPLETED|Overall Study|One subject was lost to followup but rec'd the gas and images were obtained|70||
60045486|NCT01640288|76160836|FG001|COMPLETED|Overall Study||48||
60045487|NCT01640288|76160835|FG000|NOT COMPLETED|Overall Study||30||
60045488|NCT01640288|76160836|FG001|NOT COMPLETED|Overall Study||23||
60045489|NCT01639040|76160845|FG000|STARTED|Overall Study||10||
60045490|NCT01639040|76160846|FG001|STARTED|Overall Study||21||
60045491|NCT01639040|76160845|FG000|COMPLETED|Overall Study||9||
60045492|NCT01639040|76160846|FG001|COMPLETED|Overall Study||21||
60045493|NCT01639040|76160845|FG000|NOT COMPLETED|Overall Study||1||
60045494|NCT01639040|76160846|FG001|NOT COMPLETED|Overall Study||0||
60045495|NCT01640054|76160855|FG000|STARTED|Overall Study|Patients who received treatment|115||
60045496|NCT01640054|76160855|FG000|Did Not Receive Treatment|Overall Study||0||
60045497|NCT01640054|76160855|FG000|COMPLETED|Overall Study|Number of patients on treatment when the study was stopped.|109||
60045498|NCT01640054|76160855|FG000|NOT COMPLETED|Overall Study||6||
60045499|NCT01600586|76160861|FG000|STARTED|Overall Study||49||
60045500|NCT01600586|76160862|FG001|STARTED|Overall Study||51||
60045501|NCT01600586|76160861|FG000|COMPLETED|Overall Study||46||
60045502|NCT01600586|76160862|FG001|COMPLETED|Overall Study||48||
60045503|NCT01600586|76160861|FG000|NOT COMPLETED|Overall Study||3||
59511585|NCT02753842|75605212|FG003|NOT COMPLETED|Third Follow-Up (Set of Condoms)||6||
59511586|NCT02753842|75605213|FG004|NOT COMPLETED|Third Follow-Up (Set of Condoms)||4||
59511587|NCT02753842|75605214|FG005|NOT COMPLETED|Third Follow-Up (Set of Condoms)||3||
59511588|NCT00886145|75605228|FG000|STARTED|Overall Study||1||
59511589|NCT00886145|75605228|FG000|COMPLETED|Overall Study||1||
59511590|NCT00886145|75605228|FG000|NOT COMPLETED|Overall Study||0||
59511591|NCT02753920|75605236|FG000|STARTED|Overall Study||87||
59511592|NCT02753920|75605237|FG001|STARTED|Overall Study||86||
59919530|NCT02970318|76039692|FG001|Completed|Overall for Arm A & Main for Arm B||26|Patients ongoing treatment at final DCO (03Sep2021)|
59919531|NCT02970318|76039693|FG002|Completed|Overall for Arm A & Main for Arm B||0|Patients ongoing treatment at final DCO (03Sep2021)|
59919532|NCT02970318|76039694|FG003|Completed|Overall for Arm A & Main for Arm B||0|Patients ongoing treatment at final DCO (03Sep2021)|
59919533|NCT02970318|76039691|FG000|COMPLETED|Overall for Arm A & Main for Arm B|All 99 subjects ongoing treatment at final DCO.|99|Patients Ongoing Treatment + Patients Completed Study Treatment at Final DCO (03Sep2021)|
59919534|NCT02970318|76039692|FG001|COMPLETED|Overall for Arm A & Main for Arm B|26 subjects ongoing treatment + 1 subject completed study treatment and died 11 months after completing study treatment on 15Feb2020.|27|Patients Ongoing Treatment + Patients Completed Study Treatment at Final DCO (03Sep2021)|
59919535|NCT02970318|76039693|FG002|COMPLETED|Overall for Arm A & Main for Arm B||0|Patients Ongoing Treatment + Patients Completed Study Treatment at Final DCO (03Sep2021)|
59919536|NCT02970318|76039694|FG003|COMPLETED|Overall for Arm A & Main for Arm B||0|Patients Ongoing Treatment + Patients Completed Study Treatment at Final DCO (03Sep2021)|
59919537|NCT02970318|76039691|FG000|NOT COMPLETED|Overall for Arm A & Main for Arm B||56||
59919538|NCT02970318|76039692|FG001|NOT COMPLETED|Overall for Arm A & Main for Arm B||128||
59919539|NCT02970318|76039693|FG002|NOT COMPLETED|Overall for Arm A & Main for Arm B||0||
59919540|NCT02970318|76039694|FG003|NOT COMPLETED|Overall for Arm A & Main for Arm B||0||
59919541|NCT02970318|76039691|FG000|STARTED|ArmB: Inv.Choice Crossed Over to Acala||0||
59919542|NCT02970318|76039692|FG001|STARTED|ArmB: Inv.Choice Crossed Over to Acala|N/A. Note: No subjects stayed in Arm: Investigator's choice of IR/BR during cross-over period.|0||
59919543|NCT02970318|76039693|FG002|STARTED|ArmB: Inv.Choice Crossed Over to Acala|Note: There were a total of 80 subjects in Arm B crossing over to Arm A shown under the last row of Main Study Period. Among them 63 were randomized to Arm B: IR and 17 were randomized to BR.|63||
59951416|NCT01798992|76070393|FG003|NOT COMPLETED|Overall Study||1||
59951417|NCT01570868|76070404|FG000|STARTED|Overall Study||43||
59511593|NCT02753920|75605236|FG000|COMPLETED|Overall Study||87||
59951418|NCT01570868|76070405|FG001|STARTED|Overall Study||8||
60045504|NCT01600586|76160862|FG001|NOT COMPLETED|Overall Study||3||
60045505|NCT01639742|76160875|FG000|STARTED|Overall Study||18||
60045506|NCT01639742|76160875|FG000|COMPLETED|Overall Study||0||
60045507|NCT01639742|76160875|FG000|NOT COMPLETED|Overall Study||18||
60045508|NCT02164513|76160882|FG000|STARTED|Overall Study||4151||
60045509|NCT02164513|76160883|FG001|STARTED|Overall Study||4134||
59511594|NCT02753920|75605237|FG001|COMPLETED|Overall Study||86||
59511595|NCT02753920|75605236|FG000|NOT COMPLETED|Overall Study||0||
59511596|NCT02753920|75605237|FG001|NOT COMPLETED|Overall Study||0||
59511597|NCT00887471|75605249|FG000|STARTED|Overall Study||15||
59511598|NCT00887471|75605250|FG001|STARTED|Overall Study||15||
59511599|NCT00887471|75605249|FG000|COMPLETED|Overall Study||15||
59511600|NCT00887471|75605250|FG001|COMPLETED|Overall Study||15||
59511601|NCT00887471|75605249|FG000|NOT COMPLETED|Overall Study||0||
59511602|NCT00887471|75605250|FG001|NOT COMPLETED|Overall Study||0||
59511603|NCT02754310|75605258|FG000|STARTED|Overall Study||42||
59511604|NCT02754310|75605259|FG001|STARTED|Overall Study||43||
59511605|NCT02754310|75605258|FG000|COMPLETED|Overall Study||42||
59511606|NCT02754310|75605259|FG001|COMPLETED|Overall Study||43||
59511607|NCT02754310|75605258|FG000|NOT COMPLETED|Overall Study||0||
59511608|NCT02754310|75605259|FG001|NOT COMPLETED|Overall Study||0||
59511609|NCT02748070|75605267|FG000|STARTED|Overall Study||41||
59511610|NCT02748070|75605268|FG001|STARTED|Overall Study||40||
59511611|NCT02748070|75605267|FG000|Randomized and Treated|Overall Study||40||
59511612|NCT02748070|75605268|FG001|Randomized and Treated|Overall Study||40||
59511613|NCT02748070|75605267|FG000|COMPLETED|Overall Study||33||
59511614|NCT02748070|75605268|FG001|COMPLETED|Overall Study||39||
59511615|NCT02748070|75605267|FG000|NOT COMPLETED|Overall Study||8||
59511616|NCT02748070|75605268|FG001|NOT COMPLETED|Overall Study||1||
59511617|NCT02748928|75605274|FG000|STARTED|Overall Study||62||
59511618|NCT02748928|75605274|FG000|COMPLETED|Overall Study||62||
59511619|NCT02748928|75605274|FG000|NOT COMPLETED|Overall Study||0||
59511620|NCT02574312|75605281|FG000|STARTED|Pre-Operative||44||
59511621|NCT02574312|75605282|FG001|STARTED|Pre-Operative||44||
59511622|NCT02574312|75605281|FG000|COMPLETED|Pre-Operative||44||
59511623|NCT02574312|75605282|FG001|COMPLETED|Pre-Operative||44||
59511624|NCT02574312|75605281|FG000|NOT COMPLETED|Pre-Operative||0||
59511625|NCT02574312|75605282|FG001|NOT COMPLETED|Pre-Operative||0||
59511626|NCT02574312|75605281|FG000|STARTED|3 Months Follow-up||44||
59511627|NCT02574312|75605282|FG001|STARTED|3 Months Follow-up||44||
59511628|NCT02574312|75605281|FG000|COMPLETED|3 Months Follow-up|One subject withdrew consent|43||
59511629|NCT02574312|75605282|FG001|COMPLETED|3 Months Follow-up||44||
59511630|NCT02574312|75605281|FG000|NOT COMPLETED|3 Months Follow-up||1||
59511631|NCT02574312|75605282|FG001|NOT COMPLETED|3 Months Follow-up||0||
59511632|NCT02756572|75605288|FG000|STARTED|Overall Study||30||
59511633|NCT02756572|75605288|FG000|COMPLETED|Overall Study||30||
59511634|NCT02756572|75605288|FG000|NOT COMPLETED|Overall Study||0||
59511635|NCT01049035|75605304|FG000|STARTED|Overall Study||107||
59511636|NCT01049035|75605305|FG001|STARTED|Overall Study||108||
59511637|NCT01049035|75605306|FG002|STARTED|Overall Study||107||
59511638|NCT01049035|75605307|FG003|STARTED|Overall Study||75||
59511639|NCT01049035|75605308|FG004|STARTED|Overall Study||75||
59511640|NCT01049035|75605309|FG005|STARTED|Overall Study||54||
59511641|NCT01049035|75605310|FG006|STARTED|Overall Study||54||
59511642|NCT01049035|75605304|FG000|Safety Population|Overall Study||104|Participants who received at least 1 dose of study/control vaccine and had safety data available.|
59511643|NCT01049035|75605305|FG001|Safety Population|Overall Study||102|Participants who received at least 1 dose of study/control vaccine and had safety data available.|
59511644|NCT01049035|75605306|FG002|Safety Population|Overall Study||100|Participants who received at least 1 dose of study/control vaccine and had safety data available.|
59511645|NCT01049035|75605307|FG003|Safety Population|Overall Study||74|Participants who received at least 1 dose of study/control vaccine and had safety data available.|
59511646|NCT01049035|75605308|FG004|Safety Population|Overall Study||70|Participants who received at least 1 dose of study/control vaccine and had safety data available.|
59511647|NCT01049035|75605309|FG005|Safety Population|Overall Study||52|Participants who received at least 1 dose of study/control vaccine and had safety data available.|
59511648|NCT01049035|75605310|FG006|Safety Population|Overall Study||49|Participants who received at least 1 dose of study/control vaccine and had safety data available.|
59511649|NCT01049035|75605304|FG000|COMPLETED|Overall Study||74||
59511650|NCT01049035|75605305|FG001|COMPLETED|Overall Study||87||
59511651|NCT01049035|75605306|FG002|COMPLETED|Overall Study||80||
59511652|NCT01049035|75605307|FG003|COMPLETED|Overall Study||64||
59511653|NCT01049035|75605308|FG004|COMPLETED|Overall Study||71||
59511654|NCT01049035|75605309|FG005|COMPLETED|Overall Study||42||
59511655|NCT01049035|75605310|FG006|COMPLETED|Overall Study||39||
59511656|NCT01049035|75605304|FG000|NOT COMPLETED|Overall Study||33||
59511657|NCT01049035|75605305|FG001|NOT COMPLETED|Overall Study||21||
59511658|NCT01049035|75605306|FG002|NOT COMPLETED|Overall Study||27||
59511659|NCT01049035|75605307|FG003|NOT COMPLETED|Overall Study||11||
59511660|NCT01049035|75605308|FG004|NOT COMPLETED|Overall Study||4||
59511661|NCT01049035|75605309|FG005|NOT COMPLETED|Overall Study||12||
59511662|NCT01049035|75605310|FG006|NOT COMPLETED|Overall Study||15||
59511663|NCT01048333|75605336|FG000|STARTED|Treatment Period 1||21||
59511664|NCT01048333|75605337|FG001|STARTED|Treatment Period 1||19||
59511665|NCT01048333|75605338|FG002|STARTED|Treatment Period 1||16||
59511666|NCT01048333|75605339|FG003|STARTED|Treatment Period 1||18||
59511667|NCT01048333|75605340|FG004|STARTED|Treatment Period 1||17||
59511668|NCT01048333|75605341|FG005|STARTED|Treatment Period 1||18||
59511669|NCT01048333|75605336|FG000|COMPLETED|Treatment Period 1||21||
59511670|NCT01048333|75605337|FG001|COMPLETED|Treatment Period 1||19||
59511671|NCT01048333|75605338|FG002|COMPLETED|Treatment Period 1||16||
59511672|NCT01048333|75605339|FG003|COMPLETED|Treatment Period 1||18||
59511673|NCT01048333|75605340|FG004|COMPLETED|Treatment Period 1||17||
59511674|NCT01048333|75605341|FG005|COMPLETED|Treatment Period 1||18||
59511675|NCT01048333|75605336|FG000|NOT COMPLETED|Treatment Period 1||0||
59511676|NCT01048333|75605337|FG001|NOT COMPLETED|Treatment Period 1||0||
59511677|NCT01048333|75605338|FG002|NOT COMPLETED|Treatment Period 1||0||
59511678|NCT01048333|75605339|FG003|NOT COMPLETED|Treatment Period 1||0||
59511679|NCT01048333|75605340|FG004|NOT COMPLETED|Treatment Period 1||0||
59511680|NCT01048333|75605341|FG005|NOT COMPLETED|Treatment Period 1||0||
59511681|NCT01048333|75605336|FG000|STARTED|Wash-Out Period 1 of 2 - 7 Days||21||
59511682|NCT01048333|75605337|FG001|STARTED|Wash-Out Period 1 of 2 - 7 Days||19||
59511683|NCT01048333|75605338|FG002|STARTED|Wash-Out Period 1 of 2 - 7 Days||16||
59511684|NCT01048333|75605339|FG003|STARTED|Wash-Out Period 1 of 2 - 7 Days||18||
59511685|NCT01048333|75605340|FG004|STARTED|Wash-Out Period 1 of 2 - 7 Days||17||
59511686|NCT01048333|75605341|FG005|STARTED|Wash-Out Period 1 of 2 - 7 Days||18||
59511687|NCT01048333|75605336|FG000|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||21||
59511688|NCT01048333|75605337|FG001|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||19||
59511689|NCT01048333|75605338|FG002|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||16||
59511690|NCT01048333|75605339|FG003|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||18||
59511691|NCT01048333|75605340|FG004|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||17||
59511692|NCT01048333|75605341|FG005|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||18||
59511693|NCT01048333|75605336|FG000|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0||
59511694|NCT01048333|75605337|FG001|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0||
59511695|NCT01048333|75605338|FG002|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0||
59511696|NCT01048333|75605339|FG003|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0||
59511697|NCT01048333|75605340|FG004|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0||
59511698|NCT01048333|75605341|FG005|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0||
59511699|NCT01048333|75605336|FG000|STARTED|Treatment Period 2||21||
59511700|NCT01048333|75605337|FG001|STARTED|Treatment Period 2||19||
59511701|NCT01048333|75605338|FG002|STARTED|Treatment Period 2||16||
59511702|NCT01048333|75605339|FG003|STARTED|Treatment Period 2||18||
59511703|NCT01048333|75605340|FG004|STARTED|Treatment Period 2||17||
59511704|NCT01048333|75605341|FG005|STARTED|Treatment Period 2||18||
59511705|NCT01048333|75605336|FG000|COMPLETED|Treatment Period 2||21||
59511706|NCT01048333|75605337|FG001|COMPLETED|Treatment Period 2||19||
59511707|NCT01048333|75605338|FG002|COMPLETED|Treatment Period 2||16||
59511708|NCT01048333|75605339|FG003|COMPLETED|Treatment Period 2||18||
59511709|NCT01048333|75605340|FG004|COMPLETED|Treatment Period 2||17||
59511710|NCT01048333|75605341|FG005|COMPLETED|Treatment Period 2||18||
59511711|NCT01048333|75605336|FG000|NOT COMPLETED|Treatment Period 2||0||
59511712|NCT01048333|75605337|FG001|NOT COMPLETED|Treatment Period 2||0||
59511713|NCT01048333|75605338|FG002|NOT COMPLETED|Treatment Period 2||0||
59511714|NCT01048333|75605339|FG003|NOT COMPLETED|Treatment Period 2||0||
59511715|NCT01048333|75605340|FG004|NOT COMPLETED|Treatment Period 2||0||
59511716|NCT01048333|75605341|FG005|NOT COMPLETED|Treatment Period 2||0||
59511717|NCT01048333|75605336|FG000|STARTED|Wash-Out Period 2 of 2 - 7 Days||21||
59511718|NCT01048333|75605337|FG001|STARTED|Wash-Out Period 2 of 2 - 7 Days||19||
59511719|NCT01048333|75605338|FG002|STARTED|Wash-Out Period 2 of 2 - 7 Days||16||
59511720|NCT01048333|75605339|FG003|STARTED|Wash-Out Period 2 of 2 - 7 Days||18||
59919544|NCT02970318|76039694|FG003|STARTED|ArmB: Inv.Choice Crossed Over to Acala|Note: There were a total of 80 subjects in Arm B crossing over to Arm A shown under the last row of Main Study Period. Among them 63 were randomized to Arm B: IR and 17 were randomized to BR.|17||
59919545|NCT02970318|76039691|FG000|COMPLETED|ArmB: Inv.Choice Crossed Over to Acala||0|Ongoing Treatment at Final DCO (03Sep2021)|
60045510|NCT02164513|76160884|FG002|STARTED|Overall Study||2070||
60045511|NCT02164513|76160882|FG000|Completed Investigational Product (IP)|Overall Study||3393||
60045512|NCT02164513|76160883|FG001|Completed Investigational Product (IP)|Overall Study||3094||
60045513|NCT02164513|76160884|FG002|Completed Investigational Product (IP)|Overall Study||1504||
59511721|NCT01048333|75605340|FG004|STARTED|Wash-Out Period 2 of 2 - 7 Days||17||
59511722|NCT01048333|75605341|FG005|STARTED|Wash-Out Period 2 of 2 - 7 Days||18||
59511723|NCT01048333|75605336|FG000|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||21||
60045514|NCT02164513|76160882|FG000|Not Completed IP|Overall Study||758||
60045515|NCT02164513|76160883|FG001|Not Completed IP|Overall Study||1040||
59511724|NCT01048333|75605337|FG001|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||18||
59511725|NCT01048333|75605338|FG002|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||16||
59511726|NCT01048333|75605339|FG003|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||18||
59511727|NCT01048333|75605340|FG004|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||17||
59511728|NCT01048333|75605341|FG005|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||18||
59511729|NCT01048333|75605336|FG000|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0||
60045516|NCT02164513|76160884|FG002|Not Completed IP|Overall Study||566||
60045517|NCT02164513|76160882|FG000|Withdrew IP (WIP): Adverse Event|Overall Study||249||
60045518|NCT02164513|76160883|FG001|Withdrew IP (WIP): Adverse Event|Overall Study||325||
60045519|NCT02164513|76160884|FG002|Withdrew IP (WIP): Adverse Event|Overall Study||186||
60045520|NCT02164513|76160882|FG000|WIP: Lack of Efficacy|Overall Study||163||
60045521|NCT02164513|76160883|FG001|WIP: Lack of Efficacy|Overall Study||313||
60045522|NCT02164513|76160884|FG002|WIP: Lack of Efficacy|Overall Study||172||
60045523|NCT02164513|76160882|FG000|Withdrew IP: Protocol Deviation|Overall Study||32||
60045524|NCT02164513|76160883|FG001|Withdrew IP: Protocol Deviation|Overall Study||41||
60045525|NCT02164513|76160884|FG002|Withdrew IP: Protocol Deviation|Overall Study||19||
60045526|NCT02164513|76160882|FG000|WIP (Other): Stopping Criteria Reached|Overall Study||4||
60045527|NCT02164513|76160883|FG001|WIP (Other): Stopping Criteria Reached|Overall Study||1||
60045528|NCT02164513|76160884|FG002|WIP (Other): Stopping Criteria Reached|Overall Study||2||
60045529|NCT02164513|76160882|FG000|WIP: Study Closed/Terminated|Overall Study||5||
60045530|NCT02164513|76160883|FG001|WIP: Study Closed/Terminated|Overall Study||2||
60045531|NCT02164513|76160884|FG002|WIP: Study Closed/Terminated|Overall Study||5||
60045532|NCT02164513|76160882|FG000|WIP: Lost to Follow-up|Overall Study||21||
60045533|NCT02164513|76160883|FG001|WIP: Lost to Follow-up|Overall Study||25||
60045534|NCT02164513|76160884|FG002|WIP: Lost to Follow-up|Overall Study||14||
60045535|NCT02164513|76160882|FG000|WIP: Investigator Discretion|Overall Study||33||
60045536|NCT02164513|76160883|FG001|WIP: Investigator Discretion|Overall Study||36||
60045537|NCT02164513|76160884|FG002|WIP: Investigator Discretion|Overall Study||15||
60045538|NCT02164513|76160882|FG000|WIP: Withdrawal by Participant|Overall Study||250||
60045539|NCT02164513|76160883|FG001|WIP: Withdrawal by Participant|Overall Study||296||
60045540|NCT02164513|76160884|FG002|WIP: Withdrawal by Participant|Overall Study||153||
60045541|NCT02164513|76160882|FG000|WIP :Did Not Complete Study Treatment|Overall Study||1||
60045542|NCT02164513|76160883|FG001|WIP :Did Not Complete Study Treatment|Overall Study||1||
60045543|NCT02164513|76160884|FG002|WIP :Did Not Complete Study Treatment|Overall Study||0||
60045544|NCT02164513|76160882|FG000|COMPLETED|Overall Study||3714||
60045545|NCT02164513|76160883|FG001|COMPLETED|Overall Study||3598||
60045546|NCT02164513|76160884|FG002|COMPLETED|Overall Study||1775||
60045547|NCT02164513|76160882|FG000|NOT COMPLETED|Overall Study||437||
60045548|NCT02164513|76160883|FG001|NOT COMPLETED|Overall Study||536||
60045549|NCT02164513|76160884|FG002|NOT COMPLETED|Overall Study||295||
60045550|NCT04524104|76160895|FG000|STARTED|Overall Study||42||
60045551|NCT04524104|76160896|FG001|STARTED|Overall Study||21||
60045552|NCT04524104|76160895|FG000|COMPLETED|Overall Study||40||
60045553|NCT04524104|76160896|FG001|COMPLETED|Overall Study||21||
60045554|NCT04524104|76160895|FG000|NOT COMPLETED|Overall Study||2||
60045555|NCT04524104|76160896|FG001|NOT COMPLETED|Overall Study||0||
60045556|NCT02218489|76160904|FG000|STARTED|Overall Study||101||
60045557|NCT02218489|76160905|FG001|STARTED|Overall Study||104||
60045558|NCT02218489|76160904|FG000|COMPLETED|Overall Study||96||
60045559|NCT02218489|76160905|FG001|COMPLETED|Overall Study||101||
60045560|NCT02218489|76160904|FG000|NOT COMPLETED|Overall Study||5||
60045561|NCT02218489|76160905|FG001|NOT COMPLETED|Overall Study||3||
60045562|NCT02192905|76160912|FG000|STARTED|Overall Study||43||
60045563|NCT02192905|76160912|FG000|COMPLETED|Overall Study|Reporting a minimum of current weight at 16-week follow-up|42||
60045564|NCT02192905|76160912|FG000|NOT COMPLETED|Overall Study||1||
60045565|NCT01713946|76160920|FG000|STARTED|Overall Study||117||
60045566|NCT01713946|76160921|FG001|STARTED|Overall Study||130||
60045567|NCT01713946|76160922|FG002|STARTED|Overall Study|Of the 119 patients initially randomized to the Placebo arm, 5 patients never switched to everolimus|119||
60045568|NCT01713946|76160920|FG000|Completed Core Phase|Overall Study||110||
60045569|NCT01713946|76160921|FG001|Completed Core Phase|Overall Study||122||
60045570|NCT01713946|76160922|FG002|Completed Core Phase|Overall Study||114||
60045571|NCT01713946|76160920|FG000|Continued in Ext. Phase|Overall Study||110||
60045572|NCT01713946|76160921|FG001|Continued in Ext. Phase|Overall Study||119||
60045573|NCT01713946|76160922|FG002|Continued in Ext. Phase|Overall Study||114||
60045574|NCT01713946|76160920|FG000|Completed Ext. Phase|Overall Study||79||
60045575|NCT01713946|76160921|FG001|Completed Ext. Phase|Overall Study||92||
60045576|NCT01713946|76160922|FG002|Completed Ext. Phase|Overall Study||81||
59511730|NCT01048333|75605337|FG001|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||1||
59511731|NCT01048333|75605338|FG002|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0||
59511732|NCT01048333|75605339|FG003|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0||
59511733|NCT01048333|75605340|FG004|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0||
59511734|NCT01048333|75605341|FG005|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0||
59511735|NCT01048333|75605336|FG000|STARTED|Treatment Period 3||21||
59511736|NCT01048333|75605337|FG001|STARTED|Treatment Period 3||18||
59511737|NCT01048333|75605338|FG002|STARTED|Treatment Period 3||16||
59511738|NCT01048333|75605339|FG003|STARTED|Treatment Period 3||18||
59511739|NCT01048333|75605340|FG004|STARTED|Treatment Period 3||17||
59511740|NCT01048333|75605341|FG005|STARTED|Treatment Period 3||18||
59511741|NCT01048333|75605336|FG000|COMPLETED|Treatment Period 3||21||
59511742|NCT01048333|75605337|FG001|COMPLETED|Treatment Period 3||18||
59511743|NCT01048333|75605338|FG002|COMPLETED|Treatment Period 3||16||
59511744|NCT01048333|75605339|FG003|COMPLETED|Treatment Period 3||18||
59511745|NCT01048333|75605340|FG004|COMPLETED|Treatment Period 3||17||
60045577|NCT01713946|76160920|FG000|Continued in Post-Ext. Phase|Overall Study||78||
60045578|NCT01713946|76160921|FG001|Continued in Post-Ext. Phase|Overall Study||90||
60045579|NCT01713946|76160922|FG002|Continued in Post-Ext. Phase|Overall Study||81||
60045580|NCT01713946|76160920|FG000|Completed Post-Ext Phase|Overall Study||74||
60045581|NCT01713946|76160921|FG001|Completed Post-Ext Phase|Overall Study||85||
60045582|NCT01713946|76160922|FG002|Completed Post-Ext Phase|Overall Study||75||
60045583|NCT01713946|76160920|FG000|Did Not Continue in Ext Phase|Overall Study||0||
60045584|NCT01713946|76160921|FG001|Did Not Continue in Ext Phase|Overall Study||3||
60045585|NCT01713946|76160922|FG002|Did Not Continue in Ext Phase|Overall Study||0||
60045586|NCT01713946|76160920|FG000|Did Not Cont. in Post-Ext Phase|Overall Study||1||
60045587|NCT01713946|76160921|FG001|Did Not Cont. in Post-Ext Phase|Overall Study||2||
59511746|NCT01048333|75605341|FG005|COMPLETED|Treatment Period 3||18||
59511747|NCT01048333|75605336|FG000|NOT COMPLETED|Treatment Period 3||0||
59511748|NCT01048333|75605337|FG001|NOT COMPLETED|Treatment Period 3||0||
59511749|NCT01048333|75605338|FG002|NOT COMPLETED|Treatment Period 3||0||
59511750|NCT01048333|75605339|FG003|NOT COMPLETED|Treatment Period 3||0||
59511751|NCT01048333|75605340|FG004|NOT COMPLETED|Treatment Period 3||0||
59759919|NCT00907517|75879429|FG004|COMPLETED|Overall Study||1||
59759920|NCT00907517|75879425|FG000|NOT COMPLETED|Overall Study||3||
59759921|NCT00907517|75879426|FG001|NOT COMPLETED|Overall Study||3||
59759922|NCT00907517|75879427|FG002|NOT COMPLETED|Overall Study||4||
59759923|NCT00907517|75879428|FG003|NOT COMPLETED|Overall Study||4||
59759924|NCT00907517|75879429|FG004|NOT COMPLETED|Overall Study||5||
59511752|NCT01048333|75605341|FG005|NOT COMPLETED|Treatment Period 3||0||
59511753|NCT02323113|75605356|FG000|STARTED|Overall Study||4||
59511754|NCT02323113|75605357|FG001|STARTED|Overall Study||7||
59612483|NCT01701258|75723500|FG001|NOT COMPLETED|PET (Session 3)||0||
59612484|NCT01701258|75723501|FG002|NOT COMPLETED|PET (Session 3)||0||
59612485|NCT01701258|75723502|FG003|NOT COMPLETED|PET (Session 3)||0||
59511755|NCT02323113|75605358|FG002|STARTED|Overall Study||4||
59511756|NCT02323113|75605359|FG003|STARTED|Overall Study||5||
59511757|NCT02323113|75605360|FG004|STARTED|Overall Study||9||
59511758|NCT02323113|75605361|FG005|STARTED|Overall Study||8||
59511759|NCT02323113|75605362|FG006|STARTED|Overall Study||6||
59511760|NCT02323113|75605363|FG007|STARTED|Overall Study||0||
59511761|NCT02323113|75605356|FG000|COMPLETED|Overall Study||0||
59511762|NCT02323113|75605357|FG001|COMPLETED|Overall Study||0||
59511763|NCT02323113|75605358|FG002|COMPLETED|Overall Study||0||
59511764|NCT02323113|75605359|FG003|COMPLETED|Overall Study||0||
59511765|NCT02323113|75605360|FG004|COMPLETED|Overall Study||0||
59511766|NCT02323113|75605361|FG005|COMPLETED|Overall Study||0||
59511767|NCT02323113|75605362|FG006|COMPLETED|Overall Study||0||
59511768|NCT02323113|75605363|FG007|COMPLETED|Overall Study||0||
59511769|NCT02323113|75605356|FG000|NOT COMPLETED|Overall Study||4||
59511770|NCT02323113|75605357|FG001|NOT COMPLETED|Overall Study||7||
59511771|NCT02323113|75605358|FG002|NOT COMPLETED|Overall Study||4||
59511772|NCT02323113|75605359|FG003|NOT COMPLETED|Overall Study||5||
59511773|NCT02323113|75605360|FG004|NOT COMPLETED|Overall Study||9||
59511774|NCT02323113|75605361|FG005|NOT COMPLETED|Overall Study||8||
59511775|NCT02323113|75605362|FG006|NOT COMPLETED|Overall Study||6||
59511776|NCT02323113|75605363|FG007|NOT COMPLETED|Overall Study||0||
59511777|NCT02759146|75605388|FG000|STARTED|Week 1-4||57|"150 reflexology dyads, 150 mediative practice dyads, and 47 control dyads were randomized. Between the randomization and response to weekly calls, 24 reflexology dyads, 44 meditative practice dyads and 3 control dyads attrited from the study totaling n=71 attrited dyad between the start of participant flow.~In the analysis of repeated measures, participants with at least one non-missing post-baseline value were included."|
59511778|NCT02759146|75605389|FG001|STARTED|Week 1-4||36|"150 reflexology dyads, 150 mediative practice dyads, and 47 control dyads were randomized. Between the randomization and response to weekly calls, 24 reflexology dyads, 44 meditative practice dyads and 3 control dyads attrited from the study totaling n=71 attrited dyad between the start of participant flow.~In the analysis of repeated measures, participants with at least one non-missing post-baseline value were included."|
59612486|NCT01701258|75723503|FG004|NOT COMPLETED|PET (Session 3)||0||
59612487|NCT01701258|75723504|FG005|NOT COMPLETED|PET (Session 3)||0||
59612488|NCT01701258|75723505|FG006|NOT COMPLETED|PET (Session 3)||0||
59612489|NCT01701258|75723506|FG007|NOT COMPLETED|PET (Session 3)||0||
59612490|NCT01701258|75723507|FG008|NOT COMPLETED|PET (Session 3)||0||
59759925|NCT00905255|75879443|FG000|STARTED|Overall Study|Randomized.|33||
59759926|NCT00905255|75879444|FG001|STARTED|Overall Study||36||
59919546|NCT02970318|76039692|FG001|COMPLETED|ArmB: Inv.Choice Crossed Over to Acala||0|Ongoing Treatment at Final DCO (03Sep2021)|
59919547|NCT02970318|76039693|FG002|COMPLETED|ArmB: Inv.Choice Crossed Over to Acala||42|Ongoing Treatment at Final DCO (03Sep2021)|
59919548|NCT02970318|76039694|FG003|COMPLETED|ArmB: Inv.Choice Crossed Over to Acala||14|Ongoing Treatment at Final DCO (03Sep2021)|
59919549|NCT02970318|76039691|FG000|NOT COMPLETED|ArmB: Inv.Choice Crossed Over to Acala||0||
59919550|NCT02970318|76039692|FG001|NOT COMPLETED|ArmB: Inv.Choice Crossed Over to Acala||0||
59919551|NCT02970318|76039693|FG002|NOT COMPLETED|ArmB: Inv.Choice Crossed Over to Acala||21||
59919552|NCT02970318|76039694|FG003|NOT COMPLETED|ArmB: Inv.Choice Crossed Over to Acala||3||
59919553|NCT02751814|76039702|FG000|STARTED|Overall Study||175||
59919554|NCT02751814|76039702|FG000|Completed Baseline Assessments|Overall Study||112||
59951419|NCT01570868|76070404|FG000|COMPLETED|Overall Study||0||
60045588|NCT01713946|76160922|FG002|Did Not Cont. in Post-Ext Phase|Overall Study||0||
60045589|NCT01713946|76160920|FG000|COMPLETED|Overall Study||74||
60045590|NCT01713946|76160921|FG001|COMPLETED|Overall Study||85||
59511779|NCT02759146|75605390|FG002|STARTED|Week 1-4||33|"150 reflexology dyads, 150 mediative practice dyads, and 47 control dyads were randomized. Between the randomization and response to weekly calls, 24 reflexology dyads, 44 meditative practice dyads and 3 control dyads attrited from the study totaling n=71 attrited dyad between the start of participant flow.~In the analysis of repeated measures, participants with at least one non-missing post-baseline value were included."|
59511780|NCT02759146|75605391|FG003|STARTED|Week 1-4|One control participant could continue without the other after baseline.|44|"150 reflexology dyads, 150 mediative practice dyads, and 47 control dyads were randomized. Between the randomization and response to weekly calls, 24 reflexology dyads, 44 meditative practice dyads and 3 control dyads attrited from the study totaling n=71 attrited dyad between the start of participant flow.~In the analysis of repeated measures, participants with at least one non-missing post-baseline value were included."|
59511781|NCT02759146|75605392|FG004|STARTED|Week 1-4||49|"150 reflexology dyads, 150 mediative practice dyads, and 47 control dyads were randomized. Between the randomization and response to weekly calls, 24 reflexology dyads, 44 meditative practice dyads and 3 control dyads attrited from the study totaling n=71 attrited dyad between the start of participant flow.~In the analysis of repeated measures, participants with at least one non-missing post-baseline value were included."|
59511782|NCT02759146|75605393|FG005|STARTED|Week 1-4||30|"150 reflexology dyads, 150 mediative practice dyads, and 47 control dyads were randomized. Between the randomization and response to weekly calls, 24 reflexology dyads, 44 meditative practice dyads and 3 control dyads attrited from the study totaling n=71 attrited dyad between the start of participant flow.~In the analysis of repeated measures, participants with at least one non-missing post-baseline value were included."|
59511783|NCT02759146|75605394|FG006|STARTED|Week 1-4||27|"150 reflexology dyads, 150 mediative practice dyads, and 47 control dyads were randomized. Between the randomization and response to weekly calls, 24 reflexology dyads, 44 meditative practice dyads and 3 control dyads attrited from the study totaling n=71 attrited dyad between the start of participant flow.~In the analysis of repeated measures, participants with at least one non-missing post-baseline value were included."|
59511784|NCT02759146|75605388|FG000|COMPLETED|Week 1-4||56||
59511785|NCT02759146|75605389|FG001|COMPLETED|Week 1-4||34||
59511786|NCT02759146|75605390|FG002|COMPLETED|Week 1-4||32||
59511787|NCT02759146|75605391|FG003|COMPLETED|Week 1-4||44||
59511788|NCT02759146|75605392|FG004|COMPLETED|Week 1-4||49||
59511789|NCT02759146|75605393|FG005|COMPLETED|Week 1-4||29||
59511790|NCT02759146|75605394|FG006|COMPLETED|Week 1-4||26||
59511791|NCT02759146|75605388|FG000|NOT COMPLETED|Week 1-4||1||
59511792|NCT02759146|75605389|FG001|NOT COMPLETED|Week 1-4||2||
59511793|NCT02759146|75605390|FG002|NOT COMPLETED|Week 1-4||1||
59511794|NCT02759146|75605391|FG003|NOT COMPLETED|Week 1-4||0||
59511795|NCT02759146|75605392|FG004|NOT COMPLETED|Week 1-4||0||
59511796|NCT02759146|75605393|FG005|NOT COMPLETED|Week 1-4||1||
59511797|NCT02759146|75605394|FG006|NOT COMPLETED|Week 1-4||1||
59511798|NCT02759146|75605388|FG000|STARTED|Week 5-8||56|In the analysis of repeated measures, participants with at least one non-missing post-baseline value were included. For example, if a participant dropped out before week 5 but completed one of the weeks 1-4, their data were included in the analysis of weeks 1-4 under the missing at random assumption. Same applies to the analysis of longitudinal data for weeks 5-12.|
59511799|NCT02759146|75605389|FG001|STARTED|Week 5-8||34|In the analysis of repeated measures, participants with at least one non-missing post-baseline value were included. For example, if a participant dropped out before week 5 but completed one of the weeks 1-4, their data were included in the analysis of weeks 1-4 under the missing at random assumption. Same applies to the analysis of longitudinal data for weeks 5-12.|
59511800|NCT02759146|75605390|FG002|STARTED|Week 5-8||32|In the analysis of repeated measures, participants with at least one non-missing post-baseline value were included. For example, if a participant dropped out before week 5 but completed one of the weeks 1-4, their data were included in the analysis of weeks 1-4 under the missing at random assumption. Same applies to the analysis of longitudinal data for weeks 5-12.|
59519027|NCT03587428|75612870|FG000|NOT COMPLETED|Period 3||0||
59519028|NCT03587428|75612871|FG001|NOT COMPLETED|Period 3||0||
59519029|NCT03587428|75612872|FG002|NOT COMPLETED|Period 3||0||
59519030|NCT03587428|75612873|FG003|NOT COMPLETED|Period 3||0||
60045591|NCT01713946|76160922|FG002|COMPLETED|Overall Study||75||
60045592|NCT01713946|76160920|FG000|NOT COMPLETED|Overall Study||43||
60045593|NCT01713946|76160921|FG001|NOT COMPLETED|Overall Study||45||
60045594|NCT01713946|76160922|FG002|NOT COMPLETED|Overall Study||44||
60045595|NCT02163499|76160948|FG000|STARTED|Acute Phase: ZS 10 g TID||751||
60045596|NCT02163499|76160948|FG000|COMPLETED|Acute Phase: ZS 10 g TID||746||
60045597|NCT02163499|76160948|FG000|NOT COMPLETED|Acute Phase: ZS 10 g TID||5||
60045598|NCT02163499|76160948|FG000|STARTED|Extended Dosing Phase: ZS||746||
60045599|NCT02163499|76160948|FG000|COMPLETED|Extended Dosing Phase: ZS||466||
60045600|NCT02163499|76160948|FG000|NOT COMPLETED|Extended Dosing Phase: ZS||280||
60045601|NCT02163187|76160958|FG000|STARTED|Overall Study||4||
60045602|NCT02163187|76160959|FG001|STARTED|Overall Study||0||
60045603|NCT02163187|76160958|FG000|Treatment|Overall Study||2||
60045604|NCT02163187|76160959|FG001|Treatment|Overall Study||0||
60045605|NCT02163187|76160958|FG000|COMPLETED|Overall Study||2||
60045606|NCT02163187|76160959|FG001|COMPLETED|Overall Study||0||
60045607|NCT02163187|76160958|FG000|NOT COMPLETED|Overall Study||2||
60045608|NCT02163187|76160959|FG001|NOT COMPLETED|Overall Study||0||
60045609|NCT02191579|76160967|FG000|STARTED|Treatment 1||140||
60045610|NCT02191579|76160968|FG001|STARTED|Treatment 1||142||
60045611|NCT02191579|76160967|FG000|COMPLETED|Treatment 1||113||
60045612|NCT02191579|76160968|FG001|COMPLETED|Treatment 1||84||
60045613|NCT02191579|76160967|FG000|NOT COMPLETED|Treatment 1||27||
60045614|NCT02191579|76160968|FG001|NOT COMPLETED|Treatment 1||58||
60045615|NCT02191579|76160967|FG000|STARTED|Treatment 2||0||
60045616|NCT02191579|76160968|FG001|STARTED|Treatment 2||80||
59759927|NCT00905255|75879443|FG000|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|33||
59759928|NCT00905255|75879444|FG001|Safety Population|Overall Study||36||
59759929|NCT00905255|75879443|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|33||
59759930|NCT00905255|75879444|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||36||
59759931|NCT00905255|75879443|FG000|COMPLETED|Overall Study||20||
59759932|NCT00905255|75879444|FG001|COMPLETED|Overall Study||27||
59759933|NCT00905255|75879443|FG000|NOT COMPLETED|Overall Study||13||
59759934|NCT00905255|75879444|FG001|NOT COMPLETED|Overall Study||9||
60045617|NCT02191579|76160967|FG000|COMPLETED|Treatment 2||0||
60045618|NCT02191579|76160968|FG001|COMPLETED|Treatment 2||55||
60045619|NCT02191579|76160967|FG000|NOT COMPLETED|Treatment 2||0||
60045620|NCT02191579|76160968|FG001|NOT COMPLETED|Treatment 2||25||
60045621|NCT01363700|76160977|FG000|STARTED|Epinastine vs Placebo Period1||43||
60045622|NCT01363700|76160978|FG001|STARTED|Epinastine vs Placebo Period1||22||
60045623|NCT01363700|76160979|FG002|STARTED|Epinastine vs Placebo Period1||22||
60045624|NCT01363700|76160980|FG003|STARTED|Epinastine vs Placebo Period1|No Allocation|0||
60045625|NCT01363700|76160981|FG004|STARTED|Epinastine vs Placebo Period1|No Allocation|0||
60045626|NCT01363700|76160977|FG000|COMPLETED|Epinastine vs Placebo Period1||43||
60045627|NCT01363700|76160978|FG001|COMPLETED|Epinastine vs Placebo Period1||21||
60045628|NCT01363700|76160979|FG002|COMPLETED|Epinastine vs Placebo Period1||22||
60045629|NCT01363700|76160980|FG003|COMPLETED|Epinastine vs Placebo Period1||0||
60045630|NCT01363700|76160981|FG004|COMPLETED|Epinastine vs Placebo Period1||0||
60045631|NCT01363700|76160977|FG000|NOT COMPLETED|Epinastine vs Placebo Period1||0||
60045632|NCT01363700|76160978|FG001|NOT COMPLETED|Epinastine vs Placebo Period1||1||
60045633|NCT01363700|76160979|FG002|NOT COMPLETED|Epinastine vs Placebo Period1||0||
60045634|NCT01363700|76160980|FG003|NOT COMPLETED|Epinastine vs Placebo Period1||0||
60045635|NCT01363700|76160981|FG004|NOT COMPLETED|Epinastine vs Placebo Period1||0||
60045636|NCT01363700|76160977|FG000|STARTED|Epinastine vs Olopatadine Period2|No Allocation|0||
60045637|NCT01363700|76160978|FG001|STARTED|Epinastine vs Olopatadine Period2|No Allocation|0||
60045638|NCT01363700|76160979|FG002|STARTED|Epinastine vs Olopatadine Period2|No Allocation|0||
60045639|NCT01363700|76160980|FG003|STARTED|Epinastine vs Olopatadine Period2||43||
60045640|NCT01363700|76160981|FG004|STARTED|Epinastine vs Olopatadine Period2||43||
60045641|NCT01363700|76160977|FG000|COMPLETED|Epinastine vs Olopatadine Period2||0||
60045642|NCT01363700|76160978|FG001|COMPLETED|Epinastine vs Olopatadine Period2||0||
60045643|NCT01363700|76160979|FG002|COMPLETED|Epinastine vs Olopatadine Period2||0||
60045644|NCT01363700|76160980|FG003|COMPLETED|Epinastine vs Olopatadine Period2||43||
60045645|NCT01363700|76160981|FG004|COMPLETED|Epinastine vs Olopatadine Period2||43||
60045646|NCT01363700|76160977|FG000|NOT COMPLETED|Epinastine vs Olopatadine Period2||0||
60045647|NCT01363700|76160978|FG001|NOT COMPLETED|Epinastine vs Olopatadine Period2||0||
60045648|NCT01363700|76160979|FG002|NOT COMPLETED|Epinastine vs Olopatadine Period2||0||
60045649|NCT01363700|76160980|FG003|NOT COMPLETED|Epinastine vs Olopatadine Period2||0||
60045650|NCT01363700|76160981|FG004|NOT COMPLETED|Epinastine vs Olopatadine Period2||0||
60045651|NCT01637402|76160992|FG000|STARTED|Standard Dose Regimen||41||
60045652|NCT01637402|76160993|FG001|STARTED|Standard Dose Regimen|Escalated dose not introduced as treatment option until after Week 12 evaluation|0||
60045653|NCT01637402|76160992|FG000|COMPLETED|Standard Dose Regimen||38||
60045654|NCT01637402|76160993|FG001|COMPLETED|Standard Dose Regimen||0||
60045655|NCT01637402|76160992|FG000|NOT COMPLETED|Standard Dose Regimen||3||
60045656|NCT01637402|76160993|FG001|NOT COMPLETED|Standard Dose Regimen||0||
60045657|NCT01637402|76160992|FG000|STARTED|Week 12 Evaluation||38||
60045658|NCT01637402|76160993|FG001|STARTED|Week 12 Evaluation|Escalated dose not introduced as treatment option until after Week 12 evaluation|0||
60045659|NCT01637402|76160992|FG000|COMPLETED|Week 12 Evaluation||32||
59759935|NCT00905021|75879451|FG000|STARTED|Overall Study||4||
59759936|NCT00905021|75879451|FG000|COMPLETED|Overall Study|2 patients were off study due to AE.|2||
59759937|NCT00905021|75879451|FG000|NOT COMPLETED|Overall Study||2||
59759938|NCT00906971|75879458|FG000|STARTED|Overall Study||36||
59919555|NCT02751814|76039702|FG000|COMPLETED|Overall Study|Of the 130 children who completed the study, 83 had completed all measures a follow-up|130||
59919556|NCT02751814|76039702|FG000|NOT COMPLETED|Overall Study||45||
59919557|NCT02621398|76039719|FG000|STARTED|Overall Study||0||
59919558|NCT02621398|76039720|FG001|STARTED|Overall Study||4||
60045660|NCT01637402|76160993|FG001|COMPLETED|Week 12 Evaluation||0||
60045661|NCT01637402|76160992|FG000|NOT COMPLETED|Week 12 Evaluation||6||
60045662|NCT01637402|76160993|FG001|NOT COMPLETED|Week 12 Evaluation||0||
60045663|NCT01637402|76160992|FG000|STARTED|Treatment Regiments Post Week 12|Patients continuing on standard dose|14||
59759939|NCT00906971|75879459|FG001|STARTED|Overall Study||36||
59919559|NCT02621398|76039721|FG002|STARTED|Overall Study||4||
59919560|NCT02621398|76039722|FG003|STARTED|Overall Study||3||
59919561|NCT02621398|76039723|FG004|STARTED|Overall Study||3||
59919562|NCT02621398|76039724|FG005|STARTED|Overall Study||3||
59919563|NCT02621398|76039725|FG006|STARTED|Overall Study||6||
59919564|NCT02621398|76039719|FG000|COMPLETED|Overall Study||0||
59919565|NCT02621398|76039720|FG001|COMPLETED|Overall Study||4||
60045664|NCT01637402|76160993|FG001|STARTED|Treatment Regiments Post Week 12|Patients who progressed after decline on standard dose|18||
60045665|NCT01637402|76160992|FG000|COMPLETED|Treatment Regiments Post Week 12||5||
60045666|NCT01637402|76160993|FG001|COMPLETED|Treatment Regiments Post Week 12||14||
60045667|NCT01637402|76160992|FG000|NOT COMPLETED|Treatment Regiments Post Week 12||9||
60045668|NCT01637402|76160993|FG001|NOT COMPLETED|Treatment Regiments Post Week 12||4||
60045669|NCT02217475|76161021|FG000|STARTED|Treatment Period 1 (Year 1)||72||
60045670|NCT02217475|76161022|FG001|STARTED|Treatment Period 1 (Year 1)||72||
59759940|NCT00906971|75879458|FG000|COMPLETED|Overall Study||28||
59759941|NCT00906971|75879459|FG001|COMPLETED|Overall Study||33||
59759942|NCT00906971|75879458|FG000|NOT COMPLETED|Overall Study||8||
59759943|NCT00906971|75879459|FG001|NOT COMPLETED|Overall Study||3||
59759944|NCT00903929|75879465|FG000|STARTED|Overall Study||3||
60045671|NCT02217475|76161023|FG002|STARTED|Treatment Period 1 (Year 1)||145||
60045672|NCT02217475|76161021|FG000|Safety Analysis Set|Treatment Period 1 (Year 1)||72|Received at least one dose of study drug.|
59511801|NCT02759146|75605391|FG003|STARTED|Week 5-8||44|In the analysis of repeated measures, participants with at least one non-missing post-baseline value were included. For example, if a participant dropped out before week 5 but completed one of the weeks 1-4, their data were included in the analysis of weeks 1-4 under the missing at random assumption. Same applies to the analysis of longitudinal data for weeks 5-12.|
59511802|NCT02759146|75605392|FG004|STARTED|Week 5-8||49|In the analysis of repeated measures, participants with at least one non-missing post-baseline value were included. For example, if a participant dropped out before week 5 but completed one of the weeks 1-4, their data were included in the analysis of weeks 1-4 under the missing at random assumption. Same applies to the analysis of longitudinal data for weeks 5-12.|
59511803|NCT02759146|75605393|FG005|STARTED|Week 5-8||29|In the analysis of repeated measures, participants with at least one non-missing post-baseline value were included. For example, if a participant dropped out before week 5 but completed one of the weeks 1-4, their data were included in the analysis of weeks 1-4 under the missing at random assumption. Same applies to the analysis of longitudinal data for weeks 5-12.|
59511804|NCT02759146|75605394|FG006|STARTED|Week 5-8||26|In the analysis of repeated measures, participants with at least one non-missing post-baseline value were included. For example, if a participant dropped out before week 5 but completed one of the weeks 1-4, their data were included in the analysis of weeks 1-4 under the missing at random assumption. Same applies to the analysis of longitudinal data for weeks 5-12.|
59511805|NCT02759146|75605388|FG000|COMPLETED|Week 5-8||46|In the reflexology and meditative practices groups created by the first randomization, one participant could not continue without the other at week 5 unless the patient was a responder and dyad was not re-randomized.|
59519031|NCT03587428|75612874|FG004|NOT COMPLETED|Period 3||0||
59519032|NCT03587428|75612875|FG005|NOT COMPLETED|Period 3||0||
59759945|NCT00903929|75879466|FG001|STARTED|Overall Study||3||
59759946|NCT00903929|75879467|FG002|STARTED|Overall Study|Participants who did not complete the study were replaced with additional participants.|4||
59759947|NCT00903929|75879468|FG003|STARTED|Overall Study|Participants who did not complete the study were replaced with additional participants.|9||
59759948|NCT00903929|75879465|FG000|COMPLETED|Overall Study||3||
59759949|NCT00903929|75879466|FG001|COMPLETED|Overall Study||3||
59759950|NCT00903929|75879467|FG002|COMPLETED|Overall Study||3||
59759951|NCT00903929|75879468|FG003|COMPLETED|Overall Study||6||
59759952|NCT00903929|75879465|FG000|NOT COMPLETED|Overall Study||0||
59759953|NCT00903929|75879466|FG001|NOT COMPLETED|Overall Study||0||
59759954|NCT00903929|75879467|FG002|NOT COMPLETED|Overall Study||1||
59759955|NCT00903929|75879468|FG003|NOT COMPLETED|Overall Study||3||
60045673|NCT02217475|76161022|FG001|Safety Analysis Set|Treatment Period 1 (Year 1)||72|Received at least one dose of study drug.|
60045674|NCT02217475|76161023|FG002|Safety Analysis Set|Treatment Period 1 (Year 1)||144|Received at least one dose of study drug.|
60045675|NCT02217475|76161021|FG000|COMPLETED|Treatment Period 1 (Year 1)||62||
60045676|NCT02217475|76161022|FG001|COMPLETED|Treatment Period 1 (Year 1)||64||
60045677|NCT02217475|76161023|FG002|COMPLETED|Treatment Period 1 (Year 1)||124||
60045678|NCT02217475|76161021|FG000|NOT COMPLETED|Treatment Period 1 (Year 1)||10||
60045679|NCT02217475|76161022|FG001|NOT COMPLETED|Treatment Period 1 (Year 1)||8||
60045680|NCT02217475|76161023|FG002|NOT COMPLETED|Treatment Period 1 (Year 1)||21||
60045681|NCT02217475|76161021|FG000|STARTED|Discontinued After Period 1||62||
60045682|NCT02217475|76161022|FG001|STARTED|Discontinued After Period 1||64||
60045683|NCT02217475|76161023|FG002|STARTED|Discontinued After Period 1||124||
60045684|NCT02217475|76161021|FG000|COMPLETED|Discontinued After Period 1||60||
60045685|NCT02217475|76161022|FG001|COMPLETED|Discontinued After Period 1||61||
60045686|NCT02217475|76161023|FG002|COMPLETED|Discontinued After Period 1||121||
60045687|NCT02217475|76161021|FG000|NOT COMPLETED|Discontinued After Period 1||2||
59759956|NCT00903695|75879475|FG000|STARTED|Overall Study||8||
59759957|NCT00903695|75879476|FG001|STARTED|Overall Study||2||
60045688|NCT02217475|76161022|FG001|NOT COMPLETED|Discontinued After Period 1||3||
60045689|NCT02217475|76161023|FG002|NOT COMPLETED|Discontinued After Period 1||3||
60045690|NCT02217475|76161021|FG000|STARTED|Treatment Period 2 (Year 2)||60||
60045691|NCT02217475|76161022|FG001|STARTED|Treatment Period 2 (Year 2)||61||
60045692|NCT02217475|76161023|FG002|STARTED|Treatment Period 2 (Year 2)||121||
60045693|NCT02217475|76161021|FG000|COMPLETED|Treatment Period 2 (Year 2)||58||
60045694|NCT02217475|76161022|FG001|COMPLETED|Treatment Period 2 (Year 2)||59||
60045695|NCT02217475|76161023|FG002|COMPLETED|Treatment Period 2 (Year 2)||109||
60045696|NCT02217475|76161021|FG000|NOT COMPLETED|Treatment Period 2 (Year 2)||2||
60045697|NCT02217475|76161022|FG001|NOT COMPLETED|Treatment Period 2 (Year 2)||2||
59919566|NCT02621398|76039721|FG002|COMPLETED|Overall Study||4||
59919567|NCT02621398|76039722|FG003|COMPLETED|Overall Study||3||
59919568|NCT02621398|76039723|FG004|COMPLETED|Overall Study||3||
59919569|NCT02621398|76039724|FG005|COMPLETED|Overall Study||3||
59919570|NCT02621398|76039725|FG006|COMPLETED|Overall Study||6||
59919571|NCT02621398|76039719|FG000|NOT COMPLETED|Overall Study||0||
59919572|NCT02621398|76039720|FG001|NOT COMPLETED|Overall Study||0||
59919573|NCT02621398|76039721|FG002|NOT COMPLETED|Overall Study||0||
59919574|NCT02621398|76039722|FG003|NOT COMPLETED|Overall Study||0||
59919575|NCT02621398|76039723|FG004|NOT COMPLETED|Overall Study||0||
59919576|NCT02621398|76039724|FG005|NOT COMPLETED|Overall Study||0||
59919577|NCT02621398|76039725|FG006|NOT COMPLETED|Overall Study||0||
59919578|NCT02525029|76039748|FG000|STARTED|Overall Study||0||
59759958|NCT00903695|75879475|FG000|COMPLETED|Overall Study||6||
59759959|NCT00903695|75879476|FG001|COMPLETED|Overall Study||2||
59759960|NCT00903695|75879475|FG000|NOT COMPLETED|Overall Study||2||
59511806|NCT02759146|75605389|FG001|COMPLETED|Week 5-8||29|In the reflexology and meditative practices groups created by the first randomization, one participant could not continue without the other at week 5 unless the patient was a responder and dyad was not re-randomized.|
59919579|NCT02525029|76039749|FG001|STARTED|Overall Study||0||
59919580|NCT02525029|76039750|FG002|STARTED|Overall Study||0||
59919581|NCT02525029|76039751|FG003|STARTED|Overall Study||0||
59919582|NCT02525029|76039752|FG004|STARTED|Overall Study||2||
59919583|NCT02525029|76039753|FG005|STARTED|Overall Study||0||
59919584|NCT02525029|76039754|FG006|STARTED|Overall Study||2||
60045698|NCT02217475|76161023|FG002|NOT COMPLETED|Treatment Period 2 (Year 2)||12||
60045699|NCT02191267|76161043|FG000|STARTED|Overall Study||20||
60045700|NCT02191267|76161044|FG001|STARTED|Overall Study||6||
59759961|NCT00903695|75879476|FG001|NOT COMPLETED|Overall Study||0||
59759962|NCT00903617|75879488|FG000|STARTED|Overall Study||19||
59759963|NCT00903617|75879489|FG001|STARTED|Overall Study||20||
59511807|NCT02759146|75605390|FG002|COMPLETED|Week 5-8||22|In the reflexology and meditative practices groups created by the first randomization, one participant could not continue without the other at week 5 unless the patient was a responder and dyad was not re-randomized.|
59511808|NCT02759146|75605391|FG003|COMPLETED|Week 5-8||37|In the reflexology and meditative practices groups created by the first randomization, one participant could not continue without the other at week 5 unless the patient was a responder and dyad was not re-randomized.|
59519033|NCT03593200|75612883|FG000|STARTED|Overall Study||4||
59519086|NCT00939731|75612966|FG000|COMPLETED|First Intervention Period||12||
59759964|NCT00903617|75879490|FG002|STARTED|Overall Study||20||
59759965|NCT00903617|75879491|FG003|STARTED|Overall Study||21||
59759966|NCT00903617|75879488|FG000|COMPLETED|Overall Study||16||
59759967|NCT00903617|75879489|FG001|COMPLETED|Overall Study||15||
59759968|NCT00903617|75879490|FG002|COMPLETED|Overall Study||15||
60045701|NCT02191267|76161045|FG002|STARTED|Overall Study||4||
60045702|NCT02191267|76161043|FG000|COMPLETED|Overall Study||19||
60045703|NCT02191267|76161044|FG001|COMPLETED|Overall Study||6||
60045704|NCT02191267|76161045|FG002|COMPLETED|Overall Study||4||
60045705|NCT02191267|76161043|FG000|NOT COMPLETED|Overall Study||1||
60045706|NCT02191267|76161044|FG001|NOT COMPLETED|Overall Study||0||
59759969|NCT00903617|75879491|FG003|COMPLETED|Overall Study||20||
59759970|NCT00903617|75879488|FG000|NOT COMPLETED|Overall Study||3||
59759971|NCT00903617|75879489|FG001|NOT COMPLETED|Overall Study||5||
59759972|NCT00903617|75879490|FG002|NOT COMPLETED|Overall Study||5||
59759973|NCT00903617|75879491|FG003|NOT COMPLETED|Overall Study||1||
59759974|NCT00903383|75879506|FG000|STARTED|Overall Study||55||
59759975|NCT00903383|75879507|FG001|STARTED|Overall Study||54||
59759976|NCT00903383|75879508|FG002|STARTED|Overall Study||50||
59759977|NCT00903383|75879509|FG003|STARTED|Overall Study||49||
59759978|NCT00903383|75879506|FG000|COMPLETED|Overall Study||48||
59759979|NCT00903383|75879507|FG001|COMPLETED|Overall Study||48||
59759980|NCT00903383|75879508|FG002|COMPLETED|Overall Study||47||
59759981|NCT00903383|75879509|FG003|COMPLETED|Overall Study||44||
59759982|NCT00903383|75879506|FG000|NOT COMPLETED|Overall Study||7||
59759983|NCT00903383|75879507|FG001|NOT COMPLETED|Overall Study||6||
59759984|NCT00903383|75879508|FG002|NOT COMPLETED|Overall Study||3||
59759985|NCT00903383|75879509|FG003|NOT COMPLETED|Overall Study||5||
59759986|NCT02314026|75879519|FG000|STARTED|Overall Study||135||
59759987|NCT02314026|75879519|FG000|COMPLETED|Overall Study||107||
59759988|NCT02314026|75879519|FG000|NOT COMPLETED|Overall Study||28||
59759989|NCT00810017|75879523|FG000|STARTED|Overall Study||2||
59759990|NCT00810017|75879523|FG000|COMPLETED|Overall Study||0||
59759991|NCT00810017|75879523|FG000|NOT COMPLETED|Overall Study||2||
59759992|NCT01617096|75879529|FG000|STARTED|Overall Study||1313||
59759993|NCT01617096|75879530|FG001|STARTED|Overall Study||1316||
59759994|NCT01617096|75879529|FG000|COMPLETED|Overall Study||1165||
59759995|NCT01617096|75879530|FG001|COMPLETED|Overall Study||1179||
59919585|NCT02525029|76039755|FG007|STARTED|Overall Study||0||
59919586|NCT02525029|76039756|FG008|STARTED|Overall Study||9||
59919587|NCT02525029|76039757|FG009|STARTED|Overall Study||13||
60045707|NCT02191267|76161045|FG002|NOT COMPLETED|Overall Study||0||
60045708|NCT02189941|76161053|FG000|STARTED|Overall Study||4||
60045709|NCT02189941|76161054|FG001|STARTED|Overall Study||4||
60045710|NCT02189941|76161055|FG002|STARTED|Overall Study||3||
60045711|NCT02189941|76161053|FG000|COMPLETED|Overall Study||4||
59511809|NCT02759146|75605392|FG004|COMPLETED|Week 5-8||44|In the reflexology and meditative practices groups created by the first randomization, one participant could not continue without the other at week 5 unless the patient was a responder and dyad was not re-randomized.|
59511810|NCT02759146|75605393|FG005|COMPLETED|Week 5-8||23|In the reflexology and meditative practices groups created by the first randomization, one participant could not continue without the other at week 5 unless the patient was a responder and dyad was not re-randomized.|
59511811|NCT02759146|75605394|FG006|COMPLETED|Week 5-8||20|In the reflexology and meditative practices groups created by the first randomization, one participant could not continue without the other at week 5 unless the patient was a responder and dyad was not re-randomized.|
59511812|NCT02759146|75605388|FG000|NOT COMPLETED|Week 5-8||10||
59612491|NCT01701258|75723508|FG009|NOT COMPLETED|PET (Session 3)||0||
59612492|NCT01701258|75723509|FG010|NOT COMPLETED|PET (Session 3)||0||
59919588|NCT02525029|76039758|FG010|STARTED|Overall Study||0||
59919589|NCT02525029|76039759|FG011|STARTED|Overall Study||0||
60045712|NCT02189941|76161054|FG001|COMPLETED|Overall Study||4||
60045713|NCT02189941|76161055|FG002|COMPLETED|Overall Study||2||
60045714|NCT02189941|76161053|FG000|NOT COMPLETED|Overall Study||0||
60045715|NCT02189941|76161054|FG001|NOT COMPLETED|Overall Study||0||
60045716|NCT02189941|76161055|FG002|NOT COMPLETED|Overall Study||1||
60045717|NCT02216773|76161065|FG000|STARTED|Overall Study||28||
60045718|NCT02216773|76161066|FG001|STARTED|Overall Study||29||
60045719|NCT02216773|76161065|FG000|Underwent Procedure (PVE/RALPPS)|Overall Study||24||
59612493|NCT01701258|75723510|FG011|NOT COMPLETED|PET (Session 3)||0||
59759996|NCT01617096|75879529|FG000|NOT COMPLETED|Overall Study||148||
59759997|NCT01617096|75879530|FG001|NOT COMPLETED|Overall Study||137||
59759998|NCT01433016|75879536|FG000|STARTED|Overall Study||20||
59759999|NCT01433016|75879536|FG000|COMPLETED|Overall Study||20||
59760000|NCT01433016|75879536|FG000|NOT COMPLETED|Overall Study||0||
59760001|NCT00825630|75879544|FG000|STARTED|Overall Study||29||
59919590|NCT02525029|76039760|FG012|STARTED|Overall Study||0||
59919591|NCT02525029|76039761|FG013|STARTED|Overall Study||0||
59919592|NCT02525029|76039762|FG014|STARTED|Overall Study||0||
59919593|NCT02525029|76039763|FG015|STARTED|Overall Study||0||
59919594|NCT02525029|76039764|FG016|STARTED|Overall Study||1||
59919595|NCT02525029|76039765|FG017|STARTED|Overall Study||0||
59919596|NCT02525029|76039766|FG018|STARTED|Overall Study||4||
59919597|NCT02525029|76039767|FG019|STARTED|Overall Study||8||
59919598|NCT02525029|76039768|FG020|STARTED|Overall Study||0||
59919599|NCT02525029|76039769|FG021|STARTED|Overall Study||0||
59919600|NCT02525029|76039770|FG022|STARTED|Overall Study||0||
59919601|NCT02525029|76039771|FG023|STARTED|Overall Study||0||
59919602|NCT02525029|76039772|FG024|STARTED|Overall Study||2||
59919603|NCT02525029|76039773|FG025|STARTED|Overall Study||0||
59919604|NCT02525029|76039774|FG026|STARTED|Overall Study||1||
59612494|NCT01701258|75723511|FG012|NOT COMPLETED|PET (Session 3)||0||
59612495|NCT01701258|75723499|FG000|STARTED|EEG (Session 4)||0|Not all participants that were eligible or completed the MRI/PET completed the EEG.|
59760002|NCT00825630|75879545|FG001|STARTED|Overall Study||62||
59760003|NCT00825630|75879546|FG002|STARTED|Overall Study||19||
59919605|NCT02525029|76039775|FG027|STARTED|Overall Study||0||
59919606|NCT02525029|76039776|FG028|STARTED|Overall Study||5||
59919607|NCT02525029|76039777|FG029|STARTED|Overall Study||1||
59919608|NCT02525029|76039778|FG030|STARTED|Overall Study||2||
59919609|NCT02525029|76039779|FG031|STARTED|Overall Study||0||
59919610|NCT02525029|76039780|FG032|STARTED|Overall Study||3||
59919611|NCT02525029|76039781|FG033|STARTED|Overall Study||0||
59919612|NCT02525029|76039748|FG000|COMPLETED|Overall Study||0||
59919613|NCT02525029|76039749|FG001|COMPLETED|Overall Study||0||
59919614|NCT02525029|76039750|FG002|COMPLETED|Overall Study||0||
59919615|NCT02525029|76039751|FG003|COMPLETED|Overall Study||0||
59919616|NCT02525029|76039752|FG004|COMPLETED|Overall Study||2||
59919617|NCT02525029|76039753|FG005|COMPLETED|Overall Study||0||
59919618|NCT02525029|76039754|FG006|COMPLETED|Overall Study||2||
59919619|NCT02525029|76039755|FG007|COMPLETED|Overall Study||0||
59919620|NCT02525029|76039756|FG008|COMPLETED|Overall Study||9||
59919621|NCT02525029|76039757|FG009|COMPLETED|Overall Study||13||
59760004|NCT00825630|75879547|FG003|STARTED|Overall Study||13||
59760005|NCT00825630|75879544|FG000|COMPLETED|Overall Study||29||
59760006|NCT00825630|75879545|FG001|COMPLETED|Overall Study||62||
59919622|NCT02525029|76039758|FG010|COMPLETED|Overall Study||0||
59919623|NCT02525029|76039759|FG011|COMPLETED|Overall Study||0||
59919624|NCT02525029|76039760|FG012|COMPLETED|Overall Study||0||
59919625|NCT02525029|76039761|FG013|COMPLETED|Overall Study||0||
59919626|NCT02525029|76039762|FG014|COMPLETED|Overall Study||0||
59919627|NCT02525029|76039763|FG015|COMPLETED|Overall Study||0||
59919628|NCT02525029|76039764|FG016|COMPLETED|Overall Study||1||
59919629|NCT02525029|76039765|FG017|COMPLETED|Overall Study||0||
59919630|NCT02525029|76039766|FG018|COMPLETED|Overall Study||4||
59919631|NCT02525029|76039767|FG019|COMPLETED|Overall Study||8||
59919632|NCT02525029|76039768|FG020|COMPLETED|Overall Study||0||
59919633|NCT02525029|76039769|FG021|COMPLETED|Overall Study||0||
59919634|NCT02525029|76039770|FG022|COMPLETED|Overall Study||0||
59919635|NCT02525029|76039771|FG023|COMPLETED|Overall Study||0||
59919636|NCT02525029|76039772|FG024|COMPLETED|Overall Study||1||
60045720|NCT02216773|76161066|FG001|Underwent Procedure (PVE/RALPPS)|Overall Study||26||
60045721|NCT02216773|76161065|FG000|COMPLETED|Overall Study||16||
59511813|NCT02759146|75605389|FG001|NOT COMPLETED|Week 5-8||5||
59511814|NCT02759146|75605390|FG002|NOT COMPLETED|Week 5-8||10||
60045722|NCT02216773|76161066|FG001|COMPLETED|Overall Study||24||
60045723|NCT02216773|76161065|FG000|NOT COMPLETED|Overall Study||12||
60045724|NCT02216773|76161066|FG001|NOT COMPLETED|Overall Study||5||
60045725|NCT01601132|76161072|FG000|STARTED|Overall Study||30||
60045726|NCT01601132|76161072|FG000|COMPLETED|Overall Study||28||
60045727|NCT01601132|76161072|FG000|NOT COMPLETED|Overall Study||2||
60045728|NCT02162719|76161081|FG000|STARTED|Overall Study||62||
60045729|NCT02162719|76161082|FG001|STARTED|Overall Study||62||
60045730|NCT02162719|76161081|FG000|COMPLETED|Overall Study||0||
60045731|NCT02162719|76161082|FG001|COMPLETED|Overall Study||0||
60045732|NCT02162719|76161081|FG000|NOT COMPLETED|Overall Study||62||
60045733|NCT02162719|76161082|FG001|NOT COMPLETED|Overall Study||62||
59511815|NCT02759146|75605391|FG003|NOT COMPLETED|Week 5-8||7||
59511816|NCT02759146|75605392|FG004|NOT COMPLETED|Week 5-8||5||
59511817|NCT02759146|75605393|FG005|NOT COMPLETED|Week 5-8||6||
59511818|NCT02759146|75605394|FG006|NOT COMPLETED|Week 5-8||6||
59511819|NCT02281383|75605410|FG000|STARTED|Overall Study||80||
59511820|NCT02281383|75605410|FG000|COMPLETED|Overall Study||68||
59511821|NCT02281383|75605410|FG000|NOT COMPLETED|Overall Study||12||
60045734|NCT02161549|76161090|FG000|STARTED|Overall Study||40||
60045735|NCT02161549|76161091|FG001|STARTED|Overall Study||31||
60045736|NCT02161549|76161090|FG000|COMPLETED|Overall Study||34||
60045737|NCT02161549|76161091|FG001|COMPLETED|Overall Study||29||
60045738|NCT02161549|76161090|FG000|NOT COMPLETED|Overall Study||6||
60045739|NCT02161549|76161091|FG001|NOT COMPLETED|Overall Study||2||
60045740|NCT02189863|76161097|FG000|STARTED|First 2 Weeks||12||
60045741|NCT02189863|76161098|FG001|STARTED|First 2 Weeks||15||
60045742|NCT02189863|76161097|FG000|COMPLETED|First 2 Weeks||8||
60045743|NCT02189863|76161098|FG001|COMPLETED|First 2 Weeks||13||
60045744|NCT02189863|76161097|FG000|NOT COMPLETED|First 2 Weeks||4||
60045745|NCT02189863|76161098|FG001|NOT COMPLETED|First 2 Weeks||2||
60045746|NCT02189863|76161097|FG000|STARTED|Second 2 Weeks||8||
60045747|NCT02189863|76161098|FG001|STARTED|Second 2 Weeks||13||
60045748|NCT02189863|76161097|FG000|COMPLETED|Second 2 Weeks||8||
60045749|NCT02189863|76161098|FG001|COMPLETED|Second 2 Weeks||13||
60045750|NCT02189863|76161097|FG000|NOT COMPLETED|Second 2 Weeks||0||
60045751|NCT02189863|76161098|FG001|NOT COMPLETED|Second 2 Weeks||0||
60045752|NCT02189473|76161109|FG000|STARTED|Overall Study||101||
60045753|NCT02189473|76161110|FG001|STARTED|Overall Study||102||
60045754|NCT02189473|76161109|FG000|COMPLETED|Overall Study||78||
60045755|NCT02189473|76161110|FG001|COMPLETED|Overall Study||77||
60045756|NCT02189473|76161109|FG000|NOT COMPLETED|Overall Study||23||
60045757|NCT02189473|76161110|FG001|NOT COMPLETED|Overall Study||25||
60045758|NCT02188849|76161118|FG000|STARTED|Overall Study||25||
60045759|NCT02188849|76161119|FG001|STARTED|Overall Study||25||
60045760|NCT02188849|76161118|FG000|COMPLETED|Overall Study||22||
60045761|NCT02188849|76161119|FG001|COMPLETED|Overall Study||17||
59511822|NCT01047553|75605416|FG000|STARTED|Overall Study||125||
59511823|NCT01047553|75605417|FG001|STARTED|Overall Study||126||
59511824|NCT01047553|75605416|FG000|COMPLETED|Overall Study||108||
59511825|NCT01047553|75605417|FG001|COMPLETED|Overall Study||117||
59511826|NCT01047553|75605416|FG000|NOT COMPLETED|Overall Study||17||
59511827|NCT01047553|75605417|FG001|NOT COMPLETED|Overall Study||9||
59511828|NCT02760862|75605425|FG000|STARTED|Overall Study||25||
59511829|NCT02760862|75605426|FG001|STARTED|Overall Study||25||
59511830|NCT02760862|75605425|FG000|COMPLETED|Overall Study||25||
59511831|NCT02760862|75605426|FG001|COMPLETED|Overall Study||25||
59511832|NCT02760862|75605425|FG000|NOT COMPLETED|Overall Study||0||
59511833|NCT02760862|75605426|FG001|NOT COMPLETED|Overall Study||0||
59511834|NCT02761252|75605435|FG000|STARTED|Overall Study||143||
59511835|NCT02761252|75605436|FG001|STARTED|Overall Study||140||
59511836|NCT02761252|75605437|FG002|STARTED|Overall Study||137||
59511837|NCT02761252|75605435|FG000|COMPLETED|Overall Study||133||
59511838|NCT02761252|75605436|FG001|COMPLETED|Overall Study||132||
59511839|NCT02761252|75605437|FG002|COMPLETED|Overall Study||123||
59511840|NCT02761252|75605435|FG000|NOT COMPLETED|Overall Study||10||
60045762|NCT02188849|76161118|FG000|NOT COMPLETED|Overall Study||3||
60045763|NCT02188849|76161119|FG001|NOT COMPLETED|Overall Study||8||
60045764|NCT01636076|76161127|FG000|STARTED|Overall Study||316||
60045765|NCT01636076|76161128|FG001|STARTED|Overall Study||313||
60045766|NCT01636076|76161127|FG000|COMPLETED|Overall Study||299||
60045767|NCT01636076|76161128|FG001|COMPLETED|Overall Study||288||
60045768|NCT01636076|76161127|FG000|NOT COMPLETED|Overall Study||17||
60045769|NCT01636076|76161128|FG001|NOT COMPLETED|Overall Study||25||
60045770|NCT01635998|76161143|FG000|STARTED|Overall Study||28||
60045771|NCT01635998|76161144|FG001|STARTED|Overall Study||22||
60045772|NCT01635998|76161143|FG000|COMPLETED|Overall Study||24||
60045773|NCT01635998|76161144|FG001|COMPLETED|Overall Study||15||
60045774|NCT01635998|76161143|FG000|NOT COMPLETED|Overall Study||4||
60045775|NCT01635998|76161144|FG001|NOT COMPLETED|Overall Study||7||
60045776|NCT01635920|76161152|FG000|STARTED|Overall Study||125||
60045777|NCT01635920|76161153|FG001|STARTED|Overall Study||126||
60045778|NCT01635920|76161152|FG000|COMPLETED|Overall Study||122||
60045779|NCT01635920|76161153|FG001|COMPLETED|Overall Study||125||
60045780|NCT01635920|76161152|FG000|NOT COMPLETED|Overall Study||3||
60045781|NCT01635920|76161153|FG001|NOT COMPLETED|Overall Study||1||
60045782|NCT03029000|76161160|FG000|STARTED|Overall Study||1||
60045783|NCT03029000|76161160|FG000|COMPLETED|Overall Study||1||
60045784|NCT03029000|76161160|FG000|NOT COMPLETED|Overall Study||0||
60045785|NCT03760484|76161164|FG000|STARTED|Overall Study||4||
60045786|NCT03760484|76161164|FG000|COMPLETED|Overall Study||4||
60045787|NCT03760484|76161164|FG000|NOT COMPLETED|Overall Study||0||
60045788|NCT02160145|76161170|FG000|STARTED|Prerandomization Single-blind Period||1519||
60045789|NCT02160145|76161171|FG001|STARTED|Prerandomization Single-blind Period||0||
60045790|NCT02160145|76161172|FG002|STARTED|Prerandomization Single-blind Period||0||
60045791|NCT02160145|76161170|FG000|Treated in Placebo Run-in|Prerandomization Single-blind Period||1514||
60045792|NCT02160145|76161171|FG001|Treated in Placebo Run-in|Prerandomization Single-blind Period||0||
60045793|NCT02160145|76161172|FG002|Treated in Placebo Run-in|Prerandomization Single-blind Period||0||
60045794|NCT02160145|76161170|FG000|Treated in Tolvaptan Titration/Run-in|Prerandomization Single-blind Period||1491||
60045795|NCT02160145|76161171|FG001|Treated in Tolvaptan Titration/Run-in|Prerandomization Single-blind Period||0||
60045796|NCT02160145|76161172|FG002|Treated in Tolvaptan Titration/Run-in|Prerandomization Single-blind Period||0||
60045797|NCT02160145|76161170|FG000|Randomized|Prerandomization Single-blind Period||1370||
60045798|NCT02160145|76161171|FG001|Randomized|Prerandomization Single-blind Period||0||
60045799|NCT02160145|76161172|FG002|Randomized|Prerandomization Single-blind Period||0||
60045800|NCT02160145|76161170|FG000|COMPLETED|Prerandomization Single-blind Period||1370||
60045801|NCT02160145|76161171|FG001|COMPLETED|Prerandomization Single-blind Period||0||
60045802|NCT02160145|76161172|FG002|COMPLETED|Prerandomization Single-blind Period||0||
60045803|NCT02160145|76161170|FG000|NOT COMPLETED|Prerandomization Single-blind Period||149||
60045804|NCT02160145|76161171|FG001|NOT COMPLETED|Prerandomization Single-blind Period||0||
60045805|NCT02160145|76161172|FG002|NOT COMPLETED|Prerandomization Single-blind Period||0||
60045806|NCT02160145|76161170|FG000|STARTED|Randomized Double-blind Period|1370 subjects were randomized to receive tolvaptan or placebo in the double-blind period.|0||
59511841|NCT02761252|75605436|FG001|NOT COMPLETED|Overall Study||8||
59511842|NCT02761252|75605437|FG002|NOT COMPLETED|Overall Study||14||
59760007|NCT00825630|75879546|FG002|COMPLETED|Overall Study||19||
60045807|NCT02160145|76161171|FG001|STARTED|Randomized Double-blind Period|Subjects completed the single-blind period and were randomized to receive tolvaptan.|683||
60045808|NCT02160145|76161172|FG002|STARTED|Randomized Double-blind Period|Subjects completed the single-blind period and were randomized to receive placebo.|687||
60045809|NCT02160145|76161170|FG000|On-treatment Completers|Randomized Double-blind Period||0||
60045810|NCT02160145|76161171|FG001|On-treatment Completers|Randomized Double-blind Period||578||
60045811|NCT02160145|76161172|FG002|On-treatment Completers|Randomized Double-blind Period||637||
60045812|NCT02160145|76161170|FG000|Off-treatment Completers|Randomized Double-blind Period||0||
60045813|NCT02160145|76161171|FG001|Off-treatment Completers|Randomized Double-blind Period||76||
60045814|NCT02160145|76161172|FG002|Off-treatment Completers|Randomized Double-blind Period||22||
60045815|NCT02160145|76161170|FG000|COMPLETED|Randomized Double-blind Period||0|Completed Month 12 Visit|
60045816|NCT02160145|76161171|FG001|COMPLETED|Randomized Double-blind Period||654|Completed Month 12 Visit|
60045817|NCT02160145|76161172|FG002|COMPLETED|Randomized Double-blind Period||659|Completed Month 12 Visit|
60045818|NCT02160145|76161170|FG000|NOT COMPLETED|Randomized Double-blind Period||0||
60045819|NCT02160145|76161171|FG001|NOT COMPLETED|Randomized Double-blind Period||29||
60045820|NCT02160145|76161172|FG002|NOT COMPLETED|Randomized Double-blind Period||28||
60045821|NCT01696396|76161183|FG000|STARTED|Overall Study||100||
60045822|NCT01696396|76161184|FG001|STARTED|Overall Study||27||
60045823|NCT01696396|76161185|FG002|STARTED|Overall Study||85||
60045824|NCT01696396|76161186|FG003|STARTED|Overall Study||42||
60045825|NCT01696396|76161183|FG000|Received Study Drug|Overall Study||98||
60045826|NCT01696396|76161184|FG001|Received Study Drug|Overall Study||26||
60045827|NCT01696396|76161185|FG002|Received Study Drug|Overall Study||84||
60045828|NCT01696396|76161186|FG003|Received Study Drug|Overall Study||41||
60045829|NCT01696396|76161183|FG000|Entered Open-label Period|Overall Study||84||
60045830|NCT01696396|76161184|FG001|Entered Open-label Period|Overall Study||21||
60045831|NCT01696396|76161185|FG002|Entered Open-label Period|Overall Study||75||
60045832|NCT01696396|76161186|FG003|Entered Open-label Period|Overall Study||37||
60045833|NCT01696396|76161183|FG000|COMPLETED|Overall Study||69|Participants who completed the safety follow-up period|
60045834|NCT01696396|76161184|FG001|COMPLETED|Overall Study||20|Participants who completed the safety follow-up period|
60045835|NCT01696396|76161185|FG002|COMPLETED|Overall Study||59|Participants who completed the safety follow-up period|
60045836|NCT01696396|76161186|FG003|COMPLETED|Overall Study||28|Participants who completed the safety follow-up period|
60045837|NCT01696396|76161183|FG000|NOT COMPLETED|Overall Study||31||
60045838|NCT01696396|76161184|FG001|NOT COMPLETED|Overall Study||7||
60045839|NCT01696396|76161185|FG002|NOT COMPLETED|Overall Study||26||
60045840|NCT01696396|76161186|FG003|NOT COMPLETED|Overall Study||14||
59760008|NCT00825630|75879547|FG003|COMPLETED|Overall Study||13||
59511843|NCT01046695|75605449|FG000|STARTED|Overall Study||20||
59760009|NCT00825630|75879544|FG000|NOT COMPLETED|Overall Study||0||
59760010|NCT00825630|75879545|FG001|NOT COMPLETED|Overall Study||0||
59760011|NCT00825630|75879546|FG002|NOT COMPLETED|Overall Study||0||
60045841|NCT02216071|76161202|FG000|STARTED|Overall Study||254||
60045842|NCT02216071|76161203|FG001|STARTED|Overall Study||245||
60045843|NCT02216071|76161202|FG000|COMPLETED|Overall Study||239||
60045844|NCT02216071|76161203|FG001|COMPLETED|Overall Study||233||
60045845|NCT02216071|76161202|FG000|NOT COMPLETED|Overall Study||15||
60045846|NCT02216071|76161203|FG001|NOT COMPLETED|Overall Study||12||
60045847|NCT01681576|76161211|FG000|STARTED|Period 1||36||
60045848|NCT01681576|76161212|FG001|STARTED|Period 1||36||
60045849|NCT01681576|76161211|FG000|COMPLETED|Period 1||34||
60045850|NCT01681576|76161212|FG001|COMPLETED|Period 1||36||
60045851|NCT01681576|76161211|FG000|NOT COMPLETED|Period 1||2||
60045852|NCT01681576|76161212|FG001|NOT COMPLETED|Period 1||0||
60045853|NCT01681576|76161211|FG000|STARTED|Period 2|Period 2: Valsartan 320mg|34||
60045854|NCT01681576|76161212|FG001|STARTED|Period 2|Period 2: LCZ696 400mg|36||
60045855|NCT01681576|76161211|FG000|COMPLETED|Period 2||30||
60045856|NCT01681576|76161212|FG001|COMPLETED|Period 2||35||
60045857|NCT01681576|76161211|FG000|NOT COMPLETED|Period 2||4||
60045858|NCT01681576|76161212|FG001|NOT COMPLETED|Period 2||1||
60045859|NCT02188459|76161222|FG000|STARTED|Overall Study||64||
60045860|NCT02188459|76161223|FG001|STARTED|Overall Study||65||
60045861|NCT02188459|76161222|FG000|COMPLETED|Overall Study||61||
60045862|NCT02188459|76161223|FG001|COMPLETED|Overall Study||58||
60045863|NCT02188459|76161222|FG000|NOT COMPLETED|Overall Study||3||
60045864|NCT02188459|76161223|FG001|NOT COMPLETED|Overall Study||7||
60045865|NCT02743364|76161235|FG000|STARTED|Overall Study||6||
60045866|NCT02743364|76161236|FG001|STARTED|Overall Study||2||
60045867|NCT02743364|76161235|FG000|COMPLETED|Overall Study||6||
60045868|NCT02743364|76161236|FG001|COMPLETED|Overall Study||2||
60045869|NCT02743364|76161235|FG000|NOT COMPLETED|Overall Study||0||
60045870|NCT02743364|76161236|FG001|NOT COMPLETED|Overall Study||0||
60045871|NCT02214121|76161245|FG000|STARTED|Part A||46||
60045872|NCT02214121|76161246|FG001|STARTED|Part A||0||
60045873|NCT02214121|76161247|FG002|STARTED|Part A||0||
60045874|NCT02214121|76161245|FG000|COMPLETED|Part A||39||
60045875|NCT02214121|76161246|FG001|COMPLETED|Part A||0||
60045876|NCT02214121|76161247|FG002|COMPLETED|Part A||0||
60045877|NCT02214121|76161245|FG000|NOT COMPLETED|Part A||7||
60045878|NCT02214121|76161246|FG001|NOT COMPLETED|Part A||0||
60045879|NCT02214121|76161247|FG002|NOT COMPLETED|Part A||0||
60045880|NCT02214121|76161245|FG000|STARTED|Part B||0||
59919637|NCT02525029|76039773|FG025|COMPLETED|Overall Study||0||
59919638|NCT02525029|76039774|FG026|COMPLETED|Overall Study||1||
59919639|NCT02525029|76039775|FG027|COMPLETED|Overall Study||0||
59919640|NCT02525029|76039776|FG028|COMPLETED|Overall Study||5||
59919641|NCT02525029|76039777|FG029|COMPLETED|Overall Study||1||
59919642|NCT02525029|76039778|FG030|COMPLETED|Overall Study||2||
59919643|NCT02525029|76039779|FG031|COMPLETED|Overall Study||0||
59919644|NCT02525029|76039780|FG032|COMPLETED|Overall Study||3||
59919645|NCT02525029|76039781|FG033|COMPLETED|Overall Study||0||
59919646|NCT02525029|76039748|FG000|NOT COMPLETED|Overall Study||0||
59919647|NCT02525029|76039749|FG001|NOT COMPLETED|Overall Study||0||
59919648|NCT02525029|76039750|FG002|NOT COMPLETED|Overall Study||0||
59919649|NCT02525029|76039751|FG003|NOT COMPLETED|Overall Study||0||
60045881|NCT02214121|76161246|FG001|STARTED|Part B||17||
60045882|NCT02214121|76161247|FG002|STARTED|Part B||8||
60045883|NCT02214121|76161245|FG000|COMPLETED|Part B||0||
60045884|NCT02214121|76161246|FG001|COMPLETED|Part B||14||
60045885|NCT02214121|76161247|FG002|COMPLETED|Part B||7||
60045886|NCT02214121|76161245|FG000|NOT COMPLETED|Part B||0||
60045887|NCT02214121|76161246|FG001|NOT COMPLETED|Part B||3||
60045888|NCT02214121|76161247|FG002|NOT COMPLETED|Part B||1||
60045889|NCT01681186|76161275|FG000|STARTED|First Intervention||4||
60045890|NCT01681186|76161276|FG001|STARTED|First Intervention||2||
60045891|NCT01681186|76161277|FG002|STARTED|First Intervention||2||
60045892|NCT01681186|76161278|FG003|STARTED|First Intervention||3||
60045893|NCT01681186|76161279|FG004|STARTED|First Intervention||3||
60045894|NCT01681186|76161280|FG005|STARTED|First Intervention||2||
60045895|NCT01681186|76161281|FG006|STARTED|First Intervention||7||
60045896|NCT01681186|76161282|FG007|STARTED|First Intervention||7||
60045897|NCT01681186|76161275|FG000|COMPLETED|First Intervention||4||
60045898|NCT01681186|76161276|FG001|COMPLETED|First Intervention||2||
60045899|NCT01681186|76161277|FG002|COMPLETED|First Intervention||2||
60045900|NCT01681186|76161278|FG003|COMPLETED|First Intervention||3||
60045901|NCT01681186|76161279|FG004|COMPLETED|First Intervention||3||
60045902|NCT01681186|76161280|FG005|COMPLETED|First Intervention||2||
60045903|NCT01681186|76161281|FG006|COMPLETED|First Intervention||7||
60045904|NCT01681186|76161282|FG007|COMPLETED|First Intervention||7||
60045905|NCT01681186|76161275|FG000|NOT COMPLETED|First Intervention||0||
60045906|NCT01681186|76161276|FG001|NOT COMPLETED|First Intervention||0||
60045907|NCT01681186|76161277|FG002|NOT COMPLETED|First Intervention||0||
60045908|NCT01681186|76161278|FG003|NOT COMPLETED|First Intervention||0||
60045909|NCT01681186|76161279|FG004|NOT COMPLETED|First Intervention||0||
60045910|NCT01681186|76161280|FG005|NOT COMPLETED|First Intervention||0||
60045911|NCT01681186|76161281|FG006|NOT COMPLETED|First Intervention||0||
60045912|NCT01681186|76161282|FG007|NOT COMPLETED|First Intervention||0||
60045913|NCT01681186|76161275|FG000|STARTED|Washout Period From First Intervention||4||
60045914|NCT01681186|76161276|FG001|STARTED|Washout Period From First Intervention||2||
60045915|NCT01681186|76161277|FG002|STARTED|Washout Period From First Intervention||2||
60045916|NCT01681186|76161278|FG003|STARTED|Washout Period From First Intervention||3||
60045917|NCT01681186|76161279|FG004|STARTED|Washout Period From First Intervention||3||
60045918|NCT01681186|76161280|FG005|STARTED|Washout Period From First Intervention||2||
60045919|NCT01681186|76161281|FG006|STARTED|Washout Period From First Intervention||7||
60045920|NCT01681186|76161282|FG007|STARTED|Washout Period From First Intervention||7||
60045921|NCT01681186|76161275|FG000|COMPLETED|Washout Period From First Intervention||4||
60045922|NCT01681186|76161276|FG001|COMPLETED|Washout Period From First Intervention||2||
60045923|NCT01681186|76161277|FG002|COMPLETED|Washout Period From First Intervention||2||
60045924|NCT01681186|76161278|FG003|COMPLETED|Washout Period From First Intervention||3||
60045925|NCT01681186|76161279|FG004|COMPLETED|Washout Period From First Intervention||3||
60045926|NCT01681186|76161280|FG005|COMPLETED|Washout Period From First Intervention||2||
60045927|NCT01681186|76161281|FG006|COMPLETED|Washout Period From First Intervention||7||
60045928|NCT01681186|76161282|FG007|COMPLETED|Washout Period From First Intervention||7||
60045929|NCT01681186|76161275|FG000|NOT COMPLETED|Washout Period From First Intervention||0||
60045930|NCT01681186|76161276|FG001|NOT COMPLETED|Washout Period From First Intervention||0||
60045931|NCT01681186|76161277|FG002|NOT COMPLETED|Washout Period From First Intervention||0||
60045932|NCT01681186|76161278|FG003|NOT COMPLETED|Washout Period From First Intervention||0||
60045933|NCT01681186|76161279|FG004|NOT COMPLETED|Washout Period From First Intervention||0||
60045934|NCT01681186|76161280|FG005|NOT COMPLETED|Washout Period From First Intervention||0||
60045935|NCT01681186|76161281|FG006|NOT COMPLETED|Washout Period From First Intervention||0||
60045936|NCT01681186|76161282|FG007|NOT COMPLETED|Washout Period From First Intervention||0||
60045937|NCT01681186|76161275|FG000|STARTED|Second Intervention||4||
60045938|NCT01681186|76161276|FG001|STARTED|Second Intervention||2||
60045939|NCT01681186|76161277|FG002|STARTED|Second Intervention||2||
60045940|NCT01681186|76161278|FG003|STARTED|Second Intervention||3||
60045941|NCT01681186|76161279|FG004|STARTED|Second Intervention||3||
60045942|NCT01681186|76161280|FG005|STARTED|Second Intervention||2||
60045943|NCT01681186|76161281|FG006|STARTED|Second Intervention||7||
60045944|NCT01681186|76161282|FG007|STARTED|Second Intervention||7||
60045945|NCT01681186|76161275|FG000|COMPLETED|Second Intervention||4||
60045946|NCT01681186|76161276|FG001|COMPLETED|Second Intervention||2||
60045947|NCT01681186|76161277|FG002|COMPLETED|Second Intervention||2||
60045948|NCT01681186|76161278|FG003|COMPLETED|Second Intervention||3||
60045949|NCT01681186|76161279|FG004|COMPLETED|Second Intervention||3||
60045950|NCT01681186|76161280|FG005|COMPLETED|Second Intervention||2||
60045951|NCT01681186|76161281|FG006|COMPLETED|Second Intervention||7||
60045952|NCT01681186|76161282|FG007|COMPLETED|Second Intervention||7||
60045953|NCT01681186|76161275|FG000|NOT COMPLETED|Second Intervention||0||
60045954|NCT01681186|76161276|FG001|NOT COMPLETED|Second Intervention||0||
60045955|NCT01681186|76161277|FG002|NOT COMPLETED|Second Intervention||0||
60045956|NCT01681186|76161278|FG003|NOT COMPLETED|Second Intervention||0||
60045957|NCT01681186|76161279|FG004|NOT COMPLETED|Second Intervention||0||
60045958|NCT01681186|76161280|FG005|NOT COMPLETED|Second Intervention||0||
60045959|NCT01681186|76161281|FG006|NOT COMPLETED|Second Intervention||0||
60045960|NCT01681186|76161282|FG007|NOT COMPLETED|Second Intervention||0||
60045961|NCT01681186|76161275|FG000|STARTED|Washout Period From Second Intervention|Part A participants received only First Intervention and Second Intervention.|0||
60045962|NCT01681186|76161276|FG001|STARTED|Washout Period From Second Intervention|Part A participants received only First Intervention and Second Intervention.|0||
60045963|NCT01681186|76161277|FG002|STARTED|Washout Period From Second Intervention|Part A participants received only First Intervention and Second Intervention.|0||
60045964|NCT01681186|76161278|FG003|STARTED|Washout Period From Second Intervention|Part A participants received only First Intervention and Second Intervention.|0||
60045965|NCT01681186|76161279|FG004|STARTED|Washout Period From Second Intervention|Part A participants received only First Intervention and Second Intervention.|0||
60045966|NCT01681186|76161280|FG005|STARTED|Washout Period From Second Intervention|Part A participants received only First Intervention and Second Intervention.|0||
60045967|NCT01681186|76161281|FG006|STARTED|Washout Period From Second Intervention||7||
60045968|NCT01681186|76161282|FG007|STARTED|Washout Period From Second Intervention||7||
60045969|NCT01681186|76161275|FG000|COMPLETED|Washout Period From Second Intervention||0||
60045970|NCT01681186|76161276|FG001|COMPLETED|Washout Period From Second Intervention||0||
60045971|NCT01681186|76161277|FG002|COMPLETED|Washout Period From Second Intervention||0||
60045972|NCT01681186|76161278|FG003|COMPLETED|Washout Period From Second Intervention||0||
60045973|NCT01681186|76161279|FG004|COMPLETED|Washout Period From Second Intervention||0||
60045974|NCT01681186|76161280|FG005|COMPLETED|Washout Period From Second Intervention||0||
60045975|NCT01681186|76161281|FG006|COMPLETED|Washout Period From Second Intervention||6||
60067843|NCT01617967|76183031|FG002|NOT COMPLETED|Overall Study||0||
60045976|NCT01681186|76161282|FG007|COMPLETED|Washout Period From Second Intervention||6||
60045977|NCT01681186|76161275|FG000|NOT COMPLETED|Washout Period From Second Intervention||0||
60045978|NCT01681186|76161276|FG001|NOT COMPLETED|Washout Period From Second Intervention||0||
60045979|NCT01681186|76161277|FG002|NOT COMPLETED|Washout Period From Second Intervention||0||
60045980|NCT01681186|76161278|FG003|NOT COMPLETED|Washout Period From Second Intervention||0||
60045981|NCT01681186|76161279|FG004|NOT COMPLETED|Washout Period From Second Intervention||0||
59511844|NCT01046695|75605450|FG001|STARTED|Overall Study||22||
59511845|NCT01046695|75605449|FG000|COMPLETED|Overall Study||20||
59511846|NCT01046695|75605450|FG001|COMPLETED|Overall Study||20||
59511847|NCT01046695|75605449|FG000|NOT COMPLETED|Overall Study||0||
59511848|NCT01046695|75605450|FG001|NOT COMPLETED|Overall Study||2||
59511849|NCT02763124|75605456|FG000|STARTED|Overall Study||18||28
59511850|NCT02763124|75605456|FG000|COMPLETED|Overall Study||18||28
59511851|NCT02763124|75605456|FG000|NOT COMPLETED|Overall Study||0||0
59511852|NCT03304379|75605465|FG000|STARTED|Overall Study||308||
59511853|NCT03304379|75605466|FG001|STARTED|Overall Study||612||
59511854|NCT03304379|75605467|FG002|STARTED|Overall Study||612||
59511855|NCT03304379|75605468|FG003|STARTED|Overall Study||59||
59511856|NCT03304379|75605469|FG004|STARTED|Overall Study||59||
59511857|NCT03304379|75605465|FG000|Full Analysis Set (FAS)|Overall Study||308|FAS included all randomized participants excluding participants affected by the urgent safety measure and was based on the treatment allocated (as randomized)|
60045982|NCT01681186|76161280|FG005|NOT COMPLETED|Washout Period From Second Intervention||0||
60045983|NCT01681186|76161281|FG006|NOT COMPLETED|Washout Period From Second Intervention||1||
60045984|NCT01681186|76161282|FG007|NOT COMPLETED|Washout Period From Second Intervention||1||
60045985|NCT01681186|76161275|FG000|STARTED|Third Intervention||0||
60045986|NCT01681186|76161276|FG001|STARTED|Third Intervention||0||
60045987|NCT01681186|76161277|FG002|STARTED|Third Intervention||0||
60045988|NCT01681186|76161278|FG003|STARTED|Third Intervention||0||
60045989|NCT01681186|76161279|FG004|STARTED|Third Intervention||0||
60045990|NCT01681186|76161280|FG005|STARTED|Third Intervention||0||
60045991|NCT01681186|76161281|FG006|STARTED|Third Intervention||6||
60045992|NCT01681186|76161282|FG007|STARTED|Third Intervention||6||
60045993|NCT01681186|76161275|FG000|COMPLETED|Third Intervention||0||
60045994|NCT01681186|76161276|FG001|COMPLETED|Third Intervention||0||
60045995|NCT01681186|76161277|FG002|COMPLETED|Third Intervention||0||
60045996|NCT01681186|76161278|FG003|COMPLETED|Third Intervention||0||
60045997|NCT01681186|76161279|FG004|COMPLETED|Third Intervention||0||
60045998|NCT01681186|76161280|FG005|COMPLETED|Third Intervention||0||
60045999|NCT01681186|76161281|FG006|COMPLETED|Third Intervention||6||
60046000|NCT01681186|76161282|FG007|COMPLETED|Third Intervention||6||
60046001|NCT01681186|76161275|FG000|NOT COMPLETED|Third Intervention||0||
60046002|NCT01681186|76161276|FG001|NOT COMPLETED|Third Intervention||0||
60046003|NCT01681186|76161277|FG002|NOT COMPLETED|Third Intervention||0||
60046004|NCT01681186|76161278|FG003|NOT COMPLETED|Third Intervention||0||
60046005|NCT01681186|76161279|FG004|NOT COMPLETED|Third Intervention||0||
60046006|NCT01681186|76161280|FG005|NOT COMPLETED|Third Intervention||0||
60046007|NCT01681186|76161281|FG006|NOT COMPLETED|Third Intervention||0||
60046008|NCT01681186|76161282|FG007|NOT COMPLETED|Third Intervention||0||
60046009|NCT01681186|76161275|FG000|STARTED|Washout Period From Third Intervention||0||
60046010|NCT01681186|76161276|FG001|STARTED|Washout Period From Third Intervention||0||
60046011|NCT01681186|76161277|FG002|STARTED|Washout Period From Third Intervention||0||
60046012|NCT01681186|76161278|FG003|STARTED|Washout Period From Third Intervention||0||
60046013|NCT01681186|76161279|FG004|STARTED|Washout Period From Third Intervention||0||
60046014|NCT01681186|76161280|FG005|STARTED|Washout Period From Third Intervention||0||
60046015|NCT01681186|76161281|FG006|STARTED|Washout Period From Third Intervention||6||
59511858|NCT03304379|75605466|FG001|Full Analysis Set (FAS)|Overall Study||612|FAS included all randomized participants excluding participants affected by the urgent safety measure and was based on the treatment allocated (as randomized)|
59511859|NCT03304379|75605467|FG002|Full Analysis Set (FAS)|Overall Study||612|FAS included all randomized participants excluding participants affected by the urgent safety measure and was based on the treatment allocated (as randomized)|
59519087|NCT00939731|75612967|FG001|COMPLETED|First Intervention Period||12||
60046016|NCT01681186|76161282|FG007|STARTED|Washout Period From Third Intervention||6||
60046017|NCT01681186|76161275|FG000|COMPLETED|Washout Period From Third Intervention||0||
60046018|NCT01681186|76161276|FG001|COMPLETED|Washout Period From Third Intervention||0||
60046019|NCT01681186|76161277|FG002|COMPLETED|Washout Period From Third Intervention||0||
60046020|NCT01681186|76161278|FG003|COMPLETED|Washout Period From Third Intervention||0||
60046021|NCT01681186|76161279|FG004|COMPLETED|Washout Period From Third Intervention||0||
60046022|NCT01681186|76161280|FG005|COMPLETED|Washout Period From Third Intervention||0||
60046023|NCT01681186|76161281|FG006|COMPLETED|Washout Period From Third Intervention||5||
60046024|NCT01681186|76161282|FG007|COMPLETED|Washout Period From Third Intervention||6||
60046025|NCT01681186|76161275|FG000|NOT COMPLETED|Washout Period From Third Intervention||0||
60046026|NCT01681186|76161276|FG001|NOT COMPLETED|Washout Period From Third Intervention||0||
60046027|NCT01681186|76161277|FG002|NOT COMPLETED|Washout Period From Third Intervention||0||
60046028|NCT01681186|76161278|FG003|NOT COMPLETED|Washout Period From Third Intervention||0||
60046029|NCT01681186|76161279|FG004|NOT COMPLETED|Washout Period From Third Intervention||0||
60046030|NCT01681186|76161280|FG005|NOT COMPLETED|Washout Period From Third Intervention||0||
60046031|NCT01681186|76161281|FG006|NOT COMPLETED|Washout Period From Third Intervention||1||
60046032|NCT01681186|76161282|FG007|NOT COMPLETED|Washout Period From Third Intervention||0||
60046033|NCT01681186|76161275|FG000|STARTED|Fourth Intervention||0||
60046034|NCT01681186|76161276|FG001|STARTED|Fourth Intervention||0||
60046035|NCT01681186|76161277|FG002|STARTED|Fourth Intervention||0||
60046036|NCT01681186|76161278|FG003|STARTED|Fourth Intervention||0||
60046037|NCT01681186|76161279|FG004|STARTED|Fourth Intervention||0||
60046038|NCT01681186|76161280|FG005|STARTED|Fourth Intervention||0||
60046039|NCT01681186|76161281|FG006|STARTED|Fourth Intervention||5||
60046040|NCT01681186|76161282|FG007|STARTED|Fourth Intervention||6||
60046041|NCT01681186|76161275|FG000|COMPLETED|Fourth Intervention||0||
60046042|NCT01681186|76161276|FG001|COMPLETED|Fourth Intervention||0||
60046043|NCT01681186|76161277|FG002|COMPLETED|Fourth Intervention||0||
60046044|NCT01681186|76161278|FG003|COMPLETED|Fourth Intervention||0||
60046045|NCT01681186|76161279|FG004|COMPLETED|Fourth Intervention||0||
60046046|NCT01681186|76161280|FG005|COMPLETED|Fourth Intervention||0||
60046047|NCT01681186|76161281|FG006|COMPLETED|Fourth Intervention||5||
60046048|NCT01681186|76161282|FG007|COMPLETED|Fourth Intervention||5||
60046049|NCT01681186|76161275|FG000|NOT COMPLETED|Fourth Intervention||0||
60046050|NCT01681186|76161276|FG001|NOT COMPLETED|Fourth Intervention||0||
60046051|NCT01681186|76161277|FG002|NOT COMPLETED|Fourth Intervention||0||
60046052|NCT01681186|76161278|FG003|NOT COMPLETED|Fourth Intervention||0||
60046053|NCT01681186|76161279|FG004|NOT COMPLETED|Fourth Intervention||0||
60046054|NCT01681186|76161280|FG005|NOT COMPLETED|Fourth Intervention||0||
60046055|NCT01681186|76161281|FG006|NOT COMPLETED|Fourth Intervention||0||
60046056|NCT01681186|76161282|FG007|NOT COMPLETED|Fourth Intervention||1||
60046057|NCT03597464|76161314|FG000|STARTED|Overall Study||116||
60046058|NCT03597464|76161315|FG001|STARTED|Overall Study||100||
60046059|NCT03597464|76161314|FG000|COMPLETED|Overall Study||101||
60046060|NCT03597464|76161315|FG001|COMPLETED|Overall Study||85||
60046061|NCT03597464|76161314|FG000|NOT COMPLETED|Overall Study||15||
60046062|NCT03597464|76161315|FG001|NOT COMPLETED|Overall Study||15||
60046063|NCT01695772|76161323|FG000|STARTED|Overall Study||50||
60046064|NCT01695772|76161323|FG000|COMPLETED|Overall Study||12||
60046065|NCT01695772|76161323|FG000|NOT COMPLETED|Overall Study||38||
60046066|NCT02159521|76161327|FG000|STARTED|Overall Study|4 participants had both limbs treated.|81||85
59511860|NCT03304379|75605468|FG003|Full Analysis Set (FAS)|Overall Study||0|FAS included all randomized participants excluding participants affected by the urgent safety measure and was based on the treatment allocated (as randomized)|
59511861|NCT03304379|75605469|FG004|Full Analysis Set (FAS)|Overall Study||0|FAS included all randomized participants excluding participants affected by the urgent safety measure and was based on the treatment allocated (as randomized)|
59511862|NCT03304379|75605465|FG000|Safety Analysis Set (SAF)|Overall Study||309|SAF included all randomized participants from the FAS who received any study drug. It is based on the actual treatment received.|
59519034|NCT03593200|75612883|FG000|COMPLETED|Overall Study||4|All subjects transitioned to an open-label extension study after Day 364.|
60046067|NCT02159521|76161327|FG000|Received EkoSonic® Treatment|Overall Study||78||82
60046068|NCT02159521|76161327|FG000|COMPLETED|Overall Study||63||67
60046069|NCT02159521|76161327|FG000|NOT COMPLETED|Overall Study||18||18
60046070|NCT01636934|76161333|FG000|STARTED|Overall Study||25||
60046071|NCT01636934|76161334|FG001|STARTED|Overall Study||24||
60046072|NCT01636934|76161333|FG000|COMPLETED|Overall Study||19||
60046073|NCT01636934|76161334|FG001|COMPLETED|Overall Study||21||
60046074|NCT01636934|76161333|FG000|NOT COMPLETED|Overall Study||6||
60046075|NCT01636934|76161334|FG001|NOT COMPLETED|Overall Study||3||
60046076|NCT01712854|76161340|FG000|STARTED|Overall Study||9||
60046077|NCT01712854|76161340|FG000|COMPLETED|Overall Study||8||
60046078|NCT01712854|76161340|FG000|NOT COMPLETED|Overall Study||1||
60046079|NCT01693120|76161344|FG000|STARTED|Enrollment|70 subjects exited the study after consent, but prior to undergoing a study ablation procedure.|199||
60046080|NCT01693120|76161344|FG000|COMPLETED|Enrollment|129 of the 199 enrolled subjects underwent a Phased RF study procedure|129||
60046081|NCT01693120|76161344|FG000|NOT COMPLETED|Enrollment||70||
60046082|NCT01693120|76161344|FG000|STARTED|Phased RF Study Procedure and Follow-up||129||
60046083|NCT01693120|76161344|FG000|COMPLETED|Phased RF Study Procedure and Follow-up|112 of the 129 subjects with a Phased RF procedure completed the 6-month follow-up visit|112||
60046084|NCT01693120|76161344|FG000|NOT COMPLETED|Phased RF Study Procedure and Follow-up||17||
60046085|NCT02159365|76161348|FG000|STARTED|Overall Study||70||
60046086|NCT02159365|76161348|FG000|COMPLETED|Overall Study|Completed = Still on treatment|0||
60046087|NCT02159365|76161348|FG000|NOT COMPLETED|Overall Study||70||
60046088|NCT01712074|76161355|FG000|STARTED|Placebo Run-in Period||195||
60046089|NCT01712074|76161356|FG001|STARTED|Placebo Run-in Period||0||
60046090|NCT01712074|76161357|FG002|STARTED|Placebo Run-in Period||0||
60046091|NCT01712074|76161355|FG000|COMPLETED|Placebo Run-in Period||185||
60046092|NCT01712074|76161356|FG001|COMPLETED|Placebo Run-in Period||0||
60046093|NCT01712074|76161357|FG002|COMPLETED|Placebo Run-in Period||0||
60046094|NCT01712074|76161355|FG000|NOT COMPLETED|Placebo Run-in Period||10||
60046095|NCT01712074|76161356|FG001|NOT COMPLETED|Placebo Run-in Period||0||
60046096|NCT01712074|76161357|FG002|NOT COMPLETED|Placebo Run-in Period||0||
60046097|NCT01712074|76161355|FG000|STARTED|Double Blind Period||0||
60046098|NCT01712074|76161356|FG001|STARTED|Double Blind Period||91||
60046099|NCT01712074|76161357|FG002|STARTED|Double Blind Period||94||
60046100|NCT01712074|76161355|FG000|COMPLETED|Double Blind Period||0||
60046101|NCT01712074|76161356|FG001|COMPLETED|Double Blind Period||77||
60046102|NCT01712074|76161357|FG002|COMPLETED|Double Blind Period||86||
60046103|NCT01712074|76161355|FG000|NOT COMPLETED|Double Blind Period||0||
60046104|NCT01712074|76161356|FG001|NOT COMPLETED|Double Blind Period||14||
60046105|NCT01712074|76161357|FG002|NOT COMPLETED|Double Blind Period||8||
60046106|NCT01711216|76161372|FG000|STARTED|Overall Study||999||
59511863|NCT03304379|75605466|FG001|Safety Analysis Set (SAF)|Overall Study||609|SAF included all randomized participants from the FAS who received any study drug. It is based on the actual treatment received.|
59511864|NCT03304379|75605467|FG002|Safety Analysis Set (SAF)|Overall Study||609|SAF included all randomized participants from the FAS who received any study drug. It is based on the actual treatment received.|
59919650|NCT02525029|76039752|FG004|NOT COMPLETED|Overall Study||0||
59919651|NCT02525029|76039753|FG005|NOT COMPLETED|Overall Study||0||
59919652|NCT02525029|76039754|FG006|NOT COMPLETED|Overall Study||0||
59919653|NCT02525029|76039755|FG007|NOT COMPLETED|Overall Study||0||
59919654|NCT02525029|76039756|FG008|NOT COMPLETED|Overall Study||0||
59919655|NCT02525029|76039757|FG009|NOT COMPLETED|Overall Study||0||
59919656|NCT02525029|76039758|FG010|NOT COMPLETED|Overall Study||0||
59919657|NCT02525029|76039759|FG011|NOT COMPLETED|Overall Study||0||
59919658|NCT02525029|76039760|FG012|NOT COMPLETED|Overall Study||0||
59919659|NCT02525029|76039761|FG013|NOT COMPLETED|Overall Study||0||
59919660|NCT02525029|76039762|FG014|NOT COMPLETED|Overall Study||0||
59919661|NCT02525029|76039763|FG015|NOT COMPLETED|Overall Study||0||
59919662|NCT02525029|76039764|FG016|NOT COMPLETED|Overall Study||0||
59919663|NCT02525029|76039765|FG017|NOT COMPLETED|Overall Study||0||
59919664|NCT02525029|76039766|FG018|NOT COMPLETED|Overall Study||0||
59919665|NCT02525029|76039767|FG019|NOT COMPLETED|Overall Study||0||
59919666|NCT02525029|76039768|FG020|NOT COMPLETED|Overall Study||0||
59919667|NCT02525029|76039769|FG021|NOT COMPLETED|Overall Study||0||
59919668|NCT02525029|76039770|FG022|NOT COMPLETED|Overall Study||0||
59919669|NCT02525029|76039771|FG023|NOT COMPLETED|Overall Study||0||
59919670|NCT02525029|76039772|FG024|NOT COMPLETED|Overall Study||1||
60046107|NCT01711216|76161372|FG000|COMPLETED|Overall Study||782||
60046108|NCT01711216|76161372|FG000|NOT COMPLETED|Overall Study||217||
60046109|NCT02072200|76161376|FG000|STARTED|Overall Study||147||
59511865|NCT03304379|75605468|FG003|Safety Analysis Set (SAF)|Overall Study||0|SAF included all randomized participants from the FAS who received any study drug. It is based on the actual treatment received.|
59919671|NCT02525029|76039773|FG025|NOT COMPLETED|Overall Study||0||
59919672|NCT02525029|76039774|FG026|NOT COMPLETED|Overall Study||0||
59919673|NCT02525029|76039775|FG027|NOT COMPLETED|Overall Study||0||
59919674|NCT02525029|76039776|FG028|NOT COMPLETED|Overall Study||0||
59919675|NCT02525029|76039777|FG029|NOT COMPLETED|Overall Study||0||
59919676|NCT02525029|76039778|FG030|NOT COMPLETED|Overall Study||0||
59919677|NCT02525029|76039779|FG031|NOT COMPLETED|Overall Study||0||
59919678|NCT02525029|76039780|FG032|NOT COMPLETED|Overall Study||0||
59919679|NCT02525029|76039781|FG033|NOT COMPLETED|Overall Study||0||
59919680|NCT02408549|76039828|FG000|STARTED|Overall Study||239||
59919681|NCT02408549|76039828|FG000|COMPLETED|Overall Study||157||
59919682|NCT02408549|76039828|FG000|NOT COMPLETED|Overall Study||82||
59919683|NCT02242942|76039835|FG000|STARTED|Overall Study||216||
59919684|NCT02242942|76039836|FG001|STARTED|Overall Study||216||
59919685|NCT02242942|76039837|FG002|STARTED|Overall Study||13||
59919686|NCT02242942|76039835|FG000|Treated|Overall Study||214||
59919687|NCT02242942|76039836|FG001|Treated|Overall Study||212||
59919688|NCT02242942|76039837|FG002|Treated|Overall Study||13||
59919689|NCT02242942|76039835|FG000|COMPLETED|Overall Study||0||
59919690|NCT02242942|76039836|FG001|COMPLETED|Overall Study||0||
59919691|NCT02242942|76039837|FG002|COMPLETED|Overall Study||0||
59919692|NCT02242942|76039835|FG000|NOT COMPLETED|Overall Study||216||
59919693|NCT02242942|76039836|FG001|NOT COMPLETED|Overall Study||216||
59919694|NCT02242942|76039837|FG002|NOT COMPLETED|Overall Study||13||
60046110|NCT02072200|76161376|FG000|COMPLETED|Overall Study||145||
60046111|NCT02072200|76161376|FG000|NOT COMPLETED|Overall Study||2||
60046112|NCT01692730|76161382|FG000|STARTED|Overall Study||723||
60046113|NCT01692730|76161383|FG001|STARTED|Overall Study||729||
60046114|NCT01692730|76161382|FG000|COMPLETED|Overall Study||498||
60046115|NCT01692730|76161383|FG001|COMPLETED|Overall Study||502||
60046116|NCT01692730|76161382|FG000|NOT COMPLETED|Overall Study||225||
59511866|NCT03304379|75605469|FG004|Safety Analysis Set (SAF)|Overall Study||0|SAF included all randomized participants from the FAS who received any study drug. It is based on the actual treatment received.|
59511867|NCT03304379|75605465|FG000|Urgent Safety Measure Set (USMS)|Overall Study||0|USMS included all participants randomized to Fasinumab 3 mg Q4W or 6 mg Q8W and was based on the treatment allocated (as randomized)|
59511868|NCT03304379|75605466|FG001|Urgent Safety Measure Set (USMS)|Overall Study||0|USMS included all participants randomized to Fasinumab 3 mg Q4W or 6 mg Q8W and was based on the treatment allocated (as randomized)|
59511869|NCT03304379|75605467|FG002|Urgent Safety Measure Set (USMS)|Overall Study||0|USMS included all participants randomized to Fasinumab 3 mg Q4W or 6 mg Q8W and was based on the treatment allocated (as randomized)|
59511870|NCT03304379|75605468|FG003|Urgent Safety Measure Set (USMS)|Overall Study||59|USMS included all participants randomized to Fasinumab 3 mg Q4W or 6 mg Q8W and was based on the treatment allocated (as randomized)|
59511871|NCT03304379|75605469|FG004|Urgent Safety Measure Set (USMS)|Overall Study||59|USMS included all participants randomized to Fasinumab 3 mg Q4W or 6 mg Q8W and was based on the treatment allocated (as randomized)|
59511872|NCT03304379|75605465|FG000|Completed Treatment|Overall Study||218||
59511873|NCT03304379|75605466|FG001|Completed Treatment|Overall Study||436||
59511874|NCT03304379|75605467|FG002|Completed Treatment|Overall Study||454||
59511875|NCT03304379|75605468|FG003|Completed Treatment|Overall Study||0||
59511876|NCT03304379|75605469|FG004|Completed Treatment|Overall Study||0||
59511877|NCT03304379|75605465|FG000|COMPLETED|Overall Study||238||
59511878|NCT03304379|75605466|FG001|COMPLETED|Overall Study||471||
59511879|NCT03304379|75605467|FG002|COMPLETED|Overall Study||463||
59511880|NCT03304379|75605468|FG003|COMPLETED|Overall Study||42||
59511881|NCT03304379|75605469|FG004|COMPLETED|Overall Study||42||
59511882|NCT03304379|75605465|FG000|NOT COMPLETED|Overall Study||70||
59511883|NCT03304379|75605466|FG001|NOT COMPLETED|Overall Study||141||
59511884|NCT03304379|75605467|FG002|NOT COMPLETED|Overall Study||149||
59612496|NCT01701258|75723500|FG001|STARTED|EEG (Session 4)||19|Not all participants that were eligible or completed the MRI/PET completed the EEG.|
59612497|NCT01701258|75723501|FG002|STARTED|EEG (Session 4)||0|Not all participants that were eligible or completed the MRI/PET completed the EEG.|
59612498|NCT01701258|75723502|FG003|STARTED|EEG (Session 4)||0|Not all participants that were eligible or completed the MRI/PET completed the EEG.|
59612499|NCT01701258|75723503|FG004|STARTED|EEG (Session 4)||14|Not all participants that were eligible or completed the MRI/PET completed the EEG.|
59612500|NCT01701258|75723504|FG005|STARTED|EEG (Session 4)||0|Not all participants that were eligible or completed the MRI/PET completed the EEG.|
59612501|NCT01701258|75723505|FG006|STARTED|EEG (Session 4)||0|Not all participants that were eligible or completed the MRI/PET completed the EEG.|
59760012|NCT00825630|75879547|FG003|NOT COMPLETED|Overall Study||0||
59919695|NCT01837277|76039849|FG000|STARTED|Overall Study||92||
59919696|NCT01837277|76039850|FG001|STARTED|Overall Study||92||
59919697|NCT01837277|76039849|FG000|COMPLETED|Overall Study||70||
59919698|NCT01837277|76039850|FG001|COMPLETED|Overall Study||48||
59919699|NCT01837277|76039849|FG000|NOT COMPLETED|Overall Study||22||
59919700|NCT01837277|76039850|FG001|NOT COMPLETED|Overall Study||44||
59951217|NCT03783689|76070149|FG001|Per Protocol Set|Overall Study||16|Subjects who were consented, randomized, continued to meet eligibility criteria prior to undergoing Lead placement, were implanted with at least one Lead, reported coverage of comfortable sensations in the target areas during weeks 5 to 8 post-start of treatment (SOT), have adequate diary completion for each qualifying region of pain, and continued eligibility during weeks 1 to 8 post-SOT.|
59951218|NCT03783689|76070148|FG000|Group 2 (Control Group Treatment Crossover)|Overall Study||0|Subjects who were consented, randomized to Group 2 (Control), received sham stimulation treatment, and crossed over to receive active stimulation treatment.|
59951219|NCT03783689|76070149|FG001|Group 2 (Control Group Treatment Crossover)|Overall Study||9|Subjects who were consented, randomized to Group 2 (Control), received sham stimulation treatment, and crossed over to receive active stimulation treatment.|
59951220|NCT03783689|76070148|FG000|COMPLETED|Overall Study||10||
59951221|NCT03783689|76070149|FG001|COMPLETED|Overall Study||14||
59951222|NCT03783689|76070148|FG000|NOT COMPLETED|Overall Study||9||
59951223|NCT03783689|76070149|FG001|NOT COMPLETED|Overall Study||5||
59511885|NCT03304379|75605468|FG003|NOT COMPLETED|Overall Study||17||
59760013|NCT00900731|75879559|FG000|STARTED|Overall Study|Randomized participants|797||
59951224|NCT03771664|76070158|FG000|STARTED|Overall Study||43||
59951225|NCT03771664|76070159|FG001|STARTED|Overall Study||44||
60046117|NCT01692730|76161383|FG001|NOT COMPLETED|Overall Study||227||
60046118|NCT01691794|76161392|FG000|STARTED|Overall Study||3||
60046119|NCT01691794|76161393|FG001|STARTED|Overall Study||33||
60046120|NCT01691794|76161394|FG002|STARTED|Overall Study||23||
60046121|NCT01691794|76161392|FG000|COMPLETED|Overall Study|Completed baseline to End of Study|2||
60046122|NCT01691794|76161393|FG001|COMPLETED|Overall Study|Completed baseline to End of Study|15||
59951420|NCT01570868|76070405|FG001|COMPLETED|Overall Study||0||
60046123|NCT01691794|76161394|FG002|COMPLETED|Overall Study|Completed baseline to End of Study|13||
60046124|NCT01691794|76161392|FG000|NOT COMPLETED|Overall Study||1||
60046125|NCT01691794|76161393|FG001|NOT COMPLETED|Overall Study||18||
60046126|NCT01691794|76161394|FG002|NOT COMPLETED|Overall Study||10||
60046127|NCT01710514|76161404|FG000|STARTED|Overall Study||54||
60046128|NCT01710514|76161405|FG001|STARTED|Overall Study||54||
60046129|NCT01710514|76161404|FG000|Intent-To-Treat (ITT) Analysis Set|Overall Study|All randomised subjects were included in the Intent-To-Treat (ITT) analysis set.|54||
60046130|NCT01710514|76161405|FG001|Intent-To-Treat (ITT) Analysis Set|Overall Study|All randomised subjects were included in the ITT analysis set.|54||
60046131|NCT01710514|76161404|FG000|Full Analysis Set (FAS)|Overall Study|All randomised and exposed subjects with at least one completed primary efficacy assessment.|46||
60046132|NCT01710514|76161405|FG001|Full Analysis Set (FAS)|Overall Study|All randomised and exposed subjects with at least one completed primary efficacy assessment.|48||
60046133|NCT01710514|76161404|FG000|FAS With Embryo Transfer (ET)|Overall Study|Data on pregnancy was reported for the subjects with embryo transfer.|43||
60046134|NCT01710514|76161405|FG001|FAS With Embryo Transfer (ET)|Overall Study|Data on pregnancy was reported for the subjects with embryo transfer.|47||
60046135|NCT01710514|76161404|FG000|Safety Analysis Set|Overall Study|All subjects received at least one dose of Investigational Medicinal Product (IMP).|54||
60046136|NCT01710514|76161405|FG001|Safety Analysis Set|Overall Study|All subjects received at least one dose of IMP.|54||
59511886|NCT03304379|75605469|FG004|NOT COMPLETED|Overall Study||17||
60046137|NCT01710514|76161404|FG000|COMPLETED|Overall Study||47||
60046138|NCT01710514|76161405|FG001|COMPLETED|Overall Study||47||
60046139|NCT01710514|76161404|FG000|NOT COMPLETED|Overall Study||7||
60046140|NCT01710514|76161405|FG001|NOT COMPLETED|Overall Study||7||
60046141|NCT01592344|76161416|FG000|STARTED|Overall Study||45||
60046142|NCT01592344|76161417|FG001|STARTED|Overall Study||49||
60046143|NCT01592344|76161416|FG000|COMPLETED|Overall Study||41||
60046144|NCT01592344|76161417|FG001|COMPLETED|Overall Study||44||
60046145|NCT01592344|76161416|FG000|NOT COMPLETED|Overall Study||4||
60046146|NCT01592344|76161417|FG001|NOT COMPLETED|Overall Study||5||
60046147|NCT01636778|76161423|FG000|STARTED|Pre-Antiviral Treatment Period (Part 1)||45||
60046148|NCT01636778|76161424|FG001|STARTED|Pre-Antiviral Treatment Period (Part 1)||0||
60046149|NCT01636778|76161425|FG002|STARTED|Pre-Antiviral Treatment Period (Part 1)||0||
60046150|NCT01636778|76161423|FG000|COMPLETED|Pre-Antiviral Treatment Period (Part 1)||41||
60046151|NCT01636778|76161424|FG001|COMPLETED|Pre-Antiviral Treatment Period (Part 1)||0||
60046152|NCT01636778|76161425|FG002|COMPLETED|Pre-Antiviral Treatment Period (Part 1)||0||
60046153|NCT01636778|76161423|FG000|NOT COMPLETED|Pre-Antiviral Treatment Period (Part 1)||4||
60046154|NCT01636778|76161424|FG001|NOT COMPLETED|Pre-Antiviral Treatment Period (Part 1)||0||
60046155|NCT01636778|76161425|FG002|NOT COMPLETED|Pre-Antiviral Treatment Period (Part 1)||0||
60046156|NCT01636778|76161423|FG000|STARTED|Antiviral Treatment Period (Part 2)||0||
60046157|NCT01636778|76161424|FG001|STARTED|Antiviral Treatment Period (Part 2)||41||
60046158|NCT01636778|76161425|FG002|STARTED|Antiviral Treatment Period (Part 2)||0||
60046159|NCT01636778|76161423|FG000|COMPLETED|Antiviral Treatment Period (Part 2)||0||
60046160|NCT01636778|76161424|FG001|COMPLETED|Antiviral Treatment Period (Part 2)||31||
60046161|NCT01636778|76161425|FG002|COMPLETED|Antiviral Treatment Period (Part 2)||0||
60046162|NCT01636778|76161423|FG000|NOT COMPLETED|Antiviral Treatment Period (Part 2)||0||
60046163|NCT01636778|76161424|FG001|NOT COMPLETED|Antiviral Treatment Period (Part 2)||10||
60046164|NCT01636778|76161425|FG002|NOT COMPLETED|Antiviral Treatment Period (Part 2)||0||
60046165|NCT01636778|76161423|FG000|STARTED|Follow-up Period After Part 2||0||
60046166|NCT01636778|76161424|FG001|STARTED|Follow-up Period After Part 2||0||
60046167|NCT01636778|76161425|FG002|STARTED|Follow-up Period After Part 2||41||
60046168|NCT01636778|76161423|FG000|COMPLETED|Follow-up Period After Part 2||0||
60046169|NCT01636778|76161424|FG001|COMPLETED|Follow-up Period After Part 2||0||
60046170|NCT01636778|76161425|FG002|COMPLETED|Follow-up Period After Part 2||37||
60046171|NCT01636778|76161423|FG000|NOT COMPLETED|Follow-up Period After Part 2||0||
60046172|NCT01636778|76161424|FG001|NOT COMPLETED|Follow-up Period After Part 2||0||
60046173|NCT01636778|76161425|FG002|NOT COMPLETED|Follow-up Period After Part 2||4||
60046174|NCT02159053|76161436|FG000|STARTED|Overall Study||116||
60046175|NCT02159053|76161437|FG001|STARTED|Overall Study||117||
60046176|NCT02159053|76161438|FG002|STARTED|Overall Study||117||
60046177|NCT02159053|76161436|FG000|Paticipants Week 16 Onwards|Overall Study||116||
60046178|NCT02159053|76161437|FG001|Paticipants Week 16 Onwards|Overall Study||117||
60046179|NCT02159053|76161438|FG002|Paticipants Week 16 Onwards|Overall Study||113||
60046180|NCT02159053|76161436|FG000|COMPLETED|Overall Study||96||
60046181|NCT02159053|76161437|FG001|COMPLETED|Overall Study||96||
60046182|NCT02159053|76161438|FG002|COMPLETED|Overall Study||97||
60046183|NCT02159053|76161436|FG000|NOT COMPLETED|Overall Study||20||
60046184|NCT02159053|76161437|FG001|NOT COMPLETED|Overall Study||21||
60046185|NCT02159053|76161438|FG002|NOT COMPLETED|Overall Study||20||
60046186|NCT02158975|76161448|FG000|STARTED|Overall Study||13||
60046187|NCT02158975|76161448|FG000|COMPLETED|Overall Study||12||
60046188|NCT02158975|76161448|FG000|NOT COMPLETED|Overall Study||1||
60046189|NCT02158663|76161455|FG000|STARTED|Overall Study||22||
60046190|NCT02158663|76161456|FG001|STARTED|Overall Study||22||
60046191|NCT02158663|76161455|FG000|COMPLETED|Overall Study||17||
60046192|NCT02158663|76161456|FG001|COMPLETED|Overall Study||18||
60046193|NCT02158663|76161455|FG000|NOT COMPLETED|Overall Study||5||
60046194|NCT02158663|76161456|FG001|NOT COMPLETED|Overall Study||4||
60046195|NCT02158039|76161464|FG000|STARTED|Overall Study||33||
60046196|NCT02158039|76161464|FG000|COMPLETED|Overall Study||23||
60046197|NCT02158039|76161464|FG000|NOT COMPLETED|Overall Study||10||
60046198|NCT03563222|76161470|FG000|STARTED|Overall Study||1||
60046199|NCT03563222|76161471|FG001|STARTED|Overall Study||0||
60046200|NCT03563222|76161470|FG000|COMPLETED|Overall Study||1||
60046201|NCT03563222|76161471|FG001|COMPLETED|Overall Study||0||
60046202|NCT03563222|76161470|FG000|NOT COMPLETED|Overall Study||0||
60046203|NCT03563222|76161471|FG001|NOT COMPLETED|Overall Study||0||
60046204|NCT01635764|76161482|FG000|STARTED|Overall Study||508||
60046205|NCT01635764|76161482|FG000|COMPLETED|Overall Study||235||
60046206|NCT01635764|76161482|FG000|NOT COMPLETED|Overall Study||273||
60046207|NCT03432260|76161498|FG000|STARTED|Overall Study||4||
60046208|NCT03432260|76161499|FG001|STARTED|Overall Study||3||
60046209|NCT03432260|76161500|FG002|STARTED|Overall Study||4||
60046210|NCT03432260|76161501|FG003|STARTED|Overall Study||4||
60046211|NCT03432260|76161502|FG004|STARTED|Overall Study||4||
60046212|NCT03432260|76161498|FG000|COMPLETED|Overall Study||3||
60046213|NCT03432260|76161499|FG001|COMPLETED|Overall Study||2||
60046214|NCT03432260|76161500|FG002|COMPLETED|Overall Study||4||
60046215|NCT03432260|76161501|FG003|COMPLETED|Overall Study||4||
60046216|NCT03432260|76161502|FG004|COMPLETED|Overall Study||3||
60046217|NCT03432260|76161498|FG000|NOT COMPLETED|Overall Study||1||
60046218|NCT03432260|76161499|FG001|NOT COMPLETED|Overall Study||1||
60046219|NCT03432260|76161500|FG002|NOT COMPLETED|Overall Study||0||
60046220|NCT03432260|76161501|FG003|NOT COMPLETED|Overall Study||0||
60046221|NCT03432260|76161502|FG004|NOT COMPLETED|Overall Study||1||
60046222|NCT01634360|76161516|FG000|STARTED|Overall Study||49||
60046223|NCT01634360|76161517|FG001|STARTED|Overall Study||136||
60046224|NCT01634360|76161516|FG000|COMPLETED|Overall Study||0||
60046225|NCT01634360|76161517|FG001|COMPLETED|Overall Study||0||
60046226|NCT01634360|76161516|FG000|NOT COMPLETED|Overall Study||49||
60046227|NCT01634360|76161517|FG001|NOT COMPLETED|Overall Study||136||
60046228|NCT02158052|76161525|FG000|STARTED|Overall Study||1||
60046229|NCT02158052|76161526|FG001|STARTED|Overall Study||1||
60046230|NCT02158052|76161525|FG000|COMPLETED|Overall Study||1||
60046231|NCT02158052|76161526|FG001|COMPLETED|Overall Study||1||
60046232|NCT02158052|76161525|FG000|NOT COMPLETED|Overall Study||0||
60046233|NCT02158052|76161526|FG001|NOT COMPLETED|Overall Study||0||
60046234|NCT01635218|76161534|FG000|STARTED|Overall Study||44||
60046235|NCT01635218|76161535|FG001|STARTED|Overall Study||46||
60046236|NCT01635218|76161536|FG002|STARTED|Overall Study||43||
60046237|NCT01635218|76161534|FG000|COMPLETED|Overall Study||41||
60046238|NCT01635218|76161535|FG001|COMPLETED|Overall Study||39||
60046239|NCT01635218|76161536|FG002|COMPLETED|Overall Study||37||
60046240|NCT01635218|76161534|FG000|NOT COMPLETED|Overall Study||3||
60046241|NCT01635218|76161535|FG001|NOT COMPLETED|Overall Study||7||
60046242|NCT01635218|76161536|FG002|NOT COMPLETED|Overall Study||6||
60046243|NCT02049866|76161544|FG000|STARTED|Overall Study||33||
60046244|NCT02049866|76161544|FG000|COMPLETED|Overall Study||32||
60046245|NCT02049866|76161544|FG000|NOT COMPLETED|Overall Study||1||
60046246|NCT04307186|76161548|FG000|STARTED|Period 1 - Gadobutrol||57||
60046247|NCT04307186|76161548|FG000|COMPLETED|Period 1 - Gadobutrol||56||
60046248|NCT04307186|76161548|FG000|NOT COMPLETED|Period 1 - Gadobutrol||1||
60046249|NCT04307186|76161548|FG000|STARTED|Washout 3-14 Days||56||
60046250|NCT04307186|76161548|FG000|COMPLETED|Washout 3-14 Days||53||
60046251|NCT04307186|76161548|FG000|NOT COMPLETED|Washout 3-14 Days||3||
60046252|NCT04307186|76161548|FG000|STARTED|Period 2 - Gadoquatrane||53||
60046253|NCT04307186|76161548|FG000|COMPLETED|Period 2 - Gadoquatrane||52||
60046254|NCT04307186|76161548|FG000|NOT COMPLETED|Period 2 - Gadoquatrane||1||
60046255|NCT04274894|76161560|FG000|STARTED|Overall Study||246||
60046256|NCT04274894|76161560|FG000|COMPLETED|Overall Study||204||
60046257|NCT04274894|76161560|FG000|NOT COMPLETED|Overall Study||42||
60046258|NCT02213263|76161566|FG000|STARTED|Overall Study||198||
60046259|NCT02213263|76161567|FG001|STARTED|Overall Study||196||
60046260|NCT02213263|76161566|FG000|Treated|Overall Study||197||
60046261|NCT02213263|76161567|FG001|Treated|Overall Study||196||
60046262|NCT02213263|76161566|FG000|COMPLETED|Overall Study||170||
60046263|NCT02213263|76161567|FG001|COMPLETED|Overall Study||170||
60046264|NCT02213263|76161566|FG000|NOT COMPLETED|Overall Study||28||
60046265|NCT02213263|76161567|FG001|NOT COMPLETED|Overall Study||26||
60046266|NCT02211313|76161575|FG000|STARTED|Overall Study||18||
60046267|NCT02211313|76161576|FG001|STARTED|Overall Study||23||
60046268|NCT02211313|76161575|FG000|COMPLETED|Overall Study||12||
60046269|NCT02211313|76161576|FG001|COMPLETED|Overall Study||20||
60046270|NCT02211313|76161575|FG000|NOT COMPLETED|Overall Study||6||
60046271|NCT02211313|76161576|FG001|NOT COMPLETED|Overall Study||3||
60046272|NCT02210689|76161585|FG000|STARTED|Overall Study||242||
60046273|NCT02210689|76161586|FG001|STARTED|Overall Study||240||
60046274|NCT02210689|76161587|FG002|STARTED|Overall Study||122||
60046275|NCT02210689|76161585|FG000|Safety Population|Overall Study||233|Randomized participants who received the investigational product.|
60046276|NCT02210689|76161586|FG001|Safety Population|Overall Study||236|Randomized participants who received the investigational product.|
60046277|NCT02210689|76161587|FG002|Safety Population|Overall Study||122|Randomized participants who received the investigational product.|
60046278|NCT02210689|76161585|FG000|mITT Population|Overall Study||199|Randomized participants that applied the study dose, and returned for post-baseline evaluation visit|
60046279|NCT02210689|76161586|FG001|mITT Population|Overall Study||207|Randomized participants that applied the study dose, and returned for post-baseline evaluation visit|
60046280|NCT02210689|76161587|FG002|mITT Population|Overall Study||107|Randomized participants that applied the study dose, and returned for post-baseline evaluation visit|
60046281|NCT02210689|76161585|FG000|PP Population|Overall Study||164|Randomized subjects that were compliant with study treatment, and completed the study.|
60046282|NCT02210689|76161586|FG001|PP Population|Overall Study||169|Randomized subjects that were compliant with study treatment, and completed the study.|
60046283|NCT02210689|76161587|FG002|PP Population|Overall Study||84|Randomized subjects that were compliant with study treatment, and completed the study.|
60046284|NCT02210689|76161585|FG000|COMPLETED|Overall Study||190||
60046285|NCT02210689|76161586|FG001|COMPLETED|Overall Study||193||
60046286|NCT02210689|76161587|FG002|COMPLETED|Overall Study||99||
60046287|NCT02210689|76161585|FG000|NOT COMPLETED|Overall Study||52||
60046288|NCT02210689|76161586|FG001|NOT COMPLETED|Overall Study||47||
60046289|NCT02210689|76161587|FG002|NOT COMPLETED|Overall Study||23||
60046290|NCT02209597|76161595|FG000|STARTED|Phase 1 Current Tx (Non-randomized)||74||
60046291|NCT02209597|76161595|FG000|COMPLETED|Phase 1 Current Tx (Non-randomized)||71||
60046292|NCT02209597|76161595|FG000|NOT COMPLETED|Phase 1 Current Tx (Non-randomized)||3||
59919701|NCT01523002|76039858|FG000|STARTED|Period 1||26|Arm A: metaprolol (Day 1) Arm B: pyronaridine-artesunate (Days 1, 2 & 3)|
59919702|NCT01523002|76039859|FG001|STARTED|Period 1||30|Arm A: metaprolol (Day 1) Arm B: pyronaridine-artesunate (Days 1, 2 & 3)|
59919703|NCT01523002|76039858|FG000|COMPLETED|Period 1||24||
59919704|NCT01523002|76039859|FG001|COMPLETED|Period 1||19||
59919705|NCT01523002|76039858|FG000|NOT COMPLETED|Period 1||2||
59919706|NCT01523002|76039859|FG001|NOT COMPLETED|Period 1||11||
59919707|NCT01523002|76039858|FG000|STARTED|Period 2||24|Arm A: pyronaridine-artesunate (Days 8 & 9); pyronaridine-artesunate and metoprolol (Day 10) Arm B: pyronaridine-artesunate (Days 61, 62 & 63)|
59919708|NCT01523002|76039859|FG001|STARTED|Period 2||19|Arm A: pyronaridine-artesunate (Days 8 & 9); pyronaridine-artesunate and metoprolol (Day 10) Arm B: pyronaridine-artesunate (Days 61, 62 & 63)|
59919709|NCT01523002|76039858|FG000|COMPLETED|Period 2||18||
59919710|NCT01523002|76039859|FG001|COMPLETED|Period 2||13||
59919711|NCT01523002|76039858|FG000|NOT COMPLETED|Period 2||6||
59919712|NCT01523002|76039859|FG001|NOT COMPLETED|Period 2||6||
59919713|NCT01523002|76039858|FG000|STARTED|Period 3||18|Arm A: Pyronaridine-artesunate (Days 98, 99 & 100) Arm B: NA for study design|
59919714|NCT01523002|76039859|FG001|STARTED|Period 3|Arm B did not participate in Period 3|0|Arm A: Pyronaridine-artesunate (Days 98, 99 & 100) Arm B: NA for study design|
59919715|NCT01523002|76039858|FG000|COMPLETED|Period 3||14||
59919716|NCT01523002|76039859|FG001|COMPLETED|Period 3||0||
59919717|NCT01523002|76039858|FG000|NOT COMPLETED|Period 3||4||
59919718|NCT01523002|76039859|FG001|NOT COMPLETED|Period 3||0||
59919719|NCT00489307|76039867|FG000|STARTED|Overall Study||67||
59919720|NCT00489307|76039868|FG001|STARTED|Overall Study||65||
59919721|NCT00489307|76039867|FG000|COMPLETED|Overall Study||43||
59919722|NCT00489307|76039868|FG001|COMPLETED|Overall Study||41||
59919723|NCT00489307|76039867|FG000|NOT COMPLETED|Overall Study||24||
59919724|NCT00489307|76039868|FG001|NOT COMPLETED|Overall Study||24||
59919725|NCT03521141|76039877|FG000|STARTED|Overall Study||19||
59919726|NCT03521141|76039878|FG001|STARTED|Overall Study||19||
59919727|NCT03521141|76039879|FG002|STARTED|Overall Study||20||
59919728|NCT03521141|76039877|FG000|COMPLETED|Overall Study||18||
59919729|NCT03521141|76039878|FG001|COMPLETED|Overall Study||19||
59919730|NCT03521141|76039879|FG002|COMPLETED|Overall Study||19||
59919731|NCT03521141|76039877|FG000|NOT COMPLETED|Overall Study||1||
59919732|NCT03521141|76039878|FG001|NOT COMPLETED|Overall Study||0||
59919733|NCT03521141|76039879|FG002|NOT COMPLETED|Overall Study||1||
59919734|NCT02997176|76039891|FG000|STARTED|Overall Study||7||
59919735|NCT02997176|76039892|FG001|STARTED|Overall Study||10||
59919736|NCT02997176|76039893|FG002|STARTED|Overall Study||5||
59919737|NCT02997176|76039894|FG003|STARTED|Overall Study||16||
59919738|NCT02997176|76039891|FG000|COMPLETED|Overall Study||6||
59919739|NCT02997176|76039892|FG001|COMPLETED|Overall Study||8||
59919740|NCT02997176|76039893|FG002|COMPLETED|Overall Study||3||
59919741|NCT02997176|76039894|FG003|COMPLETED|Overall Study||5||
59919742|NCT02997176|76039891|FG000|NOT COMPLETED|Overall Study||1||
59919743|NCT02997176|76039892|FG001|NOT COMPLETED|Overall Study||2||
59919744|NCT02997176|76039893|FG002|NOT COMPLETED|Overall Study||2||
59919745|NCT02997176|76039894|FG003|NOT COMPLETED|Overall Study||11||
59919746|NCT03000452|76039904|FG000|STARTED|Treatment Period||18||
59919747|NCT03000452|76039904|FG000|COMPLETED|Treatment Period||0||
59919748|NCT03000452|76039904|FG000|NOT COMPLETED|Treatment Period||18||
59951421|NCT01570868|76070404|FG000|NOT COMPLETED|Overall Study||43||
60046293|NCT02209597|76161595|FG000|STARTED|Phase 2 (Randomized: 1 Brand, 3 Generic)||71||
60046294|NCT02209597|76161595|FG000|COMPLETED|Phase 2 (Randomized: 1 Brand, 3 Generic)||67||
60046295|NCT02209597|76161595|FG000|NOT COMPLETED|Phase 2 (Randomized: 1 Brand, 3 Generic)||4||
60046296|NCT02209597|76161595|FG000|STARTED|Phase 3 (Randomized: 1 Brand, 3 Generic)||67||
60046297|NCT02209597|76161595|FG000|COMPLETED|Phase 3 (Randomized: 1 Brand, 3 Generic)||67||
60046298|NCT02209597|76161595|FG000|NOT COMPLETED|Phase 3 (Randomized: 1 Brand, 3 Generic)||0||
60046299|NCT02209597|76161595|FG000|STARTED|Phase 4 (Randomized: 1 Brand, 3 Generic)||67||
60046300|NCT02209597|76161595|FG000|COMPLETED|Phase 4 (Randomized: 1 Brand, 3 Generic)||67||
60046301|NCT02209597|76161595|FG000|NOT COMPLETED|Phase 4 (Randomized: 1 Brand, 3 Generic)||0||
60046302|NCT01469156|76161607|FG000|STARTED|Overall Study||15||
60046303|NCT01469156|76161608|FG001|STARTED|Overall Study||5||
60046304|NCT01469156|76161607|FG000|COMPLETED|Overall Study||15||
60046305|NCT01469156|76161608|FG001|COMPLETED|Overall Study||5||
60046306|NCT01469156|76161607|FG000|NOT COMPLETED|Overall Study||0||
60046307|NCT01469156|76161608|FG001|NOT COMPLETED|Overall Study||0||
60046308|NCT02188303|76161624|FG000|STARTED|Overall Study||6||
60046309|NCT02188303|76161625|FG001|STARTED|Overall Study||6||
60046310|NCT02188303|76161626|FG002|STARTED|Overall Study||6||
60046311|NCT02188303|76161627|FG003|STARTED|Overall Study||6||
60046312|NCT02188303|76161628|FG004|STARTED|Overall Study||4||
60046313|NCT02188303|76161629|FG005|STARTED|Overall Study||12||
60046314|NCT02188303|76161630|FG006|STARTED|Overall Study||2||
60046315|NCT02188303|76161631|FG007|STARTED|Overall Study||6||
60046316|NCT02188303|76161624|FG000|COMPLETED|Overall Study||6||
60046317|NCT02188303|76161625|FG001|COMPLETED|Overall Study||6||
60046318|NCT02188303|76161626|FG002|COMPLETED|Overall Study||6||
60046319|NCT02188303|76161627|FG003|COMPLETED|Overall Study||6||
60046320|NCT02188303|76161628|FG004|COMPLETED|Overall Study||4||
60046321|NCT02188303|76161629|FG005|COMPLETED|Overall Study||10||
60046322|NCT02188303|76161630|FG006|COMPLETED|Overall Study|Protocol-defined dose termination criteria met, dosing stopped on Day 5 and study was terminated.|0||
60046323|NCT02188303|76161631|FG007|COMPLETED|Overall Study|Protocol-defined dose termination criteria met, dosing stopped on Day 5 and study was terminated.|0||
60046324|NCT02188303|76161624|FG000|NOT COMPLETED|Overall Study||0||
60046325|NCT02188303|76161625|FG001|NOT COMPLETED|Overall Study||0||
60046326|NCT02188303|76161626|FG002|NOT COMPLETED|Overall Study||0||
60046327|NCT02188303|76161627|FG003|NOT COMPLETED|Overall Study||0||
60046328|NCT02188303|76161628|FG004|NOT COMPLETED|Overall Study||0||
60046329|NCT02188303|76161629|FG005|NOT COMPLETED|Overall Study||2||
60046330|NCT02188303|76161630|FG006|NOT COMPLETED|Overall Study||2||
60046331|NCT02188303|76161631|FG007|NOT COMPLETED|Overall Study||6||
60046332|NCT04867382|76161657|FG000|STARTED|Overall Study||48||
60046333|NCT04867382|76161658|FG001|STARTED|Overall Study||40||
60046334|NCT04867382|76161657|FG000|Completed Stigma Reduction (Intervention) or Attention-control (Comparison) Training|Overall Study||48||
60046335|NCT04867382|76161658|FG001|Completed Stigma Reduction (Intervention) or Attention-control (Comparison) Training|Overall Study||40||
60046336|NCT04867382|76161657|FG000|COMPLETED|Overall Study||46|Primary analysis conducted with data from those who completed survey immediately following the online training.|
60046337|NCT04867382|76161658|FG001|COMPLETED|Overall Study||39|Primary analysis conducted with data from those who completed survey immediately following the online training.|
60046338|NCT04867382|76161657|FG000|NOT COMPLETED|Overall Study||2||
60046339|NCT04867382|76161658|FG001|NOT COMPLETED|Overall Study||1||
60046340|NCT02187055|76161667|FG000|STARTED|Overall Study|Treated|384||
60046341|NCT02187055|76161668|FG001|STARTED|Overall Study|Treated|376||
60046342|NCT02187055|76161669|FG002|STARTED|Overall Study|Treated|386||
60046343|NCT02187055|76161667|FG000|COMPLETED|Overall Study||315||
60046344|NCT02187055|76161668|FG001|COMPLETED|Overall Study||303||
60046345|NCT02187055|76161669|FG002|COMPLETED|Overall Study||312||
60046346|NCT02187055|76161667|FG000|NOT COMPLETED|Overall Study||69||
60046347|NCT02187055|76161668|FG001|NOT COMPLETED|Overall Study||73||
60046348|NCT02187055|76161669|FG002|NOT COMPLETED|Overall Study||74||
60046349|NCT00119366|76161682|FG000|STARTED|Overall Study||1||
60046350|NCT00119366|76161683|FG001|STARTED|Overall Study||2||
60046351|NCT00119366|76161684|FG002|STARTED|Overall Study||3||
60046352|NCT00119366|76161685|FG003|STARTED|Overall Study||2||
60046353|NCT00119366|76161686|FG004|STARTED|Overall Study||8||
60046354|NCT00119366|76161682|FG000|COMPLETED|Overall Study||1||
60046355|NCT00119366|76161683|FG001|COMPLETED|Overall Study||2||
60046356|NCT00119366|76161684|FG002|COMPLETED|Overall Study||3||
60046357|NCT00119366|76161685|FG003|COMPLETED|Overall Study||2||
60046358|NCT00119366|76161686|FG004|COMPLETED|Overall Study||8||
60046359|NCT00119366|76161682|FG000|NOT COMPLETED|Overall Study||0||
60046360|NCT00119366|76161683|FG001|NOT COMPLETED|Overall Study||0||
60046361|NCT00119366|76161684|FG002|NOT COMPLETED|Overall Study||0||
60046362|NCT00119366|76161685|FG003|NOT COMPLETED|Overall Study||0||
60046363|NCT00119366|76161686|FG004|NOT COMPLETED|Overall Study||0||
60046364|NCT02246660|76161709|FG000|STARTED|Overall Study||23||
60046365|NCT02246660|76161710|FG001|STARTED|Overall Study||21||
60046366|NCT02246660|76161711|FG002|STARTED|Overall Study||22||
60046367|NCT02246660|76161709|FG000|COMPLETED|Overall Study||23||
60046368|NCT02246660|76161710|FG001|COMPLETED|Overall Study||20||
60046369|NCT02246660|76161711|FG002|COMPLETED|Overall Study||21||
60046370|NCT02246660|76161709|FG000|NOT COMPLETED|Overall Study||0||
60046371|NCT02246660|76161710|FG001|NOT COMPLETED|Overall Study||1||
60046372|NCT02246660|76161711|FG002|NOT COMPLETED|Overall Study||1||
60046373|NCT02246582|76161719|FG000|STARTED|Overall Study||44||
60046374|NCT02246582|76161720|FG001|STARTED|Overall Study||45||
60046375|NCT02246582|76161719|FG000|COMPLETED|Overall Study||41||
60046376|NCT02246582|76161720|FG001|COMPLETED|Overall Study||41||
60046377|NCT02246582|76161719|FG000|NOT COMPLETED|Overall Study||3||
60046378|NCT02246582|76161720|FG001|NOT COMPLETED|Overall Study||4||
60046379|NCT02137369|76161726|FG000|STARTED|Overall Study||49||
60046380|NCT02137369|76161727|FG001|STARTED|Overall Study||11||
60046381|NCT02137369|76161726|FG000|COMPLETED|Overall Study||41||
60046382|NCT02137369|76161727|FG001|COMPLETED|Overall Study||9||
60046383|NCT02137369|76161726|FG000|NOT COMPLETED|Overall Study||8||
60046384|NCT02137369|76161727|FG001|NOT COMPLETED|Overall Study||2||
60046385|NCT02155309|76161736|FG000|STARTED|Overall Study||13||
60046386|NCT02155309|76161737|FG001|STARTED|Overall Study||10||
60046387|NCT02155309|76161738|FG002|STARTED|Overall Study||13||
60046388|NCT02155309|76161736|FG000|COMPLETED|Overall Study||13||
59511887|NCT00915967|75605485|FG000|STARTED|Overall Study||98||
59511888|NCT00915967|75605486|FG001|STARTED|Overall Study||100||
59511889|NCT00915967|75605485|FG000|COMPLETED|Overall Study||97||
59511890|NCT00915967|75605486|FG001|COMPLETED|Overall Study||98||
59511891|NCT00915967|75605485|FG000|NOT COMPLETED|Overall Study||1||
59511892|NCT00915967|75605486|FG001|NOT COMPLETED|Overall Study||2||
59511893|NCT02763826|75605499|FG000|STARTED|Part 1 Dose Escalation, 1 mA||3||
60046389|NCT02155309|76161737|FG001|COMPLETED|Overall Study||10||
59511894|NCT02763826|75605500|FG001|STARTED|Part 1 Dose Escalation, 1 mA||0||
59511895|NCT02763826|75605501|FG002|STARTED|Part 1 Dose Escalation, 1 mA||0||
59511896|NCT02763826|75605502|FG003|STARTED|Part 1 Dose Escalation, 1 mA||0||
59511897|NCT02763826|75605503|FG004|STARTED|Part 1 Dose Escalation, 1 mA||0||
60046390|NCT02155309|76161738|FG002|COMPLETED|Overall Study||12||
60046391|NCT02155309|76161736|FG000|NOT COMPLETED|Overall Study||0||
60046392|NCT02155309|76161737|FG001|NOT COMPLETED|Overall Study||0||
60046393|NCT02155309|76161738|FG002|NOT COMPLETED|Overall Study||1||
60046394|NCT02186821|76161745|FG000|STARTED|Overall Study||47||
60046395|NCT02186821|76161745|FG000|COMPLETED|Overall Study||0||
60046396|NCT02186821|76161745|FG000|NOT COMPLETED|Overall Study||47||
60046397|NCT01710358|76161752|FG000|STARTED|Treatment Period Part A (Weeks 0 to 24)||489||
60046398|NCT01710358|76161753|FG001|STARTED|Treatment Period Part A (Weeks 0 to 24)||488||
60046399|NCT01710358|76161754|FG002|STARTED|Treatment Period Part A (Weeks 0 to 24)||330||
60046400|NCT01710358|76161752|FG000|Received at Least 1 Dose of Study Drug|Treatment Period Part A (Weeks 0 to 24)||488||
60046401|NCT01710358|76161753|FG001|Received at Least 1 Dose of Study Drug|Treatment Period Part A (Weeks 0 to 24)||487||
60046402|NCT01710358|76161754|FG002|Received at Least 1 Dose of Study Drug|Treatment Period Part A (Weeks 0 to 24)||330||
60046403|NCT01710358|76161752|FG000|Rescued|Treatment Period Part A (Weeks 0 to 24)||128||
60046404|NCT01710358|76161753|FG001|Rescued|Treatment Period Part A (Weeks 0 to 24)||35||
60046405|NCT01710358|76161754|FG002|Rescued|Treatment Period Part A (Weeks 0 to 24)||40||
60046406|NCT01710358|76161752|FG000|COMPLETED|Treatment Period Part A (Weeks 0 to 24)|Includes all participants rescued during Part A.|438||
60046407|NCT01710358|76161753|FG001|COMPLETED|Treatment Period Part A (Weeks 0 to 24)|Includes all participants rescued during Part A.|459||
60046408|NCT01710358|76161754|FG002|COMPLETED|Treatment Period Part A (Weeks 0 to 24)|Includes all participants rescued during Part A.|307||
60046409|NCT01710358|76161752|FG000|NOT COMPLETED|Treatment Period Part A (Weeks 0 to 24)||51||
60046410|NCT01710358|76161753|FG001|NOT COMPLETED|Treatment Period Part A (Weeks 0 to 24)||29||
60046411|NCT01710358|76161754|FG002|NOT COMPLETED|Treatment Period Part A (Weeks 0 to 24)||23||
60046412|NCT01710358|76161752|FG000|STARTED|Treatment Period Part B (Weeks 24 to 52)|Excludes participants rescued during Part A.|310||
60046413|NCT01710358|76161753|FG001|STARTED|Treatment Period Part B (Weeks 24 to 52)|Excludes participants rescued during Part A.|424||
60046414|NCT01710358|76161754|FG002|STARTED|Treatment Period Part B (Weeks 24 to 52)|Excludes participants rescued during Part A.|267||
60046415|NCT01710358|76161752|FG000|Received at Least 1 Dose of Study Drug|Treatment Period Part B (Weeks 24 to 52)|Participants originally randomized to placebo received baricitinib during Part B.|306||
60046416|NCT01710358|76161753|FG001|Received at Least 1 Dose of Study Drug|Treatment Period Part B (Weeks 24 to 52)||424||
60046417|NCT01710358|76161754|FG002|Received at Least 1 Dose of Study Drug|Treatment Period Part B (Weeks 24 to 52)||267||
60046418|NCT01710358|76161752|FG000|Rescued|Treatment Period Part B (Weeks 24 to 52)||5||
60046419|NCT01710358|76161753|FG001|Rescued|Treatment Period Part B (Weeks 24 to 52)||8||
60046420|NCT01710358|76161754|FG002|Rescued|Treatment Period Part B (Weeks 24 to 52)||11||
59511898|NCT02763826|75605504|FG005|STARTED|Part 1 Dose Escalation, 1 mA||0||
59511899|NCT02763826|75605505|FG006|STARTED|Part 1 Dose Escalation, 1 mA||0||
60046421|NCT01710358|76161752|FG000|COMPLETED|Treatment Period Part B (Weeks 24 to 52)|Includes all participants rescued during Part B.|294||
60046422|NCT01710358|76161753|FG001|COMPLETED|Treatment Period Part B (Weeks 24 to 52)|Includes all participants rescued during Part B.|402||
60046423|NCT01710358|76161754|FG002|COMPLETED|Treatment Period Part B (Weeks 24 to 52)|Includes all participants rescued during Part B.|252||
60046424|NCT01710358|76161752|FG000|NOT COMPLETED|Treatment Period Part B (Weeks 24 to 52)||16||
60046425|NCT01710358|76161753|FG001|NOT COMPLETED|Treatment Period Part B (Weeks 24 to 52)||22||
60046426|NCT01710358|76161754|FG002|NOT COMPLETED|Treatment Period Part B (Weeks 24 to 52)||15||
60046427|NCT01710358|76161752|FG000|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0||
60046428|NCT01710358|76161753|FG001|STARTED|Rescue Period|Baricitinib 4 mg administered PO QD through Week 52. Participants continued background MTX therapy.|227||
60046429|NCT01710358|76161754|FG002|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0||
60046430|NCT01710358|76161752|FG000|COMPLETED|Rescue Period||0||
60046431|NCT01710358|76161753|FG001|COMPLETED|Rescue Period||196||
60046432|NCT01710358|76161754|FG002|COMPLETED|Rescue Period||0||
60046433|NCT01710358|76161752|FG000|NOT COMPLETED|Rescue Period||0||
60046434|NCT01710358|76161753|FG001|NOT COMPLETED|Rescue Period||31||
60046435|NCT01710358|76161754|FG002|NOT COMPLETED|Rescue Period||0||
60046436|NCT01710358|76161752|FG000|STARTED|Follow-up Period|Participants from treatment who entered the post-treatment follow-up period.|33||
60046437|NCT01710358|76161753|FG001|STARTED|Follow-up Period|Rescued participants who entered post-treatment follow-up are included in Baricitinib 4mg follow up.|76||
60046438|NCT01710358|76161754|FG002|STARTED|Follow-up Period|Participants from treatment who entered the post-treatment follow-up period.|20||
60046439|NCT01710358|76161752|FG000|COMPLETED|Follow-up Period||33||
60046440|NCT01710358|76161753|FG001|COMPLETED|Follow-up Period||76||
60046441|NCT01710358|76161754|FG002|COMPLETED|Follow-up Period||20||
60046442|NCT01710358|76161752|FG000|NOT COMPLETED|Follow-up Period||0||
60046443|NCT01710358|76161753|FG001|NOT COMPLETED|Follow-up Period||0||
60046444|NCT01710358|76161754|FG002|NOT COMPLETED|Follow-up Period||0||
60046445|NCT01633112|76161778|FG000|STARTED|Overall Study||352||
60046446|NCT01633112|76161779|FG001|STARTED|Overall Study||370||
60046447|NCT01633112|76161780|FG002|STARTED|Overall Study||342||
60046448|NCT01633112|76161778|FG000|COMPLETED|Overall Study||299||
60046449|NCT01633112|76161779|FG001|COMPLETED|Overall Study||310||
60046450|NCT01633112|76161780|FG002|COMPLETED|Overall Study||250||
60046451|NCT01633112|76161778|FG000|NOT COMPLETED|Overall Study||53||
60046452|NCT01633112|76161779|FG001|NOT COMPLETED|Overall Study||60||
60046453|NCT01633112|76161780|FG002|NOT COMPLETED|Overall Study||92||
60046454|NCT01691482|76161789|FG000|STARTED|Treatment Period 1||28||
60046455|NCT01691482|76161790|FG001|STARTED|Treatment Period 1||28||
60046456|NCT01691482|76161789|FG000|COMPLETED|Treatment Period 1||28||
60046457|NCT01691482|76161790|FG001|COMPLETED|Treatment Period 1||28||
60046458|NCT01691482|76161789|FG000|NOT COMPLETED|Treatment Period 1||0||
60046459|NCT01691482|76161790|FG001|NOT COMPLETED|Treatment Period 1||0||
60046460|NCT01691482|76161789|FG000|STARTED|Treatment Period 2||28||
60046461|NCT01691482|76161790|FG001|STARTED|Treatment Period 2||28||
60046462|NCT01691482|76161789|FG000|COMPLETED|Treatment Period 2||27||
60046463|NCT01691482|76161790|FG001|COMPLETED|Treatment Period 2||26||
60046464|NCT01691482|76161789|FG000|NOT COMPLETED|Treatment Period 2||1||
60046465|NCT01691482|76161790|FG001|NOT COMPLETED|Treatment Period 2||2||
60046466|NCT02246114|76161799|FG000|STARTED|Overall Study||1||
60046467|NCT02246114|76161800|FG001|STARTED|Overall Study||0||
60046468|NCT02246114|76161799|FG000|COMPLETED|Overall Study||0||
60046469|NCT02246114|76161800|FG001|COMPLETED|Overall Study||0||
60046470|NCT02246114|76161799|FG000|NOT COMPLETED|Overall Study||1||
60046471|NCT02246114|76161800|FG001|NOT COMPLETED|Overall Study||0||
60046472|NCT01710046|76161808|FG000|STARTED|Overall Study||9||
60046473|NCT01710046|76161809|FG001|STARTED|Overall Study||3||
60046474|NCT01710046|76161808|FG000|COMPLETED|Overall Study||8||
60046475|NCT01710046|76161809|FG001|COMPLETED|Overall Study||3||
60046476|NCT01710046|76161808|FG000|NOT COMPLETED|Overall Study||1||
60046477|NCT01710046|76161809|FG001|NOT COMPLETED|Overall Study||0||
60046478|NCT02154529|76161819|FG000|STARTED|Overall Study||4||
60046479|NCT02154529|76161820|FG001|STARTED|Overall Study||3||
60046480|NCT02154529|76161821|FG002|STARTED|Overall Study||8||
60046481|NCT02154529|76161822|FG003|STARTED|Overall Study||2||
60046482|NCT02154529|76161819|FG000|COMPLETED|Overall Study|Study terminated by sponsor|0||
60046483|NCT02154529|76161820|FG001|COMPLETED|Overall Study|Study terminated by sponsor|0||
60046484|NCT02154529|76161821|FG002|COMPLETED|Overall Study|Study terminated by sponsor|0||
60046485|NCT02154529|76161822|FG003|COMPLETED|Overall Study|Study terminated by sponsor|0||
60046486|NCT02154529|76161819|FG000|NOT COMPLETED|Overall Study||4||
60046487|NCT02154529|76161820|FG001|NOT COMPLETED|Overall Study||3||
60046488|NCT02154529|76161821|FG002|NOT COMPLETED|Overall Study||8||
60046489|NCT02154529|76161822|FG003|NOT COMPLETED|Overall Study||2||
60046490|NCT01954017|76161837|FG000|STARTED|Overall Study||36||
60046491|NCT01954017|76161838|FG001|STARTED|Overall Study||33||
60046492|NCT01954017|76161839|FG002|STARTED|Overall Study||34||
60046493|NCT01954017|76161837|FG000|COMPLETED|Overall Study||31||
60046494|NCT01954017|76161838|FG001|COMPLETED|Overall Study||25||
60046495|NCT01954017|76161839|FG002|COMPLETED|Overall Study||21||
60046496|NCT01954017|76161837|FG000|NOT COMPLETED|Overall Study||5||
60046497|NCT01954017|76161838|FG001|NOT COMPLETED|Overall Study||8||
60046498|NCT01954017|76161839|FG002|NOT COMPLETED|Overall Study||13||
60046499|NCT02154139|76161873|FG000|STARTED|Overall Study||651||
60046500|NCT02154139|76161873|FG000|COMPLETED|Overall Study||644||
60046501|NCT02154139|76161873|FG000|NOT COMPLETED|Overall Study||7||
60046502|NCT02245568|76161877|FG000|STARTED|Overall Study||913||
60046503|NCT02245568|76161877|FG000|COMPLETED|Overall Study||60||
60046504|NCT02245568|76161877|FG000|NOT COMPLETED|Overall Study||853||
60046505|NCT02154061|76161883|FG000|STARTED|Overall Study||16||
60046506|NCT02154061|76161884|FG001|STARTED|Overall Study||17||
60046507|NCT02154061|76161883|FG000|COMPLETED|Overall Study||14||
60046508|NCT02154061|76161884|FG001|COMPLETED|Overall Study||17||
60046509|NCT02154061|76161883|FG000|NOT COMPLETED|Overall Study||2||
60046510|NCT02154061|76161884|FG001|NOT COMPLETED|Overall Study||0||
60046511|NCT01907217|76161892|FG000|STARTED|Overall Study||69||
60046512|NCT01907217|76161893|FG001|STARTED|Overall Study||69||
60046513|NCT01907217|76161892|FG000|COMPLETED|Overall Study||69||
60046514|NCT01907217|76161893|FG001|COMPLETED|Overall Study||67||
60046515|NCT01907217|76161892|FG000|NOT COMPLETED|Overall Study||0||
60046516|NCT01907217|76161893|FG001|NOT COMPLETED|Overall Study||2||
60046517|NCT01953783|76161901|FG000|STARTED|Overall Study||7||
60046518|NCT01953783|76161901|FG000|COMPLETED|Overall Study||5||
60046519|NCT01953783|76161901|FG000|NOT COMPLETED|Overall Study||2||
60046520|NCT02134015|76161907|FG000|STARTED|Overall Study||71||
60046521|NCT02134015|76161908|FG001|STARTED|Overall Study||74||
60046522|NCT02134015|76161907|FG000|COMPLETED|Overall Study||0||
60046523|NCT02134015|76161908|FG001|COMPLETED|Overall Study||0||
60046524|NCT02134015|76161907|FG000|NOT COMPLETED|Overall Study||71||
60046525|NCT02134015|76161908|FG001|NOT COMPLETED|Overall Study||74||
60046526|NCT01924845|76161914|FG000|STARTED|Overall Study||24||
60046527|NCT01924845|76161914|FG000|COMPLETED|Overall Study||18||
60046528|NCT01924845|76161914|FG000|NOT COMPLETED|Overall Study||6||
60046529|NCT01630135|76161920|FG000|STARTED|Overall Study||131||
60046530|NCT01630135|76161921|FG001|STARTED|Overall Study||130||
60046531|NCT01630135|76161920|FG000|COMPLETED|Overall Study||131||
60046532|NCT01630135|76161921|FG001|COMPLETED|Overall Study||128||
60046533|NCT01630135|76161920|FG000|NOT COMPLETED|Overall Study||0||
60046534|NCT01630135|76161921|FG001|NOT COMPLETED|Overall Study||2||
60046535|NCT01691248|76161929|FG000|STARTED|Overall Study|Randomized|305||
60046536|NCT01691248|76161930|FG001|STARTED|Overall Study|Randomized|306||
60046537|NCT01691248|76161929|FG000|Treated|Overall Study|Received at least 1 dose of study drug|301||
60046538|NCT01691248|76161930|FG001|Treated|Overall Study|Received at least 1 dose of study drug|299||
60046539|NCT01691248|76161929|FG000|Safety Analysis Set|Overall Study|A participant randomized to Fidaxomicin, received placebo instead.|300||
60046540|NCT01691248|76161930|FG001|Safety Analysis Set|Overall Study|A participant randomized to Fidaxomicin, received placebo instead.|300||
60046541|NCT01691248|76161929|FG000|COMPLETED|Overall Study||194||
60046542|NCT01691248|76161930|FG001|COMPLETED|Overall Study||192||
60046543|NCT01691248|76161929|FG000|NOT COMPLETED|Overall Study||111||
60046544|NCT01691248|76161930|FG001|NOT COMPLETED|Overall Study||114||
60046545|NCT01924767|76161941|FG000|STARTED|Overall Study||12||
60046546|NCT01924767|76161942|FG001|STARTED|Overall Study||9||
59511900|NCT02763826|75605506|FG007|STARTED|Part 1 Dose Escalation, 1 mA||0||
59511901|NCT02763826|75605499|FG000|COMPLETED|Part 1 Dose Escalation, 1 mA||3||
59511902|NCT02763826|75605500|FG001|COMPLETED|Part 1 Dose Escalation, 1 mA||0||
59511903|NCT02763826|75605501|FG002|COMPLETED|Part 1 Dose Escalation, 1 mA||0||
59511904|NCT02763826|75605502|FG003|COMPLETED|Part 1 Dose Escalation, 1 mA||0||
59511905|NCT02763826|75605503|FG004|COMPLETED|Part 1 Dose Escalation, 1 mA||0||
60046547|NCT01924767|76161943|FG002|STARTED|Overall Study||9||
60046548|NCT01924767|76161944|FG003|STARTED|Overall Study||9||
60046549|NCT01924767|76161945|FG004|STARTED|Overall Study||9||
60046550|NCT01924767|76161941|FG000|COMPLETED|Overall Study||11||
60046551|NCT01924767|76161942|FG001|COMPLETED|Overall Study||9||
60046552|NCT01924767|76161943|FG002|COMPLETED|Overall Study||8||
60046553|NCT01924767|76161944|FG003|COMPLETED|Overall Study||9||
60046554|NCT01924767|76161945|FG004|COMPLETED|Overall Study||9||
60046555|NCT01924767|76161941|FG000|NOT COMPLETED|Overall Study||1||
60046556|NCT01924767|76161942|FG001|NOT COMPLETED|Overall Study||0||
59612502|NCT01701258|75723506|FG007|STARTED|EEG (Session 4)||16|Not all participants that were eligible or completed the MRI/PET completed the EEG.|
60046557|NCT01924767|76161943|FG002|NOT COMPLETED|Overall Study||1||
60046558|NCT01924767|76161944|FG003|NOT COMPLETED|Overall Study||0||
60046559|NCT01924767|76161945|FG004|NOT COMPLETED|Overall Study||0||
60046560|NCT01691092|76161962|FG000|STARTED|Overall Study||79||
60046561|NCT01691092|76161962|FG000|COMPLETED|Overall Study||38||
60046562|NCT01691092|76161962|FG000|NOT COMPLETED|Overall Study||41||
60046563|NCT02133001|76161968|FG000|STARTED|Double Blind (Day 1-25)||32||
60046564|NCT02133001|76161969|FG001|STARTED|Double Blind (Day 1-25)||36||
60046565|NCT02133001|76161968|FG000|Safety|Double Blind (Day 1-25)||31||
60046566|NCT02133001|76161969|FG001|Safety|Double Blind (Day 1-25)||35||
60046567|NCT02133001|76161968|FG000|COMPLETED|Double Blind (Day 1-25)|Participants who completed continued to follow-up phase.|22||
60046568|NCT02133001|76161969|FG001|COMPLETED|Double Blind (Day 1-25)|Participants who completed continued to follow-up phase.|27||
60046569|NCT02133001|76161968|FG000|NOT COMPLETED|Double Blind (Day 1-25)||10||
60046570|NCT02133001|76161969|FG001|NOT COMPLETED|Double Blind (Day 1-25)||9||
60046571|NCT02133001|76161968|FG000|STARTED|Follow-Up Phase (Day 26-81)||22||
60046572|NCT02133001|76161969|FG001|STARTED|Follow-Up Phase (Day 26-81)||27||
60046573|NCT02133001|76161968|FG000|COMPLETED|Follow-Up Phase (Day 26-81)||20||
60046574|NCT02133001|76161969|FG001|COMPLETED|Follow-Up Phase (Day 26-81)||24||
60046575|NCT02133001|76161968|FG000|NOT COMPLETED|Follow-Up Phase (Day 26-81)||2||
60046576|NCT02133001|76161969|FG001|NOT COMPLETED|Follow-Up Phase (Day 26-81)||3||
60046577|NCT01709578|76161980|FG000|STARTED|Overall Study||181||
60046578|NCT01709578|76161981|FG001|STARTED|Overall Study||181||
60046579|NCT01709578|76161982|FG002|STARTED|Overall Study||184||
60046580|NCT01709578|76161980|FG000|COMPLETED|Overall Study||101||
60046581|NCT01709578|76161981|FG001|COMPLETED|Overall Study||125||
60046582|NCT01709578|76161982|FG002|COMPLETED|Overall Study||133||
60046583|NCT01709578|76161980|FG000|NOT COMPLETED|Overall Study||80||
60046584|NCT01709578|76161981|FG001|NOT COMPLETED|Overall Study||56||
59612503|NCT01701258|75723507|FG008|STARTED|EEG (Session 4)||0|Not all participants that were eligible or completed the MRI/PET completed the EEG.|
59612504|NCT01701258|75723508|FG009|STARTED|EEG (Session 4)||0|Not all participants that were eligible or completed the MRI/PET completed the EEG.|
59612505|NCT01701258|75723509|FG010|STARTED|EEG (Session 4)||17|Not all participants that were eligible or completed the MRI/PET completed the EEG.|
59612506|NCT01701258|75723510|FG011|STARTED|EEG (Session 4)||0|Not all participants that were eligible or completed the MRI/PET completed the EEG.|
59612507|NCT01701258|75723511|FG012|STARTED|EEG (Session 4)||0|Not all participants that were eligible or completed the MRI/PET completed the EEG.|
59612508|NCT01701258|75723499|FG000|COMPLETED|EEG (Session 4)||0||
59612509|NCT01701258|75723500|FG001|COMPLETED|EEG (Session 4)||19||
59612510|NCT01701258|75723501|FG002|COMPLETED|EEG (Session 4)||0||
59612511|NCT01701258|75723502|FG003|COMPLETED|EEG (Session 4)||0||
59612512|NCT01701258|75723503|FG004|COMPLETED|EEG (Session 4)||14||
59612513|NCT01701258|75723504|FG005|COMPLETED|EEG (Session 4)||0||
59612514|NCT01701258|75723505|FG006|COMPLETED|EEG (Session 4)||0||
59919749|NCT03000452|76039904|FG000|STARTED|Follow-Up Period|1 participant died in Cycle 1 due to PD prior to evaluation.|17||
59919750|NCT03000452|76039904|FG000|COMPLETED|Follow-Up Period||10||
59919751|NCT03000452|76039904|FG000|NOT COMPLETED|Follow-Up Period||7||
59919752|NCT01373164|76039913|FG000|STARTED|Overall Study||5||
59919753|NCT01373164|76039914|FG001|STARTED|Overall Study||4||
59919754|NCT01373164|76039915|FG002|STARTED|Overall Study||5||
59919755|NCT01373164|76039916|FG003|STARTED|Overall Study||104||
59919756|NCT01373164|76039917|FG004|STARTED|Overall Study||52||
59919757|NCT01373164|76039913|FG000|Received at Least One Dose|Overall Study||5||
59919758|NCT01373164|76039914|FG001|Received at Least One Dose|Overall Study||4||
59919759|NCT01373164|76039915|FG002|Received at Least One Dose|Overall Study||5||
59919760|NCT01373164|76039916|FG003|Received at Least One Dose|Overall Study||103||
59919761|NCT01373164|76039917|FG004|Received at Least One Dose|Overall Study||52||
59919762|NCT01373164|76039913|FG000|COMPLETED|Overall Study||5||
59919763|NCT01373164|76039914|FG001|COMPLETED|Overall Study||3||
59919764|NCT01373164|76039915|FG002|COMPLETED|Overall Study||4||
59919765|NCT01373164|76039916|FG003|COMPLETED|Overall Study||92||
59919766|NCT01373164|76039917|FG004|COMPLETED|Overall Study||50||
59919767|NCT01373164|76039913|FG000|NOT COMPLETED|Overall Study||0||
59919768|NCT01373164|76039914|FG001|NOT COMPLETED|Overall Study||1||
59919769|NCT01373164|76039915|FG002|NOT COMPLETED|Overall Study||1||
59919770|NCT01373164|76039916|FG003|NOT COMPLETED|Overall Study||12||
59919771|NCT01373164|76039917|FG004|NOT COMPLETED|Overall Study||2||
59919772|NCT02999984|76039932|FG000|STARTED|Overall Study||10||
59919773|NCT02999984|76039932|FG000|COMPLETED|Overall Study||9||
59919774|NCT02999984|76039932|FG000|NOT COMPLETED|Overall Study||1||
59919775|NCT03550313|76039939|FG000|STARTED|Overall Study||192||
59919776|NCT03550313|76039940|FG001|STARTED|Overall Study||187||
59919777|NCT03550313|76039941|FG002|STARTED|Overall Study||186||
59919778|NCT03550313|76039939|FG000|Vaccinated for Dose 1|Overall Study||171||
60046585|NCT01709578|76161982|FG002|NOT COMPLETED|Overall Study||51||
60046586|NCT02132767|76161992|FG000|STARTED|Overall Study||262||
60046587|NCT02132767|76161993|FG001|STARTED|Overall Study||261||
60046588|NCT02132767|76161992|FG000|COMPLETED|Overall Study||245||
60046589|NCT02132767|76161993|FG001|COMPLETED|Overall Study||246||
60046590|NCT02132767|76161992|FG000|NOT COMPLETED|Overall Study||17||
60046591|NCT02132767|76161993|FG001|NOT COMPLETED|Overall Study||15||
60046592|NCT02153905|76162001|FG000|STARTED|Overall Study||1||
60046593|NCT02153905|76162002|FG001|STARTED|Overall Study||2||
60046594|NCT02153905|76162001|FG000|COMPLETED|Overall Study||0||
60046595|NCT02153905|76162002|FG001|COMPLETED|Overall Study||2||
60046596|NCT02153905|76162001|FG000|NOT COMPLETED|Overall Study||1||
60046597|NCT02153905|76162002|FG001|NOT COMPLETED|Overall Study||0||
60046598|NCT02153827|76162010|FG000|STARTED|Overall Study||25||
60046599|NCT02153827|76162011|FG001|STARTED|Overall Study||23||
60046600|NCT02153827|76162010|FG000|COMPLETED|Overall Study||22||
60046601|NCT02153827|76162011|FG001|COMPLETED|Overall Study||14||
60046602|NCT02153827|76162010|FG000|NOT COMPLETED|Overall Study||3||
60046603|NCT02153827|76162011|FG001|NOT COMPLETED|Overall Study||9||
60046604|NCT02153359|76162017|FG000|STARTED|Intervention 1 (1 Month)||11||
60046605|NCT02153359|76162018|FG001|STARTED|Intervention 1 (1 Month)||12||
60046606|NCT02153359|76162017|FG000|COMPLETED|Intervention 1 (1 Month)||11||
60046607|NCT02153359|76162018|FG001|COMPLETED|Intervention 1 (1 Month)||12||
60046608|NCT02153359|76162017|FG000|NOT COMPLETED|Intervention 1 (1 Month)||0||
60046609|NCT02153359|76162018|FG001|NOT COMPLETED|Intervention 1 (1 Month)||0||
60046610|NCT02153359|76162017|FG000|STARTED|Washout (at Least 1 Month)||11||
60046611|NCT02153359|76162018|FG001|STARTED|Washout (at Least 1 Month)||12||
60046612|NCT02153359|76162017|FG000|COMPLETED|Washout (at Least 1 Month)||11||
60046613|NCT02153359|76162018|FG001|COMPLETED|Washout (at Least 1 Month)||12||
60046614|NCT02153359|76162017|FG000|NOT COMPLETED|Washout (at Least 1 Month)||0||
60046615|NCT02153359|76162018|FG001|NOT COMPLETED|Washout (at Least 1 Month)||0||
60046616|NCT02153359|76162017|FG000|STARTED|Intervention 2 (1 Month)||11||
60046617|NCT02153359|76162018|FG001|STARTED|Intervention 2 (1 Month)||12||
60046618|NCT02153359|76162017|FG000|COMPLETED|Intervention 2 (1 Month)||11||
60046619|NCT02153359|76162018|FG001|COMPLETED|Intervention 2 (1 Month)||10||
60046620|NCT02153359|76162017|FG000|NOT COMPLETED|Intervention 2 (1 Month)||0||
60046621|NCT02153359|76162018|FG001|NOT COMPLETED|Intervention 2 (1 Month)||2||
60046622|NCT01691014|76162031|FG000|STARTED|Overall Study||8||
60046623|NCT01691014|76162032|FG001|STARTED|Overall Study||26||
60046624|NCT01691014|76162033|FG002|STARTED|Overall Study||36||
60046625|NCT01691014|76162034|FG003|STARTED|Overall Study||9||
60046626|NCT01691014|76162031|FG000|COMPLETED|Overall Study||5||
60046627|NCT01691014|76162032|FG001|COMPLETED|Overall Study||11||
60046628|NCT01691014|76162033|FG002|COMPLETED|Overall Study||25||
60046629|NCT01691014|76162034|FG003|COMPLETED|Overall Study||4||
60046630|NCT01691014|76162031|FG000|NOT COMPLETED|Overall Study||3||
60046631|NCT01691014|76162032|FG001|NOT COMPLETED|Overall Study||15||
60046632|NCT01691014|76162033|FG002|NOT COMPLETED|Overall Study||11||
60046633|NCT01691014|76162034|FG003|NOT COMPLETED|Overall Study||5||
60046634|NCT02245412|76162047|FG000|STARTED|Treatment Period||17||
60046635|NCT02245412|76162048|FG001|STARTED|Treatment Period||6||
60046636|NCT02245412|76162049|FG002|STARTED|Treatment Period||2||
60046637|NCT02245412|76162047|FG000|Received at Least 1 Dose of Study Drug|Treatment Period||17||
59511906|NCT02763826|75605504|FG005|COMPLETED|Part 1 Dose Escalation, 1 mA||0||
59511907|NCT02763826|75605505|FG006|COMPLETED|Part 1 Dose Escalation, 1 mA||0||
59511908|NCT02763826|75605506|FG007|COMPLETED|Part 1 Dose Escalation, 1 mA||0||
60046638|NCT02245412|76162048|FG001|Received at Least 1 Dose of Study Drug|Treatment Period||6||
60046639|NCT02245412|76162049|FG002|Received at Least 1 Dose of Study Drug|Treatment Period||2||
60046640|NCT02245412|76162047|FG000|Modified Full Analysis Set (mFAS)|Treatment Period||16|The mFAS included all participants who had at least 1 dose of ALXN1007 and had GI GVHD confirmed.|
60046641|NCT02245412|76162048|FG001|Modified Full Analysis Set (mFAS)|Treatment Period||6|The mFAS included all participants who had at least 1 dose of ALXN1007 and had GI GVHD confirmed.|
60046642|NCT02245412|76162049|FG002|Modified Full Analysis Set (mFAS)|Treatment Period||2|The mFAS included all participants who had at least 1 dose of ALXN1007 and had GI GVHD confirmed.|
60046643|NCT02245412|76162047|FG000|COMPLETED|Treatment Period||12||
60046644|NCT02245412|76162048|FG001|COMPLETED|Treatment Period||3||
60046645|NCT02245412|76162049|FG002|COMPLETED|Treatment Period||2||
60046646|NCT02245412|76162047|FG000|NOT COMPLETED|Treatment Period||5||
60046647|NCT02245412|76162048|FG001|NOT COMPLETED|Treatment Period||3||
60046648|NCT02245412|76162049|FG002|NOT COMPLETED|Treatment Period||0||
60046649|NCT02245412|76162047|FG000|STARTED|Follow-Up Period|One participant who discontinued Study Drug in Treatment Period continued to Follow-Up Period.|13||
60046650|NCT02245412|76162048|FG001|STARTED|Follow-Up Period|One participant who discontinued Study Drug in Treatment Period continued to Follow-Up Period.|4||
60046651|NCT02245412|76162049|FG002|STARTED|Follow-Up Period||2||
60046652|NCT02245412|76162047|FG000|COMPLETED|Follow-Up Period||8||
60046653|NCT02245412|76162048|FG001|COMPLETED|Follow-Up Period||2||
60046654|NCT02245412|76162049|FG002|COMPLETED|Follow-Up Period||0||
60046655|NCT02245412|76162047|FG000|NOT COMPLETED|Follow-Up Period||5||
60046656|NCT02245412|76162048|FG001|NOT COMPLETED|Follow-Up Period||2||
60046657|NCT02245412|76162049|FG002|NOT COMPLETED|Follow-Up Period||2||
60046658|NCT02244944|76162057|FG000|STARTED|Overall Study||2||
60046659|NCT02244944|76162057|FG000|COMPLETED|Overall Study||0||
60046660|NCT02244944|76162057|FG000|NOT COMPLETED|Overall Study||2||
60046661|NCT01689532|76162063|FG000|STARTED|Overall Study||61||
60046662|NCT01689532|76162064|FG001|STARTED|Overall Study||61||
60046663|NCT01689532|76162063|FG000|COMPLETED|Overall Study||47||
60046664|NCT01689532|76162064|FG001|COMPLETED|Overall Study||52||
60046665|NCT01689532|76162063|FG000|NOT COMPLETED|Overall Study||14||
60046666|NCT01689532|76162064|FG001|NOT COMPLETED|Overall Study||9||
60046667|NCT01924689|76162076|FG000|STARTED|Overall Study||3||
60046668|NCT01924689|76162077|FG001|STARTED|Overall Study||3||
60046669|NCT01924689|76162078|FG002|STARTED|Overall Study||4||
60046670|NCT01924689|76162079|FG003|STARTED|Overall Study||6||
60046671|NCT01924689|76162080|FG004|STARTED|Overall Study||6||
60046672|NCT01924689|76162081|FG005|STARTED|Overall Study||2||
60046673|NCT01924689|76162076|FG000|COMPLETED|Overall Study||0||
60046674|NCT01924689|76162077|FG001|COMPLETED|Overall Study||0||
60046675|NCT01924689|76162078|FG002|COMPLETED|Overall Study||0||
60046676|NCT01924689|76162079|FG003|COMPLETED|Overall Study||0||
60046677|NCT01924689|76162080|FG004|COMPLETED|Overall Study||0||
60046678|NCT01924689|76162081|FG005|COMPLETED|Overall Study||0||
60046679|NCT01924689|76162076|FG000|NOT COMPLETED|Overall Study||3||
60046680|NCT01924689|76162077|FG001|NOT COMPLETED|Overall Study||3||
60046681|NCT01924689|76162078|FG002|NOT COMPLETED|Overall Study||4||
60046682|NCT01924689|76162079|FG003|NOT COMPLETED|Overall Study||6||
60046683|NCT01924689|76162080|FG004|NOT COMPLETED|Overall Study||6||
60046684|NCT01924689|76162081|FG005|NOT COMPLETED|Overall Study||2||
60046685|NCT01591330|76162099|FG000|STARTED|Period 1||8||
60046686|NCT01591330|76162100|FG001|STARTED|Period 1||9||
60046687|NCT01591330|76162101|FG002|STARTED|Period 1||9||
60046688|NCT01591330|76162102|FG003|STARTED|Period 1||9||
60046689|NCT01591330|76162099|FG000|Received at Least 1 Dose of Study Drug|Period 1||8||
60046690|NCT01591330|76162100|FG001|Received at Least 1 Dose of Study Drug|Period 1||9||
59511909|NCT02763826|75605499|FG000|NOT COMPLETED|Part 1 Dose Escalation, 1 mA||0||
59511910|NCT02763826|75605500|FG001|NOT COMPLETED|Part 1 Dose Escalation, 1 mA||0||
60046691|NCT01591330|76162101|FG002|Received at Least 1 Dose of Study Drug|Period 1||9||
60046692|NCT01591330|76162102|FG003|Received at Least 1 Dose of Study Drug|Period 1||9||
60046693|NCT01591330|76162099|FG000|COMPLETED|Period 1||7||
60046694|NCT01591330|76162100|FG001|COMPLETED|Period 1||9||
60046695|NCT01591330|76162101|FG002|COMPLETED|Period 1||9||
60046696|NCT01591330|76162102|FG003|COMPLETED|Period 1||9||
60046697|NCT01591330|76162099|FG000|NOT COMPLETED|Period 1||1||
60046698|NCT01591330|76162100|FG001|NOT COMPLETED|Period 1||0||
60046699|NCT01591330|76162101|FG002|NOT COMPLETED|Period 1||0||
60046700|NCT01591330|76162102|FG003|NOT COMPLETED|Period 1||0||
60046701|NCT01591330|76162099|FG000|STARTED|Washout of at Least 3 Days||7||
60046702|NCT01591330|76162100|FG001|STARTED|Washout of at Least 3 Days||9||
60046703|NCT01591330|76162101|FG002|STARTED|Washout of at Least 3 Days||9||
60046704|NCT01591330|76162102|FG003|STARTED|Washout of at Least 3 Days||9||
60046705|NCT01591330|76162099|FG000|COMPLETED|Washout of at Least 3 Days||6||
59511911|NCT02763826|75605501|FG002|NOT COMPLETED|Part 1 Dose Escalation, 1 mA||0||
59511912|NCT02763826|75605502|FG003|NOT COMPLETED|Part 1 Dose Escalation, 1 mA||0||
60046706|NCT01591330|76162100|FG001|COMPLETED|Washout of at Least 3 Days||9||
60046707|NCT01591330|76162101|FG002|COMPLETED|Washout of at Least 3 Days||9||
60046708|NCT01591330|76162102|FG003|COMPLETED|Washout of at Least 3 Days||9||
60046709|NCT01591330|76162099|FG000|NOT COMPLETED|Washout of at Least 3 Days||1||
60046710|NCT01591330|76162100|FG001|NOT COMPLETED|Washout of at Least 3 Days||0||
60046711|NCT01591330|76162101|FG002|NOT COMPLETED|Washout of at Least 3 Days||0||
60046712|NCT01591330|76162102|FG003|NOT COMPLETED|Washout of at Least 3 Days||0||
60046713|NCT01591330|76162099|FG000|STARTED|Period 2||6||
60046714|NCT01591330|76162100|FG001|STARTED|Period 2||9||
60046715|NCT01591330|76162101|FG002|STARTED|Period 2||9||
60046716|NCT01591330|76162102|FG003|STARTED|Period 2||9||
60046717|NCT01591330|76162099|FG000|COMPLETED|Period 2||5||
60046718|NCT01591330|76162100|FG001|COMPLETED|Period 2||9||
60046719|NCT01591330|76162101|FG002|COMPLETED|Period 2||9||
60046720|NCT01591330|76162102|FG003|COMPLETED|Period 2||9||
60046721|NCT01591330|76162099|FG000|NOT COMPLETED|Period 2||1||
60046722|NCT01591330|76162100|FG001|NOT COMPLETED|Period 2||0||
60046723|NCT01591330|76162101|FG002|NOT COMPLETED|Period 2||0||
60046724|NCT01591330|76162102|FG003|NOT COMPLETED|Period 2||0||
60046725|NCT01591330|76162099|FG000|STARTED|Washout of at Least 3 Days||5||
60046726|NCT01591330|76162100|FG001|STARTED|Washout of at Least 3 Days||9||
60046727|NCT01591330|76162101|FG002|STARTED|Washout of at Least 3 Days||9||
60046728|NCT01591330|76162102|FG003|STARTED|Washout of at Least 3 Days||9||
60046729|NCT01591330|76162099|FG000|COMPLETED|Washout of at Least 3 Days||5||
60046730|NCT01591330|76162100|FG001|COMPLETED|Washout of at Least 3 Days||9||
60046731|NCT01591330|76162101|FG002|COMPLETED|Washout of at Least 3 Days||9||
60046732|NCT01591330|76162102|FG003|COMPLETED|Washout of at Least 3 Days||9||
60046733|NCT01591330|76162099|FG000|NOT COMPLETED|Washout of at Least 3 Days||0||
60046734|NCT01591330|76162100|FG001|NOT COMPLETED|Washout of at Least 3 Days||0||
60046735|NCT01591330|76162101|FG002|NOT COMPLETED|Washout of at Least 3 Days||0||
60046736|NCT01591330|76162102|FG003|NOT COMPLETED|Washout of at Least 3 Days||0||
60046737|NCT01591330|76162099|FG000|STARTED|Period 3||5||
60046738|NCT01591330|76162100|FG001|STARTED|Period 3||9||
60046739|NCT01591330|76162101|FG002|STARTED|Period 3||9||
60046740|NCT01591330|76162102|FG003|STARTED|Period 3||9||
60046741|NCT01591330|76162099|FG000|COMPLETED|Period 3||5||
60046742|NCT01591330|76162100|FG001|COMPLETED|Period 3||9||
60046743|NCT01591330|76162101|FG002|COMPLETED|Period 3||9||
60046744|NCT01591330|76162102|FG003|COMPLETED|Period 3||9||
60046745|NCT01591330|76162099|FG000|NOT COMPLETED|Period 3||0||
59612515|NCT01701258|75723506|FG007|COMPLETED|EEG (Session 4)||16||
59612516|NCT01701258|75723507|FG008|COMPLETED|EEG (Session 4)||0||
59612517|NCT01701258|75723508|FG009|COMPLETED|EEG (Session 4)||0||
59919779|NCT03550313|76039940|FG001|Vaccinated for Dose 1|Overall Study||147||
59919780|NCT03550313|76039941|FG002|Vaccinated for Dose 1|Overall Study||166||
59919781|NCT03550313|76039939|FG000|Vaccinated for Dose 2|Overall Study||159||
59919782|NCT03550313|76039940|FG001|Vaccinated for Dose 2|Overall Study||135||
59919783|NCT03550313|76039941|FG002|Vaccinated for Dose 2|Overall Study||153||
59919784|NCT03550313|76039939|FG000|Vaccinated for Dose 3|Overall Study||151||
59919785|NCT03550313|76039940|FG001|Vaccinated for Dose 3|Overall Study||127||
59919786|NCT03550313|76039941|FG002|Vaccinated for Dose 3|Overall Study||146||
59919787|NCT03550313|76039939|FG000|COMPLETED|Overall Study||95||
59919788|NCT03550313|76039940|FG001|COMPLETED|Overall Study||77||
59919789|NCT03550313|76039941|FG002|COMPLETED|Overall Study||72||
59919790|NCT03550313|76039939|FG000|NOT COMPLETED|Overall Study||97||
59919791|NCT03550313|76039940|FG001|NOT COMPLETED|Overall Study||110||
59919792|NCT03550313|76039941|FG002|NOT COMPLETED|Overall Study||114||
59919793|NCT03312907|76039953|FG000|STARTED|Overall Study||72||
59919794|NCT03312907|76039954|FG001|STARTED|Overall Study||144||
60046746|NCT01591330|76162100|FG001|NOT COMPLETED|Period 3||0||
60046747|NCT01591330|76162101|FG002|NOT COMPLETED|Period 3||0||
60046748|NCT01591330|76162102|FG003|NOT COMPLETED|Period 3||0||
60046749|NCT01591330|76162099|FG000|STARTED|Washout of at Least 3 Days||5||
60046750|NCT01591330|76162100|FG001|STARTED|Washout of at Least 3 Days||9||
60046751|NCT01591330|76162101|FG002|STARTED|Washout of at Least 3 Days||9||
60046752|NCT01591330|76162102|FG003|STARTED|Washout of at Least 3 Days||9||
60046753|NCT01591330|76162099|FG000|COMPLETED|Washout of at Least 3 Days||5||
60046754|NCT01591330|76162100|FG001|COMPLETED|Washout of at Least 3 Days||9||
59919795|NCT03312907|76039955|FG002|STARTED|Overall Study||76||
59919796|NCT03312907|76039953|FG000|COMPLETED|Overall Study||55||
59919797|NCT03312907|76039954|FG001|COMPLETED|Overall Study||114||
60046755|NCT01591330|76162101|FG002|COMPLETED|Washout of at Least 3 Days||9||
60046756|NCT01591330|76162102|FG003|COMPLETED|Washout of at Least 3 Days||9||
60046757|NCT01591330|76162099|FG000|NOT COMPLETED|Washout of at Least 3 Days||0||
60046758|NCT01591330|76162100|FG001|NOT COMPLETED|Washout of at Least 3 Days||0||
59612518|NCT01701258|75723509|FG010|COMPLETED|EEG (Session 4)||17||
59612519|NCT01701258|75723510|FG011|COMPLETED|EEG (Session 4)||0||
59612520|NCT01701258|75723511|FG012|COMPLETED|EEG (Session 4)||0||
60046759|NCT01591330|76162101|FG002|NOT COMPLETED|Washout of at Least 3 Days||0||
60046760|NCT01591330|76162102|FG003|NOT COMPLETED|Washout of at Least 3 Days||0||
59612521|NCT01701258|75723499|FG000|NOT COMPLETED|EEG (Session 4)||0||
60046761|NCT01591330|76162099|FG000|STARTED|Period 4||5||
60046762|NCT01591330|76162100|FG001|STARTED|Period 4||9||
60046763|NCT01591330|76162101|FG002|STARTED|Period 4||9||
60046764|NCT01591330|76162102|FG003|STARTED|Period 4||9||
60046765|NCT01591330|76162099|FG000|COMPLETED|Period 4||5||
60046766|NCT01591330|76162100|FG001|COMPLETED|Period 4||9||
60046767|NCT01591330|76162101|FG002|COMPLETED|Period 4||9||
60046768|NCT01591330|76162102|FG003|COMPLETED|Period 4||9||
59919798|NCT03312907|76039955|FG002|COMPLETED|Overall Study||57||
59919799|NCT03312907|76039953|FG000|NOT COMPLETED|Overall Study||17||
59919800|NCT03312907|76039954|FG001|NOT COMPLETED|Overall Study||30||
59919801|NCT03312907|76039955|FG002|NOT COMPLETED|Overall Study||19||
59919802|NCT02999672|76039965|FG000|STARTED|Overall Study||13||
59919803|NCT02999672|76039966|FG001|STARTED|Overall Study||7||
59919804|NCT02999672|76039965|FG000|COMPLETED|Overall Study||0||
59919805|NCT02999672|76039966|FG001|COMPLETED|Overall Study||0||
59919806|NCT02999672|76039965|FG000|NOT COMPLETED|Overall Study||13||
59919807|NCT02999672|76039966|FG001|NOT COMPLETED|Overall Study||7||
59919808|NCT01911676|76039976|FG000|STARTED|Period 1 of Study||23||
59919809|NCT01911676|76039977|FG001|STARTED|Period 1 of Study||23||
59919810|NCT01911676|76039978|FG002|STARTED|Period 1 of Study||12||
59919811|NCT01911676|76039979|FG003|STARTED|Period 1 of Study||13||
59919812|NCT01911676|76039976|FG000|COMPLETED|Period 1 of Study||17||
59919813|NCT01911676|76039977|FG001|COMPLETED|Period 1 of Study||21||
59919814|NCT01911676|76039978|FG002|COMPLETED|Period 1 of Study||11||
59919815|NCT01911676|76039979|FG003|COMPLETED|Period 1 of Study||10||
59919816|NCT01911676|76039976|FG000|NOT COMPLETED|Period 1 of Study||6||
59919817|NCT01911676|76039977|FG001|NOT COMPLETED|Period 1 of Study||2||
59919818|NCT01911676|76039978|FG002|NOT COMPLETED|Period 1 of Study||1||
59919819|NCT01911676|76039979|FG003|NOT COMPLETED|Period 1 of Study||3||
59919820|NCT01911676|76039976|FG000|STARTED|Period 2 of Study||17||
59919821|NCT01911676|76039977|FG001|STARTED|Period 2 of Study||21||
59919822|NCT01911676|76039978|FG002|STARTED|Period 2 of Study||11||
59919823|NCT01911676|76039979|FG003|STARTED|Period 2 of Study||10||
59919824|NCT01911676|76039976|FG000|COMPLETED|Period 2 of Study||15||
59919825|NCT01911676|76039977|FG001|COMPLETED|Period 2 of Study||21||
59919826|NCT01911676|76039978|FG002|COMPLETED|Period 2 of Study||11||
59919827|NCT01911676|76039979|FG003|COMPLETED|Period 2 of Study||8||
59919828|NCT01911676|76039976|FG000|NOT COMPLETED|Period 2 of Study||2||
59919829|NCT01911676|76039977|FG001|NOT COMPLETED|Period 2 of Study||0||
59919830|NCT01911676|76039978|FG002|NOT COMPLETED|Period 2 of Study||0||
59919831|NCT01911676|76039979|FG003|NOT COMPLETED|Period 2 of Study||2||
60046769|NCT01591330|76162099|FG000|NOT COMPLETED|Period 4||0||
60046770|NCT01591330|76162100|FG001|NOT COMPLETED|Period 4||0||
60046771|NCT01591330|76162101|FG002|NOT COMPLETED|Period 4||0||
60046772|NCT01591330|76162102|FG003|NOT COMPLETED|Period 4||0||
60046773|NCT01591096|76162112|FG000|STARTED|Overall Study||1||
59919832|NCT04056182|76039990|FG000|STARTED|Overall Study||20||
59919833|NCT04056182|76039990|FG000|COMPLETED|Overall Study||3||
59919834|NCT04056182|76039990|FG000|NOT COMPLETED|Overall Study||17||
60046774|NCT01591096|76162112|FG000|COMPLETED|Overall Study||0||
60046775|NCT01591096|76162112|FG000|NOT COMPLETED|Overall Study||1||
60046776|NCT01953003|76162118|FG000|STARTED|Overall Study||56||
60046777|NCT01953003|76162119|FG001|STARTED|Overall Study||56||
60046778|NCT01953003|76162118|FG000|COMPLETED|Overall Study||0||
60046779|NCT01953003|76162119|FG001|COMPLETED|Overall Study||1||
60046780|NCT01953003|76162118|FG000|NOT COMPLETED|Overall Study||56||
60046781|NCT01953003|76162119|FG001|NOT COMPLETED|Overall Study||55||
59919835|NCT03573323|76039996|FG000|STARTED|Blinded Treatment Period (Weeks 0-24)||520||
59919836|NCT03573323|76039997|FG001|STARTED|Blinded Treatment Period (Weeks 0-24)||507||
59919837|NCT03573323|76039996|FG000|Received at Least One Dose of Study Drug|Blinded Treatment Period (Weeks 0-24)||519||
59919838|NCT03573323|76039997|FG001|Received at Least One Dose of Study Drug|Blinded Treatment Period (Weeks 0-24)||506||
59919839|NCT03573323|76039996|FG000|COMPLETED|Blinded Treatment Period (Weeks 0-24)||465||
59951422|NCT01570868|76070405|FG001|NOT COMPLETED|Overall Study||8||
60046782|NCT01952691|76162125|FG000|STARTED|Overall Study||22||
60046783|NCT01952691|76162125|FG000|COMPLETED|Overall Study||20||
59511913|NCT02763826|75605503|FG004|NOT COMPLETED|Part 1 Dose Escalation, 1 mA||0||
59511914|NCT02763826|75605504|FG005|NOT COMPLETED|Part 1 Dose Escalation, 1 mA||0||
59511915|NCT02763826|75605505|FG006|NOT COMPLETED|Part 1 Dose Escalation, 1 mA||0||
59511916|NCT02763826|75605506|FG007|NOT COMPLETED|Part 1 Dose Escalation, 1 mA||0||
59511917|NCT02763826|75605499|FG000|STARTED|Part 1 Dose Escalation, 2 mA||0||
59511918|NCT02763826|75605500|FG001|STARTED|Part 1 Dose Escalation, 2 mA||3||
59511919|NCT02763826|75605501|FG002|STARTED|Part 1 Dose Escalation, 2 mA||0||
59511920|NCT02763826|75605502|FG003|STARTED|Part 1 Dose Escalation, 2 mA||0||
59511921|NCT02763826|75605503|FG004|STARTED|Part 1 Dose Escalation, 2 mA||0||
59511922|NCT02763826|75605504|FG005|STARTED|Part 1 Dose Escalation, 2 mA||0||
59511923|NCT02763826|75605505|FG006|STARTED|Part 1 Dose Escalation, 2 mA||0||
59511924|NCT02763826|75605506|FG007|STARTED|Part 1 Dose Escalation, 2 mA||0||
59511925|NCT02763826|75605499|FG000|COMPLETED|Part 1 Dose Escalation, 2 mA||0||
59511926|NCT02763826|75605500|FG001|COMPLETED|Part 1 Dose Escalation, 2 mA||3||
59511927|NCT02763826|75605501|FG002|COMPLETED|Part 1 Dose Escalation, 2 mA||0||
59511928|NCT02763826|75605502|FG003|COMPLETED|Part 1 Dose Escalation, 2 mA||0||
59511929|NCT02763826|75605503|FG004|COMPLETED|Part 1 Dose Escalation, 2 mA||0||
59511930|NCT02763826|75605504|FG005|COMPLETED|Part 1 Dose Escalation, 2 mA||0||
59511931|NCT02763826|75605505|FG006|COMPLETED|Part 1 Dose Escalation, 2 mA||0||
59612522|NCT01701258|75723500|FG001|NOT COMPLETED|EEG (Session 4)||0||
59919840|NCT03573323|76039997|FG001|COMPLETED|Blinded Treatment Period (Weeks 0-24)||459||
59919841|NCT03573323|76039996|FG000|NOT COMPLETED|Blinded Treatment Period (Weeks 0-24)||55||
59919842|NCT03573323|76039997|FG001|NOT COMPLETED|Blinded Treatment Period (Weeks 0-24)||48||
59919843|NCT03573323|76039996|FG000|STARTED|Post-Treatment Follow Up (Weeks 25-36)||465||
59919844|NCT03573323|76039997|FG001|STARTED|Post-Treatment Follow Up (Weeks 25-36)|Excludes participants who completed treatment and did not enter the PTFU.|456||
59919845|NCT03573323|76039996|FG000|COMPLETED|Post-Treatment Follow Up (Weeks 25-36)||406||
59919846|NCT03573323|76039997|FG001|COMPLETED|Post-Treatment Follow Up (Weeks 25-36)||399||
59919847|NCT03573323|76039996|FG000|NOT COMPLETED|Post-Treatment Follow Up (Weeks 25-36)||59||
59919848|NCT03573323|76039997|FG001|NOT COMPLETED|Post-Treatment Follow Up (Weeks 25-36)||57||
59919849|NCT04058054|76040007|FG000|STARTED|Overall Study||22||22
59919850|NCT04058054|76040008|FG001|STARTED|Overall Study||22||22
59919851|NCT04058054|76040009|FG002|STARTED|Overall Study||22||22
59919852|NCT04058054|76040010|FG003|STARTED|Overall Study||22||22
59919853|NCT04058054|76040011|FG004|STARTED|Overall Study||22||22
59919854|NCT04058054|76040007|FG000|COMPLETED|Overall Study||22||22
59919855|NCT04058054|76040008|FG001|COMPLETED|Overall Study||22||22
59919856|NCT04058054|76040009|FG002|COMPLETED|Overall Study||22||22
59919857|NCT04058054|76040010|FG003|COMPLETED|Overall Study||22||22
59919858|NCT04058054|76040011|FG004|COMPLETED|Overall Study||22||22
60046784|NCT01952691|76162125|FG000|NOT COMPLETED|Overall Study||2||
60046785|NCT01709500|76162131|FG000|STARTED|Overall Study||167||
60046786|NCT01709500|76162132|FG001|STARTED|Overall Study||82||
60046787|NCT01709500|76162131|FG000|Treated|Overall Study||167||
59511932|NCT02763826|75605506|FG007|COMPLETED|Part 1 Dose Escalation, 2 mA||0||
59511933|NCT02763826|75605499|FG000|NOT COMPLETED|Part 1 Dose Escalation, 2 mA||0||
59511934|NCT02763826|75605500|FG001|NOT COMPLETED|Part 1 Dose Escalation, 2 mA||0||
59511935|NCT02763826|75605501|FG002|NOT COMPLETED|Part 1 Dose Escalation, 2 mA||0||
59511936|NCT02763826|75605502|FG003|NOT COMPLETED|Part 1 Dose Escalation, 2 mA||0||
59511937|NCT02763826|75605503|FG004|NOT COMPLETED|Part 1 Dose Escalation, 2 mA||0||
59511938|NCT02763826|75605504|FG005|NOT COMPLETED|Part 1 Dose Escalation, 2 mA||0||
59511939|NCT02763826|75605505|FG006|NOT COMPLETED|Part 1 Dose Escalation, 2 mA||0||
59511940|NCT02763826|75605506|FG007|NOT COMPLETED|Part 1 Dose Escalation, 2 mA||0||
59511941|NCT02763826|75605499|FG000|STARTED|Part 1 Dose Escalation, 2.5 mA||0||
59511942|NCT02763826|75605500|FG001|STARTED|Part 1 Dose Escalation, 2.5 mA||0||
59511943|NCT02763826|75605501|FG002|STARTED|Part 1 Dose Escalation, 2.5 mA||3||
59511944|NCT02763826|75605502|FG003|STARTED|Part 1 Dose Escalation, 2.5 mA||0||
59511945|NCT02763826|75605503|FG004|STARTED|Part 1 Dose Escalation, 2.5 mA||0||
59511946|NCT02763826|75605504|FG005|STARTED|Part 1 Dose Escalation, 2.5 mA||0||
59511947|NCT02763826|75605505|FG006|STARTED|Part 1 Dose Escalation, 2.5 mA||0||
59511948|NCT02763826|75605506|FG007|STARTED|Part 1 Dose Escalation, 2.5 mA||0||
59511949|NCT02763826|75605499|FG000|COMPLETED|Part 1 Dose Escalation, 2.5 mA||0||
59511950|NCT02763826|75605500|FG001|COMPLETED|Part 1 Dose Escalation, 2.5 mA||0||
59511951|NCT02763826|75605501|FG002|COMPLETED|Part 1 Dose Escalation, 2.5 mA||3||
59511952|NCT02763826|75605502|FG003|COMPLETED|Part 1 Dose Escalation, 2.5 mA||0||
59511953|NCT02763826|75605503|FG004|COMPLETED|Part 1 Dose Escalation, 2.5 mA||0||
59511954|NCT02763826|75605504|FG005|COMPLETED|Part 1 Dose Escalation, 2.5 mA||0||
59511955|NCT02763826|75605505|FG006|COMPLETED|Part 1 Dose Escalation, 2.5 mA||0||
59511956|NCT02763826|75605506|FG007|COMPLETED|Part 1 Dose Escalation, 2.5 mA||0||
59760014|NCT00900731|75879560|FG001|STARTED|Overall Study||801||
59919859|NCT04058054|76040007|FG000|NOT COMPLETED|Overall Study||0||0
59919860|NCT04058054|76040008|FG001|NOT COMPLETED|Overall Study||0||0
59919861|NCT04058054|76040009|FG002|NOT COMPLETED|Overall Study||0||0
60046788|NCT01709500|76162132|FG001|Treated|Overall Study||81||
59511957|NCT02763826|75605499|FG000|NOT COMPLETED|Part 1 Dose Escalation, 2.5 mA||0||
59511958|NCT02763826|75605500|FG001|NOT COMPLETED|Part 1 Dose Escalation, 2.5 mA||0||
60046789|NCT01709500|76162131|FG000|COMPLETED|Overall Study||0||
60046790|NCT01709500|76162132|FG001|COMPLETED|Overall Study||0||
60046791|NCT01709500|76162131|FG000|NOT COMPLETED|Overall Study||167||
60046792|NCT01709500|76162132|FG001|NOT COMPLETED|Overall Study||82||
59511959|NCT02763826|75605501|FG002|NOT COMPLETED|Part 1 Dose Escalation, 2.5 mA||0||
59511960|NCT02763826|75605502|FG003|NOT COMPLETED|Part 1 Dose Escalation, 2.5 mA||0||
59511961|NCT02763826|75605503|FG004|NOT COMPLETED|Part 1 Dose Escalation, 2.5 mA||0||
59511962|NCT02763826|75605504|FG005|NOT COMPLETED|Part 1 Dose Escalation, 2.5 mA||0||
59511963|NCT02763826|75605505|FG006|NOT COMPLETED|Part 1 Dose Escalation, 2.5 mA||0||
59511964|NCT02763826|75605506|FG007|NOT COMPLETED|Part 1 Dose Escalation, 2.5 mA||0||
60046793|NCT01599806|76162140|FG000|STARTED|Overall Study||516||
60046794|NCT01599806|76162141|FG001|STARTED|Overall Study||517||
60046795|NCT01599806|76162140|FG000|COMPLETED|Overall Study||473||
60046796|NCT01599806|76162141|FG001|COMPLETED|Overall Study||476||
60046797|NCT01599806|76162140|FG000|NOT COMPLETED|Overall Study||43||
60046798|NCT01599806|76162141|FG001|NOT COMPLETED|Overall Study||41||
60046799|NCT01599325|76162147|FG000|STARTED|Primary Parent Phase||72||
60046800|NCT01599325|76162147|FG000|Intent to Treat (ITT) Population|Primary Parent Phase|Includes all participants who were enrolled into the study|72||
60046801|NCT01599325|76162147|FG000|Pharmacokinetic (PK) Population|Primary Parent Phase|Includes all participants with evaluable azacitidine plasma PK profiles.|12||
60046802|NCT01599325|76162147|FG000|COMPLETED|Primary Parent Phase|Participants still on study treatment at time of study closure|15||
60046803|NCT01599325|76162147|FG000|NOT COMPLETED|Primary Parent Phase||57||
60046804|NCT01599325|76162147|FG000|STARTED|Extension Phase||15||
60046805|NCT01599325|76162147|FG000|COMPLETED|Extension Phase||0||
60046806|NCT01599325|76162147|FG000|NOT COMPLETED|Extension Phase||15||
60046807|NCT01924299|76162154|FG000|STARTED|Period 1||18||
60046808|NCT01924299|76162155|FG001|STARTED|Period 1||18||
60046809|NCT01924299|76162154|FG000|Received Baricitinib|Period 1||18||
60046810|NCT01924299|76162155|FG001|Received Baricitinib|Period 1||18||
60046811|NCT01924299|76162154|FG000|COMPLETED|Period 1||18||
60046812|NCT01924299|76162155|FG001|COMPLETED|Period 1||18||
60046813|NCT01924299|76162154|FG000|NOT COMPLETED|Period 1||0||
60046814|NCT01924299|76162155|FG001|NOT COMPLETED|Period 1||0||
60046815|NCT01924299|76162154|FG000|STARTED|Period 2||18||
60046816|NCT01924299|76162155|FG001|STARTED|Period 2||18||
60046817|NCT01924299|76162154|FG000|Received at Least 1 Dose of Study Drug|Period 2||18||
60046818|NCT01924299|76162155|FG001|Received at Least 1 Dose of Study Drug|Period 2||18||
60046819|NCT01924299|76162154|FG000|Received Baricitinib|Period 2||17||
60046820|NCT01924299|76162155|FG001|Received Baricitinib|Period 2||17||
60046821|NCT01924299|76162154|FG000|COMPLETED|Period 2||17||
60046822|NCT01924299|76162155|FG001|COMPLETED|Period 2||17||
60046823|NCT01924299|76162154|FG000|NOT COMPLETED|Period 2||1||
60046824|NCT01924299|76162155|FG001|NOT COMPLETED|Period 2||1||
60046825|NCT02182999|76162169|FG000|STARTED|Overall Study||25||
60046826|NCT02182999|76162170|FG001|STARTED|Overall Study||25||
60046827|NCT02182999|76162169|FG000|COMPLETED|Overall Study||20||
60046828|NCT02182999|76162170|FG001|COMPLETED|Overall Study||22||
60046829|NCT02182999|76162169|FG000|NOT COMPLETED|Overall Study||5||
60046830|NCT02182999|76162170|FG001|NOT COMPLETED|Overall Study||3||
60046831|NCT02243696|76162176|FG000|STARTED|Overall Study||1694||
60046832|NCT02243696|76162176|FG000|COMPLETED|Overall Study||0||
60046833|NCT02243696|76162176|FG000|NOT COMPLETED|Overall Study||1694||
60046834|NCT01598311|76162182|FG000|STARTED|Overall Study||303|Randomized|
59511965|NCT02763826|75605499|FG000|STARTED|Part 1 Dose Escalation, 3 mA||0||
59511966|NCT02763826|75605500|FG001|STARTED|Part 1 Dose Escalation, 3 mA||0||
59511967|NCT02763826|75605501|FG002|STARTED|Part 1 Dose Escalation, 3 mA||0||
59511968|NCT02763826|75605502|FG003|STARTED|Part 1 Dose Escalation, 3 mA||3||
59511969|NCT02763826|75605503|FG004|STARTED|Part 1 Dose Escalation, 3 mA||0||
59511970|NCT02763826|75605504|FG005|STARTED|Part 1 Dose Escalation, 3 mA||0||
59511971|NCT02763826|75605505|FG006|STARTED|Part 1 Dose Escalation, 3 mA||0||
59511972|NCT02763826|75605506|FG007|STARTED|Part 1 Dose Escalation, 3 mA||0||
59511973|NCT02763826|75605499|FG000|COMPLETED|Part 1 Dose Escalation, 3 mA||0||
59511974|NCT02763826|75605500|FG001|COMPLETED|Part 1 Dose Escalation, 3 mA||0||
59511975|NCT02763826|75605501|FG002|COMPLETED|Part 1 Dose Escalation, 3 mA||0||
59919862|NCT04058054|76040010|FG003|NOT COMPLETED|Overall Study||0||0
59919863|NCT04058054|76040011|FG004|NOT COMPLETED|Overall Study||0||0
59919864|NCT03306043|76040023|FG000|STARTED|Overall Study||102||
59919865|NCT03306043|76040023|FG000|COMPLETED|Overall Study||98||
59919866|NCT03306043|76040023|FG000|NOT COMPLETED|Overall Study||4||
59919867|NCT01069172|76040027|FG000|STARTED|Overall Study|30 eyes|30||
59919868|NCT01069172|76040028|FG001|STARTED|Overall Study|30 eyes|30||
59919869|NCT01069172|76040027|FG000|COMPLETED|Overall Study|29 eyes|29||
59919870|NCT01069172|76040028|FG001|COMPLETED|Overall Study|30 eyes|30||
59919871|NCT01069172|76040027|FG000|NOT COMPLETED|Overall Study||1||
59919872|NCT01069172|76040028|FG001|NOT COMPLETED|Overall Study||0||
60046835|NCT01598311|76162183|FG001|STARTED|Overall Study||305|Randomized|
59519035|NCT03593200|75612883|FG000|NOT COMPLETED|Overall Study||0||
60046836|NCT01598311|76162182|FG000|Treated|Overall Study||294|Safety Population|
60046837|NCT01598311|76162183|FG001|Treated|Overall Study||301|Safety Population|
60046838|NCT01598311|76162182|FG000|Treated and Confirmed CDAD|Overall Study||285|mMITT Population|
59919873|NCT02911688|76040037|FG000|STARTED|First Intervention||9||
59511976|NCT02763826|75605502|FG003|COMPLETED|Part 1 Dose Escalation, 3 mA||3||
59511977|NCT02763826|75605503|FG004|COMPLETED|Part 1 Dose Escalation, 3 mA||0||
59511978|NCT02763826|75605504|FG005|COMPLETED|Part 1 Dose Escalation, 3 mA||0||
59511979|NCT02763826|75605505|FG006|COMPLETED|Part 1 Dose Escalation, 3 mA||0||
59511980|NCT02763826|75605506|FG007|COMPLETED|Part 1 Dose Escalation, 3 mA||0||
59511981|NCT02763826|75605499|FG000|NOT COMPLETED|Part 1 Dose Escalation, 3 mA||0||
59511982|NCT02763826|75605500|FG001|NOT COMPLETED|Part 1 Dose Escalation, 3 mA||0||
59511983|NCT02763826|75605501|FG002|NOT COMPLETED|Part 1 Dose Escalation, 3 mA||0||
59919874|NCT02911688|76040038|FG001|STARTED|First Intervention||9||
59919875|NCT02911688|76040037|FG000|Received Intervention|First Intervention||9||
59919876|NCT02911688|76040038|FG001|Received Intervention|First Intervention||9||
59919877|NCT02911688|76040037|FG000|COMPLETED|First Intervention||9||
59919878|NCT02911688|76040038|FG001|COMPLETED|First Intervention||9||
59919879|NCT02911688|76040037|FG000|NOT COMPLETED|First Intervention||0||
59919880|NCT02911688|76040038|FG001|NOT COMPLETED|First Intervention||0||
59919881|NCT02911688|76040037|FG000|STARTED|Washout||9||
59919882|NCT02911688|76040038|FG001|STARTED|Washout||9||
59919883|NCT02911688|76040037|FG000|COMPLETED|Washout||8||
59919884|NCT02911688|76040038|FG001|COMPLETED|Washout||7||
59919885|NCT02911688|76040037|FG000|NOT COMPLETED|Washout||1||
59919886|NCT02911688|76040038|FG001|NOT COMPLETED|Washout||2||
59919887|NCT02911688|76040037|FG000|STARTED|Second Intervention||8||
59919888|NCT02911688|76040038|FG001|STARTED|Second Intervention||7||
59919889|NCT02911688|76040037|FG000|COMPLETED|Second Intervention||8||
59919890|NCT02911688|76040038|FG001|COMPLETED|Second Intervention||7||
59919891|NCT02911688|76040037|FG000|NOT COMPLETED|Second Intervention||0||
59919892|NCT02911688|76040038|FG001|NOT COMPLETED|Second Intervention||0||
59919893|NCT02670928|76040048|FG000|STARTED|Overall Study||100|All enrolled patients (Full Analysis Set and Safety Population)|
59919894|NCT02670928|76040049|FG001|STARTED|Overall Study||30|All enrolled patients (Full Analysis Set and Safety Population)|
59919895|NCT02670928|76040048|FG000|COMPLETED|Overall Study||90||
59919896|NCT02670928|76040049|FG001|COMPLETED|Overall Study||29||
59919897|NCT02670928|76040048|FG000|NOT COMPLETED|Overall Study||10||
59919898|NCT02670928|76040049|FG001|NOT COMPLETED|Overall Study||1||
59919899|NCT03305809|76040059|FG000|STARTED|Overall Study||86||
59919900|NCT03305809|76040060|FG001|STARTED|Overall Study||86||
59919901|NCT03305809|76040061|FG002|STARTED|Overall Study||85||
59919902|NCT03305809|76040062|FG003|STARTED|Overall Study||87||
59919903|NCT03305809|76040059|FG000|Received at Least One Dose of Study Drug|Overall Study||86||
59919904|NCT03305809|76040060|FG001|Received at Least One Dose of Study Drug|Overall Study||86||
59919905|NCT03305809|76040061|FG002|Received at Least One Dose of Study Drug|Overall Study||85||
59919906|NCT03305809|76040062|FG003|Received at Least One Dose of Study Drug|Overall Study||87||
59919907|NCT03305809|76040059|FG000|COMPLETED|Overall Study||79||
59919908|NCT03305809|76040060|FG001|COMPLETED|Overall Study||78||
59919909|NCT03305809|76040061|FG002|COMPLETED|Overall Study||66||
59919910|NCT03305809|76040062|FG003|COMPLETED|Overall Study||60||
59919911|NCT03305809|76040059|FG000|NOT COMPLETED|Overall Study||7||
59919912|NCT03305809|76040060|FG001|NOT COMPLETED|Overall Study||8||
59919913|NCT03305809|76040061|FG002|NOT COMPLETED|Overall Study||19||
59919914|NCT03305809|76040062|FG003|NOT COMPLETED|Overall Study||27||
59919915|NCT02994056|76040075|FG000|STARTED|Overall Study||32||
59919916|NCT02994056|76040075|FG000|COMPLETED|Overall Study||23||
59919917|NCT02994056|76040075|FG000|NOT COMPLETED|Overall Study||9||
59919918|NCT03728153|76040088|FG000|STARTED|Overall Study||34||
59919919|NCT03728153|76040088|FG000|COMPLETED|Overall Study||32||
59919920|NCT03728153|76040088|FG000|NOT COMPLETED|Overall Study||2||
59919921|NCT03548051|76040094|FG000|STARTED|Overall Study||6||
59919922|NCT03548051|76040095|FG001|STARTED|Overall Study||4||
59919923|NCT03548051|76040094|FG000|COMPLETED|Overall Study||4||
59919924|NCT03548051|76040095|FG001|COMPLETED|Overall Study||3||
59919925|NCT03548051|76040094|FG000|NOT COMPLETED|Overall Study||2||
59919926|NCT03548051|76040095|FG001|NOT COMPLETED|Overall Study||1||
59919927|NCT03305731|76040101|FG000|STARTED|Overall Study||21|Baseline|
59919928|NCT03305731|76040101|FG000|Week 6|Overall Study||20||
59919929|NCT03305731|76040101|FG000|Week 11|Overall Study||20||
59919930|NCT03305731|76040101|FG000|COMPLETED|Overall Study||20|Week 18|
59919931|NCT03305731|76040101|FG000|NOT COMPLETED|Overall Study||1||
59919932|NCT03305575|76040107|FG000|STARTED|Overall Study||5||
59919933|NCT03305575|76040108|FG001|STARTED|Overall Study||5||
59919934|NCT03305575|76040107|FG000|COMPLETED|Overall Study||4||
59919935|NCT03305575|76040108|FG001|COMPLETED|Overall Study||5||
59919936|NCT03305575|76040107|FG000|NOT COMPLETED|Overall Study||1||
59919937|NCT03305575|76040108|FG001|NOT COMPLETED|Overall Study||0||
59919938|NCT02993822|76040118|FG000|STARTED|Overall Study||79||
59919939|NCT02993822|76040119|FG001|STARTED|Overall Study||78||
59919940|NCT02993822|76040120|FG002|STARTED|Overall Study||79||
59919941|NCT02993822|76040121|FG003|STARTED|Overall Study||79||
59919942|NCT02993822|76040118|FG000|COMPLETED|Overall Study||69||
59919943|NCT02993822|76040119|FG001|COMPLETED|Overall Study||74||
59919944|NCT02993822|76040120|FG002|COMPLETED|Overall Study||69||
59919945|NCT02993822|76040121|FG003|COMPLETED|Overall Study||75||
60046839|NCT01598311|76162183|FG001|Treated and Confirmed CDAD|Overall Study||292|mMITT Population|
60046840|NCT01598311|76162182|FG000|COMPLETED|Overall Study||256||
60046841|NCT01598311|76162183|FG001|COMPLETED|Overall Study||244||
60046842|NCT01598311|76162182|FG000|NOT COMPLETED|Overall Study||47||
60046843|NCT01598311|76162183|FG001|NOT COMPLETED|Overall Study||61||
60046844|NCT02182843|76162189|FG000|STARTED|Overall Study||81||
60046845|NCT02182843|76162189|FG000|COMPLETED|Overall Study||71||
60046846|NCT02182843|76162189|FG000|NOT COMPLETED|Overall Study||10||
60046847|NCT02208050|76162195|FG000|STARTED|Baseline Assessment Period: 2 Weeks||36||
60046848|NCT02208050|76162196|FG001|STARTED|Baseline Assessment Period: 2 Weeks||28||
60046849|NCT02208050|76162195|FG000|COMPLETED|Baseline Assessment Period: 2 Weeks||36||
60046850|NCT02208050|76162196|FG001|COMPLETED|Baseline Assessment Period: 2 Weeks||28||
60046851|NCT02208050|76162195|FG000|NOT COMPLETED|Baseline Assessment Period: 2 Weeks||0||
60046852|NCT02208050|76162196|FG001|NOT COMPLETED|Baseline Assessment Period: 2 Weeks||0||
60046853|NCT02208050|76162195|FG000|STARTED|Treatment Period 1: 8 Weeks Treatment||36||
59919946|NCT02993822|76040118|FG000|NOT COMPLETED|Overall Study||10||
59919947|NCT02993822|76040119|FG001|NOT COMPLETED|Overall Study||4||
59919948|NCT02993822|76040120|FG002|NOT COMPLETED|Overall Study||10||
59919949|NCT02993822|76040121|FG003|NOT COMPLETED|Overall Study||4||
59919950|NCT01068860|76040141|FG000|STARTED|Overall Study||33||
59919951|NCT01068860|76040142|FG001|STARTED|Overall Study||17||
59511984|NCT02763826|75605502|FG003|NOT COMPLETED|Part 1 Dose Escalation, 3 mA||0||
59511985|NCT02763826|75605503|FG004|NOT COMPLETED|Part 1 Dose Escalation, 3 mA||0||
59511986|NCT02763826|75605504|FG005|NOT COMPLETED|Part 1 Dose Escalation, 3 mA||0||
59511987|NCT02763826|75605505|FG006|NOT COMPLETED|Part 1 Dose Escalation, 3 mA||0||
59511988|NCT02763826|75605506|FG007|NOT COMPLETED|Part 1 Dose Escalation, 3 mA||0||
59511989|NCT02763826|75605499|FG000|STARTED|Part 1 Dose Escalation, 3.5 mA||0||
59919952|NCT01068860|76040143|FG002|STARTED|Overall Study||33||
59919953|NCT01068860|76040144|FG003|STARTED|Overall Study||17||
60046854|NCT02208050|76162196|FG001|STARTED|Treatment Period 1: 8 Weeks Treatment||28||
60046855|NCT02208050|76162195|FG000|COMPLETED|Treatment Period 1: 8 Weeks Treatment||36||
60046856|NCT02208050|76162196|FG001|COMPLETED|Treatment Period 1: 8 Weeks Treatment||28||
60046857|NCT02208050|76162195|FG000|NOT COMPLETED|Treatment Period 1: 8 Weeks Treatment||0||
60046858|NCT02208050|76162196|FG001|NOT COMPLETED|Treatment Period 1: 8 Weeks Treatment||0||
60046859|NCT02208050|76162195|FG000|STARTED|Washout Period 1: 2 Weeks||36||
59511990|NCT02763826|75605500|FG001|STARTED|Part 1 Dose Escalation, 3.5 mA||0||
59511991|NCT02763826|75605501|FG002|STARTED|Part 1 Dose Escalation, 3.5 mA||0||
59511992|NCT02763826|75605502|FG003|STARTED|Part 1 Dose Escalation, 3.5 mA||0||
59511993|NCT02763826|75605503|FG004|STARTED|Part 1 Dose Escalation, 3.5 mA||3||
59511994|NCT02763826|75605504|FG005|STARTED|Part 1 Dose Escalation, 3.5 mA||0||
59511995|NCT02763826|75605505|FG006|STARTED|Part 1 Dose Escalation, 3.5 mA||0||
59511996|NCT02763826|75605506|FG007|STARTED|Part 1 Dose Escalation, 3.5 mA||0||
59511997|NCT02763826|75605499|FG000|COMPLETED|Part 1 Dose Escalation, 3.5 mA||0||
59511998|NCT02763826|75605500|FG001|COMPLETED|Part 1 Dose Escalation, 3.5 mA||0||
59511999|NCT02763826|75605501|FG002|COMPLETED|Part 1 Dose Escalation, 3.5 mA||0||
59512000|NCT02763826|75605502|FG003|COMPLETED|Part 1 Dose Escalation, 3.5 mA||0||
59919954|NCT01068860|76040145|FG004|STARTED|Overall Study||32||
59919955|NCT01068860|76040146|FG005|STARTED|Overall Study||16||
59919956|NCT01068860|76040147|FG006|STARTED|Overall Study||28||
60046860|NCT02208050|76162196|FG001|STARTED|Washout Period 1: 2 Weeks||28||
60046861|NCT02208050|76162195|FG000|COMPLETED|Washout Period 1: 2 Weeks||35||
60046862|NCT02208050|76162196|FG001|COMPLETED|Washout Period 1: 2 Weeks||28||
60046863|NCT02208050|76162195|FG000|NOT COMPLETED|Washout Period 1: 2 Weeks||1||
59612523|NCT01701258|75723501|FG002|NOT COMPLETED|EEG (Session 4)||0||
59612524|NCT01701258|75723502|FG003|NOT COMPLETED|EEG (Session 4)||0||
59919957|NCT01068860|76040148|FG007|STARTED|Overall Study||15||
59919958|NCT01068860|76040149|FG008|STARTED|Overall Study||28||
59919959|NCT01068860|76040150|FG009|STARTED|Overall Study||27||
59919960|NCT01068860|76040141|FG000|COMPLETED|Overall Study||33||
59919961|NCT01068860|76040142|FG001|COMPLETED|Overall Study||16||
60046864|NCT02208050|76162196|FG001|NOT COMPLETED|Washout Period 1: 2 Weeks||0||
60046865|NCT02208050|76162195|FG000|STARTED|Treatment Period 2: 8 Weeks Treatment||35||
60046866|NCT02208050|76162196|FG001|STARTED|Treatment Period 2: 8 Weeks Treatment||28||
59512001|NCT02763826|75605503|FG004|COMPLETED|Part 1 Dose Escalation, 3.5 mA||3||
59512002|NCT02763826|75605504|FG005|COMPLETED|Part 1 Dose Escalation, 3.5 mA||0||
59919962|NCT01068860|76040143|FG002|COMPLETED|Overall Study||33||
59919963|NCT01068860|76040144|FG003|COMPLETED|Overall Study||16||
59919964|NCT01068860|76040145|FG004|COMPLETED|Overall Study||32||
59919965|NCT01068860|76040146|FG005|COMPLETED|Overall Study||14||
59919966|NCT01068860|76040147|FG006|COMPLETED|Overall Study||28||
59919967|NCT01068860|76040148|FG007|COMPLETED|Overall Study||15||
60046867|NCT02208050|76162195|FG000|COMPLETED|Treatment Period 2: 8 Weeks Treatment||33||
60046868|NCT02208050|76162196|FG001|COMPLETED|Treatment Period 2: 8 Weeks Treatment||28||
60046869|NCT02208050|76162195|FG000|NOT COMPLETED|Treatment Period 2: 8 Weeks Treatment||2||
59919968|NCT01068860|76040149|FG008|COMPLETED|Overall Study||28||
59919969|NCT01068860|76040150|FG009|COMPLETED|Overall Study||23||
59919970|NCT01068860|76040141|FG000|NOT COMPLETED|Overall Study||0||
59512003|NCT02763826|75605505|FG006|COMPLETED|Part 1 Dose Escalation, 3.5 mA||0||
60046870|NCT02208050|76162196|FG001|NOT COMPLETED|Treatment Period 2: 8 Weeks Treatment||0||
60046871|NCT02208050|76162195|FG000|STARTED|Washout Period 2: 2 Weeks Washout.||33||
60046872|NCT02208050|76162196|FG001|STARTED|Washout Period 2: 2 Weeks Washout.||28||
60046873|NCT02208050|76162195|FG000|COMPLETED|Washout Period 2: 2 Weeks Washout.||33||
60046874|NCT02208050|76162196|FG001|COMPLETED|Washout Period 2: 2 Weeks Washout.||28||
60046875|NCT02208050|76162195|FG000|NOT COMPLETED|Washout Period 2: 2 Weeks Washout.||0||
60046876|NCT02208050|76162196|FG001|NOT COMPLETED|Washout Period 2: 2 Weeks Washout.||0||
60046877|NCT02978222|76162218|FG000|STARTED|Overall Study||62||
60046878|NCT02978222|76162219|FG001|STARTED|Overall Study||58||
60046879|NCT02978222|76162218|FG000|COMPLETED|Overall Study||1||
60046880|NCT02978222|76162219|FG001|COMPLETED|Overall Study||2||
60046881|NCT02978222|76162218|FG000|NOT COMPLETED|Overall Study||61||
60046882|NCT02978222|76162219|FG001|NOT COMPLETED|Overall Study||56||
60046883|NCT02181673|76162227|FG000|STARTED|Up to Week 24||239||
60046884|NCT02181673|76162228|FG001|STARTED|Up to Week 24||0||
60046885|NCT02181673|76162229|FG002|STARTED|Up to Week 24||241||
60046886|NCT02181673|76162227|FG000|Treated|Up to Week 24||239||
59512004|NCT02763826|75605506|FG007|COMPLETED|Part 1 Dose Escalation, 3.5 mA||0||
59512005|NCT02763826|75605499|FG000|NOT COMPLETED|Part 1 Dose Escalation, 3.5 mA||0||
59512006|NCT02763826|75605500|FG001|NOT COMPLETED|Part 1 Dose Escalation, 3.5 mA||0||
59512007|NCT02763826|75605501|FG002|NOT COMPLETED|Part 1 Dose Escalation, 3.5 mA||0||
59512008|NCT02763826|75605502|FG003|NOT COMPLETED|Part 1 Dose Escalation, 3.5 mA||0||
59512009|NCT02763826|75605503|FG004|NOT COMPLETED|Part 1 Dose Escalation, 3.5 mA||0||
59612525|NCT01701258|75723503|FG004|NOT COMPLETED|EEG (Session 4)||0||
59919971|NCT01068860|76040142|FG001|NOT COMPLETED|Overall Study||1||
59919972|NCT01068860|76040143|FG002|NOT COMPLETED|Overall Study||0||
59919973|NCT01068860|76040144|FG003|NOT COMPLETED|Overall Study||1||
60046887|NCT02181673|76162228|FG001|Treated|Up to Week 24||0||
60046888|NCT02181673|76162229|FG002|Treated|Up to Week 24||240||
60046889|NCT02181673|76162227|FG000|COMPLETED|Up to Week 24||222||
60046890|NCT02181673|76162228|FG001|COMPLETED|Up to Week 24||0||
60046891|NCT02181673|76162229|FG002|COMPLETED|Up to Week 24||230||
60046892|NCT02181673|76162227|FG000|NOT COMPLETED|Up to Week 24||17||
60046893|NCT02181673|76162228|FG001|NOT COMPLETED|Up to Week 24||0||
60046894|NCT02181673|76162229|FG002|NOT COMPLETED|Up to Week 24||11||
60046895|NCT02181673|76162227|FG000|STARTED|Week 24-Week 60||0||
60046896|NCT02181673|76162228|FG001|STARTED|Week 24-Week 60||222||
60046897|NCT02181673|76162229|FG002|STARTED|Week 24-Week 60||230||
59919974|NCT01068860|76040145|FG004|NOT COMPLETED|Overall Study||0||
59919975|NCT01068860|76040146|FG005|NOT COMPLETED|Overall Study||2||
59919976|NCT01068860|76040147|FG006|NOT COMPLETED|Overall Study||0||
59919977|NCT01068860|76040148|FG007|NOT COMPLETED|Overall Study||0||
59919978|NCT01068860|76040149|FG008|NOT COMPLETED|Overall Study||0||
59919979|NCT01068860|76040150|FG009|NOT COMPLETED|Overall Study||4||
60046898|NCT02181673|76162227|FG000|Treated|Week 24-Week 60||0||
60046899|NCT02181673|76162228|FG001|Treated|Week 24-Week 60||220||
60046900|NCT02181673|76162229|FG002|Treated|Week 24-Week 60||230||
60046901|NCT02181673|76162227|FG000|COMPLETED|Week 24-Week 60||0||
60046902|NCT02181673|76162228|FG001|COMPLETED|Week 24-Week 60||214||
60046903|NCT02181673|76162229|FG002|COMPLETED|Week 24-Week 60||213||
60046904|NCT02181673|76162227|FG000|NOT COMPLETED|Week 24-Week 60||0||
60046905|NCT02181673|76162228|FG001|NOT COMPLETED|Week 24-Week 60||8||
60046906|NCT02181673|76162229|FG002|NOT COMPLETED|Week 24-Week 60||17||
60046907|NCT02131129|76162238|FG000|STARTED|Overall Study||10||
60046908|NCT02131129|76162239|FG001|STARTED|Overall Study||10||
60046909|NCT02131129|76162238|FG000|COMPLETED|Overall Study||9||
60046910|NCT02131129|76162239|FG001|COMPLETED|Overall Study||10||
60046911|NCT02131129|76162238|FG000|NOT COMPLETED|Overall Study||1||
60046912|NCT02131129|76162239|FG001|NOT COMPLETED|Overall Study||0||
60046913|NCT02152345|76162247|FG000|STARTED|Overall Study|The first subject randomized to Belatacept was on 15-Sep-2014.|28||
60046914|NCT02152345|76162248|FG001|STARTED|Overall Study|The first subject randomized to Standard Immunosuppression was on 14-Jun-2014.|29||
60046915|NCT02152345|76162247|FG000|COMPLETED|Overall Study|The last subject randomized to Belatacept was on 29-Dec-2016.|24||
60046916|NCT02152345|76162248|FG001|COMPLETED|Overall Study|The last subject randomized to Standard Immunosuppression was on 25-Dec-2016.|24||
60046917|NCT02152345|76162247|FG000|NOT COMPLETED|Overall Study||4||
60046918|NCT02152345|76162248|FG001|NOT COMPLETED|Overall Study||5||
60046919|NCT02180659|76162256|FG000|STARTED|Overall Study||87||
60046920|NCT02180659|76162257|FG001|STARTED|Overall Study|N=90 randomized, however N=89 received study medication|89||
60046921|NCT02180659|76162256|FG000|COMPLETED|Overall Study||81||
60046922|NCT02180659|76162257|FG001|COMPLETED|Overall Study||84||
60046923|NCT02180659|76162256|FG000|NOT COMPLETED|Overall Study||6||
60046924|NCT02180659|76162257|FG001|NOT COMPLETED|Overall Study||5||
60046925|NCT02130427|76162263|FG000|STARTED|Overall Study||74||
60046926|NCT02130427|76162263|FG000|COMPLETED|Overall Study||44||
60046927|NCT02130427|76162263|FG000|NOT COMPLETED|Overall Study||30||
60046928|NCT02207816|76162270|FG000|STARTED|Overall Study||1046||
60046929|NCT02207816|76162271|FG001|STARTED|Overall Study||1010||
60046930|NCT02207816|76162272|FG002|STARTED|Overall Study||1028||
60046931|NCT02207816|76162270|FG000|COMPLETED|Overall Study||995||
60046932|NCT02207816|76162271|FG001|COMPLETED|Overall Study||924||
60046933|NCT02207816|76162272|FG002|COMPLETED|Overall Study||961||
60046934|NCT02207816|76162270|FG000|NOT COMPLETED|Overall Study||51||
60046935|NCT02207816|76162271|FG001|NOT COMPLETED|Overall Study||86||
60046936|NCT02207816|76162272|FG002|NOT COMPLETED|Overall Study||67||
60046937|NCT02241512|76162285|FG000|STARTED|Overall Study||30||
60046938|NCT02241512|76162286|FG001|STARTED|Overall Study||29||
60046939|NCT02241512|76162285|FG000|COMPLETED|Overall Study||29||
60046940|NCT02241512|76162286|FG001|COMPLETED|Overall Study||29||
60046941|NCT02241512|76162285|FG000|NOT COMPLETED|Overall Study||1||
60046942|NCT02241512|76162286|FG001|NOT COMPLETED|Overall Study||0||
60046943|NCT02205476|76162294|FG000|STARTED|Overall Study||7||
60046944|NCT02205476|76162295|FG001|STARTED|Overall Study||3||
60046945|NCT02205476|76162294|FG000|COMPLETED|Overall Study||0||
60046946|NCT02205476|76162295|FG001|COMPLETED|Overall Study||0||
60046947|NCT02205476|76162294|FG000|NOT COMPLETED|Overall Study||7||
60046948|NCT02205476|76162295|FG001|NOT COMPLETED|Overall Study||3||
60046949|NCT01709110|76162309|FG000|STARTED|Overall Study||683||
60046950|NCT01709110|76162310|FG001|STARTED|Overall Study||683||
60046951|NCT01709110|76162309|FG000|Received at Least One Dose of Study Drug|Overall Study||680||
60046952|NCT01709110|76162310|FG001|Received at Least One Dose of Study Drug|Overall Study||680||
60046953|NCT01709110|76162309|FG000|COMPLETED|Overall Study||498||
60046954|NCT01709110|76162310|FG001|COMPLETED|Overall Study||515||
60046955|NCT01709110|76162309|FG000|NOT COMPLETED|Overall Study||185||
60046956|NCT01709110|76162310|FG001|NOT COMPLETED|Overall Study||168||
60046957|NCT02240108|76162318|FG000|STARTED|Overall Study||35||
60046958|NCT02240108|76162319|FG001|STARTED|Overall Study||46||
60046959|NCT02240108|76162318|FG000|Intent-to-treat (ITT) Population|Overall Study||35|Received at least 1 dose of study drug|
60046960|NCT02240108|76162319|FG001|Intent-to-treat (ITT) Population|Overall Study||45|Received at least 1 dose of study drug|
60046961|NCT02240108|76162318|FG000|COMPLETED|Overall Study||21||
60046962|NCT02240108|76162319|FG001|COMPLETED|Overall Study||21||
60046963|NCT02240108|76162318|FG000|NOT COMPLETED|Overall Study||14||
60046964|NCT02240108|76162319|FG001|NOT COMPLETED|Overall Study||25||
60046965|NCT02239640|76162325|FG000|STARTED|Overall Study||984||
60046966|NCT02239640|76162325|FG000|COMPLETED|Overall Study||767||
60046967|NCT02239640|76162325|FG000|NOT COMPLETED|Overall Study||217||
60046968|NCT01590628|76162337|FG000|STARTED|Overall Study||13||
60046969|NCT01590628|76162338|FG001|STARTED|Overall Study||3||
60046970|NCT01590628|76162337|FG000|COMPLETED|Overall Study||11||
60046971|NCT01590628|76162338|FG001|COMPLETED|Overall Study||3||
60046972|NCT01590628|76162337|FG000|NOT COMPLETED|Overall Study||2||
60046973|NCT01590628|76162338|FG001|NOT COMPLETED|Overall Study||0||
60046974|NCT02130193|76162350|FG000|STARTED|Part A: 4-week Open-label Period||9||
60046975|NCT02130193|76162351|FG001|STARTED|Part A: 4-week Open-label Period||0||
60046976|NCT02130193|76162352|FG002|STARTED|Part A: 4-week Open-label Period||0||
60046977|NCT02130193|76162350|FG000|COMPLETED|Part A: 4-week Open-label Period||9||
60046978|NCT02130193|76162351|FG001|COMPLETED|Part A: 4-week Open-label Period||0||
60046979|NCT02130193|76162352|FG002|COMPLETED|Part A: 4-week Open-label Period||0||
60046980|NCT02130193|76162350|FG000|NOT COMPLETED|Part A: 4-week Open-label Period||0||
60046981|NCT02130193|76162351|FG001|NOT COMPLETED|Part A: 4-week Open-label Period||0||
60046982|NCT02130193|76162352|FG002|NOT COMPLETED|Part A: 4-week Open-label Period||0||
60046983|NCT02130193|76162350|FG000|STARTED|Part B: 52-week Double-blind Period||0||
60046984|NCT02130193|76162351|FG001|STARTED|Part B: 52-week Double-blind Period||48||
60046985|NCT02130193|76162352|FG002|STARTED|Part B: 52-week Double-blind Period||45||
60046986|NCT02130193|76162350|FG000|COMPLETED|Part B: 52-week Double-blind Period||0||
60046987|NCT02130193|76162351|FG001|COMPLETED|Part B: 52-week Double-blind Period||38||
60046988|NCT02130193|76162352|FG002|COMPLETED|Part B: 52-week Double-blind Period||37||
60046989|NCT02130193|76162350|FG000|NOT COMPLETED|Part B: 52-week Double-blind Period||0||
59512010|NCT02763826|75605504|FG005|NOT COMPLETED|Part 1 Dose Escalation, 3.5 mA||0||
59512011|NCT02763826|75605505|FG006|NOT COMPLETED|Part 1 Dose Escalation, 3.5 mA||0||
59512012|NCT02763826|75605506|FG007|NOT COMPLETED|Part 1 Dose Escalation, 3.5 mA||0||
59512013|NCT02763826|75605499|FG000|STARTED|Part 1 Dose Escalation, 4 mA||0||
59612526|NCT01701258|75723504|FG005|NOT COMPLETED|EEG (Session 4)||0||
59612527|NCT01701258|75723505|FG006|NOT COMPLETED|EEG (Session 4)||0||
59760015|NCT00900731|75879559|FG000|Safety Set: Received Study Drug|Overall Study||794||
59760016|NCT00900731|75879560|FG001|Safety Set: Received Study Drug|Overall Study||799||
60046990|NCT02130193|76162351|FG001|NOT COMPLETED|Part B: 52-week Double-blind Period||10||
60046991|NCT02130193|76162352|FG002|NOT COMPLETED|Part B: 52-week Double-blind Period||8||
60046992|NCT01590082|76162363|FG000|STARTED|Overall Study||11||
60046993|NCT01590082|76162364|FG001|STARTED|Overall Study||1||
60046994|NCT01590082|76162363|FG000|COMPLETED|Overall Study||9||
60046995|NCT01590082|76162364|FG001|COMPLETED|Overall Study||1||
60046996|NCT01590082|76162363|FG000|NOT COMPLETED|Overall Study||2||
60046997|NCT01590082|76162364|FG001|NOT COMPLETED|Overall Study||0||
60046998|NCT01631474|76162375|FG000|STARTED|Overall Study||72||
60046999|NCT01631474|76162376|FG001|STARTED|Overall Study||76||
60047000|NCT01631474|76162377|FG002|STARTED|Overall Study||70||
60047001|NCT01631474|76162378|FG003|STARTED|Overall Study||70||
60047002|NCT01631474|76162379|FG004|STARTED|Overall Study||75||
60047003|NCT01631474|76162375|FG000|COMPLETED|Overall Study||58||
60047004|NCT01631474|76162376|FG001|COMPLETED|Overall Study||64||
60047005|NCT01631474|76162377|FG002|COMPLETED|Overall Study||61||
60047006|NCT01631474|76162378|FG003|COMPLETED|Overall Study||59||
60047007|NCT01631474|76162379|FG004|COMPLETED|Overall Study||62||
60047008|NCT01631474|76162375|FG000|NOT COMPLETED|Overall Study||14||
60047009|NCT01631474|76162376|FG001|NOT COMPLETED|Overall Study||12||
60047010|NCT01631474|76162377|FG002|NOT COMPLETED|Overall Study||9||
60047011|NCT01631474|76162378|FG003|NOT COMPLETED|Overall Study||11||
60047012|NCT01631474|76162379|FG004|NOT COMPLETED|Overall Study||13||
60047013|NCT02203916|76162394|FG000|STARTED|Overall Study||65||
60047014|NCT02203916|76162395|FG001|STARTED|Overall Study||132||
59512014|NCT02763826|75605500|FG001|STARTED|Part 1 Dose Escalation, 4 mA||0||
59512015|NCT02763826|75605501|FG002|STARTED|Part 1 Dose Escalation, 4 mA||0||
59512016|NCT02763826|75605502|FG003|STARTED|Part 1 Dose Escalation, 4 mA||0||
59512017|NCT02763826|75605503|FG004|STARTED|Part 1 Dose Escalation, 4 mA||0||
59512018|NCT02763826|75605504|FG005|STARTED|Part 1 Dose Escalation, 4 mA||3||
59612528|NCT01701258|75723506|FG007|NOT COMPLETED|EEG (Session 4)||0||
59612529|NCT01701258|75723507|FG008|NOT COMPLETED|EEG (Session 4)||0||
60047015|NCT02203916|76162396|FG002|STARTED|Overall Study|1 participant was randomized twice and counted only once.|131||
60047016|NCT02203916|76162394|FG000|Full Analysis Set (FAS)|Overall Study||65||
60047017|NCT02203916|76162395|FG001|Full Analysis Set (FAS)|Overall Study||132||
60047018|NCT02203916|76162396|FG002|Full Analysis Set (FAS)|Overall Study|1 participant was randomized twice, counted once in randomized set, and excluded from the FAS.|130||
60047019|NCT02203916|76162394|FG000|Safety Analysis Set (SAS)|Overall Study||65||
60047020|NCT02203916|76162395|FG001|Safety Analysis Set (SAS)|Overall Study||132||
60047021|NCT02203916|76162396|FG002|Safety Analysis Set (SAS)|Overall Study|1 participant was randomized twice, counted once in randomized set, and excluded from the SAS.|130||
60047022|NCT02203916|76162394|FG000|COMPLETED|Overall Study||57||
60047023|NCT02203916|76162395|FG001|COMPLETED|Overall Study||122||
60047024|NCT02203916|76162396|FG002|COMPLETED|Overall Study||120||
59612530|NCT01701258|75723508|FG009|NOT COMPLETED|EEG (Session 4)||0||
60047025|NCT02203916|76162394|FG000|NOT COMPLETED|Overall Study||8||
60047026|NCT02203916|76162395|FG001|NOT COMPLETED|Overall Study||10||
60047027|NCT02203916|76162396|FG002|NOT COMPLETED|Overall Study||11||
60047028|NCT04774328|76162407|FG000|STARTED|Overall Study||10||
60047029|NCT04774328|76162408|FG001|STARTED|Overall Study||12||
60047030|NCT04774328|76162409|FG002|STARTED|Overall Study||12||
60047031|NCT04774328|76162407|FG000|Follow-up to 29 Days Post Surgery|Overall Study||10||
60047032|NCT04774328|76162408|FG001|Follow-up to 29 Days Post Surgery|Overall Study||12||
60047033|NCT04774328|76162409|FG002|Follow-up to 29 Days Post Surgery|Overall Study||12||
60047034|NCT04774328|76162407|FG000|COMPLETED|Overall Study||10||
59919980|NCT02989610|76040172|FG000|STARTED|Overall Study||234||
59919981|NCT02989610|76040172|FG000|COMPLETED|Overall Study||195||
59919982|NCT02989610|76040172|FG000|NOT COMPLETED|Overall Study||39||
59919983|NCT01372774|76040178|FG000|STARTED|Overall Study||96||
59919984|NCT01372774|76040179|FG001|STARTED|Overall Study||98||
59919985|NCT01372774|76040178|FG000|COMPLETED|Overall Study||92||
59919986|NCT01372774|76040179|FG001|COMPLETED|Overall Study||93||
59919987|NCT01372774|76040178|FG000|NOT COMPLETED|Overall Study||4||
59919988|NCT01372774|76040179|FG001|NOT COMPLETED|Overall Study||5||
59919989|NCT02670538|76040190|FG000|STARTED|Overall Study||167||
59919990|NCT02670538|76040191|FG001|STARTED|Overall Study||168||
59919991|NCT02670538|76040192|FG002|STARTED|Overall Study||158||
59919992|NCT02670538|76040190|FG000|Safety Population : Received Study Drug|Overall Study||165||
59919993|NCT02670538|76040191|FG001|Safety Population : Received Study Drug|Overall Study||167||
59919994|NCT02670538|76040192|FG002|Safety Population : Received Study Drug|Overall Study||158||
59919995|NCT02670538|76040190|FG000|Intent-to-Treat Population|Overall Study||163||
59919996|NCT02670538|76040191|FG001|Intent-to-Treat Population|Overall Study||162||
59919997|NCT02670538|76040192|FG002|Intent-to-Treat Population|Overall Study||153||
59919998|NCT02670538|76040190|FG000|COMPLETED|Overall Study||135||
59919999|NCT02670538|76040191|FG001|COMPLETED|Overall Study||136||
59920000|NCT02670538|76040192|FG002|COMPLETED|Overall Study||128||
59920001|NCT02670538|76040190|FG000|NOT COMPLETED|Overall Study||32||
59920002|NCT02670538|76040191|FG001|NOT COMPLETED|Overall Study||32||
59920003|NCT02670538|76040192|FG002|NOT COMPLETED|Overall Study||30||
59920004|NCT03547583|76040203|FG000|STARTED|Overall Study||263||
59920005|NCT03547583|76040204|FG001|STARTED|Overall Study||264||
59920006|NCT03547583|76040205|FG002|STARTED|Overall Study||262||
59920007|NCT03547583|76040203|FG000|Treated|Overall Study||262||
59920008|NCT03547583|76040204|FG001|Treated|Overall Study||264||
59920009|NCT03547583|76040205|FG002|Treated|Overall Study||262||
59920010|NCT03547583|76040203|FG000|COMPLETED|Overall Study||218||
59920011|NCT03547583|76040204|FG001|COMPLETED|Overall Study||224||
59920012|NCT03547583|76040205|FG002|COMPLETED|Overall Study||230||
59920013|NCT03547583|76040203|FG000|NOT COMPLETED|Overall Study||45||
59920014|NCT03547583|76040204|FG001|NOT COMPLETED|Overall Study||40||
59920015|NCT03547583|76040205|FG002|NOT COMPLETED|Overall Study||32||
59920016|NCT02670382|76040216|FG000|STARTED|Placebo lead-in Phase||12||
59920017|NCT02670382|76040217|FG001|STARTED|Placebo lead-in Phase||12||
59920018|NCT02670382|76040216|FG000|COMPLETED|Placebo lead-in Phase|Two enrolled subjects randomized to receive EPA as the first intervention decided to stop participation during the placebo lead-in phase. Therefore, only 10 subjects continued to the EPA and then DHA supplementation phases. No data were collected from these two subjects.|10||
59920019|NCT02670382|76040217|FG001|COMPLETED|Placebo lead-in Phase|One enrolled subjects randomized to receive EDHA as the first intervention decided to stop participation during the placebo lead-in phase. Therefore, only 11 subjects continued to the DHA and then EPA supplementation phases. No data were collected from this subject.|11||
59920020|NCT02670382|76040216|FG000|NOT COMPLETED|Placebo lead-in Phase||2||
59920021|NCT02670382|76040217|FG001|NOT COMPLETED|Placebo lead-in Phase||1||
59920022|NCT02670382|76040216|FG000|STARTED|First Active Intervention|Only 10 of the 12 enrolled subjects randomized to receive EPA as the first supplementation completed the lead-in placebo phase and then entered the EPA supplementation phase.|10||
59920023|NCT02670382|76040217|FG001|STARTED|First Active Intervention|Only 11 of the 12 enrolled subjects randomized to receive DHA as the first supplementation completed the lead-in placebo phase and then entered the EDHA supplementation phase.|11||
59920024|NCT02670382|76040216|FG000|COMPLETED|First Active Intervention||10||
59920025|NCT02670382|76040217|FG001|COMPLETED|First Active Intervention||11||
59920026|NCT02670382|76040216|FG000|NOT COMPLETED|First Active Intervention||0||
59920027|NCT02670382|76040217|FG001|NOT COMPLETED|First Active Intervention||0||
59920028|NCT02670382|76040216|FG000|STARTED|Second Active Intervention||10||
59920029|NCT02670382|76040217|FG001|STARTED|Second Active Intervention||11||
59920030|NCT02670382|76040216|FG000|COMPLETED|Second Active Intervention||10||
59920031|NCT02670382|76040217|FG001|COMPLETED|Second Active Intervention||11||
59920032|NCT02670382|76040216|FG000|NOT COMPLETED|Second Active Intervention||0||
60047035|NCT04774328|76162408|FG001|COMPLETED|Overall Study||12||
60047036|NCT04774328|76162409|FG002|COMPLETED|Overall Study||12||
60047037|NCT04774328|76162407|FG000|NOT COMPLETED|Overall Study||0||
60047038|NCT04774328|76162408|FG001|NOT COMPLETED|Overall Study||0||
60047039|NCT04774328|76162409|FG002|NOT COMPLETED|Overall Study||0||
60047040|NCT02179177|76162420|FG000|STARTED|Overall Study||8||
60047041|NCT02179177|76162421|FG001|STARTED|Overall Study||8||
60047042|NCT02179177|76162420|FG000|COMPLETED|Overall Study||6||
60047043|NCT02179177|76162421|FG001|COMPLETED|Overall Study||6||
60047044|NCT02179177|76162420|FG000|NOT COMPLETED|Overall Study||2||
60047045|NCT02179177|76162421|FG001|NOT COMPLETED|Overall Study||2||
60047046|NCT02239328|76162427|FG000|STARTED|Overall Study||182||
60047047|NCT02239328|76162427|FG000|COMPLETED|Overall Study||174||
60047048|NCT02239328|76162427|FG000|NOT COMPLETED|Overall Study||8||
60047049|NCT02129803|76162433|FG000|STARTED|Overall Study||12||
60047050|NCT02129803|76162434|FG001|STARTED|Overall Study||12||
60047051|NCT02129803|76162433|FG000|COMPLETED|Overall Study||6||
60047052|NCT02129803|76162434|FG001|COMPLETED|Overall Study||9||
60047053|NCT02129803|76162433|FG000|NOT COMPLETED|Overall Study||6||
60047054|NCT02129803|76162434|FG001|NOT COMPLETED|Overall Study||3||
60047055|NCT02239094|76162440|FG000|STARTED|Overall Study||20||
59512019|NCT02763826|75605505|FG006|STARTED|Part 1 Dose Escalation, 4 mA||0||
59512020|NCT02763826|75605506|FG007|STARTED|Part 1 Dose Escalation, 4 mA||0||
59512021|NCT02763826|75605499|FG000|COMPLETED|Part 1 Dose Escalation, 4 mA||0||
60047056|NCT02239094|76162440|FG000|COMPLETED|Overall Study||18||
60047057|NCT02239094|76162440|FG000|NOT COMPLETED|Overall Study||2||
60047058|NCT02129647|76162444|FG000|STARTED|Overall Study||13||
60047059|NCT02129647|76162444|FG000|COMPLETED|Overall Study||10||
60047060|NCT02129647|76162444|FG000|NOT COMPLETED|Overall Study||3||
59760017|NCT00900731|75879559|FG000|COMPLETED|Overall Study||737||
59760018|NCT00900731|75879560|FG001|COMPLETED|Overall Study||740||
59760019|NCT00900731|75879559|FG000|NOT COMPLETED|Overall Study||60||
59760020|NCT00900731|75879560|FG001|NOT COMPLETED|Overall Study||61||
59760021|NCT03842436|75879566|FG000|STARTED|Overall Study||16||
59760022|NCT03842436|75879566|FG000|COMPLETED|Overall Study||15||
59512022|NCT02763826|75605500|FG001|COMPLETED|Part 1 Dose Escalation, 4 mA||0||
59512023|NCT02763826|75605501|FG002|COMPLETED|Part 1 Dose Escalation, 4 mA||0||
59512024|NCT02763826|75605502|FG003|COMPLETED|Part 1 Dose Escalation, 4 mA||0||
59512025|NCT02763826|75605503|FG004|COMPLETED|Part 1 Dose Escalation, 4 mA||0||
59760023|NCT03842436|75879566|FG000|NOT COMPLETED|Overall Study||1||
59760024|NCT03836586|75879572|FG000|STARTED|Overall Study||5||
59760025|NCT03836586|75879573|FG001|STARTED|Overall Study||5||
59760026|NCT03836586|75879572|FG000|COMPLETED|Overall Study||5||
59760027|NCT03836586|75879573|FG001|COMPLETED|Overall Study||5||
59760028|NCT03836586|75879572|FG000|NOT COMPLETED|Overall Study||0||
59760029|NCT03836586|75879573|FG001|NOT COMPLETED|Overall Study||0||
59760030|NCT03711318|75879579|FG000|STARTED|Overall Study||8||
59760031|NCT03711318|75879579|FG000|COMPLETED|Overall Study||1||
59760032|NCT03711318|75879579|FG000|NOT COMPLETED|Overall Study||7||
59760033|NCT02153645|75879586|FG000|STARTED|Overall Study||30||
59760034|NCT02153645|75879587|FG001|STARTED|Overall Study||29||
59760035|NCT02153645|75879588|FG002|STARTED|Overall Study||28||
59760036|NCT02153645|75879586|FG000|COMPLETED|Overall Study||17||
59760037|NCT02153645|75879587|FG001|COMPLETED|Overall Study||19||
59760038|NCT02153645|75879588|FG002|COMPLETED|Overall Study||18||
59760039|NCT02153645|75879586|FG000|NOT COMPLETED|Overall Study||13||
59512026|NCT02763826|75605504|FG005|COMPLETED|Part 1 Dose Escalation, 4 mA||3||
59512027|NCT02763826|75605505|FG006|COMPLETED|Part 1 Dose Escalation, 4 mA||0||
59512028|NCT02763826|75605506|FG007|COMPLETED|Part 1 Dose Escalation, 4 mA||0||
59512029|NCT02763826|75605499|FG000|NOT COMPLETED|Part 1 Dose Escalation, 4 mA||0||
59512030|NCT02763826|75605500|FG001|NOT COMPLETED|Part 1 Dose Escalation, 4 mA||0||
59512031|NCT02763826|75605501|FG002|NOT COMPLETED|Part 1 Dose Escalation, 4 mA||0||
59512032|NCT02763826|75605502|FG003|NOT COMPLETED|Part 1 Dose Escalation, 4 mA||0||
59512033|NCT02763826|75605503|FG004|NOT COMPLETED|Part 1 Dose Escalation, 4 mA||0||
59512034|NCT02763826|75605504|FG005|NOT COMPLETED|Part 1 Dose Escalation, 4 mA||0||
59512035|NCT02763826|75605505|FG006|NOT COMPLETED|Part 1 Dose Escalation, 4 mA||0||
59512036|NCT02763826|75605506|FG007|NOT COMPLETED|Part 1 Dose Escalation, 4 mA||0||
59512037|NCT02763826|75605499|FG000|STARTED|Part 2 Montage Effect, 1st Intervention||0||
59512038|NCT02763826|75605500|FG001|STARTED|Part 2 Montage Effect, 1st Intervention||0||
59512039|NCT02763826|75605501|FG002|STARTED|Part 2 Montage Effect, 1st Intervention||0||
59512040|NCT02763826|75605502|FG003|STARTED|Part 2 Montage Effect, 1st Intervention||0||
59512041|NCT02763826|75605503|FG004|STARTED|Part 2 Montage Effect, 1st Intervention||0||
59512042|NCT02763826|75605504|FG005|STARTED|Part 2 Montage Effect, 1st Intervention||6||
59512043|NCT02763826|75605505|FG006|STARTED|Part 2 Montage Effect, 1st Intervention||6||
59512044|NCT02763826|75605506|FG007|STARTED|Part 2 Montage Effect, 1st Intervention||7||
59512045|NCT02763826|75605499|FG000|COMPLETED|Part 2 Montage Effect, 1st Intervention||0||
59512046|NCT02763826|75605500|FG001|COMPLETED|Part 2 Montage Effect, 1st Intervention||0||
59512047|NCT02763826|75605501|FG002|COMPLETED|Part 2 Montage Effect, 1st Intervention||0||
59512048|NCT02763826|75605502|FG003|COMPLETED|Part 2 Montage Effect, 1st Intervention||0||
59760040|NCT02153645|75879587|FG001|NOT COMPLETED|Overall Study||10||
59760041|NCT02153645|75879588|FG002|NOT COMPLETED|Overall Study||10||
59760042|NCT01614912|75879596|FG000|STARTED|Overall Study||284||
59760043|NCT01614912|75879596|FG000|COMPLETED|Overall Study||159||
59760044|NCT01614912|75879596|FG000|NOT COMPLETED|Overall Study||125||
59760045|NCT03451578|75879600|FG000|STARTED|Overall Study||54||
59760046|NCT03451578|75879600|FG000|COMPLETED|Overall Study||54||
60047061|NCT02238626|76162452|FG000|STARTED|Overall Study||17||
60047062|NCT02238626|76162453|FG001|STARTED|Overall Study||34||
60047063|NCT02238626|76162454|FG002|STARTED|Overall Study||8||
59760047|NCT03451578|75879600|FG000|NOT COMPLETED|Overall Study||0||
59760048|NCT00602472|75879606|FG000|STARTED|Overall Study|3 randomised patients never took medication.|263||
59512049|NCT02763826|75605503|FG004|COMPLETED|Part 2 Montage Effect, 1st Intervention||0||
59512050|NCT02763826|75605504|FG005|COMPLETED|Part 2 Montage Effect, 1st Intervention||6||
59512051|NCT02763826|75605505|FG006|COMPLETED|Part 2 Montage Effect, 1st Intervention||6||
59512052|NCT02763826|75605506|FG007|COMPLETED|Part 2 Montage Effect, 1st Intervention||7||
59512053|NCT02763826|75605499|FG000|NOT COMPLETED|Part 2 Montage Effect, 1st Intervention||0||
59512054|NCT02763826|75605500|FG001|NOT COMPLETED|Part 2 Montage Effect, 1st Intervention||0||
59512055|NCT02763826|75605501|FG002|NOT COMPLETED|Part 2 Montage Effect, 1st Intervention||0||
59512056|NCT02763826|75605502|FG003|NOT COMPLETED|Part 2 Montage Effect, 1st Intervention||0||
59512057|NCT02763826|75605503|FG004|NOT COMPLETED|Part 2 Montage Effect, 1st Intervention||0||
59612531|NCT01701258|75723509|FG010|NOT COMPLETED|EEG (Session 4)||0||
59612532|NCT01701258|75723510|FG011|NOT COMPLETED|EEG (Session 4)||0||
59920033|NCT02670382|76040217|FG001|NOT COMPLETED|Second Active Intervention||0||
59920034|NCT02991482|76040227|FG000|STARTED|Overall Study||73||
59920035|NCT02991482|76040228|FG001|STARTED|Overall Study||71||
59920036|NCT02991482|76040227|FG000|Crossed-over to Pembrolizumab at Progression|Overall Study||0||
59920037|NCT02991482|76040228|FG001|Crossed-over to Pembrolizumab at Progression|Overall Study||45||
59920038|NCT02991482|76040227|FG000|COMPLETED|Overall Study||8||
59920039|NCT02991482|76040228|FG001|COMPLETED|Overall Study||5||
59920040|NCT02991482|76040227|FG000|NOT COMPLETED|Overall Study||65||
59920041|NCT02991482|76040228|FG001|NOT COMPLETED|Overall Study||66||
59920042|NCT02674750|76040237|FG000|STARTED|Overall Study||5||
59920043|NCT02674750|76040238|FG001|STARTED|Overall Study||49||
59920044|NCT02674750|76040239|FG002|STARTED|Overall Study||16||
59920045|NCT02674750|76040237|FG000|COMPLETED|Overall Study||0|Completed = subjects stopped when Sponsor stopped study.|
59920046|NCT02674750|76040238|FG001|COMPLETED|Overall Study||4|Completed = subjects stopped when Sponsor stopped study.|
59920047|NCT02674750|76040239|FG002|COMPLETED|Overall Study||4|Completed = subjects stopped when Sponsor stopped study.|
59920048|NCT02674750|76040237|FG000|NOT COMPLETED|Overall Study||5||
59920049|NCT02674750|76040238|FG001|NOT COMPLETED|Overall Study||45||
59920050|NCT02674750|76040239|FG002|NOT COMPLETED|Overall Study||12||
59920051|NCT03998566|76040246|FG000|STARTED|Overall Study||6||
59920052|NCT03998566|76040246|FG000|COMPLETED|Overall Study||1||
59920053|NCT03998566|76040246|FG000|NOT COMPLETED|Overall Study||5||
59920054|NCT02987972|76040268|FG000|STARTED|Overall Study||351||
59920055|NCT02987972|76040269|FG001|STARTED|Overall Study||350||
59920056|NCT02987972|76040270|FG002|STARTED|Overall Study||350||
59920057|NCT02987972|76040268|FG000|Vaccination 1|Overall Study||350||
59920058|NCT02987972|76040269|FG001|Vaccination 1|Overall Study||347||
59920059|NCT02987972|76040270|FG002|Vaccination 1|Overall Study||347||
59920060|NCT02987972|76040268|FG000|Vaccination 2|Overall Study||333||
59920061|NCT02987972|76040269|FG001|Vaccination 2|Overall Study||335||
59920062|NCT02987972|76040270|FG002|Vaccination 2|Overall Study||335||
59920063|NCT02987972|76040268|FG000|Vaccination 3|Overall Study||330||
59920064|NCT02987972|76040269|FG001|Vaccination 3|Overall Study||331||
59920065|NCT02987972|76040270|FG002|Vaccination 3|Overall Study||332||
59920066|NCT02987972|76040268|FG000|Vaccination 4|Overall Study||310||
59920067|NCT02987972|76040269|FG001|Vaccination 4|Overall Study||306||
59920068|NCT02987972|76040270|FG002|Vaccination 4|Overall Study||311||
59920069|NCT02987972|76040268|FG000|COMPLETED|Overall Study||308||
59920070|NCT02987972|76040269|FG001|COMPLETED|Overall Study||305||
59920071|NCT02987972|76040270|FG002|COMPLETED|Overall Study||308||
59920072|NCT02987972|76040268|FG000|NOT COMPLETED|Overall Study||43||
59920073|NCT02987972|76040269|FG001|NOT COMPLETED|Overall Study||45||
59920074|NCT02987972|76040270|FG002|NOT COMPLETED|Overall Study||42||
59920075|NCT01372618|76040278|FG000|STARTED|Overall Study||9||
59920076|NCT01372618|76040278|FG000|COMPLETED|Overall Study||0||
59920077|NCT01372618|76040278|FG000|NOT COMPLETED|Overall Study||9||
59920078|NCT03304873|76040284|FG000|STARTED|Overall Study||23||
59920079|NCT03304873|76040285|FG001|STARTED|Overall Study||24||
59920080|NCT03304873|76040284|FG000|COMPLETED|Overall Study||22||
59920081|NCT03304873|76040285|FG001|COMPLETED|Overall Study||16||
59920082|NCT03304873|76040284|FG000|NOT COMPLETED|Overall Study||1||
59920083|NCT03304873|76040285|FG001|NOT COMPLETED|Overall Study||8||
59920084|NCT02669758|76040291|FG000|STARTED|Overall Study||277||
59920085|NCT02669758|76040291|FG000|COMPLETED|Overall Study||183||
59920086|NCT02669758|76040291|FG000|NOT COMPLETED|Overall Study||94||
59612533|NCT01701258|75723511|FG012|NOT COMPLETED|EEG (Session 4)||0||
59760049|NCT00602472|75879607|FG001|STARTED|Overall Study|3 randomised patients never took medication.|792||
59920087|NCT02987660|76040297|FG000|STARTED|Overall Study||10|All randomized subjects|
59920088|NCT02987660|76040298|FG001|STARTED|Overall Study||10|All randomized subjects|
59920089|NCT02987660|76040297|FG000|COMPLETED|Overall Study||0||
59920090|NCT02987660|76040298|FG001|COMPLETED|Overall Study||0||
59920091|NCT02987660|76040297|FG000|NOT COMPLETED|Overall Study||10||
59920092|NCT02987660|76040298|FG001|NOT COMPLETED|Overall Study||10||
59920093|NCT04528069|76040304|FG000|STARTED|Overall Study||54||105
59920094|NCT04528069|76040304|FG000|First Eye Implanted|Overall Study||54||54
59920095|NCT04528069|76040304|FG000|Second Eye Implanted|Overall Study||51||51
59760050|NCT00602472|75879606|FG000|COMPLETED|Overall Study|number who completed treatment|242||
59760051|NCT00602472|75879607|FG001|COMPLETED|Overall Study|number who completed treatment|734||
59760052|NCT00602472|75879606|FG000|NOT COMPLETED|Overall Study||21||
59760053|NCT00602472|75879607|FG001|NOT COMPLETED|Overall Study||58||
59760054|NCT01067586|75879613|FG000|STARTED|Overall Study||359||
59760055|NCT01067586|75879613|FG000|COMPLETED|Overall Study||359||
59760056|NCT01067586|75879613|FG000|NOT COMPLETED|Overall Study||0||
60047064|NCT02238626|76162455|FG003|STARTED|Overall Study||11||
60047065|NCT02238626|76162452|FG000|COMPLETED|Overall Study||12||
60047066|NCT02238626|76162453|FG001|COMPLETED|Overall Study||20||
60047067|NCT02238626|76162454|FG002|COMPLETED|Overall Study||5||
60047068|NCT02238626|76162455|FG003|COMPLETED|Overall Study||4||
60047069|NCT02238626|76162452|FG000|NOT COMPLETED|Overall Study||5||
60047070|NCT02238626|76162453|FG001|NOT COMPLETED|Overall Study||14||
60047071|NCT02238626|76162454|FG002|NOT COMPLETED|Overall Study||3||
60047072|NCT02238626|76162455|FG003|NOT COMPLETED|Overall Study||7||
60047073|NCT02151643|76162481|FG000|STARTED|Overall Study||26||
60047074|NCT02151643|76162482|FG001|STARTED|Overall Study||25||
60047075|NCT02151643|76162483|FG002|STARTED|Overall Study||25||
60047076|NCT02151643|76162484|FG003|STARTED|Overall Study||39||
60047077|NCT02151643|76162485|FG004|STARTED|Overall Study||38||
60047078|NCT02151643|76162481|FG000|COMPLETED|Overall Study||20||
60047079|NCT02151643|76162482|FG001|COMPLETED|Overall Study||21||
60047080|NCT02151643|76162483|FG002|COMPLETED|Overall Study||21||
60047081|NCT02151643|76162484|FG003|COMPLETED|Overall Study||32||
60047082|NCT02151643|76162485|FG004|COMPLETED|Overall Study||35||
60047083|NCT02151643|76162481|FG000|NOT COMPLETED|Overall Study||6||
60047084|NCT02151643|76162482|FG001|NOT COMPLETED|Overall Study||4||
60047085|NCT02151643|76162483|FG002|NOT COMPLETED|Overall Study||4||
60047086|NCT02151643|76162484|FG003|NOT COMPLETED|Overall Study||7||
60047087|NCT02151643|76162485|FG004|NOT COMPLETED|Overall Study||3||
60047088|NCT02203838|76162501|FG000|STARTED|Overall Study||408||
60047089|NCT02203838|76162502|FG001|STARTED|Overall Study||28||
60047090|NCT02203838|76162503|FG002|STARTED|Overall Study||31||
60047091|NCT02203838|76162504|FG003|STARTED|Overall Study||33||
60047092|NCT02203838|76162501|FG000|COMPLETED|Overall Study||198||
60047093|NCT02203838|76162502|FG001|COMPLETED|Overall Study||6||
60047094|NCT02203838|76162503|FG002|COMPLETED|Overall Study||15||
60047095|NCT02203838|76162504|FG003|COMPLETED|Overall Study||15||
60047096|NCT02203838|76162501|FG000|NOT COMPLETED|Overall Study||210||
60047097|NCT02203838|76162502|FG001|NOT COMPLETED|Overall Study||22||
60047098|NCT02203838|76162503|FG002|NOT COMPLETED|Overall Study||16||
60047099|NCT02203838|76162504|FG003|NOT COMPLETED|Overall Study||18||
60047100|NCT02178787|76162516|FG000|STARTED|Overall Study||35||
60047101|NCT02178787|76162517|FG001|STARTED|Overall Study||39||
60047102|NCT02178787|76162516|FG000|COMPLETED|Overall Study||30||
60047103|NCT02178787|76162517|FG001|COMPLETED|Overall Study||30||
60047104|NCT02178787|76162516|FG000|NOT COMPLETED|Overall Study||5||
60047105|NCT02178787|76162517|FG001|NOT COMPLETED|Overall Study||9||
60047106|NCT02178709|76162525|FG000|STARTED|Overall Study||48||
60047107|NCT02178709|76162525|FG000|COMPLETED|Overall Study||32||
60047108|NCT02178709|76162525|FG000|NOT COMPLETED|Overall Study||16||
60047109|NCT02238080|76162529|FG000|STARTED|Overall Study||197||
60047110|NCT02238080|76162529|FG000|COMPLETED|Overall Study||172||
60047111|NCT02238080|76162529|FG000|NOT COMPLETED|Overall Study||25||
60047112|NCT02150863|76162536|FG000|STARTED|Overall Study||0||
60047113|NCT02150863|76162537|FG001|STARTED|Overall Study||1||
60047114|NCT02150863|76162538|FG002|STARTED|Overall Study||0||
60047115|NCT02150863|76162536|FG000|COMPLETED|Overall Study||0||
60047116|NCT02150863|76162537|FG001|COMPLETED|Overall Study||0||
60047117|NCT02150863|76162538|FG002|COMPLETED|Overall Study||0||
60047118|NCT02150863|76162536|FG000|NOT COMPLETED|Overall Study||0||
60047119|NCT02150863|76162537|FG001|NOT COMPLETED|Overall Study||1||
60047120|NCT02150863|76162538|FG002|NOT COMPLETED|Overall Study||0||
60047121|NCT02178553|76162548|FG000|STARTED|Overall Study||53||
60047122|NCT02178553|76162549|FG001|STARTED|Overall Study||49||
60047123|NCT02178553|76162548|FG000|COMPLETED|Overall Study||45||
60047124|NCT02178553|76162549|FG001|COMPLETED|Overall Study||39||
59760057|NCT03052842|75879627|FG000|STARTED|Overall Study||8||
60047125|NCT02178553|76162548|FG000|NOT COMPLETED|Overall Study||8||
60047126|NCT02178553|76162549|FG001|NOT COMPLETED|Overall Study||10||
60047127|NCT01627327|76162557|FG000|STARTED|Overall Study||310||
60047128|NCT01627327|76162558|FG001|STARTED|Overall Study||313||
60047129|NCT01627327|76162557|FG000|COMPLETED|Overall Study||291||
60047130|NCT01627327|76162558|FG001|COMPLETED|Overall Study||274||
60047131|NCT01627327|76162557|FG000|NOT COMPLETED|Overall Study||19||
60047132|NCT01627327|76162558|FG001|NOT COMPLETED|Overall Study||39||
60047133|NCT01627249|76162567|FG000|STARTED|Overall Study||224||
60047134|NCT01627249|76162568|FG001|STARTED|Overall Study||218||
60047135|NCT01627249|76162569|FG002|STARTED|Overall Study||218||
60047136|NCT01627249|76162567|FG000|COMPLETED|Overall Study||208||
60047137|NCT01627249|76162568|FG001|COMPLETED|Overall Study||206||
60047138|NCT01627249|76162569|FG002|COMPLETED|Overall Study||206||
60047139|NCT01627249|76162567|FG000|NOT COMPLETED|Overall Study||16||
60047140|NCT01627249|76162568|FG001|NOT COMPLETED|Overall Study||12||
60047141|NCT01627249|76162569|FG002|NOT COMPLETED|Overall Study||12||
60047142|NCT01688830|76162598|FG000|STARTED|Overall Study||21||
60047143|NCT01688830|76162599|FG001|STARTED|Overall Study||6||
60047144|NCT01688830|76162600|FG002|STARTED|Overall Study||6||
60047145|NCT01688830|76162601|FG003|STARTED|Overall Study||6||
60047146|NCT01688830|76162602|FG004|STARTED|Overall Study||5||
60047147|NCT01688830|76162603|FG005|STARTED|Overall Study||6||
60047148|NCT01688830|76162604|FG006|STARTED|Overall Study||12||
60047149|NCT01688830|76162605|FG007|STARTED|Overall Study||6||
60047150|NCT01688830|76162606|FG008|STARTED|Overall Study||6||
60047151|NCT01688830|76162607|FG009|STARTED|Overall Study||6||
60047152|NCT01688830|76162608|FG010|STARTED|Overall Study||6||
60047153|NCT01688830|76162609|FG011|STARTED|Overall Study||6||
60047154|NCT01688830|76162610|FG012|STARTED|Overall Study||6||
60047155|NCT01688830|76162611|FG013|STARTED|Overall Study||6||
60047156|NCT01688830|76162612|FG014|STARTED|Overall Study||6||
60047157|NCT01688830|76162613|FG015|STARTED|Overall Study||9||
60047158|NCT01688830|76162614|FG016|STARTED|Overall Study||9||
60047159|NCT01688830|76162615|FG017|STARTED|Overall Study||9||
60047160|NCT01688830|76162616|FG018|STARTED|Overall Study||8||
60047161|NCT01688830|76162617|FG019|STARTED|Overall Study||3||
60047162|NCT01688830|76162618|FG020|STARTED|Overall Study||9||
60047163|NCT01688830|76162598|FG000|COMPLETED|Overall Study||21||
60047164|NCT01688830|76162599|FG001|COMPLETED|Overall Study||6||
60047165|NCT01688830|76162600|FG002|COMPLETED|Overall Study||6||
60047166|NCT01688830|76162601|FG003|COMPLETED|Overall Study||6||
60047167|NCT01688830|76162602|FG004|COMPLETED|Overall Study||5||
60047168|NCT01688830|76162603|FG005|COMPLETED|Overall Study||6||
60047169|NCT01688830|76162604|FG006|COMPLETED|Overall Study||12||
60047170|NCT01688830|76162605|FG007|COMPLETED|Overall Study||6||
60047171|NCT01688830|76162606|FG008|COMPLETED|Overall Study||6||
60047172|NCT01688830|76162607|FG009|COMPLETED|Overall Study||6||
60047173|NCT01688830|76162608|FG010|COMPLETED|Overall Study||5||
60047174|NCT01688830|76162609|FG011|COMPLETED|Overall Study||6||
60047175|NCT01688830|76162610|FG012|COMPLETED|Overall Study||6||
60047176|NCT01688830|76162611|FG013|COMPLETED|Overall Study||6||
60047177|NCT01688830|76162612|FG014|COMPLETED|Overall Study||6||
60047178|NCT01688830|76162613|FG015|COMPLETED|Overall Study||9||
60047179|NCT01688830|76162614|FG016|COMPLETED|Overall Study||9||
60047180|NCT01688830|76162615|FG017|COMPLETED|Overall Study||9||
60047181|NCT01688830|76162616|FG018|COMPLETED|Overall Study||8||
60047182|NCT01688830|76162617|FG019|COMPLETED|Overall Study||3||
60047183|NCT01688830|76162618|FG020|COMPLETED|Overall Study||9||
60047184|NCT01688830|76162598|FG000|NOT COMPLETED|Overall Study||0||
60047185|NCT01688830|76162599|FG001|NOT COMPLETED|Overall Study||0||
60047186|NCT01688830|76162600|FG002|NOT COMPLETED|Overall Study||0||
60047187|NCT01688830|76162601|FG003|NOT COMPLETED|Overall Study||0||
60047188|NCT01688830|76162602|FG004|NOT COMPLETED|Overall Study||0||
60047189|NCT01688830|76162603|FG005|NOT COMPLETED|Overall Study||0||
60047190|NCT01688830|76162604|FG006|NOT COMPLETED|Overall Study||0||
60047191|NCT01688830|76162605|FG007|NOT COMPLETED|Overall Study||0||
60047192|NCT01688830|76162606|FG008|NOT COMPLETED|Overall Study||0||
60047193|NCT01688830|76162607|FG009|NOT COMPLETED|Overall Study||0||
60047194|NCT01688830|76162608|FG010|NOT COMPLETED|Overall Study||1||
60047195|NCT01688830|76162609|FG011|NOT COMPLETED|Overall Study||0||
60047196|NCT01688830|76162610|FG012|NOT COMPLETED|Overall Study||0||
60047197|NCT01688830|76162611|FG013|NOT COMPLETED|Overall Study||0||
60047198|NCT01688830|76162612|FG014|NOT COMPLETED|Overall Study||0||
60047199|NCT01688830|76162613|FG015|NOT COMPLETED|Overall Study||0||
60047200|NCT01688830|76162614|FG016|NOT COMPLETED|Overall Study||0||
60047201|NCT01688830|76162615|FG017|NOT COMPLETED|Overall Study||0||
60047202|NCT01688830|76162616|FG018|NOT COMPLETED|Overall Study||0||
60047203|NCT01688830|76162617|FG019|NOT COMPLETED|Overall Study||0||
60047204|NCT01688830|76162618|FG020|NOT COMPLETED|Overall Study||0||
60047205|NCT02178475|76162702|FG000|STARTED|Overall Study||943||
60047206|NCT02178475|76162702|FG000|Primary Analysis Set|Overall Study|All enrolled participants who met eligibility criteria|844||
60047207|NCT02178475|76162702|FG000|COMPLETED|Overall Study||814||
60047208|NCT02178475|76162702|FG000|NOT COMPLETED|Overall Study||129||
60047209|NCT01569022|76162706|FG000|STARTED|First Intervention||21||
60047210|NCT01569022|76162707|FG001|STARTED|First Intervention||21||
60047211|NCT01569022|76162706|FG000|COMPLETED|First Intervention||19||
60047212|NCT01569022|76162707|FG001|COMPLETED|First Intervention||20||
60047213|NCT01569022|76162706|FG000|NOT COMPLETED|First Intervention||2||
60047214|NCT01569022|76162707|FG001|NOT COMPLETED|First Intervention||1||
60047215|NCT01569022|76162706|FG000|STARTED|Second Intervention||19||
60047216|NCT01569022|76162707|FG001|STARTED|Second Intervention||20||
60047217|NCT01569022|76162706|FG000|COMPLETED|Second Intervention||17||
60047218|NCT01569022|76162707|FG001|COMPLETED|Second Intervention||18||
60047219|NCT01569022|76162706|FG000|NOT COMPLETED|Second Intervention||2||
60047220|NCT01569022|76162707|FG001|NOT COMPLETED|Second Intervention||2||
60047221|NCT01629823|76162718|FG000|STARTED|Trial Period||66||
60047222|NCT01629823|76162719|FG001|STARTED|Trial Period||69||
60047223|NCT01629823|76162720|FG002|STARTED|Trial Period||59||
60047224|NCT01629823|76162718|FG000|COMPLETED|Trial Period||53||
60047225|NCT01629823|76162719|FG001|COMPLETED|Trial Period||56||
60047226|NCT01629823|76162720|FG002|COMPLETED|Trial Period||49||
60047227|NCT01629823|76162718|FG000|NOT COMPLETED|Trial Period||13||
60047228|NCT01629823|76162719|FG001|NOT COMPLETED|Trial Period||13||
60047229|NCT01629823|76162720|FG002|NOT COMPLETED|Trial Period||10||
60047230|NCT01629823|76162718|FG000|STARTED|Washout Period||54||
60047231|NCT01629823|76162719|FG001|STARTED|Washout Period||57||
60047232|NCT01629823|76162720|FG002|STARTED|Washout Period||50||
60047233|NCT01629823|76162718|FG000|COMPLETED|Washout Period||51||
60047234|NCT01629823|76162719|FG001|COMPLETED|Washout Period||51||
60047235|NCT01629823|76162720|FG002|COMPLETED|Washout Period||50||
60047236|NCT01629823|76162718|FG000|NOT COMPLETED|Washout Period||3||
60047237|NCT01629823|76162719|FG001|NOT COMPLETED|Washout Period||6||
59512058|NCT02763826|75605504|FG005|NOT COMPLETED|Part 2 Montage Effect, 1st Intervention||0||
60047238|NCT01629823|76162720|FG002|NOT COMPLETED|Washout Period||0||
60047239|NCT01688050|76162728|FG000|STARTED|Overall Study||50||
60047240|NCT01688050|76162728|FG000|5-Year|Overall Study|Patients eligible for Follow-up at 5 year|22||
60047241|NCT01688050|76162728|FG000|COMPLETED|Overall Study||19||
60047242|NCT01688050|76162728|FG000|NOT COMPLETED|Overall Study||31||
60047243|NCT01604278|76162734|FG000|STARTED|Overall Study||226||
60047244|NCT01604278|76162735|FG001|STARTED|Overall Study||223||
60047245|NCT01604278|76162734|FG000|Safety Set|Overall Study||226||
60047246|NCT01604278|76162735|FG001|Safety Set|Overall Study|Two randomized participants who did not receive study drug were excluded from this set.|221||
60047247|NCT01604278|76162734|FG000|Full Analysis Set|Overall Study||226||
60047248|NCT01604278|76162735|FG001|Full Analysis Set|Overall Study|Three randomized participants excluded: 2 who did not receive study drug; 1 with a major deviation.|220||
60047249|NCT01604278|76162734|FG000|COMPLETED|Overall Study||212||
60047250|NCT01604278|76162735|FG001|COMPLETED|Overall Study||210||
60047251|NCT01604278|76162734|FG000|NOT COMPLETED|Overall Study||14||
60047252|NCT01604278|76162735|FG001|NOT COMPLETED|Overall Study||13||
60047253|NCT01687270|76162741|FG000|STARTED|Overall Study||40||
60047254|NCT01687270|76162741|FG000|COMPLETED|Overall Study||28||
60047255|NCT01687270|76162741|FG000|NOT COMPLETED|Overall Study||12||
60047256|NCT01589770|76162747|FG000|STARTED|Overall Study||67||
60047257|NCT01589770|76162748|FG001|STARTED|Overall Study||61||
60047258|NCT01589770|76162747|FG000|COMPLETED|Overall Study||59||
60047259|NCT01589770|76162748|FG001|COMPLETED|Overall Study||56||
60047260|NCT01589770|76162747|FG000|NOT COMPLETED|Overall Study||8||
60047261|NCT01589770|76162748|FG001|NOT COMPLETED|Overall Study||5||
60047262|NCT01588990|76162754|FG000|STARTED|Phase A||128||
60047263|NCT01588990|76162754|FG000|COMPLETED|Phase A|A total of 58 participants had disease progression in Phase A and ended Phase A.|58||
60047264|NCT01588990|76162754|FG000|NOT COMPLETED|Phase A||70||
60047265|NCT01588990|76162754|FG000|STARTED|Phase B|Of 58 participants who had documented disease progression in Phase A, 53 entered in Phase B.|53||
60047266|NCT01588990|76162754|FG000|COMPLETED|Phase B|A total of 37 participants had disease progression in Phase B and ended Phase B.|37||
60047267|NCT01588990|76162754|FG000|NOT COMPLETED|Phase B||16||
60047268|NCT02176525|76162770|FG000|STARTED|Overall Study|15 subjects randomized, 14 subjects treated with at least one dose, 1 subject was not treated|15||
60047269|NCT02176525|76162771|FG001|STARTED|Overall Study||9||
60047270|NCT02176525|76162772|FG002|STARTED|Overall Study||9||
60047271|NCT02176525|76162773|FG003|STARTED|Overall Study||9||
60047272|NCT02176525|76162774|FG004|STARTED|Overall Study||8||
60047273|NCT02176525|76162775|FG005|STARTED|Overall Study|6 subjects randomized, 5 subjects treated with at least one dose, 1 subject was not treated|6||
60047274|NCT02176525|76162776|FG006|STARTED|Overall Study||9||
60047275|NCT02176525|76162777|FG007|STARTED|Overall Study||10||
60047276|NCT02176525|76162770|FG000|COMPLETED|Overall Study||14||
60047277|NCT02176525|76162771|FG001|COMPLETED|Overall Study||9||
60047278|NCT02176525|76162772|FG002|COMPLETED|Overall Study||9||
59512059|NCT02763826|75605505|FG006|NOT COMPLETED|Part 2 Montage Effect, 1st Intervention||0||
59512060|NCT02763826|75605506|FG007|NOT COMPLETED|Part 2 Montage Effect, 1st Intervention||0||
60047279|NCT02176525|76162773|FG003|COMPLETED|Overall Study||8||
59512061|NCT02763826|75605499|FG000|STARTED|Part 2 Montage Effect, 2nd Intervention||0||
59512062|NCT02763826|75605500|FG001|STARTED|Part 2 Montage Effect, 2nd Intervention||0||
60047280|NCT02176525|76162774|FG004|COMPLETED|Overall Study||7||
60047281|NCT02176525|76162775|FG005|COMPLETED|Overall Study||5||
60047282|NCT02176525|76162776|FG006|COMPLETED|Overall Study||8||
60047283|NCT02176525|76162777|FG007|COMPLETED|Overall Study||10||
60047284|NCT02176525|76162770|FG000|NOT COMPLETED|Overall Study||1||
60047285|NCT02176525|76162771|FG001|NOT COMPLETED|Overall Study||0||
60047286|NCT02176525|76162772|FG002|NOT COMPLETED|Overall Study||0||
60047287|NCT02176525|76162773|FG003|NOT COMPLETED|Overall Study||1||
60047288|NCT02176525|76162774|FG004|NOT COMPLETED|Overall Study||1||
60047289|NCT02176525|76162775|FG005|NOT COMPLETED|Overall Study||1||
60047290|NCT02176525|76162776|FG006|NOT COMPLETED|Overall Study||1||
60047291|NCT02176525|76162777|FG007|NOT COMPLETED|Overall Study||0||
60047292|NCT02127931|76162803|FG000|STARTED|Overall Study||18||
60047293|NCT02127931|76162803|FG000|COMPLETED|Overall Study||17||
60047294|NCT02127931|76162803|FG000|NOT COMPLETED|Overall Study||1||
60047295|NCT02127307|76162808|FG000|STARTED|Overall Study||964||
60047296|NCT02127307|76162808|FG000|COMPLETED|Overall Study||656||
60047297|NCT02127307|76162808|FG000|NOT COMPLETED|Overall Study||308||
60047298|NCT02126839|76162814|FG000|STARTED|Overall Study||92||
60047299|NCT02126839|76162815|FG001|STARTED|Overall Study||94||
60047300|NCT02126839|76162814|FG000|Safety Population|Overall Study||92||
60047301|NCT02126839|76162815|FG001|Safety Population|Overall Study||93||
60047302|NCT02126839|76162814|FG000|Full Analysis Set|Overall Study||92||
60047303|NCT02126839|76162815|FG001|Full Analysis Set|Overall Study||92||
60047304|NCT02126839|76162814|FG000|COMPLETED|Overall Study||82||
60047305|NCT02126839|76162815|FG001|COMPLETED|Overall Study||80||
60047306|NCT02126839|76162814|FG000|NOT COMPLETED|Overall Study||10||
60047307|NCT02126839|76162815|FG001|NOT COMPLETED|Overall Study||14||
60047308|NCT02125279|76162821|FG000|STARTED|Overall Study||54||
60047309|NCT02125279|76162821|FG000|COMPLETED|Overall Study||41||
60047310|NCT02125279|76162821|FG000|NOT COMPLETED|Overall Study||13||
59519036|NCT03398278|75612889|FG000|STARTED|Period 1||19||
60047311|NCT02124811|76162829|FG000|STARTED|Overall Study||5||
60047312|NCT02124811|76162830|FG001|STARTED|Overall Study||5||
60047313|NCT02124811|76162829|FG000|COMPLETED|Overall Study||2||
60047314|NCT02124811|76162830|FG001|COMPLETED|Overall Study||3||
60047315|NCT02124811|76162829|FG000|NOT COMPLETED|Overall Study||3||
60047316|NCT02124811|76162830|FG001|NOT COMPLETED|Overall Study||2||
60047317|NCT02148445|76162838|FG000|STARTED|Overall Study||198||
60047318|NCT02148445|76162839|FG001|STARTED|Overall Study||200||
60047319|NCT02148445|76162838|FG000|COMPLETED|Overall Study||197||
60047320|NCT02148445|76162839|FG001|COMPLETED|Overall Study||197||
60047321|NCT02148445|76162838|FG000|NOT COMPLETED|Overall Study||1||
60047322|NCT02148445|76162839|FG001|NOT COMPLETED|Overall Study||3||
60047323|NCT02148211|76162847|FG000|STARTED|Overall Study||507||
60047324|NCT02148211|76162847|FG000|COMPLETED|Overall Study||155||
60047325|NCT02148211|76162847|FG000|NOT COMPLETED|Overall Study||352||
60047326|NCT02147587|76162853|FG000|STARTED|Overall Study||57||
60047327|NCT02147587|76162854|FG001|STARTED|Overall Study||55||
60047328|NCT02147587|76162853|FG000|COMPLETED|Overall Study||46||
60047329|NCT02147587|76162854|FG001|COMPLETED|Overall Study||50||
60047330|NCT02147587|76162853|FG000|NOT COMPLETED|Overall Study||11||
60047331|NCT02147587|76162854|FG001|NOT COMPLETED|Overall Study||5||
60047332|NCT02147353|76162862|FG000|STARTED|Overall Study||21||
60047333|NCT02147353|76162863|FG001|STARTED|Overall Study||21||
60047334|NCT02147353|76162862|FG000|COMPLETED|Overall Study||12||
60047335|NCT02147353|76162863|FG001|COMPLETED|Overall Study||21||
60047336|NCT02147353|76162862|FG000|NOT COMPLETED|Overall Study||9||
60047337|NCT02147353|76162863|FG001|NOT COMPLETED|Overall Study||0||
60047338|NCT02147197|76162872|FG000|STARTED|Overall Study||56||
60047339|NCT02147197|76162873|FG001|STARTED|Overall Study||53||
60047340|NCT02147197|76162874|FG002|STARTED|Overall Study||48||
60047341|NCT02147197|76162872|FG000|COMPLETED|Overall Study||47||
60047342|NCT02147197|76162873|FG001|COMPLETED|Overall Study||47||
60047343|NCT02147197|76162874|FG002|COMPLETED|Overall Study||39||
60047344|NCT02147197|76162872|FG000|NOT COMPLETED|Overall Study||9||
60047345|NCT02147197|76162873|FG001|NOT COMPLETED|Overall Study||6||
60047346|NCT02147197|76162874|FG002|NOT COMPLETED|Overall Study||9||
60047347|NCT02176291|76162884|FG000|STARTED|Overall Study||20||
60047348|NCT02176291|76162885|FG001|STARTED|Overall Study||11||
60047349|NCT02176291|76162884|FG000|COMPLETED|Overall Study||15||
60047350|NCT02176291|76162885|FG001|COMPLETED|Overall Study||11||
60047351|NCT02176291|76162884|FG000|NOT COMPLETED|Overall Study||5||
60047352|NCT02176291|76162885|FG001|NOT COMPLETED|Overall Study||0||
60047353|NCT02175745|76162891|FG000|STARTED|Overall Study||2||
60047354|NCT02175745|76162891|FG000|COMPLETED|Overall Study||1||
60047355|NCT02175745|76162891|FG000|NOT COMPLETED|Overall Study||1||
60047356|NCT02175277|76162895|FG000|STARTED|Overall Study||9||
60047357|NCT02175277|76162895|FG000|COMPLETED|Overall Study||8||
60047358|NCT02175277|76162895|FG000|NOT COMPLETED|Overall Study||1||
60047359|NCT02124265|76162899|FG000|STARTED|Overall Study||3||
60047360|NCT02124265|76162899|FG000|COMPLETED|Overall Study||2||
60047361|NCT02124265|76162899|FG000|NOT COMPLETED|Overall Study||1||
60047362|NCT02146105|76162903|FG000|STARTED|Overall Study||45||
60047363|NCT02146105|76162903|FG000|COMPLETED|Overall Study||39||
60047364|NCT02146105|76162903|FG000|NOT COMPLETED|Overall Study||6||
60047365|NCT02175199|76162909|FG000|STARTED|Overall Study||74||
60047366|NCT02175199|76162910|FG001|STARTED|Overall Study||76||
60047367|NCT02175199|76162909|FG000|Dispensed|Overall Study|Two subjects were randomized but never dispensed study lenses.|72||
60047368|NCT02175199|76162910|FG001|Dispensed|Overall Study|Two subjects were randomized but never dispensed study lenses.|74||
60047369|NCT02175199|76162909|FG000|COMPLETED|Overall Study||71||
60047370|NCT02175199|76162910|FG001|COMPLETED|Overall Study||71||
60047371|NCT02175199|76162909|FG000|NOT COMPLETED|Overall Study||3||
60047372|NCT02175199|76162910|FG001|NOT COMPLETED|Overall Study||5||
60047373|NCT02123797|76162919|FG000|STARTED|Baseline Intervention||178||
60047374|NCT02123797|76162920|FG001|STARTED|Baseline Intervention||348||
60047375|NCT02123797|76162921|FG002|STARTED|Baseline Intervention||100||
60047376|NCT02123797|76162922|FG003|STARTED|Baseline Intervention||144||
60047377|NCT02123797|76162923|FG004|STARTED|Baseline Intervention||11||
60047378|NCT02123797|76162919|FG000|COMPLETED|Baseline Intervention||156||
60047379|NCT02123797|76162920|FG001|COMPLETED|Baseline Intervention||306||
60047380|NCT02123797|76162921|FG002|COMPLETED|Baseline Intervention||100||
60047381|NCT02123797|76162922|FG003|COMPLETED|Baseline Intervention||144||
60047382|NCT02123797|76162923|FG004|COMPLETED|Baseline Intervention||11||
60047383|NCT02123797|76162919|FG000|NOT COMPLETED|Baseline Intervention||22||
60047384|NCT02123797|76162920|FG001|NOT COMPLETED|Baseline Intervention||42||
60047385|NCT02123797|76162921|FG002|NOT COMPLETED|Baseline Intervention||0||
60047386|NCT02123797|76162922|FG003|NOT COMPLETED|Baseline Intervention||0||
60047387|NCT02123797|76162923|FG004|NOT COMPLETED|Baseline Intervention||0||
59612534|NCT01700946|75723541|FG000|STARTED|Overall Study||18||
59612535|NCT01700946|75723542|FG001|STARTED|Overall Study||24||
59612536|NCT01700946|75723541|FG000|COMPLETED|Overall Study||7||
59612537|NCT01700946|75723542|FG001|COMPLETED|Overall Study||7||
59612538|NCT01700946|75723541|FG000|NOT COMPLETED|Overall Study||11||
59612539|NCT01700946|75723542|FG001|NOT COMPLETED|Overall Study||17||
59612540|NCT01748994|75723554|FG000|STARTED|Overall Study||31||
59612541|NCT01748994|75723555|FG001|STARTED|Overall Study||32||
59612542|NCT01748994|75723554|FG000|COMPLETED|Overall Study||23||
59612543|NCT01748994|75723555|FG001|COMPLETED|Overall Study||26||
59760058|NCT03052842|75879628|FG001|STARTED|Overall Study||8||
59760059|NCT03052842|75879629|FG002|STARTED|Overall Study||8||
59920096|NCT04528069|76040304|FG000|COMPLETED|Overall Study||50||97
59920097|NCT04528069|76040304|FG000|NOT COMPLETED|Overall Study||4||8
59920098|NCT03303469|76040320|FG000|STARTED|Overall Study||3||
59920099|NCT03303469|76040320|FG000|COMPLETED|Overall Study||1||
59920100|NCT03303469|76040320|FG000|NOT COMPLETED|Overall Study||2||
59920101|NCT02990000|76040326|FG000|STARTED|Overall Study|155 patients were randomly assigned to the Pragmatic Match condition|155||
59920102|NCT02990000|76040327|FG001|STARTED|Overall Study|133 patients were randomly assigned to the Scientific Match condition|133||
59920103|NCT02990000|76040326|FG000|Begin Treatment|Overall Study|119 Pragmatic Match patients actually began treatment (attended at least 1 session)|119||
59920104|NCT02990000|76040327|FG001|Begin Treatment|Overall Study|99 Scientifically Matched patients actually began treatment (attended at least one session)|99||
59920105|NCT02990000|76040326|FG000|COMPLETED|Overall Study|119 patients provided naturalistic treatment data and were included in analyses|119||
60047388|NCT02123797|76162919|FG000|STARTED|3-month Follow up (Cumulative Counts)||156||
60047389|NCT02123797|76162920|FG001|STARTED|3-month Follow up (Cumulative Counts)||306||
60047390|NCT02123797|76162921|FG002|STARTED|3-month Follow up (Cumulative Counts)||100||
60047391|NCT02123797|76162922|FG003|STARTED|3-month Follow up (Cumulative Counts)||144||
60047392|NCT02123797|76162923|FG004|STARTED|3-month Follow up (Cumulative Counts)|Clinical providers received 6 month follow-up rather than 3 month follow-up at this stage.|11||
60047393|NCT02123797|76162919|FG000|COMPLETED|3-month Follow up (Cumulative Counts)||99||
60047394|NCT02123797|76162920|FG001|COMPLETED|3-month Follow up (Cumulative Counts)||189||
60047395|NCT02123797|76162921|FG002|COMPLETED|3-month Follow up (Cumulative Counts)||50||
60047396|NCT02123797|76162922|FG003|COMPLETED|3-month Follow up (Cumulative Counts)||62||
60047397|NCT02123797|76162923|FG004|COMPLETED|3-month Follow up (Cumulative Counts)||8||
60047398|NCT02123797|76162919|FG000|NOT COMPLETED|3-month Follow up (Cumulative Counts)||57||
60047399|NCT02123797|76162920|FG001|NOT COMPLETED|3-month Follow up (Cumulative Counts)||117||
60047400|NCT02123797|76162921|FG002|NOT COMPLETED|3-month Follow up (Cumulative Counts)||50||
60047401|NCT02123797|76162922|FG003|NOT COMPLETED|3-month Follow up (Cumulative Counts)||82||
60047402|NCT02123797|76162923|FG004|NOT COMPLETED|3-month Follow up (Cumulative Counts)||3||
60047403|NCT02123797|76162919|FG000|STARTED|6-month Follow up (Cumulative Counts)||156|Participants were able to complete a 6 month survey, even if they did not complete a 3 month survey.|
60047404|NCT02123797|76162920|FG001|STARTED|6-month Follow up (Cumulative Counts)||306|Participants were able to complete a 6 month survey, even if they did not complete a 3 month survey.|
60047405|NCT02123797|76162921|FG002|STARTED|6-month Follow up (Cumulative Counts)||100|Participants were able to complete a 6 month survey, even if they did not complete a 3 month survey.|
60047406|NCT02123797|76162922|FG003|STARTED|6-month Follow up (Cumulative Counts)||144|Participants were able to complete a 6 month survey, even if they did not complete a 3 month survey.|
60047407|NCT02123797|76162923|FG004|STARTED|6-month Follow up (Cumulative Counts)|Clinical providers received 12 month follow-up rather than 6-month follow-up at this stage.|8|Participants were able to complete a 6 month survey, even if they did not complete a 3 month survey.|
60047408|NCT02123797|76162919|FG000|COMPLETED|6-month Follow up (Cumulative Counts)||101||
60047409|NCT02123797|76162920|FG001|COMPLETED|6-month Follow up (Cumulative Counts)||178||
60047410|NCT02123797|76162921|FG002|COMPLETED|6-month Follow up (Cumulative Counts)||34||
60047411|NCT02123797|76162922|FG003|COMPLETED|6-month Follow up (Cumulative Counts)||31||
60047412|NCT02123797|76162923|FG004|COMPLETED|6-month Follow up (Cumulative Counts)||5||
60047413|NCT02123797|76162919|FG000|NOT COMPLETED|6-month Follow up (Cumulative Counts)||55||
60047414|NCT02123797|76162920|FG001|NOT COMPLETED|6-month Follow up (Cumulative Counts)||128||
60047415|NCT02123797|76162921|FG002|NOT COMPLETED|6-month Follow up (Cumulative Counts)||66||
60047416|NCT02123797|76162922|FG003|NOT COMPLETED|6-month Follow up (Cumulative Counts)||113||
60047417|NCT02123797|76162923|FG004|NOT COMPLETED|6-month Follow up (Cumulative Counts)||3||
60047418|NCT02175121|76162948|FG000|STARTED|Overall Study||34||
60047419|NCT02175121|76162949|FG001|STARTED|Overall Study||35||
60047420|NCT02175121|76162950|FG002|STARTED|Overall Study||34||
60047421|NCT02175121|76162951|FG003|STARTED|Overall Study||35||
60047422|NCT02175121|76162952|FG004|STARTED|Overall Study||34||
60047423|NCT02175121|76162948|FG000|COMPLETED|Overall Study||33||
60047424|NCT02175121|76162949|FG001|COMPLETED|Overall Study||34||
60047425|NCT02175121|76162950|FG002|COMPLETED|Overall Study||32||
60047426|NCT02175121|76162951|FG003|COMPLETED|Overall Study||34||
60047427|NCT02175121|76162952|FG004|COMPLETED|Overall Study||33||
60047428|NCT02175121|76162948|FG000|NOT COMPLETED|Overall Study||1||
60047429|NCT02175121|76162949|FG001|NOT COMPLETED|Overall Study||1||
60047430|NCT02175121|76162950|FG002|NOT COMPLETED|Overall Study||2||
59612544|NCT01748994|75723554|FG000|NOT COMPLETED|Overall Study||8||
59612545|NCT01748994|75723555|FG001|NOT COMPLETED|Overall Study||6||
60047431|NCT02175121|76162951|FG003|NOT COMPLETED|Overall Study||1||
60047432|NCT02175121|76162952|FG004|NOT COMPLETED|Overall Study||1||
60047433|NCT01568866|76162970|FG000|STARTED|Overall Study||465||
60047434|NCT01568866|76162971|FG001|STARTED|Overall Study||464||
59612546|NCT01721070|75723561|FG000|STARTED|SUF NT 15 mcg||19||
59920106|NCT02990000|76040327|FG001|COMPLETED|Overall Study|99 patients provided naturalistic treatment data and were included in analyses|99||
59920107|NCT02990000|76040326|FG000|NOT COMPLETED|Overall Study||36||
59920108|NCT02990000|76040327|FG001|NOT COMPLETED|Overall Study||34||
59612547|NCT01721070|75723561|FG000|COMPLETED|SUF NT 15 mcg||19||
59612548|NCT01721070|75723561|FG000|NOT COMPLETED|SUF NT 15 mcg||0||
59612549|NCT01721070|75723561|FG000|STARTED|Ketoconazole 400 mg and SUF NT 15 mcg||19||
59612550|NCT01721070|75723561|FG000|COMPLETED|Ketoconazole 400 mg and SUF NT 15 mcg||18||
59612551|NCT01721070|75723561|FG000|NOT COMPLETED|Ketoconazole 400 mg and SUF NT 15 mcg||1||
59612552|NCT01748760|75723570|FG000|STARTED|Overall Study||25||
59612553|NCT01748760|75723571|FG001|STARTED|Overall Study||25||
59612554|NCT01748760|75723570|FG000|COMPLETED|Overall Study||19||
59612555|NCT01748760|75723571|FG001|COMPLETED|Overall Study||23||
59760060|NCT03052842|75879630|FG003|STARTED|Overall Study||6||
59920109|NCT01068626|76040335|FG000|STARTED|Overall Study||30||
59920110|NCT01068626|76040336|FG001|STARTED|Overall Study||29||
59920111|NCT01068626|76040335|FG000|COMPLETED|Overall Study||27||
59920112|NCT01068626|76040336|FG001|COMPLETED|Overall Study||27||
59920113|NCT01068626|76040335|FG000|NOT COMPLETED|Overall Study||3||
59920114|NCT01068626|76040336|FG001|NOT COMPLETED|Overall Study||2||
59920115|NCT02921750|76040344|FG000|STARTED|Overall Study||124|Safety population|
59920116|NCT02921750|76040345|FG001|STARTED|Overall Study||124|Safety population|
59920117|NCT02921750|76040344|FG000|Intention to Treat (ITT)|Overall Study||122||
59920118|NCT02921750|76040345|FG001|Intention to Treat (ITT)|Overall Study||123||
59920119|NCT02921750|76040344|FG000|Per Protocol (PP)|Overall Study||100||
59920120|NCT02921750|76040345|FG001|Per Protocol (PP)|Overall Study||107||
59920121|NCT02921750|76040344|FG000|Completed 6 Weeks Follow-up (PP)|Overall Study||97||
59920122|NCT02921750|76040345|FG001|Completed 6 Weeks Follow-up (PP)|Overall Study||104||
59760061|NCT03052842|75879627|FG000|COMPLETED|Overall Study||8||
59920123|NCT02921750|76040344|FG000|Subgroup Followed for 24 Weeks (ITT)|Overall Study||35||
59920124|NCT02921750|76040345|FG001|Subgroup Followed for 24 Weeks (ITT)|Overall Study||40||
59920125|NCT02921750|76040344|FG000|Subgroup Followed for 24 Weeks (PP)|Overall Study||19||
60047435|NCT01568866|76162970|FG000|Received Treatment|Overall Study||456||
60047436|NCT01568866|76162971|FG001|Received Treatment|Overall Study||463||
60047437|NCT01568866|76162970|FG000|COMPLETED|Overall Study|Indicates participants still receiving treatment|27||
60047438|NCT01568866|76162971|FG001|COMPLETED|Overall Study|Indicates participants still receiving treatment|48||
60047439|NCT01568866|76162970|FG000|NOT COMPLETED|Overall Study||438||
60047440|NCT01568866|76162971|FG001|NOT COMPLETED|Overall Study||416||
60047441|NCT01568320|76162977|FG000|STARTED|Overall Study||73||
60047442|NCT01568320|76162977|FG000|5-Year|Overall Study|Patients eligible for Follow-up at 5 year|36||
60047443|NCT01568320|76162977|FG000|COMPLETED|Overall Study||32||
60047444|NCT01568320|76162977|FG000|NOT COMPLETED|Overall Study||41||
60047445|NCT01567852|76162983|FG000|STARTED|Overall Study||8||
59512063|NCT02763826|75605501|FG002|STARTED|Part 2 Montage Effect, 2nd Intervention||0||
59512064|NCT02763826|75605502|FG003|STARTED|Part 2 Montage Effect, 2nd Intervention||0||
59512065|NCT02763826|75605503|FG004|STARTED|Part 2 Montage Effect, 2nd Intervention||0||
59512066|NCT02763826|75605504|FG005|STARTED|Part 2 Montage Effect, 2nd Intervention||6||
59512067|NCT02763826|75605505|FG006|STARTED|Part 2 Montage Effect, 2nd Intervention||6||
59512068|NCT02763826|75605506|FG007|STARTED|Part 2 Montage Effect, 2nd Intervention||6||
59512069|NCT02763826|75605499|FG000|COMPLETED|Part 2 Montage Effect, 2nd Intervention||0||
59512070|NCT02763826|75605500|FG001|COMPLETED|Part 2 Montage Effect, 2nd Intervention||0||
59512071|NCT02763826|75605501|FG002|COMPLETED|Part 2 Montage Effect, 2nd Intervention||0||
59512072|NCT02763826|75605502|FG003|COMPLETED|Part 2 Montage Effect, 2nd Intervention||0||
59920126|NCT02921750|76040345|FG001|Subgroup Followed for 24 Weeks (PP)|Overall Study||36||
59920127|NCT02921750|76040344|FG000|COMPLETED|Overall Study||115|Completed 6 weeks follow-up|
59920128|NCT02921750|76040345|FG001|COMPLETED|Overall Study||113|Completed 6 weeks follow-up|
59920129|NCT02921750|76040344|FG000|NOT COMPLETED|Overall Study||9||
59920130|NCT02921750|76040345|FG001|NOT COMPLETED|Overall Study||11||
59920131|NCT02920970|76040354|FG000|STARTED|First Intervention||38||
59920132|NCT02920970|76040355|FG001|STARTED|First Intervention||32||
59920133|NCT02920970|76040354|FG000|COMPLETED|First Intervention||38||
59920134|NCT02920970|76040355|FG001|COMPLETED|First Intervention||30||
59920135|NCT02920970|76040354|FG000|NOT COMPLETED|First Intervention||0||
59920136|NCT02920970|76040355|FG001|NOT COMPLETED|First Intervention||2||
59920137|NCT02920970|76040354|FG000|STARTED|Second Intervention||38||
59920138|NCT02920970|76040355|FG001|STARTED|Second Intervention||30||
59920139|NCT02920970|76040354|FG000|COMPLETED|Second Intervention||37||
59920140|NCT02920970|76040355|FG001|COMPLETED|Second Intervention||30||
59920141|NCT02920970|76040354|FG000|NOT COMPLETED|Second Intervention||1||
59920142|NCT02920970|76040355|FG001|NOT COMPLETED|Second Intervention||0||
59920143|NCT01068158|76040365|FG000|STARTED|Overall Study||169||
59920144|NCT01068158|76040366|FG001|STARTED|Overall Study||202||
59920145|NCT01068158|76040365|FG000|COMPLETED|Overall Study||161||
59920146|NCT01068158|76040366|FG001|COMPLETED|Overall Study||198||
60047446|NCT01567852|76162984|FG001|STARTED|Overall Study||12||
60047447|NCT01567852|76162983|FG000|COMPLETED|Overall Study||4||
60047448|NCT01567852|76162984|FG001|COMPLETED|Overall Study||5||
60047449|NCT01567852|76162983|FG000|NOT COMPLETED|Overall Study||4||
60047450|NCT01567852|76162984|FG001|NOT COMPLETED|Overall Study||7||
60047451|NCT01588366|76162995|FG000|STARTED|Overall Study||2||
59512073|NCT02763826|75605503|FG004|COMPLETED|Part 2 Montage Effect, 2nd Intervention||0||
59512074|NCT02763826|75605504|FG005|COMPLETED|Part 2 Montage Effect, 2nd Intervention||6||
59512075|NCT02763826|75605505|FG006|COMPLETED|Part 2 Montage Effect, 2nd Intervention||6||
59512076|NCT02763826|75605506|FG007|COMPLETED|Part 2 Montage Effect, 2nd Intervention||6||
59512077|NCT02763826|75605499|FG000|NOT COMPLETED|Part 2 Montage Effect, 2nd Intervention||0||
59512078|NCT02763826|75605500|FG001|NOT COMPLETED|Part 2 Montage Effect, 2nd Intervention||0||
59512079|NCT02763826|75605501|FG002|NOT COMPLETED|Part 2 Montage Effect, 2nd Intervention||0||
59512080|NCT02763826|75605502|FG003|NOT COMPLETED|Part 2 Montage Effect, 2nd Intervention||0||
59512081|NCT02763826|75605503|FG004|NOT COMPLETED|Part 2 Montage Effect, 2nd Intervention||0||
59512082|NCT02763826|75605504|FG005|NOT COMPLETED|Part 2 Montage Effect, 2nd Intervention||0||
59512083|NCT02763826|75605505|FG006|NOT COMPLETED|Part 2 Montage Effect, 2nd Intervention||0||
59512084|NCT02763826|75605506|FG007|NOT COMPLETED|Part 2 Montage Effect, 2nd Intervention||0||
59512085|NCT02763826|75605499|FG000|STARTED|Part 2 Montage Effect, 3rd Intervention||0||
59512086|NCT02763826|75605500|FG001|STARTED|Part 2 Montage Effect, 3rd Intervention||0||
59512087|NCT02763826|75605501|FG002|STARTED|Part 2 Montage Effect, 3rd Intervention||0||
59512088|NCT02763826|75605502|FG003|STARTED|Part 2 Montage Effect, 3rd Intervention||0||
59512089|NCT02763826|75605503|FG004|STARTED|Part 2 Montage Effect, 3rd Intervention||0||
59512090|NCT02763826|75605504|FG005|STARTED|Part 2 Montage Effect, 3rd Intervention||6||
59512091|NCT02763826|75605505|FG006|STARTED|Part 2 Montage Effect, 3rd Intervention||6||
59512092|NCT02763826|75605506|FG007|STARTED|Part 2 Montage Effect, 3rd Intervention||6||
59512093|NCT02763826|75605499|FG000|COMPLETED|Part 2 Montage Effect, 3rd Intervention||0||
59512094|NCT02763826|75605500|FG001|COMPLETED|Part 2 Montage Effect, 3rd Intervention||0||
59512095|NCT02763826|75605501|FG002|COMPLETED|Part 2 Montage Effect, 3rd Intervention||0||
59512096|NCT02763826|75605502|FG003|COMPLETED|Part 2 Montage Effect, 3rd Intervention||0||
59920147|NCT01068158|76040365|FG000|NOT COMPLETED|Overall Study||8||
59920148|NCT01068158|76040366|FG001|NOT COMPLETED|Overall Study||4||
59512097|NCT02763826|75605503|FG004|COMPLETED|Part 2 Montage Effect, 3rd Intervention||0||
59512098|NCT02763826|75605504|FG005|COMPLETED|Part 2 Montage Effect, 3rd Intervention||6||
59512099|NCT02763826|75605505|FG006|COMPLETED|Part 2 Montage Effect, 3rd Intervention||6||
59512100|NCT02763826|75605506|FG007|COMPLETED|Part 2 Montage Effect, 3rd Intervention||6||
59512101|NCT02763826|75605499|FG000|NOT COMPLETED|Part 2 Montage Effect, 3rd Intervention||0||
59512102|NCT02763826|75605500|FG001|NOT COMPLETED|Part 2 Montage Effect, 3rd Intervention||0||
59512103|NCT02763826|75605501|FG002|NOT COMPLETED|Part 2 Montage Effect, 3rd Intervention||0||
59512104|NCT02763826|75605502|FG003|NOT COMPLETED|Part 2 Montage Effect, 3rd Intervention||0||
59512105|NCT02763826|75605503|FG004|NOT COMPLETED|Part 2 Montage Effect, 3rd Intervention||0||
59920149|NCT03303079|76040375|FG000|STARTED|Overall Study||189||
59920150|NCT03303079|76040376|FG001|STARTED|Overall Study||191||
59512106|NCT02763826|75605504|FG005|NOT COMPLETED|Part 2 Montage Effect, 3rd Intervention||0||
59512107|NCT02763826|75605505|FG006|NOT COMPLETED|Part 2 Montage Effect, 3rd Intervention||0||
59512108|NCT02763826|75605506|FG007|NOT COMPLETED|Part 2 Montage Effect, 3rd Intervention||0||
59512109|NCT02766244|75605524|FG000|STARTED|Overall Study||3||
59512110|NCT02766244|75605524|FG000|COMPLETED|Overall Study||3||
59512111|NCT02766244|75605524|FG000|NOT COMPLETED|Overall Study||0||
59512112|NCT02767492|75605535|FG000|STARTED|Overall Study||45||
59512113|NCT02767492|75605536|FG001|STARTED|Overall Study||45||
59512114|NCT02767492|75605535|FG000|COMPLETED|Overall Study||35||
59512115|NCT02767492|75605536|FG001|COMPLETED|Overall Study||35||
59512116|NCT02767492|75605535|FG000|NOT COMPLETED|Overall Study||10||
59512117|NCT02767492|75605536|FG001|NOT COMPLETED|Overall Study||10||
59512118|NCT01044433|75605542|FG000|STARTED|Overall Study||44||
59512119|NCT01044433|75605542|FG000|COMPLETED|Overall Study||38||
59512120|NCT01044433|75605542|FG000|NOT COMPLETED|Overall Study||6||
59512121|NCT02758210|75605547|FG000|STARTED|Overall Study||20||
59512122|NCT02758210|75605547|FG000|COMPLETED|Overall Study||20||
59512123|NCT02758210|75605547|FG000|NOT COMPLETED|Overall Study||0||
59512124|NCT01043185|75605551|FG000|STARTED|Period 1 - First Intervention||3||
59512125|NCT01043185|75605552|FG001|STARTED|Period 1 - First Intervention||2||
59512126|NCT01043185|75605553|FG002|STARTED|Period 1 - First Intervention||3||
59512127|NCT01043185|75605554|FG003|STARTED|Period 1 - First Intervention||2||
59512128|NCT01043185|75605555|FG004|STARTED|Period 1 - First Intervention||2||
59512129|NCT01043185|75605556|FG005|STARTED|Period 1 - First Intervention||3||
59760062|NCT03052842|75879628|FG001|COMPLETED|Overall Study||8||
59760063|NCT03052842|75879629|FG002|COMPLETED|Overall Study||8||
59760064|NCT03052842|75879630|FG003|COMPLETED|Overall Study||6||
59760065|NCT03052842|75879627|FG000|NOT COMPLETED|Overall Study||0||
59760066|NCT03052842|75879628|FG001|NOT COMPLETED|Overall Study||0||
59760067|NCT03052842|75879629|FG002|NOT COMPLETED|Overall Study||0||
59760068|NCT03052842|75879630|FG003|NOT COMPLETED|Overall Study||0||
59760069|NCT00901901|75879642|FG000|STARTED|Treatment Period||362||
59760070|NCT00901901|75879643|FG001|STARTED|Treatment Period||358||
59760071|NCT00901901|75879642|FG000|Participants Received Treatment|Treatment Period||362||
59760072|NCT00901901|75879643|FG001|Participants Received Treatment|Treatment Period||355||
59760073|NCT00901901|75879642|FG000|COMPLETED|Treatment Period||193||
59920151|NCT03303079|76040377|FG002|STARTED|Overall Study||191||
59920152|NCT03303079|76040375|FG000|COMPLETED|Overall Study||182||
59920153|NCT03303079|76040376|FG001|COMPLETED|Overall Study||180||
59920154|NCT03303079|76040377|FG002|COMPLETED|Overall Study||179||
59920155|NCT03303079|76040375|FG000|NOT COMPLETED|Overall Study||7||
59920156|NCT03303079|76040376|FG001|NOT COMPLETED|Overall Study||11||
59512130|NCT01043185|75605557|FG006|STARTED|Period 1 - First Intervention||3||
59512131|NCT01043185|75605558|FG007|STARTED|Period 1 - First Intervention||3||
59512132|NCT01043185|75605559|FG008|STARTED|Period 1 - First Intervention||3||
59512133|NCT01043185|75605560|FG009|STARTED|Period 1 - First Intervention||3||
59512134|NCT01043185|75605551|FG000|COMPLETED|Period 1 - First Intervention||3||
59512135|NCT01043185|75605552|FG001|COMPLETED|Period 1 - First Intervention||2||
59512136|NCT01043185|75605553|FG002|COMPLETED|Period 1 - First Intervention||3||
59512137|NCT01043185|75605554|FG003|COMPLETED|Period 1 - First Intervention||2||
59512138|NCT01043185|75605555|FG004|COMPLETED|Period 1 - First Intervention||2||
59512139|NCT01043185|75605556|FG005|COMPLETED|Period 1 - First Intervention||3||
59512140|NCT01043185|75605557|FG006|COMPLETED|Period 1 - First Intervention||3||
59512141|NCT01043185|75605558|FG007|COMPLETED|Period 1 - First Intervention||3||
59512142|NCT01043185|75605559|FG008|COMPLETED|Period 1 - First Intervention||3||
59512143|NCT01043185|75605560|FG009|COMPLETED|Period 1 - First Intervention||3||
59512144|NCT01043185|75605551|FG000|NOT COMPLETED|Period 1 - First Intervention||0||
59512145|NCT01043185|75605552|FG001|NOT COMPLETED|Period 1 - First Intervention||0||
59512146|NCT01043185|75605553|FG002|NOT COMPLETED|Period 1 - First Intervention||0||
59760074|NCT00901901|75879643|FG001|COMPLETED|Treatment Period||181||
59760075|NCT00901901|75879642|FG000|NOT COMPLETED|Treatment Period||169||
59920157|NCT03303079|76040377|FG002|NOT COMPLETED|Overall Study||12||
59951423|NCT01251965|76070418|FG000|STARTED|Overall Study||4||
60047452|NCT01588366|76162996|FG001|STARTED|Overall Study||7||
59519037|NCT03398278|75612890|FG001|STARTED|Period 1||19||
59760076|NCT00901901|75879643|FG001|NOT COMPLETED|Treatment Period||177||
59760077|NCT00901901|75879642|FG000|STARTED|Follow-up Period||340||
59512147|NCT01043185|75605554|FG003|NOT COMPLETED|Period 1 - First Intervention||0||
59512148|NCT01043185|75605555|FG004|NOT COMPLETED|Period 1 - First Intervention||0||
59512149|NCT01043185|75605556|FG005|NOT COMPLETED|Period 1 - First Intervention||0||
59512150|NCT01043185|75605557|FG006|NOT COMPLETED|Period 1 - First Intervention||0||
59512151|NCT01043185|75605558|FG007|NOT COMPLETED|Period 1 - First Intervention||0||
59512152|NCT01043185|75605559|FG008|NOT COMPLETED|Period 1 - First Intervention||0||
59512153|NCT01043185|75605560|FG009|NOT COMPLETED|Period 1 - First Intervention||0||
59512154|NCT01043185|75605551|FG000|STARTED|Period 2 - First Washout Period||3||
59512155|NCT01043185|75605552|FG001|STARTED|Period 2 - First Washout Period||2||
59512156|NCT01043185|75605553|FG002|STARTED|Period 2 - First Washout Period||3||
59512157|NCT01043185|75605554|FG003|STARTED|Period 2 - First Washout Period||2||
59512158|NCT01043185|75605555|FG004|STARTED|Period 2 - First Washout Period||2||
59512159|NCT01043185|75605556|FG005|STARTED|Period 2 - First Washout Period||3||
59512160|NCT01043185|75605557|FG006|STARTED|Period 2 - First Washout Period||3||
59512161|NCT01043185|75605558|FG007|STARTED|Period 2 - First Washout Period||3||
59512162|NCT01043185|75605559|FG008|STARTED|Period 2 - First Washout Period||3||
59512163|NCT01043185|75605560|FG009|STARTED|Period 2 - First Washout Period||3||
59512164|NCT01043185|75605551|FG000|COMPLETED|Period 2 - First Washout Period||3||
59512165|NCT01043185|75605552|FG001|COMPLETED|Period 2 - First Washout Period||2||
59512166|NCT01043185|75605553|FG002|COMPLETED|Period 2 - First Washout Period||3||
59512167|NCT01043185|75605554|FG003|COMPLETED|Period 2 - First Washout Period||2||
59512168|NCT01043185|75605555|FG004|COMPLETED|Period 2 - First Washout Period||2||
59512169|NCT01043185|75605556|FG005|COMPLETED|Period 2 - First Washout Period||3||
59512170|NCT01043185|75605557|FG006|COMPLETED|Period 2 - First Washout Period||3||
59512171|NCT01043185|75605558|FG007|COMPLETED|Period 2 - First Washout Period||3||
59512172|NCT01043185|75605559|FG008|COMPLETED|Period 2 - First Washout Period||3||
59512173|NCT01043185|75605560|FG009|COMPLETED|Period 2 - First Washout Period||3||
59512174|NCT01043185|75605551|FG000|NOT COMPLETED|Period 2 - First Washout Period||0||
59512175|NCT01043185|75605552|FG001|NOT COMPLETED|Period 2 - First Washout Period||0||
59512176|NCT01043185|75605553|FG002|NOT COMPLETED|Period 2 - First Washout Period||0||
59512177|NCT01043185|75605554|FG003|NOT COMPLETED|Period 2 - First Washout Period||0||
59512178|NCT01043185|75605555|FG004|NOT COMPLETED|Period 2 - First Washout Period||0||
59512179|NCT01043185|75605556|FG005|NOT COMPLETED|Period 2 - First Washout Period||0||
59512180|NCT01043185|75605557|FG006|NOT COMPLETED|Period 2 - First Washout Period||0||
59512181|NCT01043185|75605558|FG007|NOT COMPLETED|Period 2 - First Washout Period||0||
59512182|NCT01043185|75605559|FG008|NOT COMPLETED|Period 2 - First Washout Period||0||
59512183|NCT01043185|75605560|FG009|NOT COMPLETED|Period 2 - First Washout Period||0||
59512184|NCT01043185|75605551|FG000|STARTED|Period 3 - Second Intervention||3||
59512185|NCT01043185|75605552|FG001|STARTED|Period 3 - Second Intervention||2||
59512186|NCT01043185|75605553|FG002|STARTED|Period 3 - Second Intervention||3||
59512187|NCT01043185|75605554|FG003|STARTED|Period 3 - Second Intervention||2||
59512188|NCT01043185|75605555|FG004|STARTED|Period 3 - Second Intervention||2||
59512189|NCT01043185|75605556|FG005|STARTED|Period 3 - Second Intervention||3||
59512190|NCT01043185|75605557|FG006|STARTED|Period 3 - Second Intervention||3||
59512191|NCT01043185|75605558|FG007|STARTED|Period 3 - Second Intervention||3||
59512192|NCT01043185|75605559|FG008|STARTED|Period 3 - Second Intervention||3||
59512193|NCT01043185|75605560|FG009|STARTED|Period 3 - Second Intervention||3||
59512194|NCT01043185|75605551|FG000|COMPLETED|Period 3 - Second Intervention||3||
59512195|NCT01043185|75605552|FG001|COMPLETED|Period 3 - Second Intervention||2||
59512196|NCT01043185|75605553|FG002|COMPLETED|Period 3 - Second Intervention||3||
59512197|NCT01043185|75605554|FG003|COMPLETED|Period 3 - Second Intervention||2||
59512198|NCT01043185|75605555|FG004|COMPLETED|Period 3 - Second Intervention||2||
59512199|NCT01043185|75605556|FG005|COMPLETED|Period 3 - Second Intervention||3||
59512200|NCT01043185|75605557|FG006|COMPLETED|Period 3 - Second Intervention||3||
59512201|NCT01043185|75605558|FG007|COMPLETED|Period 3 - Second Intervention||3||
59512202|NCT01043185|75605559|FG008|COMPLETED|Period 3 - Second Intervention||3||
59512203|NCT01043185|75605560|FG009|COMPLETED|Period 3 - Second Intervention||3||
59512204|NCT01043185|75605551|FG000|NOT COMPLETED|Period 3 - Second Intervention||0||
59512205|NCT01043185|75605552|FG001|NOT COMPLETED|Period 3 - Second Intervention||0||
59512206|NCT01043185|75605553|FG002|NOT COMPLETED|Period 3 - Second Intervention||0||
59512207|NCT01043185|75605554|FG003|NOT COMPLETED|Period 3 - Second Intervention||0||
59512208|NCT01043185|75605555|FG004|NOT COMPLETED|Period 3 - Second Intervention||0||
59512209|NCT01043185|75605556|FG005|NOT COMPLETED|Period 3 - Second Intervention||0||
59512210|NCT01043185|75605557|FG006|NOT COMPLETED|Period 3 - Second Intervention||0||
59512211|NCT01043185|75605558|FG007|NOT COMPLETED|Period 3 - Second Intervention||0||
59512212|NCT01043185|75605559|FG008|NOT COMPLETED|Period 3 - Second Intervention||0||
59512213|NCT01043185|75605560|FG009|NOT COMPLETED|Period 3 - Second Intervention||0||
59512214|NCT01043185|75605551|FG000|STARTED|Period 4 - Second Washout Period||3||
59512215|NCT01043185|75605552|FG001|STARTED|Period 4 - Second Washout Period||2||
59512216|NCT01043185|75605553|FG002|STARTED|Period 4 - Second Washout Period||3||
59512217|NCT01043185|75605554|FG003|STARTED|Period 4 - Second Washout Period||2||
59512218|NCT01043185|75605555|FG004|STARTED|Period 4 - Second Washout Period||2||
59512219|NCT01043185|75605556|FG005|STARTED|Period 4 - Second Washout Period||3||
59512220|NCT01043185|75605557|FG006|STARTED|Period 4 - Second Washout Period||3||
59512221|NCT01043185|75605558|FG007|STARTED|Period 4 - Second Washout Period||3||
59512222|NCT01043185|75605559|FG008|STARTED|Period 4 - Second Washout Period||3||
59512223|NCT01043185|75605560|FG009|STARTED|Period 4 - Second Washout Period||3||
59512224|NCT01043185|75605551|FG000|COMPLETED|Period 4 - Second Washout Period||3||
59512225|NCT01043185|75605552|FG001|COMPLETED|Period 4 - Second Washout Period||2||
59512226|NCT01043185|75605553|FG002|COMPLETED|Period 4 - Second Washout Period||3||
59512227|NCT01043185|75605554|FG003|COMPLETED|Period 4 - Second Washout Period||2||
59512228|NCT01043185|75605555|FG004|COMPLETED|Period 4 - Second Washout Period||2||
59512229|NCT01043185|75605556|FG005|COMPLETED|Period 4 - Second Washout Period||3||
59512230|NCT01043185|75605557|FG006|COMPLETED|Period 4 - Second Washout Period||3||
59512231|NCT01043185|75605558|FG007|COMPLETED|Period 4 - Second Washout Period||3||
59512232|NCT01043185|75605559|FG008|COMPLETED|Period 4 - Second Washout Period||3||
59512233|NCT01043185|75605560|FG009|COMPLETED|Period 4 - Second Washout Period||3||
59512234|NCT01043185|75605551|FG000|NOT COMPLETED|Period 4 - Second Washout Period||0||
59512235|NCT01043185|75605552|FG001|NOT COMPLETED|Period 4 - Second Washout Period||0||
59512236|NCT01043185|75605553|FG002|NOT COMPLETED|Period 4 - Second Washout Period||0||
59512237|NCT01043185|75605554|FG003|NOT COMPLETED|Period 4 - Second Washout Period||0||
59512238|NCT01043185|75605555|FG004|NOT COMPLETED|Period 4 - Second Washout Period||0||
59512239|NCT01043185|75605556|FG005|NOT COMPLETED|Period 4 - Second Washout Period||0||
59512240|NCT01043185|75605557|FG006|NOT COMPLETED|Period 4 - Second Washout Period||0||
59512241|NCT01043185|75605558|FG007|NOT COMPLETED|Period 4 - Second Washout Period||0||
59512242|NCT01043185|75605559|FG008|NOT COMPLETED|Period 4 - Second Washout Period||0||
59512243|NCT01043185|75605560|FG009|NOT COMPLETED|Period 4 - Second Washout Period||0||
59512244|NCT01043185|75605551|FG000|STARTED|Period 5 - Third Intervention||3||
59512245|NCT01043185|75605552|FG001|STARTED|Period 5 - Third Intervention||2||
59512246|NCT01043185|75605553|FG002|STARTED|Period 5 - Third Intervention||3||
59512247|NCT01043185|75605554|FG003|STARTED|Period 5 - Third Intervention||2||
59512248|NCT01043185|75605555|FG004|STARTED|Period 5 - Third Intervention||2||
59512249|NCT01043185|75605556|FG005|STARTED|Period 5 - Third Intervention||3||
59512250|NCT01043185|75605557|FG006|STARTED|Period 5 - Third Intervention||3||
59512251|NCT01043185|75605558|FG007|STARTED|Period 5 - Third Intervention||3||
59512252|NCT01043185|75605559|FG008|STARTED|Period 5 - Third Intervention||3||
59512253|NCT01043185|75605560|FG009|STARTED|Period 5 - Third Intervention||3||
59512254|NCT01043185|75605551|FG000|COMPLETED|Period 5 - Third Intervention||3||
59512255|NCT01043185|75605552|FG001|COMPLETED|Period 5 - Third Intervention||2||
59512256|NCT01043185|75605553|FG002|COMPLETED|Period 5 - Third Intervention||3||
59512257|NCT01043185|75605554|FG003|COMPLETED|Period 5 - Third Intervention||2||
59512258|NCT01043185|75605555|FG004|COMPLETED|Period 5 - Third Intervention||2||
59512259|NCT01043185|75605556|FG005|COMPLETED|Period 5 - Third Intervention||3||
59512260|NCT01043185|75605557|FG006|COMPLETED|Period 5 - Third Intervention||3||
59512261|NCT01043185|75605558|FG007|COMPLETED|Period 5 - Third Intervention||3||
59512262|NCT01043185|75605559|FG008|COMPLETED|Period 5 - Third Intervention||3||
59512263|NCT01043185|75605560|FG009|COMPLETED|Period 5 - Third Intervention||3||
59512264|NCT01043185|75605551|FG000|NOT COMPLETED|Period 5 - Third Intervention||0||
59512265|NCT01043185|75605552|FG001|NOT COMPLETED|Period 5 - Third Intervention||0||
59512266|NCT01043185|75605553|FG002|NOT COMPLETED|Period 5 - Third Intervention||0||
59512267|NCT01043185|75605554|FG003|NOT COMPLETED|Period 5 - Third Intervention||0||
59512268|NCT01043185|75605555|FG004|NOT COMPLETED|Period 5 - Third Intervention||0||
59512269|NCT01043185|75605556|FG005|NOT COMPLETED|Period 5 - Third Intervention||0||
59512270|NCT01043185|75605557|FG006|NOT COMPLETED|Period 5 - Third Intervention||0||
59512271|NCT01043185|75605558|FG007|NOT COMPLETED|Period 5 - Third Intervention||0||
59512272|NCT01043185|75605559|FG008|NOT COMPLETED|Period 5 - Third Intervention||0||
59512273|NCT01043185|75605560|FG009|NOT COMPLETED|Period 5 - Third Intervention||0||
59512274|NCT01043185|75605551|FG000|STARTED|Period 6 - Third Washout Period||3||
59512275|NCT01043185|75605552|FG001|STARTED|Period 6 - Third Washout Period||2||
59512276|NCT01043185|75605553|FG002|STARTED|Period 6 - Third Washout Period||3||
59512277|NCT01043185|75605554|FG003|STARTED|Period 6 - Third Washout Period||2||
59760078|NCT00901901|75879643|FG001|STARTED|Follow-up Period||341||
59512278|NCT01043185|75605555|FG004|STARTED|Period 6 - Third Washout Period||2||
59512279|NCT01043185|75605556|FG005|STARTED|Period 6 - Third Washout Period||3||
59512280|NCT01043185|75605557|FG006|STARTED|Period 6 - Third Washout Period||3||
59512281|NCT01043185|75605558|FG007|STARTED|Period 6 - Third Washout Period||3||
59512282|NCT01043185|75605559|FG008|STARTED|Period 6 - Third Washout Period||3||
59512283|NCT01043185|75605560|FG009|STARTED|Period 6 - Third Washout Period||3||
59512284|NCT01043185|75605551|FG000|COMPLETED|Period 6 - Third Washout Period||3||
59512285|NCT01043185|75605552|FG001|COMPLETED|Period 6 - Third Washout Period||2||
59512286|NCT01043185|75605553|FG002|COMPLETED|Period 6 - Third Washout Period||3||
59512287|NCT01043185|75605554|FG003|COMPLETED|Period 6 - Third Washout Period||2||
59512288|NCT01043185|75605555|FG004|COMPLETED|Period 6 - Third Washout Period||2||
59512289|NCT01043185|75605556|FG005|COMPLETED|Period 6 - Third Washout Period||3||
59512290|NCT01043185|75605557|FG006|COMPLETED|Period 6 - Third Washout Period||3||
59512291|NCT01043185|75605558|FG007|COMPLETED|Period 6 - Third Washout Period||3||
59512292|NCT01043185|75605559|FG008|COMPLETED|Period 6 - Third Washout Period||2||
59512293|NCT01043185|75605560|FG009|COMPLETED|Period 6 - Third Washout Period||3||
59512294|NCT01043185|75605551|FG000|NOT COMPLETED|Period 6 - Third Washout Period||0||
59512295|NCT01043185|75605552|FG001|NOT COMPLETED|Period 6 - Third Washout Period||0||
59512296|NCT01043185|75605553|FG002|NOT COMPLETED|Period 6 - Third Washout Period||0||
59512297|NCT01043185|75605554|FG003|NOT COMPLETED|Period 6 - Third Washout Period||0||
59512298|NCT01043185|75605555|FG004|NOT COMPLETED|Period 6 - Third Washout Period||0||
59512299|NCT01043185|75605556|FG005|NOT COMPLETED|Period 6 - Third Washout Period||0||
59512300|NCT01043185|75605557|FG006|NOT COMPLETED|Period 6 - Third Washout Period||0||
59512301|NCT01043185|75605558|FG007|NOT COMPLETED|Period 6 - Third Washout Period||0||
59512302|NCT01043185|75605559|FG008|NOT COMPLETED|Period 6 - Third Washout Period||1||
59512303|NCT01043185|75605560|FG009|NOT COMPLETED|Period 6 - Third Washout Period||0||
59512304|NCT01043185|75605551|FG000|STARTED|Period 7 - Fourth Intervention||3||
59512305|NCT01043185|75605552|FG001|STARTED|Period 7 - Fourth Intervention||2||
59512306|NCT01043185|75605553|FG002|STARTED|Period 7 - Fourth Intervention||3||
59512307|NCT01043185|75605554|FG003|STARTED|Period 7 - Fourth Intervention||2||
59512308|NCT01043185|75605555|FG004|STARTED|Period 7 - Fourth Intervention||2||
59512309|NCT01043185|75605556|FG005|STARTED|Period 7 - Fourth Intervention||3||
59512310|NCT01043185|75605557|FG006|STARTED|Period 7 - Fourth Intervention||3||
59512311|NCT01043185|75605558|FG007|STARTED|Period 7 - Fourth Intervention||3||
59512312|NCT01043185|75605559|FG008|STARTED|Period 7 - Fourth Intervention||2||
59512313|NCT01043185|75605560|FG009|STARTED|Period 7 - Fourth Intervention||3||
59512314|NCT01043185|75605551|FG000|COMPLETED|Period 7 - Fourth Intervention||3||
59512315|NCT01043185|75605552|FG001|COMPLETED|Period 7 - Fourth Intervention||2||
59512316|NCT01043185|75605553|FG002|COMPLETED|Period 7 - Fourth Intervention||3||
59512317|NCT01043185|75605554|FG003|COMPLETED|Period 7 - Fourth Intervention||2||
59512318|NCT01043185|75605555|FG004|COMPLETED|Period 7 - Fourth Intervention||2||
59512319|NCT01043185|75605556|FG005|COMPLETED|Period 7 - Fourth Intervention||3||
59512320|NCT01043185|75605557|FG006|COMPLETED|Period 7 - Fourth Intervention||3||
59512321|NCT01043185|75605558|FG007|COMPLETED|Period 7 - Fourth Intervention||3||
59512322|NCT01043185|75605559|FG008|COMPLETED|Period 7 - Fourth Intervention||2||
59512323|NCT01043185|75605560|FG009|COMPLETED|Period 7 - Fourth Intervention||3||
59512324|NCT01043185|75605551|FG000|NOT COMPLETED|Period 7 - Fourth Intervention||0||
59512325|NCT01043185|75605552|FG001|NOT COMPLETED|Period 7 - Fourth Intervention||0||
59512326|NCT01043185|75605553|FG002|NOT COMPLETED|Period 7 - Fourth Intervention||0||
59512327|NCT01043185|75605554|FG003|NOT COMPLETED|Period 7 - Fourth Intervention||0||
59512328|NCT01043185|75605555|FG004|NOT COMPLETED|Period 7 - Fourth Intervention||0||
59512329|NCT01043185|75605556|FG005|NOT COMPLETED|Period 7 - Fourth Intervention||0||
59512330|NCT01043185|75605557|FG006|NOT COMPLETED|Period 7 - Fourth Intervention||0||
59512331|NCT01043185|75605558|FG007|NOT COMPLETED|Period 7 - Fourth Intervention||0||
59512332|NCT01043185|75605559|FG008|NOT COMPLETED|Period 7 - Fourth Intervention||0||
59512333|NCT01043185|75605560|FG009|NOT COMPLETED|Period 7 - Fourth Intervention||0||
59512334|NCT02769442|75605574|FG000|STARTED|Overall Study||309||
59512335|NCT02769442|75605575|FG001|STARTED|Overall Study||291||
59512336|NCT02769442|75605574|FG000|COMPLETED|Overall Study||309||
59512337|NCT02769442|75605575|FG001|COMPLETED|Overall Study||291||
59512338|NCT02769442|75605574|FG000|NOT COMPLETED|Overall Study||0||
59512339|NCT02769442|75605575|FG001|NOT COMPLETED|Overall Study||0||
59512340|NCT01042093|75605585|FG000|STARTED|Overall Study||40||
59512341|NCT01042093|75605586|FG001|STARTED|Overall Study||40||
59512342|NCT01042093|75605587|FG002|STARTED|Overall Study||40||
59512343|NCT01042093|75605588|FG003|STARTED|Overall Study||40||
59512344|NCT01042093|75605585|FG000|COMPLETED|Overall Study||38||
59512345|NCT01042093|75605586|FG001|COMPLETED|Overall Study||38||
59512346|NCT01042093|75605587|FG002|COMPLETED|Overall Study||38||
59512347|NCT01042093|75605588|FG003|COMPLETED|Overall Study||36||
59512348|NCT01042093|75605585|FG000|NOT COMPLETED|Overall Study||2||
59512349|NCT01042093|75605586|FG001|NOT COMPLETED|Overall Study||2||
59512350|NCT01042093|75605587|FG002|NOT COMPLETED|Overall Study||2||
59512351|NCT01042093|75605588|FG003|NOT COMPLETED|Overall Study||4||
59512352|NCT02770846|75605603|FG000|STARTED|Overall Study||25||
59512353|NCT02770846|75605604|FG001|STARTED|Overall Study||25||
59512354|NCT02770846|75605603|FG000|COMPLETED|Overall Study||25||
59512355|NCT02770846|75605604|FG001|COMPLETED|Overall Study||25||
59512356|NCT02770846|75605603|FG000|NOT COMPLETED|Overall Study||0||
59512357|NCT02770846|75605604|FG001|NOT COMPLETED|Overall Study||0||
59512358|NCT02776774|75605612|FG000|STARTED|Overall Study||91|Total surveys submitted|
59512359|NCT02776774|75605612|FG000|COMPLETED|Overall Study|Total after data cleaning|91||
59512360|NCT02776774|75605612|FG000|NOT COMPLETED|Overall Study||0||
59512361|NCT01041859|75605618|FG000|STARTED|Open-Label Titration|Of 460 total enrollment, one subject enrolled twice; this subject's second enrollment is excluded.|459||
59512362|NCT01041859|75605619|FG001|STARTED|Open-Label Titration||0||
59512363|NCT01041859|75605620|FG002|STARTED|Open-Label Titration||0||
59512364|NCT01041859|75605618|FG000|COMPLETED|Open-Label Titration|Of 358 completed subjects, 320 were randomized to the Double-Blind Maintenance Period.|358||
59512365|NCT01041859|75605619|FG001|COMPLETED|Open-Label Titration||0||
59512366|NCT01041859|75605620|FG002|COMPLETED|Open-Label Titration||0||
59512367|NCT01041859|75605618|FG000|NOT COMPLETED|Open-Label Titration||101||
59512368|NCT01041859|75605619|FG001|NOT COMPLETED|Open-Label Titration||0||
59512369|NCT01041859|75605620|FG002|NOT COMPLETED|Open-Label Titration||0||
60047453|NCT01588366|76162997|FG002|STARTED|Overall Study||2||
60047454|NCT01588366|76162998|FG003|STARTED|Overall Study||7||
60047455|NCT01588366|76162999|FG004|STARTED|Overall Study||3||
60047456|NCT01588366|76163000|FG005|STARTED|Overall Study||9||
60047457|NCT01588366|76162995|FG000|Received at Least One Dose of Study Drug|Overall Study||2||
60047458|NCT01588366|76162996|FG001|Received at Least One Dose of Study Drug|Overall Study||7||
60047459|NCT01588366|76162997|FG002|Received at Least One Dose of Study Drug|Overall Study||2||
60047460|NCT01588366|76162998|FG003|Received at Least One Dose of Study Drug|Overall Study||7||
60047461|NCT01588366|76162999|FG004|Received at Least One Dose of Study Drug|Overall Study||3||
59512370|NCT01041859|75605618|FG000|STARTED|Double-Blind Maintenance||0||
59512371|NCT01041859|75605619|FG001|STARTED|Double-Blind Maintenance|168 were randomized, 2 were not treated (1 randomized in error, 1 withdrew consent).|166||
60047462|NCT01588366|76163000|FG005|Received at Least One Dose of Study Drug|Overall Study||9||
60047463|NCT01588366|76162995|FG000|COMPLETED|Overall Study||2||
59512372|NCT01041859|75605620|FG002|STARTED|Double-Blind Maintenance|152 randomized, all were treated.|152||
60047464|NCT01588366|76162996|FG001|COMPLETED|Overall Study||6||
59512373|NCT01041859|75605618|FG000|COMPLETED|Double-Blind Maintenance||0||
60047465|NCT01588366|76162997|FG002|COMPLETED|Overall Study||2||
60047466|NCT01588366|76162998|FG003|COMPLETED|Overall Study||6||
60047467|NCT01588366|76162999|FG004|COMPLETED|Overall Study||3||
59512374|NCT01041859|75605619|FG001|COMPLETED|Double-Blind Maintenance||120||
59512375|NCT01041859|75605620|FG002|COMPLETED|Double-Blind Maintenance||107||
59512376|NCT01041859|75605618|FG000|NOT COMPLETED|Double-Blind Maintenance||0||
59512377|NCT01041859|75605619|FG001|NOT COMPLETED|Double-Blind Maintenance||46||
59512378|NCT01041859|75605620|FG002|NOT COMPLETED|Double-Blind Maintenance||45||
59512379|NCT01040845|75605629|FG000|STARTED|Overall Study||15||
60047468|NCT01588366|76163000|FG005|COMPLETED|Overall Study||7||
60047469|NCT01588366|76162995|FG000|NOT COMPLETED|Overall Study||0||
60047470|NCT01588366|76162996|FG001|NOT COMPLETED|Overall Study||1||
60047471|NCT01588366|76162997|FG002|NOT COMPLETED|Overall Study||0||
60047472|NCT01588366|76162998|FG003|NOT COMPLETED|Overall Study||1||
60047473|NCT01588366|76162999|FG004|NOT COMPLETED|Overall Study||0||
60047474|NCT01588366|76163000|FG005|NOT COMPLETED|Overall Study||2||
60047475|NCT01686958|76163016|FG000|STARTED|Overall Study||30||
60047476|NCT01686958|76163016|FG000|COMPLETED|Overall Study|No. of patients who completed ALL assessments at 12 months post treatment; 1 pt only had PSA test.|29||
59512380|NCT01040845|75605630|FG001|STARTED|Overall Study||15||
59512381|NCT01040845|75605629|FG000|COMPLETED|Overall Study|withdrew consent due to schedule conflict (1); dropped by physician due to positive drug screen (1)|13||
59512382|NCT01040845|75605630|FG001|COMPLETED|Overall Study|withdrew consent due to schedule conflict (1)|14||
59512383|NCT01040845|75605629|FG000|NOT COMPLETED|Overall Study||2||
59512384|NCT01040845|75605630|FG001|NOT COMPLETED|Overall Study||1||
59512385|NCT01040689|75605638|FG000|STARTED|Overall Study||27||
59512386|NCT01040689|75605639|FG001|STARTED|Overall Study||27||
59512387|NCT01040689|75605640|FG002|STARTED|Overall Study||27||
59512388|NCT01040689|75605641|FG003|STARTED|Overall Study||27||
59512389|NCT01040689|75605638|FG000|COMPLETED|Overall Study||24||
59512390|NCT01040689|75605639|FG001|COMPLETED|Overall Study||25||
59512391|NCT01040689|75605640|FG002|COMPLETED|Overall Study||23||
59512392|NCT01040689|75605641|FG003|COMPLETED|Overall Study||23||
59512393|NCT01040689|75605638|FG000|NOT COMPLETED|Overall Study||3||
59512394|NCT01040689|75605639|FG001|NOT COMPLETED|Overall Study||2||
59512395|NCT01040689|75605640|FG002|NOT COMPLETED|Overall Study||4||
59512396|NCT01040689|75605641|FG003|NOT COMPLETED|Overall Study||4||
59512397|NCT03576976|75605658|FG000|STARTED|Overall Study||27||
59512398|NCT03576976|75605659|FG001|STARTED|Overall Study||28||
59512399|NCT03576976|75605658|FG000|COMPLETED|Overall Study||18||
59512400|NCT03576976|75605659|FG001|COMPLETED|Overall Study||17||
59512401|NCT03576976|75605658|FG000|NOT COMPLETED|Overall Study||9||
59512402|NCT03576976|75605659|FG001|NOT COMPLETED|Overall Study||11||
59512403|NCT00889187|75605665|FG000|STARTED|Overall Study||3||
59512404|NCT00889187|75605666|FG001|STARTED|Overall Study||3||
59512405|NCT00889187|75605667|FG002|STARTED|Overall Study||4||
59512406|NCT00889187|75605668|FG003|STARTED|Overall Study||0||
59512407|NCT00889187|75605665|FG000|COMPLETED|Overall Study||3||
59512408|NCT00889187|75605666|FG001|COMPLETED|Overall Study||3||
59512409|NCT00889187|75605667|FG002|COMPLETED|Overall Study||4||
59512410|NCT00889187|75605668|FG003|COMPLETED|Overall Study||0||
60047477|NCT01686958|76163016|FG000|NOT COMPLETED|Overall Study||1||
60047478|NCT01686568|76163023|FG000|STARTED|Main Study||16||
60047479|NCT01686568|76163024|FG001|STARTED|Main Study||15||
60047480|NCT01686568|76163023|FG000|COMPLETED|Main Study||14||
60047481|NCT01686568|76163024|FG001|COMPLETED|Main Study||11||
60047482|NCT01686568|76163023|FG000|NOT COMPLETED|Main Study||2||
60047483|NCT01686568|76163024|FG001|NOT COMPLETED|Main Study||4||
60047484|NCT01686568|76163023|FG000|STARTED|Sub-Study||14||
60047485|NCT01686568|76163024|FG001|STARTED|Sub-Study||11||
60047486|NCT01686568|76163023|FG000|COMPLETED|Sub-Study||12||
60047487|NCT01686568|76163024|FG001|COMPLETED|Sub-Study||9||
60047488|NCT01686568|76163023|FG000|NOT COMPLETED|Sub-Study||2||
60047489|NCT01686568|76163024|FG001|NOT COMPLETED|Sub-Study||2||
60047490|NCT01567462|76163032|FG000|STARTED|Overall Study||45||
60047491|NCT01567462|76163033|FG001|STARTED|Overall Study||45||
60047492|NCT01567462|76163032|FG000|COMPLETED|Overall Study||41||
59512411|NCT00889187|75605665|FG000|NOT COMPLETED|Overall Study||0||
59512412|NCT00889187|75605666|FG001|NOT COMPLETED|Overall Study||0||
59512413|NCT00889187|75605667|FG002|NOT COMPLETED|Overall Study||0||
59512414|NCT00889187|75605668|FG003|NOT COMPLETED|Overall Study||0||
60047493|NCT01567462|76163033|FG001|COMPLETED|Overall Study||38||
59512415|NCT00895817|75605680|FG000|STARTED|Overall Study||21||
59512416|NCT00895817|75605681|FG001|STARTED|Overall Study||21||
60047494|NCT01567462|76163032|FG000|NOT COMPLETED|Overall Study||4||
60047495|NCT01567462|76163033|FG001|NOT COMPLETED|Overall Study||7||
60047496|NCT01587898|76163043|FG000|STARTED|Overall Study||18||
60047497|NCT01587898|76163044|FG001|STARTED|Overall Study||17||
60047498|NCT01587898|76163045|FG002|STARTED|Overall Study||18||
59512417|NCT00895817|75605680|FG000|COMPLETED|Overall Study||21||
59512418|NCT00895817|75605681|FG001|COMPLETED|Overall Study||21||
59512419|NCT00895817|75605680|FG000|NOT COMPLETED|Overall Study||0||
59512420|NCT00895817|75605681|FG001|NOT COMPLETED|Overall Study||0||
59512421|NCT01047319|75605690|FG000|STARTED|Overall Study||345||
60047499|NCT01587898|76163046|FG003|STARTED|Overall Study||19||
60047500|NCT01587898|76163043|FG000|COMPLETED|Overall Study||14||
60047501|NCT01587898|76163044|FG001|COMPLETED|Overall Study||12||
60047502|NCT01587898|76163045|FG002|COMPLETED|Overall Study||16||
60047503|NCT01587898|76163046|FG003|COMPLETED|Overall Study||17||
60047504|NCT01587898|76163043|FG000|NOT COMPLETED|Overall Study||4||
60047505|NCT01587898|76163044|FG001|NOT COMPLETED|Overall Study||5||
60047506|NCT01587898|76163045|FG002|NOT COMPLETED|Overall Study||2||
60047507|NCT01587898|76163046|FG003|NOT COMPLETED|Overall Study||2||
60047508|NCT01567306|76163065|FG000|STARTED|Overall Study||27||
60047509|NCT01567306|76163066|FG001|STARTED|Overall Study||25||
60047510|NCT01567306|76163067|FG002|STARTED|Overall Study||24||
59920158|NCT01067846|76040387|FG000|STARTED|Overall Study|Due to exclusion prior to group assignment, Study Enrollment will not equal Total # of Participants.|29||
59920159|NCT01067846|76040388|FG001|STARTED|Overall Study|Due to exclusion prior to group assignment, Study Enrollment will not equal Total # of Participants.|30||
60047511|NCT01567306|76163068|FG003|STARTED|Overall Study||24||
60047512|NCT01567306|76163069|FG004|STARTED|Overall Study||25||
60047513|NCT01567306|76163070|FG005|STARTED|Overall Study||26||
60047514|NCT01567306|76163065|FG000|COMPLETED|Overall Study||24||
60047515|NCT01567306|76163066|FG001|COMPLETED|Overall Study||23||
60047516|NCT01567306|76163067|FG002|COMPLETED|Overall Study||24||
60047517|NCT01567306|76163068|FG003|COMPLETED|Overall Study||19||
60047518|NCT01567306|76163069|FG004|COMPLETED|Overall Study||18||
60047519|NCT01567306|76163070|FG005|COMPLETED|Overall Study||23||
60047520|NCT01567306|76163065|FG000|NOT COMPLETED|Overall Study||3||
60047521|NCT01567306|76163066|FG001|NOT COMPLETED|Overall Study||2||
60047522|NCT01567306|76163067|FG002|NOT COMPLETED|Overall Study||0||
59920160|NCT01067846|76040387|FG000|Completed 3 Tx Sessions|Overall Study|Our final analysis includes these participants.|15||
60047523|NCT01567306|76163068|FG003|NOT COMPLETED|Overall Study||5||
60047524|NCT01567306|76163069|FG004|NOT COMPLETED|Overall Study||7||
60047525|NCT01567306|76163070|FG005|NOT COMPLETED|Overall Study||3||
60047526|NCT01587274|76163087|FG000|STARTED|Overall Study||108||
60047527|NCT01587274|76163088|FG001|STARTED|Overall Study||108||
60047528|NCT01587274|76163089|FG002|STARTED|Overall Study||107||
60047529|NCT01587274|76163087|FG000|COMPLETED|Overall Study||104||
59920161|NCT01067846|76040388|FG001|Completed 3 Tx Sessions|Overall Study|Our final analysis includes these participants.|15||
59612556|NCT01748760|75723570|FG000|NOT COMPLETED|Overall Study||6||
59612557|NCT01748760|75723571|FG001|NOT COMPLETED|Overall Study||2||
59612558|NCT01748292|75723579|FG000|STARTED|Overall Study||20||
59920162|NCT01067846|76040387|FG000|COMPLETED|Overall Study|Participants that completed all 4 weeks of treatment.|10||
59920163|NCT01067846|76040388|FG001|COMPLETED|Overall Study|Participants that completed all 4 weeks of treatment.|11||
59920164|NCT01067846|76040387|FG000|NOT COMPLETED|Overall Study||19||
59920165|NCT01067846|76040388|FG001|NOT COMPLETED|Overall Study||19||
59920166|NCT03311659|76040394|FG000|STARTED|Overall Study||447||
59920167|NCT03311659|76040394|FG000|COMPLETED|Overall Study||446||
59920168|NCT03311659|76040394|FG000|NOT COMPLETED|Overall Study||1||
59920169|NCT03874234|76040411|FG000|STARTED|Part A: Cohort 1-Period 1 (Day1)||2||
59920170|NCT03874234|76040412|FG001|STARTED|Part A: Cohort 1-Period 1 (Day1)||2||
59920171|NCT03874234|76040413|FG002|STARTED|Part A: Cohort 1-Period 1 (Day1)||2||
59920172|NCT03874234|76040414|FG003|STARTED|Part A: Cohort 1-Period 1 (Day1)||2||
59920173|NCT03874234|76040415|FG004|STARTED|Part A: Cohort 1-Period 1 (Day1)||0||
59920174|NCT03874234|76040416|FG005|STARTED|Part A: Cohort 1-Period 1 (Day1)||0||
59920175|NCT03874234|76040417|FG006|STARTED|Part A: Cohort 1-Period 1 (Day1)||0||
59920176|NCT03874234|76040418|FG007|STARTED|Part A: Cohort 1-Period 1 (Day1)||0||
59920177|NCT03874234|76040419|FG008|STARTED|Part A: Cohort 1-Period 1 (Day1)||0||
59920178|NCT03874234|76040420|FG009|STARTED|Part A: Cohort 1-Period 1 (Day1)||0||
59920179|NCT03874234|76040421|FG010|STARTED|Part A: Cohort 1-Period 1 (Day1)||0||
59920180|NCT03874234|76040422|FG011|STARTED|Part A: Cohort 1-Period 1 (Day1)||0||
59920181|NCT03874234|76040423|FG012|STARTED|Part A: Cohort 1-Period 1 (Day1)||0||
59920182|NCT03874234|76040411|FG000|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 1 (Day1)||2||
59920183|NCT03874234|76040412|FG001|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 1 (Day1)||2||
59920184|NCT03874234|76040413|FG002|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 1 (Day1)||2||
59920185|NCT03874234|76040414|FG003|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 1 (Day1)||2||
59920186|NCT03874234|76040415|FG004|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 1 (Day1)||0||
60047530|NCT01587274|76163088|FG001|COMPLETED|Overall Study||103||
60047531|NCT01587274|76163089|FG002|COMPLETED|Overall Study||104||
60047532|NCT01587274|76163087|FG000|NOT COMPLETED|Overall Study||4||
60047533|NCT01587274|76163088|FG001|NOT COMPLETED|Overall Study||5||
60047534|NCT01587274|76163089|FG002|NOT COMPLETED|Overall Study||3||
60047535|NCT01587118|76163097|FG000|STARTED|Overall Study|31 signed consent and 18 were deemed eligible and initiated treatment with adjunctive asenapine.|18||
60047536|NCT01587118|76163097|FG000|COMPLETED|Overall Study||11||
60047537|NCT01587118|76163097|FG000|NOT COMPLETED|Overall Study||7||
59612559|NCT01748292|75723580|FG001|STARTED|Overall Study||40||
60047538|NCT01905657|76163104|FG000|STARTED|Overall Study||345||
60047539|NCT01905657|76163105|FG001|STARTED|Overall Study||346||
60047540|NCT01905657|76163106|FG002|STARTED|Overall Study||343||
60047541|NCT01905657|76163104|FG000|Treated|Overall Study||339||
60047542|NCT01905657|76163105|FG001|Treated|Overall Study||343||
60047543|NCT01905657|76163106|FG002|Treated|Overall Study||309||
60047544|NCT01905657|76163104|FG000|Received Second Course of Pembrolizumab|Overall Study||14||
60047545|NCT01905657|76163105|FG001|Received Second Course of Pembrolizumab|Overall Study||7||
60047546|NCT01905657|76163106|FG002|Received Second Course of Pembrolizumab|Overall Study||0||
60047547|NCT01905657|76163104|FG000|Switched Over to Pembrolizumab|Overall Study||0||
60047548|NCT01905657|76163105|FG001|Switched Over to Pembrolizumab|Overall Study||0||
60047549|NCT01905657|76163106|FG002|Switched Over to Pembrolizumab|Overall Study||8||
60047550|NCT01905657|76163104|FG000|COMPLETED|Overall Study||142||
60047551|NCT01905657|76163105|FG001|COMPLETED|Overall Study||159||
60047552|NCT01905657|76163106|FG002|COMPLETED|Overall Study||143||
59760079|NCT00901901|75879642|FG000|COMPLETED|Follow-up Period||0||
59760080|NCT00901901|75879643|FG001|COMPLETED|Follow-up Period||0||
60047553|NCT01905657|76163104|FG000|NOT COMPLETED|Overall Study||203||
60047554|NCT01905657|76163105|FG001|NOT COMPLETED|Overall Study||187||
60047555|NCT01905657|76163106|FG002|NOT COMPLETED|Overall Study||200||
60047556|NCT02202980|76163131|FG000|STARTED|Overall Study||14||
60047557|NCT02202980|76163132|FG001|STARTED|Overall Study||26||
60047558|NCT02202980|76163133|FG002|STARTED|Overall Study||27||
60047559|NCT02202980|76163134|FG003|STARTED|Overall Study||32||
60047560|NCT02202980|76163135|FG004|STARTED|Overall Study||13||
60047561|NCT02202980|76163136|FG005|STARTED|Overall Study||15||
60047562|NCT02202980|76163137|FG006|STARTED|Overall Study||15||
60047563|NCT02202980|76163138|FG007|STARTED|Overall Study||15||
60047564|NCT02202980|76163139|FG008|STARTED|Overall Study||18||
60047565|NCT02202980|76163140|FG009|STARTED|Overall Study||17||
60047566|NCT02202980|76163141|FG010|STARTED|Overall Study||19||
60047567|NCT02202980|76163142|FG011|STARTED|Overall Study||28||
60047568|NCT02202980|76163143|FG012|STARTED|Overall Study||30||
60047569|NCT02202980|76163144|FG013|STARTED|Overall Study||4||
60047570|NCT02202980|76163131|FG000|COMPLETED|Overall Study||13||
60047571|NCT02202980|76163132|FG001|COMPLETED|Overall Study||24||
60047572|NCT02202980|76163133|FG002|COMPLETED|Overall Study||17||
60047573|NCT02202980|76163134|FG003|COMPLETED|Overall Study||28||
60047574|NCT02202980|76163135|FG004|COMPLETED|Overall Study||7||
60047575|NCT02202980|76163136|FG005|COMPLETED|Overall Study||14||
60047576|NCT02202980|76163137|FG006|COMPLETED|Overall Study||4||
60047577|NCT02202980|76163138|FG007|COMPLETED|Overall Study||12||
60047578|NCT02202980|76163139|FG008|COMPLETED|Overall Study||14||
60047579|NCT02202980|76163140|FG009|COMPLETED|Overall Study||17||
60047580|NCT02202980|76163141|FG010|COMPLETED|Overall Study||19||
60047581|NCT02202980|76163142|FG011|COMPLETED|Overall Study||25||
60047582|NCT02202980|76163143|FG012|COMPLETED|Overall Study||19||
60047583|NCT02202980|76163144|FG013|COMPLETED|Overall Study||4||
60047584|NCT02202980|76163131|FG000|NOT COMPLETED|Overall Study||1||
60047585|NCT02202980|76163132|FG001|NOT COMPLETED|Overall Study||2||
59920187|NCT03874234|76040416|FG005|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 1 (Day1)||0||
59920188|NCT03874234|76040417|FG006|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 1 (Day1)||0||
59920189|NCT03874234|76040418|FG007|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 1 (Day1)||0||
59920190|NCT03874234|76040419|FG008|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 1 (Day1)||0||
59920191|NCT03874234|76040420|FG009|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 1 (Day1)||0||
59920192|NCT03874234|76040421|FG010|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 1 (Day1)||0||
59920193|NCT03874234|76040422|FG011|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 1 (Day1)||0||
59951424|NCT01251965|76070419|FG001|STARTED|Overall Study||5||
60047586|NCT02202980|76163133|FG002|NOT COMPLETED|Overall Study||10||
60047587|NCT02202980|76163134|FG003|NOT COMPLETED|Overall Study||4||
60047588|NCT02202980|76163135|FG004|NOT COMPLETED|Overall Study||6||
60047589|NCT02202980|76163136|FG005|NOT COMPLETED|Overall Study||1||
60047590|NCT02202980|76163137|FG006|NOT COMPLETED|Overall Study||11||
60047591|NCT02202980|76163138|FG007|NOT COMPLETED|Overall Study||3||
60047592|NCT02202980|76163139|FG008|NOT COMPLETED|Overall Study||4||
60047593|NCT02202980|76163140|FG009|NOT COMPLETED|Overall Study||0||
60047594|NCT02202980|76163141|FG010|NOT COMPLETED|Overall Study||0||
60047595|NCT02202980|76163142|FG011|NOT COMPLETED|Overall Study||3||
60047596|NCT02202980|76163143|FG012|NOT COMPLETED|Overall Study||11||
60047597|NCT02202980|76163144|FG013|NOT COMPLETED|Overall Study||0||
60047598|NCT01952145|76163176|FG000|STARTED|Overall Study||278||
60047599|NCT01952145|76163177|FG001|STARTED|Overall Study||279||
60047600|NCT01952145|76163176|FG000|COMPLETED|Overall Study||250||
60047601|NCT01952145|76163177|FG001|COMPLETED|Overall Study||265||
60047602|NCT01952145|76163176|FG000|NOT COMPLETED|Overall Study||28||
60047603|NCT01952145|76163177|FG001|NOT COMPLETED|Overall Study||14||
60047604|NCT01923363|76163183|FG000|STARTED|Overall Study||29||
60047605|NCT01923363|76163183|FG000|COMPLETED|Overall Study||28||
60047606|NCT01923363|76163183|FG000|NOT COMPLETED|Overall Study||1||
60047607|NCT01905267|76163189|FG000|STARTED|Overall Study||17||
60047608|NCT01905267|76163190|FG001|STARTED|Overall Study||16||
60047609|NCT01905267|76163189|FG000|COMPLETED|Overall Study||15||
60047610|NCT01905267|76163190|FG001|COMPLETED|Overall Study||14||
59512422|NCT01047319|75605691|FG001|STARTED|Overall Study||350||
59512423|NCT01047319|75605692|FG002|STARTED|Overall Study||352||
59512424|NCT01047319|75605690|FG000|COMPLETED|Overall Study||0||
59512425|NCT01047319|75605691|FG001|COMPLETED|Overall Study||0||
59512426|NCT01047319|75605692|FG002|COMPLETED|Overall Study||0||
59512427|NCT01047319|75605690|FG000|NOT COMPLETED|Overall Study||345||
60047611|NCT01905267|76163189|FG000|NOT COMPLETED|Overall Study||2||
60047612|NCT01905267|76163190|FG001|NOT COMPLETED|Overall Study||2||
60047613|NCT01923285|76163198|FG000|STARTED|Overall Study||76||
60047614|NCT01923285|76163199|FG001|STARTED|Overall Study||76||
60047615|NCT01923285|76163198|FG000|Modified Intent-to-treat|Overall Study||73|6 subjects excluded from MITT (withdrew prior to trial phase): Axium N = 3, Control N = 3|
60047616|NCT01923285|76163199|FG001|Modified Intent-to-treat|Overall Study||73|6 subjects excluded from MITT (withdrew prior to trial phase): Axium N = 3, Control N = 3|
60047617|NCT01923285|76163198|FG000|COMPLETED|Overall Study||69||
60047618|NCT01923285|76163199|FG001|COMPLETED|Overall Study||70||
60047619|NCT01923285|76163198|FG000|NOT COMPLETED|Overall Study||7||
60047620|NCT01923285|76163199|FG001|NOT COMPLETED|Overall Study||6||
59512428|NCT01047319|75605691|FG001|NOT COMPLETED|Overall Study||350||
60047621|NCT01904721|76163212|FG000|STARTED|Overall Study||13||
60047622|NCT01904721|76163213|FG001|STARTED|Overall Study||13||
60047623|NCT01904721|76163214|FG002|STARTED|Overall Study||12||
59512429|NCT01047319|75605692|FG002|NOT COMPLETED|Overall Study||352||
59512430|NCT02884414|75605700|FG000|STARTED|Overall Study||56||
59512431|NCT02884414|75605700|FG000|COMPLETED|Overall Study||56||
59512432|NCT02884414|75605700|FG000|NOT COMPLETED|Overall Study||0||
59512433|NCT01044901|75605706|FG000|STARTED|Overall Study||38||
59512434|NCT01044901|75605707|FG001|STARTED|Overall Study||13||
60047624|NCT01904721|76163215|FG003|STARTED|Overall Study||12||
60047625|NCT01904721|76163216|FG004|STARTED|Overall Study||65||
60047626|NCT01904721|76163217|FG005|STARTED|Overall Study||65||
60047627|NCT01904721|76163218|FG006|STARTED|Overall Study||64||
60047628|NCT01904721|76163212|FG000|COMPLETED|Overall Study||13||
60047629|NCT01904721|76163213|FG001|COMPLETED|Overall Study||13||
59512435|NCT01044901|75605706|FG000|COMPLETED|Overall Study||38||
59512436|NCT01044901|75605707|FG001|COMPLETED|Overall Study||13||
59512437|NCT01044901|75605706|FG000|NOT COMPLETED|Overall Study||0||
59512438|NCT01044901|75605707|FG001|NOT COMPLETED|Overall Study||0||
59512439|NCT02884492|75605715|FG000|STARTED|Overall Study||7||
59512440|NCT02884492|75605716|FG001|STARTED|Overall Study||10||
60047630|NCT01904721|76163214|FG002|COMPLETED|Overall Study||11||
60047631|NCT01904721|76163215|FG003|COMPLETED|Overall Study||11||
60047632|NCT01904721|76163216|FG004|COMPLETED|Overall Study||57||
60047633|NCT01904721|76163217|FG005|COMPLETED|Overall Study||56||
60047634|NCT01904721|76163218|FG006|COMPLETED|Overall Study||57||
60047635|NCT01904721|76163212|FG000|NOT COMPLETED|Overall Study||0||
59512441|NCT02884492|75605715|FG000|COMPLETED|Overall Study||7||
59512442|NCT02884492|75605716|FG001|COMPLETED|Overall Study||10||
59512443|NCT02884492|75605715|FG000|NOT COMPLETED|Overall Study||0||
59512444|NCT02884492|75605716|FG001|NOT COMPLETED|Overall Study||0||
59512445|NCT00896441|75605724|FG000|STARTED|Overall Study||17||
59512446|NCT00896441|75605725|FG001|STARTED|Overall Study||9||
59512447|NCT00896441|75605724|FG000|COMPLETED|Overall Study||15||
59512448|NCT00896441|75605725|FG001|COMPLETED|Overall Study||9||
59512449|NCT00896441|75605724|FG000|NOT COMPLETED|Overall Study||2||
59512450|NCT00896441|75605725|FG001|NOT COMPLETED|Overall Study||0||
59512451|NCT02885350|75605734|FG000|STARTED|Overall Study||20||
59760081|NCT00901901|75879642|FG000|NOT COMPLETED|Follow-up Period||340||
60047636|NCT01904721|76163213|FG001|NOT COMPLETED|Overall Study||0||
60047637|NCT01904721|76163214|FG002|NOT COMPLETED|Overall Study||1||
60047638|NCT01904721|76163215|FG003|NOT COMPLETED|Overall Study||1||
60047639|NCT01904721|76163216|FG004|NOT COMPLETED|Overall Study||8||
60047640|NCT01904721|76163217|FG005|NOT COMPLETED|Overall Study||9||
60047641|NCT01904721|76163218|FG006|NOT COMPLETED|Overall Study||7||
60047642|NCT01904019|76163230|FG000|STARTED|Pre-operative||95||100
60047643|NCT01904019|76163230|FG000|COMPLETED|Pre-operative||95||100
60047644|NCT01904019|76163230|FG000|NOT COMPLETED|Pre-operative||0||0
60047645|NCT01904019|76163230|FG000|STARTED|1 Year Follow-up||95||100
60047646|NCT01904019|76163230|FG000|COMPLETED|1 Year Follow-up||86||91
60047647|NCT01904019|76163230|FG000|NOT COMPLETED|1 Year Follow-up||9||9
59512452|NCT02885350|75605735|FG001|STARTED|Overall Study||20||
59512453|NCT02885350|75605736|FG002|STARTED|Overall Study||20||
59512454|NCT02885350|75605737|FG003|STARTED|Overall Study||20||
59512455|NCT02885350|75605734|FG000|COMPLETED|Overall Study||20||
59512456|NCT02885350|75605735|FG001|COMPLETED|Overall Study||20||
59512457|NCT02885350|75605736|FG002|COMPLETED|Overall Study||20||
59512458|NCT02885350|75605737|FG003|COMPLETED|Overall Study||20||
59512459|NCT02885350|75605734|FG000|NOT COMPLETED|Overall Study||0||
60047648|NCT01904019|76163230|FG000|STARTED|3 Year Follow-up||86||91
60047649|NCT01904019|76163230|FG000|COMPLETED|3 Year Follow-up||71||76
60047650|NCT01904019|76163230|FG000|NOT COMPLETED|3 Year Follow-up||15||15
60047651|NCT01904019|76163230|FG000|STARTED|5 Year Follow-up||71||76
60047652|NCT01904019|76163230|FG000|COMPLETED|5 Year Follow-up||65||69
60047653|NCT01904019|76163230|FG000|NOT COMPLETED|5 Year Follow-up||6||7
60047654|NCT01922895|76163236|FG000|STARTED|Overall Study||24||
60047655|NCT01922895|76163237|FG001|STARTED|Overall Study||21||
60047656|NCT01922895|76163236|FG000|COMPLETED|Overall Study||18||
60047657|NCT01922895|76163237|FG001|COMPLETED|Overall Study||7||
59512460|NCT02885350|75605735|FG001|NOT COMPLETED|Overall Study||0||
59512461|NCT02885350|75605736|FG002|NOT COMPLETED|Overall Study||0||
59512462|NCT02885350|75605737|FG003|NOT COMPLETED|Overall Study||0||
60047658|NCT01922895|76163236|FG000|NOT COMPLETED|Overall Study||6||
60047659|NCT01922895|76163237|FG001|NOT COMPLETED|Overall Study||14||
60047660|NCT01922739|76163245|FG000|STARTED|Titration/Adjustment Period||182||
60047661|NCT01922739|76163245|FG000|Safety Analysis Set|Titration/Adjustment Period||182||
60047662|NCT01922739|76163245|FG000|COMPLETED|Titration/Adjustment Period||170||
59512463|NCT00918931|75605747|FG000|STARTED|Overall Study||3||
59512464|NCT00918931|75605747|FG000|COMPLETED|Overall Study||3||
59512465|NCT00918931|75605747|FG000|NOT COMPLETED|Overall Study||0||
59512466|NCT02885506|75605761|FG000|STARTED|Part A||6||
59512467|NCT02885506|75605762|FG001|STARTED|Part A||6||
59512468|NCT02885506|75605763|FG002|STARTED|Part A||6||
59612560|NCT01748292|75723579|FG000|COMPLETED|Overall Study||18||
59612561|NCT01748292|75723580|FG001|COMPLETED|Overall Study||28||
59612562|NCT01748292|75723579|FG000|NOT COMPLETED|Overall Study||2||
59920194|NCT03874234|76040423|FG012|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 1 (Day1)||0||
59920195|NCT03874234|76040411|FG000|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||2||
59920196|NCT03874234|76040412|FG001|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||2||
59920197|NCT03874234|76040413|FG002|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||2||
59920198|NCT03874234|76040414|FG003|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||1||
59920199|NCT03874234|76040415|FG004|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
59920200|NCT03874234|76040416|FG005|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
59920201|NCT03874234|76040417|FG006|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
59920202|NCT03874234|76040418|FG007|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
59920203|NCT03874234|76040419|FG008|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
59920204|NCT03874234|76040420|FG009|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
59920205|NCT03874234|76040421|FG010|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
59920206|NCT03874234|76040422|FG011|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
59920207|NCT03874234|76040423|FG012|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
60047663|NCT01922739|76163245|FG000|NOT COMPLETED|Titration/Adjustment Period||12||
60047664|NCT01922739|76163245|FG000|STARTED|Open-label Treatment Period||170||
60047665|NCT01922739|76163245|FG000|Treatment SAS and FAS|Open-label Treatment Period|SAS = safety analysis set FAS = full analysis set|170||
60047666|NCT01922739|76163245|FG000|COMPLETED|Open-label Treatment Period||136||
59512469|NCT02885506|75605764|FG003|STARTED|Part A||6||
59512470|NCT02885506|75605765|FG004|STARTED|Part A||6||
59512471|NCT02885506|75605766|FG005|STARTED|Part A||6||
59612563|NCT01748292|75723580|FG001|NOT COMPLETED|Overall Study||12||
59612564|NCT01720602|75723586|FG000|STARTED|Overall Study||15||
59612565|NCT01720602|75723586|FG000|COMPLETED|Overall Study||10||
59612566|NCT01720602|75723586|FG000|NOT COMPLETED|Overall Study||5||
59612567|NCT01746732|75723590|FG000|STARTED|Lead-In Period||23||
59920208|NCT03874234|76040411|FG000|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
59920209|NCT03874234|76040412|FG001|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
59920210|NCT03874234|76040413|FG002|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
60047667|NCT01922739|76163245|FG000|NOT COMPLETED|Open-label Treatment Period||34||
60047668|NCT02236988|76163265|FG000|STARTED|Overall Study||16||
60047669|NCT02236988|76163266|FG001|STARTED|Overall Study||16||
60047670|NCT02236988|76163267|FG002|STARTED|Overall Study||18||
60047671|NCT02236988|76163268|FG003|STARTED|Overall Study||30||
60047672|NCT02236988|76163265|FG000|COMPLETED|Overall Study||16||
60047673|NCT02236988|76163266|FG001|COMPLETED|Overall Study||16||
60047674|NCT02236988|76163267|FG002|COMPLETED|Overall Study||18||
60047675|NCT02236988|76163268|FG003|COMPLETED|Overall Study||27||
60047676|NCT02236988|76163265|FG000|NOT COMPLETED|Overall Study||0||
60047677|NCT02236988|76163266|FG001|NOT COMPLETED|Overall Study||0||
60047678|NCT02236988|76163267|FG002|NOT COMPLETED|Overall Study||0||
60047679|NCT02236988|76163268|FG003|NOT COMPLETED|Overall Study||3||
60047680|NCT02236598|76163321|FG000|STARTED|Overall Study||15||
59512472|NCT02885506|75605767|FG006|STARTED|Part A||6||
59512473|NCT02885506|75605768|FG007|STARTED|Part A||14||
59512474|NCT02885506|75605769|FG008|STARTED|Part A||0||
59512475|NCT02885506|75605770|FG009|STARTED|Part A||0||
59512476|NCT02885506|75605761|FG000|COMPLETED|Part A||6||
59512477|NCT02885506|75605762|FG001|COMPLETED|Part A||6||
59512478|NCT02885506|75605763|FG002|COMPLETED|Part A||6||
59512479|NCT02885506|75605764|FG003|COMPLETED|Part A||6||
59512480|NCT02885506|75605765|FG004|COMPLETED|Part A||6||
59512481|NCT02885506|75605766|FG005|COMPLETED|Part A||6||
59612568|NCT01746732|75723591|FG001|STARTED|Lead-In Period||0||
60047681|NCT02236598|76163322|FG001|STARTED|Overall Study||14||
60047682|NCT02236598|76163321|FG000|COMPLETED|Overall Study||15||
60047683|NCT02236598|76163322|FG001|COMPLETED|Overall Study||12||
60047684|NCT02236598|76163321|FG000|NOT COMPLETED|Overall Study||0||
60047685|NCT02236598|76163322|FG001|NOT COMPLETED|Overall Study||2||
60047686|NCT01922349|76163332|FG000|STARTED|Single Rising Dose (SRD) Period||25||
60047687|NCT01922349|76163333|FG001|STARTED|Single Rising Dose (SRD) Period||27||
60047688|NCT01922349|76163334|FG002|STARTED|Single Rising Dose (SRD) Period||18||
60047689|NCT01922349|76163335|FG003|STARTED|Single Rising Dose (SRD) Period||27||
60047690|NCT01922349|76163332|FG000|COMPLETED|Single Rising Dose (SRD) Period||25||
60047691|NCT01922349|76163333|FG001|COMPLETED|Single Rising Dose (SRD) Period||27||
60047692|NCT01922349|76163334|FG002|COMPLETED|Single Rising Dose (SRD) Period||18||
60047693|NCT01922349|76163335|FG003|COMPLETED|Single Rising Dose (SRD) Period||27||
60047694|NCT01922349|76163332|FG000|NOT COMPLETED|Single Rising Dose (SRD) Period||0||
60047695|NCT01922349|76163333|FG001|NOT COMPLETED|Single Rising Dose (SRD) Period||0||
60047696|NCT01922349|76163334|FG002|NOT COMPLETED|Single Rising Dose (SRD) Period||0||
60047697|NCT01922349|76163335|FG003|NOT COMPLETED|Single Rising Dose (SRD) Period||0||
60047698|NCT01922349|76163332|FG000|STARTED|Multiple Rising Dose (MRD) Period|One subject discontinued the trial after the SRD period due to non-compliance with the protocol.|24||
60047699|NCT01922349|76163333|FG001|STARTED|Multiple Rising Dose (MRD) Period||27||
60047700|NCT01922349|76163334|FG002|STARTED|Multiple Rising Dose (MRD) Period||18||
60047701|NCT01922349|76163335|FG003|STARTED|Multiple Rising Dose (MRD) Period||27||
60047702|NCT01922349|76163332|FG000|COMPLETED|Multiple Rising Dose (MRD) Period||24||
60047703|NCT01922349|76163333|FG001|COMPLETED|Multiple Rising Dose (MRD) Period||27||
60047704|NCT01922349|76163334|FG002|COMPLETED|Multiple Rising Dose (MRD) Period||18||
60047705|NCT01922349|76163335|FG003|COMPLETED|Multiple Rising Dose (MRD) Period||26||
60047706|NCT01922349|76163332|FG000|NOT COMPLETED|Multiple Rising Dose (MRD) Period||0||
60047707|NCT01922349|76163333|FG001|NOT COMPLETED|Multiple Rising Dose (MRD) Period||0||
60047708|NCT01922349|76163334|FG002|NOT COMPLETED|Multiple Rising Dose (MRD) Period||0||
60047709|NCT01922349|76163335|FG003|NOT COMPLETED|Multiple Rising Dose (MRD) Period||1||
60047710|NCT02236520|76163373|FG000|STARTED|Overall Study||16||
60047711|NCT02236520|76163374|FG001|STARTED|Overall Study||13||
60047712|NCT02236520|76163375|FG002|STARTED|Overall Study||15||
60047713|NCT02236520|76163376|FG003|STARTED|Overall Study||15||
60047714|NCT02236520|76163373|FG000|COMPLETED|Overall Study||14||
60047715|NCT02236520|76163374|FG001|COMPLETED|Overall Study||8||
60047716|NCT02236520|76163375|FG002|COMPLETED|Overall Study||15||
60047717|NCT02236520|76163376|FG003|COMPLETED|Overall Study||14||
60047718|NCT02236520|76163373|FG000|NOT COMPLETED|Overall Study||2||
59920211|NCT03874234|76040414|FG003|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||1||
59920212|NCT03874234|76040415|FG004|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
59920213|NCT03874234|76040416|FG005|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
59920214|NCT03874234|76040417|FG006|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
60047719|NCT02236520|76163374|FG001|NOT COMPLETED|Overall Study||5||
60047720|NCT02236520|76163375|FG002|NOT COMPLETED|Overall Study||0||
60047721|NCT02236520|76163376|FG003|NOT COMPLETED|Overall Study||1||
59512482|NCT02885506|75605767|FG006|COMPLETED|Part A||6||
59512483|NCT02885506|75605768|FG007|COMPLETED|Part A||14||
59920215|NCT03874234|76040418|FG007|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
59512484|NCT02885506|75605769|FG008|COMPLETED|Part A||0||
59920216|NCT03874234|76040419|FG008|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
59920217|NCT03874234|76040420|FG009|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
59920218|NCT03874234|76040421|FG010|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
59920219|NCT03874234|76040422|FG011|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
59920220|NCT03874234|76040423|FG012|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
59920221|NCT03874234|76040411|FG000|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day10)||2||
60047722|NCT01922271|76163388|FG000|STARTED|PERIOD 1||76||
59512485|NCT02885506|75605770|FG009|COMPLETED|Part A||0||
59512486|NCT02885506|75605761|FG000|NOT COMPLETED|Part A||0||
59512487|NCT02885506|75605762|FG001|NOT COMPLETED|Part A||0||
59512488|NCT02885506|75605763|FG002|NOT COMPLETED|Part A||0||
59512489|NCT02885506|75605764|FG003|NOT COMPLETED|Part A||0||
60047723|NCT01922271|76163389|FG001|STARTED|PERIOD 1||76||
60047724|NCT01922271|76163388|FG000|COMPLETED|PERIOD 1||76||
60047725|NCT01922271|76163389|FG001|COMPLETED|PERIOD 1||76||
60047726|NCT01922271|76163388|FG000|NOT COMPLETED|PERIOD 1||0||
60047727|NCT01922271|76163389|FG001|NOT COMPLETED|PERIOD 1||0||
60047728|NCT01922271|76163388|FG000|STARTED|WASHOUT Period||76||
60047729|NCT01922271|76163389|FG001|STARTED|WASHOUT Period||76||
60047730|NCT01922271|76163388|FG000|COMPLETED|WASHOUT Period||75||
59920222|NCT03874234|76040412|FG001|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day10)||2||
59920223|NCT03874234|76040413|FG002|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day10)||2||
59920224|NCT03874234|76040414|FG003|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day10)||1||
59920225|NCT03874234|76040415|FG004|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day10)||0||
59920226|NCT03874234|76040416|FG005|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day10)||0||
59920227|NCT03874234|76040417|FG006|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day10)||0||
59512490|NCT02885506|75605765|FG004|NOT COMPLETED|Part A||0||
59512491|NCT02885506|75605766|FG005|NOT COMPLETED|Part A||0||
60047731|NCT01922271|76163389|FG001|COMPLETED|WASHOUT Period||76||
60047732|NCT01922271|76163388|FG000|NOT COMPLETED|WASHOUT Period||1||
60047733|NCT01922271|76163389|FG001|NOT COMPLETED|WASHOUT Period||0||
60047734|NCT01922271|76163388|FG000|STARTED|PERIOD 2||75||
60047735|NCT01922271|76163389|FG001|STARTED|PERIOD 2||76||
60047736|NCT01922271|76163388|FG000|COMPLETED|PERIOD 2||75||
60047737|NCT01922271|76163389|FG001|COMPLETED|PERIOD 2||76||
60047738|NCT01922271|76163388|FG000|NOT COMPLETED|PERIOD 2||0||
60047739|NCT01922271|76163389|FG001|NOT COMPLETED|PERIOD 2||0||
60047740|NCT02236130|76163397|FG000|STARTED|Overall Study||22||
60047741|NCT02236130|76163398|FG001|STARTED|Overall Study||27||
60047742|NCT02236130|76163397|FG000|COMPLETED|Overall Study||15||
60047743|NCT02236130|76163398|FG001|COMPLETED|Overall Study||15||
60047744|NCT02236130|76163397|FG000|NOT COMPLETED|Overall Study||7||
60047745|NCT02236130|76163398|FG001|NOT COMPLETED|Overall Study||12||
60047746|NCT02233946|76163406|FG000|STARTED|Baseline|Allocated to and received the intervention|628||
60047747|NCT02233946|76163407|FG001|STARTED|Baseline|Allocated to and received usual care|243||
60047748|NCT02233946|76163406|FG000|COMPLETED|Baseline|Completed baseline assessment|626||
60047749|NCT02233946|76163407|FG001|COMPLETED|Baseline|Completed baseline assessment|243||
60047750|NCT02233946|76163406|FG000|NOT COMPLETED|Baseline||2||
60047751|NCT02233946|76163407|FG001|NOT COMPLETED|Baseline||0||
60047752|NCT02233946|76163406|FG000|STARTED|Immediate Post-visit Questionnaire||626||
60047753|NCT02233946|76163407|FG001|STARTED|Immediate Post-visit Questionnaire||243||
60047754|NCT02233946|76163406|FG000|COMPLETED|Immediate Post-visit Questionnaire||624||
60047755|NCT02233946|76163407|FG001|COMPLETED|Immediate Post-visit Questionnaire||243||
60047756|NCT02233946|76163406|FG000|NOT COMPLETED|Immediate Post-visit Questionnaire||2||
60047757|NCT02233946|76163407|FG001|NOT COMPLETED|Immediate Post-visit Questionnaire||0||
60047758|NCT02233946|76163406|FG000|STARTED|3-months Follow-up||624||
60047759|NCT02233946|76163407|FG001|STARTED|3-months Follow-up||243||
60047760|NCT02233946|76163406|FG000|COMPLETED|3-months Follow-up||571||
60047761|NCT02233946|76163407|FG001|COMPLETED|3-months Follow-up||214||
60047762|NCT02233946|76163406|FG000|NOT COMPLETED|3-months Follow-up||53||
60047763|NCT02233946|76163407|FG001|NOT COMPLETED|3-months Follow-up||29||
60047764|NCT02233946|76163406|FG000|STARTED|6-months Follow-up||571||
60047765|NCT02233946|76163407|FG001|STARTED|6-months Follow-up||214||
60047766|NCT02233946|76163406|FG000|COMPLETED|6-months Follow-up||550||
60047767|NCT02233946|76163407|FG001|COMPLETED|6-months Follow-up||212||
60047768|NCT02233946|76163406|FG000|NOT COMPLETED|6-months Follow-up||21||
60047769|NCT02233946|76163407|FG001|NOT COMPLETED|6-months Follow-up||2||
60047770|NCT02233946|76163406|FG000|STARTED|9-month Follow-up||550||
60047771|NCT02233946|76163407|FG001|STARTED|9-month Follow-up||212||
60047772|NCT02233946|76163406|FG000|COMPLETED|9-month Follow-up||530||
60047773|NCT02233946|76163407|FG001|COMPLETED|9-month Follow-up||201||
60047774|NCT02233946|76163406|FG000|NOT COMPLETED|9-month Follow-up||20||
60047775|NCT02233946|76163407|FG001|NOT COMPLETED|9-month Follow-up||11||
60047776|NCT02233946|76163406|FG000|STARTED|12-month Follow-up||530||
60047777|NCT02233946|76163407|FG001|STARTED|12-month Follow-up||201||
60047778|NCT02233946|76163406|FG000|COMPLETED|12-month Follow-up||502||
60047779|NCT02233946|76163407|FG001|COMPLETED|12-month Follow-up||190||
60047780|NCT02233946|76163406|FG000|NOT COMPLETED|12-month Follow-up||28||
60047781|NCT02233946|76163407|FG001|NOT COMPLETED|12-month Follow-up||11||
60047782|NCT02232698|76163415|FG000|STARTED|Overall Study||120||
60047783|NCT02232698|76163416|FG001|STARTED|Overall Study||121||
60047784|NCT02232698|76163415|FG000|COMPLETED|Overall Study||110||
60047785|NCT02232698|76163416|FG001|COMPLETED|Overall Study||101||
60047786|NCT02232698|76163415|FG000|NOT COMPLETED|Overall Study||10||
60047787|NCT02232698|76163416|FG001|NOT COMPLETED|Overall Study||20||
60047788|NCT01632878|76163424|FG000|STARTED|Screening||1531||
60047789|NCT01632878|76163424|FG000|COMPLETED|Screening||1263||
60047790|NCT01632878|76163424|FG000|NOT COMPLETED|Screening||268||
60047791|NCT01632878|76163424|FG000|STARTED|Treatment||1263||
60047792|NCT01632878|76163424|FG000|COMPLETED|Treatment||1105||
60047793|NCT01632878|76163424|FG000|NOT COMPLETED|Treatment||158||
60047794|NCT01632800|76163428|FG000|STARTED|Overall Study||26||
60047795|NCT01632800|76163428|FG000|COMPLETED|Overall Study||25||
60047796|NCT01632800|76163428|FG000|NOT COMPLETED|Overall Study||1||
60047797|NCT01641809|76163436|FG000|STARTED|Induction Phase (Day 1 to Week 24)||60||
60047798|NCT01641809|76163437|FG001|STARTED|Induction Phase (Day 1 to Week 24)||60||
60047799|NCT01641809|76163438|FG002|STARTED|Induction Phase (Day 1 to Week 24)||61||
60047800|NCT01641809|76163439|FG003|STARTED|Induction Phase (Day 1 to Week 24)||62||
60047801|NCT01641809|76163436|FG000|COMPLETED|Induction Phase (Day 1 to Week 24)||52||
60047802|NCT01641809|76163437|FG001|COMPLETED|Induction Phase (Day 1 to Week 24)||53||
60047803|NCT01641809|76163438|FG002|COMPLETED|Induction Phase (Day 1 to Week 24)||55||
60047804|NCT01641809|76163439|FG003|COMPLETED|Induction Phase (Day 1 to Week 24)||47||
60047805|NCT01641809|76163436|FG000|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||8||
60067844|NCT01617967|76183032|FG003|NOT COMPLETED|Overall Study||1||
60047806|NCT01641809|76163437|FG001|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||7||
60047807|NCT01641809|76163438|FG002|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||6||
60047808|NCT01641809|76163439|FG003|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||15||
60047809|NCT01641809|76163436|FG000|STARTED|Maintenance Phase (Week 24 to Week 96)||52||
60047810|NCT01641809|76163437|FG001|STARTED|Maintenance Phase (Week 24 to Week 96)||53||
60047811|NCT01641809|76163438|FG002|STARTED|Maintenance Phase (Week 24 to Week 96)||55||
60047812|NCT01641809|76163439|FG003|STARTED|Maintenance Phase (Week 24 to Week 96)||47||
60047813|NCT01641809|76163436|FG000|COMPLETED|Maintenance Phase (Week 24 to Week 96)||46||
60047814|NCT01641809|76163437|FG001|COMPLETED|Maintenance Phase (Week 24 to Week 96)||48||
60047815|NCT01641809|76163438|FG002|COMPLETED|Maintenance Phase (Week 24 to Week 96)||52||
60047816|NCT01641809|76163439|FG003|COMPLETED|Maintenance Phase (Week 24 to Week 96)||41||
60047817|NCT01641809|76163436|FG000|NOT COMPLETED|Maintenance Phase (Week 24 to Week 96)||6||
60047818|NCT01641809|76163437|FG001|NOT COMPLETED|Maintenance Phase (Week 24 to Week 96)||5||
60047819|NCT01641809|76163438|FG002|NOT COMPLETED|Maintenance Phase (Week 24 to Week 96)||3||
60047820|NCT01641809|76163439|FG003|NOT COMPLETED|Maintenance Phase (Week 24 to Week 96)||6||
59512492|NCT02885506|75605767|FG006|NOT COMPLETED|Part A||0||
59512493|NCT02885506|75605768|FG007|NOT COMPLETED|Part A||0||
59512494|NCT02885506|75605769|FG008|NOT COMPLETED|Part A||0||
59512495|NCT02885506|75605770|FG009|NOT COMPLETED|Part A||0||
59512496|NCT02885506|75605761|FG000|STARTED|Part B||0||
59512497|NCT02885506|75605762|FG001|STARTED|Part B||0||
59512498|NCT02885506|75605763|FG002|STARTED|Part B||0||
59512499|NCT02885506|75605764|FG003|STARTED|Part B||0||
59512500|NCT02885506|75605765|FG004|STARTED|Part B||0||
59512501|NCT02885506|75605766|FG005|STARTED|Part B||0||
59512502|NCT02885506|75605767|FG006|STARTED|Part B||0||
59512503|NCT02885506|75605768|FG007|STARTED|Part B||0||
59512504|NCT02885506|75605769|FG008|STARTED|Part B||4||
59760082|NCT00901901|75879643|FG001|NOT COMPLETED|Follow-up Period||341||
59760083|NCT02143778|75879651|FG000|STARTED|Overall Study||246||
59760084|NCT02143778|75879651|FG000|COMPLETED|Overall Study||243||
59760085|NCT02143778|75879651|FG000|NOT COMPLETED|Overall Study||3||
59760086|NCT04748783|75879661|FG000|STARTED|Overall Study||0||
59760087|NCT04748783|75879662|FG001|STARTED|Overall Study||1||
59760088|NCT04748783|75879663|FG002|STARTED|Overall Study||0||
59760089|NCT04748783|75879664|FG003|STARTED|Overall Study||0||
59760090|NCT04748783|75879665|FG004|STARTED|Overall Study||1||
59760091|NCT04748783|75879661|FG000|COMPLETED|Overall Study||0||
59760092|NCT04748783|75879662|FG001|COMPLETED|Overall Study||1||
60047821|NCT01641809|76163436|FG000|STARTED|Open-label (Week 96 to Week 324)||46||
60047822|NCT01641809|76163437|FG001|STARTED|Open-label (Week 96 to Week 324)|1 participant completed study as per protocol at Week 96 and opted to not enter open-label phase|47||
60047823|NCT01641809|76163438|FG002|STARTED|Open-label (Week 96 to Week 324)|1 participant completed study as per protocol at Week 96 and opted to not enter open-label phase|51||
60047824|NCT01641809|76163439|FG003|STARTED|Open-label (Week 96 to Week 324)|Participants completed study at Week 96 and did not enter open-label phase|0||
60047825|NCT01641809|76163436|FG000|COMPLETED|Open-label (Week 96 to Week 324)||30||
60047826|NCT01641809|76163437|FG001|COMPLETED|Open-label (Week 96 to Week 324)||35||
60047827|NCT01641809|76163438|FG002|COMPLETED|Open-label (Week 96 to Week 324)||43||
60047828|NCT01641809|76163439|FG003|COMPLETED|Open-label (Week 96 to Week 324)||0||
60047829|NCT01641809|76163436|FG000|NOT COMPLETED|Open-label (Week 96 to Week 324)||16||
60047830|NCT01641809|76163437|FG001|NOT COMPLETED|Open-label (Week 96 to Week 324)||12||
60047831|NCT01641809|76163438|FG002|NOT COMPLETED|Open-label (Week 96 to Week 324)||8||
60047832|NCT01641809|76163439|FG003|NOT COMPLETED|Open-label (Week 96 to Week 324)||0||
60047833|NCT01632566|76163462|FG000|STARTED|Overall Study||8||
60047834|NCT01632566|76163463|FG001|STARTED|Overall Study||10||
60047835|NCT01632566|76163464|FG002|STARTED|Overall Study||9||
60047836|NCT01632566|76163465|FG003|STARTED|Overall Study||6||
60047837|NCT01632566|76163466|FG004|STARTED|Overall Study||6||
60047838|NCT01632566|76163462|FG000|Received at Least One Dose LY3031207|Overall Study||8||
60047839|NCT01632566|76163463|FG001|Received at Least One Dose LY3031207|Overall Study||10||
60047840|NCT01632566|76163464|FG002|Received at Least One Dose LY3031207|Overall Study||9||
60047841|NCT01632566|76163465|FG003|Received at Least One Dose LY3031207|Overall Study||0||
60047842|NCT01632566|76163466|FG004|Received at Least One Dose LY3031207|Overall Study||0||
60047843|NCT01632566|76163462|FG000|Received at Least One Dose Simvastatin|Overall Study||0||
60047844|NCT01632566|76163463|FG001|Received at Least One Dose Simvastatin|Overall Study||10||
60047845|NCT01632566|76163464|FG002|Received at Least One Dose Simvastatin|Overall Study||9||
60047846|NCT01632566|76163465|FG003|Received at Least One Dose Simvastatin|Overall Study||4||
60047847|NCT01632566|76163466|FG004|Received at Least One Dose Simvastatin|Overall Study||4||
60047848|NCT01632566|76163462|FG000|COMPLETED|Overall Study||8||
60047849|NCT01632566|76163463|FG001|COMPLETED|Overall Study||7||
59512505|NCT02885506|75605770|FG009|STARTED|Part B||4||
59512506|NCT02885506|75605761|FG000|COMPLETED|Part B||0||
59512507|NCT02885506|75605762|FG001|COMPLETED|Part B||0||
59512508|NCT02885506|75605763|FG002|COMPLETED|Part B||0||
59512509|NCT02885506|75605764|FG003|COMPLETED|Part B||0||
59512510|NCT02885506|75605765|FG004|COMPLETED|Part B||0||
59760093|NCT04748783|75879663|FG002|COMPLETED|Overall Study||0||
60047850|NCT01632566|76163464|FG002|COMPLETED|Overall Study||0||
60047851|NCT01632566|76163465|FG003|COMPLETED|Overall Study||4||
60047852|NCT01632566|76163466|FG004|COMPLETED|Overall Study||4||
60047853|NCT01632566|76163462|FG000|NOT COMPLETED|Overall Study||0||
60047854|NCT01632566|76163463|FG001|NOT COMPLETED|Overall Study||3||
60047855|NCT01632566|76163464|FG002|NOT COMPLETED|Overall Study||9||
60047856|NCT01632566|76163465|FG003|NOT COMPLETED|Overall Study||2||
60047857|NCT01632566|76163466|FG004|NOT COMPLETED|Overall Study||2||
60047858|NCT02254304|76163484|FG000|STARTED|Overall Study||89||
60047859|NCT02254304|76163485|FG001|STARTED|Overall Study||17||
60047860|NCT02254304|76163484|FG000|COMPLETED|Overall Study||75||
60047861|NCT02254304|76163485|FG001|COMPLETED|Overall Study||13||
60047862|NCT02254304|76163484|FG000|NOT COMPLETED|Overall Study||14||
60047863|NCT02254304|76163485|FG001|NOT COMPLETED|Overall Study||4||
60047864|NCT02174731|76163495|FG000|STARTED|Overall Study||1051|Randomized and included in the analysis|
60047865|NCT02174731|76163496|FG001|STARTED|Overall Study||1055|Randomized and included in the analysis|
60047866|NCT02174731|76163495|FG000|Received Treatment|Overall Study||1048||
60047867|NCT02174731|76163496|FG001|Received Treatment|Overall Study||1053||
60047868|NCT02174731|76163495|FG000|COMPLETED|Overall Study||982|Completed the study|
60047869|NCT02174731|76163496|FG001|COMPLETED|Overall Study||990|Completed the study|
60047870|NCT02174731|76163495|FG000|NOT COMPLETED|Overall Study||69||
60047871|NCT02174731|76163496|FG001|NOT COMPLETED|Overall Study||65||
60047872|NCT01922037|76163504|FG000|STARTED|Overall Study||69||
60047873|NCT01922037|76163505|FG001|STARTED|Overall Study||737||
60047874|NCT01922037|76163504|FG000|Treated|Overall Study||69||
60047875|NCT01922037|76163505|FG001|Treated|Overall Study||732||
60047876|NCT01922037|76163504|FG000|COMPLETED|Overall Study||59||
60047877|NCT01922037|76163505|FG001|COMPLETED|Overall Study||563||
60047878|NCT01922037|76163504|FG000|NOT COMPLETED|Overall Study||10||
60047879|NCT01922037|76163505|FG001|NOT COMPLETED|Overall Study||174||
60047880|NCT02282813|76163516|FG000|STARTED|Overall Study|ITT Population|103||
60047881|NCT02282813|76163517|FG001|STARTED|Overall Study|ITT Population - not randomized or randomized to CTAP101 monotherapy|153||
60047882|NCT02282813|76163518|FG002|STARTED|Overall Study|Randomization to take adjunctive treatment in addition to CTAP101 capsules began after week 12.|42||
60047883|NCT02282813|76163516|FG000|COMPLETED|Overall Study||91||
60047884|NCT02282813|76163517|FG001|COMPLETED|Overall Study||130||
60047885|NCT02282813|76163518|FG002|COMPLETED|Overall Study||39||
60047886|NCT02282813|76163516|FG000|NOT COMPLETED|Overall Study||12||
60047887|NCT02282813|76163517|FG001|NOT COMPLETED|Overall Study||23||
60047888|NCT02282813|76163518|FG002|NOT COMPLETED|Overall Study||3||
60047889|NCT01903863|76163530|FG000|STARTED|Overall Study||15||
60047890|NCT01903863|76163531|FG001|STARTED|Overall Study||16||
60047891|NCT01903863|76163530|FG000|COMPLETED|Overall Study||13||
60047892|NCT01903863|76163531|FG001|COMPLETED|Overall Study||16||
60047893|NCT01903863|76163530|FG000|NOT COMPLETED|Overall Study||2||
60047894|NCT01903863|76163531|FG001|NOT COMPLETED|Overall Study||0||
60047895|NCT02123251|76163539|FG000|STARTED|Overall Study||159||
60047896|NCT02123251|76163540|FG001|STARTED|Overall Study||161||
60047897|NCT02123251|76163539|FG000|COMPLETED|Overall Study||125||
60047898|NCT02123251|76163540|FG001|COMPLETED|Overall Study||131||
60047899|NCT02123251|76163539|FG000|NOT COMPLETED|Overall Study||34||
60047900|NCT02123251|76163540|FG001|NOT COMPLETED|Overall Study||30||
60047901|NCT01902303|76163549|FG000|STARTED|Overall Study|Allocated to placebo|77||
60047902|NCT01902303|76163550|FG001|STARTED|Overall Study|Allocated to active treatment|81||
60047903|NCT01902303|76163549|FG000|Number of Participants|Overall Study|Number of randomized participants who developed a cold sore and used the assigned treatment.|56||
60047904|NCT01902303|76163550|FG001|Number of Participants|Overall Study|Number of randomized participants who developed a cold sore and used the assigned treatment.|62||
60047905|NCT01902303|76163549|FG000|COMPLETED|Overall Study|21 not treated - did not use placebo medication as they did not develop cold sore|54||
60047906|NCT01902303|76163550|FG001|COMPLETED|Overall Study|19 not treated /did not use medication as they did not develop a cold sore|57||
60047907|NCT01902303|76163549|FG000|NOT COMPLETED|Overall Study||23||
60047908|NCT01902303|76163550|FG001|NOT COMPLETED|Overall Study||24||
60047909|NCT02122783|76163560|FG000|STARTED|Overall Study||2||
60047910|NCT02122783|76163561|FG001|STARTED|Overall Study||3||
60047911|NCT02122783|76163560|FG000|COMPLETED|Overall Study||2||
60047912|NCT02122783|76163561|FG001|COMPLETED|Overall Study||2||
60047913|NCT02122783|76163560|FG000|NOT COMPLETED|Overall Study||0||
60047914|NCT02122783|76163561|FG001|NOT COMPLETED|Overall Study||1||
60047915|NCT01921257|76163570|FG000|STARTED|Overall Study||16||
60047916|NCT01921257|76163570|FG000|Placebo run-in|Overall Study||16||
60047917|NCT01921257|76163570|FG000|Active Treatment|Overall Study||13||
60047918|NCT01921257|76163570|FG000|COMPLETED|Overall Study||13||
60047919|NCT01921257|76163570|FG000|NOT COMPLETED|Overall Study||3||
60047920|NCT02121847|76163575|FG000|STARTED|Overall Study||40||
60047921|NCT02121847|76163575|FG000|COMPLETED|Overall Study||37||
60047922|NCT02121847|76163575|FG000|NOT COMPLETED|Overall Study||3||
60047923|NCT01921179|76163581|FG000|STARTED|5 Week Randomized GOALS vs EDU Training||24||
60047924|NCT01921179|76163582|FG001|STARTED|5 Week Randomized GOALS vs EDU Training||22||
60047925|NCT01921179|76163581|FG000|COMPLETED|5 Week Randomized GOALS vs EDU Training||21||
60047926|NCT01921179|76163582|FG001|COMPLETED|5 Week Randomized GOALS vs EDU Training||19||
60047927|NCT01921179|76163581|FG000|NOT COMPLETED|5 Week Randomized GOALS vs EDU Training||3||
60047928|NCT01921179|76163582|FG001|NOT COMPLETED|5 Week Randomized GOALS vs EDU Training||3||
60047929|NCT01921179|76163581|FG000|STARTED|Long Term Follow-up After GOALS Training||34||
60047930|NCT01921179|76163582|FG001|STARTED|Long Term Follow-up After GOALS Training|13 out of 19 participants who completed EDU, also completed GOALS training|0||
60047931|NCT01921179|76163581|FG000|COMPLETED|Long Term Follow-up After GOALS Training||32||
60047932|NCT01921179|76163582|FG001|COMPLETED|Long Term Follow-up After GOALS Training||0||
60047933|NCT01921179|76163581|FG000|NOT COMPLETED|Long Term Follow-up After GOALS Training||2||
60047934|NCT01921179|76163582|FG001|NOT COMPLETED|Long Term Follow-up After GOALS Training||0||
60047935|NCT01587040|76163593|FG000|STARTED|Overall Study||17||
60047936|NCT01587040|76163594|FG001|STARTED|Overall Study||3||
60047937|NCT01587040|76163595|FG002|STARTED|Overall Study||37||
60047938|NCT01587040|76163596|FG003|STARTED|Overall Study||4||
60047939|NCT01587040|76163593|FG000|COMPLETED|Overall Study||0||
60047940|NCT01587040|76163594|FG001|COMPLETED|Overall Study||0||
60047941|NCT01587040|76163595|FG002|COMPLETED|Overall Study||0||
59512511|NCT02885506|75605766|FG005|COMPLETED|Part B||0||
59512512|NCT02885506|75605767|FG006|COMPLETED|Part B||0||
59512513|NCT02885506|75605768|FG007|COMPLETED|Part B||0||
59512514|NCT02885506|75605769|FG008|COMPLETED|Part B||4||
59512515|NCT02885506|75605770|FG009|COMPLETED|Part B||4||
59512516|NCT02885506|75605761|FG000|NOT COMPLETED|Part B||0||
59512517|NCT02885506|75605762|FG001|NOT COMPLETED|Part B||0||
59512518|NCT02885506|75605763|FG002|NOT COMPLETED|Part B||0||
59512519|NCT02885506|75605764|FG003|NOT COMPLETED|Part B||0||
59512520|NCT02885506|75605765|FG004|NOT COMPLETED|Part B||0||
59512521|NCT02885506|75605766|FG005|NOT COMPLETED|Part B||0||
59512522|NCT02885506|75605767|FG006|NOT COMPLETED|Part B||0||
59512523|NCT02885506|75605768|FG007|NOT COMPLETED|Part B||0||
59612569|NCT01746732|75723592|FG002|STARTED|Lead-In Period||0||
59612570|NCT01746732|75723590|FG000|Participants Received at Least 1 Dose|Lead-In Period||22||
59612571|NCT01746732|75723591|FG001|Participants Received at Least 1 Dose|Lead-In Period||0||
59612572|NCT01746732|75723592|FG002|Participants Received at Least 1 Dose|Lead-In Period||0||
59612573|NCT01746732|75723590|FG000|COMPLETED|Lead-In Period||22||
59612574|NCT01746732|75723591|FG001|COMPLETED|Lead-In Period||0||
59920228|NCT03874234|76040418|FG007|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day10)||0||
59920229|NCT03874234|76040419|FG008|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day10)||0||
59920230|NCT03874234|76040420|FG009|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day10)||0||
59920231|NCT03874234|76040421|FG010|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day10)||0||
59920232|NCT03874234|76040422|FG011|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day10)||0||
59512524|NCT02885506|75605769|FG008|NOT COMPLETED|Part B||0||
59512525|NCT02885506|75605770|FG009|NOT COMPLETED|Part B||0||
59512526|NCT02895100|75605798|FG000|STARTED|Overall Study||25||
59512527|NCT02895100|75605799|FG001|STARTED|Overall Study||25||
59512528|NCT02895100|75605800|FG002|STARTED|Overall Study||23||
59512529|NCT02895100|75605801|FG003|STARTED|Overall Study||25||
59512530|NCT02895100|75605798|FG000|COMPLETED|Overall Study||14||
59512531|NCT02895100|75605799|FG001|COMPLETED|Overall Study||14||
59920233|NCT03874234|76040423|FG012|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day10)||0||
59920234|NCT03874234|76040411|FG000|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day10)||2||
59920235|NCT03874234|76040412|FG001|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day10)||2||
60047942|NCT01587040|76163596|FG003|COMPLETED|Overall Study||0||
60047943|NCT01587040|76163593|FG000|NOT COMPLETED|Overall Study||17||
60047944|NCT01587040|76163594|FG001|NOT COMPLETED|Overall Study||3||
60047945|NCT01587040|76163595|FG002|NOT COMPLETED|Overall Study||37||
59512532|NCT02895100|75605800|FG002|COMPLETED|Overall Study||15||
59612575|NCT01746732|75723592|FG002|COMPLETED|Lead-In Period||0||
60047946|NCT01587040|76163596|FG003|NOT COMPLETED|Overall Study||4||
60047947|NCT02144701|76163608|FG000|STARTED|Overall Study||22||
60047948|NCT02144701|76163609|FG001|STARTED|Overall Study||11||
60047949|NCT02144701|76163608|FG000|COMPLETED|Overall Study||13||
60047950|NCT02144701|76163609|FG001|COMPLETED|Overall Study||8||
60047951|NCT02144701|76163608|FG000|NOT COMPLETED|Overall Study||9||
60047952|NCT02144701|76163609|FG001|NOT COMPLETED|Overall Study||3||
60047953|NCT01921101|76163617|FG000|STARTED|Overall Study||40||
60047954|NCT01921101|76163618|FG001|STARTED|Overall Study||38||
60047955|NCT01921101|76163617|FG000|COMPLETED|Overall Study||24||
60047956|NCT01921101|76163618|FG001|COMPLETED|Overall Study||32||
60047957|NCT01921101|76163617|FG000|NOT COMPLETED|Overall Study||16||
60047958|NCT01921101|76163618|FG001|NOT COMPLETED|Overall Study||6||
59512533|NCT02895100|75605801|FG003|COMPLETED|Overall Study||15||
59512534|NCT02895100|75605798|FG000|NOT COMPLETED|Overall Study||11||
59512535|NCT02895100|75605799|FG001|NOT COMPLETED|Overall Study||11||
60047959|NCT01586806|76163627|FG000|STARTED|Overall Study||65||
60047960|NCT01586806|76163628|FG001|STARTED|Overall Study||65||
60047961|NCT01586806|76163629|FG002|STARTED|Overall Study||65||
60047962|NCT01586806|76163627|FG000|COMPLETED|Overall Study||62||
60047963|NCT01586806|76163628|FG001|COMPLETED|Overall Study||61||
60047964|NCT01586806|76163629|FG002|COMPLETED|Overall Study||63||
60047965|NCT01586806|76163627|FG000|NOT COMPLETED|Overall Study||3||
60047966|NCT01586806|76163628|FG001|NOT COMPLETED|Overall Study||4||
60047967|NCT01586806|76163629|FG002|NOT COMPLETED|Overall Study||2||
60047968|NCT02144077|76163639|FG000|STARTED|Overall Study||138||
60047969|NCT02144077|76163640|FG001|STARTED|Overall Study||143||
60047970|NCT02144077|76163639|FG000|COMPLETED|Overall Study||128|5 patients did not complete due to AE. In 3 of them these AEs were unrelated to study treatment.|
60047971|NCT02144077|76163640|FG001|COMPLETED|Overall Study||132|5 patients did not complete due to AE. In 3 of them these AEs were unrelated to study treatment.|
60047972|NCT02144077|76163639|FG000|NOT COMPLETED|Overall Study||10||
60047973|NCT02144077|76163640|FG001|NOT COMPLETED|Overall Study||11||
60047974|NCT02172625|76163648|FG000|STARTED|Overall Study||19||
60047975|NCT02172625|76163649|FG001|STARTED|Overall Study||19||
60047976|NCT02172625|76163648|FG000|COMPLETED|Overall Study||19||
60047977|NCT02172625|76163649|FG001|COMPLETED|Overall Study||16||
60047978|NCT02172625|76163648|FG000|NOT COMPLETED|Overall Study||0||
60047979|NCT02172625|76163649|FG001|NOT COMPLETED|Overall Study||3||
59612576|NCT01746732|75723590|FG000|NOT COMPLETED|Lead-In Period||1||
59612577|NCT01746732|75723591|FG001|NOT COMPLETED|Lead-In Period||0||
59612578|NCT01746732|75723592|FG002|NOT COMPLETED|Lead-In Period||0||
59612579|NCT01746732|75723590|FG000|STARTED|Period 1||0||
59612580|NCT01746732|75723591|FG001|STARTED|Period 1||11||
59612581|NCT01746732|75723592|FG002|STARTED|Period 1||11||
59612582|NCT01746732|75723590|FG000|COMPLETED|Period 1||0||
59612583|NCT01746732|75723591|FG001|COMPLETED|Period 1||10||
59612584|NCT01746732|75723592|FG002|COMPLETED|Period 1||11||
59612585|NCT01746732|75723590|FG000|NOT COMPLETED|Period 1||0||
59612586|NCT01746732|75723591|FG001|NOT COMPLETED|Period 1||1||
59612587|NCT01746732|75723592|FG002|NOT COMPLETED|Period 1||0||
59920236|NCT03874234|76040413|FG002|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day10)||2||
59920237|NCT03874234|76040414|FG003|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day10)||1||
59920238|NCT03874234|76040415|FG004|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day10)||0||
59920239|NCT03874234|76040416|FG005|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day10)||0||
59920240|NCT03874234|76040417|FG006|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day10)||0||
59920241|NCT03874234|76040418|FG007|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day10)||0||
59920242|NCT03874234|76040419|FG008|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day10)||0||
59920243|NCT03874234|76040420|FG009|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day10)||0||
59920244|NCT03874234|76040421|FG010|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day10)||0||
59920245|NCT03874234|76040422|FG011|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day10)||0||
59920246|NCT03874234|76040423|FG012|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day10)||0||
59920247|NCT03874234|76040411|FG000|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day10)||0||
59920248|NCT03874234|76040412|FG001|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day10)||0||
59920249|NCT03874234|76040413|FG002|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day10)||0||
60047980|NCT02143843|76163659|FG000|STARTED|Overall Study||75||
60047981|NCT02143843|76163659|FG000|COMPLETED|Overall Study||63||
60047982|NCT02143843|76163659|FG000|NOT COMPLETED|Overall Study||12||
59760094|NCT04748783|75879664|FG003|COMPLETED|Overall Study||0||
59760095|NCT04748783|75879665|FG004|COMPLETED|Overall Study||1||
59760096|NCT04748783|75879661|FG000|NOT COMPLETED|Overall Study||0||
59760097|NCT04748783|75879662|FG001|NOT COMPLETED|Overall Study||0||
60047983|NCT02121535|76163665|FG000|STARTED|Period 1 (8 Trial Days)||36||
60047984|NCT02121535|76163666|FG001|STARTED|Period 1 (8 Trial Days)||36||
60047985|NCT02121535|76163665|FG000|COMPLETED|Period 1 (8 Trial Days)||36||
60047986|NCT02121535|76163666|FG001|COMPLETED|Period 1 (8 Trial Days)|1 subject withdrew his consent during the washout period between Period 1 and 2.|35||
60047987|NCT02121535|76163665|FG000|NOT COMPLETED|Period 1 (8 Trial Days)||0||
60047988|NCT02121535|76163666|FG001|NOT COMPLETED|Period 1 (8 Trial Days)||1||
60047989|NCT02121535|76163665|FG000|STARTED|Period 2 (8 Trial Days)||36||
60047990|NCT02121535|76163666|FG001|STARTED|Period 2 (8 Trial Days)||35||
60047991|NCT02121535|76163665|FG000|COMPLETED|Period 2 (8 Trial Days)||36||
60047992|NCT02121535|76163666|FG001|COMPLETED|Period 2 (8 Trial Days)||35||
60047993|NCT02121535|76163665|FG000|NOT COMPLETED|Period 2 (8 Trial Days)||0||
60047994|NCT02121535|76163666|FG001|NOT COMPLETED|Period 2 (8 Trial Days)||0||
60047995|NCT02121535|76163665|FG000|STARTED|Period 3 (8 Trial Days)||36||
60047996|NCT02121535|76163666|FG001|STARTED|Period 3 (8 Trial Days)||35||
60047997|NCT02121535|76163665|FG000|COMPLETED|Period 3 (8 Trial Days)|1 subject withdrew consent during the washout period between Period 3 and 4.|35||
60047998|NCT02121535|76163666|FG001|COMPLETED|Period 3 (8 Trial Days)||35||
60047999|NCT02121535|76163665|FG000|NOT COMPLETED|Period 3 (8 Trial Days)||1||
60048000|NCT02121535|76163666|FG001|NOT COMPLETED|Period 3 (8 Trial Days)||0||
60048001|NCT02121535|76163665|FG000|STARTED|Period 4 (8 Trial Days)||35||
60048002|NCT02121535|76163666|FG001|STARTED|Period 4 (8 Trial Days)||35||
60048003|NCT02121535|76163665|FG000|COMPLETED|Period 4 (8 Trial Days)||35||
60048004|NCT02121535|76163666|FG001|COMPLETED|Period 4 (8 Trial Days)||35||
60048005|NCT02121535|76163665|FG000|NOT COMPLETED|Period 4 (8 Trial Days)||0||
60048006|NCT02121535|76163666|FG001|NOT COMPLETED|Period 4 (8 Trial Days)||0||
60048007|NCT01586338|76163673|FG000|STARTED|Overall Study||237||
60048008|NCT01586338|76163673|FG000|COMPLETED|Overall Study||229||
60048009|NCT01586338|76163673|FG000|NOT COMPLETED|Overall Study||8||
60048010|NCT02143141|76163679|FG000|STARTED|Overall Study||7||
60048011|NCT02143141|76163680|FG001|STARTED|Overall Study||6||
60048012|NCT02143141|76163679|FG000|COMPLETED|Overall Study||6||
60048013|NCT02143141|76163680|FG001|COMPLETED|Overall Study||6||
60048014|NCT02143141|76163679|FG000|NOT COMPLETED|Overall Study||1||
60048015|NCT02143141|76163680|FG001|NOT COMPLETED|Overall Study||0||
60048016|NCT02171065|76163689|FG000|STARTED|Overall Study||89||
60048017|NCT02171065|76163690|FG001|STARTED|Overall Study||93||
60048018|NCT02171065|76163691|FG002|STARTED|Overall Study||716||
60048019|NCT02171065|76163689|FG000|COMPLETED|Overall Study||88||
60048020|NCT02171065|76163690|FG001|COMPLETED|Overall Study||93||
60048021|NCT02171065|76163691|FG002|COMPLETED|Overall Study||715||
60048022|NCT02171065|76163689|FG000|NOT COMPLETED|Overall Study||1||
60048023|NCT02171065|76163690|FG001|NOT COMPLETED|Overall Study||0||
60048024|NCT02171065|76163691|FG002|NOT COMPLETED|Overall Study||1||
60048025|NCT01566604|76163703|FG000|STARTED|Overall Study||306||
60048026|NCT01566604|76163704|FG001|STARTED|Overall Study||154||
60048027|NCT01566604|76163703|FG000|Safety Set|Overall Study||305||
60048028|NCT01566604|76163704|FG001|Safety Set|Overall Study||154||
60048029|NCT01566604|76163703|FG000|Full Analysis Set (FAS)|Overall Study||305||
60048030|NCT01566604|76163704|FG001|Full Analysis Set (FAS)|Overall Study||154||
60048031|NCT01566604|76163703|FG000|FAS, Serial Spirometry Subgroup|Overall Study||134||
60048032|NCT01566604|76163704|FG001|FAS, Serial Spirometry Subgroup|Overall Study||58||
60048033|NCT01566604|76163703|FG000|COMPLETED|Overall Study||282||
60048034|NCT01566604|76163704|FG001|COMPLETED|Overall Study||143||
60048035|NCT01566604|76163703|FG000|NOT COMPLETED|Overall Study||24||
60048036|NCT01566604|76163704|FG001|NOT COMPLETED|Overall Study||11||
60048037|NCT01684930|76163712|FG000|STARTED|Overall Study||12||
60048038|NCT01684930|76163713|FG001|STARTED|Overall Study||14||
60048039|NCT01684930|76163712|FG000|COMPLETED|Overall Study||9||
60048040|NCT01684930|76163713|FG001|COMPLETED|Overall Study||13||
60048041|NCT01684930|76163712|FG000|NOT COMPLETED|Overall Study||3||
60048042|NCT01684930|76163713|FG001|NOT COMPLETED|Overall Study||1||
60048043|NCT01566214|76163721|FG000|STARTED|Overall Study||6||
60048044|NCT01566214|76163722|FG001|STARTED|Overall Study||6||
60048045|NCT01566214|76163721|FG000|COMPLETED|Overall Study||3||
60048046|NCT01566214|76163722|FG001|COMPLETED|Overall Study||6||
60048047|NCT01566214|76163721|FG000|NOT COMPLETED|Overall Study||3||
60048048|NCT01566214|76163722|FG001|NOT COMPLETED|Overall Study||0||
60048049|NCT02253992|76163731|FG000|STARTED|Overall Study||6||
60048050|NCT02253992|76163732|FG001|STARTED|Overall Study||4||
60048051|NCT02253992|76163733|FG002|STARTED|Overall Study||150||
60048052|NCT02253992|76163731|FG000|COMPLETED|Overall Study||0|Completed= Continuing in the treatment period.|
60048053|NCT02253992|76163732|FG001|COMPLETED|Overall Study||0|Completed= Continuing in the treatment period.|
60048054|NCT02253992|76163733|FG002|COMPLETED|Overall Study||6|Completed= Continuing in the treatment period.|
60048055|NCT02253992|76163731|FG000|NOT COMPLETED|Overall Study||6||
60048056|NCT02253992|76163732|FG001|NOT COMPLETED|Overall Study||4||
60048057|NCT02253992|76163733|FG002|NOT COMPLETED|Overall Study||144||
60048058|NCT02252588|76163757|FG000|STARTED|Overall Study||24||
59760098|NCT04748783|75879663|FG002|NOT COMPLETED|Overall Study||0||
59760099|NCT04748783|75879664|FG003|NOT COMPLETED|Overall Study||0||
59760100|NCT04748783|75879665|FG004|NOT COMPLETED|Overall Study||0||
59760101|NCT02511132|75879681|FG000|STARTED|Overall Study||5||
59920250|NCT03874234|76040414|FG003|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day10)||0||
59920251|NCT03874234|76040415|FG004|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day10)||0||
59920252|NCT03874234|76040416|FG005|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day10)||0||
59512536|NCT02895100|75605800|FG002|NOT COMPLETED|Overall Study||8||
59512537|NCT02895100|75605801|FG003|NOT COMPLETED|Overall Study||10||
59512538|NCT00904007|75605813|FG000|STARTED|Overall Study||55||
59512539|NCT00904007|75605814|FG001|STARTED|Overall Study||56||
59512540|NCT00904007|75605813|FG000|COMPLETED|Overall Study||55||
59512541|NCT00904007|75605814|FG001|COMPLETED|Overall Study||56||
59512542|NCT00904007|75605813|FG000|NOT COMPLETED|Overall Study||0||
59512543|NCT00904007|75605814|FG001|NOT COMPLETED|Overall Study||0||
59512544|NCT02777944|75605824|FG000|STARTED|Overall Study||157||
59512545|NCT02777944|75605825|FG001|STARTED|Overall Study||156||
59512546|NCT02777944|75605824|FG000|COMPLETED|Overall Study||157||
59512547|NCT02777944|75605825|FG001|COMPLETED|Overall Study||156||
59512548|NCT02777944|75605824|FG000|NOT COMPLETED|Overall Study||0||
59512549|NCT02777944|75605825|FG001|NOT COMPLETED|Overall Study||0||
59512550|NCT02778880|75605833|FG000|STARTED|Overall Study||45||
59512551|NCT02778880|75605834|FG001|STARTED|Overall Study||45||
59512552|NCT02778880|75605833|FG000|COMPLETED|Overall Study||44||
59512553|NCT02778880|75605834|FG001|COMPLETED|Overall Study||42||
59512554|NCT02778880|75605833|FG000|NOT COMPLETED|Overall Study||1||
59512555|NCT02778880|75605834|FG001|NOT COMPLETED|Overall Study||3||
59512556|NCT00891995|75605842|FG000|STARTED|Overall Study||50||
59920253|NCT03874234|76040417|FG006|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day10)||0||
59920254|NCT03874234|76040418|FG007|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day10)||0||
59920255|NCT03874234|76040419|FG008|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day10)||0||
59920256|NCT03874234|76040420|FG009|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day10)||0||
59920257|NCT03874234|76040421|FG010|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day10)||0||
59920258|NCT03874234|76040422|FG011|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day10)||0||
59920259|NCT03874234|76040423|FG012|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day10)||0||
59920260|NCT03874234|76040411|FG000|STARTED|Part A: Cohort 1-Period 2 (Day1)||2||
59920261|NCT03874234|76040412|FG001|STARTED|Part A: Cohort 1-Period 2 (Day1)||2||
59920262|NCT03874234|76040413|FG002|STARTED|Part A: Cohort 1-Period 2 (Day1)||2||
59920263|NCT03874234|76040414|FG003|STARTED|Part A: Cohort 1-Period 2 (Day1)|New participant enrolled and dosed|2||
59920264|NCT03874234|76040415|FG004|STARTED|Part A: Cohort 1-Period 2 (Day1)||0||
59920265|NCT03874234|76040416|FG005|STARTED|Part A: Cohort 1-Period 2 (Day1)||0||
59920266|NCT03874234|76040417|FG006|STARTED|Part A: Cohort 1-Period 2 (Day1)||0||
59920267|NCT03874234|76040418|FG007|STARTED|Part A: Cohort 1-Period 2 (Day1)||0||
59920268|NCT03874234|76040419|FG008|STARTED|Part A: Cohort 1-Period 2 (Day1)||0||
59920269|NCT03874234|76040420|FG009|STARTED|Part A: Cohort 1-Period 2 (Day1)||0||
59920270|NCT03874234|76040421|FG010|STARTED|Part A: Cohort 1-Period 2 (Day1)||0||
59920271|NCT03874234|76040422|FG011|STARTED|Part A: Cohort 1-Period 2 (Day1)||0||
59920272|NCT03874234|76040423|FG012|STARTED|Part A: Cohort 1-Period 2 (Day1)||0||
59920273|NCT03874234|76040411|FG000|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 2 (Day1)||0||
59920274|NCT03874234|76040412|FG001|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 2 (Day1)||0||
59920275|NCT03874234|76040413|FG002|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 2 (Day1)||0||
59920276|NCT03874234|76040414|FG003|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 2 (Day1)||1||
59920277|NCT03874234|76040415|FG004|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 2 (Day1)||0||
59920278|NCT03874234|76040416|FG005|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 2 (Day1)||0||
59920279|NCT03874234|76040417|FG006|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 2 (Day1)||0||
59920280|NCT03874234|76040418|FG007|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 2 (Day1)||0||
59951425|NCT01251965|76070420|FG002|STARTED|Overall Study||18||
59512557|NCT00891995|75605843|FG001|STARTED|Overall Study||21||
59512558|NCT00891995|75605842|FG000|COMPLETED|Overall Study||50||
60048059|NCT02252588|76163758|FG001|STARTED|Overall Study||20||
60048060|NCT02252588|76163757|FG000|COMPLETED|Overall Study||20||
60048061|NCT02252588|76163758|FG001|COMPLETED|Overall Study||20||
60048062|NCT02252588|76163757|FG000|NOT COMPLETED|Overall Study||4||
60048063|NCT02252588|76163758|FG001|NOT COMPLETED|Overall Study||0||
60048064|NCT01585558|76163767|FG000|STARTED|Overall Study||62||
60048065|NCT01585558|76163768|FG001|STARTED|Overall Study||69||
60048066|NCT01585558|76163769|FG002|STARTED|Overall Study||49||
60048067|NCT01585558|76163767|FG000|COMPLETED|Overall Study||49||
60048068|NCT01585558|76163768|FG001|COMPLETED|Overall Study||57||
60048069|NCT01585558|76163769|FG002|COMPLETED|Overall Study||34||
60048070|NCT01585558|76163767|FG000|NOT COMPLETED|Overall Study||13||
60048071|NCT01585558|76163768|FG001|NOT COMPLETED|Overall Study||12||
60048072|NCT01585558|76163769|FG002|NOT COMPLETED|Overall Study||15||
60048073|NCT01565980|76163779|FG000|STARTED|Overall Study||20||
60048074|NCT01565980|76163780|FG001|STARTED|Overall Study|Three patients had started the intervention protocol at the time of study withdrawal.|20||
60048075|NCT01565980|76163779|FG000|COMPLETED|Overall Study||16||
60048076|NCT01565980|76163780|FG001|COMPLETED|Overall Study||16||
60048077|NCT01565980|76163779|FG000|NOT COMPLETED|Overall Study||4||
60048078|NCT01565980|76163780|FG001|NOT COMPLETED|Overall Study||4||
60048079|NCT01585246|76163795|FG000|STARTED|Overall Study||3||
60048080|NCT01585246|76163796|FG001|STARTED|Overall Study||4||
60048081|NCT01585246|76163797|FG002|STARTED|Overall Study||20||
60048082|NCT01585246|76163798|FG003|STARTED|Overall Study||10||
60048083|NCT01585246|76163799|FG004|STARTED|Overall Study||11||
60048084|NCT01585246|76163795|FG000|COMPLETED|Overall Study||3||
60048085|NCT01585246|76163796|FG001|COMPLETED|Overall Study||3||
60048086|NCT01585246|76163797|FG002|COMPLETED|Overall Study||16||
60048087|NCT01585246|76163798|FG003|COMPLETED|Overall Study||6||
60048088|NCT01585246|76163799|FG004|COMPLETED|Overall Study||9||
60048089|NCT01585246|76163795|FG000|NOT COMPLETED|Overall Study||0||
60048090|NCT01585246|76163796|FG001|NOT COMPLETED|Overall Study||1||
60048091|NCT01585246|76163797|FG002|NOT COMPLETED|Overall Study||4||
60048092|NCT01585246|76163798|FG003|NOT COMPLETED|Overall Study||4||
60048093|NCT01585246|76163799|FG004|NOT COMPLETED|Overall Study||2||
60048094|NCT01585168|76163816|FG000|STARTED|Overall Study||18||
60048095|NCT01585168|76163817|FG001|STARTED|Overall Study||18||
60048096|NCT01585168|76163818|FG002|STARTED|Overall Study||16||
60048097|NCT01585168|76163819|FG003|STARTED|Overall Study||19||
60048098|NCT01585168|76163816|FG000|COMPLETED|Overall Study||15||
60048099|NCT01585168|76163817|FG001|COMPLETED|Overall Study||17||
60048100|NCT01585168|76163818|FG002|COMPLETED|Overall Study||15||
60048101|NCT01585168|76163819|FG003|COMPLETED|Overall Study||18||
60048102|NCT01585168|76163816|FG000|NOT COMPLETED|Overall Study||3||
60048103|NCT01585168|76163817|FG001|NOT COMPLETED|Overall Study||1||
60048104|NCT01585168|76163818|FG002|NOT COMPLETED|Overall Study||1||
60048105|NCT01585168|76163819|FG003|NOT COMPLETED|Overall Study||1||
60048106|NCT02232074|76163829|FG000|STARTED|Overall Study||154||
60048107|NCT02232074|76163830|FG001|STARTED|Overall Study||152||
60048108|NCT02232074|76163829|FG000|COMPLETED|Overall Study||113||
60048109|NCT02232074|76163830|FG001|COMPLETED|Overall Study||107||
60048110|NCT02232074|76163829|FG000|NOT COMPLETED|Overall Study||41||
60048111|NCT02232074|76163830|FG001|NOT COMPLETED|Overall Study||45||
60048112|NCT02142283|76163844|FG000|STARTED|Overall Study||107||
60048113|NCT02142283|76163845|FG001|STARTED|Overall Study||99||
60048114|NCT02142283|76163844|FG000|COMPLETED|Overall Study||86||
60048115|NCT02142283|76163845|FG001|COMPLETED|Overall Study||78||
60048116|NCT02142283|76163844|FG000|NOT COMPLETED|Overall Study||21||
60048117|NCT02142283|76163845|FG001|NOT COMPLETED|Overall Study||21||
60048118|NCT02231918|76163854|FG000|STARTED|Overall Study||9||
60048119|NCT02231918|76163855|FG001|STARTED|Overall Study||15||
60048120|NCT02231918|76163856|FG002|STARTED|Overall Study||2||
60048121|NCT02231918|76163854|FG000|COMPLETED|Overall Study||9||
60048122|NCT02231918|76163855|FG001|COMPLETED|Overall Study||14||
60048123|NCT02231918|76163856|FG002|COMPLETED|Overall Study||1||
60048124|NCT02231918|76163854|FG000|NOT COMPLETED|Overall Study||0||
60048125|NCT02231918|76163855|FG001|NOT COMPLETED|Overall Study||1||
60048126|NCT02231918|76163856|FG002|NOT COMPLETED|Overall Study||1||
60048127|NCT02199314|76163864|FG000|STARTED|Overall Study||30||
60048128|NCT02199314|76163864|FG000|COMPLETED|Overall Study||14||
60048129|NCT02199314|76163864|FG000|NOT COMPLETED|Overall Study||16||
60048130|NCT02251652|76163868|FG000|STARTED|Overall Study||17||
60048131|NCT02251652|76163868|FG000|COMPLETED|Overall Study||16||
60048132|NCT02251652|76163868|FG000|NOT COMPLETED|Overall Study||1||
60048133|NCT02197520|76163874|FG000|STARTED|Period 1||12||
60048134|NCT02197520|76163875|FG001|STARTED|Period 1||12||
60048135|NCT02197520|76163874|FG000|COMPLETED|Period 1||11||
60048136|NCT02197520|76163875|FG001|COMPLETED|Period 1||12||
60048137|NCT02197520|76163874|FG000|NOT COMPLETED|Period 1||1||
60048138|NCT02197520|76163875|FG001|NOT COMPLETED|Period 1||0||
60048139|NCT02197520|76163874|FG000|STARTED|Period 2||11||
60048140|NCT02197520|76163875|FG001|STARTED|Period 2||12||
60048141|NCT02197520|76163874|FG000|COMPLETED|Period 2||10||
60048142|NCT02197520|76163875|FG001|COMPLETED|Period 2||10||
60048143|NCT02197520|76163874|FG000|NOT COMPLETED|Period 2||1||
60048144|NCT02197520|76163875|FG001|NOT COMPLETED|Period 2||2||
60048145|NCT02230904|76163885|FG000|STARTED|Overall Study||29||
60048146|NCT02230904|76163886|FG001|STARTED|Overall Study||28||
60048147|NCT02230904|76163885|FG000|COMPLETED|Overall Study||29||
60048148|NCT02230904|76163886|FG001|COMPLETED|Overall Study||27||
60048149|NCT02230904|76163885|FG000|NOT COMPLETED|Overall Study||0||
60048150|NCT02230904|76163886|FG001|NOT COMPLETED|Overall Study||1||
60048151|NCT02230670|76163896|FG000|STARTED|Overall Study||44||
60048152|NCT02230670|76163897|FG001|STARTED|Overall Study|One subject randomized to placebo withdrew from the study before receiving any study treatment.|42||
60048153|NCT02230670|76163896|FG000|COMPLETED|Overall Study||40||
59512559|NCT00891995|75605843|FG001|COMPLETED|Overall Study||21||
59512560|NCT00891995|75605842|FG000|NOT COMPLETED|Overall Study||0||
59512561|NCT00891995|75605843|FG001|NOT COMPLETED|Overall Study||0||
59512562|NCT02781454|75605852|FG000|STARTED|Overall Study||8||
59512563|NCT02781454|75605853|FG001|STARTED|Overall Study||6||
59512564|NCT02781454|75605854|FG002|STARTED|Overall Study||6||
59512565|NCT02781454|75605852|FG000|COMPLETED|Overall Study||8||
59512566|NCT02781454|75605853|FG001|COMPLETED|Overall Study||6||
59512567|NCT02781454|75605854|FG002|COMPLETED|Overall Study||5||
59512568|NCT02781454|75605852|FG000|NOT COMPLETED|Overall Study||0||
59512569|NCT02781454|75605853|FG001|NOT COMPLETED|Overall Study||0||
59512570|NCT02781454|75605854|FG002|NOT COMPLETED|Overall Study||1||
59512571|NCT00892697|75605862|FG000|STARTED|Overall Study||15||
59512572|NCT00892697|75605862|FG000|COMPLETED|Overall Study||15||
59512573|NCT00892697|75605862|FG000|NOT COMPLETED|Overall Study||0||
59512574|NCT02155465|75605874|FG000|STARTED|Overall Study||3||
59512575|NCT02155465|75605875|FG001|STARTED|Overall Study||3||
59512576|NCT02155465|75605876|FG002|STARTED|Overall Study||6||
59512577|NCT02155465|75605877|FG003|STARTED|Overall Study||2||
59512578|NCT02155465|75605878|FG004|STARTED|Overall Study||1||
59512579|NCT02155465|75605879|FG005|STARTED|Overall Study||2||
59512580|NCT02155465|75605880|FG006|STARTED|Overall Study||5||
59512581|NCT02155465|75605874|FG000|COMPLETED|Overall Study||3||
59512582|NCT02155465|75605875|FG001|COMPLETED|Overall Study||3||
59512583|NCT02155465|75605876|FG002|COMPLETED|Overall Study||6||
59512584|NCT02155465|75605877|FG003|COMPLETED|Overall Study||2||
59512585|NCT02155465|75605878|FG004|COMPLETED|Overall Study||1||
59512586|NCT02155465|75605879|FG005|COMPLETED|Overall Study||2||
59512587|NCT02155465|75605880|FG006|COMPLETED|Overall Study||5||
59760102|NCT02511132|75879682|FG001|STARTED|Overall Study||8||
59760103|NCT02511132|75879683|FG002|STARTED|Overall Study||9||
60048154|NCT02230670|76163897|FG001|COMPLETED|Overall Study||34||
60048155|NCT02230670|76163896|FG000|NOT COMPLETED|Overall Study||4||
60048156|NCT02230670|76163897|FG001|NOT COMPLETED|Overall Study||8||
59512588|NCT02155465|75605874|FG000|NOT COMPLETED|Overall Study||0||
59512589|NCT02155465|75605875|FG001|NOT COMPLETED|Overall Study||0||
59512590|NCT02155465|75605876|FG002|NOT COMPLETED|Overall Study||0||
59512591|NCT02155465|75605877|FG003|NOT COMPLETED|Overall Study||0||
59512592|NCT02155465|75605878|FG004|NOT COMPLETED|Overall Study||0||
59512593|NCT02155465|75605879|FG005|NOT COMPLETED|Overall Study||0||
59512594|NCT02155465|75605880|FG006|NOT COMPLETED|Overall Study||0||
59512595|NCT02781610|75605903|FG000|STARTED|Overall Study||140|Randomized to the ERR-10 or ERR-14 arm if allocated to ERR treatment group, or randomized to the NERR-14 or NERR-21 arm if allocated to NERR treatment group.|
59512596|NCT02781610|75605904|FG001|STARTED|Overall Study||137|Randomized to the ERR-10 or ERR-14 arm if allocated to ERR treatment group, or randomized to the NERR-14 or NERR-21 arm if allocated to NERR treatment group.|
59512597|NCT02781610|75605905|FG002|STARTED|Overall Study||353|Randomized to the ERR-10 or ERR-14 arm if allocated to ERR treatment group, or randomized to the NERR-14 or NERR-21 arm if allocated to NERR treatment group.|
59512598|NCT02781610|75605906|FG003|STARTED|Overall Study||352|Randomized to the ERR-10 or ERR-14 arm if allocated to ERR treatment group, or randomized to the NERR-14 or NERR-21 arm if allocated to NERR treatment group.|
59512599|NCT02781610|75605903|FG000|COMPLETED|Overall Study||134|Completed last study visit (Day 25 for ERR-10 arm, Day 29 for ERR-14 arm or NERR-14 arm, and Day 36 for NERR-21 arm)|
60048157|NCT02197130|76163906|FG000|STARTED|Overall Study||95||
60048158|NCT02197130|76163907|FG001|STARTED|Overall Study||89||
60048159|NCT02197130|76163908|FG002|STARTED|Overall Study||88||
59512600|NCT02781610|75605904|FG001|COMPLETED|Overall Study||130|Completed last study visit (Day 25 for ERR-10 arm, Day 29 for ERR-14 arm or NERR-14 arm, and Day 36 for NERR-21 arm)|
59512601|NCT02781610|75605905|FG002|COMPLETED|Overall Study||336|Completed last study visit (Day 25 for ERR-10 arm, Day 29 for ERR-14 arm or NERR-14 arm, and Day 36 for NERR-21 arm)|
59512602|NCT02781610|75605906|FG003|COMPLETED|Overall Study||323|Completed last study visit (Day 25 for ERR-10 arm, Day 29 for ERR-14 arm or NERR-14 arm, and Day 36 for NERR-21 arm)|
59512603|NCT02781610|75605903|FG000|NOT COMPLETED|Overall Study||6||
59512604|NCT02781610|75605904|FG001|NOT COMPLETED|Overall Study||7||
59512605|NCT02781610|75605905|FG002|NOT COMPLETED|Overall Study||17||
59512606|NCT02781610|75605906|FG003|NOT COMPLETED|Overall Study||29||
59512607|NCT02155543|75605923|FG000|STARTED|Overall Study||9||
59512608|NCT02155543|75605924|FG001|STARTED|Overall Study||9||
59512609|NCT02155543|75605925|FG002|STARTED|Overall Study||9||
59512610|NCT02155543|75605926|FG003|STARTED|Overall Study||9||
59512611|NCT02155543|75605927|FG004|STARTED|Overall Study||3||
59512612|NCT02155543|75605928|FG005|STARTED|Overall Study||3||
59512613|NCT02155543|75605929|FG006|STARTED|Overall Study||9||
59512614|NCT02155543|75605923|FG000|COMPLETED|Overall Study||9||
59512615|NCT02155543|75605924|FG001|COMPLETED|Overall Study||9||
59512616|NCT02155543|75605925|FG002|COMPLETED|Overall Study||9||
59512617|NCT02155543|75605926|FG003|COMPLETED|Overall Study||9||
59512618|NCT02155543|75605927|FG004|COMPLETED|Overall Study||3||
59512619|NCT02155543|75605928|FG005|COMPLETED|Overall Study||3||
59512620|NCT02155543|75605929|FG006|COMPLETED|Overall Study||9||
59512621|NCT02155543|75605923|FG000|NOT COMPLETED|Overall Study||0||
59512622|NCT02155543|75605924|FG001|NOT COMPLETED|Overall Study||0||
59512623|NCT02155543|75605925|FG002|NOT COMPLETED|Overall Study||0||
59512624|NCT02155543|75605926|FG003|NOT COMPLETED|Overall Study||0||
59512625|NCT02155543|75605927|FG004|NOT COMPLETED|Overall Study||0||
59512626|NCT02155543|75605928|FG005|NOT COMPLETED|Overall Study||0||
59512627|NCT02155543|75605929|FG006|NOT COMPLETED|Overall Study||0||
59512628|NCT02785354|75605945|FG000|STARTED|Overall Study||27060||
59512629|NCT02785354|75605946|FG001|STARTED|Overall Study||31388||
59512630|NCT02785354|75605947|FG002|STARTED|Overall Study||44653||
59760104|NCT02511132|75879681|FG000|COMPLETED|Overall Study||5||
60048160|NCT02197130|76163906|FG000|Received Treatment|Overall Study||95||
60048161|NCT02197130|76163907|FG001|Received Treatment|Overall Study||88||
60048162|NCT02197130|76163908|FG002|Received Treatment|Overall Study||87||
60048163|NCT02197130|76163906|FG000|COMPLETED|Overall Study||79||
60048164|NCT02197130|76163907|FG001|COMPLETED|Overall Study||81||
60048165|NCT02197130|76163908|FG002|COMPLETED|Overall Study||56||
60048166|NCT02197130|76163906|FG000|NOT COMPLETED|Overall Study||16||
60048167|NCT02197130|76163907|FG001|NOT COMPLETED|Overall Study||8||
60048168|NCT02197130|76163908|FG002|NOT COMPLETED|Overall Study||32||
60048169|NCT02196506|76163918|FG000|STARTED|Phase A||837||
60048170|NCT02196506|76163919|FG001|STARTED|Phase A||0||
60048171|NCT02196506|76163920|FG002|STARTED|Phase A||0||
60048172|NCT02196506|76163921|FG003|STARTED|Phase A||0||
60048173|NCT02196506|76163918|FG000|COMPLETED|Phase A||716||
60048174|NCT02196506|76163919|FG001|COMPLETED|Phase A||0||
60048175|NCT02196506|76163920|FG002|COMPLETED|Phase A||0||
60048176|NCT02196506|76163921|FG003|COMPLETED|Phase A||0||
60048177|NCT02196506|76163918|FG000|NOT COMPLETED|Phase A||121||
60048178|NCT02196506|76163919|FG001|NOT COMPLETED|Phase A||0||
60048179|NCT02196506|76163920|FG002|NOT COMPLETED|Phase A||0||
60048180|NCT02196506|76163921|FG003|NOT COMPLETED|Phase A||0||
60048181|NCT02196506|76163918|FG000|STARTED|Phase B||0||
60048182|NCT02196506|76163919|FG001|STARTED|Phase B||192||
59512631|NCT02785354|75605945|FG000|COMPLETED|Overall Study||27060||
60048183|NCT02196506|76163920|FG002|STARTED|Phase B||202||
60048184|NCT02196506|76163921|FG003|STARTED|Phase B||0||
60048185|NCT02196506|76163918|FG000|COMPLETED|Phase B||0||
60048186|NCT02196506|76163919|FG001|COMPLETED|Phase B||177||
59512632|NCT02785354|75605946|FG001|COMPLETED|Overall Study||31388||
60048187|NCT02196506|76163920|FG002|COMPLETED|Phase B||196||
60048188|NCT02196506|76163921|FG003|COMPLETED|Phase B||0||
59512633|NCT02785354|75605947|FG002|COMPLETED|Overall Study||44653||
59512634|NCT02785354|75605945|FG000|NOT COMPLETED|Overall Study||0||
60048189|NCT02196506|76163918|FG000|NOT COMPLETED|Phase B||0||
60048190|NCT02196506|76163919|FG001|NOT COMPLETED|Phase B||15||
60048191|NCT02196506|76163920|FG002|NOT COMPLETED|Phase B||6||
60048192|NCT02196506|76163921|FG003|NOT COMPLETED|Phase B||0||
60048193|NCT02196506|76163918|FG000|STARTED|Phase A+||0||
60048194|NCT02196506|76163919|FG001|STARTED|Phase A+||0||
59512635|NCT02785354|75605946|FG001|NOT COMPLETED|Overall Study||0||
59512636|NCT02785354|75605947|FG002|NOT COMPLETED|Overall Study||0||
59512637|NCT00898937|75605959|FG000|STARTED|Overall Study||25||
59512638|NCT00898937|75605960|FG001|STARTED|Overall Study||21||
59512639|NCT00898937|75605961|FG002|STARTED|Overall Study||9||
59512640|NCT00898937|75605959|FG000|COMPLETED|Overall Study||25||
59512641|NCT00898937|75605960|FG001|COMPLETED|Overall Study||21||
59512642|NCT00898937|75605961|FG002|COMPLETED|Overall Study||9||
59512643|NCT00898937|75605959|FG000|NOT COMPLETED|Overall Study||0||
59512644|NCT00898937|75605960|FG001|NOT COMPLETED|Overall Study||0||
60048195|NCT02196506|76163920|FG002|STARTED|Phase A+||0||
60048196|NCT02196506|76163921|FG003|STARTED|Phase A+||322||
60048197|NCT02196506|76163918|FG000|COMPLETED|Phase A+||0||
60048198|NCT02196506|76163919|FG001|COMPLETED|Phase A+||0||
60048199|NCT02196506|76163920|FG002|COMPLETED|Phase A+||0||
60048200|NCT02196506|76163921|FG003|COMPLETED|Phase A+||308||
60048201|NCT02196506|76163918|FG000|NOT COMPLETED|Phase A+||0||
60048202|NCT02196506|76163919|FG001|NOT COMPLETED|Phase A+||0||
60048203|NCT02196506|76163920|FG002|NOT COMPLETED|Phase A+||0||
60048204|NCT02196506|76163921|FG003|NOT COMPLETED|Phase A+||14||
60048205|NCT02228720|76163927|FG000|STARTED|Open Label - Baseline||15||
60048206|NCT02228720|76163927|FG000|COMPLETED|Open Label - Baseline||15||
60048207|NCT02228720|76163927|FG000|NOT COMPLETED|Open Label - Baseline||0||
60048208|NCT02228720|76163927|FG000|STARTED|Open Label - Day 30||15||
60048209|NCT02228720|76163927|FG000|COMPLETED|Open Label - Day 30||14||
60048210|NCT02228720|76163927|FG000|NOT COMPLETED|Open Label - Day 30||1||
60048211|NCT02228720|76163927|FG000|STARTED|Open Label - Day 90||14||
60048212|NCT02228720|76163927|FG000|COMPLETED|Open Label - Day 90||14||
60048213|NCT02228720|76163927|FG000|NOT COMPLETED|Open Label - Day 90||0||
60048214|NCT02228564|76163931|FG000|STARTED|Overall Study||155||
60048215|NCT02228564|76163931|FG000|COMPLETED|Overall Study||106||
60048216|NCT02228564|76163931|FG000|NOT COMPLETED|Overall Study||49||
60048217|NCT01640951|76163943|FG000|STARTED|Overall Study||77|All randomized patients (Full Analysis Set and Safety Set)|
60048218|NCT01640951|76163944|FG001|STARTED|Overall Study||75|All randomized patients (Full Analysis Set and Safety Set)|
60048219|NCT01640951|76163945|FG002|STARTED|Overall Study||168|All randomized patients (Full Analysis Set and Safety Set)|
60048220|NCT01640951|76163946|FG003|STARTED|Overall Study||55|All randomized patients (Full Analysis Set and Safety Set)|
60048221|NCT01640951|76163947|FG004|STARTED|Overall Study||95|All randomized patients (Full Analysis Set and Safety Set)|
60048222|NCT01640951|76163948|FG005|STARTED|Overall Study||60|All randomized patients (Full Analysis Set and Safety Set)|
60048223|NCT01640951|76163949|FG006|STARTED|Overall Study||112|All randomized patients (Full Analysis Set and Safety Set)|
60048224|NCT01640951|76163950|FG007|STARTED|Overall Study||33|All randomized patients (Full Analysis Set and Safety Set)|
60048225|NCT01640951|76163943|FG000|COMPLETED|Overall Study||31||
60048226|NCT01640951|76163944|FG001|COMPLETED|Overall Study||60||
60048227|NCT01640951|76163945|FG002|COMPLETED|Overall Study||126||
60048228|NCT01640951|76163946|FG003|COMPLETED|Overall Study||10||
60048229|NCT01640951|76163947|FG004|COMPLETED|Overall Study||82||
60048230|NCT01640951|76163948|FG005|COMPLETED|Overall Study||13||
60048231|NCT01640951|76163949|FG006|COMPLETED|Overall Study||94||
60048232|NCT01640951|76163950|FG007|COMPLETED|Overall Study||17||
60048233|NCT01640951|76163943|FG000|NOT COMPLETED|Overall Study||46||
60048234|NCT01640951|76163944|FG001|NOT COMPLETED|Overall Study||15||
60048235|NCT01640951|76163945|FG002|NOT COMPLETED|Overall Study||42||
60048236|NCT01640951|76163946|FG003|NOT COMPLETED|Overall Study||45||
60048237|NCT01640951|76163947|FG004|NOT COMPLETED|Overall Study||13||
60048238|NCT01640951|76163948|FG005|NOT COMPLETED|Overall Study||47||
60048239|NCT01640951|76163949|FG006|NOT COMPLETED|Overall Study||18||
60048240|NCT01640951|76163950|FG007|NOT COMPLETED|Overall Study||16||
60048241|NCT02228096|76163972|FG000|STARTED|Overall Study||75||
60048242|NCT02228096|76163972|FG000|Enrolled Into Long-term f/u Protocol|Overall Study||31||
60048243|NCT02228096|76163972|FG000|Enrolled But Not Infused|Overall Study||11|Enrolled means all eligibility criteria were met & apheresis was accepted by manufacturing facility|
60048244|NCT02228096|76163972|FG000|Enrolled and Infused|Overall Study||64||
60048245|NCT02228096|76163972|FG000|COMPLETED|Overall Study|Completed = study follow-up completed|4||
60048246|NCT02228096|76163972|FG000|NOT COMPLETED|Overall Study||71||
60048247|NCT01640873|76163992|FG000|STARTED|Overall Study||22||
59512645|NCT00898937|75605961|FG002|NOT COMPLETED|Overall Study||0||
59512646|NCT02785432|75605971|FG000|STARTED|Overall Study||4||
59512647|NCT02785432|75605972|FG001|STARTED|Overall Study||7||
59512648|NCT02785432|75605971|FG000|COMPLETED|Overall Study||4||
59512649|NCT02785432|75605972|FG001|COMPLETED|Overall Study||7||
59512650|NCT02785432|75605971|FG000|NOT COMPLETED|Overall Study||0||
60048248|NCT01640873|76163993|FG001|STARTED|Overall Study||11||
59512651|NCT02785432|75605972|FG001|NOT COMPLETED|Overall Study||0||
59512652|NCT02786134|75605980|FG000|STARTED|Overall Study||25||
59512653|NCT02786134|75605981|FG001|STARTED|Overall Study||25||
59512654|NCT02786134|75605980|FG000|COMPLETED|Overall Study||25||
60048249|NCT01640873|76163992|FG000|COMPLETED|Overall Study||20||
60048250|NCT01640873|76163993|FG001|COMPLETED|Overall Study||10||
60048251|NCT01640873|76163992|FG000|NOT COMPLETED|Overall Study||2||
60048252|NCT01640873|76163993|FG001|NOT COMPLETED|Overall Study||1||
60048253|NCT01683994|76164004|FG000|STARTED|Overall Study||4||
59512655|NCT02786134|75605981|FG001|COMPLETED|Overall Study||25||
60048254|NCT01683994|76164005|FG001|STARTED|Overall Study||8||
60048255|NCT01683994|76164006|FG002|STARTED|Overall Study||7||
60048256|NCT01683994|76164007|FG003|STARTED|Overall Study||13||
60048257|NCT01683994|76164008|FG004|STARTED|Overall Study||13||
60048258|NCT01683994|76164004|FG000|# of Patients Who Received Treatment|Overall Study||4||
60048259|NCT01683994|76164005|FG001|# of Patients Who Received Treatment|Overall Study||8||
60048260|NCT01683994|76164006|FG002|# of Patients Who Received Treatment|Overall Study||7||
60048261|NCT01683994|76164007|FG003|# of Patients Who Received Treatment|Overall Study||12||
60048262|NCT01683994|76164008|FG004|# of Patients Who Received Treatment|Overall Study||13||
60048263|NCT01683994|76164004|FG000|COMPLETED|Overall Study||3||
60048264|NCT01683994|76164005|FG001|COMPLETED|Overall Study||8||
60048265|NCT01683994|76164006|FG002|COMPLETED|Overall Study||7||
60048266|NCT01683994|76164007|FG003|COMPLETED|Overall Study||10||
60048267|NCT01683994|76164008|FG004|COMPLETED|Overall Study||12||
60048268|NCT01683994|76164004|FG000|NOT COMPLETED|Overall Study||1||
60048269|NCT01683994|76164005|FG001|NOT COMPLETED|Overall Study||0||
60048270|NCT01683994|76164006|FG002|NOT COMPLETED|Overall Study||0||
60048271|NCT01683994|76164007|FG003|NOT COMPLETED|Overall Study||3||
60048272|NCT01683994|76164008|FG004|NOT COMPLETED|Overall Study||1||
60048273|NCT02247440|76164026|FG000|STARTED|Overall Study||18||
60048274|NCT02247440|76164026|FG000|COMPLETED|Overall Study||14||
60048275|NCT02247440|76164026|FG000|NOT COMPLETED|Overall Study||4||
60048276|NCT01683838|76164032|FG000|STARTED|Overall Study||104||
60048277|NCT01683838|76164033|FG001|STARTED|Overall Study||100||
60048278|NCT01683838|76164032|FG000|Intent to Treat (ITT) Population|Overall Study||103||
60048279|NCT01683838|76164033|FG001|Intent to Treat (ITT) Population|Overall Study||100||
60048280|NCT01683838|76164032|FG000|Safety Population|Overall Study||103||
60048281|NCT01683838|76164033|FG001|Safety Population|Overall Study||100||
60048282|NCT01683838|76164032|FG000|Efficacy Population|Overall Study||89||
60048283|NCT01683838|76164033|FG001|Efficacy Population|Overall Study||93||
60048284|NCT01683838|76164032|FG000|COMPLETED|Overall Study||78||
60048285|NCT01683838|76164033|FG001|COMPLETED|Overall Study||88||
60048286|NCT01683838|76164032|FG000|NOT COMPLETED|Overall Study||26||
60048287|NCT01683838|76164033|FG001|NOT COMPLETED|Overall Study||12||
60048288|NCT01683604|76164039|FG000|STARTED|Overall Study||37||
60048289|NCT01683604|76164039|FG000|COMPLETED|Overall Study||32||
60048290|NCT01683604|76164039|FG000|NOT COMPLETED|Overall Study||5||
60048291|NCT02196038|76164050|FG000|STARTED|Overall Study||174||
60048292|NCT02196038|76164051|FG001|STARTED|Overall Study||175||
60048293|NCT02196038|76164050|FG000|COMPLETED|Overall Study||157||
60048294|NCT02196038|76164051|FG001|COMPLETED|Overall Study||153||
60048295|NCT02196038|76164050|FG000|NOT COMPLETED|Overall Study||17||
60048296|NCT02196038|76164051|FG001|NOT COMPLETED|Overall Study||22||
60048297|NCT02141659|76164063|FG000|STARTED|Overall Study||3||
60048298|NCT02141659|76164064|FG001|STARTED|Overall Study||4||
60048299|NCT02141659|76164065|FG002|STARTED|Overall Study||3||
60048300|NCT02141659|76164066|FG003|STARTED|Overall Study||3||
60048301|NCT02141659|76164067|FG004|STARTED|Overall Study||15||
60048302|NCT02141659|76164068|FG005|STARTED|Overall Study||15||
60048303|NCT02141659|76164063|FG000|COMPLETED|Overall Study||3||
60048304|NCT02141659|76164064|FG001|COMPLETED|Overall Study||3||
60048305|NCT02141659|76164065|FG002|COMPLETED|Overall Study||3||
60048306|NCT02141659|76164066|FG003|COMPLETED|Overall Study||3||
60048307|NCT02141659|76164067|FG004|COMPLETED|Overall Study||13||
60048308|NCT02141659|76164068|FG005|COMPLETED|Overall Study||13||
60048309|NCT02141659|76164063|FG000|NOT COMPLETED|Overall Study||0||
60048310|NCT02141659|76164064|FG001|NOT COMPLETED|Overall Study||1||
60048311|NCT02141659|76164065|FG002|NOT COMPLETED|Overall Study||0||
59512656|NCT02786134|75605980|FG000|NOT COMPLETED|Overall Study||0||
60048312|NCT02141659|76164066|FG003|NOT COMPLETED|Overall Study||0||
60048313|NCT02141659|76164067|FG004|NOT COMPLETED|Overall Study||2||
60048314|NCT02141659|76164068|FG005|NOT COMPLETED|Overall Study||2||
60048315|NCT01640249|76164089|FG000|STARTED|Period 1||3||
60048316|NCT01640249|76164090|FG001|STARTED|Period 1||2||
60048317|NCT01640249|76164091|FG002|STARTED|Period 1||2||
60048318|NCT01640249|76164092|FG003|STARTED|Period 1||2||
60048319|NCT01640249|76164093|FG004|STARTED|Period 1||2||
60048320|NCT01640249|76164094|FG005|STARTED|Period 1||5||
60048321|NCT01640249|76164095|FG006|STARTED|Period 1||2||
60048322|NCT01640249|76164089|FG000|Received at Least 1 Dose of Study Drug|Period 1||3||
60048323|NCT01640249|76164090|FG001|Received at Least 1 Dose of Study Drug|Period 1||2||
60048324|NCT01640249|76164091|FG002|Received at Least 1 Dose of Study Drug|Period 1||2||
60048325|NCT01640249|76164092|FG003|Received at Least 1 Dose of Study Drug|Period 1||2||
60048326|NCT01640249|76164093|FG004|Received at Least 1 Dose of Study Drug|Period 1||2||
60048327|NCT01640249|76164094|FG005|Received at Least 1 Dose of Study Drug|Period 1||5||
60067845|NCT01617967|76183033|FG004|NOT COMPLETED|Overall Study||0||
59512657|NCT02786134|75605981|FG001|NOT COMPLETED|Overall Study||0||
59512658|NCT02903446|75605989|FG000|STARTED|Overall Study||10||
59512659|NCT02903446|75605990|FG001|STARTED|Overall Study||10||
59512660|NCT02903446|75605989|FG000|COMPLETED|Overall Study||10||
59512661|NCT02903446|75605990|FG001|COMPLETED|Overall Study||10||
59512662|NCT02903446|75605989|FG000|NOT COMPLETED|Overall Study||0||
59512663|NCT02903446|75605990|FG001|NOT COMPLETED|Overall Study||0||
59512664|NCT02903836|75605999|FG000|STARTED|Overall Study||74||
59512665|NCT02903836|75606000|FG001|STARTED|Overall Study||73||
59512666|NCT02903836|75606001|FG002|STARTED|Overall Study||77||
59512667|NCT02903836|75605999|FG000|COMPLETED|Overall Study||71||
59512668|NCT02903836|75606000|FG001|COMPLETED|Overall Study||69||
60048328|NCT01640249|76164095|FG006|Received at Least 1 Dose of Study Drug|Period 1||2||
60048329|NCT01640249|76164089|FG000|COMPLETED|Period 1||2||
60048330|NCT01640249|76164090|FG001|COMPLETED|Period 1||2||
60048331|NCT01640249|76164091|FG002|COMPLETED|Period 1||2||
60048332|NCT01640249|76164092|FG003|COMPLETED|Period 1||2||
60048333|NCT01640249|76164093|FG004|COMPLETED|Period 1||2||
60048334|NCT01640249|76164094|FG005|COMPLETED|Period 1||4||
60048335|NCT01640249|76164095|FG006|COMPLETED|Period 1||2||
60048336|NCT01640249|76164089|FG000|NOT COMPLETED|Period 1||1||
60048337|NCT01640249|76164090|FG001|NOT COMPLETED|Period 1||0||
60048338|NCT01640249|76164091|FG002|NOT COMPLETED|Period 1||0||
60048339|NCT01640249|76164092|FG003|NOT COMPLETED|Period 1||0||
60048340|NCT01640249|76164093|FG004|NOT COMPLETED|Period 1||0||
60048341|NCT01640249|76164094|FG005|NOT COMPLETED|Period 1||1||
60048342|NCT01640249|76164095|FG006|NOT COMPLETED|Period 1||0||
59512669|NCT02903836|75606001|FG002|COMPLETED|Overall Study||73||
59512670|NCT02903836|75605999|FG000|NOT COMPLETED|Overall Study||3||
59512671|NCT02903836|75606000|FG001|NOT COMPLETED|Overall Study||4||
59512672|NCT02903836|75606001|FG002|NOT COMPLETED|Overall Study||4||
59512673|NCT00014911|75606009|FG000|STARTED|Overall Study||36||
59920281|NCT03874234|76040419|FG008|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 2 (Day1)||0||
60048343|NCT01640249|76164089|FG000|STARTED|Period 2||2||
60048344|NCT01640249|76164090|FG001|STARTED|Period 2||2||
60048345|NCT01640249|76164091|FG002|STARTED|Period 2||2||
60048346|NCT01640249|76164092|FG003|STARTED|Period 2||2||
60048347|NCT01640249|76164093|FG004|STARTED|Period 2||2||
60048348|NCT01640249|76164094|FG005|STARTED|Period 2||4||
60048349|NCT01640249|76164095|FG006|STARTED|Period 2||2||
60048350|NCT01640249|76164089|FG000|COMPLETED|Period 2||2||
60048351|NCT01640249|76164090|FG001|COMPLETED|Period 2||2||
60048352|NCT01640249|76164091|FG002|COMPLETED|Period 2||2||
60048353|NCT01640249|76164092|FG003|COMPLETED|Period 2||2||
60048354|NCT01640249|76164093|FG004|COMPLETED|Period 2||2||
60048355|NCT01640249|76164094|FG005|COMPLETED|Period 2||4||
60048356|NCT01640249|76164095|FG006|COMPLETED|Period 2||2||
60048357|NCT01640249|76164089|FG000|NOT COMPLETED|Period 2||0||
60048358|NCT01640249|76164090|FG001|NOT COMPLETED|Period 2||0||
60048359|NCT01640249|76164091|FG002|NOT COMPLETED|Period 2||0||
60048360|NCT01640249|76164092|FG003|NOT COMPLETED|Period 2||0||
60048361|NCT01640249|76164093|FG004|NOT COMPLETED|Period 2||0||
60048362|NCT01640249|76164094|FG005|NOT COMPLETED|Period 2||0||
60048363|NCT01640249|76164095|FG006|NOT COMPLETED|Period 2||0||
60048364|NCT01640249|76164089|FG000|STARTED|Period 3||2||
60048365|NCT01640249|76164090|FG001|STARTED|Period 3||2||
59512674|NCT00014911|75606009|FG000|COMPLETED|Overall Study|One subject experienced pneumonia, myocardial infarction, and acute renal failure|25||
59512675|NCT00014911|75606009|FG000|NOT COMPLETED|Overall Study||11||
59512676|NCT00899717|75606015|FG000|STARTED|Overall Study||10||
59512677|NCT00899717|75606016|FG001|STARTED|Overall Study||11||
59512678|NCT00899717|75606015|FG000|COMPLETED|Overall Study||10||
59512679|NCT00899717|75606016|FG001|COMPLETED|Overall Study||11||
59512680|NCT00899717|75606015|FG000|NOT COMPLETED|Overall Study||0||
59512681|NCT00899717|75606016|FG001|NOT COMPLETED|Overall Study||0||
59920282|NCT03874234|76040420|FG009|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 2 (Day1)||0||
59920283|NCT03874234|76040421|FG010|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 2 (Day1)||0||
59920284|NCT03874234|76040422|FG011|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 2 (Day1)||0||
59920285|NCT03874234|76040423|FG012|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 2 (Day1)||0||
59920286|NCT03874234|76040411|FG000|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||1||
59920287|NCT03874234|76040412|FG001|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||2||
59920288|NCT03874234|76040413|FG002|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||2||
59920289|NCT03874234|76040414|FG003|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||2||
59920290|NCT03874234|76040415|FG004|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
59920291|NCT03874234|76040416|FG005|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
59920292|NCT03874234|76040417|FG006|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
59920293|NCT03874234|76040418|FG007|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
59920294|NCT03874234|76040419|FG008|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
59920295|NCT03874234|76040420|FG009|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
59920296|NCT03874234|76040421|FG010|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
59920297|NCT03874234|76040422|FG011|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
59920298|NCT03874234|76040423|FG012|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
59920299|NCT03874234|76040411|FG000|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||1||
59920300|NCT03874234|76040412|FG001|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
59920301|NCT03874234|76040413|FG002|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
59920302|NCT03874234|76040414|FG003|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
59920303|NCT03874234|76040415|FG004|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
59920304|NCT03874234|76040416|FG005|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
59920305|NCT03874234|76040417|FG006|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
59920306|NCT03874234|76040418|FG007|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
59920307|NCT03874234|76040419|FG008|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
59612588|NCT01746732|75723590|FG000|STARTED|Period 2||0||
59612589|NCT01746732|75723591|FG001|STARTED|Period 2||10||
59920308|NCT03874234|76040420|FG009|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
59920309|NCT03874234|76040421|FG010|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
59920310|NCT03874234|76040422|FG011|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
59512682|NCT02156167|75606028|FG000|STARTED|Overall Study||15||
59512683|NCT02156167|75606028|FG000|COMPLETED|Overall Study||15||
59512684|NCT02156167|75606028|FG000|NOT COMPLETED|Overall Study||0||
59920311|NCT03874234|76040423|FG012|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
59920312|NCT03874234|76040411|FG000|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day10)||1||
59920313|NCT03874234|76040412|FG001|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day10)||2||
59920314|NCT03874234|76040413|FG002|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day10)||2||
59920315|NCT03874234|76040414|FG003|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day10)||2||
59920316|NCT03874234|76040415|FG004|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day10)||0||
59920317|NCT03874234|76040416|FG005|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day10)||0||
59920318|NCT03874234|76040417|FG006|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day10)||0||
59920319|NCT03874234|76040418|FG007|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day10)||0||
59920320|NCT03874234|76040419|FG008|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day10)||0||
59512685|NCT00895193|75606036|FG000|STARTED|Overall Study||25||
59512686|NCT00895193|75606037|FG001|STARTED|Overall Study||25||
59512687|NCT00895193|75606038|FG002|STARTED|Overall Study||25||
59512688|NCT00895193|75606039|FG003|STARTED|Overall Study||25||
59512689|NCT00895193|75606036|FG000|COMPLETED|Overall Study||25||
59612590|NCT01746732|75723592|FG002|STARTED|Period 2||11||
59612591|NCT01746732|75723590|FG000|COMPLETED|Period 2||0||
59612592|NCT01746732|75723591|FG001|COMPLETED|Period 2||10||
59612593|NCT01746732|75723592|FG002|COMPLETED|Period 2||7||
59612594|NCT01746732|75723590|FG000|NOT COMPLETED|Period 2||0||
59612595|NCT01746732|75723591|FG001|NOT COMPLETED|Period 2||0||
59512690|NCT00895193|75606037|FG001|COMPLETED|Overall Study||25||
59612596|NCT01746732|75723592|FG002|NOT COMPLETED|Period 2||4||
59920321|NCT03874234|76040420|FG009|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day10)||0||
59920322|NCT03874234|76040421|FG010|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day10)||0||
59512691|NCT00895193|75606038|FG002|COMPLETED|Overall Study||25||
59512692|NCT00895193|75606039|FG003|COMPLETED|Overall Study||25||
59512693|NCT00895193|75606036|FG000|NOT COMPLETED|Overall Study||0||
59512694|NCT00895193|75606037|FG001|NOT COMPLETED|Overall Study||0||
59512695|NCT00895193|75606038|FG002|NOT COMPLETED|Overall Study||0||
59512696|NCT00895193|75606039|FG003|NOT COMPLETED|Overall Study||0||
59512697|NCT00906425|75606051|FG000|STARTED|Overall Study||73||
59512698|NCT00906425|75606052|FG001|STARTED|Overall Study||72||
59512699|NCT00906425|75606051|FG000|6 Months|Overall Study|ITT population|69||
59512700|NCT00906425|75606052|FG001|6 Months|Overall Study|ITT population|64||
59512701|NCT00906425|75606051|FG000|1 Year|Overall Study|ITT population|67||
59512702|NCT00906425|75606052|FG001|1 Year|Overall Study|ITT population|60||
59512703|NCT00906425|75606051|FG000|2 Year|Overall Study|ITT population|62||
59512704|NCT00906425|75606052|FG001|2 Year|Overall Study|ITT population|58||
59512705|NCT00906425|75606051|FG000|COMPLETED|Overall Study|Clinical Trial expected to be completed in 2013|0||
59512706|NCT00906425|75606052|FG001|COMPLETED|Overall Study|Clinical Trial expected to be completed in 2013|0||
59512707|NCT00906425|75606051|FG000|NOT COMPLETED|Overall Study||73||
59512708|NCT00906425|75606052|FG001|NOT COMPLETED|Overall Study||72||
59512709|NCT00901199|75606058|FG000|STARTED|Overall Study||22||
59512710|NCT00901199|75606058|FG000|COMPLETED|Overall Study||18||
59612597|NCT01720524|75723602|FG000|STARTED|Part A||29||
59920323|NCT03874234|76040422|FG011|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day10)||0||
59612598|NCT01720524|75723603|FG001|STARTED|Part A||30||
59512711|NCT00901199|75606058|FG000|NOT COMPLETED|Overall Study||4||
59512712|NCT00906503|75606062|FG000|STARTED|Overall Study||9||
59512713|NCT00906503|75606062|FG000|COMPLETED|Overall Study||9||
59512714|NCT00906503|75606062|FG000|NOT COMPLETED|Overall Study||0||
59512715|NCT00920647|75606070|FG000|STARTED|Overall Study||4||
59512716|NCT00920647|75606071|FG001|STARTED|Overall Study||4||
59512717|NCT00920647|75606072|FG002|STARTED|Overall Study||4||
59512718|NCT00920647|75606073|FG003|STARTED|Overall Study||4||
59612599|NCT01720524|75723602|FG000|COMPLETED|Part A||22||
59612600|NCT01720524|75723603|FG001|COMPLETED|Part A||18||
59612601|NCT01720524|75723602|FG000|NOT COMPLETED|Part A||7||
59612602|NCT01720524|75723603|FG001|NOT COMPLETED|Part A||12||
59612603|NCT01720524|75723602|FG000|STARTED|Part B|Participants who did not complete Part A could also participate in Part B.|27||
59612604|NCT01720524|75723603|FG001|STARTED|Part B|Participants who did not complete Part A could also participate in Part B.|26||
59612605|NCT01720524|75723602|FG000|COMPLETED|Part B||22||
59612606|NCT01720524|75723603|FG001|COMPLETED|Part B||17||
59512719|NCT00920647|75606070|FG000|COMPLETED|Overall Study||4||
59512720|NCT00920647|75606071|FG001|COMPLETED|Overall Study||4||
59512721|NCT00920647|75606072|FG002|COMPLETED|Overall Study||4||
59512722|NCT00920647|75606073|FG003|COMPLETED|Overall Study||4||
59512723|NCT00920647|75606070|FG000|NOT COMPLETED|Overall Study||0||
59512724|NCT00920647|75606071|FG001|NOT COMPLETED|Overall Study||0||
59512725|NCT00920647|75606072|FG002|NOT COMPLETED|Overall Study||0||
59612607|NCT01720524|75723602|FG000|NOT COMPLETED|Part B||5||
59612608|NCT01720524|75723603|FG001|NOT COMPLETED|Part B||9||
59612609|NCT01720446|75723615|FG000|STARTED|Overall Study||826||
59760105|NCT02511132|75879682|FG001|COMPLETED|Overall Study||7||
59920324|NCT03874234|76040423|FG012|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day10)||0||
59920325|NCT03874234|76040411|FG000|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day10)||1||
59920326|NCT03874234|76040412|FG001|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day10)||2||
59920327|NCT03874234|76040413|FG002|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day10)||2||
59920328|NCT03874234|76040414|FG003|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day10)||2||
59920329|NCT03874234|76040415|FG004|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day10)||0||
59920330|NCT03874234|76040416|FG005|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day10)||0||
59920331|NCT03874234|76040417|FG006|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day10)||0||
59920332|NCT03874234|76040418|FG007|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day10)||0||
59920333|NCT03874234|76040419|FG008|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day10)||0||
59920334|NCT03874234|76040420|FG009|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day10)||0||
59920335|NCT03874234|76040421|FG010|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day10)||0||
59920336|NCT03874234|76040422|FG011|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day10)||0||
59920337|NCT03874234|76040423|FG012|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day10)||0||
59920338|NCT03874234|76040411|FG000|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day10)||0||
59920339|NCT03874234|76040412|FG001|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day10)||0||
59920340|NCT03874234|76040413|FG002|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day10)||0||
59920341|NCT03874234|76040414|FG003|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day10)||0||
59920342|NCT03874234|76040415|FG004|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day10)||0||
59920343|NCT03874234|76040416|FG005|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day10)||0||
59920344|NCT03874234|76040417|FG006|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day10)||0||
59920345|NCT03874234|76040418|FG007|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day10)||0||
59920346|NCT03874234|76040419|FG008|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day10)||0||
59920347|NCT03874234|76040420|FG009|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day10)||0||
59920348|NCT03874234|76040421|FG010|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day10)||0||
59920349|NCT03874234|76040422|FG011|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day10)||0||
59920350|NCT03874234|76040423|FG012|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day10)||0||
59920351|NCT03874234|76040411|FG000|STARTED|Part A: Cohort 1-Period 3 (Day1)|New participant enrolled and dosed.|2||
59920352|NCT03874234|76040412|FG001|STARTED|Part A: Cohort 1-Period 3 (Day1)||2||
59920353|NCT03874234|76040413|FG002|STARTED|Part A: Cohort 1-Period 3 (Day1)||2||
59920354|NCT03874234|76040414|FG003|STARTED|Part A: Cohort 1-Period 3 (Day1)||2||
59920355|NCT03874234|76040415|FG004|STARTED|Part A: Cohort 1-Period 3 (Day1)||0||
59920356|NCT03874234|76040416|FG005|STARTED|Part A: Cohort 1-Period 3 (Day1)||0||
59920357|NCT03874234|76040417|FG006|STARTED|Part A: Cohort 1-Period 3 (Day1)||0||
60048366|NCT01640249|76164091|FG002|STARTED|Period 3||2||
59512726|NCT00920647|75606073|FG003|NOT COMPLETED|Overall Study||0||
59512727|NCT00909155|75606096|FG000|STARTED|Overall Study||15||
59512728|NCT00909155|75606097|FG001|STARTED|Overall Study||14||
59612610|NCT01720446|75723616|FG001|STARTED|Overall Study||822||
59612611|NCT01720446|75723617|FG002|STARTED|Overall Study||824||
59612612|NCT01720446|75723618|FG003|STARTED|Overall Study||825||
59612613|NCT01720446|75723615|FG000|Premature Treatment Discontinuers|Overall Study|Premature treatment discontinuers were allowed to continue participation in the trial.|164||
59760106|NCT02511132|75879683|FG002|COMPLETED|Overall Study||9||
59760107|NCT02511132|75879681|FG000|NOT COMPLETED|Overall Study||0||
59760108|NCT02511132|75879682|FG001|NOT COMPLETED|Overall Study||1||
59920358|NCT03874234|76040418|FG007|STARTED|Part A: Cohort 1-Period 3 (Day1)||0||
59920359|NCT03874234|76040419|FG008|STARTED|Part A: Cohort 1-Period 3 (Day1)||0||
59920360|NCT03874234|76040420|FG009|STARTED|Part A: Cohort 1-Period 3 (Day1)||0||
59920361|NCT03874234|76040421|FG010|STARTED|Part A: Cohort 1-Period 3 (Day1)||0||
59920362|NCT03874234|76040422|FG011|STARTED|Part A: Cohort 1-Period 3 (Day1)||0||
59920363|NCT03874234|76040423|FG012|STARTED|Part A: Cohort 1-Period 3 (Day1)||0||
59920364|NCT03874234|76040411|FG000|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 3 (Day1)||1||
59951426|NCT01251965|76070418|FG000|COMPLETED|Overall Study||3||
59512729|NCT00909155|75606098|FG002|STARTED|Overall Study||21||
59512730|NCT00909155|75606096|FG000|COMPLETED|Overall Study||12||
60048367|NCT01640249|76164092|FG003|STARTED|Period 3||2||
60048368|NCT01640249|76164093|FG004|STARTED|Period 3|Cohort 2 was planned for only 2 dosing periods.|0||
60048369|NCT01640249|76164094|FG005|STARTED|Period 3|Cohort 2 was planned for only 2 dosing periods.|0||
60048370|NCT01640249|76164095|FG006|STARTED|Period 3|Cohort 2 was planned for only 2 dosing periods.|0||
60048371|NCT01640249|76164089|FG000|COMPLETED|Period 3||2||
60048372|NCT01640249|76164090|FG001|COMPLETED|Period 3||2||
60048373|NCT01640249|76164091|FG002|COMPLETED|Period 3||2||
60048374|NCT01640249|76164092|FG003|COMPLETED|Period 3||1||
60048375|NCT01640249|76164093|FG004|COMPLETED|Period 3||0||
60048376|NCT01640249|76164094|FG005|COMPLETED|Period 3||0||
60048377|NCT01640249|76164095|FG006|COMPLETED|Period 3||0||
60048378|NCT01640249|76164089|FG000|NOT COMPLETED|Period 3||0||
60048379|NCT01640249|76164090|FG001|NOT COMPLETED|Period 3||0||
60048380|NCT01640249|76164091|FG002|NOT COMPLETED|Period 3||0||
60048381|NCT01640249|76164092|FG003|NOT COMPLETED|Period 3||1||
60048382|NCT01640249|76164093|FG004|NOT COMPLETED|Period 3||0||
60048383|NCT01640249|76164094|FG005|NOT COMPLETED|Period 3||0||
60048384|NCT01640249|76164095|FG006|NOT COMPLETED|Period 3||0||
60048385|NCT02121301|76164117|FG000|STARTED|Overall Study||30||
60048386|NCT02121301|76164118|FG001|STARTED|Overall Study||30||
60048387|NCT02121301|76164119|FG002|STARTED|Overall Study||31||
60048388|NCT02121301|76164117|FG000|COMPLETED|Overall Study||29||
60048389|NCT02121301|76164118|FG001|COMPLETED|Overall Study||26||
60048390|NCT02121301|76164119|FG002|COMPLETED|Overall Study||30||
60048391|NCT02121301|76164117|FG000|NOT COMPLETED|Overall Study||1||
60048392|NCT02121301|76164118|FG001|NOT COMPLETED|Overall Study||4||
60048393|NCT02121301|76164119|FG002|NOT COMPLETED|Overall Study||1||
60048394|NCT02227862|76164129|FG000|STARTED|Overall Study||280||
60048395|NCT02227862|76164130|FG001|STARTED|Overall Study||278||
60048396|NCT02227862|76164129|FG000|Week 24|Overall Study||269||
60048397|NCT02227862|76164130|FG001|Week 24|Overall Study||263||
59512731|NCT00909155|75606097|FG001|COMPLETED|Overall Study||9||
59512732|NCT00909155|75606098|FG002|COMPLETED|Overall Study||14||
59512733|NCT00909155|75606096|FG000|NOT COMPLETED|Overall Study||3||
59512734|NCT00909155|75606097|FG001|NOT COMPLETED|Overall Study||5||
59512735|NCT00909155|75606098|FG002|NOT COMPLETED|Overall Study||7||
59512736|NCT00926185|75606113|FG000|STARTED|Overall Study||57||
60048398|NCT02227862|76164129|FG000|COMPLETED|Overall Study||261||
60048399|NCT02227862|76164130|FG001|COMPLETED|Overall Study||256||
60048400|NCT02227862|76164129|FG000|NOT COMPLETED|Overall Study||19||
60048401|NCT02227862|76164130|FG001|NOT COMPLETED|Overall Study||22||
60048402|NCT02120833|76164138|FG000|STARTED|Overall Study||39||
60048403|NCT02120833|76164139|FG001|STARTED|Overall Study||12||
59612614|NCT01720446|75723616|FG001|Premature Treatment Discontinuers|Overall Study|Premature treatment discontinuers were allowed to continue participation in the trial.|186||
60048404|NCT02120833|76164138|FG000|COMPLETED|Overall Study||35||
60048405|NCT02120833|76164139|FG001|COMPLETED|Overall Study||11||
60048406|NCT02120833|76164138|FG000|NOT COMPLETED|Overall Study||4||
60048407|NCT02120833|76164139|FG001|NOT COMPLETED|Overall Study||1||
59512737|NCT00926185|75606114|FG001|STARTED|Overall Study||57||
59512738|NCT00926185|75606115|FG002|STARTED|Overall Study||58||
59512739|NCT00926185|75606116|FG003|STARTED|Overall Study||58||
59512740|NCT00926185|75606113|FG000|COMPLETED|Overall Study||54||
59512741|NCT00926185|75606114|FG001|COMPLETED|Overall Study||51||
59512742|NCT00926185|75606115|FG002|COMPLETED|Overall Study||48||
59512743|NCT00926185|75606116|FG003|COMPLETED|Overall Study||48||
59512744|NCT00926185|75606113|FG000|NOT COMPLETED|Overall Study||3||
59512745|NCT00926185|75606114|FG001|NOT COMPLETED|Overall Study||6||
59512746|NCT00926185|75606115|FG002|NOT COMPLETED|Overall Study||10||
59512747|NCT00926185|75606116|FG003|NOT COMPLETED|Overall Study||10||
59512748|NCT00921895|75606126|FG000|STARTED|Overall Study||128||
59512749|NCT00921895|75606126|FG000|COMPLETED|Overall Study||128||
59512750|NCT00921895|75606126|FG000|NOT COMPLETED|Overall Study||0||
60048408|NCT02170207|76164145|FG000|STARTED|Overall Study||63||
60048409|NCT02170207|76164145|FG000|COMPLETED|Overall Study||58||
60048410|NCT02170207|76164145|FG000|NOT COMPLETED|Overall Study||5||
60048411|NCT02227784|76164153|FG000|STARTED|Double-Blind Phase||123||
60048412|NCT02227784|76164154|FG001|STARTED|Double-Blind Phase||54||
60048413|NCT02227784|76164155|FG002|STARTED|Double-Blind Phase||62||
60048414|NCT02227784|76164156|FG003|STARTED|Double-Blind Phase||127||
60048415|NCT02227784|76164157|FG004|STARTED|Double-Blind Phase||0||
60048416|NCT02227784|76164153|FG000|COMPLETED|Double-Blind Phase||83||
60048417|NCT02227784|76164154|FG001|COMPLETED|Double-Blind Phase||36||
60048418|NCT02227784|76164155|FG002|COMPLETED|Double-Blind Phase||41||
60048419|NCT02227784|76164156|FG003|COMPLETED|Double-Blind Phase||88||
59512751|NCT00920023|75606131|FG000|STARTED|Overall Study||15||
59512752|NCT00920023|75606131|FG000|COMPLETED|Overall Study||15||
59512753|NCT00920023|75606131|FG000|NOT COMPLETED|Overall Study||0||
59512754|NCT03212963|75606135|FG000|STARTED|Overall Study||16||
59512755|NCT03212963|75606135|FG000|COMPLETED|Overall Study||16||
60048420|NCT02227784|76164157|FG004|COMPLETED|Double-Blind Phase||0||
60048421|NCT02227784|76164153|FG000|NOT COMPLETED|Double-Blind Phase||40||
60048422|NCT02227784|76164154|FG001|NOT COMPLETED|Double-Blind Phase||18||
60048423|NCT02227784|76164155|FG002|NOT COMPLETED|Double-Blind Phase||21||
59920365|NCT03874234|76040412|FG001|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 3 (Day1)||0||
60048424|NCT02227784|76164156|FG003|NOT COMPLETED|Double-Blind Phase||39||
60048425|NCT02227784|76164157|FG004|NOT COMPLETED|Double-Blind Phase||0||
60048426|NCT02227784|76164153|FG000|STARTED|Open-Label Extension Phase (OLE)|After the double-blind treatment phase, participants entered an OLE phase.|0||
60048427|NCT02227784|76164154|FG001|STARTED|Open-Label Extension Phase (OLE)|After the double-blind treatment phase, participants entered an OLE phase.|0||
60048428|NCT02227784|76164155|FG002|STARTED|Open-Label Extension Phase (OLE)|After the double-blind treatment phase, participants entered an OLE phase.|0||
60048429|NCT02227784|76164156|FG003|STARTED|Open-Label Extension Phase (OLE)|After the double-blind treatment phase, participants entered an OLE phase.|0||
60048430|NCT02227784|76164157|FG004|STARTED|Open-Label Extension Phase (OLE)|After the double-blind treatment phase, participants entered an OLE phase.|248||
60048431|NCT02227784|76164153|FG000|Received at Least 1 Dose of Study Drug|Open-Label Extension Phase (OLE)||0||
60048432|NCT02227784|76164154|FG001|Received at Least 1 Dose of Study Drug|Open-Label Extension Phase (OLE)||0||
60048433|NCT02227784|76164155|FG002|Received at Least 1 Dose of Study Drug|Open-Label Extension Phase (OLE)||0||
60048434|NCT02227784|76164156|FG003|Received at Least 1 Dose of Study Drug|Open-Label Extension Phase (OLE)||0||
60048435|NCT02227784|76164157|FG004|Received at Least 1 Dose of Study Drug|Open-Label Extension Phase (OLE)||247||
60048436|NCT02227784|76164153|FG000|COMPLETED|Open-Label Extension Phase (OLE)||0||
60048437|NCT02227784|76164154|FG001|COMPLETED|Open-Label Extension Phase (OLE)||0||
60048438|NCT02227784|76164155|FG002|COMPLETED|Open-Label Extension Phase (OLE)||0||
60048439|NCT02227784|76164156|FG003|COMPLETED|Open-Label Extension Phase (OLE)||0||
60048440|NCT02227784|76164157|FG004|COMPLETED|Open-Label Extension Phase (OLE)||0||
60048441|NCT02227784|76164153|FG000|NOT COMPLETED|Open-Label Extension Phase (OLE)||0||
60048442|NCT02227784|76164154|FG001|NOT COMPLETED|Open-Label Extension Phase (OLE)||0||
60048443|NCT02227784|76164155|FG002|NOT COMPLETED|Open-Label Extension Phase (OLE)||0||
60048444|NCT02227784|76164156|FG003|NOT COMPLETED|Open-Label Extension Phase (OLE)||0||
60048445|NCT02227784|76164157|FG004|NOT COMPLETED|Open-Label Extension Phase (OLE)||248||
60048446|NCT01565668|76164172|FG000|STARTED|Overall Study||38||
60048447|NCT01565668|76164173|FG001|STARTED|Overall Study||38||
60048448|NCT01565668|76164172|FG000|Completed Treatment Per Protocol|Overall Study||0||
60048449|NCT01565668|76164173|FG001|Completed Treatment Per Protocol|Overall Study||0||
60048450|NCT01565668|76164172|FG000|Started 30-day Follow-up|Overall Study||37||
60048451|NCT01565668|76164173|FG001|Started 30-day Follow-up|Overall Study||37||
59612615|NCT01720446|75723617|FG002|Premature Treatment Discontinuers|Overall Study|Premature treatment discontinuers were allowed to continue participation in the trial.|151||
59612616|NCT01720446|75723618|FG003|Premature Treatment Discontinuers|Overall Study|Premature treatment discontinuers were allowed to continue participation in the trial.|159||
59612617|NCT01720446|75723615|FG000|COMPLETED|Overall Study|Subjects who did not permanently discontinue treatment prematurely.|812||
59612618|NCT01720446|75723616|FG001|COMPLETED|Overall Study|Subjects who did not permanently discontinue treatment prematurely.|811||
59760109|NCT02511132|75879683|FG002|NOT COMPLETED|Overall Study||0||
59920366|NCT03874234|76040413|FG002|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 3 (Day1)||0||
59920367|NCT03874234|76040414|FG003|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 3 (Day1)||0||
59920368|NCT03874234|76040415|FG004|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 3 (Day1)||0||
59920369|NCT03874234|76040416|FG005|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 3 (Day1)||0||
59920370|NCT03874234|76040417|FG006|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 3 (Day1)||0||
59920371|NCT03874234|76040418|FG007|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 3 (Day1)||0||
59920372|NCT03874234|76040419|FG008|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 3 (Day1)||0||
59920373|NCT03874234|76040420|FG009|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 3 (Day1)||0||
60048452|NCT01565668|76164172|FG000|Completed 30-day Follow-up|Overall Study||11||
60048453|NCT01565668|76164173|FG001|Completed 30-day Follow-up|Overall Study||5||
60048454|NCT01565668|76164172|FG000|Started Long-term Follow-up|Overall Study||36||
60048455|NCT01565668|76164173|FG001|Started Long-term Follow-up|Overall Study||33||
60048456|NCT01565668|76164172|FG000|Completed Long-term Follow-up|Overall Study||0||
60048457|NCT01565668|76164173|FG001|Completed Long-term Follow-up|Overall Study||0||
60048458|NCT01565668|76164172|FG000|COMPLETED|Overall Study||0||
60048459|NCT01565668|76164173|FG001|COMPLETED|Overall Study||0||
60048460|NCT01565668|76164172|FG000|NOT COMPLETED|Overall Study||38||
60048461|NCT01565668|76164173|FG001|NOT COMPLETED|Overall Study||38||
60048462|NCT01683058|76164179|FG000|STARTED|Overall Study||74||
60048463|NCT01683058|76164179|FG000|COMPLETED|Overall Study||45||
60048464|NCT01683058|76164179|FG000|NOT COMPLETED|Overall Study||29||
60048465|NCT01626859|76164187|FG000|STARTED|Overall Study||11||
60048466|NCT01626859|76164188|FG001|STARTED|Overall Study||16||
60048467|NCT01626859|76164189|FG002|STARTED|Overall Study||11||
60048468|NCT01626859|76164187|FG000|COMPLETED|Overall Study||9||
60048469|NCT01626859|76164188|FG001|COMPLETED|Overall Study||8||
60048470|NCT01626859|76164189|FG002|COMPLETED|Overall Study||7||
60048471|NCT01626859|76164187|FG000|NOT COMPLETED|Overall Study||2||
60048472|NCT01626859|76164188|FG001|NOT COMPLETED|Overall Study||8||
60048473|NCT01626859|76164189|FG002|NOT COMPLETED|Overall Study||4||
60048474|NCT02193776|76164201|FG000|STARTED|Overall Study||59||
60048475|NCT02193776|76164202|FG001|STARTED|Overall Study||60||
60048476|NCT02193776|76164203|FG002|STARTED|Overall Study||61||
60048477|NCT02193776|76164204|FG003|STARTED|Overall Study||60||
60048478|NCT02193776|76164201|FG000|Completed Day 70 Follow-up|Overall Study||54||
60048479|NCT02193776|76164202|FG001|Completed Day 70 Follow-up|Overall Study||56||
60048480|NCT02193776|76164203|FG002|Completed Day 70 Follow-up|Overall Study||60||
60048481|NCT02193776|76164204|FG003|Completed Day 70 Follow-up|Overall Study||60||
60048482|NCT02193776|76164201|FG000|Completed Day 140 Follow-up|Overall Study||52||
60048483|NCT02193776|76164202|FG001|Completed Day 140 Follow-up|Overall Study||52||
60048484|NCT02193776|76164203|FG002|Completed Day 140 Follow-up|Overall Study||58||
60048485|NCT02193776|76164204|FG003|Completed Day 140 Follow-up|Overall Study||58||
60048486|NCT02193776|76164201|FG000|COMPLETED|Overall Study||51|Completed Treatment|
60048487|NCT02193776|76164202|FG001|COMPLETED|Overall Study||53|Completed Treatment|
60048488|NCT02193776|76164203|FG002|COMPLETED|Overall Study||59|Completed Treatment|
60048489|NCT02193776|76164204|FG003|COMPLETED|Overall Study||58|Completed Treatment|
59512756|NCT03212963|75606135|FG000|NOT COMPLETED|Overall Study||0||
59920374|NCT03874234|76040421|FG010|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 3 (Day1)||0||
59920375|NCT03874234|76040422|FG011|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 3 (Day1)||0||
59920376|NCT03874234|76040423|FG012|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 3 (Day1)||0||
59920377|NCT03874234|76040411|FG000|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||2||
59920378|NCT03874234|76040412|FG001|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||2||
59920379|NCT03874234|76040413|FG002|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||2||
59920380|NCT03874234|76040414|FG003|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||1||
59920381|NCT03874234|76040415|FG004|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
60048490|NCT02193776|76164201|FG000|NOT COMPLETED|Overall Study||8||
60048491|NCT02193776|76164202|FG001|NOT COMPLETED|Overall Study||7||
60048492|NCT02193776|76164203|FG002|NOT COMPLETED|Overall Study||2||
60048493|NCT02193776|76164204|FG003|NOT COMPLETED|Overall Study||2||
60048494|NCT02170064|76164217|FG000|STARTED|Overall Study||15||
60048495|NCT02170064|76164218|FG001|STARTED|Overall Study||9||
60048496|NCT02170064|76164219|FG002|STARTED|Overall Study||11||
60048497|NCT02170064|76164217|FG000|Safety Population (SP)|Overall Study||12||
59760110|NCT00896363|75879695|FG000|STARTED|Overall Study||31||
59512757|NCT00926263|75606141|FG000|STARTED|Overall Study||16||
59512758|NCT00926263|75606142|FG001|STARTED|Overall Study||12||
59760111|NCT00896363|75879696|FG001|STARTED|Overall Study||36||
59920382|NCT03874234|76040416|FG005|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
59920383|NCT03874234|76040417|FG006|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
59920384|NCT03874234|76040418|FG007|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
59920385|NCT03874234|76040419|FG008|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
59920386|NCT03874234|76040420|FG009|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
59920387|NCT03874234|76040421|FG010|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
59920388|NCT03874234|76040422|FG011|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
59920389|NCT03874234|76040423|FG012|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
59920390|NCT03874234|76040411|FG000|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
59920391|NCT03874234|76040412|FG001|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
59920392|NCT03874234|76040413|FG002|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
59920393|NCT03874234|76040414|FG003|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||1||
59920394|NCT03874234|76040415|FG004|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
59920395|NCT03874234|76040416|FG005|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
59920396|NCT03874234|76040417|FG006|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
59920397|NCT03874234|76040418|FG007|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
59920398|NCT03874234|76040419|FG008|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
60048498|NCT02170064|76164218|FG001|Safety Population (SP)|Overall Study||8||
59760112|NCT00896363|75879697|FG002|STARTED|Overall Study||32||
59760113|NCT00896363|75879695|FG000|COMPLETED|Overall Study||25||
60048499|NCT02170064|76164219|FG002|Safety Population (SP)|Overall Study||11||
59512759|NCT00926263|75606141|FG000|COMPLETED|Overall Study||16||
59760114|NCT00896363|75879696|FG001|COMPLETED|Overall Study||25||
59920399|NCT03874234|76040420|FG009|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
59920400|NCT03874234|76040421|FG010|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
59920401|NCT03874234|76040422|FG011|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
59612619|NCT01720446|75723617|FG002|COMPLETED|Overall Study|Subjects who did not permanently discontinue treatment prematurely.|804||
59760115|NCT00896363|75879697|FG002|COMPLETED|Overall Study||24||
59920402|NCT03874234|76040423|FG012|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
59512760|NCT00926263|75606142|FG001|COMPLETED|Overall Study||12||
59512761|NCT00926263|75606141|FG000|NOT COMPLETED|Overall Study||0||
59512762|NCT00926263|75606142|FG001|NOT COMPLETED|Overall Study||0||
59512763|NCT00926497|75606151|FG000|STARTED|Overall Study||60||
59512764|NCT00926497|75606152|FG001|STARTED|Overall Study||61||
59512765|NCT00926497|75606151|FG000|COMPLETED|Overall Study||60||
59512766|NCT00926497|75606152|FG001|COMPLETED|Overall Study||61||
59512767|NCT00926497|75606151|FG000|NOT COMPLETED|Overall Study||0||
59512768|NCT00926497|75606152|FG001|NOT COMPLETED|Overall Study||0||
59920403|NCT03874234|76040411|FG000|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day10)||2||
59920404|NCT03874234|76040412|FG001|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day10)||2||
59920405|NCT03874234|76040413|FG002|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day10)||2||
59920406|NCT03874234|76040414|FG003|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day10)||1||
59920407|NCT03874234|76040415|FG004|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day10)||0||
59920408|NCT03874234|76040416|FG005|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day10)||0||
60048500|NCT02170064|76164217|FG000|Pharmacokinetic Population (PKP)|Overall Study||11||
60048501|NCT02170064|76164218|FG001|Pharmacokinetic Population (PKP)|Overall Study||8||
60048502|NCT02170064|76164219|FG002|Pharmacokinetic Population (PKP)|Overall Study||10||
60048503|NCT02170064|76164217|FG000|Efficacy Population (EP)|Overall Study||11||
60048504|NCT02170064|76164218|FG001|Efficacy Population (EP)|Overall Study||8||
60048505|NCT02170064|76164219|FG002|Efficacy Population (EP)|Overall Study||10||
60048506|NCT02170064|76164217|FG000|COMPLETED|Overall Study||9||
60048507|NCT02170064|76164218|FG001|COMPLETED|Overall Study||7||
60048508|NCT02170064|76164219|FG002|COMPLETED|Overall Study||10||
60048509|NCT02170064|76164217|FG000|NOT COMPLETED|Overall Study||6||
60048510|NCT02170064|76164218|FG001|NOT COMPLETED|Overall Study||2||
60048511|NCT02170064|76164219|FG002|NOT COMPLETED|Overall Study||1||
60048512|NCT02169830|76164230|FG000|STARTED|Diet Intervention (4 Weeks)||0||
60048513|NCT02169830|76164231|FG001|STARTED|Diet Intervention (4 Weeks)||0||
60048514|NCT02169830|76164232|FG002|STARTED|Diet Intervention (4 Weeks)||33||
60048515|NCT02169830|76164230|FG000|COMPLETED|Diet Intervention (4 Weeks)||0||
60048516|NCT02169830|76164231|FG001|COMPLETED|Diet Intervention (4 Weeks)||0||
60048517|NCT02169830|76164232|FG002|COMPLETED|Diet Intervention (4 Weeks)||32||
60048518|NCT02169830|76164230|FG000|NOT COMPLETED|Diet Intervention (4 Weeks)||0||
60048519|NCT02169830|76164231|FG001|NOT COMPLETED|Diet Intervention (4 Weeks)||0||
60048520|NCT02169830|76164232|FG002|NOT COMPLETED|Diet Intervention (4 Weeks)||1||
60048521|NCT02169830|76164230|FG000|STARTED|Second Intervention (8 Weeks)||12||
60048522|NCT02169830|76164231|FG001|STARTED|Second Intervention (8 Weeks)||5||
60048523|NCT02169830|76164232|FG002|STARTED|Second Intervention (8 Weeks)||0||
60048524|NCT02169830|76164230|FG000|COMPLETED|Second Intervention (8 Weeks)||9||
60048525|NCT02169830|76164231|FG001|COMPLETED|Second Intervention (8 Weeks)||0||
60048526|NCT02169830|76164232|FG002|COMPLETED|Second Intervention (8 Weeks)||0||
60048527|NCT02169830|76164230|FG000|NOT COMPLETED|Second Intervention (8 Weeks)||3||
60048528|NCT02169830|76164231|FG001|NOT COMPLETED|Second Intervention (8 Weeks)||5||
60048529|NCT02169830|76164232|FG002|NOT COMPLETED|Second Intervention (8 Weeks)||0||
60048530|NCT02169830|76164230|FG000|STARTED|Third Intervention (8 Weeks)||0||
60048531|NCT02169830|76164231|FG001|STARTED|Third Intervention (8 Weeks)|These four subjects were randomized to Diet first Topiramate second, and Nortriptyline third. No subjects from this group were weaned and moved to Nortriptyline.|4||
60048532|NCT02169830|76164232|FG002|STARTED|Third Intervention (8 Weeks)||0||
60048533|NCT02169830|76164230|FG000|COMPLETED|Third Intervention (8 Weeks)||0||
60048534|NCT02169830|76164231|FG001|COMPLETED|Third Intervention (8 Weeks)||2||
60048535|NCT02169830|76164232|FG002|COMPLETED|Third Intervention (8 Weeks)||0||
60048536|NCT02169830|76164230|FG000|NOT COMPLETED|Third Intervention (8 Weeks)||0||
60048537|NCT02169830|76164231|FG001|NOT COMPLETED|Third Intervention (8 Weeks)||2||
60048538|NCT02169830|76164232|FG002|NOT COMPLETED|Third Intervention (8 Weeks)||0||
60048539|NCT02169674|76164242|FG000|STARTED|Overall Study||137||
60048540|NCT02169674|76164243|FG001|STARTED|Overall Study||213||
60048541|NCT02169674|76164242|FG000|COMPLETED|Overall Study||105||
59512769|NCT00916643|75606158|FG000|STARTED|Overall Study||113||
59512770|NCT00916643|75606158|FG000|COMPLETED|Overall Study||113||
59512771|NCT00916643|75606158|FG000|NOT COMPLETED|Overall Study||0||
59512772|NCT00917735|75606164|FG000|STARTED|Overall Study||538||
59512773|NCT00917735|75606165|FG001|STARTED|Overall Study||537||
59920409|NCT03874234|76040417|FG006|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day10)||0||
60048542|NCT02169674|76164243|FG001|COMPLETED|Overall Study||135||
60048543|NCT02169674|76164242|FG000|NOT COMPLETED|Overall Study||32||
60048544|NCT02169674|76164243|FG001|NOT COMPLETED|Overall Study||78||
60048545|NCT02169284|76164251|FG000|STARTED|Overall Study||24||
60048546|NCT02169284|76164252|FG001|STARTED|Overall Study||13||
59512774|NCT00917735|75606164|FG000|COMPLETED|Overall Study||463||
60048547|NCT02169284|76164251|FG000|COMPLETED|Overall Study||24||
60048548|NCT02169284|76164252|FG001|COMPLETED|Overall Study||12||
60048549|NCT02169284|76164251|FG000|NOT COMPLETED|Overall Study||0||
60048550|NCT02169284|76164252|FG001|NOT COMPLETED|Overall Study||1||
60048551|NCT02119819|76164266|FG000|STARTED|Overall Study||66||
60048552|NCT02119819|76164267|FG001|STARTED|Overall Study||71||
60048553|NCT02119819|76164268|FG002|STARTED|Overall Study||73||
60048554|NCT02119819|76164269|FG003|STARTED|Overall Study||70||
60048555|NCT02119819|76164270|FG004|STARTED|Overall Study||69||
60048556|NCT02119819|76164271|FG005|STARTED|Overall Study||71||
60048557|NCT02119819|76164266|FG000|COMPLETED|Overall Study||57||
60048558|NCT02119819|76164267|FG001|COMPLETED|Overall Study||66||
60048559|NCT02119819|76164268|FG002|COMPLETED|Overall Study||69||
60048560|NCT02119819|76164269|FG003|COMPLETED|Overall Study||63||
60048561|NCT02119819|76164270|FG004|COMPLETED|Overall Study||62||
60048562|NCT02119819|76164271|FG005|COMPLETED|Overall Study||56||
60048563|NCT02119819|76164266|FG000|NOT COMPLETED|Overall Study||9||
60048564|NCT02119819|76164267|FG001|NOT COMPLETED|Overall Study||5||
60048565|NCT02119819|76164268|FG002|NOT COMPLETED|Overall Study||4||
60048566|NCT02119819|76164269|FG003|NOT COMPLETED|Overall Study||7||
60048567|NCT02119819|76164270|FG004|NOT COMPLETED|Overall Study||7||
60048568|NCT02119819|76164271|FG005|NOT COMPLETED|Overall Study||15||
60048569|NCT02168816|76164287|FG000|STARTED|Overall Study||5||
60048570|NCT02168816|76164288|FG001|STARTED|Overall Study||7||
60048571|NCT02168816|76164287|FG000|COMPLETED|Overall Study||3||
60048572|NCT02168816|76164288|FG001|COMPLETED|Overall Study||5||
60048573|NCT02168816|76164287|FG000|NOT COMPLETED|Overall Study||2||
60048574|NCT02168816|76164288|FG001|NOT COMPLETED|Overall Study||2||
60048575|NCT01584232|76164296|FG000|STARTED|Overall Study||181||
60048576|NCT01584232|76164297|FG001|STARTED|Overall Study||180||
60048577|NCT01584232|76164296|FG000|Received at Least 1 Dose of Study Drug|Overall Study||181||
60048578|NCT01584232|76164297|FG001|Received at Least 1 Dose of Study Drug|Overall Study||180||
60048579|NCT01584232|76164296|FG000|COMPLETED|Overall Study||173||
60048580|NCT01584232|76164297|FG001|COMPLETED|Overall Study||177||
60048581|NCT01584232|76164296|FG000|NOT COMPLETED|Overall Study||8||
60048582|NCT01584232|76164297|FG001|NOT COMPLETED|Overall Study||3||
60048583|NCT01639703|76164303|FG000|STARTED|Overall Study||96||
60048584|NCT01639703|76164303|FG000|COMPLETED|Overall Study||84||
60048585|NCT01639703|76164303|FG000|NOT COMPLETED|Overall Study||12||
59512775|NCT00917735|75606165|FG001|COMPLETED|Overall Study||474||
59512776|NCT00917735|75606164|FG000|NOT COMPLETED|Overall Study||75||
59512777|NCT00917735|75606165|FG001|NOT COMPLETED|Overall Study||63||
59512778|NCT00926887|75606173|FG000|STARTED|Overall Study||54||
59512779|NCT00926887|75606174|FG001|STARTED|Overall Study||50||
59512780|NCT00926887|75606173|FG000|COMPLETED|Overall Study||54||
59512781|NCT00926887|75606174|FG001|COMPLETED|Overall Study||50||
60048586|NCT02119663|76164321|FG000|STARTED|Overall Study||43||
60048587|NCT02119663|76164322|FG001|STARTED|Overall Study||43||
60048588|NCT02119663|76164321|FG000|COMPLETED|Overall Study|Treatment ongoing as of 13APR2016 for remaining participants in the study.|3||
60048589|NCT02119663|76164322|FG001|COMPLETED|Overall Study|Treatment ongoing as of 13APR2016 for remaining participants in the study.|2||
60048590|NCT02119663|76164321|FG000|NOT COMPLETED|Overall Study||40||
60048591|NCT02119663|76164322|FG001|NOT COMPLETED|Overall Study||41||
60048592|NCT01639469|76164330|FG000|STARTED|Overall Study||89||
60048593|NCT01639469|76164331|FG001|STARTED|Overall Study||80||
59512782|NCT00926887|75606173|FG000|NOT COMPLETED|Overall Study||0||
59512783|NCT00926887|75606174|FG001|NOT COMPLETED|Overall Study||0||
59512784|NCT00918125|75606182|FG000|STARTED|Overall Study||20||
59512785|NCT00918125|75606183|FG001|STARTED|Overall Study||39||
59512786|NCT00918125|75606182|FG000|COMPLETED|Overall Study||20||
59512787|NCT00918125|75606183|FG001|COMPLETED|Overall Study||39||
59512788|NCT00918125|75606182|FG000|NOT COMPLETED|Overall Study||0||
59512789|NCT00918125|75606183|FG001|NOT COMPLETED|Overall Study||0||
59512790|NCT00909545|75606196|FG000|STARTED|Overall Study||26||
59512791|NCT00909545|75606197|FG001|STARTED|Overall Study||23||
60048594|NCT01639469|76164330|FG000|COMPLETED|Overall Study||84||
59512792|NCT00909545|75606198|FG002|STARTED|Overall Study||26||
59512793|NCT00909545|75606199|FG003|STARTED|Overall Study||24||
59512794|NCT00909545|75606196|FG000|COMPLETED|Overall Study||25||
60048595|NCT01639469|76164331|FG001|COMPLETED|Overall Study||77||
60048596|NCT01639469|76164330|FG000|NOT COMPLETED|Overall Study||5||
60048597|NCT01639469|76164331|FG001|NOT COMPLETED|Overall Study||3||
60048598|NCT02193074|76164339|FG000|STARTED|Overall Study|Randomized and received double-blind treatment.|41||
60048599|NCT02193074|76164340|FG001|STARTED|Overall Study|Randomized and received double-blind treatment.|80||
60048600|NCT02193074|76164339|FG000|Completed During Follow-Up Period|Overall Study||11||
60048601|NCT02193074|76164340|FG001|Completed During Follow-Up Period|Overall Study||26||
60048602|NCT02193074|76164339|FG000|Completed Due to Early Study Termination|Overall Study||13||
59512795|NCT00909545|75606197|FG001|COMPLETED|Overall Study||22||
59512796|NCT00909545|75606198|FG002|COMPLETED|Overall Study||25||
59512797|NCT00909545|75606199|FG003|COMPLETED|Overall Study||19||
59512798|NCT00909545|75606196|FG000|NOT COMPLETED|Overall Study||1||
59512799|NCT00909545|75606197|FG001|NOT COMPLETED|Overall Study||1||
59512800|NCT00909545|75606198|FG002|NOT COMPLETED|Overall Study||1||
60048603|NCT02193074|76164340|FG001|Completed Due to Early Study Termination|Overall Study||39||
60048604|NCT02193074|76164339|FG000|COMPLETED|Overall Study||24||
59512801|NCT00909545|75606199|FG003|NOT COMPLETED|Overall Study||5||
59512802|NCT02157103|75606210|FG000|STARTED|Overall Study||3||
59512803|NCT02157103|75606210|FG000|COMPLETED|Overall Study||3||
59512804|NCT02157103|75606210|FG000|NOT COMPLETED|Overall Study||0||
59512805|NCT00924001|75606214|FG000|STARTED|Overall Study||1||
59512806|NCT00924001|75606214|FG000|COMPLETED|Overall Study||1||
59512807|NCT00924001|75606214|FG000|NOT COMPLETED|Overall Study||0||
59612620|NCT01720446|75723618|FG003|COMPLETED|Overall Study|Subjects who did not permanently discontinue treatment prematurely.|805||
59612621|NCT01720446|75723615|FG000|NOT COMPLETED|Overall Study||14||
59512808|NCT00910481|75606220|FG000|STARTED|Overall Study||151||
59512809|NCT00910481|75606221|FG001|STARTED|Overall Study||150||
59512810|NCT00910481|75606220|FG000|COMPLETED|Overall Study||151||
59512811|NCT00910481|75606221|FG001|COMPLETED|Overall Study||150||
59512812|NCT00910481|75606220|FG000|NOT COMPLETED|Overall Study||0||
59512813|NCT00910481|75606221|FG001|NOT COMPLETED|Overall Study||0||
59512814|NCT00911495|75606227|FG000|STARTED|Overall Study||15||
59512815|NCT00911495|75606227|FG000|COMPLETED|Overall Study||14||
59512816|NCT00911495|75606227|FG000|NOT COMPLETED|Overall Study||1||
59512817|NCT00918671|75606231|FG000|STARTED|Overall Study||60||
59512818|NCT00918671|75606231|FG000|COMPLETED|Overall Study||60||
59612622|NCT01720446|75723616|FG001|NOT COMPLETED|Overall Study||11||
59612623|NCT01720446|75723617|FG002|NOT COMPLETED|Overall Study||20||
59612624|NCT01720446|75723618|FG003|NOT COMPLETED|Overall Study||20||
59612625|NCT01746108|75723634|FG000|STARTED|Overall Study||18||
59612626|NCT01746108|75723635|FG001|STARTED|Overall Study||28||
59920410|NCT03874234|76040418|FG007|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day10)||0||
59920411|NCT03874234|76040419|FG008|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day10)||0||
59920412|NCT03874234|76040420|FG009|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day10)||0||
59920413|NCT03874234|76040421|FG010|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day10)||0||
59920414|NCT03874234|76040422|FG011|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day10)||0||
59920415|NCT03874234|76040423|FG012|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day10)||0||
59920416|NCT03874234|76040411|FG000|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day10)||2||
59920417|NCT03874234|76040412|FG001|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day10)||2||
59920418|NCT03874234|76040413|FG002|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day10)||2||
59920419|NCT03874234|76040414|FG003|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day10)||1||
59920420|NCT03874234|76040415|FG004|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day10)||0||
59920421|NCT03874234|76040416|FG005|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day10)||0||
59920422|NCT03874234|76040417|FG006|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day10)||0||
59920423|NCT03874234|76040418|FG007|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day10)||0||
59920424|NCT03874234|76040419|FG008|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day10)||0||
59920425|NCT03874234|76040420|FG009|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day10)||0||
59920426|NCT03874234|76040421|FG010|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day10)||0||
59920427|NCT03874234|76040422|FG011|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day10)||0||
59920428|NCT03874234|76040423|FG012|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day10)||0||
59920429|NCT03874234|76040411|FG000|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day10)||0||
59920430|NCT03874234|76040412|FG001|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day10)||0||
59920431|NCT03874234|76040413|FG002|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day10)||0||
59920432|NCT03874234|76040414|FG003|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day10)||0||
59920433|NCT03874234|76040415|FG004|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day10)||0||
59920434|NCT03874234|76040416|FG005|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day10)||0||
60048605|NCT02193074|76164340|FG001|COMPLETED|Overall Study||65||
60048606|NCT02193074|76164339|FG000|NOT COMPLETED|Overall Study||17||
59512819|NCT00918671|75606231|FG000|NOT COMPLETED|Overall Study||0||
59512820|NCT00929071|75606235|FG000|STARTED|Overall Study||10||
59512821|NCT00929071|75606235|FG000|COMPLETED|Overall Study||10||
59512822|NCT00929071|75606235|FG000|NOT COMPLETED|Overall Study||0||
59612627|NCT01746108|75723636|FG002|STARTED|Overall Study||6||
59612628|NCT01746108|75723634|FG000|COMPLETED|Overall Study||18||
59612629|NCT01746108|75723635|FG001|COMPLETED|Overall Study||24||
59612630|NCT01746108|75723636|FG002|COMPLETED|Overall Study||6||
59512823|NCT00929305|75606244|FG000|STARTED|Overall Study||43||
59512824|NCT00929305|75606245|FG001|STARTED|Overall Study||43||
59512825|NCT00929305|75606244|FG000|COMPLETED|Overall Study||43||
59512826|NCT00929305|75606245|FG001|COMPLETED|Overall Study||43||
59512827|NCT00929305|75606244|FG000|NOT COMPLETED|Overall Study||0||
59512828|NCT00929305|75606245|FG001|NOT COMPLETED|Overall Study||0||
59512829|NCT00937105|75606254|FG000|STARTED|Overall Study||109||
59612631|NCT01746108|75723634|FG000|NOT COMPLETED|Overall Study||0||
59612632|NCT01746108|75723635|FG001|NOT COMPLETED|Overall Study||4||
59612633|NCT01746108|75723636|FG002|NOT COMPLETED|Overall Study||0||
59612634|NCT01717638|75723665|FG000|STARTED|Overall Study||67||
59612635|NCT01717638|75723666|FG001|STARTED|Overall Study||61||
59512830|NCT00937105|75606255|FG001|STARTED|Overall Study||109||
59512831|NCT00937105|75606254|FG000|COMPLETED|Overall Study||69||
59512832|NCT00937105|75606255|FG001|COMPLETED|Overall Study||70||
60048607|NCT02193074|76164340|FG001|NOT COMPLETED|Overall Study||15||
60048608|NCT02192606|76164348|FG000|STARTED|Overall Study||29||
60048609|NCT02192606|76164349|FG001|STARTED|Overall Study||28||
60048610|NCT02192606|76164348|FG000|COMPLETED|Overall Study||27||
60048611|NCT02192606|76164349|FG001|COMPLETED|Overall Study||24||
60048612|NCT02192606|76164348|FG000|NOT COMPLETED|Overall Study||2||
60048613|NCT02192606|76164349|FG001|NOT COMPLETED|Overall Study||4||
60048614|NCT01628107|76164355|FG000|STARTED|Overall Study||414||
60048615|NCT01628107|76164355|FG000|Treated|Overall Study||406||
60048616|NCT01628107|76164355|FG000|COMPLETED|Overall Study||295||
60048617|NCT01628107|76164355|FG000|NOT COMPLETED|Overall Study||119||
60048618|NCT01583530|76164365|FG000|STARTED|Overall Study||19||
60048619|NCT01583530|76164366|FG001|STARTED|Overall Study||20||
60048620|NCT01583530|76164367|FG002|STARTED|Overall Study||20||
60048621|NCT01583530|76164368|FG003|STARTED|Overall Study||19||
60048622|NCT01583530|76164369|FG004|STARTED|Overall Study||20||
60048623|NCT01583530|76164370|FG005|STARTED|Overall Study||20||
60048624|NCT01583530|76164365|FG000|COMPLETED|Overall Study||19||
60048625|NCT01583530|76164366|FG001|COMPLETED|Overall Study||17||
59512833|NCT00937105|75606254|FG000|NOT COMPLETED|Overall Study||40||
59512834|NCT00937105|75606255|FG001|NOT COMPLETED|Overall Study||39||
60048626|NCT01583530|76164367|FG002|COMPLETED|Overall Study||20||
60048627|NCT01583530|76164368|FG003|COMPLETED|Overall Study||18||
60048628|NCT01583530|76164369|FG004|COMPLETED|Overall Study||15||
60048629|NCT01583530|76164370|FG005|COMPLETED|Overall Study||17||
60048630|NCT01583530|76164365|FG000|NOT COMPLETED|Overall Study||0||
60048631|NCT01583530|76164366|FG001|NOT COMPLETED|Overall Study||3||
60048632|NCT01583530|76164367|FG002|NOT COMPLETED|Overall Study||0||
60048633|NCT01583530|76164368|FG003|NOT COMPLETED|Overall Study||1||
60048634|NCT01583530|76164369|FG004|NOT COMPLETED|Overall Study||5||
60048635|NCT01583530|76164370|FG005|NOT COMPLETED|Overall Study||3||
60048636|NCT01639001|76164389|FG000|STARTED|Overall Study||104||
60048637|NCT01639001|76164390|FG001|STARTED|Overall Study||103||
59512835|NCT00929383|75606270|FG000|STARTED|Overall Study||82||
60048638|NCT01639001|76164389|FG000|Treated|Overall Study||104||
60048639|NCT01639001|76164390|FG001|Treated|Overall Study||101||
60048640|NCT01639001|76164389|FG000|COMPLETED|Overall Study||29|"Completed refers to either those patients who switched to commercial supplies of crizotinib or those patients who were in survival follow up, when the Sponsor sent a written End of Study notification to the study sites."|
60048641|NCT01639001|76164390|FG001|COMPLETED|Overall Study||26|"Completed refers to either those patients who switched to commercial supplies of crizotinib or those patients who were in survival follow up, when the Sponsor sent a written End of Study notification to the study sites."|
60048642|NCT01639001|76164389|FG000|NOT COMPLETED|Overall Study||75||
60048643|NCT01639001|76164390|FG001|NOT COMPLETED|Overall Study||77||
60048644|NCT02224664|76164398|FG000|STARTED|Lead-in Period (3 Days)||50||
60048645|NCT02224664|76164399|FG001|STARTED|Lead-in Period (3 Days)||0||
60048646|NCT02224664|76164400|FG002|STARTED|Lead-in Period (3 Days)||0||
60048647|NCT02224664|76164401|FG003|STARTED|Lead-in Period (3 Days)||0||
60048648|NCT02224664|76164402|FG004|STARTED|Lead-in Period (3 Days)||0||
60048649|NCT02224664|76164398|FG000|COMPLETED|Lead-in Period (3 Days)||45||
60048650|NCT02224664|76164399|FG001|COMPLETED|Lead-in Period (3 Days)||0||
60048651|NCT02224664|76164400|FG002|COMPLETED|Lead-in Period (3 Days)||0||
60048652|NCT02224664|76164401|FG003|COMPLETED|Lead-in Period (3 Days)||0||
60048653|NCT02224664|76164402|FG004|COMPLETED|Lead-in Period (3 Days)||0||
60048654|NCT02224664|76164398|FG000|NOT COMPLETED|Lead-in Period (3 Days)||5||
60048655|NCT02224664|76164399|FG001|NOT COMPLETED|Lead-in Period (3 Days)||0||
60048656|NCT02224664|76164400|FG002|NOT COMPLETED|Lead-in Period (3 Days)||0||
60048657|NCT02224664|76164401|FG003|NOT COMPLETED|Lead-in Period (3 Days)||0||
60048658|NCT02224664|76164402|FG004|NOT COMPLETED|Lead-in Period (3 Days)||0||
60048659|NCT02224664|76164398|FG000|STARTED|Dose Escalation Period (21 Days)||0||
60048660|NCT02224664|76164399|FG001|STARTED|Dose Escalation Period (21 Days)||9||
60048661|NCT02224664|76164400|FG002|STARTED|Dose Escalation Period (21 Days)||11||
60048662|NCT02224664|76164401|FG003|STARTED|Dose Escalation Period (21 Days)||6||
60048663|NCT02224664|76164402|FG004|STARTED|Dose Escalation Period (21 Days)||19||
60048664|NCT02224664|76164398|FG000|COMPLETED|Dose Escalation Period (21 Days)||0||
60048665|NCT02224664|76164399|FG001|COMPLETED|Dose Escalation Period (21 Days)||9||
59512836|NCT00929383|75606270|FG000|COMPLETED|Overall Study||67||
59512837|NCT00929383|75606270|FG000|NOT COMPLETED|Overall Study||15||
60048666|NCT02224664|76164400|FG002|COMPLETED|Dose Escalation Period (21 Days)||9||
59512838|NCT00929773|75606276|FG000|STARTED|Overall Study||50||
60048667|NCT02224664|76164401|FG003|COMPLETED|Dose Escalation Period (21 Days)||3||
60048668|NCT02224664|76164402|FG004|COMPLETED|Dose Escalation Period (21 Days)||8||
60048669|NCT02224664|76164398|FG000|NOT COMPLETED|Dose Escalation Period (21 Days)||0||
60048670|NCT02224664|76164399|FG001|NOT COMPLETED|Dose Escalation Period (21 Days)||0||
60048671|NCT02224664|76164400|FG002|NOT COMPLETED|Dose Escalation Period (21 Days)||2||
60048672|NCT02224664|76164401|FG003|NOT COMPLETED|Dose Escalation Period (21 Days)||3||
60048673|NCT02224664|76164402|FG004|NOT COMPLETED|Dose Escalation Period (21 Days)||11||
60048674|NCT02167256|76164420|FG000|STARTED|Overall Study||79||
60048675|NCT02167256|76164421|FG001|STARTED|Overall Study||80||
60048676|NCT02167256|76164420|FG000|COMPLETED|Overall Study||58||
59612636|NCT01717638|75723667|FG002|STARTED|Overall Study||60||
59612637|NCT01717638|75723668|FG003|STARTED|Overall Study||66||
59612638|NCT01717638|75723669|FG004|STARTED|Overall Study||64||
59612639|NCT01717638|75723670|FG005|STARTED|Overall Study||55||
59612640|NCT01717638|75723671|FG006|STARTED|Overall Study||43||
59612641|NCT01717638|75723672|FG007|STARTED|Overall Study||29||
59612642|NCT01717638|75723673|FG008|STARTED|Overall Study||28||
59612643|NCT01717638|75723674|FG009|STARTED|Overall Study||100||
59612644|NCT01717638|75723675|FG010|STARTED|Overall Study||11||
59612645|NCT01717638|75723676|FG011|STARTED|Overall Study||12||
59612646|NCT01717638|75723677|FG012|STARTED|Overall Study||209||
59612647|NCT01717638|75723665|FG000|COMPLETED|Overall Study||67||
59612648|NCT01717638|75723666|FG001|COMPLETED|Overall Study||60||
59612649|NCT01717638|75723667|FG002|COMPLETED|Overall Study||59||
59612650|NCT01717638|75723668|FG003|COMPLETED|Overall Study||66||
59612651|NCT01717638|75723669|FG004|COMPLETED|Overall Study||63||
59612652|NCT01717638|75723670|FG005|COMPLETED|Overall Study||54||
59612653|NCT01717638|75723671|FG006|COMPLETED|Overall Study||41||
59612654|NCT01717638|75723672|FG007|COMPLETED|Overall Study||28||
59612655|NCT01717638|75723673|FG008|COMPLETED|Overall Study||26||
59612656|NCT01717638|75723674|FG009|COMPLETED|Overall Study||99||
59612657|NCT01717638|75723675|FG010|COMPLETED|Overall Study||11||
59612658|NCT01717638|75723676|FG011|COMPLETED|Overall Study||12||
59612659|NCT01717638|75723677|FG012|COMPLETED|Overall Study||190||
59612660|NCT01717638|75723665|FG000|NOT COMPLETED|Overall Study||0||
59612661|NCT01717638|75723666|FG001|NOT COMPLETED|Overall Study||1||
59612662|NCT01717638|75723667|FG002|NOT COMPLETED|Overall Study||1||
59612663|NCT01717638|75723668|FG003|NOT COMPLETED|Overall Study||0||
59612664|NCT01717638|75723669|FG004|NOT COMPLETED|Overall Study||1||
59612665|NCT01717638|75723670|FG005|NOT COMPLETED|Overall Study||1||
59612666|NCT01717638|75723671|FG006|NOT COMPLETED|Overall Study||2||
59612667|NCT01717638|75723672|FG007|NOT COMPLETED|Overall Study||1||
59612668|NCT01717638|75723673|FG008|NOT COMPLETED|Overall Study||2||
59612669|NCT01717638|75723674|FG009|NOT COMPLETED|Overall Study||1||
59920435|NCT03874234|76040417|FG006|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day10)||0||
59920436|NCT03874234|76040418|FG007|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day10)||0||
59920437|NCT03874234|76040419|FG008|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day10)||0||
59920438|NCT03874234|76040420|FG009|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day10)||0||
59920439|NCT03874234|76040421|FG010|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day10)||0||
59920440|NCT03874234|76040422|FG011|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day10)||0||
59920441|NCT03874234|76040423|FG012|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day10)||0||
60048677|NCT02167256|76164421|FG001|COMPLETED|Overall Study||70||
60048678|NCT02167256|76164420|FG000|NOT COMPLETED|Overall Study||21||
60048679|NCT02167256|76164421|FG001|NOT COMPLETED|Overall Study||10||
60048680|NCT02191046|76164429|FG000|STARTED|Overall Study||41||
60048681|NCT02191046|76164430|FG001|STARTED|Overall Study||39||
60048682|NCT02191046|76164429|FG000|COMPLETED|Overall Study|exclude 5 patients because low compliance|36||
59612670|NCT01717638|75723675|FG010|NOT COMPLETED|Overall Study||0||
59612671|NCT01717638|75723676|FG011|NOT COMPLETED|Overall Study||0||
59612672|NCT01717638|75723677|FG012|NOT COMPLETED|Overall Study||19||
59612673|NCT01745094|75723715|FG000|STARTED|Overall Study||35||
59612674|NCT01745094|75723716|FG001|STARTED|Overall Study||37||
59612675|NCT01745094|75723717|FG002|STARTED|Overall Study||58||
59612676|NCT01745094|75723718|FG003|STARTED|Overall Study||93||
59612677|NCT01745094|75723715|FG000|COMPLETED|Overall Study||30||
59612678|NCT01745094|75723716|FG001|COMPLETED|Overall Study||37||
59612679|NCT01745094|75723717|FG002|COMPLETED|Overall Study||46||
59612680|NCT01745094|75723718|FG003|COMPLETED|Overall Study||90||
59612681|NCT01745094|75723715|FG000|NOT COMPLETED|Overall Study||5||
59612682|NCT01745094|75723716|FG001|NOT COMPLETED|Overall Study||0||
59612683|NCT01745094|75723717|FG002|NOT COMPLETED|Overall Study||12||
59920442|NCT03874234|76040411|FG000|STARTED|Part A: Cohort 1-Period 4 (Day1)||2||
59920443|NCT03874234|76040412|FG001|STARTED|Part A: Cohort 1-Period 4 (Day1)||2||
59920444|NCT03874234|76040413|FG002|STARTED|Part A: Cohort 1-Period 4 (Day1)||2||
59920445|NCT03874234|76040414|FG003|STARTED|Part A: Cohort 1-Period 4 (Day1)|New participant enrolled and dosed.|2||
59920446|NCT03874234|76040415|FG004|STARTED|Part A: Cohort 1-Period 4 (Day1)||0||
59920447|NCT03874234|76040416|FG005|STARTED|Part A: Cohort 1-Period 4 (Day1)||0||
59920448|NCT03874234|76040417|FG006|STARTED|Part A: Cohort 1-Period 4 (Day1)||0||
59920449|NCT03874234|76040418|FG007|STARTED|Part A: Cohort 1-Period 4 (Day1)||0||
59920450|NCT03874234|76040419|FG008|STARTED|Part A: Cohort 1-Period 4 (Day1)||0||
59920451|NCT03874234|76040420|FG009|STARTED|Part A: Cohort 1-Period 4 (Day1)||0||
60048683|NCT02191046|76164430|FG001|COMPLETED|Overall Study|exclude 1 patient because low compliance|38||
59920452|NCT03874234|76040421|FG010|STARTED|Part A: Cohort 1-Period 4 (Day1)||0||
59920453|NCT03874234|76040422|FG011|STARTED|Part A: Cohort 1-Period 4 (Day1)||0||
59920454|NCT03874234|76040423|FG012|STARTED|Part A: Cohort 1-Period 4 (Day1)||0||
59612684|NCT01745094|75723718|FG003|NOT COMPLETED|Overall Study||3||
59612685|NCT01697748|75723733|FG000|STARTED|Overall Study||329||
59612686|NCT01697748|75723734|FG001|STARTED|Overall Study||328||
59612687|NCT01697748|75723733|FG000|COMPLETED|Overall Study||271||
59612688|NCT01697748|75723734|FG001|COMPLETED|Overall Study||260||
59920455|NCT03874234|76040411|FG000|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 4 (Day1)||0||
59920456|NCT03874234|76040412|FG001|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 4 (Day1)||0||
59920457|NCT03874234|76040413|FG002|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 4 (Day1)||0||
59920458|NCT03874234|76040414|FG003|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 4 (Day1)||1||
59920459|NCT03874234|76040415|FG004|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 4 (Day1)||0||
59920460|NCT03874234|76040416|FG005|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 4 (Day1)||0||
59920461|NCT03874234|76040417|FG006|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 4 (Day1)||0||
59920462|NCT03874234|76040418|FG007|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 4 (Day1)||0||
59920463|NCT03874234|76040419|FG008|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 4 (Day1)||0||
59920464|NCT03874234|76040420|FG009|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 4 (Day1)||0||
59920465|NCT03874234|76040421|FG010|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 4 (Day1)||0||
59920466|NCT03874234|76040422|FG011|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 4 (Day1)||0||
59920467|NCT03874234|76040423|FG012|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 1-Period 4 (Day1)||0||
59920468|NCT03874234|76040411|FG000|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||2||
59920469|NCT03874234|76040412|FG001|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||2||
59920470|NCT03874234|76040413|FG002|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||2||
59920471|NCT03874234|76040414|FG003|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||2||
59920472|NCT03874234|76040415|FG004|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
59920473|NCT03874234|76040416|FG005|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
59920474|NCT03874234|76040417|FG006|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
59920475|NCT03874234|76040418|FG007|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
59920476|NCT03874234|76040419|FG008|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
59920477|NCT03874234|76040420|FG009|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
59920478|NCT03874234|76040421|FG010|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
59920479|NCT03874234|76040422|FG011|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
59920480|NCT03874234|76040423|FG012|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
59920481|NCT03874234|76040411|FG000|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
59920482|NCT03874234|76040412|FG001|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
59920483|NCT03874234|76040413|FG002|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
59920484|NCT03874234|76040414|FG003|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
59920485|NCT03874234|76040415|FG004|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
59920486|NCT03874234|76040416|FG005|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
59920487|NCT03874234|76040417|FG006|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
59920488|NCT03874234|76040418|FG007|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
59920489|NCT03874234|76040419|FG008|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
59920490|NCT03874234|76040420|FG009|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
59920491|NCT03874234|76040421|FG010|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
59920492|NCT03874234|76040422|FG011|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
59920493|NCT03874234|76040423|FG012|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
59920494|NCT03874234|76040411|FG000|STARTED|Part A: Cohort 2-Period 1 (Day1)||0||
59920495|NCT03874234|76040412|FG001|STARTED|Part A: Cohort 2-Period 1 (Day1)||0||
59920496|NCT03874234|76040413|FG002|STARTED|Part A: Cohort 2-Period 1 (Day1)||0||
59920497|NCT03874234|76040414|FG003|STARTED|Part A: Cohort 2-Period 1 (Day1)||0||
59920498|NCT03874234|76040415|FG004|STARTED|Part A: Cohort 2-Period 1 (Day1)||3||
59920499|NCT03874234|76040416|FG005|STARTED|Part A: Cohort 2-Period 1 (Day1)||2||
59920500|NCT03874234|76040417|FG006|STARTED|Part A: Cohort 2-Period 1 (Day1)||2||
59920501|NCT03874234|76040418|FG007|STARTED|Part A: Cohort 2-Period 1 (Day1)||2||
59920502|NCT03874234|76040419|FG008|STARTED|Part A: Cohort 2-Period 1 (Day1)||0||
59920503|NCT03874234|76040420|FG009|STARTED|Part A: Cohort 2-Period 1 (Day1)||0||
59920504|NCT03874234|76040421|FG010|STARTED|Part A: Cohort 2-Period 1 (Day1)||0||
59920505|NCT03874234|76040422|FG011|STARTED|Part A: Cohort 2-Period 1 (Day1)||0||
59920506|NCT03874234|76040423|FG012|STARTED|Part A: Cohort 2-Period 1 (Day1)||0||
59612689|NCT01697748|75723733|FG000|NOT COMPLETED|Overall Study||58||
59612690|NCT01697748|75723734|FG001|NOT COMPLETED|Overall Study||68||
60048684|NCT02191046|76164429|FG000|NOT COMPLETED|Overall Study||5||
60048685|NCT02191046|76164430|FG001|NOT COMPLETED|Overall Study||1||
60048686|NCT02166476|76164438|FG000|STARTED|Overall Study||272|5 participants were randomized but not dosed: 4 withdrew consent, 1 did not meet inclusion criteria.|
60048687|NCT02166476|76164439|FG001|STARTED|Overall Study||273|5 participants were randomized but not dosed: 4 withdrew consent, 1 did not meet inclusion criteria.|
60048688|NCT02166476|76164438|FG000|Received at Least 1 Dose of Study Drug|Overall Study||272|Randomized participants included in the Safety and modified intent-to-treat [MITT] populations.|
60048689|NCT02166476|76164439|FG001|Received at Least 1 Dose of Study Drug|Overall Study||273|Randomized participants included in the Safety and modified intent-to-treat [MITT] populations.|
60048690|NCT02166476|76164438|FG000|COMPLETED|Overall Study||258||
60048691|NCT02166476|76164439|FG001|COMPLETED|Overall Study||250||
60048692|NCT02166476|76164438|FG000|NOT COMPLETED|Overall Study||14||
60048693|NCT02166476|76164439|FG001|NOT COMPLETED|Overall Study||23||
60048694|NCT02224274|76164450|FG000|STARTED|Overall Study||17||
60048695|NCT02224274|76164451|FG001|STARTED|Overall Study||20||
60048696|NCT02224274|76164450|FG000|COMPLETED|Overall Study||16||
60048697|NCT02224274|76164451|FG001|COMPLETED|Overall Study||20||
60048698|NCT02224274|76164450|FG000|NOT COMPLETED|Overall Study||1||
60048699|NCT02224274|76164451|FG001|NOT COMPLETED|Overall Study||0||
60048700|NCT04373369|76164457|FG000|STARTED|Overall Study||11||
60048701|NCT04373369|76164457|FG000|COMPLETED|Overall Study||11||
60048702|NCT04373369|76164457|FG000|NOT COMPLETED|Overall Study||0||
60048703|NCT02189252|76164465|FG000|STARTED|Period 1 (Visit 4b, Week 4)||4||
60048704|NCT02189252|76164466|FG001|STARTED|Period 1 (Visit 4b, Week 4)||4||
60048705|NCT02189252|76164467|FG002|STARTED|Period 1 (Visit 4b, Week 4)||3||
60048706|NCT02189252|76164468|FG003|STARTED|Period 1 (Visit 4b, Week 4)||4||
60048707|NCT02189252|76164465|FG000|COMPLETED|Period 1 (Visit 4b, Week 4)||4||
60048708|NCT02189252|76164466|FG001|COMPLETED|Period 1 (Visit 4b, Week 4)||2||
60048709|NCT02189252|76164467|FG002|COMPLETED|Period 1 (Visit 4b, Week 4)||3||
60048710|NCT02189252|76164468|FG003|COMPLETED|Period 1 (Visit 4b, Week 4)||4||
60048711|NCT02189252|76164465|FG000|NOT COMPLETED|Period 1 (Visit 4b, Week 4)||0||
60048712|NCT02189252|76164466|FG001|NOT COMPLETED|Period 1 (Visit 4b, Week 4)||2||
60048713|NCT02189252|76164467|FG002|NOT COMPLETED|Period 1 (Visit 4b, Week 4)||0||
60048714|NCT02189252|76164468|FG003|NOT COMPLETED|Period 1 (Visit 4b, Week 4)||0||
60048715|NCT02189252|76164465|FG000|STARTED|Period 2 (Visit6b, Week 12)||4||
60048716|NCT02189252|76164466|FG001|STARTED|Period 2 (Visit6b, Week 12)||2||
60048717|NCT02189252|76164467|FG002|STARTED|Period 2 (Visit6b, Week 12)||3||
60048718|NCT02189252|76164468|FG003|STARTED|Period 2 (Visit6b, Week 12)||4||
60048719|NCT02189252|76164465|FG000|COMPLETED|Period 2 (Visit6b, Week 12)||4||
60048720|NCT02189252|76164466|FG001|COMPLETED|Period 2 (Visit6b, Week 12)||2||
60048721|NCT02189252|76164467|FG002|COMPLETED|Period 2 (Visit6b, Week 12)||3||
60048722|NCT02189252|76164468|FG003|COMPLETED|Period 2 (Visit6b, Week 12)||4||
60048723|NCT02189252|76164465|FG000|NOT COMPLETED|Period 2 (Visit6b, Week 12)||0||
60048724|NCT02189252|76164466|FG001|NOT COMPLETED|Period 2 (Visit6b, Week 12)||0||
60048725|NCT02189252|76164467|FG002|NOT COMPLETED|Period 2 (Visit6b, Week 12)||0||
59512839|NCT00929773|75606277|FG001|STARTED|Overall Study||50||
59512840|NCT00929773|75606276|FG000|COMPLETED|Overall Study||50||
59512841|NCT00929773|75606277|FG001|COMPLETED|Overall Study||50||
59512842|NCT00929773|75606276|FG000|NOT COMPLETED|Overall Study||0||
59512843|NCT00929773|75606277|FG001|NOT COMPLETED|Overall Study||0||
59512844|NCT02906566|75606286|FG000|STARTED|Overall Study||24||48
60048726|NCT02189252|76164468|FG003|NOT COMPLETED|Period 2 (Visit6b, Week 12)||0||
59512845|NCT02906566|75606287|FG001|STARTED|Overall Study||10||10
59512846|NCT02906566|75606286|FG000|COMPLETED|Overall Study||21||42
59512847|NCT02906566|75606287|FG001|COMPLETED|Overall Study||10||10
59512848|NCT02906566|75606286|FG000|NOT COMPLETED|Overall Study||3||6
59512849|NCT02906566|75606287|FG001|NOT COMPLETED|Overall Study||0||0
59512850|NCT00913133|75606295|FG000|STARTED|Overall Study||516||
59512851|NCT00913133|75606295|FG000|COMPLETED|Overall Study||516||
59920507|NCT03874234|76040411|FG000|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 2-Period 1 (Day1)||0||
59920508|NCT03874234|76040412|FG001|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 2-Period 1 (Day1)||0||
59920509|NCT03874234|76040413|FG002|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 2-Period 1 (Day1)||0||
59920510|NCT03874234|76040414|FG003|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 2-Period 1 (Day1)||0||
59951427|NCT01251965|76070419|FG001|COMPLETED|Overall Study||3||
60048727|NCT01583374|76164482|FG000|STARTED|Placebo-controlled Phase (Week 0-24)||164||
60048728|NCT01583374|76164483|FG001|STARTED|Placebo-controlled Phase (Week 0-24)||163||
60048729|NCT01583374|76164484|FG002|STARTED|Placebo-controlled Phase (Week 0-24)||163||
60048730|NCT01583374|76164485|FG003|STARTED|Placebo-controlled Phase (Week 0-24)||0||
60048731|NCT01583374|76164486|FG004|STARTED|Placebo-controlled Phase (Week 0-24)||0||
59512852|NCT00913133|75606295|FG000|NOT COMPLETED|Overall Study||0||
59512853|NCT02787694|75606299|FG000|STARTED|Overall Study||22||
59512854|NCT02787694|75606299|FG000|COMPLETED|Overall Study||17||
60048732|NCT01583374|76164487|FG005|STARTED|Placebo-controlled Phase (Week 0-24)||0||
60048733|NCT01583374|76164488|FG006|STARTED|Placebo-controlled Phase (Week 0-24)||0||
60048734|NCT01583374|76164489|FG007|STARTED|Placebo-controlled Phase (Week 0-24)||0||
60048735|NCT01583374|76164490|FG008|STARTED|Placebo-controlled Phase (Week 0-24)||0||
60048736|NCT01583374|76164482|FG000|Received Treatment|Placebo-controlled Phase (Week 0-24)||164||
60048737|NCT01583374|76164483|FG001|Received Treatment|Placebo-controlled Phase (Week 0-24)||163||
60048738|NCT01583374|76164484|FG002|Received Treatment|Placebo-controlled Phase (Week 0-24)||163||
60048739|NCT01583374|76164485|FG003|Received Treatment|Placebo-controlled Phase (Week 0-24)||0||
60048740|NCT01583374|76164486|FG004|Received Treatment|Placebo-controlled Phase (Week 0-24)||0||
60048741|NCT01583374|76164487|FG005|Received Treatment|Placebo-controlled Phase (Week 0-24)||0||
60048742|NCT01583374|76164488|FG006|Received Treatment|Placebo-controlled Phase (Week 0-24)||0||
60048743|NCT01583374|76164489|FG007|Received Treatment|Placebo-controlled Phase (Week 0-24)||0||
60048744|NCT01583374|76164490|FG008|Received Treatment|Placebo-controlled Phase (Week 0-24)||0||
60048745|NCT01583374|76164482|FG000|Completed Week 16|Placebo-controlled Phase (Week 0-24)||150||
60048746|NCT01583374|76164483|FG001|Completed Week 16|Placebo-controlled Phase (Week 0-24)||151||
60048747|NCT01583374|76164484|FG002|Completed Week 16|Placebo-controlled Phase (Week 0-24)||144||
60048748|NCT01583374|76164485|FG003|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0||
60048749|NCT01583374|76164486|FG004|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0||
60048750|NCT01583374|76164487|FG005|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0||
60048751|NCT01583374|76164488|FG006|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0||
60048752|NCT01583374|76164489|FG007|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0||
60048753|NCT01583374|76164490|FG008|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0||
60048754|NCT01583374|76164482|FG000|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)|One participant who escaped early did not complete Week 24|51||
60048755|NCT01583374|76164483|FG001|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||49||
60048756|NCT01583374|76164484|FG002|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)|One participant who escaped early did not complete Week 24|49||
60048757|NCT01583374|76164485|FG003|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0||
59512855|NCT02787694|75606299|FG000|NOT COMPLETED|Overall Study||5||
59512856|NCT02789410|75606305|FG000|STARTED|Overall Study||66||
59512857|NCT02789410|75606306|FG001|STARTED|Overall Study||68||
59512858|NCT02789410|75606305|FG000|COMPLETED|Overall Study||66||
59512859|NCT02789410|75606306|FG001|COMPLETED|Overall Study||68||
59512860|NCT02789410|75606305|FG000|NOT COMPLETED|Overall Study||0||
59512861|NCT02789410|75606306|FG001|NOT COMPLETED|Overall Study||0||
59512862|NCT00939211|75606312|FG000|STARTED|AZD9164 100 Mcg First, Then Placebo|Cross-over study|28||
59512863|NCT00939211|75606312|FG000|COMPLETED|AZD9164 100 Mcg First, Then Placebo||28||
59512864|NCT00939211|75606312|FG000|NOT COMPLETED|AZD9164 100 Mcg First, Then Placebo||0||
59760116|NCT00896363|75879695|FG000|NOT COMPLETED|Overall Study||6||
59760117|NCT00896363|75879696|FG001|NOT COMPLETED|Overall Study||11||
59760118|NCT00896363|75879697|FG002|NOT COMPLETED|Overall Study||8||
59760119|NCT00900029|75879713|FG000|STARTED|Overall Study||38||
59760120|NCT00900029|75879714|FG001|STARTED|Overall Study||41||
59760121|NCT00900029|75879715|FG002|STARTED|Overall Study||41||
59760122|NCT00900029|75879716|FG003|STARTED|Overall Study||42||
59760123|NCT00900029|75879717|FG004|STARTED|Overall Study||44||
59760124|NCT00900029|75879713|FG000|COMPLETED|Overall Study||35||
60048758|NCT01583374|76164486|FG004|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0||
60048759|NCT01583374|76164487|FG005|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0||
60048760|NCT01583374|76164488|FG006|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0||
60048761|NCT01583374|76164489|FG007|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0||
60048762|NCT01583374|76164490|FG008|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0||
59512865|NCT00939211|75606312|FG000|STARTED|AZD9164 400 Mcg First, Then Placebo||28||
59512866|NCT00939211|75606312|FG000|COMPLETED|AZD9164 400 Mcg First, Then Placebo||28||
59512867|NCT00939211|75606312|FG000|NOT COMPLETED|AZD9164 400 Mcg First, Then Placebo||0||
59512868|NCT00939211|75606312|FG000|STARTED|AZD9164 1200 Mcg First, Then Placebo||28||
59760125|NCT00900029|75879714|FG001|COMPLETED|Overall Study||37||
60048763|NCT01583374|76164482|FG000|COMPLETED|Placebo-controlled Phase (Week 0-24)|Completed = participants who completed the Placebo-controlled Phase|145||
60048764|NCT01583374|76164483|FG001|COMPLETED|Placebo-controlled Phase (Week 0-24)|Completed = participants who completed the Placebo-controlled Phase|147||
60048765|NCT01583374|76164484|FG002|COMPLETED|Placebo-controlled Phase (Week 0-24)|Completed = participants who completed the Placebo-controlled Phase|138||
60048766|NCT01583374|76164485|FG003|COMPLETED|Placebo-controlled Phase (Week 0-24)||0||
60048767|NCT01583374|76164486|FG004|COMPLETED|Placebo-controlled Phase (Week 0-24)||0||
60048768|NCT01583374|76164487|FG005|COMPLETED|Placebo-controlled Phase (Week 0-24)||0||
60048769|NCT01583374|76164488|FG006|COMPLETED|Placebo-controlled Phase (Week 0-24)||0||
60048770|NCT01583374|76164489|FG007|COMPLETED|Placebo-controlled Phase (Week 0-24)||0||
59512869|NCT00939211|75606312|FG000|COMPLETED|AZD9164 1200 Mcg First, Then Placebo||28||
59512870|NCT00939211|75606312|FG000|NOT COMPLETED|AZD9164 1200 Mcg First, Then Placebo||0||
59512871|NCT00939211|75606312|FG000|STARTED|Spiriva 18 Mcg First, Then Placebo||28||
59512872|NCT00939211|75606312|FG000|COMPLETED|Spiriva 18 Mcg First, Then Placebo||28||
59512873|NCT00939211|75606312|FG000|NOT COMPLETED|Spiriva 18 Mcg First, Then Placebo||0||
59512874|NCT00939211|75606312|FG000|STARTED|Placebo||28||
59512875|NCT00939211|75606312|FG000|COMPLETED|Placebo||28||
59512876|NCT00939211|75606312|FG000|NOT COMPLETED|Placebo||0||
59512877|NCT02791906|75606326|FG000|STARTED|Overall Study||4||
59512878|NCT02791906|75606327|FG001|STARTED|Overall Study||3||
59512879|NCT02791906|75606326|FG000|COMPLETED|Overall Study||2||
59512880|NCT02791906|75606327|FG001|COMPLETED|Overall Study||2||
60048771|NCT01583374|76164490|FG008|COMPLETED|Placebo-controlled Phase (Week 0-24)||0||
60048772|NCT01583374|76164482|FG000|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||19||
60048773|NCT01583374|76164483|FG001|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||16||
60048774|NCT01583374|76164484|FG002|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||25||
60048775|NCT01583374|76164485|FG003|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0||
60048776|NCT01583374|76164486|FG004|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0||
60048777|NCT01583374|76164487|FG005|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0||
60048778|NCT01583374|76164488|FG006|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0||
60048779|NCT01583374|76164489|FG007|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0||
60048780|NCT01583374|76164490|FG008|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0||
60048781|NCT01583374|76164482|FG000|STARTED|Extension Phase (Weeks 24 to 52)||0|9 participants who completed Week 24 did not continue in the extension phase.|
60048782|NCT01583374|76164483|FG001|STARTED|Extension Phase (Weeks 24 to 52)||74|9 participants who completed Week 24 did not continue in the extension phase.|
60048783|NCT01583374|76164484|FG002|STARTED|Extension Phase (Weeks 24 to 52)||65|9 participants who completed Week 24 did not continue in the extension phase.|
60048784|NCT01583374|76164485|FG003|STARTED|Extension Phase (Weeks 24 to 52)||47|9 participants who completed Week 24 did not continue in the extension phase.|
60048785|NCT01583374|76164486|FG004|STARTED|Extension Phase (Weeks 24 to 52)||91|9 participants who completed Week 24 did not continue in the extension phase.|
60048786|NCT01583374|76164487|FG005|STARTED|Extension Phase (Weeks 24 to 52)||48|9 participants who completed Week 24 did not continue in the extension phase.|
60048787|NCT01583374|76164488|FG006|STARTED|Extension Phase (Weeks 24 to 52)||48|9 participants who completed Week 24 did not continue in the extension phase.|
60048788|NCT01583374|76164489|FG007|STARTED|Extension Phase (Weeks 24 to 52)||25|9 participants who completed Week 24 did not continue in the extension phase.|
60048789|NCT01583374|76164490|FG008|STARTED|Extension Phase (Weeks 24 to 52)||23|9 participants who completed Week 24 did not continue in the extension phase.|
60048790|NCT01583374|76164482|FG000|COMPLETED|Extension Phase (Weeks 24 to 52)||0||
60048791|NCT01583374|76164483|FG001|COMPLETED|Extension Phase (Weeks 24 to 52)||69||
60048792|NCT01583374|76164484|FG002|COMPLETED|Extension Phase (Weeks 24 to 52)||61||
60048793|NCT01583374|76164485|FG003|COMPLETED|Extension Phase (Weeks 24 to 52)||41||
60048794|NCT01583374|76164486|FG004|COMPLETED|Extension Phase (Weeks 24 to 52)||85||
60048795|NCT01583374|76164487|FG005|COMPLETED|Extension Phase (Weeks 24 to 52)||43||
60048796|NCT01583374|76164488|FG006|COMPLETED|Extension Phase (Weeks 24 to 52)||43||
60048797|NCT01583374|76164489|FG007|COMPLETED|Extension Phase (Weeks 24 to 52)||22||
60048798|NCT01583374|76164490|FG008|COMPLETED|Extension Phase (Weeks 24 to 52)||21||
60048799|NCT01583374|76164482|FG000|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||0||
60048800|NCT01583374|76164483|FG001|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||5||
60048801|NCT01583374|76164484|FG002|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||4||
60048802|NCT01583374|76164485|FG003|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||6||
60048803|NCT01583374|76164486|FG004|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||6||
60048804|NCT01583374|76164487|FG005|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||5||
60048805|NCT01583374|76164488|FG006|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||5||
60048806|NCT01583374|76164489|FG007|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||3||
60048807|NCT01583374|76164490|FG008|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||2||
60048808|NCT01583374|76164482|FG000|STARTED|Long-Term Extension Phase Weeks 52-260||0|24 participants who completed Week 52 did not continue in the Week 52-260 study period|
60048809|NCT01583374|76164483|FG001|STARTED|Long-Term Extension Phase Weeks 52-260||66|24 participants who completed Week 52 did not continue in the Week 52-260 study period|
60067846|NCT01617967|76183034|FG005|NOT COMPLETED|Overall Study||1||
59512881|NCT02791906|75606326|FG000|NOT COMPLETED|Overall Study||2||
59512882|NCT02791906|75606327|FG001|NOT COMPLETED|Overall Study||1||
60048810|NCT01583374|76164484|FG002|STARTED|Long-Term Extension Phase Weeks 52-260||61|24 participants who completed Week 52 did not continue in the Week 52-260 study period|
60048811|NCT01583374|76164485|FG003|STARTED|Long-Term Extension Phase Weeks 52-260||35|24 participants who completed Week 52 did not continue in the Week 52-260 study period|
60048812|NCT01583374|76164486|FG004|STARTED|Long-Term Extension Phase Weeks 52-260||81|24 participants who completed Week 52 did not continue in the Week 52-260 study period|
60048813|NCT01583374|76164487|FG005|STARTED|Long-Term Extension Phase Weeks 52-260||39|24 participants who completed Week 52 did not continue in the Week 52-260 study period|
60048814|NCT01583374|76164488|FG006|STARTED|Long-Term Extension Phase Weeks 52-260||38|24 participants who completed Week 52 did not continue in the Week 52-260 study period|
60048815|NCT01583374|76164489|FG007|STARTED|Long-Term Extension Phase Weeks 52-260||21|24 participants who completed Week 52 did not continue in the Week 52-260 study period|
60048816|NCT01583374|76164490|FG008|STARTED|Long-Term Extension Phase Weeks 52-260||20|24 participants who completed Week 52 did not continue in the Week 52-260 study period|
60048817|NCT01583374|76164482|FG000|COMPLETED|Long-Term Extension Phase Weeks 52-260||0||
60048818|NCT01583374|76164483|FG001|COMPLETED|Long-Term Extension Phase Weeks 52-260||40||
60048819|NCT01583374|76164484|FG002|COMPLETED|Long-Term Extension Phase Weeks 52-260||41||
60048820|NCT01583374|76164485|FG003|COMPLETED|Long-Term Extension Phase Weeks 52-260||22||
60048821|NCT01583374|76164486|FG004|COMPLETED|Long-Term Extension Phase Weeks 52-260||50||
59512883|NCT02793154|75606338|FG000|STARTED|Part A (Single Group-up to 12 Days)||4||
59512884|NCT02793154|75606339|FG001|STARTED|Part A (Single Group-up to 12 Days)||0||
59512885|NCT02793154|75606340|FG002|STARTED|Part A (Single Group-up to 12 Days)||0||
59512886|NCT02793154|75606338|FG000|COMPLETED|Part A (Single Group-up to 12 Days)||4||
59512887|NCT02793154|75606339|FG001|COMPLETED|Part A (Single Group-up to 12 Days)||0||
59512888|NCT02793154|75606340|FG002|COMPLETED|Part A (Single Group-up to 12 Days)||0||
59512889|NCT02793154|75606338|FG000|NOT COMPLETED|Part A (Single Group-up to 12 Days)||0||
59512890|NCT02793154|75606339|FG001|NOT COMPLETED|Part A (Single Group-up to 12 Days)||0||
59512891|NCT02793154|75606340|FG002|NOT COMPLETED|Part A (Single Group-up to 12 Days)||0||
59512892|NCT02793154|75606338|FG000|STARTED|Part B (Parallel Group-up to 84 Days)||0||
59512893|NCT02793154|75606339|FG001|STARTED|Part B (Parallel Group-up to 84 Days)||0||
59512894|NCT02793154|75606340|FG002|STARTED|Part B (Parallel Group-up to 84 Days)||0||
59512895|NCT02793154|75606338|FG000|COMPLETED|Part B (Parallel Group-up to 84 Days)||0||
59512896|NCT02793154|75606339|FG001|COMPLETED|Part B (Parallel Group-up to 84 Days)||0||
59512897|NCT02793154|75606340|FG002|COMPLETED|Part B (Parallel Group-up to 84 Days)||0||
60048822|NCT01583374|76164487|FG005|COMPLETED|Long-Term Extension Phase Weeks 52-260||22||
60048823|NCT01583374|76164488|FG006|COMPLETED|Long-Term Extension Phase Weeks 52-260||20||
60048824|NCT01583374|76164489|FG007|COMPLETED|Long-Term Extension Phase Weeks 52-260||12||
60048825|NCT01583374|76164490|FG008|COMPLETED|Long-Term Extension Phase Weeks 52-260||10||
60048826|NCT01583374|76164482|FG000|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||0||
60048827|NCT01583374|76164483|FG001|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||26||
60048828|NCT01583374|76164484|FG002|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||20||
60048829|NCT01583374|76164485|FG003|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||13||
60048830|NCT01583374|76164486|FG004|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||31||
60048831|NCT01583374|76164487|FG005|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||17||
60048832|NCT01583374|76164488|FG006|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||18||
60048833|NCT01583374|76164489|FG007|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||9||
60048834|NCT01583374|76164490|FG008|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||10||
60048835|NCT01583296|76164511|FG000|STARTED|Overall Study||27||
60048836|NCT01583296|76164512|FG001|STARTED|Overall Study||26||
60048837|NCT01583296|76164511|FG000|COMPLETED|Overall Study||16||
60048838|NCT01583296|76164512|FG001|COMPLETED|Overall Study||16||
60048839|NCT01583296|76164511|FG000|NOT COMPLETED|Overall Study||11||
59512898|NCT02793154|75606338|FG000|NOT COMPLETED|Part B (Parallel Group-up to 84 Days)||0||
59512899|NCT02793154|75606339|FG001|NOT COMPLETED|Part B (Parallel Group-up to 84 Days)||0||
59512900|NCT02793154|75606340|FG002|NOT COMPLETED|Part B (Parallel Group-up to 84 Days)||0||
59512901|NCT02907268|75606350|FG000|STARTED|Overall Study||5||
59512902|NCT02907268|75606351|FG001|STARTED|Overall Study||5||
59612691|NCT01717326|75723760|FG000|STARTED|Overall Study||25||
60048840|NCT01583296|76164512|FG001|NOT COMPLETED|Overall Study||10||
60048841|NCT02222714|76164523|FG000|STARTED|Overall Study||15||
60048842|NCT02222714|76164524|FG001|STARTED|Overall Study||24||
60048843|NCT02222714|76164525|FG002|STARTED|Overall Study||12||
60048844|NCT02222714|76164526|FG003|STARTED|Overall Study||15||
60048845|NCT02222714|76164527|FG004|STARTED|Overall Study||44||
60048846|NCT02222714|76164523|FG000|COMPLETED|Overall Study||15||
60048847|NCT02222714|76164524|FG001|COMPLETED|Overall Study||22||
60048848|NCT02222714|76164525|FG002|COMPLETED|Overall Study||8||
60048849|NCT02222714|76164526|FG003|COMPLETED|Overall Study||11||
60048850|NCT02222714|76164527|FG004|COMPLETED|Overall Study||37||
60048851|NCT02222714|76164523|FG000|NOT COMPLETED|Overall Study||0||
60048852|NCT02222714|76164524|FG001|NOT COMPLETED|Overall Study||2||
60048853|NCT02222714|76164525|FG002|NOT COMPLETED|Overall Study||4||
60048854|NCT02222714|76164526|FG003|NOT COMPLETED|Overall Study||4||
60048855|NCT02222714|76164527|FG004|NOT COMPLETED|Overall Study||7||
60048856|NCT02164916|76164544|FG000|STARTED|Overall Study||52||
60048857|NCT02164916|76164545|FG001|STARTED|Overall Study||54||
60048858|NCT02164916|76164544|FG000|Eligible|Overall Study||50||
60048859|NCT02164916|76164545|FG001|Eligible|Overall Study||49||
60048860|NCT02164916|76164544|FG000|Cross-over to Arm II|Overall Study|Following disease progression on Arm 1. Note: these patients are also counted in 'Not Completed'.|24||
59512903|NCT02907268|75606350|FG000|COMPLETED|Overall Study||5||
59512904|NCT02907268|75606351|FG001|COMPLETED|Overall Study||5||
59512905|NCT02907268|75606350|FG000|NOT COMPLETED|Overall Study||0||
60048861|NCT02164916|76164545|FG001|Cross-over to Arm II|Overall Study||0||
60048862|NCT02164916|76164544|FG000|COMPLETED|Overall Study||0||
60048863|NCT02164916|76164545|FG001|COMPLETED|Overall Study||0||
60048864|NCT02164916|76164544|FG000|NOT COMPLETED|Overall Study||52||
60048865|NCT02164916|76164545|FG001|NOT COMPLETED|Overall Study||54||
60048866|NCT02222558|76164556|FG000|STARTED|Period 1: Single Dose||25||
60048867|NCT02222558|76164557|FG001|STARTED|Period 1: Single Dose||0||
60048868|NCT02222558|76164558|FG002|STARTED|Period 1: Single Dose||0||
60048869|NCT02222558|76164559|FG003|STARTED|Period 1: Single Dose||0||
60048870|NCT02222558|76164560|FG004|STARTED|Period 1: Single Dose||0||
60048871|NCT02222558|76164561|FG005|STARTED|Period 1: Single Dose||0||
60048872|NCT02222558|76164556|FG000|COMPLETED|Period 1: Single Dose||21||
60048873|NCT02222558|76164557|FG001|COMPLETED|Period 1: Single Dose||0||
60048874|NCT02222558|76164558|FG002|COMPLETED|Period 1: Single Dose||0||
60048875|NCT02222558|76164559|FG003|COMPLETED|Period 1: Single Dose||0||
60048876|NCT02222558|76164560|FG004|COMPLETED|Period 1: Single Dose||0||
60048877|NCT02222558|76164561|FG005|COMPLETED|Period 1: Single Dose||0||
60048878|NCT02222558|76164556|FG000|NOT COMPLETED|Period 1: Single Dose||4||
59512906|NCT02907268|75606351|FG001|NOT COMPLETED|Overall Study||0||
59512907|NCT02907814|75606358|FG000|STARTED|Overall Study||6||
59512908|NCT02907814|75606359|FG001|STARTED|Overall Study||0||
59512909|NCT02907814|75606358|FG000|COMPLETED|Overall Study||0||
60048879|NCT02222558|76164557|FG001|NOT COMPLETED|Period 1: Single Dose||0||
60048880|NCT02222558|76164558|FG002|NOT COMPLETED|Period 1: Single Dose||0||
60048881|NCT02222558|76164559|FG003|NOT COMPLETED|Period 1: Single Dose||0||
60048882|NCT02222558|76164560|FG004|NOT COMPLETED|Period 1: Single Dose||0||
60048883|NCT02222558|76164561|FG005|NOT COMPLETED|Period 1: Single Dose||0||
60048884|NCT02222558|76164556|FG000|STARTED|Period 2: Two Times Daily Dosing 90 mg||0||
60048885|NCT02222558|76164557|FG001|STARTED|Period 2: Two Times Daily Dosing 90 mg||21||
60048886|NCT02222558|76164558|FG002|STARTED|Period 2: Two Times Daily Dosing 90 mg||0||
60048887|NCT02222558|76164559|FG003|STARTED|Period 2: Two Times Daily Dosing 90 mg||0||
60048888|NCT02222558|76164560|FG004|STARTED|Period 2: Two Times Daily Dosing 90 mg||0||
60048889|NCT02222558|76164561|FG005|STARTED|Period 2: Two Times Daily Dosing 90 mg||0||
60048890|NCT02222558|76164556|FG000|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0||
60048891|NCT02222558|76164557|FG001|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||21||
60048892|NCT02222558|76164558|FG002|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0||
60048893|NCT02222558|76164559|FG003|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0||
60048894|NCT02222558|76164560|FG004|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0||
60048895|NCT02222558|76164561|FG005|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0||
60048896|NCT02222558|76164556|FG000|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0||
60048897|NCT02222558|76164557|FG001|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0||
60048898|NCT02222558|76164558|FG002|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0||
60048899|NCT02222558|76164559|FG003|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0||
60048900|NCT02222558|76164560|FG004|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0||
60048901|NCT02222558|76164561|FG005|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0||
60048902|NCT02222558|76164556|FG000|STARTED|Period 3||0||
59512910|NCT02907814|75606359|FG001|COMPLETED|Overall Study||0||
59512911|NCT02907814|75606358|FG000|NOT COMPLETED|Overall Study||6||
59512912|NCT02907814|75606359|FG001|NOT COMPLETED|Overall Study||0||
59512913|NCT02909140|75606368|FG000|STARTED|Overall Study||0||
59512914|NCT02909140|75606369|FG001|STARTED|Overall Study||2||
59512915|NCT02909140|75606370|FG002|STARTED|Overall Study||0||
59512916|NCT02909140|75606368|FG000|COMPLETED|Overall Study||0||
59512917|NCT02909140|75606369|FG001|COMPLETED|Overall Study||2||
60048903|NCT02222558|76164557|FG001|STARTED|Period 3||0||
60048904|NCT02222558|76164558|FG002|STARTED|Period 3||4||
60048905|NCT02222558|76164559|FG003|STARTED|Period 3||1||
60048906|NCT02222558|76164560|FG004|STARTED|Period 3||8||
60048907|NCT02222558|76164561|FG005|STARTED|Period 3||8||
60048908|NCT02222558|76164556|FG000|COMPLETED|Period 3||0||
60048909|NCT02222558|76164557|FG001|COMPLETED|Period 3||0||
59512918|NCT02909140|75606370|FG002|COMPLETED|Overall Study||0||
59512919|NCT02909140|75606368|FG000|NOT COMPLETED|Overall Study||0||
59512920|NCT02909140|75606369|FG001|NOT COMPLETED|Overall Study||0||
60048910|NCT02222558|76164558|FG002|COMPLETED|Period 3||4||
60048911|NCT02222558|76164559|FG003|COMPLETED|Period 3||1||
60048912|NCT02222558|76164560|FG004|COMPLETED|Period 3||8||
60048913|NCT02222558|76164561|FG005|COMPLETED|Period 3||7||
60048914|NCT02222558|76164556|FG000|NOT COMPLETED|Period 3||0||
60048915|NCT02222558|76164557|FG001|NOT COMPLETED|Period 3||0||
60048916|NCT02222558|76164558|FG002|NOT COMPLETED|Period 3||0||
60048917|NCT02222558|76164559|FG003|NOT COMPLETED|Period 3||0||
60048918|NCT02222558|76164560|FG004|NOT COMPLETED|Period 3||0||
59920511|NCT03874234|76040415|FG004|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 2-Period 1 (Day1)||2||
59920512|NCT03874234|76040416|FG005|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 2-Period 1 (Day1)||2||
59920513|NCT03874234|76040417|FG006|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 2-Period 1 (Day1)||2||
59920514|NCT03874234|76040418|FG007|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 2-Period 1 (Day1)||2||
59920515|NCT03874234|76040419|FG008|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 2-Period 1 (Day1)||0||
59920516|NCT03874234|76040420|FG009|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 2-Period 1 (Day1)||0||
59920517|NCT03874234|76040421|FG010|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 2-Period 1 (Day1)||0||
59920518|NCT03874234|76040422|FG011|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 2-Period 1 (Day1)||0||
59920519|NCT03874234|76040423|FG012|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 2-Period 1 (Day1)||0||
59920520|NCT03874234|76040411|FG000|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
59920521|NCT03874234|76040412|FG001|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
59920522|NCT03874234|76040413|FG002|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
59920523|NCT03874234|76040414|FG003|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
59920524|NCT03874234|76040415|FG004|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||1||
59920525|NCT03874234|76040416|FG005|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||1||
59920526|NCT03874234|76040417|FG006|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||2||
59920527|NCT03874234|76040418|FG007|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||1||
59920528|NCT03874234|76040419|FG008|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
59920529|NCT03874234|76040420|FG009|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
59920530|NCT03874234|76040421|FG010|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
59920531|NCT03874234|76040422|FG011|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
59920532|NCT03874234|76040423|FG012|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
59920533|NCT03874234|76040411|FG000|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
59920534|NCT03874234|76040412|FG001|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
59920535|NCT03874234|76040413|FG002|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
59920536|NCT03874234|76040414|FG003|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
59920537|NCT03874234|76040415|FG004|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||2||
59920538|NCT03874234|76040416|FG005|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||1||
59920539|NCT03874234|76040417|FG006|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
59920540|NCT03874234|76040418|FG007|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||1||
59920541|NCT03874234|76040419|FG008|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
59920542|NCT03874234|76040420|FG009|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
59920543|NCT03874234|76040421|FG010|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
59920544|NCT03874234|76040422|FG011|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
59920545|NCT03874234|76040423|FG012|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
59920546|NCT03874234|76040411|FG000|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day10)||0||
59920547|NCT03874234|76040412|FG001|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day10)||0||
59920548|NCT03874234|76040413|FG002|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day10)||0||
59920549|NCT03874234|76040414|FG003|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day10)||0||
59920550|NCT03874234|76040415|FG004|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day10)||1||
59920551|NCT03874234|76040416|FG005|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day10)||1||
59920552|NCT03874234|76040417|FG006|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day10)||2||
59920553|NCT03874234|76040418|FG007|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day10)||1||
59920554|NCT03874234|76040419|FG008|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day10)||0||
59920555|NCT03874234|76040420|FG009|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day10)||0||
59920556|NCT03874234|76040421|FG010|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day10)||0||
59920557|NCT03874234|76040422|FG011|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day10)||0||
59920558|NCT03874234|76040423|FG012|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day10)||0||
59920559|NCT03874234|76040411|FG000|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day10)||0||
59920560|NCT03874234|76040412|FG001|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day10)||0||
59920561|NCT03874234|76040413|FG002|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day10)||0||
59920562|NCT03874234|76040414|FG003|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day10)||0||
59920563|NCT03874234|76040415|FG004|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day10)||1||
59920564|NCT03874234|76040416|FG005|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day10)||1||
59920565|NCT03874234|76040417|FG006|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day10)||2||
59920566|NCT03874234|76040418|FG007|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day10)||1||
59920567|NCT03874234|76040419|FG008|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day10)||0||
59920568|NCT03874234|76040420|FG009|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day10)||0||
59920569|NCT03874234|76040421|FG010|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day10)||0||
59920570|NCT03874234|76040422|FG011|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day10)||0||
59920571|NCT03874234|76040423|FG012|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day10)||0||
59920572|NCT03874234|76040411|FG000|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day10)||0||
59920573|NCT03874234|76040412|FG001|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day10)||0||
59920574|NCT03874234|76040413|FG002|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day10)||0||
59920575|NCT03874234|76040414|FG003|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day10)||0||
59920576|NCT03874234|76040415|FG004|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day10)||0||
59920577|NCT03874234|76040416|FG005|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day10)||0||
59920578|NCT03874234|76040417|FG006|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day10)||0||
59920579|NCT03874234|76040418|FG007|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day10)||0||
59920580|NCT03874234|76040419|FG008|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day10)||0||
59920581|NCT03874234|76040420|FG009|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day10)||0||
59920582|NCT03874234|76040421|FG010|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day10)||0||
59920583|NCT03874234|76040422|FG011|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day10)||0||
59920584|NCT03874234|76040423|FG012|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day10)||0||
59920585|NCT03874234|76040411|FG000|STARTED|Part A: Cohort 2-Period 2 (Day1)||0||
59920586|NCT03874234|76040412|FG001|STARTED|Part A: Cohort 2-Period 2 (Day1)||0||
59612692|NCT01717326|75723761|FG001|STARTED|Overall Study||27||
59612693|NCT01717326|75723762|FG002|STARTED|Overall Study||13||
59920587|NCT03874234|76040413|FG002|STARTED|Part A: Cohort 2-Period 2 (Day1)||0||
59920588|NCT03874234|76040414|FG003|STARTED|Part A: Cohort 2-Period 2 (Day1)||0||
59920589|NCT03874234|76040415|FG004|STARTED|Part A: Cohort 2-Period 2 (Day1)|New participant enrolled and dosed.|2||
59612694|NCT01717326|75723763|FG003|STARTED|Overall Study||30||
59612695|NCT01717326|75723764|FG004|STARTED|Overall Study||33||
59612696|NCT01717326|75723765|FG005|STARTED|Overall Study||31||
59920590|NCT03874234|76040416|FG005|STARTED|Part A: Cohort 2-Period 2 (Day1)|New participant enrolled and dosed.|2||
59920591|NCT03874234|76040417|FG006|STARTED|Part A: Cohort 2-Period 2 (Day1)||2||
59920592|NCT03874234|76040418|FG007|STARTED|Part A: Cohort 2-Period 2 (Day1)|New participant enrolled and dosed.|2||
59920593|NCT03874234|76040419|FG008|STARTED|Part A: Cohort 2-Period 2 (Day1)||0||
59920594|NCT03874234|76040420|FG009|STARTED|Part A: Cohort 2-Period 2 (Day1)||0||
59920595|NCT03874234|76040421|FG010|STARTED|Part A: Cohort 2-Period 2 (Day1)||0||
59920596|NCT03874234|76040422|FG011|STARTED|Part A: Cohort 2-Period 2 (Day1)||0||
59920597|NCT03874234|76040423|FG012|STARTED|Part A: Cohort 2-Period 2 (Day1)||0||
59920598|NCT03874234|76040411|FG000|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 2-Period 2 (Day1)||0||
59920599|NCT03874234|76040412|FG001|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 2-Period 2 (Day1)||0||
59920600|NCT03874234|76040413|FG002|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 2-Period 2 (Day1)||0||
59920601|NCT03874234|76040414|FG003|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 2-Period 2 (Day1)||0||
59920602|NCT03874234|76040415|FG004|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 2-Period 2 (Day1)||1||
59920603|NCT03874234|76040416|FG005|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 2-Period 2 (Day1)||1||
60048919|NCT02222558|76164561|FG005|NOT COMPLETED|Period 3||1||
60048920|NCT02188784|76164577|FG000|STARTED|Overall Study||111||
60048921|NCT02188784|76164578|FG001|STARTED|Overall Study||114||
60067847|NCT01785615|76183052|FG000|STARTED|Dietary Phase||0||
59512921|NCT02909140|75606370|FG002|NOT COMPLETED|Overall Study||0||
59512922|NCT02909764|75606380|FG000|STARTED|Overall Study||19||
59512923|NCT02909764|75606381|FG001|STARTED|Overall Study||20||
59512924|NCT02909764|75606380|FG000|COMPLETED|Overall Study||19||
59512925|NCT02909764|75606381|FG001|COMPLETED|Overall Study||20||
59512926|NCT02909764|75606380|FG000|NOT COMPLETED|Overall Study||0||
59512927|NCT02909764|75606381|FG001|NOT COMPLETED|Overall Study||0||
59512928|NCT04348435|75606394|FG000|STARTED|Overall Study||19||
59512929|NCT04348435|75606395|FG001|STARTED|Overall Study||9||
59512930|NCT04348435|75606396|FG002|STARTED|Overall Study||12||
59512931|NCT04348435|75606397|FG003|STARTED|Overall Study||13||
59512932|NCT04348435|75606394|FG000|COMPLETED|Overall Study||11||
59512933|NCT04348435|75606395|FG001|COMPLETED|Overall Study||5||
59512934|NCT04348435|75606396|FG002|COMPLETED|Overall Study||9||
59512935|NCT04348435|75606397|FG003|COMPLETED|Overall Study||10||
59512936|NCT04348435|75606394|FG000|NOT COMPLETED|Overall Study||8||
59512937|NCT04348435|75606395|FG001|NOT COMPLETED|Overall Study||4||
59512938|NCT04348435|75606396|FG002|NOT COMPLETED|Overall Study||3||
59512939|NCT04348435|75606397|FG003|NOT COMPLETED|Overall Study||3||
59512940|NCT01722929|75606407|FG000|STARTED|Overall Study||4||
59512941|NCT01722929|75606407|FG000|COMPLETED|Overall Study||4||
59512942|NCT01722929|75606407|FG000|NOT COMPLETED|Overall Study||0||
59512943|NCT02793856|75606416|FG000|STARTED|Overall Study||2||
59512944|NCT02793856|75606417|FG001|STARTED|Overall Study||4||
59512945|NCT02793856|75606418|FG002|STARTED|Overall Study||3||
59512946|NCT02793856|75606419|FG003|STARTED|Overall Study||3||
59612697|NCT01717326|75723766|FG006|STARTED|Overall Study||31||
59612698|NCT01717326|75723767|FG007|STARTED|Overall Study||29||
59512947|NCT02793856|75606416|FG000|COMPLETED|Overall Study||2||
59512948|NCT02793856|75606417|FG001|COMPLETED|Overall Study||4||
59512949|NCT02793856|75606418|FG002|COMPLETED|Overall Study||3||
59512950|NCT02793856|75606419|FG003|COMPLETED|Overall Study||3||
59920604|NCT03874234|76040417|FG006|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 2-Period 2 (Day1)||0||
59920605|NCT03874234|76040418|FG007|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 2-Period 2 (Day1)||1||
59920606|NCT03874234|76040419|FG008|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 2-Period 2 (Day1)||0||
59920607|NCT03874234|76040420|FG009|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 2-Period 2 (Day1)||0||
59920608|NCT03874234|76040421|FG010|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 2-Period 2 (Day1)||0||
59920609|NCT03874234|76040422|FG011|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 2-Period 2 (Day1)||0||
59920610|NCT03874234|76040423|FG012|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 2-Period 2 (Day1)||0||
59920611|NCT03874234|76040411|FG000|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
59920612|NCT03874234|76040412|FG001|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
59920613|NCT03874234|76040413|FG002|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
59920614|NCT03874234|76040414|FG003|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
59512951|NCT02793856|75606416|FG000|NOT COMPLETED|Overall Study||0||
59512952|NCT02793856|75606417|FG001|NOT COMPLETED|Overall Study||0||
59512953|NCT02793856|75606418|FG002|NOT COMPLETED|Overall Study||0||
59512954|NCT02793856|75606419|FG003|NOT COMPLETED|Overall Study||0||
59512955|NCT02911324|75606459|FG000|STARTED|Overall Study||9||
59512956|NCT02911324|75606460|FG001|STARTED|Overall Study||7||
59920615|NCT03874234|76040415|FG004|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||1||
59920616|NCT03874234|76040416|FG005|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||2||
59920617|NCT03874234|76040417|FG006|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||1||
59920618|NCT03874234|76040418|FG007|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||2||
59920619|NCT03874234|76040419|FG008|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
59920620|NCT03874234|76040420|FG009|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
59920621|NCT03874234|76040421|FG010|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
59920622|NCT03874234|76040422|FG011|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
59920623|NCT03874234|76040423|FG012|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
59920624|NCT03874234|76040411|FG000|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
59920625|NCT03874234|76040412|FG001|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
59920626|NCT03874234|76040413|FG002|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
59512957|NCT02911324|75606459|FG000|COMPLETED|Overall Study||6||
59512958|NCT02911324|75606460|FG001|COMPLETED|Overall Study||6||
59512959|NCT02911324|75606459|FG000|NOT COMPLETED|Overall Study||3||
59512960|NCT02911324|75606460|FG001|NOT COMPLETED|Overall Study||1||
59512961|NCT02914132|75606467|FG000|STARTED|Overall Study||15||
59512962|NCT02914132|75606467|FG000|COMPLETED|Overall Study||15||
59512963|NCT02914132|75606467|FG000|NOT COMPLETED|Overall Study||0||
59512964|NCT02914210|75606473|FG000|STARTED|Overall Study||153||
59920627|NCT03874234|76040414|FG003|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
59920628|NCT03874234|76040415|FG004|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||1||
59920629|NCT03874234|76040416|FG005|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
59920630|NCT03874234|76040417|FG006|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||1||
59920631|NCT03874234|76040418|FG007|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
59920632|NCT03874234|76040419|FG008|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
59920633|NCT03874234|76040420|FG009|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
59920634|NCT03874234|76040421|FG010|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
59920635|NCT03874234|76040422|FG011|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
59920636|NCT03874234|76040423|FG012|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
59920637|NCT03874234|76040411|FG000|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day10)||0||
59920638|NCT03874234|76040412|FG001|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day10)||0||
59920639|NCT03874234|76040413|FG002|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day10)||0||
59920640|NCT03874234|76040414|FG003|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day10)||0||
59920641|NCT03874234|76040415|FG004|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day10)||1||
59920642|NCT03874234|76040416|FG005|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day10)||2||
59920643|NCT03874234|76040417|FG006|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day10)||1||
59920644|NCT03874234|76040418|FG007|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day10)||2||
59920645|NCT03874234|76040419|FG008|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day10)||0||
59920646|NCT03874234|76040420|FG009|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day10)||0||
59920647|NCT03874234|76040421|FG010|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day10)||0||
59920648|NCT03874234|76040422|FG011|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day10)||0||
59920649|NCT03874234|76040423|FG012|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day10)||0||
59920650|NCT03874234|76040411|FG000|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day10)||0||
59920651|NCT03874234|76040412|FG001|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day10)||0||
59920652|NCT03874234|76040413|FG002|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day10)||0||
59512965|NCT02914210|75606474|FG001|STARTED|Overall Study||153||
59512966|NCT02914210|75606473|FG000|COMPLETED|Overall Study||143||
59512967|NCT02914210|75606474|FG001|COMPLETED|Overall Study||144||
59512968|NCT02914210|75606473|FG000|NOT COMPLETED|Overall Study||10||
59512969|NCT02914210|75606474|FG001|NOT COMPLETED|Overall Study||9||
59920653|NCT03874234|76040414|FG003|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day10)||0||
59920654|NCT03874234|76040415|FG004|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day10)||1||
59920655|NCT03874234|76040416|FG005|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day10)||2||
59920656|NCT03874234|76040417|FG006|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day10)||1||
59920657|NCT03874234|76040418|FG007|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day10)||2||
59920658|NCT03874234|76040419|FG008|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day10)||0||
59920659|NCT03874234|76040420|FG009|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day10)||0||
59920660|NCT03874234|76040421|FG010|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day10)||0||
59920661|NCT03874234|76040422|FG011|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day10)||0||
59920662|NCT03874234|76040423|FG012|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day10)||0||
59920663|NCT03874234|76040411|FG000|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day10)||0||
59920664|NCT03874234|76040412|FG001|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day10)||0||
59512970|NCT00913913|75606480|FG000|STARTED|Overall Study||8||
59512971|NCT00913913|75606480|FG000|COMPLETED|Overall Study||0||
59920665|NCT03874234|76040413|FG002|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day10)||0||
59920666|NCT03874234|76040414|FG003|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day10)||0||
59920667|NCT03874234|76040415|FG004|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day10)||0||
59920668|NCT03874234|76040416|FG005|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day10)||0||
59920669|NCT03874234|76040417|FG006|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day10)||0||
59920670|NCT03874234|76040418|FG007|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day10)||0||
59920671|NCT03874234|76040419|FG008|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day10)||0||
59920672|NCT03874234|76040420|FG009|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day10)||0||
59920673|NCT03874234|76040421|FG010|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day10)||0||
59920674|NCT03874234|76040422|FG011|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day10)||0||
59920675|NCT03874234|76040423|FG012|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day10)||0||
59920676|NCT03874234|76040411|FG000|STARTED|Part A: Cohort 2-Period 3 (Day1)||0||
59920677|NCT03874234|76040412|FG001|STARTED|Part A: Cohort 2-Period 3 (Day1)||0||
59920678|NCT03874234|76040413|FG002|STARTED|Part A: Cohort 2-Period 3 (Day1)||0||
59920679|NCT03874234|76040414|FG003|STARTED|Part A: Cohort 2-Period 3 (Day1)||0||
59920680|NCT03874234|76040415|FG004|STARTED|Part A: Cohort 2-Period 3 (Day1)|New participant enrolled and dosed.|2||
59920681|NCT03874234|76040416|FG005|STARTED|Part A: Cohort 2-Period 3 (Day1)||2||
59920682|NCT03874234|76040417|FG006|STARTED|Part A: Cohort 2-Period 3 (Day1)|New participant enrolled and dosed.|2||
59920683|NCT03874234|76040418|FG007|STARTED|Part A: Cohort 2-Period 3 (Day1)||2||
59920684|NCT03874234|76040419|FG008|STARTED|Part A: Cohort 2-Period 3 (Day1)||0||
59920685|NCT03874234|76040420|FG009|STARTED|Part A: Cohort 2-Period 3 (Day1)||0||
59920686|NCT03874234|76040421|FG010|STARTED|Part A: Cohort 2-Period 3 (Day1)||0||
59920687|NCT03874234|76040422|FG011|STARTED|Part A: Cohort 2-Period 3 (Day1)||0||
59920688|NCT03874234|76040423|FG012|STARTED|Part A: Cohort 2-Period 3 (Day1)||0||
59920689|NCT03874234|76040411|FG000|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 2-Period 3 (Day1)||0||
59920690|NCT03874234|76040412|FG001|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 2-Period 3 (Day1)||0||
59951428|NCT01251965|76070420|FG002|COMPLETED|Overall Study||7||
60048922|NCT02188784|76164577|FG000|COMPLETED|Overall Study|Patients completing the protocol excluding death, lost to follow-up and withdrawn consent.|102||
59512972|NCT00913913|75606480|FG000|NOT COMPLETED|Overall Study||8||
59512973|NCT02796274|75606484|FG000|STARTED|Overall Study||219||438
59512974|NCT02796274|75606484|FG000|COMPLETED|Overall Study||219||438
59920691|NCT03874234|76040413|FG002|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 2-Period 3 (Day1)||0||
59920692|NCT03874234|76040414|FG003|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 2-Period 3 (Day1)||0||
59920693|NCT03874234|76040415|FG004|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 2-Period 3 (Day1)||1||
59920694|NCT03874234|76040416|FG005|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 2-Period 3 (Day1)||0||
59920695|NCT03874234|76040417|FG006|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 2-Period 3 (Day1)||1||
59920696|NCT03874234|76040418|FG007|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 2-Period 3 (Day1)||0||
59920697|NCT03874234|76040419|FG008|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 2-Period 3 (Day1)||0||
59920698|NCT03874234|76040420|FG009|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 2-Period 3 (Day1)||0||
60048923|NCT02188784|76164578|FG001|COMPLETED|Overall Study|Patients completing the protocol excluding death, lost to follow-up and withdrawn consent.|101||
60048924|NCT02188784|76164577|FG000|NOT COMPLETED|Overall Study||9||
59512975|NCT02796274|75606484|FG000|NOT COMPLETED|Overall Study||0||0
59512976|NCT02796352|75606488|FG000|STARTED|Overall Study||1||
59512977|NCT02796352|75606488|FG000|COMPLETED|Overall Study||1||
59512978|NCT02796352|75606488|FG000|NOT COMPLETED|Overall Study||0||
59512979|NCT00939367|75606492|FG000|STARTED|First Intervention||15||
59512980|NCT00939367|75606493|FG001|STARTED|First Intervention||15||
59512981|NCT00939367|75606492|FG000|COMPLETED|First Intervention||15||
59512982|NCT00939367|75606493|FG001|COMPLETED|First Intervention||15||
59760126|NCT00900029|75879715|FG002|COMPLETED|Overall Study||38||
59760127|NCT00900029|75879716|FG003|COMPLETED|Overall Study||35||
59760128|NCT00900029|75879717|FG004|COMPLETED|Overall Study||38||
59760129|NCT00900029|75879713|FG000|NOT COMPLETED|Overall Study||3||
59760130|NCT00900029|75879714|FG001|NOT COMPLETED|Overall Study||4||
59760131|NCT00900029|75879715|FG002|NOT COMPLETED|Overall Study||3||
59760132|NCT00900029|75879716|FG003|NOT COMPLETED|Overall Study||7||
59760133|NCT00900029|75879717|FG004|NOT COMPLETED|Overall Study||6||
59760134|NCT02359019|75879729|FG000|STARTED|Overall Study||45||
59760135|NCT02359019|75879729|FG000|COMPLETED|Overall Study||45||
59760136|NCT02359019|75879729|FG000|NOT COMPLETED|Overall Study||0||
59760137|NCT00896051|75879735|FG000|STARTED|Overall Study||25||
59760138|NCT00896051|75879736|FG001|STARTED|Overall Study||25||
59760139|NCT00896051|75879735|FG000|COMPLETED|Overall Study||15||
59760140|NCT00896051|75879736|FG001|COMPLETED|Overall Study||16||
59760141|NCT00896051|75879735|FG000|NOT COMPLETED|Overall Study||10||
59760142|NCT00896051|75879736|FG001|NOT COMPLETED|Overall Study||9||
59760143|NCT00894647|75879753|FG000|STARTED|Overall Study||121||
59760144|NCT00894647|75879754|FG001|STARTED|Overall Study||126||
59760145|NCT00894647|75879753|FG000|COMPLETED|Overall Study||111||
59760146|NCT00894647|75879754|FG001|COMPLETED|Overall Study||112||
59760147|NCT00894647|75879753|FG000|NOT COMPLETED|Overall Study||10||
59760148|NCT00894647|75879754|FG001|NOT COMPLETED|Overall Study||14||
59760149|NCT00892775|75879762|FG000|STARTED|Overall Study||332||
59760150|NCT00892775|75879763|FG001|STARTED|Overall Study||166||
59760151|NCT00892775|75879762|FG000|COMPLETED|Overall Study||327||
59760152|NCT00892775|75879763|FG001|COMPLETED|Overall Study||165||
59760153|NCT00892775|75879762|FG000|NOT COMPLETED|Overall Study||5||
59760154|NCT00892775|75879763|FG001|NOT COMPLETED|Overall Study||1||
59760155|NCT00895895|75879774|FG000|STARTED|Period 1||107||
59760156|NCT00895895|75879775|FG001|STARTED|Period 1||105||
59760157|NCT00895895|75879776|FG002|STARTED|Period 1||104||
59760158|NCT00895895|75879777|FG003|STARTED|Period 1||104||
59760159|NCT00895895|75879778|FG004|STARTED|Period 1||106||
59760160|NCT00895895|75879774|FG000|Randomized But Not Treated|Period 1||1||
59760161|NCT00895895|75879775|FG001|Randomized But Not Treated|Period 1||3||
59760162|NCT00895895|75879776|FG002|Randomized But Not Treated|Period 1||1||
59760163|NCT00895895|75879777|FG003|Randomized But Not Treated|Period 1||1||
59760164|NCT00895895|75879778|FG004|Randomized But Not Treated|Period 1||2||
59760165|NCT00895895|75879774|FG000|COMPLETED|Period 1||86||
59760166|NCT00895895|75879775|FG001|COMPLETED|Period 1||84||
59760167|NCT00895895|75879776|FG002|COMPLETED|Period 1||84||
59760168|NCT00895895|75879777|FG003|COMPLETED|Period 1||91||
59760169|NCT00895895|75879778|FG004|COMPLETED|Period 1||86||
59512983|NCT00939367|75606492|FG000|NOT COMPLETED|First Intervention||0||
59512984|NCT00939367|75606493|FG001|NOT COMPLETED|First Intervention||0||
59512985|NCT00939367|75606492|FG000|STARTED|Second Intervention||15||
59512986|NCT00939367|75606493|FG001|STARTED|Second Intervention||15||
59512987|NCT00939367|75606492|FG000|COMPLETED|Second Intervention||15||
59512988|NCT00939367|75606493|FG001|COMPLETED|Second Intervention||15||
59512989|NCT00939367|75606492|FG000|NOT COMPLETED|Second Intervention||0||
59512990|NCT00939367|75606493|FG001|NOT COMPLETED|Second Intervention||0||
59512991|NCT02797054|75606502|FG000|STARTED|Post-test||387||
59760170|NCT00895895|75879774|FG000|NOT COMPLETED|Period 1||21||
59760171|NCT00895895|75879775|FG001|NOT COMPLETED|Period 1||21||
59760172|NCT00895895|75879776|FG002|NOT COMPLETED|Period 1||20||
59512992|NCT02797054|75606503|FG001|STARTED|Post-test||383||
59920699|NCT03874234|76040421|FG010|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 2-Period 3 (Day1)||0||
59920700|NCT03874234|76040422|FG011|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 2-Period 3 (Day1)||0||
59920701|NCT03874234|76040423|FG012|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Part A: Cohort 2-Period 3 (Day1)||0||
59920702|NCT03874234|76040411|FG000|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
59920703|NCT03874234|76040412|FG001|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
59920704|NCT03874234|76040413|FG002|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
59920705|NCT03874234|76040414|FG003|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
59920706|NCT03874234|76040415|FG004|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||2||
59920707|NCT03874234|76040416|FG005|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||2||
59920708|NCT03874234|76040417|FG006|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||2||
59920709|NCT03874234|76040418|FG007|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||2||
59920710|NCT03874234|76040419|FG008|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
59920711|NCT03874234|76040420|FG009|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
59920712|NCT03874234|76040421|FG010|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
59920713|NCT03874234|76040422|FG011|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
59920714|NCT03874234|76040423|FG012|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
59920715|NCT03874234|76040411|FG000|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
59920716|NCT03874234|76040412|FG001|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
59920717|NCT03874234|76040413|FG002|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
59920718|NCT03874234|76040414|FG003|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
59920719|NCT03874234|76040415|FG004|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
59920720|NCT03874234|76040416|FG005|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
59920721|NCT03874234|76040417|FG006|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
59920722|NCT03874234|76040418|FG007|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
59920723|NCT03874234|76040419|FG008|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
59920724|NCT03874234|76040420|FG009|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
59920725|NCT03874234|76040421|FG010|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
59920726|NCT03874234|76040422|FG011|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
59920727|NCT03874234|76040423|FG012|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
59920728|NCT03874234|76040411|FG000|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day10)||0||
59920729|NCT03874234|76040412|FG001|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day10)||0||
59920730|NCT03874234|76040413|FG002|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day10)||0||
59920731|NCT03874234|76040414|FG003|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day10)||0||
59920732|NCT03874234|76040415|FG004|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day10)||2||
59920733|NCT03874234|76040416|FG005|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day10)||2||
59920734|NCT03874234|76040417|FG006|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day10)||2||
59920735|NCT03874234|76040418|FG007|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day10)||2||
59512993|NCT02797054|75606504|FG002|STARTED|Post-test||435||
59920736|NCT03874234|76040419|FG008|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day10)||0||
59920737|NCT03874234|76040420|FG009|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day10)||0||
59920738|NCT03874234|76040421|FG010|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day10)||0||
59920739|NCT03874234|76040422|FG011|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day10)||0||
59920740|NCT03874234|76040423|FG012|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day10)||0||
59920741|NCT03874234|76040411|FG000|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day10)||0||
59920742|NCT03874234|76040412|FG001|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day10)||0||
59920743|NCT03874234|76040413|FG002|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day10)||0||
60048925|NCT02188784|76164578|FG001|NOT COMPLETED|Overall Study||13||
60048926|NCT02848781|76164587|FG000|STARTED|Overall Study||67||
60048927|NCT02848781|76164588|FG001|STARTED|Overall Study||66||
60048928|NCT02848781|76164589|FG002|STARTED|Overall Study||47||
59512994|NCT02797054|75606502|FG000|COMPLETED|Post-test||380||
59512995|NCT02797054|75606503|FG001|COMPLETED|Post-test||372||
59512996|NCT02797054|75606504|FG002|COMPLETED|Post-test||87||
59920744|NCT03874234|76040414|FG003|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day10)||0||
59920745|NCT03874234|76040415|FG004|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day10)||2||
60048929|NCT02848781|76164587|FG000|COMPLETED|Overall Study||60||
60048930|NCT02848781|76164588|FG001|COMPLETED|Overall Study||61||
60048931|NCT02848781|76164589|FG002|COMPLETED|Overall Study||47||
60048932|NCT02848781|76164587|FG000|NOT COMPLETED|Overall Study||7||
60048933|NCT02848781|76164588|FG001|NOT COMPLETED|Overall Study||5||
59920746|NCT03874234|76040416|FG005|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day10)||2||
59920747|NCT03874234|76040417|FG006|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day10)||2||
60048934|NCT02848781|76164589|FG002|NOT COMPLETED|Overall Study||0||
60048935|NCT02222246|76164601|FG000|STARTED|Overall Study||53||
60048936|NCT02222246|76164602|FG001|STARTED|Overall Study||53||
60048937|NCT02222246|76164601|FG000|COMPLETED|Overall Study||26||
60048938|NCT02222246|76164602|FG001|COMPLETED|Overall Study||26||
60048939|NCT02222246|76164601|FG000|NOT COMPLETED|Overall Study||27||
59920748|NCT03874234|76040418|FG007|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day10)||2||
60048940|NCT02222246|76164602|FG001|NOT COMPLETED|Overall Study||27||
60048941|NCT02188160|76164612|FG000|STARTED|Overall Study||73||
60048942|NCT02188160|76164613|FG001|STARTED|Overall Study||77||
60048943|NCT02188160|76164612|FG000|COMPLETED|Overall Study||72||
60048944|NCT02188160|76164613|FG001|COMPLETED|Overall Study||76||
60048945|NCT02188160|76164612|FG000|NOT COMPLETED|Overall Study||1||
59920749|NCT03874234|76040419|FG008|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day10)||0||
59920750|NCT03874234|76040420|FG009|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day10)||0||
59920751|NCT03874234|76040421|FG010|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day10)||0||
59920752|NCT03874234|76040422|FG011|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day10)||0||
59920753|NCT03874234|76040423|FG012|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day10)||0||
59920754|NCT03874234|76040411|FG000|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day10)||0||
59920755|NCT03874234|76040412|FG001|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day10)||0||
59920756|NCT03874234|76040413|FG002|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day10)||0||
59920757|NCT03874234|76040414|FG003|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day10)||0||
59920758|NCT03874234|76040415|FG004|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day10)||0||
59920759|NCT03874234|76040416|FG005|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day10)||0||
59920760|NCT03874234|76040417|FG006|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day10)||0||
59920761|NCT03874234|76040418|FG007|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day10)||0||
59920762|NCT03874234|76040419|FG008|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day10)||0||
59920763|NCT03874234|76040420|FG009|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day10)||0||
59920764|NCT03874234|76040421|FG010|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day10)||0||
59920765|NCT03874234|76040422|FG011|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day10)||0||
59920766|NCT03874234|76040423|FG012|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day10)||0||
59920767|NCT03874234|76040411|FG000|STARTED|Part A: Cohort 2-Period 4 (Day1)||0||
59920768|NCT03874234|76040412|FG001|STARTED|Part A: Cohort 2-Period 4 (Day1)||0||
59920769|NCT03874234|76040413|FG002|STARTED|Part A: Cohort 2-Period 4 (Day1)||0||
59920770|NCT03874234|76040414|FG003|STARTED|Part A: Cohort 2-Period 4 (Day1)||0||
59920771|NCT03874234|76040415|FG004|STARTED|Part A: Cohort 2-Period 4 (Day1)||0||
59920772|NCT03874234|76040416|FG005|STARTED|Part A: Cohort 2-Period 4 (Day1)||0||
59920773|NCT03874234|76040417|FG006|STARTED|Part A: Cohort 2-Period 4 (Day1)||0||
59920774|NCT03874234|76040418|FG007|STARTED|Part A: Cohort 2-Period 4 (Day1)||0||
59920775|NCT03874234|76040419|FG008|STARTED|Part A: Cohort 2-Period 4 (Day1)||0||
59920776|NCT03874234|76040420|FG009|STARTED|Part A: Cohort 2-Period 4 (Day1)||0||
59920777|NCT03874234|76040421|FG010|STARTED|Part A: Cohort 2-Period 4 (Day1)||0||
59920778|NCT03874234|76040422|FG011|STARTED|Part A: Cohort 2-Period 4 (Day1)||0||
59920779|NCT03874234|76040423|FG012|STARTED|Part A: Cohort 2-Period 4 (Day1)||0||
59920780|NCT03874234|76040411|FG000|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
59920781|NCT03874234|76040412|FG001|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
59920782|NCT03874234|76040413|FG002|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
59920783|NCT03874234|76040414|FG003|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
59920784|NCT03874234|76040415|FG004|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
59920785|NCT03874234|76040416|FG005|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
59920786|NCT03874234|76040417|FG006|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
59920787|NCT03874234|76040418|FG007|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
59920788|NCT03874234|76040419|FG008|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
59920789|NCT03874234|76040420|FG009|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
60048946|NCT02188160|76164613|FG001|NOT COMPLETED|Overall Study||1||
60048947|NCT02220998|76164621|FG000|STARTED|Overall Study||135||
60048948|NCT02220998|76164622|FG001|STARTED|Overall Study||134||
60048949|NCT02220998|76164621|FG000|COMPLETED|Overall Study||128||
60048950|NCT02220998|76164622|FG001|COMPLETED|Overall Study||123||
60048951|NCT02220998|76164621|FG000|NOT COMPLETED|Overall Study||7||
59512997|NCT02797054|75606502|FG000|NOT COMPLETED|Post-test||7||
59512998|NCT02797054|75606503|FG001|NOT COMPLETED|Post-test||11||
59920790|NCT03874234|76040421|FG010|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
59920791|NCT03874234|76040422|FG011|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
59920792|NCT03874234|76040423|FG012|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
59920793|NCT03874234|76040411|FG000|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
59920794|NCT03874234|76040412|FG001|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
59920795|NCT03874234|76040413|FG002|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
59920796|NCT03874234|76040414|FG003|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
59920797|NCT03874234|76040415|FG004|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
59920798|NCT03874234|76040416|FG005|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
59920799|NCT03874234|76040417|FG006|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
59920800|NCT03874234|76040418|FG007|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
59920801|NCT03874234|76040419|FG008|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
59920802|NCT03874234|76040420|FG009|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
59920803|NCT03874234|76040421|FG010|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
59920804|NCT03874234|76040422|FG011|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
59920805|NCT03874234|76040423|FG012|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
59920806|NCT03874234|76040411|FG000|STARTED|Part A: Cohort 3- Period 1 (Day 1)||0||
59920807|NCT03874234|76040412|FG001|STARTED|Part A: Cohort 3- Period 1 (Day 1)||0||
59920808|NCT03874234|76040413|FG002|STARTED|Part A: Cohort 3- Period 1 (Day 1)||0||
59920809|NCT03874234|76040414|FG003|STARTED|Part A: Cohort 3- Period 1 (Day 1)||0||
59920810|NCT03874234|76040415|FG004|STARTED|Part A: Cohort 3- Period 1 (Day 1)||0||
59920811|NCT03874234|76040416|FG005|STARTED|Part A: Cohort 3- Period 1 (Day 1)||0||
59920812|NCT03874234|76040417|FG006|STARTED|Part A: Cohort 3- Period 1 (Day 1)||0||
59920813|NCT03874234|76040418|FG007|STARTED|Part A: Cohort 3- Period 1 (Day 1)||0||
59920814|NCT03874234|76040419|FG008|STARTED|Part A: Cohort 3- Period 1 (Day 1)||0||
59920815|NCT03874234|76040420|FG009|STARTED|Part A: Cohort 3- Period 1 (Day 1)||0||
59920816|NCT03874234|76040421|FG010|STARTED|Part A: Cohort 3- Period 1 (Day 1)||0||
59920817|NCT03874234|76040422|FG011|STARTED|Part A: Cohort 3- Period 1 (Day 1)||0||
59920818|NCT03874234|76040423|FG012|STARTED|Part A: Cohort 3- Period 1 (Day 1)||0||
59920819|NCT03874234|76040411|FG000|COMPLETED|Part A: Cohort 3- Period 1 (Day 1)||0||
59920820|NCT03874234|76040412|FG001|COMPLETED|Part A: Cohort 3- Period 1 (Day 1)||0||
59920821|NCT03874234|76040413|FG002|COMPLETED|Part A: Cohort 3- Period 1 (Day 1)||0||
59920822|NCT03874234|76040414|FG003|COMPLETED|Part A: Cohort 3- Period 1 (Day 1)||0||
59920823|NCT03874234|76040415|FG004|COMPLETED|Part A: Cohort 3- Period 1 (Day 1)||0||
59920824|NCT03874234|76040416|FG005|COMPLETED|Part A: Cohort 3- Period 1 (Day 1)||0||
59920825|NCT03874234|76040417|FG006|COMPLETED|Part A: Cohort 3- Period 1 (Day 1)||0||
59920826|NCT03874234|76040418|FG007|COMPLETED|Part A: Cohort 3- Period 1 (Day 1)||0||
59920827|NCT03874234|76040419|FG008|COMPLETED|Part A: Cohort 3- Period 1 (Day 1)||0||
59920828|NCT03874234|76040420|FG009|COMPLETED|Part A: Cohort 3- Period 1 (Day 1)||0||
59920829|NCT03874234|76040421|FG010|COMPLETED|Part A: Cohort 3- Period 1 (Day 1)||0||
59920830|NCT03874234|76040422|FG011|COMPLETED|Part A: Cohort 3- Period 1 (Day 1)||0||
59920831|NCT03874234|76040423|FG012|COMPLETED|Part A: Cohort 3- Period 1 (Day 1)||0||
59920832|NCT03874234|76040411|FG000|NOT COMPLETED|Part A: Cohort 3- Period 1 (Day 1)||0||
59920833|NCT03874234|76040412|FG001|NOT COMPLETED|Part A: Cohort 3- Period 1 (Day 1)||0||
59920834|NCT03874234|76040413|FG002|NOT COMPLETED|Part A: Cohort 3- Period 1 (Day 1)||0||
59920835|NCT03874234|76040414|FG003|NOT COMPLETED|Part A: Cohort 3- Period 1 (Day 1)||0||
59920836|NCT03874234|76040415|FG004|NOT COMPLETED|Part A: Cohort 3- Period 1 (Day 1)||0||
59920837|NCT03874234|76040416|FG005|NOT COMPLETED|Part A: Cohort 3- Period 1 (Day 1)||0||
59920838|NCT03874234|76040417|FG006|NOT COMPLETED|Part A: Cohort 3- Period 1 (Day 1)||0||
59920839|NCT03874234|76040418|FG007|NOT COMPLETED|Part A: Cohort 3- Period 1 (Day 1)||0||
59920840|NCT03874234|76040419|FG008|NOT COMPLETED|Part A: Cohort 3- Period 1 (Day 1)||0||
59920841|NCT03874234|76040420|FG009|NOT COMPLETED|Part A: Cohort 3- Period 1 (Day 1)||0||
59920842|NCT03874234|76040421|FG010|NOT COMPLETED|Part A: Cohort 3- Period 1 (Day 1)||0||
59920843|NCT03874234|76040422|FG011|NOT COMPLETED|Part A: Cohort 3- Period 1 (Day 1)||0||
59920844|NCT03874234|76040423|FG012|NOT COMPLETED|Part A: Cohort 3- Period 1 (Day 1)||0||
59920845|NCT03874234|76040411|FG000|STARTED|PartA:Cohort3-WashoutPeriod (Upto Day10)||0||
59920846|NCT03874234|76040412|FG001|STARTED|PartA:Cohort3-WashoutPeriod (Upto Day10)||0||
59920847|NCT03874234|76040413|FG002|STARTED|PartA:Cohort3-WashoutPeriod (Upto Day10)||0||
59920848|NCT03874234|76040414|FG003|STARTED|PartA:Cohort3-WashoutPeriod (Upto Day10)||0||
59920849|NCT03874234|76040415|FG004|STARTED|PartA:Cohort3-WashoutPeriod (Upto Day10)||0||
59920850|NCT03874234|76040416|FG005|STARTED|PartA:Cohort3-WashoutPeriod (Upto Day10)||0||
59920851|NCT03874234|76040417|FG006|STARTED|PartA:Cohort3-WashoutPeriod (Upto Day10)||0||
59920852|NCT03874234|76040418|FG007|STARTED|PartA:Cohort3-WashoutPeriod (Upto Day10)||0||
59920853|NCT03874234|76040419|FG008|STARTED|PartA:Cohort3-WashoutPeriod (Upto Day10)||0||
59920854|NCT03874234|76040420|FG009|STARTED|PartA:Cohort3-WashoutPeriod (Upto Day10)||0||
59920855|NCT03874234|76040421|FG010|STARTED|PartA:Cohort3-WashoutPeriod (Upto Day10)||0||
59920856|NCT03874234|76040422|FG011|STARTED|PartA:Cohort3-WashoutPeriod (Upto Day10)||0||
59920857|NCT03874234|76040423|FG012|STARTED|PartA:Cohort3-WashoutPeriod (Upto Day10)||0||
59920858|NCT03874234|76040411|FG000|COMPLETED|PartA:Cohort3-WashoutPeriod (Upto Day10)||0||
59920859|NCT03874234|76040412|FG001|COMPLETED|PartA:Cohort3-WashoutPeriod (Upto Day10)||0||
59920860|NCT03874234|76040413|FG002|COMPLETED|PartA:Cohort3-WashoutPeriod (Upto Day10)||0||
59612699|NCT01717326|75723768|FG008|STARTED|Overall Study||32||
59612700|NCT01717326|75723769|FG009|STARTED|Overall Study||31||
59612701|NCT01717326|75723770|FG010|STARTED|Overall Study||32||
59612702|NCT01717326|75723771|FG011|STARTED|Overall Study||33||
59612703|NCT01717326|75723772|FG012|STARTED|Overall Study||33||
59612704|NCT01717326|75723773|FG013|STARTED|Overall Study||32||
59612705|NCT01717326|75723774|FG014|STARTED|Overall Study||29||
59612706|NCT01717326|75723775|FG015|STARTED|Overall Study||30||
59612707|NCT01717326|75723776|FG016|STARTED|Overall Study||30||
59612708|NCT01717326|75723777|FG017|STARTED|Overall Study||31||
59612709|NCT01717326|75723778|FG018|STARTED|Overall Study||20||
59612710|NCT01717326|75723779|FG019|STARTED|Overall Study||21||
59612711|NCT01717326|75723760|FG000|Treated|Overall Study||25||
59612712|NCT01717326|75723761|FG001|Treated|Overall Study|Number includes 1 additional participant randomized to A3 but treated on A2|28||
59612713|NCT01717326|75723762|FG002|Treated|Overall Study|Number excludes 1 participant randomized to A3 but treated on Arm A2|12||
59920861|NCT03874234|76040414|FG003|COMPLETED|PartA:Cohort3-WashoutPeriod (Upto Day10)||0||
59920862|NCT03874234|76040415|FG004|COMPLETED|PartA:Cohort3-WashoutPeriod (Upto Day10)||0||
59920863|NCT03874234|76040416|FG005|COMPLETED|PartA:Cohort3-WashoutPeriod (Upto Day10)||0||
59920864|NCT03874234|76040417|FG006|COMPLETED|PartA:Cohort3-WashoutPeriod (Upto Day10)||0||
59920865|NCT03874234|76040418|FG007|COMPLETED|PartA:Cohort3-WashoutPeriod (Upto Day10)||0||
59920866|NCT03874234|76040419|FG008|COMPLETED|PartA:Cohort3-WashoutPeriod (Upto Day10)||0||
59920867|NCT03874234|76040420|FG009|COMPLETED|PartA:Cohort3-WashoutPeriod (Upto Day10)||0||
59920868|NCT03874234|76040421|FG010|COMPLETED|PartA:Cohort3-WashoutPeriod (Upto Day10)||0||
59920869|NCT03874234|76040422|FG011|COMPLETED|PartA:Cohort3-WashoutPeriod (Upto Day10)||0||
59920870|NCT03874234|76040423|FG012|COMPLETED|PartA:Cohort3-WashoutPeriod (Upto Day10)||0||
59920871|NCT03874234|76040411|FG000|NOT COMPLETED|PartA:Cohort3-WashoutPeriod (Upto Day10)||0||
59920872|NCT03874234|76040412|FG001|NOT COMPLETED|PartA:Cohort3-WashoutPeriod (Upto Day10)||0||
59920873|NCT03874234|76040413|FG002|NOT COMPLETED|PartA:Cohort3-WashoutPeriod (Upto Day10)||0||
59920874|NCT03874234|76040414|FG003|NOT COMPLETED|PartA:Cohort3-WashoutPeriod (Upto Day10)||0||
59920875|NCT03874234|76040415|FG004|NOT COMPLETED|PartA:Cohort3-WashoutPeriod (Upto Day10)||0||
59920876|NCT03874234|76040416|FG005|NOT COMPLETED|PartA:Cohort3-WashoutPeriod (Upto Day10)||0||
59920877|NCT03874234|76040417|FG006|NOT COMPLETED|PartA:Cohort3-WashoutPeriod (Upto Day10)||0||
59920878|NCT03874234|76040418|FG007|NOT COMPLETED|PartA:Cohort3-WashoutPeriod (Upto Day10)||0||
59920879|NCT03874234|76040419|FG008|NOT COMPLETED|PartA:Cohort3-WashoutPeriod (Upto Day10)||0||
59920880|NCT03874234|76040420|FG009|NOT COMPLETED|PartA:Cohort3-WashoutPeriod (Upto Day10)||0||
59920881|NCT03874234|76040421|FG010|NOT COMPLETED|PartA:Cohort3-WashoutPeriod (Upto Day10)||0||
59920882|NCT03874234|76040422|FG011|NOT COMPLETED|PartA:Cohort3-WashoutPeriod (Upto Day10)||0||
59920883|NCT03874234|76040423|FG012|NOT COMPLETED|PartA:Cohort3-WashoutPeriod (Upto Day10)||0||
59920884|NCT03874234|76040411|FG000|STARTED|Part A: Cohort 3- Period 2 (Day 1)||0||
59920885|NCT03874234|76040412|FG001|STARTED|Part A: Cohort 3- Period 2 (Day 1)||0||
59920886|NCT03874234|76040413|FG002|STARTED|Part A: Cohort 3- Period 2 (Day 1)||0||
59920887|NCT03874234|76040414|FG003|STARTED|Part A: Cohort 3- Period 2 (Day 1)||0||
59920888|NCT03874234|76040415|FG004|STARTED|Part A: Cohort 3- Period 2 (Day 1)||0||
59920889|NCT03874234|76040416|FG005|STARTED|Part A: Cohort 3- Period 2 (Day 1)||0||
59920890|NCT03874234|76040417|FG006|STARTED|Part A: Cohort 3- Period 2 (Day 1)||0||
59920891|NCT03874234|76040418|FG007|STARTED|Part A: Cohort 3- Period 2 (Day 1)||0||
59920892|NCT03874234|76040419|FG008|STARTED|Part A: Cohort 3- Period 2 (Day 1)||0||
59920893|NCT03874234|76040420|FG009|STARTED|Part A: Cohort 3- Period 2 (Day 1)||0||
59920894|NCT03874234|76040421|FG010|STARTED|Part A: Cohort 3- Period 2 (Day 1)||0||
59920895|NCT03874234|76040422|FG011|STARTED|Part A: Cohort 3- Period 2 (Day 1)||0||
59920896|NCT03874234|76040423|FG012|STARTED|Part A: Cohort 3- Period 2 (Day 1)||0||
59920897|NCT03874234|76040411|FG000|COMPLETED|Part A: Cohort 3- Period 2 (Day 1)||0||
59920898|NCT03874234|76040412|FG001|COMPLETED|Part A: Cohort 3- Period 2 (Day 1)||0||
59920899|NCT03874234|76040413|FG002|COMPLETED|Part A: Cohort 3- Period 2 (Day 1)||0||
59920900|NCT03874234|76040414|FG003|COMPLETED|Part A: Cohort 3- Period 2 (Day 1)||0||
59920901|NCT03874234|76040415|FG004|COMPLETED|Part A: Cohort 3- Period 2 (Day 1)||0||
59920902|NCT03874234|76040416|FG005|COMPLETED|Part A: Cohort 3- Period 2 (Day 1)||0||
59920903|NCT03874234|76040417|FG006|COMPLETED|Part A: Cohort 3- Period 2 (Day 1)||0||
59920904|NCT03874234|76040418|FG007|COMPLETED|Part A: Cohort 3- Period 2 (Day 1)||0||
59920905|NCT03874234|76040419|FG008|COMPLETED|Part A: Cohort 3- Period 2 (Day 1)||0||
59920906|NCT03874234|76040420|FG009|COMPLETED|Part A: Cohort 3- Period 2 (Day 1)||0||
59920907|NCT03874234|76040421|FG010|COMPLETED|Part A: Cohort 3- Period 2 (Day 1)||0||
59920908|NCT03874234|76040422|FG011|COMPLETED|Part A: Cohort 3- Period 2 (Day 1)||0||
59920909|NCT03874234|76040423|FG012|COMPLETED|Part A: Cohort 3- Period 2 (Day 1)||0||
59920910|NCT03874234|76040411|FG000|NOT COMPLETED|Part A: Cohort 3- Period 2 (Day 1)||0||
59920911|NCT03874234|76040412|FG001|NOT COMPLETED|Part A: Cohort 3- Period 2 (Day 1)||0||
59920912|NCT03874234|76040413|FG002|NOT COMPLETED|Part A: Cohort 3- Period 2 (Day 1)||0||
59920913|NCT03874234|76040414|FG003|NOT COMPLETED|Part A: Cohort 3- Period 2 (Day 1)||0||
59920914|NCT03874234|76040415|FG004|NOT COMPLETED|Part A: Cohort 3- Period 2 (Day 1)||0||
59920915|NCT03874234|76040416|FG005|NOT COMPLETED|Part A: Cohort 3- Period 2 (Day 1)||0||
60048952|NCT02220998|76164622|FG001|NOT COMPLETED|Overall Study||11||
60048953|NCT02220920|76164630|FG000|STARTED|Overall Study||76||
59512999|NCT02797054|75606504|FG002|NOT COMPLETED|Post-test||348||
59513000|NCT02797054|75606502|FG000|STARTED|Follow-up||387|All participants who volunteered at consent were contacted for follow-up.|
59513001|NCT02797054|75606503|FG001|STARTED|Follow-up||383|All participants who volunteered at consent were contacted for follow-up.|
59513002|NCT02797054|75606504|FG002|STARTED|Follow-up||435|All participants who volunteered at consent were contacted for follow-up.|
59513003|NCT02797054|75606502|FG000|COMPLETED|Follow-up||178||
59513004|NCT02797054|75606503|FG001|COMPLETED|Follow-up||155||
59513005|NCT02797054|75606504|FG002|COMPLETED|Follow-up||150||
59513006|NCT02797054|75606502|FG000|NOT COMPLETED|Follow-up||209||
59513007|NCT02797054|75606503|FG001|NOT COMPLETED|Follow-up||228||
59513008|NCT02797054|75606504|FG002|NOT COMPLETED|Follow-up||285||
59513009|NCT00920075|75606512|FG000|STARTED|Last Study, 25 Pts Invited,11 Responded||11||
59513010|NCT00920075|75606512|FG000|COMPLETED|Last Study, 25 Pts Invited,11 Responded||11||
59513011|NCT00920075|75606512|FG000|NOT COMPLETED|Last Study, 25 Pts Invited,11 Responded||0||
59513012|NCT00920075|75606512|FG000|STARTED|Post Study, 11 Pts Responded||11||
59513013|NCT00920075|75606512|FG000|COMPLETED|Post Study, 11 Pts Responded||11||
59513014|NCT00920075|75606512|FG000|NOT COMPLETED|Post Study, 11 Pts Responded||0||
59920916|NCT03874234|76040417|FG006|NOT COMPLETED|Part A: Cohort 3- Period 2 (Day 1)||0||
59920917|NCT03874234|76040418|FG007|NOT COMPLETED|Part A: Cohort 3- Period 2 (Day 1)||0||
59920918|NCT03874234|76040419|FG008|NOT COMPLETED|Part A: Cohort 3- Period 2 (Day 1)||0||
59920919|NCT03874234|76040420|FG009|NOT COMPLETED|Part A: Cohort 3- Period 2 (Day 1)||0||
59513015|NCT00920231|75606518|FG000|STARTED|Overall Study||8||
59920920|NCT03874234|76040421|FG010|NOT COMPLETED|Part A: Cohort 3- Period 2 (Day 1)||0||
59920921|NCT03874234|76040422|FG011|NOT COMPLETED|Part A: Cohort 3- Period 2 (Day 1)||0||
59920922|NCT03874234|76040423|FG012|NOT COMPLETED|Part A: Cohort 3- Period 2 (Day 1)||0||
59920923|NCT03874234|76040411|FG000|STARTED|Part B: Cohorts 4 to 6 (Days 1 to 10)||0||
59920924|NCT03874234|76040412|FG001|STARTED|Part B: Cohorts 4 to 6 (Days 1 to 10)||0||
59920925|NCT03874234|76040413|FG002|STARTED|Part B: Cohorts 4 to 6 (Days 1 to 10)||0||
59920926|NCT03874234|76040414|FG003|STARTED|Part B: Cohorts 4 to 6 (Days 1 to 10)||0||
59920927|NCT03874234|76040415|FG004|STARTED|Part B: Cohorts 4 to 6 (Days 1 to 10)||0||
59920928|NCT03874234|76040416|FG005|STARTED|Part B: Cohorts 4 to 6 (Days 1 to 10)||0||
59920929|NCT03874234|76040417|FG006|STARTED|Part B: Cohorts 4 to 6 (Days 1 to 10)||0||
59920930|NCT03874234|76040418|FG007|STARTED|Part B: Cohorts 4 to 6 (Days 1 to 10)||0||
59920931|NCT03874234|76040419|FG008|STARTED|Part B: Cohorts 4 to 6 (Days 1 to 10)||0||
59920932|NCT03874234|76040420|FG009|STARTED|Part B: Cohorts 4 to 6 (Days 1 to 10)||0||
60048954|NCT02220920|76164631|FG001|STARTED|Overall Study||70||
60048955|NCT02220920|76164630|FG000|COMPLETED|Overall Study||73||
59920933|NCT03874234|76040421|FG010|STARTED|Part B: Cohorts 4 to 6 (Days 1 to 10)||0||
59920934|NCT03874234|76040422|FG011|STARTED|Part B: Cohorts 4 to 6 (Days 1 to 10)||0||
59920935|NCT03874234|76040423|FG012|STARTED|Part B: Cohorts 4 to 6 (Days 1 to 10)||0||
59920936|NCT03874234|76040411|FG000|COMPLETED|Part B: Cohorts 4 to 6 (Days 1 to 10)||0||
59920937|NCT03874234|76040412|FG001|COMPLETED|Part B: Cohorts 4 to 6 (Days 1 to 10)||0||
59920938|NCT03874234|76040413|FG002|COMPLETED|Part B: Cohorts 4 to 6 (Days 1 to 10)||0||
59920939|NCT03874234|76040414|FG003|COMPLETED|Part B: Cohorts 4 to 6 (Days 1 to 10)||0||
59920940|NCT03874234|76040415|FG004|COMPLETED|Part B: Cohorts 4 to 6 (Days 1 to 10)||0||
59920941|NCT03874234|76040416|FG005|COMPLETED|Part B: Cohorts 4 to 6 (Days 1 to 10)||0||
59920942|NCT03874234|76040417|FG006|COMPLETED|Part B: Cohorts 4 to 6 (Days 1 to 10)||0||
59920943|NCT03874234|76040418|FG007|COMPLETED|Part B: Cohorts 4 to 6 (Days 1 to 10)||0||
59920944|NCT03874234|76040419|FG008|COMPLETED|Part B: Cohorts 4 to 6 (Days 1 to 10)||0||
59920945|NCT03874234|76040420|FG009|COMPLETED|Part B: Cohorts 4 to 6 (Days 1 to 10)||0||
59920946|NCT03874234|76040421|FG010|COMPLETED|Part B: Cohorts 4 to 6 (Days 1 to 10)||0||
59920947|NCT03874234|76040422|FG011|COMPLETED|Part B: Cohorts 4 to 6 (Days 1 to 10)||0||
59920948|NCT03874234|76040423|FG012|COMPLETED|Part B: Cohorts 4 to 6 (Days 1 to 10)||0||
59920949|NCT03874234|76040411|FG000|NOT COMPLETED|Part B: Cohorts 4 to 6 (Days 1 to 10)||0||
59920950|NCT03874234|76040412|FG001|NOT COMPLETED|Part B: Cohorts 4 to 6 (Days 1 to 10)||0||
59920951|NCT03874234|76040413|FG002|NOT COMPLETED|Part B: Cohorts 4 to 6 (Days 1 to 10)||0||
59920952|NCT03874234|76040414|FG003|NOT COMPLETED|Part B: Cohorts 4 to 6 (Days 1 to 10)||0||
59920953|NCT03874234|76040415|FG004|NOT COMPLETED|Part B: Cohorts 4 to 6 (Days 1 to 10)||0||
59920954|NCT03874234|76040416|FG005|NOT COMPLETED|Part B: Cohorts 4 to 6 (Days 1 to 10)||0||
60048956|NCT02220920|76164631|FG001|COMPLETED|Overall Study||67||
59513016|NCT00920231|75606519|FG001|STARTED|Overall Study||8||
59513017|NCT00920231|75606518|FG000|COMPLETED|Overall Study||8||
59513018|NCT00920231|75606519|FG001|COMPLETED|Overall Study||8||
59513019|NCT00920231|75606518|FG000|NOT COMPLETED|Overall Study||0||
59513020|NCT00920231|75606519|FG001|NOT COMPLETED|Overall Study||0||
59513021|NCT04737538|75606530|FG000|STARTED|Overall Study||36||
59513022|NCT04737538|75606531|FG001|STARTED|Overall Study||36||
59513023|NCT04737538|75606532|FG002|STARTED|Overall Study||38||
59513024|NCT04737538|75606530|FG000|COMPLETED|Overall Study||36||
59513025|NCT04737538|75606531|FG001|COMPLETED|Overall Study||36||
59513026|NCT04737538|75606532|FG002|COMPLETED|Overall Study||38||
59513027|NCT04737538|75606530|FG000|NOT COMPLETED|Overall Study||0||
60048957|NCT02220920|76164630|FG000|NOT COMPLETED|Overall Study||3||
59513028|NCT04737538|75606531|FG001|NOT COMPLETED|Overall Study||0||
59513029|NCT04737538|75606532|FG002|NOT COMPLETED|Overall Study||0||
59513030|NCT02798380|75606541|FG000|STARTED|Overall Study||30||
59513031|NCT02798380|75606541|FG000|COMPLETED|Overall Study||30||
59513032|NCT02798380|75606541|FG000|NOT COMPLETED|Overall Study||0||
59513033|NCT02917642|75606547|FG000|STARTED|Overall Study||25||
59513034|NCT02917642|75606548|FG001|STARTED|Overall Study||25||
59513035|NCT02917642|75606547|FG000|COMPLETED|Overall Study||25||
59513036|NCT02917642|75606548|FG001|COMPLETED|Overall Study||25||
59513037|NCT02917642|75606547|FG000|NOT COMPLETED|Overall Study||0||
59513038|NCT02917642|75606548|FG001|NOT COMPLETED|Overall Study||0||
59513039|NCT01049009|75606556|FG000|STARTED|Treatment Period 1 (12 Weeks)||23||
59513040|NCT01049009|75606557|FG001|STARTED|Treatment Period 1 (12 Weeks)||21||
59612714|NCT01717326|75723763|FG003|Treated|Overall Study||30||
59612715|NCT01717326|75723764|FG004|Treated|Overall Study||33||
59513041|NCT01049009|75606556|FG000|COMPLETED|Treatment Period 1 (12 Weeks)||21||
59513042|NCT01049009|75606557|FG001|COMPLETED|Treatment Period 1 (12 Weeks)||18||
59513043|NCT01049009|75606556|FG000|NOT COMPLETED|Treatment Period 1 (12 Weeks)||2||
59513044|NCT01049009|75606557|FG001|NOT COMPLETED|Treatment Period 1 (12 Weeks)||3||
59513045|NCT01049009|75606556|FG000|STARTED|Treatment Period 2 (12 Weeks)||21||
59513046|NCT01049009|75606557|FG001|STARTED|Treatment Period 2 (12 Weeks)||18||
59513047|NCT01049009|75606556|FG000|COMPLETED|Treatment Period 2 (12 Weeks)||11||
59513048|NCT01049009|75606557|FG001|COMPLETED|Treatment Period 2 (12 Weeks)||8||
59513049|NCT01049009|75606556|FG000|NOT COMPLETED|Treatment Period 2 (12 Weeks)||10||
59513050|NCT01049009|75606557|FG001|NOT COMPLETED|Treatment Period 2 (12 Weeks)||10||
59513051|NCT02918656|75606566|FG000|STARTED|Overall Study||54||
59513052|NCT02918656|75606567|FG001|STARTED|Overall Study||60||
59513053|NCT02918656|75606568|FG002|STARTED|Overall Study||57||
59513054|NCT02918656|75606566|FG000|COMPLETED|Overall Study||54||
59612716|NCT01717326|75723765|FG005|Treated|Overall Study||31||
59612717|NCT01717326|75723766|FG006|Treated|Overall Study||31||
59612718|NCT01717326|75723767|FG007|Treated|Overall Study||29||
59612719|NCT01717326|75723768|FG008|Treated|Overall Study||32||
59612720|NCT01717326|75723769|FG009|Treated|Overall Study||31||
59612721|NCT01717326|75723770|FG010|Treated|Overall Study||32||
59760173|NCT00895895|75879777|FG003|NOT COMPLETED|Period 1||13||
59612722|NCT01717326|75723771|FG011|Treated|Overall Study||33||
59760174|NCT00895895|75879778|FG004|NOT COMPLETED|Period 1||20||
59760175|NCT00895895|75879774|FG000|STARTED|After Period 1, Prior to Period 2||86||
59760176|NCT00895895|75879775|FG001|STARTED|After Period 1, Prior to Period 2||84||
59760177|NCT00895895|75879776|FG002|STARTED|After Period 1, Prior to Period 2||84||
59760178|NCT00895895|75879777|FG003|STARTED|After Period 1, Prior to Period 2||91||
59760179|NCT00895895|75879778|FG004|STARTED|After Period 1, Prior to Period 2||86||
59760180|NCT00895895|75879774|FG000|COMPLETED|After Period 1, Prior to Period 2||86||
59760181|NCT00895895|75879775|FG001|COMPLETED|After Period 1, Prior to Period 2||84||
59760182|NCT00895895|75879776|FG002|COMPLETED|After Period 1, Prior to Period 2||82||
59920955|NCT03874234|76040417|FG006|NOT COMPLETED|Part B: Cohorts 4 to 6 (Days 1 to 10)||0||
59920956|NCT03874234|76040418|FG007|NOT COMPLETED|Part B: Cohorts 4 to 6 (Days 1 to 10)||0||
59920957|NCT03874234|76040419|FG008|NOT COMPLETED|Part B: Cohorts 4 to 6 (Days 1 to 10)||0||
59920958|NCT03874234|76040420|FG009|NOT COMPLETED|Part B: Cohorts 4 to 6 (Days 1 to 10)||0||
59920959|NCT03874234|76040421|FG010|NOT COMPLETED|Part B: Cohorts 4 to 6 (Days 1 to 10)||0||
59920960|NCT03874234|76040422|FG011|NOT COMPLETED|Part B: Cohorts 4 to 6 (Days 1 to 10)||0||
59920961|NCT03874234|76040423|FG012|NOT COMPLETED|Part B: Cohorts 4 to 6 (Days 1 to 10)||0||
60048958|NCT02220920|76164631|FG001|NOT COMPLETED|Overall Study||3||
60048959|NCT03966053|76164637|FG000|STARTED|Overall Study||2||
60048960|NCT03966053|76164637|FG000|COMPLETED|Overall Study||1||
60048961|NCT03966053|76164637|FG000|NOT COMPLETED|Overall Study||1||
60048962|NCT03877055|76164643|FG000|STARTED|Overall Study||6||
59513055|NCT02918656|75606567|FG001|COMPLETED|Overall Study||60||
59513056|NCT02918656|75606568|FG002|COMPLETED|Overall Study||57||
59920962|NCT02985398|76040459|FG000|STARTED|Overall Study||128||
59920963|NCT02985398|76040459|FG000|Participants Treated|Overall Study||128||
59920964|NCT02985398|76040459|FG000|COMPLETED|Overall Study||106||
59920965|NCT02985398|76040459|FG000|NOT COMPLETED|Overall Study||22||
59920966|NCT03310723|76040465|FG000|STARTED|Overall Study||20||
59920967|NCT03310723|76040466|FG001|STARTED|Overall Study||20||
59920968|NCT03310723|76040465|FG000|COMPLETED|Overall Study||20|Discontinued|
59920969|NCT03310723|76040466|FG001|COMPLETED|Overall Study||17|Discontinued|
59920970|NCT03310723|76040465|FG000|NOT COMPLETED|Overall Study||0||
59920971|NCT03310723|76040466|FG001|NOT COMPLETED|Overall Study||3||
59920972|NCT02663674|76040474|FG000|STARTED|Overall Study||33||
59920973|NCT02663674|76040475|FG001|STARTED|Overall Study||39||
59920974|NCT02663674|76040474|FG000|COMPLETED|Overall Study||26||
59920975|NCT02663674|76040475|FG001|COMPLETED|Overall Study||29||
59920976|NCT02663674|76040474|FG000|NOT COMPLETED|Overall Study||7||
59920977|NCT02663674|76040475|FG001|NOT COMPLETED|Overall Study||10||
59920978|NCT02908880|76040481|FG000|STARTED|Overall Study|Subjects within the Primary Analysis Cohort that received the MANTA Device|263||
59920979|NCT02908880|76040481|FG000|COMPLETED|Overall Study|Subjects within the Primary Analysis Cohort that completed all follow-up time points.|236||
59920980|NCT02908880|76040481|FG000|NOT COMPLETED|Overall Study||27||
59920981|NCT03310411|76040485|FG000|STARTED|Period 1||10||
59920982|NCT03310411|76040486|FG001|STARTED|Period 1||10||
59920983|NCT03310411|76040487|FG002|STARTED|Period 1||10||
59920984|NCT03310411|76040488|FG003|STARTED|Period 1||10||
59920985|NCT03310411|76040485|FG000|Received at Least 1 Dose of Study Drug|Period 1||10||
59920986|NCT03310411|76040486|FG001|Received at Least 1 Dose of Study Drug|Period 1||10||
59920987|NCT03310411|76040487|FG002|Received at Least 1 Dose of Study Drug|Period 1||10||
59920988|NCT03310411|76040488|FG003|Received at Least 1 Dose of Study Drug|Period 1||10||
59920989|NCT03310411|76040485|FG000|COMPLETED|Period 1||10||
59920990|NCT03310411|76040486|FG001|COMPLETED|Period 1||10||
59920991|NCT03310411|76040487|FG002|COMPLETED|Period 1||10||
59920992|NCT03310411|76040488|FG003|COMPLETED|Period 1||9||
59920993|NCT03310411|76040485|FG000|NOT COMPLETED|Period 1||0||
59920994|NCT03310411|76040486|FG001|NOT COMPLETED|Period 1||0||
59920995|NCT03310411|76040487|FG002|NOT COMPLETED|Period 1||0||
59920996|NCT03310411|76040488|FG003|NOT COMPLETED|Period 1||1||
59920997|NCT03310411|76040485|FG000|STARTED|Period 2||10||
59920998|NCT03310411|76040486|FG001|STARTED|Period 2||10||
59920999|NCT03310411|76040487|FG002|STARTED|Period 2||10||
59921000|NCT03310411|76040488|FG003|STARTED|Period 2||9||
59921001|NCT03310411|76040485|FG000|COMPLETED|Period 2||10||
59921002|NCT03310411|76040486|FG001|COMPLETED|Period 2||10||
59921003|NCT03310411|76040487|FG002|COMPLETED|Period 2||10||
59921004|NCT03310411|76040488|FG003|COMPLETED|Period 2||9||
59921005|NCT03310411|76040485|FG000|NOT COMPLETED|Period 2||0||
59921006|NCT03310411|76040486|FG001|NOT COMPLETED|Period 2||0||
59921007|NCT03310411|76040487|FG002|NOT COMPLETED|Period 2||0||
59921008|NCT03310411|76040488|FG003|NOT COMPLETED|Period 2||0||
59513057|NCT02918656|75606566|FG000|NOT COMPLETED|Overall Study||0||
59513058|NCT02918656|75606567|FG001|NOT COMPLETED|Overall Study||0||
59513059|NCT02918656|75606568|FG002|NOT COMPLETED|Overall Study||0||
59513060|NCT01047683|75606579|FG000|STARTED|Overall Study||76||
59513061|NCT01047683|75606580|FG001|STARTED|Overall Study||76||
59513062|NCT01047683|75606581|FG002|STARTED|Overall Study||77||
59513063|NCT01047683|75606579|FG000|COMPLETED|Overall Study||71||
59513064|NCT01047683|75606580|FG001|COMPLETED|Overall Study||70||
59921009|NCT03310411|76040485|FG000|STARTED|Period 3||10||
59921010|NCT03310411|76040486|FG001|STARTED|Period 3||10||
59921011|NCT03310411|76040487|FG002|STARTED|Period 3||10||
59921012|NCT03310411|76040488|FG003|STARTED|Period 3||9||
59921013|NCT03310411|76040485|FG000|COMPLETED|Period 3||10||
59921014|NCT03310411|76040486|FG001|COMPLETED|Period 3||10||
59921015|NCT03310411|76040487|FG002|COMPLETED|Period 3||10||
59513065|NCT01047683|75606581|FG002|COMPLETED|Overall Study||74||
59513066|NCT01047683|75606579|FG000|NOT COMPLETED|Overall Study||5||
59513067|NCT01047683|75606580|FG001|NOT COMPLETED|Overall Study||6||
59921016|NCT03310411|76040488|FG003|COMPLETED|Period 3||9||
59921017|NCT03310411|76040485|FG000|NOT COMPLETED|Period 3||0||
59921018|NCT03310411|76040486|FG001|NOT COMPLETED|Period 3||0||
59921019|NCT03310411|76040487|FG002|NOT COMPLETED|Period 3||0||
59921020|NCT03310411|76040488|FG003|NOT COMPLETED|Period 3||0||
59921021|NCT03310411|76040485|FG000|STARTED|Period Title: Period 4||10||
59921022|NCT03310411|76040486|FG001|STARTED|Period Title: Period 4||10||
59921023|NCT03310411|76040487|FG002|STARTED|Period Title: Period 4||10||
59921024|NCT03310411|76040488|FG003|STARTED|Period Title: Period 4||9||
59921025|NCT03310411|76040485|FG000|COMPLETED|Period Title: Period 4||10||
59921026|NCT03310411|76040486|FG001|COMPLETED|Period Title: Period 4||10||
59921027|NCT03310411|76040487|FG002|COMPLETED|Period Title: Period 4||10||
59921028|NCT03310411|76040488|FG003|COMPLETED|Period Title: Period 4||9||
59921029|NCT03310411|76040485|FG000|NOT COMPLETED|Period Title: Period 4||0||
59921030|NCT03310411|76040486|FG001|NOT COMPLETED|Period Title: Period 4||0||
59921031|NCT03310411|76040487|FG002|NOT COMPLETED|Period Title: Period 4||0||
59921032|NCT03310411|76040488|FG003|NOT COMPLETED|Period Title: Period 4||0||
59921033|NCT03301831|76040506|FG000|STARTED|Overall Study||46||
59921034|NCT03301831|76040507|FG001|STARTED|Overall Study||47||
59921035|NCT03301831|76040506|FG000|COMPLETED|Overall Study||26||
59921036|NCT03301831|76040507|FG001|COMPLETED|Overall Study||44||
59760183|NCT00895895|75879777|FG003|COMPLETED|After Period 1, Prior to Period 2||91||
59760184|NCT00895895|75879778|FG004|COMPLETED|After Period 1, Prior to Period 2||84||
59760185|NCT00895895|75879774|FG000|NOT COMPLETED|After Period 1, Prior to Period 2||0||
59760186|NCT00895895|75879775|FG001|NOT COMPLETED|After Period 1, Prior to Period 2||0||
59760187|NCT00895895|75879776|FG002|NOT COMPLETED|After Period 1, Prior to Period 2||2||
59760188|NCT00895895|75879777|FG003|NOT COMPLETED|After Period 1, Prior to Period 2||0||
59760189|NCT00895895|75879778|FG004|NOT COMPLETED|After Period 1, Prior to Period 2||2||
59760190|NCT00895895|75879774|FG000|STARTED|Period 2||86||
59760191|NCT00895895|75879775|FG001|STARTED|Period 2||84||
59760192|NCT00895895|75879776|FG002|STARTED|Period 2||82||
59760193|NCT00895895|75879777|FG003|STARTED|Period 2||91||
59760194|NCT00895895|75879778|FG004|STARTED|Period 2||84||
60048963|NCT03877055|76164644|FG001|STARTED|Overall Study||2||
60048964|NCT03877055|76164643|FG000|COMPLETED|Overall Study||6||
59760195|NCT00895895|75879774|FG000|COMPLETED|Period 2||30||
59760196|NCT00895895|75879775|FG001|COMPLETED|Period 2||31||
59760197|NCT00895895|75879776|FG002|COMPLETED|Period 2||33||
59760198|NCT00895895|75879777|FG003|COMPLETED|Period 2||37||
59760199|NCT00895895|75879778|FG004|COMPLETED|Period 2||35||
59760200|NCT00895895|75879774|FG000|NOT COMPLETED|Period 2||56||
59760201|NCT00895895|75879775|FG001|NOT COMPLETED|Period 2||53||
59760202|NCT00895895|75879776|FG002|NOT COMPLETED|Period 2||49||
59760203|NCT00895895|75879777|FG003|NOT COMPLETED|Period 2||54||
59921037|NCT03301831|76040506|FG000|NOT COMPLETED|Overall Study||20||
59921038|NCT03301831|76040507|FG001|NOT COMPLETED|Overall Study||3||
60048965|NCT03877055|76164644|FG001|COMPLETED|Overall Study||2||
59513068|NCT01047683|75606581|FG002|NOT COMPLETED|Overall Study||3||
59921039|NCT02909504|76040513|FG000|STARTED|Overall Study||24||
59921040|NCT02909504|76040513|FG000|COMPLETED|Overall Study||12||
59921041|NCT02909504|76040513|FG000|NOT COMPLETED|Overall Study||12||
59921042|NCT02199691|76040522|FG000|STARTED|Overall Study||505||
59921043|NCT02199691|76040523|FG001|STARTED|Overall Study||507||
59921044|NCT02199691|76040524|FG002|STARTED|Overall Study||403||
59921045|NCT02199691|76040525|FG003|STARTED|Overall Study||300||
59921046|NCT02199691|76040522|FG000|Safety Analysis Set (SafAS)|Overall Study||503|SafAS:participants who received at least 1 dose of study vaccine(s) & had any safety data available.|
59951429|NCT01251965|76070418|FG000|NOT COMPLETED|Overall Study||1||
60048966|NCT03877055|76164643|FG000|NOT COMPLETED|Overall Study||0||
60048967|NCT03877055|76164644|FG001|NOT COMPLETED|Overall Study||0||
60048968|NCT01634555|76164650|FG000|STARTED|Overall Study||29||
60048969|NCT01634555|76164650|FG000|Received at Least 1 Dose of Study Drug|Overall Study||29||
60048970|NCT01634555|76164650|FG000|Drug-Drug Interaction (DDI) Population|Overall Study|Completed the required treatment in Cycle 1, Day 1 and Cycle 2, Day 1.|25||
60048971|NCT01634555|76164650|FG000|COMPLETED|Overall Study|Completed the required treatment and assessment.|25||
60048972|NCT01634555|76164650|FG000|NOT COMPLETED|Overall Study||4||
60048973|NCT01634243|76164657|FG000|STARTED|Overall Study||21||
60048974|NCT01634243|76164658|FG001|STARTED|Overall Study||43||
60048975|NCT01634243|76164657|FG000|COMPLETED|Overall Study||15||
60048976|NCT01634243|76164658|FG001|COMPLETED|Overall Study||38||
60048977|NCT01634243|76164657|FG000|NOT COMPLETED|Overall Study||6||
60048978|NCT01634243|76164658|FG001|NOT COMPLETED|Overall Study||5||
60048979|NCT02402309|76164666|FG000|STARTED|Overall Study||6||
60048980|NCT02402309|76164667|FG001|STARTED|Overall Study||6||
60048981|NCT02402309|76164666|FG000|COMPLETED|Overall Study||6||
60048982|NCT02402309|76164667|FG001|COMPLETED|Overall Study||6||
60048983|NCT02402309|76164666|FG000|NOT COMPLETED|Overall Study||0||
60048984|NCT02402309|76164667|FG001|NOT COMPLETED|Overall Study||0||
60048985|NCT01542034|76164675|FG000|STARTED|Overall Study||256||
60048986|NCT01542034|76164676|FG001|STARTED|Overall Study||250||
60048987|NCT01542034|76164675|FG000|Received Treatment|Overall Study||256||
60048988|NCT01542034|76164676|FG001|Received Treatment|Overall Study||249||
60048989|NCT01542034|76164675|FG000|COMPLETED|Overall Study|Participants who completed long-term follow-up 24 weeks after the last treatment|226||
60048990|NCT01542034|76164676|FG001|COMPLETED|Overall Study|Participants who completed long-term follow-up 24 weeks after the last treatment|227||
60048991|NCT01542034|76164675|FG000|NOT COMPLETED|Overall Study||30||
60048992|NCT01542034|76164676|FG001|NOT COMPLETED|Overall Study||23||
60048993|NCT01564732|76164684|FG000|STARTED|Overall Study||6||
60048994|NCT01564732|76164685|FG001|STARTED|Overall Study||5||
60048995|NCT01564732|76164684|FG000|COMPLETED|Overall Study||0||
60048996|NCT01564732|76164685|FG001|COMPLETED|Overall Study||0||
60048997|NCT01564732|76164684|FG000|NOT COMPLETED|Overall Study||6||
60048998|NCT01564732|76164685|FG001|NOT COMPLETED|Overall Study||5||
59760204|NCT00895895|75879778|FG004|NOT COMPLETED|Period 2||49||
59760205|NCT00895661|75879796|FG000|STARTED|Overall Study||40||
59760206|NCT00895661|75879796|FG000|COMPLETED|Overall Study||37||
59760207|NCT00895661|75879796|FG000|NOT COMPLETED|Overall Study||3||
59760208|NCT00895583|75879802|FG000|STARTED|Overall Study||131||
59921047|NCT02199691|76040523|FG001|Safety Analysis Set (SafAS)|Overall Study||501|SafAS:participants who received at least 1 dose of study vaccine(s) & had any safety data available.|
59921048|NCT02199691|76040524|FG002|Safety Analysis Set (SafAS)|Overall Study||392|SafAS:participants who received at least 1 dose of study vaccine(s) & had any safety data available.|
59921049|NCT02199691|76040525|FG003|Safety Analysis Set (SafAS)|Overall Study||296|SafAS:participants who received at least 1 dose of study vaccine(s) & had any safety data available.|
59921050|NCT02199691|76040522|FG000|COMPLETED|Overall Study||495||
59921051|NCT02199691|76040523|FG001|COMPLETED|Overall Study||500||
59921052|NCT02199691|76040524|FG002|COMPLETED|Overall Study||376||
59921053|NCT02199691|76040525|FG003|COMPLETED|Overall Study||270||
59921054|NCT02199691|76040522|FG000|NOT COMPLETED|Overall Study||10||
59921055|NCT02199691|76040523|FG001|NOT COMPLETED|Overall Study||7||
59921056|NCT02199691|76040524|FG002|NOT COMPLETED|Overall Study||27||
59921057|NCT02199691|76040525|FG003|NOT COMPLETED|Overall Study||30||
59921058|NCT03299881|76040539|FG000|STARTED|Overall Study||39||
60048999|NCT01541644|76164691|FG000|STARTED|Overall Study||27||
60049000|NCT01541644|76164691|FG000|COMPLETED|Overall Study||24||
60049001|NCT01541644|76164691|FG000|NOT COMPLETED|Overall Study||3||
60049002|NCT01582282|76164698|FG000|STARTED|Overall Study||15||
60049003|NCT01582282|76164699|FG001|STARTED|Overall Study||14||
60049004|NCT01582282|76164700|FG002|STARTED|Overall Study||8||
60049005|NCT01582282|76164698|FG000|COMPLETED|Overall Study||13||
60049006|NCT01582282|76164699|FG001|COMPLETED|Overall Study||12||
60049007|NCT01582282|76164700|FG002|COMPLETED|Overall Study||8||
60049008|NCT01582282|76164698|FG000|NOT COMPLETED|Overall Study||2||
60049009|NCT01582282|76164699|FG001|NOT COMPLETED|Overall Study||2||
60049010|NCT01582282|76164700|FG002|NOT COMPLETED|Overall Study||0||
60049011|NCT01599650|76164711|FG000|STARTED|Overall Study||183||
60049012|NCT01599650|76164712|FG001|STARTED|Overall Study||180||
60049013|NCT01599650|76164713|FG002|STARTED|Overall Study||92||
60049014|NCT01599650|76164711|FG000|Completed 6 Mos|Overall Study||174||
60049015|NCT01599650|76164712|FG001|Completed 6 Mos|Overall Study||170||
60049016|NCT01599650|76164713|FG002|Completed 6 Mos|Overall Study||80||
60049017|NCT01599650|76164711|FG000|COMPLETED|Overall Study||161||
60049018|NCT01599650|76164712|FG001|COMPLETED|Overall Study||154||
60049019|NCT01599650|76164713|FG002|COMPLETED|Overall Study||65||
59513069|NCT02919826|75606591|FG000|STARTED|Overall Study||10||
59513070|NCT02919826|75606592|FG001|STARTED|Overall Study||10||
59513071|NCT02919826|75606591|FG000|COMPLETED|Overall Study||10||
59513072|NCT02919826|75606592|FG001|COMPLETED|Overall Study||8||
59513073|NCT02919826|75606591|FG000|NOT COMPLETED|Overall Study||0||
59513074|NCT02919826|75606592|FG001|NOT COMPLETED|Overall Study||2||
59612723|NCT01717326|75723772|FG012|Treated|Overall Study||33||
59612724|NCT01717326|75723773|FG013|Treated|Overall Study||32||
59612725|NCT01717326|75723774|FG014|Treated|Overall Study||29||
59612726|NCT01717326|75723775|FG015|Treated|Overall Study||30||
59612727|NCT01717326|75723776|FG016|Treated|Overall Study||30||
59612728|NCT01717326|75723777|FG017|Treated|Overall Study||31||
59921059|NCT03299881|76040540|FG001|STARTED|Overall Study||38||
59612729|NCT01717326|75723778|FG018|Treated|Overall Study||20||
59921060|NCT03299881|76040539|FG000|COMPLETED|Overall Study||22||
59921061|NCT03299881|76040540|FG001|COMPLETED|Overall Study||25||
59921062|NCT03299881|76040539|FG000|NOT COMPLETED|Overall Study||17||
59921063|NCT03299881|76040540|FG001|NOT COMPLETED|Overall Study||13||
59921064|NCT03299101|76040546|FG000|STARTED|Overall Study||35||
59921065|NCT03299101|76040546|FG000|COMPLETED|Overall Study||25||
59921066|NCT03299101|76040546|FG000|NOT COMPLETED|Overall Study||10||
59921067|NCT02663128|76040552|FG000|STARTED|Period 1||3||
59921068|NCT02663128|76040553|FG001|STARTED|Period 1||3||
59921069|NCT02663128|76040554|FG002|STARTED|Period 1||3||
59921070|NCT02663128|76040555|FG003|STARTED|Period 1||3||
60049020|NCT01599650|76164711|FG000|NOT COMPLETED|Overall Study||22||
60049021|NCT01599650|76164712|FG001|NOT COMPLETED|Overall Study||26||
60049022|NCT01599650|76164713|FG002|NOT COMPLETED|Overall Study||27||
60049023|NCT01541254|76164723|FG000|STARTED|Overall Study||36||
60049024|NCT01541254|76164723|FG000|COMPLETED|Overall Study||30||
60049025|NCT01541254|76164723|FG000|NOT COMPLETED|Overall Study||6||
59921071|NCT02663128|76040556|FG004|STARTED|Period 1||3||
59921072|NCT02663128|76040557|FG005|STARTED|Period 1||3||
60049026|NCT02163902|76164729|FG000|STARTED|Overall Study||113||
60049027|NCT02163902|76164730|FG001|STARTED|Overall Study||111||
60049028|NCT02163902|76164729|FG000|COMPLETED|Overall Study||102||
60049029|NCT02163902|76164730|FG001|COMPLETED|Overall Study||98||
60049030|NCT02163902|76164729|FG000|NOT COMPLETED|Overall Study||11||
60049031|NCT02163902|76164730|FG001|NOT COMPLETED|Overall Study||13||
60049032|NCT01630616|76164742|FG000|STARTED|Overall Study||5||
60049033|NCT01630616|76164743|FG001|STARTED|Overall Study||3||
59612730|NCT01717326|75723779|FG019|Treated|Overall Study||21||
59921073|NCT02663128|76040552|FG000|Received at Least One Dose of Study Drug|Period 1||3||
60049034|NCT01630616|76164744|FG002|STARTED|Overall Study||3||
60049035|NCT01630616|76164745|FG003|STARTED|Overall Study||12||
59513075|NCT02920918|75606602|FG000|STARTED|Overall Study||17||
59513076|NCT02920918|75606603|FG001|STARTED|Overall Study||19||
59513077|NCT02920918|75606602|FG000|COMPLETED|Overall Study||17||
59612731|NCT01717326|75723760|FG000|COMPLETED|Overall Study||22||
59612732|NCT01717326|75723761|FG001|COMPLETED|Overall Study||26||
59921074|NCT02663128|76040553|FG001|Received at Least One Dose of Study Drug|Period 1||3||
59513078|NCT02920918|75606603|FG001|COMPLETED|Overall Study||19||
59513079|NCT02920918|75606602|FG000|NOT COMPLETED|Overall Study||0||
59921075|NCT02663128|76040554|FG002|Received at Least One Dose of Study Drug|Period 1||3||
59921076|NCT02663128|76040555|FG003|Received at Least One Dose of Study Drug|Period 1||3||
60049036|NCT01630616|76164746|FG004|STARTED|Overall Study||6||
60049037|NCT01630616|76164747|FG005|STARTED|Overall Study||2||
59513080|NCT02920918|75606603|FG001|NOT COMPLETED|Overall Study||0||
60049038|NCT01630616|76164742|FG000|COMPLETED|Overall Study||5||
60049039|NCT01630616|76164743|FG001|COMPLETED|Overall Study||3||
60049040|NCT01630616|76164744|FG002|COMPLETED|Overall Study||3||
60049041|NCT01630616|76164745|FG003|COMPLETED|Overall Study||9||
60049042|NCT01630616|76164746|FG004|COMPLETED|Overall Study||6||
60049043|NCT01630616|76164747|FG005|COMPLETED|Overall Study||2||
60049044|NCT01630616|76164742|FG000|NOT COMPLETED|Overall Study||0||
60049045|NCT01630616|76164743|FG001|NOT COMPLETED|Overall Study||0||
60049046|NCT01630616|76164744|FG002|NOT COMPLETED|Overall Study||0||
60049047|NCT01630616|76164745|FG003|NOT COMPLETED|Overall Study||3||
60049048|NCT01630616|76164746|FG004|NOT COMPLETED|Overall Study||0||
60049049|NCT01630616|76164747|FG005|NOT COMPLETED|Overall Study||0||
60049050|NCT03774875|76164766|FG000|STARTED|Placebo-controlled Period (Week 1-16)||92||
60049051|NCT03774875|76164767|FG001|STARTED|Placebo-controlled Period (Week 1-16)||185||
59513081|NCT00944047|75606609|FG000|STARTED|Overall Study||32||
59513082|NCT00944047|75606609|FG000|COMPLETED|Overall Study||27||
59513083|NCT00944047|75606609|FG000|NOT COMPLETED|Overall Study||5||
59513084|NCT02921386|75606613|FG000|STARTED|Sequence A: Fasting||18||
59513085|NCT02921386|75606613|FG000|COMPLETED|Sequence A: Fasting||18||
59513086|NCT02921386|75606613|FG000|NOT COMPLETED|Sequence A: Fasting||0||
60049052|NCT03774875|76164766|FG000|Received Study Drug|Placebo-controlled Period (Week 1-16)||91||
60049053|NCT03774875|76164767|FG001|Received Study Drug|Placebo-controlled Period (Week 1-16)||185||
60049054|NCT03774875|76164766|FG000|COMPLETED|Placebo-controlled Period (Week 1-16)||69||
60049055|NCT03774875|76164767|FG001|COMPLETED|Placebo-controlled Period (Week 1-16)||152||
60049056|NCT03774875|76164766|FG000|NOT COMPLETED|Placebo-controlled Period (Week 1-16)||23||
60049057|NCT03774875|76164767|FG001|NOT COMPLETED|Placebo-controlled Period (Week 1-16)||33||
60049058|NCT03774875|76164766|FG000|STARTED|Apremilast Extension Period (Week 16-52)||69||
60049059|NCT03774875|76164767|FG001|STARTED|Apremilast Extension Period (Week 16-52)||152||
60049060|NCT03774875|76164766|FG000|COMPLETED|Apremilast Extension Period (Week 16-52)||53||
60049061|NCT03774875|76164767|FG001|COMPLETED|Apremilast Extension Period (Week 16-52)||105||
59513087|NCT02921386|75606613|FG000|STARTED|Sequence B: 15 g Fat Breakfast||18||
59513088|NCT02921386|75606613|FG000|COMPLETED|Sequence B: 15 g Fat Breakfast||18||
59513089|NCT02921386|75606613|FG000|NOT COMPLETED|Sequence B: 15 g Fat Breakfast||0||
59513090|NCT02921386|75606613|FG000|STARTED|Sequence C: 30 g Fat Breakfast||18||
59513091|NCT02921386|75606613|FG000|COMPLETED|Sequence C: 30 g Fat Breakfast||18||
59513092|NCT02921386|75606613|FG000|NOT COMPLETED|Sequence C: 30 g Fat Breakfast||0||
59513093|NCT02921386|75606613|FG000|STARTED|Sequence D: 45 g Fat Breakfast||18||
59513094|NCT02921386|75606613|FG000|COMPLETED|Sequence D: 45 g Fat Breakfast||18||
59513095|NCT02921386|75606613|FG000|NOT COMPLETED|Sequence D: 45 g Fat Breakfast||0||
59513096|NCT02921386|75606613|FG000|STARTED|Sequence E: FDA High Fat Breakfast||18||
59760209|NCT00895583|75879803|FG001|STARTED|Overall Study||123||
59921077|NCT02663128|76040556|FG004|Received at Least One Dose of Study Drug|Period 1||3||
59921078|NCT02663128|76040557|FG005|Received at Least One Dose of Study Drug|Period 1||3||
59921079|NCT02663128|76040552|FG000|COMPLETED|Period 1||3||
59921080|NCT02663128|76040553|FG001|COMPLETED|Period 1||3||
59921081|NCT02663128|76040554|FG002|COMPLETED|Period 1||3||
59921082|NCT02663128|76040555|FG003|COMPLETED|Period 1||3||
59921083|NCT02663128|76040556|FG004|COMPLETED|Period 1||3||
59921084|NCT02663128|76040557|FG005|COMPLETED|Period 1||3||
59921085|NCT02663128|76040552|FG000|NOT COMPLETED|Period 1||0||
60049062|NCT03774875|76164766|FG000|NOT COMPLETED|Apremilast Extension Period (Week 16-52)||16||
60049063|NCT03774875|76164767|FG001|NOT COMPLETED|Apremilast Extension Period (Week 16-52)||47||
60049064|NCT02220764|76164780|FG000|STARTED|Overall Study||24||
60049065|NCT02220764|76164781|FG001|STARTED|Overall Study||8||
60049066|NCT02220764|76164780|FG000|COMPLETED|Overall Study||20||
60049067|NCT02220764|76164781|FG001|COMPLETED|Overall Study||7||
60049068|NCT02220764|76164780|FG000|NOT COMPLETED|Overall Study||4||
60049069|NCT02220764|76164781|FG001|NOT COMPLETED|Overall Study||1||
60049070|NCT01563172|76164787|FG000|STARTED|Overall Study||65||
60049071|NCT01563172|76164787|FG000|Experimental Dentifrice 0.5g/2 Min|Overall Study||59||
60049072|NCT01563172|76164787|FG000|Experimental Dentifrice 0.5g/45 Sec|Overall Study||59||
60049073|NCT01563172|76164787|FG000|Experimental Dentifrice 1.5g/ 2min|Overall Study||58||
60049074|NCT01563172|76164787|FG000|Experimental Dentifrice 1.5g/ 45 Sec|Overall Study||58||
60049075|NCT01563172|76164787|FG000|Control Dentifrice|Overall Study||60||
60049076|NCT01563172|76164787|FG000|COMPLETED|Overall Study||52||
60049077|NCT01563172|76164787|FG000|NOT COMPLETED|Overall Study||13||
60049078|NCT02161718|76164804|FG000|STARTED|Open-Label ALKS 3831 Period||255||
60049079|NCT02161718|76164805|FG001|STARTED|Open-Label ALKS 3831 Period||0||
60049080|NCT02161718|76164806|FG002|STARTED|Open-Label ALKS 3831 Period||0||
59513097|NCT02921386|75606613|FG000|COMPLETED|Sequence E: FDA High Fat Breakfast||18||
59513098|NCT02921386|75606613|FG000|NOT COMPLETED|Sequence E: FDA High Fat Breakfast||0||
59513099|NCT02802514|75606621|FG000|STARTED|Session 1 (up to Day 8)||1||
59921086|NCT02663128|76040553|FG001|NOT COMPLETED|Period 1||0||
59921087|NCT02663128|76040554|FG002|NOT COMPLETED|Period 1||0||
59921088|NCT02663128|76040555|FG003|NOT COMPLETED|Period 1||0||
59921089|NCT02663128|76040556|FG004|NOT COMPLETED|Period 1||0||
60049081|NCT02161718|76164804|FG000|COMPLETED|Open-Label ALKS 3831 Period||234||
60049082|NCT02161718|76164805|FG001|COMPLETED|Open-Label ALKS 3831 Period||0||
60049083|NCT02161718|76164806|FG002|COMPLETED|Open-Label ALKS 3831 Period||0||
60049084|NCT02161718|76164804|FG000|NOT COMPLETED|Open-Label ALKS 3831 Period||21||
60049085|NCT02161718|76164805|FG001|NOT COMPLETED|Open-Label ALKS 3831 Period||0||
60049086|NCT02161718|76164806|FG002|NOT COMPLETED|Open-Label ALKS 3831 Period||0||
60049087|NCT02161718|76164804|FG000|STARTED|Post- Randomization Period||0||
60049088|NCT02161718|76164805|FG001|STARTED|Post- Randomization Period||112||
59513100|NCT02802514|75606622|FG001|STARTED|Session 1 (up to Day 8)||1||
59513101|NCT02802514|75606623|FG002|STARTED|Session 1 (up to Day 8)||1||
59513102|NCT02802514|75606624|FG003|STARTED|Session 1 (up to Day 8)||1||
59921090|NCT02663128|76040557|FG005|NOT COMPLETED|Period 1||0||
59921091|NCT02663128|76040552|FG000|STARTED|Period 2||3||
59921092|NCT02663128|76040553|FG001|STARTED|Period 2||3||
59921093|NCT02663128|76040554|FG002|STARTED|Period 2||3||
59921094|NCT02663128|76040555|FG003|STARTED|Period 2||3||
59921095|NCT02663128|76040556|FG004|STARTED|Period 2||3||
59921096|NCT02663128|76040557|FG005|STARTED|Period 2||3||
59921097|NCT02663128|76040552|FG000|COMPLETED|Period 2||3||
59921098|NCT02663128|76040553|FG001|COMPLETED|Period 2||3||
59921099|NCT02663128|76040554|FG002|COMPLETED|Period 2||3||
59921100|NCT02663128|76040555|FG003|COMPLETED|Period 2||3||
59921101|NCT02663128|76040556|FG004|COMPLETED|Period 2||2||
59921102|NCT02663128|76040557|FG005|COMPLETED|Period 2||3||
59921103|NCT02663128|76040552|FG000|NOT COMPLETED|Period 2||0||
59921104|NCT02663128|76040553|FG001|NOT COMPLETED|Period 2||0||
59921105|NCT02663128|76040554|FG002|NOT COMPLETED|Period 2||0||
59921106|NCT02663128|76040555|FG003|NOT COMPLETED|Period 2||0||
59921107|NCT02663128|76040556|FG004|NOT COMPLETED|Period 2||1||
59921108|NCT02663128|76040557|FG005|NOT COMPLETED|Period 2||0||
59921109|NCT02663128|76040552|FG000|STARTED|Period 3||3||
59921110|NCT02663128|76040553|FG001|STARTED|Period 3||3||
59921111|NCT02663128|76040554|FG002|STARTED|Period 3||3||
59921112|NCT02663128|76040555|FG003|STARTED|Period 3||3||
59921113|NCT02663128|76040556|FG004|STARTED|Period 3||2||
59921114|NCT02663128|76040557|FG005|STARTED|Period 3||3||
59921115|NCT02663128|76040552|FG000|COMPLETED|Period 3||3||
59921116|NCT02663128|76040553|FG001|COMPLETED|Period 3||3||
59921117|NCT02663128|76040554|FG002|COMPLETED|Period 3||3||
59921118|NCT02663128|76040555|FG003|COMPLETED|Period 3||3||
59921119|NCT02663128|76040556|FG004|COMPLETED|Period 3||2||
59921120|NCT02663128|76040557|FG005|COMPLETED|Period 3||3||
59921121|NCT02663128|76040552|FG000|NOT COMPLETED|Period 3||0||
59921122|NCT02663128|76040553|FG001|NOT COMPLETED|Period 3||0||
59921123|NCT02663128|76040554|FG002|NOT COMPLETED|Period 3||0||
59921124|NCT02663128|76040555|FG003|NOT COMPLETED|Period 3||0||
59921125|NCT02663128|76040556|FG004|NOT COMPLETED|Period 3||0||
60049089|NCT02161718|76164806|FG002|STARTED|Post- Randomization Period||117||
60049090|NCT02161718|76164804|FG000|COMPLETED|Post- Randomization Period||0||
60049091|NCT02161718|76164805|FG001|COMPLETED|Post- Randomization Period||53||
60049092|NCT02161718|76164806|FG002|COMPLETED|Post- Randomization Period||58||
60049093|NCT02161718|76164804|FG000|NOT COMPLETED|Post- Randomization Period||0||
59513103|NCT02802514|75606621|FG000|COMPLETED|Session 1 (up to Day 8)||1||
59513104|NCT02802514|75606622|FG001|COMPLETED|Session 1 (up to Day 8)||1||
59513105|NCT02802514|75606623|FG002|COMPLETED|Session 1 (up to Day 8)||1||
59513106|NCT02802514|75606624|FG003|COMPLETED|Session 1 (up to Day 8)||1||
59513107|NCT02802514|75606621|FG000|NOT COMPLETED|Session 1 (up to Day 8)||0||
59513108|NCT02802514|75606622|FG001|NOT COMPLETED|Session 1 (up to Day 8)||0||
59513109|NCT02802514|75606623|FG002|NOT COMPLETED|Session 1 (up to Day 8)||0||
59513110|NCT02802514|75606624|FG003|NOT COMPLETED|Session 1 (up to Day 8)||0||
59513111|NCT02802514|75606621|FG000|STARTED|Wash Out Period (up to Week 9)||1||
59513112|NCT02802514|75606622|FG001|STARTED|Wash Out Period (up to Week 9)||1||
59513113|NCT02802514|75606623|FG002|STARTED|Wash Out Period (up to Week 9)||1||
59513114|NCT02802514|75606624|FG003|STARTED|Wash Out Period (up to Week 9)||1||
59921126|NCT02663128|76040557|FG005|NOT COMPLETED|Period 3||0||
59921127|NCT03298867|76040568|FG000|STARTED|Double-Masked 24-Week Treatment Period||42||
59921128|NCT03298867|76040569|FG001|STARTED|Double-Masked 24-Week Treatment Period||41||
59921129|NCT03298867|76040568|FG000|COMPLETED|Double-Masked 24-Week Treatment Period|36 participants who completed the double-masked treatment period as nonresponders chose to enroll in the OPTIC-X open-label extension study (NCT03461211).|40||
59921130|NCT03298867|76040569|FG001|COMPLETED|Double-Masked 24-Week Treatment Period|3 participants who completed the double-masked treatment period as nonresponders chose to enroll in the OPTIC-X open-label extension study (NCT03461211).|39||
59921131|NCT03298867|76040568|FG000|NOT COMPLETED|Double-Masked 24-Week Treatment Period||2||
59921132|NCT03298867|76040569|FG001|NOT COMPLETED|Double-Masked 24-Week Treatment Period||2||
59921133|NCT03298867|76040568|FG000|STARTED|48-Week Follow-Up Period (Weeks 24-72)||4||
59921134|NCT03298867|76040569|FG001|STARTED|48-Week Follow-Up Period (Weeks 24-72)||36||
59921135|NCT03298867|76040568|FG000|COMPLETED|48-Week Follow-Up Period (Weeks 24-72)||3||
59921136|NCT03298867|76040569|FG001|COMPLETED|48-Week Follow-Up Period (Weeks 24-72)||20||
59921137|NCT03298867|76040568|FG000|NOT COMPLETED|48-Week Follow-Up Period (Weeks 24-72)||1||
59921138|NCT03298867|76040569|FG001|NOT COMPLETED|48-Week Follow-Up Period (Weeks 24-72)||16||
59921139|NCT03298867|76040568|FG000|STARTED|48-Week Follow-Up Contact (Weeks 96-120)||3||
60049094|NCT02161718|76164805|FG001|NOT COMPLETED|Post- Randomization Period||59||
60049095|NCT02161718|76164806|FG002|NOT COMPLETED|Post- Randomization Period||59||
59513115|NCT02802514|75606621|FG000|COMPLETED|Wash Out Period (up to Week 9)||1||
59513116|NCT02802514|75606622|FG001|COMPLETED|Wash Out Period (up to Week 9)||1||
59513117|NCT02802514|75606623|FG002|COMPLETED|Wash Out Period (up to Week 9)||1||
59513118|NCT02802514|75606624|FG003|COMPLETED|Wash Out Period (up to Week 9)||1||
59513119|NCT02802514|75606621|FG000|NOT COMPLETED|Wash Out Period (up to Week 9)||0||
59513120|NCT02802514|75606622|FG001|NOT COMPLETED|Wash Out Period (up to Week 9)||0||
59513121|NCT02802514|75606623|FG002|NOT COMPLETED|Wash Out Period (up to Week 9)||0||
59513122|NCT02802514|75606624|FG003|NOT COMPLETED|Wash Out Period (up to Week 9)||0||
59921140|NCT03298867|76040569|FG001|STARTED|48-Week Follow-Up Contact (Weeks 96-120)||20||
59921141|NCT03298867|76040568|FG000|COMPLETED|48-Week Follow-Up Contact (Weeks 96-120)||3||
59921142|NCT03298867|76040569|FG001|COMPLETED|48-Week Follow-Up Contact (Weeks 96-120)||19||
59921143|NCT03298867|76040568|FG000|NOT COMPLETED|48-Week Follow-Up Contact (Weeks 96-120)||0||
59921144|NCT03298867|76040569|FG001|NOT COMPLETED|48-Week Follow-Up Contact (Weeks 96-120)||1||
59921145|NCT02906930|76040579|FG000|STARTED|Overall Study||175||
59921146|NCT02906930|76040580|FG001|STARTED|Overall Study||175||
59921147|NCT02906930|76040581|FG002|STARTED|Overall Study||175||
59921148|NCT02906930|76040582|FG003|STARTED|Overall Study||178||
59921149|NCT02906930|76040579|FG000|Full Analysis Set (FAS)|Overall Study||175||
59921150|NCT02906930|76040580|FG001|Full Analysis Set (FAS)|Overall Study||175||
59921151|NCT02906930|76040581|FG002|Full Analysis Set (FAS)|Overall Study||175||
59921152|NCT02906930|76040582|FG003|Full Analysis Set (FAS)|Overall Study||178||
59921153|NCT02906930|76040579|FG000|Safety Analysis Set (SAS)|Overall Study||175||
59921154|NCT02906930|76040580|FG001|Safety Analysis Set (SAS)|Overall Study||175||
59921155|NCT02906930|76040581|FG002|Safety Analysis Set (SAS)|Overall Study||175||
59921156|NCT02906930|76040582|FG003|Safety Analysis Set (SAS)|Overall Study||178||
59921157|NCT02906930|76040579|FG000|COMPLETED|Overall Study||169||
59921158|NCT02906930|76040580|FG001|COMPLETED|Overall Study||161||
59921159|NCT02906930|76040581|FG002|COMPLETED|Overall Study||163||
59921160|NCT02906930|76040582|FG003|COMPLETED|Overall Study||170||
59921161|NCT02906930|76040579|FG000|NOT COMPLETED|Overall Study||6||
59921162|NCT02906930|76040580|FG001|NOT COMPLETED|Overall Study||14||
59921163|NCT02906930|76040581|FG002|NOT COMPLETED|Overall Study||12||
59921164|NCT02906930|76040582|FG003|NOT COMPLETED|Overall Study||8||
59921165|NCT02983604|76040596|FG000|STARTED|Overall Study||4||
59921166|NCT02983604|76040597|FG001|STARTED|Overall Study||3||
59921167|NCT02983604|76040598|FG002|STARTED|Overall Study||4||
59921168|NCT02983604|76040599|FG003|STARTED|Overall Study||3||
59921169|NCT02983604|76040596|FG000|COMPLETED|Overall Study||4||
59921170|NCT02983604|76040597|FG001|COMPLETED|Overall Study||3||
59921171|NCT02983604|76040598|FG002|COMPLETED|Overall Study||3||
59921172|NCT02983604|76040599|FG003|COMPLETED|Overall Study||3||
59921173|NCT02983604|76040596|FG000|NOT COMPLETED|Overall Study||0||
59921174|NCT02983604|76040597|FG001|NOT COMPLETED|Overall Study||0||
59921175|NCT02983604|76040598|FG002|NOT COMPLETED|Overall Study||1||
59921176|NCT02983604|76040599|FG003|NOT COMPLETED|Overall Study||0||
59921177|NCT02662582|76040611|FG000|STARTED|Treatment Period 1 (14 Days)||23||
59921178|NCT02662582|76040612|FG001|STARTED|Treatment Period 1 (14 Days)||23||
59921179|NCT02662582|76040611|FG000|COMPLETED|Treatment Period 1 (14 Days)||18||
59921180|NCT02662582|76040612|FG001|COMPLETED|Treatment Period 1 (14 Days)||19||
59921181|NCT02662582|76040611|FG000|NOT COMPLETED|Treatment Period 1 (14 Days)||5||
59921182|NCT02662582|76040612|FG001|NOT COMPLETED|Treatment Period 1 (14 Days)||4||
59921183|NCT02662582|76040611|FG000|STARTED|Washout Period (14 Days)||18||
59921184|NCT02662582|76040612|FG001|STARTED|Washout Period (14 Days)||19||
59921185|NCT02662582|76040611|FG000|COMPLETED|Washout Period (14 Days)||18||
59921186|NCT02662582|76040612|FG001|COMPLETED|Washout Period (14 Days)||19||
59921187|NCT02662582|76040611|FG000|NOT COMPLETED|Washout Period (14 Days)||0||
59921188|NCT02662582|76040612|FG001|NOT COMPLETED|Washout Period (14 Days)||0||
59921189|NCT02662582|76040611|FG000|STARTED|Treatment Period 2 (14 Days)||18||
59921190|NCT02662582|76040612|FG001|STARTED|Treatment Period 2 (14 Days)||19||
59921191|NCT02662582|76040611|FG000|COMPLETED|Treatment Period 2 (14 Days)||18||
59921192|NCT02662582|76040612|FG001|COMPLETED|Treatment Period 2 (14 Days)||19||
59921193|NCT02662582|76040611|FG000|NOT COMPLETED|Treatment Period 2 (14 Days)||0||
59921194|NCT02662582|76040612|FG001|NOT COMPLETED|Treatment Period 2 (14 Days)||0||
59921195|NCT02908100|76040622|FG000|STARTED|Overall Study||86||
59921196|NCT02908100|76040623|FG001|STARTED|Overall Study||87||
59921197|NCT02908100|76040624|FG002|STARTED|Overall Study||87||
59921198|NCT02908100|76040622|FG000|COMPLETED|Overall Study||63||
59921199|NCT02908100|76040623|FG001|COMPLETED|Overall Study||66||
59921200|NCT02908100|76040624|FG002|COMPLETED|Overall Study||66||
59921201|NCT02908100|76040622|FG000|NOT COMPLETED|Overall Study||23||
59921202|NCT02908100|76040623|FG001|NOT COMPLETED|Overall Study||21||
59921203|NCT02908100|76040624|FG002|NOT COMPLETED|Overall Study||21||
59921204|NCT04341298|76040636|FG000|STARTED|Overall Study||38||
59921205|NCT04341298|76040637|FG001|STARTED|Overall Study||40||
59921206|NCT04341298|76040636|FG000|COMPLETED|Overall Study||38||
59921207|NCT04341298|76040637|FG001|COMPLETED|Overall Study||40||
59921208|NCT04341298|76040636|FG000|NOT COMPLETED|Overall Study||0||
59921209|NCT04341298|76040637|FG001|NOT COMPLETED|Overall Study||0||
59921210|NCT02982590|76040648|FG000|STARTED|Overall Study||13||
59513123|NCT02802514|75606621|FG000|STARTED|Session 2 (Up to Day 8)||1||
59513124|NCT02802514|75606622|FG001|STARTED|Session 2 (Up to Day 8)||1||
59513125|NCT02802514|75606623|FG002|STARTED|Session 2 (Up to Day 8)||1||
59513126|NCT02802514|75606624|FG003|STARTED|Session 2 (Up to Day 8)||1||
59921211|NCT02982590|76040649|FG001|STARTED|Overall Study||14||
59921212|NCT02982590|76040648|FG000|COMPLETED|Overall Study||9||
59513127|NCT02802514|75606621|FG000|COMPLETED|Session 2 (Up to Day 8)||1||
59513128|NCT02802514|75606622|FG001|COMPLETED|Session 2 (Up to Day 8)||1||
59513129|NCT02802514|75606623|FG002|COMPLETED|Session 2 (Up to Day 8)||1||
59513130|NCT02802514|75606624|FG003|COMPLETED|Session 2 (Up to Day 8)||1||
59513131|NCT02802514|75606621|FG000|NOT COMPLETED|Session 2 (Up to Day 8)||0||
59513132|NCT02802514|75606622|FG001|NOT COMPLETED|Session 2 (Up to Day 8)||0||
59513133|NCT02802514|75606623|FG002|NOT COMPLETED|Session 2 (Up to Day 8)||0||
59513134|NCT02802514|75606624|FG003|NOT COMPLETED|Session 2 (Up to Day 8)||0||
59513135|NCT00944671|75606643|FG000|STARTED|Period I||4||
59513136|NCT00944671|75606644|FG001|STARTED|Period I||4||
59513137|NCT00944671|75606645|FG002|STARTED|Period I||4||
59513138|NCT00944671|75606646|FG003|STARTED|Period I||4||
59513139|NCT00944671|75606647|FG004|STARTED|Period I||4||
59513140|NCT00944671|75606648|FG005|STARTED|Period I||4||
59513141|NCT00944671|75606643|FG000|COMPLETED|Period I||4||
59513142|NCT00944671|75606644|FG001|COMPLETED|Period I||4||
59513143|NCT00944671|75606645|FG002|COMPLETED|Period I||4||
59513144|NCT00944671|75606646|FG003|COMPLETED|Period I||4||
59513145|NCT00944671|75606647|FG004|COMPLETED|Period I||4||
59513146|NCT00944671|75606648|FG005|COMPLETED|Period I||4||
59513147|NCT00944671|75606643|FG000|NOT COMPLETED|Period I||0||
59513148|NCT00944671|75606644|FG001|NOT COMPLETED|Period I||0||
59513149|NCT00944671|75606645|FG002|NOT COMPLETED|Period I||0||
59513150|NCT00944671|75606646|FG003|NOT COMPLETED|Period I||0||
59513151|NCT00944671|75606647|FG004|NOT COMPLETED|Period I||0||
59513152|NCT00944671|75606648|FG005|NOT COMPLETED|Period I||0||
59513153|NCT00944671|75606643|FG000|STARTED|Period II||4||
59513154|NCT00944671|75606644|FG001|STARTED|Period II||4||
59513155|NCT00944671|75606645|FG002|STARTED|Period II||4||
59513156|NCT00944671|75606646|FG003|STARTED|Period II||4||
59513157|NCT00944671|75606647|FG004|STARTED|Period II||4||
59513158|NCT00944671|75606648|FG005|STARTED|Period II||4||
59513159|NCT00944671|75606643|FG000|COMPLETED|Period II||4||
59513160|NCT00944671|75606644|FG001|COMPLETED|Period II||4||
59513161|NCT00944671|75606645|FG002|COMPLETED|Period II||4||
59513162|NCT00944671|75606646|FG003|COMPLETED|Period II||4||
59513163|NCT00944671|75606647|FG004|COMPLETED|Period II||4||
59513164|NCT00944671|75606648|FG005|COMPLETED|Period II||4||
59513165|NCT00944671|75606643|FG000|NOT COMPLETED|Period II||0||
59513166|NCT00944671|75606644|FG001|NOT COMPLETED|Period II||0||
59513167|NCT00944671|75606645|FG002|NOT COMPLETED|Period II||0||
59513168|NCT00944671|75606646|FG003|NOT COMPLETED|Period II||0||
59513169|NCT00944671|75606647|FG004|NOT COMPLETED|Period II||0||
59513170|NCT00944671|75606648|FG005|NOT COMPLETED|Period II||0||
59921213|NCT02982590|76040649|FG001|COMPLETED|Overall Study||13||
59513171|NCT00944671|75606643|FG000|STARTED|Period III||4||
59513172|NCT00944671|75606644|FG001|STARTED|Period III||4||
59513173|NCT00944671|75606645|FG002|STARTED|Period III||4||
59513174|NCT00944671|75606646|FG003|STARTED|Period III||4||
59513175|NCT00944671|75606647|FG004|STARTED|Period III||4||
59513176|NCT00944671|75606648|FG005|STARTED|Period III||4||
59513177|NCT00944671|75606643|FG000|COMPLETED|Period III||4||
59513178|NCT00944671|75606644|FG001|COMPLETED|Period III||4||
59513179|NCT00944671|75606645|FG002|COMPLETED|Period III||4||
59513180|NCT00944671|75606646|FG003|COMPLETED|Period III||4||
59921214|NCT02982590|76040648|FG000|NOT COMPLETED|Overall Study||4||
59921215|NCT02982590|76040649|FG001|NOT COMPLETED|Overall Study||1||
59921216|NCT03310021|76040675|FG000|STARTED|Overall Study||6||
59921217|NCT03310021|76040676|FG001|STARTED|Overall Study||3||
59921218|NCT03310021|76040677|FG002|STARTED|Overall Study||6||
59921219|NCT03310021|76040678|FG003|STARTED|Overall Study||3||
59921220|NCT03310021|76040679|FG004|STARTED|Overall Study||8||
59921221|NCT03310021|76040680|FG005|STARTED|Overall Study||4||
59513181|NCT00944671|75606647|FG004|COMPLETED|Period III||4||
59513182|NCT00944671|75606648|FG005|COMPLETED|Period III||4||
59513183|NCT00944671|75606643|FG000|NOT COMPLETED|Period III||0||
59921222|NCT03310021|76040681|FG006|STARTED|Overall Study||8||
59513184|NCT00944671|75606644|FG001|NOT COMPLETED|Period III||0||
59921223|NCT03310021|76040682|FG007|STARTED|Overall Study||4||
59921224|NCT03310021|76040683|FG008|STARTED|Overall Study||6||
59921225|NCT03310021|76040684|FG009|STARTED|Overall Study||3||
59921226|NCT03310021|76040685|FG010|STARTED|Overall Study||6||
59921227|NCT03310021|76040686|FG011|STARTED|Overall Study||3||
59921228|NCT03310021|76040687|FG012|STARTED|Overall Study||8||
59921229|NCT03310021|76040688|FG013|STARTED|Overall Study||4||
59921230|NCT03310021|76040689|FG014|STARTED|Overall Study||6||
59921231|NCT03310021|76040690|FG015|STARTED|Overall Study||3||
59921232|NCT03310021|76040691|FG016|STARTED|Overall Study||10||
59513185|NCT00944671|75606645|FG002|NOT COMPLETED|Period III||0||
59513186|NCT00944671|75606646|FG003|NOT COMPLETED|Period III||0||
59513187|NCT00944671|75606647|FG004|NOT COMPLETED|Period III||0||
59513188|NCT00944671|75606648|FG005|NOT COMPLETED|Period III||0||
59513189|NCT02922868|75606658|FG000|STARTED|Overall Study||30||
59513190|NCT02922868|75606659|FG001|STARTED|Overall Study||30||
59760210|NCT00895583|75879802|FG000|COMPLETED|Overall Study||87||
59760211|NCT00895583|75879803|FG001|COMPLETED|Overall Study||111||
59760212|NCT00895583|75879802|FG000|NOT COMPLETED|Overall Study||44||
59760213|NCT00895583|75879803|FG001|NOT COMPLETED|Overall Study||12||
59760214|NCT04066686|75879811|FG000|STARTED|Overall Study||14||
59921233|NCT03310021|76040692|FG017|STARTED|Overall Study||5||
59921234|NCT03310021|76040693|FG018|STARTED|Overall Study||8||
59921235|NCT03310021|76040694|FG019|STARTED|Overall Study||3||
59921236|NCT03310021|76040675|FG000|COMPLETED|Overall Study||6||
59921237|NCT03310021|76040676|FG001|COMPLETED|Overall Study||3||
59921238|NCT03310021|76040677|FG002|COMPLETED|Overall Study||6||
59921239|NCT03310021|76040678|FG003|COMPLETED|Overall Study||3||
59760215|NCT04066686|75879812|FG001|STARTED|Overall Study||13||
59921240|NCT03310021|76040679|FG004|COMPLETED|Overall Study||8||
59921241|NCT03310021|76040680|FG005|COMPLETED|Overall Study||4||
59921242|NCT03310021|76040681|FG006|COMPLETED|Overall Study||7||
59921243|NCT03310021|76040682|FG007|COMPLETED|Overall Study||4||
59921244|NCT03310021|76040683|FG008|COMPLETED|Overall Study||6||
59921245|NCT03310021|76040684|FG009|COMPLETED|Overall Study||3||
60049096|NCT02219048|76164815|FG000|STARTED|Overall Study||26||
60049097|NCT02219048|76164816|FG001|STARTED|Overall Study||25||
60049098|NCT02219048|76164815|FG000|COMPLETED|Overall Study||5||
59513191|NCT02922868|75606658|FG000|COMPLETED|Overall Study||30||
59513192|NCT02922868|75606659|FG001|COMPLETED|Overall Study||30||
59513193|NCT02922868|75606658|FG000|NOT COMPLETED|Overall Study||0||
59513194|NCT02922868|75606659|FG001|NOT COMPLETED|Overall Study||0||
59513195|NCT00944749|75606665|FG000|STARTED|Overall Study||23||
59513196|NCT00944749|75606665|FG000|COMPLETED|Overall Study||22||
59513197|NCT00944749|75606665|FG000|NOT COMPLETED|Overall Study||1||
59513198|NCT01047293|75606669|FG000|STARTED|Overall Study||4||
59513199|NCT01047293|75606670|FG001|STARTED|Overall Study||8||
59513200|NCT01047293|75606671|FG002|STARTED|Overall Study||9||
59513201|NCT01047293|75606672|FG003|STARTED|Overall Study||26||
59513202|NCT01047293|75606669|FG000|COMPLETED|Overall Study||3||
59513203|NCT01047293|75606670|FG001|COMPLETED|Overall Study||7||
59513204|NCT01047293|75606671|FG002|COMPLETED|Overall Study||9||
59513205|NCT01047293|75606672|FG003|COMPLETED|Overall Study||26||
59513206|NCT01047293|75606669|FG000|NOT COMPLETED|Overall Study||1||
59513207|NCT01047293|75606670|FG001|NOT COMPLETED|Overall Study||1||
59513208|NCT01047293|75606671|FG002|NOT COMPLETED|Overall Study||0||
59513209|NCT01047293|75606672|FG003|NOT COMPLETED|Overall Study||0||
59513210|NCT01045967|75606681|FG000|STARTED|First Intervention||28||
59513211|NCT01045967|75606682|FG001|STARTED|First Intervention||28||
59760216|NCT04066686|75879811|FG000|COMPLETED|Overall Study||12||
59760217|NCT04066686|75879812|FG001|COMPLETED|Overall Study||13||
59760218|NCT04066686|75879811|FG000|NOT COMPLETED|Overall Study||2||
59760219|NCT04066686|75879812|FG001|NOT COMPLETED|Overall Study||0||
59760220|NCT00894413|75879820|FG000|STARTED|Overall Study||15||
59760221|NCT00894413|75879821|FG001|STARTED|Overall Study||25||
59760222|NCT00894413|75879820|FG000|COMPLETED|Overall Study||15||
59760223|NCT00894413|75879821|FG001|COMPLETED|Overall Study||17||
59760224|NCT00894413|75879820|FG000|NOT COMPLETED|Overall Study||0||
59760225|NCT00894413|75879821|FG001|NOT COMPLETED|Overall Study||8||
59760226|NCT00895037|75879830|FG000|STARTED|Overall Study||22||
59760227|NCT00895037|75879831|FG001|STARTED|Overall Study||77||
59760228|NCT00895037|75879832|FG002|STARTED|Overall Study||2||
59760229|NCT00895037|75879830|FG000|COMPLETED|Overall Study||22||
59760230|NCT00895037|75879831|FG001|COMPLETED|Overall Study||75||
59921246|NCT03310021|76040685|FG010|COMPLETED|Overall Study||5||
59921247|NCT03310021|76040686|FG011|COMPLETED|Overall Study||3||
59921248|NCT03310021|76040687|FG012|COMPLETED|Overall Study||8||
59921249|NCT03310021|76040688|FG013|COMPLETED|Overall Study||4||
59921250|NCT03310021|76040689|FG014|COMPLETED|Overall Study||6||
59921251|NCT03310021|76040690|FG015|COMPLETED|Overall Study||3||
59513212|NCT01045967|75606681|FG000|COMPLETED|First Intervention||28||
59513213|NCT01045967|75606682|FG001|COMPLETED|First Intervention||28||
59513214|NCT01045967|75606681|FG000|NOT COMPLETED|First Intervention||0||
59513215|NCT01045967|75606682|FG001|NOT COMPLETED|First Intervention||0||
59513216|NCT01045967|75606681|FG000|STARTED|Washout of 7 Days||28||
59921252|NCT03310021|76040691|FG016|COMPLETED|Overall Study||10||
59513217|NCT01045967|75606682|FG001|STARTED|Washout of 7 Days||28||
59513218|NCT01045967|75606681|FG000|COMPLETED|Washout of 7 Days||28||
59513219|NCT01045967|75606682|FG001|COMPLETED|Washout of 7 Days||28||
59612733|NCT01717326|75723762|FG002|COMPLETED|Overall Study||13||
59612734|NCT01717326|75723763|FG003|COMPLETED|Overall Study||28||
59612735|NCT01717326|75723764|FG004|COMPLETED|Overall Study||31||
59612736|NCT01717326|75723765|FG005|COMPLETED|Overall Study||31||
59612737|NCT01717326|75723766|FG006|COMPLETED|Overall Study||30||
59612738|NCT01717326|75723767|FG007|COMPLETED|Overall Study||29||
59760231|NCT00895037|75879832|FG002|COMPLETED|Overall Study||1||
60049099|NCT02219048|76164816|FG001|COMPLETED|Overall Study||4||
59513220|NCT01045967|75606681|FG000|NOT COMPLETED|Washout of 7 Days||0||
59513221|NCT01045967|75606682|FG001|NOT COMPLETED|Washout of 7 Days||0||
59513222|NCT01045967|75606681|FG000|STARTED|Second Intervention||28||
59513223|NCT01045967|75606682|FG001|STARTED|Second Intervention|Subject was dropped prior to dosing in Period II due to positive drug screen.|28||
59513224|NCT01045967|75606681|FG000|COMPLETED|Second Intervention||28||
59513225|NCT01045967|75606682|FG001|COMPLETED|Second Intervention||27||
59513226|NCT01045967|75606681|FG000|NOT COMPLETED|Second Intervention||0||
59513227|NCT01045967|75606682|FG001|NOT COMPLETED|Second Intervention||1||
60049100|NCT02219048|76164815|FG000|NOT COMPLETED|Overall Study||21||
60049101|NCT02219048|76164816|FG001|NOT COMPLETED|Overall Study||21||
60049102|NCT02218736|76164824|FG000|STARTED|Overall Study||45||
60049103|NCT02218736|76164825|FG001|STARTED|Overall Study||44||
60049104|NCT02218736|76164824|FG000|COMPLETED|Overall Study||33||
60049105|NCT02218736|76164825|FG001|COMPLETED|Overall Study||35||
59513228|NCT02808052|75606691|FG000|STARTED|Overall Study||4||
59513229|NCT02808052|75606692|FG001|STARTED|Overall Study||3||
59513230|NCT02808052|75606693|FG002|STARTED|Overall Study||2||
59513231|NCT02808052|75606691|FG000|COMPLETED|Overall Study||4||
60049106|NCT02218736|76164824|FG000|NOT COMPLETED|Overall Study||12||
60049107|NCT02218736|76164825|FG001|NOT COMPLETED|Overall Study||9||
60049108|NCT01540474|76164835|FG000|STARTED|Vaccination Period||10||
60049109|NCT01540474|76164836|FG001|STARTED|Vaccination Period||10||
60049110|NCT01540474|76164837|FG002|STARTED|Vaccination Period||10||
60049111|NCT01540474|76164838|FG003|STARTED|Vaccination Period||0||
60049112|NCT01540474|76164835|FG000|COMPLETED|Vaccination Period||10||
60049113|NCT01540474|76164836|FG001|COMPLETED|Vaccination Period||9||
60049114|NCT01540474|76164837|FG002|COMPLETED|Vaccination Period||10||
60049115|NCT01540474|76164838|FG003|COMPLETED|Vaccination Period||0||
60049116|NCT01540474|76164835|FG000|NOT COMPLETED|Vaccination Period||0||
60049117|NCT01540474|76164836|FG001|NOT COMPLETED|Vaccination Period||1||
60049118|NCT01540474|76164837|FG002|NOT COMPLETED|Vaccination Period||0||
60049119|NCT01540474|76164838|FG003|NOT COMPLETED|Vaccination Period||0||
60049120|NCT01540474|76164835|FG000|STARTED|Malaria Challenge||10||
60049121|NCT01540474|76164836|FG001|STARTED|Malaria Challenge||9||
60049122|NCT01540474|76164837|FG002|STARTED|Malaria Challenge||10||
60049123|NCT01540474|76164838|FG003|STARTED|Malaria Challenge||6||
59513232|NCT02808052|75606692|FG001|COMPLETED|Overall Study||3||
59513233|NCT02808052|75606693|FG002|COMPLETED|Overall Study||2||
59513234|NCT02808052|75606691|FG000|NOT COMPLETED|Overall Study||0||
59513235|NCT02808052|75606692|FG001|NOT COMPLETED|Overall Study||0||
59513236|NCT02808052|75606693|FG002|NOT COMPLETED|Overall Study||0||
59513237|NCT02808130|75606707|FG000|STARTED|Overall Study||15||
59612739|NCT01717326|75723768|FG008|COMPLETED|Overall Study||32||
59760232|NCT00895037|75879830|FG000|NOT COMPLETED|Overall Study||0||
59612740|NCT01717326|75723769|FG009|COMPLETED|Overall Study||29||
59612741|NCT01717326|75723770|FG010|COMPLETED|Overall Study||30||
59760233|NCT00895037|75879831|FG001|NOT COMPLETED|Overall Study||2||
59612742|NCT01717326|75723771|FG011|COMPLETED|Overall Study||33||
59612743|NCT01717326|75723772|FG012|COMPLETED|Overall Study||32||
59612744|NCT01717326|75723773|FG013|COMPLETED|Overall Study||32||
59760234|NCT00895037|75879832|FG002|NOT COMPLETED|Overall Study||1||
59760235|NCT00892151|75879840|FG000|STARTED|Overall Study||51||
59760236|NCT00892151|75879840|FG000|COMPLETED|Overall Study||50||
59760237|NCT00892151|75879840|FG000|NOT COMPLETED|Overall Study||1||
59760238|NCT01706705|75879844|FG000|STARTED|Overall Study||57||
59760239|NCT01706705|75879844|FG000|COMPLETED|Overall Study||37||
59921253|NCT03310021|76040692|FG017|COMPLETED|Overall Study||5||
59921254|NCT03310021|76040693|FG018|COMPLETED|Overall Study||8||
59921255|NCT03310021|76040694|FG019|COMPLETED|Overall Study||3||
59921256|NCT03310021|76040675|FG000|NOT COMPLETED|Overall Study||0||
59921257|NCT03310021|76040676|FG001|NOT COMPLETED|Overall Study||0||
59921258|NCT03310021|76040677|FG002|NOT COMPLETED|Overall Study||0||
59921259|NCT03310021|76040678|FG003|NOT COMPLETED|Overall Study||0||
59921260|NCT03310021|76040679|FG004|NOT COMPLETED|Overall Study||0||
59921261|NCT03310021|76040680|FG005|NOT COMPLETED|Overall Study||0||
59921262|NCT03310021|76040681|FG006|NOT COMPLETED|Overall Study||1||
59612745|NCT01717326|75723774|FG014|COMPLETED|Overall Study||29||
59612746|NCT01717326|75723775|FG015|COMPLETED|Overall Study||27||
60049124|NCT01540474|76164835|FG000|COMPLETED|Malaria Challenge||10||
59513238|NCT02808130|75606708|FG001|STARTED|Overall Study||15||
59513239|NCT02808130|75606709|FG002|STARTED|Overall Study||15||
59513240|NCT02808130|75606710|FG003|STARTED|Overall Study||15||
59612747|NCT01717326|75723776|FG016|COMPLETED|Overall Study||29||
59760240|NCT01706705|75879844|FG000|NOT COMPLETED|Overall Study||20||
59760241|NCT04481568|75879851|FG000|STARTED|Overall Study||79||
59760242|NCT04481568|75879852|FG001|STARTED|Overall Study||79||
59760243|NCT04481568|75879851|FG000|COMPLETED|Overall Study||79||
59760244|NCT04481568|75879852|FG001|COMPLETED|Overall Study||79||
59760245|NCT04481568|75879851|FG000|NOT COMPLETED|Overall Study||0||
59921263|NCT03310021|76040682|FG007|NOT COMPLETED|Overall Study||0||
59921264|NCT03310021|76040683|FG008|NOT COMPLETED|Overall Study||0||
59921265|NCT03310021|76040684|FG009|NOT COMPLETED|Overall Study||0||
59921266|NCT03310021|76040685|FG010|NOT COMPLETED|Overall Study||1||
59921267|NCT03310021|76040686|FG011|NOT COMPLETED|Overall Study||0||
59921268|NCT03310021|76040687|FG012|NOT COMPLETED|Overall Study||0||
59921269|NCT03310021|76040688|FG013|NOT COMPLETED|Overall Study||0||
59921270|NCT03310021|76040689|FG014|NOT COMPLETED|Overall Study||0||
59921271|NCT03310021|76040690|FG015|NOT COMPLETED|Overall Study||0||
59921272|NCT03310021|76040691|FG016|NOT COMPLETED|Overall Study||0||
59921273|NCT03310021|76040692|FG017|NOT COMPLETED|Overall Study||0||
60049125|NCT01540474|76164836|FG001|COMPLETED|Malaria Challenge||9||
60049126|NCT01540474|76164837|FG002|COMPLETED|Malaria Challenge||10||
60049127|NCT01540474|76164838|FG003|COMPLETED|Malaria Challenge||5||
60049128|NCT01540474|76164835|FG000|NOT COMPLETED|Malaria Challenge||0||
60049129|NCT01540474|76164836|FG001|NOT COMPLETED|Malaria Challenge||0||
60049130|NCT01540474|76164837|FG002|NOT COMPLETED|Malaria Challenge||0||
60049131|NCT01540474|76164838|FG003|NOT COMPLETED|Malaria Challenge||1||
60049132|NCT01580488|76164849|FG000|STARTED|Overall Study||24||
60049133|NCT01580488|76164849|FG000|COMPLETED|Overall Study||23||
59513241|NCT02808130|75606711|FG004|STARTED|Overall Study||15||
59513242|NCT02808130|75606712|FG005|STARTED|Overall Study||15||
59513243|NCT02808130|75606707|FG000|COMPLETED|Overall Study||15||
59513244|NCT02808130|75606708|FG001|COMPLETED|Overall Study||15||
59513245|NCT02808130|75606709|FG002|COMPLETED|Overall Study||15||
59513246|NCT02808130|75606710|FG003|COMPLETED|Overall Study||15||
59921274|NCT03310021|76040693|FG018|NOT COMPLETED|Overall Study||0||
59513247|NCT02808130|75606711|FG004|COMPLETED|Overall Study||15||
59513248|NCT02808130|75606712|FG005|COMPLETED|Overall Study||15||
59513249|NCT02808130|75606707|FG000|NOT COMPLETED|Overall Study||0||
59513250|NCT02808130|75606708|FG001|NOT COMPLETED|Overall Study||0||
59513251|NCT02808130|75606709|FG002|NOT COMPLETED|Overall Study||0||
59513252|NCT02808130|75606710|FG003|NOT COMPLETED|Overall Study||0||
59513253|NCT02808130|75606711|FG004|NOT COMPLETED|Overall Study||0||
59513254|NCT02808130|75606712|FG005|NOT COMPLETED|Overall Study||0||
59513255|NCT02677870|75606729|FG000|STARTED|Diet Treatment (4 Weeks)||4||
59513256|NCT02677870|75606730|FG001|STARTED|Diet Treatment (4 Weeks)||3||
59513257|NCT02677870|75606729|FG000|COMPLETED|Diet Treatment (4 Weeks)||4||
59513258|NCT02677870|75606730|FG001|COMPLETED|Diet Treatment (4 Weeks)||3||
59513259|NCT02677870|75606729|FG000|NOT COMPLETED|Diet Treatment (4 Weeks)||0||
59513260|NCT02677870|75606730|FG001|NOT COMPLETED|Diet Treatment (4 Weeks)||0||
59513261|NCT02677870|75606729|FG000|STARTED|First Saproterin Dihydrochloride tx||4||
59513262|NCT02677870|75606730|FG001|STARTED|First Saproterin Dihydrochloride tx||3||
59513263|NCT02677870|75606729|FG000|COMPLETED|First Saproterin Dihydrochloride tx||4||
59513264|NCT02677870|75606730|FG001|COMPLETED|First Saproterin Dihydrochloride tx||3||
59513265|NCT02677870|75606729|FG000|NOT COMPLETED|First Saproterin Dihydrochloride tx||0||
59513266|NCT02677870|75606730|FG001|NOT COMPLETED|First Saproterin Dihydrochloride tx||0||
59513267|NCT02677870|75606729|FG000|STARTED|Washout (2 Weeks)||4||
59513268|NCT02677870|75606730|FG001|STARTED|Washout (2 Weeks)||3||
59513269|NCT02677870|75606729|FG000|COMPLETED|Washout (2 Weeks)||4||
59760246|NCT04481568|75879852|FG001|NOT COMPLETED|Overall Study||0||
59760247|NCT00894803|75879860|FG000|STARTED|Overall Study||101||
59760248|NCT00894803|75879861|FG001|STARTED|Overall Study||25||
59760249|NCT00894803|75879860|FG000|COMPLETED|Overall Study||81||
59760250|NCT00894803|75879861|FG001|COMPLETED|Overall Study||20||
59760251|NCT00894803|75879860|FG000|NOT COMPLETED|Overall Study||20||
59760252|NCT00894803|75879861|FG001|NOT COMPLETED|Overall Study||5||
59760253|NCT00601458|75879870|FG000|STARTED|Overall Study||36||
59760254|NCT00601458|75879871|FG001|STARTED|Overall Study||34||
59921275|NCT03310021|76040694|FG019|NOT COMPLETED|Overall Study||0||
59921276|NCT03333109|76040739|FG000|STARTED|Double-blind Treatment Period (DBTP)||338||
59921277|NCT03333109|76040740|FG001|STARTED|Double-blind Treatment Period (DBTP)||224||
59921278|NCT03333109|76040741|FG002|STARTED|Double-blind Treatment Period (DBTP)||338||
59921279|NCT03333109|76040739|FG000|Full Analysis Set|Double-blind Treatment Period (DBTP)||329|All participants who started the study medication and completed at least one post-baseline efficacy measurement|
60049134|NCT01580488|76164849|FG000|NOT COMPLETED|Overall Study||1||
60049135|NCT01580020|76164865|FG000|STARTED|Overall Study||52||
59513270|NCT02677870|75606730|FG001|COMPLETED|Washout (2 Weeks)||3||
59513271|NCT02677870|75606729|FG000|NOT COMPLETED|Washout (2 Weeks)||0||
59513272|NCT02677870|75606730|FG001|NOT COMPLETED|Washout (2 Weeks)||0||
59513273|NCT02677870|75606729|FG000|STARTED|Second Saproterin Dihydrochloride tx||4||
59513274|NCT02677870|75606730|FG001|STARTED|Second Saproterin Dihydrochloride tx||3||
59760255|NCT00601458|75879872|FG002|STARTED|Overall Study||30||
59951430|NCT01251965|76070419|FG001|NOT COMPLETED|Overall Study||2||
59951431|NCT01251965|76070420|FG002|NOT COMPLETED|Overall Study||11||
60049136|NCT01580020|76164866|FG001|STARTED|Overall Study||40||
60049137|NCT01580020|76164867|FG002|STARTED|Overall Study||61||
60049138|NCT01580020|76164868|FG003|STARTED|Overall Study||22||
60049139|NCT01580020|76164865|FG000|COMPLETED|Overall Study||51||
60049140|NCT01580020|76164866|FG001|COMPLETED|Overall Study||33||
60049141|NCT01580020|76164867|FG002|COMPLETED|Overall Study||57||
60049142|NCT01580020|76164868|FG003|COMPLETED|Overall Study||20||
60049143|NCT01580020|76164865|FG000|NOT COMPLETED|Overall Study||1||
60049144|NCT01580020|76164866|FG001|NOT COMPLETED|Overall Study||7||
59612748|NCT01717326|75723777|FG017|COMPLETED|Overall Study||31||
59612749|NCT01717326|75723778|FG018|COMPLETED|Overall Study||16||
59612750|NCT01717326|75723779|FG019|COMPLETED|Overall Study||15||
60049145|NCT01580020|76164867|FG002|NOT COMPLETED|Overall Study||4||
60049146|NCT01580020|76164868|FG003|NOT COMPLETED|Overall Study||2||
60049147|NCT01579474|76164884|FG000|STARTED|Overall Study||44||
60049148|NCT01579474|76164885|FG001|STARTED|Overall Study||43||
60049149|NCT01579474|76164886|FG002|STARTED|Overall Study||29||
60049150|NCT01579474|76164887|FG003|STARTED|Overall Study||3||
60049151|NCT01579474|76164888|FG004|STARTED|Overall Study||10||
60049152|NCT01579474|76164889|FG005|STARTED|Overall Study||2||
60049153|NCT01579474|76164884|FG000|COMPLETED|Overall Study||41||
60049154|NCT01579474|76164885|FG001|COMPLETED|Overall Study||30||
60049155|NCT01579474|76164886|FG002|COMPLETED|Overall Study||27||
60049156|NCT01579474|76164887|FG003|COMPLETED|Overall Study||3||
60049157|NCT01579474|76164888|FG004|COMPLETED|Overall Study||9||
59921280|NCT03333109|76040740|FG001|Full Analysis Set|Double-blind Treatment Period (DBTP)||219|All participants who started the study medication and completed at least one post-baseline efficacy measurement|
59921281|NCT03333109|76040741|FG002|Full Analysis Set|Double-blind Treatment Period (DBTP)||330|All participants who started the study medication and completed at least one post-baseline efficacy measurement|
59921282|NCT03333109|76040739|FG000|Safety Analysis Set|Double-blind Treatment Period (DBTP)||335|Safety analysis set consisted of all randomized subjects who received at least one dose of investigational product and were analyzed based on the actual treatment received|
59951432|NCT01190644|76070429|FG000|STARTED|Overall Study||5||
60049158|NCT01579474|76164889|FG005|COMPLETED|Overall Study||1||
60049159|NCT01579474|76164884|FG000|NOT COMPLETED|Overall Study||3||
60049160|NCT01579474|76164885|FG001|NOT COMPLETED|Overall Study||13||
59513275|NCT02677870|75606729|FG000|COMPLETED|Second Saproterin Dihydrochloride tx||4||
59513276|NCT02677870|75606730|FG001|COMPLETED|Second Saproterin Dihydrochloride tx||3||
59513277|NCT02677870|75606729|FG000|NOT COMPLETED|Second Saproterin Dihydrochloride tx||0||
59513278|NCT02677870|75606730|FG001|NOT COMPLETED|Second Saproterin Dihydrochloride tx||0||
59513279|NCT02809846|75606740|FG000|STARTED|Overall Study||17||
59513280|NCT02809846|75606741|FG001|STARTED|Overall Study||16||
59513281|NCT02809846|75606740|FG000|COMPLETED|Overall Study||8||
59513282|NCT02809846|75606741|FG001|COMPLETED|Overall Study||9||
59513283|NCT02809846|75606740|FG000|NOT COMPLETED|Overall Study||9||
59612751|NCT01717326|75723760|FG000|NOT COMPLETED|Overall Study||3||
59612752|NCT01717326|75723761|FG001|NOT COMPLETED|Overall Study||1||
59612753|NCT01717326|75723762|FG002|NOT COMPLETED|Overall Study||0||
59951433|NCT01190644|76070429|FG000|Treated|Overall Study||4||
60049161|NCT01579474|76164886|FG002|NOT COMPLETED|Overall Study||2||
60049162|NCT01579474|76164887|FG003|NOT COMPLETED|Overall Study||0||
59513284|NCT02809846|75606741|FG001|NOT COMPLETED|Overall Study||7||
59513285|NCT00945061|75606749|FG000|STARTED|Overall Study||12||
59513286|NCT00945061|75606750|FG001|STARTED|Overall Study||1||
59513287|NCT00945061|75606749|FG000|COMPLETED|Overall Study||12||
59513288|NCT00945061|75606750|FG001|COMPLETED|Overall Study||1||
59513289|NCT00945061|75606749|FG000|NOT COMPLETED|Overall Study||0||
59513290|NCT00945061|75606750|FG001|NOT COMPLETED|Overall Study||0||
59513291|NCT02924350|75606767|FG000|STARTED|Overall Study||102||
59513292|NCT02924350|75606768|FG001|STARTED|Overall Study||102||
59513293|NCT02924350|75606767|FG000|COMPLETED|Overall Study||102||
59612754|NCT01717326|75723763|FG003|NOT COMPLETED|Overall Study||2||
59612755|NCT01717326|75723764|FG004|NOT COMPLETED|Overall Study||2||
59612756|NCT01717326|75723765|FG005|NOT COMPLETED|Overall Study||0||
59612757|NCT01717326|75723766|FG006|NOT COMPLETED|Overall Study||1||
59612758|NCT01717326|75723767|FG007|NOT COMPLETED|Overall Study||0||
60049163|NCT01579474|76164888|FG004|NOT COMPLETED|Overall Study||1||
60049164|NCT01579474|76164889|FG005|NOT COMPLETED|Overall Study||1||
59513294|NCT02924350|75606768|FG001|COMPLETED|Overall Study||100||
59612759|NCT01717326|75723768|FG008|NOT COMPLETED|Overall Study||0||
59612760|NCT01717326|75723769|FG009|NOT COMPLETED|Overall Study||2||
59760256|NCT00601458|75879870|FG000|COMPLETED|Overall Study||32||
60049165|NCT01579318|76164902|FG000|STARTED|Overall Study||2||
60049166|NCT01579318|76164902|FG000|COMPLETED|Overall Study||1||
60049167|NCT01579318|76164902|FG000|NOT COMPLETED|Overall Study||1||
60049168|NCT01562782|76164908|FG000|STARTED|Overall Study||19||
60049169|NCT01562782|76164909|FG001|STARTED|Overall Study||20||
60049170|NCT01562782|76164908|FG000|COMPLETED|Overall Study||15||
59513295|NCT02924350|75606767|FG000|NOT COMPLETED|Overall Study||0||
60049171|NCT01562782|76164909|FG001|COMPLETED|Overall Study||15||
60049172|NCT01562782|76164908|FG000|NOT COMPLETED|Overall Study||4||
60049173|NCT01562782|76164909|FG001|NOT COMPLETED|Overall Study||5||
60049174|NCT01579006|76164915|FG000|STARTED|Overall Study||184||
60049175|NCT01579006|76164915|FG000|COMPLETED|Overall Study||151||
60049176|NCT01579006|76164915|FG000|NOT COMPLETED|Overall Study||33||
60049177|NCT01578850|76164921|FG000|STARTED|Period 1|491 participants were enrolled in open-label treatment but 2 did not receive study medication.|489||
60049178|NCT01578850|76164922|FG001|STARTED|Period 1||0||
60049179|NCT01578850|76164923|FG002|STARTED|Period 1||0||
60049180|NCT01578850|76164921|FG000|COMPLETED|Period 1||452||
60049181|NCT01578850|76164922|FG001|COMPLETED|Period 1||0||
60049182|NCT01578850|76164923|FG002|COMPLETED|Period 1||0||
60049183|NCT01578850|76164921|FG000|NOT COMPLETED|Period 1||37||
60049184|NCT01578850|76164922|FG001|NOT COMPLETED|Period 1||0||
60049185|NCT01578850|76164923|FG002|NOT COMPLETED|Period 1||0||
60049186|NCT01578850|76164921|FG000|STARTED|Period 2||0||
60049187|NCT01578850|76164922|FG001|STARTED|Period 2|Two participants in ETN did not receive treatment.|167||
60049188|NCT01578850|76164923|FG002|STARTED|Period 2|One participants in PBO did not receive treatment.|176||
60049189|NCT01578850|76164921|FG000|COMPLETED|Period 2||0||
60049190|NCT01578850|76164922|FG001|COMPLETED|Period 2||154||
60049191|NCT01578850|76164923|FG002|COMPLETED|Period 2||162||
60049192|NCT01578850|76164921|FG000|NOT COMPLETED|Period 2||0||
60049193|NCT01578850|76164922|FG001|NOT COMPLETED|Period 2||13||
60049194|NCT01578850|76164923|FG002|NOT COMPLETED|Period 2||14||
60049195|NCT01539538|76164933|FG000|STARTED|Overall Study||177||
60049196|NCT01539538|76164934|FG001|STARTED|Overall Study||180||
60049197|NCT01539538|76164933|FG000|COMPLETED|Overall Study||146||
60049198|NCT01539538|76164934|FG001|COMPLETED|Overall Study||136||
60049199|NCT01539538|76164933|FG000|NOT COMPLETED|Overall Study||31||
60049200|NCT01539538|76164934|FG001|NOT COMPLETED|Overall Study||44||
59612761|NCT01717326|75723770|FG010|NOT COMPLETED|Overall Study||2||
59612762|NCT01717326|75723771|FG011|NOT COMPLETED|Overall Study||0||
60049201|NCT01562548|76164944|FG000|STARTED|Overall Study||25||
60049202|NCT01562548|76164945|FG001|STARTED|Overall Study||15||
60049203|NCT01562548|76164946|FG002|STARTED|Overall Study||25||
60049204|NCT01562548|76164947|FG003|STARTED|Overall Study||14||
60049205|NCT01562548|76164944|FG000|COMPLETED|Overall Study||25||
60049206|NCT01562548|76164945|FG001|COMPLETED|Overall Study||15||
60049207|NCT01562548|76164946|FG002|COMPLETED|Overall Study||24||
60049208|NCT01562548|76164947|FG003|COMPLETED|Overall Study||14||
60049209|NCT01562548|76164944|FG000|NOT COMPLETED|Overall Study||0||
60049210|NCT01562548|76164945|FG001|NOT COMPLETED|Overall Study||0||
60049211|NCT01562548|76164946|FG002|NOT COMPLETED|Overall Study||1||
60049212|NCT01562548|76164947|FG003|NOT COMPLETED|Overall Study||0||
60049213|NCT01562314|76164961|FG000|STARTED|Overall Study||29||
60049214|NCT01562314|76164962|FG001|STARTED|Overall Study||31||
60049215|NCT01562314|76164961|FG000|Received at Least 1 Dose of Study Drug|Overall Study||29|Safety analysis set; participants analyzed according to treatment received.|
60049216|NCT01562314|76164962|FG001|Received at Least 1 Dose of Study Drug|Overall Study||31|Safety analysis set; participants analyzed according to treatment received.|
60049217|NCT01562314|76164961|FG000|Intent-to-Treat (ITT) Analysis Set|Overall Study||29|All randomized participants who received ≥1 dose of study drug; analyzed by randomization group.|
60049218|NCT01562314|76164962|FG001|Intent-to-Treat (ITT) Analysis Set|Overall Study||31|All randomized participants who received ≥1 dose of study drug; analyzed by randomization group.|
60049219|NCT01562314|76164961|FG000|Per Protocol (PP) Analysis Set|Overall Study||17|All participants without protocol violations that compromised the assessments of efficacy.|
60049220|NCT01562314|76164962|FG001|Per Protocol (PP) Analysis Set|Overall Study||27|All participants without protocol violations that compromised the assessments of efficacy.|
60049221|NCT01562314|76164961|FG000|COMPLETED|Overall Study||16||
60049222|NCT01562314|76164962|FG001|COMPLETED|Overall Study||23||
60049223|NCT01562314|76164961|FG000|NOT COMPLETED|Overall Study||13||
60049224|NCT01562314|76164962|FG001|NOT COMPLETED|Overall Study||8||
60049225|NCT01539226|76164970|FG000|STARTED|Overall Study||652||
60049226|NCT01539226|76164971|FG001|STARTED|Overall Study||1307||
60049227|NCT01539226|76164970|FG000|COMPLETED|Overall Study|107 participants rolled over to the open-label extension of the trial|435|A number of completed participants rolled over to the open-label extension of this trial (IPM 032, NCT02862171)|
60049228|NCT01539226|76164971|FG001|COMPLETED|Overall Study|238 participants rolled over to the open-label extension of the trial|902|A number of completed participants rolled over to the open-label extension of this trial (IPM 032, NCT02862171)|
60049229|NCT01539226|76164970|FG000|NOT COMPLETED|Overall Study||217||
60049230|NCT01539226|76164971|FG001|NOT COMPLETED|Overall Study||405||
60049231|NCT01577758|76164977|FG000|STARTED|Dose Escalation Phase||2||
60049232|NCT01577758|76164978|FG001|STARTED|Dose Escalation Phase||2||
60049233|NCT01577758|76164979|FG002|STARTED|Dose Escalation Phase||2||
60049234|NCT01577758|76164980|FG003|STARTED|Dose Escalation Phase||2||
60049235|NCT01577758|76164981|FG004|STARTED|Dose Escalation Phase||6||
60049236|NCT01577758|76164982|FG005|STARTED|Dose Escalation Phase||4||
60049237|NCT01577758|76164983|FG006|STARTED|Dose Escalation Phase||1||
60049238|NCT01577758|76164984|FG007|STARTED|Dose Escalation Phase||0||
60049239|NCT01577758|76164977|FG000|COMPLETED|Dose Escalation Phase||0||
59612763|NCT01717326|75723772|FG012|NOT COMPLETED|Overall Study||1||
60049240|NCT01577758|76164978|FG001|COMPLETED|Dose Escalation Phase||0||
60049241|NCT01577758|76164979|FG002|COMPLETED|Dose Escalation Phase||0||
59513296|NCT02924350|75606768|FG001|NOT COMPLETED|Overall Study||2||
59513297|NCT00945139|75606774|FG000|STARTED|Overall Study||46||
59513298|NCT00945139|75606774|FG000|COMPLETED|Overall Study||46||
59513299|NCT00945139|75606774|FG000|NOT COMPLETED|Overall Study||0||
59513300|NCT02812342|75606779|FG000|STARTED|Overall Study||10||
59513301|NCT02812342|75606779|FG000|COMPLETED|Overall Study||10||
60049242|NCT01577758|76164980|FG003|COMPLETED|Dose Escalation Phase||0||
59921283|NCT03333109|76040740|FG001|Safety Analysis Set|Double-blind Treatment Period (DBTP)||224|Safety analysis set consisted of all randomized subjects who received at least one dose of investigational product and were analyzed based on the actual treatment received|
60049243|NCT01577758|76164981|FG004|COMPLETED|Dose Escalation Phase||0||
60049244|NCT01577758|76164982|FG005|COMPLETED|Dose Escalation Phase||0||
60049245|NCT01577758|76164983|FG006|COMPLETED|Dose Escalation Phase||0||
60049246|NCT01577758|76164984|FG007|COMPLETED|Dose Escalation Phase||0||
60049247|NCT01577758|76164977|FG000|NOT COMPLETED|Dose Escalation Phase||2||
60049248|NCT01577758|76164978|FG001|NOT COMPLETED|Dose Escalation Phase||2||
60049249|NCT01577758|76164979|FG002|NOT COMPLETED|Dose Escalation Phase||2||
60049250|NCT01577758|76164980|FG003|NOT COMPLETED|Dose Escalation Phase||2||
60049251|NCT01577758|76164981|FG004|NOT COMPLETED|Dose Escalation Phase||6||
60049252|NCT01577758|76164982|FG005|NOT COMPLETED|Dose Escalation Phase||4||
60049253|NCT01577758|76164983|FG006|NOT COMPLETED|Dose Escalation Phase||1||
60049254|NCT01577758|76164984|FG007|NOT COMPLETED|Dose Escalation Phase||0||
59513302|NCT02812342|75606779|FG000|NOT COMPLETED|Overall Study||0||
59513303|NCT02814448|75606788|FG000|STARTED|Overall Study||27||
59513304|NCT02814448|75606789|FG001|STARTED|Overall Study||24||
59612764|NCT01717326|75723773|FG013|NOT COMPLETED|Overall Study||0||
59612765|NCT01717326|75723774|FG014|NOT COMPLETED|Overall Study||0||
59760257|NCT00601458|75879871|FG001|COMPLETED|Overall Study||29||
59760258|NCT00601458|75879872|FG002|COMPLETED|Overall Study||28||
59760259|NCT00601458|75879870|FG000|NOT COMPLETED|Overall Study||4||
59760260|NCT00601458|75879871|FG001|NOT COMPLETED|Overall Study||5||
59921284|NCT03333109|76040741|FG002|Safety Analysis Set|Double-blind Treatment Period (DBTP)||335|Safety analysis set consisted of all randomized subjects who received at least one dose of investigational product and were analyzed based on the actual treatment received|
59921285|NCT03333109|76040739|FG000|COMPLETED|Double-blind Treatment Period (DBTP)||321||
59921286|NCT03333109|76040740|FG001|COMPLETED|Double-blind Treatment Period (DBTP)||218||
60049255|NCT01577758|76164977|FG000|STARTED|mCRC Expansion Phase||0||
60049256|NCT01577758|76164978|FG001|STARTED|mCRC Expansion Phase||0||
59513305|NCT02814448|75606790|FG002|STARTED|Overall Study||26||
59760261|NCT00601458|75879872|FG002|NOT COMPLETED|Overall Study||2||
59760262|NCT02141282|75879884|FG000|STARTED|Overall Study||43||
59760263|NCT02141282|75879885|FG001|STARTED|Overall Study||21||
59760264|NCT02141282|75879886|FG002|STARTED|Overall Study||48||
59760265|NCT02141282|75879887|FG003|STARTED|Overall Study||15||
59760266|NCT02141282|75879884|FG000|COMPLETED|Overall Study||0||
59760267|NCT02141282|75879885|FG001|COMPLETED|Overall Study||0||
59760268|NCT02141282|75879886|FG002|COMPLETED|Overall Study||0||
59760269|NCT02141282|75879887|FG003|COMPLETED|Overall Study||0||
59760270|NCT02141282|75879884|FG000|NOT COMPLETED|Overall Study||43||
59760271|NCT02141282|75879885|FG001|NOT COMPLETED|Overall Study||21||
59760272|NCT02141282|75879886|FG002|NOT COMPLETED|Overall Study||48||
59760273|NCT02141282|75879887|FG003|NOT COMPLETED|Overall Study||15||
59760274|NCT00003479|75879900|FG000|STARTED|Overall Study||9||
59760275|NCT00003479|75879900|FG000|COMPLETED|Overall Study||6||
59760276|NCT00003479|75879900|FG000|NOT COMPLETED|Overall Study||3||
59760277|NCT00891839|75879904|FG000|STARTED|Overall Study||45||
59760278|NCT00891839|75879904|FG000|COMPLETED|Overall Study|completed treatment|38||
59760279|NCT00891839|75879904|FG000|NOT COMPLETED|Overall Study||7||
59760280|NCT00600756|75879910|FG000|STARTED|Analysis After 6 Months||395||
59513306|NCT02814448|75606791|FG003|STARTED|Overall Study||25||
59513307|NCT02814448|75606792|FG004|STARTED|Overall Study||28||
59513308|NCT02814448|75606788|FG000|COMPLETED|Overall Study||27||
59513309|NCT02814448|75606789|FG001|COMPLETED|Overall Study||24||
59513310|NCT02814448|75606790|FG002|COMPLETED|Overall Study||25||
59513311|NCT02814448|75606791|FG003|COMPLETED|Overall Study||25||
59513312|NCT02814448|75606792|FG004|COMPLETED|Overall Study||26||
59612766|NCT01717326|75723775|FG015|NOT COMPLETED|Overall Study||3||
59612767|NCT01717326|75723776|FG016|NOT COMPLETED|Overall Study||1||
59760281|NCT00600756|75879911|FG001|STARTED|Analysis After 6 Months||403||
60049257|NCT01577758|76164979|FG002|STARTED|mCRC Expansion Phase||0||
59513313|NCT02814448|75606788|FG000|NOT COMPLETED|Overall Study||0||
59513314|NCT02814448|75606789|FG001|NOT COMPLETED|Overall Study||0||
59513315|NCT02814448|75606790|FG002|NOT COMPLETED|Overall Study||1||
59513316|NCT02814448|75606791|FG003|NOT COMPLETED|Overall Study||0||
59513317|NCT02814448|75606792|FG004|NOT COMPLETED|Overall Study||2||
59612768|NCT01717326|75723777|FG017|NOT COMPLETED|Overall Study||0||
59921287|NCT03333109|76040741|FG002|COMPLETED|Double-blind Treatment Period (DBTP)||326||
59921288|NCT03333109|76040739|FG000|NOT COMPLETED|Double-blind Treatment Period (DBTP)||17||
59921289|NCT03333109|76040740|FG001|NOT COMPLETED|Double-blind Treatment Period (DBTP)||6||
59921290|NCT03333109|76040741|FG002|NOT COMPLETED|Double-blind Treatment Period (DBTP)||12||
59921291|NCT03333109|76040739|FG000|STARTED|Safety Follow-up Period|Subjects discontinued from DBTP and still entered the safety follow-up.|324||
59921292|NCT03333109|76040740|FG001|STARTED|Safety Follow-up Period||218||
59921293|NCT03333109|76040741|FG002|STARTED|Safety Follow-up Period|Subjects discontinued from DBTP and still entered the safety follow-up.|328||
59921294|NCT03333109|76040739|FG000|COMPLETED|Safety Follow-up Period||311||
59921295|NCT03333109|76040740|FG001|COMPLETED|Safety Follow-up Period||214||
59921296|NCT03333109|76040741|FG002|COMPLETED|Safety Follow-up Period||315||
59921297|NCT03333109|76040739|FG000|NOT COMPLETED|Safety Follow-up Period||13||
59921298|NCT03333109|76040740|FG001|NOT COMPLETED|Safety Follow-up Period||4||
59921299|NCT03333109|76040741|FG002|NOT COMPLETED|Safety Follow-up Period||13||
59921300|NCT02940223|76040751|FG000|STARTED|Overall Study||2||
59921301|NCT02940223|76040752|FG001|STARTED|Overall Study||0||
59921302|NCT02940223|76040751|FG000|COMPLETED|Overall Study||0||
59921303|NCT02940223|76040752|FG001|COMPLETED|Overall Study||0||
59921304|NCT02940223|76040751|FG000|NOT COMPLETED|Overall Study||2||
59921305|NCT02940223|76040752|FG001|NOT COMPLETED|Overall Study||0||
59921306|NCT03295201|76040760|FG000|STARTED|Overall Study||11||
59921307|NCT03295201|76040761|FG001|STARTED|Overall Study||11||
59921308|NCT03295201|76040760|FG000|COMPLETED|Overall Study||10||
59921309|NCT03295201|76040761|FG001|COMPLETED|Overall Study||9||
59921310|NCT03295201|76040760|FG000|NOT COMPLETED|Overall Study||1||
59921311|NCT03295201|76040761|FG001|NOT COMPLETED|Overall Study||2||
59921312|NCT03293485|76040767|FG000|STARTED|Overall Study||83||
59921313|NCT03293485|76040767|FG000|Treated|Overall Study||81||
59921314|NCT03293485|76040767|FG000|COMPLETED|Overall Study||78||
59921315|NCT03293485|76040767|FG000|NOT COMPLETED|Overall Study||5||
59921316|NCT03309943|76040775|FG000|STARTED|Overall Study||22||
59921317|NCT03309943|76040776|FG001|STARTED|Overall Study||22||
59921318|NCT03309943|76040775|FG000|COMPLETED|Overall Study||22||
59921319|NCT03309943|76040776|FG001|COMPLETED|Overall Study||20||
59921320|NCT03309943|76040775|FG000|NOT COMPLETED|Overall Study||0||
59921321|NCT03309943|76040776|FG001|NOT COMPLETED|Overall Study||2||
59921322|NCT01732627|76040784|FG000|STARTED|Overall Study||201|Randomized and vaccinated.|
59921323|NCT01732627|76040785|FG001|STARTED|Overall Study||100|Randomized and vaccinated.|
59921324|NCT01732627|76040784|FG000|Safety Analysis Set (SafAS)|Overall Study||199|Participants who received at least 1 dose of study or control vaccine and had safety data available.|
59921325|NCT01732627|76040785|FG001|Safety Analysis Set (SafAS)|Overall Study||100|Participants who received at least 1 dose of study or control vaccine and had safety data available.|
59921326|NCT01732627|76040784|FG000|COMPLETED|Overall Study||200||
59921327|NCT01732627|76040785|FG001|COMPLETED|Overall Study||100||
59921328|NCT01732627|76040784|FG000|NOT COMPLETED|Overall Study||1||
59921329|NCT01732627|76040785|FG001|NOT COMPLETED|Overall Study||0||
59921330|NCT03307837|76040797|FG000|STARTED|Overall Study||6||
59921331|NCT03307837|76040798|FG001|STARTED|Overall Study||6||
59921332|NCT03307837|76040799|FG002|STARTED|Overall Study||6||
59921333|NCT03307837|76040800|FG003|STARTED|Overall Study||6||
59921334|NCT03307837|76040801|FG004|STARTED|Overall Study||6||
59921335|NCT03307837|76040802|FG005|STARTED|Overall Study||10||
59921336|NCT03307837|76040797|FG000|COMPLETED|Overall Study||5||
59921337|NCT03307837|76040798|FG001|COMPLETED|Overall Study||5||
59921338|NCT03307837|76040799|FG002|COMPLETED|Overall Study||5||
59921339|NCT03307837|76040800|FG003|COMPLETED|Overall Study||6||
59921340|NCT03307837|76040801|FG004|COMPLETED|Overall Study||6||
59921341|NCT03307837|76040802|FG005|COMPLETED|Overall Study||8||
59513318|NCT00931489|75606809|FG000|STARTED|Overall Study||40||
59513319|NCT00931489|75606810|FG001|STARTED|Overall Study||40||
59513320|NCT00931489|75606811|FG002|STARTED|Overall Study||5||
59513321|NCT00931489|75606812|FG003|STARTED|Overall Study||39||
59513322|NCT00931489|75606813|FG004|STARTED|Overall Study||7||
59513323|NCT00931489|75606809|FG000|COMPLETED|Overall Study||40||
59513324|NCT00931489|75606810|FG001|COMPLETED|Overall Study||40||
59513325|NCT00931489|75606811|FG002|COMPLETED|Overall Study|3 subjects enrolled in Group 1 (responders) were moved to Group 3 (non-responders)|5||
59513326|NCT00931489|75606812|FG003|COMPLETED|Overall Study||39||
59513327|NCT00931489|75606813|FG004|COMPLETED|Overall Study||7||
59513328|NCT00931489|75606809|FG000|NOT COMPLETED|Overall Study||0||
59513329|NCT00931489|75606810|FG001|NOT COMPLETED|Overall Study||0||
59513330|NCT00931489|75606811|FG002|NOT COMPLETED|Overall Study||0||
59513331|NCT00931489|75606812|FG003|NOT COMPLETED|Overall Study||0||
59921342|NCT03307837|76040797|FG000|NOT COMPLETED|Overall Study||1||
59921343|NCT03307837|76040798|FG001|NOT COMPLETED|Overall Study||1||
59921344|NCT03307837|76040799|FG002|NOT COMPLETED|Overall Study||1||
60049258|NCT01577758|76164980|FG003|STARTED|mCRC Expansion Phase||0||
60049259|NCT01577758|76164981|FG004|STARTED|mCRC Expansion Phase||0||
60049260|NCT01577758|76164982|FG005|STARTED|mCRC Expansion Phase||0||
60049261|NCT01577758|76164983|FG006|STARTED|mCRC Expansion Phase||0||
60049262|NCT01577758|76164984|FG007|STARTED|mCRC Expansion Phase||25||
60049263|NCT01577758|76164977|FG000|COMPLETED|mCRC Expansion Phase||0||
60049264|NCT01577758|76164978|FG001|COMPLETED|mCRC Expansion Phase||0||
60049265|NCT01577758|76164979|FG002|COMPLETED|mCRC Expansion Phase||0||
60049266|NCT01577758|76164980|FG003|COMPLETED|mCRC Expansion Phase||0||
60049267|NCT01577758|76164981|FG004|COMPLETED|mCRC Expansion Phase||0||
60049268|NCT01577758|76164982|FG005|COMPLETED|mCRC Expansion Phase||0||
60049269|NCT01577758|76164983|FG006|COMPLETED|mCRC Expansion Phase||0||
60049270|NCT01577758|76164984|FG007|COMPLETED|mCRC Expansion Phase||0||
60049271|NCT01577758|76164977|FG000|NOT COMPLETED|mCRC Expansion Phase||0||
60049272|NCT01577758|76164978|FG001|NOT COMPLETED|mCRC Expansion Phase||0||
60049273|NCT01577758|76164979|FG002|NOT COMPLETED|mCRC Expansion Phase||0||
60049274|NCT01577758|76164980|FG003|NOT COMPLETED|mCRC Expansion Phase||0||
60049275|NCT01577758|76164981|FG004|NOT COMPLETED|mCRC Expansion Phase||0||
60049276|NCT01577758|76164982|FG005|NOT COMPLETED|mCRC Expansion Phase||0||
60049277|NCT01577758|76164983|FG006|NOT COMPLETED|mCRC Expansion Phase||0||
60049278|NCT01577758|76164984|FG007|NOT COMPLETED|mCRC Expansion Phase||25||
60049279|NCT01537432|76165006|FG000|STARTED|Overall Study||24||
60049280|NCT01537432|76165007|FG001|STARTED|Overall Study||12||
60049281|NCT01537432|76165006|FG000|COMPLETED|Overall Study||18||
60049282|NCT01537432|76165007|FG001|COMPLETED|Overall Study||10||
60049283|NCT01537432|76165006|FG000|NOT COMPLETED|Overall Study||6||
60049284|NCT01537432|76165007|FG001|NOT COMPLETED|Overall Study||2||
60049285|NCT01537198|76165013|FG000|STARTED|Overall Study||617||
60049286|NCT01537198|76165013|FG000|COMPLETED|Overall Study||463||
60049287|NCT01537198|76165013|FG000|NOT COMPLETED|Overall Study||154||
60049288|NCT01537120|76165017|FG000|STARTED|Enrolled||25||
60049289|NCT01537120|76165017|FG000|COMPLETED|Enrolled||25||
60049290|NCT01537120|76165017|FG000|NOT COMPLETED|Enrolled||0||
60049291|NCT01537120|76165017|FG000|STARTED|8 Weeks Washout||25||
60049292|NCT01537120|76165017|FG000|COMPLETED|8 Weeks Washout||24||
59513332|NCT00931489|75606813|FG004|NOT COMPLETED|Overall Study||0||
59513333|NCT02816710|75606827|FG000|STARTED|Overall Study||38||
59513334|NCT02816710|75606828|FG001|STARTED|Overall Study||38||
59513335|NCT02816710|75606829|FG002|STARTED|Overall Study||36||
60049293|NCT01537120|76165017|FG000|NOT COMPLETED|8 Weeks Washout||1||
60049294|NCT01537120|76165017|FG000|STARTED|3 Weeks Placebo||24||
60049295|NCT01537120|76165017|FG000|COMPLETED|3 Weeks Placebo||23||
60049296|NCT01537120|76165017|FG000|NOT COMPLETED|3 Weeks Placebo||1||
60049297|NCT01537120|76165017|FG000|STARTED|12 Weeks Vildagliptin||23||
60049298|NCT01537120|76165017|FG000|COMPLETED|12 Weeks Vildagliptin||23||
60049299|NCT01537120|76165017|FG000|NOT COMPLETED|12 Weeks Vildagliptin||0||
60049300|NCT01537042|76165025|FG000|STARTED|Overall Study||10||
60049301|NCT01537042|76165026|FG001|STARTED|Overall Study||20||
60049302|NCT01537042|76165025|FG000|COMPLETED|Overall Study||10||
60049303|NCT01537042|76165026|FG001|COMPLETED|Overall Study||15||
60049304|NCT01537042|76165025|FG000|NOT COMPLETED|Overall Study||0||
60049305|NCT01537042|76165026|FG001|NOT COMPLETED|Overall Study||5||
60049306|NCT03897712|76165038|FG000|STARTED|Overall Study||56||112
60049307|NCT03897712|76165039|FG001|STARTED|Overall Study||28||56
60049308|NCT03897712|76165038|FG000|COMPLETED|Overall Study||46||92
60049309|NCT03897712|76165039|FG001|COMPLETED|Overall Study||25||50
60049310|NCT03897712|76165038|FG000|NOT COMPLETED|Overall Study||10||20
59513336|NCT02816710|75606827|FG000|COMPLETED|Overall Study||34||
59513337|NCT02816710|75606828|FG001|COMPLETED|Overall Study||35||
60049311|NCT03897712|76165039|FG001|NOT COMPLETED|Overall Study||3||6
60049312|NCT01536574|76165047|FG000|STARTED|Overall Study||162||
60049313|NCT01536574|76165048|FG001|STARTED|Overall Study||133||
60049314|NCT01536574|76165047|FG000|COMPLETED|Overall Study||156||
59513338|NCT02816710|75606829|FG002|COMPLETED|Overall Study||29||
60049315|NCT01536574|76165048|FG001|COMPLETED|Overall Study||126||
60049316|NCT01536574|76165047|FG000|NOT COMPLETED|Overall Study||6||
60049317|NCT01536574|76165048|FG001|NOT COMPLETED|Overall Study||7||
60049318|NCT01536418|76165056|FG000|STARTED|Overall Study||127||
60049319|NCT01536418|76165057|FG001|STARTED|Overall Study||126||
60049320|NCT01536418|76165056|FG000|COMPLETED|Overall Study||58||
60049321|NCT01536418|76165057|FG001|COMPLETED|Overall Study||60||
59513339|NCT02816710|75606827|FG000|NOT COMPLETED|Overall Study||4||
59513340|NCT02816710|75606828|FG001|NOT COMPLETED|Overall Study||3||
59513341|NCT02816710|75606829|FG002|NOT COMPLETED|Overall Study||7||
59513342|NCT02818114|75606840|FG000|STARTED|Overall Study||8||
59513343|NCT02818114|75606840|FG000|COMPLETED|Overall Study||7||
60049322|NCT01536418|76165056|FG000|NOT COMPLETED|Overall Study||69||
60049323|NCT01536418|76165057|FG001|NOT COMPLETED|Overall Study||66||
60049324|NCT01576042|76165066|FG000|STARTED|Overall Study||13||
60049325|NCT01576042|76165067|FG001|STARTED|Overall Study||14||
60049326|NCT01576042|76165066|FG000|Switched to the Other Arm|Overall Study||5||
60049327|NCT01576042|76165067|FG001|Switched to the Other Arm|Overall Study||1||
60049328|NCT01576042|76165066|FG000|COMPLETED|Overall Study||11||
60049329|NCT01576042|76165067|FG001|COMPLETED|Overall Study||14||
60049330|NCT01576042|76165066|FG000|NOT COMPLETED|Overall Study||2||
60049331|NCT01576042|76165067|FG001|NOT COMPLETED|Overall Study||0||
60049332|NCT01561300|76165073|FG000|STARTED|Run in on Placebo||15||
60049333|NCT01561300|76165074|FG001|STARTED|Run in on Placebo||15||
60049334|NCT01561300|76165073|FG000|COMPLETED|Run in on Placebo||14||
60049335|NCT01561300|76165074|FG001|COMPLETED|Run in on Placebo||15||
60049336|NCT01561300|76165073|FG000|NOT COMPLETED|Run in on Placebo||1||
60049337|NCT01561300|76165074|FG001|NOT COMPLETED|Run in on Placebo||0||
60049338|NCT01561300|76165073|FG000|STARTED|First Intervention||14||
60049339|NCT01561300|76165074|FG001|STARTED|First Intervention||15||
60049340|NCT01561300|76165073|FG000|COMPLETED|First Intervention||14||
60049341|NCT01561300|76165074|FG001|COMPLETED|First Intervention||15||
60049342|NCT01561300|76165073|FG000|NOT COMPLETED|First Intervention||0||
60049343|NCT01561300|76165074|FG001|NOT COMPLETED|First Intervention||0||
60049344|NCT01561300|76165073|FG000|STARTED|Washout on Placebo||14||
60049345|NCT01561300|76165074|FG001|STARTED|Washout on Placebo||15||
60049346|NCT01561300|76165073|FG000|COMPLETED|Washout on Placebo||14||
60049347|NCT01561300|76165074|FG001|COMPLETED|Washout on Placebo||15||
60049348|NCT01561300|76165073|FG000|NOT COMPLETED|Washout on Placebo||0||
60049349|NCT01561300|76165074|FG001|NOT COMPLETED|Washout on Placebo||0||
60049350|NCT01561300|76165073|FG000|STARTED|Second Intervention||14||
60049351|NCT01561300|76165074|FG001|STARTED|Second Intervention||15||
60049352|NCT01561300|76165073|FG000|COMPLETED|Second Intervention||14||
60049353|NCT01561300|76165074|FG001|COMPLETED|Second Intervention||15||
60049354|NCT01561300|76165073|FG000|NOT COMPLETED|Second Intervention||0||
60049355|NCT01561300|76165074|FG001|NOT COMPLETED|Second Intervention||0||
60049356|NCT01536262|76165084|FG000|STARTED|Overall Study||41||
60049357|NCT01536262|76165085|FG001|STARTED|Overall Study||40||
60049358|NCT01536262|76165086|FG002|STARTED|Overall Study||41||
60049359|NCT01536262|76165084|FG000|COMPLETED|Overall Study||33||
60049360|NCT01536262|76165085|FG001|COMPLETED|Overall Study||38||
60049361|NCT01536262|76165086|FG002|COMPLETED|Overall Study||39||
60049362|NCT01536262|76165084|FG000|NOT COMPLETED|Overall Study||8||
60049363|NCT01536262|76165085|FG001|NOT COMPLETED|Overall Study||2||
60049364|NCT01536262|76165086|FG002|NOT COMPLETED|Overall Study||2||
60049365|NCT01560988|76165095|FG000|STARTED|First Intervention (Six Weeks)||32||
60049366|NCT01560988|76165096|FG001|STARTED|First Intervention (Six Weeks)||30||
60049367|NCT01560988|76165095|FG000|COMPLETED|First Intervention (Six Weeks)||22||
60049368|NCT01560988|76165096|FG001|COMPLETED|First Intervention (Six Weeks)||26||
60049369|NCT01560988|76165095|FG000|NOT COMPLETED|First Intervention (Six Weeks)||10||
60049370|NCT01560988|76165096|FG001|NOT COMPLETED|First Intervention (Six Weeks)||4||
60049371|NCT01560988|76165095|FG000|STARTED|Washout (Six Weeks)||22||
60049372|NCT01560988|76165096|FG001|STARTED|Washout (Six Weeks)||26||
60049373|NCT01560988|76165095|FG000|COMPLETED|Washout (Six Weeks)||20||
60049374|NCT01560988|76165096|FG001|COMPLETED|Washout (Six Weeks)||24||
60049375|NCT01560988|76165095|FG000|NOT COMPLETED|Washout (Six Weeks)||2||
60049376|NCT01560988|76165096|FG001|NOT COMPLETED|Washout (Six Weeks)||2||
60049377|NCT01560988|76165095|FG000|STARTED|Second Intervention (Six Weeks)||20||
60049378|NCT01560988|76165096|FG001|STARTED|Second Intervention (Six Weeks)||24||
60049379|NCT01560988|76165095|FG000|COMPLETED|Second Intervention (Six Weeks)||18||
60049380|NCT01560988|76165096|FG001|COMPLETED|Second Intervention (Six Weeks)||22||
60049381|NCT01560988|76165095|FG000|NOT COMPLETED|Second Intervention (Six Weeks)||2||
60049382|NCT01560988|76165096|FG001|NOT COMPLETED|Second Intervention (Six Weeks)||2||
60049383|NCT01535638|76165107|FG000|STARTED|Treatment 1 (Single Dose)||3||
60049384|NCT01535638|76165108|FG001|STARTED|Treatment 1 (Single Dose)||3||
60049385|NCT01535638|76165109|FG002|STARTED|Treatment 1 (Single Dose)||3||
60049386|NCT01535638|76165110|FG003|STARTED|Treatment 1 (Single Dose)||3||
60049387|NCT01535638|76165111|FG004|STARTED|Treatment 1 (Single Dose)||3||
60049388|NCT01535638|76165112|FG005|STARTED|Treatment 1 (Single Dose)||3||
60049389|NCT01535638|76165107|FG000|COMPLETED|Treatment 1 (Single Dose)||3||
60049390|NCT01535638|76165108|FG001|COMPLETED|Treatment 1 (Single Dose)||3||
60049391|NCT01535638|76165109|FG002|COMPLETED|Treatment 1 (Single Dose)||3||
60049392|NCT01535638|76165110|FG003|COMPLETED|Treatment 1 (Single Dose)||3||
60049393|NCT01535638|76165111|FG004|COMPLETED|Treatment 1 (Single Dose)||3||
60049394|NCT01535638|76165112|FG005|COMPLETED|Treatment 1 (Single Dose)||2||
60049395|NCT01535638|76165107|FG000|NOT COMPLETED|Treatment 1 (Single Dose)||0||
60049396|NCT01535638|76165108|FG001|NOT COMPLETED|Treatment 1 (Single Dose)||0||
60049397|NCT01535638|76165109|FG002|NOT COMPLETED|Treatment 1 (Single Dose)||0||
60049398|NCT01535638|76165110|FG003|NOT COMPLETED|Treatment 1 (Single Dose)||0||
60049399|NCT01535638|76165111|FG004|NOT COMPLETED|Treatment 1 (Single Dose)||0||
60049400|NCT01535638|76165112|FG005|NOT COMPLETED|Treatment 1 (Single Dose)||1||
60049401|NCT01535638|76165107|FG000|STARTED|Treatment 2 (Single Dose)||3||
60049402|NCT01535638|76165108|FG001|STARTED|Treatment 2 (Single Dose)||3||
60049403|NCT01535638|76165109|FG002|STARTED|Treatment 2 (Single Dose)||3||
60049404|NCT01535638|76165110|FG003|STARTED|Treatment 2 (Single Dose)||3||
60049405|NCT01535638|76165111|FG004|STARTED|Treatment 2 (Single Dose)||3||
60049406|NCT01535638|76165112|FG005|STARTED|Treatment 2 (Single Dose)||2||
60049407|NCT01535638|76165107|FG000|COMPLETED|Treatment 2 (Single Dose)||3||
60049408|NCT01535638|76165108|FG001|COMPLETED|Treatment 2 (Single Dose)||3||
60049409|NCT01535638|76165109|FG002|COMPLETED|Treatment 2 (Single Dose)||3||
60049410|NCT01535638|76165110|FG003|COMPLETED|Treatment 2 (Single Dose)||3||
60049411|NCT01535638|76165111|FG004|COMPLETED|Treatment 2 (Single Dose)||3||
60049412|NCT01535638|76165112|FG005|COMPLETED|Treatment 2 (Single Dose)||2||
60049413|NCT01535638|76165107|FG000|NOT COMPLETED|Treatment 2 (Single Dose)||0||
60049414|NCT01535638|76165108|FG001|NOT COMPLETED|Treatment 2 (Single Dose)||0||
60049415|NCT01535638|76165109|FG002|NOT COMPLETED|Treatment 2 (Single Dose)||0||
60049416|NCT01535638|76165110|FG003|NOT COMPLETED|Treatment 2 (Single Dose)||0||
60049417|NCT01535638|76165111|FG004|NOT COMPLETED|Treatment 2 (Single Dose)||0||
60049418|NCT01535638|76165112|FG005|NOT COMPLETED|Treatment 2 (Single Dose)||0||
60049419|NCT01535638|76165107|FG000|STARTED|Treatment 3 (Single Dose)||3||
60049420|NCT01535638|76165108|FG001|STARTED|Treatment 3 (Single Dose)||3||
60049421|NCT01535638|76165109|FG002|STARTED|Treatment 3 (Single Dose)||3||
60049422|NCT01535638|76165110|FG003|STARTED|Treatment 3 (Single Dose)||3||
60049423|NCT01535638|76165111|FG004|STARTED|Treatment 3 (Single Dose)||3||
60049424|NCT01535638|76165112|FG005|STARTED|Treatment 3 (Single Dose)||2||
60049425|NCT01535638|76165107|FG000|COMPLETED|Treatment 3 (Single Dose)||3||
60049426|NCT01535638|76165108|FG001|COMPLETED|Treatment 3 (Single Dose)||3||
60049427|NCT01535638|76165109|FG002|COMPLETED|Treatment 3 (Single Dose)||3||
60049428|NCT01535638|76165110|FG003|COMPLETED|Treatment 3 (Single Dose)||2||
60049429|NCT01535638|76165111|FG004|COMPLETED|Treatment 3 (Single Dose)||3||
60049430|NCT01535638|76165112|FG005|COMPLETED|Treatment 3 (Single Dose)||2||
60049431|NCT01535638|76165107|FG000|NOT COMPLETED|Treatment 3 (Single Dose)||0||
60049432|NCT01535638|76165108|FG001|NOT COMPLETED|Treatment 3 (Single Dose)||0||
60049433|NCT01535638|76165109|FG002|NOT COMPLETED|Treatment 3 (Single Dose)||0||
60049434|NCT01535638|76165110|FG003|NOT COMPLETED|Treatment 3 (Single Dose)||1||
60049435|NCT01535638|76165111|FG004|NOT COMPLETED|Treatment 3 (Single Dose)||0||
60049436|NCT01535638|76165112|FG005|NOT COMPLETED|Treatment 3 (Single Dose)||0||
60049437|NCT01535560|76165123|FG000|STARTED|Overall Study||274||
60049438|NCT01535560|76165124|FG001|STARTED|Overall Study||275||
60049439|NCT01535560|76165123|FG000|COMPLETED|Overall Study||237||
60049440|NCT01535560|76165124|FG001|COMPLETED|Overall Study||179||
60049441|NCT01535560|76165123|FG000|NOT COMPLETED|Overall Study||37||
60049442|NCT01535560|76165124|FG001|NOT COMPLETED|Overall Study||96||
60049443|NCT01575028|76165132|FG000|STARTED|Overall Study||2||
60049444|NCT01575028|76165133|FG001|STARTED|Overall Study||1||
60049445|NCT01575028|76165132|FG000|COMPLETED|Overall Study||2||
60049446|NCT01575028|76165133|FG001|COMPLETED|Overall Study||0||
60049447|NCT01575028|76165132|FG000|NOT COMPLETED|Overall Study||0||
60049448|NCT01575028|76165133|FG001|NOT COMPLETED|Overall Study||1||
60049449|NCT04443569|76165141|FG000|STARTED|Overall Study||46||
60049450|NCT04443569|76165142|FG001|STARTED|Overall Study||47||
60049451|NCT04443569|76165141|FG000|COMPLETED|Overall Study||46||
60049452|NCT04443569|76165142|FG001|COMPLETED|Overall Study||47||
60049453|NCT04443569|76165141|FG000|NOT COMPLETED|Overall Study||0||
60049454|NCT04443569|76165142|FG001|NOT COMPLETED|Overall Study||0||
60049455|NCT01313351|76165148|FG000|STARTED|Overall Study||206||
60049456|NCT01313351|76165148|FG000|COMPLETED|Overall Study||206||
60049457|NCT01313351|76165148|FG000|NOT COMPLETED|Overall Study||0||
60049458|NCT01574716|76165158|FG000|STARTED|Part 1||3||
60049459|NCT01574716|76165159|FG001|STARTED|Part 1||4||
60049460|NCT01574716|76165160|FG002|STARTED|Part 1||9||
60049461|NCT01574716|76165161|FG003|STARTED|Part 1||0||
60049462|NCT01574716|76165162|FG004|STARTED|Part 1||0||
60049463|NCT01574716|76165158|FG000|COMPLETED|Part 1||0||
60049464|NCT01574716|76165159|FG001|COMPLETED|Part 1||0||
60049465|NCT01574716|76165160|FG002|COMPLETED|Part 1||0||
59513344|NCT02818114|75606840|FG000|NOT COMPLETED|Overall Study||1||
59513345|NCT02930824|75606849|FG000|STARTED|Overall Study||62||
60049466|NCT01574716|76165161|FG003|COMPLETED|Part 1||0||
60049467|NCT01574716|76165162|FG004|COMPLETED|Part 1||0||
60049468|NCT01574716|76165158|FG000|NOT COMPLETED|Part 1||3||
60049469|NCT01574716|76165159|FG001|NOT COMPLETED|Part 1||4||
60049470|NCT01574716|76165160|FG002|NOT COMPLETED|Part 1||9||
60049471|NCT01574716|76165161|FG003|NOT COMPLETED|Part 1||0||
60049472|NCT01574716|76165162|FG004|NOT COMPLETED|Part 1||0||
60049473|NCT01574716|76165158|FG000|STARTED|Part 2||0||
60049474|NCT01574716|76165159|FG001|STARTED|Part 2||0||
60049475|NCT01574716|76165160|FG002|STARTED|Part 2||0||
59513346|NCT02930824|75606850|FG001|STARTED|Overall Study||63||
60049476|NCT01574716|76165161|FG003|STARTED|Part 2||139||
60049477|NCT01574716|76165162|FG004|STARTED|Part 2||70||
60067848|NCT01785615|76183053|FG001|STARTED|Dietary Phase||0||
60049478|NCT01574716|76165158|FG000|Treated Participants|Part 2||0|MORAb: 2 discontinued prior to treatment. Placebo: 3 randomized but received MORAb are in MORAb.|
60049479|NCT01574716|76165159|FG001|Treated Participants|Part 2||0|MORAb: 2 discontinued prior to treatment. Placebo: 3 randomized but received MORAb are in MORAb.|
60049480|NCT01574716|76165160|FG002|Treated Participants|Part 2||0|MORAb: 2 discontinued prior to treatment. Placebo: 3 randomized but received MORAb are in MORAb.|
60049481|NCT01574716|76165161|FG003|Treated Participants|Part 2||140|MORAb: 2 discontinued prior to treatment. Placebo: 3 randomized but received MORAb are in MORAb.|
60049482|NCT01574716|76165162|FG004|Treated Participants|Part 2||67|MORAb: 2 discontinued prior to treatment. Placebo: 3 randomized but received MORAb are in MORAb.|
60049483|NCT01574716|76165158|FG000|COMPLETED|Part 2||0||
60049484|NCT01574716|76165159|FG001|COMPLETED|Part 2||0||
60049485|NCT01574716|76165160|FG002|COMPLETED|Part 2||0||
60049486|NCT01574716|76165161|FG003|COMPLETED|Part 2||2||
60049487|NCT01574716|76165162|FG004|COMPLETED|Part 2||0||
60049488|NCT01574716|76165158|FG000|NOT COMPLETED|Part 2||0||
59513347|NCT02930824|75606851|FG002|STARTED|Overall Study||30||
59513348|NCT02930824|75606852|FG003|STARTED|Overall Study||30||
59513349|NCT02930824|75606849|FG000|COMPLETED|Overall Study||56||
60049489|NCT01574716|76165159|FG001|NOT COMPLETED|Part 2||0||
60049490|NCT01574716|76165160|FG002|NOT COMPLETED|Part 2||0||
60049491|NCT01574716|76165161|FG003|NOT COMPLETED|Part 2||137||
60049492|NCT01574716|76165162|FG004|NOT COMPLETED|Part 2||70||
60049493|NCT02161562|76165173|FG000|STARTED|Overall Study||178||
60049494|NCT02161562|76165174|FG001|STARTED|Overall Study||136||
60049495|NCT02161562|76165173|FG000|COMPLETED|Overall Study||152||
60049496|NCT02161562|76165174|FG001|COMPLETED|Overall Study||119||
60049497|NCT02161562|76165173|FG000|NOT COMPLETED|Overall Study||26||
60049498|NCT02161562|76165174|FG001|NOT COMPLETED|Overall Study||17||
60049499|NCT01559116|76165193|FG000|STARTED|Overall Study|Randomised|219||
60049500|NCT01559116|76165193|FG000|COMPLETED|Overall Study|Completed all 4 treatment periods|193||
60049501|NCT01559116|76165193|FG000|NOT COMPLETED|Overall Study||26||
60049502|NCT01574326|76165212|FG000|STARTED|Overall Study||51||
60049503|NCT01574326|76165213|FG001|STARTED|Overall Study||50||
60049504|NCT01574326|76165212|FG000|Treated|Overall Study||51||
60049505|NCT01574326|76165213|FG001|Treated|Overall Study||49||
60049506|NCT01574326|76165212|FG000|COMPLETED|Overall Study||35||
60049507|NCT01574326|76165213|FG001|COMPLETED|Overall Study||31||
60049508|NCT01574326|76165212|FG000|NOT COMPLETED|Overall Study||16||
60049509|NCT01574326|76165213|FG001|NOT COMPLETED|Overall Study||19||
60049510|NCT01574248|76165226|FG000|STARTED|Overall Study||15||
60049511|NCT01574248|76165227|FG001|STARTED|Overall Study||18||
60049512|NCT01574248|76165226|FG000|COMPLETED|Overall Study||12||
60049513|NCT01574248|76165227|FG001|COMPLETED|Overall Study||18||
60049514|NCT01574248|76165226|FG000|NOT COMPLETED|Overall Study||3||
60049515|NCT01574248|76165227|FG001|NOT COMPLETED|Overall Study||0||
60049516|NCT01573624|76165233|FG000|STARTED|Period 1 : Treatment Period 1 (14 Days)||64||
60049517|NCT01573624|76165234|FG001|STARTED|Period 1 : Treatment Period 1 (14 Days)||62||
60049518|NCT01573624|76165235|FG002|STARTED|Period 1 : Treatment Period 1 (14 Days)||60||
59513350|NCT02930824|75606850|FG001|COMPLETED|Overall Study||57||
59513351|NCT02930824|75606851|FG002|COMPLETED|Overall Study||20||
59513352|NCT02930824|75606852|FG003|COMPLETED|Overall Study||23||
59513353|NCT02930824|75606849|FG000|NOT COMPLETED|Overall Study||6||
59513354|NCT02930824|75606850|FG001|NOT COMPLETED|Overall Study||6||
59513355|NCT02930824|75606851|FG002|NOT COMPLETED|Overall Study||10||
59513356|NCT02930824|75606852|FG003|NOT COMPLETED|Overall Study||7||
60049519|NCT01573624|76165236|FG003|STARTED|Period 1 : Treatment Period 1 (14 Days)||63||
60049520|NCT01573624|76165237|FG004|STARTED|Period 1 : Treatment Period 1 (14 Days)||58||
60049521|NCT01573624|76165238|FG005|STARTED|Period 1 : Treatment Period 1 (14 Days)||55||
60049522|NCT01573624|76165239|FG006|STARTED|Period 1 : Treatment Period 1 (14 Days)||59||
60049523|NCT01573624|76165233|FG000|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||58||
60049524|NCT01573624|76165234|FG001|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||59||
60049525|NCT01573624|76165235|FG002|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||51||
60049526|NCT01573624|76165236|FG003|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||61||
60049527|NCT01573624|76165237|FG004|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||56||
60049528|NCT01573624|76165238|FG005|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||51||
60049529|NCT01573624|76165239|FG006|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||57||
60049530|NCT01573624|76165233|FG000|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||6||
60049531|NCT01573624|76165234|FG001|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||3||
59513357|NCT00931879|75606870|FG000|STARTED|Overall Study||22||
60049532|NCT01573624|76165235|FG002|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||9||
60049533|NCT01573624|76165236|FG003|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||2||
60049534|NCT01573624|76165237|FG004|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||2||
60049535|NCT01573624|76165238|FG005|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||4||
60049536|NCT01573624|76165239|FG006|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||2||
60049537|NCT01573624|76165233|FG000|STARTED|Period 2 : Washout Period 1 (12-14 Days)||58||
60049538|NCT01573624|76165234|FG001|STARTED|Period 2 : Washout Period 1 (12-14 Days)||59||
60049539|NCT01573624|76165235|FG002|STARTED|Period 2 : Washout Period 1 (12-14 Days)||51||
60049540|NCT01573624|76165236|FG003|STARTED|Period 2 : Washout Period 1 (12-14 Days)||61||
60049541|NCT01573624|76165237|FG004|STARTED|Period 2 : Washout Period 1 (12-14 Days)||56||
60049542|NCT01573624|76165238|FG005|STARTED|Period 2 : Washout Period 1 (12-14 Days)||51||
60049543|NCT01573624|76165239|FG006|STARTED|Period 2 : Washout Period 1 (12-14 Days)||57||
60049544|NCT01573624|76165233|FG000|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||57||
60049545|NCT01573624|76165234|FG001|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||58||
60049546|NCT01573624|76165235|FG002|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||48||
60049547|NCT01573624|76165236|FG003|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||56||
60049548|NCT01573624|76165237|FG004|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||56||
60049549|NCT01573624|76165238|FG005|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||48||
60049550|NCT01573624|76165239|FG006|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||55||
60049551|NCT01573624|76165233|FG000|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||1||
60049552|NCT01573624|76165234|FG001|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||1||
60049553|NCT01573624|76165235|FG002|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||3||
60049554|NCT01573624|76165236|FG003|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||5||
60049555|NCT01573624|76165237|FG004|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||0||
60049556|NCT01573624|76165238|FG005|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||3||
60049557|NCT01573624|76165239|FG006|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||2||
60049558|NCT01573624|76165233|FG000|STARTED|Period 3 : Treatment Period 2 (14 Days)||57||
60049559|NCT01573624|76165234|FG001|STARTED|Period 3 : Treatment Period 2 (14 Days)||58||
60049560|NCT01573624|76165235|FG002|STARTED|Period 3 : Treatment Period 2 (14 Days)||48||
60049561|NCT01573624|76165236|FG003|STARTED|Period 3 : Treatment Period 2 (14 Days)||56||
60049562|NCT01573624|76165237|FG004|STARTED|Period 3 : Treatment Period 2 (14 Days)||56||
60049563|NCT01573624|76165238|FG005|STARTED|Period 3 : Treatment Period 2 (14 Days)||48||
60049564|NCT01573624|76165239|FG006|STARTED|Period 3 : Treatment Period 2 (14 Days)||55||
60049565|NCT01573624|76165233|FG000|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||50||
60049566|NCT01573624|76165234|FG001|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||52||
60049567|NCT01573624|76165235|FG002|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||45||
60049568|NCT01573624|76165236|FG003|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||55||
59760282|NCT00600756|75879910|FG000|COMPLETED|Analysis After 6 Months|Completers are all patients who completed the study up to Visit 5 (including premature withdraw)|264||
59760283|NCT00600756|75879911|FG001|COMPLETED|Analysis After 6 Months|Completers are all patients who completed the study up to Visit 5 (including premature withdraw)|283||
59513358|NCT00931879|75606871|FG001|STARTED|Overall Study||22||
59513359|NCT00931879|75606870|FG000|COMPLETED|Overall Study||19||
60049569|NCT01573624|76165237|FG004|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||53||
60049570|NCT01573624|76165238|FG005|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||43||
60049571|NCT01573624|76165239|FG006|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||55||
60049572|NCT01573624|76165233|FG000|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||7||
60049573|NCT01573624|76165234|FG001|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||6||
60049574|NCT01573624|76165235|FG002|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||3||
60049575|NCT01573624|76165236|FG003|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||1||
60049576|NCT01573624|76165237|FG004|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||3||
59513360|NCT00931879|75606871|FG001|COMPLETED|Overall Study||19||
60049577|NCT01573624|76165238|FG005|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||5||
60049578|NCT01573624|76165239|FG006|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||0||
60049579|NCT01573624|76165233|FG000|STARTED|Period 4 : Washout Period 2 (12-14 Days)||50||
60049580|NCT01573624|76165234|FG001|STARTED|Period 4 : Washout Period 2 (12-14 Days)||52||
59513361|NCT00931879|75606870|FG000|NOT COMPLETED|Overall Study||3||
59760284|NCT00600756|75879910|FG000|NOT COMPLETED|Analysis After 6 Months||131||
60067849|NCT01785615|76183054|FG002|STARTED|Dietary Phase||35||
60049581|NCT01573624|76165235|FG002|STARTED|Period 4 : Washout Period 2 (12-14 Days)||45||
60049582|NCT01573624|76165236|FG003|STARTED|Period 4 : Washout Period 2 (12-14 Days)||55||
60049583|NCT01573624|76165237|FG004|STARTED|Period 4 : Washout Period 2 (12-14 Days)||53||
60049584|NCT01573624|76165238|FG005|STARTED|Period 4 : Washout Period 2 (12-14 Days)||43||
60049585|NCT01573624|76165239|FG006|STARTED|Period 4 : Washout Period 2 (12-14 Days)||55||
60049586|NCT01573624|76165233|FG000|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||49||
60049587|NCT01573624|76165234|FG001|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||48||
60049588|NCT01573624|76165235|FG002|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||43||
60049589|NCT01573624|76165236|FG003|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||53||
60049590|NCT01573624|76165237|FG004|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||52||
60049591|NCT01573624|76165238|FG005|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||41||
60049592|NCT01573624|76165239|FG006|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||52||
60049593|NCT01573624|76165233|FG000|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||1||
60049594|NCT01573624|76165234|FG001|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||4||
60049595|NCT01573624|76165235|FG002|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||2||
60049596|NCT01573624|76165236|FG003|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||2||
60049597|NCT01573624|76165237|FG004|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||1||
60049598|NCT01573624|76165238|FG005|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||2||
60049599|NCT01573624|76165239|FG006|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||3||
60049600|NCT01573624|76165233|FG000|STARTED|Period 5 : Treatment Period 3 (14 Days)||49||
60049601|NCT01573624|76165234|FG001|STARTED|Period 5 : Treatment Period 3 (14 Days)||48||
60049602|NCT01573624|76165235|FG002|STARTED|Period 5 : Treatment Period 3 (14 Days)||43||
60049603|NCT01573624|76165236|FG003|STARTED|Period 5 : Treatment Period 3 (14 Days)||53||
60049604|NCT01573624|76165237|FG004|STARTED|Period 5 : Treatment Period 3 (14 Days)||52||
60049605|NCT01573624|76165238|FG005|STARTED|Period 5 : Treatment Period 3 (14 Days)||41||
60049606|NCT01573624|76165239|FG006|STARTED|Period 5 : Treatment Period 3 (14 Days)||52||
60049607|NCT01573624|76165233|FG000|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||46||
60049608|NCT01573624|76165234|FG001|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||47||
60049609|NCT01573624|76165235|FG002|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||43||
60049610|NCT01573624|76165236|FG003|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||53||
60049611|NCT01573624|76165237|FG004|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||51||
60049612|NCT01573624|76165238|FG005|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||39||
60049613|NCT01573624|76165239|FG006|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||48||
60049614|NCT01573624|76165233|FG000|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||3||
60049615|NCT01573624|76165234|FG001|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||1||
60049616|NCT01573624|76165235|FG002|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||0||
60049617|NCT01573624|76165236|FG003|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||0||
60049618|NCT01573624|76165237|FG004|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||1||
60049619|NCT01573624|76165238|FG005|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||2||
59513362|NCT00931879|75606871|FG001|NOT COMPLETED|Overall Study||3||
59513363|NCT02930980|75606878|FG000|STARTED|Overall Study||43||
60049620|NCT01573624|76165239|FG006|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||4||
60049621|NCT01573624|76165233|FG000|STARTED|Period 6 : Follow-up Period (7 Days)||46||
60049622|NCT01573624|76165234|FG001|STARTED|Period 6 : Follow-up Period (7 Days)||47||
60049623|NCT01573624|76165235|FG002|STARTED|Period 6 : Follow-up Period (7 Days)||43||
60049624|NCT01573624|76165236|FG003|STARTED|Period 6 : Follow-up Period (7 Days)||53||
60049625|NCT01573624|76165237|FG004|STARTED|Period 6 : Follow-up Period (7 Days)||51||
60049626|NCT01573624|76165238|FG005|STARTED|Period 6 : Follow-up Period (7 Days)||39||
60049627|NCT01573624|76165239|FG006|STARTED|Period 6 : Follow-up Period (7 Days)||48||
60049628|NCT01573624|76165233|FG000|COMPLETED|Period 6 : Follow-up Period (7 Days)||45||
60049629|NCT01573624|76165234|FG001|COMPLETED|Period 6 : Follow-up Period (7 Days)||47||
59513364|NCT02930980|75606878|FG000|COMPLETED|Overall Study||43||
59513365|NCT02930980|75606878|FG000|NOT COMPLETED|Overall Study||0||
59513366|NCT03001258|75606885|FG000|STARTED|Overall Study||765||
59513367|NCT03001258|75606886|FG001|STARTED|Overall Study||751||
59513368|NCT03001258|75606887|FG002|STARTED|Overall Study||485||
59513369|NCT03001258|75606885|FG000|COMPLETED|Overall Study||765||
59513370|NCT03001258|75606886|FG001|COMPLETED|Overall Study||751||
59513371|NCT03001258|75606887|FG002|COMPLETED|Overall Study||485||
59513372|NCT03001258|75606885|FG000|NOT COMPLETED|Overall Study||0||
59513373|NCT03001258|75606886|FG001|NOT COMPLETED|Overall Study||0||
59513374|NCT03001258|75606887|FG002|NOT COMPLETED|Overall Study||0||
59513375|NCT00945295|75606897|FG000|STARTED|Overall Study||15||
59513376|NCT00945295|75606898|FG001|STARTED|Overall Study||16||
59513377|NCT00945295|75606897|FG000|COMPLETED|Overall Study||15||
59513378|NCT00945295|75606898|FG001|COMPLETED|Overall Study||14||
59513379|NCT00945295|75606897|FG000|NOT COMPLETED|Overall Study||0||
59513380|NCT00945295|75606898|FG001|NOT COMPLETED|Overall Study||2||
59513381|NCT03634813|75606906|FG000|STARTED|Overall Study||49||
59513382|NCT03634813|75606907|FG001|STARTED|Overall Study||51||
59513383|NCT03634813|75606906|FG000|COMPLETED|Overall Study||49||
59513384|NCT03634813|75606907|FG001|COMPLETED|Overall Study||51||
59612769|NCT01717326|75723778|FG018|NOT COMPLETED|Overall Study||4||
59612770|NCT01717326|75723779|FG019|NOT COMPLETED|Overall Study||6||
59760285|NCT00600756|75879911|FG001|NOT COMPLETED|Analysis After 6 Months||120||
60049630|NCT01573624|76165235|FG002|COMPLETED|Period 6 : Follow-up Period (7 Days)||43||
60049631|NCT01573624|76165236|FG003|COMPLETED|Period 6 : Follow-up Period (7 Days)||53||
60049632|NCT01573624|76165237|FG004|COMPLETED|Period 6 : Follow-up Period (7 Days)||49||
60049633|NCT01573624|76165238|FG005|COMPLETED|Period 6 : Follow-up Period (7 Days)||38||
60049634|NCT01573624|76165239|FG006|COMPLETED|Period 6 : Follow-up Period (7 Days)||48||
60049635|NCT01573624|76165233|FG000|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||1||
60049636|NCT01573624|76165234|FG001|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||0||
60049637|NCT01573624|76165235|FG002|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||0||
60049638|NCT01573624|76165236|FG003|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||0||
60049639|NCT01573624|76165237|FG004|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||2||
60049640|NCT01573624|76165238|FG005|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||1||
60049641|NCT01573624|76165239|FG006|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||0||
60049642|NCT01557946|76165263|FG000|STARTED|Overall Study||20||
60049643|NCT01557946|76165264|FG001|STARTED|Overall Study||12||
60049644|NCT01557946|76165263|FG000|COMPLETED|Overall Study|20 consented and scanned - 1 subject's data not used due to ongoing neurological condition.|17||
60049645|NCT01557946|76165264|FG001|COMPLETED|Overall Study|2 subjects with unusable imaging data.|12||
60049646|NCT01557946|76165263|FG000|NOT COMPLETED|Overall Study||3||
60049647|NCT01557946|76165264|FG001|NOT COMPLETED|Overall Study||0||
60049648|NCT01534078|76165269|FG000|STARTED|Overall Study||34||
60049649|NCT01534078|76165269|FG000|COMPLETED|Overall Study||32||
60049650|NCT01534078|76165269|FG000|NOT COMPLETED|Overall Study||2||
60049651|NCT02185040|76165278|FG000|STARTED|Part 1 Treatment Phase||8||
60049652|NCT02185040|76165279|FG001|STARTED|Part 1 Treatment Phase||8||
60049653|NCT02185040|76165280|FG002|STARTED|Part 1 Treatment Phase||8||
60049654|NCT02185040|76165281|FG003|STARTED|Part 1 Treatment Phase||9||
60049655|NCT02185040|76165282|FG004|STARTED|Part 1 Treatment Phase||9||
60049656|NCT02185040|76165283|FG005|STARTED|Part 1 Treatment Phase||0||
60049657|NCT02185040|76165284|FG006|STARTED|Part 1 Treatment Phase||0||
60049658|NCT02185040|76165278|FG000|COMPLETED|Part 1 Treatment Phase||7||
60049659|NCT02185040|76165279|FG001|COMPLETED|Part 1 Treatment Phase||6||
60049660|NCT02185040|76165280|FG002|COMPLETED|Part 1 Treatment Phase||7||
60049661|NCT02185040|76165281|FG003|COMPLETED|Part 1 Treatment Phase||7||
60049662|NCT02185040|76165282|FG004|COMPLETED|Part 1 Treatment Phase||6||
60049663|NCT02185040|76165283|FG005|COMPLETED|Part 1 Treatment Phase||0||
60049664|NCT02185040|76165284|FG006|COMPLETED|Part 1 Treatment Phase||0||
59513385|NCT03634813|75606906|FG000|NOT COMPLETED|Overall Study||0||
59513386|NCT03634813|75606907|FG001|NOT COMPLETED|Overall Study||0||
59513387|NCT00932035|75606917|FG000|STARTED|Overall Study||18||
59513388|NCT00932035|75606918|FG001|STARTED|Overall Study||21||
59612771|NCT01697592|75723831|FG000|STARTED|Phase A (Up to 24 Weeks)||126||
59760286|NCT00600756|75879910|FG000|STARTED|Overall Study Analysis After 12 Months||395||
59921345|NCT03307837|76040800|FG003|NOT COMPLETED|Overall Study||0||
59921346|NCT03307837|76040801|FG004|NOT COMPLETED|Overall Study||0||
59921347|NCT03307837|76040802|FG005|NOT COMPLETED|Overall Study||2||
59921348|NCT03331315|76040823|FG000|STARTED|Overall Study||88||
59921349|NCT03331315|76040824|FG001|STARTED|Overall Study||82||
59921350|NCT03331315|76040823|FG000|COMPLETED|Overall Study||70||
59921351|NCT03331315|76040824|FG001|COMPLETED|Overall Study||68||
59921352|NCT03331315|76040823|FG000|NOT COMPLETED|Overall Study||18||
59921353|NCT03331315|76040824|FG001|NOT COMPLETED|Overall Study||14||
59921354|NCT03329989|76040832|FG000|STARTED|Overall Study||158||
59921355|NCT03329989|76040832|FG000|COMPLETED|Overall Study||135||
59921356|NCT03329989|76040832|FG000|NOT COMPLETED|Overall Study||23||
60049665|NCT02185040|76165278|FG000|NOT COMPLETED|Part 1 Treatment Phase||1||
60049666|NCT02185040|76165279|FG001|NOT COMPLETED|Part 1 Treatment Phase||2||
60049667|NCT02185040|76165280|FG002|NOT COMPLETED|Part 1 Treatment Phase||1||
59513389|NCT00932035|75606917|FG000|COMPLETED|Overall Study||18||
59513390|NCT00932035|75606918|FG001|COMPLETED|Overall Study||21||
59513391|NCT00932035|75606917|FG000|NOT COMPLETED|Overall Study||0||
59513392|NCT00932035|75606918|FG001|NOT COMPLETED|Overall Study||0||
59513393|NCT02933320|75606928|FG000|STARTED|Overall Study||13||
59921357|NCT03287869|76040838|FG000|STARTED|Overall Study||188||
60049668|NCT02185040|76165281|FG003|NOT COMPLETED|Part 1 Treatment Phase||2||
60049669|NCT02185040|76165282|FG004|NOT COMPLETED|Part 1 Treatment Phase||3||
60049670|NCT02185040|76165283|FG005|NOT COMPLETED|Part 1 Treatment Phase||0||
60049671|NCT02185040|76165284|FG006|NOT COMPLETED|Part 1 Treatment Phase||0||
60049672|NCT02185040|76165278|FG000|STARTED|Active Treatment Extension Phase||0||
60049673|NCT02185040|76165279|FG001|STARTED|Active Treatment Extension Phase||0||
60049674|NCT02185040|76165280|FG002|STARTED|Active Treatment Extension Phase||0||
60049675|NCT02185040|76165281|FG003|STARTED|Active Treatment Extension Phase||0||
60049676|NCT02185040|76165282|FG004|STARTED|Active Treatment Extension Phase||0||
60049677|NCT02185040|76165283|FG005|STARTED|Active Treatment Extension Phase||9||
60049678|NCT02185040|76165284|FG006|STARTED|Active Treatment Extension Phase||8||
60049679|NCT02185040|76165278|FG000|COMPLETED|Active Treatment Extension Phase||0||
60049680|NCT02185040|76165279|FG001|COMPLETED|Active Treatment Extension Phase||0||
60049681|NCT02185040|76165280|FG002|COMPLETED|Active Treatment Extension Phase||0||
59513394|NCT02933320|75606929|FG001|STARTED|Overall Study||1||
59513395|NCT02933320|75606930|FG002|STARTED|Overall Study|Trial terminated early|0||
59513396|NCT02933320|75606931|FG003|STARTED|Overall Study|Trial terminated early|0||
60049682|NCT02185040|76165281|FG003|COMPLETED|Active Treatment Extension Phase||0||
60049683|NCT02185040|76165282|FG004|COMPLETED|Active Treatment Extension Phase||0||
60049684|NCT02185040|76165283|FG005|COMPLETED|Active Treatment Extension Phase||6||
60049685|NCT02185040|76165284|FG006|COMPLETED|Active Treatment Extension Phase||1||
60049686|NCT02185040|76165278|FG000|NOT COMPLETED|Active Treatment Extension Phase||0||
60049687|NCT02185040|76165279|FG001|NOT COMPLETED|Active Treatment Extension Phase||0||
60049688|NCT02185040|76165280|FG002|NOT COMPLETED|Active Treatment Extension Phase||0||
60049689|NCT02185040|76165281|FG003|NOT COMPLETED|Active Treatment Extension Phase||0||
60049690|NCT02185040|76165282|FG004|NOT COMPLETED|Active Treatment Extension Phase||0||
60049691|NCT02185040|76165283|FG005|NOT COMPLETED|Active Treatment Extension Phase||3||
60049692|NCT02185040|76165284|FG006|NOT COMPLETED|Active Treatment Extension Phase||7||
60049693|NCT02161406|76165306|FG000|STARTED|Overall Study||44||
60049694|NCT02161406|76165307|FG001|STARTED|Overall Study||44||
60049695|NCT02161406|76165306|FG000|COMPLETED|Overall Study||34||
60049696|NCT02161406|76165307|FG001|COMPLETED|Overall Study||35||
60049697|NCT02161406|76165306|FG000|NOT COMPLETED|Overall Study||10||
60049698|NCT02161406|76165307|FG001|NOT COMPLETED|Overall Study||9||
60049699|NCT02161016|76165313|FG000|STARTED|Overall Study||1||
60049700|NCT02161016|76165313|FG000|COMPLETED|Overall Study||0||
60049701|NCT02161016|76165313|FG000|NOT COMPLETED|Overall Study||1||
60049702|NCT01573000|76165319|FG000|STARTED|Dosimetric and Therapeutic Treatment||42||
60049703|NCT01573000|76165320|FG001|STARTED|Dosimetric and Therapeutic Treatment||36||
60049704|NCT01573000|76165319|FG000|COMPLETED|Dosimetric and Therapeutic Treatment|These participants completed 2 years of follow up and enrolled in BEX104526.|7||
60049705|NCT01573000|76165320|FG001|COMPLETED|Dosimetric and Therapeutic Treatment|These participants completed 2 years of follow up and enrolled in BEX104526.|1||
60049706|NCT01573000|76165319|FG000|NOT COMPLETED|Dosimetric and Therapeutic Treatment||35||
60049707|NCT01573000|76165320|FG001|NOT COMPLETED|Dosimetric and Therapeutic Treatment||35||
60049708|NCT01573000|76165319|FG000|STARTED|Crossover Phase||0||
60049709|NCT01573000|76165320|FG001|STARTED|Crossover Phase|19 of 36 par. randomized to receive Unlabeled TST crossed over to receive TST and Iodine I 131 TST.|19||
60049710|NCT01573000|76165319|FG000|COMPLETED|Crossover Phase||0||
60049711|NCT01573000|76165320|FG001|COMPLETED|Crossover Phase|This participant completed 2 years of follow up and enrolled in BEX104526.|1||
60049712|NCT01573000|76165319|FG000|NOT COMPLETED|Crossover Phase||0||
60049713|NCT01573000|76165320|FG001|NOT COMPLETED|Crossover Phase||18||
60049714|NCT01573000|76165319|FG000|STARTED|Long-Term Follow-Up|14 of the 35 participants withdrawing from Study BEX104515 enrolled in long-term follow-up study.|14||
60049715|NCT01573000|76165320|FG001|STARTED|Long-Term Follow-Up|5 of the 35 participants withdrawing from Study BEX104515 enrolled in long-term follow-up study.|5||
59513397|NCT02933320|75606928|FG000|COMPLETED|Overall Study||13||
59513398|NCT02933320|75606929|FG001|COMPLETED|Overall Study||1||
59513399|NCT02933320|75606930|FG002|COMPLETED|Overall Study||0||
59513400|NCT02933320|75606931|FG003|COMPLETED|Overall Study||0||
60049716|NCT01573000|76165319|FG000|COMPLETED|Long-Term Follow-Up||11||
60049717|NCT01573000|76165320|FG001|COMPLETED|Long-Term Follow-Up|One participant who received crossover treatment was lost to follow up.|4||
60049718|NCT01573000|76165319|FG000|NOT COMPLETED|Long-Term Follow-Up||3||
60049719|NCT01573000|76165320|FG001|NOT COMPLETED|Long-Term Follow-Up||1||
60049720|NCT01572922|76165330|FG000|STARTED|Overall Study||142||
60049721|NCT01572922|76165330|FG000|COMPLETED|Overall Study||139||
60049722|NCT01572922|76165330|FG000|NOT COMPLETED|Overall Study||3||
60049723|NCT01572844|76165339|FG000|STARTED|Overall Study||3||3
59921358|NCT03287869|76040839|FG001|STARTED|Overall Study||193||
59921359|NCT03287869|76040838|FG000|Analyzed For Safety (Safety Sample)|Overall Study||184|Participants who received at least 1 dose of investigational medicinal product (IMP-brexpiprazole).|
59921360|NCT03287869|76040839|FG001|Analyzed For Safety (Safety Sample)|Overall Study||184|Participants who received at least 1 dose of investigational medicinal product (IMP-brexpiprazole).|
59921361|NCT03287869|76040838|FG000|COMPLETED|Overall Study||105||
59921362|NCT03287869|76040839|FG001|COMPLETED|Overall Study||100||
59921363|NCT03287869|76040838|FG000|NOT COMPLETED|Overall Study||83||
59921364|NCT03287869|76040839|FG001|NOT COMPLETED|Overall Study||93||
59921365|NCT02661490|76040850|FG000|STARTED|Overall Study||76||
59921366|NCT02661490|76040851|FG001|STARTED|Overall Study||74||
59921367|NCT02661490|76040852|FG002|STARTED|Overall Study||72||
59921368|NCT02661490|76040853|FG003|STARTED|Overall Study||72||
59921369|NCT02661490|76040854|FG004|STARTED|Overall Study||26||
60049724|NCT01572844|76165340|FG001|STARTED|Overall Study||3||3
60049725|NCT01572844|76165339|FG000|COMPLETED|Overall Study||2||2
60049726|NCT01572844|76165340|FG001|COMPLETED|Overall Study||2||2
60049727|NCT01572844|76165339|FG000|NOT COMPLETED|Overall Study||1||1
60049728|NCT01572844|76165340|FG001|NOT COMPLETED|Overall Study||1||1
60049729|NCT01557400|76165349|FG000|STARTED|Overall Study||94||
60049730|NCT01557400|76165349|FG000|Received at Least 1 Dose of Study Drug|Overall Study||94||
60049731|NCT01557400|76165349|FG000|COMPLETED|Overall Study||37||
60049732|NCT01557400|76165349|FG000|NOT COMPLETED|Overall Study||57||
60049733|NCT01533922|76165353|FG000|STARTED|Overall Study||59||
60049734|NCT01533922|76165354|FG001|STARTED|Overall Study||59||
60049735|NCT01533922|76165355|FG002|STARTED|Overall Study||60||
60049736|NCT01533922|76165356|FG003|STARTED|Overall Study||58||
60049737|NCT01533922|76165357|FG004|STARTED|Overall Study||59||
60049738|NCT01533922|76165353|FG000|Received Placebo|Overall Study||0||
60049739|NCT01533922|76165354|FG001|Received Placebo|Overall Study||49||
60049740|NCT01533922|76165355|FG002|Received Placebo|Overall Study||57||
59760287|NCT00600756|75879911|FG001|STARTED|Overall Study Analysis After 12 Months||403||
59760288|NCT00600756|75879910|FG000|Randomized Analysis|Overall Study Analysis After 12 Months||395||
59760289|NCT00600756|75879911|FG001|Randomized Analysis|Overall Study Analysis After 12 Months||403||
59921370|NCT02661490|76040850|FG000|COMPLETED|Overall Study||73||
59921371|NCT02661490|76040851|FG001|COMPLETED|Overall Study||72||
59921372|NCT02661490|76040852|FG002|COMPLETED|Overall Study||70||
59921373|NCT02661490|76040853|FG003|COMPLETED|Overall Study||71||
59921374|NCT02661490|76040854|FG004|COMPLETED|Overall Study||23||
59921375|NCT02661490|76040850|FG000|NOT COMPLETED|Overall Study||3||
59921376|NCT02661490|76040851|FG001|NOT COMPLETED|Overall Study||2||
59921377|NCT02661490|76040852|FG002|NOT COMPLETED|Overall Study||2||
59921378|NCT02661490|76040853|FG003|NOT COMPLETED|Overall Study||1||
60049741|NCT01533922|76165356|FG003|Received Placebo|Overall Study||57||
60049742|NCT01533922|76165357|FG004|Received Placebo|Overall Study||59||
60049743|NCT01533922|76165353|FG000|Received Olo 5|Overall Study||51||
60049744|NCT01533922|76165354|FG001|Received Olo 5|Overall Study||52||
60049745|NCT01533922|76165355|FG002|Received Olo 5|Overall Study||57||
60049746|NCT01533922|76165356|FG003|Received Olo 5|Overall Study||57||
59921379|NCT02661490|76040854|FG004|NOT COMPLETED|Overall Study||3||
59921380|NCT03287791|76040869|FG000|STARTED|Overall Study||312||
59921381|NCT03287791|76040870|FG001|STARTED|Overall Study||312||
60049747|NCT01533922|76165357|FG004|Received Olo 5|Overall Study||0||
60049748|NCT01533922|76165353|FG000|Received Tio 5|Overall Study||54||
60049749|NCT01533922|76165354|FG001|Received Tio 5|Overall Study||58||
60049750|NCT01533922|76165355|FG002|Received Tio 5|Overall Study||59||
59513401|NCT02933320|75606928|FG000|NOT COMPLETED|Overall Study||0||
59760290|NCT00600756|75879910|FG000|Safety Analysis|Overall Study Analysis After 12 Months||391||
59760291|NCT00600756|75879911|FG001|Safety Analysis|Overall Study Analysis After 12 Months||402||
59921382|NCT03287791|76040871|FG002|STARTED|Overall Study||300||
59921383|NCT03287791|76040869|FG000|Safety Population|Overall Study||306|Randomized participants with evidence in diary card of using ≥1 dose of study drug.|
59921384|NCT03287791|76040870|FG001|Safety Population|Overall Study||297|Randomized participants with evidence in diary card of using ≥1 dose of study drug.|
60067850|NCT01785615|76183055|FG003|STARTED|Dietary Phase||140||
59513402|NCT02933320|75606929|FG001|NOT COMPLETED|Overall Study||0||
59513403|NCT02933320|75606930|FG002|NOT COMPLETED|Overall Study||0||
59513404|NCT02933320|75606931|FG003|NOT COMPLETED|Overall Study||0||
59513405|NCT02933476|75606941|FG000|STARTED|Overall Study||5||
59513406|NCT02933476|75606941|FG000|COMPLETED|Overall Study||5||
59513407|NCT02933476|75606941|FG000|NOT COMPLETED|Overall Study||0||
59513408|NCT02933866|75606947|FG000|STARTED|Overall Study||186||
59513409|NCT02933866|75606948|FG001|STARTED|Overall Study||185||
59513410|NCT02933866|75606947|FG000|COMPLETED|Overall Study||174||
59513411|NCT02933866|75606948|FG001|COMPLETED|Overall Study||176||
59513412|NCT02933866|75606947|FG000|NOT COMPLETED|Overall Study||12||
59513413|NCT02933866|75606948|FG001|NOT COMPLETED|Overall Study||9||
59513414|NCT02935036|75606956|FG000|STARTED|Overall Study||147||
59513415|NCT02935036|75606957|FG001|STARTED|Overall Study||147||
59513416|NCT02935036|75606956|FG000|COMPLETED|Overall Study||137||
59513417|NCT02935036|75606957|FG001|COMPLETED|Overall Study||136||
59513418|NCT02935036|75606956|FG000|NOT COMPLETED|Overall Study||10||
59513419|NCT02935036|75606957|FG001|NOT COMPLETED|Overall Study||11||
59612772|NCT01697592|75723832|FG001|STARTED|Phase A (Up to 24 Weeks)||65||
59612773|NCT01697592|75723833|FG002|STARTED|Phase A (Up to 24 Weeks)||66||
59760292|NCT00600756|75879910|FG000|ITT Analysis|Overall Study Analysis After 12 Months||379||
59760293|NCT00600756|75879911|FG001|ITT Analysis|Overall Study Analysis After 12 Months||392||
59760294|NCT00600756|75879910|FG000|COMPLETED|Overall Study Analysis After 12 Months|Completed study to Visit 7 (includes premature withdrawals with final visit in the Visit 7 window)|212||
59760295|NCT00600756|75879911|FG001|COMPLETED|Overall Study Analysis After 12 Months|Completed study to Visit 7 (includes premature withdrawals with final visit in the Visit 7 window)|227||
59760296|NCT00600756|75879910|FG000|NOT COMPLETED|Overall Study Analysis After 12 Months||183||
59760297|NCT00600756|75879911|FG001|NOT COMPLETED|Overall Study Analysis After 12 Months||176||
59921385|NCT03287791|76040871|FG002|Safety Population|Overall Study||291|Randomized participants with evidence in diary card of using ≥1 dose of study drug.|
59921386|NCT03287791|76040869|FG000|mITT Population|Overall Study||291|Safety Population, met inclusion/exclusion criteria, have ≥1 post-baseline efficacy data|
59760298|NCT04115228|75879917|FG000|STARTED|Overall Study||10||
59760299|NCT04115228|75879917|FG000|COMPLETED|Overall Study||10||
59760300|NCT04115228|75879917|FG000|NOT COMPLETED|Overall Study||0||
59760301|NCT00890825|75879923|FG000|STARTED|Overall Study||44||
59760302|NCT00890825|75879924|FG001|STARTED|Overall Study|A patient randomized to this arm was excluded from the safety population for not receiving treatment|43||
59760303|NCT00890825|75879923|FG000|COMPLETED|Overall Study||30||
59760304|NCT00890825|75879924|FG001|COMPLETED|Overall Study||29||
59760305|NCT00890825|75879923|FG000|NOT COMPLETED|Overall Study||14||
59760306|NCT00890825|75879924|FG001|NOT COMPLETED|Overall Study||14||
59760307|NCT00890201|75879932|FG000|STARTED|Overall Study|5 patients with gastric cancer and gallstone disease|38||
59921387|NCT03287791|76040870|FG001|mITT Population|Overall Study||291|Safety Population, met inclusion/exclusion criteria, have ≥1 post-baseline efficacy data|
59921388|NCT03287791|76040871|FG002|mITT Population|Overall Study||283|Safety Population, met inclusion/exclusion criteria, have ≥1 post-baseline efficacy data|
59921389|NCT03287791|76040869|FG000|PP Population|Overall Study||262|mITT, >75-125% doses and >6 consecutive doses, or discontinued for lack of treatment-completed ≥8wks|
59921390|NCT03287791|76040870|FG001|PP Population|Overall Study||259|mITT, >75-125% doses and >6 consecutive doses, or discontinued for lack of treatment-completed ≥8wks|
59921391|NCT03287791|76040871|FG002|PP Population|Overall Study||245|mITT, >75-125% doses and >6 consecutive doses, or discontinued for lack of treatment-completed ≥8wks|
59921392|NCT03287791|76040869|FG000|COMPLETED|Overall Study||280||
59921393|NCT03287791|76040870|FG001|COMPLETED|Overall Study||276||
59921394|NCT03287791|76040871|FG002|COMPLETED|Overall Study||264||
59921395|NCT03287791|76040869|FG000|NOT COMPLETED|Overall Study||32||
59921396|NCT03287791|76040870|FG001|NOT COMPLETED|Overall Study||36||
59921397|NCT03287791|76040871|FG002|NOT COMPLETED|Overall Study||36||
59760308|NCT00890201|75879933|FG001|STARTED|Overall Study|41 patients with acute cholecystitis and 15 patients with common bile duct stones|159||
59760309|NCT00890201|75879932|FG000|COMPLETED|Overall Study|33 patients with gastric cancer and without gallstone disease|33||
59760310|NCT00890201|75879933|FG001|COMPLETED|Overall Study|103 patients without acute cholecystitis or common bile duct stones|103||
59760311|NCT00890201|75879932|FG000|NOT COMPLETED|Overall Study||5||
59760312|NCT00890201|75879933|FG001|NOT COMPLETED|Overall Study||56||
59760313|NCT00891527|75879939|FG000|STARTED|Overall Study||50||
59760314|NCT00891527|75879939|FG000|COMPLETED|Overall Study||48||
59760315|NCT00891527|75879939|FG000|NOT COMPLETED|Overall Study||2||
59760316|NCT03861078|75879944|FG000|STARTED|Overall Study||22||
59760317|NCT03861078|75879944|FG000|Session 1: Own Brand Cigarette Use|Overall Study||14||
59760318|NCT03861078|75879944|FG000|Session 2: ECIG 15 mg Nicotine, Sweetened|Overall Study||14||
59760319|NCT03861078|75879944|FG000|Session 3: ECIG Lab Session ECIG 15 mg Nicotine, Unsweetened|Overall Study||14||
59760320|NCT03861078|75879944|FG000|Session 4: ECIG Lab Session ECIG 0 mg Nicotine, Sweetened|Overall Study||14||
59760321|NCT03861078|75879944|FG000|Session 5: ECIG Lab Session ECIG 0 mg Nicotine, Unsweetened|Overall Study||14||
59513420|NCT02158273|75606965|FG000|STARTED|Overall Study||25||
59513421|NCT02158273|75606966|FG001|STARTED|Overall Study||25||
59513422|NCT02158273|75606965|FG000|COMPLETED|Overall Study||22||
59513423|NCT02158273|75606966|FG001|COMPLETED|Overall Study||22||
59513424|NCT02158273|75606965|FG000|NOT COMPLETED|Overall Study||3||
60049751|NCT01533922|76165356|FG003|Received Tio 5|Overall Study|One patient received Tio 5 instead of Olo 5 by mistake.|1||
60049752|NCT01533922|76165357|FG004|Received Tio 5|Overall Study||54||
60049753|NCT01533922|76165353|FG000|Received Tio+Olo 2.5/5|Overall Study||59||
60049754|NCT01533922|76165354|FG001|Received Tio+Olo 2.5/5|Overall Study||0||
60049755|NCT01533922|76165355|FG002|Received Tio+Olo 2.5/5|Overall Study||52||
59513425|NCT02158273|75606966|FG001|NOT COMPLETED|Overall Study||3||
59513426|NCT02819284|75606974|FG000|STARTED|Overall Study||452||
59513427|NCT02819284|75606975|FG001|STARTED|Overall Study||453||
60049756|NCT01533922|76165356|FG003|Received Tio+Olo 2.5/5|Overall Study||55||
60049757|NCT01533922|76165357|FG004|Received Tio+Olo 2.5/5|Overall Study||56||
60049758|NCT01533922|76165353|FG000|Received Tio+Olo 5/5|Overall Study||58||
60049759|NCT01533922|76165354|FG001|Received Tio+Olo 5/5|Overall Study||59||
60049760|NCT01533922|76165355|FG002|Received Tio+Olo 5/5|Overall Study||0||
60049761|NCT01533922|76165356|FG003|Received Tio+Olo 5/5|Overall Study||53||
60049762|NCT01533922|76165357|FG004|Received Tio+Olo 5/5|Overall Study||56||
60049763|NCT01533922|76165353|FG000|COMPLETED|Overall Study|Completed all treatment arms|49||
60049764|NCT01533922|76165354|FG001|COMPLETED|Overall Study|Completed all treatment arms|47||
60049765|NCT01533922|76165355|FG002|COMPLETED|Overall Study|Completed all treatment arms|50||
60049766|NCT01533922|76165356|FG003|COMPLETED|Overall Study|Completed all treatment arms|53||
60049767|NCT01533922|76165357|FG004|COMPLETED|Overall Study|Completed all treatment arms|53||
60049768|NCT01533922|76165353|FG000|NOT COMPLETED|Overall Study||10||
60049769|NCT01533922|76165354|FG001|NOT COMPLETED|Overall Study||12||
60049770|NCT01533922|76165355|FG002|NOT COMPLETED|Overall Study||10||
60049771|NCT01533922|76165356|FG003|NOT COMPLETED|Overall Study||5||
60049772|NCT01533922|76165357|FG004|NOT COMPLETED|Overall Study||6||
60049773|NCT01533688|76165372|FG000|STARTED|Overall Study||71||
60049774|NCT01533688|76165373|FG001|STARTED|Overall Study||70||
60049775|NCT01533688|76165374|FG002|STARTED|Overall Study||71||
60049776|NCT01533688|76165372|FG000|COMPLETED|Overall Study||63||
60049777|NCT01533688|76165373|FG001|COMPLETED|Overall Study||60||
60049778|NCT01533688|76165374|FG002|COMPLETED|Overall Study||63||
60049779|NCT01533688|76165372|FG000|NOT COMPLETED|Overall Study||8||
60049780|NCT01533688|76165373|FG001|NOT COMPLETED|Overall Study||10||
60049781|NCT01533688|76165374|FG002|NOT COMPLETED|Overall Study||8||
60049782|NCT01532986|76165386|FG000|STARTED|Overall Study||166||
60049783|NCT01532986|76165387|FG001|STARTED|Overall Study||162||
60049784|NCT01532986|76165386|FG000|COMPLETED|Overall Study||143||
60049785|NCT01532986|76165387|FG001|COMPLETED|Overall Study||138||
60049786|NCT01532986|76165386|FG000|NOT COMPLETED|Overall Study||23||
60049787|NCT01532986|76165387|FG001|NOT COMPLETED|Overall Study||24||
60049788|NCT01532908|76165396|FG000|STARTED|Overall Study||9||
60049789|NCT01532908|76165397|FG001|STARTED|Overall Study||2||
60049790|NCT01532908|76165396|FG000|Infused|Overall Study||9||
60049791|NCT01532908|76165397|FG001|Infused|Overall Study||2||
60049792|NCT01532908|76165396|FG000|Transplanted|Overall Study||8||
60049793|NCT01532908|76165397|FG001|Transplanted|Overall Study||2||
60049794|NCT01532908|76165396|FG000|COMPLETED|Overall Study||8||
60049795|NCT01532908|76165397|FG001|COMPLETED|Overall Study||2||
60049796|NCT01532908|76165396|FG000|NOT COMPLETED|Overall Study||1||
60049797|NCT01532908|76165397|FG001|NOT COMPLETED|Overall Study||0||
60049798|NCT02160782|76165403|FG000|STARTED|Open-label Period: Maralixibat||31||
60049799|NCT02160782|76165404|FG001|STARTED|Open-label Period: Maralixibat||0||
60049800|NCT02160782|76165405|FG002|STARTED|Open-label Period: Maralixibat||0||
60049801|NCT02160782|76165406|FG003|STARTED|Open-label Period: Maralixibat||0||
60049802|NCT02160782|76165407|FG004|STARTED|Open-label Period: Maralixibat||0||
60049803|NCT02160782|76165403|FG000|COMPLETED|Open-label Period: Maralixibat||29||
60049804|NCT02160782|76165404|FG001|COMPLETED|Open-label Period: Maralixibat||0||
60049805|NCT02160782|76165405|FG002|COMPLETED|Open-label Period: Maralixibat||0||
60049806|NCT02160782|76165406|FG003|COMPLETED|Open-label Period: Maralixibat||0||
60049807|NCT02160782|76165407|FG004|COMPLETED|Open-label Period: Maralixibat||0||
60049808|NCT02160782|76165403|FG000|NOT COMPLETED|Open-label Period: Maralixibat||2||
60049809|NCT02160782|76165404|FG001|NOT COMPLETED|Open-label Period: Maralixibat||0||
60049810|NCT02160782|76165405|FG002|NOT COMPLETED|Open-label Period: Maralixibat||0||
60049811|NCT02160782|76165406|FG003|NOT COMPLETED|Open-label Period: Maralixibat||0||
60049812|NCT02160782|76165407|FG004|NOT COMPLETED|Open-label Period: Maralixibat||0||
60049813|NCT02160782|76165403|FG000|STARTED|Randomized Withdrawal Period- Pbo vs MRX||0||
60049814|NCT02160782|76165404|FG001|STARTED|Randomized Withdrawal Period- Pbo vs MRX||13||
60049815|NCT02160782|76165405|FG002|STARTED|Randomized Withdrawal Period- Pbo vs MRX||16||
60049816|NCT02160782|76165406|FG003|STARTED|Randomized Withdrawal Period- Pbo vs MRX||0||
60049817|NCT02160782|76165407|FG004|STARTED|Randomized Withdrawal Period- Pbo vs MRX||0||
60049818|NCT02160782|76165403|FG000|COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||0||
60049819|NCT02160782|76165404|FG001|COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||13||
60049820|NCT02160782|76165405|FG002|COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||16||
60049821|NCT02160782|76165406|FG003|COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||0||
59513428|NCT02819284|75606974|FG000|COMPLETED|Overall Study||447||
59513429|NCT02819284|75606975|FG001|COMPLETED|Overall Study||448||
60049822|NCT02160782|76165407|FG004|COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||0||
60049823|NCT02160782|76165403|FG000|NOT COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||0||
60049824|NCT02160782|76165404|FG001|NOT COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||0||
60049825|NCT02160782|76165405|FG002|NOT COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||0||
60049826|NCT02160782|76165406|FG003|NOT COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||0||
60049827|NCT02160782|76165407|FG004|NOT COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||0||
60049828|NCT02160782|76165403|FG000|STARTED|After Randomized Withdrawal: Maralixibat||0||
60049829|NCT02160782|76165404|FG001|STARTED|After Randomized Withdrawal: Maralixibat||0||
60049830|NCT02160782|76165405|FG002|STARTED|After Randomized Withdrawal: Maralixibat||0||
60049831|NCT02160782|76165406|FG003|STARTED|After Randomized Withdrawal: Maralixibat||29||
60049832|NCT02160782|76165407|FG004|STARTED|After Randomized Withdrawal: Maralixibat||0||
60049833|NCT02160782|76165403|FG000|COMPLETED|After Randomized Withdrawal: Maralixibat||0||
60049834|NCT02160782|76165404|FG001|COMPLETED|After Randomized Withdrawal: Maralixibat||0||
60049835|NCT02160782|76165405|FG002|COMPLETED|After Randomized Withdrawal: Maralixibat||0||
60049836|NCT02160782|76165406|FG003|COMPLETED|After Randomized Withdrawal: Maralixibat||23||
60049837|NCT02160782|76165407|FG004|COMPLETED|After Randomized Withdrawal: Maralixibat||0||
60049838|NCT02160782|76165403|FG000|NOT COMPLETED|After Randomized Withdrawal: Maralixibat||0||
60049839|NCT02160782|76165404|FG001|NOT COMPLETED|After Randomized Withdrawal: Maralixibat||0||
60049840|NCT02160782|76165405|FG002|NOT COMPLETED|After Randomized Withdrawal: Maralixibat||0||
60049841|NCT02160782|76165406|FG003|NOT COMPLETED|After Randomized Withdrawal: Maralixibat||6||
60049842|NCT02160782|76165407|FG004|NOT COMPLETED|After Randomized Withdrawal: Maralixibat||0||
60049843|NCT02160782|76165403|FG000|STARTED|Long-term Extension Period: Maralixibat||0||
60049844|NCT02160782|76165404|FG001|STARTED|Long-term Extension Period: Maralixibat||0||
60049845|NCT02160782|76165405|FG002|STARTED|Long-term Extension Period: Maralixibat||0||
60049846|NCT02160782|76165406|FG003|STARTED|Long-term Extension Period: Maralixibat||0||
60049847|NCT02160782|76165407|FG004|STARTED|Long-term Extension Period: Maralixibat||23||
60049848|NCT02160782|76165403|FG000|COMPLETED|Long-term Extension Period: Maralixibat||0||
60049849|NCT02160782|76165404|FG001|COMPLETED|Long-term Extension Period: Maralixibat||0||
60049850|NCT02160782|76165405|FG002|COMPLETED|Long-term Extension Period: Maralixibat||0||
59513430|NCT02819284|75606974|FG000|NOT COMPLETED|Overall Study||5||
59513431|NCT02819284|75606975|FG001|NOT COMPLETED|Overall Study||5||
59513432|NCT03002506|75606981|FG000|STARTED|Overall Study||6||
59513433|NCT03002506|75606981|FG000|COMPLETED|Overall Study||6||
59513434|NCT03002506|75606981|FG000|NOT COMPLETED|Overall Study||0||
59513435|NCT02822950|75606985|FG000|STARTED|Overall Study||10||
59513436|NCT02822950|75606985|FG000|COMPLETED|Overall Study||10||
59513437|NCT02822950|75606985|FG000|NOT COMPLETED|Overall Study||0||
59513438|NCT02935738|75606993|FG000|STARTED|Overall Study||67||
59513439|NCT02935738|75606994|FG001|STARTED|Overall Study||74||
59513440|NCT02935738|75606995|FG002|STARTED|Overall Study||47||
59513441|NCT02935738|75606996|FG003|STARTED|Overall Study||53||
59513442|NCT02935738|75606993|FG000|COMPLETED|Overall Study||50||
59513443|NCT02935738|75606994|FG001|COMPLETED|Overall Study||53||
59513444|NCT02935738|75606995|FG002|COMPLETED|Overall Study||46||
59513445|NCT02935738|75606996|FG003|COMPLETED|Overall Study||48||
59513446|NCT02935738|75606993|FG000|NOT COMPLETED|Overall Study||17||
59513447|NCT02935738|75606994|FG001|NOT COMPLETED|Overall Study||21||
59513448|NCT02935738|75606995|FG002|NOT COMPLETED|Overall Study||1||
59513449|NCT02935738|75606996|FG003|NOT COMPLETED|Overall Study||5||
59513450|NCT00932659|75607006|FG000|STARTED|Overall Study||8||
59513451|NCT00932659|75607006|FG000|COMPLETED|Overall Study||8||
59921398|NCT03287635|76040879|FG000|STARTED|Overall Study||19||
59513452|NCT00932659|75607006|FG000|NOT COMPLETED|Overall Study||0||
59513453|NCT00939991|75607012|FG000|STARTED|Overall Study||9||
59513454|NCT00939991|75607013|FG001|STARTED|Overall Study||39||
59513455|NCT00939991|75607012|FG000|COMPLETED|Overall Study||9||
59921399|NCT03287635|76040879|FG000|COMPLETED|Overall Study||12||
59921400|NCT03287635|76040879|FG000|NOT COMPLETED|Overall Study||7||
59921401|NCT03287089|76040885|FG000|STARTED|Overall Study||82||
59921402|NCT03287089|76040886|FG001|STARTED|Overall Study||82||
59921403|NCT03287089|76040885|FG000|COMPLETED|Overall Study||82||
59921404|NCT03287089|76040886|FG001|COMPLETED|Overall Study||76||
59921405|NCT03287089|76040885|FG000|NOT COMPLETED|Overall Study||0||
59921406|NCT03287089|76040886|FG001|NOT COMPLETED|Overall Study||6||
59921407|NCT03286543|76040894|FG000|STARTED|Consented||47||
60049851|NCT02160782|76165406|FG003|COMPLETED|Long-term Extension Period: Maralixibat||0||
60049852|NCT02160782|76165407|FG004|COMPLETED|Long-term Extension Period: Maralixibat||14||
60049853|NCT02160782|76165403|FG000|NOT COMPLETED|Long-term Extension Period: Maralixibat||0||
60049854|NCT02160782|76165404|FG001|NOT COMPLETED|Long-term Extension Period: Maralixibat||0||
60049855|NCT02160782|76165405|FG002|NOT COMPLETED|Long-term Extension Period: Maralixibat||0||
59513456|NCT00939991|75607013|FG001|COMPLETED|Overall Study||39||
59513457|NCT00939991|75607012|FG000|NOT COMPLETED|Overall Study||0||
59513458|NCT00939991|75607013|FG001|NOT COMPLETED|Overall Study||0||
59513459|NCT00940537|75607021|FG000|STARTED|Overall Study||5||
59513460|NCT00940537|75607022|FG001|STARTED|Overall Study||9||
59513461|NCT00940537|75607021|FG000|COMPLETED|Overall Study||5||
59513462|NCT00940537|75607022|FG001|COMPLETED|Overall Study||9||
59921408|NCT03286543|76040895|FG001|STARTED|Consented||0||
60049856|NCT02160782|76165406|FG003|NOT COMPLETED|Long-term Extension Period: Maralixibat||0||
60049857|NCT02160782|76165407|FG004|NOT COMPLETED|Long-term Extension Period: Maralixibat||9||
59760322|NCT03861078|75879944|FG000|COMPLETED|Overall Study||14||
59760323|NCT03861078|75879944|FG000|NOT COMPLETED|Overall Study||8||
59760324|NCT04950465|75879955|FG000|STARTED|Overall Study||66||
59760325|NCT04950465|75879956|FG001|STARTED|Overall Study||67||
59760326|NCT04950465|75879957|FG002|STARTED|Overall Study||64||
59760327|NCT04950465|75879955|FG000|COMPLETED|Overall Study||65||
59760328|NCT04950465|75879956|FG001|COMPLETED|Overall Study||67||
59760329|NCT04950465|75879957|FG002|COMPLETED|Overall Study||64||
59760330|NCT04950465|75879955|FG000|NOT COMPLETED|Overall Study||1||
59760331|NCT04950465|75879956|FG001|NOT COMPLETED|Overall Study||0||
59760332|NCT04950465|75879957|FG002|NOT COMPLETED|Overall Study||0||
59760333|NCT04857320|75879965|FG000|STARTED|Overall Study||7||
59760334|NCT04857320|75879965|FG000|COMPLETED|Overall Study||5||
59760335|NCT04857320|75879965|FG000|NOT COMPLETED|Overall Study||2||
59760336|NCT04495816|75879979|FG000|STARTED|Overall Study||70||
59760337|NCT04495816|75879980|FG001|STARTED|Overall Study||69||
59760338|NCT04495816|75879979|FG000|COMPLETED|Overall Study||57||
59760339|NCT04495816|75879980|FG001|COMPLETED|Overall Study||60||
59760340|NCT04495816|75879979|FG000|NOT COMPLETED|Overall Study||13||
59760341|NCT04495816|75879980|FG001|NOT COMPLETED|Overall Study||9||
59760342|NCT04324359|75879988|FG000|STARTED|Overall Study||40||
59760343|NCT04324359|75879989|FG001|STARTED|Overall Study||43||
59760344|NCT04324359|75879988|FG000|COMPLETED|Overall Study||39||
59760345|NCT04324359|75879989|FG001|COMPLETED|Overall Study||41||
59760346|NCT04324359|75879988|FG000|NOT COMPLETED|Overall Study||1||
59760347|NCT04324359|75879989|FG001|NOT COMPLETED|Overall Study||2||
59760348|NCT04267562|75879995|FG000|STARTED|Assessed for Eligibility||219||
59760349|NCT04267562|75879995|FG000|COMPLETED|Assessed for Eligibility||114||
59921409|NCT03286543|76040896|FG002|STARTED|Consented||0||
60049858|NCT02160626|76165434|FG000|STARTED|Overall Study||58||
60049859|NCT02160626|76165435|FG001|STARTED|Overall Study||57||
59760350|NCT04267562|75879995|FG000|NOT COMPLETED|Assessed for Eligibility||105||
59760351|NCT04267562|75879995|FG000|STARTED|Treated-Enrolled||114||
59760352|NCT04267562|75879995|FG000|COMPLETED|Treated-Enrolled||114||
59760353|NCT04267562|75879995|FG000|NOT COMPLETED|Treated-Enrolled||0||
59760354|NCT04267562|75879995|FG000|STARTED|24-Hour Contact||114||
59760355|NCT04267562|75879995|FG000|COMPLETED|24-Hour Contact||114||
59760356|NCT04267562|75879995|FG000|NOT COMPLETED|24-Hour Contact||0||
59760357|NCT04267562|75879995|FG000|STARTED|Week 2||114||
59760358|NCT04267562|75879995|FG000|COMPLETED|Week 2||114||
59760359|NCT04267562|75879995|FG000|NOT COMPLETED|Week 2||0||
59760360|NCT04267562|75879995|FG000|STARTED|Month 3||114||
59760361|NCT04267562|75879995|FG000|COMPLETED|Month 3||114||
59760362|NCT04267562|75879995|FG000|NOT COMPLETED|Month 3||0||
59760363|NCT04267562|75879995|FG000|STARTED|Month 6||114||
59760364|NCT04267562|75879995|FG000|COMPLETED|Month 6||114||
59760365|NCT04267562|75879995|FG000|NOT COMPLETED|Month 6||0||
59760366|NCT04267562|75879995|FG000|STARTED|Month 12||114||
59760367|NCT04267562|75879995|FG000|COMPLETED|Month 12||114||
59760368|NCT04267562|75879995|FG000|NOT COMPLETED|Month 12||0||
59760369|NCT04246489|75879999|FG000|STARTED|Overall Study||146||
59760370|NCT04246489|75879999|FG000|COMPLETED|Overall Study||146||
59921410|NCT03286543|76040894|FG000|Randomized|Consented||45|All subjects who were consented, met eligibility criteria, and were randomized.|
59921411|NCT03286543|76040895|FG001|Randomized|Consented||0|All subjects who were consented, met eligibility criteria, and were randomized.|
59921412|NCT03286543|76040896|FG002|Randomized|Consented||0|All subjects who were consented, met eligibility criteria, and were randomized.|
59921413|NCT03286543|76040894|FG000|Enrolled|Consented||41|Treatment Group subjects who were consented, randomized, and underwent Lead placement, AND Control Group subjects who were consented and randomized.|
60049860|NCT02160626|76165436|FG002|STARTED|Overall Study||57||
60049861|NCT02160626|76165434|FG000|COMPLETED|Overall Study||57||
59760371|NCT04246489|75879999|FG000|NOT COMPLETED|Overall Study||0||
60049862|NCT02160626|76165435|FG001|COMPLETED|Overall Study||56||
60049863|NCT02160626|76165436|FG002|COMPLETED|Overall Study||56||
60049864|NCT02160626|76165434|FG000|NOT COMPLETED|Overall Study||1||
60049865|NCT02160626|76165435|FG001|NOT COMPLETED|Overall Study||1||
59760372|NCT03891901|75880006|FG000|STARTED|Overall Study||16||
59760373|NCT03891901|75880007|FG001|STARTED|Overall Study||6||
59760374|NCT03891901|75880008|FG002|STARTED|Overall Study||0||
59760375|NCT03891901|75880009|FG003|STARTED|Overall Study||0||
59760376|NCT03891901|75880010|FG004|STARTED|Overall Study||0||
59760377|NCT03891901|75880011|FG005|STARTED|Overall Study||0||
59760378|NCT03891901|75880012|FG006|STARTED|Overall Study||2||
59760379|NCT03891901|75880013|FG007|STARTED|Overall Study||0||
59760380|NCT03891901|75880014|FG008|STARTED|Overall Study||0||
60049866|NCT02160626|76165436|FG002|NOT COMPLETED|Overall Study||1||
60049867|NCT02160314|76165448|FG000|STARTED|Overall Study||73||
60049868|NCT02160314|76165449|FG001|STARTED|Overall Study||72||
60049869|NCT02160314|76165448|FG000|COMPLETED|Overall Study||72||
60049870|NCT02160314|76165449|FG001|COMPLETED|Overall Study||59||
60049871|NCT02160314|76165448|FG000|NOT COMPLETED|Overall Study||1||
60049872|NCT02160314|76165449|FG001|NOT COMPLETED|Overall Study||13||
60049873|NCT02160002|76165457|FG000|STARTED|Overall Study||187||
60049874|NCT02160002|76165458|FG001|STARTED|Overall Study||179||
60049875|NCT02160002|76165457|FG000|Primary Outcome|Overall Study||185||
59513463|NCT00940537|75607021|FG000|NOT COMPLETED|Overall Study||0||
59513464|NCT00940537|75607022|FG001|NOT COMPLETED|Overall Study||0||
59513465|NCT00947167|75607029|FG000|STARTED|Pertuzumab Alone||4||
59513466|NCT00947167|75607029|FG000|COMPLETED|Pertuzumab Alone||4||
59513467|NCT00947167|75607029|FG000|NOT COMPLETED|Pertuzumab Alone||0||
59513468|NCT00947167|75607029|FG000|STARTED|Erlotinib Added to Pertuzumab||3||
59513469|NCT00947167|75607029|FG000|COMPLETED|Erlotinib Added to Pertuzumab||3||
59513470|NCT00947167|75607029|FG000|NOT COMPLETED|Erlotinib Added to Pertuzumab||0||
59513471|NCT00940771|75607033|FG000|STARTED|Pre-Entry||10||
59513472|NCT00940771|75607033|FG000|COMPLETED|Pre-Entry||10||
59513473|NCT00940771|75607033|FG000|NOT COMPLETED|Pre-Entry||0||
59513474|NCT00940771|75607033|FG000|STARTED|4 Weeks||10||
59513475|NCT00940771|75607033|FG000|COMPLETED|4 Weeks||10||
60049876|NCT02160002|76165458|FG001|Primary Outcome|Overall Study||178||
60049877|NCT02160002|76165457|FG000|COMPLETED|Overall Study||185||
60049878|NCT02160002|76165458|FG001|COMPLETED|Overall Study||178||
60049879|NCT02160002|76165457|FG000|NOT COMPLETED|Overall Study||2||
60049880|NCT02160002|76165458|FG001|NOT COMPLETED|Overall Study||1||
59513476|NCT00940771|75607033|FG000|NOT COMPLETED|4 Weeks||0||
59513477|NCT00940771|75607033|FG000|STARTED|12 Weeks||10||
59513478|NCT00940771|75607033|FG000|COMPLETED|12 Weeks||10||
59513479|NCT00940771|75607033|FG000|NOT COMPLETED|12 Weeks||0||
59513480|NCT00940771|75607033|FG000|STARTED|24 Weeks||10||
60049881|NCT02218268|76165464|FG000|STARTED|First Phase (2 Hours)||30||
60049882|NCT02218268|76165465|FG001|STARTED|First Phase (2 Hours)||30||
60049883|NCT02218268|76165464|FG000|COMPLETED|First Phase (2 Hours)||30||
60049884|NCT02218268|76165465|FG001|COMPLETED|First Phase (2 Hours)||30||
60067851|NCT01785615|76183052|FG000|COMPLETED|Dietary Phase||0||
60049885|NCT02218268|76165464|FG000|NOT COMPLETED|First Phase (2 Hours)||0||
60049886|NCT02218268|76165465|FG001|NOT COMPLETED|First Phase (2 Hours)||0||
60049887|NCT02218268|76165464|FG000|STARTED|24 Hour Washout||30||
60049888|NCT02218268|76165465|FG001|STARTED|24 Hour Washout||30||
60049889|NCT02218268|76165464|FG000|COMPLETED|24 Hour Washout||19||
60049890|NCT02218268|76165465|FG001|COMPLETED|24 Hour Washout||21||
60049891|NCT02218268|76165464|FG000|NOT COMPLETED|24 Hour Washout||11||
60049892|NCT02218268|76165465|FG001|NOT COMPLETED|24 Hour Washout||9||
60049893|NCT02218268|76165464|FG000|STARTED|Final Phase (2 Hours)||19||
60049894|NCT02218268|76165465|FG001|STARTED|Final Phase (2 Hours)||21||
60049895|NCT02218268|76165464|FG000|COMPLETED|Final Phase (2 Hours)||19||
60049896|NCT02218268|76165465|FG001|COMPLETED|Final Phase (2 Hours)||21||
60049897|NCT02218268|76165464|FG000|NOT COMPLETED|Final Phase (2 Hours)||0||
60049898|NCT02218268|76165465|FG001|NOT COMPLETED|Final Phase (2 Hours)||0||
60049899|NCT02217878|76165473|FG000|STARTED|Overall Study||37||
60049900|NCT02217878|76165474|FG001|STARTED|Overall Study||37||
60049901|NCT02217878|76165473|FG000|COMPLETED|Overall Study||35||
60049902|NCT02217878|76165474|FG001|COMPLETED|Overall Study||35||
60049903|NCT02217878|76165473|FG000|NOT COMPLETED|Overall Study||2||
60049904|NCT02217878|76165474|FG001|NOT COMPLETED|Overall Study||2||
60049905|NCT02217566|76165480|FG000|STARTED|Overall Study||46||
60049906|NCT02217566|76165480|FG000|COMPLETED|Overall Study||35||
60049907|NCT02217566|76165480|FG000|NOT COMPLETED|Overall Study||11||
60049908|NCT02217410|76165487|FG000|STARTED|Overall Study||7||
60049909|NCT02217410|76165488|FG001|STARTED|Overall Study||34||
60049910|NCT02217410|76165489|FG002|STARTED|Overall Study||18||
60049911|NCT02217410|76165487|FG000|COMPLETED|Overall Study||6||
60049912|NCT02217410|76165488|FG001|COMPLETED|Overall Study||30||
60049913|NCT02217410|76165489|FG002|COMPLETED|Overall Study||13||
60049914|NCT02217410|76165487|FG000|NOT COMPLETED|Overall Study||1||
60049915|NCT02217410|76165488|FG001|NOT COMPLETED|Overall Study||4||
60049916|NCT02217410|76165489|FG002|NOT COMPLETED|Overall Study||5||
60049917|NCT02217332|76165502|FG000|STARTED|Overall Study|Safety Population|20||
60049918|NCT02217332|76165502|FG000|COMPLETED|Overall Study|Subjects who continued to optional open-label treatment|13||
60049919|NCT02217332|76165502|FG000|NOT COMPLETED|Overall Study||7||
60049920|NCT02184572|76165508|FG000|STARTED|Overall Study||1164||
60049921|NCT02184572|76165509|FG001|STARTED|Overall Study||572||
60049922|NCT02184572|76165508|FG000|COMPLETED|Overall Study||1117||
60049923|NCT02184572|76165509|FG001|COMPLETED|Overall Study||542||
60049924|NCT02184572|76165508|FG000|NOT COMPLETED|Overall Study||47||
60049925|NCT02184572|76165509|FG001|NOT COMPLETED|Overall Study||30||
60049926|NCT02181842|76165517|FG000|STARTED|Overall Study||246||
60049927|NCT02181842|76165517|FG000|COMPLETED|Overall Study||244||
60049928|NCT02181842|76165517|FG000|NOT COMPLETED|Overall Study||2||
60049929|NCT01632020|76165523|FG000|STARTED|Overall Study||4||
60049930|NCT01632020|76165524|FG001|STARTED|Overall Study||3||
60049931|NCT01632020|76165523|FG000|COMPLETED|Overall Study||2||
60049932|NCT01632020|76165524|FG001|COMPLETED|Overall Study||3||
60049933|NCT01632020|76165523|FG000|NOT COMPLETED|Overall Study||2||
60049934|NCT01632020|76165524|FG001|NOT COMPLETED|Overall Study||0||
60049935|NCT02181296|76165532|FG000|STARTED|Overall Study||25||
59921414|NCT03286543|76040895|FG001|Enrolled|Consented||0|Treatment Group subjects who were consented, randomized, and underwent Lead placement, AND Control Group subjects who were consented and randomized.|
59921415|NCT03286543|76040896|FG002|Enrolled|Consented||0|Treatment Group subjects who were consented, randomized, and underwent Lead placement, AND Control Group subjects who were consented and randomized.|
59921416|NCT03286543|76040894|FG000|Intent to Treat Set|Consented||37|Subjects that were consented, randomized, enrolled, and progressed in study to designated randomization assignment therapy.|
59921417|NCT03286543|76040895|FG001|Intent to Treat Set|Consented||0|Subjects that were consented, randomized, enrolled, and progressed in study to designated randomization assignment therapy.|
59921418|NCT03286543|76040896|FG002|Intent to Treat Set|Consented||0|Subjects that were consented, randomized, enrolled, and progressed in study to designated randomization assignment therapy.|
59921419|NCT03286543|76040894|FG000|Per Protocol Set|Consented||23|Subjects that were consented, randomized, enrolled, have adequate diary completion, and continued study eligibility. Additionally, Treatment Group subjects must have received a Lead and experienced stimulation-evoked comfortable sensations or a reduction in pain with stimulation in the target area during Visit 2 (original or unscheduled) or Visit 4.|
59921420|NCT03286543|76040895|FG001|Per Protocol Set|Consented||0|Subjects that were consented, randomized, enrolled, have adequate diary completion, and continued study eligibility. Additionally, Treatment Group subjects must have received a Lead and experienced stimulation-evoked comfortable sensations or a reduction in pain with stimulation in the target area during Visit 2 (original or unscheduled) or Visit 4.|
59951434|NCT01190644|76070429|FG000|COMPLETED|Overall Study||2||
60049936|NCT02181296|76165533|FG001|STARTED|Overall Study||25||
60049937|NCT02181296|76165532|FG000|COMPLETED|Overall Study||18||
60049938|NCT02181296|76165533|FG001|COMPLETED|Overall Study||19||
60049939|NCT02181296|76165532|FG000|NOT COMPLETED|Overall Study||7||
60049940|NCT02181296|76165533|FG001|NOT COMPLETED|Overall Study||6||
60049941|NCT02215616|76165543|FG000|STARTED|Overall Study||108||
60049942|NCT02215616|76165544|FG001|STARTED|Overall Study||107||
60049943|NCT02215616|76165545|FG002|STARTED|Overall Study||107||
60049944|NCT02215616|76165546|FG003|STARTED|Overall Study||30||
60049945|NCT02215616|76165543|FG000|Received at Least 1 Dose of Study Drug|Overall Study||108||
60049946|NCT02215616|76165544|FG001|Received at Least 1 Dose of Study Drug|Overall Study||107||
60049947|NCT02215616|76165545|FG002|Received at Least 1 Dose of Study Drug|Overall Study||106||
60049948|NCT02215616|76165546|FG003|Received at Least 1 Dose of Study Drug|Overall Study||29||
60049949|NCT02215616|76165543|FG000|COMPLETED|Overall Study||97||
60049950|NCT02215616|76165544|FG001|COMPLETED|Overall Study||90||
60049951|NCT02215616|76165545|FG002|COMPLETED|Overall Study||93||
60049952|NCT02215616|76165546|FG003|COMPLETED|Overall Study||17||
60049953|NCT02215616|76165543|FG000|NOT COMPLETED|Overall Study||11||
60049954|NCT02215616|76165544|FG001|NOT COMPLETED|Overall Study||17||
60049955|NCT02215616|76165545|FG002|NOT COMPLETED|Overall Study||14||
60049956|NCT02215616|76165546|FG003|NOT COMPLETED|Overall Study||13||
60049957|NCT02213666|76165556|FG000|STARTED|Overall Study||72||
60049958|NCT02213666|76165556|FG000|COMPLETED|Overall Study||71||
60049959|NCT02213666|76165556|FG000|NOT COMPLETED|Overall Study||1||
60049960|NCT02213510|76165562|FG000|STARTED|Overall Study||21||
60049961|NCT02213510|76165563|FG001|STARTED|Overall Study||19||
60049962|NCT02213510|76165562|FG000|COMPLETED|Overall Study||20||
60049963|NCT02213510|76165563|FG001|COMPLETED|Overall Study||18||
60049964|NCT02213510|76165562|FG000|NOT COMPLETED|Overall Study||1||
60049965|NCT02213510|76165563|FG001|NOT COMPLETED|Overall Study||1||
60049966|NCT02158442|76165571|FG000|STARTED|Overall Study||8||
60049967|NCT02158442|76165572|FG001|STARTED|Overall Study||7||
60049968|NCT02158442|76165571|FG000|COMPLETED|Overall Study||6||
60049969|NCT02158442|76165572|FG001|COMPLETED|Overall Study||7||
60049970|NCT02158442|76165571|FG000|NOT COMPLETED|Overall Study||2||
60049971|NCT02158442|76165572|FG001|NOT COMPLETED|Overall Study||0||
60049972|NCT02158364|76165578|FG000|STARTED|Overall Study||3331||
60049973|NCT02158364|76165578|FG000|COMPLETED|Overall Study||3271||
60049974|NCT02158364|76165578|FG000|NOT COMPLETED|Overall Study||60||
60049975|NCT02180672|76165584|FG000|STARTED|Overall Study||91||
60049976|NCT02180672|76165585|FG001|STARTED|Overall Study||43||
60049977|NCT02180672|76165584|FG000|COMPLETED|Overall Study||86||
60049978|NCT02180672|76165585|FG001|COMPLETED|Overall Study||36||
60049979|NCT02180672|76165584|FG000|NOT COMPLETED|Overall Study||5||
60049980|NCT02180672|76165585|FG001|NOT COMPLETED|Overall Study||7||
60049981|NCT02213198|76165593|FG000|STARTED|Baseline||306||
60049982|NCT02213198|76165594|FG001|STARTED|Baseline||159||
60049983|NCT02213198|76165593|FG000|COMPLETED|Baseline||218||
60049984|NCT02213198|76165594|FG001|COMPLETED|Baseline||108||
60049985|NCT02213198|76165593|FG000|NOT COMPLETED|Baseline||88||
60049986|NCT02213198|76165594|FG001|NOT COMPLETED|Baseline||51||
60049987|NCT02213198|76165593|FG000|STARTED|Follow up 1 3 Mos Post BL End of TCC tx||218||
60049988|NCT02213198|76165594|FG001|STARTED|Follow up 1 3 Mos Post BL End of TCC tx||108||
60049989|NCT02213198|76165593|FG000|COMPLETED|Follow up 1 3 Mos Post BL End of TCC tx||125||
60049990|NCT02213198|76165594|FG001|COMPLETED|Follow up 1 3 Mos Post BL End of TCC tx||67||
60049991|NCT02213198|76165593|FG000|NOT COMPLETED|Follow up 1 3 Mos Post BL End of TCC tx||93||
60049992|NCT02213198|76165594|FG001|NOT COMPLETED|Follow up 1 3 Mos Post BL End of TCC tx||41||
60049993|NCT02213198|76165593|FG000|STARTED|Follow up 2 6 Months Post TCC Treatment||125||
60049994|NCT02213198|76165594|FG001|STARTED|Follow up 2 6 Months Post TCC Treatment||67||
60049995|NCT02213198|76165593|FG000|COMPLETED|Follow up 2 6 Months Post TCC Treatment||102||
60049996|NCT02213198|76165594|FG001|COMPLETED|Follow up 2 6 Months Post TCC Treatment||60||
60049997|NCT02213198|76165593|FG000|NOT COMPLETED|Follow up 2 6 Months Post TCC Treatment||23||
60049998|NCT02213198|76165594|FG001|NOT COMPLETED|Follow up 2 6 Months Post TCC Treatment||7||
59513481|NCT00940771|75607033|FG000|COMPLETED|24 Weeks||10||
59513482|NCT00940771|75607033|FG000|NOT COMPLETED|24 Weeks||0||
60049999|NCT02157506|76165605|FG000|STARTED|Overall Study||12||
60050000|NCT02157506|76165606|FG001|STARTED|Overall Study||6||
60050001|NCT02157506|76165607|FG002|STARTED|Overall Study||9||
60050002|NCT02157506|76165608|FG003|STARTED|Overall Study||12||
60050003|NCT02157506|76165609|FG004|STARTED|Overall Study||7||
60050004|NCT02157506|76165605|FG000|COMPLETED|Overall Study||12||
60050005|NCT02157506|76165606|FG001|COMPLETED|Overall Study||5||
59513483|NCT00934141|75607041|FG000|STARTED|Overall Study||49||
60050006|NCT02157506|76165607|FG002|COMPLETED|Overall Study||8||
60050007|NCT02157506|76165608|FG003|COMPLETED|Overall Study||12||
60050008|NCT02157506|76165609|FG004|COMPLETED|Overall Study||7||
60050009|NCT02157506|76165605|FG000|NOT COMPLETED|Overall Study||0||
60050010|NCT02157506|76165606|FG001|NOT COMPLETED|Overall Study||1||
60050011|NCT02157506|76165607|FG002|NOT COMPLETED|Overall Study||1||
60050012|NCT02157506|76165608|FG003|NOT COMPLETED|Overall Study||0||
60050013|NCT02157506|76165609|FG004|NOT COMPLETED|Overall Study||0||
60050014|NCT01920711|76165623|FG000|STARTED|Overall Study||2419||
59513484|NCT00934141|75607042|FG001|STARTED|Overall Study||50||
59513485|NCT00934141|75607043|FG002|STARTED|Overall Study||48||
59513486|NCT00934141|75607044|FG003|STARTED|Overall Study||54||
59513487|NCT00934141|75607041|FG000|COMPLETED|Overall Study||45||
59513488|NCT00934141|75607042|FG001|COMPLETED|Overall Study||47||
59513489|NCT00934141|75607043|FG002|COMPLETED|Overall Study||48||
59513490|NCT00934141|75607044|FG003|COMPLETED|Overall Study||51||
59513491|NCT00934141|75607041|FG000|NOT COMPLETED|Overall Study||4||
59513492|NCT00934141|75607042|FG001|NOT COMPLETED|Overall Study||3||
59513493|NCT00934141|75607043|FG002|NOT COMPLETED|Overall Study||0||
59513494|NCT00934141|75607044|FG003|NOT COMPLETED|Overall Study||3||
59513495|NCT00940927|75607056|FG000|STARTED|Overall Study||81||
59513496|NCT00940927|75607056|FG000|COMPLETED|Overall Study||81||
59513497|NCT00940927|75607056|FG000|NOT COMPLETED|Overall Study||0||
59513498|NCT00941005|75607062|FG000|STARTED|Overall Study||61||
60050015|NCT01920711|76165624|FG001|STARTED|Overall Study||2403||
60050016|NCT01920711|76165623|FG000|COMPLETED|Overall Study||2055||
60050017|NCT01920711|76165624|FG001|COMPLETED|Overall Study||2030||
59513499|NCT00941005|75607063|FG001|STARTED|Overall Study||61||
59513500|NCT00941005|75607062|FG000|COMPLETED|Overall Study||61||
59513501|NCT00941005|75607063|FG001|COMPLETED|Overall Study||61||
59513502|NCT00941005|75607062|FG000|NOT COMPLETED|Overall Study||0||
59513503|NCT00941005|75607063|FG001|NOT COMPLETED|Overall Study||0||
59513504|NCT00934375|75607073|FG000|STARTED|Overall Study||68||
59513505|NCT00934375|75607074|FG001|STARTED|Overall Study||77||
59513506|NCT00934375|75607073|FG000|COMPLETED|Overall Study||55||
59513507|NCT00934375|75607074|FG001|COMPLETED|Overall Study||55||
59513508|NCT00934375|75607073|FG000|NOT COMPLETED|Overall Study||13||
59513509|NCT00934375|75607074|FG001|NOT COMPLETED|Overall Study||22||
59513510|NCT03002974|75607083|FG000|STARTED|Overall Study||55||
59513511|NCT03002974|75607084|FG001|STARTED|Overall Study||56||
59513512|NCT03002974|75607085|FG002|STARTED|Overall Study||54||
59513513|NCT03002974|75607083|FG000|Intention To Treat Populatio|Overall Study||55||
59612774|NCT01697592|75723834|FG003|STARTED|Phase A (Up to 24 Weeks)||65||
59612775|NCT01697592|75723835|FG004|STARTED|Phase A (Up to 24 Weeks)||67||
59612776|NCT01697592|75723836|FG005|STARTED|Phase A (Up to 24 Weeks)||63||
60050018|NCT01920711|76165623|FG000|NOT COMPLETED|Overall Study||364||
60050019|NCT01920711|76165624|FG001|NOT COMPLETED|Overall Study||373||
60050020|NCT02180438|76165631|FG000|STARTED|Overall Study||30||
60050021|NCT02180438|76165631|FG000|COMPLETED|Overall Study||29||
60050022|NCT02180438|76165631|FG000|NOT COMPLETED|Overall Study||1||
60050023|NCT02179190|76165635|FG000|STARTED|Enrollment||138|Participants Consented and Assessed for Eligibility|
60050024|NCT02179190|76165635|FG000|COMPLETED|Enrollment||127|Attempted with the Study Device - Intent to Treat Population|
60050025|NCT02179190|76165635|FG000|NOT COMPLETED|Enrollment||11||
60050026|NCT02179190|76165635|FG000|STARTED|Index Procedure With Barrel VRD Attempt||127|Participants with an attempted Barrel VRD Implant|
60050027|NCT02179190|76165635|FG000|COMPLETED|Index Procedure With Barrel VRD Attempt||120|Participants with a Successful Barrel Implant|
60050028|NCT02179190|76165635|FG000|NOT COMPLETED|Index Procedure With Barrel VRD Attempt||7||
60050029|NCT02179190|76165635|FG000|STARTED|Follow-Up Post Barrel VRD Implanted||120|Participants Implanted with the Barrel VRD Expected to Complete the 12 Month Visit|
60050030|NCT02179190|76165635|FG000|COMPLETED|Follow-Up Post Barrel VRD Implanted||111|Participants Implanted with the Barrel VRD that Completed the 12 Month Visit|
60050031|NCT02179190|76165635|FG000|NOT COMPLETED|Follow-Up Post Barrel VRD Implanted||9||
60050032|NCT02157116|76165639|FG000|STARTED|Overall Study|signed consent form|13||
60050033|NCT02157116|76165639|FG000|COMPLETED|Overall Study||4||
60050034|NCT02157116|76165639|FG000|NOT COMPLETED|Overall Study||9||
60050035|NCT01920555|76165648|FG000|STARTED|Overall Study||18||
60050036|NCT01920555|76165649|FG001|STARTED|Overall Study||20||
60050037|NCT01920555|76165650|FG002|STARTED|Overall Study||22||
60050038|NCT01920555|76165651|FG003|STARTED|Overall Study||20||
60050039|NCT01920555|76165652|FG004|STARTED|Overall Study||19||
60050040|NCT01920555|76165648|FG000|COMPLETED|Overall Study||14||
60050041|NCT01920555|76165649|FG001|COMPLETED|Overall Study||16||
60050042|NCT01920555|76165650|FG002|COMPLETED|Overall Study||21||
60050043|NCT01920555|76165651|FG003|COMPLETED|Overall Study||17||
60050044|NCT01920555|76165652|FG004|COMPLETED|Overall Study||18||
60050045|NCT01920555|76165648|FG000|NOT COMPLETED|Overall Study||4||
60050046|NCT01920555|76165649|FG001|NOT COMPLETED|Overall Study||4||
60050047|NCT01920555|76165650|FG002|NOT COMPLETED|Overall Study||1||
59513514|NCT03002974|75607084|FG001|Intention To Treat Populatio|Overall Study||56||
59513515|NCT03002974|75607085|FG002|Intention To Treat Populatio|Overall Study||54||
59513516|NCT03002974|75607083|FG000|Safety Population|Overall Study||54||
59513517|NCT03002974|75607084|FG001|Safety Population|Overall Study||55||
59513518|NCT03002974|75607085|FG002|Safety Population|Overall Study||52||
59513519|NCT03002974|75607083|FG000|COMPLETED|Overall Study||35||
59513520|NCT03002974|75607084|FG001|COMPLETED|Overall Study||40||
59513521|NCT03002974|75607085|FG002|COMPLETED|Overall Study||36||
59513522|NCT03002974|75607083|FG000|NOT COMPLETED|Overall Study||20||
59513523|NCT03002974|75607084|FG001|NOT COMPLETED|Overall Study||16||
59513524|NCT03002974|75607085|FG002|NOT COMPLETED|Overall Study||18||
59513525|NCT02825212|75607093|FG000|STARTED|Overall Study||10||
59513526|NCT02825212|75607093|FG000|COMPLETED|Overall Study||10||
59513527|NCT02825212|75607093|FG000|NOT COMPLETED|Overall Study||0||
59513528|NCT02825680|75607099|FG000|STARTED|Overall Study||82||
59513529|NCT02825680|75607100|FG001|STARTED|Overall Study||55||
59513530|NCT02825680|75607099|FG000|COMPLETED|Overall Study||82||
59513531|NCT02825680|75607100|FG001|COMPLETED|Overall Study||39||
59513532|NCT02825680|75607099|FG000|NOT COMPLETED|Overall Study||0||
59513533|NCT02825680|75607100|FG001|NOT COMPLETED|Overall Study||16||
59513534|NCT03004534|75607106|FG000|STARTED|Overall Study||36||
59513535|NCT03004534|75607106|FG000|COMPLETED|Overall Study||36||
59513536|NCT03004534|75607106|FG000|NOT COMPLETED|Overall Study||0||
59513537|NCT02826694|75607112|FG000|STARTED|Overall Study||61||
59513538|NCT02826694|75607113|FG001|STARTED|Overall Study||45||
59513539|NCT02826694|75607112|FG000|Decision Group|Overall Study||41||
59513540|NCT02826694|75607113|FG001|Decision Group|Overall Study||30||
59513541|NCT02826694|75607112|FG000|Control Group|Overall Study||20||
59513542|NCT02826694|75607113|FG001|Control Group|Overall Study||15||
59513543|NCT02826694|75607112|FG000|COMPLETED|Overall Study||61||
59513544|NCT02826694|75607113|FG001|COMPLETED|Overall Study||45||
59513545|NCT02826694|75607112|FG000|NOT COMPLETED|Overall Study||0||
59513546|NCT02826694|75607113|FG001|NOT COMPLETED|Overall Study||0||
59513547|NCT02939170|75607123|FG000|STARTED|Overall Study||40||
59513548|NCT02939170|75607124|FG001|STARTED|Overall Study||40||
59513549|NCT02939170|75607123|FG000|COMPLETED|Overall Study||40||
59513550|NCT02939170|75607124|FG001|COMPLETED|Overall Study||40||
59513551|NCT02939170|75607123|FG000|NOT COMPLETED|Overall Study||0||
59513552|NCT02939170|75607124|FG001|NOT COMPLETED|Overall Study||0||
59513553|NCT03004846|75607134|FG000|STARTED|Part A (Up to 14 Weeks)||8||
59921421|NCT03286543|76040896|FG002|Per Protocol Set|Consented||0|Subjects that were consented, randomized, enrolled, have adequate diary completion, and continued study eligibility. Additionally, Treatment Group subjects must have received a Lead and experienced stimulation-evoked comfortable sensations or a reduction in pain with stimulation in the target area during Visit 2 (original or unscheduled) or Visit 4.|
59921422|NCT03286543|76040894|FG000|COMPLETED|Consented||28||
59921423|NCT03286543|76040895|FG001|COMPLETED|Consented||0||
59921424|NCT03286543|76040896|FG002|COMPLETED|Consented||0||
59921425|NCT03286543|76040894|FG000|NOT COMPLETED|Consented||19||
59921426|NCT03286543|76040895|FG001|NOT COMPLETED|Consented||0||
59921427|NCT03286543|76040896|FG002|NOT COMPLETED|Consented||0||
59921428|NCT03286543|76040894|FG000|STARTED|Study Enrollment||0||
59921429|NCT03286543|76040895|FG001|STARTED|Study Enrollment||18||
59921430|NCT03286543|76040896|FG002|STARTED|Study Enrollment||23||
59921431|NCT03286543|76040894|FG000|Intent to Treat Set|Study Enrollment||0|Subjects that were consented, randomized, and enrolled.|
59921432|NCT03286543|76040895|FG001|Intent to Treat Set|Study Enrollment||18|Subjects that were consented, randomized, and enrolled.|
59921433|NCT03286543|76040896|FG002|Intent to Treat Set|Study Enrollment||19|Subjects that were consented, randomized, and enrolled.|
59921434|NCT03286543|76040894|FG000|Per Protocol Set|Study Enrollment||0|Subjects that were consented, randomized, enrolled, have adequate diary completion, and continued study eligibility. Additionally, Treatment Group subjects must have received a Lead and experienced stimulation-evoked comfortable sensations or a reduction in pain with stimulation in the target area during Visit 2 (original or unscheduled) or Visit 4.|
59921435|NCT03286543|76040895|FG001|Per Protocol Set|Study Enrollment||7|Subjects that were consented, randomized, enrolled, have adequate diary completion, and continued study eligibility. Additionally, Treatment Group subjects must have received a Lead and experienced stimulation-evoked comfortable sensations or a reduction in pain with stimulation in the target area during Visit 2 (original or unscheduled) or Visit 4.|
59921436|NCT03286543|76040896|FG002|Per Protocol Set|Study Enrollment||16|Subjects that were consented, randomized, enrolled, have adequate diary completion, and continued study eligibility. Additionally, Treatment Group subjects must have received a Lead and experienced stimulation-evoked comfortable sensations or a reduction in pain with stimulation in the target area during Visit 2 (original or unscheduled) or Visit 4.|
59921437|NCT03286543|76040894|FG000|COMPLETED|Study Enrollment||0||
59921438|NCT03286543|76040895|FG001|COMPLETED|Study Enrollment||12||
59921439|NCT03286543|76040896|FG002|COMPLETED|Study Enrollment||16||
59921440|NCT03286543|76040894|FG000|NOT COMPLETED|Study Enrollment||0||
59921441|NCT03286543|76040895|FG001|NOT COMPLETED|Study Enrollment||6||
59921442|NCT03286543|76040896|FG002|NOT COMPLETED|Study Enrollment||7||
59921443|NCT03306433|76040902|FG000|STARTED|Overall Study||16||
59921444|NCT03306433|76040902|FG000|UDMA-K18|Overall Study||12||
59921445|NCT03306433|76040902|FG000|Adhesive Control|Overall Study||12||
59921446|NCT03306433|76040902|FG000|UDMA-control|Overall Study||9||
59921447|NCT03306433|76040902|FG000|COMPLETED|Overall Study||9||
59921448|NCT03306433|76040902|FG000|NOT COMPLETED|Overall Study||7||
59921449|NCT02940691|76040910|FG000|STARTED|Overall Study||32||
59921450|NCT02940691|76040910|FG000|COMPLETED|Overall Study||26||
59513554|NCT03004846|75607135|FG001|STARTED|Part A (Up to 14 Weeks)||0||
59513555|NCT03004846|75607136|FG002|STARTED|Part A (Up to 14 Weeks)||0||
59513556|NCT03004846|75607134|FG000|COMPLETED|Part A (Up to 14 Weeks)||8||
59513557|NCT03004846|75607135|FG001|COMPLETED|Part A (Up to 14 Weeks)||0||
59513558|NCT03004846|75607136|FG002|COMPLETED|Part A (Up to 14 Weeks)||0||
59513559|NCT03004846|75607134|FG000|NOT COMPLETED|Part A (Up to 14 Weeks)||0||
60050048|NCT01920555|76165651|FG003|NOT COMPLETED|Overall Study||3||
60050049|NCT01920555|76165652|FG004|NOT COMPLETED|Overall Study||1||
59513560|NCT03004846|75607135|FG001|NOT COMPLETED|Part A (Up to 14 Weeks)||0||
59513561|NCT03004846|75607136|FG002|NOT COMPLETED|Part A (Up to 14 Weeks)||0||
59513562|NCT03004846|75607134|FG000|STARTED|Part B (Up to 14 Weeks)||0||
60050050|NCT02156804|76165664|FG000|STARTED|Overall Study||1009||
60050051|NCT02156804|76165664|FG000|COMPLETED|Overall Study||1008||
60050052|NCT02156804|76165664|FG000|NOT COMPLETED|Overall Study||1||
60050053|NCT02156492|76165671|FG000|STARTED|Period 1||16||
60050054|NCT02156492|76165672|FG001|STARTED|Period 1||24||
60050055|NCT02156492|76165673|FG002|STARTED|Period 1||22||
60050056|NCT02156492|76165671|FG000|Received at Least One Dose of Study Drug|Period 1||16||
60050057|NCT02156492|76165672|FG001|Received at Least One Dose of Study Drug|Period 1||24||
59513563|NCT03004846|75607135|FG001|STARTED|Part B (Up to 14 Weeks)||0||
59513564|NCT03004846|75607136|FG002|STARTED|Part B (Up to 14 Weeks)||0||
59513565|NCT03004846|75607134|FG000|COMPLETED|Part B (Up to 14 Weeks)||0||
59513566|NCT03004846|75607135|FG001|COMPLETED|Part B (Up to 14 Weeks)||0||
59513567|NCT03004846|75607136|FG002|COMPLETED|Part B (Up to 14 Weeks)||0||
60050058|NCT02156492|76165673|FG002|Received at Least One Dose of Study Drug|Period 1||22||
60050059|NCT02156492|76165671|FG000|COMPLETED|Period 1||16||
60050060|NCT02156492|76165672|FG001|COMPLETED|Period 1||23||
60050061|NCT02156492|76165673|FG002|COMPLETED|Period 1||22||
60050062|NCT02156492|76165671|FG000|NOT COMPLETED|Period 1||0||
60050063|NCT02156492|76165672|FG001|NOT COMPLETED|Period 1||1||
60050064|NCT02156492|76165673|FG002|NOT COMPLETED|Period 1||0||
60050065|NCT02156492|76165671|FG000|STARTED|Period 2||16||
60050066|NCT02156492|76165672|FG001|STARTED|Period 2||23||
60050067|NCT02156492|76165673|FG002|STARTED|Period 2||22||
60050068|NCT02156492|76165671|FG000|COMPLETED|Period 2||16||
60050069|NCT02156492|76165672|FG001|COMPLETED|Period 2||23||
60050070|NCT02156492|76165673|FG002|COMPLETED|Period 2||22||
60050071|NCT02156492|76165671|FG000|NOT COMPLETED|Period 2||0||
60050072|NCT02156492|76165672|FG001|NOT COMPLETED|Period 2||0||
60050073|NCT02156492|76165673|FG002|NOT COMPLETED|Period 2||0||
60050074|NCT02156492|76165671|FG000|STARTED|Period 3|Cohort A participated in Period 1 and Period 2 only.|0||
60050075|NCT02156492|76165672|FG001|STARTED|Period 3||23||
60050076|NCT02156492|76165673|FG002|STARTED|Period 3||22||
60050077|NCT02156492|76165671|FG000|COMPLETED|Period 3||0||
60050078|NCT02156492|76165672|FG001|COMPLETED|Period 3||22||
60050079|NCT02156492|76165673|FG002|COMPLETED|Period 3||22||
60050080|NCT02156492|76165671|FG000|NOT COMPLETED|Period 3||0||
60050081|NCT02156492|76165672|FG001|NOT COMPLETED|Period 3||1||
60050082|NCT02156492|76165673|FG002|NOT COMPLETED|Period 3||0||
60050083|NCT01920477|76165693|FG000|STARTED|Overall Study||17||
60050084|NCT01920477|76165694|FG001|STARTED|Overall Study||18||
60050085|NCT01920477|76165693|FG000|Requiried Individualized Follow-up|Overall Study||1||
60050086|NCT01920477|76165694|FG001|Requiried Individualized Follow-up|Overall Study||0||
60050087|NCT01920477|76165693|FG000|COMPLETED|Overall Study||2||
60050088|NCT01920477|76165694|FG001|COMPLETED|Overall Study||1||
60050089|NCT01920477|76165693|FG000|NOT COMPLETED|Overall Study||15||
60050090|NCT01920477|76165694|FG001|NOT COMPLETED|Overall Study||17||
60050091|NCT02213042|76165703|FG000|STARTED|Overall Study||17||
60050092|NCT02213042|76165704|FG001|STARTED|Overall Study||15||
60050093|NCT02213042|76165705|FG002|STARTED|Overall Study||10||
60050094|NCT02213042|76165703|FG000|Total Deaths|Overall Study||11||
60050095|NCT02213042|76165704|FG001|Total Deaths|Overall Study||9||
60050096|NCT02213042|76165705|FG002|Total Deaths|Overall Study||6||
60050097|NCT02213042|76165703|FG000|COMPLETED|Overall Study||0||
60050098|NCT02213042|76165704|FG001|COMPLETED|Overall Study||0||
60050099|NCT02213042|76165705|FG002|COMPLETED|Overall Study||0||
60050100|NCT02213042|76165703|FG000|NOT COMPLETED|Overall Study||17||
59513568|NCT03004846|75607134|FG000|NOT COMPLETED|Part B (Up to 14 Weeks)||0||
60050101|NCT02213042|76165704|FG001|NOT COMPLETED|Overall Study||15||
60050102|NCT02213042|76165705|FG002|NOT COMPLETED|Overall Study||10||
60050103|NCT02212730|76165717|FG000|STARTED|Overall Study||6||
60050104|NCT02212730|76165718|FG001|STARTED|Overall Study||4||
60050105|NCT02212730|76165717|FG000|Received Neoadjuvant Pembrolizumab|Overall Study||4||
60050106|NCT02212730|76165718|FG001|Received Neoadjuvant Pembrolizumab|Overall Study||0||
60050107|NCT02212730|76165717|FG000|Underwent RCC|Overall Study||4||
60050108|NCT02212730|76165718|FG001|Underwent RCC|Overall Study||3||
60050109|NCT02212730|76165717|FG000|Received Post-RCC Pembrolizumab|Overall Study||1||
60050110|NCT02212730|76165718|FG001|Received Post-RCC Pembrolizumab|Overall Study||1||
60050111|NCT02212730|76165717|FG000|COMPLETED|Overall Study||4||
60050112|NCT02212730|76165718|FG001|COMPLETED|Overall Study||3||
60050113|NCT02212730|76165717|FG000|NOT COMPLETED|Overall Study||2||
60050114|NCT02212730|76165718|FG001|NOT COMPLETED|Overall Study||1||
60050115|NCT02178956|76165728|FG000|STARTED|Overall Study||357||
60050116|NCT02178956|76165729|FG001|STARTED|Overall Study||357||
60050117|NCT02178956|76165728|FG000|COMPLETED|Overall Study||286||
60050118|NCT02178956|76165729|FG001|COMPLETED|Overall Study||279||
60050119|NCT02178956|76165728|FG000|NOT COMPLETED|Overall Study||71||
60050120|NCT02178956|76165729|FG001|NOT COMPLETED|Overall Study||78||
60050121|NCT02211638|76165739|FG000|STARTED|Overall Study||18113||
60050122|NCT02211638|76165739|FG000|COMPLETED|Overall Study||17130||
60050123|NCT02211638|76165739|FG000|NOT COMPLETED|Overall Study||983||
60050124|NCT02178566|76165745|FG000|STARTED|Overall Study||0|no data available|
60050125|NCT02178566|76165746|FG001|STARTED|Overall Study|no data available|1|no data available|
60050126|NCT02178566|76165745|FG000|COMPLETED|Overall Study||0|no data available|
60050127|NCT02178566|76165746|FG001|COMPLETED|Overall Study|no data available|0|no data available|
60050128|NCT02178566|76165745|FG000|NOT COMPLETED|Overall Study||0||
60050129|NCT02178566|76165746|FG001|NOT COMPLETED|Overall Study||1||
60050130|NCT02211014|76165754|FG000|STARTED|Overall Study||13||
60050131|NCT02211014|76165755|FG001|STARTED|Overall Study||14||
60050132|NCT02211014|76165754|FG000|COMPLETED|Overall Study||11||
60050133|NCT02211014|76165755|FG001|COMPLETED|Overall Study||8||
60050134|NCT02211014|76165754|FG000|NOT COMPLETED|Overall Study||2||
60050135|NCT02211014|76165755|FG001|NOT COMPLETED|Overall Study||6||
60050136|NCT01631864|76165779|FG000|STARTED|Overall Study||50||
60050137|NCT01631864|76165780|FG001|STARTED|Overall Study||48||
60050138|NCT01631864|76165779|FG000|COMPLETED|Overall Study||48||
60050139|NCT01631864|76165780|FG001|COMPLETED|Overall Study||44||
60050140|NCT01631864|76165779|FG000|NOT COMPLETED|Overall Study||2||
60050141|NCT01631864|76165780|FG001|NOT COMPLETED|Overall Study||4||
60050142|NCT02210780|76165788|FG000|STARTED|Overall Study||97||
60050143|NCT02210780|76165789|FG001|STARTED|Overall Study||97||
60050144|NCT02210780|76165788|FG000|COMPLETED|Overall Study||92||
60050145|NCT02210780|76165789|FG001|COMPLETED|Overall Study||89||
60050146|NCT02210780|76165788|FG000|NOT COMPLETED|Overall Study||5||
60050147|NCT02210780|76165789|FG001|NOT COMPLETED|Overall Study||8||
60050148|NCT01557244|76165800|FG000|STARTED|Active Comparator/Efficacy Phase:12Weeks||42||
60050149|NCT01557244|76165801|FG001|STARTED|Active Comparator/Efficacy Phase:12Weeks||42||
59513569|NCT03004846|75607135|FG001|NOT COMPLETED|Part B (Up to 14 Weeks)||0||
59513570|NCT03004846|75607136|FG002|NOT COMPLETED|Part B (Up to 14 Weeks)||0||
59513571|NCT03008590|75607147|FG000|STARTED|Overall Study||14||
59513572|NCT03008590|75607148|FG001|STARTED|Overall Study||15||
59513573|NCT03008590|75607147|FG000|COMPLETED|Overall Study||11||
59513574|NCT03008590|75607148|FG001|COMPLETED|Overall Study||12||
59513575|NCT03008590|75607147|FG000|NOT COMPLETED|Overall Study||3||
60050150|NCT01557244|76165802|FG002|STARTED|Active Comparator/Efficacy Phase:12Weeks||40||
60050151|NCT01557244|76165803|FG003|STARTED|Active Comparator/Efficacy Phase:12Weeks||0||
60050152|NCT01557244|76165804|FG004|STARTED|Active Comparator/Efficacy Phase:12Weeks||0||
60050153|NCT01557244|76165805|FG005|STARTED|Active Comparator/Efficacy Phase:12Weeks||28||
60050154|NCT01557244|76165806|FG006|STARTED|Active Comparator/Efficacy Phase:12Weeks||29||
60050155|NCT01557244|76165800|FG000|Treated|Active Comparator/Efficacy Phase:12Weeks||42||
60050156|NCT01557244|76165801|FG001|Treated|Active Comparator/Efficacy Phase:12Weeks||42||
60050157|NCT01557244|76165802|FG002|Treated|Active Comparator/Efficacy Phase:12Weeks||40||
60050158|NCT01557244|76165803|FG003|Treated|Active Comparator/Efficacy Phase:12Weeks||0||
60050159|NCT01557244|76165804|FG004|Treated|Active Comparator/Efficacy Phase:12Weeks||0||
60050160|NCT01557244|76165805|FG005|Treated|Active Comparator/Efficacy Phase:12Weeks||28||
60050161|NCT01557244|76165806|FG006|Treated|Active Comparator/Efficacy Phase:12Weeks||29||
60050162|NCT01557244|76165800|FG000|COMPLETED|Active Comparator/Efficacy Phase:12Weeks||33||
60050163|NCT01557244|76165801|FG001|COMPLETED|Active Comparator/Efficacy Phase:12Weeks||40||
60050164|NCT01557244|76165802|FG002|COMPLETED|Active Comparator/Efficacy Phase:12Weeks||36||
60050165|NCT01557244|76165803|FG003|COMPLETED|Active Comparator/Efficacy Phase:12Weeks||0||
60050166|NCT01557244|76165804|FG004|COMPLETED|Active Comparator/Efficacy Phase:12Weeks||0||
60050167|NCT01557244|76165805|FG005|COMPLETED|Active Comparator/Efficacy Phase:12Weeks||21||
60050168|NCT01557244|76165806|FG006|COMPLETED|Active Comparator/Efficacy Phase:12Weeks||28||
60050169|NCT01557244|76165800|FG000|NOT COMPLETED|Active Comparator/Efficacy Phase:12Weeks||9||
60050170|NCT01557244|76165801|FG001|NOT COMPLETED|Active Comparator/Efficacy Phase:12Weeks||2||
60050171|NCT01557244|76165802|FG002|NOT COMPLETED|Active Comparator/Efficacy Phase:12Weeks||4||
60050172|NCT01557244|76165803|FG003|NOT COMPLETED|Active Comparator/Efficacy Phase:12Weeks||0||
60050173|NCT01557244|76165804|FG004|NOT COMPLETED|Active Comparator/Efficacy Phase:12Weeks||0||
60050174|NCT01557244|76165805|FG005|NOT COMPLETED|Active Comparator/Efficacy Phase:12Weeks||7||
60050175|NCT01557244|76165806|FG006|NOT COMPLETED|Active Comparator/Efficacy Phase:12Weeks||1||
59513576|NCT03008590|75607148|FG001|NOT COMPLETED|Overall Study||3||
59513577|NCT00955513|75607157|FG000|STARTED|Overall Study||80||
60050176|NCT01557244|76165800|FG000|STARTED|Safety Extension Phase: 12 Weeks||33||
60050177|NCT01557244|76165801|FG001|STARTED|Safety Extension Phase: 12 Weeks||40||
59513578|NCT00955513|75607158|FG001|STARTED|Overall Study||80||
59513579|NCT00955513|75607159|FG002|STARTED|Overall Study||82||
59513580|NCT00955513|75607157|FG000|COMPLETED|Overall Study||79||
60050178|NCT01557244|76165802|FG002|STARTED|Safety Extension Phase: 12 Weeks|Did not receive oxybutynin in safety extension phase.|0||
60050179|NCT01557244|76165803|FG003|STARTED|Safety Extension Phase: 12 Weeks|Allocated from oxybutynin arm to this arm by investigator in safety extension phase.|16||
60050180|NCT01557244|76165804|FG004|STARTED|Safety Extension Phase: 12 Weeks|Allocated from oxybutynin arm to this arm by investigator in safety extension phase.|20||
60050181|NCT01557244|76165805|FG005|STARTED|Safety Extension Phase: 12 Weeks||21||
60050182|NCT01557244|76165806|FG006|STARTED|Safety Extension Phase: 12 Weeks||28||
60050183|NCT01557244|76165800|FG000|Treated|Safety Extension Phase: 12 Weeks||30||
60050184|NCT01557244|76165801|FG001|Treated|Safety Extension Phase: 12 Weeks||37||
60050185|NCT01557244|76165802|FG002|Treated|Safety Extension Phase: 12 Weeks||0||
60050186|NCT01557244|76165803|FG003|Treated|Safety Extension Phase: 12 Weeks||16||
60050187|NCT01557244|76165804|FG004|Treated|Safety Extension Phase: 12 Weeks||20||
60050188|NCT01557244|76165805|FG005|Treated|Safety Extension Phase: 12 Weeks||20||
60050189|NCT01557244|76165806|FG006|Treated|Safety Extension Phase: 12 Weeks||28||
60050190|NCT01557244|76165800|FG000|COMPLETED|Safety Extension Phase: 12 Weeks||30||
60050191|NCT01557244|76165801|FG001|COMPLETED|Safety Extension Phase: 12 Weeks||36||
60050192|NCT01557244|76165802|FG002|COMPLETED|Safety Extension Phase: 12 Weeks||0||
59513581|NCT00955513|75607158|FG001|COMPLETED|Overall Study||78||
59760381|NCT03891901|75880006|FG000|Began Imatinib Plus Rifabutin and Isoniazid Portion of the Intervention (if Applicable)|Overall Study||14||
59760382|NCT03891901|75880007|FG001|Began Imatinib Plus Rifabutin and Isoniazid Portion of the Intervention (if Applicable)|Overall Study||3||
59760383|NCT03891901|75880008|FG002|Began Imatinib Plus Rifabutin and Isoniazid Portion of the Intervention (if Applicable)|Overall Study||0||
59760384|NCT03891901|75880009|FG003|Began Imatinib Plus Rifabutin and Isoniazid Portion of the Intervention (if Applicable)|Overall Study||0||
59762609|NCT00866307|75882444|FG001|NOT COMPLETED|Induction||0||
60050193|NCT01557244|76165803|FG003|COMPLETED|Safety Extension Phase: 12 Weeks||15||
60050194|NCT01557244|76165804|FG004|COMPLETED|Safety Extension Phase: 12 Weeks||20||
60050195|NCT01557244|76165805|FG005|COMPLETED|Safety Extension Phase: 12 Weeks||20||
60050196|NCT01557244|76165806|FG006|COMPLETED|Safety Extension Phase: 12 Weeks||28||
60050197|NCT01557244|76165800|FG000|NOT COMPLETED|Safety Extension Phase: 12 Weeks||3||
60050198|NCT01557244|76165801|FG001|NOT COMPLETED|Safety Extension Phase: 12 Weeks||4||
60050199|NCT01557244|76165802|FG002|NOT COMPLETED|Safety Extension Phase: 12 Weeks||0||
60050200|NCT01557244|76165803|FG003|NOT COMPLETED|Safety Extension Phase: 12 Weeks||1||
60050201|NCT01557244|76165804|FG004|NOT COMPLETED|Safety Extension Phase: 12 Weeks||0||
60050202|NCT01557244|76165805|FG005|NOT COMPLETED|Safety Extension Phase: 12 Weeks||1||
60050203|NCT01557244|76165806|FG006|NOT COMPLETED|Safety Extension Phase: 12 Weeks||0||
60050204|NCT02177942|76165836|FG000|STARTED|Overall Study||262||
60050205|NCT02177942|76165837|FG001|STARTED|Overall Study||266||
60050206|NCT02177942|76165836|FG000|COMPLETED|Overall Study||185||
60050207|NCT02177942|76165837|FG001|COMPLETED|Overall Study||178||
60050208|NCT02177942|76165836|FG000|NOT COMPLETED|Overall Study||77||
60050209|NCT02177942|76165837|FG001|NOT COMPLETED|Overall Study||88||
60050210|NCT02155322|76165847|FG000|STARTED|Overall Study||33||
60050211|NCT02155322|76165847|FG000|Treated|Overall Study|32 of 33 participants treated. 1 participant not treated at the discretion of the investigator.|32||
60050212|NCT02155322|76165847|FG000|COMPLETED|Overall Study||19||
60050213|NCT02155322|76165847|FG000|NOT COMPLETED|Overall Study||14||
60050214|NCT02210000|76165853|FG000|STARTED|Overall Study||57||
60050215|NCT02210000|76165854|FG001|STARTED|Overall Study||57||
60050216|NCT02210000|76165853|FG000|COMPLETED|Overall Study||38||
60050217|NCT02210000|76165854|FG001|COMPLETED|Overall Study||36||
60050218|NCT02210000|76165853|FG000|NOT COMPLETED|Overall Study||19||
60050219|NCT02210000|76165854|FG001|NOT COMPLETED|Overall Study||21||
60050220|NCT01531894|76165860|FG000|STARTED|Overall Study||11||
60050221|NCT01531894|76165860|FG000|COMPLETED|Overall Study||2||
60050222|NCT01531894|76165860|FG000|NOT COMPLETED|Overall Study||9||
60050223|NCT02209766|76165868|FG000|STARTED|Overall Study||6||
60050224|NCT02209766|76165869|FG001|STARTED|Overall Study||3||
60050225|NCT02209766|76165870|FG002|STARTED|Overall Study||6||
60050226|NCT02209766|76165871|FG003|STARTED|Overall Study||3||
60050227|NCT02209766|76165872|FG004|STARTED|Overall Study||6||
60050228|NCT02209766|76165868|FG000|COMPLETED|Overall Study||6||
60050229|NCT02209766|76165869|FG001|COMPLETED|Overall Study||3||
60050230|NCT02209766|76165870|FG002|COMPLETED|Overall Study||6||
60050231|NCT02209766|76165871|FG003|COMPLETED|Overall Study||2||
60050232|NCT02209766|76165872|FG004|COMPLETED|Overall Study||6||
60050233|NCT02209766|76165868|FG000|NOT COMPLETED|Overall Study||0||
60050234|NCT02209766|76165869|FG001|NOT COMPLETED|Overall Study||0||
60050235|NCT02209766|76165870|FG002|NOT COMPLETED|Overall Study||0||
60050236|NCT02209766|76165871|FG003|NOT COMPLETED|Overall Study||1||
60050237|NCT02209766|76165872|FG004|NOT COMPLETED|Overall Study||0||
60050238|NCT02209454|76165882|FG000|STARTED|First Period||13||
59513582|NCT00955513|75607159|FG002|COMPLETED|Overall Study||79||
59513583|NCT00955513|75607157|FG000|NOT COMPLETED|Overall Study||1||
60050239|NCT02209454|76165883|FG001|STARTED|First Period||13||
60050240|NCT02209454|76165882|FG000|COMPLETED|First Period||13||
60050241|NCT02209454|76165883|FG001|COMPLETED|First Period||13||
60050242|NCT02209454|76165882|FG000|NOT COMPLETED|First Period||0||
60050243|NCT02209454|76165883|FG001|NOT COMPLETED|First Period||0||
60050244|NCT02209454|76165882|FG000|STARTED|Washout Period a Minimum of a 7 Day||13||
60050245|NCT02209454|76165883|FG001|STARTED|Washout Period a Minimum of a 7 Day||13||
60050246|NCT02209454|76165882|FG000|COMPLETED|Washout Period a Minimum of a 7 Day||13||
60050247|NCT02209454|76165883|FG001|COMPLETED|Washout Period a Minimum of a 7 Day||13||
60050248|NCT02209454|76165882|FG000|NOT COMPLETED|Washout Period a Minimum of a 7 Day||0||
60050249|NCT02209454|76165883|FG001|NOT COMPLETED|Washout Period a Minimum of a 7 Day||0||
60050250|NCT02209454|76165882|FG000|STARTED|Second Period||13||
60050251|NCT02209454|76165883|FG001|STARTED|Second Period||13||
60050252|NCT02209454|76165882|FG000|COMPLETED|Second Period||12||
60050253|NCT02209454|76165883|FG001|COMPLETED|Second Period||13||
60050254|NCT02209454|76165882|FG000|NOT COMPLETED|Second Period||1||
60050255|NCT02209454|76165883|FG001|NOT COMPLETED|Second Period||0||
60050256|NCT01571596|76165892|FG000|STARTED|Overall Study||21||
60050257|NCT01571596|76165893|FG001|STARTED|Overall Study||1||
60050258|NCT01571596|76165894|FG002|STARTED|Overall Study||1||
60050259|NCT01571596|76165892|FG000|COMPLETED|Overall Study||19||
60050260|NCT01571596|76165893|FG001|COMPLETED|Overall Study||0||
60050261|NCT01571596|76165894|FG002|COMPLETED|Overall Study||0||
60050262|NCT01571596|76165892|FG000|NOT COMPLETED|Overall Study||2||
60050263|NCT01571596|76165893|FG001|NOT COMPLETED|Overall Study||1||
60050264|NCT01571596|76165894|FG002|NOT COMPLETED|Overall Study||1||
60050265|NCT01557166|76165906|FG000|STARTED|Overall Study||180||
60050266|NCT01557166|76165907|FG001|STARTED|Overall Study||179||
60050267|NCT01557166|76165906|FG000|Exposed|Overall Study||176||
60050268|NCT01557166|76165907|FG001|Exposed|Overall Study||179||
60050269|NCT01557166|76165906|FG000|COMPLETED|Overall Study||134||
60050270|NCT01557166|76165907|FG001|COMPLETED|Overall Study||142||
60050271|NCT01557166|76165906|FG000|NOT COMPLETED|Overall Study||46||
60050272|NCT01557166|76165907|FG001|NOT COMPLETED|Overall Study||37||
60050273|NCT01556932|76165913|FG000|STARTED|Baseline First Treatment||13||
60050274|NCT01556932|76165914|FG001|STARTED|Baseline First Treatment||9||
60050275|NCT01556932|76165913|FG000|Recieved|Baseline First Treatment||13||
60050276|NCT01556932|76165914|FG001|Recieved|Baseline First Treatment||9||
60050277|NCT01556932|76165913|FG000|COMPLETED|Baseline First Treatment||13||
60050278|NCT01556932|76165914|FG001|COMPLETED|Baseline First Treatment||9||
60050279|NCT01556932|76165913|FG000|NOT COMPLETED|Baseline First Treatment||0||
60050280|NCT01556932|76165914|FG001|NOT COMPLETED|Baseline First Treatment||0||
60050281|NCT01556932|76165913|FG000|STARTED|Time Point 60 Minutes|1 subject withdrew and never started second treatment.|13||
60050282|NCT01556932|76165914|FG001|STARTED|Time Point 60 Minutes|1 subject withdrew and never started second treatment.|9||
60050283|NCT01556932|76165913|FG000|Recieved|Time Point 60 Minutes||12||
60050284|NCT01556932|76165914|FG001|Recieved|Time Point 60 Minutes||8||
60050285|NCT01556932|76165913|FG000|COMPLETED|Time Point 60 Minutes||12||
60050286|NCT01556932|76165914|FG001|COMPLETED|Time Point 60 Minutes||8||
60050287|NCT01556932|76165913|FG000|NOT COMPLETED|Time Point 60 Minutes||1||
60050288|NCT01556932|76165914|FG001|NOT COMPLETED|Time Point 60 Minutes||1||
60050289|NCT01556932|76165913|FG000|STARTED|Second Treament||12||
60050290|NCT01556932|76165914|FG001|STARTED|Second Treament||8||
60050291|NCT01556932|76165913|FG000|Recieved|Second Treament||12||
60050292|NCT01556932|76165914|FG001|Recieved|Second Treament||8||
60050293|NCT01556932|76165913|FG000|COMPLETED|Second Treament||12||
60050294|NCT01556932|76165914|FG001|COMPLETED|Second Treament||8||
60050295|NCT01556932|76165913|FG000|NOT COMPLETED|Second Treament||0||
60050296|NCT01556932|76165914|FG001|NOT COMPLETED|Second Treament||0||
60050297|NCT02177786|76165923|FG000|STARTED|Overall Study||81||
60050298|NCT02177786|76165924|FG001|STARTED|Overall Study||84||
60050299|NCT02177786|76165925|FG002|STARTED|Overall Study||84||
60050300|NCT02177786|76165926|FG003|STARTED|Overall Study||85||
60050301|NCT02177786|76165923|FG000|Randomized and Treated|Overall Study||81||
60050302|NCT02177786|76165924|FG001|Randomized and Treated|Overall Study||84||
60050303|NCT02177786|76165925|FG002|Randomized and Treated|Overall Study||83||
60050304|NCT02177786|76165926|FG003|Randomized and Treated|Overall Study||85||
60050305|NCT02177786|76165923|FG000|COMPLETED|Overall Study||75||
60050306|NCT02177786|76165924|FG001|COMPLETED|Overall Study||70||
60050307|NCT02177786|76165925|FG002|COMPLETED|Overall Study||66||
60050308|NCT02177786|76165926|FG003|COMPLETED|Overall Study||72||
60050309|NCT02177786|76165923|FG000|NOT COMPLETED|Overall Study||6||
60050310|NCT02177786|76165924|FG001|NOT COMPLETED|Overall Study||14||
60050311|NCT02177786|76165925|FG002|NOT COMPLETED|Overall Study||18||
60050312|NCT02177786|76165926|FG003|NOT COMPLETED|Overall Study||13||
60050313|NCT01555762|76165936|FG000|STARTED|Overall Study||402||
60050314|NCT01555762|76165936|FG000|Safety Population|Overall Study||383||
60050315|NCT01555762|76165936|FG000|Efficacy Population|Overall Study||358||
60050316|NCT01555762|76165936|FG000|COMPLETED|Overall Study||128||
60050317|NCT01555762|76165936|FG000|NOT COMPLETED|Overall Study||274||
60050318|NCT02153918|76165940|FG000|STARTED|Overall Study||27||
60050319|NCT02153918|76165940|FG000|COMPLETED|Overall Study||26||
60050320|NCT02153918|76165940|FG000|NOT COMPLETED|Overall Study||1||
60050321|NCT02176928|76165946|FG000|STARTED|Overall Study||21||
60050322|NCT02176928|76165947|FG001|STARTED|Overall Study||21||
60050323|NCT02176928|76165946|FG000|COMPLETED|Overall Study||19||
60050324|NCT02176928|76165947|FG001|COMPLETED|Overall Study||17||
60050325|NCT02176928|76165946|FG000|NOT COMPLETED|Overall Study||2||
60050326|NCT02176928|76165947|FG001|NOT COMPLETED|Overall Study||4||
60050327|NCT01628510|76165955|FG000|STARTED|Overall Study||51||
60050328|NCT01628510|76165956|FG001|STARTED|Overall Study||49||
60050329|NCT01628510|76165955|FG000|COMPLETED|Overall Study||48||
60050330|NCT01628510|76165956|FG001|COMPLETED|Overall Study||44||
60050331|NCT01628510|76165955|FG000|NOT COMPLETED|Overall Study||3||
60050332|NCT01628510|76165956|FG001|NOT COMPLETED|Overall Study||5||
60050333|NCT01571362|76165964|FG000|STARTED|Open-Label Conversion + Titration Period||410||
60050334|NCT01571362|76165965|FG001|STARTED|Open-Label Conversion + Titration Period|This phase commenced after the Open-Label Period.|0||
60050335|NCT01571362|76165966|FG002|STARTED|Open-Label Conversion + Titration Period|This phase commenced after the Open-Label Period.|0||
60050336|NCT01571362|76165964|FG000|COMPLETED|Open-Label Conversion + Titration Period||281||
60050337|NCT01571362|76165965|FG001|COMPLETED|Open-Label Conversion + Titration Period|This phase commenced after the Open-Label Period.|0||
60050338|NCT01571362|76165966|FG002|COMPLETED|Open-Label Conversion + Titration Period|This phase commenced after the Open-Label Period.|0||
60050339|NCT01571362|76165964|FG000|NOT COMPLETED|Open-Label Conversion + Titration Period||129||
60050340|NCT01571362|76165965|FG001|NOT COMPLETED|Open-Label Conversion + Titration Period||0||
60050341|NCT01571362|76165966|FG002|NOT COMPLETED|Open-Label Conversion + Titration Period||0||
60050342|NCT01571362|76165964|FG000|STARTED|Double-Blind Treatment Period|This phase preceded the Double-Blind Treatment Period.|0||
60050343|NCT01571362|76165965|FG001|STARTED|Double-Blind Treatment Period||134||
60050344|NCT01571362|76165966|FG002|STARTED|Double-Blind Treatment Period||146||
60050345|NCT01571362|76165964|FG000|COMPLETED|Double-Blind Treatment Period|This phase preceded the Double-Blind Treatment Period.|0||
60050346|NCT01571362|76165965|FG001|COMPLETED|Double-Blind Treatment Period||81||
60050347|NCT01571362|76165966|FG002|COMPLETED|Double-Blind Treatment Period||107||
60050348|NCT01571362|76165964|FG000|NOT COMPLETED|Double-Blind Treatment Period||0||
60050349|NCT01571362|76165965|FG001|NOT COMPLETED|Double-Blind Treatment Period||53||
60050350|NCT01571362|76165966|FG002|NOT COMPLETED|Double-Blind Treatment Period||39||
60050351|NCT01571284|76165974|FG000|STARTED|Overall Study||781||
60050352|NCT01571284|76165974|FG000|Safety Population|Overall Study||779|Participants who signed informed consent form and received at least part of one dose of treatment.|
60050353|NCT01571284|76165974|FG000|COMPLETED|Overall Study|403 participants with DP and 209 with adverse events were considered as completed.|612||
60050354|NCT01571284|76165974|FG000|NOT COMPLETED|Overall Study||169||
60050355|NCT02137772|76165980|FG000|STARTED|Overall Study|Randomized participants|376||
60050356|NCT02137772|76165981|FG001|STARTED|Overall Study|Randomized participants|194||
60050357|NCT02137772|76165980|FG000|Treated Participants|Overall Study||373||
60050358|NCT02137772|76165981|FG001|Treated Participants|Overall Study||192||
60050359|NCT02137772|76165980|FG000|COMPLETED|Overall Study||244||
60050360|NCT02137772|76165981|FG001|COMPLETED|Overall Study||119||
60050361|NCT02137772|76165980|FG000|NOT COMPLETED|Overall Study||132||
60050362|NCT02137772|76165981|FG001|NOT COMPLETED|Overall Study||75||
60050363|NCT01555138|76165989|FG000|STARTED|Overall Study||293||
60050364|NCT01555138|76165990|FG001|STARTED|Overall Study||288||
60050365|NCT01555138|76165989|FG000|COMPLETED|Overall Study||246||
60050366|NCT01555138|76165990|FG001|COMPLETED|Overall Study||250||
60050367|NCT01555138|76165989|FG000|NOT COMPLETED|Overall Study||47||
59760385|NCT03891901|75880010|FG004|Began Imatinib Plus Rifabutin and Isoniazid Portion of the Intervention (if Applicable)|Overall Study||0||
59760386|NCT03891901|75880011|FG005|Began Imatinib Plus Rifabutin and Isoniazid Portion of the Intervention (if Applicable)|Overall Study||0||
59760387|NCT03891901|75880012|FG006|Began Imatinib Plus Rifabutin and Isoniazid Portion of the Intervention (if Applicable)|Overall Study||0||
59760388|NCT03891901|75880013|FG007|Began Imatinib Plus Rifabutin and Isoniazid Portion of the Intervention (if Applicable)|Overall Study||0||
59760389|NCT03891901|75880014|FG008|Began Imatinib Plus Rifabutin and Isoniazid Portion of the Intervention (if Applicable)|Overall Study||0||
59760390|NCT03891901|75880006|FG000|COMPLETED|Overall Study||12||
59760391|NCT03891901|75880007|FG001|COMPLETED|Overall Study||2||
59921451|NCT02940691|76040910|FG000|NOT COMPLETED|Overall Study||6||
59921452|NCT01411267|76040921|FG000|STARTED|Overall Study||0||
59921453|NCT01411267|76040922|FG001|STARTED|Overall Study||3||
59921454|NCT01411267|76040923|FG002|STARTED|Overall Study||2||
59921455|NCT01411267|76040924|FG003|STARTED|Overall Study||5||
59921456|NCT01411267|76040925|FG004|STARTED|Overall Study||2||
59921457|NCT01411267|76040926|FG005|STARTED|Overall Study||12||
59921458|NCT01411267|76040927|FG006|STARTED|Overall Study||0||
59921459|NCT01411267|76040928|FG007|STARTED|Overall Study||0||
59921460|NCT01411267|76040929|FG008|STARTED|Overall Study||0||
59921461|NCT01411267|76040930|FG009|STARTED|Overall Study||0||
59921462|NCT01411267|76040921|FG000|COMPLETED|Overall Study||0||
59921463|NCT01411267|76040922|FG001|COMPLETED|Overall Study||3||
59921464|NCT01411267|76040923|FG002|COMPLETED|Overall Study||2||
59921465|NCT01411267|76040924|FG003|COMPLETED|Overall Study||4||
59921466|NCT01411267|76040925|FG004|COMPLETED|Overall Study||0||
59921467|NCT01411267|76040926|FG005|COMPLETED|Overall Study||10||
59760392|NCT03891901|75880008|FG002|COMPLETED|Overall Study||0||
59760393|NCT03891901|75880009|FG003|COMPLETED|Overall Study||0||
59760394|NCT03891901|75880010|FG004|COMPLETED|Overall Study||0||
59760395|NCT03891901|75880011|FG005|COMPLETED|Overall Study||0||
59760396|NCT03891901|75880012|FG006|COMPLETED|Overall Study||2||
59513584|NCT00955513|75607158|FG001|NOT COMPLETED|Overall Study||2||
59513585|NCT00955513|75607159|FG002|NOT COMPLETED|Overall Study||3||
59513586|NCT02939326|75607175|FG000|STARTED|Overall Study||7||
59513587|NCT02939326|75607176|FG001|STARTED|Overall Study||5||
59513588|NCT02939326|75607177|FG002|STARTED|Overall Study||5||
59513589|NCT02939326|75607178|FG003|STARTED|Overall Study||5||
59513590|NCT02939326|75607179|FG004|STARTED|Overall Study||5||
59513591|NCT02939326|75607180|FG005|STARTED|Overall Study||5||
59513592|NCT02939326|75607181|FG006|STARTED|Overall Study||5||
59513593|NCT02939326|75607182|FG007|STARTED|Overall Study||5||
59513594|NCT02939326|75607175|FG000|COMPLETED|Overall Study||7||
59513595|NCT02939326|75607176|FG001|COMPLETED|Overall Study||5||
59513596|NCT02939326|75607177|FG002|COMPLETED|Overall Study||5||
59513597|NCT02939326|75607178|FG003|COMPLETED|Overall Study||5||
59513598|NCT02939326|75607179|FG004|COMPLETED|Overall Study||5||
59513599|NCT02939326|75607180|FG005|COMPLETED|Overall Study||5||
59513600|NCT02939326|75607181|FG006|COMPLETED|Overall Study||5||
59612777|NCT01697592|75723837|FG006|STARTED|Phase A (Up to 24 Weeks)||34||
60050368|NCT01555138|76165990|FG001|NOT COMPLETED|Overall Study||38||
60050369|NCT02137226|76165998|FG000|STARTED|Period 1 (Initial Randomization)||324||
60050370|NCT02137226|76165999|FG001|STARTED|Period 1 (Initial Randomization)||321||
60050371|NCT02137226|76166000|FG002|STARTED|Period 1 (Initial Randomization)||0||
60050372|NCT02137226|76166001|FG003|STARTED|Period 1 (Initial Randomization)||0||
60050373|NCT02137226|76166002|FG004|STARTED|Period 1 (Initial Randomization)||0||
60050374|NCT02137226|76165998|FG000|COMPLETED|Period 1 (Initial Randomization)|Not completed are discontinued from study|304||
60050375|NCT02137226|76165999|FG001|COMPLETED|Period 1 (Initial Randomization)|Not completed are discontinued from study|305||
60050376|NCT02137226|76166000|FG002|COMPLETED|Period 1 (Initial Randomization)||0||
60050377|NCT02137226|76166001|FG003|COMPLETED|Period 1 (Initial Randomization)||0||
60050378|NCT02137226|76166002|FG004|COMPLETED|Period 1 (Initial Randomization)||0||
60050379|NCT02137226|76165998|FG000|NOT COMPLETED|Period 1 (Initial Randomization)||20||
60050380|NCT02137226|76165999|FG001|NOT COMPLETED|Period 1 (Initial Randomization)||16||
60050381|NCT02137226|76166000|FG002|NOT COMPLETED|Period 1 (Initial Randomization)||0||
60050382|NCT02137226|76166001|FG003|NOT COMPLETED|Period 1 (Initial Randomization)||0||
60050383|NCT02137226|76166002|FG004|NOT COMPLETED|Period 1 (Initial Randomization)||0||
60050384|NCT02137226|76165998|FG000|STARTED|Period 2 (Re - Randomization)||0||
60050385|NCT02137226|76165999|FG001|STARTED|Period 2 (Re - Randomization)||0||
60050386|NCT02137226|76166000|FG002|STARTED|Period 2 (Re - Randomization)||298||
60050387|NCT02137226|76166001|FG003|STARTED|Period 2 (Re - Randomization)||148||
60050388|NCT02137226|76166002|FG004|STARTED|Period 2 (Re - Randomization)||147||
60050389|NCT02137226|76165998|FG000|COMPLETED|Period 2 (Re - Randomization)||0||
60050390|NCT02137226|76165999|FG001|COMPLETED|Period 2 (Re - Randomization)||0||
60050391|NCT02137226|76166000|FG002|COMPLETED|Period 2 (Re - Randomization)|Not completed are discontinued from study|281||
60050392|NCT02137226|76166001|FG003|COMPLETED|Period 2 (Re - Randomization)|Not completed are discontinued from study|140||
60050393|NCT02137226|76166002|FG004|COMPLETED|Period 2 (Re - Randomization)|Not completed are discontinued from study|138||
60050394|NCT02137226|76165998|FG000|NOT COMPLETED|Period 2 (Re - Randomization)||0||
60050395|NCT02137226|76165999|FG001|NOT COMPLETED|Period 2 (Re - Randomization)||0||
60050396|NCT02137226|76166000|FG002|NOT COMPLETED|Period 2 (Re - Randomization)||17||
60050397|NCT02137226|76166001|FG003|NOT COMPLETED|Period 2 (Re - Randomization)||8||
60050398|NCT02137226|76166002|FG004|NOT COMPLETED|Period 2 (Re - Randomization)||9||
60050399|NCT01530334|76166010|FG000|STARTED|Overall Study||61||
60050400|NCT01530334|76166010|FG000|COMPLETED|Overall Study||10||
60050401|NCT01530334|76166010|FG000|NOT COMPLETED|Overall Study||51||
60050402|NCT01570192|76166016|FG000|STARTED|Overall Study||13||
60050403|NCT01570192|76166017|FG001|STARTED|Overall Study||30||
60050404|NCT01570192|76166016|FG000|COMPLETED|Overall Study||6||
60050405|NCT01570192|76166017|FG001|COMPLETED|Overall Study||17||
60050406|NCT01570192|76166016|FG000|NOT COMPLETED|Overall Study||7||
60050407|NCT01570192|76166017|FG001|NOT COMPLETED|Overall Study||13||
59513601|NCT02939326|75607182|FG007|COMPLETED|Overall Study||5||
59513602|NCT02939326|75607175|FG000|NOT COMPLETED|Overall Study||0||
59513603|NCT02939326|75607176|FG001|NOT COMPLETED|Overall Study||0||
59513604|NCT02939326|75607177|FG002|NOT COMPLETED|Overall Study||0||
59513605|NCT02939326|75607178|FG003|NOT COMPLETED|Overall Study||0||
59513606|NCT02939326|75607179|FG004|NOT COMPLETED|Overall Study||0||
59513607|NCT02939326|75607180|FG005|NOT COMPLETED|Overall Study||0||
59760397|NCT03891901|75880013|FG007|COMPLETED|Overall Study||0||
59513608|NCT02939326|75607181|FG006|NOT COMPLETED|Overall Study||0||
59513609|NCT02939326|75607182|FG007|NOT COMPLETED|Overall Study||0||
59513610|NCT02943226|75607202|FG000|STARTED|Overall Study||31||
59513611|NCT02943226|75607203|FG001|STARTED|Overall Study||30||
59513612|NCT02943226|75607202|FG000|COMPLETED|Overall Study||31||
59513613|NCT02943226|75607203|FG001|COMPLETED|Overall Study||30||
59760398|NCT03891901|75880014|FG008|COMPLETED|Overall Study||0||
60050408|NCT02136914|76166030|FG000|STARTED|Overall Study||63||
60050409|NCT02136914|76166031|FG001|STARTED|Overall Study||63||
60050410|NCT02136914|76166030|FG000|Received Study Drug|Overall Study||60||
60050411|NCT02136914|76166031|FG001|Received Study Drug|Overall Study||63||
60050412|NCT02136914|76166030|FG000|COMPLETED|Overall Study||42||
60050413|NCT02136914|76166031|FG001|COMPLETED|Overall Study||42||
60050414|NCT02136914|76166030|FG000|NOT COMPLETED|Overall Study||21||
60050415|NCT02136914|76166031|FG001|NOT COMPLETED|Overall Study||21||
60050416|NCT01530256|76166037|FG000|STARTED|Overall Study||3||
60050417|NCT01530256|76166037|FG000|COMPLETED|Overall Study||1||
60050418|NCT01530256|76166037|FG000|NOT COMPLETED|Overall Study||2||
60050419|NCT01554904|76166041|FG000|STARTED|Overall Study||18||
60050420|NCT01554904|76166041|FG000|Home Sleep Study 1|Overall Study|After informed consent signed.|18||
60050421|NCT01554904|76166041|FG000|Start 6 Weeks of Facial Training|Overall Study|1 participant was found to have obstructive sleep apnea on the home sleep study #1|17||
60050422|NCT01554904|76166041|FG000|Complete 6 Weeks of Facial Training|Overall Study|3 subjects withdrew during training|14||
60050423|NCT01554904|76166041|FG000|Home Sleep Study 2|Overall Study||14||
60050424|NCT01554904|76166041|FG000|COMPLETED|Overall Study||14||
60050425|NCT01554904|76166041|FG000|NOT COMPLETED|Overall Study||4||
60050426|NCT01529632|76166047|FG000|STARTED|Overall Study||90||
60050427|NCT01529632|76166048|FG001|STARTED|Overall Study||103||
60050428|NCT01529632|76166047|FG000|COMPLETED|Overall Study||87||
60050429|NCT01529632|76166048|FG001|COMPLETED|Overall Study||100||
60050430|NCT01529632|76166047|FG000|NOT COMPLETED|Overall Study||3||
60050431|NCT01529632|76166048|FG001|NOT COMPLETED|Overall Study||3||
60050432|NCT01554514|76166054|FG000|STARTED|Overall Study||19||
60050433|NCT01554514|76166054|FG000|COMPLETED|Overall Study||17||
60050434|NCT01554514|76166054|FG000|NOT COMPLETED|Overall Study||2||
60050435|NCT01553188|76166062|FG000|STARTED|Overall Study||3||
60050436|NCT01553188|76166063|FG001|STARTED|Overall Study||6||
60050437|NCT01553188|76166064|FG002|STARTED|Overall Study||16||
60050438|NCT01553188|76166065|FG003|STARTED|Overall Study||11||
60050439|NCT01553188|76166062|FG000|COMPLETED|Overall Study||2||
60050440|NCT01553188|76166063|FG001|COMPLETED|Overall Study||5||
60050441|NCT01553188|76166064|FG002|COMPLETED|Overall Study||14||
60050442|NCT01553188|76166065|FG003|COMPLETED|Overall Study||11||
60050443|NCT01553188|76166062|FG000|NOT COMPLETED|Overall Study||1||
60050444|NCT01553188|76166063|FG001|NOT COMPLETED|Overall Study||1||
60050445|NCT01553188|76166064|FG002|NOT COMPLETED|Overall Study||2||
60050446|NCT01553188|76166065|FG003|NOT COMPLETED|Overall Study||0||
60050447|NCT02175758|76166084|FG000|STARTED|PK Lead-in Phase||4||
60050448|NCT02175758|76166085|FG001|STARTED|PK Lead-in Phase||6||
60050449|NCT02175758|76166086|FG002|STARTED|PK Lead-in Phase||2||
60050450|NCT02175758|76166087|FG003|STARTED|PK Lead-in Phase||10||
60050451|NCT02175758|76166088|FG004|STARTED|PK Lead-in Phase||4||
60050452|NCT02175758|76166089|FG005|STARTED|PK Lead-in Phase||8||
60050453|NCT02175758|76166084|FG000|COMPLETED|PK Lead-in Phase||4||
60050454|NCT02175758|76166085|FG001|COMPLETED|PK Lead-in Phase||6||
60050455|NCT02175758|76166086|FG002|COMPLETED|PK Lead-in Phase||2||
60050456|NCT02175758|76166087|FG003|COMPLETED|PK Lead-in Phase||10||
60050457|NCT02175758|76166088|FG004|COMPLETED|PK Lead-in Phase||4||
60050458|NCT02175758|76166089|FG005|COMPLETED|PK Lead-in Phase||8||
60050459|NCT02175758|76166084|FG000|NOT COMPLETED|PK Lead-in Phase||0||
60050460|NCT02175758|76166085|FG001|NOT COMPLETED|PK Lead-in Phase||0||
60050461|NCT02175758|76166086|FG002|NOT COMPLETED|PK Lead-in Phase||0||
59513614|NCT02943226|75607202|FG000|NOT COMPLETED|Overall Study||0||
59513615|NCT02943226|75607203|FG001|NOT COMPLETED|Overall Study||0||
59513616|NCT00935311|75607212|FG000|STARTED|Overall Study||43||
60050462|NCT02175758|76166087|FG003|NOT COMPLETED|PK Lead-in Phase||0||
60050463|NCT02175758|76166088|FG004|NOT COMPLETED|PK Lead-in Phase||0||
60050464|NCT02175758|76166089|FG005|NOT COMPLETED|PK Lead-in Phase||0||
60050465|NCT02175758|76166084|FG000|STARTED|Treatment Phase|9 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|13||
60050466|NCT02175758|76166085|FG001|STARTED|Treatment Phase|33 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|39||
60050467|NCT02175758|76166086|FG002|STARTED|Treatment Phase|11 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|13||
60050468|NCT02175758|76166087|FG003|STARTED|Treatment Phase|18 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|28||
60050469|NCT02175758|76166088|FG004|STARTED|Treatment Phase|1 participant enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|5||
60050470|NCT02175758|76166089|FG005|STARTED|Treatment Phase||8||
60050471|NCT02175758|76166084|FG000|COMPLETED|Treatment Phase||13||
60050472|NCT02175758|76166085|FG001|COMPLETED|Treatment Phase||38||
60050473|NCT02175758|76166086|FG002|COMPLETED|Treatment Phase||13||
59760399|NCT03891901|75880006|FG000|NOT COMPLETED|Overall Study||4||
59760400|NCT03891901|75880007|FG001|NOT COMPLETED|Overall Study||4||
60050474|NCT02175758|76166087|FG003|COMPLETED|Treatment Phase||28||
60050475|NCT02175758|76166088|FG004|COMPLETED|Treatment Phase||4||
60050476|NCT02175758|76166089|FG005|COMPLETED|Treatment Phase||8||
60050477|NCT02175758|76166084|FG000|NOT COMPLETED|Treatment Phase||0||
60050478|NCT02175758|76166085|FG001|NOT COMPLETED|Treatment Phase||1||
60050479|NCT02175758|76166086|FG002|NOT COMPLETED|Treatment Phase||0||
60050480|NCT02175758|76166087|FG003|NOT COMPLETED|Treatment Phase||0||
60050481|NCT02175758|76166088|FG004|NOT COMPLETED|Treatment Phase||1||
60050482|NCT02175758|76166089|FG005|NOT COMPLETED|Treatment Phase||0||
60050483|NCT01529008|76166131|FG000|STARTED|Screening||35||
60050484|NCT01529008|76166132|FG001|STARTED|Screening||33||
60050485|NCT01529008|76166131|FG000|COMPLETED|Screening||35||
60050486|NCT01529008|76166132|FG001|COMPLETED|Screening||33||
60050487|NCT01529008|76166131|FG000|NOT COMPLETED|Screening||0||
60050488|NCT01529008|76166132|FG001|NOT COMPLETED|Screening||0||
60050489|NCT01529008|76166131|FG000|STARTED|Bone Marrow Harvesting||35||
60050490|NCT01529008|76166132|FG001|STARTED|Bone Marrow Harvesting||33||
60050491|NCT01529008|76166131|FG000|COMPLETED|Bone Marrow Harvesting||34||
60050492|NCT01529008|76166132|FG001|COMPLETED|Bone Marrow Harvesting||30||
60050493|NCT01529008|76166131|FG000|NOT COMPLETED|Bone Marrow Harvesting||1||
60050494|NCT01529008|76166132|FG001|NOT COMPLETED|Bone Marrow Harvesting||3||
60050495|NCT01529008|76166131|FG000|STARTED|Treatment||34||
60050496|NCT01529008|76166132|FG001|STARTED|Treatment||30||
60050497|NCT01529008|76166131|FG000|COMPLETED|Treatment||25||
60050498|NCT01529008|76166132|FG001|COMPLETED|Treatment||29||
60050499|NCT01529008|76166131|FG000|NOT COMPLETED|Treatment||9||
60050500|NCT01529008|76166132|FG001|NOT COMPLETED|Treatment||1||
60050501|NCT01529008|76166131|FG000|STARTED|Efficacy Analysis||25||
60050502|NCT01529008|76166132|FG001|STARTED|Efficacy Analysis||29||
60050503|NCT01529008|76166131|FG000|COMPLETED|Efficacy Analysis||23||
60050504|NCT01529008|76166132|FG001|COMPLETED|Efficacy Analysis||26||
60050505|NCT01529008|76166131|FG000|NOT COMPLETED|Efficacy Analysis||2||
60050506|NCT01529008|76166132|FG001|NOT COMPLETED|Efficacy Analysis||3||
60050507|NCT01599104|76166141|FG000|STARTED|Overall Study||387||
60050508|NCT01599104|76166142|FG001|STARTED|Overall Study||385||
60050509|NCT01599104|76166143|FG002|STARTED|Overall Study||389||
60050510|NCT01599104|76166141|FG000|COMPLETED|Overall Study||371||
60050511|NCT01599104|76166142|FG001|COMPLETED|Overall Study||371||
60050512|NCT01599104|76166143|FG002|COMPLETED|Overall Study||363||
60050513|NCT01599104|76166141|FG000|NOT COMPLETED|Overall Study||16||
60050514|NCT01599104|76166142|FG001|NOT COMPLETED|Overall Study||14||
60050515|NCT01599104|76166143|FG002|NOT COMPLETED|Overall Study||26||
60050516|NCT01569568|76166153|FG000|STARTED|Overall Study||20||
60050517|NCT01569568|76166154|FG001|STARTED|Overall Study||29||
60050518|NCT01569568|76166153|FG000|COMPLETED|Overall Study||20||
60050519|NCT01569568|76166154|FG001|COMPLETED|Overall Study||27||
60050520|NCT01569568|76166153|FG000|NOT COMPLETED|Overall Study||0||
60050521|NCT01569568|76166154|FG001|NOT COMPLETED|Overall Study||2||
60050522|NCT02136680|76166162|FG000|STARTED|Overall Study||112||
60050523|NCT02136680|76166163|FG001|STARTED|Overall Study||85||
60050524|NCT02136680|76166162|FG000|Interview 1|Overall Study||112||
60050525|NCT02136680|76166163|FG001|Interview 1|Overall Study||85||
60050526|NCT02136680|76166162|FG000|Interview 2|Overall Study||97||
60050527|NCT02136680|76166163|FG001|Interview 2|Overall Study||70||
60050528|NCT02136680|76166162|FG000|Interview 3|Overall Study||80||
59760401|NCT03891901|75880008|FG002|NOT COMPLETED|Overall Study||0||
59760402|NCT03891901|75880009|FG003|NOT COMPLETED|Overall Study||0||
60050529|NCT02136680|76166163|FG001|Interview 3|Overall Study||56||
60050530|NCT02136680|76166162|FG000|COMPLETED|Overall Study||80||
60050531|NCT02136680|76166163|FG001|COMPLETED|Overall Study||56||
60050532|NCT02136680|76166162|FG000|NOT COMPLETED|Overall Study||32||
60050533|NCT02136680|76166163|FG001|NOT COMPLETED|Overall Study||29||
60050534|NCT01552954|76166171|FG000|STARTED|Overall Study|A total of 13 patients were withdrawn from 269 patients. The remained 256 patients were randomized.|131||
60050535|NCT01552954|76166172|FG001|STARTED|Overall Study||125||
59513617|NCT00935311|75607213|FG001|STARTED|Overall Study||39||
60050536|NCT01552954|76166171|FG000|COMPLETED|Overall Study||126||
60050537|NCT01552954|76166172|FG001|COMPLETED|Overall Study||119||
60050538|NCT01552954|76166171|FG000|NOT COMPLETED|Overall Study||5||
60050539|NCT01552954|76166172|FG001|NOT COMPLETED|Overall Study||6||
60050540|NCT02175368|76166178|FG000|STARTED|Overall Study||28||
60050541|NCT02175368|76166178|FG000|COMPLETED|Overall Study||27||
60050542|NCT02175368|76166178|FG000|NOT COMPLETED|Overall Study||1||
60050543|NCT01518244|76166182|FG000|STARTED|Overall Study||50||
60050544|NCT01518244|76166182|FG000|COMPLETED|Overall Study||47||
60050545|NCT01518244|76166182|FG000|NOT COMPLETED|Overall Study||3||
60050546|NCT01552408|76166188|FG000|STARTED|Overall Study||20||20
60050547|NCT01552408|76166189|FG001|STARTED|Overall Study||20||20
60050548|NCT01552408|76166188|FG000|COMPLETED|Overall Study||16||16
60050549|NCT01552408|76166189|FG001|COMPLETED|Overall Study||18||18
59760403|NCT03891901|75880010|FG004|NOT COMPLETED|Overall Study||0||
60050550|NCT01552408|76166188|FG000|NOT COMPLETED|Overall Study||4||4
60050551|NCT01552408|76166189|FG001|NOT COMPLETED|Overall Study||2||2
60050552|NCT01528696|76166198|FG000|STARTED|Overall Study||18||
60050553|NCT01528696|76166199|FG001|STARTED|Overall Study||19||
60050554|NCT01528696|76166198|FG000|Hospital Stay (2-5 Days)|Overall Study||18||
60050555|NCT01528696|76166199|FG001|Hospital Stay (2-5 Days)|Overall Study||19||
60050556|NCT01528696|76166198|FG000|COMPLETED|Overall Study||0||
60050557|NCT01528696|76166199|FG001|COMPLETED|Overall Study||0||
60050558|NCT01528696|76166198|FG000|NOT COMPLETED|Overall Study||18||
60050559|NCT01528696|76166199|FG001|NOT COMPLETED|Overall Study||19||
60050560|NCT02174276|76166209|FG000|STARTED|Study Treatment Phase (Weeks 1 to 48)||27||
60050561|NCT02174276|76166210|FG001|STARTED|Study Treatment Phase (Weeks 1 to 48)||57||
60050562|NCT02174276|76166211|FG002|STARTED|Study Treatment Phase (Weeks 1 to 48)||56||
60050563|NCT02174276|76166212|FG003|STARTED|Study Treatment Phase (Weeks 1 to 48)||55||
60050564|NCT02174276|76166209|FG000|COMPLETED|Study Treatment Phase (Weeks 1 to 48)||26||
60050565|NCT02174276|76166210|FG001|COMPLETED|Study Treatment Phase (Weeks 1 to 48)||56||
60050566|NCT02174276|76166211|FG002|COMPLETED|Study Treatment Phase (Weeks 1 to 48)||53||
60050567|NCT02174276|76166212|FG003|COMPLETED|Study Treatment Phase (Weeks 1 to 48)||55||
60050568|NCT02174276|76166209|FG000|NOT COMPLETED|Study Treatment Phase (Weeks 1 to 48)||1||
60050569|NCT02174276|76166210|FG001|NOT COMPLETED|Study Treatment Phase (Weeks 1 to 48)||1||
60050570|NCT02174276|76166211|FG002|NOT COMPLETED|Study Treatment Phase (Weeks 1 to 48)||3||
60050571|NCT02174276|76166212|FG003|NOT COMPLETED|Study Treatment Phase (Weeks 1 to 48)||0||
60050572|NCT02174276|76166209|FG000|STARTED|OTEP (Weeks 48 to 144)||26||
60050573|NCT02174276|76166210|FG001|STARTED|OTEP (Weeks 48 to 144)|2 Participants completed the study treatment phase but did not continue in OTEP.|54||
60050574|NCT02174276|76166211|FG002|STARTED|OTEP (Weeks 48 to 144)|2 Participants completed the study treatment phase but did not continue in OTEP.|51||
60050575|NCT02174276|76166212|FG003|STARTED|OTEP (Weeks 48 to 144)|3 Participants completed the study treatment phase but did not continue in OTEP.|52||
60050576|NCT02174276|76166209|FG000|COMPLETED|OTEP (Weeks 48 to 144)||25||
60050577|NCT02174276|76166210|FG001|COMPLETED|OTEP (Weeks 48 to 144)||54||
60050578|NCT02174276|76166211|FG002|COMPLETED|OTEP (Weeks 48 to 144)||48||
60050579|NCT02174276|76166212|FG003|COMPLETED|OTEP (Weeks 48 to 144)||50||
60050580|NCT02174276|76166209|FG000|NOT COMPLETED|OTEP (Weeks 48 to 144)||1||
60050581|NCT02174276|76166210|FG001|NOT COMPLETED|OTEP (Weeks 48 to 144)||0||
60050582|NCT02174276|76166211|FG002|NOT COMPLETED|OTEP (Weeks 48 to 144)||3||
60050583|NCT02174276|76166212|FG003|NOT COMPLETED|OTEP (Weeks 48 to 144)||2||
60050584|NCT01528072|76166222|FG000|STARTED|Overall Study||140||
60050585|NCT01528072|76166222|FG000|COMPLETED|Overall Study||66||
60050586|NCT01528072|76166222|FG000|NOT COMPLETED|Overall Study||74||
60050587|NCT01527682|76166226|FG000|STARTED|Overall Study||37||69
60050588|NCT01527682|76166226|FG000|COMPLETED|Overall Study||29||45
60050589|NCT01527682|76166226|FG000|NOT COMPLETED|Overall Study||8||24
60050590|NCT01527370|76166230|FG000|STARTED|Overall Study||250||
60050591|NCT01527370|76166230|FG000|COMPLETED|Overall Study||244||
60050592|NCT01527370|76166230|FG000|NOT COMPLETED|Overall Study||6||
60050593|NCT01527292|76166236|FG000|STARTED|Overall Study||0||
60050594|NCT01527292|76166237|FG001|STARTED|Overall Study||3||
60050595|NCT01527292|76166236|FG000|COMPLETED|Overall Study||0||
60050596|NCT01527292|76166237|FG001|COMPLETED|Overall Study||0||
60050597|NCT01527292|76166236|FG000|NOT COMPLETED|Overall Study||0||
59760404|NCT03891901|75880011|FG005|NOT COMPLETED|Overall Study||0||
59760405|NCT03891901|75880012|FG006|NOT COMPLETED|Overall Study||0||
59760406|NCT03891901|75880013|FG007|NOT COMPLETED|Overall Study||0||
59760407|NCT03891901|75880014|FG008|NOT COMPLETED|Overall Study||0||
60050598|NCT01527292|76166237|FG001|NOT COMPLETED|Overall Study||3||
60050599|NCT01516216|76166245|FG000|STARTED|Overall Study||70||
60050600|NCT01516216|76166246|FG001|STARTED|Overall Study||69||
60050601|NCT01516216|76166245|FG000|AE Evaluable|Overall Study||67|Participants who started treatment were evaluable for AEs however all participants were followed for death (all-cause mortality).|
60050602|NCT01516216|76166246|FG001|AE Evaluable|Overall Study||68|Participants who started treatment were evaluable for AEs however all participants were followed for death (all-cause mortality).|
60050603|NCT01516216|76166245|FG000|Response Evaluable|Overall Study||62|Participants who started treatment were evaluable for response if underwent >/=1 restaging scan.|
60050604|NCT01516216|76166246|FG001|Response Evaluable|Overall Study||66|Participants who started treatment were evaluable for response if underwent >/=1 restaging scan.|
60050605|NCT01516216|76166245|FG000|COMPLETED|Overall Study||0|Given treatment duration is not fixed, all participants are considered as 'Non Completed' and reason discontinued treatment provided.|
60050606|NCT01516216|76166246|FG001|COMPLETED|Overall Study||0|Given treatment duration is not fixed, all participants are considered as 'Non Completed' and reason discontinued treatment provided.|
60050607|NCT01516216|76166245|FG000|NOT COMPLETED|Overall Study||70||
60050608|NCT01516216|76166246|FG001|NOT COMPLETED|Overall Study||69||
60050609|NCT01950819|76166256|FG000|STARTED|Overall Study||1022||
60050610|NCT01950819|76166257|FG001|STARTED|Overall Study||1015||
60050611|NCT01950819|76166256|FG000|COMPLETED|Overall Study||893||
60050612|NCT01950819|76166257|FG001|COMPLETED|Overall Study||881||
60050613|NCT01950819|76166256|FG000|NOT COMPLETED|Overall Study||129||
60050614|NCT01950819|76166257|FG001|NOT COMPLETED|Overall Study||134||
60050615|NCT01514422|76166263|FG000|STARTED|Overall Study||20||
60050616|NCT01514422|76166263|FG000|COMPLETED|Overall Study||19||
60050617|NCT01514422|76166263|FG000|NOT COMPLETED|Overall Study||1||
60050618|NCT01513330|76166267|FG000|STARTED|SenSura Mio First,||64||
60050619|NCT01513330|76166268|FG001|STARTED|SenSura Mio First,||58||
60050620|NCT01513330|76166267|FG000|COMPLETED|SenSura Mio First,||60||
60050621|NCT01513330|76166268|FG001|COMPLETED|SenSura Mio First,||56||
60050622|NCT01513330|76166267|FG000|NOT COMPLETED|SenSura Mio First,||4||
60050623|NCT01513330|76166268|FG001|NOT COMPLETED|SenSura Mio First,||2||
60050624|NCT01513330|76166267|FG000|STARTED|Standard Care First,||60||
60050625|NCT01513330|76166268|FG001|STARTED|Standard Care First,||56||
60050626|NCT01513330|76166267|FG000|COMPLETED|Standard Care First,||56||
60050627|NCT01513330|76166268|FG001|COMPLETED|Standard Care First,||52||
60050628|NCT01513330|76166267|FG000|NOT COMPLETED|Standard Care First,||4||
60050629|NCT01513330|76166268|FG001|NOT COMPLETED|Standard Care First,||4||
60050630|NCT01524796|76166274|FG000|STARTED|Overall Study||128||
60050631|NCT01524796|76166274|FG000|COMPLETED|Overall Study||100||
60050632|NCT01524796|76166274|FG000|NOT COMPLETED|Overall Study||28||
60050633|NCT01547728|76166278|FG000|STARTED|Overall Study||42||
60050634|NCT01547728|76166278|FG000|COMPLETED|Overall Study||1||
60050635|NCT01547728|76166278|FG000|NOT COMPLETED|Overall Study||41||
60050636|NCT01523392|76166284|FG000|STARTED|Treatment Period 1||20||
60050637|NCT01523392|76166285|FG001|STARTED|Treatment Period 1||14||
60050638|NCT01523392|76166284|FG000|COMPLETED|Treatment Period 1||17||
60050639|NCT01523392|76166285|FG001|COMPLETED|Treatment Period 1||14||
60050640|NCT01523392|76166284|FG000|NOT COMPLETED|Treatment Period 1||3||
60050641|NCT01523392|76166285|FG001|NOT COMPLETED|Treatment Period 1||0||
60050642|NCT01523392|76166284|FG000|STARTED|Washout Period - 10 to 14 Days|1 patient did not complete 7-9 days of Period 1 treatment but continued in the Washout and Period 2|18||
60050643|NCT01523392|76166285|FG001|STARTED|Washout Period - 10 to 14 Days||14||
60050644|NCT01523392|76166284|FG000|COMPLETED|Washout Period - 10 to 14 Days||17||
60050645|NCT01523392|76166285|FG001|COMPLETED|Washout Period - 10 to 14 Days||14||
60050646|NCT01523392|76166284|FG000|NOT COMPLETED|Washout Period - 10 to 14 Days||1||
60050647|NCT01523392|76166285|FG001|NOT COMPLETED|Washout Period - 10 to 14 Days||0||
60050648|NCT01523392|76166284|FG000|STARTED|Treatment Period 2||17||
60050649|NCT01523392|76166285|FG001|STARTED|Treatment Period 2||14||
60050650|NCT01523392|76166284|FG000|COMPLETED|Treatment Period 2||17||
60050651|NCT01523392|76166285|FG001|COMPLETED|Treatment Period 2||14||
60050652|NCT01523392|76166284|FG000|NOT COMPLETED|Treatment Period 2||0||
60050653|NCT01523392|76166285|FG001|NOT COMPLETED|Treatment Period 2||0||
60050654|NCT01512160|76166297|FG000|STARTED|Overall Study||22||
60050655|NCT01512160|76166298|FG001|STARTED|Overall Study||23||
60050656|NCT01512160|76166299|FG002|STARTED|Overall Study||22||
60050657|NCT01512160|76166300|FG003|STARTED|Overall Study||23||
60050658|NCT01512160|76166297|FG000|COMPLETED|Overall Study||20||
60050659|NCT01512160|76166298|FG001|COMPLETED|Overall Study||23||
60050660|NCT01512160|76166299|FG002|COMPLETED|Overall Study||22||
60050661|NCT01512160|76166300|FG003|COMPLETED|Overall Study||22||
60050662|NCT01512160|76166297|FG000|NOT COMPLETED|Overall Study||2||
60050663|NCT01512160|76166298|FG001|NOT COMPLETED|Overall Study||0||
60050664|NCT01512160|76166299|FG002|NOT COMPLETED|Overall Study||0||
60050665|NCT01512160|76166300|FG003|NOT COMPLETED|Overall Study||1||
60050666|NCT01546168|76166313|FG000|STARTED|Overall Study||55||
60050667|NCT01546168|76166314|FG001|STARTED|Overall Study||33||
60050668|NCT01546168|76166313|FG000|COMPLETED|Overall Study||51||
60050669|NCT01546168|76166314|FG001|COMPLETED|Overall Study||33||
60050670|NCT01546168|76166313|FG000|NOT COMPLETED|Overall Study||4||
60050671|NCT01546168|76166314|FG001|NOT COMPLETED|Overall Study||0||
60050672|NCT01901289|76166320|FG000|STARTED|Overall Study||200||
60050673|NCT01901289|76166320|FG000|12-Month Follow-up|Overall Study||194||
60050674|NCT01901289|76166320|FG000|COMPLETED|Overall Study||115||
60050675|NCT01901289|76166320|FG000|NOT COMPLETED|Overall Study||85||
60050676|NCT01950741|76166324|FG000|STARTED|Overall Study||48||
60050677|NCT01950741|76166324|FG000|COMPLETED|Overall Study||45||
60050678|NCT01950741|76166324|FG000|NOT COMPLETED|Overall Study||3||
60050679|NCT01950273|76166330|FG000|STARTED|Overall Study||49||
60050680|NCT01950273|76166331|FG001|STARTED|Overall Study||46||
60050681|NCT01950273|76166330|FG000|COMPLETED|Overall Study||45||
60050682|NCT01950273|76166331|FG001|COMPLETED|Overall Study||46||
60050683|NCT01950273|76166330|FG000|NOT COMPLETED|Overall Study||4||
60050684|NCT01950273|76166331|FG001|NOT COMPLETED|Overall Study||0||
60050685|NCT01919307|76166337|FG000|STARTED|Overall Study||29||
60050686|NCT01919307|76166337|FG000|COMPLETED|Overall Study||20||
60050687|NCT01919307|76166337|FG000|NOT COMPLETED|Overall Study||9||
60050688|NCT01919229|76166344|FG000|STARTED|Overall Study||4||
60050689|NCT01919229|76166345|FG001|STARTED|Overall Study||6||
60050690|NCT01919229|76166346|FG002|STARTED|Overall Study||4||
60050691|NCT01919229|76166344|FG000|COMPLETED|Overall Study||4||
60050692|NCT01919229|76166345|FG001|COMPLETED|Overall Study||6||
60050693|NCT01919229|76166346|FG002|COMPLETED|Overall Study||3||
60050694|NCT01919229|76166344|FG000|NOT COMPLETED|Overall Study||0||
60050695|NCT01919229|76166345|FG001|NOT COMPLETED|Overall Study||0||
60050696|NCT01919229|76166346|FG002|NOT COMPLETED|Overall Study||1||
60050697|NCT01901055|76166356|FG000|STARTED|Randomization But Not Titrated||49|49 Subjects were randomized to each group. Milestone is that they completed overnight sleep study and were successfully titrated to CPAP or sham-CPAP/|
60050698|NCT01901055|76166357|FG001|STARTED|Randomization But Not Titrated||49|49 Subjects were randomized to each group. Milestone is that they completed overnight sleep study and were successfully titrated to CPAP or sham-CPAP/|
60050699|NCT01901055|76166356|FG000|COMPLETED|Randomization But Not Titrated||48||
60050700|NCT01901055|76166357|FG001|COMPLETED|Randomization But Not Titrated||47||
60050701|NCT01901055|76166356|FG000|NOT COMPLETED|Randomization But Not Titrated||1||
60050702|NCT01901055|76166357|FG001|NOT COMPLETED|Randomization But Not Titrated||2||
60050703|NCT01901055|76166356|FG000|STARTED|Started Protocol to Week 6||48||
60050704|NCT01901055|76166357|FG001|STARTED|Started Protocol to Week 6||47||
60050705|NCT01901055|76166356|FG000|COMPLETED|Started Protocol to Week 6||45||
60050706|NCT01901055|76166357|FG001|COMPLETED|Started Protocol to Week 6||43||
60050707|NCT01901055|76166356|FG000|NOT COMPLETED|Started Protocol to Week 6||3||
60050708|NCT01901055|76166357|FG001|NOT COMPLETED|Started Protocol to Week 6||4||
60050709|NCT01901055|76166356|FG000|STARTED|Week 12 Assessment||45||
60050710|NCT01901055|76166357|FG001|STARTED|Week 12 Assessment||43||
60050711|NCT01901055|76166356|FG000|COMPLETED|Week 12 Assessment||44||
60050712|NCT01901055|76166357|FG001|COMPLETED|Week 12 Assessment||39||
59513618|NCT00935311|75607214|FG002|STARTED|Overall Study||40||
59513619|NCT00935311|75607212|FG000|COMPLETED|Overall Study||43||
59760408|NCT03827018|75880026|FG000|STARTED|Overall Study||42||
59760409|NCT03827018|75880027|FG001|STARTED|Overall Study||28||
59760410|NCT03827018|75880026|FG000|Completed Treatment|Overall Study||31||
59760411|NCT03827018|75880027|FG001|Completed Treatment|Overall Study||12||
59760412|NCT03827018|75880026|FG000|COMPLETED|Overall Study||39|Completed Study|
59762610|NCT00866307|75882445|FG002|NOT COMPLETED|Induction||0||
59921468|NCT01411267|76040927|FG006|COMPLETED|Overall Study||0||
59921469|NCT01411267|76040928|FG007|COMPLETED|Overall Study||0||
59921470|NCT01411267|76040929|FG008|COMPLETED|Overall Study||0||
59921471|NCT01411267|76040930|FG009|COMPLETED|Overall Study||0||
59921472|NCT01411267|76040921|FG000|NOT COMPLETED|Overall Study||0||
59921473|NCT01411267|76040922|FG001|NOT COMPLETED|Overall Study||0||
60050713|NCT01901055|76166356|FG000|NOT COMPLETED|Week 12 Assessment||1||
60050714|NCT01901055|76166357|FG001|NOT COMPLETED|Week 12 Assessment||4||
60050715|NCT01901055|76166356|FG000|STARTED|Week 24||44|This is the final assessment of persons on active CPAP treatment. After the 12 week assessment, all participant were told their group assignment. Those on sham-CPAP were allowed to titrate to active CPAP. This assessment (week 24 in protocol) is 12 weeks after the participants started active treatment.|
60050716|NCT01901055|76166357|FG001|STARTED|Week 24||39|This is the final assessment of persons on active CPAP treatment. After the 12 week assessment, all participant were told their group assignment. Those on sham-CPAP were allowed to titrate to active CPAP. This assessment (week 24 in protocol) is 12 weeks after the participants started active treatment.|
60050717|NCT01901055|76166356|FG000|COMPLETED|Week 24||30||
60050718|NCT01901055|76166357|FG001|COMPLETED|Week 24||20||
60050719|NCT01901055|76166356|FG000|NOT COMPLETED|Week 24||14||
60050720|NCT01901055|76166357|FG001|NOT COMPLETED|Week 24||19||
60050721|NCT01901055|76166356|FG000|STARTED|Week 36||30||
60050722|NCT01901055|76166357|FG001|STARTED|Week 36||20||
60050723|NCT01901055|76166356|FG000|COMPLETED|Week 36||30|Only participants originally in the sham-CPAP group were in this time period where they completed being on 24 weeks active CPAP.|
60050724|NCT01901055|76166357|FG001|COMPLETED|Week 36||15|Only participants originally in the sham-CPAP group were in this time period where they completed being on 24 weeks active CPAP.|
60050725|NCT01901055|76166356|FG000|NOT COMPLETED|Week 36||0||
60050726|NCT01901055|76166357|FG001|NOT COMPLETED|Week 36||5||
60050727|NCT01511536|76166369|FG000|STARTED|Phase 1||3||
60050728|NCT01511536|76166370|FG001|STARTED|Phase 1||7||
60050729|NCT01511536|76166371|FG002|STARTED|Phase 1|Phase 1 and phase 2 are separate populations.|0||
60050730|NCT01511536|76166369|FG000|COMPLETED|Phase 1|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|3||
60050731|NCT01511536|76166370|FG001|COMPLETED|Phase 1|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|6||
60050732|NCT01511536|76166371|FG002|COMPLETED|Phase 1||0||
60050733|NCT01511536|76166369|FG000|NOT COMPLETED|Phase 1||0||
59513620|NCT00935311|75607213|FG001|COMPLETED|Overall Study||39||
59921474|NCT01411267|76040923|FG002|NOT COMPLETED|Overall Study||0||
59921475|NCT01411267|76040924|FG003|NOT COMPLETED|Overall Study||1||
59921476|NCT01411267|76040925|FG004|NOT COMPLETED|Overall Study||2||
59921477|NCT01411267|76040926|FG005|NOT COMPLETED|Overall Study||2||
59921478|NCT01411267|76040927|FG006|NOT COMPLETED|Overall Study||0||
59921479|NCT01411267|76040928|FG007|NOT COMPLETED|Overall Study||0||
59921480|NCT01411267|76040929|FG008|NOT COMPLETED|Overall Study||0||
59921481|NCT01411267|76040930|FG009|NOT COMPLETED|Overall Study||0||
59921482|NCT03306277|76040948|FG000|STARTED|Overall Study||22||
59921483|NCT03306277|76040948|FG000|COMPLETED|Overall Study||19||
59921484|NCT03306277|76040948|FG000|NOT COMPLETED|Overall Study||3||
59921485|NCT03130959|76040962|FG000|STARTED|Overall Study||23|Started = initiated treatment|
59951435|NCT01190644|76070429|FG000|NOT COMPLETED|Overall Study||3||
59513621|NCT00935311|75607214|FG002|COMPLETED|Overall Study||40||
59513622|NCT00935311|75607212|FG000|NOT COMPLETED|Overall Study||0||
59513623|NCT00935311|75607213|FG001|NOT COMPLETED|Overall Study||0||
59513624|NCT00935311|75607214|FG002|NOT COMPLETED|Overall Study||0||
59513625|NCT03019744|75607224|FG000|STARTED|Overall Study||38||
60050734|NCT01511536|76166370|FG001|NOT COMPLETED|Phase 1||1||
60050735|NCT01511536|76166371|FG002|NOT COMPLETED|Phase 1||0||
60050736|NCT01511536|76166369|FG000|STARTED|Phase 2||0||
60050737|NCT01511536|76166370|FG001|STARTED|Phase 2||0||
60050738|NCT01511536|76166371|FG002|STARTED|Phase 2||27||
60050739|NCT01511536|76166369|FG000|COMPLETED|Phase 2||0||
60050740|NCT01511536|76166370|FG001|COMPLETED|Phase 2||0||
60050741|NCT01511536|76166371|FG002|COMPLETED|Phase 2|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|18||
60050742|NCT01511536|76166369|FG000|NOT COMPLETED|Phase 2||0||
60050743|NCT01511536|76166370|FG001|NOT COMPLETED|Phase 2||0||
60050744|NCT01511536|76166371|FG002|NOT COMPLETED|Phase 2||9||
60050745|NCT01890759|76166381|FG000|STARTED|Overall Study||100||
60050746|NCT01890759|76166382|FG001|STARTED|Overall Study||200||
60050747|NCT01890759|76166381|FG000|COMPLETED|Overall Study||98||
60050748|NCT01890759|76166382|FG001|COMPLETED|Overall Study||188||
60050749|NCT01890759|76166381|FG000|NOT COMPLETED|Overall Study||2||
60050750|NCT01890759|76166382|FG001|NOT COMPLETED|Overall Study||12||
60050751|NCT01900899|76166390|FG000|STARTED|Overall Study||159||
60050752|NCT01900899|76166391|FG001|STARTED|Overall Study||25||
60050753|NCT01900899|76166390|FG000|COMPLETED|Overall Study||150||
60050754|NCT01900899|76166391|FG001|COMPLETED|Overall Study||24||
60050755|NCT01900899|76166390|FG000|NOT COMPLETED|Overall Study||9||
60050756|NCT01900899|76166391|FG001|NOT COMPLETED|Overall Study||1||
60050757|NCT01510912|76166397|FG000|STARTED|Overall Study||602||
60050758|NCT01510912|76166397|FG000|COMPLETED|Overall Study||360||
60050759|NCT01510912|76166397|FG000|NOT COMPLETED|Overall Study||242||
60050760|NCT01510756|76166401|FG000|STARTED|Overall Study||4||
60050761|NCT01510756|76166401|FG000|COMPLETED|Overall Study||0||
60050762|NCT01510756|76166401|FG000|NOT COMPLETED|Overall Study||4||
60050763|NCT01522456|76166405|FG000|STARTED|Overall Study||73||
60050764|NCT01522456|76166405|FG000|COMPLETED|Overall Study||65||
60050765|NCT01522456|76166405|FG000|NOT COMPLETED|Overall Study||8||
60050766|NCT01545934|76166418|FG000|STARTED|Overall Study||132||
60050767|NCT01545934|76166419|FG001|STARTED|Overall Study||132||
60050768|NCT01545934|76166418|FG000|COMPLETED|Overall Study||127||
60050769|NCT01545934|76166419|FG001|COMPLETED|Overall Study||129||
59513626|NCT03019744|75607225|FG001|STARTED|Overall Study||44||
59513627|NCT03019744|75607224|FG000|COMPLETED|Overall Study||32||
59513628|NCT03019744|75607225|FG001|COMPLETED|Overall Study||36||
59513629|NCT03019744|75607224|FG000|NOT COMPLETED|Overall Study||6||
59513630|NCT03019744|75607225|FG001|NOT COMPLETED|Overall Study||8||
59513631|NCT02946034|75607231|FG000|STARTED|Overall Study||10||
60050770|NCT01545934|76166418|FG000|NOT COMPLETED|Overall Study||5||
60050771|NCT01545934|76166419|FG001|NOT COMPLETED|Overall Study||3||
60050772|NCT01521364|76166426|FG000|STARTED|Linezolid Without Clarithromycin (1 wk)||7||
60050773|NCT01521364|76166426|FG000|COMPLETED|Linezolid Without Clarithromycin (1 wk)||7||
60050774|NCT01521364|76166426|FG000|NOT COMPLETED|Linezolid Without Clarithromycin (1 wk)||0||
60050775|NCT01521364|76166426|FG000|STARTED|Linezolid + 250mg Claritromycin (wk 2&3)||7||
60050776|NCT01521364|76166426|FG000|COMPLETED|Linezolid + 250mg Claritromycin (wk 2&3)||6||
60050777|NCT01521364|76166426|FG000|NOT COMPLETED|Linezolid + 250mg Claritromycin (wk 2&3)||1||
60050778|NCT01521364|76166426|FG000|STARTED|Linezolid + 500mg Claritromycin (wk 4&5)||6||
60050779|NCT01521364|76166426|FG000|COMPLETED|Linezolid + 500mg Claritromycin (wk 4&5)||5||
60050780|NCT01521364|76166426|FG000|NOT COMPLETED|Linezolid + 500mg Claritromycin (wk 4&5)||1||
60050781|NCT01545388|76166440|FG000|STARTED|Overall Study||138||
60050782|NCT01545388|76166441|FG001|STARTED|Overall Study||133||
60050783|NCT01545388|76166442|FG002|STARTED|Overall Study||66||
60050784|NCT01545388|76166440|FG000|COMPLETED|Overall Study||130||
60050785|NCT01545388|76166441|FG001|COMPLETED|Overall Study||122||
60050786|NCT01545388|76166442|FG002|COMPLETED|Overall Study||58||
60050787|NCT01545388|76166440|FG000|NOT COMPLETED|Overall Study||8||
60050788|NCT01545388|76166441|FG001|NOT COMPLETED|Overall Study||11||
60050789|NCT01545388|76166442|FG002|NOT COMPLETED|Overall Study||8||
60050790|NCT01545076|76166450|FG000|STARTED|IgPro10 Restabilization Period||208||
60050791|NCT01545076|76166451|FG001|STARTED|IgPro10 Restabilization Period||0||
60050792|NCT01545076|76166452|FG002|STARTED|IgPro10 Restabilization Period||0||
60050793|NCT01545076|76166453|FG003|STARTED|IgPro10 Restabilization Period||0||
60050794|NCT01545076|76166454|FG004|STARTED|IgPro10 Restabilization Period||0||
60050795|NCT01545076|76166450|FG000|COMPLETED|IgPro10 Restabilization Period||172||
60050796|NCT01545076|76166451|FG001|COMPLETED|IgPro10 Restabilization Period||0||
60050797|NCT01545076|76166452|FG002|COMPLETED|IgPro10 Restabilization Period||0||
60050798|NCT01545076|76166453|FG003|COMPLETED|IgPro10 Restabilization Period||0||
60050799|NCT01545076|76166454|FG004|COMPLETED|IgPro10 Restabilization Period||0||
60050800|NCT01545076|76166450|FG000|NOT COMPLETED|IgPro10 Restabilization Period||36||
60050801|NCT01545076|76166451|FG001|NOT COMPLETED|IgPro10 Restabilization Period||0||
60050802|NCT01545076|76166452|FG002|NOT COMPLETED|IgPro10 Restabilization Period||0||
60050803|NCT01545076|76166453|FG003|NOT COMPLETED|IgPro10 Restabilization Period||0||
60050804|NCT01545076|76166454|FG004|NOT COMPLETED|IgPro10 Restabilization Period||0||
60050805|NCT01545076|76166450|FG000|STARTED|IgPro20 Subcutaneous Treatment Period||0||
60050806|NCT01545076|76166451|FG001|STARTED|IgPro20 Subcutaneous Treatment Period||58||
60050807|NCT01545076|76166452|FG002|STARTED|IgPro20 Subcutaneous Treatment Period||57||
60050808|NCT01545076|76166453|FG003|STARTED|IgPro20 Subcutaneous Treatment Period||57||
60050809|NCT01545076|76166454|FG004|STARTED|IgPro20 Subcutaneous Treatment Period||0||
60050810|NCT01545076|76166450|FG000|COMPLETED|IgPro20 Subcutaneous Treatment Period||0||
60050811|NCT01545076|76166451|FG001|COMPLETED|IgPro20 Subcutaneous Treatment Period||39||
60050812|NCT01545076|76166452|FG002|COMPLETED|IgPro20 Subcutaneous Treatment Period||36||
60050813|NCT01545076|76166453|FG003|COMPLETED|IgPro20 Subcutaneous Treatment Period||21||
60050814|NCT01545076|76166454|FG004|COMPLETED|IgPro20 Subcutaneous Treatment Period||0||
60050815|NCT01545076|76166450|FG000|NOT COMPLETED|IgPro20 Subcutaneous Treatment Period||0||
60050816|NCT01545076|76166451|FG001|NOT COMPLETED|IgPro20 Subcutaneous Treatment Period||19||
60050817|NCT01545076|76166452|FG002|NOT COMPLETED|IgPro20 Subcutaneous Treatment Period||21||
60050818|NCT01545076|76166453|FG003|NOT COMPLETED|IgPro20 Subcutaneous Treatment Period||36||
60050819|NCT01545076|76166454|FG004|NOT COMPLETED|IgPro20 Subcutaneous Treatment Period||0||
60050820|NCT01545076|76166450|FG000|STARTED|IgPro10 Rescue Period||0||
60050821|NCT01545076|76166451|FG001|STARTED|IgPro10 Rescue Period||0||
60050822|NCT01545076|76166452|FG002|STARTED|IgPro10 Rescue Period||0||
60050823|NCT01545076|76166453|FG003|STARTED|IgPro10 Rescue Period||0||
60050824|NCT01545076|76166454|FG004|STARTED|IgPro10 Rescue Period||60||
60050825|NCT01545076|76166450|FG000|COMPLETED|IgPro10 Rescue Period||0||
60050826|NCT01545076|76166451|FG001|COMPLETED|IgPro10 Rescue Period||0||
60050827|NCT01545076|76166452|FG002|COMPLETED|IgPro10 Rescue Period||0||
60050828|NCT01545076|76166453|FG003|COMPLETED|IgPro10 Rescue Period||0||
60050829|NCT01545076|76166454|FG004|COMPLETED|IgPro10 Rescue Period||60||
60050830|NCT01545076|76166450|FG000|NOT COMPLETED|IgPro10 Rescue Period||0||
60050831|NCT01545076|76166451|FG001|NOT COMPLETED|IgPro10 Rescue Period||0||
60050832|NCT01545076|76166452|FG002|NOT COMPLETED|IgPro10 Rescue Period||0||
60050833|NCT01545076|76166453|FG003|NOT COMPLETED|IgPro10 Rescue Period||0||
60050834|NCT01545076|76166454|FG004|NOT COMPLETED|IgPro10 Rescue Period||0||
60050835|NCT01544920|76166469|FG000|STARTED|Overall Study||368||
60050836|NCT01544920|76166470|FG001|STARTED|Overall Study||369||
60050837|NCT01544920|76166469|FG000|COMPLETED|Overall Study||349||
60050838|NCT01544920|76166470|FG001|COMPLETED|Overall Study||346||
60050839|NCT01544920|76166469|FG000|NOT COMPLETED|Overall Study||19||
59513632|NCT02946034|75607231|FG000|COMPLETED|Overall Study||10||
59513633|NCT02946034|75607231|FG000|NOT COMPLETED|Overall Study||0||
59513634|NCT00955747|75607239|FG000|STARTED|Overall Study||253||
59513635|NCT00955747|75607240|FG001|STARTED|Overall Study||241||
59513636|NCT00955747|75607239|FG000|COMPLETED|Overall Study||184||
60050840|NCT01544920|76166470|FG001|NOT COMPLETED|Overall Study||23||
60050841|NCT01509664|76166480|FG000|STARTED|Overall Study||49||
60050842|NCT01509664|76166481|FG001|STARTED|Overall Study||49||
60050843|NCT01509664|76166480|FG000|T2 Follow-up|Overall Study||45||
60050844|NCT01509664|76166481|FG001|T2 Follow-up|Overall Study||38||
60050845|NCT01509664|76166480|FG000|T3 Follow-up|Overall Study||40||
60050846|NCT01509664|76166481|FG001|T3 Follow-up|Overall Study||33||
60050847|NCT01509664|76166480|FG000|COMPLETED|Overall Study||34||
60050848|NCT01509664|76166481|FG001|COMPLETED|Overall Study||28||
60050849|NCT01509664|76166480|FG000|NOT COMPLETED|Overall Study||15||
60050850|NCT01509664|76166481|FG001|NOT COMPLETED|Overall Study||21||
60050851|NCT01543828|76166489|FG000|STARTED|Treatment 1||20||
60050852|NCT01543828|76166490|FG001|STARTED|Treatment 1||20||
59513637|NCT00955747|75607240|FG001|COMPLETED|Overall Study||172||
60050853|NCT01543828|76166489|FG000|COMPLETED|Treatment 1||20||
60050854|NCT01543828|76166490|FG001|COMPLETED|Treatment 1||20||
60050855|NCT01543828|76166489|FG000|NOT COMPLETED|Treatment 1||0||
60050856|NCT01543828|76166490|FG001|NOT COMPLETED|Treatment 1||0||
59513638|NCT00955747|75607239|FG000|NOT COMPLETED|Overall Study||69||
59513639|NCT00955747|75607240|FG001|NOT COMPLETED|Overall Study||69||
60050857|NCT01543828|76166489|FG000|STARTED|Treatment 2||20||
60050858|NCT01543828|76166490|FG001|STARTED|Treatment 2|1 participant completed treatment 1, had an adverse event, and did not receive treatment 2.|19||
60050859|NCT01543828|76166489|FG000|COMPLETED|Treatment 2||19||
60050860|NCT01543828|76166490|FG001|COMPLETED|Treatment 2||19||
60050861|NCT01543828|76166489|FG000|NOT COMPLETED|Treatment 2||1||
60050862|NCT01543828|76166490|FG001|NOT COMPLETED|Treatment 2||0||
60050863|NCT01520506|76166498|FG000|STARTED|Overall Study||50||
60050864|NCT01520506|76166498|FG000|COMPLETED|Overall Study||44||
60050865|NCT01520506|76166498|FG000|NOT COMPLETED|Overall Study||6||
60050866|NCT01519960|76166505|FG000|STARTED|Overall Study||101||
60050867|NCT01519960|76166506|FG001|STARTED|Overall Study||50||
60050868|NCT01519960|76166507|FG002|STARTED|Overall Study||10||
60050869|NCT01519960|76166505|FG000|Completed Week 48|Overall Study||99||
60050870|NCT01519960|76166506|FG001|Completed Week 48|Overall Study||47||
60050871|NCT01519960|76166507|FG002|Completed Week 48|Overall Study||10||
60050872|NCT01519960|76166505|FG000|Completed Follow-Up (FU) Week 12|Overall Study||99||
60050873|NCT01519960|76166506|FG001|Completed Follow-Up (FU) Week 12|Overall Study||26||
60050874|NCT01519960|76166507|FG002|Completed Follow-Up (FU) Week 12|Overall Study||10||
60050875|NCT01519960|76166505|FG000|Completed FU Week 24|Overall Study||99||
60050876|NCT01519960|76166506|FG001|Completed FU Week 24|Overall Study||15||
60050877|NCT01519960|76166507|FG002|Completed FU Week 24|Overall Study||10||
60050878|NCT01519960|76166505|FG000|Completed FU 5 Year|Overall Study||75||
60050879|NCT01519960|76166506|FG001|Completed FU 5 Year|Overall Study||28||
59513640|NCT02946892|75607246|FG000|STARTED|First Intervention (12 Weeks)||11||
59513641|NCT02946892|75607247|FG001|STARTED|First Intervention (12 Weeks)||15||
59513642|NCT02946892|75607246|FG000|COMPLETED|First Intervention (12 Weeks)||11||
59513643|NCT02946892|75607247|FG001|COMPLETED|First Intervention (12 Weeks)||14||
59513644|NCT02946892|75607246|FG000|NOT COMPLETED|First Intervention (12 Weeks)||0||
59513645|NCT02946892|75607247|FG001|NOT COMPLETED|First Intervention (12 Weeks)||1||
60050880|NCT01519960|76166507|FG002|Completed FU 5 Year|Overall Study||5||
60050881|NCT01519960|76166505|FG000|Switch Group|Overall Study||0||
60050882|NCT01519960|76166506|FG001|Switch Group|Overall Study||33||
60050883|NCT01519960|76166507|FG002|Switch Group|Overall Study||0||
60050884|NCT01519960|76166505|FG000|COMPLETED|Overall Study||75||
60050885|NCT01519960|76166506|FG001|COMPLETED|Overall Study||28||
60050886|NCT01519960|76166507|FG002|COMPLETED|Overall Study||5||
60050887|NCT01519960|76166505|FG000|NOT COMPLETED|Overall Study||26||
60050888|NCT01519960|76166506|FG001|NOT COMPLETED|Overall Study||22||
60050889|NCT01519960|76166507|FG002|NOT COMPLETED|Overall Study||5||
60050890|NCT01543204|76166523|FG000|STARTED|Overall Study||64||
60050891|NCT01543204|76166523|FG000|COMPLETED|Overall Study||56||
60050892|NCT01543204|76166523|FG000|NOT COMPLETED|Overall Study||8||
60050893|NCT01488994|76166533|FG000|STARTED|Overall Study||11||
60050894|NCT01488994|76166534|FG001|STARTED|Overall Study||12||
60050895|NCT01488994|76166533|FG000|COMPLETED|Overall Study||11||
60050896|NCT01488994|76166534|FG001|COMPLETED|Overall Study||11||
60050897|NCT01488994|76166533|FG000|NOT COMPLETED|Overall Study||0||
60050898|NCT01488994|76166534|FG001|NOT COMPLETED|Overall Study||1||
60050899|NCT01508650|76166547|FG000|STARTED|Overall Study||12||
60050900|NCT01508650|76166548|FG001|STARTED|Overall Study||15||
59513646|NCT02946892|75607246|FG000|STARTED|Washout (6 Weeks)||11||
59513647|NCT02946892|75607247|FG001|STARTED|Washout (6 Weeks)||14||
59513648|NCT02946892|75607246|FG000|COMPLETED|Washout (6 Weeks)||9||
59513649|NCT02946892|75607247|FG001|COMPLETED|Washout (6 Weeks)||14||
59513650|NCT02946892|75607246|FG000|NOT COMPLETED|Washout (6 Weeks)||2||
59513651|NCT02946892|75607247|FG001|NOT COMPLETED|Washout (6 Weeks)||0||
59513652|NCT02946892|75607246|FG000|STARTED|Second Intervention||9||
59513653|NCT02946892|75607247|FG001|STARTED|Second Intervention||14||
59513654|NCT02946892|75607246|FG000|COMPLETED|Second Intervention||9||
59513655|NCT02946892|75607247|FG001|COMPLETED|Second Intervention||14||
59513656|NCT02946892|75607246|FG000|NOT COMPLETED|Second Intervention||0||
59513657|NCT02946892|75607247|FG001|NOT COMPLETED|Second Intervention||0||
59513658|NCT00935857|75607255|FG000|STARTED|Overall Study||14||
60050901|NCT01508650|76166547|FG000|COMPLETED|Overall Study||12||
60050902|NCT01508650|76166548|FG001|COMPLETED|Overall Study||12||
60050903|NCT01508650|76166547|FG000|NOT COMPLETED|Overall Study||0||
60050904|NCT01508650|76166548|FG001|NOT COMPLETED|Overall Study||3||
59513659|NCT00935857|75607256|FG001|STARTED|Overall Study||16||
60050905|NCT01488448|76166556|FG000|STARTED|Overall Study||113||
60050906|NCT01488448|76166557|FG001|STARTED|Overall Study||114||
60050907|NCT01488448|76166556|FG000|COMPLETED|Overall Study||93||
60050908|NCT01488448|76166557|FG001|COMPLETED|Overall Study||97||
60050909|NCT01488448|76166556|FG000|NOT COMPLETED|Overall Study||20||
60050910|NCT01488448|76166557|FG001|NOT COMPLETED|Overall Study||17||
60050911|NCT01518946|76166567|FG000|STARTED|Open-label Phase||24||
59513660|NCT00935857|75607255|FG000|COMPLETED|Overall Study||14||
59513661|NCT00935857|75607256|FG001|COMPLETED|Overall Study||16||
59513662|NCT00935857|75607255|FG000|NOT COMPLETED|Overall Study||0||
60050912|NCT01518946|76166568|FG001|STARTED|Open-label Phase||0||
60050913|NCT01518946|76166569|FG002|STARTED|Open-label Phase||0||
60050914|NCT01518946|76166567|FG000|COMPLETED|Open-label Phase||20||
60050915|NCT01518946|76166568|FG001|COMPLETED|Open-label Phase||0||
59513663|NCT00935857|75607256|FG001|NOT COMPLETED|Overall Study||0||
60050916|NCT01518946|76166569|FG002|COMPLETED|Open-label Phase||0||
60050917|NCT01518946|76166567|FG000|NOT COMPLETED|Open-label Phase||4||
60050918|NCT01518946|76166568|FG001|NOT COMPLETED|Open-label Phase||0||
60050919|NCT01518946|76166569|FG002|NOT COMPLETED|Open-label Phase||0||
60050920|NCT01518946|76166567|FG000|STARTED|Randomized Phase (First Intervention)||0||
60050921|NCT01518946|76166568|FG001|STARTED|Randomized Phase (First Intervention)||10||
60050922|NCT01518946|76166569|FG002|STARTED|Randomized Phase (First Intervention)||10||
59513664|NCT01045421|75607268|FG000|STARTED|Phase 1||1||
59513665|NCT01045421|75607269|FG001|STARTED|Phase 1||3||
59513666|NCT01045421|75607270|FG002|STARTED|Phase 1||4||
59513667|NCT01045421|75607271|FG003|STARTED|Phase 1||12||
59513668|NCT01045421|75607272|FG004|STARTED|Phase 1||3||
59513669|NCT01045421|75607273|FG005|STARTED|Phase 1||1||
59513670|NCT01045421|75607274|FG006|STARTED|Phase 1||0||
59513671|NCT01045421|75607275|FG007|STARTED|Phase 1||0||
59513672|NCT01045421|75607276|FG008|STARTED|Phase 1||0||
59513673|NCT01045421|75607277|FG009|STARTED|Phase 1||0||
59513674|NCT01045421|75607278|FG010|STARTED|Phase 1||0||
59513675|NCT01045421|75607268|FG000|COMPLETED|Phase 1||1||
59513676|NCT01045421|75607269|FG001|COMPLETED|Phase 1||3||
59513677|NCT01045421|75607270|FG002|COMPLETED|Phase 1||4||
59513678|NCT01045421|75607271|FG003|COMPLETED|Phase 1||11||
59513679|NCT01045421|75607272|FG004|COMPLETED|Phase 1||2||
59513680|NCT01045421|75607273|FG005|COMPLETED|Phase 1||1||
59513681|NCT01045421|75607274|FG006|COMPLETED|Phase 1||0||
59513682|NCT01045421|75607275|FG007|COMPLETED|Phase 1||0||
59513683|NCT01045421|75607276|FG008|COMPLETED|Phase 1||0||
59513684|NCT01045421|75607277|FG009|COMPLETED|Phase 1||0||
59513685|NCT01045421|75607278|FG010|COMPLETED|Phase 1||0||
59513686|NCT01045421|75607268|FG000|NOT COMPLETED|Phase 1||0||
59513687|NCT01045421|75607269|FG001|NOT COMPLETED|Phase 1||0||
59513688|NCT01045421|75607270|FG002|NOT COMPLETED|Phase 1||0||
59513689|NCT01045421|75607271|FG003|NOT COMPLETED|Phase 1||1||
59513690|NCT01045421|75607272|FG004|NOT COMPLETED|Phase 1||1||
59513691|NCT01045421|75607273|FG005|NOT COMPLETED|Phase 1||0||
59513692|NCT01045421|75607274|FG006|NOT COMPLETED|Phase 1||0||
59513693|NCT01045421|75607275|FG007|NOT COMPLETED|Phase 1||0||
59513694|NCT01045421|75607276|FG008|NOT COMPLETED|Phase 1||0||
59513695|NCT01045421|75607277|FG009|NOT COMPLETED|Phase 1||0||
59513696|NCT01045421|75607278|FG010|NOT COMPLETED|Phase 1||0||
59513697|NCT01045421|75607268|FG000|STARTED|Phase 2||0||
59513698|NCT01045421|75607269|FG001|STARTED|Phase 2||0||
59513699|NCT01045421|75607270|FG002|STARTED|Phase 2||0||
59513700|NCT01045421|75607271|FG003|STARTED|Phase 2||0||
59513701|NCT01045421|75607272|FG004|STARTED|Phase 2||0||
59513702|NCT01045421|75607273|FG005|STARTED|Phase 2||0||
59513703|NCT01045421|75607274|FG006|STARTED|Phase 2||53||
59513704|NCT01045421|75607275|FG007|STARTED|Phase 2||55||
59513705|NCT01045421|75607276|FG008|STARTED|Phase 2||55||
59513706|NCT01045421|75607277|FG009|STARTED|Phase 2||26||
59513707|NCT01045421|75607278|FG010|STARTED|Phase 2||60||
59513708|NCT01045421|75607268|FG000|COMPLETED|Phase 2||0||
59513709|NCT01045421|75607269|FG001|COMPLETED|Phase 2||0||
59513710|NCT01045421|75607270|FG002|COMPLETED|Phase 2||0||
59513711|NCT01045421|75607271|FG003|COMPLETED|Phase 2||0||
59513712|NCT01045421|75607272|FG004|COMPLETED|Phase 2||0||
59513713|NCT01045421|75607273|FG005|COMPLETED|Phase 2||0||
59513714|NCT01045421|75607274|FG006|COMPLETED|Phase 2||53||
59513715|NCT01045421|75607275|FG007|COMPLETED|Phase 2||50||
59513716|NCT01045421|75607276|FG008|COMPLETED|Phase 2||53||
59513717|NCT01045421|75607277|FG009|COMPLETED|Phase 2||23||
59612778|NCT01697592|75723838|FG007|STARTED|Phase A (Up to 24 Weeks)||33||
59612779|NCT01697592|75723839|FG008|STARTED|Phase A (Up to 24 Weeks)||34||
60050923|NCT01518946|76166567|FG000|COMPLETED|Randomized Phase (First Intervention)||0||
60050924|NCT01518946|76166568|FG001|COMPLETED|Randomized Phase (First Intervention)||9||
60050925|NCT01518946|76166569|FG002|COMPLETED|Randomized Phase (First Intervention)||10||
60050926|NCT01518946|76166567|FG000|NOT COMPLETED|Randomized Phase (First Intervention)||0||
60050927|NCT01518946|76166568|FG001|NOT COMPLETED|Randomized Phase (First Intervention)||1||
59513718|NCT01045421|75607278|FG010|COMPLETED|Phase 2||58||
59513719|NCT01045421|75607268|FG000|NOT COMPLETED|Phase 2||0||
59513720|NCT01045421|75607269|FG001|NOT COMPLETED|Phase 2||0||
59513721|NCT01045421|75607270|FG002|NOT COMPLETED|Phase 2||0||
59513722|NCT01045421|75607271|FG003|NOT COMPLETED|Phase 2||0||
59513723|NCT01045421|75607272|FG004|NOT COMPLETED|Phase 2||0||
59513724|NCT01045421|75607273|FG005|NOT COMPLETED|Phase 2||0||
59513725|NCT01045421|75607274|FG006|NOT COMPLETED|Phase 2||0||
59513726|NCT01045421|75607275|FG007|NOT COMPLETED|Phase 2||5||
59513727|NCT01045421|75607276|FG008|NOT COMPLETED|Phase 2||2||
59513728|NCT01045421|75607277|FG009|NOT COMPLETED|Phase 2||3||
59513729|NCT01045421|75607278|FG010|NOT COMPLETED|Phase 2||2||
59513730|NCT00936481|75607301|FG000|STARTED|Overall Study||17||
59513731|NCT00936481|75607302|FG001|STARTED|Overall Study||17||
59513732|NCT00936481|75607301|FG000|COMPLETED|Overall Study||17||
59513733|NCT00936481|75607302|FG001|COMPLETED|Overall Study||17||
59513734|NCT00936481|75607301|FG000|NOT COMPLETED|Overall Study||0||
59513735|NCT00936481|75607302|FG001|NOT COMPLETED|Overall Study||0||
59513736|NCT02947984|75607310|FG000|STARTED|Overall Study||22||
59513737|NCT02947984|75607311|FG001|STARTED|Overall Study||22||
59513738|NCT02947984|75607310|FG000|COMPLETED|Overall Study||22||
59513739|NCT02947984|75607311|FG001|COMPLETED|Overall Study||22||
59513740|NCT02947984|75607310|FG000|NOT COMPLETED|Overall Study||0||
59513741|NCT02947984|75607311|FG001|NOT COMPLETED|Overall Study||0||
59513742|NCT00914069|75607319|FG000|STARTED|Overall Study||84||
59513743|NCT00914069|75607320|FG001|STARTED|Overall Study||88||
59513744|NCT00914069|75607319|FG000|COMPLETED|Overall Study||84||
59513745|NCT00914069|75607320|FG001|COMPLETED|Overall Study||88||
59513746|NCT00914069|75607319|FG000|NOT COMPLETED|Overall Study||0||
60050928|NCT01518946|76166569|FG002|NOT COMPLETED|Randomized Phase (First Intervention)||0||
60050929|NCT01518946|76166567|FG000|STARTED|Randomized Phase (Second Intervention)||0||
60050930|NCT01518946|76166568|FG001|STARTED|Randomized Phase (Second Intervention)||9||
59513747|NCT00914069|75607320|FG001|NOT COMPLETED|Overall Study||0||
59513748|NCT01042535|75607326|FG000|STARTED|Overall Study||44||
59513749|NCT01042535|75607326|FG000|COMPLETED|Overall Study||36||
59513750|NCT01042535|75607326|FG000|NOT COMPLETED|Overall Study||8||
59513751|NCT01041287|75607332|FG000|STARTED|Treatment Period 1 (3 Months)||19||
59513752|NCT01041287|75607333|FG001|STARTED|Treatment Period 1 (3 Months)||19||
59513753|NCT01041287|75607332|FG000|COMPLETED|Treatment Period 1 (3 Months)||19||
59513754|NCT01041287|75607333|FG001|COMPLETED|Treatment Period 1 (3 Months)||19||
60050931|NCT01518946|76166569|FG002|STARTED|Randomized Phase (Second Intervention)||10||
60050932|NCT01518946|76166567|FG000|COMPLETED|Randomized Phase (Second Intervention)||0||
60050933|NCT01518946|76166568|FG001|COMPLETED|Randomized Phase (Second Intervention)||9||
60050934|NCT01518946|76166569|FG002|COMPLETED|Randomized Phase (Second Intervention)||10||
60050935|NCT01518946|76166567|FG000|NOT COMPLETED|Randomized Phase (Second Intervention)||0||
60050936|NCT01518946|76166568|FG001|NOT COMPLETED|Randomized Phase (Second Intervention)||0||
60050937|NCT01518946|76166569|FG002|NOT COMPLETED|Randomized Phase (Second Intervention)||0||
60050938|NCT01488370|76166579|FG000|STARTED|Overall Study||22||
60050939|NCT01488370|76166580|FG001|STARTED|Overall Study||23||
60050940|NCT01488370|76166581|FG002|STARTED|Overall Study||20||
60050941|NCT01488370|76166579|FG000|COMPLETED|Overall Study||22||
60050942|NCT01488370|76166580|FG001|COMPLETED|Overall Study||22||
60050943|NCT01488370|76166581|FG002|COMPLETED|Overall Study||19||
60050944|NCT01488370|76166579|FG000|NOT COMPLETED|Overall Study||0||
60050945|NCT01488370|76166580|FG001|NOT COMPLETED|Overall Study||1||
60050946|NCT01488370|76166581|FG002|NOT COMPLETED|Overall Study||1||
60050947|NCT01518322|76166589|FG000|STARTED|Overall Study||235||
60050948|NCT01518322|76166589|FG000|COMPLETED|Overall Study||222||
60050949|NCT01518322|76166589|FG000|NOT COMPLETED|Overall Study||13||
60050950|NCT01507246|76166600|FG000|STARTED|Overall Study||20||
60050951|NCT01507246|76166601|FG001|STARTED|Overall Study||22||
60050952|NCT01507246|76166600|FG000|COMPLETED|Overall Study||18||
60050953|NCT01507246|76166601|FG001|COMPLETED|Overall Study||21||
60050954|NCT01507246|76166600|FG000|NOT COMPLETED|Overall Study||2||
60050955|NCT01507246|76166601|FG001|NOT COMPLETED|Overall Study||1||
60050956|NCT01507090|76166610|FG000|STARTED|Overall Study||642||
60050957|NCT01507090|76166610|FG000|COMPLETED|Overall Study||624||
60050958|NCT01507090|76166610|FG000|NOT COMPLETED|Overall Study||18||
60050959|NCT03870022|76166619|FG000|STARTED|Overall Study||70||
60050960|NCT03870022|76166619|FG000|COMPLETED|Overall Study||70||
60050961|NCT03870022|76166619|FG000|NOT COMPLETED|Overall Study||0||
60050962|NCT01464346|76166624|FG000|STARTED|Overall Study||29||
60050963|NCT01464346|76166625|FG001|STARTED|Overall Study||32||
60050964|NCT01464346|76166626|FG002|STARTED|Overall Study||29||
59513755|NCT01041287|75607332|FG000|NOT COMPLETED|Treatment Period 1 (3 Months)||0||
59513756|NCT01041287|75607333|FG001|NOT COMPLETED|Treatment Period 1 (3 Months)||0||
59513757|NCT01041287|75607332|FG000|STARTED|Treatment Period 2 (3 Months)||19||
59513758|NCT01041287|75607333|FG001|STARTED|Treatment Period 2 (3 Months)||19||
59513759|NCT01041287|75607332|FG000|COMPLETED|Treatment Period 2 (3 Months)||16||
59513760|NCT01041287|75607333|FG001|COMPLETED|Treatment Period 2 (3 Months)||14||
59513761|NCT01041287|75607332|FG000|NOT COMPLETED|Treatment Period 2 (3 Months)||3||
59513762|NCT01041287|75607333|FG001|NOT COMPLETED|Treatment Period 2 (3 Months)||5||
59513763|NCT00955903|75607342|FG000|STARTED|Overall Study||55||
59513764|NCT00955903|75607343|FG001|STARTED|Overall Study||54||
59513765|NCT00955903|75607344|FG002|STARTED|Overall Study||55||
60050965|NCT01464346|76166624|FG000|COMPLETED|Overall Study||29||
60050966|NCT01464346|76166625|FG001|COMPLETED|Overall Study||32||
60050967|NCT01464346|76166626|FG002|COMPLETED|Overall Study||28||
60050968|NCT01464346|76166624|FG000|NOT COMPLETED|Overall Study||0||
59513766|NCT00955903|75607342|FG000|COMPLETED|Overall Study||49||
59513767|NCT00955903|75607343|FG001|COMPLETED|Overall Study||51||
59513768|NCT00955903|75607344|FG002|COMPLETED|Overall Study||48||
59513769|NCT00955903|75607342|FG000|NOT COMPLETED|Overall Study||6||
59513770|NCT00955903|75607343|FG001|NOT COMPLETED|Overall Study||3||
59513771|NCT00955903|75607344|FG002|NOT COMPLETED|Overall Study||7||
59513772|NCT01040351|75607354|FG000|STARTED|Overall Study|October 2006|55||
60050969|NCT01464346|76166625|FG001|NOT COMPLETED|Overall Study||0||
60050970|NCT01464346|76166626|FG002|NOT COMPLETED|Overall Study||1||
60050971|NCT02073448|76166637|FG000|STARTED|Overall Study||101||
60050972|NCT02073448|76166638|FG001|STARTED|Overall Study||212||
60050973|NCT02073448|76166639|FG002|STARTED|Overall Study||104||
59513773|NCT01040351|75607355|FG001|STARTED|Overall Study|October 2006|55||
59513774|NCT01040351|75607354|FG000|COMPLETED|Overall Study|May 2010|54||
59513775|NCT01040351|75607355|FG001|COMPLETED|Overall Study|May 2010|53||
59513776|NCT01040351|75607354|FG000|NOT COMPLETED|Overall Study||1||
59513777|NCT01040351|75607355|FG001|NOT COMPLETED|Overall Study||2||
59513778|NCT00956761|75607361|FG000|STARTED|Overall Study||63||
59513779|NCT00956761|75607361|FG000|COMPLETED|Overall Study||63||
59513780|NCT00956761|75607361|FG000|NOT COMPLETED|Overall Study||0||
59513781|NCT02049957|75607375|FG000|STARTED|Overall Study||6||
59513782|NCT02049957|75607376|FG001|STARTED|Overall Study||6||
59513783|NCT02049957|75607377|FG002|STARTED|Overall Study||3||
59513784|NCT02049957|75607378|FG003|STARTED|Overall Study||3||
59513785|NCT02049957|75607379|FG004|STARTED|Overall Study||6||
59513786|NCT02049957|75607380|FG005|STARTED|Overall Study||43||
59513787|NCT02049957|75607381|FG006|STARTED|Overall Study||8||
59513788|NCT02049957|75607382|FG007|STARTED|Overall Study||35||
59513789|NCT02049957|75607383|FG008|STARTED|Overall Study||8||
59513790|NCT02049957|75607375|FG000|COMPLETED|Overall Study||0|Completed=Completed Study Treatment|
59513791|NCT02049957|75607376|FG001|COMPLETED|Overall Study||0|Completed=Completed Study Treatment|
59513792|NCT02049957|75607377|FG002|COMPLETED|Overall Study||0|Completed=Completed Study Treatment|
59513793|NCT02049957|75607378|FG003|COMPLETED|Overall Study||0|Completed=Completed Study Treatment|
59513794|NCT02049957|75607379|FG004|COMPLETED|Overall Study||0|Completed=Completed Study Treatment|
59513795|NCT02049957|75607380|FG005|COMPLETED|Overall Study||0|Completed=Completed Study Treatment|
59513796|NCT02049957|75607381|FG006|COMPLETED|Overall Study||0|Completed=Completed Study Treatment|
59513797|NCT02049957|75607382|FG007|COMPLETED|Overall Study||0|Completed=Completed Study Treatment|
59513798|NCT02049957|75607383|FG008|COMPLETED|Overall Study||0|Completed=Completed Study Treatment|
59513799|NCT02049957|75607375|FG000|NOT COMPLETED|Overall Study||6||
59513800|NCT02049957|75607376|FG001|NOT COMPLETED|Overall Study||6||
59513801|NCT02049957|75607377|FG002|NOT COMPLETED|Overall Study||3||
59513802|NCT02049957|75607378|FG003|NOT COMPLETED|Overall Study||3||
60050974|NCT02073448|76166637|FG000|COMPLETED|Overall Study||99||
60050975|NCT02073448|76166638|FG001|COMPLETED|Overall Study||200||
60050976|NCT02073448|76166639|FG002|COMPLETED|Overall Study||99||
60050977|NCT02073448|76166637|FG000|NOT COMPLETED|Overall Study||2||
60050978|NCT02073448|76166638|FG001|NOT COMPLETED|Overall Study||12||
60050979|NCT02073448|76166639|FG002|NOT COMPLETED|Overall Study||5||
60050980|NCT01487200|76166653|FG000|STARTED|Overall Study||5||
60050981|NCT01487200|76166654|FG001|STARTED|Overall Study||7||
60050982|NCT01487200|76166655|FG002|STARTED|Overall Study||7||
59513803|NCT02049957|75607379|FG004|NOT COMPLETED|Overall Study||6||
59513804|NCT02049957|75607380|FG005|NOT COMPLETED|Overall Study||43||
59513805|NCT02049957|75607381|FG006|NOT COMPLETED|Overall Study||8||
59513806|NCT02049957|75607382|FG007|NOT COMPLETED|Overall Study||35||
59513807|NCT02049957|75607383|FG008|NOT COMPLETED|Overall Study||8||
59513808|NCT00950365|75607405|FG000|STARTED|Overall Study||27||
59513809|NCT00950365|75607406|FG001|STARTED|Overall Study||52||
59513810|NCT00950365|75607405|FG000|COMPLETED|Overall Study||25||
59513811|NCT00950365|75607406|FG001|COMPLETED|Overall Study||50||
59513812|NCT00950365|75607405|FG000|NOT COMPLETED|Overall Study||2||
59513813|NCT00950365|75607406|FG001|NOT COMPLETED|Overall Study||2||
59513814|NCT00950833|75607415|FG000|STARTED|Overall Study||112||
59513815|NCT00950833|75607416|FG001|STARTED|Overall Study||108||
59513816|NCT00950833|75607417|FG002|STARTED|Overall Study||223||
59513817|NCT00950833|75607415|FG000|COMPLETED|Overall Study||112||
59513818|NCT00950833|75607416|FG001|COMPLETED|Overall Study||108||
59513819|NCT00950833|75607417|FG002|COMPLETED|Overall Study||223||
59513820|NCT00950833|75607415|FG000|NOT COMPLETED|Overall Study||0||
59513821|NCT00950833|75607416|FG001|NOT COMPLETED|Overall Study||0||
59513822|NCT00950833|75607417|FG002|NOT COMPLETED|Overall Study||0||
59513823|NCT00924053|75607431|FG000|STARTED|Overall Study||6||
59513824|NCT00924053|75607432|FG001|STARTED|Overall Study||6||
59513825|NCT00924053|75607433|FG002|STARTED|Overall Study||6||
59513826|NCT00924053|75607434|FG003|STARTED|Overall Study||6||
59513827|NCT00924053|75607431|FG000|COMPLETED|Overall Study||6||
59513828|NCT00924053|75607432|FG001|COMPLETED|Overall Study||6||
59513829|NCT00924053|75607433|FG002|COMPLETED|Overall Study||6||
59513830|NCT00924053|75607434|FG003|COMPLETED|Overall Study||6||
59513831|NCT00924053|75607431|FG000|NOT COMPLETED|Overall Study||0||
59513832|NCT00924053|75607432|FG001|NOT COMPLETED|Overall Study||0||
59513833|NCT00924053|75607433|FG002|NOT COMPLETED|Overall Study||0||
59513834|NCT00924053|75607434|FG003|NOT COMPLETED|Overall Study||0||
59513835|NCT02951182|75607450|FG000|STARTED|Overall Study||11||
59513836|NCT02951182|75607451|FG001|STARTED|Overall Study||9||
59513837|NCT02951182|75607452|FG002|STARTED|Overall Study||9||
59513838|NCT02951182|75607453|FG003|STARTED|Overall Study||18||
59513839|NCT02951182|75607454|FG004|STARTED|Overall Study||6||
59513840|NCT02951182|75607455|FG005|STARTED|Overall Study||20||
60050983|NCT01487200|76166656|FG003|STARTED|Overall Study||5||
60050984|NCT01487200|76166653|FG000|COMPLETED|Overall Study||5||
60050985|NCT01487200|76166654|FG001|COMPLETED|Overall Study||6||
60050986|NCT01487200|76166655|FG002|COMPLETED|Overall Study||7||
60050987|NCT01487200|76166656|FG003|COMPLETED|Overall Study||5||
60050988|NCT01487200|76166653|FG000|NOT COMPLETED|Overall Study||0||
60050989|NCT01487200|76166654|FG001|NOT COMPLETED|Overall Study||1||
60050990|NCT01487200|76166655|FG002|NOT COMPLETED|Overall Study||0||
60050991|NCT01487200|76166656|FG003|NOT COMPLETED|Overall Study||0||
60050992|NCT01463878|76166669|FG000|STARTED|Overall Study||9||
60050993|NCT01463878|76166670|FG001|STARTED|Overall Study||9||
60050994|NCT01463878|76166669|FG000|COMPLETED|Overall Study||7||
60050995|NCT01463878|76166670|FG001|COMPLETED|Overall Study||7||
60050996|NCT01463878|76166669|FG000|NOT COMPLETED|Overall Study||2||
60050997|NCT01463878|76166670|FG001|NOT COMPLETED|Overall Study||2||
60050998|NCT01486966|76166678|FG000|STARTED|Overall Study||29||
60050999|NCT01486966|76166679|FG001|STARTED|Overall Study||29||
60051000|NCT01486966|76166678|FG000|COMPLETED|Overall Study||29||
60051001|NCT01486966|76166679|FG001|COMPLETED|Overall Study||27||
60051002|NCT01486966|76166678|FG000|NOT COMPLETED|Overall Study||0||
60051003|NCT01486966|76166679|FG001|NOT COMPLETED|Overall Study||2||
60051004|NCT01900665|76166687|FG000|STARTED|Placebo Controlled Period||1057||
60051005|NCT01900665|76166688|FG001|STARTED|Placebo Controlled Period||1072||
60051006|NCT01900665|76166687|FG000|Received at Least 1 Dose of Study Drug|Placebo Controlled Period||1054||
60051007|NCT01900665|76166688|FG001|Received at Least 1 Dose of Study Drug|Placebo Controlled Period||1067||
60051008|NCT01900665|76166687|FG000|COMPLETED|Placebo Controlled Period||914||
60051009|NCT01900665|76166688|FG001|COMPLETED|Placebo Controlled Period||908||
60051010|NCT01900665|76166687|FG000|NOT COMPLETED|Placebo Controlled Period||143||
60051011|NCT01900665|76166688|FG001|NOT COMPLETED|Placebo Controlled Period||164||
60051012|NCT01900665|76166687|FG000|STARTED|Open Label Period|Patients from Placebo Controlled Period were not required to enter into Open Label Period.|881||
60051013|NCT01900665|76166688|FG001|STARTED|Open Label Period|Patients from Placebo Controlled Period were not required to enter into Open Label Period.|859||
60051014|NCT01900665|76166687|FG000|COMPLETED|Open Label Period||0||
60051015|NCT01900665|76166688|FG001|COMPLETED|Open Label Period||0||
60051016|NCT01900665|76166687|FG000|NOT COMPLETED|Open Label Period||881||
60051017|NCT01900665|76166688|FG001|NOT COMPLETED|Open Label Period||859||
60051018|NCT01900431|76166699|FG000|STARTED|Principal Treatment Period (Part A)||20||
60051019|NCT01900431|76166700|FG001|STARTED|Principal Treatment Period (Part A)||38||
60051020|NCT01900431|76166701|FG002|STARTED|Principal Treatment Period (Part A)||0||
60051021|NCT01900431|76166699|FG000|COMPLETED|Principal Treatment Period (Part A)|8 responders entered Part B and 5 non-responders entered Part C.|13||
60051022|NCT01900431|76166700|FG001|COMPLETED|Principal Treatment Period (Part A)|22 responders entered Part B, 5 non-responders entered Part C, 1 discontinued the study.|28||
60051023|NCT01900431|76166701|FG002|COMPLETED|Principal Treatment Period (Part A)||0||
60051024|NCT01900431|76166699|FG000|NOT COMPLETED|Principal Treatment Period (Part A)||7||
60051025|NCT01900431|76166700|FG001|NOT COMPLETED|Principal Treatment Period (Part A)||10||
60051026|NCT01900431|76166701|FG002|NOT COMPLETED|Principal Treatment Period (Part A)||0||
60051027|NCT01900431|76166699|FG000|STARTED|Extended Treatment Period (Part B)||8||
60051028|NCT01900431|76166700|FG001|STARTED|Extended Treatment Period (Part B)||22||
60051029|NCT01900431|76166701|FG002|STARTED|Extended Treatment Period (Part B)||0||
60051030|NCT01900431|76166699|FG000|COMPLETED|Extended Treatment Period (Part B)||7||
60051031|NCT01900431|76166700|FG001|COMPLETED|Extended Treatment Period (Part B)||12||
60051032|NCT01900431|76166701|FG002|COMPLETED|Extended Treatment Period (Part B)||0||
60051033|NCT01900431|76166699|FG000|NOT COMPLETED|Extended Treatment Period (Part B)||1||
60051034|NCT01900431|76166700|FG001|NOT COMPLETED|Extended Treatment Period (Part B)||10||
60051035|NCT01900431|76166701|FG002|NOT COMPLETED|Extended Treatment Period (Part B)||0||
60051036|NCT01900431|76166699|FG000|STARTED|Open-Label Treatment Period (Part C)||0||
60051037|NCT01900431|76166700|FG001|STARTED|Open-Label Treatment Period (Part C)||0||
60051038|NCT01900431|76166701|FG002|STARTED|Open-Label Treatment Period (Part C)|10 non-responders (5 Placebo, 5 Sarilumab) & 11 non-completers (6 Placebo, 5 Sarilumab) from Part A.|21||
60051039|NCT01900431|76166699|FG000|COMPLETED|Open-Label Treatment Period (Part C)||0||
60051040|NCT01900431|76166700|FG001|COMPLETED|Open-Label Treatment Period (Part C)||0||
60051041|NCT01900431|76166701|FG002|COMPLETED|Open-Label Treatment Period (Part C)||13||
60051042|NCT01900431|76166699|FG000|NOT COMPLETED|Open-Label Treatment Period (Part C)||0||
60051043|NCT01900431|76166700|FG001|NOT COMPLETED|Open-Label Treatment Period (Part C)||0||
60051044|NCT01900431|76166701|FG002|NOT COMPLETED|Open-Label Treatment Period (Part C)||8||
60051045|NCT01948791|76166709|FG000|STARTED|Overall Study||222||
60051046|NCT01948791|76166709|FG000|COMPLETED|Overall Study||151||
60051047|NCT01948791|76166709|FG000|NOT COMPLETED|Overall Study||71||
60051048|NCT01899729|76166718|FG000|STARTED|Overall Study||9||
60051049|NCT01899729|76166719|FG001|STARTED|Overall Study||9||
60051050|NCT01899729|76166720|FG002|STARTED|Overall Study||8||
60051051|NCT01899729|76166721|FG003|STARTED|Overall Study||9||
60051052|NCT01899729|76166722|FG004|STARTED|Overall Study||11||
60051053|NCT01899729|76166718|FG000|COMPLETED|Overall Study||7||
60051054|NCT01899729|76166719|FG001|COMPLETED|Overall Study||7||
60051055|NCT01899729|76166720|FG002|COMPLETED|Overall Study||6||
60051056|NCT01899729|76166721|FG003|COMPLETED|Overall Study||9||
60051057|NCT01899729|76166722|FG004|COMPLETED|Overall Study||9||
60051058|NCT01899729|76166718|FG000|NOT COMPLETED|Overall Study||2||
60051059|NCT01899729|76166719|FG001|NOT COMPLETED|Overall Study||2||
60051060|NCT01899729|76166720|FG002|NOT COMPLETED|Overall Study||2||
60051061|NCT01899729|76166721|FG003|NOT COMPLETED|Overall Study||0||
60051062|NCT01899729|76166722|FG004|NOT COMPLETED|Overall Study||2||
60051063|NCT01898091|76166736|FG000|STARTED|Overall Study|Allocated to intervention. All allocated received intervention.|25||
60051064|NCT01898091|76166737|FG001|STARTED|Overall Study|Allocated to intervention. All allocated received intervention.|25||
60051065|NCT01898091|76166736|FG000|COMPLETED|Overall Study||23||
60051066|NCT01898091|76166737|FG001|COMPLETED|Overall Study||19||
60051067|NCT01898091|76166736|FG000|NOT COMPLETED|Overall Study||2||
60051068|NCT01898091|76166737|FG001|NOT COMPLETED|Overall Study||6||
60051069|NCT01947855|76166746|FG000|STARTED|Overall Study||21||
60051070|NCT01947855|76166747|FG001|STARTED|Overall Study||20||
60051071|NCT01947855|76166748|FG002|STARTED|Overall Study||19||
60051072|NCT01947855|76166746|FG000|COMPLETED|Overall Study||20||
60051073|NCT01947855|76166747|FG001|COMPLETED|Overall Study||20||
60051074|NCT01947855|76166748|FG002|COMPLETED|Overall Study||19||
60051075|NCT01947855|76166746|FG000|NOT COMPLETED|Overall Study||1||
60051076|NCT01947855|76166747|FG001|NOT COMPLETED|Overall Study||0||
60051077|NCT01947855|76166748|FG002|NOT COMPLETED|Overall Study||0||
60051078|NCT01888965|76166756|FG000|STARTED|Overall Study||9||
60051079|NCT01888965|76166756|FG000|COMPLETED|Overall Study||0||
60051080|NCT01888965|76166756|FG000|NOT COMPLETED|Overall Study||9||
60051081|NCT01888497|76166760|FG000|STARTED|First Intervention Period||13||
60051082|NCT01888497|76166761|FG001|STARTED|First Intervention Period||14||
60051083|NCT01888497|76166762|FG002|STARTED|First Intervention Period||15||
60051084|NCT01888497|76166763|FG003|STARTED|First Intervention Period||17||
60051085|NCT01888497|76166760|FG000|COMPLETED|First Intervention Period||13||
60051086|NCT01888497|76166761|FG001|COMPLETED|First Intervention Period||14||
60051087|NCT01888497|76166762|FG002|COMPLETED|First Intervention Period||15||
60051088|NCT01888497|76166763|FG003|COMPLETED|First Intervention Period||17||
60051089|NCT01888497|76166760|FG000|NOT COMPLETED|First Intervention Period||0||
60051090|NCT01888497|76166761|FG001|NOT COMPLETED|First Intervention Period||0||
60051091|NCT01888497|76166762|FG002|NOT COMPLETED|First Intervention Period||0||
60051092|NCT01888497|76166763|FG003|NOT COMPLETED|First Intervention Period||0||
60051093|NCT01888497|76166760|FG000|STARTED|Washout Period 1||13||
60051094|NCT01888497|76166761|FG001|STARTED|Washout Period 1||14||
60051095|NCT01888497|76166762|FG002|STARTED|Washout Period 1||15||
60051096|NCT01888497|76166763|FG003|STARTED|Washout Period 1||17||
60051097|NCT01888497|76166760|FG000|COMPLETED|Washout Period 1||13||
59612780|NCT01697592|75723840|FG009|STARTED|Phase A (Up to 24 Weeks)||32||
59612781|NCT01697592|75723831|FG000|COMPLETED|Phase A (Up to 24 Weeks)||123||
59612782|NCT01697592|75723832|FG001|COMPLETED|Phase A (Up to 24 Weeks)||62||
59612783|NCT01697592|75723833|FG002|COMPLETED|Phase A (Up to 24 Weeks)||65||
59612784|NCT01697592|75723834|FG003|COMPLETED|Phase A (Up to 24 Weeks)||63||
59762611|NCT00866307|75882443|FG000|STARTED|Consolidation/Maintenance||0||
60051098|NCT01888497|76166761|FG001|COMPLETED|Washout Period 1||14||
60051099|NCT01888497|76166762|FG002|COMPLETED|Washout Period 1||14||
60051100|NCT01888497|76166763|FG003|COMPLETED|Washout Period 1||16||
60051101|NCT01888497|76166760|FG000|NOT COMPLETED|Washout Period 1||0||
60051102|NCT01888497|76166761|FG001|NOT COMPLETED|Washout Period 1||0||
60051103|NCT01888497|76166762|FG002|NOT COMPLETED|Washout Period 1||1||
60051104|NCT01888497|76166763|FG003|NOT COMPLETED|Washout Period 1||1||
60051105|NCT01888497|76166760|FG000|STARTED|Second Intervention Period||13||
60051106|NCT01888497|76166761|FG001|STARTED|Second Intervention Period||14||
60051107|NCT01888497|76166762|FG002|STARTED|Second Intervention Period||14||
60051108|NCT01888497|76166763|FG003|STARTED|Second Intervention Period||16||
60051109|NCT01888497|76166760|FG000|COMPLETED|Second Intervention Period||13||
60051110|NCT01888497|76166761|FG001|COMPLETED|Second Intervention Period||14||
60051111|NCT01888497|76166762|FG002|COMPLETED|Second Intervention Period||14||
60051112|NCT01888497|76166763|FG003|COMPLETED|Second Intervention Period||16||
60051113|NCT01888497|76166760|FG000|NOT COMPLETED|Second Intervention Period||0||
59612785|NCT01697592|75723835|FG004|COMPLETED|Phase A (Up to 24 Weeks)||67||
60051114|NCT01888497|76166761|FG001|NOT COMPLETED|Second Intervention Period||0||
60051115|NCT01888497|76166762|FG002|NOT COMPLETED|Second Intervention Period||0||
60051116|NCT01888497|76166763|FG003|NOT COMPLETED|Second Intervention Period||0||
60051117|NCT01888497|76166760|FG000|STARTED|Washout Period 2||13||
60051118|NCT01888497|76166761|FG001|STARTED|Washout Period 2||14||
60051119|NCT01888497|76166762|FG002|STARTED|Washout Period 2||14||
60051120|NCT01888497|76166763|FG003|STARTED|Washout Period 2||16||
60051121|NCT01888497|76166760|FG000|COMPLETED|Washout Period 2||13||
60051122|NCT01888497|76166761|FG001|COMPLETED|Washout Period 2||14||
60051123|NCT01888497|76166762|FG002|COMPLETED|Washout Period 2||14||
60051124|NCT01888497|76166763|FG003|COMPLETED|Washout Period 2||14||
60051125|NCT01888497|76166760|FG000|NOT COMPLETED|Washout Period 2||0||
60051126|NCT01888497|76166761|FG001|NOT COMPLETED|Washout Period 2||0||
60051127|NCT01888497|76166762|FG002|NOT COMPLETED|Washout Period 2||0||
60051128|NCT01888497|76166763|FG003|NOT COMPLETED|Washout Period 2||2||
60051129|NCT01888497|76166760|FG000|STARTED|Third Intervention Period||13||
60051130|NCT01888497|76166761|FG001|STARTED|Third Intervention Period||14||
60051131|NCT01888497|76166762|FG002|STARTED|Third Intervention Period||14||
60051132|NCT01888497|76166763|FG003|STARTED|Third Intervention Period||14||
60051133|NCT01888497|76166760|FG000|COMPLETED|Third Intervention Period||13||
60051134|NCT01888497|76166761|FG001|COMPLETED|Third Intervention Period||14||
60051135|NCT01888497|76166762|FG002|COMPLETED|Third Intervention Period||14||
60051136|NCT01888497|76166763|FG003|COMPLETED|Third Intervention Period||14||
60051137|NCT01888497|76166760|FG000|NOT COMPLETED|Third Intervention Period||0||
60051138|NCT01888497|76166761|FG001|NOT COMPLETED|Third Intervention Period||0||
60051139|NCT01888497|76166762|FG002|NOT COMPLETED|Third Intervention Period||0||
60051140|NCT01888497|76166763|FG003|NOT COMPLETED|Third Intervention Period||0||
60051141|NCT01888497|76166760|FG000|STARTED|Washout Period 3||13||
60051142|NCT01888497|76166761|FG001|STARTED|Washout Period 3||14||
60051143|NCT01888497|76166762|FG002|STARTED|Washout Period 3||14||
60051144|NCT01888497|76166763|FG003|STARTED|Washout Period 3||14||
60051145|NCT01888497|76166760|FG000|COMPLETED|Washout Period 3||13||
60051146|NCT01888497|76166761|FG001|COMPLETED|Washout Period 3||14||
60051147|NCT01888497|76166762|FG002|COMPLETED|Washout Period 3||14||
60051148|NCT01888497|76166763|FG003|COMPLETED|Washout Period 3||14||
60051149|NCT01888497|76166760|FG000|NOT COMPLETED|Washout Period 3||0||
60051150|NCT01888497|76166761|FG001|NOT COMPLETED|Washout Period 3||0||
60051151|NCT01888497|76166762|FG002|NOT COMPLETED|Washout Period 3||0||
59513841|NCT02951182|75607450|FG000|COMPLETED|Overall Study||11||
59513842|NCT02951182|75607451|FG001|COMPLETED|Overall Study||9||
59513843|NCT02951182|75607452|FG002|COMPLETED|Overall Study||9||
60051152|NCT01888497|76166763|FG003|NOT COMPLETED|Washout Period 3||0||
60051153|NCT01888497|76166760|FG000|STARTED|Fourth Intervention Period||13||
60051154|NCT01888497|76166761|FG001|STARTED|Fourth Intervention Period||14||
60051155|NCT01888497|76166762|FG002|STARTED|Fourth Intervention Period||14||
60051156|NCT01888497|76166763|FG003|STARTED|Fourth Intervention Period||14||
60051157|NCT01888497|76166760|FG000|COMPLETED|Fourth Intervention Period||13||
60051158|NCT01888497|76166761|FG001|COMPLETED|Fourth Intervention Period||14||
60051159|NCT01888497|76166762|FG002|COMPLETED|Fourth Intervention Period||14||
60051160|NCT01888497|76166763|FG003|COMPLETED|Fourth Intervention Period||14||
60051161|NCT01888497|76166760|FG000|NOT COMPLETED|Fourth Intervention Period||0||
60051162|NCT01888497|76166761|FG001|NOT COMPLETED|Fourth Intervention Period||0||
60051163|NCT01888497|76166762|FG002|NOT COMPLETED|Fourth Intervention Period||0||
60051164|NCT01888497|76166763|FG003|NOT COMPLETED|Fourth Intervention Period||0||
60051165|NCT01505530|76166776|FG000|STARTED|Overall Study||41||
60051166|NCT01505530|76166777|FG001|STARTED|Overall Study||43||
60051167|NCT01505530|76166778|FG002|STARTED|Overall Study||41||
60051168|NCT01505530|76166776|FG000|Received At Least One Dose of Study Drug|Overall Study||41||
60051169|NCT01505530|76166777|FG001|Received At Least One Dose of Study Drug|Overall Study||42||
60051170|NCT01505530|76166778|FG002|Received At Least One Dose of Study Drug|Overall Study||41||
60051171|NCT01505530|76166776|FG000|Completed One Cycle of Study Drug|Overall Study||29||
60051172|NCT01505530|76166777|FG001|Completed One Cycle of Study Drug|Overall Study||27||
60051173|NCT01505530|76166778|FG002|Completed One Cycle of Study Drug|Overall Study||31||
60051174|NCT01505530|76166776|FG000|COMPLETED|Overall Study||0||
60051175|NCT01505530|76166777|FG001|COMPLETED|Overall Study||0||
60051176|NCT01505530|76166778|FG002|COMPLETED|Overall Study||0||
60051177|NCT01505530|76166776|FG000|NOT COMPLETED|Overall Study||41||
60051178|NCT01505530|76166777|FG001|NOT COMPLETED|Overall Study||43||
60051179|NCT01505530|76166778|FG002|NOT COMPLETED|Overall Study||41||
60051180|NCT01485796|76166786|FG000|STARTED|Period 1: Epoch 1 (Ramp-up)||37||
60051181|NCT01485796|76166786|FG000|Treated in Epoch 1|Period 1: Epoch 1 (Ramp-up)||37||
60051182|NCT01485796|76166786|FG000|COMPLETED|Period 1: Epoch 1 (Ramp-up)||36||
60051183|NCT01485796|76166786|FG000|NOT COMPLETED|Period 1: Epoch 1 (Ramp-up)||1||
60051184|NCT01485796|76166786|FG000|STARTED|Period 2: Epoch 2||36||
60051185|NCT01485796|76166786|FG000|Treated in Epoch 2|Period 2: Epoch 2||36||
59513844|NCT02951182|75607453|FG003|COMPLETED|Overall Study||18||
59513845|NCT02951182|75607454|FG004|COMPLETED|Overall Study||6||
59513846|NCT02951182|75607455|FG005|COMPLETED|Overall Study||20||
59513847|NCT02951182|75607450|FG000|NOT COMPLETED|Overall Study||0||
59513848|NCT02951182|75607451|FG001|NOT COMPLETED|Overall Study||0||
59921486|NCT03130959|76040963|FG001|STARTED|Overall Study||22|Started = initiated treatment|
59921487|NCT03130959|76040964|FG002|STARTED|Overall Study||16|Started = initiated treatment|
59921488|NCT03130959|76040965|FG003|STARTED|Overall Study||15|Started = initiated treatment|
59921489|NCT03130959|76040966|FG004|STARTED|Overall Study||15|Started = initiated treatment|
59921490|NCT03130959|76040967|FG005|STARTED|Overall Study||15|Started = initiated treatment|
59921491|NCT03130959|76040968|FG006|STARTED|Overall Study||12|Started = initiated treatment|
59921492|NCT03130959|76040969|FG007|STARTED|Overall Study||10|Started = initiated treatment|
59921493|NCT03130959|76040970|FG008|STARTED|Overall Study||19|Started = initiated treatment|
59921494|NCT03130959|76040971|FG009|STARTED|Overall Study||19|Started = initiated treatment|
59921495|NCT03130959|76040962|FG000|COMPLETED|Overall Study||0|Completed = completed treatment|
59921496|NCT03130959|76040963|FG001|COMPLETED|Overall Study||12|Completed = completed treatment|
59921497|NCT03130959|76040964|FG002|COMPLETED|Overall Study||0|Completed = completed treatment|
59921498|NCT03130959|76040965|FG003|COMPLETED|Overall Study||1|Completed = completed treatment|
59921499|NCT03130959|76040966|FG004|COMPLETED|Overall Study||0|Completed = completed treatment|
59921500|NCT03130959|76040967|FG005|COMPLETED|Overall Study||9|Completed = completed treatment|
59921501|NCT03130959|76040968|FG006|COMPLETED|Overall Study||0|Completed = completed treatment|
59921502|NCT03130959|76040969|FG007|COMPLETED|Overall Study||6|Completed = completed treatment|
59921503|NCT03130959|76040970|FG008|COMPLETED|Overall Study||0|Completed = completed treatment|
59921504|NCT03130959|76040971|FG009|COMPLETED|Overall Study||4|Completed = completed treatment|
59921505|NCT03130959|76040962|FG000|NOT COMPLETED|Overall Study||23||
59921506|NCT03130959|76040963|FG001|NOT COMPLETED|Overall Study||10||
59921507|NCT03130959|76040964|FG002|NOT COMPLETED|Overall Study||16||
59921508|NCT03130959|76040965|FG003|NOT COMPLETED|Overall Study||14||
59921509|NCT03130959|76040966|FG004|NOT COMPLETED|Overall Study||15||
59921510|NCT03130959|76040967|FG005|NOT COMPLETED|Overall Study||6||
59921511|NCT03130959|76040968|FG006|NOT COMPLETED|Overall Study||12||
59921512|NCT03130959|76040969|FG007|NOT COMPLETED|Overall Study||4||
59921513|NCT03130959|76040970|FG008|NOT COMPLETED|Overall Study||19||
59921514|NCT03130959|76040971|FG009|NOT COMPLETED|Overall Study||15||
59921515|NCT03124407|76041010|FG000|STARTED|Overall Study||40||
59921516|NCT03124407|76041011|FG001|STARTED|Overall Study||20||
59921517|NCT03124407|76041012|FG002|STARTED|Overall Study||40||
59921518|NCT03124407|76041013|FG003|STARTED|Overall Study||20||
59921519|NCT03124407|76041010|FG000|COMPLETED|Overall Study||39||
59921520|NCT03124407|76041011|FG001|COMPLETED|Overall Study||20||
59921521|NCT03124407|76041012|FG002|COMPLETED|Overall Study||39||
59921522|NCT03124407|76041013|FG003|COMPLETED|Overall Study||20||
59921523|NCT03124407|76041010|FG000|NOT COMPLETED|Overall Study||1||
59921524|NCT03124407|76041011|FG001|NOT COMPLETED|Overall Study||0||
59921525|NCT03124407|76041012|FG002|NOT COMPLETED|Overall Study||1||
59921526|NCT03124407|76041013|FG003|NOT COMPLETED|Overall Study||0||
59921527|NCT02929407|76041027|FG000|STARTED|Overall Study||4||
59921528|NCT02929407|76041027|FG000|COMPLETED|Overall Study||3||
59921529|NCT02929407|76041027|FG000|NOT COMPLETED|Overall Study||1||
59921530|NCT03123939|76041031|FG000|STARTED|Overall Study||74|enrolled participants|
59921531|NCT03123939|76041031|FG000|CTL019 Infused|Overall Study||69|all enrolled participants who received CTL019 infusion|
59921532|NCT03123939|76041031|FG000|Full Analysis Set (FAS)|Overall Study||69|all enrolled participants who received CTL019 infusion|
59921533|NCT03123939|76041031|FG000|Cellular Kinetic Analysis Set (CKAS)|Overall Study||69|participants who had at least 1 sample providing evaluable data|
59921534|NCT03123939|76041031|FG000|Safety Set (SAF)|Overall Study||69|all enrolled participants who received CTL019 infusion|
59921535|NCT03123939|76041031|FG000|COMPLETED|Overall Study||33||
59921536|NCT03123939|76041031|FG000|NOT COMPLETED|Overall Study||41||
59921537|NCT02358681|76041037|FG000|STARTED|Overall Study||29||
59921538|NCT02358681|76041038|FG001|STARTED|Overall Study||30||
59921539|NCT02358681|76041037|FG000|COMPLETED|Overall Study||27||
59921540|NCT02358681|76041038|FG001|COMPLETED|Overall Study||29||
59921541|NCT02358681|76041037|FG000|NOT COMPLETED|Overall Study||2||
59921542|NCT02358681|76041038|FG001|NOT COMPLETED|Overall Study||1||
59921543|NCT03123861|76041046|FG000|STARTED|Overall Study||22||
59921544|NCT03123861|76041047|FG001|STARTED|Overall Study||23||
59921545|NCT03123861|76041046|FG000|Received Intervention|Overall Study||21||
59921546|NCT03123861|76041047|FG001|Received Intervention|Overall Study||22||
59921547|NCT03123861|76041046|FG000|COMPLETED|Overall Study||19||
59921548|NCT03123861|76041047|FG001|COMPLETED|Overall Study||20||
59921549|NCT03123861|76041046|FG000|NOT COMPLETED|Overall Study||3||
59921550|NCT03123861|76041047|FG001|NOT COMPLETED|Overall Study||3||
59921551|NCT03123471|76041055|FG000|STARTED|Placebo-controlled Phase||102||
59921552|NCT03123471|76041056|FG001|STARTED|Placebo-controlled Phase||201||
59921553|NCT03123471|76041055|FG000|Received at Least 1 Dose of Study Drug|Placebo-controlled Phase||102||
59921554|NCT03123471|76041056|FG001|Received at Least 1 Dose of Study Drug|Placebo-controlled Phase||200||
59921555|NCT03123471|76041055|FG000|COMPLETED|Placebo-controlled Phase||84||
59921556|NCT03123471|76041056|FG001|COMPLETED|Placebo-controlled Phase||168||
59921557|NCT03123471|76041055|FG000|NOT COMPLETED|Placebo-controlled Phase||18||
59921558|NCT03123471|76041056|FG001|NOT COMPLETED|Placebo-controlled Phase||33||
59921559|NCT03123471|76041055|FG000|STARTED|Apremilast Extension Phase||84||
60051186|NCT01485796|76166786|FG000|COMPLETED|Period 2: Epoch 2||1||
60051187|NCT01485796|76166786|FG000|NOT COMPLETED|Period 2: Epoch 2||35||
60051188|NCT01485796|76166786|FG000|STARTED|Overall Trial (Incl. Safety Follow-up)||37||
60051189|NCT01485796|76166786|FG000|Treated in Epoch 1 (Ramp-up)|Overall Trial (Incl. Safety Follow-up)||37||
60051190|NCT01485796|76166786|FG000|Completed Epoch 1 (Ramp-up)|Overall Trial (Incl. Safety Follow-up)||36||
60051191|NCT01485796|76166786|FG000|Started Epoch 2|Overall Trial (Incl. Safety Follow-up)||36||
60051192|NCT01485796|76166786|FG000|Treated in Epoch 2|Overall Trial (Incl. Safety Follow-up)||36||
60051193|NCT01485796|76166786|FG000|Completed Epoch 2|Overall Trial (Incl. Safety Follow-up)||1||
60051194|NCT01485796|76166786|FG000|Switch to Safety Follow-up|Overall Trial (Incl. Safety Follow-up)||26||
60051195|NCT01485796|76166786|FG000|Completed Safety Follow-up|Overall Trial (Incl. Safety Follow-up)||24||
60051196|NCT01485796|76166786|FG000|COMPLETED|Overall Trial (Incl. Safety Follow-up)|1 subject who completed Epoch 2 + 24 subjects who completed the safety follow-up|25||
60051197|NCT01485796|76166786|FG000|NOT COMPLETED|Overall Trial (Incl. Safety Follow-up)||12||
60051198|NCT01505374|76166794|FG000|STARTED|Overall Study||30||
60051199|NCT01505374|76166795|FG001|STARTED|Overall Study||30||
60051200|NCT01505374|76166794|FG000|COMPLETED|Overall Study||29||
60051201|NCT01505374|76166795|FG001|COMPLETED|Overall Study||30||
60051202|NCT01505374|76166794|FG000|NOT COMPLETED|Overall Study||1||
60051203|NCT01505374|76166795|FG001|NOT COMPLETED|Overall Study||0||
60051204|NCT01897233|76166802|FG000|STARTED|Part A (14 Days)||10||
60051205|NCT01897233|76166802|FG000|Part A Cohort 1 (6 to 8 Years)|Part A (14 Days)||5||
60051206|NCT01897233|76166802|FG000|Part A Cohort 2 (9 to 11 Years)|Part A (14 Days)||5||
60051207|NCT01897233|76166802|FG000|COMPLETED|Part A (14 Days)||10||
60051208|NCT01897233|76166802|FG000|NOT COMPLETED|Part A (14 Days)||0||
60051209|NCT01897233|76166802|FG000|STARTED|Part B (24 Weeks)|6 participants from Part A also participated in Part B of the study.|58||
60051210|NCT01897233|76166802|FG000|COMPLETED|Part B (24 Weeks)||54||
60051211|NCT01897233|76166802|FG000|NOT COMPLETED|Part B (24 Weeks)||4||
60051212|NCT01887717|76166812|FG000|STARTED|Overall Study||17||
60051213|NCT01887717|76166813|FG001|STARTED|Overall Study||19||
60051214|NCT01887717|76166812|FG000|Received at Least 1 Dose of Study Drug|Overall Study||15||
60051215|NCT01887717|76166813|FG001|Received at Least 1 Dose of Study Drug|Overall Study||16||
60051216|NCT01887717|76166812|FG000|COMPLETED|Overall Study||11||
60051217|NCT01887717|76166813|FG001|COMPLETED|Overall Study||8||
60051218|NCT01887717|76166812|FG000|NOT COMPLETED|Overall Study||6||
60051219|NCT01887717|76166813|FG001|NOT COMPLETED|Overall Study||11||
60051220|NCT01886781|76166821|FG000|STARTED|Overall Study||54||
60051221|NCT01886781|76166822|FG001|STARTED|Overall Study||27||
60051222|NCT01886781|76166821|FG000|COMPLETED|Overall Study||40||
60051223|NCT01886781|76166822|FG001|COMPLETED|Overall Study||25||
60051224|NCT01886781|76166821|FG000|NOT COMPLETED|Overall Study||14||
60051225|NCT01886781|76166822|FG001|NOT COMPLETED|Overall Study||2||
60051226|NCT01463098|76166842|FG000|STARTED|Part A (11 Days)||16||
60051227|NCT01463098|76166843|FG001|STARTED|Part A (11 Days)||6||
60051228|NCT01463098|76166844|FG002|STARTED|Part A (11 Days)||6||
60051229|NCT01463098|76166845|FG003|STARTED|Part A (11 Days)||6||
60051230|NCT01463098|76166846|FG004|STARTED|Part A (11 Days)||6||
60051231|NCT01463098|76166847|FG005|STARTED|Part A (11 Days)||6||
60051232|NCT01463098|76166848|FG006|STARTED|Part A (11 Days)||6||
60051233|NCT01463098|76166849|FG007|STARTED|Part A (11 Days)||6||
60051234|NCT01463098|76166850|FG008|STARTED|Part A (11 Days)||6||
60051235|NCT01463098|76166851|FG009|STARTED|Part A (11 Days)||0||
60051236|NCT01463098|76166852|FG010|STARTED|Part A (11 Days)||0||
60051237|NCT01463098|76166853|FG011|STARTED|Part A (11 Days)||0||
60051238|NCT01463098|76166854|FG012|STARTED|Part A (11 Days)||0||
60051239|NCT01463098|76166855|FG013|STARTED|Part A (11 Days)||0||
60051240|NCT01463098|76166842|FG000|COMPLETED|Part A (11 Days)||14||
60051241|NCT01463098|76166843|FG001|COMPLETED|Part A (11 Days)||6||
60051242|NCT01463098|76166844|FG002|COMPLETED|Part A (11 Days)||6||
60051243|NCT01463098|76166845|FG003|COMPLETED|Part A (11 Days)||6||
60051244|NCT01463098|76166846|FG004|COMPLETED|Part A (11 Days)||5||
60051245|NCT01463098|76166847|FG005|COMPLETED|Part A (11 Days)||6||
60051246|NCT01463098|76166848|FG006|COMPLETED|Part A (11 Days)||6||
60051247|NCT01463098|76166849|FG007|COMPLETED|Part A (11 Days)||6||
60051248|NCT01463098|76166850|FG008|COMPLETED|Part A (11 Days)||5||
60051249|NCT01463098|76166851|FG009|COMPLETED|Part A (11 Days)||0||
60051250|NCT01463098|76166852|FG010|COMPLETED|Part A (11 Days)||0||
60051251|NCT01463098|76166853|FG011|COMPLETED|Part A (11 Days)||0||
60051252|NCT01463098|76166854|FG012|COMPLETED|Part A (11 Days)||0||
60051253|NCT01463098|76166855|FG013|COMPLETED|Part A (11 Days)||0||
60051254|NCT01463098|76166842|FG000|NOT COMPLETED|Part A (11 Days)||2||
60051255|NCT01463098|76166843|FG001|NOT COMPLETED|Part A (11 Days)||0||
60051256|NCT01463098|76166844|FG002|NOT COMPLETED|Part A (11 Days)||0||
60051257|NCT01463098|76166845|FG003|NOT COMPLETED|Part A (11 Days)||0||
60051258|NCT01463098|76166846|FG004|NOT COMPLETED|Part A (11 Days)||1||
60051259|NCT01463098|76166847|FG005|NOT COMPLETED|Part A (11 Days)||0||
60051260|NCT01463098|76166848|FG006|NOT COMPLETED|Part A (11 Days)||0||
60051261|NCT01463098|76166849|FG007|NOT COMPLETED|Part A (11 Days)||0||
60051262|NCT01463098|76166850|FG008|NOT COMPLETED|Part A (11 Days)||1||
60051263|NCT01463098|76166851|FG009|NOT COMPLETED|Part A (11 Days)||0||
60051264|NCT01463098|76166852|FG010|NOT COMPLETED|Part A (11 Days)||0||
60051265|NCT01463098|76166853|FG011|NOT COMPLETED|Part A (11 Days)||0||
60051266|NCT01463098|76166854|FG012|NOT COMPLETED|Part A (11 Days)||0||
60051267|NCT01463098|76166855|FG013|NOT COMPLETED|Part A (11 Days)||0||
60051268|NCT01463098|76166842|FG000|STARTED|Part B (11 Days)||0||
60051269|NCT01463098|76166843|FG001|STARTED|Part B (11 Days)||0||
60051270|NCT01463098|76166844|FG002|STARTED|Part B (11 Days)||0||
60051271|NCT01463098|76166845|FG003|STARTED|Part B (11 Days)||0||
60051272|NCT01463098|76166846|FG004|STARTED|Part B (11 Days)||0||
60051273|NCT01463098|76166847|FG005|STARTED|Part B (11 Days)||0||
60051274|NCT01463098|76166848|FG006|STARTED|Part B (11 Days)||0||
60051275|NCT01463098|76166849|FG007|STARTED|Part B (11 Days)||0||
60051276|NCT01463098|76166850|FG008|STARTED|Part B (11 Days)||0||
60051277|NCT01463098|76166851|FG009|STARTED|Part B (11 Days)||12||
60051278|NCT01463098|76166852|FG010|STARTED|Part B (11 Days)||11||
60051279|NCT01463098|76166853|FG011|STARTED|Part B (11 Days)||13||
60051280|NCT01463098|76166854|FG012|STARTED|Part B (11 Days)||10||
60051281|NCT01463098|76166855|FG013|STARTED|Part B (11 Days)||12||
60051282|NCT01463098|76166842|FG000|COMPLETED|Part B (11 Days)||0||
60051283|NCT01463098|76166843|FG001|COMPLETED|Part B (11 Days)||0||
60051284|NCT01463098|76166844|FG002|COMPLETED|Part B (11 Days)||0||
60051285|NCT01463098|76166845|FG003|COMPLETED|Part B (11 Days)||0||
60051286|NCT01463098|76166846|FG004|COMPLETED|Part B (11 Days)||0||
60051287|NCT01463098|76166847|FG005|COMPLETED|Part B (11 Days)||0||
60051288|NCT01463098|76166848|FG006|COMPLETED|Part B (11 Days)||0||
60051289|NCT01463098|76166849|FG007|COMPLETED|Part B (11 Days)||0||
60051290|NCT01463098|76166850|FG008|COMPLETED|Part B (11 Days)||0||
60051291|NCT01463098|76166851|FG009|COMPLETED|Part B (11 Days)||12||
60051292|NCT01463098|76166852|FG010|COMPLETED|Part B (11 Days)||11||
60051293|NCT01463098|76166853|FG011|COMPLETED|Part B (11 Days)||12||
60051294|NCT01463098|76166854|FG012|COMPLETED|Part B (11 Days)||10||
60051295|NCT01463098|76166855|FG013|COMPLETED|Part B (11 Days)||12||
60051296|NCT01463098|76166842|FG000|NOT COMPLETED|Part B (11 Days)||0||
60051297|NCT01463098|76166843|FG001|NOT COMPLETED|Part B (11 Days)||0||
60051298|NCT01463098|76166844|FG002|NOT COMPLETED|Part B (11 Days)||0||
60051299|NCT01463098|76166845|FG003|NOT COMPLETED|Part B (11 Days)||0||
60051300|NCT01463098|76166846|FG004|NOT COMPLETED|Part B (11 Days)||0||
60051301|NCT01463098|76166847|FG005|NOT COMPLETED|Part B (11 Days)||0||
60051302|NCT01463098|76166848|FG006|NOT COMPLETED|Part B (11 Days)||0||
60051303|NCT01463098|76166849|FG007|NOT COMPLETED|Part B (11 Days)||0||
60051304|NCT01463098|76166850|FG008|NOT COMPLETED|Part B (11 Days)||0||
60051305|NCT01463098|76166851|FG009|NOT COMPLETED|Part B (11 Days)||0||
60051306|NCT01463098|76166852|FG010|NOT COMPLETED|Part B (11 Days)||0||
60051307|NCT01463098|76166853|FG011|NOT COMPLETED|Part B (11 Days)||1||
60051308|NCT01463098|76166854|FG012|NOT COMPLETED|Part B (11 Days)||0||
60051309|NCT01463098|76166855|FG013|NOT COMPLETED|Part B (11 Days)||0||
60051310|NCT01462942|76166909|FG000|STARTED|Overall Study||194||
60051311|NCT01462942|76166910|FG001|STARTED|Overall Study||385||
60051312|NCT01462942|76166911|FG002|STARTED|Overall Study||381||
60051313|NCT01462942|76166912|FG003|STARTED|Overall Study||385||
60051314|NCT01462942|76166913|FG004|STARTED|Overall Study||384||
60051315|NCT01462942|76166909|FG000|COMPLETED|Overall Study||160||
60051316|NCT01462942|76166910|FG001|COMPLETED|Overall Study||351||
60051317|NCT01462942|76166911|FG002|COMPLETED|Overall Study||341||
60051318|NCT01462942|76166912|FG003|COMPLETED|Overall Study||335||
60051319|NCT01462942|76166913|FG004|COMPLETED|Overall Study||339||
60051320|NCT01462942|76166909|FG000|NOT COMPLETED|Overall Study||34||
60051321|NCT01462942|76166910|FG001|NOT COMPLETED|Overall Study||34||
60051322|NCT01462942|76166911|FG002|NOT COMPLETED|Overall Study||40||
60051323|NCT01462942|76166912|FG003|NOT COMPLETED|Overall Study||50||
60051324|NCT01462942|76166913|FG004|NOT COMPLETED|Overall Study||45||
60051325|NCT01462630|76166925|FG000|STARTED|Overall Study||29||
60051326|NCT01462630|76166925|FG000|COMPLETED|Overall Study||22||
60051327|NCT01462630|76166925|FG000|NOT COMPLETED|Overall Study||7||
60051328|NCT01504204|76166931|FG000|STARTED|Overall Study||10||
60051329|NCT01504204|76166932|FG001|STARTED|Overall Study||10||
60051330|NCT01504204|76166931|FG000|COMPLETED|Overall Study||9||
60051331|NCT01504204|76166932|FG001|COMPLETED|Overall Study||9||
60051332|NCT01504204|76166931|FG000|NOT COMPLETED|Overall Study||1||
60051333|NCT01504204|76166932|FG001|NOT COMPLETED|Overall Study||1||
60051334|NCT01485640|76166938|FG000|STARTED|Overall Study||162||
60051335|NCT01485640|76166938|FG000|COMPLETED|Overall Study||40||
60051336|NCT01485640|76166938|FG000|NOT COMPLETED|Overall Study||122||
60051337|NCT02118961|76166944|FG000|STARTED|Overall Study||224||
60051338|NCT02118961|76166945|FG001|STARTED|Overall Study||222||
60051339|NCT02118961|76166944|FG000|COMPLETED|Overall Study||223||
60051340|NCT02118961|76166945|FG001|COMPLETED|Overall Study||222||
60051341|NCT02118961|76166944|FG000|NOT COMPLETED|Overall Study||1||
60051342|NCT02118961|76166945|FG001|NOT COMPLETED|Overall Study||0||
60051343|NCT02140645|76166957|FG000|STARTED|Overall Study||5732||
60051344|NCT02140645|76166958|FG001|STARTED|Overall Study||64695||
60051345|NCT02140645|76166959|FG002|STARTED|Overall Study||4441||
60051346|NCT02140645|76166960|FG003|STARTED|Overall Study||14363||
60051347|NCT02140645|76166961|FG004|STARTED|Overall Study||3436||
60051348|NCT02140645|76166962|FG005|STARTED|Overall Study||73946||
60051349|NCT02140645|76166957|FG000|COMPLETED|Overall Study||243||
60051350|NCT02140645|76166958|FG001|COMPLETED|Overall Study||3041||
60051351|NCT02140645|76166959|FG002|COMPLETED|Overall Study||205||
60051352|NCT02140645|76166960|FG003|COMPLETED|Overall Study||530||
60051353|NCT02140645|76166961|FG004|COMPLETED|Overall Study||150||
60051354|NCT02140645|76166962|FG005|COMPLETED|Overall Study||3050||
60051355|NCT02140645|76166957|FG000|NOT COMPLETED|Overall Study||5489||
60051356|NCT02140645|76166958|FG001|NOT COMPLETED|Overall Study||61654||
60051357|NCT02140645|76166959|FG002|NOT COMPLETED|Overall Study||4236||
60051358|NCT02140645|76166960|FG003|NOT COMPLETED|Overall Study||13833||
60051359|NCT02140645|76166961|FG004|NOT COMPLETED|Overall Study||3286||
60051360|NCT02140645|76166962|FG005|NOT COMPLETED|Overall Study||70896||
60051361|NCT02140567|76166971|FG000|STARTED|Overall Study||140||
60051362|NCT02140567|76166971|FG000|COMPLETED|Overall Study||134||
60051363|NCT02140567|76166971|FG000|NOT COMPLETED|Overall Study||6||
60051364|NCT02140411|76166976|FG000|STARTED|Overall Study||21||
60051365|NCT02140411|76166976|FG000|COMPLETED|Overall Study||20||
60051366|NCT02140411|76166976|FG000|NOT COMPLETED|Overall Study||1||
60051367|NCT02139943|76166983|FG000|STARTED|Overall Study||117||
60051368|NCT02139943|76166984|FG001|STARTED|Overall Study||117||
60051369|NCT02139943|76166985|FG002|STARTED|Overall Study||117||
60051370|NCT02139943|76166983|FG000|COMPLETED|Overall Study||107||
60051371|NCT02139943|76166984|FG001|COMPLETED|Overall Study||111||
60051372|NCT02139943|76166985|FG002|COMPLETED|Overall Study||110||
60051373|NCT02139943|76166983|FG000|NOT COMPLETED|Overall Study||10||
60051374|NCT02139943|76166984|FG001|NOT COMPLETED|Overall Study||6||
60051375|NCT02139943|76166985|FG002|NOT COMPLETED|Overall Study||7||
60051376|NCT01485172|76166999|FG000|STARTED|Overall Study||40||
60051377|NCT01485172|76167000|FG001|STARTED|Overall Study||13||
60051378|NCT01485172|76167001|FG002|STARTED|Overall Study||41||
60051379|NCT01485172|76167002|FG003|STARTED|Overall Study||40||
60051380|NCT01485172|76167003|FG004|STARTED|Overall Study||39||
60051381|NCT01485172|76167004|FG005|STARTED|Overall Study||13||
60051382|NCT01485172|76166999|FG000|COMPLETED|Overall Study||33||
60051383|NCT01485172|76167000|FG001|COMPLETED|Overall Study||12||
60051384|NCT01485172|76167001|FG002|COMPLETED|Overall Study||34||
60051385|NCT01485172|76167002|FG003|COMPLETED|Overall Study||32||
60051386|NCT01485172|76167003|FG004|COMPLETED|Overall Study||34||
60051387|NCT01485172|76167004|FG005|COMPLETED|Overall Study||9||
60051388|NCT01485172|76166999|FG000|NOT COMPLETED|Overall Study||7||
60051389|NCT01485172|76167000|FG001|NOT COMPLETED|Overall Study||1||
60051390|NCT01485172|76167001|FG002|NOT COMPLETED|Overall Study||7||
60051391|NCT01485172|76167002|FG003|NOT COMPLETED|Overall Study||8||
60051392|NCT01485172|76167003|FG004|NOT COMPLETED|Overall Study||5||
60051393|NCT01485172|76167004|FG005|NOT COMPLETED|Overall Study||4||
60051394|NCT02105701|76167022|FG000|STARTED|Overall Study||105||
60051395|NCT02105701|76167023|FG001|STARTED|Overall Study||104||
60051396|NCT02105701|76167024|FG002|STARTED|Overall Study||105||
60051397|NCT02105701|76167025|FG003|STARTED|Overall Study||106||
60051398|NCT02105701|76167022|FG000|COMPLETED|Overall Study||101||
60051399|NCT02105701|76167023|FG001|COMPLETED|Overall Study||103||
60051400|NCT02105701|76167024|FG002|COMPLETED|Overall Study||102||
60051401|NCT02105701|76167025|FG003|COMPLETED|Overall Study||104||
60051402|NCT02105701|76167022|FG000|NOT COMPLETED|Overall Study||4||
60051403|NCT02105701|76167023|FG001|NOT COMPLETED|Overall Study||1||
60051404|NCT02105701|76167024|FG002|NOT COMPLETED|Overall Study||3||
60051405|NCT02105701|76167025|FG003|NOT COMPLETED|Overall Study||2||
60051406|NCT01502956|76167037|FG000|STARTED|Overall Study||192||
60051407|NCT01502956|76167038|FG001|STARTED|Overall Study||194||
60051408|NCT01502956|76167037|FG000|COMPLETED|Overall Study||168||
60051409|NCT01502956|76167038|FG001|COMPLETED|Overall Study||168||
60051410|NCT01502956|76167037|FG000|NOT COMPLETED|Overall Study||24||
60051411|NCT01502956|76167038|FG001|NOT COMPLETED|Overall Study||26||
60051412|NCT01502644|76167047|FG000|STARTED|Enrolled at Visit 1 After Pre-screening||81||
60051413|NCT01502644|76167048|FG001|STARTED|Enrolled at Visit 1 After Pre-screening||0||
60051414|NCT01502644|76167049|FG002|STARTED|Enrolled at Visit 1 After Pre-screening||0||
60051415|NCT01502644|76167050|FG003|STARTED|Enrolled at Visit 1 After Pre-screening||0||
60051416|NCT01502644|76167047|FG000|COMPLETED|Enrolled at Visit 1 After Pre-screening|Participants who completed Visit 1 were assigned to 1 of the 3 NA groups for remainder of the trial|72||
60051417|NCT01502644|76167048|FG001|COMPLETED|Enrolled at Visit 1 After Pre-screening||0||
60051418|NCT01502644|76167049|FG002|COMPLETED|Enrolled at Visit 1 After Pre-screening||0||
60051419|NCT01502644|76167050|FG003|COMPLETED|Enrolled at Visit 1 After Pre-screening||0||
60051420|NCT01502644|76167047|FG000|NOT COMPLETED|Enrolled at Visit 1 After Pre-screening||9||
60051421|NCT01502644|76167048|FG001|NOT COMPLETED|Enrolled at Visit 1 After Pre-screening||0||
60051422|NCT01502644|76167049|FG002|NOT COMPLETED|Enrolled at Visit 1 After Pre-screening||0||
60051423|NCT01502644|76167050|FG003|NOT COMPLETED|Enrolled at Visit 1 After Pre-screening||0||
60051424|NCT01502644|76167047|FG000|STARTED|Assigned to NA Groups||0||
60051425|NCT01502644|76167048|FG001|STARTED|Assigned to NA Groups||30||
60051426|NCT01502644|76167049|FG002|STARTED|Assigned to NA Groups||10||
59513849|NCT02951182|75607452|FG002|NOT COMPLETED|Overall Study||0||
59513850|NCT02951182|75607453|FG003|NOT COMPLETED|Overall Study||0||
59513851|NCT02951182|75607454|FG004|NOT COMPLETED|Overall Study||0||
59513852|NCT02951182|75607455|FG005|NOT COMPLETED|Overall Study||0||
59513853|NCT02829034|75607477|FG000|STARTED|Overall Study||14||
59513854|NCT02829034|75607478|FG001|STARTED|Overall Study||8||
59513855|NCT02829034|75607477|FG000|COMPLETED|Overall Study||9||
59513856|NCT02829034|75607478|FG001|COMPLETED|Overall Study||6||
59513857|NCT02829034|75607477|FG000|NOT COMPLETED|Overall Study||5||
59513858|NCT02829034|75607478|FG001|NOT COMPLETED|Overall Study||2||
59513859|NCT00924209|75607484|FG000|STARTED|Overall Study||7||
59513860|NCT00924209|75607484|FG000|COMPLETED|Overall Study||7||
59513861|NCT00924209|75607484|FG000|NOT COMPLETED|Overall Study||0||
59513862|NCT02830438|75607488|FG000|STARTED|Overall Study||8||
59513863|NCT02830438|75607488|FG000|COMPLETED|Overall Study||8||
59513864|NCT02830438|75607488|FG000|NOT COMPLETED|Overall Study||0||
59513865|NCT02832154|75607492|FG000|STARTED|Overall Study||43||
59513866|NCT02832154|75607492|FG000|COMPLETED|Overall Study||43||
59513867|NCT02832154|75607492|FG000|NOT COMPLETED|Overall Study||0||
59513868|NCT02951884|75607499|FG000|STARTED|Overall Study||0||
59513869|NCT02951884|75607500|FG001|STARTED|Overall Study||1||
59513870|NCT02951884|75607501|FG002|STARTED|Overall Study||1||
59921560|NCT03123471|76041056|FG001|STARTED|Apremilast Extension Phase|3 participants completed the first phase; did not enter in extension phase|165||
59921561|NCT03123471|76041055|FG000|Received at Least 1 Dose of Study Drug|Apremilast Extension Phase||84||
59921562|NCT03123471|76041056|FG001|Received at Least 1 Dose of Study Drug|Apremilast Extension Phase||163||
59921563|NCT03123471|76041055|FG000|COMPLETED|Apremilast Extension Phase||76||
59921564|NCT03123471|76041056|FG001|COMPLETED|Apremilast Extension Phase||140||
59921565|NCT03123471|76041055|FG000|NOT COMPLETED|Apremilast Extension Phase||8||
59921566|NCT03123471|76041056|FG001|NOT COMPLETED|Apremilast Extension Phase||25||
59921567|NCT02661178|76041083|FG000|STARTED|Part 1||1||
59921568|NCT02661178|76041084|FG001|STARTED|Part 1||5||
59921569|NCT02661178|76041085|FG002|STARTED|Part 1||6||
59921570|NCT02661178|76041086|FG003|STARTED|Part 1||6||
59921571|NCT02661178|76041087|FG004|STARTED|Part 1||5||
59921572|NCT02661178|76041088|FG005|STARTED|Part 1||6||
59921573|NCT02661178|76041089|FG006|STARTED|Part 1||6||
59921574|NCT02661178|76041090|FG007|STARTED|Part 1||6||
59921575|NCT02661178|76041091|FG008|STARTED|Part 1||6||
59921576|NCT02661178|76041092|FG009|STARTED|Part 1||12||
59921577|NCT02661178|76041093|FG010|STARTED|Part 1||4||
59921578|NCT02661178|76041094|FG011|STARTED|Part 1||0||
59921579|NCT02661178|76041095|FG012|STARTED|Part 1||0||
59921580|NCT02661178|76041096|FG013|STARTED|Part 1||0||
59921581|NCT02661178|76041097|FG014|STARTED|Part 1||0||
59921582|NCT02661178|76041083|FG000|COMPLETED|Part 1||0||
59921583|NCT02661178|76041084|FG001|COMPLETED|Part 1||5||
59921584|NCT02661178|76041085|FG002|COMPLETED|Part 1||6||
59921585|NCT02661178|76041086|FG003|COMPLETED|Part 1||6||
59921586|NCT02661178|76041087|FG004|COMPLETED|Part 1||5||
59921587|NCT02661178|76041088|FG005|COMPLETED|Part 1||6||
59921588|NCT02661178|76041089|FG006|COMPLETED|Part 1||6||
59921589|NCT02661178|76041090|FG007|COMPLETED|Part 1||6||
59921590|NCT02661178|76041091|FG008|COMPLETED|Part 1||6||
59921591|NCT02661178|76041092|FG009|COMPLETED|Part 1||12||
59921592|NCT02661178|76041093|FG010|COMPLETED|Part 1||4||
59921593|NCT02661178|76041094|FG011|COMPLETED|Part 1||0||
59921594|NCT02661178|76041095|FG012|COMPLETED|Part 1||0||
59921595|NCT02661178|76041096|FG013|COMPLETED|Part 1||0||
59921596|NCT02661178|76041097|FG014|COMPLETED|Part 1||0||
59921597|NCT02661178|76041083|FG000|NOT COMPLETED|Part 1||1||
59513871|NCT02951884|75607499|FG000|COMPLETED|Overall Study||0||
59513872|NCT02951884|75607500|FG001|COMPLETED|Overall Study||1||
59513873|NCT02951884|75607501|FG002|COMPLETED|Overall Study||1||
59513874|NCT02951884|75607499|FG000|NOT COMPLETED|Overall Study||0||
59513875|NCT02951884|75607500|FG001|NOT COMPLETED|Overall Study||0||
59921598|NCT02661178|76041084|FG001|NOT COMPLETED|Part 1||0||
59513876|NCT02951884|75607501|FG002|NOT COMPLETED|Overall Study||0||
59513877|NCT03021538|75607511|FG000|STARTED|Overall Study||6||
59513878|NCT03021538|75607512|FG001|STARTED|Overall Study||7||
59921599|NCT02661178|76041085|FG002|NOT COMPLETED|Part 1||0||
59921600|NCT02661178|76041086|FG003|NOT COMPLETED|Part 1||0||
59921601|NCT02661178|76041087|FG004|NOT COMPLETED|Part 1||0||
59921602|NCT02661178|76041088|FG005|NOT COMPLETED|Part 1||0||
59921603|NCT02661178|76041089|FG006|NOT COMPLETED|Part 1||0||
59921604|NCT02661178|76041090|FG007|NOT COMPLETED|Part 1||0||
59921605|NCT02661178|76041091|FG008|NOT COMPLETED|Part 1||0||
59921606|NCT02661178|76041092|FG009|NOT COMPLETED|Part 1||0||
59921607|NCT02661178|76041093|FG010|NOT COMPLETED|Part 1||0||
59921608|NCT02661178|76041094|FG011|NOT COMPLETED|Part 1||0||
59921609|NCT02661178|76041095|FG012|NOT COMPLETED|Part 1||0||
59513879|NCT03021538|75607511|FG000|COMPLETED|Overall Study||6||
59513880|NCT03021538|75607512|FG001|COMPLETED|Overall Study||7||
59513881|NCT03021538|75607511|FG000|NOT COMPLETED|Overall Study||0||
59513882|NCT03021538|75607512|FG001|NOT COMPLETED|Overall Study||0||
59921610|NCT02661178|76041096|FG013|NOT COMPLETED|Part 1||0||
59921611|NCT02661178|76041097|FG014|NOT COMPLETED|Part 1||0||
60051427|NCT01502644|76167050|FG003|STARTED|Assigned to NA Groups||32||
60051428|NCT01502644|76167047|FG000|COMPLETED|Assigned to NA Groups||0||
60051429|NCT01502644|76167048|FG001|COMPLETED|Assigned to NA Groups|Completed = completed at least 50% of the opioid treatment period (at least 10 weeks of treatment)|24||
60051430|NCT01502644|76167049|FG002|COMPLETED|Assigned to NA Groups|Completed = completed at least 50% of the opioid treatment period (at least 10 weeks of treatment)|7||
60051431|NCT01502644|76167050|FG003|COMPLETED|Assigned to NA Groups|Completed = completed at least 50% of the opioid treatment period (at least 10 weeks of treatment)|24||
60051432|NCT01502644|76167047|FG000|NOT COMPLETED|Assigned to NA Groups||0||
60051433|NCT01502644|76167048|FG001|NOT COMPLETED|Assigned to NA Groups||6||
60051434|NCT01502644|76167049|FG002|NOT COMPLETED|Assigned to NA Groups||3||
60051435|NCT01502644|76167050|FG003|NOT COMPLETED|Assigned to NA Groups||8||
60051436|NCT01462318|76167060|FG000|STARTED|Main Study / TP-DI Study||113||
60051437|NCT01462318|76167061|FG001|STARTED|Main Study / TP-DI Study||20||
60051438|NCT01462318|76167062|FG002|STARTED|Main Study / TP-DI Study||0||
60051439|NCT01462318|76167060|FG000|Enrolled in Intensive PK Substudy|Main Study / TP-DI Study||26||
60051440|NCT01462318|76167061|FG001|Enrolled in Intensive PK Substudy|Main Study / TP-DI Study||0||
60051441|NCT01462318|76167062|FG002|Enrolled in Intensive PK Substudy|Main Study / TP-DI Study||0||
60051442|NCT01462318|76167060|FG000|COMPLETED|Main Study / TP-DI Study||105||
60051443|NCT01462318|76167061|FG001|COMPLETED|Main Study / TP-DI Study||20||
60051444|NCT01462318|76167062|FG002|COMPLETED|Main Study / TP-DI Study||0||
60051445|NCT01462318|76167060|FG000|NOT COMPLETED|Main Study / TP-DI Study||8||
60051446|NCT01462318|76167061|FG001|NOT COMPLETED|Main Study / TP-DI Study||0||
60051447|NCT01462318|76167062|FG002|NOT COMPLETED|Main Study / TP-DI Study||0||
60051448|NCT01462318|76167060|FG000|STARTED|Extension Phase|95 participants from the Main Study entered the Extension Phase|0||
60051449|NCT01462318|76167061|FG001|STARTED|Extension Phase|20 participants from the TP-DI Study entered the Extension Phase|0||
60051450|NCT01462318|76167062|FG002|STARTED|Extension Phase|10 participants from the Main Study did not enter the Extension Phase.|115||
60051451|NCT01462318|76167060|FG000|COMPLETED|Extension Phase||0||
60051452|NCT01462318|76167061|FG001|COMPLETED|Extension Phase||0||
60051453|NCT01462318|76167062|FG002|COMPLETED|Extension Phase||70||
60051454|NCT01462318|76167060|FG000|NOT COMPLETED|Extension Phase||0||
60051455|NCT01462318|76167061|FG001|NOT COMPLETED|Extension Phase||0||
60051456|NCT01462318|76167062|FG002|NOT COMPLETED|Extension Phase||45||
60051457|NCT01485094|76167070|FG000|STARTED|Overall Study||20||
60051458|NCT01485094|76167071|FG001|STARTED|Overall Study||20||
60051459|NCT01485094|76167072|FG002|STARTED|Overall Study||19||
60051460|NCT01485094|76167070|FG000|COMPLETED|Overall Study||17||
60051461|NCT01485094|76167071|FG001|COMPLETED|Overall Study||18||
60051462|NCT01485094|76167072|FG002|COMPLETED|Overall Study||18||
60051463|NCT01485094|76167070|FG000|NOT COMPLETED|Overall Study||3||
60051464|NCT01485094|76167071|FG001|NOT COMPLETED|Overall Study||2||
60051465|NCT01485094|76167072|FG002|NOT COMPLETED|Overall Study||1||
60051466|NCT01484938|76167080|FG000|STARTED|Overall Study||175||
60051467|NCT01484938|76167080|FG000|COMPLETED|Overall Study||171||
60051468|NCT01484938|76167080|FG000|NOT COMPLETED|Overall Study||4||
60051469|NCT01502410|76167088|FG000|STARTED|Overall Study||10||
60051470|NCT01502410|76167089|FG001|STARTED|Overall Study||10||
60051471|NCT01502410|76167090|FG002|STARTED|Overall Study||0||
60051472|NCT01502410|76167091|FG003|STARTED|Overall Study||0||
60051473|NCT01502410|76167088|FG000|COMPLETED|Overall Study||0||
60051474|NCT01502410|76167089|FG001|COMPLETED|Overall Study||0||
60051475|NCT01502410|76167090|FG002|COMPLETED|Overall Study||0||
60051476|NCT01502410|76167091|FG003|COMPLETED|Overall Study||0||
60051477|NCT01502410|76167088|FG000|NOT COMPLETED|Overall Study||10||
60051478|NCT01502410|76167089|FG001|NOT COMPLETED|Overall Study||10||
60051479|NCT01502410|76167090|FG002|NOT COMPLETED|Overall Study||0||
60051480|NCT01502410|76167091|FG003|NOT COMPLETED|Overall Study||0||
60051481|NCT01462162|76167100|FG000|STARTED|Overall Study||120||
60051482|NCT01462162|76167100|FG000|COMPLETED|Overall Study||108||
60051483|NCT01462162|76167100|FG000|NOT COMPLETED|Overall Study||12||
60051484|NCT01483924|76167110|FG000|STARTED|Overall Study||12||
60051485|NCT01483924|76167111|FG001|STARTED|Overall Study||12||
60051486|NCT01483924|76167112|FG002|STARTED|Overall Study||12||
60051487|NCT01483924|76167113|FG003|STARTED|Overall Study||12||
60051488|NCT01483924|76167114|FG004|STARTED|Overall Study||12||
60051489|NCT01483924|76167110|FG000|COMPLETED|Overall Study||10||
60051490|NCT01483924|76167111|FG001|COMPLETED|Overall Study||12||
60051491|NCT01483924|76167112|FG002|COMPLETED|Overall Study||11||
60051492|NCT01483924|76167113|FG003|COMPLETED|Overall Study||8||
60051493|NCT01483924|76167114|FG004|COMPLETED|Overall Study||10||
60051494|NCT01483924|76167110|FG000|NOT COMPLETED|Overall Study||2||
60051495|NCT01483924|76167111|FG001|NOT COMPLETED|Overall Study||0||
60051496|NCT01483924|76167112|FG002|NOT COMPLETED|Overall Study||1||
60051497|NCT01483924|76167113|FG003|NOT COMPLETED|Overall Study||4||
60051498|NCT01483924|76167114|FG004|NOT COMPLETED|Overall Study||2||
60051499|NCT01462084|76167135|FG000|STARTED|Overall Study||11||
60051500|NCT01462084|76167136|FG001|STARTED|Overall Study||10||
60051501|NCT01462084|76167135|FG000|Included for Analysis|Overall Study||9||
60051502|NCT01462084|76167136|FG001|Included for Analysis|Overall Study||9||
60051503|NCT01462084|76167135|FG000|COMPLETED|Overall Study||9||
59513883|NCT02834806|75607518|FG000|STARTED|Overall Study||58||
59513884|NCT02834806|75607518|FG000|COMPLETED|Overall Study||58||
59513885|NCT02834806|75607518|FG000|NOT COMPLETED|Overall Study||0||
59513886|NCT02835274|75607524|FG000|STARTED|Overall Study||6||
59513887|NCT02835274|75607525|FG001|STARTED|Overall Study||6||
59513888|NCT02835274|75607524|FG000|COMPLETED|Overall Study||6||
59513889|NCT02835274|75607525|FG001|COMPLETED|Overall Study||6||
59513890|NCT02835274|75607524|FG000|NOT COMPLETED|Overall Study||0||
59513891|NCT02835274|75607525|FG001|NOT COMPLETED|Overall Study||0||
59513892|NCT02836990|75607533|FG000|STARTED|Overall Study||50||
59513893|NCT02836990|75607534|FG001|STARTED|Overall Study||55||
59513894|NCT02836990|75607533|FG000|COMPLETED|Overall Study||50||
59513895|NCT02836990|75607534|FG001|COMPLETED|Overall Study||55||
59513896|NCT02836990|75607533|FG000|NOT COMPLETED|Overall Study||0||
59612786|NCT01697592|75723836|FG005|COMPLETED|Phase A (Up to 24 Weeks)||62||
59612787|NCT01697592|75723837|FG006|COMPLETED|Phase A (Up to 24 Weeks)||32||
59612788|NCT01697592|75723838|FG007|COMPLETED|Phase A (Up to 24 Weeks)||33||
59612789|NCT01697592|75723839|FG008|COMPLETED|Phase A (Up to 24 Weeks)||34||
59612790|NCT01697592|75723840|FG009|COMPLETED|Phase A (Up to 24 Weeks)||30||
59612791|NCT01697592|75723831|FG000|NOT COMPLETED|Phase A (Up to 24 Weeks)||3||
59612792|NCT01697592|75723832|FG001|NOT COMPLETED|Phase A (Up to 24 Weeks)||3||
59612793|NCT01697592|75723833|FG002|NOT COMPLETED|Phase A (Up to 24 Weeks)||1||
59612794|NCT01697592|75723834|FG003|NOT COMPLETED|Phase A (Up to 24 Weeks)||2||
59612795|NCT01697592|75723835|FG004|NOT COMPLETED|Phase A (Up to 24 Weeks)||0||
59612796|NCT01697592|75723836|FG005|NOT COMPLETED|Phase A (Up to 24 Weeks)||1||
59612797|NCT01697592|75723837|FG006|NOT COMPLETED|Phase A (Up to 24 Weeks)||2||
59612798|NCT01697592|75723838|FG007|NOT COMPLETED|Phase A (Up to 24 Weeks)||0||
59612799|NCT01697592|75723839|FG008|NOT COMPLETED|Phase A (Up to 24 Weeks)||0||
59612800|NCT01697592|75723840|FG009|NOT COMPLETED|Phase A (Up to 24 Weeks)||2||
59612801|NCT01697592|75723831|FG000|STARTED|Phase B (Week 25 to Week 52)||123||
59612802|NCT01697592|75723832|FG001|STARTED|Phase B (Week 25 to Week 52)||62||
59612803|NCT01697592|75723833|FG002|STARTED|Phase B (Week 25 to Week 52)||65||
59612804|NCT01697592|75723834|FG003|STARTED|Phase B (Week 25 to Week 52)||63||
59612805|NCT01697592|75723835|FG004|STARTED|Phase B (Week 25 to Week 52)||67||
59612806|NCT01697592|75723836|FG005|STARTED|Phase B (Week 25 to Week 52)||62||
59612807|NCT01697592|75723837|FG006|STARTED|Phase B (Week 25 to Week 52)||32||
59612808|NCT01697592|75723838|FG007|STARTED|Phase B (Week 25 to Week 52)||33||
59612809|NCT01697592|75723839|FG008|STARTED|Phase B (Week 25 to Week 52)||34||
59612810|NCT01697592|75723840|FG009|STARTED|Phase B (Week 25 to Week 52)||30||
59612811|NCT01697592|75723831|FG000|COMPLETED|Phase B (Week 25 to Week 52)||118||
59921612|NCT02661178|76041083|FG000|STARTED|Part 2||0||
59921613|NCT02661178|76041084|FG001|STARTED|Part 2||0||
59921614|NCT02661178|76041085|FG002|STARTED|Part 2||0||
59921615|NCT02661178|76041086|FG003|STARTED|Part 2||0||
59921616|NCT02661178|76041087|FG004|STARTED|Part 2||0||
59921617|NCT02661178|76041088|FG005|STARTED|Part 2||0||
59921618|NCT02661178|76041089|FG006|STARTED|Part 2||0||
59921619|NCT02661178|76041090|FG007|STARTED|Part 2||0||
59921620|NCT02661178|76041091|FG008|STARTED|Part 2||0||
59921621|NCT02661178|76041092|FG009|STARTED|Part 2||0||
59921622|NCT02661178|76041093|FG010|STARTED|Part 2||0||
59921623|NCT02661178|76041094|FG011|STARTED|Part 2||6||
59921624|NCT02661178|76041095|FG012|STARTED|Part 2||6||
59921625|NCT02661178|76041096|FG013|STARTED|Part 2||2||
59921626|NCT02661178|76041097|FG014|STARTED|Part 2||2||
59921627|NCT02661178|76041083|FG000|COMPLETED|Part 2||0||
59921628|NCT02661178|76041084|FG001|COMPLETED|Part 2||0||
59921629|NCT02661178|76041085|FG002|COMPLETED|Part 2||0||
59921630|NCT02661178|76041086|FG003|COMPLETED|Part 2||0||
59921631|NCT02661178|76041087|FG004|COMPLETED|Part 2||0||
59921632|NCT02661178|76041088|FG005|COMPLETED|Part 2||0||
59921633|NCT02661178|76041089|FG006|COMPLETED|Part 2||0||
59921634|NCT02661178|76041090|FG007|COMPLETED|Part 2||0||
59921635|NCT02661178|76041091|FG008|COMPLETED|Part 2||0||
59921636|NCT02661178|76041092|FG009|COMPLETED|Part 2||0||
59921637|NCT02661178|76041093|FG010|COMPLETED|Part 2||0||
59921638|NCT02661178|76041094|FG011|COMPLETED|Part 2||6||
59921639|NCT02661178|76041095|FG012|COMPLETED|Part 2||6||
59921640|NCT02661178|76041096|FG013|COMPLETED|Part 2||2||
59921641|NCT02661178|76041097|FG014|COMPLETED|Part 2||2||
59921642|NCT02661178|76041083|FG000|NOT COMPLETED|Part 2||0||
59921643|NCT02661178|76041084|FG001|NOT COMPLETED|Part 2||0||
59921644|NCT02661178|76041085|FG002|NOT COMPLETED|Part 2||0||
59921645|NCT02661178|76041086|FG003|NOT COMPLETED|Part 2||0||
59921646|NCT02661178|76041087|FG004|NOT COMPLETED|Part 2||0||
59921647|NCT02661178|76041088|FG005|NOT COMPLETED|Part 2||0||
59921648|NCT02661178|76041089|FG006|NOT COMPLETED|Part 2||0||
59921649|NCT02661178|76041090|FG007|NOT COMPLETED|Part 2||0||
59921650|NCT02661178|76041091|FG008|NOT COMPLETED|Part 2||0||
59921651|NCT02661178|76041092|FG009|NOT COMPLETED|Part 2||0||
59921652|NCT02661178|76041093|FG010|NOT COMPLETED|Part 2||0||
59921653|NCT02661178|76041094|FG011|NOT COMPLETED|Part 2||0||
59921654|NCT02661178|76041095|FG012|NOT COMPLETED|Part 2||0||
59921655|NCT02661178|76041096|FG013|NOT COMPLETED|Part 2||0||
59921656|NCT02661178|76041097|FG014|NOT COMPLETED|Part 2||0||
59921657|NCT02660944|76041149|FG000|STARTED|Overall Study||42||
60051504|NCT01462084|76167136|FG001|COMPLETED|Overall Study||9||
60051505|NCT01462084|76167135|FG000|NOT COMPLETED|Overall Study||2||
60051506|NCT01462084|76167136|FG001|NOT COMPLETED|Overall Study||1||
60051507|NCT02134028|76167151|FG000|STARTED|Overall Study||111|Participants who completed studies DRI12544, PDY14192, EFC13579, and EFC13691.|
60051508|NCT02134028|76167152|FG001|STARTED|Overall Study||421|Participants who completed studies DRI12544, PDY14192, EFC13579, and EFC13691.|
60051509|NCT02134028|76167153|FG002|STARTED|Overall Study||517|Participants who completed studies DRI12544, PDY14192, EFC13579, and EFC13691.|
60051510|NCT02134028|76167154|FG003|STARTED|Overall Study||1013|Participants who completed studies DRI12544, PDY14192, EFC13579, and EFC13691.|
60051511|NCT02134028|76167155|FG004|STARTED|Overall Study||97|Participants who completed studies DRI12544, PDY14192, EFC13579, and EFC13691.|
60051512|NCT02134028|76167156|FG005|STARTED|Overall Study||90|Participants who completed studies DRI12544, PDY14192, EFC13579, and EFC13691.|
60051513|NCT02134028|76167157|FG006|STARTED|Overall Study||19|Participants who completed studies DRI12544, PDY14192, EFC13579, and EFC13691.|
60051514|NCT02134028|76167158|FG007|STARTED|Overall Study||14|Participants who completed studies DRI12544, PDY14192, EFC13579, and EFC13691.|
60051515|NCT02134028|76167151|FG000|COMPLETED|Overall Study||102||
60051516|NCT02134028|76167152|FG001|COMPLETED|Overall Study||379||
60051517|NCT02134028|76167153|FG002|COMPLETED|Overall Study||465||
60051518|NCT02134028|76167154|FG003|COMPLETED|Overall Study||908||
60051519|NCT02134028|76167155|FG004|COMPLETED|Overall Study||83||
60051520|NCT02134028|76167156|FG005|COMPLETED|Overall Study||76||
60051521|NCT02134028|76167157|FG006|COMPLETED|Overall Study||15||
60051522|NCT02134028|76167158|FG007|COMPLETED|Overall Study||11||
60051523|NCT02134028|76167151|FG000|NOT COMPLETED|Overall Study||9||
60051524|NCT02134028|76167152|FG001|NOT COMPLETED|Overall Study||42||
60051525|NCT02134028|76167153|FG002|NOT COMPLETED|Overall Study||52||
60051526|NCT02134028|76167154|FG003|NOT COMPLETED|Overall Study||105||
60051527|NCT02134028|76167155|FG004|NOT COMPLETED|Overall Study||14||
60051528|NCT02134028|76167156|FG005|NOT COMPLETED|Overall Study||14||
60051529|NCT02134028|76167157|FG006|NOT COMPLETED|Overall Study||4||
60051530|NCT02134028|76167158|FG007|NOT COMPLETED|Overall Study||3||
60051531|NCT02172950|76167180|FG000|STARTED|Overall Study||222||
60051532|NCT02172950|76167181|FG001|STARTED|Overall Study||24||
60051533|NCT02172950|76167180|FG000|COMPLETED|Overall Study||197||
60051534|NCT02172950|76167181|FG001|COMPLETED|Overall Study||19||
60051535|NCT02172950|76167180|FG000|NOT COMPLETED|Overall Study||25||
60051536|NCT02172950|76167181|FG001|NOT COMPLETED|Overall Study||5||
60051537|NCT02151266|76167191|FG000|STARTED|Overall Study||19||
60051538|NCT02151266|76167192|FG001|STARTED|Overall Study||29||
60051539|NCT02151266|76167193|FG002|STARTED|Overall Study||21||
60051540|NCT02151266|76167191|FG000|COMPLETED|Overall Study||11||
60051541|NCT02151266|76167192|FG001|COMPLETED|Overall Study||14||
60051542|NCT02151266|76167193|FG002|COMPLETED|Overall Study||14||
60051543|NCT02151266|76167191|FG000|NOT COMPLETED|Overall Study||8||
60051544|NCT02151266|76167192|FG001|NOT COMPLETED|Overall Study||15||
60051545|NCT02151266|76167193|FG002|NOT COMPLETED|Overall Study||7||
60051546|NCT02151110|76167209|FG000|STARTED|Overall Study||12||
60051547|NCT02151110|76167210|FG001|STARTED|Overall Study||2||
60051548|NCT02151110|76167211|FG002|STARTED|Overall Study||2||
60051549|NCT02151110|76167212|FG003|STARTED|Overall Study||8||
60051550|NCT02151110|76167213|FG004|STARTED|Overall Study||8||
60051551|NCT02151110|76167214|FG005|STARTED|Overall Study||8||
60051552|NCT02151110|76167215|FG006|STARTED|Overall Study||8||
60051553|NCT02151110|76167216|FG007|STARTED|Overall Study||8||
60051554|NCT02151110|76167209|FG000|COMPLETED|Overall Study||12||
60051555|NCT02151110|76167210|FG001|COMPLETED|Overall Study||2||
60051556|NCT02151110|76167211|FG002|COMPLETED|Overall Study||2||
60051557|NCT02151110|76167212|FG003|COMPLETED|Overall Study||8||
60051558|NCT02151110|76167213|FG004|COMPLETED|Overall Study||8||
60051559|NCT02151110|76167214|FG005|COMPLETED|Overall Study||8||
60051560|NCT02151110|76167215|FG006|COMPLETED|Overall Study||8||
60051561|NCT02151110|76167216|FG007|COMPLETED|Overall Study||5||
60051562|NCT02151110|76167209|FG000|NOT COMPLETED|Overall Study||0||
60051563|NCT02151110|76167210|FG001|NOT COMPLETED|Overall Study||0||
60051564|NCT02151110|76167211|FG002|NOT COMPLETED|Overall Study||0||
60051565|NCT02151110|76167212|FG003|NOT COMPLETED|Overall Study||0||
60051566|NCT02151110|76167213|FG004|NOT COMPLETED|Overall Study||0||
60051567|NCT02151110|76167214|FG005|NOT COMPLETED|Overall Study||0||
60051568|NCT02151110|76167215|FG006|NOT COMPLETED|Overall Study||0||
60051569|NCT02151110|76167216|FG007|NOT COMPLETED|Overall Study||3||
60051570|NCT02132312|76167243|FG000|STARTED|Overall Study||37||
60051571|NCT02132312|76167244|FG001|STARTED|Overall Study||41||
60051572|NCT02132312|76167243|FG000|COMPLETED|Overall Study||31||
60051573|NCT02132312|76167244|FG001|COMPLETED|Overall Study||38||
60051574|NCT02132312|76167243|FG000|NOT COMPLETED|Overall Study||6||
60051575|NCT02132312|76167244|FG001|NOT COMPLETED|Overall Study||3||
60051576|NCT02131766|76167250|FG000|STARTED|Overall Study||44||
60051577|NCT02131766|76167250|FG000|COMPLETED|Overall Study||40||
60051578|NCT02131766|76167250|FG000|NOT COMPLETED|Overall Study||4||
60051579|NCT02150954|76167259|FG000|STARTED|Overall Study||58||
60051580|NCT02150954|76167260|FG001|STARTED|Overall Study||59||
60051581|NCT02150954|76167259|FG000|COMPLETED|Overall Study||57||
60051582|NCT02150954|76167260|FG001|COMPLETED|Overall Study||59||
60051583|NCT02150954|76167259|FG000|NOT COMPLETED|Overall Study||1||
60051584|NCT02150954|76167260|FG001|NOT COMPLETED|Overall Study||0||
60051585|NCT02131532|76167266|FG000|STARTED|Overall Study||12||
60051586|NCT02131532|76167266|FG000|COMPLETED|Overall Study||8||
60051587|NCT02131532|76167266|FG000|NOT COMPLETED|Overall Study||4||
60051588|NCT04188392|76167271|FG000|STARTED|Overall Study||6||
60051589|NCT04188392|76167271|FG000|Sleep Studies 1 and 2|Overall Study||6||
60051590|NCT04188392|76167271|FG000|Mid-point Visit (Treatment Week-3)|Overall Study||6||
60051591|NCT04188392|76167271|FG000|Sleep Study 3|Overall Study|1 subject could not complete sleep study 3 due to hospital-wide shut-downs during the COVID pandemic.|5||
60051592|NCT04188392|76167271|FG000|COMPLETED|Overall Study||6||
60051593|NCT04188392|76167271|FG000|NOT COMPLETED|Overall Study||0||
60051594|NCT02170688|76167280|FG000|STARTED|Overall Study||29||
60051595|NCT02170688|76167281|FG001|STARTED|Overall Study||29||
60051596|NCT02170688|76167282|FG002|STARTED|Overall Study||29||
60051597|NCT02170688|76167283|FG003|STARTED|Overall Study||27||
60051598|NCT02170688|76167284|FG004|STARTED|Overall Study||25||
60051599|NCT02170688|76167280|FG000|COMPLETED|Overall Study||25||
60051600|NCT02170688|76167281|FG001|COMPLETED|Overall Study||26||
60051601|NCT02170688|76167282|FG002|COMPLETED|Overall Study||25||
59760413|NCT03827018|75880027|FG001|COMPLETED|Overall Study||25|Completed Study|
59921658|NCT02660944|76041150|FG001|STARTED|Overall Study||22||
59921659|NCT02660944|76041149|FG000|COMPLETED|Overall Study||25||
59921660|NCT02660944|76041150|FG001|COMPLETED|Overall Study||12||
59921661|NCT02660944|76041149|FG000|NOT COMPLETED|Overall Study||17||
59921662|NCT02660944|76041150|FG001|NOT COMPLETED|Overall Study||10||
59921663|NCT02975336|76041160|FG000|STARTED|DBPC (52 Weeks)||117||
59921664|NCT02975336|76041161|FG001|STARTED|DBPC (52 Weeks)||118||
59921665|NCT02975336|76041162|FG002|STARTED|DBPC (52 Weeks)||117||
59921666|NCT02975336|76041163|FG003|STARTED|DBPC (52 Weeks)||117||
59921667|NCT02975336|76041164|FG004|STARTED|DBPC (52 Weeks)||0||
59921668|NCT02975336|76041165|FG005|STARTED|DBPC (52 Weeks)||0||
59921669|NCT02975336|76041166|FG006|STARTED|DBPC (52 Weeks)||0||
59921670|NCT02975336|76041167|FG007|STARTED|DBPC (52 Weeks)||0||
59921671|NCT02975336|76041160|FG000|COMPLETED|DBPC (52 Weeks)||85||
59921672|NCT02975336|76041161|FG001|COMPLETED|DBPC (52 Weeks)||89||
59921673|NCT02975336|76041162|FG002|COMPLETED|DBPC (52 Weeks)||90||
59921674|NCT02975336|76041163|FG003|COMPLETED|DBPC (52 Weeks)||84||
59921675|NCT02975336|76041164|FG004|COMPLETED|DBPC (52 Weeks)||0||
59921676|NCT02975336|76041165|FG005|COMPLETED|DBPC (52 Weeks)||0||
59921677|NCT02975336|76041166|FG006|COMPLETED|DBPC (52 Weeks)||0||
59921678|NCT02975336|76041167|FG007|COMPLETED|DBPC (52 Weeks)||0||
59921679|NCT02975336|76041160|FG000|NOT COMPLETED|DBPC (52 Weeks)||32||
59921680|NCT02975336|76041161|FG001|NOT COMPLETED|DBPC (52 Weeks)||29||
59921681|NCT02975336|76041162|FG002|NOT COMPLETED|DBPC (52 Weeks)||27||
59921682|NCT02975336|76041163|FG003|NOT COMPLETED|DBPC (52 Weeks)||33||
60051602|NCT02170688|76167283|FG003|COMPLETED|Overall Study||25||
60051603|NCT02170688|76167284|FG004|COMPLETED|Overall Study||25||
60051604|NCT02170688|76167280|FG000|NOT COMPLETED|Overall Study||4||
60051605|NCT02170688|76167281|FG001|NOT COMPLETED|Overall Study||3||
60051606|NCT02170688|76167282|FG002|NOT COMPLETED|Overall Study||4||
60051607|NCT02170688|76167283|FG003|NOT COMPLETED|Overall Study||2||
60051608|NCT02170688|76167284|FG004|NOT COMPLETED|Overall Study||0||
60051609|NCT02170298|76167298|FG000|STARTED|Overall Study||1||
60051610|NCT02170298|76167299|FG001|STARTED|Overall Study||5||
59921683|NCT02975336|76041164|FG004|NOT COMPLETED|DBPC (52 Weeks)||0||
59921684|NCT02975336|76041165|FG005|NOT COMPLETED|DBPC (52 Weeks)||0||
59921685|NCT02975336|76041166|FG006|NOT COMPLETED|DBPC (52 Weeks)||0||
60051611|NCT02170298|76167298|FG000|COMPLETED|Overall Study||0||
60051612|NCT02170298|76167299|FG001|COMPLETED|Overall Study||4||
60051613|NCT02170298|76167298|FG000|NOT COMPLETED|Overall Study||1||
60051614|NCT02170298|76167299|FG001|NOT COMPLETED|Overall Study||1||
60051615|NCT02131064|76167307|FG000|STARTED|Overall Study||221||
59612812|NCT01697592|75723832|FG001|COMPLETED|Phase B (Week 25 to Week 52)||61||
59612813|NCT01697592|75723833|FG002|COMPLETED|Phase B (Week 25 to Week 52)||64||
59921686|NCT02975336|76041167|FG007|NOT COMPLETED|DBPC (52 Weeks)||0||
59921687|NCT02975336|76041160|FG000|STARTED|LTE (104 Weeks)||0||
59921688|NCT02975336|76041161|FG001|STARTED|LTE (104 Weeks)||0||
59921689|NCT02975336|76041162|FG002|STARTED|LTE (104 Weeks)||0||
59921690|NCT02975336|76041163|FG003|STARTED|LTE (104 Weeks)||0||
59921691|NCT02975336|76041164|FG004|STARTED|LTE (104 Weeks)||62||
59921692|NCT02975336|76041165|FG005|STARTED|LTE (104 Weeks)||69||
59921693|NCT02975336|76041166|FG006|STARTED|LTE (104 Weeks)||80||
60051616|NCT02131064|76167308|FG001|STARTED|Overall Study||223||
60051617|NCT02131064|76167307|FG000|COMPLETED|Overall Study||196||
60051618|NCT02131064|76167308|FG001|COMPLETED|Overall Study||189||
60051619|NCT02131064|76167307|FG000|NOT COMPLETED|Overall Study||25||
60051620|NCT02131064|76167308|FG001|NOT COMPLETED|Overall Study||34||
60051621|NCT02130986|76167317|FG000|STARTED|Overall Study||830||
60051622|NCT02130986|76167318|FG001|STARTED|Overall Study||834||
60051623|NCT02130986|76167317|FG000|COMPLETED|Overall Study||675||
60051624|NCT02130986|76167318|FG001|COMPLETED|Overall Study||670||
60051625|NCT02130986|76167317|FG000|NOT COMPLETED|Overall Study||155||
59612814|NCT01697592|75723834|FG003|COMPLETED|Phase B (Week 25 to Week 52)||60||
59612815|NCT01697592|75723835|FG004|COMPLETED|Phase B (Week 25 to Week 52)||67||
59612816|NCT01697592|75723836|FG005|COMPLETED|Phase B (Week 25 to Week 52)||60||
59612817|NCT01697592|75723837|FG006|COMPLETED|Phase B (Week 25 to Week 52)||31||
59612818|NCT01697592|75723838|FG007|COMPLETED|Phase B (Week 25 to Week 52)||32||
59612819|NCT01697592|75723839|FG008|COMPLETED|Phase B (Week 25 to Week 52)||32||
59921694|NCT02975336|76041167|FG007|STARTED|LTE (104 Weeks)||72||
59921695|NCT02975336|76041160|FG000|COMPLETED|LTE (104 Weeks)||0||
59921696|NCT02975336|76041161|FG001|COMPLETED|LTE (104 Weeks)||0||
59921697|NCT02975336|76041162|FG002|COMPLETED|LTE (104 Weeks)||0||
59921698|NCT02975336|76041163|FG003|COMPLETED|LTE (104 Weeks)||0||
59921699|NCT02975336|76041164|FG004|COMPLETED|LTE (104 Weeks)||0||
59921700|NCT02975336|76041165|FG005|COMPLETED|LTE (104 Weeks)||0||
59921701|NCT02975336|76041166|FG006|COMPLETED|LTE (104 Weeks)||0||
59921702|NCT02975336|76041167|FG007|COMPLETED|LTE (104 Weeks)||0||
59921703|NCT02975336|76041160|FG000|NOT COMPLETED|LTE (104 Weeks)||0||
59921704|NCT02975336|76041161|FG001|NOT COMPLETED|LTE (104 Weeks)||0||
59921705|NCT02975336|76041162|FG002|NOT COMPLETED|LTE (104 Weeks)||0||
59921706|NCT02975336|76041163|FG003|NOT COMPLETED|LTE (104 Weeks)||0||
59921707|NCT02975336|76041164|FG004|NOT COMPLETED|LTE (104 Weeks)||62||
59921708|NCT02975336|76041165|FG005|NOT COMPLETED|LTE (104 Weeks)||69||
59921709|NCT02975336|76041166|FG006|NOT COMPLETED|LTE (104 Weeks)||80||
59921710|NCT02975336|76041167|FG007|NOT COMPLETED|LTE (104 Weeks)||72||
59921711|NCT03124563|76041183|FG000|STARTED|Overall Study||32|Number of participants enrolled in study and randomly assigned to group|
59921712|NCT03124563|76041184|FG001|STARTED|Overall Study||31|Number of participants enrolled in study and randomly assigned to group|
59921713|NCT03124563|76041183|FG000|Pre-test|Overall Study||30|Number of participants that filled out pre-test measures and started the study|
59921714|NCT03124563|76041184|FG001|Pre-test|Overall Study||30|Number of participants that filled out pre-test measures and started the study|
59921715|NCT03124563|76041183|FG000|COMPLETED|Overall Study||30|Number of participants that completed the study|
59951436|NCT00849290|76070434|FG000|STARTED|Overall Study||113||
60051626|NCT02130986|76167318|FG001|NOT COMPLETED|Overall Study||164||
60051627|NCT02130284|76167326|FG000|STARTED|Overall Study||80||
60051628|NCT02130284|76167326|FG000|COMPLETED|Overall Study||71||
60051629|NCT02130284|76167326|FG000|NOT COMPLETED|Overall Study||9||
60051630|NCT02147288|76167332|FG000|STARTED|Overall Study||22||
60051631|NCT02147288|76167333|FG001|STARTED|Overall Study||24||
60051632|NCT02147288|76167334|FG002|STARTED|Overall Study||0||
60051633|NCT02147288|76167335|FG003|STARTED|Overall Study||0||
60051634|NCT02147288|76167336|FG004|STARTED|Overall Study||0||
60051635|NCT02147288|76167337|FG005|STARTED|Overall Study||0||
60051636|NCT02147288|76167338|FG006|STARTED|Overall Study||0||
60051637|NCT02147288|76167339|FG007|STARTED|Overall Study||0||
60051638|NCT02147288|76167340|FG008|STARTED|Overall Study||0||
60051639|NCT02147288|76167341|FG009|STARTED|Overall Study||0||
60051640|NCT02147288|76167332|FG000|COMPLETED|Overall Study||21||
60051641|NCT02147288|76167333|FG001|COMPLETED|Overall Study||22||
60051642|NCT02147288|76167334|FG002|COMPLETED|Overall Study||0||
60051643|NCT02147288|76167335|FG003|COMPLETED|Overall Study||0||
60051644|NCT02147288|76167336|FG004|COMPLETED|Overall Study||0||
60051645|NCT02147288|76167337|FG005|COMPLETED|Overall Study||0||
60051646|NCT02147288|76167338|FG006|COMPLETED|Overall Study||0||
60051647|NCT02147288|76167339|FG007|COMPLETED|Overall Study||0||
60051648|NCT02147288|76167340|FG008|COMPLETED|Overall Study||0||
60051649|NCT02147288|76167341|FG009|COMPLETED|Overall Study||0||
60051650|NCT02147288|76167332|FG000|NOT COMPLETED|Overall Study||1||
60051651|NCT02147288|76167333|FG001|NOT COMPLETED|Overall Study||2||
60051652|NCT02147288|76167334|FG002|NOT COMPLETED|Overall Study||0||
60051653|NCT02147288|76167335|FG003|NOT COMPLETED|Overall Study||0||
60051654|NCT02147288|76167336|FG004|NOT COMPLETED|Overall Study||0||
60051655|NCT02147288|76167337|FG005|NOT COMPLETED|Overall Study||0||
60051656|NCT02147288|76167338|FG006|NOT COMPLETED|Overall Study||0||
60051657|NCT02147288|76167339|FG007|NOT COMPLETED|Overall Study||0||
60051658|NCT02147288|76167340|FG008|NOT COMPLETED|Overall Study||0||
60051659|NCT02147288|76167341|FG009|NOT COMPLETED|Overall Study||0||
60051660|NCT02147132|76167347|FG000|STARTED|Overall Study||2||
60051661|NCT02147132|76167348|FG001|STARTED|Overall Study||2||
60051662|NCT02147132|76167349|FG002|STARTED|Overall Study||1||
60051663|NCT02147132|76167350|FG003|STARTED|Overall Study||2||
60051664|NCT02147132|76167347|FG000|COMPLETED|Overall Study||1||
60051665|NCT02147132|76167348|FG001|COMPLETED|Overall Study||2||
60051666|NCT02147132|76167349|FG002|COMPLETED|Overall Study||1||
60051667|NCT02147132|76167350|FG003|COMPLETED|Overall Study||2||
60051668|NCT02147132|76167347|FG000|NOT COMPLETED|Overall Study||1||
60051669|NCT02147132|76167348|FG001|NOT COMPLETED|Overall Study||0||
60051670|NCT02147132|76167349|FG002|NOT COMPLETED|Overall Study||0||
60051671|NCT02147132|76167350|FG003|NOT COMPLETED|Overall Study||0||
60051672|NCT02146430|76167364|FG000|STARTED|Overall Study||323||
60051673|NCT02146430|76167365|FG001|STARTED|Overall Study||323||
60051674|NCT02146430|76167366|FG002|STARTED|Overall Study||324||
60051675|NCT02146430|76167367|FG003|STARTED|Overall Study||323||
60051676|NCT02146430|76167364|FG000|Safety Analysis Set|Overall Study||318||
60051677|NCT02146430|76167365|FG001|Safety Analysis Set|Overall Study||318||
60051678|NCT02146430|76167366|FG002|Safety Analysis Set|Overall Study||320||
60051679|NCT02146430|76167367|FG003|Safety Analysis Set|Overall Study||320||
60051680|NCT02146430|76167364|FG000|Modified Intent to Treat Set (mITT)|Overall Study||318||
60051681|NCT02146430|76167365|FG001|Modified Intent to Treat Set (mITT)|Overall Study||317||
60051682|NCT02146430|76167366|FG002|Modified Intent to Treat Set (mITT)|Overall Study||319||
60051683|NCT02146430|76167367|FG003|Modified Intent to Treat Set (mITT)|Overall Study||319||
60051684|NCT02146430|76167364|FG000|COMPLETED|Overall Study||256||
60051685|NCT02146430|76167365|FG001|COMPLETED|Overall Study||236||
60051686|NCT02146430|76167366|FG002|COMPLETED|Overall Study||242||
60051687|NCT02146430|76167367|FG003|COMPLETED|Overall Study||224||
60051688|NCT02146430|76167364|FG000|NOT COMPLETED|Overall Study||67||
60051689|NCT02146430|76167365|FG001|NOT COMPLETED|Overall Study||87||
60051690|NCT02146430|76167366|FG002|NOT COMPLETED|Overall Study||82||
60051691|NCT02146430|76167367|FG003|NOT COMPLETED|Overall Study||99||
60051692|NCT02129192|76167383|FG000|STARTED|Period 1 Including Washout Period||36||
60051693|NCT02129192|76167384|FG001|STARTED|Period 1 Including Washout Period||36||
60051694|NCT02129192|76167383|FG000|COMPLETED|Period 1 Including Washout Period||36||
60051695|NCT02129192|76167384|FG001|COMPLETED|Period 1 Including Washout Period|Withdrawal by one subject in washout period|35||
60051696|NCT02129192|76167383|FG000|NOT COMPLETED|Period 1 Including Washout Period||0||
60051697|NCT02129192|76167384|FG001|NOT COMPLETED|Period 1 Including Washout Period||1||
60051698|NCT02129192|76167383|FG000|STARTED|Period 2 Including Washout Period||36||
60051699|NCT02129192|76167384|FG001|STARTED|Period 2 Including Washout Period||35||
60051700|NCT02129192|76167383|FG000|COMPLETED|Period 2 Including Washout Period||36||
60051701|NCT02129192|76167384|FG001|COMPLETED|Period 2 Including Washout Period||35||
60051702|NCT02129192|76167383|FG000|NOT COMPLETED|Period 2 Including Washout Period||0||
60051703|NCT02129192|76167384|FG001|NOT COMPLETED|Period 2 Including Washout Period||0||
60051704|NCT02129192|76167383|FG000|STARTED|Period 3 Including Washout Period||36||
60051705|NCT02129192|76167384|FG001|STARTED|Period 3 Including Washout Period||35||
60051706|NCT02129192|76167383|FG000|COMPLETED|Period 3 Including Washout Period||36||
60051707|NCT02129192|76167384|FG001|COMPLETED|Period 3 Including Washout Period||35||
60051708|NCT02129192|76167383|FG000|NOT COMPLETED|Period 3 Including Washout Period||0||
60051709|NCT02129192|76167384|FG001|NOT COMPLETED|Period 3 Including Washout Period||0||
60051710|NCT02129192|76167383|FG000|STARTED|Period 4 Including Washout Period||36||
60051711|NCT02129192|76167384|FG001|STARTED|Period 4 Including Washout Period||35||
60051712|NCT02129192|76167383|FG000|COMPLETED|Period 4 Including Washout Period||36||
60051713|NCT02129192|76167384|FG001|COMPLETED|Period 4 Including Washout Period||35||
60051714|NCT02129192|76167383|FG000|NOT COMPLETED|Period 4 Including Washout Period||0||
60051715|NCT02129192|76167384|FG001|NOT COMPLETED|Period 4 Including Washout Period||0||
60051716|NCT02129192|76167383|FG000|STARTED|Period 5||36||
60051717|NCT02129192|76167384|FG001|STARTED|Period 5|This sequence consists of only 4 periods.|0||
60051718|NCT02129192|76167383|FG000|COMPLETED|Period 5||36||
60051719|NCT02129192|76167384|FG001|COMPLETED|Period 5||0||
60051720|NCT02129192|76167383|FG000|NOT COMPLETED|Period 5||0||
60051721|NCT02129192|76167384|FG001|NOT COMPLETED|Period 5||0||
60051722|NCT02105948|76167397|FG000|STARTED|Overall Study||229||
60051723|NCT02105948|76167398|FG001|STARTED|Overall Study||233||
60051724|NCT02105948|76167399|FG002|STARTED|Overall Study||190||
59921716|NCT03124563|76041184|FG001|COMPLETED|Overall Study||29|Number of participants that completed the study|
59921717|NCT03124563|76041183|FG000|NOT COMPLETED|Overall Study||2||
60051725|NCT02105948|76167400|FG003|STARTED|Overall Study||184||
60051726|NCT02105948|76167397|FG000|Completed Investigational Product (IP)|Overall Study||185||
60051727|NCT02105948|76167398|FG001|Completed Investigational Product (IP)|Overall Study||203||
60051728|NCT02105948|76167399|FG002|Completed Investigational Product (IP)|Overall Study||148||
59513897|NCT02836990|75607534|FG001|NOT COMPLETED|Overall Study||0||
59513898|NCT02841046|75607544|FG000|STARTED|Overall Study||25||
59513899|NCT02841046|75607545|FG001|STARTED|Overall Study||25||
59513900|NCT02841046|75607544|FG000|COMPLETED|Overall Study||25||
59513901|NCT02841046|75607545|FG001|COMPLETED|Overall Study||25||
59513902|NCT02841046|75607544|FG000|NOT COMPLETED|Overall Study||0||
59513903|NCT02841046|75607545|FG001|NOT COMPLETED|Overall Study||0||
59513904|NCT03022396|75607557|FG000|STARTED|Overall Study||16||
59513905|NCT03022396|75607558|FG001|STARTED|Overall Study||14||
59513906|NCT03022396|75607559|FG002|STARTED|Overall Study||10||
59513907|NCT03022396|75607560|FG003|STARTED|Overall Study||20||
59513908|NCT03022396|75607561|FG004|STARTED|Overall Study||14||
59513909|NCT03022396|75607562|FG005|STARTED|Overall Study||8||
59513910|NCT03022396|75607557|FG000|COMPLETED|Overall Study||16||
59513911|NCT03022396|75607558|FG001|COMPLETED|Overall Study||14||
59513912|NCT03022396|75607559|FG002|COMPLETED|Overall Study||10||
59513913|NCT03022396|75607560|FG003|COMPLETED|Overall Study||20||
59513914|NCT03022396|75607561|FG004|COMPLETED|Overall Study||14||
59513915|NCT03022396|75607562|FG005|COMPLETED|Overall Study||8||
59760414|NCT03827018|75880026|FG000|NOT COMPLETED|Overall Study||3||
59760415|NCT03827018|75880027|FG001|NOT COMPLETED|Overall Study||3||
59760416|NCT03777319|75880035|FG000|STARTED|Overall Study||1||
59760417|NCT03777319|75880036|FG001|STARTED|Overall Study||1||
59921718|NCT03124563|76041184|FG001|NOT COMPLETED|Overall Study||2||
59921719|NCT03079869|76041192|FG000|STARTED|Overall Study||28||
59921720|NCT03079869|76041193|FG001|STARTED|Overall Study||27||
59921721|NCT03079869|76041192|FG000|COMPLETED|Overall Study||15||
59921722|NCT03079869|76041193|FG001|COMPLETED|Overall Study||16||
59921723|NCT03079869|76041192|FG000|NOT COMPLETED|Overall Study||13||
59921724|NCT03079869|76041193|FG001|NOT COMPLETED|Overall Study||11||
59921725|NCT03085914|76041206|FG000|STARTED|Overall Study||9||
59921726|NCT03085914|76041207|FG001|STARTED|Overall Study||9||
59921727|NCT03085914|76041208|FG002|STARTED|Overall Study||11||
59921728|NCT03085914|76041209|FG003|STARTED|Overall Study||9||
59921729|NCT03085914|76041210|FG004|STARTED|Overall Study||13||
59921730|NCT03085914|76041211|FG005|STARTED|Overall Study||8||
59921731|NCT03085914|76041212|FG006|STARTED|Overall Study||11||
59921732|NCT03085914|76041206|FG000|COMPLETED|Overall Study||0||
59921733|NCT03085914|76041207|FG001|COMPLETED|Overall Study||0||
59921734|NCT03085914|76041208|FG002|COMPLETED|Overall Study||0||
59921735|NCT03085914|76041209|FG003|COMPLETED|Overall Study||0||
60051729|NCT02105948|76167400|FG003|Completed Investigational Product (IP)|Overall Study||149||
60051730|NCT02105948|76167397|FG000|Not Completed IP|Overall Study||44||
60051731|NCT02105948|76167398|FG001|Not Completed IP|Overall Study||30||
60051732|NCT02105948|76167399|FG002|Not Completed IP|Overall Study||42||
60051733|NCT02105948|76167400|FG003|Not Completed IP|Overall Study||35||
59513916|NCT03022396|75607557|FG000|NOT COMPLETED|Overall Study||0||
59513917|NCT03022396|75607558|FG001|NOT COMPLETED|Overall Study||0||
59513918|NCT03022396|75607559|FG002|NOT COMPLETED|Overall Study||0||
59513919|NCT03022396|75607560|FG003|NOT COMPLETED|Overall Study||0||
59513920|NCT03022396|75607561|FG004|NOT COMPLETED|Overall Study||0||
59513921|NCT03022396|75607562|FG005|NOT COMPLETED|Overall Study||0||
59513922|NCT03023176|75607576|FG000|STARTED|Overall Study||20||
59513923|NCT03023176|75607576|FG000|COMPLETED|Overall Study||20||
59513924|NCT03023176|75607576|FG000|NOT COMPLETED|Overall Study||0||
59760418|NCT03777319|75880035|FG000|COMPLETED|Overall Study||1||
59921736|NCT03085914|76041210|FG004|COMPLETED|Overall Study||0||
59921737|NCT03085914|76041211|FG005|COMPLETED|Overall Study||0||
60051734|NCT02105948|76167397|FG000|Withdrew IP Due to: Adverse Event|Overall Study||20||
60051735|NCT02105948|76167398|FG001|Withdrew IP Due to: Adverse Event|Overall Study||16||
60051736|NCT02105948|76167399|FG002|Withdrew IP Due to: Adverse Event|Overall Study||15||
60051737|NCT02105948|76167400|FG003|Withdrew IP Due to: Adverse Event|Overall Study||13||
60051738|NCT02105948|76167397|FG000|Withdrew IP Due to: Lack of Efficacy|Overall Study||5||
60051739|NCT02105948|76167398|FG001|Withdrew IP Due to: Lack of Efficacy|Overall Study||2||
60051740|NCT02105948|76167399|FG002|Withdrew IP Due to: Lack of Efficacy|Overall Study||8||
60051741|NCT02105948|76167400|FG003|Withdrew IP Due to: Lack of Efficacy|Overall Study||2||
60051742|NCT02105948|76167397|FG000|Withdrew IP Due to: Protocol Deviation|Overall Study||1||
60051743|NCT02105948|76167398|FG001|Withdrew IP Due to: Protocol Deviation|Overall Study||3||
60051744|NCT02105948|76167399|FG002|Withdrew IP Due to: Protocol Deviation|Overall Study||3||
60051745|NCT02105948|76167400|FG003|Withdrew IP Due to: Protocol Deviation|Overall Study||0||
60051746|NCT02105948|76167397|FG000|Withdrew IP Due to: Lost to Follow-up|Overall Study||0||
59921738|NCT03085914|76041212|FG006|COMPLETED|Overall Study||0||
60051747|NCT02105948|76167398|FG001|Withdrew IP Due to: Lost to Follow-up|Overall Study||0||
60051748|NCT02105948|76167399|FG002|Withdrew IP Due to: Lost to Follow-up|Overall Study||1||
60051749|NCT02105948|76167400|FG003|Withdrew IP Due to: Lost to Follow-up|Overall Study||2||
60051750|NCT02105948|76167397|FG000|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||16||
60051751|NCT02105948|76167398|FG001|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||8||
60051752|NCT02105948|76167399|FG002|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||11||
60051753|NCT02105948|76167400|FG003|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||15||
60051754|NCT02105948|76167397|FG000|Withdrew IP Due to: Physician Decision|Overall Study||2||
60051755|NCT02105948|76167398|FG001|Withdrew IP Due to: Physician Decision|Overall Study||1||
60051756|NCT02105948|76167399|FG002|Withdrew IP Due to: Physician Decision|Overall Study||4||
60051757|NCT02105948|76167400|FG003|Withdrew IP Due to: Physician Decision|Overall Study||2||
60051758|NCT02105948|76167397|FG000|Withdrew IP Due to: Stopping Criteria|Overall Study||0||
60051759|NCT02105948|76167398|FG001|Withdrew IP Due to: Stopping Criteria|Overall Study||0||
59513925|NCT03023488|75607580|FG000|STARTED|Overall Study||46||
59513926|NCT03023488|75607580|FG000|COMPLETED|Overall Study||46||
59513927|NCT03023488|75607580|FG000|NOT COMPLETED|Overall Study||0||
59513928|NCT03024112|75607592|FG000|STARTED|Overall Study||25||
59513929|NCT03024112|75607593|FG001|STARTED|Overall Study||26||
59513930|NCT03024112|75607592|FG000|COMPLETED|Overall Study||18||
59513931|NCT03024112|75607593|FG001|COMPLETED|Overall Study||26||
59513932|NCT03024112|75607592|FG000|NOT COMPLETED|Overall Study||7||
59513933|NCT03024112|75607593|FG001|NOT COMPLETED|Overall Study||0||
59513934|NCT02842060|75607601|FG000|STARTED|Overall Study||120||
59513935|NCT02842060|75607602|FG001|STARTED|Overall Study||60||
59513936|NCT02842060|75607601|FG000|COMPLETED|Overall Study||120||
59921739|NCT03085914|76041206|FG000|NOT COMPLETED|Overall Study||9||
59921740|NCT03085914|76041207|FG001|NOT COMPLETED|Overall Study||9||
59921741|NCT03085914|76041208|FG002|NOT COMPLETED|Overall Study||11||
59921742|NCT03085914|76041209|FG003|NOT COMPLETED|Overall Study||9||
59921743|NCT03085914|76041210|FG004|NOT COMPLETED|Overall Study||13||
59921744|NCT03085914|76041211|FG005|NOT COMPLETED|Overall Study||8||
59921745|NCT03085914|76041212|FG006|NOT COMPLETED|Overall Study||11||
59921746|NCT03112720|76041231|FG000|STARTED|Overall Study||5||
59921747|NCT03112720|76041232|FG001|STARTED|Overall Study||3||
59921748|NCT03112720|76041231|FG000|COMPLETED|Overall Study||5||
59921749|NCT03112720|76041232|FG001|COMPLETED|Overall Study||3||
59921750|NCT03112720|76041231|FG000|NOT COMPLETED|Overall Study||0||
59921751|NCT03112720|76041232|FG001|NOT COMPLETED|Overall Study||0||
59921752|NCT03078582|76041240|FG000|STARTED|Overall Study||10||
59921753|NCT03078582|76041241|FG001|STARTED|Overall Study||16||
59921754|NCT03078582|76041240|FG000|COMPLETED|Overall Study||10||
59921755|NCT03078582|76041241|FG001|COMPLETED|Overall Study||8||
60051760|NCT02105948|76167399|FG002|Withdrew IP Due to: Stopping Criteria|Overall Study||0||
60051761|NCT02105948|76167400|FG003|Withdrew IP Due to: Stopping Criteria|Overall Study||1||
60051762|NCT02105948|76167397|FG000|COMPLETED|Overall Study||202||
60051763|NCT02105948|76167398|FG001|COMPLETED|Overall Study||213||
60051764|NCT02105948|76167399|FG002|COMPLETED|Overall Study||162||
60051765|NCT02105948|76167400|FG003|COMPLETED|Overall Study||157||
60051766|NCT02105948|76167397|FG000|NOT COMPLETED|Overall Study||27||
60051767|NCT02105948|76167398|FG001|NOT COMPLETED|Overall Study||20||
60051768|NCT02105948|76167399|FG002|NOT COMPLETED|Overall Study||28||
59921756|NCT03078582|76041240|FG000|NOT COMPLETED|Overall Study||0||
59921757|NCT03078582|76041241|FG001|NOT COMPLETED|Overall Study||8||
59921758|NCT03077724|76041249|FG000|STARTED|Overall Study||14||
60051769|NCT02105948|76167400|FG003|NOT COMPLETED|Overall Study||27||
59513937|NCT02842060|75607602|FG001|COMPLETED|Overall Study||60||
59513938|NCT02842060|75607601|FG000|NOT COMPLETED|Overall Study||0||
59513939|NCT02842060|75607602|FG001|NOT COMPLETED|Overall Study||0||
60051770|NCT02128724|76167415|FG000|STARTED|Overall Study||4||
59921759|NCT03077724|76041250|FG001|STARTED|Overall Study||14||
59513940|NCT00958477|75607612|FG000|STARTED|Overall Study||8||
59513941|NCT00958477|75607613|FG001|STARTED|Overall Study||6||
59513942|NCT00958477|75607614|FG002|STARTED|Overall Study||6||
60051771|NCT02128724|76167416|FG001|STARTED|Overall Study||4||
60051772|NCT02128724|76167417|FG002|STARTED|Overall Study||3||
60051773|NCT02128724|76167418|FG003|STARTED|Overall Study||10||
60051774|NCT02128724|76167415|FG000|COMPLETED|Overall Study||3||
60051775|NCT02128724|76167416|FG001|COMPLETED|Overall Study||3||
60051776|NCT02128724|76167417|FG002|COMPLETED|Overall Study||3||
60051777|NCT02128724|76167418|FG003|COMPLETED|Overall Study||7||
60051778|NCT02128724|76167415|FG000|NOT COMPLETED|Overall Study||1||
60051779|NCT02128724|76167416|FG001|NOT COMPLETED|Overall Study||1||
59921760|NCT03077724|76041249|FG000|COMPLETED|Overall Study||6||
60051780|NCT02128724|76167417|FG002|NOT COMPLETED|Overall Study||0||
60051781|NCT02128724|76167418|FG003|NOT COMPLETED|Overall Study||3||
59513943|NCT00958477|75607615|FG003|STARTED|Overall Study||6||
59513944|NCT00958477|75607612|FG000|COMPLETED|Overall Study||8||
59513945|NCT00958477|75607613|FG001|COMPLETED|Overall Study||6||
59513946|NCT00958477|75607614|FG002|COMPLETED|Overall Study||6||
59513947|NCT00958477|75607615|FG003|COMPLETED|Overall Study||6||
59513948|NCT00958477|75607612|FG000|NOT COMPLETED|Overall Study||0||
59513949|NCT00958477|75607613|FG001|NOT COMPLETED|Overall Study||0||
59513950|NCT00958477|75607614|FG002|NOT COMPLETED|Overall Study||0||
59513951|NCT00958477|75607615|FG003|NOT COMPLETED|Overall Study||0||
59513952|NCT02958826|75607633|FG000|STARTED|Overall Study||80||
59760419|NCT03777319|75880036|FG001|COMPLETED|Overall Study||1||
59921761|NCT03077724|76041250|FG001|COMPLETED|Overall Study||12||
59921762|NCT03077724|76041249|FG000|NOT COMPLETED|Overall Study||8||
59921763|NCT03077724|76041250|FG001|NOT COMPLETED|Overall Study||2||
59760420|NCT03777319|75880035|FG000|NOT COMPLETED|Overall Study||0||
59760421|NCT03777319|75880036|FG001|NOT COMPLETED|Overall Study||0||
59760422|NCT03624413|75880044|FG000|STARTED|Overall Study||40||
59760423|NCT03624413|75880045|FG001|STARTED|Overall Study||40||
59921764|NCT00979212|76041258|FG000|STARTED|Overall Study||24||
59921765|NCT00979212|76041259|FG001|STARTED|Overall Study||47||
59921766|NCT00979212|76041258|FG000|COMPLETED|Overall Study|Subjects with data available for primary analysis are considered to have completed the study.|22||
59921767|NCT00979212|76041259|FG001|COMPLETED|Overall Study|Subjects with data available for primary analysis are considered to have completed the study.|39||
59921768|NCT00979212|76041258|FG000|NOT COMPLETED|Overall Study||2||
59921769|NCT00979212|76041259|FG001|NOT COMPLETED|Overall Study||8||
59921770|NCT03080454|76041265|FG000|STARTED|Baseline||26||
59921771|NCT03080454|76041265|FG000|COMPLETED|Baseline|Two participants (pts) dropped out after consent due to hospitalizations unrelated to the study.|24||
59921772|NCT03080454|76041265|FG000|NOT COMPLETED|Baseline||2||
59921773|NCT03080454|76041265|FG000|STARTED|Sham Doublestim (5days)||24||
59921774|NCT03080454|76041265|FG000|COMPLETED|Sham Doublestim (5days)||24||
59921775|NCT03080454|76041265|FG000|NOT COMPLETED|Sham Doublestim (5days)||0||
59921776|NCT03080454|76041265|FG000|STARTED|Sham FU (7days)||24||
59921777|NCT03080454|76041265|FG000|COMPLETED|Sham FU (7days)||24||
59921778|NCT03080454|76041265|FG000|NOT COMPLETED|Sham FU (7days)||0||
59921779|NCT03080454|76041265|FG000|STARTED|Anodal Doublestim (5 Days)||24||
59921780|NCT03080454|76041265|FG000|COMPLETED|Anodal Doublestim (5 Days)||23||
59921781|NCT03080454|76041265|FG000|NOT COMPLETED|Anodal Doublestim (5 Days)||1||
59921782|NCT03080454|76041265|FG000|STARTED|Anodal FU (7 Days)||23||
59921783|NCT03080454|76041265|FG000|COMPLETED|Anodal FU (7 Days)||19||
59921784|NCT03080454|76041265|FG000|NOT COMPLETED|Anodal FU (7 Days)||4||
59921785|NCT03501966|76041275|FG000|STARTED|Overall Study||2||
59921786|NCT03501966|76041276|FG001|STARTED|Overall Study||2||
59921787|NCT03501966|76041277|FG002|STARTED|Overall Study||3||
59921788|NCT03501966|76041275|FG000|COMPLETED|Overall Study||0||
59921789|NCT03501966|76041276|FG001|COMPLETED|Overall Study||0||
59921790|NCT03501966|76041277|FG002|COMPLETED|Overall Study||0||
59921791|NCT03501966|76041275|FG000|NOT COMPLETED|Overall Study||2||
59921792|NCT03501966|76041276|FG001|NOT COMPLETED|Overall Study||2||
59921793|NCT03501966|76041277|FG002|NOT COMPLETED|Overall Study||3||
59921794|NCT02981342|76041289|FG000|STARTED|Overall Study||7||
59921795|NCT02981342|76041290|FG001|STARTED|Overall Study||33||
59921796|NCT02981342|76041291|FG002|STARTED|Overall Study||33||
60051782|NCT02128490|76167432|FG000|STARTED|Overall Study||38||
59513953|NCT02958826|75607634|FG001|STARTED|Overall Study||80||
59760424|NCT03624413|75880044|FG000|COMPLETED|Overall Study||40||
59513954|NCT02958826|75607633|FG000|COMPLETED|Overall Study||80||
59921797|NCT02981342|76041292|FG003|STARTED|Overall Study||33||
59921798|NCT02981342|76041289|FG000|Received at Least One Dose of Study Drug|Overall Study||7||
59513955|NCT02958826|75607634|FG001|COMPLETED|Overall Study||80||
59513956|NCT02958826|75607633|FG000|NOT COMPLETED|Overall Study||0||
59921799|NCT02981342|76041290|FG001|Received at Least One Dose of Study Drug|Overall Study||32||
59921800|NCT02981342|76041291|FG002|Received at Least One Dose of Study Drug|Overall Study||33||
59921801|NCT02981342|76041292|FG003|Received at Least One Dose of Study Drug|Overall Study||26||
60051783|NCT02128490|76167433|FG001|STARTED|Overall Study||37||
60051784|NCT02128490|76167434|FG002|STARTED|Overall Study||39||
60051785|NCT02128490|76167435|FG003|STARTED|Overall Study||37||
60051786|NCT02128490|76167436|FG004|STARTED|Overall Study||38||
60051787|NCT02128490|76167432|FG000|COMPLETED|Overall Study||33||
60051788|NCT02128490|76167433|FG001|COMPLETED|Overall Study||31||
60051789|NCT02128490|76167434|FG002|COMPLETED|Overall Study||34||
60051790|NCT02128490|76167435|FG003|COMPLETED|Overall Study||31||
59760425|NCT03624413|75880045|FG001|COMPLETED|Overall Study||40||
60051791|NCT02128490|76167436|FG004|COMPLETED|Overall Study||31||
60051792|NCT02128490|76167432|FG000|NOT COMPLETED|Overall Study||5||
60051793|NCT02128490|76167433|FG001|NOT COMPLETED|Overall Study||6||
60051794|NCT02128490|76167434|FG002|NOT COMPLETED|Overall Study||5||
60051795|NCT02128490|76167435|FG003|NOT COMPLETED|Overall Study||6||
60051796|NCT02128490|76167436|FG004|NOT COMPLETED|Overall Study||7||
59513957|NCT02958826|75607634|FG001|NOT COMPLETED|Overall Study||0||
59513958|NCT00014495|75607646|FG000|STARTED|Overall Study||3||
59513959|NCT00014495|75607647|FG001|STARTED|Overall Study||3||
59513960|NCT00014495|75607648|FG002|STARTED|Overall Study||20||
59513961|NCT00014495|75607649|FG003|STARTED|Overall Study||6||
59513962|NCT00014495|75607646|FG000|COMPLETED|Overall Study||3||
59760426|NCT03624413|75880044|FG000|NOT COMPLETED|Overall Study||0||
59760427|NCT03624413|75880045|FG001|NOT COMPLETED|Overall Study||0||
59760428|NCT03575325|75880051|FG000|STARTED|Overall Study||11||
60051797|NCT02146352|76167448|FG000|STARTED|Overall Study||30||
60051798|NCT02146352|76167448|FG000|30 or 60 Days Post-procedure|Overall Study||30||
60051799|NCT02146352|76167448|FG000|7 Days Post-stent Removal|Overall Study||28||
60051800|NCT02146352|76167448|FG000|COMPLETED|Overall Study||28||
60051801|NCT02146352|76167448|FG000|NOT COMPLETED|Overall Study||2||
60051802|NCT02146274|76167452|FG000|STARTED|Overall Study||1877||
60051803|NCT02146274|76167452|FG000|COMPLETED|Overall Study||1804||
59513963|NCT00014495|75607647|FG001|COMPLETED|Overall Study||3||
59513964|NCT00014495|75607648|FG002|COMPLETED|Overall Study||19||
59760429|NCT03575325|75880051|FG000|COMPLETED|Overall Study||10||
59760430|NCT03575325|75880051|FG000|NOT COMPLETED|Overall Study||1||
59760431|NCT03439254|75880060|FG000|STARTED|Double-blind Phase (18 Months)||313||
59760432|NCT03439254|75880061|FG001|STARTED|Double-blind Phase (18 Months)||296||
59760433|NCT03439254|75880062|FG002|STARTED|Double-blind Phase (18 Months)||310||
59760434|NCT03439254|75880063|FG003|STARTED|Double-blind Phase (18 Months)||0||
59760435|NCT03439254|75880064|FG004|STARTED|Double-blind Phase (18 Months)||0||
59760436|NCT03439254|75880065|FG005|STARTED|Double-blind Phase (18 Months)||0||
59760437|NCT03439254|75880060|FG000|COMPLETED|Double-blind Phase (18 Months)||284||
59760438|NCT03439254|75880061|FG001|COMPLETED|Double-blind Phase (18 Months)||274||
59760439|NCT03439254|75880062|FG002|COMPLETED|Double-blind Phase (18 Months)||275||
59760440|NCT03439254|75880063|FG003|COMPLETED|Double-blind Phase (18 Months)||0||
59760441|NCT03439254|75880064|FG004|COMPLETED|Double-blind Phase (18 Months)||0||
59760442|NCT03439254|75880065|FG005|COMPLETED|Double-blind Phase (18 Months)||0||
59760443|NCT03439254|75880060|FG000|NOT COMPLETED|Double-blind Phase (18 Months)||29||
59760444|NCT03439254|75880061|FG001|NOT COMPLETED|Double-blind Phase (18 Months)||22||
59760445|NCT03439254|75880062|FG002|NOT COMPLETED|Double-blind Phase (18 Months)||35||
59760446|NCT03439254|75880063|FG003|NOT COMPLETED|Double-blind Phase (18 Months)||0||
59760447|NCT03439254|75880064|FG004|NOT COMPLETED|Double-blind Phase (18 Months)||0||
59760448|NCT03439254|75880065|FG005|NOT COMPLETED|Double-blind Phase (18 Months)||0||
59760449|NCT03439254|75880060|FG000|STARTED|Open Label Extension Phase (12 Months)||0||
59760450|NCT03439254|75880061|FG001|STARTED|Open Label Extension Phase (12 Months)||0||
59760451|NCT03439254|75880062|FG002|STARTED|Open Label Extension Phase (12 Months)||0||
59760452|NCT03439254|75880063|FG003|STARTED|Open Label Extension Phase (12 Months)||231||
59760453|NCT03439254|75880064|FG004|STARTED|Open Label Extension Phase (12 Months)||221||
59760454|NCT03439254|75880065|FG005|STARTED|Open Label Extension Phase (12 Months)||207||
59760455|NCT03439254|75880060|FG000|COMPLETED|Open Label Extension Phase (12 Months)||0||
59760456|NCT03439254|75880061|FG001|COMPLETED|Open Label Extension Phase (12 Months)||0||
59760457|NCT03439254|75880062|FG002|COMPLETED|Open Label Extension Phase (12 Months)||0||
59513965|NCT00014495|75607649|FG003|COMPLETED|Overall Study||5||
59513966|NCT00014495|75607646|FG000|NOT COMPLETED|Overall Study||0||
59513967|NCT00014495|75607647|FG001|NOT COMPLETED|Overall Study||0||
59760458|NCT03439254|75880063|FG003|COMPLETED|Open Label Extension Phase (12 Months)||215||
59760459|NCT03439254|75880064|FG004|COMPLETED|Open Label Extension Phase (12 Months)||208||
59760460|NCT03439254|75880065|FG005|COMPLETED|Open Label Extension Phase (12 Months)||192||
60051804|NCT02146274|76167452|FG000|NOT COMPLETED|Overall Study||73||
60051805|NCT02105636|76167461|FG000|STARTED|Pre-Treatment||240|Started = Randomized|
60051806|NCT02105636|76167462|FG001|STARTED|Pre-Treatment||121|Started = Randomized|
60051807|NCT02105636|76167461|FG000|COMPLETED|Pre-Treatment||236|Completed = Entering treatment|
60051808|NCT02105636|76167462|FG001|COMPLETED|Pre-Treatment||111|Completed = Entering treatment|
60051809|NCT02105636|76167461|FG000|NOT COMPLETED|Pre-Treatment||4||
60051810|NCT02105636|76167462|FG001|NOT COMPLETED|Pre-Treatment||10||
59513968|NCT00014495|75607648|FG002|NOT COMPLETED|Overall Study||1||
59513969|NCT00014495|75607649|FG003|NOT COMPLETED|Overall Study||1||
59513970|NCT00960505|75607659|FG000|STARTED|Overall Study||34||
59513971|NCT00960505|75607660|FG001|STARTED|Overall Study||35||
59513972|NCT00960505|75607661|FG002|STARTED|Overall Study||31||
59513973|NCT00960505|75607659|FG000|COMPLETED|Overall Study||21||
59513974|NCT00960505|75607660|FG001|COMPLETED|Overall Study||25||
59921802|NCT02981342|76041289|FG000|COMPLETED|Overall Study||7||
59921803|NCT02981342|76041290|FG001|COMPLETED|Overall Study||22||
59921804|NCT02981342|76041291|FG002|COMPLETED|Overall Study||20||
59921805|NCT02981342|76041292|FG003|COMPLETED|Overall Study||19||
59921806|NCT02981342|76041289|FG000|NOT COMPLETED|Overall Study||0||
59921807|NCT02981342|76041290|FG001|NOT COMPLETED|Overall Study||11||
59513975|NCT00960505|75607661|FG002|COMPLETED|Overall Study||23||
59921808|NCT02981342|76041291|FG002|NOT COMPLETED|Overall Study||13||
59921809|NCT02981342|76041292|FG003|NOT COMPLETED|Overall Study||14||
59921810|NCT02794246|76041304|FG000|STARTED|Overall Study||6||
59921811|NCT02794246|76041304|FG000|Treated|Overall Study||3||
59921812|NCT02794246|76041304|FG000|COMPLETED|Overall Study||0||
59921813|NCT02794246|76041304|FG000|NOT COMPLETED|Overall Study||6||
59513976|NCT00960505|75607659|FG000|NOT COMPLETED|Overall Study||13||
59513977|NCT00960505|75607660|FG001|NOT COMPLETED|Overall Study||10||
59513978|NCT00960505|75607661|FG002|NOT COMPLETED|Overall Study||8||
59513979|NCT02958982|75607680|FG000|STARTED|Cohort 1: 25 mg in SAD Study||1||
59513980|NCT02958982|75607681|FG001|STARTED|Cohort 1: 25 mg in SAD Study||3||
59513981|NCT02958982|75607682|FG002|STARTED|Cohort 1: 25 mg in SAD Study||0||
59921814|NCT03428100|76041312|FG000|STARTED|Overall Study||93||
59921815|NCT03428100|76041313|FG001|STARTED|Overall Study||93||
59921816|NCT03428100|76041314|FG002|STARTED|Overall Study||185||
59921817|NCT03428100|76041315|FG003|STARTED|Overall Study||92||
59921818|NCT03428100|76041312|FG000|Received at Least One Dose of Study Drug|Overall Study||93||
59921819|NCT03428100|76041313|FG001|Received at Least One Dose of Study Drug|Overall Study||93||
59513982|NCT02958982|75607683|FG003|STARTED|Cohort 1: 25 mg in SAD Study||0||
59612820|NCT01697592|75723840|FG009|COMPLETED|Phase B (Week 25 to Week 52)||30||
59513983|NCT02958982|75607684|FG004|STARTED|Cohort 1: 25 mg in SAD Study||0||
59513984|NCT02958982|75607685|FG005|STARTED|Cohort 1: 25 mg in SAD Study||0||
59513985|NCT02958982|75607686|FG006|STARTED|Cohort 1: 25 mg in SAD Study||0||
59513986|NCT02958982|75607687|FG007|STARTED|Cohort 1: 25 mg in SAD Study||0||
59513987|NCT02958982|75607688|FG008|STARTED|Cohort 1: 25 mg in SAD Study||0||
59612821|NCT01697592|75723831|FG000|NOT COMPLETED|Phase B (Week 25 to Week 52)||5||
59921820|NCT03428100|76041314|FG002|Received at Least One Dose of Study Drug|Overall Study||184||
59921821|NCT03428100|76041315|FG003|Received at Least One Dose of Study Drug|Overall Study||92||
59921822|NCT03428100|76041312|FG000|COMPLETED|Overall Study||72||
59921823|NCT03428100|76041313|FG001|COMPLETED|Overall Study||80||
59921824|NCT03428100|76041314|FG002|COMPLETED|Overall Study||173||
59612822|NCT01697592|75723832|FG001|NOT COMPLETED|Phase B (Week 25 to Week 52)||1||
59612823|NCT01697592|75723833|FG002|NOT COMPLETED|Phase B (Week 25 to Week 52)||1||
59921825|NCT03428100|76041315|FG003|COMPLETED|Overall Study||85||
59921826|NCT03428100|76041312|FG000|NOT COMPLETED|Overall Study||21||
59921827|NCT03428100|76041313|FG001|NOT COMPLETED|Overall Study||13||
59921828|NCT03428100|76041314|FG002|NOT COMPLETED|Overall Study||12||
59921829|NCT03428100|76041315|FG003|NOT COMPLETED|Overall Study||7||
59921830|NCT02980874|76041337|FG000|STARTED|Overall Study||231||
59921831|NCT02980874|76041338|FG001|STARTED|Overall Study||229||
59921832|NCT02980874|76041337|FG000|COMPLETED|Overall Study||128||
59921833|NCT02980874|76041338|FG001|COMPLETED|Overall Study||127||
59921834|NCT02980874|76041337|FG000|NOT COMPLETED|Overall Study||103||
59921835|NCT02980874|76041338|FG001|NOT COMPLETED|Overall Study||102||
59921836|NCT01066052|76041346|FG000|STARTED|Overall Study||64||
59921837|NCT01066052|76041347|FG001|STARTED|Overall Study||51||
59921838|NCT01066052|76041346|FG000|Treated|Overall Study||61||
59921839|NCT01066052|76041347|FG001|Treated|Overall Study||0||
59921840|NCT01066052|76041346|FG000|COMPLETED|Overall Study||61||
59921841|NCT01066052|76041347|FG001|COMPLETED|Overall Study||51||
59921842|NCT01066052|76041346|FG000|NOT COMPLETED|Overall Study||3||
59921843|NCT01066052|76041347|FG001|NOT COMPLETED|Overall Study||0||
59921844|NCT03077646|76041355|FG000|STARTED|Overall Study||76||
59921845|NCT03077646|76041356|FG001|STARTED|Overall Study||75||
59921846|NCT03077646|76041357|FG002|STARTED|Overall Study||74||
59921847|NCT03077646|76041355|FG000|COMPLETED|Overall Study|Of these 47, there were 25 paired samples for primary outcome|47||
59921848|NCT03077646|76041356|FG001|COMPLETED|Overall Study|Of these 45, there were 27 paired samples for primary outcome|45||
59921849|NCT03077646|76041357|FG002|COMPLETED|Overall Study|Of these 43, there were 20 paired samples for primary outcome|43||
59921850|NCT03077646|76041355|FG000|NOT COMPLETED|Overall Study||29||
59921851|NCT03077646|76041356|FG001|NOT COMPLETED|Overall Study||30||
59921852|NCT03077646|76041357|FG002|NOT COMPLETED|Overall Study||31||
59921853|NCT02892149|76041367|FG000|STARTED|Overall Study||1777||
59921854|NCT02892149|76041368|FG001|STARTED|Overall Study||1777||
59921855|NCT02892149|76041367|FG000|COMPLETED|Overall Study||1425||
59513988|NCT02958982|75607689|FG009|STARTED|Cohort 1: 25 mg in SAD Study||0||
59513989|NCT02958982|75607690|FG010|STARTED|Cohort 1: 25 mg in SAD Study||0||
59513990|NCT02958982|75607680|FG000|COMPLETED|Cohort 1: 25 mg in SAD Study||1||
59513991|NCT02958982|75607681|FG001|COMPLETED|Cohort 1: 25 mg in SAD Study||3||
60051811|NCT02105636|76167461|FG000|STARTED|Treatment||236||
60051812|NCT02105636|76167462|FG001|STARTED|Treatment||111||
60051813|NCT02105636|76167461|FG000|COMPLETED|Treatment||1||
60051814|NCT02105636|76167462|FG001|COMPLETED|Treatment||0||
60051815|NCT02105636|76167461|FG000|NOT COMPLETED|Treatment||235||
60051816|NCT02105636|76167462|FG001|NOT COMPLETED|Treatment||111||
60051817|NCT01626872|76167471|FG000|STARTED|Overall Study||81||
60051818|NCT01626872|76167472|FG001|STARTED|Overall Study||109||
60051819|NCT01626872|76167473|FG002|STARTED|Overall Study||58||
60051820|NCT01626872|76167471|FG000|COMPLETED|Overall Study||29||
60051821|NCT01626872|76167472|FG001|COMPLETED|Overall Study||43||
60051822|NCT01626872|76167473|FG002|COMPLETED|Overall Study||34||
60051823|NCT01626872|76167471|FG000|NOT COMPLETED|Overall Study||52||
60051824|NCT01626872|76167472|FG001|NOT COMPLETED|Overall Study||66||
60051825|NCT01626872|76167473|FG002|NOT COMPLETED|Overall Study||24||
60051826|NCT01598090|76167484|FG000|STARTED|Treatment Period||27||
60051827|NCT01598090|76167485|FG001|STARTED|Treatment Period||411||
60051828|NCT01598090|76167486|FG002|STARTED|Treatment Period||206||
60051829|NCT01598090|76167484|FG000|COMPLETED|Treatment Period||16||
60051830|NCT01598090|76167485|FG001|COMPLETED|Treatment Period||339||
60051831|NCT01598090|76167486|FG002|COMPLETED|Treatment Period||171||
60051832|NCT01598090|76167484|FG000|NOT COMPLETED|Treatment Period||11||
60051833|NCT01598090|76167485|FG001|NOT COMPLETED|Treatment Period||72||
60051834|NCT01598090|76167486|FG002|NOT COMPLETED|Treatment Period||35||
60051835|NCT01598090|76167484|FG000|STARTED|Follow-up Period|Includes 10 participants who re-joined from treatment period to follow-up period.|26||
60051836|NCT01598090|76167485|FG001|STARTED|Follow-up Period|Includes 60 participants who re-joined from treatment period to follow-up period.|399||
60051837|NCT01598090|76167486|FG002|STARTED|Follow-up Period|Includes 28 participants who re-joined from treatment period to follow-up period.|199||
60051838|NCT01598090|76167484|FG000|COMPLETED|Follow-up Period||21||
60051839|NCT01598090|76167485|FG001|COMPLETED|Follow-up Period||364||
60051840|NCT01598090|76167486|FG002|COMPLETED|Follow-up Period||171||
60051841|NCT01598090|76167484|FG000|NOT COMPLETED|Follow-up Period||5||
60051842|NCT01598090|76167485|FG001|NOT COMPLETED|Follow-up Period||35||
60051843|NCT01598090|76167486|FG002|NOT COMPLETED|Follow-up Period||28||
60051844|NCT02105012|76167497|FG000|STARTED|Overall Study||147||
60051845|NCT02105012|76167497|FG000|BD MDI 320 µg|Overall Study||124||
60051846|NCT02105012|76167497|FG000|BD MDI 160 µg|Overall Study||132||
60051847|NCT02105012|76167497|FG000|BD MDI 80 µg|Overall Study||64||
60051848|NCT02105012|76167497|FG000|BD MDI 40 µg|Overall Study||63||
60051849|NCT02105012|76167497|FG000|Placebo MDI|Overall Study||127||
60051850|NCT02105012|76167497|FG000|COMPLETED|Overall Study||114||
60051851|NCT02105012|76167497|FG000|NOT COMPLETED|Overall Study||33||
60051852|NCT02145182|76167511|FG000|STARTED|Overall Study||142||
60051853|NCT02145182|76167512|FG001|STARTED|Overall Study||146||
60051854|NCT02145182|76167511|FG000|Received at Least 1 Dose of Study Drug|Overall Study||142||
60051855|NCT02145182|76167512|FG001|Received at Least 1 Dose of Study Drug|Overall Study||146||
59513992|NCT02958982|75607682|FG002|COMPLETED|Cohort 1: 25 mg in SAD Study||0||
59513993|NCT02958982|75607683|FG003|COMPLETED|Cohort 1: 25 mg in SAD Study||0||
59513994|NCT02958982|75607684|FG004|COMPLETED|Cohort 1: 25 mg in SAD Study||0||
59513995|NCT02958982|75607685|FG005|COMPLETED|Cohort 1: 25 mg in SAD Study||0||
59513996|NCT02958982|75607686|FG006|COMPLETED|Cohort 1: 25 mg in SAD Study||0||
59513997|NCT02958982|75607687|FG007|COMPLETED|Cohort 1: 25 mg in SAD Study||0||
59513998|NCT02958982|75607688|FG008|COMPLETED|Cohort 1: 25 mg in SAD Study||0||
59513999|NCT02958982|75607689|FG009|COMPLETED|Cohort 1: 25 mg in SAD Study||0||
59514000|NCT02958982|75607690|FG010|COMPLETED|Cohort 1: 25 mg in SAD Study||0||
59514001|NCT02958982|75607680|FG000|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0||
59514002|NCT02958982|75607681|FG001|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0||
60051856|NCT02145182|76167511|FG000|COMPLETED|Overall Study||124||
60051857|NCT02145182|76167512|FG001|COMPLETED|Overall Study||130||
60051858|NCT02145182|76167511|FG000|NOT COMPLETED|Overall Study||18||
60051859|NCT02145182|76167512|FG001|NOT COMPLETED|Overall Study||16||
60051860|NCT02145026|76167518|FG000|STARTED|Overall Study||100||
60051861|NCT02145026|76167518|FG000|COMPLETED|Overall Study||88||
60051862|NCT02145026|76167518|FG000|NOT COMPLETED|Overall Study||12||
60051863|NCT02144012|76167524|FG000|STARTED|Overall Study||34||
59514003|NCT02958982|75607682|FG002|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0||
60051864|NCT02144012|76167525|FG001|STARTED|Overall Study||15||
60051865|NCT02144012|76167524|FG000|COMPLETED|Overall Study||0||
60051866|NCT02144012|76167525|FG001|COMPLETED|Overall Study||0||
60051867|NCT02144012|76167524|FG000|NOT COMPLETED|Overall Study||34||
60051868|NCT02144012|76167525|FG001|NOT COMPLETED|Overall Study||15||
60051869|NCT02103062|76167533|FG000|STARTED|Overall Study||18||
60051870|NCT02103062|76167534|FG001|STARTED|Overall Study||23||
60051871|NCT02103062|76167533|FG000|Safety Population|Overall Study|Includes participants who received at least one dose of study drug.|18||
60051872|NCT02103062|76167534|FG001|Safety Population|Overall Study|Includes participants who received at least one dose of study drug.|23||
60051873|NCT02103062|76167533|FG000|Intent to Treat Population|Overall Study|Includes participants who met all eligibility criteria and received at least one dose of study drug.|17||
60051874|NCT02103062|76167534|FG001|Intent to Treat Population|Overall Study|Includes participants who met all eligibility criteria and received at least one dose of study drug.|20||
60051875|NCT02103062|76167533|FG000|COMPLETED|Overall Study||0||
59514004|NCT02958982|75607683|FG003|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0||
59514005|NCT02958982|75607684|FG004|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0||
59514006|NCT02958982|75607685|FG005|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0||
59514007|NCT02958982|75607686|FG006|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0||
60051876|NCT02103062|76167534|FG001|COMPLETED|Overall Study||0||
60051877|NCT02103062|76167533|FG000|NOT COMPLETED|Overall Study||18||
60051878|NCT02103062|76167534|FG001|NOT COMPLETED|Overall Study||23||
60051879|NCT02141984|76167542|FG000|STARTED|Overall Study||28||
60051880|NCT02141984|76167542|FG000|COMPLETED|Overall Study||26||
60051881|NCT02141984|76167542|FG000|NOT COMPLETED|Overall Study||2||
60051882|NCT02141672|76167549|FG000|STARTED|Overall Study||89||
60051883|NCT02141672|76167550|FG001|STARTED|Overall Study||88||
60051884|NCT02141672|76167551|FG002|STARTED|Overall Study||88||
60051885|NCT02141672|76167549|FG000|COMPLETED|Overall Study||73||
60051886|NCT02141672|76167550|FG001|COMPLETED|Overall Study||80||
60051887|NCT02141672|76167551|FG002|COMPLETED|Overall Study||70||
60051888|NCT02141672|76167549|FG000|NOT COMPLETED|Overall Study||16||
60051889|NCT02141672|76167550|FG001|NOT COMPLETED|Overall Study||8||
60051890|NCT02141672|76167551|FG002|NOT COMPLETED|Overall Study||18||
60051891|NCT02141516|76167562|FG000|STARTED|Overall Study||40||
60051892|NCT02141516|76167563|FG001|STARTED|Overall Study||112||
60051893|NCT02141516|76167564|FG002|STARTED|Overall Study||87||
60051894|NCT02141516|76167562|FG000|COMPLETED|Overall Study||40||
60051895|NCT02141516|76167563|FG001|COMPLETED|Overall Study||107||
60051896|NCT02141516|76167564|FG002|COMPLETED|Overall Study||87||
60051897|NCT02141516|76167562|FG000|NOT COMPLETED|Overall Study||0||
60051898|NCT02141516|76167563|FG001|NOT COMPLETED|Overall Study||5||
60051899|NCT02141516|76167564|FG002|NOT COMPLETED|Overall Study||0||
60051900|NCT02141360|76167578|FG000|STARTED|Overall Study||11||
60051901|NCT02141360|76167579|FG001|STARTED|Overall Study||6||
60051902|NCT02141360|76167580|FG002|STARTED|Overall Study||6||
60051903|NCT02141360|76167578|FG000|COMPLETED|Overall Study||4||
60051904|NCT02141360|76167579|FG001|COMPLETED|Overall Study||6||
60051905|NCT02141360|76167580|FG002|COMPLETED|Overall Study||6||
60051906|NCT02141360|76167578|FG000|NOT COMPLETED|Overall Study||7||
60051907|NCT02141360|76167579|FG001|NOT COMPLETED|Overall Study||0||
60051908|NCT02141360|76167580|FG002|NOT COMPLETED|Overall Study||0||
60051909|NCT01628198|76167588|FG000|STARTED|Overall Study||38||
60051910|NCT01628198|76167588|FG000|COMPLETED|Overall Study||20||
60051911|NCT01628198|76167588|FG000|NOT COMPLETED|Overall Study||18||
60051912|NCT01628120|76167592|FG000|STARTED|Overall Study||173||
60051913|NCT01628120|76167592|FG000|Treated|Overall Study||170||
60051914|NCT01628120|76167592|FG000|COMPLETED|Overall Study||129||
60051915|NCT01628120|76167592|FG000|NOT COMPLETED|Overall Study||44||
60051916|NCT01627340|76167598|FG000|STARTED|Overall Study||416||
60051917|NCT01627340|76167599|FG001|STARTED|Overall Study||258||
60051918|NCT01627340|76167598|FG000|COMPLETED|Overall Study||404||
60051919|NCT01627340|76167599|FG001|COMPLETED|Overall Study||254||
59514008|NCT02958982|75607687|FG007|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0||
59514009|NCT02958982|75607688|FG008|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0||
59514010|NCT02958982|75607689|FG009|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0||
59514011|NCT02958982|75607690|FG010|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0||
59514012|NCT02958982|75607680|FG000|STARTED|Cohort 2: 50 mg in SAD Study||2||
60051920|NCT01627340|76167598|FG000|NOT COMPLETED|Overall Study||12||
60051921|NCT01627340|76167599|FG001|NOT COMPLETED|Overall Study||4||
60051922|NCT02125838|76167609|FG000|STARTED|Overall Study|Lost to follow-up (n= 4 ) Turned to laparotomy (Adhesions)(n= 2) NBA used (n= 2)|54||
59514013|NCT02958982|75607681|FG001|STARTED|Cohort 2: 50 mg in SAD Study||0||
59514014|NCT02958982|75607682|FG002|STARTED|Cohort 2: 50 mg in SAD Study||4||
59514015|NCT02958982|75607683|FG003|STARTED|Cohort 2: 50 mg in SAD Study||0||
60051923|NCT02125838|76167610|FG001|STARTED|Overall Study|Lost to follow-up (n= 4 ) Turned to laparotomy (Adhesions) (n= 2) NBA used (n= 2)|54||
60051924|NCT02125838|76167609|FG000|COMPLETED|Overall Study|Analysed (n=50 )|50||
60051925|NCT02125838|76167610|FG001|COMPLETED|Overall Study|Analysed (n=50 )|50||
60051926|NCT02125838|76167609|FG000|NOT COMPLETED|Overall Study||4||
60051927|NCT02125838|76167610|FG001|NOT COMPLETED|Overall Study||4||
60051928|NCT02125604|76167616|FG000|STARTED|Overall Study|enrolled and received at least 1 dose of study drug|211||
60051929|NCT02125604|76167616|FG000|COMPLETED|Overall Study||180||
59514016|NCT02958982|75607684|FG004|STARTED|Cohort 2: 50 mg in SAD Study||0||
59514017|NCT02958982|75607685|FG005|STARTED|Cohort 2: 50 mg in SAD Study||0||
59519038|NCT03398278|75612889|FG000|COMPLETED|Period 1||18||
60051930|NCT02125604|76167616|FG000|NOT COMPLETED|Overall Study||31||
60051931|NCT02124746|76167623|FG000|STARTED|Overall Study||30||
60051932|NCT02124746|76167624|FG001|STARTED|Overall Study||22||
60051933|NCT02124746|76167625|FG002|STARTED|Overall Study||22||
60051934|NCT02124746|76167623|FG000|COMPLETED|Overall Study||11||
60051935|NCT02124746|76167624|FG001|COMPLETED|Overall Study||4||
59921856|NCT02892149|76041368|FG001|COMPLETED|Overall Study||1421||
59921857|NCT02892149|76041367|FG000|NOT COMPLETED|Overall Study||352||
59921858|NCT02892149|76041368|FG001|NOT COMPLETED|Overall Study||356||
59921859|NCT04187092|76041376|FG000|STARTED|Overall Study||17||
59921860|NCT04187092|76041377|FG001|STARTED|Overall Study||17||
59921861|NCT04187092|76041376|FG000|COMPLETED|Overall Study||15||
59921862|NCT04187092|76041377|FG001|COMPLETED|Overall Study||14||
59921863|NCT04187092|76041376|FG000|NOT COMPLETED|Overall Study||2||
59921864|NCT04187092|76041377|FG001|NOT COMPLETED|Overall Study||3||
59921865|NCT02896127|76041385|FG000|STARTED|COMPLETED WEEK 52||305|Started the Week 52 period|
59921866|NCT02896127|76041386|FG001|STARTED|COMPLETED WEEK 52|Includes participants originally assigned to placebo and switched to AIN457150 mg after Wk 16.|153|Started the Week 52 period|
59921867|NCT02896127|76041385|FG000|COMPLETED|COMPLETED WEEK 52||278|Discontinued before or at Week 52|
59921868|NCT02896127|76041386|FG001|COMPLETED|COMPLETED WEEK 52||142|Discontinued before or at Week 52|
59921869|NCT02896127|76041385|FG000|NOT COMPLETED|COMPLETED WEEK 52||27||
59921870|NCT02896127|76041386|FG001|NOT COMPLETED|COMPLETED WEEK 52||11||
59921871|NCT02896127|76041385|FG000|STARTED|COMPLETED POST-TREATMENT FOLLOW UP|Participants enter follow-up if they exited before Wk 52 Thus numbers different from previous period|280|All patients independent of completer status were asked to enter follow up whenever they exited the study no matter at what time in their participation. Moreover, not all participants who completed Week 52 entered the follow up period and some did not complete follow-up. Therefore, the number of participants who started the follow-up period is not equal to the number of participants who completed the previous period.|
59921872|NCT02896127|76041386|FG001|STARTED|COMPLETED POST-TREATMENT FOLLOW UP|Participants enter follow-up if they exited before Wk 52 Thus numbers different from previous period|139|All patients independent of completer status were asked to enter follow up whenever they exited the study no matter at what time in their participation. Moreover, not all participants who completed Week 52 entered the follow up period and some did not complete follow-up. Therefore, the number of participants who started the follow-up period is not equal to the number of participants who completed the previous period.|
59921873|NCT02896127|76041385|FG000|COMPLETED|COMPLETED POST-TREATMENT FOLLOW UP|Participants enter follow-up if they exited before Wk 52 Thus numbers different from previous period|276||
59921874|NCT02896127|76041386|FG001|COMPLETED|COMPLETED POST-TREATMENT FOLLOW UP|Participants enter follow-up if they exited before Wk 52 Thus numbers different from previous period|134||
59921875|NCT02896127|76041385|FG000|NOT COMPLETED|COMPLETED POST-TREATMENT FOLLOW UP||4||
59921876|NCT02896127|76041386|FG001|NOT COMPLETED|COMPLETED POST-TREATMENT FOLLOW UP||5||
59921877|NCT03546647|76041392|FG000|STARTED|Overall Study||18||
59921878|NCT03546647|76041393|FG001|STARTED|Overall Study|34|17||
59921879|NCT03546647|76041392|FG000|COMPLETED|Overall Study||17||
59921880|NCT03546647|76041393|FG001|COMPLETED|Overall Study||17||
59921881|NCT03546647|76041392|FG000|NOT COMPLETED|Overall Study||1||
59921882|NCT03546647|76041393|FG001|NOT COMPLETED|Overall Study||0||
59921883|NCT03077412|76041402|FG000|STARTED|Overall Study||17||
59921884|NCT03077412|76041403|FG001|STARTED|Overall Study||25||
59921885|NCT03077412|76041404|FG002|STARTED|Overall Study||15||
59921886|NCT03077412|76041402|FG000|COMPLETED|Overall Study||14||
59921887|NCT03077412|76041403|FG001|COMPLETED|Overall Study||12||
59921888|NCT03077412|76041404|FG002|COMPLETED|Overall Study||6||
59921889|NCT03077412|76041402|FG000|NOT COMPLETED|Overall Study||3||
59921890|NCT03077412|76041403|FG001|NOT COMPLETED|Overall Study||13||
59921891|NCT03077412|76041404|FG002|NOT COMPLETED|Overall Study||9||
59921892|NCT03544229|76041416|FG000|STARTED|Overall Study||73||
59921893|NCT03544229|76041417|FG001|STARTED|Overall Study||23||
59921894|NCT03544229|76041418|FG002|STARTED|Overall Study||72||
59921895|NCT03544229|76041419|FG003|STARTED|Overall Study||74||
59921896|NCT03544229|76041416|FG000|COMPLETED|Overall Study||67||
59921897|NCT03544229|76041417|FG001|COMPLETED|Overall Study||21||
59921898|NCT03544229|76041418|FG002|COMPLETED|Overall Study||67||
59921899|NCT03544229|76041419|FG003|COMPLETED|Overall Study||72||
59921900|NCT03544229|76041416|FG000|NOT COMPLETED|Overall Study||6||
59921901|NCT03544229|76041417|FG001|NOT COMPLETED|Overall Study||2||
59921902|NCT03544229|76041418|FG002|NOT COMPLETED|Overall Study||5||
59921903|NCT03544229|76041419|FG003|NOT COMPLETED|Overall Study||2||
59921904|NCT03078816|76041429|FG000|STARTED|Overall Study||5||
59921905|NCT03078816|76041429|FG000|COMPLETED|Overall Study||4||
59921906|NCT03078816|76041429|FG000|NOT COMPLETED|Overall Study||1||
59921907|NCT03510455|76041433|FG000|STARTED|Overall Study||4||
59921908|NCT03510455|76041433|FG000|Treated|Overall Study||4||
59921909|NCT03510455|76041433|FG000|Extension Phase|Overall Study||1||
59921910|NCT03510455|76041433|FG000|Screening Failures|Overall Study||0||
59921911|NCT03510455|76041433|FG000|COMPLETED|Overall Study|3 of 4 patients completed the 24 week treatment phase of the study|3||
59921912|NCT03510455|76041433|FG000|NOT COMPLETED|Overall Study||1||
59921913|NCT03509675|76041441|FG000|STARTED|First Intervention (7 Days)||11||
59921914|NCT03509675|76041442|FG001|STARTED|First Intervention (7 Days)||12||
59921915|NCT03509675|76041441|FG000|COMPLETED|First Intervention (7 Days)||6||
59921916|NCT03509675|76041442|FG001|COMPLETED|First Intervention (7 Days)||8||
59921917|NCT03509675|76041441|FG000|NOT COMPLETED|First Intervention (7 Days)||5||
59921918|NCT03509675|76041442|FG001|NOT COMPLETED|First Intervention (7 Days)||4||
59921919|NCT03509675|76041441|FG000|STARTED|Washout Period (7 Days)||6||
59921920|NCT03509675|76041442|FG001|STARTED|Washout Period (7 Days)||8||
59921921|NCT03509675|76041441|FG000|COMPLETED|Washout Period (7 Days)||6||
59921922|NCT03509675|76041442|FG001|COMPLETED|Washout Period (7 Days)||8||
59921923|NCT03509675|76041441|FG000|NOT COMPLETED|Washout Period (7 Days)||0||
59921924|NCT03509675|76041442|FG001|NOT COMPLETED|Washout Period (7 Days)||0||
59921925|NCT03509675|76041441|FG000|STARTED|Second Intervention )7 Days)||6||
59921926|NCT03509675|76041442|FG001|STARTED|Second Intervention )7 Days)||8||
59921927|NCT03509675|76041441|FG000|COMPLETED|Second Intervention )7 Days)||4||
59921928|NCT03509675|76041442|FG001|COMPLETED|Second Intervention )7 Days)||8||
59921929|NCT03509675|76041441|FG000|NOT COMPLETED|Second Intervention )7 Days)||2||
59921930|NCT03509675|76041442|FG001|NOT COMPLETED|Second Intervention )7 Days)||0||
59921931|NCT03509207|76041448|FG000|STARTED|Overall Study||3||
59921932|NCT03509207|76041448|FG000|COMPLETED|Overall Study||1||
59921933|NCT03509207|76041448|FG000|NOT COMPLETED|Overall Study||2||
59921934|NCT03543137|76041452|FG000|STARTED|Study Period 1: Up to Day 1||18||
59921935|NCT03543137|76041453|FG001|STARTED|Study Period 1: Up to Day 1||19||
59921936|NCT03543137|76041452|FG000|COMPLETED|Study Period 1: Up to Day 1||18||
59921937|NCT03543137|76041453|FG001|COMPLETED|Study Period 1: Up to Day 1||19||
59921938|NCT03543137|76041452|FG000|NOT COMPLETED|Study Period 1: Up to Day 1||0||
59921939|NCT03543137|76041453|FG001|NOT COMPLETED|Study Period 1: Up to Day 1||0||
59921940|NCT03543137|76041452|FG000|STARTED|Washout Period: 5 to 7 Days||18||
59921941|NCT03543137|76041453|FG001|STARTED|Washout Period: 5 to 7 Days||19||
59921942|NCT03543137|76041452|FG000|COMPLETED|Washout Period: 5 to 7 Days||18||
59921943|NCT03543137|76041453|FG001|COMPLETED|Washout Period: 5 to 7 Days||19||
59921944|NCT03543137|76041452|FG000|NOT COMPLETED|Washout Period: 5 to 7 Days||0||
59921945|NCT03543137|76041453|FG001|NOT COMPLETED|Washout Period: 5 to 7 Days||0||
59921946|NCT03543137|76041452|FG000|STARTED|Study Period 2: Up to Day 8||18||
59921947|NCT03543137|76041453|FG001|STARTED|Study Period 2: Up to Day 8||19||
59921948|NCT03543137|76041452|FG000|Treated|Study Period 2: Up to Day 8||16||
59921949|NCT03543137|76041453|FG001|Treated|Study Period 2: Up to Day 8||18||
59921950|NCT03543137|76041452|FG000|COMPLETED|Study Period 2: Up to Day 8||16||
59921951|NCT03543137|76041453|FG001|COMPLETED|Study Period 2: Up to Day 8||18||
59921952|NCT03543137|76041452|FG000|NOT COMPLETED|Study Period 2: Up to Day 8||2||
59921953|NCT03543137|76041453|FG001|NOT COMPLETED|Study Period 2: Up to Day 8||1||
59921954|NCT02895347|76041463|FG000|STARTED|Overall Study||20||
59921955|NCT02895347|76041464|FG001|STARTED|Overall Study||20||
59921956|NCT02895347|76041463|FG000|COMPLETED|Overall Study||17||
59921957|NCT02895347|76041464|FG001|COMPLETED|Overall Study||19||
59921958|NCT02895347|76041463|FG000|NOT COMPLETED|Overall Study||3||
59921959|NCT02895347|76041464|FG001|NOT COMPLETED|Overall Study||1||
59921960|NCT03539549|76041471|FG000|STARTED|Overall Study||123||
59921961|NCT03539549|76041471|FG000|COMPLETED|Overall Study||106||
59921962|NCT03539549|76041471|FG000|NOT COMPLETED|Overall Study||17||
59921963|NCT03506477|76041477|FG000|STARTED|Overall Study||20||
59921964|NCT03506477|76041478|FG001|STARTED|Overall Study||5||
59921965|NCT03506477|76041477|FG000|COMPLETED|Overall Study||19||
59921966|NCT03506477|76041478|FG001|COMPLETED|Overall Study||5||
59921967|NCT03506477|76041477|FG000|NOT COMPLETED|Overall Study||1||
59921968|NCT03506477|76041478|FG001|NOT COMPLETED|Overall Study||0||
59921969|NCT03073980|76041487|FG000|STARTED|Overall Study||53||
59921970|NCT03073980|76041488|FG001|STARTED|Overall Study||54||
59921971|NCT03073980|76041489|FG002|STARTED|Overall Study||54||
59921972|NCT03073980|76041487|FG000|COMPLETED|Overall Study||43||
59921973|NCT03073980|76041488|FG001|COMPLETED|Overall Study||52||
59921974|NCT03073980|76041489|FG002|COMPLETED|Overall Study||43||
59921975|NCT03073980|76041487|FG000|NOT COMPLETED|Overall Study||10||
59921976|NCT03073980|76041488|FG001|NOT COMPLETED|Overall Study||2||
59921977|NCT03073980|76041489|FG002|NOT COMPLETED|Overall Study||11||
59921978|NCT03930186|76041501|FG000|STARTED|Weeks 0 to 16||152||
59921979|NCT03930186|76041501|FG000|Received Study Drug|Weeks 0 to 16||152||
59921980|NCT03930186|76041501|FG000|COMPLETED|Weeks 0 to 16||140||
59921981|NCT03930186|76041501|FG000|NOT COMPLETED|Weeks 0 to 16||12||
59921982|NCT03930186|76041501|FG000|STARTED|Weeks 16 to 32||140||
59921983|NCT03930186|76041501|FG000|COMPLETED|Weeks 16 to 32||136||
59921984|NCT03930186|76041501|FG000|NOT COMPLETED|Weeks 16 to 32||4||
59921985|NCT03504917|76041507|FG000|STARTED|Blinded Treatment Period||163|ITT Population|
59921986|NCT03504917|76041508|FG001|STARTED|Blinded Treatment Period||158|ITT Population|
59921987|NCT03504917|76041507|FG000|COMPLETED|Blinded Treatment Period||103|ITT Population|
59921988|NCT03504917|76041508|FG001|COMPLETED|Blinded Treatment Period||102|ITT Population|
59921989|NCT03504917|76041507|FG000|NOT COMPLETED|Blinded Treatment Period||60||
59921990|NCT03504917|76041508|FG001|NOT COMPLETED|Blinded Treatment Period||56||
59921991|NCT03504917|76041507|FG000|STARTED|Open Label Extension Treatment Period||100|ITT Population, 63 and 61 Participants did not continue in open-label extension in Balovaptan and Placebo Arms respectively.|
59921992|NCT03504917|76041508|FG001|STARTED|Open Label Extension Treatment Period||97|ITT Population, 63 and 61 Participants did not continue in open-label extension in Balovaptan and Placebo Arms respectively.|
59921993|NCT03504917|76041507|FG000|COMPLETED|Open Label Extension Treatment Period||0|ITT Population|
59921994|NCT03504917|76041508|FG001|COMPLETED|Open Label Extension Treatment Period||0|ITT Population|
59921995|NCT03504917|76041507|FG000|NOT COMPLETED|Open Label Extension Treatment Period||100||
59921996|NCT03504917|76041508|FG001|NOT COMPLETED|Open Label Extension Treatment Period||97||
59921997|NCT03536663|76041520|FG000|STARTED|Optiflux||23||
59921998|NCT03536663|76041520|FG000|COMPLETED|Optiflux||19||
60051936|NCT02124746|76167625|FG002|COMPLETED|Overall Study||0||
60051937|NCT02124746|76167623|FG000|NOT COMPLETED|Overall Study||19||
60051938|NCT02124746|76167624|FG001|NOT COMPLETED|Overall Study||18||
60051939|NCT02124746|76167625|FG002|NOT COMPLETED|Overall Study||22||
60051940|NCT02123966|76167633|FG000|STARTED|Overall Study||10||
59514018|NCT02958982|75607686|FG006|STARTED|Cohort 2: 50 mg in SAD Study||0||
59514019|NCT02958982|75607687|FG007|STARTED|Cohort 2: 50 mg in SAD Study||0||
59514020|NCT02958982|75607688|FG008|STARTED|Cohort 2: 50 mg in SAD Study||0||
60051941|NCT02123966|76167633|FG000|COMPLETED|Overall Study||9||
60051942|NCT02123966|76167633|FG000|NOT COMPLETED|Overall Study||1||
60051943|NCT02123576|76167639|FG000|STARTED|Overall Study||6||
60051944|NCT02123576|76167640|FG001|STARTED|Overall Study||6||
60051945|NCT02123576|76167639|FG000|COMPLETED|Overall Study||5||
60051946|NCT02123576|76167640|FG001|COMPLETED|Overall Study||6||
60051947|NCT02123576|76167639|FG000|NOT COMPLETED|Overall Study||1||
60051948|NCT02123576|76167640|FG001|NOT COMPLETED|Overall Study||0||
60051949|NCT01177397|76167658|FG000|STARTED|Overall Study||1||
60051950|NCT01177397|76167659|FG001|STARTED|Overall Study||2||
60051951|NCT01177397|76167660|FG002|STARTED|Overall Study||9||
60051952|NCT01177397|76167661|FG003|STARTED|Overall Study||9||
60051953|NCT01177397|76167662|FG004|STARTED|Overall Study||7||
60051954|NCT01177397|76167663|FG005|STARTED|Overall Study||26||
60051955|NCT01177397|76167664|FG006|STARTED|Overall Study||13||
60051956|NCT01177397|76167665|FG007|STARTED|Overall Study||53||
60051957|NCT01177397|76167666|FG008|STARTED|Overall Study||47||
60051958|NCT01177397|76167667|FG009|STARTED|Overall Study||28||
60051959|NCT01177397|76167668|FG010|STARTED|Overall Study||14||
60051960|NCT01177397|76167669|FG011|STARTED|Overall Study||17||
60051961|NCT01177397|76167658|FG000|COMPLETED|Overall Study||0||
60051962|NCT01177397|76167659|FG001|COMPLETED|Overall Study||0||
60051963|NCT01177397|76167660|FG002|COMPLETED|Overall Study||0||
60051964|NCT01177397|76167661|FG003|COMPLETED|Overall Study||0||
60051965|NCT01177397|76167662|FG004|COMPLETED|Overall Study||0||
60051966|NCT01177397|76167663|FG005|COMPLETED|Overall Study||0||
60051967|NCT01177397|76167664|FG006|COMPLETED|Overall Study||0||
60051968|NCT01177397|76167665|FG007|COMPLETED|Overall Study||0||
60051969|NCT01177397|76167666|FG008|COMPLETED|Overall Study||0||
60051970|NCT01177397|76167667|FG009|COMPLETED|Overall Study||0||
60051971|NCT01177397|76167668|FG010|COMPLETED|Overall Study||0||
60051972|NCT01177397|76167669|FG011|COMPLETED|Overall Study||0||
60051973|NCT01177397|76167658|FG000|NOT COMPLETED|Overall Study||1||
60051974|NCT01177397|76167659|FG001|NOT COMPLETED|Overall Study||2||
60051975|NCT01177397|76167660|FG002|NOT COMPLETED|Overall Study||9||
60051976|NCT01177397|76167661|FG003|NOT COMPLETED|Overall Study||9||
60051977|NCT01177397|76167662|FG004|NOT COMPLETED|Overall Study||7||
60051978|NCT01177397|76167663|FG005|NOT COMPLETED|Overall Study||26||
60051979|NCT01177397|76167664|FG006|NOT COMPLETED|Overall Study||13||
60051980|NCT01177397|76167665|FG007|NOT COMPLETED|Overall Study||53||
60051981|NCT01177397|76167666|FG008|NOT COMPLETED|Overall Study||47||
60051982|NCT01177397|76167667|FG009|NOT COMPLETED|Overall Study||28||
60051983|NCT01177397|76167668|FG010|NOT COMPLETED|Overall Study||14||
60051984|NCT01177397|76167669|FG011|NOT COMPLETED|Overall Study||17||
60051985|NCT00864227|76167710|FG000|STARTED|Overall Study||54||
60051986|NCT00864227|76167710|FG000|COMPLETED|Overall Study||50||
60051987|NCT00864227|76167710|FG000|NOT COMPLETED|Overall Study||4||
60051988|NCT02102204|76167714|FG000|STARTED|Overall Study||902||
60051989|NCT02102204|76167714|FG000|Received Etelcalcetide|Overall Study||884||
60051990|NCT02102204|76167714|FG000|COMPLETED|Overall Study||598||
60051991|NCT02102204|76167714|FG000|NOT COMPLETED|Overall Study||304||
60051992|NCT02141204|76167720|FG000|STARTED|Overall Study||224||
60051993|NCT02141204|76167721|FG001|STARTED|Overall Study||225||
60051994|NCT02141204|76167720|FG000|COMPLETED|Overall Study||209||
60051995|NCT02141204|76167721|FG001|COMPLETED|Overall Study||210||
59514021|NCT02958982|75607689|FG009|STARTED|Cohort 2: 50 mg in SAD Study||0||
60051996|NCT02141204|76167720|FG000|NOT COMPLETED|Overall Study||15||
60051997|NCT02141204|76167721|FG001|NOT COMPLETED|Overall Study||15||
60051998|NCT02140970|76167729|FG000|STARTED|Overall Study||24||
59514022|NCT02958982|75607690|FG010|STARTED|Cohort 2: 50 mg in SAD Study||0||
59514023|NCT02958982|75607680|FG000|COMPLETED|Cohort 2: 50 mg in SAD Study||2||
59514024|NCT02958982|75607681|FG001|COMPLETED|Cohort 2: 50 mg in SAD Study||0||
60051999|NCT02140970|76167730|FG001|STARTED|Overall Study||25||
60052000|NCT02140970|76167729|FG000|Received Intervention|Overall Study||23||
60052001|NCT02140970|76167730|FG001|Received Intervention|Overall Study||25||
60052002|NCT02140970|76167729|FG000|Analyzed|Overall Study||22||
60052003|NCT02140970|76167730|FG001|Analyzed|Overall Study||22||
60052004|NCT02140970|76167729|FG000|COMPLETED|Overall Study||22||
60052005|NCT02140970|76167730|FG001|COMPLETED|Overall Study||22||
60052006|NCT02140970|76167729|FG000|NOT COMPLETED|Overall Study||2||
60052007|NCT02140970|76167730|FG001|NOT COMPLETED|Overall Study||3||
60052008|NCT02101112|76167736|FG000|STARTED|Overall Study||6||
60052009|NCT02101112|76167737|FG001|STARTED|Overall Study||5||
60052010|NCT02101112|76167738|FG002|STARTED|Overall Study||6||
60052011|NCT02101112|76167739|FG003|STARTED|Overall Study||5||
60052012|NCT02101112|76167740|FG004|STARTED|Overall Study||6||
60052013|NCT02101112|76167741|FG005|STARTED|Overall Study||5||
60052014|NCT02101112|76167736|FG000|COMPLETED|Overall Study||6||
60052015|NCT02101112|76167737|FG001|COMPLETED|Overall Study||5||
60052016|NCT02101112|76167738|FG002|COMPLETED|Overall Study||5||
60052017|NCT02101112|76167739|FG003|COMPLETED|Overall Study||5||
60052018|NCT02101112|76167740|FG004|COMPLETED|Overall Study||5||
60052019|NCT02101112|76167741|FG005|COMPLETED|Overall Study||5||
60052020|NCT02101112|76167736|FG000|NOT COMPLETED|Overall Study||0||
60052021|NCT02101112|76167737|FG001|NOT COMPLETED|Overall Study||0||
59514025|NCT02958982|75607682|FG002|COMPLETED|Cohort 2: 50 mg in SAD Study||4||
59519039|NCT03398278|75612890|FG001|COMPLETED|Period 1||19||
60052022|NCT02101112|76167738|FG002|NOT COMPLETED|Overall Study||1||
60052023|NCT02101112|76167739|FG003|NOT COMPLETED|Overall Study||0||
60052024|NCT02101112|76167740|FG004|NOT COMPLETED|Overall Study||1||
60052025|NCT02101112|76167741|FG005|NOT COMPLETED|Overall Study||0||
60052026|NCT02139644|76167756|FG000|STARTED|Run-In Period (Pre-assignment)|Enrolled|787||
60052027|NCT02139644|76167757|FG001|STARTED|Run-In Period (Pre-assignment)||0||
60052028|NCT02139644|76167758|FG002|STARTED|Run-In Period (Pre-assignment)||0||
60052029|NCT02139644|76167759|FG003|STARTED|Run-In Period (Pre-assignment)||0||
60052030|NCT02139644|76167760|FG004|STARTED|Run-In Period (Pre-assignment)||0||
60052031|NCT02139644|76167761|FG005|STARTED|Run-In Period (Pre-assignment)||0||
60052032|NCT02139644|76167756|FG000|COMPLETED|Run-In Period (Pre-assignment)||647||
60052033|NCT02139644|76167757|FG001|COMPLETED|Run-In Period (Pre-assignment)||0||
60052034|NCT02139644|76167758|FG002|COMPLETED|Run-In Period (Pre-assignment)||0||
60052035|NCT02139644|76167759|FG003|COMPLETED|Run-In Period (Pre-assignment)||0||
60052036|NCT02139644|76167760|FG004|COMPLETED|Run-In Period (Pre-assignment)||0||
60052037|NCT02139644|76167761|FG005|COMPLETED|Run-In Period (Pre-assignment)||0||
60052038|NCT02139644|76167756|FG000|NOT COMPLETED|Run-In Period (Pre-assignment)||140||
60052039|NCT02139644|76167757|FG001|NOT COMPLETED|Run-In Period (Pre-assignment)||0||
60052040|NCT02139644|76167758|FG002|NOT COMPLETED|Run-In Period (Pre-assignment)||0||
60052041|NCT02139644|76167759|FG003|NOT COMPLETED|Run-In Period (Pre-assignment)||0||
60052042|NCT02139644|76167760|FG004|NOT COMPLETED|Run-In Period (Pre-assignment)||0||
60052043|NCT02139644|76167761|FG005|NOT COMPLETED|Run-In Period (Pre-assignment)||0||
60052044|NCT02139644|76167756|FG000|STARTED|Treatment Period||0||
60052045|NCT02139644|76167757|FG001|STARTED|Treatment Period|Randomized|129||
60052046|NCT02139644|76167758|FG002|STARTED|Treatment Period|Randomized|129||
60052047|NCT02139644|76167759|FG003|STARTED|Treatment Period|Randomized|130||
60052048|NCT02139644|76167760|FG004|STARTED|Treatment Period|Randomized|129||
60052049|NCT02139644|76167761|FG005|STARTED|Treatment Period|Randomized|130||
60052050|NCT02139644|76167756|FG000|COMPLETED|Treatment Period||0||
60052051|NCT02139644|76167757|FG001|COMPLETED|Treatment Period||126||
60052052|NCT02139644|76167758|FG002|COMPLETED|Treatment Period||121||
60052053|NCT02139644|76167759|FG003|COMPLETED|Treatment Period||121||
60052054|NCT02139644|76167760|FG004|COMPLETED|Treatment Period||121||
60052055|NCT02139644|76167761|FG005|COMPLETED|Treatment Period||113||
60052056|NCT02139644|76167756|FG000|NOT COMPLETED|Treatment Period||0||
60052057|NCT02139644|76167757|FG001|NOT COMPLETED|Treatment Period||3||
60052058|NCT02139644|76167758|FG002|NOT COMPLETED|Treatment Period||8||
60052059|NCT02139644|76167759|FG003|NOT COMPLETED|Treatment Period||9||
60052060|NCT02139644|76167760|FG004|NOT COMPLETED|Treatment Period||8||
60052061|NCT02139644|76167761|FG005|NOT COMPLETED|Treatment Period||17||
60052062|NCT02100644|76167773|FG000|STARTED|LTG Escalation Phase||33||
60052063|NCT02100644|76167774|FG001|STARTED|LTG Escalation Phase||0||
60052064|NCT02100644|76167775|FG002|STARTED|LTG Escalation Phase||0||
60052065|NCT02100644|76167773|FG000|COMPLETED|LTG Escalation Phase||20||
60052066|NCT02100644|76167774|FG001|COMPLETED|LTG Escalation Phase||0||
60052067|NCT02100644|76167775|FG002|COMPLETED|LTG Escalation Phase||0||
60052068|NCT02100644|76167773|FG000|NOT COMPLETED|LTG Escalation Phase||13||
60052069|NCT02100644|76167774|FG001|NOT COMPLETED|LTG Escalation Phase||0||
60052070|NCT02100644|76167775|FG002|NOT COMPLETED|LTG Escalation Phase||0||
60052071|NCT02100644|76167773|FG000|STARTED|VPA Reduction Phase||0||
60052072|NCT02100644|76167774|FG001|STARTED|VPA Reduction Phase||20||
60052073|NCT02100644|76167775|FG002|STARTED|VPA Reduction Phase||0||
60052074|NCT02100644|76167773|FG000|COMPLETED|VPA Reduction Phase||0||
60052075|NCT02100644|76167774|FG001|COMPLETED|VPA Reduction Phase||20||
60052076|NCT02100644|76167775|FG002|COMPLETED|VPA Reduction Phase||0||
60052077|NCT02100644|76167773|FG000|NOT COMPLETED|VPA Reduction Phase||0||
59612824|NCT01697592|75723834|FG003|NOT COMPLETED|Phase B (Week 25 to Week 52)||3||
59612825|NCT01697592|75723835|FG004|NOT COMPLETED|Phase B (Week 25 to Week 52)||0||
59612826|NCT01697592|75723836|FG005|NOT COMPLETED|Phase B (Week 25 to Week 52)||2||
60052078|NCT02100644|76167774|FG001|NOT COMPLETED|VPA Reduction Phase||0||
60052079|NCT02100644|76167775|FG002|NOT COMPLETED|VPA Reduction Phase||0||
60052080|NCT02100644|76167773|FG000|STARTED|LTG and VPA Maintenance Phase||0||
60052081|NCT02100644|76167774|FG001|STARTED|LTG and VPA Maintenance Phase||0||
60052082|NCT02100644|76167775|FG002|STARTED|LTG and VPA Maintenance Phase||20||
60052083|NCT02100644|76167773|FG000|COMPLETED|LTG and VPA Maintenance Phase||0||
60052084|NCT02100644|76167774|FG001|COMPLETED|LTG and VPA Maintenance Phase||0||
60052085|NCT02100644|76167775|FG002|COMPLETED|LTG and VPA Maintenance Phase||20||
60052086|NCT02100644|76167773|FG000|NOT COMPLETED|LTG and VPA Maintenance Phase||0||
60052087|NCT02100644|76167774|FG001|NOT COMPLETED|LTG and VPA Maintenance Phase||0||
60052088|NCT02100644|76167775|FG002|NOT COMPLETED|LTG and VPA Maintenance Phase||0||
60052089|NCT02074982|76167781|FG000|STARTED|Overall Study||337||
60052090|NCT02074982|76167782|FG001|STARTED|Overall Study||339||
60052091|NCT02074982|76167781|FG000|Full Analysis Set (FAS)|Overall Study||336||
60052092|NCT02074982|76167782|FG001|Full Analysis Set (FAS)|Overall Study||339||
60052093|NCT02074982|76167781|FG000|Safety Set (SF)|Overall Study||335||
60052094|NCT02074982|76167782|FG001|Safety Set (SF)|Overall Study||336||
60052095|NCT02074982|76167781|FG000|COMPLETED|Overall Study||286||
60052096|NCT02074982|76167782|FG001|COMPLETED|Overall Study||285||
60052097|NCT02074982|76167781|FG000|NOT COMPLETED|Overall Study||51||
60052098|NCT02074982|76167782|FG001|NOT COMPLETED|Overall Study||54||
60052099|NCT02074514|76167792|FG000|STARTED|Overall Study||59||
60052100|NCT02074514|76167793|FG001|STARTED|Overall Study||58||
60052101|NCT02074514|76167792|FG000|COMPLETED|Overall Study||56||
59612827|NCT01697592|75723837|FG006|NOT COMPLETED|Phase B (Week 25 to Week 52)||1||
59612828|NCT01697592|75723838|FG007|NOT COMPLETED|Phase B (Week 25 to Week 52)||1||
59612829|NCT01697592|75723839|FG008|NOT COMPLETED|Phase B (Week 25 to Week 52)||2||
59612830|NCT01697592|75723840|FG009|NOT COMPLETED|Phase B (Week 25 to Week 52)||0||
59612831|NCT01744782|75723876|FG000|STARTED|Overall Study||17||
59612832|NCT01744782|75723876|FG000|COMPLETED|Overall Study||16||
59921999|NCT03536663|76041520|FG000|NOT COMPLETED|Optiflux||4||
59922000|NCT03536663|76041520|FG000|STARTED|Endexo|One subject completed the Optiflux period but missed Visit 13 and was withdrawn per protocol.|18||
59922001|NCT03536663|76041520|FG000|COMPLETED|Endexo||17||
59922002|NCT03536663|76041520|FG000|NOT COMPLETED|Endexo||1||
59922003|NCT03565211|76041529|FG000|STARTED|Overall Study||254||
59922004|NCT03565211|76041529|FG000|Modified Intention-to-treat (mITT)|Overall Study|Had successful oocyte retrieval, received >=1 dose of IMP, and completed fresh embryo transfer|243||
59922005|NCT03565211|76041529|FG000|COMPLETED|Overall Study||206||
60052102|NCT02074514|76167793|FG001|COMPLETED|Overall Study||54||
60052103|NCT02074514|76167792|FG000|NOT COMPLETED|Overall Study||3||
60052104|NCT02074514|76167793|FG001|NOT COMPLETED|Overall Study||4||
60052105|NCT02099708|76167803|FG000|STARTED|Overall Study|Number of cases.|3502||
60052106|NCT02099708|76167803|FG000|Safety Analysis Set (SAS)|Overall Study|All participants who took the study drug at least once.|3302||
60052107|NCT02099708|76167803|FG000|COMPLETED|Overall Study||3302||
60052108|NCT02099708|76167803|FG000|NOT COMPLETED|Overall Study||200||
60052109|NCT02073656|76167807|FG000|STARTED|Primary Study||335||
60052110|NCT02073656|76167807|FG000|COMPLETED|Primary Study||327||
60052111|NCT02073656|76167807|FG000|NOT COMPLETED|Primary Study||8||
60052112|NCT02073656|76167807|FG000|STARTED|Retreatment Substudy|Only participants experiencing virologic relapse in the Primary Study were eligible for retreatment.|9||
59612833|NCT01744782|75723876|FG000|NOT COMPLETED|Overall Study||1||
59612834|NCT01744392|75723880|FG000|STARTED|Overall Study||23||
59612835|NCT01744392|75723880|FG000|COMPLETED|Overall Study||22||
59612836|NCT01744392|75723880|FG000|NOT COMPLETED|Overall Study||1||
59762612|NCT00866307|75882444|FG001|STARTED|Consolidation/Maintenance||54||
59922006|NCT03565211|76041529|FG000|NOT COMPLETED|Overall Study||48||
60052113|NCT02073656|76167807|FG000|COMPLETED|Retreatment Substudy||9||
60052114|NCT02073656|76167807|FG000|NOT COMPLETED|Retreatment Substudy||0||
60052115|NCT02242643|76167815|FG000|STARTED|Overall Study||1207||
60052116|NCT02242643|76167816|FG001|STARTED|Overall Study||1217||
59922007|NCT03531905|76041536|FG000|STARTED|Overall Study||81||
59922008|NCT03531905|76041537|FG001|STARTED|Overall Study||81||
59922009|NCT03531905|76041538|FG002|STARTED|Overall Study||80||
59922010|NCT03531905|76041536|FG000|COMPLETED|Overall Study||74||
59922011|NCT03531905|76041537|FG001|COMPLETED|Overall Study||76||
60052117|NCT02242643|76167815|FG000|COMPLETED|Overall Study||1132||
60052118|NCT02242643|76167816|FG001|COMPLETED|Overall Study||1139||
60052119|NCT02242643|76167815|FG000|NOT COMPLETED|Overall Study||75||
60052120|NCT02242643|76167816|FG001|NOT COMPLETED|Overall Study||78||
60052121|NCT02097290|76167824|FG000|STARTED|Overall Study||210||
60052122|NCT02097290|76167824|FG000|COMPLETED|Overall Study|Active subjects at the end of 3 month follow up visit for primary end point data collection|193||
60052123|NCT02097290|76167824|FG000|NOT COMPLETED|Overall Study||17||
60052124|NCT02072174|76167830|FG000|STARTED|Overall Study||290||
60052125|NCT02072174|76167831|FG001|STARTED|Overall Study||279||
60052126|NCT02072174|76167830|FG000|COMPLETED|Overall Study||258||
60052127|NCT02072174|76167831|FG001|COMPLETED|Overall Study||240||
60052128|NCT02072174|76167830|FG000|NOT COMPLETED|Overall Study||32||
60052129|NCT02072174|76167831|FG001|NOT COMPLETED|Overall Study||39||
59922012|NCT03531905|76041538|FG002|COMPLETED|Overall Study||77||
59922013|NCT03531905|76041536|FG000|NOT COMPLETED|Overall Study||7||
60052130|NCT02209181|76167843|FG000|STARTED|Overall Study||67||
60052131|NCT02209181|76167844|FG001|STARTED|Overall Study||67||
60052132|NCT02209181|76167845|FG002|STARTED|Overall Study||69||
59922014|NCT03531905|76041537|FG001|NOT COMPLETED|Overall Study||5||
59922015|NCT03531905|76041538|FG002|NOT COMPLETED|Overall Study||3||
59922016|NCT03531827|76041548|FG000|STARTED|Overall Study||4||
60052133|NCT02209181|76167846|FG003|STARTED|Overall Study||66||
60052134|NCT02209181|76167843|FG000|COMPLETED|Overall Study||66||
60052135|NCT02209181|76167844|FG001|COMPLETED|Overall Study||66||
59514026|NCT02958982|75607683|FG003|COMPLETED|Cohort 2: 50 mg in SAD Study||0||
59514027|NCT02958982|75607684|FG004|COMPLETED|Cohort 2: 50 mg in SAD Study||0||
59514028|NCT02958982|75607685|FG005|COMPLETED|Cohort 2: 50 mg in SAD Study||0||
59514029|NCT02958982|75607686|FG006|COMPLETED|Cohort 2: 50 mg in SAD Study||0||
59922017|NCT03531827|76041549|FG001|STARTED|Overall Study||0||
59922018|NCT03531827|76041548|FG000|COMPLETED|Overall Study||1||
59922019|NCT03531827|76041549|FG001|COMPLETED|Overall Study||0||
59922020|NCT03531827|76041548|FG000|NOT COMPLETED|Overall Study||3||
59922021|NCT03531827|76041549|FG001|NOT COMPLETED|Overall Study||0||
59922022|NCT03657264|76041558|FG000|STARTED|Overall Study||12||
59922023|NCT03657264|76041559|FG001|STARTED|Overall Study||12||
59922024|NCT03657264|76041560|FG002|STARTED|Overall Study||12||
59922025|NCT03657264|76041561|FG003|STARTED|Overall Study||12||
59922026|NCT03657264|76041558|FG000|COMPLETED|Overall Study||12||
59922027|NCT03657264|76041559|FG001|COMPLETED|Overall Study||12||
59922028|NCT03657264|76041560|FG002|COMPLETED|Overall Study||12||
59922029|NCT03657264|76041561|FG003|COMPLETED|Overall Study||12||
59922030|NCT03657264|76041558|FG000|NOT COMPLETED|Overall Study||0||
59922031|NCT03657264|76041559|FG001|NOT COMPLETED|Overall Study||0||
59922032|NCT03657264|76041560|FG002|NOT COMPLETED|Overall Study||0||
59922033|NCT03657264|76041561|FG003|NOT COMPLETED|Overall Study||0||
59922034|NCT03895632|76041572|FG000|STARTED|Overall Study||25||
59922035|NCT03895632|76041572|FG000|COMPLETED|Overall Study||25||
59922036|NCT03895632|76041572|FG000|NOT COMPLETED|Overall Study||0||
59922037|NCT03530345|76041578|FG000|STARTED|Treatment Period A/Follow-up Period 1||28||
59922038|NCT03530345|76041579|FG001|STARTED|Treatment Period A/Follow-up Period 1||29||
59922039|NCT03530345|76041578|FG000|Treatment Period A Completers|Treatment Period A/Follow-up Period 1||26||
59922040|NCT03530345|76041579|FG001|Treatment Period A Completers|Treatment Period A/Follow-up Period 1||27||
59922041|NCT03530345|76041578|FG000|COMPLETED|Treatment Period A/Follow-up Period 1||7|Participants completing Follow-up Period 1.|
59922042|NCT03530345|76041579|FG001|COMPLETED|Treatment Period A/Follow-up Period 1||7|Participants completing Follow-up Period 1.|
59922043|NCT03530345|76041578|FG000|NOT COMPLETED|Treatment Period A/Follow-up Period 1||21||
59922044|NCT03530345|76041579|FG001|NOT COMPLETED|Treatment Period A/Follow-up Period 1||22||
59922045|NCT03530345|76041578|FG000|STARTED|Treatment Period B/Follow-up Period 2|2 participants completed Treatment Period A/Follow-up Period 1 but were not allocated in Period B.|5||
59922046|NCT03530345|76041579|FG001|STARTED|Treatment Period B/Follow-up Period 2||7||
59922047|NCT03530345|76041578|FG000|Treatment Period B Completers|Treatment Period B/Follow-up Period 2||4||
59922048|NCT03530345|76041579|FG001|Treatment Period B Completers|Treatment Period B/Follow-up Period 2||6||
59922049|NCT03530345|76041578|FG000|COMPLETED|Treatment Period B/Follow-up Period 2||0|Participants completing Follow-up Period 2.|
59922050|NCT03530345|76041579|FG001|COMPLETED|Treatment Period B/Follow-up Period 2||0|Participants completing Follow-up Period 2.|
59922051|NCT03530345|76041578|FG000|NOT COMPLETED|Treatment Period B/Follow-up Period 2||5||
59922052|NCT03530345|76041579|FG001|NOT COMPLETED|Treatment Period B/Follow-up Period 2||7||
59922053|NCT03500159|76041593|FG000|STARTED|Overall Study||2||
59922054|NCT03500159|76041594|FG001|STARTED|Overall Study||1||
59922055|NCT03500159|76041593|FG000|COMPLETED|Overall Study||0||
59922056|NCT03500159|76041594|FG001|COMPLETED|Overall Study||0||
59922057|NCT03500159|76041593|FG000|NOT COMPLETED|Overall Study||2||
60052136|NCT02209181|76167845|FG002|COMPLETED|Overall Study||68||
59922058|NCT03500159|76041594|FG001|NOT COMPLETED|Overall Study||1||
59922059|NCT03785340|76041602|FG000|STARTED|Overall Study||126||
59922060|NCT03785340|76041603|FG001|STARTED|Overall Study||126||
60052137|NCT02209181|76167846|FG003|COMPLETED|Overall Study||66||
60052138|NCT02209181|76167843|FG000|NOT COMPLETED|Overall Study||1||
60052139|NCT02209181|76167844|FG001|NOT COMPLETED|Overall Study||1||
60052140|NCT02209181|76167845|FG002|NOT COMPLETED|Overall Study||1||
60052141|NCT02209181|76167846|FG003|NOT COMPLETED|Overall Study||0||
59514030|NCT02958982|75607687|FG007|COMPLETED|Cohort 2: 50 mg in SAD Study||0||
60052142|NCT02208089|76167858|FG000|STARTED|Overall Study||47||
60052143|NCT02208089|76167859|FG001|STARTED|Overall Study||47||
60052144|NCT02208089|76167858|FG000|COMPLETED|Overall Study||40||
60052145|NCT02208089|76167859|FG001|COMPLETED|Overall Study||47||
60052146|NCT02208089|76167858|FG000|NOT COMPLETED|Overall Study||7||
60052147|NCT02208089|76167859|FG001|NOT COMPLETED|Overall Study||0||
60052148|NCT02242487|76167868|FG000|STARTED|Overall Study||161||
60052149|NCT02242487|76167869|FG001|STARTED|Overall Study||164||
60052150|NCT02242487|76167868|FG000|COMPLETED|Overall Study||99||
60052151|NCT02242487|76167869|FG001|COMPLETED|Overall Study||117||
60052152|NCT02242487|76167868|FG000|NOT COMPLETED|Overall Study||62||
60052153|NCT02242487|76167869|FG001|NOT COMPLETED|Overall Study||47||
60052154|NCT02241785|76167877|FG000|STARTED|Overall Study||47||
60052155|NCT02241785|76167877|FG000|COMPLETED|Overall Study||0||
60052156|NCT02241785|76167877|FG000|NOT COMPLETED|Overall Study||47||
60052157|NCT02241551|76167883|FG000|STARTED|Overall Study||1||
60052158|NCT02241551|76167884|FG001|STARTED|Overall Study||0||
60052159|NCT02241551|76167883|FG000|COMPLETED|Overall Study||0||
60052160|NCT02241551|76167884|FG001|COMPLETED|Overall Study||0||
60052161|NCT02241551|76167883|FG000|NOT COMPLETED|Overall Study||1||
60052162|NCT02241551|76167884|FG001|NOT COMPLETED|Overall Study||0||
60052163|NCT02207621|76167895|FG000|STARTED|Overall Study||251||
60052164|NCT02207621|76167896|FG001|STARTED|Overall Study||251||
60052165|NCT02207621|76167897|FG002|STARTED|Overall Study||254||
60052166|NCT02207621|76167895|FG000|COMPLETED|Overall Study||146||
60052167|NCT02207621|76167896|FG001|COMPLETED|Overall Study||204||
60052168|NCT02207621|76167897|FG002|COMPLETED|Overall Study||86||
60052169|NCT02207621|76167895|FG000|NOT COMPLETED|Overall Study||105||
60052170|NCT02207621|76167896|FG001|NOT COMPLETED|Overall Study||47||
60052171|NCT02207621|76167897|FG002|NOT COMPLETED|Overall Study||168||
60052172|NCT02240693|76167911|FG000|STARTED|Overall Study||22||
60052173|NCT02240693|76167912|FG001|STARTED|Overall Study||21||
60052174|NCT02240693|76167913|FG002|STARTED|Overall Study||21||
60052175|NCT02240693|76167914|FG003|STARTED|Overall Study||21||
60052176|NCT02240693|76167915|FG004|STARTED|Overall Study||43||
60052177|NCT02240693|76167911|FG000|COMPLETED|Overall Study||22||
60052178|NCT02240693|76167912|FG001|COMPLETED|Overall Study||21||
60052179|NCT02240693|76167913|FG002|COMPLETED|Overall Study||17||
60052180|NCT02240693|76167914|FG003|COMPLETED|Overall Study||20||
60052181|NCT02240693|76167915|FG004|COMPLETED|Overall Study||42||
60052182|NCT02240693|76167911|FG000|NOT COMPLETED|Overall Study||0||
60052183|NCT02240693|76167912|FG001|NOT COMPLETED|Overall Study||0||
60052184|NCT02240693|76167913|FG002|NOT COMPLETED|Overall Study||4||
60052185|NCT02240693|76167914|FG003|NOT COMPLETED|Overall Study||1||
60052186|NCT02240693|76167915|FG004|NOT COMPLETED|Overall Study||1||
60052187|NCT02239679|76167932|FG000|STARTED|Overall Study||53||
60052188|NCT02239679|76167933|FG001|STARTED|Overall Study||59||
60052189|NCT02239679|76167934|FG002|STARTED|Overall Study||54||
60052190|NCT02239679|76167932|FG000|COMPLETED|Overall Study||50||
60052191|NCT02239679|76167933|FG001|COMPLETED|Overall Study||56||
60052192|NCT02239679|76167934|FG002|COMPLETED|Overall Study||53||
60052193|NCT02239679|76167932|FG000|NOT COMPLETED|Overall Study||3||
60052194|NCT02239679|76167933|FG001|NOT COMPLETED|Overall Study||3||
60052195|NCT02239679|76167934|FG002|NOT COMPLETED|Overall Study||1||
60052196|NCT02072096|76167944|FG000|STARTED|Overall Study||99||
60052197|NCT02072096|76167945|FG001|STARTED|Overall Study||93||
60052198|NCT02072096|76167944|FG000|Received at Least One Dose of Study Drug|Overall Study||98||
60052199|NCT02072096|76167945|FG001|Received at Least One Dose of Study Drug|Overall Study||93||
60052200|NCT02072096|76167944|FG000|COMPLETED|Overall Study||14||
60052201|NCT02072096|76167945|FG001|COMPLETED|Overall Study||15||
60052202|NCT02072096|76167944|FG000|NOT COMPLETED|Overall Study||85||
60052203|NCT02072096|76167945|FG001|NOT COMPLETED|Overall Study||78||
59514031|NCT02958982|75607688|FG008|COMPLETED|Cohort 2: 50 mg in SAD Study||0||
60052204|NCT02071706|76167952|FG000|STARTED|Overall Study||62||
60052205|NCT02071706|76167952|FG000|COMPLETED|Overall Study||59||
60052206|NCT02071706|76167952|FG000|NOT COMPLETED|Overall Study||3||
60052207|NCT01631825|76167956|FG000|STARTED|Overall Study||321||
60052208|NCT01631825|76167956|FG000|COMPLETED|Overall Study||256||
60052209|NCT01631825|76167956|FG000|NOT COMPLETED|Overall Study||65||
60052210|NCT02071082|76167962|FG000|STARTED|Overall Study||4||
60052211|NCT02071082|76167963|FG001|STARTED|Overall Study||75||
60052212|NCT02071082|76167962|FG000|COMPLETED|Overall Study||2||
60052213|NCT02071082|76167963|FG001|COMPLETED|Overall Study||68||
60052214|NCT02071082|76167962|FG000|NOT COMPLETED|Overall Study||2||
60052215|NCT02071082|76167963|FG001|NOT COMPLETED|Overall Study||7||
60052216|NCT02123108|76167971|FG000|STARTED|Overall Study||30||
60052217|NCT02123108|76167972|FG001|STARTED|Overall Study||29||
60052218|NCT02123108|76167971|FG000|COMPLETED|Overall Study||28||
60052219|NCT02123108|76167972|FG001|COMPLETED|Overall Study||26||
60052220|NCT02123108|76167971|FG000|NOT COMPLETED|Overall Study||2||
60052221|NCT02123108|76167972|FG001|NOT COMPLETED|Overall Study||3||
60052222|NCT02121392|76167980|FG000|STARTED|Prior to Intervention||83||
60052223|NCT02121392|76167981|FG001|STARTED|Prior to Intervention||82||
60052224|NCT02121392|76167980|FG000|COMPLETED|Prior to Intervention||35||
60052225|NCT02121392|76167981|FG001|COMPLETED|Prior to Intervention||41||
60052226|NCT02121392|76167980|FG000|NOT COMPLETED|Prior to Intervention||48||
60052227|NCT02121392|76167981|FG001|NOT COMPLETED|Prior to Intervention||41||
60052228|NCT02121392|76167980|FG000|STARTED|After Placement of AC Block vs Sham||35||
60052229|NCT02121392|76167981|FG001|STARTED|After Placement of AC Block vs Sham||41||
60052230|NCT02121392|76167980|FG000|COMPLETED|After Placement of AC Block vs Sham||32||
60052231|NCT02121392|76167981|FG001|COMPLETED|After Placement of AC Block vs Sham||38||
60052232|NCT02121392|76167980|FG000|NOT COMPLETED|After Placement of AC Block vs Sham||3||
60052233|NCT02121392|76167981|FG001|NOT COMPLETED|After Placement of AC Block vs Sham||3||
60052234|NCT02097056|76167987|FG000|STARTED|Overall Study||171||
60052235|NCT02097056|76167987|FG000|ParticipantsTreated|Overall Study||170||
60052236|NCT02097056|76167987|FG000|COMPLETED|Overall Study||113||
60052237|NCT02097056|76167987|FG000|NOT COMPLETED|Overall Study||58||
60052238|NCT02121002|76167994|FG000|STARTED|Overall Study||392||
60052239|NCT02121002|76167995|FG001|STARTED|Overall Study||393||
60052240|NCT02121002|76167996|FG002|STARTED|Overall Study||391||
60052241|NCT02121002|76167994|FG000|COMPLETED|Overall Study||385||
60052242|NCT02121002|76167995|FG001|COMPLETED|Overall Study||389||
59514032|NCT02958982|75607689|FG009|COMPLETED|Cohort 2: 50 mg in SAD Study||0||
59514033|NCT02958982|75607690|FG010|COMPLETED|Cohort 2: 50 mg in SAD Study||0||
59514034|NCT02958982|75607680|FG000|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0||
59514035|NCT02958982|75607681|FG001|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0||
59514036|NCT02958982|75607682|FG002|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0||
59514037|NCT02958982|75607683|FG003|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0||
59514038|NCT02958982|75607684|FG004|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0||
60052243|NCT02121002|76167996|FG002|COMPLETED|Overall Study||381||
60052244|NCT02121002|76167994|FG000|NOT COMPLETED|Overall Study||7||
60052245|NCT02121002|76167995|FG001|NOT COMPLETED|Overall Study||4||
60052246|NCT02121002|76167996|FG002|NOT COMPLETED|Overall Study||10||
60052247|NCT02096900|76168006|FG000|STARTED|Overall Study|Allocated to Midazolam|42||
60052248|NCT02096900|76168007|FG001|STARTED|Overall Study|Allocated to Zolpidem|44||
60052249|NCT02096900|76168006|FG000|COMPLETED|Overall Study||38||
60052250|NCT02096900|76168007|FG001|COMPLETED|Overall Study||42||
60052251|NCT02096900|76168006|FG000|NOT COMPLETED|Overall Study||4||
60052252|NCT02096900|76168007|FG001|NOT COMPLETED|Overall Study||2||
60052253|NCT02120924|76168016|FG000|STARTED|Overall Study||404||
60052254|NCT02120924|76168017|FG001|STARTED|Overall Study||403||
60052255|NCT02120924|76168018|FG002|STARTED|Overall Study||202||
60052256|NCT02120924|76168016|FG000|COMPLETED|Overall Study||362||
60052257|NCT02120924|76168017|FG001|COMPLETED|Overall Study||357||
60052258|NCT02120924|76168018|FG002|COMPLETED|Overall Study||173||
60052259|NCT02120924|76168016|FG000|NOT COMPLETED|Overall Study||42||
60052260|NCT02120924|76168017|FG001|NOT COMPLETED|Overall Study||46||
60052261|NCT02120924|76168018|FG002|NOT COMPLETED|Overall Study||29||
60052262|NCT02096744|76168027|FG000|STARTED|Treatment Period 1(7 Days)||29||
60052263|NCT02096744|76168028|FG001|STARTED|Treatment Period 1(7 Days)||29||
60052264|NCT02096744|76168027|FG000|COMPLETED|Treatment Period 1(7 Days)||28||
60052265|NCT02096744|76168028|FG001|COMPLETED|Treatment Period 1(7 Days)||28||
60052266|NCT02096744|76168027|FG000|NOT COMPLETED|Treatment Period 1(7 Days)||1||
60052267|NCT02096744|76168028|FG001|NOT COMPLETED|Treatment Period 1(7 Days)||1||
60052268|NCT02096744|76168027|FG000|STARTED|Washout Period 1(7 Days)||28||
60052269|NCT02096744|76168028|FG001|STARTED|Washout Period 1(7 Days)||28||
60052270|NCT02096744|76168027|FG000|COMPLETED|Washout Period 1(7 Days)||28||
60052271|NCT02096744|76168028|FG001|COMPLETED|Washout Period 1(7 Days)||28||
60052272|NCT02096744|76168027|FG000|NOT COMPLETED|Washout Period 1(7 Days)||0||
60052273|NCT02096744|76168028|FG001|NOT COMPLETED|Washout Period 1(7 Days)||0||
60052274|NCT02096744|76168027|FG000|STARTED|Treatment Period 2 (7 Days)||28||
60052275|NCT02096744|76168028|FG001|STARTED|Treatment Period 2 (7 Days)||28||
60052276|NCT02096744|76168027|FG000|COMPLETED|Treatment Period 2 (7 Days)||28||
60052277|NCT02096744|76168028|FG001|COMPLETED|Treatment Period 2 (7 Days)||28||
60052278|NCT02096744|76168027|FG000|NOT COMPLETED|Treatment Period 2 (7 Days)||0||
60052279|NCT02096744|76168028|FG001|NOT COMPLETED|Treatment Period 2 (7 Days)||0||
60052280|NCT02096744|76168027|FG000|STARTED|Washout Period 2 (3 Days)||28||
60052281|NCT02096744|76168028|FG001|STARTED|Washout Period 2 (3 Days)||28||
60052282|NCT02096744|76168027|FG000|COMPLETED|Washout Period 2 (3 Days)||28||
60052283|NCT02096744|76168028|FG001|COMPLETED|Washout Period 2 (3 Days)||28||
60052284|NCT02096744|76168027|FG000|NOT COMPLETED|Washout Period 2 (3 Days)||0||
60052285|NCT02096744|76168028|FG001|NOT COMPLETED|Washout Period 2 (3 Days)||0||
60052286|NCT02096744|76168027|FG000|STARTED|Treatment Period 3 (7 Days)||28||
60052287|NCT02096744|76168028|FG001|STARTED|Treatment Period 3 (7 Days)||28||
60052288|NCT02096744|76168027|FG000|COMPLETED|Treatment Period 3 (7 Days)||28||
60052289|NCT02096744|76168028|FG001|COMPLETED|Treatment Period 3 (7 Days)||27||
60052290|NCT02096744|76168027|FG000|NOT COMPLETED|Treatment Period 3 (7 Days)||0||
60052291|NCT02096744|76168028|FG001|NOT COMPLETED|Treatment Period 3 (7 Days)||1||
59514039|NCT02958982|75607685|FG005|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0||
59514040|NCT02958982|75607686|FG006|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0||
59514041|NCT02958982|75607687|FG007|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0||
59514042|NCT02958982|75607688|FG008|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0||
59514043|NCT02958982|75607689|FG009|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0||
59514044|NCT02958982|75607690|FG010|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0||
59514045|NCT02958982|75607680|FG000|STARTED|Cohort 3: 100 mg in SAD Study||2||
59514046|NCT02958982|75607681|FG001|STARTED|Cohort 3: 100 mg in SAD Study||0||
59514047|NCT02958982|75607682|FG002|STARTED|Cohort 3: 100 mg in SAD Study||0||
59514048|NCT02958982|75607683|FG003|STARTED|Cohort 3: 100 mg in SAD Study||4||
59514049|NCT02958982|75607684|FG004|STARTED|Cohort 3: 100 mg in SAD Study||0||
59514050|NCT02958982|75607685|FG005|STARTED|Cohort 3: 100 mg in SAD Study||0||
59514051|NCT02958982|75607686|FG006|STARTED|Cohort 3: 100 mg in SAD Study||0||
59514052|NCT02958982|75607687|FG007|STARTED|Cohort 3: 100 mg in SAD Study||0||
60052292|NCT02120456|76168045|FG000|STARTED|Part 1 Open-label, Dose-escalation Phase||12||
60052293|NCT02120456|76168046|FG001|STARTED|Part 1 Open-label, Dose-escalation Phase||12||
60052294|NCT02120456|76168047|FG002|STARTED|Part 1 Open-label, Dose-escalation Phase||12||
60052295|NCT02120456|76168048|FG003|STARTED|Part 1 Open-label, Dose-escalation Phase||12||
60052296|NCT02120456|76168049|FG004|STARTED|Part 1 Open-label, Dose-escalation Phase||12||
60052297|NCT02120456|76168050|FG005|STARTED|Part 1 Open-label, Dose-escalation Phase||9||
60052298|NCT02120456|76168051|FG006|STARTED|Part 1 Open-label, Dose-escalation Phase||0||
60052299|NCT02120456|76168052|FG007|STARTED|Part 1 Open-label, Dose-escalation Phase||0||
60052300|NCT02120456|76168053|FG008|STARTED|Part 1 Open-label, Dose-escalation Phase||0||
60052301|NCT02120456|76168045|FG000|COMPLETED|Part 1 Open-label, Dose-escalation Phase||12||
60052302|NCT02120456|76168046|FG001|COMPLETED|Part 1 Open-label, Dose-escalation Phase||12||
60052303|NCT02120456|76168047|FG002|COMPLETED|Part 1 Open-label, Dose-escalation Phase||12||
60052304|NCT02120456|76168048|FG003|COMPLETED|Part 1 Open-label, Dose-escalation Phase||12||
60052305|NCT02120456|76168049|FG004|COMPLETED|Part 1 Open-label, Dose-escalation Phase||12||
60052306|NCT02120456|76168050|FG005|COMPLETED|Part 1 Open-label, Dose-escalation Phase||9||
60052307|NCT02120456|76168051|FG006|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0||
60052308|NCT02120456|76168052|FG007|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0||
60052309|NCT02120456|76168053|FG008|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0||
60052310|NCT02120456|76168045|FG000|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0||
60052311|NCT02120456|76168046|FG001|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0||
60052312|NCT02120456|76168047|FG002|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0||
60052313|NCT02120456|76168048|FG003|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0||
60052314|NCT02120456|76168049|FG004|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0||
60052315|NCT02120456|76168050|FG005|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0||
60052316|NCT02120456|76168051|FG006|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0||
60052317|NCT02120456|76168052|FG007|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0||
60052318|NCT02120456|76168053|FG008|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0||
60052319|NCT02120456|76168045|FG000|STARTED|Part 2 Double-blind Phase||0||
60052320|NCT02120456|76168046|FG001|STARTED|Part 2 Double-blind Phase||0||
60052321|NCT02120456|76168047|FG002|STARTED|Part 2 Double-blind Phase||0||
60052322|NCT02120456|76168048|FG003|STARTED|Part 2 Double-blind Phase||0||
60052323|NCT02120456|76168049|FG004|STARTED|Part 2 Double-blind Phase||0||
60052324|NCT02120456|76168050|FG005|STARTED|Part 2 Double-blind Phase||0||
60052325|NCT02120456|76168051|FG006|STARTED|Part 2 Double-blind Phase||32||
60052326|NCT02120456|76168052|FG007|STARTED|Part 2 Double-blind Phase||60||
60052327|NCT02120456|76168053|FG008|STARTED|Part 2 Double-blind Phase||63||
60052328|NCT02120456|76168045|FG000|COMPLETED|Part 2 Double-blind Phase||0||
59514053|NCT02958982|75607688|FG008|STARTED|Cohort 3: 100 mg in SAD Study||0||
60052329|NCT02120456|76168046|FG001|COMPLETED|Part 2 Double-blind Phase||0||
60052330|NCT02120456|76168047|FG002|COMPLETED|Part 2 Double-blind Phase||0||
60052331|NCT02120456|76168048|FG003|COMPLETED|Part 2 Double-blind Phase||0||
60052332|NCT02120456|76168049|FG004|COMPLETED|Part 2 Double-blind Phase||0||
60052333|NCT02120456|76168050|FG005|COMPLETED|Part 2 Double-blind Phase||0||
60052334|NCT02120456|76168051|FG006|COMPLETED|Part 2 Double-blind Phase||30||
60052335|NCT02120456|76168052|FG007|COMPLETED|Part 2 Double-blind Phase||60||
60052336|NCT02120456|76168053|FG008|COMPLETED|Part 2 Double-blind Phase||62||
60052337|NCT02120456|76168045|FG000|NOT COMPLETED|Part 2 Double-blind Phase||0||
60052338|NCT02120456|76168046|FG001|NOT COMPLETED|Part 2 Double-blind Phase||0||
60052339|NCT02120456|76168047|FG002|NOT COMPLETED|Part 2 Double-blind Phase||0||
60052340|NCT02120456|76168048|FG003|NOT COMPLETED|Part 2 Double-blind Phase||0||
60052341|NCT02120456|76168049|FG004|NOT COMPLETED|Part 2 Double-blind Phase||0||
60052342|NCT02120456|76168050|FG005|NOT COMPLETED|Part 2 Double-blind Phase||0||
60052343|NCT02120456|76168051|FG006|NOT COMPLETED|Part 2 Double-blind Phase||2||
60052344|NCT02120456|76168052|FG007|NOT COMPLETED|Part 2 Double-blind Phase||0||
60052345|NCT02120456|76168053|FG008|NOT COMPLETED|Part 2 Double-blind Phase||1||
60052346|NCT02120300|76168077|FG000|STARTED|Overall Study||101||
60052347|NCT02120300|76168078|FG001|STARTED|Overall Study||5||
60052348|NCT02120300|76168079|FG002|STARTED|Overall Study||10||
59514054|NCT02958982|75607689|FG009|STARTED|Cohort 3: 100 mg in SAD Study||0||
59514055|NCT02958982|75607690|FG010|STARTED|Cohort 3: 100 mg in SAD Study||0||
59514056|NCT02958982|75607680|FG000|COMPLETED|Cohort 3: 100 mg in SAD Study||2||
59514057|NCT02958982|75607681|FG001|COMPLETED|Cohort 3: 100 mg in SAD Study||0||
59514058|NCT02958982|75607682|FG002|COMPLETED|Cohort 3: 100 mg in SAD Study||0||
59514059|NCT02958982|75607683|FG003|COMPLETED|Cohort 3: 100 mg in SAD Study||4||
60052349|NCT02120300|76168080|FG003|STARTED|Overall Study||6||
60052350|NCT02120300|76168077|FG000|COMPLETED|Overall Study||98||
60052351|NCT02120300|76168078|FG001|COMPLETED|Overall Study||5||
60052352|NCT02120300|76168079|FG002|COMPLETED|Overall Study||10||
60052353|NCT02120300|76168080|FG003|COMPLETED|Overall Study||5||
60052354|NCT02120300|76168077|FG000|NOT COMPLETED|Overall Study||3||
60052355|NCT02120300|76168078|FG001|NOT COMPLETED|Overall Study||0||
60052356|NCT02120300|76168079|FG002|NOT COMPLETED|Overall Study||0||
60052357|NCT02120300|76168080|FG003|NOT COMPLETED|Overall Study||1||
60052358|NCT02070380|76168096|FG000|STARTED|First Injection||31||
60052359|NCT02070380|76168097|FG001|STARTED|First Injection||39||
60052360|NCT02070380|76168098|FG002|STARTED|First Injection||53||
60052361|NCT02070380|76168099|FG003|STARTED|First Injection||54||
60052362|NCT02070380|76168096|FG000|COMPLETED|First Injection||31||
60052363|NCT02070380|76168097|FG001|COMPLETED|First Injection||39||
60052364|NCT02070380|76168098|FG002|COMPLETED|First Injection||53||
60052365|NCT02070380|76168099|FG003|COMPLETED|First Injection||54||
60052366|NCT02070380|76168096|FG000|NOT COMPLETED|First Injection||0||
60052367|NCT02070380|76168097|FG001|NOT COMPLETED|First Injection||0||
60052368|NCT02070380|76168098|FG002|NOT COMPLETED|First Injection||0||
60052369|NCT02070380|76168099|FG003|NOT COMPLETED|First Injection||0||
60052370|NCT02070380|76168096|FG000|STARTED|Washout (no Second Injection/MRI)||31||
60052371|NCT02070380|76168097|FG001|STARTED|Washout (no Second Injection/MRI)||39||
59514060|NCT02958982|75607684|FG004|COMPLETED|Cohort 3: 100 mg in SAD Study||0||
60052372|NCT02070380|76168098|FG002|STARTED|Washout (no Second Injection/MRI)||53||
60052373|NCT02070380|76168099|FG003|STARTED|Washout (no Second Injection/MRI)||54||
60052374|NCT02070380|76168096|FG000|COMPLETED|Washout (no Second Injection/MRI)||31||
60052375|NCT02070380|76168097|FG001|COMPLETED|Washout (no Second Injection/MRI)||34||
60052376|NCT02070380|76168098|FG002|COMPLETED|Washout (no Second Injection/MRI)||51||
60052377|NCT02070380|76168099|FG003|COMPLETED|Washout (no Second Injection/MRI)||51||
60052378|NCT02070380|76168096|FG000|NOT COMPLETED|Washout (no Second Injection/MRI)||0||
60052379|NCT02070380|76168097|FG001|NOT COMPLETED|Washout (no Second Injection/MRI)||5||
59514061|NCT02958982|75607685|FG005|COMPLETED|Cohort 3: 100 mg in SAD Study||0||
59514062|NCT02958982|75607686|FG006|COMPLETED|Cohort 3: 100 mg in SAD Study||0||
60052380|NCT02070380|76168098|FG002|NOT COMPLETED|Washout (no Second Injection/MRI)||2||
60052381|NCT02070380|76168099|FG003|NOT COMPLETED|Washout (no Second Injection/MRI)||3||
60052382|NCT02070380|76168096|FG000|STARTED|Second Injection||31||
60052383|NCT02070380|76168097|FG001|STARTED|Second Injection||34||
60052384|NCT02070380|76168098|FG002|STARTED|Second Injection||51||
60052385|NCT02070380|76168099|FG003|STARTED|Second Injection||51||
60052386|NCT02070380|76168096|FG000|COMPLETED|Second Injection||31||
60052387|NCT02070380|76168097|FG001|COMPLETED|Second Injection||32||
60052388|NCT02070380|76168098|FG002|COMPLETED|Second Injection||50||
60052389|NCT02070380|76168099|FG003|COMPLETED|Second Injection||46||
60052390|NCT02070380|76168096|FG000|NOT COMPLETED|Second Injection||0||
60052391|NCT02070380|76168097|FG001|NOT COMPLETED|Second Injection||2||
60052392|NCT02070380|76168098|FG002|NOT COMPLETED|Second Injection||1||
60052393|NCT02070380|76168099|FG003|NOT COMPLETED|Second Injection||5||
60052394|NCT02069366|76168117|FG000|STARTED|Overall Study||13||
60052395|NCT02069366|76168118|FG001|STARTED|Overall Study||10||
60052396|NCT02069366|76168119|FG002|STARTED|Overall Study||18||
60052397|NCT02069366|76168120|FG003|STARTED|Overall Study||17||
60052398|NCT02069366|76168121|FG004|STARTED|Overall Study||14||
60052399|NCT02069366|76168122|FG005|STARTED|Overall Study||14||
60052400|NCT02069366|76168117|FG000|COMPLETED|Overall Study||12||
59612837|NCT01604850|75723887|FG000|STARTED|Overall Study||103||
59612838|NCT01604850|75723888|FG001|STARTED|Overall Study||99||
59612839|NCT01604850|75723887|FG000|Enrolled and Treated|Overall Study||103||
59612840|NCT01604850|75723888|FG001|Enrolled and Treated|Overall Study||98||
59612841|NCT01604850|75723887|FG000|COMPLETED|Overall Study||51||
59612842|NCT01604850|75723888|FG001|COMPLETED|Overall Study||69||
60052401|NCT02069366|76168118|FG001|COMPLETED|Overall Study||10||
60052402|NCT02069366|76168119|FG002|COMPLETED|Overall Study||15||
60052403|NCT02069366|76168120|FG003|COMPLETED|Overall Study||15||
60052404|NCT02069366|76168121|FG004|COMPLETED|Overall Study||14||
60052405|NCT02069366|76168122|FG005|COMPLETED|Overall Study||12||
60052406|NCT02069366|76168117|FG000|NOT COMPLETED|Overall Study||1||
60052407|NCT02069366|76168118|FG001|NOT COMPLETED|Overall Study||0||
60052408|NCT02069366|76168119|FG002|NOT COMPLETED|Overall Study||3||
60052409|NCT02069366|76168120|FG003|NOT COMPLETED|Overall Study||2||
60052410|NCT02069366|76168121|FG004|NOT COMPLETED|Overall Study||0||
60052411|NCT02069366|76168122|FG005|NOT COMPLETED|Overall Study||2||
60052412|NCT02068508|76168137|FG000|STARTED|Overall Study||1067||
60052413|NCT02068508|76168137|FG000|COMPLETED|Overall Study||1035||
60052414|NCT02068508|76168137|FG000|NOT COMPLETED|Overall Study||32||
60052415|NCT02068352|76168144|FG000|STARTED|Overall Study||41||
60052416|NCT02068352|76168145|FG001|STARTED|Overall Study||43||
60052417|NCT02068352|76168146|FG002|STARTED|Overall Study||37||
60052418|NCT02068352|76168144|FG000|COMPLETED|Overall Study||31||
60052419|NCT02068352|76168145|FG001|COMPLETED|Overall Study||35||
60052420|NCT02068352|76168146|FG002|COMPLETED|Overall Study||28||
59514063|NCT02958982|75607687|FG007|COMPLETED|Cohort 3: 100 mg in SAD Study||0||
59514064|NCT02958982|75607688|FG008|COMPLETED|Cohort 3: 100 mg in SAD Study||0||
59514065|NCT02958982|75607689|FG009|COMPLETED|Cohort 3: 100 mg in SAD Study||0||
59514066|NCT02958982|75607690|FG010|COMPLETED|Cohort 3: 100 mg in SAD Study||0||
59612843|NCT01604850|75723887|FG000|NOT COMPLETED|Overall Study||52||
60052421|NCT02068352|76168144|FG000|NOT COMPLETED|Overall Study||10||
60052422|NCT02068352|76168145|FG001|NOT COMPLETED|Overall Study||8||
60052423|NCT02068352|76168146|FG002|NOT COMPLETED|Overall Study||9||
60052424|NCT02207231|76168157|FG000|STARTED|Placebo Controlled Period: Week 0 - 16||174||
60052425|NCT02207231|76168158|FG001|STARTED|Placebo Controlled Period: Week 0 - 16||329||
60052426|NCT02207231|76168159|FG002|STARTED|Placebo Controlled Period: Week 0 - 16||334||
60052427|NCT02207231|76168160|FG003|STARTED|Placebo Controlled Period: Week 0 - 16||0||
60052428|NCT02207231|76168157|FG000|Treated|Placebo Controlled Period: Week 0 - 16||174||
60052429|NCT02207231|76168158|FG001|Treated|Placebo Controlled Period: Week 0 - 16||329||
60052430|NCT02207231|76168159|FG002|Treated|Placebo Controlled Period: Week 0 - 16||333||
60052431|NCT02207231|76168160|FG003|Treated|Placebo Controlled Period: Week 0 - 16||0||
60052432|NCT02207231|76168157|FG000|COMPLETED|Placebo Controlled Period: Week 0 - 16||167||
60052433|NCT02207231|76168158|FG001|COMPLETED|Placebo Controlled Period: Week 0 - 16||322||
60052434|NCT02207231|76168159|FG002|COMPLETED|Placebo Controlled Period: Week 0 - 16||324||
60052435|NCT02207231|76168160|FG003|COMPLETED|Placebo Controlled Period: Week 0 - 16||0||
60052436|NCT02207231|76168157|FG000|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||7||
59514067|NCT02958982|75607680|FG000|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0||
59514068|NCT02958982|75607681|FG001|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0||
59514069|NCT02958982|75607682|FG002|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0||
59514070|NCT02958982|75607683|FG003|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0||
59612844|NCT01604850|75723888|FG001|NOT COMPLETED|Overall Study||30||
59612845|NCT01742286|75723901|FG000|STARTED|Escalation Phase||5||
60052437|NCT02207231|76168158|FG001|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||7||
60052438|NCT02207231|76168159|FG002|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||10||
60052439|NCT02207231|76168160|FG003|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||0||
60052440|NCT02207231|76168157|FG000|STARTED|Active Controlled Period: Week 16 - 48|2 participants did not cross-over.|165||
60052441|NCT02207231|76168158|FG001|STARTED|Active Controlled Period: Week 16 - 48||322||
60052442|NCT02207231|76168159|FG002|STARTED|Active Controlled Period: Week 16 - 48||324||
60052443|NCT02207231|76168160|FG003|STARTED|Active Controlled Period: Week 16 - 48||0||
60052444|NCT02207231|76168157|FG000|COMPLETED|Active Controlled Period: Week 16 - 48||162||
60052445|NCT02207231|76168158|FG001|COMPLETED|Active Controlled Period: Week 16 - 48||301||
60052446|NCT02207231|76168159|FG002|COMPLETED|Active Controlled Period: Week 16 - 48||281||
60052447|NCT02207231|76168160|FG003|COMPLETED|Active Controlled Period: Week 16 - 48||0||
60052448|NCT02207231|76168157|FG000|NOT COMPLETED|Active Controlled Period: Week 16 - 48||3||
60052449|NCT02207231|76168158|FG001|NOT COMPLETED|Active Controlled Period: Week 16 - 48||21||
60052450|NCT02207231|76168159|FG002|NOT COMPLETED|Active Controlled Period: Week 16 - 48||43||
60052451|NCT02207231|76168160|FG003|NOT COMPLETED|Active Controlled Period: Week 16 - 48||0||
60052452|NCT02207231|76168157|FG000|STARTED|Open-label Guselkumab: Week 48 - 264||0||
60052453|NCT02207231|76168158|FG001|STARTED|Open-label Guselkumab: Week 48 - 264||0||
60052454|NCT02207231|76168159|FG002|STARTED|Open-label Guselkumab: Week 48 - 264|One participant did not crossover at Week 52 due to adverse event.|280||
60052455|NCT02207231|76168160|FG003|STARTED|Open-label Guselkumab: Week 48 - 264|162 + 301= 463|463||
60052456|NCT02207231|76168157|FG000|COMPLETED|Open-label Guselkumab: Week 48 - 264||0||
60052457|NCT02207231|76168158|FG001|COMPLETED|Open-label Guselkumab: Week 48 - 264||0||
60052458|NCT02207231|76168159|FG002|COMPLETED|Open-label Guselkumab: Week 48 - 264||242||
60052459|NCT02207231|76168160|FG003|COMPLETED|Open-label Guselkumab: Week 48 - 264||380||
60052460|NCT02207231|76168157|FG000|NOT COMPLETED|Open-label Guselkumab: Week 48 - 264||0||
60052461|NCT02207231|76168158|FG001|NOT COMPLETED|Open-label Guselkumab: Week 48 - 264||0||
60052462|NCT02207231|76168159|FG002|NOT COMPLETED|Open-label Guselkumab: Week 48 - 264||38||
60052463|NCT02207231|76168160|FG003|NOT COMPLETED|Open-label Guselkumab: Week 48 - 264||83||
60052464|NCT02239601|76168180|FG000|STARTED|Overall Study||29||
60052465|NCT02239601|76168181|FG001|STARTED|Overall Study||32||
60052466|NCT02239601|76168180|FG000|COMPLETED|Overall Study||22||
60052467|NCT02239601|76168181|FG001|COMPLETED|Overall Study||26||
60052468|NCT02239601|76168180|FG000|NOT COMPLETED|Overall Study||7||
60052469|NCT02239601|76168181|FG001|NOT COMPLETED|Overall Study||6||
60052470|NCT02236559|76168194|FG000|STARTED|Overall Study||112||
60052471|NCT02236559|76168195|FG001|STARTED|Overall Study||116||
60052472|NCT02236559|76168194|FG000|COMPLETED|Overall Study||100||
60052473|NCT02236559|76168195|FG001|COMPLETED|Overall Study||104||
60052474|NCT02236559|76168194|FG000|NOT COMPLETED|Overall Study||12||
60052475|NCT02236559|76168195|FG001|NOT COMPLETED|Overall Study||12||
60052476|NCT02206685|76168203|FG000|STARTED|Overall Study||37||
60052477|NCT02206685|76168204|FG001|STARTED|Overall Study||37||
60052478|NCT02206685|76168203|FG000|COMPLETED|Overall Study||32||
60052479|NCT02206685|76168204|FG001|COMPLETED|Overall Study||30||
60052480|NCT02206685|76168203|FG000|NOT COMPLETED|Overall Study||5||
60052481|NCT02206685|76168204|FG001|NOT COMPLETED|Overall Study||7||
60052482|NCT02206607|76168210|FG000|STARTED|Open-Label Run-In||42||
60052483|NCT02206607|76168211|FG001|STARTED|Open-Label Run-In||0||
60052484|NCT02206607|76168212|FG002|STARTED|Open-Label Run-In||0||
60052485|NCT02206607|76168213|FG003|STARTED|Open-Label Run-In||0||
60052486|NCT02206607|76168214|FG004|STARTED|Open-Label Run-In||0||
60052487|NCT02206607|76168210|FG000|COMPLETED|Open-Label Run-In||39||
60052488|NCT02206607|76168211|FG001|COMPLETED|Open-Label Run-In||0||
60052489|NCT02206607|76168212|FG002|COMPLETED|Open-Label Run-In||0||
60052490|NCT02206607|76168213|FG003|COMPLETED|Open-Label Run-In||0||
60052491|NCT02206607|76168214|FG004|COMPLETED|Open-Label Run-In||0||
60052492|NCT02206607|76168210|FG000|NOT COMPLETED|Open-Label Run-In||3||
59760461|NCT03439254|75880060|FG000|NOT COMPLETED|Open Label Extension Phase (12 Months)||0||
59760462|NCT03439254|75880061|FG001|NOT COMPLETED|Open Label Extension Phase (12 Months)||0||
59760463|NCT03439254|75880062|FG002|NOT COMPLETED|Open Label Extension Phase (12 Months)||0||
59760464|NCT03439254|75880063|FG003|NOT COMPLETED|Open Label Extension Phase (12 Months)||16||
59760465|NCT03439254|75880064|FG004|NOT COMPLETED|Open Label Extension Phase (12 Months)||13||
59760466|NCT03439254|75880065|FG005|NOT COMPLETED|Open Label Extension Phase (12 Months)||15||
59760467|NCT03434379|75880081|FG000|STARTED|Global Period||165||
60052493|NCT02206607|76168211|FG001|NOT COMPLETED|Open-Label Run-In||0||
60052494|NCT02206607|76168212|FG002|NOT COMPLETED|Open-Label Run-In||0||
60052495|NCT02206607|76168213|FG003|NOT COMPLETED|Open-Label Run-In||0||
60052496|NCT02206607|76168214|FG004|NOT COMPLETED|Open-Label Run-In||0||
60052497|NCT02206607|76168210|FG000|STARTED|First Intervention Period||0||
60052498|NCT02206607|76168211|FG001|STARTED|First Intervention Period||9||
60052499|NCT02206607|76168212|FG002|STARTED|First Intervention Period||9||
60052500|NCT02206607|76168213|FG003|STARTED|First Intervention Period||11||
60052501|NCT02206607|76168214|FG004|STARTED|First Intervention Period||10||
60052502|NCT02206607|76168210|FG000|COMPLETED|First Intervention Period||0||
60052503|NCT02206607|76168211|FG001|COMPLETED|First Intervention Period||9||
59760468|NCT03434379|75880082|FG001|STARTED|Global Period||336||
59760469|NCT03434379|75880083|FG002|STARTED|Global Period||0||
60052504|NCT02206607|76168212|FG002|COMPLETED|First Intervention Period||9||
59760470|NCT03434379|75880084|FG003|STARTED|Global Period||0||
60052505|NCT02206607|76168213|FG003|COMPLETED|First Intervention Period||11||
60052506|NCT02206607|76168214|FG004|COMPLETED|First Intervention Period||10||
60052507|NCT02206607|76168210|FG000|NOT COMPLETED|First Intervention Period||0||
60052508|NCT02206607|76168211|FG001|NOT COMPLETED|First Intervention Period||0||
60052509|NCT02206607|76168212|FG002|NOT COMPLETED|First Intervention Period||0||
60052510|NCT02206607|76168213|FG003|NOT COMPLETED|First Intervention Period||0||
60052511|NCT02206607|76168214|FG004|NOT COMPLETED|First Intervention Period||0||
59760471|NCT03434379|75880081|FG000|COMPLETED|Global Period||0||
59760472|NCT03434379|75880082|FG001|COMPLETED|Global Period||0||
59760473|NCT03434379|75880083|FG002|COMPLETED|Global Period||0||
59760474|NCT03434379|75880084|FG003|COMPLETED|Global Period||0||
59760475|NCT03434379|75880081|FG000|NOT COMPLETED|Global Period||165||
59760476|NCT03434379|75880082|FG001|NOT COMPLETED|Global Period||336||
59760477|NCT03434379|75880083|FG002|NOT COMPLETED|Global Period||0||
59760478|NCT03434379|75880084|FG003|NOT COMPLETED|Global Period||0||
59760479|NCT03434379|75880081|FG000|STARTED|China Extension Period||0||
59760480|NCT03434379|75880082|FG001|STARTED|China Extension Period||0||
59760481|NCT03434379|75880083|FG002|STARTED|China Extension Period|n=43 Chinese participants from the sorafenib Global population are included in the China population.|61||
59760482|NCT03434379|75880084|FG003|STARTED|China Extension Period|n=94 Chinese participants from the Atezolizumab + Bevacizumab Global population are included in the China population.|133||
59760483|NCT03434379|75880081|FG000|COMPLETED|China Extension Period||0||
59760484|NCT03434379|75880082|FG001|COMPLETED|China Extension Period||0||
59760485|NCT03434379|75880083|FG002|COMPLETED|China Extension Period||0||
59760486|NCT03434379|75880084|FG003|COMPLETED|China Extension Period||0||
59760487|NCT03434379|75880081|FG000|NOT COMPLETED|China Extension Period||0||
59760488|NCT03434379|75880082|FG001|NOT COMPLETED|China Extension Period||0||
59760489|NCT03434379|75880083|FG002|NOT COMPLETED|China Extension Period||61||
59760490|NCT03434379|75880084|FG003|NOT COMPLETED|China Extension Period||133||
59760491|NCT03309046|75880098|FG000|STARTED|Overall Study||82||
59760492|NCT03309046|75880099|FG001|STARTED|Overall Study||81||
59760493|NCT03309046|75880098|FG000|COMPLETED|Overall Study||78||
59760494|NCT03309046|75880099|FG001|COMPLETED|Overall Study||64||
60052512|NCT02206607|76168210|FG000|STARTED|First Washout Period 5 to 10 Days||0||
60052513|NCT02206607|76168211|FG001|STARTED|First Washout Period 5 to 10 Days||9||
60052514|NCT02206607|76168212|FG002|STARTED|First Washout Period 5 to 10 Days||9||
60052515|NCT02206607|76168213|FG003|STARTED|First Washout Period 5 to 10 Days||11||
60052516|NCT02206607|76168214|FG004|STARTED|First Washout Period 5 to 10 Days||10||
60052517|NCT02206607|76168210|FG000|COMPLETED|First Washout Period 5 to 10 Days||0||
60052518|NCT02206607|76168211|FG001|COMPLETED|First Washout Period 5 to 10 Days||9||
60052519|NCT02206607|76168212|FG002|COMPLETED|First Washout Period 5 to 10 Days||9||
60052520|NCT02206607|76168213|FG003|COMPLETED|First Washout Period 5 to 10 Days||11||
60052521|NCT02206607|76168214|FG004|COMPLETED|First Washout Period 5 to 10 Days||10||
60052522|NCT02206607|76168210|FG000|NOT COMPLETED|First Washout Period 5 to 10 Days||0||
60052523|NCT02206607|76168211|FG001|NOT COMPLETED|First Washout Period 5 to 10 Days||0||
60052524|NCT02206607|76168212|FG002|NOT COMPLETED|First Washout Period 5 to 10 Days||0||
60052525|NCT02206607|76168213|FG003|NOT COMPLETED|First Washout Period 5 to 10 Days||0||
60052526|NCT02206607|76168214|FG004|NOT COMPLETED|First Washout Period 5 to 10 Days||0||
60052527|NCT02206607|76168210|FG000|STARTED|Second Intervention Period||0||
60052528|NCT02206607|76168211|FG001|STARTED|Second Intervention Period||9||
60052529|NCT02206607|76168212|FG002|STARTED|Second Intervention Period||9||
60052530|NCT02206607|76168213|FG003|STARTED|Second Intervention Period||11||
60052531|NCT02206607|76168214|FG004|STARTED|Second Intervention Period||10||
60052532|NCT02206607|76168210|FG000|COMPLETED|Second Intervention Period||0||
60052533|NCT02206607|76168211|FG001|COMPLETED|Second Intervention Period||9||
60052534|NCT02206607|76168212|FG002|COMPLETED|Second Intervention Period||9||
60052535|NCT02206607|76168213|FG003|COMPLETED|Second Intervention Period||10||
59760495|NCT03309046|75880098|FG000|NOT COMPLETED|Overall Study||4||
59760496|NCT03309046|75880099|FG001|NOT COMPLETED|Overall Study||17||
59760497|NCT03228186|75880105|FG000|STARTED|Overall Study||31||
59760498|NCT03228186|75880105|FG000|COMPLETED|Overall Study||30||
59514071|NCT02958982|75607684|FG004|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0||
59760499|NCT03228186|75880105|FG000|NOT COMPLETED|Overall Study||1||
59760500|NCT02869633|75880111|FG000|STARTED|Overall Study||16||
59760501|NCT02869633|75880112|FG001|STARTED|Overall Study||7||
59760502|NCT02869633|75880111|FG000|COMPLETED|Overall Study||3||
59760503|NCT02869633|75880112|FG001|COMPLETED|Overall Study||2||
59760504|NCT02869633|75880111|FG000|NOT COMPLETED|Overall Study||13||
59760505|NCT02869633|75880112|FG001|NOT COMPLETED|Overall Study||5||
59760506|NCT02855268|75880122|FG000|STARTED|DB Period (up to 48 Weeks)||14||
59760507|NCT02855268|75880123|FG001|STARTED|DB Period (up to 48 Weeks)||29||
60052536|NCT02206607|76168214|FG004|COMPLETED|Second Intervention Period||10||
60052537|NCT02206607|76168210|FG000|NOT COMPLETED|Second Intervention Period||0||
60052538|NCT02206607|76168211|FG001|NOT COMPLETED|Second Intervention Period||0||
60052539|NCT02206607|76168212|FG002|NOT COMPLETED|Second Intervention Period||0||
60052540|NCT02206607|76168213|FG003|NOT COMPLETED|Second Intervention Period||1||
60052541|NCT02206607|76168214|FG004|NOT COMPLETED|Second Intervention Period||0||
59760508|NCT02855268|75880122|FG000|COMPLETED|DB Period (up to 48 Weeks)||9||
59760509|NCT02855268|75880123|FG001|COMPLETED|DB Period (up to 48 Weeks)||19||
60052542|NCT02206607|76168210|FG000|STARTED|Second Washout Period 5 to 10 Days||0||
59922061|NCT03785340|76041602|FG000|Received at Least 1 Study Treatment|Overall Study||126||
59922062|NCT03785340|76041603|FG001|Received at Least 1 Study Treatment|Overall Study||126||
59922063|NCT03785340|76041602|FG000|COMPLETED|Overall Study||123||
59922064|NCT03785340|76041603|FG001|COMPLETED|Overall Study||126||
59922065|NCT03785340|76041602|FG000|NOT COMPLETED|Overall Study||3||
59922066|NCT03785340|76041603|FG001|NOT COMPLETED|Overall Study||0||
59922067|NCT03499067|76041609|FG000|STARTED|First Intervention||27||
59922068|NCT03499067|76041610|FG001|STARTED|First Intervention||31||
59922069|NCT03499067|76041609|FG000|COMPLETED|First Intervention||22||
59922070|NCT03499067|76041610|FG001|COMPLETED|First Intervention||24||
59922071|NCT03499067|76041609|FG000|NOT COMPLETED|First Intervention||5||
59922072|NCT03499067|76041610|FG001|NOT COMPLETED|First Intervention||7||
59922073|NCT03499067|76041609|FG000|STARTED|Second Intervention||22||
59922074|NCT03499067|76041610|FG001|STARTED|Second Intervention||24||
59922075|NCT03499067|76041609|FG000|COMPLETED|Second Intervention||22||
59922076|NCT03499067|76041610|FG001|COMPLETED|Second Intervention||24||
59922077|NCT03499067|76041609|FG000|NOT COMPLETED|Second Intervention||0||
59922078|NCT03499067|76041610|FG001|NOT COMPLETED|Second Intervention||0||
59922079|NCT03562481|76041618|FG000|STARTED|First Intervention||12||
59922080|NCT03562481|76041619|FG001|STARTED|First Intervention||14||
59922081|NCT03562481|76041618|FG000|COMPLETED|First Intervention||11||
59922082|NCT03562481|76041619|FG001|COMPLETED|First Intervention||14||
59922083|NCT03562481|76041618|FG000|NOT COMPLETED|First Intervention||1||
59922084|NCT03562481|76041619|FG001|NOT COMPLETED|First Intervention||0||
59922085|NCT03562481|76041618|FG000|STARTED|Washout||11||
59922086|NCT03562481|76041619|FG001|STARTED|Washout||14||
59922087|NCT03562481|76041618|FG000|COMPLETED|Washout||11||
59922088|NCT03562481|76041619|FG001|COMPLETED|Washout||14||
59922089|NCT03562481|76041618|FG000|NOT COMPLETED|Washout||0||
59922090|NCT03562481|76041619|FG001|NOT COMPLETED|Washout||0||
59922091|NCT03562481|76041618|FG000|STARTED|Second Intervention||11||
59922092|NCT03562481|76041619|FG001|STARTED|Second Intervention||14||
59922093|NCT03562481|76041618|FG000|COMPLETED|Second Intervention||11||
59922094|NCT03562481|76041619|FG001|COMPLETED|Second Intervention||14||
59922095|NCT03562481|76041618|FG000|NOT COMPLETED|Second Intervention||0||
59922096|NCT03562481|76041619|FG001|NOT COMPLETED|Second Intervention||0||
59922097|NCT03760224|76041631|FG000|STARTED|Overall Study||469||
59922098|NCT03760224|76041632|FG001|STARTED|Overall Study||459||
59922099|NCT03760224|76041631|FG000|COMPLETED|Overall Study||469||
59922100|NCT03760224|76041632|FG001|COMPLETED|Overall Study||459||
59922101|NCT03760224|76041631|FG000|NOT COMPLETED|Overall Study||0||
59922102|NCT03760224|76041632|FG001|NOT COMPLETED|Overall Study||0||
59922103|NCT03197064|76041638|FG000|STARTED|Overall Study||11||
59922104|NCT03197064|76041638|FG000|COMPLETED|Overall Study||11||
59922105|NCT03197064|76041638|FG000|NOT COMPLETED|Overall Study||0||
59922106|NCT03529409|76041645|FG000|STARTED|Randomized||30||
59922107|NCT03529409|76041646|FG001|STARTED|Randomized||31||
59922108|NCT03529409|76041647|FG002|STARTED|Randomized||5||
60052543|NCT02206607|76168211|FG001|STARTED|Second Washout Period 5 to 10 Days||9||
60052544|NCT02206607|76168212|FG002|STARTED|Second Washout Period 5 to 10 Days||9||
60052545|NCT02206607|76168213|FG003|STARTED|Second Washout Period 5 to 10 Days||10||
60052546|NCT02206607|76168214|FG004|STARTED|Second Washout Period 5 to 10 Days||10||
60052547|NCT02206607|76168210|FG000|COMPLETED|Second Washout Period 5 to 10 Days||0||
60052548|NCT02206607|76168211|FG001|COMPLETED|Second Washout Period 5 to 10 Days||9||
60052549|NCT02206607|76168212|FG002|COMPLETED|Second Washout Period 5 to 10 Days||9||
60052550|NCT02206607|76168213|FG003|COMPLETED|Second Washout Period 5 to 10 Days||10||
60052551|NCT02206607|76168214|FG004|COMPLETED|Second Washout Period 5 to 10 Days||10||
60052552|NCT02206607|76168210|FG000|NOT COMPLETED|Second Washout Period 5 to 10 Days||0||
60052553|NCT02206607|76168211|FG001|NOT COMPLETED|Second Washout Period 5 to 10 Days||0||
59922109|NCT03529409|76041645|FG000|COMPLETED|Randomized||30||
59922110|NCT03529409|76041646|FG001|COMPLETED|Randomized||31||
59922111|NCT03529409|76041647|FG002|COMPLETED|Randomized||0||
59922112|NCT03529409|76041645|FG000|NOT COMPLETED|Randomized||0||
59922113|NCT03529409|76041646|FG001|NOT COMPLETED|Randomized||0||
59922114|NCT03529409|76041647|FG002|NOT COMPLETED|Randomized||5||
60052554|NCT02206607|76168212|FG002|NOT COMPLETED|Second Washout Period 5 to 10 Days||0||
60052555|NCT02206607|76168213|FG003|NOT COMPLETED|Second Washout Period 5 to 10 Days||0||
59922115|NCT03529409|76041645|FG000|STARTED|Post-treatment Assessment||30||
59922116|NCT03529409|76041646|FG001|STARTED|Post-treatment Assessment||31||
59922117|NCT03529409|76041647|FG002|STARTED|Post-treatment Assessment||0||
60052556|NCT02206607|76168214|FG004|NOT COMPLETED|Second Washout Period 5 to 10 Days||0||
60052557|NCT02206607|76168210|FG000|STARTED|Third Intervention Period||0||
60052558|NCT02206607|76168211|FG001|STARTED|Third Intervention Period||9||
60052559|NCT02206607|76168212|FG002|STARTED|Third Intervention Period||9||
60052560|NCT02206607|76168213|FG003|STARTED|Third Intervention Period||10||
60052561|NCT02206607|76168214|FG004|STARTED|Third Intervention Period||10||
59922118|NCT03529409|76041645|FG000|COMPLETED|Post-treatment Assessment||26||
59922119|NCT03529409|76041646|FG001|COMPLETED|Post-treatment Assessment||26||
60052562|NCT02206607|76168210|FG000|COMPLETED|Third Intervention Period||0||
60052563|NCT02206607|76168211|FG001|COMPLETED|Third Intervention Period||9||
60052564|NCT02206607|76168212|FG002|COMPLETED|Third Intervention Period||9||
60052565|NCT02206607|76168213|FG003|COMPLETED|Third Intervention Period||10||
60052566|NCT02206607|76168214|FG004|COMPLETED|Third Intervention Period||10||
60052567|NCT02206607|76168210|FG000|NOT COMPLETED|Third Intervention Period||0||
60052568|NCT02206607|76168211|FG001|NOT COMPLETED|Third Intervention Period||0||
60052569|NCT02206607|76168212|FG002|NOT COMPLETED|Third Intervention Period||0||
60052570|NCT02206607|76168213|FG003|NOT COMPLETED|Third Intervention Period||0||
60052571|NCT02206607|76168214|FG004|NOT COMPLETED|Third Intervention Period||0||
60052572|NCT02206607|76168210|FG000|STARTED|Third Washout Period 5 to 10 Days||0||
60052573|NCT02206607|76168211|FG001|STARTED|Third Washout Period 5 to 10 Days||9||
60052574|NCT02206607|76168212|FG002|STARTED|Third Washout Period 5 to 10 Days||9||
60052575|NCT02206607|76168213|FG003|STARTED|Third Washout Period 5 to 10 Days||10||
60052576|NCT02206607|76168214|FG004|STARTED|Third Washout Period 5 to 10 Days||10||
60052577|NCT02206607|76168210|FG000|COMPLETED|Third Washout Period 5 to 10 Days||0||
60052578|NCT02206607|76168211|FG001|COMPLETED|Third Washout Period 5 to 10 Days||9||
60052579|NCT02206607|76168212|FG002|COMPLETED|Third Washout Period 5 to 10 Days||9||
59514072|NCT02958982|75607685|FG005|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0||
59514073|NCT02958982|75607686|FG006|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0||
59514074|NCT02958982|75607687|FG007|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0||
59514075|NCT02958982|75607688|FG008|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0||
59514076|NCT02958982|75607689|FG009|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0||
59514077|NCT02958982|75607690|FG010|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0||
59514078|NCT02958982|75607680|FG000|STARTED|Cohort 4: 200 mg in SAD Study||2||
59514079|NCT02958982|75607681|FG001|STARTED|Cohort 4: 200 mg in SAD Study||0||
59514080|NCT02958982|75607682|FG002|STARTED|Cohort 4: 200 mg in SAD Study||0||
59514081|NCT02958982|75607683|FG003|STARTED|Cohort 4: 200 mg in SAD Study||0||
59514082|NCT02958982|75607684|FG004|STARTED|Cohort 4: 200 mg in SAD Study||6||
59514083|NCT02958982|75607685|FG005|STARTED|Cohort 4: 200 mg in SAD Study||0||
59514084|NCT02958982|75607686|FG006|STARTED|Cohort 4: 200 mg in SAD Study||0||
59514085|NCT02958982|75607687|FG007|STARTED|Cohort 4: 200 mg in SAD Study||0||
59514086|NCT02958982|75607688|FG008|STARTED|Cohort 4: 200 mg in SAD Study||0||
59922120|NCT03529409|76041647|FG002|COMPLETED|Post-treatment Assessment||0||
59922121|NCT03529409|76041645|FG000|NOT COMPLETED|Post-treatment Assessment||4||
59922122|NCT03529409|76041646|FG001|NOT COMPLETED|Post-treatment Assessment||5||
59922123|NCT03529409|76041647|FG002|NOT COMPLETED|Post-treatment Assessment||0||
59922124|NCT03529409|76041645|FG000|STARTED|Follow-up Assessment|All participants were eligible for Follow-Up regardless of Post-Treatment attendance.|28||
59922125|NCT03529409|76041646|FG001|STARTED|Follow-up Assessment|All participants (n=31) were eligible for Follow-Up regardless of Post-Treatment attendance|30||
60052580|NCT02206607|76168213|FG003|COMPLETED|Third Washout Period 5 to 10 Days||10||
60052581|NCT02206607|76168214|FG004|COMPLETED|Third Washout Period 5 to 10 Days||10||
60052582|NCT02206607|76168210|FG000|NOT COMPLETED|Third Washout Period 5 to 10 Days||0||
59514087|NCT02958982|75607689|FG009|STARTED|Cohort 4: 200 mg in SAD Study||0||
59514088|NCT02958982|75607690|FG010|STARTED|Cohort 4: 200 mg in SAD Study||0||
59514089|NCT02958982|75607680|FG000|COMPLETED|Cohort 4: 200 mg in SAD Study||2||
59514090|NCT02958982|75607681|FG001|COMPLETED|Cohort 4: 200 mg in SAD Study||0||
59514091|NCT02958982|75607682|FG002|COMPLETED|Cohort 4: 200 mg in SAD Study||0||
59514092|NCT02958982|75607683|FG003|COMPLETED|Cohort 4: 200 mg in SAD Study||0||
59514093|NCT02958982|75607684|FG004|COMPLETED|Cohort 4: 200 mg in SAD Study||6||
59514094|NCT02958982|75607685|FG005|COMPLETED|Cohort 4: 200 mg in SAD Study||0||
59514095|NCT02958982|75607686|FG006|COMPLETED|Cohort 4: 200 mg in SAD Study||0||
59514096|NCT02958982|75607687|FG007|COMPLETED|Cohort 4: 200 mg in SAD Study||0||
59514097|NCT02958982|75607688|FG008|COMPLETED|Cohort 4: 200 mg in SAD Study||0||
59514098|NCT02958982|75607689|FG009|COMPLETED|Cohort 4: 200 mg in SAD Study||0||
59922126|NCT03529409|76041647|FG002|STARTED|Follow-up Assessment||0||
59922127|NCT03529409|76041645|FG000|COMPLETED|Follow-up Assessment||27||
59922128|NCT03529409|76041646|FG001|COMPLETED|Follow-up Assessment||29||
59922129|NCT03529409|76041647|FG002|COMPLETED|Follow-up Assessment||0||
59922130|NCT03529409|76041645|FG000|NOT COMPLETED|Follow-up Assessment||1||
59922131|NCT03529409|76041646|FG001|NOT COMPLETED|Follow-up Assessment||1||
60052583|NCT02206607|76168211|FG001|NOT COMPLETED|Third Washout Period 5 to 10 Days||0||
60067852|NCT01785615|76183053|FG001|COMPLETED|Dietary Phase||0||
59514099|NCT02958982|75607690|FG010|COMPLETED|Cohort 4: 200 mg in SAD Study||0||
59922132|NCT03529409|76041647|FG002|NOT COMPLETED|Follow-up Assessment||0||
59922133|NCT03498287|76041656|FG000|STARTED|Overall Study||45||
59922134|NCT03498287|76041657|FG001|STARTED|Overall Study||43||
59922135|NCT03498287|76041656|FG000|COMPLETED|Overall Study||42||
59922136|NCT03498287|76041657|FG001|COMPLETED|Overall Study||38||
59922137|NCT03498287|76041656|FG000|NOT COMPLETED|Overall Study||3||
59922138|NCT03498287|76041657|FG001|NOT COMPLETED|Overall Study||5||
59922139|NCT03497429|76041665|FG000|STARTED|Overall Study||3||
60052584|NCT02206607|76168212|FG002|NOT COMPLETED|Third Washout Period 5 to 10 Days||0||
60052585|NCT02206607|76168213|FG003|NOT COMPLETED|Third Washout Period 5 to 10 Days||0||
59922140|NCT03497429|76041666|FG001|STARTED|Overall Study||6||
59922141|NCT03497429|76041665|FG000|Started|Overall Study||3||
59922142|NCT03497429|76041666|FG001|Started|Overall Study||6||
59922143|NCT03497429|76041665|FG000|Completed|Overall Study||0||
59922144|NCT03497429|76041666|FG001|Completed|Overall Study||0||
59922145|NCT03497429|76041665|FG000|COMPLETED|Overall Study||0||
59922146|NCT03497429|76041666|FG001|COMPLETED|Overall Study||0||
59922147|NCT03497429|76041665|FG000|NOT COMPLETED|Overall Study||3||
59922148|NCT03497429|76041666|FG001|NOT COMPLETED|Overall Study||6||
59922149|NCT03497039|76041674|FG000|STARTED|Overall Study||30||
59922150|NCT03497039|76041675|FG001|STARTED|Overall Study||17||
59922151|NCT03497039|76041674|FG000|Treated|Overall Study||29||
59922152|NCT03497039|76041675|FG001|Treated|Overall Study||17||
59922153|NCT03497039|76041674|FG000|COMPLETED|Overall Study||29||
59922154|NCT03497039|76041675|FG001|COMPLETED|Overall Study||16||
59922155|NCT03497039|76041674|FG000|NOT COMPLETED|Overall Study||1||
59922156|NCT03497039|76041675|FG001|NOT COMPLETED|Overall Study||1||
59922157|NCT03720899|76041683|FG000|STARTED|Overall Study||21||
59922158|NCT03720899|76041684|FG001|STARTED|Overall Study||24||
59922159|NCT03720899|76041683|FG000|COMPLETED|Overall Study||13||
59922160|NCT03720899|76041684|FG001|COMPLETED|Overall Study||13||
59922161|NCT03720899|76041683|FG000|NOT COMPLETED|Overall Study||8||
59922162|NCT03720899|76041684|FG001|NOT COMPLETED|Overall Study||11||
59922163|NCT03495869|76041694|FG000|STARTED|Overall Study||54||
59922164|NCT03495869|76041695|FG001|STARTED|Overall Study||124||
59922165|NCT03495869|76041696|FG002|STARTED|Overall Study||61||
59922166|NCT03495869|76041697|FG003|STARTED|Overall Study||129||
59922167|NCT03495869|76041694|FG000|COMPLETED|Overall Study||50||
59922168|NCT03495869|76041695|FG001|COMPLETED|Overall Study||97||
59922169|NCT03495869|76041696|FG002|COMPLETED|Overall Study||51||
59922170|NCT03495869|76041697|FG003|COMPLETED|Overall Study||108||
59922171|NCT03495869|76041694|FG000|NOT COMPLETED|Overall Study||4||
59922172|NCT03495869|76041695|FG001|NOT COMPLETED|Overall Study||27||
59922173|NCT03495869|76041696|FG002|NOT COMPLETED|Overall Study||10||
59922174|NCT03495869|76041697|FG003|NOT COMPLETED|Overall Study||21||
59922175|NCT03145480|76041709|FG000|STARTED|Overall Study||3||
60052586|NCT02206607|76168214|FG004|NOT COMPLETED|Third Washout Period 5 to 10 Days||0||
60052587|NCT02206607|76168210|FG000|STARTED|Fourth Intervention Period||0||
60052588|NCT02206607|76168211|FG001|STARTED|Fourth Intervention Period||9||
60052589|NCT02206607|76168212|FG002|STARTED|Fourth Intervention Period||9||
60052590|NCT02206607|76168213|FG003|STARTED|Fourth Intervention Period||10||
59514100|NCT02958982|75607680|FG000|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0||
59514101|NCT02958982|75607681|FG001|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0||
59514102|NCT02958982|75607682|FG002|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0||
59514103|NCT02958982|75607683|FG003|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0||
59922176|NCT03145480|76041710|FG001|STARTED|Overall Study||0||
59922177|NCT03145480|76041709|FG000|COMPLETED|Overall Study||0||
59922178|NCT03145480|76041710|FG001|COMPLETED|Overall Study||0||
59922179|NCT03145480|76041709|FG000|NOT COMPLETED|Overall Study||3||
60052591|NCT02206607|76168214|FG004|STARTED|Fourth Intervention Period||10||
59514104|NCT02958982|75607684|FG004|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0||
59514105|NCT02958982|75607685|FG005|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0||
59922180|NCT03145480|76041710|FG001|NOT COMPLETED|Overall Study||0||
59922181|NCT03071094|76041718|FG000|STARTED|Overall Study||7||
59922182|NCT03071094|76041719|FG001|STARTED|Overall Study||5||
59922183|NCT03071094|76041718|FG000|COMPLETED|Overall Study||5||
59922184|NCT03071094|76041719|FG001|COMPLETED|Overall Study||4||
59922185|NCT03071094|76041718|FG000|NOT COMPLETED|Overall Study||2||
59922186|NCT03071094|76041719|FG001|NOT COMPLETED|Overall Study||1||
59922187|NCT03559517|76041728|FG000|STARTED|Overall Study||8||
59922188|NCT03559517|76041729|FG001|STARTED|Overall Study||9||
59922189|NCT03559517|76041730|FG002|STARTED|Overall Study||12||
60052592|NCT02206607|76168210|FG000|COMPLETED|Fourth Intervention Period||0||
59922190|NCT03559517|76041728|FG000|COMPLETED|Overall Study||7||
60052593|NCT02206607|76168211|FG001|COMPLETED|Fourth Intervention Period||9||
60052594|NCT02206607|76168212|FG002|COMPLETED|Fourth Intervention Period||9||
59514106|NCT02958982|75607686|FG006|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0||
59514107|NCT02958982|75607687|FG007|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0||
59922191|NCT03559517|76041729|FG001|COMPLETED|Overall Study||9||
59922192|NCT03559517|76041730|FG002|COMPLETED|Overall Study||12||
59922193|NCT03559517|76041728|FG000|NOT COMPLETED|Overall Study||1||
59760510|NCT02855268|75880122|FG000|NOT COMPLETED|DB Period (up to 48 Weeks)||5||
60052595|NCT02206607|76168213|FG003|COMPLETED|Fourth Intervention Period||10||
60052596|NCT02206607|76168214|FG004|COMPLETED|Fourth Intervention Period||10||
60052597|NCT02206607|76168210|FG000|NOT COMPLETED|Fourth Intervention Period||0||
60052598|NCT02206607|76168211|FG001|NOT COMPLETED|Fourth Intervention Period||0||
60052599|NCT02206607|76168212|FG002|NOT COMPLETED|Fourth Intervention Period||0||
60052600|NCT02206607|76168213|FG003|NOT COMPLETED|Fourth Intervention Period||0||
60052601|NCT02206607|76168214|FG004|NOT COMPLETED|Fourth Intervention Period||0||
60052602|NCT02119676|76168234|FG000|STARTED|Overall Study||87||
60052603|NCT02119676|76168235|FG001|STARTED|Overall Study||88||
60052604|NCT02119676|76168236|FG002|STARTED|Overall Study||110||
60052605|NCT02119676|76168237|FG003|STARTED|Overall Study||111||
60052606|NCT02119676|76168234|FG000|Treated Patients|Overall Study||85||
60052607|NCT02119676|76168235|FG001|Treated Patients|Overall Study||86||
60052608|NCT02119676|76168236|FG002|Treated Patients|Overall Study||106||
60052609|NCT02119676|76168237|FG003|Treated Patients|Overall Study||106||
60052610|NCT02119676|76168234|FG000|COMPLETED|Overall Study||4|Ongoing treatment at time of termination. Termination=Substudy 1: 27Jan2016; Substudy 2: 11Feb2016.|
59760511|NCT02855268|75880123|FG001|NOT COMPLETED|DB Period (up to 48 Weeks)||10||
59760512|NCT02855268|75880122|FG000|STARTED|OLE Period (up to 96 Weeks)||9||
60052611|NCT02119676|76168235|FG001|COMPLETED|Overall Study||2|Ongoing treatment at time of termination. Termination=Substudy 1: 27Jan2016; Substudy 2: 11Feb2016.|
60052612|NCT02119676|76168236|FG002|COMPLETED|Overall Study||13|Ongoing treatment at time of termination. Termination=Substudy 1: 27Jan2016; Substudy 2: 11Feb2016.|
60052613|NCT02119676|76168237|FG003|COMPLETED|Overall Study||10|Ongoing treatment at time of termination. Termination=Substudy 1: 27Jan2016; Substudy 2: 11Feb2016.|
60052614|NCT02119676|76168234|FG000|NOT COMPLETED|Overall Study||83||
60052615|NCT02119676|76168235|FG001|NOT COMPLETED|Overall Study||86||
60052616|NCT02119676|76168236|FG002|NOT COMPLETED|Overall Study||97||
60052617|NCT02119676|76168237|FG003|NOT COMPLETED|Overall Study||101||
60052618|NCT02206061|76168250|FG000|STARTED|Overall Study||149||
60052619|NCT02206061|76168251|FG001|STARTED|Overall Study||142||
60052620|NCT02206061|76168252|FG002|STARTED|Overall Study||139||
60052621|NCT02206061|76168250|FG000|COMPLETED|Overall Study||131||
60052622|NCT02206061|76168251|FG001|COMPLETED|Overall Study||128||
60052623|NCT02206061|76168252|FG002|COMPLETED|Overall Study||118||
60052624|NCT02206061|76168250|FG000|NOT COMPLETED|Overall Study||18||
60052625|NCT02206061|76168251|FG001|NOT COMPLETED|Overall Study||14||
60052626|NCT02206061|76168252|FG002|NOT COMPLETED|Overall Study||21||
60052627|NCT02095106|76168262|FG000|STARTED|First Intervention (14 Days)||14||
60052628|NCT02095106|76168263|FG001|STARTED|First Intervention (14 Days)||13||
60052629|NCT02095106|76168262|FG000|COMPLETED|First Intervention (14 Days)||14||
60052630|NCT02095106|76168263|FG001|COMPLETED|First Intervention (14 Days)||13||
60052631|NCT02095106|76168262|FG000|NOT COMPLETED|First Intervention (14 Days)||0||
60052632|NCT02095106|76168263|FG001|NOT COMPLETED|First Intervention (14 Days)||0||
60052633|NCT02095106|76168262|FG000|STARTED|Second Intervention (14 Days)||14||
60052634|NCT02095106|76168263|FG001|STARTED|Second Intervention (14 Days)||13||
60052635|NCT02095106|76168262|FG000|COMPLETED|Second Intervention (14 Days)||14||
60052636|NCT02095106|76168263|FG001|COMPLETED|Second Intervention (14 Days)||12||
60052637|NCT02095106|76168262|FG000|NOT COMPLETED|Second Intervention (14 Days)||0||
60052638|NCT02095106|76168263|FG001|NOT COMPLETED|Second Intervention (14 Days)||1||
60052639|NCT01631747|76168275|FG000|STARTED|Randomization Through End of Pregnancy||141||
60052640|NCT01631747|76168276|FG001|STARTED|Randomization Through End of Pregnancy||140||
60052641|NCT01631747|76168275|FG000|COMPLETED|Randomization Through End of Pregnancy||140||
60052642|NCT01631747|76168276|FG001|COMPLETED|Randomization Through End of Pregnancy||140||
60052643|NCT01631747|76168275|FG000|NOT COMPLETED|Randomization Through End of Pregnancy||1||
60052644|NCT01631747|76168276|FG001|NOT COMPLETED|Randomization Through End of Pregnancy||0||
60052645|NCT01631747|76168275|FG000|STARTED|Live Birth||140||
60052646|NCT01631747|76168276|FG001|STARTED|Live Birth||140||
59760513|NCT02855268|75880123|FG001|STARTED|OLE Period (up to 96 Weeks)||19||
59760514|NCT02855268|75880122|FG000|COMPLETED|OLE Period (up to 96 Weeks)||1||
59760515|NCT02855268|75880123|FG001|COMPLETED|OLE Period (up to 96 Weeks)||0||
59760516|NCT02855268|75880122|FG000|NOT COMPLETED|OLE Period (up to 96 Weeks)||8||
59760517|NCT02855268|75880123|FG001|NOT COMPLETED|OLE Period (up to 96 Weeks)||19||
60052647|NCT01631747|76168275|FG000|COMPLETED|Live Birth||136||
60052648|NCT01631747|76168276|FG001|COMPLETED|Live Birth||139||
60052649|NCT01631747|76168275|FG000|NOT COMPLETED|Live Birth||4||
60052650|NCT01631747|76168276|FG001|NOT COMPLETED|Live Birth||1||
60052651|NCT01631747|76168275|FG000|STARTED|One Year Infant Outcomes||136||
60052652|NCT01631747|76168276|FG001|STARTED|One Year Infant Outcomes||139||
60052653|NCT01631747|76168275|FG000|COMPLETED|One Year Infant Outcomes||123||
60052654|NCT01631747|76168276|FG001|COMPLETED|One Year Infant Outcomes||130||
60052655|NCT01631747|76168275|FG000|NOT COMPLETED|One Year Infant Outcomes||13||
60052656|NCT01631747|76168276|FG001|NOT COMPLETED|One Year Infant Outcomes||9||
60052657|NCT02068118|76168285|FG000|STARTED|18-month Comparative Study Period||455|"990 patients signed an informed consent, 937 returned home and started their ambulatory monitoring. These 937 patients constituted the Intent to Treat (ITT) population: 455 patients were in the Standard Care group and 482 patients in the Tele-cardiology Group."|
60052658|NCT02068118|76168286|FG001|STARTED|18-month Comparative Study Period||482|"990 patients signed an informed consent, 937 returned home and started their ambulatory monitoring. These 937 patients constituted the Intent to Treat (ITT) population: 455 patients were in the Standard Care group and 482 patients in the Tele-cardiology Group."|
60052659|NCT02068118|76168285|FG000|COMPLETED|18-month Comparative Study Period||327||
60052660|NCT02068118|76168286|FG001|COMPLETED|18-month Comparative Study Period||305||
60052661|NCT02068118|76168285|FG000|NOT COMPLETED|18-month Comparative Study Period||128||
60052662|NCT02068118|76168286|FG001|NOT COMPLETED|18-month Comparative Study Period||177||
60052663|NCT02068118|76168285|FG000|STARTED|Extension Period|Standard Care/Tele-cardiology : Patients entered Period 2 if they wished and consented|7||
60052664|NCT02068118|76168286|FG001|STARTED|Extension Period|Tele-cardiology/Tele-cardiology : Patients entered Period 2 if they wished and consented|13||
60052665|NCT02068118|76168285|FG000|COMPLETED|Extension Period||5||
60052666|NCT02068118|76168286|FG001|COMPLETED|Extension Period||10||
60052667|NCT02068118|76168285|FG000|NOT COMPLETED|Extension Period||2||
60052668|NCT02068118|76168286|FG001|NOT COMPLETED|Extension Period||3||
60052669|NCT01623830|76168296|FG000|STARTED|Overall Study||45||
60052670|NCT01623830|76168297|FG001|STARTED|Overall Study||44||
60052671|NCT01623830|76168296|FG000|COMPLETED|Overall Study||38||
60052672|NCT01623830|76168297|FG001|COMPLETED|Overall Study||35||
60052673|NCT01623830|76168296|FG000|NOT COMPLETED|Overall Study||7||
60052674|NCT01623830|76168297|FG001|NOT COMPLETED|Overall Study||9||
60052675|NCT01634165|76168303|FG000|STARTED|Period 1||6||
60052676|NCT01634165|76168304|FG001|STARTED|Period 1||6||
60052677|NCT01634165|76168305|FG002|STARTED|Period 1||6||
60052678|NCT01634165|76168306|FG003|STARTED|Period 1||6||
60052679|NCT01634165|76168303|FG000|Received at Least 1 Dose of Study Drug|Period 1||6||
59612846|NCT01742286|75723902|FG001|STARTED|Escalation Phase||12||
59612847|NCT01742286|75723903|FG002|STARTED|Escalation Phase||6||
59612848|NCT01742286|75723904|FG003|STARTED|Escalation Phase||2||
59612849|NCT01742286|75723905|FG004|STARTED|Escalation Phase||4||
59612850|NCT01742286|75723906|FG005|STARTED|Escalation Phase||5||
59612851|NCT01742286|75723907|FG006|STARTED|Escalation Phase||6||
59612852|NCT01742286|75723901|FG000|Ended Treatment = Not Completed)|Escalation Phase||5||
59612853|NCT01742286|75723902|FG001|Ended Treatment = Not Completed)|Escalation Phase||12||
59612854|NCT01742286|75723903|FG002|Ended Treatment = Not Completed)|Escalation Phase||6||
59612855|NCT01742286|75723904|FG003|Ended Treatment = Not Completed)|Escalation Phase||2||
60052680|NCT01634165|76168304|FG001|Received at Least 1 Dose of Study Drug|Period 1||6||
60052681|NCT01634165|76168305|FG002|Received at Least 1 Dose of Study Drug|Period 1||6||
60052682|NCT01634165|76168306|FG003|Received at Least 1 Dose of Study Drug|Period 1||6||
60052683|NCT01634165|76168303|FG000|COMPLETED|Period 1||6||
60052684|NCT01634165|76168304|FG001|COMPLETED|Period 1||6||
60052685|NCT01634165|76168305|FG002|COMPLETED|Period 1||6||
60052686|NCT01634165|76168306|FG003|COMPLETED|Period 1||6||
60052687|NCT01634165|76168303|FG000|NOT COMPLETED|Period 1||0||
60052688|NCT01634165|76168304|FG001|NOT COMPLETED|Period 1||0||
60052689|NCT01634165|76168305|FG002|NOT COMPLETED|Period 1||0||
60052690|NCT01634165|76168306|FG003|NOT COMPLETED|Period 1||0||
60052691|NCT01634165|76168303|FG000|STARTED|Period 2||6||
60052692|NCT01634165|76168304|FG001|STARTED|Period 2||6||
60052693|NCT01634165|76168305|FG002|STARTED|Period 2||6||
60052694|NCT01634165|76168306|FG003|STARTED|Period 2||6||
60052695|NCT01634165|76168303|FG000|COMPLETED|Period 2||6||
60052696|NCT01634165|76168304|FG001|COMPLETED|Period 2||5||
60052697|NCT01634165|76168305|FG002|COMPLETED|Period 2||6||
60052698|NCT01634165|76168306|FG003|COMPLETED|Period 2||6||
60052699|NCT01634165|76168303|FG000|NOT COMPLETED|Period 2||0||
60052700|NCT01634165|76168304|FG001|NOT COMPLETED|Period 2||1||
60052701|NCT01634165|76168305|FG002|NOT COMPLETED|Period 2||0||
60052702|NCT01634165|76168306|FG003|NOT COMPLETED|Period 2||0||
60052703|NCT01634165|76168303|FG000|STARTED|Period 3||6||
60052704|NCT01634165|76168304|FG001|STARTED|Period 3||5||
60052705|NCT01634165|76168305|FG002|STARTED|Period 3||6||
60052706|NCT01634165|76168306|FG003|STARTED|Period 3||6||
60052707|NCT01634165|76168303|FG000|COMPLETED|Period 3||6||
60052708|NCT01634165|76168304|FG001|COMPLETED|Period 3||5||
60052709|NCT01634165|76168305|FG002|COMPLETED|Period 3||6||
60052710|NCT01634165|76168306|FG003|COMPLETED|Period 3||6||
59612856|NCT01742286|75723905|FG004|Ended Treatment = Not Completed)|Escalation Phase||4||
59612857|NCT01742286|75723906|FG005|Ended Treatment = Not Completed)|Escalation Phase||5||
59612858|NCT01742286|75723907|FG006|Ended Treatment = Not Completed)|Escalation Phase||6||
59612859|NCT01742286|75723901|FG000|COMPLETED|Escalation Phase||0||
59612860|NCT01742286|75723902|FG001|COMPLETED|Escalation Phase||0||
60052711|NCT01634165|76168303|FG000|NOT COMPLETED|Period 3||0||
60052712|NCT01634165|76168304|FG001|NOT COMPLETED|Period 3||0||
60052713|NCT01634165|76168305|FG002|NOT COMPLETED|Period 3||0||
60052714|NCT01634165|76168306|FG003|NOT COMPLETED|Period 3||0||
60052715|NCT01634165|76168303|FG000|STARTED|Period 4||6||
60052716|NCT01634165|76168304|FG001|STARTED|Period 4||5||
60052717|NCT01634165|76168305|FG002|STARTED|Period 4||6||
60052718|NCT01634165|76168306|FG003|STARTED|Period 4||6||
60052719|NCT01634165|76168303|FG000|COMPLETED|Period 4||6||
60052720|NCT01634165|76168304|FG001|COMPLETED|Period 4||5||
60052721|NCT01634165|76168305|FG002|COMPLETED|Period 4||6||
60052722|NCT01634165|76168306|FG003|COMPLETED|Period 4||6||
60052723|NCT01634165|76168303|FG000|NOT COMPLETED|Period 4||0||
59612861|NCT01742286|75723903|FG002|COMPLETED|Escalation Phase||0||
59612862|NCT01742286|75723904|FG003|COMPLETED|Escalation Phase||0||
59612863|NCT01742286|75723905|FG004|COMPLETED|Escalation Phase||0||
59612864|NCT01742286|75723906|FG005|COMPLETED|Escalation Phase||0||
59612865|NCT01742286|75723907|FG006|COMPLETED|Escalation Phase||0||
59612866|NCT01742286|75723901|FG000|NOT COMPLETED|Escalation Phase||5||
59612867|NCT01742286|75723902|FG001|NOT COMPLETED|Escalation Phase||12||
59612868|NCT01742286|75723903|FG002|NOT COMPLETED|Escalation Phase||6||
59612869|NCT01742286|75723904|FG003|NOT COMPLETED|Escalation Phase||2||
59612870|NCT01742286|75723905|FG004|NOT COMPLETED|Escalation Phase||4||
59922194|NCT03559517|76041729|FG001|NOT COMPLETED|Overall Study||0||
59922195|NCT03559517|76041730|FG002|NOT COMPLETED|Overall Study||0||
59922196|NCT02509494|76041747|FG000|STARTED|Overall Study||43||
59922197|NCT02509494|76041748|FG001|STARTED|Overall Study||298||
59922198|NCT02509494|76041749|FG002|STARTED|Overall Study||102||
59922199|NCT02509494|76041750|FG003|STARTED|Overall Study||143||
59922200|NCT02509494|76041751|FG004|STARTED|Overall Study||48||
59922201|NCT02509494|76041752|FG005|STARTED|Overall Study||144||
59922202|NCT02509494|76041753|FG006|STARTED|Overall Study||48||
59922203|NCT02509494|76041754|FG007|STARTED|Overall Study||144||
59922204|NCT02509494|76041755|FG008|STARTED|Overall Study||48||
59922205|NCT02509494|76041747|FG000|COMPLETED|Overall Study||28||
59922206|NCT02509494|76041748|FG001|COMPLETED|Overall Study||217||
59922207|NCT02509494|76041749|FG002|COMPLETED|Overall Study||64||
59922208|NCT02509494|76041750|FG003|COMPLETED|Overall Study||132||
59922209|NCT02509494|76041751|FG004|COMPLETED|Overall Study||43||
59922210|NCT02509494|76041752|FG005|COMPLETED|Overall Study||133||
59922211|NCT02509494|76041753|FG006|COMPLETED|Overall Study||45||
59922212|NCT02509494|76041754|FG007|COMPLETED|Overall Study||137||
59922213|NCT02509494|76041755|FG008|COMPLETED|Overall Study||46||
59922214|NCT02509494|76041747|FG000|NOT COMPLETED|Overall Study||15||
59922215|NCT02509494|76041748|FG001|NOT COMPLETED|Overall Study||81||
59922216|NCT02509494|76041749|FG002|NOT COMPLETED|Overall Study||38||
59922217|NCT02509494|76041750|FG003|NOT COMPLETED|Overall Study||11||
59922218|NCT02509494|76041751|FG004|NOT COMPLETED|Overall Study||5||
59922219|NCT02509494|76041752|FG005|NOT COMPLETED|Overall Study||11||
59922220|NCT02509494|76041753|FG006|NOT COMPLETED|Overall Study||3||
59922221|NCT02509494|76041754|FG007|NOT COMPLETED|Overall Study||7||
59922222|NCT02509494|76041755|FG008|NOT COMPLETED|Overall Study||2||
60052724|NCT01634165|76168304|FG001|NOT COMPLETED|Period 4||0||
60052725|NCT01634165|76168305|FG002|NOT COMPLETED|Period 4||0||
60052726|NCT01634165|76168306|FG003|NOT COMPLETED|Period 4||0||
60052727|NCT02235311|76168318|FG000|STARTED|Overall Study||1||
60052728|NCT02235311|76168319|FG001|STARTED|Overall Study||2||
60052729|NCT02235311|76168318|FG000|COMPLETED|Overall Study||1||
60052730|NCT02235311|76168319|FG001|COMPLETED|Overall Study||0||
60052731|NCT02235311|76168318|FG000|NOT COMPLETED|Overall Study||0||
60052732|NCT02235311|76168319|FG001|NOT COMPLETED|Overall Study||2||
59612871|NCT01742286|75723906|FG005|NOT COMPLETED|Escalation Phase||5||
59922223|NCT03493451|76041792|FG000|STARTED|Overall Study||22||
59922224|NCT03493451|76041793|FG001|STARTED|Overall Study||44||
59922225|NCT03493451|76041794|FG002|STARTED|Overall Study||11||
59922226|NCT03493451|76041792|FG000|COMPLETED|Overall Study||0||
59922227|NCT03493451|76041793|FG001|COMPLETED|Overall Study||0||
59922228|NCT03493451|76041794|FG002|COMPLETED|Overall Study||0||
59922229|NCT03493451|76041792|FG000|NOT COMPLETED|Overall Study||22||
59922230|NCT03493451|76041793|FG001|NOT COMPLETED|Overall Study||44||
59612872|NCT01742286|75723907|FG006|NOT COMPLETED|Escalation Phase||6||
59612873|NCT01742286|75723901|FG000|STARTED|Expansion Phase||0||
59612874|NCT01742286|75723902|FG001|STARTED|Expansion Phase||0||
60052733|NCT02204579|76168325|FG000|STARTED|Overall Study||7||
60052734|NCT02204579|76168325|FG000|Participants Started in Pre-Amendment|Overall Study|Two participants completed treatment in pre-amendment and were re-enrolled in post-amendment.|2||
60067853|NCT01785615|76183054|FG002|COMPLETED|Dietary Phase||35||
59922231|NCT03493451|76041794|FG002|NOT COMPLETED|Overall Study||11||
59922232|NCT03492281|76041805|FG000|STARTED|Overall Study||540||
59922233|NCT03492281|76041806|FG001|STARTED|Overall Study||547||
59922234|NCT03492281|76041807|FG002|STARTED|Overall Study||431||
59922235|NCT03492281|76041805|FG000|COMPLETED|Overall Study||486||
59922236|NCT03492281|76041806|FG001|COMPLETED|Overall Study||502||
59922237|NCT03492281|76041807|FG002|COMPLETED|Overall Study||385||
59922238|NCT03492281|76041805|FG000|NOT COMPLETED|Overall Study||54||
59922239|NCT03492281|76041806|FG001|NOT COMPLETED|Overall Study||45||
60067854|NCT01785615|76183055|FG003|COMPLETED|Dietary Phase||116||
60052735|NCT02204579|76168325|FG000|Participants Started in Post-Amendment|Overall Study|Two participants from pre-amendment were re-enrolled with different identification numbers.|5||
60052736|NCT02204579|76168325|FG000|Treated|Overall Study||5||
60052737|NCT02204579|76168325|FG000|COMPLETED|Overall Study||5||
60052738|NCT02204579|76168325|FG000|NOT COMPLETED|Overall Study||2||
60052739|NCT02235077|76168336|FG000|STARTED|Overall Study||182||
60052740|NCT02235077|76168337|FG001|STARTED|Overall Study||178||
60052741|NCT02235077|76168336|FG000|COMPLETED|Overall Study||164||
60052742|NCT02235077|76168337|FG001|COMPLETED|Overall Study||159||
59922240|NCT03492281|76041807|FG002|NOT COMPLETED|Overall Study||46||
59922241|NCT03070782|76041824|FG000|STARTED|Overall Study||48||
59922242|NCT03070782|76041825|FG001|STARTED|Overall Study||48||
60052743|NCT02235077|76168336|FG000|NOT COMPLETED|Overall Study||18||
60052744|NCT02235077|76168337|FG001|NOT COMPLETED|Overall Study||19||
60052745|NCT02234141|76168347|FG000|STARTED|Treatment Period (24 Weeks)||39||
60052746|NCT02234141|76168348|FG001|STARTED|Treatment Period (24 Weeks)||38||
60052747|NCT02234141|76168349|FG002|STARTED|Treatment Period (24 Weeks)||37||
60052748|NCT02234141|76168350|FG003|STARTED|Treatment Period (24 Weeks)||37||
60052749|NCT02234141|76168351|FG004|STARTED|Treatment Period (24 Weeks)||0||
60052750|NCT02234141|76168352|FG005|STARTED|Treatment Period (24 Weeks)||0||
59922243|NCT03070782|76041826|FG002|STARTED|Overall Study||47||
59922244|NCT03070782|76041827|FG003|STARTED|Overall Study||48||
59922245|NCT03070782|76041828|FG004|STARTED|Overall Study||48||
60052751|NCT02234141|76168353|FG006|STARTED|Treatment Period (24 Weeks)||0||
59612875|NCT01742286|75723903|FG002|STARTED|Expansion Phase||7||
59612876|NCT01742286|75723904|FG003|STARTED|Expansion Phase||0||
59612877|NCT01742286|75723905|FG004|STARTED|Expansion Phase||0||
59612878|NCT01742286|75723906|FG005|STARTED|Expansion Phase||0||
59612879|NCT01742286|75723907|FG006|STARTED|Expansion Phase||36||
59612880|NCT01742286|75723901|FG000|End of Treatment = Not Ccompleted|Expansion Phase||0||
59612881|NCT01742286|75723902|FG001|End of Treatment = Not Ccompleted|Expansion Phase||0||
59612882|NCT01742286|75723903|FG002|End of Treatment = Not Ccompleted|Expansion Phase||7||
59612883|NCT01742286|75723904|FG003|End of Treatment = Not Ccompleted|Expansion Phase||0||
59922246|NCT03070782|76041829|FG005|STARTED|Overall Study||47||
59922247|NCT03070782|76041824|FG000|COMPLETED|Overall Study||41|Completed here refers to participants who completed study treatment.|
59922248|NCT03070782|76041825|FG001|COMPLETED|Overall Study||47|Completed here refers to participants who completed study treatment.|
59922249|NCT03070782|76041826|FG002|COMPLETED|Overall Study||43|Completed here refers to participants who completed study treatment.|
59922250|NCT03070782|76041827|FG003|COMPLETED|Overall Study||43|Completed here refers to participants who completed study treatment.|
59922251|NCT03070782|76041828|FG004|COMPLETED|Overall Study||36|Completed here refers to participants who completed study treatment.|
59922252|NCT03070782|76041829|FG005|COMPLETED|Overall Study||40|Completed here refers to participants who completed study treatment.|
60052752|NCT02234141|76168347|FG000|COMPLETED|Treatment Period (24 Weeks)||35||
60052753|NCT02234141|76168348|FG001|COMPLETED|Treatment Period (24 Weeks)||32||
60052754|NCT02234141|76168349|FG002|COMPLETED|Treatment Period (24 Weeks)||35||
59612884|NCT01742286|75723905|FG004|End of Treatment = Not Ccompleted|Expansion Phase||0||
59922253|NCT03070782|76041824|FG000|NOT COMPLETED|Overall Study||7||
59922254|NCT03070782|76041825|FG001|NOT COMPLETED|Overall Study||1||
59922255|NCT03070782|76041826|FG002|NOT COMPLETED|Overall Study||4||
59922256|NCT03070782|76041827|FG003|NOT COMPLETED|Overall Study||5||
59922257|NCT03070782|76041828|FG004|NOT COMPLETED|Overall Study||12||
59922258|NCT03070782|76041829|FG005|NOT COMPLETED|Overall Study||7||
59922259|NCT03756688|76041847|FG000|STARTED|Overall Study||28||
59922260|NCT03756688|76041848|FG001|STARTED|Overall Study||28||
59922261|NCT03756688|76041849|FG002|STARTED|Overall Study||27||
59922262|NCT03756688|76041850|FG003|STARTED|Overall Study||27||
59922263|NCT03756688|76041847|FG000|COMPLETED|Overall Study||26||
59922264|NCT03756688|76041848|FG001|COMPLETED|Overall Study||17||
59922265|NCT03756688|76041849|FG002|COMPLETED|Overall Study||19||
60052755|NCT02234141|76168350|FG003|COMPLETED|Treatment Period (24 Weeks)||32||
60052756|NCT02234141|76168351|FG004|COMPLETED|Treatment Period (24 Weeks)||0||
60052757|NCT02234141|76168352|FG005|COMPLETED|Treatment Period (24 Weeks)||0||
60052758|NCT02234141|76168353|FG006|COMPLETED|Treatment Period (24 Weeks)||0||
60052759|NCT02234141|76168347|FG000|NOT COMPLETED|Treatment Period (24 Weeks)||4||
59612885|NCT01742286|75723906|FG005|End of Treatment = Not Ccompleted|Expansion Phase||0||
59612886|NCT01742286|75723907|FG006|End of Treatment = Not Ccompleted|Expansion Phase||36||
59612887|NCT01742286|75723901|FG000|COMPLETED|Expansion Phase||0||
59612888|NCT01742286|75723902|FG001|COMPLETED|Expansion Phase||0||
59612889|NCT01742286|75723903|FG002|COMPLETED|Expansion Phase||0||
59612890|NCT01742286|75723904|FG003|COMPLETED|Expansion Phase||0||
59612891|NCT01742286|75723905|FG004|COMPLETED|Expansion Phase||0||
59612892|NCT01742286|75723906|FG005|COMPLETED|Expansion Phase||0||
60052760|NCT02234141|76168348|FG001|NOT COMPLETED|Treatment Period (24 Weeks)||6||
59612893|NCT01742286|75723907|FG006|COMPLETED|Expansion Phase||0||
59612894|NCT01742286|75723901|FG000|NOT COMPLETED|Expansion Phase||0||
59612895|NCT01742286|75723902|FG001|NOT COMPLETED|Expansion Phase||0||
59922266|NCT03756688|76041850|FG003|COMPLETED|Overall Study||24||
60052761|NCT02234141|76168349|FG002|NOT COMPLETED|Treatment Period (24 Weeks)||2||
60052762|NCT02234141|76168350|FG003|NOT COMPLETED|Treatment Period (24 Weeks)||5||
60052763|NCT02234141|76168351|FG004|NOT COMPLETED|Treatment Period (24 Weeks)||0||
60052764|NCT02234141|76168352|FG005|NOT COMPLETED|Treatment Period (24 Weeks)||0||
60052765|NCT02234141|76168353|FG006|NOT COMPLETED|Treatment Period (24 Weeks)||0||
60052766|NCT02234141|76168347|FG000|STARTED|Long-Term Treatment Period|2 participants who completed Period 1 did not continue into the Long-Term Treatment Phase.|33||
60052767|NCT02234141|76168348|FG001|STARTED|Long-Term Treatment Period|1 participant who completed the Period 1 did not continue into the Long-Term Treatment Phase.|31||
60052768|NCT02234141|76168349|FG002|STARTED|Long-Term Treatment Period|2 participants who completed Period 1 did not continue into the Long-Term Treatment Phase.|33||
60052769|NCT02234141|76168350|FG003|STARTED|Long-Term Treatment Period|Participants were rerandomized to receive selonsertib during the Long-Term Treatment Phase.|0||
60052770|NCT02234141|76168351|FG004|STARTED|Long-Term Treatment Period|The Placebo group was rerandomized to receive selonsertib during the Long-Term Treatment Phase.|10||
60052771|NCT02234141|76168352|FG005|STARTED|Long-Term Treatment Period|The Placebo group was rerandomized to receive selonsertib during the Long-Term Treatment Phase.|12||
60052772|NCT02234141|76168353|FG006|STARTED|Long-Term Treatment Period|The Placebo group was rerandomized to receive selonsertib during the Long-Term Treatment Phase.|10||
60052773|NCT02234141|76168347|FG000|COMPLETED|Long-Term Treatment Period||0||
60052774|NCT02234141|76168348|FG001|COMPLETED|Long-Term Treatment Period||0||
60052775|NCT02234141|76168349|FG002|COMPLETED|Long-Term Treatment Period||0||
60052776|NCT02234141|76168350|FG003|COMPLETED|Long-Term Treatment Period||0||
60052777|NCT02234141|76168351|FG004|COMPLETED|Long-Term Treatment Period||0||
60052778|NCT02234141|76168352|FG005|COMPLETED|Long-Term Treatment Period||0||
60052779|NCT02234141|76168353|FG006|COMPLETED|Long-Term Treatment Period||0||
60052780|NCT02234141|76168347|FG000|NOT COMPLETED|Long-Term Treatment Period||33||
60052781|NCT02234141|76168348|FG001|NOT COMPLETED|Long-Term Treatment Period||31||
60052782|NCT02234141|76168349|FG002|NOT COMPLETED|Long-Term Treatment Period||33||
60052783|NCT02234141|76168350|FG003|NOT COMPLETED|Long-Term Treatment Period||0||
60052784|NCT02234141|76168351|FG004|NOT COMPLETED|Long-Term Treatment Period||10||
60052785|NCT02234141|76168352|FG005|NOT COMPLETED|Long-Term Treatment Period||12||
60052786|NCT02234141|76168353|FG006|NOT COMPLETED|Long-Term Treatment Period||10||
60052787|NCT02234063|76168366|FG000|STARTED|Overall Study||1795||
60052788|NCT02234063|76168367|FG001|STARTED|Overall Study||255||
60052789|NCT02234063|76168366|FG000|COMPLETED|Overall Study||1540||
60052790|NCT02234063|76168367|FG001|COMPLETED|Overall Study||212||
60052791|NCT02234063|76168366|FG000|NOT COMPLETED|Overall Study||255||
60052792|NCT02234063|76168367|FG001|NOT COMPLETED|Overall Study||43||
60052793|NCT02232893|76168380|FG000|STARTED|Overall Study||35||
60052794|NCT02232893|76168381|FG001|STARTED|Overall Study||34||
60052795|NCT02232893|76168380|FG000|Safety Population|Overall Study|Pts who rec'd at least 1 dose of study drug. All safety analyses performed using this population.|34||
60052796|NCT02232893|76168381|FG001|Safety Population|Overall Study|Pts who rec'd at least 1 dose of study drug. All safety analyses performed using this population.|32||
60052797|NCT02232893|76168380|FG000|Primary Endpoint Population|Overall Study|Patients who provided GIQLI scores both at baseline and Visit 4 were analyzed for primary endpoint|24||
60052798|NCT02232893|76168381|FG001|Primary Endpoint Population|Overall Study|Patients who provided GIQLI scores both at baseline and Visit 4 were analyzed for primary endpoint|19||
60052799|NCT02232893|76168380|FG000|COMPLETED|Overall Study||31||
60052800|NCT02232893|76168381|FG001|COMPLETED|Overall Study||27||
60052801|NCT02232893|76168380|FG000|NOT COMPLETED|Overall Study||4||
60052802|NCT02232893|76168381|FG001|NOT COMPLETED|Overall Study||7||
60052803|NCT02203721|76168389|FG000|STARTED|Overall Study||148||
60052804|NCT02203721|76168390|FG001|STARTED|Overall Study||151||
60052805|NCT02203721|76168389|FG000|COMPLETED|Overall Study||147||
60052806|NCT02203721|76168390|FG001|COMPLETED|Overall Study||148||
60052807|NCT02203721|76168389|FG000|NOT COMPLETED|Overall Study||1||
60052808|NCT02203721|76168390|FG001|NOT COMPLETED|Overall Study||3||
60052809|NCT01618695|76168400|FG000|STARTED|Core Phase||177||
60052810|NCT01618695|76168401|FG001|STARTED|Core Phase||176||
60052811|NCT01618695|76168402|FG002|STARTED|Core Phase||177||
60052812|NCT01618695|76168403|FG003|STARTED|Core Phase||180||
60052813|NCT01618695|76168400|FG000|Treated (Safety Analysis Set)|Core Phase||176||
60052814|NCT01618695|76168401|FG001|Treated (Safety Analysis Set)|Core Phase||176||
60052815|NCT01618695|76168402|FG002|Treated (Safety Analysis Set)|Core Phase||175||
60052816|NCT01618695|76168403|FG003|Treated (Safety Analysis Set)|Core Phase||180||
60052817|NCT01618695|76168400|FG000|COMPLETED|Core Phase||152||
60052818|NCT01618695|76168401|FG001|COMPLETED|Core Phase||156||
60052819|NCT01618695|76168402|FG002|COMPLETED|Core Phase||147||
60052820|NCT01618695|76168403|FG003|COMPLETED|Core Phase||144||
60052821|NCT01618695|76168400|FG000|NOT COMPLETED|Core Phase||25||
60052822|NCT01618695|76168401|FG001|NOT COMPLETED|Core Phase||20||
60052823|NCT01618695|76168402|FG002|NOT COMPLETED|Core Phase||30||
60052824|NCT01618695|76168403|FG003|NOT COMPLETED|Core Phase||36||
60052825|NCT01618695|76168400|FG000|STARTED|Extension Phase|Participants who completed Core Phase and gave consent, entered the Extension Phase.|151||
60052826|NCT01618695|76168401|FG001|STARTED|Extension Phase||156||
60052827|NCT01618695|76168402|FG002|STARTED|Extension Phase|Participants who completed Core Phase and gave consent, entered the Extension Phase.|146||
60052828|NCT01618695|76168403|FG003|STARTED|Extension Phase|Participants who completed Core Phase and gave consent, entered the Extension Phase.|143||
60052829|NCT01618695|76168400|FG000|COMPLETED|Extension Phase||56||
60052830|NCT01618695|76168401|FG001|COMPLETED|Extension Phase||40||
60052831|NCT01618695|76168402|FG002|COMPLETED|Extension Phase||54||
60052832|NCT01618695|76168403|FG003|COMPLETED|Extension Phase||46||
60052833|NCT01618695|76168400|FG000|NOT COMPLETED|Extension Phase||95||
60052834|NCT01618695|76168401|FG001|NOT COMPLETED|Extension Phase||116||
60052835|NCT01618695|76168402|FG002|NOT COMPLETED|Extension Phase||92||
60052836|NCT01618695|76168403|FG003|NOT COMPLETED|Extension Phase||97||
60052837|NCT01896531|76168416|FG000|STARTED|Overall Study||71||
60052838|NCT01896531|76168417|FG001|STARTED|Overall Study||82||
60052839|NCT01896531|76168416|FG000|Treated|Overall Study||70||
60052840|NCT01896531|76168417|FG001|Treated|Overall Study||82||
60052841|NCT01896531|76168416|FG000|COMPLETED|Overall Study||0||
60052842|NCT01896531|76168417|FG001|COMPLETED|Overall Study||0||
60052843|NCT01896531|76168416|FG000|NOT COMPLETED|Overall Study||71||
60052844|NCT01896531|76168417|FG001|NOT COMPLETED|Overall Study||82||
60052845|NCT01618305|76168425|FG000|STARTED|Overall Study||202||
60052846|NCT01618305|76168426|FG001|STARTED|Overall Study||206||
60052847|NCT01618305|76168425|FG000|COMPLETED|Overall Study||187||
60052848|NCT01618305|76168426|FG001|COMPLETED|Overall Study||196||
60052849|NCT01618305|76168425|FG000|NOT COMPLETED|Overall Study||15||
60052850|NCT01618305|76168426|FG001|NOT COMPLETED|Overall Study||10||
60052851|NCT01886313|76168438|FG000|STARTED|Overall Study||6||
60052852|NCT01886313|76168439|FG001|STARTED|Overall Study||5||
60052853|NCT01886313|76168438|FG000|COMPLETED|Overall Study||5||
60052854|NCT01886313|76168439|FG001|COMPLETED|Overall Study||4||
60052855|NCT01886313|76168438|FG000|NOT COMPLETED|Overall Study||1||
60052856|NCT01886313|76168439|FG001|NOT COMPLETED|Overall Study||1||
60052857|NCT01896297|76168445|FG000|STARTED|Overall Study||60||
60052858|NCT01896297|76168445|FG000|COMPLETED|Overall Study||59||
60052859|NCT01896297|76168445|FG000|NOT COMPLETED|Overall Study||1||
60052860|NCT01884675|76168451|FG000|STARTED|Overall Study||16||
60052861|NCT01884675|76168452|FG001|STARTED|Overall Study||17||
60052862|NCT01884675|76168451|FG000|COMPLETED|Overall Study||13||
60052863|NCT01884675|76168452|FG001|COMPLETED|Overall Study||15||
60052864|NCT01884675|76168451|FG000|NOT COMPLETED|Overall Study||3||
60052865|NCT01884675|76168452|FG001|NOT COMPLETED|Overall Study||2||
60052866|NCT01884597|76168463|FG000|STARTED|Overall Study||5||
60052867|NCT01884597|76168464|FG001|STARTED|Overall Study||3||
60052868|NCT01884597|76168465|FG002|STARTED|Overall Study||16||
60052869|NCT01884597|76168463|FG000|COMPLETED|Overall Study||4||
60052870|NCT01884597|76168464|FG001|COMPLETED|Overall Study||2||
60052871|NCT01884597|76168465|FG002|COMPLETED|Overall Study||15||
60052872|NCT01884597|76168463|FG000|NOT COMPLETED|Overall Study||1||
60052873|NCT01884597|76168464|FG001|NOT COMPLETED|Overall Study||1||
60052874|NCT01884597|76168465|FG002|NOT COMPLETED|Overall Study||1||
60052875|NCT01895361|76168482|FG000|STARTED|Overall Study||67||
60052876|NCT01895361|76168483|FG001|STARTED|Overall Study||66||
60052877|NCT01895361|76168484|FG002|STARTED|Overall Study||65||
60052878|NCT01895361|76168482|FG000|COMPLETED|Overall Study||43||
60052879|NCT01895361|76168483|FG001|COMPLETED|Overall Study||45||
60052880|NCT01895361|76168484|FG002|COMPLETED|Overall Study||41||
60052881|NCT01895361|76168482|FG000|NOT COMPLETED|Overall Study||24||
59922267|NCT03756688|76041847|FG000|NOT COMPLETED|Overall Study||2||
59922268|NCT03756688|76041848|FG001|NOT COMPLETED|Overall Study||11||
59922269|NCT03756688|76041849|FG002|NOT COMPLETED|Overall Study||8||
59922270|NCT03756688|76041850|FG003|NOT COMPLETED|Overall Study||3||
59922271|NCT03525119|76041865|FG000|STARTED|Overall Study||300||
59922272|NCT03525119|76041866|FG001|STARTED|Overall Study||300||
59922273|NCT03525119|76041867|FG002|STARTED|Overall Study||300||
59922274|NCT03525119|76041865|FG000|Safety Population|Overall Study||299|Received at Least 1 Vaccination with Investigational Products (IPs) i.e. HAV vaccine/placebo/TDV|
59922275|NCT03525119|76041866|FG001|Safety Population|Overall Study||300|Received at Least 1 Vaccination with Investigational Products (IPs) i.e. HAV vaccine/placebo/TDV|
60052882|NCT01895361|76168483|FG001|NOT COMPLETED|Overall Study||21||
60052883|NCT01895361|76168484|FG002|NOT COMPLETED|Overall Study||24||
60052884|NCT01883895|76168492|FG000|STARTED|Overall Study||34||
60052885|NCT01883895|76168492|FG000|COMPLETED|Overall Study||32||
59514108|NCT02958982|75607688|FG008|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0||
59922276|NCT03525119|76041867|FG002|Safety Population|Overall Study||298|Received at Least 1 Vaccination with Investigational Products (IPs) i.e. HAV vaccine/placebo/TDV|
59922277|NCT03525119|76041865|FG000|COMPLETED|Overall Study||260||
60052886|NCT01883895|76168492|FG000|NOT COMPLETED|Overall Study||2||
60052887|NCT01864005|76168498|FG000|STARTED|Overall Study||29||
60052888|NCT01864005|76168499|FG001|STARTED|Overall Study||31||
60052889|NCT01864005|76168498|FG000|COMPLETED|Overall Study||26||
60052890|NCT01864005|76168499|FG001|COMPLETED|Overall Study||25||
60052891|NCT01864005|76168498|FG000|NOT COMPLETED|Overall Study||3||
60052892|NCT01864005|76168499|FG001|NOT COMPLETED|Overall Study||6||
60052893|NCT01863849|76168507|FG000|STARTED|Overall Study||60||
60052894|NCT01863849|76168508|FG001|STARTED|Overall Study||60||
60052895|NCT01863849|76168507|FG000|COMPLETED|Overall Study||59||
60052896|NCT01863849|76168508|FG001|COMPLETED|Overall Study||60||
60052897|NCT01863849|76168507|FG000|NOT COMPLETED|Overall Study||1||
60052898|NCT01863849|76168508|FG001|NOT COMPLETED|Overall Study||0||
60052899|NCT01863771|76168515|FG000|STARTED|Induction Phase||144||
60052900|NCT01863771|76168516|FG001|STARTED|Induction Phase||0||
60052901|NCT01863771|76168517|FG002|STARTED|Induction Phase||0||
60052902|NCT01863771|76168518|FG003|STARTED|Induction Phase||0||
60052903|NCT01863771|76168515|FG000|COMPLETED|Induction Phase|Same participants who completed the induction phase participated in the maintenance phase.|123||
60052904|NCT01863771|76168516|FG001|COMPLETED|Induction Phase||0||
60052905|NCT01863771|76168517|FG002|COMPLETED|Induction Phase||0||
60052906|NCT01863771|76168518|FG003|COMPLETED|Induction Phase||0||
60052907|NCT01863771|76168515|FG000|NOT COMPLETED|Induction Phase||21||
59514109|NCT02958982|75607689|FG009|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0||
59514110|NCT02958982|75607690|FG010|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0||
59514111|NCT02958982|75607680|FG000|STARTED|Cohort 5: 400 mg in SAD Study||2||
59514112|NCT02958982|75607681|FG001|STARTED|Cohort 5: 400 mg in SAD Study||0||
59514113|NCT02958982|75607682|FG002|STARTED|Cohort 5: 400 mg in SAD Study||0||
59514114|NCT02958982|75607683|FG003|STARTED|Cohort 5: 400 mg in SAD Study||0||
59514115|NCT02958982|75607684|FG004|STARTED|Cohort 5: 400 mg in SAD Study||0||
59514116|NCT02958982|75607685|FG005|STARTED|Cohort 5: 400 mg in SAD Study||6||
59514117|NCT02958982|75607686|FG006|STARTED|Cohort 5: 400 mg in SAD Study||0||
59514118|NCT02958982|75607687|FG007|STARTED|Cohort 5: 400 mg in SAD Study||0||
59514119|NCT02958982|75607688|FG008|STARTED|Cohort 5: 400 mg in SAD Study||0||
59514120|NCT02958982|75607689|FG009|STARTED|Cohort 5: 400 mg in SAD Study||0||
59514121|NCT02958982|75607690|FG010|STARTED|Cohort 5: 400 mg in SAD Study||0||
59514122|NCT02958982|75607680|FG000|COMPLETED|Cohort 5: 400 mg in SAD Study||2||
59514123|NCT02958982|75607681|FG001|COMPLETED|Cohort 5: 400 mg in SAD Study||0||
59514124|NCT02958982|75607682|FG002|COMPLETED|Cohort 5: 400 mg in SAD Study||0||
59514125|NCT02958982|75607683|FG003|COMPLETED|Cohort 5: 400 mg in SAD Study||0||
59514126|NCT02958982|75607684|FG004|COMPLETED|Cohort 5: 400 mg in SAD Study||0||
59514127|NCT02958982|75607685|FG005|COMPLETED|Cohort 5: 400 mg in SAD Study||6||
59514128|NCT02958982|75607686|FG006|COMPLETED|Cohort 5: 400 mg in SAD Study||0||
59514129|NCT02958982|75607687|FG007|COMPLETED|Cohort 5: 400 mg in SAD Study||0||
59514130|NCT02958982|75607688|FG008|COMPLETED|Cohort 5: 400 mg in SAD Study||0||
60052908|NCT01863771|76168516|FG001|NOT COMPLETED|Induction Phase||0||
60052909|NCT01863771|76168517|FG002|NOT COMPLETED|Induction Phase||0||
60052910|NCT01863771|76168518|FG003|NOT COMPLETED|Induction Phase||0||
60052911|NCT01863771|76168515|FG000|STARTED|Maintenance Phase||0||
60052912|NCT01863771|76168516|FG001|STARTED|Maintenance Phase||32||
60052913|NCT01863771|76168517|FG002|STARTED|Maintenance Phase||31||
60052914|NCT01863771|76168518|FG003|STARTED|Maintenance Phase||60||
60052915|NCT01863771|76168515|FG000|COMPLETED|Maintenance Phase||0||
60052916|NCT01863771|76168516|FG001|COMPLETED|Maintenance Phase||27||
60052917|NCT01863771|76168517|FG002|COMPLETED|Maintenance Phase||19||
60052918|NCT01863771|76168518|FG003|COMPLETED|Maintenance Phase||17||
60052919|NCT01863771|76168515|FG000|NOT COMPLETED|Maintenance Phase||0||
60052920|NCT01863771|76168516|FG001|NOT COMPLETED|Maintenance Phase||5||
60052921|NCT01863771|76168517|FG002|NOT COMPLETED|Maintenance Phase||12||
60052922|NCT01863771|76168518|FG003|NOT COMPLETED|Maintenance Phase||43||
59514131|NCT02958982|75607689|FG009|COMPLETED|Cohort 5: 400 mg in SAD Study||0||
59514132|NCT02958982|75607690|FG010|COMPLETED|Cohort 5: 400 mg in SAD Study||0||
59514133|NCT02958982|75607680|FG000|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0||
59514134|NCT02958982|75607681|FG001|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0||
59514135|NCT02958982|75607682|FG002|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0||
59514136|NCT02958982|75607683|FG003|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0||
59514137|NCT02958982|75607684|FG004|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0||
59514138|NCT02958982|75607685|FG005|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0||
59514139|NCT02958982|75607686|FG006|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0||
59514140|NCT02958982|75607687|FG007|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0||
59514141|NCT02958982|75607688|FG008|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0||
59514142|NCT02958982|75607689|FG009|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0||
59514143|NCT02958982|75607690|FG010|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0||
59514144|NCT02958982|75607680|FG000|STARTED|Cohort 1 : 25 mg in MAD Study||0||
59514145|NCT02958982|75607681|FG001|STARTED|Cohort 1 : 25 mg in MAD Study||0||
59514146|NCT02958982|75607682|FG002|STARTED|Cohort 1 : 25 mg in MAD Study||0||
59514147|NCT02958982|75607683|FG003|STARTED|Cohort 1 : 25 mg in MAD Study||0||
59514148|NCT02958982|75607684|FG004|STARTED|Cohort 1 : 25 mg in MAD Study||0||
59514149|NCT02958982|75607685|FG005|STARTED|Cohort 1 : 25 mg in MAD Study||0||
59514150|NCT02958982|75607686|FG006|STARTED|Cohort 1 : 25 mg in MAD Study||2||
59514151|NCT02958982|75607687|FG007|STARTED|Cohort 1 : 25 mg in MAD Study||6||
59514152|NCT02958982|75607688|FG008|STARTED|Cohort 1 : 25 mg in MAD Study||0||
59514153|NCT02958982|75607689|FG009|STARTED|Cohort 1 : 25 mg in MAD Study||0||
60052923|NCT01894581|76168528|FG000|STARTED|Overall Study||20||
60052924|NCT01894581|76168529|FG001|STARTED|Overall Study||19||
60052925|NCT01894581|76168528|FG000|COMPLETED|Overall Study||15||
60052926|NCT01894581|76168529|FG001|COMPLETED|Overall Study||12||
60052927|NCT01894581|76168528|FG000|NOT COMPLETED|Overall Study||5||
60052928|NCT01894581|76168529|FG001|NOT COMPLETED|Overall Study||7||
60052929|NCT01893411|76168538|FG000|STARTED|Overall Study||156||
60052930|NCT01893411|76168539|FG001|STARTED|Overall Study||77||
60052931|NCT01893411|76168540|FG002|STARTED|Overall Study||78||
60052932|NCT01893411|76168538|FG000|COMPLETED|Overall Study||139||
59514154|NCT02958982|75607690|FG010|STARTED|Cohort 1 : 25 mg in MAD Study||0||
59514155|NCT02958982|75607680|FG000|COMPLETED|Cohort 1 : 25 mg in MAD Study||0||
59514156|NCT02958982|75607681|FG001|COMPLETED|Cohort 1 : 25 mg in MAD Study||0||
59514157|NCT02958982|75607682|FG002|COMPLETED|Cohort 1 : 25 mg in MAD Study||0||
59514158|NCT02958982|75607683|FG003|COMPLETED|Cohort 1 : 25 mg in MAD Study||0||
59514159|NCT02958982|75607684|FG004|COMPLETED|Cohort 1 : 25 mg in MAD Study||0||
59514160|NCT02958982|75607685|FG005|COMPLETED|Cohort 1 : 25 mg in MAD Study||0||
59514161|NCT02958982|75607686|FG006|COMPLETED|Cohort 1 : 25 mg in MAD Study||2||
59514162|NCT02958982|75607687|FG007|COMPLETED|Cohort 1 : 25 mg in MAD Study||6||
59514163|NCT02958982|75607688|FG008|COMPLETED|Cohort 1 : 25 mg in MAD Study||0||
59514164|NCT02958982|75607689|FG009|COMPLETED|Cohort 1 : 25 mg in MAD Study||0||
59514165|NCT02958982|75607690|FG010|COMPLETED|Cohort 1 : 25 mg in MAD Study||0||
59514166|NCT02958982|75607680|FG000|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0||
59514167|NCT02958982|75607681|FG001|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0||
59514168|NCT02958982|75607682|FG002|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0||
59514169|NCT02958982|75607683|FG003|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0||
59514170|NCT02958982|75607684|FG004|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0||
59514171|NCT02958982|75607685|FG005|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0||
59514172|NCT02958982|75607686|FG006|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0||
59514173|NCT02958982|75607687|FG007|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0||
59514174|NCT02958982|75607688|FG008|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0||
59922278|NCT03525119|76041866|FG001|COMPLETED|Overall Study||261||
59922279|NCT03525119|76041867|FG002|COMPLETED|Overall Study||257||
59922280|NCT03525119|76041865|FG000|NOT COMPLETED|Overall Study||40||
59922281|NCT03525119|76041866|FG001|NOT COMPLETED|Overall Study||39||
59514175|NCT02958982|75607689|FG009|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0||
59514176|NCT02958982|75607690|FG010|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0||
59514177|NCT02958982|75607680|FG000|STARTED|Cohort 2: 100 mg in MAD Study||0||
59514178|NCT02958982|75607681|FG001|STARTED|Cohort 2: 100 mg in MAD Study||0||
59514179|NCT02958982|75607682|FG002|STARTED|Cohort 2: 100 mg in MAD Study||0||
59514180|NCT02958982|75607683|FG003|STARTED|Cohort 2: 100 mg in MAD Study||0||
59514181|NCT02958982|75607684|FG004|STARTED|Cohort 2: 100 mg in MAD Study||0||
59922282|NCT03525119|76041867|FG002|NOT COMPLETED|Overall Study||43||
59922283|NCT03558503|76041875|FG000|STARTED|Overall Study||63||
59922284|NCT03558503|76041875|FG000|COMPLETED|Overall Study||60||
59922285|NCT03558503|76041875|FG000|NOT COMPLETED|Overall Study||3||
59922286|NCT03489863|76041881|FG000|STARTED|Overall Study||7||
59922287|NCT03489863|76041882|FG001|STARTED|Overall Study||7||
59922288|NCT03489863|76041881|FG000|COMPLETED|Overall Study||7||
59922289|NCT03489863|76041882|FG001|COMPLETED|Overall Study||6||
59922290|NCT03489863|76041881|FG000|NOT COMPLETED|Overall Study||0||
59922291|NCT03489863|76041882|FG001|NOT COMPLETED|Overall Study||1||
59922292|NCT03489551|76041888|FG000|STARTED|Overall Study||17||
59922293|NCT03489551|76041888|FG000|COMPLETED|Overall Study||15||
59514182|NCT02958982|75607685|FG005|STARTED|Cohort 2: 100 mg in MAD Study||0||
59514183|NCT02958982|75607686|FG006|STARTED|Cohort 2: 100 mg in MAD Study||2||
59514184|NCT02958982|75607687|FG007|STARTED|Cohort 2: 100 mg in MAD Study||0||
59514185|NCT02958982|75607688|FG008|STARTED|Cohort 2: 100 mg in MAD Study||6||
59514186|NCT02958982|75607689|FG009|STARTED|Cohort 2: 100 mg in MAD Study||0||
59514187|NCT02958982|75607690|FG010|STARTED|Cohort 2: 100 mg in MAD Study||0||
59514188|NCT02958982|75607680|FG000|COMPLETED|Cohort 2: 100 mg in MAD Study||0||
59514189|NCT02958982|75607681|FG001|COMPLETED|Cohort 2: 100 mg in MAD Study||0||
59514190|NCT02958982|75607682|FG002|COMPLETED|Cohort 2: 100 mg in MAD Study||0||
59514191|NCT02958982|75607683|FG003|COMPLETED|Cohort 2: 100 mg in MAD Study||0||
59514192|NCT02958982|75607684|FG004|COMPLETED|Cohort 2: 100 mg in MAD Study||0||
59514193|NCT02958982|75607685|FG005|COMPLETED|Cohort 2: 100 mg in MAD Study||0||
59514194|NCT02958982|75607686|FG006|COMPLETED|Cohort 2: 100 mg in MAD Study||2||
59514195|NCT02958982|75607687|FG007|COMPLETED|Cohort 2: 100 mg in MAD Study||0||
59514196|NCT02958982|75607688|FG008|COMPLETED|Cohort 2: 100 mg in MAD Study||6||
59514197|NCT02958982|75607689|FG009|COMPLETED|Cohort 2: 100 mg in MAD Study||0||
59514198|NCT02958982|75607690|FG010|COMPLETED|Cohort 2: 100 mg in MAD Study||0||
59514199|NCT02958982|75607680|FG000|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0||
59514200|NCT02958982|75607681|FG001|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0||
59514201|NCT02958982|75607682|FG002|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0||
59519040|NCT03398278|75612889|FG000|NOT COMPLETED|Period 1||1||
59922294|NCT03489551|76041888|FG000|NOT COMPLETED|Overall Study||2||
59922295|NCT03557801|76041895|FG000|STARTED|Overall Study||34||
59514202|NCT02958982|75607683|FG003|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0||
59514203|NCT02958982|75607684|FG004|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0||
59514204|NCT02958982|75607685|FG005|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0||
59514205|NCT02958982|75607686|FG006|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0||
59514206|NCT02958982|75607687|FG007|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0||
59514207|NCT02958982|75607688|FG008|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0||
59514208|NCT02958982|75607689|FG009|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0||
59514209|NCT02958982|75607690|FG010|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0||
59514210|NCT02958982|75607680|FG000|STARTED|Cohort 3: 400 mg in MAD Study||0||
59514211|NCT02958982|75607681|FG001|STARTED|Cohort 3: 400 mg in MAD Study||0||
59514212|NCT02958982|75607682|FG002|STARTED|Cohort 3: 400 mg in MAD Study||0||
59514213|NCT02958982|75607683|FG003|STARTED|Cohort 3: 400 mg in MAD Study||0||
59514214|NCT02958982|75607684|FG004|STARTED|Cohort 3: 400 mg in MAD Study||0||
59514215|NCT02958982|75607685|FG005|STARTED|Cohort 3: 400 mg in MAD Study||0||
59514216|NCT02958982|75607686|FG006|STARTED|Cohort 3: 400 mg in MAD Study||2||
59514217|NCT02958982|75607687|FG007|STARTED|Cohort 3: 400 mg in MAD Study||0||
59514218|NCT02958982|75607688|FG008|STARTED|Cohort 3: 400 mg in MAD Study||0||
59514219|NCT02958982|75607689|FG009|STARTED|Cohort 3: 400 mg in MAD Study||6||
59514220|NCT02958982|75607690|FG010|STARTED|Cohort 3: 400 mg in MAD Study||0||
59514221|NCT02958982|75607680|FG000|COMPLETED|Cohort 3: 400 mg in MAD Study||0||
59514222|NCT02958982|75607681|FG001|COMPLETED|Cohort 3: 400 mg in MAD Study||0||
59514223|NCT02958982|75607682|FG002|COMPLETED|Cohort 3: 400 mg in MAD Study||0||
59514224|NCT02958982|75607683|FG003|COMPLETED|Cohort 3: 400 mg in MAD Study||0||
59514225|NCT02958982|75607684|FG004|COMPLETED|Cohort 3: 400 mg in MAD Study||0||
59760518|NCT02840721|75880138|FG000|STARTED|Treatment Period||50||
59760519|NCT02840721|75880138|FG000|COMPLETED|Treatment Period||49||
59760520|NCT02840721|75880138|FG000|NOT COMPLETED|Treatment Period||1||
59760521|NCT02840721|75880138|FG000|STARTED|Follow-Up||49||
59760522|NCT02840721|75880138|FG000|COMPLETED|Follow-Up||42||
59760523|NCT02840721|75880138|FG000|NOT COMPLETED|Follow-Up||7||
59760524|NCT02777593|75880147|FG000|STARTED|Overall Study|One participant excluded from results analysis as pre-specified due to a major I/E violation (i.e. drug abuse), n=84 for analysis.|85||
59760525|NCT02777593|75880148|FG001|STARTED|Overall Study||136||
59760526|NCT02777593|75880149|FG002|STARTED|Overall Study|One participant excluded from results analysis as pre-specified (i.e. per FDA request for enrollment into the wrong cohort), n=9 for analysis.|10||
59760527|NCT02777593|75880150|FG003|STARTED|Overall Study||13||
59760528|NCT02777593|75880151|FG004|STARTED|Overall Study||6||
59760529|NCT02777593|75880147|FG000|COMPLETED|Overall Study||23||
59760530|NCT02777593|75880148|FG001|COMPLETED|Overall Study||24||
59760531|NCT02777593|75880149|FG002|COMPLETED|Overall Study||0||
59760532|NCT02777593|75880150|FG003|COMPLETED|Overall Study||1||
59760533|NCT02777593|75880151|FG004|COMPLETED|Overall Study||0||
59760534|NCT02777593|75880147|FG000|NOT COMPLETED|Overall Study||62||
59760535|NCT02777593|75880148|FG001|NOT COMPLETED|Overall Study||112||
59760536|NCT02777593|75880149|FG002|NOT COMPLETED|Overall Study||10||
59760537|NCT02777593|75880150|FG003|NOT COMPLETED|Overall Study||12||
59760538|NCT02777593|75880151|FG004|NOT COMPLETED|Overall Study||6||
59760539|NCT02701283|75880166|FG000|STARTED|Overall Study||737||
59760540|NCT02701283|75880167|FG001|STARTED|Overall Study||741||
59760541|NCT02701283|75880168|FG002|STARTED|Overall Study||745||
59760542|NCT02701283|75880166|FG000|As Treated (Attempted Implant)|Overall Study||730|"Randomized Controlled Trial - The As Treated set includes 4 subjects that crossed over from the Medtronic TAVR Systems arm to the SAVR arm, which accounts for 727 subjects in the Implanted set for the Medtronic TAVR Systems arm.~The As Treated set includes 1 subject that crossed over from the SAVR arm to the Medtronic TAVR Systems arm, and 1 subject that was not implanted, which accounts for 686 subjects in the Implanted set for the SAVR arm."|
59922296|NCT03557801|76041896|FG001|STARTED|Overall Study||33||
59922297|NCT03557801|76041897|FG002|STARTED|Overall Study||33||
59922298|NCT03557801|76041895|FG000|COMPLETED|Overall Study||32||
59922299|NCT03557801|76041896|FG001|COMPLETED|Overall Study||32||
59922300|NCT03557801|76041897|FG002|COMPLETED|Overall Study||30||
59922301|NCT03557801|76041895|FG000|NOT COMPLETED|Overall Study||2||
59922302|NCT03557801|76041896|FG001|NOT COMPLETED|Overall Study||1||
59922303|NCT03557801|76041897|FG002|NOT COMPLETED|Overall Study||3||
59922304|NCT04210180|76041905|FG000|STARTED|Overall Study||25||
59514226|NCT02958982|75607685|FG005|COMPLETED|Cohort 3: 400 mg in MAD Study||0||
59514227|NCT02958982|75607686|FG006|COMPLETED|Cohort 3: 400 mg in MAD Study||2||
59514228|NCT02958982|75607687|FG007|COMPLETED|Cohort 3: 400 mg in MAD Study||0||
59514229|NCT02958982|75607688|FG008|COMPLETED|Cohort 3: 400 mg in MAD Study||0||
59514230|NCT02958982|75607689|FG009|COMPLETED|Cohort 3: 400 mg in MAD Study||6||
59514231|NCT02958982|75607690|FG010|COMPLETED|Cohort 3: 400 mg in MAD Study||0||
59514232|NCT02958982|75607680|FG000|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0||
59514233|NCT02958982|75607681|FG001|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0||
59514234|NCT02958982|75607682|FG002|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0||
59514235|NCT02958982|75607683|FG003|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0||
59514236|NCT02958982|75607684|FG004|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0||
59514237|NCT02958982|75607685|FG005|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0||
59514238|NCT02958982|75607686|FG006|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0||
59760543|NCT02701283|75880167|FG001|As Treated (Attempted Implant)|Overall Study||684|"Randomized Controlled Trial - The As Treated set includes 4 subjects that crossed over from the Medtronic TAVR Systems arm to the SAVR arm, which accounts for 727 subjects in the Implanted set for the Medtronic TAVR Systems arm.~The As Treated set includes 1 subject that crossed over from the SAVR arm to the Medtronic TAVR Systems arm, and 1 subject that was not implanted, which accounts for 686 subjects in the Implanted set for the SAVR arm."|
59762613|NCT00866307|75882445|FG002|STARTED|Consolidation/Maintenance||30||
59762614|NCT00866307|75882443|FG000|COMPLETED|Consolidation/Maintenance||0||
59514239|NCT02958982|75607687|FG007|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0||
59514240|NCT02958982|75607688|FG008|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0||
59514241|NCT02958982|75607689|FG009|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0||
59514242|NCT02958982|75607690|FG010|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0||
59514243|NCT02958982|75607680|FG000|STARTED|Proof of Concept Study||0||
59514244|NCT02958982|75607681|FG001|STARTED|Proof of Concept Study||0||
59514245|NCT02958982|75607682|FG002|STARTED|Proof of Concept Study||0||
59514246|NCT02958982|75607683|FG003|STARTED|Proof of Concept Study||0||
59514247|NCT02958982|75607684|FG004|STARTED|Proof of Concept Study||0||
59514248|NCT02958982|75607685|FG005|STARTED|Proof of Concept Study||0||
59514249|NCT02958982|75607686|FG006|STARTED|Proof of Concept Study||0||
59514250|NCT02958982|75607687|FG007|STARTED|Proof of Concept Study||0||
59514251|NCT02958982|75607688|FG008|STARTED|Proof of Concept Study||0||
59514252|NCT02958982|75607689|FG009|STARTED|Proof of Concept Study||0||
59514253|NCT02958982|75607690|FG010|STARTED|Proof of Concept Study||1||
59514254|NCT02958982|75607680|FG000|COMPLETED|Proof of Concept Study||0||
59514255|NCT02958982|75607681|FG001|COMPLETED|Proof of Concept Study||0||
59514256|NCT02958982|75607682|FG002|COMPLETED|Proof of Concept Study||0||
59514257|NCT02958982|75607683|FG003|COMPLETED|Proof of Concept Study||0||
59514258|NCT02958982|75607684|FG004|COMPLETED|Proof of Concept Study||0||
59514259|NCT02958982|75607685|FG005|COMPLETED|Proof of Concept Study||0||
59514260|NCT02958982|75607686|FG006|COMPLETED|Proof of Concept Study||0||
59514261|NCT02958982|75607687|FG007|COMPLETED|Proof of Concept Study||0||
59514262|NCT02958982|75607688|FG008|COMPLETED|Proof of Concept Study||0||
59514263|NCT02958982|75607689|FG009|COMPLETED|Proof of Concept Study||0||
59514264|NCT02958982|75607690|FG010|COMPLETED|Proof of Concept Study||1||
59514265|NCT02958982|75607680|FG000|NOT COMPLETED|Proof of Concept Study||0||
59514266|NCT02958982|75607681|FG001|NOT COMPLETED|Proof of Concept Study||0||
59514267|NCT02958982|75607682|FG002|NOT COMPLETED|Proof of Concept Study||0||
59514268|NCT02958982|75607683|FG003|NOT COMPLETED|Proof of Concept Study||0||
59514269|NCT02958982|75607684|FG004|NOT COMPLETED|Proof of Concept Study||0||
59514270|NCT02958982|75607685|FG005|NOT COMPLETED|Proof of Concept Study||0||
59514271|NCT02958982|75607686|FG006|NOT COMPLETED|Proof of Concept Study||0||
59514272|NCT02958982|75607687|FG007|NOT COMPLETED|Proof of Concept Study||0||
59514273|NCT02958982|75607688|FG008|NOT COMPLETED|Proof of Concept Study||0||
59514274|NCT02958982|75607689|FG009|NOT COMPLETED|Proof of Concept Study||0||
59514275|NCT02958982|75607690|FG010|NOT COMPLETED|Proof of Concept Study||0||
59514276|NCT02157623|75607723|FG000|STARTED|Overall Study|3 patients, each received red light on half of body and blue light on the contralateral side.|3||
59514277|NCT02157623|75607723|FG000|COMPLETED|Overall Study||3||
59514278|NCT02157623|75607723|FG000|NOT COMPLETED|Overall Study||0||
59514279|NCT03028324|75607733|FG000|STARTED|Overall Study||4||
59514280|NCT03028324|75607733|FG000|COMPLETED|Overall Study||4||
59514281|NCT03028324|75607733|FG000|NOT COMPLETED|Overall Study||0||
59514282|NCT00952081|75607737|FG000|STARTED|Overall Study||22||
59514283|NCT00952081|75607737|FG000|COMPLETED|Overall Study||22||
59514284|NCT00952081|75607737|FG000|NOT COMPLETED|Overall Study||0||
59514285|NCT02959840|75607744|FG000|STARTED|Overall Study||60||
59514286|NCT02959840|75607745|FG001|STARTED|Overall Study||60||
59514287|NCT02959840|75607746|FG002|STARTED|Overall Study||60||
59514288|NCT02959840|75607744|FG000|COMPLETED|Overall Study||60||
59514289|NCT02959840|75607745|FG001|COMPLETED|Overall Study||60||
59514290|NCT02959840|75607746|FG002|COMPLETED|Overall Study||60||
59514291|NCT02959840|75607744|FG000|NOT COMPLETED|Overall Study||0||
59514292|NCT02959840|75607745|FG001|NOT COMPLETED|Overall Study||0||
59514293|NCT02959840|75607746|FG002|NOT COMPLETED|Overall Study||0||
59514294|NCT00929357|75607756|FG000|STARTED|Overall Study||92||
59514295|NCT00929357|75607757|FG001|STARTED|Overall Study||64||
59514296|NCT00929357|75607756|FG000|COMPLETED|Overall Study||92||
59514297|NCT00929357|75607757|FG001|COMPLETED|Overall Study||64||
59514298|NCT00929357|75607756|FG000|NOT COMPLETED|Overall Study||0||
59514299|NCT00929357|75607757|FG001|NOT COMPLETED|Overall Study||0||
59514300|NCT00961051|75607765|FG000|STARTED|Overall Study||177||
59514301|NCT00961051|75607766|FG001|STARTED|Overall Study||93||
59514302|NCT00961051|75607765|FG000|COMPLETED|Overall Study||165||
59514303|NCT00961051|75607766|FG001|COMPLETED|Overall Study||79||
59514304|NCT00961051|75607765|FG000|NOT COMPLETED|Overall Study||12||
59514305|NCT00961051|75607766|FG001|NOT COMPLETED|Overall Study||14||
59514306|NCT02959996|75607774|FG000|STARTED|Overall Study||40||
59514307|NCT02959996|75607775|FG001|STARTED|Overall Study||39||
59514308|NCT02959996|75607774|FG000|COMPLETED|Overall Study||40||
59514309|NCT02959996|75607775|FG001|COMPLETED|Overall Study||39||
59514310|NCT02959996|75607774|FG000|NOT COMPLETED|Overall Study||0||
59514311|NCT02959996|75607775|FG001|NOT COMPLETED|Overall Study||0||
59514312|NCT00929981|75607781|FG000|STARTED|Overall Study||80||
59514313|NCT00929981|75607781|FG000|COMPLETED|Overall Study||80||
59514314|NCT00929981|75607781|FG000|NOT COMPLETED|Overall Study||0||
59514315|NCT00961441|75607787|FG000|STARTED|Overall Study||12||
59514316|NCT00961441|75607788|FG001|STARTED|Overall Study||13||
59514317|NCT00961441|75607787|FG000|Pharmacokinetic (PK-PP) Population|Overall Study||12||
59514318|NCT00961441|75607788|FG001|Pharmacokinetic (PK-PP) Population|Overall Study|Two subjects were excluded due to study medication noncompliance, one due to wrong dosing regimen.|10||
59514319|NCT00961441|75607787|FG000|COMPLETED|Overall Study||12||
59514320|NCT00961441|75607788|FG001|COMPLETED|Overall Study||13||
59514321|NCT00961441|75607787|FG000|NOT COMPLETED|Overall Study||0||
59514322|NCT00961441|75607788|FG001|NOT COMPLETED|Overall Study||0||
59514323|NCT02961946|75607797|FG000|STARTED|Overall Study||66||
59514324|NCT02961946|75607798|FG001|STARTED|Overall Study||66||
59514325|NCT02961946|75607799|FG002|STARTED|Overall Study||66||
59514326|NCT02961946|75607797|FG000|COMPLETED|Overall Study||66||
59514327|NCT02961946|75607798|FG001|COMPLETED|Overall Study||66||
59514328|NCT02961946|75607799|FG002|COMPLETED|Overall Study||66||
59514329|NCT02961946|75607797|FG000|NOT COMPLETED|Overall Study||0||
59514330|NCT02961946|75607798|FG001|NOT COMPLETED|Overall Study||0||
59514331|NCT02961946|75607799|FG002|NOT COMPLETED|Overall Study||0||
59514332|NCT02846740|75607809|FG000|STARTED|Overall Study||15||
59514333|NCT02846740|75607810|FG001|STARTED|Overall Study||15||
59514334|NCT02846740|75607809|FG000|COMPLETED|Overall Study||15||
59514335|NCT02846740|75607810|FG001|COMPLETED|Overall Study||14||
59514336|NCT02846740|75607809|FG000|NOT COMPLETED|Overall Study||0||
59514337|NCT02846740|75607810|FG001|NOT COMPLETED|Overall Study||1||
59514338|NCT03028636|75607816|FG000|STARTED|Overall Study||17||
59514339|NCT03028636|75607816|FG000|COMPLETED|Overall Study||11||
59514340|NCT03028636|75607816|FG000|NOT COMPLETED|Overall Study||6||
59514341|NCT02848222|75607828|FG000|STARTED|Overall Study||25||
59514342|NCT02848222|75607829|FG001|STARTED|Overall Study||18||
59514343|NCT02848222|75607830|FG002|STARTED|Overall Study||17||
59514344|NCT02848222|75607828|FG000|COMPLETED|Overall Study||18||
59514345|NCT02848222|75607829|FG001|COMPLETED|Overall Study||17||
59514346|NCT02848222|75607830|FG002|COMPLETED|Overall Study||17||
59514347|NCT02848222|75607828|FG000|NOT COMPLETED|Overall Study||7||
59514348|NCT02848222|75607829|FG001|NOT COMPLETED|Overall Study||1||
59514349|NCT02848222|75607830|FG002|NOT COMPLETED|Overall Study||0||
59514350|NCT00962065|75607841|FG000|STARTED|Overall Study||12||
59514351|NCT00962065|75607842|FG001|STARTED|Overall Study||12||
59514352|NCT00962065|75607843|FG002|STARTED|Overall Study||12||
59514353|NCT00962065|75607841|FG000|COMPLETED|Overall Study||12||
59514354|NCT00962065|75607842|FG001|COMPLETED|Overall Study||12||
59514355|NCT00962065|75607843|FG002|COMPLETED|Overall Study||12||
59514356|NCT00962065|75607841|FG000|NOT COMPLETED|Overall Study||0||
59514357|NCT00962065|75607842|FG001|NOT COMPLETED|Overall Study||0||
59514358|NCT00962065|75607843|FG002|NOT COMPLETED|Overall Study||0||
59514359|NCT03038308|75607851|FG000|STARTED|Overall Study||15||
59514360|NCT03038308|75607851|FG000|COMPLETED|Overall Study||11||
59514361|NCT03038308|75607851|FG000|NOT COMPLETED|Overall Study||4||
59514362|NCT02849938|75607857|FG000|STARTED|Overall Study||9||
59514363|NCT02849938|75607858|FG001|STARTED|Overall Study||15||
59514364|NCT02849938|75607857|FG000|COMPLETED|Overall Study||9||
59514365|NCT02849938|75607858|FG001|COMPLETED|Overall Study||15||
59514366|NCT02849938|75607857|FG000|NOT COMPLETED|Overall Study||0||
59514367|NCT02849938|75607858|FG001|NOT COMPLETED|Overall Study||0||
59514368|NCT02851108|75607866|FG000|STARTED|Overall Study||50||
59514369|NCT02851108|75607867|FG001|STARTED|Overall Study||50||
59514370|NCT02851108|75607866|FG000|COMPLETED|Overall Study||42||
59514371|NCT02851108|75607867|FG001|COMPLETED|Overall Study||49||
59514372|NCT02851108|75607866|FG000|NOT COMPLETED|Overall Study||8||
59514373|NCT02851108|75607867|FG001|NOT COMPLETED|Overall Study||1||
59514374|NCT02854540|75607873|FG000|STARTED|Overall Study||13||
59514375|NCT02854540|75607873|FG000|COMPLETED|Overall Study||11||
59514376|NCT02854540|75607873|FG000|NOT COMPLETED|Overall Study||2||
59514377|NCT00930293|75607881|FG000|STARTED|Overall Study||24||
59514378|NCT00930293|75607882|FG001|STARTED|Overall Study||26||
59514379|NCT00930293|75607881|FG000|COMPLETED|Overall Study||17||
59514380|NCT00930293|75607882|FG001|COMPLETED|Overall Study||19||
59514381|NCT00930293|75607881|FG000|NOT COMPLETED|Overall Study||7||
59514382|NCT00930293|75607882|FG001|NOT COMPLETED|Overall Study||7||
59514383|NCT02855086|75607890|FG000|STARTED|Overall Study||2||
59514384|NCT02855086|75607891|FG001|STARTED|Overall Study||1||
59922305|NCT04210180|76041905|FG000|COMPLETED|Overall Study||23||
59922306|NCT04210180|76041905|FG000|NOT COMPLETED|Overall Study||2||
59922307|NCT03523871|76041909|FG000|STARTED|Overall Study||20||
59922308|NCT03523871|76041909|FG000|COMPLETED|Overall Study||19||
59922309|NCT03523871|76041909|FG000|NOT COMPLETED|Overall Study||1||
59922310|NCT03523715|76041915|FG000|STARTED|Overall Study||38||
59922311|NCT03523715|76041916|FG001|STARTED|Overall Study||39||
59922312|NCT03523715|76041915|FG000|COMPLETED|Overall Study||26||
59922313|NCT03523715|76041916|FG001|COMPLETED|Overall Study||23||
59922314|NCT03523715|76041915|FG000|NOT COMPLETED|Overall Study||12||
59922315|NCT03523715|76041916|FG001|NOT COMPLETED|Overall Study||16||
59922316|NCT03980730|76041924|FG000|STARTED|Overall Study||21||
59922317|NCT03980730|76041925|FG001|STARTED|Overall Study||22||
59922318|NCT03980730|76041924|FG000|COMPLETED|Overall Study||19||
59922319|NCT03980730|76041925|FG001|COMPLETED|Overall Study||18||
59922320|NCT03980730|76041924|FG000|NOT COMPLETED|Overall Study||2||
59922321|NCT03980730|76041925|FG001|NOT COMPLETED|Overall Study||4||
59922322|NCT03523091|76041933|FG000|STARTED|Overall Study||1||
59922323|NCT03523091|76041934|FG001|STARTED|Overall Study||5||
59922324|NCT03523091|76041933|FG000|COMPLETED|Overall Study||0||
59922325|NCT03523091|76041934|FG001|COMPLETED|Overall Study||1||
59922326|NCT03523091|76041933|FG000|NOT COMPLETED|Overall Study||1||
59922327|NCT03523091|76041934|FG001|NOT COMPLETED|Overall Study||4||
59922328|NCT02512510|76041943|FG000|STARTED|Overall Study||205||
59922329|NCT02512510|76041944|FG001|STARTED|Overall Study||197||
59922330|NCT02512510|76041945|FG002|STARTED|Overall Study||209||
59922331|NCT02512510|76041943|FG000|COMPLETED|Overall Study||163||
59922332|NCT02512510|76041944|FG001|COMPLETED|Overall Study||162||
59922333|NCT02512510|76041945|FG002|COMPLETED|Overall Study||157||
59922334|NCT02512510|76041943|FG000|NOT COMPLETED|Overall Study||42||
59922335|NCT02512510|76041944|FG001|NOT COMPLETED|Overall Study||35||
59922336|NCT02512510|76041945|FG002|NOT COMPLETED|Overall Study||52||
59922337|NCT03438383|76041955|FG000|STARTED|Overall Study||23||
59922338|NCT03438383|76041956|FG001|STARTED|Overall Study||24||
59922339|NCT03438383|76041955|FG000|COMPLETED|Overall Study||14||
59922340|NCT03438383|76041956|FG001|COMPLETED|Overall Study||21||
59514385|NCT02855086|75607890|FG000|COMPLETED|Overall Study||2||
59514386|NCT02855086|75607891|FG001|COMPLETED|Overall Study||1||
59514387|NCT02855086|75607890|FG000|NOT COMPLETED|Overall Study||0||
59514388|NCT02855086|75607891|FG001|NOT COMPLETED|Overall Study||0||
59514389|NCT02856490|75607900|FG000|STARTED|Overall Study||2||
59514390|NCT02856490|75607901|FG001|STARTED|Overall Study||2||
59514391|NCT02856490|75607902|FG002|STARTED|Overall Study||2||
59514392|NCT02856490|75607900|FG000|COMPLETED|Overall Study||2||
59514393|NCT02856490|75607901|FG001|COMPLETED|Overall Study||2||
59514394|NCT02856490|75607902|FG002|COMPLETED|Overall Study||2||
59514395|NCT02856490|75607900|FG000|NOT COMPLETED|Overall Study||0||
59514396|NCT02856490|75607901|FG001|NOT COMPLETED|Overall Study||0||
59514397|NCT02856490|75607902|FG002|NOT COMPLETED|Overall Study||0||
59514398|NCT02963974|75607910|FG000|STARTED|Overall Study||20||
59514399|NCT02963974|75607910|FG000|COMPLETED|Overall Study||19||
59514400|NCT02963974|75607910|FG000|NOT COMPLETED|Overall Study||1||
59514401|NCT02964910|75607916|FG000|STARTED|Overall Study||235||
59514402|NCT02964910|75607917|FG001|STARTED|Overall Study||240||
59514403|NCT02964910|75607916|FG000|COMPLETED|Overall Study||192||
59514404|NCT02964910|75607917|FG001|COMPLETED|Overall Study||196||
59514405|NCT02964910|75607916|FG000|NOT COMPLETED|Overall Study||43||
59514406|NCT02964910|75607917|FG001|NOT COMPLETED|Overall Study||44||
59514407|NCT02156687|75607927|FG000|STARTED|Overall Study||30||
59514408|NCT02156687|75607928|FG001|STARTED|Overall Study||29||
59514409|NCT02156687|75607927|FG000|COMPLETED|Overall Study||20||
59514410|NCT02156687|75607928|FG001|COMPLETED|Overall Study||24||
59514411|NCT02156687|75607927|FG000|NOT COMPLETED|Overall Study||10||
59514412|NCT02156687|75607928|FG001|NOT COMPLETED|Overall Study||5||
59514413|NCT02965144|75607934|FG000|STARTED|Overall Study||13||
59514414|NCT02965144|75607934|FG000|COMPLETED|Overall Study||13||
59514415|NCT02965144|75607934|FG000|NOT COMPLETED|Overall Study||0||
59514416|NCT02965534|75607941|FG000|STARTED|Overall Study|test period: 14 days with each test glasses|45||
59514417|NCT02965534|75607942|FG001|STARTED|Overall Study|test period: 14 days with each test glasses|55||
59514418|NCT02965534|75607941|FG000|COMPLETED|Overall Study||45||
59514419|NCT02965534|75607942|FG001|COMPLETED|Overall Study||55||
59514420|NCT02965534|75607941|FG000|NOT COMPLETED|Overall Study||0||
59514421|NCT02965534|75607942|FG001|NOT COMPLETED|Overall Study||0||
59514422|NCT02965924|75607949|FG000|STARTED|Overall Study||20||
59514423|NCT02965924|75607949|FG000|COMPLETED|Overall Study||20||
59514424|NCT02965924|75607949|FG000|NOT COMPLETED|Overall Study||0||
59514425|NCT02967016|75607955|FG000|STARTED|Overall Study||25||
59514426|NCT02967016|75607956|FG001|STARTED|Overall Study||25||
59514427|NCT02967016|75607955|FG000|COMPLETED|Overall Study||25||
59514428|NCT02967016|75607956|FG001|COMPLETED|Overall Study||25||
59514429|NCT02967016|75607955|FG000|NOT COMPLETED|Overall Study||0||
59514430|NCT02967016|75607956|FG001|NOT COMPLETED|Overall Study||0||
59514431|NCT02968420|75607965|FG000|STARTED|Overall Study||6||
59514432|NCT02968420|75607966|FG001|STARTED|Overall Study||6||
59514433|NCT02968420|75607967|FG002|STARTED|Overall Study||6||
59514434|NCT02968420|75607965|FG000|COMPLETED|Overall Study||6||
59514435|NCT02968420|75607966|FG001|COMPLETED|Overall Study||6||
59514436|NCT02968420|75607967|FG002|COMPLETED|Overall Study||6||
59514437|NCT02968420|75607965|FG000|NOT COMPLETED|Overall Study||0||
59514438|NCT02968420|75607966|FG001|NOT COMPLETED|Overall Study||0||
59514439|NCT02968420|75607967|FG002|NOT COMPLETED|Overall Study||0||
59514440|NCT03039088|75607977|FG000|STARTED|Overall Study||192||
59514441|NCT03039088|75607978|FG001|STARTED|Overall Study||316||
59514442|NCT03039088|75607977|FG000|COMPLETED|Overall Study||192||
59514443|NCT03039088|75607978|FG001|COMPLETED|Overall Study||316||
59514444|NCT03039088|75607977|FG000|NOT COMPLETED|Overall Study||0||
59514445|NCT03039088|75607978|FG001|NOT COMPLETED|Overall Study||0||
59514446|NCT03040414|75607986|FG000|STARTED|Overall Study||57|Started Period 1|
59514447|NCT03040414|75607987|FG001|STARTED|Overall Study||56|Started Period 1|
59514448|NCT03040414|75607986|FG000|Completed Period 1|Overall Study||56||
59514449|NCT03040414|75607987|FG001|Completed Period 1|Overall Study||55||
59514450|NCT03040414|75607986|FG000|Started Period 2|Overall Study||56||
59514451|NCT03040414|75607987|FG001|Started Period 2|Overall Study||55||
59514452|NCT03040414|75607986|FG000|COMPLETED|Overall Study||56|Completed Period 2|
59514453|NCT03040414|75607987|FG001|COMPLETED|Overall Study||55|Completed Period 2|
59514454|NCT03040414|75607986|FG000|NOT COMPLETED|Overall Study||1||
59514455|NCT03040414|75607987|FG001|NOT COMPLETED|Overall Study||1||
59514456|NCT02863198|75607995|FG000|STARTED|Overall Study||60||
59514457|NCT02863198|75607996|FG001|STARTED|Overall Study||60||
59514458|NCT02863198|75607995|FG000|COMPLETED|Overall Study||60||
59514459|NCT02863198|75607996|FG001|COMPLETED|Overall Study||60||
59514460|NCT02863198|75607995|FG000|NOT COMPLETED|Overall Study||0||
59514461|NCT02863198|75607996|FG001|NOT COMPLETED|Overall Study||0||
59514462|NCT03040804|75608002|FG000|STARTED|Overall Study||2||
59514463|NCT03040804|75608002|FG000|COMPLETED|Overall Study||2||
59514464|NCT03040804|75608002|FG000|NOT COMPLETED|Overall Study||0||
59514465|NCT00963157|75608011|FG000|STARTED|Overall Study||156||
59514466|NCT00963157|75608012|FG001|STARTED|Overall Study||163||
59514467|NCT00963157|75608013|FG002|STARTED|Overall Study||160||
59514468|NCT00963157|75608014|FG003|STARTED|Overall Study||157||
59514469|NCT00963157|75608015|FG004|STARTED|Overall Study||153||
59514470|NCT00963157|75608011|FG000|COMPLETED|Overall Study||151||
59514471|NCT00963157|75608012|FG001|COMPLETED|Overall Study||159||
59514472|NCT00963157|75608013|FG002|COMPLETED|Overall Study||155||
59514473|NCT00963157|75608014|FG003|COMPLETED|Overall Study||150||
59514474|NCT00963157|75608015|FG004|COMPLETED|Overall Study||151||
59514475|NCT00963157|75608011|FG000|NOT COMPLETED|Overall Study||5||
59514476|NCT00963157|75608012|FG001|NOT COMPLETED|Overall Study||4||
59514477|NCT00963157|75608013|FG002|NOT COMPLETED|Overall Study||5||
59514478|NCT00963157|75608014|FG003|NOT COMPLETED|Overall Study||7||
59514479|NCT00963157|75608015|FG004|NOT COMPLETED|Overall Study||2||
59514480|NCT02972554|75608029|FG000|STARTED|Overall Study||44||
59514481|NCT02972554|75608030|FG001|STARTED|Overall Study||48||
59514482|NCT02972554|75608029|FG000|COMPLETED|Overall Study||44||
59514483|NCT02972554|75608030|FG001|COMPLETED|Overall Study||48||
59514484|NCT02972554|75608029|FG000|NOT COMPLETED|Overall Study||0||
59514485|NCT02972554|75608030|FG001|NOT COMPLETED|Overall Study||0||
59514486|NCT00921947|75608038|FG000|STARTED|Day 0||30||
59514487|NCT00921947|75608039|FG001|STARTED|Day 0||30||
59514488|NCT00921947|75608038|FG000|COMPLETED|Day 0||30||
59514489|NCT00921947|75608039|FG001|COMPLETED|Day 0||30||
59514490|NCT00921947|75608038|FG000|NOT COMPLETED|Day 0||0||
59514491|NCT00921947|75608039|FG001|NOT COMPLETED|Day 0||0||
59514492|NCT00921947|75608038|FG000|STARTED|Day 28|2 subjects were lost to follow-up and did not receive the 2nd vaccination of 1.0 ug i.m.|28||
59514493|NCT00921947|75608039|FG001|STARTED|Day 28||30||
59514494|NCT00921947|75608038|FG000|COMPLETED|Day 28||28||
59514495|NCT00921947|75608039|FG001|COMPLETED|Day 28||30||
59514496|NCT00921947|75608038|FG000|NOT COMPLETED|Day 28||0||
59514497|NCT00921947|75608039|FG001|NOT COMPLETED|Day 28||0||
59514498|NCT03041896|75608049|FG000|STARTED|Overall Study||1486||
59514499|NCT03041896|75608050|FG001|STARTED|Overall Study||1009||
59514500|NCT03041896|75608051|FG002|STARTED|Overall Study||2299||
59514501|NCT03041896|75608052|FG003|STARTED|Overall Study||256||
59514502|NCT03041896|75608049|FG000|COMPLETED|Overall Study||1486||
59514503|NCT03041896|75608050|FG001|COMPLETED|Overall Study||1009||
59514504|NCT03041896|75608051|FG002|COMPLETED|Overall Study||2236||
59514505|NCT03041896|75608052|FG003|COMPLETED|Overall Study||253||
59514506|NCT03041896|75608049|FG000|NOT COMPLETED|Overall Study||0||
59514507|NCT03041896|75608050|FG001|NOT COMPLETED|Overall Study||0||
59514508|NCT03041896|75608051|FG002|NOT COMPLETED|Overall Study||63||
59514509|NCT03041896|75608052|FG003|NOT COMPLETED|Overall Study||3||
59514510|NCT03043534|75608068|FG000|STARTED|Overall Study||15||
59514511|NCT03043534|75608069|FG001|STARTED|Overall Study||14||
59514512|NCT03043534|75608068|FG000|COMPLETED|Overall Study||15||
59514513|NCT03043534|75608069|FG001|COMPLETED|Overall Study||14||
59514514|NCT03043534|75608068|FG000|NOT COMPLETED|Overall Study||0||
59514515|NCT03043534|75608069|FG001|NOT COMPLETED|Overall Study||0||
59514516|NCT02979262|75608077|FG000|STARTED|Overall Study||33||
59514517|NCT02979262|75608078|FG001|STARTED|Overall Study||29||
59514518|NCT02979262|75608077|FG000|Received Allocated Intervention|Overall Study||30||
59514519|NCT02979262|75608078|FG001|Received Allocated Intervention|Overall Study||27||
59514520|NCT02979262|75608077|FG000|COMPLETED|Overall Study||21||
59514521|NCT02979262|75608078|FG001|COMPLETED|Overall Study||20||
59514522|NCT02979262|75608077|FG000|NOT COMPLETED|Overall Study||12||
59514523|NCT02979262|75608078|FG001|NOT COMPLETED|Overall Study||9||
59514524|NCT02980978|75608086|FG000|STARTED|Overall Study||60||
59514525|NCT02980978|75608087|FG001|STARTED|Overall Study||58||
59514526|NCT02980978|75608086|FG000|COMPLETED|Overall Study||54||
59514527|NCT02980978|75608087|FG001|COMPLETED|Overall Study||50||
59514528|NCT02980978|75608086|FG000|NOT COMPLETED|Overall Study||6||
59514529|NCT02980978|75608087|FG001|NOT COMPLETED|Overall Study||8||
59514530|NCT01005355|75608096|FG000|STARTED|Overall Study||3||
59514531|NCT01005355|75608097|FG001|STARTED|Overall Study||6||
59514532|NCT01005355|75608098|FG002|STARTED|Overall Study||6||
59514533|NCT01005355|75608096|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3||
59514534|NCT01005355|75608097|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6||
59514535|NCT01005355|75608098|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6||
59514536|NCT01005355|75608096|FG000|COMPLETED|Overall Study||3||
59514537|NCT01005355|75608097|FG001|COMPLETED|Overall Study||6||
59514538|NCT01005355|75608098|FG002|COMPLETED|Overall Study||6||
59514539|NCT01005355|75608096|FG000|NOT COMPLETED|Overall Study||0||
59514540|NCT01005355|75608097|FG001|NOT COMPLETED|Overall Study||0||
59514541|NCT01005355|75608098|FG002|NOT COMPLETED|Overall Study||0||
59514542|NCT02981368|75608111|FG000|STARTED|Overall Study||268||
59514543|NCT02981368|75608112|FG001|STARTED|Overall Study||117||
59514544|NCT02981368|75608111|FG000|COMPLETED|Overall Study||248||
59514545|NCT02981368|75608112|FG001|COMPLETED|Overall Study||102||
59514546|NCT02981368|75608111|FG000|NOT COMPLETED|Overall Study||20||
59762615|NCT00866307|75882444|FG001|COMPLETED|Consolidation/Maintenance||45||
59762616|NCT00866307|75882445|FG002|COMPLETED|Consolidation/Maintenance||14||
59514547|NCT02981368|75608112|FG001|NOT COMPLETED|Overall Study||15||
59514548|NCT00963859|75608145|FG000|STARTED|Overall Study||11||
59514549|NCT00963859|75608145|FG000|COMPLETED|Overall Study||11||
59514550|NCT00963859|75608145|FG000|NOT COMPLETED|Overall Study||0||
59514551|NCT02982928|75608149|FG000|STARTED|Overall Study||11||
59514552|NCT02982928|75608149|FG000|COMPLETED|Overall Study||11||
59514553|NCT02982928|75608149|FG000|NOT COMPLETED|Overall Study||0||
59514554|NCT00966433|75608156|FG000|STARTED|Overall Study||11||
59514555|NCT00966433|75608157|FG001|STARTED|Overall Study||11||
59514556|NCT00966433|75608158|FG002|STARTED|Overall Study||11||
59514557|NCT00966433|75608156|FG000|COMPLETED|Overall Study||10||
59514558|NCT00966433|75608157|FG001|COMPLETED|Overall Study||10||
59514559|NCT00966433|75608158|FG002|COMPLETED|Overall Study||11||
59514560|NCT00966433|75608156|FG000|NOT COMPLETED|Overall Study||1||
60052933|NCT01893411|76168539|FG001|COMPLETED|Overall Study||70||
60052934|NCT01893411|76168540|FG002|COMPLETED|Overall Study||69||
60052935|NCT01893411|76168538|FG000|NOT COMPLETED|Overall Study||17||
60052936|NCT01893411|76168539|FG001|NOT COMPLETED|Overall Study||7||
60052937|NCT01893411|76168540|FG002|NOT COMPLETED|Overall Study||9||
60052938|NCT02232425|76168550|FG000|STARTED|Overall Study||58||
60052939|NCT02232425|76168551|FG001|STARTED|Overall Study||30||
60052940|NCT02232425|76168550|FG000|COMPLETED|Overall Study||44||
60052941|NCT02232425|76168551|FG001|COMPLETED|Overall Study||22||
60052942|NCT02232425|76168550|FG000|NOT COMPLETED|Overall Study||14||
60052943|NCT02232425|76168551|FG001|NOT COMPLETED|Overall Study||8||
60052944|NCT01631435|76168557|FG000|STARTED|Overall Study||75||
60052945|NCT01631435|76168557|FG000|COMPLETED|Overall Study||66||
60052946|NCT01631435|76168557|FG000|NOT COMPLETED|Overall Study||9||
60052947|NCT02230085|76168562|FG000|STARTED|Overall Study||110||
60052948|NCT02230085|76168562|FG000|COMPLETED|Overall Study||106||
60052949|NCT02230085|76168562|FG000|NOT COMPLETED|Overall Study||4||
60052950|NCT02202785|76168569|FG000|STARTED|Overall Study||11||
60052951|NCT02202785|76168570|FG001|STARTED|Overall Study||15||
60052952|NCT02202785|76168571|FG002|STARTED|Overall Study||17||
60052953|NCT02202785|76168569|FG000|COMPLETED|Overall Study||0||
60052954|NCT02202785|76168570|FG001|COMPLETED|Overall Study||0||
60052955|NCT02202785|76168571|FG002|COMPLETED|Overall Study||0||
60052956|NCT02202785|76168569|FG000|NOT COMPLETED|Overall Study||11||
60052957|NCT02202785|76168570|FG001|NOT COMPLETED|Overall Study||15||
60052958|NCT02202785|76168571|FG002|NOT COMPLETED|Overall Study||17||
60052959|NCT01882647|76168581|FG000|STARTED|Overall Study||110||
60052960|NCT01882647|76168582|FG001|STARTED|Overall Study||112||
60052961|NCT01882647|76168581|FG000|COMPLETED|Overall Study||108||
60052962|NCT01882647|76168582|FG001|COMPLETED|Overall Study||106||
60052963|NCT01882647|76168581|FG000|NOT COMPLETED|Overall Study||2||
60052964|NCT01882647|76168582|FG001|NOT COMPLETED|Overall Study||6||
60052965|NCT01882257|76168591|FG000|STARTED|Study Origination to Beginning Therapy||11||
60052966|NCT01882257|76168592|FG001|STARTED|Study Origination to Beginning Therapy||40||
60052967|NCT01882257|76168593|FG002|STARTED|Study Origination to Beginning Therapy||23||
60052968|NCT01882257|76168591|FG000|Started Therapy Using Device|Study Origination to Beginning Therapy||11||
60052969|NCT01882257|76168592|FG001|Started Therapy Using Device|Study Origination to Beginning Therapy|Of the 40 who were given the device, 2 chose not to begin the actual therapy|38||
60052970|NCT01882257|76168593|FG002|Started Therapy Using Device|Study Origination to Beginning Therapy|Of the 23 who were given the device, 1 chose not to begin the actual therapy|22||
60052971|NCT01882257|76168591|FG000|COMPLETED|Study Origination to Beginning Therapy||11|Month 0 Visit Attended|
60052972|NCT01882257|76168592|FG001|COMPLETED|Study Origination to Beginning Therapy||38|Month 0 Visit Attended|
60052973|NCT01882257|76168593|FG002|COMPLETED|Study Origination to Beginning Therapy||22|Month 0 Visit Attended|
59762617|NCT00866307|75882443|FG000|NOT COMPLETED|Consolidation/Maintenance||0||
60052974|NCT01882257|76168591|FG000|NOT COMPLETED|Study Origination to Beginning Therapy||0||
60052975|NCT01882257|76168592|FG001|NOT COMPLETED|Study Origination to Beginning Therapy||2||
60052976|NCT01882257|76168593|FG002|NOT COMPLETED|Study Origination to Beginning Therapy||1||
60052977|NCT01882257|76168591|FG000|STARTED|Therapy Portion of Study (12 Months)||11||
59514561|NCT00966433|75608157|FG001|NOT COMPLETED|Overall Study||1||
59514562|NCT00966433|75608158|FG002|NOT COMPLETED|Overall Study||0||
59514563|NCT02983552|75608172|FG000|STARTED|Overall Study||69||
59514564|NCT02983552|75608173|FG001|STARTED|Overall Study||69||
59762681|NCT00857259|75882528|FG001|COMPLETED|Overall Study||1||
59514565|NCT02983552|75608174|FG002|STARTED|Overall Study||92||
59514566|NCT02983552|75608175|FG003|STARTED|Overall Study||90||
60052978|NCT01882257|76168592|FG001|STARTED|Therapy Portion of Study (12 Months)||38||
60052979|NCT01882257|76168593|FG002|STARTED|Therapy Portion of Study (12 Months)||22||
60052980|NCT01882257|76168591|FG000|COMPLETED|Therapy Portion of Study (12 Months)||11|Completed Study, Month 12 Final Visit|
60052981|NCT01882257|76168592|FG001|COMPLETED|Therapy Portion of Study (12 Months)||27|Completed Study, Month 12 Final Visit|
60052982|NCT01882257|76168593|FG002|COMPLETED|Therapy Portion of Study (12 Months)||18|Completed Study, Month 12 Final Visit|
60052983|NCT01882257|76168591|FG000|NOT COMPLETED|Therapy Portion of Study (12 Months)||0||
60052984|NCT01882257|76168592|FG001|NOT COMPLETED|Therapy Portion of Study (12 Months)||11||
60052985|NCT01882257|76168593|FG002|NOT COMPLETED|Therapy Portion of Study (12 Months)||4||
60052986|NCT01862991|76168603|FG000|STARTED|Overall Study||24||
60052987|NCT01862991|76168604|FG001|STARTED|Overall Study||28||
60052988|NCT01862991|76168605|FG002|STARTED|Overall Study||28||
60052989|NCT01862991|76168603|FG000|COMPLETED|Overall Study||21||
60052990|NCT01862991|76168604|FG001|COMPLETED|Overall Study||27||
60052991|NCT01862991|76168605|FG002|COMPLETED|Overall Study||27||
60052992|NCT01862991|76168603|FG000|NOT COMPLETED|Overall Study||3||
60052993|NCT01862991|76168604|FG001|NOT COMPLETED|Overall Study||1||
60052994|NCT01862991|76168605|FG002|NOT COMPLETED|Overall Study||1||
60052995|NCT02202551|76168617|FG000|STARTED|Overall Study||60||
60052996|NCT02202551|76168618|FG001|STARTED|Overall Study||78||
60052997|NCT02202551|76168619|FG002|STARTED|Overall Study||24||
60052998|NCT02202551|76168620|FG003|STARTED|Overall Study||61||
60052999|NCT02202551|76168617|FG000|COMPLETED|Overall Study||35||
60053000|NCT02202551|76168618|FG001|COMPLETED|Overall Study||41||
60053001|NCT02202551|76168619|FG002|COMPLETED|Overall Study||14||
60053002|NCT02202551|76168620|FG003|COMPLETED|Overall Study||39||
60053003|NCT02202551|76168617|FG000|NOT COMPLETED|Overall Study||25||
60053004|NCT02202551|76168618|FG001|NOT COMPLETED|Overall Study||37||
60053005|NCT02202551|76168619|FG002|NOT COMPLETED|Overall Study||10||
60053006|NCT02202551|76168620|FG003|NOT COMPLETED|Overall Study||22||
60053007|NCT02202317|76168634|FG000|STARTED|Overall Study||9||
60053008|NCT02202317|76168634|FG000|COMPLETED|Overall Study||8||
60053009|NCT02202317|76168634|FG000|NOT COMPLETED|Overall Study||1||
60053010|NCT02118337|76168647|FG000|STARTED|Overall Study||4||
60053011|NCT02118337|76168648|FG001|STARTED|Overall Study||5||
60053012|NCT02118337|76168649|FG002|STARTED|Overall Study||3||
60053013|NCT02118337|76168650|FG003|STARTED|Overall Study||3||
60053014|NCT02118337|76168651|FG004|STARTED|Overall Study||9||
60053015|NCT02118337|76168652|FG005|STARTED|Overall Study||6||
60053016|NCT02118337|76168653|FG006|STARTED|Overall Study||4||
59922341|NCT03438383|76041955|FG000|NOT COMPLETED|Overall Study||9||
59922342|NCT03438383|76041956|FG001|NOT COMPLETED|Overall Study||3||
59922343|NCT03478787|76041964|FG000|STARTED|Overall Study||163||
59922344|NCT03478787|76041965|FG001|STARTED|Overall Study||164||
59922345|NCT03478787|76041964|FG000|COMPLETED|Overall Study||134||
59922346|NCT03478787|76041965|FG001|COMPLETED|Overall Study||151||
59922347|NCT03478787|76041964|FG000|NOT COMPLETED|Overall Study||29||
59922348|NCT03478787|76041965|FG001|NOT COMPLETED|Overall Study||13||
59922349|NCT03488927|76041974|FG000|STARTED|Overall Study||305||
59922350|NCT03488927|76041975|FG001|STARTED|Overall Study||432||
59922351|NCT03488927|76041976|FG002|STARTED|Overall Study||531||
59922352|NCT03488927|76041974|FG000|COMPLETED|Overall Study||261||
59922353|NCT03488927|76041975|FG001|COMPLETED|Overall Study||314||
59922354|NCT03488927|76041976|FG002|COMPLETED|Overall Study||314||
59922355|NCT03488927|76041974|FG000|NOT COMPLETED|Overall Study||44||
59922356|NCT03488927|76041975|FG001|NOT COMPLETED|Overall Study||118||
59922357|NCT03488927|76041976|FG002|NOT COMPLETED|Overall Study||217||
59922358|NCT03437447|76041987|FG000|STARTED|Treatment Period 1||20||
59922359|NCT03437447|76041988|FG001|STARTED|Treatment Period 1||20||
59922360|NCT03437447|76041989|FG002|STARTED|Treatment Period 1||20||
59922361|NCT03437447|76041987|FG000|COMPLETED|Treatment Period 1||20||
59922362|NCT03437447|76041988|FG001|COMPLETED|Treatment Period 1||20||
59922363|NCT03437447|76041989|FG002|COMPLETED|Treatment Period 1||19||
59922364|NCT03437447|76041987|FG000|NOT COMPLETED|Treatment Period 1||0||
60053017|NCT02118337|76168654|FG007|STARTED|Overall Study||42||
60053018|NCT02118337|76168655|FG008|STARTED|Overall Study||21||
59922365|NCT03437447|76041988|FG001|NOT COMPLETED|Treatment Period 1||0||
59922366|NCT03437447|76041989|FG002|NOT COMPLETED|Treatment Period 1||1||
59922367|NCT03437447|76041987|FG000|STARTED|Treatment Period 2||20||
59922368|NCT03437447|76041988|FG001|STARTED|Treatment Period 2||20||
59922369|NCT03437447|76041989|FG002|STARTED|Treatment Period 2||19||
59922370|NCT03437447|76041987|FG000|COMPLETED|Treatment Period 2||20||
59922371|NCT03437447|76041988|FG001|COMPLETED|Treatment Period 2||20||
59922372|NCT03437447|76041989|FG002|COMPLETED|Treatment Period 2||19||
59922373|NCT03437447|76041987|FG000|NOT COMPLETED|Treatment Period 2||0||
59922374|NCT03437447|76041988|FG001|NOT COMPLETED|Treatment Period 2||0||
59922375|NCT03437447|76041989|FG002|NOT COMPLETED|Treatment Period 2||0||
59922376|NCT03437447|76041987|FG000|STARTED|Treatment Period 3||20||
59922377|NCT03437447|76041988|FG001|STARTED|Treatment Period 3||20||
59922378|NCT03437447|76041989|FG002|STARTED|Treatment Period 3||19||
59922379|NCT03437447|76041987|FG000|COMPLETED|Treatment Period 3||20||
59922380|NCT03437447|76041988|FG001|COMPLETED|Treatment Period 3||20||
59922381|NCT03437447|76041989|FG002|COMPLETED|Treatment Period 3||19||
59922382|NCT03437447|76041987|FG000|NOT COMPLETED|Treatment Period 3||0||
60053019|NCT02118337|76168647|FG000|COMPLETED|Overall Study||0||
59922383|NCT03437447|76041988|FG001|NOT COMPLETED|Treatment Period 3||0||
60053020|NCT02118337|76168648|FG001|COMPLETED|Overall Study||0||
59514567|NCT02983552|75608172|FG000|4 Week Visit|Overall Study||69||
59922384|NCT03437447|76041989|FG002|NOT COMPLETED|Treatment Period 3||0||
59922385|NCT02459080|76042000|FG000|STARTED|Overall Study||212||
59922386|NCT02459080|76042001|FG001|STARTED|Overall Study||198||
59922387|NCT02459080|76042002|FG002|STARTED|Overall Study||209||
59922388|NCT02459080|76042000|FG000|COMPLETED|Overall Study||168||
59922389|NCT02459080|76042001|FG001|COMPLETED|Overall Study||158||
59922390|NCT02459080|76042002|FG002|COMPLETED|Overall Study||151||
59922391|NCT02459080|76042000|FG000|NOT COMPLETED|Overall Study||44||
59922392|NCT02459080|76042001|FG001|NOT COMPLETED|Overall Study||40||
59922393|NCT02459080|76042002|FG002|NOT COMPLETED|Overall Study||58||
59922394|NCT03487445|76042012|FG000|STARTED|Randomization||25||
59922395|NCT03487445|76042013|FG001|STARTED|Randomization||23||
59922396|NCT03487445|76042012|FG000|COMPLETED|Randomization||24||
59922397|NCT03487445|76042013|FG001|COMPLETED|Randomization||23||
59922398|NCT03487445|76042012|FG000|NOT COMPLETED|Randomization||1||
59922399|NCT03487445|76042013|FG001|NOT COMPLETED|Randomization||0||
59922400|NCT03487445|76042012|FG000|STARTED|Treatment Period||24||
59922401|NCT03487445|76042013|FG001|STARTED|Treatment Period||23||
59922402|NCT03487445|76042012|FG000|Modified Full Analysis Set (mFAS)|Treatment Period||23|mFAS: all participants with a 30-min post dose VerifyNow® blood sample analysis.|
59922403|NCT03487445|76042013|FG001|Modified Full Analysis Set (mFAS)|Treatment Period||22|mFAS: all participants with a 30-min post dose VerifyNow® blood sample analysis.|
59922404|NCT03487445|76042012|FG000|Per Protocol Set|Treatment Period||20||
59922405|NCT03487445|76042013|FG001|Per Protocol Set|Treatment Period||20||
59922406|NCT03487445|76042012|FG000|COMPLETED|Treatment Period||24||
59922407|NCT03487445|76042013|FG001|COMPLETED|Treatment Period||23||
59922408|NCT03487445|76042012|FG000|NOT COMPLETED|Treatment Period||0||
59922409|NCT03487445|76042013|FG001|NOT COMPLETED|Treatment Period||0||
59922410|NCT02109172|76042019|FG000|STARTED|Overall Study||11||
59922411|NCT02109172|76042020|FG001|STARTED|Overall Study||11||
59922412|NCT02109172|76042021|FG002|STARTED|Overall Study||10||
59922413|NCT02109172|76042022|FG003|STARTED|Overall Study||11||
59922414|NCT02109172|76042023|FG004|STARTED|Overall Study||10||
59922415|NCT02109172|76042024|FG005|STARTED|Overall Study||11||
59922416|NCT02109172|76042019|FG000|COMPLETED|Overall Study||10||
59922417|NCT02109172|76042020|FG001|COMPLETED|Overall Study||11||
59922418|NCT02109172|76042021|FG002|COMPLETED|Overall Study||9||
59922419|NCT02109172|76042022|FG003|COMPLETED|Overall Study||10||
59922420|NCT02109172|76042023|FG004|COMPLETED|Overall Study||9||
59922421|NCT02109172|76042024|FG005|COMPLETED|Overall Study||10||
59922422|NCT02109172|76042019|FG000|NOT COMPLETED|Overall Study||1||
59922423|NCT02109172|76042020|FG001|NOT COMPLETED|Overall Study||0||
59922424|NCT02109172|76042021|FG002|NOT COMPLETED|Overall Study||1||
59922425|NCT02109172|76042022|FG003|NOT COMPLETED|Overall Study||1||
59922426|NCT02109172|76042023|FG004|NOT COMPLETED|Overall Study||1||
59922427|NCT02109172|76042024|FG005|NOT COMPLETED|Overall Study||1||
59922428|NCT02974868|76042035|FG000|STARTED|Initial 24-Week Treatment Period (TP)||24||
59922429|NCT02974868|76042036|FG001|STARTED|Initial 24-Week Treatment Period (TP)||23||
59922430|NCT02974868|76042037|FG002|STARTED|Initial 24-Week Treatment Period (TP)||48||
59922431|NCT02974868|76042038|FG003|STARTED|Initial 24-Week Treatment Period (TP)||47||
59922432|NCT02974868|76042035|FG000|COMPLETED|Initial 24-Week Treatment Period (TP)||20||
59922433|NCT02974868|76042036|FG001|COMPLETED|Initial 24-Week Treatment Period (TP)||14||
59922434|NCT02974868|76042037|FG002|COMPLETED|Initial 24-Week Treatment Period (TP)||45||
59922435|NCT02974868|76042038|FG003|COMPLETED|Initial 24-Week Treatment Period (TP)||35||
59922436|NCT02974868|76042035|FG000|NOT COMPLETED|Initial 24-Week Treatment Period (TP)||4||
59922437|NCT02974868|76042036|FG001|NOT COMPLETED|Initial 24-Week Treatment Period (TP)||9||
59922438|NCT02974868|76042037|FG002|NOT COMPLETED|Initial 24-Week Treatment Period (TP)||3||
59922439|NCT02974868|76042038|FG003|NOT COMPLETED|Initial 24-Week Treatment Period (TP)||12||
59922440|NCT02974868|76042035|FG000|STARTED|Single-Blind Extension (SBE) Period||17|Among 114 participants completed initial treatment period, 96 participants entered SBE period|
59922441|NCT02974868|76042036|FG001|STARTED|Single-Blind Extension (SBE) Period||12|Among 114 participants completed initial treatment period, 96 participants entered SBE period|
59922442|NCT02974868|76042037|FG002|STARTED|Single-Blind Extension (SBE) Period||38|Among 114 participants completed initial treatment period, 96 participants entered SBE period|
59922443|NCT02974868|76042038|FG003|STARTED|Single-Blind Extension (SBE) Period||29|Among 114 participants completed initial treatment period, 96 participants entered SBE period|
59922444|NCT02974868|76042035|FG000|COMPLETED|Single-Blind Extension (SBE) Period||15|Week 28-52 and additional 24 weeks(AT Day 1 -AT Week 24) for those retreated with active treatment|
59922445|NCT02974868|76042036|FG001|COMPLETED|Single-Blind Extension (SBE) Period||11|Week 28-52 and additional 24 weeks(AT Day 1 -AT Week 24) for those retreated with active treatment|
59922446|NCT02974868|76042037|FG002|COMPLETED|Single-Blind Extension (SBE) Period||27|Week 28-52 and additional 24 weeks(AT Day 1 -AT Week 24) for those retreated with active treatment|
60053021|NCT02118337|76168649|FG002|COMPLETED|Overall Study||0||
59922447|NCT02974868|76042038|FG003|COMPLETED|Single-Blind Extension (SBE) Period||23|Week 28-52 and additional 24 weeks(AT Day 1 -AT Week 24) for those retreated with active treatment|
59922448|NCT02974868|76042035|FG000|NOT COMPLETED|Single-Blind Extension (SBE) Period||2||
59922449|NCT02974868|76042036|FG001|NOT COMPLETED|Single-Blind Extension (SBE) Period||1||
59922450|NCT02974868|76042037|FG002|NOT COMPLETED|Single-Blind Extension (SBE) Period||11||
59922451|NCT02974868|76042038|FG003|NOT COMPLETED|Single-Blind Extension (SBE) Period||6||
59922452|NCT02974868|76042035|FG000|STARTED|Cross-Over Extension (COE) Period||7|Among 76 participants completed SBE period, 23 participants entered COE period.|
59922453|NCT02974868|76042036|FG001|STARTED|Cross-Over Extension (COE) Period||2|Among 76 participants completed SBE period, 23 participants entered COE period.|
59922454|NCT02974868|76042037|FG002|STARTED|Cross-Over Extension (COE) Period||11|Among 76 participants completed SBE period, 23 participants entered COE period.|
59922455|NCT02974868|76042038|FG003|STARTED|Cross-Over Extension (COE) Period||3|Among 76 participants completed SBE period, 23 participants entered COE period.|
59922456|NCT02974868|76042035|FG000|COMPLETED|Cross-Over Extension (COE) Period||5|Participants who were PF-06651600 non-responders at Week 52 received PF-06700841, vice versa.|
59922457|NCT02974868|76042036|FG001|COMPLETED|Cross-Over Extension (COE) Period||1|Participants who were PF-06651600 non-responders at Week 52 received PF-06700841, vice versa.|
59922458|NCT02974868|76042037|FG002|COMPLETED|Cross-Over Extension (COE) Period||8|Participants who were PF-06651600 non-responders at Week 52 received PF-06700841, vice versa.|
59922459|NCT02974868|76042038|FG003|COMPLETED|Cross-Over Extension (COE) Period||3|Participants who were PF-06651600 non-responders at Week 52 received PF-06700841, vice versa.|
59922460|NCT02974868|76042035|FG000|NOT COMPLETED|Cross-Over Extension (COE) Period||2||
59922461|NCT02974868|76042036|FG001|NOT COMPLETED|Cross-Over Extension (COE) Period||1||
59922462|NCT02974868|76042037|FG002|NOT COMPLETED|Cross-Over Extension (COE) Period||3||
59922463|NCT02974868|76042038|FG003|NOT COMPLETED|Cross-Over Extension (COE) Period||0||
59922464|NCT03486899|76042083|FG000|STARTED|Overall Study||49||
59922465|NCT03486899|76042084|FG001|STARTED|Overall Study||50||
59922466|NCT03486899|76042085|FG002|STARTED|Overall Study||49||
59922467|NCT03486899|76042086|FG003|STARTED|Overall Study||49||
59922468|NCT03486899|76042083|FG000|COMPLETED|Overall Study||41||
59922469|NCT03486899|76042084|FG001|COMPLETED|Overall Study||39||
59922470|NCT03486899|76042085|FG002|COMPLETED|Overall Study||41||
59922471|NCT03486899|76042086|FG003|COMPLETED|Overall Study||39||
59922472|NCT03486899|76042083|FG000|NOT COMPLETED|Overall Study||8||
59922473|NCT03486899|76042084|FG001|NOT COMPLETED|Overall Study||11||
59922474|NCT03486899|76042085|FG002|NOT COMPLETED|Overall Study||8||
59922475|NCT03486899|76042086|FG003|NOT COMPLETED|Overall Study||10||
59922476|NCT02918552|76042098|FG000|STARTED|Overall Study||7||
59922477|NCT02918552|76042099|FG001|STARTED|Overall Study||8||
59922478|NCT02918552|76042098|FG000|COMPLETED|Overall Study||6||
59922479|NCT02918552|76042099|FG001|COMPLETED|Overall Study||6||
59922480|NCT02918552|76042098|FG000|NOT COMPLETED|Overall Study||1||
59922481|NCT02918552|76042099|FG001|NOT COMPLETED|Overall Study||2||
59922482|NCT03485495|76042107|FG000|STARTED|Overall Study||65||
59922483|NCT03485495|76042108|FG001|STARTED|Overall Study||59||
59922484|NCT03485495|76042107|FG000|COMPLETED|Overall Study||64||
59922485|NCT03485495|76042108|FG001|COMPLETED|Overall Study||59||
59922486|NCT03485495|76042107|FG000|NOT COMPLETED|Overall Study||1||
59922487|NCT03485495|76042108|FG001|NOT COMPLETED|Overall Study||0||
59922488|NCT01065818|76042114|FG000|STARTED|Overall Study||6||
59922489|NCT01065818|76042114|FG000|COMPLETED|Overall Study||4||
59922490|NCT01065818|76042114|FG000|NOT COMPLETED|Overall Study||2||
59922491|NCT03483623|76042118|FG000|STARTED|Overall Study||44||
59922492|NCT03483623|76042118|FG000|Started NATO WELP|Overall Study||44||
59922493|NCT03483623|76042118|FG000|Completeded NATO WELP|Overall Study|1 subject was withdrawn after the target of 43 complete sets was achieved|43||
59922494|NCT03483623|76042118|FG000|Started NATO FIS|Overall Study||44||
59922495|NCT03483623|76042118|FG000|Completed NATO FIS|Overall Study|1 subject was withdrawn after the target of 43 complete sets was achieved|43||
59922496|NCT03483623|76042118|FG000|Started RAVEN WELP|Overall Study||44||
59922497|NCT03483623|76042118|FG000|Completed RAVEN WELP|Overall Study|1 subject was withdrawn after the target of 43 complete sets was achieved|43||
59922498|NCT03483623|76042118|FG000|Started RAVEN FIS|Overall Study||44||
59922499|NCT03483623|76042118|FG000|Completed RAVEN FIS|Overall Study|1 subject was withdrawn after the target of 43 complete sets was achieved|43||
59922500|NCT03483623|76042118|FG000|COMPLETED|Overall Study|1 subject was withdrawn after the target of 43 complete sets was achieved|43||
59922501|NCT03483623|76042118|FG000|NOT COMPLETED|Overall Study||1||
60053022|NCT02118337|76168650|FG003|COMPLETED|Overall Study||0||
60053023|NCT02118337|76168651|FG004|COMPLETED|Overall Study||0||
60053024|NCT02118337|76168652|FG005|COMPLETED|Overall Study||0||
59922502|NCT02318277|76042130|FG000|STARTED|Overall Study||6||
59922503|NCT02318277|76042131|FG001|STARTED|Overall Study||3||
59922504|NCT02318277|76042132|FG002|STARTED|Overall Study||4||
59922505|NCT02318277|76042133|FG003|STARTED|Overall Study||4||
59922506|NCT02318277|76042134|FG004|STARTED|Overall Study||8||
59922507|NCT02318277|76042135|FG005|STARTED|Overall Study||9||
60053025|NCT02118337|76168653|FG006|COMPLETED|Overall Study||0||
60053026|NCT02118337|76168654|FG007|COMPLETED|Overall Study||0||
60053027|NCT02118337|76168655|FG008|COMPLETED|Overall Study||0||
60053028|NCT02118337|76168647|FG000|NOT COMPLETED|Overall Study||4||
60053029|NCT02118337|76168648|FG001|NOT COMPLETED|Overall Study||5||
59514568|NCT02983552|75608173|FG001|4 Week Visit|Overall Study||67||
59514569|NCT02983552|75608174|FG002|4 Week Visit|Overall Study||85||
59514570|NCT02983552|75608175|FG003|4 Week Visit|Overall Study||84||
59514571|NCT02983552|75608172|FG000|8 Week Visit|Overall Study||67||
59514572|NCT02983552|75608173|FG001|8 Week Visit|Overall Study||68||
59514573|NCT02983552|75608174|FG002|8 Week Visit|Overall Study||85||
59514574|NCT02983552|75608175|FG003|8 Week Visit|Overall Study||84||
59514575|NCT02983552|75608172|FG000|16 Week Visit|Overall Study|The 16 week visit was elective for those who were originally assigned to continued spectacle correction. After completing 8 weeks of continued spectacle correction, participants were able to complete 8 weeks of binocular therapy. Values are not provided for the binocular computer game treatment cohorts as this visit was not applicable.|0|The 16 week visit was elective for those who were originally assigned to continued spectacle correction. After completing 8 weeks of continued spectacle correction, participants were able to complete 8 weeks of binocular therapy. Values are not provided for the binocular computer game treatment cohorts as this visit was not applicable.|
59514576|NCT02983552|75608173|FG001|16 Week Visit|Overall Study||66|The 16 week visit was elective for those who were originally assigned to continued spectacle correction. After completing 8 weeks of continued spectacle correction, participants were able to complete 8 weeks of binocular therapy. Values are not provided for the binocular computer game treatment cohorts as this visit was not applicable.|
59514577|NCT02983552|75608174|FG002|16 Week Visit|Overall Study|The 16 week visit was elective for those who were originally assigned to continued spectacle correction. After completing 8 weeks of continued spectacle correction, participants were able to complete 8 weeks of binocular therapy. Values are not provided for the binocular computer game treatment cohorts as this visit was not applicable.|0|The 16 week visit was elective for those who were originally assigned to continued spectacle correction. After completing 8 weeks of continued spectacle correction, participants were able to complete 8 weeks of binocular therapy. Values are not provided for the binocular computer game treatment cohorts as this visit was not applicable.|
59519041|NCT03398278|75612890|FG001|NOT COMPLETED|Period 1||0||
59519042|NCT03398278|75612889|FG000|STARTED|Period 2||18||
59519043|NCT03398278|75612890|FG001|STARTED|Period 2||19||
59612896|NCT01742286|75723903|FG002|NOT COMPLETED|Expansion Phase||7||
59612897|NCT01742286|75723904|FG003|NOT COMPLETED|Expansion Phase||0||
59612898|NCT01742286|75723905|FG004|NOT COMPLETED|Expansion Phase||0||
59612899|NCT01742286|75723906|FG005|NOT COMPLETED|Expansion Phase||0||
59612900|NCT01742286|75723907|FG006|NOT COMPLETED|Expansion Phase||36||
60053030|NCT02118337|76168649|FG002|NOT COMPLETED|Overall Study||3||
60053031|NCT02118337|76168650|FG003|NOT COMPLETED|Overall Study||3||
60053032|NCT02118337|76168651|FG004|NOT COMPLETED|Overall Study||9||
60053033|NCT02118337|76168652|FG005|NOT COMPLETED|Overall Study||6||
60053034|NCT02118337|76168653|FG006|NOT COMPLETED|Overall Study||4||
60053035|NCT02118337|76168654|FG007|NOT COMPLETED|Overall Study||42||
59922508|NCT02318277|76042136|FG006|STARTED|Overall Study||49||
60053036|NCT02118337|76168655|FG008|NOT COMPLETED|Overall Study||21||
60053037|NCT02117713|76168679|FG000|STARTED|Week 48||34||
60053038|NCT02117713|76168679|FG000|COMPLETED|Week 48||26||
60053039|NCT02117713|76168679|FG000|NOT COMPLETED|Week 48||8||
59612901|NCT01697358|75723932|FG000|STARTED|Period I: Randomization to 6 Months||110||
59612902|NCT01697358|75723933|FG001|STARTED|Period I: Randomization to 6 Months||108||
59612903|NCT01697358|75723932|FG000|COMPLETED|Period I: Randomization to 6 Months||97||
59612904|NCT01697358|75723933|FG001|COMPLETED|Period I: Randomization to 6 Months||107||
59612905|NCT01697358|75723932|FG000|NOT COMPLETED|Period I: Randomization to 6 Months||13||
59922509|NCT02318277|76042137|FG007|STARTED|Overall Study||93||
59922510|NCT02318277|76042130|FG000|COMPLETED|Overall Study||0||
59922511|NCT02318277|76042131|FG001|COMPLETED|Overall Study||0||
59922512|NCT02318277|76042132|FG002|COMPLETED|Overall Study||0||
59922513|NCT02318277|76042133|FG003|COMPLETED|Overall Study||0||
59922514|NCT02318277|76042134|FG004|COMPLETED|Overall Study||0||
59922515|NCT02318277|76042135|FG005|COMPLETED|Overall Study||0||
59922516|NCT02318277|76042136|FG006|COMPLETED|Overall Study||0||
59922517|NCT02318277|76042137|FG007|COMPLETED|Overall Study||0||
59922518|NCT02318277|76042130|FG000|NOT COMPLETED|Overall Study||6||
59922519|NCT02318277|76042131|FG001|NOT COMPLETED|Overall Study||3||
59922520|NCT02318277|76042132|FG002|NOT COMPLETED|Overall Study||4||
59922521|NCT02318277|76042133|FG003|NOT COMPLETED|Overall Study||4||
59922522|NCT02318277|76042134|FG004|NOT COMPLETED|Overall Study||8||
59922523|NCT02318277|76042135|FG005|NOT COMPLETED|Overall Study||9||
59922524|NCT02318277|76042136|FG006|NOT COMPLETED|Overall Study||49||
59922525|NCT02318277|76042137|FG007|NOT COMPLETED|Overall Study||93||
59922526|NCT03693742|76042171|FG000|STARTED|Overall Study||7||
59922527|NCT03693742|76042172|FG001|STARTED|Overall Study||3||
59922528|NCT03693742|76042171|FG000|COMPLETED|Overall Study||7||
59922529|NCT03693742|76042172|FG001|COMPLETED|Overall Study||3||
59922530|NCT03693742|76042171|FG000|NOT COMPLETED|Overall Study||0||
59922531|NCT03693742|76042172|FG001|NOT COMPLETED|Overall Study||0||
59922532|NCT01063868|76042182|FG000|STARTED|Overall Study||35||
59922533|NCT01063868|76042183|FG001|STARTED|Overall Study||12||
59922534|NCT01063868|76042182|FG000|COMPLETED|Overall Study||0||
59922535|NCT01063868|76042183|FG001|COMPLETED|Overall Study||0||
59922536|NCT01063868|76042182|FG000|NOT COMPLETED|Overall Study||35||
59922537|NCT01063868|76042183|FG001|NOT COMPLETED|Overall Study||12||
60053040|NCT02117713|76168679|FG000|STARTED|Long Term Follow-up Treatment||26||
60053041|NCT02117713|76168679|FG000|COMPLETED|Long Term Follow-up Treatment||20||
59922538|NCT02974088|76042191|FG000|STARTED|Overall Study||23||
59922539|NCT02974088|76042192|FG001|STARTED|Overall Study||24||
59922540|NCT02974088|76042191|FG000|COMPLETED|Overall Study||23||
59922541|NCT02974088|76042192|FG001|COMPLETED|Overall Study|Nurse left without notice and took CRFs and data for 2 subjects.|21||
59922542|NCT02974088|76042191|FG000|NOT COMPLETED|Overall Study||0||
59922543|NCT02974088|76042192|FG001|NOT COMPLETED|Overall Study||3||
59922544|NCT02385045|76042198|FG000|STARTED|Overall Study||157||
59922545|NCT02385045|76042198|FG000|COMPLETED|Overall Study|4 patients could not complete endoscopy as planned|153||
59922546|NCT02385045|76042198|FG000|NOT COMPLETED|Overall Study||4||
59922547|NCT02974010|76042206|FG000|STARTED|Overall Study||12||
59922548|NCT02974010|76042207|FG001|STARTED|Overall Study||5||
59922549|NCT02974010|76042208|FG002|STARTED|Overall Study||4||
59922550|NCT02974010|76042209|FG003|STARTED|Overall Study||1||
59922551|NCT02974010|76042206|FG000|COMPLETED|Overall Study||6||
59922552|NCT02974010|76042207|FG001|COMPLETED|Overall Study||2||
59922553|NCT02974010|76042208|FG002|COMPLETED|Overall Study||2||
59922554|NCT02974010|76042209|FG003|COMPLETED|Overall Study||1||
59922555|NCT02974010|76042206|FG000|NOT COMPLETED|Overall Study||6||
59922556|NCT02974010|76042207|FG001|NOT COMPLETED|Overall Study||3||
59922557|NCT02974010|76042208|FG002|NOT COMPLETED|Overall Study||2||
59922558|NCT02974010|76042209|FG003|NOT COMPLETED|Overall Study||0||
59922559|NCT02030938|76042219|FG000|STARTED|Overall Study||34||
59922560|NCT02030938|76042219|FG000|COMPLETED|Overall Study||29||
59922561|NCT02030938|76042219|FG000|NOT COMPLETED|Overall Study||5||
59922562|NCT03122535|76042227|FG000|STARTED|Overall Study||115||115
59922563|NCT03122535|76042228|FG001|STARTED|Overall Study||115||115
59922564|NCT03122535|76042227|FG000|3 Months|Overall Study||92||92
59922565|NCT03122535|76042228|FG001|3 Months|Overall Study||92||92
59922566|NCT03122535|76042227|FG000|12 Months|Overall Study||42||42
59922567|NCT03122535|76042228|FG001|12 Months|Overall Study||42||42
59922568|NCT03122535|76042227|FG000|COMPLETED|Overall Study||42||42
59922569|NCT03122535|76042228|FG001|COMPLETED|Overall Study||42||42
59922570|NCT03122535|76042227|FG000|NOT COMPLETED|Overall Study||73||73
59922571|NCT03122535|76042228|FG001|NOT COMPLETED|Overall Study||73||73
59922572|NCT01061606|76042234|FG000|STARTED|Overall Study||8||
59922573|NCT01061606|76042234|FG000|COMPLETED|Overall Study||0||
59922574|NCT01061606|76042234|FG000|NOT COMPLETED|Overall Study||8||
59922575|NCT03122457|76042238|FG000|STARTED|Overall Study||22||
59922576|NCT03122457|76042238|FG000|COMPLETED|Overall Study||16||
59922577|NCT03122457|76042238|FG000|NOT COMPLETED|Overall Study||6||
59922578|NCT03482453|76042254|FG000|STARTED|Part 1 (1 Day)||10||
59922579|NCT03482453|76042255|FG001|STARTED|Part 1 (1 Day)||6||
59922580|NCT03482453|76042256|FG002|STARTED|Part 1 (1 Day)||6||
59922581|NCT03482453|76042257|FG003|STARTED|Part 1 (1 Day)||6||
59922582|NCT03482453|76042258|FG004|STARTED|Part 1 (1 Day)||6||
59922583|NCT03482453|76042259|FG005|STARTED|Part 1 (1 Day)||6||
59922584|NCT03482453|76042260|FG006|STARTED|Part 1 (1 Day)||0||
59922585|NCT03482453|76042261|FG007|STARTED|Part 1 (1 Day)||0||
59922586|NCT03482453|76042262|FG008|STARTED|Part 1 (1 Day)||0||
59922587|NCT03482453|76042263|FG009|STARTED|Part 1 (1 Day)||0||
59922588|NCT03482453|76042264|FG010|STARTED|Part 1 (1 Day)||0||
59922589|NCT03482453|76042265|FG011|STARTED|Part 1 (1 Day)||0||
59922590|NCT03482453|76042254|FG000|COMPLETED|Part 1 (1 Day)||10||
59922591|NCT03482453|76042255|FG001|COMPLETED|Part 1 (1 Day)||6||
59922592|NCT03482453|76042256|FG002|COMPLETED|Part 1 (1 Day)||6||
59922593|NCT03482453|76042257|FG003|COMPLETED|Part 1 (1 Day)||6||
59922594|NCT03482453|76042258|FG004|COMPLETED|Part 1 (1 Day)||6||
59922595|NCT03482453|76042259|FG005|COMPLETED|Part 1 (1 Day)||6||
59922596|NCT03482453|76042260|FG006|COMPLETED|Part 1 (1 Day)||0||
59922597|NCT03482453|76042261|FG007|COMPLETED|Part 1 (1 Day)||0||
59922598|NCT03482453|76042262|FG008|COMPLETED|Part 1 (1 Day)||0||
59922599|NCT03482453|76042263|FG009|COMPLETED|Part 1 (1 Day)||0||
59922600|NCT03482453|76042264|FG010|COMPLETED|Part 1 (1 Day)||0||
59922601|NCT03482453|76042265|FG011|COMPLETED|Part 1 (1 Day)||0||
59922602|NCT03482453|76042254|FG000|NOT COMPLETED|Part 1 (1 Day)||0||
59922603|NCT03482453|76042255|FG001|NOT COMPLETED|Part 1 (1 Day)||0||
59922604|NCT03482453|76042256|FG002|NOT COMPLETED|Part 1 (1 Day)||0||
59922605|NCT03482453|76042257|FG003|NOT COMPLETED|Part 1 (1 Day)||0||
59922606|NCT03482453|76042258|FG004|NOT COMPLETED|Part 1 (1 Day)||0||
59922607|NCT03482453|76042259|FG005|NOT COMPLETED|Part 1 (1 Day)||0||
59922608|NCT03482453|76042260|FG006|NOT COMPLETED|Part 1 (1 Day)||0||
59922609|NCT03482453|76042261|FG007|NOT COMPLETED|Part 1 (1 Day)||0||
59922610|NCT03482453|76042262|FG008|NOT COMPLETED|Part 1 (1 Day)||0||
59922611|NCT03482453|76042263|FG009|NOT COMPLETED|Part 1 (1 Day)||0||
59922612|NCT03482453|76042264|FG010|NOT COMPLETED|Part 1 (1 Day)||0||
59922613|NCT03482453|76042265|FG011|NOT COMPLETED|Part 1 (1 Day)||0||
59922614|NCT03482453|76042254|FG000|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||0||
59922615|NCT03482453|76042255|FG001|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||0||
59922616|NCT03482453|76042256|FG002|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||0||
59922617|NCT03482453|76042257|FG003|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||0||
59922618|NCT03482453|76042258|FG004|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||0||
59922619|NCT03482453|76042259|FG005|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||0||
59922620|NCT03482453|76042260|FG006|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||3||
60053042|NCT02117713|76168679|FG000|NOT COMPLETED|Long Term Follow-up Treatment||6||
60053043|NCT02105467|76168693|FG000|STARTED|Period 1||316||
60053044|NCT02105467|76168694|FG001|STARTED|Period 1||105||
60053045|NCT02105467|76168693|FG000|COMPLETED|Period 1||314||
60053046|NCT02105467|76168694|FG001|COMPLETED|Period 1||105||
60053047|NCT02105467|76168693|FG000|NOT COMPLETED|Period 1||2||
60053048|NCT02105467|76168694|FG001|NOT COMPLETED|Period 1||0||
60053049|NCT02105467|76168693|FG000|STARTED|Period 2||314||
60053050|NCT02105467|76168694|FG001|STARTED|Period 2|One participant did not receive deferred treatment (Period 2) but proceeded directly to Period 3|104||
60053051|NCT02105467|76168693|FG000|COMPLETED|Period 2||312||
60053052|NCT02105467|76168694|FG001|COMPLETED|Period 2||102||
60053053|NCT02105467|76168693|FG000|NOT COMPLETED|Period 2||2||
60053054|NCT02105467|76168694|FG001|NOT COMPLETED|Period 2||2||
60053055|NCT02105467|76168693|FG000|STARTED|Period 3|The Immediate Treatment Group completed the study with Period 2|0||
60053056|NCT02105467|76168694|FG001|STARTED|Period 3|One participant did not receive deferred treatment (Period 2) but proceeded directly to Period 3|103||
60053057|NCT02105467|76168693|FG000|COMPLETED|Period 3||0||
60053058|NCT02105467|76168694|FG001|COMPLETED|Period 3||102||
60053059|NCT02105467|76168693|FG000|NOT COMPLETED|Period 3||0||
60053060|NCT02105467|76168694|FG001|NOT COMPLETED|Period 3||1||
60053061|NCT02202161|76168709|FG000|STARTED|Overall Study||13||
60053062|NCT02202161|76168710|FG001|STARTED|Overall Study||5||
60053063|NCT02202161|76168711|FG002|STARTED|Overall Study||5||
60053064|NCT02202161|76168712|FG003|STARTED|Overall Study||9||
60053065|NCT02202161|76168713|FG004|STARTED|Overall Study||9||
60053066|NCT02202161|76168714|FG005|STARTED|Overall Study||10||
60053067|NCT02202161|76168715|FG006|STARTED|Overall Study||13||
60053068|NCT02202161|76168716|FG007|STARTED|Overall Study||6||
60053069|NCT02202161|76168709|FG000|COMPLETED|Overall Study||12||
60053070|NCT02202161|76168710|FG001|COMPLETED|Overall Study||4||
60053071|NCT02202161|76168711|FG002|COMPLETED|Overall Study||5||
60053072|NCT02202161|76168712|FG003|COMPLETED|Overall Study||9||
60053073|NCT02202161|76168713|FG004|COMPLETED|Overall Study||8||
60053074|NCT02202161|76168714|FG005|COMPLETED|Overall Study||9||
60053075|NCT02202161|76168715|FG006|COMPLETED|Overall Study||13||
60053076|NCT02202161|76168716|FG007|COMPLETED|Overall Study||0||
60053077|NCT02202161|76168709|FG000|NOT COMPLETED|Overall Study||1||
60053078|NCT02202161|76168710|FG001|NOT COMPLETED|Overall Study||1||
60053079|NCT02202161|76168711|FG002|NOT COMPLETED|Overall Study||0||
60053080|NCT02202161|76168712|FG003|NOT COMPLETED|Overall Study||0||
60053081|NCT02202161|76168713|FG004|NOT COMPLETED|Overall Study||1||
60053082|NCT02202161|76168714|FG005|NOT COMPLETED|Overall Study||1||
60053083|NCT02202161|76168715|FG006|NOT COMPLETED|Overall Study||0||
60053084|NCT02202161|76168716|FG007|NOT COMPLETED|Overall Study||6||
60053085|NCT01461928|76168735|FG000|STARTED|Induction (up to 8 Months)||692|Induction period only|
60053086|NCT01461928|76168736|FG001|STARTED|Induction (up to 8 Months)||0|Induction period only|
60053087|NCT01461928|76168737|FG002|STARTED|Induction (up to 8 Months)||0|Induction period only|
60053088|NCT01461928|76168735|FG000|COMPLETED|Induction (up to 8 Months)||494|Induction period only|
60053089|NCT01461928|76168736|FG001|COMPLETED|Induction (up to 8 Months)||0|Induction period only|
60053090|NCT01461928|76168737|FG002|COMPLETED|Induction (up to 8 Months)||0|Induction period only|
60053091|NCT01461928|76168735|FG000|NOT COMPLETED|Induction (up to 8 Months)||198||
60053092|NCT01461928|76168736|FG001|NOT COMPLETED|Induction (up to 8 Months)||0||
60053093|NCT01461928|76168737|FG002|NOT COMPLETED|Induction (up to 8 Months)||0||
60053094|NCT01461928|76168735|FG000|STARTED|Maintenance I (24 Months)||494|Maintenance I only|
60053095|NCT01461928|76168736|FG001|STARTED|Maintenance I (24 Months)||0|Maintenance I only|
60053096|NCT01461928|76168737|FG002|STARTED|Maintenance I (24 Months)||0|Maintenance I only|
60053097|NCT01461928|76168735|FG000|COMPLETED|Maintenance I (24 Months)|Responders during 2 yrs Maint I treatment|276|Maintenance I only|
60053098|NCT01461928|76168736|FG001|COMPLETED|Maintenance I (24 Months)||0|Maintenance I only|
60053099|NCT01461928|76168737|FG002|COMPLETED|Maintenance I (24 Months)||0|Maintenance I only|
60053100|NCT01461928|76168735|FG000|NOT COMPLETED|Maintenance I (24 Months)||218||
60053101|NCT01461928|76168736|FG001|NOT COMPLETED|Maintenance I (24 Months)||0||
60053102|NCT01461928|76168737|FG002|NOT COMPLETED|Maintenance I (24 Months)||0||
60053103|NCT01461928|76168735|FG000|STARTED|Maintenance II (15 Months)||0|Maintenance II only|
59519044|NCT03398278|75612889|FG000|COMPLETED|Period 2||16||
60053104|NCT01461928|76168736|FG001|STARTED|Maintenance II (15 Months)||138|Maintenance II only|
60053105|NCT01461928|76168737|FG002|STARTED|Maintenance II (15 Months)||138|Maintenance II only|
60053106|NCT01461928|76168735|FG000|COMPLETED|Maintenance II (15 Months)||0|Maintenance II only|
60053107|NCT01461928|76168736|FG001|COMPLETED|Maintenance II (15 Months)|6 participants did not receive treatment|115|Maintenance II only|
60053108|NCT01461928|76168737|FG002|COMPLETED|Maintenance II (15 Months)||111|Maintenance II only|
60053109|NCT01461928|76168735|FG000|NOT COMPLETED|Maintenance II (15 Months)||0||
60053110|NCT01461928|76168736|FG001|NOT COMPLETED|Maintenance II (15 Months)||23||
60053111|NCT01461928|76168737|FG002|NOT COMPLETED|Maintenance II (15 Months)||27||
60053112|NCT03097991|76168750|FG000|STARTED|Overall Study||140||70
60053113|NCT03097991|76168751|FG001|STARTED|Overall Study||136||68
60053114|NCT03097991|76168750|FG000|3 Months Post|Overall Study||88||44
60053115|NCT03097991|76168751|FG001|3 Months Post|Overall Study||102||54
60067855|NCT01785615|76183052|FG000|NOT COMPLETED|Dietary Phase||0||
59922621|NCT03482453|76042261|FG007|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||3||
59922622|NCT03482453|76042262|FG008|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||5||
59922623|NCT03482453|76042263|FG009|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||5||
59922624|NCT03482453|76042264|FG010|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||7||
59922625|NCT03482453|76042265|FG011|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||6||
59922626|NCT03482453|76042254|FG000|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0||
59922627|NCT03482453|76042255|FG001|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0||
59922628|NCT03482453|76042256|FG002|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0||
59922629|NCT03482453|76042257|FG003|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0||
59922630|NCT03482453|76042258|FG004|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0||
59922631|NCT03482453|76042259|FG005|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0||
59922632|NCT03482453|76042260|FG006|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||3||
59922633|NCT03482453|76042261|FG007|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||3||
59922634|NCT03482453|76042262|FG008|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||5||
59922635|NCT03482453|76042263|FG009|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||5||
59922636|NCT03482453|76042264|FG010|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||6||
59922637|NCT03482453|76042265|FG011|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||6||
59922638|NCT03482453|76042254|FG000|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0||
59922639|NCT03482453|76042255|FG001|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0||
59922640|NCT03482453|76042256|FG002|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0||
59922641|NCT03482453|76042257|FG003|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0||
59922642|NCT03482453|76042258|FG004|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0||
59922643|NCT03482453|76042259|FG005|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0||
59922644|NCT03482453|76042260|FG006|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0||
59922645|NCT03482453|76042261|FG007|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0||
59922646|NCT03482453|76042262|FG008|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0||
59922647|NCT03482453|76042263|FG009|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0||
59922648|NCT03482453|76042264|FG010|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||1||
59922649|NCT03482453|76042265|FG011|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0||
59922650|NCT03482453|76042254|FG000|STARTED|Parts 2, 3 Washout Period (7 Days)||0||
59922651|NCT03482453|76042255|FG001|STARTED|Parts 2, 3 Washout Period (7 Days)||0||
59922652|NCT03482453|76042256|FG002|STARTED|Parts 2, 3 Washout Period (7 Days)||0||
59922653|NCT03482453|76042257|FG003|STARTED|Parts 2, 3 Washout Period (7 Days)||0||
59922654|NCT03482453|76042258|FG004|STARTED|Parts 2, 3 Washout Period (7 Days)||0||
59922655|NCT03482453|76042259|FG005|STARTED|Parts 2, 3 Washout Period (7 Days)||0||
59922656|NCT03482453|76042260|FG006|STARTED|Parts 2, 3 Washout Period (7 Days)||3||
59922657|NCT03482453|76042261|FG007|STARTED|Parts 2, 3 Washout Period (7 Days)||3||
59922658|NCT03482453|76042262|FG008|STARTED|Parts 2, 3 Washout Period (7 Days)||5||
59922659|NCT03482453|76042263|FG009|STARTED|Parts 2, 3 Washout Period (7 Days)||5||
59922660|NCT03482453|76042264|FG010|STARTED|Parts 2, 3 Washout Period (7 Days)||6||
59922661|NCT03482453|76042265|FG011|STARTED|Parts 2, 3 Washout Period (7 Days)||6||
59922662|NCT03482453|76042254|FG000|COMPLETED|Parts 2, 3 Washout Period (7 Days)||0||
59922663|NCT03482453|76042255|FG001|COMPLETED|Parts 2, 3 Washout Period (7 Days)||0||
59922664|NCT03482453|76042256|FG002|COMPLETED|Parts 2, 3 Washout Period (7 Days)||0||
59922665|NCT03482453|76042257|FG003|COMPLETED|Parts 2, 3 Washout Period (7 Days)||0||
59922666|NCT03482453|76042258|FG004|COMPLETED|Parts 2, 3 Washout Period (7 Days)||0||
59922667|NCT03482453|76042259|FG005|COMPLETED|Parts 2, 3 Washout Period (7 Days)||0||
59922668|NCT03482453|76042260|FG006|COMPLETED|Parts 2, 3 Washout Period (7 Days)||3||
59922669|NCT03482453|76042261|FG007|COMPLETED|Parts 2, 3 Washout Period (7 Days)||3||
59922670|NCT03482453|76042262|FG008|COMPLETED|Parts 2, 3 Washout Period (7 Days)||5||
59922671|NCT03482453|76042263|FG009|COMPLETED|Parts 2, 3 Washout Period (7 Days)||5||
59922672|NCT03482453|76042264|FG010|COMPLETED|Parts 2, 3 Washout Period (7 Days)||6||
59922673|NCT03482453|76042265|FG011|COMPLETED|Parts 2, 3 Washout Period (7 Days)||6||
59922674|NCT03482453|76042254|FG000|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0||
59922675|NCT03482453|76042255|FG001|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0||
59922676|NCT03482453|76042256|FG002|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0||
59922677|NCT03482453|76042257|FG003|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0||
59922678|NCT03482453|76042258|FG004|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0||
59922679|NCT03482453|76042259|FG005|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0||
59922680|NCT03482453|76042260|FG006|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0||
59922681|NCT03482453|76042261|FG007|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0||
59922682|NCT03482453|76042262|FG008|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0||
59922683|NCT03482453|76042263|FG009|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0||
59922684|NCT03482453|76042264|FG010|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0||
59922685|NCT03482453|76042265|FG011|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0||
59922686|NCT03482453|76042254|FG000|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||0||
59922687|NCT03482453|76042255|FG001|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||0||
60053116|NCT03097991|76168750|FG000|COMPLETED|Overall Study||90|12 months post|45
60053117|NCT03097991|76168751|FG001|COMPLETED|Overall Study||86|12 months post|43
60053118|NCT03097991|76168750|FG000|NOT COMPLETED|Overall Study||50||25
60053119|NCT03097991|76168751|FG001|NOT COMPLETED|Overall Study||50||25
59514578|NCT02983552|75608175|FG003|16 Week Visit|Overall Study||72|The 16 week visit was elective for those who were originally assigned to continued spectacle correction. After completing 8 weeks of continued spectacle correction, participants were able to complete 8 weeks of binocular therapy. Values are not provided for the binocular computer game treatment cohorts as this visit was not applicable.|
59514579|NCT02983552|75608172|FG000|COMPLETED|Overall Study||69||
59514580|NCT02983552|75608173|FG001|COMPLETED|Overall Study||67||
59514581|NCT02983552|75608174|FG002|COMPLETED|Overall Study||92||
59514582|NCT02983552|75608175|FG003|COMPLETED|Overall Study||90||
59514583|NCT02983552|75608172|FG000|NOT COMPLETED|Overall Study||0||
59514584|NCT02983552|75608173|FG001|NOT COMPLETED|Overall Study||2||
59514585|NCT02983552|75608174|FG002|NOT COMPLETED|Overall Study||0||
59514586|NCT02983552|75608175|FG003|NOT COMPLETED|Overall Study||0||
59514587|NCT01006369|75608191|FG000|STARTED|Overall Study||13||
59612906|NCT01697358|75723933|FG001|NOT COMPLETED|Period I: Randomization to 6 Months||1||
59612907|NCT01697358|75723932|FG000|STARTED|Period II: 6-24M Long-term Follow-up||97||
59922688|NCT03482453|76042256|FG002|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||0||
59922689|NCT03482453|76042257|FG003|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||0||
59922690|NCT03482453|76042258|FG004|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||0||
59922691|NCT03482453|76042259|FG005|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||0||
59922692|NCT03482453|76042260|FG006|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||3||
59922693|NCT03482453|76042261|FG007|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||3||
59922694|NCT03482453|76042262|FG008|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||5||
59922695|NCT03482453|76042263|FG009|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||5||
59922696|NCT03482453|76042264|FG010|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||6||
59922697|NCT03482453|76042265|FG011|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||6||
59922698|NCT03482453|76042254|FG000|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0||
59922699|NCT03482453|76042255|FG001|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0||
59922700|NCT03482453|76042256|FG002|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0||
59922701|NCT03482453|76042257|FG003|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0||
59922702|NCT03482453|76042258|FG004|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0||
59922703|NCT03482453|76042259|FG005|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0||
59922704|NCT03482453|76042260|FG006|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||3||
59922705|NCT03482453|76042261|FG007|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||3||
59922706|NCT03482453|76042262|FG008|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||5||
59922707|NCT03482453|76042263|FG009|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||5||
59922708|NCT03482453|76042264|FG010|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||6||
59922709|NCT03482453|76042265|FG011|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||6||
59922710|NCT03482453|76042254|FG000|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0||
59922711|NCT03482453|76042255|FG001|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0||
59922712|NCT03482453|76042256|FG002|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0||
59922713|NCT03482453|76042257|FG003|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0||
59922714|NCT03482453|76042258|FG004|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0||
59922715|NCT03482453|76042259|FG005|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0||
59922716|NCT03482453|76042260|FG006|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0||
59922717|NCT03482453|76042261|FG007|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0||
59922718|NCT03482453|76042262|FG008|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0||
59922719|NCT03482453|76042263|FG009|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0||
59922720|NCT03482453|76042264|FG010|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0||
60053120|NCT02623205|76168763|FG000|STARTED|Overall Study||42||
60053121|NCT02623205|76168764|FG001|STARTED|Overall Study||43||
60053122|NCT02623205|76168763|FG000|COMPLETED|Overall Study||38||
60053123|NCT02623205|76168764|FG001|COMPLETED|Overall Study||40||
60053124|NCT02623205|76168763|FG000|NOT COMPLETED|Overall Study||4||
60053125|NCT02623205|76168764|FG001|NOT COMPLETED|Overall Study||3||
60053126|NCT01500694|76168773|FG000|STARTED|Overall Study||131||
60053127|NCT01500694|76168774|FG001|STARTED|Overall Study|Participants who received treatment were reported as Started.|83||
60053128|NCT01500694|76168773|FG000|COMPLETED|Overall Study||79||
60053129|NCT01500694|76168774|FG001|COMPLETED|Overall Study||54||
60053130|NCT01500694|76168773|FG000|NOT COMPLETED|Overall Study||52||
60053131|NCT01500694|76168774|FG001|NOT COMPLETED|Overall Study||29||
60053132|NCT01500382|76168784|FG000|STARTED|Treatment Period 1||1||
60053133|NCT01500382|76168785|FG001|STARTED|Treatment Period 1||1||
60053134|NCT01500382|76168786|FG002|STARTED|Treatment Period 1||1||
60053135|NCT01500382|76168787|FG003|STARTED|Treatment Period 1||1||
60053136|NCT01500382|76168784|FG000|COMPLETED|Treatment Period 1||1||
60053137|NCT01500382|76168785|FG001|COMPLETED|Treatment Period 1||1||
60053138|NCT01500382|76168786|FG002|COMPLETED|Treatment Period 1||1||
60053139|NCT01500382|76168787|FG003|COMPLETED|Treatment Period 1||1||
60053140|NCT01500382|76168784|FG000|NOT COMPLETED|Treatment Period 1||0||
60053141|NCT01500382|76168785|FG001|NOT COMPLETED|Treatment Period 1||0||
60053142|NCT01500382|76168786|FG002|NOT COMPLETED|Treatment Period 1||0||
60053143|NCT01500382|76168787|FG003|NOT COMPLETED|Treatment Period 1||0||
59922721|NCT03482453|76042265|FG011|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0||
59922722|NCT03480425|76042301|FG000|STARTED|Overall Study||11||
59922723|NCT03480425|76042301|FG000|COMPLETED|Overall Study||10||
59922724|NCT03480425|76042301|FG000|NOT COMPLETED|Overall Study||1||
60053144|NCT01500382|76168784|FG000|STARTED|Washout Period||1||
60053145|NCT01500382|76168785|FG001|STARTED|Washout Period||1||
60053146|NCT01500382|76168786|FG002|STARTED|Washout Period||1||
60053147|NCT01500382|76168787|FG003|STARTED|Washout Period||1||
60053148|NCT01500382|76168784|FG000|COMPLETED|Washout Period||1||
59922725|NCT03472547|76042305|FG000|STARTED|Overall Study||234||702
59922726|NCT03472547|76042305|FG000|COMPLETED|Overall Study||204||612
59922727|NCT03472547|76042305|FG000|NOT COMPLETED|Overall Study||30||90
59922728|NCT00799396|76042309|FG000|STARTED|Clopidogrel Treatment||682||
59922729|NCT00799396|76042309|FG000|COMPLETED|Clopidogrel Treatment||669||
59922730|NCT00799396|76042309|FG000|NOT COMPLETED|Clopidogrel Treatment||13||
59922731|NCT00799396|76042309|FG000|STARTED|Clopidogrel Plus Aspirin||669||
59922732|NCT00799396|76042309|FG000|COMPLETED|Clopidogrel Plus Aspirin||663||
59922733|NCT00799396|76042309|FG000|NOT COMPLETED|Clopidogrel Plus Aspirin||6||
59922734|NCT03469349|76042315|FG000|STARTED|Overall Study||182||
59922735|NCT03469349|76042316|FG001|STARTED|Overall Study||184||
59922736|NCT03469349|76042315|FG000|COMPLETED|Overall Study||177||
59922737|NCT03469349|76042316|FG001|COMPLETED|Overall Study||174||
59922738|NCT03469349|76042315|FG000|NOT COMPLETED|Overall Study||5||
59922739|NCT03469349|76042316|FG001|NOT COMPLETED|Overall Study||10||
59922740|NCT03467945|76042326|FG000|STARTED|Treatment Period 1||10||
59922741|NCT03467945|76042327|FG001|STARTED|Treatment Period 1||10||
59922742|NCT03467945|76042328|FG002|STARTED|Treatment Period 1||10||
59922743|NCT03467945|76042329|FG003|STARTED|Treatment Period 1||10||
59922744|NCT03467945|76042326|FG000|COMPLETED|Treatment Period 1||10||
59922745|NCT03467945|76042327|FG001|COMPLETED|Treatment Period 1||10||
59922746|NCT03467945|76042328|FG002|COMPLETED|Treatment Period 1||10||
59922747|NCT03467945|76042329|FG003|COMPLETED|Treatment Period 1||10||
59922748|NCT03467945|76042326|FG000|NOT COMPLETED|Treatment Period 1||0||
59922749|NCT03467945|76042327|FG001|NOT COMPLETED|Treatment Period 1||0||
59922750|NCT03467945|76042328|FG002|NOT COMPLETED|Treatment Period 1||0||
59922751|NCT03467945|76042329|FG003|NOT COMPLETED|Treatment Period 1||0||
59922752|NCT03467945|76042326|FG000|STARTED|Treatment Period 2||10||
59922753|NCT03467945|76042327|FG001|STARTED|Treatment Period 2||10||
59922754|NCT03467945|76042328|FG002|STARTED|Treatment Period 2||10||
59922755|NCT03467945|76042329|FG003|STARTED|Treatment Period 2||10||
59922756|NCT03467945|76042326|FG000|COMPLETED|Treatment Period 2||10||
59922757|NCT03467945|76042327|FG001|COMPLETED|Treatment Period 2||9||
59922758|NCT03467945|76042328|FG002|COMPLETED|Treatment Period 2||10||
59922759|NCT03467945|76042329|FG003|COMPLETED|Treatment Period 2||10||
59922760|NCT03467945|76042326|FG000|NOT COMPLETED|Treatment Period 2||0||
59922761|NCT03467945|76042327|FG001|NOT COMPLETED|Treatment Period 2||1||
60053149|NCT01500382|76168785|FG001|COMPLETED|Washout Period||1||
60053150|NCT01500382|76168786|FG002|COMPLETED|Washout Period||0||
60053151|NCT01500382|76168787|FG003|COMPLETED|Washout Period||1||
60053152|NCT01500382|76168784|FG000|NOT COMPLETED|Washout Period||0||
60053153|NCT01500382|76168785|FG001|NOT COMPLETED|Washout Period||0||
60053154|NCT01500382|76168786|FG002|NOT COMPLETED|Washout Period||1||
60053155|NCT01500382|76168787|FG003|NOT COMPLETED|Washout Period||0||
60053156|NCT01500382|76168784|FG000|STARTED|Treatment Period 2||1||
60053157|NCT01500382|76168785|FG001|STARTED|Treatment Period 2||1||
60053158|NCT01500382|76168786|FG002|STARTED|Treatment Period 2||0||
60053159|NCT01500382|76168787|FG003|STARTED|Treatment Period 2||1||
60053160|NCT01500382|76168784|FG000|COMPLETED|Treatment Period 2||1||
60053161|NCT01500382|76168785|FG001|COMPLETED|Treatment Period 2||1||
60053162|NCT01500382|76168786|FG002|COMPLETED|Treatment Period 2||0||
60053163|NCT01500382|76168787|FG003|COMPLETED|Treatment Period 2||1||
60053164|NCT01500382|76168784|FG000|NOT COMPLETED|Treatment Period 2||0||
60053165|NCT01500382|76168785|FG001|NOT COMPLETED|Treatment Period 2||0||
60053166|NCT01500382|76168786|FG002|NOT COMPLETED|Treatment Period 2||0||
60053167|NCT01500382|76168787|FG003|NOT COMPLETED|Treatment Period 2||0||
60053168|NCT02137837|76168800|FG000|STARTED|Overall Study||13||
60053169|NCT02137837|76168801|FG001|STARTED|Overall Study||12||
60053170|NCT02137837|76168802|FG002|STARTED|Overall Study||12||
60053171|NCT02137837|76168800|FG000|Received Protocol Therapy|Overall Study||13||
60053172|NCT02137837|76168801|FG001|Received Protocol Therapy|Overall Study||11||
60053173|NCT02137837|76168802|FG002|Received Protocol Therapy|Overall Study||12||
60053174|NCT02137837|76168800|FG000|COMPLETED|Overall Study||0||
60053175|NCT02137837|76168801|FG001|COMPLETED|Overall Study||0||
60053176|NCT02137837|76168802|FG002|COMPLETED|Overall Study||0||
60053177|NCT02137837|76168800|FG000|NOT COMPLETED|Overall Study||13||
60053178|NCT02137837|76168801|FG001|NOT COMPLETED|Overall Study||12||
60053179|NCT02137837|76168802|FG002|NOT COMPLETED|Overall Study||12||
60053180|NCT01483690|76168817|FG000|STARTED|Overall Study||5||
60053181|NCT01483690|76168818|FG001|STARTED|Overall Study||18||
60053182|NCT01483690|76168817|FG000|COMPLETED|Overall Study||3||
60053183|NCT01483690|76168818|FG001|COMPLETED|Overall Study||13||
60053184|NCT01483690|76168817|FG000|NOT COMPLETED|Overall Study||2||
59922762|NCT03467945|76042328|FG002|NOT COMPLETED|Treatment Period 2||0||
59922763|NCT03467945|76042329|FG003|NOT COMPLETED|Treatment Period 2||0||
60053185|NCT01483690|76168818|FG001|NOT COMPLETED|Overall Study||5||
60053186|NCT02104765|76168831|FG000|STARTED|Overall Study||8||
60053187|NCT02104765|76168832|FG001|STARTED|Overall Study||6||
60053188|NCT02104765|76168833|FG002|STARTED|Overall Study||6||
60053189|NCT02104765|76168834|FG003|STARTED|Overall Study||7||
60053190|NCT02104765|76168835|FG004|STARTED|Overall Study||8||
60053191|NCT02104765|76168836|FG005|STARTED|Overall Study||2||
60053192|NCT02104765|76168837|FG006|STARTED|Overall Study||8||
60053193|NCT02104765|76168831|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8||
60053194|NCT02104765|76168832|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6||
60053195|NCT02104765|76168833|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6||
60053196|NCT02104765|76168834|FG003|Received at Least 1 Dose of Study Drug|Overall Study||7||
60053197|NCT02104765|76168835|FG004|Received at Least 1 Dose of Study Drug|Overall Study||8||
60053198|NCT02104765|76168836|FG005|Received at Least 1 Dose of Study Drug|Overall Study||2||
59922764|NCT03467945|76042326|FG000|STARTED|Treatment Period 3||10||
59922765|NCT03467945|76042327|FG001|STARTED|Treatment Period 3||9||
59922766|NCT03467945|76042328|FG002|STARTED|Treatment Period 3||10||
59922767|NCT03467945|76042329|FG003|STARTED|Treatment Period 3||10||
59922768|NCT03467945|76042326|FG000|COMPLETED|Treatment Period 3||9||
59922769|NCT03467945|76042327|FG001|COMPLETED|Treatment Period 3||9||
59922770|NCT03467945|76042328|FG002|COMPLETED|Treatment Period 3||8||
59922771|NCT03467945|76042329|FG003|COMPLETED|Treatment Period 3||9||
59922772|NCT03467945|76042326|FG000|NOT COMPLETED|Treatment Period 3||1||
59922773|NCT03467945|76042327|FG001|NOT COMPLETED|Treatment Period 3||0||
60053199|NCT02104765|76168837|FG006|Received at Least 1 Dose of Study Drug|Overall Study||8||
60053200|NCT02104765|76168831|FG000|COMPLETED|Overall Study||8||
60053201|NCT02104765|76168832|FG001|COMPLETED|Overall Study||6||
60053202|NCT02104765|76168833|FG002|COMPLETED|Overall Study||5||
60053203|NCT02104765|76168834|FG003|COMPLETED|Overall Study||6||
60053204|NCT02104765|76168835|FG004|COMPLETED|Overall Study||7||
60053205|NCT02104765|76168836|FG005|COMPLETED|Overall Study||2||
60053206|NCT02104765|76168837|FG006|COMPLETED|Overall Study||7||
60053207|NCT02104765|76168831|FG000|NOT COMPLETED|Overall Study||0||
60053208|NCT02104765|76168832|FG001|NOT COMPLETED|Overall Study||0||
60053209|NCT02104765|76168833|FG002|NOT COMPLETED|Overall Study||1||
60053210|NCT02104765|76168834|FG003|NOT COMPLETED|Overall Study||1||
60053211|NCT02104765|76168835|FG004|NOT COMPLETED|Overall Study||1||
60053212|NCT02104765|76168836|FG005|NOT COMPLETED|Overall Study||0||
60053213|NCT02104765|76168837|FG006|NOT COMPLETED|Overall Study||1||
60053214|NCT01483144|76168862|FG000|STARTED|Overall Study||56||
60053215|NCT01483144|76168863|FG001|STARTED|Overall Study||57||
60053216|NCT01483144|76168864|FG002|STARTED|Overall Study||58||
60053217|NCT01483144|76168862|FG000|COMPLETED|Overall Study||41||
59514588|NCT01006369|75608192|FG001|STARTED|Overall Study||25||
59514589|NCT01006369|75608191|FG000|COMPLETED|Overall Study||1||
60053218|NCT01483144|76168863|FG001|COMPLETED|Overall Study||44||
60053219|NCT01483144|76168864|FG002|COMPLETED|Overall Study||43||
60053220|NCT01483144|76168862|FG000|NOT COMPLETED|Overall Study||15||
60053221|NCT01483144|76168863|FG001|NOT COMPLETED|Overall Study||13||
60053222|NCT01483144|76168864|FG002|NOT COMPLETED|Overall Study||15||
60053223|NCT01881789|76168878|FG000|STARTED|Overall Study||3||
60053224|NCT01881789|76168879|FG001|STARTED|Overall Study||7||
60053225|NCT01881789|76168880|FG002|STARTED|Overall Study||3||
60053226|NCT01881789|76168881|FG003|STARTED|Overall Study||3||
60053227|NCT01881789|76168882|FG004|STARTED|Overall Study||2||
60053228|NCT01881789|76168883|FG005|STARTED|Overall Study||3||
60053229|NCT01881789|76168878|FG000|COMPLETED|Overall Study||0||
60053230|NCT01881789|76168879|FG001|COMPLETED|Overall Study||0||
60053231|NCT01881789|76168880|FG002|COMPLETED|Overall Study||0||
60053232|NCT01881789|76168881|FG003|COMPLETED|Overall Study||0||
60053233|NCT01881789|76168882|FG004|COMPLETED|Overall Study||0||
59922774|NCT03467945|76042328|FG002|NOT COMPLETED|Treatment Period 3||2||
59922775|NCT03467945|76042329|FG003|NOT COMPLETED|Treatment Period 3||1||
59922776|NCT03467945|76042326|FG000|STARTED|Treatment Period 4||9||
59514590|NCT01006369|75608192|FG001|COMPLETED|Overall Study||0||
59922777|NCT03467945|76042327|FG001|STARTED|Treatment Period 4||9||
59922778|NCT03467945|76042328|FG002|STARTED|Treatment Period 4||8||
59922779|NCT03467945|76042329|FG003|STARTED|Treatment Period 4||9||
59922780|NCT03467945|76042326|FG000|COMPLETED|Treatment Period 4||9||
59922781|NCT03467945|76042327|FG001|COMPLETED|Treatment Period 4||9||
59922782|NCT03467945|76042328|FG002|COMPLETED|Treatment Period 4||8||
59922783|NCT03467945|76042329|FG003|COMPLETED|Treatment Period 4||9||
59922784|NCT03467945|76042326|FG000|NOT COMPLETED|Treatment Period 4||0||
59922785|NCT03467945|76042327|FG001|NOT COMPLETED|Treatment Period 4||0||
59922786|NCT03467945|76042328|FG002|NOT COMPLETED|Treatment Period 4||0||
59922787|NCT03467945|76042329|FG003|NOT COMPLETED|Treatment Period 4||0||
59922788|NCT00069238|76042340|FG000|STARTED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||25||
59922789|NCT00069238|76042341|FG001|STARTED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0||
59922790|NCT00069238|76042342|FG002|STARTED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0||
59922791|NCT00069238|76042340|FG000|COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||16||
59922792|NCT00069238|76042341|FG001|COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0||
59922793|NCT00069238|76042342|FG002|COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0||
59922794|NCT00069238|76042340|FG000|NOT COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||9||
59922795|NCT00069238|76042341|FG001|NOT COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0||
59922796|NCT00069238|76042342|FG002|NOT COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0||
59922797|NCT00069238|76042340|FG000|STARTED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0||
59922798|NCT00069238|76042341|FG001|STARTED|Cohort 2 - Dose Level 2 (Weeks 1-18)||3||
60053234|NCT01881789|76168883|FG005|COMPLETED|Overall Study||0||
60053235|NCT01881789|76168878|FG000|NOT COMPLETED|Overall Study||3||
60053236|NCT01881789|76168879|FG001|NOT COMPLETED|Overall Study||7||
60053237|NCT01881789|76168880|FG002|NOT COMPLETED|Overall Study||3||
60053238|NCT01881789|76168881|FG003|NOT COMPLETED|Overall Study||3||
60053239|NCT01881789|76168882|FG004|NOT COMPLETED|Overall Study||2||
60053240|NCT01881789|76168883|FG005|NOT COMPLETED|Overall Study||3||
60053241|NCT02075203|76168901|FG000|STARTED|Overall Study||330||
60053242|NCT02075203|76168902|FG001|STARTED|Overall Study||330||
60053243|NCT02075203|76168903|FG002|STARTED|Overall Study||329||
60053244|NCT02075203|76168901|FG000|COMPLETED|Overall Study||327||
60053245|NCT02075203|76168902|FG001|COMPLETED|Overall Study||330||
60053246|NCT02075203|76168903|FG002|COMPLETED|Overall Study||328||
60053247|NCT02075203|76168901|FG000|NOT COMPLETED|Overall Study||3||
60053248|NCT02075203|76168902|FG001|NOT COMPLETED|Overall Study||0||
60053249|NCT02075203|76168903|FG002|NOT COMPLETED|Overall Study||1||
60053250|NCT01892163|76168913|FG000|STARTED|Overall Study||50||
60053251|NCT01892163|76168914|FG001|STARTED|Overall Study||50||
60053252|NCT01892163|76168913|FG000|COMPLETED|Overall Study||48||
60053253|NCT01892163|76168914|FG001|COMPLETED|Overall Study||49||
60053254|NCT01892163|76168913|FG000|NOT COMPLETED|Overall Study||2||
60053255|NCT01892163|76168914|FG001|NOT COMPLETED|Overall Study||1||
60053256|NCT01881009|76168922|FG000|STARTED|Inpatient Safety Testing (22 Hours)||16||
59922799|NCT00069238|76042342|FG002|STARTED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0||
59951437|NCT00849290|76070434|FG000|COMPLETED|Overall Study||58||
60053257|NCT01881009|76168923|FG001|STARTED|Inpatient Safety Testing (22 Hours)||0||
60053258|NCT01881009|76168922|FG000|COMPLETED|Inpatient Safety Testing (22 Hours)||16||
60053259|NCT01881009|76168923|FG001|COMPLETED|Inpatient Safety Testing (22 Hours)||0||
60053260|NCT01881009|76168922|FG000|NOT COMPLETED|Inpatient Safety Testing (22 Hours)||0||
60053261|NCT01881009|76168923|FG001|NOT COMPLETED|Inpatient Safety Testing (22 Hours)||0||
60053262|NCT01881009|76168922|FG000|STARTED|Summer Camp Session (6 Days)||0||
60053263|NCT01881009|76168923|FG001|STARTED|Summer Camp Session (6 Days)||22||
60053264|NCT01881009|76168922|FG000|COMPLETED|Summer Camp Session (6 Days)||0||
60053265|NCT01881009|76168923|FG001|COMPLETED|Summer Camp Session (6 Days)||21||
60053266|NCT01881009|76168922|FG000|NOT COMPLETED|Summer Camp Session (6 Days)||0||
59514591|NCT01006369|75608191|FG000|NOT COMPLETED|Overall Study||12||
59514592|NCT01006369|75608192|FG001|NOT COMPLETED|Overall Study||25||
59514593|NCT03046966|75608199|FG000|STARTED|Overall Study||51||
59922800|NCT00069238|76042340|FG000|COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0||
59922801|NCT00069238|76042341|FG001|COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||1||
59922802|NCT00069238|76042342|FG002|COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0||
59922803|NCT00069238|76042340|FG000|NOT COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0||
59922804|NCT00069238|76042341|FG001|NOT COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||2||
59922805|NCT00069238|76042342|FG002|NOT COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0||
59922806|NCT00069238|76042340|FG000|STARTED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0||
59922807|NCT00069238|76042341|FG001|STARTED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0||
59922808|NCT00069238|76042342|FG002|STARTED|Cohort 3 - Dose Level 3 (Weeks 1-18)||3||
59922809|NCT00069238|76042340|FG000|COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0||
59922810|NCT00069238|76042341|FG001|COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0||
59922811|NCT00069238|76042342|FG002|COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||1||
59922812|NCT00069238|76042340|FG000|NOT COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0||
59922813|NCT00069238|76042341|FG001|NOT COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0||
59922814|NCT00069238|76042342|FG002|NOT COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||2||
59922815|NCT03435497|76042349|FG000|STARTED|Overall Study||51||
59922816|NCT03435497|76042350|FG001|STARTED|Overall Study||47||
59922817|NCT03435497|76042349|FG000|COMPLETED|Overall Study||49||
59922818|NCT03435497|76042350|FG001|COMPLETED|Overall Study||41||
59922819|NCT03435497|76042349|FG000|NOT COMPLETED|Overall Study||2||
59922820|NCT03435497|76042350|FG001|NOT COMPLETED|Overall Study||6||
59922821|NCT03073200|76042359|FG000|STARTED|Double Blind Treatment Period||56||
59922822|NCT03073200|76042360|FG001|STARTED|Double Blind Treatment Period||115||
59922823|NCT03073200|76042361|FG002|STARTED|Double Blind Treatment Period||30||
59922824|NCT03073200|76042362|FG003|STARTED|Double Blind Treatment Period||0||
59922825|NCT03073200|76042363|FG004|STARTED|Double Blind Treatment Period||0||
59922826|NCT03073200|76042364|FG005|STARTED|Double Blind Treatment Period||0||
59922827|NCT03073200|76042365|FG006|STARTED|Double Blind Treatment Period||0||
59922828|NCT03073200|76042366|FG007|STARTED|Double Blind Treatment Period||0||
59922829|NCT03073200|76042367|FG008|STARTED|Double Blind Treatment Period||0||
59922830|NCT03073200|76042368|FG009|STARTED|Double Blind Treatment Period||0||
59922831|NCT03073200|76042369|FG010|STARTED|Double Blind Treatment Period||0||
59922832|NCT03073200|76042370|FG011|STARTED|Double Blind Treatment Period||0||
59922833|NCT03073200|76042371|FG012|STARTED|Double Blind Treatment Period||0||
59922834|NCT03073200|76042372|FG013|STARTED|Double Blind Treatment Period||0||
59922835|NCT03073200|76042373|FG014|STARTED|Double Blind Treatment Period||0||
59922836|NCT03073200|76042359|FG000|Participants in Etanercept Approved Countries|Double Blind Treatment Period||19||
59922837|NCT03073200|76042360|FG001|Participants in Etanercept Approved Countries|Double Blind Treatment Period||38||
59922838|NCT03073200|76042361|FG002|Participants in Etanercept Approved Countries|Double Blind Treatment Period||30||
59922839|NCT03073200|76042362|FG003|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0||
59922840|NCT03073200|76042363|FG004|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0||
59922841|NCT03073200|76042364|FG005|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0||
59922842|NCT03073200|76042365|FG006|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0||
59922843|NCT03073200|76042366|FG007|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0||
59922844|NCT03073200|76042367|FG008|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0||
59922845|NCT03073200|76042368|FG009|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0||
59922846|NCT03073200|76042369|FG010|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0||
59922847|NCT03073200|76042370|FG011|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0||
59922848|NCT03073200|76042371|FG012|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0||
59922849|NCT03073200|76042372|FG013|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0||
59922850|NCT03073200|76042373|FG014|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0||
59922851|NCT03073200|76042359|FG000|COMPLETED|Double Blind Treatment Period||54||
59922852|NCT03073200|76042360|FG001|COMPLETED|Double Blind Treatment Period||114||
59922853|NCT03073200|76042361|FG002|COMPLETED|Double Blind Treatment Period||30||
59922854|NCT03073200|76042362|FG003|COMPLETED|Double Blind Treatment Period||0||
59922855|NCT03073200|76042363|FG004|COMPLETED|Double Blind Treatment Period||0||
59922856|NCT03073200|76042364|FG005|COMPLETED|Double Blind Treatment Period||0||
59922857|NCT03073200|76042365|FG006|COMPLETED|Double Blind Treatment Period||0||
59922858|NCT03073200|76042366|FG007|COMPLETED|Double Blind Treatment Period||0||
59612908|NCT01697358|75723933|FG001|STARTED|Period II: 6-24M Long-term Follow-up||107||
59922859|NCT03073200|76042367|FG008|COMPLETED|Double Blind Treatment Period||0||
59922860|NCT03073200|76042368|FG009|COMPLETED|Double Blind Treatment Period||0||
59922861|NCT03073200|76042369|FG010|COMPLETED|Double Blind Treatment Period||0||
59922862|NCT03073200|76042370|FG011|COMPLETED|Double Blind Treatment Period||0||
59922863|NCT03073200|76042371|FG012|COMPLETED|Double Blind Treatment Period||0||
59922864|NCT03073200|76042372|FG013|COMPLETED|Double Blind Treatment Period||0||
59922865|NCT03073200|76042373|FG014|COMPLETED|Double Blind Treatment Period||0||
59951438|NCT00849290|76070434|FG000|NOT COMPLETED|Overall Study||55||
59612909|NCT01697358|75723932|FG000|COMPLETED|Period II: 6-24M Long-term Follow-up||48||
59514594|NCT03046966|75608200|FG001|STARTED|Overall Study||51||
59514595|NCT03046966|75608199|FG000|COMPLETED|Overall Study||51||
59514596|NCT03046966|75608200|FG001|COMPLETED|Overall Study||51||
59514597|NCT03046966|75608199|FG000|NOT COMPLETED|Overall Study||0||
59514598|NCT03046966|75608200|FG001|NOT COMPLETED|Overall Study||0||
59514599|NCT01007071|75608208|FG000|STARTED|Overall Study||6||
59514600|NCT01007071|75608209|FG001|STARTED|Overall Study||5||
59514601|NCT01007071|75608208|FG000|COMPLETED|Overall Study||6||
59514602|NCT01007071|75608209|FG001|COMPLETED|Overall Study||5||
59514603|NCT01007071|75608208|FG000|NOT COMPLETED|Overall Study||0||
59514604|NCT01007071|75608209|FG001|NOT COMPLETED|Overall Study||0||
59922866|NCT03073200|76042359|FG000|NOT COMPLETED|Double Blind Treatment Period||2||
59922867|NCT03073200|76042360|FG001|NOT COMPLETED|Double Blind Treatment Period||1||
59922868|NCT03073200|76042361|FG002|NOT COMPLETED|Double Blind Treatment Period||0||
59922869|NCT03073200|76042362|FG003|NOT COMPLETED|Double Blind Treatment Period||0||
59922870|NCT03073200|76042363|FG004|NOT COMPLETED|Double Blind Treatment Period||0||
59922871|NCT03073200|76042364|FG005|NOT COMPLETED|Double Blind Treatment Period||0||
59922872|NCT03073200|76042365|FG006|NOT COMPLETED|Double Blind Treatment Period||0||
59922873|NCT03073200|76042366|FG007|NOT COMPLETED|Double Blind Treatment Period||0||
59922874|NCT03073200|76042367|FG008|NOT COMPLETED|Double Blind Treatment Period||0||
59922875|NCT03073200|76042368|FG009|NOT COMPLETED|Double Blind Treatment Period||0||
59922876|NCT03073200|76042369|FG010|NOT COMPLETED|Double Blind Treatment Period||0||
59922877|NCT03073200|76042370|FG011|NOT COMPLETED|Double Blind Treatment Period||0||
59922878|NCT03073200|76042371|FG012|NOT COMPLETED|Double Blind Treatment Period||0||
59922879|NCT03073200|76042372|FG013|NOT COMPLETED|Double Blind Treatment Period||0||
59922880|NCT03073200|76042373|FG014|NOT COMPLETED|Double Blind Treatment Period||0||
59922881|NCT03073200|76042359|FG000|STARTED|Open-Label Maintenance Period|This period is to report Maintenance Period participants.|0||
59922882|NCT03073200|76042360|FG001|STARTED|Open-Label Maintenance Period|This period is to report Maintenance Period participants.|0||
59922883|NCT03073200|76042361|FG002|STARTED|Open-Label Maintenance Period|This period is to report Maintenance Period participants.|0||
59922884|NCT03073200|76042362|FG003|STARTED|Open-Label Maintenance Period|This period is to report Maintenance Period participants.|53||
59922885|NCT03073200|76042363|FG004|STARTED|Open-Label Maintenance Period|This period is to report Maintenance Period participants.|113||
59922886|NCT03073200|76042364|FG005|STARTED|Open-Label Maintenance Period|This period is to report Maintenance Period participants.|28||
59922887|NCT03073200|76042365|FG006|STARTED|Open-Label Maintenance Period||0||
59922888|NCT03073200|76042366|FG007|STARTED|Open-Label Maintenance Period||0||
59922889|NCT03073200|76042367|FG008|STARTED|Open-Label Maintenance Period||0||
59922890|NCT03073200|76042368|FG009|STARTED|Open-Label Maintenance Period||0||
59922891|NCT03073200|76042369|FG010|STARTED|Open-Label Maintenance Period||0||
59922892|NCT03073200|76042370|FG011|STARTED|Open-Label Maintenance Period||0||
59922893|NCT03073200|76042371|FG012|STARTED|Open-Label Maintenance Period||0||
59922894|NCT03073200|76042372|FG013|STARTED|Open-Label Maintenance Period||0||
59922895|NCT03073200|76042373|FG014|STARTED|Open-Label Maintenance Period||0||
59922896|NCT03073200|76042359|FG000|COMPLETED|Open-Label Maintenance Period||0||
59922897|NCT03073200|76042360|FG001|COMPLETED|Open-Label Maintenance Period||0||
59922898|NCT03073200|76042361|FG002|COMPLETED|Open-Label Maintenance Period||0||
59922899|NCT03073200|76042362|FG003|COMPLETED|Open-Label Maintenance Period||49||
59922900|NCT03073200|76042363|FG004|COMPLETED|Open-Label Maintenance Period||109||
59922901|NCT03073200|76042364|FG005|COMPLETED|Open-Label Maintenance Period||28||
59922902|NCT03073200|76042365|FG006|COMPLETED|Open-Label Maintenance Period||0||
59922903|NCT03073200|76042366|FG007|COMPLETED|Open-Label Maintenance Period||0||
59922904|NCT03073200|76042367|FG008|COMPLETED|Open-Label Maintenance Period||0||
59922905|NCT03073200|76042368|FG009|COMPLETED|Open-Label Maintenance Period||0||
59514605|NCT02984644|75608218|FG000|STARTED|Overall Study||20||
59514606|NCT02984644|75608219|FG001|STARTED|Overall Study||10||
59514607|NCT02984644|75608218|FG000|COMPLETED|Overall Study||20||
59514608|NCT02984644|75608219|FG001|COMPLETED|Overall Study||10||
59514609|NCT02984644|75608218|FG000|NOT COMPLETED|Overall Study||0||
59514610|NCT02984644|75608219|FG001|NOT COMPLETED|Overall Study||0||
59514611|NCT00966823|75608246|FG000|STARTED|Overall Study||3||
59922906|NCT03073200|76042369|FG010|COMPLETED|Open-Label Maintenance Period||0||
59922907|NCT03073200|76042370|FG011|COMPLETED|Open-Label Maintenance Period||0||
59951439|NCT00674479|76070438|FG000|STARTED|Overall Study||51||
59514612|NCT00966823|75608246|FG000|COMPLETED|Overall Study||2||
60053267|NCT01881009|76168923|FG001|NOT COMPLETED|Summer Camp Session (6 Days)||1||
59612910|NCT01697358|75723933|FG001|COMPLETED|Period II: 6-24M Long-term Follow-up||52||
59612911|NCT01697358|75723932|FG000|NOT COMPLETED|Period II: 6-24M Long-term Follow-up||49||
59612912|NCT01697358|75723933|FG001|NOT COMPLETED|Period II: 6-24M Long-term Follow-up||55||
59922908|NCT03073200|76042371|FG012|COMPLETED|Open-Label Maintenance Period||0||
59922909|NCT03073200|76042372|FG013|COMPLETED|Open-Label Maintenance Period||0||
59922910|NCT03073200|76042373|FG014|COMPLETED|Open-Label Maintenance Period||0||
59922911|NCT03073200|76042359|FG000|NOT COMPLETED|Open-Label Maintenance Period||0||
59922912|NCT03073200|76042360|FG001|NOT COMPLETED|Open-Label Maintenance Period||0||
59922913|NCT03073200|76042361|FG002|NOT COMPLETED|Open-Label Maintenance Period||0||
59922914|NCT03073200|76042362|FG003|NOT COMPLETED|Open-Label Maintenance Period||4||
59922915|NCT03073200|76042363|FG004|NOT COMPLETED|Open-Label Maintenance Period||4||
59922916|NCT03073200|76042364|FG005|NOT COMPLETED|Open-Label Maintenance Period||0||
59922917|NCT03073200|76042365|FG006|NOT COMPLETED|Open-Label Maintenance Period||0||
59922918|NCT03073200|76042366|FG007|NOT COMPLETED|Open-Label Maintenance Period||0||
59922919|NCT03073200|76042367|FG008|NOT COMPLETED|Open-Label Maintenance Period||0||
59922920|NCT03073200|76042368|FG009|NOT COMPLETED|Open-Label Maintenance Period||0||
59922921|NCT03073200|76042369|FG010|NOT COMPLETED|Open-Label Maintenance Period||0||
59922922|NCT03073200|76042370|FG011|NOT COMPLETED|Open-Label Maintenance Period||0||
59922923|NCT03073200|76042371|FG012|NOT COMPLETED|Open-Label Maintenance Period||0||
59922924|NCT03073200|76042372|FG013|NOT COMPLETED|Open-Label Maintenance Period||0||
59922925|NCT03073200|76042373|FG014|NOT COMPLETED|Open-Label Maintenance Period||0||
59922926|NCT03073200|76042359|FG000|STARTED|Extension Period||0||
59922927|NCT03073200|76042360|FG001|STARTED|Extension Period||0||
59922928|NCT03073200|76042361|FG002|STARTED|Extension Period||0||
59922929|NCT03073200|76042362|FG003|STARTED|Extension Period|This period is to report Extension Period participants.|0||
59922930|NCT03073200|76042363|FG004|STARTED|Extension Period|This period is to report Extension Period participants.|0||
59922931|NCT03073200|76042364|FG005|STARTED|Extension Period|This period is to report Extension Period participants.|0||
59922932|NCT03073200|76042365|FG006|STARTED|Extension Period|This period is to report Extension Period participants.|34||
59922933|NCT03073200|76042366|FG007|STARTED|Extension Period|This period is to report Extension Period participants.|68||
59922934|NCT03073200|76042367|FG008|STARTED|Extension Period|This period is to report Extension Period participants.|9||
59922935|NCT03073200|76042368|FG009|STARTED|Extension Period||0||
59922936|NCT03073200|76042369|FG010|STARTED|Extension Period||0||
59922937|NCT03073200|76042370|FG011|STARTED|Extension Period||0||
59922938|NCT03073200|76042371|FG012|STARTED|Extension Period||0||
59922939|NCT03073200|76042372|FG013|STARTED|Extension Period||0||
59922940|NCT03073200|76042373|FG014|STARTED|Extension Period||0||
59922941|NCT03073200|76042359|FG000|COMPLETED|Extension Period||0||
59922942|NCT03073200|76042360|FG001|COMPLETED|Extension Period||0||
59922943|NCT03073200|76042361|FG002|COMPLETED|Extension Period||0||
59922944|NCT03073200|76042362|FG003|COMPLETED|Extension Period||0||
59922945|NCT03073200|76042363|FG004|COMPLETED|Extension Period||0||
59922946|NCT03073200|76042364|FG005|COMPLETED|Extension Period||0||
59922947|NCT03073200|76042365|FG006|COMPLETED|Extension Period||31||
59922948|NCT03073200|76042366|FG007|COMPLETED|Extension Period||62||
59922949|NCT03073200|76042367|FG008|COMPLETED|Extension Period||7||
59922950|NCT03073200|76042368|FG009|COMPLETED|Extension Period||0||
59922951|NCT03073200|76042369|FG010|COMPLETED|Extension Period||0||
59922952|NCT03073200|76042370|FG011|COMPLETED|Extension Period||0||
59922953|NCT03073200|76042371|FG012|COMPLETED|Extension Period||0||
59922954|NCT03073200|76042372|FG013|COMPLETED|Extension Period||0||
59922955|NCT03073200|76042373|FG014|COMPLETED|Extension Period||0||
59922956|NCT03073200|76042359|FG000|NOT COMPLETED|Extension Period||0||
59922957|NCT03073200|76042360|FG001|NOT COMPLETED|Extension Period||0||
59922958|NCT03073200|76042361|FG002|NOT COMPLETED|Extension Period||0||
59922959|NCT03073200|76042362|FG003|NOT COMPLETED|Extension Period||0||
59922960|NCT03073200|76042363|FG004|NOT COMPLETED|Extension Period||0||
59922961|NCT03073200|76042364|FG005|NOT COMPLETED|Extension Period||0||
59922962|NCT03073200|76042365|FG006|NOT COMPLETED|Extension Period||3||
59922963|NCT03073200|76042366|FG007|NOT COMPLETED|Extension Period||6||
59922964|NCT03073200|76042367|FG008|NOT COMPLETED|Extension Period||2||
59922965|NCT03073200|76042368|FG009|NOT COMPLETED|Extension Period||0||
59922966|NCT03073200|76042369|FG010|NOT COMPLETED|Extension Period||0||
59922967|NCT03073200|76042370|FG011|NOT COMPLETED|Extension Period||0||
59922968|NCT03073200|76042371|FG012|NOT COMPLETED|Extension Period||0||
59922969|NCT03073200|76042372|FG013|NOT COMPLETED|Extension Period||0||
59922970|NCT03073200|76042373|FG014|NOT COMPLETED|Extension Period||0||
59922971|NCT03073200|76042359|FG000|STARTED|Randomized Withdrawal Period||0||
60053268|NCT01500226|76168932|FG000|STARTED|Overall Study|Number of randomized patients|684||
60053269|NCT01500226|76168933|FG001|STARTED|Overall Study||685||
60053270|NCT01500226|76168932|FG000|COMPLETED|Overall Study|Number of patients who completed 6 cycles|185||
60053271|NCT01500226|76168933|FG001|COMPLETED|Overall Study||191||
59612913|NCT01716234|75723946|FG000|STARTED|Overall Study||24||
59612914|NCT01716234|75723947|FG001|STARTED|Overall Study||22||
59612915|NCT01716234|75723948|FG002|STARTED|Overall Study||20||
60053272|NCT01500226|76168932|FG000|NOT COMPLETED|Overall Study||499||
60053273|NCT01500226|76168933|FG001|NOT COMPLETED|Overall Study||494||
60053274|NCT02075047|76168941|FG000|STARTED|Treatment Phase (4 Weeks)||86||
60053275|NCT02075047|76168942|FG001|STARTED|Treatment Phase (4 Weeks)||85||
60053276|NCT02075047|76168941|FG000|COMPLETED|Treatment Phase (4 Weeks)||63||
60053277|NCT02075047|76168942|FG001|COMPLETED|Treatment Phase (4 Weeks)||75||
60053278|NCT02075047|76168941|FG000|NOT COMPLETED|Treatment Phase (4 Weeks)||23||
60053279|NCT02075047|76168942|FG001|NOT COMPLETED|Treatment Phase (4 Weeks)||10||
60053280|NCT02075047|76168941|FG000|STARTED|Follow up Phase (5 Weeks)|Participants were followed up after completion or discontinuation of treatment.|86||
60053281|NCT02075047|76168942|FG001|STARTED|Follow up Phase (5 Weeks)|Participants were followed up after completion or discontinuation of treatment.|85||
60053282|NCT02075047|76168941|FG000|COMPLETED|Follow up Phase (5 Weeks)||60||
60053283|NCT02075047|76168942|FG001|COMPLETED|Follow up Phase (5 Weeks)||72||
60053284|NCT02075047|76168941|FG000|NOT COMPLETED|Follow up Phase (5 Weeks)||26||
59514613|NCT00966823|75608246|FG000|NOT COMPLETED|Overall Study||1||
59514614|NCT02984878|75608252|FG000|STARTED|Overall Study||30||
59514615|NCT02984878|75608253|FG001|STARTED|Overall Study||41||
59514616|NCT02984878|75608252|FG000|COMPLETED|Overall Study||30||
59514617|NCT02984878|75608253|FG001|COMPLETED|Overall Study||41||
59514618|NCT02984878|75608252|FG000|NOT COMPLETED|Overall Study||0||
59514619|NCT02984878|75608253|FG001|NOT COMPLETED|Overall Study||0||
59514620|NCT02986282|75608262|FG000|STARTED|Overall Study||115||
59514621|NCT02986282|75608262|FG000|COMPLETED|Overall Study||99||
59514622|NCT02986282|75608262|FG000|NOT COMPLETED|Overall Study||16||
59514623|NCT01008319|75608268|FG000|STARTED|Overall Study||60||
59514624|NCT01008319|75608269|FG001|STARTED|Overall Study||60||
59514625|NCT01008319|75608268|FG000|COMPLETED|Overall Study||60||
59514626|NCT01008319|75608269|FG001|COMPLETED|Overall Study||60||
59514627|NCT01008319|75608268|FG000|NOT COMPLETED|Overall Study||0||
59514628|NCT01008319|75608269|FG001|NOT COMPLETED|Overall Study||0||
60053285|NCT02075047|76168942|FG001|NOT COMPLETED|Follow up Phase (5 Weeks)||13||
60053286|NCT01859949|76168950|FG000|STARTED|Overall Study|Treated participants|29||
60053287|NCT01859949|76168951|FG001|STARTED|Overall Study|Treated participants|32||
60053288|NCT01859949|76168950|FG000|COMPLETED|Overall Study||15||
60053289|NCT01859949|76168951|FG001|COMPLETED|Overall Study||15||
60053290|NCT01859949|76168950|FG000|NOT COMPLETED|Overall Study||14||
60053291|NCT01859949|76168951|FG001|NOT COMPLETED|Overall Study||17||
60053292|NCT01859793|76168959|FG000|STARTED|First Intervention (8 Weeks)||20||
60053293|NCT01859793|76168960|FG001|STARTED|First Intervention (8 Weeks)||18||
60053294|NCT01859793|76168959|FG000|COMPLETED|First Intervention (8 Weeks)||15||
60053295|NCT01859793|76168960|FG001|COMPLETED|First Intervention (8 Weeks)||17||
60053296|NCT01859793|76168959|FG000|NOT COMPLETED|First Intervention (8 Weeks)||5||
60053297|NCT01859793|76168960|FG001|NOT COMPLETED|First Intervention (8 Weeks)||1||
60053298|NCT01859793|76168959|FG000|STARTED|Washout Period (4 Weeks)||15||
60053299|NCT01859793|76168960|FG001|STARTED|Washout Period (4 Weeks)||17||
60053300|NCT01859793|76168959|FG000|COMPLETED|Washout Period (4 Weeks)||14||
60053301|NCT01859793|76168960|FG001|COMPLETED|Washout Period (4 Weeks)||16||
60053302|NCT01859793|76168959|FG000|NOT COMPLETED|Washout Period (4 Weeks)||1||
60053303|NCT01859793|76168960|FG001|NOT COMPLETED|Washout Period (4 Weeks)||1||
60053304|NCT01859793|76168959|FG000|STARTED|2nd Intervention Period||14||
60053305|NCT01859793|76168960|FG001|STARTED|2nd Intervention Period||16||
60053306|NCT01859793|76168959|FG000|COMPLETED|2nd Intervention Period||14||
60053307|NCT01859793|76168960|FG001|COMPLETED|2nd Intervention Period||16||
60053308|NCT01859793|76168959|FG000|NOT COMPLETED|2nd Intervention Period||0||
60053309|NCT01859793|76168960|FG001|NOT COMPLETED|2nd Intervention Period||0||
60053310|NCT01859715|76168969|FG000|STARTED|Overall Study||141||
60053311|NCT01859715|76168970|FG001|STARTED|Overall Study||91||
60053312|NCT01859715|76168971|FG002|STARTED|Overall Study||116||
60053313|NCT01859715|76168969|FG000|COMPLETED|Overall Study||125||
60053314|NCT01859715|76168970|FG001|COMPLETED|Overall Study||83||
60053315|NCT01859715|76168971|FG002|COMPLETED|Overall Study||93||
60053316|NCT01859715|76168969|FG000|NOT COMPLETED|Overall Study||16||
60053317|NCT01859715|76168970|FG001|NOT COMPLETED|Overall Study||8||
60053318|NCT01859715|76168971|FG002|NOT COMPLETED|Overall Study||23||
60053319|NCT01890915|76168983|FG000|STARTED|Overall Study||11||
60053320|NCT01890915|76168984|FG001|STARTED|Overall Study||10||
60053321|NCT01890915|76168983|FG000|COMPLETED|Overall Study||8||
60053322|NCT01890915|76168984|FG001|COMPLETED|Overall Study||9||
60053323|NCT01890915|76168983|FG000|NOT COMPLETED|Overall Study||3||
60053324|NCT01890915|76168984|FG001|NOT COMPLETED|Overall Study||1||
60053325|NCT01615263|76168992|FG000|STARTED|Overall Study||20||
60053326|NCT01615263|76168993|FG001|STARTED|Overall Study||20||
59514629|NCT02873104|75608281|FG000|STARTED|Overall Study||47||
59514630|NCT02873104|75608282|FG001|STARTED|Overall Study||23||
59514631|NCT02873104|75608281|FG000|COMPLETED|Overall Study||46||
59514632|NCT02873104|75608282|FG001|COMPLETED|Overall Study||23||
59514633|NCT02873104|75608281|FG000|NOT COMPLETED|Overall Study||1||
59514634|NCT02873104|75608282|FG001|NOT COMPLETED|Overall Study||0||
59514635|NCT00967369|75608290|FG000|STARTED|Overall Study||10||
59514636|NCT00967369|75608291|FG001|STARTED|Overall Study||10||
60053327|NCT01615263|76168992|FG000|COMPLETED|Overall Study||20||
59514637|NCT00967369|75608290|FG000|Relapsed|Overall Study||4||
59514638|NCT00967369|75608291|FG001|Relapsed|Overall Study||7||
59514639|NCT00967369|75608290|FG000|Refractory|Overall Study||6||
59514640|NCT00967369|75608291|FG001|Refractory|Overall Study||3||
59514641|NCT00967369|75608290|FG000|COMPLETED|Overall Study||10||
59514642|NCT00967369|75608291|FG001|COMPLETED|Overall Study||10||
59514643|NCT00967369|75608290|FG000|NOT COMPLETED|Overall Study||0||
59514644|NCT00967369|75608291|FG001|NOT COMPLETED|Overall Study||0||
59514645|NCT02876926|75608300|FG000|STARTED|Overall Study||21||
59514646|NCT02876926|75608301|FG001|STARTED|Overall Study||22||
59612916|NCT01716234|75723949|FG003|STARTED|Overall Study||28||
60053328|NCT01615263|76168993|FG001|COMPLETED|Overall Study||18||
60053329|NCT01615263|76168992|FG000|NOT COMPLETED|Overall Study||0||
60053330|NCT01615263|76168993|FG001|NOT COMPLETED|Overall Study||2||
60053331|NCT04590495|76169001|FG000|STARTED|Overall Study||21||
60053332|NCT04590495|76169002|FG001|STARTED|Overall Study||19||
60053333|NCT04590495|76169001|FG000|COMPLETED|Overall Study||21||
60053334|NCT04590495|76169002|FG001|COMPLETED|Overall Study||19||
60053335|NCT04590495|76169001|FG000|NOT COMPLETED|Overall Study||0||
60053336|NCT04590495|76169002|FG001|NOT COMPLETED|Overall Study||0||
60053337|NCT01859403|76169010|FG000|STARTED|Primary Endpoint Measure||21||
60053338|NCT01859403|76169011|FG001|STARTED|Primary Endpoint Measure||30||
60053339|NCT01859403|76169010|FG000|COMPLETED|Primary Endpoint Measure||20||
60053340|NCT01859403|76169011|FG001|COMPLETED|Primary Endpoint Measure||26||
60053341|NCT01859403|76169010|FG000|NOT COMPLETED|Primary Endpoint Measure||1||
60053342|NCT01859403|76169011|FG001|NOT COMPLETED|Primary Endpoint Measure||4||
60053343|NCT01859403|76169010|FG000|STARTED|Secondary Endpoint Measure||20||
60053344|NCT01859403|76169011|FG001|STARTED|Secondary Endpoint Measure||26||
60053345|NCT01859403|76169010|FG000|COMPLETED|Secondary Endpoint Measure||14||
60053346|NCT01859403|76169011|FG001|COMPLETED|Secondary Endpoint Measure||18||
60053347|NCT01859403|76169010|FG000|NOT COMPLETED|Secondary Endpoint Measure||6||
60053348|NCT01859403|76169011|FG001|NOT COMPLETED|Secondary Endpoint Measure||8||
60053349|NCT01858701|76169017|FG000|STARTED|Period 1, First 30 Days of Wear||20||
60053350|NCT01858701|76169018|FG001|STARTED|Period 1, First 30 Days of Wear||20||
60053351|NCT01858701|76169017|FG000|COMPLETED|Period 1, First 30 Days of Wear||20||
60053352|NCT01858701|76169018|FG001|COMPLETED|Period 1, First 30 Days of Wear||19||
60053353|NCT01858701|76169017|FG000|NOT COMPLETED|Period 1, First 30 Days of Wear||0||
60053354|NCT01858701|76169018|FG001|NOT COMPLETED|Period 1, First 30 Days of Wear||1||
60053355|NCT01858701|76169017|FG000|STARTED|Washout Period, 1-13 Days||20||
60053356|NCT01858701|76169018|FG001|STARTED|Washout Period, 1-13 Days||19||
60053357|NCT01858701|76169017|FG000|COMPLETED|Washout Period, 1-13 Days||18||
60053358|NCT01858701|76169018|FG001|COMPLETED|Washout Period, 1-13 Days||17||
60053359|NCT01858701|76169017|FG000|NOT COMPLETED|Washout Period, 1-13 Days||2||
60053360|NCT01858701|76169018|FG001|NOT COMPLETED|Washout Period, 1-13 Days||2||
60053361|NCT01858701|76169017|FG000|STARTED|Period 2, Second 30 Days of Wear||18||
60053362|NCT01858701|76169018|FG001|STARTED|Period 2, Second 30 Days of Wear||17||
60053363|NCT01858701|76169017|FG000|COMPLETED|Period 2, Second 30 Days of Wear||18||
60053364|NCT01858701|76169018|FG001|COMPLETED|Period 2, Second 30 Days of Wear||16||
60053365|NCT01858701|76169017|FG000|NOT COMPLETED|Period 2, Second 30 Days of Wear||0||
60053366|NCT01858701|76169018|FG001|NOT COMPLETED|Period 2, Second 30 Days of Wear||1||
60053367|NCT01461538|76169027|FG000|STARTED|Overall Study||46||
60053368|NCT01461538|76169028|FG001|STARTED|Overall Study||28||
60053369|NCT01461538|76169029|FG002|STARTED|Overall Study||9||
60053370|NCT01461538|76169027|FG000|COMPLETED|Overall Study||28||
60053371|NCT01461538|76169028|FG001|COMPLETED|Overall Study||20||
60053372|NCT01461538|76169029|FG002|COMPLETED|Overall Study||7||
60053373|NCT01461538|76169027|FG000|NOT COMPLETED|Overall Study||18||
60053374|NCT01461538|76169028|FG001|NOT COMPLETED|Overall Study||8||
60053375|NCT01461538|76169029|FG002|NOT COMPLETED|Overall Study||2||
60053376|NCT02117479|76169041|FG000|STARTED|Overall Study||161||
60053377|NCT02117479|76169042|FG001|STARTED|Overall Study||160||
60053378|NCT02117479|76169041|FG000|COMPLETED|Overall Study|Treatment ongoing as of 20APR2016 for remaining participants in the study.|5||
60053379|NCT02117479|76169042|FG001|COMPLETED|Overall Study|Treatment ongoing as of 20APR2016 for remaining participants in the study.|4||
60053380|NCT02117479|76169041|FG000|NOT COMPLETED|Overall Study||156||
60053381|NCT02117479|76169042|FG001|NOT COMPLETED|Overall Study||156||
60053382|NCT02229851|76169051|FG000|STARTED|Main Phase (Double-blind Phase)||61||
60053383|NCT02229851|76169052|FG001|STARTED|Main Phase (Double-blind Phase)||119||
60053384|NCT02229851|76169053|FG002|STARTED|Main Phase (Double-blind Phase)||120||
59514647|NCT02876926|75608302|FG002|STARTED|Overall Study||22||
59514648|NCT02876926|75608300|FG000|COMPLETED|Overall Study||3||
59514649|NCT02876926|75608301|FG001|COMPLETED|Overall Study||3||
59514650|NCT02876926|75608302|FG002|COMPLETED|Overall Study||2||
60053385|NCT02229851|76169054|FG003|STARTED|Main Phase (Double-blind Phase)|This arm is not applicable for the Main phase.|0||
60053386|NCT02229851|76169055|FG004|STARTED|Main Phase (Double-blind Phase)|This arm is not applicable for the Main phase.|0||
60053387|NCT02229851|76169056|FG005|STARTED|Main Phase (Double-blind Phase)|This arm is not applicable for the Main phase.|0||
60053388|NCT02229851|76169057|FG006|STARTED|Main Phase (Double-blind Phase)|This arm is not applicable for the Main phase.|0||
59514651|NCT02876926|75608300|FG000|NOT COMPLETED|Overall Study||18||
60053389|NCT02229851|76169051|FG000|Full Analysis Set|Main Phase (Double-blind Phase)||61||
60053390|NCT02229851|76169052|FG001|Full Analysis Set|Main Phase (Double-blind Phase)||119||
59514652|NCT02876926|75608301|FG001|NOT COMPLETED|Overall Study||19||
59514653|NCT02876926|75608302|FG002|NOT COMPLETED|Overall Study||20||
59514654|NCT03050320|75608312|FG000|STARTED|Overall Study||21||
59514655|NCT03050320|75608313|FG001|STARTED|Overall Study||22||
59514656|NCT03050320|75608312|FG000|COMPLETED|Overall Study||20||
59514657|NCT03050320|75608313|FG001|COMPLETED|Overall Study||21||
59514658|NCT03050320|75608312|FG000|NOT COMPLETED|Overall Study||1||
59514659|NCT03050320|75608313|FG001|NOT COMPLETED|Overall Study||1||
59514660|NCT00967993|75608319|FG000|STARTED|Overall Study||22||
59514661|NCT00967993|75608319|FG000|COMPLETED|Overall Study||18||
60053391|NCT02229851|76169053|FG002|Full Analysis Set|Main Phase (Double-blind Phase)||120||
60053392|NCT02229851|76169054|FG003|Full Analysis Set|Main Phase (Double-blind Phase)||0||
60053393|NCT02229851|76169055|FG004|Full Analysis Set|Main Phase (Double-blind Phase)||0||
60053394|NCT02229851|76169056|FG005|Full Analysis Set|Main Phase (Double-blind Phase)||0||
60053395|NCT02229851|76169057|FG006|Full Analysis Set|Main Phase (Double-blind Phase)||0||
60053396|NCT02229851|76169051|FG000|Safety Analysis Set|Main Phase (Double-blind Phase)||61||
60053397|NCT02229851|76169052|FG001|Safety Analysis Set|Main Phase (Double-blind Phase)||119||
60053398|NCT02229851|76169053|FG002|Safety Analysis Set|Main Phase (Double-blind Phase)||120||
60053399|NCT02229851|76169054|FG003|Safety Analysis Set|Main Phase (Double-blind Phase)||0||
60053400|NCT02229851|76169055|FG004|Safety Analysis Set|Main Phase (Double-blind Phase)||0||
60053401|NCT02229851|76169056|FG005|Safety Analysis Set|Main Phase (Double-blind Phase)||0||
60053402|NCT02229851|76169057|FG006|Safety Analysis Set|Main Phase (Double-blind Phase)||0||
60053403|NCT02229851|76169051|FG000|COMPLETED|Main Phase (Double-blind Phase)||55||
60053404|NCT02229851|76169052|FG001|COMPLETED|Main Phase (Double-blind Phase)||103||
60053405|NCT02229851|76169053|FG002|COMPLETED|Main Phase (Double-blind Phase)||114||
60053406|NCT02229851|76169054|FG003|COMPLETED|Main Phase (Double-blind Phase)||0||
60053407|NCT02229851|76169055|FG004|COMPLETED|Main Phase (Double-blind Phase)||0||
60053408|NCT02229851|76169056|FG005|COMPLETED|Main Phase (Double-blind Phase)||0||
60053409|NCT02229851|76169057|FG006|COMPLETED|Main Phase (Double-blind Phase)||0||
60053410|NCT02229851|76169051|FG000|NOT COMPLETED|Main Phase (Double-blind Phase)||6||
60053411|NCT02229851|76169052|FG001|NOT COMPLETED|Main Phase (Double-blind Phase)||16||
60053412|NCT02229851|76169053|FG002|NOT COMPLETED|Main Phase (Double-blind Phase)||6||
60053413|NCT02229851|76169054|FG003|NOT COMPLETED|Main Phase (Double-blind Phase)||0||
60053414|NCT02229851|76169055|FG004|NOT COMPLETED|Main Phase (Double-blind Phase)||0||
59514662|NCT00967993|75608319|FG000|NOT COMPLETED|Overall Study||4||
59514663|NCT02878486|75608325|FG000|STARTED|Overall Study||3||
59514664|NCT02878486|75608326|FG001|STARTED|Overall Study||3||
60053415|NCT02229851|76169056|FG005|NOT COMPLETED|Main Phase (Double-blind Phase)||0||
60053416|NCT02229851|76169057|FG006|NOT COMPLETED|Main Phase (Double-blind Phase)||0||
60053417|NCT02229851|76169051|FG000|STARTED|Extension Phase (Open-label Phase)|This arm is not applicable for the Extension phase.|0||
60053418|NCT02229851|76169052|FG001|STARTED|Extension Phase (Open-label Phase)|This arm is not applicable for the Extension phase.|0||
60053419|NCT02229851|76169053|FG002|STARTED|Extension Phase (Open-label Phase)|This arm is not applicable for the Extension phase.|0||
60053420|NCT02229851|76169054|FG003|STARTED|Extension Phase (Open-label Phase)||55||
60053421|NCT02229851|76169055|FG004|STARTED|Extension Phase (Open-label Phase)||114||
60053422|NCT02229851|76169056|FG005|STARTED|Extension Phase (Open-label Phase)||52||
60053423|NCT02229851|76169057|FG006|STARTED|Extension Phase (Open-label Phase)||51||
60053424|NCT02229851|76169051|FG000|COMPLETED|Extension Phase (Open-label Phase)||0||
60053425|NCT02229851|76169052|FG001|COMPLETED|Extension Phase (Open-label Phase)||0||
59514665|NCT02878486|75608325|FG000|COMPLETED|Overall Study||3||
59514666|NCT02878486|75608326|FG001|COMPLETED|Overall Study||3||
59514667|NCT02878486|75608325|FG000|NOT COMPLETED|Overall Study||0||
59514668|NCT02878486|75608326|FG001|NOT COMPLETED|Overall Study||0||
59514669|NCT01009333|75608332|FG000|STARTED|Week 1||2||
59514670|NCT01009333|75608333|FG001|STARTED|Week 1||3||
60053426|NCT02229851|76169053|FG002|COMPLETED|Extension Phase (Open-label Phase)||0||
60053427|NCT02229851|76169054|FG003|COMPLETED|Extension Phase (Open-label Phase)||53||
60053428|NCT02229851|76169055|FG004|COMPLETED|Extension Phase (Open-label Phase)||109||
60053429|NCT02229851|76169056|FG005|COMPLETED|Extension Phase (Open-label Phase)||47||
60053430|NCT02229851|76169057|FG006|COMPLETED|Extension Phase (Open-label Phase)||48||
59514671|NCT01009333|75608334|FG002|STARTED|Week 1||2||
59514672|NCT01009333|75608335|FG003|STARTED|Week 1||2||
59514673|NCT01009333|75608336|FG004|STARTED|Week 1||2||
59514674|NCT01009333|75608337|FG005|STARTED|Week 1||2||
59514675|NCT01009333|75608332|FG000|COMPLETED|Week 1||2||
59514676|NCT01009333|75608333|FG001|COMPLETED|Week 1|1 participant did not progress to the second period due to a protocol violation.|3||
59514677|NCT01009333|75608334|FG002|COMPLETED|Week 1||2||
59514678|NCT01009333|75608335|FG003|COMPLETED|Week 1||2||
59514679|NCT01009333|75608336|FG004|COMPLETED|Week 1||2||
60053431|NCT02229851|76169051|FG000|NOT COMPLETED|Extension Phase (Open-label Phase)||0||
59514680|NCT01009333|75608337|FG005|COMPLETED|Week 1||2||
59514681|NCT01009333|75608332|FG000|NOT COMPLETED|Week 1||0||
59514682|NCT01009333|75608333|FG001|NOT COMPLETED|Week 1||0||
59514683|NCT01009333|75608334|FG002|NOT COMPLETED|Week 1||0||
59514684|NCT01009333|75608335|FG003|NOT COMPLETED|Week 1||0||
59514685|NCT01009333|75608336|FG004|NOT COMPLETED|Week 1||0||
59514686|NCT01009333|75608337|FG005|NOT COMPLETED|Week 1||0||
59514687|NCT01009333|75608332|FG000|STARTED|Week 2||2||
59514688|NCT01009333|75608333|FG001|STARTED|Week 2||2||
60053432|NCT02229851|76169052|FG001|NOT COMPLETED|Extension Phase (Open-label Phase)||0||
60053433|NCT02229851|76169053|FG002|NOT COMPLETED|Extension Phase (Open-label Phase)||0||
60053434|NCT02229851|76169054|FG003|NOT COMPLETED|Extension Phase (Open-label Phase)||2||
60053435|NCT02229851|76169055|FG004|NOT COMPLETED|Extension Phase (Open-label Phase)||5||
60053436|NCT02229851|76169056|FG005|NOT COMPLETED|Extension Phase (Open-label Phase)||5||
60053437|NCT02229851|76169057|FG006|NOT COMPLETED|Extension Phase (Open-label Phase)||3||
60053438|NCT01482910|76169074|FG000|STARTED|Overall Study||228||
60053439|NCT01482910|76169075|FG001|STARTED|Overall Study||76||
60053440|NCT01482910|76169074|FG000|Completed Week 28|Overall Study||216||
60053441|NCT01482910|76169075|FG001|Completed Week 28|Overall Study||71||
60053442|NCT01482910|76169074|FG000|COMPLETED|Overall Study||213||
60053443|NCT01482910|76169075|FG001|COMPLETED|Overall Study||67||
60053444|NCT01482910|76169074|FG000|NOT COMPLETED|Overall Study||15||
60053445|NCT01482910|76169075|FG001|NOT COMPLETED|Overall Study||9||
60053446|NCT01626391|76169085|FG000|STARTED|Overall Study||5||
60053447|NCT01626391|76169086|FG001|STARTED|Overall Study||4||
60053448|NCT01626391|76169085|FG000|COMPLETED|Overall Study||3||
60053449|NCT01626391|76169086|FG001|COMPLETED|Overall Study||4||
60053450|NCT01626391|76169085|FG000|NOT COMPLETED|Overall Study||2||
60053451|NCT01626391|76169086|FG001|NOT COMPLETED|Overall Study||0||
60053452|NCT02103439|76169094|FG000|STARTED|Overall Study||70||
60053453|NCT02103439|76169095|FG001|STARTED|Overall Study||70||
60053454|NCT02103439|76169094|FG000|COMPLETED|Overall Study||67||
60053455|NCT02103439|76169095|FG001|COMPLETED|Overall Study||67||
60053456|NCT02103439|76169094|FG000|NOT COMPLETED|Overall Study||3||
60053457|NCT02103439|76169095|FG001|NOT COMPLETED|Overall Study||3||
60053458|NCT02229539|76169108|FG000|STARTED|Cycle 1 (Treatment Per Protocol)||77||
60053459|NCT02229539|76169109|FG001|STARTED|Cycle 1 (Treatment Per Protocol)||76||
60053460|NCT02229539|76169110|FG002|STARTED|Cycle 1 (Treatment Per Protocol)||75||
60053461|NCT02229539|76169108|FG000|COMPLETED|Cycle 1 (Treatment Per Protocol)||74||
60053462|NCT02229539|76169109|FG001|COMPLETED|Cycle 1 (Treatment Per Protocol)||71||
60053463|NCT02229539|76169110|FG002|COMPLETED|Cycle 1 (Treatment Per Protocol)||72||
60053464|NCT02229539|76169108|FG000|NOT COMPLETED|Cycle 1 (Treatment Per Protocol)||3||
60053465|NCT02229539|76169109|FG001|NOT COMPLETED|Cycle 1 (Treatment Per Protocol)||5||
60053466|NCT02229539|76169110|FG002|NOT COMPLETED|Cycle 1 (Treatment Per Protocol)||3||
60053467|NCT02229539|76169108|FG000|STARTED|Cycle 2 (Optional Continuation Phase)||35|Include only those who completed cycle 1 and chose to continue the study drug for up to 7 days.|
60053468|NCT02229539|76169109|FG001|STARTED|Cycle 2 (Optional Continuation Phase)||36|Include only those who completed cycle 1 and chose to continue the study drug for up to 7 days.|
60053469|NCT02229539|76169110|FG002|STARTED|Cycle 2 (Optional Continuation Phase)||32|Include only those who completed cycle 1 and chose to continue the study drug for up to 7 days.|
59514689|NCT01009333|75608334|FG002|STARTED|Week 2||2||
59514690|NCT01009333|75608335|FG003|STARTED|Week 2||2||
59514691|NCT01009333|75608336|FG004|STARTED|Week 2||2||
59514692|NCT01009333|75608337|FG005|STARTED|Week 2||2||
59514693|NCT01009333|75608332|FG000|COMPLETED|Week 2||2||
59514694|NCT01009333|75608333|FG001|COMPLETED|Week 2||2||
60053470|NCT02229539|76169108|FG000|COMPLETED|Cycle 2 (Optional Continuation Phase)||26||
60053471|NCT02229539|76169109|FG001|COMPLETED|Cycle 2 (Optional Continuation Phase)||29||
60053472|NCT02229539|76169110|FG002|COMPLETED|Cycle 2 (Optional Continuation Phase)||22||
60053473|NCT02229539|76169108|FG000|NOT COMPLETED|Cycle 2 (Optional Continuation Phase)||9||
60053474|NCT02229539|76169109|FG001|NOT COMPLETED|Cycle 2 (Optional Continuation Phase)||7||
60053475|NCT02229539|76169110|FG002|NOT COMPLETED|Cycle 2 (Optional Continuation Phase)||10||
60053476|NCT01835223|76169120|FG000|STARTED|Overall Study||30||
60053477|NCT01835223|76169121|FG001|STARTED|Overall Study||3||
60053478|NCT01835223|76169120|FG000|COMPLETED|Overall Study||21||
60053479|NCT01835223|76169121|FG001|COMPLETED|Overall Study||2||
59514695|NCT01009333|75608334|FG002|COMPLETED|Week 2||2||
59514696|NCT01009333|75608335|FG003|COMPLETED|Week 2||2||
60053480|NCT01835223|76169120|FG000|NOT COMPLETED|Overall Study||9||
60053481|NCT01835223|76169121|FG001|NOT COMPLETED|Overall Study||1||
60053482|NCT01482598|76169131|FG000|STARTED|Overall Study||66|1st subject was enrolled on 19th October 2011|
60053483|NCT01482598|76169132|FG001|STARTED|Overall Study||73|1st subject was enrolled on 19th October 2011|
60053484|NCT01482598|76169131|FG000|COMPLETED|Overall Study||50|last subject was enrolled on 9th June 2014|
60053485|NCT01482598|76169132|FG001|COMPLETED|Overall Study||51|last subject was enrolled on 9th June 2014|
60053486|NCT01482598|76169131|FG000|NOT COMPLETED|Overall Study||16||
60053487|NCT01482598|76169132|FG001|NOT COMPLETED|Overall Study||22||
60053488|NCT01460446|76169140|FG000|STARTED|Overall Study||105||
60053489|NCT01460446|76169141|FG001|STARTED|Overall Study||113||
60053490|NCT01460446|76169140|FG000|COMPLETED|Overall Study||100||
59514697|NCT01009333|75608336|FG004|COMPLETED|Week 2||2||
59514698|NCT01009333|75608337|FG005|COMPLETED|Week 2||2||
59514699|NCT01009333|75608332|FG000|NOT COMPLETED|Week 2||0||
59514700|NCT01009333|75608333|FG001|NOT COMPLETED|Week 2||0||
59514701|NCT01009333|75608334|FG002|NOT COMPLETED|Week 2||0||
59922972|NCT03073200|76042360|FG001|STARTED|Randomized Withdrawal Period||0||
60053491|NCT01460446|76169141|FG001|COMPLETED|Overall Study||93||
60053492|NCT01460446|76169140|FG000|NOT COMPLETED|Overall Study||5||
60053493|NCT01460446|76169141|FG001|NOT COMPLETED|Overall Study||20||
60053494|NCT02229383|76169150|FG000|STARTED|Overall Study||232||
60053495|NCT02229383|76169151|FG001|STARTED|Overall Study||229||
60053496|NCT02229383|76169150|FG000|Received Treatment|Overall Study||231||
60053497|NCT02229383|76169151|FG001|Received Treatment|Overall Study||229||
60053498|NCT02229383|76169150|FG000|Safety Analysis Set|Overall Study||231||
60053499|NCT02229383|76169151|FG001|Safety Analysis Set|Overall Study||229||
60053500|NCT02229383|76169150|FG000|Intent-to-treat (ITT) Analysis Set|Overall Study||230||
60053501|NCT02229383|76169151|FG001|Intent-to-treat (ITT) Analysis Set|Overall Study||228||
60053502|NCT02229383|76169150|FG000|COMPLETED|Overall Study||212||
60053503|NCT02229383|76169151|FG001|COMPLETED|Overall Study||207||
60053504|NCT02229383|76169150|FG000|NOT COMPLETED|Overall Study||20||
60053505|NCT02229383|76169151|FG001|NOT COMPLETED|Overall Study||22||
60053506|NCT01499368|76169160|FG000|STARTED|Overall Study||165||
60053507|NCT01499368|76169161|FG001|STARTED|Overall Study||163||
60053508|NCT01499368|76169162|FG002|STARTED|Overall Study||167||
60053509|NCT01499368|76169160|FG000|COMPLETED|Overall Study||138||
60053510|NCT01499368|76169161|FG001|COMPLETED|Overall Study||145||
60053511|NCT01499368|76169162|FG002|COMPLETED|Overall Study||146||
60053512|NCT01499368|76169160|FG000|NOT COMPLETED|Overall Study||27||
60053513|NCT01499368|76169161|FG001|NOT COMPLETED|Overall Study||18||
60053514|NCT01499368|76169162|FG002|NOT COMPLETED|Overall Study||21||
60053515|NCT01835145|76169172|FG000|STARTED|Overall Study||32||
60053516|NCT01835145|76169173|FG001|STARTED|Overall Study||15||
60053517|NCT01835145|76169172|FG000|COMPLETED|Overall Study||31||
60053518|NCT01835145|76169173|FG001|COMPLETED|Overall Study||15||
60053519|NCT01835145|76169172|FG000|NOT COMPLETED|Overall Study||1||
60053520|NCT01835145|76169173|FG001|NOT COMPLETED|Overall Study||0||
60053521|NCT02229227|76169183|FG000|STARTED|Overall Study||402||
60053522|NCT02229227|76169184|FG001|STARTED|Overall Study||412||
60053523|NCT02229227|76169183|FG000|COMPLETED|Overall Study||351||
60053524|NCT02229227|76169184|FG001|COMPLETED|Overall Study||350||
60053525|NCT02229227|76169183|FG000|NOT COMPLETED|Overall Study||51||
60053526|NCT02229227|76169184|FG001|NOT COMPLETED|Overall Study||62||
60053527|NCT01499290|76169192|FG000|STARTED|Overall Study|Patients dosed in pooled protocols D4280C00001/D4280C00005 (NCT01499290/NCT01500239) agreed with FDA|529||
60053528|NCT01499290|76169193|FG001|STARTED|Overall Study|Patients dosed in pooled protocols D4280C00001/D4280C00005 (NCT01499290/NCT01500239) agreed with FDA|529||
60053529|NCT01499290|76169192|FG000|COMPLETED|Overall Study|(Numbers indicate patients who completed treatment)|474||
60053530|NCT01499290|76169193|FG001|COMPLETED|Overall Study|(Numbers indicate patients who completed treatment)|494||
60053531|NCT01499290|76169192|FG000|NOT COMPLETED|Overall Study||55||
60053532|NCT01499290|76169193|FG001|NOT COMPLETED|Overall Study||35||
60053533|NCT01833897|76169218|FG000|STARTED|Overall Study||8||
60053534|NCT01833897|76169218|FG000|COMPLETED|Overall Study||7||
60053535|NCT01833897|76169218|FG000|NOT COMPLETED|Overall Study||1||
60053536|NCT01481896|76169222|FG000|STARTED|Overall Study|The 126 participants includes 5 participants with bilateral hip replacements for a total of 131 THAs|126||
60053537|NCT01481896|76169222|FG000|Min 4.75 yr Follow-up, Revised or Dead|Overall Study|114 participants with 119 THAs had at least 4.75 year follow-up or were known revised or deceased|114||
60053538|NCT01481896|76169222|FG000|COMPLETED|Overall Study|The 114 participants includes 5 participants with bilateral hip replacements for a total of 119 THAs|114||
60053539|NCT01481896|76169222|FG000|NOT COMPLETED|Overall Study||12||
60053540|NCT02226653|76169238|FG000|STARTED|Treatment Period 1 Fasted State||24||
60053541|NCT02226653|76169239|FG001|STARTED|Treatment Period 1 Fasted State||24||
59922973|NCT03073200|76042361|FG002|STARTED|Randomized Withdrawal Period||0||
59922974|NCT03073200|76042362|FG003|STARTED|Randomized Withdrawal Period||0||
59922975|NCT03073200|76042363|FG004|STARTED|Randomized Withdrawal Period||0||
59922976|NCT03073200|76042364|FG005|STARTED|Randomized Withdrawal Period||0||
59922977|NCT03073200|76042365|FG006|STARTED|Randomized Withdrawal Period|This period is to report randomized withdrawal period participants.|0||
59922978|NCT03073200|76042366|FG007|STARTED|Randomized Withdrawal Period|This period is to report randomized withdrawal period participants.|0||
59922979|NCT03073200|76042367|FG008|STARTED|Randomized Withdrawal Period|This period is to report randomized withdrawal period participants.|0||
59922980|NCT03073200|76042368|FG009|STARTED|Randomized Withdrawal Period|This period is to report randomized withdrawal period participants.|33||
59922981|NCT03073200|76042369|FG010|STARTED|Randomized Withdrawal Period|This period is to report randomized withdrawal period participants.|34||
60053542|NCT02226653|76169238|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 1 Fasted State||24||
60053543|NCT02226653|76169239|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 1 Fasted State||24||
60067856|NCT01785615|76183053|FG001|NOT COMPLETED|Dietary Phase||0||
59514702|NCT01009333|75608335|FG003|NOT COMPLETED|Week 2||0||
59514703|NCT01009333|75608336|FG004|NOT COMPLETED|Week 2||0||
59514704|NCT01009333|75608337|FG005|NOT COMPLETED|Week 2||0||
59514705|NCT01009333|75608332|FG000|STARTED|Week 3||2||
59514706|NCT01009333|75608333|FG001|STARTED|Week 3||2||
59514707|NCT01009333|75608334|FG002|STARTED|Week 3||2||
59514708|NCT01009333|75608335|FG003|STARTED|Week 3||2||
59514709|NCT01009333|75608336|FG004|STARTED|Week 3||2||
59514710|NCT01009333|75608337|FG005|STARTED|Week 3||2||
59514711|NCT01009333|75608332|FG000|COMPLETED|Week 3||2||
59514712|NCT01009333|75608333|FG001|COMPLETED|Week 3||2||
59514713|NCT01009333|75608334|FG002|COMPLETED|Week 3||2||
59514714|NCT01009333|75608335|FG003|COMPLETED|Week 3||2||
60053544|NCT02226653|76169238|FG000|COMPLETED|Treatment Period 1 Fasted State||24||
60053545|NCT02226653|76169239|FG001|COMPLETED|Treatment Period 1 Fasted State||24||
60053546|NCT02226653|76169238|FG000|NOT COMPLETED|Treatment Period 1 Fasted State||0||
60053547|NCT02226653|76169239|FG001|NOT COMPLETED|Treatment Period 1 Fasted State||0||
60053548|NCT02226653|76169238|FG000|STARTED|Washout Period 1 (at Least 21 Days)||24||
60053549|NCT02226653|76169239|FG001|STARTED|Washout Period 1 (at Least 21 Days)||24||
59514715|NCT01009333|75608336|FG004|COMPLETED|Week 3||2||
59514716|NCT01009333|75608337|FG005|COMPLETED|Week 3||2||
59514717|NCT01009333|75608332|FG000|NOT COMPLETED|Week 3||0||
59514718|NCT01009333|75608333|FG001|NOT COMPLETED|Week 3||0||
59514719|NCT01009333|75608334|FG002|NOT COMPLETED|Week 3||0||
59514720|NCT01009333|75608335|FG003|NOT COMPLETED|Week 3||0||
59514721|NCT01009333|75608336|FG004|NOT COMPLETED|Week 3||0||
59514722|NCT01009333|75608337|FG005|NOT COMPLETED|Week 3||0||
59514723|NCT02879032|75608345|FG000|STARTED|Overall Study||130|Patients were selected by purposive sampling as samples were taken according to selection criteria|
59514724|NCT02879032|75608345|FG000|COMPLETED|Overall Study||130||
59514725|NCT02879032|75608345|FG000|NOT COMPLETED|Overall Study||0||
59514726|NCT02880514|75608351|FG000|STARTED|Overall Study|A total of 50 subjects with one sinus side assigned to the treatment group|50||50
59612917|NCT01716234|75723950|FG004|STARTED|Overall Study||15||
60053550|NCT02226653|76169238|FG000|COMPLETED|Washout Period 1 (at Least 21 Days)||24||
60053551|NCT02226653|76169239|FG001|COMPLETED|Washout Period 1 (at Least 21 Days)||24||
60053552|NCT02226653|76169238|FG000|NOT COMPLETED|Washout Period 1 (at Least 21 Days)||0||
60053553|NCT02226653|76169239|FG001|NOT COMPLETED|Washout Period 1 (at Least 21 Days)||0||
60053554|NCT02226653|76169238|FG000|STARTED|Treatment Period 2 Fasted State||24||
60053555|NCT02226653|76169239|FG001|STARTED|Treatment Period 2 Fasted State||24||
60053556|NCT02226653|76169238|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 2 Fasted State||24||
60053557|NCT02226653|76169239|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 2 Fasted State||24||
60053558|NCT02226653|76169238|FG000|COMPLETED|Treatment Period 2 Fasted State||23||
60053559|NCT02226653|76169239|FG001|COMPLETED|Treatment Period 2 Fasted State||24||
60053560|NCT02226653|76169238|FG000|NOT COMPLETED|Treatment Period 2 Fasted State||1||
60053561|NCT02226653|76169239|FG001|NOT COMPLETED|Treatment Period 2 Fasted State||0||
60053562|NCT02226653|76169238|FG000|STARTED|Washout Period 2 (at Least 21 Days)||23||
60053563|NCT02226653|76169239|FG001|STARTED|Washout Period 2 (at Least 21 Days)||24||
60053564|NCT02226653|76169238|FG000|COMPLETED|Washout Period 2 (at Least 21 Days)||23||
60053565|NCT02226653|76169239|FG001|COMPLETED|Washout Period 2 (at Least 21 Days)||24||
59612918|NCT01716234|75723951|FG005|STARTED|Overall Study||32||
59612919|NCT01716234|75723952|FG006|STARTED|Overall Study||1||
59612920|NCT01716234|75723946|FG000|Treated|Overall Study||22||
60053566|NCT02226653|76169238|FG000|NOT COMPLETED|Washout Period 2 (at Least 21 Days)||0||
60053567|NCT02226653|76169239|FG001|NOT COMPLETED|Washout Period 2 (at Least 21 Days)||0||
60053568|NCT02226653|76169238|FG000|STARTED|Treatment Period 3 Fasted State||23||
60053569|NCT02226653|76169239|FG001|STARTED|Treatment Period 3 Fasted State||24||
60053570|NCT02226653|76169238|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 3 Fasted State||23||
60053571|NCT02226653|76169239|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 3 Fasted State||24||
60053572|NCT02226653|76169238|FG000|COMPLETED|Treatment Period 3 Fasted State||23||
60053573|NCT02226653|76169239|FG001|COMPLETED|Treatment Period 3 Fasted State||24||
60053574|NCT02226653|76169238|FG000|NOT COMPLETED|Treatment Period 3 Fasted State||0||
60053575|NCT02226653|76169239|FG001|NOT COMPLETED|Treatment Period 3 Fasted State||0||
60053576|NCT02226653|76169238|FG000|STARTED|Washout Period 3 (at Least 21 Days)||23||
60053577|NCT02226653|76169239|FG001|STARTED|Washout Period 3 (at Least 21 Days)||24||
59612921|NCT01716234|75723947|FG001|Treated|Overall Study||21||
60053578|NCT02226653|76169238|FG000|COMPLETED|Washout Period 3 (at Least 21 Days)||23||
59514727|NCT02880514|75608352|FG001|STARTED|Overall Study|A total of 50 subjects with one sinus side assigned to the control group|50||50
59514728|NCT02880514|75608351|FG000|COMPLETED|Overall Study||50||50
59514729|NCT02880514|75608352|FG001|COMPLETED|Overall Study||50||50
59514730|NCT02880514|75608351|FG000|NOT COMPLETED|Overall Study||0||0
59514731|NCT02880514|75608352|FG001|NOT COMPLETED|Overall Study||0||0
59514732|NCT00968071|75608359|FG000|STARTED|Overall Study||71||
59612922|NCT01716234|75723948|FG002|Treated|Overall Study||19||
59612923|NCT01716234|75723949|FG003|Treated|Overall Study||28||
59612924|NCT01716234|75723950|FG004|Treated|Overall Study||15||
59612925|NCT01716234|75723951|FG005|Treated|Overall Study||30||
60053579|NCT02226653|76169239|FG001|COMPLETED|Washout Period 3 (at Least 21 Days)||24||
60053580|NCT02226653|76169238|FG000|NOT COMPLETED|Washout Period 3 (at Least 21 Days)||0||
60053581|NCT02226653|76169239|FG001|NOT COMPLETED|Washout Period 3 (at Least 21 Days)||0||
60053582|NCT02226653|76169238|FG000|STARTED|Treatment Period 4 Fasted State||23||
60053583|NCT02226653|76169239|FG001|STARTED|Treatment Period 4 Fasted State||24||
60053584|NCT02226653|76169238|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 4 Fasted State||23||
60053585|NCT02226653|76169239|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 4 Fasted State||24||
60053586|NCT02226653|76169238|FG000|COMPLETED|Treatment Period 4 Fasted State||23||
60053587|NCT02226653|76169239|FG001|COMPLETED|Treatment Period 4 Fasted State||24||
60053588|NCT02226653|76169238|FG000|NOT COMPLETED|Treatment Period 4 Fasted State||0||
60053589|NCT02226653|76169239|FG001|NOT COMPLETED|Treatment Period 4 Fasted State||0||
60053590|NCT02226653|76169238|FG000|STARTED|Washout Period 4 (at Least 21 Days)||23||
60053591|NCT02226653|76169239|FG001|STARTED|Washout Period 4 (at Least 21 Days)||24||
60053592|NCT02226653|76169238|FG000|COMPLETED|Washout Period 4 (at Least 21 Days)||23||
60053593|NCT02226653|76169239|FG001|COMPLETED|Washout Period 4 (at Least 21 Days)||24||
60053594|NCT02226653|76169238|FG000|NOT COMPLETED|Washout Period 4 (at Least 21 Days)||0||
60053595|NCT02226653|76169239|FG001|NOT COMPLETED|Washout Period 4 (at Least 21 Days)||0||
60053596|NCT02226653|76169238|FG000|STARTED|Treatment Period 5 Fed State||23||
60053597|NCT02226653|76169239|FG001|STARTED|Treatment Period 5 Fed State||24||
60053598|NCT02226653|76169238|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 5 Fed State||23||
60053599|NCT02226653|76169239|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 5 Fed State||24||
60053600|NCT02226653|76169238|FG000|COMPLETED|Treatment Period 5 Fed State||23||
60053601|NCT02226653|76169239|FG001|COMPLETED|Treatment Period 5 Fed State||23||
60053602|NCT02226653|76169238|FG000|NOT COMPLETED|Treatment Period 5 Fed State||0||
60053603|NCT02226653|76169239|FG001|NOT COMPLETED|Treatment Period 5 Fed State||1||
60053604|NCT02226653|76169238|FG000|STARTED|Washout Period 5 (at Least 21 Days)||23||
60053605|NCT02226653|76169239|FG001|STARTED|Washout Period 5 (at Least 21 Days)||23||
60053606|NCT02226653|76169238|FG000|COMPLETED|Washout Period 5 (at Least 21 Days)||23||
60053607|NCT02226653|76169239|FG001|COMPLETED|Washout Period 5 (at Least 21 Days)||23||
60053608|NCT02226653|76169238|FG000|NOT COMPLETED|Washout Period 5 (at Least 21 Days)||0||
60053609|NCT02226653|76169239|FG001|NOT COMPLETED|Washout Period 5 (at Least 21 Days)||0||
60053610|NCT02201771|76169255|FG000|STARTED|Overall Study||166||
60053611|NCT02201771|76169256|FG001|STARTED|Overall Study||168||
60053612|NCT02201771|76169257|FG002|STARTED|Overall Study||166||
60053613|NCT02201771|76169255|FG000|COMPLETED|Overall Study||153||
60053614|NCT02201771|76169256|FG001|COMPLETED|Overall Study||158||
60053615|NCT02201771|76169257|FG002|COMPLETED|Overall Study||156||
60053616|NCT02201771|76169255|FG000|NOT COMPLETED|Overall Study||13||
60053617|NCT02201771|76169256|FG001|NOT COMPLETED|Overall Study||10||
60053618|NCT02201771|76169257|FG002|NOT COMPLETED|Overall Study||10||
60053619|NCT01460368|76169267|FG000|STARTED|Part A||7||
60053620|NCT01460368|76169268|FG001|STARTED|Part A||0||
60053621|NCT01460368|76169269|FG002|STARTED|Part A||0||
60053622|NCT01460368|76169270|FG003|STARTED|Part A||0||
60053623|NCT01460368|76169271|FG004|STARTED|Part A||0||
60053624|NCT01460368|76169272|FG005|STARTED|Part A||0||
60053625|NCT01460368|76169273|FG006|STARTED|Part A||0||
60053626|NCT01460368|76169267|FG000|Received at Least One Dose of Study Drug|Part A||7||
60053627|NCT01460368|76169268|FG001|Received at Least One Dose of Study Drug|Part A||0||
60053628|NCT01460368|76169269|FG002|Received at Least One Dose of Study Drug|Part A||0||
60053629|NCT01460368|76169270|FG003|Received at Least One Dose of Study Drug|Part A||0||
60053630|NCT01460368|76169271|FG004|Received at Least One Dose of Study Drug|Part A||0||
60053631|NCT01460368|76169272|FG005|Received at Least One Dose of Study Drug|Part A||0||
60053632|NCT01460368|76169273|FG006|Received at Least One Dose of Study Drug|Part A||0||
60053633|NCT01460368|76169267|FG000|COMPLETED|Part A||7||
60053634|NCT01460368|76169268|FG001|COMPLETED|Part A||0||
60053635|NCT01460368|76169269|FG002|COMPLETED|Part A||0||
60053636|NCT01460368|76169270|FG003|COMPLETED|Part A||0||
60053637|NCT01460368|76169271|FG004|COMPLETED|Part A||0||
60053638|NCT01460368|76169272|FG005|COMPLETED|Part A||0||
60053639|NCT01460368|76169273|FG006|COMPLETED|Part A||0||
60053640|NCT01460368|76169267|FG000|NOT COMPLETED|Part A||0||
60053641|NCT01460368|76169268|FG001|NOT COMPLETED|Part A||0||
60053642|NCT01460368|76169269|FG002|NOT COMPLETED|Part A||0||
60053643|NCT01460368|76169270|FG003|NOT COMPLETED|Part A||0||
60053644|NCT01460368|76169271|FG004|NOT COMPLETED|Part A||0||
60053645|NCT01460368|76169272|FG005|NOT COMPLETED|Part A||0||
60053646|NCT01460368|76169273|FG006|NOT COMPLETED|Part A||0||
60053647|NCT01460368|76169267|FG000|STARTED|Part B: First Intervention (Period 1)||0||
60053648|NCT01460368|76169268|FG001|STARTED|Part B: First Intervention (Period 1)||10||
60053649|NCT01460368|76169269|FG002|STARTED|Part B: First Intervention (Period 1)||10||
60053650|NCT01460368|76169270|FG003|STARTED|Part B: First Intervention (Period 1)||10||
60053651|NCT01460368|76169271|FG004|STARTED|Part B: First Intervention (Period 1)||10||
60053652|NCT01460368|76169272|FG005|STARTED|Part B: First Intervention (Period 1)||10||
60053653|NCT01460368|76169273|FG006|STARTED|Part B: First Intervention (Period 1)||10||
60053654|NCT01460368|76169267|FG000|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||0||
60053655|NCT01460368|76169268|FG001|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10||
60053656|NCT01460368|76169269|FG002|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10||
60053657|NCT01460368|76169270|FG003|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10||
60053658|NCT01460368|76169271|FG004|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10||
60053659|NCT01460368|76169272|FG005|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10||
60053660|NCT01460368|76169273|FG006|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10||
60053661|NCT01460368|76169267|FG000|COMPLETED|Part B: First Intervention (Period 1)||0||
60053662|NCT01460368|76169268|FG001|COMPLETED|Part B: First Intervention (Period 1)||10||
60053663|NCT01460368|76169269|FG002|COMPLETED|Part B: First Intervention (Period 1)||10||
60053664|NCT01460368|76169270|FG003|COMPLETED|Part B: First Intervention (Period 1)||10||
60053665|NCT01460368|76169271|FG004|COMPLETED|Part B: First Intervention (Period 1)||9||
60053666|NCT01460368|76169272|FG005|COMPLETED|Part B: First Intervention (Period 1)||10||
60053667|NCT01460368|76169273|FG006|COMPLETED|Part B: First Intervention (Period 1)||10||
60053668|NCT01460368|76169267|FG000|NOT COMPLETED|Part B: First Intervention (Period 1)||0||
60053669|NCT01460368|76169268|FG001|NOT COMPLETED|Part B: First Intervention (Period 1)||0||
60053670|NCT01460368|76169269|FG002|NOT COMPLETED|Part B: First Intervention (Period 1)||0||
60053671|NCT01460368|76169270|FG003|NOT COMPLETED|Part B: First Intervention (Period 1)||0||
60053672|NCT01460368|76169271|FG004|NOT COMPLETED|Part B: First Intervention (Period 1)||1||
60053673|NCT01460368|76169272|FG005|NOT COMPLETED|Part B: First Intervention (Period 1)||0||
60053674|NCT01460368|76169273|FG006|NOT COMPLETED|Part B: First Intervention (Period 1)||0||
60053675|NCT01460368|76169267|FG000|STARTED|Part B: Washout (up to 15 Days)||0||
60053676|NCT01460368|76169268|FG001|STARTED|Part B: Washout (up to 15 Days)||10||
60053677|NCT01460368|76169269|FG002|STARTED|Part B: Washout (up to 15 Days)||10||
60053678|NCT01460368|76169270|FG003|STARTED|Part B: Washout (up to 15 Days)||10||
60053679|NCT01460368|76169271|FG004|STARTED|Part B: Washout (up to 15 Days)||9||
60053680|NCT01460368|76169272|FG005|STARTED|Part B: Washout (up to 15 Days)||10||
60053681|NCT01460368|76169273|FG006|STARTED|Part B: Washout (up to 15 Days)||10||
60053682|NCT01460368|76169267|FG000|COMPLETED|Part B: Washout (up to 15 Days)||0||
60053683|NCT01460368|76169268|FG001|COMPLETED|Part B: Washout (up to 15 Days)||10||
60053684|NCT01460368|76169269|FG002|COMPLETED|Part B: Washout (up to 15 Days)||10||
60053685|NCT01460368|76169270|FG003|COMPLETED|Part B: Washout (up to 15 Days)||10||
60053686|NCT01460368|76169271|FG004|COMPLETED|Part B: Washout (up to 15 Days)||9||
60053687|NCT01460368|76169272|FG005|COMPLETED|Part B: Washout (up to 15 Days)||10||
60053688|NCT01460368|76169273|FG006|COMPLETED|Part B: Washout (up to 15 Days)||10||
60053689|NCT01460368|76169267|FG000|NOT COMPLETED|Part B: Washout (up to 15 Days)||0||
60053690|NCT01460368|76169268|FG001|NOT COMPLETED|Part B: Washout (up to 15 Days)||0||
60053691|NCT01460368|76169269|FG002|NOT COMPLETED|Part B: Washout (up to 15 Days)||0||
60053692|NCT01460368|76169270|FG003|NOT COMPLETED|Part B: Washout (up to 15 Days)||0||
60053693|NCT01460368|76169271|FG004|NOT COMPLETED|Part B: Washout (up to 15 Days)||0||
60053694|NCT01460368|76169272|FG005|NOT COMPLETED|Part B: Washout (up to 15 Days)||0||
60053695|NCT01460368|76169273|FG006|NOT COMPLETED|Part B: Washout (up to 15 Days)||0||
60053696|NCT01460368|76169267|FG000|STARTED|Part B: Second Intervention (Period 2)||0||
60053697|NCT01460368|76169268|FG001|STARTED|Part B: Second Intervention (Period 2)||10||
60053698|NCT01460368|76169269|FG002|STARTED|Part B: Second Intervention (Period 2)||10||
60053699|NCT01460368|76169270|FG003|STARTED|Part B: Second Intervention (Period 2)||10||
60053700|NCT01460368|76169271|FG004|STARTED|Part B: Second Intervention (Period 2)||9||
60053701|NCT01460368|76169272|FG005|STARTED|Part B: Second Intervention (Period 2)||10||
60053702|NCT01460368|76169273|FG006|STARTED|Part B: Second Intervention (Period 2)||10||
60053703|NCT01460368|76169267|FG000|COMPLETED|Part B: Second Intervention (Period 2)||0||
60053704|NCT01460368|76169268|FG001|COMPLETED|Part B: Second Intervention (Period 2)||8||
60053705|NCT01460368|76169269|FG002|COMPLETED|Part B: Second Intervention (Period 2)||10||
60053706|NCT01460368|76169270|FG003|COMPLETED|Part B: Second Intervention (Period 2)||10||
60053707|NCT01460368|76169271|FG004|COMPLETED|Part B: Second Intervention (Period 2)||9||
60053708|NCT01460368|76169272|FG005|COMPLETED|Part B: Second Intervention (Period 2)||10||
60053709|NCT01460368|76169273|FG006|COMPLETED|Part B: Second Intervention (Period 2)||9||
60053710|NCT01460368|76169267|FG000|NOT COMPLETED|Part B: Second Intervention (Period 2)||0||
60053711|NCT01460368|76169268|FG001|NOT COMPLETED|Part B: Second Intervention (Period 2)||2||
60053712|NCT01460368|76169269|FG002|NOT COMPLETED|Part B: Second Intervention (Period 2)||0||
60053713|NCT01460368|76169270|FG003|NOT COMPLETED|Part B: Second Intervention (Period 2)||0||
60053714|NCT01460368|76169271|FG004|NOT COMPLETED|Part B: Second Intervention (Period 2)||0||
60053715|NCT01460368|76169272|FG005|NOT COMPLETED|Part B: Second Intervention (Period 2)||0||
60053716|NCT01460368|76169273|FG006|NOT COMPLETED|Part B: Second Intervention (Period 2)||1||
60053717|NCT01460368|76169267|FG000|STARTED|Part B: Washout (up to 15 Days)||0||
60053718|NCT01460368|76169268|FG001|STARTED|Part B: Washout (up to 15 Days)||8||
60053719|NCT01460368|76169269|FG002|STARTED|Part B: Washout (up to 15 Days)||10||
60053720|NCT01460368|76169270|FG003|STARTED|Part B: Washout (up to 15 Days)||10||
60053721|NCT01460368|76169271|FG004|STARTED|Part B: Washout (up to 15 Days)||9||
60053722|NCT01460368|76169272|FG005|STARTED|Part B: Washout (up to 15 Days)||10||
60053723|NCT01460368|76169273|FG006|STARTED|Part B: Washout (up to 15 Days)||9||
60053724|NCT01460368|76169267|FG000|COMPLETED|Part B: Washout (up to 15 Days)||0||
60053725|NCT01460368|76169268|FG001|COMPLETED|Part B: Washout (up to 15 Days)||8||
60053726|NCT01460368|76169269|FG002|COMPLETED|Part B: Washout (up to 15 Days)||9||
59514733|NCT00968071|75608359|FG000|COMPLETED|Overall Study||71||
59514734|NCT00968071|75608359|FG000|NOT COMPLETED|Overall Study||0||
59514735|NCT02987374|75608363|FG000|STARTED|Overall Study||10||
60053727|NCT01460368|76169270|FG003|COMPLETED|Part B: Washout (up to 15 Days)||10||
60053728|NCT01460368|76169271|FG004|COMPLETED|Part B: Washout (up to 15 Days)||9||
60053729|NCT01460368|76169272|FG005|COMPLETED|Part B: Washout (up to 15 Days)||10||
60053730|NCT01460368|76169273|FG006|COMPLETED|Part B: Washout (up to 15 Days)||9||
60053731|NCT01460368|76169267|FG000|NOT COMPLETED|Part B: Washout (up to 15 Days)||0||
60053732|NCT01460368|76169268|FG001|NOT COMPLETED|Part B: Washout (up to 15 Days)||0||
59514736|NCT02987374|75608363|FG000|COMPLETED|Overall Study||10||
60053733|NCT01460368|76169269|FG002|NOT COMPLETED|Part B: Washout (up to 15 Days)||1||
60053734|NCT01460368|76169270|FG003|NOT COMPLETED|Part B: Washout (up to 15 Days)||0||
60053735|NCT01460368|76169271|FG004|NOT COMPLETED|Part B: Washout (up to 15 Days)||0||
60053736|NCT01460368|76169272|FG005|NOT COMPLETED|Part B: Washout (up to 15 Days)||0||
60053737|NCT01460368|76169273|FG006|NOT COMPLETED|Part B: Washout (up to 15 Days)||0||
60053738|NCT01460368|76169267|FG000|STARTED|Part B: Third Interventions (Period 3)||0||
59514737|NCT02987374|75608363|FG000|NOT COMPLETED|Overall Study||0||
59514738|NCT00968227|75608367|FG000|STARTED|Overall Study||56||
59514739|NCT00968227|75608367|FG000|COMPLETED|Overall Study||56||
59514740|NCT00968227|75608367|FG000|NOT COMPLETED|Overall Study||0||
59514741|NCT02988856|75608371|FG000|STARTED|Overall Study||11||
59514742|NCT02988856|75608371|FG000|COMPLETED|Overall Study||8||
59514743|NCT02988856|75608371|FG000|NOT COMPLETED|Overall Study||3||
59514744|NCT02989246|75608375|FG000|STARTED|Overall Study||32||
59514745|NCT02989246|75608375|FG000|COMPLETED|Overall Study||32||
59514746|NCT02989246|75608375|FG000|NOT COMPLETED|Overall Study||0||
59514747|NCT00971737|75608381|FG000|STARTED|Overall Study||30||
59514748|NCT00971737|75608382|FG001|STARTED|Overall Study||30||
60053739|NCT01460368|76169268|FG001|STARTED|Part B: Third Interventions (Period 3)||8||
60053740|NCT01460368|76169269|FG002|STARTED|Part B: Third Interventions (Period 3)||9||
60053741|NCT01460368|76169270|FG003|STARTED|Part B: Third Interventions (Period 3)||10||
59514749|NCT00971737|75608381|FG000|COMPLETED|Overall Study||30||
60053742|NCT01460368|76169271|FG004|STARTED|Part B: Third Interventions (Period 3)||9||
60053743|NCT01460368|76169272|FG005|STARTED|Part B: Third Interventions (Period 3)||10||
60053744|NCT01460368|76169273|FG006|STARTED|Part B: Third Interventions (Period 3)||9||
60053745|NCT01460368|76169267|FG000|COMPLETED|Part B: Third Interventions (Period 3)||0||
60053746|NCT01460368|76169268|FG001|COMPLETED|Part B: Third Interventions (Period 3)||8||
60053747|NCT01460368|76169269|FG002|COMPLETED|Part B: Third Interventions (Period 3)||8||
60053748|NCT01460368|76169270|FG003|COMPLETED|Part B: Third Interventions (Period 3)||9||
60053749|NCT01460368|76169271|FG004|COMPLETED|Part B: Third Interventions (Period 3)||9||
60053750|NCT01460368|76169272|FG005|COMPLETED|Part B: Third Interventions (Period 3)||9||
60053751|NCT01460368|76169273|FG006|COMPLETED|Part B: Third Interventions (Period 3)||9||
60053752|NCT01460368|76169267|FG000|NOT COMPLETED|Part B: Third Interventions (Period 3)||0||
60053753|NCT01460368|76169268|FG001|NOT COMPLETED|Part B: Third Interventions (Period 3)||0||
60053754|NCT01460368|76169269|FG002|NOT COMPLETED|Part B: Third Interventions (Period 3)||1||
60053755|NCT01460368|76169270|FG003|NOT COMPLETED|Part B: Third Interventions (Period 3)||1||
60053756|NCT01460368|76169271|FG004|NOT COMPLETED|Part B: Third Interventions (Period 3)||0||
60053757|NCT01460368|76169272|FG005|NOT COMPLETED|Part B: Third Interventions (Period 3)||1||
59514750|NCT00971737|75608382|FG001|COMPLETED|Overall Study||30||
59514751|NCT00971737|75608381|FG000|NOT COMPLETED|Overall Study||0||
59514752|NCT00971737|75608382|FG001|NOT COMPLETED|Overall Study||0||
59514753|NCT00972205|75608388|FG000|STARTED|Overall Study||12||
59514754|NCT00972205|75608388|FG000|COMPLETED|Overall Study||12||
59514755|NCT00972205|75608388|FG000|NOT COMPLETED|Overall Study||0||
59514756|NCT00928421|75608392|FG000|STARTED|Overall Study||16||
59514757|NCT00928421|75608392|FG000|Treated With Study Drug|Overall Study||16||
59922982|NCT03073200|76042370|FG011|STARTED|Randomized Withdrawal Period|This period is to report randomized withdrawal period participants.|33||
59922983|NCT03073200|76042371|FG012|STARTED|Randomized Withdrawal Period||0||
59514758|NCT00928421|75608392|FG000|COMPLETED|Overall Study||16||
59514759|NCT00928421|75608392|FG000|NOT COMPLETED|Overall Study||0||
59514760|NCT00952315|75608399|FG000|STARTED|Overall Study||90||
59514761|NCT00952315|75608400|FG001|STARTED|Overall Study||90||
59514762|NCT00952315|75608401|FG002|STARTED|Overall Study||90||
59514763|NCT00952315|75608399|FG000|COMPLETED|Overall Study||64||
59514764|NCT00952315|75608400|FG001|COMPLETED|Overall Study||66||
59514765|NCT00952315|75608401|FG002|COMPLETED|Overall Study||71||
59514766|NCT00952315|75608399|FG000|NOT COMPLETED|Overall Study||26||
59514767|NCT00952315|75608400|FG001|NOT COMPLETED|Overall Study||24||
59514768|NCT00952315|75608401|FG002|NOT COMPLETED|Overall Study||19||
59514769|NCT00932321|75608414|FG000|STARTED|Overall Study||751||
59514770|NCT00932321|75608415|FG001|STARTED|Overall Study||187||
59514771|NCT00932321|75608414|FG000|MITT Population|Overall Study||705||
59922984|NCT03073200|76042372|FG013|STARTED|Randomized Withdrawal Period||0||
59922985|NCT03073200|76042373|FG014|STARTED|Randomized Withdrawal Period||0||
59922986|NCT03073200|76042359|FG000|COMPLETED|Randomized Withdrawal Period||0||
59922987|NCT03073200|76042360|FG001|COMPLETED|Randomized Withdrawal Period||0||
59922988|NCT03073200|76042361|FG002|COMPLETED|Randomized Withdrawal Period||0||
59922989|NCT03073200|76042362|FG003|COMPLETED|Randomized Withdrawal Period||0||
59922990|NCT03073200|76042363|FG004|COMPLETED|Randomized Withdrawal Period||0||
59922991|NCT03073200|76042364|FG005|COMPLETED|Randomized Withdrawal Period||0||
59922992|NCT03073200|76042365|FG006|COMPLETED|Randomized Withdrawal Period||0||
59922993|NCT03073200|76042366|FG007|COMPLETED|Randomized Withdrawal Period||0||
59922994|NCT03073200|76042367|FG008|COMPLETED|Randomized Withdrawal Period||0||
59922995|NCT03073200|76042368|FG009|COMPLETED|Randomized Withdrawal Period||33||
59922996|NCT03073200|76042369|FG010|COMPLETED|Randomized Withdrawal Period||32||
59922997|NCT03073200|76042370|FG011|COMPLETED|Randomized Withdrawal Period||30||
59922998|NCT03073200|76042371|FG012|COMPLETED|Randomized Withdrawal Period||0||
60053758|NCT01460368|76169273|FG006|NOT COMPLETED|Part B: Third Interventions (Period 3)||0||
60053759|NCT01460290|76169282|FG000|STARTED|Overall Study||15||
59922999|NCT03073200|76042372|FG013|COMPLETED|Randomized Withdrawal Period||0||
59923000|NCT03073200|76042373|FG014|COMPLETED|Randomized Withdrawal Period||0||
59923001|NCT03073200|76042359|FG000|NOT COMPLETED|Randomized Withdrawal Period||0||
59923002|NCT03073200|76042360|FG001|NOT COMPLETED|Randomized Withdrawal Period||0||
59923003|NCT03073200|76042361|FG002|NOT COMPLETED|Randomized Withdrawal Period||0||
59923004|NCT03073200|76042362|FG003|NOT COMPLETED|Randomized Withdrawal Period||0||
59923005|NCT03073200|76042363|FG004|NOT COMPLETED|Randomized Withdrawal Period||0||
59923006|NCT03073200|76042364|FG005|NOT COMPLETED|Randomized Withdrawal Period||0||
59923007|NCT03073200|76042365|FG006|NOT COMPLETED|Randomized Withdrawal Period||0||
59923008|NCT03073200|76042366|FG007|NOT COMPLETED|Randomized Withdrawal Period||0||
59923009|NCT03073200|76042367|FG008|NOT COMPLETED|Randomized Withdrawal Period||0||
59923010|NCT03073200|76042368|FG009|NOT COMPLETED|Randomized Withdrawal Period||0||
59923011|NCT03073200|76042369|FG010|NOT COMPLETED|Randomized Withdrawal Period||2||
59923012|NCT03073200|76042370|FG011|NOT COMPLETED|Randomized Withdrawal Period||3||
59923013|NCT03073200|76042371|FG012|NOT COMPLETED|Randomized Withdrawal Period||0||
59923014|NCT03073200|76042372|FG013|NOT COMPLETED|Randomized Withdrawal Period||0||
59923015|NCT03073200|76042373|FG014|NOT COMPLETED|Randomized Withdrawal Period||0||
59923016|NCT03073200|76042359|FG000|STARTED|Post-Treatment Follow-Up Period||0||
59923017|NCT03073200|76042360|FG001|STARTED|Post-Treatment Follow-Up Period||0||
59923018|NCT03073200|76042361|FG002|STARTED|Post-Treatment Follow-Up Period||0||
59923019|NCT03073200|76042362|FG003|STARTED|Post-Treatment Follow-Up Period||0||
59923020|NCT03073200|76042363|FG004|STARTED|Post-Treatment Follow-Up Period||0||
59923021|NCT03073200|76042364|FG005|STARTED|Post-Treatment Follow-Up Period||0||
60053760|NCT01460290|76169282|FG000|COMPLETED|Overall Study||11||
60053761|NCT01460290|76169282|FG000|NOT COMPLETED|Overall Study||4||
60053762|NCT02200211|76169291|FG000|STARTED|Overall Study||190||
60053763|NCT02200211|76169292|FG001|STARTED|Overall Study||195||
59514772|NCT00932321|75608415|FG001|MITT Population|Overall Study||181||
59514773|NCT00932321|75608414|FG000|COMPLETED|Overall Study||580||
59514774|NCT00932321|75608415|FG001|COMPLETED|Overall Study||141||
59514775|NCT00932321|75608414|FG000|NOT COMPLETED|Overall Study||171||
59514776|NCT00932321|75608415|FG001|NOT COMPLETED|Overall Study||46||
59514777|NCT00952393|75608421|FG000|STARTED|Overall Study|10|10||
59514778|NCT00952393|75608421|FG000|COMPLETED|Overall Study||10||
59514779|NCT00952393|75608421|FG000|NOT COMPLETED|Overall Study||0||
59514780|NCT00932399|75608427|FG000|STARTED|Overall Study||759||
59514781|NCT00932399|75608428|FG001|STARTED|Overall Study||3790||
59514782|NCT00932399|75608427|FG000|COMPLETED|Overall Study||759||
59514783|NCT00932399|75608428|FG001|COMPLETED|Overall Study||3790||
59514784|NCT00932399|75608427|FG000|NOT COMPLETED|Overall Study||0||
59514785|NCT00932399|75608428|FG001|NOT COMPLETED|Overall Study||0||
59514786|NCT01011829|75608436|FG000|STARTED|Overall Study||10||
59514787|NCT01011829|75608437|FG001|STARTED|Overall Study||10||
59514788|NCT01011829|75608436|FG000|COMPLETED|Overall Study||6||
59514789|NCT01011829|75608437|FG001|COMPLETED|Overall Study||1||
59514790|NCT01011829|75608436|FG000|NOT COMPLETED|Overall Study||4||
59514791|NCT01011829|75608437|FG001|NOT COMPLETED|Overall Study||9||
59923022|NCT03073200|76042365|FG006|STARTED|Post-Treatment Follow-Up Period||0||
59923023|NCT03073200|76042366|FG007|STARTED|Post-Treatment Follow-Up Period||0||
59923024|NCT03073200|76042367|FG008|STARTED|Post-Treatment Follow-Up Period||0||
59923025|NCT03073200|76042368|FG009|STARTED|Post-Treatment Follow-Up Period|This period is to report Follow-Up period participants.|0||
59923026|NCT03073200|76042369|FG010|STARTED|Post-Treatment Follow-Up Period|This period is to report Follow-Up period participants.|0||
59923027|NCT03073200|76042370|FG011|STARTED|Post-Treatment Follow-Up Period|This period is to report Follow-Up period participants.|0||
59923028|NCT03073200|76042371|FG012|STARTED|Post-Treatment Follow-Up Period|This period is to report Follow-Up period participants.|6||
59923029|NCT03073200|76042372|FG013|STARTED|Post-Treatment Follow-Up Period|This period is to report Follow-Up period participants.|166||
59923030|NCT03073200|76042373|FG014|STARTED|Post-Treatment Follow-Up Period|This period is to report Follow-Up period participants.|2||
59923031|NCT03073200|76042359|FG000|COMPLETED|Post-Treatment Follow-Up Period||0||
59923032|NCT03073200|76042360|FG001|COMPLETED|Post-Treatment Follow-Up Period||0||
59923033|NCT03073200|76042361|FG002|COMPLETED|Post-Treatment Follow-Up Period||0||
59923034|NCT03073200|76042362|FG003|COMPLETED|Post-Treatment Follow-Up Period||0||
59923035|NCT03073200|76042363|FG004|COMPLETED|Post-Treatment Follow-Up Period||0||
59923036|NCT03073200|76042364|FG005|COMPLETED|Post-Treatment Follow-Up Period||0||
59923037|NCT03073200|76042365|FG006|COMPLETED|Post-Treatment Follow-Up Period||0||
59923038|NCT03073200|76042366|FG007|COMPLETED|Post-Treatment Follow-Up Period||0||
59923039|NCT03073200|76042367|FG008|COMPLETED|Post-Treatment Follow-Up Period||0||
59923040|NCT03073200|76042368|FG009|COMPLETED|Post-Treatment Follow-Up Period||0||
59923041|NCT03073200|76042369|FG010|COMPLETED|Post-Treatment Follow-Up Period||0||
59923042|NCT03073200|76042370|FG011|COMPLETED|Post-Treatment Follow-Up Period||0||
59923043|NCT03073200|76042371|FG012|COMPLETED|Post-Treatment Follow-Up Period||6||
59923044|NCT03073200|76042372|FG013|COMPLETED|Post-Treatment Follow-Up Period||139||
59923045|NCT03073200|76042373|FG014|COMPLETED|Post-Treatment Follow-Up Period||1||
59923046|NCT03073200|76042359|FG000|NOT COMPLETED|Post-Treatment Follow-Up Period||0||
59923047|NCT03073200|76042360|FG001|NOT COMPLETED|Post-Treatment Follow-Up Period||0||
59923048|NCT03073200|76042361|FG002|NOT COMPLETED|Post-Treatment Follow-Up Period||0||
59923049|NCT03073200|76042362|FG003|NOT COMPLETED|Post-Treatment Follow-Up Period||0||
59923050|NCT03073200|76042363|FG004|NOT COMPLETED|Post-Treatment Follow-Up Period||0||
59923051|NCT03073200|76042364|FG005|NOT COMPLETED|Post-Treatment Follow-Up Period||0||
59923052|NCT03073200|76042365|FG006|NOT COMPLETED|Post-Treatment Follow-Up Period||0||
59923053|NCT03073200|76042366|FG007|NOT COMPLETED|Post-Treatment Follow-Up Period||0||
59923054|NCT03073200|76042367|FG008|NOT COMPLETED|Post-Treatment Follow-Up Period||0||
59923055|NCT03073200|76042368|FG009|NOT COMPLETED|Post-Treatment Follow-Up Period||0||
59923056|NCT03073200|76042369|FG010|NOT COMPLETED|Post-Treatment Follow-Up Period||0||
59923057|NCT03073200|76042370|FG011|NOT COMPLETED|Post-Treatment Follow-Up Period||0||
59923058|NCT03073200|76042371|FG012|NOT COMPLETED|Post-Treatment Follow-Up Period||0||
59923059|NCT03073200|76042372|FG013|NOT COMPLETED|Post-Treatment Follow-Up Period||27||
59923060|NCT03073200|76042373|FG014|NOT COMPLETED|Post-Treatment Follow-Up Period||1||
59923061|NCT03290781|76042402|FG000|STARTED|Overall Study||73||
59923062|NCT03290781|76042403|FG001|STARTED|Overall Study||71||
59923063|NCT03290781|76042404|FG002|STARTED|Overall Study||86||
59923064|NCT03290781|76042405|FG003|STARTED|Overall Study||82||
59923065|NCT03290781|76042406|FG004|STARTED|Overall Study||11||
59923066|NCT03290781|76042407|FG005|STARTED|Overall Study||22||
59923067|NCT03290781|76042408|FG006|STARTED|Overall Study||21||
59923068|NCT03290781|76042402|FG000|COMPLETED|Overall Study||24||
59923069|NCT03290781|76042403|FG001|COMPLETED|Overall Study||53||
59923070|NCT03290781|76042404|FG002|COMPLETED|Overall Study||30||
59923071|NCT03290781|76042405|FG003|COMPLETED|Overall Study||59||
59923072|NCT03290781|76042406|FG004|COMPLETED|Overall Study||6||
59923073|NCT03290781|76042407|FG005|COMPLETED|Overall Study||19||
59923074|NCT03290781|76042408|FG006|COMPLETED|Overall Study||17||
59923075|NCT03290781|76042402|FG000|NOT COMPLETED|Overall Study||49||
59923076|NCT03290781|76042403|FG001|NOT COMPLETED|Overall Study||18||
59923077|NCT03290781|76042404|FG002|NOT COMPLETED|Overall Study||56||
59923078|NCT03290781|76042405|FG003|NOT COMPLETED|Overall Study||23||
59923079|NCT03290781|76042406|FG004|NOT COMPLETED|Overall Study||5||
60053764|NCT02200211|76169293|FG002|STARTED|Overall Study||40||
59923080|NCT03290781|76042407|FG005|NOT COMPLETED|Overall Study||3||
59923081|NCT03290781|76042408|FG006|NOT COMPLETED|Overall Study||4||
59923082|NCT03466073|76042437|FG000|STARTED|Overall Study||6||
59923083|NCT03466073|76042438|FG001|STARTED|Overall Study||2||
59923084|NCT03466073|76042439|FG002|STARTED|Overall Study||6||
59923085|NCT03466073|76042440|FG003|STARTED|Overall Study||6||
59923086|NCT03466073|76042441|FG004|STARTED|Overall Study||6||
59923087|NCT03466073|76042442|FG005|STARTED|Overall Study||7||
59923088|NCT03466073|76042437|FG000|COMPLETED|Overall Study||5||
59923089|NCT03466073|76042438|FG001|COMPLETED|Overall Study||2||
59923090|NCT03466073|76042439|FG002|COMPLETED|Overall Study||6||
59514792|NCT00932477|75608443|FG000|STARTED|Treatment 1||7||
59514793|NCT00932477|75608444|FG001|STARTED|Treatment 1||8||
59923091|NCT03466073|76042440|FG003|COMPLETED|Overall Study||6||
59923092|NCT03466073|76042441|FG004|COMPLETED|Overall Study||6||
59923093|NCT03466073|76042442|FG005|COMPLETED|Overall Study||6||
59923094|NCT03466073|76042437|FG000|NOT COMPLETED|Overall Study||1||
59923095|NCT03466073|76042438|FG001|NOT COMPLETED|Overall Study||0||
59923096|NCT03466073|76042439|FG002|NOT COMPLETED|Overall Study||0||
59923097|NCT03466073|76042440|FG003|NOT COMPLETED|Overall Study||0||
59923098|NCT03466073|76042441|FG004|NOT COMPLETED|Overall Study||0||
59923099|NCT03466073|76042442|FG005|NOT COMPLETED|Overall Study||1||
59923100|NCT03412019|76042465|FG000|STARTED|Overall Study||11||
59923101|NCT03412019|76042466|FG001|STARTED|Overall Study||11||
59923102|NCT03412019|76042465|FG000|COMPLETED|Overall Study||10||
59923103|NCT03412019|76042466|FG001|COMPLETED|Overall Study||10||
59923104|NCT03412019|76042465|FG000|NOT COMPLETED|Overall Study||1||
59923105|NCT03412019|76042466|FG001|NOT COMPLETED|Overall Study||1||
59923106|NCT03070002|76042472|FG000|STARTED|3 Cycles of Treatment||1||
59923107|NCT03070002|76042472|FG000|COMPLETED|3 Cycles of Treatment||1||
59923108|NCT03070002|76042472|FG000|NOT COMPLETED|3 Cycles of Treatment||0||
59923109|NCT03070002|76042472|FG000|STARTED|Follow up for 2 Years||1|Everyone that receives treatment on study goes into the follow up phase|
59923110|NCT03070002|76042472|FG000|COMPLETED|Follow up for 2 Years||0||
59923111|NCT03070002|76042472|FG000|NOT COMPLETED|Follow up for 2 Years||1||
59923112|NCT02918318|76042480|FG000|STARTED|Double-blind Induction Phase: 4 Weeks||41||
59923113|NCT02918318|76042481|FG001|STARTED|Double-blind Induction Phase: 4 Weeks||40||
59923114|NCT02918318|76042482|FG002|STARTED|Double-blind Induction Phase: 4 Weeks||41||
59923115|NCT02918318|76042483|FG003|STARTED|Double-blind Induction Phase: 4 Weeks||80||
59923116|NCT02918318|76042484|FG004|STARTED|Double-blind Induction Phase: 4 Weeks||0||
59923117|NCT02918318|76042480|FG000|Responders|Double-blind Induction Phase: 4 Weeks||13||
59923118|NCT02918318|76042481|FG001|Responders|Double-blind Induction Phase: 4 Weeks||11||
59923119|NCT02918318|76042482|FG002|Responders|Double-blind Induction Phase: 4 Weeks||17||
59923120|NCT02918318|76042483|FG003|Responders|Double-blind Induction Phase: 4 Weeks||27||
59923121|NCT02918318|76042484|FG004|Responders|Double-blind Induction Phase: 4 Weeks||0||
59923122|NCT02918318|76042480|FG000|COMPLETED|Double-blind Induction Phase: 4 Weeks||39||
59923123|NCT02918318|76042481|FG001|COMPLETED|Double-blind Induction Phase: 4 Weeks||33||
59923124|NCT02918318|76042482|FG002|COMPLETED|Double-blind Induction Phase: 4 Weeks||39||
59923125|NCT02918318|76042483|FG003|COMPLETED|Double-blind Induction Phase: 4 Weeks||72||
59923126|NCT02918318|76042484|FG004|COMPLETED|Double-blind Induction Phase: 4 Weeks||0||
59923127|NCT02918318|76042480|FG000|NOT COMPLETED|Double-blind Induction Phase: 4 Weeks||2||
59923128|NCT02918318|76042481|FG001|NOT COMPLETED|Double-blind Induction Phase: 4 Weeks||7||
59923129|NCT02918318|76042482|FG002|NOT COMPLETED|Double-blind Induction Phase: 4 Weeks||2||
59923130|NCT02918318|76042483|FG003|NOT COMPLETED|Double-blind Induction Phase: 4 Weeks||8||
59923131|NCT02918318|76042484|FG004|NOT COMPLETED|Double-blind Induction Phase: 4 Weeks||0||
59923132|NCT02918318|76042480|FG000|STARTED|Double-blind Follow-up Phase: 4 Weeks||27||
59923133|NCT02918318|76042481|FG001|STARTED|Double-blind Follow-up Phase: 4 Weeks||28||
59923134|NCT02918318|76042482|FG002|STARTED|Double-blind Follow-up Phase: 4 Weeks||24||
59923135|NCT02918318|76042483|FG003|STARTED|Double-blind Follow-up Phase: 4 Weeks||53||
59923136|NCT02918318|76042484|FG004|STARTED|Double-blind Follow-up Phase: 4 Weeks||0||
59923137|NCT02918318|76042480|FG000|COMPLETED|Double-blind Follow-up Phase: 4 Weeks||26||
59923138|NCT02918318|76042481|FG001|COMPLETED|Double-blind Follow-up Phase: 4 Weeks||28||
59923139|NCT02918318|76042482|FG002|COMPLETED|Double-blind Follow-up Phase: 4 Weeks||23||
59923140|NCT02918318|76042483|FG003|COMPLETED|Double-blind Follow-up Phase: 4 Weeks||50||
59923141|NCT02918318|76042484|FG004|COMPLETED|Double-blind Follow-up Phase: 4 Weeks||0||
59923142|NCT02918318|76042480|FG000|NOT COMPLETED|Double-blind Follow-up Phase: 4 Weeks||1||
59923143|NCT02918318|76042481|FG001|NOT COMPLETED|Double-blind Follow-up Phase: 4 Weeks||0||
59923144|NCT02918318|76042482|FG002|NOT COMPLETED|Double-blind Follow-up Phase: 4 Weeks||1||
59923145|NCT02918318|76042483|FG003|NOT COMPLETED|Double-blind Follow-up Phase: 4 Weeks||3||
59923146|NCT02918318|76042484|FG004|NOT COMPLETED|Double-blind Follow-up Phase: 4 Weeks||0||
59923147|NCT02918318|76042480|FG000|STARTED|Posttreatment Phase: Up to 24 Weeks||13||
59923148|NCT02918318|76042481|FG001|STARTED|Posttreatment Phase: Up to 24 Weeks||11||
59923149|NCT02918318|76042482|FG002|STARTED|Posttreatment Phase: Up to 24 Weeks||17||
59923150|NCT02918318|76042483|FG003|STARTED|Posttreatment Phase: Up to 24 Weeks||27||
59923151|NCT02918318|76042484|FG004|STARTED|Posttreatment Phase: Up to 24 Weeks||0||
59923152|NCT02918318|76042480|FG000|COMPLETED|Posttreatment Phase: Up to 24 Weeks||12||
59923153|NCT02918318|76042481|FG001|COMPLETED|Posttreatment Phase: Up to 24 Weeks||8||
59923154|NCT02918318|76042482|FG002|COMPLETED|Posttreatment Phase: Up to 24 Weeks||16||
59923155|NCT02918318|76042483|FG003|COMPLETED|Posttreatment Phase: Up to 24 Weeks||25||
59923156|NCT02918318|76042484|FG004|COMPLETED|Posttreatment Phase: Up to 24 Weeks||0||
59923157|NCT02918318|76042480|FG000|NOT COMPLETED|Posttreatment Phase: Up to 24 Weeks||1||
59923158|NCT02918318|76042481|FG001|NOT COMPLETED|Posttreatment Phase: Up to 24 Weeks||3||
59923159|NCT02918318|76042482|FG002|NOT COMPLETED|Posttreatment Phase: Up to 24 Weeks||1||
59923160|NCT02918318|76042483|FG003|NOT COMPLETED|Posttreatment Phase: Up to 24 Weeks||2||
59923161|NCT02918318|76042484|FG004|NOT COMPLETED|Posttreatment Phase: Up to 24 Weeks||0||
59923162|NCT02918318|76042480|FG000|STARTED|Open Label Treatment Phase: 4 Weeks||0||
59514794|NCT00932477|75608445|FG002|STARTED|Treatment 1||9||
59514795|NCT00932477|75608446|FG003|STARTED|Treatment 1||7||
59760544|NCT02701283|75880168|FG002|As Treated (Attempted Implant)|Overall Study||745|"Randomized Controlled Trial - The As Treated set includes 4 subjects that crossed over from the Medtronic TAVR Systems arm to the SAVR arm, which accounts for 727 subjects in the Implanted set for the Medtronic TAVR Systems arm.~The As Treated set includes 1 subject that crossed over from the SAVR arm to the Medtronic TAVR Systems arm, and 1 subject that was not implanted, which accounts for 686 subjects in the Implanted set for the SAVR arm."|
59760545|NCT02701283|75880166|FG000|Implanted|Overall Study||727||
59760546|NCT02701283|75880167|FG001|Implanted|Overall Study||686||
59760547|NCT02701283|75880168|FG002|Implanted|Overall Study||745||
59762682|NCT00857259|75882529|FG002|COMPLETED|Overall Study||6||
59923163|NCT02918318|76042481|FG001|STARTED|Open Label Treatment Phase: 4 Weeks||0||
59923164|NCT02918318|76042482|FG002|STARTED|Open Label Treatment Phase: 4 Weeks||0||
59923165|NCT02918318|76042483|FG003|STARTED|Open Label Treatment Phase: 4 Weeks||0||
59923166|NCT02918318|76042484|FG004|STARTED|Open Label Treatment Phase: 4 Weeks||48||
59923167|NCT02918318|76042480|FG000|COMPLETED|Open Label Treatment Phase: 4 Weeks||0||
59923168|NCT02918318|76042481|FG001|COMPLETED|Open Label Treatment Phase: 4 Weeks||0||
59923169|NCT02918318|76042482|FG002|COMPLETED|Open Label Treatment Phase: 4 Weeks||0||
59923170|NCT02918318|76042483|FG003|COMPLETED|Open Label Treatment Phase: 4 Weeks||0||
59923171|NCT02918318|76042484|FG004|COMPLETED|Open Label Treatment Phase: 4 Weeks||47||
59923172|NCT02918318|76042480|FG000|NOT COMPLETED|Open Label Treatment Phase: 4 Weeks||0||
59923173|NCT02918318|76042481|FG001|NOT COMPLETED|Open Label Treatment Phase: 4 Weeks||0||
59923174|NCT02918318|76042482|FG002|NOT COMPLETED|Open Label Treatment Phase: 4 Weeks||0||
59923175|NCT02918318|76042483|FG003|NOT COMPLETED|Open Label Treatment Phase: 4 Weeks||0||
59923176|NCT02918318|76042484|FG004|NOT COMPLETED|Open Label Treatment Phase: 4 Weeks||1||
59923177|NCT02918318|76042480|FG000|STARTED|Open Label Follow-up Phase: 4 Weeks||0||
59923178|NCT02918318|76042481|FG001|STARTED|Open Label Follow-up Phase: 4 Weeks||0||
59923179|NCT02918318|76042482|FG002|STARTED|Open Label Follow-up Phase: 4 Weeks||0||
59923180|NCT02918318|76042483|FG003|STARTED|Open Label Follow-up Phase: 4 Weeks||0||
59923181|NCT02918318|76042484|FG004|STARTED|Open Label Follow-up Phase: 4 Weeks||48||
59923182|NCT02918318|76042480|FG000|COMPLETED|Open Label Follow-up Phase: 4 Weeks||0||
59923183|NCT02918318|76042481|FG001|COMPLETED|Open Label Follow-up Phase: 4 Weeks||0||
59923184|NCT02918318|76042482|FG002|COMPLETED|Open Label Follow-up Phase: 4 Weeks||0||
59923185|NCT02918318|76042483|FG003|COMPLETED|Open Label Follow-up Phase: 4 Weeks||0||
59923186|NCT02918318|76042484|FG004|COMPLETED|Open Label Follow-up Phase: 4 Weeks||47||
59923187|NCT02918318|76042480|FG000|NOT COMPLETED|Open Label Follow-up Phase: 4 Weeks||0||
59923188|NCT02918318|76042481|FG001|NOT COMPLETED|Open Label Follow-up Phase: 4 Weeks||0||
59923189|NCT02918318|76042482|FG002|NOT COMPLETED|Open Label Follow-up Phase: 4 Weeks||0||
59923190|NCT02918318|76042483|FG003|NOT COMPLETED|Open Label Follow-up Phase: 4 Weeks||0||
59923191|NCT02918318|76042484|FG004|NOT COMPLETED|Open Label Follow-up Phase: 4 Weeks||1||
59923192|NCT03713957|76042507|FG000|STARTED|Overall Study||53||
59923193|NCT03713957|76042508|FG001|STARTED|Overall Study||26||
59923194|NCT03713957|76042507|FG000|COMPLETED|Overall Study||35||
59923195|NCT03713957|76042508|FG001|COMPLETED|Overall Study||16||
59923196|NCT03713957|76042507|FG000|NOT COMPLETED|Overall Study||18||
59923197|NCT03713957|76042508|FG001|NOT COMPLETED|Overall Study||10||
59923198|NCT03196167|76042516|FG000|STARTED|Overall Study||45||
59923199|NCT03196167|76042517|FG001|STARTED|Overall Study||45||
59923200|NCT03196167|76042516|FG000|COMPLETED|Overall Study||40||
59923201|NCT03196167|76042517|FG001|COMPLETED|Overall Study||43||
59923202|NCT03196167|76042516|FG000|NOT COMPLETED|Overall Study||5||
59923203|NCT03196167|76042517|FG001|NOT COMPLETED|Overall Study||2||
59923204|NCT03411863|76042529|FG000|STARTED|Overall Study||8||
59923205|NCT03411863|76042530|FG001|STARTED|Overall Study||11||
59923206|NCT03411863|76042529|FG000|COMPLETED|Overall Study||5||
59923207|NCT03411863|76042530|FG001|COMPLETED|Overall Study||9||
59923208|NCT03411863|76042529|FG000|NOT COMPLETED|Overall Study||3||
59923209|NCT03411863|76042530|FG001|NOT COMPLETED|Overall Study||2||
59923210|NCT01065350|76042539|FG000|STARTED|Overall Study||43||
59923211|NCT01065350|76042540|FG001|STARTED|Overall Study||42||
59923212|NCT01065350|76042539|FG000|COMPLETED|Overall Study||43||
59923213|NCT01065350|76042540|FG001|COMPLETED|Overall Study||41||
59923214|NCT01065350|76042539|FG000|NOT COMPLETED|Overall Study||0||
59923215|NCT01065350|76042540|FG001|NOT COMPLETED|Overall Study||1||
59923216|NCT03434249|76042548|FG000|STARTED|Overall Study||40||
59923217|NCT03434249|76042549|FG001|STARTED|Overall Study||40||
59923218|NCT03434249|76042548|FG000|COMPLETED|Overall Study||35||
59923219|NCT03434249|76042549|FG001|COMPLETED|Overall Study||37||
59923220|NCT03434249|76042548|FG000|NOT COMPLETED|Overall Study||5||
59923221|NCT03434249|76042549|FG001|NOT COMPLETED|Overall Study||3||
59923222|NCT03114969|76042564|FG000|STARTED|Overall Study||50||
59514796|NCT00932477|75608447|FG004|STARTED|Treatment 1||8||
59923223|NCT03114969|76042565|FG001|STARTED|Overall Study||50||
59923224|NCT03114969|76042566|FG002|STARTED|Overall Study||50||
59923225|NCT03114969|76042567|FG003|STARTED|Overall Study||50||
59923226|NCT03114969|76042568|FG004|STARTED|Overall Study||51||
59514797|NCT00932477|75608448|FG005|STARTED|Treatment 1||8||
59514798|NCT00932477|75608443|FG000|COMPLETED|Treatment 1||7||
59514799|NCT00932477|75608444|FG001|COMPLETED|Treatment 1||8||
59923227|NCT03114969|76042569|FG005|STARTED|Overall Study||49||
59923228|NCT03114969|76042570|FG006|STARTED|Overall Study||50||
59923229|NCT03114969|76042571|FG007|STARTED|Overall Study||50||
59923230|NCT03114969|76042572|FG008|STARTED|Overall Study||50||
59923231|NCT03114969|76042564|FG000|COMPLETED|Overall Study||50||
59923232|NCT03114969|76042565|FG001|COMPLETED|Overall Study||50||
59923233|NCT03114969|76042566|FG002|COMPLETED|Overall Study||46||
59923234|NCT03114969|76042567|FG003|COMPLETED|Overall Study||48||
59923235|NCT03114969|76042568|FG004|COMPLETED|Overall Study||51||
59923236|NCT03114969|76042569|FG005|COMPLETED|Overall Study||48||
59923237|NCT03114969|76042570|FG006|COMPLETED|Overall Study||49||
59923238|NCT03114969|76042571|FG007|COMPLETED|Overall Study||50||
59923239|NCT03114969|76042572|FG008|COMPLETED|Overall Study||48||
59923240|NCT03114969|76042564|FG000|NOT COMPLETED|Overall Study||0||
59923241|NCT03114969|76042565|FG001|NOT COMPLETED|Overall Study||0||
59923242|NCT03114969|76042566|FG002|NOT COMPLETED|Overall Study||4||
59923243|NCT03114969|76042567|FG003|NOT COMPLETED|Overall Study||2||
59923244|NCT03114969|76042568|FG004|NOT COMPLETED|Overall Study||0||
59923245|NCT03114969|76042569|FG005|NOT COMPLETED|Overall Study||1||
59923246|NCT03114969|76042570|FG006|NOT COMPLETED|Overall Study||1||
59923247|NCT03114969|76042571|FG007|NOT COMPLETED|Overall Study||0||
59923248|NCT03114969|76042572|FG008|NOT COMPLETED|Overall Study||2||
59923249|NCT02046096|76042601|FG000|STARTED|Overall Study||149||
59923250|NCT02046096|76042602|FG001|STARTED|Overall Study||324||
59923251|NCT02046096|76042601|FG000|COMPLETED|Overall Study||105||
59923252|NCT02046096|76042602|FG001|COMPLETED|Overall Study||223||
59923253|NCT02046096|76042601|FG000|NOT COMPLETED|Overall Study||44||
59923254|NCT02046096|76042602|FG001|NOT COMPLETED|Overall Study||101||
59923255|NCT03463577|76042616|FG000|STARTED|Overall Study||16606||
59923256|NCT03463577|76042617|FG001|STARTED|Overall Study||16606||
59923257|NCT03463577|76042618|FG002|STARTED|Overall Study||65||
59923258|NCT03463577|76042619|FG003|STARTED|Overall Study||16350||
59923259|NCT03463577|76042620|FG004|STARTED|Overall Study||16088||
59923260|NCT03463577|76042621|FG005|STARTED|Overall Study||68||
59923261|NCT03463577|76042616|FG000|COMPLETED|Overall Study||16366||
59923262|NCT03463577|76042617|FG001|COMPLETED|Overall Study||16166||
59923263|NCT03463577|76042618|FG002|COMPLETED|Overall Study||65||
59923264|NCT03463577|76042619|FG003|COMPLETED|Overall Study||16335||
59923265|NCT03463577|76042620|FG004|COMPLETED|Overall Study||16071||
59923266|NCT03463577|76042621|FG005|COMPLETED|Overall Study||68||
59923267|NCT03463577|76042616|FG000|NOT COMPLETED|Overall Study||240||
59923268|NCT03463577|76042617|FG001|NOT COMPLETED|Overall Study||440||
59923269|NCT03463577|76042618|FG002|NOT COMPLETED|Overall Study||0||
59923270|NCT03463577|76042619|FG003|NOT COMPLETED|Overall Study||15||
59923271|NCT03463577|76042620|FG004|NOT COMPLETED|Overall Study||17||
59923272|NCT03463577|76042621|FG005|NOT COMPLETED|Overall Study||0||
59923273|NCT03122145|76042637|FG000|STARTED|Overall Study|34 participants completed the first sub study under this IRB|37||
59923274|NCT03122145|76042638|FG001|STARTED|Overall Study||12||
59923275|NCT03122145|76042637|FG000|COMPLETED|Overall Study||34||
59923276|NCT03122145|76042638|FG001|COMPLETED|Overall Study||12||
59923277|NCT03122145|76042637|FG000|NOT COMPLETED|Overall Study||3||
59923278|NCT03122145|76042638|FG001|NOT COMPLETED|Overall Study||0||
59923279|NCT03114657|76042646|FG000|STARTED|Overall Study||399||
59923280|NCT03114657|76042647|FG001|STARTED|Overall Study||407||
59923281|NCT03114657|76042646|FG000|COMPLETED|Overall Study||0||
59923282|NCT03114657|76042647|FG001|COMPLETED|Overall Study||0||
59923283|NCT03114657|76042646|FG000|NOT COMPLETED|Overall Study||399||
59923284|NCT03114657|76042647|FG001|NOT COMPLETED|Overall Study||407||
59923285|NCT02926950|76042656|FG000|STARTED|Overall Study||259||
59923286|NCT02926950|76042657|FG001|STARTED|Overall Study||259||
59923287|NCT02926950|76042656|FG000|COMPLETED|Overall Study||210||
59923288|NCT02926950|76042657|FG001|COMPLETED|Overall Study||211||
59923289|NCT02926950|76042656|FG000|NOT COMPLETED|Overall Study||49||
59923290|NCT02926950|76042657|FG001|NOT COMPLETED|Overall Study||48||
59923291|NCT03410693|76042666|FG000|STARTED|Overall Study||87||
59923292|NCT03410693|76042667|FG001|STARTED|Overall Study||88||
59923293|NCT03410693|76042666|FG000|Started Treatment|Overall Study||86||
59923294|NCT03410693|76042667|FG001|Started Treatment|Overall Study||82||
59923295|NCT03410693|76042666|FG000|Active Follow-up Performed|Overall Study||61||
59923296|NCT03410693|76042667|FG001|Active Follow-up Performed|Overall Study||56||
59923297|NCT03410693|76042666|FG000|Entered Long Term Follow-up|Overall Study||56||
59923298|NCT03410693|76042667|FG001|Entered Long Term Follow-up|Overall Study||69||
59923299|NCT03410693|76042666|FG000|COMPLETED|Overall Study|Completed treatment|0|Completed treatment, participants who discontinued treatment could enter follow-up.|
59923300|NCT03410693|76042667|FG001|COMPLETED|Overall Study|Completed treatment|0|Completed treatment, participants who discontinued treatment could enter follow-up.|
59923301|NCT03410693|76042666|FG000|NOT COMPLETED|Overall Study||87||
59923302|NCT03410693|76042667|FG001|NOT COMPLETED|Overall Study||88||
59923303|NCT01064414|76042682|FG000|STARTED|Core Period: Baseline to Week 26||90||
59923304|NCT01064414|76042683|FG001|STARTED|Core Period: Baseline to Week 26||90||
59923305|NCT01064414|76042684|FG002|STARTED|Core Period: Baseline to Week 26||89||
59923306|NCT01064414|76042682|FG000|COMPLETED|Core Period: Baseline to Week 26||77||
60053765|NCT02200211|76169294|FG003|STARTED|Overall Study||60||
60053766|NCT02200211|76169291|FG000|Included in 16-week Primary Analysis|Overall Study||177|16-week visits completed within pre-specified analysis window (148-196 days after randomization)|
60053767|NCT02200211|76169292|FG001|Included in 16-week Primary Analysis|Overall Study||186|16-week visits completed within pre-specified analysis window (148-196 days after randomization)|
60053768|NCT02200211|76169293|FG002|Included in 16-week Primary Analysis|Overall Study||39|16-week visits completed within pre-specified analysis window (148-196 days after randomization)|
60053769|NCT02200211|76169294|FG003|Included in 16-week Primary Analysis|Overall Study||56|16-week visits completed within pre-specified analysis window (148-196 days after randomization)|
60053770|NCT02200211|76169291|FG000|COMPLETED|Overall Study||182|Completed 16-week study|
60053771|NCT02200211|76169292|FG001|COMPLETED|Overall Study||188|Completed 16-week study|
60053772|NCT02200211|76169293|FG002|COMPLETED|Overall Study||39|Completed 16-week study|
60053773|NCT02200211|76169294|FG003|COMPLETED|Overall Study||58|Completed 16-week study|
60053774|NCT02200211|76169291|FG000|NOT COMPLETED|Overall Study||8||
60053775|NCT02200211|76169292|FG001|NOT COMPLETED|Overall Study||7||
60053776|NCT02200211|76169293|FG002|NOT COMPLETED|Overall Study||1||
60053777|NCT02200211|76169294|FG003|NOT COMPLETED|Overall Study||2||
60053778|NCT01459666|76169314|FG000|STARTED|Overall Study||5||
60053779|NCT01459666|76169315|FG001|STARTED|Overall Study||4||
60053780|NCT01459666|76169314|FG000|COMPLETED|Overall Study||0||
60053781|NCT01459666|76169315|FG001|COMPLETED|Overall Study||0||
60053782|NCT01459666|76169314|FG000|NOT COMPLETED|Overall Study||5||
60053783|NCT01459666|76169315|FG001|NOT COMPLETED|Overall Study||4||
60053784|NCT01858389|76169323|FG000|STARTED|Overall Study|Enrolled|16||
60053785|NCT01858389|76169324|FG001|STARTED|Overall Study|Enrolled|25||
60053786|NCT01858389|76169323|FG000|Received Treatment|Overall Study||16||
60053787|NCT01858389|76169324|FG001|Received Treatment|Overall Study||22||
60053788|NCT01858389|76169323|FG000|COMPLETED|Overall Study||0||
60053789|NCT01858389|76169324|FG001|COMPLETED|Overall Study||0||
60053790|NCT01858389|76169323|FG000|NOT COMPLETED|Overall Study||16||
60053791|NCT01858389|76169324|FG001|NOT COMPLETED|Overall Study||25||
60053792|NCT02199509|76169332|FG000|STARTED|Overall Study||3||
60053793|NCT02199509|76169333|FG001|STARTED|Overall Study||4||
60053794|NCT02199509|76169332|FG000|COMPLETED|Overall Study||2||
60053795|NCT02199509|76169333|FG001|COMPLETED|Overall Study||3||
60053796|NCT02199509|76169332|FG000|NOT COMPLETED|Overall Study||1||
60053797|NCT02199509|76169333|FG001|NOT COMPLETED|Overall Study||1||
60053798|NCT01458574|76169346|FG000|STARTED|Overall Study||198||
60053799|NCT01458574|76169347|FG001|STARTED|Overall Study||197||
60053800|NCT01458574|76169348|FG002|STARTED|Overall Study||198||
60053801|NCT01458574|76169346|FG000|Treated|Overall Study||198||
60053802|NCT01458574|76169347|FG001|Treated|Overall Study||196||
60053803|NCT01458574|76169348|FG002|Treated|Overall Study||198||
60053804|NCT01458574|76169346|FG000|COMPLETED|Overall Study||111||
60053805|NCT01458574|76169347|FG001|COMPLETED|Overall Study||126||
60053806|NCT01458574|76169348|FG002|COMPLETED|Overall Study||53||
60053807|NCT01458574|76169346|FG000|NOT COMPLETED|Overall Study||87||
60053808|NCT01458574|76169347|FG001|NOT COMPLETED|Overall Study||71||
60053809|NCT01458574|76169348|FG002|NOT COMPLETED|Overall Study||145||
60053810|NCT02224703|76169359|FG000|STARTED|Overall Study||67||
60053811|NCT02224703|76169360|FG001|STARTED|Overall Study||67||
60053812|NCT02224703|76169361|FG002|STARTED|Overall Study||65||
60053813|NCT02224703|76169359|FG000|Received at Least 1 Dose of Study Drug|Overall Study||66||
60053814|NCT02224703|76169360|FG001|Received at Least 1 Dose of Study Drug|Overall Study||67||
60053815|NCT02224703|76169361|FG002|Received at Least 1 Dose of Study Drug|Overall Study||65||
60053816|NCT02224703|76169359|FG000|Safety Analysis Set|Overall Study|Two participants assigned to the 10 mg/kg/day dose were included in the 20 mg/kg/day group|64|Received at least 1 dose of study drug and analyzed as per actual treatment received|
60053817|NCT02224703|76169360|FG001|Safety Analysis Set|Overall Study|Two participants assigned to the 10 mg/kg/day dose were included in the 20 mg/kg/day group|69|Received at least 1 dose of study drug and analyzed as per actual treatment received|
60053818|NCT02224703|76169361|FG002|Safety Analysis Set|Overall Study||65|Received at least 1 dose of study drug and analyzed as per actual treatment received|
60053819|NCT02224703|76169359|FG000|Intent to Treat (ITT) Analysis Set|Overall Study||66|Randomized, received study drug, and had post-baseline efficacy data|
60053820|NCT02224703|76169360|FG001|Intent to Treat (ITT) Analysis Set|Overall Study||67|Randomized, received study drug, and had post-baseline efficacy data|
60053821|NCT02224703|76169361|FG002|Intent to Treat (ITT) Analysis Set|Overall Study||65|Randomized, received study drug, and had post-baseline efficacy data|
60053822|NCT02224703|76169359|FG000|COMPLETED|Overall Study||64||
60053823|NCT02224703|76169360|FG001|COMPLETED|Overall Study||61||
60053824|NCT02224703|76169361|FG002|COMPLETED|Overall Study||65||
60053825|NCT02224703|76169359|FG000|NOT COMPLETED|Overall Study||3||
60053826|NCT02224703|76169360|FG001|NOT COMPLETED|Overall Study||6||
60053827|NCT02224703|76169361|FG002|NOT COMPLETED|Overall Study||0||
60053828|NCT02198963|76169370|FG000|STARTED|Overall Study||43||
60053829|NCT02198963|76169370|FG000|COMPLETED|Overall Study||36||
60053830|NCT02198963|76169370|FG000|NOT COMPLETED|Overall Study||7||
60067857|NCT01785615|76183054|FG002|NOT COMPLETED|Dietary Phase||0||
60067858|NCT01785615|76183055|FG003|NOT COMPLETED|Dietary Phase||24||
60067859|NCT01785615|76183052|FG000|STARTED|Atorvastatin Phase||44||
60067860|NCT01785615|76183053|FG001|STARTED|Atorvastatin Phase||44||
60053831|NCT02074384|76169382|FG000|STARTED|Overall Study||74||
60053832|NCT02074384|76169383|FG001|STARTED|Overall Study||70||
60053833|NCT02074384|76169384|FG002|STARTED|Overall Study||17||
60053834|NCT02074384|76169382|FG000|COMPLETED|Overall Study||74||
60053835|NCT02074384|76169383|FG001|COMPLETED|Overall Study||70||
60053836|NCT02074384|76169384|FG002|COMPLETED|Overall Study||17||
60053837|NCT02074384|76169382|FG000|NOT COMPLETED|Overall Study||0||
60053838|NCT02074384|76169383|FG001|NOT COMPLETED|Overall Study||0||
60053839|NCT02074384|76169384|FG002|NOT COMPLETED|Overall Study||0||
60053840|NCT01458106|76169394|FG000|STARTED|Overall Study||36||
60053841|NCT01458106|76169395|FG001|STARTED|Overall Study||35||
60053842|NCT01458106|76169394|FG000|PK Subgroup|Overall Study||25||
60053843|NCT01458106|76169395|FG001|PK Subgroup|Overall Study||35||
60053844|NCT01458106|76169394|FG000|Non-PK Subgroup|Overall Study||11||
60053845|NCT01458106|76169395|FG001|Non-PK Subgroup|Overall Study||0||
60053846|NCT01458106|76169394|FG000|COMPLETED|Overall Study||33||
60053847|NCT01458106|76169395|FG001|COMPLETED|Overall Study||34||
60053848|NCT01458106|76169394|FG000|NOT COMPLETED|Overall Study||3||
60053849|NCT01458106|76169395|FG001|NOT COMPLETED|Overall Study||1||
60053850|NCT01457950|76169406|FG000|STARTED|Double-Blind Phase||69||
60053851|NCT01457950|76169407|FG001|STARTED|Double-Blind Phase||66||
60053852|NCT01457950|76169408|FG002|STARTED|Double-Blind Phase||0||
60053853|NCT01457950|76169409|FG003|STARTED|Double-Blind Phase||0||
60053854|NCT01457950|76169406|FG000|Completed the 6 Month Assessment|Double-Blind Phase|"Completed 6 month assessment refers to par. that completed at least one 6 month assessment."|62||
60053855|NCT01457950|76169407|FG001|Completed the 6 Month Assessment|Double-Blind Phase|"Completed 6 month assessment refers to par. that completed at least one 6 month assessment."|64||
60053856|NCT01457950|76169408|FG002|Completed the 6 Month Assessment|Double-Blind Phase||0||
60053857|NCT01457950|76169409|FG003|Completed the 6 Month Assessment|Double-Blind Phase||0||
60053858|NCT01457950|76169406|FG000|COMPLETED|Double-Blind Phase|"Completed refers to par. that did not have a withdraw reason at the 6 month visit."|60||
60053859|NCT01457950|76169407|FG001|COMPLETED|Double-Blind Phase|"Completed refers to par. that did not have a withdraw reason at the 6 month visit."|63||
60053860|NCT01457950|76169408|FG002|COMPLETED|Double-Blind Phase||0||
59514800|NCT00932477|75608445|FG002|COMPLETED|Treatment 1||9||
60053861|NCT01457950|76169409|FG003|COMPLETED|Double-Blind Phase||0||
60053862|NCT01457950|76169406|FG000|NOT COMPLETED|Double-Blind Phase||9||
60053863|NCT01457950|76169407|FG001|NOT COMPLETED|Double-Blind Phase||3||
60053864|NCT01457950|76169408|FG002|NOT COMPLETED|Double-Blind Phase||0||
60053865|NCT01457950|76169409|FG003|NOT COMPLETED|Double-Blind Phase||0||
60053866|NCT01457950|76169406|FG000|STARTED|Open-Label Phase||0||
60053867|NCT01457950|76169407|FG001|STARTED|Open-Label Phase||0||
60053868|NCT01457950|76169408|FG002|STARTED|Open-Label Phase||60||
60053869|NCT01457950|76169409|FG003|STARTED|Open-Label Phase||63||
60053870|NCT01457950|76169406|FG000|COMPLETED|Open-Label Phase||0||
60053871|NCT01457950|76169407|FG001|COMPLETED|Open-Label Phase||0||
60053872|NCT01457950|76169408|FG002|COMPLETED|Open-Label Phase||58||
60053873|NCT01457950|76169409|FG003|COMPLETED|Open-Label Phase||61||
60053874|NCT01457950|76169406|FG000|NOT COMPLETED|Open-Label Phase||0||
60053875|NCT01457950|76169407|FG001|NOT COMPLETED|Open-Label Phase||0||
60053876|NCT01457950|76169408|FG002|NOT COMPLETED|Open-Label Phase||2||
60053877|NCT01457950|76169409|FG003|NOT COMPLETED|Open-Label Phase||2||
60053878|NCT01499134|76169422|FG000|STARTED|Overall Study||9||
60053879|NCT01499134|76169423|FG001|STARTED|Overall Study||8||
60053880|NCT01499134|76169422|FG000|COMPLETED|Overall Study||9||
60053881|NCT01499134|76169423|FG001|COMPLETED|Overall Study||7||
60053882|NCT01499134|76169422|FG000|NOT COMPLETED|Overall Study||0||
60053883|NCT01499134|76169423|FG001|NOT COMPLETED|Overall Study||1||
60053884|NCT02198651|76169429|FG000|STARTED|Lead-in Period||149||
60053885|NCT02198651|76169430|FG001|STARTED|Lead-in Period||0||
60053886|NCT02198651|76169431|FG002|STARTED|Lead-in Period||0||
60053887|NCT02198651|76169432|FG003|STARTED|Lead-in Period||0||
59514801|NCT00932477|75608446|FG003|COMPLETED|Treatment 1||7||
60053888|NCT02198651|76169433|FG004|STARTED|Lead-in Period||0||
60053889|NCT02198651|76169429|FG000|Participants Treated in Lead-In Period|Lead-in Period||146||
60053890|NCT02198651|76169430|FG001|Participants Treated in Lead-In Period|Lead-in Period||0||
60053891|NCT02198651|76169431|FG002|Participants Treated in Lead-In Period|Lead-in Period||0||
60053892|NCT02198651|76169432|FG003|Participants Treated in Lead-In Period|Lead-in Period||0||
60053893|NCT02198651|76169433|FG004|Participants Treated in Lead-In Period|Lead-in Period||0||
60053894|NCT02198651|76169429|FG000|COMPLETED|Lead-in Period||112||
60053895|NCT02198651|76169430|FG001|COMPLETED|Lead-in Period||0||
59514802|NCT00932477|75608447|FG004|COMPLETED|Treatment 1||8||
59514803|NCT00932477|75608448|FG005|COMPLETED|Treatment 1||8||
60053896|NCT02198651|76169431|FG002|COMPLETED|Lead-in Period||0||
60053897|NCT02198651|76169432|FG003|COMPLETED|Lead-in Period||0||
60053898|NCT02198651|76169433|FG004|COMPLETED|Lead-in Period||0||
60053899|NCT02198651|76169429|FG000|NOT COMPLETED|Lead-in Period||37||
60053900|NCT02198651|76169430|FG001|NOT COMPLETED|Lead-in Period||0||
60053901|NCT02198651|76169431|FG002|NOT COMPLETED|Lead-in Period||0||
60053902|NCT02198651|76169432|FG003|NOT COMPLETED|Lead-in Period||0||
60053903|NCT02198651|76169433|FG004|NOT COMPLETED|Lead-in Period||0||
60053904|NCT02198651|76169429|FG000|STARTED|Double-blind Period||0||
60053905|NCT02198651|76169430|FG001|STARTED|Double-blind Period||102||
60053906|NCT02198651|76169431|FG002|STARTED|Double-blind Period||20||
60053907|NCT02198651|76169432|FG003|STARTED|Double-blind Period||0||
60053908|NCT02198651|76169433|FG004|STARTED|Double-blind Period||0||
60053909|NCT02198651|76169429|FG000|COMPLETED|Double-blind Period||0||
59923307|NCT01064414|76042683|FG001|COMPLETED|Core Period: Baseline to Week 26||75||
59923308|NCT01064414|76042684|FG002|COMPLETED|Core Period: Baseline to Week 26||82||
59923309|NCT01064414|76042682|FG000|NOT COMPLETED|Core Period: Baseline to Week 26||13||
59923310|NCT01064414|76042683|FG001|NOT COMPLETED|Core Period: Baseline to Week 26||15||
59923311|NCT01064414|76042684|FG002|NOT COMPLETED|Core Period: Baseline to Week 26||7||
59923312|NCT01064414|76042682|FG000|STARTED|Extension Period: Week 26 to Week 52|1 pt completed core but did not enter ext. Reason: other (not specified).|76||
59923313|NCT01064414|76042683|FG001|STARTED|Extension Period: Week 26 to Week 52|3 pts completed core but did not enter ext. Reason: other (not specified) (3).|72||
59923314|NCT01064414|76042684|FG002|STARTED|Extension Period: Week 26 to Week 52|1 pt completed core but did not enter ext. Reason: other (not specified).|81||
59923315|NCT01064414|76042682|FG000|COMPLETED|Extension Period: Week 26 to Week 52||64||
59923316|NCT01064414|76042683|FG001|COMPLETED|Extension Period: Week 26 to Week 52||67||
59923317|NCT01064414|76042684|FG002|COMPLETED|Extension Period: Week 26 to Week 52||76||
59923318|NCT01064414|76042682|FG000|NOT COMPLETED|Extension Period: Week 26 to Week 52||12||
59923319|NCT01064414|76042683|FG001|NOT COMPLETED|Extension Period: Week 26 to Week 52||5||
59923320|NCT01064414|76042684|FG002|NOT COMPLETED|Extension Period: Week 26 to Week 52||5||
59923321|NCT03433703|76042695|FG000|STARTED|Overall Study||2||
59923322|NCT03433703|76042695|FG000|COMPLETED|Overall Study||0||
59923323|NCT03433703|76042695|FG000|NOT COMPLETED|Overall Study||2||
59923324|NCT01178814|76042699|FG000|STARTED|Overall Study||57||
59923325|NCT01178814|76042699|FG000|COMPLETED|Overall Study||57||
59923326|NCT01178814|76042699|FG000|NOT COMPLETED|Overall Study||0||
59923327|NCT03463031|76042705|FG000|STARTED|Overall Study||225||
59923328|NCT03463031|76042706|FG001|STARTED|Overall Study||221||
59923329|NCT03463031|76042705|FG000|COMPLETED|Overall Study||215||
59923330|NCT03463031|76042706|FG001|COMPLETED|Overall Study||216||
59923331|NCT03463031|76042705|FG000|NOT COMPLETED|Overall Study||10||
59923332|NCT03463031|76042706|FG001|NOT COMPLETED|Overall Study||5||
59923333|NCT03462641|76042714|FG000|STARTED|Visit 1||19||
59923334|NCT03462641|76042715|FG001|STARTED|Visit 1||11||
59923335|NCT03462641|76042714|FG000|Actually Received Drug or Placebo|Visit 1||18||
59923336|NCT03462641|76042715|FG001|Actually Received Drug or Placebo|Visit 1||11||
59923337|NCT03462641|76042714|FG000|COMPLETED|Visit 1||18||
59923338|NCT03462641|76042715|FG001|COMPLETED|Visit 1||11||
59923339|NCT03462641|76042714|FG000|NOT COMPLETED|Visit 1||1||
59923340|NCT03462641|76042715|FG001|NOT COMPLETED|Visit 1||0||
59923341|NCT03462641|76042714|FG000|STARTED|Visit 2||18||
59923342|NCT03462641|76042715|FG001|STARTED|Visit 2||11||
59923343|NCT03462641|76042714|FG000|Actually Received Drug or Placebo|Visit 2||18||
59923344|NCT03462641|76042715|FG001|Actually Received Drug or Placebo|Visit 2||10||
59923345|NCT03462641|76042714|FG000|COMPLETED|Visit 2||18||
59923346|NCT03462641|76042715|FG001|COMPLETED|Visit 2||10||
59923347|NCT03462641|76042714|FG000|NOT COMPLETED|Visit 2||0||
59923348|NCT03462641|76042715|FG001|NOT COMPLETED|Visit 2||1||
59923349|NCT02974634|76042725|FG000|STARTED|Overall Study||106||
59923350|NCT02974634|76042726|FG001|STARTED|Overall Study||110||
59923351|NCT02974634|76042725|FG000|COMPLETED|Overall Study||78||
59923352|NCT02974634|76042726|FG001|COMPLETED|Overall Study||89||
59923353|NCT02974634|76042725|FG000|NOT COMPLETED|Overall Study||28||
59923354|NCT02974634|76042726|FG001|NOT COMPLETED|Overall Study||21||
59923355|NCT01060670|76042735|FG000|STARTED|Run In||0||
59923356|NCT01060670|76042736|FG001|STARTED|Run In||545||
59923357|NCT01060670|76042735|FG000|COMPLETED|Run In||0||
59923358|NCT01060670|76042736|FG001|COMPLETED|Run In||307||
59923359|NCT01060670|76042735|FG000|NOT COMPLETED|Run In||0||
59923360|NCT01060670|76042736|FG001|NOT COMPLETED|Run In||238||
59923361|NCT01060670|76042735|FG000|STARTED|Treatment Phase||154||
59923362|NCT01060670|76042736|FG001|STARTED|Treatment Phase||153||
59923363|NCT01060670|76042735|FG000|Healed at End of Treatment Phase|Treatment Phase||79||
59923364|NCT01060670|76042736|FG001|Healed at End of Treatment Phase|Treatment Phase||49||
59923365|NCT01060670|76042735|FG000|Did Not Heal by Treatment Visit 17|Treatment Phase||49||
59923366|NCT01060670|76042736|FG001|Did Not Heal by Treatment Visit 17|Treatment Phase||68||
60053910|NCT02198651|76169430|FG001|COMPLETED|Double-blind Period||93||
60053911|NCT02198651|76169431|FG002|COMPLETED|Double-blind Period||19||
60053912|NCT02198651|76169432|FG003|COMPLETED|Double-blind Period||0||
60053913|NCT02198651|76169433|FG004|COMPLETED|Double-blind Period||0||
59923367|NCT01060670|76042735|FG000|Withdrew From Treatment|Treatment Phase||26||
59923368|NCT01060670|76042736|FG001|Withdrew From Treatment|Treatment Phase||36||
59923369|NCT01060670|76042735|FG000|COMPLETED|Treatment Phase||128||
59923370|NCT01060670|76042736|FG001|COMPLETED|Treatment Phase||117||
59923371|NCT01060670|76042735|FG000|NOT COMPLETED|Treatment Phase||26||
60053914|NCT02198651|76169429|FG000|NOT COMPLETED|Double-blind Period||0||
59923372|NCT01060670|76042736|FG001|NOT COMPLETED|Treatment Phase||36||
59923373|NCT01060670|76042735|FG000|STARTED|Follow up Phase||128||
60053915|NCT02198651|76169430|FG001|NOT COMPLETED|Double-blind Period||9||
60053916|NCT02198651|76169431|FG002|NOT COMPLETED|Double-blind Period||1||
59923374|NCT01060670|76042736|FG001|STARTED|Follow up Phase||117||
59923375|NCT01060670|76042735|FG000|Recurrence|Follow up Phase||14||
60053917|NCT02198651|76169432|FG003|NOT COMPLETED|Double-blind Period||0||
59923376|NCT01060670|76042736|FG001|Recurrence|Follow up Phase||9||
59923377|NCT01060670|76042735|FG000|Withdrew From Follow up Phase|Follow up Phase||22||
59923378|NCT01060670|76042736|FG001|Withdrew From Follow up Phase|Follow up Phase||35||
59923379|NCT01060670|76042735|FG000|COMPLETED|Follow up Phase||106||
59923380|NCT01060670|76042736|FG001|COMPLETED|Follow up Phase||82||
59923381|NCT01060670|76042735|FG000|NOT COMPLETED|Follow up Phase||22||
59923382|NCT01060670|76042736|FG001|NOT COMPLETED|Follow up Phase||35||
59923383|NCT02971670|76042748|FG000|STARTED|Overall Study||13||
59923384|NCT02971670|76042749|FG001|STARTED|Overall Study||2||
59923385|NCT02971670|76042750|FG002|STARTED|Overall Study||5||
59923386|NCT02971670|76042751|FG003|STARTED|Overall Study||3||
59923387|NCT02971670|76042748|FG000|COMPLETED|Overall Study||9||
59923388|NCT02971670|76042749|FG001|COMPLETED|Overall Study||1||
59923389|NCT02971670|76042750|FG002|COMPLETED|Overall Study||4||
59923390|NCT02971670|76042751|FG003|COMPLETED|Overall Study||1||
59923391|NCT02971670|76042748|FG000|NOT COMPLETED|Overall Study||4||
59923392|NCT02971670|76042749|FG001|NOT COMPLETED|Overall Study||1||
59923393|NCT02971670|76042750|FG002|NOT COMPLETED|Overall Study||1||
59923394|NCT02971670|76042751|FG003|NOT COMPLETED|Overall Study||2||
59923395|NCT02971202|76042764|FG000|STARTED|Overall Study||12||
59923396|NCT02971202|76042765|FG001|STARTED|Overall Study||10||
59923397|NCT02971202|76042766|FG002|STARTED|Overall Study||11||
59923398|NCT02971202|76042764|FG000|Started Study|Overall Study||11||
59923399|NCT02971202|76042765|FG001|Started Study|Overall Study||10||
59923400|NCT02971202|76042766|FG002|Started Study|Overall Study||10||
59923401|NCT02971202|76042764|FG000|COMPLETED|Overall Study||10||
59923402|NCT02971202|76042765|FG001|COMPLETED|Overall Study||10||
59923403|NCT02971202|76042766|FG002|COMPLETED|Overall Study||10||
59923404|NCT02971202|76042764|FG000|NOT COMPLETED|Overall Study||2||
59923405|NCT02971202|76042765|FG001|NOT COMPLETED|Overall Study||0||
59923406|NCT02971202|76042766|FG002|NOT COMPLETED|Overall Study||1||
59923407|NCT02926638|76042776|FG000|STARTED|Overall Study||4||
59923408|NCT02926638|76042777|FG001|STARTED|Overall Study||5||
59923409|NCT02926638|76042776|FG000|Eligible|Overall Study||3||
59923410|NCT02926638|76042777|FG001|Eligible|Overall Study||5||
59923411|NCT02926638|76042776|FG000|COMPLETED|Overall Study||0||
59923412|NCT02926638|76042777|FG001|COMPLETED|Overall Study||0||
59923413|NCT02926638|76042776|FG000|NOT COMPLETED|Overall Study||4||
59923414|NCT02926638|76042777|FG001|NOT COMPLETED|Overall Study||5||
59923415|NCT02903030|76042785|FG000|STARTED|First Intervention (8 Weeks)||8||
59923416|NCT02903030|76042786|FG001|STARTED|First Intervention (8 Weeks)||5||
59923417|NCT02903030|76042785|FG000|Received Intervention|First Intervention (8 Weeks)||6||
59923418|NCT02903030|76042786|FG001|Received Intervention|First Intervention (8 Weeks)||4||
59923419|NCT02903030|76042785|FG000|COMPLETED|First Intervention (8 Weeks)||6||
59923420|NCT02903030|76042786|FG001|COMPLETED|First Intervention (8 Weeks)||4||
59923421|NCT02903030|76042785|FG000|NOT COMPLETED|First Intervention (8 Weeks)||2||
59923422|NCT02903030|76042786|FG001|NOT COMPLETED|First Intervention (8 Weeks)||1||
59923423|NCT02903030|76042785|FG000|STARTED|Washout (3 Weeks)||6||
59923424|NCT02903030|76042786|FG001|STARTED|Washout (3 Weeks)||4||
59923425|NCT02903030|76042785|FG000|COMPLETED|Washout (3 Weeks)||6||
59923426|NCT02903030|76042786|FG001|COMPLETED|Washout (3 Weeks)||4||
59923427|NCT02903030|76042785|FG000|NOT COMPLETED|Washout (3 Weeks)||0||
59923428|NCT02903030|76042786|FG001|NOT COMPLETED|Washout (3 Weeks)||0||
59923429|NCT02903030|76042785|FG000|STARTED|Second Intervention (8 Weeks)||6||
59923430|NCT02903030|76042786|FG001|STARTED|Second Intervention (8 Weeks)||4||
59923431|NCT02903030|76042785|FG000|COMPLETED|Second Intervention (8 Weeks)||6||
59923432|NCT02903030|76042786|FG001|COMPLETED|Second Intervention (8 Weeks)||4||
59923433|NCT02903030|76042785|FG000|NOT COMPLETED|Second Intervention (8 Weeks)||0||
59923434|NCT02903030|76042786|FG001|NOT COMPLETED|Second Intervention (8 Weeks)||0||
59923435|NCT02969408|76042795|FG000|STARTED|Overall Study||397||
59923436|NCT02969408|76042795|FG000|Used ABS eMDPI at Least Once|Overall Study||370||
59923437|NCT02969408|76042795|FG000|COMPLETED|Overall Study||381||
59923438|NCT02969408|76042795|FG000|NOT COMPLETED|Overall Study||16||
59923439|NCT03462563|76042801|FG000|STARTED|Overall Study||94||
59923440|NCT03462563|76042802|FG001|STARTED|Overall Study||81||
59923441|NCT03462563|76042801|FG000|COMPLETED|Overall Study||79||
59923442|NCT03462563|76042802|FG001|COMPLETED|Overall Study||64||
59923443|NCT03462563|76042801|FG000|NOT COMPLETED|Overall Study||15||
59923444|NCT03462563|76042802|FG001|NOT COMPLETED|Overall Study||17||
59923445|NCT01060124|76042808|FG000|STARTED|Overall Study||103||
59923446|NCT01060124|76042808|FG000|COMPLETED|Overall Study||66||
59923447|NCT01060124|76042808|FG000|NOT COMPLETED|Overall Study||37||
59923448|NCT03461003|76042814|FG000|STARTED|Overall Study||23||
59923449|NCT03461003|76042815|FG001|STARTED|Overall Study||26||
59923450|NCT03461003|76042814|FG000|Received Intervention|Overall Study||21||
59923451|NCT03461003|76042815|FG001|Received Intervention|Overall Study||22||
59923452|NCT03461003|76042814|FG000|Completed 6-month Follow up|Overall Study||18||
59923453|NCT03461003|76042815|FG001|Completed 6-month Follow up|Overall Study||23||
60053918|NCT02198651|76169433|FG004|NOT COMPLETED|Double-blind Period||0||
60053919|NCT02198651|76169429|FG000|STARTED|Open-label Rescue Period||0||
60053920|NCT02198651|76169430|FG001|STARTED|Open-label Rescue Period||0||
60053921|NCT02198651|76169431|FG002|STARTED|Open-label Rescue Period||0||
60053922|NCT02198651|76169432|FG003|STARTED|Open-label Rescue Period||31||
60053923|NCT02198651|76169433|FG004|STARTED|Open-label Rescue Period||8||
60053924|NCT02198651|76169429|FG000|Correctly Entered Open-label Rescue|Open-label Rescue Period||0||
60053925|NCT02198651|76169430|FG001|Correctly Entered Open-label Rescue|Open-label Rescue Period||0||
60053926|NCT02198651|76169431|FG002|Correctly Entered Open-label Rescue|Open-label Rescue Period||0||
60053927|NCT02198651|76169432|FG003|Correctly Entered Open-label Rescue|Open-label Rescue Period||30||
60053928|NCT02198651|76169433|FG004|Correctly Entered Open-label Rescue|Open-label Rescue Period||8||
60053929|NCT02198651|76169429|FG000|COMPLETED|Open-label Rescue Period||0||
59923454|NCT03461003|76042814|FG000|COMPLETED|Overall Study||18||
59923455|NCT03461003|76042815|FG001|COMPLETED|Overall Study||23||
59923456|NCT03461003|76042814|FG000|NOT COMPLETED|Overall Study||5||
59923457|NCT03461003|76042815|FG001|NOT COMPLETED|Overall Study||3||
59923458|NCT02904902|76042821|FG000|STARTED|Overall Study||15||
59923459|NCT02904902|76042821|FG000|COMPLETED|Overall Study||14||
59923460|NCT02904902|76042821|FG000|NOT COMPLETED|Overall Study||1||
59923461|NCT04425720|76042827|FG000|STARTED|Overall Study||150||
59923462|NCT04425720|76042828|FG001|STARTED|Overall Study||150||
59923463|NCT04425720|76042827|FG000|COMPLETED|Overall Study||150||
59923464|NCT04425720|76042828|FG001|COMPLETED|Overall Study||130||
59923465|NCT04425720|76042827|FG000|NOT COMPLETED|Overall Study||0||
59923466|NCT04425720|76042828|FG001|NOT COMPLETED|Overall Study||20||
59923467|NCT02904512|76042837|FG000|STARTED|Overall Study||9||
59923468|NCT02904512|76042838|FG001|STARTED|Overall Study||7||
59923469|NCT02904512|76042837|FG000|COMPLETED|Overall Study||6||
59923470|NCT02904512|76042838|FG001|COMPLETED|Overall Study||7||
59923471|NCT02904512|76042837|FG000|NOT COMPLETED|Overall Study||3||
59923472|NCT02904512|76042838|FG001|NOT COMPLETED|Overall Study||0||
59923473|NCT02904200|76042844|FG000|STARTED|Overall Study|One pat. early terminated on own decision, due to travelling distance between home and hospital.|2||
59923474|NCT02904200|76042845|FG001|STARTED|Overall Study|No statistical evaluation was performed because only 2 subjects were included in one arm.|0||
59923475|NCT02904200|76042844|FG000|COMPLETED|Overall Study||1||
59923476|NCT02904200|76042845|FG001|COMPLETED|Overall Study||0||
59923477|NCT02904200|76042844|FG000|NOT COMPLETED|Overall Study||1||
59923478|NCT02904200|76042845|FG001|NOT COMPLETED|Overall Study||0||
59923479|NCT03432533|76042851|FG000|STARTED|Overall Study||141||
59923480|NCT03432533|76042852|FG001|STARTED|Overall Study||142||
59923481|NCT03432533|76042851|FG000|Completed 6-Month Treatment Period|Overall Study||136||
59923482|NCT03432533|76042852|FG001|Completed 6-Month Treatment Period|Overall Study||137||
59923483|NCT03432533|76042851|FG000|COMPLETED|Overall Study||126|Completed 9-Month Study Period|
59923484|NCT03432533|76042852|FG001|COMPLETED|Overall Study||131|Completed 9-Month Study Period|
59923485|NCT03432533|76042851|FG000|NOT COMPLETED|Overall Study||15||
59923486|NCT03432533|76042852|FG001|NOT COMPLETED|Overall Study||11||
59923487|NCT02901548|76042858|FG000|STARTED|Overall Study||17||
59923488|NCT02901548|76042858|FG000|COMPLETED|Overall Study||13||
59923489|NCT02901548|76042858|FG000|NOT COMPLETED|Overall Study||4||
59923490|NCT02903966|76042864|FG000|STARTED|Part A (Day 1 to 43)||12||
60053930|NCT02198651|76169430|FG001|COMPLETED|Open-label Rescue Period||0||
60053931|NCT02198651|76169431|FG002|COMPLETED|Open-label Rescue Period||0||
60053932|NCT02198651|76169432|FG003|COMPLETED|Open-label Rescue Period||28||
60053933|NCT02198651|76169433|FG004|COMPLETED|Open-label Rescue Period||8||
60053934|NCT02198651|76169429|FG000|NOT COMPLETED|Open-label Rescue Period||0||
60053935|NCT02198651|76169430|FG001|NOT COMPLETED|Open-label Rescue Period||0||
60053936|NCT02198651|76169431|FG002|NOT COMPLETED|Open-label Rescue Period||0||
60053937|NCT02198651|76169432|FG003|NOT COMPLETED|Open-label Rescue Period||3||
60053938|NCT02198651|76169433|FG004|NOT COMPLETED|Open-label Rescue Period||0||
60053939|NCT01498822|76169448|FG000|STARTED|Overall Study||175||
60053940|NCT01498822|76169449|FG001|STARTED|Overall Study||178||
60053941|NCT01498822|76169448|FG000|COMPLETED|Overall Study||121||
60053942|NCT01498822|76169449|FG001|COMPLETED|Overall Study||122||
60053943|NCT01498822|76169448|FG000|NOT COMPLETED|Overall Study||54||
60053944|NCT01498822|76169449|FG001|NOT COMPLETED|Overall Study||56||
60053945|NCT01498120|76169457|FG000|STARTED|Overall Study||14||
60053946|NCT01498120|76169457|FG000|COMPLETED|Overall Study||1||
60053947|NCT01498120|76169457|FG000|NOT COMPLETED|Overall Study||13||
60053948|NCT01497262|76169461|FG000|STARTED|Overall Study||162||
60053949|NCT01497262|76169461|FG000|COMPLETED|Overall Study||151||
60053950|NCT01497262|76169461|FG000|NOT COMPLETED|Overall Study||11||
60053951|NCT02224625|76169465|FG000|STARTED|Irritation||39||
60053952|NCT02224625|76169465|FG000|COMPLETED|Irritation||33||
59923491|NCT02903966|76042865|FG001|STARTED|Part A (Day 1 to 43)||24||
59923492|NCT02903966|76042864|FG000|COMPLETED|Part A (Day 1 to 43)||11||
59923493|NCT02903966|76042865|FG001|COMPLETED|Part A (Day 1 to 43)||24||
59923494|NCT02903966|76042864|FG000|NOT COMPLETED|Part A (Day 1 to 43)||1||
59923495|NCT02903966|76042865|FG001|NOT COMPLETED|Part A (Day 1 to 43)||0||
60053953|NCT02224625|76169465|FG000|NOT COMPLETED|Irritation||6||
59612926|NCT01716234|75723952|FG006|Treated|Overall Study||1||
59612927|NCT01716234|75723946|FG000|COMPLETED|Overall Study||14||
59612928|NCT01716234|75723947|FG001|COMPLETED|Overall Study||12||
59923496|NCT02903966|76042864|FG000|STARTED|Part B (Day 44 to 112)||11||
59923497|NCT02903966|76042865|FG001|STARTED|Part B (Day 44 to 112)||24||
59923498|NCT02903966|76042864|FG000|COMPLETED|Part B (Day 44 to 112)||11||
59923499|NCT02903966|76042865|FG001|COMPLETED|Part B (Day 44 to 112)||22||
59923500|NCT02903966|76042864|FG000|NOT COMPLETED|Part B (Day 44 to 112)||0||
59923501|NCT02903966|76042865|FG001|NOT COMPLETED|Part B (Day 44 to 112)||2||
59923502|NCT03457727|76042881|FG000|STARTED|Part 1, Period 1 (1 Day)||8||
59923503|NCT03457727|76042882|FG001|STARTED|Part 1, Period 1 (1 Day)||8||
59923504|NCT03457727|76042883|FG002|STARTED|Part 1, Period 1 (1 Day)||0||
59923505|NCT03457727|76042884|FG003|STARTED|Part 1, Period 1 (1 Day)||0||
59923506|NCT03457727|76042881|FG000|COMPLETED|Part 1, Period 1 (1 Day)||8||
59923507|NCT03457727|76042882|FG001|COMPLETED|Part 1, Period 1 (1 Day)||8||
59923508|NCT03457727|76042883|FG002|COMPLETED|Part 1, Period 1 (1 Day)||0||
59923509|NCT03457727|76042884|FG003|COMPLETED|Part 1, Period 1 (1 Day)||0||
59923510|NCT03457727|76042881|FG000|NOT COMPLETED|Part 1, Period 1 (1 Day)||0||
59923511|NCT03457727|76042882|FG001|NOT COMPLETED|Part 1, Period 1 (1 Day)||0||
59923512|NCT03457727|76042883|FG002|NOT COMPLETED|Part 1, Period 1 (1 Day)||0||
59923513|NCT03457727|76042884|FG003|NOT COMPLETED|Part 1, Period 1 (1 Day)||0||
59923514|NCT03457727|76042881|FG000|STARTED|Part 1, Washout Period 1 (5 Days)||8||
59923515|NCT03457727|76042882|FG001|STARTED|Part 1, Washout Period 1 (5 Days)||8||
59923516|NCT03457727|76042883|FG002|STARTED|Part 1, Washout Period 1 (5 Days)||0||
59923517|NCT03457727|76042884|FG003|STARTED|Part 1, Washout Period 1 (5 Days)||0||
59923518|NCT03457727|76042881|FG000|COMPLETED|Part 1, Washout Period 1 (5 Days)||8||
59923519|NCT03457727|76042882|FG001|COMPLETED|Part 1, Washout Period 1 (5 Days)||8||
59923520|NCT03457727|76042883|FG002|COMPLETED|Part 1, Washout Period 1 (5 Days)||0||
59923521|NCT03457727|76042884|FG003|COMPLETED|Part 1, Washout Period 1 (5 Days)||0||
59612929|NCT01716234|75723948|FG002|COMPLETED|Overall Study||15||
59612930|NCT01716234|75723949|FG003|COMPLETED|Overall Study||16||
59923522|NCT03457727|76042881|FG000|NOT COMPLETED|Part 1, Washout Period 1 (5 Days)||0||
59923523|NCT03457727|76042882|FG001|NOT COMPLETED|Part 1, Washout Period 1 (5 Days)||0||
59923524|NCT03457727|76042883|FG002|NOT COMPLETED|Part 1, Washout Period 1 (5 Days)||0||
59923525|NCT03457727|76042884|FG003|NOT COMPLETED|Part 1, Washout Period 1 (5 Days)||0||
59923526|NCT03457727|76042881|FG000|STARTED|Part 1, Period 2 (1 Day)||8||
59923527|NCT03457727|76042882|FG001|STARTED|Part 1, Period 2 (1 Day)||8||
59923528|NCT03457727|76042883|FG002|STARTED|Part 1, Period 2 (1 Day)||0||
59923529|NCT03457727|76042884|FG003|STARTED|Part 1, Period 2 (1 Day)||0||
59923530|NCT03457727|76042881|FG000|COMPLETED|Part 1, Period 2 (1 Day)||8||
59951440|NCT00674479|76070438|FG000|COMPLETED|Overall Study||51||
59951441|NCT00674479|76070438|FG000|NOT COMPLETED|Overall Study||0||
59951442|NCT00542451|76070442|FG000|STARTED|Overall Study||406||
59951443|NCT00542451|76070442|FG000|COMPLETED|Overall Study||327||
59951444|NCT00542451|76070442|FG000|NOT COMPLETED|Overall Study||79||
59951445|NCT00506493|76070449|FG000|STARTED|Overall Study||75||
59951446|NCT00506493|76070449|FG000|COMPLETED|Overall Study||64||
59951447|NCT00506493|76070449|FG000|NOT COMPLETED|Overall Study||11||
59951448|NCT00336232|76070455|FG000|STARTED|Baseline (200mcg Daily)||59||
59951449|NCT00336232|76070455|FG000|COMPLETED|Baseline (200mcg Daily)||42||
59951450|NCT00336232|76070455|FG000|NOT COMPLETED|Baseline (200mcg Daily)||17||
59951451|NCT00336232|76070455|FG000|STARTED|Low Vitamin K (10mcg Daily)||42||
59951452|NCT00336232|76070455|FG000|COMPLETED|Low Vitamin K (10mcg Daily)||42||
59951453|NCT00336232|76070455|FG000|NOT COMPLETED|Low Vitamin K (10mcg Daily)||0||
59951454|NCT00336232|76070455|FG000|STARTED|High Vitamin K (500mcg Daily)||42||
59951455|NCT00336232|76070455|FG000|COMPLETED|High Vitamin K (500mcg Daily)||42||
59951456|NCT00336232|76070455|FG000|NOT COMPLETED|High Vitamin K (500mcg Daily)||0||
59951457|NCT00157248|76070463|FG000|STARTED|Overall Study|Started: Participant completed previous trial on Dabigatran and took study drug of present trial.|98||
59951458|NCT00157248|76070464|FG001|STARTED|Overall Study||89||
59951459|NCT00157248|76070465|FG002|STARTED|Overall Study||50||
59951460|NCT00157248|76070466|FG003|STARTED|Overall Study||124||
59951461|NCT00157248|76070463|FG000|COMPLETED|Overall Study|Completed: Participant without premature discontinuation of study medication.|50||
59951462|NCT00157248|76070464|FG001|COMPLETED|Overall Study||52||
59951463|NCT00157248|76070465|FG002|COMPLETED|Overall Study||29||
59951464|NCT00157248|76070466|FG003|COMPLETED|Overall Study||77||
59951465|NCT00157248|76070463|FG000|NOT COMPLETED|Overall Study||48||
59951466|NCT00157248|76070464|FG001|NOT COMPLETED|Overall Study||37||
59951467|NCT00157248|76070465|FG002|NOT COMPLETED|Overall Study||21||
59951468|NCT00157248|76070466|FG003|NOT COMPLETED|Overall Study||47||
59951469|NCT02504580|76070488|FG000|STARTED|Overall Study||19||
59951470|NCT02504580|76070489|FG001|STARTED|Overall Study||17||
59951471|NCT02504580|76070490|FG002|STARTED|Overall Study||16||
59951472|NCT02504580|76070491|FG003|STARTED|Overall Study||20||
59951473|NCT02504580|76070492|FG004|STARTED|Overall Study||17||
59951474|NCT02504580|76070493|FG005|STARTED|Overall Study||18||
59951475|NCT02504580|76070494|FG006|STARTED|Overall Study||40||
60053954|NCT02224625|76169465|FG000|STARTED|Sensitization|Subjects from Irritation study also participated in Sensitization Study|249||
60053955|NCT02224625|76169465|FG000|COMPLETED|Sensitization||194||
60053956|NCT02224625|76169465|FG000|NOT COMPLETED|Sensitization||55||
60053957|NCT02197247|76169477|FG000|STARTED|Part A: Day 1-28 (AZD9291 Alone)||41||
60053958|NCT02197247|76169477|FG000|COMPLETED|Part A: Day 1-28 (AZD9291 Alone)||41||
60053959|NCT02197247|76169477|FG000|NOT COMPLETED|Part A: Day 1-28 (AZD9291 Alone)||0||
60053960|NCT02197247|76169477|FG000|STARTED|Part A: Day 29-49 (AZD9291+Rifampicin)||41||
60053961|NCT02197247|76169477|FG000|COMPLETED|Part A: Day 29-49 (AZD9291+Rifampicin)||37||
60053962|NCT02197247|76169477|FG000|NOT COMPLETED|Part A: Day 29-49 (AZD9291+Rifampicin)||4||
60053963|NCT02197247|76169477|FG000|STARTED|Part A: Day 50-77 (AZD9291 Alone)||37||
60053964|NCT02197247|76169477|FG000|COMPLETED|Part A: Day 50-77 (AZD9291 Alone)||32||
60053965|NCT02197247|76169477|FG000|NOT COMPLETED|Part A: Day 50-77 (AZD9291 Alone)||5||
60053966|NCT02197247|76169477|FG000|STARTED|Part B: Day 78 to End Part B (AZD9291)|32 completed Part A + 2 entered Part B without completing Part A (both due to AE) =34 started Part B|34||
60053967|NCT02197247|76169477|FG000|COMPLETED|Part B: Day 78 to End Part B (AZD9291)||19||
59514804|NCT00932477|75608443|FG000|NOT COMPLETED|Treatment 1||0||
59514805|NCT00932477|75608444|FG001|NOT COMPLETED|Treatment 1||0||
59514806|NCT00932477|75608445|FG002|NOT COMPLETED|Treatment 1||0||
59514807|NCT00932477|75608446|FG003|NOT COMPLETED|Treatment 1||0||
59514808|NCT00932477|75608447|FG004|NOT COMPLETED|Treatment 1||0||
59514809|NCT00932477|75608448|FG005|NOT COMPLETED|Treatment 1||0||
59514810|NCT00932477|75608443|FG000|STARTED|Treatment 2||7||
59514811|NCT00932477|75608444|FG001|STARTED|Treatment 2||8||
59514812|NCT00932477|75608445|FG002|STARTED|Treatment 2||9||
59514813|NCT00932477|75608446|FG003|STARTED|Treatment 2||7||
59514814|NCT00932477|75608447|FG004|STARTED|Treatment 2||8||
59514815|NCT00932477|75608448|FG005|STARTED|Treatment 2||8||
59514816|NCT00932477|75608443|FG000|COMPLETED|Treatment 2||7||
59514817|NCT00932477|75608444|FG001|COMPLETED|Treatment 2||8||
59923531|NCT03457727|76042882|FG001|COMPLETED|Part 1, Period 2 (1 Day)||8||
59923532|NCT03457727|76042883|FG002|COMPLETED|Part 1, Period 2 (1 Day)||0||
59923533|NCT03457727|76042884|FG003|COMPLETED|Part 1, Period 2 (1 Day)||0||
59923534|NCT03457727|76042881|FG000|NOT COMPLETED|Part 1, Period 2 (1 Day)||0||
59923535|NCT03457727|76042882|FG001|NOT COMPLETED|Part 1, Period 2 (1 Day)||0||
59923536|NCT03457727|76042883|FG002|NOT COMPLETED|Part 1, Period 2 (1 Day)||0||
59923537|NCT03457727|76042884|FG003|NOT COMPLETED|Part 1, Period 2 (1 Day)||0||
59923538|NCT03457727|76042881|FG000|STARTED|Part 1, Washout Period 2 (5 Days)||8||
59923539|NCT03457727|76042882|FG001|STARTED|Part 1, Washout Period 2 (5 Days)||8||
59923540|NCT03457727|76042883|FG002|STARTED|Part 1, Washout Period 2 (5 Days)||0||
59923541|NCT03457727|76042884|FG003|STARTED|Part 1, Washout Period 2 (5 Days)||0||
59923542|NCT03457727|76042881|FG000|COMPLETED|Part 1, Washout Period 2 (5 Days)||8||
59923543|NCT03457727|76042882|FG001|COMPLETED|Part 1, Washout Period 2 (5 Days)||8||
59923544|NCT03457727|76042883|FG002|COMPLETED|Part 1, Washout Period 2 (5 Days)||0||
59923545|NCT03457727|76042884|FG003|COMPLETED|Part 1, Washout Period 2 (5 Days)||0||
59923546|NCT03457727|76042881|FG000|NOT COMPLETED|Part 1, Washout Period 2 (5 Days)||0||
59923547|NCT03457727|76042882|FG001|NOT COMPLETED|Part 1, Washout Period 2 (5 Days)||0||
59923548|NCT03457727|76042883|FG002|NOT COMPLETED|Part 1, Washout Period 2 (5 Days)||0||
59923549|NCT03457727|76042884|FG003|NOT COMPLETED|Part 1, Washout Period 2 (5 Days)||0||
59923550|NCT03457727|76042881|FG000|STARTED|Part 1, Period 3 (1 Day)||8||
60053968|NCT02197247|76169477|FG000|NOT COMPLETED|Part B: Day 78 to End Part B (AZD9291)||15||
59514818|NCT00932477|75608445|FG002|COMPLETED|Treatment 2||9||
59514819|NCT00932477|75608446|FG003|COMPLETED|Treatment 2||7||
59923551|NCT03457727|76042882|FG001|STARTED|Part 1, Period 3 (1 Day)||8||
59923552|NCT03457727|76042883|FG002|STARTED|Part 1, Period 3 (1 Day)||0||
59923553|NCT03457727|76042884|FG003|STARTED|Part 1, Period 3 (1 Day)||0||
59923554|NCT03457727|76042881|FG000|COMPLETED|Part 1, Period 3 (1 Day)||8||
59923555|NCT03457727|76042882|FG001|COMPLETED|Part 1, Period 3 (1 Day)||8||
59923556|NCT03457727|76042883|FG002|COMPLETED|Part 1, Period 3 (1 Day)||0||
59923557|NCT03457727|76042884|FG003|COMPLETED|Part 1, Period 3 (1 Day)||0||
59923558|NCT03457727|76042881|FG000|NOT COMPLETED|Part 1, Period 3 (1 Day)||0||
59923559|NCT03457727|76042882|FG001|NOT COMPLETED|Part 1, Period 3 (1 Day)||0||
59514820|NCT00932477|75608447|FG004|COMPLETED|Treatment 2||8||
59514821|NCT00932477|75608448|FG005|COMPLETED|Treatment 2||8||
59514822|NCT00932477|75608443|FG000|NOT COMPLETED|Treatment 2||0||
59514823|NCT00932477|75608444|FG001|NOT COMPLETED|Treatment 2||0||
59923560|NCT03457727|76042883|FG002|NOT COMPLETED|Part 1, Period 3 (1 Day)||0||
59923561|NCT03457727|76042884|FG003|NOT COMPLETED|Part 1, Period 3 (1 Day)||0||
59923562|NCT03457727|76042881|FG000|STARTED|Part 1, Washout Period 3 (5 Days)||8||
59923563|NCT03457727|76042882|FG001|STARTED|Part 1, Washout Period 3 (5 Days)||8||
59923564|NCT03457727|76042883|FG002|STARTED|Part 1, Washout Period 3 (5 Days)||0||
59923565|NCT03457727|76042884|FG003|STARTED|Part 1, Washout Period 3 (5 Days)||0||
59923566|NCT03457727|76042881|FG000|COMPLETED|Part 1, Washout Period 3 (5 Days)||8||
59923567|NCT03457727|76042882|FG001|COMPLETED|Part 1, Washout Period 3 (5 Days)||8||
59923568|NCT03457727|76042883|FG002|COMPLETED|Part 1, Washout Period 3 (5 Days)||0||
59923569|NCT03457727|76042884|FG003|COMPLETED|Part 1, Washout Period 3 (5 Days)||0||
59923570|NCT03457727|76042881|FG000|NOT COMPLETED|Part 1, Washout Period 3 (5 Days)||0||
59514824|NCT00932477|75608445|FG002|NOT COMPLETED|Treatment 2||0||
59923571|NCT03457727|76042882|FG001|NOT COMPLETED|Part 1, Washout Period 3 (5 Days)||0||
59923572|NCT03457727|76042883|FG002|NOT COMPLETED|Part 1, Washout Period 3 (5 Days)||0||
59923573|NCT03457727|76042884|FG003|NOT COMPLETED|Part 1, Washout Period 3 (5 Days)||0||
59923574|NCT03457727|76042881|FG000|STARTED|Part 1, Period 4 (1 Day)||8||
59923575|NCT03457727|76042882|FG001|STARTED|Part 1, Period 4 (1 Day)||8||
59923576|NCT03457727|76042883|FG002|STARTED|Part 1, Period 4 (1 Day)||0||
59923577|NCT03457727|76042884|FG003|STARTED|Part 1, Period 4 (1 Day)||0||
59923578|NCT03457727|76042881|FG000|COMPLETED|Part 1, Period 4 (1 Day)||8||
59923579|NCT03457727|76042882|FG001|COMPLETED|Part 1, Period 4 (1 Day)||8||
59923580|NCT03457727|76042883|FG002|COMPLETED|Part 1, Period 4 (1 Day)||0||
59923581|NCT03457727|76042884|FG003|COMPLETED|Part 1, Period 4 (1 Day)||0||
59923582|NCT03457727|76042881|FG000|NOT COMPLETED|Part 1, Period 4 (1 Day)||0||
59923583|NCT03457727|76042882|FG001|NOT COMPLETED|Part 1, Period 4 (1 Day)||0||
59923584|NCT03457727|76042883|FG002|NOT COMPLETED|Part 1, Period 4 (1 Day)||0||
59923585|NCT03457727|76042884|FG003|NOT COMPLETED|Part 1, Period 4 (1 Day)||0||
59923586|NCT03457727|76042881|FG000|STARTED|Part 2, Period 1 (1 Day)||0||
59923587|NCT03457727|76042882|FG001|STARTED|Part 2, Period 1 (1 Day)||0||
59923588|NCT03457727|76042883|FG002|STARTED|Part 2, Period 1 (1 Day)||12||
59923589|NCT03457727|76042884|FG003|STARTED|Part 2, Period 1 (1 Day)||12||
59923590|NCT03457727|76042881|FG000|COMPLETED|Part 2, Period 1 (1 Day)||0||
59923591|NCT03457727|76042882|FG001|COMPLETED|Part 2, Period 1 (1 Day)||0||
59923592|NCT03457727|76042883|FG002|COMPLETED|Part 2, Period 1 (1 Day)||12||
59923593|NCT03457727|76042884|FG003|COMPLETED|Part 2, Period 1 (1 Day)||12||
59923594|NCT03457727|76042881|FG000|NOT COMPLETED|Part 2, Period 1 (1 Day)||0||
59923595|NCT03457727|76042882|FG001|NOT COMPLETED|Part 2, Period 1 (1 Day)||0||
59923596|NCT03457727|76042883|FG002|NOT COMPLETED|Part 2, Period 1 (1 Day)||0||
59923597|NCT03457727|76042884|FG003|NOT COMPLETED|Part 2, Period 1 (1 Day)||0||
59923598|NCT03457727|76042881|FG000|STARTED|Part 2, Washout Period 1 (5 Days)||0||
59923599|NCT03457727|76042882|FG001|STARTED|Part 2, Washout Period 1 (5 Days)||0||
59923600|NCT03457727|76042883|FG002|STARTED|Part 2, Washout Period 1 (5 Days)||12||
59923601|NCT03457727|76042884|FG003|STARTED|Part 2, Washout Period 1 (5 Days)||12||
59923602|NCT03457727|76042881|FG000|COMPLETED|Part 2, Washout Period 1 (5 Days)||0||
59923603|NCT03457727|76042882|FG001|COMPLETED|Part 2, Washout Period 1 (5 Days)||0||
59923604|NCT03457727|76042883|FG002|COMPLETED|Part 2, Washout Period 1 (5 Days)||12||
59923605|NCT03457727|76042884|FG003|COMPLETED|Part 2, Washout Period 1 (5 Days)||11||
59923606|NCT03457727|76042881|FG000|NOT COMPLETED|Part 2, Washout Period 1 (5 Days)||0||
59923607|NCT03457727|76042882|FG001|NOT COMPLETED|Part 2, Washout Period 1 (5 Days)||0||
59923608|NCT03457727|76042883|FG002|NOT COMPLETED|Part 2, Washout Period 1 (5 Days)||0||
59923609|NCT03457727|76042884|FG003|NOT COMPLETED|Part 2, Washout Period 1 (5 Days)||1||
59923610|NCT03457727|76042881|FG000|STARTED|Part 2, Period 2 (1 Day)||0||
59923611|NCT03457727|76042882|FG001|STARTED|Part 2, Period 2 (1 Day)||0||
59923612|NCT03457727|76042883|FG002|STARTED|Part 2, Period 2 (1 Day)||12||
59923613|NCT03457727|76042884|FG003|STARTED|Part 2, Period 2 (1 Day)||11||
59923614|NCT03457727|76042881|FG000|COMPLETED|Part 2, Period 2 (1 Day)||0||
59923615|NCT03457727|76042882|FG001|COMPLETED|Part 2, Period 2 (1 Day)||0||
59923616|NCT03457727|76042883|FG002|COMPLETED|Part 2, Period 2 (1 Day)||12||
59923617|NCT03457727|76042884|FG003|COMPLETED|Part 2, Period 2 (1 Day)||11||
59923618|NCT03457727|76042881|FG000|NOT COMPLETED|Part 2, Period 2 (1 Day)||0||
59923619|NCT03457727|76042882|FG001|NOT COMPLETED|Part 2, Period 2 (1 Day)||0||
59923620|NCT03457727|76042883|FG002|NOT COMPLETED|Part 2, Period 2 (1 Day)||0||
59923621|NCT03457727|76042884|FG003|NOT COMPLETED|Part 2, Period 2 (1 Day)||0||
59923622|NCT03457727|76042881|FG000|STARTED|Part 2, Washout Period 2 (5 Days)||0||
59923623|NCT03457727|76042882|FG001|STARTED|Part 2, Washout Period 2 (5 Days)||0||
59923624|NCT03457727|76042883|FG002|STARTED|Part 2, Washout Period 2 (5 Days)||12||
59923625|NCT03457727|76042884|FG003|STARTED|Part 2, Washout Period 2 (5 Days)||11||
59923626|NCT03457727|76042881|FG000|COMPLETED|Part 2, Washout Period 2 (5 Days)||0||
59923627|NCT03457727|76042882|FG001|COMPLETED|Part 2, Washout Period 2 (5 Days)||0||
59514825|NCT00932477|75608446|FG003|NOT COMPLETED|Treatment 2||0||
59923628|NCT03457727|76042883|FG002|COMPLETED|Part 2, Washout Period 2 (5 Days)||12||
59923629|NCT03457727|76042884|FG003|COMPLETED|Part 2, Washout Period 2 (5 Days)||11||
59923630|NCT03457727|76042881|FG000|NOT COMPLETED|Part 2, Washout Period 2 (5 Days)||0||
59923631|NCT03457727|76042882|FG001|NOT COMPLETED|Part 2, Washout Period 2 (5 Days)||0||
59923632|NCT03457727|76042883|FG002|NOT COMPLETED|Part 2, Washout Period 2 (5 Days)||0||
59923633|NCT03457727|76042884|FG003|NOT COMPLETED|Part 2, Washout Period 2 (5 Days)||0||
59923634|NCT03457727|76042881|FG000|STARTED|Part 2, Period 3 (1 Day)||0||
59923635|NCT03457727|76042882|FG001|STARTED|Part 2, Period 3 (1 Day)||0||
59923636|NCT03457727|76042883|FG002|STARTED|Part 2, Period 3 (1 Day)||12||
59923637|NCT03457727|76042884|FG003|STARTED|Part 2, Period 3 (1 Day)||11||
59923638|NCT03457727|76042881|FG000|COMPLETED|Part 2, Period 3 (1 Day)||0||
59923639|NCT03457727|76042882|FG001|COMPLETED|Part 2, Period 3 (1 Day)||0||
59923640|NCT03457727|76042883|FG002|COMPLETED|Part 2, Period 3 (1 Day)||12||
59923641|NCT03457727|76042884|FG003|COMPLETED|Part 2, Period 3 (1 Day)||11||
59923642|NCT03457727|76042881|FG000|NOT COMPLETED|Part 2, Period 3 (1 Day)||0||
59923643|NCT03457727|76042882|FG001|NOT COMPLETED|Part 2, Period 3 (1 Day)||0||
59923644|NCT03457727|76042883|FG002|NOT COMPLETED|Part 2, Period 3 (1 Day)||0||
59923645|NCT03457727|76042884|FG003|NOT COMPLETED|Part 2, Period 3 (1 Day)||0||
59923646|NCT03457727|76042881|FG000|STARTED|Part 2, Washout Period 3 (5 Days)||0||
59923647|NCT03457727|76042882|FG001|STARTED|Part 2, Washout Period 3 (5 Days)||0||
59923648|NCT03457727|76042883|FG002|STARTED|Part 2, Washout Period 3 (5 Days)||12||
59923649|NCT03457727|76042884|FG003|STARTED|Part 2, Washout Period 3 (5 Days)||11||
59923650|NCT03457727|76042881|FG000|COMPLETED|Part 2, Washout Period 3 (5 Days)||0||
59923651|NCT03457727|76042882|FG001|COMPLETED|Part 2, Washout Period 3 (5 Days)||0||
59923652|NCT03457727|76042883|FG002|COMPLETED|Part 2, Washout Period 3 (5 Days)||12||
59923653|NCT03457727|76042884|FG003|COMPLETED|Part 2, Washout Period 3 (5 Days)||11||
59923654|NCT03457727|76042881|FG000|NOT COMPLETED|Part 2, Washout Period 3 (5 Days)||0||
59923655|NCT03457727|76042882|FG001|NOT COMPLETED|Part 2, Washout Period 3 (5 Days)||0||
59923656|NCT03457727|76042883|FG002|NOT COMPLETED|Part 2, Washout Period 3 (5 Days)||0||
59923657|NCT03457727|76042884|FG003|NOT COMPLETED|Part 2, Washout Period 3 (5 Days)||0||
59923658|NCT03457727|76042881|FG000|STARTED|Part 2, Period 4 (1 Day)||0||
59923659|NCT03457727|76042882|FG001|STARTED|Part 2, Period 4 (1 Day)||0||
59923660|NCT03457727|76042883|FG002|STARTED|Part 2, Period 4 (1 Day)||12||
59923661|NCT03457727|76042884|FG003|STARTED|Part 2, Period 4 (1 Day)||0||
59923662|NCT03457727|76042881|FG000|COMPLETED|Part 2, Period 4 (1 Day)||0||
59923663|NCT03457727|76042882|FG001|COMPLETED|Part 2, Period 4 (1 Day)||0||
59923664|NCT03457727|76042883|FG002|COMPLETED|Part 2, Period 4 (1 Day)||12||
59923665|NCT03457727|76042884|FG003|COMPLETED|Part 2, Period 4 (1 Day)||0||
59923666|NCT03457727|76042881|FG000|NOT COMPLETED|Part 2, Period 4 (1 Day)||0||
59923667|NCT03457727|76042882|FG001|NOT COMPLETED|Part 2, Period 4 (1 Day)||0||
59923668|NCT03457727|76042883|FG002|NOT COMPLETED|Part 2, Period 4 (1 Day)||0||
59923669|NCT03457727|76042884|FG003|NOT COMPLETED|Part 2, Period 4 (1 Day)||0||
59923670|NCT03431441|76042916|FG000|STARTED|Overall Study||24|24|
59923671|NCT03431441|76042916|FG000|COMPLETED|Overall Study||19|19|
59923672|NCT03431441|76042916|FG000|NOT COMPLETED|Overall Study||5||
59923673|NCT03457103|76042922|FG000|STARTED|Overall Study||22||
59923674|NCT03457103|76042923|FG001|STARTED|Overall Study||9||
59923675|NCT03457103|76042922|FG000|COMPLETED|Overall Study||14||
59923676|NCT03457103|76042923|FG001|COMPLETED|Overall Study||3||
59923677|NCT03457103|76042922|FG000|NOT COMPLETED|Overall Study||8||
59923678|NCT03457103|76042923|FG001|NOT COMPLETED|Overall Study||6||
59923679|NCT03455543|76042931|FG000|STARTED|Part A: Randomized Treatment (17 Weeks)||92||
59923680|NCT03455543|76042932|FG001|STARTED|Part A: Randomized Treatment (17 Weeks)||90||
59923681|NCT03455543|76042933|FG002|STARTED|Part A: Randomized Treatment (17 Weeks)||0||
59923682|NCT03455543|76042931|FG000|COMPLETED|Part A: Randomized Treatment (17 Weeks)||81||
59923683|NCT03455543|76042932|FG001|COMPLETED|Part A: Randomized Treatment (17 Weeks)||83||
59923684|NCT03455543|76042933|FG002|COMPLETED|Part A: Randomized Treatment (17 Weeks)||0||
59923685|NCT03455543|76042931|FG000|NOT COMPLETED|Part A: Randomized Treatment (17 Weeks)||11||
60067861|NCT01785615|76183054|FG002|STARTED|Atorvastatin Phase||0||
59923686|NCT03455543|76042932|FG001|NOT COMPLETED|Part A: Randomized Treatment (17 Weeks)||7||
59923687|NCT03455543|76042933|FG002|NOT COMPLETED|Part A: Randomized Treatment (17 Weeks)||0||
59923688|NCT03455543|76042931|FG000|STARTED|Part B: Open-label Extension (24 Weeks)||0||
59923689|NCT03455543|76042932|FG001|STARTED|Part B: Open-label Extension (24 Weeks)||0||
59923690|NCT03455543|76042933|FG002|STARTED|Part B: Open-label Extension (24 Weeks)||152||
59923691|NCT03455543|76042931|FG000|COMPLETED|Part B: Open-label Extension (24 Weeks)||0||
59923692|NCT03455543|76042932|FG001|COMPLETED|Part B: Open-label Extension (24 Weeks)||0||
59923693|NCT03455543|76042933|FG002|COMPLETED|Part B: Open-label Extension (24 Weeks)||115||
59923694|NCT03455543|76042931|FG000|NOT COMPLETED|Part B: Open-label Extension (24 Weeks)||0||
59923695|NCT03455543|76042932|FG001|NOT COMPLETED|Part B: Open-label Extension (24 Weeks)||0||
59923696|NCT03455543|76042933|FG002|NOT COMPLETED|Part B: Open-label Extension (24 Weeks)||37||
59923697|NCT03068754|76042943|FG000|STARTED|Randomized Treatment Period (RTP)||95||
59923698|NCT03068754|76042944|FG001|STARTED|Randomized Treatment Period (RTP)||48||
59923699|NCT03068754|76042945|FG002|STARTED|Randomized Treatment Period (RTP)|OLE Arms were not included during the RTP|0||
59923700|NCT03068754|76042946|FG003|STARTED|Randomized Treatment Period (RTP)||0||
60053969|NCT02224157|76169489|FG000|STARTED|Overall Study||2095|Patients randomised and received treatment|
60053970|NCT02224157|76169490|FG001|STARTED|Overall Study||2094|Patients randomised and received treatment|
60053971|NCT02224157|76169489|FG000|Patients Who Completed Treatment|Overall Study||1924||
60053972|NCT02224157|76169490|FG001|Patients Who Completed Treatment|Overall Study||1903||
60053973|NCT02224157|76169489|FG000|COMPLETED|Overall Study||1985||
60053974|NCT02224157|76169490|FG001|COMPLETED|Overall Study||1983||
60053975|NCT02224157|76169489|FG000|NOT COMPLETED|Overall Study||110||
60053976|NCT02224157|76169490|FG001|NOT COMPLETED|Overall Study||111||
60053977|NCT02196701|76169498|FG000|STARTED|Overall Study||46||
60053978|NCT02196701|76169498|FG000|COMPLETED|Overall Study||43||
60053979|NCT02196701|76169498|FG000|NOT COMPLETED|Overall Study||3||
60053980|NCT01481116|76169508|FG000|STARTED|Overall Study||824||
60053981|NCT01481116|76169509|FG001|STARTED|Overall Study||817||
60053982|NCT01481116|76169510|FG002|STARTED|Overall Study||813||
60053983|NCT01481116|76169508|FG000|Treated|Overall Study||822||
60053984|NCT01481116|76169509|FG001|Treated|Overall Study||816||
60053985|NCT01481116|76169510|FG002|Treated|Overall Study||813||
60053986|NCT01481116|76169508|FG000|COMPLETED|Overall Study||0||
60053987|NCT01481116|76169509|FG001|COMPLETED|Overall Study||0||
60053988|NCT01481116|76169510|FG002|COMPLETED|Overall Study||0||
60053989|NCT01481116|76169508|FG000|NOT COMPLETED|Overall Study||824||
60053990|NCT01481116|76169509|FG001|NOT COMPLETED|Overall Study||817||
60053991|NCT01481116|76169510|FG002|NOT COMPLETED|Overall Study||813||
60053992|NCT02222207|76169518|FG000|STARTED|Overall Study||52||
60053993|NCT02222207|76169518|FG000|Treated and Valid for Full Analysis Set|Overall Study||51||
60053994|NCT02222207|76169518|FG000|COMPLETED|Overall Study||48||
59923701|NCT03068754|76042943|FG000|Intention to Treat (ITT) Population|Randomized Treatment Period (RTP)||95||
59923702|NCT03068754|76042944|FG001|Intention to Treat (ITT) Population|Randomized Treatment Period (RTP)||48||
60053995|NCT02222207|76169518|FG000|NOT COMPLETED|Overall Study||4||
60053996|NCT01457014|76169522|FG000|STARTED|First Night||74||
60053997|NCT01457014|76169523|FG001|STARTED|First Night||0||
59514826|NCT00932477|75608447|FG004|NOT COMPLETED|Treatment 2||0||
59514827|NCT00932477|75608448|FG005|NOT COMPLETED|Treatment 2||0||
59514828|NCT00932477|75608443|FG000|STARTED|Treatment 3||7||
59514829|NCT00932477|75608444|FG001|STARTED|Treatment 3||8||
59923703|NCT03068754|76042945|FG002|Intention to Treat (ITT) Population|Randomized Treatment Period (RTP)||0||
59923704|NCT03068754|76042946|FG003|Intention to Treat (ITT) Population|Randomized Treatment Period (RTP)||0||
59923705|NCT03068754|76042943|FG000|Safety Population|Randomized Treatment Period (RTP)||95||
59923706|NCT03068754|76042944|FG001|Safety Population|Randomized Treatment Period (RTP)||47||
59923707|NCT03068754|76042945|FG002|Safety Population|Randomized Treatment Period (RTP)||0||
59923708|NCT03068754|76042946|FG003|Safety Population|Randomized Treatment Period (RTP)||0||
59923709|NCT03068754|76042943|FG000|Modified ITT (mITT)|Randomized Treatment Period (RTP)||93||
59923710|NCT03068754|76042944|FG001|Modified ITT (mITT)|Randomized Treatment Period (RTP)||46||
59923711|NCT03068754|76042945|FG002|Modified ITT (mITT)|Randomized Treatment Period (RTP)||0||
59923712|NCT03068754|76042946|FG003|Modified ITT (mITT)|Randomized Treatment Period (RTP)||0||
59923713|NCT03068754|76042943|FG000|Completed Taper|Randomized Treatment Period (RTP)||58|Defined as completing the End of RTP Taper Visit at about Week 39 or an early termination visit|
59923714|NCT03068754|76042944|FG001|Completed Taper|Randomized Treatment Period (RTP)||28|Defined as completing the End of RTP Taper Visit at about Week 39 or an early termination visit|
59923715|NCT03068754|76042945|FG002|Completed Taper|Randomized Treatment Period (RTP)||0|Defined as completing the End of RTP Taper Visit at about Week 39 or an early termination visit|
60053998|NCT01457014|76169524|FG002|STARTED|First Night||0||
60053999|NCT01457014|76169525|FG003|STARTED|First Night||0||
60054000|NCT01457014|76169522|FG000|COMPLETED|First Night||34||
60054001|NCT01457014|76169523|FG001|COMPLETED|First Night||0||
60054002|NCT01457014|76169524|FG002|COMPLETED|First Night||0||
60054003|NCT01457014|76169525|FG003|COMPLETED|First Night||0||
60054004|NCT01457014|76169522|FG000|NOT COMPLETED|First Night||40||
60054005|NCT01457014|76169523|FG001|NOT COMPLETED|First Night||0||
60054006|NCT01457014|76169524|FG002|NOT COMPLETED|First Night||0||
59514830|NCT00932477|75608445|FG002|STARTED|Treatment 3||9||
59923716|NCT03068754|76042946|FG003|Completed Taper|Randomized Treatment Period (RTP)||0|Defined as completing the End of RTP Taper Visit at about Week 39 or an early termination visit|
59923717|NCT03068754|76042943|FG000|Completed 36 Weeks of Treatment|Randomized Treatment Period (RTP)||28||
60054007|NCT01457014|76169525|FG003|NOT COMPLETED|First Night||0||
60054008|NCT01457014|76169522|FG000|STARTED|Second Night|The Diagnostic PSG was only completed on the First night|0||
60054009|NCT01457014|76169523|FG001|STARTED|Second Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|12||
60067862|NCT01785615|76183055|FG003|STARTED|Atorvastatin Phase||0||
60054010|NCT01457014|76169524|FG002|STARTED|Second Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11||
60054011|NCT01457014|76169525|FG003|STARTED|Second Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11||
60054012|NCT01457014|76169522|FG000|COMPLETED|Second Night|The Diagnostic PSG was only completed on the First night|0||
60054013|NCT01457014|76169523|FG001|COMPLETED|Second Night||12||
60054014|NCT01457014|76169524|FG002|COMPLETED|Second Night||11||
60054015|NCT01457014|76169525|FG003|COMPLETED|Second Night||11||
60054016|NCT01457014|76169522|FG000|NOT COMPLETED|Second Night||0||
60054017|NCT01457014|76169523|FG001|NOT COMPLETED|Second Night||0||
60054018|NCT01457014|76169524|FG002|NOT COMPLETED|Second Night||0||
60054019|NCT01457014|76169525|FG003|NOT COMPLETED|Second Night||0||
60054020|NCT01457014|76169522|FG000|STARTED|Third Night|The Diagnostic PSG was only completed on the First night|0||
60054021|NCT01457014|76169523|FG001|STARTED|Third Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11||
60054022|NCT01457014|76169524|FG002|STARTED|Third Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11||
60054023|NCT01457014|76169525|FG003|STARTED|Third Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|12||
60054024|NCT01457014|76169522|FG000|COMPLETED|Third Night|The Diagnostic PSG was only completed on the First night|0||
60054025|NCT01457014|76169523|FG001|COMPLETED|Third Night||11||
60054026|NCT01457014|76169524|FG002|COMPLETED|Third Night||11||
60054027|NCT01457014|76169525|FG003|COMPLETED|Third Night||12||
60054028|NCT01457014|76169522|FG000|NOT COMPLETED|Third Night||0||
60054029|NCT01457014|76169523|FG001|NOT COMPLETED|Third Night||0||
60054030|NCT01457014|76169524|FG002|NOT COMPLETED|Third Night||0||
60054031|NCT01457014|76169525|FG003|NOT COMPLETED|Third Night||0||
60054032|NCT01457014|76169522|FG000|STARTED|Fourth Night|The Diagnostic PSG was only completed on the First night|0||
60054033|NCT01457014|76169523|FG001|STARTED|Fourth Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11||
60054034|NCT01457014|76169524|FG002|STARTED|Fourth Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|12||
60054035|NCT01457014|76169525|FG003|STARTED|Fourth Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11||
60054036|NCT01457014|76169522|FG000|COMPLETED|Fourth Night|The Diagnostic PSG was only completed on the First night|0||
60054037|NCT01457014|76169523|FG001|COMPLETED|Fourth Night||11||
60054038|NCT01457014|76169524|FG002|COMPLETED|Fourth Night||12||
60054039|NCT01457014|76169525|FG003|COMPLETED|Fourth Night||11||
60054040|NCT01457014|76169522|FG000|NOT COMPLETED|Fourth Night||0||
60054041|NCT01457014|76169523|FG001|NOT COMPLETED|Fourth Night||0||
60054042|NCT01457014|76169524|FG002|NOT COMPLETED|Fourth Night||0||
60054043|NCT01457014|76169525|FG003|NOT COMPLETED|Fourth Night||0||
60054044|NCT02254421|76169535|FG000|STARTED|Overall Study||31||
60054045|NCT02254421|76169536|FG001|STARTED|Overall Study||29||
60054046|NCT02254421|76169535|FG000|COMPLETED|Overall Study||29||
60054047|NCT02254421|76169536|FG001|COMPLETED|Overall Study||26||
60054048|NCT02254421|76169535|FG000|NOT COMPLETED|Overall Study||2||
60054049|NCT02254421|76169536|FG001|NOT COMPLETED|Overall Study||3||
60054050|NCT02252939|76169542|FG000|STARTED|Overall Study||62||
60054051|NCT02252939|76169542|FG000|COMPLETED|Overall Study||59||
60054052|NCT02252939|76169542|FG000|NOT COMPLETED|Overall Study||3||
60054053|NCT02196077|76169551|FG000|STARTED|Overall Study||180||
60054054|NCT02196077|76169551|FG000|BFF MDI 320/9.6 μg|Overall Study||155||
60054055|NCT02196077|76169551|FG000|BFF MDI 160/9.6 μg|Overall Study||106||
60054056|NCT02196077|76169551|FG000|BFF MDI 80/9.6 μg|Overall Study||103||
60054057|NCT02196077|76169551|FG000|BD MDI 320 μg|Overall Study||108||
60054058|NCT02196077|76169551|FG000|FF MDI 9.6 μg|Overall Study||157||
59514831|NCT00932477|75608446|FG003|STARTED|Treatment 3||7||
59514832|NCT00932477|75608447|FG004|STARTED|Treatment 3||8||
59514833|NCT00932477|75608448|FG005|STARTED|Treatment 3||8||
59514834|NCT00932477|75608443|FG000|COMPLETED|Treatment 3||7||
60054059|NCT02196077|76169551|FG000|COMPLETED|Overall Study||133||
60054060|NCT02196077|76169551|FG000|NOT COMPLETED|Overall Study||47||
60054061|NCT02195687|76169565|FG000|STARTED|Overall Study||316||
60054062|NCT02195687|76169566|FG001|STARTED|Overall Study||101||
59514835|NCT00932477|75608444|FG001|COMPLETED|Treatment 3||8||
59514836|NCT00932477|75608445|FG002|COMPLETED|Treatment 3||9||
59514837|NCT00932477|75608446|FG003|COMPLETED|Treatment 3||7||
59514838|NCT00932477|75608447|FG004|COMPLETED|Treatment 3||8||
59514839|NCT00932477|75608448|FG005|COMPLETED|Treatment 3||8||
59514840|NCT00932477|75608443|FG000|NOT COMPLETED|Treatment 3||0||
59514841|NCT00932477|75608444|FG001|NOT COMPLETED|Treatment 3||0||
60054063|NCT02195687|76169565|FG000|COMPLETED|Overall Study||311||
60054064|NCT02195687|76169566|FG001|COMPLETED|Overall Study||99||
60054065|NCT02195687|76169565|FG000|NOT COMPLETED|Overall Study||5||
60054066|NCT02195687|76169566|FG001|NOT COMPLETED|Overall Study||2||
60054067|NCT02195531|76169575|FG000|STARTED|Overall Study||64||
60054068|NCT02195531|76169576|FG001|STARTED|Overall Study||49||
60054069|NCT02195531|76169577|FG002|STARTED|Overall Study||56||
60054070|NCT02195531|76169575|FG000|COMPLETED|Overall Study||63||
60054071|NCT02195531|76169576|FG001|COMPLETED|Overall Study||48||
59514842|NCT00932477|75608445|FG002|NOT COMPLETED|Treatment 3||0||
59514843|NCT00932477|75608446|FG003|NOT COMPLETED|Treatment 3||0||
59514844|NCT00932477|75608447|FG004|NOT COMPLETED|Treatment 3||0||
59514845|NCT00932477|75608448|FG005|NOT COMPLETED|Treatment 3||0||
59514846|NCT00972439|75608458|FG000|STARTED|Overall Study||17||
59514847|NCT00972439|75608459|FG001|STARTED|Overall Study||16||
59514848|NCT00972439|75608458|FG000|COMPLETED|Overall Study||17||
59514849|NCT00972439|75608459|FG001|COMPLETED|Overall Study||16||
59514850|NCT00972439|75608458|FG000|NOT COMPLETED|Overall Study||0||
59923718|NCT03068754|76042944|FG001|Completed 36 Weeks of Treatment|Randomized Treatment Period (RTP)||9||
59923719|NCT03068754|76042945|FG002|Completed 36 Weeks of Treatment|Randomized Treatment Period (RTP)||0||
59923720|NCT03068754|76042946|FG003|Completed 36 Weeks of Treatment|Randomized Treatment Period (RTP)||0||
59923721|NCT03068754|76042943|FG000|Completed RTP|Randomized Treatment Period (RTP)||27|Defined as completing 36 weeks of treatment, followed by Week 39 visit or entering the OLE period|
59923722|NCT03068754|76042944|FG001|Completed RTP|Randomized Treatment Period (RTP)||9|Defined as completing 36 weeks of treatment, followed by Week 39 visit or entering the OLE period|
59923723|NCT03068754|76042945|FG002|Completed RTP|Randomized Treatment Period (RTP)||0|Defined as completing 36 weeks of treatment, followed by Week 39 visit or entering the OLE period|
59923724|NCT03068754|76042946|FG003|Completed RTP|Randomized Treatment Period (RTP)||0|Defined as completing 36 weeks of treatment, followed by Week 39 visit or entering the OLE period|
59923725|NCT03068754|76042943|FG000|Enrolled in OLE Period|Randomized Treatment Period (RTP)||25||
59514851|NCT00972439|75608459|FG001|NOT COMPLETED|Overall Study||0||
59514852|NCT02989714|75608465|FG000|STARTED|Overall Study||13|Started Interleukin-2|
59514853|NCT02989714|75608465|FG000|Started Nivolumab|Overall Study||12||
59612931|NCT01716234|75723950|FG004|COMPLETED|Overall Study||10||
59612932|NCT01716234|75723951|FG005|COMPLETED|Overall Study||18||
59612933|NCT01716234|75723952|FG006|COMPLETED|Overall Study||1||
59612934|NCT01716234|75723946|FG000|NOT COMPLETED|Overall Study||10||
59612935|NCT01716234|75723947|FG001|NOT COMPLETED|Overall Study||10||
59612936|NCT01716234|75723948|FG002|NOT COMPLETED|Overall Study||5||
59612937|NCT01716234|75723949|FG003|NOT COMPLETED|Overall Study||12||
59612938|NCT01716234|75723950|FG004|NOT COMPLETED|Overall Study||5||
59923726|NCT03068754|76042944|FG001|Enrolled in OLE Period|Randomized Treatment Period (RTP)||8||
59923727|NCT03068754|76042945|FG002|Enrolled in OLE Period|Randomized Treatment Period (RTP)||0||
59923728|NCT03068754|76042946|FG003|Enrolled in OLE Period|Randomized Treatment Period (RTP)||0||
59923729|NCT03068754|76042943|FG000|COMPLETED|Randomized Treatment Period (RTP)||28||
59923730|NCT03068754|76042944|FG001|COMPLETED|Randomized Treatment Period (RTP)||9||
59923731|NCT03068754|76042945|FG002|COMPLETED|Randomized Treatment Period (RTP)||0||
59923732|NCT03068754|76042946|FG003|COMPLETED|Randomized Treatment Period (RTP)||0||
59923733|NCT03068754|76042943|FG000|NOT COMPLETED|Randomized Treatment Period (RTP)||67||
59923734|NCT03068754|76042944|FG001|NOT COMPLETED|Randomized Treatment Period (RTP)||39||
59923735|NCT03068754|76042945|FG002|NOT COMPLETED|Randomized Treatment Period (RTP)||0||
59923736|NCT03068754|76042946|FG003|NOT COMPLETED|Randomized Treatment Period (RTP)||0||
59923737|NCT03068754|76042943|FG000|STARTED|Open Label Extension Period (OLE)|RTP arms were not included during the OLE period|0|Safety Population in the OLE - 4 participants who completed RTP were not treated in the OLE|
59923738|NCT03068754|76042944|FG001|STARTED|Open Label Extension Period (OLE)||0|Safety Population in the OLE - 4 participants who completed RTP were not treated in the OLE|
59923739|NCT03068754|76042945|FG002|STARTED|Open Label Extension Period (OLE)||25|Safety Population in the OLE - 4 participants who completed RTP were not treated in the OLE|
59951476|NCT02504580|76070495|FG007|STARTED|Overall Study||131||
59514854|NCT02989714|75608465|FG000|COMPLETED|Overall Study||12||
59514855|NCT02989714|75608465|FG000|NOT COMPLETED|Overall Study||1||
59514856|NCT02991820|75608472|FG000|STARTED|Overall Study||12||
59514857|NCT02991820|75608473|FG001|STARTED|Overall Study||31||
59514858|NCT02991820|75608472|FG000|COMPLETED|Overall Study||12||
59514859|NCT02991820|75608473|FG001|COMPLETED|Overall Study||31||
59612939|NCT01716234|75723951|FG005|NOT COMPLETED|Overall Study||14||
59612940|NCT01716234|75723952|FG006|NOT COMPLETED|Overall Study||0||
59612941|NCT01716156|75723971|FG000|STARTED|Overall Study||9||
59612942|NCT01716156|75723972|FG001|STARTED|Overall Study||4||
59612943|NCT01716156|75723973|FG002|STARTED|Overall Study||13||
59612944|NCT01716156|75723971|FG000|COMPLETED|Overall Study||7||
59612945|NCT01716156|75723972|FG001|COMPLETED|Overall Study||3||
59612946|NCT01716156|75723973|FG002|COMPLETED|Overall Study||11||
59612947|NCT01716156|75723971|FG000|NOT COMPLETED|Overall Study||2||
59612948|NCT01716156|75723972|FG001|NOT COMPLETED|Overall Study||1||
59612949|NCT01716156|75723973|FG002|NOT COMPLETED|Overall Study||2||
59612950|NCT01739790|75723987|FG000|STARTED|Overall Study||24||
59612951|NCT01739790|75723988|FG001|STARTED|Overall Study||27||
59612952|NCT01739790|75723987|FG000|COMPLETED|Overall Study||22||
59612953|NCT01739790|75723988|FG001|COMPLETED|Overall Study||23||
59612954|NCT01739790|75723987|FG000|NOT COMPLETED|Overall Study||2||
59612955|NCT01739790|75723988|FG001|NOT COMPLETED|Overall Study||4||
59612956|NCT01696032|75723998|FG000|STARTED|Overall Study||14||
59612957|NCT01696032|75723999|FG001|STARTED|Overall Study||6||
59612958|NCT01696032|75724000|FG002|STARTED|Overall Study||51||
59612959|NCT01696032|75724001|FG003|STARTED|Overall Study||49||
59612960|NCT01696032|75723998|FG000|COMPLETED|Overall Study||0||
59612961|NCT01696032|75723999|FG001|COMPLETED|Overall Study||0||
59612962|NCT01696032|75724000|FG002|COMPLETED|Overall Study||0||
59612963|NCT01696032|75724001|FG003|COMPLETED|Overall Study||27||
60054072|NCT02195531|76169577|FG002|COMPLETED|Overall Study||55||
60054073|NCT02195531|76169575|FG000|NOT COMPLETED|Overall Study||1||
60054074|NCT02195531|76169576|FG001|NOT COMPLETED|Overall Study||1||
60054075|NCT02195531|76169577|FG002|NOT COMPLETED|Overall Study||1||
60054076|NCT02252081|76169587|FG000|STARTED|Overall Study||30||
60054077|NCT02252081|76169588|FG001|STARTED|Overall Study||30||
60054078|NCT02252081|76169587|FG000|COMPLETED|Overall Study||24||
60054079|NCT02252081|76169588|FG001|COMPLETED|Overall Study||26||
60054080|NCT02252081|76169587|FG000|NOT COMPLETED|Overall Study||6||
60054081|NCT02252081|76169588|FG001|NOT COMPLETED|Overall Study||4||
60054082|NCT01623752|76169602|FG000|STARTED|Phase 1 (78 Weeks)||1378||
60054083|NCT01623752|76169603|FG001|STARTED|Phase 1 (78 Weeks)||440||
60054084|NCT01623752|76169604|FG002|STARTED|Phase 1 (78 Weeks)||3||
60054085|NCT01623752|76169602|FG000|COMPLETED|Phase 1 (78 Weeks)||747||
60054086|NCT01623752|76169603|FG001|COMPLETED|Phase 1 (78 Weeks)||233||
60054087|NCT01623752|76169604|FG002|COMPLETED|Phase 1 (78 Weeks)||1||
60054088|NCT01623752|76169602|FG000|NOT COMPLETED|Phase 1 (78 Weeks)||631||
60054089|NCT01623752|76169603|FG001|NOT COMPLETED|Phase 1 (78 Weeks)||207||
60054090|NCT01623752|76169604|FG002|NOT COMPLETED|Phase 1 (78 Weeks)||2||
60054091|NCT01623752|76169602|FG000|STARTED|Phase 2 (78 Weeks)|Participants only who consented to continue in Period 2.|291||
60054092|NCT01623752|76169603|FG001|STARTED|Phase 2 (78 Weeks)|Participants only who consented to continue in Period 2.|116||
60054093|NCT01623752|76169604|FG002|STARTED|Phase 2 (78 Weeks)|Participants only who consented to continue in Period 2.|0||
60054094|NCT01623752|76169602|FG000|COMPLETED|Phase 2 (78 Weeks)||225||
60054095|NCT01623752|76169603|FG001|COMPLETED|Phase 2 (78 Weeks)||98||
60054096|NCT01623752|76169604|FG002|COMPLETED|Phase 2 (78 Weeks)||0||
60054097|NCT01623752|76169602|FG000|NOT COMPLETED|Phase 2 (78 Weeks)||66||
60054098|NCT01623752|76169603|FG001|NOT COMPLETED|Phase 2 (78 Weeks)||18||
60054099|NCT01623752|76169604|FG002|NOT COMPLETED|Phase 2 (78 Weeks)||0||
60054100|NCT01623596|76169615|FG000|STARTED|Overall Study||436||
60054101|NCT01623596|76169616|FG001|STARTED|Overall Study||439||
60054102|NCT01623596|76169615|FG000|On Randomized Treatment|Overall Study||352||
60054103|NCT01623596|76169616|FG001|On Randomized Treatment|Overall Study||125||
60054104|NCT01623596|76169615|FG000|On Switched Treatment|Overall Study||22||
60054105|NCT01623596|76169616|FG001|On Switched Treatment|Overall Study||214||
60054106|NCT01623596|76169615|FG000|COMPLETED|Overall Study||374||
60054107|NCT01623596|76169616|FG001|COMPLETED|Overall Study||339||
60054108|NCT01623596|76169615|FG000|NOT COMPLETED|Overall Study||62||
60054109|NCT01623596|76169616|FG001|NOT COMPLETED|Overall Study||100||
59612964|NCT01696032|75723998|FG000|NOT COMPLETED|Overall Study||14||
59612965|NCT01696032|75723999|FG001|NOT COMPLETED|Overall Study||6||
60054110|NCT02219477|76169627|FG000|STARTED|Overall Study||9||
60054111|NCT02219477|76169628|FG001|STARTED|Overall Study||24||
60054112|NCT02219477|76169629|FG002|STARTED|Overall Study||3||
59514860|NCT02991820|75608472|FG000|NOT COMPLETED|Overall Study||0||
59514861|NCT02991820|75608473|FG001|NOT COMPLETED|Overall Study||0||
59514862|NCT02991898|75608481|FG000|STARTED|Overall Study||3||
59612966|NCT01696032|75724000|FG002|NOT COMPLETED|Overall Study||51||
59612967|NCT01696032|75724001|FG003|NOT COMPLETED|Overall Study||22||
59612968|NCT01695954|75724017|FG000|STARTED|Overall Study||18||
59923740|NCT03068754|76042946|FG003|STARTED|Open Label Extension Period (OLE)||8|Safety Population in the OLE - 4 participants who completed RTP were not treated in the OLE|
59923741|NCT03068754|76042943|FG000|Completed Taper|Open Label Extension Period (OLE)||0|Completed End of Taper visits after Week 84 visit or being terminated early from the OLE period|
59923742|NCT03068754|76042944|FG001|Completed Taper|Open Label Extension Period (OLE)||0|Completed End of Taper visits after Week 84 visit or being terminated early from the OLE period|
59923743|NCT03068754|76042945|FG002|Completed Taper|Open Label Extension Period (OLE)||19|Completed End of Taper visits after Week 84 visit or being terminated early from the OLE period|
59923744|NCT03068754|76042946|FG003|Completed Taper|Open Label Extension Period (OLE)||7|Completed End of Taper visits after Week 84 visit or being terminated early from the OLE period|
59923745|NCT03068754|76042943|FG000|Completed OLE Period|Open Label Extension Period (OLE)||0|Completed Week 84 visit, End of Taper visit and follow up visit|
59951477|NCT02504580|76070496|FG008|STARTED|Overall Study||52||
60054113|NCT02219477|76169627|FG000|COMPLETED|Overall Study||9||
60054114|NCT02219477|76169628|FG001|COMPLETED|Overall Study||22||
60054115|NCT02219477|76169629|FG002|COMPLETED|Overall Study||2||
60054116|NCT02219477|76169627|FG000|NOT COMPLETED|Overall Study||0||
60054117|NCT02219477|76169628|FG001|NOT COMPLETED|Overall Study||2||
60054118|NCT02219477|76169629|FG002|NOT COMPLETED|Overall Study||1||
60054119|NCT02119286|76169641|FG000|STARTED|Overall Study||206||
60054120|NCT02119286|76169642|FG001|STARTED|Overall Study||206||
60054121|NCT02119286|76169643|FG002|STARTED|Overall Study||207||
60054122|NCT02119286|76169641|FG000|COMPLETED|Overall Study||180||
60054123|NCT02119286|76169642|FG001|COMPLETED|Overall Study||195||
60054124|NCT02119286|76169643|FG002|COMPLETED|Overall Study||200||
60054125|NCT02119286|76169641|FG000|NOT COMPLETED|Overall Study||26||
59514863|NCT02991898|75608481|FG000|COMPLETED|Overall Study||3||
59514864|NCT02991898|75608481|FG000|NOT COMPLETED|Overall Study||0||
59514865|NCT00933491|75608487|FG000|STARTED|Overall Study||14||
59514866|NCT00933491|75608488|FG001|STARTED|Overall Study||18||
59514867|NCT00933491|75608487|FG000|COMPLETED|Overall Study||14||
59514868|NCT00933491|75608488|FG001|COMPLETED|Overall Study||18||
60054126|NCT02119286|76169642|FG001|NOT COMPLETED|Overall Study||11||
59760548|NCT02701283|75880166|FG000|COMPLETED|Overall Study||668|"The number of completed participants in the Randomized Controlled Trial arms account for the subjects in the As Treated set who completed the 2-year visit.~The number of completed participants in the Continued Access Study arm account for the subjects in the Attempted Implant set who completed the 1-year visit."|
59760549|NCT02701283|75880167|FG001|COMPLETED|Overall Study||579|"The number of completed participants in the Randomized Controlled Trial arms account for the subjects in the As Treated set who completed the 2-year visit.~The number of completed participants in the Continued Access Study arm account for the subjects in the Attempted Implant set who completed the 1-year visit."|
59923746|NCT03068754|76042944|FG001|Completed OLE Period|Open Label Extension Period (OLE)||0|Completed Week 84 visit, End of Taper visit and follow up visit|
59923747|NCT03068754|76042945|FG002|Completed OLE Period|Open Label Extension Period (OLE)||3|Completed Week 84 visit, End of Taper visit and follow up visit|
59923748|NCT03068754|76042946|FG003|Completed OLE Period|Open Label Extension Period (OLE)||2|Completed Week 84 visit, End of Taper visit and follow up visit|
59923749|NCT03068754|76042943|FG000|Completed Treatment in OLE|Open Label Extension Period (OLE)||0|Completed Week 84 visit|
59760550|NCT02701283|75880168|FG002|COMPLETED|Overall Study||724|"The number of completed participants in the Randomized Controlled Trial arms account for the subjects in the As Treated set who completed the 2-year visit.~The number of completed participants in the Continued Access Study arm account for the subjects in the Attempted Implant set who completed the 1-year visit."|
59923750|NCT03068754|76042944|FG001|Completed Treatment in OLE|Open Label Extension Period (OLE)||0|Completed Week 84 visit|
59923751|NCT03068754|76042945|FG002|Completed Treatment in OLE|Open Label Extension Period (OLE)||4|Completed Week 84 visit|
59514869|NCT00933491|75608487|FG000|NOT COMPLETED|Overall Study||0||
59923752|NCT03068754|76042946|FG003|Completed Treatment in OLE|Open Label Extension Period (OLE)||2|Completed Week 84 visit|
59923753|NCT03068754|76042943|FG000|COMPLETED|Open Label Extension Period (OLE)||0|Completed treatment in OLE period|
59923754|NCT03068754|76042944|FG001|COMPLETED|Open Label Extension Period (OLE)||0|Completed treatment in OLE period|
59923755|NCT03068754|76042945|FG002|COMPLETED|Open Label Extension Period (OLE)||4|Completed treatment in OLE period|
59923756|NCT03068754|76042946|FG003|COMPLETED|Open Label Extension Period (OLE)||2|Completed treatment in OLE period|
59923757|NCT03068754|76042943|FG000|NOT COMPLETED|Open Label Extension Period (OLE)||0||
59923758|NCT03068754|76042944|FG001|NOT COMPLETED|Open Label Extension Period (OLE)||0||
59923759|NCT03068754|76042945|FG002|NOT COMPLETED|Open Label Extension Period (OLE)||21||
59923760|NCT03068754|76042946|FG003|NOT COMPLETED|Open Label Extension Period (OLE)||6||
59923761|NCT02965820|76042956|FG000|STARTED|Period 1, First 30 Days||59||
59923762|NCT02965820|76042957|FG001|STARTED|Period 1, First 30 Days||62||
59923763|NCT02965820|76042956|FG000|COMPLETED|Period 1, First 30 Days||59||
59923764|NCT02965820|76042957|FG001|COMPLETED|Period 1, First 30 Days||62||
59923765|NCT02965820|76042956|FG000|NOT COMPLETED|Period 1, First 30 Days||0||
59923766|NCT02965820|76042957|FG001|NOT COMPLETED|Period 1, First 30 Days||0||
59923767|NCT02965820|76042956|FG000|STARTED|Period 2, Second 30 Days|One subject discontinued due to an AE after completion of Period 1 but before beginning Period 2.|58||
59923768|NCT02965820|76042957|FG001|STARTED|Period 2, Second 30 Days||62||
59923769|NCT02965820|76042956|FG000|COMPLETED|Period 2, Second 30 Days||57||
59923770|NCT02965820|76042957|FG001|COMPLETED|Period 2, Second 30 Days||61||
59923771|NCT02965820|76042956|FG000|NOT COMPLETED|Period 2, Second 30 Days||1||
59923772|NCT02965820|76042957|FG001|NOT COMPLETED|Period 2, Second 30 Days||1||
59923773|NCT03430895|76042963|FG000|STARTED|Overall Study||15||
59923774|NCT03430895|76042963|FG000|COMPLETED|Overall Study||13||
59923775|NCT03430895|76042963|FG000|NOT COMPLETED|Overall Study||2||
59923776|NCT03452189|76042967|FG000|STARTED|First Intervention (3 Months)||10||
59923777|NCT03452189|76042968|FG001|STARTED|First Intervention (3 Months)||5||
59923778|NCT03452189|76042967|FG000|COMPLETED|First Intervention (3 Months)||5||
59923779|NCT03452189|76042968|FG001|COMPLETED|First Intervention (3 Months)||5||
59923780|NCT03452189|76042967|FG000|NOT COMPLETED|First Intervention (3 Months)||5||
59923781|NCT03452189|76042968|FG001|NOT COMPLETED|First Intervention (3 Months)||0||
59923782|NCT03452189|76042967|FG000|STARTED|Intervention 2 (3 Months)||5||
59923783|NCT03452189|76042968|FG001|STARTED|Intervention 2 (3 Months)||5||
59923784|NCT03452189|76042967|FG000|COMPLETED|Intervention 2 (3 Months)||5||
59923785|NCT03452189|76042968|FG001|COMPLETED|Intervention 2 (3 Months)||5||
59923786|NCT03452189|76042967|FG000|NOT COMPLETED|Intervention 2 (3 Months)||0||
59923787|NCT03452189|76042968|FG001|NOT COMPLETED|Intervention 2 (3 Months)||0||
60054127|NCT02119286|76169643|FG002|NOT COMPLETED|Overall Study||7||
60054128|NCT02250443|76169651|FG000|STARTED|Overall Study||10||
60054129|NCT02250443|76169651|FG000|COMPLETED|Overall Study||0||
60054130|NCT02250443|76169651|FG000|NOT COMPLETED|Overall Study||10||
60054131|NCT02093390|76169657|FG000|STARTED|Overall Study||20||
60054132|NCT02093390|76169658|FG001|STARTED|Overall Study||20||
60054133|NCT02093390|76169657|FG000|COMPLETED|Overall Study||20||
60054134|NCT02093390|76169658|FG001|COMPLETED|Overall Study||19||
60054135|NCT02093390|76169657|FG000|NOT COMPLETED|Overall Study||0||
60054136|NCT02093390|76169658|FG001|NOT COMPLETED|Overall Study||1||
60054137|NCT02194985|76169665|FG000|STARTED|Overall Study||84||
60054138|NCT02194985|76169665|FG000|Received at Least 1 Dose of Study Drug|Overall Study||84||
60054139|NCT02194985|76169665|FG000|COMPLETED|Overall Study||73||
60054140|NCT02194985|76169665|FG000|NOT COMPLETED|Overall Study||11||
60054141|NCT02219087|76169671|FG000|STARTED|Overall Study||30||
60054142|NCT02219087|76169672|FG001|STARTED|Overall Study||30||
60054143|NCT02219087|76169671|FG000|COMPLETED|Overall Study||30||
60054144|NCT02219087|76169672|FG001|COMPLETED|Overall Study|Randomization envelope pulled out of sequence for consented patient. Excluded by request of IRB|29||
60054145|NCT02219087|76169671|FG000|NOT COMPLETED|Overall Study||0||
60054146|NCT02219087|76169672|FG001|NOT COMPLETED|Overall Study||1||
60054147|NCT02248961|76169680|FG000|STARTED|Overall Study||89||
60054148|NCT02248961|76169681|FG001|STARTED|Overall Study||90||
60054149|NCT02248961|76169680|FG000|COMPLETED|Overall Study||86||
60054150|NCT02248961|76169681|FG001|COMPLETED|Overall Study||88||
60054151|NCT02248961|76169680|FG000|NOT COMPLETED|Overall Study||3||
60054152|NCT02248961|76169681|FG001|NOT COMPLETED|Overall Study||2||
60054153|NCT02219009|76169689|FG000|STARTED|Overall Study||37||
60054154|NCT02219009|76169690|FG001|STARTED|Overall Study||30||
60054155|NCT02219009|76169689|FG000|COMPLETED|Overall Study||27||
60054156|NCT02219009|76169690|FG001|COMPLETED|Overall Study||22||
60054157|NCT02219009|76169689|FG000|NOT COMPLETED|Overall Study||10||
60054158|NCT02219009|76169690|FG001|NOT COMPLETED|Overall Study||8||
60054159|NCT02248649|76169698|FG000|STARTED|Overall Study||80||
60054160|NCT02248649|76169699|FG001|STARTED|Overall Study||80||
60054161|NCT02248649|76169698|FG000|COMPLETED|Overall Study||59||
60054162|NCT02248649|76169699|FG001|COMPLETED|Overall Study||59||
60054163|NCT02248649|76169698|FG000|NOT COMPLETED|Overall Study||21||
60054164|NCT02248649|76169699|FG001|NOT COMPLETED|Overall Study||21||
60054165|NCT02218541|76169707|FG000|STARTED|Overall Study||11||
60054166|NCT02218541|76169708|FG001|STARTED|Overall Study||11||
60054167|NCT02218541|76169707|FG000|COMPLETED|Overall Study||5||
60054168|NCT02218541|76169708|FG001|COMPLETED|Overall Study||9||
60054169|NCT02218541|76169707|FG000|NOT COMPLETED|Overall Study||6||
60054170|NCT02218541|76169708|FG001|NOT COMPLETED|Overall Study||2||
60054171|NCT02217527|76169717|FG000|STARTED|Drug Condition 1: First Study Phase||18||
60054172|NCT02217527|76169718|FG001|STARTED|Drug Condition 1: First Study Phase||18||
60054173|NCT02217527|76169717|FG000|COMPLETED|Drug Condition 1: First Study Phase||17||
60054174|NCT02217527|76169718|FG001|COMPLETED|Drug Condition 1: First Study Phase||15||
60054175|NCT02217527|76169717|FG000|NOT COMPLETED|Drug Condition 1: First Study Phase||1||
60054176|NCT02217527|76169718|FG001|NOT COMPLETED|Drug Condition 1: First Study Phase||3||
60054177|NCT02217527|76169717|FG000|STARTED|Drug Condition 2: Second Study Phase||17||
60054178|NCT02217527|76169718|FG001|STARTED|Drug Condition 2: Second Study Phase||15||
60054179|NCT02217527|76169717|FG000|COMPLETED|Drug Condition 2: Second Study Phase||17||
60054180|NCT02217527|76169718|FG001|COMPLETED|Drug Condition 2: Second Study Phase||14||
60054181|NCT02217527|76169717|FG000|NOT COMPLETED|Drug Condition 2: Second Study Phase||0||
60054182|NCT02217527|76169718|FG001|NOT COMPLETED|Drug Condition 2: Second Study Phase||1||
60054183|NCT01456936|76169728|FG000|STARTED|Overall Study||2037||
60054184|NCT01456936|76169729|FG001|STARTED|Overall Study||2034||
59514870|NCT00933491|75608488|FG001|NOT COMPLETED|Overall Study||0||
59514871|NCT02881840|75608494|FG000|STARTED|Overall Study||6||
59514872|NCT02881840|75608494|FG000|COMPLETED|Overall Study||6||
59514873|NCT02881840|75608494|FG000|NOT COMPLETED|Overall Study||0||
59514874|NCT02881996|75608500|FG000|STARTED|Overall Study||45||
60054185|NCT01456936|76169730|FG002|STARTED|Overall Study||2038||
60054186|NCT01456936|76169731|FG003|STARTED|Overall Study||2035||
60054187|NCT01456936|76169728|FG000|Randomized and Treated|Overall Study||2016||
60054188|NCT01456936|76169729|FG001|Randomized and Treated|Overall Study||2006||
60054189|NCT01456936|76169730|FG002|Randomized and Treated|Overall Study||2022||
60054190|NCT01456936|76169731|FG003|Randomized and Treated|Overall Study||2014||
59514875|NCT02881996|75608501|FG001|STARTED|Overall Study||45||
60054191|NCT01456936|76169728|FG000|COMPLETED|Overall Study||1598||
60054192|NCT01456936|76169729|FG001|COMPLETED|Overall Study||1586||
60054193|NCT01456936|76169730|FG002|COMPLETED|Overall Study||1557||
60054194|NCT01456936|76169731|FG003|COMPLETED|Overall Study||1552||
60054195|NCT01456936|76169728|FG000|NOT COMPLETED|Overall Study||439||
60054196|NCT01456936|76169729|FG001|NOT COMPLETED|Overall Study||448||
60054197|NCT01456936|76169730|FG002|NOT COMPLETED|Overall Study||481||
60054198|NCT01456936|76169731|FG003|NOT COMPLETED|Overall Study||483||
60054199|NCT01456780|76169744|FG000|STARTED|Overall Study||20||
60054200|NCT01456780|76169745|FG001|STARTED|Overall Study||20||
60054201|NCT01456780|76169746|FG002|STARTED|Overall Study||20||
60054202|NCT01456780|76169744|FG000|COMPLETED|Overall Study||17||
60054203|NCT01456780|76169745|FG001|COMPLETED|Overall Study||17||
60054204|NCT01456780|76169746|FG002|COMPLETED|Overall Study||20||
60054205|NCT01456780|76169744|FG000|NOT COMPLETED|Overall Study||3||
60054206|NCT01456780|76169745|FG001|NOT COMPLETED|Overall Study||3||
60054207|NCT01456780|76169746|FG002|NOT COMPLETED|Overall Study||0||
60054208|NCT01480258|76169756|FG000|STARTED|Infant Series||656||
60054209|NCT01480258|76169757|FG001|STARTED|Infant Series||659||
60054210|NCT01480258|76169756|FG000|Vaccinated|Infant Series||653||
60054211|NCT01480258|76169757|FG001|Vaccinated|Infant Series||659||
60054212|NCT01480258|76169756|FG000|COMPLETED|Infant Series||649||
60054213|NCT01480258|76169757|FG001|COMPLETED|Infant Series||651||
60054214|NCT01480258|76169756|FG000|NOT COMPLETED|Infant Series||7||
60054215|NCT01480258|76169757|FG001|NOT COMPLETED|Infant Series||8||
60054216|NCT01480258|76169756|FG000|STARTED|Interim Period||649||
60054217|NCT01480258|76169757|FG001|STARTED|Interim Period||651||
60054218|NCT01480258|76169756|FG000|COMPLETED|Interim Period||639||
60054219|NCT01480258|76169757|FG001|COMPLETED|Interim Period||642||
60054220|NCT01480258|76169756|FG000|NOT COMPLETED|Interim Period||10||
60054221|NCT01480258|76169757|FG001|NOT COMPLETED|Interim Period||9||
60054222|NCT01480258|76169756|FG000|STARTED|Toddler Dose||639||
60054223|NCT01480258|76169757|FG001|STARTED|Toddler Dose||642||
60054224|NCT01480258|76169756|FG000|COMPLETED|Toddler Dose||639||
60054225|NCT01480258|76169757|FG001|COMPLETED|Toddler Dose||642||
60054226|NCT01480258|76169756|FG000|NOT COMPLETED|Toddler Dose||0||
60054227|NCT01480258|76169757|FG001|NOT COMPLETED|Toddler Dose||0||
60054228|NCT01479868|76169763|FG000|STARTED|Overall Study|Restricted to subject who received at least one dose of treatment (TMC435/RBV/PegIFN).|106||
60054229|NCT01479868|76169763|FG000|COMPLETED|Overall Study||97||
60054230|NCT01479868|76169763|FG000|NOT COMPLETED|Overall Study||9||
60054231|NCT01478620|76169767|FG000|STARTED|Overall Study||125||
60054232|NCT01478620|76169767|FG000|COMPLETED|Overall Study||119||
60054233|NCT01478620|76169767|FG000|NOT COMPLETED|Overall Study||6||
60054234|NCT01455220|76169771|FG000|STARTED|Overall Study||45||
60054235|NCT01455220|76169771|FG000|COMPLETED|Overall Study||15||
60054236|NCT01455220|76169771|FG000|NOT COMPLETED|Overall Study||30||
60054237|NCT01454830|76169780|FG000|STARTED|Overall Study||61||
60054238|NCT01454830|76169781|FG001|STARTED|Overall Study||57||
60054239|NCT01454830|76169780|FG000|COMPLETED|Overall Study||30||
60054240|NCT01454830|76169781|FG001|COMPLETED|Overall Study||30||
60054241|NCT01454830|76169780|FG000|NOT COMPLETED|Overall Study||31||
60054242|NCT01454830|76169781|FG001|NOT COMPLETED|Overall Study||27||
60054243|NCT01454596|76169799|FG000|STARTED|Overall Study||1||
60054244|NCT01454596|76169800|FG001|STARTED|Overall Study||1||
60054245|NCT01454596|76169801|FG002|STARTED|Overall Study||1||
60054246|NCT01454596|76169802|FG003|STARTED|Overall Study||1||
60054247|NCT01454596|76169803|FG004|STARTED|Overall Study||1||
60054248|NCT01454596|76169804|FG005|STARTED|Overall Study||1||
60054249|NCT01454596|76169805|FG006|STARTED|Overall Study||1||
60054250|NCT01454596|76169806|FG007|STARTED|Overall Study||3||
60054251|NCT01454596|76169807|FG008|STARTED|Overall Study||3||
60054252|NCT01454596|76169808|FG009|STARTED|Overall Study||3||
60054253|NCT01454596|76169809|FG010|STARTED|Overall Study||1||
60054254|NCT01454596|76169810|FG011|STARTED|Overall Study||1||
60054255|NCT01454596|76169799|FG000|COMPLETED|Overall Study||1||
60054256|NCT01454596|76169800|FG001|COMPLETED|Overall Study||1||
60054257|NCT01454596|76169801|FG002|COMPLETED|Overall Study||1||
60054258|NCT01454596|76169802|FG003|COMPLETED|Overall Study||1||
60054259|NCT01454596|76169803|FG004|COMPLETED|Overall Study||1||
60054260|NCT01454596|76169804|FG005|COMPLETED|Overall Study||1||
60054261|NCT01454596|76169805|FG006|COMPLETED|Overall Study||1||
60054262|NCT01454596|76169806|FG007|COMPLETED|Overall Study||3||
60054263|NCT01454596|76169807|FG008|COMPLETED|Overall Study||3||
60054264|NCT01454596|76169808|FG009|COMPLETED|Overall Study||2||
60054265|NCT01454596|76169809|FG010|COMPLETED|Overall Study||0||
60054266|NCT01454596|76169810|FG011|COMPLETED|Overall Study||1||
60054267|NCT01454596|76169799|FG000|NOT COMPLETED|Overall Study||0||
60054268|NCT01454596|76169800|FG001|NOT COMPLETED|Overall Study||0||
60054269|NCT01454596|76169801|FG002|NOT COMPLETED|Overall Study||0||
60054270|NCT01454596|76169802|FG003|NOT COMPLETED|Overall Study||0||
60054271|NCT01454596|76169803|FG004|NOT COMPLETED|Overall Study||0||
60054272|NCT01454596|76169804|FG005|NOT COMPLETED|Overall Study||0||
60054273|NCT01454596|76169805|FG006|NOT COMPLETED|Overall Study||0||
60054274|NCT01454596|76169806|FG007|NOT COMPLETED|Overall Study||0||
60054275|NCT01454596|76169807|FG008|NOT COMPLETED|Overall Study||0||
60054276|NCT01454596|76169808|FG009|NOT COMPLETED|Overall Study||1||
60054277|NCT01454596|76169809|FG010|NOT COMPLETED|Overall Study||1||
60054278|NCT01454596|76169810|FG011|NOT COMPLETED|Overall Study||0||
60054279|NCT02247479|76169839|FG000|STARTED|Overall Study||305||
60054280|NCT02247479|76169840|FG001|STARTED|Overall Study||298||
60054281|NCT02247479|76169841|FG002|STARTED|Overall Study||303||
60054282|NCT02247479|76169839|FG000|COMPLETED|Overall Study||163||
60054283|NCT02247479|76169840|FG001|COMPLETED|Overall Study||160||
60054284|NCT02247479|76169841|FG002|COMPLETED|Overall Study||165||
60054285|NCT02247479|76169839|FG000|NOT COMPLETED|Overall Study||142||
60054286|NCT02247479|76169840|FG001|NOT COMPLETED|Overall Study||138||
60054287|NCT02247479|76169841|FG002|NOT COMPLETED|Overall Study||138||
60054288|NCT01454284|76169851|FG000|STARTED|Overall Study||664||
60054289|NCT01454284|76169852|FG001|STARTED|Overall Study||450||
60054290|NCT01454284|76169851|FG000|Received at Least 1 Dose of Study Drug|Overall Study||663||
60054291|NCT01454284|76169852|FG001|Received at Least 1 Dose of Study Drug|Overall Study||449||
60054292|NCT01454284|76169851|FG000|COMPLETED|Overall Study||548||
60054293|NCT01454284|76169852|FG001|COMPLETED|Overall Study||377||
59514876|NCT02881996|75608500|FG000|COMPLETED|Overall Study||39||
59514877|NCT02881996|75608501|FG001|COMPLETED|Overall Study||43||
59514878|NCT02881996|75608500|FG000|NOT COMPLETED|Overall Study||6||
59514879|NCT02881996|75608501|FG001|NOT COMPLETED|Overall Study||2||
59514880|NCT03051646|75608509|FG000|STARTED|Overall Study||6||
59514881|NCT03051646|75608510|FG001|STARTED|Overall Study||6||
60054294|NCT01454284|76169851|FG000|NOT COMPLETED|Overall Study||116||
60054295|NCT01454284|76169852|FG001|NOT COMPLETED|Overall Study||73||
60054296|NCT02247401|76169861|FG000|STARTED|Overall Study||100||
60054297|NCT02247401|76169862|FG001|STARTED|Overall Study||31||
60054298|NCT02247401|76169863|FG002|STARTED|Overall Study||29||
60054299|NCT02247401|76169861|FG000|COMPLETED|Overall Study||94||
60054300|NCT02247401|76169862|FG001|COMPLETED|Overall Study||29||
60054301|NCT02247401|76169863|FG002|COMPLETED|Overall Study||27||
60054302|NCT02247401|76169861|FG000|NOT COMPLETED|Overall Study||6||
60054303|NCT02247401|76169862|FG001|NOT COMPLETED|Overall Study||2||
60054304|NCT02247401|76169863|FG002|NOT COMPLETED|Overall Study||2||
60054305|NCT02247011|76169874|FG000|STARTED|Overall Study||1100||
60054306|NCT02247011|76169874|FG000|COMPLETED|Overall Study||975||
60054307|NCT02247011|76169874|FG000|NOT COMPLETED|Overall Study||125||
60054308|NCT02246777|76169881|FG000|STARTED|Overall Study||32||
60054309|NCT02246777|76169881|FG000|COMPLETED|Overall Study||29||
60054310|NCT02246777|76169881|FG000|NOT COMPLETED|Overall Study||3||
60054311|NCT01495702|76169892|FG000|STARTED|Randomized Phase||292||
60054312|NCT01495702|76169893|FG001|STARTED|Randomized Phase||147||
60054313|NCT01495702|76169892|FG000|COMPLETED|Randomized Phase||266||
60054314|NCT01495702|76169893|FG001|COMPLETED|Randomized Phase||119||
60054315|NCT01495702|76169892|FG000|NOT COMPLETED|Randomized Phase||26||
60054316|NCT01495702|76169893|FG001|NOT COMPLETED|Randomized Phase||28||
60054317|NCT01495702|76169892|FG000|STARTED|Extension Phase||26||
60054318|NCT01495702|76169893|FG001|STARTED|Extension Phase||2||
60054319|NCT01495702|76169892|FG000|COMPLETED|Extension Phase||26||
60054320|NCT01495702|76169893|FG001|COMPLETED|Extension Phase||2||
60054321|NCT01495702|76169892|FG000|NOT COMPLETED|Extension Phase||0||
60054322|NCT01495702|76169893|FG001|NOT COMPLETED|Extension Phase||0||
60054323|NCT01630889|76169900|FG000|STARTED|Overall Study||15||
60054324|NCT01630889|76169900|FG000|Received at Least 1 Dose of Study Drug|Overall Study||15||
60054325|NCT01630889|76169900|FG000|COMPLETED|Overall Study||5||
60054326|NCT01630889|76169900|FG000|NOT COMPLETED|Overall Study||10||
60054327|NCT01495000|76169906|FG000|STARTED|Overall Study||124||
60054328|NCT01495000|76169907|FG001|STARTED|Overall Study||126||
60054329|NCT01495000|76169906|FG000|COMPLETED|Overall Study||111||
60054330|NCT01495000|76169907|FG001|COMPLETED|Overall Study||114||
60054331|NCT01495000|76169906|FG000|NOT COMPLETED|Overall Study||13||
59514882|NCT03051646|75608509|FG000|COMPLETED|Overall Study||6||
59514883|NCT03051646|75608510|FG001|COMPLETED|Overall Study||6||
59514884|NCT03051646|75608509|FG000|NOT COMPLETED|Overall Study||0||
59514885|NCT03051646|75608510|FG001|NOT COMPLETED|Overall Study||0||
59514886|NCT03110458|75608521|FG000|STARTED|Overall Study||37||
59514887|NCT03110458|75608522|FG001|STARTED|Overall Study||36||
59514888|NCT03110458|75608523|FG002|STARTED|Overall Study||34||
59514889|NCT03110458|75608521|FG000|COMPLETED|Overall Study||31||
59514890|NCT03110458|75608522|FG001|COMPLETED|Overall Study||32||
59514891|NCT03110458|75608523|FG002|COMPLETED|Overall Study||31||
59514892|NCT03110458|75608521|FG000|NOT COMPLETED|Overall Study||6||
59514893|NCT03110458|75608522|FG001|NOT COMPLETED|Overall Study||4||
59514894|NCT03110458|75608523|FG002|NOT COMPLETED|Overall Study||3||
59514895|NCT02993302|75608533|FG000|STARTED|Overall Study||13||
59514896|NCT02993302|75608534|FG001|STARTED|Overall Study||12||
60054332|NCT01495000|76169907|FG001|NOT COMPLETED|Overall Study||12||
60054333|NCT01494922|76169913|FG000|STARTED|Overall Study||14||
60054334|NCT01494922|76169913|FG000|COMPLETED|Overall Study||13||
60054335|NCT01494922|76169913|FG000|NOT COMPLETED|Overall Study||1||
60054336|NCT02192099|76169917|FG000|STARTED|Overall Study||61||
60054337|NCT02192099|76169917|FG000|COMPLETED|Overall Study||0||
60054338|NCT02192099|76169917|FG000|NOT COMPLETED|Overall Study||61||
60054339|NCT01494610|76169921|FG000|STARTED|Period 1||31||
60054340|NCT01494610|76169922|FG001|STARTED|Period 1||29||
60054341|NCT01494610|76169921|FG000|COMPLETED|Period 1||30||
60054342|NCT01494610|76169922|FG001|COMPLETED|Period 1||28||
60054343|NCT01494610|76169921|FG000|NOT COMPLETED|Period 1||1||
60054344|NCT01494610|76169922|FG001|NOT COMPLETED|Period 1||1||
60054345|NCT01494610|76169921|FG000|STARTED|Period 2||30||
60054346|NCT01494610|76169922|FG001|STARTED|Period 2||28||
60054347|NCT01494610|76169921|FG000|COMPLETED|Period 2||30||
60054348|NCT01494610|76169922|FG001|COMPLETED|Period 2||28||
60054349|NCT01494610|76169921|FG000|NOT COMPLETED|Period 2||0||
60054350|NCT01494610|76169922|FG001|NOT COMPLETED|Period 2||0||
60054351|NCT01494610|76169921|FG000|STARTED|Period 3||30||
60054352|NCT01494610|76169922|FG001|STARTED|Period 3||28||
60054353|NCT01494610|76169921|FG000|COMPLETED|Period 3||28||
60054354|NCT01494610|76169922|FG001|COMPLETED|Period 3||28||
60054355|NCT01494610|76169921|FG000|NOT COMPLETED|Period 3||2||
60054356|NCT01494610|76169922|FG001|NOT COMPLETED|Period 3||0||
60054357|NCT01494610|76169921|FG000|STARTED|Period 4||28||
60054358|NCT01494610|76169922|FG001|STARTED|Period 4||28||
60054359|NCT01494610|76169921|FG000|COMPLETED|Period 4||27||
60054360|NCT01494610|76169922|FG001|COMPLETED|Period 4||28||
60054361|NCT01494610|76169921|FG000|NOT COMPLETED|Period 4||1||
60054362|NCT01494610|76169922|FG001|NOT COMPLETED|Period 4||0||
60054363|NCT02116777|76169941|FG000|STARTED|Overall Study||3||
60054364|NCT02116777|76169942|FG001|STARTED|Overall Study||3||
60054365|NCT02116777|76169943|FG002|STARTED|Overall Study||3||
60054366|NCT02116777|76169944|FG003|STARTED|Overall Study||13||
60054367|NCT02116777|76169945|FG004|STARTED|Overall Study||6||
60054368|NCT02116777|76169946|FG005|STARTED|Overall Study||3||
60054369|NCT02116777|76169947|FG006|STARTED|Overall Study||9||
60054370|NCT02116777|76169941|FG000|COMPLETED|Overall Study||0||
60054371|NCT02116777|76169942|FG001|COMPLETED|Overall Study||0||
60054372|NCT02116777|76169943|FG002|COMPLETED|Overall Study||0||
60054373|NCT02116777|76169944|FG003|COMPLETED|Overall Study||0||
60054374|NCT02116777|76169945|FG004|COMPLETED|Overall Study||0||
60054375|NCT02116777|76169946|FG005|COMPLETED|Overall Study||0||
60054376|NCT02116777|76169947|FG006|COMPLETED|Overall Study||0||
60054377|NCT02116777|76169941|FG000|NOT COMPLETED|Overall Study||3||
60054378|NCT02116777|76169942|FG001|NOT COMPLETED|Overall Study||3||
60054379|NCT02116777|76169943|FG002|NOT COMPLETED|Overall Study||3||
60054380|NCT02116777|76169944|FG003|NOT COMPLETED|Overall Study||13||
60054381|NCT02116777|76169945|FG004|NOT COMPLETED|Overall Study||6||
60054382|NCT02116777|76169946|FG005|NOT COMPLETED|Overall Study||3||
60054383|NCT02116777|76169947|FG006|NOT COMPLETED|Overall Study||9||
60054384|NCT01494532|76169972|FG000|STARTED|Overall Study||75||
60054385|NCT01494532|76169973|FG001|STARTED|Overall Study||25||
60054386|NCT01494532|76169974|FG002|STARTED|Overall Study||76||
60054387|NCT01494532|76169975|FG003|STARTED|Overall Study||75||
60054388|NCT01494532|76169976|FG004|STARTED|Overall Study||76||
59514897|NCT02993302|75608533|FG000|COMPLETED|Overall Study||13||
59514898|NCT02993302|75608534|FG001|COMPLETED|Overall Study||12||
60054389|NCT01494532|76169977|FG005|STARTED|Overall Study||25||
60054390|NCT01494532|76169972|FG000|COMPLETED|Overall Study||65||
60054391|NCT01494532|76169973|FG001|COMPLETED|Overall Study||21||
60054392|NCT01494532|76169974|FG002|COMPLETED|Overall Study||59||
60054393|NCT01494532|76169975|FG003|COMPLETED|Overall Study||60||
60054394|NCT01494532|76169976|FG004|COMPLETED|Overall Study||64||
60054395|NCT01494532|76169977|FG005|COMPLETED|Overall Study||25||
60054396|NCT01494532|76169972|FG000|NOT COMPLETED|Overall Study||10||
60054397|NCT01494532|76169973|FG001|NOT COMPLETED|Overall Study||4||
60054398|NCT01494532|76169974|FG002|NOT COMPLETED|Overall Study||17||
60054399|NCT01494532|76169975|FG003|NOT COMPLETED|Overall Study||15||
60054400|NCT01494532|76169976|FG004|NOT COMPLETED|Overall Study||12||
60054401|NCT01494532|76169977|FG005|NOT COMPLETED|Overall Study||0||
60054402|NCT02191397|76169994|FG000|STARTED|Overall Study||266||
60054403|NCT02191397|76169995|FG001|STARTED|Overall Study||268||
60054404|NCT02191397|76169994|FG000|COMPLETED|Overall Study||183||
60054405|NCT02191397|76169995|FG001|COMPLETED|Overall Study||198||
60054406|NCT02191397|76169994|FG000|NOT COMPLETED|Overall Study||83||
60054407|NCT02191397|76169995|FG001|NOT COMPLETED|Overall Study||70||
60054408|NCT01630811|76170001|FG000|STARTED|First Intervention (8 Weeks)||7||
60054409|NCT01630811|76170002|FG001|STARTED|First Intervention (8 Weeks)||6||
60054410|NCT01630811|76170001|FG000|COMPLETED|First Intervention (8 Weeks)||7||
60054411|NCT01630811|76170002|FG001|COMPLETED|First Intervention (8 Weeks)||6||
60054412|NCT01630811|76170001|FG000|NOT COMPLETED|First Intervention (8 Weeks)||0||
60054413|NCT01630811|76170002|FG001|NOT COMPLETED|First Intervention (8 Weeks)||0||
60054414|NCT01630811|76170001|FG000|STARTED|Washout (4 Weeks)||7||
60054415|NCT01630811|76170002|FG001|STARTED|Washout (4 Weeks)||6||
60054416|NCT01630811|76170001|FG000|COMPLETED|Washout (4 Weeks)||7||
60054417|NCT01630811|76170002|FG001|COMPLETED|Washout (4 Weeks)||6||
60054418|NCT01630811|76170001|FG000|NOT COMPLETED|Washout (4 Weeks)||0||
60054419|NCT01630811|76170002|FG001|NOT COMPLETED|Washout (4 Weeks)||0||
60054420|NCT01630811|76170001|FG000|STARTED|Second Intervention (8 Weeks)||7||
60054421|NCT01630811|76170002|FG001|STARTED|Second Intervention (8 Weeks)||6||
60054422|NCT01630811|76170001|FG000|COMPLETED|Second Intervention (8 Weeks)||6||
60054423|NCT01630811|76170002|FG001|COMPLETED|Second Intervention (8 Weeks)||6||
60054424|NCT01630811|76170001|FG000|NOT COMPLETED|Second Intervention (8 Weeks)||1||
60054425|NCT01630811|76170002|FG001|NOT COMPLETED|Second Intervention (8 Weeks)||0||
60054426|NCT01630811|76170001|FG000|STARTED|Second Washout (4 Weeks)||6||
60054427|NCT01630811|76170002|FG001|STARTED|Second Washout (4 Weeks)||6||
60054428|NCT01630811|76170001|FG000|COMPLETED|Second Washout (4 Weeks)||6||
60054429|NCT01630811|76170002|FG001|COMPLETED|Second Washout (4 Weeks)||6||
60054430|NCT01630811|76170001|FG000|NOT COMPLETED|Second Washout (4 Weeks)||0||
60054431|NCT01630811|76170002|FG001|NOT COMPLETED|Second Washout (4 Weeks)||0||
60054432|NCT01494298|76170012|FG000|STARTED|Overall Study||56||
60054433|NCT01494298|76170013|FG001|STARTED|Overall Study||55||
60054434|NCT01494298|76170012|FG000|COMPLETED|Overall Study||54||
60054435|NCT01494298|76170013|FG001|COMPLETED|Overall Study||47||
60054436|NCT01494298|76170012|FG000|NOT COMPLETED|Overall Study||2||
60054437|NCT01494298|76170013|FG001|NOT COMPLETED|Overall Study||8||
60054438|NCT02169791|76170021|FG000|STARTED|Overall Study||25||
60054439|NCT02169791|76170021|FG000|COMPLETED|Overall Study||18|18 patients completed the full study including follow up.|
60054440|NCT02169791|76170021|FG000|NOT COMPLETED|Overall Study||7||
60054441|NCT02216591|76170027|FG000|STARTED|Overall Study||11||
60054442|NCT02216591|76170028|FG001|STARTED|Overall Study||10||
60054443|NCT02216591|76170027|FG000|COMPLETED|Overall Study||11||
60054444|NCT02216591|76170028|FG001|COMPLETED|Overall Study||9||
60054445|NCT02216591|76170027|FG000|NOT COMPLETED|Overall Study||0||
60054446|NCT02216591|76170028|FG001|NOT COMPLETED|Overall Study||1||
60054447|NCT02216357|76170036|FG000|STARTED|Overall Study||14||
60054448|NCT02216357|76170037|FG001|STARTED|Overall Study||5||
60054449|NCT02216357|76170036|FG000|COMPLETED|Overall Study||12||
60054450|NCT02216357|76170037|FG001|COMPLETED|Overall Study||4||
60054451|NCT02216357|76170036|FG000|NOT COMPLETED|Overall Study||2||
60054452|NCT02216357|76170037|FG001|NOT COMPLETED|Overall Study||1||
60054453|NCT01492426|76170045|FG000|STARTED|Treatment||402||
60054454|NCT01492426|76170046|FG001|STARTED|Treatment||200||
60054455|NCT01492426|76170045|FG000|COMPLETED|Treatment||319||
60054456|NCT01492426|76170046|FG001|COMPLETED|Treatment||160||
60054457|NCT01492426|76170045|FG000|NOT COMPLETED|Treatment||83||
60054458|NCT01492426|76170046|FG001|NOT COMPLETED|Treatment||40||
60054459|NCT01492426|76170045|FG000|STARTED|Follow-Up|This total number includes 319 who completed treatment plus 65 who rejoined for follow-up.|384||
60054460|NCT01492426|76170046|FG001|STARTED|Follow-Up|This total number includes 160 who completed treatment plus 31 who rejoined for follow-up.|191||
60054461|NCT01492426|76170045|FG000|COMPLETED|Follow-Up||359||
60054462|NCT01492426|76170046|FG001|COMPLETED|Follow-Up||181||
60054463|NCT01492426|76170045|FG000|NOT COMPLETED|Follow-Up||25||
60054464|NCT01492426|76170046|FG001|NOT COMPLETED|Follow-Up||10||
60054465|NCT01453348|76170059|FG000|STARTED|Overall Study||84||
60054466|NCT01453348|76170060|FG001|STARTED|Overall Study||84||
60054467|NCT01453348|76170061|FG002|STARTED|Overall Study||84||
60054468|NCT01453348|76170059|FG000|COMPLETED|Overall Study||83||
60054469|NCT01453348|76170060|FG001|COMPLETED|Overall Study||83||
60054470|NCT01453348|76170061|FG002|COMPLETED|Overall Study||83||
60054471|NCT01453348|76170059|FG000|NOT COMPLETED|Overall Study||1||
60054472|NCT01453348|76170060|FG001|NOT COMPLETED|Overall Study||1||
60054473|NCT01453348|76170061|FG002|NOT COMPLETED|Overall Study||1||
60054474|NCT01453036|76170075|FG000|STARTED|Overall Study||308||
60054475|NCT01453036|76170076|FG001|STARTED|Overall Study||308||
60054476|NCT01453036|76170077|FG002|STARTED|Overall Study||308||
60054477|NCT01453036|76170075|FG000|COMPLETED|Overall Study||282||
60054478|NCT01453036|76170076|FG001|COMPLETED|Overall Study||193||
60054479|NCT01453036|76170077|FG002|COMPLETED|Overall Study||277||
60054480|NCT01453036|76170075|FG000|NOT COMPLETED|Overall Study||26||
60054481|NCT01453036|76170076|FG001|NOT COMPLETED|Overall Study||115||
59514899|NCT02993302|75608533|FG000|NOT COMPLETED|Overall Study||0||
59514900|NCT02993302|75608534|FG001|NOT COMPLETED|Overall Study||0||
59514901|NCT03052972|75608542|FG000|STARTED|Overall Study||18||
60054482|NCT01453036|76170077|FG002|NOT COMPLETED|Overall Study||31||
60054483|NCT01475734|76170087|FG000|STARTED|Overall Study||22||
60054484|NCT01475734|76170088|FG001|STARTED|Overall Study||22||
60054485|NCT01475734|76170087|FG000|COMPLETED|Overall Study||20||
60054486|NCT01475734|76170088|FG001|COMPLETED|Overall Study||21||
60054487|NCT01475734|76170087|FG000|NOT COMPLETED|Overall Study||2||
60054488|NCT01475734|76170088|FG001|NOT COMPLETED|Overall Study||1||
60054489|NCT01452412|76170096|FG000|STARTED|Overall Study||74||
60054490|NCT01452412|76170097|FG001|STARTED|Overall Study||75||
60054491|NCT01452412|76170096|FG000|COMPLETED|Overall Study||46||
60054492|NCT01452412|76170097|FG001|COMPLETED|Overall Study||58||
60054493|NCT01452412|76170096|FG000|NOT COMPLETED|Overall Study||28||
60054494|NCT01452412|76170097|FG001|NOT COMPLETED|Overall Study||17||
60054495|NCT01474876|76170106|FG000|STARTED|Overall Study||403||
60054496|NCT01474876|76170107|FG001|STARTED|Overall Study||151||
60054497|NCT01474876|76170108|FG002|STARTED|Overall Study||1||
60054498|NCT01474876|76170106|FG000|COMPLETED|Overall Study||337||
60054499|NCT01474876|76170107|FG001|COMPLETED|Overall Study||128||
60054500|NCT01474876|76170108|FG002|COMPLETED|Overall Study||1||
60054501|NCT01474876|76170106|FG000|NOT COMPLETED|Overall Study||66||
60054502|NCT01474876|76170107|FG001|NOT COMPLETED|Overall Study||23||
60054503|NCT01474876|76170108|FG002|NOT COMPLETED|Overall Study||0||
60054504|NCT01491802|76170114|FG000|STARTED|Overall Study||9||
60054505|NCT01491802|76170115|FG001|STARTED|Overall Study||8||
60054506|NCT01491802|76170114|FG000|COMPLETED|Overall Study||8||
60054507|NCT01491802|76170115|FG001|COMPLETED|Overall Study||6||
60054508|NCT01491802|76170114|FG000|NOT COMPLETED|Overall Study||1||
60054509|NCT01491802|76170115|FG001|NOT COMPLETED|Overall Study||2||
60054510|NCT02168777|76170125|FG000|STARTED|Overall Study||2||
60054511|NCT02168777|76170126|FG001|STARTED|Overall Study||7||
60054512|NCT02168777|76170127|FG002|STARTED|Overall Study||11||
60054513|NCT02168777|76170125|FG000|COMPLETED|Overall Study||0||
60054514|NCT02168777|76170126|FG001|COMPLETED|Overall Study||0||
60054515|NCT02168777|76170127|FG002|COMPLETED|Overall Study||0||
60054516|NCT02168777|76170125|FG000|NOT COMPLETED|Overall Study||2||
60054517|NCT02168777|76170126|FG001|NOT COMPLETED|Overall Study||7||
60054518|NCT02168777|76170127|FG002|NOT COMPLETED|Overall Study||11||
60054519|NCT01491178|76170138|FG000|STARTED|Overall Study|Started are the enrolled subjects who followed registration rule and for who eCRF was collected.|6443||
60054520|NCT01491178|76170138|FG000|COMPLETED|Overall Study|Completed is defined as 104 weeks follow-up after enrollment.|3649||
60054521|NCT01491178|76170138|FG000|NOT COMPLETED|Overall Study||2794||
60054522|NCT02189837|76170146|FG000|STARTED|Overall Study||22||
60054523|NCT02189837|76170147|FG001|STARTED|Overall Study||23||
60054524|NCT02189837|76170148|FG002|STARTED|Overall Study||23||
60054525|NCT02189837|76170149|FG003|STARTED|Overall Study||21||
60054526|NCT02189837|76170146|FG000|Received Treatment|Overall Study||21||
60054527|NCT02189837|76170147|FG001|Received Treatment|Overall Study||22||
60054528|NCT02189837|76170148|FG002|Received Treatment|Overall Study||22||
60054529|NCT02189837|76170149|FG003|Received Treatment|Overall Study||20||
60054530|NCT02189837|76170146|FG000|COMPLETED|Overall Study||20||
59514902|NCT03052972|75608543|FG001|STARTED|Overall Study||5||
59514903|NCT03052972|75608542|FG000|COMPLETED|Overall Study||18||
59514904|NCT03052972|75608543|FG001|COMPLETED|Overall Study||5||
59514905|NCT03052972|75608542|FG000|NOT COMPLETED|Overall Study||0||
60054531|NCT02189837|76170147|FG001|COMPLETED|Overall Study||22||
60054532|NCT02189837|76170148|FG002|COMPLETED|Overall Study||20||
60054533|NCT02189837|76170149|FG003|COMPLETED|Overall Study||19||
60054534|NCT02189837|76170146|FG000|NOT COMPLETED|Overall Study||2||
60054535|NCT02189837|76170147|FG001|NOT COMPLETED|Overall Study||1||
60054536|NCT02189837|76170148|FG002|NOT COMPLETED|Overall Study||3||
60054537|NCT02189837|76170149|FG003|NOT COMPLETED|Overall Study||2||
60054538|NCT02216123|76170161|FG000|STARTED|Overall Study||166||
60054539|NCT02216123|76170162|FG001|STARTED|Overall Study||85||
60054540|NCT02216123|76170161|FG000|COMPLETED|Overall Study||160||
60054541|NCT02216123|76170162|FG001|COMPLETED|Overall Study||83||
60054542|NCT02216123|76170161|FG000|NOT COMPLETED|Overall Study||6||
60054543|NCT02216123|76170162|FG001|NOT COMPLETED|Overall Study||2||
60054544|NCT02189759|76170176|FG000|STARTED|Overall Study||102||
60054545|NCT02189759|76170177|FG001|STARTED|Overall Study||101||
60054546|NCT02189759|76170178|FG002|STARTED|Overall Study||83||
60054547|NCT02189759|76170179|FG003|STARTED|Overall Study||89||
60054548|NCT02189759|76170176|FG000|COMPLETED|Overall Study||102||
60054549|NCT02189759|76170177|FG001|COMPLETED|Overall Study||101||
59514906|NCT03052972|75608543|FG001|NOT COMPLETED|Overall Study||0||
59514907|NCT02994238|75608552|FG000|STARTED|Overall Study||125||
60054550|NCT02189759|76170178|FG002|COMPLETED|Overall Study||81||
60054551|NCT02189759|76170179|FG003|COMPLETED|Overall Study||84||
60054552|NCT02189759|76170176|FG000|NOT COMPLETED|Overall Study||0||
60054553|NCT02189759|76170177|FG001|NOT COMPLETED|Overall Study||0||
60054554|NCT02189759|76170178|FG002|NOT COMPLETED|Overall Study||2||
60054555|NCT02189759|76170179|FG003|NOT COMPLETED|Overall Study||5||
60054556|NCT01490866|76170191|FG000|STARTED|FOLFOX/Bevacizumab Treatment||70||
60054557|NCT01490866|76170191|FG000|COMPLETED|FOLFOX/Bevacizumab Treatment||49||
60054558|NCT01490866|76170191|FG000|NOT COMPLETED|FOLFOX/Bevacizumab Treatment||21||
60054559|NCT01490866|76170191|FG000|STARTED|Axitinib Maintenance Therapy||49||
60054560|NCT01490866|76170191|FG000|COMPLETED|Axitinib Maintenance Therapy|No protocol defined endpoint to Axitinib maintenance treatment.|0||
60054561|NCT01490866|76170191|FG000|NOT COMPLETED|Axitinib Maintenance Therapy||49||
60054562|NCT02215967|76170202|FG000|STARTED|Overall Study||3||
60054563|NCT02215967|76170203|FG001|STARTED|Overall Study||3||
60054564|NCT02215967|76170204|FG002|STARTED|Overall Study||5||
60054565|NCT02215967|76170205|FG003|STARTED|Overall Study||19||
60054566|NCT02215967|76170202|FG000|COMPLETED|Overall Study||3||
60054567|NCT02215967|76170203|FG001|COMPLETED|Overall Study||3||
60054568|NCT02215967|76170204|FG002|COMPLETED|Overall Study||4||
60054569|NCT02215967|76170205|FG003|COMPLETED|Overall Study||16||
60054570|NCT02215967|76170202|FG000|NOT COMPLETED|Overall Study||0||
60054571|NCT02215967|76170203|FG001|NOT COMPLETED|Overall Study||0||
60054572|NCT02215967|76170204|FG002|NOT COMPLETED|Overall Study||1||
60054573|NCT02215967|76170205|FG003|NOT COMPLETED|Overall Study||3||
60054574|NCT02168387|76170217|FG000|STARTED|Overall Study||20||
59514908|NCT02994238|75608553|FG001|STARTED|Overall Study||127||
59514909|NCT02994238|75608552|FG000|COMPLETED|Overall Study||125||
60054575|NCT02168387|76170218|FG001|STARTED|Overall Study||19||
60054576|NCT02168387|76170217|FG000|COMPLETED|Overall Study||13||
60054577|NCT02168387|76170218|FG001|COMPLETED|Overall Study||16||
60054578|NCT02168387|76170217|FG000|NOT COMPLETED|Overall Study||7||
60054579|NCT02168387|76170218|FG001|NOT COMPLETED|Overall Study||3||
60054580|NCT02188589|76170224|FG000|STARTED|Overall Study||30||
60054581|NCT02188589|76170224|FG000|6 Months|Overall Study||30||
60054582|NCT02188589|76170224|FG000|12 Months|Overall Study||30|Final follow-up under initial protocol.|
60054583|NCT02188589|76170224|FG000|24 Months|Overall Study||25|Extended follow-up protocol, participants signed additional consent for follow-up beyond 12 months.|
60054584|NCT02188589|76170224|FG000|COMPLETED|Overall Study||25||
60054585|NCT02188589|76170224|FG000|NOT COMPLETED|Overall Study||5||
60054586|NCT02167451|76170229|FG000|STARTED|Overall Study||31||
60054587|NCT02167451|76170229|FG000|COMPLETED|Overall Study||30||
60054588|NCT02167451|76170229|FG000|NOT COMPLETED|Overall Study||1||
60054589|NCT02167139|76170235|FG000|STARTED|Randomised, Double-blind||271||
60054590|NCT02167139|76170236|FG001|STARTED|Randomised, Double-blind||273||
60054591|NCT02167139|76170237|FG002|STARTED|Randomised, Double-blind||0||
60054592|NCT02167139|76170238|FG003|STARTED|Randomised, Double-blind||0||
60054593|NCT02167139|76170235|FG000|COMPLETED|Randomised, Double-blind||254||
60054594|NCT02167139|76170236|FG001|COMPLETED|Randomised, Double-blind||254||
60054595|NCT02167139|76170237|FG002|COMPLETED|Randomised, Double-blind||0||
60054596|NCT02167139|76170238|FG003|COMPLETED|Randomised, Double-blind||0||
60054597|NCT02167139|76170235|FG000|NOT COMPLETED|Randomised, Double-blind||17||
60054598|NCT02167139|76170236|FG001|NOT COMPLETED|Randomised, Double-blind||19||
60054599|NCT02167139|76170237|FG002|NOT COMPLETED|Randomised, Double-blind||0||
60054600|NCT02167139|76170238|FG003|NOT COMPLETED|Randomised, Double-blind||0||
60054601|NCT02167139|76170235|FG000|STARTED|Transition-extension||254||
60054602|NCT02167139|76170236|FG001|STARTED|Transition-extension||0||
60054603|NCT02167139|76170237|FG002|STARTED|Transition-extension||125||
60054604|NCT02167139|76170238|FG003|STARTED|Transition-extension||129||
60054605|NCT02167139|76170235|FG000|COMPLETED|Transition-extension||248||
60054606|NCT02167139|76170236|FG001|COMPLETED|Transition-extension||0||
60054607|NCT02167139|76170237|FG002|COMPLETED|Transition-extension||117||
60054608|NCT02167139|76170238|FG003|COMPLETED|Transition-extension||124||
60054609|NCT02167139|76170235|FG000|NOT COMPLETED|Transition-extension||6||
60054610|NCT02167139|76170236|FG001|NOT COMPLETED|Transition-extension||0||
60054611|NCT02167139|76170237|FG002|NOT COMPLETED|Transition-extension||8||
60054612|NCT02167139|76170238|FG003|NOT COMPLETED|Transition-extension||5||
60054613|NCT02116621|76170254|FG000|STARTED|Baseline||108||
60054614|NCT02116621|76170255|FG001|STARTED|Baseline||107||
60054615|NCT02116621|76170254|FG000|Completed Baseline Visit|Baseline||108||
60054616|NCT02116621|76170255|FG001|Completed Baseline Visit|Baseline||103||
60054617|NCT02116621|76170254|FG000|Completed Intervention Period|Baseline||95||
60054618|NCT02116621|76170255|FG001|Completed Intervention Period|Baseline||103||
60054619|NCT02116621|76170254|FG000|COMPLETED|Baseline||108||
60054620|NCT02116621|76170255|FG001|COMPLETED|Baseline||103||
60054621|NCT02116621|76170254|FG000|NOT COMPLETED|Baseline||0||
60054622|NCT02116621|76170255|FG001|NOT COMPLETED|Baseline||4||
60054623|NCT02116621|76170254|FG000|STARTED|Three Month Follow-up||108||
60054624|NCT02116621|76170255|FG001|STARTED|Three Month Follow-up||103||
60054625|NCT02116621|76170254|FG000|COMPLETED|Three Month Follow-up||89||
60054626|NCT02116621|76170255|FG001|COMPLETED|Three Month Follow-up||96||
60054627|NCT02116621|76170254|FG000|NOT COMPLETED|Three Month Follow-up||19||
60054628|NCT02116621|76170255|FG001|NOT COMPLETED|Three Month Follow-up||7||
60054629|NCT02116621|76170254|FG000|STARTED|Six Month Follow-up|Patients who didn't complete 3mo survey but didn't drop from study were contacted for 6mo follow-up.|103||
60054630|NCT02116621|76170255|FG001|STARTED|Six Month Follow-up|Patients who didn't complete 3mo survey but didn't drop from study were contacted for 6mo follow-up|100||
60054631|NCT02116621|76170254|FG000|COMPLETED|Six Month Follow-up||99||
60054632|NCT02116621|76170255|FG001|COMPLETED|Six Month Follow-up||97||
60054633|NCT02116621|76170254|FG000|NOT COMPLETED|Six Month Follow-up||4||
60054634|NCT02116621|76170255|FG001|NOT COMPLETED|Six Month Follow-up||3||
60054635|NCT02116621|76170254|FG000|STARTED|Twelve Month Follow-up|Patients who didn't complete 6mo survey but didn't drop from study were contacted for 12mo follow-up|100||
60054636|NCT02116621|76170255|FG001|STARTED|Twelve Month Follow-up|Patients who didn't complete 6mo survey but didn't drop from study were contacted for 12mo follow-up|98||
60054637|NCT02116621|76170254|FG000|COMPLETED|Twelve Month Follow-up||84||
60054638|NCT02116621|76170255|FG001|COMPLETED|Twelve Month Follow-up||86||
60054639|NCT02116621|76170254|FG000|NOT COMPLETED|Twelve Month Follow-up||16||
60054640|NCT02116621|76170255|FG001|NOT COMPLETED|Twelve Month Follow-up||12||
60054641|NCT02116309|76170263|FG000|STARTED|Overall Study||482||
59514910|NCT02994238|75608553|FG001|COMPLETED|Overall Study||127||
59514911|NCT02994238|75608552|FG000|NOT COMPLETED|Overall Study||0||
59514912|NCT02994238|75608553|FG001|NOT COMPLETED|Overall Study||0||
59514913|NCT03110692|75608561|FG000|STARTED|Overall Study||679||
59514914|NCT03110692|75608562|FG001|STARTED|Overall Study||509||
59514915|NCT03110692|75608561|FG000|COMPLETED|Overall Study||679||
59514916|NCT03110692|75608562|FG001|COMPLETED|Overall Study||509||
59612969|NCT01695954|75724018|FG001|STARTED|Overall Study||16||
59514917|NCT03110692|75608561|FG000|NOT COMPLETED|Overall Study||0||
59514918|NCT03110692|75608562|FG001|NOT COMPLETED|Overall Study||0||
59514919|NCT03111316|75608572|FG000|STARTED|Overall Study||26||
59514920|NCT03111316|75608573|FG001|STARTED|Overall Study||24||
59514921|NCT03111316|75608574|FG002|STARTED|Overall Study||25||
59514922|NCT03111316|75608575|FG003|STARTED|Overall Study||25||
59514923|NCT03111316|75608572|FG000|COMPLETED|Overall Study||26||
59514924|NCT03111316|75608573|FG001|COMPLETED|Overall Study||24||
59514925|NCT03111316|75608574|FG002|COMPLETED|Overall Study||25||
59514926|NCT03111316|75608575|FG003|COMPLETED|Overall Study||25||
59514927|NCT03111316|75608572|FG000|NOT COMPLETED|Overall Study||0||
59514928|NCT03111316|75608573|FG001|NOT COMPLETED|Overall Study||0||
59514929|NCT03111316|75608574|FG002|NOT COMPLETED|Overall Study||0||
59514930|NCT03111316|75608575|FG003|NOT COMPLETED|Overall Study||0||
59514931|NCT03054844|75608587|FG000|STARTED|Overall Study||28||
59514932|NCT03054844|75608588|FG001|STARTED|Overall Study||27||
59514933|NCT03054844|75608587|FG000|COMPLETED|Overall Study||25||
59514934|NCT03054844|75608588|FG001|COMPLETED|Overall Study||26||
59612970|NCT01695954|75724017|FG000|COMPLETED|Overall Study||14||
59612971|NCT01695954|75724018|FG001|COMPLETED|Overall Study||14||
59612972|NCT01695954|75724017|FG000|NOT COMPLETED|Overall Study||4||
59612973|NCT01695954|75724018|FG001|NOT COMPLETED|Overall Study||2||
59923788|NCT03451721|76042974|FG000|STARTED|Overall Study||20||
59923789|NCT03451721|76042974|FG000|COMPLETED|Overall Study||19||
59923790|NCT03451721|76042974|FG000|NOT COMPLETED|Overall Study||1||
59923791|NCT00603954|76042980|FG000|STARTED|Overall Study|5 patients in Screening failure between inclusion and transplantation|50||
59923792|NCT00603954|76042981|FG001|STARTED|Overall Study|5 patients in Screening failure between inclusion and transplantation|47||
59923793|NCT00603954|76042980|FG000|COMPLETED|Overall Study||49||
59923794|NCT00603954|76042981|FG001|COMPLETED|Overall Study||45||
59923795|NCT00603954|76042980|FG000|NOT COMPLETED|Overall Study||1||
60054642|NCT02116309|76170264|FG001|STARTED|Overall Study||478||
60054643|NCT02116309|76170263|FG000|COMPLETED|Overall Study||482||
60054644|NCT02116309|76170264|FG001|COMPLETED|Overall Study||477||
59612974|NCT01694706|75724026|FG000|STARTED|Overall Study||5||
59612975|NCT01694706|75724027|FG001|STARTED|Overall Study||5||
59923796|NCT00603954|76042981|FG001|NOT COMPLETED|Overall Study||2||
59923797|NCT03427619|76042988|FG000|STARTED|Overall Study||275||
59923798|NCT03427619|76042988|FG000|Safety Population|Overall Study||275||
59923799|NCT03427619|76042988|FG000|Modified Intention to Treat Population|Overall Study||143||
60054645|NCT02116309|76170263|FG000|NOT COMPLETED|Overall Study||0||
60054646|NCT02116309|76170264|FG001|NOT COMPLETED|Overall Study||1||
60054647|NCT02115607|76170270|FG000|STARTED|Overall Study||17||
60054648|NCT02115607|76170270|FG000|COMPLETED|Overall Study||16||
60054649|NCT02115607|76170270|FG000|NOT COMPLETED|Overall Study||1||
60054650|NCT01490632|76170279|FG000|STARTED|Part A: Initial Treatment Period||34||
60054651|NCT01490632|76170280|FG001|STARTED|Part A: Initial Treatment Period||32||
60054652|NCT01490632|76170281|FG002|STARTED|Part A: Initial Treatment Period||72||
59923800|NCT03427619|76042988|FG000|COMPLETED|Overall Study||209||
59923801|NCT03427619|76042988|FG000|NOT COMPLETED|Overall Study||66||
59923802|NCT03407729|76042994|FG000|STARTED|Overall Study||11||
59514935|NCT03054844|75608587|FG000|NOT COMPLETED|Overall Study||3||
59514936|NCT03054844|75608588|FG001|NOT COMPLETED|Overall Study||1||
59514937|NCT03111550|75608597|FG000|STARTED|Overall Study|First eye|77||
59514938|NCT03111550|75608598|FG001|STARTED|Overall Study|First eye|73||
59514939|NCT03111550|75608599|FG002|STARTED|Overall Study|First eye|79||
59514940|NCT03111550|75608597|FG000|COMPLETED|Overall Study||73||
59514941|NCT03111550|75608598|FG001|COMPLETED|Overall Study||71||
59514942|NCT03111550|75608599|FG002|COMPLETED|Overall Study||76||
59514943|NCT03111550|75608597|FG000|NOT COMPLETED|Overall Study||4||
59514944|NCT03111550|75608598|FG001|NOT COMPLETED|Overall Study||2||
59514945|NCT03111550|75608599|FG002|NOT COMPLETED|Overall Study||3||
59514946|NCT03111628|75608607|FG000|STARTED|Overall Study||18||
59514947|NCT03111628|75608607|FG000|COMPLETED|Overall Study||18||
59514948|NCT03111628|75608607|FG000|NOT COMPLETED|Overall Study||0||
59514949|NCT03111940|75608614|FG000|STARTED|Overall Study||21||
59514950|NCT03111940|75608615|FG001|STARTED|Overall Study||14||
59514951|NCT03111940|75608614|FG000|COMPLETED|Overall Study||21||
59514952|NCT03111940|75608615|FG001|COMPLETED|Overall Study||14||
59514953|NCT03111940|75608614|FG000|NOT COMPLETED|Overall Study||0||
59514954|NCT03111940|75608615|FG001|NOT COMPLETED|Overall Study||0||
59514955|NCT03113656|75608625|FG000|STARTED|Overall Study||9||
59514956|NCT03113656|75608626|FG001|STARTED|Overall Study||7||
59514957|NCT03113656|75608625|FG000|COMPLETED|Overall Study||9||
59514958|NCT03113656|75608626|FG001|COMPLETED|Overall Study||7||
59514959|NCT03113656|75608625|FG000|NOT COMPLETED|Overall Study||0||
59514960|NCT03113656|75608626|FG001|NOT COMPLETED|Overall Study||0||
59514961|NCT03114124|75608634|FG000|STARTED|Overall Study||15||
59514962|NCT03114124|75608635|FG001|STARTED|Overall Study||15||
59514963|NCT03114124|75608634|FG000|COMPLETED|Overall Study||15||
59514964|NCT03114124|75608635|FG001|COMPLETED|Overall Study||15||
59514965|NCT03114124|75608634|FG000|NOT COMPLETED|Overall Study||0||
59514966|NCT03114124|75608635|FG001|NOT COMPLETED|Overall Study||0||
59514967|NCT02997904|75608643|FG000|STARTED|Overall Study||51||
59514968|NCT02997904|75608644|FG001|STARTED|Overall Study||49||
59514969|NCT02997904|75608643|FG000|COMPLETED|Overall Study||51||
59514970|NCT02997904|75608644|FG001|COMPLETED|Overall Study||49||
59514971|NCT02997904|75608643|FG000|NOT COMPLETED|Overall Study||0||
59514972|NCT02997904|75608644|FG001|NOT COMPLETED|Overall Study||0||
59514973|NCT01012297|75608656|FG000|STARTED|Overall Study||54||
59514974|NCT01012297|75608657|FG001|STARTED|Overall Study||53||
59514975|NCT01012297|75608656|FG000|COMPLETED|Overall Study||54||
59514976|NCT01012297|75608657|FG001|COMPLETED|Overall Study||53||
59514977|NCT01012297|75608656|FG000|NOT COMPLETED|Overall Study||0||
59514978|NCT01012297|75608657|FG001|NOT COMPLETED|Overall Study||0||
59514979|NCT02998684|75608665|FG000|STARTED|Overall Study||7||
59514980|NCT02998684|75608666|FG001|STARTED|Overall Study||7||
59514981|NCT02998684|75608665|FG000|COMPLETED|Overall Study||4||
59514982|NCT02998684|75608666|FG001|COMPLETED|Overall Study||6||
59514983|NCT02998684|75608665|FG000|NOT COMPLETED|Overall Study||3||
59514984|NCT02998684|75608666|FG001|NOT COMPLETED|Overall Study||1||
59514985|NCT03000010|75608674|FG000|STARTED|Overall Study||21||
59514986|NCT03000010|75608675|FG001|STARTED|Overall Study||20||
59514987|NCT03000010|75608674|FG000|COMPLETED|Overall Study||21||
59514988|NCT03000010|75608675|FG001|COMPLETED|Overall Study||20||
59514989|NCT03000010|75608674|FG000|NOT COMPLETED|Overall Study||0||
59514990|NCT03000010|75608675|FG001|NOT COMPLETED|Overall Study||0||
59514991|NCT03000088|75608683|FG000|STARTED|Overall Study||70||
59514992|NCT03000088|75608684|FG001|STARTED|Overall Study||70||
59514993|NCT03000088|75608683|FG000|COMPLETED|Overall Study||70||
59514994|NCT03000088|75608684|FG001|COMPLETED|Overall Study||70||
59514995|NCT03000088|75608683|FG000|NOT COMPLETED|Overall Study||0||
59514996|NCT03000088|75608684|FG001|NOT COMPLETED|Overall Study||0||
59514997|NCT03000166|75608692|FG000|STARTED|Overall Study||25||
59514998|NCT03000166|75608693|FG001|STARTED|Overall Study||22||
59514999|NCT03000166|75608692|FG000|COMPLETED|Overall Study||25||
59515000|NCT03000166|75608693|FG001|COMPLETED|Overall Study||19||
59515001|NCT03000166|75608692|FG000|NOT COMPLETED|Overall Study||0||
59515002|NCT03000166|75608693|FG001|NOT COMPLETED|Overall Study||3||
59515003|NCT00923117|75608702|FG000|STARTED|Overall Study||44||
59515004|NCT00923117|75608703|FG001|STARTED|Overall Study||43||
59515005|NCT00923117|75608702|FG000|COMPLETED|Overall Study||44||
59515006|NCT00923117|75608703|FG001|COMPLETED|Overall Study||43||
59515007|NCT00923117|75608702|FG000|NOT COMPLETED|Overall Study||0||
59515008|NCT00923117|75608703|FG001|NOT COMPLETED|Overall Study||0||
59515009|NCT00953173|75608709|FG000|STARTED|Overall Study||671||
59515010|NCT00953173|75608709|FG000|COMPLETED|Overall Study||389||
59515011|NCT00953173|75608709|FG000|NOT COMPLETED|Overall Study||282||
59515012|NCT03054922|75608716|FG000|STARTED|Overall Study||20||
59515013|NCT03054922|75608717|FG001|STARTED|Overall Study||19||
59515014|NCT03054922|75608718|FG002|STARTED|Overall Study||20||
59515015|NCT03054922|75608716|FG000|COMPLETED|Overall Study||20||
59515016|NCT03054922|75608717|FG001|COMPLETED|Overall Study||19||
59515017|NCT03054922|75608718|FG002|COMPLETED|Overall Study||20||
59515018|NCT03054922|75608716|FG000|NOT COMPLETED|Overall Study||0||
59515019|NCT03054922|75608717|FG001|NOT COMPLETED|Overall Study||0||
59515020|NCT03054922|75608718|FG002|NOT COMPLETED|Overall Study||0||
59515021|NCT03116230|75608726|FG000|STARTED|Overall Study||19||
59515022|NCT03116230|75608727|FG001|STARTED|Overall Study||19||
59515023|NCT03116230|75608726|FG000|COMPLETED|Overall Study||15||
59515024|NCT03116230|75608727|FG001|COMPLETED|Overall Study||17||
59515025|NCT03116230|75608726|FG000|NOT COMPLETED|Overall Study||4||
59515026|NCT03116230|75608727|FG001|NOT COMPLETED|Overall Study||2||
59515027|NCT00975637|75608738|FG000|STARTED|Overall Study||40||
59515028|NCT00975637|75608739|FG001|STARTED|Overall Study||39||
59515029|NCT00975637|75608740|FG002|STARTED|Overall Study||42||
59515030|NCT00975637|75608741|FG003|STARTED|Overall Study||38||
59515031|NCT00975637|75608742|FG004|STARTED|Overall Study||39||
60054653|NCT01490632|76170282|FG003|STARTED|Part A: Initial Treatment Period||64||
60054654|NCT01490632|76170283|FG004|STARTED|Part A: Initial Treatment Period||69||
60054655|NCT01490632|76170284|FG005|STARTED|Part A: Initial Treatment Period||0||
60054656|NCT01490632|76170285|FG006|STARTED|Part A: Initial Treatment Period||0||
60054657|NCT01490632|76170286|FG007|STARTED|Part A: Initial Treatment Period||0||
60054658|NCT01490632|76170287|FG008|STARTED|Part A: Initial Treatment Period||0||
60054659|NCT01490632|76170288|FG009|STARTED|Part A: Initial Treatment Period||0||
60054660|NCT01490632|76170289|FG010|STARTED|Part A: Initial Treatment Period||0||
60054661|NCT01490632|76170290|FG011|STARTED|Part A: Initial Treatment Period||0||
60054662|NCT01490632|76170291|FG012|STARTED|Part A: Initial Treatment Period||0||
60054663|NCT01490632|76170292|FG013|STARTED|Part A: Initial Treatment Period||0||
60054664|NCT01490632|76170293|FG014|STARTED|Part A: Initial Treatment Period||0||
60054665|NCT01490632|76170294|FG015|STARTED|Part A: Initial Treatment Period||0||
60054666|NCT01490632|76170295|FG016|STARTED|Part A: Initial Treatment Period||0||
60054667|NCT01490632|76170296|FG017|STARTED|Part A: Initial Treatment Period||0||
60054668|NCT01490632|76170297|FG018|STARTED|Part A: Initial Treatment Period||0||
60054669|NCT01490632|76170298|FG019|STARTED|Part A: Initial Treatment Period||0||
60054670|NCT01490632|76170279|FG000|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||34||
60054671|NCT01490632|76170280|FG001|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||32||
60054672|NCT01490632|76170281|FG002|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||72||
60054673|NCT01490632|76170282|FG003|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||64||
60054674|NCT01490632|76170283|FG004|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||69||
60054675|NCT01490632|76170284|FG005|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0||
60054676|NCT01490632|76170285|FG006|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0||
60054677|NCT01490632|76170286|FG007|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0||
60054678|NCT01490632|76170287|FG008|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0||
60054679|NCT01490632|76170288|FG009|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0||
60054680|NCT01490632|76170289|FG010|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0||
60054681|NCT01490632|76170290|FG011|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0||
60054682|NCT01490632|76170291|FG012|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0||
60054683|NCT01490632|76170292|FG013|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0||
59515032|NCT00975637|75608738|FG000|COMPLETED|Overall Study||37||
59515033|NCT00975637|75608739|FG001|COMPLETED|Overall Study||38||
59515034|NCT00975637|75608740|FG002|COMPLETED|Overall Study||40||
59515035|NCT00975637|75608741|FG003|COMPLETED|Overall Study||32||
59515036|NCT00975637|75608742|FG004|COMPLETED|Overall Study||37||
59515037|NCT00975637|75608738|FG000|NOT COMPLETED|Overall Study||3||
59515038|NCT00975637|75608739|FG001|NOT COMPLETED|Overall Study||1||
59515039|NCT00975637|75608740|FG002|NOT COMPLETED|Overall Study||2||
59515040|NCT00975637|75608741|FG003|NOT COMPLETED|Overall Study||6||
59515041|NCT00975637|75608742|FG004|NOT COMPLETED|Overall Study||2||
59515042|NCT00953719|75608756|FG000|STARTED|Overall Study||169||
59515043|NCT00953719|75608757|FG001|STARTED|Overall Study||74||
59515044|NCT00953719|75608756|FG000|COMPLETED|Overall Study||150||
59515045|NCT00953719|75608757|FG001|COMPLETED|Overall Study||69||
60054684|NCT01490632|76170293|FG014|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0||
60054685|NCT01490632|76170294|FG015|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0||
60054686|NCT01490632|76170295|FG016|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0||
60054687|NCT01490632|76170296|FG017|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0||
60054688|NCT01490632|76170297|FG018|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0||
60054689|NCT01490632|76170298|FG019|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0||
60054690|NCT01490632|76170279|FG000|COMPLETED|Part A: Initial Treatment Period||27||
60054691|NCT01490632|76170280|FG001|COMPLETED|Part A: Initial Treatment Period||28||
60054692|NCT01490632|76170281|FG002|COMPLETED|Part A: Initial Treatment Period||67||
60054693|NCT01490632|76170282|FG003|COMPLETED|Part A: Initial Treatment Period||55||
60054694|NCT01490632|76170283|FG004|COMPLETED|Part A: Initial Treatment Period|Includes participants who completed Part A, but discontinued per protocol using Part A PASI score.|52||
60054695|NCT01490632|76170284|FG005|COMPLETED|Part A: Initial Treatment Period||0||
60054696|NCT01490632|76170285|FG006|COMPLETED|Part A: Initial Treatment Period||0||
59515046|NCT00953719|75608756|FG000|NOT COMPLETED|Overall Study||19||
59515047|NCT00953719|75608757|FG001|NOT COMPLETED|Overall Study||5||
59515048|NCT01012921|75608765|FG000|STARTED|Overall Study||57||
59515049|NCT01012921|75608766|FG001|STARTED|Overall Study||60||
59515050|NCT01012921|75608765|FG000|COMPLETED|Overall Study||47||
59515051|NCT01012921|75608766|FG001|COMPLETED|Overall Study||47||
59515052|NCT01012921|75608765|FG000|NOT COMPLETED|Overall Study||10||
59515053|NCT01012921|75608766|FG001|NOT COMPLETED|Overall Study||13||
59515054|NCT03055000|75608775|FG000|STARTED|Overall Study||16||
60054697|NCT01490632|76170286|FG007|COMPLETED|Part A: Initial Treatment Period||0||
60054698|NCT01490632|76170287|FG008|COMPLETED|Part A: Initial Treatment Period||0||
60054699|NCT01490632|76170288|FG009|COMPLETED|Part A: Initial Treatment Period||0||
60054700|NCT01490632|76170289|FG010|COMPLETED|Part A: Initial Treatment Period||0||
60054701|NCT01490632|76170290|FG011|COMPLETED|Part A: Initial Treatment Period||0||
60054702|NCT01490632|76170291|FG012|COMPLETED|Part A: Initial Treatment Period||0||
60054703|NCT01490632|76170292|FG013|COMPLETED|Part A: Initial Treatment Period||0||
60054704|NCT01490632|76170293|FG014|COMPLETED|Part A: Initial Treatment Period||0||
60054705|NCT01490632|76170294|FG015|COMPLETED|Part A: Initial Treatment Period||0||
60054706|NCT01490632|76170295|FG016|COMPLETED|Part A: Initial Treatment Period||0||
60054707|NCT01490632|76170296|FG017|COMPLETED|Part A: Initial Treatment Period||0||
60054708|NCT01490632|76170297|FG018|COMPLETED|Part A: Initial Treatment Period||0||
60054709|NCT01490632|76170298|FG019|COMPLETED|Part A: Initial Treatment Period||0||
60054710|NCT01490632|76170279|FG000|NOT COMPLETED|Part A: Initial Treatment Period||7||
60054711|NCT01490632|76170280|FG001|NOT COMPLETED|Part A: Initial Treatment Period||4||
60054712|NCT01490632|76170281|FG002|NOT COMPLETED|Part A: Initial Treatment Period||5||
60054713|NCT01490632|76170282|FG003|NOT COMPLETED|Part A: Initial Treatment Period||9||
60054714|NCT01490632|76170283|FG004|NOT COMPLETED|Part A: Initial Treatment Period||17||
60054715|NCT01490632|76170284|FG005|NOT COMPLETED|Part A: Initial Treatment Period||0||
60054716|NCT01490632|76170285|FG006|NOT COMPLETED|Part A: Initial Treatment Period||0||
60054717|NCT01490632|76170286|FG007|NOT COMPLETED|Part A: Initial Treatment Period||0||
60054718|NCT01490632|76170287|FG008|NOT COMPLETED|Part A: Initial Treatment Period||0||
60054719|NCT01490632|76170288|FG009|NOT COMPLETED|Part A: Initial Treatment Period||0||
60054720|NCT01490632|76170289|FG010|NOT COMPLETED|Part A: Initial Treatment Period||0||
60054721|NCT01490632|76170290|FG011|NOT COMPLETED|Part A: Initial Treatment Period||0||
60054722|NCT01490632|76170291|FG012|NOT COMPLETED|Part A: Initial Treatment Period||0||
60054723|NCT01490632|76170292|FG013|NOT COMPLETED|Part A: Initial Treatment Period||0||
60054724|NCT01490632|76170293|FG014|NOT COMPLETED|Part A: Initial Treatment Period||0||
60054725|NCT01490632|76170294|FG015|NOT COMPLETED|Part A: Initial Treatment Period||0||
60054726|NCT01490632|76170295|FG016|NOT COMPLETED|Part A: Initial Treatment Period||0||
60054727|NCT01490632|76170296|FG017|NOT COMPLETED|Part A: Initial Treatment Period||0||
60054728|NCT01490632|76170297|FG018|NOT COMPLETED|Part A: Initial Treatment Period||0||
60054729|NCT01490632|76170298|FG019|NOT COMPLETED|Part A: Initial Treatment Period||0||
60054730|NCT01490632|76170279|FG000|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0||
60054731|NCT01490632|76170280|FG001|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0||
60054732|NCT01490632|76170281|FG002|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0||
60054733|NCT01490632|76170282|FG003|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0||
60054734|NCT01490632|76170283|FG004|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0||
60054735|NCT01490632|76170284|FG005|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to 2 mg or 4 mg with a PASI ≥75 remained on 2 mg or 4 mg.|29||
60054736|NCT01490632|76170285|FG006|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to 8 mg or 10 mg with a PASI ≥75 remained on 8 mg or 10 mg.|64||
60054737|NCT01490632|76170286|FG007|STARTED|Part B: Extension or Step-Up Period|Placebo participants in Part A with a PASI <75 were re-randomized to 8 mg or 10 mg.|19||
60054738|NCT01490632|76170287|FG008|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to 2 mg or 4 mg with a PASI ≥50 to <75 remained on 2 mg or 4 mg.|16||
59515055|NCT03055000|75608776|FG001|STARTED|Overall Study||17||
59515056|NCT03055000|75608777|FG002|STARTED|Overall Study||16||
59515057|NCT03055000|75608775|FG000|COMPLETED|Overall Study||16||
59515058|NCT03055000|75608776|FG001|COMPLETED|Overall Study||17||
59515059|NCT03055000|75608777|FG002|COMPLETED|Overall Study||16||
59515060|NCT03055000|75608775|FG000|NOT COMPLETED|Overall Study||0||
59515061|NCT03055000|75608776|FG001|NOT COMPLETED|Overall Study||0||
59515062|NCT03055000|75608777|FG002|NOT COMPLETED|Overall Study||0||
59515063|NCT00922883|75608785|FG000|STARTED|Overall Study||43||
59515064|NCT00922883|75608785|FG000|COMPLETED|Overall Study||43||
59515065|NCT00922883|75608785|FG000|NOT COMPLETED|Overall Study||0||
59515066|NCT03055156|75608791|FG000|STARTED|Overall Study||281||
59515067|NCT03055156|75608792|FG001|STARTED|Overall Study||273||
59515068|NCT03055156|75608791|FG000|COMPLETED|Overall Study||281||
59515069|NCT03055156|75608792|FG001|COMPLETED|Overall Study||273||
59515070|NCT03055156|75608791|FG000|NOT COMPLETED|Overall Study||0||
60054739|NCT01490632|76170288|FG009|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to 2 mg or 4 mg with a PASI <50 were re-randomized to 8 mg or 10 mg.|50||
60054740|NCT01490632|76170289|FG010|STARTED|Part B: Extension or Step-Up Period|Part A 10 mg non-responders were discontinued from the study.|43||
60054741|NCT01490632|76170290|FG011|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to Placebo remained on Placebo.|8||
60054742|NCT01490632|76170291|FG012|STARTED|Part B: Extension or Step-Up Period||0||
60054743|NCT01490632|76170292|FG013|STARTED|Part B: Extension or Step-Up Period||0||
60054744|NCT01490632|76170293|FG014|STARTED|Part B: Extension or Step-Up Period||0||
60054745|NCT01490632|76170294|FG015|STARTED|Part B: Extension or Step-Up Period||0||
60054746|NCT01490632|76170295|FG016|STARTED|Part B: Extension or Step-Up Period||0||
60054747|NCT01490632|76170296|FG017|STARTED|Part B: Extension or Step-Up Period||0||
60054748|NCT01490632|76170297|FG018|STARTED|Part B: Extension or Step-Up Period||0||
60054749|NCT01490632|76170298|FG019|STARTED|Part B: Extension or Step-Up Period||0||
60054750|NCT01490632|76170279|FG000|COMPLETED|Part B: Extension or Step-Up Period||0||
59515071|NCT03055156|75608792|FG001|NOT COMPLETED|Overall Study||0||
59515072|NCT03062488|75608801|FG000|STARTED|Overall Study||51||
59515073|NCT03062488|75608802|FG001|STARTED|Overall Study||51||
59515074|NCT03062488|75608803|FG002|STARTED|Overall Study||41||
59515075|NCT03062488|75608801|FG000|COMPLETED|Overall Study||51||
60054751|NCT01490632|76170280|FG001|COMPLETED|Part B: Extension or Step-Up Period||0||
60054752|NCT01490632|76170281|FG002|COMPLETED|Part B: Extension or Step-Up Period||0||
60054753|NCT01490632|76170282|FG003|COMPLETED|Part B: Extension or Step-Up Period||0||
60054754|NCT01490632|76170283|FG004|COMPLETED|Part B: Extension or Step-Up Period||0||
60054755|NCT01490632|76170284|FG005|COMPLETED|Part B: Extension or Step-Up Period||25||
60054756|NCT01490632|76170285|FG006|COMPLETED|Part B: Extension or Step-Up Period||51||
60054757|NCT01490632|76170286|FG007|COMPLETED|Part B: Extension or Step-Up Period||13||
60054758|NCT01490632|76170287|FG008|COMPLETED|Part B: Extension or Step-Up Period||6||
60054759|NCT01490632|76170288|FG009|COMPLETED|Part B: Extension or Step-Up Period||25||
60054760|NCT01490632|76170289|FG010|COMPLETED|Part B: Extension or Step-Up Period||22||
60054761|NCT01490632|76170290|FG011|COMPLETED|Part B: Extension or Step-Up Period||0||
60054762|NCT01490632|76170291|FG012|COMPLETED|Part B: Extension or Step-Up Period||0||
60054763|NCT01490632|76170292|FG013|COMPLETED|Part B: Extension or Step-Up Period||0||
60054764|NCT01490632|76170293|FG014|COMPLETED|Part B: Extension or Step-Up Period||0||
60054765|NCT01490632|76170294|FG015|COMPLETED|Part B: Extension or Step-Up Period||0||
60054766|NCT01490632|76170295|FG016|COMPLETED|Part B: Extension or Step-Up Period||0||
60054767|NCT01490632|76170296|FG017|COMPLETED|Part B: Extension or Step-Up Period||0||
60054768|NCT01490632|76170297|FG018|COMPLETED|Part B: Extension or Step-Up Period||0||
60054769|NCT01490632|76170298|FG019|COMPLETED|Part B: Extension or Step-Up Period||0||
60054770|NCT01490632|76170279|FG000|NOT COMPLETED|Part B: Extension or Step-Up Period||0||
60054771|NCT01490632|76170280|FG001|NOT COMPLETED|Part B: Extension or Step-Up Period||0||
60054772|NCT01490632|76170281|FG002|NOT COMPLETED|Part B: Extension or Step-Up Period||0||
60054773|NCT01490632|76170282|FG003|NOT COMPLETED|Part B: Extension or Step-Up Period||0||
60054774|NCT01490632|76170283|FG004|NOT COMPLETED|Part B: Extension or Step-Up Period||0||
60054775|NCT01490632|76170284|FG005|NOT COMPLETED|Part B: Extension or Step-Up Period||4||
60054776|NCT01490632|76170285|FG006|NOT COMPLETED|Part B: Extension or Step-Up Period||13||
60054777|NCT01490632|76170286|FG007|NOT COMPLETED|Part B: Extension or Step-Up Period||6||
60054778|NCT01490632|76170287|FG008|NOT COMPLETED|Part B: Extension or Step-Up Period||10||
60054779|NCT01490632|76170288|FG009|NOT COMPLETED|Part B: Extension or Step-Up Period||25||
60054780|NCT01490632|76170289|FG010|NOT COMPLETED|Part B: Extension or Step-Up Period||21||
60054781|NCT01490632|76170290|FG011|NOT COMPLETED|Part B: Extension or Step-Up Period||8||
60054782|NCT01490632|76170291|FG012|NOT COMPLETED|Part B: Extension or Step-Up Period||0||
60054783|NCT01490632|76170292|FG013|NOT COMPLETED|Part B: Extension or Step-Up Period||0||
60054784|NCT01490632|76170293|FG014|NOT COMPLETED|Part B: Extension or Step-Up Period||0||
60054785|NCT01490632|76170294|FG015|NOT COMPLETED|Part B: Extension or Step-Up Period||0||
60054786|NCT01490632|76170295|FG016|NOT COMPLETED|Part B: Extension or Step-Up Period||0||
60054787|NCT01490632|76170296|FG017|NOT COMPLETED|Part B: Extension or Step-Up Period||0||
60054788|NCT01490632|76170297|FG018|NOT COMPLETED|Part B: Extension or Step-Up Period||0||
60054789|NCT01490632|76170298|FG019|NOT COMPLETED|Part B: Extension or Step-Up Period||0||
60054790|NCT01490632|76170279|FG000|STARTED|Part C: Washout or Step-Down Period||0||
60054791|NCT01490632|76170280|FG001|STARTED|Part C: Washout or Step-Down Period||0||
59515076|NCT03062488|75608802|FG001|COMPLETED|Overall Study||51||
59515077|NCT03062488|75608803|FG002|COMPLETED|Overall Study||41||
59515078|NCT03062488|75608801|FG000|NOT COMPLETED|Overall Study||0||
59515079|NCT03062488|75608802|FG001|NOT COMPLETED|Overall Study||0||
59515080|NCT03062488|75608803|FG002|NOT COMPLETED|Overall Study||0||
59515081|NCT00936299|75608813|FG000|STARTED|Overall Study||53||
59515082|NCT00936299|75608814|FG001|STARTED|Overall Study||52||
59515083|NCT00936299|75608813|FG000|COMPLETED|Overall Study||40||
59515084|NCT00936299|75608814|FG001|COMPLETED|Overall Study||40||
59515085|NCT00936299|75608813|FG000|NOT COMPLETED|Overall Study||13||
59515086|NCT00936299|75608814|FG001|NOT COMPLETED|Overall Study||12||
59515087|NCT01014091|75608828|FG000|STARTED|Overall Study||7||
59515088|NCT01014091|75608829|FG001|STARTED|Overall Study||13||
59515089|NCT01014091|75608830|FG002|STARTED|Overall Study||5||
59515090|NCT01014091|75608831|FG003|STARTED|Overall Study||15||
59515091|NCT01014091|75608832|FG004|STARTED|Overall Study||6||
60054792|NCT01490632|76170281|FG002|STARTED|Part C: Washout or Step-Down Period||0||
59515092|NCT01014091|75608833|FG005|STARTED|Overall Study||12||
59515093|NCT01014091|75608828|FG000|COMPLETED|Overall Study||7||
59515094|NCT01014091|75608829|FG001|COMPLETED|Overall Study||13||
59515095|NCT01014091|75608830|FG002|COMPLETED|Overall Study||5||
59515096|NCT01014091|75608831|FG003|COMPLETED|Overall Study||15||
59515097|NCT01014091|75608832|FG004|COMPLETED|Overall Study||6||
59515098|NCT01014091|75608833|FG005|COMPLETED|Overall Study||12||
59515099|NCT01014091|75608828|FG000|NOT COMPLETED|Overall Study||0||
59923803|NCT03407729|76042995|FG001|STARTED|Overall Study||10||
59923804|NCT03407729|76042994|FG000|COMPLETED|Overall Study||9||
59923805|NCT03407729|76042995|FG001|COMPLETED|Overall Study||7||
59923806|NCT03407729|76042994|FG000|NOT COMPLETED|Overall Study||2||
59923807|NCT03407729|76042995|FG001|NOT COMPLETED|Overall Study||3||
59923808|NCT02435433|76043006|FG000|STARTED|Overall Study||197||
59923809|NCT02435433|76043007|FG001|STARTED|Overall Study||95||
59923810|NCT02435433|76043008|FG002|STARTED|Overall Study||47||
59923811|NCT02435433|76043009|FG003|STARTED|Overall Study||39||
59515100|NCT01014091|75608829|FG001|NOT COMPLETED|Overall Study||0||
59515101|NCT01014091|75608830|FG002|NOT COMPLETED|Overall Study||0||
59515102|NCT01014091|75608831|FG003|NOT COMPLETED|Overall Study||0||
59923812|NCT02435433|76043010|FG004|STARTED|Overall Study||21||
59951478|NCT02504580|76070497|FG009|STARTED|Overall Study||18||
59951479|NCT02504580|76070498|FG010|STARTED|Overall Study||32||
59951480|NCT02504580|76070499|FG011|STARTED|Overall Study||83||
59951481|NCT02504580|76070488|FG000|COMPLETED|Overall Study||18||
59951482|NCT02504580|76070489|FG001|COMPLETED|Overall Study||16||
59951483|NCT02504580|76070490|FG002|COMPLETED|Overall Study||16||
59951484|NCT02504580|76070491|FG003|COMPLETED|Overall Study||18||
59951485|NCT02504580|76070492|FG004|COMPLETED|Overall Study||16||
59951486|NCT02504580|76070493|FG005|COMPLETED|Overall Study||17||
59951487|NCT02504580|76070494|FG006|COMPLETED|Overall Study||39||
59951488|NCT02504580|76070495|FG007|COMPLETED|Overall Study||129||
59951489|NCT02504580|76070496|FG008|COMPLETED|Overall Study||52||
59951490|NCT02504580|76070497|FG009|COMPLETED|Overall Study||18||
59951491|NCT02504580|76070498|FG010|COMPLETED|Overall Study||32||
59951492|NCT02504580|76070499|FG011|COMPLETED|Overall Study||81||
59951493|NCT02504580|76070488|FG000|NOT COMPLETED|Overall Study||1||
59951494|NCT02504580|76070489|FG001|NOT COMPLETED|Overall Study||1||
59951495|NCT02504580|76070490|FG002|NOT COMPLETED|Overall Study||0||
59951496|NCT02504580|76070491|FG003|NOT COMPLETED|Overall Study||2||
59951497|NCT02504580|76070492|FG004|NOT COMPLETED|Overall Study||1||
59951498|NCT02504580|76070493|FG005|NOT COMPLETED|Overall Study||1||
59951499|NCT02504580|76070494|FG006|NOT COMPLETED|Overall Study||1||
59951500|NCT02504580|76070495|FG007|NOT COMPLETED|Overall Study||2||
59951501|NCT02504580|76070496|FG008|NOT COMPLETED|Overall Study||0||
59951502|NCT02504580|76070497|FG009|NOT COMPLETED|Overall Study||0||
59951503|NCT02504580|76070498|FG010|NOT COMPLETED|Overall Study||0||
59951504|NCT02504580|76070499|FG011|NOT COMPLETED|Overall Study||2||
59951505|NCT01328756|76070521|FG000|STARTED|Overall Study||314||
59951506|NCT01328756|76070521|FG000|COMPLETED|Overall Study||191||
59951507|NCT01328756|76070521|FG000|NOT COMPLETED|Overall Study||123||
59951508|NCT03922308|76070528|FG000|STARTED|Overall Study||10||
59951509|NCT03922308|76070529|FG001|STARTED|Overall Study||9||
59951510|NCT03922308|76070530|FG002|STARTED|Overall Study||9||
59951511|NCT03922308|76070528|FG000|Pharmacokinetic Population|Overall Study||10|Pharmacokinetic (PK) set included all enrolled participants with confirmed aTTP diagnosis who have received at least 1 dose of investigational product and who have at least 1 evaluable post-dose PK value.|
59951512|NCT03922308|76070529|FG001|Pharmacokinetic Population|Overall Study||8|Pharmacokinetic (PK) set included all enrolled participants with confirmed aTTP diagnosis who have received at least 1 dose of investigational product and who have at least 1 evaluable post-dose PK value.|
59951513|NCT03922308|76070530|FG002|Pharmacokinetic Population|Overall Study||9|Pharmacokinetic (PK) set included all enrolled participants with confirmed aTTP diagnosis who have received at least 1 dose of investigational product and who have at least 1 evaluable post-dose PK value.|
59951514|NCT03922308|76070528|FG000|COMPLETED|Overall Study||9||
59951515|NCT03922308|76070529|FG001|COMPLETED|Overall Study||6||
59951516|NCT03922308|76070530|FG002|COMPLETED|Overall Study||8||
59951517|NCT03922308|76070528|FG000|NOT COMPLETED|Overall Study||1||
59951518|NCT03922308|76070529|FG001|NOT COMPLETED|Overall Study||3||
59951519|NCT03922308|76070530|FG002|NOT COMPLETED|Overall Study||1||
59951520|NCT02607930|76070543|FG000|STARTED|Double-Blinded Treatment Phase||316||
59951521|NCT02607930|76070544|FG001|STARTED|Double-Blinded Treatment Phase||315||
59951522|NCT02607930|76070545|FG002|STARTED|Double-Blinded Treatment Phase||0||
59951523|NCT02607930|76070546|FG003|STARTED|Double-Blinded Treatment Phase||0||
59951524|NCT02607930|76070543|FG000|COMPLETED|Double-Blinded Treatment Phase||262||
59951525|NCT02607930|76070544|FG001|COMPLETED|Double-Blinded Treatment Phase||262||
59951526|NCT02607930|76070545|FG002|COMPLETED|Double-Blinded Treatment Phase||0||
59951527|NCT02607930|76070546|FG003|COMPLETED|Double-Blinded Treatment Phase||0||
60054793|NCT01490632|76170282|FG003|STARTED|Part C: Washout or Step-Down Period||0||
60054794|NCT01490632|76170283|FG004|STARTED|Part C: Washout or Step-Down Period|One participant completed Part B but discontinued without receiving a Part C treatment assignment.|0||
60054795|NCT01490632|76170284|FG005|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to 2 mg or 4 mg with a PASI ≥75 remained on 2 mg or 4 mg.|0||
60054796|NCT01490632|76170285|FG006|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to 8 mg or 10 mg with a PASI ≥75 remained on 8 mg or 10 mg.|0||
60054797|NCT01490632|76170286|FG007|STARTED|Part C: Washout or Step-Down Period|Placebo participants in Part A with a PASI <75 were re-randomized to 8 mg or 10 mg.|0||
60054798|NCT01490632|76170287|FG008|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to 2 mg or 4 mg with a PASI ≥50 to <75 remained on 2 mg or 4 mg.|0||
60054799|NCT01490632|76170288|FG009|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to 2 mg or 4 mg with a PASI <50 were re-randomized to 8 mg or 10 mg.|0||
59515103|NCT01014091|75608832|FG004|NOT COMPLETED|Overall Study||0||
59515104|NCT01014091|75608833|FG005|NOT COMPLETED|Overall Study||0||
59515105|NCT03117634|75608858|FG000|STARTED|Overall Study||41||41
59515106|NCT03117634|75608859|FG001|STARTED|Overall Study||13||13
59515107|NCT03117634|75608858|FG000|COMPLETED|Overall Study||39||39
59515108|NCT03117634|75608859|FG001|COMPLETED|Overall Study||13||13
59515109|NCT03117634|75608858|FG000|NOT COMPLETED|Overall Study||2||2
59515110|NCT03117634|75608859|FG001|NOT COMPLETED|Overall Study||0||0
59515111|NCT01014169|75608867|FG000|STARTED|Overall Study||65||
59515112|NCT01014169|75608868|FG001|STARTED|Overall Study||61||
59515113|NCT01014169|75608867|FG000|COMPLETED|Overall Study||58||
60054800|NCT01490632|76170289|FG010|STARTED|Part C: Washout or Step-Down Period|Part A 10 mg non-responders were discontinued from the study.|0||
60054801|NCT01490632|76170290|FG011|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to Placebo remained on Placebo.|0||
60054802|NCT01490632|76170291|FG012|STARTED|Part C: Washout or Step-Down Period|Responders receiving 2 or 4 mg were re-randomized to receive placebo.|15||
60054803|NCT01490632|76170292|FG013|STARTED|Part C: Washout or Step-Down Period|Responders receiving 2 or 4 mg were re-randomized to receive half of the dose from Part B.|16||
60054804|NCT01490632|76170293|FG014|STARTED|Part C: Washout or Step-Down Period|Responders receiving 8 or 10 mg were re-randomized to receive placebo.|55||
60054805|NCT01490632|76170294|FG015|STARTED|Part C: Washout or Step-Down Period|Responders receiving 8 or 10 mg were re-randomized to receive 4 mg.|55||
60054806|NCT01490632|76170295|FG016|STARTED|Part C: Washout or Step-Down Period||0||
59515114|NCT01014169|75608868|FG001|COMPLETED|Overall Study||48||
59515115|NCT01014169|75608867|FG000|NOT COMPLETED|Overall Study||7||
59515116|NCT01014169|75608868|FG001|NOT COMPLETED|Overall Study||13||
59515117|NCT00937235|75608876|FG000|STARTED|Overall Study||72||
59515118|NCT00937235|75608877|FG001|STARTED|Overall Study||70||
59515119|NCT00937235|75608876|FG000|COMPLETED|Overall Study||72||
59515120|NCT00937235|75608877|FG001|COMPLETED|Overall Study||70||
59515121|NCT00937235|75608876|FG000|NOT COMPLETED|Overall Study||0||
59515122|NCT00937235|75608877|FG001|NOT COMPLETED|Overall Study||0||
59515123|NCT01014403|75608885|FG000|STARTED|Overall Study||34||
59515124|NCT01014403|75608886|FG001|STARTED|Overall Study||28||
59515125|NCT01014403|75608885|FG000|COMPLETED|Overall Study||34||
59515126|NCT01014403|75608886|FG001|COMPLETED|Overall Study||28||
59515127|NCT01014403|75608885|FG000|NOT COMPLETED|Overall Study||0||
59515128|NCT01014403|75608886|FG001|NOT COMPLETED|Overall Study||0||
59515129|NCT03120832|75608895|FG000|STARTED|Overall Study||3||
59515130|NCT03120832|75608896|FG001|STARTED|Overall Study||3||
59515131|NCT03120832|75608897|FG002|STARTED|Overall Study||6||
59515132|NCT03120832|75608895|FG000|COMPLETED|Overall Study||3||
59515133|NCT03120832|75608896|FG001|COMPLETED|Overall Study||3||
59515134|NCT03120832|75608897|FG002|COMPLETED|Overall Study||6||
59515135|NCT03120832|75608895|FG000|NOT COMPLETED|Overall Study||0||
59515136|NCT03120832|75608896|FG001|NOT COMPLETED|Overall Study||0||
59515137|NCT03120832|75608897|FG002|NOT COMPLETED|Overall Study||0||
59515138|NCT00937859|75608907|FG000|STARTED|Overall Study||148||
59515139|NCT00937859|75608908|FG001|STARTED|Overall Study||153||
59515140|NCT00937859|75608907|FG000|COMPLETED|Overall Study||129||
59515141|NCT00937859|75608908|FG001|COMPLETED|Overall Study||134||
59515142|NCT00937859|75608907|FG000|NOT COMPLETED|Overall Study||19||
59515143|NCT00937859|75608908|FG001|NOT COMPLETED|Overall Study||19||
60054807|NCT01490632|76170296|FG017|STARTED|Part C: Washout or Step-Down Period||0||
60054808|NCT01490632|76170297|FG018|STARTED|Part C: Washout or Step-Down Period||0||
60054809|NCT01490632|76170298|FG019|STARTED|Part C: Washout or Step-Down Period||0||
60054810|NCT01490632|76170279|FG000|COMPLETED|Part C: Washout or Step-Down Period||0||
60054811|NCT01490632|76170280|FG001|COMPLETED|Part C: Washout or Step-Down Period||0||
60054812|NCT01490632|76170281|FG002|COMPLETED|Part C: Washout or Step-Down Period||0||
60054813|NCT01490632|76170282|FG003|COMPLETED|Part C: Washout or Step-Down Period||0||
60054814|NCT01490632|76170283|FG004|COMPLETED|Part C: Washout or Step-Down Period||0||
60054815|NCT01490632|76170284|FG005|COMPLETED|Part C: Washout or Step-Down Period||0||
60054816|NCT01490632|76170285|FG006|COMPLETED|Part C: Washout or Step-Down Period||0||
60054817|NCT01490632|76170286|FG007|COMPLETED|Part C: Washout or Step-Down Period||0||
60054818|NCT01490632|76170287|FG008|COMPLETED|Part C: Washout or Step-Down Period||0||
60054819|NCT01490632|76170288|FG009|COMPLETED|Part C: Washout or Step-Down Period||0||
60054820|NCT01490632|76170289|FG010|COMPLETED|Part C: Washout or Step-Down Period||0||
60054821|NCT01490632|76170290|FG011|COMPLETED|Part C: Washout or Step-Down Period||0||
60054822|NCT01490632|76170291|FG012|COMPLETED|Part C: Washout or Step-Down Period||10||
60054823|NCT01490632|76170292|FG013|COMPLETED|Part C: Washout or Step-Down Period||6||
60054824|NCT01490632|76170293|FG014|COMPLETED|Part C: Washout or Step-Down Period||37||
59515144|NCT01014871|75608914|FG000|STARTED|Overall Study||30||
59515145|NCT01014871|75608914|FG000|COMPLETED|Overall Study||30||
59515146|NCT01014871|75608914|FG000|NOT COMPLETED|Overall Study||0||
60054825|NCT01490632|76170294|FG015|COMPLETED|Part C: Washout or Step-Down Period||18||
60054826|NCT01490632|76170295|FG016|COMPLETED|Part C: Washout or Step-Down Period||0||
60054827|NCT01490632|76170296|FG017|COMPLETED|Part C: Washout or Step-Down Period||0||
60054828|NCT01490632|76170297|FG018|COMPLETED|Part C: Washout or Step-Down Period||0||
60054829|NCT01490632|76170298|FG019|COMPLETED|Part C: Washout or Step-Down Period||0||
60054830|NCT01490632|76170279|FG000|NOT COMPLETED|Part C: Washout or Step-Down Period||0||
60054831|NCT01490632|76170280|FG001|NOT COMPLETED|Part C: Washout or Step-Down Period||0||
60054832|NCT01490632|76170281|FG002|NOT COMPLETED|Part C: Washout or Step-Down Period||0||
60054833|NCT01490632|76170282|FG003|NOT COMPLETED|Part C: Washout or Step-Down Period||0||
60054834|NCT01490632|76170283|FG004|NOT COMPLETED|Part C: Washout or Step-Down Period||0||
60054835|NCT01490632|76170284|FG005|NOT COMPLETED|Part C: Washout or Step-Down Period||0||
60054836|NCT01490632|76170285|FG006|NOT COMPLETED|Part C: Washout or Step-Down Period||0||
60054837|NCT01490632|76170286|FG007|NOT COMPLETED|Part C: Washout or Step-Down Period||0||
60054838|NCT01490632|76170287|FG008|NOT COMPLETED|Part C: Washout or Step-Down Period||0||
60054839|NCT01490632|76170288|FG009|NOT COMPLETED|Part C: Washout or Step-Down Period||0||
60054840|NCT01490632|76170289|FG010|NOT COMPLETED|Part C: Washout or Step-Down Period||0||
60054841|NCT01490632|76170290|FG011|NOT COMPLETED|Part C: Washout or Step-Down Period||0||
60054842|NCT01490632|76170291|FG012|NOT COMPLETED|Part C: Washout or Step-Down Period||5||
60054843|NCT01490632|76170292|FG013|NOT COMPLETED|Part C: Washout or Step-Down Period||10||
60054844|NCT01490632|76170293|FG014|NOT COMPLETED|Part C: Washout or Step-Down Period||18||
60054845|NCT01490632|76170294|FG015|NOT COMPLETED|Part C: Washout or Step-Down Period||37||
60054846|NCT01490632|76170295|FG016|NOT COMPLETED|Part C: Washout or Step-Down Period||0||
60054847|NCT01490632|76170296|FG017|NOT COMPLETED|Part C: Washout or Step-Down Period||0||
60054848|NCT01490632|76170297|FG018|NOT COMPLETED|Part C: Washout or Step-Down Period||0||
60054849|NCT01490632|76170298|FG019|NOT COMPLETED|Part C: Washout or Step-Down Period||0||
60054850|NCT01490632|76170279|FG000|STARTED|Part D: Re-Treatment Period||0||
60054851|NCT01490632|76170280|FG001|STARTED|Part D: Re-Treatment Period||0||
60054852|NCT01490632|76170281|FG002|STARTED|Part D: Re-Treatment Period||0||
60054853|NCT01490632|76170282|FG003|STARTED|Part D: Re-Treatment Period||0||
60054854|NCT01490632|76170283|FG004|STARTED|Part D: Re-Treatment Period||0||
60054855|NCT01490632|76170284|FG005|STARTED|Part D: Re-Treatment Period||0||
59515147|NCT00976183|75608920|FG000|STARTED|Overall Study||18||
59515148|NCT00976183|75608920|FG000|COMPLETED|Overall Study|The study was closed on 05/30/12 due to adverse events. We did not complete enrollment|18||
59515149|NCT00976183|75608920|FG000|NOT COMPLETED|Overall Study||0||
59515150|NCT03121144|75608924|FG000|STARTED|Overall Study||34||
59515151|NCT03121144|75608924|FG000|COMPLETED|Overall Study||34||
59515152|NCT03121144|75608924|FG000|NOT COMPLETED|Overall Study||0||
59515153|NCT01015807|75608931|FG000|STARTED|Overall Study||30||
59515154|NCT01015807|75608932|FG001|STARTED|Overall Study||30||
59515155|NCT01015807|75608933|FG002|STARTED|Overall Study||30||
59515156|NCT01015807|75608931|FG000|COMPLETED|Overall Study||30||
59515157|NCT01015807|75608932|FG001|COMPLETED|Overall Study||30||
59515158|NCT01015807|75608933|FG002|COMPLETED|Overall Study||30||
59515159|NCT01015807|75608931|FG000|NOT COMPLETED|Overall Study||0||
59515160|NCT01015807|75608932|FG001|NOT COMPLETED|Overall Study||0||
59515161|NCT01015807|75608933|FG002|NOT COMPLETED|Overall Study||0||
60054856|NCT01490632|76170285|FG006|STARTED|Part D: Re-Treatment Period||0||
60054857|NCT01490632|76170286|FG007|STARTED|Part D: Re-Treatment Period||0||
60054858|NCT01490632|76170287|FG008|STARTED|Part D: Re-Treatment Period||0||
60054859|NCT01490632|76170288|FG009|STARTED|Part D: Re-Treatment Period||0||
60054860|NCT01490632|76170289|FG010|STARTED|Part D: Re-Treatment Period||0||
60054861|NCT01490632|76170290|FG011|STARTED|Part D: Re-Treatment Period||0||
60054862|NCT01490632|76170291|FG012|STARTED|Part D: Re-Treatment Period|Responders receiving 2 or 4 mg were re-randomized to receive placebo.|0||
60054863|NCT01490632|76170292|FG013|STARTED|Part D: Re-Treatment Period|Responders receiving 2 or 4 mg were re-randomized to receive half of the dose from Part B.|0||
60054864|NCT01490632|76170293|FG014|STARTED|Part D: Re-Treatment Period|Responders receiving 8 or 10 mg were re-randomized to receive placebo.|0||
60054865|NCT01490632|76170294|FG015|STARTED|Part D: Re-Treatment Period|Responders receiving 8 or 10 mg were re-randomized to receive 4 mg.|0||
60054866|NCT01490632|76170295|FG016|STARTED|Part D: Re-Treatment Period|Responders who experienced a relapse or flare proceeded for retreatment with 2 mg.|3||
60054867|NCT01490632|76170296|FG017|STARTED|Part D: Re-Treatment Period|Responders who experienced a relapse or flare proceeded for retreatment with 4 mg.|13||
60054868|NCT01490632|76170297|FG018|STARTED|Part D: Re-Treatment Period|Responders who experienced a relapse or flare proceeded for retreatment with 8 mg.|19||
60054869|NCT01490632|76170298|FG019|STARTED|Part D: Re-Treatment Period|Responders who experienced a relapse or flare proceeded for retreatment with 10 mg.|37||
60054870|NCT01490632|76170279|FG000|COMPLETED|Part D: Re-Treatment Period||0||
60054871|NCT01490632|76170280|FG001|COMPLETED|Part D: Re-Treatment Period||0||
60054872|NCT01490632|76170281|FG002|COMPLETED|Part D: Re-Treatment Period||0||
60054873|NCT01490632|76170282|FG003|COMPLETED|Part D: Re-Treatment Period||0||
60054874|NCT01490632|76170283|FG004|COMPLETED|Part D: Re-Treatment Period||0||
60054875|NCT01490632|76170284|FG005|COMPLETED|Part D: Re-Treatment Period||0||
60054876|NCT01490632|76170285|FG006|COMPLETED|Part D: Re-Treatment Period||0||
60054877|NCT01490632|76170286|FG007|COMPLETED|Part D: Re-Treatment Period||0||
60054878|NCT01490632|76170287|FG008|COMPLETED|Part D: Re-Treatment Period||0||
60054879|NCT01490632|76170288|FG009|COMPLETED|Part D: Re-Treatment Period||0||
60054880|NCT01490632|76170289|FG010|COMPLETED|Part D: Re-Treatment Period||0||
60054881|NCT01490632|76170290|FG011|COMPLETED|Part D: Re-Treatment Period||0||
60054882|NCT01490632|76170291|FG012|COMPLETED|Part D: Re-Treatment Period||0||
60054883|NCT01490632|76170292|FG013|COMPLETED|Part D: Re-Treatment Period||0||
60054884|NCT01490632|76170293|FG014|COMPLETED|Part D: Re-Treatment Period||0||
60054885|NCT01490632|76170294|FG015|COMPLETED|Part D: Re-Treatment Period||0||
60054886|NCT01490632|76170295|FG016|COMPLETED|Part D: Re-Treatment Period||3||
60054887|NCT01490632|76170296|FG017|COMPLETED|Part D: Re-Treatment Period||8||
60054888|NCT01490632|76170297|FG018|COMPLETED|Part D: Re-Treatment Period||12||
60054889|NCT01490632|76170298|FG019|COMPLETED|Part D: Re-Treatment Period||30||
60054890|NCT01490632|76170279|FG000|NOT COMPLETED|Part D: Re-Treatment Period||0||
60054891|NCT01490632|76170280|FG001|NOT COMPLETED|Part D: Re-Treatment Period||0||
60054892|NCT01490632|76170281|FG002|NOT COMPLETED|Part D: Re-Treatment Period||0||
60054893|NCT01490632|76170282|FG003|NOT COMPLETED|Part D: Re-Treatment Period||0||
60054894|NCT01490632|76170283|FG004|NOT COMPLETED|Part D: Re-Treatment Period||0||
60054895|NCT01490632|76170284|FG005|NOT COMPLETED|Part D: Re-Treatment Period||0||
60054896|NCT01490632|76170285|FG006|NOT COMPLETED|Part D: Re-Treatment Period||0||
60054897|NCT01490632|76170286|FG007|NOT COMPLETED|Part D: Re-Treatment Period||0||
60054898|NCT01490632|76170287|FG008|NOT COMPLETED|Part D: Re-Treatment Period||0||
60054899|NCT01490632|76170288|FG009|NOT COMPLETED|Part D: Re-Treatment Period||0||
60054900|NCT01490632|76170289|FG010|NOT COMPLETED|Part D: Re-Treatment Period||0||
60054901|NCT01490632|76170290|FG011|NOT COMPLETED|Part D: Re-Treatment Period||0||
60054902|NCT01490632|76170291|FG012|NOT COMPLETED|Part D: Re-Treatment Period||0||
60054903|NCT01490632|76170292|FG013|NOT COMPLETED|Part D: Re-Treatment Period||0||
60054904|NCT01490632|76170293|FG014|NOT COMPLETED|Part D: Re-Treatment Period||0||
60054905|NCT01490632|76170294|FG015|NOT COMPLETED|Part D: Re-Treatment Period||0||
60054906|NCT01490632|76170295|FG016|NOT COMPLETED|Part D: Re-Treatment Period||0||
60054907|NCT01490632|76170296|FG017|NOT COMPLETED|Part D: Re-Treatment Period||5||
60054908|NCT01490632|76170297|FG018|NOT COMPLETED|Part D: Re-Treatment Period||7||
60054909|NCT01490632|76170298|FG019|NOT COMPLETED|Part D: Re-Treatment Period||7||
60054910|NCT02073643|76170341|FG000|STARTED|Overall Study||204||
60054911|NCT02073643|76170341|FG000|COMPLETED|Overall Study||180||
60054912|NCT02073643|76170341|FG000|NOT COMPLETED|Overall Study||24||
60054913|NCT01451554|76170347|FG000|STARTED|Overall Study||33||
60054914|NCT01451554|76170348|FG001|STARTED|Overall Study||32||
60054915|NCT01451554|76170347|FG000|COMPLETED|Overall Study||19||
60054916|NCT01451554|76170348|FG001|COMPLETED|Overall Study||23||
60054917|NCT01451554|76170347|FG000|NOT COMPLETED|Overall Study||14||
60054918|NCT01451554|76170348|FG001|NOT COMPLETED|Overall Study||9||
60054919|NCT01474486|76170354|FG000|STARTED|Overall Study||28||
60054920|NCT01474486|76170354|FG000|Treated|Overall Study||22||
60054921|NCT01474486|76170354|FG000|COMPLETED|Overall Study||20||
59515162|NCT03067948|75608941|FG000|STARTED|Overall Study||32||
59515163|NCT03067948|75608941|FG000|COMPLETED|Overall Study||32||
59515164|NCT03067948|75608941|FG000|NOT COMPLETED|Overall Study||0||
59515165|NCT03121612|75608947|FG000|STARTED|Overall Study||26||
59515166|NCT03121612|75608948|FG001|STARTED|Overall Study||25||
59515167|NCT03121612|75608947|FG000|COMPLETED|Overall Study||26||
59515168|NCT03121612|75608948|FG001|COMPLETED|Overall Study||25||
59515169|NCT03121612|75608947|FG000|NOT COMPLETED|Overall Study||0||
59515170|NCT03121612|75608948|FG001|NOT COMPLETED|Overall Study||0||
59515171|NCT00978445|75608956|FG000|STARTED|Overall Study||12||
59515172|NCT00978445|75608957|FG001|STARTED|Overall Study||13||
59515173|NCT00978445|75608956|FG000|COMPLETED|Overall Study||10||
59515174|NCT00978445|75608957|FG001|COMPLETED|Overall Study||12||
59515175|NCT00978445|75608956|FG000|NOT COMPLETED|Overall Study||2||
59515176|NCT00978445|75608957|FG001|NOT COMPLETED|Overall Study||1||
59760551|NCT02701283|75880166|FG000|NOT COMPLETED|Overall Study||69||
59760552|NCT02701283|75880167|FG001|NOT COMPLETED|Overall Study||162||
59760553|NCT02701283|75880168|FG002|NOT COMPLETED|Overall Study||21||
59760554|NCT02552199|75880181|FG000|STARTED|Overall Study||13||
59760555|NCT02552199|75880182|FG001|STARTED|Overall Study||9||
59760556|NCT02552199|75880181|FG000|COMPLETED|Overall Study||13||
59760557|NCT02552199|75880182|FG001|COMPLETED|Overall Study||9||
59760558|NCT02552199|75880181|FG000|NOT COMPLETED|Overall Study||0||
59760559|NCT02552199|75880182|FG001|NOT COMPLETED|Overall Study||0||
60054922|NCT01474486|76170354|FG000|NOT COMPLETED|Overall Study||8||
60054923|NCT01451398|76170364|FG000|STARTED|Overall Study||177||
60054924|NCT01451398|76170365|FG001|STARTED|Overall Study||176||
60054925|NCT01451398|76170364|FG000|COMPLETED|Overall Study||150||
60054926|NCT01451398|76170365|FG001|COMPLETED|Overall Study||139||
60054927|NCT01451398|76170364|FG000|NOT COMPLETED|Overall Study||27||
60054928|NCT01451398|76170365|FG001|NOT COMPLETED|Overall Study||37||
60054929|NCT02073565|76170373|FG000|STARTED|Intention-To-Treat Subjects-Cohorts AB&C||287||
60054930|NCT02073565|76170374|FG001|STARTED|Intention-To-Treat Subjects-Cohorts AB&C||285||
60054931|NCT02073565|76170373|FG000|COMPLETED|Intention-To-Treat Subjects-Cohorts AB&C||285||
60054932|NCT02073565|76170374|FG001|COMPLETED|Intention-To-Treat Subjects-Cohorts AB&C||279||
60054933|NCT02073565|76170373|FG000|NOT COMPLETED|Intention-To-Treat Subjects-Cohorts AB&C||2||
60054934|NCT02073565|76170374|FG001|NOT COMPLETED|Intention-To-Treat Subjects-Cohorts AB&C||6||
60054935|NCT02073565|76170373|FG000|STARTED|Cohort A||16||
60054936|NCT02073565|76170374|FG001|STARTED|Cohort A||14||
60054937|NCT02073565|76170373|FG000|COMPLETED|Cohort A||15||
60054938|NCT02073565|76170374|FG001|COMPLETED|Cohort A||14||
60054939|NCT02073565|76170373|FG000|NOT COMPLETED|Cohort A||1||
60054940|NCT02073565|76170374|FG001|NOT COMPLETED|Cohort A||0||
60054941|NCT02073565|76170373|FG000|STARTED|Cohort B||54||
60054942|NCT02073565|76170374|FG001|STARTED|Cohort B||56||
60054943|NCT02073565|76170373|FG000|COMPLETED|Cohort B||53||
59515177|NCT00936377|75608967|FG000|STARTED|Overall Study||8||
59515178|NCT00936377|75608968|FG001|STARTED|Overall Study||8||
59515179|NCT00936377|75608969|FG002|STARTED|Overall Study||8||
59760560|NCT02399085|75880188|FG000|STARTED|Overall Study||81||
59760561|NCT02399085|75880188|FG000|Received MOR00208 + LEN|Overall Study||80||
60054944|NCT02073565|76170374|FG001|COMPLETED|Cohort B||54||
60054945|NCT02073565|76170373|FG000|NOT COMPLETED|Cohort B||1||
60054946|NCT02073565|76170374|FG001|NOT COMPLETED|Cohort B||2||
60054947|NCT02073565|76170373|FG000|STARTED|Cohort C||217||
60054948|NCT02073565|76170374|FG001|STARTED|Cohort C||215||
60054949|NCT02073565|76170373|FG000|COMPLETED|Cohort C||217||
60054950|NCT02073565|76170374|FG001|COMPLETED|Cohort C||211||
60054951|NCT02073565|76170373|FG000|NOT COMPLETED|Cohort C||0||
59515180|NCT00936377|75608967|FG000|COMPLETED|Overall Study||8||
59515181|NCT00936377|75608968|FG001|COMPLETED|Overall Study||8||
59515182|NCT00936377|75608969|FG002|COMPLETED|Overall Study||8||
59515183|NCT00936377|75608967|FG000|NOT COMPLETED|Overall Study||0||
59515184|NCT00936377|75608968|FG001|NOT COMPLETED|Overall Study||0||
60054952|NCT02073565|76170374|FG001|NOT COMPLETED|Cohort C||4||
60054953|NCT02072941|76170382|FG000|STARTED|Overall Study||219||
60054954|NCT02072941|76170383|FG001|STARTED|Overall Study||226||
60054955|NCT02072941|76170382|FG000|COMPLETED|Overall Study||181||
60054956|NCT02072941|76170383|FG001|COMPLETED|Overall Study||197||
60054957|NCT02072941|76170382|FG000|NOT COMPLETED|Overall Study||38||
60054958|NCT02072941|76170383|FG001|NOT COMPLETED|Overall Study||29||
60054959|NCT02100631|76170392|FG000|STARTED|Overall Study||299||
60054960|NCT02100631|76170393|FG001|STARTED|Overall Study||99||
60054961|NCT02100631|76170394|FG002|STARTED|Overall Study||2688||
60054962|NCT02100631|76170392|FG000|COMPLETED|Overall Study||292||
60054963|NCT02100631|76170393|FG001|COMPLETED|Overall Study||95||
60054964|NCT02100631|76170394|FG002|COMPLETED|Overall Study||2688||
59515185|NCT00936377|75608969|FG002|NOT COMPLETED|Overall Study||0||
60054965|NCT02100631|76170392|FG000|NOT COMPLETED|Overall Study||7||
60054966|NCT02100631|76170393|FG001|NOT COMPLETED|Overall Study||4||
60054967|NCT02100631|76170394|FG002|NOT COMPLETED|Overall Study||0||
60054968|NCT01451164|76170406|FG000|STARTED|Overall Study||115||
60054969|NCT01451164|76170407|FG001|STARTED|Overall Study||115||
60054970|NCT01451164|76170408|FG002|STARTED|Overall Study||113||
60054971|NCT01451164|76170409|FG003|STARTED|Overall Study||116||
60054972|NCT01451164|76170406|FG000|COMPLETED|Overall Study||72||
60054973|NCT01451164|76170407|FG001|COMPLETED|Overall Study||81||
60054974|NCT01451164|76170408|FG002|COMPLETED|Overall Study||68||
60054975|NCT01451164|76170409|FG003|COMPLETED|Overall Study||70||
60054976|NCT01451164|76170406|FG000|NOT COMPLETED|Overall Study||43||
60054977|NCT01451164|76170407|FG001|NOT COMPLETED|Overall Study||34||
60054978|NCT01451164|76170408|FG002|NOT COMPLETED|Overall Study||45||
60054979|NCT01451164|76170409|FG003|NOT COMPLETED|Overall Study||46||
60054980|NCT02071849|76170419|FG000|STARTED|6-month Primary Endpoint||20||
60054981|NCT02071849|76170419|FG000|COMPLETED|6-month Primary Endpoint||15||
60054982|NCT02071849|76170419|FG000|NOT COMPLETED|6-month Primary Endpoint||5||
60054983|NCT02071849|76170419|FG000|STARTED|2-year Extended Follow-up||15||
60054984|NCT02071849|76170419|FG000|COMPLETED|2-year Extended Follow-up||14||
60054985|NCT02071849|76170419|FG000|NOT COMPLETED|2-year Extended Follow-up||1||
60054986|NCT02071771|76170423|FG000|STARTED|Period 1: First 10 Days||41||
60054987|NCT02071771|76170424|FG001|STARTED|Period 1: First 10 Days||39||
60054988|NCT02071771|76170423|FG000|Dispensed|Period 1: First 10 Days||39||
60054989|NCT02071771|76170424|FG001|Dispensed|Period 1: First 10 Days||39||
60054990|NCT02071771|76170423|FG000|COMPLETED|Period 1: First 10 Days||39||
60054991|NCT02071771|76170424|FG001|COMPLETED|Period 1: First 10 Days||39||
60054992|NCT02071771|76170423|FG000|NOT COMPLETED|Period 1: First 10 Days||2||
60054993|NCT02071771|76170424|FG001|NOT COMPLETED|Period 1: First 10 Days||0||
60054994|NCT02071771|76170423|FG000|STARTED|Period 2: Second 10 Days||39||
60054995|NCT02071771|76170424|FG001|STARTED|Period 2: Second 10 Days|One participant completed Period 1 but did not start Period 2 due to unacceptable fit with DACP T.|38||
60054996|NCT02071771|76170423|FG000|COMPLETED|Period 2: Second 10 Days||39||
59515186|NCT03123874|75608979|FG000|STARTED|Overall Study||27||
59923813|NCT02435433|76043006|FG000|Participants Who Received Study Drug|Overall Study||197||
59923814|NCT02435433|76043007|FG001|Participants Who Received Study Drug|Overall Study||95||
59923815|NCT02435433|76043008|FG002|Participants Who Received Study Drug|Overall Study||47||
59923816|NCT02435433|76043009|FG003|Participants Who Received Study Drug|Overall Study||39||
59923817|NCT02435433|76043010|FG004|Participants Who Received Study Drug|Overall Study||21||
59923818|NCT02435433|76043006|FG000|COMPLETED|Overall Study||193|Completers include participants who had died due to any cause or alive and on study at the end of study, but off treatment.|
59923819|NCT02435433|76043007|FG001|COMPLETED|Overall Study||90|Completers include participants who had died due to any cause or alive and on study at the end of study, but off treatment.|
59923820|NCT02435433|76043008|FG002|COMPLETED|Overall Study||42|Completers include participants who had died due to any cause or alive and on study at the end of study, but off treatment.|
59923821|NCT02435433|76043009|FG003|COMPLETED|Overall Study||38|Completers include participants who had died due to any cause or alive and on study at the end of study, but off treatment.|
59923822|NCT02435433|76043010|FG004|COMPLETED|Overall Study||21|Completers include participants who had died due to any cause or alive and on study at the end of study, but off treatment.|
59923823|NCT02435433|76043006|FG000|NOT COMPLETED|Overall Study||4||
59923824|NCT02435433|76043007|FG001|NOT COMPLETED|Overall Study||5||
59923825|NCT02435433|76043008|FG002|NOT COMPLETED|Overall Study||5||
59923826|NCT02435433|76043009|FG003|NOT COMPLETED|Overall Study||1||
59923827|NCT02435433|76043010|FG004|NOT COMPLETED|Overall Study||0||
59923828|NCT03120351|76043023|FG000|STARTED|Overall Study||40||
59923829|NCT03120351|76043024|FG001|STARTED|Overall Study||40||
59923830|NCT03120351|76043023|FG000|COMPLETED|Overall Study||39||
59923831|NCT03120351|76043024|FG001|COMPLETED|Overall Study||39||
59923832|NCT03120351|76043023|FG000|NOT COMPLETED|Overall Study||1||
60054997|NCT02071771|76170424|FG001|COMPLETED|Period 2: Second 10 Days||38||
60054998|NCT02071771|76170423|FG000|NOT COMPLETED|Period 2: Second 10 Days||0||
60054999|NCT02071771|76170424|FG001|NOT COMPLETED|Period 2: Second 10 Days||0||
60055000|NCT02071225|76170430|FG000|STARTED|Overall Study||72||
60055001|NCT02071225|76170430|FG000|COMPLETED|Overall Study||42||
60055002|NCT02071225|76170430|FG000|NOT COMPLETED|Overall Study||30||
60055003|NCT01450696|76170436|FG000|STARTED|Overall Study||148||
60055004|NCT01450696|76170437|FG001|STARTED|Overall Study||148||
60055005|NCT01450696|76170436|FG000|Treated (Safety Population)|Overall Study||147||
60055006|NCT01450696|76170437|FG001|Treated (Safety Population)|Overall Study||147||
60055007|NCT01450696|76170436|FG000|COMPLETED|Overall Study||0||
60055008|NCT01450696|76170437|FG001|COMPLETED|Overall Study||0||
60055009|NCT01450696|76170436|FG000|NOT COMPLETED|Overall Study||148||
60055010|NCT01450696|76170437|FG001|NOT COMPLETED|Overall Study||148||
59515187|NCT03123874|75608980|FG001|STARTED|Overall Study||25||
60055011|NCT02070991|76170445|FG000|STARTED|Overall Study||31||
59515188|NCT03123874|75608979|FG000|COMPLETED|Overall Study||27||
60055012|NCT02070991|76170446|FG001|STARTED|Overall Study||32||
60055013|NCT02070991|76170445|FG000|COMPLETED|Overall Study||28||
60055014|NCT02070991|76170446|FG001|COMPLETED|Overall Study||32||
59515189|NCT03123874|75608980|FG001|COMPLETED|Overall Study||25||
59515190|NCT03123874|75608979|FG000|NOT COMPLETED|Overall Study||0||
59515191|NCT03123874|75608980|FG001|NOT COMPLETED|Overall Study||0||
59515192|NCT00936455|75608992|FG000|STARTED|Overall Study||37||
59515193|NCT00936455|75608993|FG001|STARTED|Overall Study||38||
59515194|NCT00936455|75608992|FG000|COMPLETED|Overall Study||37||
59515195|NCT00936455|75608993|FG001|COMPLETED|Overall Study||38||
59515196|NCT00936455|75608992|FG000|NOT COMPLETED|Overall Study||0||
59515197|NCT00936455|75608993|FG001|NOT COMPLETED|Overall Study||0||
60055015|NCT02070991|76170445|FG000|NOT COMPLETED|Overall Study||3||
60055016|NCT02070991|76170446|FG001|NOT COMPLETED|Overall Study||0||
60055017|NCT02114515|76170454|FG000|STARTED|Overall Study||511||
60055018|NCT02114515|76170455|FG001|STARTED|Overall Study||518||
60055019|NCT02114515|76170454|FG000|COMPLETED|Overall Study||378||
60055020|NCT02114515|76170455|FG001|COMPLETED|Overall Study||368||
60055021|NCT02114515|76170454|FG000|NOT COMPLETED|Overall Study||133||
60055022|NCT02114515|76170455|FG001|NOT COMPLETED|Overall Study||150||
60055023|NCT01490086|76170466|FG000|STARTED|Overall Study||58||
60055024|NCT01490086|76170467|FG001|STARTED|Overall Study||59||
60055025|NCT01490086|76170468|FG002|STARTED|Overall Study||58||
60055026|NCT01490086|76170469|FG003|STARTED|Overall Study||20||
60055027|NCT01490086|76170470|FG004|STARTED|Overall Study||39||
60055028|NCT01490086|76170466|FG000|COMPLETED|Overall Study||50||
60055029|NCT01490086|76170467|FG001|COMPLETED|Overall Study||44||
60055030|NCT01490086|76170468|FG002|COMPLETED|Overall Study||51||
60055031|NCT01490086|76170469|FG003|COMPLETED|Overall Study||13||
60055032|NCT01490086|76170470|FG004|COMPLETED|Overall Study||28||
60055033|NCT01490086|76170466|FG000|NOT COMPLETED|Overall Study||8||
60055034|NCT01490086|76170467|FG001|NOT COMPLETED|Overall Study||15||
60055035|NCT01490086|76170468|FG002|NOT COMPLETED|Overall Study||7||
60055036|NCT01490086|76170469|FG003|NOT COMPLETED|Overall Study||7||
60055037|NCT01490086|76170470|FG004|NOT COMPLETED|Overall Study||11||
60055038|NCT02114203|76170485|FG000|STARTED|Overall Study||7||
60055039|NCT02114203|76170486|FG001|STARTED|Overall Study||16||
60055040|NCT02114203|76170487|FG002|STARTED|Overall Study||7||
60055041|NCT02114203|76170485|FG000|COMPLETED|Overall Study||7||
60055042|NCT02114203|76170486|FG001|COMPLETED|Overall Study||14||
60055043|NCT02114203|76170487|FG002|COMPLETED|Overall Study||7||
60055044|NCT02114203|76170485|FG000|NOT COMPLETED|Overall Study||0||
60055045|NCT02114203|76170486|FG001|NOT COMPLETED|Overall Study||2||
60055046|NCT02114203|76170487|FG002|NOT COMPLETED|Overall Study||0||
60055047|NCT02113579|76170497|FG000|STARTED|Overall Study||186||
60055048|NCT02113579|76170498|FG001|STARTED|Overall Study||189||
60055049|NCT02113579|76170497|FG000|COMPLETED|Overall Study||176||
60055050|NCT02113579|76170498|FG001|COMPLETED|Overall Study||185||
60055051|NCT02113579|76170497|FG000|NOT COMPLETED|Overall Study||10||
60055052|NCT02113579|76170498|FG001|NOT COMPLETED|Overall Study||4||
60055053|NCT01474018|76170506|FG000|STARTED|Overall Study||5||
60055054|NCT01474018|76170507|FG001|STARTED|Overall Study||10||
60055055|NCT01474018|76170506|FG000|COMPLETED|Overall Study|Writing paper|5||
60055056|NCT01474018|76170507|FG001|COMPLETED|Overall Study||7||
59515198|NCT03124342|75609007|FG000|STARTED|Overall Study||111||
59515199|NCT03124342|75609008|FG001|STARTED|Overall Study||121||
59515200|NCT03124342|75609007|FG000|COMPLETED|Overall Study||111||
60055057|NCT01474018|76170506|FG000|NOT COMPLETED|Overall Study||0||
60055058|NCT01474018|76170507|FG001|NOT COMPLETED|Overall Study||3||
60055059|NCT02100475|76170515|FG000|STARTED|Overall Study||16||
60055060|NCT02100475|76170516|FG001|STARTED|Overall Study||15||
60055061|NCT02100475|76170515|FG000|COMPLETED|Overall Study||14||
60055062|NCT02100475|76170516|FG001|COMPLETED|Overall Study||13||
60055063|NCT02100475|76170515|FG000|NOT COMPLETED|Overall Study||2||
60055064|NCT02100475|76170516|FG001|NOT COMPLETED|Overall Study||2||
60055065|NCT02113189|76170525|FG000|STARTED|Overall Study||4||
60055066|NCT02113189|76170526|FG001|STARTED|Overall Study||4||
60055067|NCT02113189|76170527|FG002|STARTED|Overall Study||5||
60055068|NCT02113189|76170525|FG000|COMPLETED|Overall Study||2||
60055069|NCT02113189|76170526|FG001|COMPLETED|Overall Study||3||
60055070|NCT02113189|76170527|FG002|COMPLETED|Overall Study||2||
60055071|NCT02113189|76170525|FG000|NOT COMPLETED|Overall Study||2||
60055072|NCT02113189|76170526|FG001|NOT COMPLETED|Overall Study||1||
60055073|NCT02113189|76170527|FG002|NOT COMPLETED|Overall Study||3||
60055074|NCT01440946|76170540|FG000|STARTED|Overall Study||15||
60055075|NCT01440946|76170541|FG001|STARTED|Overall Study||15||
60055076|NCT01440946|76170540|FG000|COMPLETED|Overall Study||13||
60055077|NCT01440946|76170541|FG001|COMPLETED|Overall Study||14||
60055078|NCT01440946|76170540|FG000|NOT COMPLETED|Overall Study||2||
60055079|NCT01440946|76170541|FG001|NOT COMPLETED|Overall Study||1||
60055080|NCT01450540|76170550|FG000|STARTED|Overall Study||123||
60055081|NCT01450540|76170551|FG001|STARTED|Overall Study||118||
60055082|NCT01450540|76170550|FG000|COMPLETED|Overall Study||101||
60055083|NCT01450540|76170551|FG001|COMPLETED|Overall Study||82||
60055084|NCT01450540|76170550|FG000|NOT COMPLETED|Overall Study||22||
60055085|NCT01450540|76170551|FG001|NOT COMPLETED|Overall Study||36||
60055086|NCT02070757|76170561|FG000|STARTED|Overall Study||362||
60055087|NCT02070757|76170562|FG001|STARTED|Overall Study||364||
60055088|NCT02070757|76170561|FG000|Treated Participants|Overall Study||361||
60055089|NCT02070757|76170562|FG001|Treated Participants|Overall Study||359||
60055090|NCT02070757|76170561|FG000|COMPLETED|Overall Study||245||
60055091|NCT02070757|76170562|FG001|COMPLETED|Overall Study||250||
60055092|NCT02070757|76170561|FG000|NOT COMPLETED|Overall Study||117||
60055093|NCT02070757|76170562|FG001|NOT COMPLETED|Overall Study||114||
60055094|NCT02100319|76170568|FG000|STARTED|Overall Study||387||
60055095|NCT02100319|76170568|FG000|COMPLETED|Overall Study||371||
59760562|NCT02399085|75880188|FG000|Received MOR00208 Only|Overall Study||1||
59760563|NCT02399085|75880188|FG000|Completed: Participants Who Were Still on Treatment at EOS|Overall Study||8||
59760564|NCT02399085|75880188|FG000|Not Completed: Participants Who Were no Longer Receiving Treatment at EOS|Overall Study||73||
59760565|NCT02399085|75880188|FG000|COMPLETED|Overall Study||8||
60055096|NCT02100319|76170568|FG000|NOT COMPLETED|Overall Study||16||
60055097|NCT01625845|76170574|FG000|STARTED|Overall Study||10||
60055098|NCT01625845|76170575|FG001|STARTED|Overall Study||6||
60055099|NCT01625845|76170574|FG000|COMPLETED|Overall Study||5||
60055100|NCT01625845|76170575|FG001|COMPLETED|Overall Study||3||
60055101|NCT01625845|76170574|FG000|NOT COMPLETED|Overall Study||5||
60055102|NCT01625845|76170575|FG001|NOT COMPLETED|Overall Study||3||
60055103|NCT01473940|76170585|FG000|STARTED|Induction Therapy||3||
60055104|NCT01473940|76170586|FG001|STARTED|Induction Therapy||4||
60055105|NCT01473940|76170587|FG002|STARTED|Induction Therapy||6||
60055106|NCT01473940|76170588|FG003|STARTED|Induction Therapy||8||
60055107|NCT01473940|76170585|FG000|Started Treatment|Induction Therapy||3||
60055108|NCT01473940|76170586|FG001|Started Treatment|Induction Therapy||4||
60055109|NCT01473940|76170587|FG002|Started Treatment|Induction Therapy||6||
60055110|NCT01473940|76170588|FG003|Started Treatment|Induction Therapy||8||
60055111|NCT01473940|76170585|FG000|Completed Induction- 12 Weeks|Induction Therapy||3||
60055112|NCT01473940|76170586|FG001|Completed Induction- 12 Weeks|Induction Therapy||3||
60055113|NCT01473940|76170587|FG002|Completed Induction- 12 Weeks|Induction Therapy||4||
60055114|NCT01473940|76170588|FG003|Completed Induction- 12 Weeks|Induction Therapy||7||
60055115|NCT01473940|76170585|FG000|COMPLETED|Induction Therapy||3||
60055116|NCT01473940|76170586|FG001|COMPLETED|Induction Therapy||3||
59760566|NCT02399085|75880188|FG000|NOT COMPLETED|Overall Study||73||
60055117|NCT01473940|76170587|FG002|COMPLETED|Induction Therapy||4||
60055118|NCT01473940|76170588|FG003|COMPLETED|Induction Therapy||7||
60055119|NCT01473940|76170585|FG000|NOT COMPLETED|Induction Therapy||0||
60055120|NCT01473940|76170586|FG001|NOT COMPLETED|Induction Therapy||1||
60055121|NCT01473940|76170587|FG002|NOT COMPLETED|Induction Therapy||2||
60055122|NCT01473940|76170588|FG003|NOT COMPLETED|Induction Therapy||1||
60055123|NCT01473940|76170585|FG000|STARTED|Maintenance Therapy||3||
60055124|NCT01473940|76170586|FG001|STARTED|Maintenance Therapy||3||
60055125|NCT01473940|76170587|FG002|STARTED|Maintenance Therapy||4||
60055126|NCT01473940|76170588|FG003|STARTED|Maintenance Therapy||7||
60055127|NCT01473940|76170585|FG000|Evaluated for Response|Maintenance Therapy||3||
60055128|NCT01473940|76170586|FG001|Evaluated for Response|Maintenance Therapy||3||
60055129|NCT01473940|76170587|FG002|Evaluated for Response|Maintenance Therapy||4||
60055130|NCT01473940|76170588|FG003|Evaluated for Response|Maintenance Therapy||7||
59515201|NCT03124342|75609008|FG001|COMPLETED|Overall Study||121||
59515202|NCT03124342|75609007|FG000|NOT COMPLETED|Overall Study||0||
59923833|NCT03120351|76043024|FG001|NOT COMPLETED|Overall Study||1||
59923834|NCT02354703|76043034|FG000|STARTED|Overall Study||12||
59923835|NCT02354703|76043035|FG001|STARTED|Overall Study||34||
59923836|NCT02354703|76043036|FG002|STARTED|Overall Study||39||
59923837|NCT02354703|76043037|FG003|STARTED|Overall Study||10||
59923838|NCT02354703|76043034|FG000|COMPLETED|Overall Study||9||
59923839|NCT02354703|76043035|FG001|COMPLETED|Overall Study||26||
59923840|NCT02354703|76043036|FG002|COMPLETED|Overall Study||28||
59923841|NCT02354703|76043037|FG003|COMPLETED|Overall Study||7||
59923842|NCT02354703|76043034|FG000|NOT COMPLETED|Overall Study||3||
59923843|NCT02354703|76043035|FG001|NOT COMPLETED|Overall Study||8||
59923844|NCT02354703|76043036|FG002|NOT COMPLETED|Overall Study||11||
59923845|NCT02354703|76043037|FG003|NOT COMPLETED|Overall Study||3||
59923846|NCT00740181|76043049|FG000|STARTED|Overall Study||9||
59923847|NCT00740181|76043049|FG000|COMPLETED|Overall Study||9||
59923848|NCT00740181|76043049|FG000|NOT COMPLETED|Overall Study||0||
59923849|NCT00384111|76043053|FG000|STARTED|Overall Study||26||
59923850|NCT00384111|76043053|FG000|COMPLETED|Overall Study||0||
59923851|NCT00384111|76043053|FG000|NOT COMPLETED|Overall Study||26||
59923852|NCT03113409|76043057|FG000|STARTED|Overall Study||10||
59923853|NCT03113409|76043058|FG001|STARTED|Overall Study|Study procedure was never started|0||
59923854|NCT03113409|76043059|FG002|STARTED|Overall Study|Study procedure was never started|0||
59923855|NCT03113409|76043057|FG000|COMPLETED|Overall Study||5||
59923856|NCT03113409|76043058|FG001|COMPLETED|Overall Study||0||
59923857|NCT03113409|76043059|FG002|COMPLETED|Overall Study||0||
59923858|NCT03113409|76043057|FG000|NOT COMPLETED|Overall Study||5||
59923859|NCT03113409|76043058|FG001|NOT COMPLETED|Overall Study||0||
59923860|NCT03113409|76043059|FG002|NOT COMPLETED|Overall Study||0||
59923861|NCT01319877|76043065|FG000|STARTED|Overall Study||453||
59923862|NCT01319877|76043066|FG001|STARTED|Overall Study||153||
59515203|NCT03124342|75609008|FG001|NOT COMPLETED|Overall Study||0||
59515204|NCT02163421|75609019|FG000|STARTED|Overall Study||12||
59515205|NCT02163421|75609020|FG001|STARTED|Overall Study||12||
59515206|NCT02163421|75609021|FG002|STARTED|Overall Study||12||
59923863|NCT01319877|76043065|FG000|COMPLETED|Overall Study||345||
59923864|NCT01319877|76043066|FG001|COMPLETED|Overall Study||108||
59923865|NCT01319877|76043065|FG000|NOT COMPLETED|Overall Study||108||
59923866|NCT01319877|76043066|FG001|NOT COMPLETED|Overall Study||45||
59923867|NCT03427073|76043079|FG000|STARTED|Overall Study||1||
59923868|NCT03427073|76043080|FG001|STARTED|Overall Study||1||
59923869|NCT03427073|76043081|FG002|STARTED|Overall Study||1||
59923870|NCT03427073|76043082|FG003|STARTED|Overall Study||3||
59923871|NCT03427073|76043083|FG004|STARTED|Overall Study||3||
59923872|NCT03427073|76043084|FG005|STARTED|Overall Study||4||
59923873|NCT03427073|76043085|FG006|STARTED|Overall Study||3||
59923874|NCT03427073|76043086|FG007|STARTED|Overall Study||4||
59923875|NCT03427073|76043079|FG000|COMPLETED|Overall Study||0||
59923876|NCT03427073|76043080|FG001|COMPLETED|Overall Study||0||
59923877|NCT03427073|76043081|FG002|COMPLETED|Overall Study||0||
59923878|NCT03427073|76043082|FG003|COMPLETED|Overall Study||0||
59923879|NCT03427073|76043083|FG004|COMPLETED|Overall Study||0||
59923880|NCT03427073|76043084|FG005|COMPLETED|Overall Study||0||
59923881|NCT03427073|76043085|FG006|COMPLETED|Overall Study||0||
59923882|NCT03427073|76043086|FG007|COMPLETED|Overall Study||0||
59923883|NCT03427073|76043079|FG000|NOT COMPLETED|Overall Study||1||
59923884|NCT03427073|76043080|FG001|NOT COMPLETED|Overall Study||1||
59923885|NCT03427073|76043081|FG002|NOT COMPLETED|Overall Study||1||
59923886|NCT03427073|76043082|FG003|NOT COMPLETED|Overall Study||3||
59923887|NCT03427073|76043083|FG004|NOT COMPLETED|Overall Study||3||
59515207|NCT02163421|75609022|FG003|STARTED|Overall Study||12||
59515208|NCT02163421|75609019|FG000|COMPLETED|Overall Study||12||
59515209|NCT02163421|75609020|FG001|COMPLETED|Overall Study||12||
59515210|NCT02163421|75609021|FG002|COMPLETED|Overall Study||12||
59515211|NCT02163421|75609022|FG003|COMPLETED|Overall Study||12||
59515212|NCT02163421|75609019|FG000|NOT COMPLETED|Overall Study||0||
59515213|NCT02163421|75609020|FG001|NOT COMPLETED|Overall Study||0||
59515214|NCT02163421|75609021|FG002|NOT COMPLETED|Overall Study||0||
59515215|NCT02163421|75609022|FG003|NOT COMPLETED|Overall Study||0||
59515216|NCT00979069|75609031|FG000|STARTED|Overall Study||10||
59515217|NCT00979069|75609032|FG001|STARTED|Overall Study||10||
59515218|NCT00979069|75609031|FG000|COMPLETED|Overall Study||10||
59515219|NCT00979069|75609032|FG001|COMPLETED|Overall Study||8||
59515220|NCT00979069|75609031|FG000|NOT COMPLETED|Overall Study||0||
59515221|NCT00979069|75609032|FG001|NOT COMPLETED|Overall Study||2||
59515222|NCT03124966|75609038|FG000|STARTED|Overall Study||118||
59515223|NCT03124966|75609038|FG000|COMPLETED|Overall Study||118||
59515224|NCT03124966|75609038|FG000|NOT COMPLETED|Overall Study||0||
59515225|NCT00979303|75609044|FG000|STARTED|Overall Study||37||
59515226|NCT00979303|75609045|FG001|STARTED|Overall Study||37||
59515227|NCT00979303|75609044|FG000|COMPLETED|Overall Study||37||
59515228|NCT00979303|75609045|FG001|COMPLETED|Overall Study||37||
59515229|NCT00979303|75609044|FG000|NOT COMPLETED|Overall Study||0||
59515230|NCT00979303|75609045|FG001|NOT COMPLETED|Overall Study||0||
59515231|NCT03126370|75609051|FG000|STARTED|TDF With a Boosted PI||10||
59515232|NCT03126370|75609051|FG000|COMPLETED|TDF With a Boosted PI||10||
59923888|NCT03427073|76043084|FG005|NOT COMPLETED|Overall Study||4||
59923889|NCT03427073|76043085|FG006|NOT COMPLETED|Overall Study||3||
59923890|NCT03427073|76043086|FG007|NOT COMPLETED|Overall Study||4||
59760567|NCT01317160|75880196|FG000|STARTED|Overall Study||75||
59760568|NCT01317160|75880197|FG001|STARTED|Overall Study||75||
59515233|NCT03126370|75609051|FG000|NOT COMPLETED|TDF With a Boosted PI||0||
59515234|NCT03126370|75609051|FG000|STARTED|TAF With a Boosted PI||10||
59515235|NCT03126370|75609051|FG000|COMPLETED|TAF With a Boosted PI||10||
59515236|NCT03126370|75609051|FG000|NOT COMPLETED|TAF With a Boosted PI||0||
59515237|NCT03126370|75609051|FG000|STARTED|TAF With a Boosted PI and LDV/SOF||10||
59515238|NCT03126370|75609051|FG000|COMPLETED|TAF With a Boosted PI and LDV/SOF||10||
59515239|NCT03126370|75609051|FG000|NOT COMPLETED|TAF With a Boosted PI and LDV/SOF||0||
59515240|NCT03126370|75609051|FG000|STARTED|TAF With a Boosted PI||10||
59515241|NCT03126370|75609051|FG000|COMPLETED|TAF With a Boosted PI||10||
59515242|NCT03126370|75609051|FG000|NOT COMPLETED|TAF With a Boosted PI||0||
59515243|NCT00979459|75609059|FG000|STARTED|First Intervention||6||
59515244|NCT00979459|75609060|FG001|STARTED|First Intervention||6||
59515245|NCT00979459|75609059|FG000|COMPLETED|First Intervention||6||
59515246|NCT00979459|75609060|FG001|COMPLETED|First Intervention||6||
59515247|NCT00979459|75609059|FG000|NOT COMPLETED|First Intervention||0||
59515248|NCT00979459|75609060|FG001|NOT COMPLETED|First Intervention||0||
59515249|NCT00979459|75609059|FG000|STARTED|7-day Washout Period||6||
59760569|NCT01317160|75880196|FG000|Allocation to Treatment|Overall Study|1 patient was incorrect included|74||
59760570|NCT01317160|75880197|FG001|Allocation to Treatment|Overall Study|1 patient was incorrect included|74||
59923891|NCT03066804|76043106|FG000|STARTED|Overall Study||1286||
59923892|NCT03066804|76043107|FG001|STARTED|Overall Study||1286||
59515250|NCT00979459|75609060|FG001|STARTED|7-day Washout Period||6||
59923893|NCT03066804|76043106|FG000|COMPLETED|Overall Study||1235||
59923894|NCT03066804|76043107|FG001|COMPLETED|Overall Study||1236||
59923895|NCT03066804|76043106|FG000|NOT COMPLETED|Overall Study||51||
59515251|NCT00979459|75609059|FG000|COMPLETED|7-day Washout Period||6||
59515252|NCT00979459|75609060|FG001|COMPLETED|7-day Washout Period||6||
59515253|NCT00979459|75609059|FG000|NOT COMPLETED|7-day Washout Period||0||
59515254|NCT00979459|75609060|FG001|NOT COMPLETED|7-day Washout Period||0||
59515255|NCT00979459|75609059|FG000|STARTED|Second Intervention||6||
59515256|NCT00979459|75609060|FG001|STARTED|Second Intervention||6||
59515257|NCT00979459|75609059|FG000|COMPLETED|Second Intervention||6||
59515258|NCT00979459|75609060|FG001|COMPLETED|Second Intervention||6||
59515259|NCT00979459|75609059|FG000|NOT COMPLETED|Second Intervention||0||
59515260|NCT00979459|75609060|FG001|NOT COMPLETED|Second Intervention||0||
59515261|NCT03126448|75609071|FG000|STARTED|Overall Study||56||
59515262|NCT03126448|75609072|FG001|STARTED|Overall Study||49||
59515263|NCT03126448|75609073|FG002|STARTED|Overall Study||37||
59515264|NCT03126448|75609071|FG000|COMPLETED|Overall Study||43||
59515265|NCT03126448|75609072|FG001|COMPLETED|Overall Study||41||
59515266|NCT03126448|75609073|FG002|COMPLETED|Overall Study||27||
59760571|NCT01317160|75880196|FG000|COMPLETED|Overall Study||71||
59923896|NCT03066804|76043107|FG001|NOT COMPLETED|Overall Study||50||
59515267|NCT03126448|75609071|FG000|NOT COMPLETED|Overall Study||13||
59515268|NCT03126448|75609072|FG001|NOT COMPLETED|Overall Study||8||
59515269|NCT03126448|75609073|FG002|NOT COMPLETED|Overall Study||10||
59515270|NCT01019707|75609081|FG000|STARTED|First Phase||3||
59515271|NCT01019707|75609082|FG001|STARTED|First Phase||3||
59515272|NCT01019707|75609081|FG000|COMPLETED|First Phase||3||
59515273|NCT01019707|75609082|FG001|COMPLETED|First Phase||3||
59515274|NCT01019707|75609081|FG000|NOT COMPLETED|First Phase||0||
59515275|NCT01019707|75609082|FG001|NOT COMPLETED|First Phase||0||
59515276|NCT01019707|75609081|FG000|STARTED|Washout||3||
59515277|NCT01019707|75609082|FG001|STARTED|Washout||3||
59515278|NCT01019707|75609081|FG000|COMPLETED|Washout||3||
59515279|NCT01019707|75609082|FG001|COMPLETED|Washout||1||
59515280|NCT01019707|75609081|FG000|NOT COMPLETED|Washout||0||
59515281|NCT01019707|75609082|FG001|NOT COMPLETED|Washout||2||
59515282|NCT01019707|75609081|FG000|STARTED|Second Phase||3||
59923897|NCT02954237|76043114|FG000|STARTED|Overall Study||91||
59923898|NCT02954237|76043114|FG000|COMPLETED|Overall Study||48||
59923899|NCT02954237|76043114|FG000|NOT COMPLETED|Overall Study||43||
59923900|NCT04250337|76043120|FG000|STARTED|Overall Study||75||
59923901|NCT04250337|76043121|FG001|STARTED|Overall Study||153||
59923902|NCT04250337|76043120|FG000|Received at Least One Dose of Study Drug|Overall Study||75||
59923903|NCT04250337|76043121|FG001|Received at Least One Dose of Study Drug|Overall Study||153||
59923904|NCT04250337|76043120|FG000|COMPLETED|Overall Study||67||
59923905|NCT04250337|76043121|FG001|COMPLETED|Overall Study||142||
59923906|NCT04250337|76043120|FG000|NOT COMPLETED|Overall Study||8||
59923907|NCT04250337|76043121|FG001|NOT COMPLETED|Overall Study||11||
59923908|NCT03118947|76043128|FG000|STARTED|Overall Study||78||
59923909|NCT03118947|76043128|FG000|COMPLETED|Overall Study||49||
59923910|NCT03118947|76043128|FG000|NOT COMPLETED|Overall Study||29||
59923911|NCT03953079|76043135|FG000|STARTED|Core Study||21||
59923912|NCT03953079|76043136|FG001|STARTED|Core Study||22||
59923913|NCT03953079|76043137|FG002|STARTED|Core Study||13||
59923914|NCT03953079|76043135|FG000|COMPLETED|Core Study||20||
60055131|NCT01473940|76170585|FG000|Went on to Start Maintenance Therapy|Maintenance Therapy||2||
60055132|NCT01473940|76170586|FG001|Went on to Start Maintenance Therapy|Maintenance Therapy||1||
60055133|NCT01473940|76170587|FG002|Went on to Start Maintenance Therapy|Maintenance Therapy||3||
59515283|NCT01019707|75609082|FG001|STARTED|Second Phase||1||
59515284|NCT01019707|75609081|FG000|COMPLETED|Second Phase||3||
59515285|NCT01019707|75609082|FG001|COMPLETED|Second Phase||1||
59515286|NCT01019707|75609081|FG000|NOT COMPLETED|Second Phase||0||
59515287|NCT01019707|75609082|FG001|NOT COMPLETED|Second Phase||0||
59515288|NCT00979615|75609090|FG000|STARTED|Overall Study||63||
59515289|NCT00979615|75609091|FG001|STARTED|Overall Study||66||
59515290|NCT00979615|75609090|FG000|COMPLETED|Overall Study||57||
59515291|NCT00979615|75609091|FG001|COMPLETED|Overall Study||58||
59515292|NCT00979615|75609090|FG000|NOT COMPLETED|Overall Study||6||
59515293|NCT00979615|75609091|FG001|NOT COMPLETED|Overall Study||8||
59515294|NCT03126682|75609099|FG000|STARTED|Overall Study||5||
59515295|NCT03126682|75609100|FG001|STARTED|Overall Study||5||
59515296|NCT03126682|75609099|FG000|COMPLETED|Overall Study||5||
59515297|NCT03126682|75609100|FG001|COMPLETED|Overall Study||5||
59515298|NCT03126682|75609099|FG000|NOT COMPLETED|Overall Study||0||
59515299|NCT03126682|75609100|FG001|NOT COMPLETED|Overall Study||0||
59923915|NCT03953079|76043136|FG001|COMPLETED|Core Study||18||
59923916|NCT03953079|76043137|FG002|COMPLETED|Core Study||12||
59923917|NCT03953079|76043135|FG000|NOT COMPLETED|Core Study||1||
59923918|NCT03953079|76043136|FG001|NOT COMPLETED|Core Study||4||
59923919|NCT03953079|76043137|FG002|NOT COMPLETED|Core Study||1||
59923920|NCT03953079|76043135|FG000|STARTED|Extension Study||12||
60055134|NCT01473940|76170588|FG003|Went on to Start Maintenance Therapy|Maintenance Therapy||3||
60055135|NCT01473940|76170585|FG000|COMPLETED|Maintenance Therapy||2||
60055136|NCT01473940|76170586|FG001|COMPLETED|Maintenance Therapy||1||
60055137|NCT01473940|76170587|FG002|COMPLETED|Maintenance Therapy||3||
60055138|NCT01473940|76170588|FG003|COMPLETED|Maintenance Therapy||3||
60055139|NCT01473940|76170585|FG000|NOT COMPLETED|Maintenance Therapy||1||
60055140|NCT01473940|76170586|FG001|NOT COMPLETED|Maintenance Therapy||2||
60055141|NCT01473940|76170587|FG002|NOT COMPLETED|Maintenance Therapy||1||
59515300|NCT00980395|75609106|FG000|STARTED|Overall Study||24||
59515301|NCT00980395|75609106|FG000|COMPLETED|Overall Study||24||
59515302|NCT00980395|75609106|FG000|NOT COMPLETED|Overall Study||0||
59515303|NCT03072550|75609110|FG000|STARTED|Overall Study||26||
60055142|NCT01473940|76170588|FG003|NOT COMPLETED|Maintenance Therapy||4||
59612976|NCT01694706|75724028|FG002|STARTED|Overall Study||5||
59923921|NCT03953079|76043136|FG001|STARTED|Extension Study||10||
59923922|NCT03953079|76043137|FG002|STARTED|Extension Study||6||
59923923|NCT03953079|76043135|FG000|COMPLETED|Extension Study||6|Completed Month 18 without receiving a rescue treatment.|
59923924|NCT03953079|76043136|FG001|COMPLETED|Extension Study||4|Completed Month 18 without receiving a rescue treatment.|
59923925|NCT03953079|76043137|FG002|COMPLETED|Extension Study||1|Completed Month 18 without receiving a rescue treatment.|
59923926|NCT03953079|76043135|FG000|NOT COMPLETED|Extension Study||6||
59923927|NCT03953079|76043136|FG001|NOT COMPLETED|Extension Study||6||
59923928|NCT03953079|76043137|FG002|NOT COMPLETED|Extension Study||5||
59923929|NCT04572399|76043146|FG000|STARTED|Overall Study||5||
60055143|NCT01473940|76170585|FG000|STARTED|Follow-up Until Death||3|All patients that receive at least one dose of study treatment go into the follow up phase.|
60055144|NCT01473940|76170586|FG001|STARTED|Follow-up Until Death||4|All patients that receive at least one dose of study treatment go into the follow up phase.|
60055145|NCT01473940|76170587|FG002|STARTED|Follow-up Until Death||5|All patients that receive at least one dose of study treatment go into the follow up phase.|
60055146|NCT01473940|76170588|FG003|STARTED|Follow-up Until Death||7|All patients that receive at least one dose of study treatment go into the follow up phase.|
60055147|NCT01473940|76170585|FG000|COMPLETED|Follow-up Until Death||3||
60055148|NCT01473940|76170586|FG001|COMPLETED|Follow-up Until Death||4||
60055149|NCT01473940|76170587|FG002|COMPLETED|Follow-up Until Death||5||
60055150|NCT01473940|76170588|FG003|COMPLETED|Follow-up Until Death||7||
60055151|NCT01473940|76170585|FG000|NOT COMPLETED|Follow-up Until Death||0||
60055152|NCT01473940|76170586|FG001|NOT COMPLETED|Follow-up Until Death||0||
60055153|NCT01473940|76170587|FG002|NOT COMPLETED|Follow-up Until Death||0||
60055154|NCT01473940|76170588|FG003|NOT COMPLETED|Follow-up Until Death||0||
60055155|NCT01832727|76170610|FG000|STARTED|Overall Study||9||
60055156|NCT01832727|76170611|FG001|STARTED|Overall Study||7||
60055157|NCT01832727|76170612|FG002|STARTED|Overall Study||3||
60055158|NCT01832727|76170613|FG003|STARTED|Overall Study||4||
60055159|NCT01832727|76170614|FG004|STARTED|Overall Study||4||
60055160|NCT01832727|76170615|FG005|STARTED|Overall Study||6||
60055161|NCT01832727|76170616|FG006|STARTED|Overall Study||8||
60055162|NCT01832727|76170617|FG007|STARTED|Overall Study||6||
60055163|NCT01832727|76170618|FG008|STARTED|Overall Study||18||
60055164|NCT01832727|76170610|FG000|COMPLETED|Overall Study||0||
60055165|NCT01832727|76170611|FG001|COMPLETED|Overall Study||0||
60055166|NCT01832727|76170612|FG002|COMPLETED|Overall Study||0||
60055167|NCT01832727|76170613|FG003|COMPLETED|Overall Study||0||
60055168|NCT01832727|76170614|FG004|COMPLETED|Overall Study||0||
60055169|NCT01832727|76170615|FG005|COMPLETED|Overall Study||0||
60055170|NCT01832727|76170616|FG006|COMPLETED|Overall Study||0||
60055171|NCT01832727|76170617|FG007|COMPLETED|Overall Study||0||
60055172|NCT01832727|76170618|FG008|COMPLETED|Overall Study||0||
60055173|NCT01832727|76170610|FG000|NOT COMPLETED|Overall Study||9||
60055174|NCT01832727|76170611|FG001|NOT COMPLETED|Overall Study||7||
60055175|NCT01832727|76170612|FG002|NOT COMPLETED|Overall Study||3||
60055176|NCT01832727|76170613|FG003|NOT COMPLETED|Overall Study||4||
60055177|NCT01832727|76170614|FG004|NOT COMPLETED|Overall Study||4||
60055178|NCT01832727|76170615|FG005|NOT COMPLETED|Overall Study||6||
60055179|NCT01832727|76170616|FG006|NOT COMPLETED|Overall Study||8||
60055180|NCT01832727|76170617|FG007|NOT COMPLETED|Overall Study||6||
60055181|NCT01832727|76170618|FG008|NOT COMPLETED|Overall Study||18||
59923930|NCT04572399|76043146|FG000|COMPLETED|Overall Study||5||
59923931|NCT04572399|76043146|FG000|NOT COMPLETED|Overall Study||0||
59923932|NCT03885999|76043150|FG000|STARTED|Overall Study||12||
59923933|NCT03885999|76043150|FG000|COMPLETED|Overall Study||11||
60055182|NCT01473394|76170649|FG000|STARTED|Overall Study||253||
60055183|NCT01473394|76170650|FG001|STARTED|Overall Study||255||
60055184|NCT01473394|76170649|FG000|COMPLETED|Overall Study||208||
60055185|NCT01473394|76170650|FG001|COMPLETED|Overall Study||212||
60055186|NCT01473394|76170649|FG000|NOT COMPLETED|Overall Study||45||
60055187|NCT01473394|76170650|FG001|NOT COMPLETED|Overall Study||43||
60055188|NCT01449682|76170658|FG000|STARTED|Overall Study||5||
60055189|NCT01449682|76170659|FG001|STARTED|Overall Study||5||
60055190|NCT01449682|76170658|FG000|COMPLETED|Overall Study||4||
60055191|NCT01449682|76170659|FG001|COMPLETED|Overall Study||4||
60055192|NCT01449682|76170658|FG000|NOT COMPLETED|Overall Study||1||
60055193|NCT01449682|76170659|FG001|NOT COMPLETED|Overall Study||1||
60055194|NCT01449526|76170667|FG000|STARTED|Overall Study||83||
60055195|NCT01449526|76170668|FG001|STARTED|Overall Study||83||
60055196|NCT01449526|76170667|FG000|COMPLETED|Overall Study||81||
60055197|NCT01449526|76170668|FG001|COMPLETED|Overall Study||77||
59515304|NCT03072550|75609110|FG000|COMPLETED|Overall Study||24||
60055198|NCT01449526|76170667|FG000|NOT COMPLETED|Overall Study||2||
60055199|NCT01449526|76170668|FG001|NOT COMPLETED|Overall Study||6||
60055200|NCT01440322|76170676|FG000|STARTED|Overall Study||97||
60055201|NCT01440322|76170677|FG001|STARTED|Overall Study||50||
60055202|NCT01440322|76170676|FG000|COMPLETED|Overall Study||90||
60055203|NCT01440322|76170677|FG001|COMPLETED|Overall Study||49||
60055204|NCT01440322|76170676|FG000|NOT COMPLETED|Overall Study||7||
60055205|NCT01440322|76170677|FG001|NOT COMPLETED|Overall Study||1||
60055206|NCT01832493|76170683|FG000|STARTED|Overall Study||50||
60055207|NCT01832493|76170683|FG000|COMPLETED|Overall Study||42||
60055208|NCT01832493|76170683|FG000|NOT COMPLETED|Overall Study||8||
60055209|NCT01831791|76170687|FG000|STARTED|Overall Study||120||
60055210|NCT01831791|76170687|FG000|COMPLETED|Overall Study||110||
60055211|NCT01831791|76170687|FG000|NOT COMPLETED|Overall Study||10||
60055212|NCT01857531|76170691|FG000|STARTED|Overall Study||16||
60055213|NCT01857531|76170691|FG000|COMPLETED|Overall Study||12||
60055214|NCT01857531|76170691|FG000|NOT COMPLETED|Overall Study||4||
60055215|NCT02166047|76170707|FG000|STARTED|Overall Study||16||
60055216|NCT02166047|76170708|FG001|STARTED|Overall Study||15||
60055217|NCT02166047|76170709|FG002|STARTED|Overall Study||16||
60055218|NCT02166047|76170710|FG003|STARTED|Overall Study||5||
60055219|NCT02166047|76170711|FG004|STARTED|Overall Study||18||
60055220|NCT02166047|76170712|FG005|STARTED|Overall Study||17||
60055221|NCT02166047|76170713|FG006|STARTED|Overall Study||17||
60055222|NCT02166047|76170714|FG007|STARTED|Overall Study||5||
60055223|NCT02166047|76170715|FG008|STARTED|Overall Study||16||
60055224|NCT02166047|76170716|FG009|STARTED|Overall Study||17||
60055225|NCT02166047|76170717|FG010|STARTED|Overall Study||14||
60055226|NCT02166047|76170718|FG011|STARTED|Overall Study||6||
60055227|NCT02166047|76170707|FG000|COMPLETED|Overall Study||16||
60055228|NCT02166047|76170708|FG001|COMPLETED|Overall Study||14||
60055229|NCT02166047|76170709|FG002|COMPLETED|Overall Study||14||
60055230|NCT02166047|76170710|FG003|COMPLETED|Overall Study||5||
60055231|NCT02166047|76170711|FG004|COMPLETED|Overall Study||17||
60055232|NCT02166047|76170712|FG005|COMPLETED|Overall Study||17||
60055233|NCT02166047|76170713|FG006|COMPLETED|Overall Study||15||
60055234|NCT02166047|76170714|FG007|COMPLETED|Overall Study||5||
60055235|NCT02166047|76170715|FG008|COMPLETED|Overall Study||16||
60055236|NCT02166047|76170716|FG009|COMPLETED|Overall Study||17||
60055237|NCT02166047|76170717|FG010|COMPLETED|Overall Study||12||
60055238|NCT02166047|76170718|FG011|COMPLETED|Overall Study||6||
60055239|NCT02166047|76170707|FG000|NOT COMPLETED|Overall Study||0||
60055240|NCT02166047|76170708|FG001|NOT COMPLETED|Overall Study||1||
60055241|NCT02166047|76170709|FG002|NOT COMPLETED|Overall Study||2||
60055242|NCT02166047|76170710|FG003|NOT COMPLETED|Overall Study||0||
60055243|NCT02166047|76170711|FG004|NOT COMPLETED|Overall Study||1||
60055244|NCT02166047|76170712|FG005|NOT COMPLETED|Overall Study||0||
60055245|NCT02166047|76170713|FG006|NOT COMPLETED|Overall Study||2||
60055246|NCT02166047|76170714|FG007|NOT COMPLETED|Overall Study||0||
60055247|NCT02166047|76170715|FG008|NOT COMPLETED|Overall Study||0||
60055248|NCT02166047|76170716|FG009|NOT COMPLETED|Overall Study||0||
60055249|NCT02166047|76170717|FG010|NOT COMPLETED|Overall Study||2||
60055250|NCT02166047|76170718|FG011|NOT COMPLETED|Overall Study||0||
60055251|NCT01493284|76170744|FG000|STARTED|Overall Study||222||
59515305|NCT03072550|75609110|FG000|NOT COMPLETED|Overall Study||2||
59515306|NCT01021111|75609114|FG000|STARTED|Overall Study||17||
59515307|NCT01021111|75609114|FG000|COMPLETED|Overall Study||17||
59515308|NCT01021111|75609114|FG000|NOT COMPLETED|Overall Study||0||
59515309|NCT00980785|75609120|FG000|STARTED|Overall Study||6||
60055252|NCT01493284|76170744|FG000|COMPLETED|Overall Study||161||
60055253|NCT01493284|76170744|FG000|NOT COMPLETED|Overall Study||61||
60055254|NCT02165735|76170750|FG000|STARTED|Overall Study||180||
60055255|NCT02165735|76170751|FG001|STARTED|Overall Study||180||
60055256|NCT02165735|76170750|FG000|COMPLETED|Overall Study||164||
60055257|NCT02165735|76170751|FG001|COMPLETED|Overall Study||166||
60055258|NCT02165735|76170750|FG000|NOT COMPLETED|Overall Study||16||
59515310|NCT00980785|75609121|FG001|STARTED|Overall Study||8||
59515311|NCT00980785|75609120|FG000|COMPLETED|Overall Study||6||
60055259|NCT02165735|76170751|FG001|NOT COMPLETED|Overall Study||14||
60055260|NCT02069899|76170760|FG000|STARTED|Overall Study||37||
60055261|NCT02069899|76170761|FG001|STARTED|Overall Study||14||
60055262|NCT02069899|76170762|FG002|STARTED|Overall Study||7||
60055263|NCT02069899|76170760|FG000|Treated in Current Study|Overall Study||22||
60055264|NCT02069899|76170761|FG001|Treated in Current Study|Overall Study||0||
60055265|NCT02069899|76170762|FG002|Treated in Current Study|Overall Study||5||
60055266|NCT02069899|76170760|FG000|COMPLETED|Overall Study||24||
60055267|NCT02069899|76170761|FG001|COMPLETED|Overall Study||13||
60055268|NCT02069899|76170762|FG002|COMPLETED|Overall Study||4||
60055269|NCT02069899|76170760|FG000|NOT COMPLETED|Overall Study||13||
60055270|NCT02069899|76170761|FG001|NOT COMPLETED|Overall Study||1||
60055271|NCT02069899|76170762|FG002|NOT COMPLETED|Overall Study||3||
60055272|NCT01831089|76170777|FG000|STARTED|Cohort I: Dose Level 1||3||
60055273|NCT01831089|76170778|FG001|STARTED|Cohort I: Dose Level 1||0||
60055274|NCT01831089|76170779|FG002|STARTED|Cohort I: Dose Level 1||0||
60055275|NCT01831089|76170780|FG003|STARTED|Cohort I: Dose Level 1||0||
60055276|NCT01831089|76170781|FG004|STARTED|Cohort I: Dose Level 1||0||
60055277|NCT01831089|76170782|FG005|STARTED|Cohort I: Dose Level 1||0||
60055278|NCT01831089|76170777|FG000|COMPLETED|Cohort I: Dose Level 1||0||
60055279|NCT01831089|76170778|FG001|COMPLETED|Cohort I: Dose Level 1||0||
60055280|NCT01831089|76170779|FG002|COMPLETED|Cohort I: Dose Level 1||0||
60055281|NCT01831089|76170780|FG003|COMPLETED|Cohort I: Dose Level 1||0||
60055282|NCT01831089|76170781|FG004|COMPLETED|Cohort I: Dose Level 1||0||
60055283|NCT01831089|76170782|FG005|COMPLETED|Cohort I: Dose Level 1||0||
60055284|NCT01831089|76170777|FG000|NOT COMPLETED|Cohort I: Dose Level 1||3||
59923934|NCT03885999|76043150|FG000|NOT COMPLETED|Overall Study||1||
59923935|NCT03879525|76043156|FG000|STARTED|Overall Study||15||
59923936|NCT03879525|76043157|FG001|STARTED|Overall Study||15||
60055285|NCT01831089|76170778|FG001|NOT COMPLETED|Cohort I: Dose Level 1||0||
60055286|NCT01831089|76170779|FG002|NOT COMPLETED|Cohort I: Dose Level 1||0||
60055287|NCT01831089|76170780|FG003|NOT COMPLETED|Cohort I: Dose Level 1||0||
60055288|NCT01831089|76170781|FG004|NOT COMPLETED|Cohort I: Dose Level 1||0||
60055289|NCT01831089|76170782|FG005|NOT COMPLETED|Cohort I: Dose Level 1||0||
60055290|NCT01831089|76170777|FG000|STARTED|Cohort II: Dose Level 2||0||
60055291|NCT01831089|76170778|FG001|STARTED|Cohort II: Dose Level 2||3||
60055292|NCT01831089|76170779|FG002|STARTED|Cohort II: Dose Level 2||0||
60055293|NCT01831089|76170780|FG003|STARTED|Cohort II: Dose Level 2||0||
60055294|NCT01831089|76170781|FG004|STARTED|Cohort II: Dose Level 2||0||
60055295|NCT01831089|76170782|FG005|STARTED|Cohort II: Dose Level 2||0||
59515312|NCT00980785|75609121|FG001|COMPLETED|Overall Study||8||
59515313|NCT00980785|75609120|FG000|NOT COMPLETED|Overall Study||0||
59515314|NCT00980785|75609121|FG001|NOT COMPLETED|Overall Study||0||
59515315|NCT00981253|75609129|FG000|STARTED|Overall Study||76||
59515316|NCT00981253|75609130|FG001|STARTED|Overall Study||75||
59515317|NCT00981253|75609129|FG000|COMPLETED|Overall Study||73||
59515318|NCT00981253|75609130|FG001|COMPLETED|Overall Study||72||
59515319|NCT00981253|75609129|FG000|NOT COMPLETED|Overall Study||3||
59515320|NCT00981253|75609130|FG001|NOT COMPLETED|Overall Study||3||
59515321|NCT03126760|75609139|FG000|STARTED|Overall Study||18||
59515322|NCT03126760|75609140|FG001|STARTED|Overall Study||17||
59515323|NCT03126760|75609139|FG000|Modified Intent to Treat (mITT)|Overall Study||18|All participants who received study treatment|
59515324|NCT03126760|75609140|FG001|Modified Intent to Treat (mITT)|Overall Study||17|All participants who received study treatment|
59515325|NCT03126760|75609139|FG000|Completed Treatment|Overall Study|One participant halted treatment for adverse event, but completed the study|17||
59515326|NCT03126760|75609140|FG001|Completed Treatment|Overall Study||17||
59515327|NCT03126760|75609139|FG000|COMPLETED|Overall Study||18||
59515328|NCT03126760|75609140|FG001|COMPLETED|Overall Study||17||
59515329|NCT03126760|75609139|FG000|NOT COMPLETED|Overall Study||0||
59515330|NCT03126760|75609140|FG001|NOT COMPLETED|Overall Study||0||
59515331|NCT00982033|75609148|FG000|STARTED|Overall Study||25||
59515332|NCT00982033|75609149|FG001|STARTED|Overall Study||27||
59515333|NCT00982033|75609148|FG000|COMPLETED|Overall Study||25||
59515334|NCT00982033|75609149|FG001|COMPLETED|Overall Study||27||
59515335|NCT00982033|75609148|FG000|NOT COMPLETED|Overall Study||0||
59923937|NCT03879525|76043156|FG000|COMPLETED|Overall Study||15||
59923938|NCT03879525|76043157|FG001|COMPLETED|Overall Study||15||
59923939|NCT03879525|76043156|FG000|NOT COMPLETED|Overall Study||0||
59923940|NCT03879525|76043157|FG001|NOT COMPLETED|Overall Study||0||
59923941|NCT03108027|76043164|FG000|STARTED|Period 1||7||
60055296|NCT01831089|76170777|FG000|COMPLETED|Cohort II: Dose Level 2||0||
60055297|NCT01831089|76170778|FG001|COMPLETED|Cohort II: Dose Level 2||0||
59515336|NCT00982033|75609149|FG001|NOT COMPLETED|Overall Study||0||
59515337|NCT03127228|75609157|FG000|STARTED|Overall Study||12||
59515338|NCT03127228|75609158|FG001|STARTED|Overall Study||12||
59515339|NCT03127228|75609157|FG000|COMPLETED|Overall Study||12||
59515340|NCT03127228|75609158|FG001|COMPLETED|Overall Study||12||
59515341|NCT03127228|75609157|FG000|NOT COMPLETED|Overall Study||0||
59923942|NCT03108027|76043165|FG001|STARTED|Period 1||6||
59923943|NCT03108027|76043166|FG002|STARTED|Period 1||6||
59923944|NCT03108027|76043167|FG003|STARTED|Period 1||6||
59923945|NCT03108027|76043168|FG004|STARTED|Period 1||6||
59923946|NCT03108027|76043169|FG005|STARTED|Period 1||6||
59923947|NCT03108027|76043164|FG000|COMPLETED|Period 1||7||
59923948|NCT03108027|76043165|FG001|COMPLETED|Period 1||6||
59923949|NCT03108027|76043166|FG002|COMPLETED|Period 1||6||
60055298|NCT01831089|76170779|FG002|COMPLETED|Cohort II: Dose Level 2||0||
60055299|NCT01831089|76170780|FG003|COMPLETED|Cohort II: Dose Level 2||0||
60055300|NCT01831089|76170781|FG004|COMPLETED|Cohort II: Dose Level 2||0||
60055301|NCT01831089|76170782|FG005|COMPLETED|Cohort II: Dose Level 2||0||
60055302|NCT01831089|76170777|FG000|NOT COMPLETED|Cohort II: Dose Level 2||0||
60055303|NCT01831089|76170778|FG001|NOT COMPLETED|Cohort II: Dose Level 2||3||
60055304|NCT01831089|76170779|FG002|NOT COMPLETED|Cohort II: Dose Level 2||0||
60055305|NCT01831089|76170780|FG003|NOT COMPLETED|Cohort II: Dose Level 2||0||
60055306|NCT01831089|76170781|FG004|NOT COMPLETED|Cohort II: Dose Level 2||0||
60055307|NCT01831089|76170782|FG005|NOT COMPLETED|Cohort II: Dose Level 2||0||
60055308|NCT01831089|76170777|FG000|STARTED|Cohort III: Dose Level 3||0||
60055309|NCT01831089|76170778|FG001|STARTED|Cohort III: Dose Level 3||0||
59515342|NCT03127228|75609158|FG001|NOT COMPLETED|Overall Study||0||
59923950|NCT03108027|76043167|FG003|COMPLETED|Period 1||4||
60055310|NCT01831089|76170779|FG002|STARTED|Cohort III: Dose Level 3||6||
60055311|NCT01831089|76170780|FG003|STARTED|Cohort III: Dose Level 3||0||
60055312|NCT01831089|76170781|FG004|STARTED|Cohort III: Dose Level 3||0||
60055313|NCT01831089|76170782|FG005|STARTED|Cohort III: Dose Level 3||0||
60055314|NCT01831089|76170777|FG000|COMPLETED|Cohort III: Dose Level 3||0||
60055315|NCT01831089|76170778|FG001|COMPLETED|Cohort III: Dose Level 3||0||
60055316|NCT01831089|76170779|FG002|COMPLETED|Cohort III: Dose Level 3||0||
60055317|NCT01831089|76170780|FG003|COMPLETED|Cohort III: Dose Level 3||0||
59515343|NCT00982189|75609168|FG000|STARTED|Overall Study||10||
59515344|NCT00982189|75609169|FG001|STARTED|Overall Study||9||
59923951|NCT03108027|76043168|FG004|COMPLETED|Period 1||6||
59923952|NCT03108027|76043169|FG005|COMPLETED|Period 1||6||
59923953|NCT03108027|76043164|FG000|NOT COMPLETED|Period 1||0||
59923954|NCT03108027|76043165|FG001|NOT COMPLETED|Period 1||0||
59923955|NCT03108027|76043166|FG002|NOT COMPLETED|Period 1||0||
59923956|NCT03108027|76043167|FG003|NOT COMPLETED|Period 1||2||
59923957|NCT03108027|76043168|FG004|NOT COMPLETED|Period 1||0||
59923958|NCT03108027|76043169|FG005|NOT COMPLETED|Period 1||0||
59923959|NCT03108027|76043164|FG000|STARTED|Period 2||7||
59923960|NCT03108027|76043165|FG001|STARTED|Period 2||6||
59923961|NCT03108027|76043166|FG002|STARTED|Period 2||6||
59923962|NCT03108027|76043167|FG003|STARTED|Period 2||4||
59923963|NCT03108027|76043168|FG004|STARTED|Period 2||6||
59923964|NCT03108027|76043169|FG005|STARTED|Period 2||6||
59923965|NCT03108027|76043164|FG000|COMPLETED|Period 2||7||
59923966|NCT03108027|76043165|FG001|COMPLETED|Period 2||6||
59923967|NCT03108027|76043166|FG002|COMPLETED|Period 2||6||
59923968|NCT03108027|76043167|FG003|COMPLETED|Period 2||4||
59923969|NCT03108027|76043168|FG004|COMPLETED|Period 2||6||
59923970|NCT03108027|76043169|FG005|COMPLETED|Period 2||6||
59923971|NCT03108027|76043164|FG000|NOT COMPLETED|Period 2||0||
59923972|NCT03108027|76043165|FG001|NOT COMPLETED|Period 2||0||
59923973|NCT03108027|76043166|FG002|NOT COMPLETED|Period 2||0||
59923974|NCT03108027|76043167|FG003|NOT COMPLETED|Period 2||0||
59923975|NCT03108027|76043168|FG004|NOT COMPLETED|Period 2||0||
59923976|NCT03108027|76043169|FG005|NOT COMPLETED|Period 2||0||
59923977|NCT03108027|76043164|FG000|STARTED|Period 3||7||
59923978|NCT03108027|76043165|FG001|STARTED|Period 3||6||
59923979|NCT03108027|76043166|FG002|STARTED|Period 3||6||
59923980|NCT03108027|76043167|FG003|STARTED|Period 3||4||
59923981|NCT03108027|76043168|FG004|STARTED|Period 3||6||
59923982|NCT03108027|76043169|FG005|STARTED|Period 3||6||
59923983|NCT03108027|76043164|FG000|COMPLETED|Period 3||7||
59923984|NCT03108027|76043165|FG001|COMPLETED|Period 3||5||
59923985|NCT03108027|76043166|FG002|COMPLETED|Period 3||6||
59923986|NCT03108027|76043167|FG003|COMPLETED|Period 3||4||
59923987|NCT03108027|76043168|FG004|COMPLETED|Period 3||6||
59923988|NCT03108027|76043169|FG005|COMPLETED|Period 3||6||
59923989|NCT03108027|76043164|FG000|NOT COMPLETED|Period 3||0||
59923990|NCT03108027|76043165|FG001|NOT COMPLETED|Period 3||1||
59923991|NCT03108027|76043166|FG002|NOT COMPLETED|Period 3||0||
59923992|NCT03108027|76043167|FG003|NOT COMPLETED|Period 3||0||
59923993|NCT03108027|76043168|FG004|NOT COMPLETED|Period 3||0||
59923994|NCT03108027|76043169|FG005|NOT COMPLETED|Period 3||0||
59923995|NCT03713073|76043177|FG000|STARTED|Overall Study||19||38
59923996|NCT03713073|76043177|FG000|Allogenic Amnion Chorion Membrane|Overall Study||19||19
59923997|NCT03713073|76043177|FG000|Collagen Dressing|Overall Study||19||19
59923998|NCT03713073|76043177|FG000|COMPLETED|Overall Study||19||38
60055318|NCT01831089|76170781|FG004|COMPLETED|Cohort III: Dose Level 3||0||
60055319|NCT01831089|76170782|FG005|COMPLETED|Cohort III: Dose Level 3||0||
60055320|NCT01831089|76170777|FG000|NOT COMPLETED|Cohort III: Dose Level 3||0||
60055321|NCT01831089|76170778|FG001|NOT COMPLETED|Cohort III: Dose Level 3||0||
60055322|NCT01831089|76170779|FG002|NOT COMPLETED|Cohort III: Dose Level 3||6||
59515345|NCT00982189|75609170|FG002|STARTED|Overall Study||9||
59515346|NCT00982189|75609171|FG003|STARTED|Overall Study||9||
59515347|NCT00982189|75609168|FG000|COMPLETED|Overall Study||10||
60055323|NCT01831089|76170780|FG003|NOT COMPLETED|Cohort III: Dose Level 3||0||
60055324|NCT01831089|76170781|FG004|NOT COMPLETED|Cohort III: Dose Level 3||0||
59515348|NCT00982189|75609169|FG001|COMPLETED|Overall Study||9||
59923999|NCT03713073|76043177|FG000|NOT COMPLETED|Overall Study||0||0
59924000|NCT03107715|76043185|FG000|STARTED|Overall Study||132||
59924001|NCT03107715|76043186|FG001|STARTED|Overall Study||111||
59924002|NCT03107715|76043185|FG000|COMPLETED|Overall Study||128||
59924003|NCT03107715|76043186|FG001|COMPLETED|Overall Study||104||
59924004|NCT03107715|76043185|FG000|NOT COMPLETED|Overall Study||4||
59924005|NCT03107715|76043186|FG001|NOT COMPLETED|Overall Study||7||
59924006|NCT03567057|76043195|FG000|STARTED|Overall Study||159||
59924007|NCT03567057|76043196|FG001|STARTED|Overall Study||151||
59924008|NCT03567057|76043197|FG002|STARTED|Overall Study||114||
59924009|NCT03567057|76043195|FG000|COMPLETED|Overall Study||64||
59924010|NCT03567057|76043196|FG001|COMPLETED|Overall Study||64||
59924011|NCT03567057|76043197|FG002|COMPLETED|Overall Study||68||
59924012|NCT03567057|76043195|FG000|NOT COMPLETED|Overall Study||95||
60055325|NCT01831089|76170782|FG005|NOT COMPLETED|Cohort III: Dose Level 3||0||
59515349|NCT00982189|75609170|FG002|COMPLETED|Overall Study||9||
59515350|NCT00982189|75609171|FG003|COMPLETED|Overall Study||9||
59924013|NCT03567057|76043196|FG001|NOT COMPLETED|Overall Study||87||
59924014|NCT03567057|76043197|FG002|NOT COMPLETED|Overall Study||46||
60055326|NCT01831089|76170777|FG000|STARTED|Cohort IV: Dose Level 4||0||
60055327|NCT01831089|76170778|FG001|STARTED|Cohort IV: Dose Level 4||0||
59924015|NCT04388787|76043205|FG000|STARTED|Blinded Period||16||
60055328|NCT01831089|76170779|FG002|STARTED|Cohort IV: Dose Level 4||0||
59515351|NCT00982189|75609168|FG000|NOT COMPLETED|Overall Study||0||
59515352|NCT00982189|75609169|FG001|NOT COMPLETED|Overall Study||0||
59515353|NCT00982189|75609170|FG002|NOT COMPLETED|Overall Study||0||
59924016|NCT04388787|76043205|FG000|Completed First Assessment - Approximately 15 Minutes (Specific Treatment Unknown)|Blinded Period||15||
59924017|NCT04388787|76043205|FG000|Completed Second Assessment - Approximately 15 Minutes (Specific Treatment Unknown)|Blinded Period||15||
59924018|NCT04388787|76043205|FG000|COMPLETED|Blinded Period||15||
59924019|NCT04388787|76043205|FG000|NOT COMPLETED|Blinded Period||1||
59924020|NCT04388787|76043205|FG000|STARTED|Unblinded Period||15||
59924021|NCT04388787|76043205|FG000|COMPLETED|Unblinded Period||6||
59924022|NCT04388787|76043205|FG000|NOT COMPLETED|Unblinded Period||9||
59924023|NCT03057600|76043217|FG000|STARTED|Overall Study||9||
59924024|NCT03057600|76043218|FG001|STARTED|Overall Study||10||
59924025|NCT03057600|76043219|FG002|STARTED|Overall Study||20||
59924026|NCT03057600|76043220|FG003|STARTED|Overall Study||13||
59924027|NCT03057600|76043217|FG000|COMPLETED|Overall Study||0||
59924028|NCT03057600|76043218|FG001|COMPLETED|Overall Study||0||
59924029|NCT03057600|76043219|FG002|COMPLETED|Overall Study||0||
59924030|NCT03057600|76043220|FG003|COMPLETED|Overall Study||0||
59924031|NCT03057600|76043217|FG000|NOT COMPLETED|Overall Study||9||
59924032|NCT03057600|76043218|FG001|NOT COMPLETED|Overall Study||10||
59924033|NCT03057600|76043219|FG002|NOT COMPLETED|Overall Study||20||
59924034|NCT03057600|76043220|FG003|NOT COMPLETED|Overall Study||13||
59924035|NCT04355169|76043235|FG000|STARTED|Overall Study||0||
59924036|NCT04355169|76043236|FG001|STARTED|Overall Study||0||
59924037|NCT04355169|76043237|FG002|STARTED|Overall Study||0||
59924038|NCT04355169|76043238|FG003|STARTED|Overall Study||0||
59924039|NCT04355169|76043235|FG000|COMPLETED|Overall Study||0||
59924040|NCT04355169|76043236|FG001|COMPLETED|Overall Study||0||
59924041|NCT04355169|76043237|FG002|COMPLETED|Overall Study||0||
59924042|NCT04355169|76043238|FG003|COMPLETED|Overall Study||0||
59924043|NCT04355169|76043235|FG000|NOT COMPLETED|Overall Study||0||
59924044|NCT04355169|76043236|FG001|NOT COMPLETED|Overall Study||0||
59924045|NCT04355169|76043237|FG002|NOT COMPLETED|Overall Study||0||
59924046|NCT04355169|76043238|FG003|NOT COMPLETED|Overall Study||0||
59924047|NCT03371823|76043250|FG000|STARTED|Overall Study||8||
59924048|NCT03371823|76043251|FG001|STARTED|Overall Study|We had trouble enrolling naive to therapy women with high blood pressure|0||
59924049|NCT03371823|76043250|FG000|COMPLETED|Overall Study||7||
59924050|NCT03371823|76043251|FG001|COMPLETED|Overall Study||0||
59924051|NCT03371823|76043250|FG000|NOT COMPLETED|Overall Study||1||
59924052|NCT03371823|76043251|FG001|NOT COMPLETED|Overall Study||0||
59924053|NCT03879642|76043259|FG000|STARTED|Overall Study||22||
59924054|NCT03879642|76043260|FG001|STARTED|Overall Study||21||
59924055|NCT03879642|76043259|FG000|COMPLETED|Overall Study||19||
59924056|NCT03879642|76043260|FG001|COMPLETED|Overall Study||18||
59924057|NCT03879642|76043259|FG000|NOT COMPLETED|Overall Study||3||
59924058|NCT03879642|76043260|FG001|NOT COMPLETED|Overall Study||3||
59924059|NCT02966301|76043266|FG000|STARTED|Overall Study||21||
59924060|NCT02966301|76043266|FG000|Full Analysis Set (FAS)|Overall Study|All patients who entered the study, completed their first cycle of ATO (11 infusions) and for whom the response at Week 6 after diagnosis of chronic GvHD has been evaluated.|20||
59924061|NCT02966301|76043266|FG000|Safety Analysis (SA)|Overall Study|All patients included in the study for whom received at least one ATO infusion. One patient received 2 infusions and then exited the study due to SAE (reversible liver toxicity).|21||
59924062|NCT02966301|76043266|FG000|COMPLETED|Overall Study||18||
59924063|NCT02966301|76043266|FG000|NOT COMPLETED|Overall Study||3||
59924064|NCT03107091|76043270|FG000|STARTED|Overall Study||6||
59924065|NCT03107091|76043270|FG000|COMPLETED|Overall Study||5||
59924066|NCT03107091|76043270|FG000|NOT COMPLETED|Overall Study||1||
59924067|NCT03849768|76043277|FG000|STARTED|Overall Study||214||
59924068|NCT03849768|76043278|FG001|STARTED|Overall Study||215||
59924069|NCT03849768|76043277|FG000|COMPLETED|Overall Study||121||
59924070|NCT03849768|76043278|FG001|COMPLETED|Overall Study||181||
59924071|NCT03849768|76043277|FG000|NOT COMPLETED|Overall Study||93||
59924072|NCT03849768|76043278|FG001|NOT COMPLETED|Overall Study||34||
59924073|NCT03065400|76043284|FG000|STARTED|Overall Study||10||
59924074|NCT03065400|76043284|FG000|COMPLETED|Overall Study||0||
59924075|NCT03065400|76043284|FG000|NOT COMPLETED|Overall Study||10||
59924076|NCT03085095|76043290|FG000|STARTED|Overall Study||624||
59924077|NCT03085095|76043291|FG001|STARTED|Overall Study||310||
60055329|NCT01831089|76170780|FG003|STARTED|Cohort IV: Dose Level 4||6||
60055330|NCT01831089|76170781|FG004|STARTED|Cohort IV: Dose Level 4||0||
60055331|NCT01831089|76170782|FG005|STARTED|Cohort IV: Dose Level 4||0||
59515354|NCT00982189|75609171|FG003|NOT COMPLETED|Overall Study||0||
59951528|NCT02607930|76070543|FG000|NOT COMPLETED|Double-Blinded Treatment Phase||54||
59515355|NCT03128008|75609183|FG000|STARTED|Overall Study||10||
59515356|NCT03128008|75609183|FG000|COMPLETED|Overall Study|9 participants are in follow up|1||
59515357|NCT03128008|75609183|FG000|NOT COMPLETED|Overall Study||9||
59515358|NCT03128086|75609190|FG000|STARTED|Overall Study||50||
59515359|NCT03128086|75609191|FG001|STARTED|Overall Study||44||
59515360|NCT03128086|75609190|FG000|COMPLETED|Overall Study||50||
59515361|NCT03128086|75609191|FG001|COMPLETED|Overall Study||44||
59612977|NCT01694706|75724026|FG000|Received Faldaprevir|Overall Study||5||
59612978|NCT01694706|75724027|FG001|Received Faldaprevir|Overall Study||5||
59612979|NCT01694706|75724028|FG002|Received Faldaprevir|Overall Study||5||
59612980|NCT01694706|75724026|FG000|Received Faldaprevir +OMP|Overall Study||5||
59612981|NCT01694706|75724027|FG001|Received Faldaprevir +OMP|Overall Study||5||
59612982|NCT01694706|75724028|FG002|Received Faldaprevir +OMP|Overall Study||5||
59612983|NCT01694706|75724026|FG000|Received Faldaprevir Fed|Overall Study||4||
59924078|NCT03085095|76043290|FG000|Received at Least 1 Dose of Study Drug|Overall Study||622|Four participants (2 in each treatment group) were randomized but did not receive study drug.|
59924079|NCT03085095|76043291|FG001|Received at Least 1 Dose of Study Drug|Overall Study||308|Four participants (2 in each treatment group) were randomized but did not receive study drug.|
59924080|NCT03085095|76043290|FG000|COMPLETED|Overall Study||563|Completed 48 weeks of treatment.|
59924081|NCT03085095|76043291|FG001|COMPLETED|Overall Study||276|Completed 48 weeks of treatment.|
59924082|NCT03085095|76043290|FG000|NOT COMPLETED|Overall Study||61||
59924083|NCT03085095|76043291|FG001|NOT COMPLETED|Overall Study||34||
59924084|NCT04097301|76043300|FG000|STARTED|Overall Study|Enrolled patients. Overall, 8 patients were enrolled in the study and underwent the screening phase to evaluate the compliance to the clinical inclusion / exclusion criteria as well as the CD44v6 expression by tumor cells.|8||
59924085|NCT04097301|76043300|FG000|Treated Patients|Overall Study|Of the 8 enrolled patients, 2 were treated with MLM-CAR44.1 T-cell at the first dose level.|2||
59924086|NCT04097301|76043300|FG000|COMPLETED|Overall Study||1||
59924087|NCT04097301|76043300|FG000|NOT COMPLETED|Overall Study||7||
59924088|NCT02276547|76043306|FG000|STARTED|Overall Study||27||
59924089|NCT02276547|76043306|FG000|COMPLETED|Overall Study||23||
59924090|NCT02276547|76043306|FG000|NOT COMPLETED|Overall Study||4||
59924091|NCT02966834|76043316|FG000|STARTED|Main Study Period (Up to 12 Weeks)||36||
59924092|NCT02966834|76043317|FG001|STARTED|Main Study Period (Up to 12 Weeks)||16||
59924093|NCT02966834|76043318|FG002|STARTED|Main Study Period (Up to 12 Weeks)||23||
59924094|NCT02966834|76043319|FG003|STARTED|Main Study Period (Up to 12 Weeks)||27||
59924095|NCT02966834|76043320|FG004|STARTED|Main Study Period (Up to 12 Weeks)||23||
59924096|NCT02966834|76043321|FG005|STARTED|Main Study Period (Up to 12 Weeks)||22||
59924097|NCT02966834|76043316|FG000|COMPLETED|Main Study Period (Up to 12 Weeks)||35||
59924098|NCT02966834|76043317|FG001|COMPLETED|Main Study Period (Up to 12 Weeks)||16||
59924099|NCT02966834|76043318|FG002|COMPLETED|Main Study Period (Up to 12 Weeks)||19||
59924100|NCT02966834|76043319|FG003|COMPLETED|Main Study Period (Up to 12 Weeks)||19||
59924101|NCT02966834|76043320|FG004|COMPLETED|Main Study Period (Up to 12 Weeks)||22||
59924102|NCT02966834|76043321|FG005|COMPLETED|Main Study Period (Up to 12 Weeks)||17||
59924103|NCT02966834|76043316|FG000|NOT COMPLETED|Main Study Period (Up to 12 Weeks)||1||
59924104|NCT02966834|76043317|FG001|NOT COMPLETED|Main Study Period (Up to 12 Weeks)||0||
59924105|NCT02966834|76043318|FG002|NOT COMPLETED|Main Study Period (Up to 12 Weeks)||4||
59924106|NCT02966834|76043319|FG003|NOT COMPLETED|Main Study Period (Up to 12 Weeks)||8||
59924107|NCT02966834|76043320|FG004|NOT COMPLETED|Main Study Period (Up to 12 Weeks)||1||
59924108|NCT02966834|76043321|FG005|NOT COMPLETED|Main Study Period (Up to 12 Weeks)||5||
59924109|NCT02966834|76043316|FG000|STARTED|Final Study Period (Up to 4 Weeks)||35||
59924110|NCT02966834|76043317|FG001|STARTED|Final Study Period (Up to 4 Weeks)||16||
59924111|NCT02966834|76043318|FG002|STARTED|Final Study Period (Up to 4 Weeks)||19||
59924112|NCT02966834|76043319|FG003|STARTED|Final Study Period (Up to 4 Weeks)||19||
59924113|NCT02966834|76043320|FG004|STARTED|Final Study Period (Up to 4 Weeks)|One participant did not enter Final Study Period.|21||
59924114|NCT02966834|76043321|FG005|STARTED|Final Study Period (Up to 4 Weeks)||17||
59924115|NCT02966834|76043316|FG000|COMPLETED|Final Study Period (Up to 4 Weeks)||35||
59924116|NCT02966834|76043317|FG001|COMPLETED|Final Study Period (Up to 4 Weeks)||16||
59924117|NCT02966834|76043318|FG002|COMPLETED|Final Study Period (Up to 4 Weeks)||19||
59924118|NCT02966834|76043319|FG003|COMPLETED|Final Study Period (Up to 4 Weeks)||19||
59924119|NCT02966834|76043320|FG004|COMPLETED|Final Study Period (Up to 4 Weeks)||21||
59924120|NCT02966834|76043321|FG005|COMPLETED|Final Study Period (Up to 4 Weeks)||17||
59924121|NCT02966834|76043316|FG000|NOT COMPLETED|Final Study Period (Up to 4 Weeks)||0||
59924122|NCT02966834|76043317|FG001|NOT COMPLETED|Final Study Period (Up to 4 Weeks)||0||
59924123|NCT02966834|76043318|FG002|NOT COMPLETED|Final Study Period (Up to 4 Weeks)||0||
59924124|NCT02966834|76043319|FG003|NOT COMPLETED|Final Study Period (Up to 4 Weeks)||0||
59924125|NCT02966834|76043320|FG004|NOT COMPLETED|Final Study Period (Up to 4 Weeks)||0||
59924126|NCT02966834|76043321|FG005|NOT COMPLETED|Final Study Period (Up to 4 Weeks)||0||
59924127|NCT02966834|76043316|FG000|STARTED|Follow-up (Up to 4 Weeks)||35||
59924128|NCT02966834|76043317|FG001|STARTED|Follow-up (Up to 4 Weeks)||16||
59924129|NCT02966834|76043318|FG002|STARTED|Follow-up (Up to 4 Weeks)|4 participants discontinued study treatment in Main study period and directly entered follow-up.|23||
59515362|NCT03128086|75609190|FG000|NOT COMPLETED|Overall Study||0||
59515363|NCT03128086|75609191|FG001|NOT COMPLETED|Overall Study||0||
60055332|NCT01831089|76170777|FG000|COMPLETED|Cohort IV: Dose Level 4||0||
60055333|NCT01831089|76170778|FG001|COMPLETED|Cohort IV: Dose Level 4||0||
60055334|NCT01831089|76170779|FG002|COMPLETED|Cohort IV: Dose Level 4||0||
60055335|NCT01831089|76170780|FG003|COMPLETED|Cohort IV: Dose Level 4||0||
60055336|NCT01831089|76170781|FG004|COMPLETED|Cohort IV: Dose Level 4||0||
60055337|NCT01831089|76170782|FG005|COMPLETED|Cohort IV: Dose Level 4||0||
60055338|NCT01831089|76170777|FG000|NOT COMPLETED|Cohort IV: Dose Level 4||0||
60055339|NCT01831089|76170778|FG001|NOT COMPLETED|Cohort IV: Dose Level 4||0||
60055340|NCT01831089|76170779|FG002|NOT COMPLETED|Cohort IV: Dose Level 4||0||
60055341|NCT01831089|76170780|FG003|NOT COMPLETED|Cohort IV: Dose Level 4||6||
60055342|NCT01831089|76170781|FG004|NOT COMPLETED|Cohort IV: Dose Level 4||0||
60055343|NCT01831089|76170782|FG005|NOT COMPLETED|Cohort IV: Dose Level 4||0||
60055344|NCT01831089|76170777|FG000|STARTED|Cohort V: Dose Level 5||0||
60055345|NCT01831089|76170778|FG001|STARTED|Cohort V: Dose Level 5||0||
60055346|NCT01831089|76170779|FG002|STARTED|Cohort V: Dose Level 5||0||
60055347|NCT01831089|76170780|FG003|STARTED|Cohort V: Dose Level 5||0||
60055348|NCT01831089|76170781|FG004|STARTED|Cohort V: Dose Level 5||37||
60055349|NCT01831089|76170782|FG005|STARTED|Cohort V: Dose Level 5||0||
60055350|NCT01831089|76170777|FG000|COMPLETED|Cohort V: Dose Level 5||0||
59515364|NCT00982423|75609199|FG000|STARTED|Overall Study||13||
59515365|NCT00982423|75609200|FG001|STARTED|Overall Study||19||
59515366|NCT00982423|75609199|FG000|COMPLETED|Overall Study||13||
59515367|NCT00982423|75609200|FG001|COMPLETED|Overall Study||19||
59515368|NCT00982423|75609199|FG000|NOT COMPLETED|Overall Study||0||
59515369|NCT00982423|75609200|FG001|NOT COMPLETED|Overall Study||0||
59515370|NCT03073486|75609209|FG000|STARTED|Overall Study||493||
59515371|NCT03073486|75609210|FG001|STARTED|Overall Study||251||
59515372|NCT03073486|75609209|FG000|COMPLETED|Overall Study||405||
59515373|NCT03073486|75609210|FG001|COMPLETED|Overall Study||207||
59515374|NCT03073486|75609209|FG000|NOT COMPLETED|Overall Study||88||
59515375|NCT03073486|75609210|FG001|NOT COMPLETED|Overall Study||44||
59515376|NCT00983281|75609218|FG000|STARTED|Overall Study||805||
59515377|NCT00983281|75609219|FG001|STARTED|Overall Study||909||
59515378|NCT00983281|75609218|FG000|COMPLETED|Overall Study||805||
59515379|NCT00983281|75609219|FG001|COMPLETED|Overall Study||909||
59515380|NCT00983281|75609218|FG000|NOT COMPLETED|Overall Study||0||
59515381|NCT00983281|75609219|FG001|NOT COMPLETED|Overall Study||0||
59515382|NCT03129178|75609227|FG000|STARTED|Overall Study||13||
59515383|NCT03129178|75609228|FG001|STARTED|Overall Study||13||
59515384|NCT03129178|75609227|FG000|COMPLETED|Overall Study||12||
59515385|NCT03129178|75609228|FG001|COMPLETED|Overall Study||11||
59515386|NCT03129178|75609227|FG000|NOT COMPLETED|Overall Study||1||
59515387|NCT03129178|75609228|FG001|NOT COMPLETED|Overall Study||2||
59612984|NCT01694706|75724027|FG001|Received Faldaprevir Fed|Overall Study||5||
59760572|NCT01317160|75880197|FG001|COMPLETED|Overall Study||69||
59515388|NCT03129568|75609235|FG000|STARTED|Overall Study||5||
59515389|NCT03129568|75609235|FG000|COMPLETED|Overall Study||5||
59515390|NCT03129568|75609235|FG000|NOT COMPLETED|Overall Study||0||
59515391|NCT00983359|75609239|FG000|STARTED|Overall Study||40||
59515392|NCT00983359|75609239|FG000|Not Eligible for Analysis|Overall Study||1||
59515393|NCT00983359|75609239|FG000|COMPLETED|Overall Study||39||
60055351|NCT01831089|76170778|FG001|COMPLETED|Cohort V: Dose Level 5||0||
60055352|NCT01831089|76170779|FG002|COMPLETED|Cohort V: Dose Level 5||0||
60055353|NCT01831089|76170780|FG003|COMPLETED|Cohort V: Dose Level 5||0||
60055354|NCT01831089|76170781|FG004|COMPLETED|Cohort V: Dose Level 5||0||
60055355|NCT01831089|76170782|FG005|COMPLETED|Cohort V: Dose Level 5||0||
60055356|NCT01831089|76170777|FG000|NOT COMPLETED|Cohort V: Dose Level 5||0||
60055357|NCT01831089|76170778|FG001|NOT COMPLETED|Cohort V: Dose Level 5||0||
60055358|NCT01831089|76170779|FG002|NOT COMPLETED|Cohort V: Dose Level 5||0||
60055359|NCT01831089|76170780|FG003|NOT COMPLETED|Cohort V: Dose Level 5||0||
60055360|NCT01831089|76170781|FG004|NOT COMPLETED|Cohort V: Dose Level 5||37||
60055361|NCT01831089|76170782|FG005|NOT COMPLETED|Cohort V: Dose Level 5||0||
60055362|NCT01831089|76170777|FG000|STARTED|Cohort B: Arm B||0||
60055363|NCT01831089|76170778|FG001|STARTED|Cohort B: Arm B||0||
60055364|NCT01831089|76170779|FG002|STARTED|Cohort B: Arm B||0||
60055365|NCT01831089|76170780|FG003|STARTED|Cohort B: Arm B||0||
60055366|NCT01831089|76170781|FG004|STARTED|Cohort B: Arm B||0||
60055367|NCT01831089|76170782|FG005|STARTED|Cohort B: Arm B||14||
60055368|NCT01831089|76170777|FG000|COMPLETED|Cohort B: Arm B||0||
60055369|NCT01831089|76170778|FG001|COMPLETED|Cohort B: Arm B||0||
60055370|NCT01831089|76170779|FG002|COMPLETED|Cohort B: Arm B||0||
60055371|NCT01831089|76170780|FG003|COMPLETED|Cohort B: Arm B||0||
60055372|NCT01831089|76170781|FG004|COMPLETED|Cohort B: Arm B||0||
60055373|NCT01831089|76170782|FG005|COMPLETED|Cohort B: Arm B||0||
60055374|NCT01831089|76170777|FG000|NOT COMPLETED|Cohort B: Arm B||0||
60055375|NCT01831089|76170778|FG001|NOT COMPLETED|Cohort B: Arm B||0||
60055376|NCT01831089|76170779|FG002|NOT COMPLETED|Cohort B: Arm B||0||
60055377|NCT01831089|76170780|FG003|NOT COMPLETED|Cohort B: Arm B||0||
60055378|NCT01831089|76170781|FG004|NOT COMPLETED|Cohort B: Arm B||0||
60055379|NCT01831089|76170782|FG005|NOT COMPLETED|Cohort B: Arm B||14||
60055380|NCT02112877|76170799|FG000|STARTED|Overall Study||30||
60055381|NCT02112877|76170800|FG001|STARTED|Overall Study||170||
60055382|NCT02112877|76170799|FG000|COMPLETED|Overall Study||28||
60055383|NCT02112877|76170800|FG001|COMPLETED|Overall Study||157||
60055384|NCT02112877|76170799|FG000|NOT COMPLETED|Overall Study||2||
60055385|NCT02112877|76170800|FG001|NOT COMPLETED|Overall Study||13||
60055386|NCT02098369|76170811|FG000|STARTED|Overall Study||142||
60055387|NCT02098369|76170812|FG001|STARTED|Overall Study||154||
60055388|NCT02098369|76170813|FG002|STARTED|Overall Study||148||
60055389|NCT02098369|76170811|FG000|COMPLETED|Overall Study||135||
60055390|NCT02098369|76170812|FG001|COMPLETED|Overall Study||145||
60055391|NCT02098369|76170813|FG002|COMPLETED|Overall Study||143||
60055392|NCT02098369|76170811|FG000|NOT COMPLETED|Overall Study||7||
60055393|NCT02098369|76170812|FG001|NOT COMPLETED|Overall Study||9||
60055394|NCT02098369|76170813|FG002|NOT COMPLETED|Overall Study||5||
60055395|NCT02111785|76170825|FG000|STARTED|Overall Study||3||
59515394|NCT00983359|75609239|FG000|NOT COMPLETED|Overall Study||1||
60055396|NCT02111785|76170826|FG001|STARTED|Overall Study||5||
60055397|NCT02111785|76170827|FG002|STARTED|Overall Study||1||
60055398|NCT02111785|76170828|FG003|STARTED|Overall Study||1||
60055399|NCT02111785|76170825|FG000|COMPLETED|Overall Study||3||
60055400|NCT02111785|76170826|FG001|COMPLETED|Overall Study||4||
60055401|NCT02111785|76170827|FG002|COMPLETED|Overall Study||1||
60055402|NCT02111785|76170828|FG003|COMPLETED|Overall Study||1||
60055403|NCT02111785|76170825|FG000|NOT COMPLETED|Overall Study||0||
59515395|NCT03073876|75609245|FG000|STARTED|Overall Study||12||
59515396|NCT03073876|75609246|FG001|STARTED|Overall Study||11||
59515397|NCT03073876|75609245|FG000|COMPLETED|Overall Study||12||
59515398|NCT03073876|75609246|FG001|COMPLETED|Overall Study||11||
59515399|NCT03073876|75609245|FG000|NOT COMPLETED|Overall Study||0||
59515400|NCT03073876|75609246|FG001|NOT COMPLETED|Overall Study||0||
59515401|NCT00954109|75609257|FG000|STARTED|Overall Study||11||
59515402|NCT00954109|75609257|FG000|COMPLETED|Overall Study||11||
59515403|NCT00954109|75609257|FG000|NOT COMPLETED|Overall Study||0||
59760573|NCT01317160|75880196|FG000|NOT COMPLETED|Overall Study||4||
60055404|NCT02111785|76170826|FG001|NOT COMPLETED|Overall Study||1||
60055405|NCT02111785|76170827|FG002|NOT COMPLETED|Overall Study||0||
60055406|NCT02111785|76170828|FG003|NOT COMPLETED|Overall Study||0||
60055407|NCT02068885|76170845|FG000|STARTED|Overall Study||57|Sample size randomized|
59515404|NCT03130738|75609264|FG000|STARTED|Overall Study||23||
59515405|NCT03130738|75609265|FG001|STARTED|Overall Study||22||
60055408|NCT02068885|76170846|FG001|STARTED|Overall Study||53|Sample size randomized|
60055409|NCT02068885|76170847|FG002|STARTED|Overall Study||54|Sample size randomized|
60055410|NCT02068885|76170845|FG000|Provided Data at Midpoint Test Phase|Overall Study||56||
60055411|NCT02068885|76170846|FG001|Provided Data at Midpoint Test Phase|Overall Study||50||
60055412|NCT02068885|76170847|FG002|Provided Data at Midpoint Test Phase|Overall Study||48||
60055413|NCT02068885|76170845|FG000|Provided Data at End of Test Phase|Overall Study||54|Sample size completers|
60055414|NCT02068885|76170846|FG001|Provided Data at End of Test Phase|Overall Study||48|Sample size completers|
60055415|NCT02068885|76170847|FG002|Provided Data at End of Test Phase|Overall Study||46|Sample size completers|
60055416|NCT02068885|76170845|FG000|Included in Intention-to-treat Analysis|Overall Study||56|Two randomized participants excluded: unreliable doubly labeled water (DLW) data, hypothyroidism|
60055417|NCT02068885|76170846|FG001|Included in Intention-to-treat Analysis|Overall Study||52|Two randomized participants excluded: unreliable doubly labeled water (DLW) data, hypothyroidism|
60055418|NCT02068885|76170847|FG002|Included in Intention-to-treat Analysis|Overall Study||54|Two randomized participants excluded: unreliable doubly labeled water (DLW) data, hypothyroidism|
60055419|NCT02068885|76170845|FG000|COMPLETED|Overall Study||54||
60055420|NCT02068885|76170846|FG001|COMPLETED|Overall Study||48||
60055421|NCT02068885|76170847|FG002|COMPLETED|Overall Study||46||
60055422|NCT02068885|76170845|FG000|NOT COMPLETED|Overall Study||3||
60055423|NCT02068885|76170846|FG001|NOT COMPLETED|Overall Study||5||
60055424|NCT02068885|76170847|FG002|NOT COMPLETED|Overall Study||8||
60055425|NCT02068495|76170856|FG000|STARTED|Overall Study||3409||
60055426|NCT02068495|76170856|FG000|COMPLETED|Overall Study||3300||
60055427|NCT02068495|76170856|FG000|NOT COMPLETED|Overall Study||109||
59515406|NCT03130738|75609266|FG002|STARTED|Overall Study||20||
59515407|NCT03130738|75609264|FG000|COMPLETED|Overall Study||20||
60055428|NCT02097823|76170862|FG000|STARTED|Overall Study||11||
60055429|NCT02097823|76170863|FG001|STARTED|Overall Study||4||
60055430|NCT02097823|76170862|FG000|COMPLETED|Overall Study||10||
60055431|NCT02097823|76170863|FG001|COMPLETED|Overall Study||3||
60055432|NCT02097823|76170862|FG000|NOT COMPLETED|Overall Study||1||
60055433|NCT02097823|76170863|FG001|NOT COMPLETED|Overall Study||1||
60055434|NCT01830855|76170874|FG000|STARTED|Overall Study||1508||
60055435|NCT01830855|76170875|FG001|STARTED|Overall Study||598||
60055436|NCT01830855|76170876|FG002|STARTED|Overall Study||587||
60055437|NCT01830855|76170877|FG003|STARTED|Overall Study||897||
60055438|NCT01830855|76170874|FG000|COMPLETED|Overall Study||1353||
60055439|NCT01830855|76170875|FG001|COMPLETED|Overall Study||537||
60055440|NCT01830855|76170876|FG002|COMPLETED|Overall Study||521||
60055441|NCT01830855|76170877|FG003|COMPLETED|Overall Study||815||
60055442|NCT01830855|76170874|FG000|NOT COMPLETED|Overall Study||155||
60055443|NCT01830855|76170875|FG001|NOT COMPLETED|Overall Study||61||
60055444|NCT01830855|76170876|FG002|NOT COMPLETED|Overall Study||66||
60055445|NCT01830855|76170877|FG003|NOT COMPLETED|Overall Study||82||
60055446|NCT01857063|76170894|FG000|STARTED|Period 1 (7 Days)||110||
60055447|NCT01857063|76170895|FG001|STARTED|Period 1 (7 Days)||110||
60055448|NCT01857063|76170894|FG000|COMPLETED|Period 1 (7 Days)||108||
60055449|NCT01857063|76170895|FG001|COMPLETED|Period 1 (7 Days)||106||
60055450|NCT01857063|76170894|FG000|NOT COMPLETED|Period 1 (7 Days)||2||
60055451|NCT01857063|76170895|FG001|NOT COMPLETED|Period 1 (7 Days)||4||
60055452|NCT01857063|76170894|FG000|STARTED|Period 2 (7 Days)||108||
60055453|NCT01857063|76170895|FG001|STARTED|Period 2 (7 Days)||106||
60055454|NCT01857063|76170894|FG000|COMPLETED|Period 2 (7 Days)||104||
60055455|NCT01857063|76170895|FG001|COMPLETED|Period 2 (7 Days)||104||
60055456|NCT01857063|76170894|FG000|NOT COMPLETED|Period 2 (7 Days)||4||
60055457|NCT01857063|76170895|FG001|NOT COMPLETED|Period 2 (7 Days)||2||
60055458|NCT01856907|76170904|FG000|STARTED|Overall Study||12||
60055459|NCT01856907|76170905|FG001|STARTED|Overall Study||12||
60055460|NCT01856907|76170906|FG002|STARTED|Overall Study||12||
60055461|NCT01856907|76170904|FG000|COMPLETED|Overall Study||12||
60055462|NCT01856907|76170905|FG001|COMPLETED|Overall Study||9||
60055463|NCT01856907|76170906|FG002|COMPLETED|Overall Study||12||
59515408|NCT03130738|75609265|FG001|COMPLETED|Overall Study||20||
60055464|NCT01856907|76170904|FG000|NOT COMPLETED|Overall Study||0||
60055465|NCT01856907|76170905|FG001|NOT COMPLETED|Overall Study||3||
60055466|NCT01856907|76170906|FG002|NOT COMPLETED|Overall Study||0||
60055467|NCT02212457|76170923|FG000|STARTED|Overall Study||228||
60055468|NCT02212457|76170924|FG001|STARTED|Overall Study||232||
60055469|NCT02212457|76170925|FG002|STARTED|Overall Study||157||
60055470|NCT02212457|76170926|FG003|STARTED|Overall Study||134||
60055471|NCT02212457|76170927|FG004|STARTED|Overall Study||152||
60055472|NCT02212457|76170928|FG005|STARTED|Overall Study||160||
60055473|NCT02212457|76170923|FG000|COMPLETED|Overall Study||209||
60055474|NCT02212457|76170924|FG001|COMPLETED|Overall Study||211||
60055475|NCT02212457|76170925|FG002|COMPLETED|Overall Study||141||
60055476|NCT02212457|76170926|FG003|COMPLETED|Overall Study||123||
60055477|NCT02212457|76170927|FG004|COMPLETED|Overall Study||137||
60055478|NCT02212457|76170928|FG005|COMPLETED|Overall Study||147||
60055479|NCT02212457|76170923|FG000|NOT COMPLETED|Overall Study||19||
60055480|NCT02212457|76170924|FG001|NOT COMPLETED|Overall Study||21||
60055481|NCT02212457|76170925|FG002|NOT COMPLETED|Overall Study||16||
60055482|NCT02212457|76170926|FG003|NOT COMPLETED|Overall Study||11||
60055483|NCT02212457|76170927|FG004|NOT COMPLETED|Overall Study||15||
60055484|NCT02212457|76170928|FG005|NOT COMPLETED|Overall Study||13||
60067863|NCT01785615|76183052|FG000|COMPLETED|Atorvastatin Phase||44||
59924130|NCT02966834|76043319|FG003|STARTED|Follow-up (Up to 4 Weeks)|8 participants discontinued study treatment in Main Study period and directly entered follow-up.|27||
59924131|NCT02966834|76043320|FG004|STARTED|Follow-up (Up to 4 Weeks)|1 participant who completed main study period directly entered follow-up in this arm|22||
59924132|NCT02966834|76043321|FG005|STARTED|Follow-up (Up to 4 Weeks)|5 participants discontinued study treatment in Main study period and directly entered follow-up|22||
59924133|NCT02966834|76043316|FG000|COMPLETED|Follow-up (Up to 4 Weeks)||35||
59924134|NCT02966834|76043317|FG001|COMPLETED|Follow-up (Up to 4 Weeks)||16||
59924135|NCT02966834|76043318|FG002|COMPLETED|Follow-up (Up to 4 Weeks)||22||
59924136|NCT02966834|76043319|FG003|COMPLETED|Follow-up (Up to 4 Weeks)||22||
59924137|NCT02966834|76043320|FG004|COMPLETED|Follow-up (Up to 4 Weeks)||22||
59924138|NCT02966834|76043321|FG005|COMPLETED|Follow-up (Up to 4 Weeks)||21||
59924139|NCT02966834|76043316|FG000|NOT COMPLETED|Follow-up (Up to 4 Weeks)||0||
59924140|NCT02966834|76043317|FG001|NOT COMPLETED|Follow-up (Up to 4 Weeks)||0||
59924141|NCT02966834|76043318|FG002|NOT COMPLETED|Follow-up (Up to 4 Weeks)||1||
59924142|NCT02966834|76043319|FG003|NOT COMPLETED|Follow-up (Up to 4 Weeks)||5||
59924143|NCT02966834|76043320|FG004|NOT COMPLETED|Follow-up (Up to 4 Weeks)||0||
59924144|NCT02966834|76043321|FG005|NOT COMPLETED|Follow-up (Up to 4 Weeks)||1||
59924145|NCT03106077|76043370|FG000|STARTED|Overall Study||96||
59924146|NCT03106077|76043371|FG001|STARTED|Overall Study||0||
59924147|NCT03106077|76043370|FG000|COMPLETED|Overall Study||2||
59924148|NCT03106077|76043371|FG001|COMPLETED|Overall Study||0||
59924149|NCT03106077|76043370|FG000|NOT COMPLETED|Overall Study||94||
59924150|NCT03106077|76043371|FG001|NOT COMPLETED|Overall Study||0||
59924151|NCT03105297|76043376|FG000|STARTED|Baseline Phase (Day 1)||91||
59924152|NCT03105297|76043376|FG000|COMPLETED|Baseline Phase (Day 1)||70||
59924153|NCT03105297|76043376|FG000|NOT COMPLETED|Baseline Phase (Day 1)||21||
59924154|NCT03105297|76043376|FG000|STARTED|Active Phase (Day 2-29)||70||
59924155|NCT03105297|76043376|FG000|COMPLETED|Active Phase (Day 2-29)||70||
59924156|NCT03105297|76043376|FG000|NOT COMPLETED|Active Phase (Day 2-29)||0||
59924157|NCT03105297|76043376|FG000|STARTED|Nasal Resistance Phase (Day 30, 31)|14 participants withdrew from the study after the completion of active phase|56||
59924158|NCT03105297|76043376|FG000|Treated|Nasal Resistance Phase (Day 30, 31)||55||
59924159|NCT03105297|76043376|FG000|COMPLETED|Nasal Resistance Phase (Day 30, 31)||48||
59924160|NCT03105297|76043376|FG000|NOT COMPLETED|Nasal Resistance Phase (Day 30, 31)||8||
59924161|NCT03426995|76043406|FG000|STARTED|Part A: Cohort 1-Period 1 (Day1)||0||
59924162|NCT03426995|76043407|FG001|STARTED|Part A: Cohort 1-Period 1 (Day1)||2||
59924163|NCT03426995|76043408|FG002|STARTED|Part A: Cohort 1-Period 1 (Day1)||1||
59924164|NCT03426995|76043409|FG003|STARTED|Part A: Cohort 1-Period 1 (Day1)||2||
59924165|NCT03426995|76043410|FG004|STARTED|Part A: Cohort 1-Period 1 (Day1)||1||
59924166|NCT03426995|76043411|FG005|STARTED|Part A: Cohort 1-Period 1 (Day1)||1||
59924167|NCT03426995|76043412|FG006|STARTED|Part A: Cohort 1-Period 1 (Day1)||0||
59924168|NCT03426995|76043413|FG007|STARTED|Part A: Cohort 1-Period 1 (Day1)||0||
59924169|NCT03426995|76043414|FG008|STARTED|Part A: Cohort 1-Period 1 (Day1)||0||
59924170|NCT03426995|76043415|FG009|STARTED|Part A: Cohort 1-Period 1 (Day1)||0||
59924171|NCT03426995|76043416|FG010|STARTED|Part A: Cohort 1-Period 1 (Day1)||0||
59924172|NCT03426995|76043417|FG011|STARTED|Part A: Cohort 1-Period 1 (Day1)||0||
59924173|NCT03426995|76043418|FG012|STARTED|Part A: Cohort 1-Period 1 (Day1)||0||
59924174|NCT03426995|76043419|FG013|STARTED|Part A: Cohort 1-Period 1 (Day1)||0||
59924175|NCT03426995|76043420|FG014|STARTED|Part A: Cohort 1-Period 1 (Day1)||0||
59924176|NCT03426995|76043421|FG015|STARTED|Part A: Cohort 1-Period 1 (Day1)||0||
59924177|NCT03426995|76043422|FG016|STARTED|Part A: Cohort 1-Period 1 (Day1)||0||
59924178|NCT03426995|76043423|FG017|STARTED|Part A: Cohort 1-Period 1 (Day1)||0||
59924179|NCT03426995|76043424|FG018|STARTED|Part A: Cohort 1-Period 1 (Day1)||0||
59612985|NCT01694706|75724028|FG002|Received Faldaprevir Fed|Overall Study||5||
59924180|NCT03426995|76043406|FG000|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
59924181|NCT03426995|76043407|FG001|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||2||
59924182|NCT03426995|76043408|FG002|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
59924183|NCT03426995|76043409|FG003|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||2||
59924184|NCT03426995|76043410|FG004|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||1||
59924185|NCT03426995|76043411|FG005|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||1||
59924186|NCT03426995|76043412|FG006|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
59924187|NCT03426995|76043413|FG007|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
59924188|NCT03426995|76043414|FG008|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
59924189|NCT03426995|76043415|FG009|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
59924190|NCT03426995|76043416|FG010|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
59924191|NCT03426995|76043417|FG011|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
59924192|NCT03426995|76043418|FG012|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
59924193|NCT03426995|76043419|FG013|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
59924194|NCT03426995|76043420|FG014|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
59924195|NCT03426995|76043421|FG015|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
59924196|NCT03426995|76043422|FG016|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
59924197|NCT03426995|76043423|FG017|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
59924198|NCT03426995|76043424|FG018|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
59924199|NCT03426995|76043406|FG000|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
59924200|NCT03426995|76043407|FG001|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
59924201|NCT03426995|76043408|FG002|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||1||
59924202|NCT03426995|76043409|FG003|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
59924203|NCT03426995|76043410|FG004|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
59924204|NCT03426995|76043411|FG005|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
59924205|NCT03426995|76043412|FG006|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
59924206|NCT03426995|76043413|FG007|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
59924207|NCT03426995|76043414|FG008|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
59924208|NCT03426995|76043415|FG009|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
59924209|NCT03426995|76043416|FG010|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
59924210|NCT03426995|76043417|FG011|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
59924211|NCT03426995|76043418|FG012|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
59924212|NCT03426995|76043419|FG013|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
59924213|NCT03426995|76043420|FG014|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
59924214|NCT03426995|76043421|FG015|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
59924215|NCT03426995|76043422|FG016|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
59924216|NCT03426995|76043423|FG017|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
59924217|NCT03426995|76043424|FG018|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0||
59924218|NCT03426995|76043406|FG000|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
59924219|NCT03426995|76043407|FG001|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||2||
59924220|NCT03426995|76043408|FG002|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
59924221|NCT03426995|76043409|FG003|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||2||
59924222|NCT03426995|76043410|FG004|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||1||
59924223|NCT03426995|76043411|FG005|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||1||
59924224|NCT03426995|76043412|FG006|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
59924225|NCT03426995|76043413|FG007|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
59924226|NCT03426995|76043414|FG008|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
59924227|NCT03426995|76043415|FG009|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
59924228|NCT03426995|76043416|FG010|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
59924229|NCT03426995|76043417|FG011|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
59924230|NCT03426995|76043418|FG012|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
59924231|NCT03426995|76043419|FG013|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
59924232|NCT03426995|76043420|FG014|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
59924233|NCT03426995|76043421|FG015|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
59924234|NCT03426995|76043422|FG016|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
59924235|NCT03426995|76043423|FG017|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
59924236|NCT03426995|76043424|FG018|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
59924237|NCT03426995|76043406|FG000|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
59924238|NCT03426995|76043407|FG001|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||2||
59924239|NCT03426995|76043408|FG002|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
59924240|NCT03426995|76043409|FG003|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||2||
59924241|NCT03426995|76043410|FG004|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||1||
60055485|NCT02097745|76170949|FG000|STARTED|Overall Study|Six participants did not receive any treatment and were not included in any analyses.|335||
60055486|NCT02097745|76170949|FG000|COMPLETED|Overall Study||157||
59924242|NCT03426995|76043411|FG005|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||1||
59924243|NCT03426995|76043412|FG006|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
59924244|NCT03426995|76043413|FG007|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
59924245|NCT03426995|76043414|FG008|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
59924246|NCT03426995|76043415|FG009|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
59924247|NCT03426995|76043416|FG010|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
59924248|NCT03426995|76043417|FG011|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
59924249|NCT03426995|76043418|FG012|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
59924250|NCT03426995|76043419|FG013|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
59924251|NCT03426995|76043420|FG014|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
59924252|NCT03426995|76043421|FG015|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
59924253|NCT03426995|76043422|FG016|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
59924254|NCT03426995|76043423|FG017|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
59924255|NCT03426995|76043424|FG018|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
59924256|NCT03426995|76043406|FG000|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
60055487|NCT02097745|76170949|FG000|NOT COMPLETED|Overall Study||178||
60055488|NCT02111083|76170958|FG000|STARTED|First Intervention (1 Day)||19||
60055489|NCT02111083|76170959|FG001|STARTED|First Intervention (1 Day)||19||
60055490|NCT02111083|76170958|FG000|COMPLETED|First Intervention (1 Day)||19||
59515409|NCT03130738|75609266|FG002|COMPLETED|Overall Study||14||
59515410|NCT03130738|75609264|FG000|NOT COMPLETED|Overall Study||3||
59515411|NCT03130738|75609265|FG001|NOT COMPLETED|Overall Study||2||
59515412|NCT03130738|75609266|FG002|NOT COMPLETED|Overall Study||6||
59515413|NCT00983983|75609277|FG000|STARTED|Overall Study||8||
59515414|NCT00983983|75609278|FG001|STARTED|Overall Study||9||
59924257|NCT03426995|76043407|FG001|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
59924258|NCT03426995|76043408|FG002|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
59924259|NCT03426995|76043409|FG003|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
59924260|NCT03426995|76043410|FG004|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
59924261|NCT03426995|76043411|FG005|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
59924262|NCT03426995|76043412|FG006|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
59924263|NCT03426995|76043413|FG007|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
59924264|NCT03426995|76043414|FG008|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
60055491|NCT02111083|76170959|FG001|COMPLETED|First Intervention (1 Day)||19||
60055492|NCT02111083|76170958|FG000|NOT COMPLETED|First Intervention (1 Day)||0||
60055493|NCT02111083|76170959|FG001|NOT COMPLETED|First Intervention (1 Day)||0||
60055494|NCT02111083|76170958|FG000|STARTED|Interval Between Dosing (7-8 Days)||19||
60055495|NCT02111083|76170959|FG001|STARTED|Interval Between Dosing (7-8 Days)||19||
60055496|NCT02111083|76170958|FG000|COMPLETED|Interval Between Dosing (7-8 Days)||19||
60055497|NCT02111083|76170959|FG001|COMPLETED|Interval Between Dosing (7-8 Days)||19||
60055498|NCT02111083|76170958|FG000|NOT COMPLETED|Interval Between Dosing (7-8 Days)||0||
59515415|NCT00983983|75609279|FG002|STARTED|Overall Study||7||
59515416|NCT00983983|75609277|FG000|COMPLETED|Overall Study||6||
59515417|NCT00983983|75609278|FG001|COMPLETED|Overall Study||8||
59515418|NCT00983983|75609279|FG002|COMPLETED|Overall Study||6||
59515419|NCT00983983|75609277|FG000|NOT COMPLETED|Overall Study||2||
59515420|NCT00983983|75609278|FG001|NOT COMPLETED|Overall Study||1||
59924265|NCT03426995|76043415|FG009|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
59924266|NCT03426995|76043416|FG010|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
59924267|NCT03426995|76043417|FG011|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
59924268|NCT03426995|76043418|FG012|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
59924269|NCT03426995|76043419|FG013|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
59924270|NCT03426995|76043420|FG014|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
59924271|NCT03426995|76043421|FG015|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
59924272|NCT03426995|76043422|FG016|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
59924273|NCT03426995|76043423|FG017|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
59924274|NCT03426995|76043424|FG018|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0||
59924275|NCT03426995|76043406|FG000|STARTED|Part A: Cohort 1-Period 2 (Day1)|New participant enrolled and dosed.|1||
59924276|NCT03426995|76043407|FG001|STARTED|Part A: Cohort 1-Period 2 (Day1)||2||
59924277|NCT03426995|76043408|FG002|STARTED|Part A: Cohort 1-Period 2 (Day1)|New participant enrolled and dosed.|1||
60055499|NCT02111083|76170959|FG001|NOT COMPLETED|Interval Between Dosing (7-8 Days)||0||
59515421|NCT00983983|75609279|FG002|NOT COMPLETED|Overall Study||1||
59515422|NCT00984139|75609288|FG000|STARTED|Overall Study||306||
59515423|NCT00984139|75609288|FG000|COMPLETED|Overall Study||306||
59515424|NCT00984139|75609288|FG000|NOT COMPLETED|Overall Study||0||
59515425|NCT03131206|75609296|FG000|STARTED|Dose Level 1 (600mg BID 7d, 900mg BID)||5||
60055500|NCT02111083|76170958|FG000|STARTED|Second Intervention (1 Day)||19||
60055501|NCT02111083|76170959|FG001|STARTED|Second Intervention (1 Day)||19||
60055502|NCT02111083|76170958|FG000|COMPLETED|Second Intervention (1 Day)||19||
60055503|NCT02111083|76170959|FG001|COMPLETED|Second Intervention (1 Day)||19||
60055504|NCT02111083|76170958|FG000|NOT COMPLETED|Second Intervention (1 Day)||0||
60055505|NCT02111083|76170959|FG001|NOT COMPLETED|Second Intervention (1 Day)||0||
59515426|NCT03131206|75609297|FG001|STARTED|Dose Level 1 (600mg BID 7d, 900mg BID)||0||
59515427|NCT03131206|75609298|FG002|STARTED|Dose Level 1 (600mg BID 7d, 900mg BID)||0||
59515428|NCT03131206|75609299|FG003|STARTED|Dose Level 1 (600mg BID 7d, 900mg BID)||0||
60055506|NCT02111083|76170958|FG000|STARTED|Interval Between Dosing (7-8 Days)||19||
60055507|NCT02111083|76170959|FG001|STARTED|Interval Between Dosing (7-8 Days)||19||
60055508|NCT02111083|76170958|FG000|COMPLETED|Interval Between Dosing (7-8 Days)||19||
60055509|NCT02111083|76170959|FG001|COMPLETED|Interval Between Dosing (7-8 Days)||19||
60055510|NCT02111083|76170958|FG000|NOT COMPLETED|Interval Between Dosing (7-8 Days)||0||
60055511|NCT02111083|76170959|FG001|NOT COMPLETED|Interval Between Dosing (7-8 Days)||0||
60055512|NCT02111083|76170958|FG000|STARTED|Third Intervention (1 Day)||19||
60055513|NCT02111083|76170959|FG001|STARTED|Third Intervention (1 Day)||19||
60055514|NCT02111083|76170958|FG000|COMPLETED|Third Intervention (1 Day)||19||
60055515|NCT02111083|76170959|FG001|COMPLETED|Third Intervention (1 Day)||19||
60055516|NCT02111083|76170958|FG000|NOT COMPLETED|Third Intervention (1 Day)||0||
60055517|NCT02111083|76170959|FG001|NOT COMPLETED|Third Intervention (1 Day)||0||
60055518|NCT02111083|76170958|FG000|STARTED|Interval Between Dosing (7-8 Days)||19||
60055519|NCT02111083|76170959|FG001|STARTED|Interval Between Dosing (7-8 Days)||19||
60055520|NCT02111083|76170958|FG000|COMPLETED|Interval Between Dosing (7-8 Days)||18||
60055521|NCT02111083|76170959|FG001|COMPLETED|Interval Between Dosing (7-8 Days)||18||
60055522|NCT02111083|76170958|FG000|NOT COMPLETED|Interval Between Dosing (7-8 Days)||1||
60055523|NCT02111083|76170959|FG001|NOT COMPLETED|Interval Between Dosing (7-8 Days)||1||
60055524|NCT02111083|76170958|FG000|STARTED|Fourth Intervention (1 Day)||18||
60055525|NCT02111083|76170959|FG001|STARTED|Fourth Intervention (1 Day)||18||
60055526|NCT02111083|76170958|FG000|COMPLETED|Fourth Intervention (1 Day)||18||
60055527|NCT02111083|76170959|FG001|COMPLETED|Fourth Intervention (1 Day)||18||
60055528|NCT02111083|76170958|FG000|NOT COMPLETED|Fourth Intervention (1 Day)||0||
60055529|NCT02111083|76170959|FG001|NOT COMPLETED|Fourth Intervention (1 Day)||0||
60055530|NCT01629563|76170967|FG000|STARTED|Overall Study||228|FAS population analysed As Randomised, Safety population analysed As Treated|
60055531|NCT01629563|76170968|FG001|STARTED|Overall Study|2 subjects randomised to 10mg received 5mg treatment in error (FAS 1: 10mg, Safety Set: 5mg)|223|FAS population analysed As Randomised, Safety population analysed As Treated|
59515429|NCT03131206|75609296|FG000|COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||5||
59515430|NCT03131206|75609297|FG001|COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0||
59515431|NCT03131206|75609298|FG002|COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0||
59612986|NCT01694706|75724026|FG000|COMPLETED|Overall Study||4||
60055532|NCT01629563|76170967|FG000|Safety Population|Overall Study||230||
60055533|NCT01629563|76170968|FG001|Safety Population|Overall Study||221||
60055534|NCT01629563|76170967|FG000|Started Treatment Course 2|Overall Study||213||
60055535|NCT01629563|76170968|FG001|Started Treatment Course 2|Overall Study||207||
60055536|NCT01629563|76170967|FG000|Started Treatment Course 3|Overall Study||191||
60055537|NCT01629563|76170968|FG001|Started Treatment Course 3|Overall Study||190||
60055538|NCT01629563|76170967|FG000|Started Treatment Course 4|Overall Study||178||
60055539|NCT01629563|76170968|FG001|Started Treatment Course 4|Overall Study||176||
60055540|NCT01629563|76170967|FG000|COMPLETED|Overall Study||167||
60055541|NCT01629563|76170968|FG001|COMPLETED|Overall Study||170||
60055542|NCT01629563|76170967|FG000|NOT COMPLETED|Overall Study||61||
60055543|NCT01629563|76170968|FG001|NOT COMPLETED|Overall Study||53||
60055544|NCT02097277|76170979|FG000|STARTED|Overall Study||24||
60055545|NCT02097277|76170980|FG001|STARTED|Overall Study||24||
60055546|NCT02097277|76170981|FG002|STARTED|Overall Study||24||
60055547|NCT02097277|76170982|FG003|STARTED|Overall Study||24||
60055548|NCT02097277|76170983|FG004|STARTED|Overall Study||24||
60055549|NCT02097277|76170979|FG000|COMPLETED|Overall Study||22||
60055550|NCT02097277|76170980|FG001|COMPLETED|Overall Study||21||
60055551|NCT02097277|76170981|FG002|COMPLETED|Overall Study||22||
60055552|NCT02097277|76170982|FG003|COMPLETED|Overall Study||20||
60055553|NCT02097277|76170983|FG004|COMPLETED|Overall Study||23||
60055554|NCT02097277|76170979|FG000|NOT COMPLETED|Overall Study||2||
59515432|NCT03131206|75609299|FG003|COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0||
59515433|NCT03131206|75609296|FG000|NOT COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0||
59612987|NCT01694706|75724027|FG001|COMPLETED|Overall Study||4||
59612988|NCT01694706|75724028|FG002|COMPLETED|Overall Study||5||
59612989|NCT01694706|75724026|FG000|NOT COMPLETED|Overall Study||1||
59612990|NCT01694706|75724027|FG001|NOT COMPLETED|Overall Study||1||
60055555|NCT02097277|76170980|FG001|NOT COMPLETED|Overall Study||3||
60055556|NCT02097277|76170981|FG002|NOT COMPLETED|Overall Study||2||
60055557|NCT02097277|76170982|FG003|NOT COMPLETED|Overall Study||4||
60055558|NCT02097277|76170983|FG004|NOT COMPLETED|Overall Study||1||
60055559|NCT02212379|76170999|FG000|STARTED|From Baseline to Week 48||165||
60055560|NCT02212379|76170999|FG000|COMPLETED|From Baseline to Week 48||156||
59515434|NCT03131206|75609297|FG001|NOT COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0||
59515435|NCT03131206|75609298|FG002|NOT COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0||
59515436|NCT03131206|75609299|FG003|NOT COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0||
59612991|NCT01694706|75724028|FG002|NOT COMPLETED|Overall Study||0||
60055561|NCT02212379|76170999|FG000|NOT COMPLETED|From Baseline to Week 48||9||
60055562|NCT02212379|76170999|FG000|STARTED|From Week 48 to Week 96||156||
60055563|NCT02212379|76170999|FG000|COMPLETED|From Week 48 to Week 96||152||
60055564|NCT02212379|76170999|FG000|NOT COMPLETED|From Week 48 to Week 96||4||
60055565|NCT02110693|76171006|FG000|STARTED|Overall Study||1026||
60055566|NCT02110693|76171007|FG001|STARTED|Overall Study||1031||
60055567|NCT02110693|76171006|FG000|COMPLETED|Overall Study||998||
60055568|NCT02110693|76171007|FG001|COMPLETED|Overall Study||1002||
60055569|NCT02110693|76171006|FG000|NOT COMPLETED|Overall Study||28||
60055570|NCT02110693|76171007|FG001|NOT COMPLETED|Overall Study||29||
60055571|NCT02212301|76171027|FG000|STARTED|Period 1||21||
60055572|NCT02212301|76171028|FG001|STARTED|Period 1||22||
60055573|NCT02212301|76171027|FG000|COMPLETED|Period 1||21||
60055574|NCT02212301|76171028|FG001|COMPLETED|Period 1||21||
60055575|NCT02212301|76171027|FG000|NOT COMPLETED|Period 1||0||
60055576|NCT02212301|76171028|FG001|NOT COMPLETED|Period 1||1||
60055577|NCT02212301|76171027|FG000|STARTED|Period 2||21||
60055578|NCT02212301|76171028|FG001|STARTED|Period 2||21||
60055579|NCT02212301|76171027|FG000|COMPLETED|Period 2||21||
60055580|NCT02212301|76171028|FG001|COMPLETED|Period 2||21||
60055581|NCT02212301|76171027|FG000|NOT COMPLETED|Period 2||0||
60055582|NCT02212301|76171028|FG001|NOT COMPLETED|Period 2||0||
60055583|NCT02211209|76171037|FG000|STARTED|Overall Study||34||
60055584|NCT02211209|76171038|FG001|STARTED|Overall Study||33||
60055585|NCT02211209|76171037|FG000|Dosed|Overall Study||33||
60055586|NCT02211209|76171038|FG001|Dosed|Overall Study||33||
60055587|NCT02211209|76171037|FG000|COMPLETED|Overall Study||32||
60055588|NCT02211209|76171038|FG001|COMPLETED|Overall Study||19||
60055589|NCT02211209|76171037|FG000|NOT COMPLETED|Overall Study||2||
60055590|NCT02211209|76171038|FG001|NOT COMPLETED|Overall Study||14||
60055591|NCT02187809|76171044|FG000|STARTED|Overall Study||3||
60055592|NCT02187809|76171044|FG000|Treated|Overall Study||1||
60055593|NCT02187809|76171044|FG000|COMPLETED|Overall Study||0||
60055594|NCT02187809|76171044|FG000|NOT COMPLETED|Overall Study||3||
60055595|NCT02187029|76171052|FG000|STARTED|Overall Study||7||
60055596|NCT02187029|76171053|FG001|STARTED|Overall Study||3||
60055597|NCT02187029|76171054|FG002|STARTED|Overall Study||11||
60055598|NCT02187029|76171055|FG003|STARTED|Overall Study||9||
60055599|NCT02187029|76171052|FG000|COMPLETED|Overall Study||6||
60055600|NCT02187029|76171053|FG001|COMPLETED|Overall Study||2||
60055601|NCT02187029|76171054|FG002|COMPLETED|Overall Study||0||
60055602|NCT02187029|76171055|FG003|COMPLETED|Overall Study||6||
60055603|NCT02187029|76171052|FG000|NOT COMPLETED|Overall Study||1||
60055604|NCT02187029|76171053|FG001|NOT COMPLETED|Overall Study||1||
60055605|NCT02187029|76171054|FG002|NOT COMPLETED|Overall Study||11||
60055606|NCT02187029|76171055|FG003|NOT COMPLETED|Overall Study||3||
60055607|NCT02162771|76171067|FG000|STARTED|Core Study Period (Part 2)||70||
60055608|NCT02162771|76171068|FG001|STARTED|Core Study Period (Part 2)||70||
60055609|NCT02162771|76171067|FG000|COMPLETED|Core Study Period (Part 2)||62||
60055610|NCT02162771|76171068|FG001|COMPLETED|Core Study Period (Part 2)||62||
60055611|NCT02162771|76171067|FG000|NOT COMPLETED|Core Study Period (Part 2)||8||
60055612|NCT02162771|76171068|FG001|NOT COMPLETED|Core Study Period (Part 2)||8||
60055613|NCT02162771|76171067|FG000|STARTED|Maintenance Study Period (Part 2)||62||
60055614|NCT02162771|76171068|FG001|STARTED|Maintenance Study Period (Part 2)|Two subjects did not enter this period due to Withdrawal by subject and Non-responder, 1 for each.|60||
60055615|NCT02162771|76171067|FG000|COMPLETED|Maintenance Study Period (Part 2)||46||
60055616|NCT02162771|76171068|FG001|COMPLETED|Maintenance Study Period (Part 2)||38||
59924278|NCT03426995|76043409|FG003|STARTED|Part A: Cohort 1-Period 2 (Day1)||2||
59924279|NCT03426995|76043410|FG004|STARTED|Part A: Cohort 1-Period 2 (Day1)||1||
59924280|NCT03426995|76043411|FG005|STARTED|Part A: Cohort 1-Period 2 (Day1)|Two additional participants were enrolled and dosed.|3||
59924281|NCT03426995|76043412|FG006|STARTED|Part A: Cohort 1-Period 2 (Day1)||0||
59924282|NCT03426995|76043413|FG007|STARTED|Part A: Cohort 1-Period 2 (Day1)||0||
59924283|NCT03426995|76043414|FG008|STARTED|Part A: Cohort 1-Period 2 (Day1)||0||
59924284|NCT03426995|76043415|FG009|STARTED|Part A: Cohort 1-Period 2 (Day1)||0||
59924285|NCT03426995|76043416|FG010|STARTED|Part A: Cohort 1-Period 2 (Day1)||0||
59924286|NCT03426995|76043417|FG011|STARTED|Part A: Cohort 1-Period 2 (Day1)||0||
59924287|NCT03426995|76043418|FG012|STARTED|Part A: Cohort 1-Period 2 (Day1)||0||
60055617|NCT02162771|76171067|FG000|NOT COMPLETED|Maintenance Study Period (Part 2)||16||
60055618|NCT02162771|76171068|FG001|NOT COMPLETED|Maintenance Study Period (Part 2)||22||
60055619|NCT02161757|76171077|FG000|STARTED|Randomised Through Start Treatment||401||
60055620|NCT02161757|76171078|FG001|STARTED|Randomised Through Start Treatment||406||
60055621|NCT02161757|76171079|FG002|STARTED|Randomised Through Start Treatment||400||
60055622|NCT02161757|76171077|FG000|COMPLETED|Randomised Through Start Treatment||398||
60055623|NCT02161757|76171078|FG001|COMPLETED|Randomised Through Start Treatment||404||
60055624|NCT02161757|76171079|FG002|COMPLETED|Randomised Through Start Treatment||400||
60055625|NCT02161757|76171077|FG000|NOT COMPLETED|Randomised Through Start Treatment||3||
60055626|NCT02161757|76171078|FG001|NOT COMPLETED|Randomised Through Start Treatment||2||
60055627|NCT02161757|76171079|FG002|NOT COMPLETED|Randomised Through Start Treatment||0||
60055628|NCT02161757|76171077|FG000|STARTED|Treatment Through Study Completion||398||
60055629|NCT02161757|76171078|FG001|STARTED|Treatment Through Study Completion||404||
60055630|NCT02161757|76171079|FG002|STARTED|Treatment Through Study Completion||400||
60055631|NCT02161757|76171077|FG000|Completed Treatment for Week 52 Cut-off|Treatment Through Study Completion||332||
60055632|NCT02161757|76171078|FG001|Completed Treatment for Week 52 Cut-off|Treatment Through Study Completion||355||
60055633|NCT02161757|76171079|FG002|Completed Treatment for Week 52 Cut-off|Treatment Through Study Completion||360||
60055634|NCT02161757|76171077|FG000|COMPLETED|Treatment Through Study Completion||341|Completed the study|
60055635|NCT02161757|76171078|FG001|COMPLETED|Treatment Through Study Completion||361|Completed the study|
60055636|NCT02161757|76171079|FG002|COMPLETED|Treatment Through Study Completion||361|Completed the study|
60055637|NCT02161757|76171077|FG000|NOT COMPLETED|Treatment Through Study Completion||57||
60055638|NCT02161757|76171078|FG001|NOT COMPLETED|Treatment Through Study Completion||43||
59515437|NCT03131206|75609296|FG000|STARTED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0||
59515438|NCT03131206|75609297|FG001|STARTED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0||
59515439|NCT03131206|75609298|FG002|STARTED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0||
59515440|NCT03131206|75609299|FG003|STARTED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0||
59515441|NCT03131206|75609296|FG000|COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0||
59515442|NCT03131206|75609297|FG001|COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0||
59515443|NCT03131206|75609298|FG002|COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0||
59515444|NCT03131206|75609299|FG003|COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0||
59515445|NCT03131206|75609296|FG000|NOT COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0||
60055639|NCT02161757|76171079|FG002|NOT COMPLETED|Treatment Through Study Completion||39||
60055640|NCT02160977|76171089|FG000|STARTED|One Week After Surgery||45||
60055641|NCT02160977|76171090|FG001|STARTED|One Week After Surgery||45||
60055642|NCT02160977|76171089|FG000|COMPLETED|One Week After Surgery||45||
59515446|NCT03131206|75609297|FG001|NOT COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0||
59924288|NCT03426995|76043419|FG013|STARTED|Part A: Cohort 1-Period 2 (Day1)||0||
59924289|NCT03426995|76043420|FG014|STARTED|Part A: Cohort 1-Period 2 (Day1)||0||
59924290|NCT03426995|76043421|FG015|STARTED|Part A: Cohort 1-Period 2 (Day1)||0||
59924291|NCT03426995|76043422|FG016|STARTED|Part A: Cohort 1-Period 2 (Day1)||0||
59924292|NCT03426995|76043423|FG017|STARTED|Part A: Cohort 1-Period 2 (Day1)||0||
60055643|NCT02160977|76171090|FG001|COMPLETED|One Week After Surgery||45||
60055644|NCT02160977|76171089|FG000|NOT COMPLETED|One Week After Surgery||0||
60055645|NCT02160977|76171090|FG001|NOT COMPLETED|One Week After Surgery||0||
60055646|NCT02160977|76171089|FG000|STARTED|Six Weeks After Surgery||45||
60055647|NCT02160977|76171090|FG001|STARTED|Six Weeks After Surgery||45||
60055648|NCT02160977|76171089|FG000|COMPLETED|Six Weeks After Surgery||44||
60055649|NCT02160977|76171090|FG001|COMPLETED|Six Weeks After Surgery||45||
60055650|NCT02160977|76171089|FG000|NOT COMPLETED|Six Weeks After Surgery||1||
60055651|NCT02160977|76171090|FG001|NOT COMPLETED|Six Weeks After Surgery||0||
60055652|NCT02160977|76171089|FG000|STARTED|Three Months After Surgery||44||
60055653|NCT02160977|76171090|FG001|STARTED|Three Months After Surgery||45||
60055654|NCT02160977|76171089|FG000|COMPLETED|Three Months After Surgery||44||
60055655|NCT02160977|76171090|FG001|COMPLETED|Three Months After Surgery||43||
60055656|NCT02160977|76171089|FG000|NOT COMPLETED|Three Months After Surgery||0||
60055657|NCT02160977|76171090|FG001|NOT COMPLETED|Three Months After Surgery||2||
59924293|NCT03426995|76043424|FG018|STARTED|Part A: Cohort 1-Period 2 (Day1)||0||
59924294|NCT03426995|76043406|FG000|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||1||
59924295|NCT03426995|76043407|FG001|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||2||
59924296|NCT03426995|76043408|FG002|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||1||
59924297|NCT03426995|76043409|FG003|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||2||
59924298|NCT03426995|76043410|FG004|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
59924299|NCT03426995|76043411|FG005|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||1||
59924300|NCT03426995|76043412|FG006|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
59924301|NCT03426995|76043413|FG007|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
59924302|NCT03426995|76043414|FG008|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
59924303|NCT03426995|76043415|FG009|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
59924304|NCT03426995|76043416|FG010|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
59924305|NCT03426995|76043417|FG011|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
59924306|NCT03426995|76043418|FG012|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
59924307|NCT03426995|76043419|FG013|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
59924308|NCT03426995|76043420|FG014|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
59924309|NCT03426995|76043421|FG015|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
59924310|NCT03426995|76043422|FG016|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
60055658|NCT02160977|76171089|FG000|STARTED|Six Months After Surgery||44||
60055659|NCT02160977|76171090|FG001|STARTED|Six Months After Surgery||43||
60055660|NCT02160977|76171089|FG000|COMPLETED|Six Months After Surgery||42||
60055661|NCT02160977|76171090|FG001|COMPLETED|Six Months After Surgery||42||
60055662|NCT02160977|76171089|FG000|NOT COMPLETED|Six Months After Surgery||2||
59515447|NCT03131206|75609298|FG002|NOT COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0||
59515448|NCT03131206|75609299|FG003|NOT COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0||
59924311|NCT03426995|76043423|FG017|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
59924312|NCT03426995|76043424|FG018|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
59924313|NCT03426995|76043406|FG000|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
59924314|NCT03426995|76043407|FG001|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
60055663|NCT02160977|76171090|FG001|NOT COMPLETED|Six Months After Surgery||1||
60055664|NCT02160899|76171102|FG000|STARTED|Overall Study||26||
60055665|NCT02160899|76171103|FG001|STARTED|Overall Study||4||
60055666|NCT02160899|76171104|FG002|STARTED|Overall Study||21||
60055667|NCT02160899|76171105|FG003|STARTED|Overall Study||3||
60055668|NCT02160899|76171106|FG004|STARTED|Overall Study||2||
60055669|NCT02160899|76171107|FG005|STARTED|Overall Study||8||
60055670|NCT02160899|76171102|FG000|COMPLETED|Overall Study||26||
60055671|NCT02160899|76171103|FG001|COMPLETED|Overall Study||3||
60055672|NCT02160899|76171104|FG002|COMPLETED|Overall Study||21||
60055673|NCT02160899|76171105|FG003|COMPLETED|Overall Study||2||
60055674|NCT02160899|76171106|FG004|COMPLETED|Overall Study||0||
60055675|NCT02160899|76171107|FG005|COMPLETED|Overall Study||8||
60055676|NCT02160899|76171102|FG000|NOT COMPLETED|Overall Study||0||
60055677|NCT02160899|76171103|FG001|NOT COMPLETED|Overall Study||1||
60055678|NCT02160899|76171104|FG002|NOT COMPLETED|Overall Study||0||
60055679|NCT02160899|76171105|FG003|NOT COMPLETED|Overall Study||1||
60055680|NCT02160899|76171106|FG004|NOT COMPLETED|Overall Study||2||
60055681|NCT02160899|76171107|FG005|NOT COMPLETED|Overall Study||0||
60055682|NCT02160041|76171121|FG000|STARTED|Overall Study||84||
60055683|NCT02160041|76171121|FG000|COMPLETED|Overall Study||0||
60055684|NCT02160041|76171121|FG000|NOT COMPLETED|Overall Study||84||
60055685|NCT02186873|76171127|FG000|STARTED|Overall Study||103||
60055686|NCT02186873|76171128|FG001|STARTED|Overall Study||105||
59924315|NCT03426995|76043408|FG002|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
59924316|NCT03426995|76043409|FG003|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
59924317|NCT03426995|76043410|FG004|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||1||
59924318|NCT03426995|76043411|FG005|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||2||
59924319|NCT03426995|76043412|FG006|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
59924320|NCT03426995|76043413|FG007|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
59924321|NCT03426995|76043414|FG008|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
59924322|NCT03426995|76043415|FG009|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
59924323|NCT03426995|76043416|FG010|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
59924324|NCT03426995|76043417|FG011|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
60055687|NCT02186873|76171127|FG000|End of Control Period|Overall Study|Participants taking placebo crossed over to golimumab|99||
60055688|NCT02186873|76171128|FG001|End of Control Period|Overall Study|Participants continued to receive golimumab|105||
60055689|NCT02186873|76171127|FG000|COMPLETED|Overall Study||94||
60055690|NCT02186873|76171128|FG001|COMPLETED|Overall Study||97||
60055691|NCT02186873|76171127|FG000|NOT COMPLETED|Overall Study||9||
60055692|NCT02186873|76171128|FG001|NOT COMPLETED|Overall Study||8||
60055693|NCT02096263|76171138|FG000|STARTED|Overall Study||195||
60055694|NCT02096263|76171139|FG001|STARTED|Overall Study||194||
60055695|NCT02096263|76171140|FG002|STARTED|Overall Study||196||
60055696|NCT02096263|76171138|FG000|COMPLETED|Overall Study||161||
60055697|NCT02096263|76171139|FG001|COMPLETED|Overall Study||158||
60055698|NCT02096263|76171140|FG002|COMPLETED|Overall Study||157||
60055699|NCT02096263|76171138|FG000|NOT COMPLETED|Overall Study||34||
60055700|NCT02096263|76171139|FG001|NOT COMPLETED|Overall Study||36||
60055701|NCT02096263|76171140|FG002|NOT COMPLETED|Overall Study||39||
60055702|NCT01830543|76171151|FG000|STARTED|Overall Study||709||
60055703|NCT01830543|76171152|FG001|STARTED|Overall Study||709||
60055704|NCT01830543|76171153|FG002|STARTED|Overall Study||706||
60055705|NCT01830543|76171151|FG000|Treated|Overall Study||696||
59924325|NCT03426995|76043418|FG012|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
59924326|NCT03426995|76043419|FG013|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
60055706|NCT01830543|76171152|FG001|Treated|Overall Study||706||
60055707|NCT01830543|76171153|FG002|Treated|Overall Study||697||
60055708|NCT01830543|76171151|FG000|COMPLETED|Overall Study||550||
60055709|NCT01830543|76171152|FG001|COMPLETED|Overall Study||557||
60055710|NCT01830543|76171153|FG002|COMPLETED|Overall Study||492||
60055711|NCT01830543|76171151|FG000|NOT COMPLETED|Overall Study||159||
60055712|NCT01830543|76171152|FG001|NOT COMPLETED|Overall Study||152||
60055713|NCT01830543|76171153|FG002|NOT COMPLETED|Overall Study||214||
60055714|NCT02109445|76171161|FG000|STARTED|Overall Study||3||
60055715|NCT02109445|76171161|FG000|COMPLETED|Overall Study||0||
60055716|NCT02109445|76171161|FG000|NOT COMPLETED|Overall Study||3||
60055717|NCT02109133|76171167|FG000|STARTED|Overall Study||33||
60055718|NCT02109133|76171168|FG001|STARTED|Overall Study||34||
60055719|NCT02109133|76171167|FG000|COMPLETED|Overall Study||32||
60055720|NCT02109133|76171168|FG001|COMPLETED|Overall Study||34||
60055721|NCT02109133|76171167|FG000|NOT COMPLETED|Overall Study||1||
60055722|NCT02109133|76171168|FG001|NOT COMPLETED|Overall Study||0||
60055723|NCT01623271|76171176|FG000|STARTED|Overall Study||5||
60055724|NCT01623271|76171176|FG000|COMPLETED|Overall Study||3||
60055725|NCT01623271|76171176|FG000|NOT COMPLETED|Overall Study||2||
59924327|NCT03426995|76043420|FG014|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
60055726|NCT01856673|76171183|FG000|STARTED|Overall Study||175||
60055727|NCT01856673|76171184|FG001|STARTED|Overall Study||175||
60055728|NCT01856673|76171185|FG002|STARTED|Overall Study||171||
60055729|NCT01856673|76171183|FG000|Buenaventura Participants|Overall Study||92||
60055730|NCT01856673|76171184|FG001|Buenaventura Participants|Overall Study||89||
60055731|NCT01856673|76171185|FG002|Buenaventura Participants|Overall Study||88||
60055732|NCT01856673|76171183|FG000|Quibdó Participants|Overall Study||83||
60055733|NCT01856673|76171184|FG001|Quibdó Participants|Overall Study||86||
60055734|NCT01856673|76171185|FG002|Quibdó Participants|Overall Study||83||
60067864|NCT01785615|76183053|FG001|COMPLETED|Atorvastatin Phase||44||
60055735|NCT01856673|76171183|FG000|COMPLETED|Overall Study|A percentage of 75.1% completed the follow-up (exit survey)|80||
60055736|NCT01856673|76171184|FG001|COMPLETED|Overall Study|A percentage of 80.9% completed the follow-up (exit survey)|90||
60055737|NCT01856673|76171185|FG002|COMPLETED|Overall Study||137||
60055738|NCT01856673|76171183|FG000|NOT COMPLETED|Overall Study||95||
60055739|NCT01856673|76171184|FG001|NOT COMPLETED|Overall Study||85||
59924328|NCT03426995|76043421|FG015|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
59924329|NCT03426995|76043422|FG016|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
59924330|NCT03426995|76043423|FG017|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
59924331|NCT03426995|76043424|FG018|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0||
59924332|NCT03426995|76043406|FG000|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||1||
59924333|NCT03426995|76043407|FG001|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||2||
59924334|NCT03426995|76043408|FG002|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||1||
59924335|NCT03426995|76043409|FG003|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||2||
59924336|NCT03426995|76043410|FG004|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0||
59924337|NCT03426995|76043411|FG005|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||1||
59515449|NCT03132298|75609315|FG000|STARTED|Overall Study||48||
59515450|NCT03132298|75609316|FG001|STARTED|Overall Study||48||
59515451|NCT03132298|75609315|FG000|COMPLETED|Overall Study||36||
59515452|NCT03132298|75609316|FG001|COMPLETED|Overall Study||35||
59515453|NCT03132298|75609315|FG000|NOT COMPLETED|Overall Study||12||
59515454|NCT03132298|75609316|FG001|NOT COMPLETED|Overall Study||13||
60055740|NCT01856673|76171185|FG002|NOT COMPLETED|Overall Study||34||
60055741|NCT02095951|76171195|FG000|STARTED|Overall Study|2 participants with 4 episodes of catheter infection was enrolled twice in this group.|13|12 infection episodes from 6 participants; 6 of these episodes (3 participants) were in both groups.|15
60055742|NCT02095951|76171196|FG001|STARTED|Overall Study|1 participant with 2 episodes of catheter infection was enrolled twice in this group.|14|12 infection episodes from 6 participants; 6 of these episodes (3 participants) were in both groups.|18
60055743|NCT02095951|76171195|FG000|COMPLETED|Overall Study||4|Catheter Infection Episodes (Cases) reflect completed episodes with Positive blood cultures|5
60055744|NCT02095951|76171196|FG001|COMPLETED|Overall Study||8|Catheter Infection Episodes (Cases) reflect completed episodes with Positive blood cultures|9
60055745|NCT02095951|76171195|FG000|NOT COMPLETED|Overall Study||9||10
60055746|NCT02095951|76171196|FG001|NOT COMPLETED|Overall Study||6||9
60055747|NCT02095873|76171208|FG000|STARTED|First Intervention (8 Weeks)||16||
60055748|NCT02095873|76171209|FG001|STARTED|First Intervention (8 Weeks)||16||
60055749|NCT02095873|76171208|FG000|COMPLETED|First Intervention (8 Weeks)||15||
60055750|NCT02095873|76171209|FG001|COMPLETED|First Intervention (8 Weeks)||16||
60055751|NCT02095873|76171208|FG000|NOT COMPLETED|First Intervention (8 Weeks)||1||
60055752|NCT02095873|76171209|FG001|NOT COMPLETED|First Intervention (8 Weeks)||0||
60055753|NCT02095873|76171208|FG000|STARTED|Second Intervention (8 Weeks)||15||
60055754|NCT02095873|76171209|FG001|STARTED|Second Intervention (8 Weeks)||16||
60055755|NCT02095873|76171208|FG000|COMPLETED|Second Intervention (8 Weeks)||13||
60055756|NCT02095873|76171209|FG001|COMPLETED|Second Intervention (8 Weeks)||16||
60055757|NCT02095873|76171208|FG000|NOT COMPLETED|Second Intervention (8 Weeks)||2||
60055758|NCT02095873|76171209|FG001|NOT COMPLETED|Second Intervention (8 Weeks)||0||
60055759|NCT02094937|76171217|FG000|STARTED|8 Weeks in Period 1||430||
59924338|NCT03426995|76043412|FG006|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0||
60055760|NCT02094937|76171218|FG001|STARTED|8 Weeks in Period 1||0||
60055761|NCT02094937|76171219|FG002|STARTED|8 Weeks in Period 1||0||
60055762|NCT02094937|76171220|FG003|STARTED|8 Weeks in Period 1||0||
60055763|NCT02094937|76171217|FG000|COMPLETED|8 Weeks in Period 1||370||
60055764|NCT02094937|76171218|FG001|COMPLETED|8 Weeks in Period 1||0||
59515455|NCT00985543|75609322|FG000|STARTED|Overall Study||22||
59515456|NCT00985543|75609322|FG000|COMPLETED|Overall Study||22||
59515457|NCT00985543|75609322|FG000|NOT COMPLETED|Overall Study||0||
59515458|NCT03134092|75609331|FG000|STARTED|Overall Study||434||
59515459|NCT03134092|75609332|FG001|STARTED|Overall Study||435||
59515460|NCT03134092|75609333|FG002|STARTED|Overall Study||433||
59515461|NCT03134092|75609331|FG000|COMPLETED|Overall Study||434||
59612992|NCT01693692|75724040|FG000|STARTED|Overall Study||130||
59612993|NCT01693692|75724041|FG001|STARTED|Overall Study||131||
60055765|NCT02094937|76171219|FG002|COMPLETED|8 Weeks in Period 1||0||
60055766|NCT02094937|76171220|FG003|COMPLETED|8 Weeks in Period 1||0||
60055767|NCT02094937|76171217|FG000|NOT COMPLETED|8 Weeks in Period 1||60||
59612994|NCT01693692|75724042|FG002|STARTED|Overall Study||131||
60055768|NCT02094937|76171218|FG001|NOT COMPLETED|8 Weeks in Period 1||0||
60055769|NCT02094937|76171219|FG002|NOT COMPLETED|8 Weeks in Period 1||0||
60055770|NCT02094937|76171220|FG003|NOT COMPLETED|8 Weeks in Period 1||0||
60055771|NCT02094937|76171217|FG000|STARTED|12 Weeks in Period 2||0||
60055772|NCT02094937|76171218|FG001|STARTED|12 Weeks in Period 2||123||
59515462|NCT03134092|75609332|FG001|COMPLETED|Overall Study||435||
59515463|NCT03134092|75609333|FG002|COMPLETED|Overall Study||433||
59515464|NCT03134092|75609331|FG000|NOT COMPLETED|Overall Study||0||
59515465|NCT03134092|75609332|FG001|NOT COMPLETED|Overall Study||0||
59515466|NCT03134092|75609333|FG002|NOT COMPLETED|Overall Study||0||
59515467|NCT03134248|75609345|FG000|STARTED|Week 1||7||
59515468|NCT03134248|75609346|FG001|STARTED|Week 1||8||
59515469|NCT03134248|75609347|FG002|STARTED|Week 1||9||
59515470|NCT03134248|75609348|FG003|STARTED|Week 1||7||
60055773|NCT02094937|76171219|FG002|STARTED|12 Weeks in Period 2||124||
60055774|NCT02094937|76171220|FG003|STARTED|12 Weeks in Period 2||124||
60055775|NCT02094937|76171217|FG000|COMPLETED|12 Weeks in Period 2||0||
60055776|NCT02094937|76171218|FG001|COMPLETED|12 Weeks in Period 2||112||
60055777|NCT02094937|76171219|FG002|COMPLETED|12 Weeks in Period 2||112||
60055778|NCT02094937|76171220|FG003|COMPLETED|12 Weeks in Period 2||112||
60055779|NCT02094937|76171217|FG000|NOT COMPLETED|12 Weeks in Period 2||0||
60055780|NCT02094937|76171218|FG001|NOT COMPLETED|12 Weeks in Period 2||11||
60055781|NCT02094937|76171219|FG002|NOT COMPLETED|12 Weeks in Period 2||12||
60055782|NCT02094937|76171220|FG003|NOT COMPLETED|12 Weeks in Period 2||12||
60055783|NCT02093923|76171234|FG000|STARTED|Overall Study||4||
60055784|NCT02093923|76171235|FG001|STARTED|Overall Study||4||
59924339|NCT03426995|76043413|FG007|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0||
59924340|NCT03426995|76043414|FG008|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0||
59924341|NCT03426995|76043415|FG009|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0||
59924342|NCT03426995|76043416|FG010|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0||
59924343|NCT03426995|76043417|FG011|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0||
59924344|NCT03426995|76043418|FG012|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0||
59924345|NCT03426995|76043419|FG013|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0||
59924346|NCT03426995|76043420|FG014|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0||
59924347|NCT03426995|76043421|FG015|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0||
59924348|NCT03426995|76043422|FG016|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0||
60055785|NCT02093923|76171236|FG002|STARTED|Overall Study||5||
60055786|NCT02093923|76171237|FG003|STARTED|Overall Study||12||
60055787|NCT02093923|76171238|FG004|STARTED|Overall Study||13||
60055788|NCT02093923|76171234|FG000|Total Treated|Overall Study||4||
60055789|NCT02093923|76171235|FG001|Total Treated|Overall Study||4||
60055790|NCT02093923|76171236|FG002|Total Treated|Overall Study||5||
60055791|NCT02093923|76171237|FG003|Total Treated|Overall Study||11||
60055792|NCT02093923|76171238|FG004|Total Treated|Overall Study||13||
60055793|NCT02093923|76171234|FG000|Treated - 1 Dose Only:|Overall Study||0||
60055794|NCT02093923|76171235|FG001|Treated - 1 Dose Only:|Overall Study||0||
60055795|NCT02093923|76171236|FG002|Treated - 1 Dose Only:|Overall Study||0||
60055796|NCT02093923|76171237|FG003|Treated - 1 Dose Only:|Overall Study||1||
60055797|NCT02093923|76171238|FG004|Treated - 1 Dose Only:|Overall Study||0||
60055798|NCT02093923|76171234|FG000|Treated - 2 Doses:|Overall Study||4||
60055799|NCT02093923|76171235|FG001|Treated - 2 Doses:|Overall Study||4||
60055800|NCT02093923|76171236|FG002|Treated - 2 Doses:|Overall Study||5||
60055801|NCT02093923|76171237|FG003|Treated - 2 Doses:|Overall Study||10||
60055802|NCT02093923|76171238|FG004|Treated - 2 Doses:|Overall Study||13||
59924349|NCT03426995|76043423|FG017|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0||
59924350|NCT03426995|76043424|FG018|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0||
59924351|NCT03426995|76043406|FG000|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||1||
59924352|NCT03426995|76043407|FG001|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||2||
60055803|NCT02093923|76171234|FG000|COMPLETED|Overall Study||4||
60055804|NCT02093923|76171235|FG001|COMPLETED|Overall Study||4||
60055805|NCT02093923|76171236|FG002|COMPLETED|Overall Study||5||
60055806|NCT02093923|76171237|FG003|COMPLETED|Overall Study||10||
60055807|NCT02093923|76171238|FG004|COMPLETED|Overall Study||13||
60055808|NCT02093923|76171234|FG000|NOT COMPLETED|Overall Study||0||
60055809|NCT02093923|76171235|FG001|NOT COMPLETED|Overall Study||0||
60055810|NCT02093923|76171236|FG002|NOT COMPLETED|Overall Study||0||
60055811|NCT02093923|76171237|FG003|NOT COMPLETED|Overall Study||2||
60055812|NCT02093923|76171238|FG004|NOT COMPLETED|Overall Study||0||
59924353|NCT03426995|76043408|FG002|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||1||
60055813|NCT02186561|76171254|FG000|STARTED|Enrollment||197|Participants Consented and Assessed for Eligibility|
60055814|NCT02186561|76171254|FG000|COMPLETED|Enrollment||141|Enrolled Participants in Whom Deployment of the Investigational Device was Attempted- ITT Population|
59924354|NCT03426995|76043409|FG003|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||2||
59924355|NCT03426995|76043410|FG004|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0||
60055815|NCT02186561|76171254|FG000|NOT COMPLETED|Enrollment||56||
60055816|NCT02186561|76171254|FG000|STARTED|Subjects Implanted With Device||141|Participants with an Attempted Investigational Device Implant|
60055817|NCT02186561|76171254|FG000|COMPLETED|Subjects Implanted With Device||141|Participants with a Successful Investigational Device Implant|
60055818|NCT02186561|76171254|FG000|NOT COMPLETED|Subjects Implanted With Device||0||
60055819|NCT02186561|76171254|FG000|STARTED|30-Day Post Index Procedure Visit||141|Participants implanted with the investigational device.|
60055820|NCT02186561|76171254|FG000|COMPLETED|30-Day Post Index Procedure Visit||140|Participants Implanted with the Investigational Device that Completed the 30 Day Visit|
60055821|NCT02186561|76171254|FG000|NOT COMPLETED|30-Day Post Index Procedure Visit||1||
60055822|NCT02186561|76171254|FG000|STARTED|180- Day Post Index Procedure Visit||141|Participants implanted with the investigational device.|
60055823|NCT02186561|76171254|FG000|COMPLETED|180- Day Post Index Procedure Visit||134|Participants Implanted with the Investigational Device that Completed the 30 Day Visit|
60055824|NCT02186561|76171254|FG000|NOT COMPLETED|180- Day Post Index Procedure Visit||7||
60055825|NCT02186561|76171254|FG000|STARTED|1- Year Post Index Procedure Visit||141|Participants implanted with the investigational device.|
60055826|NCT02186561|76171254|FG000|COMPLETED|1- Year Post Index Procedure Visit||139|Participants Implanted with the Investigational Device that Completed the 1 Year Visit|
60055827|NCT02186561|76171254|FG000|NOT COMPLETED|1- Year Post Index Procedure Visit||2||
60055828|NCT02186561|76171254|FG000|STARTED|2 - Year Post Index Procedure Visit||141|Participants implanted with the investigational device.|
60055829|NCT02186561|76171254|FG000|COMPLETED|2 - Year Post Index Procedure Visit||134|Participants Implanted with the Investigational Device that Completed the 2 Year Visit|
60055830|NCT02186561|76171254|FG000|NOT COMPLETED|2 - Year Post Index Procedure Visit||7||
60055831|NCT02186561|76171254|FG000|STARTED|3 - Year Post Index Procedure Visit||141|Participants implanted with the investigational device.|
60055832|NCT02186561|76171254|FG000|COMPLETED|3 - Year Post Index Procedure Visit||128|Participants Implanted with the Investigational Device that Completed the 3 Year Visit|
60055833|NCT02186561|76171254|FG000|NOT COMPLETED|3 - Year Post Index Procedure Visit||13||
60055834|NCT02066467|76171260|FG000|STARTED|Overall Study||863||
60055835|NCT02066467|76171260|FG000|COMPLETED|Overall Study||648||
60055836|NCT02066467|76171260|FG000|NOT COMPLETED|Overall Study||215||
60055837|NCT02186171|76171266|FG000|STARTED|Overall Study||82||
60055838|NCT02186171|76171267|FG001|STARTED|Overall Study||163||
60055839|NCT02186171|76171266|FG000|Received Treatment|Overall Study||81||
60055840|NCT02186171|76171267|FG001|Received Treatment|Overall Study||163||
60055841|NCT02186171|76171266|FG000|COMPLETED|Overall Study||78||
60055842|NCT02186171|76171267|FG001|COMPLETED|Overall Study||148||
60055843|NCT02186171|76171266|FG000|NOT COMPLETED|Overall Study||4||
60055844|NCT02186171|76171267|FG001|NOT COMPLETED|Overall Study||15||
60055845|NCT02186015|76171275|FG000|STARTED|Overall Study||11||
60055846|NCT02186015|76171276|FG001|STARTED|Overall Study||31||
60055847|NCT02186015|76171275|FG000|COMPLETED|Overall Study||10||
60055848|NCT02186015|76171276|FG001|COMPLETED|Overall Study||31||
60055849|NCT02186015|76171275|FG000|NOT COMPLETED|Overall Study||1||
60055850|NCT02186015|76171276|FG001|NOT COMPLETED|Overall Study||0||
60055851|NCT02066389|76171289|FG000|STARTED|Overall Study||50||
60055852|NCT02066389|76171290|FG001|STARTED|Overall Study||50||
60055853|NCT02066389|76171291|FG002|STARTED|Overall Study||50||
60055854|NCT02066389|76171292|FG003|STARTED|Overall Study||50||
60055855|NCT02066389|76171293|FG004|STARTED|Overall Study||50||
60055856|NCT02066389|76171294|FG005|STARTED|Overall Study||50||
60055857|NCT02066389|76171289|FG000|Received Study Drug|Overall Study||50||
60055858|NCT02066389|76171290|FG001|Received Study Drug|Overall Study||50||
60055859|NCT02066389|76171291|FG002|Received Study Drug|Overall Study||50||
60055860|NCT02066389|76171292|FG003|Received Study Drug|Overall Study||50||
60055861|NCT02066389|76171293|FG004|Received Study Drug|Overall Study||50||
60055862|NCT02066389|76171294|FG005|Received Study Drug|Overall Study||49||
60055863|NCT02066389|76171289|FG000|COMPLETED|Overall Study||45||
60055864|NCT02066389|76171290|FG001|COMPLETED|Overall Study||49||
60055865|NCT02066389|76171291|FG002|COMPLETED|Overall Study||44||
60055866|NCT02066389|76171292|FG003|COMPLETED|Overall Study||47||
60055867|NCT02066389|76171293|FG004|COMPLETED|Overall Study||43||
60055868|NCT02066389|76171294|FG005|COMPLETED|Overall Study||45||
60055869|NCT02066389|76171289|FG000|NOT COMPLETED|Overall Study||5||
60055870|NCT02066389|76171290|FG001|NOT COMPLETED|Overall Study||1||
60055871|NCT02066389|76171291|FG002|NOT COMPLETED|Overall Study||6||
60055872|NCT02066389|76171292|FG003|NOT COMPLETED|Overall Study||3||
60055873|NCT02066389|76171293|FG004|NOT COMPLETED|Overall Study||7||
59515471|NCT03134248|75609349|FG004|STARTED|Week 1||9||
59515472|NCT03134248|75609350|FG005|STARTED|Week 1||9||
59515473|NCT03134248|75609345|FG000|COMPLETED|Week 1||7||
59515474|NCT03134248|75609346|FG001|COMPLETED|Week 1||8||
59515475|NCT03134248|75609347|FG002|COMPLETED|Week 1||9||
59515476|NCT03134248|75609348|FG003|COMPLETED|Week 1||7||
59515477|NCT03134248|75609349|FG004|COMPLETED|Week 1||9||
59515478|NCT03134248|75609350|FG005|COMPLETED|Week 1||9||
59515479|NCT03134248|75609345|FG000|NOT COMPLETED|Week 1||0||
59515480|NCT03134248|75609346|FG001|NOT COMPLETED|Week 1||0||
59612995|NCT01693692|75724040|FG000|Received Study Drug|Overall Study||128||
60055874|NCT02066389|76171294|FG005|NOT COMPLETED|Overall Study||5||
59515481|NCT03134248|75609347|FG002|NOT COMPLETED|Week 1||0||
59515482|NCT03134248|75609348|FG003|NOT COMPLETED|Week 1||0||
59515483|NCT03134248|75609349|FG004|NOT COMPLETED|Week 1||0||
59515484|NCT03134248|75609350|FG005|NOT COMPLETED|Week 1||0||
59515485|NCT03134248|75609345|FG000|STARTED|Week 2||7||
59515486|NCT03134248|75609346|FG001|STARTED|Week 2||8||
59515487|NCT03134248|75609347|FG002|STARTED|Week 2||9||
59515488|NCT03134248|75609348|FG003|STARTED|Week 2||7||
60055875|NCT02106403|76171308|FG000|STARTED|Visit 1, Treatment Period 1||8||
60055876|NCT02106403|76171309|FG001|STARTED|Visit 1, Treatment Period 1||8||
59515489|NCT03134248|75609349|FG004|STARTED|Week 2||9||
59515490|NCT03134248|75609350|FG005|STARTED|Week 2||9||
59515491|NCT03134248|75609345|FG000|COMPLETED|Week 2||7||
59515492|NCT03134248|75609346|FG001|COMPLETED|Week 2||8||
59515493|NCT03134248|75609347|FG002|COMPLETED|Week 2||9||
59515494|NCT03134248|75609348|FG003|COMPLETED|Week 2||7||
59515495|NCT03134248|75609349|FG004|COMPLETED|Week 2||9||
59515496|NCT03134248|75609350|FG005|COMPLETED|Week 2||9||
59515497|NCT03134248|75609345|FG000|NOT COMPLETED|Week 2||0||
59515498|NCT03134248|75609346|FG001|NOT COMPLETED|Week 2||0||
59515499|NCT03134248|75609347|FG002|NOT COMPLETED|Week 2||0||
59515500|NCT03134248|75609348|FG003|NOT COMPLETED|Week 2||0||
59515501|NCT03134248|75609349|FG004|NOT COMPLETED|Week 2||0||
59515502|NCT03134248|75609350|FG005|NOT COMPLETED|Week 2||0||
59515503|NCT03134248|75609345|FG000|STARTED|Week 3||7||
59515504|NCT03134248|75609346|FG001|STARTED|Week 3||8||
59515505|NCT03134248|75609347|FG002|STARTED|Week 3||9||
59515506|NCT03134248|75609348|FG003|STARTED|Week 3||7||
59515507|NCT03134248|75609349|FG004|STARTED|Week 3||9||
59515508|NCT03134248|75609350|FG005|STARTED|Week 3||9||
59515509|NCT03134248|75609345|FG000|COMPLETED|Week 3||7||
59515510|NCT03134248|75609346|FG001|COMPLETED|Week 3||8||
59515511|NCT03134248|75609347|FG002|COMPLETED|Week 3||9||
59515512|NCT03134248|75609348|FG003|COMPLETED|Week 3||7||
59515513|NCT03134248|75609349|FG004|COMPLETED|Week 3||9||
59515514|NCT03134248|75609350|FG005|COMPLETED|Week 3||9||
59515515|NCT03134248|75609345|FG000|NOT COMPLETED|Week 3||0||
59515516|NCT03134248|75609346|FG001|NOT COMPLETED|Week 3||0||
59515517|NCT03134248|75609347|FG002|NOT COMPLETED|Week 3||0||
59515518|NCT03134248|75609348|FG003|NOT COMPLETED|Week 3||0||
59515519|NCT03134248|75609349|FG004|NOT COMPLETED|Week 3||0||
59515520|NCT03134248|75609350|FG005|NOT COMPLETED|Week 3||0||
59515521|NCT03134326|75609360|FG000|STARTED|Overall Study||21||
59515522|NCT03134326|75609360|FG000|COMPLETED|Overall Study||21||
59515523|NCT03134326|75609360|FG000|NOT COMPLETED|Overall Study||0||
59924356|NCT03426995|76043411|FG005|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||1||
59924357|NCT03426995|76043412|FG006|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0||
59924358|NCT03426995|76043413|FG007|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0||
59924359|NCT03426995|76043414|FG008|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0||
59924360|NCT03426995|76043415|FG009|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0||
59924361|NCT03426995|76043416|FG010|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0||
59924362|NCT03426995|76043417|FG011|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0||
59924363|NCT03426995|76043418|FG012|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0||
59924364|NCT03426995|76043419|FG013|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0||
59924365|NCT03426995|76043420|FG014|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0||
59924366|NCT03426995|76043421|FG015|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0||
59924367|NCT03426995|76043422|FG016|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0||
59924368|NCT03426995|76043423|FG017|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0||
59924369|NCT03426995|76043424|FG018|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0||
59924370|NCT03426995|76043406|FG000|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0||
59924371|NCT03426995|76043407|FG001|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0||
59924372|NCT03426995|76043408|FG002|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0||
59924373|NCT03426995|76043409|FG003|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0||
59924374|NCT03426995|76043410|FG004|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0||
59515524|NCT00986401|75609366|FG000|STARTED|Period 1||22||
59515525|NCT00986401|75609367|FG001|STARTED|Period 1||22||
59515526|NCT00986401|75609366|FG000|COMPLETED|Period 1||22||
59515527|NCT00986401|75609367|FG001|COMPLETED|Period 1||21||
59515528|NCT00986401|75609366|FG000|NOT COMPLETED|Period 1||0||
59515529|NCT00986401|75609367|FG001|NOT COMPLETED|Period 1||1||
59924375|NCT03426995|76043411|FG005|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0||
59924376|NCT03426995|76043412|FG006|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0||
59515530|NCT00986401|75609366|FG000|STARTED|Period 2||22||
59515531|NCT00986401|75609367|FG001|STARTED|Period 2||21||
59515532|NCT00986401|75609366|FG000|COMPLETED|Period 2||22||
59515533|NCT00986401|75609367|FG001|COMPLETED|Period 2||21||
59515534|NCT00986401|75609366|FG000|NOT COMPLETED|Period 2||0||
59515535|NCT00986401|75609367|FG001|NOT COMPLETED|Period 2||0||
59515536|NCT04957498|75609378|FG000|STARTED|Overall Study||20||
59515537|NCT04957498|75609379|FG001|STARTED|Overall Study||20||
59515538|NCT04957498|75609378|FG000|COMPLETED|Overall Study||19||
59515539|NCT04957498|75609379|FG001|COMPLETED|Overall Study||18||
59924377|NCT03426995|76043413|FG007|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0||
59924378|NCT03426995|76043414|FG008|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0||
59924379|NCT03426995|76043415|FG009|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0||
59924380|NCT03426995|76043416|FG010|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0||
59924381|NCT03426995|76043417|FG011|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0||
59924382|NCT03426995|76043418|FG012|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0||
59924383|NCT03426995|76043419|FG013|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0||
59924384|NCT03426995|76043420|FG014|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0||
59924385|NCT03426995|76043421|FG015|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0||
59924386|NCT03426995|76043422|FG016|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0||
59924387|NCT03426995|76043423|FG017|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0||
59924388|NCT03426995|76043424|FG018|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0||
59924389|NCT03426995|76043406|FG000|STARTED|Part A: Cohort 1-Period 3 (Day1)||1||
59924390|NCT03426995|76043407|FG001|STARTED|Part A: Cohort 1-Period 3 (Day1)||2||
59924391|NCT03426995|76043408|FG002|STARTED|Part A: Cohort 1-Period 3 (Day1)||1||
59924392|NCT03426995|76043409|FG003|STARTED|Part A: Cohort 1-Period 3 (Day1)||2||
59924393|NCT03426995|76043410|FG004|STARTED|Part A: Cohort 1-Period 3 (Day1)|New participant enrolled and dosed.|1||
59924394|NCT03426995|76043411|FG005|STARTED|Part A: Cohort 1-Period 3 (Day1)|New participant enrolled and dosed.|2||
59924395|NCT03426995|76043412|FG006|STARTED|Part A: Cohort 1-Period 3 (Day1)||0||
59924396|NCT03426995|76043413|FG007|STARTED|Part A: Cohort 1-Period 3 (Day1)||0||
59924397|NCT03426995|76043414|FG008|STARTED|Part A: Cohort 1-Period 3 (Day1)||0||
59924398|NCT03426995|76043415|FG009|STARTED|Part A: Cohort 1-Period 3 (Day1)||0||
59924399|NCT03426995|76043416|FG010|STARTED|Part A: Cohort 1-Period 3 (Day1)||0||
59924400|NCT03426995|76043417|FG011|STARTED|Part A: Cohort 1-Period 3 (Day1)||0||
59924401|NCT03426995|76043418|FG012|STARTED|Part A: Cohort 1-Period 3 (Day1)||0||
59924402|NCT03426995|76043419|FG013|STARTED|Part A: Cohort 1-Period 3 (Day1)||0||
59924403|NCT03426995|76043420|FG014|STARTED|Part A: Cohort 1-Period 3 (Day1)||0||
59924404|NCT03426995|76043421|FG015|STARTED|Part A: Cohort 1-Period 3 (Day1)||0||
59924405|NCT03426995|76043422|FG016|STARTED|Part A: Cohort 1-Period 3 (Day1)||0||
59924406|NCT03426995|76043423|FG017|STARTED|Part A: Cohort 1-Period 3 (Day1)||0||
59924407|NCT03426995|76043424|FG018|STARTED|Part A: Cohort 1-Period 3 (Day1)||0||
59924408|NCT03426995|76043406|FG000|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||1||
59924409|NCT03426995|76043407|FG001|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||2||
59924410|NCT03426995|76043408|FG002|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||1||
59924411|NCT03426995|76043409|FG003|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||2||
59924412|NCT03426995|76043410|FG004|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||1||
59924413|NCT03426995|76043411|FG005|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||2||
59924414|NCT03426995|76043412|FG006|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
59924415|NCT03426995|76043413|FG007|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
59924416|NCT03426995|76043414|FG008|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
59924417|NCT03426995|76043415|FG009|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
59924418|NCT03426995|76043416|FG010|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
59924419|NCT03426995|76043417|FG011|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
59924420|NCT03426995|76043418|FG012|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
59924421|NCT03426995|76043419|FG013|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
59924422|NCT03426995|76043420|FG014|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
59924423|NCT03426995|76043421|FG015|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
59924424|NCT03426995|76043422|FG016|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
59924425|NCT03426995|76043423|FG017|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
59924426|NCT03426995|76043424|FG018|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
59924427|NCT03426995|76043406|FG000|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
59924428|NCT03426995|76043407|FG001|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
59924429|NCT03426995|76043408|FG002|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
59924430|NCT03426995|76043409|FG003|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
59924431|NCT03426995|76043410|FG004|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
59924432|NCT03426995|76043411|FG005|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
59924433|NCT03426995|76043412|FG006|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
59924434|NCT03426995|76043413|FG007|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
59924435|NCT03426995|76043414|FG008|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
59924436|NCT03426995|76043415|FG009|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
59924437|NCT03426995|76043416|FG010|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
59924438|NCT03426995|76043417|FG011|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
59924439|NCT03426995|76043418|FG012|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
59924440|NCT03426995|76043419|FG013|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
59924441|NCT03426995|76043420|FG014|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
59924442|NCT03426995|76043421|FG015|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
59924443|NCT03426995|76043422|FG016|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
59924444|NCT03426995|76043423|FG017|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
59924445|NCT03426995|76043424|FG018|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0||
59924446|NCT03426995|76043406|FG000|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||1||
59924447|NCT03426995|76043407|FG001|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||2||
59924448|NCT03426995|76043408|FG002|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||1||
59924449|NCT03426995|76043409|FG003|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||2||
59924450|NCT03426995|76043410|FG004|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||1||
59924451|NCT03426995|76043411|FG005|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||2||
59924452|NCT03426995|76043412|FG006|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0||
59924453|NCT03426995|76043413|FG007|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0||
59924454|NCT03426995|76043414|FG008|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0||
60055877|NCT02106403|76171310|FG002|STARTED|Visit 1, Treatment Period 1||9||
60055878|NCT02106403|76171311|FG003|STARTED|Visit 1, Treatment Period 1||8||
60055879|NCT02106403|76171312|FG004|STARTED|Visit 1, Treatment Period 1||8||
60055880|NCT02106403|76171313|FG005|STARTED|Visit 1, Treatment Period 1||9||
60055881|NCT02106403|76171308|FG000|COMPLETED|Visit 1, Treatment Period 1||8||
60055882|NCT02106403|76171309|FG001|COMPLETED|Visit 1, Treatment Period 1||8||
60055883|NCT02106403|76171310|FG002|COMPLETED|Visit 1, Treatment Period 1||9||
60055884|NCT02106403|76171311|FG003|COMPLETED|Visit 1, Treatment Period 1||8||
60055885|NCT02106403|76171312|FG004|COMPLETED|Visit 1, Treatment Period 1||8||
60055886|NCT02106403|76171313|FG005|COMPLETED|Visit 1, Treatment Period 1||9||
60055887|NCT02106403|76171308|FG000|NOT COMPLETED|Visit 1, Treatment Period 1||0||
60055888|NCT02106403|76171309|FG001|NOT COMPLETED|Visit 1, Treatment Period 1||0||
60055889|NCT02106403|76171310|FG002|NOT COMPLETED|Visit 1, Treatment Period 1||0||
60055890|NCT02106403|76171311|FG003|NOT COMPLETED|Visit 1, Treatment Period 1||0||
60055891|NCT02106403|76171312|FG004|NOT COMPLETED|Visit 1, Treatment Period 1||0||
60055892|NCT02106403|76171313|FG005|NOT COMPLETED|Visit 1, Treatment Period 1||0||
60055893|NCT02106403|76171308|FG000|STARTED|Visit 1, Treatment Period 2||8||
59924455|NCT03426995|76043415|FG009|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0||
59924456|NCT03426995|76043416|FG010|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0||
59924457|NCT03426995|76043417|FG011|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0||
59924458|NCT03426995|76043418|FG012|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0||
59924459|NCT03426995|76043419|FG013|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0||
59924460|NCT03426995|76043420|FG014|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0||
59924461|NCT03426995|76043421|FG015|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0||
59924462|NCT03426995|76043422|FG016|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0||
59924463|NCT03426995|76043423|FG017|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0||
59924464|NCT03426995|76043424|FG018|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0||
59924465|NCT03426995|76043406|FG000|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||1||
59924466|NCT03426995|76043407|FG001|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||2||
59924467|NCT03426995|76043408|FG002|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||1||
59924468|NCT03426995|76043409|FG003|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||2||
59924469|NCT03426995|76043410|FG004|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||1||
59924470|NCT03426995|76043411|FG005|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||2||
59924471|NCT03426995|76043412|FG006|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0||
59924472|NCT03426995|76043413|FG007|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0||
59924473|NCT03426995|76043414|FG008|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0||
59924474|NCT03426995|76043415|FG009|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0||
59924475|NCT03426995|76043416|FG010|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0||
59924476|NCT03426995|76043417|FG011|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0||
59924477|NCT03426995|76043418|FG012|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0||
59924478|NCT03426995|76043419|FG013|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0||
59924479|NCT03426995|76043420|FG014|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0||
59924480|NCT03426995|76043421|FG015|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0||
59924481|NCT03426995|76043422|FG016|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0||
60055894|NCT02106403|76171309|FG001|STARTED|Visit 1, Treatment Period 2||8||
60055895|NCT02106403|76171310|FG002|STARTED|Visit 1, Treatment Period 2||9||
60055896|NCT02106403|76171311|FG003|STARTED|Visit 1, Treatment Period 2||8||
60055897|NCT02106403|76171312|FG004|STARTED|Visit 1, Treatment Period 2||8||
60055898|NCT02106403|76171313|FG005|STARTED|Visit 1, Treatment Period 2||9||
59924482|NCT03426995|76043423|FG017|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0||
59924483|NCT03426995|76043424|FG018|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0||
59924484|NCT03426995|76043406|FG000|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0||
59924485|NCT03426995|76043407|FG001|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0||
59924486|NCT03426995|76043408|FG002|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0||
59924487|NCT03426995|76043409|FG003|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0||
60055899|NCT02106403|76171308|FG000|COMPLETED|Visit 1, Treatment Period 2||8||
60055900|NCT02106403|76171309|FG001|COMPLETED|Visit 1, Treatment Period 2||8||
60055901|NCT02106403|76171310|FG002|COMPLETED|Visit 1, Treatment Period 2||9||
59515540|NCT04957498|75609378|FG000|NOT COMPLETED|Overall Study||1||
59924488|NCT03426995|76043410|FG004|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0||
59924489|NCT03426995|76043411|FG005|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0||
59924490|NCT03426995|76043412|FG006|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0||
59924491|NCT03426995|76043413|FG007|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0||
59924492|NCT03426995|76043414|FG008|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0||
59924493|NCT03426995|76043415|FG009|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0||
59924494|NCT03426995|76043416|FG010|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0||
59924495|NCT03426995|76043417|FG011|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0||
59924496|NCT03426995|76043418|FG012|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0||
59924497|NCT03426995|76043419|FG013|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0||
59924498|NCT03426995|76043420|FG014|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0||
59924499|NCT03426995|76043421|FG015|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0||
59924500|NCT03426995|76043422|FG016|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0||
59924501|NCT03426995|76043423|FG017|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0||
59924502|NCT03426995|76043424|FG018|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0||
59924503|NCT03426995|76043406|FG000|STARTED|Part A: Cohort 1-Period 4 (Day1)||1||
59924504|NCT03426995|76043407|FG001|STARTED|Part A: Cohort 1-Period 4 (Day1)||2||
59924505|NCT03426995|76043408|FG002|STARTED|Part A: Cohort 1-Period 4 (Day1)||1||
59924506|NCT03426995|76043409|FG003|STARTED|Part A: Cohort 1-Period 4 (Day1)||2||
59924507|NCT03426995|76043410|FG004|STARTED|Part A: Cohort 1-Period 4 (Day1)||1||
59924508|NCT03426995|76043411|FG005|STARTED|Part A: Cohort 1-Period 4 (Day1)||2||
59924509|NCT03426995|76043412|FG006|STARTED|Part A: Cohort 1-Period 4 (Day1)||0||
59924510|NCT03426995|76043413|FG007|STARTED|Part A: Cohort 1-Period 4 (Day1)||0||
59924511|NCT03426995|76043414|FG008|STARTED|Part A: Cohort 1-Period 4 (Day1)||0||
59924512|NCT03426995|76043415|FG009|STARTED|Part A: Cohort 1-Period 4 (Day1)||0||
59924513|NCT03426995|76043416|FG010|STARTED|Part A: Cohort 1-Period 4 (Day1)||0||
59924514|NCT03426995|76043417|FG011|STARTED|Part A: Cohort 1-Period 4 (Day1)||0||
59924515|NCT03426995|76043418|FG012|STARTED|Part A: Cohort 1-Period 4 (Day1)||0||
59924516|NCT03426995|76043419|FG013|STARTED|Part A: Cohort 1-Period 4 (Day1)||0||
59924517|NCT03426995|76043420|FG014|STARTED|Part A: Cohort 1-Period 4 (Day1)||0||
59924518|NCT03426995|76043421|FG015|STARTED|Part A: Cohort 1-Period 4 (Day1)||0||
59924519|NCT03426995|76043422|FG016|STARTED|Part A: Cohort 1-Period 4 (Day1)||0||
59924520|NCT03426995|76043423|FG017|STARTED|Part A: Cohort 1-Period 4 (Day1)||0||
59924521|NCT03426995|76043424|FG018|STARTED|Part A: Cohort 1-Period 4 (Day1)||0||
59924522|NCT03426995|76043406|FG000|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||1||
59924523|NCT03426995|76043407|FG001|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||2||
59924524|NCT03426995|76043408|FG002|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||1||
59924525|NCT03426995|76043409|FG003|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||2||
59924526|NCT03426995|76043410|FG004|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||1||
59924527|NCT03426995|76043411|FG005|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||2||
59924528|NCT03426995|76043412|FG006|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
59924529|NCT03426995|76043413|FG007|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
59924530|NCT03426995|76043414|FG008|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
59924531|NCT03426995|76043415|FG009|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
59924532|NCT03426995|76043416|FG010|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
59924533|NCT03426995|76043417|FG011|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
59924534|NCT03426995|76043418|FG012|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
59924535|NCT03426995|76043419|FG013|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
59924536|NCT03426995|76043420|FG014|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
59924537|NCT03426995|76043421|FG015|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
59924538|NCT03426995|76043422|FG016|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
59924539|NCT03426995|76043423|FG017|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
59924540|NCT03426995|76043424|FG018|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
59924541|NCT03426995|76043406|FG000|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
59924542|NCT03426995|76043407|FG001|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
59924543|NCT03426995|76043408|FG002|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
59924544|NCT03426995|76043409|FG003|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
59924545|NCT03426995|76043410|FG004|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
59924546|NCT03426995|76043411|FG005|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
59924547|NCT03426995|76043412|FG006|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
59924548|NCT03426995|76043413|FG007|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
59515541|NCT04957498|75609379|FG001|NOT COMPLETED|Overall Study||2||
60055902|NCT02106403|76171311|FG003|COMPLETED|Visit 1, Treatment Period 2||8||
60055903|NCT02106403|76171312|FG004|COMPLETED|Visit 1, Treatment Period 2||8||
60055904|NCT02106403|76171313|FG005|COMPLETED|Visit 1, Treatment Period 2||9||
60055905|NCT02106403|76171308|FG000|NOT COMPLETED|Visit 1, Treatment Period 2||0||
60055906|NCT02106403|76171309|FG001|NOT COMPLETED|Visit 1, Treatment Period 2||0||
60055907|NCT02106403|76171310|FG002|NOT COMPLETED|Visit 1, Treatment Period 2||0||
60055908|NCT02106403|76171311|FG003|NOT COMPLETED|Visit 1, Treatment Period 2||0||
60055909|NCT02106403|76171312|FG004|NOT COMPLETED|Visit 1, Treatment Period 2||0||
60055910|NCT02106403|76171313|FG005|NOT COMPLETED|Visit 1, Treatment Period 2||0||
60055911|NCT02106403|76171308|FG000|STARTED|Visit 1, Treatment Period 3||8||
60055912|NCT02106403|76171309|FG001|STARTED|Visit 1, Treatment Period 3||8||
60055913|NCT02106403|76171310|FG002|STARTED|Visit 1, Treatment Period 3||9||
60055914|NCT02106403|76171311|FG003|STARTED|Visit 1, Treatment Period 3||8||
60055915|NCT02106403|76171312|FG004|STARTED|Visit 1, Treatment Period 3||8||
60055916|NCT02106403|76171313|FG005|STARTED|Visit 1, Treatment Period 3||9||
60055917|NCT02106403|76171308|FG000|COMPLETED|Visit 1, Treatment Period 3||8||
60055918|NCT02106403|76171309|FG001|COMPLETED|Visit 1, Treatment Period 3||8||
59924549|NCT03426995|76043414|FG008|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
60055919|NCT02106403|76171310|FG002|COMPLETED|Visit 1, Treatment Period 3||9||
60055920|NCT02106403|76171311|FG003|COMPLETED|Visit 1, Treatment Period 3||8||
60055921|NCT02106403|76171312|FG004|COMPLETED|Visit 1, Treatment Period 3||8||
60055922|NCT02106403|76171313|FG005|COMPLETED|Visit 1, Treatment Period 3||9||
60055923|NCT02106403|76171308|FG000|NOT COMPLETED|Visit 1, Treatment Period 3||0||
60055924|NCT02106403|76171309|FG001|NOT COMPLETED|Visit 1, Treatment Period 3||0||
60055925|NCT02106403|76171310|FG002|NOT COMPLETED|Visit 1, Treatment Period 3||0||
60055926|NCT02106403|76171311|FG003|NOT COMPLETED|Visit 1, Treatment Period 3||0||
60055927|NCT02106403|76171312|FG004|NOT COMPLETED|Visit 1, Treatment Period 3||0||
60055928|NCT02106403|76171313|FG005|NOT COMPLETED|Visit 1, Treatment Period 3||0||
60055929|NCT02106403|76171308|FG000|STARTED|Follow-Up Visit 2||8||
60055930|NCT02106403|76171309|FG001|STARTED|Follow-Up Visit 2||8||
60055931|NCT02106403|76171310|FG002|STARTED|Follow-Up Visit 2||9||
60055932|NCT02106403|76171311|FG003|STARTED|Follow-Up Visit 2||8||
60055933|NCT02106403|76171312|FG004|STARTED|Follow-Up Visit 2||8||
60055934|NCT02106403|76171313|FG005|STARTED|Follow-Up Visit 2||9||
60055935|NCT02106403|76171308|FG000|COMPLETED|Follow-Up Visit 2||8||
60055936|NCT02106403|76171309|FG001|COMPLETED|Follow-Up Visit 2||8||
59515542|NCT00987415|75609389|FG000|STARTED|Overall Study||128||
59515543|NCT00987415|75609390|FG001|STARTED|Overall Study||125||
59515544|NCT00987415|75609389|FG000|COMPLETED|Overall Study||119||
59515545|NCT00987415|75609390|FG001|COMPLETED|Overall Study||116||
59515546|NCT00987415|75609389|FG000|NOT COMPLETED|Overall Study||9||
59924550|NCT03426995|76043415|FG009|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
59924551|NCT03426995|76043416|FG010|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
59924552|NCT03426995|76043417|FG011|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
59924553|NCT03426995|76043418|FG012|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
59924554|NCT03426995|76043419|FG013|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
60055937|NCT02106403|76171310|FG002|COMPLETED|Follow-Up Visit 2||9||
60055938|NCT02106403|76171311|FG003|COMPLETED|Follow-Up Visit 2||8||
60055939|NCT02106403|76171312|FG004|COMPLETED|Follow-Up Visit 2||8||
60055940|NCT02106403|76171313|FG005|COMPLETED|Follow-Up Visit 2||9||
60055941|NCT02106403|76171308|FG000|NOT COMPLETED|Follow-Up Visit 2||0||
60055942|NCT02106403|76171309|FG001|NOT COMPLETED|Follow-Up Visit 2||0||
60055943|NCT02106403|76171310|FG002|NOT COMPLETED|Follow-Up Visit 2||0||
60055944|NCT02106403|76171311|FG003|NOT COMPLETED|Follow-Up Visit 2||0||
60055945|NCT02106403|76171312|FG004|NOT COMPLETED|Follow-Up Visit 2||0||
60055946|NCT02106403|76171313|FG005|NOT COMPLETED|Follow-Up Visit 2||0||
60055947|NCT02106403|76171308|FG000|STARTED|Follow-Up Visit 3||8||
60055948|NCT02106403|76171309|FG001|STARTED|Follow-Up Visit 3||8||
60055949|NCT02106403|76171310|FG002|STARTED|Follow-Up Visit 3||9||
59515547|NCT00987415|75609390|FG001|NOT COMPLETED|Overall Study||9||
59515548|NCT03138382|75609398|FG000|STARTED|Overall Study||10||
59924555|NCT03426995|76043420|FG014|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
59924556|NCT03426995|76043421|FG015|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
59924557|NCT03426995|76043422|FG016|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
59924558|NCT03426995|76043423|FG017|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
59924559|NCT03426995|76043424|FG018|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0||
59924560|NCT03426995|76043406|FG000|STARTED|Part A: Cohort 2-Period 1 (Day1)||0||
59924561|NCT03426995|76043407|FG001|STARTED|Part A: Cohort 2-Period 1 (Day1)||0||
60055950|NCT02106403|76171311|FG003|STARTED|Follow-Up Visit 3||8||
60055951|NCT02106403|76171312|FG004|STARTED|Follow-Up Visit 3||8||
60055952|NCT02106403|76171313|FG005|STARTED|Follow-Up Visit 3||9||
60055953|NCT02106403|76171308|FG000|COMPLETED|Follow-Up Visit 3||8||
60055954|NCT02106403|76171309|FG001|COMPLETED|Follow-Up Visit 3||8||
60055955|NCT02106403|76171310|FG002|COMPLETED|Follow-Up Visit 3||9||
60055956|NCT02106403|76171311|FG003|COMPLETED|Follow-Up Visit 3||8||
60055957|NCT02106403|76171312|FG004|COMPLETED|Follow-Up Visit 3||8||
59515549|NCT03138382|75609399|FG001|STARTED|Overall Study||10||
59515550|NCT03138382|75609398|FG000|COMPLETED|Overall Study||10||
60055958|NCT02106403|76171313|FG005|COMPLETED|Follow-Up Visit 3||8||
60055959|NCT02106403|76171308|FG000|NOT COMPLETED|Follow-Up Visit 3||0||
59924562|NCT03426995|76043408|FG002|STARTED|Part A: Cohort 2-Period 1 (Day1)||0||
59924563|NCT03426995|76043409|FG003|STARTED|Part A: Cohort 2-Period 1 (Day1)||0||
59924564|NCT03426995|76043410|FG004|STARTED|Part A: Cohort 2-Period 1 (Day1)||0||
59924565|NCT03426995|76043411|FG005|STARTED|Part A: Cohort 2-Period 1 (Day1)||0||
59924566|NCT03426995|76043412|FG006|STARTED|Part A: Cohort 2-Period 1 (Day1)||1||
60055960|NCT02106403|76171309|FG001|NOT COMPLETED|Follow-Up Visit 3||0||
60055961|NCT02106403|76171310|FG002|NOT COMPLETED|Follow-Up Visit 3||0||
59924567|NCT03426995|76043413|FG007|STARTED|Part A: Cohort 2-Period 1 (Day1)||2||
59924568|NCT03426995|76043414|FG008|STARTED|Part A: Cohort 2-Period 1 (Day1)||1||
59924569|NCT03426995|76043415|FG009|STARTED|Part A: Cohort 2-Period 1 (Day1)||0||
60055962|NCT02106403|76171311|FG003|NOT COMPLETED|Follow-Up Visit 3||0||
60055963|NCT02106403|76171312|FG004|NOT COMPLETED|Follow-Up Visit 3||0||
60055964|NCT02106403|76171313|FG005|NOT COMPLETED|Follow-Up Visit 3||1||
60055965|NCT02133131|76171330|FG000|STARTED|Overall Study||31||
60055966|NCT02133131|76171331|FG001|STARTED|Overall Study||30||
60055967|NCT02133131|76171332|FG002|STARTED|Overall Study||20||
60055968|NCT02133131|76171333|FG003|STARTED|Overall Study||21||
60055969|NCT02133131|76171334|FG004|STARTED|Overall Study||15||
59924570|NCT03426995|76043416|FG010|STARTED|Part A: Cohort 2-Period 1 (Day1)||1||
59924571|NCT03426995|76043417|FG011|STARTED|Part A: Cohort 2-Period 1 (Day1)||1||
59924572|NCT03426995|76043418|FG012|STARTED|Part A: Cohort 2-Period 1 (Day1)||0||
59924573|NCT03426995|76043419|FG013|STARTED|Part A: Cohort 2-Period 1 (Day1)||0||
59924574|NCT03426995|76043420|FG014|STARTED|Part A: Cohort 2-Period 1 (Day1)||0||
59924575|NCT03426995|76043421|FG015|STARTED|Part A: Cohort 2-Period 1 (Day1)||0||
59924576|NCT03426995|76043422|FG016|STARTED|Part A: Cohort 2-Period 1 (Day1)||0||
59924577|NCT03426995|76043423|FG017|STARTED|Part A: Cohort 2-Period 1 (Day1)||0||
59924578|NCT03426995|76043424|FG018|STARTED|Part A: Cohort 2-Period 1 (Day1)||0||
59924579|NCT03426995|76043406|FG000|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
59924580|NCT03426995|76043407|FG001|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
59924581|NCT03426995|76043408|FG002|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
59924582|NCT03426995|76043409|FG003|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
59924583|NCT03426995|76043410|FG004|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
59924584|NCT03426995|76043411|FG005|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
59924585|NCT03426995|76043412|FG006|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||1||
59924586|NCT03426995|76043413|FG007|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||2||
59924587|NCT03426995|76043414|FG008|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||1||
59924588|NCT03426995|76043415|FG009|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
59924589|NCT03426995|76043416|FG010|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||1||
59924590|NCT03426995|76043417|FG011|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||1||
59924591|NCT03426995|76043418|FG012|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
59924592|NCT03426995|76043419|FG013|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
59924593|NCT03426995|76043420|FG014|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
59924594|NCT03426995|76043421|FG015|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
59924595|NCT03426995|76043422|FG016|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
59924596|NCT03426995|76043423|FG017|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
59924597|NCT03426995|76043424|FG018|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
59924598|NCT03426995|76043406|FG000|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
59924599|NCT03426995|76043407|FG001|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
59924600|NCT03426995|76043408|FG002|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
60055970|NCT02133131|76171335|FG005|STARTED|Overall Study||14||
60055971|NCT02133131|76171336|FG006|STARTED|Overall Study||12||
60055972|NCT02133131|76171330|FG000|COMPLETED|Overall Study||26||
60055973|NCT02133131|76171331|FG001|COMPLETED|Overall Study||25||
60055974|NCT02133131|76171332|FG002|COMPLETED|Overall Study||19||
60055975|NCT02133131|76171333|FG003|COMPLETED|Overall Study||15||
60055976|NCT02133131|76171334|FG004|COMPLETED|Overall Study||0||
60055977|NCT02133131|76171335|FG005|COMPLETED|Overall Study||0||
60055978|NCT02133131|76171336|FG006|COMPLETED|Overall Study||0||
60055979|NCT02133131|76171330|FG000|NOT COMPLETED|Overall Study||5||
60055980|NCT02133131|76171331|FG001|NOT COMPLETED|Overall Study||5||
60055981|NCT02133131|76171332|FG002|NOT COMPLETED|Overall Study||1||
60055982|NCT02133131|76171333|FG003|NOT COMPLETED|Overall Study||6||
60055983|NCT02133131|76171334|FG004|NOT COMPLETED|Overall Study||15||
60055984|NCT02133131|76171335|FG005|NOT COMPLETED|Overall Study||14||
60055985|NCT02133131|76171336|FG006|NOT COMPLETED|Overall Study||12||
60055986|NCT02106325|76171354|FG000|STARTED|Phase 1||5||
60055987|NCT02106325|76171355|FG001|STARTED|Phase 1||3||
60055988|NCT02106325|76171354|FG000|COMPLETED|Phase 1||3||
60055989|NCT02106325|76171355|FG001|COMPLETED|Phase 1||1||
60055990|NCT02106325|76171354|FG000|NOT COMPLETED|Phase 1||2||
60055991|NCT02106325|76171355|FG001|NOT COMPLETED|Phase 1||2||
60055992|NCT02106325|76171354|FG000|STARTED|Phase 2||4||
60055993|NCT02106325|76171355|FG001|STARTED|Phase 2||4||
60055994|NCT02106325|76171354|FG000|COMPLETED|Phase 2||2||
60055995|NCT02106325|76171355|FG001|COMPLETED|Phase 2||1||
60055996|NCT02106325|76171354|FG000|NOT COMPLETED|Phase 2||2||
60055997|NCT02106325|76171355|FG001|NOT COMPLETED|Phase 2||3||
60055998|NCT02106325|76171354|FG000|STARTED|Phase 3||2||
60055999|NCT02106325|76171355|FG001|STARTED|Phase 3||3||
60056000|NCT02106325|76171354|FG000|COMPLETED|Phase 3||0||
59924601|NCT03426995|76043409|FG003|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
59924602|NCT03426995|76043410|FG004|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
59924603|NCT03426995|76043411|FG005|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
59924604|NCT03426995|76043412|FG006|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
59924605|NCT03426995|76043413|FG007|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
59924606|NCT03426995|76043414|FG008|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
59924607|NCT03426995|76043415|FG009|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
59924608|NCT03426995|76043416|FG010|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
59924609|NCT03426995|76043417|FG011|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
59924610|NCT03426995|76043418|FG012|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
59924611|NCT03426995|76043419|FG013|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
59924612|NCT03426995|76043420|FG014|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
59924613|NCT03426995|76043421|FG015|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
59924614|NCT03426995|76043422|FG016|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
59924615|NCT03426995|76043423|FG017|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
59924616|NCT03426995|76043424|FG018|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0||
59924617|NCT03426995|76043406|FG000|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0||
59924618|NCT03426995|76043407|FG001|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0||
59924619|NCT03426995|76043408|FG002|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0||
59924620|NCT03426995|76043409|FG003|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0||
59924621|NCT03426995|76043410|FG004|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0||
59924622|NCT03426995|76043411|FG005|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0||
59924623|NCT03426995|76043412|FG006|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||1||
59924624|NCT03426995|76043413|FG007|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||2||
59924625|NCT03426995|76043414|FG008|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||1||
59924626|NCT03426995|76043415|FG009|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0||
59924627|NCT03426995|76043416|FG010|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||1||
59924628|NCT03426995|76043417|FG011|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||1||
59924629|NCT03426995|76043418|FG012|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0||
59924630|NCT03426995|76043419|FG013|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0||
59924631|NCT03426995|76043420|FG014|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0||
59924632|NCT03426995|76043421|FG015|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0||
59924633|NCT03426995|76043422|FG016|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0||
59924634|NCT03426995|76043423|FG017|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0||
59924635|NCT03426995|76043424|FG018|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0||
59924636|NCT03426995|76043406|FG000|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0||
59924637|NCT03426995|76043407|FG001|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0||
59924638|NCT03426995|76043408|FG002|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0||
59924639|NCT03426995|76043409|FG003|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0||
59924640|NCT03426995|76043410|FG004|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0||
59924641|NCT03426995|76043411|FG005|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0||
59924642|NCT03426995|76043412|FG006|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||1||
59924643|NCT03426995|76043413|FG007|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||2||
59924644|NCT03426995|76043414|FG008|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||1||
59924645|NCT03426995|76043415|FG009|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0||
59924646|NCT03426995|76043416|FG010|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||1||
59924647|NCT03426995|76043417|FG011|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||1||
59924648|NCT03426995|76043418|FG012|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0||
59924649|NCT03426995|76043419|FG013|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0||
59924650|NCT03426995|76043420|FG014|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0||
59924651|NCT03426995|76043421|FG015|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0||
59924652|NCT03426995|76043422|FG016|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0||
59924653|NCT03426995|76043423|FG017|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0||
59924654|NCT03426995|76043424|FG018|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0||
59924655|NCT03426995|76043406|FG000|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0||
59924656|NCT03426995|76043407|FG001|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0||
59924657|NCT03426995|76043408|FG002|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0||
59924658|NCT03426995|76043409|FG003|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0||
59924659|NCT03426995|76043410|FG004|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0||
60056001|NCT02106325|76171355|FG001|COMPLETED|Phase 3||2||
60056002|NCT02106325|76171354|FG000|NOT COMPLETED|Phase 3||2||
60056003|NCT02106325|76171355|FG001|NOT COMPLETED|Phase 3||1||
60056004|NCT01625689|76171363|FG000|STARTED|Overall Study||150||
59515551|NCT03138382|75609399|FG001|COMPLETED|Overall Study||10||
59515552|NCT03138382|75609398|FG000|NOT COMPLETED|Overall Study||0||
59515553|NCT03138382|75609399|FG001|NOT COMPLETED|Overall Study||0||
59515554|NCT00955201|75609409|FG000|STARTED|Overall Study||12||
59924660|NCT03426995|76043411|FG005|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0||
59924661|NCT03426995|76043412|FG006|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0||
59924662|NCT03426995|76043413|FG007|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0||
59924663|NCT03426995|76043414|FG008|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0||
59924664|NCT03426995|76043415|FG009|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0||
59924665|NCT03426995|76043416|FG010|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0||
59924666|NCT03426995|76043417|FG011|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0||
59924667|NCT03426995|76043418|FG012|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0||
59924668|NCT03426995|76043419|FG013|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0||
59924669|NCT03426995|76043420|FG014|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0||
59924670|NCT03426995|76043421|FG015|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0||
59924671|NCT03426995|76043422|FG016|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0||
59924672|NCT03426995|76043423|FG017|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0||
59924673|NCT03426995|76043424|FG018|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0||
59515555|NCT00955201|75609410|FG001|STARTED|Overall Study||11||
59515556|NCT00955201|75609411|FG002|STARTED|Overall Study||11||
59515557|NCT00955201|75609412|FG003|STARTED|Overall Study||11||
59515558|NCT00955201|75609409|FG000|COMPLETED|Overall Study||8||
59515559|NCT00955201|75609410|FG001|COMPLETED|Overall Study||11||
59515560|NCT00955201|75609411|FG002|COMPLETED|Overall Study||10||
59515561|NCT00955201|75609412|FG003|COMPLETED|Overall Study||7||
59515562|NCT00955201|75609409|FG000|NOT COMPLETED|Overall Study||4||
59515563|NCT00955201|75609410|FG001|NOT COMPLETED|Overall Study||0||
59515564|NCT00955201|75609411|FG002|NOT COMPLETED|Overall Study||1||
59515565|NCT00955201|75609412|FG003|NOT COMPLETED|Overall Study||4||
59515566|NCT03086356|75609431|FG000|STARTED|Overall Study||12||
59515567|NCT03086356|75609431|FG000|COMPLETED|Overall Study||12||
59924674|NCT03426995|76043406|FG000|STARTED|Part A: Cohort 2-Period 2 (Day1)||0||
59924675|NCT03426995|76043407|FG001|STARTED|Part A: Cohort 2-Period 2 (Day1)||0||
59924676|NCT03426995|76043408|FG002|STARTED|Part A: Cohort 2-Period 2 (Day1)||0||
59924677|NCT03426995|76043409|FG003|STARTED|Part A: Cohort 2-Period 2 (Day1)||0||
59924678|NCT03426995|76043410|FG004|STARTED|Part A: Cohort 2-Period 2 (Day1)||0||
59924679|NCT03426995|76043411|FG005|STARTED|Part A: Cohort 2-Period 2 (Day1)||0||
59924680|NCT03426995|76043412|FG006|STARTED|Part A: Cohort 2-Period 2 (Day1)||1||
59924681|NCT03426995|76043413|FG007|STARTED|Part A: Cohort 2-Period 2 (Day1)||2||
59924682|NCT03426995|76043414|FG008|STARTED|Part A: Cohort 2-Period 2 (Day1)||1||
59924683|NCT03426995|76043415|FG009|STARTED|Part A: Cohort 2-Period 2 (Day1)|Two additional participants were enrolled and dosed.|2||
59924684|NCT03426995|76043416|FG010|STARTED|Part A: Cohort 2-Period 2 (Day1)||1||
59924685|NCT03426995|76043417|FG011|STARTED|Part A: Cohort 2-Period 2 (Day1)|New participant enrolled and dosed.|2||
59924686|NCT03426995|76043418|FG012|STARTED|Part A: Cohort 2-Period 2 (Day1)||0||
59924687|NCT03426995|76043419|FG013|STARTED|Part A: Cohort 2-Period 2 (Day1)||0||
59924688|NCT03426995|76043420|FG014|STARTED|Part A: Cohort 2-Period 2 (Day1)||0||
59924689|NCT03426995|76043421|FG015|STARTED|Part A: Cohort 2-Period 2 (Day1)||0||
59924690|NCT03426995|76043422|FG016|STARTED|Part A: Cohort 2-Period 2 (Day1)||0||
59924691|NCT03426995|76043423|FG017|STARTED|Part A: Cohort 2-Period 2 (Day1)||0||
59924692|NCT03426995|76043424|FG018|STARTED|Part A: Cohort 2-Period 2 (Day1)||0||
59924693|NCT03426995|76043406|FG000|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
59924694|NCT03426995|76043407|FG001|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
59924695|NCT03426995|76043408|FG002|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
59924696|NCT03426995|76043409|FG003|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
59924697|NCT03426995|76043410|FG004|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
59924698|NCT03426995|76043411|FG005|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
59515568|NCT03086356|75609431|FG000|NOT COMPLETED|Overall Study||0||
59515569|NCT03140254|75609435|FG000|STARTED|Overall Study||145||
59515570|NCT03140254|75609435|FG000|Treatment IP - Groin|Overall Study||51||
59924699|NCT03426995|76043412|FG006|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||1||
60056005|NCT01625689|76171364|FG001|STARTED|Overall Study||150||
59924700|NCT03426995|76043413|FG007|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||2||
59924701|NCT03426995|76043414|FG008|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||1||
59924702|NCT03426995|76043415|FG009|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||2||
59924703|NCT03426995|76043416|FG010|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||1||
59924704|NCT03426995|76043417|FG011|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||2||
59924705|NCT03426995|76043418|FG012|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
59924706|NCT03426995|76043419|FG013|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
59924707|NCT03426995|76043420|FG014|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
59924708|NCT03426995|76043421|FG015|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
59924709|NCT03426995|76043422|FG016|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
59924710|NCT03426995|76043423|FG017|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
59924711|NCT03426995|76043424|FG018|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
59924712|NCT03426995|76043406|FG000|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
59924713|NCT03426995|76043407|FG001|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
59924714|NCT03426995|76043408|FG002|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
59924715|NCT03426995|76043409|FG003|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
59924716|NCT03426995|76043410|FG004|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
59924717|NCT03426995|76043411|FG005|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
59924718|NCT03426995|76043412|FG006|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
59924719|NCT03426995|76043413|FG007|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
59924720|NCT03426995|76043414|FG008|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
59924721|NCT03426995|76043415|FG009|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
59924722|NCT03426995|76043416|FG010|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
59924723|NCT03426995|76043417|FG011|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
59924724|NCT03426995|76043418|FG012|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
59924725|NCT03426995|76043419|FG013|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
59924726|NCT03426995|76043420|FG014|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
59924727|NCT03426995|76043421|FG015|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
59924728|NCT03426995|76043422|FG016|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
59924729|NCT03426995|76043423|FG017|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
59924730|NCT03426995|76043424|FG018|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0||
59924731|NCT03426995|76043406|FG000|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0||
59924732|NCT03426995|76043407|FG001|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0||
59924733|NCT03426995|76043408|FG002|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0||
59924734|NCT03426995|76043409|FG003|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0||
59924735|NCT03426995|76043410|FG004|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0||
59924736|NCT03426995|76043411|FG005|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0||
59924737|NCT03426995|76043412|FG006|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||1||
59924738|NCT03426995|76043413|FG007|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||2||
59924739|NCT03426995|76043414|FG008|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||1||
59924740|NCT03426995|76043415|FG009|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||2||
59924741|NCT03426995|76043416|FG010|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||1||
59924742|NCT03426995|76043417|FG011|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||2||
59924743|NCT03426995|76043418|FG012|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0||
59924744|NCT03426995|76043419|FG013|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0||
59924745|NCT03426995|76043420|FG014|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0||
59924746|NCT03426995|76043421|FG015|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0||
59924747|NCT03426995|76043422|FG016|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0||
59924748|NCT03426995|76043423|FG017|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0||
59924749|NCT03426995|76043424|FG018|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0||
59924750|NCT03426995|76043406|FG000|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0||
59924751|NCT03426995|76043407|FG001|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0||
59924752|NCT03426995|76043408|FG002|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0||
59924753|NCT03426995|76043409|FG003|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0||
59924754|NCT03426995|76043410|FG004|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0||
59924755|NCT03426995|76043411|FG005|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0||
59924756|NCT03426995|76043412|FG006|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||1||
59924757|NCT03426995|76043413|FG007|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||2||
59924758|NCT03426995|76043414|FG008|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||1||
59924759|NCT03426995|76043415|FG009|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||2||
59924760|NCT03426995|76043416|FG010|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||1||
59924761|NCT03426995|76043417|FG011|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||2||
59924762|NCT03426995|76043418|FG012|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0||
59924763|NCT03426995|76043419|FG013|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0||
59924764|NCT03426995|76043420|FG014|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0||
59924765|NCT03426995|76043421|FG015|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0||
59924766|NCT03426995|76043422|FG016|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0||
59924767|NCT03426995|76043423|FG017|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0||
59924768|NCT03426995|76043424|FG018|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0||
60056006|NCT01625689|76171363|FG000|COMPLETED|Overall Study||148||
60056007|NCT01625689|76171364|FG001|COMPLETED|Overall Study||149||
60056008|NCT01625689|76171363|FG000|NOT COMPLETED|Overall Study||2||
60056009|NCT01625689|76171364|FG001|NOT COMPLETED|Overall Study||1||
60056010|NCT02184611|76171372|FG000|STARTED|Overall Study||101||
60056011|NCT02184611|76171373|FG001|STARTED|Overall Study||205||
60056012|NCT02184611|76171372|FG000|COMPLETED|Overall Study||80||
60056013|NCT02184611|76171373|FG001|COMPLETED|Overall Study||177||
60056014|NCT02184611|76171372|FG000|NOT COMPLETED|Overall Study||21||
60056015|NCT02184611|76171373|FG001|NOT COMPLETED|Overall Study||28||
59612996|NCT01693692|75724041|FG001|Received Study Drug|Overall Study||127||
60056016|NCT02066311|76171379|FG000|STARTED|Overall Study||15||
60056017|NCT02066311|76171379|FG000|COMPLETED|Overall Study|Stage 1 terminated 6/1/18 prior to completion of Stage 1 due to low enrollment and efficacy.|10||
60056018|NCT02066311|76171379|FG000|NOT COMPLETED|Overall Study||5||
60056019|NCT02184455|76171383|FG000|STARTED|Overall Study||11||
60056020|NCT02184455|76171383|FG000|COMPLETED|Overall Study||10||
60056021|NCT02184455|76171383|FG000|NOT COMPLETED|Overall Study||1||
60056022|NCT02184143|76171389|FG000|STARTED|Overall Study|124 participants randomized; 118 participant received intervention|124||
60056023|NCT02184143|76171390|FG001|STARTED|Overall Study|124 participants randomized; 121 received intervention|124||
60056024|NCT02184143|76171389|FG000|COMPLETED|Overall Study|114 patients completed PROs. 98 actigraph valid wear time.|114||
60056025|NCT02184143|76171390|FG001|COMPLETED|Overall Study|117 patients completed PROs. 100 actigraph valid wear time.|117||
60056026|NCT02184143|76171389|FG000|NOT COMPLETED|Overall Study||10||
60056027|NCT02184143|76171390|FG001|NOT COMPLETED|Overall Study||7||
60056028|NCT01625611|76171400|FG000|STARTED|Overall Study||55||
60056029|NCT01625611|76171401|FG001|STARTED|Overall Study||4||
60056030|NCT01625611|76171400|FG000|PET Scan 1|Overall Study||49||
60056031|NCT01625611|76171401|FG001|PET Scan 1|Overall Study||4||
60056032|NCT01625611|76171400|FG000|Lab 2|Overall Study||48||
60056033|NCT01625611|76171401|FG001|Lab 2|Overall Study||0||
60056034|NCT01625611|76171400|FG000|PET Scan 2|Overall Study||47||
60056035|NCT01625611|76171401|FG001|PET Scan 2|Overall Study||0||
60056036|NCT01625611|76171400|FG000|COMPLETED|Overall Study||47||
60056037|NCT01625611|76171401|FG001|COMPLETED|Overall Study||4||
60056038|NCT01625611|76171400|FG000|NOT COMPLETED|Overall Study||8||
60056039|NCT01625611|76171401|FG001|NOT COMPLETED|Overall Study||0||
60056040|NCT02159807|76171411|FG000|STARTED|Overall Study||67||
60056041|NCT02159807|76171412|FG001|STARTED|Overall Study||52||
60056042|NCT02159807|76171413|FG002|STARTED|Overall Study||51||
60056043|NCT02159807|76171411|FG000|COMPLETED|Overall Study||66||
60056044|NCT02159807|76171412|FG001|COMPLETED|Overall Study||51||
60056045|NCT02159807|76171413|FG002|COMPLETED|Overall Study||48||
60056046|NCT02159807|76171411|FG000|NOT COMPLETED|Overall Study||1||
60056047|NCT02159807|76171412|FG001|NOT COMPLETED|Overall Study||1||
60056048|NCT02159807|76171413|FG002|NOT COMPLETED|Overall Study||3||
60056049|NCT02066233|76171423|FG000|STARTED|EG Scan II (Day 1)||50||
60056050|NCT02066233|76171424|FG001|STARTED|EG Scan II (Day 1)||50||
60056051|NCT02066233|76171423|FG000|COMPLETED|EG Scan II (Day 1)||44||
60056052|NCT02066233|76171424|FG001|COMPLETED|EG Scan II (Day 1)||44||
60056053|NCT02066233|76171423|FG000|NOT COMPLETED|EG Scan II (Day 1)||6||
60056054|NCT02066233|76171424|FG001|NOT COMPLETED|EG Scan II (Day 1)||6||
60056055|NCT02066233|76171423|FG000|STARTED|Standard Endoscopy (Day 2)||44||
60056056|NCT02066233|76171424|FG001|STARTED|Standard Endoscopy (Day 2)||44||
60056057|NCT02066233|76171423|FG000|COMPLETED|Standard Endoscopy (Day 2)||44||
60056058|NCT02066233|76171424|FG001|COMPLETED|Standard Endoscopy (Day 2)||44||
60056059|NCT02066233|76171423|FG000|NOT COMPLETED|Standard Endoscopy (Day 2)||0||
60056060|NCT02066233|76171424|FG001|NOT COMPLETED|Standard Endoscopy (Day 2)||0||
60056061|NCT02159729|76171432|FG000|STARTED|Overall Study||140||
60056062|NCT02159729|76171433|FG001|STARTED|Overall Study||65||
60056063|NCT02159729|76171432|FG000|COMPLETED|Overall Study||98||
60056064|NCT02159729|76171433|FG001|COMPLETED|Overall Study||44||
60056065|NCT02159729|76171432|FG000|NOT COMPLETED|Overall Study||42||
60056066|NCT02159729|76171433|FG001|NOT COMPLETED|Overall Study||21||
60056067|NCT02159183|76171441|FG000|STARTED|Analysis After the 36 Months Follow-up||22||
60056068|NCT02159183|76171442|FG001|STARTED|Analysis After the 36 Months Follow-up||21||
60056069|NCT02159183|76171441|FG000|COMPLETED|Analysis After the 36 Months Follow-up||19||
60056070|NCT02159183|76171442|FG001|COMPLETED|Analysis After the 36 Months Follow-up||19||
59612997|NCT01693692|75724042|FG002|Received Study Drug|Overall Study||128||
59612998|NCT01693692|75724040|FG000|COMPLETED|Overall Study||100||
60056071|NCT02159183|76171441|FG000|NOT COMPLETED|Analysis After the 36 Months Follow-up||3||
60056072|NCT02159183|76171442|FG001|NOT COMPLETED|Analysis After the 36 Months Follow-up||2||
60056073|NCT02159183|76171441|FG000|STARTED|Analysis of Primary Endpoint (12 Mts)||22||
60056074|NCT02159183|76171442|FG001|STARTED|Analysis of Primary Endpoint (12 Mts)||21||
60056075|NCT02159183|76171441|FG000|COMPLETED|Analysis of Primary Endpoint (12 Mts)||19||
60056076|NCT02159183|76171442|FG001|COMPLETED|Analysis of Primary Endpoint (12 Mts)||20||
60056077|NCT02159183|76171441|FG000|NOT COMPLETED|Analysis of Primary Endpoint (12 Mts)||3||
60056078|NCT02159183|76171442|FG001|NOT COMPLETED|Analysis of Primary Endpoint (12 Mts)||1||
60056079|NCT02183675|76171454|FG000|STARTED|Treatment Period 1 (10 Days)||6||
59612999|NCT01693692|75724041|FG001|COMPLETED|Overall Study||97||
60056080|NCT02183675|76171455|FG001|STARTED|Treatment Period 1 (10 Days)||6||
59613000|NCT01693692|75724042|FG002|COMPLETED|Overall Study||95||
59613001|NCT01693692|75724040|FG000|NOT COMPLETED|Overall Study||30||
59613002|NCT01693692|75724041|FG001|NOT COMPLETED|Overall Study||34||
60056081|NCT02183675|76171456|FG002|STARTED|Treatment Period 1 (10 Days)||6||
60056082|NCT02183675|76171457|FG003|STARTED|Treatment Period 1 (10 Days)||6||
60056083|NCT02183675|76171458|FG004|STARTED|Treatment Period 1 (10 Days)||6||
60056084|NCT02183675|76171459|FG005|STARTED|Treatment Period 1 (10 Days)||6||
60056085|NCT02183675|76171454|FG000|COMPLETED|Treatment Period 1 (10 Days)||6||
60056086|NCT02183675|76171455|FG001|COMPLETED|Treatment Period 1 (10 Days)||6||
60056087|NCT02183675|76171456|FG002|COMPLETED|Treatment Period 1 (10 Days)||6||
60056088|NCT02183675|76171457|FG003|COMPLETED|Treatment Period 1 (10 Days)||6||
60056089|NCT02183675|76171458|FG004|COMPLETED|Treatment Period 1 (10 Days)||6||
60056090|NCT02183675|76171459|FG005|COMPLETED|Treatment Period 1 (10 Days)||6||
60056091|NCT02183675|76171454|FG000|NOT COMPLETED|Treatment Period 1 (10 Days)||0||
60056092|NCT02183675|76171455|FG001|NOT COMPLETED|Treatment Period 1 (10 Days)||0||
60056093|NCT02183675|76171456|FG002|NOT COMPLETED|Treatment Period 1 (10 Days)||0||
60056094|NCT02183675|76171457|FG003|NOT COMPLETED|Treatment Period 1 (10 Days)||0||
60056095|NCT02183675|76171458|FG004|NOT COMPLETED|Treatment Period 1 (10 Days)||0||
60056096|NCT02183675|76171459|FG005|NOT COMPLETED|Treatment Period 1 (10 Days)||0||
60056097|NCT02183675|76171454|FG000|STARTED|Treatment Period 2 (10 Days)||6||
60056098|NCT02183675|76171455|FG001|STARTED|Treatment Period 2 (10 Days)||6||
60056099|NCT02183675|76171456|FG002|STARTED|Treatment Period 2 (10 Days)||6||
60056100|NCT02183675|76171457|FG003|STARTED|Treatment Period 2 (10 Days)||6||
60056101|NCT02183675|76171458|FG004|STARTED|Treatment Period 2 (10 Days)||6||
60056102|NCT02183675|76171459|FG005|STARTED|Treatment Period 2 (10 Days)||6||
60056103|NCT02183675|76171454|FG000|COMPLETED|Treatment Period 2 (10 Days)||6||
60056104|NCT02183675|76171455|FG001|COMPLETED|Treatment Period 2 (10 Days)||6||
60056105|NCT02183675|76171456|FG002|COMPLETED|Treatment Period 2 (10 Days)||6||
60056106|NCT02183675|76171457|FG003|COMPLETED|Treatment Period 2 (10 Days)||6||
60056107|NCT02183675|76171458|FG004|COMPLETED|Treatment Period 2 (10 Days)||6||
60056108|NCT02183675|76171459|FG005|COMPLETED|Treatment Period 2 (10 Days)|Patients withdrew after completion of treatment period 2 but before beginning of treatment period 3|4||
60056109|NCT02183675|76171454|FG000|NOT COMPLETED|Treatment Period 2 (10 Days)||0||
60056110|NCT02183675|76171455|FG001|NOT COMPLETED|Treatment Period 2 (10 Days)||0||
60056111|NCT02183675|76171456|FG002|NOT COMPLETED|Treatment Period 2 (10 Days)||0||
60056112|NCT02183675|76171457|FG003|NOT COMPLETED|Treatment Period 2 (10 Days)||0||
59760574|NCT01317160|75880197|FG001|NOT COMPLETED|Overall Study||6||
60056113|NCT02183675|76171458|FG004|NOT COMPLETED|Treatment Period 2 (10 Days)||0||
60056114|NCT02183675|76171459|FG005|NOT COMPLETED|Treatment Period 2 (10 Days)||2||
60056115|NCT02183675|76171454|FG000|STARTED|Treatment Period 3 (10 Days)||6||
60056116|NCT02183675|76171455|FG001|STARTED|Treatment Period 3 (10 Days)||6||
60056117|NCT02183675|76171456|FG002|STARTED|Treatment Period 3 (10 Days)||6||
60056118|NCT02183675|76171457|FG003|STARTED|Treatment Period 3 (10 Days)||6||
60056119|NCT02183675|76171458|FG004|STARTED|Treatment Period 3 (10 Days)||6||
60056120|NCT02183675|76171459|FG005|STARTED|Treatment Period 3 (10 Days)||4||
60056121|NCT02183675|76171454|FG000|COMPLETED|Treatment Period 3 (10 Days)||6||
60056122|NCT02183675|76171455|FG001|COMPLETED|Treatment Period 3 (10 Days)||6||
60056123|NCT02183675|76171456|FG002|COMPLETED|Treatment Period 3 (10 Days)||6||
60056124|NCT02183675|76171457|FG003|COMPLETED|Treatment Period 3 (10 Days)||6||
60056125|NCT02183675|76171458|FG004|COMPLETED|Treatment Period 3 (10 Days)||6||
60056126|NCT02183675|76171459|FG005|COMPLETED|Treatment Period 3 (10 Days)||4||
60056127|NCT02183675|76171454|FG000|NOT COMPLETED|Treatment Period 3 (10 Days)||0||
60056128|NCT02183675|76171455|FG001|NOT COMPLETED|Treatment Period 3 (10 Days)||0||
60056129|NCT02183675|76171456|FG002|NOT COMPLETED|Treatment Period 3 (10 Days)||0||
60056130|NCT02183675|76171457|FG003|NOT COMPLETED|Treatment Period 3 (10 Days)||0||
60056131|NCT02183675|76171458|FG004|NOT COMPLETED|Treatment Period 3 (10 Days)||0||
60056132|NCT02183675|76171459|FG005|NOT COMPLETED|Treatment Period 3 (10 Days)||0||
60056133|NCT02183519|76171471|FG000|STARTED|Overall Study||28||
59613003|NCT01693692|75724042|FG002|NOT COMPLETED|Overall Study||36||
60056134|NCT02183519|76171472|FG001|STARTED|Overall Study||16||
60056135|NCT02183519|76171471|FG000|COMPLETED|Overall Study||25||
60056136|NCT02183519|76171472|FG001|COMPLETED|Overall Study||13||
60056137|NCT02183519|76171471|FG000|NOT COMPLETED|Overall Study||3||
60056138|NCT02183519|76171472|FG001|NOT COMPLETED|Overall Study||3||
60056139|NCT02132195|76171481|FG000|STARTED|Initial Assignment||15||
60056140|NCT02132195|76171482|FG001|STARTED|Initial Assignment||16||
60056141|NCT02132195|76171483|FG002|STARTED|Initial Assignment||0||
60056142|NCT02132195|76171481|FG000|COMPLETED|Initial Assignment||1||
60056143|NCT02132195|76171482|FG001|COMPLETED|Initial Assignment||16||
60056144|NCT02132195|76171483|FG002|COMPLETED|Initial Assignment||0||
60056145|NCT02132195|76171481|FG000|NOT COMPLETED|Initial Assignment||14||
59613004|NCT01693614|75724053|FG000|STARTED|Overall Study||26||
59613005|NCT01693614|75724054|FG001|STARTED|Overall Study||22||
59760575|NCT00891371|75880203|FG000|STARTED|Pre-assignment||42||
59760576|NCT00891371|75880203|FG000|COMPLETED|Pre-assignment||36||
60056146|NCT02132195|76171482|FG001|NOT COMPLETED|Initial Assignment||0||
60056147|NCT02132195|76171483|FG002|NOT COMPLETED|Initial Assignment||0||
60056148|NCT02132195|76171481|FG000|STARTED|Rescue Therapy||0|There was an option for No-treatment pts to be placed on ACTH (rescue therapy). 13 pts used it|
60056149|NCT02132195|76171482|FG001|STARTED|Rescue Therapy||0|There was an option for No-treatment pts to be placed on ACTH (rescue therapy). 13 pts used it|
59515571|NCT03140254|75609435|FG000|Treatment IP - Abdomen|Overall Study||48||
59760577|NCT00891371|75880203|FG000|NOT COMPLETED|Pre-assignment||6||
60056150|NCT02132195|76171483|FG002|STARTED|Rescue Therapy||13|There was an option for No-treatment pts to be placed on ACTH (rescue therapy). 13 pts used it|
60056151|NCT02132195|76171481|FG000|COMPLETED|Rescue Therapy||0||
60056152|NCT02132195|76171482|FG001|COMPLETED|Rescue Therapy||0||
60056153|NCT02132195|76171483|FG002|COMPLETED|Rescue Therapy||2||
60056154|NCT02132195|76171481|FG000|NOT COMPLETED|Rescue Therapy||0||
60056155|NCT02132195|76171482|FG001|NOT COMPLETED|Rescue Therapy||0||
60056156|NCT02132195|76171483|FG002|NOT COMPLETED|Rescue Therapy||11||
60056157|NCT02182973|76171493|FG000|STARTED|Overall Study||12||
60056158|NCT02182973|76171494|FG001|STARTED|Overall Study||9||
60056159|NCT02182973|76171493|FG000|COMPLETED|Overall Study||9||
60056160|NCT02182973|76171494|FG001|COMPLETED|Overall Study||9||
60056161|NCT02182973|76171493|FG000|NOT COMPLETED|Overall Study||3||
60056162|NCT02182973|76171494|FG001|NOT COMPLETED|Overall Study||0||
60056163|NCT02182895|76171503|FG000|STARTED|Overall Study||35||
60056164|NCT02182895|76171504|FG001|STARTED|Overall Study||37||
60056165|NCT02182895|76171503|FG000|COMPLETED|Overall Study||33||
60056166|NCT02182895|76171504|FG001|COMPLETED|Overall Study||33||
60056167|NCT02182895|76171503|FG000|NOT COMPLETED|Overall Study||2||
60056168|NCT02182895|76171504|FG001|NOT COMPLETED|Overall Study||4||
60056169|NCT01625377|76171512|FG000|STARTED|Overall Study|"Started indicates randomized patients."|95||
60056170|NCT01625377|76171513|FG001|STARTED|Overall Study||93||
60056171|NCT01625377|76171512|FG000|Safety Set of Population|Overall Study||94||
60056172|NCT01625377|76171513|FG001|Safety Set of Population|Overall Study||90||
60056173|NCT01625377|76171512|FG000|Intent to Treat Population|Overall Study||93||
60056174|NCT01625377|76171513|FG001|Intent to Treat Population|Overall Study||90||
60056175|NCT01625377|76171512|FG000|COMPLETED|Overall Study||88||
60056176|NCT01625377|76171513|FG001|COMPLETED|Overall Study||71||
60056177|NCT01625377|76171512|FG000|NOT COMPLETED|Overall Study||7||
60056178|NCT01625377|76171513|FG001|NOT COMPLETED|Overall Study||22||
60056179|NCT02158949|76171521|FG000|STARTED|Overall Study||24||
60056180|NCT02158949|76171522|FG001|STARTED|Overall Study||24||
60056181|NCT02158949|76171521|FG000|COMPLETED|Overall Study||18||
60056182|NCT02158949|76171522|FG001|COMPLETED|Overall Study||13||
60056183|NCT02158949|76171521|FG000|NOT COMPLETED|Overall Study||6||
60056184|NCT02158949|76171522|FG001|NOT COMPLETED|Overall Study||11||
60056185|NCT02132117|76171530|FG000|STARTED|Overall Study||224||
60056186|NCT02132117|76171531|FG001|STARTED|Overall Study||221||
60056187|NCT02132117|76171530|FG000|COMPLETED|Overall Study||213||
60056188|NCT02132117|76171531|FG001|COMPLETED|Overall Study||216||
60056189|NCT02132117|76171530|FG000|NOT COMPLETED|Overall Study||11||
60056190|NCT02132117|76171531|FG001|NOT COMPLETED|Overall Study||5||
60056191|NCT02093689|76171540|FG000|STARTED|Overall Study||18||
60056192|NCT02093689|76171541|FG001|STARTED|Overall Study||0||
60056193|NCT02093689|76171542|FG002|STARTED|Overall Study||0||
60056194|NCT02093689|76171540|FG000|COMPLETED|Overall Study||14||
60056195|NCT02093689|76171541|FG001|COMPLETED|Overall Study||0||
60056196|NCT02093689|76171542|FG002|COMPLETED|Overall Study||0||
60056197|NCT02093689|76171540|FG000|NOT COMPLETED|Overall Study||4||
60056198|NCT02093689|76171541|FG001|NOT COMPLETED|Overall Study||0||
60056199|NCT02093689|76171542|FG002|NOT COMPLETED|Overall Study||0||
60056200|NCT02047045|76171550|FG000|STARTED|Baseline||280||
60056201|NCT02047045|76171551|FG001|STARTED|Baseline||280||
60056202|NCT02047045|76171550|FG000|COMPLETED|Baseline||277||
60056203|NCT02047045|76171551|FG001|COMPLETED|Baseline||278||
60056204|NCT02047045|76171550|FG000|NOT COMPLETED|Baseline||3||
60056205|NCT02047045|76171551|FG001|NOT COMPLETED|Baseline||2||
60056206|NCT02047045|76171550|FG000|STARTED|Treatment Period (8 Weeks )||277||
60056207|NCT02047045|76171551|FG001|STARTED|Treatment Period (8 Weeks )||278||
60056208|NCT02047045|76171550|FG000|COMPLETED|Treatment Period (8 Weeks )||266||
60056209|NCT02047045|76171551|FG001|COMPLETED|Treatment Period (8 Weeks )||263||
60056210|NCT02047045|76171550|FG000|NOT COMPLETED|Treatment Period (8 Weeks )||11||
60056211|NCT02047045|76171551|FG001|NOT COMPLETED|Treatment Period (8 Weeks )||15||
60056212|NCT02047045|76171550|FG000|STARTED|Follow-up Period (24 Weeks)||266||
60056213|NCT02047045|76171551|FG001|STARTED|Follow-up Period (24 Weeks)||263||
60056214|NCT02047045|76171550|FG000|COMPLETED|Follow-up Period (24 Weeks)||265||
60056215|NCT02047045|76171551|FG001|COMPLETED|Follow-up Period (24 Weeks)||262||
60056216|NCT02047045|76171550|FG000|NOT COMPLETED|Follow-up Period (24 Weeks)||1||
60056217|NCT02047045|76171551|FG001|NOT COMPLETED|Follow-up Period (24 Weeks)||1||
60056218|NCT02131259|76171557|FG000|STARTED|Overall Study|Patients received treatment of GIOTRIF® Tablets|1602||
60056219|NCT02131259|76171557|FG000|COMPLETED|Overall Study|Completed is defined as 52 weeks follow-up after starting administration of GIOTRIF® tablets.|377||
60056220|NCT02131259|76171557|FG000|NOT COMPLETED|Overall Study||1225||
60056221|NCT01856595|76171570|FG000|STARTED|Overall Study||18||
60056222|NCT01856595|76171571|FG001|STARTED|Overall Study||12||
60056223|NCT01856595|76171572|FG002|STARTED|Overall Study||12||
60056224|NCT01856595|76171573|FG003|STARTED|Overall Study||12||
60056225|NCT01856595|76171574|FG004|STARTED|Overall Study||14||
60056226|NCT01856595|76171575|FG005|STARTED|Overall Study||12||
60056227|NCT01856595|76171576|FG006|STARTED|Overall Study||13||
60056228|NCT01856595|76171577|FG007|STARTED|Overall Study||10||
60056229|NCT01856595|76171578|FG008|STARTED|Overall Study||14||
60056230|NCT01856595|76171570|FG000|COMPLETED|Overall Study||18||
60056231|NCT01856595|76171571|FG001|COMPLETED|Overall Study||11||
60056232|NCT01856595|76171572|FG002|COMPLETED|Overall Study||12||
60056233|NCT01856595|76171573|FG003|COMPLETED|Overall Study||12||
60056234|NCT01856595|76171574|FG004|COMPLETED|Overall Study||14||
60056235|NCT01856595|76171575|FG005|COMPLETED|Overall Study||12||
60056236|NCT01856595|76171576|FG006|COMPLETED|Overall Study||12||
60056237|NCT01856595|76171577|FG007|COMPLETED|Overall Study||10||
60056238|NCT01856595|76171578|FG008|COMPLETED|Overall Study||14||
60056239|NCT01856595|76171570|FG000|NOT COMPLETED|Overall Study||0||
60056240|NCT01856595|76171571|FG001|NOT COMPLETED|Overall Study||1||
60056241|NCT01856595|76171572|FG002|NOT COMPLETED|Overall Study||0||
60056242|NCT01856595|76171573|FG003|NOT COMPLETED|Overall Study||0||
60056243|NCT01856595|76171574|FG004|NOT COMPLETED|Overall Study||0||
60056244|NCT01856595|76171575|FG005|NOT COMPLETED|Overall Study||0||
60056245|NCT01856595|76171576|FG006|NOT COMPLETED|Overall Study||1||
60056246|NCT01856595|76171577|FG007|NOT COMPLETED|Overall Study||0||
60056247|NCT01856595|76171578|FG008|NOT COMPLETED|Overall Study||0||
60056248|NCT02158247|76171615|FG000|STARTED|Overall Study||181||
60056249|NCT02158247|76171615|FG000|COMPLETED|Overall Study||176||
60056250|NCT02158247|76171615|FG000|NOT COMPLETED|Overall Study||5||
60056251|NCT04589559|76171631|FG000|STARTED|Overall Study||10||
60056252|NCT04589559|76171631|FG000|COMPLETED|Overall Study||10||
60056253|NCT04589559|76171631|FG000|NOT COMPLETED|Overall Study||0||
60056254|NCT01829295|76171637|FG000|STARTED|0-6 Months||107||
60056255|NCT01829295|76171638|FG001|STARTED|0-6 Months||109||
60056256|NCT01829295|76171639|FG002|STARTED|0-6 Months||0||
60056257|NCT01829295|76171640|FG003|STARTED|0-6 Months||0||
60056258|NCT01829295|76171637|FG000|COMPLETED|0-6 Months||96||
60056259|NCT01829295|76171638|FG001|COMPLETED|0-6 Months||98||
60056260|NCT01829295|76171639|FG002|COMPLETED|0-6 Months||0||
60056261|NCT01829295|76171640|FG003|COMPLETED|0-6 Months||0||
60056262|NCT01829295|76171637|FG000|NOT COMPLETED|0-6 Months||11||
60056263|NCT01829295|76171638|FG001|NOT COMPLETED|0-6 Months||11||
60056264|NCT01829295|76171639|FG002|NOT COMPLETED|0-6 Months||0||
60056265|NCT01829295|76171640|FG003|NOT COMPLETED|0-6 Months||0||
60056266|NCT01829295|76171637|FG000|STARTED|6-12 Months|64 patients were a treatment success on methotrexate at 6 mo and had the option to continue|64||
60056267|NCT01829295|76171638|FG001|STARTED|6-12 Months|56 patients were a treatment success on mycophenolate mofetil at 6 mo and had the option to continue|56||
60056268|NCT01829295|76171639|FG002|STARTED|6-12 Months|32 patients failed methotrexate within the first 6 months|32||
60056269|NCT01829295|76171640|FG003|STARTED|6-12 Months|42 patients failed on mycophenolate mofetil within the first 6 months|42||
60056270|NCT01829295|76171637|FG000|COMPLETED|6-12 Months||60||
60056271|NCT01829295|76171638|FG001|COMPLETED|6-12 Months||54||
60056272|NCT01829295|76171639|FG002|COMPLETED|6-12 Months||20||
60056273|NCT01829295|76171640|FG003|COMPLETED|6-12 Months||29||
60056274|NCT01829295|76171637|FG000|NOT COMPLETED|6-12 Months||4||
60056275|NCT01829295|76171638|FG001|NOT COMPLETED|6-12 Months||2||
60056276|NCT01829295|76171639|FG002|NOT COMPLETED|6-12 Months||12||
60056277|NCT01829295|76171640|FG003|NOT COMPLETED|6-12 Months||13||
60056278|NCT02157935|76171652|FG000|STARTED|Overall Study||606||
60056279|NCT02157935|76171653|FG001|STARTED|Overall Study||613||
60056280|NCT02157935|76171652|FG000|COMPLETED|Overall Study||567||
60056281|NCT02157935|76171653|FG001|COMPLETED|Overall Study||548||
60056282|NCT02157935|76171652|FG000|NOT COMPLETED|Overall Study||39||
60056283|NCT02157935|76171653|FG001|NOT COMPLETED|Overall Study||65||
60056284|NCT02157779|76171661|FG000|STARTED|Overall Study||47||
60056285|NCT02157779|76171662|FG001|STARTED|Overall Study||45||
60056286|NCT02157779|76171661|FG000|COMPLETED|Overall Study||23||
60056287|NCT02157779|76171662|FG001|COMPLETED|Overall Study||34||
60056288|NCT02157779|76171661|FG000|NOT COMPLETED|Overall Study||24||
60056289|NCT02157779|76171662|FG001|NOT COMPLETED|Overall Study||11||
60056290|NCT02093221|76171676|FG000|STARTED|Overall Study||15||
60056291|NCT02093221|76171677|FG001|STARTED|Overall Study||16||
60056292|NCT02093221|76171678|FG002|STARTED|Overall Study||15||
60056293|NCT02093221|76171679|FG003|STARTED|Overall Study||15||
60056294|NCT02093221|76171680|FG004|STARTED|Overall Study||15||
60056295|NCT02093221|76171676|FG000|COMPLETED|Overall Study||5||
60056296|NCT02093221|76171677|FG001|COMPLETED|Overall Study||8||
60056297|NCT02093221|76171678|FG002|COMPLETED|Overall Study||6||
60056298|NCT02093221|76171679|FG003|COMPLETED|Overall Study||7||
60056299|NCT02093221|76171680|FG004|COMPLETED|Overall Study||7||
60056300|NCT02093221|76171676|FG000|NOT COMPLETED|Overall Study||10||
60056301|NCT02093221|76171677|FG001|NOT COMPLETED|Overall Study||8||
60056302|NCT02093221|76171678|FG002|NOT COMPLETED|Overall Study||9||
60056303|NCT02093221|76171679|FG003|NOT COMPLETED|Overall Study||8||
60056304|NCT02093221|76171680|FG004|NOT COMPLETED|Overall Study||8||
60056305|NCT02092909|76171696|FG000|STARTED|Overall Study||6||
60056306|NCT02092909|76171697|FG001|STARTED|Overall Study||5||
60056307|NCT02092909|76171698|FG002|STARTED|Overall Study||14||
60056308|NCT02092909|76171699|FG003|STARTED|Overall Study||6||
60056309|NCT02092909|76171696|FG000|COMPLETED|Overall Study||5||
60056310|NCT02092909|76171697|FG001|COMPLETED|Overall Study||2||
60056311|NCT02092909|76171698|FG002|COMPLETED|Overall Study||5||
60056312|NCT02092909|76171699|FG003|COMPLETED|Overall Study||0||
60056313|NCT02092909|76171696|FG000|NOT COMPLETED|Overall Study||1||
60056314|NCT02092909|76171697|FG001|NOT COMPLETED|Overall Study||3||
60056315|NCT02092909|76171698|FG002|NOT COMPLETED|Overall Study||9||
60056316|NCT02092909|76171699|FG003|NOT COMPLETED|Overall Study||6||
60056317|NCT01623115|76171711|FG000|STARTED|Overall Study|Randomized|163||
60056318|NCT01623115|76171712|FG001|STARTED|Overall Study|Randomized|323||
60056319|NCT01623115|76171711|FG000|Treated|Overall Study||163||
60056320|NCT01623115|76171712|FG001|Treated|Overall Study||322||
60056321|NCT01623115|76171711|FG000|COMPLETED|Overall Study||130||
60056322|NCT01623115|76171712|FG001|COMPLETED|Overall Study||246||
60056323|NCT01623115|76171711|FG000|NOT COMPLETED|Overall Study||33||
60056324|NCT01623115|76171712|FG001|NOT COMPLETED|Overall Study||77||
60056325|NCT02092285|76171718|FG000|STARTED|Induction Phase||205||
60056326|NCT02092285|76171718|FG000|COMPLETED|Induction Phase||170||
60056327|NCT02092285|76171718|FG000|NOT COMPLETED|Induction Phase||35||
60056328|NCT02092285|76171718|FG000|STARTED|Maintenance Phase & Follow-up||170||
60056329|NCT02092285|76171718|FG000|COMPLETED|Maintenance Phase & Follow-up||60||
60056330|NCT02092285|76171718|FG000|NOT COMPLETED|Maintenance Phase & Follow-up||110||
60056331|NCT02091739|76171725|FG000|STARTED|MP: 16 Weeks||36||
60056332|NCT02091739|76171726|FG001|STARTED|MP: 16 Weeks||74||
60056333|NCT02091739|76171727|FG002|STARTED|MP: 16 Weeks||74||
60056334|NCT02091739|76171728|FG003|STARTED|MP: 16 Weeks||0||
60056335|NCT02091739|76171729|FG004|STARTED|MP: 16 Weeks||0||
60056336|NCT02091739|76171725|FG000|COMPLETED|MP: 16 Weeks||32||
60056337|NCT02091739|76171726|FG001|COMPLETED|MP: 16 Weeks||69||
60056338|NCT02091739|76171727|FG002|COMPLETED|MP: 16 Weeks||72||
60056339|NCT02091739|76171728|FG003|COMPLETED|MP: 16 Weeks||0||
60056340|NCT02091739|76171729|FG004|COMPLETED|MP: 16 Weeks||0||
60056341|NCT02091739|76171725|FG000|NOT COMPLETED|MP: 16 Weeks||4||
60056342|NCT02091739|76171726|FG001|NOT COMPLETED|MP: 16 Weeks||5||
60056343|NCT02091739|76171727|FG002|NOT COMPLETED|MP: 16 Weeks||2||
60056344|NCT02091739|76171728|FG003|NOT COMPLETED|MP: 16 Weeks||0||
60056345|NCT02091739|76171729|FG004|NOT COMPLETED|MP: 16 Weeks||0||
60056346|NCT02091739|76171725|FG000|STARTED|EP: 48 Weeks||0||
60056347|NCT02091739|76171726|FG001|STARTED|EP: 48 Weeks||0||
60056348|NCT02091739|76171727|FG002|STARTED|EP: 48 Weeks||0||
60056349|NCT02091739|76171728|FG003|STARTED|EP: 48 Weeks||84||
60056350|NCT02091739|76171729|FG004|STARTED|EP: 48 Weeks||89||
60056351|NCT02091739|76171725|FG000|COMPLETED|EP: 48 Weeks||0|Participants who completed the MP (n=173), entered the 2 treatment arms of the EP of the study.|
60056352|NCT02091739|76171726|FG001|COMPLETED|EP: 48 Weeks||0|Participants who completed the MP (n=173), entered the 2 treatment arms of the EP of the study.|
60056353|NCT02091739|76171727|FG002|COMPLETED|EP: 48 Weeks||0|Participants who completed the MP (n=173), entered the 2 treatment arms of the EP of the study.|
60056354|NCT02091739|76171728|FG003|COMPLETED|EP: 48 Weeks||76|Participants who completed the MP (n=173), entered the 2 treatment arms of the EP of the study.|
60056355|NCT02091739|76171729|FG004|COMPLETED|EP: 48 Weeks||75|Participants who completed the MP (n=173), entered the 2 treatment arms of the EP of the study.|
60056356|NCT02091739|76171725|FG000|NOT COMPLETED|EP: 48 Weeks||0||
60056357|NCT02091739|76171726|FG001|NOT COMPLETED|EP: 48 Weeks||0||
60056358|NCT02091739|76171727|FG002|NOT COMPLETED|EP: 48 Weeks||0||
60056359|NCT02091739|76171728|FG003|NOT COMPLETED|EP: 48 Weeks||8||
60056360|NCT02091739|76171729|FG004|NOT COMPLETED|EP: 48 Weeks||14||
60056361|NCT02045875|76171741|FG000|STARTED|Overall Study||27||
60056362|NCT02045875|76171742|FG001|STARTED|Overall Study||23||
60056363|NCT02045875|76171741|FG000|COMPLETED|Overall Study||20||
60056364|NCT02045875|76171742|FG001|COMPLETED|Overall Study||20||
60056365|NCT02045875|76171741|FG000|NOT COMPLETED|Overall Study||7||
60056366|NCT02045875|76171742|FG001|NOT COMPLETED|Overall Study||3||
60056367|NCT01597635|76171751|FG000|STARTED|Part A||5||
60056368|NCT01597635|76171752|FG001|STARTED|Part A||0||
60056369|NCT01597635|76171753|FG002|STARTED|Part A||0||
60056370|NCT01597635|76171751|FG000|COMPLETED|Part A||2||
60056371|NCT01597635|76171752|FG001|COMPLETED|Part A||0||
60056372|NCT01597635|76171753|FG002|COMPLETED|Part A||0||
60056373|NCT01597635|76171751|FG000|NOT COMPLETED|Part A||3||
60056374|NCT01597635|76171752|FG001|NOT COMPLETED|Part A||0||
60056375|NCT01597635|76171753|FG002|NOT COMPLETED|Part A||0||
60056376|NCT01597635|76171751|FG000|STARTED|Part B||0||
60056377|NCT01597635|76171752|FG001|STARTED|Part B||20||
60056378|NCT01597635|76171753|FG002|STARTED|Part B||19||
60056379|NCT01597635|76171751|FG000|COMPLETED|Part B||0||
60056380|NCT01597635|76171752|FG001|COMPLETED|Part B||14||
60056381|NCT01597635|76171753|FG002|COMPLETED|Part B||15||
60056382|NCT01597635|76171751|FG000|NOT COMPLETED|Part B||0||
60056383|NCT01597635|76171752|FG001|NOT COMPLETED|Part B||6||
60056384|NCT01597635|76171753|FG002|NOT COMPLETED|Part B||4||
60056385|NCT01828281|76171764|FG000|STARTED|Overall Study||45||
60056386|NCT01828281|76171765|FG001|STARTED|Overall Study||45||
60056387|NCT01828281|76171764|FG000|COMPLETED|Overall Study||44||
60056388|NCT01828281|76171765|FG001|COMPLETED|Overall Study||45||
60056389|NCT01828281|76171764|FG000|NOT COMPLETED|Overall Study||1||
60056390|NCT01828281|76171765|FG001|NOT COMPLETED|Overall Study||0||
60056391|NCT01827267|76171774|FG000|STARTED|Overall Study|18 subjects were randomized but 17 received treatment.|18|Number of subjects randomized|
60056392|NCT01827267|76171775|FG001|STARTED|Overall Study|44 subjects were randomized; 43 subjects were treated.|44|Number of subjects randomized|
60056393|NCT01827267|76171774|FG000|Received Study Drug|Overall Study||17||
60056394|NCT01827267|76171775|FG001|Received Study Drug|Overall Study||43||
60056395|NCT01827267|76171774|FG000|Crossed Over to Neratinib + Temsirolimus|Overall Study||11||
60056396|NCT01827267|76171775|FG001|Crossed Over to Neratinib + Temsirolimus|Overall Study||0||
60056397|NCT01827267|76171774|FG000|COMPLETED|Overall Study||13|Subjects completed study upon death.|
60056398|NCT01827267|76171775|FG001|COMPLETED|Overall Study||32|Subjects completed study upon death.|
60056399|NCT01827267|76171774|FG000|NOT COMPLETED|Overall Study||5||
60056400|NCT01827267|76171775|FG001|NOT COMPLETED|Overall Study||12||
60056401|NCT01855425|76171782|FG000|STARTED|Overall Study||96||
60056402|NCT01855425|76171782|FG000|COMPLETED|Overall Study||76||
60056403|NCT01855425|76171782|FG000|NOT COMPLETED|Overall Study||20||
60056404|NCT01854879|76171786|FG000|STARTED|Overall Study|97 consented|97||
60056405|NCT01854879|76171786|FG000|COMPLETED|Overall Study|92 had matched endpoint data|92||
60056406|NCT01854879|76171786|FG000|NOT COMPLETED|Overall Study||5||
60056407|NCT01827111|76171790|FG000|STARTED|Overall Study||19||
60056408|NCT01827111|76171790|FG000|COMPLETED|Overall Study||18||
60056409|NCT01827111|76171790|FG000|NOT COMPLETED|Overall Study||1||
60056410|NCT02045095|76171794|FG000|STARTED|Overall Study||3||
60056411|NCT02045095|76171795|FG001|STARTED|Overall Study||4||
60056412|NCT02045095|76171796|FG002|STARTED|Overall Study||4||
60056413|NCT02045095|76171797|FG003|STARTED|Overall Study||4||
59515572|NCT03140254|75609435|FG000|Treatment AC - Groin|Overall Study||51||
59515573|NCT03140254|75609435|FG000|Treatment AC - Abdomen|Overall Study||48||
59515574|NCT03140254|75609435|FG000|Treatment VC - Groin|Overall Study||18||
60056414|NCT02045095|76171798|FG004|STARTED|Overall Study||5||
60056415|NCT02045095|76171799|FG005|STARTED|Overall Study||8||
60056416|NCT02045095|76171800|FG006|STARTED|Overall Study||1||
60056417|NCT02045095|76171794|FG000|COMPLETED|Overall Study||0||
60056418|NCT02045095|76171795|FG001|COMPLETED|Overall Study||0||
60056419|NCT02045095|76171796|FG002|COMPLETED|Overall Study||0||
60056420|NCT02045095|76171797|FG003|COMPLETED|Overall Study||0||
60056421|NCT02045095|76171798|FG004|COMPLETED|Overall Study||0||
60056422|NCT02045095|76171799|FG005|COMPLETED|Overall Study||0||
60056423|NCT02045095|76171800|FG006|COMPLETED|Overall Study||0||
60056424|NCT02045095|76171794|FG000|NOT COMPLETED|Overall Study||3||
60056425|NCT02045095|76171795|FG001|NOT COMPLETED|Overall Study||4||
60056426|NCT02045095|76171796|FG002|NOT COMPLETED|Overall Study||4||
60056427|NCT02045095|76171797|FG003|NOT COMPLETED|Overall Study||4||
60056428|NCT02045095|76171798|FG004|NOT COMPLETED|Overall Study||5||
60056429|NCT02045095|76171799|FG005|NOT COMPLETED|Overall Study||8||
60056430|NCT02045095|76171800|FG006|NOT COMPLETED|Overall Study||1||
60056431|NCT02181803|76171825|FG000|STARTED|Overall Study||1||
60056432|NCT02181803|76171826|FG001|STARTED|Overall Study||13||
60056433|NCT02181803|76171827|FG002|STARTED|Overall Study||4||
60056434|NCT02181803|76171828|FG003|STARTED|Overall Study||13||
59924769|NCT03426995|76043406|FG000|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0||
59924770|NCT03426995|76043407|FG001|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0||
60056435|NCT02181803|76171829|FG004|STARTED|Overall Study||6||
60056436|NCT02181803|76171830|FG005|STARTED|Overall Study||6||
60056437|NCT02181803|76171831|FG006|STARTED|Overall Study||9||
60056438|NCT02181803|76171832|FG007|STARTED|Overall Study||1||
60056439|NCT02181803|76171833|FG008|STARTED|Overall Study||2||
60056440|NCT02181803|76171825|FG000|COMPLETED|Overall Study||1||
60056441|NCT02181803|76171826|FG001|COMPLETED|Overall Study||9||
59515575|NCT03140254|75609435|FG000|Treatment VC - Abdomen|Overall Study||19||
59515576|NCT03140254|75609435|FG000|COMPLETED|Overall Study||144||
59924771|NCT03426995|76043408|FG002|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0||
59515577|NCT03140254|75609435|FG000|NOT COMPLETED|Overall Study||1||
59515578|NCT03140722|75609443|FG000|STARTED|Overall Study||0||
59924772|NCT03426995|76043409|FG003|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0||
59924773|NCT03426995|76043410|FG004|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0||
59924774|NCT03426995|76043411|FG005|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0||
59924775|NCT03426995|76043412|FG006|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0||
59924776|NCT03426995|76043413|FG007|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0||
59924777|NCT03426995|76043414|FG008|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0||
59924778|NCT03426995|76043415|FG009|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0||
59924779|NCT03426995|76043416|FG010|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0||
59924780|NCT03426995|76043417|FG011|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0||
59924781|NCT03426995|76043418|FG012|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0||
59924782|NCT03426995|76043419|FG013|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0||
59924783|NCT03426995|76043420|FG014|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0||
59924784|NCT03426995|76043421|FG015|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0||
59924785|NCT03426995|76043422|FG016|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0||
59924786|NCT03426995|76043423|FG017|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0||
59924787|NCT03426995|76043424|FG018|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0||
59924788|NCT03426995|76043406|FG000|STARTED|Part A: Cohort 2-Period 3 (Day1)||0||
59924789|NCT03426995|76043407|FG001|STARTED|Part A: Cohort 2-Period 3 (Day1)||0||
59924790|NCT03426995|76043408|FG002|STARTED|Part A: Cohort 2-Period 3 (Day1)||0||
59924791|NCT03426995|76043409|FG003|STARTED|Part A: Cohort 2-Period 3 (Day1)||0||
59924792|NCT03426995|76043410|FG004|STARTED|Part A: Cohort 2-Period 3 (Day1)||0||
59924793|NCT03426995|76043411|FG005|STARTED|Part A: Cohort 2-Period 3 (Day1)||0||
59924794|NCT03426995|76043412|FG006|STARTED|Part A: Cohort 2-Period 3 (Day1)||1||
59924795|NCT03426995|76043413|FG007|STARTED|Part A: Cohort 2-Period 3 (Day1)||2||
59924796|NCT03426995|76043414|FG008|STARTED|Part A: Cohort 2-Period 3 (Day1)||1||
59924797|NCT03426995|76043415|FG009|STARTED|Part A: Cohort 2-Period 3 (Day1)||2||
59924798|NCT03426995|76043416|FG010|STARTED|Part A: Cohort 2-Period 3 (Day1)||1||
59924799|NCT03426995|76043417|FG011|STARTED|Part A: Cohort 2-Period 3 (Day1)||2||
59924800|NCT03426995|76043418|FG012|STARTED|Part A: Cohort 2-Period 3 (Day1)||0||
59924801|NCT03426995|76043419|FG013|STARTED|Part A: Cohort 2-Period 3 (Day1)||0||
59924802|NCT03426995|76043420|FG014|STARTED|Part A: Cohort 2-Period 3 (Day1)||0||
59924803|NCT03426995|76043421|FG015|STARTED|Part A: Cohort 2-Period 3 (Day1)||0||
59924804|NCT03426995|76043422|FG016|STARTED|Part A: Cohort 2-Period 3 (Day1)||0||
59924805|NCT03426995|76043423|FG017|STARTED|Part A: Cohort 2-Period 3 (Day1)||0||
59924806|NCT03426995|76043424|FG018|STARTED|Part A: Cohort 2-Period 3 (Day1)||0||
59924807|NCT03426995|76043406|FG000|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
59924808|NCT03426995|76043407|FG001|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
59924809|NCT03426995|76043408|FG002|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
59924810|NCT03426995|76043409|FG003|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
59924811|NCT03426995|76043410|FG004|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
59924812|NCT03426995|76043411|FG005|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
59924813|NCT03426995|76043412|FG006|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||1||
59924814|NCT03426995|76043413|FG007|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||2||
59924815|NCT03426995|76043414|FG008|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||1||
59924816|NCT03426995|76043415|FG009|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||2||
59924817|NCT03426995|76043416|FG010|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||1||
59924818|NCT03426995|76043417|FG011|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||2||
59924819|NCT03426995|76043418|FG012|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
59924820|NCT03426995|76043419|FG013|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
59924821|NCT03426995|76043420|FG014|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
59515579|NCT03140722|75609444|FG001|STARTED|Overall Study||2||
59924822|NCT03426995|76043421|FG015|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
59924823|NCT03426995|76043422|FG016|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
59924824|NCT03426995|76043423|FG017|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
59924825|NCT03426995|76043424|FG018|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
59924826|NCT03426995|76043406|FG000|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
59924827|NCT03426995|76043407|FG001|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
59924828|NCT03426995|76043408|FG002|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
60056442|NCT02181803|76171827|FG002|COMPLETED|Overall Study||4||
60056443|NCT02181803|76171828|FG003|COMPLETED|Overall Study||11||
60056444|NCT02181803|76171829|FG004|COMPLETED|Overall Study||6||
60056445|NCT02181803|76171830|FG005|COMPLETED|Overall Study||6||
60056446|NCT02181803|76171831|FG006|COMPLETED|Overall Study||8||
60056447|NCT02181803|76171832|FG007|COMPLETED|Overall Study||0||
60056448|NCT02181803|76171833|FG008|COMPLETED|Overall Study||2||
60056449|NCT02181803|76171825|FG000|NOT COMPLETED|Overall Study||0||
60056450|NCT02181803|76171826|FG001|NOT COMPLETED|Overall Study||4||
60056451|NCT02181803|76171827|FG002|NOT COMPLETED|Overall Study||0||
60056452|NCT02181803|76171828|FG003|NOT COMPLETED|Overall Study||2||
60056453|NCT02181803|76171829|FG004|NOT COMPLETED|Overall Study||0||
60056454|NCT02181803|76171830|FG005|NOT COMPLETED|Overall Study||0||
60056455|NCT02181803|76171831|FG006|NOT COMPLETED|Overall Study||1||
60056456|NCT02181803|76171832|FG007|NOT COMPLETED|Overall Study||1||
60056457|NCT02181803|76171833|FG008|NOT COMPLETED|Overall Study||0||
60056458|NCT01826487|76171880|FG000|STARTED|Overall Study||115||
60056459|NCT01826487|76171881|FG001|STARTED|Overall Study||115||
60056460|NCT01826487|76171880|FG000|As-treated Population|Overall Study||115|All Randomized participants who received any study treatment.|
60056461|NCT01826487|76171881|FG001|As-treated Population|Overall Study||115|All Randomized participants who received any study treatment.|
60056462|NCT01826487|76171880|FG000|ITT Population|Overall Study||114|Received any study treatment; had a valid baseline, and at least 1 valid post-baseline 6MWD value.|
59924829|NCT03426995|76043409|FG003|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
59924830|NCT03426995|76043410|FG004|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
59924831|NCT03426995|76043411|FG005|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
59924832|NCT03426995|76043412|FG006|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
59924833|NCT03426995|76043413|FG007|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
59924834|NCT03426995|76043414|FG008|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
59924835|NCT03426995|76043415|FG009|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
59924836|NCT03426995|76043416|FG010|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
59924837|NCT03426995|76043417|FG011|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
59924838|NCT03426995|76043418|FG012|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
59924839|NCT03426995|76043419|FG013|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
59924840|NCT03426995|76043420|FG014|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
59924841|NCT03426995|76043421|FG015|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
59924842|NCT03426995|76043422|FG016|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
59924843|NCT03426995|76043423|FG017|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
59924844|NCT03426995|76043424|FG018|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0||
59924845|NCT03426995|76043406|FG000|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0||
59924846|NCT03426995|76043407|FG001|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0||
59924847|NCT03426995|76043408|FG002|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0||
59924848|NCT03426995|76043409|FG003|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0||
59924849|NCT03426995|76043410|FG004|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0||
59924850|NCT03426995|76043411|FG005|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0||
59924851|NCT03426995|76043412|FG006|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||1||
59924852|NCT03426995|76043413|FG007|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||2||
60056463|NCT01826487|76171881|FG001|ITT Population|Overall Study||114|Received any study treatment; had a valid baseline, and at least 1 valid post-baseline 6MWD value.|
60056464|NCT01826487|76171880|FG000|COMPLETED|Overall Study||111||
60056465|NCT01826487|76171881|FG001|COMPLETED|Overall Study||110||
60056466|NCT01826487|76171880|FG000|NOT COMPLETED|Overall Study||4||
60056467|NCT01826487|76171881|FG001|NOT COMPLETED|Overall Study||5||
60056468|NCT02064439|76171891|FG000|STARTED|Overall Study|Full Analysis Set (FAS), randomized and received study medication|1127||
60056469|NCT02064439|76171892|FG001|STARTED|Overall Study|FAS, randomized and received study medication|1107||
60056470|NCT02064439|76171893|FG002|STARTED|Overall Study|FAS, randomized and received study medication|1131||
60056471|NCT02064439|76171891|FG000|COMPLETED|Overall Study||984||
59924853|NCT03426995|76043414|FG008|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||1||
59924854|NCT03426995|76043415|FG009|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||2||
59924855|NCT03426995|76043416|FG010|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||1||
59924856|NCT03426995|76043417|FG011|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||2||
59924857|NCT03426995|76043418|FG012|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0||
59924858|NCT03426995|76043419|FG013|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0||
59924859|NCT03426995|76043420|FG014|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0||
59924860|NCT03426995|76043421|FG015|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0||
59924861|NCT03426995|76043422|FG016|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0||
59924862|NCT03426995|76043423|FG017|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0||
59924863|NCT03426995|76043424|FG018|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0||
59924864|NCT03426995|76043406|FG000|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0||
59924865|NCT03426995|76043407|FG001|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0||
59924866|NCT03426995|76043408|FG002|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0||
59924867|NCT03426995|76043409|FG003|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0||
59924868|NCT03426995|76043410|FG004|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0||
59924869|NCT03426995|76043411|FG005|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0||
59924870|NCT03426995|76043412|FG006|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||1||
59924871|NCT03426995|76043413|FG007|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||2||
59924872|NCT03426995|76043414|FG008|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||1||
59924873|NCT03426995|76043415|FG009|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||2||
59924874|NCT03426995|76043416|FG010|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||1||
59924875|NCT03426995|76043417|FG011|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||2||
59924876|NCT03426995|76043418|FG012|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0||
59924877|NCT03426995|76043419|FG013|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0||
59924878|NCT03426995|76043420|FG014|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0||
59924879|NCT03426995|76043421|FG015|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0||
59924880|NCT03426995|76043422|FG016|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0||
59924881|NCT03426995|76043423|FG017|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0||
59924882|NCT03426995|76043424|FG018|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0||
59924883|NCT03426995|76043406|FG000|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0||
59924884|NCT03426995|76043407|FG001|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0||
59924885|NCT03426995|76043408|FG002|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0||
59924886|NCT03426995|76043409|FG003|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0||
59924887|NCT03426995|76043410|FG004|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0||
59924888|NCT03426995|76043411|FG005|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0||
59924889|NCT03426995|76043412|FG006|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0||
59924890|NCT03426995|76043413|FG007|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0||
59924891|NCT03426995|76043414|FG008|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0||
59924892|NCT03426995|76043415|FG009|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0||
59924893|NCT03426995|76043416|FG010|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0||
59924894|NCT03426995|76043417|FG011|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0||
59924895|NCT03426995|76043418|FG012|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0||
59924896|NCT03426995|76043419|FG013|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0||
59924897|NCT03426995|76043420|FG014|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0||
59924898|NCT03426995|76043421|FG015|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0||
59924899|NCT03426995|76043422|FG016|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0||
59924900|NCT03426995|76043423|FG017|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0||
59924901|NCT03426995|76043424|FG018|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0||
59924902|NCT03426995|76043406|FG000|STARTED|Part A: Cohort 2-Period 4 (Day1)||0||
59924903|NCT03426995|76043407|FG001|STARTED|Part A: Cohort 2-Period 4 (Day1)||0||
59924904|NCT03426995|76043408|FG002|STARTED|Part A: Cohort 2-Period 4 (Day1)||0||
59924905|NCT03426995|76043409|FG003|STARTED|Part A: Cohort 2-Period 4 (Day1)||0||
59924906|NCT03426995|76043410|FG004|STARTED|Part A: Cohort 2-Period 4 (Day1)||0||
60056472|NCT02064439|76171892|FG001|COMPLETED|Overall Study||969||
60056473|NCT02064439|76171893|FG002|COMPLETED|Overall Study||949||
60056474|NCT02064439|76171891|FG000|NOT COMPLETED|Overall Study||143||
60056475|NCT02064439|76171892|FG001|NOT COMPLETED|Overall Study||138||
60056476|NCT02064439|76171893|FG002|NOT COMPLETED|Overall Study||182||
60056477|NCT02130557|76171903|FG000|STARTED|Overall Study||268||
60056478|NCT02130557|76171904|FG001|STARTED|Overall Study||268||
60056479|NCT02130557|76171903|FG000|Treated|Overall Study||268||
60056480|NCT02130557|76171904|FG001|Treated|Overall Study||265||
60056481|NCT02130557|76171903|FG000|mITT Population|Overall Study||246||
60056482|NCT02130557|76171904|FG001|mITT Population|Overall Study||241||
60056483|NCT02130557|76171903|FG000|COMPLETED|Overall Study||232||
60056484|NCT02130557|76171904|FG001|COMPLETED|Overall Study||231||
59515580|NCT03140722|75609443|FG000|COMPLETED|Overall Study||0||
59515581|NCT03140722|75609444|FG001|COMPLETED|Overall Study||2||
59515582|NCT03140722|75609443|FG000|NOT COMPLETED|Overall Study||0||
59515583|NCT03140722|75609444|FG001|NOT COMPLETED|Overall Study||0||
59515584|NCT03142438|75609450|FG000|STARTED|Overall Study||57||
60056485|NCT02130557|76171903|FG000|NOT COMPLETED|Overall Study||36||
60056486|NCT02130557|76171904|FG001|NOT COMPLETED|Overall Study||37||
60056487|NCT01854645|76171915|FG000|STARTED|Overall Study||527||
60056488|NCT01854645|76171916|FG001|STARTED|Overall Study||451||
60056489|NCT01854645|76171917|FG002|STARTED|Overall Study||452||
60056490|NCT01854645|76171918|FG003|STARTED|Overall Study||453||
60056491|NCT01854645|76171919|FG004|STARTED|Overall Study||220||
60056492|NCT01854645|76171915|FG000|COMPLETED|Overall Study||429||
59515585|NCT03142438|75609450|FG000|COMPLETED|Overall Study||57||
59515586|NCT03142438|75609450|FG000|NOT COMPLETED|Overall Study||0||
59515587|NCT00982345|75609454|FG000|STARTED|Overall Study||20||
59760578|NCT00891371|75880203|FG000|STARTED|Treatment||36||
59760579|NCT00891371|75880203|FG000|COMPLETED|Treatment||27||
59760580|NCT00891371|75880203|FG000|NOT COMPLETED|Treatment||9||
60056493|NCT01854645|76171916|FG001|COMPLETED|Overall Study||345||
60056494|NCT01854645|76171917|FG002|COMPLETED|Overall Study||370||
60056495|NCT01854645|76171918|FG003|COMPLETED|Overall Study||391||
60056496|NCT01854645|76171919|FG004|COMPLETED|Overall Study||160||
60056497|NCT01854645|76171915|FG000|NOT COMPLETED|Overall Study||98||
59924907|NCT03426995|76043411|FG005|STARTED|Part A: Cohort 2-Period 4 (Day1)||0||
59924908|NCT03426995|76043412|FG006|STARTED|Part A: Cohort 2-Period 4 (Day1)||1||
59924909|NCT03426995|76043413|FG007|STARTED|Part A: Cohort 2-Period 4 (Day1)|New participant enrolled and dosed.|3||
59924910|NCT03426995|76043414|FG008|STARTED|Part A: Cohort 2-Period 4 (Day1)||1||
59924911|NCT03426995|76043415|FG009|STARTED|Part A: Cohort 2-Period 4 (Day1)||2||
59924912|NCT03426995|76043416|FG010|STARTED|Part A: Cohort 2-Period 4 (Day1)||1||
59924913|NCT03426995|76043417|FG011|STARTED|Part A: Cohort 2-Period 4 (Day1)||2||
59924914|NCT03426995|76043418|FG012|STARTED|Part A: Cohort 2-Period 4 (Day1)||0||
59924915|NCT03426995|76043419|FG013|STARTED|Part A: Cohort 2-Period 4 (Day1)||0||
59924916|NCT03426995|76043420|FG014|STARTED|Part A: Cohort 2-Period 4 (Day1)||0||
59924917|NCT03426995|76043421|FG015|STARTED|Part A: Cohort 2-Period 4 (Day1)||0||
59924918|NCT03426995|76043422|FG016|STARTED|Part A: Cohort 2-Period 4 (Day1)||0||
59924919|NCT03426995|76043423|FG017|STARTED|Part A: Cohort 2-Period 4 (Day1)||0||
59924920|NCT03426995|76043424|FG018|STARTED|Part A: Cohort 2-Period 4 (Day1)||0||
59924921|NCT03426995|76043406|FG000|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
59924922|NCT03426995|76043407|FG001|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
59924923|NCT03426995|76043408|FG002|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
59924924|NCT03426995|76043409|FG003|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
59924925|NCT03426995|76043410|FG004|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
59924926|NCT03426995|76043411|FG005|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
59924927|NCT03426995|76043412|FG006|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||1||
59924928|NCT03426995|76043413|FG007|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||2||
59924929|NCT03426995|76043414|FG008|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||1||
59924930|NCT03426995|76043415|FG009|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||2||
59924931|NCT03426995|76043416|FG010|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
59924932|NCT03426995|76043417|FG011|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||2||
59924933|NCT03426995|76043418|FG012|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
59924934|NCT03426995|76043419|FG013|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
59924935|NCT03426995|76043420|FG014|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
59924936|NCT03426995|76043421|FG015|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
59924937|NCT03426995|76043422|FG016|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
59924938|NCT03426995|76043423|FG017|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
59924939|NCT03426995|76043424|FG018|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
59924940|NCT03426995|76043406|FG000|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
59924941|NCT03426995|76043407|FG001|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
59924942|NCT03426995|76043408|FG002|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
60056498|NCT01854645|76171916|FG001|NOT COMPLETED|Overall Study||106||
60056499|NCT01854645|76171917|FG002|NOT COMPLETED|Overall Study||82||
59515588|NCT00982345|75609454|FG000|COMPLETED|Overall Study||18||
60056500|NCT01854645|76171918|FG003|NOT COMPLETED|Overall Study||62||
59924943|NCT03426995|76043409|FG003|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
59924944|NCT03426995|76043410|FG004|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
59924945|NCT03426995|76043411|FG005|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
59924946|NCT03426995|76043412|FG006|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
59924947|NCT03426995|76043413|FG007|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||1||
59924948|NCT03426995|76043414|FG008|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
60056501|NCT01854645|76171919|FG004|NOT COMPLETED|Overall Study||60||
59760587|NCT00891293|75880216|FG000|STARTED|Overall Study|93 participants were enrolled; baseline data are provided for 89 participants (Safety Population).|93||
60056502|NCT01825941|76171933|FG000|STARTED|Overall Study||104||
59515589|NCT00982345|75609454|FG000|NOT COMPLETED|Overall Study||2||
59515590|NCT03087604|75609460|FG000|STARTED|Overall Study||50||
60056503|NCT01825941|76171934|FG001|STARTED|Overall Study||104||
60056504|NCT01825941|76171933|FG000|COMPLETED|Overall Study||100||
60056505|NCT01825941|76171934|FG001|COMPLETED|Overall Study||103||
60056506|NCT01825941|76171933|FG000|NOT COMPLETED|Overall Study||4||
60056507|NCT01825941|76171934|FG001|NOT COMPLETED|Overall Study||1||
60056508|NCT02064205|76171940|FG000|STARTED|Overall Study||32||
60056509|NCT02064205|76171940|FG000|Condition A|Overall Study||32||
60056510|NCT02064205|76171940|FG000|Condition B|Overall Study||32||
60056511|NCT02064205|76171940|FG000|Condition C|Overall Study||31||
60056512|NCT02064205|76171940|FG000|Condition D|Overall Study||32||
60056513|NCT02064205|76171940|FG000|COMPLETED|Overall Study||31||
60056514|NCT02064205|76171940|FG000|NOT COMPLETED|Overall Study||1||
60056515|NCT02090959|76171956|FG000|STARTED|Overall Study||219||
60056516|NCT02090959|76171956|FG000|As-treated Population|Overall Study||218|All participants who received at least 1 dose of study drug.|
60056517|NCT02090959|76171956|FG000|COMPLETED|Overall Study||68||
60056518|NCT02090959|76171956|FG000|NOT COMPLETED|Overall Study||151||
60056519|NCT02044159|76171962|FG000|STARTED|Overall Study||27|Fifty-seven patients were randomized (86.4%, 57/66 approached for consent)|
60056520|NCT02044159|76171963|FG001|STARTED|Overall Study||30|Fifty-seven patients were randomized (86.4%, 57/66 approached for consent)|
60056521|NCT02044159|76171962|FG000|COMPLETED|Overall Study||23||
60056522|NCT02044159|76171963|FG001|COMPLETED|Overall Study||26||
60056523|NCT02044159|76171962|FG000|NOT COMPLETED|Overall Study||4||
60056524|NCT02044159|76171963|FG001|NOT COMPLETED|Overall Study||4||
60056525|NCT02090725|76171972|FG000|STARTED|Overall Study||4||
60056526|NCT02090725|76171972|FG000|COMPLETED|Overall Study||0||
60056527|NCT02090725|76171972|FG000|NOT COMPLETED|Overall Study||4||
60056528|NCT02180165|76171980|FG000|STARTED|Overall Study||15|Randomized participants|
60056529|NCT02180165|76171981|FG001|STARTED|Overall Study||7|Randomized participants|
60056530|NCT02180165|76171982|FG002|STARTED|Overall Study||63|Randomized participants|
60056531|NCT02180165|76171983|FG003|STARTED|Overall Study||31|Randomized participants|
60056532|NCT02180165|76171980|FG000|Treated Participants|Overall Study||15||
60056533|NCT02180165|76171981|FG001|Treated Participants|Overall Study||7||
60056534|NCT02180165|76171982|FG002|Treated Participants|Overall Study||62||
59515591|NCT03087604|75609461|FG001|STARTED|Overall Study||50||
59515592|NCT03087604|75609460|FG000|COMPLETED|Overall Study||50||
59515593|NCT03087604|75609461|FG001|COMPLETED|Overall Study||50||
59515594|NCT03087604|75609460|FG000|NOT COMPLETED|Overall Study||0||
59515595|NCT03087604|75609461|FG001|NOT COMPLETED|Overall Study||0||
59515596|NCT03090256|75609467|FG000|STARTED|Overall Study||68||
59515597|NCT03090256|75609467|FG000|COMPLETED|Overall Study||68||
59515598|NCT03090256|75609467|FG000|NOT COMPLETED|Overall Study||0||
59515599|NCT00987727|75609474|FG000|STARTED|Overall Study||41||
59515600|NCT00987727|75609475|FG001|STARTED|Overall Study||41||
59515601|NCT00987727|75609474|FG000|COMPLETED|Overall Study||36||
59515602|NCT00987727|75609475|FG001|COMPLETED|Overall Study||34||
59515603|NCT00987727|75609474|FG000|NOT COMPLETED|Overall Study||5||
59515604|NCT00987727|75609475|FG001|NOT COMPLETED|Overall Study||7||
60056535|NCT02180165|76171983|FG003|Treated Participants|Overall Study||31||
60056536|NCT02180165|76171980|FG000|Type of Aspergillosis|Overall Study|Chronic Pulmonary Aspergillosis|15||
60056537|NCT02180165|76171981|FG001|Type of Aspergillosis|Overall Study|Chronic Pulmonary Aspergillosis|7||
60056538|NCT02180165|76171982|FG002|Type of Aspergillosis|Overall Study|Invasive Aspergillosis and Chronic Pulmonary Aspergillosis|57||
60056539|NCT02180165|76171983|FG003|Type of Aspergillosis|Overall Study|Invasive Aspergillosis and Chronic Pulmonary Aspergillosis|27||
60056540|NCT02180165|76171980|FG000|COMPLETED|Overall Study||4|Completed Through Day 84|
60056541|NCT02180165|76171981|FG001|COMPLETED|Overall Study||6|Completed Through Day 84|
60056542|NCT02180165|76171982|FG002|COMPLETED|Overall Study||34|Completed Through Day 84|
59515605|NCT02160535|75609481|FG000|STARTED|Overall Study||13||
59515606|NCT02160535|75609481|FG000|COMPLETED|Overall Study||10||
59515607|NCT02160535|75609481|FG000|NOT COMPLETED|Overall Study||3||
60056543|NCT02180165|76171983|FG003|COMPLETED|Overall Study||25|Completed Through Day 84|
60056544|NCT02180165|76171980|FG000|NOT COMPLETED|Overall Study||11||
60056545|NCT02180165|76171981|FG001|NOT COMPLETED|Overall Study||1||
59515608|NCT02160847|75609487|FG000|STARTED|Overall Study||16||
59515609|NCT02160847|75609488|FG001|STARTED|Overall Study||16||
59515610|NCT02160847|75609487|FG000|COMPLETED|Overall Study||16||
59515611|NCT02160847|75609488|FG001|COMPLETED|Overall Study||16||
59515612|NCT02160847|75609487|FG000|NOT COMPLETED|Overall Study||0||
59515613|NCT02160847|75609488|FG001|NOT COMPLETED|Overall Study||0||
59515614|NCT00989911|75609494|FG000|STARTED|Overall Study||10||
59924949|NCT03426995|76043415|FG009|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
60056546|NCT02180165|76171982|FG002|NOT COMPLETED|Overall Study||29||
60056547|NCT02180165|76171983|FG003|NOT COMPLETED|Overall Study||6||
60056548|NCT02155985|76171998|FG000|STARTED|Overall Study||40||
60056549|NCT02155985|76171999|FG001|STARTED|Overall Study||41||
60056550|NCT02155985|76172000|FG002|STARTED|Overall Study||40||
60056551|NCT02155985|76171998|FG000|COMPLETED|Overall Study||39||
60056552|NCT02155985|76171999|FG001|COMPLETED|Overall Study||41||
60056553|NCT02155985|76172000|FG002|COMPLETED|Overall Study||39||
60056554|NCT02155985|76171998|FG000|NOT COMPLETED|Overall Study||1||
60056555|NCT02155985|76171999|FG001|NOT COMPLETED|Overall Study||0||
60056556|NCT02155985|76172000|FG002|NOT COMPLETED|Overall Study||1||
59924950|NCT03426995|76043416|FG010|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||1||
59924951|NCT03426995|76043417|FG011|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
59924952|NCT03426995|76043418|FG012|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
59924953|NCT03426995|76043419|FG013|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
59924954|NCT03426995|76043420|FG014|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
59924955|NCT03426995|76043421|FG015|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
59924956|NCT03426995|76043422|FG016|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
59924957|NCT03426995|76043423|FG017|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
59924958|NCT03426995|76043424|FG018|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0||
59924959|NCT03426995|76043406|FG000|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0||
59924960|NCT03426995|76043407|FG001|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0||
59924961|NCT03426995|76043408|FG002|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0||
59924962|NCT03426995|76043409|FG003|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0||
59924963|NCT03426995|76043410|FG004|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0||
59924964|NCT03426995|76043411|FG005|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0||
59924965|NCT03426995|76043412|FG006|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0||
59924966|NCT03426995|76043413|FG007|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0||
59924967|NCT03426995|76043414|FG008|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0||
59924968|NCT03426995|76043415|FG009|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0||
59924969|NCT03426995|76043416|FG010|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0||
59924970|NCT03426995|76043417|FG011|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0||
59924971|NCT03426995|76043418|FG012|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0||
59924972|NCT03426995|76043419|FG013|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0||
59924973|NCT03426995|76043420|FG014|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0||
59924974|NCT03426995|76043421|FG015|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0||
59924975|NCT03426995|76043422|FG016|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0||
59924976|NCT03426995|76043423|FG017|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0||
59924977|NCT03426995|76043424|FG018|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0||
59924978|NCT03426995|76043406|FG000|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0||
59924979|NCT03426995|76043407|FG001|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0||
59924980|NCT03426995|76043408|FG002|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0||
59924981|NCT03426995|76043409|FG003|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0||
59924982|NCT03426995|76043410|FG004|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0||
59924983|NCT03426995|76043411|FG005|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0||
59924984|NCT03426995|76043412|FG006|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0||
59924985|NCT03426995|76043413|FG007|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0||
59924986|NCT03426995|76043414|FG008|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0||
59924987|NCT03426995|76043415|FG009|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0||
59924988|NCT03426995|76043416|FG010|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0||
59924989|NCT03426995|76043417|FG011|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0||
59924990|NCT03426995|76043418|FG012|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0||
59924991|NCT03426995|76043419|FG013|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0||
59924992|NCT03426995|76043420|FG014|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0||
59924993|NCT03426995|76043421|FG015|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0||
59924994|NCT03426995|76043422|FG016|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0||
59924995|NCT03426995|76043423|FG017|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0||
59924996|NCT03426995|76043424|FG018|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0||
59924997|NCT03426995|76043406|FG000|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0||
59924998|NCT03426995|76043407|FG001|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0||
59924999|NCT03426995|76043408|FG002|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0||
59925000|NCT03426995|76043409|FG003|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0||
60056557|NCT02155829|76172010|FG000|STARTED|Overall Study||37||
60056558|NCT02155829|76172011|FG001|STARTED|Overall Study||38||
60056559|NCT02155829|76172010|FG000|COMPLETED|Overall Study||31||
60056560|NCT02155829|76172011|FG001|COMPLETED|Overall Study||35||
60056561|NCT02155829|76172010|FG000|NOT COMPLETED|Overall Study||6||
60056562|NCT02155829|76172011|FG001|NOT COMPLETED|Overall Study||3||
60056563|NCT02129777|76172023|FG000|STARTED|Double-Blind Period||24||
60056564|NCT02129777|76172024|FG001|STARTED|Double-Blind Period||24||
60056565|NCT02129777|76172025|FG002|STARTED|Double-Blind Period||24||
60056566|NCT02129777|76172026|FG003|STARTED|Double-Blind Period||25||
60056567|NCT02129777|76172027|FG004|STARTED|Double-Blind Period||25||
60056568|NCT02129777|76172028|FG005|STARTED|Double-Blind Period||0||
60056569|NCT02129777|76172029|FG006|STARTED|Double-Blind Period||0||
60056570|NCT02129777|76172023|FG000|COMPLETED|Double-Blind Period||17||
60056571|NCT02129777|76172024|FG001|COMPLETED|Double-Blind Period||16||
60056572|NCT02129777|76172025|FG002|COMPLETED|Double-Blind Period||20||
60056573|NCT02129777|76172026|FG003|COMPLETED|Double-Blind Period||18||
60056574|NCT02129777|76172027|FG004|COMPLETED|Double-Blind Period||18||
60056575|NCT02129777|76172028|FG005|COMPLETED|Double-Blind Period||0||
60056576|NCT02129777|76172029|FG006|COMPLETED|Double-Blind Period||0||
60056577|NCT02129777|76172023|FG000|NOT COMPLETED|Double-Blind Period||7||
60056578|NCT02129777|76172024|FG001|NOT COMPLETED|Double-Blind Period||8||
60056579|NCT02129777|76172025|FG002|NOT COMPLETED|Double-Blind Period||4||
60056580|NCT02129777|76172026|FG003|NOT COMPLETED|Double-Blind Period||7||
60056581|NCT02129777|76172027|FG004|NOT COMPLETED|Double-Blind Period||7||
60056582|NCT02129777|76172028|FG005|NOT COMPLETED|Double-Blind Period||0||
60056583|NCT02129777|76172029|FG006|NOT COMPLETED|Double-Blind Period||0||
60056584|NCT02129777|76172023|FG000|STARTED|Open-Label Period||0||
60056585|NCT02129777|76172024|FG001|STARTED|Open-Label Period||0||
60056586|NCT02129777|76172025|FG002|STARTED|Open-Label Period||0||
60056587|NCT02129777|76172026|FG003|STARTED|Open-Label Period||0||
60056588|NCT02129777|76172027|FG004|STARTED|Open-Label Period||0||
60056589|NCT02129777|76172028|FG005|STARTED|Open-Label Period||12||
60056590|NCT02129777|76172029|FG006|STARTED|Open-Label Period||48||
60056591|NCT02129777|76172023|FG000|COMPLETED|Open-Label Period||0||
60056592|NCT02129777|76172024|FG001|COMPLETED|Open-Label Period||0||
60056593|NCT02129777|76172025|FG002|COMPLETED|Open-Label Period||0||
60056594|NCT02129777|76172026|FG003|COMPLETED|Open-Label Period||0||
60056595|NCT02129777|76172027|FG004|COMPLETED|Open-Label Period||0||
59515615|NCT00989911|75609494|FG000|COMPLETED|Overall Study||7||
59515616|NCT00989911|75609494|FG000|NOT COMPLETED|Overall Study||3||
59515617|NCT03146806|75609498|FG000|STARTED|Overall Study||10||
59515618|NCT03146806|75609498|FG000|COMPLETED|Overall Study||10||
59515619|NCT03146806|75609498|FG000|NOT COMPLETED|Overall Study||0||
59515620|NCT03090958|75609514|FG000|STARTED|Overall Study||20||
59515621|NCT03090958|75609514|FG000|COMPLETED|Overall Study||20||
59515622|NCT03090958|75609514|FG000|NOT COMPLETED|Overall Study||0||
59515623|NCT03095638|75609520|FG000|STARTED|P1: Period 1 (4 Days)||7||
60056596|NCT02129777|76172028|FG005|COMPLETED|Open-Label Period||0||
60056597|NCT02129777|76172029|FG006|COMPLETED|Open-Label Period||0||
60056598|NCT02129777|76172023|FG000|NOT COMPLETED|Open-Label Period||0||
60056599|NCT02129777|76172024|FG001|NOT COMPLETED|Open-Label Period||0||
60056600|NCT02129777|76172025|FG002|NOT COMPLETED|Open-Label Period||0||
60056601|NCT02129777|76172026|FG003|NOT COMPLETED|Open-Label Period||0||
60056602|NCT02129777|76172027|FG004|NOT COMPLETED|Open-Label Period||0||
59515624|NCT03095638|75609521|FG001|STARTED|P1: Period 1 (4 Days)||7||
59515625|NCT03095638|75609522|FG002|STARTED|P1: Period 1 (4 Days)||0||
60056603|NCT02129777|76172028|FG005|NOT COMPLETED|Open-Label Period||12||
60056604|NCT02129777|76172029|FG006|NOT COMPLETED|Open-Label Period||48||
60056605|NCT02178995|76172050|FG000|STARTED|Double Blind||0||
60056606|NCT02178995|76172051|FG001|STARTED|Double Blind||16||
60056607|NCT02178995|76172052|FG002|STARTED|Double Blind||5||
59515626|NCT03095638|75609523|FG003|STARTED|P1: Period 1 (4 Days)||0||
59515627|NCT03095638|75609524|FG004|STARTED|P1: Period 1 (4 Days)||0||
59515628|NCT03095638|75609525|FG005|STARTED|P1: Period 1 (4 Days)||0||
59515629|NCT03095638|75609526|FG006|STARTED|P1: Period 1 (4 Days)||0||
60056608|NCT02178995|76172053|FG003|STARTED|Double Blind||6||
60056609|NCT02178995|76172054|FG004|STARTED|Double Blind||6||
60056610|NCT02178995|76172055|FG005|STARTED|Double Blind||6||
60056611|NCT02178995|76172056|FG006|STARTED|Double Blind||5||
59613006|NCT01693614|75724055|FG002|STARTED|Overall Study||24||
60056612|NCT02178995|76172057|FG007|STARTED|Double Blind||6||
60056613|NCT02178995|76172058|FG008|STARTED|Double Blind||1||
60056614|NCT02178995|76172050|FG000|COMPLETED|Double Blind||0||
59515630|NCT03095638|75609527|FG007|STARTED|P1: Period 1 (4 Days)||0||
59515631|NCT03095638|75609520|FG000|COMPLETED|P1: Period 1 (4 Days)||7||
59515632|NCT03095638|75609521|FG001|COMPLETED|P1: Period 1 (4 Days)||7||
59515633|NCT03095638|75609522|FG002|COMPLETED|P1: Period 1 (4 Days)||0||
59613007|NCT01693614|75724053|FG000|COMPLETED|Overall Study||0||
60056615|NCT02178995|76172051|FG001|COMPLETED|Double Blind||15||
60056616|NCT02178995|76172052|FG002|COMPLETED|Double Blind||5||
60056617|NCT02178995|76172053|FG003|COMPLETED|Double Blind||6||
60056618|NCT02178995|76172054|FG004|COMPLETED|Double Blind||6||
60056619|NCT02178995|76172055|FG005|COMPLETED|Double Blind||5||
59613008|NCT01693614|75724054|FG001|COMPLETED|Overall Study||0||
60056620|NCT02178995|76172056|FG006|COMPLETED|Double Blind||5||
60056621|NCT02178995|76172057|FG007|COMPLETED|Double Blind||4||
60056622|NCT02178995|76172058|FG008|COMPLETED|Double Blind||0||
60056623|NCT02178995|76172050|FG000|NOT COMPLETED|Double Blind||0||
60056624|NCT02178995|76172051|FG001|NOT COMPLETED|Double Blind||1||
60056625|NCT02178995|76172052|FG002|NOT COMPLETED|Double Blind||0||
60056626|NCT02178995|76172053|FG003|NOT COMPLETED|Double Blind||0||
60056627|NCT02178995|76172054|FG004|NOT COMPLETED|Double Blind||0||
60056628|NCT02178995|76172055|FG005|NOT COMPLETED|Double Blind||1||
60056629|NCT02178995|76172056|FG006|NOT COMPLETED|Double Blind||0||
60056630|NCT02178995|76172057|FG007|NOT COMPLETED|Double Blind||2||
60056631|NCT02178995|76172058|FG008|NOT COMPLETED|Double Blind||1||
60056632|NCT02178995|76172050|FG000|STARTED|Open Label|2 declined to join open-label. 1 withdrew from double-blind but rejoined open-label due to benefit.|30||
60056633|NCT02178995|76172051|FG001|STARTED|Open Label|One was lost to follow-up after completion of visit 4.|14||
60056634|NCT02178995|76172052|FG002|STARTED|Open Label||0||
60056635|NCT02178995|76172053|FG003|STARTED|Open Label||0||
60056636|NCT02178995|76172054|FG004|STARTED|Open Label||0||
59515634|NCT03095638|75609523|FG003|COMPLETED|P1: Period 1 (4 Days)||0||
60056637|NCT02178995|76172055|FG005|STARTED|Open Label||0||
60056638|NCT02178995|76172056|FG006|STARTED|Open Label||0||
60056639|NCT02178995|76172057|FG007|STARTED|Open Label||0||
60056640|NCT02178995|76172058|FG008|STARTED|Open Label||0||
60056641|NCT02178995|76172050|FG000|COMPLETED|Open Label||28||
60056642|NCT02178995|76172051|FG001|COMPLETED|Open Label||14||
60056643|NCT02178995|76172052|FG002|COMPLETED|Open Label||0||
60056644|NCT02178995|76172053|FG003|COMPLETED|Open Label||0||
60056645|NCT02178995|76172054|FG004|COMPLETED|Open Label||0||
60056646|NCT02178995|76172055|FG005|COMPLETED|Open Label||0||
60056647|NCT02178995|76172056|FG006|COMPLETED|Open Label||0||
60056648|NCT02178995|76172057|FG007|COMPLETED|Open Label||0||
60056649|NCT02178995|76172058|FG008|COMPLETED|Open Label||0||
60056650|NCT02178995|76172050|FG000|NOT COMPLETED|Open Label||2||
60056651|NCT02178995|76172051|FG001|NOT COMPLETED|Open Label||0||
60056652|NCT02178995|76172052|FG002|NOT COMPLETED|Open Label||0||
60056653|NCT02178995|76172053|FG003|NOT COMPLETED|Open Label||0||
60056654|NCT02178995|76172054|FG004|NOT COMPLETED|Open Label||0||
60056655|NCT02178995|76172055|FG005|NOT COMPLETED|Open Label||0||
60056656|NCT02178995|76172056|FG006|NOT COMPLETED|Open Label||0||
60056657|NCT02178995|76172057|FG007|NOT COMPLETED|Open Label||0||
60056658|NCT02178995|76172058|FG008|NOT COMPLETED|Open Label||0||
60056659|NCT02128997|76172084|FG000|STARTED|Overall Study||67||
60056660|NCT02128997|76172085|FG001|STARTED|Overall Study||69||
60056661|NCT02128997|76172084|FG000|COMPLETED|Overall Study||61||
60056662|NCT02128997|76172085|FG001|COMPLETED|Overall Study||58||
60056663|NCT02128997|76172084|FG000|NOT COMPLETED|Overall Study||6||
60056664|NCT02128997|76172085|FG001|NOT COMPLETED|Overall Study||11||
60056665|NCT02155283|76172091|FG000|STARTED|Overall Study||16||
60056666|NCT02155283|76172091|FG000|COMPLETED|Overall Study||9||
60056667|NCT02155283|76172091|FG000|NOT COMPLETED|Overall Study||7||
60056668|NCT02154581|76172097|FG000|STARTED|Overall Study||21||
60056669|NCT02154581|76172098|FG001|STARTED|Overall Study||20||
60056670|NCT02154581|76172097|FG000|COMPLETED|Overall Study||14||
60056671|NCT02154581|76172098|FG001|COMPLETED|Overall Study||12||
60056672|NCT02154581|76172097|FG000|NOT COMPLETED|Overall Study||7||
60056673|NCT02154581|76172098|FG001|NOT COMPLETED|Overall Study||8||
60056674|NCT02154425|76172106|FG000|STARTED|Screening Period||18||
60056675|NCT02154425|76172106|FG000|COMPLETED|Screening Period||17||
60056676|NCT02154425|76172106|FG000|NOT COMPLETED|Screening Period||1||
60056677|NCT02154425|76172106|FG000|STARTED|Sampling Period||17||
60056678|NCT02154425|76172106|FG000|COMPLETED|Sampling Period||17||
59515635|NCT03095638|75609524|FG004|COMPLETED|P1: Period 1 (4 Days)||0||
60056679|NCT02154425|76172106|FG000|NOT COMPLETED|Sampling Period||0||
60056680|NCT02154347|76172116|FG000|STARTED|Double-blind Period||60||
60056681|NCT02154347|76172117|FG001|STARTED|Double-blind Period||118||
60056682|NCT02154347|76172116|FG000|COMPLETED|Double-blind Period||57||
60056683|NCT02154347|76172117|FG001|COMPLETED|Double-blind Period||114||
60056684|NCT02154347|76172116|FG000|NOT COMPLETED|Double-blind Period||3||
60056685|NCT02154347|76172117|FG001|NOT COMPLETED|Double-blind Period||4||
60056686|NCT02154347|76172116|FG000|STARTED|Open-label Period||57||
60056687|NCT02154347|76172117|FG001|STARTED|Open-label Period||113||
60056688|NCT02154347|76172116|FG000|COMPLETED|Open-label Period||50||
60056689|NCT02154347|76172117|FG001|COMPLETED|Open-label Period||88||
60056690|NCT02154347|76172116|FG000|NOT COMPLETED|Open-label Period||7||
60056691|NCT02154347|76172117|FG001|NOT COMPLETED|Open-label Period||25||
59515636|NCT03095638|75609525|FG005|COMPLETED|P1: Period 1 (4 Days)||0||
60056692|NCT01627067|76172124|FG000|STARTED|Overall Study||23||
60056693|NCT01627067|76172124|FG000|COMPLETED|Overall Study||22||
60056694|NCT01627067|76172124|FG000|NOT COMPLETED|Overall Study||1||
60056695|NCT02178059|76172130|FG000|STARTED|First Intervention||17||
60056696|NCT02178059|76172131|FG001|STARTED|First Intervention||17||
60056697|NCT02178059|76172130|FG000|COMPLETED|First Intervention||17||
59515637|NCT03095638|75609526|FG006|COMPLETED|P1: Period 1 (4 Days)||0||
60056698|NCT02178059|76172131|FG001|COMPLETED|First Intervention||17||
60056699|NCT02178059|76172130|FG000|NOT COMPLETED|First Intervention||0||
60056700|NCT02178059|76172131|FG001|NOT COMPLETED|First Intervention||0||
60056701|NCT02178059|76172130|FG000|STARTED|Washout||17||
60056702|NCT02178059|76172131|FG001|STARTED|Washout||17||
60056703|NCT02178059|76172130|FG000|COMPLETED|Washout||16||
60056704|NCT02178059|76172131|FG001|COMPLETED|Washout||17||
60056705|NCT02178059|76172130|FG000|NOT COMPLETED|Washout||1||
60056706|NCT02178059|76172131|FG001|NOT COMPLETED|Washout||0||
60056707|NCT02178059|76172130|FG000|STARTED|Second Intervention||16||
60056708|NCT02178059|76172131|FG001|STARTED|Second Intervention||17||
60056709|NCT02178059|76172130|FG000|COMPLETED|Second Intervention||16||
60056710|NCT02178059|76172131|FG001|COMPLETED|Second Intervention||17||
60056711|NCT02178059|76172130|FG000|NOT COMPLETED|Second Intervention||0||
60056712|NCT02178059|76172131|FG001|NOT COMPLETED|Second Intervention||0||
60056713|NCT01626989|76172137|FG000|STARTED|Screening Period||44||
60056714|NCT01626989|76172138|FG001|STARTED|Screening Period||0||
60056715|NCT01626989|76172139|FG002|STARTED|Screening Period||0||
60056716|NCT01626989|76172137|FG000|COMPLETED|Screening Period||27||
60056717|NCT01626989|76172138|FG001|COMPLETED|Screening Period||0||
60056718|NCT01626989|76172139|FG002|COMPLETED|Screening Period||0||
60056719|NCT01626989|76172137|FG000|NOT COMPLETED|Screening Period||17||
60056720|NCT01626989|76172138|FG001|NOT COMPLETED|Screening Period||0||
60056721|NCT01626989|76172139|FG002|NOT COMPLETED|Screening Period||0||
60056722|NCT01626989|76172137|FG000|STARTED|Fist Intervention (Night 1)||0||
60056723|NCT01626989|76172138|FG001|STARTED|Fist Intervention (Night 1)||15||
60056724|NCT01626989|76172139|FG002|STARTED|Fist Intervention (Night 1)||12||
60056725|NCT01626989|76172137|FG000|COMPLETED|Fist Intervention (Night 1)||0||
60056726|NCT01626989|76172138|FG001|COMPLETED|Fist Intervention (Night 1)||15||
60056727|NCT01626989|76172139|FG002|COMPLETED|Fist Intervention (Night 1)||12||
60056728|NCT01626989|76172137|FG000|NOT COMPLETED|Fist Intervention (Night 1)||0||
60056729|NCT01626989|76172138|FG001|NOT COMPLETED|Fist Intervention (Night 1)||0||
60056730|NCT01626989|76172139|FG002|NOT COMPLETED|Fist Intervention (Night 1)||0||
60056731|NCT01626989|76172137|FG000|STARTED|Second Intervention (Night 2)||0||
60056732|NCT01626989|76172138|FG001|STARTED|Second Intervention (Night 2)||15||
60056733|NCT01626989|76172139|FG002|STARTED|Second Intervention (Night 2)||12||
60056734|NCT01626989|76172137|FG000|COMPLETED|Second Intervention (Night 2)||0||
60056735|NCT01626989|76172138|FG001|COMPLETED|Second Intervention (Night 2)||15||
60056736|NCT01626989|76172139|FG002|COMPLETED|Second Intervention (Night 2)||12||
60056737|NCT01626989|76172137|FG000|NOT COMPLETED|Second Intervention (Night 2)||0||
60056738|NCT01626989|76172138|FG001|NOT COMPLETED|Second Intervention (Night 2)||0||
60056739|NCT01626989|76172139|FG002|NOT COMPLETED|Second Intervention (Night 2)||0||
60056740|NCT02128217|76172150|FG000|STARTED|Overall Study||17||
60056741|NCT02128217|76172151|FG001|STARTED|Overall Study||27||
60056742|NCT02128217|76172150|FG000|COMPLETED|Overall Study||17||
60056743|NCT02128217|76172151|FG001|COMPLETED|Overall Study||26||
60056744|NCT02128217|76172150|FG000|NOT COMPLETED|Overall Study||0||
59613009|NCT01693614|75724055|FG002|COMPLETED|Overall Study||0||
59925001|NCT03426995|76043410|FG004|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0||
59925002|NCT03426995|76043411|FG005|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0||
59925003|NCT03426995|76043412|FG006|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0||
59925004|NCT03426995|76043413|FG007|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0||
59925005|NCT03426995|76043414|FG008|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0||
59925006|NCT03426995|76043415|FG009|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0||
59925007|NCT03426995|76043416|FG010|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0||
59925008|NCT03426995|76043417|FG011|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0||
59925009|NCT03426995|76043418|FG012|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0||
59925010|NCT03426995|76043419|FG013|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0||
59925011|NCT03426995|76043420|FG014|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0||
59925012|NCT03426995|76043421|FG015|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0||
59925013|NCT03426995|76043422|FG016|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0||
59925014|NCT03426995|76043423|FG017|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0||
60056745|NCT02128217|76172151|FG001|NOT COMPLETED|Overall Study||1||
60056746|NCT01629953|76172164|FG000|STARTED|Overall Study||65||
60056747|NCT01629953|76172165|FG001|STARTED|Overall Study||75||
60056748|NCT01629953|76172164|FG000|COMPLETED|Overall Study||52||
60056749|NCT01629953|76172165|FG001|COMPLETED|Overall Study||60||
60056750|NCT01629953|76172164|FG000|NOT COMPLETED|Overall Study||13||
60056751|NCT01629953|76172165|FG001|NOT COMPLETED|Overall Study||15||
60056752|NCT02127281|76172173|FG000|STARTED|Overall Study||80||
60056753|NCT02127281|76172174|FG001|STARTED|Overall Study||80||
60056754|NCT02127281|76172173|FG000|COMPLETED|Overall Study||79||
60056755|NCT02127281|76172174|FG001|COMPLETED|Overall Study||80||
60056756|NCT02127281|76172173|FG000|NOT COMPLETED|Overall Study||1||
60056757|NCT02127281|76172174|FG001|NOT COMPLETED|Overall Study||0||
59613010|NCT01693614|75724053|FG000|NOT COMPLETED|Overall Study||26||
59925015|NCT03426995|76043424|FG018|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0||
59925016|NCT03426995|76043406|FG000|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
59925017|NCT03426995|76043407|FG001|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
59925018|NCT03426995|76043408|FG002|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
60056758|NCT01628549|76172184|FG000|STARTED|Overall Study||73||
60056759|NCT01628549|76172185|FG001|STARTED|Overall Study||76||
60056760|NCT01628549|76172186|FG002|STARTED|Overall Study||70||
60056761|NCT01628549|76172187|FG003|STARTED|Overall Study||66||
60056762|NCT01628549|76172184|FG000|COMPLETED|Overall Study||64||
60056763|NCT01628549|76172185|FG001|COMPLETED|Overall Study||64||
60056764|NCT01628549|76172186|FG002|COMPLETED|Overall Study||60||
59515638|NCT03095638|75609527|FG007|COMPLETED|P1: Period 1 (4 Days)||0||
59515639|NCT03095638|75609520|FG000|NOT COMPLETED|P1: Period 1 (4 Days)||0||
59515640|NCT03095638|75609521|FG001|NOT COMPLETED|P1: Period 1 (4 Days)||0||
60056765|NCT01628549|76172187|FG003|COMPLETED|Overall Study||57||
60056766|NCT01628549|76172184|FG000|NOT COMPLETED|Overall Study||9||
60056767|NCT01628549|76172185|FG001|NOT COMPLETED|Overall Study||12||
60056768|NCT01628549|76172186|FG002|NOT COMPLETED|Overall Study||10||
59515641|NCT03095638|75609522|FG002|NOT COMPLETED|P1: Period 1 (4 Days)||0||
59515642|NCT03095638|75609523|FG003|NOT COMPLETED|P1: Period 1 (4 Days)||0||
59515643|NCT03095638|75609524|FG004|NOT COMPLETED|P1: Period 1 (4 Days)||0||
59515644|NCT03095638|75609525|FG005|NOT COMPLETED|P1: Period 1 (4 Days)||0||
59515645|NCT03095638|75609526|FG006|NOT COMPLETED|P1: Period 1 (4 Days)||0||
59515646|NCT03095638|75609527|FG007|NOT COMPLETED|P1: Period 1 (4 Days)||0||
59515647|NCT03095638|75609520|FG000|STARTED|P1: Period 1, Washout (7 [-4 Hours])||7||
59515648|NCT03095638|75609521|FG001|STARTED|P1: Period 1, Washout (7 [-4 Hours])||7||
59515649|NCT03095638|75609522|FG002|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0||
59515650|NCT03095638|75609523|FG003|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0||
59515651|NCT03095638|75609524|FG004|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0||
59925019|NCT03426995|76043409|FG003|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
59925020|NCT03426995|76043410|FG004|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
59925021|NCT03426995|76043411|FG005|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
59925022|NCT03426995|76043412|FG006|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
60056769|NCT01628549|76172187|FG003|NOT COMPLETED|Overall Study||9||
60056770|NCT02127125|76172206|FG000|STARTED|Overall Study||6|Passed screening for inclusion in study, assigned to intervention after baseline measurements.|
60056771|NCT02127125|76172207|FG001|STARTED|Overall Study||8|Passed screening for inclusion in study, assigned to intervention after baseline measurements.|
60056772|NCT02127125|76172208|FG002|STARTED|Overall Study||9|Passed screening for inclusion in study, assigned to intervention after baseline measurements.|
60056773|NCT02127125|76172209|FG003|STARTED|Overall Study||11|Passed screening for inclusion in study, assigned to intervention after baseline measurements.|
60056774|NCT02127125|76172210|FG004|STARTED|Overall Study||12|Passed screening for inclusion in study, assigned to intervention after baseline measurements.|
59515652|NCT03095638|75609525|FG005|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0||
59925023|NCT03426995|76043413|FG007|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
59925024|NCT03426995|76043414|FG008|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
59925025|NCT03426995|76043415|FG009|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
59925026|NCT03426995|76043416|FG010|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
59925027|NCT03426995|76043417|FG011|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
59925028|NCT03426995|76043418|FG012|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
59925029|NCT03426995|76043419|FG013|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
59925030|NCT03426995|76043420|FG014|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
59925031|NCT03426995|76043421|FG015|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
59925032|NCT03426995|76043422|FG016|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
59925033|NCT03426995|76043423|FG017|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
59925034|NCT03426995|76043424|FG018|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
59925035|NCT03426995|76043406|FG000|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
59925036|NCT03426995|76043407|FG001|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
59925037|NCT03426995|76043408|FG002|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
59925038|NCT03426995|76043409|FG003|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
59925039|NCT03426995|76043410|FG004|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
59925040|NCT03426995|76043411|FG005|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
60056775|NCT02127125|76172211|FG005|STARTED|Overall Study||12|Passed screening for inclusion in study, assigned to intervention after baseline measurements.|
59613011|NCT01693614|75724054|FG001|NOT COMPLETED|Overall Study||22||
59925041|NCT03426995|76043412|FG006|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
60056776|NCT02127125|76172212|FG006|STARTED|Overall Study||2|Passed screening for inclusion in study, assigned to intervention after baseline measurements.|
60056777|NCT02127125|76172213|FG007|STARTED|Overall Study||0|Passed screening for inclusion in study, assigned to intervention after baseline measurements.|
60056778|NCT02127125|76172214|FG008|STARTED|Overall Study||1|Passed screening for inclusion in study, assigned to intervention after baseline measurements.|
60056779|NCT02127125|76172206|FG000|COMPLETED|Overall Study||6||
59515653|NCT03095638|75609526|FG006|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0||
59515654|NCT03095638|75609527|FG007|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0||
59515655|NCT03095638|75609520|FG000|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||7||
59515656|NCT03095638|75609521|FG001|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||7||
59515657|NCT03095638|75609522|FG002|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0||
59613012|NCT01693614|75724055|FG002|NOT COMPLETED|Overall Study||24||
59925042|NCT03426995|76043413|FG007|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
59925043|NCT03426995|76043414|FG008|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
59925044|NCT03426995|76043415|FG009|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
59925045|NCT03426995|76043416|FG010|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
59925046|NCT03426995|76043417|FG011|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
59925047|NCT03426995|76043418|FG012|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
59925048|NCT03426995|76043419|FG013|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
59925049|NCT03426995|76043420|FG014|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
59925050|NCT03426995|76043421|FG015|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
59925051|NCT03426995|76043422|FG016|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
59925052|NCT03426995|76043423|FG017|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
59925053|NCT03426995|76043424|FG018|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
59925054|NCT03426995|76043406|FG000|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
59925055|NCT03426995|76043407|FG001|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
59925056|NCT03426995|76043408|FG002|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
59925057|NCT03426995|76043409|FG003|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
59925058|NCT03426995|76043410|FG004|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
59925059|NCT03426995|76043411|FG005|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
59925060|NCT03426995|76043412|FG006|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
59925061|NCT03426995|76043413|FG007|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
59925062|NCT03426995|76043414|FG008|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
59925063|NCT03426995|76043415|FG009|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
59925064|NCT03426995|76043416|FG010|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
59925065|NCT03426995|76043417|FG011|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
59925066|NCT03426995|76043418|FG012|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
59925067|NCT03426995|76043419|FG013|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
59925068|NCT03426995|76043420|FG014|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
59925069|NCT03426995|76043421|FG015|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
59925070|NCT03426995|76043422|FG016|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
59925071|NCT03426995|76043423|FG017|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
59925072|NCT03426995|76043424|FG018|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0||
59925073|NCT03426995|76043406|FG000|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0||
59925074|NCT03426995|76043407|FG001|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0||
59925075|NCT03426995|76043408|FG002|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0||
59925076|NCT03426995|76043409|FG003|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0||
59925077|NCT03426995|76043410|FG004|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0||
59925078|NCT03426995|76043411|FG005|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0||
59925079|NCT03426995|76043412|FG006|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0||
59925080|NCT03426995|76043413|FG007|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0||
59925081|NCT03426995|76043414|FG008|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0||
59925082|NCT03426995|76043415|FG009|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0||
59925083|NCT03426995|76043416|FG010|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0||
59925084|NCT03426995|76043417|FG011|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0||
59925085|NCT03426995|76043418|FG012|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0||
59925086|NCT03426995|76043419|FG013|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0||
59925087|NCT03426995|76043420|FG014|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0||
59925088|NCT03426995|76043421|FG015|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0||
59925089|NCT03426995|76043422|FG016|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0||
59925090|NCT03426995|76043423|FG017|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0||
59925091|NCT03426995|76043424|FG018|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0||
59925092|NCT03426995|76043406|FG000|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0||
59925093|NCT03426995|76043407|FG001|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0||
59925094|NCT03426995|76043408|FG002|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0||
59925095|NCT03426995|76043409|FG003|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0||
59925096|NCT03426995|76043410|FG004|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0||
59925097|NCT03426995|76043411|FG005|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0||
59925098|NCT03426995|76043412|FG006|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0||
59925099|NCT03426995|76043413|FG007|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0||
59925100|NCT03426995|76043414|FG008|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0||
59925101|NCT03426995|76043415|FG009|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0||
59925102|NCT03426995|76043416|FG010|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0||
59925103|NCT03426995|76043417|FG011|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0||
59925104|NCT03426995|76043418|FG012|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0||
59925105|NCT03426995|76043419|FG013|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0||
59925106|NCT03426995|76043420|FG014|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0||
60056780|NCT02127125|76172207|FG001|COMPLETED|Overall Study||8||
60056781|NCT02127125|76172208|FG002|COMPLETED|Overall Study||8||
60056782|NCT02127125|76172209|FG003|COMPLETED|Overall Study||10||
60056783|NCT02127125|76172210|FG004|COMPLETED|Overall Study||9||
60056784|NCT02127125|76172211|FG005|COMPLETED|Overall Study||9||
60056785|NCT02127125|76172212|FG006|COMPLETED|Overall Study||2||
60056786|NCT02127125|76172213|FG007|COMPLETED|Overall Study||0||
60056787|NCT02127125|76172214|FG008|COMPLETED|Overall Study||1||
60056788|NCT02127125|76172206|FG000|NOT COMPLETED|Overall Study||0||
60056789|NCT02127125|76172207|FG001|NOT COMPLETED|Overall Study||0||
60056790|NCT02127125|76172208|FG002|NOT COMPLETED|Overall Study||1||
60056791|NCT02127125|76172209|FG003|NOT COMPLETED|Overall Study||1||
60056792|NCT02127125|76172210|FG004|NOT COMPLETED|Overall Study||3||
60056793|NCT02127125|76172211|FG005|NOT COMPLETED|Overall Study||3||
60056794|NCT02127125|76172212|FG006|NOT COMPLETED|Overall Study||0||
60056795|NCT02127125|76172213|FG007|NOT COMPLETED|Overall Study||0||
60056796|NCT02127125|76172214|FG008|NOT COMPLETED|Overall Study||0||
60056797|NCT02090413|76172237|FG000|STARTED|Overall Study||81||
60056798|NCT02090413|76172238|FG001|STARTED|Overall Study||80||
60056799|NCT02090413|76172239|FG002|STARTED|Overall Study||80||
60056800|NCT02090413|76172237|FG000|COMPLETED|Overall Study||62||
60056801|NCT02090413|76172238|FG001|COMPLETED|Overall Study||60||
60056802|NCT02090413|76172239|FG002|COMPLETED|Overall Study||57||
60056803|NCT02090413|76172237|FG000|NOT COMPLETED|Overall Study||19||
60056804|NCT02090413|76172238|FG001|NOT COMPLETED|Overall Study||20||
60056805|NCT02090413|76172239|FG002|NOT COMPLETED|Overall Study||23||
60056806|NCT02063737|76172250|FG000|STARTED|Overall Study||52||
60056807|NCT02063737|76172251|FG001|STARTED|Overall Study||48||
60056808|NCT02063737|76172250|FG000|COMPLETED|Overall Study||41||
60056809|NCT02063737|76172251|FG001|COMPLETED|Overall Study||44||
60056810|NCT02063737|76172250|FG000|NOT COMPLETED|Overall Study||11||
60056811|NCT02063737|76172251|FG001|NOT COMPLETED|Overall Study||4||
60056812|NCT02125877|76172259|FG000|STARTED|Overall Study||86||
60056813|NCT02125877|76172260|FG001|STARTED|Overall Study||87||
60056814|NCT02125877|76172259|FG000|Pharmacokinetic Analysis Set|Overall Study||83||
60056815|NCT02125877|76172260|FG001|Pharmacokinetic Analysis Set|Overall Study||83||
60056816|NCT02125877|76172259|FG000|Pharmacokinetic Subset A|Overall Study||16||
60056817|NCT02125877|76172260|FG001|Pharmacokinetic Subset A|Overall Study||15||
60056818|NCT02125877|76172259|FG000|Safety Set|Overall Study||86||
60056819|NCT02125877|76172260|FG001|Safety Set|Overall Study||87||
60056820|NCT02125877|76172259|FG000|COMPLETED|Overall Study||73||
60056821|NCT02125877|76172260|FG001|COMPLETED|Overall Study||77||
60056822|NCT02125877|76172259|FG000|NOT COMPLETED|Overall Study||13||
60056823|NCT02125877|76172260|FG001|NOT COMPLETED|Overall Study||10||
60056824|NCT01598987|76172266|FG000|STARTED|Baseline to Month 12||56||
60056825|NCT01598987|76172266|FG000|COMPLETED|Baseline to Month 12||50||
60056826|NCT01598987|76172266|FG000|NOT COMPLETED|Baseline to Month 12||6||
60056827|NCT01598987|76172266|FG000|STARTED|Baseline to 24 Month||56||
60056828|NCT01598987|76172266|FG000|COMPLETED|Baseline to 24 Month||48||
60056829|NCT01598987|76172266|FG000|NOT COMPLETED|Baseline to 24 Month||8||
60056830|NCT02063659|76172280|FG000|STARTED|Double-Blind Treatment Period||26||
60056831|NCT02063659|76172281|FG001|STARTED|Double-Blind Treatment Period||25||
60056832|NCT02063659|76172282|FG002|STARTED|Double-Blind Treatment Period||25||
60056833|NCT02063659|76172283|FG003|STARTED|Double-Blind Treatment Period||0||
60056834|NCT02063659|76172280|FG000|COMPLETED|Double-Blind Treatment Period||24||
60056835|NCT02063659|76172281|FG001|COMPLETED|Double-Blind Treatment Period||22||
60056836|NCT02063659|76172282|FG002|COMPLETED|Double-Blind Treatment Period||22||
60056837|NCT02063659|76172283|FG003|COMPLETED|Double-Blind Treatment Period||0||
60056838|NCT02063659|76172280|FG000|NOT COMPLETED|Double-Blind Treatment Period||2||
60056839|NCT02063659|76172281|FG001|NOT COMPLETED|Double-Blind Treatment Period||3||
60056840|NCT02063659|76172282|FG002|NOT COMPLETED|Double-Blind Treatment Period||3||
60056841|NCT02063659|76172283|FG003|NOT COMPLETED|Double-Blind Treatment Period||0||
60056842|NCT02063659|76172280|FG000|STARTED|Open-Label Extension Period (OLE)||0||
60056843|NCT02063659|76172281|FG001|STARTED|Open-Label Extension Period (OLE)||0||
60056844|NCT02063659|76172282|FG002|STARTED|Open-Label Extension Period (OLE)||0||
60056845|NCT02063659|76172283|FG003|STARTED|Open-Label Extension Period (OLE)||67||
60056846|NCT02063659|76172280|FG000|COMPLETED|Open-Label Extension Period (OLE)||0||
60056847|NCT02063659|76172281|FG001|COMPLETED|Open-Label Extension Period (OLE)||0||
60056848|NCT02063659|76172282|FG002|COMPLETED|Open-Label Extension Period (OLE)||0||
60056849|NCT02063659|76172283|FG003|COMPLETED|Open-Label Extension Period (OLE)||47||
60056850|NCT02063659|76172280|FG000|NOT COMPLETED|Open-Label Extension Period (OLE)||0||
60056851|NCT02063659|76172281|FG001|NOT COMPLETED|Open-Label Extension Period (OLE)||0||
60056852|NCT02063659|76172282|FG002|NOT COMPLETED|Open-Label Extension Period (OLE)||0||
60056853|NCT02063659|76172283|FG003|NOT COMPLETED|Open-Label Extension Period (OLE)||20||
60056854|NCT02062879|76172299|FG000|STARTED|Overall Study||10||
60056855|NCT02062879|76172300|FG001|STARTED|Overall Study||10||
60056856|NCT02062879|76172299|FG000|COMPLETED|Overall Study||6||
60056857|NCT02062879|76172300|FG001|COMPLETED|Overall Study||9||
60056858|NCT02062879|76172299|FG000|NOT COMPLETED|Overall Study||4||
60056859|NCT02062879|76172300|FG001|NOT COMPLETED|Overall Study||1||
60056860|NCT02062645|76172306|FG000|STARTED|Overall Study||115||
59515658|NCT03095638|75609523|FG003|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0||
59515659|NCT03095638|75609524|FG004|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0||
59515660|NCT03095638|75609525|FG005|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0||
59515661|NCT03095638|75609526|FG006|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0||
59515662|NCT03095638|75609527|FG007|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0||
59925107|NCT03426995|76043421|FG015|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0||
59925108|NCT03426995|76043422|FG016|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0||
59925109|NCT03426995|76043423|FG017|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0||
59925110|NCT03426995|76043424|FG018|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0||
59925111|NCT03426995|76043406|FG000|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0||
59925112|NCT03426995|76043407|FG001|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0||
59925113|NCT03426995|76043408|FG002|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0||
59925114|NCT03426995|76043409|FG003|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0||
59925115|NCT03426995|76043410|FG004|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0||
59925116|NCT03426995|76043411|FG005|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0||
59925117|NCT03426995|76043412|FG006|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0||
59925118|NCT03426995|76043413|FG007|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0||
59925119|NCT03426995|76043414|FG008|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0||
59925120|NCT03426995|76043415|FG009|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0||
59925121|NCT03426995|76043416|FG010|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0||
59925122|NCT03426995|76043417|FG011|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0||
59925123|NCT03426995|76043418|FG012|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0||
59925124|NCT03426995|76043419|FG013|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0||
59925125|NCT03426995|76043420|FG014|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0||
59925126|NCT03426995|76043421|FG015|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0||
59925127|NCT03426995|76043422|FG016|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0||
59925128|NCT03426995|76043423|FG017|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0||
59925129|NCT03426995|76043424|FG018|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0||
59925130|NCT03426995|76043406|FG000|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
59925131|NCT03426995|76043407|FG001|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
59925132|NCT03426995|76043408|FG002|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
59925133|NCT03426995|76043409|FG003|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
59925134|NCT03426995|76043410|FG004|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
59925135|NCT03426995|76043411|FG005|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
59925136|NCT03426995|76043412|FG006|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
59925137|NCT03426995|76043413|FG007|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
59925138|NCT03426995|76043414|FG008|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
59925139|NCT03426995|76043415|FG009|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
59925140|NCT03426995|76043416|FG010|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
59925141|NCT03426995|76043417|FG011|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
59925142|NCT03426995|76043418|FG012|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
59925143|NCT03426995|76043419|FG013|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
60056861|NCT02062645|76172306|FG000|COMPLETED|Overall Study||100||
60056862|NCT02062645|76172306|FG000|NOT COMPLETED|Overall Study||15||
60056863|NCT02088697|76172312|FG000|STARTED|Period I||25||
60056864|NCT02088697|76172313|FG001|STARTED|Period I||25||
60056865|NCT02088697|76172312|FG000|COMPLETED|Period I||24||
60056866|NCT02088697|76172313|FG001|COMPLETED|Period I||21||
59515663|NCT03095638|75609520|FG000|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0||
59515664|NCT03095638|75609521|FG001|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0||
59515665|NCT03095638|75609522|FG002|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0||
59515666|NCT03095638|75609523|FG003|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0||
59515667|NCT03095638|75609524|FG004|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0||
59515668|NCT03095638|75609525|FG005|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0||
59925144|NCT03426995|76043420|FG014|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||11||
59925145|NCT03426995|76043421|FG015|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||14||
59925146|NCT03426995|76043422|FG016|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
59925147|NCT03426995|76043423|FG017|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
59925148|NCT03426995|76043424|FG018|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
59925149|NCT03426995|76043406|FG000|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
59925150|NCT03426995|76043407|FG001|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
59925151|NCT03426995|76043408|FG002|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
59925152|NCT03426995|76043409|FG003|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
60056867|NCT02088697|76172312|FG000|NOT COMPLETED|Period I||1||
60056868|NCT02088697|76172313|FG001|NOT COMPLETED|Period I||4||
60056869|NCT02088697|76172312|FG000|STARTED|Wash-out Period (at Least 10 Days)||24||
60056870|NCT02088697|76172313|FG001|STARTED|Wash-out Period (at Least 10 Days)||21||
60056871|NCT02088697|76172312|FG000|COMPLETED|Wash-out Period (at Least 10 Days)||23||
60056872|NCT02088697|76172313|FG001|COMPLETED|Wash-out Period (at Least 10 Days)||21||
60056873|NCT02088697|76172312|FG000|NOT COMPLETED|Wash-out Period (at Least 10 Days)||1||
60056874|NCT02088697|76172313|FG001|NOT COMPLETED|Wash-out Period (at Least 10 Days)||0||
60056875|NCT02088697|76172312|FG000|STARTED|Period II||23||
60056876|NCT02088697|76172313|FG001|STARTED|Period II||21||
60056877|NCT02088697|76172312|FG000|COMPLETED|Period II||23||
60056878|NCT02088697|76172313|FG001|COMPLETED|Period II||21||
60056879|NCT02088697|76172312|FG000|NOT COMPLETED|Period II||0||
60056880|NCT02088697|76172313|FG001|NOT COMPLETED|Period II||0||
59925153|NCT03426995|76043410|FG004|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
59925154|NCT03426995|76043411|FG005|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
59925155|NCT03426995|76043412|FG006|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
59925156|NCT03426995|76043413|FG007|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
59925157|NCT03426995|76043414|FG008|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
59925158|NCT03426995|76043415|FG009|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
59925159|NCT03426995|76043416|FG010|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
59925160|NCT03426995|76043417|FG011|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
60056881|NCT01825785|76172326|FG000|STARTED|Overall Study||12||
60056882|NCT01825785|76172327|FG001|STARTED|Overall Study||6||
60056883|NCT01825785|76172328|FG002|STARTED|Overall Study||6||
60056884|NCT01825785|76172329|FG003|STARTED|Overall Study||6||
60056885|NCT01825785|76172330|FG004|STARTED|Overall Study||6||
60056886|NCT01825785|76172331|FG005|STARTED|Overall Study||6||
60056887|NCT01825785|76172332|FG006|STARTED|Overall Study||6||
60056888|NCT01825785|76172326|FG000|COMPLETED|Overall Study||12||
59515669|NCT03095638|75609526|FG006|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0||
59515670|NCT03095638|75609527|FG007|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0||
59515671|NCT03095638|75609520|FG000|STARTED|P1: Period 2 (4 Days)||7||
59925161|NCT03426995|76043418|FG012|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
59925162|NCT03426995|76043419|FG013|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
60056889|NCT01825785|76172327|FG001|COMPLETED|Overall Study||6||
60056890|NCT01825785|76172328|FG002|COMPLETED|Overall Study||6||
60056891|NCT01825785|76172329|FG003|COMPLETED|Overall Study||6||
60056892|NCT01825785|76172330|FG004|COMPLETED|Overall Study||4||
60056893|NCT01825785|76172331|FG005|COMPLETED|Overall Study||5||
60056894|NCT01825785|76172332|FG006|COMPLETED|Overall Study||6||
60056895|NCT01825785|76172326|FG000|NOT COMPLETED|Overall Study||0||
60056896|NCT01825785|76172327|FG001|NOT COMPLETED|Overall Study||0||
60056897|NCT01825785|76172328|FG002|NOT COMPLETED|Overall Study||0||
60056898|NCT01825785|76172329|FG003|NOT COMPLETED|Overall Study||0||
60056899|NCT01825785|76172330|FG004|NOT COMPLETED|Overall Study||2||
60056900|NCT01825785|76172331|FG005|NOT COMPLETED|Overall Study||1||
60056901|NCT01825785|76172332|FG006|NOT COMPLETED|Overall Study||0||
60056902|NCT02043301|76172357|FG000|STARTED|Overall Study||25||
60056903|NCT02043301|76172358|FG001|STARTED|Overall Study||25||
60056904|NCT02043301|76172359|FG002|STARTED|Overall Study||25||
60056905|NCT02043301|76172357|FG000|COMPLETED|Overall Study||25||
60056906|NCT02043301|76172358|FG001|COMPLETED|Overall Study||24||
59515672|NCT03095638|75609521|FG001|STARTED|P1: Period 2 (4 Days)||7||
59515673|NCT03095638|75609522|FG002|STARTED|P1: Period 2 (4 Days)||0||
59515674|NCT03095638|75609523|FG003|STARTED|P1: Period 2 (4 Days)||0||
59515675|NCT03095638|75609524|FG004|STARTED|P1: Period 2 (4 Days)||0||
60056907|NCT02043301|76172359|FG002|COMPLETED|Overall Study||25||
60056908|NCT02043301|76172357|FG000|NOT COMPLETED|Overall Study||0||
60056909|NCT02043301|76172358|FG001|NOT COMPLETED|Overall Study||1||
60056910|NCT02043301|76172359|FG002|NOT COMPLETED|Overall Study||0||
60056911|NCT01598753|76172371|FG000|STARTED|Overall Study||37||
60056912|NCT01598753|76172372|FG001|STARTED|Overall Study||31||
60056913|NCT01598753|76172373|FG002|STARTED|Overall Study||32||
60056914|NCT01598753|76172374|FG003|STARTED|Overall Study||34||
60056915|NCT01598753|76172371|FG000|COMPLETED|Overall Study||25||
60056916|NCT01598753|76172372|FG001|COMPLETED|Overall Study||16||
60056917|NCT01598753|76172373|FG002|COMPLETED|Overall Study||24||
60056918|NCT01598753|76172374|FG003|COMPLETED|Overall Study||19||
60056919|NCT01598753|76172371|FG000|NOT COMPLETED|Overall Study||12||
60056920|NCT01598753|76172372|FG001|NOT COMPLETED|Overall Study||15||
60056921|NCT01598753|76172373|FG002|NOT COMPLETED|Overall Study||8||
60056922|NCT01598753|76172374|FG003|NOT COMPLETED|Overall Study||15||
60056923|NCT02177123|76172384|FG000|STARTED|Overall Study||107||
60056924|NCT02177123|76172384|FG000|COMPLETED|Overall Study||83||
60056925|NCT02177123|76172384|FG000|NOT COMPLETED|Overall Study||24||
60056926|NCT01824693|76172394|FG000|STARTED|Overall Study||6||
59925163|NCT03426995|76043420|FG014|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||2||
60056927|NCT01824693|76172395|FG001|STARTED|Overall Study||9||
60056928|NCT01824693|76172396|FG002|STARTED|Overall Study||15||
60056929|NCT01824693|76172394|FG000|COMPLETED|Overall Study||5||
60056930|NCT01824693|76172395|FG001|COMPLETED|Overall Study||2||
60056931|NCT01824693|76172396|FG002|COMPLETED|Overall Study||0||
60056932|NCT01824693|76172394|FG000|NOT COMPLETED|Overall Study||1||
60056933|NCT01824693|76172395|FG001|NOT COMPLETED|Overall Study||7||
60056934|NCT01824693|76172396|FG002|NOT COMPLETED|Overall Study||15||
60056935|NCT02176655|76172403|FG000|STARTED|Overall Study||31||
60056936|NCT02176655|76172403|FG000|COMPLETED|Overall Study||25||
60056937|NCT02176655|76172403|FG000|NOT COMPLETED|Overall Study||6||
60056938|NCT02125331|76172410|FG000|STARTED|Overall Study||58||
60056939|NCT02125331|76172411|FG001|STARTED|Overall Study||25||
60056940|NCT02125331|76172410|FG000|COMPLETED|Overall Study||53||
60056941|NCT02125331|76172411|FG001|COMPLETED|Overall Study||25||
60056942|NCT02125331|76172410|FG000|NOT COMPLETED|Overall Study||5||
60056943|NCT02125331|76172411|FG001|NOT COMPLETED|Overall Study||0||
60056944|NCT01622569|76172421|FG000|STARTED|Double-Blind Treatment Phase (Wks 1-16)||82||
60056945|NCT01622569|76172422|FG001|STARTED|Double-Blind Treatment Phase (Wks 1-16)||81||
60056946|NCT01622569|76172423|FG002|STARTED|Double-Blind Treatment Phase (Wks 1-16)||80||
60056947|NCT01622569|76172424|FG003|STARTED|Double-Blind Treatment Phase (Wks 1-16)||80||
60056948|NCT01622569|76172421|FG000|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||70||
60056949|NCT01622569|76172422|FG001|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||75||
60056950|NCT01622569|76172423|FG002|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||71||
59925164|NCT03426995|76043421|FG015|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||2||
59925165|NCT03426995|76043422|FG016|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
59925166|NCT03426995|76043423|FG017|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
59925167|NCT03426995|76043424|FG018|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
59925168|NCT03426995|76043406|FG000|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
59925169|NCT03426995|76043407|FG001|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
59925170|NCT03426995|76043408|FG002|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
59925171|NCT03426995|76043409|FG003|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
59925172|NCT03426995|76043410|FG004|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
59925173|NCT03426995|76043411|FG005|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
59925174|NCT03426995|76043412|FG006|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
59925175|NCT03426995|76043413|FG007|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
59925176|NCT03426995|76043414|FG008|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
59925177|NCT03426995|76043415|FG009|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
59925178|NCT03426995|76043416|FG010|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
59925179|NCT03426995|76043417|FG011|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
59925180|NCT03426995|76043418|FG012|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
59925181|NCT03426995|76043419|FG013|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
59925182|NCT03426995|76043420|FG014|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||9||
60056951|NCT01622569|76172424|FG003|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||76||
60056952|NCT01622569|76172421|FG000|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||12||
60056953|NCT01622569|76172422|FG001|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||6||
60056954|NCT01622569|76172423|FG002|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||9||
60056955|NCT01622569|76172424|FG003|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||4||
60056956|NCT01622569|76172421|FG000|STARTED|Open-Label Extension Phase (Wks 17-24)||68||
60056957|NCT01622569|76172422|FG001|STARTED|Open-Label Extension Phase (Wks 17-24)||72||
60056958|NCT01622569|76172423|FG002|STARTED|Open-Label Extension Phase (Wks 17-24)||67||
60056959|NCT01622569|76172424|FG003|STARTED|Open-Label Extension Phase (Wks 17-24)||75||
60056960|NCT01622569|76172421|FG000|COMPLETED|Open-Label Extension Phase (Wks 17-24)||67||
60056961|NCT01622569|76172422|FG001|COMPLETED|Open-Label Extension Phase (Wks 17-24)||70||
60056962|NCT01622569|76172423|FG002|COMPLETED|Open-Label Extension Phase (Wks 17-24)||64||
60056963|NCT01622569|76172424|FG003|COMPLETED|Open-Label Extension Phase (Wks 17-24)||73||
60056964|NCT01622569|76172421|FG000|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||1||
60056965|NCT01622569|76172422|FG001|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||2||
60056966|NCT01622569|76172423|FG002|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||3||
60056967|NCT01622569|76172424|FG003|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||2||
60056968|NCT01824303|76172446|FG000|STARTED|Randomized Study||16||
60056969|NCT01824303|76172447|FG001|STARTED|Randomized Study||14||
60056970|NCT01824303|76172446|FG000|COMPLETED|Randomized Study||14||
60056971|NCT01824303|76172447|FG001|COMPLETED|Randomized Study||13||
60056972|NCT01824303|76172446|FG000|NOT COMPLETED|Randomized Study||2||
60056973|NCT01824303|76172447|FG001|NOT COMPLETED|Randomized Study||1||
60056974|NCT01824303|76172446|FG000|STARTED|Open Label Extension|2 participants completed the Randomized Study but did not enter the Open Label Extension.|12||
60056975|NCT01824303|76172447|FG001|STARTED|Open Label Extension|2 participants completed the Randomized Study but did not enter the Open Label Extension.|11||
60056976|NCT01824303|76172446|FG000|COMPLETED|Open Label Extension||12||
60056977|NCT01824303|76172447|FG001|COMPLETED|Open Label Extension||11||
60056978|NCT01824303|76172446|FG000|NOT COMPLETED|Open Label Extension||0||
60056979|NCT01824303|76172447|FG001|NOT COMPLETED|Open Label Extension||0||
60056980|NCT01853397|76172459|FG000|STARTED|Overall Study||18||
59515676|NCT03095638|75609525|FG005|STARTED|P1: Period 2 (4 Days)||0||
59515677|NCT03095638|75609526|FG006|STARTED|P1: Period 2 (4 Days)||0||
59515678|NCT03095638|75609527|FG007|STARTED|P1: Period 2 (4 Days)||0||
59515679|NCT03095638|75609520|FG000|COMPLETED|P1: Period 2 (4 Days)||7||
59515680|NCT03095638|75609521|FG001|COMPLETED|P1: Period 2 (4 Days)||7||
59515681|NCT03095638|75609522|FG002|COMPLETED|P1: Period 2 (4 Days)||0||
59515682|NCT03095638|75609523|FG003|COMPLETED|P1: Period 2 (4 Days)||0||
59515683|NCT03095638|75609524|FG004|COMPLETED|P1: Period 2 (4 Days)||0||
59515684|NCT03095638|75609525|FG005|COMPLETED|P1: Period 2 (4 Days)||0||
59515685|NCT03095638|75609526|FG006|COMPLETED|P1: Period 2 (4 Days)||0||
59515686|NCT03095638|75609527|FG007|COMPLETED|P1: Period 2 (4 Days)||0||
59515687|NCT03095638|75609520|FG000|NOT COMPLETED|P1: Period 2 (4 Days)||0||
60056981|NCT01853397|76172460|FG001|STARTED|Overall Study||20||
60056982|NCT01853397|76172461|FG002|STARTED|Overall Study||17||
60056983|NCT01853397|76172462|FG003|STARTED|Overall Study||17||
60056984|NCT01853397|76172459|FG000|COMPLETED|Overall Study||18||
59515688|NCT03095638|75609521|FG001|NOT COMPLETED|P1: Period 2 (4 Days)||0||
59515689|NCT03095638|75609522|FG002|NOT COMPLETED|P1: Period 2 (4 Days)||0||
59515690|NCT03095638|75609523|FG003|NOT COMPLETED|P1: Period 2 (4 Days)||0||
59515691|NCT03095638|75609524|FG004|NOT COMPLETED|P1: Period 2 (4 Days)||0||
60056985|NCT01853397|76172460|FG001|COMPLETED|Overall Study||20||
60056986|NCT01853397|76172461|FG002|COMPLETED|Overall Study||17||
60056987|NCT01853397|76172462|FG003|COMPLETED|Overall Study||15||
60056988|NCT01853397|76172459|FG000|NOT COMPLETED|Overall Study||0||
60056989|NCT01853397|76172460|FG001|NOT COMPLETED|Overall Study||0||
60056990|NCT01853397|76172461|FG002|NOT COMPLETED|Overall Study||0||
60056991|NCT01853397|76172462|FG003|NOT COMPLETED|Overall Study||2||
60056992|NCT02088073|76172477|FG000|STARTED|Acute Phase||258||
60056993|NCT02088073|76172478|FG001|STARTED|Acute Phase||0||
60056994|NCT02088073|76172479|FG002|STARTED|Acute Phase||0||
60056995|NCT02088073|76172480|FG003|STARTED|Acute Phase||0||
60056996|NCT02088073|76172481|FG004|STARTED|Acute Phase||0||
60056997|NCT02088073|76172477|FG000|COMPLETED|Acute Phase||251||
59515692|NCT03095638|75609525|FG005|NOT COMPLETED|P1: Period 2 (4 Days)||0||
59515693|NCT03095638|75609526|FG006|NOT COMPLETED|P1: Period 2 (4 Days)||0||
59515694|NCT03095638|75609527|FG007|NOT COMPLETED|P1: Period 2 (4 Days)||0||
59925183|NCT03426995|76043421|FG015|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||12||
59925184|NCT03426995|76043422|FG016|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
59925185|NCT03426995|76043423|FG017|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
59925186|NCT03426995|76043424|FG018|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0||
59925187|NCT03424265|76043473|FG000|STARTED|Overall Study||29||
59925188|NCT03424265|76043474|FG001|STARTED|Overall Study||34||
59925189|NCT03424265|76043473|FG000|COMPLETED|Overall Study||28||
59925190|NCT03424265|76043474|FG001|COMPLETED|Overall Study||32||
59925191|NCT03424265|76043473|FG000|NOT COMPLETED|Overall Study||1||
59925192|NCT03424265|76043474|FG001|NOT COMPLETED|Overall Study||2||
59925193|NCT03322566|76043483|FG000|STARTED|Overall Study||91||
59925194|NCT03322566|76043484|FG001|STARTED|Overall Study||87||
59925195|NCT03322566|76043485|FG002|STARTED|Overall Study||55||
59925196|NCT03322566|76043483|FG000|COMPLETED|Overall Study||46||
59925197|NCT03322566|76043484|FG001|COMPLETED|Overall Study||42||
59925198|NCT03322566|76043485|FG002|COMPLETED|Overall Study||22||
59925199|NCT03322566|76043483|FG000|NOT COMPLETED|Overall Study||45||
60056998|NCT02088073|76172478|FG001|COMPLETED|Acute Phase||0||
60056999|NCT02088073|76172479|FG002|COMPLETED|Acute Phase||0||
59515695|NCT03095638|75609520|FG000|STARTED|P1: Period 2, Washout (7[-4 Hours])||7||
59925200|NCT03322566|76043484|FG001|NOT COMPLETED|Overall Study||45||
59925201|NCT03322566|76043485|FG002|NOT COMPLETED|Overall Study||33||
59925202|NCT02969018|76043501|FG000|STARTED|Overall Study||25||
59925203|NCT02969018|76043502|FG001|STARTED|Overall Study||29||
60057000|NCT02088073|76172480|FG003|COMPLETED|Acute Phase||0||
59515696|NCT03095638|75609521|FG001|STARTED|P1: Period 2, Washout (7[-4 Hours])||7||
59515697|NCT03095638|75609522|FG002|STARTED|P1: Period 2, Washout (7[-4 Hours])||0||
59515698|NCT03095638|75609523|FG003|STARTED|P1: Period 2, Washout (7[-4 Hours])||0||
59515699|NCT03095638|75609524|FG004|STARTED|P1: Period 2, Washout (7[-4 Hours])||0||
60057001|NCT02088073|76172481|FG004|COMPLETED|Acute Phase||0||
60057002|NCT02088073|76172477|FG000|NOT COMPLETED|Acute Phase||7||
60057003|NCT02088073|76172478|FG001|NOT COMPLETED|Acute Phase||0||
60057004|NCT02088073|76172479|FG002|NOT COMPLETED|Acute Phase||0||
60057005|NCT02088073|76172480|FG003|NOT COMPLETED|Acute Phase||0||
60057006|NCT02088073|76172481|FG004|NOT COMPLETED|Acute Phase||0||
60057007|NCT02088073|76172477|FG000|STARTED|Maintanance Phase||0||
60057008|NCT02088073|76172478|FG001|STARTED|Maintanance Phase||85||
60057009|NCT02088073|76172479|FG002|STARTED|Maintanance Phase||45||
60057010|NCT02088073|76172480|FG003|STARTED|Maintanance Phase||51||
60057011|NCT02088073|76172481|FG004|STARTED|Maintanance Phase||56||
60057012|NCT02088073|76172477|FG000|COMPLETED|Maintanance Phase|251 subjects completed the AP; 240 were eligible to enter the MP. 237 entered the MP.|0||
60057013|NCT02088073|76172478|FG001|COMPLETED|Maintanance Phase||75||
60057014|NCT02088073|76172479|FG002|COMPLETED|Maintanance Phase||40||
60057015|NCT02088073|76172480|FG003|COMPLETED|Maintanance Phase||44||
60057016|NCT02088073|76172481|FG004|COMPLETED|Maintanance Phase||49||
60057017|NCT02088073|76172477|FG000|NOT COMPLETED|Maintanance Phase||0||
60057018|NCT02088073|76172478|FG001|NOT COMPLETED|Maintanance Phase||10||
60057019|NCT02088073|76172479|FG002|NOT COMPLETED|Maintanance Phase||5||
60057020|NCT02088073|76172480|FG003|NOT COMPLETED|Maintanance Phase||7||
60057021|NCT02088073|76172481|FG004|NOT COMPLETED|Maintanance Phase||7||
60057022|NCT01823991|76172496|FG000|STARTED|Overall Study||18||
60057023|NCT01823991|76172497|FG001|STARTED|Overall Study||18||
60057024|NCT01823991|76172496|FG000|COMPLETED|Overall Study||10||
59925204|NCT02969018|76043503|FG002|STARTED|Overall Study||26||
60057025|NCT01823991|76172497|FG001|COMPLETED|Overall Study||13||
60057026|NCT01823991|76172496|FG000|NOT COMPLETED|Overall Study||8||
60057027|NCT01823991|76172497|FG001|NOT COMPLETED|Overall Study||5||
60057028|NCT02087059|76172507|FG000|STARTED|Overall Study||51||
60057029|NCT02087059|76172507|FG000|COMPLETED|Overall Study||44||
59515700|NCT03095638|75609525|FG005|STARTED|P1: Period 2, Washout (7[-4 Hours])||0||
59515701|NCT03095638|75609526|FG006|STARTED|P1: Period 2, Washout (7[-4 Hours])||0||
59515702|NCT03095638|75609527|FG007|STARTED|P1: Period 2, Washout (7[-4 Hours])||0||
59515703|NCT03095638|75609520|FG000|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||7||
59515704|NCT03095638|75609521|FG001|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||7||
59925205|NCT02969018|76043504|FG003|STARTED|Overall Study||25||
59925206|NCT02969018|76043505|FG004|STARTED|Overall Study||29||
59925207|NCT02969018|76043506|FG005|STARTED|Overall Study||25||
59925208|NCT02969018|76043507|FG006|STARTED|Overall Study||30||
59925209|NCT02969018|76043508|FG007|STARTED|Overall Study||23||
59925210|NCT02969018|76043501|FG000|COMPLETED|Overall Study||21||
60057030|NCT02087059|76172507|FG000|NOT COMPLETED|Overall Study||7||
60057031|NCT02152163|76172513|FG000|STARTED|Overall Study||51||
60057032|NCT02152163|76172514|FG001|STARTED|Overall Study||48||
60057033|NCT02152163|76172513|FG000|COMPLETED|Overall Study||39||
59515705|NCT03095638|75609522|FG002|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0||
59515706|NCT03095638|75609523|FG003|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0||
59515707|NCT03095638|75609524|FG004|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0||
59515708|NCT03095638|75609525|FG005|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0||
59515709|NCT03095638|75609526|FG006|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0||
59515710|NCT03095638|75609527|FG007|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0||
59515711|NCT03095638|75609520|FG000|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0||
59515712|NCT03095638|75609521|FG001|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0||
59515713|NCT03095638|75609522|FG002|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0||
59515714|NCT03095638|75609523|FG003|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0||
59515715|NCT03095638|75609524|FG004|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0||
59515716|NCT03095638|75609525|FG005|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0||
59515717|NCT03095638|75609526|FG006|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0||
59515718|NCT03095638|75609527|FG007|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0||
59515719|NCT03095638|75609520|FG000|STARTED|P2: Period 1 (4 Days)||0||
59515720|NCT03095638|75609521|FG001|STARTED|P2: Period 1 (4 Days)||0||
59515721|NCT03095638|75609522|FG002|STARTED|P2: Period 1 (4 Days)||4||
59515722|NCT03095638|75609523|FG003|STARTED|P2: Period 1 (4 Days)||4||
59515723|NCT03095638|75609524|FG004|STARTED|P2: Period 1 (4 Days)||4||
59760588|NCT00891293|75880216|FG000|COMPLETED|Overall Study||9||
59925211|NCT02969018|76043502|FG001|COMPLETED|Overall Study||21||
59925212|NCT02969018|76043503|FG002|COMPLETED|Overall Study||20||
60057034|NCT02152163|76172514|FG001|COMPLETED|Overall Study||35||
60057035|NCT02152163|76172513|FG000|NOT COMPLETED|Overall Study||12||
60057036|NCT02152163|76172514|FG001|NOT COMPLETED|Overall Study||13||
60057037|NCT02152007|76172520|FG000|STARTED|Overall Study||15||
59515724|NCT03095638|75609525|FG005|STARTED|P2: Period 1 (4 Days)||4||
59515725|NCT03095638|75609526|FG006|STARTED|P2: Period 1 (4 Days)||4||
59515726|NCT03095638|75609527|FG007|STARTED|P2: Period 1 (4 Days)||4||
59515727|NCT03095638|75609520|FG000|COMPLETED|P2: Period 1 (4 Days)||0||
59515728|NCT03095638|75609521|FG001|COMPLETED|P2: Period 1 (4 Days)||0||
59925213|NCT02969018|76043504|FG003|COMPLETED|Overall Study||20||
60057038|NCT02152007|76172520|FG000|COMPLETED|Overall Study||14||
60057039|NCT02152007|76172520|FG000|NOT COMPLETED|Overall Study||1||
60057040|NCT02151851|76172527|FG000|STARTED|Overall Study||114||
60057041|NCT02151851|76172528|FG001|STARTED|Overall Study||316||
60057042|NCT02151851|76172527|FG000|Included in the Safety Set|Overall Study||113||
60057043|NCT02151851|76172528|FG001|Included in the Safety Set|Overall Study||316||
60057044|NCT02151851|76172527|FG000|COMPLETED|Overall Study||38||
60057045|NCT02151851|76172528|FG001|COMPLETED|Overall Study||186||
60057046|NCT02151851|76172527|FG000|NOT COMPLETED|Overall Study||76||
60057047|NCT02151851|76172528|FG001|NOT COMPLETED|Overall Study||130||
59925214|NCT02969018|76043505|FG004|COMPLETED|Overall Study||27||
59925215|NCT02969018|76043506|FG005|COMPLETED|Overall Study||17||
59925216|NCT02969018|76043507|FG006|COMPLETED|Overall Study||22||
59925217|NCT02969018|76043508|FG007|COMPLETED|Overall Study||16||
59925218|NCT02969018|76043501|FG000|NOT COMPLETED|Overall Study||4||
59925219|NCT02969018|76043502|FG001|NOT COMPLETED|Overall Study||8||
59925220|NCT02969018|76043503|FG002|NOT COMPLETED|Overall Study||6||
59925221|NCT02969018|76043504|FG003|NOT COMPLETED|Overall Study||5||
59925222|NCT02969018|76043505|FG004|NOT COMPLETED|Overall Study||2||
59925223|NCT02969018|76043506|FG005|NOT COMPLETED|Overall Study||8||
59925224|NCT02969018|76043507|FG006|NOT COMPLETED|Overall Study||8||
59925225|NCT02969018|76043508|FG007|NOT COMPLETED|Overall Study||7||
59925226|NCT01319721|76043531|FG000|STARTED|Overall Study|The unit of measure is eyes.|48||
59925227|NCT01319721|76043532|FG001|STARTED|Overall Study|The unit of measure is eyes.|48||
59925228|NCT01319721|76043531|FG000|COMPLETED|Overall Study|The unit of measure is eyes.|47||
59925229|NCT01319721|76043532|FG001|COMPLETED|Overall Study|The unit of measure is eyes.|42||
59925230|NCT01319721|76043531|FG000|NOT COMPLETED|Overall Study||1||
59925231|NCT01319721|76043532|FG001|NOT COMPLETED|Overall Study||6||
59925232|NCT02905032|76043541|FG000|STARTED|Overall Study||467||
59925233|NCT02905032|76043542|FG001|STARTED|Overall Study||475||
59925234|NCT02905032|76043543|FG002|STARTED|Overall Study||244||
59925235|NCT02905032|76043541|FG000|COMPLETED|Overall Study||459||
59925236|NCT02905032|76043542|FG001|COMPLETED|Overall Study||463||
59925237|NCT02905032|76043543|FG002|COMPLETED|Overall Study||244||
59925238|NCT02905032|76043541|FG000|NOT COMPLETED|Overall Study||8||
59925239|NCT02905032|76043542|FG001|NOT COMPLETED|Overall Study||12||
59925240|NCT02905032|76043543|FG002|NOT COMPLETED|Overall Study||0||
59925241|NCT03259425|76043550|FG000|STARTED|Overall Study||7||
59925242|NCT03259425|76043550|FG000|Surgery|Overall Study||6||
59925243|NCT03259425|76043550|FG000|COMPLETED|Overall Study||6||
59925244|NCT03259425|76043550|FG000|NOT COMPLETED|Overall Study||1||
59925245|NCT03101241|76043556|FG000|STARTED|Overall Study||48||
59925246|NCT03101241|76043557|FG001|STARTED|Overall Study||47||
59925247|NCT03101241|76043556|FG000|COMPLETED|Overall Study||37||
59925248|NCT03101241|76043557|FG001|COMPLETED|Overall Study||42||
59925249|NCT03101241|76043556|FG000|NOT COMPLETED|Overall Study||11||
59925250|NCT03101241|76043557|FG001|NOT COMPLETED|Overall Study||5||
59925251|NCT03061188|76043567|FG000|STARTED|Completed 1st Cycle||0|The starting dose (Cohort 1) was not de-escalated.|
59925252|NCT03061188|76043568|FG001|STARTED|Completed 1st Cycle||3|The starting dose (Cohort 1) was not de-escalated.|
59925253|NCT03061188|76043569|FG002|STARTED|Completed 1st Cycle||6|The starting dose (Cohort 1) was not de-escalated.|
59925254|NCT03061188|76043570|FG003|STARTED|Completed 1st Cycle||6|The starting dose (Cohort 1) was not de-escalated.|
59925255|NCT03061188|76043567|FG000|COMPLETED|Completed 1st Cycle||0||
59925256|NCT03061188|76043568|FG001|COMPLETED|Completed 1st Cycle||3||
59925257|NCT03061188|76043569|FG002|COMPLETED|Completed 1st Cycle||6||
59925258|NCT03061188|76043570|FG003|COMPLETED|Completed 1st Cycle||6||
59925259|NCT03061188|76043567|FG000|NOT COMPLETED|Completed 1st Cycle||0||
59925260|NCT03061188|76043568|FG001|NOT COMPLETED|Completed 1st Cycle||0||
59925261|NCT03061188|76043569|FG002|NOT COMPLETED|Completed 1st Cycle||0||
59925262|NCT03061188|76043570|FG003|NOT COMPLETED|Completed 1st Cycle||0||
60057048|NCT02176421|76172534|FG000|STARTED|Overall Study||80||
60057049|NCT02176421|76172534|FG000|COMPLETED|Overall Study||75||
60057050|NCT02176421|76172534|FG000|NOT COMPLETED|Overall Study||5||
60057051|NCT02042443|76172540|FG000|STARTED|Overall Study||27||
60057052|NCT02042443|76172541|FG001|STARTED|Overall Study||26||
59925263|NCT03061188|76043567|FG000|STARTED|Went on to Cycle 2 and Beyond||0|The starting dose (Cohort 1) was not de-escalated.|
59925264|NCT03061188|76043568|FG001|STARTED|Went on to Cycle 2 and Beyond||3|The starting dose (Cohort 1) was not de-escalated.|
59925265|NCT03061188|76043569|FG002|STARTED|Went on to Cycle 2 and Beyond||6|The starting dose (Cohort 1) was not de-escalated.|
59925266|NCT03061188|76043570|FG003|STARTED|Went on to Cycle 2 and Beyond||6|The starting dose (Cohort 1) was not de-escalated.|
59925267|NCT03061188|76043567|FG000|Received Dose of Study Drugs|Went on to Cycle 2 and Beyond||0||
59925268|NCT03061188|76043568|FG001|Received Dose of Study Drugs|Went on to Cycle 2 and Beyond||3||
59925269|NCT03061188|76043569|FG002|Received Dose of Study Drugs|Went on to Cycle 2 and Beyond||5||
59515729|NCT03095638|75609522|FG002|COMPLETED|P2: Period 1 (4 Days)||4||
59515730|NCT03095638|75609523|FG003|COMPLETED|P2: Period 1 (4 Days)||4||
59760589|NCT00891293|75880216|FG000|NOT COMPLETED|Overall Study||84||
59613013|NCT01715298|75724066|FG000|STARTED|Overall Study||216||
59613014|NCT01715298|75724067|FG001|STARTED|Overall Study||216||
59613015|NCT01715298|75724066|FG000|Full Analysis Set (FAS)|Overall Study|patients were analyzed according to the treatment to which they were randomized|215||
59613016|NCT01715298|75724067|FG001|Full Analysis Set (FAS)|Overall Study||214||
59613017|NCT01715298|75724066|FG000|COMPLETED|Overall Study||209||
59613018|NCT01715298|75724067|FG001|COMPLETED|Overall Study||205||
59760590|NCT00889421|75880220|FG000|STARTED|Overall Study||3||
60057053|NCT02042443|76172540|FG000|Eligible and Analyzable|Overall Study||24||
60057054|NCT02042443|76172541|FG001|Eligible and Analyzable|Overall Study||20||
60057055|NCT02042443|76172540|FG000|COMPLETED|Overall Study||0||
60057056|NCT02042443|76172541|FG001|COMPLETED|Overall Study||0||
60057057|NCT02042443|76172540|FG000|NOT COMPLETED|Overall Study||27||
60057058|NCT02042443|76172541|FG001|NOT COMPLETED|Overall Study||26||
60057059|NCT02118896|76172558|FG000|STARTED|Overall Study||47||
60057060|NCT02118896|76172559|FG001|STARTED|Overall Study||47||
60057061|NCT02118896|76172560|FG002|STARTED|Overall Study||67||
60057062|NCT02118896|76172561|FG003|STARTED|Overall Study||79||
60057063|NCT02118896|76172562|FG004|STARTED|Overall Study||130||
60057064|NCT02118896|76172563|FG005|STARTED|Overall Study||191||
60057065|NCT02118896|76172564|FG006|STARTED|Overall Study||85||
60057066|NCT02118896|76172565|FG007|STARTED|Overall Study||107||
60057067|NCT02118896|76172566|FG008|STARTED|Overall Study||88||
60057068|NCT02118896|76172567|FG009|STARTED|Overall Study||9||
60057069|NCT02118896|76172558|FG000|COMPLETED|Overall Study||30||
60057070|NCT02118896|76172559|FG001|COMPLETED|Overall Study||32||
60057071|NCT02118896|76172560|FG002|COMPLETED|Overall Study||53||
60057072|NCT02118896|76172561|FG003|COMPLETED|Overall Study||55||
60057073|NCT02118896|76172562|FG004|COMPLETED|Overall Study||113||
60057074|NCT02118896|76172563|FG005|COMPLETED|Overall Study||163||
60057075|NCT02118896|76172564|FG006|COMPLETED|Overall Study||83||
60057076|NCT02118896|76172565|FG007|COMPLETED|Overall Study||105||
60057077|NCT02118896|76172566|FG008|COMPLETED|Overall Study||84||
60057078|NCT02118896|76172567|FG009|COMPLETED|Overall Study||7||
60057079|NCT02118896|76172558|FG000|NOT COMPLETED|Overall Study||17||
60057080|NCT02118896|76172559|FG001|NOT COMPLETED|Overall Study||15||
60057081|NCT02118896|76172560|FG002|NOT COMPLETED|Overall Study||14||
60057082|NCT02118896|76172561|FG003|NOT COMPLETED|Overall Study||24||
60057083|NCT02118896|76172562|FG004|NOT COMPLETED|Overall Study||17||
60057084|NCT02118896|76172563|FG005|NOT COMPLETED|Overall Study||28||
60057085|NCT02118896|76172564|FG006|NOT COMPLETED|Overall Study||2||
60057086|NCT02118896|76172565|FG007|NOT COMPLETED|Overall Study||2||
60057087|NCT02118896|76172566|FG008|NOT COMPLETED|Overall Study||4||
60057088|NCT02118896|76172567|FG009|NOT COMPLETED|Overall Study||2||
60057089|NCT02124707|76172590|FG000|STARTED|Overall Study||14||
60057090|NCT02124707|76172590|FG000|COMPLETED|Overall Study||7||
60057091|NCT02124707|76172590|FG000|NOT COMPLETED|Overall Study||7||
60057092|NCT02067728|76172597|FG000|STARTED|Baseline - 1 Month Follow up Survey||220||
60057093|NCT02067728|76172598|FG001|STARTED|Baseline - 1 Month Follow up Survey||210||
60057094|NCT02067728|76172597|FG000|COMPLETED|Baseline - 1 Month Follow up Survey|213 parents/guardians completed the surveys, along with 82 teens.|213||
60057095|NCT02067728|76172598|FG001|COMPLETED|Baseline - 1 Month Follow up Survey|182 parent/guardians completed the surveys, along with 75 teens.|182||
60057096|NCT02067728|76172597|FG000|NOT COMPLETED|Baseline - 1 Month Follow up Survey||7||
60057097|NCT02067728|76172598|FG001|NOT COMPLETED|Baseline - 1 Month Follow up Survey||28||
60057098|NCT02067728|76172597|FG000|STARTED|6 Month Follow up Survey|Participants completed the 6 month follow up even if 1 month data wasn't able to be collected.|220||
60057099|NCT02067728|76172598|FG001|STARTED|6 Month Follow up Survey|Participants completed the 6 month follow up even if 1 month data wasn't able to be collected.|210||
60057100|NCT02067728|76172597|FG000|COMPLETED|6 Month Follow up Survey|172 parent/guardians completed surveys at this time point, along with 71 teens.|172||
60057101|NCT02067728|76172598|FG001|COMPLETED|6 Month Follow up Survey|150 parent/guardians completed surveys at this time point, along with 69 teens.|150||
60057102|NCT02067728|76172597|FG000|NOT COMPLETED|6 Month Follow up Survey||48||
60057103|NCT02067728|76172598|FG001|NOT COMPLETED|6 Month Follow up Survey||60||
60057104|NCT02067728|76172597|FG000|STARTED|6 Month Measurements||220||
60057105|NCT02067728|76172598|FG001|STARTED|6 Month Measurements||210||
60057106|NCT02067728|76172597|FG000|COMPLETED|6 Month Measurements|Number includes 6 month measurements & chart review for visits at 6 months +/- 2 months from initial|106||
60057107|NCT02067728|76172598|FG001|COMPLETED|6 Month Measurements|Number includes 6 month measurements & chart review for visits at 6 months +/- 2 months from initial|113||
60057108|NCT02067728|76172597|FG000|NOT COMPLETED|6 Month Measurements||114||
60057109|NCT02067728|76172598|FG001|NOT COMPLETED|6 Month Measurements||97||
60057110|NCT02118428|76172606|FG000|STARTED|Overall Study||113||
60057111|NCT02118428|76172607|FG001|STARTED|Overall Study||113||
60057112|NCT02118428|76172608|FG002|STARTED|Overall Study||1||
60067865|NCT01785615|76183054|FG002|COMPLETED|Atorvastatin Phase||0||
59613019|NCT01715298|75724066|FG000|NOT COMPLETED|Overall Study||7||
59613020|NCT01715298|75724067|FG001|NOT COMPLETED|Overall Study||11||
59925270|NCT03061188|76043570|FG003|Received Dose of Study Drugs|Went on to Cycle 2 and Beyond||5||
59925271|NCT03061188|76043567|FG000|COMPLETED|Went on to Cycle 2 and Beyond||0||
59925272|NCT03061188|76043568|FG001|COMPLETED|Went on to Cycle 2 and Beyond||3||
59925273|NCT03061188|76043569|FG002|COMPLETED|Went on to Cycle 2 and Beyond||5||
59925274|NCT03061188|76043570|FG003|COMPLETED|Went on to Cycle 2 and Beyond||5||
59925275|NCT03061188|76043567|FG000|NOT COMPLETED|Went on to Cycle 2 and Beyond||0||
59925276|NCT03061188|76043568|FG001|NOT COMPLETED|Went on to Cycle 2 and Beyond||0||
59925277|NCT03061188|76043569|FG002|NOT COMPLETED|Went on to Cycle 2 and Beyond||1||
59925278|NCT03061188|76043570|FG003|NOT COMPLETED|Went on to Cycle 2 and Beyond||1||
59925279|NCT03061188|76043567|FG000|STARTED|On Follow-up for 3 Years||0|The starting dose (Cohort 1) was not de-escalated.|
59925280|NCT03061188|76043568|FG001|STARTED|On Follow-up for 3 Years||3|The starting dose (Cohort 1) was not de-escalated.|
59925281|NCT03061188|76043569|FG002|STARTED|On Follow-up for 3 Years|Patients who received at least one dose of study drug go into follow-up.|6|The starting dose (Cohort 1) was not de-escalated.|
59925282|NCT03061188|76043570|FG003|STARTED|On Follow-up for 3 Years|Patients who receive at least one dose of study drug go into follow-up.|6|The starting dose (Cohort 1) was not de-escalated.|
59925283|NCT03061188|76043567|FG000|COMPLETED|On Follow-up for 3 Years||0||
59925284|NCT03061188|76043568|FG001|COMPLETED|On Follow-up for 3 Years||0||
59925285|NCT03061188|76043569|FG002|COMPLETED|On Follow-up for 3 Years||1||
59925286|NCT03061188|76043570|FG003|COMPLETED|On Follow-up for 3 Years||1||
59925287|NCT03061188|76043567|FG000|NOT COMPLETED|On Follow-up for 3 Years||0||
59925288|NCT03061188|76043568|FG001|NOT COMPLETED|On Follow-up for 3 Years||3||
59925289|NCT03061188|76043569|FG002|NOT COMPLETED|On Follow-up for 3 Years||5||
59925290|NCT03061188|76043570|FG003|NOT COMPLETED|On Follow-up for 3 Years||5||
59925291|NCT03449147|76043588|FG000|STARTED|52-week Treatment Period||436||
59925292|NCT03449147|76043589|FG001|STARTED|52-week Treatment Period||442||
59925293|NCT03449147|76043590|FG002|STARTED|52-week Treatment Period||439||
59925294|NCT03449147|76043588|FG000|COMPLETED|52-week Treatment Period||382||
59925295|NCT03449147|76043589|FG001|COMPLETED|52-week Treatment Period||368||
59925296|NCT03449147|76043590|FG002|COMPLETED|52-week Treatment Period||355||
59925297|NCT03449147|76043588|FG000|NOT COMPLETED|52-week Treatment Period||54||
59925298|NCT03449147|76043589|FG001|NOT COMPLETED|52-week Treatment Period||74||
59925299|NCT03449147|76043590|FG002|NOT COMPLETED|52-week Treatment Period||84||
59925300|NCT03449147|76043588|FG000|STARTED|12-Week Off-Treatment Durability Period|Not all participants continued in the optional Off-Treatment Period.|48||
59925301|NCT03449147|76043589|FG001|STARTED|12-Week Off-Treatment Durability Period|Not all participants continued in the optional Off-Treatment Period.|37||
59925302|NCT03449147|76043590|FG002|STARTED|12-Week Off-Treatment Durability Period|Not all participants continued in the optional Off-Treatment Period.|37||
59925303|NCT03449147|76043588|FG000|COMPLETED|12-Week Off-Treatment Durability Period||47||
59925304|NCT03449147|76043589|FG001|COMPLETED|12-Week Off-Treatment Durability Period||36||
59925305|NCT03449147|76043590|FG002|COMPLETED|12-Week Off-Treatment Durability Period||37||
59925306|NCT03449147|76043588|FG000|NOT COMPLETED|12-Week Off-Treatment Durability Period||1||
59925307|NCT03449147|76043589|FG001|NOT COMPLETED|12-Week Off-Treatment Durability Period||1||
59925308|NCT03449147|76043590|FG002|NOT COMPLETED|12-Week Off-Treatment Durability Period||0||
59925309|NCT03423173|76043606|FG000|STARTED|Overall Study||132||
59925310|NCT03423173|76043607|FG001|STARTED|Overall Study||263||
59925311|NCT03423173|76043608|FG002|STARTED|Overall Study||264||
59925312|NCT03423173|76043609|FG003|STARTED|Overall Study||264||
59925313|NCT03423173|76043606|FG000|Received at Least 1 Dose of the IP|Overall Study||131|Investigational Product (IP) includes TDV and placebo.|
59925314|NCT03423173|76043607|FG001|Received at Least 1 Dose of the IP|Overall Study||263|Investigational Product (IP) includes TDV and placebo.|
59925315|NCT03423173|76043608|FG002|Received at Least 1 Dose of the IP|Overall Study|1 participant of TDV Lot 2 received vaccine of Lot 1 and was included in TDV Lot 1 in Safety Set.|262|Investigational Product (IP) includes TDV and placebo.|
59925316|NCT03423173|76043609|FG003|Received at Least 1 Dose of the IP|Overall Study||263|Investigational Product (IP) includes TDV and placebo.|
59925317|NCT03423173|76043606|FG000|COMPLETED|Overall Study||113||
59925318|NCT03423173|76043607|FG001|COMPLETED|Overall Study||228||
59925319|NCT03423173|76043608|FG002|COMPLETED|Overall Study||237||
59925320|NCT03423173|76043609|FG003|COMPLETED|Overall Study||234||
59925321|NCT03423173|76043606|FG000|NOT COMPLETED|Overall Study||19||
59925322|NCT03423173|76043607|FG001|NOT COMPLETED|Overall Study||35||
59925323|NCT03423173|76043608|FG002|NOT COMPLETED|Overall Study||27||
59925324|NCT03423173|76043609|FG003|NOT COMPLETED|Overall Study||30||
59925325|NCT03447821|76043622|FG000|STARTED|Overall Study||14||
59925326|NCT03447821|76043623|FG001|STARTED|Overall Study||13||
59925327|NCT03447821|76043624|FG002|STARTED|Overall Study||13||
59925328|NCT03447821|76043622|FG000|COMPLETED|Overall Study||13||
59925329|NCT03447821|76043623|FG001|COMPLETED|Overall Study||12||
59925330|NCT03447821|76043624|FG002|COMPLETED|Overall Study||12||
59925331|NCT03447821|76043622|FG000|NOT COMPLETED|Overall Study||1||
59925332|NCT03447821|76043623|FG001|NOT COMPLETED|Overall Study||1||
59925333|NCT03447821|76043624|FG002|NOT COMPLETED|Overall Study||1||
59925334|NCT03079284|76043632|FG000|STARTED|Overall Study||10||
59925335|NCT03079284|76043632|FG000|COMPLETED|Overall Study||10||
60057113|NCT02118428|76172606|FG000|Received Study Transfusion|Overall Study||111||
60057114|NCT02118428|76172607|FG001|Received Study Transfusion|Overall Study||112||
60057115|NCT02118428|76172608|FG002|Received Study Transfusion|Overall Study||0||
60057116|NCT02118428|76172606|FG000|COMPLETED|Overall Study||100||
60057117|NCT02118428|76172607|FG001|COMPLETED|Overall Study||104||
60057118|NCT02118428|76172608|FG002|COMPLETED|Overall Study||0||
60057119|NCT02118428|76172606|FG000|NOT COMPLETED|Overall Study||13||
60057120|NCT02118428|76172607|FG001|NOT COMPLETED|Overall Study||9||
60057121|NCT02118428|76172608|FG002|NOT COMPLETED|Overall Study||1||
60057122|NCT02067104|76172616|FG000|STARTED|Overall Study||4||
60057123|NCT02067104|76172617|FG001|STARTED|Overall Study||5||
60057124|NCT02067104|76172616|FG000|COMPLETED|Overall Study||0||
60057125|NCT02067104|76172617|FG001|COMPLETED|Overall Study||0||
60057126|NCT02067104|76172616|FG000|NOT COMPLETED|Overall Study||4||
60057127|NCT02067104|76172617|FG001|NOT COMPLETED|Overall Study||5||
60057128|NCT02092220|76172623|FG000|STARTED|Period 1||21||
60057129|NCT02092220|76172624|FG001|STARTED|Period 1||22||
60057130|NCT02092220|76172623|FG000|COMPLETED|Period 1||21||
60057131|NCT02092220|76172624|FG001|COMPLETED|Period 1||20||
60057132|NCT02092220|76172623|FG000|NOT COMPLETED|Period 1||0||
60057133|NCT02092220|76172624|FG001|NOT COMPLETED|Period 1||2||
59515731|NCT03095638|75609524|FG004|COMPLETED|P2: Period 1 (4 Days)||4||
60057134|NCT02092220|76172623|FG000|STARTED|Period 2||21||
60057135|NCT02092220|76172624|FG001|STARTED|Period 2||20||
60057136|NCT02092220|76172623|FG000|COMPLETED|Period 2||20||
60057137|NCT02092220|76172624|FG001|COMPLETED|Period 2||19||
60057138|NCT02092220|76172623|FG000|NOT COMPLETED|Period 2||1||
60057139|NCT02092220|76172624|FG001|NOT COMPLETED|Period 2||1||
60057140|NCT02066402|76172634|FG000|STARTED|Overall Study||300||
60057141|NCT02066402|76172635|FG001|STARTED|Overall Study||298||
60057142|NCT02066402|76172634|FG000|Participants Received Treatment|Overall Study||292||
60057143|NCT02066402|76172635|FG001|Participants Received Treatment|Overall Study||297||
60057144|NCT02066402|76172634|FG000|Completed Study Treatment Period|Overall Study||261||
60057145|NCT02066402|76172635|FG001|Completed Study Treatment Period|Overall Study||256||
60057146|NCT02066402|76172634|FG000|COMPLETED|Overall Study||274||
60057147|NCT02066402|76172635|FG001|COMPLETED|Overall Study||275||
60057148|NCT02066402|76172634|FG000|NOT COMPLETED|Overall Study||26||
60057149|NCT02066402|76172635|FG001|NOT COMPLETED|Overall Study||23||
60057150|NCT02060383|76172646|FG000|STARTED|Core Phase||38|Entered Core Phase of Study|
60057151|NCT02060383|76172647|FG001|STARTED|Core Phase||43|Entered Core Phase of Study|
60057152|NCT02060383|76172648|FG002|STARTED|Core Phase||19|Entered Core Phase of Study|
60057153|NCT02060383|76172649|FG003|STARTED|Core Phase||46|Entered Core Phase of Study|
60057154|NCT02060383|76172650|FG004|STARTED|Core Phase||103|Entered Core Phase of Study|
60057155|NCT02060383|76172646|FG000|Completed Core/Entered Extension|Core Phase||17||
60057156|NCT02060383|76172647|FG001|Completed Core/Entered Extension|Core Phase||17||
60057157|NCT02060383|76172648|FG002|Completed Core/Entered Extension|Core Phase||10||
60057158|NCT02060383|76172649|FG003|Completed Core/Entered Extension|Core Phase||21||
60057159|NCT02060383|76172650|FG004|Completed Core/Entered Extension|Core Phase||53||
60057160|NCT02060383|76172646|FG000|Completed Core/Did Not Enter Extension|Core Phase||18||
60057161|NCT02060383|76172647|FG001|Completed Core/Did Not Enter Extension|Core Phase||20||
60057162|NCT02060383|76172648|FG002|Completed Core/Did Not Enter Extension|Core Phase||9||
60057163|NCT02060383|76172649|FG003|Completed Core/Did Not Enter Extension|Core Phase||18||
60057164|NCT02060383|76172650|FG004|Completed Core/Did Not Enter Extension|Core Phase||42||
60057165|NCT02060383|76172646|FG000|COMPLETED|Core Phase||35||
60057166|NCT02060383|76172647|FG001|COMPLETED|Core Phase||37||
60057167|NCT02060383|76172648|FG002|COMPLETED|Core Phase||19||
60057168|NCT02060383|76172649|FG003|COMPLETED|Core Phase||39||
60057169|NCT02060383|76172650|FG004|COMPLETED|Core Phase||95||
60057170|NCT02060383|76172646|FG000|NOT COMPLETED|Core Phase||3||
60057171|NCT02060383|76172647|FG001|NOT COMPLETED|Core Phase||6||
60057172|NCT02060383|76172648|FG002|NOT COMPLETED|Core Phase||0||
60057173|NCT02060383|76172649|FG003|NOT COMPLETED|Core Phase||7||
60057174|NCT02060383|76172650|FG004|NOT COMPLETED|Core Phase||8||
60057175|NCT02060383|76172646|FG000|STARTED|Extension Phase||17|Entered the Extension phase from the Core phase|
60057176|NCT02060383|76172647|FG001|STARTED|Extension Phase||17|Entered the Extension phase from the Core phase|
60057177|NCT02060383|76172648|FG002|STARTED|Extension Phase||10|Entered the Extension phase from the Core phase|
60057178|NCT02060383|76172649|FG003|STARTED|Extension Phase||21|Entered the Extension phase from the Core phase|
60057179|NCT02060383|76172650|FG004|STARTED|Extension Phase||53|Entered the Extension phase from the Core phase|
60057180|NCT02060383|76172646|FG000|COMPLETED|Extension Phase||14|Completed the Extension phase|
60057181|NCT02060383|76172647|FG001|COMPLETED|Extension Phase||14|Completed the Extension phase|
60057182|NCT02060383|76172648|FG002|COMPLETED|Extension Phase||7|Completed the Extension phase|
60057183|NCT02060383|76172649|FG003|COMPLETED|Extension Phase||19|Completed the Extension phase|
60057184|NCT02060383|76172650|FG004|COMPLETED|Extension Phase||46|Completed the Extension phase|
59515732|NCT03095638|75609525|FG005|COMPLETED|P2: Period 1 (4 Days)||4||
59515733|NCT03095638|75609526|FG006|COMPLETED|P2: Period 1 (4 Days)||4||
59515734|NCT03095638|75609527|FG007|COMPLETED|P2: Period 1 (4 Days)||4||
59515735|NCT03095638|75609520|FG000|NOT COMPLETED|P2: Period 1 (4 Days)||0||
59515736|NCT03095638|75609521|FG001|NOT COMPLETED|P2: Period 1 (4 Days)||0||
59515737|NCT03095638|75609522|FG002|NOT COMPLETED|P2: Period 1 (4 Days)||0||
60057185|NCT02060383|76172646|FG000|NOT COMPLETED|Extension Phase||3||
60057186|NCT02060383|76172647|FG001|NOT COMPLETED|Extension Phase||3||
60057187|NCT02060383|76172648|FG002|NOT COMPLETED|Extension Phase||3||
60057188|NCT02060383|76172649|FG003|NOT COMPLETED|Extension Phase||2||
60057189|NCT02060383|76172650|FG004|NOT COMPLETED|Extension Phase||7||
60057190|NCT02086591|76172662|FG000|STARTED|Overall Study||7||
60057191|NCT02086591|76172662|FG000|COMPLETED|Overall Study||2||
60057192|NCT02086591|76172662|FG000|NOT COMPLETED|Overall Study||5||
60057193|NCT02065622|76172668|FG000|STARTED|Induction Study||379||
60057194|NCT02065622|76172669|FG001|STARTED|Induction Study||573||
60057195|NCT02065622|76172670|FG002|STARTED|Induction Study||0||
60057196|NCT02065622|76172671|FG003|STARTED|Induction Study||0||
60057197|NCT02065622|76172672|FG004|STARTED|Induction Study||0||
60057198|NCT02065622|76172668|FG000|Enrolled in Main Study|Induction Study||340||
60057199|NCT02065622|76172669|FG001|Enrolled in Main Study|Induction Study||512||
60057200|NCT02065622|76172670|FG002|Enrolled in Main Study|Induction Study||0||
60057201|NCT02065622|76172671|FG003|Enrolled in Main Study|Induction Study||0||
60057202|NCT02065622|76172672|FG004|Enrolled in Main Study|Induction Study||0||
60057203|NCT02065622|76172668|FG000|Enrolled in Japan Sub-Study|Induction Study||39||
60057204|NCT02065622|76172669|FG001|Enrolled in Japan Sub-Study|Induction Study||61||
60057205|NCT02065622|76172670|FG002|Enrolled in Japan Sub-Study|Induction Study||0||
60057206|NCT02065622|76172671|FG003|Enrolled in Japan Sub-Study|Induction Study||0||
60057207|NCT02065622|76172672|FG004|Enrolled in Japan Sub-Study|Induction Study||0||
60057208|NCT02065622|76172668|FG000|COMPLETED|Induction Study||332||
60057209|NCT02065622|76172669|FG001|COMPLETED|Induction Study||514||
60057210|NCT02065622|76172670|FG002|COMPLETED|Induction Study||0||
60057211|NCT02065622|76172671|FG003|COMPLETED|Induction Study||0||
60057212|NCT02065622|76172672|FG004|COMPLETED|Induction Study||0||
59515738|NCT03095638|75609523|FG003|NOT COMPLETED|P2: Period 1 (4 Days)||0||
59515739|NCT03095638|75609524|FG004|NOT COMPLETED|P2: Period 1 (4 Days)||0||
60057213|NCT02065622|76172668|FG000|NOT COMPLETED|Induction Study||47||
60057214|NCT02065622|76172669|FG001|NOT COMPLETED|Induction Study||59||
60057215|NCT02065622|76172670|FG002|NOT COMPLETED|Induction Study||0||
60057216|NCT02065622|76172671|FG003|NOT COMPLETED|Induction Study||0||
60057217|NCT02065622|76172672|FG004|NOT COMPLETED|Induction Study||0||
60057218|NCT02065622|76172668|FG000|STARTED|Maintenance Study||0||
60057219|NCT02065622|76172669|FG001|STARTED|Maintenance Study||0||
60057220|NCT02065622|76172670|FG002|STARTED|Maintenance Study||345||
60057221|NCT02065622|76172671|FG003|STARTED|Maintenance Study||350||
60057222|NCT02065622|76172672|FG004|STARTED|Maintenance Study||151||
60057223|NCT02065622|76172668|FG000|COMPLETED|Maintenance Study||0||
60057224|NCT02065622|76172669|FG001|COMPLETED|Maintenance Study||0||
60057225|NCT02065622|76172670|FG002|COMPLETED|Maintenance Study||221||
60057226|NCT02065622|76172671|FG003|COMPLETED|Maintenance Study||246||
60057227|NCT02065622|76172672|FG004|COMPLETED|Maintenance Study||105||
60057228|NCT02065622|76172668|FG000|NOT COMPLETED|Maintenance Study||0||
60057229|NCT02065622|76172669|FG001|NOT COMPLETED|Maintenance Study||0||
60057230|NCT02065622|76172670|FG002|NOT COMPLETED|Maintenance Study||124||
60057231|NCT02065622|76172671|FG003|NOT COMPLETED|Maintenance Study||104||
60057232|NCT02065622|76172672|FG004|NOT COMPLETED|Maintenance Study||46||
60057233|NCT02117648|76172687|FG000|STARTED|Abemaciclib Alone Period 1||26||
59925336|NCT03079284|76043632|FG000|NOT COMPLETED|Overall Study||0||
59925337|NCT03447353|76043638|FG000|STARTED|Overall Study||18||
60057234|NCT02117648|76172687|FG000|Received at Least 1 Dose of Study Drug|Abemaciclib Alone Period 1||26||
60057235|NCT02117648|76172687|FG000|COMPLETED|Abemaciclib Alone Period 1||24||
60057236|NCT02117648|76172687|FG000|NOT COMPLETED|Abemaciclib Alone Period 1||2||
60057237|NCT02117648|76172687|FG000|STARTED|Abemaciclib + Clarithromycin Period 2||24||
60057238|NCT02117648|76172687|FG000|Received at Least 1 Dose of Study Drug|Abemaciclib + Clarithromycin Period 2||21||
60057239|NCT02117648|76172687|FG000|COMPLETED|Abemaciclib + Clarithromycin Period 2||20||
60057240|NCT02117648|76172687|FG000|NOT COMPLETED|Abemaciclib + Clarithromycin Period 2||4||
60057241|NCT02117648|76172687|FG000|STARTED|Abemaciclib Safety-Extension Phase||20||
60057242|NCT02117648|76172687|FG000|COMPLETED|Abemaciclib Safety-Extension Phase||0||
60057243|NCT02117648|76172687|FG000|NOT COMPLETED|Abemaciclib Safety-Extension Phase||20||
60057244|NCT02124161|76172697|FG000|STARTED|Overall Study||441||
60057245|NCT02124161|76172698|FG001|STARTED|Overall Study||441||
60057246|NCT02124161|76172697|FG000|Vaccination 1|Overall Study||439||
59515740|NCT03095638|75609525|FG005|NOT COMPLETED|P2: Period 1 (4 Days)||0||
59925338|NCT03447353|76043638|FG000|COMPLETED|Overall Study||8||
59925339|NCT03447353|76043638|FG000|NOT COMPLETED|Overall Study||10||
59925340|NCT03446885|76043648|FG000|STARTED|Overall Study||12||
59925341|NCT03446885|76043649|FG001|STARTED|Overall Study||10||
59925342|NCT03446885|76043648|FG000|COMPLETED|Overall Study||10||
59925343|NCT03446885|76043649|FG001|COMPLETED|Overall Study||10||
59925344|NCT03446885|76043648|FG000|NOT COMPLETED|Overall Study||2||
59925345|NCT03446885|76043649|FG001|NOT COMPLETED|Overall Study||0||
59925346|NCT00710970|76043657|FG000|STARTED|Overall Study||28||
59925347|NCT00710970|76043657|FG000|COMPLETED|Overall Study||25||
59925348|NCT00710970|76043657|FG000|NOT COMPLETED|Overall Study||3||
59925349|NCT03421379|76043663|FG000|STARTED|Period 1||34||
59925350|NCT03421379|76043664|FG001|STARTED|Period 1||41||
59925351|NCT03421379|76043663|FG000|Received at Least One Dose of Study Drug|Period 1||33||
59925352|NCT03421379|76043664|FG001|Received at Least One Dose of Study Drug|Period 1||39||
59925353|NCT03421379|76043663|FG000|COMPLETED|Period 1||32||
59925354|NCT03421379|76043664|FG001|COMPLETED|Period 1||37||
59925355|NCT03421379|76043663|FG000|NOT COMPLETED|Period 1||2||
59925356|NCT03421379|76043664|FG001|NOT COMPLETED|Period 1||4||
59925357|NCT03421379|76043663|FG000|STARTED|Washout Period (3 to 14 Days)||32||
59925358|NCT03421379|76043664|FG001|STARTED|Washout Period (3 to 14 Days)||37||
59925359|NCT03421379|76043663|FG000|COMPLETED|Washout Period (3 to 14 Days)||32||
59925360|NCT03421379|76043664|FG001|COMPLETED|Washout Period (3 to 14 Days)||37||
59925361|NCT03421379|76043663|FG000|NOT COMPLETED|Washout Period (3 to 14 Days)||0||
59925362|NCT03421379|76043664|FG001|NOT COMPLETED|Washout Period (3 to 14 Days)||0||
59925363|NCT03421379|76043663|FG000|STARTED|Period 2||32||
59925364|NCT03421379|76043664|FG001|STARTED|Period 2||37||
59925365|NCT03421379|76043663|FG000|COMPLETED|Period 2||32||
59925366|NCT03421379|76043664|FG001|COMPLETED|Period 2||37||
59925367|NCT03421379|76043663|FG000|NOT COMPLETED|Period 2||0||
59925368|NCT03421379|76043664|FG001|NOT COMPLETED|Period 2||0||
59925369|NCT02900378|76043672|FG000|STARTED|Randomization (Visit 2)||310|All randomized patients|
59925370|NCT02900378|76043673|FG001|STARTED|Randomization (Visit 2)||311|All randomized patients|
59925371|NCT02900378|76043672|FG000|COMPLETED|Randomization (Visit 2)||287||
59925372|NCT02900378|76043673|FG001|COMPLETED|Randomization (Visit 2)||283||
59925373|NCT02900378|76043672|FG000|NOT COMPLETED|Randomization (Visit 2)||23||
59925374|NCT02900378|76043673|FG001|NOT COMPLETED|Randomization (Visit 2)||28||
59925375|NCT02900378|76043672|FG000|STARTED|Treatment Phase||309|All randomized patients with at least 1 dose of study treatment|
60057247|NCT02124161|76172698|FG001|Vaccination 1|Overall Study||437||
60057248|NCT02124161|76172697|FG000|Vaccination 2|Overall Study||431||
59925376|NCT02900378|76043673|FG001|STARTED|Treatment Phase||310|All randomized patients with at least 1 dose of study treatment|
59925377|NCT02900378|76043672|FG000|Full Analysis Set|Treatment Phase||302|At least 1 dose of study treatment and 1 post baseline safety assessment|
59925378|NCT02900378|76043673|FG001|Full Analysis Set|Treatment Phase||302|At least 1 dose of study treatment and 1 post baseline safety assessment|
59925379|NCT02900378|76043672|FG000|COMPLETED|Treatment Phase||309||
59925380|NCT02900378|76043673|FG001|COMPLETED|Treatment Phase||310||
59925381|NCT02900378|76043672|FG000|NOT COMPLETED|Treatment Phase||0||
59925382|NCT02900378|76043673|FG001|NOT COMPLETED|Treatment Phase||0||
59925383|NCT03058692|76043681|FG000|STARTED|Overall Study||61||
59925384|NCT03058692|76043682|FG001|STARTED|Overall Study||59||
59925385|NCT03058692|76043681|FG000|COMPLETED|Overall Study||58||
59925386|NCT03058692|76043682|FG001|COMPLETED|Overall Study||57||
59925387|NCT03058692|76043681|FG000|NOT COMPLETED|Overall Study||3||
59925388|NCT03058692|76043682|FG001|NOT COMPLETED|Overall Study||2||
59925389|NCT02964338|76043692|FG000|STARTED|Overall Study||84|Intent-to-Treat (ITT) Analysis Set: All randomized participants|
59925390|NCT02964338|76043693|FG001|STARTED|Overall Study||88|Intent-to-Treat (ITT) Analysis Set: All randomized participants|
59925391|NCT02964338|76043694|FG002|STARTED|Overall Study||87|Intent-to-Treat (ITT) Analysis Set: All randomized participants|
59925392|NCT02964338|76043692|FG000|Safety Analysis Set|Overall Study||83|All randomized participants who received at least 1 dose of study drug.|
59925393|NCT02964338|76043693|FG001|Safety Analysis Set|Overall Study||88|All randomized participants who received at least 1 dose of study drug.|
59925394|NCT02964338|76043694|FG002|Safety Analysis Set|Overall Study||87|All randomized participants who received at least 1 dose of study drug.|
59925395|NCT02964338|76043692|FG000|Full Analysis Set|Overall Study||81|ITT analysis set, received ≥1 dose of study drug, ≥10 days of postbaseline efficacy assessments|
59925396|NCT02964338|76043693|FG001|Full Analysis Set|Overall Study||86|ITT analysis set, received ≥1 dose of study drug, ≥10 days of postbaseline efficacy assessments|
59925397|NCT02964338|76043694|FG002|Full Analysis Set|Overall Study||87|ITT analysis set, received ≥1 dose of study drug, ≥10 days of postbaseline efficacy assessments|
59925398|NCT02964338|76043692|FG000|COMPLETED|Overall Study||67||
59925399|NCT02964338|76043693|FG001|COMPLETED|Overall Study||64||
59925400|NCT02964338|76043694|FG002|COMPLETED|Overall Study||68||
59925401|NCT02964338|76043692|FG000|NOT COMPLETED|Overall Study||17||
59925402|NCT02964338|76043693|FG001|NOT COMPLETED|Overall Study||24||
59925403|NCT02964338|76043694|FG002|NOT COMPLETED|Overall Study||19||
59925404|NCT03056352|76043702|FG000|STARTED|Overall Study||21||
59925405|NCT03056352|76043702|FG000|COMPLETED|Overall Study||20||
59925406|NCT03056352|76043702|FG000|NOT COMPLETED|Overall Study||1||
59925407|NCT02898662|76043708|FG000|STARTED|Overall Study||40||
59925408|NCT02898662|76043709|FG001|STARTED|Overall Study||41||
59925409|NCT02898662|76043708|FG000|Completed Treatment|Overall Study||25||
59925410|NCT02898662|76043709|FG001|Completed Treatment|Overall Study||29||
59925411|NCT02898662|76043708|FG000|COMPLETED|Overall Study||11|Completed the study|
59925412|NCT02898662|76043709|FG001|COMPLETED|Overall Study||13|Completed the study|
59925413|NCT02898662|76043708|FG000|NOT COMPLETED|Overall Study||29||
59925414|NCT02898662|76043709|FG001|NOT COMPLETED|Overall Study||28||
59925415|NCT03055338|76043718|FG000|STARTED|Overall Study||90||
59925416|NCT03055338|76043719|FG001|STARTED|Overall Study||45||
59925417|NCT03055338|76043720|FG002|STARTED|Overall Study||89||
59925418|NCT03055338|76043718|FG000|COMPLETED|Overall Study||72||
59925419|NCT03055338|76043719|FG001|COMPLETED|Overall Study||34||
59925420|NCT03055338|76043720|FG002|COMPLETED|Overall Study||77||
59925421|NCT03055338|76043718|FG000|NOT COMPLETED|Overall Study||18||
59925422|NCT03055338|76043719|FG001|NOT COMPLETED|Overall Study||11||
59925423|NCT03055338|76043720|FG002|NOT COMPLETED|Overall Study||12||
59925424|NCT03913130|76043728|FG000|STARTED|Overall Study||9||
59925425|NCT03913130|76043728|FG000|COMPLETED|Overall Study||8||
59925426|NCT03913130|76043728|FG000|NOT COMPLETED|Overall Study||1||
59925427|NCT03419741|76043734|FG000|STARTED|Overall Study||5||
59925428|NCT03419741|76043735|FG001|STARTED|Overall Study||6||
59925429|NCT03419741|76043734|FG000|Treated|Overall Study||4|Treated: to indicate the number of participants who began treatment.|
59925430|NCT03419741|76043735|FG001|Treated|Overall Study||4|Treated: to indicate the number of participants who began treatment.|
59925431|NCT03419741|76043734|FG000|COMPLETED|Overall Study||3||
59925432|NCT03419741|76043735|FG001|COMPLETED|Overall Study||4||
59925433|NCT03419741|76043734|FG000|NOT COMPLETED|Overall Study||2||
59925434|NCT03419741|76043735|FG001|NOT COMPLETED|Overall Study||2||
59925435|NCT02896400|76043757|FG000|STARTED|Baseline||66||
60057249|NCT02124161|76172698|FG001|Vaccination 2|Overall Study||432||
59925436|NCT02896400|76043758|FG001|STARTED|Baseline||66||
59925437|NCT02896400|76043759|FG002|STARTED|Baseline||66||
59925438|NCT02896400|76043760|FG003|STARTED|Baseline||66||
59925439|NCT02896400|76043761|FG004|STARTED|Baseline||66||
59925440|NCT02896400|76043762|FG005|STARTED|Baseline||66||
59925441|NCT02896400|76043763|FG006|STARTED|Baseline||66||
59925442|NCT02896400|76043764|FG007|STARTED|Baseline||66||
59925443|NCT02896400|76043765|FG008|STARTED|Baseline||66||
59925444|NCT02896400|76043766|FG009|STARTED|Baseline||66||
59925445|NCT02896400|76043767|FG010|STARTED|Baseline||66||
59925446|NCT02896400|76043768|FG011|STARTED|Baseline||66||
59925447|NCT02896400|76043769|FG012|STARTED|Baseline||66||
59925448|NCT02896400|76043770|FG013|STARTED|Baseline||66||
60057250|NCT02124161|76172697|FG000|COMPLETED|Overall Study||425||
59515741|NCT03095638|75609526|FG006|NOT COMPLETED|P2: Period 1 (4 Days)||0||
59515742|NCT03095638|75609527|FG007|NOT COMPLETED|P2: Period 1 (4 Days)||0||
59515743|NCT03095638|75609520|FG000|STARTED|P2: Period 1, Washout (7[-4 Hours])||0||
59515744|NCT03095638|75609521|FG001|STARTED|P2: Period 1, Washout (7[-4 Hours])||0||
59925449|NCT02896400|76043771|FG014|STARTED|Baseline||66||
59925450|NCT02896400|76043772|FG015|STARTED|Baseline||66||
59925451|NCT02896400|76043757|FG000|COMPLETED|Baseline||66||
59925452|NCT02896400|76043758|FG001|COMPLETED|Baseline||66||
59925453|NCT02896400|76043759|FG002|COMPLETED|Baseline||66||
59925454|NCT02896400|76043760|FG003|COMPLETED|Baseline||66||
59925455|NCT02896400|76043761|FG004|COMPLETED|Baseline||66||
59925456|NCT02896400|76043762|FG005|COMPLETED|Baseline||66||
59925457|NCT02896400|76043763|FG006|COMPLETED|Baseline||66||
59925458|NCT02896400|76043764|FG007|COMPLETED|Baseline||66||
59925459|NCT02896400|76043765|FG008|COMPLETED|Baseline||66||
59925460|NCT02896400|76043766|FG009|COMPLETED|Baseline||66||
59925461|NCT02896400|76043767|FG010|COMPLETED|Baseline||66||
59925462|NCT02896400|76043768|FG011|COMPLETED|Baseline||66||
59925463|NCT02896400|76043769|FG012|COMPLETED|Baseline||66||
59925464|NCT02896400|76043770|FG013|COMPLETED|Baseline||66||
59925465|NCT02896400|76043771|FG014|COMPLETED|Baseline||66||
59925466|NCT02896400|76043772|FG015|COMPLETED|Baseline||66||
59925467|NCT02896400|76043757|FG000|NOT COMPLETED|Baseline||0||
59925468|NCT02896400|76043758|FG001|NOT COMPLETED|Baseline||0||
59925469|NCT02896400|76043759|FG002|NOT COMPLETED|Baseline||0||
59925470|NCT02896400|76043760|FG003|NOT COMPLETED|Baseline||0||
59925471|NCT02896400|76043761|FG004|NOT COMPLETED|Baseline||0||
59925472|NCT02896400|76043762|FG005|NOT COMPLETED|Baseline||0||
59925473|NCT02896400|76043763|FG006|NOT COMPLETED|Baseline||0||
59925474|NCT02896400|76043764|FG007|NOT COMPLETED|Baseline||0||
59925475|NCT02896400|76043765|FG008|NOT COMPLETED|Baseline||0||
59925476|NCT02896400|76043766|FG009|NOT COMPLETED|Baseline||0||
59925477|NCT02896400|76043767|FG010|NOT COMPLETED|Baseline||0||
59925478|NCT02896400|76043768|FG011|NOT COMPLETED|Baseline||0||
59925479|NCT02896400|76043769|FG012|NOT COMPLETED|Baseline||0||
59925480|NCT02896400|76043770|FG013|NOT COMPLETED|Baseline||0||
59925481|NCT02896400|76043771|FG014|NOT COMPLETED|Baseline||0||
59925482|NCT02896400|76043772|FG015|NOT COMPLETED|Baseline||0||
59925483|NCT02896400|76043757|FG000|STARTED|1 Month Follow-up||66||
59925484|NCT02896400|76043758|FG001|STARTED|1 Month Follow-up||66||
59925485|NCT02896400|76043759|FG002|STARTED|1 Month Follow-up||66||
59925486|NCT02896400|76043760|FG003|STARTED|1 Month Follow-up||66||
59925487|NCT02896400|76043761|FG004|STARTED|1 Month Follow-up||66||
59925488|NCT02896400|76043762|FG005|STARTED|1 Month Follow-up||66||
59925489|NCT02896400|76043763|FG006|STARTED|1 Month Follow-up||66||
59925490|NCT02896400|76043764|FG007|STARTED|1 Month Follow-up||66||
59925491|NCT02896400|76043765|FG008|STARTED|1 Month Follow-up||66||
59925492|NCT02896400|76043766|FG009|STARTED|1 Month Follow-up||66||
59925493|NCT02896400|76043767|FG010|STARTED|1 Month Follow-up||66||
59925494|NCT02896400|76043768|FG011|STARTED|1 Month Follow-up||66||
59925495|NCT02896400|76043769|FG012|STARTED|1 Month Follow-up||66||
59925496|NCT02896400|76043770|FG013|STARTED|1 Month Follow-up||66||
59925497|NCT02896400|76043771|FG014|STARTED|1 Month Follow-up||66||
59925498|NCT02896400|76043772|FG015|STARTED|1 Month Follow-up||66||
59925499|NCT02896400|76043757|FG000|COMPLETED|1 Month Follow-up||59||
59925500|NCT02896400|76043758|FG001|COMPLETED|1 Month Follow-up||59||
59925501|NCT02896400|76043759|FG002|COMPLETED|1 Month Follow-up||61||
59925502|NCT02896400|76043760|FG003|COMPLETED|1 Month Follow-up||58||
59925503|NCT02896400|76043761|FG004|COMPLETED|1 Month Follow-up||57||
59925504|NCT02896400|76043762|FG005|COMPLETED|1 Month Follow-up||60||
59925505|NCT02896400|76043763|FG006|COMPLETED|1 Month Follow-up||61||
59925506|NCT02896400|76043764|FG007|COMPLETED|1 Month Follow-up||60||
59925507|NCT02896400|76043765|FG008|COMPLETED|1 Month Follow-up||62||
59925508|NCT02896400|76043766|FG009|COMPLETED|1 Month Follow-up||59||
59925509|NCT02896400|76043767|FG010|COMPLETED|1 Month Follow-up||61||
59925510|NCT02896400|76043768|FG011|COMPLETED|1 Month Follow-up||61||
59515745|NCT03095638|75609522|FG002|STARTED|P2: Period 1, Washout (7[-4 Hours])||4||
59515746|NCT03095638|75609523|FG003|STARTED|P2: Period 1, Washout (7[-4 Hours])||4||
59925511|NCT02896400|76043769|FG012|COMPLETED|1 Month Follow-up||63||
59925512|NCT02896400|76043770|FG013|COMPLETED|1 Month Follow-up||62||
59925513|NCT02896400|76043771|FG014|COMPLETED|1 Month Follow-up||65||
59925514|NCT02896400|76043772|FG015|COMPLETED|1 Month Follow-up||63||
59925515|NCT02896400|76043757|FG000|NOT COMPLETED|1 Month Follow-up||7||
59925516|NCT02896400|76043758|FG001|NOT COMPLETED|1 Month Follow-up||7||
59925517|NCT02896400|76043759|FG002|NOT COMPLETED|1 Month Follow-up||5||
59925518|NCT02896400|76043760|FG003|NOT COMPLETED|1 Month Follow-up||8||
59925519|NCT02896400|76043761|FG004|NOT COMPLETED|1 Month Follow-up||9||
59925520|NCT02896400|76043762|FG005|NOT COMPLETED|1 Month Follow-up||6||
59925521|NCT02896400|76043763|FG006|NOT COMPLETED|1 Month Follow-up||5||
59925522|NCT02896400|76043764|FG007|NOT COMPLETED|1 Month Follow-up||6||
59925523|NCT02896400|76043765|FG008|NOT COMPLETED|1 Month Follow-up||4||
59925524|NCT02896400|76043766|FG009|NOT COMPLETED|1 Month Follow-up||7||
59925525|NCT02896400|76043767|FG010|NOT COMPLETED|1 Month Follow-up||5||
59925526|NCT02896400|76043768|FG011|NOT COMPLETED|1 Month Follow-up||5||
59925527|NCT02896400|76043769|FG012|NOT COMPLETED|1 Month Follow-up||3||
59925528|NCT02896400|76043770|FG013|NOT COMPLETED|1 Month Follow-up||4||
59925529|NCT02896400|76043771|FG014|NOT COMPLETED|1 Month Follow-up||1||
59925530|NCT02896400|76043772|FG015|NOT COMPLETED|1 Month Follow-up||3||
59925531|NCT02896400|76043757|FG000|STARTED|3 Month Follow-up||66|We call all participants at the 3m follow-up time point even if the 1m follow-up was not completed.|
60057251|NCT02124161|76172698|FG001|COMPLETED|Overall Study||426||
59925532|NCT02896400|76043758|FG001|STARTED|3 Month Follow-up||66|We call all participants at the 3m follow-up time point even if the 1m follow-up was not completed.|
59925533|NCT02896400|76043759|FG002|STARTED|3 Month Follow-up||66|We call all participants at the 3m follow-up time point even if the 1m follow-up was not completed.|
59925534|NCT02896400|76043760|FG003|STARTED|3 Month Follow-up||66|We call all participants at the 3m follow-up time point even if the 1m follow-up was not completed.|
59925535|NCT02896400|76043761|FG004|STARTED|3 Month Follow-up||66|We call all participants at the 3m follow-up time point even if the 1m follow-up was not completed.|
59925536|NCT02896400|76043762|FG005|STARTED|3 Month Follow-up||66|We call all participants at the 3m follow-up time point even if the 1m follow-up was not completed.|
59925537|NCT02896400|76043763|FG006|STARTED|3 Month Follow-up||66|We call all participants at the 3m follow-up time point even if the 1m follow-up was not completed.|
59925538|NCT02896400|76043764|FG007|STARTED|3 Month Follow-up||66|We call all participants at the 3m follow-up time point even if the 1m follow-up was not completed.|
59925539|NCT02896400|76043765|FG008|STARTED|3 Month Follow-up||66|We call all participants at the 3m follow-up time point even if the 1m follow-up was not completed.|
59925540|NCT02896400|76043766|FG009|STARTED|3 Month Follow-up||66|We call all participants at the 3m follow-up time point even if the 1m follow-up was not completed.|
59925541|NCT02896400|76043767|FG010|STARTED|3 Month Follow-up||66|We call all participants at the 3m follow-up time point even if the 1m follow-up was not completed.|
59925542|NCT02896400|76043768|FG011|STARTED|3 Month Follow-up||66|We call all participants at the 3m follow-up time point even if the 1m follow-up was not completed.|
59925543|NCT02896400|76043769|FG012|STARTED|3 Month Follow-up||66|We call all participants at the 3m follow-up time point even if the 1m follow-up was not completed.|
59925544|NCT02896400|76043770|FG013|STARTED|3 Month Follow-up||66|We call all participants at the 3m follow-up time point even if the 1m follow-up was not completed.|
59925545|NCT02896400|76043771|FG014|STARTED|3 Month Follow-up||66|We call all participants at the 3m follow-up time point even if the 1m follow-up was not completed.|
59925546|NCT02896400|76043772|FG015|STARTED|3 Month Follow-up||65|We call all participants at the 3m follow-up time point even if the 1m follow-up was not completed.|
59925547|NCT02896400|76043757|FG000|COMPLETED|3 Month Follow-up||60||
59925548|NCT02896400|76043758|FG001|COMPLETED|3 Month Follow-up||63||
59925549|NCT02896400|76043759|FG002|COMPLETED|3 Month Follow-up||60||
59925550|NCT02896400|76043760|FG003|COMPLETED|3 Month Follow-up||55||
59925551|NCT02896400|76043761|FG004|COMPLETED|3 Month Follow-up||54||
59925552|NCT02896400|76043762|FG005|COMPLETED|3 Month Follow-up||60||
59925553|NCT02896400|76043763|FG006|COMPLETED|3 Month Follow-up||62||
59925554|NCT02896400|76043764|FG007|COMPLETED|3 Month Follow-up||63||
59925555|NCT02896400|76043765|FG008|COMPLETED|3 Month Follow-up||60||
60057252|NCT02124161|76172697|FG000|NOT COMPLETED|Overall Study||16||
60057253|NCT02124161|76172698|FG001|NOT COMPLETED|Overall Study||15||
60057254|NCT02175641|76172713|FG000|STARTED|Overall Study||157||
60057255|NCT02175641|76172714|FG001|STARTED|Overall Study||157||
60057256|NCT02175641|76172713|FG000|6-month Follow up|Overall Study||144||
60057257|NCT02175641|76172714|FG001|6-month Follow up|Overall Study||149||
60057258|NCT02175641|76172713|FG000|12-month Follow up|Overall Study||129||
60057259|NCT02175641|76172714|FG001|12-month Follow up|Overall Study||136||
60057260|NCT02175641|76172713|FG000|18-month Follow up|Overall Study||122||
60057261|NCT02175641|76172714|FG001|18-month Follow up|Overall Study||130||
60057262|NCT02175641|76172713|FG000|COMPLETED|Overall Study||122||
60057263|NCT02175641|76172714|FG001|COMPLETED|Overall Study||130||
60057264|NCT02175641|76172713|FG000|NOT COMPLETED|Overall Study||35||
60057265|NCT02175641|76172714|FG001|NOT COMPLETED|Overall Study||27||
60057266|NCT02117570|76172723|FG000|STARTED|Stage 1 Participants Aged 50 to 64 Years|Randomized|6||
60057267|NCT02117570|76172724|FG001|STARTED|Stage 1 Participants Aged 50 to 64 Years|Randomized|18||
60057268|NCT02117570|76172725|FG002|STARTED|Stage 1 Participants Aged 50 to 64 Years|Randomized|18||
60057269|NCT02117570|76172723|FG000|Vaccine: Dose 1|Stage 1 Participants Aged 50 to 64 Years||6||
60057270|NCT02117570|76172724|FG001|Vaccine: Dose 1|Stage 1 Participants Aged 50 to 64 Years||18||
60057271|NCT02117570|76172725|FG002|Vaccine: Dose 1|Stage 1 Participants Aged 50 to 64 Years||18||
60057272|NCT02117570|76172723|FG000|Vaccine: Dose 2|Stage 1 Participants Aged 50 to 64 Years||6||
60057273|NCT02117570|76172724|FG001|Vaccine: Dose 2|Stage 1 Participants Aged 50 to 64 Years||18||
60057274|NCT02117570|76172725|FG002|Vaccine: Dose 2|Stage 1 Participants Aged 50 to 64 Years||18||
60057275|NCT02117570|76172723|FG000|Vaccine: Dose 3|Stage 1 Participants Aged 50 to 64 Years||6||
60057276|NCT02117570|76172724|FG001|Vaccine: Dose 3|Stage 1 Participants Aged 50 to 64 Years||17||
60057277|NCT02117570|76172725|FG002|Vaccine: Dose 3|Stage 1 Participants Aged 50 to 64 Years||18||
60057278|NCT02117570|76172723|FG000|COMPLETED|Stage 1 Participants Aged 50 to 64 Years||5||
59515747|NCT03095638|75609524|FG004|STARTED|P2: Period 1, Washout (7[-4 Hours])||4||
59515748|NCT03095638|75609525|FG005|STARTED|P2: Period 1, Washout (7[-4 Hours])||4||
59515749|NCT03095638|75609526|FG006|STARTED|P2: Period 1, Washout (7[-4 Hours])||4||
59515750|NCT03095638|75609527|FG007|STARTED|P2: Period 1, Washout (7[-4 Hours])||4||
59515751|NCT03095638|75609520|FG000|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0||
59515752|NCT03095638|75609521|FG001|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0||
59515753|NCT03095638|75609522|FG002|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4||
59515754|NCT03095638|75609523|FG003|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4||
59925556|NCT02896400|76043766|FG009|COMPLETED|3 Month Follow-up||61||
59925557|NCT02896400|76043767|FG010|COMPLETED|3 Month Follow-up||60||
59925558|NCT02896400|76043768|FG011|COMPLETED|3 Month Follow-up||60||
59925559|NCT02896400|76043769|FG012|COMPLETED|3 Month Follow-up||63||
59925560|NCT02896400|76043770|FG013|COMPLETED|3 Month Follow-up||60||
59925561|NCT02896400|76043771|FG014|COMPLETED|3 Month Follow-up||62||
59925562|NCT02896400|76043772|FG015|COMPLETED|3 Month Follow-up||63||
59925563|NCT02896400|76043757|FG000|NOT COMPLETED|3 Month Follow-up||6||
59925564|NCT02896400|76043758|FG001|NOT COMPLETED|3 Month Follow-up||3||
59925565|NCT02896400|76043759|FG002|NOT COMPLETED|3 Month Follow-up||6||
59925566|NCT02896400|76043760|FG003|NOT COMPLETED|3 Month Follow-up||11||
59925567|NCT02896400|76043761|FG004|NOT COMPLETED|3 Month Follow-up||12||
59515755|NCT03095638|75609524|FG004|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4||
59925568|NCT02896400|76043762|FG005|NOT COMPLETED|3 Month Follow-up||6||
59925569|NCT02896400|76043763|FG006|NOT COMPLETED|3 Month Follow-up||4||
59925570|NCT02896400|76043764|FG007|NOT COMPLETED|3 Month Follow-up||3||
59925571|NCT02896400|76043765|FG008|NOT COMPLETED|3 Month Follow-up||6||
59925572|NCT02896400|76043766|FG009|NOT COMPLETED|3 Month Follow-up||5||
59925573|NCT02896400|76043767|FG010|NOT COMPLETED|3 Month Follow-up||6||
59925574|NCT02896400|76043768|FG011|NOT COMPLETED|3 Month Follow-up||6||
59925575|NCT02896400|76043769|FG012|NOT COMPLETED|3 Month Follow-up||3||
59925576|NCT02896400|76043770|FG013|NOT COMPLETED|3 Month Follow-up||6||
59925577|NCT02896400|76043771|FG014|NOT COMPLETED|3 Month Follow-up||4||
59925578|NCT02896400|76043772|FG015|NOT COMPLETED|3 Month Follow-up||2||
59925579|NCT02896400|76043757|FG000|STARTED|Biochemical Verification at 3 Months||60||
59925580|NCT02896400|76043758|FG001|STARTED|Biochemical Verification at 3 Months||63||
59925581|NCT02896400|76043759|FG002|STARTED|Biochemical Verification at 3 Months||60||
59925582|NCT02896400|76043760|FG003|STARTED|Biochemical Verification at 3 Months||55||
59925583|NCT02896400|76043761|FG004|STARTED|Biochemical Verification at 3 Months||54||
59925584|NCT02896400|76043762|FG005|STARTED|Biochemical Verification at 3 Months||60||
59925585|NCT02896400|76043763|FG006|STARTED|Biochemical Verification at 3 Months||62||
59925586|NCT02896400|76043764|FG007|STARTED|Biochemical Verification at 3 Months||63||
59925587|NCT02896400|76043765|FG008|STARTED|Biochemical Verification at 3 Months||60||
59925588|NCT02896400|76043766|FG009|STARTED|Biochemical Verification at 3 Months||61||
59925589|NCT02896400|76043767|FG010|STARTED|Biochemical Verification at 3 Months||60||
59925590|NCT02896400|76043768|FG011|STARTED|Biochemical Verification at 3 Months||60||
59925591|NCT02896400|76043769|FG012|STARTED|Biochemical Verification at 3 Months||63||
59925592|NCT02896400|76043770|FG013|STARTED|Biochemical Verification at 3 Months||60||
59925593|NCT02896400|76043771|FG014|STARTED|Biochemical Verification at 3 Months||62||
59925594|NCT02896400|76043772|FG015|STARTED|Biochemical Verification at 3 Months||63||
59925595|NCT02896400|76043757|FG000|COMPLETED|Biochemical Verification at 3 Months||14|Only participants reporting abstinence at the 3m follow-up complete the biochem.|
59925596|NCT02896400|76043758|FG001|COMPLETED|Biochemical Verification at 3 Months||15|Only participants reporting abstinence at the 3m follow-up complete the biochem.|
59925597|NCT02896400|76043759|FG002|COMPLETED|Biochemical Verification at 3 Months||13|Only participants reporting abstinence at the 3m follow-up complete the biochem.|
59925598|NCT02896400|76043760|FG003|COMPLETED|Biochemical Verification at 3 Months||14|Only participants reporting abstinence at the 3m follow-up complete the biochem.|
59951529|NCT02607930|76070544|FG001|NOT COMPLETED|Double-Blinded Treatment Phase||53||
59515756|NCT03095638|75609525|FG005|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4||
59515757|NCT03095638|75609526|FG006|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4||
59515758|NCT03095638|75609527|FG007|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4||
59613021|NCT01713582|75724094|FG000|STARTED|Overall Study|Number treated|3||
59613022|NCT01713582|75724095|FG001|STARTED|Overall Study|Number treated|3||
59613023|NCT01713582|75724096|FG002|STARTED|Overall Study|Number treated|4||
59613024|NCT01713582|75724097|FG003|STARTED|Overall Study|Number treated|3||
59925599|NCT02896400|76043761|FG004|COMPLETED|Biochemical Verification at 3 Months||9|Only participants reporting abstinence at the 3m follow-up complete the biochem.|
59925600|NCT02896400|76043762|FG005|COMPLETED|Biochemical Verification at 3 Months||11|Only participants reporting abstinence at the 3m follow-up complete the biochem.|
59925601|NCT02896400|76043763|FG006|COMPLETED|Biochemical Verification at 3 Months||11|Only participants reporting abstinence at the 3m follow-up complete the biochem.|
59925602|NCT02896400|76043764|FG007|COMPLETED|Biochemical Verification at 3 Months||14|Only participants reporting abstinence at the 3m follow-up complete the biochem.|
59925603|NCT02896400|76043765|FG008|COMPLETED|Biochemical Verification at 3 Months||15|Only participants reporting abstinence at the 3m follow-up complete the biochem.|
60057279|NCT02117570|76172724|FG001|COMPLETED|Stage 1 Participants Aged 50 to 64 Years||15||
60057280|NCT02117570|76172725|FG002|COMPLETED|Stage 1 Participants Aged 50 to 64 Years||17||
60057281|NCT02117570|76172723|FG000|NOT COMPLETED|Stage 1 Participants Aged 50 to 64 Years||1||
60057282|NCT02117570|76172724|FG001|NOT COMPLETED|Stage 1 Participants Aged 50 to 64 Years||3||
60057283|NCT02117570|76172725|FG002|NOT COMPLETED|Stage 1 Participants Aged 50 to 64 Years||1||
60057284|NCT02117570|76172723|FG000|STARTED|Stage 2 Participants Aged 65 to 85 Years|Randomized|21||
59925604|NCT02896400|76043766|FG009|COMPLETED|Biochemical Verification at 3 Months||8|Only participants reporting abstinence at the 3m follow-up complete the biochem.|
59925605|NCT02896400|76043767|FG010|COMPLETED|Biochemical Verification at 3 Months||5|Only participants reporting abstinence at the 3m follow-up complete the biochem.|
59925606|NCT02896400|76043768|FG011|COMPLETED|Biochemical Verification at 3 Months||19|Only participants reporting abstinence at the 3m follow-up complete the biochem.|
60057285|NCT02117570|76172724|FG001|STARTED|Stage 2 Participants Aged 65 to 85 Years|Randomized|62||
60057286|NCT02117570|76172725|FG002|STARTED|Stage 2 Participants Aged 65 to 85 Years|Randomized|60||
59925607|NCT02896400|76043769|FG012|COMPLETED|Biochemical Verification at 3 Months||10|Only participants reporting abstinence at the 3m follow-up complete the biochem.|
59951530|NCT02607930|76070545|FG002|NOT COMPLETED|Double-Blinded Treatment Phase||0||
60057287|NCT02117570|76172723|FG000|Vaccine: Dose 1|Stage 2 Participants Aged 65 to 85 Years||21||
60057288|NCT02117570|76172724|FG001|Vaccine: Dose 1|Stage 2 Participants Aged 65 to 85 Years||61||
60057289|NCT02117570|76172725|FG002|Vaccine: Dose 1|Stage 2 Participants Aged 65 to 85 Years||60||
60057290|NCT02117570|76172723|FG000|Vaccine: Dose 2|Stage 2 Participants Aged 65 to 85 Years||17||
60057291|NCT02117570|76172724|FG001|Vaccine: Dose 2|Stage 2 Participants Aged 65 to 85 Years||53||
60057292|NCT02117570|76172725|FG002|Vaccine: Dose 2|Stage 2 Participants Aged 65 to 85 Years||50||
60057293|NCT02117570|76172723|FG000|Vaccine: Dose 3|Stage 2 Participants Aged 65 to 85 Years||4||
60057294|NCT02117570|76172724|FG001|Vaccine: Dose 3|Stage 2 Participants Aged 65 to 85 Years||12||
60057295|NCT02117570|76172725|FG002|Vaccine: Dose 3|Stage 2 Participants Aged 65 to 85 Years||12||
60057296|NCT02117570|76172723|FG000|COMPLETED|Stage 2 Participants Aged 65 to 85 Years||20||
60057297|NCT02117570|76172724|FG001|COMPLETED|Stage 2 Participants Aged 65 to 85 Years||59||
60057298|NCT02117570|76172725|FG002|COMPLETED|Stage 2 Participants Aged 65 to 85 Years||54||
60057299|NCT02117570|76172723|FG000|NOT COMPLETED|Stage 2 Participants Aged 65 to 85 Years||1||
60057300|NCT02117570|76172724|FG001|NOT COMPLETED|Stage 2 Participants Aged 65 to 85 Years||3||
60057301|NCT02117570|76172725|FG002|NOT COMPLETED|Stage 2 Participants Aged 65 to 85 Years||6||
60057302|NCT02123459|76172736|FG000|STARTED|Period 1 (7 Days)||14||
60057303|NCT02123459|76172737|FG001|STARTED|Period 1 (7 Days)||14||
60057304|NCT02123459|76172736|FG000|COMPLETED|Period 1 (7 Days)||14||
60057305|NCT02123459|76172737|FG001|COMPLETED|Period 1 (7 Days)||14||
60057306|NCT02123459|76172736|FG000|NOT COMPLETED|Period 1 (7 Days)||0||
60057307|NCT02123459|76172737|FG001|NOT COMPLETED|Period 1 (7 Days)||0||
60057308|NCT02123459|76172736|FG000|STARTED|Washout Period (1 Day)||14||
60057309|NCT02123459|76172737|FG001|STARTED|Washout Period (1 Day)||14||
60057310|NCT02123459|76172736|FG000|COMPLETED|Washout Period (1 Day)||13||
60057311|NCT02123459|76172737|FG001|COMPLETED|Washout Period (1 Day)||14||
60057312|NCT02123459|76172736|FG000|NOT COMPLETED|Washout Period (1 Day)||1||
60057313|NCT02123459|76172737|FG001|NOT COMPLETED|Washout Period (1 Day)||0||
60057314|NCT02123459|76172736|FG000|STARTED|Period 2 (7 Days)||13||
60057315|NCT02123459|76172737|FG001|STARTED|Period 2 (7 Days)||14||
60057316|NCT02123459|76172736|FG000|COMPLETED|Period 2 (7 Days)||13||
60057317|NCT02123459|76172737|FG001|COMPLETED|Period 2 (7 Days)||14||
60057318|NCT02123459|76172736|FG000|NOT COMPLETED|Period 2 (7 Days)||0||
60057319|NCT02123459|76172737|FG001|NOT COMPLETED|Period 2 (7 Days)||0||
60057320|NCT01853475|76172746|FG000|STARTED|Overall Study||8||
60057321|NCT01853475|76172747|FG001|STARTED|Overall Study||8||
60057322|NCT01853475|76172748|FG002|STARTED|Overall Study||8||
60057323|NCT01853475|76172746|FG000|COMPLETED|Overall Study||8||
60057324|NCT01853475|76172747|FG001|COMPLETED|Overall Study||7||
60057325|NCT01853475|76172748|FG002|COMPLETED|Overall Study||8||
60057326|NCT01853475|76172746|FG000|NOT COMPLETED|Overall Study||0||
60057327|NCT01853475|76172747|FG001|NOT COMPLETED|Overall Study||1||
60057328|NCT01853475|76172748|FG002|NOT COMPLETED|Overall Study||0||
60057329|NCT02151773|76172756|FG000|STARTED|Overall Study||3493||
60057330|NCT02151773|76172756|FG000|COMPLETED|Overall Study||3429||
60057331|NCT02151773|76172756|FG000|NOT COMPLETED|Overall Study||64||
60057332|NCT02151461|76172764|FG000|STARTED|Overall Study||24||
60057333|NCT02151461|76172765|FG001|STARTED|Overall Study||25||
60057334|NCT02151461|76172766|FG002|STARTED|Overall Study||24||
60057335|NCT02151461|76172767|FG003|STARTED|Overall Study||23||
60057336|NCT02151461|76172764|FG000|COMPLETED|Overall Study||18||
60057337|NCT02151461|76172765|FG001|COMPLETED|Overall Study||24||
60057338|NCT02151461|76172766|FG002|COMPLETED|Overall Study||21||
60057339|NCT02151461|76172767|FG003|COMPLETED|Overall Study||19||
60057340|NCT02151461|76172764|FG000|NOT COMPLETED|Overall Study||6||
60057341|NCT02151461|76172765|FG001|NOT COMPLETED|Overall Study||1||
60057342|NCT02151461|76172766|FG002|NOT COMPLETED|Overall Study||3||
60057343|NCT02151461|76172767|FG003|NOT COMPLETED|Overall Study||4||
60057344|NCT02117414|76172779|FG000|STARTED|Overall Study|Subjects randomized to the MRI group.|175||
60057345|NCT02117414|76172780|FG001|STARTED|Overall Study|Subjects randomized to the Control group.|88||
60057346|NCT02117414|76172779|FG000|COMPLETED|Overall Study|Subject followed up at least to the one-month post MRI/Waiting period visit in the MRI group.|160||
60057347|NCT02117414|76172780|FG001|COMPLETED|Overall Study|Subject followed up at least to the one-month post MRI/Waiting period visit in the Control group.|82||
60057348|NCT02117414|76172779|FG000|NOT COMPLETED|Overall Study||15||
60057349|NCT02117414|76172780|FG001|NOT COMPLETED|Overall Study||6||
60057350|NCT02091986|76172791|FG000|STARTED|Overall Study||92||
60057351|NCT02091986|76172792|FG001|STARTED|Overall Study||95||
60057352|NCT02091986|76172793|FG002|STARTED|Overall Study||92||
60057353|NCT02091986|76172791|FG000|COMPLETED|Overall Study||85||
60057354|NCT02091986|76172792|FG001|COMPLETED|Overall Study||84||
60057355|NCT02091986|76172793|FG002|COMPLETED|Overall Study||84||
60057356|NCT02091986|76172791|FG000|NOT COMPLETED|Overall Study||7||
60057357|NCT02091986|76172792|FG001|NOT COMPLETED|Overall Study||11||
60057358|NCT02091986|76172793|FG002|NOT COMPLETED|Overall Study||8||
60057359|NCT02091752|76172801|FG000|STARTED|Overall Study||3||
60057360|NCT02091752|76172801|FG000|COMPLETED|Overall Study||0||
60057361|NCT02091752|76172801|FG000|NOT COMPLETED|Overall Study||3||
60057362|NCT02117024|76172807|FG000|STARTED|Overall Study||45||
60057363|NCT02117024|76172808|FG001|STARTED|Overall Study||21||
60057364|NCT02117024|76172807|FG000|COMPLETED|Overall Study||1||
60057365|NCT02117024|76172808|FG001|COMPLETED|Overall Study||1||
60057366|NCT02117024|76172807|FG000|NOT COMPLETED|Overall Study||44||
60057367|NCT02117024|76172808|FG001|NOT COMPLETED|Overall Study||20||
60057368|NCT02091440|76172814|FG000|STARTED|Overall Study||6||
60057369|NCT02091440|76172814|FG000|Primary Endpoint (Success at 180 Days)|Overall Study||6||
60057370|NCT02091440|76172814|FG000|Overall Survival at 180 Days|Overall Study||6||
60057371|NCT02091440|76172814|FG000|COMPLETED|Overall Study||4||
60057372|NCT02091440|76172814|FG000|NOT COMPLETED|Overall Study||2||
60057373|NCT02064920|76172820|FG000|STARTED|Overall Study||6||
60057374|NCT02064920|76172821|FG001|STARTED|Overall Study||30||
60057375|NCT02064920|76172820|FG000|Treated|Overall Study||6||
60057376|NCT02064920|76172821|FG001|Treated|Overall Study|Two participants discontinued from study prior to treatment|28||
60057377|NCT02064920|76172820|FG000|COMPLETED|Overall Study||5||
60057378|NCT02064920|76172821|FG001|COMPLETED|Overall Study||21||
60057379|NCT02064920|76172820|FG000|NOT COMPLETED|Overall Study||1||
60057380|NCT02064920|76172821|FG001|NOT COMPLETED|Overall Study||9||
59515759|NCT03095638|75609520|FG000|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0||
60057381|NCT02151149|76172829|FG000|STARTED|Treatment Period|3 participants did not receive treatment|71||
59515760|NCT03095638|75609521|FG001|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0||
59760591|NCT00889421|75880220|FG000|COMPLETED|Overall Study||0||
59760592|NCT00889421|75880220|FG000|NOT COMPLETED|Overall Study||3||
59760593|NCT00889265|75880224|FG000|STARTED|Overall Study|Date Enrollment Started: 07/21/2009 Date Enrollment Completed: 02/15/2011 Total enrolled: 51|51||
60057382|NCT02151149|76172830|FG001|STARTED|Treatment Period|2 participants did not receive treatment|72||
60057383|NCT02151149|76172829|FG000|Treated Population|Treatment Period||68||
60057384|NCT02151149|76172830|FG001|Treated Population|Treatment Period||70||
59760594|NCT00889265|75880224|FG000|COMPLETED|Overall Study||44||
59760595|NCT00889265|75880224|FG000|NOT COMPLETED|Overall Study||7||
59760596|NCT00603746|75880234|FG000|STARTED|Overall Study||103||
59760597|NCT00603746|75880235|FG001|STARTED|Overall Study||99||
59760598|NCT00603746|75880236|FG002|STARTED|Overall Study||101||
59760599|NCT00603746|75880237|FG003|STARTED|Overall Study||107||
59760600|NCT00603746|75880238|FG004|STARTED|Overall Study||102||
59760601|NCT00603746|75880239|FG005|STARTED|Overall Study||110||
59760602|NCT00603746|75880234|FG000|COMPLETED|Overall Study||65||
59760603|NCT00603746|75880235|FG001|COMPLETED|Overall Study||81||
59760604|NCT00603746|75880236|FG002|COMPLETED|Overall Study||93||
59760605|NCT00603746|75880237|FG003|COMPLETED|Overall Study||94||
59760606|NCT00603746|75880238|FG004|COMPLETED|Overall Study||85||
59760607|NCT00603746|75880239|FG005|COMPLETED|Overall Study||97||
59760608|NCT00603746|75880234|FG000|NOT COMPLETED|Overall Study||38||
59760609|NCT00603746|75880235|FG001|NOT COMPLETED|Overall Study||18||
59760610|NCT00603746|75880236|FG002|NOT COMPLETED|Overall Study||8||
59760611|NCT00603746|75880237|FG003|NOT COMPLETED|Overall Study||13||
59760612|NCT00603746|75880238|FG004|NOT COMPLETED|Overall Study||17||
59760613|NCT00603746|75880239|FG005|NOT COMPLETED|Overall Study||13||
59760614|NCT00888329|75880255|FG000|STARTED|Overall Study||125||
59760615|NCT00888329|75880256|FG001|STARTED|Overall Study||131||
59760616|NCT00888329|75880255|FG000|COMPLETED|Overall Study||119||
59760617|NCT00888329|75880256|FG001|COMPLETED|Overall Study||122||
59760618|NCT00888329|75880255|FG000|NOT COMPLETED|Overall Study||6||
59760619|NCT00888329|75880256|FG001|NOT COMPLETED|Overall Study||9||
59760620|NCT00603590|75880264|FG000|STARTED|Overall Study||241||
59760621|NCT00603590|75880265|FG001|STARTED|Overall Study||234||
59760622|NCT00603590|75880264|FG000|One Month|Overall Study||204||
59760623|NCT00603590|75880265|FG001|One Month|Overall Study||212||
59760624|NCT00603590|75880264|FG000|Four Months|Overall Study||187||
59760625|NCT00603590|75880265|FG001|Four Months|Overall Study||200||
59760626|NCT00603590|75880264|FG000|Eight Months|Overall Study||178||
59760627|NCT00603590|75880265|FG001|Eight Months|Overall Study||194||
59760628|NCT00603590|75880264|FG000|COMPLETED|Overall Study||165||
59760629|NCT00603590|75880265|FG001|COMPLETED|Overall Study||183||
59760630|NCT00603590|75880264|FG000|NOT COMPLETED|Overall Study||76||
59760631|NCT00603590|75880265|FG001|NOT COMPLETED|Overall Study||51||
59760632|NCT00888173|75880271|FG000|STARTED|Overall Study||45||
59760633|NCT00888173|75880271|FG000|COMPLETED|Overall Study||43||
59760634|NCT00888173|75880271|FG000|NOT COMPLETED|Overall Study||2||
59760635|NCT03883724|75880277|FG000|STARTED|Overall Study||29||
59760636|NCT03883724|75880278|FG001|STARTED|Overall Study||27||
59760637|NCT03883724|75880277|FG000|COMPLETED|Overall Study||29||
59760638|NCT03883724|75880278|FG001|COMPLETED|Overall Study||27||
59760639|NCT03883724|75880277|FG000|NOT COMPLETED|Overall Study||0||
59760640|NCT03883724|75880278|FG001|NOT COMPLETED|Overall Study||0||
59760641|NCT00887549|75880284|FG000|STARTED|Induction Therapy||70||
59760642|NCT00887549|75880284|FG000|COMPLETED|Induction Therapy||43||
60057385|NCT02151149|76172829|FG000|COMPLETED|Treatment Period||1|Completed indicates participants with missing disposition data.|
60057386|NCT02151149|76172830|FG001|COMPLETED|Treatment Period||1|Completed indicates participants with missing disposition data.|
60057387|NCT02151149|76172829|FG000|NOT COMPLETED|Treatment Period||70||
60057388|NCT02151149|76172830|FG001|NOT COMPLETED|Treatment Period||71||
60057389|NCT02151149|76172829|FG000|STARTED|Follow-Up Period||58||
60057390|NCT02151149|76172830|FG001|STARTED|Follow-Up Period||55||
59760643|NCT00887549|75880284|FG000|NOT COMPLETED|Induction Therapy||27||
59760644|NCT00887549|75880284|FG000|STARTED|Maintenance Therapy||43||
59760645|NCT00887549|75880284|FG000|COMPLETED|Maintenance Therapy||0||
59760646|NCT00887549|75880284|FG000|NOT COMPLETED|Maintenance Therapy||43||
59760647|NCT00887315|75880290|FG000|STARTED|Overall Study||7||
59760648|NCT00887315|75880291|FG001|STARTED|Overall Study||4||
59760649|NCT00887315|75880290|FG000|COMPLETED|Overall Study||0||
59760650|NCT00887315|75880291|FG001|COMPLETED|Overall Study||0||
59760651|NCT00887315|75880290|FG000|NOT COMPLETED|Overall Study||7||
59515761|NCT03095638|75609522|FG002|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0||
59515762|NCT03095638|75609523|FG003|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0||
60057391|NCT02151149|76172829|FG000|COMPLETED|Follow-Up Period|Completed = participants alive at final data cut-off date|19||
60057392|NCT02151149|76172830|FG001|COMPLETED|Follow-Up Period|Completed = participants alive at final data cut-off date|18||
60057393|NCT02151149|76172829|FG000|NOT COMPLETED|Follow-Up Period||39||
60057394|NCT02151149|76172830|FG001|NOT COMPLETED|Follow-Up Period||37||
60057395|NCT02150213|76172836|FG000|STARTED|Overall Study||59||
60057396|NCT02150213|76172836|FG000|COMPLETED|Overall Study||57||
60057397|NCT02150213|76172836|FG000|NOT COMPLETED|Overall Study||2||
60057398|NCT02091362|76172842|FG000|STARTED|Period 1||133||
60057399|NCT02091362|76172843|FG001|STARTED|Period 1||137||
60057400|NCT02091362|76172842|FG000|COMPLETED|Period 1||128||
60057401|NCT02091362|76172843|FG001|COMPLETED|Period 1||133||
60057402|NCT02091362|76172842|FG000|NOT COMPLETED|Period 1||5||
60057403|NCT02091362|76172843|FG001|NOT COMPLETED|Period 1||4||
60057404|NCT02091362|76172842|FG000|STARTED|Wash-out||128||
60057405|NCT02091362|76172843|FG001|STARTED|Wash-out||133||
60057406|NCT02091362|76172842|FG000|COMPLETED|Wash-out||127||
60057407|NCT02091362|76172843|FG001|COMPLETED|Wash-out||130||
60057408|NCT02091362|76172842|FG000|NOT COMPLETED|Wash-out||1||
60057409|NCT02091362|76172843|FG001|NOT COMPLETED|Wash-out||3||
60057410|NCT02091362|76172842|FG000|STARTED|Period 2||127||
60057411|NCT02091362|76172843|FG001|STARTED|Period 2||130||
60057412|NCT02091362|76172842|FG000|COMPLETED|Period 2||125||
60057413|NCT02091362|76172843|FG001|COMPLETED|Period 2||128||
60057414|NCT02091362|76172842|FG000|NOT COMPLETED|Period 2||2||
60057415|NCT02091362|76172843|FG001|NOT COMPLETED|Period 2||2||
60057416|NCT02150057|76172855|FG000|STARTED|Overall Study||25||
60057417|NCT02150057|76172856|FG001|STARTED|Overall Study||26||
60057418|NCT02150057|76172855|FG000|COMPLETED|Overall Study||19||
60057419|NCT02150057|76172856|FG001|COMPLETED|Overall Study||22||
60057420|NCT02150057|76172855|FG000|NOT COMPLETED|Overall Study||6||
60057421|NCT02150057|76172856|FG001|NOT COMPLETED|Overall Study||4||
60057422|NCT02064296|76172865|FG000|STARTED|Eligibility to Baseline Data Collection||27||
60057423|NCT02064296|76172866|FG001|STARTED|Eligibility to Baseline Data Collection||39||
60057424|NCT02064296|76172867|FG002|STARTED|Eligibility to Baseline Data Collection||40||
60057425|NCT02064296|76172865|FG000|COMPLETED|Eligibility to Baseline Data Collection||26||
60057426|NCT02064296|76172866|FG001|COMPLETED|Eligibility to Baseline Data Collection||39||
60057427|NCT02064296|76172867|FG002|COMPLETED|Eligibility to Baseline Data Collection||40||
60057428|NCT02064296|76172865|FG000|NOT COMPLETED|Eligibility to Baseline Data Collection||1||
60057429|NCT02064296|76172866|FG001|NOT COMPLETED|Eligibility to Baseline Data Collection||0||
60057430|NCT02064296|76172867|FG002|NOT COMPLETED|Eligibility to Baseline Data Collection||0||
60057431|NCT02064296|76172865|FG000|STARTED|Baseline Data Collection|No healthy volunteers were given any treatment as they were used for baseline comparison purposes.|26||
60057432|NCT02064296|76172866|FG001|STARTED|Baseline Data Collection||39||
60057433|NCT02064296|76172867|FG002|STARTED|Baseline Data Collection||40||
60057434|NCT02064296|76172865|FG000|COMPLETED|Baseline Data Collection||26||
60057435|NCT02064296|76172866|FG001|COMPLETED|Baseline Data Collection||39||
60057436|NCT02064296|76172867|FG002|COMPLETED|Baseline Data Collection||40||
60057437|NCT02064296|76172865|FG000|NOT COMPLETED|Baseline Data Collection||0||
60057438|NCT02064296|76172866|FG001|NOT COMPLETED|Baseline Data Collection||0||
60057439|NCT02064296|76172867|FG002|NOT COMPLETED|Baseline Data Collection||0||
60057440|NCT02064296|76172865|FG000|STARTED|Intervention|Healthy controls were never intended to have interventions.|0||
60057441|NCT02064296|76172866|FG001|STARTED|Intervention||39||
60057442|NCT02064296|76172867|FG002|STARTED|Intervention||40||
60057443|NCT02064296|76172865|FG000|COMPLETED|Intervention||0||
60057444|NCT02064296|76172866|FG001|COMPLETED|Intervention||38||
60057445|NCT02064296|76172867|FG002|COMPLETED|Intervention||38||
60057446|NCT02064296|76172865|FG000|NOT COMPLETED|Intervention||0||
60057447|NCT02064296|76172866|FG001|NOT COMPLETED|Intervention||1||
60057448|NCT02064296|76172867|FG002|NOT COMPLETED|Intervention||2||
60057449|NCT02063984|76172879|FG000|STARTED|Overall Study||29||
60057450|NCT02063984|76172880|FG001|STARTED|Overall Study||30||
60057451|NCT02063984|76172879|FG000|COMPLETED|Overall Study||23||
60057452|NCT02063984|76172880|FG001|COMPLETED|Overall Study||25||
60057453|NCT02063984|76172879|FG000|NOT COMPLETED|Overall Study||6||
60057454|NCT02063984|76172880|FG001|NOT COMPLETED|Overall Study||5||
60057455|NCT02091284|76172892|FG000|STARTED|Overall Study|Two subjects from this group discontinued the protocol, data from one subject could not be included.|26||
60057456|NCT02091284|76172893|FG001|STARTED|Overall Study|One subject from this group discontinued the protocol|23||
60057457|NCT02091284|76172892|FG000|COMPLETED|Overall Study||23||
60057458|NCT02091284|76172893|FG001|COMPLETED|Overall Study||22||
60057459|NCT02091284|76172892|FG000|NOT COMPLETED|Overall Study||3||
60057460|NCT02091284|76172893|FG001|NOT COMPLETED|Overall Study||1||
60057461|NCT02115386|76172901|FG000|STARTED|Overall Study||7||
60057462|NCT02115386|76172901|FG000|COMPLETED|Overall Study||0||
60057463|NCT02115386|76172901|FG000|NOT COMPLETED|Overall Study||7||
60057464|NCT02091206|76172909|FG000|STARTED|Treatment Period||10||
60057465|NCT02091206|76172910|FG001|STARTED|Treatment Period||8||
60057466|NCT02091206|76172911|FG002|STARTED|Treatment Period||9||
60057467|NCT02091206|76172912|FG003|STARTED|Treatment Period||7||
60057468|NCT02091206|76172909|FG000|Safety Analysis Set|Treatment Period||10|All randomized participants who received at least 1 dose of IMP|
60057469|NCT02091206|76172910|FG001|Safety Analysis Set|Treatment Period||8|All randomized participants who received at least 1 dose of IMP|
60057470|NCT02091206|76172911|FG002|Safety Analysis Set|Treatment Period||9|All randomized participants who received at least 1 dose of IMP|
60057471|NCT02091206|76172912|FG003|Safety Analysis Set|Treatment Period||7|All randomized participants who received at least 1 dose of IMP|
60057472|NCT02091206|76172909|FG000|COMPLETED|Treatment Period||10||
60057473|NCT02091206|76172910|FG001|COMPLETED|Treatment Period||7||
59515763|NCT03095638|75609524|FG004|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0||
59515764|NCT03095638|75609525|FG005|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0||
59515765|NCT03095638|75609526|FG006|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0||
59515766|NCT03095638|75609527|FG007|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0||
59515767|NCT03095638|75609520|FG000|STARTED|P2: Period 2 (4 Days)||0||
59515768|NCT03095638|75609521|FG001|STARTED|P2: Period 2 (4 Days)||0||
60057474|NCT02091206|76172911|FG002|COMPLETED|Treatment Period||8||
60057475|NCT02091206|76172912|FG003|COMPLETED|Treatment Period||7||
60057476|NCT02091206|76172909|FG000|NOT COMPLETED|Treatment Period||0||
60057477|NCT02091206|76172910|FG001|NOT COMPLETED|Treatment Period||1||
60057478|NCT02091206|76172911|FG002|NOT COMPLETED|Treatment Period||1||
60057479|NCT02091206|76172912|FG003|NOT COMPLETED|Treatment Period||0||
60057480|NCT02091206|76172909|FG000|STARTED|Taper Period||10||
60057481|NCT02091206|76172910|FG001|STARTED|Taper Period||7||
60057482|NCT02091206|76172911|FG002|STARTED|Taper Period||8||
60057483|NCT02091206|76172912|FG003|STARTED|Taper Period||7||
60057484|NCT02091206|76172909|FG000|COMPLETED|Taper Period||9||
60057485|NCT02091206|76172910|FG001|COMPLETED|Taper Period||7||
60057486|NCT02091206|76172911|FG002|COMPLETED|Taper Period||8||
60057487|NCT02091206|76172912|FG003|COMPLETED|Taper Period||5||
60057488|NCT02091206|76172909|FG000|NOT COMPLETED|Taper Period||1||
60057489|NCT02091206|76172910|FG001|NOT COMPLETED|Taper Period||0||
60057490|NCT02091206|76172911|FG002|NOT COMPLETED|Taper Period||0||
60057491|NCT02091206|76172912|FG003|NOT COMPLETED|Taper Period||2||
59515769|NCT03095638|75609522|FG002|STARTED|P2: Period 2 (4 Days)||4||
59515770|NCT03095638|75609523|FG003|STARTED|P2: Period 2 (4 Days)||4||
59515771|NCT03095638|75609524|FG004|STARTED|P2: Period 2 (4 Days)||4||
59515772|NCT03095638|75609525|FG005|STARTED|P2: Period 2 (4 Days)||4||
60057492|NCT02090426|76172924|FG000|STARTED|Overall Study||401||
60057493|NCT02090426|76172925|FG001|STARTED|Overall Study||399||
60057494|NCT02090426|76172924|FG000|Analysis Population|Overall Study||389|Subset of randomized participants that matched to discharge data in which we observe outcomes.|
59515773|NCT03095638|75609526|FG006|STARTED|P2: Period 2 (4 Days)||4||
59515774|NCT03095638|75609527|FG007|STARTED|P2: Period 2 (4 Days)||4||
59515775|NCT03095638|75609520|FG000|COMPLETED|P2: Period 2 (4 Days)||0||
59515776|NCT03095638|75609521|FG001|COMPLETED|P2: Period 2 (4 Days)||0||
59515777|NCT03095638|75609522|FG002|COMPLETED|P2: Period 2 (4 Days)||4||
59515778|NCT03095638|75609523|FG003|COMPLETED|P2: Period 2 (4 Days)||4||
59515779|NCT03095638|75609524|FG004|COMPLETED|P2: Period 2 (4 Days)||4||
59515780|NCT03095638|75609525|FG005|COMPLETED|P2: Period 2 (4 Days)||4||
59515781|NCT03095638|75609526|FG006|COMPLETED|P2: Period 2 (4 Days)||4||
59515782|NCT03095638|75609527|FG007|COMPLETED|P2: Period 2 (4 Days)||4||
59515783|NCT03095638|75609520|FG000|NOT COMPLETED|P2: Period 2 (4 Days)||0||
60057495|NCT02090426|76172925|FG001|Analysis Population|Overall Study||393|Subset of randomized participants that matched to discharge data in which we observe outcomes.|
60057496|NCT02090426|76172924|FG000|COMPLETED|Overall Study||389||
60057497|NCT02090426|76172925|FG001|COMPLETED|Overall Study||393||
60057498|NCT02090426|76172924|FG000|NOT COMPLETED|Overall Study||12||
60057499|NCT02090426|76172925|FG001|NOT COMPLETED|Overall Study||6||
60057500|NCT02063828|76172934|FG000|STARTED|Overall Study||14||
60057501|NCT02063828|76172935|FG001|STARTED|Overall Study||14||
60057502|NCT02063828|76172936|FG002|STARTED|Overall Study||18||
60057503|NCT02063828|76172934|FG000|Week 6|Overall Study||11||
60057504|NCT02063828|76172935|FG001|Week 6|Overall Study||9||
60057505|NCT02063828|76172936|FG002|Week 6|Overall Study||14||
59515784|NCT03095638|75609521|FG001|NOT COMPLETED|P2: Period 2 (4 Days)||0||
59515785|NCT03095638|75609522|FG002|NOT COMPLETED|P2: Period 2 (4 Days)||0||
59515786|NCT03095638|75609523|FG003|NOT COMPLETED|P2: Period 2 (4 Days)||0||
59515787|NCT03095638|75609524|FG004|NOT COMPLETED|P2: Period 2 (4 Days)||0||
59515788|NCT03095638|75609525|FG005|NOT COMPLETED|P2: Period 2 (4 Days)||0||
59515789|NCT03095638|75609526|FG006|NOT COMPLETED|P2: Period 2 (4 Days)||0||
59515790|NCT03095638|75609527|FG007|NOT COMPLETED|P2: Period 2 (4 Days)||0||
59515791|NCT03095638|75609520|FG000|STARTED|P2: Period 2, Washout (7[-4 Hours])||0||
60057506|NCT02063828|76172934|FG000|COMPLETED|Overall Study||10||
60057507|NCT02063828|76172935|FG001|COMPLETED|Overall Study||8||
60057508|NCT02063828|76172936|FG002|COMPLETED|Overall Study||14||
60057509|NCT02063828|76172934|FG000|NOT COMPLETED|Overall Study||4||
60057510|NCT02063828|76172935|FG001|NOT COMPLETED|Overall Study||6||
60057511|NCT02063828|76172936|FG002|NOT COMPLETED|Overall Study||4||
60057512|NCT02063672|76172946|FG000|STARTED|Overall Study||53||
60057513|NCT02063672|76172947|FG001|STARTED|Overall Study||29||
60057514|NCT02063672|76172946|FG000|COMPLETED|Overall Study||18||
60057515|NCT02063672|76172947|FG001|COMPLETED|Overall Study||7||
60057516|NCT02063672|76172946|FG000|NOT COMPLETED|Overall Study||35||
60057517|NCT02063672|76172947|FG001|NOT COMPLETED|Overall Study||22||
60057518|NCT02062658|76172953|FG000|STARTED|Overall Study||10||
60057519|NCT02062658|76172953|FG000|COMPLETED|Overall Study||8||
59925608|NCT02896400|76043770|FG013|COMPLETED|Biochemical Verification at 3 Months||12|Only participants reporting abstinence at the 3m follow-up complete the biochem.|
59925609|NCT02896400|76043771|FG014|COMPLETED|Biochemical Verification at 3 Months||7|Only participants reporting abstinence at the 3m follow-up complete the biochem.|
59925610|NCT02896400|76043772|FG015|COMPLETED|Biochemical Verification at 3 Months||6|Only participants reporting abstinence at the 3m follow-up complete the biochem.|
59925611|NCT02896400|76043757|FG000|NOT COMPLETED|Biochemical Verification at 3 Months||46||
60057520|NCT02062658|76172953|FG000|NOT COMPLETED|Overall Study||2||
60057521|NCT02115308|76172959|FG000|STARTED|Overall Study|Number of subjects recruited for the CONTROL group.|15|03SEPT2014|
60057522|NCT02115308|76172960|FG001|STARTED|Overall Study|Number of subjects recruited for the CAD group.|25|03SEPT2014|
60057523|NCT02115308|76172959|FG000|COMPLETED|Overall Study|Number of subjects recruited to the Control group meeting all inclusion criteria.|13|16JAN2018|
60057524|NCT02115308|76172960|FG001|COMPLETED|Overall Study|Number of subjects recruited to the CAD group meeting all inclusion criteria.|23|16JAN2018|
60057525|NCT02115308|76172959|FG000|NOT COMPLETED|Overall Study||2||
60057526|NCT02115308|76172960|FG001|NOT COMPLETED|Overall Study||2||
60057527|NCT02114684|76172972|FG000|STARTED|Overall Study||98||
60057528|NCT02114684|76172973|FG001|STARTED|Overall Study||98||
60057529|NCT02114684|76172972|FG000|COMPLETED|Overall Study||86||
60057530|NCT02114684|76172973|FG001|COMPLETED|Overall Study||88||
60057531|NCT02114684|76172972|FG000|NOT COMPLETED|Overall Study||12||
60057532|NCT02114684|76172973|FG001|NOT COMPLETED|Overall Study||10||
59925612|NCT02896400|76043758|FG001|NOT COMPLETED|Biochemical Verification at 3 Months||48||
59925613|NCT02896400|76043759|FG002|NOT COMPLETED|Biochemical Verification at 3 Months||47||
59925614|NCT02896400|76043760|FG003|NOT COMPLETED|Biochemical Verification at 3 Months||41||
59925615|NCT02896400|76043761|FG004|NOT COMPLETED|Biochemical Verification at 3 Months||45||
59925616|NCT02896400|76043762|FG005|NOT COMPLETED|Biochemical Verification at 3 Months||49||
59925617|NCT02896400|76043763|FG006|NOT COMPLETED|Biochemical Verification at 3 Months||51||
59925618|NCT02896400|76043764|FG007|NOT COMPLETED|Biochemical Verification at 3 Months||49||
59925619|NCT02896400|76043765|FG008|NOT COMPLETED|Biochemical Verification at 3 Months||45||
59925620|NCT02896400|76043766|FG009|NOT COMPLETED|Biochemical Verification at 3 Months||53||
59925621|NCT02896400|76043767|FG010|NOT COMPLETED|Biochemical Verification at 3 Months||55||
59925622|NCT02896400|76043768|FG011|NOT COMPLETED|Biochemical Verification at 3 Months||41||
59925623|NCT02896400|76043769|FG012|NOT COMPLETED|Biochemical Verification at 3 Months||53||
59925624|NCT02896400|76043770|FG013|NOT COMPLETED|Biochemical Verification at 3 Months||48||
59925625|NCT02896400|76043771|FG014|NOT COMPLETED|Biochemical Verification at 3 Months||55||
60057533|NCT02090114|76172987|FG000|STARTED|Overall Study||30||
60057534|NCT02090114|76172988|FG001|STARTED|Overall Study||29||
60057535|NCT02090114|76172989|FG002|STARTED|Overall Study||29||
60057536|NCT02090114|76172990|FG003|STARTED|Overall Study||8||
60057537|NCT02090114|76172987|FG000|COMPLETED|Overall Study||0||
60057538|NCT02090114|76172988|FG001|COMPLETED|Overall Study||0||
60057539|NCT02090114|76172989|FG002|COMPLETED|Overall Study||0||
60057540|NCT02090114|76172990|FG003|COMPLETED|Overall Study||0||
59925626|NCT02896400|76043772|FG015|NOT COMPLETED|Biochemical Verification at 3 Months||57||
60057541|NCT02090114|76172987|FG000|NOT COMPLETED|Overall Study||30||
59925627|NCT03405935|76043798|FG000|STARTED|Overall Study||86||
60057542|NCT02090114|76172988|FG001|NOT COMPLETED|Overall Study||29||
60057543|NCT02090114|76172989|FG002|NOT COMPLETED|Overall Study||29||
59515792|NCT03095638|75609521|FG001|STARTED|P2: Period 2, Washout (7[-4 Hours])||0||
59515793|NCT03095638|75609522|FG002|STARTED|P2: Period 2, Washout (7[-4 Hours])||4||
59613025|NCT01713582|75724098|FG004|STARTED|Overall Study|Number treated|4||
59613026|NCT01713582|75724099|FG005|STARTED|Overall Study|Number treated|8||
59613027|NCT01713582|75724100|FG006|STARTED|Overall Study|Number treated|7||
59925628|NCT03405935|76043798|FG000|COMPLETED|Overall Study||78||
59925629|NCT03405935|76043798|FG000|NOT COMPLETED|Overall Study||8||
59925630|NCT03055260|76043804|FG000|STARTED|Overall Study||8||
59515794|NCT03095638|75609523|FG003|STARTED|P2: Period 2, Washout (7[-4 Hours])||4||
59515795|NCT03095638|75609524|FG004|STARTED|P2: Period 2, Washout (7[-4 Hours])||4||
59515796|NCT03095638|75609525|FG005|STARTED|P2: Period 2, Washout (7[-4 Hours])||4||
59515797|NCT03095638|75609526|FG006|STARTED|P2: Period 2, Washout (7[-4 Hours])||4||
59925631|NCT03055260|76043805|FG001|STARTED|Overall Study||0||
59925632|NCT03055260|76043804|FG000|COMPLETED|Overall Study||7||
59925633|NCT03055260|76043805|FG001|COMPLETED|Overall Study||0||
59925634|NCT03055260|76043804|FG000|NOT COMPLETED|Overall Study||1||
59925635|NCT03055260|76043805|FG001|NOT COMPLETED|Overall Study||0||
60057544|NCT02090114|76172990|FG003|NOT COMPLETED|Overall Study||8||
60057545|NCT01623050|76173000|FG000|STARTED|Overall Study||36||
60057546|NCT01623050|76173000|FG000|Treated|Overall Study||34||
60057547|NCT01623050|76173000|FG000|COMPLETED|Overall Study||27||
60057548|NCT01623050|76173000|FG000|NOT COMPLETED|Overall Study||9||
60057549|NCT02089334|76173008|FG000|STARTED|Overall Study||3||
60057550|NCT02089334|76173009|FG001|STARTED|Overall Study||4||
60057551|NCT02089334|76173010|FG002|STARTED|Overall Study||4||
60057552|NCT02089334|76173011|FG003|STARTED|Overall Study||13||
60057553|NCT02089334|76173008|FG000|Received Study Drug|Overall Study||3||
59515798|NCT03095638|75609527|FG007|STARTED|P2: Period 2, Washout (7[-4 Hours])||4||
59515799|NCT03095638|75609520|FG000|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0||
59515800|NCT03095638|75609521|FG001|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0||
59515801|NCT03095638|75609522|FG002|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4||
59515802|NCT03095638|75609523|FG003|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4||
59515803|NCT03095638|75609524|FG004|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4||
59515804|NCT03095638|75609525|FG005|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4||
59613028|NCT01713582|75724101|FG007|STARTED|Overall Study|Number treated|6||
59613029|NCT01713582|75724102|FG008|STARTED|Overall Study|Number treated|6||
59925636|NCT03404843|76043813|FG000|STARTED|Overall Study||17||
60057554|NCT02089334|76173009|FG001|Received Study Drug|Overall Study||4||
60057555|NCT02089334|76173010|FG002|Received Study Drug|Overall Study||3||
60057556|NCT02089334|76173011|FG003|Received Study Drug|Overall Study||11||
60057557|NCT02089334|76173008|FG000|COMPLETED|Overall Study||3||
60057558|NCT02089334|76173009|FG001|COMPLETED|Overall Study||4||
60057559|NCT02089334|76173010|FG002|COMPLETED|Overall Study||3||
60057560|NCT02089334|76173011|FG003|COMPLETED|Overall Study||6||
60057561|NCT02089334|76173008|FG000|NOT COMPLETED|Overall Study||0||
60057562|NCT02089334|76173009|FG001|NOT COMPLETED|Overall Study||0||
60057563|NCT02089334|76173010|FG002|NOT COMPLETED|Overall Study||1||
60057564|NCT02089334|76173011|FG003|NOT COMPLETED|Overall Study||7||
60057565|NCT02114606|76173024|FG000|STARTED|Overall Study||86||
60057566|NCT02114606|76173024|FG000|COMPLETED|Overall Study||80||
60057567|NCT02114606|76173024|FG000|NOT COMPLETED|Overall Study||6||
60057568|NCT02113436|76173030|FG000|STARTED|Period 1: 8 Weeks||150||
60057569|NCT02113436|76173031|FG001|STARTED|Period 1: 8 Weeks||150||
60057570|NCT02113436|76173032|FG002|STARTED|Period 1: 8 Weeks||0||
59515805|NCT03095638|75609526|FG006|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4||
59613030|NCT01713582|75724103|FG009|STARTED|Overall Study|Number treated|18||
59613031|NCT01713582|75724104|FG010|STARTED|Overall Study|Number treated|16||
59613032|NCT01713582|75724105|FG011|STARTED|Overall Study|Number treated|5||
59613033|NCT01713582|75724106|FG012|STARTED|Overall Study|Number treated|3||
59613034|NCT01713582|75724107|FG013|STARTED|Overall Study|Number treated|4||
59613035|NCT01713582|75724108|FG014|STARTED|Overall Study|Number treated|7||
59613036|NCT01713582|75724109|FG015|STARTED|Overall Study|Number treated|6||
59613037|NCT01713582|75724110|FG016|STARTED|Overall Study|Number treated|7||
59925637|NCT03404843|76043814|FG001|STARTED|Overall Study||14||
59925638|NCT03404843|76043813|FG000|COMPLETED|Overall Study||13||
59925639|NCT03404843|76043814|FG001|COMPLETED|Overall Study||13||
59925640|NCT03404843|76043813|FG000|NOT COMPLETED|Overall Study||4||
59925641|NCT03404843|76043814|FG001|NOT COMPLETED|Overall Study||1||
60057571|NCT02113436|76173033|FG003|STARTED|Period 1: 8 Weeks||0||
60057572|NCT02113436|76173030|FG000|COMPLETED|Period 1: 8 Weeks||142||
60057573|NCT02113436|76173031|FG001|COMPLETED|Period 1: 8 Weeks||148||
59925642|NCT03032250|76043826|FG000|STARTED|Overall Study||17||
59925643|NCT03032250|76043827|FG001|STARTED|Overall Study||18||
59925644|NCT03032250|76043826|FG000|COMPLETED|Overall Study||17||
59925645|NCT03032250|76043827|FG001|COMPLETED|Overall Study||18||
59925646|NCT03032250|76043826|FG000|NOT COMPLETED|Overall Study||0||
59925647|NCT03032250|76043827|FG001|NOT COMPLETED|Overall Study||0||
60057574|NCT02113436|76173032|FG002|COMPLETED|Period 1: 8 Weeks||0||
60057575|NCT02113436|76173033|FG003|COMPLETED|Period 1: 8 Weeks||0||
60057576|NCT02113436|76173030|FG000|NOT COMPLETED|Period 1: 8 Weeks||8||
60057577|NCT02113436|76173031|FG001|NOT COMPLETED|Period 1: 8 Weeks||2||
59925648|NCT03444155|76043838|FG000|STARTED|First Intervention (6 Weeks)||15||
59925649|NCT03444155|76043839|FG001|STARTED|First Intervention (6 Weeks)||15||
59925650|NCT03444155|76043838|FG000|COMPLETED|First Intervention (6 Weeks)||14||
59925651|NCT03444155|76043839|FG001|COMPLETED|First Intervention (6 Weeks)||15||
59925652|NCT03444155|76043838|FG000|NOT COMPLETED|First Intervention (6 Weeks)||1||
59925653|NCT03444155|76043839|FG001|NOT COMPLETED|First Intervention (6 Weeks)||0||
59925654|NCT03444155|76043838|FG000|STARTED|Washout (2 Weeks)||14||
59925655|NCT03444155|76043839|FG001|STARTED|Washout (2 Weeks)||15||
59925656|NCT03444155|76043838|FG000|COMPLETED|Washout (2 Weeks)||14||
59925657|NCT03444155|76043839|FG001|COMPLETED|Washout (2 Weeks)||15||
59925658|NCT03444155|76043838|FG000|NOT COMPLETED|Washout (2 Weeks)||0||
60057578|NCT02113436|76173032|FG002|NOT COMPLETED|Period 1: 8 Weeks||0||
60057579|NCT02113436|76173033|FG003|NOT COMPLETED|Period 1: 8 Weeks||0||
60057580|NCT02113436|76173030|FG000|STARTED|Period 2: 16 Weeks||0||
60057581|NCT02113436|76173031|FG001|STARTED|Period 2: 16 Weeks||0||
60057582|NCT02113436|76173032|FG002|STARTED|Period 2: 16 Weeks|Par. started TP2 are not equal to that completed TP1 as 1 par. in each arm didn't transfer to TP2.|141||
60057583|NCT02113436|76173033|FG003|STARTED|Period 2: 16 Weeks|Par. started TP2 are not equal to that completed TP1 as 1 par. in each arm didn't transfer to TP2.|147||
60057584|NCT02113436|76173030|FG000|COMPLETED|Period 2: 16 Weeks||0||
60057585|NCT02113436|76173031|FG001|COMPLETED|Period 2: 16 Weeks||0||
60057586|NCT02113436|76173032|FG002|COMPLETED|Period 2: 16 Weeks||132||
60057587|NCT02113436|76173033|FG003|COMPLETED|Period 2: 16 Weeks||136||
60057588|NCT02113436|76173030|FG000|NOT COMPLETED|Period 2: 16 Weeks||0||
60057589|NCT02113436|76173031|FG001|NOT COMPLETED|Period 2: 16 Weeks||0||
60057590|NCT02113436|76173032|FG002|NOT COMPLETED|Period 2: 16 Weeks||9||
60057591|NCT02113436|76173033|FG003|NOT COMPLETED|Period 2: 16 Weeks||11||
60057592|NCT02113124|76173044|FG000|STARTED|Overall Study||18||
60057593|NCT02113124|76173045|FG001|STARTED|Overall Study||25||
60057594|NCT02113124|76173044|FG000|COMPLETED|Overall Study||17||
60057595|NCT02113124|76173045|FG001|COMPLETED|Overall Study||24||
59760652|NCT00887315|75880291|FG001|NOT COMPLETED|Overall Study||4||
59760653|NCT03608826|75880297|FG000|STARTED|Overall Study||12||
59760654|NCT03608826|75880297|FG000|COMPLETED|Overall Study||2||
59760655|NCT03608826|75880297|FG000|NOT COMPLETED|Overall Study||10||
59925659|NCT03444155|76043839|FG001|NOT COMPLETED|Washout (2 Weeks)||0||
59925660|NCT03444155|76043838|FG000|STARTED|Second Intervention (6 Weeks)||14||
59925661|NCT03444155|76043839|FG001|STARTED|Second Intervention (6 Weeks)||15||
59925662|NCT03444155|76043838|FG000|COMPLETED|Second Intervention (6 Weeks)||14||
59925663|NCT03444155|76043839|FG001|COMPLETED|Second Intervention (6 Weeks)||15||
59925664|NCT03444155|76043838|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0||
59925665|NCT03444155|76043839|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||0||
59925666|NCT02898116|76043845|FG000|STARTED|Overall Study||2||
59925667|NCT02898116|76043845|FG000|COMPLETED|Overall Study||0||
59925668|NCT02898116|76043845|FG000|NOT COMPLETED|Overall Study||2||
59925669|NCT03658304|76043849|FG000|STARTED|Overall Study||29||
59925670|NCT03658304|76043849|FG000|COMPLETED|Overall Study||21||
59925671|NCT03658304|76043849|FG000|NOT COMPLETED|Overall Study||8||
59925672|NCT03422159|76043855|FG000|STARTED|Overall Study||70||
60057596|NCT02113124|76173044|FG000|NOT COMPLETED|Overall Study||1||
59515806|NCT03095638|75609527|FG007|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4||
59760656|NCT00887159|75880304|FG000|STARTED|Overall Study||56||
59760657|NCT00887159|75880305|FG001|STARTED|Overall Study||56||
59760658|NCT00887159|75880306|FG002|STARTED|Overall Study||56||
59760659|NCT00887159|75880304|FG000|Patients Who Started Assigned Treatment|Overall Study||53||
59925673|NCT03422159|76043856|FG001|STARTED|Overall Study||70||
59925674|NCT03422159|76043855|FG000|COMPLETED|Overall Study||68||
59925675|NCT03422159|76043856|FG001|COMPLETED|Overall Study||69||
59925676|NCT03422159|76043855|FG000|NOT COMPLETED|Overall Study||2||
59925677|NCT03422159|76043856|FG001|NOT COMPLETED|Overall Study||1||
59925678|NCT03403751|76043866|FG000|STARTED|Overall Study||28||
59925679|NCT03403751|76043867|FG001|STARTED|Overall Study||30||
59925680|NCT03403751|76043866|FG000|COMPLETED|Overall Study||21||
59925681|NCT03403751|76043867|FG001|COMPLETED|Overall Study||22||
59925682|NCT03403751|76043866|FG000|NOT COMPLETED|Overall Study||7||
59925683|NCT03403751|76043867|FG001|NOT COMPLETED|Overall Study||8||
59925684|NCT02297412|76043877|FG000|STARTED|Overall Study||23||
59925685|NCT02297412|76043878|FG001|STARTED|Overall Study||24||
59760660|NCT00887159|75880305|FG001|Patients Who Started Assigned Treatment|Overall Study||53||
59760661|NCT00887159|75880306|FG002|Patients Who Started Assigned Treatment|Overall Study||52||
59760662|NCT00887159|75880304|FG000|Eligible and Treated Patients|Overall Study||48||
59760663|NCT00887159|75880305|FG001|Eligible and Treated Patients|Overall Study||52||
59760664|NCT00887159|75880306|FG002|Eligible and Treated Patients|Overall Study||52||
59760665|NCT00887159|75880304|FG000|Eligible/Treated Pts With CTCs Results|Overall Study||40||
59760666|NCT00887159|75880305|FG001|Eligible/Treated Pts With CTCs Results|Overall Study||42||
59760667|NCT00887159|75880306|FG002|Eligible/Treated Pts With CTCs Results|Overall Study||38||
59760668|NCT00887159|75880304|FG000|COMPLETED|Overall Study||27||
59760669|NCT00887159|75880305|FG001|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicity.|0||
59760670|NCT00887159|75880306|FG002|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicity.|0||
59760671|NCT00887159|75880304|FG000|NOT COMPLETED|Overall Study||29||
59760672|NCT00887159|75880305|FG001|NOT COMPLETED|Overall Study||56||
59760673|NCT00887159|75880306|FG002|NOT COMPLETED|Overall Study||56||
59760674|NCT00886769|75880318|FG000|STARTED|Overall Study||43||
59760675|NCT00886769|75880319|FG001|STARTED|Overall Study||41||
59760676|NCT00886769|75880318|FG000|COMPLETED|Overall Study||37||
59760677|NCT00886769|75880319|FG001|COMPLETED|Overall Study||4||
59925686|NCT02297412|76043877|FG000|COMPLETED|Overall Study||22||
59925687|NCT02297412|76043878|FG001|COMPLETED|Overall Study||23||
59925688|NCT02297412|76043877|FG000|NOT COMPLETED|Overall Study||1||
59925689|NCT02297412|76043878|FG001|NOT COMPLETED|Overall Study||1||
59925690|NCT03418727|76043887|FG000|STARTED|Overall Study||29||
59925691|NCT03418727|76043888|FG001|STARTED|Overall Study||28||
59760678|NCT00886769|75880318|FG000|NOT COMPLETED|Overall Study||6||
59925692|NCT03418727|76043889|FG002|STARTED|Overall Study||27||
59925693|NCT03418727|76043887|FG000|Received at Least 1 Study Treatment|Overall Study||29||
59925694|NCT03418727|76043888|FG001|Received at Least 1 Study Treatment|Overall Study||28||
59925695|NCT03418727|76043889|FG002|Received at Least 1 Study Treatment|Overall Study||27||
59925696|NCT03418727|76043887|FG000|COMPLETED|Overall Study||28||
59925697|NCT03418727|76043888|FG001|COMPLETED|Overall Study||26||
59925698|NCT03418727|76043889|FG002|COMPLETED|Overall Study||25||
59925699|NCT03418727|76043887|FG000|NOT COMPLETED|Overall Study||1||
59925700|NCT03418727|76043888|FG001|NOT COMPLETED|Overall Study||2||
59925701|NCT03418727|76043889|FG002|NOT COMPLETED|Overall Study||2||
59925702|NCT03418571|76043899|FG000|STARTED|Overall Study||12||
59925703|NCT03418571|76043900|FG001|STARTED|Overall Study||3||
59925704|NCT03418571|76043899|FG000|COMPLETED|Overall Study||11||
59925705|NCT03418571|76043900|FG001|COMPLETED|Overall Study||3||
59925706|NCT03418571|76043899|FG000|NOT COMPLETED|Overall Study||1||
59760679|NCT00886769|75880319|FG001|NOT COMPLETED|Overall Study||37||
59760680|NCT00886613|75880328|FG000|STARTED|Overall Study||41||
59760681|NCT00886613|75880329|FG001|STARTED|Overall Study||39||
59760682|NCT00886613|75880330|FG002|STARTED|Overall Study||40||
59760683|NCT00886613|75880328|FG000|COMPLETED|Overall Study||39||
59760684|NCT00886613|75880329|FG001|COMPLETED|Overall Study||39||
59760685|NCT00886613|75880330|FG002|COMPLETED|Overall Study||37||
59760686|NCT00886613|75880328|FG000|NOT COMPLETED|Overall Study||2||
59760687|NCT00886613|75880329|FG001|NOT COMPLETED|Overall Study||0||
59760688|NCT00886613|75880330|FG002|NOT COMPLETED|Overall Study||3||
59760689|NCT00886379|75880346|FG000|STARTED|Overall Study||104||
59760690|NCT00886379|75880347|FG001|STARTED|Overall Study||143||
59760691|NCT00886379|75880348|FG002|STARTED|Overall Study||143||
59760692|NCT00886379|75880349|FG003|STARTED|Overall Study||112||
59760693|NCT00886379|75880350|FG004|STARTED|Overall Study||95||
59760694|NCT00886379|75880346|FG000|COMPLETED|Overall Study||101||
59760695|NCT00886379|75880347|FG001|COMPLETED|Overall Study||140||
59760696|NCT00886379|75880348|FG002|COMPLETED|Overall Study||137||
59760697|NCT00886379|75880349|FG003|COMPLETED|Overall Study||109||
59760698|NCT00886379|75880350|FG004|COMPLETED|Overall Study||92||
59760699|NCT00886379|75880346|FG000|NOT COMPLETED|Overall Study||3||
59760700|NCT00886379|75880347|FG001|NOT COMPLETED|Overall Study||3||
59760701|NCT00886379|75880348|FG002|NOT COMPLETED|Overall Study||6||
59925707|NCT03418571|76043900|FG001|NOT COMPLETED|Overall Study||0||
59925708|NCT03402893|76043906|FG000|STARTED|Overall Study||21||
59925709|NCT03402893|76043906|FG000|COMPLETED|Overall Study||20||
59925710|NCT03402893|76043906|FG000|NOT COMPLETED|Overall Study||1||
59925711|NCT03442985|76043914|FG000|STARTED|Overall Study||62|Received treatment|
59613038|NCT01713582|75724111|FG017|STARTED|Overall Study|Number treated|3||
59760702|NCT00886379|75880349|FG003|NOT COMPLETED|Overall Study||3||
59760703|NCT00886379|75880350|FG004|NOT COMPLETED|Overall Study||3||
59760704|NCT00599196|75880362|FG000|STARTED|Overall Study||381||
59762618|NCT00866307|75882444|FG001|NOT COMPLETED|Consolidation/Maintenance||9||
59925712|NCT03442985|76043915|FG001|STARTED|Overall Study||66|Received treatment|
59925713|NCT03442985|76043916|FG002|STARTED|Overall Study||65|Received treatment|
59760705|NCT00599196|75880362|FG000|COMPLETED|Overall Study|Study fully recruited. Completed upon market authorization and commercial availability of Neupro.|0||
59760706|NCT00599196|75880362|FG000|NOT COMPLETED|Overall Study||381||
59760707|NCT00603512|75880371|FG000|STARTED|Overall Study||28||
59925714|NCT03442985|76043914|FG000|COMPLETED|Overall Study||0||
59925715|NCT03442985|76043915|FG001|COMPLETED|Overall Study||0||
59925716|NCT03442985|76043916|FG002|COMPLETED|Overall Study||0||
59515807|NCT03095638|75609520|FG000|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0||
59515808|NCT03095638|75609521|FG001|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0||
59515809|NCT03095638|75609522|FG002|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0||
59515810|NCT03095638|75609523|FG003|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0||
59515811|NCT03095638|75609524|FG004|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0||
59925717|NCT03442985|76043914|FG000|NOT COMPLETED|Overall Study||62||
59515812|NCT03095638|75609525|FG005|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0||
59760708|NCT00603512|75880372|FG001|STARTED|Overall Study||28||
59760709|NCT00603512|75880373|FG002|STARTED|Overall Study||28||
59760710|NCT00603512|75880374|FG003|STARTED|Overall Study||28||
59760711|NCT00603512|75880375|FG004|STARTED|Overall Study||28||
59760712|NCT00603512|75880371|FG000|Treated|Overall Study||28||
59760713|NCT00603512|75880372|FG001|Treated|Overall Study||27||
59760714|NCT00603512|75880373|FG002|Treated|Overall Study||27||
59760715|NCT00603512|75880374|FG003|Treated|Overall Study||26||
59760716|NCT00603512|75880375|FG004|Treated|Overall Study||28||
59760717|NCT00603512|75880371|FG000|COMPLETED|Overall Study||26||
59760718|NCT00603512|75880372|FG001|COMPLETED|Overall Study||23||
59760719|NCT00603512|75880373|FG002|COMPLETED|Overall Study||23||
59760720|NCT00603512|75880374|FG003|COMPLETED|Overall Study||21||
59760721|NCT00603512|75880375|FG004|COMPLETED|Overall Study||23||
59760722|NCT00603512|75880371|FG000|NOT COMPLETED|Overall Study||2||
59760723|NCT00603512|75880372|FG001|NOT COMPLETED|Overall Study||5||
59760724|NCT00603512|75880373|FG002|NOT COMPLETED|Overall Study||5||
59760725|NCT00603512|75880374|FG003|NOT COMPLETED|Overall Study||7||
59760726|NCT00603512|75880375|FG004|NOT COMPLETED|Overall Study||5||
59760727|NCT04242875|75880387|FG000|STARTED|Overall Study||30||60
59760728|NCT04242875|75880387|FG000|COMPLETED|Overall Study||28||56
59760729|NCT04242875|75880387|FG000|NOT COMPLETED|Overall Study||2||4
59760730|NCT00603278|75880401|FG000|STARTED|Overall Study||107||
59760731|NCT00603278|75880402|FG001|STARTED|Overall Study||105||
59760732|NCT00603278|75880403|FG002|STARTED|Overall Study||101||
59760733|NCT00603278|75880404|FG003|STARTED|Overall Study||103||
59760734|NCT00603278|75880405|FG004|STARTED|Overall Study||99||
59760735|NCT00603278|75880406|FG005|STARTED|Overall Study||100||
59760736|NCT00603278|75880401|FG000|COMPLETED|Overall Study||66||
59760737|NCT00603278|75880402|FG001|COMPLETED|Overall Study||88||
59760738|NCT00603278|75880403|FG002|COMPLETED|Overall Study||87||
59760739|NCT00603278|75880404|FG003|COMPLETED|Overall Study||92||
59760740|NCT00603278|75880405|FG004|COMPLETED|Overall Study||86||
59760741|NCT00603278|75880406|FG005|COMPLETED|Overall Study||81||
59760742|NCT00603278|75880401|FG000|NOT COMPLETED|Overall Study||41||
59760743|NCT00603278|75880402|FG001|NOT COMPLETED|Overall Study||17||
59760744|NCT00603278|75880403|FG002|NOT COMPLETED|Overall Study||14||
59760745|NCT00603278|75880404|FG003|NOT COMPLETED|Overall Study||11||
59760746|NCT00603278|75880405|FG004|NOT COMPLETED|Overall Study||13||
59760747|NCT00603278|75880406|FG005|NOT COMPLETED|Overall Study||19||
59760748|NCT00876447|75880422|FG000|STARTED|Overall Study||185||
59760749|NCT00876447|75880423|FG001|STARTED|Overall Study||203||
59760750|NCT00876447|75880422|FG000|COMPLETED|Overall Study||105||
59760751|NCT00876447|75880423|FG001|COMPLETED|Overall Study||122||
59760752|NCT00876447|75880422|FG000|NOT COMPLETED|Overall Study||80||
59925718|NCT03442985|76043915|FG001|NOT COMPLETED|Overall Study||66||
59925719|NCT03442985|76043916|FG002|NOT COMPLETED|Overall Study||65||
60057597|NCT02113124|76173045|FG001|NOT COMPLETED|Overall Study||1||
59515813|NCT03095638|75609526|FG006|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0||
59515814|NCT03095638|75609527|FG007|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0||
59760753|NCT00876447|75880423|FG001|NOT COMPLETED|Overall Study||81||
59760754|NCT00598650|75880453|FG000|STARTED|Overall Study||108||
59760755|NCT00598650|75880453|FG000|COMPLETED|Overall Study|5 subjects withdrew for multiple reasons|81||
59760756|NCT00598650|75880453|FG000|NOT COMPLETED|Overall Study||27||
59760757|NCT04249076|75880460|FG000|STARTED|Overall Study||141||
59760758|NCT04249076|75880461|FG001|STARTED|Overall Study||74||
59760759|NCT04249076|75880460|FG000|COMPLETED|Overall Study||139||
59760760|NCT04249076|75880461|FG001|COMPLETED|Overall Study||69||
59760761|NCT04249076|75880460|FG000|NOT COMPLETED|Overall Study||2||
59760762|NCT04249076|75880461|FG001|NOT COMPLETED|Overall Study||5||
59760763|NCT04150107|75880469|FG000|STARTED|Period 1- Placebo run-in (All Patients)||14||
59760764|NCT04150107|75880470|FG001|STARTED|Period 1- Placebo run-in (All Patients)||16||
60057598|NCT02087774|76173053|FG000|STARTED|Overall Study||150||
59760765|NCT04150107|75880469|FG000|COMPLETED|Period 1- Placebo run-in (All Patients)||14||
59951531|NCT02607930|76070546|FG003|NOT COMPLETED|Double-Blinded Treatment Phase||0||
59515815|NCT03095638|75609520|FG000|STARTED|P2: Period 3 (4 Days)||0||
59515816|NCT03095638|75609521|FG001|STARTED|P2: Period 3 (4 Days)||0||
59515817|NCT03095638|75609522|FG002|STARTED|P2: Period 3 (4 Days)||4||
59515818|NCT03095638|75609523|FG003|STARTED|P2: Period 3 (4 Days)||4||
59515819|NCT03095638|75609524|FG004|STARTED|P2: Period 3 (4 Days)||4||
59515820|NCT03095638|75609525|FG005|STARTED|P2: Period 3 (4 Days)||4||
59515821|NCT03095638|75609526|FG006|STARTED|P2: Period 3 (4 Days)||4||
59925720|NCT01318122|76043928|FG000|STARTED|Enrolled - Long-Term Extension Study|5 randomized participants from alogliptin 12.5 & 25 mg group CCT-004 study did not enter this study|106||
59925721|NCT01318122|76043929|FG001|STARTED|Enrolled - Long-Term Extension Study|5 randomized participants from alogliptin 12.5 & 25 mg group CCT-004 study did not enter this study|110||
59925722|NCT01318122|76043930|FG002|STARTED|Enrolled - Long-Term Extension Study||57||
59925723|NCT01318122|76043931|FG003|STARTED|Enrolled - Long-Term Extension Study||53||
59925724|NCT01318122|76043928|FG000|COMPLETED|Enrolled - Long-Term Extension Study||105||
59925725|NCT01318122|76043929|FG001|COMPLETED|Enrolled - Long-Term Extension Study||110||
59515822|NCT03095638|75609527|FG007|STARTED|P2: Period 3 (4 Days)||4||
59515823|NCT03095638|75609520|FG000|COMPLETED|P2: Period 3 (4 Days)||0||
59515824|NCT03095638|75609521|FG001|COMPLETED|P2: Period 3 (4 Days)||0||
59925726|NCT01318122|76043930|FG002|COMPLETED|Enrolled - Long-Term Extension Study||55||
59925727|NCT01318122|76043931|FG003|COMPLETED|Enrolled - Long-Term Extension Study||52||
59515825|NCT03095638|75609522|FG002|COMPLETED|P2: Period 3 (4 Days)||4||
59515826|NCT03095638|75609523|FG003|COMPLETED|P2: Period 3 (4 Days)||4||
59515827|NCT03095638|75609524|FG004|COMPLETED|P2: Period 3 (4 Days)||4||
59515828|NCT03095638|75609525|FG005|COMPLETED|P2: Period 3 (4 Days)||4||
59515829|NCT03095638|75609526|FG006|COMPLETED|P2: Period 3 (4 Days)||4||
59515830|NCT03095638|75609527|FG007|COMPLETED|P2: Period 3 (4 Days)||4||
59515831|NCT03095638|75609520|FG000|NOT COMPLETED|P2: Period 3 (4 Days)||0||
59515832|NCT03095638|75609521|FG001|NOT COMPLETED|P2: Period 3 (4 Days)||0||
59515833|NCT03095638|75609522|FG002|NOT COMPLETED|P2: Period 3 (4 Days)||0||
59515834|NCT03095638|75609523|FG003|NOT COMPLETED|P2: Period 3 (4 Days)||0||
59515835|NCT03095638|75609524|FG004|NOT COMPLETED|P2: Period 3 (4 Days)||0||
59515836|NCT03095638|75609525|FG005|NOT COMPLETED|P2: Period 3 (4 Days)||0||
59515837|NCT03095638|75609526|FG006|NOT COMPLETED|P2: Period 3 (4 Days)||0||
59925728|NCT01318122|76043928|FG000|NOT COMPLETED|Enrolled - Long-Term Extension Study||1||
59925729|NCT01318122|76043929|FG001|NOT COMPLETED|Enrolled - Long-Term Extension Study||0||
59925730|NCT01318122|76043930|FG002|NOT COMPLETED|Enrolled - Long-Term Extension Study||2||
59925731|NCT01318122|76043931|FG003|NOT COMPLETED|Enrolled - Long-Term Extension Study||1||
59925732|NCT01318122|76043928|FG000|STARTED|Entered - Long-Term Extension Study||105||
59925733|NCT01318122|76043929|FG001|STARTED|Entered - Long-Term Extension Study||110||
59925734|NCT01318122|76043930|FG002|STARTED|Entered - Long-Term Extension Study||55||
59925735|NCT01318122|76043931|FG003|STARTED|Entered - Long-Term Extension Study||52||
59925736|NCT01318122|76043928|FG000|COMPLETED|Entered - Long-Term Extension Study||96||
59925737|NCT01318122|76043929|FG001|COMPLETED|Entered - Long-Term Extension Study||99||
59925738|NCT01318122|76043930|FG002|COMPLETED|Entered - Long-Term Extension Study||49||
59925739|NCT01318122|76043931|FG003|COMPLETED|Entered - Long-Term Extension Study||48||
59925740|NCT01318122|76043928|FG000|NOT COMPLETED|Entered - Long-Term Extension Study||9||
59925741|NCT01318122|76043929|FG001|NOT COMPLETED|Entered - Long-Term Extension Study||11||
59925742|NCT01318122|76043930|FG002|NOT COMPLETED|Entered - Long-Term Extension Study||6||
59925743|NCT01318122|76043931|FG003|NOT COMPLETED|Entered - Long-Term Extension Study||4||
59925744|NCT02954159|76043939|FG000|STARTED|Overall Study||2||
59925745|NCT02954159|76043940|FG001|STARTED|Overall Study||2||
59925746|NCT02954159|76043939|FG000|COMPLETED|Overall Study||1||
59925747|NCT02954159|76043940|FG001|COMPLETED|Overall Study||1||
59925748|NCT02954159|76043939|FG000|NOT COMPLETED|Overall Study||1||
59515838|NCT03095638|75609527|FG007|NOT COMPLETED|P2: Period 3 (4 Days)||0||
59515839|NCT03095638|75609520|FG000|STARTED|P2: Period 3, Washout (7[-4 Hours])||0||
59515840|NCT03095638|75609521|FG001|STARTED|P2: Period 3, Washout (7[-4 Hours])||0||
59925749|NCT02954159|76043940|FG001|NOT COMPLETED|Overall Study||1||
59925750|NCT03442829|76043948|FG000|STARTED|Overall Study||27||
59925751|NCT03442829|76043949|FG001|STARTED|Overall Study||27||
59925752|NCT03442829|76043948|FG000|COMPLETED|Overall Study||23||
59925753|NCT03442829|76043949|FG001|COMPLETED|Overall Study||25||
59925754|NCT03442829|76043948|FG000|NOT COMPLETED|Overall Study||4||
59925755|NCT03442829|76043949|FG001|NOT COMPLETED|Overall Study||2||
59925756|NCT03442595|76043957|FG000|STARTED|Overall Study||460||
59925757|NCT03442595|76043958|FG001|STARTED|Overall Study||366||
59925758|NCT03442595|76043957|FG000|COMPLETED|Overall Study||366||
59925759|NCT03442595|76043958|FG001|COMPLETED|Overall Study||366||
59925760|NCT03442595|76043957|FG000|NOT COMPLETED|Overall Study||94||
59925761|NCT03442595|76043958|FG001|NOT COMPLETED|Overall Study||0||
59515841|NCT03095638|75609522|FG002|STARTED|P2: Period 3, Washout (7[-4 Hours])||4||
59515842|NCT03095638|75609523|FG003|STARTED|P2: Period 3, Washout (7[-4 Hours])||4||
59515843|NCT03095638|75609524|FG004|STARTED|P2: Period 3, Washout (7[-4 Hours])||4||
59515844|NCT03095638|75609525|FG005|STARTED|P2: Period 3, Washout (7[-4 Hours])||4||
59515845|NCT03095638|75609526|FG006|STARTED|P2: Period 3, Washout (7[-4 Hours])||4||
59515846|NCT03095638|75609527|FG007|STARTED|P2: Period 3, Washout (7[-4 Hours])||4||
59515847|NCT03095638|75609520|FG000|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0||
59515848|NCT03095638|75609521|FG001|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0||
59515849|NCT03095638|75609522|FG002|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4||
59515850|NCT03095638|75609523|FG003|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4||
59515851|NCT03095638|75609524|FG004|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4||
59760766|NCT04150107|75880470|FG001|COMPLETED|Period 1- Placebo run-in (All Patients)||16||
59760767|NCT04150107|75880469|FG000|NOT COMPLETED|Period 1- Placebo run-in (All Patients)||0||
59760768|NCT04150107|75880470|FG001|NOT COMPLETED|Period 1- Placebo run-in (All Patients)||0||
60057599|NCT02087774|76173054|FG001|STARTED|Overall Study||150||
60057600|NCT02087774|76173053|FG000|COMPLETED|Overall Study||142||
59515852|NCT03095638|75609525|FG005|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4||
59760769|NCT04150107|75880469|FG000|STARTED|Period 2- Either Treatment A or B||14||
59760770|NCT04150107|75880470|FG001|STARTED|Period 2- Either Treatment A or B||16||
59760771|NCT04150107|75880469|FG000|COMPLETED|Period 2- Either Treatment A or B||14||
59760772|NCT04150107|75880470|FG001|COMPLETED|Period 2- Either Treatment A or B||16||
59760773|NCT04150107|75880469|FG000|NOT COMPLETED|Period 2- Either Treatment A or B||0||
59760774|NCT04150107|75880470|FG001|NOT COMPLETED|Period 2- Either Treatment A or B||0||
59760775|NCT04150107|75880469|FG000|STARTED|Period 3 Crossover-Treatment B or A||14||
59515853|NCT03095638|75609526|FG006|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4||
59515854|NCT03095638|75609527|FG007|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4||
59515855|NCT03095638|75609520|FG000|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0||
59760776|NCT04150107|75880470|FG001|STARTED|Period 3 Crossover-Treatment B or A||16||
59760777|NCT04150107|75880469|FG000|COMPLETED|Period 3 Crossover-Treatment B or A||12||
59515856|NCT03095638|75609521|FG001|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0||
59760778|NCT04150107|75880470|FG001|COMPLETED|Period 3 Crossover-Treatment B or A||15||
59760779|NCT04150107|75880469|FG000|NOT COMPLETED|Period 3 Crossover-Treatment B or A||2||
59760780|NCT04150107|75880470|FG001|NOT COMPLETED|Period 3 Crossover-Treatment B or A||1||
59760781|NCT00875979|75880480|FG000|STARTED|Dose Escalation Phase - 3.0 mg/kg||3||
59760782|NCT00875979|75880481|FG001|STARTED|Dose Escalation Phase - 3.0 mg/kg||0||
59760783|NCT00875979|75880480|FG000|COMPLETED|Dose Escalation Phase - 3.0 mg/kg||0||
59760784|NCT00875979|75880481|FG001|COMPLETED|Dose Escalation Phase - 3.0 mg/kg||0||
59760785|NCT00875979|75880480|FG000|NOT COMPLETED|Dose Escalation Phase - 3.0 mg/kg||3||
59760786|NCT00875979|75880481|FG001|NOT COMPLETED|Dose Escalation Phase - 3.0 mg/kg||0||
59760787|NCT00875979|75880480|FG000|STARTED|Dose Escalation Phase - 3.6 mg/kg||0||
59760788|NCT00875979|75880481|FG001|STARTED|Dose Escalation Phase - 3.6 mg/kg||6||
59760789|NCT00875979|75880480|FG000|COMPLETED|Dose Escalation Phase - 3.6 mg/kg||0||
59760790|NCT00875979|75880481|FG001|COMPLETED|Dose Escalation Phase - 3.6 mg/kg||0||
59760791|NCT00875979|75880480|FG000|NOT COMPLETED|Dose Escalation Phase - 3.6 mg/kg||0||
59760792|NCT00875979|75880481|FG001|NOT COMPLETED|Dose Escalation Phase - 3.6 mg/kg||6||
59760793|NCT00875979|75880480|FG000|STARTED|Dose Expansion Phase - 3.6 mg/kg||0||
59760794|NCT00875979|75880481|FG001|STARTED|Dose Expansion Phase - 3.6 mg/kg||58||
59760795|NCT00875979|75880480|FG000|COMPLETED|Dose Expansion Phase - 3.6 mg/kg||0||
59760796|NCT00875979|75880481|FG001|COMPLETED|Dose Expansion Phase - 3.6 mg/kg||11||
59760797|NCT00875979|75880480|FG000|NOT COMPLETED|Dose Expansion Phase - 3.6 mg/kg||0||
59760798|NCT00875979|75880481|FG001|NOT COMPLETED|Dose Expansion Phase - 3.6 mg/kg||47||
59760799|NCT00602420|75880489|FG000|STARTED|Overall Study||257||
59760800|NCT00602420|75880490|FG001|STARTED|Overall Study||253||
59760801|NCT00602420|75880489|FG000|COMPLETED|Overall Study||232||
59760802|NCT00602420|75880490|FG001|COMPLETED|Overall Study||229||
59760803|NCT00602420|75880489|FG000|NOT COMPLETED|Overall Study||25||
59760804|NCT00602420|75880490|FG001|NOT COMPLETED|Overall Study||24||
59760805|NCT03992768|75880496|FG000|STARTED|Overall Study||540||540
59760806|NCT03992768|75880496|FG000|COMPLETED|Overall Study||540||540
59760807|NCT03992768|75880496|FG000|NOT COMPLETED|Overall Study||0||0
59760808|NCT00875667|75880504|FG000|STARTED|Overall Study||170||
59760809|NCT00875667|75880505|FG001|STARTED|Overall Study||84||
59760810|NCT00875667|75880504|FG000|Crossover From IC to Lenalidomide|Overall Study|NA = Participants in the IC arm were able to crossover to lenalidomide|0|Upon disease progression, participants crossed over to lenalidomide|
59760811|NCT00875667|75880505|FG001|Crossover From IC to Lenalidomide|Overall Study|Upon disease progression, participants crossed over to lenalidomide|40|Upon disease progression, participants crossed over to lenalidomide|
59760812|NCT00875667|75880504|FG000|Participants Treated|Overall Study||167||
59760813|NCT00875667|75880505|FG001|Participants Treated|Overall Study||83||
59760814|NCT00875667|75880504|FG000|COMPLETED|Overall Study||0||
59760815|NCT00875667|75880505|FG001|COMPLETED|Overall Study|Participants completed 6 cycles of IC single agent cytarabine, fludarabine, or gemcitabine.|11||
59760816|NCT00875667|75880504|FG000|NOT COMPLETED|Overall Study||170||
59760817|NCT00875667|75880505|FG001|NOT COMPLETED|Overall Study||73||
59760818|NCT00602030|75880515|FG000|STARTED|Lead-in Phase||3||
59760819|NCT00602030|75880516|FG001|STARTED|Lead-in Phase||6||
59760820|NCT00602030|75880517|FG002|STARTED|Lead-in Phase||0||
59760821|NCT00602030|75880518|FG003|STARTED|Lead-in Phase||0||
59760822|NCT00602030|75880519|FG004|STARTED|Lead-in Phase||0||
59760823|NCT00602030|75880515|FG000|COMPLETED|Lead-in Phase||1||
59760824|NCT00602030|75880516|FG001|COMPLETED|Lead-in Phase||1||
59760825|NCT00602030|75880517|FG002|COMPLETED|Lead-in Phase||0||
59760826|NCT00602030|75880518|FG003|COMPLETED|Lead-in Phase||0||
59760827|NCT00602030|75880519|FG004|COMPLETED|Lead-in Phase||0||
59760828|NCT00602030|75880515|FG000|NOT COMPLETED|Lead-in Phase||2||
60057601|NCT02087774|76173054|FG001|COMPLETED|Overall Study||130||
59760829|NCT00602030|75880516|FG001|NOT COMPLETED|Lead-in Phase||5||
59760830|NCT00602030|75880517|FG002|NOT COMPLETED|Lead-in Phase||0||
59760831|NCT00602030|75880518|FG003|NOT COMPLETED|Lead-in Phase||0||
59760832|NCT00602030|75880519|FG004|NOT COMPLETED|Lead-in Phase||0||
59760833|NCT00602030|75880515|FG000|STARTED|Double-blind Phase||0||
59760834|NCT00602030|75880516|FG001|STARTED|Double-blind Phase||0||
59760835|NCT00602030|75880517|FG002|STARTED|Double-blind Phase||65||
59760836|NCT00602030|75880518|FG003|STARTED|Double-blind Phase||67||
59760837|NCT00602030|75880519|FG004|STARTED|Double-blind Phase||0||
59760838|NCT00602030|75880515|FG000|Received Treatment|Double-blind Phase||0||
59760839|NCT00602030|75880516|FG001|Received Treatment|Double-blind Phase||0||
59760840|NCT00602030|75880517|FG002|Received Treatment|Double-blind Phase||63||
59760841|NCT00602030|75880518|FG003|Received Treatment|Double-blind Phase||65||
59760842|NCT00602030|75880519|FG004|Received Treatment|Double-blind Phase||0||
59760843|NCT00602030|75880515|FG000|COMPLETED|Double-blind Phase||0||
59760844|NCT00602030|75880516|FG001|COMPLETED|Double-blind Phase||0||
59760845|NCT00602030|75880517|FG002|COMPLETED|Double-blind Phase||11||
59760846|NCT00602030|75880518|FG003|COMPLETED|Double-blind Phase||8||
59760847|NCT00602030|75880519|FG004|COMPLETED|Double-blind Phase||0||
59760848|NCT00602030|75880515|FG000|NOT COMPLETED|Double-blind Phase||0||
59760849|NCT00602030|75880516|FG001|NOT COMPLETED|Double-blind Phase||0||
59760850|NCT00602030|75880517|FG002|NOT COMPLETED|Double-blind Phase||54||
59760851|NCT00602030|75880518|FG003|NOT COMPLETED|Double-blind Phase||59||
59760852|NCT00602030|75880519|FG004|NOT COMPLETED|Double-blind Phase||0||
59760853|NCT00602030|75880515|FG000|STARTED|Crossover Phase||0||
59760854|NCT00602030|75880516|FG001|STARTED|Crossover Phase||0||
59760855|NCT00602030|75880517|FG002|STARTED|Crossover Phase||0||
59760856|NCT00602030|75880518|FG003|STARTED|Crossover Phase||0||
59760857|NCT00602030|75880519|FG004|STARTED|Crossover Phase||16||
59760858|NCT00602030|75880515|FG000|COMPLETED|Crossover Phase||0||
59760859|NCT00602030|75880516|FG001|COMPLETED|Crossover Phase||0||
59760860|NCT00602030|75880517|FG002|COMPLETED|Crossover Phase||0||
59760861|NCT00602030|75880518|FG003|COMPLETED|Crossover Phase||0||
59760862|NCT00602030|75880519|FG004|COMPLETED|Crossover Phase||0||
59760863|NCT00602030|75880515|FG000|NOT COMPLETED|Crossover Phase||0||
59760864|NCT00602030|75880516|FG001|NOT COMPLETED|Crossover Phase||0||
59760865|NCT00602030|75880517|FG002|NOT COMPLETED|Crossover Phase||0||
59760866|NCT00602030|75880518|FG003|NOT COMPLETED|Crossover Phase||0||
59760867|NCT00602030|75880519|FG004|NOT COMPLETED|Crossover Phase||16||
59760868|NCT00549757|75880533|FG000|STARTED|Active Treatment Phase: Max. 50 Months|"Started indicates randomized patients."|4296||
59760869|NCT00549757|75880534|FG001|STARTED|Active Treatment Phase: Max. 50 Months||4310||
59760870|NCT00549757|75880533|FG000|Full Analysis Set|Active Treatment Phase: Max. 50 Months||4274||
59760871|NCT00549757|75880534|FG001|Full Analysis Set|Active Treatment Phase: Max. 50 Months||4287||
59760872|NCT00549757|75880533|FG000|Safety Set|Active Treatment Phase: Max. 50 Months||4272||
59760873|NCT00549757|75880534|FG001|Safety Set|Active Treatment Phase: Max. 50 Months||4285||
59760874|NCT00549757|75880533|FG000|COMPLETED|Active Treatment Phase: Max. 50 Months||0||
59760875|NCT00549757|75880534|FG001|COMPLETED|Active Treatment Phase: Max. 50 Months||0||
59760876|NCT00549757|75880533|FG000|NOT COMPLETED|Active Treatment Phase: Max. 50 Months||4296||
59760877|NCT00549757|75880534|FG001|NOT COMPLETED|Active Treatment Phase: Max. 50 Months||4310||
59760878|NCT00549757|75880533|FG000|STARTED|Extension Period (in Average 9 Months)|"As explained in pre-assignment detail, follow up was made after drug discontinuation"|3773||
59760879|NCT00549757|75880534|FG001|STARTED|Extension Period (in Average 9 Months)|"As explained in pre-assignment detail, follow up was made after drug discontinuation"|3817||
59760880|NCT00549757|75880533|FG000|COMPLETED|Extension Period (in Average 9 Months)||3148||
59760881|NCT00549757|75880534|FG001|COMPLETED|Extension Period (in Average 9 Months)||3182||
59760882|NCT00549757|75880533|FG000|NOT COMPLETED|Extension Period (in Average 9 Months)||625||
59760883|NCT00549757|75880534|FG001|NOT COMPLETED|Extension Period (in Average 9 Months)||635||
59760884|NCT00549601|75880549|FG000|STARTED|Randomized||43||
59760885|NCT00549601|75880550|FG001|STARTED|Randomized||48||
59760886|NCT00549601|75880551|FG002|STARTED|Randomized||51||
59760887|NCT00549601|75880549|FG000|COMPLETED|Randomized||43||
59760888|NCT00549601|75880550|FG001|COMPLETED|Randomized||47||
59760889|NCT00549601|75880551|FG002|COMPLETED|Randomized||49||
59760890|NCT00549601|75880549|FG000|NOT COMPLETED|Randomized||0||
59760891|NCT00549601|75880550|FG001|NOT COMPLETED|Randomized||1||
59760892|NCT00549601|75880551|FG002|NOT COMPLETED|Randomized||2||
59760893|NCT00549601|75880549|FG000|STARTED|Received Study Drug|Subjects who started this period (safety population) received at least 1 dose of study drug.|43||
59760894|NCT00549601|75880550|FG001|STARTED|Received Study Drug|Subjects who started this period (safety population) received at least 1 dose of study drug.|47||
59760895|NCT00549601|75880551|FG002|STARTED|Received Study Drug|Subjects who started this period (safety population) received at least 1 dose of study drug.|49||
59760896|NCT00549601|75880549|FG000|COMPLETED|Received Study Drug||36||
59760897|NCT00549601|75880550|FG001|COMPLETED|Received Study Drug||36||
59760898|NCT00549601|75880551|FG002|COMPLETED|Received Study Drug||45||
59760899|NCT00549601|75880549|FG000|NOT COMPLETED|Received Study Drug||7||
59760900|NCT00549601|75880550|FG001|NOT COMPLETED|Received Study Drug||11||
59760901|NCT00549601|75880551|FG002|NOT COMPLETED|Received Study Drug||4||
59760902|NCT04115189|75880563|FG000|STARTED|Overall Study||42||
59760903|NCT04115189|75880564|FG001|STARTED|Overall Study||15||
60057602|NCT02087774|76173053|FG000|NOT COMPLETED|Overall Study||8||
60057603|NCT02087774|76173054|FG001|NOT COMPLETED|Overall Study||20||
60057604|NCT02111564|76173062|FG000|STARTED|Overall Study||6007||
60057605|NCT02111564|76173063|FG001|STARTED|Overall Study||6012||
60057606|NCT02111564|76173062|FG000|Treated|Overall Study||5982||
60057607|NCT02111564|76173063|FG001|Treated|Overall Study||5980||
60057608|NCT02111564|76173062|FG000|COMPLETED|Overall Study||5876||
60057609|NCT02111564|76173063|FG001|COMPLETED|Overall Study||5869||
60057610|NCT02111564|76173062|FG000|NOT COMPLETED|Overall Study||131||
60057611|NCT02111564|76173063|FG001|NOT COMPLETED|Overall Study||143||
60057612|NCT02087150|76173072|FG000|STARTED|Overall Study||81||
60057613|NCT02087150|76173073|FG001|STARTED|Overall Study||162||
60057614|NCT02087150|76173074|FG002|STARTED|Overall Study||80||
60057615|NCT02087150|76173072|FG000|Had a Lead-in or Randomized ETBC Proc|Overall Study||80||
60057616|NCT02087150|76173073|FG001|Had a Lead-in or Randomized ETBC Proc|Overall Study||149||
60057617|NCT02087150|76173074|FG002|Had a Lead-in or Randomized ETBC Proc|Overall Study||0||
59925762|NCT03440411|76043967|FG000|STARTED|Overall Study||3||
59925763|NCT03440411|76043968|FG001|STARTED|Overall Study||1||
59925764|NCT03440411|76043969|FG002|STARTED|Overall Study||2||
60057618|NCT02087150|76173072|FG000|Received a Crossover MM ETBC Procedure|Overall Study||0||
60057619|NCT02087150|76173073|FG001|Received a Crossover MM ETBC Procedure|Overall Study||0||
60057620|NCT02087150|76173074|FG002|Received a Crossover MM ETBC Procedure|Overall Study||70||
60057621|NCT02087150|76173072|FG000|COMPLETED|Overall Study||71||
60057622|NCT02087150|76173073|FG001|COMPLETED|Overall Study||128||
60057623|NCT02087150|76173074|FG002|COMPLETED|Overall Study||69||
60057624|NCT02087150|76173072|FG000|NOT COMPLETED|Overall Study||10||
60057625|NCT02087150|76173073|FG001|NOT COMPLETED|Overall Study||34||
60057626|NCT02087150|76173074|FG002|NOT COMPLETED|Overall Study||11||
60057627|NCT02111174|76173085|FG000|STARTED|Treatment and Primary Outcome||18||
60057628|NCT02111174|76173086|FG001|STARTED|Treatment and Primary Outcome||18||
60057629|NCT02111174|76173085|FG000|COMPLETED|Treatment and Primary Outcome||15||
60057630|NCT02111174|76173086|FG001|COMPLETED|Treatment and Primary Outcome||16||
60057631|NCT02111174|76173085|FG000|NOT COMPLETED|Treatment and Primary Outcome||3||
60057632|NCT02111174|76173086|FG001|NOT COMPLETED|Treatment and Primary Outcome||2||
60057633|NCT02111174|76173085|FG000|STARTED|Secondary Outcomes (2 and 3 Month f/u)||15||
59519045|NCT03398278|75612890|FG001|COMPLETED|Period 2||17||
59925765|NCT03440411|76043970|FG003|STARTED|Overall Study||2||
59925766|NCT03440411|76043967|FG000|COMPLETED|Overall Study||0|"Treatment is continous until progression disease (PD), so treatment has not a specific duration and so completed is Not Applicable."|
59925767|NCT03440411|76043968|FG001|COMPLETED|Overall Study||0|"Treatment is continous until progression disease (PD), so treatment has not a specific duration and so completed is Not Applicable."|
59925768|NCT03440411|76043969|FG002|COMPLETED|Overall Study||0|"Treatment is continous until progression disease (PD), so treatment has not a specific duration and so completed is Not Applicable."|
59925769|NCT03440411|76043970|FG003|COMPLETED|Overall Study||0|"Treatment is continous until progression disease (PD), so treatment has not a specific duration and so completed is Not Applicable."|
59925770|NCT03440411|76043967|FG000|NOT COMPLETED|Overall Study||3||
59925771|NCT03440411|76043968|FG001|NOT COMPLETED|Overall Study||1||
59925772|NCT03440411|76043969|FG002|NOT COMPLETED|Overall Study||2||
59925773|NCT03440411|76043970|FG003|NOT COMPLETED|Overall Study||2||
59925774|NCT03438539|76043991|FG000|STARTED|Overall Study||76||
59925775|NCT03438539|76043992|FG001|STARTED|Overall Study||72||
59925776|NCT03438539|76043993|FG002|STARTED|Overall Study||76||
59925777|NCT03438539|76043994|FG003|STARTED|Overall Study||73||
59925778|NCT03438539|76043995|FG004|STARTED|Overall Study||73||
59925779|NCT03438539|76043996|FG005|STARTED|Overall Study||74||
60057634|NCT02111174|76173086|FG001|STARTED|Secondary Outcomes (2 and 3 Month f/u)||16||
60057635|NCT02111174|76173085|FG000|2 Month Follow up Complete|Secondary Outcomes (2 and 3 Month f/u)||8||
60057636|NCT02111174|76173086|FG001|2 Month Follow up Complete|Secondary Outcomes (2 and 3 Month f/u)||11||
60057637|NCT02111174|76173085|FG000|COMPLETED|Secondary Outcomes (2 and 3 Month f/u)||7||
60057638|NCT02111174|76173086|FG001|COMPLETED|Secondary Outcomes (2 and 3 Month f/u)||9||
60057639|NCT02111174|76173085|FG000|NOT COMPLETED|Secondary Outcomes (2 and 3 Month f/u)||8||
60057640|NCT02111174|76173086|FG001|NOT COMPLETED|Secondary Outcomes (2 and 3 Month f/u)||7||
60057641|NCT02111096|76173095|FG000|STARTED|Overall Study||65||
60057642|NCT02111096|76173096|FG001|STARTED|Overall Study||41||
60057643|NCT02111096|76173097|FG002|STARTED|Overall Study||68||
60057644|NCT02111096|76173095|FG000|Received at Least 1 Dose of Study Drug|Overall Study||65||
60057645|NCT02111096|76173096|FG001|Received at Least 1 Dose of Study Drug|Overall Study||41||
60057646|NCT02111096|76173097|FG002|Received at Least 1 Dose of Study Drug|Overall Study||68||
60057647|NCT02111096|76173095|FG000|COMPLETED|Overall Study||1||
60057648|NCT02111096|76173096|FG001|COMPLETED|Overall Study||0||
60057649|NCT02111096|76173097|FG002|COMPLETED|Overall Study||2||
60057650|NCT02111096|76173095|FG000|NOT COMPLETED|Overall Study||64||
60057651|NCT02111096|76173096|FG001|NOT COMPLETED|Overall Study||41||
60057652|NCT02111096|76173097|FG002|NOT COMPLETED|Overall Study||66||
60057653|NCT02110706|76173110|FG000|STARTED|Overall Study||25||
60057654|NCT02110706|76173111|FG001|STARTED|Overall Study||27||
60057655|NCT02110706|76173110|FG000|No. Completing Study Through Week 52|Overall Study||23||
60057656|NCT02110706|76173111|FG001|No. Completing Study Through Week 52|Overall Study||24||
59515857|NCT03095638|75609522|FG002|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0||
59515858|NCT03095638|75609523|FG003|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0||
59515859|NCT03095638|75609524|FG004|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0||
59515860|NCT03095638|75609525|FG005|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0||
59515861|NCT03095638|75609526|FG006|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0||
59613039|NCT01713582|75724112|FG018|STARTED|Overall Study|Number treated|5||
59613040|NCT01713582|75724113|FG019|STARTED|Overall Study|Number treated|5||
59925780|NCT03438539|76043991|FG000|COMPLETED|Overall Study||68||
59925781|NCT03438539|76043992|FG001|COMPLETED|Overall Study||68||
59925782|NCT03438539|76043993|FG002|COMPLETED|Overall Study||66||
59925783|NCT03438539|76043994|FG003|COMPLETED|Overall Study||64||
59925784|NCT03438539|76043995|FG004|COMPLETED|Overall Study||70||
59925785|NCT03438539|76043996|FG005|COMPLETED|Overall Study||66||
59925786|NCT03438539|76043991|FG000|NOT COMPLETED|Overall Study||8||
59925787|NCT03438539|76043992|FG001|NOT COMPLETED|Overall Study||4||
59925788|NCT03438539|76043993|FG002|NOT COMPLETED|Overall Study||10||
59925789|NCT03438539|76043994|FG003|NOT COMPLETED|Overall Study||9||
59925790|NCT03438539|76043995|FG004|NOT COMPLETED|Overall Study||3||
59925791|NCT03438539|76043996|FG005|NOT COMPLETED|Overall Study||8||
59925792|NCT03400787|76044012|FG000|STARTED|Overall Study||66||
59925793|NCT03400787|76044013|FG001|STARTED|Overall Study||71||
60057657|NCT02110706|76173110|FG000|COMPLETED|Overall Study||20|No. of participants who completed two-cycle rituximab/placebo treatment|
60057658|NCT02110706|76173111|FG001|COMPLETED|Overall Study||23|No. of participants who completed two-cycle rituximab/placebo treatment|
59925794|NCT03400787|76044012|FG000|3-Month Follow-up|Overall Study||64|1 participant randomized to sham inadvertently received an implant and was analyzed as treated.|
59515862|NCT03095638|75609527|FG007|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0||
59515863|NCT04450108|75609547|FG000|STARTED|Overall Study||122||
59515864|NCT04450108|75609547|FG000|COMPLETED|Overall Study||120||
59515865|NCT04450108|75609547|FG000|NOT COMPLETED|Overall Study||2||
59515866|NCT03158038|75609553|FG000|STARTED|Overall Study||240||
59515867|NCT03158038|75609554|FG001|STARTED|Overall Study||60||
59515868|NCT03158038|75609553|FG000|COMPLETED|Overall Study||240||
59515869|NCT03158038|75609554|FG001|COMPLETED|Overall Study||60||
59515870|NCT03158038|75609553|FG000|NOT COMPLETED|Overall Study||0||
59515871|NCT03158038|75609554|FG001|NOT COMPLETED|Overall Study||0||
59613041|NCT01713582|75724114|FG020|STARTED|Overall Study|Number treated|15||
59613042|NCT01713582|75724094|FG000|COMPLETED|Overall Study||0||
59613043|NCT01713582|75724095|FG001|COMPLETED|Overall Study||0||
59925795|NCT03400787|76044013|FG001|3-Month Follow-up|Overall Study||63|1 participant randomized to sham inadvertently received an implant and was analyzed as treated.|
59925796|NCT03400787|76044012|FG000|COMPLETED|Overall Study||64||
59925797|NCT03400787|76044013|FG001|COMPLETED|Overall Study||63||
59925798|NCT03400787|76044012|FG000|NOT COMPLETED|Overall Study||2||
59925799|NCT03400787|76044013|FG001|NOT COMPLETED|Overall Study||8||
59925800|NCT03417245|76044021|FG000|STARTED|Overall Study||40||
59925801|NCT03417245|76044022|FG001|STARTED|Overall Study||80||
59925802|NCT03417245|76044021|FG000|Treated|Overall Study||40||
59925803|NCT03417245|76044022|FG001|Treated|Overall Study||79||
59925804|NCT03417245|76044021|FG000|COMPLETED|Overall Study||37||
59925805|NCT03417245|76044022|FG001|COMPLETED|Overall Study||79||
59925806|NCT03417245|76044021|FG000|NOT COMPLETED|Overall Study||3||
59925807|NCT03417245|76044022|FG001|NOT COMPLETED|Overall Study||1||
59925808|NCT03389555|76044030|FG000|STARTED|Overall Study||103||
59925809|NCT03389555|76044031|FG001|STARTED|Overall Study||102||
60057659|NCT02110706|76173110|FG000|NOT COMPLETED|Overall Study||5||
60057660|NCT02110706|76173111|FG001|NOT COMPLETED|Overall Study||4||
60057661|NCT02110238|76173121|FG000|STARTED|12 Week Pivotal Phase|One subject was randomized but not treated. As a result there were 211 safety subjects|212||
60057662|NCT02110238|76173122|FG001|STARTED|12 Week Pivotal Phase||209||
60057663|NCT02110238|76173121|FG000|COMPLETED|12 Week Pivotal Phase||202||
60057664|NCT02110238|76173122|FG001|COMPLETED|12 Week Pivotal Phase||200||
60057665|NCT02110238|76173121|FG000|NOT COMPLETED|12 Week Pivotal Phase||10||
60057666|NCT02110238|76173122|FG001|NOT COMPLETED|12 Week Pivotal Phase||9||
59613044|NCT01713582|75724096|FG002|COMPLETED|Overall Study||0||
59925810|NCT03389555|76044030|FG000|COMPLETED|Overall Study||101||
59515872|NCT03158116|75609560|FG000|STARTED|Overall Study||5||
59515873|NCT03158116|75609560|FG000|COMPLETED|Overall Study||5||
59515874|NCT03158116|75609560|FG000|NOT COMPLETED|Overall Study||0||
60057667|NCT02110238|76173121|FG000|STARTED|14 Week Blinded Extension Phase||202||
60057668|NCT02110238|76173122|FG001|STARTED|14 Week Blinded Extension Phase||200||
60057669|NCT02110238|76173121|FG000|COMPLETED|14 Week Blinded Extension Phase||190||
60057670|NCT02110238|76173122|FG001|COMPLETED|14 Week Blinded Extension Phase||188||
60057671|NCT02110238|76173121|FG000|NOT COMPLETED|14 Week Blinded Extension Phase||12||
60057672|NCT02110238|76173122|FG001|NOT COMPLETED|14 Week Blinded Extension Phase||12||
60057673|NCT02108912|76173130|FG000|STARTED|Overall Study||9||
60057674|NCT02108912|76173131|FG001|STARTED|Overall Study||7||
60057675|NCT02108912|76173130|FG000|COMPLETED|Overall Study||6||
60057676|NCT02108912|76173131|FG001|COMPLETED|Overall Study||6||
60057677|NCT02108912|76173130|FG000|NOT COMPLETED|Overall Study||3||
60057678|NCT02108912|76173131|FG001|NOT COMPLETED|Overall Study||1||
60057679|NCT02108600|76173139|FG000|STARTED|Overall Study||17||
60057680|NCT02108600|76173140|FG001|STARTED|Overall Study||16||
60057681|NCT02108600|76173139|FG000|COMPLETED|Overall Study||14||
60057682|NCT02108600|76173140|FG001|COMPLETED|Overall Study|1 patient lost to follow up after the primary endpoint biopsy|15||
60057683|NCT02108600|76173139|FG000|NOT COMPLETED|Overall Study||3||
60057684|NCT02108600|76173140|FG001|NOT COMPLETED|Overall Study||1||
60057685|NCT02107898|76173148|FG000|STARTED|Overall Study|Randomized|72||
60057686|NCT02107898|76173149|FG001|STARTED|Overall Study|Randomized|144||
60057687|NCT02107898|76173148|FG000|Treated|Overall Study||72||
60057688|NCT02107898|76173149|FG001|Treated|Overall Study||143||
60057689|NCT02107898|76173148|FG000|COMPLETED|Overall Study||66||
60057690|NCT02107898|76173149|FG001|COMPLETED|Overall Study||132||
60057691|NCT02107898|76173148|FG000|NOT COMPLETED|Overall Study||6||
60057692|NCT02107898|76173149|FG001|NOT COMPLETED|Overall Study||12||
60057693|NCT02059148|76173155|FG000|STARTED|Treatment 1||4||
60057694|NCT02059148|76173156|FG001|STARTED|Treatment 1||4||
60057695|NCT02059148|76173157|FG002|STARTED|Treatment 1||4||
60057696|NCT02059148|76173158|FG003|STARTED|Treatment 1||4||
60057697|NCT02059148|76173159|FG004|STARTED|Treatment 1||4||
60057698|NCT02059148|76173160|FG005|STARTED|Treatment 1||4||
60057699|NCT02059148|76173155|FG000|COMPLETED|Treatment 1||4||
60057700|NCT02059148|76173156|FG001|COMPLETED|Treatment 1||4||
60057701|NCT02059148|76173157|FG002|COMPLETED|Treatment 1||4||
60057702|NCT02059148|76173158|FG003|COMPLETED|Treatment 1||4||
60057703|NCT02059148|76173159|FG004|COMPLETED|Treatment 1||4||
59925811|NCT03389555|76044031|FG001|COMPLETED|Overall Study||99||
59925812|NCT03389555|76044030|FG000|NOT COMPLETED|Overall Study||2||
59925813|NCT03389555|76044031|FG001|NOT COMPLETED|Overall Study||3||
59925814|NCT03395639|76044039|FG000|STARTED|Main Treatment Period (0 to 4 Months)||110||
59925815|NCT03395639|76044040|FG001|STARTED|Main Treatment Period (0 to 4 Months)||58||
60057704|NCT02059148|76173160|FG005|COMPLETED|Treatment 1||3||
60057705|NCT02059148|76173155|FG000|NOT COMPLETED|Treatment 1||0||
60057706|NCT02059148|76173156|FG001|NOT COMPLETED|Treatment 1||0||
60057707|NCT02059148|76173157|FG002|NOT COMPLETED|Treatment 1||0||
60057708|NCT02059148|76173158|FG003|NOT COMPLETED|Treatment 1||0||
60057709|NCT02059148|76173159|FG004|NOT COMPLETED|Treatment 1||0||
60057710|NCT02059148|76173160|FG005|NOT COMPLETED|Treatment 1||1||
60057711|NCT02059148|76173155|FG000|STARTED|Treatment 2||4||
60057712|NCT02059148|76173156|FG001|STARTED|Treatment 2||4||
60057713|NCT02059148|76173157|FG002|STARTED|Treatment 2||4||
60057714|NCT02059148|76173158|FG003|STARTED|Treatment 2||4||
60057715|NCT02059148|76173159|FG004|STARTED|Treatment 2||4||
60057716|NCT02059148|76173160|FG005|STARTED|Treatment 2||3||
60057717|NCT02059148|76173155|FG000|COMPLETED|Treatment 2||4||
60057718|NCT02059148|76173156|FG001|COMPLETED|Treatment 2||4||
60057719|NCT02059148|76173157|FG002|COMPLETED|Treatment 2||4||
60057720|NCT02059148|76173158|FG003|COMPLETED|Treatment 2||4||
60057721|NCT02059148|76173159|FG004|COMPLETED|Treatment 2||4||
60057722|NCT02059148|76173160|FG005|COMPLETED|Treatment 2||3||
60057723|NCT02059148|76173155|FG000|NOT COMPLETED|Treatment 2||0||
59925816|NCT03395639|76044041|FG002|STARTED|Main Treatment Period (0 to 4 Months)||0||
59925817|NCT03395639|76044039|FG000|Modified Intent to Treat Population|Main Treatment Period (0 to 4 Months)||109||
59925818|NCT03395639|76044040|FG001|Modified Intent to Treat Population|Main Treatment Period (0 to 4 Months)||58||
60057724|NCT02059148|76173156|FG001|NOT COMPLETED|Treatment 2||0||
59925819|NCT03395639|76044041|FG002|Modified Intent to Treat Population|Main Treatment Period (0 to 4 Months)||0||
59925820|NCT03395639|76044039|FG000|COMPLETED|Main Treatment Period (0 to 4 Months)||107||
60057725|NCT02059148|76173157|FG002|NOT COMPLETED|Treatment 2||0||
60057726|NCT02059148|76173158|FG003|NOT COMPLETED|Treatment 2||0||
60057727|NCT02059148|76173159|FG004|NOT COMPLETED|Treatment 2||0||
60057728|NCT02059148|76173160|FG005|NOT COMPLETED|Treatment 2||0||
60057729|NCT02059148|76173155|FG000|STARTED|Treatment 3||4||
60057730|NCT02059148|76173156|FG001|STARTED|Treatment 3||4||
60057731|NCT02059148|76173157|FG002|STARTED|Treatment 3||4||
60057732|NCT02059148|76173158|FG003|STARTED|Treatment 3||4||
60057733|NCT02059148|76173159|FG004|STARTED|Treatment 3||4||
60057734|NCT02059148|76173160|FG005|STARTED|Treatment 3||3||
60057735|NCT02059148|76173155|FG000|COMPLETED|Treatment 3||4||
60057736|NCT02059148|76173156|FG001|COMPLETED|Treatment 3||4||
60057737|NCT02059148|76173157|FG002|COMPLETED|Treatment 3||4||
60057738|NCT02059148|76173158|FG003|COMPLETED|Treatment 3||4||
60057739|NCT02059148|76173159|FG004|COMPLETED|Treatment 3||4||
60057740|NCT02059148|76173160|FG005|COMPLETED|Treatment 3||3||
60057741|NCT02059148|76173155|FG000|NOT COMPLETED|Treatment 3||0||
60057742|NCT02059148|76173156|FG001|NOT COMPLETED|Treatment 3||0||
60057743|NCT02059148|76173157|FG002|NOT COMPLETED|Treatment 3||0||
60057744|NCT02059148|76173158|FG003|NOT COMPLETED|Treatment 3||0||
60057745|NCT02059148|76173159|FG004|NOT COMPLETED|Treatment 3||0||
60057746|NCT02059148|76173160|FG005|NOT COMPLETED|Treatment 3||0||
60057747|NCT02058992|76173171|FG000|STARTED|Overall Study||3339||
60057748|NCT02058992|76173171|FG000|COMPLETED|Overall Study||3223||
60057749|NCT02058992|76173171|FG000|NOT COMPLETED|Overall Study||116||
60057750|NCT02058836|76173177|FG000|STARTED|Overall Study||4||
60057751|NCT02058836|76173178|FG001|STARTED|Overall Study||4||
60057752|NCT02058836|76173177|FG000|COMPLETED|Overall Study||3||
60057753|NCT02058836|76173178|FG001|COMPLETED|Overall Study||3||
60057754|NCT02058836|76173177|FG000|NOT COMPLETED|Overall Study||1||
60057755|NCT02058836|76173178|FG001|NOT COMPLETED|Overall Study||1||
60057756|NCT02107274|76173186|FG000|STARTED|Treatment vs. Placebo||39||
60057757|NCT02107274|76173187|FG001|STARTED|Treatment vs. Placebo||39||
60057758|NCT02107274|76173186|FG000|COMPLETED|Treatment vs. Placebo||36||
60057759|NCT02107274|76173187|FG001|COMPLETED|Treatment vs. Placebo||37||
60057760|NCT02107274|76173186|FG000|NOT COMPLETED|Treatment vs. Placebo||3||
60057761|NCT02107274|76173187|FG001|NOT COMPLETED|Treatment vs. Placebo||2||
59925821|NCT03395639|76044040|FG001|COMPLETED|Main Treatment Period (0 to 4 Months)||55||
59925822|NCT03395639|76044041|FG002|COMPLETED|Main Treatment Period (0 to 4 Months)||0||
59925823|NCT03395639|76044039|FG000|NOT COMPLETED|Main Treatment Period (0 to 4 Months)||3||
59925824|NCT03395639|76044040|FG001|NOT COMPLETED|Main Treatment Period (0 to 4 Months)||3||
59925825|NCT03395639|76044041|FG002|NOT COMPLETED|Main Treatment Period (0 to 4 Months)||0||
59925826|NCT03395639|76044039|FG000|STARTED|Extension Period (4-13 Months)||0||
59925827|NCT03395639|76044040|FG001|STARTED|Extension Period (4-13 Months)||0||
59925828|NCT03395639|76044041|FG002|STARTED|Extension Period (4-13 Months)|15 participants who completed the Main Treatment Period did not participate in the Extension Period|147||
59925829|NCT03395639|76044039|FG000|COMPLETED|Extension Period (4-13 Months)||0||
59925830|NCT03395639|76044040|FG001|COMPLETED|Extension Period (4-13 Months)||0||
59925831|NCT03395639|76044041|FG002|COMPLETED|Extension Period (4-13 Months)||144||
59925832|NCT03395639|76044039|FG000|NOT COMPLETED|Extension Period (4-13 Months)||0||
59925833|NCT03395639|76044040|FG001|NOT COMPLETED|Extension Period (4-13 Months)||0||
59925834|NCT03395639|76044041|FG002|NOT COMPLETED|Extension Period (4-13 Months)||3||
59925835|NCT03353922|76044048|FG000|STARTED|Overall Study||6||
59925836|NCT03353922|76044049|FG001|STARTED|Overall Study||6||
59925837|NCT03353922|76044050|FG002|STARTED|Overall Study||6||
59925838|NCT03353922|76044051|FG003|STARTED|Overall Study||6||
59925839|NCT03353922|76044052|FG004|STARTED|Overall Study||5||
59925840|NCT03353922|76044053|FG005|STARTED|Overall Study||6||
59925841|NCT03353922|76044048|FG000|COMPLETED|Overall Study||5|35 subjects signed consent; 4 discont.-3 withdrew consent before tx, 1 for AE in tolperisone tx arm|
59925842|NCT03353922|76044049|FG001|COMPLETED|Overall Study||5|35 subjects signed consent; 4 discont.-3 withdrew consent before tx, 1 for AE in tolperisone tx arm|
59925843|NCT03353922|76044050|FG002|COMPLETED|Overall Study||5|35 subjects signed consent; 4 discont.-3 withdrew consent before tx, 1 for AE in tolperisone tx arm|
59925844|NCT03353922|76044051|FG003|COMPLETED|Overall Study||5|35 subjects signed consent; 4 discont.-3 withdrew consent before tx, 1 for AE in tolperisone tx arm|
59925845|NCT03353922|76044052|FG004|COMPLETED|Overall Study||5|35 subjects signed consent; 4 discont.-3 withdrew consent before tx, 1 for AE in tolperisone tx arm|
59925846|NCT03353922|76044053|FG005|COMPLETED|Overall Study||6|35 subjects signed consent; 4 discont.-3 withdrew consent before tx, 1 for AE in tolperisone tx arm|
59925847|NCT03353922|76044048|FG000|NOT COMPLETED|Overall Study||1||
59925848|NCT03353922|76044049|FG001|NOT COMPLETED|Overall Study||1||
59925849|NCT03353922|76044050|FG002|NOT COMPLETED|Overall Study||1||
59925850|NCT03353922|76044051|FG003|NOT COMPLETED|Overall Study||1||
59925851|NCT03353922|76044052|FG004|NOT COMPLETED|Overall Study||0||
60057762|NCT02107274|76173186|FG000|STARTED|Control Phase||36||
59925852|NCT03353922|76044053|FG005|NOT COMPLETED|Overall Study||0||
59925853|NCT03387683|76044066|FG000|STARTED|Overall Study||27||
59925854|NCT03387683|76044067|FG001|STARTED|Overall Study||26||
59925855|NCT03387683|76044066|FG000|COMPLETED|Overall Study||25||
59925856|NCT03387683|76044067|FG001|COMPLETED|Overall Study||26||
59925857|NCT03387683|76044066|FG000|NOT COMPLETED|Overall Study||2||
59925858|NCT03387683|76044067|FG001|NOT COMPLETED|Overall Study||0||
59925859|NCT03387059|76044075|FG000|STARTED|Overall Study||5||
59925860|NCT03387059|76044076|FG001|STARTED|Overall Study||4||
60057763|NCT02107274|76173187|FG001|STARTED|Control Phase||37||
60057764|NCT02107274|76173186|FG000|COMPLETED|Control Phase||33||
60057765|NCT02107274|76173187|FG001|COMPLETED|Control Phase||35||
60057766|NCT02107274|76173186|FG000|NOT COMPLETED|Control Phase||3||
60057767|NCT02107274|76173187|FG001|NOT COMPLETED|Control Phase||2||
60057768|NCT02174627|76173195|FG000|STARTED|Overall Study||1384|Randomized and included in the analysis|
60057769|NCT02174627|76173196|FG001|STARTED|Overall Study||1377|Randomized and included in the analysis|
60057770|NCT02174627|76173195|FG000|Received Treatment|Overall Study||1384||
60057771|NCT02174627|76173196|FG001|Received Treatment|Overall Study||1376||
60057772|NCT02174627|76173195|FG000|Discontinued Treatment|Overall Study||499||
60057773|NCT02174627|76173196|FG001|Discontinued Treatment|Overall Study||801||
60057774|NCT02174627|76173195|FG000|COMPLETED|Overall Study||1300|Completed the study|
60057775|NCT02174627|76173196|FG001|COMPLETED|Overall Study||1247|Completed the study|
60057776|NCT02174627|76173195|FG000|NOT COMPLETED|Overall Study||84||
60057777|NCT02174627|76173196|FG001|NOT COMPLETED|Overall Study||130||
60057778|NCT02173769|76173202|FG000|STARTED|Overall Study||1858||
60057779|NCT02173769|76173202|FG000|COMPLETED|Overall Study||1854||
60057780|NCT02173769|76173202|FG000|NOT COMPLETED|Overall Study||4||
60057781|NCT02121509|76173209|FG000|STARTED|Treatment Period-1 (4 Days)||30||
60057782|NCT02121509|76173210|FG001|STARTED|Treatment Period-1 (4 Days)||28||
60057783|NCT02121509|76173211|FG002|STARTED|Treatment Period-1 (4 Days)||8||
60057784|NCT02121509|76173212|FG003|STARTED|Treatment Period-1 (4 Days)||8||
60057785|NCT02121509|76173209|FG000|COMPLETED|Treatment Period-1 (4 Days)||30||
60057786|NCT02121509|76173210|FG001|COMPLETED|Treatment Period-1 (4 Days)||28||
60057787|NCT02121509|76173211|FG002|COMPLETED|Treatment Period-1 (4 Days)||8||
60057788|NCT02121509|76173212|FG003|COMPLETED|Treatment Period-1 (4 Days)||8||
60057789|NCT02121509|76173209|FG000|NOT COMPLETED|Treatment Period-1 (4 Days)||0||
60057790|NCT02121509|76173210|FG001|NOT COMPLETED|Treatment Period-1 (4 Days)||0||
60057791|NCT02121509|76173211|FG002|NOT COMPLETED|Treatment Period-1 (4 Days)||0||
60057792|NCT02121509|76173212|FG003|NOT COMPLETED|Treatment Period-1 (4 Days)||0||
59925861|NCT03387059|76044075|FG000|COMPLETED|Overall Study||0||
60057793|NCT02121509|76173209|FG000|STARTED|Washout Period (35 Days)||30||
60057794|NCT02121509|76173210|FG001|STARTED|Washout Period (35 Days)||28||
59925862|NCT03387059|76044076|FG001|COMPLETED|Overall Study||0||
59925863|NCT03387059|76044075|FG000|NOT COMPLETED|Overall Study||5||
59925864|NCT03387059|76044076|FG001|NOT COMPLETED|Overall Study||4||
59925865|NCT02942004|76044085|FG000|STARTED|Overall Study||46||
59925866|NCT02942004|76044086|FG001|STARTED|Overall Study||47||
59925867|NCT02942004|76044087|FG002|STARTED|Overall Study||45||
59925868|NCT02942004|76044085|FG000|Participants Who Received Study Drug|Overall Study||43||
59925869|NCT02942004|76044086|FG001|Participants Who Received Study Drug|Overall Study||38||
59925870|NCT02942004|76044087|FG002|Participants Who Received Study Drug|Overall Study||41||
59925871|NCT02942004|76044085|FG000|COMPLETED|Overall Study||42||
59925872|NCT02942004|76044086|FG001|COMPLETED|Overall Study||35||
60057795|NCT02121509|76173211|FG002|STARTED|Washout Period (35 Days)||8||
60057796|NCT02121509|76173212|FG003|STARTED|Washout Period (35 Days)||8||
60057797|NCT02121509|76173209|FG000|COMPLETED|Washout Period (35 Days)||28||
60057798|NCT02121509|76173210|FG001|COMPLETED|Washout Period (35 Days)||24||
60057799|NCT02121509|76173211|FG002|COMPLETED|Washout Period (35 Days)||8||
60057800|NCT02121509|76173212|FG003|COMPLETED|Washout Period (35 Days)||8||
60057801|NCT02121509|76173209|FG000|NOT COMPLETED|Washout Period (35 Days)||2||
60057802|NCT02121509|76173210|FG001|NOT COMPLETED|Washout Period (35 Days)||4||
60057803|NCT02121509|76173211|FG002|NOT COMPLETED|Washout Period (35 Days)||0||
59925873|NCT02942004|76044087|FG002|COMPLETED|Overall Study||36||
59925874|NCT02942004|76044085|FG000|NOT COMPLETED|Overall Study||4||
59925875|NCT02942004|76044086|FG001|NOT COMPLETED|Overall Study||12||
59925876|NCT02942004|76044087|FG002|NOT COMPLETED|Overall Study||9||
59925877|NCT03394391|76044097|FG000|STARTED|Overall Study||106||
59925878|NCT03394391|76044098|FG001|STARTED|Overall Study||106||
59925879|NCT03394391|76044097|FG000|COMPLETED|Overall Study||105||
59925880|NCT03394391|76044098|FG001|COMPLETED|Overall Study||104||
59925881|NCT03394391|76044097|FG000|NOT COMPLETED|Overall Study||1||
59925882|NCT03394391|76044098|FG001|NOT COMPLETED|Overall Study||2||
59925883|NCT03386435|76044106|FG000|STARTED|Overall Study||80||
59925884|NCT03386435|76044107|FG001|STARTED|Overall Study||80||
59925885|NCT03386435|76044106|FG000|COMPLETED|Overall Study||75||
59925886|NCT03386435|76044107|FG001|COMPLETED|Overall Study||73||
59925887|NCT03386435|76044106|FG000|NOT COMPLETED|Overall Study||5||
59925888|NCT03386435|76044107|FG001|NOT COMPLETED|Overall Study||7||
59925889|NCT02726880|76044115|FG000|STARTED|Overall Study||17||
59925890|NCT02726880|76044116|FG001|STARTED|Overall Study||19||
59925891|NCT02726880|76044115|FG000|COMPLETED|Overall Study||14||
59925892|NCT02726880|76044116|FG001|COMPLETED|Overall Study||16||
59925893|NCT02726880|76044115|FG000|NOT COMPLETED|Overall Study||3||
59925894|NCT02726880|76044116|FG001|NOT COMPLETED|Overall Study||3||
59925895|NCT03275389|76044133|FG000|STARTED|Overall Study||45||
60057804|NCT02121509|76173212|FG003|NOT COMPLETED|Washout Period (35 Days)||0||
60057805|NCT02121509|76173209|FG000|STARTED|Treatment Period-2 (4 Days)||28||
60057806|NCT02121509|76173210|FG001|STARTED|Treatment Period-2 (4 Days)||24||
60057807|NCT02121509|76173211|FG002|STARTED|Treatment Period-2 (4 Days)||8||
60057808|NCT02121509|76173212|FG003|STARTED|Treatment Period-2 (4 Days)||8||
59925896|NCT03275389|76044134|FG001|STARTED|Overall Study||46||
59925897|NCT03275389|76044135|FG002|STARTED|Overall Study||47||
59925898|NCT03275389|76044136|FG003|STARTED|Overall Study||47||
59925899|NCT03275389|76044137|FG004|STARTED|Overall Study||48||
60057809|NCT02121509|76173209|FG000|COMPLETED|Treatment Period-2 (4 Days)||28||
60057810|NCT02121509|76173210|FG001|COMPLETED|Treatment Period-2 (4 Days)||24||
59925900|NCT03275389|76044138|FG005|STARTED|Overall Study||47||
59925901|NCT03275389|76044139|FG006|STARTED|Overall Study||47||
59925902|NCT03275389|76044140|FG007|STARTED|Overall Study||48||
59925903|NCT03275389|76044141|FG008|STARTED|Overall Study||46||
59925904|NCT03275389|76044142|FG009|STARTED|Overall Study||47||
60057811|NCT02121509|76173211|FG002|COMPLETED|Treatment Period-2 (4 Days)||8||
60057812|NCT02121509|76173212|FG003|COMPLETED|Treatment Period-2 (4 Days)||8||
60057813|NCT02121509|76173209|FG000|NOT COMPLETED|Treatment Period-2 (4 Days)||0||
60057814|NCT02121509|76173210|FG001|NOT COMPLETED|Treatment Period-2 (4 Days)||0||
60057815|NCT02121509|76173211|FG002|NOT COMPLETED|Treatment Period-2 (4 Days)||0||
60057816|NCT02121509|76173212|FG003|NOT COMPLETED|Treatment Period-2 (4 Days)||0||
60057817|NCT02149199|76173225|FG000|STARTED|Overall Study||1277||
60057818|NCT02149199|76173226|FG001|STARTED|Overall Study||1277||
60057819|NCT02149199|76173227|FG002|STARTED|Overall Study||1282||
60057820|NCT02149199|76173225|FG000|COMPLETED|Overall Study||1144||
60057821|NCT02149199|76173226|FG001|COMPLETED|Overall Study||1084||
60057822|NCT02149199|76173227|FG002|COMPLETED|Overall Study||1135||
60057823|NCT02149199|76173225|FG000|NOT COMPLETED|Overall Study||133||
60057824|NCT02149199|76173226|FG001|NOT COMPLETED|Overall Study||193||
60057825|NCT02149199|76173227|FG002|NOT COMPLETED|Overall Study||147||
60057826|NCT02120417|76173237|FG000|STARTED|Overall Study||76|Overall Number of Participants Analyzed|
60057827|NCT02120417|76173238|FG001|STARTED|Overall Study||73|Overall Number of Participants Analyzed|
60057828|NCT02120417|76173237|FG000|COMPLETED|Overall Study||16|Number of participants remaining on treatment at the 08 FEB 2016 data cutoff.|
60057829|NCT02120417|76173238|FG001|COMPLETED|Overall Study||5|Number of participants remaining on treatment at the 08 FEB 2016 data cutoff.|
60057830|NCT02120417|76173237|FG000|NOT COMPLETED|Overall Study||60||
60057831|NCT02120417|76173238|FG001|NOT COMPLETED|Overall Study||68||
60057832|NCT02148263|76173246|FG000|STARTED|Overall Study||12||
60057833|NCT02148263|76173247|FG001|STARTED|Overall Study||13||
60057834|NCT02148263|76173246|FG000|COMPLETED|Overall Study||9||
60057835|NCT02148263|76173247|FG001|COMPLETED|Overall Study||11||
60057836|NCT02148263|76173246|FG000|NOT COMPLETED|Overall Study||3||
60057837|NCT02148263|76173247|FG001|NOT COMPLETED|Overall Study||2||
60057838|NCT02147561|76173253|FG000|STARTED|Overall Study||280||
60057839|NCT02147561|76173253|FG000|COMPLETED|Overall Study||276||
60057840|NCT02147561|76173253|FG000|NOT COMPLETED|Overall Study||4||
60057841|NCT02058368|76173259|FG000|STARTED|Overall Study||302||
60057842|NCT02058368|76173260|FG001|STARTED|Overall Study||305||
60057843|NCT02058368|76173259|FG000|COMPLETED|Overall Study||261||
60057844|NCT02058368|76173260|FG001|COMPLETED|Overall Study||251||
60057845|NCT02058368|76173259|FG000|NOT COMPLETED|Overall Study||41||
60057846|NCT02058368|76173260|FG001|NOT COMPLETED|Overall Study||54||
60057847|NCT02107196|76173268|FG000|STARTED|12-week Treatment Period|Safety population, all enrolled patients who received at least one dose of study drug|271||
60057848|NCT02107196|76173269|FG001|STARTED|12-week Treatment Period|Safety population, all enrolled patients who received at least one dose of study drug|264||
60057849|NCT02107196|76173268|FG000|Intention To Treat (ITT)|12-week Treatment Period|All randomised patients who took at least one dose of study drug during 12-week treatment period|271||
60057850|NCT02107196|76173269|FG001|Intention To Treat (ITT)|12-week Treatment Period|All randomised patients who took at least one dose of study drug during 12-week treatment period|264||
59925905|NCT03275389|76044133|FG000|COMPLETED|Overall Study||34||
59925906|NCT03275389|76044134|FG001|COMPLETED|Overall Study||30||
59925907|NCT03275389|76044135|FG002|COMPLETED|Overall Study||24||
59925908|NCT03275389|76044136|FG003|COMPLETED|Overall Study||25||
59925909|NCT03275389|76044137|FG004|COMPLETED|Overall Study||32||
59925910|NCT03275389|76044138|FG005|COMPLETED|Overall Study||29||
59925911|NCT03275389|76044139|FG006|COMPLETED|Overall Study||22||
59925912|NCT03275389|76044140|FG007|COMPLETED|Overall Study||30||
59925913|NCT03275389|76044141|FG008|COMPLETED|Overall Study||31||
59925914|NCT03275389|76044142|FG009|COMPLETED|Overall Study||29||
59925915|NCT03275389|76044133|FG000|NOT COMPLETED|Overall Study||11||
59925916|NCT03275389|76044134|FG001|NOT COMPLETED|Overall Study||16||
59925917|NCT03275389|76044135|FG002|NOT COMPLETED|Overall Study||23||
59925918|NCT03275389|76044136|FG003|NOT COMPLETED|Overall Study||22||
59925919|NCT03275389|76044137|FG004|NOT COMPLETED|Overall Study||16||
59925920|NCT03275389|76044138|FG005|NOT COMPLETED|Overall Study||18||
59925921|NCT03275389|76044139|FG006|NOT COMPLETED|Overall Study||25||
59925922|NCT03275389|76044140|FG007|NOT COMPLETED|Overall Study||18||
59925923|NCT03275389|76044141|FG008|NOT COMPLETED|Overall Study||15||
60057851|NCT02107196|76173268|FG000|Modified ITT|12-week Treatment Period|All ITT patients, excluding patients of two sites (serious breach of GCP, disqualified Investigator)|221||
59925924|NCT03275389|76044142|FG009|NOT COMPLETED|Overall Study||18||
59925925|NCT03414359|76044166|FG000|STARTED|Overall Study||35||
59925926|NCT03414359|76044167|FG001|STARTED|Overall Study||35||
59925927|NCT03414359|76044166|FG000|COMPLETED|Overall Study||34||
59925928|NCT03414359|76044167|FG001|COMPLETED|Overall Study||33||
60057852|NCT02107196|76173269|FG001|Modified ITT|12-week Treatment Period|All ITT patients, excluding patients of two sites (serious breach of GCP, disqualified Investigator)|216||
60057853|NCT02107196|76173268|FG000|COMPLETED|12-week Treatment Period||227||
60057854|NCT02107196|76173269|FG001|COMPLETED|12-week Treatment Period||225||
60057855|NCT02107196|76173268|FG000|NOT COMPLETED|12-week Treatment Period||44||
60057856|NCT02107196|76173269|FG001|NOT COMPLETED|12-week Treatment Period||39||
60057857|NCT02107196|76173268|FG000|STARTED|4-week Randomized Withdrawal (RW) Period|all re-randomized patients at Visit 6 [Day85]|338||
60057858|NCT02107196|76173269|FG001|STARTED|4-week Randomized Withdrawal (RW) Period|all re-randomized patients at Visit 6 [Day85]|114||
60057859|NCT02107196|76173268|FG000|RW Population|4-week Randomized Withdrawal (RW) Period|All re-randomized ITT patients,who received at least 1 dose of ibodutant during RW period|338||
60057860|NCT02107196|76173269|FG001|RW Population|4-week Randomized Withdrawal (RW) Period|All re-randomized ITT patients,who received at least 1 dose of placebo during RW period|114||
60057861|NCT02107196|76173268|FG000|Modified RW Population|4-week Randomized Withdrawal (RW) Period|all RW patients, excluding patients of two sites (serious breach of GCP, disqualified Investigator)|272||
60057862|NCT02107196|76173269|FG001|Modified RW Population|4-week Randomized Withdrawal (RW) Period|all RW patients, excluding patients of two sites (serious breach of GCP, disqualified Investigator)|90||
60057863|NCT02107196|76173268|FG000|COMPLETED|4-week Randomized Withdrawal (RW) Period||315||
60057864|NCT02107196|76173269|FG001|COMPLETED|4-week Randomized Withdrawal (RW) Period||109||
60057865|NCT02107196|76173268|FG000|NOT COMPLETED|4-week Randomized Withdrawal (RW) Period||23||
60057866|NCT02107196|76173269|FG001|NOT COMPLETED|4-week Randomized Withdrawal (RW) Period||5||
60057867|NCT02058290|76173277|FG000|STARTED|Overall Study||77||
60057868|NCT02058290|76173278|FG001|STARTED|Overall Study||45||
60057869|NCT02058290|76173277|FG000|COMPLETED|Overall Study||66||
60057870|NCT02058290|76173278|FG001|COMPLETED|Overall Study||36||
60057871|NCT02058290|76173277|FG000|NOT COMPLETED|Overall Study||11||
60057872|NCT02058290|76173278|FG001|NOT COMPLETED|Overall Study||9||
60057873|NCT02082158|76173290|FG000|STARTED|Overall Study||66||
60057874|NCT02082158|76173291|FG001|STARTED|Overall Study||61||
60057875|NCT02082158|76173292|FG002|STARTED|Overall Study||52||
60057876|NCT02082158|76173293|FG003|STARTED|Overall Study||72||
60057877|NCT02082158|76173294|FG004|STARTED|Overall Study||68||
60057878|NCT02082158|76173295|FG005|STARTED|Overall Study||63||
60057879|NCT02082158|76173290|FG000|COMPLETED|Overall Study||58||
60057880|NCT02082158|76173291|FG001|COMPLETED|Overall Study||53||
60057881|NCT02082158|76173292|FG002|COMPLETED|Overall Study||38||
60057882|NCT02082158|76173293|FG003|COMPLETED|Overall Study|Includes completion with respirator from secondary randomization after fit-test failure of 1st model|68||
60057883|NCT02082158|76173294|FG004|COMPLETED|Overall Study||64||
60057884|NCT02082158|76173295|FG005|COMPLETED|Overall Study||56||
60057885|NCT02082158|76173290|FG000|NOT COMPLETED|Overall Study||8||
60057886|NCT02082158|76173291|FG001|NOT COMPLETED|Overall Study||8||
60057887|NCT02082158|76173292|FG002|NOT COMPLETED|Overall Study||14||
60057888|NCT02082158|76173293|FG003|NOT COMPLETED|Overall Study||4||
60057889|NCT02082158|76173294|FG004|NOT COMPLETED|Overall Study||4||
60057890|NCT02082158|76173295|FG005|NOT COMPLETED|Overall Study||7||
60057891|NCT02106884|76173317|FG000|STARTED|Overall Study||72||
60057892|NCT02106884|76173318|FG001|STARTED|Overall Study||74||
60057893|NCT02106884|76173317|FG000|COMPLETED|Overall Study||72||
60057894|NCT02106884|76173318|FG001|COMPLETED|Overall Study|ITT analysis based on treatment assigned at baseline.|73||
60057895|NCT02106884|76173317|FG000|NOT COMPLETED|Overall Study||0||
60057896|NCT02106884|76173318|FG001|NOT COMPLETED|Overall Study||1||
60057897|NCT02081846|76173329|FG000|STARTED|Overall Study||751||
60057898|NCT02081846|76173330|FG001|STARTED|Overall Study||749||
60057899|NCT02081846|76173329|FG000|COMPLETED|Overall Study||749||
60057900|NCT02081846|76173330|FG001|COMPLETED|Overall Study||749||
60057901|NCT02081846|76173329|FG000|NOT COMPLETED|Overall Study||2||
60057902|NCT02081846|76173330|FG001|NOT COMPLETED|Overall Study||0||
60057903|NCT02081690|76173336|FG000|STARTED|Overall Study||88||
60057904|NCT02081690|76173336|FG000|COMPLETED|Overall Study||81||
60057905|NCT02081690|76173336|FG000|NOT COMPLETED|Overall Study||7||
60057906|NCT02057666|76173342|FG000|STARTED|Double Blind Treatment Period||96||
60057907|NCT02057666|76173343|FG001|STARTED|Double Blind Treatment Period||50||
60057908|NCT02057666|76173342|FG000|COMPLETED|Double Blind Treatment Period|Number of patients who continued into the open-label treatment period.|0||
60057909|NCT02057666|76173343|FG001|COMPLETED|Double Blind Treatment Period|Number of patients who continued into the open-label treatment period.|6||
60057910|NCT02057666|76173342|FG000|NOT COMPLETED|Double Blind Treatment Period||96||
60057911|NCT02057666|76173343|FG001|NOT COMPLETED|Double Blind Treatment Period||44||
60057912|NCT02057666|76173342|FG000|STARTED|Open-Label Treatment Period||0||
60057913|NCT02057666|76173343|FG001|STARTED|Open-Label Treatment Period||6||
60057914|NCT02057666|76173342|FG000|COMPLETED|Open-Label Treatment Period||0||
60057915|NCT02057666|76173343|FG001|COMPLETED|Open-Label Treatment Period||0||
60057916|NCT02057666|76173342|FG000|NOT COMPLETED|Open-Label Treatment Period||0||
60057917|NCT02057666|76173343|FG001|NOT COMPLETED|Open-Label Treatment Period||6||
60057918|NCT01625000|76173354|FG000|STARTED|Overall Study||126||
60057919|NCT01625000|76173355|FG001|STARTED|Overall Study||133||
60057920|NCT01625000|76173356|FG002|STARTED|Overall Study||67||
60057921|NCT01625000|76173357|FG003|STARTED|Overall Study||56||
60057922|NCT01625000|76173358|FG004|STARTED|Overall Study||126||
60057923|NCT01625000|76173354|FG000|COMPLETED|Overall Study||74||
60057924|NCT01625000|76173355|FG001|COMPLETED|Overall Study||81||
60057925|NCT01625000|76173356|FG002|COMPLETED|Overall Study||34||
60057926|NCT01625000|76173357|FG003|COMPLETED|Overall Study||37||
60057927|NCT01625000|76173358|FG004|COMPLETED|Overall Study||71||
60057928|NCT01625000|76173354|FG000|NOT COMPLETED|Overall Study||52||
60057929|NCT01625000|76173355|FG001|NOT COMPLETED|Overall Study||52||
60057930|NCT01625000|76173356|FG002|NOT COMPLETED|Overall Study||33||
60057931|NCT01625000|76173357|FG003|NOT COMPLETED|Overall Study||19||
60057932|NCT01625000|76173358|FG004|NOT COMPLETED|Overall Study||55||
60057933|NCT02081534|76173377|FG000|STARTED|Overall Study||23||
60057934|NCT02081534|76173378|FG001|STARTED|Overall Study||21||
60057935|NCT02081534|76173379|FG002|STARTED|Overall Study||23||
60057936|NCT02081534|76173380|FG003|STARTED|Overall Study||26||
60057937|NCT02081534|76173381|FG004|STARTED|Overall Study||22||
60057938|NCT02081534|76173382|FG005|STARTED|Overall Study||21||
60057939|NCT02081534|76173383|FG006|STARTED|Overall Study||26||
60057940|NCT02081534|76173377|FG000|COMPLETED|Overall Study||18||
60057941|NCT02081534|76173378|FG001|COMPLETED|Overall Study||13||
60057942|NCT02081534|76173379|FG002|COMPLETED|Overall Study||19||
60057943|NCT02081534|76173380|FG003|COMPLETED|Overall Study||13||
60057944|NCT02081534|76173381|FG004|COMPLETED|Overall Study||18||
60057945|NCT02081534|76173382|FG005|COMPLETED|Overall Study||12||
60057946|NCT02081534|76173383|FG006|COMPLETED|Overall Study||22||
60057947|NCT02081534|76173377|FG000|NOT COMPLETED|Overall Study||5||
60057948|NCT02081534|76173378|FG001|NOT COMPLETED|Overall Study||8||
60057949|NCT02081534|76173379|FG002|NOT COMPLETED|Overall Study||4||
60057950|NCT02081534|76173380|FG003|NOT COMPLETED|Overall Study||13||
60057951|NCT02081534|76173381|FG004|NOT COMPLETED|Overall Study||4||
60057952|NCT02081534|76173382|FG005|NOT COMPLETED|Overall Study||9||
60057953|NCT02081534|76173383|FG006|NOT COMPLETED|Overall Study||4||
60057954|NCT02057198|76173402|FG000|STARTED|Overall Study||11||
60057955|NCT02057198|76173403|FG001|STARTED|Overall Study||11||
60057956|NCT02057198|76173404|FG002|STARTED|Overall Study||11||
60057957|NCT02057198|76173402|FG000|COMPLETED|Overall Study||11||
60057958|NCT02057198|76173403|FG001|COMPLETED|Overall Study||10||
60057959|NCT02057198|76173404|FG002|COMPLETED|Overall Study||10||
60057960|NCT02057198|76173402|FG000|NOT COMPLETED|Overall Study||0||
60057961|NCT02057198|76173403|FG001|NOT COMPLETED|Overall Study||1||
60057962|NCT02057198|76173404|FG002|NOT COMPLETED|Overall Study||1||
60057963|NCT02056652|76173414|FG000|STARTED|Overall Study||61||
60057964|NCT02056652|76173415|FG001|STARTED|Overall Study||61||
60057965|NCT02056652|76173414|FG000|COMPLETED|Overall Study||60||
60057966|NCT02056652|76173415|FG001|COMPLETED|Overall Study||58||
60057967|NCT02056652|76173414|FG000|NOT COMPLETED|Overall Study||1||
60057968|NCT02056652|76173415|FG001|NOT COMPLETED|Overall Study||3||
60057969|NCT02056340|76173423|FG000|STARTED|Overall Study||59||
60057970|NCT02056340|76173424|FG001|STARTED|Overall Study||57||
59515875|NCT03096730|75609569|FG000|STARTED|Overall Study||30||
59515876|NCT03096730|75609570|FG001|STARTED|Overall Study||30||
59515877|NCT03096730|75609571|FG002|STARTED|Overall Study||30||
59515878|NCT03096730|75609572|FG003|STARTED|Overall Study||30||
60057971|NCT02056340|76173423|FG000|COMPLETED|Overall Study||52||
60057972|NCT02056340|76173424|FG001|COMPLETED|Overall Study||46||
60057973|NCT02056340|76173423|FG000|NOT COMPLETED|Overall Study||7||
60057974|NCT02056340|76173424|FG001|NOT COMPLETED|Overall Study||11||
60057975|NCT02046122|76173430|FG000|STARTED|Overall Study||17||
60057976|NCT02046122|76173430|FG000|COMPLETED|Overall Study||8||
60057977|NCT02046122|76173430|FG000|NOT COMPLETED|Overall Study||9||
60057978|NCT02080832|76173437|FG000|STARTED|Overall Study||15||
60057979|NCT02080832|76173438|FG001|STARTED|Overall Study||17||
60057980|NCT02080832|76173439|FG002|STARTED|Overall Study||22||
60057981|NCT02080832|76173437|FG000|COMPLETED|Overall Study||6||
60057982|NCT02080832|76173438|FG001|COMPLETED|Overall Study||5||
60057983|NCT02080832|76173439|FG002|COMPLETED|Overall Study||6||
59515879|NCT03096730|75609573|FG004|STARTED|Overall Study||30||
59515880|NCT03096730|75609569|FG000|COMPLETED|Overall Study||27||
59515881|NCT03096730|75609570|FG001|COMPLETED|Overall Study||27||
59515882|NCT03096730|75609571|FG002|COMPLETED|Overall Study||27||
59515883|NCT03096730|75609572|FG003|COMPLETED|Overall Study||27||
60057984|NCT02080832|76173437|FG000|NOT COMPLETED|Overall Study||9||
60057985|NCT02080832|76173438|FG001|NOT COMPLETED|Overall Study||12||
60057986|NCT02080832|76173439|FG002|NOT COMPLETED|Overall Study||16||
60057987|NCT02080364|76173453|FG000|STARTED|Baseline Period||197||
60057988|NCT02080364|76173454|FG001|STARTED|Baseline Period||208||
60057989|NCT02080364|76173455|FG002|STARTED|Baseline Period||247||
60057990|NCT02080364|76173456|FG003|STARTED|Baseline Period||228||
60057991|NCT02080364|76173453|FG000|COMPLETED|Baseline Period||195||
60057992|NCT02080364|76173454|FG001|COMPLETED|Baseline Period||206||
60057993|NCT02080364|76173455|FG002|COMPLETED|Baseline Period||246||
60057994|NCT02080364|76173456|FG003|COMPLETED|Baseline Period||228||
60057995|NCT02080364|76173453|FG000|NOT COMPLETED|Baseline Period||2||
60057996|NCT02080364|76173454|FG001|NOT COMPLETED|Baseline Period||2||
60057997|NCT02080364|76173455|FG002|NOT COMPLETED|Baseline Period||1||
60057998|NCT02080364|76173456|FG003|NOT COMPLETED|Baseline Period||0||
60057999|NCT02080364|76173453|FG000|STARTED|Treatment Period||195||
60058000|NCT02080364|76173454|FG001|STARTED|Treatment Period||206||
60058001|NCT02080364|76173455|FG002|STARTED|Treatment Period||246||
60058002|NCT02080364|76173456|FG003|STARTED|Treatment Period||228||
60058003|NCT02080364|76173453|FG000|COMPLETED|Treatment Period||148||
60058004|NCT02080364|76173454|FG001|COMPLETED|Treatment Period||157||
60058005|NCT02080364|76173455|FG002|COMPLETED|Treatment Period||9||
60058006|NCT02080364|76173456|FG003|COMPLETED|Treatment Period||4||
60058007|NCT02080364|76173453|FG000|NOT COMPLETED|Treatment Period||47||
60058008|NCT02080364|76173454|FG001|NOT COMPLETED|Treatment Period||49||
60058009|NCT02080364|76173455|FG002|NOT COMPLETED|Treatment Period||237||
60058010|NCT02080364|76173456|FG003|NOT COMPLETED|Treatment Period||224||
60058011|NCT02079038|76173468|FG000|STARTED|Modified Intent to Treat Population||112||
60058012|NCT02079038|76173469|FG001|STARTED|Modified Intent to Treat Population||56||
59515884|NCT03096730|75609573|FG004|COMPLETED|Overall Study||27||
59515885|NCT03096730|75609569|FG000|NOT COMPLETED|Overall Study||3||
59515886|NCT03096730|75609570|FG001|NOT COMPLETED|Overall Study||3||
59515887|NCT03096730|75609571|FG002|NOT COMPLETED|Overall Study||3||
59515888|NCT03096730|75609572|FG003|NOT COMPLETED|Overall Study||3||
59515889|NCT03096730|75609573|FG004|NOT COMPLETED|Overall Study||3||
60058013|NCT02079038|76173468|FG000|COMPLETED|Modified Intent to Treat Population||105||
60058014|NCT02079038|76173469|FG001|COMPLETED|Modified Intent to Treat Population||51||
60058015|NCT02079038|76173468|FG000|NOT COMPLETED|Modified Intent to Treat Population||7||
60058016|NCT02079038|76173469|FG001|NOT COMPLETED|Modified Intent to Treat Population||5||
60058017|NCT02079038|76173468|FG000|STARTED|Completed 6 Months||105||
60058018|NCT02079038|76173469|FG001|STARTED|Completed 6 Months||51||
60058019|NCT02079038|76173468|FG000|COMPLETED|Completed 6 Months||103||
60058020|NCT02079038|76173469|FG001|COMPLETED|Completed 6 Months||50||
60058021|NCT02079038|76173468|FG000|NOT COMPLETED|Completed 6 Months||2||
60058022|NCT02079038|76173469|FG001|NOT COMPLETED|Completed 6 Months||1||
60058023|NCT02045732|76173477|FG000|STARTED|Overall Study||1||
60058024|NCT02045732|76173478|FG001|STARTED|Overall Study||3||
60058025|NCT02045732|76173477|FG000|COMPLETED|Overall Study||0||
60058026|NCT02045732|76173478|FG001|COMPLETED|Overall Study||2||
60058027|NCT02045732|76173477|FG000|NOT COMPLETED|Overall Study||1||
59515890|NCT03834441|75609587|FG000|STARTED|Allocation||115||
59515891|NCT03834441|75609588|FG001|STARTED|Allocation||121||
59515892|NCT03834441|75609587|FG000|COMPLETED|Allocation||112||
59515893|NCT03834441|75609588|FG001|COMPLETED|Allocation||116||
59515894|NCT03834441|75609587|FG000|NOT COMPLETED|Allocation||3||
59515895|NCT03834441|75609588|FG001|NOT COMPLETED|Allocation||5||
59515896|NCT03834441|75609587|FG000|STARTED|Analysis||112||
59515897|NCT03834441|75609588|FG001|STARTED|Analysis||116||
59515898|NCT03834441|75609587|FG000|COMPLETED|Analysis||105||
60058028|NCT02045732|76173478|FG001|NOT COMPLETED|Overall Study||1||
60058029|NCT02044874|76173487|FG000|STARTED|Overall Study||201||
60058030|NCT02044874|76173488|FG001|STARTED|Overall Study||202||
60058031|NCT02044874|76173489|FG002|STARTED|Overall Study||200||
59515899|NCT03834441|75609588|FG001|COMPLETED|Analysis||109||
59515900|NCT03834441|75609587|FG000|NOT COMPLETED|Analysis||7||
59515901|NCT03834441|75609588|FG001|NOT COMPLETED|Analysis||7||
59515902|NCT03161158|75609596|FG000|STARTED|Overall Study||18|Patients in the FAS|
59515903|NCT03161158|75609597|FG001|STARTED|Overall Study||19|Patients in the FAS|
59515904|NCT03161158|75609596|FG000|COMPLETED|Overall Study||9|Patients in the FAS|
59515905|NCT03161158|75609597|FG001|COMPLETED|Overall Study||13|Patients in the FAS|
59515906|NCT03161158|75609596|FG000|NOT COMPLETED|Overall Study||9||
59515907|NCT03161158|75609597|FG001|NOT COMPLETED|Overall Study||6||
59613045|NCT01713582|75724097|FG003|COMPLETED|Overall Study||0||
59613046|NCT01713582|75724098|FG004|COMPLETED|Overall Study||0||
60058032|NCT02044874|76173487|FG000|COMPLETED|Overall Study||171||
60058033|NCT02044874|76173488|FG001|COMPLETED|Overall Study||147||
60058034|NCT02044874|76173489|FG002|COMPLETED|Overall Study||140||
60058035|NCT02044874|76173487|FG000|NOT COMPLETED|Overall Study||30||
59515908|NCT03161938|75609605|FG000|STARTED|Overall Study||32||
59515909|NCT03161938|75609606|FG001|STARTED|Overall Study||32||
60058036|NCT02044874|76173488|FG001|NOT COMPLETED|Overall Study||55||
60058037|NCT02044874|76173489|FG002|NOT COMPLETED|Overall Study||60||
60058038|NCT02078960|76173502|FG000|STARTED|Treatment Period||2||
59515910|NCT03161938|75609605|FG000|COMPLETED|Overall Study||32||
59515911|NCT03161938|75609606|FG001|COMPLETED|Overall Study||32||
59515912|NCT03161938|75609605|FG000|NOT COMPLETED|Overall Study||0||
59515913|NCT03161938|75609606|FG001|NOT COMPLETED|Overall Study||0||
59515914|NCT00989989|75609615|FG000|STARTED|Overall Study||132||
59515915|NCT00989989|75609616|FG001|STARTED|Overall Study||133||
59613047|NCT01713582|75724099|FG005|COMPLETED|Overall Study||0||
60058039|NCT02078960|76173503|FG001|STARTED|Treatment Period||4||
60058040|NCT02078960|76173504|FG002|STARTED|Treatment Period||4||
60058041|NCT02078960|76173502|FG000|COMPLETED|Treatment Period||0|Treatment completed|
60058042|NCT02078960|76173503|FG001|COMPLETED|Treatment Period||1|Treatment completed|
60058043|NCT02078960|76173504|FG002|COMPLETED|Treatment Period||1|Treatment completed|
59515916|NCT00989989|75609617|FG002|STARTED|Overall Study||131||
59515917|NCT00989989|75609615|FG000|COMPLETED|Overall Study||114||
59515918|NCT00989989|75609616|FG001|COMPLETED|Overall Study||123||
59515919|NCT00989989|75609617|FG002|COMPLETED|Overall Study||108||
59515920|NCT00989989|75609615|FG000|NOT COMPLETED|Overall Study||18||
59515921|NCT00989989|75609616|FG001|NOT COMPLETED|Overall Study||10||
59515922|NCT00989989|75609617|FG002|NOT COMPLETED|Overall Study||23||
59515923|NCT03100864|75609625|FG000|STARTED|Overall Study||8||
59515924|NCT03100864|75609625|FG000|COMPLETED|Overall Study||8||
59515925|NCT03100864|75609625|FG000|NOT COMPLETED|Overall Study||0||
59515926|NCT00990769|75609631|FG000|STARTED|Overall Study|Signed consent and assigned to High-normal BIS|22||
59515927|NCT00990769|75609632|FG001|STARTED|Overall Study|Signed consent and assigned to Low-normal BIS|18||
59515928|NCT00990769|75609631|FG000|COMPLETED|Overall Study||22||
59515929|NCT00990769|75609632|FG001|COMPLETED|Overall Study||18||
59515930|NCT00990769|75609631|FG000|NOT COMPLETED|Overall Study||0||
59515931|NCT00990769|75609632|FG001|NOT COMPLETED|Overall Study||0||
59515932|NCT00991081|75609640|FG000|STARTED|Phase I, Formative Research||20||
59515933|NCT00991081|75609641|FG001|STARTED|Phase I, Formative Research||0||
59515934|NCT00991081|75609642|FG002|STARTED|Phase I, Formative Research||0||
59515935|NCT00991081|75609640|FG000|COMPLETED|Phase I, Formative Research|The 10 smokers interviewed were not enrolled in the Phase II RCT.|20||
60058044|NCT02078960|76173502|FG000|NOT COMPLETED|Treatment Period||2||
60058045|NCT02078960|76173503|FG001|NOT COMPLETED|Treatment Period||3||
60058046|NCT02078960|76173504|FG002|NOT COMPLETED|Treatment Period||3||
60058047|NCT02078960|76173502|FG000|STARTED|Follow-up Period||2||
60058048|NCT02078960|76173503|FG001|STARTED|Follow-up Period||2||
60058049|NCT02078960|76173504|FG002|STARTED|Follow-up Period||1||
60058050|NCT02078960|76173502|FG000|COMPLETED|Follow-up Period||0|Monitored for progression and survival for at least 1 year following treatment.|
60058051|NCT02078960|76173503|FG001|COMPLETED|Follow-up Period||1|Monitored for progression and survival for at least 1 year following treatment.|
60058052|NCT02078960|76173504|FG002|COMPLETED|Follow-up Period||1|Monitored for progression and survival for at least 1 year following treatment.|
60058053|NCT02078960|76173502|FG000|NOT COMPLETED|Follow-up Period||2||
60058054|NCT02078960|76173503|FG001|NOT COMPLETED|Follow-up Period||1||
60058055|NCT02078960|76173504|FG002|NOT COMPLETED|Follow-up Period||0||
60058056|NCT02078102|76173516|FG000|STARTED|Overall Study||25||
60058057|NCT02078102|76173517|FG001|STARTED|Overall Study||13||
60058058|NCT02078102|76173516|FG000|COMPLETED|Overall Study||23||
60058059|NCT02078102|76173517|FG001|COMPLETED|Overall Study||12||
60058060|NCT02078102|76173516|FG000|NOT COMPLETED|Overall Study||2||
60058061|NCT02078102|76173517|FG001|NOT COMPLETED|Overall Study||1||
60058062|NCT02054702|76173526|FG000|STARTED|Overall Study||64||
60058063|NCT02054702|76173527|FG001|STARTED|Overall Study||33||
60058064|NCT02054702|76173526|FG000|COMPLETED|Overall Study||40||
60058065|NCT02054702|76173527|FG001|COMPLETED|Overall Study||21||
60058066|NCT02054702|76173526|FG000|NOT COMPLETED|Overall Study||24||
60058067|NCT02054702|76173527|FG001|NOT COMPLETED|Overall Study||12||
60058068|NCT02044094|76173533|FG000|STARTED|RBP-6000 Injection 1 (Day 1 to Day 28)||39||
60058069|NCT02044094|76173533|FG000|Intent to Treat Population|RBP-6000 Injection 1 (Day 1 to Day 28)|Subjects who receive >=1 dose of RBP-6000 and have >=1 complete sequence of hydromorphone challenges|38||
60058070|NCT02044094|76173533|FG000|Completers Population|RBP-6000 Injection 1 (Day 1 to Day 28)|Subjects that reached Day 28 + completed all challenges at Week 4 were considered study completers.|30||
60058071|NCT02044094|76173533|FG000|COMPLETED|RBP-6000 Injection 1 (Day 1 to Day 28)||30||
60058072|NCT02044094|76173533|FG000|NOT COMPLETED|RBP-6000 Injection 1 (Day 1 to Day 28)||9||
60058073|NCT02044094|76173533|FG000|STARTED|RBP-6000 Injection 2 (Day 29 to Week 12)||30||
60058074|NCT02044094|76173533|FG000|COMPLETED|RBP-6000 Injection 2 (Day 29 to Week 12)||17||
60058075|NCT02044094|76173533|FG000|NOT COMPLETED|RBP-6000 Injection 2 (Day 29 to Week 12)||13||
59515936|NCT00991081|75609641|FG001|COMPLETED|Phase I, Formative Research||0||
59515937|NCT00991081|75609642|FG002|COMPLETED|Phase I, Formative Research||0||
60058076|NCT02043938|76173548|FG000|STARTED|Overall Study||46||
60058077|NCT02043938|76173548|FG000|COMPLETED|Overall Study||36||
60058078|NCT02043938|76173548|FG000|NOT COMPLETED|Overall Study||10||
59515938|NCT00991081|75609640|FG000|NOT COMPLETED|Phase I, Formative Research||0||
60058079|NCT02053610|76173557|FG000|STARTED|Overall Study||330||
60058080|NCT02053610|76173558|FG001|STARTED|Overall Study||333||
60058081|NCT02053610|76173557|FG000|Received Study Drug|Overall Study||326||
60058082|NCT02053610|76173558|FG001|Received Study Drug|Overall Study||331||
60058083|NCT02053610|76173557|FG000|COMPLETED|Overall Study|Completed=Completed Treatment|288||
60058084|NCT02053610|76173558|FG001|COMPLETED|Overall Study|Completed=Completed Treatment|266||
60058085|NCT02053610|76173557|FG000|NOT COMPLETED|Overall Study||42||
60058086|NCT02053610|76173558|FG001|NOT COMPLETED|Overall Study||67||
60058087|NCT02075606|76173564|FG000|STARTED|Overall Study||50||
60058088|NCT02075606|76173564|FG000|COMPLETED|Overall Study||40||
60058089|NCT02075606|76173564|FG000|NOT COMPLETED|Overall Study||10||
60058090|NCT02043782|76173573|FG000|STARTED|Period 1||7||
60058091|NCT02043782|76173574|FG001|STARTED|Period 1||6||
60058092|NCT02043782|76173575|FG002|STARTED|Period 1||7||
59515939|NCT00991081|75609641|FG001|NOT COMPLETED|Phase I, Formative Research||0||
59515940|NCT00991081|75609642|FG002|NOT COMPLETED|Phase I, Formative Research||0||
60058093|NCT02043782|76173576|FG003|STARTED|Period 1||6||
60058094|NCT02043782|76173577|FG004|STARTED|Period 1||6||
60058095|NCT02043782|76173578|FG005|STARTED|Period 1||6||
60058096|NCT02043782|76173573|FG000|COMPLETED|Period 1||7||
60058097|NCT02043782|76173574|FG001|COMPLETED|Period 1||6||
60058098|NCT02043782|76173575|FG002|COMPLETED|Period 1|One subject discontinued due to an adverse event while testing own product|6||
60058099|NCT02043782|76173576|FG003|COMPLETED|Period 1||6||
60058100|NCT02043782|76173577|FG004|COMPLETED|Period 1||6||
60058101|NCT02043782|76173578|FG005|COMPLETED|Period 1||6||
60058102|NCT02043782|76173573|FG000|NOT COMPLETED|Period 1||0||
60058103|NCT02043782|76173574|FG001|NOT COMPLETED|Period 1||0||
60058104|NCT02043782|76173575|FG002|NOT COMPLETED|Period 1||1||
60058105|NCT02043782|76173576|FG003|NOT COMPLETED|Period 1||0||
60058106|NCT02043782|76173577|FG004|NOT COMPLETED|Period 1||0||
60058107|NCT02043782|76173578|FG005|NOT COMPLETED|Period 1||0||
60058108|NCT02043782|76173573|FG000|STARTED|Period 2||7||
60058109|NCT02043782|76173574|FG001|STARTED|Period 2||6||
60058110|NCT02043782|76173575|FG002|STARTED|Period 2||6||
60058111|NCT02043782|76173576|FG003|STARTED|Period 2||6||
60058112|NCT02043782|76173577|FG004|STARTED|Period 2||6||
60058113|NCT02043782|76173578|FG005|STARTED|Period 2||6||
60058114|NCT02043782|76173573|FG000|COMPLETED|Period 2||7||
60058115|NCT02043782|76173574|FG001|COMPLETED|Period 2||6||
60058116|NCT02043782|76173575|FG002|COMPLETED|Period 2||6||
60058117|NCT02043782|76173576|FG003|COMPLETED|Period 2||6||
60058118|NCT02043782|76173577|FG004|COMPLETED|Period 2||6||
60058119|NCT02043782|76173578|FG005|COMPLETED|Period 2||6||
60058120|NCT02043782|76173573|FG000|NOT COMPLETED|Period 2||0||
60058121|NCT02043782|76173574|FG001|NOT COMPLETED|Period 2||0||
60058122|NCT02043782|76173575|FG002|NOT COMPLETED|Period 2||0||
60058123|NCT02043782|76173576|FG003|NOT COMPLETED|Period 2||0||
60058124|NCT02043782|76173577|FG004|NOT COMPLETED|Period 2||0||
60058125|NCT02043782|76173578|FG005|NOT COMPLETED|Period 2||0||
60058126|NCT02043782|76173573|FG000|STARTED|Period 3||7||
60058127|NCT02043782|76173574|FG001|STARTED|Period 3||6||
60058128|NCT02043782|76173575|FG002|STARTED|Period 3||6||
60058129|NCT02043782|76173576|FG003|STARTED|Period 3||6||
60058130|NCT02043782|76173577|FG004|STARTED|Period 3||6||
60058131|NCT02043782|76173578|FG005|STARTED|Period 3||6||
60058132|NCT02043782|76173573|FG000|COMPLETED|Period 3||7||
60058133|NCT02043782|76173574|FG001|COMPLETED|Period 3||6||
60058134|NCT02043782|76173575|FG002|COMPLETED|Period 3||6||
60058135|NCT02043782|76173576|FG003|COMPLETED|Period 3||6||
60058136|NCT02043782|76173577|FG004|COMPLETED|Period 3||6||
60058137|NCT02043782|76173578|FG005|COMPLETED|Period 3||6||
60058138|NCT02043782|76173573|FG000|NOT COMPLETED|Period 3||0||
60058139|NCT02043782|76173574|FG001|NOT COMPLETED|Period 3||0||
60058140|NCT02043782|76173575|FG002|NOT COMPLETED|Period 3||0||
60058141|NCT02043782|76173576|FG003|NOT COMPLETED|Period 3||0||
60058142|NCT02043782|76173577|FG004|NOT COMPLETED|Period 3||0||
60058143|NCT02043782|76173578|FG005|NOT COMPLETED|Period 3||0||
60058144|NCT02052596|76173588|FG000|STARTED|Active Phase||412||
60058145|NCT02052596|76173589|FG001|STARTED|Active Phase||418||
60058146|NCT02052596|76173588|FG000|COMPLETED|Active Phase||396||
60058147|NCT02052596|76173589|FG001|COMPLETED|Active Phase||398||
60058148|NCT02052596|76173588|FG000|NOT COMPLETED|Active Phase||16||
60058149|NCT02052596|76173589|FG001|NOT COMPLETED|Active Phase||20||
60058150|NCT02052596|76173588|FG000|STARTED|Safety Phase||412||
60058151|NCT02052596|76173589|FG001|STARTED|Safety Phase||418||
60058152|NCT02052596|76173588|FG000|COMPLETED|Safety Phase||385||
60058153|NCT02052596|76173589|FG001|COMPLETED|Safety Phase||383||
60058154|NCT02052596|76173588|FG000|NOT COMPLETED|Safety Phase||27||
60058155|NCT02052596|76173589|FG001|NOT COMPLETED|Safety Phase||35||
60058156|NCT02052440|76173597|FG000|STARTED|Overall Study||50||
60058157|NCT02052440|76173598|FG001|STARTED|Overall Study||52||
60058158|NCT02052440|76173597|FG000|COMPLETED|Overall Study||50||
60058159|NCT02052440|76173598|FG001|COMPLETED|Overall Study||51||
60058160|NCT02052440|76173597|FG000|NOT COMPLETED|Overall Study||0||
60058161|NCT02052440|76173598|FG001|NOT COMPLETED|Overall Study||1||
60058162|NCT02049944|76173604|FG000|STARTED|Overall Study||30||
60058163|NCT02049944|76173604|FG000|Obese (BMI 30-40kg/m^2)|Overall Study||14||
60058164|NCT02049944|76173604|FG000|Extremely Obese (BMI >40kg/m^2)|Overall Study||14||
60058165|NCT02049944|76173604|FG000|COMPLETED|Overall Study||28||
60058166|NCT02049944|76173604|FG000|NOT COMPLETED|Overall Study||2||
60058167|NCT02043548|76173610|FG000|STARTED|Overall Study||18||
60058168|NCT02043548|76173611|FG001|STARTED|Overall Study||18||
60058169|NCT02043548|76173610|FG000|COMPLETED|Overall Study||17||
60058170|NCT02043548|76173611|FG001|COMPLETED|Overall Study||17||
60058171|NCT02043548|76173610|FG000|NOT COMPLETED|Overall Study||1||
60058172|NCT02043548|76173611|FG001|NOT COMPLETED|Overall Study||1||
60058173|NCT01622348|76173620|FG000|STARTED|Overall Study||15||
60058174|NCT01622348|76173621|FG001|STARTED|Overall Study||14||
60058175|NCT01622348|76173622|FG002|STARTED|Overall Study||15||
60058176|NCT01622348|76173620|FG000|COMPLETED|Overall Study||14||
60058177|NCT01622348|76173621|FG001|COMPLETED|Overall Study||14||
60058178|NCT01622348|76173622|FG002|COMPLETED|Overall Study||14||
60058179|NCT01622348|76173620|FG000|NOT COMPLETED|Overall Study||1||
60058180|NCT01622348|76173621|FG001|NOT COMPLETED|Overall Study||0||
60058181|NCT01622348|76173622|FG002|NOT COMPLETED|Overall Study||1||
60058182|NCT01621880|76173632|FG000|STARTED|Overall Study||58||
60058183|NCT01621880|76173633|FG001|STARTED|Overall Study||54||
60058184|NCT01621880|76173632|FG000|COMPLETED|Overall Study||48||
60058185|NCT01621880|76173633|FG001|COMPLETED|Overall Study||49||
60058186|NCT01621880|76173632|FG000|NOT COMPLETED|Overall Study||10||
60058187|NCT01621880|76173633|FG001|NOT COMPLETED|Overall Study||5||
60058188|NCT01621802|76173646|FG000|STARTED|Overall Study||802||
60058189|NCT01621802|76173647|FG001|STARTED|Overall Study||298||
60058190|NCT01621802|76173648|FG002|STARTED|Overall Study||796||
60058191|NCT01621802|76173649|FG003|STARTED|Overall Study||303||
60058192|NCT01621802|76173650|FG004|STARTED|Overall Study||1319||
60058193|NCT01621802|76173651|FG005|STARTED|Overall Study||489||
60058194|NCT01621802|76173646|FG000|COMPLETED|Overall Study||755||
60058195|NCT01621802|76173647|FG001|COMPLETED|Overall Study||275||
60058196|NCT01621802|76173648|FG002|COMPLETED|Overall Study||763||
60058197|NCT01621802|76173649|FG003|COMPLETED|Overall Study||292||
60058198|NCT01621802|76173650|FG004|COMPLETED|Overall Study||1284||
60058199|NCT01621802|76173651|FG005|COMPLETED|Overall Study||477||
60058200|NCT01621802|76173646|FG000|NOT COMPLETED|Overall Study||47||
60058201|NCT01621802|76173647|FG001|NOT COMPLETED|Overall Study||23||
60058202|NCT01621802|76173648|FG002|NOT COMPLETED|Overall Study||33||
60058203|NCT01621802|76173649|FG003|NOT COMPLETED|Overall Study||11||
60058204|NCT01621802|76173650|FG004|NOT COMPLETED|Overall Study||35||
60058205|NCT01621802|76173651|FG005|NOT COMPLETED|Overall Study||12||
60058206|NCT02059291|76173677|FG000|STARTED|Epoch 2||31||
60058207|NCT02059291|76173678|FG001|STARTED|Epoch 2||32||
60058208|NCT02059291|76173679|FG002|STARTED|Epoch 2||37||
60058209|NCT02059291|76173680|FG003|STARTED|Epoch 2||35||
60058210|NCT02059291|76173681|FG004|STARTED|Epoch 2||22||
60058211|NCT02059291|76173682|FG005|STARTED|Epoch 2||24||
60058212|NCT02059291|76173683|FG006|STARTED|Epoch 2||2||
60058213|NCT02059291|76173684|FG007|STARTED|Epoch 2||2||
60058214|NCT02059291|76173685|FG008|STARTED|Epoch 2|This Epoch 3 group is shown in Epoch 2 to account for the 203 patients enrolled in the study.|18||
60058215|NCT02059291|76173686|FG009|STARTED|Epoch 2||0||
60058216|NCT02059291|76173687|FG010|STARTED|Epoch 2||0||
60058217|NCT02059291|76173688|FG011|STARTED|Epoch 2||0||
60058218|NCT02059291|76173689|FG012|STARTED|Epoch 2||0||
60058219|NCT02059291|76173690|FG013|STARTED|Epoch 2||0||
60058220|NCT02059291|76173691|FG014|STARTED|Epoch 2||0||
60058221|NCT02059291|76173692|FG015|STARTED|Epoch 2||0||
60058222|NCT02059291|76173693|FG016|STARTED|Epoch 2||0||
60058223|NCT02059291|76173694|FG017|STARTED|Epoch 2||0||
60058224|NCT02059291|76173695|FG018|STARTED|Epoch 2||0||
60058225|NCT02059291|76173696|FG019|STARTED|Epoch 2||0||
60058226|NCT02059291|76173697|FG020|STARTED|Epoch 2||0||
60058227|NCT02059291|76173698|FG021|STARTED|Epoch 2||0||
60058228|NCT02059291|76173699|FG022|STARTED|Epoch 2||0||
60058229|NCT02059291|76173700|FG023|STARTED|Epoch 2||0||
60058230|NCT02059291|76173701|FG024|STARTED|Epoch 2||0||
60058231|NCT02059291|76173677|FG000|COMPLETED|Epoch 2||31||
60058232|NCT02059291|76173678|FG001|COMPLETED|Epoch 2||31||
60058233|NCT02059291|76173679|FG002|COMPLETED|Epoch 2||36||
60058234|NCT02059291|76173680|FG003|COMPLETED|Epoch 2||33||
60058235|NCT02059291|76173681|FG004|COMPLETED|Epoch 2||22||
60058236|NCT02059291|76173682|FG005|COMPLETED|Epoch 2||22||
60058237|NCT02059291|76173683|FG006|COMPLETED|Epoch 2||2||
60058238|NCT02059291|76173684|FG007|COMPLETED|Epoch 2||1||
60058239|NCT02059291|76173685|FG008|COMPLETED|Epoch 2||16||
60058240|NCT02059291|76173686|FG009|COMPLETED|Epoch 2||0||
60058241|NCT02059291|76173687|FG010|COMPLETED|Epoch 2||0||
60058242|NCT02059291|76173688|FG011|COMPLETED|Epoch 2||0||
60058243|NCT02059291|76173689|FG012|COMPLETED|Epoch 2||0||
60058244|NCT02059291|76173690|FG013|COMPLETED|Epoch 2||0||
60058245|NCT02059291|76173691|FG014|COMPLETED|Epoch 2||0||
60058246|NCT02059291|76173692|FG015|COMPLETED|Epoch 2||0||
60058247|NCT02059291|76173693|FG016|COMPLETED|Epoch 2||0||
60058248|NCT02059291|76173694|FG017|COMPLETED|Epoch 2||0||
60058249|NCT02059291|76173695|FG018|COMPLETED|Epoch 2||0||
60058250|NCT02059291|76173696|FG019|COMPLETED|Epoch 2||0||
60058251|NCT02059291|76173697|FG020|COMPLETED|Epoch 2||0||
60058252|NCT02059291|76173698|FG021|COMPLETED|Epoch 2||0||
60058253|NCT02059291|76173699|FG022|COMPLETED|Epoch 2||0||
60058254|NCT02059291|76173700|FG023|COMPLETED|Epoch 2||0||
60058255|NCT02059291|76173701|FG024|COMPLETED|Epoch 2||0||
60058256|NCT02059291|76173677|FG000|NOT COMPLETED|Epoch 2||0||
60058257|NCT02059291|76173678|FG001|NOT COMPLETED|Epoch 2||1||
60058258|NCT02059291|76173679|FG002|NOT COMPLETED|Epoch 2||1||
60058259|NCT02059291|76173680|FG003|NOT COMPLETED|Epoch 2||2||
60058260|NCT02059291|76173681|FG004|NOT COMPLETED|Epoch 2||0||
60058261|NCT02059291|76173682|FG005|NOT COMPLETED|Epoch 2||2||
60058262|NCT02059291|76173683|FG006|NOT COMPLETED|Epoch 2||0||
60058263|NCT02059291|76173684|FG007|NOT COMPLETED|Epoch 2||1||
60058264|NCT02059291|76173685|FG008|NOT COMPLETED|Epoch 2||2||
60058265|NCT02059291|76173686|FG009|NOT COMPLETED|Epoch 2||0||
60058266|NCT02059291|76173687|FG010|NOT COMPLETED|Epoch 2||0||
60058267|NCT02059291|76173688|FG011|NOT COMPLETED|Epoch 2||0||
60058268|NCT02059291|76173689|FG012|NOT COMPLETED|Epoch 2||0||
60058269|NCT02059291|76173690|FG013|NOT COMPLETED|Epoch 2||0||
60058270|NCT02059291|76173691|FG014|NOT COMPLETED|Epoch 2||0||
60058271|NCT02059291|76173692|FG015|NOT COMPLETED|Epoch 2||0||
60058272|NCT02059291|76173693|FG016|NOT COMPLETED|Epoch 2||0||
60058273|NCT02059291|76173694|FG017|NOT COMPLETED|Epoch 2||0||
60058274|NCT02059291|76173695|FG018|NOT COMPLETED|Epoch 2||0||
60058275|NCT02059291|76173696|FG019|NOT COMPLETED|Epoch 2||0||
60058276|NCT02059291|76173697|FG020|NOT COMPLETED|Epoch 2||0||
60058277|NCT02059291|76173698|FG021|NOT COMPLETED|Epoch 2||0||
60058278|NCT02059291|76173699|FG022|NOT COMPLETED|Epoch 2||0||
60058279|NCT02059291|76173700|FG023|NOT COMPLETED|Epoch 2||0||
60058280|NCT02059291|76173701|FG024|NOT COMPLETED|Epoch 2||0||
60058281|NCT02059291|76173677|FG000|STARTED|Epoch 3||0||
60058282|NCT02059291|76173678|FG001|STARTED|Epoch 3||0||
60058283|NCT02059291|76173679|FG002|STARTED|Epoch 3||0||
60058284|NCT02059291|76173680|FG003|STARTED|Epoch 3||0||
60058285|NCT02059291|76173681|FG004|STARTED|Epoch 3||0||
60058286|NCT02059291|76173682|FG005|STARTED|Epoch 3||0||
60058287|NCT02059291|76173683|FG006|STARTED|Epoch 3||2||
60058288|NCT02059291|76173684|FG007|STARTED|Epoch 3||1||
60058289|NCT02059291|76173685|FG008|STARTED|Epoch 3|Presented in Epoch 2.|0||
59515941|NCT00991081|75609640|FG000|STARTED|Phase II, Randomized Control Trial||0||
59515942|NCT00991081|75609641|FG001|STARTED|Phase II, Randomized Control Trial|Phase I interview participants were not enrolled in the Phase II RCT.|17||
59515943|NCT00991081|75609642|FG002|STARTED|Phase II, Randomized Control Trial|Phase I interview participants were not enrolled in the Phase II RCT.|19||
59515944|NCT00991081|75609640|FG000|Received First Clinical Call|Phase II, Randomized Control Trial||0||
59515945|NCT00991081|75609641|FG001|Received First Clinical Call|Phase II, Randomized Control Trial||16||
59515946|NCT00991081|75609642|FG002|Received First Clinical Call|Phase II, Randomized Control Trial||17||
60058290|NCT02059291|76173686|FG009|STARTED|Epoch 3||9||
60058291|NCT02059291|76173687|FG010|STARTED|Epoch 3||10||
60058292|NCT02059291|76173688|FG011|STARTED|Epoch 3||6||
60058293|NCT02059291|76173689|FG012|STARTED|Epoch 3||7||
60058294|NCT02059291|76173690|FG013|STARTED|Epoch 3||4||
60058295|NCT02059291|76173691|FG014|STARTED|Epoch 3||5||
60058296|NCT02059291|76173692|FG015|STARTED|Epoch 3||126||
60058297|NCT02059291|76173693|FG016|STARTED|Epoch 3||0||
60058298|NCT02059291|76173694|FG017|STARTED|Epoch 3||0||
60058299|NCT02059291|76173695|FG018|STARTED|Epoch 3||0||
60058300|NCT02059291|76173696|FG019|STARTED|Epoch 3||0||
59515947|NCT00991081|75609640|FG000|COMPLETED|Phase II, Randomized Control Trial||0||
60058301|NCT02059291|76173697|FG020|STARTED|Epoch 3||0||
59519046|NCT03398278|75612889|FG000|NOT COMPLETED|Period 2||2||
60058302|NCT02059291|76173698|FG021|STARTED|Epoch 3||0||
60058303|NCT02059291|76173699|FG022|STARTED|Epoch 3||0||
60058304|NCT02059291|76173700|FG023|STARTED|Epoch 3||0||
60058305|NCT02059291|76173701|FG024|STARTED|Epoch 3||0||
60058306|NCT02059291|76173677|FG000|COMPLETED|Epoch 3||0||
60058307|NCT02059291|76173678|FG001|COMPLETED|Epoch 3||0||
60058308|NCT02059291|76173679|FG002|COMPLETED|Epoch 3||0||
60058309|NCT02059291|76173680|FG003|COMPLETED|Epoch 3||0||
60058310|NCT02059291|76173681|FG004|COMPLETED|Epoch 3||0||
60058311|NCT02059291|76173682|FG005|COMPLETED|Epoch 3||0||
60058312|NCT02059291|76173683|FG006|COMPLETED|Epoch 3||2||
60058313|NCT02059291|76173684|FG007|COMPLETED|Epoch 3||1||
60058314|NCT02059291|76173685|FG008|COMPLETED|Epoch 3||0||
60058315|NCT02059291|76173686|FG009|COMPLETED|Epoch 3||9||
60058316|NCT02059291|76173687|FG010|COMPLETED|Epoch 3||10||
60058317|NCT02059291|76173688|FG011|COMPLETED|Epoch 3||6||
60058318|NCT02059291|76173689|FG012|COMPLETED|Epoch 3||7||
60058319|NCT02059291|76173690|FG013|COMPLETED|Epoch 3||3||
60058320|NCT02059291|76173691|FG014|COMPLETED|Epoch 3||5||
60058321|NCT02059291|76173692|FG015|COMPLETED|Epoch 3||120||
60058322|NCT02059291|76173693|FG016|COMPLETED|Epoch 3||0||
60058323|NCT02059291|76173694|FG017|COMPLETED|Epoch 3||0||
60058324|NCT02059291|76173695|FG018|COMPLETED|Epoch 3||0||
60058325|NCT02059291|76173696|FG019|COMPLETED|Epoch 3||0||
60058326|NCT02059291|76173697|FG020|COMPLETED|Epoch 3||0||
60058327|NCT02059291|76173698|FG021|COMPLETED|Epoch 3||0||
60058328|NCT02059291|76173699|FG022|COMPLETED|Epoch 3||0||
60058329|NCT02059291|76173700|FG023|COMPLETED|Epoch 3||0||
60058330|NCT02059291|76173701|FG024|COMPLETED|Epoch 3||0||
60058331|NCT02059291|76173677|FG000|NOT COMPLETED|Epoch 3||0||
60058332|NCT02059291|76173678|FG001|NOT COMPLETED|Epoch 3||0||
60058333|NCT02059291|76173679|FG002|NOT COMPLETED|Epoch 3||0||
60058334|NCT02059291|76173680|FG003|NOT COMPLETED|Epoch 3||0||
60058335|NCT02059291|76173681|FG004|NOT COMPLETED|Epoch 3||0||
60058336|NCT02059291|76173682|FG005|NOT COMPLETED|Epoch 3||0||
60058337|NCT02059291|76173683|FG006|NOT COMPLETED|Epoch 3||0||
60058338|NCT02059291|76173684|FG007|NOT COMPLETED|Epoch 3||0||
60058339|NCT02059291|76173685|FG008|NOT COMPLETED|Epoch 3||0||
59925929|NCT03414359|76044166|FG000|NOT COMPLETED|Overall Study||1||
59925930|NCT03414359|76044167|FG001|NOT COMPLETED|Overall Study||2||
59925931|NCT03285295|76044178|FG000|STARTED|Alinity s HBsAg||17095||
59925932|NCT03285295|76044179|FG001|STARTED|Alinity s HBsAg||438||
59925933|NCT03285295|76044180|FG002|STARTED|Alinity s HBsAg||403||
59925934|NCT03285295|76044181|FG003|STARTED|Alinity s HBsAg||0||
59925935|NCT03285295|76044182|FG004|STARTED|Alinity s HBsAg||51||
59925936|NCT03285295|76044178|FG000|COMPLETED|Alinity s HBsAg||16993||
59925937|NCT03285295|76044179|FG001|COMPLETED|Alinity s HBsAg||432||
59925938|NCT03285295|76044180|FG002|COMPLETED|Alinity s HBsAg||403||
59925939|NCT03285295|76044181|FG003|COMPLETED|Alinity s HBsAg||0||
60058340|NCT02059291|76173686|FG009|NOT COMPLETED|Epoch 3||0||
60058341|NCT02059291|76173687|FG010|NOT COMPLETED|Epoch 3||0||
60058342|NCT02059291|76173688|FG011|NOT COMPLETED|Epoch 3||0||
60058343|NCT02059291|76173689|FG012|NOT COMPLETED|Epoch 3||0||
60058344|NCT02059291|76173690|FG013|NOT COMPLETED|Epoch 3||1||
60058345|NCT02059291|76173691|FG014|NOT COMPLETED|Epoch 3||0||
60058346|NCT02059291|76173692|FG015|NOT COMPLETED|Epoch 3||6||
60058347|NCT02059291|76173693|FG016|NOT COMPLETED|Epoch 3||0||
60058348|NCT02059291|76173694|FG017|NOT COMPLETED|Epoch 3||0||
60058349|NCT02059291|76173695|FG018|NOT COMPLETED|Epoch 3||0||
60058350|NCT02059291|76173696|FG019|NOT COMPLETED|Epoch 3||0||
60058351|NCT02059291|76173697|FG020|NOT COMPLETED|Epoch 3||0||
60058352|NCT02059291|76173698|FG021|NOT COMPLETED|Epoch 3||0||
60058353|NCT02059291|76173699|FG022|NOT COMPLETED|Epoch 3||0||
60058354|NCT02059291|76173700|FG023|NOT COMPLETED|Epoch 3||0||
60058355|NCT02059291|76173701|FG024|NOT COMPLETED|Epoch 3||0||
60058356|NCT02059291|76173677|FG000|STARTED|Epoch 4||0||
60058357|NCT02059291|76173678|FG001|STARTED|Epoch 4||0||
60058358|NCT02059291|76173679|FG002|STARTED|Epoch 4||0||
60058359|NCT02059291|76173680|FG003|STARTED|Epoch 4||0||
60058360|NCT02059291|76173681|FG004|STARTED|Epoch 4||0||
60058361|NCT02059291|76173682|FG005|STARTED|Epoch 4||0||
60058362|NCT02059291|76173683|FG006|STARTED|Epoch 4||0||
60058363|NCT02059291|76173684|FG007|STARTED|Epoch 4||0||
59925940|NCT03285295|76044182|FG004|COMPLETED|Alinity s HBsAg||51||
60058364|NCT02059291|76173685|FG008|STARTED|Epoch 4||0||
60058365|NCT02059291|76173686|FG009|STARTED|Epoch 4||0||
60058366|NCT02059291|76173687|FG010|STARTED|Epoch 4||0||
60058367|NCT02059291|76173688|FG011|STARTED|Epoch 4||0||
59925941|NCT03285295|76044178|FG000|NOT COMPLETED|Alinity s HBsAg||102||
59925942|NCT03285295|76044179|FG001|NOT COMPLETED|Alinity s HBsAg||6||
59925943|NCT03285295|76044180|FG002|NOT COMPLETED|Alinity s HBsAg||0||
59925944|NCT03285295|76044181|FG003|NOT COMPLETED|Alinity s HBsAg||0||
60058368|NCT02059291|76173689|FG012|STARTED|Epoch 4||0||
60058369|NCT02059291|76173690|FG013|STARTED|Epoch 4||0||
60058370|NCT02059291|76173691|FG014|STARTED|Epoch 4||0||
60058371|NCT02059291|76173692|FG015|STARTED|Epoch 4||0||
60058372|NCT02059291|76173693|FG016|STARTED|Epoch 4||43||
60058373|NCT02059291|76173694|FG017|STARTED|Epoch 4||14||
60058374|NCT02059291|76173695|FG018|STARTED|Epoch 4||2||
60058375|NCT02059291|76173696|FG019|STARTED|Epoch 4||18||
60058376|NCT02059291|76173697|FG020|STARTED|Epoch 4||34||
60058377|NCT02059291|76173698|FG021|STARTED|Epoch 4||14||
60058378|NCT02059291|76173699|FG022|STARTED|Epoch 4||31||
60058379|NCT02059291|76173700|FG023|STARTED|Epoch 4||22||
60058380|NCT02059291|76173701|FG024|STARTED|Epoch 4||0||
60058381|NCT02059291|76173677|FG000|COMPLETED|Epoch 4||0||
60058382|NCT02059291|76173678|FG001|COMPLETED|Epoch 4||0||
60058383|NCT02059291|76173679|FG002|COMPLETED|Epoch 4||0||
60058384|NCT02059291|76173680|FG003|COMPLETED|Epoch 4||0||
60058385|NCT02059291|76173681|FG004|COMPLETED|Epoch 4||0||
60058386|NCT02059291|76173682|FG005|COMPLETED|Epoch 4||0||
60058387|NCT02059291|76173683|FG006|COMPLETED|Epoch 4||0||
60058388|NCT02059291|76173684|FG007|COMPLETED|Epoch 4||0||
60058389|NCT02059291|76173685|FG008|COMPLETED|Epoch 4||0||
60058390|NCT02059291|76173686|FG009|COMPLETED|Epoch 4||0||
60058391|NCT02059291|76173687|FG010|COMPLETED|Epoch 4||0||
60058392|NCT02059291|76173688|FG011|COMPLETED|Epoch 4||0||
60058393|NCT02059291|76173689|FG012|COMPLETED|Epoch 4||0||
60058394|NCT02059291|76173690|FG013|COMPLETED|Epoch 4||0||
60058395|NCT02059291|76173691|FG014|COMPLETED|Epoch 4||0||
60058396|NCT02059291|76173692|FG015|COMPLETED|Epoch 4||0||
59515948|NCT00991081|75609641|FG001|COMPLETED|Phase II, Randomized Control Trial||15||
59515949|NCT00991081|75609642|FG002|COMPLETED|Phase II, Randomized Control Trial||15||
59925945|NCT03285295|76044182|FG004|NOT COMPLETED|Alinity s HBsAg||0||
59925946|NCT03285295|76044178|FG000|STARTED|Alinity s HBsAg Confirmatory||8||
59925947|NCT03285295|76044179|FG001|STARTED|Alinity s HBsAg Confirmatory||432||
59925948|NCT03285295|76044180|FG002|STARTED|Alinity s HBsAg Confirmatory||3||
59925949|NCT03285295|76044181|FG003|STARTED|Alinity s HBsAg Confirmatory||0||
59925950|NCT03285295|76044182|FG004|STARTED|Alinity s HBsAg Confirmatory||0||
59925951|NCT03285295|76044178|FG000|COMPLETED|Alinity s HBsAg Confirmatory||8||
59925952|NCT03285295|76044179|FG001|COMPLETED|Alinity s HBsAg Confirmatory||432||
59925953|NCT03285295|76044180|FG002|COMPLETED|Alinity s HBsAg Confirmatory||3||
59925954|NCT03285295|76044181|FG003|COMPLETED|Alinity s HBsAg Confirmatory||0||
59925955|NCT03285295|76044182|FG004|COMPLETED|Alinity s HBsAg Confirmatory||0||
59925956|NCT03285295|76044178|FG000|NOT COMPLETED|Alinity s HBsAg Confirmatory||0||
59925957|NCT03285295|76044179|FG001|NOT COMPLETED|Alinity s HBsAg Confirmatory||0||
59925958|NCT03285295|76044180|FG002|NOT COMPLETED|Alinity s HBsAg Confirmatory||0||
59925959|NCT03285295|76044181|FG003|NOT COMPLETED|Alinity s HBsAg Confirmatory||0||
59925960|NCT03285295|76044182|FG004|NOT COMPLETED|Alinity s HBsAg Confirmatory||0||
59925961|NCT03285295|76044178|FG000|STARTED|Alinity s HBsAg Follow-Up||0||
59925962|NCT03285295|76044179|FG001|STARTED|Alinity s HBsAg Follow-Up||0||
59925963|NCT03285295|76044180|FG002|STARTED|Alinity s HBsAg Follow-Up||0||
59925964|NCT03285295|76044181|FG003|STARTED|Alinity s HBsAg Follow-Up||0||
59925965|NCT03285295|76044182|FG004|STARTED|Alinity s HBsAg Follow-Up||0||
59925966|NCT03285295|76044178|FG000|COMPLETED|Alinity s HBsAg Follow-Up||0||
59925967|NCT03285295|76044179|FG001|COMPLETED|Alinity s HBsAg Follow-Up||0||
59925968|NCT03285295|76044180|FG002|COMPLETED|Alinity s HBsAg Follow-Up||0||
60058397|NCT02059291|76173693|FG016|COMPLETED|Epoch 4||41||
59515950|NCT00991081|75609640|FG000|NOT COMPLETED|Phase II, Randomized Control Trial||0||
59925969|NCT03285295|76044181|FG003|COMPLETED|Alinity s HBsAg Follow-Up||0||
59925970|NCT03285295|76044182|FG004|COMPLETED|Alinity s HBsAg Follow-Up||0||
59925971|NCT03285295|76044178|FG000|NOT COMPLETED|Alinity s HBsAg Follow-Up||0||
59925972|NCT03285295|76044179|FG001|NOT COMPLETED|Alinity s HBsAg Follow-Up||0||
59925973|NCT03285295|76044180|FG002|NOT COMPLETED|Alinity s HBsAg Follow-Up||0||
59925974|NCT03285295|76044181|FG003|NOT COMPLETED|Alinity s HBsAg Follow-Up||0||
59925975|NCT03285295|76044182|FG004|NOT COMPLETED|Alinity s HBsAg Follow-Up||0||
59925976|NCT03285295|76044178|FG000|STARTED|Alinity s HTLV I/II||15968||
59925977|NCT03285295|76044179|FG001|STARTED|Alinity s HTLV I/II||706||
60058398|NCT02059291|76173694|FG017|COMPLETED|Epoch 4||14||
60058399|NCT02059291|76173695|FG018|COMPLETED|Epoch 4||2||
60058400|NCT02059291|76173696|FG019|COMPLETED|Epoch 4||18||
60058401|NCT02059291|76173697|FG020|COMPLETED|Epoch 4||33||
60058402|NCT02059291|76173698|FG021|COMPLETED|Epoch 4||14||
60058403|NCT02059291|76173699|FG022|COMPLETED|Epoch 4||30||
60058404|NCT02059291|76173700|FG023|COMPLETED|Epoch 4||21||
60058405|NCT02059291|76173701|FG024|COMPLETED|Epoch 4||0||
60058406|NCT02059291|76173677|FG000|NOT COMPLETED|Epoch 4||0||
60058407|NCT02059291|76173678|FG001|NOT COMPLETED|Epoch 4||0||
60058408|NCT02059291|76173679|FG002|NOT COMPLETED|Epoch 4||0||
59515951|NCT00991081|75609641|FG001|NOT COMPLETED|Phase II, Randomized Control Trial||2||
59515952|NCT00991081|75609642|FG002|NOT COMPLETED|Phase II, Randomized Control Trial||4||
59515953|NCT03163342|75609648|FG000|STARTED|Overall Study||20||
59515954|NCT03163342|75609648|FG000|COMPLETED|Overall Study||20||
59515955|NCT03163342|75609648|FG000|NOT COMPLETED|Overall Study||0||
59515956|NCT03165058|75609654|FG000|STARTED|Overall Study||21||
59515957|NCT03165058|75609655|FG001|STARTED|Overall Study||11||
60058409|NCT02059291|76173680|FG003|NOT COMPLETED|Epoch 4||0||
60058410|NCT02059291|76173681|FG004|NOT COMPLETED|Epoch 4||0||
60058411|NCT02059291|76173682|FG005|NOT COMPLETED|Epoch 4||0||
60058412|NCT02059291|76173683|FG006|NOT COMPLETED|Epoch 4||0||
60058413|NCT02059291|76173684|FG007|NOT COMPLETED|Epoch 4||0||
60058414|NCT02059291|76173685|FG008|NOT COMPLETED|Epoch 4||0||
60058415|NCT02059291|76173686|FG009|NOT COMPLETED|Epoch 4||0||
60058416|NCT02059291|76173687|FG010|NOT COMPLETED|Epoch 4||0||
60058417|NCT02059291|76173688|FG011|NOT COMPLETED|Epoch 4||0||
60058418|NCT02059291|76173689|FG012|NOT COMPLETED|Epoch 4||0||
60058419|NCT02059291|76173690|FG013|NOT COMPLETED|Epoch 4||0||
60058420|NCT02059291|76173691|FG014|NOT COMPLETED|Epoch 4||0||
60058421|NCT02059291|76173692|FG015|NOT COMPLETED|Epoch 4||0||
60058422|NCT02059291|76173693|FG016|NOT COMPLETED|Epoch 4||2||
60058423|NCT02059291|76173694|FG017|NOT COMPLETED|Epoch 4||0||
60058424|NCT02059291|76173695|FG018|NOT COMPLETED|Epoch 4||0||
60058425|NCT02059291|76173696|FG019|NOT COMPLETED|Epoch 4||0||
60058426|NCT02059291|76173697|FG020|NOT COMPLETED|Epoch 4||1||
60058427|NCT02059291|76173698|FG021|NOT COMPLETED|Epoch 4||0||
60058428|NCT02059291|76173699|FG022|NOT COMPLETED|Epoch 4||1||
60058429|NCT02059291|76173700|FG023|NOT COMPLETED|Epoch 4||1||
60058430|NCT02059291|76173701|FG024|NOT COMPLETED|Epoch 4||0||
60058431|NCT02042924|76173729|FG000|STARTED|Overall Study||2||
60058432|NCT02042924|76173729|FG000|COMPLETED|Overall Study||1||
60058433|NCT02042924|76173729|FG000|NOT COMPLETED|Overall Study||1||
60058434|NCT02041520|76173735|FG000|STARTED|Overall Study|35 patients randomly assigned to omega 3 fatty acids|35||
60058435|NCT02041520|76173736|FG001|STARTED|Overall Study|35 patients randomly assigned to placebo|35||
60058436|NCT02041520|76173735|FG000|COMPLETED|Overall Study||29||
60058437|NCT02041520|76173736|FG001|COMPLETED|Overall Study||28||
60058438|NCT02041520|76173735|FG000|NOT COMPLETED|Overall Study||6||
60058439|NCT02041520|76173736|FG001|NOT COMPLETED|Overall Study||7||
60058440|NCT02041429|76173748|FG000|STARTED|Overall Study||3||
60058441|NCT02041429|76173749|FG001|STARTED|Overall Study||4||
60058442|NCT02041429|76173750|FG002|STARTED|Overall Study||7||
60058443|NCT02041429|76173751|FG003|STARTED|Overall Study||6||
60058444|NCT02041429|76173748|FG000|Treated|Overall Study||3||
60058445|NCT02041429|76173749|FG001|Treated|Overall Study||3||
60058446|NCT02041429|76173750|FG002|Treated|Overall Study||7||
60058447|NCT02041429|76173751|FG003|Treated|Overall Study||6||
59515958|NCT03165058|75609654|FG000|COMPLETED|Overall Study||21||
59515959|NCT03165058|75609655|FG001|COMPLETED|Overall Study||11||
59515960|NCT03165058|75609654|FG000|NOT COMPLETED|Overall Study||0||
59515961|NCT03165058|75609655|FG001|NOT COMPLETED|Overall Study||0||
59515962|NCT01351623|75609661|FG000|STARTED|Overall Study||44||
59515963|NCT01351623|75609661|FG000|COMPLETED|Overall Study||35||
59515964|NCT01351623|75609661|FG000|NOT COMPLETED|Overall Study||9||
59515965|NCT03168022|75609665|FG000|STARTED|Overall Study||21||
60058448|NCT02041429|76173748|FG000|Evaluable for Dose Limiting Toxicity|Overall Study||3||
60058449|NCT02041429|76173749|FG001|Evaluable for Dose Limiting Toxicity|Overall Study||3||
60058450|NCT02041429|76173750|FG002|Evaluable for Dose Limiting Toxicity|Overall Study||6||
60058451|NCT02041429|76173751|FG003|Evaluable for Dose Limiting Toxicity|Overall Study||6||
60058452|NCT02041429|76173748|FG000|COMPLETED|Overall Study||0||
60058453|NCT02041429|76173749|FG001|COMPLETED|Overall Study||0||
60058454|NCT02041429|76173750|FG002|COMPLETED|Overall Study||0||
60058455|NCT02041429|76173751|FG003|COMPLETED|Overall Study||0||
60058456|NCT02041429|76173748|FG000|NOT COMPLETED|Overall Study||3||
60058457|NCT02041429|76173749|FG001|NOT COMPLETED|Overall Study||4||
60058458|NCT02041429|76173750|FG002|NOT COMPLETED|Overall Study||7||
60058459|NCT02041429|76173751|FG003|NOT COMPLETED|Overall Study||6||
60058460|NCT02083783|76173768|FG000|STARTED|Overall Study||52|Open-Label Optimization|
60058461|NCT02083783|76173769|FG001|STARTED|Overall Study||48|Open-Label Optimization|
60058462|NCT02083783|76173768|FG000|COMPLETED|Overall Study||51||
60058463|NCT02083783|76173769|FG001|COMPLETED|Overall Study||48||
60058464|NCT02083783|76173768|FG000|NOT COMPLETED|Overall Study||1||
60058465|NCT02083783|76173769|FG001|NOT COMPLETED|Overall Study||0||
60058466|NCT02083081|76173779|FG000|STARTED|Overall Study||188||
60058467|NCT02083081|76173780|FG001|STARTED|Overall Study||164||
60058468|NCT02083081|76173779|FG000|COMPLETED|Overall Study||157||
60058469|NCT02083081|76173780|FG001|COMPLETED|Overall Study||155||
60058470|NCT02083081|76173779|FG000|NOT COMPLETED|Overall Study||31||
60058471|NCT02083081|76173780|FG001|NOT COMPLETED|Overall Study||9||
59515966|NCT03168022|75609666|FG001|STARTED|Overall Study||22||
59515967|NCT03168022|75609665|FG000|COMPLETED|Overall Study||21||
59515968|NCT03168022|75609666|FG001|COMPLETED|Overall Study||21||
59515969|NCT03168022|75609665|FG000|NOT COMPLETED|Overall Study||0||
59515970|NCT03168022|75609666|FG001|NOT COMPLETED|Overall Study||1||
60058472|NCT02040805|76173788|FG000|STARTED|Overall Study||160||
60058473|NCT02040805|76173789|FG001|STARTED|Overall Study||163||
60058474|NCT02040805|76173788|FG000|COMPLETED|Overall Study||118||
60058475|NCT02040805|76173789|FG001|COMPLETED|Overall Study||113||
60058476|NCT02040805|76173788|FG000|NOT COMPLETED|Overall Study||42||
60058477|NCT02040805|76173789|FG001|NOT COMPLETED|Overall Study||50||
60058478|NCT02040259|76173795|FG000|STARTED|Overall Study||2008||
60058479|NCT02040259|76173795|FG000|COMPLETED|Overall Study||1645||
60058480|NCT02040259|76173795|FG000|NOT COMPLETED|Overall Study||363||
60058481|NCT02059135|76173803|FG000|STARTED|Maternal Follow-up (ITT Population)||62||
60058482|NCT02059135|76173804|FG001|STARTED|Maternal Follow-up (ITT Population)||58||
60058483|NCT02059135|76173803|FG000|COMPLETED|Maternal Follow-up (ITT Population)||59||
60058484|NCT02059135|76173804|FG001|COMPLETED|Maternal Follow-up (ITT Population)||51||
60058485|NCT02059135|76173803|FG000|NOT COMPLETED|Maternal Follow-up (ITT Population)||3||
60058486|NCT02059135|76173804|FG001|NOT COMPLETED|Maternal Follow-up (ITT Population)||7||
60058487|NCT02059135|76173803|FG000|STARTED|Neonatal Follow-up (Safety Population)||60||
60058488|NCT02059135|76173804|FG001|STARTED|Neonatal Follow-up (Safety Population)||54||
60058489|NCT02059135|76173803|FG000|COMPLETED|Neonatal Follow-up (Safety Population)||56||
60058490|NCT02059135|76173804|FG001|COMPLETED|Neonatal Follow-up (Safety Population)||50||
60058491|NCT02059135|76173803|FG000|NOT COMPLETED|Neonatal Follow-up (Safety Population)||4||
60058492|NCT02059135|76173804|FG001|NOT COMPLETED|Neonatal Follow-up (Safety Population)||4||
60058493|NCT02081677|76173816|FG000|STARTED|Overall Study||19||
60058494|NCT02081677|76173817|FG001|STARTED|Overall Study||19||
60058495|NCT02081677|76173818|FG002|STARTED|Overall Study||19||
60058496|NCT02081677|76173819|FG003|STARTED|Overall Study||19||
60058497|NCT02081677|76173816|FG000|COMPLETED|Overall Study||18||
60058498|NCT02081677|76173817|FG001|COMPLETED|Overall Study||18||
60058499|NCT02081677|76173818|FG002|COMPLETED|Overall Study||17||
60058500|NCT02081677|76173819|FG003|COMPLETED|Overall Study||19||
60058501|NCT02081677|76173816|FG000|NOT COMPLETED|Overall Study||1||
60058502|NCT02081677|76173817|FG001|NOT COMPLETED|Overall Study||1||
60058503|NCT02081677|76173818|FG002|NOT COMPLETED|Overall Study||2||
60058504|NCT02081677|76173819|FG003|NOT COMPLETED|Overall Study||0||
60058505|NCT02038933|76173831|FG000|STARTED|Overall Study||121||
60058506|NCT02038933|76173831|FG000|COMPLETED|Overall Study||0||
60058507|NCT02038933|76173831|FG000|NOT COMPLETED|Overall Study||121||
60058508|NCT02081599|76173838|FG000|STARTED|Period 1：Double-blind Period||71||
60058509|NCT02081599|76173839|FG001|STARTED|Period 1：Double-blind Period||77||
60058510|NCT02081599|76173838|FG000|COMPLETED|Period 1：Double-blind Period||63||
60058511|NCT02081599|76173839|FG001|COMPLETED|Period 1：Double-blind Period||75||
60058512|NCT02081599|76173838|FG000|NOT COMPLETED|Period 1：Double-blind Period||8||
60058513|NCT02081599|76173839|FG001|NOT COMPLETED|Period 1：Double-blind Period||2||
60058514|NCT02081599|76173838|FG000|STARTED|Period 2：Open-label Period||63||
60058515|NCT02081599|76173839|FG001|STARTED|Period 2：Open-label Period||75||
60058516|NCT02081599|76173838|FG000|COMPLETED|Period 2：Open-label Period||57||
60058517|NCT02081599|76173839|FG001|COMPLETED|Period 2：Open-label Period||71||
60058518|NCT02081599|76173838|FG000|NOT COMPLETED|Period 2：Open-label Period||6||
60058519|NCT02081599|76173839|FG001|NOT COMPLETED|Period 2：Open-label Period||4||
60058520|NCT02038543|76173851|FG000|STARTED|Overall Study||7||
60058521|NCT02038543|76173852|FG001|STARTED|Overall Study||4||
60058522|NCT02038543|76173853|FG002|STARTED|Overall Study||8||
60058523|NCT02038543|76173854|FG003|STARTED|Overall Study||3||
60058524|NCT02038543|76173851|FG000|COMPLETED|Overall Study||7||
60058525|NCT02038543|76173852|FG001|COMPLETED|Overall Study||4||
60058526|NCT02038543|76173853|FG002|COMPLETED|Overall Study||8||
60058527|NCT02038543|76173854|FG003|COMPLETED|Overall Study||1||
60058528|NCT02038543|76173851|FG000|NOT COMPLETED|Overall Study||0||
60058529|NCT02038543|76173852|FG001|NOT COMPLETED|Overall Study||0||
60058530|NCT02038543|76173853|FG002|NOT COMPLETED|Overall Study||0||
60058531|NCT02038543|76173854|FG003|NOT COMPLETED|Overall Study||2||
60058532|NCT02038153|76173864|FG000|STARTED|Overall Study||3||
60058533|NCT02038153|76173864|FG000|COMPLETED|Overall Study||2||
60058534|NCT02038153|76173864|FG000|NOT COMPLETED|Overall Study||1||
60058535|NCT02058589|76173870|FG000|STARTED|Overall Study||132||
60058536|NCT02058589|76173871|FG001|STARTED|Overall Study||132||
60058537|NCT02058589|76173870|FG000|COMPLETED|Overall Study||130||
60058538|NCT02058589|76173871|FG001|COMPLETED|Overall Study||130||
60058539|NCT02058589|76173870|FG000|NOT COMPLETED|Overall Study||2||
60058540|NCT02058589|76173871|FG001|NOT COMPLETED|Overall Study||2||
60058541|NCT02079805|76173881|FG000|STARTED|Overall Study||16||
60058542|NCT02079805|76173882|FG001|STARTED|Overall Study||17||
60058543|NCT02079805|76173881|FG000|COMPLETED|Overall Study||16||
60058544|NCT02079805|76173882|FG001|COMPLETED|Overall Study||15||
60058545|NCT02079805|76173881|FG000|NOT COMPLETED|Overall Study||0||
60058546|NCT02079805|76173882|FG001|NOT COMPLETED|Overall Study||2||
60058547|NCT02037295|76173892|FG000|STARTED|Phase 1: Crossover UF and OF||9||
60058548|NCT02037295|76173893|FG001|STARTED|Phase 1: Crossover UF and OF||7||
60058549|NCT02037295|76173894|FG002|STARTED|Phase 1: Crossover UF and OF||4||
60058550|NCT02037295|76173895|FG003|STARTED|Phase 1: Crossover UF and OF||7||
59515971|NCT03102190|75609674|FG000|STARTED|Overall Study||6||
60058551|NCT02037295|76173892|FG000|COMPLETED|Phase 1: Crossover UF and OF||9||
60058552|NCT02037295|76173893|FG001|COMPLETED|Phase 1: Crossover UF and OF||7||
60058553|NCT02037295|76173894|FG002|COMPLETED|Phase 1: Crossover UF and OF||4||
60058554|NCT02037295|76173895|FG003|COMPLETED|Phase 1: Crossover UF and OF||7||
60058555|NCT02037295|76173892|FG000|NOT COMPLETED|Phase 1: Crossover UF and OF||0||
60058556|NCT02037295|76173893|FG001|NOT COMPLETED|Phase 1: Crossover UF and OF||0||
60058557|NCT02037295|76173894|FG002|NOT COMPLETED|Phase 1: Crossover UF and OF||0||
60058558|NCT02037295|76173895|FG003|NOT COMPLETED|Phase 1: Crossover UF and OF||0||
60058559|NCT02037295|76173892|FG000|STARTED|Phase 2: Vancomycin and Placebo||9||
60058560|NCT02037295|76173893|FG001|STARTED|Phase 2: Vancomycin and Placebo||7||
60058561|NCT02037295|76173894|FG002|STARTED|Phase 2: Vancomycin and Placebo||4||
60058562|NCT02037295|76173895|FG003|STARTED|Phase 2: Vancomycin and Placebo||7||
60058563|NCT02037295|76173892|FG000|COMPLETED|Phase 2: Vancomycin and Placebo||8||
60058564|NCT02037295|76173893|FG001|COMPLETED|Phase 2: Vancomycin and Placebo||7||
60058565|NCT02037295|76173894|FG002|COMPLETED|Phase 2: Vancomycin and Placebo||4||
60058566|NCT02037295|76173895|FG003|COMPLETED|Phase 2: Vancomycin and Placebo||6||
60058567|NCT02037295|76173892|FG000|NOT COMPLETED|Phase 2: Vancomycin and Placebo||1||
59515972|NCT03102190|75609674|FG000|COMPLETED|Overall Study||6||
59515973|NCT03102190|75609674|FG000|NOT COMPLETED|Overall Study||0||
59515974|NCT02163811|75609680|FG000|STARTED|Overall Study||71||
60058568|NCT02037295|76173893|FG001|NOT COMPLETED|Phase 2: Vancomycin and Placebo||0||
60058569|NCT02037295|76173894|FG002|NOT COMPLETED|Phase 2: Vancomycin and Placebo||0||
60058570|NCT02037295|76173895|FG003|NOT COMPLETED|Phase 2: Vancomycin and Placebo||1||
60058571|NCT02079649|76173911|FG000|STARTED|Overall Study||42||
60058572|NCT02079649|76173912|FG001|STARTED|Overall Study||41||
60058573|NCT02079649|76173913|FG002|STARTED|Overall Study||41||
60058574|NCT02079649|76173914|FG003|STARTED|Overall Study||40||
60058575|NCT02079649|76173911|FG000|Treated|Overall Study||41||
60058576|NCT02079649|76173912|FG001|Treated|Overall Study||41||
60058577|NCT02079649|76173913|FG002|Treated|Overall Study||40||
60058578|NCT02079649|76173914|FG003|Treated|Overall Study||40||
60058579|NCT02079649|76173911|FG000|COMPLETED|Overall Study||41||
60058580|NCT02079649|76173912|FG001|COMPLETED|Overall Study||41||
60058581|NCT02079649|76173913|FG002|COMPLETED|Overall Study||40||
60058582|NCT02079649|76173914|FG003|COMPLETED|Overall Study||38||
60058583|NCT02079649|76173911|FG000|NOT COMPLETED|Overall Study||1||
60058584|NCT02079649|76173912|FG001|NOT COMPLETED|Overall Study||0||
60058585|NCT02079649|76173913|FG002|NOT COMPLETED|Overall Study||1||
60058586|NCT02079649|76173914|FG003|NOT COMPLETED|Overall Study||2||
60058587|NCT02036515|76173928|FG000|STARTED|Overall Study||156||
60058588|NCT02036515|76173929|FG001|STARTED|Overall Study||155||
60058589|NCT02036515|76173930|FG002|STARTED|Overall Study||153||
60058590|NCT02036515|76173928|FG000|Treated|Overall Study||156||
60058591|NCT02036515|76173929|FG001|Treated|Overall Study||153||
60058592|NCT02036515|76173930|FG002|Treated|Overall Study||153||
60058593|NCT02036515|76173928|FG000|COMPLETED|Overall Study||151||
60058594|NCT02036515|76173929|FG001|COMPLETED|Overall Study||143||
60058595|NCT02036515|76173930|FG002|COMPLETED|Overall Study||139||
60058596|NCT02036515|76173928|FG000|NOT COMPLETED|Overall Study||5||
60058597|NCT02036515|76173929|FG001|NOT COMPLETED|Overall Study||12||
60058598|NCT02036515|76173930|FG002|NOT COMPLETED|Overall Study||14||
60058599|NCT02078713|76173942|FG000|STARTED|Overall Study||407||
60058600|NCT02078713|76173943|FG001|STARTED|Overall Study||351||
60058601|NCT02078713|76173944|FG002|STARTED|Overall Study||15||
60058602|NCT02078713|76173945|FG003|STARTED|Overall Study||13||
60058603|NCT02078713|76173942|FG000|COMPLETED|Overall Study||355||
60058604|NCT02078713|76173943|FG001|COMPLETED|Overall Study||290||
60058605|NCT02078713|76173944|FG002|COMPLETED|Overall Study||15||
60058606|NCT02078713|76173945|FG003|COMPLETED|Overall Study||13||
60058607|NCT02078713|76173942|FG000|NOT COMPLETED|Overall Study||52||
60058608|NCT02078713|76173943|FG001|NOT COMPLETED|Overall Study||61||
60058609|NCT02078713|76173944|FG002|NOT COMPLETED|Overall Study||0||
60058610|NCT02078713|76173945|FG003|NOT COMPLETED|Overall Study||0||
60058611|NCT02035267|76173961|FG000|STARTED|Overall Study||31||
60058612|NCT02035267|76173962|FG001|STARTED|Overall Study||16||
59515975|NCT02163811|75609681|FG001|STARTED|Overall Study||76||
60058613|NCT02035267|76173963|FG002|STARTED|Overall Study||30||
60058614|NCT02035267|76173964|FG003|STARTED|Overall Study||16||
60058615|NCT02035267|76173961|FG000|COMPLETED|Overall Study||31||
60058616|NCT02035267|76173962|FG001|COMPLETED|Overall Study||15||
60058617|NCT02035267|76173963|FG002|COMPLETED|Overall Study||28||
60058618|NCT02035267|76173964|FG003|COMPLETED|Overall Study||15||
60058619|NCT02035267|76173961|FG000|NOT COMPLETED|Overall Study||0||
60058620|NCT02035267|76173962|FG001|NOT COMPLETED|Overall Study||1||
60058621|NCT02035267|76173963|FG002|NOT COMPLETED|Overall Study||2||
60058622|NCT02035267|76173964|FG003|NOT COMPLETED|Overall Study||1||
60058623|NCT05653362|76173978|FG000|STARTED|Overall Study||20||
60058624|NCT05653362|76173979|FG001|STARTED|Overall Study||20||
60058625|NCT05653362|76173978|FG000|COMPLETED|Overall Study||20||
60058626|NCT05653362|76173979|FG001|COMPLETED|Overall Study||20||
60058627|NCT05653362|76173978|FG000|NOT COMPLETED|Overall Study||0||
60058628|NCT05653362|76173979|FG001|NOT COMPLETED|Overall Study||0||
60058629|NCT04822467|76173989|FG000|STARTED|Overall Study||29||
60058630|NCT04822467|76173990|FG001|STARTED|Overall Study||30||
60058631|NCT04822467|76173989|FG000|COMPLETED|Overall Study||29||
60058632|NCT04822467|76173990|FG001|COMPLETED|Overall Study||30||
60058633|NCT04822467|76173989|FG000|NOT COMPLETED|Overall Study||0||
60058634|NCT04822467|76173990|FG001|NOT COMPLETED|Overall Study||0||
60058635|NCT04373460|76173998|FG000|STARTED|Overall Study||610||
60058636|NCT04373460|76173999|FG001|STARTED|Overall Study||615||
60058637|NCT04373460|76173998|FG000|COMPLETED|Overall Study||592||
60058638|NCT04373460|76173999|FG001|COMPLETED|Overall Study||589||
60058639|NCT04373460|76173998|FG000|NOT COMPLETED|Overall Study||18||
60058640|NCT04373460|76173999|FG001|NOT COMPLETED|Overall Study||26||
60058641|NCT04280081|76174009|FG000|STARTED|Overall Study||77||
60058642|NCT04280081|76174009|FG000|Enrolled: All NSCLC|Overall Study||47||
60058643|NCT04280081|76174009|FG000|Enrolled: All TC|Overall Study||1||
60058644|NCT04280081|76174009|FG000|Enrolled: All MTC|Overall Study||29||
60058645|NCT04280081|76174009|FG000|PAS: RET Fusion Positive NSCLC|Overall Study||26||
60058646|NCT04280081|76174009|FG000|PAS: RET Fusion Positive TC|Overall Study||1||
60058647|NCT04280081|76174009|FG000|PAS: Advance RET-mutant MTC|Overall Study||26||
60058648|NCT04280081|76174009|FG000|COMPLETED|Overall Study||65||
60058649|NCT04280081|76174009|FG000|NOT COMPLETED|Overall Study||12||
60058650|NCT04159805|76174025|FG000|STARTED|Overall Study||12||
60058651|NCT04159805|76174026|FG001|STARTED|Overall Study||12||
60058652|NCT04159805|76174027|FG002|STARTED|Overall Study||12||
60058653|NCT04159805|76174025|FG000|COMPLETED|Overall Study||12||
60058654|NCT04159805|76174026|FG001|COMPLETED|Overall Study||10||
60058655|NCT04159805|76174027|FG002|COMPLETED|Overall Study||10||
60058656|NCT04159805|76174025|FG000|NOT COMPLETED|Overall Study||0||
60058657|NCT04159805|76174026|FG001|NOT COMPLETED|Overall Study||2||
60058658|NCT04159805|76174027|FG002|NOT COMPLETED|Overall Study||2||
60058659|NCT03901456|76174038|FG000|STARTED|Overall Study||20||
60058660|NCT03901456|76174039|FG001|STARTED|Overall Study||22||
60058661|NCT03901456|76174040|FG002|STARTED|Overall Study||21||
60058662|NCT03901456|76174038|FG000|COMPLETED|Overall Study||20||
60058663|NCT03901456|76174039|FG001|COMPLETED|Overall Study||21||
60058664|NCT03901456|76174040|FG002|COMPLETED|Overall Study||20||
60058665|NCT03901456|76174038|FG000|NOT COMPLETED|Overall Study||0||
60058666|NCT03901456|76174039|FG001|NOT COMPLETED|Overall Study||1||
60058667|NCT03901456|76174040|FG002|NOT COMPLETED|Overall Study||1||
60058668|NCT03811847|76174050|FG000|STARTED|Block 1A||1||
60058669|NCT03811847|76174051|FG001|STARTED|Block 1A||1||
60058670|NCT03811847|76174052|FG002|STARTED|Block 1A||1||
60058671|NCT03811847|76174053|FG003|STARTED|Block 1A||2||
60058672|NCT03811847|76174054|FG004|STARTED|Block 1A||1||
60058673|NCT03811847|76174055|FG005|STARTED|Block 1A||1||
60058674|NCT03811847|76174050|FG000|COMPLETED|Block 1A||1||
60058675|NCT03811847|76174051|FG001|COMPLETED|Block 1A||1||
60058676|NCT03811847|76174052|FG002|COMPLETED|Block 1A||1||
60058677|NCT03811847|76174053|FG003|COMPLETED|Block 1A||2||
60058678|NCT03811847|76174054|FG004|COMPLETED|Block 1A||1||
60058679|NCT03811847|76174055|FG005|COMPLETED|Block 1A||1||
60058680|NCT03811847|76174050|FG000|NOT COMPLETED|Block 1A||0||
60058681|NCT03811847|76174051|FG001|NOT COMPLETED|Block 1A||0||
60058682|NCT03811847|76174052|FG002|NOT COMPLETED|Block 1A||0||
60058683|NCT03811847|76174053|FG003|NOT COMPLETED|Block 1A||0||
60058684|NCT03811847|76174054|FG004|NOT COMPLETED|Block 1A||0||
60058685|NCT03811847|76174055|FG005|NOT COMPLETED|Block 1A||0||
60058686|NCT03811847|76174050|FG000|STARTED|Block 1B||1||
60058687|NCT03811847|76174051|FG001|STARTED|Block 1B||1||
60058688|NCT03811847|76174052|FG002|STARTED|Block 1B||1||
60058689|NCT03811847|76174053|FG003|STARTED|Block 1B||2||
60058690|NCT03811847|76174054|FG004|STARTED|Block 1B||1||
60058691|NCT03811847|76174055|FG005|STARTED|Block 1B||1||
60058692|NCT03811847|76174050|FG000|COMPLETED|Block 1B||1||
60058693|NCT03811847|76174051|FG001|COMPLETED|Block 1B||1||
60058694|NCT03811847|76174052|FG002|COMPLETED|Block 1B||1||
60058695|NCT03811847|76174053|FG003|COMPLETED|Block 1B||2||
60058696|NCT03811847|76174054|FG004|COMPLETED|Block 1B||1||
60058697|NCT03811847|76174055|FG005|COMPLETED|Block 1B||1||
60058698|NCT03811847|76174050|FG000|NOT COMPLETED|Block 1B||0||
60058699|NCT03811847|76174051|FG001|NOT COMPLETED|Block 1B||0||
60058700|NCT03811847|76174052|FG002|NOT COMPLETED|Block 1B||0||
60058701|NCT03811847|76174053|FG003|NOT COMPLETED|Block 1B||0||
60058702|NCT03811847|76174054|FG004|NOT COMPLETED|Block 1B||0||
60058703|NCT03811847|76174055|FG005|NOT COMPLETED|Block 1B||0||
60058704|NCT03811847|76174050|FG000|STARTED|Block 2 A||1||
60058705|NCT03811847|76174051|FG001|STARTED|Block 2 A||1||
60058706|NCT03811847|76174052|FG002|STARTED|Block 2 A||1||
60058707|NCT03811847|76174053|FG003|STARTED|Block 2 A||2||
60058708|NCT03811847|76174054|FG004|STARTED|Block 2 A||1||
60058709|NCT03811847|76174055|FG005|STARTED|Block 2 A||1||
60058710|NCT03811847|76174050|FG000|COMPLETED|Block 2 A||1||
60058711|NCT03811847|76174051|FG001|COMPLETED|Block 2 A||1||
60058712|NCT03811847|76174052|FG002|COMPLETED|Block 2 A||1||
59515976|NCT02163811|75609680|FG000|COMPLETED|Overall Study||35||
59515977|NCT02163811|75609681|FG001|COMPLETED|Overall Study||60||
59515978|NCT02163811|75609680|FG000|NOT COMPLETED|Overall Study||36||
59515979|NCT02163811|75609681|FG001|NOT COMPLETED|Overall Study||16||
59515980|NCT03168334|75609689|FG000|STARTED|Overall Study||397||
59515981|NCT03168334|75609690|FG001|STARTED|Overall Study||404||
59515982|NCT03168334|75609689|FG000|COMPLETED|Overall Study||345||
59515983|NCT03168334|75609690|FG001|COMPLETED|Overall Study||366||
59515984|NCT03168334|75609689|FG000|NOT COMPLETED|Overall Study||52||
60058713|NCT03811847|76174053|FG003|COMPLETED|Block 2 A||2||
60058714|NCT03811847|76174054|FG004|COMPLETED|Block 2 A||1||
60058715|NCT03811847|76174055|FG005|COMPLETED|Block 2 A||1||
60058716|NCT03811847|76174050|FG000|NOT COMPLETED|Block 2 A||0||
60058717|NCT03811847|76174051|FG001|NOT COMPLETED|Block 2 A||0||
60058718|NCT03811847|76174052|FG002|NOT COMPLETED|Block 2 A||0||
60058719|NCT03811847|76174053|FG003|NOT COMPLETED|Block 2 A||0||
60058720|NCT03811847|76174054|FG004|NOT COMPLETED|Block 2 A||0||
60058721|NCT03811847|76174055|FG005|NOT COMPLETED|Block 2 A||0||
60058722|NCT03811847|76174050|FG000|STARTED|Block 2B||1||
60058723|NCT03811847|76174051|FG001|STARTED|Block 2B||1||
60058724|NCT03811847|76174052|FG002|STARTED|Block 2B||1||
60058725|NCT03811847|76174053|FG003|STARTED|Block 2B||2||
60058726|NCT03811847|76174054|FG004|STARTED|Block 2B||1||
60058727|NCT03811847|76174055|FG005|STARTED|Block 2B||1||
60058728|NCT03811847|76174050|FG000|COMPLETED|Block 2B||1||
60058729|NCT03811847|76174051|FG001|COMPLETED|Block 2B||1||
60058730|NCT03811847|76174052|FG002|COMPLETED|Block 2B||1||
60058731|NCT03811847|76174053|FG003|COMPLETED|Block 2B||2||
60058732|NCT03811847|76174054|FG004|COMPLETED|Block 2B||1||
60058733|NCT03811847|76174055|FG005|COMPLETED|Block 2B||1||
60058734|NCT03811847|76174050|FG000|NOT COMPLETED|Block 2B||0||
60058735|NCT03811847|76174051|FG001|NOT COMPLETED|Block 2B||0||
60058736|NCT03811847|76174052|FG002|NOT COMPLETED|Block 2B||0||
60058737|NCT03811847|76174053|FG003|NOT COMPLETED|Block 2B||0||
60058738|NCT03811847|76174054|FG004|NOT COMPLETED|Block 2B||0||
60058739|NCT03811847|76174055|FG005|NOT COMPLETED|Block 2B||0||
60058740|NCT03811847|76174050|FG000|STARTED|Block 3A||1||
59515985|NCT03168334|75609690|FG001|NOT COMPLETED|Overall Study||38||
59515986|NCT03102736|75609698|FG000|STARTED|Overall Study||7||
59515987|NCT03102736|75609699|FG001|STARTED|Overall Study||9||
59515988|NCT03102736|75609698|FG000|COMPLETED|Overall Study||7||
59515989|NCT03102736|75609699|FG001|COMPLETED|Overall Study||9||
59515990|NCT03102736|75609698|FG000|NOT COMPLETED|Overall Study||0||
59515991|NCT03102736|75609699|FG001|NOT COMPLETED|Overall Study||0||
59515992|NCT00992719|75609708|FG000|STARTED|Overall Study||28||
59515993|NCT00992719|75609709|FG001|STARTED|Overall Study||28||
59515994|NCT00992719|75609710|FG002|STARTED|Overall Study||28||
59515995|NCT00992719|75609708|FG000|COMPLETED|Overall Study||27||
60058741|NCT03811847|76174051|FG001|STARTED|Block 3A||1||
60058742|NCT03811847|76174052|FG002|STARTED|Block 3A||1||
60058743|NCT03811847|76174053|FG003|STARTED|Block 3A||2||
60058744|NCT03811847|76174054|FG004|STARTED|Block 3A||1||
60058745|NCT03811847|76174055|FG005|STARTED|Block 3A||1||
60058746|NCT03811847|76174050|FG000|COMPLETED|Block 3A||1||
60058747|NCT03811847|76174051|FG001|COMPLETED|Block 3A||1||
60058748|NCT03811847|76174052|FG002|COMPLETED|Block 3A||1||
60058749|NCT03811847|76174053|FG003|COMPLETED|Block 3A||2||
60058750|NCT03811847|76174054|FG004|COMPLETED|Block 3A||1||
60058751|NCT03811847|76174055|FG005|COMPLETED|Block 3A||1||
60058752|NCT03811847|76174050|FG000|NOT COMPLETED|Block 3A||0||
60058753|NCT03811847|76174051|FG001|NOT COMPLETED|Block 3A||0||
60058754|NCT03811847|76174052|FG002|NOT COMPLETED|Block 3A||0||
60058755|NCT03811847|76174053|FG003|NOT COMPLETED|Block 3A||0||
60058756|NCT03811847|76174054|FG004|NOT COMPLETED|Block 3A||0||
60058757|NCT03811847|76174055|FG005|NOT COMPLETED|Block 3A||0||
60058758|NCT03811847|76174050|FG000|STARTED|Block 3B||1||
60058759|NCT03811847|76174051|FG001|STARTED|Block 3B||1||
60058760|NCT03811847|76174052|FG002|STARTED|Block 3B||1||
60058761|NCT03811847|76174053|FG003|STARTED|Block 3B||2||
60058762|NCT03811847|76174054|FG004|STARTED|Block 3B||1||
60058763|NCT03811847|76174055|FG005|STARTED|Block 3B||1||
60058764|NCT03811847|76174050|FG000|COMPLETED|Block 3B||1||
60058765|NCT03811847|76174051|FG001|COMPLETED|Block 3B||1||
60058766|NCT03811847|76174052|FG002|COMPLETED|Block 3B||1||
60058767|NCT03811847|76174053|FG003|COMPLETED|Block 3B||2||
60058768|NCT03811847|76174054|FG004|COMPLETED|Block 3B||1||
60058769|NCT03811847|76174055|FG005|COMPLETED|Block 3B||1||
60058770|NCT03811847|76174050|FG000|NOT COMPLETED|Block 3B||0||
60058771|NCT03811847|76174051|FG001|NOT COMPLETED|Block 3B||0||
60058772|NCT03811847|76174052|FG002|NOT COMPLETED|Block 3B||0||
60058773|NCT03811847|76174053|FG003|NOT COMPLETED|Block 3B||0||
60058774|NCT03811847|76174054|FG004|NOT COMPLETED|Block 3B||0||
60058775|NCT03811847|76174055|FG005|NOT COMPLETED|Block 3B||0||
60058776|NCT03675477|76174072|FG000|STARTED|Treatment Phase||41||
60058777|NCT03675477|76174073|FG001|STARTED|Treatment Phase||41||
60058778|NCT03675477|76174074|FG002|STARTED|Treatment Phase||41||
60058779|NCT03675477|76174075|FG003|STARTED|Treatment Phase||41||
60058780|NCT03675477|76174072|FG000|COMPLETED|Treatment Phase||41||
60058781|NCT03675477|76174073|FG001|COMPLETED|Treatment Phase||41||
60058782|NCT03675477|76174074|FG002|COMPLETED|Treatment Phase||41||
60058783|NCT03675477|76174075|FG003|COMPLETED|Treatment Phase||41||
60058784|NCT03675477|76174072|FG000|NOT COMPLETED|Treatment Phase||0||
60058785|NCT03675477|76174073|FG001|NOT COMPLETED|Treatment Phase||0||
60058786|NCT03675477|76174074|FG002|NOT COMPLETED|Treatment Phase||0||
60058787|NCT03675477|76174075|FG003|NOT COMPLETED|Treatment Phase||0||
60058788|NCT03675477|76174072|FG000|STARTED|Extension Phase|11 participants in the placebo arm in the treatment phase were randomized into the 8mg QD arm in the extension phase. 36 participants in the 8mg QD arm in the treatment phase remained in the same dose group in the extension phase.|47||
60058789|NCT03675477|76174073|FG001|STARTED|Extension Phase|10 participants in the placebo arm in the treatment phase were randomized into the 4mg BD arm in the extension phase. 39 participants in the 4mg BD arm in the treatment phase remained in the same dose group in the extension phase.|49||
60058790|NCT03675477|76174074|FG002|STARTED|Extension Phase|13 participants in the placebo arm in the treatment phase were randomized into the 4mg QD arm in the extension phase. 35 participants in the 4mg QD arm in the treatment phase remained in the same dose group in the extension phase.|48||
60058791|NCT03675477|76174075|FG003|STARTED|Extension Phase||0||
60058792|NCT03675477|76174072|FG000|COMPLETED|Extension Phase||47||
60058793|NCT03675477|76174073|FG001|COMPLETED|Extension Phase||49||
60058794|NCT03675477|76174074|FG002|COMPLETED|Extension Phase||48||
60058795|NCT03675477|76174075|FG003|COMPLETED|Extension Phase||0||
60058796|NCT03675477|76174072|FG000|NOT COMPLETED|Extension Phase||0||
60058797|NCT03675477|76174073|FG001|NOT COMPLETED|Extension Phase||0||
60058798|NCT03675477|76174074|FG002|NOT COMPLETED|Extension Phase||0||
60058799|NCT03675477|76174075|FG003|NOT COMPLETED|Extension Phase||0||
60058800|NCT03226249|76174091|FG000|STARTED|PEM Induction Cycles 1-3, and PET#2||30||
60058801|NCT03226249|76174091|FG000|PEM Cycle 1|PEM Induction Cycles 1-3, and PET#2||30||
60058802|NCT03226249|76174091|FG000|PEM Cycle 2|PEM Induction Cycles 1-3, and PET#2||30||
60058803|NCT03226249|76174091|FG000|PEM Cycle 3|PEM Induction Cycles 1-3, and PET#2||30||
60058804|NCT03226249|76174091|FG000|PET#2|PEM Induction Cycles 1-3, and PET#2||30||
59515996|NCT00992719|75609709|FG001|COMPLETED|Overall Study||27||
59760904|NCT04115189|75880563|FG000|COMPLETED|Overall Study||42||
60058805|NCT03226249|76174091|FG000|COMPLETED|PEM Induction Cycles 1-3, and PET#2||30||
60058806|NCT03226249|76174091|FG000|NOT COMPLETED|PEM Induction Cycles 1-3, and PET#2||0||
60058807|NCT03226249|76174091|FG000|STARTED|2 Cycles of AVD + PET#3||30||
60058808|NCT03226249|76174091|FG000|AVD Cycle 1|2 Cycles of AVD + PET#3||30||
60058809|NCT03226249|76174091|FG000|AVD Cycle 2|2 Cycles of AVD + PET#3||30||
60058810|NCT03226249|76174091|FG000|PET#3|2 Cycles of AVD + PET#3||30||
60058811|NCT03226249|76174091|FG000|COMPLETED|2 Cycles of AVD + PET#3||30||
60058812|NCT03226249|76174091|FG000|NOT COMPLETED|2 Cycles of AVD + PET#3||0||
60058813|NCT03226249|76174091|FG000|STARTED|2-4 Cycles of AVD +/- Chemo & RT, PET#4||30||
60058814|NCT03226249|76174091|FG000|2-4 Cycles of AVD +/- Chemo & RT|2-4 Cycles of AVD +/- Chemo & RT, PET#4||29||
60058815|NCT03226249|76174091|FG000|PET#4|2-4 Cycles of AVD +/- Chemo & RT, PET#4||29||
60058816|NCT03226249|76174091|FG000|COMPLETED|2-4 Cycles of AVD +/- Chemo & RT, PET#4||29||
60058817|NCT03226249|76174091|FG000|NOT COMPLETED|2-4 Cycles of AVD +/- Chemo & RT, PET#4||1||
60058818|NCT03226249|76174091|FG000|STARTED|PEM Consolidation (1-2 Years)||29||
59515997|NCT00992719|75609710|FG002|COMPLETED|Overall Study||28||
60058819|NCT03226249|76174091|FG000|COMPLETED|PEM Consolidation (1-2 Years)||0||
60058820|NCT03226249|76174091|FG000|NOT COMPLETED|PEM Consolidation (1-2 Years)||29||
60058821|NCT03226249|76174091|FG000|STARTED|Survival Follow-up|All patients that are treated with one dose of study drug go into follow-up.|30||
60058822|NCT03226249|76174091|FG000|COMPLETED|Survival Follow-up||0||
60058823|NCT03226249|76174091|FG000|NOT COMPLETED|Survival Follow-up||30||
60058824|NCT02849548|76174097|FG000|STARTED|Overall Study||13||
60058825|NCT02849548|76174098|FG001|STARTED|Overall Study||14||
60058826|NCT02849548|76174097|FG000|COMPLETED|Overall Study||11||
60058827|NCT02849548|76174098|FG001|COMPLETED|Overall Study||12||
60058828|NCT02849548|76174097|FG000|NOT COMPLETED|Overall Study||2||
60058829|NCT02849548|76174098|FG001|NOT COMPLETED|Overall Study||2||
60058830|NCT02763072|76174106|FG000|STARTED|Overall Study||12||
60058831|NCT02763072|76174107|FG001|STARTED|Overall Study||12||
60058832|NCT02763072|76174106|FG000|COMPLETED|Overall Study||11||
60058833|NCT02763072|76174107|FG001|COMPLETED|Overall Study||12||
60058834|NCT02763072|76174106|FG000|NOT COMPLETED|Overall Study||1||
60058835|NCT02763072|76174107|FG001|NOT COMPLETED|Overall Study||0||
60058836|NCT02411448|76174116|FG000|STARTED|Overall Study||14||
60058837|NCT02411448|76174117|FG001|STARTED|Overall Study||224||
60058838|NCT02411448|76174118|FG002|STARTED|Overall Study||225||
60058839|NCT02411448|76174116|FG000|Received at Least One Dose of Study Drug|Overall Study||14||
60058840|NCT02411448|76174117|FG001|Received at Least One Dose of Study Drug|Overall Study||221||
60058841|NCT02411448|76174118|FG002|Received at Least One Dose of Study Drug|Overall Study||225||
60058842|NCT02411448|76174116|FG000|COMPLETED|Overall Study||10||
60058843|NCT02411448|76174117|FG001|COMPLETED|Overall Study||141||
60058844|NCT02411448|76174118|FG002|COMPLETED|Overall Study||173||
60058845|NCT02411448|76174116|FG000|NOT COMPLETED|Overall Study||4||
60058846|NCT02411448|76174117|FG001|NOT COMPLETED|Overall Study||83||
60058847|NCT02411448|76174118|FG002|NOT COMPLETED|Overall Study||52||
60058848|NCT02321514|76174130|FG000|STARTED|Overall Study||191||
60058849|NCT02321514|76174130|FG000|COMPLETED|Overall Study||166||
60058850|NCT02321514|76174130|FG000|NOT COMPLETED|Overall Study||25||
60058851|NCT02266134|76174138|FG000|STARTED|Clinics #1-2: Beginning Aug 2015||9||1
60058852|NCT02266134|76174139|FG001|STARTED|Clinics #1-2: Beginning Aug 2015||11||1
60058853|NCT02266134|76174140|FG002|STARTED|Clinics #1-2: Beginning Aug 2015||14||1
60058854|NCT02266134|76174141|FG003|STARTED|Clinics #1-2: Beginning Aug 2015||14||1
60058855|NCT02266134|76174138|FG000|COMPLETED|Clinics #1-2: Beginning Aug 2015||3|"For patients, completion of the study refers to patients who completed both a baseline PHQ-9 and a 12-week PHQ-9.~For therapists, completion of the study refers to therapists who completed a baseline assessment and contributed to PHQ-9 fidelity data."|1
60058856|NCT02266134|76174139|FG001|COMPLETED|Clinics #1-2: Beginning Aug 2015||8|"For patients, completion of the study refers to patients who completed both a baseline PHQ-9 and a 12-week PHQ-9.~For therapists, completion of the study refers to therapists who completed a baseline assessment and contributed to PHQ-9 fidelity data."|1
60058857|NCT02266134|76174140|FG002|COMPLETED|Clinics #1-2: Beginning Aug 2015||14|"For patients, completion of the study refers to patients who completed both a baseline PHQ-9 and a 12-week PHQ-9.~For therapists, completion of the study refers to therapists who completed a baseline assessment and contributed to PHQ-9 fidelity data."|1
60058858|NCT02266134|76174141|FG003|COMPLETED|Clinics #1-2: Beginning Aug 2015||14|"For patients, completion of the study refers to patients who completed both a baseline PHQ-9 and a 12-week PHQ-9.~For therapists, completion of the study refers to therapists who completed a baseline assessment and contributed to PHQ-9 fidelity data."|1
60058859|NCT02266134|76174138|FG000|NOT COMPLETED|Clinics #1-2: Beginning Aug 2015||6||0
60058860|NCT02266134|76174139|FG001|NOT COMPLETED|Clinics #1-2: Beginning Aug 2015||3||0
60058861|NCT02266134|76174140|FG002|NOT COMPLETED|Clinics #1-2: Beginning Aug 2015||0||0
60058862|NCT02266134|76174141|FG003|NOT COMPLETED|Clinics #1-2: Beginning Aug 2015||0||0
60058863|NCT02266134|76174138|FG000|STARTED|Clinics #3-6: Beginning Dec 2015||47||2
60058864|NCT02266134|76174139|FG001|STARTED|Clinics #3-6: Beginning Dec 2015||24||2
60058865|NCT02266134|76174140|FG002|STARTED|Clinics #3-6: Beginning Dec 2015||14||2
60058866|NCT02266134|76174141|FG003|STARTED|Clinics #3-6: Beginning Dec 2015||17||2
60058867|NCT02266134|76174138|FG000|COMPLETED|Clinics #3-6: Beginning Dec 2015||39||2
60058868|NCT02266134|76174139|FG001|COMPLETED|Clinics #3-6: Beginning Dec 2015||22||2
60058869|NCT02266134|76174140|FG002|COMPLETED|Clinics #3-6: Beginning Dec 2015||14||2
60058870|NCT02266134|76174141|FG003|COMPLETED|Clinics #3-6: Beginning Dec 2015||17||2
60058871|NCT02266134|76174138|FG000|NOT COMPLETED|Clinics #3-6: Beginning Dec 2015||8||0
60058872|NCT02266134|76174139|FG001|NOT COMPLETED|Clinics #3-6: Beginning Dec 2015||2||0
60058873|NCT02266134|76174140|FG002|NOT COMPLETED|Clinics #3-6: Beginning Dec 2015||0||0
60058874|NCT02266134|76174141|FG003|NOT COMPLETED|Clinics #3-6: Beginning Dec 2015||0||0
60058875|NCT02266134|76174138|FG000|STARTED|Clinics #7-10: Beginning May 2016||39||2
60058876|NCT02266134|76174139|FG001|STARTED|Clinics #7-10: Beginning May 2016||33||2
60058877|NCT02266134|76174140|FG002|STARTED|Clinics #7-10: Beginning May 2016||28||2
60058878|NCT02266134|76174141|FG003|STARTED|Clinics #7-10: Beginning May 2016||29||2
60058879|NCT02266134|76174138|FG000|COMPLETED|Clinics #7-10: Beginning May 2016||26||2
60058880|NCT02266134|76174139|FG001|COMPLETED|Clinics #7-10: Beginning May 2016||28||2
60058881|NCT02266134|76174140|FG002|COMPLETED|Clinics #7-10: Beginning May 2016||28||2
60058882|NCT02266134|76174141|FG003|COMPLETED|Clinics #7-10: Beginning May 2016||29||2
60058883|NCT02266134|76174138|FG000|NOT COMPLETED|Clinics #7-10: Beginning May 2016||13||0
60058884|NCT02266134|76174139|FG001|NOT COMPLETED|Clinics #7-10: Beginning May 2016||5||0
60058885|NCT02266134|76174140|FG002|NOT COMPLETED|Clinics #7-10: Beginning May 2016||0||0
60058886|NCT02266134|76174141|FG003|NOT COMPLETED|Clinics #7-10: Beginning May 2016||0||0
60058887|NCT02266134|76174138|FG000|STARTED|Clinics #11-12: Beginning Dec 2016||46||1
60067866|NCT01785615|76183055|FG003|COMPLETED|Atorvastatin Phase||0||
60058888|NCT02266134|76174139|FG001|STARTED|Clinics #11-12: Beginning Dec 2016||19||1
60058889|NCT02266134|76174140|FG002|STARTED|Clinics #11-12: Beginning Dec 2016||15||1
60058890|NCT02266134|76174141|FG003|STARTED|Clinics #11-12: Beginning Dec 2016||23||1
59515998|NCT00992719|75609708|FG000|NOT COMPLETED|Overall Study||1||
59515999|NCT00992719|75609709|FG001|NOT COMPLETED|Overall Study||1||
60058891|NCT02266134|76174138|FG000|COMPLETED|Clinics #11-12: Beginning Dec 2016||37||1
60058892|NCT02266134|76174139|FG001|COMPLETED|Clinics #11-12: Beginning Dec 2016||17||1
60058893|NCT02266134|76174140|FG002|COMPLETED|Clinics #11-12: Beginning Dec 2016||15||1
60058894|NCT02266134|76174141|FG003|COMPLETED|Clinics #11-12: Beginning Dec 2016||23||1
60058895|NCT02266134|76174138|FG000|NOT COMPLETED|Clinics #11-12: Beginning Dec 2016||9||0
60058896|NCT02266134|76174139|FG001|NOT COMPLETED|Clinics #11-12: Beginning Dec 2016||2||0
60058897|NCT02266134|76174140|FG002|NOT COMPLETED|Clinics #11-12: Beginning Dec 2016||0||0
60058898|NCT02266134|76174141|FG003|NOT COMPLETED|Clinics #11-12: Beginning Dec 2016||0||0
60058899|NCT01860170|76174152|FG000|STARTED|Overall Study||3||
60058900|NCT01860170|76174153|FG001|STARTED|Overall Study||3||
60058901|NCT01860170|76174154|FG002|STARTED|Overall Study||22||
60058902|NCT01860170|76174152|FG000|COMPLETED|Overall Study||3||
59516000|NCT00992719|75609710|FG002|NOT COMPLETED|Overall Study||0||
59516001|NCT03169816|75609720|FG000|STARTED|Overall Study||33||
59516002|NCT03169816|75609721|FG001|STARTED|Overall Study||16||
59516003|NCT03169816|75609720|FG000|COMPLETED|Overall Study||6||
59516004|NCT03169816|75609721|FG001|COMPLETED|Overall Study||3||
59516005|NCT03169816|75609720|FG000|NOT COMPLETED|Overall Study||27||
60058903|NCT01860170|76174153|FG001|COMPLETED|Overall Study||3||
60058904|NCT01860170|76174154|FG002|COMPLETED|Overall Study||22||
60058905|NCT01860170|76174152|FG000|NOT COMPLETED|Overall Study||0||
60058906|NCT01860170|76174153|FG001|NOT COMPLETED|Overall Study||0||
60058907|NCT01860170|76174154|FG002|NOT COMPLETED|Overall Study||0||
60058908|NCT01847274|76174169|FG000|STARTED|Main Study (Upto 7years 7months 6 Days)||138||
60058909|NCT01847274|76174170|FG001|STARTED|Main Study (Upto 7years 7months 6 Days)||65||
60058910|NCT01847274|76174171|FG002|STARTED|Main Study (Upto 7years 7months 6 Days)||234||
60058911|NCT01847274|76174172|FG003|STARTED|Main Study (Upto 7years 7months 6 Days)||116||
60058912|NCT01847274|76174173|FG004|STARTED|Main Study (Upto 7years 7months 6 Days)||0||
60058913|NCT01847274|76174174|FG005|STARTED|Main Study (Upto 7years 7months 6 Days)||0||
60058914|NCT01847274|76174175|FG006|STARTED|Main Study (Upto 7years 7months 6 Days)||0||
60058915|NCT01847274|76174176|FG007|STARTED|Main Study (Upto 7years 7months 6 Days)||0||
60058916|NCT01847274|76174177|FG008|STARTED|Main Study (Upto 7years 7months 6 Days)||0||
60058917|NCT01847274|76174178|FG009|STARTED|Main Study (Upto 7years 7months 6 Days)||0||
60058918|NCT01847274|76174179|FG010|STARTED|Main Study (Upto 7years 7months 6 Days)||0||
60058919|NCT01847274|76174169|FG000|COMPLETED|Main Study (Upto 7years 7months 6 Days)||0||
60058920|NCT01847274|76174170|FG001|COMPLETED|Main Study (Upto 7years 7months 6 Days)||0||
60058921|NCT01847274|76174171|FG002|COMPLETED|Main Study (Upto 7years 7months 6 Days)||0||
60058922|NCT01847274|76174172|FG003|COMPLETED|Main Study (Upto 7years 7months 6 Days)||0||
60058923|NCT01847274|76174173|FG004|COMPLETED|Main Study (Upto 7years 7months 6 Days)||0||
60058924|NCT01847274|76174174|FG005|COMPLETED|Main Study (Upto 7years 7months 6 Days)||0||
60058925|NCT01847274|76174175|FG006|COMPLETED|Main Study (Upto 7years 7months 6 Days)||0||
60058926|NCT01847274|76174176|FG007|COMPLETED|Main Study (Upto 7years 7months 6 Days)||0||
60058927|NCT01847274|76174177|FG008|COMPLETED|Main Study (Upto 7years 7months 6 Days)||0||
60058928|NCT01847274|76174178|FG009|COMPLETED|Main Study (Upto 7years 7months 6 Days)||0||
60058929|NCT01847274|76174179|FG010|COMPLETED|Main Study (Upto 7years 7months 6 Days)||0||
60058930|NCT01847274|76174169|FG000|NOT COMPLETED|Main Study (Upto 7years 7months 6 Days)||138||
60058931|NCT01847274|76174170|FG001|NOT COMPLETED|Main Study (Upto 7years 7months 6 Days)||65||
60058932|NCT01847274|76174171|FG002|NOT COMPLETED|Main Study (Upto 7years 7months 6 Days)||234||
60058933|NCT01847274|76174172|FG003|NOT COMPLETED|Main Study (Upto 7years 7months 6 Days)||116||
60058934|NCT01847274|76174173|FG004|NOT COMPLETED|Main Study (Upto 7years 7months 6 Days)||0||
60058935|NCT01847274|76174174|FG005|NOT COMPLETED|Main Study (Upto 7years 7months 6 Days)||0||
60058936|NCT01847274|76174175|FG006|NOT COMPLETED|Main Study (Upto 7years 7months 6 Days)||0||
60058937|NCT01847274|76174176|FG007|NOT COMPLETED|Main Study (Upto 7years 7months 6 Days)||0||
60058938|NCT01847274|76174177|FG008|NOT COMPLETED|Main Study (Upto 7years 7months 6 Days)||0||
60058939|NCT01847274|76174178|FG009|NOT COMPLETED|Main Study (Upto 7years 7months 6 Days)||0||
59516006|NCT03169816|75609721|FG001|NOT COMPLETED|Overall Study||13||
59516007|NCT03103282|75609727|FG000|STARTED|Overall Study||65||
59516008|NCT03103282|75609727|FG000|COMPLETED|Overall Study||65||
59516009|NCT03103282|75609727|FG000|NOT COMPLETED|Overall Study||0||
60058940|NCT01847274|76174179|FG010|NOT COMPLETED|Main Study (Upto 7years 7months 6 Days)||0||
60058941|NCT01847274|76174169|FG000|STARTED|FE Sub-study, Period1 (Day1)||0||
59516010|NCT03103438|75609738|FG000|STARTED|Overall Study||1||
59516011|NCT03103438|75609739|FG001|STARTED|Overall Study||3||
59516012|NCT03103438|75609740|FG002|STARTED|Overall Study||3||
60058942|NCT01847274|76174170|FG001|STARTED|FE Sub-study, Period1 (Day1)||0||
60058943|NCT01847274|76174171|FG002|STARTED|FE Sub-study, Period1 (Day1)||0||
60058944|NCT01847274|76174172|FG003|STARTED|FE Sub-study, Period1 (Day1)||0||
59516013|NCT03103438|75609741|FG003|STARTED|Overall Study||3||
59516014|NCT03103438|75609742|FG004|STARTED|Overall Study||3||
60058945|NCT01847274|76174173|FG004|STARTED|FE Sub-study, Period1 (Day1)||8||
60058946|NCT01847274|76174174|FG005|STARTED|FE Sub-study, Period1 (Day1)||9||
60058947|NCT01847274|76174175|FG006|STARTED|FE Sub-study, Period1 (Day1)||0||
60058948|NCT01847274|76174176|FG007|STARTED|FE Sub-study, Period1 (Day1)||0||
60058949|NCT01847274|76174177|FG008|STARTED|FE Sub-study, Period1 (Day1)||0||
60058950|NCT01847274|76174178|FG009|STARTED|FE Sub-study, Period1 (Day1)||0||
60058951|NCT01847274|76174179|FG010|STARTED|FE Sub-study, Period1 (Day1)||0||
60058952|NCT01847274|76174169|FG000|COMPLETED|FE Sub-study, Period1 (Day1)||0||
60058953|NCT01847274|76174170|FG001|COMPLETED|FE Sub-study, Period1 (Day1)||0||
60058954|NCT01847274|76174171|FG002|COMPLETED|FE Sub-study, Period1 (Day1)||0||
60058955|NCT01847274|76174172|FG003|COMPLETED|FE Sub-study, Period1 (Day1)||0||
60058956|NCT01847274|76174173|FG004|COMPLETED|FE Sub-study, Period1 (Day1)||8||
60058957|NCT01847274|76174174|FG005|COMPLETED|FE Sub-study, Period1 (Day1)||8||
60058958|NCT01847274|76174175|FG006|COMPLETED|FE Sub-study, Period1 (Day1)||0||
60058959|NCT01847274|76174176|FG007|COMPLETED|FE Sub-study, Period1 (Day1)||0||
59516015|NCT03103438|75609743|FG005|STARTED|Overall Study||3||
59516016|NCT03103438|75609744|FG006|STARTED|Overall Study||3||
60058960|NCT01847274|76174177|FG008|COMPLETED|FE Sub-study, Period1 (Day1)||0||
60058961|NCT01847274|76174178|FG009|COMPLETED|FE Sub-study, Period1 (Day1)||0||
60058962|NCT01847274|76174179|FG010|COMPLETED|FE Sub-study, Period1 (Day1)||0||
60058963|NCT01847274|76174169|FG000|NOT COMPLETED|FE Sub-study, Period1 (Day1)||0||
60058964|NCT01847274|76174170|FG001|NOT COMPLETED|FE Sub-study, Period1 (Day1)||0||
60058965|NCT01847274|76174171|FG002|NOT COMPLETED|FE Sub-study, Period1 (Day1)||0||
60058966|NCT01847274|76174172|FG003|NOT COMPLETED|FE Sub-study, Period1 (Day1)||0||
60058967|NCT01847274|76174173|FG004|NOT COMPLETED|FE Sub-study, Period1 (Day1)||0||
60058968|NCT01847274|76174174|FG005|NOT COMPLETED|FE Sub-study, Period1 (Day1)||1||
60058969|NCT01847274|76174175|FG006|NOT COMPLETED|FE Sub-study, Period1 (Day1)||0||
60058970|NCT01847274|76174176|FG007|NOT COMPLETED|FE Sub-study, Period1 (Day1)||0||
60058971|NCT01847274|76174177|FG008|NOT COMPLETED|FE Sub-study, Period1 (Day1)||0||
60058972|NCT01847274|76174178|FG009|NOT COMPLETED|FE Sub-study, Period1 (Day1)||0||
60058973|NCT01847274|76174179|FG010|NOT COMPLETED|FE Sub-study, Period1 (Day1)||0||
60058974|NCT01847274|76174169|FG000|STARTED|FE Sub-study, Washout 1 (Up to Day 7)||0||
60058975|NCT01847274|76174170|FG001|STARTED|FE Sub-study, Washout 1 (Up to Day 7)||0||
60058976|NCT01847274|76174171|FG002|STARTED|FE Sub-study, Washout 1 (Up to Day 7)||0||
60058977|NCT01847274|76174172|FG003|STARTED|FE Sub-study, Washout 1 (Up to Day 7)||0||
60058978|NCT01847274|76174173|FG004|STARTED|FE Sub-study, Washout 1 (Up to Day 7)||8||
60058979|NCT01847274|76174174|FG005|STARTED|FE Sub-study, Washout 1 (Up to Day 7)||8||
60058980|NCT01847274|76174175|FG006|STARTED|FE Sub-study, Washout 1 (Up to Day 7)||0||
60058981|NCT01847274|76174176|FG007|STARTED|FE Sub-study, Washout 1 (Up to Day 7)||0||
60058982|NCT01847274|76174177|FG008|STARTED|FE Sub-study, Washout 1 (Up to Day 7)||0||
60058983|NCT01847274|76174178|FG009|STARTED|FE Sub-study, Washout 1 (Up to Day 7)||0||
60058984|NCT01847274|76174179|FG010|STARTED|FE Sub-study, Washout 1 (Up to Day 7)||0||
60058985|NCT01847274|76174169|FG000|COMPLETED|FE Sub-study, Washout 1 (Up to Day 7)||0||
60058986|NCT01847274|76174170|FG001|COMPLETED|FE Sub-study, Washout 1 (Up to Day 7)||0||
60058987|NCT01847274|76174171|FG002|COMPLETED|FE Sub-study, Washout 1 (Up to Day 7)||0||
60058988|NCT01847274|76174172|FG003|COMPLETED|FE Sub-study, Washout 1 (Up to Day 7)||0||
60058989|NCT01847274|76174173|FG004|COMPLETED|FE Sub-study, Washout 1 (Up to Day 7)||7||
60058990|NCT01847274|76174174|FG005|COMPLETED|FE Sub-study, Washout 1 (Up to Day 7)||8||
60058991|NCT01847274|76174175|FG006|COMPLETED|FE Sub-study, Washout 1 (Up to Day 7)||0||
60058992|NCT01847274|76174176|FG007|COMPLETED|FE Sub-study, Washout 1 (Up to Day 7)||0||
60058993|NCT01847274|76174177|FG008|COMPLETED|FE Sub-study, Washout 1 (Up to Day 7)||0||
60058994|NCT01847274|76174178|FG009|COMPLETED|FE Sub-study, Washout 1 (Up to Day 7)||0||
60058995|NCT01847274|76174179|FG010|COMPLETED|FE Sub-study, Washout 1 (Up to Day 7)||0||
60058996|NCT01847274|76174169|FG000|NOT COMPLETED|FE Sub-study, Washout 1 (Up to Day 7)||0||
60058997|NCT01847274|76174170|FG001|NOT COMPLETED|FE Sub-study, Washout 1 (Up to Day 7)||0||
60058998|NCT01847274|76174171|FG002|NOT COMPLETED|FE Sub-study, Washout 1 (Up to Day 7)||0||
60058999|NCT01847274|76174172|FG003|NOT COMPLETED|FE Sub-study, Washout 1 (Up to Day 7)||0||
60059000|NCT01847274|76174173|FG004|NOT COMPLETED|FE Sub-study, Washout 1 (Up to Day 7)||1||
60059001|NCT01847274|76174174|FG005|NOT COMPLETED|FE Sub-study, Washout 1 (Up to Day 7)||0||
60059002|NCT01847274|76174175|FG006|NOT COMPLETED|FE Sub-study, Washout 1 (Up to Day 7)||0||
60059003|NCT01847274|76174176|FG007|NOT COMPLETED|FE Sub-study, Washout 1 (Up to Day 7)||0||
60059004|NCT01847274|76174177|FG008|NOT COMPLETED|FE Sub-study, Washout 1 (Up to Day 7)||0||
60059005|NCT01847274|76174178|FG009|NOT COMPLETED|FE Sub-study, Washout 1 (Up to Day 7)||0||
60059006|NCT01847274|76174179|FG010|NOT COMPLETED|FE Sub-study, Washout 1 (Up to Day 7)||0||
60059007|NCT01847274|76174169|FG000|STARTED|FE Sub-study, Period 2 (Day 1)||0||
60059008|NCT01847274|76174170|FG001|STARTED|FE Sub-study, Period 2 (Day 1)||0||
60059009|NCT01847274|76174171|FG002|STARTED|FE Sub-study, Period 2 (Day 1)||0||
60059010|NCT01847274|76174172|FG003|STARTED|FE Sub-study, Period 2 (Day 1)||0||
60059011|NCT01847274|76174173|FG004|STARTED|FE Sub-study, Period 2 (Day 1)||7||
60059012|NCT01847274|76174174|FG005|STARTED|FE Sub-study, Period 2 (Day 1)||8||
60059013|NCT01847274|76174175|FG006|STARTED|FE Sub-study, Period 2 (Day 1)||0||
59516017|NCT03103438|75609738|FG000|COMPLETED|Overall Study||1||
59516018|NCT03103438|75609739|FG001|COMPLETED|Overall Study||3||
59516019|NCT03103438|75609740|FG002|COMPLETED|Overall Study||3||
59516020|NCT03103438|75609741|FG003|COMPLETED|Overall Study||3||
59516021|NCT03103438|75609742|FG004|COMPLETED|Overall Study||3||
59516022|NCT03103438|75609743|FG005|COMPLETED|Overall Study||3||
59516023|NCT03103438|75609744|FG006|COMPLETED|Overall Study||3||
59516024|NCT03103438|75609738|FG000|NOT COMPLETED|Overall Study||0||
59516025|NCT03103438|75609739|FG001|NOT COMPLETED|Overall Study||0||
59516026|NCT03103438|75609740|FG002|NOT COMPLETED|Overall Study||0||
59516027|NCT03103438|75609741|FG003|NOT COMPLETED|Overall Study||0||
59516028|NCT03103438|75609742|FG004|NOT COMPLETED|Overall Study||0||
59516029|NCT03103438|75609743|FG005|NOT COMPLETED|Overall Study||0||
59516030|NCT03103438|75609744|FG006|NOT COMPLETED|Overall Study||0||
59516031|NCT00993187|75609762|FG000|STARTED|Overall Study||147||
59516032|NCT00993187|75609763|FG001|STARTED|Overall Study||145||
59516033|NCT00993187|75609762|FG000|Received at Least 1 Dose of Study Drug|Overall Study||146||
59516034|NCT00993187|75609763|FG001|Received at Least 1 Dose of Study Drug|Overall Study||144||
59516035|NCT00993187|75609762|FG000|COMPLETED|Overall Study||121||
59516036|NCT00993187|75609763|FG001|COMPLETED|Overall Study||108||
59516037|NCT00993187|75609762|FG000|NOT COMPLETED|Overall Study||26||
59516038|NCT00993187|75609763|FG001|NOT COMPLETED|Overall Study||37||
59516039|NCT03106636|75609771|FG000|STARTED|Overall Study||226||
59516040|NCT03106636|75609772|FG001|STARTED|Overall Study||190||
59516041|NCT03106636|75609771|FG000|COMPLETED|Overall Study||182|Completed post-intervention data collection|
59516042|NCT03106636|75609772|FG001|COMPLETED|Overall Study||164|Completed post-intervention data collection|
59516043|NCT03106636|75609771|FG000|NOT COMPLETED|Overall Study||44||
59516044|NCT03106636|75609772|FG001|NOT COMPLETED|Overall Study||26||
59516045|NCT03173170|75609778|FG000|STARTED|First Intervention Period (6 Days)||10||
59516046|NCT03173170|75609778|FG000|COMPLETED|First Intervention Period (6 Days)||10||
59516047|NCT03173170|75609778|FG000|NOT COMPLETED|First Intervention Period (6 Days)||0||
59516048|NCT03173170|75609778|FG000|STARTED|Washout Period (at Least 7 Days)||10||
59516049|NCT03173170|75609778|FG000|COMPLETED|Washout Period (at Least 7 Days)||10||
59516050|NCT03173170|75609778|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||0||
59516051|NCT03173170|75609778|FG000|STARTED|Intervention Period 2 (9 Days)||10||
59516052|NCT03173170|75609778|FG000|COMPLETED|Intervention Period 2 (9 Days)||10||
59516053|NCT03173170|75609778|FG000|NOT COMPLETED|Intervention Period 2 (9 Days)||0||
59516054|NCT03106870|75609788|FG000|STARTED|Overall Study||31||
59516055|NCT03106870|75609789|FG001|STARTED|Overall Study||31||
59516056|NCT03106870|75609788|FG000|COMPLETED|Overall Study||31||
59516057|NCT03106870|75609789|FG001|COMPLETED|Overall Study||31||
59516058|NCT03106870|75609788|FG000|NOT COMPLETED|Overall Study||0||
59516059|NCT03106870|75609789|FG001|NOT COMPLETED|Overall Study||0||
59516060|NCT03687892|75609795|FG000|STARTED|Overall Study||37||
59516061|NCT03687892|75609795|FG000|COMPLETED|Overall Study||0||
59516062|NCT03687892|75609795|FG000|NOT COMPLETED|Overall Study||37||
59516063|NCT03670953|75609802|FG000|STARTED|Dose Adjustment (Weeks 1- 3)||630||
59516064|NCT03670953|75609803|FG001|STARTED|Dose Adjustment (Weeks 1- 3)||0||
59516065|NCT03670953|75609804|FG002|STARTED|Dose Adjustment (Weeks 1- 3)||0||
59516066|NCT03670953|75609805|FG003|STARTED|Dose Adjustment (Weeks 1- 3)||0||
59516067|NCT03670953|75609802|FG000|COMPLETED|Dose Adjustment (Weeks 1- 3)||589||
59516068|NCT03670953|75609803|FG001|COMPLETED|Dose Adjustment (Weeks 1- 3)||0||
59516069|NCT03670953|75609804|FG002|COMPLETED|Dose Adjustment (Weeks 1- 3)||0||
59516070|NCT03670953|75609805|FG003|COMPLETED|Dose Adjustment (Weeks 1- 3)||0||
59516071|NCT03670953|75609802|FG000|NOT COMPLETED|Dose Adjustment (Weeks 1- 3)||41||
59516072|NCT03670953|75609803|FG001|NOT COMPLETED|Dose Adjustment (Weeks 1- 3)||0||
59516073|NCT03670953|75609804|FG002|NOT COMPLETED|Dose Adjustment (Weeks 1- 3)||0||
59516074|NCT03670953|75609805|FG003|NOT COMPLETED|Dose Adjustment (Weeks 1- 3)||0||
59516075|NCT03670953|75609802|FG000|STARTED|Dose Conversion (Weeks 4 - 7)|Participants who completed dose adjustment period entered the dose conversion period.|0||
59516076|NCT03670953|75609803|FG001|STARTED|Dose Conversion (Weeks 4 - 7)|Participants who completed dose adjustment period started the dose conversion period.|589||
59516077|NCT03670953|75609804|FG002|STARTED|Dose Conversion (Weeks 4 - 7)||0||
59516078|NCT03670953|75609805|FG003|STARTED|Dose Conversion (Weeks 4 - 7)||0||
59516079|NCT03670953|75609802|FG000|COMPLETED|Dose Conversion (Weeks 4 - 7)||0||
59516080|NCT03670953|75609803|FG001|COMPLETED|Dose Conversion (Weeks 4 - 7)||506||
59516081|NCT03670953|75609804|FG002|COMPLETED|Dose Conversion (Weeks 4 - 7)||0||
59516082|NCT03670953|75609805|FG003|COMPLETED|Dose Conversion (Weeks 4 - 7)||0||
59516083|NCT03670953|75609802|FG000|NOT COMPLETED|Dose Conversion (Weeks 4 - 7)||0||
59516084|NCT03670953|75609803|FG001|NOT COMPLETED|Dose Conversion (Weeks 4 - 7)||83||
59516085|NCT03670953|75609804|FG002|NOT COMPLETED|Dose Conversion (Weeks 4 - 7)||0||
59516086|NCT03670953|75609805|FG003|NOT COMPLETED|Dose Conversion (Weeks 4 - 7)||0||
59516087|NCT03670953|75609802|FG000|STARTED|Double Blind Maintenance (Weeks 8 - 20)||0||
59516088|NCT03670953|75609803|FG001|STARTED|Double Blind Maintenance (Weeks 8 - 20)|Participants who completed the dose conversion period were randomized to start double blind period|0||
59516089|NCT03670953|75609804|FG002|STARTED|Double Blind Maintenance (Weeks 8 - 20)|Participants who completed the dose conversion period were randomized to start double blind period|256||
59516090|NCT03670953|75609805|FG003|STARTED|Double Blind Maintenance (Weeks 8 - 20)|Participants who completed the dose conversion period were randomized to start double blind period|250||
59516091|NCT03670953|75609802|FG000|COMPLETED|Double Blind Maintenance (Weeks 8 - 20)||0||
59516092|NCT03670953|75609803|FG001|COMPLETED|Double Blind Maintenance (Weeks 8 - 20)||0||
59516093|NCT03670953|75609804|FG002|COMPLETED|Double Blind Maintenance (Weeks 8 - 20)||222||
59516094|NCT03670953|75609805|FG003|COMPLETED|Double Blind Maintenance (Weeks 8 - 20)||227||
59516095|NCT03670953|75609802|FG000|NOT COMPLETED|Double Blind Maintenance (Weeks 8 - 20)||0||
59516096|NCT03670953|75609803|FG001|NOT COMPLETED|Double Blind Maintenance (Weeks 8 - 20)||0||
59516097|NCT03670953|75609804|FG002|NOT COMPLETED|Double Blind Maintenance (Weeks 8 - 20)||34||
59516098|NCT03670953|75609805|FG003|NOT COMPLETED|Double Blind Maintenance (Weeks 8 - 20)||23||
59516099|NCT00657241|75609816|FG000|STARTED|Overall Study||15||
59516100|NCT00657241|75609817|FG001|STARTED|Overall Study||15||
59516101|NCT00657241|75609816|FG000|COMPLETED|Overall Study||15||
59516102|NCT00657241|75609817|FG001|COMPLETED|Overall Study||15||
59516103|NCT00657241|75609816|FG000|NOT COMPLETED|Overall Study||0||
59516104|NCT00657241|75609817|FG001|NOT COMPLETED|Overall Study||0||
59516105|NCT03179410|75609827|FG000|STARTED|Overall Study||15||
59516106|NCT03179410|75609827|FG000|COMPLETED|Overall Study||15||
59516107|NCT03179410|75609827|FG000|NOT COMPLETED|Overall Study||0||
59516108|NCT00636818|75609831|FG000|STARTED|Overall Study||45||
59516109|NCT00636818|75609831|FG000|Received at Least One Dose of Study Drug|Overall Study|One patient was lost to follow up and did not receive any study drug.|44||
59516110|NCT00636818|75609831|FG000|COMPLETED|Overall Study||34||
59516111|NCT00636818|75609831|FG000|NOT COMPLETED|Overall Study||11||
59516112|NCT03127137|75609837|FG000|STARTED|Overall Study||62||
59516113|NCT03127137|75609838|FG001|STARTED|Overall Study||61||
59516114|NCT03127137|75609837|FG000|COMPLETED|Overall Study||60||
59516115|NCT03127137|75609838|FG001|COMPLETED|Overall Study||60||
59516116|NCT03127137|75609837|FG000|NOT COMPLETED|Overall Study||2||
59516117|NCT03127137|75609838|FG001|NOT COMPLETED|Overall Study||1||
59516118|NCT00636506|75609846|FG000|STARTED|Overall Study||76||
59516119|NCT00636506|75609846|FG000|COMPLETED|Overall Study||60||
59516120|NCT00636506|75609846|FG000|NOT COMPLETED|Overall Study||16||
59516121|NCT00636194|75609870|FG000|STARTED|Overall Study||175||
59516122|NCT00636194|75609871|FG001|STARTED|Overall Study||175||
59516123|NCT00636194|75609870|FG000|COMPLETED|Overall Study||172||
59516124|NCT00636194|75609871|FG001|COMPLETED|Overall Study||175||
59516125|NCT00636194|75609870|FG000|NOT COMPLETED|Overall Study||3||
59516126|NCT00636194|75609871|FG001|NOT COMPLETED|Overall Study||0||
59516127|NCT03623373|75609877|FG000|STARTED|Overall Study||13||
59516128|NCT03623373|75609877|FG000|COMPLETED|Overall Study||13||
59516129|NCT03623373|75609877|FG000|NOT COMPLETED|Overall Study||0||
59516130|NCT00994123|75609884|FG000|STARTED|Overall Study||33||
59516131|NCT00994123|75609885|FG001|STARTED|Overall Study||85||
59516132|NCT00994123|75609886|FG002|STARTED|Overall Study||44||
59516133|NCT00994123|75609884|FG000|COMPLETED|Overall Study||33||
59516134|NCT00994123|75609885|FG001|COMPLETED|Overall Study||85||
59516135|NCT00994123|75609886|FG002|COMPLETED|Overall Study||44||
59516136|NCT00994123|75609884|FG000|NOT COMPLETED|Overall Study||0||
59516137|NCT00994123|75609885|FG001|NOT COMPLETED|Overall Study||0||
59516138|NCT00994123|75609886|FG002|NOT COMPLETED|Overall Study||0||
59516139|NCT03595527|75609905|FG000|STARTED|Overall Study||6350||
59516140|NCT03595527|75609905|FG000|Patients Screened for HIV|Overall Study|This number includes patients tested for HIV or both HIV and HCV.|3905||
59516141|NCT03595527|75609905|FG000|Patients Screened for HCV|Overall Study|This number includes patients tested for HCV or both HCV and HIV.|3910||
59516142|NCT03595527|75609905|FG000|COMPLETED|Overall Study|All patients informed about the screening program are considered in the denominator of overall prevalence.|6350||
59516143|NCT03595527|75609905|FG000|NOT COMPLETED|Overall Study||0||
59516144|NCT00995215|75609915|FG000|STARTED|Overall Study||6||
59516145|NCT00995215|75609915|FG000|COMPLETED|Overall Study||6||
59760905|NCT04115189|75880564|FG001|COMPLETED|Overall Study||15||
59516146|NCT00995215|75609915|FG000|NOT COMPLETED|Overall Study||0||
59516147|NCT01022359|75609922|FG000|STARTED|Overall Study||39||
59516148|NCT01022359|75609923|FG001|STARTED|Overall Study||41||
59516149|NCT01022359|75609922|FG000|COMPLETED|Overall Study||39||
59516150|NCT01022359|75609923|FG001|COMPLETED|Overall Study||41||
59516151|NCT01022359|75609922|FG000|NOT COMPLETED|Overall Study||0||
59516152|NCT01022359|75609923|FG001|NOT COMPLETED|Overall Study||0||
59516153|NCT00635804|75609937|FG000|STARTED|Overall Study||7||
59516154|NCT00635804|75609938|FG001|STARTED|Overall Study||6||
59516155|NCT00635804|75609939|FG002|STARTED|Overall Study||6||
59516156|NCT00635804|75609940|FG003|STARTED|Overall Study||6||
59516157|NCT00635804|75609941|FG004|STARTED|Overall Study||6||
59516158|NCT00635804|75609942|FG005|STARTED|Overall Study||12||
59516159|NCT00635804|75609943|FG006|STARTED|Overall Study||3||
59516160|NCT00635804|75609944|FG007|STARTED|Overall Study||14||
59516161|NCT00635804|75609937|FG000|COMPLETED|Overall Study||6||
59516162|NCT00635804|75609938|FG001|COMPLETED|Overall Study||6||
59516163|NCT00635804|75609939|FG002|COMPLETED|Overall Study||6||
59760906|NCT04115189|75880563|FG000|NOT COMPLETED|Overall Study||0||
59760907|NCT04115189|75880564|FG001|NOT COMPLETED|Overall Study||0||
59516164|NCT00635804|75609940|FG003|COMPLETED|Overall Study||6||
59516165|NCT00635804|75609941|FG004|COMPLETED|Overall Study||6||
59516166|NCT00635804|75609942|FG005|COMPLETED|Overall Study||11||
59516167|NCT00635804|75609943|FG006|COMPLETED|Overall Study||3||
59516168|NCT00635804|75609944|FG007|COMPLETED|Overall Study||14||
59516169|NCT00635804|75609937|FG000|NOT COMPLETED|Overall Study||1||
59516170|NCT00635804|75609938|FG001|NOT COMPLETED|Overall Study||0||
59516171|NCT00635804|75609939|FG002|NOT COMPLETED|Overall Study||0||
59516172|NCT00635804|75609940|FG003|NOT COMPLETED|Overall Study||0||
59516173|NCT00635804|75609941|FG004|NOT COMPLETED|Overall Study||0||
59516174|NCT00635804|75609942|FG005|NOT COMPLETED|Overall Study||1||
59516175|NCT00635804|75609943|FG006|NOT COMPLETED|Overall Study||0||
59516176|NCT00635804|75609944|FG007|NOT COMPLETED|Overall Study||0||
59516177|NCT01023841|75609967|FG000|STARTED|Overall Study||48||
59516178|NCT01023841|75609968|FG001|STARTED|Overall Study||23||
59516179|NCT01023841|75609967|FG000|COMPLETED|Overall Study||47||
59516180|NCT01023841|75609968|FG001|COMPLETED|Overall Study||23||
59516181|NCT01023841|75609967|FG000|NOT COMPLETED|Overall Study||1||
59516182|NCT01023841|75609968|FG001|NOT COMPLETED|Overall Study||0||
59516183|NCT00635648|75609974|FG000|STARTED|Overall Study||63||
59516184|NCT00635648|75609974|FG000|COMPLETED|Overall Study||26||
59516185|NCT00635648|75609974|FG000|NOT COMPLETED|Overall Study||37||
59516186|NCT00995449|75609982|FG000|STARTED|Overall Study||0||
59516187|NCT00995449|75609983|FG001|STARTED|Overall Study||0||
59516188|NCT00995449|75609984|FG002|STARTED|Overall Study||7||
59516189|NCT00995449|75609985|FG003|STARTED|Overall Study||2||
59516190|NCT00995449|75609982|FG000|COMPLETED|Overall Study||0||
59516191|NCT00995449|75609983|FG001|COMPLETED|Overall Study||0||
59516192|NCT00995449|75609984|FG002|COMPLETED|Overall Study||5||
59516193|NCT00995449|75609985|FG003|COMPLETED|Overall Study||2||
59516194|NCT00995449|75609982|FG000|NOT COMPLETED|Overall Study||0||
59516195|NCT00995449|75609983|FG001|NOT COMPLETED|Overall Study||0||
59516196|NCT00995449|75609984|FG002|NOT COMPLETED|Overall Study||2||
59516197|NCT00995449|75609985|FG003|NOT COMPLETED|Overall Study||0||
59516198|NCT00995761|75609993|FG000|STARTED|Overall Study||48||
59516199|NCT00995761|75609993|FG000|COMPLETED|Overall Study||48||
59516200|NCT00995761|75609993|FG000|NOT COMPLETED|Overall Study||0||
59516201|NCT00635102|75609999|FG000|STARTED|Overall Study||27||
59516202|NCT00635102|75610000|FG001|STARTED|Overall Study||30||
59516203|NCT00635102|75609999|FG000|COMPLETED|Overall Study||20||
59516204|NCT00635102|75610000|FG001|COMPLETED|Overall Study||22||
59516205|NCT00635102|75609999|FG000|NOT COMPLETED|Overall Study||7||
59516206|NCT00635102|75610000|FG001|NOT COMPLETED|Overall Study||8||
59516207|NCT00996775|75610008|FG000|STARTED|Overall Study||78||
59516208|NCT00996775|75610009|FG001|STARTED|Overall Study||89||
59516209|NCT00996775|75610008|FG000|COMPLETED|Overall Study||67||
59516210|NCT00996775|75610009|FG001|COMPLETED|Overall Study||75||
59516211|NCT00996775|75610008|FG000|NOT COMPLETED|Overall Study||11||
59516212|NCT00996775|75610009|FG001|NOT COMPLETED|Overall Study||14||
59516213|NCT00635024|75610015|FG000|STARTED|Overall Study||1||
59516214|NCT00635024|75610015|FG000|COMPLETED|Overall Study||0||
59516215|NCT00635024|75610015|FG000|NOT COMPLETED|Overall Study||1||
59516216|NCT03005379|75610021|FG000|STARTED|Overall Study||76||
59516217|NCT03005379|75610022|FG001|STARTED|Overall Study||77||
59516218|NCT03005379|75610021|FG000|COMPLETED|Overall Study||76||
59516219|NCT03005379|75610022|FG001|COMPLETED|Overall Study||76||
59516220|NCT03005379|75610021|FG000|NOT COMPLETED|Overall Study||0||
59516221|NCT03005379|75610022|FG001|NOT COMPLETED|Overall Study||1||
59516222|NCT03182920|75610030|FG000|STARTED|Period 1||9||
59516223|NCT03182920|75610031|FG001|STARTED|Period 1||9||
59516224|NCT03182920|75610032|FG002|STARTED|Period 1||17||
59516225|NCT03182920|75610030|FG000|COMPLETED|Period 1||9||
59516226|NCT03182920|75610031|FG001|COMPLETED|Period 1||9||
59516227|NCT03182920|75610032|FG002|COMPLETED|Period 1||17||
59516228|NCT03182920|75610030|FG000|NOT COMPLETED|Period 1||0||
59516229|NCT03182920|75610031|FG001|NOT COMPLETED|Period 1||0||
59516230|NCT03182920|75610032|FG002|NOT COMPLETED|Period 1||0||
59516231|NCT03182920|75610030|FG000|STARTED|Washout Period||9||
59516232|NCT03182920|75610031|FG001|STARTED|Washout Period||9||
59516233|NCT03182920|75610032|FG002|STARTED|Washout Period||0||
59516234|NCT03182920|75610030|FG000|COMPLETED|Washout Period||9||
59516235|NCT03182920|75610031|FG001|COMPLETED|Washout Period||9||
59516236|NCT03182920|75610032|FG002|COMPLETED|Washout Period||0||
59516237|NCT03182920|75610030|FG000|NOT COMPLETED|Washout Period||0||
59516238|NCT03182920|75610031|FG001|NOT COMPLETED|Washout Period||0||
59516239|NCT03182920|75610032|FG002|NOT COMPLETED|Washout Period||0||
59516240|NCT03182920|75610030|FG000|STARTED|Period 2||9||
59516241|NCT03182920|75610031|FG001|STARTED|Period 2||9||
59516242|NCT03182920|75610032|FG002|STARTED|Period 2|Young participants on Lasmiditan did not move to study period 2.|0||
59516243|NCT03182920|75610030|FG000|COMPLETED|Period 2||9||
59516244|NCT03182920|75610031|FG001|COMPLETED|Period 2||9||
59516245|NCT03182920|75610032|FG002|COMPLETED|Period 2||0||
59516246|NCT03182920|75610030|FG000|NOT COMPLETED|Period 2||0||
59516247|NCT03182920|75610031|FG001|NOT COMPLETED|Period 2||0||
59516248|NCT03182920|75610032|FG002|NOT COMPLETED|Period 2||0||
59516249|NCT03185182|75610039|FG000|STARTED|Overall Study||5||
59516250|NCT03185182|75610039|FG000|COMPLETED|Overall Study||5||
59516251|NCT03185182|75610039|FG000|NOT COMPLETED|Overall Study||0||
59516252|NCT03187678|75610044|FG000|STARTED|Period 1 (Oral Selexipag)||20||
59516253|NCT03187678|75610044|FG000|COMPLETED|Period 1 (Oral Selexipag)||20||
59516254|NCT03187678|75610044|FG000|NOT COMPLETED|Period 1 (Oral Selexipag)||0||
59516255|NCT03187678|75610044|FG000|STARTED|Period 2 (Intravenous Selexipag)||20||
59516256|NCT03187678|75610044|FG000|COMPLETED|Period 2 (Intravenous Selexipag)||20||
59516257|NCT03187678|75610044|FG000|NOT COMPLETED|Period 2 (Intravenous Selexipag)||0||
59516258|NCT03187678|75610044|FG000|STARTED|Period 3 (Oral Selexipag)||20||
59516259|NCT03187678|75610044|FG000|COMPLETED|Period 3 (Oral Selexipag)||20||
59516260|NCT03187678|75610044|FG000|NOT COMPLETED|Period 3 (Oral Selexipag)||0||
59516261|NCT03192826|75610051|FG000|STARTED|Overall Study||27||
59516262|NCT03192826|75610052|FG001|STARTED|Overall Study||27||
59516263|NCT03192826|75610053|FG002|STARTED|Overall Study||25||
59516264|NCT03192826|75610051|FG000|COMPLETED|Overall Study||27||
59516265|NCT03192826|75610052|FG001|COMPLETED|Overall Study||27||
59516266|NCT03192826|75610053|FG002|COMPLETED|Overall Study||25||
59516267|NCT03192826|75610051|FG000|NOT COMPLETED|Overall Study||0||
59516268|NCT03192826|75610052|FG001|NOT COMPLETED|Overall Study||0||
59516269|NCT03192826|75610053|FG002|NOT COMPLETED|Overall Study||0||
59516270|NCT03285724|75610061|FG000|STARTED|Overall Study||1||
59516271|NCT03285724|75610061|FG000|COMPLETED|Overall Study||1||
59516272|NCT03285724|75610061|FG000|NOT COMPLETED|Overall Study||0||
59516273|NCT03287674|75610065|FG000|STARTED|Overall Study||7||
59516274|NCT03287674|75610065|FG000|All Treated With TILs|Overall Study||6||
59516275|NCT03287674|75610065|FG000|COMPLETED|Overall Study||6||
59516276|NCT03287674|75610065|FG000|NOT COMPLETED|Overall Study||1||
59516277|NCT00634244|75610073|FG000|STARTED|Overall Study||35||
59516278|NCT00634244|75610074|FG001|STARTED|Overall Study||37||
59516279|NCT00634244|75610075|FG002|STARTED|Overall Study||20||
59516280|NCT00634244|75610073|FG000|Eligible and Treated|Overall Study||35||
59516281|NCT00634244|75610074|FG001|Eligible and Treated|Overall Study||36||
59516282|NCT00634244|75610075|FG002|Eligible and Treated|Overall Study||20||
59516283|NCT00634244|75610073|FG000|COMPLETED|Overall Study||34||
59516284|NCT00634244|75610074|FG001|COMPLETED|Overall Study||24||
59516285|NCT00634244|75610075|FG002|COMPLETED|Overall Study||20||
59516286|NCT00634244|75610073|FG000|NOT COMPLETED|Overall Study||1||
59516287|NCT00634244|75610074|FG001|NOT COMPLETED|Overall Study||13||
59516288|NCT00634244|75610075|FG002|NOT COMPLETED|Overall Study||0||
59516289|NCT03194698|75610085|FG000|STARTED|Overall Study||10||
59516290|NCT03194698|75610086|FG001|STARTED|Overall Study||10||
59516291|NCT03194698|75610085|FG000|COMPLETED|Overall Study||10||
59516292|NCT03194698|75610086|FG001|COMPLETED|Overall Study||10||
59516293|NCT03194698|75610085|FG000|NOT COMPLETED|Overall Study||0||
59516294|NCT03194698|75610086|FG001|NOT COMPLETED|Overall Study||0||
59516295|NCT03289858|75610094|FG000|STARTED|Overall Study||27||
59516296|NCT03289858|75610095|FG001|STARTED|Overall Study||28||
59516297|NCT03289858|75610094|FG000|COMPLETED|Overall Study||25||
59516298|NCT03289858|75610095|FG001|COMPLETED|Overall Study||28||
59516299|NCT03289858|75610094|FG000|NOT COMPLETED|Overall Study||2||
59516300|NCT03289858|75610095|FG001|NOT COMPLETED|Overall Study||0||
59516301|NCT03418714|75610101|FG000|STARTED|Overall Study||13||
59516302|NCT03418714|75610101|FG000|COMPLETED|Overall Study|One participant moved too much during the practice session and was therefore excluded from the scan.|12||
59516303|NCT03418714|75610101|FG000|NOT COMPLETED|Overall Study||1||
59516304|NCT03194776|75610107|FG000|STARTED|Overall Study||23||
59516305|NCT03194776|75610108|FG001|STARTED|Overall Study||23||
59516306|NCT03194776|75610107|FG000|COMPLETED|Overall Study||23||
59516307|NCT03194776|75610108|FG001|COMPLETED|Overall Study||23||
59516308|NCT03194776|75610107|FG000|NOT COMPLETED|Overall Study||0||
59516309|NCT03194776|75610108|FG001|NOT COMPLETED|Overall Study||0||
59516310|NCT03421210|75610115|FG000|STARTED|Overall Study||88||
59516311|NCT03421210|75610115|FG000|Received Functional Magnetic Resonance Imaging (fMRI)|Overall Study||42||
59516312|NCT03421210|75610115|FG000|COMPLETED|Overall Study||35||
59516313|NCT03421210|75610115|FG000|NOT COMPLETED|Overall Study||53||
59516314|NCT01025791|75610122|FG000|STARTED|Period 1||2||
59516315|NCT01025791|75610123|FG001|STARTED|Period 1||2||
59516316|NCT01025791|75610124|FG002|STARTED|Period 1||2||
59516317|NCT01025791|75610125|FG003|STARTED|Period 1||2||
59516318|NCT01025791|75610126|FG004|STARTED|Period 1||2||
59516319|NCT01025791|75610127|FG005|STARTED|Period 1||2||
59516320|NCT01025791|75610128|FG006|STARTED|Period 1||2||
59516321|NCT01025791|75610129|FG007|STARTED|Period 1||2||
59516322|NCT01025791|75610130|FG008|STARTED|Period 1||2||
59516323|NCT01025791|75610131|FG009|STARTED|Period 1||1||
59516324|NCT01025791|75610132|FG010|STARTED|Period 1||2||
59516325|NCT01025791|75610133|FG011|STARTED|Period 1||1||
59516326|NCT01025791|75610134|FG012|STARTED|Period 1||2||
59516327|NCT01025791|75610135|FG013|STARTED|Period 1||1||
59516328|NCT01025791|75610122|FG000|COMPLETED|Period 1||2||
59516329|NCT01025791|75610123|FG001|COMPLETED|Period 1||2||
59516330|NCT01025791|75610124|FG002|COMPLETED|Period 1||2||
59516331|NCT01025791|75610125|FG003|COMPLETED|Period 1||2||
59516332|NCT01025791|75610126|FG004|COMPLETED|Period 1||2||
59516333|NCT01025791|75610127|FG005|COMPLETED|Period 1||2||
59516334|NCT01025791|75610128|FG006|COMPLETED|Period 1||2||
59516335|NCT01025791|75610129|FG007|COMPLETED|Period 1||2||
59516336|NCT01025791|75610130|FG008|COMPLETED|Period 1||2||
59516337|NCT01025791|75610131|FG009|COMPLETED|Period 1||1||
59516338|NCT01025791|75610132|FG010|COMPLETED|Period 1||2||
59516339|NCT01025791|75610133|FG011|COMPLETED|Period 1||1||
59516340|NCT01025791|75610134|FG012|COMPLETED|Period 1||2||
59516341|NCT01025791|75610135|FG013|COMPLETED|Period 1||1||
59516342|NCT01025791|75610122|FG000|NOT COMPLETED|Period 1||0||
59516343|NCT01025791|75610123|FG001|NOT COMPLETED|Period 1||0||
59516344|NCT01025791|75610124|FG002|NOT COMPLETED|Period 1||0||
59516345|NCT01025791|75610125|FG003|NOT COMPLETED|Period 1||0||
59516346|NCT01025791|75610126|FG004|NOT COMPLETED|Period 1||0||
59516347|NCT01025791|75610127|FG005|NOT COMPLETED|Period 1||0||
59516348|NCT01025791|75610128|FG006|NOT COMPLETED|Period 1||0||
59516349|NCT01025791|75610129|FG007|NOT COMPLETED|Period 1||0||
59516350|NCT01025791|75610130|FG008|NOT COMPLETED|Period 1||0||
59516351|NCT01025791|75610131|FG009|NOT COMPLETED|Period 1||0||
59516352|NCT01025791|75610132|FG010|NOT COMPLETED|Period 1||0||
59516353|NCT01025791|75610133|FG011|NOT COMPLETED|Period 1||0||
59516354|NCT01025791|75610134|FG012|NOT COMPLETED|Period 1||0||
59516355|NCT01025791|75610135|FG013|NOT COMPLETED|Period 1||0||
59516356|NCT01025791|75610122|FG000|STARTED|Period 2||2||
59516357|NCT01025791|75610123|FG001|STARTED|Period 2||2||
59516358|NCT01025791|75610124|FG002|STARTED|Period 2||2||
59516359|NCT01025791|75610125|FG003|STARTED|Period 2||2||
59516360|NCT01025791|75610126|FG004|STARTED|Period 2||2||
59516361|NCT01025791|75610127|FG005|STARTED|Period 2||2||
59516362|NCT01025791|75610128|FG006|STARTED|Period 2||2||
59516363|NCT01025791|75610129|FG007|STARTED|Period 2||2||
59516364|NCT01025791|75610130|FG008|STARTED|Period 2||2||
59516365|NCT01025791|75610131|FG009|STARTED|Period 2||1||
59516366|NCT01025791|75610132|FG010|STARTED|Period 2||2||
59516367|NCT01025791|75610133|FG011|STARTED|Period 2||1||
59516368|NCT01025791|75610134|FG012|STARTED|Period 2||2||
59516369|NCT01025791|75610135|FG013|STARTED|Period 2||1||
59516370|NCT01025791|75610122|FG000|COMPLETED|Period 2||2||
59516371|NCT01025791|75610123|FG001|COMPLETED|Period 2||2||
59516372|NCT01025791|75610124|FG002|COMPLETED|Period 2||2||
59516373|NCT01025791|75610125|FG003|COMPLETED|Period 2||2||
59516374|NCT01025791|75610126|FG004|COMPLETED|Period 2||2||
59516375|NCT01025791|75610127|FG005|COMPLETED|Period 2||2||
59516376|NCT01025791|75610128|FG006|COMPLETED|Period 2||2||
59516377|NCT01025791|75610129|FG007|COMPLETED|Period 2||2||
59516378|NCT01025791|75610130|FG008|COMPLETED|Period 2||2||
59516379|NCT01025791|75610131|FG009|COMPLETED|Period 2||1||
59516380|NCT01025791|75610132|FG010|COMPLETED|Period 2||2||
59516381|NCT01025791|75610133|FG011|COMPLETED|Period 2||1||
59516382|NCT01025791|75610134|FG012|COMPLETED|Period 2||2||
59516383|NCT01025791|75610135|FG013|COMPLETED|Period 2||1||
59516384|NCT01025791|75610122|FG000|NOT COMPLETED|Period 2||0||
59516385|NCT01025791|75610123|FG001|NOT COMPLETED|Period 2||0||
59516386|NCT01025791|75610124|FG002|NOT COMPLETED|Period 2||0||
59516387|NCT01025791|75610125|FG003|NOT COMPLETED|Period 2||0||
59516388|NCT01025791|75610126|FG004|NOT COMPLETED|Period 2||0||
59516389|NCT01025791|75610127|FG005|NOT COMPLETED|Period 2||0||
59516390|NCT01025791|75610128|FG006|NOT COMPLETED|Period 2||0||
59516391|NCT01025791|75610129|FG007|NOT COMPLETED|Period 2||0||
59516392|NCT01025791|75610130|FG008|NOT COMPLETED|Period 2||0||
59516393|NCT01025791|75610131|FG009|NOT COMPLETED|Period 2||0||
59516394|NCT01025791|75610132|FG010|NOT COMPLETED|Period 2||0||
59516395|NCT01025791|75610133|FG011|NOT COMPLETED|Period 2||0||
59516396|NCT01025791|75610134|FG012|NOT COMPLETED|Period 2||0||
59516397|NCT01025791|75610135|FG013|NOT COMPLETED|Period 2||0||
59516398|NCT01025791|75610122|FG000|STARTED|Period 3||2||
59516399|NCT01025791|75610123|FG001|STARTED|Period 3||2||
59516400|NCT01025791|75610124|FG002|STARTED|Period 3||2||
59516401|NCT01025791|75610125|FG003|STARTED|Period 3||2||
59516402|NCT01025791|75610126|FG004|STARTED|Period 3||2||
59516403|NCT01025791|75610127|FG005|STARTED|Period 3||2||
59516404|NCT01025791|75610128|FG006|STARTED|Period 3||2||
59516405|NCT01025791|75610129|FG007|STARTED|Period 3||2||
59516406|NCT01025791|75610130|FG008|STARTED|Period 3||2||
59516407|NCT01025791|75610131|FG009|STARTED|Period 3||1||
59516408|NCT01025791|75610132|FG010|STARTED|Period 3||2||
59516409|NCT01025791|75610133|FG011|STARTED|Period 3||1||
59516410|NCT01025791|75610134|FG012|STARTED|Period 3||2||
59516411|NCT01025791|75610135|FG013|STARTED|Period 3||1||
59516412|NCT01025791|75610122|FG000|COMPLETED|Period 3||2||
59516413|NCT01025791|75610123|FG001|COMPLETED|Period 3||2||
59516414|NCT01025791|75610124|FG002|COMPLETED|Period 3||2||
59516415|NCT01025791|75610125|FG003|COMPLETED|Period 3||2||
59516416|NCT01025791|75610126|FG004|COMPLETED|Period 3||2||
59516417|NCT01025791|75610127|FG005|COMPLETED|Period 3||2||
59516418|NCT01025791|75610128|FG006|COMPLETED|Period 3||2||
59516419|NCT01025791|75610129|FG007|COMPLETED|Period 3||2||
59516420|NCT01025791|75610130|FG008|COMPLETED|Period 3||2||
59516421|NCT01025791|75610131|FG009|COMPLETED|Period 3||1||
59516422|NCT01025791|75610132|FG010|COMPLETED|Period 3||2||
59516423|NCT01025791|75610133|FG011|COMPLETED|Period 3||1||
59516424|NCT01025791|75610134|FG012|COMPLETED|Period 3||2||
59516425|NCT01025791|75610135|FG013|COMPLETED|Period 3||1||
59516426|NCT01025791|75610122|FG000|NOT COMPLETED|Period 3||0||
59516427|NCT01025791|75610123|FG001|NOT COMPLETED|Period 3||0||
59516428|NCT01025791|75610124|FG002|NOT COMPLETED|Period 3||0||
59516429|NCT01025791|75610125|FG003|NOT COMPLETED|Period 3||0||
59516430|NCT01025791|75610126|FG004|NOT COMPLETED|Period 3||0||
59516431|NCT01025791|75610127|FG005|NOT COMPLETED|Period 3||0||
59516432|NCT01025791|75610128|FG006|NOT COMPLETED|Period 3||0||
59516433|NCT01025791|75610129|FG007|NOT COMPLETED|Period 3||0||
59516434|NCT01025791|75610130|FG008|NOT COMPLETED|Period 3||0||
59516435|NCT01025791|75610131|FG009|NOT COMPLETED|Period 3||0||
59516436|NCT01025791|75610132|FG010|NOT COMPLETED|Period 3||0||
59516437|NCT01025791|75610133|FG011|NOT COMPLETED|Period 3||0||
59516438|NCT01025791|75610134|FG012|NOT COMPLETED|Period 3||0||
59516439|NCT01025791|75610135|FG013|NOT COMPLETED|Period 3||0||
59516440|NCT01025791|75610122|FG000|STARTED|Period 4||2||
59516441|NCT01025791|75610123|FG001|STARTED|Period 4||2||
59516442|NCT01025791|75610124|FG002|STARTED|Period 4||2||
59516443|NCT01025791|75610125|FG003|STARTED|Period 4||2||
59516444|NCT01025791|75610126|FG004|STARTED|Period 4||2||
59516445|NCT01025791|75610127|FG005|STARTED|Period 4||2||
59516446|NCT01025791|75610128|FG006|STARTED|Period 4||2||
59516447|NCT01025791|75610129|FG007|STARTED|Period 4||2||
59516448|NCT01025791|75610130|FG008|STARTED|Period 4||2||
59516449|NCT01025791|75610131|FG009|STARTED|Period 4||1||
59516450|NCT01025791|75610132|FG010|STARTED|Period 4||2||
59516451|NCT01025791|75610133|FG011|STARTED|Period 4||1||
59516452|NCT01025791|75610134|FG012|STARTED|Period 4||2||
59516453|NCT01025791|75610135|FG013|STARTED|Period 4||1||
59516454|NCT01025791|75610122|FG000|COMPLETED|Period 4||2||
59516455|NCT01025791|75610123|FG001|COMPLETED|Period 4||2||
59516456|NCT01025791|75610124|FG002|COMPLETED|Period 4||2||
59516457|NCT01025791|75610125|FG003|COMPLETED|Period 4||2||
59516458|NCT01025791|75610126|FG004|COMPLETED|Period 4||2||
59516459|NCT01025791|75610127|FG005|COMPLETED|Period 4||2||
59516460|NCT01025791|75610128|FG006|COMPLETED|Period 4||2||
59516461|NCT01025791|75610129|FG007|COMPLETED|Period 4||2||
59516462|NCT01025791|75610130|FG008|COMPLETED|Period 4||2||
59516463|NCT01025791|75610131|FG009|COMPLETED|Period 4||1||
59516464|NCT01025791|75610132|FG010|COMPLETED|Period 4||2||
59516465|NCT01025791|75610133|FG011|COMPLETED|Period 4||1||
59516466|NCT01025791|75610134|FG012|COMPLETED|Period 4||2||
59516467|NCT01025791|75610135|FG013|COMPLETED|Period 4||1||
60059014|NCT01847274|76174176|FG007|STARTED|FE Sub-study, Period 2 (Day 1)||0||
60059015|NCT01847274|76174177|FG008|STARTED|FE Sub-study, Period 2 (Day 1)||0||
60059016|NCT01847274|76174178|FG009|STARTED|FE Sub-study, Period 2 (Day 1)||0||
60059017|NCT01847274|76174179|FG010|STARTED|FE Sub-study, Period 2 (Day 1)||0||
60059018|NCT01847274|76174169|FG000|COMPLETED|FE Sub-study, Period 2 (Day 1)||0||
60059019|NCT01847274|76174170|FG001|COMPLETED|FE Sub-study, Period 2 (Day 1)||0||
60059020|NCT01847274|76174171|FG002|COMPLETED|FE Sub-study, Period 2 (Day 1)||0||
60059021|NCT01847274|76174172|FG003|COMPLETED|FE Sub-study, Period 2 (Day 1)||0||
60059022|NCT01847274|76174173|FG004|COMPLETED|FE Sub-study, Period 2 (Day 1)||7||
60059023|NCT01847274|76174174|FG005|COMPLETED|FE Sub-study, Period 2 (Day 1)||8||
60059024|NCT01847274|76174175|FG006|COMPLETED|FE Sub-study, Period 2 (Day 1)||0||
60059025|NCT01847274|76174176|FG007|COMPLETED|FE Sub-study, Period 2 (Day 1)||0||
60059026|NCT01847274|76174177|FG008|COMPLETED|FE Sub-study, Period 2 (Day 1)||0||
60059027|NCT01847274|76174178|FG009|COMPLETED|FE Sub-study, Period 2 (Day 1)||0||
60059028|NCT01847274|76174179|FG010|COMPLETED|FE Sub-study, Period 2 (Day 1)||0||
60059029|NCT01847274|76174169|FG000|NOT COMPLETED|FE Sub-study, Period 2 (Day 1)||0||
60059030|NCT01847274|76174170|FG001|NOT COMPLETED|FE Sub-study, Period 2 (Day 1)||0||
60059031|NCT01847274|76174171|FG002|NOT COMPLETED|FE Sub-study, Period 2 (Day 1)||0||
60059032|NCT01847274|76174172|FG003|NOT COMPLETED|FE Sub-study, Period 2 (Day 1)||0||
60059033|NCT01847274|76174173|FG004|NOT COMPLETED|FE Sub-study, Period 2 (Day 1)||0||
60059034|NCT01847274|76174174|FG005|NOT COMPLETED|FE Sub-study, Period 2 (Day 1)||0||
59516468|NCT01025791|75610122|FG000|NOT COMPLETED|Period 4||0||
59516469|NCT01025791|75610123|FG001|NOT COMPLETED|Period 4||0||
59516470|NCT01025791|75610124|FG002|NOT COMPLETED|Period 4||0||
59516471|NCT01025791|75610125|FG003|NOT COMPLETED|Period 4||0||
59516472|NCT01025791|75610126|FG004|NOT COMPLETED|Period 4||0||
59516473|NCT01025791|75610127|FG005|NOT COMPLETED|Period 4||0||
59516474|NCT01025791|75610128|FG006|NOT COMPLETED|Period 4||0||
59516475|NCT01025791|75610129|FG007|NOT COMPLETED|Period 4||0||
59516476|NCT01025791|75610130|FG008|NOT COMPLETED|Period 4||0||
59516477|NCT01025791|75610131|FG009|NOT COMPLETED|Period 4||0||
59516478|NCT01025791|75610132|FG010|NOT COMPLETED|Period 4||0||
59516479|NCT01025791|75610133|FG011|NOT COMPLETED|Period 4||0||
59516480|NCT01025791|75610134|FG012|NOT COMPLETED|Period 4||0||
59516481|NCT01025791|75610135|FG013|NOT COMPLETED|Period 4||0||
59760908|NCT00601640|75880577|FG000|STARTED|Overall Study||52||
59516482|NCT01025791|75610122|FG000|STARTED|Period 5||2||
59516483|NCT01025791|75610123|FG001|STARTED|Period 5||2||
59516484|NCT01025791|75610124|FG002|STARTED|Period 5||2||
59516485|NCT01025791|75610125|FG003|STARTED|Period 5||2||
59516486|NCT01025791|75610126|FG004|STARTED|Period 5||0||
59516487|NCT01025791|75610127|FG005|STARTED|Period 5||0||
59516488|NCT01025791|75610128|FG006|STARTED|Period 5||0||
59516489|NCT01025791|75610129|FG007|STARTED|Period 5||0||
59516490|NCT01025791|75610130|FG008|STARTED|Period 5||0||
60059035|NCT01847274|76174175|FG006|NOT COMPLETED|FE Sub-study, Period 2 (Day 1)||0||
60059036|NCT01847274|76174176|FG007|NOT COMPLETED|FE Sub-study, Period 2 (Day 1)||0||
60059037|NCT01847274|76174177|FG008|NOT COMPLETED|FE Sub-study, Period 2 (Day 1)||0||
60059038|NCT01847274|76174178|FG009|NOT COMPLETED|FE Sub-study, Period 2 (Day 1)||0||
60059039|NCT01847274|76174179|FG010|NOT COMPLETED|FE Sub-study, Period 2 (Day 1)||0||
60059040|NCT01847274|76174169|FG000|STARTED|QTcSub-study(Upto 5 Year,10 Month,22day)||0||
60059041|NCT01847274|76174170|FG001|STARTED|QTcSub-study(Upto 5 Year,10 Month,22day)||0||
60059042|NCT01847274|76174171|FG002|STARTED|QTcSub-study(Upto 5 Year,10 Month,22day)||0||
60059043|NCT01847274|76174172|FG003|STARTED|QTcSub-study(Upto 5 Year,10 Month,22day)||0||
60059044|NCT01847274|76174173|FG004|STARTED|QTcSub-study(Upto 5 Year,10 Month,22day)||0||
60059045|NCT01847274|76174174|FG005|STARTED|QTcSub-study(Upto 5 Year,10 Month,22day)||0||
60059046|NCT01847274|76174175|FG006|STARTED|QTcSub-study(Upto 5 Year,10 Month,22day)||26||
60059047|NCT01847274|76174176|FG007|STARTED|QTcSub-study(Upto 5 Year,10 Month,22day)||0||
60059048|NCT01847274|76174177|FG008|STARTED|QTcSub-study(Upto 5 Year,10 Month,22day)||0||
60059049|NCT01847274|76174178|FG009|STARTED|QTcSub-study(Upto 5 Year,10 Month,22day)||0||
60059050|NCT01847274|76174179|FG010|STARTED|QTcSub-study(Upto 5 Year,10 Month,22day)||0||
60059051|NCT01847274|76174169|FG000|COMPLETED|QTcSub-study(Upto 5 Year,10 Month,22day)||0||
60059052|NCT01847274|76174170|FG001|COMPLETED|QTcSub-study(Upto 5 Year,10 Month,22day)||0||
60059053|NCT01847274|76174171|FG002|COMPLETED|QTcSub-study(Upto 5 Year,10 Month,22day)||0||
60059054|NCT01847274|76174172|FG003|COMPLETED|QTcSub-study(Upto 5 Year,10 Month,22day)||0||
60059055|NCT01847274|76174173|FG004|COMPLETED|QTcSub-study(Upto 5 Year,10 Month,22day)||0||
60059056|NCT01847274|76174174|FG005|COMPLETED|QTcSub-study(Upto 5 Year,10 Month,22day)||0||
60059057|NCT01847274|76174175|FG006|COMPLETED|QTcSub-study(Upto 5 Year,10 Month,22day)||0||
60059058|NCT01847274|76174176|FG007|COMPLETED|QTcSub-study(Upto 5 Year,10 Month,22day)||0||
60059059|NCT01847274|76174177|FG008|COMPLETED|QTcSub-study(Upto 5 Year,10 Month,22day)||0||
60059060|NCT01847274|76174178|FG009|COMPLETED|QTcSub-study(Upto 5 Year,10 Month,22day)||0||
60059061|NCT01847274|76174179|FG010|COMPLETED|QTcSub-study(Upto 5 Year,10 Month,22day)||0||
60059062|NCT01847274|76174169|FG000|NOT COMPLETED|QTcSub-study(Upto 5 Year,10 Month,22day)||0||
60059063|NCT01847274|76174170|FG001|NOT COMPLETED|QTcSub-study(Upto 5 Year,10 Month,22day)||0||
60059064|NCT01847274|76174171|FG002|NOT COMPLETED|QTcSub-study(Upto 5 Year,10 Month,22day)||0||
60059065|NCT01847274|76174172|FG003|NOT COMPLETED|QTcSub-study(Upto 5 Year,10 Month,22day)||0||
60059066|NCT01847274|76174173|FG004|NOT COMPLETED|QTcSub-study(Upto 5 Year,10 Month,22day)||0||
60059067|NCT01847274|76174174|FG005|NOT COMPLETED|QTcSub-study(Upto 5 Year,10 Month,22day)||0||
60059068|NCT01847274|76174175|FG006|NOT COMPLETED|QTcSub-study(Upto 5 Year,10 Month,22day)||26||
60059069|NCT01847274|76174176|FG007|NOT COMPLETED|QTcSub-study(Upto 5 Year,10 Month,22day)||0||
60059070|NCT01847274|76174177|FG008|NOT COMPLETED|QTcSub-study(Upto 5 Year,10 Month,22day)||0||
60059071|NCT01847274|76174178|FG009|NOT COMPLETED|QTcSub-study(Upto 5 Year,10 Month,22day)||0||
60059072|NCT01847274|76174179|FG010|NOT COMPLETED|QTcSub-study(Upto 5 Year,10 Month,22day)||0||
60059073|NCT01847274|76174169|FG000|STARTED|Main Study PSU (Up to 8months, 26days)||0||
60059074|NCT01847274|76174170|FG001|STARTED|Main Study PSU (Up to 8months, 26days)||0||
60059075|NCT01847274|76174171|FG002|STARTED|Main Study PSU (Up to 8months, 26days)||0||
60059076|NCT01847274|76174172|FG003|STARTED|Main Study PSU (Up to 8months, 26days)||0||
60059077|NCT01847274|76174173|FG004|STARTED|Main Study PSU (Up to 8months, 26days)||0||
60059078|NCT01847274|76174174|FG005|STARTED|Main Study PSU (Up to 8months, 26days)||0||
60059079|NCT01847274|76174175|FG006|STARTED|Main Study PSU (Up to 8months, 26days)||0||
60059080|NCT01847274|76174176|FG007|STARTED|Main Study PSU (Up to 8months, 26days)||22||
60059081|NCT01847274|76174177|FG008|STARTED|Main Study PSU (Up to 8months, 26days)||8||
60059082|NCT01847274|76174178|FG009|STARTED|Main Study PSU (Up to 8months, 26days)||31||
60059083|NCT01847274|76174179|FG010|STARTED|Main Study PSU (Up to 8months, 26days)||13||
60059084|NCT01847274|76174169|FG000|COMPLETED|Main Study PSU (Up to 8months, 26days)||0||
60059085|NCT01847274|76174170|FG001|COMPLETED|Main Study PSU (Up to 8months, 26days)||0||
60059086|NCT01847274|76174171|FG002|COMPLETED|Main Study PSU (Up to 8months, 26days)||0||
60059087|NCT01847274|76174172|FG003|COMPLETED|Main Study PSU (Up to 8months, 26days)||0||
60059088|NCT01847274|76174173|FG004|COMPLETED|Main Study PSU (Up to 8months, 26days)||0||
60059089|NCT01847274|76174174|FG005|COMPLETED|Main Study PSU (Up to 8months, 26days)||0||
60059090|NCT01847274|76174175|FG006|COMPLETED|Main Study PSU (Up to 8months, 26days)||0||
60059091|NCT01847274|76174176|FG007|COMPLETED|Main Study PSU (Up to 8months, 26days)||0||
60059092|NCT01847274|76174177|FG008|COMPLETED|Main Study PSU (Up to 8months, 26days)||0||
60059093|NCT01847274|76174178|FG009|COMPLETED|Main Study PSU (Up to 8months, 26days)||0||
60059094|NCT01847274|76174179|FG010|COMPLETED|Main Study PSU (Up to 8months, 26days)||0||
60059095|NCT01847274|76174169|FG000|NOT COMPLETED|Main Study PSU (Up to 8months, 26days)||0||
60059096|NCT01847274|76174170|FG001|NOT COMPLETED|Main Study PSU (Up to 8months, 26days)||0||
60059097|NCT01847274|76174171|FG002|NOT COMPLETED|Main Study PSU (Up to 8months, 26days)||0||
60059098|NCT01847274|76174172|FG003|NOT COMPLETED|Main Study PSU (Up to 8months, 26days)||0||
60059099|NCT01847274|76174173|FG004|NOT COMPLETED|Main Study PSU (Up to 8months, 26days)||0||
60059100|NCT01847274|76174174|FG005|NOT COMPLETED|Main Study PSU (Up to 8months, 26days)||0||
60059101|NCT01847274|76174175|FG006|NOT COMPLETED|Main Study PSU (Up to 8months, 26days)||0||
60059102|NCT01847274|76174176|FG007|NOT COMPLETED|Main Study PSU (Up to 8months, 26days)||22||
60059103|NCT01847274|76174177|FG008|NOT COMPLETED|Main Study PSU (Up to 8months, 26days)||8||
60059104|NCT01847274|76174178|FG009|NOT COMPLETED|Main Study PSU (Up to 8months, 26days)||31||
60059105|NCT01847274|76174179|FG010|NOT COMPLETED|Main Study PSU (Up to 8months, 26days)||13||
60059106|NCT01802788|76174211|FG000|STARTED|Overall Study||941||
60059107|NCT01802788|76174212|FG001|STARTED|Overall Study||59||
60059108|NCT01802788|76174211|FG000|COMPLETED|Overall Study||755||
60059109|NCT01802788|76174212|FG001|COMPLETED|Overall Study||59||
60059110|NCT01802788|76174211|FG000|NOT COMPLETED|Overall Study||186||
60059111|NCT01802788|76174212|FG001|NOT COMPLETED|Overall Study||0||
60059112|NCT01560819|76174218|FG000|STARTED|Overall Study||10||
60059113|NCT01560819|76174219|FG001|STARTED|Overall Study||10||
60059114|NCT01560819|76174218|FG000|COMPLETED|Overall Study||9||
60059115|NCT01560819|76174219|FG001|COMPLETED|Overall Study||10||
60059116|NCT01560819|76174218|FG000|NOT COMPLETED|Overall Study||1||
60059117|NCT01560819|76174219|FG001|NOT COMPLETED|Overall Study||0||
60059118|NCT01425528|76174225|FG000|STARTED|Overall Study||6||
60059119|NCT01425528|76174226|FG001|STARTED|Overall Study||6||
60059120|NCT01425528|76174225|FG000|COMPLETED|Overall Study||5||
60059121|NCT01425528|76174226|FG001|COMPLETED|Overall Study||5||
60059122|NCT01425528|76174225|FG000|NOT COMPLETED|Overall Study||1||
60059123|NCT01425528|76174226|FG001|NOT COMPLETED|Overall Study||1||
60059124|NCT00442104|76174232|FG000|STARTED|Overall Study||54||
60059125|NCT00442104|76174232|FG000|COMPLETED|Overall Study||7||
60059126|NCT00442104|76174232|FG000|NOT COMPLETED|Overall Study||47||
60059127|NCT00441896|76174246|FG000|STARTED|Overall Study||6||
60059128|NCT00441896|76174247|FG001|STARTED|Overall Study||3||
60059129|NCT00441896|76174248|FG002|STARTED|Overall Study||7||
60059130|NCT00441896|76174249|FG003|STARTED|Overall Study||4||
60059131|NCT00441896|76174250|FG004|STARTED|Overall Study||12||
60059132|NCT00441896|76174251|FG005|STARTED|Overall Study||3||
60059133|NCT00441896|76174252|FG006|STARTED|Overall Study||7||
60059134|NCT00441896|76174253|FG007|STARTED|Overall Study||5||
60059135|NCT00441896|76174254|FG008|STARTED|Overall Study||6||
60059136|NCT00441896|76174255|FG009|STARTED|Overall Study||4||
60059137|NCT00441896|76174246|FG000|COMPLETED|Overall Study||6||
60059138|NCT00441896|76174247|FG001|COMPLETED|Overall Study||3||
60059139|NCT00441896|76174248|FG002|COMPLETED|Overall Study||7||
60059140|NCT00441896|76174249|FG003|COMPLETED|Overall Study||3||
60059141|NCT00441896|76174250|FG004|COMPLETED|Overall Study||11||
60059142|NCT00441896|76174251|FG005|COMPLETED|Overall Study||3||
60059143|NCT00441896|76174252|FG006|COMPLETED|Overall Study||7||
60059144|NCT00441896|76174253|FG007|COMPLETED|Overall Study||5||
60059145|NCT00441896|76174254|FG008|COMPLETED|Overall Study||6||
60059146|NCT00441896|76174255|FG009|COMPLETED|Overall Study||4||
60059147|NCT00441896|76174246|FG000|NOT COMPLETED|Overall Study||0||
60059148|NCT00441896|76174247|FG001|NOT COMPLETED|Overall Study||0||
60059149|NCT00441896|76174248|FG002|NOT COMPLETED|Overall Study||0||
60059150|NCT00441896|76174249|FG003|NOT COMPLETED|Overall Study||1||
60059151|NCT00441896|76174250|FG004|NOT COMPLETED|Overall Study||1||
60059152|NCT00441896|76174251|FG005|NOT COMPLETED|Overall Study||0||
60059153|NCT00441896|76174252|FG006|NOT COMPLETED|Overall Study||0||
60059154|NCT00441896|76174253|FG007|NOT COMPLETED|Overall Study||0||
60059155|NCT00441896|76174254|FG008|NOT COMPLETED|Overall Study||0||
60059156|NCT00441896|76174255|FG009|NOT COMPLETED|Overall Study||0||
60059157|NCT00194714|76174277|FG000|STARTED|Overall Study|Number of patients consented|22||
60059158|NCT00194714|76174277|FG000|COMPLETED|Overall Study|Number of patients that received study treatment with the study vaccine|21||
60059159|NCT00194714|76174277|FG000|NOT COMPLETED|Overall Study||1||
60059160|NCT02034877|76174283|FG000|STARTED|Overall Study||200||
60059161|NCT02034877|76174284|FG001|STARTED|Overall Study||999||
60059162|NCT02034877|76174283|FG000|COMPLETED|Overall Study||200||
60059163|NCT02034877|76174284|FG001|COMPLETED|Overall Study||993||
60059164|NCT02034877|76174283|FG000|NOT COMPLETED|Overall Study||0||
60059165|NCT02034877|76174284|FG001|NOT COMPLETED|Overall Study||6||
60059166|NCT02034799|76174292|FG000|STARTED|Overall Study||129||
60059167|NCT02034799|76174293|FG001|STARTED|Overall Study||127||
60059168|NCT02034799|76174292|FG000|COMPLETED|Overall Study||127||
60059169|NCT02034799|76174293|FG001|COMPLETED|Overall Study||123||
60059170|NCT02034799|76174292|FG000|NOT COMPLETED|Overall Study||2||
60059171|NCT02034799|76174293|FG001|NOT COMPLETED|Overall Study||4||
60059172|NCT02057575|76174303|FG000|STARTED|Overall Study||74||
60059173|NCT02057575|76174304|FG001|STARTED|Overall Study||73||
60059174|NCT02057575|76174305|FG002|STARTED|Overall Study||78||
60059175|NCT02057575|76174306|FG003|STARTED|Overall Study||73||
60059176|NCT02057575|76174303|FG000|COMPLETED|Overall Study||73||
60059177|NCT02057575|76174304|FG001|COMPLETED|Overall Study||69||
60059178|NCT02057575|76174305|FG002|COMPLETED|Overall Study||78||
60059179|NCT02057575|76174306|FG003|COMPLETED|Overall Study||72||
60059180|NCT02057575|76174303|FG000|NOT COMPLETED|Overall Study||1||
60059181|NCT02057575|76174304|FG001|NOT COMPLETED|Overall Study||4||
60059182|NCT02057575|76174305|FG002|NOT COMPLETED|Overall Study||0||
60059183|NCT02057575|76174306|FG003|NOT COMPLETED|Overall Study||1||
60059184|NCT02077465|76174318|FG000|STARTED|Overall Study||8||
60059185|NCT02077465|76174319|FG001|STARTED|Overall Study||3||
60059186|NCT02077465|76174318|FG000|COMPLETED|Overall Study||7||
60059187|NCT02077465|76174319|FG001|COMPLETED|Overall Study||2||
59516491|NCT01025791|75610131|FG009|STARTED|Period 5||0||
59925978|NCT03285295|76044180|FG002|STARTED|Alinity s HTLV I/II||502||
59925979|NCT03285295|76044181|FG003|STARTED|Alinity s HTLV I/II||509||
59925980|NCT03285295|76044182|FG004|STARTED|Alinity s HTLV I/II||0||
59516492|NCT01025791|75610132|FG010|STARTED|Period 5||0||
59516493|NCT01025791|75610133|FG011|STARTED|Period 5||0||
59925981|NCT03285295|76044178|FG000|COMPLETED|Alinity s HTLV I/II||15877||
59925982|NCT03285295|76044179|FG001|COMPLETED|Alinity s HTLV I/II||706||
59925983|NCT03285295|76044180|FG002|COMPLETED|Alinity s HTLV I/II||502||
59516494|NCT01025791|75610134|FG012|STARTED|Period 5||0||
59516495|NCT01025791|75610135|FG013|STARTED|Period 5||0||
59925984|NCT03285295|76044181|FG003|COMPLETED|Alinity s HTLV I/II||509||
59925985|NCT03285295|76044182|FG004|COMPLETED|Alinity s HTLV I/II||0||
59925986|NCT03285295|76044178|FG000|NOT COMPLETED|Alinity s HTLV I/II||91||
59925987|NCT03285295|76044179|FG001|NOT COMPLETED|Alinity s HTLV I/II||0||
59925988|NCT03285295|76044180|FG002|NOT COMPLETED|Alinity s HTLV I/II||0||
59925989|NCT03285295|76044181|FG003|NOT COMPLETED|Alinity s HTLV I/II||0||
59925990|NCT03285295|76044182|FG004|NOT COMPLETED|Alinity s HTLV I/II||0||
59925991|NCT03285295|76044178|FG000|STARTED|Alinity s HTLV I/II Follow-Up||12||
59925992|NCT03285295|76044179|FG001|STARTED|Alinity s HTLV I/II Follow-Up||0||
59925993|NCT03285295|76044180|FG002|STARTED|Alinity s HTLV I/II Follow-Up||0||
59925994|NCT03285295|76044181|FG003|STARTED|Alinity s HTLV I/II Follow-Up||0||
59925995|NCT03285295|76044182|FG004|STARTED|Alinity s HTLV I/II Follow-Up||0||
59925996|NCT03285295|76044178|FG000|COMPLETED|Alinity s HTLV I/II Follow-Up||8||
59925997|NCT03285295|76044179|FG001|COMPLETED|Alinity s HTLV I/II Follow-Up||0||
59925998|NCT03285295|76044180|FG002|COMPLETED|Alinity s HTLV I/II Follow-Up||0||
59925999|NCT03285295|76044181|FG003|COMPLETED|Alinity s HTLV I/II Follow-Up||0||
59926000|NCT03285295|76044182|FG004|COMPLETED|Alinity s HTLV I/II Follow-Up||0||
59926001|NCT03285295|76044178|FG000|NOT COMPLETED|Alinity s HTLV I/II Follow-Up||4||
59926002|NCT03285295|76044179|FG001|NOT COMPLETED|Alinity s HTLV I/II Follow-Up||0||
59926003|NCT03285295|76044180|FG002|NOT COMPLETED|Alinity s HTLV I/II Follow-Up||0||
59926004|NCT03285295|76044181|FG003|NOT COMPLETED|Alinity s HTLV I/II Follow-Up||0||
59926005|NCT03285295|76044182|FG004|NOT COMPLETED|Alinity s HTLV I/II Follow-Up||0||
59926006|NCT03285295|76044178|FG000|STARTED|Alinity s Anti-HCV||17095||
59926007|NCT03285295|76044179|FG001|STARTED|Alinity s Anti-HCV||402||
59926008|NCT03285295|76044180|FG002|STARTED|Alinity s Anti-HCV||407||
59926009|NCT03285295|76044181|FG003|STARTED|Alinity s Anti-HCV||0||
59926010|NCT03285295|76044182|FG004|STARTED|Alinity s Anti-HCV||0||
59926011|NCT03285295|76044178|FG000|COMPLETED|Alinity s Anti-HCV||16999||
59926012|NCT03285295|76044179|FG001|COMPLETED|Alinity s Anti-HCV||402||
59926013|NCT03285295|76044180|FG002|COMPLETED|Alinity s Anti-HCV||407||
59926014|NCT03285295|76044181|FG003|COMPLETED|Alinity s Anti-HCV||0||
59926015|NCT03285295|76044182|FG004|COMPLETED|Alinity s Anti-HCV||0||
59926016|NCT03285295|76044178|FG000|NOT COMPLETED|Alinity s Anti-HCV||96||
59926017|NCT03285295|76044179|FG001|NOT COMPLETED|Alinity s Anti-HCV||0||
59926018|NCT03285295|76044180|FG002|NOT COMPLETED|Alinity s Anti-HCV||0||
59926019|NCT03285295|76044181|FG003|NOT COMPLETED|Alinity s Anti-HCV||0||
59926020|NCT03285295|76044182|FG004|NOT COMPLETED|Alinity s Anti-HCV||0||
59926021|NCT03285295|76044178|FG000|STARTED|Alinity s Anti-HCV Follow-Up||20||
59926022|NCT03285295|76044179|FG001|STARTED|Alinity s Anti-HCV Follow-Up||0||
59926023|NCT03285295|76044180|FG002|STARTED|Alinity s Anti-HCV Follow-Up||0||
59926024|NCT03285295|76044181|FG003|STARTED|Alinity s Anti-HCV Follow-Up||0||
59926025|NCT03285295|76044182|FG004|STARTED|Alinity s Anti-HCV Follow-Up||0||
59926026|NCT03285295|76044178|FG000|COMPLETED|Alinity s Anti-HCV Follow-Up||2||
59926027|NCT03285295|76044179|FG001|COMPLETED|Alinity s Anti-HCV Follow-Up||0||
59926028|NCT03285295|76044180|FG002|COMPLETED|Alinity s Anti-HCV Follow-Up||0||
59926029|NCT03285295|76044181|FG003|COMPLETED|Alinity s Anti-HCV Follow-Up||0||
59926030|NCT03285295|76044182|FG004|COMPLETED|Alinity s Anti-HCV Follow-Up||0||
59926031|NCT03285295|76044178|FG000|NOT COMPLETED|Alinity s Anti-HCV Follow-Up||18||
59926032|NCT03285295|76044179|FG001|NOT COMPLETED|Alinity s Anti-HCV Follow-Up||0||
59926033|NCT03285295|76044180|FG002|NOT COMPLETED|Alinity s Anti-HCV Follow-Up||0||
59926034|NCT03285295|76044181|FG003|NOT COMPLETED|Alinity s Anti-HCV Follow-Up||0||
59926035|NCT03285295|76044182|FG004|NOT COMPLETED|Alinity s Anti-HCV Follow-Up||0||
59926036|NCT03285295|76044178|FG000|STARTED|Alinity s HIV Ag/Ab Combo||17095||
59926037|NCT03285295|76044179|FG001|STARTED|Alinity s HIV Ag/Ab Combo||1336||
59926038|NCT03285295|76044180|FG002|STARTED|Alinity s HIV Ag/Ab Combo||605||
59926039|NCT03285295|76044181|FG003|STARTED|Alinity s HIV Ag/Ab Combo|Individuals at Increased Risk of HIV Infection from HIV-2 Endemic Areas|535||
60059188|NCT02077465|76174318|FG000|NOT COMPLETED|Overall Study||1||
60059189|NCT02077465|76174319|FG001|NOT COMPLETED|Overall Study||1||
60059190|NCT02034565|76174325|FG000|STARTED|Overall Study||7||
60059191|NCT02034565|76174326|FG001|STARTED|Overall Study||7||
60059192|NCT02034565|76174325|FG000|COMPLETED|Overall Study||6||
60059193|NCT02034565|76174326|FG001|COMPLETED|Overall Study||7||
60059194|NCT02034565|76174325|FG000|NOT COMPLETED|Overall Study||1||
60059195|NCT02034565|76174326|FG001|NOT COMPLETED|Overall Study||0||
60059196|NCT02075515|76174337|FG000|STARTED|Overall Study||218||
60059197|NCT02075515|76174338|FG001|STARTED|Overall Study||217||
60059198|NCT02075515|76174339|FG002|STARTED|Overall Study||216||
60059199|NCT02075515|76174337|FG000|COMPLETED|Overall Study||214||
60059200|NCT02075515|76174338|FG001|COMPLETED|Overall Study||212||
60059201|NCT02075515|76174339|FG002|COMPLETED|Overall Study||208||
60059202|NCT02075515|76174337|FG000|NOT COMPLETED|Overall Study||4||
60059203|NCT02075515|76174338|FG001|NOT COMPLETED|Overall Study||5||
60059204|NCT02075515|76174339|FG002|NOT COMPLETED|Overall Study||8||
60059205|NCT02034409|76174350|FG000|STARTED|Sham Run-in Period||140||
60059206|NCT02034409|76174351|FG001|STARTED|Sham Run-in Period|Number started is zero because there is no PLIUS arm in Sham Run-in Period|0||
60059207|NCT02034409|76174350|FG000|COMPLETED|Sham Run-in Period||136||
60059208|NCT02034409|76174351|FG001|COMPLETED|Sham Run-in Period|Number started is zero because there is no PLIUS arm in Sham Run-in Period|0||
60059209|NCT02034409|76174350|FG000|NOT COMPLETED|Sham Run-in Period||4||
60059210|NCT02034409|76174351|FG001|NOT COMPLETED|Sham Run-in Period||0||
60059211|NCT02034409|76174350|FG000|STARTED|Sham-Controlled Treatment Period|Number started in Sham Arm of Sham-Controlled Treatment Period Milestone not equal to Sham Run-in Period Milestone because participants in this Milestone are randomly assigned to either Sham or PLIUS treatment arm.|67||
60059212|NCT02034409|76174351|FG001|STARTED|Sham-Controlled Treatment Period|Number started in PLIUS Arm of Sham-Controlled Treatment Period Milestone not equal to Sham Run-in Period Milestone because participants in this Milestone are randomly assigned to either Sham or PLIUS treatment arm.|69||
60059213|NCT02034409|76174350|FG000|COMPLETED|Sham-Controlled Treatment Period||55||
60059214|NCT02034409|76174351|FG001|COMPLETED|Sham-Controlled Treatment Period||54||
60059215|NCT02034409|76174350|FG000|NOT COMPLETED|Sham-Controlled Treatment Period||12||
60059216|NCT02034409|76174351|FG001|NOT COMPLETED|Sham-Controlled Treatment Period||15||
60059217|NCT02021318|76174359|FG000|STARTED|Overall Study||323||
60059218|NCT02021318|76174360|FG001|STARTED|Overall Study||293||
59516496|NCT01025791|75610122|FG000|COMPLETED|Period 5||2||
59516497|NCT01025791|75610123|FG001|COMPLETED|Period 5||2||
59516498|NCT01025791|75610124|FG002|COMPLETED|Period 5||2||
59516499|NCT01025791|75610125|FG003|COMPLETED|Period 5||2||
59516500|NCT01025791|75610126|FG004|COMPLETED|Period 5||0||
59516501|NCT01025791|75610127|FG005|COMPLETED|Period 5||0||
59516502|NCT01025791|75610128|FG006|COMPLETED|Period 5||0||
59516503|NCT01025791|75610129|FG007|COMPLETED|Period 5||0||
59516504|NCT01025791|75610130|FG008|COMPLETED|Period 5||0||
59516505|NCT01025791|75610131|FG009|COMPLETED|Period 5||0||
59516506|NCT01025791|75610132|FG010|COMPLETED|Period 5||0||
59516507|NCT01025791|75610133|FG011|COMPLETED|Period 5||0||
59516508|NCT01025791|75610134|FG012|COMPLETED|Period 5||0||
59516509|NCT01025791|75610135|FG013|COMPLETED|Period 5||0||
59760909|NCT00601640|75880578|FG001|STARTED|Overall Study||52||
59760910|NCT00601640|75880579|FG002|STARTED|Overall Study||52||
59760911|NCT00601640|75880577|FG000|COMPLETED|Overall Study||47||
59760912|NCT00601640|75880578|FG001|COMPLETED|Overall Study||47||
59760913|NCT00601640|75880579|FG002|COMPLETED|Overall Study||42||
59760914|NCT00601640|75880577|FG000|NOT COMPLETED|Overall Study||5||
59926040|NCT03285295|76044182|FG004|STARTED|Alinity s HIV Ag/Ab Combo||0||
59926041|NCT03285295|76044178|FG000|COMPLETED|Alinity s HIV Ag/Ab Combo||16996||
59926042|NCT03285295|76044179|FG001|COMPLETED|Alinity s HIV Ag/Ab Combo||1336||
59926043|NCT03285295|76044180|FG002|COMPLETED|Alinity s HIV Ag/Ab Combo||605||
59926044|NCT03285295|76044181|FG003|COMPLETED|Alinity s HIV Ag/Ab Combo|Individuals at Increased Risk of HIV Infection from HIV-2 Endemic Areas|535||
59926045|NCT03285295|76044182|FG004|COMPLETED|Alinity s HIV Ag/Ab Combo||0||
59926046|NCT03285295|76044178|FG000|NOT COMPLETED|Alinity s HIV Ag/Ab Combo||99||
59926047|NCT03285295|76044179|FG001|NOT COMPLETED|Alinity s HIV Ag/Ab Combo||0||
59926048|NCT03285295|76044180|FG002|NOT COMPLETED|Alinity s HIV Ag/Ab Combo||0||
59926049|NCT03285295|76044181|FG003|NOT COMPLETED|Alinity s HIV Ag/Ab Combo||0||
59926050|NCT03285295|76044182|FG004|NOT COMPLETED|Alinity s HIV Ag/Ab Combo||0||
59926051|NCT03285295|76044178|FG000|STARTED|Alinity s HIV Ag/Ab Combo Follow-Up||15||
59926052|NCT03285295|76044179|FG001|STARTED|Alinity s HIV Ag/Ab Combo Follow-Up||0||
59926053|NCT03285295|76044180|FG002|STARTED|Alinity s HIV Ag/Ab Combo Follow-Up||0||
59926054|NCT03285295|76044181|FG003|STARTED|Alinity s HIV Ag/Ab Combo Follow-Up||0||
59926055|NCT03285295|76044182|FG004|STARTED|Alinity s HIV Ag/Ab Combo Follow-Up||0||
59516510|NCT01025791|75610122|FG000|NOT COMPLETED|Period 5||0||
59516511|NCT01025791|75610123|FG001|NOT COMPLETED|Period 5||0||
59516512|NCT01025791|75610124|FG002|NOT COMPLETED|Period 5||0||
59760915|NCT00601640|75880578|FG001|NOT COMPLETED|Overall Study||5||
59760916|NCT00601640|75880579|FG002|NOT COMPLETED|Overall Study||10||
59926056|NCT03285295|76044178|FG000|COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||4||
59516513|NCT01025791|75610125|FG003|NOT COMPLETED|Period 5||0||
59760917|NCT02805725|75880594|FG000|STARTED|Phase I (Dose Escalation Part)||3||
59516514|NCT01025791|75610126|FG004|NOT COMPLETED|Period 5||0||
59516515|NCT01025791|75610127|FG005|NOT COMPLETED|Period 5||0||
59516516|NCT01025791|75610128|FG006|NOT COMPLETED|Period 5||0||
59516517|NCT01025791|75610129|FG007|NOT COMPLETED|Period 5||0||
59516518|NCT01025791|75610130|FG008|NOT COMPLETED|Period 5||0||
59516519|NCT01025791|75610131|FG009|NOT COMPLETED|Period 5||0||
59516520|NCT01025791|75610132|FG010|NOT COMPLETED|Period 5||0||
59516521|NCT01025791|75610133|FG011|NOT COMPLETED|Period 5||0||
59516522|NCT01025791|75610134|FG012|NOT COMPLETED|Period 5||0||
59516523|NCT01025791|75610135|FG013|NOT COMPLETED|Period 5||0||
59516524|NCT03195010|75610188|FG000|STARTED|Overall Study||2||
59516525|NCT03195010|75610189|FG001|STARTED|Overall Study||2||
59516526|NCT03195010|75610188|FG000|COMPLETED|Overall Study||2||
59516527|NCT03195010|75610189|FG001|COMPLETED|Overall Study||2||
59516528|NCT03195010|75610188|FG000|NOT COMPLETED|Overall Study||0||
59516529|NCT03195010|75610189|FG001|NOT COMPLETED|Overall Study||0||
59516530|NCT03423082|75610197|FG000|STARTED|Overall Study||1||
59516531|NCT03423082|75610197|FG000|COMPLETED|Overall Study||1||
59516532|NCT03423082|75610197|FG000|NOT COMPLETED|Overall Study||0||
59516533|NCT01026181|75610204|FG000|STARTED|Overall Study||51||
60059219|NCT02021318|76174359|FG000|COMPLETED|Overall Study||250||
60059220|NCT02021318|76174360|FG001|COMPLETED|Overall Study||230||
60059221|NCT02021318|76174359|FG000|NOT COMPLETED|Overall Study||73||
60059222|NCT02021318|76174360|FG001|NOT COMPLETED|Overall Study||63||
60059223|NCT02041286|76174367|FG000|STARTED|Overall Study||136||
60059224|NCT02041286|76174367|FG000|COMPLETED|Overall Study|One subject discontinued from testing after low BG fingerstick result (hypoglycemia AE).|135||
60059225|NCT02041286|76174367|FG000|NOT COMPLETED|Overall Study||1||
60059226|NCT02020616|76174380|FG000|STARTED|Overall Study||10||
60059227|NCT02020616|76174381|FG001|STARTED|Overall Study||8||
60059228|NCT02020616|76174382|FG002|STARTED|Overall Study||8||
60059229|NCT02020616|76174383|FG003|STARTED|Overall Study||8||
60059230|NCT02020616|76174384|FG004|STARTED|Overall Study||8||
60059231|NCT02020616|76174385|FG005|STARTED|Overall Study||8||
60059232|NCT02020616|76174386|FG006|STARTED|Overall Study||10||
60059233|NCT02020616|76174380|FG000|Received at Least One Dose of Study Drug|Overall Study||10||
60059234|NCT02020616|76174381|FG001|Received at Least One Dose of Study Drug|Overall Study||8||
60059235|NCT02020616|76174382|FG002|Received at Least One Dose of Study Drug|Overall Study||8||
60059236|NCT02020616|76174383|FG003|Received at Least One Dose of Study Drug|Overall Study||7||
60059237|NCT02020616|76174384|FG004|Received at Least One Dose of Study Drug|Overall Study||8||
60059238|NCT02020616|76174385|FG005|Received at Least One Dose of Study Drug|Overall Study||8||
60059239|NCT02020616|76174386|FG006|Received at Least One Dose of Study Drug|Overall Study||10||
60059240|NCT02020616|76174380|FG000|COMPLETED|Overall Study||10||
60059241|NCT02020616|76174381|FG001|COMPLETED|Overall Study||7||
60059242|NCT02020616|76174382|FG002|COMPLETED|Overall Study||6||
60059243|NCT02020616|76174383|FG003|COMPLETED|Overall Study||6||
60059244|NCT02020616|76174384|FG004|COMPLETED|Overall Study||6||
60059245|NCT02020616|76174385|FG005|COMPLETED|Overall Study||3||
60059246|NCT02020616|76174386|FG006|COMPLETED|Overall Study||6||
60059247|NCT02020616|76174380|FG000|NOT COMPLETED|Overall Study||0||
60059248|NCT02020616|76174381|FG001|NOT COMPLETED|Overall Study||1||
60059249|NCT02020616|76174382|FG002|NOT COMPLETED|Overall Study||2||
60059250|NCT02020616|76174383|FG003|NOT COMPLETED|Overall Study||2||
60059251|NCT02020616|76174384|FG004|NOT COMPLETED|Overall Study||2||
60059252|NCT02020616|76174385|FG005|NOT COMPLETED|Overall Study||5||
60059253|NCT02020616|76174386|FG006|NOT COMPLETED|Overall Study||4||
60059254|NCT02048072|76174416|FG000|STARTED|Overall Study||33||
59516534|NCT01026181|75610205|FG001|STARTED|Overall Study||51||
59516535|NCT01026181|75610206|FG002|STARTED|Overall Study||48||
60059255|NCT02048072|76174416|FG000|COMPLETED|Overall Study||29||
60059256|NCT02048072|76174416|FG000|NOT COMPLETED|Overall Study||4||
60059257|NCT02047604|76174426|FG000|STARTED|Overall Study||6||
60059258|NCT02047604|76174427|FG001|STARTED|Overall Study||7||
60059259|NCT02047604|76174428|FG002|STARTED|Overall Study||6||
60059260|NCT02047604|76174429|FG003|STARTED|Overall Study||6||
60059261|NCT02047604|76174430|FG004|STARTED|Overall Study||6||
60059262|NCT02047604|76174431|FG005|STARTED|Overall Study||10||
60059263|NCT02047604|76174426|FG000|COMPLETED|Overall Study||6||
59516536|NCT01026181|75610204|FG000|COMPLETED|Overall Study||51||
59516537|NCT01026181|75610205|FG001|COMPLETED|Overall Study||51||
59516538|NCT01026181|75610206|FG002|COMPLETED|Overall Study||48||
59516539|NCT01026181|75610204|FG000|NOT COMPLETED|Overall Study||0||
59516540|NCT01026181|75610205|FG001|NOT COMPLETED|Overall Study||0||
59516541|NCT01026181|75610206|FG002|NOT COMPLETED|Overall Study||0||
59516542|NCT03294850|75610216|FG000|STARTED|Overall Study||4||
59516543|NCT03294850|75610217|FG001|STARTED|Overall Study||10||
59516544|NCT03294850|75610216|FG000|COMPLETED|Overall Study||4||
60059264|NCT02047604|76174427|FG001|COMPLETED|Overall Study||7||
60059265|NCT02047604|76174428|FG002|COMPLETED|Overall Study||6||
60059266|NCT02047604|76174429|FG003|COMPLETED|Overall Study||6||
60059267|NCT02047604|76174430|FG004|COMPLETED|Overall Study||5||
60059268|NCT02047604|76174431|FG005|COMPLETED|Overall Study||9||
60059269|NCT02047604|76174426|FG000|NOT COMPLETED|Overall Study||0||
60059270|NCT02047604|76174427|FG001|NOT COMPLETED|Overall Study||0||
60059271|NCT02047604|76174428|FG002|NOT COMPLETED|Overall Study||0||
60059272|NCT02047604|76174429|FG003|NOT COMPLETED|Overall Study||0||
60059273|NCT02047604|76174430|FG004|NOT COMPLETED|Overall Study||1||
60059274|NCT02047604|76174431|FG005|NOT COMPLETED|Overall Study||1||
60059275|NCT01622660|76174445|FG000|STARTED|Overall Study||2||
60059276|NCT01622660|76174445|FG000|COMPLETED|Overall Study||1||
60059277|NCT01622660|76174445|FG000|NOT COMPLETED|Overall Study||1||
59516545|NCT03294850|75610217|FG001|COMPLETED|Overall Study||10||
59516546|NCT03294850|75610216|FG000|NOT COMPLETED|Overall Study||0||
59516547|NCT03294850|75610217|FG001|NOT COMPLETED|Overall Study||0||
59516548|NCT00996931|75610223|FG000|STARTED|Overall Study||6||
59516549|NCT00996931|75610223|FG000|COMPLETED|Overall Study||6||
59516550|NCT00996931|75610223|FG000|NOT COMPLETED|Overall Study||0||
59516551|NCT03295630|75610228|FG000|STARTED|Overall Study||20||
59516552|NCT03295630|75610228|FG000|COMPLETED|Overall Study||20||
59516553|NCT03295630|75610228|FG000|NOT COMPLETED|Overall Study||0||
59516554|NCT01026805|75610233|FG000|STARTED|Overall Study||11||
59516555|NCT01026805|75610233|FG000|COMPLETED|Overall Study||11||
59516556|NCT01026805|75610233|FG000|NOT COMPLETED|Overall Study||0||
59516557|NCT00997555|75610239|FG000|STARTED|Overall Study||13||
59516558|NCT00997555|75610240|FG001|STARTED|Overall Study||15||
59613048|NCT01713582|75724100|FG006|COMPLETED|Overall Study||0||
59613049|NCT01713582|75724101|FG007|COMPLETED|Overall Study||0||
59926057|NCT03285295|76044179|FG001|COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0||
59926058|NCT03285295|76044180|FG002|COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0||
59926059|NCT03285295|76044181|FG003|COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0||
59926060|NCT03285295|76044182|FG004|COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0||
59926061|NCT03285295|76044178|FG000|NOT COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||11||
59926062|NCT03285295|76044179|FG001|NOT COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0||
59926063|NCT03285295|76044180|FG002|NOT COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0||
59926064|NCT03285295|76044181|FG003|NOT COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0||
59926065|NCT03285295|76044182|FG004|NOT COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0||
59926066|NCT03285295|76044178|FG000|STARTED|Alinity s Anti-HBc||15968||
59926067|NCT03285295|76044179|FG001|STARTED|Alinity s Anti-HBc||405||
59926068|NCT03285295|76044180|FG002|STARTED|Alinity s Anti-HBc||403||
59926069|NCT03285295|76044181|FG003|STARTED|Alinity s Anti-HBc||0||
59926070|NCT03285295|76044182|FG004|STARTED|Alinity s Anti-HBc||0||
59926071|NCT03285295|76044178|FG000|COMPLETED|Alinity s Anti-HBc||15877||
59926072|NCT03285295|76044179|FG001|COMPLETED|Alinity s Anti-HBc||404||
59926073|NCT03285295|76044180|FG002|COMPLETED|Alinity s Anti-HBc||403||
59926074|NCT03285295|76044181|FG003|COMPLETED|Alinity s Anti-HBc||0||
59926075|NCT03285295|76044182|FG004|COMPLETED|Alinity s Anti-HBc||0||
59926076|NCT03285295|76044178|FG000|NOT COMPLETED|Alinity s Anti-HBc||91||
59926077|NCT03285295|76044179|FG001|NOT COMPLETED|Alinity s Anti-HBc||1||
59926078|NCT03285295|76044180|FG002|NOT COMPLETED|Alinity s Anti-HBc||0||
59926079|NCT03285295|76044181|FG003|NOT COMPLETED|Alinity s Anti-HBc||0||
59926080|NCT03285295|76044182|FG004|NOT COMPLETED|Alinity s Anti-HBc||0||
59926081|NCT03285295|76044178|FG000|STARTED|Alinity s Anti-HBc Follow-Up||16||
59926082|NCT03285295|76044179|FG001|STARTED|Alinity s Anti-HBc Follow-Up||0||
59926083|NCT03285295|76044180|FG002|STARTED|Alinity s Anti-HBc Follow-Up||0||
59926084|NCT03285295|76044181|FG003|STARTED|Alinity s Anti-HBc Follow-Up||0||
59926085|NCT03285295|76044182|FG004|STARTED|Alinity s Anti-HBc Follow-Up||0||
59926086|NCT03285295|76044178|FG000|COMPLETED|Alinity s Anti-HBc Follow-Up||2||
59926087|NCT03285295|76044179|FG001|COMPLETED|Alinity s Anti-HBc Follow-Up||0||
59926088|NCT03285295|76044180|FG002|COMPLETED|Alinity s Anti-HBc Follow-Up||0||
60059278|NCT02019602|76174451|FG000|STARTED|Screening Period||21||
60059279|NCT02019602|76174452|FG001|STARTED|Screening Period||16||
60059280|NCT02019602|76174451|FG000|COMPLETED|Screening Period||16||
60059281|NCT02019602|76174452|FG001|COMPLETED|Screening Period||16||
59516559|NCT00997555|75610239|FG000|COMPLETED|Overall Study||13||
59516560|NCT00997555|75610240|FG001|COMPLETED|Overall Study||15||
59516561|NCT00997555|75610239|FG000|NOT COMPLETED|Overall Study||0||
60059282|NCT02019602|76174451|FG000|NOT COMPLETED|Screening Period||5||
59516562|NCT00997555|75610240|FG001|NOT COMPLETED|Overall Study||0||
59516563|NCT03197038|75610248|FG000|STARTED|Overall Study||22||
59760918|NCT02805725|75880595|FG001|STARTED|Phase I (Dose Escalation Part)||3||
59760919|NCT02805725|75880596|FG002|STARTED|Phase I (Dose Escalation Part)||7||
60059283|NCT02019602|76174452|FG001|NOT COMPLETED|Screening Period||0||
60059284|NCT02019602|76174451|FG000|STARTED|Sampling Period||16||
60059285|NCT02019602|76174452|FG001|STARTED|Sampling Period||16||
60059286|NCT02019602|76174451|FG000|COMPLETED|Sampling Period||16||
60059287|NCT02019602|76174452|FG001|COMPLETED|Sampling Period||16||
60059288|NCT02019602|76174451|FG000|NOT COMPLETED|Sampling Period||0||
60059289|NCT02019602|76174452|FG001|NOT COMPLETED|Sampling Period||0||
60059290|NCT01994876|76174459|FG000|STARTED|Baseline - Own Product||9||
60059291|NCT01994876|76174460|FG001|STARTED|Baseline - Own Product||9||
59760920|NCT02805725|75880597|FG003|STARTED|Phase I (Dose Escalation Part)||7||
59760921|NCT02805725|75880598|FG004|STARTED|Phase I (Dose Escalation Part)||0||
60059292|NCT01994876|76174459|FG000|COMPLETED|Baseline - Own Product||9||
60059293|NCT01994876|76174460|FG001|COMPLETED|Baseline - Own Product||9||
60059294|NCT01994876|76174459|FG000|NOT COMPLETED|Baseline - Own Product||0||
60059295|NCT01994876|76174460|FG001|NOT COMPLETED|Baseline - Own Product||0||
60059296|NCT01994876|76174459|FG000|STARTED|Test Period 1||9||
60059297|NCT01994876|76174460|FG001|STARTED|Test Period 1||9||
60059298|NCT01994876|76174459|FG000|COMPLETED|Test Period 1||9||
60059299|NCT01994876|76174460|FG001|COMPLETED|Test Period 1||7||
60059300|NCT01994876|76174459|FG000|NOT COMPLETED|Test Period 1||0||
60059301|NCT01994876|76174460|FG001|NOT COMPLETED|Test Period 1||2||
60059302|NCT01994876|76174459|FG000|STARTED|Test Period 2||9||
60059303|NCT01994876|76174460|FG001|STARTED|Test Period 2||7||
60059304|NCT01994876|76174459|FG000|COMPLETED|Test Period 2||8||
60059305|NCT01994876|76174460|FG001|COMPLETED|Test Period 2||6||
60059306|NCT01994876|76174459|FG000|NOT COMPLETED|Test Period 2||1||
60059307|NCT01994876|76174460|FG001|NOT COMPLETED|Test Period 2||1||
60059308|NCT02040428|76174470|FG000|STARTED|Overall Study||75||
60059309|NCT02040428|76174471|FG001|STARTED|Overall Study||81||
60059310|NCT02040428|76174470|FG000|Intent to Treat (Randomized Subjects)|Overall Study||76||
60059311|NCT02040428|76174471|FG001|Intent to Treat (Randomized Subjects)|Overall Study||80||
60059312|NCT02040428|76174470|FG000|COMPLETED|Overall Study||70||
60059313|NCT02040428|76174471|FG001|COMPLETED|Overall Study||77||
60059314|NCT02040428|76174470|FG000|NOT COMPLETED|Overall Study||5||
60059315|NCT02040428|76174471|FG001|NOT COMPLETED|Overall Study||4||
60059316|NCT02018822|76174479|FG000|STARTED|Overall Study||50||50
60059317|NCT02018822|76174480|FG001|STARTED|Overall Study||50||50
60059318|NCT02018822|76174481|FG002|STARTED|Overall Study||35||50
60059319|NCT02018822|76174479|FG000|COMPLETED|Overall Study||44|Completed 24 months|44
60059320|NCT02018822|76174480|FG001|COMPLETED|Overall Study||42|Completed 24 months|42
60059321|NCT02018822|76174481|FG002|COMPLETED|Overall Study||29|Completed 24 months|41
60059322|NCT02018822|76174479|FG000|NOT COMPLETED|Overall Study||6||6
60059323|NCT02018822|76174480|FG001|NOT COMPLETED|Overall Study||8||8
59516564|NCT03197038|75610249|FG001|STARTED|Overall Study||17||
59516565|NCT03197038|75610248|FG000|COMPLETED|Overall Study||18||
59516566|NCT03197038|75610249|FG001|COMPLETED|Overall Study||17||
59516567|NCT03197038|75610248|FG000|NOT COMPLETED|Overall Study||4||
59926089|NCT03285295|76044181|FG003|COMPLETED|Alinity s Anti-HBc Follow-Up||0||
59926090|NCT03285295|76044182|FG004|COMPLETED|Alinity s Anti-HBc Follow-Up||0||
59926091|NCT03285295|76044178|FG000|NOT COMPLETED|Alinity s Anti-HBc Follow-Up||14||
59926092|NCT03285295|76044179|FG001|NOT COMPLETED|Alinity s Anti-HBc Follow-Up||0||
59926093|NCT03285295|76044180|FG002|NOT COMPLETED|Alinity s Anti-HBc Follow-Up||0||
59926094|NCT03285295|76044181|FG003|NOT COMPLETED|Alinity s Anti-HBc Follow-Up||0||
59926095|NCT03285295|76044182|FG004|NOT COMPLETED|Alinity s Anti-HBc Follow-Up||0||
59926096|NCT03285295|76044178|FG000|STARTED|Alinity s Chagas||16023||
59926097|NCT03285295|76044179|FG001|STARTED|Alinity s Chagas||320||
59926098|NCT03285295|76044180|FG002|STARTED|Alinity s Chagas||0||
59926099|NCT03285295|76044181|FG003|STARTED|Alinity s Chagas||615||
59926100|NCT03285295|76044182|FG004|STARTED|Alinity s Chagas||0||
59926101|NCT03285295|76044178|FG000|COMPLETED|Alinity s Chagas||15804||
59926102|NCT03285295|76044179|FG001|COMPLETED|Alinity s Chagas||320||
59926103|NCT03285295|76044180|FG002|COMPLETED|Alinity s Chagas||0||
59926104|NCT03285295|76044181|FG003|COMPLETED|Alinity s Chagas||615||
59926105|NCT03285295|76044182|FG004|COMPLETED|Alinity s Chagas||0||
59926106|NCT03285295|76044178|FG000|NOT COMPLETED|Alinity s Chagas||219||
59926107|NCT03285295|76044179|FG001|NOT COMPLETED|Alinity s Chagas||0||
59926108|NCT03285295|76044180|FG002|NOT COMPLETED|Alinity s Chagas||0||
60059324|NCT02018822|76174481|FG002|NOT COMPLETED|Overall Study||6||9
60059325|NCT02055157|76174496|FG000|STARTED|Initial 6 Months||8||
60059326|NCT02055157|76174497|FG001|STARTED|Initial 6 Months||8||
60059327|NCT02055157|76174498|FG002|STARTED|Initial 6 Months||10||
60059328|NCT02055157|76174499|FG003|STARTED|Initial 6 Months||9||
60059329|NCT02055157|76174496|FG000|COMPLETED|Initial 6 Months||7||
60059330|NCT02055157|76174497|FG001|COMPLETED|Initial 6 Months||7||
60059331|NCT02055157|76174498|FG002|COMPLETED|Initial 6 Months||10||
60059332|NCT02055157|76174499|FG003|COMPLETED|Initial 6 Months||8||
60059333|NCT02055157|76174496|FG000|NOT COMPLETED|Initial 6 Months||1||
60059334|NCT02055157|76174497|FG001|NOT COMPLETED|Initial 6 Months||1||
60059335|NCT02055157|76174498|FG002|NOT COMPLETED|Initial 6 Months||0||
60059336|NCT02055157|76174499|FG003|NOT COMPLETED|Initial 6 Months||1||
60059337|NCT02055157|76174496|FG000|STARTED|18-month Extension||7||
60059338|NCT02055157|76174497|FG001|STARTED|18-month Extension||7||
60059339|NCT02055157|76174498|FG002|STARTED|18-month Extension||10||
60059340|NCT02055157|76174499|FG003|STARTED|18-month Extension||8||
60059341|NCT02055157|76174496|FG000|COMPLETED|18-month Extension||6||
60059342|NCT02055157|76174497|FG001|COMPLETED|18-month Extension||6||
60059343|NCT02055157|76174498|FG002|COMPLETED|18-month Extension||10||
60059344|NCT02055157|76174499|FG003|COMPLETED|18-month Extension||8||
60059345|NCT02055157|76174496|FG000|NOT COMPLETED|18-month Extension||1||
60059346|NCT02055157|76174497|FG001|NOT COMPLETED|18-month Extension||1||
60059347|NCT02055157|76174498|FG002|NOT COMPLETED|18-month Extension||0||
60059348|NCT02055157|76174499|FG003|NOT COMPLETED|18-month Extension||0||
60059349|NCT02022007|76174523|FG000|STARTED|Overall Study||13||
60059350|NCT02022007|76174524|FG001|STARTED|Overall Study||12||
60059351|NCT02022007|76174525|FG002|STARTED|Overall Study||13||
60059352|NCT02022007|76174523|FG000|COMPLETED|Overall Study||12||
60059353|NCT02022007|76174524|FG001|COMPLETED|Overall Study||11||
60059354|NCT02022007|76174525|FG002|COMPLETED|Overall Study||11||
60059355|NCT02022007|76174523|FG000|NOT COMPLETED|Overall Study||1||
60059356|NCT02022007|76174524|FG001|NOT COMPLETED|Overall Study||1||
60059357|NCT02022007|76174525|FG002|NOT COMPLETED|Overall Study||2||
60059358|NCT02031679|76174535|FG000|STARTED|Overall Study||14||
60059359|NCT02031679|76174536|FG001|STARTED|Overall Study||14||
60059360|NCT02031679|76174535|FG000|COMPLETED|Overall Study||14||
60059361|NCT02031679|76174536|FG001|COMPLETED|Overall Study||12||
60059362|NCT02031679|76174535|FG000|NOT COMPLETED|Overall Study||0||
60059363|NCT02031679|76174536|FG001|NOT COMPLETED|Overall Study||2||
60059364|NCT02053753|76174544|FG000|STARTED|Overall Study||72||
60059365|NCT02053753|76174545|FG001|STARTED|Overall Study||74||
60059366|NCT02053753|76174544|FG000|Received Treatment|Overall Study||71||
60059367|NCT02053753|76174545|FG001|Received Treatment|Overall Study||71||
60059368|NCT02053753|76174544|FG000|COMPLETED|Overall Study||65||
60059369|NCT02053753|76174545|FG001|COMPLETED|Overall Study||66||
60059370|NCT02053753|76174544|FG000|NOT COMPLETED|Overall Study||7||
60059371|NCT02053753|76174545|FG001|NOT COMPLETED|Overall Study||8||
60059372|NCT02019979|76174551|FG000|STARTED|Overall Study||14||
60059373|NCT02019979|76174551|FG000|COMPLETED|Overall Study||0||
60059374|NCT02019979|76174551|FG000|NOT COMPLETED|Overall Study||14||
60059375|NCT02019667|76174555|FG000|STARTED|First Intervention (6 Months)||10||
60059376|NCT02019667|76174556|FG001|STARTED|First Intervention (6 Months)||9||
60059377|NCT02019667|76174555|FG000|COMPLETED|First Intervention (6 Months)||10||
60059378|NCT02019667|76174556|FG001|COMPLETED|First Intervention (6 Months)||8||
60059379|NCT02019667|76174555|FG000|NOT COMPLETED|First Intervention (6 Months)||0||
60059380|NCT02019667|76174556|FG001|NOT COMPLETED|First Intervention (6 Months)||1||
60059381|NCT02019667|76174555|FG000|STARTED|Washout Period (9 Weeks)||10||
60059382|NCT02019667|76174556|FG001|STARTED|Washout Period (9 Weeks)||8||
60059383|NCT02019667|76174555|FG000|COMPLETED|Washout Period (9 Weeks)||10||
60059384|NCT02019667|76174556|FG001|COMPLETED|Washout Period (9 Weeks)||8||
60059385|NCT02019667|76174555|FG000|NOT COMPLETED|Washout Period (9 Weeks)||0||
60059386|NCT02019667|76174556|FG001|NOT COMPLETED|Washout Period (9 Weeks)||0||
60059387|NCT02019667|76174555|FG000|STARTED|2nd Intervention (6 Months)||10||
60059388|NCT02019667|76174556|FG001|STARTED|2nd Intervention (6 Months)||8||
60059389|NCT02019667|76174555|FG000|COMPLETED|2nd Intervention (6 Months)||10||
60059390|NCT02019667|76174556|FG001|COMPLETED|2nd Intervention (6 Months)||6||
60059391|NCT02019667|76174555|FG000|NOT COMPLETED|2nd Intervention (6 Months)||0||
60059392|NCT02019667|76174556|FG001|NOT COMPLETED|2nd Intervention (6 Months)||2||
60059393|NCT02019667|76174555|FG000|STARTED|Washout Period (9 Weeks)||10||
59516568|NCT03197038|75610249|FG001|NOT COMPLETED|Overall Study||0||
59516569|NCT00634088|75610259|FG000|STARTED|Time Period 1: Dose Level 1||6||
59516570|NCT00634088|75610260|FG001|STARTED|Time Period 1: Dose Level 1||0||
59516571|NCT00634088|75610261|FG002|STARTED|Time Period 1: Dose Level 1||0||
59516572|NCT00634088|75610262|FG003|STARTED|Time Period 1: Dose Level 1||0||
59516573|NCT00634088|75610259|FG000|COMPLETED|Time Period 1: Dose Level 1||0||
60059394|NCT02019667|76174556|FG001|STARTED|Washout Period (9 Weeks)||6||
60059395|NCT02019667|76174555|FG000|COMPLETED|Washout Period (9 Weeks)||10||
60059396|NCT02019667|76174556|FG001|COMPLETED|Washout Period (9 Weeks)||6||
60059397|NCT02019667|76174555|FG000|NOT COMPLETED|Washout Period (9 Weeks)||0||
60059398|NCT02019667|76174556|FG001|NOT COMPLETED|Washout Period (9 Weeks)||0||
60059399|NCT02030821|76174568|FG000|STARTED|Overall Study||48||
60059400|NCT02030821|76174569|FG001|STARTED|Overall Study||46||
60059401|NCT02030821|76174570|FG002|STARTED|Overall Study||78||
60059402|NCT02030821|76174571|FG003|STARTED|Overall Study||74||
60059403|NCT02030821|76174568|FG000|COMPLETED|Overall Study||46||
60059404|NCT02030821|76174569|FG001|COMPLETED|Overall Study||44||
60059405|NCT02030821|76174570|FG002|COMPLETED|Overall Study||73||
60059406|NCT02030821|76174571|FG003|COMPLETED|Overall Study||72||
60059407|NCT02030821|76174568|FG000|NOT COMPLETED|Overall Study||2||
60059408|NCT02030821|76174569|FG001|NOT COMPLETED|Overall Study||2||
60059409|NCT02030821|76174570|FG002|NOT COMPLETED|Overall Study||5||
60059410|NCT02030821|76174571|FG003|NOT COMPLETED|Overall Study||2||
60059411|NCT02052739|76174583|FG000|STARTED|Overall Study||19||
60059412|NCT02052739|76174584|FG001|STARTED|Overall Study||6||
60059413|NCT02052739|76174583|FG000|COMPLETED|Overall Study||14||
60059414|NCT02052739|76174584|FG001|COMPLETED|Overall Study||5||
60059415|NCT02052739|76174583|FG000|NOT COMPLETED|Overall Study||5||
60059416|NCT02052739|76174584|FG001|NOT COMPLETED|Overall Study||1||
60059417|NCT02019277|76174592|FG000|STARTED|Overall Study||50||
60059418|NCT02019277|76174592|FG000|COMPLETED|Overall Study||38||
60059419|NCT02019277|76174592|FG000|NOT COMPLETED|Overall Study||12||
60059420|NCT02030119|76174600|FG000|STARTED|Overall Study||70||
60059421|NCT02030119|76174601|FG001|STARTED|Overall Study||70||
60059422|NCT02030119|76174602|FG002|STARTED|Overall Study||71||
60059423|NCT02030119|76174603|FG003|STARTED|Overall Study||70||
60059424|NCT02030119|76174600|FG000|COMPLETED|Overall Study||67||
60059425|NCT02030119|76174601|FG001|COMPLETED|Overall Study||68||
60059426|NCT02030119|76174602|FG002|COMPLETED|Overall Study||65||
60059427|NCT02030119|76174603|FG003|COMPLETED|Overall Study||67||
60059428|NCT02030119|76174600|FG000|NOT COMPLETED|Overall Study||3||
60059429|NCT02030119|76174601|FG001|NOT COMPLETED|Overall Study||2||
60059430|NCT02030119|76174602|FG002|NOT COMPLETED|Overall Study||6||
60059431|NCT02030119|76174603|FG003|NOT COMPLETED|Overall Study||3||
60059432|NCT01823835|76174628|FG000|STARTED|Overall Study||3||
60059433|NCT01823835|76174629|FG001|STARTED|Overall Study||4||
60059434|NCT01823835|76174630|FG002|STARTED|Overall Study||4||
60059435|NCT01823835|76174631|FG003|STARTED|Overall Study||6||
60059436|NCT01823835|76174632|FG004|STARTED|Overall Study||6||
60059437|NCT01823835|76174633|FG005|STARTED|Overall Study||6||
60059438|NCT01823835|76174634|FG006|STARTED|Overall Study||6||
60059439|NCT01823835|76174635|FG007|STARTED|Overall Study||3||
60059440|NCT01823835|76174636|FG008|STARTED|Overall Study||3||
60059441|NCT01823835|76174637|FG009|STARTED|Overall Study||19||
60059442|NCT01823835|76174638|FG010|STARTED|Overall Study||10||
60059443|NCT01823835|76174639|FG011|STARTED|Overall Study||53||
59516574|NCT00634088|75610260|FG001|COMPLETED|Time Period 1: Dose Level 1||0||
59516575|NCT00634088|75610261|FG002|COMPLETED|Time Period 1: Dose Level 1||0||
60059444|NCT01823835|76174640|FG012|STARTED|Overall Study||19||
60059445|NCT01823835|76174641|FG013|STARTED|Overall Study||4||
60059446|NCT01823835|76174642|FG014|STARTED|Overall Study||6||
60059447|NCT01823835|76174628|FG000|COMPLETED|Overall Study||0||
60059448|NCT01823835|76174629|FG001|COMPLETED|Overall Study||0||
60059449|NCT01823835|76174630|FG002|COMPLETED|Overall Study||0||
60059450|NCT01823835|76174631|FG003|COMPLETED|Overall Study||0||
59516576|NCT00634088|75610262|FG003|COMPLETED|Time Period 1: Dose Level 1||0||
59516577|NCT00634088|75610259|FG000|NOT COMPLETED|Time Period 1: Dose Level 1||6||
59516578|NCT00634088|75610260|FG001|NOT COMPLETED|Time Period 1: Dose Level 1||0||
60059451|NCT01823835|76174632|FG004|COMPLETED|Overall Study||0||
60059452|NCT01823835|76174633|FG005|COMPLETED|Overall Study||0||
60059453|NCT01823835|76174634|FG006|COMPLETED|Overall Study||0||
60059454|NCT01823835|76174635|FG007|COMPLETED|Overall Study||0||
60059455|NCT01823835|76174636|FG008|COMPLETED|Overall Study||0||
60059456|NCT01823835|76174637|FG009|COMPLETED|Overall Study||0||
60059457|NCT01823835|76174638|FG010|COMPLETED|Overall Study||0||
60059458|NCT01823835|76174639|FG011|COMPLETED|Overall Study||0||
60059459|NCT01823835|76174640|FG012|COMPLETED|Overall Study||0||
60059460|NCT01823835|76174641|FG013|COMPLETED|Overall Study||0||
60059461|NCT01823835|76174642|FG014|COMPLETED|Overall Study||0||
60059462|NCT01823835|76174628|FG000|NOT COMPLETED|Overall Study||3||
60059463|NCT01823835|76174629|FG001|NOT COMPLETED|Overall Study||4||
60059464|NCT01823835|76174630|FG002|NOT COMPLETED|Overall Study||4||
60059465|NCT01823835|76174631|FG003|NOT COMPLETED|Overall Study||6||
60059466|NCT01823835|76174632|FG004|NOT COMPLETED|Overall Study||6||
60059467|NCT01823835|76174633|FG005|NOT COMPLETED|Overall Study||6||
60059468|NCT01823835|76174634|FG006|NOT COMPLETED|Overall Study||6||
60059469|NCT01823835|76174635|FG007|NOT COMPLETED|Overall Study||3||
60059470|NCT01823835|76174636|FG008|NOT COMPLETED|Overall Study||3||
60059471|NCT01823835|76174637|FG009|NOT COMPLETED|Overall Study||19||
60059472|NCT01823835|76174638|FG010|NOT COMPLETED|Overall Study||10||
60059473|NCT01823835|76174639|FG011|NOT COMPLETED|Overall Study||53||
60059474|NCT01823835|76174640|FG012|NOT COMPLETED|Overall Study||19||
60059475|NCT01823835|76174641|FG013|NOT COMPLETED|Overall Study||4||
60059476|NCT01823835|76174642|FG014|NOT COMPLETED|Overall Study||6||
60059477|NCT01823679|76174682|FG000|STARTED|Overall Study||2||
60059478|NCT01823679|76174682|FG000|COMPLETED|Overall Study||1||
60059479|NCT01823679|76174682|FG000|NOT COMPLETED|Overall Study||1||
60059480|NCT01823289|76174687|FG000|STARTED|Overall Study||71||
60059481|NCT01823289|76174687|FG000|COMPLETED|Overall Study||47||
60059482|NCT01823289|76174687|FG000|NOT COMPLETED|Overall Study||24||
60059483|NCT01822899|76174693|FG000|STARTED|Overall Study||358||
60059484|NCT01822899|76174694|FG001|STARTED|Overall Study||358||
60059485|NCT01822899|76174693|FG000|COMPLETED|Overall Study||334||
60059486|NCT01822899|76174694|FG001|COMPLETED|Overall Study||340||
60059487|NCT01822899|76174693|FG000|NOT COMPLETED|Overall Study||24||
60059488|NCT01822899|76174694|FG001|NOT COMPLETED|Overall Study||18||
60059489|NCT01822821|76174702|FG000|STARTED|Overall Study||75||
60059490|NCT01822821|76174703|FG001|STARTED|Overall Study||75||
60059491|NCT01822821|76174702|FG000|COMPLETED|Overall Study||73||
60059492|NCT01822821|76174703|FG001|COMPLETED|Overall Study||74||
60059493|NCT01822821|76174702|FG000|NOT COMPLETED|Overall Study||2||
60059494|NCT01822821|76174703|FG001|NOT COMPLETED|Overall Study||1||
60059495|NCT01822665|76174709|FG000|STARTED|Overall Study||28||
60059496|NCT01822665|76174709|FG000|Received Ibuprofen Tablet (400 mg)|Overall Study|5 participants did not complete; Period 3(2:adverse events;1:other reason); Period 4(2:other reason)|23||
60059497|NCT01822665|76174709|FG000|Received Placebo Tablet|Overall Study|5 participants did not complete; Period 2(1:other reason); Period 4(3:adverse event; 1:other reason)|23||
60059498|NCT01822665|76174709|FG000|Received Ibuprofen Capsule (400 mg)|Overall Study|Two participants, each in period 3 and period 4 did not complete treatment for 'other reason'.|24||
60059499|NCT01822665|76174709|FG000|Received Paracetamol Tablet (1000 mg)|Overall Study||28||
60059500|NCT01822665|76174709|FG000|COMPLETED|Overall Study||20||
60059501|NCT01822665|76174709|FG000|NOT COMPLETED|Overall Study||8||
60059502|NCT02173301|76174731|FG000|STARTED|Overall Study||49||
60059503|NCT02173301|76174732|FG001|STARTED|Overall Study||55||
60059504|NCT02173301|76174733|FG002|STARTED|Overall Study||48||
60059505|NCT02173301|76174734|FG003|STARTED|Overall Study||48||
60059506|NCT02173301|76174731|FG000|COMPLETED|Overall Study||29||
60059507|NCT02173301|76174732|FG001|COMPLETED|Overall Study||32||
60059508|NCT02173301|76174733|FG002|COMPLETED|Overall Study||28||
60059509|NCT02173301|76174734|FG003|COMPLETED|Overall Study||33||
60059510|NCT02173301|76174731|FG000|NOT COMPLETED|Overall Study||20||
60059511|NCT02173301|76174732|FG001|NOT COMPLETED|Overall Study||23||
60059512|NCT02173301|76174733|FG002|NOT COMPLETED|Overall Study||20||
60059513|NCT02173301|76174734|FG003|NOT COMPLETED|Overall Study||15||
60059514|NCT01822587|76174747|FG000|STARTED|Overall Study||59|Not all participant who were started were able to complete the study.|
60059515|NCT01822587|76174748|FG001|STARTED|Overall Study||60|Not all participant who were started were able to complete the study.|
60059516|NCT01822587|76174749|FG002|STARTED|Overall Study||62|Not all participant who were started were able to complete the study.|
60059517|NCT01822587|76174747|FG000|COMPLETED|Overall Study||43||
60059518|NCT01822587|76174748|FG001|COMPLETED|Overall Study||45||
60059519|NCT01822587|76174749|FG002|COMPLETED|Overall Study||44||
60059520|NCT01822587|76174747|FG000|NOT COMPLETED|Overall Study||16||
60059521|NCT01822587|76174748|FG001|NOT COMPLETED|Overall Study||15||
60059522|NCT01822587|76174749|FG002|NOT COMPLETED|Overall Study||18||
60059523|NCT01822353|76174760|FG000|STARTED|Overall Study||10||
60059524|NCT01822353|76174761|FG001|STARTED|Overall Study||9||
60059525|NCT01822353|76174762|FG002|STARTED|Overall Study||4||
60059526|NCT01822353|76174760|FG000|COMPLETED|Overall Study||6||
60059527|NCT01822353|76174761|FG001|COMPLETED|Overall Study||4||
60059528|NCT01822353|76174762|FG002|COMPLETED|Overall Study||3||
60059529|NCT01822353|76174760|FG000|NOT COMPLETED|Overall Study||4||
60059530|NCT01822353|76174761|FG001|NOT COMPLETED|Overall Study||5||
60059531|NCT01822353|76174762|FG002|NOT COMPLETED|Overall Study||1||
60059532|NCT01821963|76174773|FG000|STARTED|Overall Study||1||
60059533|NCT01821963|76174773|FG000|COMPLETED|Overall Study||0||
60059534|NCT01821963|76174773|FG000|NOT COMPLETED|Overall Study||1||
60059535|NCT01821807|76174779|FG000|STARTED|Overall Study||150||
60059536|NCT01821807|76174780|FG001|STARTED|Overall Study||110||
60059537|NCT01821807|76174779|FG000|COMPLETED|Overall Study||147||
60059538|NCT01821807|76174780|FG001|COMPLETED|Overall Study||109||
60059539|NCT01821807|76174779|FG000|NOT COMPLETED|Overall Study||3||
60059540|NCT01821807|76174780|FG001|NOT COMPLETED|Overall Study||1||
60059541|NCT01821729|76174786|FG000|STARTED|Overall Study||50||
60059542|NCT01821729|76174786|FG000|Received Chemoradiotherapy|Overall Study||45||
60059543|NCT01821729|76174786|FG000|Underwent Attempted Surgery|Overall Study||42||
60059544|NCT01821729|76174786|FG000|COMPLETED|Overall Study||49||
60059545|NCT01821729|76174786|FG000|NOT COMPLETED|Overall Study||1||
60059546|NCT01820637|76174790|FG000|STARTED|Overall Study||57||
60059547|NCT01820637|76174790|FG000|COMPLETED|Overall Study||54||
60059548|NCT01820637|76174790|FG000|NOT COMPLETED|Overall Study||3||
59516579|NCT00634088|75610261|FG002|NOT COMPLETED|Time Period 1: Dose Level 1||0||
59516580|NCT00634088|75610262|FG003|NOT COMPLETED|Time Period 1: Dose Level 1||0||
59926109|NCT03285295|76044181|FG003|NOT COMPLETED|Alinity s Chagas||0||
59926110|NCT03285295|76044182|FG004|NOT COMPLETED|Alinity s Chagas||0||
59926111|NCT03285295|76044178|FG000|STARTED|Alinity s Chagas Follow-Up||14||
59926112|NCT03285295|76044179|FG001|STARTED|Alinity s Chagas Follow-Up||0||
59926113|NCT03285295|76044180|FG002|STARTED|Alinity s Chagas Follow-Up||0||
59926114|NCT03285295|76044181|FG003|STARTED|Alinity s Chagas Follow-Up||0||
59926115|NCT03285295|76044182|FG004|STARTED|Alinity s Chagas Follow-Up||0||
59926116|NCT03285295|76044178|FG000|COMPLETED|Alinity s Chagas Follow-Up||1||
59926117|NCT03285295|76044179|FG001|COMPLETED|Alinity s Chagas Follow-Up||0||
59926118|NCT03285295|76044180|FG002|COMPLETED|Alinity s Chagas Follow-Up||0||
59926119|NCT03285295|76044181|FG003|COMPLETED|Alinity s Chagas Follow-Up||0||
59926120|NCT03285295|76044182|FG004|COMPLETED|Alinity s Chagas Follow-Up||0||
59926121|NCT03285295|76044178|FG000|NOT COMPLETED|Alinity s Chagas Follow-Up||13||
59926122|NCT03285295|76044179|FG001|NOT COMPLETED|Alinity s Chagas Follow-Up||0||
59926123|NCT03285295|76044180|FG002|NOT COMPLETED|Alinity s Chagas Follow-Up||0||
59926124|NCT03285295|76044181|FG003|NOT COMPLETED|Alinity s Chagas Follow-Up||0||
59926125|NCT03285295|76044182|FG004|NOT COMPLETED|Alinity s Chagas Follow-Up||0||
59926126|NCT02583048|76044214|FG000|STARTED|Overall Study||28||
59926127|NCT02583048|76044215|FG001|STARTED|Overall Study||28||
59926128|NCT02583048|76044216|FG002|STARTED|Overall Study||28||
59926129|NCT02583048|76044214|FG000|COMPLETED|Overall Study||28||
59926130|NCT02583048|76044215|FG001|COMPLETED|Overall Study||27||
59926131|NCT02583048|76044216|FG002|COMPLETED|Overall Study||27||
59926132|NCT02583048|76044214|FG000|NOT COMPLETED|Overall Study||0||
59926133|NCT02583048|76044215|FG001|NOT COMPLETED|Overall Study||1||
59926134|NCT02583048|76044216|FG002|NOT COMPLETED|Overall Study||1||
59926135|NCT02939599|76044229|FG000|STARTED|Overall Study||3||
59926136|NCT02939599|76044230|FG001|STARTED|Overall Study||2||
59926137|NCT02939599|76044229|FG000|COMPLETED|Overall Study||0||
59926138|NCT02939599|76044230|FG001|COMPLETED|Overall Study||0||
59926139|NCT02939599|76044229|FG000|NOT COMPLETED|Overall Study||3||
59926140|NCT02939599|76044230|FG001|NOT COMPLETED|Overall Study||2||
59926141|NCT01318512|76044237|FG000|STARTED|Titration Period (4 Months)||340||
59926142|NCT01318512|76044237|FG000|COMPLETED|Titration Period (4 Months)||340||
59926143|NCT01318512|76044237|FG000|NOT COMPLETED|Titration Period (4 Months)||0||
59926144|NCT01318512|76044237|FG000|STARTED|Maintenance Period (6 Months)||340||
59926145|NCT01318512|76044237|FG000|COMPLETED|Maintenance Period (6 Months)||329||
59926146|NCT01318512|76044237|FG000|NOT COMPLETED|Maintenance Period (6 Months)||11||
59926147|NCT03546439|76044246|FG000|STARTED|Overall Study||203||
59926148|NCT03546439|76044247|FG001|STARTED|Overall Study||156||
59926149|NCT03546439|76044248|FG002|STARTED|Overall Study||75||
59926150|NCT03546439|76044246|FG000|COMPLETED|Overall Study||203||
59926151|NCT03546439|76044247|FG001|COMPLETED|Overall Study||156||
59926152|NCT03546439|76044248|FG002|COMPLETED|Overall Study||75||
59926153|NCT03546439|76044246|FG000|NOT COMPLETED|Overall Study||0||
59926154|NCT03546439|76044247|FG001|NOT COMPLETED|Overall Study||0||
59926155|NCT03546439|76044248|FG002|NOT COMPLETED|Overall Study||0||
59926156|NCT03274687|76044258|FG000|STARTED|Overall Study||152||
59926157|NCT03274687|76044259|FG001|STARTED|Overall Study||144||
59926158|NCT03274687|76044258|FG000|Eligible|Overall Study||151||
59926159|NCT03274687|76044259|FG001|Eligible|Overall Study||143||
59926160|NCT03274687|76044258|FG000|Eligible With Adverse Event Data|Overall Study||148||
59926161|NCT03274687|76044259|FG001|Eligible With Adverse Event Data|Overall Study||141||
59926162|NCT03274687|76044258|FG000|COMPLETED|Overall Study||151|Participants contributing data to results are considered to have completed the study.|
59926163|NCT03274687|76044259|FG001|COMPLETED|Overall Study||143|Participants contributing data to results are considered to have completed the study.|
59926164|NCT03274687|76044258|FG000|NOT COMPLETED|Overall Study||1||
59926165|NCT03274687|76044259|FG001|NOT COMPLETED|Overall Study||1||
59926166|NCT04651218|76044265|FG000|STARTED|Overall Study||16||
59926167|NCT04651218|76044266|FG001|STARTED|Overall Study||16||
59926168|NCT04651218|76044265|FG000|COMPLETED|Overall Study||16||
59926169|NCT04651218|76044266|FG001|COMPLETED|Overall Study||14||
59926170|NCT04651218|76044265|FG000|NOT COMPLETED|Overall Study||0||
59926171|NCT04651218|76044266|FG001|NOT COMPLETED|Overall Study||2||
59926172|NCT03274453|76044276|FG000|STARTED|Overall Study||38||
59926173|NCT03274453|76044277|FG001|STARTED|Overall Study||30||
59926174|NCT03274453|76044278|FG002|STARTED|Overall Study||32||
59926175|NCT03274453|76044279|FG003|STARTED|Overall Study||29||
59926176|NCT03274453|76044276|FG000|COMPLETED|Overall Study||34||
59926177|NCT03274453|76044277|FG001|COMPLETED|Overall Study||24||
59926178|NCT03274453|76044278|FG002|COMPLETED|Overall Study||28||
59926179|NCT03274453|76044279|FG003|COMPLETED|Overall Study||25||
59926180|NCT03274453|76044276|FG000|NOT COMPLETED|Overall Study||4||
59926181|NCT03274453|76044277|FG001|NOT COMPLETED|Overall Study||6||
59926182|NCT03274453|76044278|FG002|NOT COMPLETED|Overall Study||4||
60059549|NCT02172911|76174796|FG000|STARTED|Overall Study||7||
60059550|NCT02172911|76174797|FG001|STARTED|Overall Study||3||
60059551|NCT02172911|76174796|FG000|COMPLETED|Overall Study||6||
60059552|NCT02172911|76174797|FG001|COMPLETED|Overall Study||1||
60059553|NCT02172911|76174796|FG000|NOT COMPLETED|Overall Study||1||
60059554|NCT02172911|76174797|FG001|NOT COMPLETED|Overall Study||2||
60059555|NCT02120027|76174805|FG000|STARTED|Overall Study||277||
60059556|NCT02120027|76174806|FG001|STARTED|Overall Study||279||
60059557|NCT02120027|76174805|FG000|COMPLETED|Overall Study||161||
60059558|NCT02120027|76174806|FG001|COMPLETED|Overall Study||160||
60059559|NCT02120027|76174805|FG000|NOT COMPLETED|Overall Study||116||
60059560|NCT02120027|76174806|FG001|NOT COMPLETED|Overall Study||119||
60059561|NCT01850823|76174815|FG000|STARTED|Overall Study||175||
60059562|NCT01850823|76174816|FG001|STARTED|Overall Study||350||
60059563|NCT01850823|76174817|FG002|STARTED|Overall Study||355||
60059564|NCT01850823|76174815|FG000|COMPLETED|Overall Study||172||
60059565|NCT01850823|76174816|FG001|COMPLETED|Overall Study||347||
60059566|NCT01850823|76174817|FG002|COMPLETED|Overall Study||345||
60059567|NCT01850823|76174815|FG000|NOT COMPLETED|Overall Study||3||
60059568|NCT01850823|76174816|FG001|NOT COMPLETED|Overall Study||3||
60059569|NCT01850823|76174817|FG002|NOT COMPLETED|Overall Study||10||
60059570|NCT01820559|76174830|FG000|STARTED|Overall Study||136||
60059571|NCT01820559|76174831|FG001|STARTED|Overall Study||135||
60059572|NCT01820559|76174832|FG002|STARTED|Overall Study||139||
60059573|NCT01820559|76174830|FG000|Randomized and Treated|Overall Study||136||
60059574|NCT01820559|76174831|FG001|Randomized and Treated|Overall Study||135||
60059575|NCT01820559|76174832|FG002|Randomized and Treated|Overall Study||139||
60059576|NCT01820559|76174830|FG000|Completed Tutration Period|Overall Study||130||
60059577|NCT01820559|76174831|FG001|Completed Tutration Period|Overall Study||134||
60059578|NCT01820559|76174832|FG002|Completed Tutration Period|Overall Study||131||
60059579|NCT01820559|76174830|FG000|Entered Maintenance Period|Overall Study||129||
60059580|NCT01820559|76174831|FG001|Entered Maintenance Period|Overall Study||133||
60059581|NCT01820559|76174832|FG002|Entered Maintenance Period|Overall Study||129||
60059582|NCT01820559|76174830|FG000|Completed Maintenance Period|Overall Study||122||
60059583|NCT01820559|76174831|FG001|Completed Maintenance Period|Overall Study||123||
60059584|NCT01820559|76174832|FG002|Completed Maintenance Period|Overall Study||110||
60059585|NCT01820559|76174830|FG000|COMPLETED|Overall Study||122||
60059586|NCT01820559|76174831|FG001|COMPLETED|Overall Study||122||
60059587|NCT01820559|76174832|FG002|COMPLETED|Overall Study||110||
60059588|NCT01820559|76174830|FG000|NOT COMPLETED|Overall Study||14||
60059589|NCT01820559|76174831|FG001|NOT COMPLETED|Overall Study||13||
59613050|NCT01713582|75724102|FG008|COMPLETED|Overall Study||0||
59613051|NCT01713582|75724103|FG009|COMPLETED|Overall Study||0||
59613052|NCT01713582|75724104|FG010|COMPLETED|Overall Study||0||
59926183|NCT03274453|76044279|FG003|NOT COMPLETED|Overall Study||4||
59926184|NCT03273907|76044289|FG000|STARTED|Overall Study||43||
59926185|NCT03273907|76044289|FG000|COMPLETED|Overall Study||34||
59926186|NCT03273907|76044289|FG000|NOT COMPLETED|Overall Study||9||
59926187|NCT04246021|76044295|FG000|STARTED|Overall Study||84||
60059590|NCT01820559|76174832|FG002|NOT COMPLETED|Overall Study||29||
60059591|NCT01818765|76174840|FG000|STARTED|Overall Study||20||
60059592|NCT01818765|76174840|FG000|COMPLETED|Overall Study||18|Assessed at 6 months|
60059593|NCT01818765|76174840|FG000|NOT COMPLETED|Overall Study||2||
60059594|NCT01850589|76174847|FG000|STARTED|Overall Study||22||
60059595|NCT01850589|76174848|FG001|STARTED|Overall Study||22||
60059596|NCT01850589|76174847|FG000|COMPLETED|Overall Study||14||
60059597|NCT01850589|76174848|FG001|COMPLETED|Overall Study||22||
60059598|NCT01850589|76174847|FG000|NOT COMPLETED|Overall Study||8||
60059599|NCT01850589|76174848|FG001|NOT COMPLETED|Overall Study||0||
60059600|NCT01818531|76174856|FG000|STARTED|Overall Study||75||
60059601|NCT01818531|76174857|FG001|STARTED|Overall Study||75||
59926188|NCT04246021|76044295|FG000|COMPLETED|Overall Study||84||
59926189|NCT04246021|76044295|FG000|NOT COMPLETED|Overall Study||0||
59926190|NCT00659646|76044311|FG000|STARTED|Overall Study||38||
59926191|NCT00659646|76044312|FG001|STARTED|Overall Study||18||
59926192|NCT00659646|76044311|FG000|COMPLETED|Overall Study||23||
59926193|NCT00659646|76044312|FG001|COMPLETED|Overall Study||10||
59926194|NCT00659646|76044311|FG000|NOT COMPLETED|Overall Study||15||
59926195|NCT00659646|76044312|FG001|NOT COMPLETED|Overall Study||8||
60059602|NCT01818531|76174856|FG000|COMPLETED|Overall Study||74||
60059603|NCT01818531|76174857|FG001|COMPLETED|Overall Study||73||
60059604|NCT01818531|76174856|FG000|NOT COMPLETED|Overall Study||1||
60059605|NCT01818531|76174857|FG001|NOT COMPLETED|Overall Study||2||
60059606|NCT02171429|76174866|FG000|STARTED|Overall Study||72||
60059607|NCT02171429|76174867|FG001|STARTED|Overall Study||143||
60059608|NCT02171429|76174868|FG002|STARTED|Overall Study||143||
60059609|NCT02171429|76174866|FG000|Completed Week 10 Visit|Overall Study||70||
60059610|NCT02171429|76174867|FG001|Completed Week 10 Visit|Overall Study||141||
60059611|NCT02171429|76174868|FG002|Completed Week 10 Visit|Overall Study||141||
60067867|NCT01785615|76183052|FG000|NOT COMPLETED|Atorvastatin Phase||0||
59926196|NCT02236572|76044320|FG000|STARTED|Overall Study||17||
59926197|NCT02236572|76044320|FG000|COMPLETED|Overall Study||14||
59926198|NCT02236572|76044320|FG000|NOT COMPLETED|Overall Study||3||
59926199|NCT03054870|76044324|FG000|STARTED|Day of Ventilation Imaging|16 of 226 enrolled subjects were withdrawn from the study prior to receiving Technegas and were not included in further study assessments.|210||
59926200|NCT03054870|76044324|FG000|COMPLETED|Day of Ventilation Imaging||205||
59926201|NCT03054870|76044324|FG000|NOT COMPLETED|Day of Ventilation Imaging||5||
59926202|NCT03054870|76044324|FG000|STARTED|24-hour Follow-up|24-hour follow-up was omitted from Protocol Amendment 1, so 92 subjects enrolled under Amendment 1 not included.|118||
59926203|NCT03054870|76044324|FG000|COMPLETED|24-hour Follow-up||118||
59926204|NCT03054870|76044324|FG000|NOT COMPLETED|24-hour Follow-up||0||
59926205|NCT03054870|76044324|FG000|STARTED|Blinded Read of Images|At time of study termination, 200 subjects had completed the blinded read assessments. The decision to terminate was based on the positive results of an unplanned interim analysis of these blind read data by a third party statistician.|200||
59926206|NCT03054870|76044324|FG000|COMPLETED|Blinded Read of Images||200||
59926207|NCT03054870|76044324|FG000|NOT COMPLETED|Blinded Read of Images||0||
59926208|NCT03414047|76044343|FG000|STARTED|Overall Study||53||
59926209|NCT03414047|76044344|FG001|STARTED|Overall Study||46||
59926210|NCT03414047|76044345|FG002|STARTED|Overall Study||41||
59926211|NCT03414047|76044346|FG003|STARTED|Overall Study||29||
59926212|NCT03414047|76044343|FG000|Received at Least One Dose of Study Drug|Overall Study||53||
59926213|NCT03414047|76044344|FG001|Received at Least One Dose of Study Drug|Overall Study||46||
59926214|NCT03414047|76044345|FG002|Received at Least One Dose of Study Drug|Overall Study||41||
59926215|NCT03414047|76044346|FG003|Received at Least One Dose of Study Drug|Overall Study||29||
59926216|NCT03414047|76044343|FG000|COMPLETED|Overall Study||51||
59926217|NCT03414047|76044344|FG001|COMPLETED|Overall Study||46||
59926218|NCT03414047|76044345|FG002|COMPLETED|Overall Study||38||
59926219|NCT03414047|76044346|FG003|COMPLETED|Overall Study||27||
59926220|NCT03414047|76044343|FG000|NOT COMPLETED|Overall Study||2||
59926221|NCT03414047|76044344|FG001|NOT COMPLETED|Overall Study||0||
59926222|NCT03414047|76044345|FG002|NOT COMPLETED|Overall Study||3||
59926223|NCT03414047|76044346|FG003|NOT COMPLETED|Overall Study||2||
59926224|NCT03351335|76044360|FG000|STARTED|Overall Study||21||
59926225|NCT03351335|76044361|FG001|STARTED|Overall Study||19||
59926226|NCT03351335|76044362|FG002|STARTED|Overall Study||20||
59926227|NCT03351335|76044360|FG000|COMPLETED|Overall Study||21||
59926228|NCT03351335|76044361|FG001|COMPLETED|Overall Study||19||
59926229|NCT03351335|76044362|FG002|COMPLETED|Overall Study||16||
59926230|NCT03351335|76044360|FG000|NOT COMPLETED|Overall Study||0||
59926231|NCT03351335|76044361|FG001|NOT COMPLETED|Overall Study||0||
59926232|NCT03351335|76044362|FG002|NOT COMPLETED|Overall Study||4||
59926233|NCT03055806|76044374|FG000|STARTED|Overall Study||48||
59926234|NCT03055806|76044375|FG001|STARTED|Overall Study||48||
59926235|NCT03055806|76044376|FG002|STARTED|Overall Study||71||
59926236|NCT03055806|76044377|FG003|STARTED|Overall Study||72||
59926237|NCT03055806|76044374|FG000|COMPLETED|Overall Study||42||
59926238|NCT03055806|76044375|FG001|COMPLETED|Overall Study||41||
59926239|NCT03055806|76044376|FG002|COMPLETED|Overall Study||58||
59926240|NCT03055806|76044377|FG003|COMPLETED|Overall Study||57||
59926241|NCT03055806|76044374|FG000|NOT COMPLETED|Overall Study||6||
59926242|NCT03055806|76044375|FG001|NOT COMPLETED|Overall Study||7||
59926243|NCT03055806|76044376|FG002|NOT COMPLETED|Overall Study||13||
59926244|NCT03055806|76044377|FG003|NOT COMPLETED|Overall Study||15||
59926245|NCT04620798|76044389|FG000|STARTED|Overall Study||536|Includes all eligible participants who consented to enrollment and were randomized to received either immediate or delayed results.|
59926246|NCT04620798|76044390|FG001|STARTED|Overall Study||540|Includes all eligible participants who consented to enrollment and were randomized to received either immediate or delayed results.|
59926247|NCT04620798|76044389|FG000|Completed Behavioral Survey|Overall Study||477|Includes all participants who completed the behavioral survey two weeks following baseline antibody testing.|
59926248|NCT04620798|76044390|FG001|Completed Behavioral Survey|Overall Study||508|Includes all participants who completed the behavioral survey two weeks following baseline antibody testing.|
59926249|NCT04620798|76044389|FG000|COMPLETED|Overall Study||410|Includes all participants who completed endline antibody testing eight weeks following baseline antibody testing.|
59926250|NCT04620798|76044390|FG001|COMPLETED|Overall Study||402|Includes all participants who completed endline antibody testing eight weeks following baseline antibody testing.|
59926251|NCT04620798|76044389|FG000|NOT COMPLETED|Overall Study||126||
59926252|NCT04620798|76044390|FG001|NOT COMPLETED|Overall Study||138||
59926253|NCT03052764|76044398|FG000|STARTED|Double-Blind Treatment Period||80||
59926254|NCT03052764|76044399|FG001|STARTED|Double-Blind Treatment Period||40||
59926255|NCT03052764|76044398|FG000|mITT|Double-Blind Treatment Period||78||
59926256|NCT03052764|76044399|FG001|mITT|Double-Blind Treatment Period||39||
59926257|NCT03052764|76044398|FG000|COMPLETED|Double-Blind Treatment Period||70||
59926258|NCT03052764|76044399|FG001|COMPLETED|Double-Blind Treatment Period||37||
59926259|NCT03052764|76044398|FG000|NOT COMPLETED|Double-Blind Treatment Period||10||
59926260|NCT03052764|76044399|FG001|NOT COMPLETED|Double-Blind Treatment Period||3||
59926261|NCT03052764|76044398|FG000|STARTED|Open-Label Re-Treatment Period||58||
59926262|NCT03052764|76044399|FG001|STARTED|Open-Label Re-Treatment Period||33||
59926263|NCT03052764|76044398|FG000|COMPLETED|Open-Label Re-Treatment Period||58||
59926264|NCT03052764|76044399|FG001|COMPLETED|Open-Label Re-Treatment Period||33||
60059612|NCT02171429|76174866|FG000|COMPLETED|Overall Study||71|Participants who rolled into open-label extension study or completed 12 weeks safety follow-up following treatment completion or discontinuation.|
60059613|NCT02171429|76174867|FG001|COMPLETED|Overall Study||140|Participants who rolled into open-label extension study or completed 12 weeks safety follow-up following treatment completion or discontinuation.|
60059614|NCT02171429|76174868|FG002|COMPLETED|Overall Study||138|Participants who rolled into open-label extension study or completed 12 weeks safety follow-up following treatment completion or discontinuation.|
60059615|NCT02171429|76174866|FG000|NOT COMPLETED|Overall Study||1||
60059616|NCT02171429|76174867|FG001|NOT COMPLETED|Overall Study||3||
60059617|NCT02171429|76174868|FG002|NOT COMPLETED|Overall Study||5||
60059618|NCT01818297|76174881|FG000|STARTED|Blinded Phase (Randomization - 3 Months)||32||
60059619|NCT01818297|76174882|FG001|STARTED|Blinded Phase (Randomization - 3 Months)||30||
60059620|NCT01818297|76174881|FG000|Week 1|Blinded Phase (Randomization - 3 Months)||32||
60059621|NCT01818297|76174882|FG001|Week 1|Blinded Phase (Randomization - 3 Months)||30||
60059622|NCT01818297|76174881|FG000|Week 6|Blinded Phase (Randomization - 3 Months)||32||
60059623|NCT01818297|76174882|FG001|Week 6|Blinded Phase (Randomization - 3 Months)||29||
60059624|NCT01818297|76174881|FG000|COMPLETED|Blinded Phase (Randomization - 3 Months)||32||
60059625|NCT01818297|76174882|FG001|COMPLETED|Blinded Phase (Randomization - 3 Months)||29||
60059626|NCT01818297|76174881|FG000|NOT COMPLETED|Blinded Phase (Randomization - 3 Months)||0||
60059627|NCT01818297|76174882|FG001|NOT COMPLETED|Blinded Phase (Randomization - 3 Months)||1||
60059628|NCT01818297|76174881|FG000|STARTED|Open Label Phase (3-12 Months)||32||
60059629|NCT01818297|76174882|FG001|STARTED|Open Label Phase (3-12 Months)||29||
60059630|NCT01818297|76174881|FG000|COMPLETED|Open Label Phase (3-12 Months)||14||
60059631|NCT01818297|76174882|FG001|COMPLETED|Open Label Phase (3-12 Months)||19||
60059632|NCT01818297|76174881|FG000|NOT COMPLETED|Open Label Phase (3-12 Months)||18||
60059633|NCT01818297|76174882|FG001|NOT COMPLETED|Open Label Phase (3-12 Months)||10||
60059634|NCT01818141|76174890|FG000|STARTED|Overall Study||18||
60059635|NCT01818141|76174891|FG001|STARTED|Overall Study||16||
60059636|NCT01818141|76174890|FG000|COMPLETED|Overall Study||15||
60059637|NCT01818141|76174891|FG001|COMPLETED|Overall Study||13||
60059638|NCT01818141|76174890|FG000|NOT COMPLETED|Overall Study||3||
60059639|NCT01818141|76174891|FG001|NOT COMPLETED|Overall Study||3||
60059640|NCT01849497|76174899|FG000|STARTED|Overall Study||75||
60059641|NCT01849497|76174900|FG001|STARTED|Overall Study||74||
60059642|NCT01849497|76174899|FG000|Received Treatment|Overall Study||75||
60059643|NCT01849497|76174900|FG001|Received Treatment|Overall Study||74||
60059644|NCT01849497|76174899|FG000|COMPLETED|Overall Study||74||
60059645|NCT01849497|76174900|FG001|COMPLETED|Overall Study||70||
60059646|NCT01849497|76174899|FG000|NOT COMPLETED|Overall Study||1||
60059647|NCT01849497|76174900|FG001|NOT COMPLETED|Overall Study||4||
60059648|NCT02147093|76174908|FG000|STARTED|Period 1||20||
60059649|NCT02147093|76174909|FG001|STARTED|Period 1||20||
60059650|NCT02147093|76174908|FG000|COMPLETED|Period 1||20||
60059651|NCT02147093|76174909|FG001|COMPLETED|Period 1||19||
60059652|NCT02147093|76174908|FG000|NOT COMPLETED|Period 1||0||
60059653|NCT02147093|76174909|FG001|NOT COMPLETED|Period 1||1||
60059654|NCT02147093|76174908|FG000|STARTED|Period 2||20||
60059655|NCT02147093|76174909|FG001|STARTED|Period 2||19||
60059656|NCT02147093|76174908|FG000|COMPLETED|Period 2||18||
60059657|NCT02147093|76174909|FG001|COMPLETED|Period 2||19||
60059658|NCT02147093|76174908|FG000|NOT COMPLETED|Period 2||2||
60059659|NCT02147093|76174909|FG001|NOT COMPLETED|Period 2||0||
60059660|NCT02119325|76174915|FG000|STARTED|Period 1||48||
60059661|NCT02119325|76174916|FG001|STARTED|Period 1||48||
60059662|NCT02119325|76174915|FG000|COMPLETED|Period 1||48||
60059663|NCT02119325|76174916|FG001|COMPLETED|Period 1||48||
60059664|NCT02119325|76174915|FG000|NOT COMPLETED|Period 1||0||
60059665|NCT02119325|76174916|FG001|NOT COMPLETED|Period 1||0||
60059666|NCT02119325|76174915|FG000|STARTED|Washout Period 1||48||
60059667|NCT02119325|76174916|FG001|STARTED|Washout Period 1||48||
60059668|NCT02119325|76174915|FG000|COMPLETED|Washout Period 1||48||
60059669|NCT02119325|76174916|FG001|COMPLETED|Washout Period 1||47||
60059670|NCT02119325|76174915|FG000|NOT COMPLETED|Washout Period 1||0||
60059671|NCT02119325|76174916|FG001|NOT COMPLETED|Washout Period 1||1||
60059672|NCT02119325|76174915|FG000|STARTED|Period 2||48||
60059673|NCT02119325|76174916|FG001|STARTED|Period 2||47||
60059674|NCT02119325|76174915|FG000|COMPLETED|Period 2||48||
60059675|NCT02119325|76174916|FG001|COMPLETED|Period 2||47||
60059676|NCT02119325|76174915|FG000|NOT COMPLETED|Period 2||0||
60059677|NCT02119325|76174916|FG001|NOT COMPLETED|Period 2||0||
60059678|NCT01816893|76174926|FG000|STARTED|Euglycemic Clamp/ Hypoglycemic Clamp||11||
60059679|NCT01816893|76174927|FG001|STARTED|Euglycemic Clamp/ Hypoglycemic Clamp||11||
60059680|NCT01816893|76174926|FG000|COMPLETED|Euglycemic Clamp/ Hypoglycemic Clamp||11||
60059681|NCT01816893|76174927|FG001|COMPLETED|Euglycemic Clamp/ Hypoglycemic Clamp||11||
60059682|NCT01816893|76174926|FG000|NOT COMPLETED|Euglycemic Clamp/ Hypoglycemic Clamp||0||
60059683|NCT01816893|76174927|FG001|NOT COMPLETED|Euglycemic Clamp/ Hypoglycemic Clamp||0||
60059684|NCT01816893|76174926|FG000|STARTED|Washout Period||11||
60059685|NCT01816893|76174927|FG001|STARTED|Washout Period||11||
60059686|NCT01816893|76174926|FG000|COMPLETED|Washout Period||9||
60059687|NCT01816893|76174927|FG001|COMPLETED|Washout Period||11||
60059688|NCT01816893|76174926|FG000|NOT COMPLETED|Washout Period||2||
60059689|NCT01816893|76174927|FG001|NOT COMPLETED|Washout Period||0||
60059690|NCT01816893|76174926|FG000|STARTED|Hypoglycemic Clamp/ Euglycemic Clamp||9||
60059691|NCT01816893|76174927|FG001|STARTED|Hypoglycemic Clamp/ Euglycemic Clamp||11||
60059692|NCT01816893|76174926|FG000|COMPLETED|Hypoglycemic Clamp/ Euglycemic Clamp||9||
60059693|NCT01816893|76174927|FG001|COMPLETED|Hypoglycemic Clamp/ Euglycemic Clamp||11||
60059694|NCT01816893|76174926|FG000|NOT COMPLETED|Hypoglycemic Clamp/ Euglycemic Clamp||0||
60059695|NCT01816893|76174927|FG001|NOT COMPLETED|Hypoglycemic Clamp/ Euglycemic Clamp||0||
60059696|NCT01848483|76174935|FG000|STARTED|Overall Study||61||
59926265|NCT03052764|76044398|FG000|NOT COMPLETED|Open-Label Re-Treatment Period||0||
59926266|NCT03052764|76044399|FG001|NOT COMPLETED|Open-Label Re-Treatment Period||0||
59926267|NCT02951819|76044409|FG000|STARTED|Overall Study||87||
59926268|NCT02951819|76044410|FG001|STARTED|Overall Study||14||
59926269|NCT02951819|76044409|FG000|Treated|Overall Study||86||
59926270|NCT02951819|76044410|FG001|Treated|Overall Study||14||
59926271|NCT02951819|76044409|FG000|COMPLETED|Overall Study||59||
59926272|NCT02951819|76044410|FG001|COMPLETED|Overall Study||7||
59926273|NCT02951819|76044409|FG000|NOT COMPLETED|Overall Study||28||
59926274|NCT02951819|76044410|FG001|NOT COMPLETED|Overall Study||7||
59926275|NCT03383783|76044416|FG000|STARTED|Overall Study||27||
59926276|NCT03383783|76044416|FG000|COMPLETED|Overall Study||25||
59926277|NCT03383783|76044416|FG000|NOT COMPLETED|Overall Study||2||
59926278|NCT03334721|76044434|FG000|STARTED|Overall Study||12||
59926279|NCT03334721|76044435|FG001|STARTED|Overall Study||11||
59926280|NCT03334721|76044434|FG000|COMPLETED|Overall Study||10||
59926281|NCT03334721|76044435|FG001|COMPLETED|Overall Study||11||
59926282|NCT03334721|76044434|FG000|NOT COMPLETED|Overall Study||2||
59926283|NCT03334721|76044435|FG001|NOT COMPLETED|Overall Study||0||
59926284|NCT03515551|76044448|FG000|STARTED|Overall Study||4||
59926285|NCT03515551|76044449|FG001|STARTED|Overall Study||3||
59926286|NCT03515551|76044450|FG002|STARTED|Overall Study||5||
59926287|NCT03515551|76044451|FG003|STARTED|Overall Study||3||
59926288|NCT03515551|76044452|FG004|STARTED|Overall Study|1 participant from the 10 mcg cohort was sequentially enrolled in the 30-100 mcg cohort and is counted as starting in both columns; reason for study discontinuation recorded as part of 30-100 mcg cohort.|5||
59926289|NCT03515551|76044453|FG005|STARTED|Overall Study||4||
59926290|NCT03515551|76044454|FG006|STARTED|Overall Study||5||
59926291|NCT03515551|76044448|FG000|COMPLETED|Overall Study||0||
59926292|NCT03515551|76044449|FG001|COMPLETED|Overall Study||0||
59926293|NCT03515551|76044450|FG002|COMPLETED|Overall Study||0||
59926294|NCT03515551|76044451|FG003|COMPLETED|Overall Study||0||
59926295|NCT03515551|76044452|FG004|COMPLETED|Overall Study||0||
59926296|NCT03515551|76044453|FG005|COMPLETED|Overall Study||0||
59926297|NCT03515551|76044454|FG006|COMPLETED|Overall Study||0||
59926298|NCT03515551|76044448|FG000|NOT COMPLETED|Overall Study||4||
59926299|NCT03515551|76044449|FG001|NOT COMPLETED|Overall Study||3||
59926300|NCT03515551|76044450|FG002|NOT COMPLETED|Overall Study||5||
59926301|NCT03515551|76044451|FG003|NOT COMPLETED|Overall Study||3||
59926302|NCT03515551|76044452|FG004|NOT COMPLETED|Overall Study||5||
59926303|NCT03515551|76044453|FG005|NOT COMPLETED|Overall Study||4||
59926304|NCT03515551|76044454|FG006|NOT COMPLETED|Overall Study||5||
59926305|NCT03380429|76044480|FG000|STARTED|Overall Study||87||
59926306|NCT03380429|76044481|FG001|STARTED|Overall Study||88||
59926307|NCT03380429|76044482|FG002|STARTED|Overall Study||88||
59926308|NCT03380429|76044483|FG003|STARTED|Overall Study||88||
59926309|NCT03380429|76044484|FG004|STARTED|Overall Study||86||
59926310|NCT03380429|76044480|FG000|COMPLETED|Overall Study||82||
59926311|NCT03380429|76044481|FG001|COMPLETED|Overall Study||81||
59926312|NCT03380429|76044482|FG002|COMPLETED|Overall Study||77||
59926313|NCT03380429|76044483|FG003|COMPLETED|Overall Study||78||
59926314|NCT03380429|76044484|FG004|COMPLETED|Overall Study||81||
59926315|NCT03380429|76044480|FG000|NOT COMPLETED|Overall Study||5||
59926316|NCT03380429|76044481|FG001|NOT COMPLETED|Overall Study||7||
59926317|NCT03380429|76044482|FG002|NOT COMPLETED|Overall Study||11||
59926318|NCT03380429|76044483|FG003|NOT COMPLETED|Overall Study||10||
59926319|NCT03380429|76044484|FG004|NOT COMPLETED|Overall Study||5||
59926320|NCT03280615|76044503|FG000|STARTED|Overall Study||50||
59926321|NCT03280615|76044504|FG001|STARTED|Overall Study||50||
59926322|NCT03280615|76044503|FG000|COMPLETED|Overall Study||46||
59926323|NCT03280615|76044504|FG001|COMPLETED|Overall Study||45||
59926324|NCT03280615|76044503|FG000|NOT COMPLETED|Overall Study||4||
59926325|NCT03280615|76044504|FG001|NOT COMPLETED|Overall Study||5||
59926326|NCT03280537|76044512|FG000|STARTED|Overall Study||65||
59926327|NCT03280537|76044513|FG001|STARTED|Overall Study||62||
59926328|NCT03280537|76044512|FG000|COMPLETED|Overall Study||63||
59926329|NCT03280537|76044513|FG001|COMPLETED|Overall Study||58||
59926330|NCT03280537|76044512|FG000|NOT COMPLETED|Overall Study||2||
59926331|NCT03280537|76044513|FG001|NOT COMPLETED|Overall Study||4||
59926332|NCT03280381|76044521|FG000|STARTED|Overall Study||101||
59926333|NCT03280381|76044522|FG001|STARTED|Overall Study||99||
59926334|NCT03280381|76044521|FG000|COMPLETED|Overall Study||101||
59926335|NCT03280381|76044522|FG001|COMPLETED|Overall Study||97||
59926336|NCT03280381|76044521|FG000|NOT COMPLETED|Overall Study||0||
59926337|NCT03280381|76044522|FG001|NOT COMPLETED|Overall Study||2||
60059697|NCT01848483|76174936|FG001|STARTED|Overall Study||60||
59926338|NCT03270085|76044531|FG000|STARTED|Overall Study||15||
59926339|NCT03270085|76044532|FG001|STARTED|Overall Study||15||
59926340|NCT03270085|76044531|FG000|COMPLETED|Overall Study||14||
59926341|NCT03270085|76044532|FG001|COMPLETED|Overall Study||15||
59926342|NCT03270085|76044531|FG000|NOT COMPLETED|Overall Study||1||
59926343|NCT03270085|76044532|FG001|NOT COMPLETED|Overall Study||0||
59926344|NCT03267511|76044542|FG000|STARTED|Overall Study||31||
59926345|NCT03267511|76044543|FG001|STARTED|Overall Study||31||
59926346|NCT03267511|76044544|FG002|STARTED|Overall Study||30||
59926347|NCT03267511|76044545|FG003|STARTED|Overall Study||31||
59926348|NCT03267511|76044542|FG000|COMPLETED|Overall Study||31||
59926349|NCT03267511|76044543|FG001|COMPLETED|Overall Study||31||
59926350|NCT03267511|76044544|FG002|COMPLETED|Overall Study||30||
59926351|NCT03267511|76044545|FG003|COMPLETED|Overall Study||30||
59926352|NCT03267511|76044542|FG000|NOT COMPLETED|Overall Study||0||
59926353|NCT03267511|76044543|FG001|NOT COMPLETED|Overall Study||0||
59926354|NCT03267511|76044544|FG002|NOT COMPLETED|Overall Study||0||
59926355|NCT03267511|76044545|FG003|NOT COMPLETED|Overall Study||1||
59926356|NCT03316807|76044559|FG000|STARTED|Overall Study||91||
59926357|NCT03316807|76044560|FG001|STARTED|Overall Study||91||
59926358|NCT03316807|76044559|FG000|COMPLETED|Overall Study||60||
59926359|NCT03316807|76044560|FG001|COMPLETED|Overall Study||65||
59760922|NCT02805725|75880594|FG000|COMPLETED|Phase I (Dose Escalation Part)||3||
59760923|NCT02805725|75880595|FG001|COMPLETED|Phase I (Dose Escalation Part)||3||
59760924|NCT02805725|75880596|FG002|COMPLETED|Phase I (Dose Escalation Part)||5||
59760925|NCT02805725|75880597|FG003|COMPLETED|Phase I (Dose Escalation Part)||5||
59760926|NCT02805725|75880598|FG004|COMPLETED|Phase I (Dose Escalation Part)||0||
59760927|NCT02805725|75880594|FG000|NOT COMPLETED|Phase I (Dose Escalation Part)||0||
59760928|NCT02805725|75880595|FG001|NOT COMPLETED|Phase I (Dose Escalation Part)||0||
59760929|NCT02805725|75880596|FG002|NOT COMPLETED|Phase I (Dose Escalation Part)||2||
59760930|NCT02805725|75880597|FG003|NOT COMPLETED|Phase I (Dose Escalation Part)||2||
59926360|NCT03316807|76044559|FG000|NOT COMPLETED|Overall Study||31||
59926361|NCT03316807|76044560|FG001|NOT COMPLETED|Overall Study||26||
59926362|NCT03379259|76044572|FG000|STARTED|Overall Study||3||
59926363|NCT03379259|76044573|FG001|STARTED|Overall Study||3||
59926364|NCT03379259|76044574|FG002|STARTED|Overall Study||6||
59926365|NCT03379259|76044575|FG003|STARTED|Overall Study||3||
59926366|NCT03379259|76044576|FG004|STARTED|Overall Study||12||
59926367|NCT03379259|76044577|FG005|STARTED|Overall Study||12||
59926368|NCT03379259|76044572|FG000|COMPLETED|Overall Study||2||
60059698|NCT01848483|76174935|FG000|COMPLETED|Overall Study||50||
60059699|NCT01848483|76174936|FG001|COMPLETED|Overall Study||49||
60059700|NCT01848483|76174935|FG000|NOT COMPLETED|Overall Study||11||
60059701|NCT01848483|76174936|FG001|NOT COMPLETED|Overall Study||11||
60059702|NCT01610271|76174945|FG000|STARTED|Overall Study||150||
60059703|NCT01610271|76174946|FG001|STARTED|Overall Study||150||
60059704|NCT01610271|76174945|FG000|COMPLETED|Overall Study||148||
60059705|NCT01610271|76174946|FG001|COMPLETED|Overall Study||146||
60059706|NCT01610271|76174945|FG000|NOT COMPLETED|Overall Study||2||
59926369|NCT03379259|76044573|FG001|COMPLETED|Overall Study||2||
59926370|NCT03379259|76044574|FG002|COMPLETED|Overall Study||3||
59926371|NCT03379259|76044575|FG003|COMPLETED|Overall Study||0||
59926372|NCT03379259|76044576|FG004|COMPLETED|Overall Study||3||
59926373|NCT03379259|76044577|FG005|COMPLETED|Overall Study||5||
59926374|NCT03379259|76044572|FG000|NOT COMPLETED|Overall Study||1||
59926375|NCT03379259|76044573|FG001|NOT COMPLETED|Overall Study||1||
59926376|NCT03379259|76044574|FG002|NOT COMPLETED|Overall Study||3||
60059707|NCT01610271|76174946|FG001|NOT COMPLETED|Overall Study||4||
59926377|NCT03379259|76044575|FG003|NOT COMPLETED|Overall Study||3||
59926378|NCT03379259|76044576|FG004|NOT COMPLETED|Overall Study||9||
59926379|NCT03379259|76044577|FG005|NOT COMPLETED|Overall Study||7||
59926380|NCT03328897|76044597|FG000|STARTED|Randomized-treatment Epoch||168|Randomized|
59926381|NCT03328897|76044598|FG001|STARTED|Randomized-treatment Epoch||167|Randomized|
59926382|NCT03328897|76044599|FG002|STARTED|Randomized-treatment Epoch||83|Randomized|
59926383|NCT03328897|76044597|FG000|Full Analysis Set (FAS)|Randomized-treatment Epoch||167|includes all randomized patients who took at least one dose of study medication.|
59926384|NCT03328897|76044598|FG001|Full Analysis Set (FAS)|Randomized-treatment Epoch||167|includes all randomized patients who took at least one dose of study medication.|
59926385|NCT03328897|76044599|FG002|Full Analysis Set (FAS)|Randomized-treatment Epoch||83|includes all randomized patients who took at least one dose of study medication.|
59926386|NCT03328897|76044597|FG000|COMPLETED|Randomized-treatment Epoch||152|Completed randomized-treatment epoch|
59926387|NCT03328897|76044598|FG001|COMPLETED|Randomized-treatment Epoch||162|Completed randomized-treatment epoch|
59926388|NCT03328897|76044599|FG002|COMPLETED|Randomized-treatment Epoch||81|Completed randomized-treatment epoch|
59926389|NCT03328897|76044597|FG000|NOT COMPLETED|Randomized-treatment Epoch||16||
60059708|NCT02170727|76174956|FG000|STARTED|Overall Study||138||
60059709|NCT02170727|76174957|FG001|STARTED|Overall Study||31||
60059710|NCT02170727|76174956|FG000|COMPLETED|Overall Study||135||
60059711|NCT02170727|76174957|FG001|COMPLETED|Overall Study||31||
60059712|NCT02170727|76174956|FG000|NOT COMPLETED|Overall Study||3||
60059713|NCT02170727|76174957|FG001|NOT COMPLETED|Overall Study||0||
60059714|NCT01847313|76174968|FG000|STARTED|Overall Study||10||
60059715|NCT01847313|76174969|FG001|STARTED|Overall Study||10||
60059716|NCT01847313|76174968|FG000|COMPLETED|Overall Study||10||
60059717|NCT01847313|76174969|FG001|COMPLETED|Overall Study||8||
60059718|NCT01847313|76174968|FG000|NOT COMPLETED|Overall Study||0||
60059719|NCT01847313|76174969|FG001|NOT COMPLETED|Overall Study||2||
60059720|NCT02144285|76174985|FG000|STARTED|Overall Study||14||
60059721|NCT02144285|76174986|FG001|STARTED|Overall Study||6||
60059722|NCT02144285|76174987|FG002|STARTED|Overall Study||6||
60059723|NCT02144285|76174988|FG003|STARTED|Overall Study||6||
60059724|NCT02144285|76174989|FG004|STARTED|Overall Study||6||
60059725|NCT02144285|76174990|FG005|STARTED|Overall Study||6||
60059726|NCT02144285|76174991|FG006|STARTED|Overall Study||6||
60059727|NCT02144285|76174992|FG007|STARTED|Overall Study||6||
60059728|NCT02144285|76174993|FG008|STARTED|Overall Study||2||
60059729|NCT02144285|76174994|FG009|STARTED|Overall Study||6||
60059730|NCT02144285|76174985|FG000|Received At Least One Dose of Study Drug|Overall Study||14||
60059731|NCT02144285|76174986|FG001|Received At Least One Dose of Study Drug|Overall Study||6||
60059732|NCT02144285|76174987|FG002|Received At Least One Dose of Study Drug|Overall Study||6||
60059733|NCT02144285|76174988|FG003|Received At Least One Dose of Study Drug|Overall Study||6||
60059734|NCT02144285|76174989|FG004|Received At Least One Dose of Study Drug|Overall Study||6||
60059735|NCT02144285|76174990|FG005|Received At Least One Dose of Study Drug|Overall Study||6||
60059736|NCT02144285|76174991|FG006|Received At Least One Dose of Study Drug|Overall Study||6||
60059737|NCT02144285|76174992|FG007|Received At Least One Dose of Study Drug|Overall Study||6||
60059738|NCT02144285|76174993|FG008|Received At Least One Dose of Study Drug|Overall Study||2||
60059739|NCT02144285|76174994|FG009|Received At Least One Dose of Study Drug|Overall Study||6||
60059740|NCT02144285|76174985|FG000|COMPLETED|Overall Study||14||
60059741|NCT02144285|76174986|FG001|COMPLETED|Overall Study||6||
60059742|NCT02144285|76174987|FG002|COMPLETED|Overall Study||6||
60059743|NCT02144285|76174988|FG003|COMPLETED|Overall Study||6||
60059744|NCT02144285|76174989|FG004|COMPLETED|Overall Study||5||
60059745|NCT02144285|76174990|FG005|COMPLETED|Overall Study||6||
60059746|NCT02144285|76174991|FG006|COMPLETED|Overall Study||6||
60059747|NCT02144285|76174992|FG007|COMPLETED|Overall Study||6||
60059748|NCT02144285|76174993|FG008|COMPLETED|Overall Study||2||
60059749|NCT02144285|76174994|FG009|COMPLETED|Overall Study||6||
60059750|NCT02144285|76174985|FG000|NOT COMPLETED|Overall Study||0||
60059751|NCT02144285|76174986|FG001|NOT COMPLETED|Overall Study||0||
60059752|NCT02144285|76174987|FG002|NOT COMPLETED|Overall Study||0||
60059753|NCT02144285|76174988|FG003|NOT COMPLETED|Overall Study||0||
60059754|NCT02144285|76174989|FG004|NOT COMPLETED|Overall Study||1||
60059755|NCT02144285|76174990|FG005|NOT COMPLETED|Overall Study||0||
60059756|NCT02144285|76174991|FG006|NOT COMPLETED|Overall Study||0||
60059757|NCT02144285|76174992|FG007|NOT COMPLETED|Overall Study||0||
60059758|NCT02144285|76174993|FG008|NOT COMPLETED|Overall Study||0||
60059759|NCT02144285|76174994|FG009|NOT COMPLETED|Overall Study||0||
60059760|NCT02117687|76175032|FG000|STARTED|Overall Study||40||
60059761|NCT02117687|76175033|FG001|STARTED|Overall Study||40||
60059762|NCT02117687|76175032|FG000|COMPLETED|Overall Study||39||
60059763|NCT02117687|76175033|FG001|COMPLETED|Overall Study||36||
60059764|NCT02117687|76175032|FG000|NOT COMPLETED|Overall Study||1||
60059765|NCT02117687|76175033|FG001|NOT COMPLETED|Overall Study||4||
60059766|NCT02143583|76175042|FG000|STARTED|Overall Study||62||
60059767|NCT02143583|76175043|FG001|STARTED|Overall Study||66||
60059768|NCT02143583|76175044|FG002|STARTED|Overall Study||68||
60059769|NCT02143583|76175042|FG000|COMPLETED|Overall Study||61||
60059770|NCT02143583|76175043|FG001|COMPLETED|Overall Study||66||
60059771|NCT02143583|76175044|FG002|COMPLETED|Overall Study||66||
60059772|NCT02143583|76175042|FG000|NOT COMPLETED|Overall Study||1||
60059773|NCT02143583|76175043|FG001|NOT COMPLETED|Overall Study||0||
60059774|NCT02143583|76175044|FG002|NOT COMPLETED|Overall Study||2||
60059775|NCT02105987|76175054|FG000|STARTED|Early Switch Phase (24 Weeks)|Number Started represents the number of par. in the Intent-To-Treat Exposed (ITT-E) Population.|275||
60059776|NCT02105987|76175055|FG001|STARTED|Early Switch Phase (24 Weeks)|Number Started represents the number of par. in the Intent-To-Treat Exposed (ITT-E) Population.|278||
59613053|NCT01713582|75724105|FG011|COMPLETED|Overall Study||0||
59613054|NCT01713582|75724106|FG012|COMPLETED|Overall Study||0||
59613055|NCT01713582|75724107|FG013|COMPLETED|Overall Study||0||
60059777|NCT02105987|76175056|FG002|STARTED|Early Switch Phase (24 Weeks)||0||
60059778|NCT02105987|76175057|FG003|STARTED|Early Switch Phase (24 Weeks)||0||
60059779|NCT02105987|76175058|FG004|STARTED|Early Switch Phase (24 Weeks)||0||
60059780|NCT02105987|76175059|FG005|STARTED|Early Switch Phase (24 Weeks)||0||
60059781|NCT02105987|76175054|FG000|COMPLETED|Early Switch Phase (24 Weeks)||239||
60059782|NCT02105987|76175055|FG001|COMPLETED|Early Switch Phase (24 Weeks)||244||
60059783|NCT02105987|76175056|FG002|COMPLETED|Early Switch Phase (24 Weeks)||0||
60059784|NCT02105987|76175057|FG003|COMPLETED|Early Switch Phase (24 Weeks)||0||
60059785|NCT02105987|76175058|FG004|COMPLETED|Early Switch Phase (24 Weeks)||0||
60059786|NCT02105987|76175059|FG005|COMPLETED|Early Switch Phase (24 Weeks)||0||
60059787|NCT02105987|76175054|FG000|NOT COMPLETED|Early Switch Phase (24 Weeks)||36||
60059788|NCT02105987|76175055|FG001|NOT COMPLETED|Early Switch Phase (24 Weeks)||34||
60059789|NCT02105987|76175056|FG002|NOT COMPLETED|Early Switch Phase (24 Weeks)||0||
60059790|NCT02105987|76175057|FG003|NOT COMPLETED|Early Switch Phase (24 Weeks)||0||
60059791|NCT02105987|76175058|FG004|NOT COMPLETED|Early Switch Phase (24 Weeks)||0||
60059792|NCT02105987|76175059|FG005|NOT COMPLETED|Early Switch Phase (24 Weeks)||0||
60059793|NCT02105987|76175054|FG000|STARTED|Late Switch Phase (24 Weeks)||0||
60059794|NCT02105987|76175055|FG001|STARTED|Late Switch Phase (24 Weeks)||0||
60059795|NCT02105987|76175056|FG002|STARTED|Late Switch Phase (24 Weeks)||275||
60059796|NCT02105987|76175057|FG003|STARTED|Late Switch Phase (24 Weeks)||244||
60059797|NCT02105987|76175058|FG004|STARTED|Late Switch Phase (24 Weeks)||0||
60059798|NCT02105987|76175059|FG005|STARTED|Late Switch Phase (24 Weeks)||0||
60059799|NCT02105987|76175054|FG000|COMPLETED|Late Switch Phase (24 Weeks)||0||
60059800|NCT02105987|76175055|FG001|COMPLETED|Late Switch Phase (24 Weeks)||0||
60059801|NCT02105987|76175056|FG002|COMPLETED|Late Switch Phase (24 Weeks)||230||
60059802|NCT02105987|76175057|FG003|COMPLETED|Late Switch Phase (24 Weeks)||230||
60059803|NCT02105987|76175058|FG004|COMPLETED|Late Switch Phase (24 Weeks)||0||
60059804|NCT02105987|76175059|FG005|COMPLETED|Late Switch Phase (24 Weeks)||0||
60059805|NCT02105987|76175054|FG000|NOT COMPLETED|Late Switch Phase (24 Weeks)||0||
60059806|NCT02105987|76175055|FG001|NOT COMPLETED|Late Switch Phase (24 Weeks)||0||
60059807|NCT02105987|76175056|FG002|NOT COMPLETED|Late Switch Phase (24 Weeks)||45||
60059808|NCT02105987|76175057|FG003|NOT COMPLETED|Late Switch Phase (24 Weeks)||14||
60059809|NCT02105987|76175058|FG004|NOT COMPLETED|Late Switch Phase (24 Weeks)||0||
60059810|NCT02105987|76175059|FG005|NOT COMPLETED|Late Switch Phase (24 Weeks)||0||
60059811|NCT02105987|76175054|FG000|STARTED|Continuation Phase||0||
60059812|NCT02105987|76175055|FG001|STARTED|Continuation Phase||0||
60059813|NCT02105987|76175056|FG002|STARTED|Continuation Phase||0||
60059814|NCT02105987|76175057|FG003|STARTED|Continuation Phase||0||
60059815|NCT02105987|76175058|FG004|STARTED|Continuation Phase||14||
60059816|NCT02105987|76175059|FG005|STARTED|Continuation Phase||23||
60059817|NCT02105987|76175054|FG000|COMPLETED|Continuation Phase||0||
60059818|NCT02105987|76175055|FG001|COMPLETED|Continuation Phase||0||
60059819|NCT02105987|76175056|FG002|COMPLETED|Continuation Phase||0||
60059820|NCT02105987|76175057|FG003|COMPLETED|Continuation Phase||0||
60059821|NCT02105987|76175058|FG004|COMPLETED|Continuation Phase||13||
60059822|NCT02105987|76175059|FG005|COMPLETED|Continuation Phase||23||
60059823|NCT02105987|76175054|FG000|NOT COMPLETED|Continuation Phase||0||
60059824|NCT02105987|76175055|FG001|NOT COMPLETED|Continuation Phase||0||
60059825|NCT02105987|76175056|FG002|NOT COMPLETED|Continuation Phase||0||
60059826|NCT02105987|76175057|FG003|NOT COMPLETED|Continuation Phase||0||
60059827|NCT02105987|76175058|FG004|NOT COMPLETED|Continuation Phase||1||
60059828|NCT02105987|76175059|FG005|NOT COMPLETED|Continuation Phase||0||
60059829|NCT02141633|76175067|FG000|STARTED|Overall Study||16||
60059830|NCT02141633|76175068|FG001|STARTED|Overall Study||15||
60059831|NCT02141633|76175067|FG000|COMPLETED|Overall Study||15||
60059832|NCT02141633|76175068|FG001|COMPLETED|Overall Study||15||
60059833|NCT02141633|76175067|FG000|NOT COMPLETED|Overall Study||1||
60059834|NCT02141633|76175068|FG001|NOT COMPLETED|Overall Study||0||
60059835|NCT01846611|76175076|FG000|STARTED|Overall Study||289||
60059836|NCT01846611|76175077|FG001|STARTED|Overall Study||287||
60059837|NCT01846611|76175076|FG000|Treated|Overall Study||286||
60059838|NCT01846611|76175077|FG001|Treated|Overall Study||282||
60059839|NCT01846611|76175076|FG000|COMPLETED|Overall Study||251||
60059840|NCT01846611|76175077|FG001|COMPLETED|Overall Study||244||
60059841|NCT01846611|76175076|FG000|NOT COMPLETED|Overall Study||38||
60059842|NCT01846611|76175077|FG001|NOT COMPLETED|Overall Study||43||
60059843|NCT02141399|76175083|FG000|STARTED|Overall Study||1485||
60059844|NCT02141399|76175083|FG000|COMPLETED|Overall Study||741||
60059845|NCT02141399|76175083|FG000|NOT COMPLETED|Overall Study||744||
60059846|NCT01846299|76175089|FG000|STARTED|Overall Study||118||
60059847|NCT01846299|76175090|FG001|STARTED|Overall Study||60||
60059848|NCT01846299|76175089|FG000|Full Analysis Set|Overall Study|One participant did not receive study treatment prior to discontinuation.|117||
60059849|NCT01846299|76175090|FG001|Full Analysis Set|Overall Study||60||
60059850|NCT01846299|76175089|FG000|Safety Set|Overall Study|Two participants randomized to sham received ranibizumab at Month 1.|119||
60059851|NCT01846299|76175090|FG001|Safety Set|Overall Study||58||
60059852|NCT01846299|76175089|FG000|COMPLETED|Overall Study||106||
60059853|NCT01846299|76175090|FG001|COMPLETED|Overall Study||50||
60059854|NCT01846299|76175089|FG000|NOT COMPLETED|Overall Study||12||
60059855|NCT01846299|76175090|FG001|NOT COMPLETED|Overall Study||10||
60067868|NCT01785615|76183053|FG001|NOT COMPLETED|Atorvastatin Phase||0||
60059856|NCT01628393|76175101|FG000|STARTED|Placebo-controlled Treatment Period||88||
60059857|NCT01628393|76175102|FG001|STARTED|Placebo-controlled Treatment Period||87||
60059858|NCT01628393|76175103|FG002|STARTED|Placebo-controlled Treatment Period||83||
60059859|NCT01628393|76175104|FG003|STARTED|Placebo-controlled Treatment Period||0||
60059860|NCT01628393|76175105|FG004|STARTED|Placebo-controlled Treatment Period||0||
60059861|NCT01628393|76175101|FG000|COMPLETED|Placebo-controlled Treatment Period||85||
60059862|NCT01628393|76175102|FG001|COMPLETED|Placebo-controlled Treatment Period||85||
60059863|NCT01628393|76175103|FG002|COMPLETED|Placebo-controlled Treatment Period||82||
60059864|NCT01628393|76175104|FG003|COMPLETED|Placebo-controlled Treatment Period||0||
60059865|NCT01628393|76175105|FG004|COMPLETED|Placebo-controlled Treatment Period||0||
60059866|NCT01628393|76175101|FG000|NOT COMPLETED|Placebo-controlled Treatment Period||3||
60059867|NCT01628393|76175102|FG001|NOT COMPLETED|Placebo-controlled Treatment Period||2||
60059868|NCT01628393|76175103|FG002|NOT COMPLETED|Placebo-controlled Treatment Period||1||
60059869|NCT01628393|76175104|FG003|NOT COMPLETED|Placebo-controlled Treatment Period||0||
60059870|NCT01628393|76175105|FG004|NOT COMPLETED|Placebo-controlled Treatment Period||0||
60059871|NCT01628393|76175101|FG000|STARTED|Blinded Active Extension Period||0|Three participants who completed the placebo-controlled treatment period declined to enter the blinded extension period.|
60059872|NCT01628393|76175102|FG001|STARTED|Blinded Active Extension Period||85|Three participants who completed the placebo-controlled treatment period declined to enter the blinded extension period.|
60059873|NCT01628393|76175103|FG002|STARTED|Blinded Active Extension Period||81|Three participants who completed the placebo-controlled treatment period declined to enter the blinded extension period.|
60059874|NCT01628393|76175104|FG003|STARTED|Blinded Active Extension Period||41|Three participants who completed the placebo-controlled treatment period declined to enter the blinded extension period.|
60059875|NCT01628393|76175105|FG004|STARTED|Blinded Active Extension Period||42|Three participants who completed the placebo-controlled treatment period declined to enter the blinded extension period.|
60059876|NCT01628393|76175101|FG000|COMPLETED|Blinded Active Extension Period||0||
60059877|NCT01628393|76175102|FG001|COMPLETED|Blinded Active Extension Period||75||
60059878|NCT01628393|76175103|FG002|COMPLETED|Blinded Active Extension Period||75||
60059879|NCT01628393|76175104|FG003|COMPLETED|Blinded Active Extension Period||37||
60059880|NCT01628393|76175105|FG004|COMPLETED|Blinded Active Extension Period||36||
60059881|NCT01628393|76175101|FG000|NOT COMPLETED|Blinded Active Extension Period||0||
60059882|NCT01628393|76175102|FG001|NOT COMPLETED|Blinded Active Extension Period||10||
60059883|NCT01628393|76175103|FG002|NOT COMPLETED|Blinded Active Extension Period||6||
60059884|NCT01628393|76175104|FG003|NOT COMPLETED|Blinded Active Extension Period||4||
60059885|NCT01628393|76175105|FG004|NOT COMPLETED|Blinded Active Extension Period||6||
60059886|NCT01846221|76175121|FG000|STARTED|Overall Study||50||
60059887|NCT01846221|76175122|FG001|STARTED|Overall Study||51||
60059888|NCT01846221|76175121|FG000|COMPLETED|Overall Study||47||
60059889|NCT01846221|76175122|FG001|COMPLETED|Overall Study||51||
60059890|NCT01846221|76175121|FG000|NOT COMPLETED|Overall Study||3||
60059891|NCT01846221|76175122|FG001|NOT COMPLETED|Overall Study||0||
60059892|NCT01815099|76175128|FG000|STARTED|Overall Study||4||
60059893|NCT01815099|76175128|FG000|Began rTMS Treatment|Overall Study||3||
60059894|NCT01815099|76175128|FG000|COMPLETED|Overall Study||2|For completers: one completed a protocol of 10 sessions and one completed a protocol of 15 sessions|
60059895|NCT01815099|76175128|FG000|NOT COMPLETED|Overall Study||2||
60059896|NCT01845831|76175135|FG000|STARTED|Inpatient Phase||140||
60059897|NCT01845831|76175136|FG001|STARTED|Inpatient Phase||139||
60059898|NCT01845831|76175137|FG002|STARTED|Inpatient Phase||0||
60059899|NCT01845831|76175138|FG003|STARTED|Inpatient Phase||0||
60059900|NCT01845831|76175139|FG004|STARTED|Inpatient Phase||0||
60059901|NCT01845831|76175135|FG000|COMPLETED|Inpatient Phase||139||
60059902|NCT01845831|76175136|FG001|COMPLETED|Inpatient Phase||138||
60059903|NCT01845831|76175137|FG002|COMPLETED|Inpatient Phase||0||
60059904|NCT01845831|76175138|FG003|COMPLETED|Inpatient Phase||0||
60059905|NCT01845831|76175139|FG004|COMPLETED|Inpatient Phase||0||
60059906|NCT01845831|76175135|FG000|NOT COMPLETED|Inpatient Phase||1||
60059907|NCT01845831|76175136|FG001|NOT COMPLETED|Inpatient Phase||1||
60059908|NCT01845831|76175137|FG002|NOT COMPLETED|Inpatient Phase||0||
60059909|NCT01845831|76175138|FG003|NOT COMPLETED|Inpatient Phase||0||
60059910|NCT01845831|76175139|FG004|NOT COMPLETED|Inpatient Phase||0||
60059911|NCT01845831|76175135|FG000|STARTED|Outpatient Phase||0||
60059912|NCT01845831|76175136|FG001|STARTED|Outpatient Phase||0||
60059913|NCT01845831|76175137|FG002|STARTED|Outpatient Phase||68||
60059914|NCT01845831|76175138|FG003|STARTED|Outpatient Phase||98||
60059915|NCT01845831|76175139|FG004|STARTED|Outpatient Phase||87||
60059916|NCT01845831|76175135|FG000|COMPLETED|Outpatient Phase||0||
60059917|NCT01845831|76175136|FG001|COMPLETED|Outpatient Phase||0||
60059918|NCT01845831|76175137|FG002|COMPLETED|Outpatient Phase||68||
60059919|NCT01845831|76175138|FG003|COMPLETED|Outpatient Phase||98||
60059920|NCT01845831|76175139|FG004|COMPLETED|Outpatient Phase||87||
60059921|NCT01845831|76175135|FG000|NOT COMPLETED|Outpatient Phase||0||
60059922|NCT01845831|76175136|FG001|NOT COMPLETED|Outpatient Phase||0||
60059923|NCT01845831|76175137|FG002|NOT COMPLETED|Outpatient Phase||0||
60059924|NCT01845831|76175138|FG003|NOT COMPLETED|Outpatient Phase||0||
60059925|NCT01845831|76175139|FG004|NOT COMPLETED|Outpatient Phase||0||
60059926|NCT01627691|76175150|FG000|STARTED|Overall Study||250||
60059927|NCT01627691|76175150|FG000|Primary Endpoint (30days)|Overall Study||239||
60059928|NCT01627691|76175150|FG000|COMPLETED|Overall Study||232||
60059929|NCT01627691|76175150|FG000|NOT COMPLETED|Overall Study||18||
60059930|NCT01844895|76175154|FG000|STARTED|Day 1 to Day 28 - Pre-filled Syringe||120||
60059931|NCT01844895|76175154|FG000|COMPLETED|Day 1 to Day 28 - Pre-filled Syringe||117||
60059932|NCT01844895|76175154|FG000|NOT COMPLETED|Day 1 to Day 28 - Pre-filled Syringe||3||
60059933|NCT01844895|76175154|FG000|STARTED|Day 29 - Day113 - Autoinjector||117||
60059934|NCT01844895|76175154|FG000|COMPLETED|Day 29 - Day113 - Autoinjector||111||
60059935|NCT01844895|76175154|FG000|NOT COMPLETED|Day 29 - Day113 - Autoinjector||6||
60059936|NCT02116361|76175171|FG000|STARTED|Overall Study||69||
60059937|NCT02116361|76175172|FG001|STARTED|Overall Study||65||
60059938|NCT02116361|76175173|FG002|STARTED|Overall Study||59||
60059939|NCT02116361|76175174|FG003|STARTED|Overall Study||65||
60059940|NCT02116361|76175171|FG000|COMPLETED|Overall Study||38||
60059941|NCT02116361|76175172|FG001|COMPLETED|Overall Study||34||
60059942|NCT02116361|76175173|FG002|COMPLETED|Overall Study||33||
60059943|NCT02116361|76175174|FG003|COMPLETED|Overall Study||34||
60059944|NCT02116361|76175171|FG000|NOT COMPLETED|Overall Study||31||
60059945|NCT02116361|76175172|FG001|NOT COMPLETED|Overall Study||31||
60059946|NCT02116361|76175173|FG002|NOT COMPLETED|Overall Study||26||
60059947|NCT02116361|76175174|FG003|NOT COMPLETED|Overall Study||31||
60059948|NCT02140775|76175186|FG000|STARTED|Overall Study||87||
60059949|NCT02140775|76175187|FG001|STARTED|Overall Study||29||
60059950|NCT02140775|76175186|FG000|COMPLETED|Overall Study||57||
60059951|NCT02140775|76175187|FG001|COMPLETED|Overall Study||22||
60059952|NCT02140775|76175186|FG000|NOT COMPLETED|Overall Study||30||
60059953|NCT02140775|76175187|FG001|NOT COMPLETED|Overall Study||7||
60059954|NCT01844817|76175197|FG000|STARTED|Enrolled and Randomized||66||
60059955|NCT01844817|76175198|FG001|STARTED|Enrolled and Randomized||66||
60059956|NCT01844817|76175197|FG000|COMPLETED|Enrolled and Randomized||64|5 patients withdrew prior to treatment.|
60059957|NCT01844817|76175198|FG001|COMPLETED|Enrolled and Randomized||63|5 patients withdrew prior to treatment.|
60059958|NCT01844817|76175197|FG000|NOT COMPLETED|Enrolled and Randomized||2||
60059959|NCT01844817|76175198|FG001|NOT COMPLETED|Enrolled and Randomized||3||
60059960|NCT01844817|76175197|FG000|STARTED|Treatment||64||
60059961|NCT01844817|76175198|FG001|STARTED|Treatment||63||
60059962|NCT01844817|76175197|FG000|COMPLETED|Treatment||0||
60059963|NCT01844817|76175198|FG001|COMPLETED|Treatment||0||
60059964|NCT01844817|76175197|FG000|NOT COMPLETED|Treatment||64||
60059965|NCT01844817|76175198|FG001|NOT COMPLETED|Treatment||63||
60059966|NCT04594239|76175209|FG000|STARTED|Overall Study||49||
60059967|NCT04594239|76175210|FG001|STARTED|Overall Study||48||
60059968|NCT04594239|76175211|FG002|STARTED|Overall Study||27||
60059969|NCT04594239|76175212|FG003|STARTED|Overall Study||26||
60059970|NCT04594239|76175209|FG000|Safety Population|Overall Study||49||
60059971|NCT04594239|76175210|FG001|Safety Population|Overall Study||48||
60059972|NCT04594239|76175211|FG002|Safety Population|Overall Study||26||
60059973|NCT04594239|76175212|FG003|Safety Population|Overall Study||21||
60059974|NCT04594239|76175209|FG000|COMPLETED|Overall Study||38||
60059975|NCT04594239|76175210|FG001|COMPLETED|Overall Study||39||
60059976|NCT04594239|76175211|FG002|COMPLETED|Overall Study||21||
60059977|NCT04594239|76175212|FG003|COMPLETED|Overall Study||15||
60059978|NCT04594239|76175209|FG000|NOT COMPLETED|Overall Study||11||
60059979|NCT04594239|76175210|FG001|NOT COMPLETED|Overall Study||9||
60059980|NCT04594239|76175211|FG002|NOT COMPLETED|Overall Study||6||
60059981|NCT04594239|76175212|FG003|NOT COMPLETED|Overall Study||11||
60059982|NCT01814553|76175230|FG000|STARTED|Overall Study||18||
60059983|NCT01814553|76175231|FG001|STARTED|Overall Study||22||
60059984|NCT01814553|76175230|FG000|COMPLETED|Overall Study||0||
60059985|NCT01814553|76175231|FG001|COMPLETED|Overall Study||0||
60059986|NCT01814553|76175230|FG000|NOT COMPLETED|Overall Study||18||
60059987|NCT01814553|76175231|FG001|NOT COMPLETED|Overall Study||22||
60059988|NCT02116205|76175241|FG000|STARTED|Overall Study||31||
60059989|NCT02116205|76175242|FG001|STARTED|Overall Study||33||
60059990|NCT02116205|76175243|FG002|STARTED|Overall Study||33||
60059991|NCT02116205|76175244|FG003|STARTED|Overall Study||33||
60059992|NCT02116205|76175241|FG000|COMPLETED|Overall Study||29||
60059993|NCT02116205|76175242|FG001|COMPLETED|Overall Study||26||
59926390|NCT03328897|76044598|FG001|NOT COMPLETED|Randomized-treatment Epoch||5||
59926391|NCT03328897|76044599|FG002|NOT COMPLETED|Randomized-treatment Epoch||2||
59926392|NCT03328897|76044597|FG000|STARTED|Follow-up Epoch||161|Entered follow-up epoch|
59926393|NCT03328897|76044598|FG001|STARTED|Follow-up Epoch||163|Entered follow-up epoch|
59926394|NCT03328897|76044599|FG002|STARTED|Follow-up Epoch||81|Entered follow-up epoch|
59926395|NCT03328897|76044597|FG000|COMPLETED|Follow-up Epoch||153|Completed follow-up epoch|
59926396|NCT03328897|76044598|FG001|COMPLETED|Follow-up Epoch||160|Completed follow-up epoch|
59926397|NCT03328897|76044599|FG002|COMPLETED|Follow-up Epoch||79|Completed follow-up epoch|
59926398|NCT03328897|76044597|FG000|NOT COMPLETED|Follow-up Epoch||8||
59926399|NCT03328897|76044598|FG001|NOT COMPLETED|Follow-up Epoch||3||
59926400|NCT03328897|76044599|FG002|NOT COMPLETED|Follow-up Epoch||2||
59926401|NCT03266107|76044607|FG000|STARTED|Enrollment to Procedure||50||
59926402|NCT03266107|76044607|FG000|COMPLETED|Enrollment to Procedure||47||
59926403|NCT03266107|76044607|FG000|NOT COMPLETED|Enrollment to Procedure||3||
59926404|NCT03266107|76044607|FG000|STARTED|3-Month Follow-up Visit||47||
59926405|NCT03266107|76044607|FG000|COMPLETED|3-Month Follow-up Visit||46||
59926406|NCT03266107|76044607|FG000|NOT COMPLETED|3-Month Follow-up Visit||1||
59926407|NCT03266107|76044607|FG000|STARTED|12-Month Follow-up Visit||46||
59926408|NCT03266107|76044607|FG000|COMPLETED|12-Month Follow-up Visit||45||
59926409|NCT03266107|76044607|FG000|NOT COMPLETED|12-Month Follow-up Visit||1||
59926410|NCT03378635|76044616|FG000|STARTED|Overall Study||84|Started is defined as randomized|
59926411|NCT03378635|76044617|FG001|STARTED|Overall Study||43|Started is defined as randomized|
59926412|NCT03378635|76044618|FG002|STARTED|Overall Study||43|Started is defined as randomized|
59926413|NCT03378635|76044616|FG000|Randomized and Exposed to Treatment|Overall Study||82||
59926414|NCT03378635|76044617|FG001|Randomized and Exposed to Treatment|Overall Study||43||
59926415|NCT03378635|76044618|FG002|Randomized and Exposed to Treatment|Overall Study||43||
59926416|NCT03378635|76044616|FG000|COMPLETED|Overall Study||82||
59926417|NCT03378635|76044617|FG001|COMPLETED|Overall Study||43||
59926418|NCT03378635|76044618|FG002|COMPLETED|Overall Study||43||
59926419|NCT03378635|76044616|FG000|NOT COMPLETED|Overall Study||2||
59926420|NCT03378635|76044617|FG001|NOT COMPLETED|Overall Study||0||
59926421|NCT03378635|76044618|FG002|NOT COMPLETED|Overall Study||0||
59926422|NCT03326869|76044629|FG000|STARTED|Overall Study||1||
59926423|NCT03326869|76044630|FG001|STARTED|Overall Study||1||
59926424|NCT03326869|76044629|FG000|COMPLETED|Overall Study||0||
59926425|NCT03326869|76044630|FG001|COMPLETED|Overall Study||0||
59926426|NCT03326869|76044629|FG000|NOT COMPLETED|Overall Study||1||
59926427|NCT03326869|76044630|FG001|NOT COMPLETED|Overall Study||1||
59926428|NCT01182727|76044636|FG000|STARTED|Overall Study||10||
59926429|NCT01182727|76044636|FG000|COMPLETED|Overall Study||10||
59926430|NCT01182727|76044636|FG000|NOT COMPLETED|Overall Study||0||
59926431|NCT03334409|76044642|FG000|STARTED|Overall Study||2||
59926432|NCT03334409|76044643|FG001|STARTED|Overall Study||3||
59926433|NCT03334409|76044642|FG000|COMPLETED|Overall Study||1||
59926434|NCT03334409|76044643|FG001|COMPLETED|Overall Study||3||
59926435|NCT03334409|76044642|FG000|NOT COMPLETED|Overall Study||1||
59926436|NCT03334409|76044643|FG001|NOT COMPLETED|Overall Study||0||
59926437|NCT02891915|76044651|FG000|STARTED|Overall Study||192||
59926438|NCT02891915|76044652|FG001|STARTED|Overall Study||193||
60059994|NCT02116205|76175243|FG002|COMPLETED|Overall Study||29||
60059995|NCT02116205|76175244|FG003|COMPLETED|Overall Study||27||
60059996|NCT02116205|76175241|FG000|NOT COMPLETED|Overall Study||2||
60059997|NCT02116205|76175242|FG001|NOT COMPLETED|Overall Study||7||
60059998|NCT02116205|76175243|FG002|NOT COMPLETED|Overall Study||4||
60059999|NCT02116205|76175244|FG003|NOT COMPLETED|Overall Study||6||
59519047|NCT03398278|75612890|FG001|NOT COMPLETED|Period 2||2||
59926439|NCT02891915|76044651|FG000|COMPLETED|Overall Study||179||
59926440|NCT02891915|76044652|FG001|COMPLETED|Overall Study||181||
59926441|NCT02891915|76044651|FG000|NOT COMPLETED|Overall Study||13||
59926442|NCT02891915|76044652|FG001|NOT COMPLETED|Overall Study||12||
59926443|NCT02891681|76044661|FG000|STARTED|Overall Study||39||
59926444|NCT02891681|76044662|FG001|STARTED|Overall Study||1||
59926445|NCT02891681|76044663|FG002|STARTED|Overall Study||1||
60060000|NCT01844583|76175256|FG000|STARTED|Overall Study||26||
59926446|NCT02891681|76044661|FG000|COMPLETED|Overall Study||36||
59926447|NCT02891681|76044662|FG001|COMPLETED|Overall Study||1||
59926448|NCT02891681|76044663|FG002|COMPLETED|Overall Study||0||
59926449|NCT02891681|76044661|FG000|NOT COMPLETED|Overall Study||3||
59926450|NCT02891681|76044662|FG001|NOT COMPLETED|Overall Study||0||
59926451|NCT02891681|76044663|FG002|NOT COMPLETED|Overall Study||1||
59926452|NCT04671342|76044671|FG000|STARTED|Consented and Screened (Visit 1)||306||
59926453|NCT04671342|76044671|FG000|COMPLETED|Consented and Screened (Visit 1)||259||
60060001|NCT01844583|76175257|FG001|STARTED|Overall Study||29||
60060002|NCT01844583|76175256|FG000|COMPLETED|Overall Study|Completed=Completed protocol-specified dosing and PK/ECG assessment.|18||
60060003|NCT01844583|76175257|FG001|COMPLETED|Overall Study||19||
60060004|NCT01844583|76175256|FG000|NOT COMPLETED|Overall Study||8||
59926454|NCT04671342|76044671|FG000|NOT COMPLETED|Consented and Screened (Visit 1)||47||
59926455|NCT04671342|76044671|FG000|STARTED|Completed Visit 2 With Evaluable Data||259||
59926456|NCT04671342|76044671|FG000|COMPLETED|Completed Visit 2 With Evaluable Data||200||
59926457|NCT04671342|76044671|FG000|NOT COMPLETED|Completed Visit 2 With Evaluable Data||59||
59926458|NCT03051217|76044678|FG000|STARTED|Initial Period (Week 0 to Week 16)||26||
59926459|NCT03051217|76044679|FG001|STARTED|Initial Period (Week 0 to Week 16)||48||
59926460|NCT03051217|76044680|FG002|STARTED|Initial Period (Week 0 to Week 16)||53||
59613056|NCT01713582|75724108|FG014|COMPLETED|Overall Study||0||
59613057|NCT01713582|75724109|FG015|COMPLETED|Overall Study||0||
59613058|NCT01713582|75724110|FG016|COMPLETED|Overall Study||0||
59613059|NCT01713582|75724111|FG017|COMPLETED|Overall Study||0||
59926461|NCT03051217|76044681|FG003|STARTED|Initial Period (Week 0 to Week 16)||0||
59926462|NCT03051217|76044682|FG004|STARTED|Initial Period (Week 0 to Week 16)||0||
59926463|NCT03051217|76044683|FG005|STARTED|Initial Period (Week 0 to Week 16)||0||
59926464|NCT03051217|76044684|FG006|STARTED|Initial Period (Week 0 to Week 16)||0||
59926465|NCT03051217|76044678|FG000|COMPLETED|Initial Period (Week 0 to Week 16)||23||
59926466|NCT03051217|76044679|FG001|COMPLETED|Initial Period (Week 0 to Week 16)||46||
59926467|NCT03051217|76044680|FG002|COMPLETED|Initial Period (Week 0 to Week 16)||51||
59926468|NCT03051217|76044681|FG003|COMPLETED|Initial Period (Week 0 to Week 16)||0||
59926469|NCT03051217|76044682|FG004|COMPLETED|Initial Period (Week 0 to Week 16)||0||
59926470|NCT03051217|76044683|FG005|COMPLETED|Initial Period (Week 0 to Week 16)||0||
59926471|NCT03051217|76044684|FG006|COMPLETED|Initial Period (Week 0 to Week 16)||0||
59926472|NCT03051217|76044678|FG000|NOT COMPLETED|Initial Period (Week 0 to Week 16)||3||
59926473|NCT03051217|76044679|FG001|NOT COMPLETED|Initial Period (Week 0 to Week 16)||2||
59926474|NCT03051217|76044680|FG002|NOT COMPLETED|Initial Period (Week 0 to Week 16)||2||
59926475|NCT03051217|76044681|FG003|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0||
59926476|NCT03051217|76044682|FG004|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0||
59926477|NCT03051217|76044683|FG005|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0||
59926478|NCT03051217|76044684|FG006|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0||
59926479|NCT03051217|76044678|FG000|STARTED|Maintenance Period (Week 16 to Week 52)||0||
59926480|NCT03051217|76044679|FG001|STARTED|Maintenance Period (Week 16 to Week 52)||0||
59926481|NCT03051217|76044680|FG002|STARTED|Maintenance Period (Week 16 to Week 52)||0||
59926482|NCT03051217|76044681|FG003|STARTED|Maintenance Period (Week 16 to Week 52)||23||
59926483|NCT03051217|76044682|FG004|STARTED|Maintenance Period (Week 16 to Week 52)||51||
59926484|NCT03051217|76044683|FG005|STARTED|Maintenance Period (Week 16 to Week 52)||26||
59926485|NCT03051217|76044684|FG006|STARTED|Maintenance Period (Week 16 to Week 52)||20||
59926486|NCT03051217|76044678|FG000|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||0||
59926487|NCT03051217|76044679|FG001|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||0||
59926488|NCT03051217|76044680|FG002|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||0||
59926489|NCT03051217|76044681|FG003|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||21||
59926490|NCT03051217|76044682|FG004|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||3||
59926491|NCT03051217|76044683|FG005|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||7||
59926492|NCT03051217|76044684|FG006|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||3||
59926493|NCT03051217|76044678|FG000|COMPLETED|Maintenance Period (Week 16 to Week 52)||0||
60060005|NCT01844583|76175257|FG001|NOT COMPLETED|Overall Study||10||
60060006|NCT02115815|76175275|FG000|STARTED|Overall Study||24||
60060007|NCT02115815|76175276|FG001|STARTED|Overall Study||20||
60060008|NCT02115815|76175277|FG002|STARTED|Overall Study||20||
59613060|NCT01713582|75724112|FG018|COMPLETED|Overall Study||0||
59926494|NCT03051217|76044679|FG001|COMPLETED|Maintenance Period (Week 16 to Week 52)||0||
59926495|NCT03051217|76044680|FG002|COMPLETED|Maintenance Period (Week 16 to Week 52)||0||
59926496|NCT03051217|76044681|FG003|COMPLETED|Maintenance Period (Week 16 to Week 52)||20||
59926497|NCT03051217|76044682|FG004|COMPLETED|Maintenance Period (Week 16 to Week 52)||48||
59926498|NCT03051217|76044683|FG005|COMPLETED|Maintenance Period (Week 16 to Week 52)||24||
59926499|NCT03051217|76044684|FG006|COMPLETED|Maintenance Period (Week 16 to Week 52)||19||
59926500|NCT03051217|76044678|FG000|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||0||
59926501|NCT03051217|76044679|FG001|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||0||
59926502|NCT03051217|76044680|FG002|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||0||
59926503|NCT03051217|76044681|FG003|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||3||
59926504|NCT03051217|76044682|FG004|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||3||
59926505|NCT03051217|76044683|FG005|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||2||
59926506|NCT03051217|76044684|FG006|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||1||
59926507|NCT02958319|76044700|FG000|STARTED|Overall Study||145||
59926508|NCT02958319|76044701|FG001|STARTED|Overall Study||133||
59926509|NCT02958319|76044700|FG000|COMPLETED|Overall Study||145||
59926510|NCT02958319|76044701|FG001|COMPLETED|Overall Study||133||
60060009|NCT02115815|76175278|FG003|STARTED|Overall Study||20||
60060010|NCT02115815|76175279|FG004|STARTED|Overall Study||20||
59613061|NCT01713582|75724113|FG019|COMPLETED|Overall Study||0||
59613062|NCT01713582|75724114|FG020|COMPLETED|Overall Study||0||
60060011|NCT02115815|76175280|FG005|STARTED|Overall Study||22||
59760931|NCT02805725|75880598|FG004|NOT COMPLETED|Phase I (Dose Escalation Part)||0||
59760932|NCT02805725|75880594|FG000|STARTED|Phase II||0||
59760933|NCT02805725|75880595|FG001|STARTED|Phase II||0||
59760934|NCT02805725|75880596|FG002|STARTED|Phase II||0||
59760935|NCT02805725|75880597|FG003|STARTED|Phase II||0||
59760936|NCT02805725|75880598|FG004|STARTED|Phase II||30||
59760937|NCT02805725|75880594|FG000|Interim Analysis (Stage 2 of Simon's Design)|Phase II||0||
59760938|NCT02805725|75880595|FG001|Interim Analysis (Stage 2 of Simon's Design)|Phase II||0||
59760939|NCT02805725|75880596|FG002|Interim Analysis (Stage 2 of Simon's Design)|Phase II||0||
59760940|NCT02805725|75880597|FG003|Interim Analysis (Stage 2 of Simon's Design)|Phase II||0||
59760941|NCT02805725|75880598|FG004|Interim Analysis (Stage 2 of Simon's Design)|Phase II||16||
59760942|NCT02805725|75880594|FG000|COMPLETED|Phase II||0||
59760943|NCT02805725|75880595|FG001|COMPLETED|Phase II||0||
59760944|NCT02805725|75880596|FG002|COMPLETED|Phase II||0||
59760945|NCT02805725|75880597|FG003|COMPLETED|Phase II||0||
59760946|NCT02805725|75880598|FG004|COMPLETED|Phase II||24||
59926511|NCT02958319|76044700|FG000|NOT COMPLETED|Overall Study||0||
59926512|NCT02958319|76044701|FG001|NOT COMPLETED|Overall Study||0||
59926513|NCT03046056|76044710|FG000|STARTED|Overall Study||28||
59926514|NCT03046056|76044711|FG001|STARTED|Overall Study||32||
60060012|NCT02115815|76175281|FG006|STARTED|Overall Study||20||
60060013|NCT02115815|76175275|FG000|COMPLETED|Overall Study||22||
60060014|NCT02115815|76175276|FG001|COMPLETED|Overall Study||20||
60060015|NCT02115815|76175277|FG002|COMPLETED|Overall Study||20||
60060016|NCT02115815|76175278|FG003|COMPLETED|Overall Study||20||
60060017|NCT02115815|76175279|FG004|COMPLETED|Overall Study||20||
60060018|NCT02115815|76175280|FG005|COMPLETED|Overall Study||20||
60060019|NCT02115815|76175281|FG006|COMPLETED|Overall Study||20||
60060020|NCT02115815|76175275|FG000|NOT COMPLETED|Overall Study||2||
60060021|NCT02115815|76175276|FG001|NOT COMPLETED|Overall Study||0||
60060022|NCT02115815|76175277|FG002|NOT COMPLETED|Overall Study||0||
60060023|NCT02115815|76175278|FG003|NOT COMPLETED|Overall Study||0||
60060024|NCT02115815|76175279|FG004|NOT COMPLETED|Overall Study||0||
60060025|NCT02115815|76175280|FG005|NOT COMPLETED|Overall Study||2||
60060026|NCT02115815|76175281|FG006|NOT COMPLETED|Overall Study||0||
60060027|NCT02115269|76175297|FG000|STARTED|Overall Study||759||
60060028|NCT02115269|76175297|FG000|COMPLETED|Overall Study||702||
60060029|NCT02115269|76175297|FG000|NOT COMPLETED|Overall Study||57||
60060030|NCT02115113|76175312|FG000|STARTED|Participants in Run-in Period||0||
60060031|NCT02115113|76175313|FG001|STARTED|Participants in Run-in Period||0||
60060032|NCT02115113|76175314|FG002|STARTED|Participants in Run-in Period||78||
60060033|NCT02115113|76175312|FG000|COMPLETED|Participants in Run-in Period||0||
59613063|NCT01713582|75724094|FG000|NOT COMPLETED|Overall Study||3||
59760947|NCT02805725|75880594|FG000|NOT COMPLETED|Phase II||0||
59760948|NCT02805725|75880595|FG001|NOT COMPLETED|Phase II||0||
59760949|NCT02805725|75880596|FG002|NOT COMPLETED|Phase II||0||
59760950|NCT02805725|75880597|FG003|NOT COMPLETED|Phase II||0||
59760951|NCT02805725|75880598|FG004|NOT COMPLETED|Phase II||6||
59760952|NCT00546871|75880615|FG000|STARTED|Part 1 - IV Infusions of IGIV, PK||14||
59926515|NCT03046056|76044712|FG002|STARTED|Overall Study||18||
59926516|NCT03046056|76044710|FG000|COMPLETED|Overall Study||16||
59926517|NCT03046056|76044711|FG001|COMPLETED|Overall Study||16||
59926518|NCT03046056|76044712|FG002|COMPLETED|Overall Study||11||
59926519|NCT03046056|76044710|FG000|NOT COMPLETED|Overall Study||12||
59926520|NCT03046056|76044711|FG001|NOT COMPLETED|Overall Study||16||
59926521|NCT03046056|76044712|FG002|NOT COMPLETED|Overall Study||7||
59926522|NCT02849587|76044723|FG000|STARTED|Overall Study||65||
59926523|NCT02849587|76044724|FG001|STARTED|Overall Study||70||
59926524|NCT02849587|76044725|FG002|STARTED|Overall Study||64||
59926525|NCT02849587|76044723|FG000|COMPLETED|Overall Study||63||
59926526|NCT02849587|76044724|FG001|COMPLETED|Overall Study||66||
59926527|NCT02849587|76044725|FG002|COMPLETED|Overall Study||62||
60060034|NCT02115113|76175313|FG001|COMPLETED|Participants in Run-in Period||0||
60060035|NCT02115113|76175314|FG002|COMPLETED|Participants in Run-in Period||68||
60060036|NCT02115113|76175312|FG000|NOT COMPLETED|Participants in Run-in Period||0||
59760953|NCT00546871|75880616|FG001|STARTED|Part 1 - IV Infusions of IGIV, PK||35||
59760954|NCT00546871|75880615|FG000|COMPLETED|Part 1 - IV Infusions of IGIV, PK||13||
59760955|NCT00546871|75880616|FG001|COMPLETED|Part 1 - IV Infusions of IGIV, PK||35||
59760956|NCT00546871|75880615|FG000|NOT COMPLETED|Part 1 - IV Infusions of IGIV, PK||1||
59926528|NCT02849587|76044723|FG000|NOT COMPLETED|Overall Study||2||
59926529|NCT02849587|76044724|FG001|NOT COMPLETED|Overall Study||4||
59926530|NCT02849587|76044725|FG002|NOT COMPLETED|Overall Study||2||
59926531|NCT03347279|76044739|FG000|STARTED|Overall Study||529||
59926532|NCT03347279|76044740|FG001|STARTED|Overall Study||532||
59762683|NCT00857259|75882527|FG000|NOT COMPLETED|Overall Study||1||
60060037|NCT02115113|76175313|FG001|NOT COMPLETED|Participants in Run-in Period||0||
60060038|NCT02115113|76175314|FG002|NOT COMPLETED|Participants in Run-in Period||10||
60060039|NCT02115113|76175312|FG000|STARTED|Participants Randomized||24||
60060040|NCT02115113|76175313|FG001|STARTED|Participants Randomized||26||
60060041|NCT02115113|76175314|FG002|STARTED|Participants Randomized||0||
60060042|NCT02115113|76175312|FG000|COMPLETED|Participants Randomized||22||
59760957|NCT00546871|75880616|FG001|NOT COMPLETED|Part 1 - IV Infusions of IGIV, PK||0||
60060043|NCT02115113|76175313|FG001|COMPLETED|Participants Randomized||26||
60060044|NCT02115113|76175314|FG002|COMPLETED|Participants Randomized||0||
60060045|NCT02115113|76175312|FG000|NOT COMPLETED|Participants Randomized||2||
60060046|NCT02115113|76175313|FG001|NOT COMPLETED|Participants Randomized||0||
60060047|NCT02115113|76175314|FG002|NOT COMPLETED|Participants Randomized||0||
60060048|NCT02114879|76175325|FG000|STARTED|Overall Study||115||
60060049|NCT02114879|76175326|FG001|STARTED|Overall Study||114||
60060050|NCT02114879|76175325|FG000|COMPLETED|Overall Study||96||
60060051|NCT02114879|76175326|FG001|COMPLETED|Overall Study||90||
60060052|NCT02114879|76175325|FG000|NOT COMPLETED|Overall Study||19||
60060053|NCT02114879|76175326|FG001|NOT COMPLETED|Overall Study||24||
60060054|NCT02114177|76175334|FG000|STARTED|Overall Study||155||
60060055|NCT02114177|76175335|FG001|STARTED|Overall Study||155||
60060056|NCT02114177|76175334|FG000|COMPLETED|Overall Study||146||
60060057|NCT02114177|76175335|FG001|COMPLETED|Overall Study||151||
60060058|NCT02114177|76175334|FG000|NOT COMPLETED|Overall Study||9||
60060059|NCT02114177|76175335|FG001|NOT COMPLETED|Overall Study||4||
60060060|NCT02138825|76175343|FG000|STARTED|Main Study Treatment|safety population|73||
60060061|NCT02138825|76175344|FG001|STARTED|Main Study Treatment|safety population|74||
60060062|NCT02138825|76175343|FG000|COMPLETED|Main Study Treatment||33||
60060063|NCT02138825|76175344|FG001|COMPLETED|Main Study Treatment||39||
60060064|NCT02138825|76175343|FG000|NOT COMPLETED|Main Study Treatment||40||
60060065|NCT02138825|76175344|FG001|NOT COMPLETED|Main Study Treatment||35||
60060066|NCT02138825|76175343|FG000|STARTED|Long-term Extension||32||
60060067|NCT02138825|76175344|FG001|STARTED|Long-term Extension||38||
60060068|NCT02138825|76175343|FG000|COMPLETED|Long-term Extension|no participants were considered as completed LTE phase at time of study termination|0||
60060069|NCT02138825|76175344|FG001|COMPLETED|Long-term Extension|no participants were considered as completed LTE phase at time of study termination|0||
60060070|NCT02138825|76175343|FG000|NOT COMPLETED|Long-term Extension||32||
60060071|NCT02138825|76175344|FG001|NOT COMPLETED|Long-term Extension||38||
60060072|NCT02138825|76175343|FG000|STARTED|Safety Follow-up|Participants from main study treatment and LTE phase entered safety follow-up|72||
60060073|NCT02138825|76175344|FG001|STARTED|Safety Follow-up|Participants from main study treatment and LTE phase entered safety follow-up|64||
60060074|NCT02138825|76175343|FG000|COMPLETED|Safety Follow-up||50||
60060075|NCT02138825|76175344|FG001|COMPLETED|Safety Follow-up||47||
60060076|NCT02138825|76175343|FG000|NOT COMPLETED|Safety Follow-up||22||
60060077|NCT02138825|76175344|FG001|NOT COMPLETED|Safety Follow-up||17||
60060078|NCT02138747|76175359|FG000|STARTED|Treatment Period 1||156||
60060079|NCT02138747|76175360|FG001|STARTED|Treatment Period 1||157||
60060080|NCT02138747|76175361|FG002|STARTED|Treatment Period 1||31||
60060081|NCT02138747|76175362|FG003|STARTED|Treatment Period 1||32||
60060082|NCT02138747|76175359|FG000|COMPLETED|Treatment Period 1||136||
60060083|NCT02138747|76175360|FG001|COMPLETED|Treatment Period 1||132||
60060084|NCT02138747|76175361|FG002|COMPLETED|Treatment Period 1||27||
60060085|NCT02138747|76175362|FG003|COMPLETED|Treatment Period 1||28||
60060086|NCT02138747|76175359|FG000|NOT COMPLETED|Treatment Period 1||20||
60060087|NCT02138747|76175360|FG001|NOT COMPLETED|Treatment Period 1||25||
60060088|NCT02138747|76175361|FG002|NOT COMPLETED|Treatment Period 1||4||
59760958|NCT00546871|75880615|FG000|STARTED|Part 2 - Subcutaneous (SC) IGIV, PK||13||
60060089|NCT02138747|76175362|FG003|NOT COMPLETED|Treatment Period 1||4||
60060090|NCT02138747|76175359|FG000|STARTED|Treatment Period 2|Two participants who discontinued treatment in period 1 entered period 2.|138||
60060091|NCT02138747|76175360|FG001|STARTED|Treatment Period 2||132||
60060092|NCT02138747|76175361|FG002|STARTED|Treatment Period 2|One participant completed treatment in period 1.|26||
60060093|NCT02138747|76175362|FG003|STARTED|Treatment Period 2|One participant completed treatment in period 1.|27||
60060094|NCT02138747|76175359|FG000|COMPLETED|Treatment Period 2||121||
60060095|NCT02138747|76175360|FG001|COMPLETED|Treatment Period 2||125||
60060096|NCT02138747|76175361|FG002|COMPLETED|Treatment Period 2||24||
60060097|NCT02138747|76175362|FG003|COMPLETED|Treatment Period 2||24||
60060098|NCT02138747|76175359|FG000|NOT COMPLETED|Treatment Period 2||17||
60060099|NCT02138747|76175360|FG001|NOT COMPLETED|Treatment Period 2||7||
60060100|NCT02138747|76175361|FG002|NOT COMPLETED|Treatment Period 2||2||
60060101|NCT02138747|76175362|FG003|NOT COMPLETED|Treatment Period 2||3||
60060102|NCT02105285|76175375|FG000|STARTED|Overall Study||78||
60060103|NCT02105285|76175376|FG001|STARTED|Overall Study||78||
60060104|NCT02105285|76175377|FG002|STARTED|Overall Study||37||
60060105|NCT02105285|76175375|FG000|COMPLETED|Overall Study||76||
60060106|NCT02105285|76175376|FG001|COMPLETED|Overall Study||76||
60060107|NCT02105285|76175377|FG002|COMPLETED|Overall Study||37||
60060108|NCT02105285|76175375|FG000|NOT COMPLETED|Overall Study||2||
60060109|NCT02105285|76175376|FG001|NOT COMPLETED|Overall Study||2||
60060110|NCT02105285|76175377|FG002|NOT COMPLETED|Overall Study||0||
60060111|NCT02104895|76175386|FG000|STARTED|Overall Study||260||
60060112|NCT02104895|76175387|FG001|STARTED|Overall Study||260||
60060113|NCT02104895|76175386|FG000|COMPLETED|Overall Study||260||
60060114|NCT02104895|76175387|FG001|COMPLETED|Overall Study||246||
60060115|NCT02104895|76175386|FG000|NOT COMPLETED|Overall Study||0||
60060116|NCT02104895|76175387|FG001|NOT COMPLETED|Overall Study||14||
60060117|NCT01621490|76175402|FG000|STARTED|Overall Study||41||
59926533|NCT03347279|76044739|FG000|Received Treatment|Overall Study||528||
59926534|NCT03347279|76044740|FG001|Received Treatment|Overall Study||531||
59926535|NCT03347279|76044739|FG000|COMPLETED|Overall Study||513||
60060118|NCT01621490|76175403|FG001|STARTED|Overall Study||44||
60060119|NCT01621490|76175404|FG002|STARTED|Overall Study||11||
59926536|NCT03347279|76044740|FG001|COMPLETED|Overall Study||509||
59926537|NCT03347279|76044739|FG000|NOT COMPLETED|Overall Study||16||
60060120|NCT01621490|76175405|FG003|STARTED|Overall Study||10||
60060121|NCT01621490|76175406|FG004|STARTED|Overall Study||6||
60060122|NCT01621490|76175407|FG005|STARTED|Overall Study||25||
60060123|NCT01621490|76175408|FG006|STARTED|Overall Study||11||
60060124|NCT01621490|76175409|FG007|STARTED|Overall Study||10||
60060125|NCT01621490|76175410|FG008|STARTED|Overall Study||10||
60060126|NCT01621490|76175402|FG000|COMPLETED|Overall Study||0|Completed = completed treatment period|
59926538|NCT03347279|76044740|FG001|NOT COMPLETED|Overall Study||23||
59926539|NCT03262441|76044746|FG000|STARTED|Overall Study||5||
59926540|NCT03262441|76044746|FG000|COMPLETED|Overall Study||4||
59926541|NCT03262441|76044746|FG000|NOT COMPLETED|Overall Study||1||
59516581|NCT00634088|75610259|FG000|STARTED|Time Period 2: Dose Level 2||0||
59516582|NCT00634088|75610260|FG001|STARTED|Time Period 2: Dose Level 2||3||
59926542|NCT04580394|76044750|FG000|STARTED|First Intervention||60||
59926543|NCT04580394|76044750|FG000|75mg/2.5mg|First Intervention||16|Treatment A: Atomoxetine 75 mg and R-oxybutynin 2.5 mg|
59926544|NCT04580394|76044750|FG000|75mg and Placebo|First Intervention||14|Treatment B: Atomoxetine 75 mg and placebo|
59926545|NCT04580394|76044750|FG000|2.5mg and Placebo|First Intervention||15|Treatment C: R-oxybutynin 2.5 mg and placebo|
59926546|NCT04580394|76044750|FG000|Placebo and Placebo|First Intervention||15|Treatment D|
59926547|NCT04580394|76044750|FG000|COMPLETED|First Intervention||57||
59926548|NCT04580394|76044750|FG000|NOT COMPLETED|First Intervention||3||
59926549|NCT04580394|76044750|FG000|STARTED|Washout (One Week)||57||
59926550|NCT04580394|76044750|FG000|COMPLETED|Washout (One Week)||56||
59926551|NCT04580394|76044750|FG000|NOT COMPLETED|Washout (One Week)||1||
59926552|NCT04580394|76044750|FG000|STARTED|Second Intervention||56||
59926553|NCT04580394|76044750|FG000|75mg/2.5mg|Second Intervention||15|Treatment A: Atomoxetine 75 mg and R-oxybutynin 2.5 mg|
59926554|NCT04580394|76044750|FG000|75mg and Placebo|Second Intervention||15|Treatment B: Atomoxetine 75 mg and placebo|
59926555|NCT04580394|76044750|FG000|2.5mg and Placebo|Second Intervention||13|Treatment C: R-oxybutynin 2.5 mg and placebo|
59926556|NCT04580394|76044750|FG000|Placebo and Placebo|Second Intervention||14|Treatment D|
59926557|NCT04580394|76044750|FG000|COMPLETED|Second Intervention||56||
59926558|NCT04580394|76044750|FG000|NOT COMPLETED|Second Intervention||0||
59926559|NCT04580394|76044750|FG000|STARTED|Washout (One Week)||56||
59926560|NCT04580394|76044750|FG000|COMPLETED|Washout (One Week)||53||
59926561|NCT04580394|76044750|FG000|NOT COMPLETED|Washout (One Week)||3||
59926562|NCT04580394|76044750|FG000|STARTED|Third Intervention||53||
60060127|NCT01621490|76175403|FG001|COMPLETED|Overall Study||0|Completed = completed treatment period|
60060128|NCT01621490|76175404|FG002|COMPLETED|Overall Study||0|Completed = completed treatment period|
60060129|NCT01621490|76175405|FG003|COMPLETED|Overall Study||1|Completed = completed treatment period|
60060130|NCT01621490|76175406|FG004|COMPLETED|Overall Study||0|Completed = completed treatment period|
60060131|NCT01621490|76175407|FG005|COMPLETED|Overall Study||1|Completed = completed treatment period|
59516583|NCT00634088|75610261|FG002|STARTED|Time Period 2: Dose Level 2||0||
59926563|NCT04580394|76044750|FG000|75mg /2.5mg|Third Intervention||13|Treatment A: Atomoxetine 75 mg and R-oxybutynin 2.5 mg|
59926564|NCT04580394|76044750|FG000|75mg and Placebo|Third Intervention||13|Treatment B: Atomoxetine 75 mg and placebo|
59926565|NCT04580394|76044750|FG000|2.5mg and Placebo|Third Intervention||15|Treatment C: R-oxybutynin 2.5 mg and placebo|
59926566|NCT04580394|76044750|FG000|Placebo and Placebo|Third Intervention||14|Treatment D|
59926567|NCT04580394|76044750|FG000|COMPLETED|Third Intervention||51||
59926568|NCT04580394|76044750|FG000|NOT COMPLETED|Third Intervention||2||
59926569|NCT04580394|76044750|FG000|STARTED|Washout (One Week)||51||
59926570|NCT04580394|76044750|FG000|COMPLETED|Washout (One Week)||49||
59926571|NCT04580394|76044750|FG000|NOT COMPLETED|Washout (One Week)||2||
59926572|NCT04580394|76044750|FG000|STARTED|Fourth Intervention||49||
60060132|NCT01621490|76175408|FG006|COMPLETED|Overall Study||0|Completed = completed treatment period|
60067869|NCT01785615|76183054|FG002|NOT COMPLETED|Atorvastatin Phase||0||
59926573|NCT04580394|76044750|FG000|75mg/2.5mg|Fourth Intervention||12|Treatment A: Atomoxetine 75 mg and R-oxybutynin 2.5 mg|
60060133|NCT01621490|76175409|FG007|COMPLETED|Overall Study||0|Completed = completed treatment period|
60060134|NCT01621490|76175410|FG008|COMPLETED|Overall Study||2|Completed = completed treatment period|
59926574|NCT04580394|76044750|FG000|75mg and Placebo|Fourth Intervention||12|Treatment B: Atomoxetine 75 mg and placebo|
59926575|NCT04580394|76044750|FG000|2.5mg and Placebo|Fourth Intervention||11|Treatment C: R-oxybutynin 2.5 mg and placebo|
59926576|NCT04580394|76044750|FG000|Placebo and Placebo|Fourth Intervention||14|Treatment D|
59926577|NCT04580394|76044750|FG000|COMPLETED|Fourth Intervention||49||
59926578|NCT04580394|76044750|FG000|NOT COMPLETED|Fourth Intervention||0||
59926579|NCT02781727|76044762|FG000|STARTED|Pre-dosing Period|106 subjects were randomized to the lonapegsomatropin arm, but 1 subject withdrew consent before receiving the first dose of study drug.|106||
59926580|NCT02781727|76044763|FG001|STARTED|Pre-dosing Period||56||
59926581|NCT02781727|76044762|FG000|COMPLETED|Pre-dosing Period||105||
59926582|NCT02781727|76044763|FG001|COMPLETED|Pre-dosing Period||56||
59926583|NCT02781727|76044762|FG000|NOT COMPLETED|Pre-dosing Period||1||
59926584|NCT02781727|76044763|FG001|NOT COMPLETED|Pre-dosing Period||0||
59926585|NCT02781727|76044762|FG000|STARTED|Treatment Period||105||
59926586|NCT02781727|76044763|FG001|STARTED|Treatment Period||56||
60060135|NCT01621490|76175402|FG000|NOT COMPLETED|Overall Study||41||
60060136|NCT01621490|76175403|FG001|NOT COMPLETED|Overall Study||44||
60060137|NCT01621490|76175404|FG002|NOT COMPLETED|Overall Study||11||
60060138|NCT01621490|76175405|FG003|NOT COMPLETED|Overall Study||9||
60060139|NCT01621490|76175406|FG004|NOT COMPLETED|Overall Study||6||
60060140|NCT01621490|76175407|FG005|NOT COMPLETED|Overall Study||24||
60060141|NCT01621490|76175408|FG006|NOT COMPLETED|Overall Study||11||
60060142|NCT01621490|76175409|FG007|NOT COMPLETED|Overall Study||10||
60060143|NCT01621490|76175410|FG008|NOT COMPLETED|Overall Study||8||
60060144|NCT02018887|76175531|FG000|STARTED|Part A: Cohorts 1-2: Period 1||9||
60060145|NCT02018887|76175532|FG001|STARTED|Part A: Cohorts 1-2: Period 1||9||
60060146|NCT02018887|76175533|FG002|STARTED|Part A: Cohorts 1-2: Period 1|Placebo was not administered in this period.|0||
60060147|NCT02018887|76175534|FG003|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0||
60060148|NCT02018887|76175535|FG004|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0||
60060149|NCT02018887|76175536|FG005|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0||
60060150|NCT02018887|76175537|FG006|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0||
60060151|NCT02018887|76175538|FG007|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0||
59926587|NCT02781727|76044762|FG000|COMPLETED|Treatment Period||104||
59926588|NCT02781727|76044763|FG001|COMPLETED|Treatment Period||55||
60060152|NCT02018887|76175539|FG008|STARTED|Part A: Cohorts 1-2: Period 1|Placebo was not administered in this period.|0||
60060153|NCT02018887|76175540|FG009|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0||
60060154|NCT02018887|76175541|FG010|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0||
60060155|NCT02018887|76175531|FG000|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||9||
60060156|NCT02018887|76175532|FG001|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||9||
59926589|NCT02781727|76044762|FG000|NOT COMPLETED|Treatment Period||1||
59926590|NCT02781727|76044763|FG001|NOT COMPLETED|Treatment Period||1||
59926591|NCT01343082|76044769|FG000|STARTED|The run-in Period||51||
59926592|NCT01343082|76044770|FG001|STARTED|The run-in Period||49||
59926593|NCT01343082|76044771|FG002|STARTED|The run-in Period||48||
59926594|NCT01343082|76044769|FG000|COMPLETED|The run-in Period||48||
59926595|NCT01343082|76044770|FG001|COMPLETED|The run-in Period||45||
59926596|NCT01343082|76044771|FG002|COMPLETED|The run-in Period||43||
59926597|NCT01343082|76044769|FG000|NOT COMPLETED|The run-in Period||3||
59926598|NCT01343082|76044770|FG001|NOT COMPLETED|The run-in Period||4||
59926599|NCT01343082|76044771|FG002|NOT COMPLETED|The run-in Period||5||
59926600|NCT01343082|76044769|FG000|STARTED|Treatment Period , Switched to DE-111||48||
59926601|NCT01343082|76044770|FG001|STARTED|Treatment Period , Switched to DE-111||45||
59926602|NCT01343082|76044771|FG002|STARTED|Treatment Period , Switched to DE-111||43||
59926603|NCT01343082|76044769|FG000|COMPLETED|Treatment Period , Switched to DE-111||43||
59926604|NCT01343082|76044770|FG001|COMPLETED|Treatment Period , Switched to DE-111||36||
59926605|NCT01343082|76044771|FG002|COMPLETED|Treatment Period , Switched to DE-111||31||
59926606|NCT01343082|76044769|FG000|NOT COMPLETED|Treatment Period , Switched to DE-111||5||
59926607|NCT01343082|76044770|FG001|NOT COMPLETED|Treatment Period , Switched to DE-111||9||
59926608|NCT01343082|76044771|FG002|NOT COMPLETED|Treatment Period , Switched to DE-111||12||
59926609|NCT03374189|76044777|FG000|STARTED|Overall Study||40||
59926610|NCT03374189|76044778|FG001|STARTED|Overall Study||39||
59926611|NCT03374189|76044777|FG000|COMPLETED|Overall Study||39||
59926612|NCT03374189|76044778|FG001|COMPLETED|Overall Study||39||
59926613|NCT03374189|76044777|FG000|NOT COMPLETED|Overall Study||1||
59926614|NCT03374189|76044778|FG001|NOT COMPLETED|Overall Study||0||
59926615|NCT03261037|76044788|FG000|STARTED|Overall Study||68||
59926616|NCT03261037|76044789|FG001|STARTED|Overall Study||62||
59926617|NCT03261037|76044790|FG002|STARTED|Overall Study||9||
59926618|NCT03261037|76044791|FG003|STARTED|Overall Study||39||
59926619|NCT03261037|76044788|FG000|COMPLETED|Overall Study||64||
60060157|NCT02018887|76175533|FG002|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0||
60060158|NCT02018887|76175534|FG003|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0||
60060159|NCT02018887|76175535|FG004|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0||
60060160|NCT02018887|76175536|FG005|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0||
60060161|NCT02018887|76175537|FG006|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0||
60060162|NCT02018887|76175538|FG007|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0||
60060163|NCT02018887|76175539|FG008|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0||
60060164|NCT02018887|76175540|FG009|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0||
60060165|NCT02018887|76175541|FG010|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0||
60060166|NCT02018887|76175531|FG000|COMPLETED|Part A: Cohorts 1-2: Period 1||9||
60060167|NCT02018887|76175532|FG001|COMPLETED|Part A: Cohorts 1-2: Period 1||9||
60060168|NCT02018887|76175533|FG002|COMPLETED|Part A: Cohorts 1-2: Period 1||0||
60060169|NCT02018887|76175534|FG003|COMPLETED|Part A: Cohorts 1-2: Period 1||0||
60060170|NCT02018887|76175535|FG004|COMPLETED|Part A: Cohorts 1-2: Period 1||0||
60060171|NCT02018887|76175536|FG005|COMPLETED|Part A: Cohorts 1-2: Period 1||0||
60060172|NCT02018887|76175537|FG006|COMPLETED|Part A: Cohorts 1-2: Period 1||0||
60060173|NCT02018887|76175538|FG007|COMPLETED|Part A: Cohorts 1-2: Period 1||0||
60060174|NCT02018887|76175539|FG008|COMPLETED|Part A: Cohorts 1-2: Period 1||0||
60060175|NCT02018887|76175540|FG009|COMPLETED|Part A: Cohorts 1-2: Period 1||0||
60060176|NCT02018887|76175541|FG010|COMPLETED|Part A: Cohorts 1-2: Period 1||0||
60060177|NCT02018887|76175531|FG000|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0||
60060178|NCT02018887|76175532|FG001|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0||
60060179|NCT02018887|76175533|FG002|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0||
60060180|NCT02018887|76175534|FG003|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0||
60060181|NCT02018887|76175535|FG004|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0||
60060182|NCT02018887|76175536|FG005|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0||
60060183|NCT02018887|76175537|FG006|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0||
60060184|NCT02018887|76175538|FG007|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0||
60060185|NCT02018887|76175539|FG008|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0||
60060186|NCT02018887|76175540|FG009|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0||
60060187|NCT02018887|76175541|FG010|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0||
60060188|NCT02018887|76175531|FG000|STARTED|Part A: Cohorts 1-2: Period 2||9||
60060189|NCT02018887|76175532|FG001|STARTED|Part A: Cohorts 1-2: Period 2||9||
60060190|NCT02018887|76175533|FG002|STARTED|Part A: Cohorts 1-2: Period 2|Placebo was not administered in this period.|0||
60060191|NCT02018887|76175534|FG003|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0||
60060192|NCT02018887|76175535|FG004|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0||
60060193|NCT02018887|76175536|FG005|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0||
60060194|NCT02018887|76175537|FG006|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0||
60060195|NCT02018887|76175538|FG007|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0||
60060196|NCT02018887|76175539|FG008|STARTED|Part A: Cohorts 1-2: Period 2|Placebo was not administered in this period.|0||
60060197|NCT02018887|76175540|FG009|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0||
60060198|NCT02018887|76175541|FG010|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0||
60060199|NCT02018887|76175531|FG000|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||9||
60060200|NCT02018887|76175532|FG001|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||9||
60060201|NCT02018887|76175533|FG002|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0||
60060202|NCT02018887|76175534|FG003|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0||
60060203|NCT02018887|76175535|FG004|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0||
60060204|NCT02018887|76175536|FG005|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0||
60060205|NCT02018887|76175537|FG006|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0||
60060206|NCT02018887|76175538|FG007|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0||
60060207|NCT02018887|76175539|FG008|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0||
60060208|NCT02018887|76175540|FG009|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0||
60060209|NCT02018887|76175541|FG010|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0||
60060210|NCT02018887|76175531|FG000|COMPLETED|Part A: Cohorts 1-2: Period 2||9||
60060211|NCT02018887|76175532|FG001|COMPLETED|Part A: Cohorts 1-2: Period 2||9||
60060212|NCT02018887|76175533|FG002|COMPLETED|Part A: Cohorts 1-2: Period 2||0||
60060213|NCT02018887|76175534|FG003|COMPLETED|Part A: Cohorts 1-2: Period 2||0||
60060214|NCT02018887|76175535|FG004|COMPLETED|Part A: Cohorts 1-2: Period 2||0||
60060215|NCT02018887|76175536|FG005|COMPLETED|Part A: Cohorts 1-2: Period 2||0||
60060216|NCT02018887|76175537|FG006|COMPLETED|Part A: Cohorts 1-2: Period 2||0||
60060217|NCT02018887|76175538|FG007|COMPLETED|Part A: Cohorts 1-2: Period 2||0||
60060218|NCT02018887|76175539|FG008|COMPLETED|Part A: Cohorts 1-2: Period 2||0||
60060219|NCT02018887|76175540|FG009|COMPLETED|Part A: Cohorts 1-2: Period 2||0||
60060220|NCT02018887|76175541|FG010|COMPLETED|Part A: Cohorts 1-2: Period 2||0||
60060221|NCT02018887|76175531|FG000|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0||
60060222|NCT02018887|76175532|FG001|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0||
60060223|NCT02018887|76175533|FG002|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0||
60060224|NCT02018887|76175534|FG003|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0||
60060225|NCT02018887|76175535|FG004|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0||
60060226|NCT02018887|76175536|FG005|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0||
60060227|NCT02018887|76175537|FG006|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0||
60060228|NCT02018887|76175538|FG007|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0||
60060229|NCT02018887|76175539|FG008|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0||
60060230|NCT02018887|76175540|FG009|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0||
60060231|NCT02018887|76175541|FG010|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0||
60060232|NCT02018887|76175531|FG000|STARTED|Part A: Cohorts 1-2: Period 3||9||
60060233|NCT02018887|76175532|FG001|STARTED|Part A: Cohorts 1-2: Period 3||9||
60060234|NCT02018887|76175533|FG002|STARTED|Part A: Cohorts 1-2: Period 3|Placebo was not administered in this period.|0||
60060235|NCT02018887|76175534|FG003|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0||
59926620|NCT03261037|76044789|FG001|COMPLETED|Overall Study||41||
59926621|NCT03261037|76044790|FG002|COMPLETED|Overall Study||9||
59926622|NCT03261037|76044791|FG003|COMPLETED|Overall Study||11||
59926623|NCT03261037|76044788|FG000|NOT COMPLETED|Overall Study||4||
59926624|NCT03261037|76044789|FG001|NOT COMPLETED|Overall Study||21||
59926625|NCT03261037|76044790|FG002|NOT COMPLETED|Overall Study||0||
59926626|NCT03261037|76044791|FG003|NOT COMPLETED|Overall Study||28||
59926627|NCT03372551|76044802|FG000|STARTED|First Intervention (1 Week)||17||
59926628|NCT03372551|76044803|FG001|STARTED|First Intervention (1 Week)||16||
60060236|NCT02018887|76175535|FG004|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0||
60060237|NCT02018887|76175536|FG005|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0||
60060238|NCT02018887|76175537|FG006|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0||
60060239|NCT02018887|76175538|FG007|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0||
60060240|NCT02018887|76175539|FG008|STARTED|Part A: Cohorts 1-2: Period 3|Placebo was not administered in this period.|0||
60060241|NCT02018887|76175540|FG009|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0||
60060242|NCT02018887|76175541|FG010|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0||
60060243|NCT02018887|76175531|FG000|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||8||
60060244|NCT02018887|76175532|FG001|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||9||
60060245|NCT02018887|76175533|FG002|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0||
60060246|NCT02018887|76175534|FG003|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0||
60060247|NCT02018887|76175535|FG004|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0||
60060248|NCT02018887|76175536|FG005|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0||
60060249|NCT02018887|76175537|FG006|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0||
60060250|NCT02018887|76175538|FG007|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0||
60060251|NCT02018887|76175539|FG008|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0||
60060252|NCT02018887|76175540|FG009|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0||
60060253|NCT02018887|76175541|FG010|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0||
60060254|NCT02018887|76175531|FG000|COMPLETED|Part A: Cohorts 1-2: Period 3||8||
60060255|NCT02018887|76175532|FG001|COMPLETED|Part A: Cohorts 1-2: Period 3||9||
60060256|NCT02018887|76175533|FG002|COMPLETED|Part A: Cohorts 1-2: Period 3||0||
60060257|NCT02018887|76175534|FG003|COMPLETED|Part A: Cohorts 1-2: Period 3||0||
60060258|NCT02018887|76175535|FG004|COMPLETED|Part A: Cohorts 1-2: Period 3||0||
60060259|NCT02018887|76175536|FG005|COMPLETED|Part A: Cohorts 1-2: Period 3||0||
60060260|NCT02018887|76175537|FG006|COMPLETED|Part A: Cohorts 1-2: Period 3||0||
60060261|NCT02018887|76175538|FG007|COMPLETED|Part A: Cohorts 1-2: Period 3||0||
60060262|NCT02018887|76175539|FG008|COMPLETED|Part A: Cohorts 1-2: Period 3||0||
60060263|NCT02018887|76175540|FG009|COMPLETED|Part A: Cohorts 1-2: Period 3||0||
60060264|NCT02018887|76175541|FG010|COMPLETED|Part A: Cohorts 1-2: Period 3||0||
60060265|NCT02018887|76175531|FG000|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||1||
60060266|NCT02018887|76175532|FG001|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0||
60060267|NCT02018887|76175533|FG002|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0||
60060268|NCT02018887|76175534|FG003|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0||
60060269|NCT02018887|76175535|FG004|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0||
60060270|NCT02018887|76175536|FG005|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0||
59926629|NCT03372551|76044802|FG000|COMPLETED|First Intervention (1 Week)||16||
59926630|NCT03372551|76044803|FG001|COMPLETED|First Intervention (1 Week)||16||
59926631|NCT03372551|76044802|FG000|NOT COMPLETED|First Intervention (1 Week)||1||
59926632|NCT03372551|76044803|FG001|NOT COMPLETED|First Intervention (1 Week)||0||
59926633|NCT03372551|76044802|FG000|STARTED|Second Intervention (1 Week)||16||
59926634|NCT03372551|76044803|FG001|STARTED|Second Intervention (1 Week)||16||
59926635|NCT03372551|76044802|FG000|COMPLETED|Second Intervention (1 Week)||16||
59926636|NCT03372551|76044803|FG001|COMPLETED|Second Intervention (1 Week)||16||
59926637|NCT03372551|76044802|FG000|NOT COMPLETED|Second Intervention (1 Week)||0||
59926638|NCT03372551|76044803|FG001|NOT COMPLETED|Second Intervention (1 Week)||0||
59926639|NCT03326323|76044816|FG000|STARTED|Overall Study||43||
60060271|NCT02018887|76175537|FG006|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0||
60060272|NCT02018887|76175538|FG007|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0||
60060273|NCT02018887|76175539|FG008|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0||
60060274|NCT02018887|76175540|FG009|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0||
60060275|NCT02018887|76175541|FG010|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0||
60060276|NCT02018887|76175531|FG000|STARTED|Part B: Cohorts 3-7 Overall|Column for Part A data only.|0||
60060277|NCT02018887|76175532|FG001|STARTED|Part B: Cohorts 3-7 Overall|Column for Part A data only.|0||
60060278|NCT02018887|76175533|FG002|STARTED|Part B: Cohorts 3-7 Overall||15||
60060279|NCT02018887|76175534|FG003|STARTED|Part B: Cohorts 3-7 Overall||9||
60060280|NCT02018887|76175535|FG004|STARTED|Part B: Cohorts 3-7 Overall||9||
60060281|NCT02018887|76175536|FG005|STARTED|Part B: Cohorts 3-7 Overall||9||
60060282|NCT02018887|76175537|FG006|STARTED|Part B: Cohorts 3-7 Overall||9||
60060283|NCT02018887|76175538|FG007|STARTED|Part B: Cohorts 3-7 Overall||9||
60060284|NCT02018887|76175539|FG008|STARTED|Part B: Cohorts 3-7 Overall|Placebo was not administered in this period.|0||
60060285|NCT02018887|76175540|FG009|STARTED|Part B: Cohorts 3-7 Overall|This dose was not administered in this period.|0||
60060286|NCT02018887|76175541|FG010|STARTED|Part B: Cohorts 3-7 Overall|This dose was not administered in this period.|0||
59926640|NCT03326323|76044816|FG000|COMPLETED|Overall Study||40||
59926641|NCT03326323|76044816|FG000|NOT COMPLETED|Overall Study||3||
59926642|NCT03937141|76044820|FG000|STARTED|Overall Study||16||
59926643|NCT03937141|76044820|FG000|COMPLETED|Overall Study||16||
59926644|NCT03937141|76044820|FG000|NOT COMPLETED|Overall Study||0||
59926645|NCT03259789|76044827|FG000|STARTED|Overall Study||158||
59926646|NCT03259789|76044828|FG001|STARTED|Overall Study||159||
59926647|NCT03259789|76044829|FG002|STARTED|Overall Study||34||
59926648|NCT03259789|76044827|FG000|COMPLETED|Overall Study||141||
59926649|NCT03259789|76044828|FG001|COMPLETED|Overall Study||142||
59926650|NCT03259789|76044829|FG002|COMPLETED|Overall Study||28||
59926651|NCT03259789|76044827|FG000|NOT COMPLETED|Overall Study||17||
60060287|NCT02018887|76175531|FG000|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||0||
60060288|NCT02018887|76175532|FG001|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||0||
60060289|NCT02018887|76175533|FG002|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||15||
60060290|NCT02018887|76175534|FG003|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||9||
60060291|NCT02018887|76175535|FG004|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||9||
60060292|NCT02018887|76175536|FG005|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||9||
60060293|NCT02018887|76175537|FG006|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||9||
60060294|NCT02018887|76175538|FG007|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||9||
60060295|NCT02018887|76175539|FG008|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||0||
60060296|NCT02018887|76175540|FG009|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||0||
60060297|NCT02018887|76175541|FG010|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||0||
60060298|NCT02018887|76175531|FG000|COMPLETED|Part B: Cohorts 3-7 Overall||0||
60060299|NCT02018887|76175532|FG001|COMPLETED|Part B: Cohorts 3-7 Overall||0||
60060300|NCT02018887|76175533|FG002|COMPLETED|Part B: Cohorts 3-7 Overall||15||
60060301|NCT02018887|76175534|FG003|COMPLETED|Part B: Cohorts 3-7 Overall||9||
59926652|NCT03259789|76044828|FG001|NOT COMPLETED|Overall Study||17||
59926653|NCT03259789|76044829|FG002|NOT COMPLETED|Overall Study||6||
59926654|NCT03259555|76044840|FG000|STARTED|Overall Study||158||
59926655|NCT03259555|76044841|FG001|STARTED|Overall Study||164||
59926656|NCT03259555|76044840|FG000|Received At Least 1 Dose of Study Drug|Overall Study||158|Randomized participants who received at least 1 dose of study drug were analyzed for safety.|
59926657|NCT03259555|76044841|FG001|Received At Least 1 Dose of Study Drug|Overall Study||163|Randomized participants who received at least 1 dose of study drug were analyzed for safety.|
59926658|NCT03259555|76044840|FG000|COMPLETED|Overall Study||124||
59926659|NCT03259555|76044841|FG001|COMPLETED|Overall Study||134||
59926660|NCT03259555|76044840|FG000|NOT COMPLETED|Overall Study||34||
59926661|NCT03259555|76044841|FG001|NOT COMPLETED|Overall Study||30||
59926662|NCT03259087|76044852|FG000|STARTED|Part 1 and Period 1 of Part 2||8||
59926663|NCT03259087|76044853|FG001|STARTED|Part 1 and Period 1 of Part 2||8||
59926664|NCT03259087|76044854|FG002|STARTED|Part 1 and Period 1 of Part 2||8||
59926665|NCT03259087|76044855|FG003|STARTED|Part 1 and Period 1 of Part 2||10||
59926666|NCT03259087|76044856|FG004|STARTED|Part 1 and Period 1 of Part 2||8||
59926667|NCT03259087|76044852|FG000|COMPLETED|Part 1 and Period 1 of Part 2||8||
59926668|NCT03259087|76044853|FG001|COMPLETED|Part 1 and Period 1 of Part 2||8||
59926669|NCT03259087|76044854|FG002|COMPLETED|Part 1 and Period 1 of Part 2||8||
59926670|NCT03259087|76044855|FG003|COMPLETED|Part 1 and Period 1 of Part 2||10||
59926671|NCT03259087|76044856|FG004|COMPLETED|Part 1 and Period 1 of Part 2||7||
59926672|NCT03259087|76044852|FG000|NOT COMPLETED|Part 1 and Period 1 of Part 2||0||
59926673|NCT03259087|76044853|FG001|NOT COMPLETED|Part 1 and Period 1 of Part 2||0||
59926674|NCT03259087|76044854|FG002|NOT COMPLETED|Part 1 and Period 1 of Part 2||0||
59926675|NCT03259087|76044855|FG003|NOT COMPLETED|Part 1 and Period 1 of Part 2||0||
59926676|NCT03259087|76044856|FG004|NOT COMPLETED|Part 1 and Period 1 of Part 2||1||
59926677|NCT03259087|76044852|FG000|STARTED|Period 2 of Part 2|Period 2 did not apply to Part 1 participants|0||
59926678|NCT03259087|76044853|FG001|STARTED|Period 2 of Part 2|Period 2 did not apply to Part 1 participants|0||
59926679|NCT03259087|76044854|FG002|STARTED|Period 2 of Part 2|Period 2 did not apply to Part 1 participants|0||
59926680|NCT03259087|76044855|FG003|STARTED|Period 2 of Part 2|Period 2 did not apply to Part 1 participants|0||
59926681|NCT03259087|76044856|FG004|STARTED|Period 2 of Part 2||7||
59926682|NCT03259087|76044852|FG000|COMPLETED|Period 2 of Part 2||0||
59926683|NCT03259087|76044853|FG001|COMPLETED|Period 2 of Part 2||0||
59926684|NCT03259087|76044854|FG002|COMPLETED|Period 2 of Part 2||0||
59926685|NCT03259087|76044855|FG003|COMPLETED|Period 2 of Part 2||0||
59926686|NCT03259087|76044856|FG004|COMPLETED|Period 2 of Part 2||6||
59926687|NCT03259087|76044852|FG000|NOT COMPLETED|Period 2 of Part 2||0||
60060302|NCT02018887|76175535|FG004|COMPLETED|Part B: Cohorts 3-7 Overall||8||
59926688|NCT03259087|76044853|FG001|NOT COMPLETED|Period 2 of Part 2||0||
59926689|NCT03259087|76044854|FG002|NOT COMPLETED|Period 2 of Part 2||0||
60060303|NCT02018887|76175536|FG005|COMPLETED|Part B: Cohorts 3-7 Overall||9||
59926690|NCT03259087|76044855|FG003|NOT COMPLETED|Period 2 of Part 2||0||
59926691|NCT03259087|76044856|FG004|NOT COMPLETED|Period 2 of Part 2||1||
59926692|NCT03257995|76044878|FG000|STARTED|Overall Study||9||
59926693|NCT03257995|76044879|FG001|STARTED|Overall Study||9||
59926694|NCT03257995|76044880|FG002|STARTED|Overall Study||9||
59926695|NCT03257995|76044881|FG003|STARTED|Overall Study||9||
59926696|NCT03257995|76044882|FG004|STARTED|Overall Study||9||
60060304|NCT02018887|76175537|FG006|COMPLETED|Part B: Cohorts 3-7 Overall||8||
59926697|NCT03257995|76044883|FG005|STARTED|Overall Study||9||
59926698|NCT03257995|76044878|FG000|COMPLETED|Overall Study||9||
60060305|NCT02018887|76175538|FG007|COMPLETED|Part B: Cohorts 3-7 Overall||5||
60060306|NCT02018887|76175539|FG008|COMPLETED|Part B: Cohorts 3-7 Overall||0||
60060307|NCT02018887|76175540|FG009|COMPLETED|Part B: Cohorts 3-7 Overall||0||
60060308|NCT02018887|76175541|FG010|COMPLETED|Part B: Cohorts 3-7 Overall||0||
60060309|NCT02018887|76175531|FG000|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0||
60060310|NCT02018887|76175532|FG001|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0||
59519048|NCT03593902|75612910|FG000|STARTED|Overall Study||9||
59926699|NCT03257995|76044879|FG001|COMPLETED|Overall Study||8||
59926700|NCT03257995|76044880|FG002|COMPLETED|Overall Study||9||
59926701|NCT03257995|76044881|FG003|COMPLETED|Overall Study||9||
59926702|NCT03257995|76044882|FG004|COMPLETED|Overall Study||9||
59926703|NCT03257995|76044883|FG005|COMPLETED|Overall Study||7||
59926704|NCT03257995|76044878|FG000|NOT COMPLETED|Overall Study||0||
59926705|NCT03257995|76044879|FG001|NOT COMPLETED|Overall Study||1||
59926706|NCT03257995|76044880|FG002|NOT COMPLETED|Overall Study||0||
59926707|NCT03257995|76044881|FG003|NOT COMPLETED|Overall Study||0||
59926708|NCT03257995|76044882|FG004|NOT COMPLETED|Overall Study||0||
59926709|NCT03257995|76044883|FG005|NOT COMPLETED|Overall Study||2||
59926710|NCT03049488|76044901|FG000|STARTED|Overall Study||15||
59926711|NCT03049488|76044902|FG001|STARTED|Overall Study||15||
59926712|NCT03049488|76044903|FG002|STARTED|Overall Study||20||
59926713|NCT03049488|76044904|FG003|STARTED|Overall Study||15||
59926714|NCT03049488|76044905|FG004|STARTED|Overall Study||15||
59926715|NCT03049488|76044906|FG005|STARTED|Overall Study||15||
59926716|NCT03049488|76044901|FG000|Received First Product Administration|Overall Study||15||
59926717|NCT03049488|76044902|FG001|Received First Product Administration|Overall Study||15||
59926718|NCT03049488|76044903|FG002|Received First Product Administration|Overall Study||20||
59926719|NCT03049488|76044904|FG003|Received First Product Administration|Overall Study||15||
59926720|NCT03049488|76044905|FG004|Received First Product Administration|Overall Study||15||
60060311|NCT02018887|76175533|FG002|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0||
59926721|NCT03049488|76044906|FG005|Received First Product Administration|Overall Study||15||
59926722|NCT03049488|76044901|FG000|Received Optional Second Dose|Overall Study||10||
59926723|NCT03049488|76044902|FG001|Received Optional Second Dose|Overall Study||11||
59926724|NCT03049488|76044903|FG002|Received Optional Second Dose|Overall Study||11||
60060312|NCT02018887|76175534|FG003|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0||
60060313|NCT02018887|76175535|FG004|NOT COMPLETED|Part B: Cohorts 3-7 Overall||1||
59926725|NCT03049488|76044904|FG003|Received Optional Second Dose|Overall Study||9||
59926726|NCT03049488|76044905|FG004|Received Optional Second Dose|Overall Study||11||
59926727|NCT03049488|76044906|FG005|Received Optional Second Dose|Overall Study||10||
59926728|NCT03049488|76044901|FG000|COMPLETED|Overall Study||13||
59926729|NCT03049488|76044902|FG001|COMPLETED|Overall Study||13||
59926730|NCT03049488|76044903|FG002|COMPLETED|Overall Study||20||
59926731|NCT03049488|76044904|FG003|COMPLETED|Overall Study||13||
59926732|NCT03049488|76044905|FG004|COMPLETED|Overall Study||13||
59926733|NCT03049488|76044906|FG005|COMPLETED|Overall Study||15||
59926734|NCT03049488|76044901|FG000|NOT COMPLETED|Overall Study||2||
59926735|NCT03049488|76044902|FG001|NOT COMPLETED|Overall Study||2||
59926736|NCT03049488|76044903|FG002|NOT COMPLETED|Overall Study||0||
59926737|NCT03049488|76044904|FG003|NOT COMPLETED|Overall Study||2||
59926738|NCT03049488|76044905|FG004|NOT COMPLETED|Overall Study||2||
59926739|NCT03049488|76044906|FG005|NOT COMPLETED|Overall Study||0||
59926740|NCT03257371|76044921|FG000|STARTED|Overall Study||10||
59926741|NCT03257371|76044921|FG000|COMPLETED|Overall Study||9||
60060314|NCT02018887|76175536|FG005|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0||
60060315|NCT02018887|76175537|FG006|NOT COMPLETED|Part B: Cohorts 3-7 Overall||1||
59926742|NCT03257371|76044921|FG000|NOT COMPLETED|Overall Study||1||
59926743|NCT03242863|76044925|FG000|STARTED|Study Week 1||13||
59926744|NCT03242863|76044926|FG001|STARTED|Study Week 1||16||
59926745|NCT03242863|76044927|FG002|STARTED|Study Week 1||4||
59926746|NCT03242863|76044928|FG003|STARTED|Study Week 1||4||
59926747|NCT03242863|76044929|FG004|STARTED|Study Week 1||15||
59926748|NCT03242863|76044930|FG005|STARTED|Study Week 1||5||
59926749|NCT03242863|76044925|FG000|COMPLETED|Study Week 1||13||
59926750|NCT03242863|76044926|FG001|COMPLETED|Study Week 1||15||
60060316|NCT02018887|76175538|FG007|NOT COMPLETED|Part B: Cohorts 3-7 Overall||4||
59926751|NCT03242863|76044927|FG002|COMPLETED|Study Week 1||4||
59926752|NCT03242863|76044928|FG003|COMPLETED|Study Week 1||4||
59926753|NCT03242863|76044929|FG004|COMPLETED|Study Week 1||12||
59926754|NCT03242863|76044930|FG005|COMPLETED|Study Week 1||5||
59926755|NCT03242863|76044925|FG000|NOT COMPLETED|Study Week 1||0||
59926756|NCT03242863|76044926|FG001|NOT COMPLETED|Study Week 1||1||
59926757|NCT03242863|76044927|FG002|NOT COMPLETED|Study Week 1||0||
59926758|NCT03242863|76044928|FG003|NOT COMPLETED|Study Week 1||0||
59926759|NCT03242863|76044929|FG004|NOT COMPLETED|Study Week 1||3||
59926760|NCT03242863|76044930|FG005|NOT COMPLETED|Study Week 1||0||
59926761|NCT03242863|76044925|FG000|STARTED|Study Week 2||13||
59926762|NCT03242863|76044926|FG001|STARTED|Study Week 2||15||
59926763|NCT03242863|76044927|FG002|STARTED|Study Week 2||4||
59926764|NCT03242863|76044928|FG003|STARTED|Study Week 2||4||
59926765|NCT03242863|76044929|FG004|STARTED|Study Week 2||12||
59926766|NCT03242863|76044930|FG005|STARTED|Study Week 2||5||
59926767|NCT03242863|76044925|FG000|COMPLETED|Study Week 2||13||
59926768|NCT03242863|76044926|FG001|COMPLETED|Study Week 2||15||
59926769|NCT03242863|76044927|FG002|COMPLETED|Study Week 2||4||
59926770|NCT03242863|76044928|FG003|COMPLETED|Study Week 2||4||
59926771|NCT03242863|76044929|FG004|COMPLETED|Study Week 2||12||
59926772|NCT03242863|76044930|FG005|COMPLETED|Study Week 2||5||
59926773|NCT03242863|76044925|FG000|NOT COMPLETED|Study Week 2||0||
59926774|NCT03242863|76044926|FG001|NOT COMPLETED|Study Week 2||0||
59926775|NCT03242863|76044927|FG002|NOT COMPLETED|Study Week 2||0||
59926776|NCT03242863|76044928|FG003|NOT COMPLETED|Study Week 2||0||
59926777|NCT03242863|76044929|FG004|NOT COMPLETED|Study Week 2||0||
59926778|NCT03242863|76044930|FG005|NOT COMPLETED|Study Week 2||0||
59926779|NCT03242863|76044925|FG000|STARTED|Study Week 3||13||
59926780|NCT03242863|76044926|FG001|STARTED|Study Week 3||15||
59926781|NCT03242863|76044927|FG002|STARTED|Study Week 3||4||
59926782|NCT03242863|76044928|FG003|STARTED|Study Week 3||4||
59926783|NCT03242863|76044929|FG004|STARTED|Study Week 3||12||
59926784|NCT03242863|76044930|FG005|STARTED|Study Week 3||5||
59926785|NCT03242863|76044925|FG000|COMPLETED|Study Week 3||13||
60060317|NCT02018887|76175539|FG008|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0||
59926786|NCT03242863|76044926|FG001|COMPLETED|Study Week 3||15||
59926787|NCT03242863|76044927|FG002|COMPLETED|Study Week 3||4||
59926788|NCT03242863|76044928|FG003|COMPLETED|Study Week 3||4||
59926789|NCT03242863|76044929|FG004|COMPLETED|Study Week 3||12||
60060318|NCT02018887|76175540|FG009|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0||
59516584|NCT00634088|75610262|FG003|STARTED|Time Period 2: Dose Level 2||0||
59760959|NCT00546871|75880616|FG001|STARTED|Part 2 - Subcutaneous (SC) IGIV, PK||35||
59760960|NCT00546871|75880615|FG000|COMPLETED|Part 2 - Subcutaneous (SC) IGIV, PK||12||
59760961|NCT00546871|75880616|FG001|COMPLETED|Part 2 - Subcutaneous (SC) IGIV, PK||32||
59760962|NCT00546871|75880615|FG000|NOT COMPLETED|Part 2 - Subcutaneous (SC) IGIV, PK||1||
59760963|NCT00546871|75880616|FG001|NOT COMPLETED|Part 2 - Subcutaneous (SC) IGIV, PK||3||
59760964|NCT00546871|75880615|FG000|STARTED|Part 3a- SC IGIV Adjusted Dose, PK Based||12||
59760965|NCT00546871|75880616|FG001|STARTED|Part 3a- SC IGIV Adjusted Dose, PK Based||32||
60060319|NCT02018887|76175541|FG010|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0||
60060320|NCT02018887|76175531|FG000|STARTED|Part C: Cohort 8 Overall||0||
60060321|NCT02018887|76175532|FG001|STARTED|Part C: Cohort 8 Overall||0||
60060322|NCT02018887|76175533|FG002|STARTED|Part C: Cohort 8 Overall|Placebo was not administered in this period.|0||
60060323|NCT02018887|76175534|FG003|STARTED|Part C: Cohort 8 Overall|This dose was not administered in this period.|0||
60060324|NCT02018887|76175535|FG004|STARTED|Part C: Cohort 8 Overall|This dose was not administered in this period.|0||
60060325|NCT02018887|76175536|FG005|STARTED|Part C: Cohort 8 Overall|This dose was not administered in this period.|0||
60060326|NCT02018887|76175537|FG006|STARTED|Part C: Cohort 8 Overall|This dose was not administered in this period.|0||
60060327|NCT02018887|76175538|FG007|STARTED|Part C: Cohort 8 Overall|This dose was not administered in this period.|0||
60060328|NCT02018887|76175539|FG008|STARTED|Part C: Cohort 8 Overall||10||
60060329|NCT02018887|76175540|FG009|STARTED|Part C: Cohort 8 Overall||4||
60060330|NCT02018887|76175541|FG010|STARTED|Part C: Cohort 8 Overall||7||
60060331|NCT02018887|76175531|FG000|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0||
60060332|NCT02018887|76175532|FG001|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0||
60060333|NCT02018887|76175533|FG002|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0||
60060334|NCT02018887|76175534|FG003|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0||
60060335|NCT02018887|76175535|FG004|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0||
60060336|NCT02018887|76175536|FG005|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0||
60060337|NCT02018887|76175537|FG006|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0||
60060338|NCT02018887|76175538|FG007|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0||
59760966|NCT00546871|75880615|FG000|COMPLETED|Part 3a- SC IGIV Adjusted Dose, PK Based||12||
59760967|NCT00546871|75880616|FG001|COMPLETED|Part 3a- SC IGIV Adjusted Dose, PK Based||32||
59760968|NCT00546871|75880615|FG000|NOT COMPLETED|Part 3a- SC IGIV Adjusted Dose, PK Based||0||
59760969|NCT00546871|75880616|FG001|NOT COMPLETED|Part 3a- SC IGIV Adjusted Dose, PK Based||0||
59760970|NCT00546871|75880615|FG000|STARTED|Part 3b - SC IGIV 12 Weeks||12||
59760971|NCT00546871|75880616|FG001|STARTED|Part 3b - SC IGIV 12 Weeks||32||
59760972|NCT00546871|75880615|FG000|COMPLETED|Part 3b - SC IGIV 12 Weeks||12||
59760973|NCT00546871|75880616|FG001|COMPLETED|Part 3b - SC IGIV 12 Weeks||32||
59760974|NCT00546871|75880615|FG000|NOT COMPLETED|Part 3b - SC IGIV 12 Weeks||0||
59760975|NCT00546871|75880616|FG001|NOT COMPLETED|Part 3b - SC IGIV 12 Weeks||0||
59760976|NCT00546871|75880615|FG000|STARTED|Study Extension Period|2 withdrawn after Part 3b|10||
59760977|NCT00546871|75880616|FG001|STARTED|Study Extension Period|6 withdrawn after Part 3b|26||
59760978|NCT00546871|75880615|FG000|COMPLETED|Study Extension Period||9||
59760979|NCT00546871|75880616|FG001|COMPLETED|Study Extension Period||25||
59760980|NCT00546871|75880615|FG000|NOT COMPLETED|Study Extension Period||1||
59760981|NCT00546871|75880616|FG001|NOT COMPLETED|Study Extension Period||1||
59760982|NCT03951805|75880649|FG000|STARTED|Overall Study||51||
59760983|NCT03951805|75880650|FG001|STARTED|Overall Study||51||
59760984|NCT03951805|75880651|FG002|STARTED|Overall Study||52||
59760985|NCT03951805|75880652|FG003|STARTED|Overall Study||51||
59760986|NCT03951805|75880649|FG000|Full Analysis Set (FAS)|Overall Study||51||
59760987|NCT03951805|75880650|FG001|Full Analysis Set (FAS)|Overall Study||51||
59760988|NCT03951805|75880651|FG002|Full Analysis Set (FAS)|Overall Study||52||
59760989|NCT03951805|75880652|FG003|Full Analysis Set (FAS)|Overall Study||51||
60060339|NCT02018887|76175539|FG008|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||10||
59760990|NCT03951805|75880649|FG000|Safety Analysis Set (SAS)|Overall Study||51||
59760991|NCT03951805|75880650|FG001|Safety Analysis Set (SAS)|Overall Study||51||
60060340|NCT02018887|76175540|FG009|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||4||
60060341|NCT02018887|76175541|FG010|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||7||
60060342|NCT02018887|76175531|FG000|COMPLETED|Part C: Cohort 8 Overall||0||
60060343|NCT02018887|76175532|FG001|COMPLETED|Part C: Cohort 8 Overall||0||
60060344|NCT02018887|76175533|FG002|COMPLETED|Part C: Cohort 8 Overall||0||
59760992|NCT03951805|75880651|FG002|Safety Analysis Set (SAS)|Overall Study||52||
59516585|NCT00634088|75610259|FG000|COMPLETED|Time Period 2: Dose Level 2||0||
59926790|NCT03242863|76044930|FG005|COMPLETED|Study Week 3||5||
60060345|NCT02018887|76175534|FG003|COMPLETED|Part C: Cohort 8 Overall||0||
60060346|NCT02018887|76175535|FG004|COMPLETED|Part C: Cohort 8 Overall||0||
60060347|NCT02018887|76175536|FG005|COMPLETED|Part C: Cohort 8 Overall||0||
60060348|NCT02018887|76175537|FG006|COMPLETED|Part C: Cohort 8 Overall||0||
60060349|NCT02018887|76175538|FG007|COMPLETED|Part C: Cohort 8 Overall||0||
59926791|NCT03242863|76044925|FG000|NOT COMPLETED|Study Week 3||0||
59926792|NCT03242863|76044926|FG001|NOT COMPLETED|Study Week 3||0||
59926793|NCT03242863|76044927|FG002|NOT COMPLETED|Study Week 3||0||
59926794|NCT03242863|76044928|FG003|NOT COMPLETED|Study Week 3||0||
59926795|NCT03242863|76044929|FG004|NOT COMPLETED|Study Week 3||0||
59926796|NCT03242863|76044930|FG005|NOT COMPLETED|Study Week 3||0||
59926797|NCT03044106|76044938|FG000|STARTED|Visit 1||22||
59926798|NCT03044106|76044939|FG001|STARTED|Visit 1||22||
59926799|NCT03044106|76044938|FG000|COMPLETED|Visit 1||22||
59926800|NCT03044106|76044939|FG001|COMPLETED|Visit 1||22||
59926801|NCT03044106|76044938|FG000|NOT COMPLETED|Visit 1||0||
59926802|NCT03044106|76044939|FG001|NOT COMPLETED|Visit 1||0||
59926803|NCT03044106|76044938|FG000|STARTED|Washout (1 Week)||22||
59926804|NCT03044106|76044939|FG001|STARTED|Washout (1 Week)||22||
59926805|NCT03044106|76044938|FG000|COMPLETED|Washout (1 Week)||22||
59926806|NCT03044106|76044939|FG001|COMPLETED|Washout (1 Week)||20||
59926807|NCT03044106|76044938|FG000|NOT COMPLETED|Washout (1 Week)||0||
59926808|NCT03044106|76044939|FG001|NOT COMPLETED|Washout (1 Week)||2||
59926809|NCT03044106|76044938|FG000|STARTED|Visit 2||22||
59926810|NCT03044106|76044939|FG001|STARTED|Visit 2||20||
59926811|NCT03044106|76044938|FG000|COMPLETED|Visit 2||22||
59926812|NCT03044106|76044939|FG001|COMPLETED|Visit 2||20||
59926813|NCT03044106|76044938|FG000|NOT COMPLETED|Visit 2||0||
59926814|NCT03044106|76044939|FG001|NOT COMPLETED|Visit 2||0||
59926815|NCT03170856|76044954|FG000|STARTED|Overall Study||20||
59926816|NCT03170856|76044955|FG001|STARTED|Overall Study||21||
59926817|NCT03170856|76044954|FG000|COMPLETED|Overall Study||17||
59926818|NCT03170856|76044955|FG001|COMPLETED|Overall Study||20||
59926819|NCT03170856|76044954|FG000|NOT COMPLETED|Overall Study||3||
59926820|NCT03170856|76044955|FG001|NOT COMPLETED|Overall Study||1||
59926821|NCT03043560|76044965|FG000|STARTED|Overall Study||21||
59926822|NCT03043560|76044966|FG001|STARTED|Overall Study||24||
59926823|NCT03043560|76044965|FG000|COMPLETED|Overall Study||20||
59926824|NCT03043560|76044966|FG001|COMPLETED|Overall Study||21||
59926825|NCT03043560|76044965|FG000|NOT COMPLETED|Overall Study||1||
59926826|NCT03043560|76044966|FG001|NOT COMPLETED|Overall Study||3||
59926827|NCT02145403|76044976|FG000|STARTED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||3|Started carfilzomib|
59926828|NCT02145403|76044977|FG001|STARTED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0|Started carfilzomib|
59926829|NCT02145403|76044978|FG002|STARTED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0|Started carfilzomib|
59926830|NCT02145403|76044979|FG003|STARTED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0|Started carfilzomib|
59926831|NCT02145403|76044976|FG000|COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||3|Completed all 4 doses of Carfilzomib|
59926832|NCT02145403|76044977|FG001|COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0|Completed all 4 doses of Carfilzomib|
59926833|NCT02145403|76044978|FG002|COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0|Completed all 4 doses of Carfilzomib|
59926834|NCT02145403|76044979|FG003|COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0|Completed all 4 doses of Carfilzomib|
59926835|NCT02145403|76044976|FG000|NOT COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0||
59926836|NCT02145403|76044977|FG001|NOT COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0||
59926837|NCT02145403|76044978|FG002|NOT COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0||
59926838|NCT02145403|76044979|FG003|NOT COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0||
59926839|NCT02145403|76044976|FG000|STARTED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0||
59926840|NCT02145403|76044977|FG001|STARTED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||3||
59926841|NCT02145403|76044978|FG002|STARTED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0||
59926842|NCT02145403|76044979|FG003|STARTED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0||
59926843|NCT02145403|76044976|FG000|COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0||
59926844|NCT02145403|76044977|FG001|COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||3||
59926845|NCT02145403|76044978|FG002|COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0||
59926846|NCT02145403|76044979|FG003|COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0||
59926847|NCT02145403|76044976|FG000|NOT COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0||
59926848|NCT02145403|76044977|FG001|NOT COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0||
59926849|NCT02145403|76044978|FG002|NOT COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0||
59926850|NCT02145403|76044979|FG003|NOT COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0||
59926851|NCT02145403|76044976|FG000|STARTED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0||
59926852|NCT02145403|76044977|FG001|STARTED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0||
59926853|NCT02145403|76044978|FG002|STARTED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||4||
59926854|NCT02145403|76044979|FG003|STARTED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0||
59926855|NCT02145403|76044976|FG000|COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0||
60060350|NCT02018887|76175539|FG008|COMPLETED|Part C: Cohort 8 Overall||7||
59926856|NCT02145403|76044977|FG001|COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0||
60060351|NCT02018887|76175540|FG009|COMPLETED|Part C: Cohort 8 Overall||1||
60067870|NCT01785615|76183055|FG003|NOT COMPLETED|Atorvastatin Phase||0||
60060352|NCT02018887|76175541|FG010|COMPLETED|Part C: Cohort 8 Overall||6||
60060353|NCT02018887|76175531|FG000|NOT COMPLETED|Part C: Cohort 8 Overall||0||
60060354|NCT02018887|76175532|FG001|NOT COMPLETED|Part C: Cohort 8 Overall||0||
60060355|NCT02018887|76175533|FG002|NOT COMPLETED|Part C: Cohort 8 Overall||0||
59516586|NCT00634088|75610260|FG001|COMPLETED|Time Period 2: Dose Level 2||0||
59516587|NCT00634088|75610261|FG002|COMPLETED|Time Period 2: Dose Level 2||0||
59516588|NCT00634088|75610262|FG003|COMPLETED|Time Period 2: Dose Level 2||0||
59516589|NCT00634088|75610259|FG000|NOT COMPLETED|Time Period 2: Dose Level 2||0||
59516590|NCT00634088|75610260|FG001|NOT COMPLETED|Time Period 2: Dose Level 2||3||
59516591|NCT00634088|75610261|FG002|NOT COMPLETED|Time Period 2: Dose Level 2||0||
59926857|NCT02145403|76044978|FG002|COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||3||
59926858|NCT02145403|76044979|FG003|COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0||
59926859|NCT02145403|76044976|FG000|NOT COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0||
59926860|NCT02145403|76044977|FG001|NOT COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0||
59926861|NCT02145403|76044978|FG002|NOT COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||1||
59926862|NCT02145403|76044979|FG003|NOT COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0||
59926863|NCT02145403|76044976|FG000|STARTED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0||
59926864|NCT02145403|76044977|FG001|STARTED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0||
59926865|NCT02145403|76044978|FG002|STARTED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0||
59926866|NCT02145403|76044979|FG003|STARTED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||4||
59926867|NCT02145403|76044976|FG000|COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0||
59926868|NCT02145403|76044977|FG001|COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0||
59926869|NCT02145403|76044978|FG002|COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0||
59926870|NCT02145403|76044979|FG003|COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||2||
59926871|NCT02145403|76044976|FG000|NOT COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0||
59926872|NCT02145403|76044977|FG001|NOT COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0||
59926873|NCT02145403|76044978|FG002|NOT COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0||
59926874|NCT02145403|76044979|FG003|NOT COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||2||
59926875|NCT02145403|76044976|FG000|STARTED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0||
59926876|NCT02145403|76044977|FG001|STARTED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0||
59926877|NCT02145403|76044978|FG002|STARTED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||37||
59926878|NCT02145403|76044979|FG003|STARTED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0||
59926879|NCT02145403|76044976|FG000|COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0||
59926880|NCT02145403|76044977|FG001|COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0||
59926881|NCT02145403|76044978|FG002|COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||36||
59926882|NCT02145403|76044979|FG003|COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0||
59926883|NCT02145403|76044976|FG000|NOT COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0||
59926884|NCT02145403|76044977|FG001|NOT COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0||
59926885|NCT02145403|76044978|FG002|NOT COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||1||
59926886|NCT02145403|76044979|FG003|NOT COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0||
59926887|NCT03255733|76044992|FG000|STARTED|Overall Study||29||
59926888|NCT03255733|76044992|FG000|COMPLETED|Overall Study||25||
59926889|NCT03255733|76044992|FG000|NOT COMPLETED|Overall Study||4||
59926890|NCT03255655|76044998|FG000|STARTED|Overall Study||29||
59926891|NCT03255655|76044999|FG001|STARTED|Overall Study||12||
59926892|NCT03255655|76044998|FG000|COMPLETED|Overall Study||22||
59926893|NCT03255655|76044999|FG001|COMPLETED|Overall Study||8||
59926894|NCT03255655|76044998|FG000|NOT COMPLETED|Overall Study||7||
59926895|NCT03255655|76044999|FG001|NOT COMPLETED|Overall Study||4||
59926896|NCT02899988|76045009|FG000|STARTED|Induction Period (16 Weeks)||52||
60060356|NCT02018887|76175534|FG003|NOT COMPLETED|Part C: Cohort 8 Overall||0||
60060357|NCT02018887|76175535|FG004|NOT COMPLETED|Part C: Cohort 8 Overall||0||
60060358|NCT02018887|76175536|FG005|NOT COMPLETED|Part C: Cohort 8 Overall||0||
60060359|NCT02018887|76175537|FG006|NOT COMPLETED|Part C: Cohort 8 Overall||0||
59926897|NCT02899988|76045010|FG001|STARTED|Induction Period (16 Weeks)||51||
59926898|NCT02899988|76045011|FG002|STARTED|Induction Period (16 Weeks)||51||
59926899|NCT02899988|76045012|FG003|STARTED|Induction Period (16 Weeks)||51||
59926900|NCT02899988|76045013|FG004|STARTED|Induction Period (16 Weeks)||0||
59926901|NCT02899988|76045014|FG005|STARTED|Induction Period (16 Weeks)||0||
60060360|NCT02018887|76175538|FG007|NOT COMPLETED|Part C: Cohort 8 Overall||0||
60060361|NCT02018887|76175539|FG008|NOT COMPLETED|Part C: Cohort 8 Overall||3||
60060362|NCT02018887|76175540|FG009|NOT COMPLETED|Part C: Cohort 8 Overall||3||
59926902|NCT02899988|76045015|FG006|STARTED|Induction Period (16 Weeks)||0||
59926903|NCT02899988|76045016|FG007|STARTED|Induction Period (16 Weeks)||0||
59926904|NCT02899988|76045017|FG008|STARTED|Induction Period (16 Weeks)||0||
59926905|NCT02899988|76045018|FG009|STARTED|Induction Period (16 Weeks)||0||
59926906|NCT02899988|76045019|FG010|STARTED|Induction Period (16 Weeks)||0||
59926907|NCT02899988|76045009|FG000|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||52||
59926908|NCT02899988|76045010|FG001|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||51||
59926909|NCT02899988|76045011|FG002|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||51||
59926910|NCT02899988|76045012|FG003|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||51||
59926911|NCT02899988|76045013|FG004|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0||
60060363|NCT02018887|76175541|FG010|NOT COMPLETED|Part C: Cohort 8 Overall||1||
60060364|NCT02030041|76175610|FG000|STARTED|Overall Study||11||
60060365|NCT02030041|76175611|FG001|STARTED|Overall Study||11||
60060366|NCT02030041|76175612|FG002|STARTED|Overall Study||11||
60060367|NCT02030041|76175610|FG000|COMPLETED|Overall Study||9||
60060368|NCT02030041|76175611|FG001|COMPLETED|Overall Study||9||
60060369|NCT02030041|76175612|FG002|COMPLETED|Overall Study||10||
60060370|NCT02030041|76175610|FG000|NOT COMPLETED|Overall Study||2||
60060371|NCT02030041|76175611|FG001|NOT COMPLETED|Overall Study||2||
60060372|NCT02030041|76175612|FG002|NOT COMPLETED|Overall Study||1||
60060373|NCT01994720|76175622|FG000|STARTED|Overall Study||6589||
60060374|NCT01994720|76175623|FG001|STARTED|Overall Study||6610||
60060375|NCT01994720|76175622|FG000|COMPLETED|Overall Study|Includes patients who did not withdraw informed consent prior to the Study Closure Visit|6543||
60060376|NCT01994720|76175623|FG001|COMPLETED|Overall Study|Includes patients who did not withdraw informed consent prior to the Study Closure Visit|6554||
60060377|NCT01994720|76175622|FG000|NOT COMPLETED|Overall Study||46||
60060378|NCT01994720|76175623|FG001|NOT COMPLETED|Overall Study||56||
60060379|NCT01814397|76175629|FG000|STARTED|Overall Study||50||
60060380|NCT01814397|76175629|FG000|3 Month Evaluation|Overall Study||43||
60060381|NCT01814397|76175629|FG000|COMPLETED|Overall Study||36||
60060382|NCT01814397|76175629|FG000|NOT COMPLETED|Overall Study||14||
60060383|NCT01814007|76175633|FG000|STARTED|Overall Study||35||
60060384|NCT01814007|76175633|FG000|COMPLETED|Overall Study||34||
60060385|NCT01814007|76175633|FG000|NOT COMPLETED|Overall Study||1||
60060386|NCT01844115|76175640|FG000|STARTED|Overall Study||202||
60060387|NCT01844115|76175641|FG001|STARTED|Overall Study||202||
60060388|NCT01844115|76175640|FG000|COMPLETED|Overall Study||163||
60060389|NCT01844115|76175641|FG001|COMPLETED|Overall Study||144||
60060390|NCT01844115|76175640|FG000|NOT COMPLETED|Overall Study||39||
60060391|NCT01844115|76175641|FG001|NOT COMPLETED|Overall Study||58||
60060392|NCT02018042|76175647|FG000|STARTED|Overall Study||15||
60060393|NCT02018042|76175647|FG000|COMPLETED|Overall Study||14||
60060394|NCT02018042|76175647|FG000|NOT COMPLETED|Overall Study||1||
60060395|NCT01813305|76175653|FG000|STARTED|Overall Study||98||
60060396|NCT01813305|76175654|FG001|STARTED|Overall Study||26||
60060397|NCT01813305|76175653|FG000|COMPLETED|Overall Study||63||
60060398|NCT01813305|76175654|FG001|COMPLETED|Overall Study||18||
60060399|NCT01813305|76175653|FG000|NOT COMPLETED|Overall Study||35||
60060400|NCT01813305|76175654|FG001|NOT COMPLETED|Overall Study||8||
60060401|NCT01993940|76175664|FG000|STARTED|Overall Study|Includes one participant who enrolled at two different sites|277||
60060402|NCT01993940|76175665|FG001|STARTED|Overall Study|Includes two participants who each enrolled at two different sites|276||
60060403|NCT01993940|76175664|FG000|Received Treatment|Overall Study||272||
60060404|NCT01993940|76175665|FG001|Received Treatment|Overall Study||276||
60060405|NCT01993940|76175664|FG000|COMPLETED|Overall Study||237||
60060406|NCT01993940|76175665|FG001|COMPLETED|Overall Study||232||
60060407|NCT01993940|76175664|FG000|NOT COMPLETED|Overall Study||40||
60060408|NCT01993940|76175665|FG001|NOT COMPLETED|Overall Study||44||
60060409|NCT01843803|76175673|FG000|STARTED|Overall Study||137||
60060410|NCT01843803|76175674|FG001|STARTED|Overall Study||139||
60060411|NCT01843803|76175673|FG000|COMPLETED|Overall Study||136||
60060412|NCT01843803|76175674|FG001|COMPLETED|Overall Study||136||
60060413|NCT01843803|76175673|FG000|NOT COMPLETED|Overall Study||1||
60060414|NCT01843803|76175674|FG001|NOT COMPLETED|Overall Study||3||
60060415|NCT02017171|76175682|FG000|STARTED|Overall Study||267||
60060416|NCT02017171|76175683|FG001|STARTED|Overall Study||263||
60060417|NCT02017171|76175682|FG000|COMPLETED|Overall Study||205||
60060418|NCT02017171|76175683|FG001|COMPLETED|Overall Study||217||
60060419|NCT02017171|76175682|FG000|NOT COMPLETED|Overall Study||62||
60060420|NCT02017171|76175683|FG001|NOT COMPLETED|Overall Study||46||
60060421|NCT02029417|76175690|FG000|STARTED|Overall Study||2||
60060422|NCT02029417|76175690|FG000|COMPLETED|Overall Study||0||
60060423|NCT02029417|76175690|FG000|NOT COMPLETED|Overall Study||2||
60060424|NCT02016716|76175697|FG000|STARTED|Overall Study||53||
60060425|NCT02016716|76175698|FG001|STARTED|Overall Study||118||
60060426|NCT02016716|76175699|FG002|STARTED|Overall Study||123||
60060427|NCT02016716|76175697|FG000|Received Study Treatment|Overall Study||53||
60060428|NCT02016716|76175698|FG001|Received Study Treatment|Overall Study||118||
60060429|NCT02016716|76175699|FG002|Received Study Treatment|Overall Study||123||
60060430|NCT02016716|76175697|FG000|COMPLETED|Overall Study||47||
60060431|NCT02016716|76175698|FG001|COMPLETED|Overall Study||110||
60060432|NCT02016716|76175699|FG002|COMPLETED|Overall Study||117||
60060433|NCT02016716|76175697|FG000|NOT COMPLETED|Overall Study||6||
60060434|NCT02016716|76175698|FG001|NOT COMPLETED|Overall Study||8||
60060435|NCT02016716|76175699|FG002|NOT COMPLETED|Overall Study||6||
60060436|NCT02050321|76175708|FG000|STARTED|Overall Study||2||
60060437|NCT02050321|76175708|FG000|COMPLETED|Overall Study||0||
60060438|NCT02050321|76175708|FG000|NOT COMPLETED|Overall Study||2||
60060439|NCT02039414|76175714|FG000|STARTED|Overall Study||22||
60060440|NCT02039414|76175715|FG001|STARTED|Overall Study||18||
60060441|NCT02039414|76175714|FG000|COMPLETED|Overall Study||16||
59926912|NCT02899988|76045014|FG005|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0||
59926913|NCT02899988|76045015|FG006|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0||
59926914|NCT02899988|76045016|FG007|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0||
59926915|NCT02899988|76045017|FG008|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0||
59926916|NCT02899988|76045018|FG009|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0||
60060442|NCT02039414|76175715|FG001|COMPLETED|Overall Study||16||
60060443|NCT02039414|76175714|FG000|NOT COMPLETED|Overall Study||6||
60060444|NCT02039414|76175715|FG001|NOT COMPLETED|Overall Study||2||
60060445|NCT02017015|76175721|FG000|STARTED|Overall Study||83||
60060446|NCT02017015|76175721|FG000|Safety Population|Overall Study||83||
60060447|NCT02017015|76175721|FG000|COMPLETED|Overall Study|Completed = Participants remaining on treatment at the time of the data cut-off of 01 Jun 2015|14||
60060448|NCT02017015|76175721|FG000|NOT COMPLETED|Overall Study||69||
60060449|NCT02016625|76175728|FG000|STARTED|Cyclo or Tac (Single Dose, Day 1)||16||
60060450|NCT02016625|76175729|FG001|STARTED|Cyclo or Tac (Single Dose, Day 1)||16||
59926917|NCT02899988|76045019|FG010|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0||
59926918|NCT02899988|76045009|FG000|COMPLETED|Induction Period (16 Weeks)||50||
59926919|NCT02899988|76045010|FG001|COMPLETED|Induction Period (16 Weeks)||49||
59926920|NCT02899988|76045011|FG002|COMPLETED|Induction Period (16 Weeks)||51||
59926921|NCT02899988|76045012|FG003|COMPLETED|Induction Period (16 Weeks)||49||
60060451|NCT02016625|76175728|FG000|COMPLETED|Cyclo or Tac (Single Dose, Day 1)||16||
59926922|NCT02899988|76045013|FG004|COMPLETED|Induction Period (16 Weeks)||0||
59926923|NCT02899988|76045014|FG005|COMPLETED|Induction Period (16 Weeks)||0||
60060452|NCT02016625|76175729|FG001|COMPLETED|Cyclo or Tac (Single Dose, Day 1)||15||
60060453|NCT02016625|76175728|FG000|NOT COMPLETED|Cyclo or Tac (Single Dose, Day 1)||0||
60060454|NCT02016625|76175729|FG001|NOT COMPLETED|Cyclo or Tac (Single Dose, Day 1)||1||
60060455|NCT02016625|76175728|FG000|STARTED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||16||
60060456|NCT02016625|76175729|FG001|STARTED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||15||
60060457|NCT02016625|76175728|FG000|COMPLETED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||13||
59926924|NCT02899988|76045015|FG006|COMPLETED|Induction Period (16 Weeks)||0||
59926925|NCT02899988|76045016|FG007|COMPLETED|Induction Period (16 Weeks)||0||
59926926|NCT02899988|76045017|FG008|COMPLETED|Induction Period (16 Weeks)||0||
59926927|NCT02899988|76045018|FG009|COMPLETED|Induction Period (16 Weeks)||0||
59926928|NCT02899988|76045019|FG010|COMPLETED|Induction Period (16 Weeks)||0||
59926929|NCT02899988|76045009|FG000|NOT COMPLETED|Induction Period (16 Weeks)||2||
59926930|NCT02899988|76045010|FG001|NOT COMPLETED|Induction Period (16 Weeks)||2||
59926931|NCT02899988|76045011|FG002|NOT COMPLETED|Induction Period (16 Weeks)||0||
59926932|NCT02899988|76045012|FG003|NOT COMPLETED|Induction Period (16 Weeks)||2||
59926933|NCT02899988|76045013|FG004|NOT COMPLETED|Induction Period (16 Weeks)||0||
59926934|NCT02899988|76045014|FG005|NOT COMPLETED|Induction Period (16 Weeks)||0||
59926935|NCT02899988|76045015|FG006|NOT COMPLETED|Induction Period (16 Weeks)||0||
59926936|NCT02899988|76045016|FG007|NOT COMPLETED|Induction Period (16 Weeks)||0||
59926937|NCT02899988|76045017|FG008|NOT COMPLETED|Induction Period (16 Weeks)||0||
59926938|NCT02899988|76045018|FG009|NOT COMPLETED|Induction Period (16 Weeks)||0||
60060458|NCT02016625|76175729|FG001|COMPLETED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||15||
60060459|NCT02016625|76175728|FG000|NOT COMPLETED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||3||
59926939|NCT02899988|76045019|FG010|NOT COMPLETED|Induction Period (16 Weeks)||0||
59926940|NCT02899988|76045009|FG000|STARTED|Maintenance Period (88 Weeks)|No participants received placebo during maintenance period.|0||
59926941|NCT02899988|76045010|FG001|STARTED|Maintenance Period (88 Weeks)|No participants received 30 mg mirikizumab Q8W in both induction and maintenance.|0||
59926942|NCT02899988|76045011|FG002|STARTED|Maintenance Period (88 Weeks)|No participants received 100 mg mirikizumab Q8W in both induction and maintenance.|0||
59926943|NCT02899988|76045012|FG003|STARTED|Maintenance Period (88 Weeks)||0||
59926944|NCT02899988|76045013|FG004|STARTED|Maintenance Period (88 Weeks)|Participants received 30 mg mirikizumab Q8W during induction period.|15||
59926945|NCT02899988|76045014|FG005|STARTED|Maintenance Period (88 Weeks)|Participants received 100 mg mirikizumab Q8W during induction period.|30||
59926946|NCT02899988|76045015|FG006|STARTED|Maintenance Period (88 Weeks)|Participants received 300 mg mirikizumab Q8W during induction period.|34||
59926947|NCT02899988|76045016|FG007|STARTED|Maintenance Period (88 Weeks)|Participants received placebo during induction period.|50||
59926948|NCT02899988|76045017|FG008|STARTED|Maintenance Period (88 Weeks)|Participants received 30 mg mirikizumab Q8W during induction arm.|34||
59926949|NCT02899988|76045018|FG009|STARTED|Maintenance Period (88 Weeks)|Participants received 100 mg mirikizumab Q8W during induction arm.|21||
59926950|NCT02899988|76045019|FG010|STARTED|Maintenance Period (88 Weeks)|Participants received 300 mg mirikizumab Q8W during induction arm.|15||
59926951|NCT02899988|76045009|FG000|Rescue Participants|Maintenance Period (88 Weeks)||0||
59926952|NCT02899988|76045010|FG001|Rescue Participants|Maintenance Period (88 Weeks)||0||
59926953|NCT02899988|76045011|FG002|Rescue Participants|Maintenance Period (88 Weeks)||0||
59926954|NCT02899988|76045012|FG003|Rescue Participants|Maintenance Period (88 Weeks)|In PRN not regaining ≥ PASI 90 after 3 consecutive doses of drug or have < PASI 50 after 1 dose.|10||
59926955|NCT02899988|76045013|FG004|Rescue Participants|Maintenance Period (88 Weeks)||0||
60060460|NCT02016625|76175729|FG001|NOT COMPLETED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||0||
60060461|NCT02016482|76175747|FG000|STARTED|Period A||108||
60060462|NCT02016482|76175748|FG001|STARTED|Period A||109||
60060463|NCT02016482|76175747|FG000|COMPLETED|Period A|56 participants early escaped to the end of Period A and 38 continued to the end of Period A.|94||
60060464|NCT02016482|76175748|FG001|COMPLETED|Period A|8 participants early escaped to the end of Period A and 86 continued to the end of Period A.|94||
60060465|NCT02016482|76175747|FG000|NOT COMPLETED|Period A||14||
60060466|NCT02016482|76175748|FG001|NOT COMPLETED|Period A||15||
60060467|NCT02016482|76175747|FG000|STARTED|Period B||94||
60060468|NCT02016482|76175748|FG001|STARTED|Period B||94||
60060469|NCT02016482|76175747|FG000|COMPLETED|Period B||81||
60060470|NCT02016482|76175748|FG001|COMPLETED|Period B||87||
60060471|NCT02016482|76175747|FG000|NOT COMPLETED|Period B||13||
60060472|NCT02016482|76175748|FG001|NOT COMPLETED|Period B||7||
60060473|NCT02028871|76175758|FG000|STARTED|Overall Study||14||
60060474|NCT02028871|76175759|FG001|STARTED|Overall Study||12||
60060475|NCT02028871|76175758|FG000|COMPLETED|Overall Study||10||
60060476|NCT02028871|76175759|FG001|COMPLETED|Overall Study||9||
60060477|NCT02028871|76175758|FG000|NOT COMPLETED|Overall Study||4||
60060478|NCT02028871|76175759|FG001|NOT COMPLETED|Overall Study||3||
60060479|NCT02028715|76175770|FG000|STARTED|Overall Study||34||
60060480|NCT02028715|76175771|FG001|STARTED|Overall Study||34||
60060481|NCT02028715|76175770|FG000|COMPLETED|Overall Study||29||
60060482|NCT02028715|76175771|FG001|COMPLETED|Overall Study||30||
60060483|NCT02028715|76175770|FG000|NOT COMPLETED|Overall Study||5||
60060484|NCT02028715|76175771|FG001|NOT COMPLETED|Overall Study||4||
60060485|NCT02016170|76175780|FG000|STARTED|Overall Study||27||
60060486|NCT02016170|76175781|FG001|STARTED|Overall Study||28||
60060487|NCT02016170|76175782|FG002|STARTED|Overall Study||27||
60060488|NCT02016170|76175780|FG000|COMPLETED|Overall Study||25||
60060489|NCT02016170|76175781|FG001|COMPLETED|Overall Study||27||
60060490|NCT02016170|76175782|FG002|COMPLETED|Overall Study||27||
60060491|NCT02016170|76175780|FG000|NOT COMPLETED|Overall Study||2||
60060492|NCT02016170|76175781|FG001|NOT COMPLETED|Overall Study||1||
60060493|NCT02016170|76175782|FG002|NOT COMPLETED|Overall Study||0||
60060494|NCT02028169|76175789|FG000|STARTED|Overall Study||120||
60060495|NCT02028169|76175789|FG000|COMPLETED|Overall Study||92||
60060496|NCT02028169|76175789|FG000|NOT COMPLETED|Overall Study||28||
60060497|NCT02015546|76175796|FG000|STARTED|Overall Study||23||
60060498|NCT02015546|76175797|FG001|STARTED|Overall Study||21||
60060499|NCT02015546|76175798|FG002|STARTED|Overall Study||26||
60060500|NCT02015546|76175796|FG000|COMPLETED|Overall Study||20||
60060501|NCT02015546|76175797|FG001|COMPLETED|Overall Study||19||
60060502|NCT02015546|76175798|FG002|COMPLETED|Overall Study||22||
60060503|NCT02015546|76175796|FG000|NOT COMPLETED|Overall Study||3||
60060504|NCT02015546|76175797|FG001|NOT COMPLETED|Overall Study||2||
60060505|NCT02015546|76175798|FG002|NOT COMPLETED|Overall Study||4||
60060506|NCT02027701|76175806|FG000|STARTED|Overall Study||82||
60060507|NCT02027701|76175806|FG000|COMPLETED|Overall Study||66||
60060508|NCT02027701|76175806|FG000|NOT COMPLETED|Overall Study||16||
60060509|NCT02038790|76175812|FG000|STARTED|Day 0 - First Treatment||16||
60060510|NCT02038790|76175813|FG001|STARTED|Day 0 - First Treatment||17||
60060511|NCT02038790|76175812|FG000|COMPLETED|Day 0 - First Treatment||15||
60060512|NCT02038790|76175813|FG001|COMPLETED|Day 0 - First Treatment||16||
60060513|NCT02038790|76175812|FG000|NOT COMPLETED|Day 0 - First Treatment||1||
60060514|NCT02038790|76175813|FG001|NOT COMPLETED|Day 0 - First Treatment||1||
60060515|NCT02038790|76175812|FG000|STARTED|Day 1 - Second Treatment||15||
60060516|NCT02038790|76175813|FG001|STARTED|Day 1 - Second Treatment||16||
60060517|NCT02038790|76175812|FG000|COMPLETED|Day 1 - Second Treatment||15||
60060518|NCT02038790|76175813|FG001|COMPLETED|Day 1 - Second Treatment||16||
60060519|NCT02038790|76175812|FG000|NOT COMPLETED|Day 1 - Second Treatment||0||
60060520|NCT02038790|76175813|FG001|NOT COMPLETED|Day 1 - Second Treatment||0||
60060521|NCT02027623|76175822|FG000|STARTED|Overall Study||77||
60060522|NCT02027623|76175823|FG001|STARTED|Overall Study||77||
60060523|NCT02027623|76175822|FG000|COMPLETED|Overall Study||68||
60060524|NCT02027623|76175823|FG001|COMPLETED|Overall Study||65||
60060525|NCT02027623|76175822|FG000|NOT COMPLETED|Overall Study||9||
60060526|NCT02027623|76175823|FG001|NOT COMPLETED|Overall Study||12||
60060527|NCT02015221|76175832|FG000|STARTED|Overall Study||41||
60060528|NCT02015221|76175833|FG001|STARTED|Overall Study||40||
60060529|NCT02015221|76175832|FG000|COMPLETED|Overall Study||32||
60060530|NCT02015221|76175833|FG001|COMPLETED|Overall Study||34||
60060531|NCT02015221|76175832|FG000|NOT COMPLETED|Overall Study||9||
60060532|NCT02015221|76175833|FG001|NOT COMPLETED|Overall Study||6||
60060533|NCT02027311|76175841|FG000|STARTED|Overall Study||33||
60060534|NCT02027311|76175842|FG001|STARTED|Overall Study||35||
60060535|NCT02027311|76175841|FG000|COMPLETED|Overall Study|1 case was dropped due to hypotension and 2 were desaturation.|30||
60060536|NCT02027311|76175842|FG001|COMPLETED|Overall Study|1 cases was dropped due to tachycardia and 1 were desaturation.|33||
60060537|NCT02027311|76175841|FG000|NOT COMPLETED|Overall Study||3||
60060538|NCT02027311|76175842|FG001|NOT COMPLETED|Overall Study||2||
60060539|NCT02047903|76175850|FG000|STARTED|Overall Study||161||
60060540|NCT02047903|76175850|FG000|Treated|Overall Study||152||
60060541|NCT02047903|76175850|FG000|COMPLETED|Overall Study||102||
60060542|NCT02047903|76175850|FG000|NOT COMPLETED|Overall Study||59||
60060543|NCT02015065|76175857|FG000|STARTED|Overall Study||2||
60060544|NCT02015065|76175858|FG001|STARTED|Overall Study||5||
60060545|NCT02015065|76175859|FG002|STARTED|Overall Study||2||
60060546|NCT02015065|76175857|FG000|COMPLETED|Overall Study||1||
60060547|NCT02015065|76175858|FG001|COMPLETED|Overall Study||3||
59516592|NCT00634088|75610262|FG003|NOT COMPLETED|Time Period 2: Dose Level 2||0||
59516593|NCT00634088|75610259|FG000|STARTED|Time Period 3: Dose Level 3||0||
59516594|NCT00634088|75610260|FG001|STARTED|Time Period 3: Dose Level 3||0||
59516595|NCT00634088|75610261|FG002|STARTED|Time Period 3: Dose Level 3||1||
59516596|NCT00634088|75610262|FG003|STARTED|Time Period 3: Dose Level 3||0||
59516597|NCT00634088|75610259|FG000|COMPLETED|Time Period 3: Dose Level 3||0||
59516598|NCT00634088|75610260|FG001|COMPLETED|Time Period 3: Dose Level 3||0||
59516599|NCT00634088|75610261|FG002|COMPLETED|Time Period 3: Dose Level 3||0||
59516600|NCT00634088|75610262|FG003|COMPLETED|Time Period 3: Dose Level 3||0||
59516601|NCT00634088|75610259|FG000|NOT COMPLETED|Time Period 3: Dose Level 3||0||
60060548|NCT02015065|76175859|FG002|COMPLETED|Overall Study||1||
60060549|NCT02015065|76175857|FG000|NOT COMPLETED|Overall Study||1||
60060550|NCT02015065|76175858|FG001|NOT COMPLETED|Overall Study||2||
60060551|NCT02015065|76175859|FG002|NOT COMPLETED|Overall Study||1||
60060552|NCT02026141|76175869|FG000|STARTED|Overall Study||20||
60060553|NCT02026141|76175870|FG001|STARTED|Overall Study||20||
60060554|NCT02026141|76175869|FG000|COMPLETED|Overall Study||20||
60060555|NCT02026141|76175870|FG001|COMPLETED|Overall Study||19||
60060556|NCT02026141|76175869|FG000|NOT COMPLETED|Overall Study||0||
60060557|NCT02026141|76175870|FG001|NOT COMPLETED|Overall Study||1||
60060558|NCT02026063|76175878|FG000|STARTED|Overall Study||22||
60060559|NCT02026063|76175879|FG001|STARTED|Overall Study||102||
60060560|NCT02026063|76175878|FG000|COMPLETED|Overall Study||13||
60060561|NCT02026063|76175879|FG001|COMPLETED|Overall Study||53||
60060562|NCT02026063|76175878|FG000|NOT COMPLETED|Overall Study||9||
60060563|NCT02026063|76175879|FG001|NOT COMPLETED|Overall Study||49||
60060564|NCT02025907|76175888|FG000|STARTED|Overall Study|Participant flow is presented for safety population.|108||
60060565|NCT02025907|76175889|FG001|STARTED|Overall Study|Participant flow is presented for safety population.|108||
60060566|NCT02025907|76175888|FG000|COMPLETED|Overall Study||81||
60060567|NCT02025907|76175889|FG001|COMPLETED|Overall Study||96||
60060568|NCT02025907|76175888|FG000|NOT COMPLETED|Overall Study||27||
60060569|NCT02025907|76175889|FG001|NOT COMPLETED|Overall Study||12||
60060570|NCT01813071|76175904|FG000|STARTED|Overall Study||10||
60060571|NCT01813071|76175905|FG001|STARTED|Overall Study||10||
60060572|NCT01813071|76175906|FG002|STARTED|Overall Study||10||
60060573|NCT01813071|76175907|FG003|STARTED|Overall Study||9||
60060574|NCT01813071|76175908|FG004|STARTED|Overall Study||12||
60060575|NCT01813071|76175909|FG005|STARTED|Overall Study||12||
60060576|NCT01813071|76175910|FG006|STARTED|Overall Study||12||
60060577|NCT01813071|76175911|FG007|STARTED|Overall Study||12||
60060578|NCT01813071|76175912|FG008|STARTED|Overall Study||16||
60060579|NCT01813071|76175904|FG000|COMPLETED|Overall Study||10||
60060580|NCT01813071|76175905|FG001|COMPLETED|Overall Study||10||
60060581|NCT01813071|76175906|FG002|COMPLETED|Overall Study||10||
60060582|NCT01813071|76175907|FG003|COMPLETED|Overall Study||9||
60060583|NCT01813071|76175908|FG004|COMPLETED|Overall Study||11||
60060584|NCT01813071|76175909|FG005|COMPLETED|Overall Study||5||
60060585|NCT01813071|76175910|FG006|COMPLETED|Overall Study||9||
60060586|NCT01813071|76175911|FG007|COMPLETED|Overall Study||7||
60060587|NCT01813071|76175912|FG008|COMPLETED|Overall Study||13||
60060588|NCT01813071|76175904|FG000|NOT COMPLETED|Overall Study||0||
60060589|NCT01813071|76175905|FG001|NOT COMPLETED|Overall Study||0||
60060590|NCT01813071|76175906|FG002|NOT COMPLETED|Overall Study||0||
60060591|NCT01813071|76175907|FG003|NOT COMPLETED|Overall Study||0||
60060592|NCT01813071|76175908|FG004|NOT COMPLETED|Overall Study||1||
60060593|NCT01813071|76175909|FG005|NOT COMPLETED|Overall Study||7||
60060594|NCT01813071|76175910|FG006|NOT COMPLETED|Overall Study||3||
60060595|NCT01813071|76175911|FG007|NOT COMPLETED|Overall Study||5||
60060596|NCT01813071|76175912|FG008|NOT COMPLETED|Overall Study||3||
60060597|NCT02025751|76175948|FG000|STARTED|Overall Study||26||
60060598|NCT02025751|76175949|FG001|STARTED|Overall Study||27||
60060599|NCT02025751|76175948|FG000|COMPLETED|Overall Study||25||
60060600|NCT02025751|76175949|FG001|COMPLETED|Overall Study||24||
60060601|NCT02025751|76175948|FG000|NOT COMPLETED|Overall Study||1||
60060602|NCT02025751|76175949|FG001|NOT COMPLETED|Overall Study||3||
60060603|NCT02025205|76175957|FG000|STARTED|Overall Study||43||
60060604|NCT02025205|76175958|FG001|STARTED|Overall Study||50||
60060605|NCT02025205|76175957|FG000|COMPLETED|Overall Study||40||
59516602|NCT00634088|75610260|FG001|NOT COMPLETED|Time Period 3: Dose Level 3||0||
59516603|NCT00634088|75610261|FG002|NOT COMPLETED|Time Period 3: Dose Level 3||1||
59516604|NCT00634088|75610262|FG003|NOT COMPLETED|Time Period 3: Dose Level 3||0||
59516605|NCT00634088|75610259|FG000|STARTED|Time Period 4: Triplet Combination||0||
60060606|NCT02025205|76175958|FG001|COMPLETED|Overall Study||47||
60060607|NCT02025205|76175957|FG000|NOT COMPLETED|Overall Study||3||
60060608|NCT02025205|76175958|FG001|NOT COMPLETED|Overall Study||3||
60060609|NCT01812837|76175967|FG000|STARTED|Overall Study||17||
60060610|NCT01812837|76175968|FG001|STARTED|Overall Study||17||
60060611|NCT01812837|76175969|FG002|STARTED|Overall Study||17||
60060612|NCT01812837|76175967|FG000|COMPLETED|Overall Study||15||
60060613|NCT01812837|76175968|FG001|COMPLETED|Overall Study||16||
60060614|NCT01812837|76175969|FG002|COMPLETED|Overall Study||17||
60060615|NCT01812837|76175967|FG000|NOT COMPLETED|Overall Study||2||
60060616|NCT01812837|76175968|FG001|NOT COMPLETED|Overall Study||1||
60060617|NCT01812837|76175969|FG002|NOT COMPLETED|Overall Study||0||
60060618|NCT02024971|76175977|FG000|STARTED|Overall Study||1103||
60060619|NCT02024971|76175977|FG000|Safety Analysis Set|Overall Study|All participants with available data who were enrolled prior to Day 15 of the start of treatment.|1067||
60060620|NCT02024971|76175977|FG000|COMPLETED|Overall Study|Including 162 patients with missing efficacy data at two or more time points.|1067||
60060621|NCT02024971|76175977|FG000|NOT COMPLETED|Overall Study||36||
60060622|NCT01843023|76175983|FG000|STARTED|Overall Study||144||
60060623|NCT01843023|76175984|FG001|STARTED|Overall Study||144||
60060624|NCT01843023|76175983|FG000|3 Months|Overall Study||110||
60060625|NCT01843023|76175984|FG001|3 Months|Overall Study||114||
60060626|NCT01843023|76175983|FG000|COMPLETED|Overall Study||111||
60060627|NCT01843023|76175984|FG001|COMPLETED|Overall Study||109||
60060628|NCT01843023|76175983|FG000|NOT COMPLETED|Overall Study||33||
60060629|NCT01843023|76175984|FG001|NOT COMPLETED|Overall Study||35||
60060630|NCT01812759|76175993|FG000|STARTED|Overall Study||1||
60060631|NCT01812759|76175994|FG001|STARTED|Overall Study||1||
60060632|NCT01812759|76175995|FG002|STARTED|Overall Study||1||
60060633|NCT01812759|76175993|FG000|COMPLETED|Overall Study||1||
60060634|NCT01812759|76175994|FG001|COMPLETED|Overall Study||1||
60060635|NCT01812759|76175995|FG002|COMPLETED|Overall Study||0||
60060636|NCT01812759|76175993|FG000|NOT COMPLETED|Overall Study||0||
60060637|NCT01812759|76175994|FG001|NOT COMPLETED|Overall Study||0||
60060638|NCT01812759|76175995|FG002|NOT COMPLETED|Overall Study||1||
60060639|NCT01812057|76176005|FG000|STARTED|Overall Study||25||
60060640|NCT01812057|76176006|FG001|STARTED|Overall Study||24||
60060641|NCT01812057|76176005|FG000|COMPLETED|Overall Study||23||
60060642|NCT01812057|76176006|FG001|COMPLETED|Overall Study||24||
60060643|NCT01812057|76176005|FG000|NOT COMPLETED|Overall Study||2||
60060644|NCT01812057|76176006|FG001|NOT COMPLETED|Overall Study||0||
60060645|NCT01842633|76176019|FG000|STARTED|Overall Study||65||
60060646|NCT01842633|76176020|FG001|STARTED|Overall Study||66||
60060647|NCT01842633|76176021|FG002|STARTED|Overall Study||34||
60060648|NCT01842633|76176019|FG000|COMPLETED|Overall Study||62||
60060649|NCT01842633|76176020|FG001|COMPLETED|Overall Study||64||
60060650|NCT01842633|76176021|FG002|COMPLETED|Overall Study||34||
60060651|NCT01842633|76176019|FG000|NOT COMPLETED|Overall Study||3||
60060652|NCT01842633|76176020|FG001|NOT COMPLETED|Overall Study||2||
60060653|NCT01842633|76176021|FG002|NOT COMPLETED|Overall Study||0||
60060654|NCT01810263|76176033|FG000|STARTED|Overall Study||16||
59516606|NCT00634088|75610260|FG001|STARTED|Time Period 4: Triplet Combination||0||
59516607|NCT00634088|75610261|FG002|STARTED|Time Period 4: Triplet Combination||0||
59516608|NCT00634088|75610262|FG003|STARTED|Time Period 4: Triplet Combination||0||
59926956|NCT02899988|76045014|FG005|Rescue Participants|Maintenance Period (88 Weeks)||0||
59926957|NCT02899988|76045015|FG006|Rescue Participants|Maintenance Period (88 Weeks)||0||
59926958|NCT02899988|76045016|FG007|Rescue Participants|Maintenance Period (88 Weeks)||0||
59926959|NCT02899988|76045017|FG008|Rescue Participants|Maintenance Period (88 Weeks)||0||
59926960|NCT02899988|76045018|FG009|Rescue Participants|Maintenance Period (88 Weeks)||0||
59926961|NCT02899988|76045019|FG010|Rescue Participants|Maintenance Period (88 Weeks)||0||
59926962|NCT02899988|76045009|FG000|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||0||
59516609|NCT00634088|75610259|FG000|COMPLETED|Time Period 4: Triplet Combination||0||
59516610|NCT00634088|75610260|FG001|COMPLETED|Time Period 4: Triplet Combination||0||
59516611|NCT00634088|75610261|FG002|COMPLETED|Time Period 4: Triplet Combination||0||
59516612|NCT00634088|75610262|FG003|COMPLETED|Time Period 4: Triplet Combination||0||
59926963|NCT02899988|76045010|FG001|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||0||
59926964|NCT02899988|76045011|FG002|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||0||
59926965|NCT02899988|76045012|FG003|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||13||
59926966|NCT02899988|76045013|FG004|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||9||
59926967|NCT02899988|76045014|FG005|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||18||
59926968|NCT02899988|76045015|FG006|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||26||
59926969|NCT02899988|76045016|FG007|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||42||
60060655|NCT01810263|76176034|FG001|STARTED|Overall Study||18||
60060656|NCT01810263|76176033|FG000|COMPLETED|Overall Study|2014 July|8||
60060657|NCT01810263|76176034|FG001|COMPLETED|Overall Study||11||
60060658|NCT01810263|76176033|FG000|NOT COMPLETED|Overall Study||8||
60060659|NCT01810263|76176034|FG001|NOT COMPLETED|Overall Study||7||
60060660|NCT01841697|76176042|FG000|STARTED|Overall Study||322||
60060661|NCT01841697|76176043|FG001|STARTED|Overall Study||320||
59516613|NCT00634088|75610259|FG000|NOT COMPLETED|Time Period 4: Triplet Combination||0||
59516614|NCT00634088|75610260|FG001|NOT COMPLETED|Time Period 4: Triplet Combination||0||
59516615|NCT00634088|75610261|FG002|NOT COMPLETED|Time Period 4: Triplet Combination||0||
59516616|NCT00634088|75610262|FG003|NOT COMPLETED|Time Period 4: Triplet Combination||0||
60060662|NCT01841697|76176042|FG000|COMPLETED|Overall Study||302||
60060663|NCT01841697|76176043|FG001|COMPLETED|Overall Study||302||
60060664|NCT01841697|76176042|FG000|NOT COMPLETED|Overall Study||20||
59516617|NCT01027195|75610274|FG000|STARTED|Overall Study||71||
59516618|NCT01027195|75610275|FG001|STARTED|Overall Study||69||
60060665|NCT01841697|76176043|FG001|NOT COMPLETED|Overall Study||18||
60060666|NCT01841073|76176051|FG000|STARTED|Overall Study||22||
60060667|NCT01841073|76176052|FG001|STARTED|Overall Study||22||
60060668|NCT01841073|76176051|FG000|COMPLETED|Overall Study||20||
60060669|NCT01841073|76176052|FG001|COMPLETED|Overall Study||19||
60060670|NCT01841073|76176051|FG000|NOT COMPLETED|Overall Study||2||
60060671|NCT01841073|76176052|FG001|NOT COMPLETED|Overall Study||3||
60060672|NCT01809327|76176065|FG000|STARTED|Overall Study||237||
60060673|NCT01809327|76176066|FG001|STARTED|Overall Study||237||
60060674|NCT01809327|76176067|FG002|STARTED|Overall Study||238||
60060675|NCT01809327|76176068|FG003|STARTED|Overall Study||237||
60060676|NCT01809327|76176069|FG004|STARTED|Overall Study||237||
60060677|NCT01809327|76176065|FG000|COMPLETED|Overall Study||205||
60060678|NCT01809327|76176066|FG001|COMPLETED|Overall Study||211||
60060679|NCT01809327|76176067|FG002|COMPLETED|Overall Study||216||
60060680|NCT01809327|76176068|FG003|COMPLETED|Overall Study||225||
60060681|NCT01809327|76176069|FG004|COMPLETED|Overall Study||212||
60060682|NCT01809327|76176065|FG000|NOT COMPLETED|Overall Study||32||
60060683|NCT01809327|76176066|FG001|NOT COMPLETED|Overall Study||26||
60060684|NCT01809327|76176067|FG002|NOT COMPLETED|Overall Study||22||
60060685|NCT01809327|76176068|FG003|NOT COMPLETED|Overall Study||12||
60060686|NCT01809327|76176069|FG004|NOT COMPLETED|Overall Study||25||
60060687|NCT03272139|76176083|FG000|STARTED|Overall Study||63||
60060688|NCT03272139|76176084|FG001|STARTED|Overall Study||63||
60060689|NCT03272139|76176083|FG000|COMPLETED|Overall Study||63||
60060690|NCT03272139|76176084|FG001|COMPLETED|Overall Study||63||
60060691|NCT03272139|76176083|FG000|NOT COMPLETED|Overall Study||0||
60060692|NCT03272139|76176084|FG001|NOT COMPLETED|Overall Study||0||
60060693|NCT01808313|76176090|FG000|STARTED|Overall Study||133||
60060694|NCT01808313|76176090|FG000|COMPLETED|Overall Study||123||
60060695|NCT01808313|76176090|FG000|NOT COMPLETED|Overall Study||10||
60060696|NCT01840605|76176096|FG000|STARTED|Overall Study||151||
60060697|NCT01840605|76176097|FG001|STARTED|Overall Study||152||
60060698|NCT01840605|76176096|FG000|COMPLETED|Overall Study||149||
60060699|NCT01840605|76176097|FG001|COMPLETED|Overall Study||150||
60060700|NCT01840605|76176096|FG000|NOT COMPLETED|Overall Study||2||
60060701|NCT01840605|76176097|FG001|NOT COMPLETED|Overall Study||2||
60060702|NCT02023879|76176106|FG000|STARTED|Period 1: 24-Week Double-blind Treatment||58||
60060703|NCT02023879|76176107|FG001|STARTED|Period 1: 24-Week Double-blind Treatment||116||
60060704|NCT02023879|76176108|FG002|STARTED|Period 1: 24-Week Double-blind Treatment||59||
60060705|NCT02023879|76176106|FG000|Treated|Period 1: 24-Week Double-blind Treatment||58||
60060706|NCT02023879|76176107|FG001|Treated|Period 1: 24-Week Double-blind Treatment||115||
60060707|NCT02023879|76176108|FG002|Treated|Period 1: 24-Week Double-blind Treatment||58||
60060708|NCT02023879|76176106|FG000|COMPLETED|Period 1: 24-Week Double-blind Treatment||54||
60060709|NCT02023879|76176107|FG001|COMPLETED|Period 1: 24-Week Double-blind Treatment||107||
60060710|NCT02023879|76176108|FG002|COMPLETED|Period 1: 24-Week Double-blind Treatment||50||
60060711|NCT02023879|76176106|FG000|NOT COMPLETED|Period 1: 24-Week Double-blind Treatment||4||
59516619|NCT01027195|75610274|FG000|COMPLETED|Overall Study||71||
60060712|NCT02023879|76176107|FG001|NOT COMPLETED|Period 1: 24-Week Double-blind Treatment||9||
60060713|NCT02023879|76176108|FG002|NOT COMPLETED|Period 1: 24-Week Double-blind Treatment||9||
60060714|NCT02023879|76176106|FG000|STARTED|Extension Open Label Treatment|The open-label extension period was optional for participants who completed the double-blind period.|51||
60060715|NCT02023879|76176107|FG001|STARTED|Extension Open Label Treatment|The open-label extension period was optional for participants who completed the double-blind period.|106||
60060716|NCT02023879|76176108|FG002|STARTED|Extension Open Label Treatment|The open-label extension period was optional for participants who completed the double-blind period.|48||
60060717|NCT02023879|76176106|FG000|COMPLETED|Extension Open Label Treatment||46||
60060718|NCT02023879|76176107|FG001|COMPLETED|Extension Open Label Treatment||89||
60060719|NCT02023879|76176108|FG002|COMPLETED|Extension Open Label Treatment||43||
60060720|NCT02023879|76176106|FG000|NOT COMPLETED|Extension Open Label Treatment||5||
60060721|NCT02023879|76176107|FG001|NOT COMPLETED|Extension Open Label Treatment||17||
60060722|NCT02023879|76176108|FG002|NOT COMPLETED|Extension Open Label Treatment||5||
59926970|NCT02899988|76045017|FG008|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||24||
59926971|NCT02899988|76045018|FG009|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||17||
59926972|NCT02899988|76045019|FG010|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||0||
59926973|NCT02899988|76045009|FG000|COMPLETED|Maintenance Period (88 Weeks)||0||
59926974|NCT02899988|76045010|FG001|COMPLETED|Maintenance Period (88 Weeks)||0||
59926975|NCT02899988|76045011|FG002|COMPLETED|Maintenance Period (88 Weeks)||0||
59926976|NCT02899988|76045012|FG003|COMPLETED|Maintenance Period (88 Weeks)||0||
59926977|NCT02899988|76045013|FG004|COMPLETED|Maintenance Period (88 Weeks)||13||
59926978|NCT02899988|76045014|FG005|COMPLETED|Maintenance Period (88 Weeks)||27||
59926979|NCT02899988|76045015|FG006|COMPLETED|Maintenance Period (88 Weeks)||30||
59926980|NCT02899988|76045016|FG007|COMPLETED|Maintenance Period (88 Weeks)||45||
59926981|NCT02899988|76045017|FG008|COMPLETED|Maintenance Period (88 Weeks)||30||
59926982|NCT02899988|76045018|FG009|COMPLETED|Maintenance Period (88 Weeks)||19||
59926983|NCT02899988|76045019|FG010|COMPLETED|Maintenance Period (88 Weeks)||13||
59926984|NCT02899988|76045009|FG000|NOT COMPLETED|Maintenance Period (88 Weeks)||0||
59926985|NCT02899988|76045010|FG001|NOT COMPLETED|Maintenance Period (88 Weeks)||0||
59926986|NCT02899988|76045011|FG002|NOT COMPLETED|Maintenance Period (88 Weeks)||0||
59926987|NCT02899988|76045012|FG003|NOT COMPLETED|Maintenance Period (88 Weeks)||0||
59926988|NCT02899988|76045013|FG004|NOT COMPLETED|Maintenance Period (88 Weeks)||2||
59926989|NCT02899988|76045014|FG005|NOT COMPLETED|Maintenance Period (88 Weeks)||3||
59926990|NCT02899988|76045015|FG006|NOT COMPLETED|Maintenance Period (88 Weeks)||4||
59926991|NCT02899988|76045016|FG007|NOT COMPLETED|Maintenance Period (88 Weeks)||5||
59926992|NCT02899988|76045017|FG008|NOT COMPLETED|Maintenance Period (88 Weeks)||4||
59926993|NCT02899988|76045018|FG009|NOT COMPLETED|Maintenance Period (88 Weeks)||2||
59926994|NCT02899988|76045019|FG010|NOT COMPLETED|Maintenance Period (88 Weeks)||2||
59926995|NCT02899988|76045009|FG000|STARTED|Follow-Up (16 Weeks)||0||
59926996|NCT02899988|76045010|FG001|STARTED|Follow-Up (16 Weeks)||0||
59926997|NCT02899988|76045011|FG002|STARTED|Follow-Up (16 Weeks)||0||
59926998|NCT02899988|76045012|FG003|STARTED|Follow-Up (16 Weeks)||0||
59926999|NCT02899988|76045013|FG004|STARTED|Follow-Up (16 Weeks)|Not all participants that completed maintenance period continued to follow-up period.|2||
59927000|NCT02899988|76045014|FG005|STARTED|Follow-Up (16 Weeks)|Not all participants that completed maintenance period continued to follow-up period.|4||
59927001|NCT02899988|76045015|FG006|STARTED|Follow-Up (16 Weeks)|Not all participants that completed maintenance period continued to follow-up period.|3||
59927002|NCT02899988|76045016|FG007|STARTED|Follow-Up (16 Weeks)|Not all participants that completed maintenance period continued to follow-up period.|3||
59927003|NCT02899988|76045017|FG008|STARTED|Follow-Up (16 Weeks)|Not all participants that completed maintenance period continued to follow-up period.|6||
59927004|NCT02899988|76045018|FG009|STARTED|Follow-Up (16 Weeks)|Not all participants that completed maintenance period continued to follow-up period.|2||
59927005|NCT02899988|76045019|FG010|STARTED|Follow-Up (16 Weeks)|Not all participants that completed maintenance period continued to follow-up period.|0||
59927006|NCT02899988|76045009|FG000|COMPLETED|Follow-Up (16 Weeks)||0||
59927007|NCT02899988|76045010|FG001|COMPLETED|Follow-Up (16 Weeks)||0||
59927008|NCT02899988|76045011|FG002|COMPLETED|Follow-Up (16 Weeks)||0||
59927009|NCT02899988|76045012|FG003|COMPLETED|Follow-Up (16 Weeks)||0||
60060723|NCT02014441|76176123|FG000|STARTED|Overall Study||61||
60060724|NCT02014441|76176123|FG000|Received Treatment|Overall Study||60||
60060725|NCT02014441|76176123|FG000|COMPLETED|Overall Study||49||
60060726|NCT02014441|76176123|FG000|NOT COMPLETED|Overall Study||12||
60060727|NCT02013817|76176129|FG000|STARTED|Overall Study||43||
60060728|NCT02013817|76176129|FG000|COMPLETED|Overall Study||16||
60060729|NCT02013817|76176129|FG000|NOT COMPLETED|Overall Study||27||
59927010|NCT02899988|76045013|FG004|COMPLETED|Follow-Up (16 Weeks)||2||
59927011|NCT02899988|76045014|FG005|COMPLETED|Follow-Up (16 Weeks)||4||
59927012|NCT02899988|76045015|FG006|COMPLETED|Follow-Up (16 Weeks)||3||
59927013|NCT02899988|76045016|FG007|COMPLETED|Follow-Up (16 Weeks)||3||
59927014|NCT02899988|76045017|FG008|COMPLETED|Follow-Up (16 Weeks)||6||
59927015|NCT02899988|76045018|FG009|COMPLETED|Follow-Up (16 Weeks)||2||
59927016|NCT02899988|76045019|FG010|COMPLETED|Follow-Up (16 Weeks)||0||
59927017|NCT02899988|76045009|FG000|NOT COMPLETED|Follow-Up (16 Weeks)||0||
59927018|NCT02899988|76045010|FG001|NOT COMPLETED|Follow-Up (16 Weeks)||0||
59927019|NCT02899988|76045011|FG002|NOT COMPLETED|Follow-Up (16 Weeks)||0||
59927020|NCT02899988|76045012|FG003|NOT COMPLETED|Follow-Up (16 Weeks)||0||
59927021|NCT02899988|76045013|FG004|NOT COMPLETED|Follow-Up (16 Weeks)||0||
59927022|NCT02899988|76045014|FG005|NOT COMPLETED|Follow-Up (16 Weeks)||0||
59927023|NCT02899988|76045015|FG006|NOT COMPLETED|Follow-Up (16 Weeks)||0||
59927024|NCT02899988|76045016|FG007|NOT COMPLETED|Follow-Up (16 Weeks)||0||
59927025|NCT02899988|76045017|FG008|NOT COMPLETED|Follow-Up (16 Weeks)||0||
59927026|NCT02899988|76045018|FG009|NOT COMPLETED|Follow-Up (16 Weeks)||0||
59927027|NCT02899988|76045019|FG010|NOT COMPLETED|Follow-Up (16 Weeks)||0||
59927028|NCT02939131|76045053|FG000|STARTED|Overall Study|One additional site in the COMB-R group withdrew prior to the start of participant enrollment.|81||6
59927029|NCT02939131|76045054|FG001|STARTED|Overall Study||75||7
59927030|NCT02939131|76045053|FG000|Week 24 Visit|Overall Study|These are the numbers still on study at week 24|74||6
60060730|NCT01994863|76176133|FG000|STARTED|Period 1||11||
59927031|NCT02939131|76045054|FG001|Week 24 Visit|Overall Study||72||7
59927032|NCT02939131|76045053|FG000|COMPLETED|Overall Study||70|This is the completion information for the week 48 visit|6
59927033|NCT02939131|76045054|FG001|COMPLETED|Overall Study||66|This is the completion information for the week 48 visit|7
59927034|NCT02939131|76045053|FG000|NOT COMPLETED|Overall Study||11||0
59927035|NCT02939131|76045054|FG001|NOT COMPLETED|Overall Study||9||0
59927036|NCT03345407|76045068|FG000|STARTED|Overall Study||276||
59927037|NCT03345407|76045069|FG001|STARTED|Overall Study||22||
59927038|NCT03345407|76045070|FG002|STARTED|Overall Study||91||
59927039|NCT03345407|76045071|FG003|STARTED|Overall Study||92||
59927040|NCT03345407|76045072|FG004|STARTED|Overall Study||90||
59927041|NCT03345407|76045073|FG005|STARTED|Overall Study||89||
59927042|NCT03345407|76045074|FG006|STARTED|Overall Study||278||
59927043|NCT03345407|76045068|FG000|COMPLETED|Overall Study||244||
59927044|NCT03345407|76045069|FG001|COMPLETED|Overall Study||19||
59927045|NCT03345407|76045070|FG002|COMPLETED|Overall Study||79||
59927046|NCT03345407|76045071|FG003|COMPLETED|Overall Study||81||
59927047|NCT03345407|76045072|FG004|COMPLETED|Overall Study||75||
59927048|NCT03345407|76045073|FG005|COMPLETED|Overall Study||73||
59927049|NCT03345407|76045074|FG006|COMPLETED|Overall Study||233||
59927050|NCT03345407|76045068|FG000|NOT COMPLETED|Overall Study||32||
59927051|NCT03345407|76045069|FG001|NOT COMPLETED|Overall Study||3||
59927052|NCT03345407|76045070|FG002|NOT COMPLETED|Overall Study||12||
59927053|NCT03345407|76045071|FG003|NOT COMPLETED|Overall Study||11||
59927054|NCT03345407|76045072|FG004|NOT COMPLETED|Overall Study||15||
59927055|NCT03345407|76045073|FG005|NOT COMPLETED|Overall Study||16||
59927056|NCT03345407|76045074|FG006|NOT COMPLETED|Overall Study||45||
59927057|NCT03255187|76045098|FG000|STARTED|Periodfrom Enrollment to First Follow-up||35||
59927058|NCT03255187|76045099|FG001|STARTED|Periodfrom Enrollment to First Follow-up||35||
59927059|NCT03255187|76045098|FG000|COMPLETED|Periodfrom Enrollment to First Follow-up||34||
59927060|NCT03255187|76045099|FG001|COMPLETED|Periodfrom Enrollment to First Follow-up||32||
59927061|NCT03255187|76045098|FG000|NOT COMPLETED|Periodfrom Enrollment to First Follow-up||1||
59613064|NCT01713582|75724095|FG001|NOT COMPLETED|Overall Study||3||
59613065|NCT01713582|75724096|FG002|NOT COMPLETED|Overall Study||4||
59927062|NCT03255187|76045099|FG001|NOT COMPLETED|Periodfrom Enrollment to First Follow-up||3||
59927063|NCT03255187|76045098|FG000|STARTED|Period From First to Second Follow-up||34||
59927064|NCT03255187|76045099|FG001|STARTED|Period From First to Second Follow-up||32||
59927065|NCT03255187|76045098|FG000|COMPLETED|Period From First to Second Follow-up||34||
59927066|NCT03255187|76045099|FG001|COMPLETED|Period From First to Second Follow-up||31||
59927067|NCT03255187|76045098|FG000|NOT COMPLETED|Period From First to Second Follow-up||0||
59927068|NCT03255187|76045099|FG001|NOT COMPLETED|Period From First to Second Follow-up||1||
59927069|NCT03255187|76045098|FG000|STARTED|Period From Second to Third Follow-up||34||
59927070|NCT03255187|76045099|FG001|STARTED|Period From Second to Third Follow-up||31||
59927071|NCT03255187|76045098|FG000|COMPLETED|Period From Second to Third Follow-up||34||
59927072|NCT03255187|76045099|FG001|COMPLETED|Period From Second to Third Follow-up||31||
59927073|NCT03255187|76045098|FG000|NOT COMPLETED|Period From Second to Third Follow-up||0||
59927074|NCT03255187|76045099|FG001|NOT COMPLETED|Period From Second to Third Follow-up||0||
59927075|NCT03255187|76045098|FG000|STARTED|Period From Third to Fourth Follow-up||34||
59927076|NCT03255187|76045099|FG001|STARTED|Period From Third to Fourth Follow-up||31||
59927077|NCT03255187|76045098|FG000|COMPLETED|Period From Third to Fourth Follow-up||34||
59927078|NCT03255187|76045099|FG001|COMPLETED|Period From Third to Fourth Follow-up||31||
59927079|NCT03255187|76045098|FG000|NOT COMPLETED|Period From Third to Fourth Follow-up||0||
59927080|NCT03255187|76045099|FG001|NOT COMPLETED|Period From Third to Fourth Follow-up||0||
59927081|NCT03255187|76045098|FG000|STARTED|Period at Fourth Follow-up||34||
59927082|NCT03255187|76045099|FG001|STARTED|Period at Fourth Follow-up||31||
59927083|NCT03255187|76045098|FG000|COMPLETED|Period at Fourth Follow-up||34||
59927084|NCT03255187|76045099|FG001|COMPLETED|Period at Fourth Follow-up||31||
59927085|NCT03255187|76045098|FG000|NOT COMPLETED|Period at Fourth Follow-up||0||
59927086|NCT03255187|76045099|FG001|NOT COMPLETED|Period at Fourth Follow-up||0||
59927087|NCT02929329|76045107|FG000|STARTED|Overall Study||4112||
60060731|NCT01994863|76176134|FG001|STARTED|Period 1||12||
60060732|NCT01994863|76176133|FG000|COMPLETED|Period 1||4||
60060733|NCT01994863|76176134|FG001|COMPLETED|Period 1||9||
60060734|NCT01994863|76176133|FG000|NOT COMPLETED|Period 1||7||
60060735|NCT01994863|76176134|FG001|NOT COMPLETED|Period 1||3||
60060736|NCT01994863|76176133|FG000|STARTED|Period 2||8||
60060737|NCT01994863|76176134|FG001|STARTED|Period 2||9||
60060738|NCT01994863|76176133|FG000|COMPLETED|Period 2||7||
60060739|NCT01994863|76176134|FG001|COMPLETED|Period 2||5||
60060740|NCT01994863|76176133|FG000|NOT COMPLETED|Period 2||1||
60060741|NCT01994863|76176134|FG001|NOT COMPLETED|Period 2||4||
60060742|NCT02023099|76176143|FG000|STARTED|Overall Study||215||
60060743|NCT02023099|76176144|FG001|STARTED|Overall Study||106||
60060744|NCT02023099|76176145|FG002|STARTED|Overall Study||42||
60060745|NCT02023099|76176143|FG000|COMPLETED|Overall Study||212||
60060746|NCT02023099|76176144|FG001|COMPLETED|Overall Study||106||
59613066|NCT01713582|75724097|FG003|NOT COMPLETED|Overall Study||3||
60060747|NCT02023099|76176145|FG002|COMPLETED|Overall Study||39||
59927088|NCT02929329|76045108|FG001|STARTED|Overall Study||4120||
60060748|NCT02023099|76176143|FG000|NOT COMPLETED|Overall Study||3||
59927089|NCT02929329|76045107|FG000|Received Treatment|Overall Study||4101||
59927090|NCT02929329|76045108|FG001|Received Treatment|Overall Study||4110||
59927091|NCT02929329|76045107|FG000|COMPLETED|Overall Study|7 participants in this group who discontinued the study had unknown vital status at the end of study|3008||
60060749|NCT02023099|76176144|FG001|NOT COMPLETED|Overall Study||0||
60060750|NCT02023099|76176145|FG002|NOT COMPLETED|Overall Study||3||
60060751|NCT02013037|76176153|FG000|STARTED|Overall Study||36||
60060752|NCT02013037|76176153|FG000|COMPLETED|Overall Study||20||
60060753|NCT02013037|76176153|FG000|NOT COMPLETED|Overall Study||16||
60060754|NCT01967719|76176160|FG000|STARTED|Washout Period of 1 Day (Day 0)||22||
60060755|NCT01967719|76176161|FG001|STARTED|Washout Period of 1 Day (Day 0)||22||
60060756|NCT01967719|76176162|FG002|STARTED|Washout Period of 1 Day (Day 0)||9||
60060757|NCT01967719|76176163|FG003|STARTED|Washout Period of 1 Day (Day 0)||9||
60060758|NCT01967719|76176160|FG000|COMPLETED|Washout Period of 1 Day (Day 0)||22||
60060759|NCT01967719|76176161|FG001|COMPLETED|Washout Period of 1 Day (Day 0)||22||
60060760|NCT01967719|76176162|FG002|COMPLETED|Washout Period of 1 Day (Day 0)||9||
60060761|NCT01967719|76176163|FG003|COMPLETED|Washout Period of 1 Day (Day 0)||9||
60060762|NCT01967719|76176160|FG000|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0||
60060763|NCT01967719|76176161|FG001|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0||
60060764|NCT01967719|76176162|FG002|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0||
60060765|NCT01967719|76176163|FG003|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0||
60060766|NCT01967719|76176160|FG000|STARTED|First Intervention (Day 1)||22||
60060767|NCT01967719|76176161|FG001|STARTED|First Intervention (Day 1)||22||
60060768|NCT01967719|76176162|FG002|STARTED|First Intervention (Day 1)||9||
60060769|NCT01967719|76176163|FG003|STARTED|First Intervention (Day 1)||9||
60060770|NCT01967719|76176160|FG000|COMPLETED|First Intervention (Day 1)||22||
60060771|NCT01967719|76176161|FG001|COMPLETED|First Intervention (Day 1)||21||
60060772|NCT01967719|76176162|FG002|COMPLETED|First Intervention (Day 1)||9||
60060773|NCT01967719|76176163|FG003|COMPLETED|First Intervention (Day 1)||8||
60060774|NCT01967719|76176160|FG000|NOT COMPLETED|First Intervention (Day 1)||0||
60060775|NCT01967719|76176161|FG001|NOT COMPLETED|First Intervention (Day 1)||1||
60060776|NCT01967719|76176162|FG002|NOT COMPLETED|First Intervention (Day 1)||0||
60060777|NCT01967719|76176163|FG003|NOT COMPLETED|First Intervention (Day 1)||1||
60060778|NCT01967719|76176160|FG000|STARTED|Washout Period of 1 Day (Day 2)||22||
60060779|NCT01967719|76176161|FG001|STARTED|Washout Period of 1 Day (Day 2)||21||
60060780|NCT01967719|76176162|FG002|STARTED|Washout Period of 1 Day (Day 2)||9||
60060781|NCT01967719|76176163|FG003|STARTED|Washout Period of 1 Day (Day 2)||8||
60060782|NCT01967719|76176160|FG000|COMPLETED|Washout Period of 1 Day (Day 2)||22||
60060783|NCT01967719|76176161|FG001|COMPLETED|Washout Period of 1 Day (Day 2)||21||
60060784|NCT01967719|76176162|FG002|COMPLETED|Washout Period of 1 Day (Day 2)||9||
60060785|NCT01967719|76176163|FG003|COMPLETED|Washout Period of 1 Day (Day 2)||8||
60060786|NCT01967719|76176160|FG000|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0||
60060787|NCT01967719|76176161|FG001|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0||
59927092|NCT02929329|76045108|FG001|COMPLETED|Overall Study|9 participants in this group who discontinued the study had unknown vital status at the end of study|3028||
59927093|NCT02929329|76045107|FG000|NOT COMPLETED|Overall Study||1104||
59927094|NCT02929329|76045108|FG001|NOT COMPLETED|Overall Study||1092||
59927095|NCT03240133|76045121|FG000|STARTED|Overall Study||33||
59927096|NCT03240133|76045122|FG001|STARTED|Overall Study||14||
59927097|NCT03240133|76045123|FG002|STARTED|Overall Study||11||
59927098|NCT03240133|76045121|FG000|Completed Period 1|Overall Study||33||
59927099|NCT03240133|76045122|FG001|Completed Period 1|Overall Study||14||
59927100|NCT03240133|76045123|FG002|Completed Period 1|Overall Study||11||
59927101|NCT03240133|76045121|FG000|Completed Period 2|Overall Study||32||
59927102|NCT03240133|76045122|FG001|Completed Period 2|Overall Study||11||
59927103|NCT03240133|76045123|FG002|Completed Period 2|Overall Study||11||
59927104|NCT03240133|76045121|FG000|Completed Period 3|Overall Study||30||
59927105|NCT03240133|76045122|FG001|Completed Period 3|Overall Study||11||
59927106|NCT03240133|76045123|FG002|Completed Period 3|Overall Study||11||
59927107|NCT03240133|76045121|FG000|COMPLETED|Overall Study||30||
60060788|NCT01967719|76176162|FG002|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0||
60060789|NCT01967719|76176163|FG003|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0||
60060790|NCT01967719|76176160|FG000|STARTED|Second Intervention (Day 3)||22||
60060791|NCT01967719|76176161|FG001|STARTED|Second Intervention (Day 3)||21||
60060792|NCT01967719|76176162|FG002|STARTED|Second Intervention (Day 3)||9||
60060793|NCT01967719|76176163|FG003|STARTED|Second Intervention (Day 3)||8||
60060794|NCT01967719|76176160|FG000|COMPLETED|Second Intervention (Day 3)||22||
60060795|NCT01967719|76176161|FG001|COMPLETED|Second Intervention (Day 3)||20||
60060796|NCT01967719|76176162|FG002|COMPLETED|Second Intervention (Day 3)||9||
60060797|NCT01967719|76176163|FG003|COMPLETED|Second Intervention (Day 3)||8||
60060798|NCT01967719|76176160|FG000|NOT COMPLETED|Second Intervention (Day 3)||0||
60060799|NCT01967719|76176161|FG001|NOT COMPLETED|Second Intervention (Day 3)||1||
60060800|NCT01967719|76176162|FG002|NOT COMPLETED|Second Intervention (Day 3)||0||
60060801|NCT01967719|76176163|FG003|NOT COMPLETED|Second Intervention (Day 3)||0||
60060802|NCT01967173|76176181|FG000|STARTED|Overall Study||69||
60060803|NCT01967173|76176182|FG001|STARTED|Overall Study||69||
60060804|NCT01967173|76176183|FG002|STARTED|Overall Study||71||
60060805|NCT01967173|76176184|FG003|STARTED|Overall Study||71||
60060806|NCT01967173|76176185|FG004|STARTED|Overall Study||73||
60060807|NCT01967173|76176186|FG005|STARTED|Overall Study||72||
60060808|NCT01967173|76176187|FG006|STARTED|Overall Study||75||
60060809|NCT01967173|76176188|FG007|STARTED|Overall Study||74||
60060810|NCT01967173|76176181|FG000|Completed 1st Period|Overall Study||58||
60060811|NCT01967173|76176182|FG001|Completed 1st Period|Overall Study||60||
60060812|NCT01967173|76176183|FG002|Completed 1st Period|Overall Study||67||
60060813|NCT01967173|76176184|FG003|Completed 1st Period|Overall Study||65||
60060814|NCT01967173|76176185|FG004|Completed 1st Period|Overall Study||64||
60060815|NCT01967173|76176186|FG005|Completed 1st Period|Overall Study||62||
60060816|NCT01967173|76176187|FG006|Completed 1st Period|Overall Study||67||
60060817|NCT01967173|76176188|FG007|Completed 1st Period|Overall Study||69||
60060818|NCT01967173|76176181|FG000|Completed 2nd Period|Overall Study||52||
60060819|NCT01967173|76176182|FG001|Completed 2nd Period|Overall Study||58||
60060820|NCT01967173|76176183|FG002|Completed 2nd Period|Overall Study||63||
60060821|NCT01967173|76176184|FG003|Completed 2nd Period|Overall Study||62||
60060822|NCT01967173|76176185|FG004|Completed 2nd Period|Overall Study||63||
59927108|NCT03240133|76045122|FG001|COMPLETED|Overall Study||11||
59927109|NCT03240133|76045123|FG002|COMPLETED|Overall Study||10||
59927110|NCT03240133|76045121|FG000|NOT COMPLETED|Overall Study||3||
59927111|NCT03240133|76045122|FG001|NOT COMPLETED|Overall Study||3||
59927112|NCT03240133|76045123|FG002|NOT COMPLETED|Overall Study||1||
59927113|NCT03372083|76045147|FG000|STARTED|Overall Study||44|All enrolled patients were included in both the full analysis set (FAS) and the safety set|
59927114|NCT03372083|76045147|FG000|COMPLETED|Overall Study||39||
59927115|NCT03372083|76045147|FG000|NOT COMPLETED|Overall Study||5||
59927116|NCT03044886|76045154|FG000|STARTED|Overall Study||120||
59927117|NCT03044886|76045155|FG001|STARTED|Overall Study||120||
59927118|NCT03044886|76045156|FG002|STARTED|Overall Study||120||
59927119|NCT03044886|76045154|FG000|COMPLETED|Overall Study||105||
59927120|NCT03044886|76045155|FG001|COMPLETED|Overall Study||110||
59927121|NCT03044886|76045156|FG002|COMPLETED|Overall Study||108||
59927122|NCT03044886|76045154|FG000|NOT COMPLETED|Overall Study||15||
59927123|NCT03044886|76045155|FG001|NOT COMPLETED|Overall Study||10||
59927124|NCT03044886|76045156|FG002|NOT COMPLETED|Overall Study||12||
59927125|NCT02961764|76045166|FG000|STARTED|Overall Study||160||
59927126|NCT02961764|76045167|FG001|STARTED|Overall Study||153||
59927127|NCT02961764|76045166|FG000|COMPLETED|Overall Study||121||
59927128|NCT02961764|76045167|FG001|COMPLETED|Overall Study||128||
59927129|NCT02961764|76045166|FG000|NOT COMPLETED|Overall Study||39||
59927130|NCT02961764|76045167|FG001|NOT COMPLETED|Overall Study||25||
59927131|NCT03371459|76045173|FG000|STARTED|Period 1||23||
59927132|NCT03371459|76045174|FG001|STARTED|Period 1||23||
59927133|NCT03371459|76045173|FG000|COMPLETED|Period 1||23||
59927134|NCT03371459|76045174|FG001|COMPLETED|Period 1||23||
59927135|NCT03371459|76045173|FG000|NOT COMPLETED|Period 1||0||
59927136|NCT03371459|76045174|FG001|NOT COMPLETED|Period 1||0||
59927137|NCT03371459|76045173|FG000|STARTED|Washout||23||
59927138|NCT03371459|76045174|FG001|STARTED|Washout||23||
59927139|NCT03371459|76045173|FG000|COMPLETED|Washout||23||
59927140|NCT03371459|76045174|FG001|COMPLETED|Washout||22||
59927141|NCT03371459|76045173|FG000|NOT COMPLETED|Washout||0||
59927142|NCT03371459|76045174|FG001|NOT COMPLETED|Washout||1||
59927143|NCT03371459|76045173|FG000|STARTED|Period 2||23||
59927144|NCT03371459|76045174|FG001|STARTED|Period 2||22||
59927145|NCT03371459|76045173|FG000|COMPLETED|Period 2||23||
59927146|NCT03371459|76045174|FG001|COMPLETED|Period 2||22||
59927147|NCT03371459|76045173|FG000|NOT COMPLETED|Period 2||0||
59927148|NCT03371459|76045174|FG001|NOT COMPLETED|Period 2||0||
59927149|NCT02961920|76045182|FG000|STARTED|Overall Study||25||
59927150|NCT02961920|76045183|FG001|STARTED|Overall Study||25||
59927151|NCT02961920|76045182|FG000|COMPLETED|Overall Study||24||
59927152|NCT02961920|76045183|FG001|COMPLETED|Overall Study||24||
59927153|NCT02961920|76045182|FG000|NOT COMPLETED|Overall Study||1||
59927154|NCT02961920|76045183|FG001|NOT COMPLETED|Overall Study||1||
59927155|NCT03371381|76045189|FG000|STARTED|Overall Study||12||
59927156|NCT03371381|76045189|FG000|COMPLETED|Overall Study||0||
60060823|NCT01967173|76176186|FG005|Completed 2nd Period|Overall Study||57||
60060824|NCT01967173|76176187|FG006|Completed 2nd Period|Overall Study||63||
59927157|NCT03371381|76045189|FG000|NOT COMPLETED|Overall Study||12||
59927158|NCT03044730|76045193|FG000|STARTED|3 Cycles of Pembro + Capecitab||30||
59927159|NCT03044730|76045193|FG000|Attempted Cycle 1|3 Cycles of Pembro + Capecitab||30||
59927160|NCT03044730|76045193|FG000|Attempted Cycle 2|3 Cycles of Pembro + Capecitab||28||
59927161|NCT03044730|76045193|FG000|Attempted Cycle 3|3 Cycles of Pembro + Capecitab||26||
59927162|NCT03044730|76045193|FG000|COMPLETED|3 Cycles of Pembro + Capecitab||26||
59927163|NCT03044730|76045193|FG000|NOT COMPLETED|3 Cycles of Pembro + Capecitab||4||
59927164|NCT03044730|76045193|FG000|STARTED|Cycles 4 and Beyond||26||
59927165|NCT03044730|76045193|FG000|Assessed for Cycle 4|Cycles 4 and Beyond||26||
60060825|NCT01967173|76176188|FG007|Completed 2nd Period|Overall Study||61||
60060826|NCT01967173|76176181|FG000|Completed 3rd Period|Overall Study||48||
60060827|NCT01967173|76176182|FG001|Completed 3rd Period|Overall Study||54||
60060828|NCT01967173|76176183|FG002|Completed 3rd Period|Overall Study||60||
60060829|NCT01967173|76176184|FG003|Completed 3rd Period|Overall Study||61||
60060830|NCT01967173|76176185|FG004|Completed 3rd Period|Overall Study||59||
60060831|NCT01967173|76176186|FG005|Completed 3rd Period|Overall Study||56||
60060832|NCT01967173|76176187|FG006|Completed 3rd Period|Overall Study||59||
60060833|NCT01967173|76176188|FG007|Completed 3rd Period|Overall Study||56||
60060834|NCT01967173|76176181|FG000|Completed 4th Period|Overall Study||45||
60060835|NCT01967173|76176182|FG001|Completed 4th Period|Overall Study||52||
60060836|NCT01967173|76176183|FG002|Completed 4th Period|Overall Study||55||
60060837|NCT01967173|76176184|FG003|Completed 4th Period|Overall Study||57||
60060838|NCT01967173|76176185|FG004|Completed 4th Period|Overall Study||56||
60060839|NCT01967173|76176186|FG005|Completed 4th Period|Overall Study||49||
60060840|NCT01967173|76176187|FG006|Completed 4th Period|Overall Study||57||
59927166|NCT03044730|76045193|FG000|Started Cycle 4|Cycles 4 and Beyond||20||
59927167|NCT03044730|76045193|FG000|Went on to Cycle 5 and Beyond|Cycles 4 and Beyond||16||
59927168|NCT03044730|76045193|FG000|COMPLETED|Cycles 4 and Beyond||16||
59927169|NCT03044730|76045193|FG000|NOT COMPLETED|Cycles 4 and Beyond||10||
59927170|NCT03044730|76045193|FG000|STARTED|On Follow-up for 2 Years||29|Pts who received at least 1 cycle of treatment go in follow-up. One pt is still on treatment.|
59927171|NCT03044730|76045193|FG000|COMPLETED|On Follow-up for 2 Years||4||
59927172|NCT03044730|76045193|FG000|NOT COMPLETED|On Follow-up for 2 Years||25||
59927173|NCT02961374|76045198|FG000|STARTED|Overall Study||46||
59927174|NCT02961374|76045198|FG000|COMPLETED|Overall Study||42||
59927175|NCT02961374|76045198|FG000|NOT COMPLETED|Overall Study||4||
59927176|NCT02951429|76045204|FG000|STARTED|Overall Study||88||
59927177|NCT02951429|76045205|FG001|STARTED|Overall Study||89||
59927178|NCT02951429|76045204|FG000|COMPLETED|Overall Study||16||
59927179|NCT02951429|76045205|FG001|COMPLETED|Overall Study||6||
59927180|NCT02951429|76045204|FG000|NOT COMPLETED|Overall Study||72||
59927181|NCT02951429|76045205|FG001|NOT COMPLETED|Overall Study||83||
59927182|NCT04622709|76045211|FG000|STARTED|Period 1 (First 6 Weeks)||39||
59927183|NCT04622709|76045211|FG000|COMPLETED|Period 1 (First 6 Weeks)||36||
59927184|NCT04622709|76045211|FG000|NOT COMPLETED|Period 1 (First 6 Weeks)||3||
59927185|NCT04622709|76045211|FG000|STARTED|Period 2 (Subsequent 12 Weeks)||36||
59927186|NCT04622709|76045211|FG000|COMPLETED|Period 2 (Subsequent 12 Weeks)||32||
59927187|NCT04622709|76045211|FG000|NOT COMPLETED|Period 2 (Subsequent 12 Weeks)||4||
59927188|NCT03343067|76045218|FG000|STARTED|Open Label Period: Day 1 to Month 3||7||
59927189|NCT03343067|76045219|FG001|STARTED|Open Label Period: Day 1 to Month 3||3||
59927190|NCT03343067|76045220|FG002|STARTED|Open Label Period: Day 1 to Month 3||1||
59927191|NCT03343067|76045218|FG000|COMPLETED|Open Label Period: Day 1 to Month 3||0||
59927192|NCT03343067|76045219|FG001|COMPLETED|Open Label Period: Day 1 to Month 3||3||
59927193|NCT03343067|76045220|FG002|COMPLETED|Open Label Period: Day 1 to Month 3||1||
59927194|NCT03343067|76045218|FG000|NOT COMPLETED|Open Label Period: Day 1 to Month 3||7||
59927195|NCT03343067|76045219|FG001|NOT COMPLETED|Open Label Period: Day 1 to Month 3||0||
59927196|NCT03343067|76045220|FG002|NOT COMPLETED|Open Label Period: Day 1 to Month 3||0||
59927197|NCT03343067|76045218|FG000|STARTED|Double Blind Period: Month 3 to Month 6||0||
59927198|NCT03343067|76045219|FG001|STARTED|Double Blind Period: Month 3 to Month 6||3||
59927199|NCT03343067|76045220|FG002|STARTED|Double Blind Period: Month 3 to Month 6||1||
59927200|NCT03343067|76045218|FG000|COMPLETED|Double Blind Period: Month 3 to Month 6||0||
59927201|NCT03343067|76045219|FG001|COMPLETED|Double Blind Period: Month 3 to Month 6||0||
59927202|NCT03343067|76045220|FG002|COMPLETED|Double Blind Period: Month 3 to Month 6||0||
59927203|NCT03343067|76045218|FG000|NOT COMPLETED|Double Blind Period: Month 3 to Month 6||0||
59927204|NCT03343067|76045219|FG001|NOT COMPLETED|Double Blind Period: Month 3 to Month 6||3||
59927205|NCT03343067|76045220|FG002|NOT COMPLETED|Double Blind Period: Month 3 to Month 6||1||
59927206|NCT03103503|76045228|FG000|STARTED|Overall Study||901||
60060841|NCT01967173|76176188|FG007|Completed 4th Period|Overall Study||50||
60060842|NCT01967173|76176181|FG000|COMPLETED|Overall Study||45||
59516620|NCT01027195|75610275|FG001|COMPLETED|Overall Study||69||
59516621|NCT01027195|75610274|FG000|NOT COMPLETED|Overall Study||0||
59516622|NCT01027195|75610275|FG001|NOT COMPLETED|Overall Study||0||
59516623|NCT00998023|75610283|FG000|STARTED|Overall Study||32||
59516624|NCT00998023|75610284|FG001|STARTED|Overall Study||32||
59516625|NCT00998023|75610283|FG000|COMPLETED|Overall Study||32||
59516626|NCT00998023|75610284|FG001|COMPLETED|Overall Study||32||
59516627|NCT00998023|75610283|FG000|NOT COMPLETED|Overall Study||0||
59516628|NCT00998023|75610284|FG001|NOT COMPLETED|Overall Study||0||
59516629|NCT03428230|75610294|FG000|STARTED|Overall Study||15||
59516630|NCT03428230|75610295|FG001|STARTED|Overall Study||15||
59516631|NCT03428230|75610296|FG002|STARTED|Overall Study||15||
59516632|NCT03428230|75610297|FG003|STARTED|Overall Study||15||
59516633|NCT03428230|75610294|FG000|COMPLETED|Overall Study||15||
59516634|NCT03428230|75610295|FG001|COMPLETED|Overall Study||15||
59516635|NCT03428230|75610296|FG002|COMPLETED|Overall Study||15||
59516636|NCT03428230|75610297|FG003|COMPLETED|Overall Study||15||
59516637|NCT03428230|75610294|FG000|NOT COMPLETED|Overall Study||0||
59516638|NCT03428230|75610295|FG001|NOT COMPLETED|Overall Study||0||
59516639|NCT03428230|75610296|FG002|NOT COMPLETED|Overall Study||0||
59516640|NCT03428230|75610297|FG003|NOT COMPLETED|Overall Study||0||
59516641|NCT01027819|75610309|FG000|STARTED|Overall Study||40||
59516642|NCT01027819|75610310|FG001|STARTED|Overall Study||40||
59516643|NCT01027819|75610309|FG000|COMPLETED|Overall Study||40||
59516644|NCT01027819|75610310|FG001|COMPLETED|Overall Study||40||
59516645|NCT01027819|75610309|FG000|NOT COMPLETED|Overall Study||0||
59516646|NCT01027819|75610310|FG001|NOT COMPLETED|Overall Study||0||
59516647|NCT02163967|75610316|FG000|STARTED|First Intervention/ Day 1||4||
59516648|NCT02163967|75610317|FG001|STARTED|First Intervention/ Day 1||4||
59516649|NCT02163967|75610318|FG002|STARTED|First Intervention/ Day 1||3||
59516650|NCT02163967|75610319|FG003|STARTED|First Intervention/ Day 1||4||
59516651|NCT02163967|75610320|FG004|STARTED|First Intervention/ Day 1||3||
59516652|NCT02163967|75610321|FG005|STARTED|First Intervention/ Day 1||3||
59516653|NCT02163967|75610316|FG000|COMPLETED|First Intervention/ Day 1||4||
59516654|NCT02163967|75610317|FG001|COMPLETED|First Intervention/ Day 1||4||
59516655|NCT02163967|75610318|FG002|COMPLETED|First Intervention/ Day 1||3||
59516656|NCT02163967|75610319|FG003|COMPLETED|First Intervention/ Day 1||4||
59516657|NCT02163967|75610320|FG004|COMPLETED|First Intervention/ Day 1||3||
59516658|NCT02163967|75610321|FG005|COMPLETED|First Intervention/ Day 1||3||
59516659|NCT02163967|75610316|FG000|NOT COMPLETED|First Intervention/ Day 1||0||
59516660|NCT02163967|75610317|FG001|NOT COMPLETED|First Intervention/ Day 1||0||
59516661|NCT02163967|75610318|FG002|NOT COMPLETED|First Intervention/ Day 1||0||
59516662|NCT02163967|75610319|FG003|NOT COMPLETED|First Intervention/ Day 1||0||
59516663|NCT02163967|75610320|FG004|NOT COMPLETED|First Intervention/ Day 1||0||
59516664|NCT02163967|75610321|FG005|NOT COMPLETED|First Intervention/ Day 1||0||
59516665|NCT02163967|75610316|FG000|STARTED|Second Intevention/Day 2||3||
59516666|NCT02163967|75610317|FG001|STARTED|Second Intevention/Day 2||4||
59516667|NCT02163967|75610318|FG002|STARTED|Second Intevention/Day 2||2||
59516668|NCT02163967|75610319|FG003|STARTED|Second Intevention/Day 2||4||
59516669|NCT02163967|75610320|FG004|STARTED|Second Intevention/Day 2||3||
59516670|NCT02163967|75610321|FG005|STARTED|Second Intevention/Day 2||3||
59516671|NCT02163967|75610316|FG000|COMPLETED|Second Intevention/Day 2||3||
59516672|NCT02163967|75610317|FG001|COMPLETED|Second Intevention/Day 2||4||
59516673|NCT02163967|75610318|FG002|COMPLETED|Second Intevention/Day 2||2||
59516674|NCT02163967|75610319|FG003|COMPLETED|Second Intevention/Day 2||4||
59516675|NCT02163967|75610320|FG004|COMPLETED|Second Intevention/Day 2||3||
59516676|NCT02163967|75610321|FG005|COMPLETED|Second Intevention/Day 2||3||
59516677|NCT02163967|75610316|FG000|NOT COMPLETED|Second Intevention/Day 2||0||
59516678|NCT02163967|75610317|FG001|NOT COMPLETED|Second Intevention/Day 2||0||
59516679|NCT02163967|75610318|FG002|NOT COMPLETED|Second Intevention/Day 2||0||
59516680|NCT02163967|75610319|FG003|NOT COMPLETED|Second Intevention/Day 2||0||
59516681|NCT02163967|75610320|FG004|NOT COMPLETED|Second Intevention/Day 2||0||
59516682|NCT02163967|75610321|FG005|NOT COMPLETED|Second Intevention/Day 2||0||
59516683|NCT02163967|75610316|FG000|STARTED|Third Intervention/Day 3||3||
59516684|NCT02163967|75610317|FG001|STARTED|Third Intervention/Day 3||3||
59516685|NCT02163967|75610318|FG002|STARTED|Third Intervention/Day 3||2||
59516686|NCT02163967|75610319|FG003|STARTED|Third Intervention/Day 3||4||
59516687|NCT02163967|75610320|FG004|STARTED|Third Intervention/Day 3||3||
59516688|NCT02163967|75610321|FG005|STARTED|Third Intervention/Day 3||3||
59516689|NCT02163967|75610316|FG000|COMPLETED|Third Intervention/Day 3||3||
59516690|NCT02163967|75610317|FG001|COMPLETED|Third Intervention/Day 3||3||
59516691|NCT02163967|75610318|FG002|COMPLETED|Third Intervention/Day 3||2||
59516692|NCT02163967|75610319|FG003|COMPLETED|Third Intervention/Day 3||4||
59516693|NCT02163967|75610320|FG004|COMPLETED|Third Intervention/Day 3||3||
59516694|NCT02163967|75610321|FG005|COMPLETED|Third Intervention/Day 3||3||
59516695|NCT02163967|75610316|FG000|NOT COMPLETED|Third Intervention/Day 3||0||
59516696|NCT02163967|75610317|FG001|NOT COMPLETED|Third Intervention/Day 3||0||
59516697|NCT02163967|75610318|FG002|NOT COMPLETED|Third Intervention/Day 3||0||
59613067|NCT01713582|75724098|FG004|NOT COMPLETED|Overall Study||4||
59516698|NCT02163967|75610319|FG003|NOT COMPLETED|Third Intervention/Day 3||0||
59516699|NCT02163967|75610320|FG004|NOT COMPLETED|Third Intervention/Day 3||0||
59516700|NCT02163967|75610321|FG005|NOT COMPLETED|Third Intervention/Day 3||0||
59516701|NCT03296800|75610335|FG000|STARTED|Overall Study||16||
59516702|NCT03296800|75610336|FG001|STARTED|Overall Study||16||
59516703|NCT03296800|75610337|FG002|STARTED|Overall Study||16||
59516704|NCT03296800|75610335|FG000|COMPLETED|Overall Study||16||
59516705|NCT03296800|75610336|FG001|COMPLETED|Overall Study||16||
59516706|NCT03296800|75610337|FG002|COMPLETED|Overall Study||16||
59516707|NCT03296800|75610335|FG000|NOT COMPLETED|Overall Study||0||
59927207|NCT03103503|76045228|FG000|COMPLETED|Overall Study||0||
59927208|NCT03103503|76045228|FG000|NOT COMPLETED|Overall Study||901||
60060843|NCT01967173|76176182|FG001|COMPLETED|Overall Study||52||
60060844|NCT01967173|76176183|FG002|COMPLETED|Overall Study||55||
60060845|NCT01967173|76176184|FG003|COMPLETED|Overall Study||57||
60060846|NCT01967173|76176185|FG004|COMPLETED|Overall Study||56||
60060847|NCT01967173|76176186|FG005|COMPLETED|Overall Study||49||
60060848|NCT01967173|76176187|FG006|COMPLETED|Overall Study||57||
59927209|NCT02961218|76045234|FG000|STARTED|Overall Study||25||
59927210|NCT02961218|76045235|FG001|STARTED|Overall Study||24||
59927211|NCT02961218|76045234|FG000|Safety Analysis Set|Overall Study||25|included all subjects that received any study drug|
59927212|NCT02961218|76045235|FG001|Safety Analysis Set|Overall Study||24|included all subjects that received any study drug|
59927213|NCT02961218|76045234|FG000|Pharmacokinetics (PK) Analysis Set|Overall Study||25|included all subjects with at least one available valid PK concentration measurement|
59927214|NCT02961218|76045235|FG001|Pharmacokinetics (PK) Analysis Set|Overall Study|Placebo patients were excluded from the PK analyses|0|included all subjects with at least one available valid PK concentration measurement|
59927215|NCT02961218|76045234|FG000|Primary PD Analysis Set|Overall Study||25|included all subjects with available PD data, who received any study drug.|
59927216|NCT02961218|76045235|FG001|Primary PD Analysis Set|Overall Study||24|included all subjects with available PD data, who received any study drug.|
59927217|NCT02961218|76045234|FG000|COMPLETED|Overall Study||22||
59927218|NCT02961218|76045235|FG001|COMPLETED|Overall Study||19||
59927219|NCT02961218|76045234|FG000|NOT COMPLETED|Overall Study||3||
59927220|NCT02961218|76045235|FG001|NOT COMPLETED|Overall Study||5||
59927221|NCT02949947|76045245|FG000|STARTED|Overall Study||1||
59927222|NCT02949947|76045246|FG001|STARTED|Overall Study||2||
59927223|NCT02949947|76045245|FG000|COMPLETED|Overall Study||0||
59927224|NCT02949947|76045246|FG001|COMPLETED|Overall Study||1||
59927225|NCT02949947|76045245|FG000|NOT COMPLETED|Overall Study||1||
59927226|NCT02949947|76045246|FG001|NOT COMPLETED|Overall Study||1||
59927227|NCT03341507|76045252|FG000|STARTED|Overall Study||64||
59927228|NCT03341507|76045252|FG000|COMPLETED|Overall Study||30||
59927229|NCT03341507|76045252|FG000|NOT COMPLETED|Overall Study||34||
59927230|NCT01345058|76045258|FG000|STARTED|Overall Study||20||
59927231|NCT01345058|76045259|FG001|STARTED|Overall Study||36||
59927232|NCT01345058|76045258|FG000|Received Lacosamide|Overall Study||19||
59927233|NCT01345058|76045259|FG001|Received Lacosamide|Overall Study||0||
59927234|NCT01345058|76045258|FG000|COMPLETED|Overall Study||15||
59927235|NCT01345058|76045259|FG001|COMPLETED|Overall Study||36||
59927236|NCT01345058|76045258|FG000|NOT COMPLETED|Overall Study||5||
59927237|NCT01345058|76045259|FG001|NOT COMPLETED|Overall Study||0||
59927238|NCT01345292|76045268|FG000|STARTED|Overall Study||75||
59927239|NCT01345292|76045269|FG001|STARTED|Overall Study||76||
59927240|NCT01345292|76045270|FG002|STARTED|Overall Study||75||
59927241|NCT01345292|76045268|FG000|COMPLETED|Overall Study||73||
59927242|NCT01345292|76045269|FG001|COMPLETED|Overall Study||76||
59927243|NCT01345292|76045270|FG002|COMPLETED|Overall Study||74||
59927244|NCT01345292|76045268|FG000|NOT COMPLETED|Overall Study||2||
59927245|NCT01345292|76045269|FG001|NOT COMPLETED|Overall Study||0||
59927246|NCT01345292|76045270|FG002|NOT COMPLETED|Overall Study||1||
59927247|NCT03340961|76045282|FG000|STARTED|Overall Study||53||
60060849|NCT01967173|76176188|FG007|COMPLETED|Overall Study||50||
60060850|NCT01967173|76176181|FG000|NOT COMPLETED|Overall Study||24||
60060851|NCT01967173|76176182|FG001|NOT COMPLETED|Overall Study||17||
59516708|NCT03296800|75610336|FG001|NOT COMPLETED|Overall Study||0||
59516709|NCT03296800|75610337|FG002|NOT COMPLETED|Overall Study||0||
59516710|NCT00634010|75610362|FG000|STARTED|Overall Study||18||
59516711|NCT00634010|75610363|FG001|STARTED|Overall Study||18||
59516712|NCT00634010|75610362|FG000|COMPLETED|Overall Study||8||
59516713|NCT00634010|75610363|FG001|COMPLETED|Overall Study||4||
59516714|NCT00634010|75610362|FG000|NOT COMPLETED|Overall Study||10||
59516715|NCT00634010|75610363|FG001|NOT COMPLETED|Overall Study||14||
59516716|NCT03202264|75610369|FG000|STARTED|Overall Study||30||
59927248|NCT03340961|76045283|FG001|STARTED|Overall Study||50||
60060852|NCT01967173|76176183|FG002|NOT COMPLETED|Overall Study||16||
60060853|NCT01967173|76176184|FG003|NOT COMPLETED|Overall Study||14||
59516717|NCT03202264|75610369|FG000|COMPLETED|Overall Study||14||
59516718|NCT03202264|75610369|FG000|NOT COMPLETED|Overall Study||16||
59516719|NCT00633932|75610376|FG000|STARTED|Overall Study|Randomised|191||
59516720|NCT00633932|75610377|FG001|STARTED|Overall Study|Randomised|190||
59516721|NCT00633932|75610378|FG002|STARTED|Overall Study|Randomised|191||
59516722|NCT00633932|75610376|FG000|COMPLETED|Overall Study||179||
59516723|NCT00633932|75610377|FG001|COMPLETED|Overall Study||176||
59516724|NCT00633932|75610378|FG002|COMPLETED|Overall Study||180||
60060854|NCT01967173|76176185|FG004|NOT COMPLETED|Overall Study||17||
60060855|NCT01967173|76176186|FG005|NOT COMPLETED|Overall Study||23||
60060856|NCT01967173|76176187|FG006|NOT COMPLETED|Overall Study||18||
60060857|NCT01967173|76176188|FG007|NOT COMPLETED|Overall Study||24||
60060858|NCT01994629|76176202|FG000|STARTED|Overall Study||100||
60060859|NCT01994629|76176203|FG001|STARTED|Overall Study||102||
60060860|NCT01994629|76176202|FG000|COMPLETED|Overall Study||99||
60060861|NCT01994629|76176203|FG001|COMPLETED|Overall Study||99||
60060862|NCT01994629|76176202|FG000|NOT COMPLETED|Overall Study||1||
60060863|NCT01994629|76176203|FG001|NOT COMPLETED|Overall Study||3||
60060864|NCT01994395|76176211|FG000|STARTED|Overall Study||26||
60060865|NCT01994395|76176212|FG001|STARTED|Overall Study||27||
60060866|NCT01994395|76176211|FG000|COMPLETED|Overall Study||25||
60060867|NCT01994395|76176212|FG001|COMPLETED|Overall Study||25||
60060868|NCT01994395|76176211|FG000|NOT COMPLETED|Overall Study||1||
60060869|NCT01994395|76176212|FG001|NOT COMPLETED|Overall Study||2||
60060870|NCT01992536|76176228|FG000|STARTED|Overall Study||26||
60060871|NCT01992536|76176229|FG001|STARTED|Overall Study||25||
60060872|NCT01992536|76176230|FG002|STARTED|Overall Study||17||
60060873|NCT01992536|76176231|FG003|STARTED|Overall Study||24||
60060874|NCT01992536|76176232|FG004|STARTED|Overall Study||11||
60060875|NCT01992536|76176233|FG005|STARTED|Overall Study||21||
60060876|NCT01992536|76176234|FG006|STARTED|Overall Study||7||
60060877|NCT01992536|76176235|FG007|STARTED|Overall Study||21||
60060878|NCT01992536|76176236|FG008|STARTED|Overall Study||19||
60060879|NCT01992536|76176237|FG009|STARTED|Overall Study||19||
60060880|NCT01992536|76176228|FG000|COMPLETED|Overall Study||22||
60060881|NCT01992536|76176229|FG001|COMPLETED|Overall Study||22||
60060882|NCT01992536|76176230|FG002|COMPLETED|Overall Study||16||
60060883|NCT01992536|76176231|FG003|COMPLETED|Overall Study||22||
60060884|NCT01992536|76176232|FG004|COMPLETED|Overall Study||11||
60060885|NCT01992536|76176233|FG005|COMPLETED|Overall Study||20||
60060886|NCT01992536|76176234|FG006|COMPLETED|Overall Study||0||
60060887|NCT01992536|76176235|FG007|COMPLETED|Overall Study||21||
60060888|NCT01992536|76176236|FG008|COMPLETED|Overall Study||18||
60060889|NCT01992536|76176237|FG009|COMPLETED|Overall Study||18||
60060890|NCT01992536|76176228|FG000|NOT COMPLETED|Overall Study||4||
59516725|NCT00633932|75610376|FG000|NOT COMPLETED|Overall Study||12||
59516726|NCT00633932|75610377|FG001|NOT COMPLETED|Overall Study||14||
59516727|NCT00633932|75610378|FG002|NOT COMPLETED|Overall Study||11||
59516728|NCT01028131|75610390|FG000|STARTED|Overall Study||26||
59760993|NCT03951805|75880652|FG003|Safety Analysis Set (SAS)|Overall Study||51||
59760994|NCT03951805|75880649|FG000|COMPLETED|Overall Study||50||
60060891|NCT01992536|76176229|FG001|NOT COMPLETED|Overall Study||3||
60060892|NCT01992536|76176230|FG002|NOT COMPLETED|Overall Study||1||
60060893|NCT01992536|76176231|FG003|NOT COMPLETED|Overall Study||2||
60060894|NCT01992536|76176232|FG004|NOT COMPLETED|Overall Study||0||
60060895|NCT01992536|76176233|FG005|NOT COMPLETED|Overall Study||1||
60060896|NCT01992536|76176234|FG006|NOT COMPLETED|Overall Study||7||
60060897|NCT01992536|76176235|FG007|NOT COMPLETED|Overall Study||0||
60060898|NCT01992536|76176236|FG008|NOT COMPLETED|Overall Study||1||
60060899|NCT01992536|76176237|FG009|NOT COMPLETED|Overall Study||1||
60060900|NCT01993927|76176279|FG000|STARTED|Overall Study||742||
60060901|NCT01993927|76176279|FG000|COMPLETED|Overall Study||713||
60060902|NCT01993927|76176279|FG000|NOT COMPLETED|Overall Study||29||
60060903|NCT02015390|76176285|FG000|STARTED|Overall Study||9||
59516729|NCT01028131|75610391|FG001|STARTED|Overall Study||26||
59516730|NCT01028131|75610392|FG002|STARTED|Overall Study||28||
59516731|NCT01028131|75610393|FG003|STARTED|Overall Study||30||
59516732|NCT01028131|75610390|FG000|Completed Intervention/Control Session|Overall Study||26||
59516733|NCT01028131|75610391|FG001|Completed Intervention/Control Session|Overall Study||26||
59516734|NCT01028131|75610392|FG002|Completed Intervention/Control Session|Overall Study||28||
59516735|NCT01028131|75610393|FG003|Completed Intervention/Control Session|Overall Study||30||
59516736|NCT01028131|75610390|FG000|COMPLETED|Overall Study||23||
59516737|NCT01028131|75610391|FG001|COMPLETED|Overall Study||23||
60060904|NCT02015390|76176286|FG001|STARTED|Overall Study||7||
60060905|NCT02015390|76176285|FG000|COMPLETED|Overall Study||8||
60060906|NCT02015390|76176286|FG001|COMPLETED|Overall Study||3||
60060907|NCT02015390|76176285|FG000|NOT COMPLETED|Overall Study||1||
60060908|NCT02015390|76176286|FG001|NOT COMPLETED|Overall Study||4||
60060909|NCT02012959|76176293|FG000|STARTED|Treatment Phase A||9||
60060910|NCT02012959|76176294|FG001|STARTED|Treatment Phase A|Zero participants noted because participants did not start Phase B yet|0||
60067871|NCT01913041|76183067|FG000|STARTED|Overall Study||869||
59516738|NCT01028131|75610392|FG002|COMPLETED|Overall Study||22||
59516739|NCT01028131|75610393|FG003|COMPLETED|Overall Study||26||
59516740|NCT01028131|75610390|FG000|NOT COMPLETED|Overall Study||3||
59516741|NCT01028131|75610391|FG001|NOT COMPLETED|Overall Study||3||
59516742|NCT01028131|75610392|FG002|NOT COMPLETED|Overall Study||6||
59516743|NCT01028131|75610393|FG003|NOT COMPLETED|Overall Study||4||
59516744|NCT03297112|75610403|FG000|STARTED|Overall Study||12||
59516745|NCT03297112|75610403|FG000|COMPLETED|Overall Study||12||
59516746|NCT03297112|75610403|FG000|NOT COMPLETED|Overall Study||0||
59516747|NCT01028677|75610409|FG000|STARTED|Overall Study||10||
59927249|NCT03340961|76045284|FG002|STARTED|Overall Study||49||
59927250|NCT03340961|76045285|FG003|STARTED|Overall Study||53||
59927251|NCT03340961|76045282|FG000|COMPLETED|Overall Study||47||
59927252|NCT03340961|76045283|FG001|COMPLETED|Overall Study||38||
59927253|NCT03340961|76045284|FG002|COMPLETED|Overall Study||40||
59927254|NCT03340961|76045285|FG003|COMPLETED|Overall Study||35||
59927255|NCT03340961|76045282|FG000|NOT COMPLETED|Overall Study||6||
59927256|NCT03340961|76045283|FG001|NOT COMPLETED|Overall Study||12||
59927257|NCT03340961|76045284|FG002|NOT COMPLETED|Overall Study||9||
59927258|NCT03340961|76045285|FG003|NOT COMPLETED|Overall Study||18||
59927259|NCT03340025|76045297|FG000|STARTED|Overall Study||11||
59927260|NCT03340025|76045298|FG001|STARTED|Overall Study||9||
59927261|NCT03340025|76045297|FG000|COMPLETED|Overall Study||9||
59927262|NCT03340025|76045298|FG001|COMPLETED|Overall Study||7||
59927263|NCT03340025|76045297|FG000|NOT COMPLETED|Overall Study||2||
59927264|NCT03340025|76045298|FG001|NOT COMPLETED|Overall Study||2||
59927265|NCT03339713|76045306|FG000|STARTED|Overall Study||90||
59927266|NCT03339713|76045307|FG001|STARTED|Overall Study||90||
59927267|NCT03339713|76045306|FG000|COMPLETED|Overall Study||86||
59927268|NCT03339713|76045307|FG001|COMPLETED|Overall Study||88||
59927269|NCT03339713|76045306|FG000|NOT COMPLETED|Overall Study||4||
59927270|NCT03339713|76045307|FG001|NOT COMPLETED|Overall Study||2||
59927271|NCT03254485|76045319|FG000|STARTED|Overall Study||90||
59927272|NCT03254485|76045320|FG001|STARTED|Overall Study||7||
59927273|NCT03254485|76045321|FG002|STARTED|Overall Study||7||
59927274|NCT03254485|76045322|FG003|STARTED|Overall Study||92||
59927275|NCT03254485|76045319|FG000|COMPLETED|Overall Study||78||
59927276|NCT03254485|76045320|FG001|COMPLETED|Overall Study||7||
59927277|NCT03254485|76045321|FG002|COMPLETED|Overall Study||7||
59927278|NCT03254485|76045322|FG003|COMPLETED|Overall Study||77||
59927279|NCT03254485|76045319|FG000|NOT COMPLETED|Overall Study||12||
59927280|NCT03254485|76045320|FG001|NOT COMPLETED|Overall Study||0||
59927281|NCT03254485|76045321|FG002|NOT COMPLETED|Overall Study||0||
59927282|NCT03254485|76045322|FG003|NOT COMPLETED|Overall Study||15||
59927283|NCT03339401|76045335|FG000|STARTED|Overall Study||20||
59927284|NCT03339401|76045336|FG001|STARTED|Overall Study||9||
59927285|NCT03339401|76045335|FG000|COMPLETED|Overall Study||11||
59927286|NCT03339401|76045336|FG001|COMPLETED|Overall Study||5||
59927287|NCT03339401|76045335|FG000|NOT COMPLETED|Overall Study||9||
59927288|NCT03339401|76045336|FG001|NOT COMPLETED|Overall Study||4||
59927289|NCT03370289|76045342|FG000|STARTED|Overall Study||55||
59927290|NCT03370289|76045342|FG000|COMPLETED|Overall Study||50||
59927291|NCT03370289|76045342|FG000|NOT COMPLETED|Overall Study||5||
59927292|NCT01344824|76045346|FG000|STARTED|Overall Study||38||
59927293|NCT01344824|76045346|FG000|COMPLETED|Overall Study||1||
59927294|NCT01344824|76045346|FG000|NOT COMPLETED|Overall Study||37||
59927295|NCT03339245|76045353|FG000|STARTED|Overall Study||6||
59516748|NCT01028677|75610410|FG001|STARTED|Overall Study||7||
59516749|NCT01028677|75610409|FG000|COMPLETED|Overall Study||8||
59516750|NCT01028677|75610410|FG001|COMPLETED|Overall Study||6||
59516751|NCT01028677|75610409|FG000|NOT COMPLETED|Overall Study||2||
59516752|NCT01028677|75610410|FG001|NOT COMPLETED|Overall Study||1||
59516753|NCT03298048|75610419|FG000|STARTED|Overall Study||4||
59516754|NCT03298048|75610420|FG001|STARTED|Overall Study||3||
59516755|NCT03298048|75610421|FG002|STARTED|Overall Study||8||
59516756|NCT03298048|75610419|FG000|COMPLETED|Overall Study||4||
59516757|NCT03298048|75610420|FG001|COMPLETED|Overall Study||3||
59516758|NCT03298048|75610421|FG002|COMPLETED|Overall Study||8||
59516759|NCT03298048|75610419|FG000|NOT COMPLETED|Overall Study||0||
59516760|NCT03298048|75610420|FG001|NOT COMPLETED|Overall Study||0||
59516761|NCT03298048|75610421|FG002|NOT COMPLETED|Overall Study||0||
59516762|NCT01028911|75610431|FG000|STARTED|Overall Study||7||
59516763|NCT01028911|75610432|FG001|STARTED|Overall Study||2||
59516764|NCT01028911|75610431|FG000|COMPLETED|Overall Study||7||
59516765|NCT01028911|75610432|FG001|COMPLETED|Overall Study||2||
59516766|NCT01028911|75610431|FG000|NOT COMPLETED|Overall Study||0||
59516767|NCT01028911|75610432|FG001|NOT COMPLETED|Overall Study||0||
59516768|NCT03204526|75610438|FG000|STARTED|Overall Study||15||
59516769|NCT03204526|75610438|FG000|COMPLETED|Overall Study||15||
59516770|NCT03204526|75610438|FG000|NOT COMPLETED|Overall Study||0||
59516771|NCT03302416|75610442|FG000|STARTED|Overall Study||19||
59516772|NCT03302416|75610442|FG000|COMPLETED|Overall Study||19||
59516773|NCT03302416|75610442|FG000|NOT COMPLETED|Overall Study||0||
59516774|NCT03435562|75610446|FG000|STARTED|Overall Study||22||
59927296|NCT03339245|76045354|FG001|STARTED|Overall Study||7||
60067872|NCT01913041|76183067|FG000|COMPLETED|Overall Study||830||
59927297|NCT03339245|76045353|FG000|COMPLETED|Overall Study|"1 withdrawn due to elevated glucose during pre-intervention testing~1 withdrawn for personal reason"|4||
59927298|NCT03339245|76045354|FG001|COMPLETED|Overall Study|1 withdrawn due to elevated glucose on baseline testing|6||
59927299|NCT03339245|76045353|FG000|NOT COMPLETED|Overall Study||2||
59927300|NCT03339245|76045354|FG001|NOT COMPLETED|Overall Study||1||
59927301|NCT03044574|76045362|FG000|STARTED|Overall Study||204||
59927302|NCT03044574|76045363|FG001|STARTED|Overall Study||203||
59927303|NCT03044574|76045362|FG000|Inpatient Period|Overall Study||204||
59927304|NCT03044574|76045363|FG001|Inpatient Period|Overall Study||203||
59927305|NCT03044574|76045362|FG000|30 Days After Surgery|Overall Study||193||
59927306|NCT03044574|76045363|FG001|30 Days After Surgery|Overall Study||194||
59927307|NCT03044574|76045362|FG000|180 Days After Surgery|Overall Study||167||
59927308|NCT03044574|76045363|FG001|180 Days After Surgery|Overall Study||158||
59927309|NCT03044574|76045362|FG000|COMPLETED|Overall Study||167||
59927310|NCT03044574|76045363|FG001|COMPLETED|Overall Study||158||
59927311|NCT03044574|76045362|FG000|NOT COMPLETED|Overall Study||37||
59927312|NCT03044574|76045363|FG001|NOT COMPLETED|Overall Study||45||
59927313|NCT02959892|76045371|FG000|STARTED|Overall Study||6||
59927314|NCT02959892|76045372|FG001|STARTED|Overall Study||6||
59927315|NCT02959892|76045371|FG000|COMPLETED|Overall Study||5||
59927316|NCT02959892|76045372|FG001|COMPLETED|Overall Study||5||
59927317|NCT02959892|76045371|FG000|NOT COMPLETED|Overall Study||1||
59927318|NCT02959892|76045372|FG001|NOT COMPLETED|Overall Study||1||
59927319|NCT03252145|76045380|FG000|STARTED|Overall Study||13||
59927320|NCT03252145|76045381|FG001|STARTED|Overall Study||15||
59927321|NCT03252145|76045380|FG000|COMPLETED|Overall Study||11||
59927322|NCT03252145|76045381|FG001|COMPLETED|Overall Study||13||
59927323|NCT03252145|76045380|FG000|NOT COMPLETED|Overall Study||2||
59927324|NCT03252145|76045381|FG001|NOT COMPLETED|Overall Study||2||
59927325|NCT02959814|76045387|FG000|STARTED|Overall Study|22-02-2017|329||
59927326|NCT02959814|76045387|FG000|COMPLETED|Overall Study|17-10-2017|272||
59927327|NCT02959814|76045387|FG000|NOT COMPLETED|Overall Study||57||
59927328|NCT03666624|76045394|FG000|STARTED|Overall Study||15||
59927329|NCT03666624|76045395|FG001|STARTED|Overall Study||15||
59927330|NCT03666624|76045394|FG000|COMPLETED|Overall Study||14||
59927331|NCT03666624|76045395|FG001|COMPLETED|Overall Study||15||
59927332|NCT03666624|76045394|FG000|NOT COMPLETED|Overall Study||1||
59927333|NCT03666624|76045395|FG001|NOT COMPLETED|Overall Study||0||
59927334|NCT03368807|76045401|FG000|STARTED|Period 1 (Blinded CGM)||79||
59927335|NCT03368807|76045401|FG000|Received at Least 1 Dose of Study Drug|Period 1 (Blinded CGM)||78||
59927336|NCT03368807|76045401|FG000|COMPLETED|Period 1 (Blinded CGM)||73||
59927337|NCT03368807|76045401|FG000|NOT COMPLETED|Period 1 (Blinded CGM)||6||
59927338|NCT03368807|76045401|FG000|STARTED|Period 2 (Unblinded CGM)||73||
59927339|NCT03368807|76045401|FG000|COMPLETED|Period 2 (Unblinded CGM)||73||
59927340|NCT03368807|76045401|FG000|NOT COMPLETED|Period 2 (Unblinded CGM)||0||
59927341|NCT03338855|76045409|FG000|STARTED|Overall Study||12||
59927342|NCT03338855|76045410|FG001|STARTED|Overall Study||14||
59927343|NCT03338855|76045409|FG000|Received Treatment in Period 1|Overall Study||12||
59927344|NCT03338855|76045410|FG001|Received Treatment in Period 1|Overall Study||14||
59927345|NCT03338855|76045409|FG000|Received Treatment in Period 2|Overall Study||11||
59927346|NCT03338855|76045410|FG001|Received Treatment in Period 2|Overall Study||14||
59927347|NCT03338855|76045409|FG000|COMPLETED|Overall Study||11||
59927348|NCT03338855|76045410|FG001|COMPLETED|Overall Study||14||
59927349|NCT03338855|76045409|FG000|NOT COMPLETED|Overall Study||1||
59927350|NCT03338855|76045410|FG001|NOT COMPLETED|Overall Study||0||
59927351|NCT03367793|76045422|FG000|STARTED|Initial Acuity at Dispense Visit (10min)||5||
59927352|NCT03367793|76045423|FG001|STARTED|Initial Acuity at Dispense Visit (10min)||5||
59927353|NCT03367793|76045424|FG002|STARTED|Initial Acuity at Dispense Visit (10min)||5||
59927354|NCT03367793|76045425|FG003|STARTED|Initial Acuity at Dispense Visit (10min)||5||
59927355|NCT03367793|76045426|FG004|STARTED|Initial Acuity at Dispense Visit (10min)||5||
59927356|NCT03367793|76045427|FG005|STARTED|Initial Acuity at Dispense Visit (10min)||5||
60060911|NCT02012959|76176295|FG002|STARTED|Treatment Phase A|Zero participants noted because participants did not start Phase B yet|0||
60060912|NCT02012959|76176296|FG003|STARTED|Treatment Phase A|Zero participants noted because participants did not start Phase B yet|0||
60060913|NCT02012959|76176297|FG004|STARTED|Treatment Phase A|Zero participants noted because participants did not start Phase B yet|0||
60060914|NCT02012959|76176293|FG000|Received At Least 1 Dose of Study Drug|Treatment Phase A||9|Phase A Safety Sample|
60060915|NCT02012959|76176294|FG001|Received At Least 1 Dose of Study Drug|Treatment Phase A||0|Phase A Safety Sample|
59927357|NCT03367793|76045422|FG000|COMPLETED|Initial Acuity at Dispense Visit (10min)||5||
59927358|NCT03367793|76045423|FG001|COMPLETED|Initial Acuity at Dispense Visit (10min)||5||
59927359|NCT03367793|76045424|FG002|COMPLETED|Initial Acuity at Dispense Visit (10min)||5||
59927360|NCT03367793|76045425|FG003|COMPLETED|Initial Acuity at Dispense Visit (10min)||5||
59927361|NCT03367793|76045426|FG004|COMPLETED|Initial Acuity at Dispense Visit (10min)||5||
59927362|NCT03367793|76045427|FG005|COMPLETED|Initial Acuity at Dispense Visit (10min)||5||
59927363|NCT03367793|76045422|FG000|NOT COMPLETED|Initial Acuity at Dispense Visit (10min)||0||
59927364|NCT03367793|76045423|FG001|NOT COMPLETED|Initial Acuity at Dispense Visit (10min)||0||
59927365|NCT03367793|76045424|FG002|NOT COMPLETED|Initial Acuity at Dispense Visit (10min)||0||
59927366|NCT03367793|76045425|FG003|NOT COMPLETED|Initial Acuity at Dispense Visit (10min)||0||
59927367|NCT03367793|76045426|FG004|NOT COMPLETED|Initial Acuity at Dispense Visit (10min)||0||
59927368|NCT03367793|76045427|FG005|NOT COMPLETED|Initial Acuity at Dispense Visit (10min)||0||
59927369|NCT03367793|76045422|FG000|STARTED|Treatment 1 Dispense to 2 Months Wear||5||
59927370|NCT03367793|76045423|FG001|STARTED|Treatment 1 Dispense to 2 Months Wear||5||
59927371|NCT03367793|76045424|FG002|STARTED|Treatment 1 Dispense to 2 Months Wear||5||
59927372|NCT03367793|76045425|FG003|STARTED|Treatment 1 Dispense to 2 Months Wear||5||
59927373|NCT03367793|76045426|FG004|STARTED|Treatment 1 Dispense to 2 Months Wear||5||
59927374|NCT03367793|76045427|FG005|STARTED|Treatment 1 Dispense to 2 Months Wear||5||
59927375|NCT03367793|76045422|FG000|COMPLETED|Treatment 1 Dispense to 2 Months Wear||5||
60060916|NCT02012959|76176295|FG002|Received At Least 1 Dose of Study Drug|Treatment Phase A||0|Phase A Safety Sample|
60060917|NCT02012959|76176296|FG003|Received At Least 1 Dose of Study Drug|Treatment Phase A||0|Phase A Safety Sample|
60060918|NCT02012959|76176297|FG004|Received At Least 1 Dose of Study Drug|Treatment Phase A||0|Phase A Safety Sample|
59927376|NCT03367793|76045423|FG001|COMPLETED|Treatment 1 Dispense to 2 Months Wear||5||
59927377|NCT03367793|76045424|FG002|COMPLETED|Treatment 1 Dispense to 2 Months Wear||5||
59927378|NCT03367793|76045425|FG003|COMPLETED|Treatment 1 Dispense to 2 Months Wear||5||
59927379|NCT03367793|76045426|FG004|COMPLETED|Treatment 1 Dispense to 2 Months Wear||5||
59927380|NCT03367793|76045427|FG005|COMPLETED|Treatment 1 Dispense to 2 Months Wear||5||
60060919|NCT02012959|76176293|FG000|COMPLETED|Treatment Phase A||7||
60060920|NCT02012959|76176294|FG001|COMPLETED|Treatment Phase A||0||
59927381|NCT03367793|76045422|FG000|NOT COMPLETED|Treatment 1 Dispense to 2 Months Wear||0||
59927382|NCT03367793|76045423|FG001|NOT COMPLETED|Treatment 1 Dispense to 2 Months Wear||0||
59927383|NCT03367793|76045424|FG002|NOT COMPLETED|Treatment 1 Dispense to 2 Months Wear||0||
59927384|NCT03367793|76045425|FG003|NOT COMPLETED|Treatment 1 Dispense to 2 Months Wear||0||
59927385|NCT03367793|76045426|FG004|NOT COMPLETED|Treatment 1 Dispense to 2 Months Wear||0||
59927386|NCT03367793|76045427|FG005|NOT COMPLETED|Treatment 1 Dispense to 2 Months Wear||0||
59927387|NCT03367793|76045422|FG000|STARTED|Treatment 2 Dispense to 2 Months Wear||5||
59927388|NCT03367793|76045423|FG001|STARTED|Treatment 2 Dispense to 2 Months Wear||5||
59927389|NCT03367793|76045424|FG002|STARTED|Treatment 2 Dispense to 2 Months Wear||5||
59927390|NCT03367793|76045425|FG003|STARTED|Treatment 2 Dispense to 2 Months Wear||5||
59927391|NCT03367793|76045426|FG004|STARTED|Treatment 2 Dispense to 2 Months Wear||5||
59927392|NCT03367793|76045427|FG005|STARTED|Treatment 2 Dispense to 2 Months Wear||5||
59927393|NCT03367793|76045422|FG000|COMPLETED|Treatment 2 Dispense to 2 Months Wear||5||
59927394|NCT03367793|76045423|FG001|COMPLETED|Treatment 2 Dispense to 2 Months Wear||5||
59927395|NCT03367793|76045424|FG002|COMPLETED|Treatment 2 Dispense to 2 Months Wear||4||
59927396|NCT03367793|76045425|FG003|COMPLETED|Treatment 2 Dispense to 2 Months Wear||5||
59927397|NCT03367793|76045426|FG004|COMPLETED|Treatment 2 Dispense to 2 Months Wear||5||
59927398|NCT03367793|76045427|FG005|COMPLETED|Treatment 2 Dispense to 2 Months Wear||5||
59927399|NCT03367793|76045422|FG000|NOT COMPLETED|Treatment 2 Dispense to 2 Months Wear||0||
59927400|NCT03367793|76045423|FG001|NOT COMPLETED|Treatment 2 Dispense to 2 Months Wear||0||
59927401|NCT03367793|76045424|FG002|NOT COMPLETED|Treatment 2 Dispense to 2 Months Wear||1||
59927402|NCT03367793|76045425|FG003|NOT COMPLETED|Treatment 2 Dispense to 2 Months Wear||0||
59927403|NCT03367793|76045426|FG004|NOT COMPLETED|Treatment 2 Dispense to 2 Months Wear||0||
59927404|NCT03367793|76045427|FG005|NOT COMPLETED|Treatment 2 Dispense to 2 Months Wear||0||
59927405|NCT03367793|76045422|FG000|STARTED|Treatment 3 Dispense to 2 Months Wear||5||
59927406|NCT03367793|76045423|FG001|STARTED|Treatment 3 Dispense to 2 Months Wear||5||
59927407|NCT03367793|76045424|FG002|STARTED|Treatment 3 Dispense to 2 Months Wear||5||
59927408|NCT03367793|76045425|FG003|STARTED|Treatment 3 Dispense to 2 Months Wear||5||
59927409|NCT03367793|76045426|FG004|STARTED|Treatment 3 Dispense to 2 Months Wear||5||
59927410|NCT03367793|76045427|FG005|STARTED|Treatment 3 Dispense to 2 Months Wear||5||
59927411|NCT03367793|76045422|FG000|COMPLETED|Treatment 3 Dispense to 2 Months Wear||5||
59927412|NCT03367793|76045423|FG001|COMPLETED|Treatment 3 Dispense to 2 Months Wear||5||
59927413|NCT03367793|76045424|FG002|COMPLETED|Treatment 3 Dispense to 2 Months Wear||5||
59927414|NCT03367793|76045425|FG003|COMPLETED|Treatment 3 Dispense to 2 Months Wear||5||
59927415|NCT03367793|76045426|FG004|COMPLETED|Treatment 3 Dispense to 2 Months Wear||5||
59927416|NCT03367793|76045427|FG005|COMPLETED|Treatment 3 Dispense to 2 Months Wear||5||
59927417|NCT03367793|76045422|FG000|NOT COMPLETED|Treatment 3 Dispense to 2 Months Wear||0||
60060921|NCT02012959|76176295|FG002|COMPLETED|Treatment Phase A||0||
60060922|NCT02012959|76176296|FG003|COMPLETED|Treatment Phase A||0||
59927418|NCT03367793|76045423|FG001|NOT COMPLETED|Treatment 3 Dispense to 2 Months Wear||0||
59927419|NCT03367793|76045424|FG002|NOT COMPLETED|Treatment 3 Dispense to 2 Months Wear||0||
59927420|NCT03367793|76045425|FG003|NOT COMPLETED|Treatment 3 Dispense to 2 Months Wear||0||
59927421|NCT03367793|76045426|FG004|NOT COMPLETED|Treatment 3 Dispense to 2 Months Wear||0||
60060923|NCT02012959|76176297|FG004|COMPLETED|Treatment Phase A||0||
60060924|NCT02012959|76176293|FG000|NOT COMPLETED|Treatment Phase A||2||
60060925|NCT02012959|76176294|FG001|NOT COMPLETED|Treatment Phase A||0||
60060926|NCT02012959|76176295|FG002|NOT COMPLETED|Treatment Phase A||0||
60060927|NCT02012959|76176296|FG003|NOT COMPLETED|Treatment Phase A||0||
60060928|NCT02012959|76176297|FG004|NOT COMPLETED|Treatment Phase A||0||
60060929|NCT02012959|76176293|FG000|STARTED|Treatment Phase B|Zero participants noted because participants had completed Phase A|0||
60060930|NCT02012959|76176294|FG001|STARTED|Treatment Phase B|Participants in this group continued treatment with the study drug|2||
60060931|NCT02012959|76176295|FG002|STARTED|Treatment Phase B|Participants in this group did not receive additional study drug after Phase A|3||
60060932|NCT02012959|76176296|FG003|STARTED|Treatment Phase B|Participants in this group could continue study drug treatment, per the investigator's discretion|1||
60060933|NCT02012959|76176297|FG004|STARTED|Treatment Phase B|Participants in this group could receive the investigator's preferred standard of care|1||
60060934|NCT02012959|76176293|FG000|Received At Least 1 Dose of Study Drug|Treatment Phase B||0|Phase B Safety Sample|
60060935|NCT02012959|76176294|FG001|Received At Least 1 Dose of Study Drug|Treatment Phase B||2|Phase B Safety Sample|
60060936|NCT02012959|76176295|FG002|Received At Least 1 Dose of Study Drug|Treatment Phase B||3|Phase B Safety Sample|
60060937|NCT02012959|76176296|FG003|Received At Least 1 Dose of Study Drug|Treatment Phase B||1|Phase B Safety Sample|
60060938|NCT02012959|76176297|FG004|Received At Least 1 Dose of Study Drug|Treatment Phase B||1|Phase B Safety Sample|
60060939|NCT02012959|76176293|FG000|COMPLETED|Treatment Phase B||0||
60060940|NCT02012959|76176294|FG001|COMPLETED|Treatment Phase B||2||
60060941|NCT02012959|76176295|FG002|COMPLETED|Treatment Phase B||3||
60060942|NCT02012959|76176296|FG003|COMPLETED|Treatment Phase B||1||
60060943|NCT02012959|76176297|FG004|COMPLETED|Treatment Phase B||1||
60060944|NCT02012959|76176293|FG000|NOT COMPLETED|Treatment Phase B||0||
60060945|NCT02012959|76176294|FG001|NOT COMPLETED|Treatment Phase B||0||
60060946|NCT02012959|76176295|FG002|NOT COMPLETED|Treatment Phase B||0||
60060947|NCT02012959|76176296|FG003|NOT COMPLETED|Treatment Phase B||0||
59516775|NCT03435562|75610446|FG000|COMPLETED|Overall Study||18||
59516776|NCT03435562|75610446|FG000|NOT COMPLETED|Overall Study||4||
59516777|NCT01000285|75610459|FG000|STARTED|Overall Study||18||
59516778|NCT01000285|75610459|FG000|COMPLETED|Overall Study||18||
59516779|NCT01000285|75610459|FG000|NOT COMPLETED|Overall Study||0||
59613068|NCT01713582|75724099|FG005|NOT COMPLETED|Overall Study||8||
59613069|NCT01713582|75724100|FG006|NOT COMPLETED|Overall Study||7||
59613070|NCT01713582|75724101|FG007|NOT COMPLETED|Overall Study||6||
59613071|NCT01713582|75724102|FG008|NOT COMPLETED|Overall Study||6||
59760995|NCT03951805|75880650|FG001|COMPLETED|Overall Study||51||
59760996|NCT03951805|75880651|FG002|COMPLETED|Overall Study||52||
59760997|NCT03951805|75880652|FG003|COMPLETED|Overall Study||51||
59760998|NCT03951805|75880649|FG000|NOT COMPLETED|Overall Study||1||
59927422|NCT03367793|76045427|FG005|NOT COMPLETED|Treatment 3 Dispense to 2 Months Wear||0||
59927423|NCT01209234|76045440|FG000|STARTED|Overall Study||1070||
59927424|NCT01209234|76045441|FG001|STARTED|Overall Study||1070||
59927425|NCT01209234|76045440|FG000|COMPLETED|Overall Study||1058||
59927426|NCT01209234|76045441|FG001|COMPLETED|Overall Study||1063||
59927427|NCT01209234|76045440|FG000|NOT COMPLETED|Overall Study||12||
59927428|NCT01209234|76045441|FG001|NOT COMPLETED|Overall Study||7||
59927429|NCT01347307|76045449|FG000|STARTED|Overall Study||3||
59927430|NCT01347307|76045450|FG001|STARTED|Overall Study||33||
59927431|NCT01347307|76045449|FG000|COMPLETED|Overall Study||3||
59927432|NCT01347307|76045450|FG001|COMPLETED|Overall Study||28||
60060948|NCT02012959|76176297|FG004|NOT COMPLETED|Treatment Phase B||0||
60060949|NCT01990742|76176309|FG000|STARTED|Overall Study|This is a facility-level intervention, access to individual level records occurred via MDS data only|3259||16
60060950|NCT01990742|76176310|FG001|STARTED|Overall Study|This is a facility-level control , access to individual participants occurred only via MDS records.|4331||15
60060951|NCT01990742|76176309|FG000|COMPLETED|Overall Study|Fourteen facilities completed the intervention.|2852||14
60060952|NCT01990742|76176310|FG001|COMPLETED|Overall Study|Eleven nursing homes completed the control group /usual care allocation.|2978||11
60060953|NCT01990742|76176309|FG000|NOT COMPLETED|Overall Study||407||2
60060954|NCT01990742|76176310|FG001|NOT COMPLETED|Overall Study||1353||4
60060955|NCT02012491|76176318|FG000|STARTED|Overall Study||151||
60060956|NCT02012491|76176319|FG001|STARTED|Overall Study||149||
60060957|NCT02012491|76176318|FG000|COMPLETED|Overall Study||149||
60060958|NCT02012491|76176319|FG001|COMPLETED|Overall Study||148||
60060959|NCT02012491|76176318|FG000|NOT COMPLETED|Overall Study||2||
59516780|NCT03207022|75610475|FG000|STARTED|Overall Study||12||
59516781|NCT03207022|75610476|FG001|STARTED|Overall Study||12||
59516782|NCT03207022|75610475|FG000|COMPLETED|Overall Study||12||
59516783|NCT03207022|75610476|FG001|COMPLETED|Overall Study||12||
59516784|NCT03207022|75610475|FG000|NOT COMPLETED|Overall Study||0||
59516785|NCT03207022|75610476|FG001|NOT COMPLETED|Overall Study||0||
59516786|NCT03208192|75610484|FG000|STARTED|Overall Study||32||
59760999|NCT03951805|75880650|FG001|NOT COMPLETED|Overall Study||0||
59761000|NCT03951805|75880651|FG002|NOT COMPLETED|Overall Study||0||
59761001|NCT03951805|75880652|FG003|NOT COMPLETED|Overall Study||0||
59927433|NCT01347307|76045449|FG000|NOT COMPLETED|Overall Study||0||
59927434|NCT01347307|76045450|FG001|NOT COMPLETED|Overall Study||5||
59927435|NCT03373110|76045459|FG000|STARTED|Overall Study||133||
59927436|NCT03373110|76045460|FG001|STARTED|Overall Study||137||
59927437|NCT03373110|76045461|FG002|STARTED|Overall Study||70||
59927438|NCT03373110|76045459|FG000|Provided Fitbit Data|Overall Study||123||
59927439|NCT03373110|76045460|FG001|Provided Fitbit Data|Overall Study||130||
59927440|NCT03373110|76045461|FG002|Provided Fitbit Data|Overall Study||63||
59927441|NCT03373110|76045459|FG000|COMPLETED|Overall Study||55||
59927442|NCT03373110|76045460|FG001|COMPLETED|Overall Study||58||
59927443|NCT03373110|76045461|FG002|COMPLETED|Overall Study||26||
59927444|NCT03373110|76045459|FG000|NOT COMPLETED|Overall Study||78||
59927445|NCT03373110|76045460|FG001|NOT COMPLETED|Overall Study||79||
59927446|NCT03373110|76045461|FG002|NOT COMPLETED|Overall Study||44||
59927447|NCT03993457|76045473|FG000|STARTED|Overall Study||4||
59927448|NCT03993457|76045474|FG001|STARTED|Overall Study||2||
59927449|NCT03993457|76045475|FG002|STARTED|Overall Study||1||
59927450|NCT03993457|76045476|FG003|STARTED|Overall Study||4||
59927451|NCT03993457|76045473|FG000|COMPLETED|Overall Study||4||
59927452|NCT03993457|76045474|FG001|COMPLETED|Overall Study||2||
59927453|NCT03993457|76045475|FG002|COMPLETED|Overall Study||1||
59927454|NCT03993457|76045476|FG003|COMPLETED|Overall Study||2||
59927455|NCT03993457|76045473|FG000|NOT COMPLETED|Overall Study||0||
59927456|NCT03993457|76045474|FG001|NOT COMPLETED|Overall Study||0||
59927457|NCT03993457|76045475|FG002|NOT COMPLETED|Overall Study||0||
59927458|NCT03993457|76045476|FG003|NOT COMPLETED|Overall Study||2||
59927459|NCT03309072|76045488|FG000|STARTED|Overall Study||15||
59927460|NCT03309072|76045489|FG001|STARTED|Overall Study||15||
59927461|NCT03309072|76045488|FG000|COMPLETED|Overall Study||15||
59927462|NCT03309072|76045489|FG001|COMPLETED|Overall Study||15||
59927463|NCT03309072|76045488|FG000|NOT COMPLETED|Overall Study||0||
59927464|NCT03309072|76045489|FG001|NOT COMPLETED|Overall Study||0||
59927465|NCT02986789|76045497|FG000|STARTED|Overall Study||43||
59927466|NCT02986789|76045498|FG001|STARTED|Overall Study||0||
59927467|NCT02986789|76045497|FG000|COMPLETED|Overall Study||43||
59927468|NCT02986789|76045498|FG001|COMPLETED|Overall Study||0||
59927469|NCT02986789|76045497|FG000|NOT COMPLETED|Overall Study||0||
59927470|NCT02986789|76045498|FG001|NOT COMPLETED|Overall Study||0||
59927471|NCT03247543|76045507|FG000|STARTED|Overall Study||102|The number of subjects reported here is based on the Safety Population (assigned treatment arm); includes subjects who were randomized and took at least one dose of study medication.|
59927472|NCT03247543|76045508|FG001|STARTED|Overall Study||107|The number of subjects reported here is based on the Safety Population (assigned treatment arm); includes subjects who were randomized and took at least one dose of study medication.|
59927473|NCT03247543|76045509|FG002|STARTED|Overall Study|One subject randomized to the 400mg/day SPN-812 arm received Placebo during the trial.|101|The number of subjects reported here is based on the Safety Population (assigned treatment arm); includes subjects who were randomized and took at least one dose of study medication.|
59927474|NCT03247543|76045507|FG000|COMPLETED|Overall Study||85||
59927475|NCT03247543|76045508|FG001|COMPLETED|Overall Study||88||
59927476|NCT03247543|76045509|FG002|COMPLETED|Overall Study||78||
59927477|NCT03247543|76045507|FG000|NOT COMPLETED|Overall Study||17||
59927478|NCT03247543|76045508|FG001|NOT COMPLETED|Overall Study||19||
59927479|NCT03247543|76045509|FG002|NOT COMPLETED|Overall Study||23||
59927480|NCT01347073|76045519|FG000|STARTED|Overall Study||23||
59927481|NCT01347073|76045519|FG000|COMPLETED|Overall Study||21||
59927482|NCT01347073|76045519|FG000|NOT COMPLETED|Overall Study||2||
59927483|NCT01315236|76045531|FG000|STARTED|Double-blind Phase||44||
60060960|NCT02012491|76176319|FG001|NOT COMPLETED|Overall Study||1||
60060961|NCT01990664|76176327|FG000|STARTED|Overall Study||102||
60060962|NCT01990664|76176328|FG001|STARTED|Overall Study||90||
60060963|NCT01990664|76176327|FG000|COMPLETED|Overall Study||95||
59927484|NCT01315236|76045532|FG001|STARTED|Double-blind Phase||45||
59927485|NCT01315236|76045531|FG000|COMPLETED|Double-blind Phase||40||
59927486|NCT01315236|76045532|FG001|COMPLETED|Double-blind Phase||45||
59927487|NCT01315236|76045531|FG000|NOT COMPLETED|Double-blind Phase||4||
59927488|NCT01315236|76045532|FG001|NOT COMPLETED|Double-blind Phase||0||
59927489|NCT01315236|76045531|FG000|STARTED|Open-label Phase|Some subjects did not consent to the open label after the double blind phase.|35||
59927490|NCT01315236|76045532|FG001|STARTED|Open-label Phase|Some subjects did not consent to the open label after the double blind phase.|43||
59927491|NCT01315236|76045531|FG000|COMPLETED|Open-label Phase||34||
59927492|NCT01315236|76045532|FG001|COMPLETED|Open-label Phase||41||
59927493|NCT01315236|76045531|FG000|NOT COMPLETED|Open-label Phase||1||
59927494|NCT01315236|76045532|FG001|NOT COMPLETED|Open-label Phase||2||
59927495|NCT01315236|76045531|FG000|STARTED|12-Month Follow-up Period|Some subjects did not consent to the 12 month safety.|27||
59927496|NCT01315236|76045532|FG001|STARTED|12-Month Follow-up Period|Some subjects did not consent to the 12 month safety.|32||
59927497|NCT01315236|76045531|FG000|COMPLETED|12-Month Follow-up Period||26||
59927498|NCT01315236|76045532|FG001|COMPLETED|12-Month Follow-up Period||31||
59927499|NCT01315236|76045531|FG000|NOT COMPLETED|12-Month Follow-up Period||1||
59927500|NCT01315236|76045532|FG001|NOT COMPLETED|12-Month Follow-up Period||1||
59927501|NCT03232567|76045544|FG000|STARTED|Overall Study||15||
59927502|NCT03232567|76045545|FG001|STARTED|Overall Study||15||
59927503|NCT03232567|76045546|FG002|STARTED|Overall Study||15||
59927504|NCT03232567|76045547|FG003|STARTED|Overall Study||15||
59927505|NCT03232567|76045544|FG000|COMPLETED|Overall Study||15||
59927506|NCT03232567|76045545|FG001|COMPLETED|Overall Study||14||
59927507|NCT03232567|76045546|FG002|COMPLETED|Overall Study||15||
59516787|NCT03208192|75610485|FG001|STARTED|Overall Study||36||
59516788|NCT03208192|75610484|FG000|COMPLETED|Overall Study||32||
59516789|NCT03208192|75610485|FG001|COMPLETED|Overall Study||36||
59927508|NCT03232567|76045547|FG003|COMPLETED|Overall Study||15||
59927509|NCT03232567|76045544|FG000|NOT COMPLETED|Overall Study||0||
59927510|NCT03232567|76045545|FG001|NOT COMPLETED|Overall Study||1||
59927511|NCT03232567|76045546|FG002|NOT COMPLETED|Overall Study||0||
59927512|NCT03232567|76045547|FG003|NOT COMPLETED|Overall Study||0||
59927513|NCT01348490|76045557|FG000|STARTED|Overall Study||66||
59927514|NCT01348490|76045557|FG000|COMPLETED|Overall Study||42||
59927515|NCT01348490|76045557|FG000|NOT COMPLETED|Overall Study||24||
59927516|NCT03040674|76045578|FG000|STARTED|Overall Study||489||
59927517|NCT03040674|76045578|FG000|Participants Completing 3 Month Survey|Overall Study||351||
59927518|NCT03040674|76045578|FG000|Participants Completing 6 Month Survey|Overall Study||241||
59927519|NCT03040674|76045578|FG000|COMPLETED|Overall Study||241|Total number of participants completing the study (6 months post-treatment)|
59927520|NCT03040674|76045578|FG000|NOT COMPLETED|Overall Study||248||
59927521|NCT03232333|76045583|FG000|STARTED|Overall Study||53||
59927522|NCT03232333|76045583|FG000|COMPLETED|Overall Study||38||
59927523|NCT03232333|76045583|FG000|NOT COMPLETED|Overall Study||15||
59927524|NCT03364049|76045591|FG000|STARTED|Overall Study||6||
59927525|NCT03364049|76045592|FG001|STARTED|Overall Study||6||
59927526|NCT03364049|76045593|FG002|STARTED|Overall Study||6||
59927527|NCT03364049|76045594|FG003|STARTED|Overall Study||15||
59927528|NCT03364049|76045591|FG000|COMPLETED|Overall Study||0||
59927529|NCT03364049|76045592|FG001|COMPLETED|Overall Study||0||
59927530|NCT03364049|76045593|FG002|COMPLETED|Overall Study||0||
59927531|NCT03364049|76045594|FG003|COMPLETED|Overall Study||0||
59927532|NCT03364049|76045591|FG000|NOT COMPLETED|Overall Study||6||
59927533|NCT03364049|76045592|FG001|NOT COMPLETED|Overall Study||6||
59927534|NCT03364049|76045593|FG002|NOT COMPLETED|Overall Study||6||
59927535|NCT03364049|76045594|FG003|NOT COMPLETED|Overall Study||15||
59927536|NCT03238963|76045606|FG000|STARTED|Overall Study||40||
59927537|NCT03238963|76045607|FG001|STARTED|Overall Study||39||
59927538|NCT03238963|76045606|FG000|COMPLETED|Overall Study||35||
59927539|NCT03238963|76045607|FG001|COMPLETED|Overall Study||37||
59927540|NCT03238963|76045606|FG000|NOT COMPLETED|Overall Study||5||
59927541|NCT03238963|76045607|FG001|NOT COMPLETED|Overall Study||2||
59927542|NCT03337139|76045615|FG000|STARTED|Phase I||87||
59927543|NCT03337139|76045616|FG001|STARTED|Phase I|There were not two conditions in Phase I: all participants received standard group LM treatment.|0||
59927544|NCT03337139|76045615|FG000|COMPLETED|Phase I||77||
59927545|NCT03337139|76045616|FG001|COMPLETED|Phase I||0||
59927546|NCT03337139|76045615|FG000|NOT COMPLETED|Phase I||10||
59927547|NCT03337139|76045616|FG001|NOT COMPLETED|Phase I||0||
59927548|NCT03337139|76045615|FG000|STARTED|Phase II||38||
59927549|NCT03337139|76045616|FG001|STARTED|Phase II||39||
59927550|NCT03337139|76045615|FG000|26 Week Assessment|Phase II||34||
59516790|NCT03208192|75610484|FG000|NOT COMPLETED|Overall Study||0||
59516791|NCT03208192|75610485|FG001|NOT COMPLETED|Overall Study||0||
59516792|NCT01000987|75610496|FG000|STARTED|Overall Study||12||
59516793|NCT01000987|75610497|FG001|STARTED|Overall Study||15||
59516794|NCT01000987|75610498|FG002|STARTED|Overall Study||17||
59516795|NCT01000987|75610496|FG000|COMPLETED|Overall Study||12||
59516796|NCT01000987|75610497|FG001|COMPLETED|Overall Study||15||
59516797|NCT01000987|75610498|FG002|COMPLETED|Overall Study||17||
59516798|NCT01000987|75610496|FG000|NOT COMPLETED|Overall Study||0||
59516799|NCT01000987|75610497|FG001|NOT COMPLETED|Overall Study||0||
59927551|NCT03337139|76045616|FG001|26 Week Assessment|Phase II||37||
59927552|NCT03337139|76045615|FG000|COMPLETED|Phase II||33||
59927553|NCT03337139|76045616|FG001|COMPLETED|Phase II||36||
59927554|NCT03337139|76045615|FG000|NOT COMPLETED|Phase II||5||
60060964|NCT01990664|76176328|FG001|COMPLETED|Overall Study||79||
60060965|NCT01990664|76176327|FG000|NOT COMPLETED|Overall Study||7||
59927555|NCT03337139|76045616|FG001|NOT COMPLETED|Phase II||3||
59927556|NCT03042312|76045624|FG000|STARTED|Overall Study||28|All randomized participants were included in Intent-to-treat (ITT) population|
59927557|NCT03042312|76045625|FG001|STARTED|Overall Study||43|All randomized participants were included in Intent-to-treat (ITT) population|
59927558|NCT03042312|76045624|FG000|Safety Population|Overall Study||23|The subset of patients in the ITT population who received at least one dose of randomized therapy.|
59927559|NCT03042312|76045625|FG001|Safety Population|Overall Study||41|The subset of patients in the ITT population who received at least one dose of randomized therapy.|
59927560|NCT03042312|76045624|FG000|COMPLETED|Overall Study||18||
59927561|NCT03042312|76045625|FG001|COMPLETED|Overall Study||31||
59927562|NCT03042312|76045624|FG000|NOT COMPLETED|Overall Study||10||
59927563|NCT03042312|76045625|FG001|NOT COMPLETED|Overall Study||12||
59927564|NCT03360071|76045633|FG000|STARTED|Overall Study||17||
59927565|NCT03360071|76045634|FG001|STARTED|Overall Study||14||
59927566|NCT03360071|76045633|FG000|COMPLETED|Overall Study||16||
59927567|NCT03360071|76045634|FG001|COMPLETED|Overall Study||14||
59927568|NCT03360071|76045633|FG000|NOT COMPLETED|Overall Study||1||
59927569|NCT03360071|76045634|FG001|NOT COMPLETED|Overall Study||0||
59927570|NCT02949011|76045643|FG000|STARTED|Overall Study||730||
59927571|NCT02949011|76045644|FG001|STARTED|Overall Study||729||
59927572|NCT02949011|76045645|FG002|STARTED|Overall Study||725||
59927573|NCT02949011|76045643|FG000|Received Study Drug|Overall Study||728||
59927574|NCT02949011|76045644|FG001|Received Study Drug|Overall Study|Includes one participant who received baloxavir marboxil in error|728||
59927575|NCT02949011|76045645|FG002|Received Study Drug|Overall Study|Includes one participant who received baloxavir marboxil in error|722||
59927576|NCT02949011|76045643|FG000|Intention to Treat Infected Population|Overall Study||388||
59927577|NCT02949011|76045644|FG001|Intention to Treat Infected Population|Overall Study||386||
59927578|NCT02949011|76045645|FG002|Intention to Treat Infected Population|Overall Study||389||
59927579|NCT02949011|76045643|FG000|COMPLETED|Overall Study||697||
59927580|NCT02949011|76045644|FG001|COMPLETED|Overall Study||695||
59927581|NCT02949011|76045645|FG002|COMPLETED|Overall Study||683||
59927582|NCT02949011|76045643|FG000|NOT COMPLETED|Overall Study||33||
59927583|NCT02949011|76045644|FG001|NOT COMPLETED|Overall Study||34||
59927584|NCT02949011|76045645|FG002|NOT COMPLETED|Overall Study||42||
59927585|NCT05143541|76045653|FG000|STARTED|Overall Study||80||
59927586|NCT05143541|76045653|FG000|COMPLETED|Overall Study||80||
59927587|NCT05143541|76045653|FG000|NOT COMPLETED|Overall Study||0||
59927588|NCT03357731|76045657|FG000|STARTED|Overall Study||8|started = received Period 1 assigned treatment|
59927589|NCT03357731|76045658|FG001|STARTED|Overall Study||7|started = received Period 1 assigned treatment|
59927590|NCT03357731|76045659|FG002|STARTED|Overall Study||7|started = received Period 1 assigned treatment|
59927591|NCT03357731|76045660|FG003|STARTED|Overall Study||7|started = received Period 1 assigned treatment|
59927592|NCT03357731|76045661|FG004|STARTED|Overall Study||8|started = received Period 1 assigned treatment|
59927593|NCT03357731|76045662|FG005|STARTED|Overall Study||8|started = received Period 1 assigned treatment|
59927594|NCT03357731|76045657|FG000|Completed Period 1 (P1)|Overall Study|1 withdrew post-P1 completion/prior to P2 therapy due to acute cholecystitis, but returned for P2/P3|8||
59927595|NCT03357731|76045658|FG001|Completed Period 1 (P1)|Overall Study||7||
59927596|NCT03357731|76045659|FG002|Completed Period 1 (P1)|Overall Study||7||
59927597|NCT03357731|76045660|FG003|Completed Period 1 (P1)|Overall Study|1 discontinued P1 due to acute bradycardia and hypotension|6||
59927598|NCT03357731|76045661|FG004|Completed Period 1 (P1)|Overall Study|1 discontinued P1 due to hypotension but resumed P2/P3|7||
59927599|NCT03357731|76045662|FG005|Completed Period 1 (P1)|Overall Study||8||
59927600|NCT03357731|76045657|FG000|Completed Period 2 (P2)|Overall Study||8||
59927601|NCT03357731|76045658|FG001|Completed Period 2 (P2)|Overall Study||7||
59927602|NCT03357731|76045659|FG002|Completed Period 2 (P2)|Overall Study||7||
59927603|NCT03357731|76045660|FG003|Completed Period 2 (P2)|Overall Study|"1 completed P1, did not proceed to P2/P3 (lost to follow-up);~1 discontinued P2 due to hypotension"|4||
59927604|NCT03357731|76045661|FG004|Completed Period 2 (P2)|Overall Study|1 only completed P1, did not continue to P2/P3 (withdrew consent due to personal reasons)|7||
59927605|NCT03357731|76045662|FG005|Completed Period 2 (P2)|Overall Study|1 discontinued P2 due to an Adverse Event (AE)|7||
59927606|NCT03357731|76045657|FG000|COMPLETED|Overall Study||8|completed = finished Period 3 (P3) assigned treatment|
59927607|NCT03357731|76045658|FG001|COMPLETED|Overall Study||7|completed = finished Period 3 (P3) assigned treatment|
59927608|NCT03357731|76045659|FG002|COMPLETED|Overall Study|1 discontinuation due to hypotension|6|completed = finished Period 3 (P3) assigned treatment|
59927609|NCT03357731|76045660|FG003|COMPLETED|Overall Study||4|completed = finished Period 3 (P3) assigned treatment|
59927610|NCT03357731|76045661|FG004|COMPLETED|Overall Study||7|completed = finished Period 3 (P3) assigned treatment|
59927611|NCT03357731|76045662|FG005|COMPLETED|Overall Study||7|completed = finished Period 3 (P3) assigned treatment|
60060966|NCT01990664|76176328|FG001|NOT COMPLETED|Overall Study||11||
60060967|NCT02038010|76176334|FG000|STARTED|Completed 1st Cycle and Started Cycle 2||11||
60060968|NCT02038010|76176335|FG001|STARTED|Completed 1st Cycle and Started Cycle 2||6||
60060969|NCT02038010|76176336|FG002|STARTED|Completed 1st Cycle and Started Cycle 2|Due to safety data, dose was de-escalated and no patients enrolled at this dose.|0||
60067873|NCT01913041|76183067|FG000|NOT COMPLETED|Overall Study||39||
60060970|NCT02038010|76176337|FG003|STARTED|Completed 1st Cycle and Started Cycle 2|Due to safety data, dose was de-escalated and no patients enrolled at this dose.|0||
60060971|NCT02038010|76176334|FG000|Completed 1st Cycle|Completed 1st Cycle and Started Cycle 2||11||
60060972|NCT02038010|76176335|FG001|Completed 1st Cycle|Completed 1st Cycle and Started Cycle 2||5||
60060973|NCT02038010|76176336|FG002|Completed 1st Cycle|Completed 1st Cycle and Started Cycle 2||0||
60060974|NCT02038010|76176337|FG003|Completed 1st Cycle|Completed 1st Cycle and Started Cycle 2||0||
60060975|NCT02038010|76176334|FG000|Continued on to Cycle 2|Completed 1st Cycle and Started Cycle 2||10||
60060976|NCT02038010|76176335|FG001|Continued on to Cycle 2|Completed 1st Cycle and Started Cycle 2||4||
60060977|NCT02038010|76176336|FG002|Continued on to Cycle 2|Completed 1st Cycle and Started Cycle 2||0||
60060978|NCT02038010|76176337|FG003|Continued on to Cycle 2|Completed 1st Cycle and Started Cycle 2||0||
60060979|NCT02038010|76176334|FG000|COMPLETED|Completed 1st Cycle and Started Cycle 2||10||
60060980|NCT02038010|76176335|FG001|COMPLETED|Completed 1st Cycle and Started Cycle 2||4||
60060981|NCT02038010|76176336|FG002|COMPLETED|Completed 1st Cycle and Started Cycle 2||0||
60060982|NCT02038010|76176337|FG003|COMPLETED|Completed 1st Cycle and Started Cycle 2||0||
60060983|NCT02038010|76176334|FG000|NOT COMPLETED|Completed 1st Cycle and Started Cycle 2||1||
60060984|NCT02038010|76176335|FG001|NOT COMPLETED|Completed 1st Cycle and Started Cycle 2||2||
60060985|NCT02038010|76176336|FG002|NOT COMPLETED|Completed 1st Cycle and Started Cycle 2||0||
60060986|NCT02038010|76176337|FG003|NOT COMPLETED|Completed 1st Cycle and Started Cycle 2||0||
60060987|NCT02038010|76176334|FG000|STARTED|Completed 3 Cycles/Reached 1st Response||10||
60060988|NCT02038010|76176335|FG001|STARTED|Completed 3 Cycles/Reached 1st Response||4||
60060989|NCT02038010|76176336|FG002|STARTED|Completed 3 Cycles/Reached 1st Response||0||
60060990|NCT02038010|76176337|FG003|STARTED|Completed 3 Cycles/Reached 1st Response||0||
60060991|NCT02038010|76176334|FG000|Completed 3 Cycles|Completed 3 Cycles/Reached 1st Response||10||
60060992|NCT02038010|76176335|FG001|Completed 3 Cycles|Completed 3 Cycles/Reached 1st Response||4||
60060993|NCT02038010|76176336|FG002|Completed 3 Cycles|Completed 3 Cycles/Reached 1st Response||0||
60060994|NCT02038010|76176337|FG003|Completed 3 Cycles|Completed 3 Cycles/Reached 1st Response||0||
60060995|NCT02038010|76176334|FG000|Continued to Cycle 4|Completed 3 Cycles/Reached 1st Response||9||
60060996|NCT02038010|76176335|FG001|Continued to Cycle 4|Completed 3 Cycles/Reached 1st Response||3||
60060997|NCT02038010|76176336|FG002|Continued to Cycle 4|Completed 3 Cycles/Reached 1st Response||0||
60060998|NCT02038010|76176337|FG003|Continued to Cycle 4|Completed 3 Cycles/Reached 1st Response||0||
60060999|NCT02038010|76176334|FG000|COMPLETED|Completed 3 Cycles/Reached 1st Response||9||
60061000|NCT02038010|76176335|FG001|COMPLETED|Completed 3 Cycles/Reached 1st Response||3||
60061001|NCT02038010|76176336|FG002|COMPLETED|Completed 3 Cycles/Reached 1st Response||0||
60061002|NCT02038010|76176337|FG003|COMPLETED|Completed 3 Cycles/Reached 1st Response||0||
60061003|NCT02038010|76176334|FG000|NOT COMPLETED|Completed 3 Cycles/Reached 1st Response||1||
60061004|NCT02038010|76176335|FG001|NOT COMPLETED|Completed 3 Cycles/Reached 1st Response||1||
60061005|NCT02038010|76176336|FG002|NOT COMPLETED|Completed 3 Cycles/Reached 1st Response||0||
60061006|NCT02038010|76176337|FG003|NOT COMPLETED|Completed 3 Cycles/Reached 1st Response||0||
60061007|NCT02038010|76176334|FG000|STARTED|Follow Up||11||
60061008|NCT02038010|76176335|FG001|STARTED|Follow Up||6||
60061009|NCT02038010|76176336|FG002|STARTED|Follow Up||0||
60061010|NCT02038010|76176337|FG003|STARTED|Follow Up||0||
60061011|NCT02038010|76176334|FG000|COMPLETED|Follow Up||4||
60061012|NCT02038010|76176335|FG001|COMPLETED|Follow Up||3||
60061013|NCT02038010|76176336|FG002|COMPLETED|Follow Up||0||
60061014|NCT02038010|76176337|FG003|COMPLETED|Follow Up||0||
60061015|NCT02038010|76176334|FG000|NOT COMPLETED|Follow Up||7||
60061016|NCT02038010|76176335|FG001|NOT COMPLETED|Follow Up||3||
60061017|NCT02038010|76176336|FG002|NOT COMPLETED|Follow Up||0||
60061018|NCT02038010|76176337|FG003|NOT COMPLETED|Follow Up||0||
60061019|NCT01989572|76176351|FG000|STARTED|Overall Study||109||
60061020|NCT01989572|76176352|FG001|STARTED|Overall Study||111||
60061021|NCT01989572|76176353|FG002|STARTED|Overall Study||109||
60061022|NCT01989572|76176354|FG003|STARTED|Overall Study||107||
60061023|NCT01989572|76176355|FG004|STARTED|Overall Study||190||
60061024|NCT01989572|76176356|FG005|STARTED|Overall Study||189||
60061025|NCT01989572|76176351|FG000|Treated|Overall Study||104||
60061026|NCT01989572|76176352|FG001|Treated|Overall Study||110||
60061027|NCT01989572|76176353|FG002|Treated|Overall Study||107||
60061028|NCT01989572|76176354|FG003|Treated|Overall Study||104||
60061029|NCT01989572|76176355|FG004|Treated|Overall Study||186||
60061030|NCT01989572|76176356|FG005|Treated|Overall Study||171||
60061031|NCT01989572|76176351|FG000|COMPLETED|Overall Study||54||
60061032|NCT01989572|76176352|FG001|COMPLETED|Overall Study||53||
60061033|NCT01989572|76176353|FG002|COMPLETED|Overall Study||47||
60061034|NCT01989572|76176354|FG003|COMPLETED|Overall Study||56||
60061035|NCT01989572|76176355|FG004|COMPLETED|Overall Study||92||
60061036|NCT01989572|76176356|FG005|COMPLETED|Overall Study||79||
60061037|NCT01989572|76176351|FG000|NOT COMPLETED|Overall Study||55||
60061038|NCT01989572|76176352|FG001|NOT COMPLETED|Overall Study||58||
60061039|NCT01989572|76176353|FG002|NOT COMPLETED|Overall Study||62||
60061040|NCT01989572|76176354|FG003|NOT COMPLETED|Overall Study||51||
60061041|NCT01989572|76176355|FG004|NOT COMPLETED|Overall Study||98||
60061042|NCT01989572|76176356|FG005|NOT COMPLETED|Overall Study||110||
60061043|NCT02036294|76176376|FG000|STARTED|Overall Study||120||
60061044|NCT02036294|76176377|FG001|STARTED|Overall Study||120||
60061045|NCT02036294|76176376|FG000|COMPLETED|Overall Study||111||
60061046|NCT02036294|76176377|FG001|COMPLETED|Overall Study||109||
60061047|NCT02036294|76176376|FG000|NOT COMPLETED|Overall Study||9||
60061048|NCT02036294|76176377|FG001|NOT COMPLETED|Overall Study||11||
60061049|NCT02035748|76176383|FG000|STARTED|Overall Study||468||
60061050|NCT02035748|76176383|FG000|COMPLETED|Overall Study||448||
60061051|NCT02035748|76176383|FG000|NOT COMPLETED|Overall Study||20||
60061052|NCT02014376|76176391|FG000|STARTED|Overall Study||15||
60061053|NCT02014376|76176392|FG001|STARTED|Overall Study||16||
60061054|NCT02014376|76176393|FG002|STARTED|Overall Study||17||
60061055|NCT02014376|76176391|FG000|Received at Least 1 Dose of Study Drug|Overall Study||15|Intent-to-treat (ITT) Population|
60061056|NCT02014376|76176392|FG001|Received at Least 1 Dose of Study Drug|Overall Study||16|Intent-to-treat (ITT) Population|
60061057|NCT02014376|76176393|FG002|Received at Least 1 Dose of Study Drug|Overall Study||17|Intent-to-treat (ITT) Population|
60061058|NCT02014376|76176391|FG000|COMPLETED|Overall Study||12||
59516800|NCT01000987|75610498|FG002|NOT COMPLETED|Overall Study||0||
59516801|NCT00633464|75610508|FG000|STARTED|Overall Study||40||
59516802|NCT00633464|75610509|FG001|STARTED|Overall Study||39||
59516803|NCT00633464|75610508|FG000|Treated|Overall Study||40||
59516804|NCT00633464|75610509|FG001|Treated|Overall Study||37||
59516805|NCT00633464|75610508|FG000|COMPLETED|Overall Study|Completed=Offstudy;major reasons:Disease progression-27,study drug toxicity-7,max clinical benefit-3|40||
60061059|NCT02014376|76176392|FG001|COMPLETED|Overall Study||15||
60061060|NCT02014376|76176393|FG002|COMPLETED|Overall Study||17||
60061061|NCT02014376|76176391|FG000|NOT COMPLETED|Overall Study||3||
60061062|NCT02014376|76176392|FG001|NOT COMPLETED|Overall Study||1||
60061063|NCT02014376|76176393|FG002|NOT COMPLETED|Overall Study||0||
60061064|NCT02035202|76176404|FG000|STARTED|Overall Study||85||
60061065|NCT02035202|76176405|FG001|STARTED|Overall Study||85||
60061066|NCT02035202|76176406|FG002|STARTED|Overall Study||85||
60061067|NCT02035202|76176404|FG000|COMPLETED|Overall Study||77||
60061068|NCT02035202|76176405|FG001|COMPLETED|Overall Study||69||
60061069|NCT02035202|76176406|FG002|COMPLETED|Overall Study||83||
60061070|NCT02035202|76176404|FG000|NOT COMPLETED|Overall Study||8||
60061071|NCT02035202|76176405|FG001|NOT COMPLETED|Overall Study||16||
60061072|NCT02035202|76176406|FG002|NOT COMPLETED|Overall Study||2||
60061073|NCT01988402|76176416|FG000|STARTED|Overall Study||16||
60061074|NCT01988402|76176417|FG001|STARTED|Overall Study||19||
60061075|NCT01988402|76176416|FG000|COMPLETED|Overall Study||14||
60061076|NCT01988402|76176417|FG001|COMPLETED|Overall Study||17||
60061077|NCT01988402|76176416|FG000|NOT COMPLETED|Overall Study||2||
60061078|NCT01988402|76176417|FG001|NOT COMPLETED|Overall Study||2||
60061079|NCT01988090|76176425|FG000|STARTED|Start Treament After Randomization||46||
60061080|NCT01988090|76176426|FG001|STARTED|Start Treament After Randomization||47||
60061081|NCT01988090|76176425|FG000|COMPLETED|Start Treament After Randomization||44|Complete 12 weeks treatment|
60061082|NCT01988090|76176426|FG001|COMPLETED|Start Treament After Randomization||43|Complete 12 weeks treatment|
60061083|NCT01988090|76176425|FG000|NOT COMPLETED|Start Treament After Randomization||2||
60061084|NCT01988090|76176426|FG001|NOT COMPLETED|Start Treament After Randomization||4||
59613072|NCT01713582|75724103|FG009|NOT COMPLETED|Overall Study||18||
59613073|NCT01713582|75724104|FG010|NOT COMPLETED|Overall Study||16||
59761002|NCT03944707|75880664|FG000|STARTED|Overall Study||47||
60061085|NCT01988090|76176425|FG000|STARTED|Complete Study After Start||44||
60061086|NCT01988090|76176426|FG001|STARTED|Complete Study After Start||43||
60061087|NCT01988090|76176425|FG000|COMPLETED|Complete Study After Start||41||
60061088|NCT01988090|76176426|FG001|COMPLETED|Complete Study After Start||42||
60061089|NCT01988090|76176425|FG000|NOT COMPLETED|Complete Study After Start||3||
60061090|NCT01988090|76176426|FG001|NOT COMPLETED|Complete Study After Start||1||
60061091|NCT01988012|76176432|FG000|STARTED|Overall Study||100||
60061092|NCT01988012|76176432|FG000|COMPLETED|Overall Study||85||
60061093|NCT01988012|76176432|FG000|NOT COMPLETED|Overall Study||15||
60061094|NCT02011945|76176439|FG000|STARTED|Overall Study||2||
60061095|NCT02011945|76176440|FG001|STARTED|Overall Study||13||
60061096|NCT02011945|76176441|FG002|STARTED|Overall Study||16||
60061097|NCT02011945|76176439|FG000|COMPLETED|Overall Study||0||
60061098|NCT02011945|76176440|FG001|COMPLETED|Overall Study||3||
60061099|NCT02011945|76176441|FG002|COMPLETED|Overall Study||6||
60061100|NCT02011945|76176439|FG000|NOT COMPLETED|Overall Study||2||
60061101|NCT02011945|76176440|FG001|NOT COMPLETED|Overall Study||10||
60061102|NCT02011945|76176441|FG002|NOT COMPLETED|Overall Study||10||
59516806|NCT00633464|75610509|FG001|COMPLETED|Overall Study|Completed=Offstudy;major reasons:Disease progression-25,study drug toxicity-4,subject request-3|37||
59516807|NCT00633464|75610508|FG000|NOT COMPLETED|Overall Study||0||
59516808|NCT00633464|75610509|FG001|NOT COMPLETED|Overall Study||2||
59516809|NCT03436810|75610517|FG000|STARTED|Overall Study||20||
59516810|NCT03436810|75610518|FG001|STARTED|Overall Study||20||
59516811|NCT03436810|75610517|FG000|COMPLETED|Overall Study||20||
59516812|NCT03436810|75610518|FG001|COMPLETED|Overall Study||20||
60061103|NCT02013830|76176449|FG000|STARTED|Overall Study||45||
60061104|NCT02013830|76176449|FG000|COMPLETED|Overall Study||15||
60061105|NCT02013830|76176449|FG000|NOT COMPLETED|Overall Study||30||
60061106|NCT02010775|76176458|FG000|STARTED|Overall Study||38||
60061107|NCT02010775|76176459|FG001|STARTED|Overall Study||38||
60061108|NCT02010775|76176460|FG002|STARTED|Overall Study||37||
60061109|NCT02010775|76176461|FG003|STARTED|Overall Study||37||
60061110|NCT02010775|76176462|FG004|STARTED|Overall Study||37||
60061111|NCT02010775|76176458|FG000|COMPLETED|Overall Study||33||
60061112|NCT02010775|76176459|FG001|COMPLETED|Overall Study||35||
60061113|NCT02010775|76176460|FG002|COMPLETED|Overall Study||34||
60061114|NCT02010775|76176461|FG003|COMPLETED|Overall Study||34||
60061115|NCT02010775|76176462|FG004|COMPLETED|Overall Study||31||
60061116|NCT02010775|76176458|FG000|NOT COMPLETED|Overall Study||5||
60061117|NCT02010775|76176459|FG001|NOT COMPLETED|Overall Study||3||
60061118|NCT02010775|76176460|FG002|NOT COMPLETED|Overall Study||3||
60061119|NCT02010775|76176461|FG003|NOT COMPLETED|Overall Study||3||
59516813|NCT03436810|75610517|FG000|NOT COMPLETED|Overall Study||0||
59516814|NCT03436810|75610518|FG001|NOT COMPLETED|Overall Study||0||
59927612|NCT03357731|76045657|FG000|NOT COMPLETED|Overall Study||0||
59516815|NCT03437044|75610526|FG000|STARTED|Overall Study||20||
59516816|NCT03437044|75610527|FG001|STARTED|Overall Study||20||
59516817|NCT03437044|75610526|FG000|COMPLETED|Overall Study||17||
59516818|NCT03437044|75610527|FG001|COMPLETED|Overall Study||18||
59927613|NCT03357731|76045658|FG001|NOT COMPLETED|Overall Study||0||
59927614|NCT03357731|76045659|FG002|NOT COMPLETED|Overall Study||1||
59927615|NCT03357731|76045660|FG003|NOT COMPLETED|Overall Study||3||
59927616|NCT03357731|76045661|FG004|NOT COMPLETED|Overall Study||1||
59927617|NCT03357731|76045662|FG005|NOT COMPLETED|Overall Study||1||
59927618|NCT03357341|76045672|FG000|STARTED|Overall Study||96||
59927619|NCT03357341|76045673|FG001|STARTED|Overall Study||98||
59927620|NCT03357341|76045672|FG000|COMPLETED|Overall Study||89||
59927621|NCT03357341|76045673|FG001|COMPLETED|Overall Study||86||
59927622|NCT03357341|76045672|FG000|NOT COMPLETED|Overall Study||7||
59927623|NCT03357341|76045673|FG001|NOT COMPLETED|Overall Study||12||
59927624|NCT03039738|76045682|FG000|STARTED|Overall Study||206||
59927625|NCT03039738|76045683|FG001|STARTED|Overall Study|This arm did not initiate. The study was terminated following the completion of the telemetry phase.|0||
59927626|NCT03039738|76045682|FG000|COMPLETED|Overall Study||152||
59927627|NCT03039738|76045683|FG001|COMPLETED|Overall Study||0||
59927628|NCT03039738|76045682|FG000|NOT COMPLETED|Overall Study||54||
59927629|NCT03039738|76045683|FG001|NOT COMPLETED|Overall Study||0||
59927630|NCT05007899|76045691|FG000|STARTED|Overall Study||7||
59927631|NCT05007899|76045692|FG001|STARTED|Overall Study||6||
59927632|NCT05007899|76045691|FG000|COMPLETED|Overall Study||5||
59927633|NCT05007899|76045692|FG001|COMPLETED|Overall Study||2||
59927634|NCT05007899|76045691|FG000|NOT COMPLETED|Overall Study||2||
59927635|NCT05007899|76045692|FG001|NOT COMPLETED|Overall Study||4||
59927636|NCT04507373|76045701|FG000|STARTED|Overall Study||0||
59927637|NCT04507373|76045702|FG001|STARTED|Overall Study||0||
59927638|NCT04507373|76045701|FG000|COMPLETED|Overall Study||0||
59927639|NCT04507373|76045702|FG001|COMPLETED|Overall Study||0||
59927640|NCT04507373|76045701|FG000|NOT COMPLETED|Overall Study||0||
59927641|NCT04507373|76045702|FG001|NOT COMPLETED|Overall Study||0||
59927642|NCT03036852|76045714|FG000|STARTED|Overall Study||59||
59927643|NCT03036852|76045714|FG000|COMPLETED|Overall Study||53||
59927644|NCT03036852|76045714|FG000|NOT COMPLETED|Overall Study||6||
59927645|NCT02945657|76045725|FG000|STARTED|Overall Study||32||
59927646|NCT02945657|76045725|FG000|COMPLETED|Overall Study||28||
59927647|NCT02945657|76045725|FG000|NOT COMPLETED|Overall Study||4||
59927648|NCT02948777|76045730|FG000|STARTED|Overall Study||14||
59927649|NCT02948777|76045730|FG000|COMPLETED|Overall Study||13||
59927650|NCT02948777|76045730|FG000|NOT COMPLETED|Overall Study||1||
59927651|NCT03324581|76045738|FG000|STARTED|Overall Study||77||
60061120|NCT02010775|76176462|FG004|NOT COMPLETED|Overall Study||6||
60061121|NCT01993615|76176476|FG000|STARTED|Overall Study||40||
60061122|NCT01993615|76176477|FG001|STARTED|Overall Study||40||
60061123|NCT01993615|76176476|FG000|COMPLETED|Overall Study||39||
60061124|NCT01993615|76176477|FG001|COMPLETED|Overall Study||40||
60061125|NCT01993615|76176476|FG000|NOT COMPLETED|Overall Study||1||
60061126|NCT01993615|76176477|FG001|NOT COMPLETED|Overall Study||0||
60061127|NCT01619059|76176485|FG000|STARTED|Short-Term (ST) Treatment Period||162||
60061128|NCT01619059|76176486|FG001|STARTED|Short-Term (ST) Treatment Period||153||
60061129|NCT01619059|76176485|FG000|COMPLETED|Short-Term (ST) Treatment Period||156||
60061130|NCT01619059|76176486|FG001|COMPLETED|Short-Term (ST) Treatment Period||142||
60061131|NCT01619059|76176485|FG000|NOT COMPLETED|Short-Term (ST) Treatment Period||6||
60061132|NCT01619059|76176486|FG001|NOT COMPLETED|Short-Term (ST) Treatment Period||11||
60061133|NCT01619059|76176485|FG000|STARTED|Long-Term (LT) Treatment Period||155||
60061134|NCT01619059|76176486|FG001|STARTED|Long-Term (LT) Treatment Period||142||
60061135|NCT01619059|76176485|FG000|COMPLETED|Long-Term (LT) Treatment Period||147||
59927652|NCT03324581|76045739|FG001|STARTED|Overall Study||80||
59927653|NCT03324581|76045740|FG002|STARTED|Overall Study||82||
59927654|NCT03324581|76045738|FG000|COMPLETED|Overall Study||38||
59927655|NCT03324581|76045739|FG001|COMPLETED|Overall Study||44||
59927656|NCT03324581|76045740|FG002|COMPLETED|Overall Study||57||
59927657|NCT03324581|76045738|FG000|NOT COMPLETED|Overall Study||39||
59927658|NCT03324581|76045739|FG001|NOT COMPLETED|Overall Study||36||
59927659|NCT03324581|76045740|FG002|NOT COMPLETED|Overall Study||25||
59927660|NCT02943473|76045748|FG000|STARTED|Overall Study||9||
59927661|NCT02943473|76045748|FG000|COMPLETED|Overall Study||3||
59927662|NCT02943473|76045748|FG000|NOT COMPLETED|Overall Study||6||
59927663|NCT03320369|76045752|FG000|STARTED|Overall Study||18||
59927664|NCT03320369|76045752|FG000|COMPLETED|Overall Study||15||
59927665|NCT03320369|76045752|FG000|NOT COMPLETED|Overall Study||3||
59927666|NCT02650895|76045762|FG000|STARTED|Overall Study||10||
59927667|NCT02650895|76045763|FG001|STARTED|Overall Study||6||
59927668|NCT02650895|76045764|FG002|STARTED|Overall Study||6||
59927669|NCT02650895|76045765|FG003|STARTED|Overall Study||6||
59927670|NCT02650895|76045766|FG004|STARTED|Overall Study||6||
59927671|NCT02650895|76045767|FG005|STARTED|Overall Study||6||
59927672|NCT02650895|76045762|FG000|COMPLETED|Overall Study||10||
59927673|NCT02650895|76045763|FG001|COMPLETED|Overall Study||5||
59927674|NCT02650895|76045764|FG002|COMPLETED|Overall Study||6||
59927675|NCT02650895|76045765|FG003|COMPLETED|Overall Study||6||
59927676|NCT02650895|76045766|FG004|COMPLETED|Overall Study||6||
59927677|NCT02650895|76045767|FG005|COMPLETED|Overall Study||6||
59927678|NCT02650895|76045762|FG000|NOT COMPLETED|Overall Study||0||
59927679|NCT02650895|76045763|FG001|NOT COMPLETED|Overall Study||1||
59927680|NCT02650895|76045764|FG002|NOT COMPLETED|Overall Study||0||
59927681|NCT02650895|76045765|FG003|NOT COMPLETED|Overall Study||0||
59927682|NCT02650895|76045766|FG004|NOT COMPLETED|Overall Study||0||
59927683|NCT02650895|76045767|FG005|NOT COMPLETED|Overall Study||0||
59927684|NCT03320057|76045786|FG000|STARTED|Overall Study||266||
59927685|NCT03320057|76045787|FG001|STARTED|Overall Study|Includes pharmacists at study pharmacies that consented to training on mifepristone dispensing.|60||
59927686|NCT03320057|76045786|FG000|Patient's Clinical Outcome Information Obtained|Overall Study||262||
59927687|NCT03320057|76045787|FG001|Patient's Clinical Outcome Information Obtained|Overall Study|Clinical outcome data were not collected for pharmacists - this milestone does not apply|0||
59927688|NCT03320057|76045786|FG000|Received Pharmacist Training|Overall Study||0||
59927689|NCT03320057|76045787|FG001|Received Pharmacist Training|Overall Study||56||
59927690|NCT03320057|76045786|FG000|Pharmacists Completed Baseline Survey|Overall Study||0||
59927691|NCT03320057|76045787|FG001|Pharmacists Completed Baseline Survey|Overall Study||47||
59927692|NCT03320057|76045786|FG000|COMPLETED|Overall Study||260||
59927693|NCT03320057|76045787|FG001|COMPLETED|Overall Study|This includes pharmacists who completed the endline survey. Only trained pharmacists (n=56) were eligible.|43||
59927694|NCT03320057|76045786|FG000|NOT COMPLETED|Overall Study||6||
59927695|NCT03320057|76045787|FG001|NOT COMPLETED|Overall Study||17||
59927696|NCT03316547|76045795|FG000|STARTED|Overall Study||39||
59927697|NCT03316547|76045796|FG001|STARTED|Overall Study||31||
59927698|NCT03316547|76045795|FG000|COMPLETED|Overall Study||21||
59927699|NCT03316547|76045796|FG001|COMPLETED|Overall Study||18||
59927700|NCT03316547|76045795|FG000|NOT COMPLETED|Overall Study||18||
59927701|NCT03316547|76045796|FG001|NOT COMPLETED|Overall Study||13||
59927702|NCT02738255|76045806|FG000|STARTED|Overall Study||11||
59927703|NCT02738255|76045807|FG001|STARTED|Overall Study||15||
59927704|NCT02738255|76045806|FG000|COMPLETED|Overall Study||11||
59927705|NCT02738255|76045807|FG001|COMPLETED|Overall Study||14||
59927706|NCT02738255|76045806|FG000|NOT COMPLETED|Overall Study||0||
59927707|NCT02738255|76045807|FG001|NOT COMPLETED|Overall Study||1||
59927708|NCT03315689|76045819|FG000|STARTED|Double-blind Period = 28 Days||4||
59927709|NCT03315689|76045820|FG001|STARTED|Double-blind Period = 28 Days||7||
59927710|NCT03315689|76045819|FG000|COMPLETED|Double-blind Period = 28 Days||3||
59927711|NCT03315689|76045820|FG001|COMPLETED|Double-blind Period = 28 Days||7||
60061136|NCT01619059|76176486|FG001|COMPLETED|Long-Term (LT) Treatment Period||133||
60061137|NCT01619059|76176485|FG000|NOT COMPLETED|Long-Term (LT) Treatment Period||8||
59516819|NCT03437044|75610526|FG000|NOT COMPLETED|Overall Study||3||
59927712|NCT03315689|76045819|FG000|NOT COMPLETED|Double-blind Period = 28 Days||1||
59927713|NCT03315689|76045820|FG001|NOT COMPLETED|Double-blind Period = 28 Days||0||
59927714|NCT03315689|76045819|FG000|STARTED|Open Label Extension = 52 Weeks||0|All participants entering the Open Label Extension were provided ATI-50002 0.46% Topical Solution.|
59927715|NCT03315689|76045820|FG001|STARTED|Open Label Extension = 52 Weeks||10|All participants entering the Open Label Extension were provided ATI-50002 0.46% Topical Solution.|
59927716|NCT03315689|76045819|FG000|COMPLETED|Open Label Extension = 52 Weeks||0||
60061138|NCT01619059|76176486|FG001|NOT COMPLETED|Long-Term (LT) Treatment Period||9||
60061139|NCT02013206|76176494|FG000|STARTED|Overall Study||29||
60061140|NCT02013206|76176495|FG001|STARTED|Overall Study||23||
60061141|NCT02013206|76176494|FG000|Received Study Drug|Overall Study||26||
60061142|NCT02013206|76176495|FG001|Received Study Drug|Overall Study||23||
60061143|NCT02013206|76176494|FG000|COMPLETED|Overall Study|3 Patients were on-going at clinical cut-off. Not Completed=patients who discontinued treatment.|2||
60061144|NCT02013206|76176495|FG001|COMPLETED|Overall Study||1||
60061145|NCT02013206|76176494|FG000|NOT COMPLETED|Overall Study||27||
60061146|NCT02013206|76176495|FG001|NOT COMPLETED|Overall Study||22||
60061147|NCT01807923|76176504|FG000|STARTED|Overall Study||187||
60061148|NCT01807923|76176505|FG001|STARTED|Overall Study||185||
60061149|NCT01807923|76176506|FG002|STARTED|Overall Study||187||
60061150|NCT01807923|76176504|FG000|COMPLETED|Overall Study||182||
60061151|NCT01807923|76176505|FG001|COMPLETED|Overall Study||179||
60061152|NCT01807923|76176506|FG002|COMPLETED|Overall Study||176||
60061153|NCT01807923|76176504|FG000|NOT COMPLETED|Overall Study||5||
60061154|NCT01807923|76176505|FG001|NOT COMPLETED|Overall Study||6||
60061155|NCT01807923|76176506|FG002|NOT COMPLETED|Overall Study||11||
59927717|NCT03315689|76045820|FG001|COMPLETED|Open Label Extension = 52 Weeks||7||
59927718|NCT03315689|76045819|FG000|NOT COMPLETED|Open Label Extension = 52 Weeks||0||
59927719|NCT03315689|76045820|FG001|NOT COMPLETED|Open Label Extension = 52 Weeks||3||
60061156|NCT01966003|76176518|FG000|STARTED|Overall Study||328||
60061157|NCT01966003|76176519|FG001|STARTED|Overall Study||314||
60061158|NCT01966003|76176518|FG000|Received Study Drug|Overall Study||324||
60061159|NCT01966003|76176519|FG001|Received Study Drug|Overall Study||309||
60061160|NCT01966003|76176518|FG000|COMPLETED|Overall Study||58||
60061161|NCT01966003|76176519|FG001|COMPLETED|Overall Study||44||
60061162|NCT01966003|76176518|FG000|NOT COMPLETED|Overall Study||270||
60061163|NCT01966003|76176519|FG001|NOT COMPLETED|Overall Study||270||
60061164|NCT01839279|76176528|FG000|STARTED|Overall Study||72||
60061165|NCT01839279|76176529|FG001|STARTED|Overall Study||32||
60061166|NCT01839279|76176530|FG002|STARTED|Overall Study||32||
60061167|NCT01839279|76176528|FG000|QT/QTc Analysis Set|Overall Study||72||
59927720|NCT03314519|76045830|FG000|STARTED|Overall Study||100||
59927721|NCT03314519|76045831|FG001|STARTED|Overall Study||100||
59927722|NCT03314519|76045830|FG000|COMPLETED|Overall Study||97||
59927723|NCT03314519|76045831|FG001|COMPLETED|Overall Study||98||
59927724|NCT03314519|76045830|FG000|NOT COMPLETED|Overall Study||3||
59927725|NCT03314519|76045831|FG001|NOT COMPLETED|Overall Study||2||
59927726|NCT01856855|76045837|FG000|STARTED|Overall Study||26||
59927727|NCT01856855|76045837|FG000|COMPLETED|Overall Study||26||
59927728|NCT01856855|76045837|FG000|NOT COMPLETED|Overall Study||0||
59927729|NCT03313037|76045843|FG000|STARTED|Overall Study||222||
59927730|NCT03313037|76045844|FG001|STARTED|Overall Study||222||
59927731|NCT03313037|76045843|FG000|Safety Population|Overall Study||221||
59927732|NCT03313037|76045844|FG001|Safety Population|Overall Study||222||
59927733|NCT03313037|76045843|FG000|Evaluable Immunogenicity Population(EIP)|Overall Study||210||
59927734|NCT03313037|76045844|FG001|Evaluable Immunogenicity Population(EIP)|Overall Study||208||
59927735|NCT03313037|76045843|FG000|COMPLETED|Overall Study||202||
59927736|NCT03313037|76045844|FG001|COMPLETED|Overall Study||202||
59927737|NCT03313037|76045843|FG000|NOT COMPLETED|Overall Study||20||
59927738|NCT03313037|76045844|FG001|NOT COMPLETED|Overall Study||20||
59927739|NCT02420795|76045853|FG000|STARTED|Overall Study||4||
59927740|NCT02420795|76045854|FG001|STARTED|Overall Study||2||
59927741|NCT02420795|76045855|FG002|STARTED|Overall Study||5||
59927742|NCT02420795|76045853|FG000|COMPLETED|Overall Study||0||
59927743|NCT02420795|76045854|FG001|COMPLETED|Overall Study||0||
59927744|NCT02420795|76045855|FG002|COMPLETED|Overall Study||0||
59927745|NCT02420795|76045853|FG000|NOT COMPLETED|Overall Study||4||
59927746|NCT02420795|76045854|FG001|NOT COMPLETED|Overall Study||2||
59927747|NCT02420795|76045855|FG002|NOT COMPLETED|Overall Study||5||
60061168|NCT01839279|76176529|FG001|QT/QTc Analysis Set|Overall Study||32||
60061169|NCT01839279|76176530|FG002|QT/QTc Analysis Set|Overall Study||32||
60061170|NCT01839279|76176528|FG000|PK Analysis Set|Overall Study||70||
60061171|NCT01839279|76176529|FG001|PK Analysis Set|Overall Study||0||
60061172|NCT01839279|76176530|FG002|PK Analysis Set|Overall Study||0||
60061173|NCT01839279|76176528|FG000|Moxifloxacin/Placebo Analysis Set|Overall Study||0||
59516820|NCT03437044|75610527|FG001|NOT COMPLETED|Overall Study||2||
59519049|NCT03593902|75612910|FG000|COMPLETED|Overall Study||9||
59927748|NCT03334175|76045867|FG000|STARTED|Overall Study||8||
59927749|NCT03334175|76045868|FG001|STARTED|Overall Study||10||
59927750|NCT03334175|76045867|FG000|COMPLETED|Overall Study||8||
60061174|NCT01839279|76176529|FG001|Moxifloxacin/Placebo Analysis Set|Overall Study||31||
60061175|NCT01839279|76176530|FG002|Moxifloxacin/Placebo Analysis Set|Overall Study||30||
60061176|NCT01839279|76176528|FG000|PK/QTc Analysis Set|Overall Study||70||
60061177|NCT01839279|76176529|FG001|PK/QTc Analysis Set|Overall Study||0||
60061178|NCT01839279|76176530|FG002|PK/QTc Analysis Set|Overall Study||0||
60061179|NCT01839279|76176528|FG000|COMPLETED|Overall Study||59||
60061180|NCT01839279|76176529|FG001|COMPLETED|Overall Study||30||
60061181|NCT01839279|76176530|FG002|COMPLETED|Overall Study||30||
60061182|NCT01839279|76176528|FG000|NOT COMPLETED|Overall Study||13||
60061183|NCT01839279|76176529|FG001|NOT COMPLETED|Overall Study||2||
60061184|NCT01839279|76176530|FG002|NOT COMPLETED|Overall Study||2||
60061185|NCT01807299|76176549|FG000|STARTED|Overall Study||14||
60061186|NCT01807299|76176550|FG001|STARTED|Overall Study||14||
60061187|NCT01807299|76176551|FG002|STARTED|Overall Study||12||
60061188|NCT01807299|76176552|FG003|STARTED|Overall Study||13||
60061189|NCT01807299|76176549|FG000|COMPLETED|Overall Study||11||
60061190|NCT01807299|76176550|FG001|COMPLETED|Overall Study||13||
60061191|NCT01807299|76176551|FG002|COMPLETED|Overall Study||12||
60061192|NCT01807299|76176552|FG003|COMPLETED|Overall Study||11||
60061193|NCT01807299|76176549|FG000|NOT COMPLETED|Overall Study||3||
60061194|NCT01807299|76176550|FG001|NOT COMPLETED|Overall Study||1||
60061195|NCT01807299|76176551|FG002|NOT COMPLETED|Overall Study||0||
60061196|NCT01807299|76176552|FG003|NOT COMPLETED|Overall Study||2||
60061197|NCT01965535|76176564|FG000|STARTED|Overall Study||78||
60061198|NCT01965535|76176565|FG001|STARTED|Overall Study||77||
60061199|NCT01965535|76176564|FG000|COMPLETED|Overall Study||76||
60061200|NCT01965535|76176565|FG001|COMPLETED|Overall Study||76||
60061201|NCT01965535|76176564|FG000|NOT COMPLETED|Overall Study||2||
60061202|NCT01965535|76176565|FG001|NOT COMPLETED|Overall Study||1||
60061203|NCT01964755|76176571|FG000|STARTED|Overall Study||6||
60061204|NCT01964755|76176571|FG000|Cycle 2|Overall Study||5||
60061205|NCT01964755|76176571|FG000|Cycle 3|Overall Study||4||
60061206|NCT01964755|76176571|FG000|Cycle 4|Overall Study||4||
60061207|NCT01964755|76176571|FG000|Cycle 5|Overall Study||4||
60061208|NCT01964755|76176571|FG000|COMPLETED|Overall Study||4||
60061209|NCT01964755|76176571|FG000|NOT COMPLETED|Overall Study||2||
60061210|NCT01964521|76176575|FG000|STARTED|Overall Study||24||
60061211|NCT01964521|76176575|FG000|COMPLETED|Overall Study||20||
60061212|NCT01964521|76176575|FG000|NOT COMPLETED|Overall Study||4||
60061213|NCT01992757|76176580|FG000|STARTED|Overall Study||51||
60061214|NCT01992757|76176580|FG000|COMPLETED|Overall Study||49||
60061215|NCT01992757|76176580|FG000|NOT COMPLETED|Overall Study||2||
60061216|NCT01991743|76176589|FG000|STARTED|Overall Study||60||
60061217|NCT01991743|76176590|FG001|STARTED|Overall Study||60||
60061218|NCT01991743|76176591|FG002|STARTED|Overall Study||60||
60061219|NCT01991743|76176592|FG003|STARTED|Overall Study||60||
60061220|NCT01991743|76176589|FG000|COMPLETED|Overall Study||60||
60061221|NCT01991743|76176590|FG001|COMPLETED|Overall Study||60||
60061222|NCT01991743|76176591|FG002|COMPLETED|Overall Study||59||
60061223|NCT01991743|76176592|FG003|COMPLETED|Overall Study||60||
60061224|NCT01991743|76176589|FG000|NOT COMPLETED|Overall Study||0||
60061225|NCT01991743|76176590|FG001|NOT COMPLETED|Overall Study||0||
60061226|NCT01991743|76176591|FG002|NOT COMPLETED|Overall Study||1||
60061227|NCT01991743|76176592|FG003|NOT COMPLETED|Overall Study||0||
60061228|NCT01991197|76176604|FG000|STARTED|Overall Study||9||
60061229|NCT01991197|76176605|FG001|STARTED|Overall Study||11||
60061230|NCT01991197|76176604|FG000|COMPLETED|Overall Study||6||
59927751|NCT03334175|76045868|FG001|COMPLETED|Overall Study||9||
59927752|NCT03334175|76045867|FG000|NOT COMPLETED|Overall Study||0||
59927753|NCT03334175|76045868|FG001|NOT COMPLETED|Overall Study||1||
59927754|NCT02942771|76045879|FG000|STARTED|Overall Study||9||
59927755|NCT02942771|76045880|FG001|STARTED|Overall Study||6||
59927756|NCT02942771|76045881|FG002|STARTED|Overall Study||6||
59927757|NCT02942771|76045882|FG003|STARTED|Overall Study||6||
59927758|NCT02942771|76045883|FG004|STARTED|Overall Study||8||
59927759|NCT02942771|76045879|FG000|COMPLETED|Overall Study||6||
59927760|NCT02942771|76045880|FG001|COMPLETED|Overall Study||6||
59927761|NCT02942771|76045881|FG002|COMPLETED|Overall Study||6||
59927762|NCT02942771|76045882|FG003|COMPLETED|Overall Study||6||
59927763|NCT02942771|76045883|FG004|COMPLETED|Overall Study||4||
59927764|NCT02942771|76045879|FG000|NOT COMPLETED|Overall Study||3||
59927765|NCT02942771|76045880|FG001|NOT COMPLETED|Overall Study||0||
59927766|NCT02942771|76045881|FG002|NOT COMPLETED|Overall Study||0||
59927767|NCT02942771|76045882|FG003|NOT COMPLETED|Overall Study||0||
60061231|NCT01991197|76176605|FG001|COMPLETED|Overall Study||8||
60061232|NCT01991197|76176604|FG000|NOT COMPLETED|Overall Study||3||
60061233|NCT01991197|76176605|FG001|NOT COMPLETED|Overall Study||3||
60061234|NCT01990573|76176619|FG000|STARTED|Overall Study||20||
60061235|NCT01990573|76176620|FG001|STARTED|Overall Study||14||
60061236|NCT01990573|76176621|FG002|STARTED|Overall Study||17||
60061237|NCT01990573|76176619|FG000|COMPLETED|Overall Study||20||
60061238|NCT01990573|76176620|FG001|COMPLETED|Overall Study||14||
60061239|NCT01990573|76176621|FG002|COMPLETED|Overall Study||16||
60061240|NCT01990573|76176619|FG000|NOT COMPLETED|Overall Study||0||
60061241|NCT01990573|76176620|FG001|NOT COMPLETED|Overall Study||0||
60061242|NCT01990573|76176621|FG002|NOT COMPLETED|Overall Study||1||
60061243|NCT01990495|76176631|FG000|STARTED|Overall Study||18||
60061244|NCT01990495|76176632|FG001|STARTED|Overall Study||19||
60061245|NCT01990495|76176631|FG000|COMPLETED|Overall Study||13||
60061246|NCT01990495|76176632|FG001|COMPLETED|Overall Study||15||
60061247|NCT01990495|76176631|FG000|NOT COMPLETED|Overall Study||5||
60061248|NCT01990495|76176632|FG001|NOT COMPLETED|Overall Study||4||
60061249|NCT01990339|76176640|FG000|STARTED|Overall Study||14965||
60061250|NCT01990339|76176640|FG000|COMPLETED|Overall Study||12653||
60061251|NCT01990339|76176640|FG000|NOT COMPLETED|Overall Study||2312||
60061252|NCT02007577|76176646|FG000|STARTED|Overall Study||27||
60061253|NCT02007577|76176647|FG001|STARTED|Overall Study||14||
60061254|NCT02007577|76176646|FG000|COMPLETED|Overall Study||26||
60061255|NCT02007577|76176647|FG001|COMPLETED|Overall Study||13||
60061256|NCT02007577|76176646|FG000|NOT COMPLETED|Overall Study||1||
60061257|NCT02007577|76176647|FG001|NOT COMPLETED|Overall Study||1||
60061258|NCT01990261|76176653|FG000|STARTED|Overall Study||33||
60061259|NCT01990261|76176653|FG000|Treated|Overall Study||29||
60061260|NCT01990261|76176653|FG000|COMPLETED|Overall Study||8||
60061261|NCT01990261|76176653|FG000|NOT COMPLETED|Overall Study||25||
60061262|NCT01963117|76176657|FG000|STARTED|Overall Study||11||
60061263|NCT01963117|76176657|FG000|COMPLETED|Overall Study||10||
60061264|NCT01963117|76176657|FG000|NOT COMPLETED|Overall Study||1||
60061265|NCT02007109|76176661|FG000|STARTED|Overall Study||193||
60061266|NCT02007109|76176661|FG000|PACU Analysis|Overall Study||184||
60061267|NCT02007109|76176661|FG000|COMPLETED|Overall Study||82|Post-Discharge Analysis|
60061268|NCT02007109|76176661|FG000|NOT COMPLETED|Overall Study||111||
59761003|NCT03944707|75880665|FG001|STARTED|Overall Study||29||
59761004|NCT03944707|75880664|FG000|PK Analysis Set|Overall Study||33|All subjects with at least one available valid pharmacokinetics (PK) concentration measurement, who received any study drug and with no protocol deviations that affected PK data.|
59927768|NCT02942771|76045883|FG004|NOT COMPLETED|Overall Study||4||
59927769|NCT03036150|76045897|FG000|STARTED|Overall Study||2152||
59927770|NCT03036150|76045898|FG001|STARTED|Overall Study||2152||
59927771|NCT03036150|76045897|FG000|COMPLETED|Overall Study||2142||
59927772|NCT03036150|76045898|FG001|COMPLETED|Overall Study||2147||
59927773|NCT03036150|76045897|FG000|NOT COMPLETED|Overall Study||10||
59927774|NCT03036150|76045898|FG001|NOT COMPLETED|Overall Study||5||
59927775|NCT03332771|76045908|FG000|STARTED|Overall Study||159||
59927776|NCT03332771|76045909|FG001|STARTED|Overall Study||317||
59927777|NCT03332771|76045910|FG002|STARTED|Overall Study||160||
59927778|NCT03332771|76045911|FG003|STARTED|Overall Study||318||
59927779|NCT03332771|76045908|FG000|COMPLETED|Overall Study||125||
59927780|NCT03332771|76045909|FG001|COMPLETED|Overall Study||266||
59927781|NCT03332771|76045910|FG002|COMPLETED|Overall Study||128||
59927782|NCT03332771|76045911|FG003|COMPLETED|Overall Study||270||
59927783|NCT03332771|76045908|FG000|NOT COMPLETED|Overall Study||34||
59927784|NCT03332771|76045909|FG001|NOT COMPLETED|Overall Study||51||
59927785|NCT03332771|76045910|FG002|NOT COMPLETED|Overall Study||32||
60061269|NCT02006719|76176670|FG000|STARTED|Overall Study||237||
60061270|NCT02006719|76176671|FG001|STARTED|Overall Study||85||
60061271|NCT02006719|76176670|FG000|COMPLETED|Overall Study||219||
60061272|NCT02006719|76176671|FG001|COMPLETED|Overall Study||80||
60061273|NCT02006719|76176670|FG000|NOT COMPLETED|Overall Study||18||
60061274|NCT02006719|76176671|FG001|NOT COMPLETED|Overall Study||5||
60061275|NCT01962493|76176679|FG000|STARTED|Overall Study||78||
60061276|NCT01962493|76176680|FG001|STARTED|Overall Study||82||
60061277|NCT01962493|76176679|FG000|COMPLETED|Overall Study||73||
60061278|NCT01962493|76176680|FG001|COMPLETED|Overall Study||77||
60061279|NCT01962493|76176679|FG000|NOT COMPLETED|Overall Study||5||
60061280|NCT01962493|76176680|FG001|NOT COMPLETED|Overall Study||5||
60061281|NCT01989169|76176688|FG000|STARTED|Period 1||15||
60061282|NCT01989169|76176689|FG001|STARTED|Period 1||15||
60061283|NCT01989169|76176688|FG000|COMPLETED|Period 1||15||
59927786|NCT03332771|76045911|FG003|NOT COMPLETED|Overall Study||48||
59927787|NCT03310775|76045923|FG000|STARTED|Overall Study||19||
60061284|NCT01989169|76176689|FG001|COMPLETED|Period 1||15||
60061285|NCT01989169|76176688|FG000|NOT COMPLETED|Period 1||0||
60061286|NCT01989169|76176689|FG001|NOT COMPLETED|Period 1||0||
60061287|NCT01989169|76176688|FG000|STARTED|Period 2||15||
60061288|NCT01989169|76176689|FG001|STARTED|Period 2||15||
60061289|NCT01989169|76176688|FG000|COMPLETED|Period 2||15||
60061290|NCT01989169|76176689|FG001|COMPLETED|Period 2||14||
60061291|NCT01989169|76176688|FG000|NOT COMPLETED|Period 2||0||
60061292|NCT01989169|76176689|FG001|NOT COMPLETED|Period 2||1||
60061293|NCT01988779|76176697|FG000|STARTED|Overall Study||12||
60061294|NCT01988779|76176698|FG001|STARTED|Overall Study||13||
60061295|NCT01988779|76176697|FG000|COMPLETED|Overall Study||9||
60061296|NCT01988779|76176698|FG001|COMPLETED|Overall Study||11||
60061297|NCT01988779|76176697|FG000|NOT COMPLETED|Overall Study||3||
60061298|NCT01988779|76176698|FG001|NOT COMPLETED|Overall Study||2||
60061299|NCT01988233|76176706|FG000|STARTED|Overall Study||167||
60061300|NCT01988233|76176707|FG001|STARTED|Overall Study||166||
60061301|NCT01988233|76176706|FG000|COMPLETED|Overall Study||103||
60061302|NCT01988233|76176707|FG001|COMPLETED|Overall Study||115||
60061303|NCT01988233|76176706|FG000|NOT COMPLETED|Overall Study||64||
60061304|NCT01988233|76176707|FG001|NOT COMPLETED|Overall Study||51||
60061305|NCT01987765|76176713|FG000|STARTED|Overall Study||847||
60061306|NCT01987765|76176713|FG000|COMPLETED|Overall Study||745||
60061307|NCT01987765|76176713|FG000|NOT COMPLETED|Overall Study||102||
60061308|NCT01987609|76176717|FG000|STARTED|Overall Study|one arm on one patient|7||14
60061309|NCT01987609|76176717|FG000|Hylenex Injected in Arm|Overall Study||6||6
60061310|NCT01987609|76176717|FG000|Normal Saline Injected in Arm|Overall Study||6||6
60061311|NCT01987609|76176717|FG000|COMPLETED|Overall Study||6||12
59927788|NCT03310775|76045924|FG001|STARTED|Overall Study||18||
59927789|NCT03310775|76045923|FG000|COMPLETED|Overall Study||17||
59927790|NCT03310775|76045924|FG001|COMPLETED|Overall Study||14||
59927791|NCT03310775|76045923|FG000|NOT COMPLETED|Overall Study||2||
59927792|NCT03310775|76045924|FG001|NOT COMPLETED|Overall Study||4||
59927793|NCT04236245|76045930|FG000|STARTED|Overall Study||25||
59927794|NCT04236245|76045930|FG000|COMPLETED|Overall Study||25||
59927795|NCT04236245|76045930|FG000|NOT COMPLETED|Overall Study||0||
59927796|NCT03330119|76045936|FG000|STARTED|Overall Study||641|"Reason Not Completed was reported in aggregate - this data was not recorded as separate rows per reason."|
59927797|NCT03330119|76045937|FG001|STARTED|Overall Study||853|"Reason Not Completed was reported in aggregate - this data was not recorded as separate rows per reason."|
59927798|NCT03330119|76045936|FG000|COMPLETED|Overall Study||475||
59927799|NCT03330119|76045937|FG001|COMPLETED|Overall Study||571||
59927800|NCT03330119|76045936|FG000|NOT COMPLETED|Overall Study||166||
59927801|NCT03330119|76045937|FG001|NOT COMPLETED|Overall Study||282||
59927802|NCT03040986|76045945|FG000|STARTED|Overall Study||6||
59927803|NCT03040986|76045946|FG001|STARTED|Overall Study||2||
59927804|NCT03040986|76045945|FG000|COMPLETED|Overall Study||0||
59927805|NCT03040986|76045946|FG001|COMPLETED|Overall Study||0||
59927806|NCT03040986|76045945|FG000|NOT COMPLETED|Overall Study||6||
59927807|NCT03040986|76045946|FG001|NOT COMPLETED|Overall Study||2||
59927808|NCT03039192|76045956|FG000|STARTED|Overall Study||112||
59927809|NCT03039192|76045957|FG001|STARTED|Overall Study||114||
59927810|NCT03039192|76045956|FG000|Treated|Overall Study||112||
59927811|NCT03039192|76045957|FG001|Treated|Overall Study||113||
59927812|NCT03039192|76045956|FG000|COMPLETED|Overall Study||80||
59927813|NCT03039192|76045957|FG001|COMPLETED|Overall Study||84||
59927814|NCT03039192|76045956|FG000|NOT COMPLETED|Overall Study||32||
59927815|NCT03039192|76045957|FG001|NOT COMPLETED|Overall Study||30||
59927816|NCT03698279|76045969|FG000|STARTED|Overall Study||124||
59927817|NCT03698279|76045970|FG001|STARTED|Overall Study||122||
59927818|NCT03698279|76045971|FG002|STARTED|Overall Study||159||
59927819|NCT03698279|76045972|FG003|STARTED|Overall Study||234||
59927820|NCT03698279|76045973|FG004|STARTED|Overall Study||13||
59927821|NCT03698279|76045974|FG005|STARTED|Overall Study||13||
59927822|NCT03698279|76045969|FG000|Safety Analysis Set Population (SafAS)|Overall Study||122|SafAS: Included participants who had received at least one dose of the study vaccines.|
59927823|NCT03698279|76045970|FG001|Safety Analysis Set Population (SafAS)|Overall Study||121|SafAS: Included participants who had received at least one dose of the study vaccines.|
59927824|NCT03698279|76045971|FG002|Safety Analysis Set Population (SafAS)|Overall Study||158|SafAS: Included participants who had received at least one dose of the study vaccines.|
60061312|NCT01987609|76176717|FG000|NOT COMPLETED|Overall Study||1||2
60061313|NCT02013674|76176733|FG000|STARTED|Overall Study||15||
60061314|NCT02013674|76176734|FG001|STARTED|Overall Study||15||
60061315|NCT02013674|76176733|FG000|COMPLETED|Overall Study||14||
60061316|NCT02013674|76176734|FG001|COMPLETED|Overall Study||14||
60061317|NCT02013674|76176733|FG000|NOT COMPLETED|Overall Study||1||
60061318|NCT02013674|76176734|FG001|NOT COMPLETED|Overall Study||1||
60061319|NCT01987232|76176745|FG000|STARTED|Overall Study||5||
60061320|NCT01987232|76176746|FG001|STARTED|Overall Study||3||
60061321|NCT01987232|76176747|FG002|STARTED|Overall Study||3||
60061322|NCT01987232|76176748|FG003|STARTED|Overall Study||15||
60061323|NCT01987232|76176749|FG004|STARTED|Overall Study||6||
60061324|NCT01987232|76176745|FG000|COMPLETED|Overall Study||5||
60061325|NCT01987232|76176746|FG001|COMPLETED|Overall Study||3||
60061326|NCT01987232|76176747|FG002|COMPLETED|Overall Study||3||
59927825|NCT03698279|76045972|FG003|Safety Analysis Set Population (SafAS)|Overall Study||234|SafAS: Included participants who had received at least one dose of the study vaccines.|
59927826|NCT03698279|76045973|FG004|Safety Analysis Set Population (SafAS)|Overall Study||13|SafAS: Included participants who had received at least one dose of the study vaccines.|
59927827|NCT03698279|76045974|FG005|Safety Analysis Set Population (SafAS)|Overall Study||13|SafAS: Included participants who had received at least one dose of the study vaccines.|
59927828|NCT03698279|76045969|FG000|COMPLETED|Overall Study||119||
59927829|NCT03698279|76045970|FG001|COMPLETED|Overall Study||120||
59927830|NCT03698279|76045971|FG002|COMPLETED|Overall Study||152||
59927831|NCT03698279|76045972|FG003|COMPLETED|Overall Study||228||
59927832|NCT03698279|76045973|FG004|COMPLETED|Overall Study||13||
59927833|NCT03698279|76045974|FG005|COMPLETED|Overall Study||13||
59927834|NCT03698279|76045969|FG000|NOT COMPLETED|Overall Study||5||
60061327|NCT01987232|76176748|FG003|COMPLETED|Overall Study||14||
60061328|NCT01987232|76176749|FG004|COMPLETED|Overall Study||6||
60061329|NCT01987232|76176745|FG000|NOT COMPLETED|Overall Study||0||
60061330|NCT01987232|76176746|FG001|NOT COMPLETED|Overall Study||0||
60061331|NCT01987232|76176747|FG002|NOT COMPLETED|Overall Study||0||
60061332|NCT01987232|76176748|FG003|NOT COMPLETED|Overall Study||1||
60061333|NCT01987232|76176749|FG004|NOT COMPLETED|Overall Study||0||
60061334|NCT01986920|76176763|FG000|STARTED|A- 101 25%||35|It is the same 35 participants in each treatment so total participants is 35.|35
59927835|NCT03698279|76045970|FG001|NOT COMPLETED|Overall Study||2||
60061335|NCT01986920|76176764|FG001|STARTED|A- 101 25%||0|It is the same 35 participants in each treatment so total participants is 35.|0
60061336|NCT01986920|76176765|FG002|STARTED|A- 101 25%||0|It is the same 35 participants in each treatment so total participants is 35.|0
59516821|NCT03303196|75610533|FG000|STARTED|Overall Study|Individuals who were assigned to BHBP admission then SC admission.|5|4 days|
59516822|NCT03303196|75610534|FG001|STARTED|Overall Study|Individuals who were assigned to SC admission then BHBP admission.|5|4 days|
59516823|NCT03303196|75610533|FG000|Washout|Overall Study||5|Minimum 1 week at home in between study admissions.|
59927836|NCT03698279|76045971|FG002|NOT COMPLETED|Overall Study||7||
59927837|NCT03698279|76045972|FG003|NOT COMPLETED|Overall Study||6||
59927838|NCT03698279|76045973|FG004|NOT COMPLETED|Overall Study||0||
60061337|NCT01986920|76176766|FG003|STARTED|A- 101 25%||0|It is the same 35 participants in each treatment so total participants is 35.|0
60061338|NCT01986920|76176763|FG000|COMPLETED|A- 101 25%||34|Participants receives all treatments, one treatment/lesion simultaneously. 1 Participant=4 lesion|34
60061339|NCT01986920|76176764|FG001|COMPLETED|A- 101 25%||0|Participants receives all treatments, one treatment/lesion simultaneously. 1 Participant=4 lesion|0
60061340|NCT01986920|76176765|FG002|COMPLETED|A- 101 25%||0|Participants receives all treatments, one treatment/lesion simultaneously. 1 Participant=4 lesion|0
60061341|NCT01986920|76176766|FG003|COMPLETED|A- 101 25%||0|Participants receives all treatments, one treatment/lesion simultaneously. 1 Participant=4 lesion|0
60061342|NCT01986920|76176763|FG000|NOT COMPLETED|A- 101 25%||1||1
60061343|NCT01986920|76176764|FG001|NOT COMPLETED|A- 101 25%||0||0
60061344|NCT01986920|76176765|FG002|NOT COMPLETED|A- 101 25%||0||0
60061345|NCT01986920|76176766|FG003|NOT COMPLETED|A- 101 25%||0||0
60061346|NCT01986920|76176763|FG000|STARTED|A-101 32.5%||0||0
60061347|NCT01986920|76176764|FG001|STARTED|A-101 32.5%||35||35
60061348|NCT01986920|76176765|FG002|STARTED|A-101 32.5%||0||0
60061349|NCT01986920|76176766|FG003|STARTED|A-101 32.5%||0||0
59927839|NCT03698279|76045974|FG005|NOT COMPLETED|Overall Study||0||
59927840|NCT01529034|76045993|FG000|STARTED|Overall Study|Completed Study P261-401 and rolled over to Study P261-402|175||
59927841|NCT01529034|76045993|FG000|Exposed|Overall Study|Treated at least 1 seizure cluster with USL261|161||
59927842|NCT01529034|76045993|FG000|COMPLETED|Overall Study|Completed under initial protocol duration of 2 years; amended protocol open-ended duration|1||
59927843|NCT01529034|76045993|FG000|NOT COMPLETED|Overall Study||174||
59927844|NCT03036072|76046000|FG000|STARTED|Overall Study||12||
59927845|NCT03036072|76046001|FG001|STARTED|Overall Study||13||
59927846|NCT03036072|76046000|FG000|COMPLETED|Overall Study||12||
59927847|NCT03036072|76046001|FG001|COMPLETED|Overall Study||10||
59927848|NCT03036072|76046000|FG000|NOT COMPLETED|Overall Study||0||
59927849|NCT03036072|76046001|FG001|NOT COMPLETED|Overall Study||3||
59927850|NCT03038880|76046010|FG000|STARTED|Overall Study||24||
59927851|NCT03038880|76046011|FG001|STARTED|Overall Study||31||
60061350|NCT01986920|76176763|FG000|COMPLETED|A-101 32.5%||0||0
60061351|NCT01986920|76176764|FG001|COMPLETED|A-101 32.5%||34||34
60061352|NCT01986920|76176765|FG002|COMPLETED|A-101 32.5%||0||0
59927852|NCT03038880|76046012|FG002|STARTED|Overall Study||16||
59927853|NCT03038880|76046010|FG000|COMPLETED|Overall Study||21||
59516824|NCT03303196|75610534|FG001|Washout|Overall Study||5|Minimum 1 week at home in between study admissions.|
59516825|NCT03303196|75610533|FG000|COMPLETED|Overall Study||5|4 days|
59516826|NCT03303196|75610534|FG001|COMPLETED|Overall Study||5|4 days|
59927854|NCT03038880|76046011|FG001|COMPLETED|Overall Study||28||
59927855|NCT03038880|76046012|FG002|COMPLETED|Overall Study||16||
59927856|NCT03038880|76046010|FG000|NOT COMPLETED|Overall Study||3||
60061353|NCT01986920|76176766|FG003|COMPLETED|A-101 32.5%||0||0
60061354|NCT01986920|76176763|FG000|NOT COMPLETED|A-101 32.5%||0||0
60061355|NCT01986920|76176764|FG001|NOT COMPLETED|A-101 32.5%||1||1
60061356|NCT01986920|76176765|FG002|NOT COMPLETED|A-101 32.5%||0||0
60061357|NCT01986920|76176766|FG003|NOT COMPLETED|A-101 32.5%||0||0
60061358|NCT01986920|76176763|FG000|STARTED|A-101 40%||0||0
59927857|NCT03038880|76046011|FG001|NOT COMPLETED|Overall Study||3||
59927858|NCT03038880|76046012|FG002|NOT COMPLETED|Overall Study||0||
59927859|NCT03035916|76046023|FG000|STARTED|Overall Study||30||
60061359|NCT01986920|76176764|FG001|STARTED|A-101 40%||0||0
60061360|NCT01986920|76176765|FG002|STARTED|A-101 40%||35||35
60061361|NCT01986920|76176766|FG003|STARTED|A-101 40%||0||0
60061362|NCT01986920|76176763|FG000|COMPLETED|A-101 40%||0||0
60061363|NCT01986920|76176764|FG001|COMPLETED|A-101 40%||0||0
60061364|NCT01986920|76176765|FG002|COMPLETED|A-101 40%||34||34
60061365|NCT01986920|76176766|FG003|COMPLETED|A-101 40%||0||0
60061366|NCT01986920|76176763|FG000|NOT COMPLETED|A-101 40%||0||0
60061367|NCT01986920|76176764|FG001|NOT COMPLETED|A-101 40%||0||0
60061368|NCT01986920|76176765|FG002|NOT COMPLETED|A-101 40%||1||1
59927860|NCT03035916|76046024|FG001|STARTED|Overall Study||30||
59927861|NCT03035916|76046025|FG002|STARTED|Overall Study||31||
60061369|NCT01986920|76176766|FG003|NOT COMPLETED|A-101 40%||0||0
60061370|NCT01986920|76176763|FG000|STARTED|Placebo||0||0
60061371|NCT01986920|76176764|FG001|STARTED|Placebo||0||0
60061372|NCT01986920|76176765|FG002|STARTED|Placebo||0||0
60061373|NCT01986920|76176766|FG003|STARTED|Placebo||35||35
60061374|NCT01986920|76176763|FG000|COMPLETED|Placebo||0||0
59927862|NCT03035916|76046023|FG000|COMPLETED|Overall Study||30||
59927863|NCT03035916|76046024|FG001|COMPLETED|Overall Study||28||
59927864|NCT03035916|76046025|FG002|COMPLETED|Overall Study||31||
59927865|NCT03035916|76046023|FG000|NOT COMPLETED|Overall Study||0||
59927866|NCT03035916|76046024|FG001|NOT COMPLETED|Overall Study||2||
59927867|NCT03035916|76046025|FG002|NOT COMPLETED|Overall Study||0||
59927868|NCT01702571|76046035|FG000|STARTED|Overall Study||2003||
59927869|NCT01702571|76046036|FG001|STARTED|Overall Study||182||
59927870|NCT01702571|76046035|FG000|COMPLETED|Overall Study|For one participant, the site incorrectly answered the question 'Did the participant complete follow-up as per protocol?' It was answered No, however the participant was in survival follow-up and the site should have answered Yes. This participant is wrongly counted in the 'discontinued from study' number.|494||
59927871|NCT01702571|76046036|FG001|COMPLETED|Overall Study||65||
59927872|NCT01702571|76046035|FG000|NOT COMPLETED|Overall Study||1509||
59927873|NCT01702571|76046036|FG001|NOT COMPLETED|Overall Study||117||
59927874|NCT03675516|76046044|FG000|STARTED|Overall Study||6591||
59927875|NCT03675516|76046045|FG001|STARTED|Overall Study||6591||
59927876|NCT03675516|76046044|FG000|COMPLETED|Overall Study||6591||
59927877|NCT03675516|76046045|FG001|COMPLETED|Overall Study||6591||
59927878|NCT03675516|76046044|FG000|NOT COMPLETED|Overall Study||0||
59927879|NCT03675516|76046045|FG001|NOT COMPLETED|Overall Study||0||
59927880|NCT03231943|76046059|FG000|STARTED|Part 1, Period 1 (up to Day 15)||2||
59927881|NCT03231943|76046060|FG001|STARTED|Part 1, Period 1 (up to Day 15)||2||
59927882|NCT03231943|76046061|FG002|STARTED|Part 1, Period 1 (up to Day 15)||2||
59927883|NCT03231943|76046062|FG003|STARTED|Part 1, Period 1 (up to Day 15)||2||
59927884|NCT03231943|76046063|FG004|STARTED|Part 1, Period 1 (up to Day 15)||2||
59927885|NCT03231943|76046064|FG005|STARTED|Part 1, Period 1 (up to Day 15)||2||
59927886|NCT03231943|76046065|FG006|STARTED|Part 1, Period 1 (up to Day 15)||2||
59927887|NCT03231943|76046066|FG007|STARTED|Part 1, Period 1 (up to Day 15)||2||
59927888|NCT03231943|76046067|FG008|STARTED|Part 1, Period 1 (up to Day 15)||0||
59927889|NCT03231943|76046068|FG009|STARTED|Part 1, Period 1 (up to Day 15)||0||
59927890|NCT03231943|76046069|FG010|STARTED|Part 1, Period 1 (up to Day 15)||0||
59927891|NCT03231943|76046070|FG011|STARTED|Part 1, Period 1 (up to Day 15)||0||
59927892|NCT03231943|76046071|FG012|STARTED|Part 1, Period 1 (up to Day 15)||0||
59927893|NCT03231943|76046059|FG000|COMPLETED|Part 1, Period 1 (up to Day 15)||2||
59927894|NCT03231943|76046060|FG001|COMPLETED|Part 1, Period 1 (up to Day 15)||2||
59927895|NCT03231943|76046061|FG002|COMPLETED|Part 1, Period 1 (up to Day 15)||2||
59927896|NCT03231943|76046062|FG003|COMPLETED|Part 1, Period 1 (up to Day 15)||2||
59927897|NCT03231943|76046063|FG004|COMPLETED|Part 1, Period 1 (up to Day 15)||2||
59927898|NCT03231943|76046064|FG005|COMPLETED|Part 1, Period 1 (up to Day 15)||2||
59927899|NCT03231943|76046065|FG006|COMPLETED|Part 1, Period 1 (up to Day 15)||2||
59927900|NCT03231943|76046066|FG007|COMPLETED|Part 1, Period 1 (up to Day 15)||2||
59927901|NCT03231943|76046067|FG008|COMPLETED|Part 1, Period 1 (up to Day 15)||0||
60061375|NCT01986920|76176764|FG001|COMPLETED|Placebo||0||0
60061376|NCT01986920|76176765|FG002|COMPLETED|Placebo||0||0
60061377|NCT01986920|76176766|FG003|COMPLETED|Placebo||34||34
60061378|NCT01986920|76176763|FG000|NOT COMPLETED|Placebo||0||0
60061379|NCT01986920|76176764|FG001|NOT COMPLETED|Placebo||0||0
60061380|NCT01986920|76176765|FG002|NOT COMPLETED|Placebo||0||0
60061381|NCT01986920|76176766|FG003|NOT COMPLETED|Placebo||1||1
60061382|NCT02010632|76176776|FG000|STARTED|First Intervention (7 Days)||16||
60061383|NCT02010632|76176777|FG001|STARTED|First Intervention (7 Days)||16||
59927902|NCT03231943|76046068|FG009|COMPLETED|Part 1, Period 1 (up to Day 15)||0||
60061384|NCT02010632|76176776|FG000|COMPLETED|First Intervention (7 Days)||16||
60061385|NCT02010632|76176777|FG001|COMPLETED|First Intervention (7 Days)||16||
60061386|NCT02010632|76176776|FG000|NOT COMPLETED|First Intervention (7 Days)||0||
59516827|NCT03303196|75610533|FG000|NOT COMPLETED|Overall Study||0||
59516828|NCT03303196|75610534|FG001|NOT COMPLETED|Overall Study||0||
59516829|NCT03082664|75610541|FG000|STARTED|Overall Study||75||
59516830|NCT03082664|75610542|FG001|STARTED|Overall Study||79||
59516831|NCT03082664|75610541|FG000|COMPLETED|Overall Study||75||
59516832|NCT03082664|75610542|FG001|COMPLETED|Overall Study||79||
59516833|NCT03082664|75610541|FG000|NOT COMPLETED|Overall Study||0||
59516834|NCT03082664|75610542|FG001|NOT COMPLETED|Overall Study||0||
59927903|NCT03231943|76046069|FG010|COMPLETED|Part 1, Period 1 (up to Day 15)||0||
59927904|NCT03231943|76046070|FG011|COMPLETED|Part 1, Period 1 (up to Day 15)||0||
59927905|NCT03231943|76046071|FG012|COMPLETED|Part 1, Period 1 (up to Day 15)||0||
59927906|NCT03231943|76046059|FG000|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0||
59927907|NCT03231943|76046060|FG001|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0||
59927908|NCT03231943|76046061|FG002|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0||
59927909|NCT03231943|76046062|FG003|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0||
59927910|NCT03231943|76046063|FG004|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0||
59927911|NCT03231943|76046064|FG005|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0||
59927912|NCT03231943|76046065|FG006|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0||
59927913|NCT03231943|76046066|FG007|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0||
59927914|NCT03231943|76046067|FG008|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0||
59927915|NCT03231943|76046068|FG009|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0||
59927916|NCT03231943|76046069|FG010|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0||
59927917|NCT03231943|76046070|FG011|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0||
59927918|NCT03231943|76046071|FG012|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0||
59927919|NCT03231943|76046059|FG000|STARTED|Part 1, Period 2 (up to Day 30)||2||
59927920|NCT03231943|76046060|FG001|STARTED|Part 1, Period 2 (up to Day 30)||2||
59927921|NCT03231943|76046061|FG002|STARTED|Part 1, Period 2 (up to Day 30)||2||
59927922|NCT03231943|76046062|FG003|STARTED|Part 1, Period 2 (up to Day 30)||2||
59927923|NCT03231943|76046063|FG004|STARTED|Part 1, Period 2 (up to Day 30)||2||
59927924|NCT03231943|76046064|FG005|STARTED|Part 1, Period 2 (up to Day 30)||2||
59927925|NCT03231943|76046065|FG006|STARTED|Part 1, Period 2 (up to Day 30)||2||
59927926|NCT03231943|76046066|FG007|STARTED|Part 1, Period 2 (up to Day 30)||2||
59927927|NCT03231943|76046067|FG008|STARTED|Part 1, Period 2 (up to Day 30)||0||
59927928|NCT03231943|76046068|FG009|STARTED|Part 1, Period 2 (up to Day 30)||0||
59927929|NCT03231943|76046069|FG010|STARTED|Part 1, Period 2 (up to Day 30)||0||
59927930|NCT03231943|76046070|FG011|STARTED|Part 1, Period 2 (up to Day 30)||0||
59927931|NCT03231943|76046071|FG012|STARTED|Part 1, Period 2 (up to Day 30)||0||
59927932|NCT03231943|76046059|FG000|COMPLETED|Part 1, Period 2 (up to Day 30)||2||
59927933|NCT03231943|76046060|FG001|COMPLETED|Part 1, Period 2 (up to Day 30)|Two participants withdrawn were replaced|0||
59927934|NCT03231943|76046061|FG002|COMPLETED|Part 1, Period 2 (up to Day 30)|One participant withdrawn was replaced|1||
59927935|NCT03231943|76046062|FG003|COMPLETED|Part 1, Period 2 (up to Day 30)||2||
59927936|NCT03231943|76046063|FG004|COMPLETED|Part 1, Period 2 (up to Day 30)||2||
59927937|NCT03231943|76046064|FG005|COMPLETED|Part 1, Period 2 (up to Day 30)||2||
59927938|NCT03231943|76046065|FG006|COMPLETED|Part 1, Period 2 (up to Day 30)||2||
59927939|NCT03231943|76046066|FG007|COMPLETED|Part 1, Period 2 (up to Day 30)||2||
59927940|NCT03231943|76046067|FG008|COMPLETED|Part 1, Period 2 (up to Day 30)||0||
59927941|NCT03231943|76046068|FG009|COMPLETED|Part 1, Period 2 (up to Day 30)||0||
59927942|NCT03231943|76046069|FG010|COMPLETED|Part 1, Period 2 (up to Day 30)||0||
59927943|NCT03231943|76046070|FG011|COMPLETED|Part 1, Period 2 (up to Day 30)||0||
59927944|NCT03231943|76046071|FG012|COMPLETED|Part 1, Period 2 (up to Day 30)||0||
59927945|NCT03231943|76046059|FG000|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0||
59927946|NCT03231943|76046060|FG001|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||2||
59927947|NCT03231943|76046061|FG002|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||1||
59927948|NCT03231943|76046062|FG003|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0||
59927949|NCT03231943|76046063|FG004|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0||
59927950|NCT03231943|76046064|FG005|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0||
59927951|NCT03231943|76046065|FG006|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0||
59927952|NCT03231943|76046066|FG007|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0||
59927953|NCT03231943|76046067|FG008|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0||
59516835|NCT00633152|75610550|FG000|STARTED|Overall Study||103||
59927954|NCT03231943|76046068|FG009|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0||
59927955|NCT03231943|76046069|FG010|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0||
59516836|NCT00633152|75610551|FG001|STARTED|Overall Study||47||
59516837|NCT00633152|75610550|FG000|MITT and Safety Population|Overall Study||98||
59927956|NCT03231943|76046070|FG011|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0||
59927957|NCT03231943|76046071|FG012|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0||
59927958|NCT03231943|76046059|FG000|STARTED|Part 1, Period 3 (up to Day 45)||2||
59927959|NCT03231943|76046060|FG001|STARTED|Part 1, Period 3 (up to Day 45)||2||
59927960|NCT03231943|76046061|FG002|STARTED|Part 1, Period 3 (up to Day 45)||2||
59927961|NCT03231943|76046062|FG003|STARTED|Part 1, Period 3 (up to Day 45)||2||
60061387|NCT02010632|76176777|FG001|NOT COMPLETED|First Intervention (7 Days)||0||
60061388|NCT02010632|76176776|FG000|STARTED|Wash Out Period (14 Days)||16||
60061389|NCT02010632|76176777|FG001|STARTED|Wash Out Period (14 Days)||16||
60061390|NCT02010632|76176776|FG000|COMPLETED|Wash Out Period (14 Days)||16||
60061391|NCT02010632|76176777|FG001|COMPLETED|Wash Out Period (14 Days)||16||
60061392|NCT02010632|76176776|FG000|NOT COMPLETED|Wash Out Period (14 Days)||0||
60061393|NCT02010632|76176777|FG001|NOT COMPLETED|Wash Out Period (14 Days)||0||
60061394|NCT02010632|76176776|FG000|STARTED|Second Intervention (7 Days)||16||
60061395|NCT02010632|76176777|FG001|STARTED|Second Intervention (7 Days)||16||
60061396|NCT02010632|76176776|FG000|COMPLETED|Second Intervention (7 Days)||15||
60061397|NCT02010632|76176777|FG001|COMPLETED|Second Intervention (7 Days)||16||
60061398|NCT02010632|76176776|FG000|NOT COMPLETED|Second Intervention (7 Days)||1||
60061399|NCT02010632|76176777|FG001|NOT COMPLETED|Second Intervention (7 Days)||0||
60061400|NCT01986140|76176785|FG000|STARTED|Overall Study||157|subjects who were randomized|
60061401|NCT01986140|76176786|FG001|STARTED|Overall Study||79|subjects who were randomized|
60061402|NCT01986140|76176785|FG000|COMPLETED|Overall Study||122|subjects who underwent scalp cooling or non-cooling for a 4 cycles of chemotherapy|
60061403|NCT01986140|76176786|FG001|COMPLETED|Overall Study||51|subjects who underwent scalp cooling or non-cooling for a 4 cycles of chemotherapy|
60061404|NCT01986140|76176785|FG000|NOT COMPLETED|Overall Study||35||
60061405|NCT01986140|76176786|FG001|NOT COMPLETED|Overall Study||28||
60061406|NCT01986062|76176794|FG000|STARTED|Overall Study||47||
60061407|NCT01986062|76176795|FG001|STARTED|Overall Study||50||
60061408|NCT01986062|76176794|FG000|COMPLETED|Overall Study||46||
60061409|NCT01986062|76176795|FG001|COMPLETED|Overall Study||49||
60061410|NCT01986062|76176794|FG000|NOT COMPLETED|Overall Study||1||
60061411|NCT01986062|76176795|FG001|NOT COMPLETED|Overall Study||1||
60061412|NCT01985360|76176803|FG000|STARTED|Overall Study||388||
60061413|NCT01985360|76176804|FG001|STARTED|Overall Study||389||
60061414|NCT01985360|76176803|FG000|COMPLETED|Overall Study||379||
60061415|NCT01985360|76176804|FG001|COMPLETED|Overall Study||386||
60061416|NCT01985360|76176803|FG000|NOT COMPLETED|Overall Study||9||
60061417|NCT01985360|76176804|FG001|NOT COMPLETED|Overall Study||3||
60061418|NCT02032706|76176810|FG000|STARTED|Overall Study||36||
60061419|NCT02032706|76176810|FG000|COMPLETED|Overall Study||30||
60061420|NCT02032706|76176810|FG000|NOT COMPLETED|Overall Study||6||
60061421|NCT02032238|76176816|FG000|STARTED|Overall Study||12||
60061422|NCT02032238|76176817|FG001|STARTED|Overall Study|Study Terminated due to slow enrollment, no subjects enrolled in this study arm|0||
60061423|NCT02032238|76176816|FG000|COMPLETED|Overall Study||10||
60061424|NCT02032238|76176817|FG001|COMPLETED|Overall Study||0||
60061425|NCT02032238|76176816|FG000|NOT COMPLETED|Overall Study||2||
60061426|NCT02032238|76176817|FG001|NOT COMPLETED|Overall Study||0||
60061427|NCT02009930|76176823|FG000|STARTED|Overall Study|5 withdrawn|112||
60061428|NCT02009930|76176823|FG000|COMPLETED|Overall Study||107||
60061429|NCT02009930|76176823|FG000|NOT COMPLETED|Overall Study||5||
60061430|NCT01985126|76176836|FG000|STARTED|Overall Study||18||
60061431|NCT01985126|76176837|FG001|STARTED|Overall Study||106||
60061432|NCT01985126|76176836|FG000|COMPLETED|Overall Study||0||
60061433|NCT01985126|76176837|FG001|COMPLETED|Overall Study||0||
60061434|NCT01985126|76176836|FG000|NOT COMPLETED|Overall Study||18||
60061435|NCT01985126|76176837|FG001|NOT COMPLETED|Overall Study||106||
60061436|NCT01984892|76176843|FG000|STARTED|Overall Study||8||
60061437|NCT01984892|76176843|FG000|COMPLETED|Overall Study|1 completed all study visits up until the termination of the study, last study visit not done.|1||
60061438|NCT01984892|76176843|FG000|NOT COMPLETED|Overall Study||7||
60061439|NCT01807221|76176853|FG000|STARTED|Overall Study||224||
60061440|NCT01807221|76176854|FG001|STARTED|Overall Study||173||
60061441|NCT01807221|76176855|FG002|STARTED|Overall Study||165||
60061442|NCT01807221|76176856|FG003|STARTED|Overall Study||169||
60061443|NCT01807221|76176857|FG004|STARTED|Overall Study||170||
60061444|NCT01807221|76176858|FG005|STARTED|Overall Study||165||
60061445|NCT01807221|76176853|FG000|Participants Received Study Treatment and Valid for Safety Analysis Set|Overall Study||221||
60061446|NCT01807221|76176854|FG001|Participants Received Study Treatment and Valid for Safety Analysis Set|Overall Study||172||
60061447|NCT01807221|76176855|FG002|Participants Received Study Treatment and Valid for Safety Analysis Set|Overall Study||163||
60061448|NCT01807221|76176856|FG003|Participants Received Study Treatment and Valid for Safety Analysis Set|Overall Study||167||
60061449|NCT01807221|76176857|FG004|Participants Received Study Treatment and Valid for Safety Analysis Set|Overall Study||169||
60061450|NCT01807221|76176858|FG005|Participants Received Study Treatment and Valid for Safety Analysis Set|Overall Study||163||
60061451|NCT01807221|76176853|FG000|COMPLETED|Overall Study||144||
60061452|NCT01807221|76176854|FG001|COMPLETED|Overall Study||121||
60061453|NCT01807221|76176855|FG002|COMPLETED|Overall Study||122||
60061454|NCT01807221|76176856|FG003|COMPLETED|Overall Study||123||
60061455|NCT01807221|76176857|FG004|COMPLETED|Overall Study||134||
60061456|NCT01807221|76176858|FG005|COMPLETED|Overall Study||124||
60061457|NCT01807221|76176853|FG000|NOT COMPLETED|Overall Study||80||
60061458|NCT01807221|76176854|FG001|NOT COMPLETED|Overall Study||52||
60061459|NCT01807221|76176855|FG002|NOT COMPLETED|Overall Study||43||
60061460|NCT01807221|76176856|FG003|NOT COMPLETED|Overall Study||46||
60061461|NCT01807221|76176857|FG004|NOT COMPLETED|Overall Study||36||
59516838|NCT00633152|75610551|FG001|MITT and Safety Population|Overall Study||45||
59516839|NCT00633152|75610550|FG000|Clinically Evaluable Population|Overall Study||86||
59516840|NCT00633152|75610551|FG001|Clinically Evaluable Population|Overall Study||39||
59516841|NCT00633152|75610550|FG000|COMPLETED|Overall Study||89||
59516842|NCT00633152|75610551|FG001|COMPLETED|Overall Study||41||
59516843|NCT00633152|75610550|FG000|NOT COMPLETED|Overall Study||14||
59516844|NCT00633152|75610551|FG001|NOT COMPLETED|Overall Study||6||
59516845|NCT01030783|75610561|FG000|STARTED|Overall Study||260||
59516846|NCT01030783|75610562|FG001|STARTED|Overall Study||257||
59516847|NCT01030783|75610561|FG000|COMPLETED|Overall Study||211||
59516848|NCT01030783|75610562|FG001|COMPLETED|Overall Study||231||
59516849|NCT01030783|75610561|FG000|NOT COMPLETED|Overall Study||49||
59516850|NCT01030783|75610562|FG001|NOT COMPLETED|Overall Study||26||
59516851|NCT00633074|75610570|FG000|STARTED|Overall Study||360||
59516852|NCT00633074|75610571|FG001|STARTED|Overall Study||360||
59516853|NCT00633074|75610570|FG000|COMPLETED|Overall Study||359||
59927962|NCT03231943|76046063|FG004|STARTED|Part 1, Period 3 (up to Day 45)||2||
59516854|NCT00633074|75610571|FG001|COMPLETED|Overall Study||360||
59516855|NCT00633074|75610570|FG000|NOT COMPLETED|Overall Study||1||
59516856|NCT00633074|75610571|FG001|NOT COMPLETED|Overall Study||0||
59516857|NCT03304054|75610580|FG000|STARTED|Overall Study||27||
59516858|NCT03304054|75610581|FG001|STARTED|Overall Study||7||
59927963|NCT03231943|76046064|FG005|STARTED|Part 1, Period 3 (up to Day 45)||2||
59927964|NCT03231943|76046065|FG006|STARTED|Part 1, Period 3 (up to Day 45)||2||
59927965|NCT03231943|76046066|FG007|STARTED|Part 1, Period 3 (up to Day 45)||2||
59927966|NCT03231943|76046067|FG008|STARTED|Part 1, Period 3 (up to Day 45)||0||
59927967|NCT03231943|76046068|FG009|STARTED|Part 1, Period 3 (up to Day 45)||0||
59927968|NCT03231943|76046069|FG010|STARTED|Part 1, Period 3 (up to Day 45)||0||
59927969|NCT03231943|76046070|FG011|STARTED|Part 1, Period 3 (up to Day 45)||0||
59927970|NCT03231943|76046071|FG012|STARTED|Part 1, Period 3 (up to Day 45)||0||
59927971|NCT03231943|76046059|FG000|COMPLETED|Part 1, Period 3 (up to Day 45)|One participant withdrawn was replaced|1||
59927972|NCT03231943|76046060|FG001|COMPLETED|Part 1, Period 3 (up to Day 45)||2||
59927973|NCT03231943|76046061|FG002|COMPLETED|Part 1, Period 3 (up to Day 45)||2||
59927974|NCT03231943|76046062|FG003|COMPLETED|Part 1, Period 3 (up to Day 45)||2||
59927975|NCT03231943|76046063|FG004|COMPLETED|Part 1, Period 3 (up to Day 45)||2||
59927976|NCT03231943|76046064|FG005|COMPLETED|Part 1, Period 3 (up to Day 45)||2||
59927977|NCT03231943|76046065|FG006|COMPLETED|Part 1, Period 3 (up to Day 45)||2||
59927978|NCT03231943|76046066|FG007|COMPLETED|Part 1, Period 3 (up to Day 45)||2||
59927979|NCT03231943|76046067|FG008|COMPLETED|Part 1, Period 3 (up to Day 45)||0||
59927980|NCT03231943|76046068|FG009|COMPLETED|Part 1, Period 3 (up to Day 45)||0||
59927981|NCT03231943|76046069|FG010|COMPLETED|Part 1, Period 3 (up to Day 45)||0||
59927982|NCT03231943|76046070|FG011|COMPLETED|Part 1, Period 3 (up to Day 45)||0||
59927983|NCT03231943|76046071|FG012|COMPLETED|Part 1, Period 3 (up to Day 45)||0||
59927984|NCT03231943|76046059|FG000|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||1||
59927985|NCT03231943|76046060|FG001|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0||
59927986|NCT03231943|76046061|FG002|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0||
59927987|NCT03231943|76046062|FG003|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0||
59927988|NCT03231943|76046063|FG004|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0||
59927989|NCT03231943|76046064|FG005|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0||
59927990|NCT03231943|76046065|FG006|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0||
59927991|NCT03231943|76046066|FG007|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0||
59927992|NCT03231943|76046067|FG008|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0||
59927993|NCT03231943|76046068|FG009|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0||
59927994|NCT03231943|76046069|FG010|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0||
59927995|NCT03231943|76046070|FG011|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0||
59927996|NCT03231943|76046071|FG012|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0||
59927997|NCT03231943|76046059|FG000|STARTED|Part 1 Period 4 (up to Day 60)||2||
59927998|NCT03231943|76046060|FG001|STARTED|Part 1 Period 4 (up to Day 60)||2||
59927999|NCT03231943|76046061|FG002|STARTED|Part 1 Period 4 (up to Day 60)||2||
59928000|NCT03231943|76046062|FG003|STARTED|Part 1 Period 4 (up to Day 60)||2||
59928001|NCT03231943|76046063|FG004|STARTED|Part 1 Period 4 (up to Day 60)||2||
59928002|NCT03231943|76046064|FG005|STARTED|Part 1 Period 4 (up to Day 60)||2||
59928003|NCT03231943|76046065|FG006|STARTED|Part 1 Period 4 (up to Day 60)||2||
59928004|NCT03231943|76046066|FG007|STARTED|Part 1 Period 4 (up to Day 60)||2||
59928005|NCT03231943|76046067|FG008|STARTED|Part 1 Period 4 (up to Day 60)||0||
59928006|NCT03231943|76046068|FG009|STARTED|Part 1 Period 4 (up to Day 60)||0||
59928007|NCT03231943|76046069|FG010|STARTED|Part 1 Period 4 (up to Day 60)||0||
59928008|NCT03231943|76046070|FG011|STARTED|Part 1 Period 4 (up to Day 60)||0||
59516859|NCT03304054|75610582|FG002|STARTED|Overall Study||28||
59516860|NCT03304054|75610583|FG003|STARTED|Overall Study||8||
59516861|NCT03304054|75610584|FG004|STARTED|Overall Study||17||
59516862|NCT03304054|75610585|FG005|STARTED|Overall Study||6||
59516863|NCT03304054|75610580|FG000|COMPLETED|Overall Study||27||
59516864|NCT03304054|75610581|FG001|COMPLETED|Overall Study||7||
59516865|NCT03304054|75610582|FG002|COMPLETED|Overall Study||27||
59516866|NCT03304054|75610583|FG003|COMPLETED|Overall Study||8||
59516867|NCT03304054|75610584|FG004|COMPLETED|Overall Study||0||
59928009|NCT03231943|76046071|FG012|STARTED|Part 1 Period 4 (up to Day 60)||0||
59928010|NCT03231943|76046059|FG000|COMPLETED|Part 1 Period 4 (up to Day 60)||2||
59928011|NCT03231943|76046060|FG001|COMPLETED|Part 1 Period 4 (up to Day 60)||2||
59928012|NCT03231943|76046061|FG002|COMPLETED|Part 1 Period 4 (up to Day 60)||2||
59928013|NCT03231943|76046062|FG003|COMPLETED|Part 1 Period 4 (up to Day 60)||2||
59928014|NCT03231943|76046063|FG004|COMPLETED|Part 1 Period 4 (up to Day 60)||2||
59928015|NCT03231943|76046064|FG005|COMPLETED|Part 1 Period 4 (up to Day 60)||2||
59928016|NCT03231943|76046065|FG006|COMPLETED|Part 1 Period 4 (up to Day 60)||2||
59928017|NCT03231943|76046066|FG007|COMPLETED|Part 1 Period 4 (up to Day 60)||2||
59928018|NCT03231943|76046067|FG008|COMPLETED|Part 1 Period 4 (up to Day 60)||0||
59928019|NCT03231943|76046068|FG009|COMPLETED|Part 1 Period 4 (up to Day 60)||0||
59928020|NCT03231943|76046069|FG010|COMPLETED|Part 1 Period 4 (up to Day 60)||0||
59928021|NCT03231943|76046070|FG011|COMPLETED|Part 1 Period 4 (up to Day 60)||0||
59928022|NCT03231943|76046071|FG012|COMPLETED|Part 1 Period 4 (up to Day 60)||0||
59928023|NCT03231943|76046059|FG000|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0||
59928024|NCT03231943|76046060|FG001|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0||
59928025|NCT03231943|76046061|FG002|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0||
59928026|NCT03231943|76046062|FG003|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0||
59928027|NCT03231943|76046063|FG004|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0||
59928028|NCT03231943|76046064|FG005|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0||
59928029|NCT03231943|76046065|FG006|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0||
59928030|NCT03231943|76046066|FG007|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0||
59928031|NCT03231943|76046067|FG008|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0||
59928032|NCT03231943|76046068|FG009|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0||
59928033|NCT03231943|76046069|FG010|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0||
59928034|NCT03231943|76046070|FG011|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0||
59928035|NCT03231943|76046071|FG012|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0||
59928036|NCT03231943|76046059|FG000|STARTED|Part 2||0||
59928037|NCT03231943|76046060|FG001|STARTED|Part 2||0||
59928038|NCT03231943|76046061|FG002|STARTED|Part 2||0||
59928039|NCT03231943|76046062|FG003|STARTED|Part 2||0||
59928040|NCT03231943|76046063|FG004|STARTED|Part 2||0||
59928041|NCT03231943|76046064|FG005|STARTED|Part 2||0||
59928042|NCT03231943|76046065|FG006|STARTED|Part 2||0||
59928043|NCT03231943|76046066|FG007|STARTED|Part 2||0||
59928044|NCT03231943|76046067|FG008|STARTED|Part 2||6||
59928045|NCT03231943|76046068|FG009|STARTED|Part 2||6||
59928046|NCT03231943|76046069|FG010|STARTED|Part 2||25||
59928047|NCT03231943|76046070|FG011|STARTED|Part 2||7||
59928048|NCT03231943|76046071|FG012|STARTED|Part 2||14||
59928049|NCT03231943|76046059|FG000|COMPLETED|Part 2||0||
59928050|NCT03231943|76046060|FG001|COMPLETED|Part 2||0||
59928051|NCT03231943|76046061|FG002|COMPLETED|Part 2||0||
59928052|NCT03231943|76046062|FG003|COMPLETED|Part 2||0||
59928053|NCT03231943|76046063|FG004|COMPLETED|Part 2||0||
59928054|NCT03231943|76046064|FG005|COMPLETED|Part 2||0||
59928055|NCT03231943|76046065|FG006|COMPLETED|Part 2||0||
59928056|NCT03231943|76046066|FG007|COMPLETED|Part 2||0||
59928057|NCT03231943|76046067|FG008|COMPLETED|Part 2||6||
59928058|NCT03231943|76046068|FG009|COMPLETED|Part 2||6||
59928059|NCT03231943|76046069|FG010|COMPLETED|Part 2||24||
59928060|NCT03231943|76046070|FG011|COMPLETED|Part 2||6||
59928061|NCT03231943|76046071|FG012|COMPLETED|Part 2||14||
59928062|NCT03231943|76046059|FG000|NOT COMPLETED|Part 2||0||
59928063|NCT03231943|76046060|FG001|NOT COMPLETED|Part 2||0||
59928064|NCT03231943|76046061|FG002|NOT COMPLETED|Part 2||0||
59928065|NCT03231943|76046062|FG003|NOT COMPLETED|Part 2||0||
59928066|NCT03231943|76046063|FG004|NOT COMPLETED|Part 2||0||
59928067|NCT03231943|76046064|FG005|NOT COMPLETED|Part 2||0||
59928068|NCT03231943|76046065|FG006|NOT COMPLETED|Part 2||0||
59928069|NCT03231943|76046066|FG007|NOT COMPLETED|Part 2||0||
59928070|NCT03231943|76046067|FG008|NOT COMPLETED|Part 2||0||
59928071|NCT03231943|76046068|FG009|NOT COMPLETED|Part 2||0||
59928072|NCT03231943|76046069|FG010|NOT COMPLETED|Part 2||1||
59928073|NCT03231943|76046070|FG011|NOT COMPLETED|Part 2||1||
59928074|NCT03231943|76046071|FG012|NOT COMPLETED|Part 2||0||
59928075|NCT01578239|76046103|FG000|STARTED|Treatment Period||117|All patients who received a randomization number, regardless of receiving study medication were included in the Randomized Set|
59928076|NCT01578239|76046104|FG001|STARTED|Treatment Period||114|All patients who received a randomization number, regardless of receiving study medication were included in the Randomized Set|
59928077|NCT01578239|76046103|FG000|Full Analysis Set (FAS)|Treatment Period||117|All randomized participant were analyzed according to randomized treatment, regardless of the actual treatment received.|
59928078|NCT01578239|76046104|FG001|Full Analysis Set (FAS)|Treatment Period||114|All randomized participant were analyzed according to randomized treatment, regardless of the actual treatment received.|
59928079|NCT01578239|76046103|FG000|Safety Analysis Set (SAF)|Treatment Period||111|All randomized patients who received at least one dose of active study medication. In the SAF, patients were analyzed based on actual treatment received.|
59516868|NCT03304054|75610585|FG005|COMPLETED|Overall Study||0||
60061462|NCT01807221|76176858|FG005|NOT COMPLETED|Overall Study||41||
60061463|NCT01838499|76176874|FG000|STARTED|Overall Study||55||
60061464|NCT01838499|76176875|FG001|STARTED|Overall Study||54||
60061465|NCT01838499|76176874|FG000|COMPLETED|Overall Study||31||
60061466|NCT01838499|76176875|FG001|COMPLETED|Overall Study||37||
60061467|NCT01838499|76176874|FG000|NOT COMPLETED|Overall Study||24||
60061468|NCT01838499|76176875|FG001|NOT COMPLETED|Overall Study||17||
59761005|NCT03944707|75880665|FG001|PK Analysis Set|Overall Study||0|All subjects with at least one available valid pharmacokinetics (PK) concentration measurement, who received any study drug and with no protocol deviations that affected PK data.|
59761006|NCT03944707|75880664|FG000|PD Analysis Set|Overall Study||47|All subjects with available pharmacodynamics (PD) data and no protocol deviations with relevant impact on PD data. A subject with available PD data was a subject with at least one on-treatment spirometry assessment or with PD diary data for at least 14 days.|
59761007|NCT03944707|75880665|FG001|PD Analysis Set|Overall Study||29|All subjects with available pharmacodynamics (PD) data and no protocol deviations with relevant impact on PD data. A subject with available PD data was a subject with at least one on-treatment spirometry assessment or with PD diary data for at least 14 days.|
59761008|NCT03944707|75880664|FG000|COMPLETED|Overall Study||35||
59761009|NCT03944707|75880665|FG001|COMPLETED|Overall Study||19||
59761010|NCT03944707|75880664|FG000|NOT COMPLETED|Overall Study||12||
59761011|NCT03944707|75880665|FG001|NOT COMPLETED|Overall Study||10||
59761012|NCT00549055|75880671|FG000|STARTED|Overall Study||38||
59761013|NCT00549055|75880671|FG000|COMPLETED|Overall Study||3||
60061469|NCT01807065|76176883|FG000|STARTED|Overall Study||25||
60061470|NCT01807065|76176884|FG001|STARTED|Overall Study||26||
59516869|NCT03304054|75610580|FG000|NOT COMPLETED|Overall Study||0||
59761014|NCT00549055|75880671|FG000|NOT COMPLETED|Overall Study||35||
59761015|NCT00883116|75880677|FG000|STARTED|Overall Study||248||
59761016|NCT00883116|75880678|FG001|STARTED|Overall Study||248||
59761017|NCT00883116|75880677|FG000|Received Treatment|Overall Study||248||
59761018|NCT00883116|75880678|FG001|Received Treatment|Overall Study||239||
59761019|NCT00883116|75880677|FG000|COMPLETED|Overall Study||39||
59761020|NCT00883116|75880678|FG001|COMPLETED|Overall Study||29||
59761021|NCT00883116|75880677|FG000|NOT COMPLETED|Overall Study||209||
59761022|NCT00883116|75880678|FG001|NOT COMPLETED|Overall Study||219||
59761023|NCT02797067|75880688|FG000|STARTED|Overall Study||685||
59761024|NCT02797067|75880689|FG001|STARTED|Overall Study||685||
59761025|NCT02797067|75880688|FG000|COMPLETED|Overall Study||685||
59761026|NCT02797067|75880689|FG001|COMPLETED|Overall Study||685||
59761027|NCT02797067|75880688|FG000|NOT COMPLETED|Overall Study||0||
59761028|NCT02797067|75880689|FG001|NOT COMPLETED|Overall Study||0||
59761029|NCT00594399|75880697|FG000|STARTED|Initial 3 Month Counseling||180||
59761030|NCT00594399|75880698|FG001|STARTED|Initial 3 Month Counseling||122||
59761031|NCT00594399|75880699|FG002|STARTED|Initial 3 Month Counseling||0||
59761032|NCT00594399|75880697|FG000|COMPLETED|Initial 3 Month Counseling||163||
59761033|NCT00594399|75880698|FG001|COMPLETED|Initial 3 Month Counseling||118||
59761034|NCT00594399|75880699|FG002|COMPLETED|Initial 3 Month Counseling||0||
59761035|NCT00594399|75880697|FG000|NOT COMPLETED|Initial 3 Month Counseling||17||
59761036|NCT00594399|75880698|FG001|NOT COMPLETED|Initial 3 Month Counseling||4||
59761037|NCT00594399|75880699|FG002|NOT COMPLETED|Initial 3 Month Counseling||0||
59761038|NCT00594399|75880697|FG000|STARTED|Rerandomization Arm 1 Only|Total sample in Arm 1 was rerandomized and allocated to remain in Arm 1 or assigned to Arm 3|81||
59761039|NCT00594399|75880698|FG001|STARTED|Rerandomization Arm 1 Only||118||
59761040|NCT00594399|75880699|FG002|STARTED|Rerandomization Arm 1 Only|This sample reflects newly randomized study Arm|82||
59761041|NCT00594399|75880697|FG000|Rerandomization|Rerandomization Arm 1 Only|Rerandomized to continue to receive telephone calls every 2 weeks or at a reduced dose of 1/ month|81||
59761042|NCT00594399|75880698|FG001|Rerandomization|Rerandomization Arm 1 Only||114||
59761043|NCT00594399|75880699|FG002|Rerandomization|Rerandomization Arm 1 Only||82||
59761044|NCT00594399|75880697|FG000|COMPLETED|Rerandomization Arm 1 Only||79||
59761045|NCT00594399|75880698|FG001|COMPLETED|Rerandomization Arm 1 Only||114||
60061471|NCT01807065|76176883|FG000|COMPLETED|Overall Study||24||
60061472|NCT01807065|76176884|FG001|COMPLETED|Overall Study||25||
60061473|NCT01807065|76176883|FG000|NOT COMPLETED|Overall Study||1||
60061474|NCT01807065|76176884|FG001|NOT COMPLETED|Overall Study||1||
60061475|NCT04583709|76176890|FG000|STARTED|Overall Study||20|Initial enrollment|
60061476|NCT04583709|76176890|FG000|COMPLETED|Overall Study||20|Completion of study participation of last enrollment (patient 20)|
59516870|NCT03304054|75610581|FG001|NOT COMPLETED|Overall Study||0||
59928080|NCT01578239|76046104|FG001|Safety Analysis Set (SAF)|Treatment Period||112|All randomized patients who received at least one dose of active study medication. In the SAF, patients were analyzed based on actual treatment received.|
59928081|NCT01578239|76046103|FG000|FAS-Entered Long-term Follow-up|Treatment Period||101||
59928082|NCT01578239|76046104|FG001|FAS-Entered Long-term Follow-up|Treatment Period||99||
59928083|NCT01578239|76046103|FG000|COMPLETED|Treatment Period||50|refers to completion of a minimum of 72 weeks of treatment.|
59928084|NCT01578239|76046104|FG001|COMPLETED|Treatment Period||13|refers to completion of a minimum of 72 weeks of treatment.|
59928085|NCT01578239|76046103|FG000|NOT COMPLETED|Treatment Period||67||
59928086|NCT01578239|76046104|FG001|NOT COMPLETED|Treatment Period||101||
59928087|NCT01578239|76046103|FG000|STARTED|Long-term Follow-Up Period|FAS-Entered long-term follow-up|101||
59928088|NCT01578239|76046104|FG001|STARTED|Long-term Follow-Up Period|FAS-Entered long-term follow-up|99||
60061477|NCT04583709|76176890|FG000|NOT COMPLETED|Overall Study||0||
60061478|NCT02031458|76176897|FG000|STARTED|May 8, 2015 to January 11, 2019||138||
59928089|NCT01578239|76046103|FG000|COMPLETED|Long-term Follow-Up Period||24|Study ended 5 years from randomization of last participant or 158 deaths in the study achieved|
59928090|NCT01578239|76046104|FG001|COMPLETED|Long-term Follow-Up Period||19|Study ended 5 years from randomization of last participant or 158 deaths in the study achieved|
59928091|NCT01578239|76046103|FG000|NOT COMPLETED|Long-term Follow-Up Period||77||
59928092|NCT01578239|76046104|FG001|NOT COMPLETED|Long-term Follow-Up Period||80||
59928093|NCT03241927|76046110|FG000|STARTED|Overall Study||1||
59928094|NCT03241927|76046111|FG001|STARTED|Overall Study||0||
59928095|NCT03241927|76046110|FG000|COMPLETED|Overall Study||0||
59928096|NCT03241927|76046111|FG001|COMPLETED|Overall Study||0||
59928097|NCT03241927|76046110|FG000|NOT COMPLETED|Overall Study||1||
59928098|NCT03241927|76046111|FG001|NOT COMPLETED|Overall Study||0||
59928099|NCT03329885|76046123|FG000|STARTED|Overall Study||9||
59928100|NCT03329885|76046124|FG001|STARTED|Overall Study||6||
59928101|NCT03329885|76046125|FG002|STARTED|Overall Study||6||
59928102|NCT03329885|76046126|FG003|STARTED|Overall Study||6||
59928103|NCT03329885|76046127|FG004|STARTED|Overall Study||6||
59928104|NCT03329885|76046128|FG005|STARTED|Overall Study||3||
59928105|NCT03329885|76046129|FG006|STARTED|Overall Study||1||
59928106|NCT03329885|76046130|FG007|STARTED|Overall Study||1||
59928107|NCT03329885|76046131|FG008|STARTED|Overall Study|Due to early termination of study, Part C was cancelled and no patients were dosed|0||
59928108|NCT03329885|76046123|FG000|COMPLETED|Overall Study||9||
59928109|NCT03329885|76046124|FG001|COMPLETED|Overall Study||6||
59928110|NCT03329885|76046125|FG002|COMPLETED|Overall Study||6||
59928111|NCT03329885|76046126|FG003|COMPLETED|Overall Study||6||
59928112|NCT03329885|76046127|FG004|COMPLETED|Overall Study||6||
59928113|NCT03329885|76046128|FG005|COMPLETED|Overall Study||3||
59928114|NCT03329885|76046129|FG006|COMPLETED|Overall Study||0||
59928115|NCT03329885|76046130|FG007|COMPLETED|Overall Study||0||
59928116|NCT03329885|76046131|FG008|COMPLETED|Overall Study||0||
59928117|NCT03329885|76046123|FG000|NOT COMPLETED|Overall Study||0||
59928118|NCT03329885|76046124|FG001|NOT COMPLETED|Overall Study||0||
59928119|NCT03329885|76046125|FG002|NOT COMPLETED|Overall Study||0||
59928120|NCT03329885|76046126|FG003|NOT COMPLETED|Overall Study||0||
59928121|NCT03329885|76046127|FG004|NOT COMPLETED|Overall Study||0||
59928122|NCT03329885|76046128|FG005|NOT COMPLETED|Overall Study||0||
59928123|NCT03329885|76046129|FG006|NOT COMPLETED|Overall Study||1||
59928124|NCT03329885|76046130|FG007|NOT COMPLETED|Overall Study||1||
59928125|NCT03329885|76046131|FG008|NOT COMPLETED|Overall Study||0||
59928126|NCT02941523|76046153|FG000|STARTED|Monotherapy|8 received NOX66 400 mg monotherapy and combination therapy with carboplatin.|8||
59928127|NCT02941523|76046154|FG001|STARTED|Monotherapy||8||
59928128|NCT02941523|76046153|FG000|COMPLETED|Monotherapy||8||
59928129|NCT02941523|76046154|FG001|COMPLETED|Monotherapy||7||
59928130|NCT02941523|76046153|FG000|NOT COMPLETED|Monotherapy||0||
59928131|NCT02941523|76046154|FG001|NOT COMPLETED|Monotherapy||1||
59928132|NCT02941523|76046153|FG000|STARTED|Carboplatin Combination Therapy|All continued to combination therapy|8||
59928133|NCT02941523|76046154|FG001|STARTED|Carboplatin Combination Therapy|7 continued to combination therapy; 3 started combination therapy only|10||
59928134|NCT02941523|76046153|FG000|COMPLETED|Carboplatin Combination Therapy||3||
60061479|NCT02031458|76176898|FG001|STARTED|May 8, 2015 to January 11, 2019||269||
60061480|NCT02031458|76176899|FG002|STARTED|May 8, 2015 to January 11, 2019||252||
60061481|NCT02031458|76176897|FG000|COMPLETED|May 8, 2015 to January 11, 2019||0||
60061482|NCT02031458|76176898|FG001|COMPLETED|May 8, 2015 to January 11, 2019||0||
59928135|NCT02941523|76046154|FG001|COMPLETED|Carboplatin Combination Therapy||6||
59928136|NCT02941523|76046153|FG000|NOT COMPLETED|Carboplatin Combination Therapy||5||
60061483|NCT02031458|76176899|FG002|COMPLETED|May 8, 2015 to January 11, 2019||0||
60061484|NCT02031458|76176897|FG000|NOT COMPLETED|May 8, 2015 to January 11, 2019||138||
60061485|NCT02031458|76176898|FG001|NOT COMPLETED|May 8, 2015 to January 11, 2019||269||
60061486|NCT02031458|76176899|FG002|NOT COMPLETED|May 8, 2015 to January 11, 2019||252||
60061487|NCT02031458|76176897|FG000|STARTED|Baseline to May 8, 2015||139||
59928137|NCT02941523|76046154|FG001|NOT COMPLETED|Carboplatin Combination Therapy||4||
59928138|NCT02938585|76046172|FG000|STARTED|Overall Study||9||
59928139|NCT02938585|76046173|FG001|STARTED|Overall Study||33||
59928140|NCT02938585|76046174|FG002|STARTED|Overall Study||11||
59928141|NCT02938585|76046175|FG003|STARTED|Overall Study||15||
59928142|NCT02938585|76046172|FG000|Exposed to Prophylaxis Regimen|Overall Study||9|As participants were allowed to change regimen in EXT phase, some participants were exposed to both|
59928143|NCT02938585|76046173|FG001|Exposed to Prophylaxis Regimen|Overall Study||31|As participants were allowed to change regimen in EXT phase, some participants were exposed to both|
59928144|NCT02938585|76046174|FG002|Exposed to Prophylaxis Regimen|Overall Study||11|As participants were allowed to change regimen in EXT phase, some participants were exposed to both|
59928145|NCT02938585|76046175|FG003|Exposed to Prophylaxis Regimen|Overall Study||12|As participants were allowed to change regimen in EXT phase, some participants were exposed to both|
59928146|NCT02938585|76046172|FG000|Exposed to On-demand Regimen|Overall Study||1|As participants were allowed to change regimen in EXT phase, some participants were exposed to both|
59928147|NCT02938585|76046173|FG001|Exposed to On-demand Regimen|Overall Study||7|As participants were allowed to change regimen in EXT phase, some participants were exposed to both|
60061488|NCT02031458|76176898|FG001|STARTED|Baseline to May 8, 2015||267||
60061489|NCT02031458|76176899|FG002|STARTED|Baseline to May 8, 2015||253||
60061490|NCT02031458|76176897|FG000|COMPLETED|Baseline to May 8, 2015||0||
59928148|NCT02938585|76046174|FG002|Exposed to On-demand Regimen|Overall Study||1|As participants were allowed to change regimen in EXT phase, some participants were exposed to both|
59928149|NCT02938585|76046175|FG003|Exposed to On-demand Regimen|Overall Study||8|As participants were allowed to change regimen in EXT phase, some participants were exposed to both|
59928150|NCT02938585|76046172|FG000|COMPLETED|Overall Study||9||
59928151|NCT02938585|76046173|FG001|COMPLETED|Overall Study||32||
59928152|NCT02938585|76046174|FG002|COMPLETED|Overall Study||11||
59928153|NCT02938585|76046175|FG003|COMPLETED|Overall Study||10||
59928154|NCT02938585|76046172|FG000|NOT COMPLETED|Overall Study||0||
59928155|NCT02938585|76046173|FG001|NOT COMPLETED|Overall Study||1||
59928156|NCT02938585|76046174|FG002|NOT COMPLETED|Overall Study||0||
59928157|NCT02938585|76046175|FG003|NOT COMPLETED|Overall Study||5||
59928158|NCT03229759|76046199|FG000|STARTED|Overall Study||99|Participants consented and enrolled.|
59928159|NCT03229759|76046199|FG000|Participants Treated|Overall Study||69||
59928160|NCT03229759|76046199|FG000|Treated With Investigational Product|Overall Study||45|Participants were treated with 2 of 3 study products.|
59928161|NCT03229759|76046199|FG000|Treated With Vehicle Control|Overall Study||47|Participants were treated with 2 of 3 study products.|
59928162|NCT03229759|76046199|FG000|Treated With Saline Control|Overall Study||46|Participants were treated with 2 of 3 study products.|
59928163|NCT03229759|76046199|FG000|COMPLETED|Overall Study||69||
59928164|NCT03229759|76046199|FG000|NOT COMPLETED|Overall Study||30||
59928165|NCT03228433|76046211|FG000|STARTED|Overall Study||10||
59928166|NCT03228433|76046212|FG001|STARTED|Overall Study||6||
59928167|NCT03228433|76046213|FG002|STARTED|Overall Study||6||
59928168|NCT03228433|76046214|FG003|STARTED|Overall Study||6||
59928169|NCT03228433|76046215|FG004|STARTED|Overall Study||6||
59928170|NCT03228433|76046216|FG005|STARTED|Overall Study||6||
59928171|NCT03228433|76046211|FG000|COMPLETED|Overall Study||9||
59928172|NCT03228433|76046212|FG001|COMPLETED|Overall Study||6||
59928173|NCT03228433|76046213|FG002|COMPLETED|Overall Study||6||
59928174|NCT03228433|76046214|FG003|COMPLETED|Overall Study||5||
59928175|NCT03228433|76046215|FG004|COMPLETED|Overall Study||6||
59928176|NCT03228433|76046216|FG005|COMPLETED|Overall Study||6||
59928177|NCT03228433|76046211|FG000|NOT COMPLETED|Overall Study||1||
59928178|NCT03228433|76046212|FG001|NOT COMPLETED|Overall Study||0||
59928179|NCT03228433|76046213|FG002|NOT COMPLETED|Overall Study||0||
59928180|NCT03228433|76046214|FG003|NOT COMPLETED|Overall Study||1||
59928181|NCT03228433|76046215|FG004|NOT COMPLETED|Overall Study||0||
59928182|NCT03228433|76046216|FG005|NOT COMPLETED|Overall Study||0||
59928183|NCT01496118|76046246|FG000|STARTED|Overall Study||4||
59928184|NCT01496118|76046247|FG001|STARTED|Overall Study||3||
59928185|NCT01496118|76046248|FG002|STARTED|Overall Study||3||
60061491|NCT02031458|76176898|FG001|COMPLETED|Baseline to May 8, 2015||0||
60061492|NCT02031458|76176899|FG002|COMPLETED|Baseline to May 8, 2015||0||
60061493|NCT02031458|76176897|FG000|NOT COMPLETED|Baseline to May 8, 2015||139||
60061494|NCT02031458|76176898|FG001|NOT COMPLETED|Baseline to May 8, 2015||267||
60061495|NCT02031458|76176899|FG002|NOT COMPLETED|Baseline to May 8, 2015||253||
60061496|NCT02009696|76176909|FG000|STARTED|Overall Study||221||
60061497|NCT02009696|76176909|FG000|COMPLETED|Overall Study||219||
60061498|NCT02009696|76176909|FG000|NOT COMPLETED|Overall Study||2||
60061499|NCT01806597|76176916|FG000|STARTED|Period 1 (Baseline to Week 16)||68||
59928186|NCT01496118|76046249|FG003|STARTED|Overall Study||3||
59928187|NCT01496118|76046250|FG004|STARTED|Overall Study||3||
59928188|NCT01496118|76046251|FG005|STARTED|Overall Study||3||
59928189|NCT01496118|76046252|FG006|STARTED|Overall Study||31||
59928190|NCT01496118|76046253|FG007|STARTED|Overall Study||30||
59928191|NCT01496118|76046246|FG000|COMPLETED|Overall Study||0||
59928192|NCT01496118|76046247|FG001|COMPLETED|Overall Study||0||
60061500|NCT01806597|76176917|FG001|STARTED|Period 1 (Baseline to Week 16)||69||
60061501|NCT01806597|76176918|FG002|STARTED|Period 1 (Baseline to Week 16)||0||
60061502|NCT01806597|76176919|FG003|STARTED|Period 1 (Baseline to Week 16)||0||
60061503|NCT01806597|76176920|FG004|STARTED|Period 1 (Baseline to Week 16)||68||
60061504|NCT01806597|76176921|FG005|STARTED|Period 1 (Baseline to Week 16)||0||
60061505|NCT01806597|76176916|FG000|COMPLETED|Period 1 (Baseline to Week 16)||63||
60061506|NCT01806597|76176917|FG001|COMPLETED|Period 1 (Baseline to Week 16)||64||
60061507|NCT01806597|76176918|FG002|COMPLETED|Period 1 (Baseline to Week 16)||0||
60061508|NCT01806597|76176919|FG003|COMPLETED|Period 1 (Baseline to Week 16)||0||
60061509|NCT01806597|76176920|FG004|COMPLETED|Period 1 (Baseline to Week 16)||63||
59928193|NCT01496118|76046248|FG002|COMPLETED|Overall Study||0||
59928194|NCT01496118|76046249|FG003|COMPLETED|Overall Study||0||
59928195|NCT01496118|76046250|FG004|COMPLETED|Overall Study||0||
59928196|NCT01496118|76046251|FG005|COMPLETED|Overall Study||0||
59928197|NCT01496118|76046252|FG006|COMPLETED|Overall Study||0||
60061510|NCT01806597|76176921|FG005|COMPLETED|Period 1 (Baseline to Week 16)||0||
60061511|NCT01806597|76176916|FG000|NOT COMPLETED|Period 1 (Baseline to Week 16)||5||
60061512|NCT01806597|76176917|FG001|NOT COMPLETED|Period 1 (Baseline to Week 16)||5||
60061513|NCT01806597|76176918|FG002|NOT COMPLETED|Period 1 (Baseline to Week 16)||0||
60061514|NCT01806597|76176919|FG003|NOT COMPLETED|Period 1 (Baseline to Week 16)||0||
59928198|NCT01496118|76046253|FG007|COMPLETED|Overall Study||0||
59928199|NCT01496118|76046246|FG000|NOT COMPLETED|Overall Study||4||
59928200|NCT01496118|76046247|FG001|NOT COMPLETED|Overall Study||3||
59928201|NCT01496118|76046248|FG002|NOT COMPLETED|Overall Study||3||
59928202|NCT01496118|76046249|FG003|NOT COMPLETED|Overall Study||3||
59928203|NCT01496118|76046250|FG004|NOT COMPLETED|Overall Study||3||
59928204|NCT01496118|76046251|FG005|NOT COMPLETED|Overall Study||3||
59928205|NCT01496118|76046252|FG006|NOT COMPLETED|Overall Study||31||
59928206|NCT01496118|76046253|FG007|NOT COMPLETED|Overall Study||30||
59928207|NCT02936869|76046273|FG000|STARTED|Overall Study||104||
59928208|NCT02936869|76046274|FG001|STARTED|Overall Study||103||
59928209|NCT02936869|76046273|FG000|COMPLETED|Overall Study||102||
59928210|NCT02936869|76046274|FG001|COMPLETED|Overall Study||98||
59928211|NCT02936869|76046273|FG000|NOT COMPLETED|Overall Study||2||
59928212|NCT02936869|76046274|FG001|NOT COMPLETED|Overall Study||5||
59928213|NCT03309605|76046289|FG000|STARTED|Overall Study||6||
59928214|NCT03309605|76046290|FG001|STARTED|Overall Study||5||
59928215|NCT03309605|76046291|FG002|STARTED|Overall Study||6||
59928216|NCT03309605|76046292|FG003|STARTED|Overall Study||6||
59928217|NCT03309605|76046293|FG004|STARTED|Overall Study||6||
59928218|NCT03309605|76046294|FG005|STARTED|Overall Study||6||
59928219|NCT03309605|76046295|FG006|STARTED|Overall Study||6||
59928220|NCT03309605|76046296|FG007|STARTED|Overall Study||21||
59928221|NCT03309605|76046289|FG000|COMPLETED|Overall Study||6||
59928222|NCT03309605|76046290|FG001|COMPLETED|Overall Study||5||
59928223|NCT03309605|76046291|FG002|COMPLETED|Overall Study||6||
59928224|NCT03309605|76046292|FG003|COMPLETED|Overall Study||5||
59928225|NCT03309605|76046293|FG004|COMPLETED|Overall Study||5||
59928226|NCT03309605|76046294|FG005|COMPLETED|Overall Study||6||
59928227|NCT03309605|76046295|FG006|COMPLETED|Overall Study||3||
59928228|NCT03309605|76046296|FG007|COMPLETED|Overall Study||19||
59928229|NCT03309605|76046289|FG000|NOT COMPLETED|Overall Study||0||
59928230|NCT03309605|76046290|FG001|NOT COMPLETED|Overall Study||0||
59928231|NCT03309605|76046291|FG002|NOT COMPLETED|Overall Study||0||
59928232|NCT03309605|76046292|FG003|NOT COMPLETED|Overall Study||1||
59928233|NCT03309605|76046293|FG004|NOT COMPLETED|Overall Study||1||
59928234|NCT03309605|76046294|FG005|NOT COMPLETED|Overall Study||0||
59928235|NCT03309605|76046295|FG006|NOT COMPLETED|Overall Study||3||
59928236|NCT03309605|76046296|FG007|NOT COMPLETED|Overall Study||2||
59928237|NCT02936635|76046312|FG000|STARTED|Overall Study||115||
59928238|NCT02936635|76046313|FG001|STARTED|Overall Study||165||
60061515|NCT01806597|76176920|FG004|NOT COMPLETED|Period 1 (Baseline to Week 16)||5||
60061516|NCT01806597|76176921|FG005|NOT COMPLETED|Period 1 (Baseline to Week 16)||0||
60061517|NCT01806597|76176916|FG000|STARTED|Treatment Period 2 (Week 16 to Week 132)||63||
59928239|NCT02936635|76046312|FG000|COMPLETED|Overall Study||0||
59928240|NCT02936635|76046313|FG001|COMPLETED|Overall Study||0||
59928241|NCT02936635|76046312|FG000|NOT COMPLETED|Overall Study||115||
59928242|NCT02936635|76046313|FG001|NOT COMPLETED|Overall Study||165||
59928243|NCT03227029|76046322|FG000|STARTED|Overall Study||26||
59928244|NCT03227029|76046323|FG001|STARTED|Overall Study||26||
59928245|NCT03227029|76046324|FG002|STARTED|Overall Study||13||
59928246|NCT03227029|76046322|FG000|Received Inoculation|Overall Study||26||
59928247|NCT03227029|76046323|FG001|Received Inoculation|Overall Study||25||
59928248|NCT03227029|76046324|FG002|Received Inoculation|Overall Study||12||
59928249|NCT03227029|76046322|FG000|COMPLETED|Overall Study||22||
59928250|NCT03227029|76046323|FG001|COMPLETED|Overall Study||22||
59928251|NCT03227029|76046324|FG002|COMPLETED|Overall Study||9||
59928252|NCT03227029|76046322|FG000|NOT COMPLETED|Overall Study||4||
59928253|NCT03227029|76046323|FG001|NOT COMPLETED|Overall Study||4||
59928254|NCT03227029|76046324|FG002|NOT COMPLETED|Overall Study||4||
59928255|NCT03329573|76046336|FG000|STARTED|Treatment Period 1 (Up to 5 Days)||23||
59928256|NCT03329573|76046337|FG001|STARTED|Treatment Period 1 (Up to 5 Days)||24||
59928257|NCT03329573|76046338|FG002|STARTED|Treatment Period 1 (Up to 5 Days)||19||
59928258|NCT03329573|76046339|FG003|STARTED|Treatment Period 1 (Up to 5 Days)||19||
59516871|NCT03304054|75610582|FG002|NOT COMPLETED|Overall Study||1||
60067874|NCT01756053|76183071|FG000|STARTED|Period 1 (10 Days)||8||
59928259|NCT03329573|76046336|FG000|COMPLETED|Treatment Period 1 (Up to 5 Days)||22||
59928260|NCT03329573|76046337|FG001|COMPLETED|Treatment Period 1 (Up to 5 Days)||21||
60061518|NCT01806597|76176917|FG001|STARTED|Treatment Period 2 (Week 16 to Week 132)||64||
60061519|NCT01806597|76176918|FG002|STARTED|Treatment Period 2 (Week 16 to Week 132)||31||
60061520|NCT01806597|76176919|FG003|STARTED|Treatment Period 2 (Week 16 to Week 132)||31||
60061521|NCT01806597|76176920|FG004|STARTED|Treatment Period 2 (Week 16 to Week 132)||1||
60061522|NCT01806597|76176921|FG005|STARTED|Treatment Period 2 (Week 16 to Week 132)||0||
60061523|NCT01806597|76176916|FG000|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||24||
60061524|NCT01806597|76176917|FG001|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||44||
60061525|NCT01806597|76176918|FG002|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||17||
60061526|NCT01806597|76176919|FG003|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||20||
60061527|NCT01806597|76176920|FG004|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||0||
60061528|NCT01806597|76176921|FG005|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||0||
60061529|NCT01806597|76176916|FG000|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||39||
60061530|NCT01806597|76176917|FG001|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||20||
60061531|NCT01806597|76176918|FG002|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||14||
60061532|NCT01806597|76176919|FG003|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||11||
60061533|NCT01806597|76176920|FG004|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||1||
60061534|NCT01806597|76176921|FG005|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||0||
60061535|NCT01806597|76176916|FG000|STARTED|Follow-up Period (Week 132 to Week 140)||0||
60061536|NCT01806597|76176917|FG001|STARTED|Follow-up Period (Week 132 to Week 140)||0||
60061537|NCT01806597|76176918|FG002|STARTED|Follow-up Period (Week 132 to Week 140)||0||
60061538|NCT01806597|76176919|FG003|STARTED|Follow-up Period (Week 132 to Week 140)||0||
60061539|NCT01806597|76176920|FG004|STARTED|Follow-up Period (Week 132 to Week 140)||3||
60061540|NCT01806597|76176921|FG005|STARTED|Follow-up Period (Week 132 to Week 140)||161||
60061541|NCT01806597|76176916|FG000|COMPLETED|Follow-up Period (Week 132 to Week 140)||0||
60061542|NCT01806597|76176917|FG001|COMPLETED|Follow-up Period (Week 132 to Week 140)||0||
60061543|NCT01806597|76176918|FG002|COMPLETED|Follow-up Period (Week 132 to Week 140)||0||
60061544|NCT01806597|76176919|FG003|COMPLETED|Follow-up Period (Week 132 to Week 140)||0||
60061545|NCT01806597|76176920|FG004|COMPLETED|Follow-up Period (Week 132 to Week 140)||3||
60061546|NCT01806597|76176921|FG005|COMPLETED|Follow-up Period (Week 132 to Week 140)||149||
60061547|NCT01806597|76176916|FG000|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||0||
60061548|NCT01806597|76176917|FG001|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||0||
60061549|NCT01806597|76176918|FG002|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||0||
60061550|NCT01806597|76176919|FG003|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||0||
60061551|NCT01806597|76176920|FG004|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||0||
60061552|NCT01806597|76176921|FG005|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||12||
60061553|NCT02031302|76176937|FG000|STARTED|Overall Study||1014||
60061554|NCT02031302|76176938|FG001|STARTED|Overall Study||50||
60061555|NCT02031302|76176937|FG000|COMPLETED|Overall Study||850||
59761046|NCT00594399|75880699|FG002|COMPLETED|Rerandomization Arm 1 Only||82||
59761047|NCT00594399|75880697|FG000|NOT COMPLETED|Rerandomization Arm 1 Only||2||
59928261|NCT03329573|76046338|FG002|COMPLETED|Treatment Period 1 (Up to 5 Days)||19||
59928262|NCT03329573|76046339|FG003|COMPLETED|Treatment Period 1 (Up to 5 Days)||19||
59928263|NCT03329573|76046336|FG000|NOT COMPLETED|Treatment Period 1 (Up to 5 Days)||1||
59928264|NCT03329573|76046337|FG001|NOT COMPLETED|Treatment Period 1 (Up to 5 Days)||3||
59928265|NCT03329573|76046338|FG002|NOT COMPLETED|Treatment Period 1 (Up to 5 Days)||0||
59928266|NCT03329573|76046339|FG003|NOT COMPLETED|Treatment Period 1 (Up to 5 Days)||0||
59928267|NCT03329573|76046336|FG000|STARTED|Washout Period (Day 6 to Day 11)||22||
59928268|NCT03329573|76046337|FG001|STARTED|Washout Period (Day 6 to Day 11)||21||
59928269|NCT03329573|76046338|FG002|STARTED|Washout Period (Day 6 to Day 11)||19||
59928270|NCT03329573|76046339|FG003|STARTED|Washout Period (Day 6 to Day 11)||19||
59928271|NCT03329573|76046336|FG000|COMPLETED|Washout Period (Day 6 to Day 11)||22||
59928272|NCT03329573|76046337|FG001|COMPLETED|Washout Period (Day 6 to Day 11)||21||
59928273|NCT03329573|76046338|FG002|COMPLETED|Washout Period (Day 6 to Day 11)||19||
59928274|NCT03329573|76046339|FG003|COMPLETED|Washout Period (Day 6 to Day 11)||19||
59928275|NCT03329573|76046336|FG000|NOT COMPLETED|Washout Period (Day 6 to Day 11)||0||
59761048|NCT00594399|75880698|FG001|NOT COMPLETED|Rerandomization Arm 1 Only||4||
59761049|NCT00594399|75880699|FG002|NOT COMPLETED|Rerandomization Arm 1 Only||0||
59761050|NCT00546715|75880709|FG000|STARTED|Overall Study||6||
59761051|NCT00546715|75880710|FG001|STARTED|Overall Study||5||
59761052|NCT00546715|75880711|FG002|STARTED|Overall Study||5||
59761053|NCT00546715|75880712|FG003|STARTED|Overall Study||2||
59761054|NCT00546715|75880709|FG000|COMPLETED|Overall Study||6||
59928276|NCT03329573|76046337|FG001|NOT COMPLETED|Washout Period (Day 6 to Day 11)||0||
60061556|NCT02031302|76176938|FG001|COMPLETED|Overall Study||50||
59761055|NCT00546715|75880710|FG001|COMPLETED|Overall Study||4||
60061557|NCT02031302|76176937|FG000|NOT COMPLETED|Overall Study||164||
59761056|NCT00546715|75880711|FG002|COMPLETED|Overall Study||5||
59761057|NCT00546715|75880712|FG003|COMPLETED|Overall Study||2||
59928277|NCT03329573|76046338|FG002|NOT COMPLETED|Washout Period (Day 6 to Day 11)||0||
60061558|NCT02031302|76176938|FG001|NOT COMPLETED|Overall Study||0||
60061559|NCT01610037|76176948|FG000|STARTED|All Patients||407||
59761058|NCT00546715|75880709|FG000|NOT COMPLETED|Overall Study||0||
60061560|NCT01610037|76176949|FG001|STARTED|All Patients||405||
60061561|NCT01610037|76176950|FG002|STARTED|All Patients||404||
60061562|NCT01610037|76176948|FG000|Randomized Set (RAN)|All Patients||407||
60061563|NCT01610037|76176949|FG001|Randomized Set (RAN)|All Patients||405||
60061564|NCT01610037|76176950|FG002|Randomized Set (RAN)|All Patients||404||
60061565|NCT01610037|76176948|FG000|Full Analysis Set (FAS)|All Patients||407||
60061566|NCT01610037|76176949|FG001|Full Analysis Set (FAS)|All Patients||405||
60061567|NCT01610037|76176950|FG002|Full Analysis Set (FAS)|All Patients||403||
60061568|NCT01610037|76176948|FG000|COMPLETED|All Patients||348||
60061569|NCT01610037|76176949|FG001|COMPLETED|All Patients||354||
60061570|NCT01610037|76176950|FG002|COMPLETED|All Patients||320||
60061571|NCT01610037|76176948|FG000|NOT COMPLETED|All Patients||59||
60061572|NCT01610037|76176949|FG001|NOT COMPLETED|All Patients||51||
60061573|NCT01610037|76176950|FG002|NOT COMPLETED|All Patients||84||
60061574|NCT01610037|76176948|FG000|STARTED|Treatment and Follow up Period||407||
60061575|NCT01610037|76176949|FG001|STARTED|Treatment and Follow up Period||405||
60061576|NCT01610037|76176950|FG002|STARTED|Treatment and Follow up Period||404||
60061577|NCT01610037|76176948|FG000|COMPLETED|Treatment and Follow up Period||382||
60061578|NCT01610037|76176949|FG001|COMPLETED|Treatment and Follow up Period||377||
60061579|NCT01610037|76176950|FG002|COMPLETED|Treatment and Follow up Period||378||
60061580|NCT01610037|76176948|FG000|NOT COMPLETED|Treatment and Follow up Period||25||
60061581|NCT01610037|76176949|FG001|NOT COMPLETED|Treatment and Follow up Period||28||
60061582|NCT01610037|76176950|FG002|NOT COMPLETED|Treatment and Follow up Period||26||
60061583|NCT01806051|76176958|FG000|STARTED|Overall Study||6||
60061584|NCT01806051|76176958|FG000|COMPLETED|Overall Study||0||
60061585|NCT01806051|76176958|FG000|NOT COMPLETED|Overall Study||6||
60061586|NCT01837797|76176967|FG000|STARTED|Period 1||129||
60061587|NCT01837797|76176968|FG001|STARTED|Period 1||0||
60061588|NCT01837797|76176969|FG002|STARTED|Period 1||0||
60061589|NCT01837797|76176970|FG003|STARTED|Period 1||0||
60061590|NCT01837797|76176971|FG004|STARTED|Period 1||0||
60061591|NCT01837797|76176967|FG000|COMPLETED|Period 1||27||
60061592|NCT01837797|76176968|FG001|COMPLETED|Period 1||0||
60061593|NCT01837797|76176969|FG002|COMPLETED|Period 1||0||
60061594|NCT01837797|76176970|FG003|COMPLETED|Period 1||0||
60061595|NCT01837797|76176971|FG004|COMPLETED|Period 1||0||
60061596|NCT01837797|76176967|FG000|NOT COMPLETED|Period 1||102||
60061597|NCT01837797|76176968|FG001|NOT COMPLETED|Period 1||0||
60061598|NCT01837797|76176969|FG002|NOT COMPLETED|Period 1||0||
60061599|NCT01837797|76176970|FG003|NOT COMPLETED|Period 1||0||
60061600|NCT01837797|76176971|FG004|NOT COMPLETED|Period 1||0||
60061601|NCT01837797|76176967|FG000|STARTED|Period 2||0||
60061602|NCT01837797|76176968|FG001|STARTED|Period 2||6||
60061603|NCT01837797|76176969|FG002|STARTED|Period 2||3||
60061604|NCT01837797|76176970|FG003|STARTED|Period 2||6||
60061605|NCT01837797|76176971|FG004|STARTED|Period 2||0||
60061606|NCT01837797|76176967|FG000|COMPLETED|Period 2||0||
60061607|NCT01837797|76176968|FG001|COMPLETED|Period 2||1||
60061608|NCT01837797|76176969|FG002|COMPLETED|Period 2||1||
60061609|NCT01837797|76176970|FG003|COMPLETED|Period 2||1||
60061610|NCT01837797|76176971|FG004|COMPLETED|Period 2||0||
60061611|NCT01837797|76176967|FG000|NOT COMPLETED|Period 2||0||
60061612|NCT01837797|76176968|FG001|NOT COMPLETED|Period 2||5||
60061613|NCT01837797|76176969|FG002|NOT COMPLETED|Period 2||2||
60061614|NCT01837797|76176970|FG003|NOT COMPLETED|Period 2||5||
60061615|NCT01837797|76176971|FG004|NOT COMPLETED|Period 2||0||
60061616|NCT01837797|76176967|FG000|STARTED|Period 3||0||
60061617|NCT01837797|76176968|FG001|STARTED|Period 3||0||
60061618|NCT01837797|76176969|FG002|STARTED|Period 3||0||
60061619|NCT01837797|76176970|FG003|STARTED|Period 3||0||
60061620|NCT01837797|76176971|FG004|STARTED|Period 3||47||
60061621|NCT01837797|76176967|FG000|COMPLETED|Period 3||0||
60061622|NCT01837797|76176968|FG001|COMPLETED|Period 3||0||
60061623|NCT01837797|76176969|FG002|COMPLETED|Period 3||0||
60061624|NCT01837797|76176970|FG003|COMPLETED|Period 3||0||
60061625|NCT01837797|76176971|FG004|COMPLETED|Period 3||24||
60061626|NCT01837797|76176967|FG000|NOT COMPLETED|Period 3||0||
60061627|NCT01837797|76176968|FG001|NOT COMPLETED|Period 3||0||
60061628|NCT01837797|76176969|FG002|NOT COMPLETED|Period 3||0||
60061629|NCT01837797|76176970|FG003|NOT COMPLETED|Period 3||0||
60061630|NCT01837797|76176971|FG004|NOT COMPLETED|Period 3||23||
60061631|NCT01984424|76176981|FG000|STARTED|Overall Study||73||
60061632|NCT01984424|76176982|FG001|STARTED|Overall Study||145||
60061633|NCT01984424|76176981|FG000|COMPLETED|Overall Study||70||
60061634|NCT01984424|76176982|FG001|COMPLETED|Overall Study||138||
60061635|NCT01984424|76176981|FG000|NOT COMPLETED|Overall Study||3||
60061636|NCT01984424|76176982|FG001|NOT COMPLETED|Overall Study||7||
60061637|NCT01837719|76176988|FG000|STARTED|Period 1: Days 1-7 (Treatment A or B)|Received treatment|64||
60061638|NCT01837719|76176988|FG000|COMPLETED|Period 1: Days 1-7 (Treatment A or B)||64||
60061639|NCT01837719|76176988|FG000|NOT COMPLETED|Period 1: Days 1-7 (Treatment A or B)||0||
60061640|NCT01837719|76176988|FG000|STARTED|Period 2: Days 8-14 (Treatment B or A)||64||
60061641|NCT01837719|76176988|FG000|COMPLETED|Period 2: Days 8-14 (Treatment B or A)||63||
60061642|NCT01837719|76176988|FG000|NOT COMPLETED|Period 2: Days 8-14 (Treatment B or A)||1||
60061643|NCT01837719|76176988|FG000|STARTED|Period 3: Days 15-21 (Treatment C or D)||63||
60061644|NCT01837719|76176988|FG000|COMPLETED|Period 3: Days 15-21 (Treatment C or D)||63||
60061645|NCT01837719|76176988|FG000|NOT COMPLETED|Period 3: Days 15-21 (Treatment C or D)||0||
60061646|NCT01837719|76176988|FG000|STARTED|Period 4: Days 22-28 (Treatment D or C)||63||
60061647|NCT01837719|76176988|FG000|COMPLETED|Period 4: Days 22-28 (Treatment D or C)|Number finishing period; 32 patients were discharged following Period 4, as per protocol|63||
60061648|NCT01837719|76176988|FG000|NOT COMPLETED|Period 4: Days 22-28 (Treatment D or C)||0||
60061649|NCT01837719|76176988|FG000|STARTED|Period 5: Days 29-31 (Treatment E)|Reflects the 31 patients remaining after 32 were discharged at the end of Period 4, as per protocol|31||
60061650|NCT01837719|76176988|FG000|COMPLETED|Period 5: Days 29-31 (Treatment E)||30||
60061651|NCT01837719|76176988|FG000|NOT COMPLETED|Period 5: Days 29-31 (Treatment E)||1||
60061652|NCT01984268|76177003|FG000|STARTED|Overall Study||15||
60061653|NCT01984268|76177003|FG000|COMPLETED|Overall Study||0||
60061654|NCT01984268|76177003|FG000|NOT COMPLETED|Overall Study||15||
60061655|NCT02031146|76177009|FG000|STARTED|Overall Study||11|There were 231 entry visits for 219 unique individuals. There were 12 re enrollments.|
60061656|NCT02031146|76177010|FG001|STARTED|Overall Study||3|There were 231 entry visits for 219 unique individuals. There were 12 re enrollments.|
60061657|NCT02031146|76177011|FG002|STARTED|Overall Study||18|There were 231 entry visits for 219 unique individuals. There were 12 re enrollments.|
59613074|NCT01713582|75724105|FG011|NOT COMPLETED|Overall Study||5||
59613075|NCT01713582|75724106|FG012|NOT COMPLETED|Overall Study||3||
59613076|NCT01713582|75724107|FG013|NOT COMPLETED|Overall Study||4||
59613077|NCT01713582|75724108|FG014|NOT COMPLETED|Overall Study||7||
59613078|NCT01713582|75724109|FG015|NOT COMPLETED|Overall Study||6||
59613079|NCT01713582|75724110|FG016|NOT COMPLETED|Overall Study||7||
59613080|NCT01713582|75724111|FG017|NOT COMPLETED|Overall Study||3||
60061658|NCT02031146|76177012|FG003|STARTED|Overall Study||148|There were 231 entry visits for 219 unique individuals. There were 12 re enrollments.|
60061659|NCT02031146|76177013|FG004|STARTED|Overall Study||42|There were 231 entry visits for 219 unique individuals. There were 12 re enrollments.|
60061660|NCT02031146|76177014|FG005|STARTED|Overall Study||4|There were 231 entry visits for 219 unique individuals. There were 12 re enrollments.|
60061661|NCT02031146|76177015|FG006|STARTED|Overall Study||5|There were 231 entry visits for 219 unique individuals. There were 12 re enrollments.|
60061662|NCT02031146|76177009|FG000|Considered in Analysis|Overall Study||11|All participants who were randomized were included in the analysis. The first entry visit for those who were not randomized were included in the analysis if: 1) serum RPR was at or above 1:32 or 2) for PLWH, peripheral blood CD4 + T cells were at or below 350/ul. All included had to have undergone the entry CogState battery.|
60061663|NCT02031146|76177010|FG001|Considered in Analysis|Overall Study||3|All participants who were randomized were included in the analysis. The first entry visit for those who were not randomized were included in the analysis if: 1) serum RPR was at or above 1:32 or 2) for PLWH, peripheral blood CD4 + T cells were at or below 350/ul. All included had to have undergone the entry CogState battery.|
60061664|NCT02031146|76177011|FG002|Considered in Analysis|Overall Study||18|All participants who were randomized were included in the analysis. The first entry visit for those who were not randomized were included in the analysis if: 1) serum RPR was at or above 1:32 or 2) for PLWH, peripheral blood CD4 + T cells were at or below 350/ul. All included had to have undergone the entry CogState battery.|
60061665|NCT02031146|76177012|FG003|Considered in Analysis|Overall Study||48|All participants who were randomized were included in the analysis. The first entry visit for those who were not randomized were included in the analysis if: 1) serum RPR was at or above 1:32 or 2) for PLWH, peripheral blood CD4 + T cells were at or below 350/ul. All included had to have undergone the entry CogState battery.|
60061666|NCT02031146|76177013|FG004|Considered in Analysis|Overall Study||16|All participants who were randomized were included in the analysis. The first entry visit for those who were not randomized were included in the analysis if: 1) serum RPR was at or above 1:32 or 2) for PLWH, peripheral blood CD4 + T cells were at or below 350/ul. All included had to have undergone the entry CogState battery.|
60061667|NCT02031146|76177014|FG005|Considered in Analysis|Overall Study||0|All participants who were randomized were included in the analysis. The first entry visit for those who were not randomized were included in the analysis if: 1) serum RPR was at or above 1:32 or 2) for PLWH, peripheral blood CD4 + T cells were at or below 350/ul. All included had to have undergone the entry CogState battery.|
60061668|NCT02031146|76177015|FG006|Considered in Analysis|Overall Study||0|All participants who were randomized were included in the analysis. The first entry visit for those who were not randomized were included in the analysis if: 1) serum RPR was at or above 1:32 or 2) for PLWH, peripheral blood CD4 + T cells were at or below 350/ul. All included had to have undergone the entry CogState battery.|
60061669|NCT02031146|76177009|FG000|COMPLETED|Overall Study||11|Completed = considered in analysis|
60061670|NCT02031146|76177010|FG001|COMPLETED|Overall Study||3|Completed = considered in analysis|
60061671|NCT02031146|76177011|FG002|COMPLETED|Overall Study||18|Completed = considered in analysis|
60061672|NCT02031146|76177012|FG003|COMPLETED|Overall Study||48|Completed = considered in analysis|
60061673|NCT02031146|76177013|FG004|COMPLETED|Overall Study||16|Completed = considered in analysis|
60061674|NCT02031146|76177014|FG005|COMPLETED|Overall Study||0|Completed = considered in analysis|
60061675|NCT02031146|76177015|FG006|COMPLETED|Overall Study||0|Completed = considered in analysis|
60061676|NCT02031146|76177009|FG000|NOT COMPLETED|Overall Study||0||
60061677|NCT02031146|76177010|FG001|NOT COMPLETED|Overall Study||0||
60061678|NCT02031146|76177011|FG002|NOT COMPLETED|Overall Study||0||
60061679|NCT02031146|76177012|FG003|NOT COMPLETED|Overall Study||100||
60061680|NCT02031146|76177013|FG004|NOT COMPLETED|Overall Study||26||
60061681|NCT02031146|76177014|FG005|NOT COMPLETED|Overall Study||4||
59613081|NCT01713582|75724112|FG018|NOT COMPLETED|Overall Study||5||
60061682|NCT02031146|76177015|FG006|NOT COMPLETED|Overall Study||5||
60061683|NCT02009384|76177025|FG000|STARTED|Overall Study|Study was Terminated due to low subject enrollment Data was not analyzed|2||
60061684|NCT02009384|76177025|FG000|COMPLETED|Overall Study|Study was Terminated due to low subject enrollment Data was not analyzed|0||
60061685|NCT02009384|76177025|FG000|NOT COMPLETED|Overall Study||2||
60061686|NCT01805037|76177029|FG000|STARTED|Induction (4 Weeks)||0||
60061687|NCT01805037|76177030|FG001|STARTED|Induction (4 Weeks)||20||
60061688|NCT01805037|76177029|FG000|Received Dose of Study Drug|Induction (4 Weeks)||0||
60061689|NCT01805037|76177030|FG001|Received Dose of Study Drug|Induction (4 Weeks)||20||
60061690|NCT01805037|76177029|FG000|COMPLETED|Induction (4 Weeks)||0||
60061691|NCT01805037|76177030|FG001|COMPLETED|Induction (4 Weeks)||20||
60061692|NCT01805037|76177029|FG000|NOT COMPLETED|Induction (4 Weeks)||0||
60061693|NCT01805037|76177030|FG001|NOT COMPLETED|Induction (4 Weeks)||0||
60061694|NCT01805037|76177029|FG000|STARTED|Consolidation (Optional, 4 Weeks)||0||
60061695|NCT01805037|76177030|FG001|STARTED|Consolidation (Optional, 4 Weeks)|Consolidation is optional for patients who have a partial or complete response during induction.|6||
60061696|NCT01805037|76177029|FG000|Received Dose of Study Drug|Consolidation (Optional, 4 Weeks)||0||
60061697|NCT01805037|76177030|FG001|Received Dose of Study Drug|Consolidation (Optional, 4 Weeks)||6||
60061698|NCT01805037|76177029|FG000|COMPLETED|Consolidation (Optional, 4 Weeks)||0||
60061699|NCT01805037|76177030|FG001|COMPLETED|Consolidation (Optional, 4 Weeks)||6||
60061700|NCT01805037|76177029|FG000|NOT COMPLETED|Consolidation (Optional, 4 Weeks)||0||
60061701|NCT01805037|76177030|FG001|NOT COMPLETED|Consolidation (Optional, 4 Weeks)||0||
60061702|NCT01805037|76177029|FG000|STARTED|1st Cycle of Maintenance (3 Weeks)||0||
60061703|NCT01805037|76177030|FG001|STARTED|1st Cycle of Maintenance (3 Weeks)|Consolidation is optional for patients who have a partial or complete response during induction|20||
60061704|NCT01805037|76177029|FG000|Received Dose of Study Drug|1st Cycle of Maintenance (3 Weeks)||0||
60061705|NCT01805037|76177030|FG001|Received Dose of Study Drug|1st Cycle of Maintenance (3 Weeks)||14||
60061706|NCT01805037|76177029|FG000|COMPLETED|1st Cycle of Maintenance (3 Weeks)||0||
60061707|NCT01805037|76177030|FG001|COMPLETED|1st Cycle of Maintenance (3 Weeks)||14||
60061708|NCT01805037|76177029|FG000|NOT COMPLETED|1st Cycle of Maintenance (3 Weeks)||0||
60061709|NCT01805037|76177030|FG001|NOT COMPLETED|1st Cycle of Maintenance (3 Weeks)||6||
60061710|NCT01805037|76177029|FG000|STARTED|2nd Cycle of Maintenance and Beyond||0||
60061711|NCT01805037|76177030|FG001|STARTED|2nd Cycle of Maintenance and Beyond||14||
60061712|NCT01805037|76177029|FG000|Received Dose of Study Drug|2nd Cycle of Maintenance and Beyond||0||
60061713|NCT01805037|76177030|FG001|Received Dose of Study Drug|2nd Cycle of Maintenance and Beyond||14||
60061714|NCT01805037|76177029|FG000|COMPLETED|2nd Cycle of Maintenance and Beyond||0|Completion = up to 1 year of maint. treatment from time of induction (1 maint. cycle = 3 weeks).|
59516872|NCT03304054|75610583|FG003|NOT COMPLETED|Overall Study||0||
59516873|NCT03304054|75610584|FG004|NOT COMPLETED|Overall Study||17||
59928278|NCT03329573|76046339|FG003|NOT COMPLETED|Washout Period (Day 6 to Day 11)||0||
59928279|NCT03329573|76046336|FG000|STARTED|Treatment Period 2 (Day 12 to Day 26)||22||
59928280|NCT03329573|76046337|FG001|STARTED|Treatment Period 2 (Day 12 to Day 26)||21||
59928281|NCT03329573|76046338|FG002|STARTED|Treatment Period 2 (Day 12 to Day 26)||19||
59928282|NCT03329573|76046339|FG003|STARTED|Treatment Period 2 (Day 12 to Day 26)||19||
59928283|NCT03329573|76046336|FG000|COMPLETED|Treatment Period 2 (Day 12 to Day 26)||21||
59928284|NCT03329573|76046337|FG001|COMPLETED|Treatment Period 2 (Day 12 to Day 26)||20||
59928285|NCT03329573|76046338|FG002|COMPLETED|Treatment Period 2 (Day 12 to Day 26)||19||
59928286|NCT03329573|76046339|FG003|COMPLETED|Treatment Period 2 (Day 12 to Day 26)||19||
59928287|NCT03329573|76046336|FG000|NOT COMPLETED|Treatment Period 2 (Day 12 to Day 26)||1||
59928288|NCT03329573|76046337|FG001|NOT COMPLETED|Treatment Period 2 (Day 12 to Day 26)||1||
59928289|NCT03329573|76046338|FG002|NOT COMPLETED|Treatment Period 2 (Day 12 to Day 26)||0||
59928290|NCT03329573|76046339|FG003|NOT COMPLETED|Treatment Period 2 (Day 12 to Day 26)||0||
59928291|NCT00604201|76046349|FG000|STARTED|Overall Study||31||
59928292|NCT00604201|76046349|FG000|COMPLETED|Overall Study||21||
59928293|NCT00604201|76046349|FG000|NOT COMPLETED|Overall Study||10||
59928294|NCT00492349|76046355|FG000|STARTED|Overall Study||35||
59928295|NCT00492349|76046356|FG001|STARTED|Overall Study||34||
59928296|NCT00492349|76046355|FG000|Week 2|Overall Study||32||
59928297|NCT00492349|76046356|FG001|Week 2|Overall Study||33||
59516874|NCT03304054|75610585|FG005|NOT COMPLETED|Overall Study||6||
59516875|NCT03210376|75610596|FG000|STARTED|Overall Study||50||
59516876|NCT03210376|75610597|FG001|STARTED|Overall Study||50||
59761059|NCT00546715|75880710|FG001|NOT COMPLETED|Overall Study||1||
59761060|NCT00546715|75880711|FG002|NOT COMPLETED|Overall Study||0||
60061715|NCT01805037|76177030|FG001|COMPLETED|2nd Cycle of Maintenance and Beyond||2|Completion = up to 1 year of maint. treatment from time of induction (1 maint. cycle = 3 weeks).|
60061716|NCT01805037|76177029|FG000|NOT COMPLETED|2nd Cycle of Maintenance and Beyond||0||
60061717|NCT01805037|76177030|FG001|NOT COMPLETED|2nd Cycle of Maintenance and Beyond||12||
60061718|NCT01805037|76177029|FG000|STARTED|Follow Up (up to 3 Years)||0||
60061719|NCT01805037|76177030|FG001|STARTED|Follow Up (up to 3 Years)|Patients who received at least one dose of study treatment go into follow-up.|20||
60061720|NCT01805037|76177029|FG000|COMPLETED|Follow Up (up to 3 Years)||0||
60061721|NCT01805037|76177030|FG001|COMPLETED|Follow Up (up to 3 Years)||14||
60061722|NCT01805037|76177029|FG000|NOT COMPLETED|Follow Up (up to 3 Years)||0||
60061723|NCT01805037|76177030|FG001|NOT COMPLETED|Follow Up (up to 3 Years)||6||
60061724|NCT01803711|76177036|FG000|STARTED|Overall Study||2||
60061725|NCT01803711|76177037|FG001|STARTED|Overall Study||3||
60061726|NCT01803711|76177036|FG000|COMPLETED|Overall Study||1||
60061727|NCT01803711|76177037|FG001|COMPLETED|Overall Study||2||
60061728|NCT01803711|76177036|FG000|NOT COMPLETED|Overall Study||1||
60061729|NCT01803711|76177037|FG001|NOT COMPLETED|Overall Study||1||
60061730|NCT01836549|76177051|FG000|STARTED|Overall Study||1||
60061731|NCT01836549|76177052|FG001|STARTED|Overall Study||1||
60061732|NCT01836549|76177053|FG002|STARTED|Overall Study||1||
60061733|NCT01836549|76177054|FG003|STARTED|Overall Study||9||
60061734|NCT01836549|76177055|FG004|STARTED|Overall Study||18||
60061735|NCT01836549|76177056|FG005|STARTED|Overall Study||4||
60061736|NCT01836549|76177057|FG006|STARTED|Overall Study||9||
60061737|NCT01836549|76177051|FG000|COMPLETED|Overall Study||1||
60061738|NCT01836549|76177052|FG001|COMPLETED|Overall Study||1||
60061739|NCT01836549|76177053|FG002|COMPLETED|Overall Study||0||
60061740|NCT01836549|76177054|FG003|COMPLETED|Overall Study||8||
60061741|NCT01836549|76177055|FG004|COMPLETED|Overall Study||18||
60061742|NCT01836549|76177056|FG005|COMPLETED|Overall Study||4||
60061743|NCT01836549|76177057|FG006|COMPLETED|Overall Study||8||
60061744|NCT01836549|76177051|FG000|NOT COMPLETED|Overall Study||0||
59761061|NCT00546715|75880712|FG003|NOT COMPLETED|Overall Study||0||
59761062|NCT00874029|75880722|FG000|STARTED|Overall Study||137||
59761063|NCT00874029|75880722|FG000|COMPLETED|Overall Study||116||
60061745|NCT01836549|76177052|FG001|NOT COMPLETED|Overall Study||0||
60061746|NCT01836549|76177053|FG002|NOT COMPLETED|Overall Study||1||
60061747|NCT01836549|76177054|FG003|NOT COMPLETED|Overall Study||1||
60061748|NCT01836549|76177055|FG004|NOT COMPLETED|Overall Study||0||
60061749|NCT01836549|76177056|FG005|NOT COMPLETED|Overall Study||0||
60061750|NCT01836549|76177057|FG006|NOT COMPLETED|Overall Study||1||
60061751|NCT01836471|76177078|FG000|STARTED|Overall Study||93||
60061752|NCT01836471|76177079|FG001|STARTED|Overall Study||94||
60061753|NCT01836471|76177080|FG002|STARTED|Overall Study||51||
60061754|NCT01836471|76177081|FG003|STARTED|Overall Study||42||
60061755|NCT01836471|76177082|FG004|STARTED|Overall Study||54||
60061756|NCT01836471|76177078|FG000|COMPLETED|Overall Study||82||
60061757|NCT01836471|76177079|FG001|COMPLETED|Overall Study||85||
60061758|NCT01836471|76177080|FG002|COMPLETED|Overall Study||49||
60061759|NCT01836471|76177081|FG003|COMPLETED|Overall Study||40||
60061760|NCT01836471|76177082|FG004|COMPLETED|Overall Study||49||
60061761|NCT01836471|76177078|FG000|NOT COMPLETED|Overall Study||11||
59761064|NCT00874029|75880722|FG000|NOT COMPLETED|Overall Study||21||
59761065|NCT00546637|75880738|FG000|STARTED|Overall Study||474||
59761066|NCT00546637|75880739|FG001|STARTED|Overall Study||473||
59761067|NCT00546637|75880738|FG000|Received Treatment|Overall Study||471||
59761068|NCT00546637|75880739|FG001|Received Treatment|Overall Study||472||
59761069|NCT00546637|75880738|FG000|COMPLETED|Overall Study||401||
59761070|NCT00546637|75880739|FG001|COMPLETED|Overall Study||424||
59761071|NCT00546637|75880738|FG000|NOT COMPLETED|Overall Study||73||
59761072|NCT00546637|75880739|FG001|NOT COMPLETED|Overall Study||49||
60061762|NCT01836471|76177079|FG001|NOT COMPLETED|Overall Study||9||
59516877|NCT03210376|75610596|FG000|COMPLETED|Overall Study||50||
59516878|NCT03210376|75610597|FG001|COMPLETED|Overall Study||50||
60061763|NCT01836471|76177080|FG002|NOT COMPLETED|Overall Study||2||
60061764|NCT01836471|76177081|FG003|NOT COMPLETED|Overall Study||2||
60061765|NCT01836471|76177082|FG004|NOT COMPLETED|Overall Study||5||
60061766|NCT02030600|76177097|FG000|STARTED|Treatment Period 1||361||
60061767|NCT02030600|76177098|FG001|STARTED|Treatment Period 1||360||
60061768|NCT02030600|76177097|FG000|Exposed|Treatment Period 1||356||
60061769|NCT02030600|76177098|FG001|Exposed|Treatment Period 1||357||
60061770|NCT02030600|76177097|FG000|COMPLETED|Treatment Period 1||308||
60061771|NCT02030600|76177098|FG001|COMPLETED|Treatment Period 1||315||
60061772|NCT02030600|76177097|FG000|NOT COMPLETED|Treatment Period 1||53||
60061773|NCT02030600|76177098|FG001|NOT COMPLETED|Treatment Period 1||45||
60061774|NCT02030600|76177097|FG000|STARTED|Treatment Period 2||308||
60061775|NCT02030600|76177098|FG001|STARTED|Treatment Period 2||315||
60061776|NCT02030600|76177097|FG000|COMPLETED|Treatment Period 2||283||
60061777|NCT02030600|76177098|FG001|COMPLETED|Treatment Period 2||297||
60061778|NCT02030600|76177097|FG000|NOT COMPLETED|Treatment Period 2||25||
60061779|NCT02030600|76177098|FG001|NOT COMPLETED|Treatment Period 2||18||
60061780|NCT01802775|76177108|FG000|STARTED|Overall Study||102||
60061781|NCT01802775|76177109|FG001|STARTED|Overall Study||101||
60061782|NCT01802775|76177108|FG000|Received Drug (Safety Analysis Set)|Overall Study||101||
60061783|NCT01802775|76177109|FG001|Received Drug (Safety Analysis Set)|Overall Study||100||
59928298|NCT00492349|76046355|FG000|Week 8|Overall Study||32||
59928299|NCT00492349|76046356|FG001|Week 8|Overall Study||27||
60061784|NCT01802775|76177108|FG000|COMPLETED|Overall Study||96||
60061785|NCT01802775|76177109|FG001|COMPLETED|Overall Study||89||
59516879|NCT03210376|75610596|FG000|NOT COMPLETED|Overall Study||0||
59516880|NCT03210376|75610597|FG001|NOT COMPLETED|Overall Study||0||
59516881|NCT03211234|75610606|FG000|STARTED|Overall Study||17||
59516882|NCT03211234|75610607|FG001|STARTED|Overall Study||31||
59928300|NCT00492349|76046355|FG000|COMPLETED|Overall Study||32||
60061786|NCT01802775|76177108|FG000|NOT COMPLETED|Overall Study||6||
60061787|NCT01802775|76177109|FG001|NOT COMPLETED|Overall Study||12||
60061788|NCT01802385|76177117|FG000|STARTED|Overall Study||231||
60061789|NCT01802385|76177118|FG001|STARTED|Overall Study||229||
60061790|NCT01802385|76177117|FG000|COMPLETED|Overall Study||125||
60061791|NCT01802385|76177118|FG001|COMPLETED|Overall Study||109||
60061792|NCT01802385|76177117|FG000|NOT COMPLETED|Overall Study||106||
60061793|NCT01802385|76177118|FG001|NOT COMPLETED|Overall Study||120||
60061794|NCT01773993|76177124|FG000|STARTED|Overall Study||534||
60061795|NCT01773993|76177124|FG000|COMPLETED|Overall Study|Number of participants whose survey form were collected and included in analyses is shown.|499||
60061796|NCT01773993|76177124|FG000|NOT COMPLETED|Overall Study||35||
60061797|NCT01802073|76177130|FG000|STARTED|Overall Study||14||
60061798|NCT01802073|76177131|FG001|STARTED|Overall Study||20||
60061799|NCT01802073|76177130|FG000|COMPLETED|Overall Study||9||
60061800|NCT01802073|76177131|FG001|COMPLETED|Overall Study||9||
59516883|NCT03211234|75610608|FG002|STARTED|Overall Study||28||
59516884|NCT03211234|75610606|FG000|COMPLETED|Overall Study||16||
59516885|NCT03211234|75610607|FG001|COMPLETED|Overall Study||30||
59613082|NCT01713582|75724113|FG019|NOT COMPLETED|Overall Study||5||
59928301|NCT00492349|76046356|FG001|COMPLETED|Overall Study||27||
59928302|NCT00492349|76046355|FG000|NOT COMPLETED|Overall Study||3||
59928303|NCT00492349|76046356|FG001|NOT COMPLETED|Overall Study||7||
59928304|NCT03308825|76046370|FG000|STARTED|Overall Study|1 child in Group 1 received a 0.5mL dose instead of a 0.25 mL dose and is included in Group 2.|59||
59928305|NCT03308825|76046371|FG001|STARTED|Overall Study|1 child in Group 1 received a 0.5mL dose instead of a 0.25 mL dose and is included in Group 2.|61||
59928306|NCT03308825|76046372|FG002|STARTED|Overall Study||60||
59928307|NCT03308825|76046373|FG003|STARTED|Overall Study||60||
59928308|NCT03308825|76046370|FG000|COMPLETED|Overall Study||57||
59928309|NCT03308825|76046371|FG001|COMPLETED|Overall Study||57||
59928310|NCT03308825|76046372|FG002|COMPLETED|Overall Study||59||
59928311|NCT03308825|76046373|FG003|COMPLETED|Overall Study||60||
59928312|NCT03308825|76046370|FG000|NOT COMPLETED|Overall Study||2||
59928313|NCT03308825|76046371|FG001|NOT COMPLETED|Overall Study||4||
59928314|NCT03308825|76046372|FG002|NOT COMPLETED|Overall Study||1||
59928315|NCT03308825|76046373|FG003|NOT COMPLETED|Overall Study||0||
59928316|NCT03328325|76046387|FG000|STARTED|Overall Study||152||
59928317|NCT03328325|76046387|FG000|COMPLETED|Overall Study||141||
60061801|NCT01802073|76177130|FG000|NOT COMPLETED|Overall Study||5||
60061802|NCT01802073|76177131|FG001|NOT COMPLETED|Overall Study||11||
60061803|NCT01607073|76177137|FG000|STARTED|Overall Study||2||
60061804|NCT01607073|76177137|FG000|COMPLETED|Overall Study||1||
60061805|NCT01607073|76177137|FG000|NOT COMPLETED|Overall Study||1||
59516886|NCT03211234|75610608|FG002|COMPLETED|Overall Study||25||
59516887|NCT03211234|75610606|FG000|NOT COMPLETED|Overall Study||1||
59516888|NCT03211234|75610607|FG001|NOT COMPLETED|Overall Study||1||
59928318|NCT03328325|76046387|FG000|NOT COMPLETED|Overall Study||11||
59928319|NCT04098497|76046391|FG000|STARTED|Overall Study||30||
59928320|NCT04098497|76046391|FG000|Initial Interview|Overall Study||30||
59928321|NCT04098497|76046391|FG000|Set Up Study App|Overall Study||29||
60061806|NCT01773291|76177147|FG000|STARTED|Overall Study||8||
60061807|NCT01773291|76177148|FG001|STARTED|Overall Study||9||
60061808|NCT01773291|76177149|FG002|STARTED|Overall Study||7||
60061809|NCT01773291|76177147|FG000|COMPLETED|Overall Study||7||
60061810|NCT01773291|76177148|FG001|COMPLETED|Overall Study||9||
60061811|NCT01773291|76177149|FG002|COMPLETED|Overall Study||6||
59516889|NCT03211234|75610608|FG002|NOT COMPLETED|Overall Study||3||
59516890|NCT01030861|75610618|FG000|STARTED|Overall Study||44||
60061812|NCT01773291|76177147|FG000|NOT COMPLETED|Overall Study||1||
60061813|NCT01773291|76177148|FG001|NOT COMPLETED|Overall Study||0||
60061814|NCT01773291|76177149|FG002|NOT COMPLETED|Overall Study||1||
60061815|NCT01801917|76177162|FG000|STARTED|Period 1 - Randomized||7||
60061816|NCT01801917|76177163|FG001|STARTED|Period 1 - Randomized||2||
60061817|NCT01801917|76177164|FG002|STARTED|Period 1 - Randomized||4||
60061818|NCT01801917|76177165|FG003|STARTED|Period 1 - Randomized||1||
60061819|NCT01801917|76177162|FG000|COMPLETED|Period 1 - Randomized||6||
60061820|NCT01801917|76177163|FG001|COMPLETED|Period 1 - Randomized||2||
60061821|NCT01801917|76177164|FG002|COMPLETED|Period 1 - Randomized||3||
60061822|NCT01801917|76177165|FG003|COMPLETED|Period 1 - Randomized||1||
60061823|NCT01801917|76177162|FG000|NOT COMPLETED|Period 1 - Randomized||1||
60061824|NCT01801917|76177163|FG001|NOT COMPLETED|Period 1 - Randomized||0||
60061825|NCT01801917|76177164|FG002|NOT COMPLETED|Period 1 - Randomized||1||
60061826|NCT01801917|76177165|FG003|NOT COMPLETED|Period 1 - Randomized||0||
60061827|NCT01801917|76177162|FG000|STARTED|Extension - All Active||6||
59928322|NCT04098497|76046391|FG000|Logged Symptoms Into Study App at Least Once|Overall Study||26|Participants who did not log symptoms into the app were never randomized to receive or not receive an intervention|
59928323|NCT04098497|76046391|FG000|Linked Fitbit to Study Database|Overall Study||27||
59928324|NCT04098497|76046391|FG000|Used Fitbit|Overall Study||24||
59928325|NCT04098497|76046391|FG000|Exit Interview|Overall Study||29|Participant who did not do the exit interview was not included in analysis of safety outcomes.|
59928326|NCT04098497|76046391|FG000|COMPLETED|Overall Study||30|All participants were included in the analysis of feasibility outcomes|
59928327|NCT04098497|76046391|FG000|NOT COMPLETED|Overall Study||0||
59928328|NCT03305081|76046397|FG000|STARTED|Overall Study||25||
59928329|NCT03305081|76046398|FG001|STARTED|Overall Study||20||
59928330|NCT03305081|76046397|FG000|COMPLETED|Overall Study||15||
59928331|NCT03305081|76046398|FG001|COMPLETED|Overall Study||5||
59928332|NCT03305081|76046397|FG000|NOT COMPLETED|Overall Study||10||
59928333|NCT03305081|76046398|FG001|NOT COMPLETED|Overall Study||15||
59928334|NCT04079881|76046406|FG000|STARTED|Overall Study||1||
59928335|NCT04079881|76046407|FG001|STARTED|Overall Study||0||
59928336|NCT04079881|76046406|FG000|COMPLETED|Overall Study||1||
59928337|NCT04079881|76046407|FG001|COMPLETED|Overall Study||0||
59928338|NCT04079881|76046406|FG000|NOT COMPLETED|Overall Study||0||
59928339|NCT04079881|76046407|FG001|NOT COMPLETED|Overall Study||0||
59928340|NCT03325673|76046416|FG000|STARTED|Overall Study||42||
59928341|NCT03325673|76046417|FG001|STARTED|Overall Study||42||
59928342|NCT03325673|76046416|FG000|COMPLETED|Overall Study||38||
59928343|NCT03325673|76046417|FG001|COMPLETED|Overall Study||42||
59928344|NCT03325673|76046416|FG000|NOT COMPLETED|Overall Study||4||
59928345|NCT03325673|76046417|FG001|NOT COMPLETED|Overall Study||0||
59928346|NCT03223909|76046426|FG000|STARTED|Overall Study||120||
59928347|NCT03223909|76046427|FG001|STARTED|Overall Study||109||
59928348|NCT03223909|76046428|FG002|STARTED|Overall Study||97||
59928349|NCT03223909|76046426|FG000|COMPLETED|Overall Study||72||
59928350|NCT03223909|76046427|FG001|COMPLETED|Overall Study||64||
59928351|NCT03223909|76046428|FG002|COMPLETED|Overall Study||81||
59928352|NCT03223909|76046426|FG000|NOT COMPLETED|Overall Study||48||
59928353|NCT03223909|76046427|FG001|NOT COMPLETED|Overall Study||45||
59928354|NCT03223909|76046428|FG002|NOT COMPLETED|Overall Study||16||
59928355|NCT03733925|76046436|FG000|STARTED|Overall Study||100||
59928356|NCT03733925|76046436|FG000|Participants With Psoriatic Arthritis (PsA)|Overall Study||50||
59928357|NCT03733925|76046436|FG000|Participants With Ankylosing Spondylitis (AS)|Overall Study||50||
59928358|NCT03733925|76046436|FG000|COMPLETED|Overall Study||94||
59928359|NCT03733925|76046436|FG000|NOT COMPLETED|Overall Study||6||
59928360|NCT03649711|76046443|FG000|STARTED|Overall Study||26||
59928361|NCT03649711|76046444|FG001|STARTED|Overall Study||24||
59928362|NCT03649711|76046445|FG002|STARTED|Overall Study||26||
59928363|NCT03649711|76046443|FG000|COMPLETED|Overall Study||25||
59928364|NCT03649711|76046444|FG001|COMPLETED|Overall Study||23||
59928365|NCT03649711|76046445|FG002|COMPLETED|Overall Study||26||
59928366|NCT03649711|76046443|FG000|NOT COMPLETED|Overall Study||1||
59928367|NCT03649711|76046444|FG001|NOT COMPLETED|Overall Study||1||
59928368|NCT03649711|76046445|FG002|NOT COMPLETED|Overall Study||0||
59928369|NCT03303521|76046455|FG000|STARTED|Overall Study||97||
60061828|NCT01801917|76177163|FG001|STARTED|Extension - All Active||0||
60061829|NCT01801917|76177164|FG002|STARTED|Extension - All Active||3||
60061830|NCT01801917|76177165|FG003|STARTED|Extension - All Active||0||
60061831|NCT01801917|76177162|FG000|COMPLETED|Extension - All Active||6||
60061832|NCT01801917|76177163|FG001|COMPLETED|Extension - All Active||0||
59928370|NCT03303521|76046456|FG001|STARTED|Overall Study||99||
59928371|NCT03303521|76046455|FG000|COMPLETED|Overall Study||92||
59928372|NCT03303521|76046456|FG001|COMPLETED|Overall Study||96||
59928373|NCT03303521|76046455|FG000|NOT COMPLETED|Overall Study||5||
59928374|NCT03303521|76046456|FG001|NOT COMPLETED|Overall Study||3||
59928375|NCT03214081|76046462|FG000|STARTED|Overall Study||1237||
59928376|NCT03214081|76046462|FG000|COMPLETED|Overall Study||1174||
59928377|NCT03214081|76046462|FG000|NOT COMPLETED|Overall Study||63||
59928378|NCT02888171|76046468|FG000|STARTED|Overall Study||30||
59928379|NCT02888171|76046469|FG001|STARTED|Overall Study||30||
59928380|NCT02888171|76046468|FG000|COMPLETED|Overall Study||25||
59928381|NCT02888171|76046469|FG001|COMPLETED|Overall Study||26||
59928382|NCT02888171|76046468|FG000|NOT COMPLETED|Overall Study||5||
59928383|NCT02888171|76046469|FG001|NOT COMPLETED|Overall Study||4||
59928384|NCT02932891|76046475|FG000|STARTED|Overall Study||28||
59928385|NCT02932891|76046475|FG000|COMPLETED|Overall Study||24||
59928386|NCT02932891|76046475|FG000|NOT COMPLETED|Overall Study||4||
59928387|NCT03302975|76046479|FG000|STARTED|Overall Study||16||
59928388|NCT03302975|76046479|FG000|COMPLETED|Overall Study||12||
59928389|NCT03302975|76046479|FG000|NOT COMPLETED|Overall Study||4||
59928390|NCT03212521|76046483|FG000|STARTED|Overall Study||230||
59928391|NCT03212521|76046483|FG000|COMPLETED|Overall Study||223||
59928392|NCT03212521|76046483|FG000|NOT COMPLETED|Overall Study||7||
59928393|NCT03212365|76046489|FG000|STARTED|Overall Study||151||
59928394|NCT03212365|76046490|FG001|STARTED|Overall Study||144||
59928395|NCT03212365|76046489|FG000|COMPLETED|Overall Study||128||
59928396|NCT03212365|76046490|FG001|COMPLETED|Overall Study||130||
59928397|NCT03212365|76046489|FG000|NOT COMPLETED|Overall Study||23||
59928398|NCT03212365|76046490|FG001|NOT COMPLETED|Overall Study||14||
59928399|NCT03273257|76046498|FG000|STARTED|Overall Study||7||
59928400|NCT03273257|76046499|FG001|STARTED|Overall Study||7||
59928401|NCT03273257|76046498|FG000|Started Treatment|Overall Study||7||
59928402|NCT03273257|76046499|FG001|Started Treatment|Overall Study|Only 6 patients from the placebo group started treatment because 1 patient died after randomization (= study start), but before initiating treatment|6||
60061833|NCT01801917|76177164|FG002|COMPLETED|Extension - All Active||3||
60061834|NCT01801917|76177165|FG003|COMPLETED|Extension - All Active||0||
60061835|NCT01801917|76177162|FG000|NOT COMPLETED|Extension - All Active||0||
59516891|NCT01030861|75610619|FG001|STARTED|Overall Study||32||
59516892|NCT01030861|75610618|FG000|COMPLETED|Overall Study||44||
59516893|NCT01030861|75610619|FG001|COMPLETED|Overall Study||32||
59516894|NCT01030861|75610618|FG000|NOT COMPLETED|Overall Study||0||
59516895|NCT01030861|75610619|FG001|NOT COMPLETED|Overall Study||0||
59516896|NCT03105518|75610625|FG000|STARTED|Overall Study||100||
59516897|NCT03105518|75610625|FG000|COMPLETED|Overall Study||100||
59516898|NCT03105518|75610625|FG000|NOT COMPLETED|Overall Study||0||
59516899|NCT01031095|75610631|FG000|STARTED|Overall Study||100||
59516900|NCT01031095|75610632|FG001|STARTED|Overall Study||100||
59516901|NCT01031095|75610631|FG000|COMPLETED|Overall Study||100||
59516902|NCT01031095|75610632|FG001|COMPLETED|Overall Study||100||
59516903|NCT01031095|75610631|FG000|NOT COMPLETED|Overall Study||0||
59516904|NCT01031095|75610632|FG001|NOT COMPLETED|Overall Study||0||
59516905|NCT03212638|75610640|FG000|STARTED|Period 1||8||
59516906|NCT03212638|75610641|FG001|STARTED|Period 1||8||
59516907|NCT03212638|75610642|FG002|STARTED|Period 1||8||
59928403|NCT03273257|76046498|FG000|Underwent PEA|Overall Study||6||
59928404|NCT03273257|76046499|FG001|Underwent PEA|Overall Study||5||
59928405|NCT03273257|76046498|FG000|COMPLETED|Overall Study||3||
59928406|NCT03273257|76046499|FG001|COMPLETED|Overall Study||3||
59928407|NCT03273257|76046498|FG000|NOT COMPLETED|Overall Study||4||
59928408|NCT03273257|76046499|FG001|NOT COMPLETED|Overall Study||4||
59928409|NCT04316741|76046507|FG000|STARTED|Baseline Enrollment||30||
59928410|NCT04316741|76046508|FG001|STARTED|Baseline Enrollment||28||
59928411|NCT04316741|76046507|FG000|COMPLETED|Baseline Enrollment|29 participants completed some part of the intervention/health coaching|29||
59928412|NCT04316741|76046508|FG001|COMPLETED|Baseline Enrollment||27||
59928413|NCT04316741|76046507|FG000|NOT COMPLETED|Baseline Enrollment||1||
59928414|NCT04316741|76046508|FG001|NOT COMPLETED|Baseline Enrollment||1||
59928415|NCT04316741|76046507|FG000|STARTED|Immediate Post-Test||29||
59928416|NCT04316741|76046508|FG001|STARTED|Immediate Post-Test||27||
59928417|NCT04316741|76046507|FG000|COMPLETED|Immediate Post-Test||24||
59928418|NCT04316741|76046508|FG001|COMPLETED|Immediate Post-Test||26||
59928419|NCT04316741|76046507|FG000|NOT COMPLETED|Immediate Post-Test||5||
59928420|NCT04316741|76046508|FG001|NOT COMPLETED|Immediate Post-Test||1||
59928421|NCT04316741|76046507|FG000|STARTED|1-month Post-test||29||
59928422|NCT04316741|76046508|FG001|STARTED|1-month Post-test||27||
59928423|NCT04316741|76046507|FG000|COMPLETED|1-month Post-test||22||
59928424|NCT04316741|76046508|FG001|COMPLETED|1-month Post-test||25||
59928425|NCT04316741|76046507|FG000|NOT COMPLETED|1-month Post-test||7||
59928426|NCT04316741|76046508|FG001|NOT COMPLETED|1-month Post-test||2||
59928427|NCT04316741|76046507|FG000|STARTED|3-month Follow-up||29||
59516908|NCT03212638|75610643|FG003|STARTED|Period 1||0||
59516909|NCT03212638|75610644|FG004|STARTED|Period 1||0||
59516910|NCT03212638|75610640|FG000|Received at Least 1 Dose of Study Drug|Period 1||8||
59516911|NCT03212638|75610641|FG001|Received at Least 1 Dose of Study Drug|Period 1||8||
59516912|NCT03212638|75610642|FG002|Received at Least 1 Dose of Study Drug|Period 1||8||
59516913|NCT03212638|75610643|FG003|Received at Least 1 Dose of Study Drug|Period 1||0||
59928428|NCT04316741|76046508|FG001|STARTED|3-month Follow-up||27||
59928429|NCT04316741|76046507|FG000|COMPLETED|3-month Follow-up||19||
59928430|NCT04316741|76046508|FG001|COMPLETED|3-month Follow-up||25||
59928431|NCT04316741|76046507|FG000|NOT COMPLETED|3-month Follow-up||10||
59928432|NCT04316741|76046508|FG001|NOT COMPLETED|3-month Follow-up||2||
59928433|NCT03271307|76046518|FG000|STARTED|Overall Study||1951||5
59928434|NCT03271307|76046519|FG001|STARTED|Overall Study||1837||5
59928435|NCT03271307|76046520|FG002|STARTED|Overall Study||2097||5
60061836|NCT01801917|76177163|FG001|NOT COMPLETED|Extension - All Active||0||
60061837|NCT01801917|76177164|FG002|NOT COMPLETED|Extension - All Active||0||
60061838|NCT01801917|76177165|FG003|NOT COMPLETED|Extension - All Active||0||
60061839|NCT02008916|76177179|FG000|STARTED|Primary Assessment (up to Week 16)||74|Randomized set comprised all randomized patients|
60061840|NCT02008916|76177180|FG001|STARTED|Primary Assessment (up to Week 16)||76|Randomized set comprised all randomized patients|
60061841|NCT02008916|76177181|FG002|STARTED|Primary Assessment (up to Week 16)||76|Randomized set comprised all randomized patients|
60061842|NCT02008916|76177179|FG000|FAS|Primary Assessment (up to Week 16)||74|Full Analysis Set (FAS) all patients randomized and study treatment assigned.|
60061843|NCT02008916|76177180|FG001|FAS|Primary Assessment (up to Week 16)||76|Full Analysis Set (FAS) all patients randomized and study treatment assigned.|
60061844|NCT02008916|76177181|FG002|FAS|Primary Assessment (up to Week 16)||76|Full Analysis Set (FAS) all patients randomized and study treatment assigned.|
60061845|NCT02008916|76177179|FG000|Safety Set|Primary Assessment (up to Week 16)||74|all patients who received at least one dose of study treatment|
59516914|NCT03212638|75610644|FG004|Received at Least 1 Dose of Study Drug|Period 1||0||
59516915|NCT03212638|75610640|FG000|COMPLETED|Period 1||8||
59516916|NCT03212638|75610641|FG001|COMPLETED|Period 1||8||
59516917|NCT03212638|75610642|FG002|COMPLETED|Period 1||8||
59516918|NCT03212638|75610643|FG003|COMPLETED|Period 1||0||
59928436|NCT03271307|76046521|FG003|STARTED|Overall Study||135||1
59928437|NCT03271307|76046522|FG004|STARTED|Overall Study||349||2
59928438|NCT03271307|76046518|FG000|COMPLETED|Overall Study||1951||5
59928439|NCT03271307|76046519|FG001|COMPLETED|Overall Study||1837||5
59928440|NCT03271307|76046520|FG002|COMPLETED|Overall Study||2097||5
59928441|NCT03271307|76046521|FG003|COMPLETED|Overall Study||107||1
59928442|NCT03271307|76046522|FG004|COMPLETED|Overall Study||258||2
59928443|NCT03271307|76046518|FG000|NOT COMPLETED|Overall Study||0||0
60061846|NCT02008916|76177180|FG001|Safety Set|Primary Assessment (up to Week 16)||76|all patients who received at least one dose of study treatment|
60061847|NCT02008916|76177181|FG002|Safety Set|Primary Assessment (up to Week 16)||75|all patients who received at least one dose of study treatment|
60061848|NCT02008916|76177179|FG000|COMPLETED|Primary Assessment (up to Week 16)||74||
60061849|NCT02008916|76177180|FG001|COMPLETED|Primary Assessment (up to Week 16)||75||
60061850|NCT02008916|76177181|FG002|COMPLETED|Primary Assessment (up to Week 16)||73||
60061851|NCT02008916|76177179|FG000|NOT COMPLETED|Primary Assessment (up to Week 16)||0||
60061852|NCT02008916|76177180|FG001|NOT COMPLETED|Primary Assessment (up to Week 16)||1||
60061853|NCT02008916|76177181|FG002|NOT COMPLETED|Primary Assessment (up to Week 16)||3||
60061854|NCT02008916|76177179|FG000|STARTED|Week 16 - 156||74||
60061855|NCT02008916|76177180|FG001|STARTED|Week 16 - 156||75||
60061856|NCT02008916|76177181|FG002|STARTED|Week 16 - 156||73||
60061857|NCT02008916|76177179|FG000|COMPLETED|Week 16 - 156||55||
60061858|NCT02008916|76177180|FG001|COMPLETED|Week 16 - 156||62||
60061859|NCT02008916|76177181|FG002|COMPLETED|Week 16 - 156||63||
60061860|NCT02008916|76177179|FG000|NOT COMPLETED|Week 16 - 156||19||
60061861|NCT02008916|76177180|FG001|NOT COMPLETED|Week 16 - 156||13||
60061862|NCT02008916|76177181|FG002|NOT COMPLETED|Week 16 - 156||10||
60061863|NCT01772823|76177192|FG000|STARTED|Behavioral Intervention (BL -3MV or PCC)||128||
60061864|NCT01772823|76177193|FG001|STARTED|Behavioral Intervention (BL -3MV or PCC)||72||
60061865|NCT01772823|76177192|FG000|COMPLETED|Behavioral Intervention (BL -3MV or PCC)||116||
60061866|NCT01772823|76177193|FG001|COMPLETED|Behavioral Intervention (BL -3MV or PCC)||70||
60061867|NCT01772823|76177192|FG000|NOT COMPLETED|Behavioral Intervention (BL -3MV or PCC)||12||
59516919|NCT03212638|75610644|FG004|COMPLETED|Period 1||0||
59516920|NCT03212638|75610640|FG000|NOT COMPLETED|Period 1||0||
59516921|NCT03212638|75610641|FG001|NOT COMPLETED|Period 1||0||
59516922|NCT03212638|75610642|FG002|NOT COMPLETED|Period 1||0||
59516923|NCT03212638|75610643|FG003|NOT COMPLETED|Period 1||0||
59928444|NCT03271307|76046519|FG001|NOT COMPLETED|Overall Study||0||0
59928445|NCT03271307|76046520|FG002|NOT COMPLETED|Overall Study||0||0
59928446|NCT03271307|76046521|FG003|NOT COMPLETED|Overall Study||28||0
59928447|NCT03271307|76046522|FG004|NOT COMPLETED|Overall Study||91||0
59928448|NCT03271151|76046539|FG000|STARTED|Overall Study||80||
59928449|NCT03271151|76046540|FG001|STARTED|Overall Study||80||
59928450|NCT03271151|76046539|FG000|COMPLETED|Overall Study||78||
59928451|NCT03271151|76046540|FG001|COMPLETED|Overall Study||77||
59928452|NCT03271151|76046539|FG000|NOT COMPLETED|Overall Study||2||
59928453|NCT03271151|76046540|FG001|NOT COMPLETED|Overall Study||3||
60061868|NCT01772823|76177193|FG001|NOT COMPLETED|Behavioral Intervention (BL -3MV or PCC)||2||
59516924|NCT03212638|75610644|FG004|NOT COMPLETED|Period 1||0||
59516925|NCT03212638|75610640|FG000|STARTED|Period 2||8||
59516926|NCT03212638|75610641|FG001|STARTED|Period 2||8||
59516927|NCT03212638|75610642|FG002|STARTED|Period 2||8||
59516928|NCT03212638|75610643|FG003|STARTED|Period 2||0||
59516929|NCT03212638|75610644|FG004|STARTED|Period 2||0||
59516930|NCT03212638|75610640|FG000|Received at Least 1 Dose of Study Drug|Period 2||8||
59928454|NCT03245723|76046548|FG000|STARTED|Overall Study||32||
59928455|NCT03245723|76046549|FG001|STARTED|Overall Study||18||
59928456|NCT03245723|76046548|FG000|COMPLETED|Overall Study||27||
59928457|NCT03245723|76046549|FG001|COMPLETED|Overall Study||17||
59928458|NCT03245723|76046548|FG000|NOT COMPLETED|Overall Study||5||
59928459|NCT03245723|76046549|FG001|NOT COMPLETED|Overall Study||1||
59928460|NCT03301649|76046558|FG000|STARTED|Overall Study||399||
59928461|NCT03301649|76046559|FG001|STARTED|Overall Study||400||
59928462|NCT03301649|76046560|FG002|STARTED|Overall Study||112||
59516931|NCT03212638|75610641|FG001|Received at Least 1 Dose of Study Drug|Period 2||8||
59516932|NCT03212638|75610642|FG002|Received at Least 1 Dose of Study Drug|Period 2||8||
59516933|NCT03212638|75610643|FG003|Received at Least 1 Dose of Study Drug|Period 2||0||
59516934|NCT03212638|75610644|FG004|Received at Least 1 Dose of Study Drug|Period 2||0||
59516935|NCT03212638|75610640|FG000|COMPLETED|Period 2||8||
59516936|NCT03212638|75610641|FG001|COMPLETED|Period 2||8||
59516937|NCT03212638|75610642|FG002|COMPLETED|Period 2||8||
59516938|NCT03212638|75610643|FG003|COMPLETED|Period 2||0||
59516939|NCT03212638|75610644|FG004|COMPLETED|Period 2||0||
59516940|NCT03212638|75610640|FG000|NOT COMPLETED|Period 2||0||
59516941|NCT03212638|75610641|FG001|NOT COMPLETED|Period 2||0||
59516942|NCT03212638|75610642|FG002|NOT COMPLETED|Period 2||0||
59516943|NCT03212638|75610643|FG003|NOT COMPLETED|Period 2||0||
59516944|NCT03212638|75610644|FG004|NOT COMPLETED|Period 2||0||
59516945|NCT03212638|75610640|FG000|STARTED|Period 3||8||
59516946|NCT03212638|75610641|FG001|STARTED|Period 3||8||
59516947|NCT03212638|75610642|FG002|STARTED|Period 3||8||
59516948|NCT03212638|75610643|FG003|STARTED|Period 3||0||
59516949|NCT03212638|75610644|FG004|STARTED|Period 3||0||
59516950|NCT03212638|75610640|FG000|Received at Least 1 Dose of Study Drug|Period 3||8||
59516951|NCT03212638|75610641|FG001|Received at Least 1 Dose of Study Drug|Period 3||8||
59516952|NCT03212638|75610642|FG002|Received at Least 1 Dose of Study Drug|Period 3||8||
59516953|NCT03212638|75610643|FG003|Received at Least 1 Dose of Study Drug|Period 3||0||
59516954|NCT03212638|75610644|FG004|Received at Least 1 Dose of Study Drug|Period 3||0||
59516955|NCT03212638|75610640|FG000|COMPLETED|Period 3||8||
59516956|NCT03212638|75610641|FG001|COMPLETED|Period 3||8||
59516957|NCT03212638|75610642|FG002|COMPLETED|Period 3||8||
59516958|NCT03212638|75610643|FG003|COMPLETED|Period 3||0||
59516959|NCT03212638|75610644|FG004|COMPLETED|Period 3||0||
59928463|NCT03301649|76046558|FG000|Safety Population|Overall Study||399|Randomized participants who received the study drug.|
59928464|NCT03301649|76046559|FG001|Safety Population|Overall Study||400|Randomized participants who received the study drug.|
59928465|NCT03301649|76046560|FG002|Safety Population|Overall Study||112|Randomized participants who received the study drug.|
59928466|NCT03301649|76046558|FG000|Modified Intent-to-treat(mITT)Population|Overall Study||372|Randomized participants, met study criteria, applied study drug, ≥1 post-baseline evaluation visit.|
59928467|NCT03301649|76046559|FG001|Modified Intent-to-treat(mITT)Population|Overall Study||380|Randomized participants, met study criteria, applied study drug, ≥1 post-baseline evaluation visit.|
59928468|NCT03301649|76046560|FG002|Modified Intent-to-treat(mITT)Population|Overall Study||111|Randomized participants, met study criteria, applied study drug, ≥1 post-baseline evaluation visit.|
59928469|NCT03301649|76046558|FG000|Per-protocol (PP) Population|Overall Study||345|mITT, made final study visit (Day 15 ± 2 days), and had no significant protocol deviations.|
59928470|NCT03301649|76046559|FG001|Per-protocol (PP) Population|Overall Study||354|mITT, made final study visit (Day 15 ± 2 days), and had no significant protocol deviations.|
59928471|NCT03301649|76046560|FG002|Per-protocol (PP) Population|Overall Study||103|mITT, made final study visit (Day 15 ± 2 days), and had no significant protocol deviations.|
59928472|NCT03301649|76046558|FG000|COMPLETED|Overall Study||356||
59928473|NCT03301649|76046559|FG001|COMPLETED|Overall Study||356||
59516960|NCT03212638|75610640|FG000|NOT COMPLETED|Period 3||0||
59516961|NCT03212638|75610641|FG001|NOT COMPLETED|Period 3||0||
59516962|NCT03212638|75610642|FG002|NOT COMPLETED|Period 3||0||
59516963|NCT03212638|75610643|FG003|NOT COMPLETED|Period 3||0||
59516964|NCT03212638|75610644|FG004|NOT COMPLETED|Period 3||0||
59761073|NCT00546481|75880747|FG000|STARTED|Correction Phase (CERA or Epoetin Beta)||39||
59761074|NCT00546481|75880748|FG001|STARTED|Correction Phase (CERA or Epoetin Beta)||41||
59761075|NCT00546481|75880749|FG002|STARTED|Correction Phase (CERA or Epoetin Beta)||0||
59928474|NCT03301649|76046560|FG002|COMPLETED|Overall Study||27||
59928475|NCT03301649|76046558|FG000|NOT COMPLETED|Overall Study||43||
59928476|NCT03301649|76046559|FG001|NOT COMPLETED|Overall Study||44||
59928477|NCT03301649|76046560|FG002|NOT COMPLETED|Overall Study||85||
59928478|NCT03222973|76046570|FG000|STARTED|Part 1 (Week 0 to Week 72)||131||
59928479|NCT03222973|76046571|FG001|STARTED|Part 1 (Week 0 to Week 72)||132||
60061869|NCT01772823|76177192|FG000|STARTED|Treatment Phase (Week 0- Week 48)||116||
60061870|NCT01772823|76177193|FG001|STARTED|Treatment Phase (Week 0- Week 48)||70||
59516965|NCT03212638|75610640|FG000|STARTED|Period 4|Participants were not allowed to participate in Part B and have completed study.|0||
59516966|NCT03212638|75610641|FG001|STARTED|Period 4|Participants were not allowed to participate in Part B and have completed study.|0||
59516967|NCT03212638|75610642|FG002|STARTED|Period 4|Participants were not allowed to participate in Part B and have completed study.|0||
59516968|NCT03212638|75610643|FG003|STARTED|Period 4|New Participants in Part B, no participants from Part A participated in Part B.|9||
59516969|NCT03212638|75610644|FG004|STARTED|Period 4|New Participants in Part B, no participants from Part A participated in Part B.|9||
59516970|NCT03212638|75610640|FG000|Received at Least 1 Dose of Study Drug|Period 4||0||
59516971|NCT03212638|75610641|FG001|Received at Least 1 Dose of Study Drug|Period 4||0||
59516972|NCT03212638|75610642|FG002|Received at Least 1 Dose of Study Drug|Period 4||0||
59516973|NCT03212638|75610643|FG003|Received at Least 1 Dose of Study Drug|Period 4||9||
59516974|NCT03212638|75610644|FG004|Received at Least 1 Dose of Study Drug|Period 4||9||
59516975|NCT03212638|75610640|FG000|COMPLETED|Period 4||0||
59516976|NCT03212638|75610641|FG001|COMPLETED|Period 4||0||
59516977|NCT03212638|75610642|FG002|COMPLETED|Period 4||0||
59516978|NCT03212638|75610643|FG003|COMPLETED|Period 4||9||
59516979|NCT03212638|75610644|FG004|COMPLETED|Period 4||9||
59516980|NCT03212638|75610640|FG000|NOT COMPLETED|Period 4||0||
59516981|NCT03212638|75610641|FG001|NOT COMPLETED|Period 4||0||
59516982|NCT03212638|75610642|FG002|NOT COMPLETED|Period 4||0||
59516983|NCT03212638|75610643|FG003|NOT COMPLETED|Period 4||0||
59516984|NCT03212638|75610644|FG004|NOT COMPLETED|Period 4||0||
59516985|NCT03212638|75610640|FG000|STARTED|Period 5||0||
59516986|NCT03212638|75610641|FG001|STARTED|Period 5||0||
59928480|NCT03222973|76046572|FG002|STARTED|Part 1 (Week 0 to Week 72)||0||
59928481|NCT03222973|76046573|FG003|STARTED|Part 1 (Week 0 to Week 72)||0||
59928482|NCT03222973|76046570|FG000|Intent-to-treat (ITT) Population|Part 1 (Week 0 to Week 72)||131||
59928483|NCT03222973|76046571|FG001|Intent-to-treat (ITT) Population|Part 1 (Week 0 to Week 72)||132||
59928484|NCT03222973|76046572|FG002|Intent-to-treat (ITT) Population|Part 1 (Week 0 to Week 72)||0||
59928485|NCT03222973|76046573|FG003|Intent-to-treat (ITT) Population|Part 1 (Week 0 to Week 72)||0||
59928486|NCT03222973|76046570|FG000|Safety Population|Part 1 (Week 0 to Week 72)||131||
59516987|NCT03212638|75610642|FG002|STARTED|Period 5||0||
59516988|NCT03212638|75610643|FG003|STARTED|Period 5||9||
59516989|NCT03212638|75610644|FG004|STARTED|Period 5||9||
59516990|NCT03212638|75610640|FG000|Received at Least 1 Dose of Study Drug|Period 5||0||
59928487|NCT03222973|76046571|FG001|Safety Population|Part 1 (Week 0 to Week 72)||132||
59928488|NCT03222973|76046572|FG002|Safety Population|Part 1 (Week 0 to Week 72)||0||
59928489|NCT03222973|76046573|FG003|Safety Population|Part 1 (Week 0 to Week 72)||0||
59928490|NCT03222973|76046570|FG000|COMPLETED|Part 1 (Week 0 to Week 72)||107||
59928491|NCT03222973|76046571|FG001|COMPLETED|Part 1 (Week 0 to Week 72)||118||
59928492|NCT03222973|76046572|FG002|COMPLETED|Part 1 (Week 0 to Week 72)||0||
59928493|NCT03222973|76046573|FG003|COMPLETED|Part 1 (Week 0 to Week 72)||0||
59928494|NCT03222973|76046570|FG000|NOT COMPLETED|Part 1 (Week 0 to Week 72)||24||
59928495|NCT03222973|76046571|FG001|NOT COMPLETED|Part 1 (Week 0 to Week 72)||14||
59928496|NCT03222973|76046572|FG002|NOT COMPLETED|Part 1 (Week 0 to Week 72)||0||
59928497|NCT03222973|76046573|FG003|NOT COMPLETED|Part 1 (Week 0 to Week 72)||0||
59928498|NCT03222973|76046570|FG000|STARTED|Part 2 (Week 73 to Week 168)||0||
59928499|NCT03222973|76046571|FG001|STARTED|Part 2 (Week 73 to Week 168)||0||
59928500|NCT03222973|76046572|FG002|STARTED|Part 2 (Week 73 to Week 168)|6 participants who completed Part 1 did not enter Part 2.|101||
59928501|NCT03222973|76046573|FG003|STARTED|Part 2 (Week 73 to Week 168)|5 participants who completed Part 1 did not enter Part 2.|113||
59928502|NCT03222973|76046570|FG000|ITT Population|Part 2 (Week 73 to Week 168)||0||
59928503|NCT03222973|76046571|FG001|ITT Population|Part 2 (Week 73 to Week 168)||0||
59928504|NCT03222973|76046572|FG002|ITT Population|Part 2 (Week 73 to Week 168)||100||
59928505|NCT03222973|76046573|FG003|ITT Population|Part 2 (Week 73 to Week 168)||113||
59928506|NCT03222973|76046570|FG000|Safety Population|Part 2 (Week 73 to Week 168)||0||
59928507|NCT03222973|76046571|FG001|Safety Population|Part 2 (Week 73 to Week 168)||0||
59928508|NCT03222973|76046572|FG002|Safety Population|Part 2 (Week 73 to Week 168)||100||
59928509|NCT03222973|76046573|FG003|Safety Population|Part 2 (Week 73 to Week 168)||113||
59928510|NCT03222973|76046570|FG000|COMPLETED|Part 2 (Week 73 to Week 168)||0||
59928511|NCT03222973|76046571|FG001|COMPLETED|Part 2 (Week 73 to Week 168)||0||
59928512|NCT03222973|76046572|FG002|COMPLETED|Part 2 (Week 73 to Week 168)||0||
59928513|NCT03222973|76046573|FG003|COMPLETED|Part 2 (Week 73 to Week 168)||0||
59928514|NCT03222973|76046570|FG000|NOT COMPLETED|Part 2 (Week 73 to Week 168)||0||
59928515|NCT03222973|76046571|FG001|NOT COMPLETED|Part 2 (Week 73 to Week 168)||0||
59928516|NCT03222973|76046572|FG002|NOT COMPLETED|Part 2 (Week 73 to Week 168)||101||
59928517|NCT03222973|76046573|FG003|NOT COMPLETED|Part 2 (Week 73 to Week 168)||113||
59928518|NCT01144416|76046585|FG000|STARTED|Intervention Period||694||
59928519|NCT01144416|76046586|FG001|STARTED|Intervention Period||696||
59928520|NCT01144416|76046585|FG000|COMPLETED|Intervention Period||632||
59928521|NCT01144416|76046586|FG001|COMPLETED|Intervention Period||647||
59928522|NCT01144416|76046585|FG000|NOT COMPLETED|Intervention Period||62||
59928523|NCT01144416|76046586|FG001|NOT COMPLETED|Intervention Period||49||
59928524|NCT01144416|76046585|FG000|STARTED|Pregnancy Follow-up Period|Participants received 150 ug SCH 900962 in Intervention Period and became pregnant.|154||
60067875|NCT01756053|76183072|FG001|STARTED|Period 1 (10 Days)||9||
59516991|NCT03212638|75610641|FG001|Received at Least 1 Dose of Study Drug|Period 5||0||
60061871|NCT01772823|76177192|FG000|COMPLETED|Treatment Phase (Week 0- Week 48)||88||
60061872|NCT01772823|76177193|FG001|COMPLETED|Treatment Phase (Week 0- Week 48)||52||
60061873|NCT01772823|76177192|FG000|NOT COMPLETED|Treatment Phase (Week 0- Week 48)||28||
60061874|NCT01772823|76177193|FG001|NOT COMPLETED|Treatment Phase (Week 0- Week 48)||18||
60061875|NCT01772823|76177192|FG000|STARTED|Extension Phase (Visits 24,48wks Post tx|25 of the 88 subjects that completed the Treatment Phase were not eligible for the Extension Phase|63||
60061876|NCT01772823|76177193|FG001|STARTED|Extension Phase (Visits 24,48wks Post tx|10 of the 52 subjects that completed the Treatment Phase were not eligible for the Extension Phase|42||
60061877|NCT01772823|76177192|FG000|COMPLETED|Extension Phase (Visits 24,48wks Post tx||53||
60061878|NCT01772823|76177193|FG001|COMPLETED|Extension Phase (Visits 24,48wks Post tx||33||
60061879|NCT01772823|76177192|FG000|NOT COMPLETED|Extension Phase (Visits 24,48wks Post tx||10||
60061880|NCT01772823|76177193|FG001|NOT COMPLETED|Extension Phase (Visits 24,48wks Post tx||9||
59928525|NCT01144416|76046586|FG001|STARTED|Pregnancy Follow-up Period|Participants received daily injections of 300 IU recFSH in Intervention Period and became pregnant.|167||
59928526|NCT01144416|76046585|FG000|COMPLETED|Pregnancy Follow-up Period||146||
59928527|NCT01144416|76046586|FG001|COMPLETED|Pregnancy Follow-up Period||157||
60061881|NCT02029976|76177206|FG000|STARTED|YR-1 Post Intervention vs Baseline||132||
60061882|NCT02029976|76177207|FG001|STARTED|YR-1 Post Intervention vs Baseline||132||
60061883|NCT02029976|76177206|FG000|COMPLETED|YR-1 Post Intervention vs Baseline||120||
60061884|NCT02029976|76177207|FG001|COMPLETED|YR-1 Post Intervention vs Baseline||124||
60061885|NCT02029976|76177206|FG000|NOT COMPLETED|YR-1 Post Intervention vs Baseline||12||
60061886|NCT02029976|76177207|FG001|NOT COMPLETED|YR-1 Post Intervention vs Baseline||8||
60061887|NCT02029976|76177206|FG000|STARTED|YR-2 Follow Up vs Baseline|Attrition at end of year 2 was calculated based on baseline enrollment|132||
60061888|NCT02029976|76177207|FG001|STARTED|YR-2 Follow Up vs Baseline|Attrition at end of year 2 was calculated based on baseline enrollment|132||
60061889|NCT02029976|76177206|FG000|COMPLETED|YR-2 Follow Up vs Baseline||122||
60061890|NCT02029976|76177207|FG001|COMPLETED|YR-2 Follow Up vs Baseline||124||
60067876|NCT01756053|76183071|FG000|COMPLETED|Period 1 (10 Days)||7||
59928528|NCT01144416|76046585|FG000|NOT COMPLETED|Pregnancy Follow-up Period||8||
59928529|NCT01144416|76046586|FG001|NOT COMPLETED|Pregnancy Follow-up Period||10||
59928530|NCT00335777|76046596|FG000|STARTED|Enrolled and Dispensed Study Medication|64 subjects enrolled. 35 treated 2 headaches, but 22/35 at appropriate times, as per protocol.|64||
59928531|NCT00335777|76046596|FG000|COMPLETED|Enrolled and Dispensed Study Medication||35||
59928532|NCT00335777|76046596|FG000|NOT COMPLETED|Enrolled and Dispensed Study Medication||29||
59928533|NCT00335777|76046596|FG000|STARTED|Treated 2 Headaches Per Protocol||35||
59928534|NCT00335777|76046596|FG000|COMPLETED|Treated 2 Headaches Per Protocol||22||
59928535|NCT00335777|76046596|FG000|NOT COMPLETED|Treated 2 Headaches Per Protocol||13||
59928536|NCT01140048|76046601|FG000|STARTED|Overall Study||343||
59928537|NCT01140048|76046601|FG000|COMPLETED|Overall Study||298||
59928538|NCT01140048|76046601|FG000|NOT COMPLETED|Overall Study||45||
59928539|NCT03469297|76046605|FG000|STARTED|Overall Study|Implanted|8||
59928540|NCT03469297|76046605|FG000|COMPLETED|Overall Study|Completed 6 months of follow-up|7||
59928541|NCT03469297|76046605|FG000|NOT COMPLETED|Overall Study||1||
59928542|NCT00972738|76046612|FG000|STARTED|Overall Study||522||
59928543|NCT00972738|76046613|FG001|STARTED|Overall Study||171||
59928544|NCT00972738|76046614|FG002|STARTED|Overall Study||521||
59928545|NCT00972738|76046612|FG000|COMPLETED|Overall Study||501||
59928546|NCT00972738|76046613|FG001|COMPLETED|Overall Study||165||
59928547|NCT00972738|76046614|FG002|COMPLETED|Overall Study||492||
59928548|NCT00972738|76046612|FG000|NOT COMPLETED|Overall Study||21||
59928549|NCT00972738|76046613|FG001|NOT COMPLETED|Overall Study||6||
59928550|NCT00972738|76046614|FG002|NOT COMPLETED|Overall Study||29||
59928551|NCT03243305|76046622|FG000|STARTED|Overall Study||1384||
59928552|NCT03243305|76046622|FG000|COMPLETED|Overall Study||449||
59928553|NCT03243305|76046622|FG000|NOT COMPLETED|Overall Study||935||
59928554|NCT03222583|76046628|FG000|STARTED|Overall Study||363||
59928555|NCT03222583|76046629|FG001|STARTED|Overall Study||183||
59928556|NCT03222583|76046628|FG000|Received Double-blind Treatment|Overall Study||362||
59928557|NCT03222583|76046629|FG001|Received Double-blind Treatment|Overall Study||183||
59928558|NCT03222583|76046628|FG000|Completed Double-blind Period|Overall Study||360||
59928559|NCT03222583|76046629|FG001|Completed Double-blind Period|Overall Study||183||
60061891|NCT02029976|76177206|FG000|NOT COMPLETED|YR-2 Follow Up vs Baseline||10||
60061892|NCT02029976|76177207|FG001|NOT COMPLETED|YR-2 Follow Up vs Baseline||8||
60061893|NCT01983254|76177215|FG000|STARTED|Overall Study|86 patients, 39 caregivers|125||
60061894|NCT01983254|76177216|FG001|STARTED|Overall Study|89 patients, 47 caregivers|136||
60061895|NCT01983254|76177215|FG000|Interview 1|Overall Study|86 patients, 39 caregivers|125||
60061896|NCT01983254|76177216|FG001|Interview 1|Overall Study|89 patients, 47 caregivers|136||
59516992|NCT03212638|75610642|FG002|Received at Least 1 Dose of Study Drug|Period 5||0||
59516993|NCT03212638|75610643|FG003|Received at Least 1 Dose of Study Drug|Period 5||9||
59516994|NCT03212638|75610644|FG004|Received at Least 1 Dose of Study Drug|Period 5||9||
59516995|NCT03212638|75610640|FG000|COMPLETED|Period 5||0||
59516996|NCT03212638|75610641|FG001|COMPLETED|Period 5||0||
59516997|NCT03212638|75610642|FG002|COMPLETED|Period 5||0||
59516998|NCT03212638|75610643|FG003|COMPLETED|Period 5||9||
59516999|NCT03212638|75610644|FG004|COMPLETED|Period 5||9||
59517000|NCT03212638|75610640|FG000|NOT COMPLETED|Period 5||0||
59517001|NCT03212638|75610641|FG001|NOT COMPLETED|Period 5||0||
59517002|NCT03212638|75610642|FG002|NOT COMPLETED|Period 5||0||
59517003|NCT03212638|75610643|FG003|NOT COMPLETED|Period 5||0||
59517004|NCT03212638|75610644|FG004|NOT COMPLETED|Period 5||0||
59517005|NCT03506048|75610656|FG000|STARTED|Overall Study||4||
59517006|NCT03506048|75610656|FG000|COMPLETED|Overall Study||3||
59517007|NCT03506048|75610656|FG000|NOT COMPLETED|Overall Study||1||
59517008|NCT02161705|75610662|FG000|STARTED|Overall Study||9||
59517009|NCT02161705|75610663|FG001|STARTED|Overall Study||9||
59517010|NCT02161705|75610662|FG000|COMPLETED|Overall Study||9||
59517011|NCT02161705|75610663|FG001|COMPLETED|Overall Study||9||
59517012|NCT02161705|75610662|FG000|NOT COMPLETED|Overall Study||0||
59517013|NCT02161705|75610663|FG001|NOT COMPLETED|Overall Study||0||
59517014|NCT03216382|75610671|FG000|STARTED|Overall Study||41||
59517015|NCT03216382|75610672|FG001|STARTED|Overall Study||54||
59517016|NCT03216382|75610671|FG000|COMPLETED|Overall Study||34||
59517017|NCT03216382|75610672|FG001|COMPLETED|Overall Study||44||
59517018|NCT03216382|75610671|FG000|NOT COMPLETED|Overall Study||7||
59517019|NCT03216382|75610672|FG001|NOT COMPLETED|Overall Study||10||
59517020|NCT01031953|75610678|FG000|STARTED|Overall Study||11||
59517021|NCT01031953|75610678|FG000|COMPLETED|Overall Study||11||
60061897|NCT01983254|76177215|FG000|Interview 2|Overall Study|65 patients, 30 caregivers|95||
60061898|NCT01983254|76177216|FG001|Interview 2|Overall Study|71 patients, 39 caregivers|110||
60061899|NCT01983254|76177215|FG000|Interview 3|Overall Study|62 patients, 29 caregivers|91||
60061900|NCT01983254|76177216|FG001|Interview 3|Overall Study|69 patients, 37 caregivers|106||
60061901|NCT01983254|76177215|FG000|COMPLETED|Overall Study|62 patients, 29 caregivers|91||
60061902|NCT01983254|76177216|FG001|COMPLETED|Overall Study|69 patients, 37 caregivers|106||
60061903|NCT01983254|76177215|FG000|NOT COMPLETED|Overall Study||34||
60061904|NCT01983254|76177216|FG001|NOT COMPLETED|Overall Study||30||
60061905|NCT01771809|76177224|FG000|STARTED|Overall Study||164||
60061906|NCT01771809|76177225|FG001|STARTED|Overall Study||166||
60061907|NCT01771809|76177224|FG000|COMPLETED|Overall Study||93||
60061908|NCT01771809|76177225|FG001|COMPLETED|Overall Study||83||
60061909|NCT01771809|76177224|FG000|NOT COMPLETED|Overall Study||71||
60061910|NCT01771809|76177225|FG001|NOT COMPLETED|Overall Study||83||
60061911|NCT01771731|76177233|FG000|STARTED|Overall Study||13||
60061912|NCT01771731|76177234|FG001|STARTED|Overall Study||14||
60061913|NCT01771731|76177233|FG000|COMPLETED|Overall Study||11||
59517022|NCT01031953|75610678|FG000|NOT COMPLETED|Overall Study||0||
59517023|NCT03310450|75610691|FG000|STARTED|Overall Study||32||
59613083|NCT01713582|75724114|FG020|NOT COMPLETED|Overall Study||15||
59613084|NCT01739400|75724174|FG000|STARTED|Overall Study||109|Enrolled from DB parent study MAESTRO (AC-0553-305, NCT01743001)|
60061914|NCT01771731|76177234|FG001|COMPLETED|Overall Study||12||
60061915|NCT01771731|76177233|FG000|NOT COMPLETED|Overall Study||2||
60061916|NCT01771731|76177234|FG001|NOT COMPLETED|Overall Study||2||
60061917|NCT01982942|76177242|FG000|STARTED|Overall Study||129||
59517024|NCT03310450|75610692|FG001|STARTED|Overall Study||34||
59517025|NCT03310450|75610693|FG002|STARTED|Overall Study||28||
59517026|NCT03310450|75610691|FG000|COMPLETED|Overall Study||30||
59517027|NCT03310450|75610692|FG001|COMPLETED|Overall Study||30||
59517028|NCT03310450|75610693|FG002|COMPLETED|Overall Study||28||
59517029|NCT03310450|75610691|FG000|NOT COMPLETED|Overall Study||2||
59517030|NCT03310450|75610692|FG001|NOT COMPLETED|Overall Study||4||
59517031|NCT03310450|75610693|FG002|NOT COMPLETED|Overall Study||0||
59517032|NCT01032733|75610706|FG000|STARTED|Overall Study||17||
59517033|NCT01032733|75610707|FG001|STARTED|Overall Study||17||
60061918|NCT01982942|76177243|FG001|STARTED|Overall Study||126||
60061919|NCT01982942|76177242|FG000|COMPLETED|Overall Study||108||
60061920|NCT01982942|76177243|FG001|COMPLETED|Overall Study||112||
60061921|NCT01982942|76177242|FG000|NOT COMPLETED|Overall Study||21||
60061922|NCT01982942|76177243|FG001|NOT COMPLETED|Overall Study||14||
60061923|NCT01769469|76177249|FG000|STARTED|Overall Study||101||
60061924|NCT01769469|76177249|FG000|COMPLETED|Overall Study||66||
60061925|NCT01769469|76177249|FG000|NOT COMPLETED|Overall Study||35||
60061926|NCT02008526|76177258|FG000|STARTED|Overall Study||94||
60061927|NCT02008526|76177259|FG001|STARTED|Overall Study||99||
60061928|NCT02008526|76177260|FG002|STARTED|Overall Study||93||
60061929|NCT02008526|76177258|FG000|COMPLETED|Overall Study||86||
60061930|NCT02008526|76177259|FG001|COMPLETED|Overall Study||85||
60061931|NCT02008526|76177260|FG002|COMPLETED|Overall Study||84||
60061932|NCT02008526|76177258|FG000|NOT COMPLETED|Overall Study||8||
60061933|NCT02008526|76177259|FG001|NOT COMPLETED|Overall Study||14||
60061934|NCT02008526|76177260|FG002|NOT COMPLETED|Overall Study||9||
60061935|NCT01769391|76177270|FG000|STARTED|Overall Study||110||
60061936|NCT01769391|76177271|FG001|STARTED|Overall Study||57||
60061937|NCT01769391|76177270|FG000|Received at Least One Dose of Study Drug|Overall Study||106||
60061938|NCT01769391|76177271|FG001|Received at Least One Dose of Study Drug|Overall Study||55||
60061939|NCT01769391|76177270|FG000|COMPLETED|Overall Study||93||
60061940|NCT01769391|76177271|FG001|COMPLETED|Overall Study||48||
60061941|NCT01769391|76177270|FG000|NOT COMPLETED|Overall Study||17||
60061942|NCT01769391|76177271|FG001|NOT COMPLETED|Overall Study||9||
60061943|NCT01800903|76177283|FG000|STARTED|First Test Period||7||
60061944|NCT01800903|76177284|FG001|STARTED|First Test Period||6||
60061945|NCT01800903|76177285|FG002|STARTED|First Test Period||4||
60061946|NCT01800903|76177286|FG003|STARTED|First Test Period||7||
60061947|NCT01800903|76177287|FG004|STARTED|First Test Period||6||
60061948|NCT01800903|76177288|FG005|STARTED|First Test Period||6||
60061949|NCT01800903|76177283|FG000|COMPLETED|First Test Period||7||
59517034|NCT01032733|75610706|FG000|COMPLETED|Overall Study||16||
59517035|NCT01032733|75610707|FG001|COMPLETED|Overall Study||16||
59517036|NCT01032733|75610706|FG000|NOT COMPLETED|Overall Study||1||
59517037|NCT01032733|75610707|FG001|NOT COMPLETED|Overall Study||1||
59517038|NCT03441178|75610714|FG000|STARTED|Overall Study||36||
59517039|NCT03441178|75610715|FG001|STARTED|Overall Study||44||
59517040|NCT03441178|75610716|FG002|STARTED|Overall Study||21||
59517041|NCT03441178|75610714|FG000|COMPLETED|Overall Study||36||
59517042|NCT03441178|75610715|FG001|COMPLETED|Overall Study||43||
59613085|NCT01739400|75724175|FG001|STARTED|Overall Study||108|Enrolled from DB parent study MAESTRO (AC-0553-305, NCT01743001)|
60061950|NCT01800903|76177284|FG001|COMPLETED|First Test Period||6||
60061951|NCT01800903|76177285|FG002|COMPLETED|First Test Period||4||
60061952|NCT01800903|76177286|FG003|COMPLETED|First Test Period||7||
60061953|NCT01800903|76177287|FG004|COMPLETED|First Test Period||6||
60061954|NCT01800903|76177288|FG005|COMPLETED|First Test Period||6||
60061955|NCT01800903|76177283|FG000|NOT COMPLETED|First Test Period||0||
60061956|NCT01800903|76177284|FG001|NOT COMPLETED|First Test Period||0||
60061957|NCT01800903|76177285|FG002|NOT COMPLETED|First Test Period||0||
59517043|NCT03441178|75610716|FG002|COMPLETED|Overall Study||20||
59517044|NCT03441178|75610714|FG000|NOT COMPLETED|Overall Study||0||
60061958|NCT01800903|76177286|FG003|NOT COMPLETED|First Test Period||0||
60061959|NCT01800903|76177287|FG004|NOT COMPLETED|First Test Period||0||
60061960|NCT01800903|76177288|FG005|NOT COMPLETED|First Test Period||0||
60061961|NCT01800903|76177283|FG000|STARTED|Second Test Period||7||
60061962|NCT01800903|76177284|FG001|STARTED|Second Test Period||6||
60061963|NCT01800903|76177285|FG002|STARTED|Second Test Period||4||
60061964|NCT01800903|76177286|FG003|STARTED|Second Test Period||7||
60061965|NCT01800903|76177287|FG004|STARTED|Second Test Period||6||
60061966|NCT01800903|76177288|FG005|STARTED|Second Test Period||6||
60061967|NCT01800903|76177283|FG000|COMPLETED|Second Test Period||6||
60061968|NCT01800903|76177284|FG001|COMPLETED|Second Test Period||6||
60061969|NCT01800903|76177285|FG002|COMPLETED|Second Test Period||4||
60061970|NCT01800903|76177286|FG003|COMPLETED|Second Test Period||7||
60061971|NCT01800903|76177287|FG004|COMPLETED|Second Test Period||6||
60061972|NCT01800903|76177288|FG005|COMPLETED|Second Test Period||6||
60061973|NCT01800903|76177283|FG000|NOT COMPLETED|Second Test Period||1||
60061974|NCT01800903|76177284|FG001|NOT COMPLETED|Second Test Period||0||
60061975|NCT01800903|76177285|FG002|NOT COMPLETED|Second Test Period||0||
60061976|NCT01800903|76177286|FG003|NOT COMPLETED|Second Test Period||0||
60061977|NCT01800903|76177287|FG004|NOT COMPLETED|Second Test Period||0||
60061978|NCT01800903|76177288|FG005|NOT COMPLETED|Second Test Period||0||
60061979|NCT01800903|76177283|FG000|STARTED|Third Test Period||6||
60061980|NCT01800903|76177284|FG001|STARTED|Third Test Period||6||
60061981|NCT01800903|76177285|FG002|STARTED|Third Test Period||4||
60061982|NCT01800903|76177286|FG003|STARTED|Third Test Period||7||
59517045|NCT03441178|75610715|FG001|NOT COMPLETED|Overall Study||1||
59517046|NCT03441178|75610716|FG002|NOT COMPLETED|Overall Study||1||
59517047|NCT01004107|75610728|FG000|STARTED|Overall Study||76||
59517048|NCT01004107|75610729|FG001|STARTED|Overall Study||25||
59517049|NCT01004107|75610728|FG000|COMPLETED|Overall Study||75||
59517050|NCT01004107|75610729|FG001|COMPLETED|Overall Study||23||
60061983|NCT01800903|76177287|FG004|STARTED|Third Test Period||6||
60061984|NCT01800903|76177288|FG005|STARTED|Third Test Period||6||
59928560|NCT03222583|76046628|FG000|Entered Open-label Period|Overall Study||0|The open-label treatment period was only applicable for participants assigned to Arm B (placebo).|
59928561|NCT03222583|76046629|FG001|Entered Open-label Period|Overall Study||182|The open-label treatment period was only applicable for participants assigned to Arm B (placebo).|
59928562|NCT03222583|76046628|FG000|Completed Open-label Period|Overall Study||0||
59928563|NCT03222583|76046629|FG001|Completed Open-label Period|Overall Study||181||
59928564|NCT03222583|76046628|FG000|COMPLETED|Overall Study||358||
59928565|NCT03222583|76046629|FG001|COMPLETED|Overall Study||177||
59928566|NCT03222583|76046628|FG000|NOT COMPLETED|Overall Study||5||
59928567|NCT03222583|76046629|FG001|NOT COMPLETED|Overall Study||6||
59928568|NCT03295721|76046638|FG000|STARTED|Overall Study||157||
59928569|NCT03295721|76046639|FG001|STARTED|Overall Study||100||
59928570|NCT03295721|76046640|FG002|STARTED|Overall Study||155||
59928571|NCT03295721|76046638|FG000|COMPLETED|Overall Study||154||
59928572|NCT03295721|76046639|FG001|COMPLETED|Overall Study||99||
59928573|NCT03295721|76046640|FG002|COMPLETED|Overall Study||152||
59928574|NCT03295721|76046638|FG000|NOT COMPLETED|Overall Study||3||
59928575|NCT03295721|76046639|FG001|NOT COMPLETED|Overall Study||1||
59928576|NCT03295721|76046640|FG002|NOT COMPLETED|Overall Study||3||
59928577|NCT00803790|76046651|FG000|STARTED|Period 1||125||
59928578|NCT00803790|76046652|FG001|STARTED|Period 1||126||
59928579|NCT00803790|76046653|FG002|STARTED|Period 1||32||
59928580|NCT00803790|76046654|FG003|STARTED|Period 1||35||
59928581|NCT00803790|76046651|FG000|COMPLETED|Period 1||116||
59928582|NCT00803790|76046652|FG001|COMPLETED|Period 1||114||
59928583|NCT00803790|76046653|FG002|COMPLETED|Period 1||31||
59928584|NCT00803790|76046654|FG003|COMPLETED|Period 1||31||
59928585|NCT00803790|76046651|FG000|NOT COMPLETED|Period 1||9||
59928586|NCT00803790|76046652|FG001|NOT COMPLETED|Period 1||12||
59928587|NCT00803790|76046653|FG002|NOT COMPLETED|Period 1||1||
59928588|NCT00803790|76046654|FG003|NOT COMPLETED|Period 1||4||
59928589|NCT00803790|76046651|FG000|STARTED|Period 2||116||
59928590|NCT00803790|76046652|FG001|STARTED|Period 2||114||
59928591|NCT00803790|76046653|FG002|STARTED|Period 2||31||
59928592|NCT00803790|76046654|FG003|STARTED|Period 2||31||
59928593|NCT00803790|76046651|FG000|COMPLETED|Period 2||114||
59928594|NCT00803790|76046652|FG001|COMPLETED|Period 2||114||
59928595|NCT00803790|76046653|FG002|COMPLETED|Period 2||30||
59928596|NCT00803790|76046654|FG003|COMPLETED|Period 2||30||
59928597|NCT00803790|76046651|FG000|NOT COMPLETED|Period 2||2||
59928598|NCT00803790|76046652|FG001|NOT COMPLETED|Period 2||0||
59928599|NCT00803790|76046653|FG002|NOT COMPLETED|Period 2||1||
59928600|NCT00803790|76046654|FG003|NOT COMPLETED|Period 2||1||
59928601|NCT00442338|76046668|FG000|STARTED|Overall Study||30||
59928602|NCT00442338|76046669|FG001|STARTED|Overall Study||30||
59928603|NCT00442338|76046670|FG002|STARTED|Overall Study||31||
59928604|NCT00442338|76046668|FG000|COMPLETED|Overall Study||30||
59928605|NCT00442338|76046669|FG001|COMPLETED|Overall Study||30||
59928606|NCT00442338|76046670|FG002|COMPLETED|Overall Study||31||
59928607|NCT00442338|76046668|FG000|NOT COMPLETED|Overall Study||0||
59928608|NCT00442338|76046669|FG001|NOT COMPLETED|Overall Study||0||
59928609|NCT00442338|76046670|FG002|NOT COMPLETED|Overall Study||0||
59928610|NCT03506412|76046680|FG000|STARTED|Overall Study||18||
59928611|NCT03506412|76046681|FG001|STARTED|Overall Study||19||
59928612|NCT03506412|76046680|FG000|COMPLETED|Overall Study||18||
59928613|NCT03506412|76046681|FG001|COMPLETED|Overall Study||19||
59928614|NCT03506412|76046680|FG000|NOT COMPLETED|Overall Study||0||
59928615|NCT03506412|76046681|FG001|NOT COMPLETED|Overall Study||0||
59928616|NCT03420768|76046690|FG000|STARTED|Overall Study||18||
59928617|NCT03420768|76046691|FG001|STARTED|Overall Study||28||
59928618|NCT03420768|76046692|FG002|STARTED|Overall Study||15||
59928619|NCT03420768|76046690|FG000|COMPLETED|Overall Study||18||
59928620|NCT03420768|76046691|FG001|COMPLETED|Overall Study||28||
59928621|NCT03420768|76046692|FG002|COMPLETED|Overall Study||15||
59928622|NCT03420768|76046690|FG000|NOT COMPLETED|Overall Study||0||
59928623|NCT03420768|76046691|FG001|NOT COMPLETED|Overall Study||0||
59928624|NCT03420768|76046692|FG002|NOT COMPLETED|Overall Study||0||
59928625|NCT00250458|76046702|FG000|STARTED|Overall Study||232||
59928626|NCT00250458|76046703|FG001|STARTED|Overall Study||114||
59928627|NCT00250458|76046702|FG000|COMPLETED|Overall Study||200||
59928628|NCT00250458|76046703|FG001|COMPLETED|Overall Study||97||
59928629|NCT00250458|76046702|FG000|NOT COMPLETED|Overall Study||32||
59928630|NCT00250458|76046703|FG001|NOT COMPLETED|Overall Study||17||
59928631|NCT01667133|76046721|FG000|STARTED|Phase 1: Dose-escalation||1||
60061985|NCT01800903|76177283|FG000|COMPLETED|Third Test Period||6||
60061986|NCT01800903|76177284|FG001|COMPLETED|Third Test Period||6||
60061987|NCT01800903|76177285|FG002|COMPLETED|Third Test Period||4||
60061988|NCT01800903|76177286|FG003|COMPLETED|Third Test Period||7||
60061989|NCT01800903|76177287|FG004|COMPLETED|Third Test Period||6||
59928632|NCT01667133|76046722|FG001|STARTED|Phase 1: Dose-escalation||1||
59928633|NCT01667133|76046723|FG002|STARTED|Phase 1: Dose-escalation||4||
59928634|NCT01667133|76046724|FG003|STARTED|Phase 1: Dose-escalation||3||
59928635|NCT01667133|76046725|FG004|STARTED|Phase 1: Dose-escalation||1||
59928636|NCT01667133|76046726|FG005|STARTED|Phase 1: Dose-escalation||1||
60061990|NCT01800903|76177288|FG005|COMPLETED|Third Test Period||6||
60061991|NCT01800903|76177283|FG000|NOT COMPLETED|Third Test Period||0||
60061992|NCT01800903|76177284|FG001|NOT COMPLETED|Third Test Period||0||
60061993|NCT01800903|76177285|FG002|NOT COMPLETED|Third Test Period||0||
60061994|NCT01800903|76177286|FG003|NOT COMPLETED|Third Test Period||0||
60061995|NCT01800903|76177287|FG004|NOT COMPLETED|Third Test Period||0||
60061996|NCT01800903|76177288|FG005|NOT COMPLETED|Third Test Period||0||
60061997|NCT01767987|76177296|FG000|STARTED|Overall Study||4||
60061998|NCT01767987|76177297|FG001|STARTED|Overall Study||2||
60061999|NCT01767987|76177296|FG000|COMPLETED|Overall Study||0||
60062000|NCT01767987|76177297|FG001|COMPLETED|Overall Study||1||
60062001|NCT01767987|76177296|FG000|NOT COMPLETED|Overall Study||4||
60062002|NCT01767987|76177297|FG001|NOT COMPLETED|Overall Study||1||
60062003|NCT01800201|76177305|FG000|STARTED|Overall Study||506||
60062004|NCT01800201|76177306|FG001|STARTED|Overall Study||1003||
60062005|NCT01800201|76177305|FG000|COMPLETED|Overall Study||503||
60062006|NCT01800201|76177306|FG001|COMPLETED|Overall Study||1000||
60062007|NCT01800201|76177305|FG000|NOT COMPLETED|Overall Study||3||
59928637|NCT01667133|76046727|FG006|STARTED|Phase 1: Dose-escalation||1||
59517051|NCT01004107|75610728|FG000|NOT COMPLETED|Overall Study||1||
59517052|NCT01004107|75610729|FG001|NOT COMPLETED|Overall Study||2||
59517053|NCT03218566|75610754|FG000|STARTED|Overall Study||119||
59517054|NCT03218566|75610754|FG000|COMPLETED|Overall Study||110||
59517055|NCT03218566|75610754|FG000|NOT COMPLETED|Overall Study||9||
59928638|NCT01667133|76046728|FG007|STARTED|Phase 1: Dose-escalation||0||
59928639|NCT01667133|76046729|FG008|STARTED|Phase 1: Dose-escalation||0||
59928640|NCT01667133|76046730|FG009|STARTED|Phase 1: Dose-escalation||0||
59928641|NCT01667133|76046731|FG010|STARTED|Phase 1: Dose-escalation||0||
59928642|NCT01667133|76046732|FG011|STARTED|Phase 1: Dose-escalation||0||
59928643|NCT01667133|76046721|FG000|COMPLETED|Phase 1: Dose-escalation||1||
59928644|NCT01667133|76046722|FG001|COMPLETED|Phase 1: Dose-escalation||0||
59928645|NCT01667133|76046723|FG002|COMPLETED|Phase 1: Dose-escalation||0||
59928646|NCT01667133|76046724|FG003|COMPLETED|Phase 1: Dose-escalation||2||
59928647|NCT01667133|76046725|FG004|COMPLETED|Phase 1: Dose-escalation||0||
59928648|NCT01667133|76046726|FG005|COMPLETED|Phase 1: Dose-escalation||0||
59928649|NCT01667133|76046727|FG006|COMPLETED|Phase 1: Dose-escalation||0||
59928650|NCT01667133|76046728|FG007|COMPLETED|Phase 1: Dose-escalation||0||
59928651|NCT01667133|76046729|FG008|COMPLETED|Phase 1: Dose-escalation||0||
59928652|NCT01667133|76046730|FG009|COMPLETED|Phase 1: Dose-escalation||0||
59928653|NCT01667133|76046731|FG010|COMPLETED|Phase 1: Dose-escalation||0||
59928654|NCT01667133|76046732|FG011|COMPLETED|Phase 1: Dose-escalation||0||
59928655|NCT01667133|76046721|FG000|NOT COMPLETED|Phase 1: Dose-escalation||0||
59928656|NCT01667133|76046722|FG001|NOT COMPLETED|Phase 1: Dose-escalation||1||
59928657|NCT01667133|76046723|FG002|NOT COMPLETED|Phase 1: Dose-escalation||4||
59928658|NCT01667133|76046724|FG003|NOT COMPLETED|Phase 1: Dose-escalation||1||
59928659|NCT01667133|76046725|FG004|NOT COMPLETED|Phase 1: Dose-escalation||1||
59517056|NCT00630344|75610758|FG000|STARTED|Overall Study||36||
59928660|NCT01667133|76046726|FG005|NOT COMPLETED|Phase 1: Dose-escalation||1||
59928661|NCT01667133|76046727|FG006|NOT COMPLETED|Phase 1: Dose-escalation||1||
59928662|NCT01667133|76046728|FG007|NOT COMPLETED|Phase 1: Dose-escalation||0||
59928663|NCT01667133|76046729|FG008|NOT COMPLETED|Phase 1: Dose-escalation||0||
59928664|NCT01667133|76046730|FG009|NOT COMPLETED|Phase 1: Dose-escalation||0||
59928665|NCT01667133|76046731|FG010|NOT COMPLETED|Phase 1: Dose-escalation||0||
59928666|NCT01667133|76046732|FG011|NOT COMPLETED|Phase 1: Dose-escalation||0||
59928667|NCT01667133|76046721|FG000|STARTED|Phase 2: Dose-expansion||0||
59928668|NCT01667133|76046722|FG001|STARTED|Phase 2: Dose-expansion||0||
59928669|NCT01667133|76046723|FG002|STARTED|Phase 2: Dose-expansion||0||
59928670|NCT01667133|76046724|FG003|STARTED|Phase 2: Dose-expansion||0||
59928671|NCT01667133|76046725|FG004|STARTED|Phase 2: Dose-expansion||0||
59928672|NCT01667133|76046726|FG005|STARTED|Phase 2: Dose-expansion||0||
60062008|NCT01800201|76177306|FG001|NOT COMPLETED|Overall Study||3||
60062009|NCT01767909|76177315|FG000|STARTED|Overall Study||121||
60062010|NCT01767909|76177316|FG001|STARTED|Overall Study||119||
60062011|NCT01767909|76177315|FG000|COMPLETED|Overall Study||108||
60062012|NCT01767909|76177316|FG001|COMPLETED|Overall Study||107||
60062013|NCT01767909|76177315|FG000|NOT COMPLETED|Overall Study||13||
59928673|NCT01667133|76046727|FG006|STARTED|Phase 2: Dose-expansion||0||
59928674|NCT01667133|76046728|FG007|STARTED|Phase 2: Dose-expansion||2||
59928675|NCT01667133|76046729|FG008|STARTED|Phase 2: Dose-expansion||1||
59928676|NCT01667133|76046730|FG009|STARTED|Phase 2: Dose-expansion||11||
59928677|NCT01667133|76046731|FG010|STARTED|Phase 2: Dose-expansion||3||
59928678|NCT01667133|76046732|FG011|STARTED|Phase 2: Dose-expansion||6||
59928679|NCT01667133|76046721|FG000|COMPLETED|Phase 2: Dose-expansion||0||
59928680|NCT01667133|76046722|FG001|COMPLETED|Phase 2: Dose-expansion||0||
59928681|NCT01667133|76046723|FG002|COMPLETED|Phase 2: Dose-expansion||0||
59928682|NCT01667133|76046724|FG003|COMPLETED|Phase 2: Dose-expansion||0||
59928683|NCT01667133|76046725|FG004|COMPLETED|Phase 2: Dose-expansion||0||
59928684|NCT01667133|76046726|FG005|COMPLETED|Phase 2: Dose-expansion||0||
59928685|NCT01667133|76046727|FG006|COMPLETED|Phase 2: Dose-expansion||0||
59928686|NCT01667133|76046728|FG007|COMPLETED|Phase 2: Dose-expansion||0||
59928687|NCT01667133|76046729|FG008|COMPLETED|Phase 2: Dose-expansion||0||
60062014|NCT01767909|76177316|FG001|NOT COMPLETED|Overall Study||12||
60062015|NCT02029274|76177328|FG000|STARTED|Overall Study||5||
60062016|NCT02029274|76177329|FG001|STARTED|Overall Study||4||
60062017|NCT02029274|76177330|FG002|STARTED|Overall Study||4||
60062018|NCT02029274|76177331|FG003|STARTED|Overall Study||4||
60062019|NCT02029274|76177328|FG000|Fixed Dose Period 2|Overall Study||5||
60062020|NCT02029274|76177329|FG001|Fixed Dose Period 2|Overall Study||4||
60062021|NCT02029274|76177330|FG002|Fixed Dose Period 2|Overall Study||4||
60062022|NCT02029274|76177331|FG003|Fixed Dose Period 2|Overall Study||4||
60062023|NCT02029274|76177328|FG000|COMPLETED|Overall Study||4||
60062024|NCT02029274|76177329|FG001|COMPLETED|Overall Study||4||
60062025|NCT02029274|76177330|FG002|COMPLETED|Overall Study||2||
60062026|NCT02029274|76177331|FG003|COMPLETED|Overall Study||2||
59928688|NCT01667133|76046730|FG009|COMPLETED|Phase 2: Dose-expansion||5||
60062027|NCT02029274|76177328|FG000|NOT COMPLETED|Overall Study||1||
60062028|NCT02029274|76177329|FG001|NOT COMPLETED|Overall Study||0||
59928689|NCT01667133|76046731|FG010|COMPLETED|Phase 2: Dose-expansion||0||
60062029|NCT02029274|76177330|FG002|NOT COMPLETED|Overall Study||2||
60062030|NCT02029274|76177331|FG003|NOT COMPLETED|Overall Study||2||
60062031|NCT02008370|76177345|FG000|STARTED|Overall Study||7||
60062032|NCT02008370|76177345|FG000|COMPLETED|Overall Study||0||
60062033|NCT02008370|76177345|FG000|NOT COMPLETED|Overall Study||7||
60062034|NCT01981616|76177351|FG000|STARTED|Overall Study||64||
60062035|NCT01981616|76177352|FG001|STARTED|Overall Study||63||
60062036|NCT01981616|76177351|FG000|COMPLETED|Overall Study||63||
60062037|NCT01981616|76177352|FG001|COMPLETED|Overall Study||62||
60062038|NCT01981616|76177351|FG000|NOT COMPLETED|Overall Study||1||
60062039|NCT01981616|76177352|FG001|NOT COMPLETED|Overall Study||1||
60062040|NCT02104817|76177360|FG000|STARTED|Overall Study||6539||
60062041|NCT02104817|76177361|FG001|STARTED|Overall Study||6539||
60062042|NCT02104817|76177360|FG000|COMPLETED|Overall Study||80||
60062043|NCT02104817|76177361|FG001|COMPLETED|Overall Study||92||
60062044|NCT02104817|76177360|FG000|NOT COMPLETED|Overall Study||6459||
60062045|NCT02104817|76177361|FG001|NOT COMPLETED|Overall Study||6447||
60062046|NCT01962103|76177376|FG000|STARTED|Phase 1||16||
60062047|NCT01962103|76177377|FG001|STARTED|Phase 1||8||
59761076|NCT00546481|75880747|FG000|COMPLETED|Correction Phase (CERA or Epoetin Beta)||33||
59761077|NCT00546481|75880748|FG001|COMPLETED|Correction Phase (CERA or Epoetin Beta)||36||
59928690|NCT01667133|76046732|FG011|COMPLETED|Phase 2: Dose-expansion||0||
59928691|NCT01667133|76046721|FG000|NOT COMPLETED|Phase 2: Dose-expansion||0||
59928692|NCT01667133|76046722|FG001|NOT COMPLETED|Phase 2: Dose-expansion||0||
59928693|NCT01667133|76046723|FG002|NOT COMPLETED|Phase 2: Dose-expansion||0||
59928694|NCT01667133|76046724|FG003|NOT COMPLETED|Phase 2: Dose-expansion||0||
59928695|NCT01667133|76046725|FG004|NOT COMPLETED|Phase 2: Dose-expansion||0||
59761078|NCT00546481|75880749|FG002|COMPLETED|Correction Phase (CERA or Epoetin Beta)||0||
59761079|NCT00546481|75880747|FG000|NOT COMPLETED|Correction Phase (CERA or Epoetin Beta)||6||
59928696|NCT01667133|76046726|FG005|NOT COMPLETED|Phase 2: Dose-expansion||0||
59928697|NCT01667133|76046727|FG006|NOT COMPLETED|Phase 2: Dose-expansion||0||
59928698|NCT01667133|76046728|FG007|NOT COMPLETED|Phase 2: Dose-expansion||2||
60062048|NCT01962103|76177378|FG002|STARTED|Phase 1||14||
60062049|NCT01962103|76177379|FG003|STARTED|Phase 1||11||
59762684|NCT00857259|75882528|FG001|NOT COMPLETED|Overall Study||0||
60062050|NCT01962103|76177380|FG004|STARTED|Phase 1||8||
59928699|NCT01667133|76046729|FG008|NOT COMPLETED|Phase 2: Dose-expansion||1||
59928700|NCT01667133|76046730|FG009|NOT COMPLETED|Phase 2: Dose-expansion||6||
59928701|NCT01667133|76046731|FG010|NOT COMPLETED|Phase 2: Dose-expansion||3||
59928702|NCT01667133|76046732|FG011|NOT COMPLETED|Phase 2: Dose-expansion||6||
59928703|NCT01181778|76046793|FG000|STARTED|Overall Study||1919||
60062051|NCT01962103|76177381|FG005|STARTED|Phase 1||7||
60062052|NCT01962103|76177382|FG006|STARTED|Phase 1||0||
60062053|NCT01962103|76177383|FG007|STARTED|Phase 1||0||
60062054|NCT01962103|76177384|FG008|STARTED|Phase 1||0||
60062055|NCT01962103|76177376|FG000|COMPLETED|Phase 1||0||
60062056|NCT01962103|76177377|FG001|COMPLETED|Phase 1||0||
60062057|NCT01962103|76177378|FG002|COMPLETED|Phase 1||0||
60062058|NCT01962103|76177379|FG003|COMPLETED|Phase 1||0||
60062059|NCT01962103|76177380|FG004|COMPLETED|Phase 1||0||
60062060|NCT01962103|76177381|FG005|COMPLETED|Phase 1||0||
60062061|NCT01962103|76177382|FG006|COMPLETED|Phase 1||0||
60062062|NCT01962103|76177383|FG007|COMPLETED|Phase 1||0||
60062063|NCT01962103|76177384|FG008|COMPLETED|Phase 1||0||
60062064|NCT01962103|76177376|FG000|NOT COMPLETED|Phase 1||16||
60062065|NCT01962103|76177377|FG001|NOT COMPLETED|Phase 1||8||
60062066|NCT01962103|76177378|FG002|NOT COMPLETED|Phase 1||14||
60062067|NCT01962103|76177379|FG003|NOT COMPLETED|Phase 1||11||
60062068|NCT01962103|76177380|FG004|NOT COMPLETED|Phase 1||8||
60062069|NCT01962103|76177381|FG005|NOT COMPLETED|Phase 1||7||
60062070|NCT01962103|76177382|FG006|NOT COMPLETED|Phase 1||0||
60062071|NCT01962103|76177383|FG007|NOT COMPLETED|Phase 1||0||
60062072|NCT01962103|76177384|FG008|NOT COMPLETED|Phase 1||0||
60062073|NCT01962103|76177376|FG000|STARTED|Phase 2||0||
60062074|NCT01962103|76177377|FG001|STARTED|Phase 2||0||
60062075|NCT01962103|76177378|FG002|STARTED|Phase 2||0||
60062076|NCT01962103|76177379|FG003|STARTED|Phase 2||0||
60062077|NCT01962103|76177380|FG004|STARTED|Phase 2||0||
60062078|NCT01962103|76177381|FG005|STARTED|Phase 2||0||
60062079|NCT01962103|76177382|FG006|STARTED|Phase 2||14||
60062080|NCT01962103|76177383|FG007|STARTED|Phase 2||14||
60062081|NCT01962103|76177384|FG008|STARTED|Phase 2||14||
60062082|NCT01962103|76177376|FG000|COMPLETED|Phase 2||0||
60062083|NCT01962103|76177377|FG001|COMPLETED|Phase 2||0||
60062084|NCT01962103|76177378|FG002|COMPLETED|Phase 2||0||
60062085|NCT01962103|76177379|FG003|COMPLETED|Phase 2||0||
59761080|NCT00546481|75880748|FG001|NOT COMPLETED|Correction Phase (CERA or Epoetin Beta)||5||
59761081|NCT00546481|75880749|FG002|NOT COMPLETED|Correction Phase (CERA or Epoetin Beta)||0||
59761082|NCT00546481|75880747|FG000|STARTED|Maintenance Phase (CERA)||0||
60062086|NCT01962103|76177380|FG004|COMPLETED|Phase 2||0||
60062087|NCT01962103|76177381|FG005|COMPLETED|Phase 2||0||
60062088|NCT01962103|76177382|FG006|COMPLETED|Phase 2|completed treatment|0||
60062089|NCT01962103|76177383|FG007|COMPLETED|Phase 2|completed treatment|0||
60062090|NCT01962103|76177384|FG008|COMPLETED|Phase 2|completed treatment|0||
60062091|NCT01962103|76177376|FG000|NOT COMPLETED|Phase 2||0||
60062092|NCT01962103|76177377|FG001|NOT COMPLETED|Phase 2||0||
60062093|NCT01962103|76177378|FG002|NOT COMPLETED|Phase 2||0||
60062094|NCT01962103|76177379|FG003|NOT COMPLETED|Phase 2||0||
60062095|NCT01962103|76177380|FG004|NOT COMPLETED|Phase 2||0||
60062096|NCT01962103|76177381|FG005|NOT COMPLETED|Phase 2||0||
60062097|NCT01962103|76177382|FG006|NOT COMPLETED|Phase 2||14||
60062098|NCT01962103|76177383|FG007|NOT COMPLETED|Phase 2||14||
60062099|NCT01962103|76177384|FG008|NOT COMPLETED|Phase 2||14||
60062100|NCT01961323|76177404|FG000|STARTED|Overall Study||70||
60062101|NCT01961323|76177404|FG000|COMPLETED|Overall Study||21||
60062102|NCT01961323|76177404|FG000|NOT COMPLETED|Overall Study||49||
60062103|NCT01960855|76177413|FG000|STARTED|Overall Study||56||
60062104|NCT01960855|76177414|FG001|STARTED|Overall Study||55||
60062105|NCT01960855|76177415|FG002|STARTED|Overall Study||55||
60062106|NCT01960855|76177416|FG003|STARTED|Overall Study||55||
60062107|NCT01960855|76177417|FG004|STARTED|Overall Study||55||
60062108|NCT01960855|76177413|FG000|COMPLETED|Overall Study||45||
60062109|NCT01960855|76177414|FG001|COMPLETED|Overall Study||51||
60062110|NCT01960855|76177415|FG002|COMPLETED|Overall Study||46||
60062111|NCT01960855|76177416|FG003|COMPLETED|Overall Study||51||
60062112|NCT01960855|76177417|FG004|COMPLETED|Overall Study||50||
59517057|NCT00630344|75610758|FG000|COMPLETED|Overall Study||0||
59517058|NCT00630344|75610758|FG000|NOT COMPLETED|Overall Study||36||
59761083|NCT00546481|75880748|FG001|STARTED|Maintenance Phase (CERA)||0||
59761084|NCT00546481|75880749|FG002|STARTED|Maintenance Phase (CERA)||54||
59761085|NCT00546481|75880747|FG000|COMPLETED|Maintenance Phase (CERA)||0||
59761086|NCT00546481|75880748|FG001|COMPLETED|Maintenance Phase (CERA)||0||
59761087|NCT00546481|75880749|FG002|COMPLETED|Maintenance Phase (CERA)||50||
59761088|NCT00546481|75880747|FG000|NOT COMPLETED|Maintenance Phase (CERA)||0||
59761089|NCT00546481|75880748|FG001|NOT COMPLETED|Maintenance Phase (CERA)||0||
59761090|NCT00546481|75880749|FG002|NOT COMPLETED|Maintenance Phase (CERA)||4||
59761091|NCT00880698|75880761|FG000|STARTED|Overall Study||62||
59761092|NCT00880698|75880762|FG001|STARTED|Overall Study||64||
59761093|NCT00880698|75880763|FG002|STARTED|Overall Study||37||
59761094|NCT00880698|75880764|FG003|STARTED|Overall Study||39||
60062113|NCT01960855|76177413|FG000|NOT COMPLETED|Overall Study||11||
60062114|NCT01960855|76177414|FG001|NOT COMPLETED|Overall Study||4||
60062115|NCT01960855|76177415|FG002|NOT COMPLETED|Overall Study||9||
60062116|NCT01960855|76177416|FG003|NOT COMPLETED|Overall Study||4||
60062117|NCT01960855|76177417|FG004|NOT COMPLETED|Overall Study||5||
60062118|NCT02007434|76177437|FG000|STARTED|Overall Study||17||
59517059|NCT02167867|75610765|FG000|STARTED|Overall Study||22||
60062119|NCT02007434|76177438|FG001|STARTED|Overall Study||4||
60062120|NCT02007434|76177439|FG002|STARTED|Overall Study||17||
60062121|NCT02007434|76177440|FG003|STARTED|Overall Study||4||
60062122|NCT02007434|76177441|FG004|STARTED|Overall Study||16||
60062123|NCT02007434|76177442|FG005|STARTED|Overall Study||4||
60062124|NCT02007434|76177443|FG006|STARTED|Overall Study||18||
60062125|NCT02007434|76177444|FG007|STARTED|Overall Study||4||
60062126|NCT02007434|76177437|FG000|Received Treatment|Overall Study||17||
60062127|NCT02007434|76177438|FG001|Received Treatment|Overall Study||3||
60062128|NCT02007434|76177439|FG002|Received Treatment|Overall Study||17||
60062129|NCT02007434|76177440|FG003|Received Treatment|Overall Study||4||
60062130|NCT02007434|76177441|FG004|Received Treatment|Overall Study||16||
60062131|NCT02007434|76177442|FG005|Received Treatment|Overall Study||4||
60062132|NCT02007434|76177443|FG006|Received Treatment|Overall Study||18||
60062133|NCT02007434|76177444|FG007|Received Treatment|Overall Study||4||
60062134|NCT02007434|76177437|FG000|COMPLETED|Overall Study||16||
60062135|NCT02007434|76177438|FG001|COMPLETED|Overall Study||3||
60062136|NCT02007434|76177439|FG002|COMPLETED|Overall Study||16||
60062137|NCT02007434|76177440|FG003|COMPLETED|Overall Study||4||
60062138|NCT02007434|76177441|FG004|COMPLETED|Overall Study||16||
60062139|NCT02007434|76177442|FG005|COMPLETED|Overall Study||4||
60062140|NCT02007434|76177443|FG006|COMPLETED|Overall Study||18||
60062141|NCT02007434|76177444|FG007|COMPLETED|Overall Study||4||
60062142|NCT02007434|76177437|FG000|NOT COMPLETED|Overall Study||1||
60062143|NCT02007434|76177438|FG001|NOT COMPLETED|Overall Study||1||
60062144|NCT02007434|76177439|FG002|NOT COMPLETED|Overall Study||1||
60062145|NCT02007434|76177440|FG003|NOT COMPLETED|Overall Study||0||
60062146|NCT02007434|76177441|FG004|NOT COMPLETED|Overall Study||0||
59761095|NCT00880698|75880761|FG000|COMPLETED|Overall Study||61||
59761096|NCT00880698|75880762|FG001|COMPLETED|Overall Study||61||
59761097|NCT00880698|75880763|FG002|COMPLETED|Overall Study||36||
59761098|NCT00880698|75880764|FG003|COMPLETED|Overall Study||36||
59761099|NCT00880698|75880761|FG000|NOT COMPLETED|Overall Study||1||
60062147|NCT02007434|76177442|FG005|NOT COMPLETED|Overall Study||0||
60062148|NCT02007434|76177443|FG006|NOT COMPLETED|Overall Study||0||
60062149|NCT02007434|76177444|FG007|NOT COMPLETED|Overall Study||0||
60062150|NCT01987453|76177466|FG000|STARTED|Overall Study||51||
60062151|NCT01987453|76177467|FG001|STARTED|Overall Study||41||
60062152|NCT01987453|76177468|FG002|STARTED|Overall Study||8||
60062153|NCT01987453|76177466|FG000|COMPLETED|Overall Study||50||
60062154|NCT01987453|76177467|FG001|COMPLETED|Overall Study||29||
60062155|NCT01987453|76177468|FG002|COMPLETED|Overall Study||7||
60062156|NCT01987453|76177466|FG000|NOT COMPLETED|Overall Study||1||
60062157|NCT01987453|76177467|FG001|NOT COMPLETED|Overall Study||12||
60062158|NCT01987453|76177468|FG002|NOT COMPLETED|Overall Study||1||
60062159|NCT02006641|76177483|FG000|STARTED|Overall Study||284||
60062160|NCT02006641|76177484|FG001|STARTED|Overall Study||290||
60062161|NCT02006641|76177485|FG002|STARTED|Overall Study||284||
60062162|NCT02006641|76177483|FG000|Treated|Overall Study||282||
60062163|NCT02006641|76177484|FG001|Treated|Overall Study||285||
60062164|NCT02006641|76177485|FG002|Treated|Overall Study||281||
60062165|NCT02006641|76177483|FG000|COMPLETED|Overall Study||258||
60062166|NCT02006641|76177484|FG001|COMPLETED|Overall Study||257||
60062167|NCT02006641|76177485|FG002|COMPLETED|Overall Study||248||
60062168|NCT02006641|76177483|FG000|NOT COMPLETED|Overall Study||26||
60062169|NCT02006641|76177484|FG001|NOT COMPLETED|Overall Study||33||
60062170|NCT02006641|76177485|FG002|NOT COMPLETED|Overall Study||36||
59517060|NCT02167867|75610766|FG001|STARTED|Overall Study||22||
59761100|NCT00880698|75880762|FG001|NOT COMPLETED|Overall Study||3||
59761101|NCT00880698|75880763|FG002|NOT COMPLETED|Overall Study||1||
60062171|NCT01959919|76177493|FG000|STARTED|Overall Study||86||
60062172|NCT01959919|76177493|FG000|COMPLETED|Overall Study||84||
60062173|NCT01959919|76177493|FG000|NOT COMPLETED|Overall Study||2||
60062174|NCT04176601|76177497|FG000|STARTED|Overall Study||30||
60062175|NCT04176601|76177497|FG000|COMPLETED|Overall Study||25||
60062176|NCT04176601|76177497|FG000|NOT COMPLETED|Overall Study||5||
60062177|NCT01986985|76177501|FG000|STARTED|Overall Study||58||
60062178|NCT01986985|76177501|FG000|COMPLETED|Overall Study||51||
60062179|NCT01986985|76177501|FG000|NOT COMPLETED|Overall Study||7||
60062180|NCT01986907|76177505|FG000|STARTED|Overall Study||936|All treated participants (one eye or both eyes) (Safety Analysis Set)|
60062181|NCT01986907|76177505|FG000|COMPLETED|Overall Study||774||
60062182|NCT01986907|76177505|FG000|NOT COMPLETED|Overall Study||162||
60062183|NCT01959841|76177515|FG000|STARTED|Overall Study||252||
60062184|NCT01959841|76177516|FG001|STARTED|Overall Study||250||
60062185|NCT01959841|76177517|FG002|STARTED|Overall Study||249||
60062186|NCT01959841|76177515|FG000|Full Analysis Set Included|Overall Study||247||
60062187|NCT01959841|76177516|FG001|Full Analysis Set Included|Overall Study||243||
60062188|NCT01959841|76177517|FG002|Full Analysis Set Included|Overall Study||245||
60062189|NCT01959841|76177515|FG000|Full Analysis Set Excluded|Overall Study||5||
60062190|NCT01959841|76177516|FG001|Full Analysis Set Excluded|Overall Study||7||
60062191|NCT01959841|76177517|FG002|Full Analysis Set Excluded|Overall Study||4||
60062192|NCT01959841|76177515|FG000|Reason FAS Excluding 1|Overall Study||5|Subjects who are found not to have herpes zoster|
60062193|NCT01959841|76177516|FG001|Reason FAS Excluding 1|Overall Study||5|Subjects who are found not to have herpes zoster|
60062194|NCT01959841|76177517|FG002|Reason FAS Excluding 1|Overall Study||4|Subjects who are found not to have herpes zoster|
60062195|NCT01959841|76177515|FG000|Reason FAS Excluding 2|Overall Study||0|Those who have not received any dose of the study drug after randomization.|
60062196|NCT01959841|76177516|FG001|Reason FAS Excluding 2|Overall Study||1|Those who have not received any dose of the study drug after randomization.|
60062197|NCT01959841|76177517|FG002|Reason FAS Excluding 2|Overall Study||0|Those who have not received any dose of the study drug after randomization.|
60062198|NCT01959841|76177515|FG000|Reason FAS Excluding 3|Overall Study||0|Those who have no efficacy assessment data after study drug administration.|
60062199|NCT01959841|76177516|FG001|Reason FAS Excluding 3|Overall Study||1|Those who have no efficacy assessment data after study drug administration.|
59761102|NCT00880698|75880764|FG003|NOT COMPLETED|Overall Study||3||
59761103|NCT00880620|75880780|FG000|STARTED|Overall Study||92|Baseline|
60062200|NCT01959841|76177517|FG002|Reason FAS Excluding 3|Overall Study||0|Those who have no efficacy assessment data after study drug administration.|
60062201|NCT01959841|76177515|FG000|COMPLETED|Overall Study||209||
59761104|NCT00880620|75880781|FG001|STARTED|Overall Study||87|Baseline|
59761105|NCT00880620|75880782|FG002|STARTED|Overall Study||104|Baseline|
60062202|NCT01959841|76177516|FG001|COMPLETED|Overall Study||193||
60062203|NCT01959841|76177517|FG002|COMPLETED|Overall Study||206||
59761106|NCT00880620|75880783|FG003|STARTED|Overall Study||98|Baseline|
59761107|NCT00880620|75880780|FG000|Week 4|Overall Study||88||
59761108|NCT00880620|75880781|FG001|Week 4|Overall Study||79||
59761109|NCT00880620|75880782|FG002|Week 4|Overall Study||94||
59761110|NCT00880620|75880783|FG003|Week 4|Overall Study||86||
59761111|NCT00880620|75880780|FG000|Week 9|Overall Study||80||
59928704|NCT01181778|76046793|FG000|COMPLETED|Overall Study||1871||
59928705|NCT01181778|76046793|FG000|NOT COMPLETED|Overall Study||48||
59928706|NCT00092118|76046801|FG000|STARTED|Overall Study|1 patient discontinued after randomization due to a adverse experience that began pre-randomization.|990||
59928707|NCT00092118|76046802|FG001|STARTED|Overall Study|2 patients discontinued after randomization due to adverse experience that began pre-randomization.|1002||
59928708|NCT00092118|76046801|FG000|COMPLETED|Overall Study||906||
59928709|NCT00092118|76046802|FG001|COMPLETED|Overall Study||913||
59928710|NCT00092118|76046801|FG000|NOT COMPLETED|Overall Study||84||
59928711|NCT00092118|76046802|FG001|NOT COMPLETED|Overall Study||89||
59928712|NCT03261947|76046813|FG000|STARTED|Overall Study||12||
59928713|NCT03261947|76046814|FG001|STARTED|Overall Study||15||
59928714|NCT03261947|76046815|FG002|STARTED|Overall Study||35||
59928715|NCT03261947|76046816|FG003|STARTED|Overall Study||21||
59928716|NCT03261947|76046817|FG004|STARTED|Overall Study||18||
59928717|NCT03261947|76046813|FG000|COMPLETED|Overall Study||0||
59928718|NCT03261947|76046814|FG001|COMPLETED|Overall Study||2||
59928719|NCT03261947|76046815|FG002|COMPLETED|Overall Study||5||
59928720|NCT03261947|76046816|FG003|COMPLETED|Overall Study||0||
59928721|NCT03261947|76046817|FG004|COMPLETED|Overall Study||1||
59928722|NCT03261947|76046813|FG000|NOT COMPLETED|Overall Study||12||
59928723|NCT03261947|76046814|FG001|NOT COMPLETED|Overall Study||13||
59928724|NCT03261947|76046815|FG002|NOT COMPLETED|Overall Study||30||
59928725|NCT03261947|76046816|FG003|NOT COMPLETED|Overall Study||21||
59928726|NCT03261947|76046817|FG004|NOT COMPLETED|Overall Study||17||
59928727|NCT04852848|76046835|FG000|STARTED|Overall Study||105||
59928728|NCT04852848|76046836|FG001|STARTED|Overall Study||100||
59928729|NCT04852848|76046835|FG000|COMPLETED|Overall Study||105||
59928730|NCT04852848|76046836|FG001|COMPLETED|Overall Study||100||
59928731|NCT04852848|76046835|FG000|NOT COMPLETED|Overall Study||0||
59928732|NCT04852848|76046836|FG001|NOT COMPLETED|Overall Study||0||
59928733|NCT03098979|76046848|FG000|STARTED|Overall Study||76||
59928734|NCT03098979|76046849|FG001|STARTED|Overall Study||27||
59928735|NCT03098979|76046850|FG002|STARTED|Overall Study||50||
59928736|NCT03098979|76046851|FG003|STARTED|Overall Study||51||
59928737|NCT03098979|76046852|FG004|STARTED|Overall Study||50||
59928738|NCT03098979|76046853|FG005|STARTED|Overall Study||51||
59928739|NCT03098979|76046848|FG000|COMPLETED|Overall Study||70||
59928740|NCT03098979|76046849|FG001|COMPLETED|Overall Study||25||
59928741|NCT03098979|76046850|FG002|COMPLETED|Overall Study||46||
59928742|NCT03098979|76046851|FG003|COMPLETED|Overall Study||46||
59928743|NCT03098979|76046852|FG004|COMPLETED|Overall Study||41||
59928744|NCT03098979|76046853|FG005|COMPLETED|Overall Study||47||
59928745|NCT03098979|76046848|FG000|NOT COMPLETED|Overall Study||6||
59928746|NCT03098979|76046849|FG001|NOT COMPLETED|Overall Study||2||
59928747|NCT03098979|76046850|FG002|NOT COMPLETED|Overall Study||4||
59928748|NCT03098979|76046851|FG003|NOT COMPLETED|Overall Study||5||
59928749|NCT03098979|76046852|FG004|NOT COMPLETED|Overall Study||9||
59928750|NCT03098979|76046853|FG005|NOT COMPLETED|Overall Study||4||
59928751|NCT03261167|76046869|FG000|STARTED|Double Blind(Treatment cyc1,Upto Week48)||63||
59928752|NCT03261167|76046870|FG001|STARTED|Double Blind(Treatment cyc1,Upto Week48)||61||
60062204|NCT01959841|76177515|FG000|NOT COMPLETED|Overall Study||43||
60062205|NCT01959841|76177516|FG001|NOT COMPLETED|Overall Study||57||
60062206|NCT01959841|76177517|FG002|NOT COMPLETED|Overall Study||43||
60062207|NCT02005627|76177527|FG000|STARTED|Overall Study||23||
60062208|NCT02005627|76177528|FG001|STARTED|Overall Study||23||
60062209|NCT02005627|76177527|FG000|COMPLETED|Overall Study||21||
60062210|NCT02005627|76177528|FG001|COMPLETED|Overall Study||19||
60062211|NCT02005627|76177527|FG000|NOT COMPLETED|Overall Study||2||
60062212|NCT02005627|76177528|FG001|NOT COMPLETED|Overall Study||4||
60062213|NCT02104583|76177540|FG000|STARTED|Overall Study||48||
60062214|NCT02104583|76177541|FG001|STARTED|Overall Study||46||
60062215|NCT02104583|76177542|FG002|STARTED|Overall Study||70||
60062216|NCT02104583|76177543|FG003|STARTED|Overall Study||74||
60062217|NCT02104583|76177544|FG004|STARTED|Overall Study||75||
60062218|NCT02104583|76177540|FG000|COMPLETED|Overall Study||30||
60062219|NCT02104583|76177541|FG001|COMPLETED|Overall Study||35||
60062220|NCT02104583|76177542|FG002|COMPLETED|Overall Study||54||
60062221|NCT02104583|76177543|FG003|COMPLETED|Overall Study||57||
60062222|NCT02104583|76177544|FG004|COMPLETED|Overall Study||63||
60062223|NCT02104583|76177540|FG000|NOT COMPLETED|Overall Study||18||
60062224|NCT02104583|76177541|FG001|NOT COMPLETED|Overall Study||11||
60062225|NCT02104583|76177542|FG002|NOT COMPLETED|Overall Study||16||
60062226|NCT02104583|76177543|FG003|NOT COMPLETED|Overall Study||17||
60062227|NCT02104583|76177544|FG004|NOT COMPLETED|Overall Study||12||
60062228|NCT02073929|76177567|FG000|STARTED|Overall Study||48||
60062229|NCT02073929|76177568|FG001|STARTED|Overall Study||24||
60062230|NCT02073929|76177567|FG000|COMPLETED|Overall Study||44||
60062231|NCT02073929|76177568|FG001|COMPLETED|Overall Study||21||
60062232|NCT02073929|76177567|FG000|NOT COMPLETED|Overall Study||4||
60062233|NCT02073929|76177568|FG001|NOT COMPLETED|Overall Study||3||
60062234|NCT02113007|76177574|FG000|STARTED|Overall Study||2||
60062235|NCT02113007|76177574|FG000|COMPLETED|Overall Study||0||
60062236|NCT02113007|76177574|FG000|NOT COMPLETED|Overall Study||2||
60062237|NCT02104505|76177580|FG000|STARTED|First Intervention (14 Days)||12||
60062238|NCT02104505|76177581|FG001|STARTED|First Intervention (14 Days)|one participant withdrew prior to receiving study drug|11||
60062239|NCT02104505|76177580|FG000|COMPLETED|First Intervention (14 Days)||10||
60062240|NCT02104505|76177581|FG001|COMPLETED|First Intervention (14 Days)||8||
60062241|NCT02104505|76177580|FG000|NOT COMPLETED|First Intervention (14 Days)||2||
60062242|NCT02104505|76177581|FG001|NOT COMPLETED|First Intervention (14 Days)||3||
60062243|NCT02104505|76177580|FG000|STARTED|Washout (Minimum 3 Weeks)||10||
59928753|NCT03261167|76046869|FG000|COMPLETED|Double Blind(Treatment cyc1,Upto Week48)||60||
59928754|NCT03261167|76046870|FG001|COMPLETED|Double Blind(Treatment cyc1,Upto Week48)||57||
59928755|NCT03261167|76046869|FG000|NOT COMPLETED|Double Blind(Treatment cyc1,Upto Week48)||3||
59928756|NCT03261167|76046870|FG001|NOT COMPLETED|Double Blind(Treatment cyc1,Upto Week48)||4||
59928757|NCT03261167|76046869|FG000|STARTED|Open-label(Treatment cycle2,Upto Week48)||60|Participants who met retreatment criteria in Treatment cycle 1 and received second dose|
59928758|NCT03261167|76046870|FG001|STARTED|Open-label(Treatment cycle2,Upto Week48)||57|Participants who met retreatment criteria in Treatment cycle 1 and received second dose|
59928759|NCT03261167|76046869|FG000|COMPLETED|Open-label(Treatment cycle2,Upto Week48)||58||
59928760|NCT03261167|76046870|FG001|COMPLETED|Open-label(Treatment cycle2,Upto Week48)||57||
59928761|NCT03261167|76046869|FG000|NOT COMPLETED|Open-label(Treatment cycle2,Upto Week48)||2||
60062244|NCT02104505|76177581|FG001|STARTED|Washout (Minimum 3 Weeks)||8||
60062245|NCT02104505|76177580|FG000|COMPLETED|Washout (Minimum 3 Weeks)||10||
60062246|NCT02104505|76177581|FG001|COMPLETED|Washout (Minimum 3 Weeks)||8||
60062247|NCT02104505|76177580|FG000|NOT COMPLETED|Washout (Minimum 3 Weeks)||0||
60062248|NCT02104505|76177581|FG001|NOT COMPLETED|Washout (Minimum 3 Weeks)||0||
60062249|NCT02104505|76177580|FG000|STARTED|Second Intervention (14 Days)||10||
60062250|NCT02104505|76177581|FG001|STARTED|Second Intervention (14 Days)||8||
60062251|NCT02104505|76177580|FG000|COMPLETED|Second Intervention (14 Days)||8||
60062252|NCT02104505|76177581|FG001|COMPLETED|Second Intervention (14 Days)||7||
60062253|NCT02104505|76177580|FG000|NOT COMPLETED|Second Intervention (14 Days)||2||
60062254|NCT02104505|76177581|FG001|NOT COMPLETED|Second Intervention (14 Days)||1||
60062255|NCT02111993|76177590|FG000|STARTED|Overall Study||30||
60062256|NCT02111993|76177591|FG001|STARTED|Overall Study||30||
60062257|NCT02111993|76177590|FG000|COMPLETED|Overall Study||25||
60062258|NCT02111993|76177591|FG001|COMPLETED|Overall Study||26||
60062259|NCT02111993|76177590|FG000|NOT COMPLETED|Overall Study||5||
60062260|NCT02111993|76177591|FG001|NOT COMPLETED|Overall Study||4||
60062261|NCT01959607|76177601|FG000|STARTED|Washout Period of 1 Day (Day 0)||22||
60062262|NCT01959607|76177602|FG001|STARTED|Washout Period of 1 Day (Day 0)||22||
60062263|NCT01959607|76177603|FG002|STARTED|Washout Period of 1 Day (Day 0)||9||
60062264|NCT01959607|76177604|FG003|STARTED|Washout Period of 1 Day (Day 0)||9||
60062265|NCT01959607|76177601|FG000|COMPLETED|Washout Period of 1 Day (Day 0)||22||
60062266|NCT01959607|76177602|FG001|COMPLETED|Washout Period of 1 Day (Day 0)||22||
60062267|NCT01959607|76177603|FG002|COMPLETED|Washout Period of 1 Day (Day 0)||9||
60062268|NCT01959607|76177604|FG003|COMPLETED|Washout Period of 1 Day (Day 0)||9||
60062269|NCT01959607|76177601|FG000|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0||
60062270|NCT01959607|76177602|FG001|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0||
60062271|NCT01959607|76177603|FG002|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0||
60062272|NCT01959607|76177604|FG003|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0||
60062273|NCT01959607|76177601|FG000|STARTED|First Intervention (Day 1)||22||
60062274|NCT01959607|76177602|FG001|STARTED|First Intervention (Day 1)||22||
60062275|NCT01959607|76177603|FG002|STARTED|First Intervention (Day 1)||9||
60062276|NCT01959607|76177604|FG003|STARTED|First Intervention (Day 1)||9||
60062277|NCT01959607|76177601|FG000|COMPLETED|First Intervention (Day 1)||21||
60062278|NCT01959607|76177602|FG001|COMPLETED|First Intervention (Day 1)||21||
60062279|NCT01959607|76177603|FG002|COMPLETED|First Intervention (Day 1)||9||
60062280|NCT01959607|76177604|FG003|COMPLETED|First Intervention (Day 1)||9||
60062281|NCT01959607|76177601|FG000|NOT COMPLETED|First Intervention (Day 1)||1||
60062282|NCT01959607|76177602|FG001|NOT COMPLETED|First Intervention (Day 1)||1||
60062283|NCT01959607|76177603|FG002|NOT COMPLETED|First Intervention (Day 1)||0||
60062284|NCT01959607|76177604|FG003|NOT COMPLETED|First Intervention (Day 1)||0||
60062285|NCT01959607|76177601|FG000|STARTED|Washout Period of 1 Day (Day 2)||21||
60062286|NCT01959607|76177602|FG001|STARTED|Washout Period of 1 Day (Day 2)||21||
60062287|NCT01959607|76177603|FG002|STARTED|Washout Period of 1 Day (Day 2)||9||
60062288|NCT01959607|76177604|FG003|STARTED|Washout Period of 1 Day (Day 2)||9||
60062289|NCT01959607|76177601|FG000|COMPLETED|Washout Period of 1 Day (Day 2)||21||
60062290|NCT01959607|76177602|FG001|COMPLETED|Washout Period of 1 Day (Day 2)||21||
60062291|NCT01959607|76177603|FG002|COMPLETED|Washout Period of 1 Day (Day 2)||9||
60062292|NCT01959607|76177604|FG003|COMPLETED|Washout Period of 1 Day (Day 2)||9||
60062293|NCT01959607|76177601|FG000|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0||
60062294|NCT01959607|76177602|FG001|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0||
60062295|NCT01959607|76177603|FG002|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0||
60062296|NCT01959607|76177604|FG003|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0||
60062297|NCT01959607|76177601|FG000|STARTED|Second Intervention (Day 3)||21||
60062298|NCT01959607|76177602|FG001|STARTED|Second Intervention (Day 3)||21||
60062299|NCT01959607|76177603|FG002|STARTED|Second Intervention (Day 3)||9||
60062300|NCT01959607|76177604|FG003|STARTED|Second Intervention (Day 3)||9||
59517061|NCT02167867|75610765|FG000|COMPLETED|Overall Study||22||
59517062|NCT02167867|75610766|FG001|COMPLETED|Overall Study||22||
59517063|NCT02167867|75610765|FG000|NOT COMPLETED|Overall Study||0||
59517064|NCT02167867|75610766|FG001|NOT COMPLETED|Overall Study||0||
59517065|NCT03442036|75610773|FG000|STARTED|Overall Study||35||
59517066|NCT03442036|75610774|FG001|STARTED|Overall Study||35||
59928762|NCT03261167|76046870|FG001|NOT COMPLETED|Open-label(Treatment cycle2,Upto Week48)||0||
59928763|NCT03261167|76046869|FG000|STARTED|Open-label(Treatment cycle3,Upto Week48)||55|Participants who met retreatment criteria in Treatment cycle 2 and received third dose|
59928764|NCT03261167|76046870|FG001|STARTED|Open-label(Treatment cycle3,Upto Week48)||56|Participants who met retreatment criteria in Treatment cycle 2 and received third dose|
59928765|NCT03261167|76046869|FG000|COMPLETED|Open-label(Treatment cycle3,Upto Week48)||54||
59928766|NCT03261167|76046870|FG001|COMPLETED|Open-label(Treatment cycle3,Upto Week48)||55||
59928767|NCT03261167|76046869|FG000|NOT COMPLETED|Open-label(Treatment cycle3,Upto Week48)||1||
59517067|NCT03442036|75610773|FG000|COMPLETED|Overall Study||35||
59517068|NCT03442036|75610774|FG001|COMPLETED|Overall Study||35||
59517069|NCT03442036|75610773|FG000|NOT COMPLETED|Overall Study||0||
59517070|NCT03442036|75610774|FG001|NOT COMPLETED|Overall Study||0||
59517071|NCT02913261|75610784|FG000|STARTED|Overall Study||154||
59517072|NCT02913261|75610785|FG001|STARTED|Overall Study||155||
59517073|NCT02913261|75610784|FG000|Not Treated|Overall Study||2||
59928768|NCT03261167|76046870|FG001|NOT COMPLETED|Open-label(Treatment cycle3,Upto Week48)||1||
60062301|NCT01959607|76177601|FG000|COMPLETED|Second Intervention (Day 3)||21||
60062302|NCT01959607|76177602|FG001|COMPLETED|Second Intervention (Day 3)||21||
60062303|NCT01959607|76177603|FG002|COMPLETED|Second Intervention (Day 3)||9||
60062304|NCT01959607|76177604|FG003|COMPLETED|Second Intervention (Day 3)||9||
60062305|NCT01959607|76177601|FG000|NOT COMPLETED|Second Intervention (Day 3)||0||
60062306|NCT01959607|76177602|FG001|NOT COMPLETED|Second Intervention (Day 3)||0||
60062307|NCT01959607|76177603|FG002|NOT COMPLETED|Second Intervention (Day 3)||0||
60062308|NCT01959607|76177604|FG003|NOT COMPLETED|Second Intervention (Day 3)||0||
60062309|NCT02111603|76177613|FG000|STARTED|Overall Study||13||
60062310|NCT02111603|76177613|FG000|COMPLETED|Overall Study||12||
60062311|NCT02111603|76177613|FG000|NOT COMPLETED|Overall Study||1||
60062312|NCT02102399|76177619|FG000|STARTED|Overall Study||20||
60062313|NCT02102399|76177620|FG001|STARTED|Overall Study||21||
60062314|NCT02102399|76177619|FG000|COMPLETED|Overall Study||14||
60062315|NCT02102399|76177620|FG001|COMPLETED|Overall Study||17||
60062316|NCT02102399|76177619|FG000|NOT COMPLETED|Overall Study||6||
60062317|NCT02102399|76177620|FG001|NOT COMPLETED|Overall Study||4||
60062318|NCT02111369|76177631|FG000|STARTED|Overall Study||18||
59517074|NCT02913261|75610785|FG001|Not Treated|Overall Study||5||
60062319|NCT02111369|76177631|FG000|COMPLETED|Overall Study||15||
60062320|NCT02111369|76177631|FG000|NOT COMPLETED|Overall Study||3||
60062321|NCT02111213|76177637|FG000|STARTED|Overall Study||122||
60062322|NCT02111213|76177638|FG001|STARTED|Overall Study||123||
60062323|NCT02111213|76177637|FG000|COMPLETED|Overall Study||116||
60062324|NCT02111213|76177638|FG001|COMPLETED|Overall Study||117||
60062325|NCT02111213|76177637|FG000|NOT COMPLETED|Overall Study||6||
60062326|NCT02111213|76177638|FG001|NOT COMPLETED|Overall Study||6||
60062327|NCT02110901|76177646|FG000|STARTED|Overall Study||209||
60062328|NCT02110901|76177647|FG001|STARTED|Overall Study||102||
60062329|NCT02110901|76177646|FG000|COMPLETED|Overall Study||179||
60062330|NCT02110901|76177647|FG001|COMPLETED|Overall Study||88||
60062331|NCT02110901|76177646|FG000|NOT COMPLETED|Overall Study||30||
60062332|NCT02110901|76177647|FG001|NOT COMPLETED|Overall Study||14||
59517075|NCT02913261|75610784|FG000|Crossover Treatment at End of Randomized Treatment|Overall Study||0||
59761112|NCT00880620|75880781|FG001|Week 9|Overall Study||73||
59761113|NCT00880620|75880782|FG002|Week 9|Overall Study||88||
59761114|NCT00880620|75880783|FG003|Week 9|Overall Study||78||
59761115|NCT00880620|75880780|FG000|Week 16|Overall Study||74||
59517076|NCT02913261|75610785|FG001|Crossover Treatment at End of Randomized Treatment|Overall Study||49||
59517077|NCT02913261|75610784|FG000|Entered Long-term Follow-up|Overall Study||102||
59517078|NCT02913261|75610785|FG001|Entered Long-term Follow-up|Overall Study||51||
59517079|NCT02913261|75610784|FG000|Completed Screening & Randomized|Overall Study||154||
59928769|NCT03261167|76046869|FG000|STARTED|Open-label(Treatment cycle4,Upto Week48)||43|Participants who met retreatment criteria in Treatment cycle 3 and received fourth dose|
59928770|NCT03261167|76046870|FG001|STARTED|Open-label(Treatment cycle4,Upto Week48)||40|Participants who met retreatment criteria in Treatment cycle 3 and received fourth dose|
59928771|NCT03261167|76046869|FG000|COMPLETED|Open-label(Treatment cycle4,Upto Week48)||43||
59928772|NCT03261167|76046870|FG001|COMPLETED|Open-label(Treatment cycle4,Upto Week48)||40||
59928773|NCT03261167|76046869|FG000|NOT COMPLETED|Open-label(Treatment cycle4,Upto Week48)||0||
59928774|NCT03261167|76046870|FG001|NOT COMPLETED|Open-label(Treatment cycle4,Upto Week48)||0||
59928775|NCT03294941|76046884|FG000|STARTED|Overall Study||4||
59928776|NCT03294941|76046885|FG001|STARTED|Overall Study||13||
59928777|NCT03294941|76046884|FG000|COMPLETED|Overall Study||4||
59928778|NCT03294941|76046885|FG001|COMPLETED|Overall Study||11||
59928779|NCT03294941|76046884|FG000|NOT COMPLETED|Overall Study||0||
59928780|NCT03294941|76046885|FG001|NOT COMPLETED|Overall Study||2||
59928781|NCT03098433|76046892|FG000|STARTED|Overall Study||22||
59928782|NCT03098433|76046892|FG000|COMPLETED|Overall Study||12||
59928783|NCT03098433|76046892|FG000|NOT COMPLETED|Overall Study||10||
59928784|NCT03294317|76046897|FG000|STARTED|Overall Study||70||
59928785|NCT03294317|76046897|FG000|Implanted With Lead at HIS Bundle|Overall Study||61||
59928786|NCT03294317|76046897|FG000|Subjects With Available CT|Overall Study||51||
59928787|NCT03294317|76046897|FG000|COMPLETED|Overall Study||50||
59928788|NCT03294317|76046897|FG000|NOT COMPLETED|Overall Study||20||
59928789|NCT03292913|76046903|FG000|STARTED|Overall Study||397||
59928790|NCT03292913|76046904|FG001|STARTED|Overall Study||402||
59928791|NCT03292913|76046903|FG000|COMPLETED|Overall Study||315||
59928792|NCT03292913|76046904|FG001|COMPLETED|Overall Study||314||
59928793|NCT03292913|76046903|FG000|NOT COMPLETED|Overall Study||82||
59928794|NCT03292913|76046904|FG001|NOT COMPLETED|Overall Study||88||
59928795|NCT03291587|76046916|FG000|STARTED|Overall Study|5 were found ineligible after baseline|523||
59928796|NCT03291587|76046917|FG001|STARTED|Overall Study|1 was found ineligible after baseline|571||
59928797|NCT03291587|76046916|FG000|14 Day Follow-up|Overall Study|32 could not be reached, 1 not interested, 4 too busy to participate, 1 site withdrew, 1 previously consented and removed from study, 1 personal health reasons|483||
59928798|NCT03291587|76046917|FG001|14 Day Follow-up|Overall Study|22 could not be reached, 1 too busy to participate, 1 not interested in participating.|547||
59928799|NCT03291587|76046916|FG000|3 Month Follow-up|Overall Study|63 could not be reached, 2 refused to answer, 2 expired, 4 not interested in participating, 1 personal health reasons|445||
59928800|NCT03291587|76046917|FG001|3 Month Follow-up|Overall Study|26 could not be reached, 2 expired, and 3 not interested in participating|538||
59928801|NCT03291587|76046916|FG000|COMPLETED|Overall Study|62 could not be reached, 3 refused to answer, 2 not interested in participating, 1 personal health reason|442||
59928802|NCT03291587|76046917|FG001|COMPLETED|Overall Study|43 could not be reached,2 refused to answer, 2 expired, and 2 not interested in participating|514||
59928803|NCT03291587|76046916|FG000|NOT COMPLETED|Overall Study||81||
59928804|NCT03291587|76046917|FG001|NOT COMPLETED|Overall Study||57||
59928805|NCT03856788|76046926|FG000|STARTED|Overall Study||23||
59928806|NCT03856788|76046927|FG001|STARTED|Overall Study||20||
59928807|NCT03856788|76046926|FG000|COMPLETED|Overall Study||21||
59928808|NCT03856788|76046927|FG001|COMPLETED|Overall Study||19||
59928809|NCT03856788|76046926|FG000|NOT COMPLETED|Overall Study||2||
59928810|NCT03856788|76046927|FG001|NOT COMPLETED|Overall Study||1||
59928811|NCT03210961|76046948|FG000|STARTED|Overall Study||4||
59928812|NCT03210961|76046949|FG001|STARTED|Overall Study||9||
59928813|NCT03210961|76046950|FG002|STARTED|Overall Study||1||
59928814|NCT03210961|76046951|FG003|STARTED|Overall Study||2||
59928815|NCT03210961|76046952|FG004|STARTED|Overall Study||6||
59928816|NCT03210961|76046953|FG005|STARTED|Overall Study||6||
59928817|NCT03210961|76046954|FG006|STARTED|Overall Study||8||
59928818|NCT03210961|76046955|FG007|STARTED|Overall Study||7||
59928819|NCT03210961|76046956|FG008|STARTED|Overall Study||8||
59928820|NCT03210961|76046957|FG009|STARTED|Overall Study||6||
59928821|NCT03210961|76046958|FG010|STARTED|Overall Study||7||
59928822|NCT03210961|76046959|FG011|STARTED|Overall Study||5||
59517080|NCT02913261|75610785|FG001|Completed Screening & Randomized|Overall Study||155||
59517081|NCT02913261|75610784|FG000|Completed Screening & Not Randomized|Overall Study||0||
59517082|NCT02913261|75610785|FG001|Completed Screening & Not Randomized|Overall Study||1||
59761116|NCT00880620|75880781|FG001|Week 16|Overall Study||73||
59928823|NCT03210961|76046960|FG012|STARTED|Overall Study||14||
59928824|NCT03210961|76046961|FG013|STARTED|Overall Study||15||
59928825|NCT03210961|76046962|FG014|STARTED|Overall Study||11||
59517083|NCT02913261|75610784|FG000|COMPLETED|Overall Study||35|Completed = Completed the treatment period Not Completed = Discontinued from treatment period|
59761117|NCT00880620|75880782|FG002|Week 16|Overall Study||87||
59761118|NCT00880620|75880783|FG003|Week 16|Overall Study||74||
59761119|NCT00880620|75880780|FG000|Week 23|Overall Study||71||
59928826|NCT03210961|76046948|FG000|COMPLETED|Overall Study||4||
59928827|NCT03210961|76046949|FG001|COMPLETED|Overall Study||9||
59928828|NCT03210961|76046950|FG002|COMPLETED|Overall Study||1||
59928829|NCT03210961|76046951|FG003|COMPLETED|Overall Study||1||
59928830|NCT03210961|76046952|FG004|COMPLETED|Overall Study||6||
59928831|NCT03210961|76046953|FG005|COMPLETED|Overall Study||6||
59928832|NCT03210961|76046954|FG006|COMPLETED|Overall Study||7||
59928833|NCT03210961|76046955|FG007|COMPLETED|Overall Study||7||
59928834|NCT03210961|76046956|FG008|COMPLETED|Overall Study||8||
59928835|NCT03210961|76046957|FG009|COMPLETED|Overall Study||6||
59928836|NCT03210961|76046958|FG010|COMPLETED|Overall Study||6||
59928837|NCT03210961|76046959|FG011|COMPLETED|Overall Study||5||
59928838|NCT03210961|76046960|FG012|COMPLETED|Overall Study||12||
59928839|NCT03210961|76046961|FG013|COMPLETED|Overall Study||11||
59928840|NCT03210961|76046962|FG014|COMPLETED|Overall Study||9||
59928841|NCT03210961|76046948|FG000|NOT COMPLETED|Overall Study||0||
59928842|NCT03210961|76046949|FG001|NOT COMPLETED|Overall Study||0||
59928843|NCT03210961|76046950|FG002|NOT COMPLETED|Overall Study||0||
59928844|NCT03210961|76046951|FG003|NOT COMPLETED|Overall Study||1||
59928845|NCT03210961|76046952|FG004|NOT COMPLETED|Overall Study||0||
59928846|NCT03210961|76046953|FG005|NOT COMPLETED|Overall Study||0||
59928847|NCT03210961|76046954|FG006|NOT COMPLETED|Overall Study||1||
59761120|NCT00880620|75880781|FG001|Week 23|Overall Study||72||
59928848|NCT03210961|76046955|FG007|NOT COMPLETED|Overall Study||0||
59928849|NCT03210961|76046956|FG008|NOT COMPLETED|Overall Study||0||
59928850|NCT03210961|76046957|FG009|NOT COMPLETED|Overall Study||0||
59928851|NCT03210961|76046958|FG010|NOT COMPLETED|Overall Study||1||
59928852|NCT03210961|76046959|FG011|NOT COMPLETED|Overall Study||0||
59928853|NCT03210961|76046960|FG012|NOT COMPLETED|Overall Study||2||
59761121|NCT00880620|75880782|FG002|Week 23|Overall Study||85||
59761122|NCT00880620|75880783|FG003|Week 23|Overall Study||74||
59761123|NCT00880620|75880780|FG000|COMPLETED|Overall Study||71|Week 30|
59761124|NCT00880620|75880781|FG001|COMPLETED|Overall Study||72|Week 30|
59761125|NCT00880620|75880782|FG002|COMPLETED|Overall Study||83|Week 30|
59761126|NCT00880620|75880783|FG003|COMPLETED|Overall Study||74|Week 30|
59761127|NCT00880620|75880780|FG000|NOT COMPLETED|Overall Study||21||
59761128|NCT00880620|75880781|FG001|NOT COMPLETED|Overall Study||15||
59761129|NCT00880620|75880782|FG002|NOT COMPLETED|Overall Study||21||
59761130|NCT00880620|75880783|FG003|NOT COMPLETED|Overall Study||24||
59761131|NCT03967847|75880799|FG000|STARTED|Overall Study||21||
59761132|NCT03967847|75880800|FG001|STARTED|Overall Study||23||
59761133|NCT03967847|75880799|FG000|COMPLETED|Overall Study||21||
59761134|NCT03967847|75880800|FG001|COMPLETED|Overall Study||23||
59761135|NCT03967847|75880799|FG000|NOT COMPLETED|Overall Study||0||
59761136|NCT03967847|75880800|FG001|NOT COMPLETED|Overall Study||0||
59761137|NCT00881868|75880809|FG000|STARTED|Overall Study||41||
59761138|NCT00881868|75880810|FG001|STARTED|Overall Study||40||
59761139|NCT00881868|75880809|FG000|COMPLETED|Overall Study||33||
59761140|NCT00881868|75880810|FG001|COMPLETED|Overall Study||38||
59761141|NCT00881868|75880809|FG000|NOT COMPLETED|Overall Study||8||
59761142|NCT00881868|75880810|FG001|NOT COMPLETED|Overall Study||2||
59761143|NCT00881712|75880819|FG000|STARTED|Overall Study||15||
60062333|NCT02070965|76177657|FG000|STARTED|Overall Study||27||
60062334|NCT02070965|76177658|FG001|STARTED|Overall Study||23||
59761144|NCT00881712|75880820|FG001|STARTED|Overall Study|This arm was non-randomized and no enrolled patients fit the inclusion criteria for this group.|0||
59761145|NCT00881712|75880821|FG002|STARTED|Overall Study|This arm was non-randomized and no enrolled patients fit the inclusion criteria for this group.|0||
60062335|NCT02070965|76177659|FG002|STARTED|Overall Study||25||
60062336|NCT02070965|76177657|FG000|COMPLETED|Overall Study||25||
60062337|NCT02070965|76177658|FG001|COMPLETED|Overall Study||21||
60062338|NCT02070965|76177659|FG002|COMPLETED|Overall Study||24||
60062339|NCT02070965|76177657|FG000|NOT COMPLETED|Overall Study||2||
60062340|NCT02070965|76177658|FG001|NOT COMPLETED|Overall Study||2||
60062341|NCT02070965|76177659|FG002|NOT COMPLETED|Overall Study||1||
60062342|NCT02109107|76177667|FG000|STARTED|Overall Study||54||
60062343|NCT02109107|76177667|FG000|COMPLETED|Overall Study||52||
60062344|NCT02109107|76177667|FG000|NOT COMPLETED|Overall Study||2||
59761146|NCT00881712|75880819|FG000|COMPLETED|Overall Study||13||
59761147|NCT00881712|75880820|FG001|COMPLETED|Overall Study||0||
59928854|NCT03210961|76046961|FG013|NOT COMPLETED|Overall Study||4||
59928855|NCT03210961|76046962|FG014|NOT COMPLETED|Overall Study||2||
59928856|NCT03242759|76047015|FG000|STARTED|Overall Study||88||
59928857|NCT03242759|76047016|FG001|STARTED|Overall Study||13||
59928858|NCT03242759|76047015|FG000|COMPLETED|Overall Study||53||
59928859|NCT03242759|76047016|FG001|COMPLETED|Overall Study||6||
59928860|NCT03242759|76047015|FG000|NOT COMPLETED|Overall Study||35||
59928861|NCT03242759|76047016|FG001|NOT COMPLETED|Overall Study||7||
59928862|NCT03097029|76047022|FG000|STARTED|Overall Study||15||
60062345|NCT02100839|76177673|FG000|STARTED|Single Ascending Dose||24||
60062346|NCT02100839|76177674|FG001|STARTED|Single Ascending Dose||12||
60062347|NCT02100839|76177673|FG000|COMPLETED|Single Ascending Dose||24||
60062348|NCT02100839|76177674|FG001|COMPLETED|Single Ascending Dose||12||
60062349|NCT02100839|76177673|FG000|NOT COMPLETED|Single Ascending Dose||0||
60062350|NCT02100839|76177674|FG001|NOT COMPLETED|Single Ascending Dose||0||
60062351|NCT02100839|76177673|FG000|STARTED|Multiple Ascending Dose||13||
60062352|NCT02100839|76177674|FG001|STARTED|Multiple Ascending Dose||3||
60062353|NCT02100839|76177673|FG000|COMPLETED|Multiple Ascending Dose||9||
60062354|NCT02100839|76177674|FG001|COMPLETED|Multiple Ascending Dose||3||
60062355|NCT02100839|76177673|FG000|NOT COMPLETED|Multiple Ascending Dose||4||
60062356|NCT02100839|76177674|FG001|NOT COMPLETED|Multiple Ascending Dose||0||
59928863|NCT03097029|76047022|FG000|COMPLETED|Overall Study||14||
59928864|NCT03097029|76047022|FG000|NOT COMPLETED|Overall Study||1||
59928865|NCT03257813|76047028|FG000|STARTED|Overall Study||30||
59928866|NCT03257813|76047029|FG001|STARTED|Overall Study||30||
59928867|NCT03257813|76047028|FG000|COMPLETED|Overall Study||24||
59928868|NCT03257813|76047029|FG001|COMPLETED|Overall Study||27||
59928869|NCT03257813|76047028|FG000|NOT COMPLETED|Overall Study||6||
59928870|NCT03257813|76047029|FG001|NOT COMPLETED|Overall Study||3||
59928871|NCT03210259|76047040|FG000|STARTED|12-Week Run-in Period||21|Enrolled|
59928872|NCT03210259|76047041|FG001|STARTED|12-Week Run-in Period||118|Enrolled|
59928873|NCT03210259|76047042|FG002|STARTED|12-Week Run-in Period||120|Enrolled|
59928874|NCT03210259|76047040|FG000|COMPLETED|12-Week Run-in Period||0|Completed the run-in period|
59928875|NCT03210259|76047041|FG001|COMPLETED|12-Week Run-in Period||118|Completed the run-in period|
59928876|NCT03210259|76047042|FG002|COMPLETED|12-Week Run-in Period||120|Completed the run-in period|
59928877|NCT03210259|76047040|FG000|NOT COMPLETED|12-Week Run-in Period||21||
59928878|NCT03210259|76047041|FG001|NOT COMPLETED|12-Week Run-in Period||0||
59928879|NCT03210259|76047042|FG002|NOT COMPLETED|12-Week Run-in Period||0||
59928880|NCT03210259|76047040|FG000|STARTED|48-Week Randomized Responder Period||0|Randomization|
59928881|NCT03210259|76047041|FG001|STARTED|48-Week Randomized Responder Period||118|Randomization|
59928882|NCT03210259|76047042|FG002|STARTED|48-Week Randomized Responder Period||120|Randomization|
59928883|NCT03210259|76047040|FG000|COMPLETED|48-Week Randomized Responder Period||0|Completed the trial|
59928884|NCT03210259|76047041|FG001|COMPLETED|48-Week Randomized Responder Period||107|Completed the trial|
59928885|NCT03210259|76047042|FG002|COMPLETED|48-Week Randomized Responder Period||91|Completed the trial|
59928886|NCT03210259|76047040|FG000|NOT COMPLETED|48-Week Randomized Responder Period||0||
59928887|NCT03210259|76047041|FG001|NOT COMPLETED|48-Week Randomized Responder Period||11||
59928888|NCT03210259|76047042|FG002|NOT COMPLETED|48-Week Randomized Responder Period||29||
59928889|NCT03257657|76047051|FG000|STARTED|Overall Study||22||
59928890|NCT03257657|76047052|FG001|STARTED|Overall Study||20||
59928891|NCT03257657|76047051|FG000|COMPLETED|Overall Study||22||
59928892|NCT03257657|76047052|FG001|COMPLETED|Overall Study||15||
59928893|NCT03257657|76047051|FG000|NOT COMPLETED|Overall Study||0||
59928894|NCT03257657|76047052|FG001|NOT COMPLETED|Overall Study||5||
59928895|NCT02496611|76047061|FG000|STARTED|Overall Study||33||
59928896|NCT02496611|76047062|FG001|STARTED|Overall Study||33||
59928897|NCT02496611|76047061|FG000|COMPLETED|Overall Study||26||
59928898|NCT02496611|76047062|FG001|COMPLETED|Overall Study||30||
59928899|NCT02496611|76047061|FG000|NOT COMPLETED|Overall Study||7||
59928900|NCT02496611|76047062|FG001|NOT COMPLETED|Overall Study||3||
59928901|NCT03237481|76047072|FG000|STARTED|Overall Study||164||
60062357|NCT02069093|76177680|FG000|STARTED|Overall Study||86||
60062358|NCT02069093|76177680|FG000|Pharmacokinetic Analysis Set|Overall Study||50||
60062359|NCT02069093|76177680|FG000|COMPLETED|Overall Study||56||
60062360|NCT02069093|76177680|FG000|NOT COMPLETED|Overall Study||30||
60062361|NCT02109029|76177687|FG000|STARTED|Part A||2||
60062362|NCT02109029|76177688|FG001|STARTED|Part A||2||
60062363|NCT02109029|76177689|FG002|STARTED|Part A||4||
59928902|NCT03237481|76047073|FG001|STARTED|Overall Study||172||
59928903|NCT03237481|76047074|FG002|STARTED|Overall Study||82||
59928904|NCT03237481|76047072|FG000|COMPLETED|Overall Study||159||
59928905|NCT03237481|76047073|FG001|COMPLETED|Overall Study||170||
59928906|NCT03237481|76047074|FG002|COMPLETED|Overall Study||81||
59928907|NCT03237481|76047072|FG000|NOT COMPLETED|Overall Study||5||
59928908|NCT03237481|76047073|FG001|NOT COMPLETED|Overall Study||2||
59928909|NCT03237481|76047074|FG002|NOT COMPLETED|Overall Study||1||
59928910|NCT03222349|76047082|FG000|STARTED|Overall Study||11||
59928911|NCT03222349|76047083|FG001|STARTED|Overall Study||13||
59928912|NCT03222349|76047082|FG000|COMPLETED|Overall Study||3||
59928913|NCT03222349|76047083|FG001|COMPLETED|Overall Study||6||
59928914|NCT03222349|76047082|FG000|NOT COMPLETED|Overall Study||8||
59928915|NCT03222349|76047083|FG001|NOT COMPLETED|Overall Study||7||
59928916|NCT02927925|76047096|FG000|STARTED|Overall Study||32||
60062364|NCT02109029|76177690|FG003|STARTED|Part A||4||
60062365|NCT02109029|76177691|FG004|STARTED|Part A||0||
59517084|NCT02913261|75610785|FG001|COMPLETED|Overall Study||20|Completed = Completed the treatment period Not Completed = Discontinued from treatment period|
59517085|NCT02913261|75610784|FG000|NOT COMPLETED|Overall Study||119||
59517086|NCT02913261|75610785|FG001|NOT COMPLETED|Overall Study||135||
60062366|NCT02109029|76177692|FG005|STARTED|Part A||0||
60062367|NCT02109029|76177687|FG000|Received One Dose of Study Drug|Part A||2||
60062368|NCT02109029|76177688|FG001|Received One Dose of Study Drug|Part A||2||
60062369|NCT02109029|76177689|FG002|Received One Dose of Study Drug|Part A||4||
60062370|NCT02109029|76177690|FG003|Received One Dose of Study Drug|Part A||4||
60062371|NCT02109029|76177691|FG004|Received One Dose of Study Drug|Part A||0||
60062372|NCT02109029|76177692|FG005|Received One Dose of Study Drug|Part A||0||
60062373|NCT02109029|76177687|FG000|COMPLETED|Part A|Participants from Part A did not move on to Part B.|2||
60062374|NCT02109029|76177688|FG001|COMPLETED|Part A|Participants from Part A did not move on to Part B.|2||
60062375|NCT02109029|76177689|FG002|COMPLETED|Part A|Participants from Part A did not move on to Part B.|4||
60062376|NCT02109029|76177690|FG003|COMPLETED|Part A|Participants from Part A did not move on to Part B.|4||
60062377|NCT02109029|76177691|FG004|COMPLETED|Part A||0||
60062378|NCT02109029|76177692|FG005|COMPLETED|Part A||0||
60062379|NCT02109029|76177687|FG000|NOT COMPLETED|Part A||0||
60062380|NCT02109029|76177688|FG001|NOT COMPLETED|Part A||0||
60062381|NCT02109029|76177689|FG002|NOT COMPLETED|Part A||0||
60062382|NCT02109029|76177690|FG003|NOT COMPLETED|Part A||0||
60062383|NCT02109029|76177691|FG004|NOT COMPLETED|Part A||0||
60062384|NCT02109029|76177692|FG005|NOT COMPLETED|Part A||0||
60062385|NCT02109029|76177687|FG000|STARTED|Part B||0||
60062386|NCT02109029|76177688|FG001|STARTED|Part B||0||
60062387|NCT02109029|76177689|FG002|STARTED|Part B||0||
60062388|NCT02109029|76177690|FG003|STARTED|Part B||0||
60062389|NCT02109029|76177691|FG004|STARTED|Part B|New participants entered Part B.|6||
60062390|NCT02109029|76177692|FG005|STARTED|Part B|New participants entered Part B.|6||
60062391|NCT02109029|76177687|FG000|Received at Least One Dose of Study Drug|Part B||0||
59517087|NCT02169115|75610796|FG000|STARTED|Overall Study||19||
59517088|NCT02169115|75610797|FG001|STARTED|Overall Study||21||
59517089|NCT02169115|75610798|FG002|STARTED|Overall Study||21||
59517090|NCT02169115|75610796|FG000|COMPLETED|Overall Study||19||
59517091|NCT02169115|75610797|FG001|COMPLETED|Overall Study||21||
59517092|NCT02169115|75610798|FG002|COMPLETED|Overall Study||21||
60062392|NCT02109029|76177688|FG001|Received at Least One Dose of Study Drug|Part B||0||
60062393|NCT02109029|76177689|FG002|Received at Least One Dose of Study Drug|Part B||0||
60062394|NCT02109029|76177690|FG003|Received at Least One Dose of Study Drug|Part B||0||
60062395|NCT02109029|76177691|FG004|Received at Least One Dose of Study Drug|Part B||6||
60062396|NCT02109029|76177692|FG005|Received at Least One Dose of Study Drug|Part B||6||
60062397|NCT02109029|76177687|FG000|COMPLETED|Part B||0||
60062398|NCT02109029|76177688|FG001|COMPLETED|Part B||0||
60062399|NCT02109029|76177689|FG002|COMPLETED|Part B||0||
60062400|NCT02109029|76177690|FG003|COMPLETED|Part B||0||
60062401|NCT02109029|76177691|FG004|COMPLETED|Part B||5||
60062402|NCT02109029|76177692|FG005|COMPLETED|Part B||5||
60062403|NCT02109029|76177687|FG000|NOT COMPLETED|Part B||0||
60062404|NCT02109029|76177688|FG001|NOT COMPLETED|Part B||0||
60062405|NCT02109029|76177689|FG002|NOT COMPLETED|Part B||0||
60062406|NCT02109029|76177690|FG003|NOT COMPLETED|Part B||0||
60062407|NCT02109029|76177691|FG004|NOT COMPLETED|Part B||1||
60062408|NCT02109029|76177692|FG005|NOT COMPLETED|Part B||1||
60062409|NCT02069015|76177705|FG000|STARTED|Overall Study|Baseline and enrollment at Emergency Department (ED)|71||
60062410|NCT02069015|76177706|FG001|STARTED|Overall Study||68||
60062411|NCT02069015|76177705|FG000|7 Day|Overall Study|7 day post ED discharge at Clinical Research Center (CRC)|44||
60062412|NCT02069015|76177706|FG001|7 Day|Overall Study|7 day post ED discharge at CRC|45||
60062413|NCT02069015|76177705|FG000|30 Day|Overall Study|30 day post-discharge at CRC|38||
60062414|NCT02069015|76177706|FG001|30 Day|Overall Study|30 day post-discharge at CRC|43||
59517093|NCT02169115|75610796|FG000|NOT COMPLETED|Overall Study||0||
59517094|NCT02169115|75610797|FG001|NOT COMPLETED|Overall Study||0||
59517095|NCT02169115|75610798|FG002|NOT COMPLETED|Overall Study||0||
60062415|NCT02069015|76177705|FG000|90 Day|Overall Study|90 day post ED discharge at CRC|32||
60062416|NCT02069015|76177706|FG001|90 Day|Overall Study|90 day post ED discharge|35||
60062417|NCT02069015|76177705|FG000|COMPLETED|Overall Study|180 post ED discharge at CRC|31|Follow-up: 180 day post ED discharge|
60062418|NCT02069015|76177706|FG001|COMPLETED|Overall Study|180 day post ED discharge at CRC|35|Follow-up: 180 day post ED discharge|
60062419|NCT02069015|76177705|FG000|NOT COMPLETED|Overall Study||40||
60062420|NCT02069015|76177706|FG001|NOT COMPLETED|Overall Study||33||
60062421|NCT01598129|76177713|FG000|STARTED|Overall Study||12||
60062422|NCT01598129|76177713|FG000|COMPLETED|Overall Study||3||
60062423|NCT01598129|76177713|FG000|NOT COMPLETED|Overall Study||9||
60062424|NCT02068547|76177720|FG000|STARTED|Overall Study||4||
60062425|NCT02068547|76177721|FG001|STARTED|Overall Study||4||
59928917|NCT02927925|76047096|FG000|COMPLETED|Overall Study||0||
59928918|NCT02927925|76047096|FG000|NOT COMPLETED|Overall Study||32||
59928919|NCT03208933|76047100|FG000|STARTED|Overall Study||60||
60062426|NCT02068547|76177720|FG000|COMPLETED|Overall Study||0||
60062427|NCT02068547|76177721|FG001|COMPLETED|Overall Study||1||
60062428|NCT02068547|76177720|FG000|NOT COMPLETED|Overall Study||4||
60062429|NCT02068547|76177721|FG001|NOT COMPLETED|Overall Study||3||
60062430|NCT02108951|76177727|FG000|STARTED|Overall Study|Indicates patients in enrolled, full analysis and safety set|20||
60062431|NCT02108951|76177727|FG000|COMPLETED|Overall Study||4||
60062432|NCT02108951|76177727|FG000|NOT COMPLETED|Overall Study||16||
59517096|NCT03219892|75610809|FG000|STARTED|Overall Study||20||
59928920|NCT03208933|76047100|FG000|COMPLETED|Overall Study||47||
59928921|NCT03208933|76047100|FG000|NOT COMPLETED|Overall Study||13||
59928922|NCT03207763|76047106|FG000|STARTED|Overall Study||8||
59517097|NCT03219892|75610810|FG001|STARTED|Overall Study||10||
59517098|NCT03219892|75610809|FG000|COMPLETED|Overall Study||20||
59928923|NCT03207763|76047107|FG001|STARTED|Overall Study||25||
59928924|NCT03207763|76047106|FG000|Eligible and Opted for Patches 2 and 3|Overall Study||5||
59928925|NCT03207763|76047107|FG001|Eligible and Opted for Patches 2 and 3|Overall Study||23||
59928926|NCT03207763|76047106|FG000|Completed Patches 2 and 3 Study|Overall Study||5||
59928927|NCT03207763|76047107|FG001|Completed Patches 2 and 3 Study|Overall Study||23||
59928928|NCT03207763|76047106|FG000|COMPLETED|Overall Study||7|Completed follow up for the main study of application of Patch 1|
59928929|NCT03207763|76047107|FG001|COMPLETED|Overall Study||25|Completed follow up for the main study of application of Patch 1|
59928930|NCT03207763|76047106|FG000|NOT COMPLETED|Overall Study||1||
59928931|NCT03207763|76047107|FG001|NOT COMPLETED|Overall Study||0||
60062433|NCT02107859|76177731|FG000|STARTED|Overall Study||61||
60062434|NCT02107859|76177731|FG000|As-treated Population|Overall Study||61|Received at .least 1 dose of study drug|
60062435|NCT02107859|76177731|FG000|Intent-to-treat (ITT) Population|Overall Study||60|All participants who had at least 1 post-baseline efficacy assessment.|
60062436|NCT02107859|76177731|FG000|COMPLETED|Overall Study||0||
60062437|NCT02107859|76177731|FG000|NOT COMPLETED|Overall Study||61||
60062438|NCT02007278|76177737|FG000|STARTED|Overall Study||20||
60062439|NCT02007278|76177738|FG001|STARTED|Overall Study||20||
60062440|NCT02007278|76177737|FG000|COMPLETED|Overall Study||18||
60062441|NCT02007278|76177738|FG001|COMPLETED|Overall Study||17||
60062442|NCT02007278|76177737|FG000|NOT COMPLETED|Overall Study||2||
60062443|NCT02007278|76177738|FG001|NOT COMPLETED|Overall Study||3||
60062444|NCT02107313|76177744|FG000|STARTED|Overall Study||9||
60062445|NCT02107313|76177745|FG001|STARTED|Overall Study|One participant from the study did not cross over and participate in the FED cohort|9||
60062446|NCT02107313|76177744|FG000|COMPLETED|Overall Study||9||
60062447|NCT02107313|76177745|FG001|COMPLETED|Overall Study||8||
60062448|NCT02107313|76177744|FG000|NOT COMPLETED|Overall Study||0||
60062449|NCT02107313|76177745|FG001|NOT COMPLETED|Overall Study||1||
60062450|NCT02028338|76177753|FG000|STARTED|Overall Study||73||
60062451|NCT02028338|76177754|FG001|STARTED|Overall Study||23||
59517099|NCT03219892|75610810|FG001|COMPLETED|Overall Study||10||
59928932|NCT04766034|76047126|FG000|STARTED|Aim 2 - Pre-Randomization Survey||0||
59928933|NCT04766034|76047127|FG001|STARTED|Aim 2 - Pre-Randomization Survey||0||
59928934|NCT04766034|76047128|FG002|STARTED|Aim 2 - Pre-Randomization Survey||0||
59928935|NCT04766034|76047129|FG003|STARTED|Aim 2 - Pre-Randomization Survey||0||
59928936|NCT04766034|76047130|FG004|STARTED|Aim 2 - Pre-Randomization Survey||7710||
59928937|NCT04766034|76047126|FG000|COMPLETED|Aim 2 - Pre-Randomization Survey||0||
60062452|NCT02028338|76177753|FG000|COMPLETED|Overall Study||69||
60062453|NCT02028338|76177754|FG001|COMPLETED|Overall Study||22||
59517100|NCT03219892|75610809|FG000|NOT COMPLETED|Overall Study||0||
60062454|NCT02028338|76177753|FG000|NOT COMPLETED|Overall Study||4||
60062455|NCT02028338|76177754|FG001|NOT COMPLETED|Overall Study||1||
60062456|NCT01625897|76177762|FG000|STARTED|Overall Study||83||
60062457|NCT01625897|76177763|FG001|STARTED|Overall Study||42||
60062458|NCT01625897|76177762|FG000|COMPLETED|Overall Study||31||
60062459|NCT01625897|76177763|FG001|COMPLETED|Overall Study||28||
60062460|NCT01625897|76177762|FG000|NOT COMPLETED|Overall Study||52||
60062461|NCT01625897|76177763|FG001|NOT COMPLETED|Overall Study||14||
60062462|NCT02106923|76177772|FG000|STARTED|Overall Study||12||
60062463|NCT02106923|76177773|FG001|STARTED|Overall Study||12||
60062464|NCT02106923|76177774|FG002|STARTED|Overall Study||12||
60062465|NCT02106923|76177775|FG003|STARTED|Overall Study||12||
60062466|NCT02106923|76177776|FG004|STARTED|Overall Study||12||
60062467|NCT02106923|76177777|FG005|STARTED|Overall Study||12||
60062468|NCT02106923|76177772|FG000|COMPLETED|Overall Study||12||
59928938|NCT04766034|76047127|FG001|COMPLETED|Aim 2 - Pre-Randomization Survey||0||
59928939|NCT04766034|76047128|FG002|COMPLETED|Aim 2 - Pre-Randomization Survey||0||
60062469|NCT02106923|76177773|FG001|COMPLETED|Overall Study||12||
60062470|NCT02106923|76177774|FG002|COMPLETED|Overall Study||12||
60062471|NCT02106923|76177775|FG003|COMPLETED|Overall Study||12||
60062472|NCT02106923|76177776|FG004|COMPLETED|Overall Study||12||
60062473|NCT02106923|76177777|FG005|COMPLETED|Overall Study||11||
60062474|NCT02106923|76177772|FG000|NOT COMPLETED|Overall Study||0||
60062475|NCT02106923|76177773|FG001|NOT COMPLETED|Overall Study||0||
60062476|NCT02106923|76177774|FG002|NOT COMPLETED|Overall Study||0||
59517101|NCT03219892|75610810|FG001|NOT COMPLETED|Overall Study||0||
59517102|NCT03656107|75610818|FG000|STARTED|Overall Study||28||
59517103|NCT03656107|75610819|FG001|STARTED|Overall Study||28||
59517104|NCT03656107|75610818|FG000|COMPLETED|Overall Study||25||
59517105|NCT03656107|75610819|FG001|COMPLETED|Overall Study||27||
59517106|NCT03656107|75610818|FG000|NOT COMPLETED|Overall Study||3||
59928940|NCT04766034|76047129|FG003|COMPLETED|Aim 2 - Pre-Randomization Survey||0||
59928941|NCT04766034|76047130|FG004|COMPLETED|Aim 2 - Pre-Randomization Survey||3838||
59928942|NCT04766034|76047126|FG000|NOT COMPLETED|Aim 2 - Pre-Randomization Survey||0||
59928943|NCT04766034|76047127|FG001|NOT COMPLETED|Aim 2 - Pre-Randomization Survey||0||
59928944|NCT04766034|76047128|FG002|NOT COMPLETED|Aim 2 - Pre-Randomization Survey||0||
59928945|NCT04766034|76047129|FG003|NOT COMPLETED|Aim 2 - Pre-Randomization Survey||0||
59928946|NCT04766034|76047130|FG004|NOT COMPLETED|Aim 2 - Pre-Randomization Survey||3872||
59928947|NCT04766034|76047126|FG000|STARTED|Aim 3 - Randomization/Online Shopping||922||
59928948|NCT04766034|76047127|FG001|STARTED|Aim 3 - Randomization/Online Shopping||991||
59928949|NCT04766034|76047128|FG002|STARTED|Aim 3 - Randomization/Online Shopping||957||
59928950|NCT04766034|76047129|FG003|STARTED|Aim 3 - Randomization/Online Shopping||968||
59928951|NCT04766034|76047130|FG004|STARTED|Aim 3 - Randomization/Online Shopping||0||
59928952|NCT04766034|76047126|FG000|COMPLETED|Aim 3 - Randomization/Online Shopping||649||
59928953|NCT04766034|76047127|FG001|COMPLETED|Aim 3 - Randomization/Online Shopping||682||
59928954|NCT04766034|76047128|FG002|COMPLETED|Aim 3 - Randomization/Online Shopping||727||
59928955|NCT04766034|76047129|FG003|COMPLETED|Aim 3 - Randomization/Online Shopping||686||
59928956|NCT04766034|76047130|FG004|COMPLETED|Aim 3 - Randomization/Online Shopping||0||
59928957|NCT04766034|76047126|FG000|NOT COMPLETED|Aim 3 - Randomization/Online Shopping||273||
59928958|NCT04766034|76047127|FG001|NOT COMPLETED|Aim 3 - Randomization/Online Shopping||309||
59928959|NCT04766034|76047128|FG002|NOT COMPLETED|Aim 3 - Randomization/Online Shopping||230||
59928960|NCT04766034|76047129|FG003|NOT COMPLETED|Aim 3 - Randomization/Online Shopping||282||
59928961|NCT04766034|76047130|FG004|NOT COMPLETED|Aim 3 - Randomization/Online Shopping||0||
59928962|NCT03237013|76047145|FG000|STARTED|Baseline to Immediate Post-treatment||73||
60062477|NCT02106923|76177775|FG003|NOT COMPLETED|Overall Study||0||
60062478|NCT02106923|76177776|FG004|NOT COMPLETED|Overall Study||0||
60062479|NCT02106923|76177777|FG005|NOT COMPLETED|Overall Study||1||
60062480|NCT02006732|76177795|FG000|STARTED|Overall Study||202||
60062481|NCT02006732|76177796|FG001|STARTED|Overall Study||203||
60062482|NCT02006732|76177797|FG002|STARTED|Overall Study||202||
60062483|NCT02006732|76177798|FG003|STARTED|Overall Study||202||
60062484|NCT02006732|76177795|FG000|COMPLETED|Overall Study||182||
60062485|NCT02006732|76177796|FG001|COMPLETED|Overall Study||191||
59517107|NCT03656107|75610819|FG001|NOT COMPLETED|Overall Study||1||
59517108|NCT03220048|75610828|FG000|STARTED|Overall Study||11||
59928963|NCT03237013|76047146|FG001|STARTED|Baseline to Immediate Post-treatment||73||
59928964|NCT03237013|76047147|FG002|STARTED|Baseline to Immediate Post-treatment||73||
59928965|NCT03237013|76047145|FG000|COMPLETED|Baseline to Immediate Post-treatment||73||
60062486|NCT02006732|76177797|FG002|COMPLETED|Overall Study||193||
60062487|NCT02006732|76177798|FG003|COMPLETED|Overall Study||198||
60062488|NCT02006732|76177795|FG000|NOT COMPLETED|Overall Study||20||
60062489|NCT02006732|76177796|FG001|NOT COMPLETED|Overall Study||12||
60062490|NCT02006732|76177797|FG002|NOT COMPLETED|Overall Study||9||
60062491|NCT02006732|76177798|FG003|NOT COMPLETED|Overall Study||4||
60062492|NCT02098733|76177808|FG000|STARTED|Overall Study||1168||
60062493|NCT02098733|76177808|FG000|COMPLETED|Overall Study||1158||
60062494|NCT02098733|76177808|FG000|NOT COMPLETED|Overall Study||10||
60062495|NCT02028182|76177812|FG000|STARTED|Overall Study||22||
60062496|NCT02028182|76177812|FG000|COMPLETED|Overall Study||20||
59517109|NCT03220048|75610829|FG001|STARTED|Overall Study||27||
59517110|NCT03220048|75610830|FG002|STARTED|Overall Study||28||
59517111|NCT03220048|75610828|FG000|COMPLETED|Overall Study||11||
59517112|NCT03220048|75610829|FG001|COMPLETED|Overall Study||25||
59928966|NCT03237013|76047146|FG001|COMPLETED|Baseline to Immediate Post-treatment||73||
59517113|NCT03220048|75610830|FG002|COMPLETED|Overall Study||27||
59517114|NCT03220048|75610828|FG000|NOT COMPLETED|Overall Study||0||
59517115|NCT03220048|75610829|FG001|NOT COMPLETED|Overall Study||2||
59928967|NCT03237013|76047147|FG002|COMPLETED|Baseline to Immediate Post-treatment||73||
59928968|NCT03237013|76047145|FG000|NOT COMPLETED|Baseline to Immediate Post-treatment||0||
59928969|NCT03237013|76047146|FG001|NOT COMPLETED|Baseline to Immediate Post-treatment||0||
59928970|NCT03237013|76047147|FG002|NOT COMPLETED|Baseline to Immediate Post-treatment||0||
59928971|NCT03237013|76047145|FG000|STARTED|Immediate Post-treatment to 1-mo F/u||73||
59928972|NCT03237013|76047146|FG001|STARTED|Immediate Post-treatment to 1-mo F/u||73||
59928973|NCT03237013|76047147|FG002|STARTED|Immediate Post-treatment to 1-mo F/u||73||
59928974|NCT03237013|76047145|FG000|COMPLETED|Immediate Post-treatment to 1-mo F/u||30|The number of participants who responded to the follow-up survey 1 month after intervention|
59928975|NCT03237013|76047146|FG001|COMPLETED|Immediate Post-treatment to 1-mo F/u||43|The number of participants who responded to the follow-up survey 1 month after intervention|
59928976|NCT03237013|76047147|FG002|COMPLETED|Immediate Post-treatment to 1-mo F/u||36|The number of participants who responded to the follow-up survey 1 month after intervention|
59928977|NCT03237013|76047145|FG000|NOT COMPLETED|Immediate Post-treatment to 1-mo F/u||43||
59928978|NCT03237013|76047146|FG001|NOT COMPLETED|Immediate Post-treatment to 1-mo F/u||30||
59928979|NCT03237013|76047147|FG002|NOT COMPLETED|Immediate Post-treatment to 1-mo F/u||37||
59928980|NCT03236779|76047157|FG000|STARTED|Overall Study||51||
59928981|NCT03236779|76047158|FG001|STARTED|Overall Study||51||
59928982|NCT03236779|76047157|FG000|COMPLETED|Overall Study||38||
59928983|NCT03236779|76047158|FG001|COMPLETED|Overall Study||30||
59928984|NCT03236779|76047157|FG000|NOT COMPLETED|Overall Study||13||
59928985|NCT03236779|76047158|FG001|NOT COMPLETED|Overall Study||21||
59928986|NCT03096483|76047166|FG000|STARTED|Overall Study||12||
59928987|NCT03096483|76047166|FG000|COMPLETED|Overall Study||11||
59928988|NCT03096483|76047166|FG000|NOT COMPLETED|Overall Study||1||
59928989|NCT02932579|76047172|FG000|STARTED|Overall Study||33||
59928990|NCT02932579|76047173|FG001|STARTED|Overall Study||26||
59928991|NCT02932579|76047172|FG000|COMPLETED|Overall Study||29||
59928992|NCT02932579|76047173|FG001|COMPLETED|Overall Study||25||
59928993|NCT02932579|76047172|FG000|NOT COMPLETED|Overall Study||4||
59928994|NCT02932579|76047173|FG001|NOT COMPLETED|Overall Study||1||
59928995|NCT03207451|76047183|FG000|STARTED|Overall Study||21||
59928996|NCT03207451|76047184|FG001|STARTED|Overall Study||8||
59928997|NCT03207451|76047185|FG002|STARTED|Overall Study||29||
59928998|NCT03207451|76047186|FG003|STARTED|Overall Study||23||
59928999|NCT03207451|76047183|FG000|COMPLETED|Overall Study|Scheduling conflict|20||
59929000|NCT03207451|76047184|FG001|COMPLETED|Overall Study||8||
59929001|NCT03207451|76047185|FG002|COMPLETED|Overall Study|Patients had scheduling issues|27||
59929002|NCT03207451|76047186|FG003|COMPLETED|Overall Study|Minor bleeding and scheduling conflicts|20||
59929003|NCT03207451|76047183|FG000|NOT COMPLETED|Overall Study||1||
59929004|NCT03207451|76047184|FG001|NOT COMPLETED|Overall Study||0||
59929005|NCT03207451|76047185|FG002|NOT COMPLETED|Overall Study||2||
59929006|NCT03207451|76047186|FG003|NOT COMPLETED|Overall Study||3||
59929007|NCT03704142|76047200|FG000|STARTED|Overall Study||10||
59929008|NCT03704142|76047201|FG001|STARTED|Overall Study||10||
59929009|NCT03704142|76047202|FG002|STARTED|Overall Study||10||
59929010|NCT03704142|76047203|FG003|STARTED|Overall Study||10||
59929011|NCT03704142|76047200|FG000|COMPLETED|Overall Study||10||
59929012|NCT03704142|76047201|FG001|COMPLETED|Overall Study||10||
59929013|NCT03704142|76047202|FG002|COMPLETED|Overall Study||10||
59929014|NCT03704142|76047203|FG003|COMPLETED|Overall Study||10||
59929015|NCT03704142|76047200|FG000|NOT COMPLETED|Overall Study||0||
59929016|NCT03704142|76047201|FG001|NOT COMPLETED|Overall Study||0||
59929017|NCT03704142|76047202|FG002|NOT COMPLETED|Overall Study||0||
59929018|NCT03704142|76047203|FG003|NOT COMPLETED|Overall Study||0||
59929019|NCT03350503|76047213|FG000|STARTED|Overall Study||121||121
59929020|NCT03350503|76047213|FG000|Successful Implantation|Overall Study||120||120
59929021|NCT03350503|76047213|FG000|Implanted With SN6AT3|Overall Study||61||61
59929022|NCT03350503|76047213|FG000|Implanted With SN6AT4|Overall Study||27||27
59929023|NCT03350503|76047213|FG000|Implanted With SN6AT5|Overall Study||33||33
59929024|NCT03350503|76047213|FG000|COMPLETED|Overall Study||104||104
59929025|NCT03350503|76047213|FG000|NOT COMPLETED|Overall Study||17||17
59929026|NCT03288779|76047236|FG000|STARTED|Overall Study||6||
59929027|NCT03288779|76047236|FG000|COMPLETED|Overall Study||3||
59929028|NCT03288779|76047236|FG000|NOT COMPLETED|Overall Study||3||
59929029|NCT03206749|76047243|FG000|STARTED|Overall Study||80||
59929030|NCT03206749|76047244|FG001|STARTED|Overall Study||81||
59929031|NCT03206749|76047245|FG002|STARTED|Overall Study||82||
59929032|NCT03206749|76047243|FG000|COMPLETED|Overall Study||75||
59929033|NCT03206749|76047244|FG001|COMPLETED|Overall Study||78||
59517116|NCT03220048|75610830|FG002|NOT COMPLETED|Overall Study||1||
59517117|NCT00635882|75610849|FG000|STARTED|Overall Study||20||
59517118|NCT00635882|75610850|FG001|STARTED|Overall Study||17||
59929034|NCT03206749|76047245|FG002|COMPLETED|Overall Study||75||
59929035|NCT03206749|76047243|FG000|NOT COMPLETED|Overall Study||5||
59517119|NCT00635882|75610851|FG002|STARTED|Overall Study||12||
59517120|NCT00635882|75610852|FG003|STARTED|Overall Study||15||
59517121|NCT00635882|75610853|FG004|STARTED|Overall Study||16||
59517122|NCT00635882|75610854|FG005|STARTED|Overall Study||13||
59517123|NCT00635882|75610849|FG000|COMPLETED|Overall Study||19||
59517124|NCT00635882|75610850|FG001|COMPLETED|Overall Study||17||
59517125|NCT00635882|75610851|FG002|COMPLETED|Overall Study||12||
59517126|NCT00635882|75610852|FG003|COMPLETED|Overall Study||15||
59517127|NCT00635882|75610853|FG004|COMPLETED|Overall Study||16||
59517128|NCT00635882|75610854|FG005|COMPLETED|Overall Study||13||
59517129|NCT00635882|75610849|FG000|NOT COMPLETED|Overall Study||1||
59517130|NCT00635882|75610850|FG001|NOT COMPLETED|Overall Study||0||
59517131|NCT00635882|75610851|FG002|NOT COMPLETED|Overall Study||0||
59517132|NCT00635882|75610852|FG003|NOT COMPLETED|Overall Study||0||
59517133|NCT00635882|75610853|FG004|NOT COMPLETED|Overall Study||0||
59517134|NCT00635882|75610854|FG005|NOT COMPLETED|Overall Study||0||
59517135|NCT03445156|75610873|FG000|STARTED|Pilot Study||20||
59517136|NCT03445156|75610874|FG001|STARTED|Pilot Study||20||
59517137|NCT03445156|75610875|FG002|STARTED|Pilot Study||0||
59517138|NCT03445156|75610873|FG000|COMPLETED|Pilot Study||20||
59517139|NCT03445156|75610874|FG001|COMPLETED|Pilot Study||20||
59517140|NCT03445156|75610875|FG002|COMPLETED|Pilot Study||0||
59517141|NCT03445156|75610873|FG000|NOT COMPLETED|Pilot Study||0||
59517142|NCT03445156|75610874|FG001|NOT COMPLETED|Pilot Study||0||
59517143|NCT03445156|75610875|FG002|NOT COMPLETED|Pilot Study||0||
59517144|NCT03445156|75610873|FG000|STARTED|Experiment Proper||113||
59517145|NCT03445156|75610874|FG001|STARTED|Experiment Proper||115||
59517146|NCT03445156|75610875|FG002|STARTED|Experiment Proper||59||
59517147|NCT03445156|75610873|FG000|COMPLETED|Experiment Proper||113||
59517148|NCT03445156|75610874|FG001|COMPLETED|Experiment Proper||115||
59517149|NCT03445156|75610875|FG002|COMPLETED|Experiment Proper||59||
59517150|NCT03445156|75610873|FG000|NOT COMPLETED|Experiment Proper||0||
59517151|NCT03445156|75610874|FG001|NOT COMPLETED|Experiment Proper||0||
59517152|NCT03445156|75610875|FG002|NOT COMPLETED|Experiment Proper||0||
59517153|NCT03316378|75610889|FG000|STARTED|Overall Study||23||
59517154|NCT03316378|75610890|FG001|STARTED|Overall Study||23||
59517155|NCT03316378|75610889|FG000|COMPLETED|Overall Study||23||
59517156|NCT03316378|75610890|FG001|COMPLETED|Overall Study||23||
59517157|NCT03316378|75610889|FG000|NOT COMPLETED|Overall Study||0||
59517158|NCT03316378|75610890|FG001|NOT COMPLETED|Overall Study||0||
59517159|NCT03220204|75610900|FG000|STARTED|Overall Study||15||
59517160|NCT03220204|75610901|FG001|STARTED|Overall Study||15||
59517161|NCT03220204|75610902|FG002|STARTED|Overall Study||15||
59517162|NCT03220204|75610900|FG000|COMPLETED|Overall Study||14||
59517163|NCT03220204|75610901|FG001|COMPLETED|Overall Study||13||
59517164|NCT03220204|75610902|FG002|COMPLETED|Overall Study||12||
59517165|NCT03220204|75610900|FG000|NOT COMPLETED|Overall Study||1||
59517166|NCT03220204|75610901|FG001|NOT COMPLETED|Overall Study||2||
59517167|NCT03220204|75610902|FG002|NOT COMPLETED|Overall Study||3||
59517168|NCT02165605|75610913|FG000|STARTED|Overall Study||28||
59517169|NCT02165605|75610913|FG000|COMPLETED|Overall Study||28||
59517170|NCT02165605|75610913|FG000|NOT COMPLETED|Overall Study||0||
59517171|NCT03445390|75610920|FG000|STARTED|First Intervention||14||
59517172|NCT03445390|75610921|FG001|STARTED|First Intervention||13||
59517173|NCT03445390|75610920|FG000|COMPLETED|First Intervention||12||
59517174|NCT03445390|75610921|FG001|COMPLETED|First Intervention||11||
59517175|NCT03445390|75610920|FG000|NOT COMPLETED|First Intervention||2||
59517176|NCT03445390|75610921|FG001|NOT COMPLETED|First Intervention||2||
59517177|NCT03445390|75610920|FG000|STARTED|Second Intervention||12||
59517178|NCT03445390|75610921|FG001|STARTED|Second Intervention||11||
59517179|NCT03445390|75610920|FG000|COMPLETED|Second Intervention||10||
59517180|NCT03445390|75610921|FG001|COMPLETED|Second Intervention||10||
59517181|NCT03445390|75610920|FG000|NOT COMPLETED|Second Intervention||2||
59517182|NCT03445390|75610921|FG001|NOT COMPLETED|Second Intervention||1||
59517183|NCT02165761|75610929|FG000|STARTED|Overall Study||23||
59517184|NCT02165761|75610930|FG001|STARTED|Overall Study||19||
59517185|NCT02165761|75610929|FG000|COMPLETED|Overall Study||4||
59517186|NCT02165761|75610930|FG001|COMPLETED|Overall Study||5||
59517187|NCT02165761|75610929|FG000|NOT COMPLETED|Overall Study||19||
59517188|NCT02165761|75610930|FG001|NOT COMPLETED|Overall Study||14||
59517189|NCT03221764|75610936|FG000|STARTED|Overall Study||20||
59517190|NCT03221764|75610936|FG000|COMPLETED|Overall Study||20||
59517191|NCT03221764|75610936|FG000|NOT COMPLETED|Overall Study||0||
59517192|NCT03317002|75610943|FG000|STARTED|Overall Study||52||
59517193|NCT03317002|75610944|FG001|STARTED|Overall Study||25||
59517194|NCT03317002|75610945|FG002|STARTED|Overall Study||52||
59517195|NCT03317002|75610943|FG000|COMPLETED|Overall Study||50||
59517196|NCT03317002|75610944|FG001|COMPLETED|Overall Study||24||
59517197|NCT03317002|75610945|FG002|COMPLETED|Overall Study||51||
59517198|NCT03317002|75610943|FG000|NOT COMPLETED|Overall Study||2||
59517199|NCT03317002|75610944|FG001|NOT COMPLETED|Overall Study||1||
59517200|NCT03317002|75610945|FG002|NOT COMPLETED|Overall Study||1||
59517201|NCT03223246|75610955|FG000|STARTED|48-72 Hours||83||
59517202|NCT03223246|75610956|FG001|STARTED|48-72 Hours||66||
59517203|NCT03223246|75610955|FG000|COMPLETED|48-72 Hours||62||
59929036|NCT03206749|76047244|FG001|NOT COMPLETED|Overall Study||3||
59929037|NCT03206749|76047245|FG002|NOT COMPLETED|Overall Study||7||
59929038|NCT04754646|76047254|FG000|STARTED|Overall Study||50||
60062497|NCT02028182|76177812|FG000|NOT COMPLETED|Overall Study||2||
60062498|NCT02098109|76177819|FG000|STARTED|Overall Study||49||
60062499|NCT02098109|76177820|FG001|STARTED|Overall Study||51||
60062500|NCT02098109|76177819|FG000|COMPLETED|Overall Study||46||
60062501|NCT02098109|76177820|FG001|COMPLETED|Overall Study||51||
60062502|NCT02098109|76177819|FG000|NOT COMPLETED|Overall Study||3||
60062503|NCT02098109|76177820|FG001|NOT COMPLETED|Overall Study||0||
60062504|NCT02097719|76177828|FG000|STARTED|Overall Study||49||
60062505|NCT02097719|76177829|FG001|STARTED|Overall Study||51||
60062506|NCT02097719|76177828|FG000|COMPLETED|Overall Study||46||
60062507|NCT02097719|76177829|FG001|COMPLETED|Overall Study||50||
60062508|NCT02097719|76177828|FG000|NOT COMPLETED|Overall Study||3||
60062509|NCT02097719|76177829|FG001|NOT COMPLETED|Overall Study||1||
60062510|NCT01449370|76177860|FG000|STARTED|Overall Study||6||
60062511|NCT01449370|76177861|FG001|STARTED|Overall Study||6||
60062512|NCT01449370|76177862|FG002|STARTED|Overall Study||8||
60062513|NCT01449370|76177863|FG003|STARTED|Overall Study||4||
60062514|NCT01449370|76177864|FG004|STARTED|Overall Study||3||
59929039|NCT04754646|76047254|FG000|COMPLETED|Overall Study||50||
59929040|NCT04754646|76047254|FG000|NOT COMPLETED|Overall Study||0||
59929041|NCT03255941|76047265|FG000|STARTED|Overall Study||177|The 460 randomized participants were equally randomized between lay health workers and clinical providers. These 460 were then assessed by the gold standard nurse and 92 participants were deemed to be not eligible or refused injection.|
60062515|NCT01449370|76177865|FG005|STARTED|Overall Study||3||
60062516|NCT01449370|76177866|FG006|STARTED|Overall Study||3||
60062517|NCT01449370|76177867|FG007|STARTED|Overall Study||3||
60062518|NCT01449370|76177868|FG008|STARTED|Overall Study||12||
60062519|NCT01449370|76177869|FG009|STARTED|Overall Study||3||
60062520|NCT01449370|76177870|FG010|STARTED|Overall Study||3||
60062521|NCT01449370|76177871|FG011|STARTED|Overall Study||3||
60062522|NCT01449370|76177872|FG012|STARTED|Overall Study||3||
60062523|NCT01449370|76177873|FG013|STARTED|Overall Study||11||
60062524|NCT01449370|76177874|FG014|STARTED|Overall Study||3||
60062525|NCT01449370|76177875|FG015|STARTED|Overall Study||3||
60062526|NCT01449370|76177876|FG016|STARTED|Overall Study||7||
60062527|NCT01449370|76177877|FG017|STARTED|Overall Study||3||
60062528|NCT01449370|76177878|FG018|STARTED|Overall Study||3||
60062529|NCT01449370|76177879|FG019|STARTED|Overall Study||3||
60062530|NCT01449370|76177880|FG020|STARTED|Overall Study||6||
60062531|NCT01449370|76177881|FG021|STARTED|Overall Study||4||
60062532|NCT01449370|76177882|FG022|STARTED|Overall Study||4||
60062533|NCT01449370|76177883|FG023|STARTED|Overall Study||10||
60062534|NCT01449370|76177884|FG024|STARTED|Overall Study||8||
60062535|NCT01449370|76177860|FG000|COMPLETED|Overall Study||0||
60062536|NCT01449370|76177861|FG001|COMPLETED|Overall Study||0||
59929042|NCT03255941|76047266|FG001|STARTED|Overall Study||178|The 460 randomized participants were equally randomized between lay health workers and clinical providers. These 460 were then assessed by the gold standard nurse and 92 participants were deemed to be not eligible or refused injection.|
59929043|NCT03255941|76047267|FG002|STARTED|Overall Study||53|The 460 randomized participants were equally randomized between lay health workers and clinical providers. These 460 were then assessed by the gold standard nurse and 92 participants were deemed to be not eligible or refused injection.|
59929044|NCT03255941|76047268|FG003|STARTED|Overall Study||52|The 460 randomized participants were equally randomized between lay health workers and clinical providers. These 460 were then assessed by the gold standard nurse and 92 participants were deemed to be not eligible or refused injection.|
59929045|NCT03255941|76047265|FG000|Deemed Eligible to Receive DMPA|Overall Study||140||
60062537|NCT01449370|76177862|FG002|COMPLETED|Overall Study||0||
60062538|NCT01449370|76177863|FG003|COMPLETED|Overall Study||0||
60062539|NCT01449370|76177864|FG004|COMPLETED|Overall Study||0||
59929046|NCT03255941|76047266|FG001|Deemed Eligible to Receive DMPA|Overall Study||134||
60062540|NCT01449370|76177865|FG005|COMPLETED|Overall Study||0||
60062541|NCT01449370|76177866|FG006|COMPLETED|Overall Study||0||
60062542|NCT01449370|76177867|FG007|COMPLETED|Overall Study||0||
60062543|NCT01449370|76177868|FG008|COMPLETED|Overall Study||0||
60062544|NCT01449370|76177869|FG009|COMPLETED|Overall Study||0||
60062545|NCT01449370|76177870|FG010|COMPLETED|Overall Study||0||
60062546|NCT01449370|76177871|FG011|COMPLETED|Overall Study||0||
60062547|NCT01449370|76177872|FG012|COMPLETED|Overall Study||0||
60062548|NCT01449370|76177873|FG013|COMPLETED|Overall Study||0||
60062549|NCT01449370|76177874|FG014|COMPLETED|Overall Study||0||
60062550|NCT01449370|76177875|FG015|COMPLETED|Overall Study||0||
59929047|NCT03255941|76047267|FG002|Deemed Eligible to Receive DMPA|Overall Study||48||
59929048|NCT03255941|76047268|FG003|Deemed Eligible to Receive DMPA|Overall Study||46||
59929049|NCT03255941|76047265|FG000|COMPLETED|Overall Study||139||
59929050|NCT03255941|76047266|FG001|COMPLETED|Overall Study||132||
59929051|NCT03255941|76047267|FG002|COMPLETED|Overall Study||48||
59929052|NCT03255941|76047268|FG003|COMPLETED|Overall Study||46||
59929053|NCT03255941|76047265|FG000|NOT COMPLETED|Overall Study||38||
59929054|NCT03255941|76047266|FG001|NOT COMPLETED|Overall Study||46||
59929055|NCT03255941|76047267|FG002|NOT COMPLETED|Overall Study||5||
59929056|NCT03255941|76047268|FG003|NOT COMPLETED|Overall Study||6||
59929057|NCT03255629|76047290|FG000|STARTED|Overall Study||8||
59929058|NCT03255629|76047291|FG001|STARTED|Overall Study||8||
59929059|NCT03255629|76047290|FG000|COMPLETED|Overall Study|"One participant developed intractable nausea and emesis after consuming the mixed meal, and was withdrawn.~Two participants were withdrawn due to not experiencing hypoglycemia during mixed meal testing."|5||
59929060|NCT03255629|76047291|FG001|COMPLETED|Overall Study|One participant was withdrawn due to not experiencing hypoglycemia during mixed meal testing.|7||
59929061|NCT03255629|76047290|FG000|NOT COMPLETED|Overall Study||3||
59929062|NCT03255629|76047291|FG001|NOT COMPLETED|Overall Study||1||
59929063|NCT03031938|76047300|FG000|STARTED|Overall Study||2||
59929064|NCT03031938|76047301|FG001|STARTED|Overall Study||2||
59929065|NCT03031938|76047300|FG000|COMPLETED|Overall Study||1||
59929066|NCT03031938|76047301|FG001|COMPLETED|Overall Study||2||
59929067|NCT03031938|76047300|FG000|NOT COMPLETED|Overall Study||1||
59929068|NCT03031938|76047301|FG001|NOT COMPLETED|Overall Study||0||
59929069|NCT01137773|76047309|FG000|STARTED|Overall Study||33||
59929070|NCT01137773|76047310|FG001|STARTED|Overall Study||23||
59929071|NCT01137773|76047309|FG000|COMPLETED|Overall Study||24||
59929072|NCT01137773|76047310|FG001|COMPLETED|Overall Study||20||
59929073|NCT01137773|76047309|FG000|NOT COMPLETED|Overall Study||9||
59929074|NCT01137773|76047310|FG001|NOT COMPLETED|Overall Study||3||
59929075|NCT03094611|76047318|FG000|STARTED|Overall Study||4||
59929076|NCT03094611|76047318|FG000|COMPLETED|Overall Study||2||
59929077|NCT03094611|76047318|FG000|NOT COMPLETED|Overall Study||2||
59929078|NCT01030575|76047326|FG000|STARTED|Overall Study||29|3 infants were randomized but did not receive treatment; 2 died and 1 was determined ineligible.|
59929079|NCT01030575|76047327|FG001|STARTED|Overall Study||30|3 infants were randomized but did not receive treatment; 2 died and 1 was determined ineligible.|
59929080|NCT01030575|76047328|FG002|STARTED|Overall Study||28|3 infants were randomized but did not receive treatment; 2 died and 1 was determined ineligible.|
59929081|NCT01030575|76047329|FG003|STARTED|Overall Study||35|3 infants were randomized but did not receive treatment; 2 died and 1 was determined ineligible.|
59929082|NCT01030575|76047326|FG000|COMPLETED|Overall Study|1 infant randomized to the placebo arm incorrectly received the low dose. The infant was included in the low dose arm for the pharmacokinetics analyses and as randomized to the placebo arm for all other analyzes.|29||
59929083|NCT01030575|76047327|FG001|COMPLETED|Overall Study||30||
59929084|NCT01030575|76047328|FG002|COMPLETED|Overall Study||28||
59929085|NCT01030575|76047329|FG003|COMPLETED|Overall Study|1 infant randomized to the placebo arm incorrectly received the low dose. The infant was included in the low dose arm for the pharmacokinetics analyses and as randomized to the placebo arm for all other analyzes.|35||
59929086|NCT01030575|76047326|FG000|NOT COMPLETED|Overall Study||0||
59929087|NCT01030575|76047327|FG001|NOT COMPLETED|Overall Study||0||
59929088|NCT01030575|76047328|FG002|NOT COMPLETED|Overall Study||0||
59929089|NCT01030575|76047329|FG003|NOT COMPLETED|Overall Study||0||
59929090|NCT04105725|76047342|FG000|STARTED|Primary Intervention||37||
59929091|NCT04105725|76047343|FG001|STARTED|Primary Intervention||29||
59929092|NCT04105725|76047342|FG000|COMPLETED|Primary Intervention||37||
59929093|NCT04105725|76047343|FG001|COMPLETED|Primary Intervention||26||
59929094|NCT04105725|76047342|FG000|NOT COMPLETED|Primary Intervention||0||
59929095|NCT04105725|76047343|FG001|NOT COMPLETED|Primary Intervention||3||
59929096|NCT04105725|76047342|FG000|STARTED|Mini-Session Week 1|Number based on number completed both sessions of the BMI+Substance-Free Activity Session.|37||
59929097|NCT04105725|76047343|FG001|STARTED|Mini-Session Week 1|Number based on number completed both sessions of the Alcohol + Nutrition Education Session.|26||
59929098|NCT04105725|76047342|FG000|COMPLETED|Mini-Session Week 1|Number of participants who completed both sessions of the BMI+Substance-Free Activity Session and Mini-Session Week 1|36||
59929099|NCT04105725|76047343|FG001|COMPLETED|Mini-Session Week 1|Number of participants who completed both sessions of the Alcohol + Nutrition Education and Mini-Session Week 1|25||
60062551|NCT01449370|76177876|FG016|COMPLETED|Overall Study||0||
59929100|NCT04105725|76047342|FG000|NOT COMPLETED|Mini-Session Week 1||1||
59929101|NCT04105725|76047343|FG001|NOT COMPLETED|Mini-Session Week 1||1||
59929102|NCT04105725|76047342|FG000|STARTED|Mini-Session Week 2|Number based on number completed both sessions of the BMI+Substance-Free Activity Session.|37||
59929103|NCT04105725|76047343|FG001|STARTED|Mini-Session Week 2|Number based on number completed both sessions of the Alcohol + Nutrition Education Session.|26||
59929104|NCT04105725|76047342|FG000|COMPLETED|Mini-Session Week 2|Number of participants who completed both sessions of the BMI+Substance-Free Activity Session and Mini-Session Week 2|34||
59929105|NCT04105725|76047343|FG001|COMPLETED|Mini-Session Week 2|Number of participants who completed both sessions of the Alcohol + Nutrition Education and Mini-Session Week 2|22||
59929106|NCT04105725|76047342|FG000|NOT COMPLETED|Mini-Session Week 2||3||
59929107|NCT04105725|76047343|FG001|NOT COMPLETED|Mini-Session Week 2||4||
60062552|NCT01449370|76177877|FG017|COMPLETED|Overall Study||0||
60062553|NCT01449370|76177878|FG018|COMPLETED|Overall Study||0||
60062554|NCT01449370|76177879|FG019|COMPLETED|Overall Study||0||
60062555|NCT01449370|76177880|FG020|COMPLETED|Overall Study||0||
60062556|NCT01449370|76177881|FG021|COMPLETED|Overall Study||0||
59929108|NCT04105725|76047342|FG000|STARTED|Mini-Session Week 3|Number based on number completed both sessions of the BMI+Substance-Free Activity Session.|37||
59929109|NCT04105725|76047343|FG001|STARTED|Mini-Session Week 3|Number based on number completed both sessions of the Alcohol + Nutrition Education Session.|26||
59929110|NCT04105725|76047342|FG000|COMPLETED|Mini-Session Week 3|Number of participants who completed both sessions of the BMI+Substance-Free Activity Session and Mini-Session Week 3|34||
59929111|NCT04105725|76047343|FG001|COMPLETED|Mini-Session Week 3|Number of participants who completed both sessions of the Alcohol + Nutrition Education and Mini-Session Week 3|22||
59929112|NCT04105725|76047342|FG000|NOT COMPLETED|Mini-Session Week 3||3||
59929113|NCT04105725|76047343|FG001|NOT COMPLETED|Mini-Session Week 3||4||
59929114|NCT04105725|76047342|FG000|STARTED|Mini-Session Week 4|Number based on number completed both sessions of the BMI+Substance-Free Activity Session.|37||
59929115|NCT04105725|76047343|FG001|STARTED|Mini-Session Week 4|Number based on number completed both sessions of the Alcohol + Nutrition Education Session.|26||
59929116|NCT04105725|76047342|FG000|COMPLETED|Mini-Session Week 4|Number of participants who completed both sessions of the BMI+Substance-Free Activity Session and Mini-Session Week 4|35||
59929117|NCT04105725|76047343|FG001|COMPLETED|Mini-Session Week 4|Number of participants who completed both sessions of the Alcohol + Nutrition Education and Mini-Session Week 4|21||
59929118|NCT04105725|76047342|FG000|NOT COMPLETED|Mini-Session Week 4||2||
59929119|NCT04105725|76047343|FG001|NOT COMPLETED|Mini-Session Week 4||5||
59929120|NCT04105725|76047342|FG000|STARTED|Post-Intervention Survey|Number based on number completed both sessions of the BMI+Substance-Free Activity Session.|37||
59929121|NCT04105725|76047343|FG001|STARTED|Post-Intervention Survey|Number based on number completed both sessions of the Alcohol + Nutrition Education Session.|26||
59929122|NCT04105725|76047342|FG000|COMPLETED|Post-Intervention Survey|Number of participants who completed both sessions of the BMI+Substance-Free Activity Session and the Post-Intervention Survey|33||
59929123|NCT04105725|76047343|FG001|COMPLETED|Post-Intervention Survey|Number of participants who completed both sessions of the Alcohol + Nutrition Education and the Post-Intervention Survey|18||
59929124|NCT04105725|76047342|FG000|NOT COMPLETED|Post-Intervention Survey||4||
59929125|NCT04105725|76047343|FG001|NOT COMPLETED|Post-Intervention Survey||8||
59929126|NCT04105725|76047342|FG000|STARTED|3-Month Follow-up Survey|Number based on number completed both sessions of the BMI+Substance-Free Activity Session.|37||
59517204|NCT03223246|75610956|FG001|COMPLETED|48-72 Hours||35||
59929127|NCT04105725|76047343|FG001|STARTED|3-Month Follow-up Survey|Number based on number completed both sessions of the Alcohol + Nutrition Education Session.|26||
59929128|NCT04105725|76047342|FG000|COMPLETED|3-Month Follow-up Survey|Number of participants who completed both sessions of the BMI+Substance-Free Activity Session and the 3-Month Follow-up Survey|33||
59929129|NCT04105725|76047343|FG001|COMPLETED|3-Month Follow-up Survey|Number of participants who completed both sessions of the Alcohol + Nutrition Education and the 3-Month Follow-up Survey|22||
59929130|NCT04105725|76047342|FG000|NOT COMPLETED|3-Month Follow-up Survey||4||
59929131|NCT04105725|76047343|FG001|NOT COMPLETED|3-Month Follow-up Survey||4||
59929132|NCT04066023|76047352|FG000|STARTED|Overall Study||12||
59929133|NCT04066023|76047353|FG001|STARTED|Overall Study||17||
59929134|NCT04066023|76047354|FG002|STARTED|Overall Study||13||
59929135|NCT04066023|76047352|FG000|COMPLETED|Overall Study||9||
59929136|NCT04066023|76047353|FG001|COMPLETED|Overall Study||9||
59929137|NCT04066023|76047354|FG002|COMPLETED|Overall Study||7||
59929138|NCT04066023|76047352|FG000|NOT COMPLETED|Overall Study||3||
59929139|NCT04066023|76047353|FG001|NOT COMPLETED|Overall Study||8||
59929140|NCT04066023|76047354|FG002|NOT COMPLETED|Overall Study||6||
59929141|NCT03106987|76047366|FG000|STARTED|Overall Study||74||
59929142|NCT03106987|76047367|FG001|STARTED|Overall Study||38||
59929143|NCT03106987|76047368|FG002|STARTED|Overall Study||72||
59929144|NCT03106987|76047369|FG003|STARTED|Overall Study||36||
59929145|NCT03106987|76047366|FG000|COMPLETED|Overall Study||30||
59929146|NCT03106987|76047367|FG001|COMPLETED|Overall Study||15||
59929147|NCT03106987|76047368|FG002|COMPLETED|Overall Study||54||
59929148|NCT03106987|76047369|FG003|COMPLETED|Overall Study||25||
59929149|NCT03106987|76047366|FG000|NOT COMPLETED|Overall Study||44||
59929150|NCT03106987|76047367|FG001|NOT COMPLETED|Overall Study||23||
59929151|NCT03106987|76047368|FG002|NOT COMPLETED|Overall Study||18||
59929152|NCT03106987|76047369|FG003|NOT COMPLETED|Overall Study||11||
59929153|NCT02932267|76047379|FG000|STARTED|Overall Study||50||
59929154|NCT02932267|76047379|FG000|COMPLETED|Overall Study||42||
59929155|NCT02932267|76047379|FG000|NOT COMPLETED|Overall Study||8||
59929156|NCT03217591|76047386|FG000|STARTED|Overall Study||54||
59929157|NCT03217591|76047387|FG001|STARTED|Overall Study||50||
59929158|NCT03217591|76047388|FG002|STARTED|Overall Study||52||
59929159|NCT03217591|76047386|FG000|COMPLETED|Overall Study||51||
59929160|NCT03217591|76047387|FG001|COMPLETED|Overall Study||47||
59929161|NCT03217591|76047388|FG002|COMPLETED|Overall Study||42||
59929162|NCT03217591|76047386|FG000|NOT COMPLETED|Overall Study||3||
59929163|NCT03217591|76047387|FG001|NOT COMPLETED|Overall Study||3||
59929164|NCT03217591|76047388|FG002|NOT COMPLETED|Overall Study||10||
59929165|NCT03031782|76047397|FG000|STARTED|Treatment Period 1||86||
60062557|NCT01449370|76177882|FG022|COMPLETED|Overall Study||0||
60062558|NCT01449370|76177883|FG023|COMPLETED|Overall Study||0||
60062559|NCT01449370|76177884|FG024|COMPLETED|Overall Study||0||
60062560|NCT01449370|76177860|FG000|NOT COMPLETED|Overall Study||6||
60062561|NCT01449370|76177861|FG001|NOT COMPLETED|Overall Study||6||
60062562|NCT01449370|76177862|FG002|NOT COMPLETED|Overall Study||8||
60062563|NCT01449370|76177863|FG003|NOT COMPLETED|Overall Study||4||
60062564|NCT01449370|76177864|FG004|NOT COMPLETED|Overall Study||3||
60062565|NCT01449370|76177865|FG005|NOT COMPLETED|Overall Study||3||
60062566|NCT01449370|76177866|FG006|NOT COMPLETED|Overall Study||3||
60062567|NCT01449370|76177867|FG007|NOT COMPLETED|Overall Study||3||
60062568|NCT01449370|76177868|FG008|NOT COMPLETED|Overall Study||12||
60062569|NCT01449370|76177869|FG009|NOT COMPLETED|Overall Study||3||
60062570|NCT01449370|76177870|FG010|NOT COMPLETED|Overall Study||3||
60062571|NCT01449370|76177871|FG011|NOT COMPLETED|Overall Study||3||
60062572|NCT01449370|76177872|FG012|NOT COMPLETED|Overall Study||3||
60062573|NCT01449370|76177873|FG013|NOT COMPLETED|Overall Study||11||
59929166|NCT03031782|76047398|FG001|STARTED|Treatment Period 1||0||
59929167|NCT03031782|76047399|FG002|STARTED|Treatment Period 1||0||
60062574|NCT01449370|76177874|FG014|NOT COMPLETED|Overall Study||3||
59929168|NCT03031782|76047400|FG003|STARTED|Treatment Period 1||0||
59929169|NCT03031782|76047401|FG004|STARTED|Treatment Period 1||0||
60062575|NCT01449370|76177875|FG015|NOT COMPLETED|Overall Study||3||
60062576|NCT01449370|76177876|FG016|NOT COMPLETED|Overall Study||7||
60062577|NCT01449370|76177877|FG017|NOT COMPLETED|Overall Study||3||
60062578|NCT01449370|76177878|FG018|NOT COMPLETED|Overall Study||3||
60062579|NCT01449370|76177879|FG019|NOT COMPLETED|Overall Study||3||
60062580|NCT01449370|76177880|FG020|NOT COMPLETED|Overall Study||6||
60062581|NCT01449370|76177881|FG021|NOT COMPLETED|Overall Study||4||
60062582|NCT01449370|76177882|FG022|NOT COMPLETED|Overall Study||4||
60062583|NCT01449370|76177883|FG023|NOT COMPLETED|Overall Study||10||
60062584|NCT01449370|76177884|FG024|NOT COMPLETED|Overall Study||8||
60062585|NCT02067533|76177959|FG000|STARTED|Overall Study||45||
60062586|NCT02067533|76177960|FG001|STARTED|Overall Study||46||
60062587|NCT02067533|76177959|FG000|COMPLETED|Overall Study||41||
60062588|NCT02067533|76177960|FG001|COMPLETED|Overall Study||44||
60062589|NCT02067533|76177959|FG000|NOT COMPLETED|Overall Study||4||
60062590|NCT02067533|76177960|FG001|NOT COMPLETED|Overall Study||2||
60062591|NCT02066129|76177968|FG000|STARTED|Overall Study||127||
60062592|NCT02066129|76177969|FG001|STARTED|Overall Study||127||
60062593|NCT02066129|76177968|FG000|COMPLETED|Overall Study||98||
60062594|NCT02066129|76177969|FG001|COMPLETED|Overall Study||94||
60062595|NCT02066129|76177968|FG000|NOT COMPLETED|Overall Study||29||
60062596|NCT02066129|76177969|FG001|NOT COMPLETED|Overall Study||33||
60062597|NCT02066051|76177975|FG000|STARTED|Overall Study||8||
60062598|NCT02066051|76177975|FG000|COMPLETED|Overall Study||7||
60062599|NCT02066051|76177975|FG000|NOT COMPLETED|Overall Study||1||
60062600|NCT01980992|76177981|FG000|STARTED|52 Weeks Blinded Study Treatment||23||
60062601|NCT01980992|76177982|FG001|STARTED|52 Weeks Blinded Study Treatment||23||
59929170|NCT03031782|76047397|FG000|COMPLETED|Treatment Period 1||83||
59929171|NCT03031782|76047398|FG001|COMPLETED|Treatment Period 1||0||
59929172|NCT03031782|76047399|FG002|COMPLETED|Treatment Period 1||0||
60062602|NCT01980992|76177981|FG000|COMPLETED|52 Weeks Blinded Study Treatment||21||
60062603|NCT01980992|76177982|FG001|COMPLETED|52 Weeks Blinded Study Treatment||19||
60062604|NCT01980992|76177981|FG000|NOT COMPLETED|52 Weeks Blinded Study Treatment||2||
60062605|NCT01980992|76177982|FG001|NOT COMPLETED|52 Weeks Blinded Study Treatment||4||
60062606|NCT01980992|76177981|FG000|STARTED|52 Weeks Open Label Active Wheat OIT||21||
60062607|NCT01980992|76177982|FG001|STARTED|52 Weeks Open Label Active Wheat OIT||19||
60062608|NCT01980992|76177981|FG000|COMPLETED|52 Weeks Open Label Active Wheat OIT||18||
60062609|NCT01980992|76177982|FG001|COMPLETED|52 Weeks Open Label Active Wheat OIT||18||
60062610|NCT01980992|76177981|FG000|NOT COMPLETED|52 Weeks Open Label Active Wheat OIT||3||
60062611|NCT01980992|76177982|FG001|NOT COMPLETED|52 Weeks Open Label Active Wheat OIT||1||
60062612|NCT02065895|76177995|FG000|STARTED|Overall Study||1||
60062613|NCT02065895|76177996|FG001|STARTED|Overall Study||3||
60062614|NCT02065895|76177997|FG002|STARTED|Overall Study||1||
60062615|NCT02065895|76177998|FG003|STARTED|Overall Study||1||
60062616|NCT02065895|76177999|FG004|STARTED|Overall Study||1||
60062617|NCT02065895|76178000|FG005|STARTED|Overall Study||1||
60062618|NCT02065895|76177995|FG000|COMPLETED|Overall Study||0||
60062619|NCT02065895|76177996|FG001|COMPLETED|Overall Study||2||
60062620|NCT02065895|76177997|FG002|COMPLETED|Overall Study||1||
60062621|NCT02065895|76177998|FG003|COMPLETED|Overall Study||0||
59929173|NCT03031782|76047400|FG003|COMPLETED|Treatment Period 1||0||
59929174|NCT03031782|76047401|FG004|COMPLETED|Treatment Period 1||0||
59929175|NCT03031782|76047397|FG000|NOT COMPLETED|Treatment Period 1||3||
59929176|NCT03031782|76047398|FG001|NOT COMPLETED|Treatment Period 1||0||
59929177|NCT03031782|76047399|FG002|NOT COMPLETED|Treatment Period 1||0||
60062622|NCT02065895|76177999|FG004|COMPLETED|Overall Study||1||
60062623|NCT02065895|76178000|FG005|COMPLETED|Overall Study||1||
60062624|NCT02065895|76177995|FG000|NOT COMPLETED|Overall Study||1||
60062625|NCT02065895|76177996|FG001|NOT COMPLETED|Overall Study||1||
60062626|NCT02065895|76177997|FG002|NOT COMPLETED|Overall Study||0||
60062627|NCT02065895|76177998|FG003|NOT COMPLETED|Overall Study||1||
60062628|NCT02065895|76177999|FG004|NOT COMPLETED|Overall Study||0||
60062629|NCT02065895|76178000|FG005|NOT COMPLETED|Overall Study||0||
60062630|NCT02106455|76178017|FG000|STARTED|Overall Study||315||
60062631|NCT02106455|76178017|FG000|COMPLETED|Overall Study||307||
60062632|NCT02106455|76178017|FG000|NOT COMPLETED|Overall Study||8||
60062633|NCT02006654|76178023|FG000|STARTED|Overall Study||369||
60062634|NCT02006654|76178024|FG001|STARTED|Overall Study||365||
60062635|NCT02006654|76178023|FG000|Treated|Overall Study||365||
60062636|NCT02006654|76178024|FG001|Treated|Overall Study||363||
60062637|NCT02006654|76178023|FG000|COMPLETED|Overall Study||324||
60062638|NCT02006654|76178024|FG001|COMPLETED|Overall Study||321||
60062639|NCT02006654|76178023|FG000|NOT COMPLETED|Overall Study||45||
60062640|NCT02006654|76178024|FG001|NOT COMPLETED|Overall Study||44||
60062641|NCT01980056|76178034|FG000|STARTED|Overall Study||4||
60062642|NCT01980056|76178035|FG001|STARTED|Overall Study||4||
60062643|NCT01980056|76178036|FG002|STARTED|Overall Study||2||
60062644|NCT01980056|76178034|FG000|COMPLETED|Overall Study||3||
60062645|NCT01980056|76178035|FG001|COMPLETED|Overall Study||3||
60062646|NCT01980056|76178036|FG002|COMPLETED|Overall Study||2||
60062647|NCT01980056|76178034|FG000|NOT COMPLETED|Overall Study||1||
60062648|NCT01980056|76178035|FG001|NOT COMPLETED|Overall Study||1||
60062649|NCT01980056|76178036|FG002|NOT COMPLETED|Overall Study||0||
60062650|NCT02027558|76178050|FG000|STARTED|Overall Study||62||
60062651|NCT02027558|76178051|FG001|STARTED|Overall Study||63||
60062652|NCT02027558|76178050|FG000|Post-treatment|Overall Study||49||
60062653|NCT02027558|76178051|FG001|Post-treatment|Overall Study||60||
60062654|NCT02027558|76178050|FG000|3-month Follow-up|Overall Study||53||
60062655|NCT02027558|76178051|FG001|3-month Follow-up|Overall Study||58||
60062656|NCT02027558|76178050|FG000|6-month Follow-up|Overall Study||53||
60062657|NCT02027558|76178051|FG001|6-month Follow-up|Overall Study||61||
60062658|NCT02027558|76178050|FG000|COMPLETED|Overall Study||53||
60062659|NCT02027558|76178051|FG001|COMPLETED|Overall Study||61||
60062660|NCT02027558|76178050|FG000|NOT COMPLETED|Overall Study||9||
60062661|NCT02027558|76178051|FG001|NOT COMPLETED|Overall Study||2||
60062662|NCT02027402|76178061|FG000|STARTED|Overall Study||98||
60062663|NCT02027402|76178062|FG001|STARTED|Overall Study||100||
60062664|NCT02027402|76178061|FG000|COMPLETED|Overall Study||94||
60062665|NCT02027402|76178062|FG001|COMPLETED|Overall Study||99||
60062666|NCT02027402|76178061|FG000|NOT COMPLETED|Overall Study||4||
60062667|NCT02027402|76178062|FG001|NOT COMPLETED|Overall Study||1||
60062668|NCT01448824|76178078|FG000|STARTED|Part 1 Period 1: Multiple Ascending Dose||12||
60062669|NCT01448824|76178079|FG001|STARTED|Part 1 Period 1: Multiple Ascending Dose||4||
60062670|NCT01448824|76178080|FG002|STARTED|Part 1 Period 1: Multiple Ascending Dose||4||
60062671|NCT01448824|76178081|FG003|STARTED|Part 1 Period 1: Multiple Ascending Dose||10||
60062672|NCT01448824|76178082|FG004|STARTED|Part 1 Period 1: Multiple Ascending Dose||16||
60062673|NCT01448824|76178083|FG005|STARTED|Part 1 Period 1: Multiple Ascending Dose||12||
60062674|NCT01448824|76178084|FG006|STARTED|Part 1 Period 1: Multiple Ascending Dose||12||
60062675|NCT01448824|76178085|FG007|STARTED|Part 1 Period 1: Multiple Ascending Dose||0||
60062676|NCT01448824|76178078|FG000|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||12||
60062677|NCT01448824|76178079|FG001|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||4||
60062678|NCT01448824|76178080|FG002|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||4||
60062679|NCT01448824|76178081|FG003|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||10||
60062680|NCT01448824|76178082|FG004|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||16||
60062681|NCT01448824|76178083|FG005|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||12||
60062682|NCT01448824|76178084|FG006|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||12||
60062683|NCT01448824|76178085|FG007|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||0||
60062684|NCT01448824|76178078|FG000|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||12||
60062685|NCT01448824|76178079|FG001|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||4||
60062686|NCT01448824|76178080|FG002|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||4||
60062687|NCT01448824|76178081|FG003|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||9||
60062688|NCT01448824|76178082|FG004|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||14||
60062689|NCT01448824|76178083|FG005|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||10||
60062690|NCT01448824|76178084|FG006|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||11||
60062691|NCT01448824|76178085|FG007|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||0||
60062692|NCT01448824|76178078|FG000|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||0||
60062693|NCT01448824|76178079|FG001|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||0||
60062694|NCT01448824|76178080|FG002|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||0||
60062695|NCT01448824|76178081|FG003|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||1||
60062696|NCT01448824|76178082|FG004|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||2||
60062697|NCT01448824|76178083|FG005|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||2||
60062698|NCT01448824|76178084|FG006|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||1||
60062699|NCT01448824|76178085|FG007|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||0||
60062700|NCT01448824|76178078|FG000|STARTED|Part 1: Washout Period||12||
60062701|NCT01448824|76178079|FG001|STARTED|Part 1: Washout Period||4||
60062702|NCT01448824|76178080|FG002|STARTED|Part 1: Washout Period||4||
60062703|NCT01448824|76178081|FG003|STARTED|Part 1: Washout Period|Participants in Part 1 Cohorts B through D participated in Period 1 only.|0||
60062704|NCT01448824|76178082|FG004|STARTED|Part 1: Washout Period|Participants in Part 1 Cohort B participated in Period 1 only.|0||
60062705|NCT01448824|76178083|FG005|STARTED|Part 1: Washout Period|Participants in Part 1 Cohort C participated in Period 1 only.|0||
60062706|NCT01448824|76178084|FG006|STARTED|Part 1: Washout Period|Participants in Part 1 Cohort D participated in Period 1 only.|0||
60062707|NCT01448824|76178085|FG007|STARTED|Part 1: Washout Period||0||
60062708|NCT01448824|76178078|FG000|COMPLETED|Part 1: Washout Period||11||
60062709|NCT01448824|76178079|FG001|COMPLETED|Part 1: Washout Period||4||
59517205|NCT03223246|75610955|FG000|NOT COMPLETED|48-72 Hours||21||
59517206|NCT03223246|75610956|FG001|NOT COMPLETED|48-72 Hours||31||
59517207|NCT03223246|75610955|FG000|STARTED|5-7 Days||83|Note: participants were called at 5-7 days even if they could not be reached at 48-72 hours|
59517208|NCT03223246|75610956|FG001|STARTED|5-7 Days||66|Note: participants were called at 5-7 days even if they could not be reached at 48-72 hours|
59517209|NCT03223246|75610955|FG000|COMPLETED|5-7 Days||41||
59517210|NCT03223246|75610956|FG001|COMPLETED|5-7 Days||35||
60062710|NCT01448824|76178080|FG002|COMPLETED|Part 1: Washout Period||4||
60062711|NCT01448824|76178081|FG003|COMPLETED|Part 1: Washout Period||0||
60062712|NCT01448824|76178082|FG004|COMPLETED|Part 1: Washout Period||0||
60062713|NCT01448824|76178083|FG005|COMPLETED|Part 1: Washout Period||0||
60062714|NCT01448824|76178084|FG006|COMPLETED|Part 1: Washout Period||0||
60062715|NCT01448824|76178085|FG007|COMPLETED|Part 1: Washout Period||0||
60062716|NCT01448824|76178078|FG000|NOT COMPLETED|Part 1: Washout Period||1||
60062717|NCT01448824|76178079|FG001|NOT COMPLETED|Part 1: Washout Period||0||
60062718|NCT01448824|76178080|FG002|NOT COMPLETED|Part 1: Washout Period||0||
60062719|NCT01448824|76178081|FG003|NOT COMPLETED|Part 1: Washout Period||0||
60062720|NCT01448824|76178082|FG004|NOT COMPLETED|Part 1: Washout Period||0||
60062721|NCT01448824|76178083|FG005|NOT COMPLETED|Part 1: Washout Period||0||
60062722|NCT01448824|76178084|FG006|NOT COMPLETED|Part 1: Washout Period||0||
60062723|NCT01448824|76178085|FG007|NOT COMPLETED|Part 1: Washout Period||0||
60062724|NCT01448824|76178078|FG000|STARTED|Part 1 Period 2: Multiple Ascending Dose||11||
60062725|NCT01448824|76178079|FG001|STARTED|Part 1 Period 2: Multiple Ascending Dose||4||
60062726|NCT01448824|76178080|FG002|STARTED|Part 1 Period 2: Multiple Ascending Dose||4||
60062727|NCT01448824|76178081|FG003|STARTED|Part 1 Period 2: Multiple Ascending Dose|Participants in Part 1 Cohorts B through D participated in Period 1 only.|0||
60062728|NCT01448824|76178082|FG004|STARTED|Part 1 Period 2: Multiple Ascending Dose|Participants in Part 1 Cohort B participated in Period 1 only.|0||
60062729|NCT01448824|76178083|FG005|STARTED|Part 1 Period 2: Multiple Ascending Dose|Participants in Part 1 Cohort C participated in Period 1 only.|0||
60062730|NCT01448824|76178084|FG006|STARTED|Part 1 Period 2: Multiple Ascending Dose|Participants in Part 1 Cohort D participated in Period 1 only.|0||
60062731|NCT01448824|76178085|FG007|STARTED|Part 1 Period 2: Multiple Ascending Dose||0||
59517211|NCT03223246|75610955|FG000|NOT COMPLETED|5-7 Days||42||
59517212|NCT03223246|75610956|FG001|NOT COMPLETED|5-7 Days||31||
59517213|NCT02169427|75610962|FG000|STARTED|Overall Study||6||
59517214|NCT02169427|75610962|FG000|COMPLETED|Overall Study||6||
59517215|NCT02169427|75610962|FG000|NOT COMPLETED|Overall Study||0||
59517216|NCT03452176|75610968|FG000|STARTED|Overall Study||11||
59517217|NCT03452176|75610969|FG001|STARTED|Overall Study||11||
59517218|NCT03452176|75610968|FG000|COMPLETED|Overall Study||11||
59517219|NCT03452176|75610969|FG001|COMPLETED|Overall Study||11||
59517220|NCT03452176|75610968|FG000|NOT COMPLETED|Overall Study||0||
59517221|NCT03452176|75610969|FG001|NOT COMPLETED|Overall Study||0||
59517222|NCT03454048|75610987|FG000|STARTED|Overall Study||6||
59517223|NCT03454048|75610988|FG001|STARTED|Overall Study||6||
59517224|NCT03454048|75610989|FG002|STARTED|Overall Study||6||
59517225|NCT03454048|75610990|FG003|STARTED|Overall Study||6||
60062732|NCT01448824|76178078|FG000|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||11||
60062733|NCT01448824|76178079|FG001|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||4||
60062734|NCT01448824|76178080|FG002|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||4||
59517226|NCT03454048|75610987|FG000|COMPLETED|Overall Study||6||
59517227|NCT03454048|75610988|FG001|COMPLETED|Overall Study||6||
59517228|NCT03454048|75610989|FG002|COMPLETED|Overall Study||6||
59761148|NCT00881712|75880821|FG002|COMPLETED|Overall Study||0||
59517229|NCT03454048|75610990|FG003|COMPLETED|Overall Study||6||
59517230|NCT03454048|75610987|FG000|NOT COMPLETED|Overall Study||0||
60062735|NCT01448824|76178081|FG003|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||0||
59929178|NCT03031782|76047400|FG003|NOT COMPLETED|Treatment Period 1||0||
59929179|NCT03031782|76047401|FG004|NOT COMPLETED|Treatment Period 1||0||
59929180|NCT03031782|76047397|FG000|STARTED|Treatment Period 2||0||
59929181|NCT03031782|76047398|FG001|STARTED|Treatment Period 2||37||
59929182|NCT03031782|76047399|FG002|STARTED|Treatment Period 2||38||
59929183|NCT03031782|76047400|FG003|STARTED|Treatment Period 2||0||
59929184|NCT03031782|76047401|FG004|STARTED|Treatment Period 2||21||
59929185|NCT03031782|76047397|FG000|COMPLETED|Treatment Period 2||0||
59929186|NCT03031782|76047398|FG001|COMPLETED|Treatment Period 2||31||
59929187|NCT03031782|76047399|FG002|COMPLETED|Treatment Period 2||36||
59929188|NCT03031782|76047400|FG003|COMPLETED|Treatment Period 2||0||
59929189|NCT03031782|76047401|FG004|COMPLETED|Treatment Period 2||16||
59929190|NCT03031782|76047397|FG000|NOT COMPLETED|Treatment Period 2||0||
59929191|NCT03031782|76047398|FG001|NOT COMPLETED|Treatment Period 2||6||
59929192|NCT03031782|76047399|FG002|NOT COMPLETED|Treatment Period 2||2||
59929193|NCT03031782|76047400|FG003|NOT COMPLETED|Treatment Period 2||0||
59929194|NCT03031782|76047401|FG004|NOT COMPLETED|Treatment Period 2||5||
60062736|NCT01448824|76178082|FG004|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||0||
60062737|NCT01448824|76178083|FG005|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||0||
60062738|NCT01448824|76178084|FG006|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||0||
60062739|NCT01448824|76178085|FG007|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||0||
60062740|NCT01448824|76178078|FG000|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||11||
60062741|NCT01448824|76178079|FG001|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||4||
60062742|NCT01448824|76178080|FG002|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||4||
59929195|NCT03031782|76047397|FG000|STARTED|Treatment Period 3||0||
59929196|NCT03031782|76047398|FG001|STARTED|Treatment Period 3||0||
59929197|NCT03031782|76047399|FG002|STARTED|Treatment Period 3||0||
59929198|NCT03031782|76047400|FG003|STARTED|Treatment Period 3||11||
59929199|NCT03031782|76047401|FG004|STARTED|Treatment Period 3||0||
59929200|NCT03031782|76047397|FG000|COMPLETED|Treatment Period 3||0||
59929201|NCT03031782|76047398|FG001|COMPLETED|Treatment Period 3||0||
59929202|NCT03031782|76047399|FG002|COMPLETED|Treatment Period 3||0||
59929203|NCT03031782|76047400|FG003|COMPLETED|Treatment Period 3||10||
59929204|NCT03031782|76047401|FG004|COMPLETED|Treatment Period 3||0||
59929205|NCT03031782|76047397|FG000|NOT COMPLETED|Treatment Period 3||0||
59929206|NCT03031782|76047398|FG001|NOT COMPLETED|Treatment Period 3||0||
59929207|NCT03031782|76047399|FG002|NOT COMPLETED|Treatment Period 3||0||
59929208|NCT03031782|76047400|FG003|NOT COMPLETED|Treatment Period 3||1||
59929209|NCT03031782|76047401|FG004|NOT COMPLETED|Treatment Period 3||0||
59929210|NCT03216265|76047418|FG000|STARTED|Overall Study||22||
59929211|NCT03216265|76047419|FG001|STARTED|Overall Study||22||
59929212|NCT03216265|76047420|FG002|STARTED|Overall Study||22||
59929213|NCT03216265|76047418|FG000|COMPLETED|Overall Study||20||
59929214|NCT03216265|76047419|FG001|COMPLETED|Overall Study||21||
59929215|NCT03216265|76047420|FG002|COMPLETED|Overall Study||19||
59929216|NCT03216265|76047418|FG000|NOT COMPLETED|Overall Study||2||
59929217|NCT03216265|76047419|FG001|NOT COMPLETED|Overall Study||1||
59929218|NCT03216265|76047420|FG002|NOT COMPLETED|Overall Study||3||
59929219|NCT04050384|76047437|FG000|STARTED|Overall Study||67||
59929220|NCT04050384|76047438|FG001|STARTED|Overall Study||67||
59929221|NCT04050384|76047437|FG000|COMPLETED|Overall Study||67||
59929222|NCT04050384|76047438|FG001|COMPLETED|Overall Study||67||
59929223|NCT04050384|76047437|FG000|NOT COMPLETED|Overall Study||0||
59929224|NCT04050384|76047438|FG001|NOT COMPLETED|Overall Study||0||
59929225|NCT04486950|76047451|FG000|STARTED|Overall Study||4||
59929226|NCT04486950|76047452|FG001|STARTED|Overall Study||2||
59929227|NCT04486950|76047453|FG002|STARTED|Overall Study||2||
59929228|NCT04486950|76047454|FG003|STARTED|Overall Study||6||
59929229|NCT04486950|76047455|FG004|STARTED|Overall Study||6||
59929230|NCT04486950|76047456|FG005|STARTED|Overall Study||6||
59929231|NCT04486950|76047457|FG006|STARTED|Overall Study||6||
59929232|NCT04486950|76047451|FG000|COMPLETED|Overall Study||4||
59929233|NCT04486950|76047452|FG001|COMPLETED|Overall Study||2||
59929234|NCT04486950|76047453|FG002|COMPLETED|Overall Study||2||
59929235|NCT04486950|76047454|FG003|COMPLETED|Overall Study||6||
59929236|NCT04486950|76047455|FG004|COMPLETED|Overall Study||6||
59929237|NCT04486950|76047456|FG005|COMPLETED|Overall Study||5||
59929238|NCT04486950|76047457|FG006|COMPLETED|Overall Study||6||
59929239|NCT04486950|76047451|FG000|NOT COMPLETED|Overall Study||0||
59929240|NCT04486950|76047452|FG001|NOT COMPLETED|Overall Study||0||
59929241|NCT04486950|76047453|FG002|NOT COMPLETED|Overall Study||0||
59929242|NCT04486950|76047454|FG003|NOT COMPLETED|Overall Study||0||
59929243|NCT04486950|76047455|FG004|NOT COMPLETED|Overall Study||0||
59929244|NCT04486950|76047456|FG005|NOT COMPLETED|Overall Study||1||
59929245|NCT04486950|76047457|FG006|NOT COMPLETED|Overall Study||0||
60062743|NCT01448824|76178081|FG003|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0||
60062744|NCT01448824|76178082|FG004|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0||
60062745|NCT01448824|76178083|FG005|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0||
60062746|NCT01448824|76178084|FG006|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0||
60062747|NCT01448824|76178085|FG007|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0||
60062748|NCT01448824|76178078|FG000|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0||
60062749|NCT01448824|76178079|FG001|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0||
60062750|NCT01448824|76178080|FG002|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0||
60062751|NCT01448824|76178081|FG003|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0||
60062752|NCT01448824|76178082|FG004|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0||
60062753|NCT01448824|76178083|FG005|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0||
60062754|NCT01448824|76178084|FG006|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0||
60062755|NCT01448824|76178085|FG007|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0||
60062756|NCT01448824|76178078|FG000|STARTED|Part 2 Period 1: Drug-drug Interaction||0||
60062757|NCT01448824|76178079|FG001|STARTED|Part 2 Period 1: Drug-drug Interaction||0||
60062758|NCT01448824|76178080|FG002|STARTED|Part 2 Period 1: Drug-drug Interaction||0||
60062759|NCT01448824|76178081|FG003|STARTED|Part 2 Period 1: Drug-drug Interaction||0||
60062760|NCT01448824|76178082|FG004|STARTED|Part 2 Period 1: Drug-drug Interaction||0||
60062761|NCT01448824|76178083|FG005|STARTED|Part 2 Period 1: Drug-drug Interaction||0||
60062762|NCT01448824|76178084|FG006|STARTED|Part 2 Period 1: Drug-drug Interaction||0||
60062763|NCT01448824|76178085|FG007|STARTED|Part 2 Period 1: Drug-drug Interaction||12||
60062764|NCT01448824|76178078|FG000|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0||
60062765|NCT01448824|76178079|FG001|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0||
59517231|NCT03454048|75610988|FG001|NOT COMPLETED|Overall Study||0||
60062766|NCT01448824|76178080|FG002|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0||
60062767|NCT01448824|76178081|FG003|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0||
60062768|NCT01448824|76178082|FG004|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0||
60062769|NCT01448824|76178083|FG005|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0||
60062770|NCT01448824|76178084|FG006|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0||
60062771|NCT01448824|76178085|FG007|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||12||
60062772|NCT01448824|76178078|FG000|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0||
60062773|NCT01448824|76178079|FG001|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0||
60062774|NCT01448824|76178080|FG002|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0||
60062775|NCT01448824|76178081|FG003|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0||
60062776|NCT01448824|76178082|FG004|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0||
60062777|NCT01448824|76178083|FG005|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0||
60062778|NCT01448824|76178084|FG006|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0||
60062779|NCT01448824|76178085|FG007|COMPLETED|Part 2 Period 1: Drug-drug Interaction||11||
60062780|NCT01448824|76178078|FG000|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0||
60062781|NCT01448824|76178079|FG001|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0||
60062782|NCT01448824|76178080|FG002|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0||
60062783|NCT01448824|76178081|FG003|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0||
60062784|NCT01448824|76178082|FG004|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0||
60062785|NCT01448824|76178083|FG005|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0||
60062786|NCT01448824|76178084|FG006|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0||
60062787|NCT01448824|76178085|FG007|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||1||
60062788|NCT01448824|76178078|FG000|STARTED|Part 2: Washout Period||0||
60062789|NCT01448824|76178079|FG001|STARTED|Part 2: Washout Period||0||
60062790|NCT01448824|76178080|FG002|STARTED|Part 2: Washout Period||0||
60062791|NCT01448824|76178081|FG003|STARTED|Part 2: Washout Period||0||
60062792|NCT01448824|76178082|FG004|STARTED|Part 2: Washout Period||0||
60062793|NCT01448824|76178083|FG005|STARTED|Part 2: Washout Period||0||
60062794|NCT01448824|76178084|FG006|STARTED|Part 2: Washout Period||0||
60062795|NCT01448824|76178085|FG007|STARTED|Part 2: Washout Period||11||
60062796|NCT01448824|76178078|FG000|COMPLETED|Part 2: Washout Period||0||
60062797|NCT01448824|76178079|FG001|COMPLETED|Part 2: Washout Period||0||
60062798|NCT01448824|76178080|FG002|COMPLETED|Part 2: Washout Period||0||
60062799|NCT01448824|76178081|FG003|COMPLETED|Part 2: Washout Period||0||
60062800|NCT01448824|76178082|FG004|COMPLETED|Part 2: Washout Period||0||
60062801|NCT01448824|76178083|FG005|COMPLETED|Part 2: Washout Period||0||
60062802|NCT01448824|76178084|FG006|COMPLETED|Part 2: Washout Period||0||
60062803|NCT01448824|76178085|FG007|COMPLETED|Part 2: Washout Period||11||
60062804|NCT01448824|76178078|FG000|NOT COMPLETED|Part 2: Washout Period||0||
60062805|NCT01448824|76178079|FG001|NOT COMPLETED|Part 2: Washout Period||0||
60062806|NCT01448824|76178080|FG002|NOT COMPLETED|Part 2: Washout Period||0||
60062807|NCT01448824|76178081|FG003|NOT COMPLETED|Part 2: Washout Period||0||
60062808|NCT01448824|76178082|FG004|NOT COMPLETED|Part 2: Washout Period||0||
60062809|NCT01448824|76178083|FG005|NOT COMPLETED|Part 2: Washout Period||0||
60062810|NCT01448824|76178084|FG006|NOT COMPLETED|Part 2: Washout Period||0||
60062811|NCT01448824|76178085|FG007|NOT COMPLETED|Part 2: Washout Period||0||
60062812|NCT01448824|76178078|FG000|STARTED|Part 2 Period 2: Drug-drug Interaction||0||
60062813|NCT01448824|76178079|FG001|STARTED|Part 2 Period 2: Drug-drug Interaction||0||
60062814|NCT01448824|76178080|FG002|STARTED|Part 2 Period 2: Drug-drug Interaction||0||
60062815|NCT01448824|76178081|FG003|STARTED|Part 2 Period 2: Drug-drug Interaction||0||
60062816|NCT01448824|76178082|FG004|STARTED|Part 2 Period 2: Drug-drug Interaction||0||
60062817|NCT01448824|76178083|FG005|STARTED|Part 2 Period 2: Drug-drug Interaction||0||
60062818|NCT01448824|76178084|FG006|STARTED|Part 2 Period 2: Drug-drug Interaction||0||
60062819|NCT01448824|76178085|FG007|STARTED|Part 2 Period 2: Drug-drug Interaction||11||
60062820|NCT01448824|76178078|FG000|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0||
60062821|NCT01448824|76178079|FG001|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0||
60062822|NCT01448824|76178080|FG002|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0||
60062823|NCT01448824|76178081|FG003|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0||
60062824|NCT01448824|76178082|FG004|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0||
60062825|NCT01448824|76178083|FG005|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0||
60062826|NCT01448824|76178084|FG006|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0||
60062827|NCT01448824|76178085|FG007|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||11||
60062828|NCT01448824|76178078|FG000|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0||
60062829|NCT01448824|76178079|FG001|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0||
60062830|NCT01448824|76178080|FG002|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0||
60062831|NCT01448824|76178081|FG003|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0||
60062832|NCT01448824|76178082|FG004|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0||
60062833|NCT01448824|76178083|FG005|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0||
60062834|NCT01448824|76178084|FG006|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0||
60062835|NCT01448824|76178085|FG007|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||10||
60062836|NCT01448824|76178078|FG000|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0||
60062837|NCT01448824|76178079|FG001|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0||
60062838|NCT01448824|76178080|FG002|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0||
60062839|NCT01448824|76178081|FG003|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0||
60062840|NCT01448824|76178082|FG004|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0||
60062841|NCT01448824|76178083|FG005|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0||
60062842|NCT01448824|76178084|FG006|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0||
60062843|NCT01448824|76178085|FG007|COMPLETED|Part 2 Period 2: Drug-drug Interaction||8||
60062844|NCT01448824|76178078|FG000|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0||
60062845|NCT01448824|76178079|FG001|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0||
60062846|NCT01448824|76178080|FG002|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0||
60062847|NCT01448824|76178081|FG003|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0||
60062848|NCT01448824|76178082|FG004|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0||
60062849|NCT01448824|76178083|FG005|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0||
60062850|NCT01448824|76178084|FG006|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0||
60062851|NCT01448824|76178085|FG007|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||3||
60062852|NCT02005562|76178115|FG000|STARTED|Overall Study||127||
60062853|NCT02005562|76178116|FG001|STARTED|Overall Study||125||
60062854|NCT02005562|76178115|FG000|Transplanted|Overall Study||126||
60062855|NCT02005562|76178116|FG001|Transplanted|Overall Study||121||
60062856|NCT02005562|76178115|FG000|COMPLETED|Overall Study||115||
60062857|NCT02005562|76178116|FG001|COMPLETED|Overall Study||110||
60062858|NCT02005562|76178115|FG000|NOT COMPLETED|Overall Study||12||
60062859|NCT02005562|76178116|FG001|NOT COMPLETED|Overall Study||15||
60062860|NCT01448044|76178124|FG000|STARTED|Treatment Period||82||
60062861|NCT01448044|76178125|FG001|STARTED|Treatment Period||42||
60062862|NCT01448044|76178124|FG000|COMPLETED|Treatment Period||59||
60062863|NCT01448044|76178125|FG001|COMPLETED|Treatment Period||26||
59929246|NCT04693416|76047479|FG000|STARTED|Overall Study||50||
59929247|NCT04693416|76047480|FG001|STARTED|Overall Study||21||
59929248|NCT04693416|76047479|FG000|COMPLETED|Overall Study||37||
59929249|NCT04693416|76047480|FG001|COMPLETED|Overall Study||21||
59929250|NCT04693416|76047479|FG000|NOT COMPLETED|Overall Study||13||
59929251|NCT04693416|76047480|FG001|NOT COMPLETED|Overall Study||0||
59929252|NCT00265941|76047488|FG000|STARTED|Overall Study||470||
59929253|NCT00265941|76047489|FG001|STARTED|Overall Study||470||
59929254|NCT00265941|76047488|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|447||
59929255|NCT00265941|76047489|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|444||
59929256|NCT00265941|76047488|FG000|NOT COMPLETED|Overall Study||23||
59929257|NCT00265941|76047489|FG001|NOT COMPLETED|Overall Study||26||
59929258|NCT03882957|76047503|FG000|STARTED|Overall Study||92||
59929259|NCT03882957|76047503|FG000|Participant Flow 1|Overall Study|participant flow sequence: video --> media multitask --> sustained attention|17||
59929260|NCT03882957|76047503|FG000|Participant Flow 2|Overall Study|participant flow sequence: video --> sustained attention -- media multitask|16||
59929261|NCT03882957|76047503|FG000|Participant Flow 3|Overall Study|participant flow sequence: media multitask --> video --> sustained attention|13||
59929262|NCT03882957|76047503|FG000|Participant Flow 4|Overall Study|participant flow sequence: sustained attention --> video -- media multitask|15||
59929263|NCT03882957|76047503|FG000|Participant Flow 5|Overall Study|participant flow sequence: sustained attention --> media multitask --> video|16||
59929264|NCT03882957|76047503|FG000|Participant Flow 6|Overall Study|participant flow 6: media multitask --> sustained attention --> video|14||
59929265|NCT03882957|76047503|FG000|COMPLETED|Overall Study||91||
59929266|NCT03882957|76047503|FG000|NOT COMPLETED|Overall Study||1||
59929267|NCT03201211|76047515|FG000|STARTED|Overall Study||27||
59929268|NCT03201211|76047516|FG001|STARTED|Overall Study||26||
59929269|NCT03201211|76047517|FG002|STARTED|Overall Study||28||
59929270|NCT03201211|76047515|FG000|COMPLETED|Overall Study||25||
59929271|NCT03201211|76047516|FG001|COMPLETED|Overall Study||25||
59929272|NCT03201211|76047517|FG002|COMPLETED|Overall Study||27||
59929273|NCT03201211|76047515|FG000|NOT COMPLETED|Overall Study||2||
59929274|NCT03201211|76047516|FG001|NOT COMPLETED|Overall Study||1||
59929275|NCT03201211|76047517|FG002|NOT COMPLETED|Overall Study||1||
59929276|NCT04633837|76047527|FG000|STARTED|Overall Study||5||
59929277|NCT04633837|76047528|FG001|STARTED|Overall Study||0||
59929278|NCT04633837|76047527|FG000|COMPLETED|Overall Study||0||
59929279|NCT04633837|76047528|FG001|COMPLETED|Overall Study||0||
59929280|NCT04633837|76047527|FG000|NOT COMPLETED|Overall Study||5||
59929281|NCT04633837|76047528|FG001|NOT COMPLETED|Overall Study||0||
59929282|NCT03029832|76047536|FG000|STARTED|Overall Study||4||
59929283|NCT03029832|76047537|FG001|STARTED|Overall Study||1||
59929284|NCT03029832|76047536|FG000|COMPLETED|Overall Study||0||
59929285|NCT03029832|76047537|FG001|COMPLETED|Overall Study||0||
59929286|NCT03029832|76047536|FG000|NOT COMPLETED|Overall Study||4||
59929287|NCT03029832|76047537|FG001|NOT COMPLETED|Overall Study||1||
59929288|NCT03089697|76047545|FG000|STARTED|Overall Study||13||
59929289|NCT03089697|76047546|FG001|STARTED|Overall Study||12||
59929290|NCT03089697|76047545|FG000|COMPLETED|Overall Study||11||
59929291|NCT03089697|76047546|FG001|COMPLETED|Overall Study||10||
59929292|NCT03089697|76047545|FG000|NOT COMPLETED|Overall Study||2||
59929293|NCT03089697|76047546|FG001|NOT COMPLETED|Overall Study||2||
59929294|NCT03199963|76047554|FG000|STARTED|Blinded Phase - Overall Study||149||
59929295|NCT03199963|76047555|FG001|STARTED|Blinded Phase - Overall Study||74||
59929296|NCT03199963|76047554|FG000|Received at Least 1 Gel Application|Blinded Phase - Overall Study||149||
59929297|NCT03199963|76047555|FG001|Received at Least 1 Gel Application|Blinded Phase - Overall Study||73||
59929298|NCT03199963|76047554|FG000|COMPLETED|Blinded Phase - Overall Study||16|Completed 52 week visit|
59929299|NCT03199963|76047555|FG001|COMPLETED|Blinded Phase - Overall Study||8|Completed 52 week visit|
59929300|NCT03199963|76047554|FG000|NOT COMPLETED|Blinded Phase - Overall Study||133||
59929301|NCT03199963|76047555|FG001|NOT COMPLETED|Blinded Phase - Overall Study||66||
59929302|NCT03199963|76047554|FG000|STARTED|Optional Open-Label Phase - BHR-700||7||
59929303|NCT03199963|76047555|FG001|STARTED|Optional Open-Label Phase - BHR-700||6||
59929304|NCT03199963|76047554|FG000|COMPLETED|Optional Open-Label Phase - BHR-700||0||
59929305|NCT03199963|76047555|FG001|COMPLETED|Optional Open-Label Phase - BHR-700||0||
59929306|NCT03199963|76047554|FG000|NOT COMPLETED|Optional Open-Label Phase - BHR-700||7||
60062864|NCT01448044|76178124|FG000|NOT COMPLETED|Treatment Period||23||
60062865|NCT01448044|76178125|FG001|NOT COMPLETED|Treatment Period||16||
60062866|NCT01448044|76178124|FG000|STARTED|Follow Up Period|Out of 82 participants who entered the treatment period, 77 continued in the follow-up period.|77||
60062867|NCT01448044|76178125|FG001|STARTED|Follow Up Period|Out of 42 participants who entered the treatment period, 40 continued in the follow-up period.|40||
60062868|NCT01448044|76178124|FG000|COMPLETED|Follow Up Period||65||
60062869|NCT01448044|76178125|FG001|COMPLETED|Follow Up Period||26||
60062870|NCT01448044|76178124|FG000|NOT COMPLETED|Follow Up Period||12||
60062871|NCT01448044|76178125|FG001|NOT COMPLETED|Follow Up Period||14||
60062872|NCT02025530|76178133|FG000|STARTED|Overall Study||296||
60062873|NCT02025530|76178134|FG001|STARTED|Overall Study||734||
60062874|NCT02025530|76178133|FG000|COMPLETED|Overall Study||291||
60062875|NCT02025530|76178134|FG001|COMPLETED|Overall Study||733||
60062876|NCT02025530|76178133|FG000|NOT COMPLETED|Overall Study||5||
60062877|NCT02025530|76178134|FG001|NOT COMPLETED|Overall Study||1||
60062878|NCT01472380|76178140|FG000|STARTED|Efavirenz Alone||30||
60062879|NCT01472380|76178140|FG000|COMPLETED|Efavirenz Alone||29||
60062880|NCT01472380|76178140|FG000|NOT COMPLETED|Efavirenz Alone||1||
60062881|NCT01472380|76178140|FG000|STARTED|Fenofibric Acid (FFA) Alone||29||
60062882|NCT01472380|76178140|FG000|COMPLETED|Fenofibric Acid (FFA) Alone||29||
60062883|NCT01472380|76178140|FG000|NOT COMPLETED|Fenofibric Acid (FFA) Alone||0||
60062884|NCT01472380|76178140|FG000|STARTED|1 Day Period Between Dosing||29||
60062885|NCT01472380|76178140|FG000|COMPLETED|1 Day Period Between Dosing||28||
60062886|NCT01472380|76178140|FG000|NOT COMPLETED|1 Day Period Between Dosing||1||
60062887|NCT01472380|76178140|FG000|STARTED|Efavirenz and FFA||28||
60062888|NCT01472380|76178140|FG000|COMPLETED|Efavirenz and FFA||28||
60062889|NCT01472380|76178140|FG000|NOT COMPLETED|Efavirenz and FFA||0||
60062890|NCT01978262|76178147|FG000|STARTED|Overall Study||103||
60062891|NCT01978262|76178147|FG000|COMPLETED|Overall Study||92||
60062892|NCT01978262|76178147|FG000|NOT COMPLETED|Overall Study||11||
60062893|NCT01447576|76178152|FG000|STARTED|Overall Study||1036||
60062894|NCT01447576|76178152|FG000|COMPLETED|Overall Study||560||
60062895|NCT01447576|76178152|FG000|NOT COMPLETED|Overall Study||476||
60062896|NCT01447420|76178159|FG000|STARTED|Overall Study||39||
59517232|NCT03454048|75610989|FG002|NOT COMPLETED|Overall Study||0||
59517233|NCT03454048|75610990|FG003|NOT COMPLETED|Overall Study||0||
59517234|NCT02165839|75611004|FG000|STARTED|Overall Study||66||
59517235|NCT02165839|75611005|FG001|STARTED|Overall Study||73||
59517236|NCT02165839|75611004|FG000|COMPLETED|Overall Study||66||
59517237|NCT02165839|75611005|FG001|COMPLETED|Overall Study||73||
59517238|NCT02165839|75611004|FG000|NOT COMPLETED|Overall Study||0||
59517239|NCT02165839|75611005|FG001|NOT COMPLETED|Overall Study||0||
59517240|NCT03226366|75611016|FG000|STARTED|Overall Study||911||
59517241|NCT03226366|75611017|FG001|STARTED|Overall Study||495||
59517242|NCT03226366|75611018|FG002|STARTED|Overall Study||1183||
59517243|NCT03226366|75611019|FG003|STARTED|Overall Study||641||
59517244|NCT03226366|75611016|FG000|COMPLETED|Overall Study||911||
59517245|NCT03226366|75611017|FG001|COMPLETED|Overall Study||495||
59517246|NCT03226366|75611018|FG002|COMPLETED|Overall Study||1183||
59517247|NCT03226366|75611019|FG003|COMPLETED|Overall Study||641||
59517248|NCT03226366|75611016|FG000|NOT COMPLETED|Overall Study||0||
59517249|NCT03226366|75611017|FG001|NOT COMPLETED|Overall Study||0||
59517250|NCT03226366|75611018|FG002|NOT COMPLETED|Overall Study||0||
59517251|NCT03226366|75611019|FG003|NOT COMPLETED|Overall Study||0||
59613086|NCT01739400|75724174|FG000|Treated With 10 mg Macitentan|Overall Study||109||
59613087|NCT01739400|75724175|FG001|Treated With 10 mg Macitentan|Overall Study||108||
59613088|NCT01739400|75724174|FG000|COMPLETED|Overall Study||92|Completed OL study|
59613089|NCT01739400|75724175|FG001|COMPLETED|Overall Study||99|Completed OL study|
59613090|NCT01739400|75724174|FG000|NOT COMPLETED|Overall Study||17||
59613091|NCT01739400|75724175|FG001|NOT COMPLETED|Overall Study||9||
59613092|NCT01713348|75724184|FG000|STARTED|Overall Study||29||
59613093|NCT01713348|75724185|FG001|STARTED|Overall Study||13||
59613094|NCT01713348|75724186|FG002|STARTED|Overall Study||30||
59613095|NCT01713348|75724187|FG003|STARTED|Overall Study||15||
59613096|NCT01713348|75724184|FG000|COMPLETED|Overall Study||25||
60062897|NCT01447420|76178160|FG001|STARTED|Overall Study||72||
59517252|NCT03455218|75611031|FG000|STARTED|Overall Study||18||
59517253|NCT03455218|75611032|FG001|STARTED|Overall Study||22||
59517254|NCT03455218|75611031|FG000|COMPLETED|Overall Study||18||
59517255|NCT03455218|75611032|FG001|COMPLETED|Overall Study||22||
60062898|NCT01447420|76178161|FG002|STARTED|Overall Study||18||
60062899|NCT01447420|76178159|FG000|COMPLETED|Overall Study||29||
60062900|NCT01447420|76178160|FG001|COMPLETED|Overall Study||45||
60062901|NCT01447420|76178161|FG002|COMPLETED|Overall Study||8||
60062902|NCT01447420|76178159|FG000|NOT COMPLETED|Overall Study||10||
60062903|NCT01447420|76178160|FG001|NOT COMPLETED|Overall Study||27||
60062904|NCT01447420|76178161|FG002|NOT COMPLETED|Overall Study||10||
60062905|NCT01446874|76178171|FG000|STARTED|Overall Study||20||
60062906|NCT01446874|76178172|FG001|STARTED|Overall Study||50||
60062907|NCT01446874|76178173|FG002|STARTED|Overall Study||80||
60062908|NCT01446874|76178171|FG000|COMPLETED|Overall Study||18||
60062909|NCT01446874|76178172|FG001|COMPLETED|Overall Study||46||
60062910|NCT01446874|76178173|FG002|COMPLETED|Overall Study||62||
60062911|NCT01446874|76178171|FG000|NOT COMPLETED|Overall Study||2||
59517256|NCT03455218|75611031|FG000|NOT COMPLETED|Overall Study||0||
59517257|NCT03455218|75611032|FG001|NOT COMPLETED|Overall Study||0||
59517258|NCT01050907|75611038|FG000|STARTED|Overall Study||4||
59613097|NCT01713348|75724185|FG001|COMPLETED|Overall Study||11||
59613098|NCT01713348|75724186|FG002|COMPLETED|Overall Study||28||
60062912|NCT01446874|76178172|FG001|NOT COMPLETED|Overall Study||4||
59517259|NCT01050907|75611038|FG000|COMPLETED|Overall Study||4||
59517260|NCT01050907|75611038|FG000|NOT COMPLETED|Overall Study||0||
60062913|NCT01446874|76178173|FG002|NOT COMPLETED|Overall Study||18||
60062914|NCT01446796|76178181|FG000|STARTED|Overall Study||3||
60062915|NCT01446796|76178182|FG001|STARTED|Overall Study||0||
60062916|NCT01446796|76178181|FG000|COMPLETED|Overall Study|"Study terminated early~One subject of three withdrew prior to randomization and did not start"|2||
60062917|NCT01446796|76178182|FG001|COMPLETED|Overall Study|Study terminated early|0||
60062918|NCT01446796|76178181|FG000|NOT COMPLETED|Overall Study||1||
60062919|NCT01446796|76178182|FG001|NOT COMPLETED|Overall Study||0||
60062920|NCT01439074|76178192|FG000|STARTED|Overall Study||75||
60062921|NCT01439074|76178193|FG001|STARTED|Overall Study||87||
60062922|NCT01439074|76178192|FG000|COMPLETED|Overall Study||66||
60062923|NCT01439074|76178193|FG001|COMPLETED|Overall Study||74||
59761149|NCT00881712|75880819|FG000|NOT COMPLETED|Overall Study||2||
59929307|NCT03199963|76047555|FG001|NOT COMPLETED|Optional Open-Label Phase - BHR-700||6||
59929308|NCT03883581|76047567|FG000|STARTED|Overall Study||28||
59929309|NCT03883581|76047567|FG000|COMPLETED|Overall Study||24||
59929310|NCT03883581|76047567|FG000|NOT COMPLETED|Overall Study||4||
59929311|NCT03029208|76047573|FG000|STARTED|Overall Study||157||
59929312|NCT03029208|76047574|FG001|STARTED|Overall Study||155||
59929313|NCT03029208|76047573|FG000|COMPLETED|Overall Study||155||
59929314|NCT03029208|76047574|FG001|COMPLETED|Overall Study||151||
59929315|NCT03029208|76047573|FG000|NOT COMPLETED|Overall Study||2||
59929316|NCT03029208|76047574|FG001|NOT COMPLETED|Overall Study||4||
59929317|NCT03198715|76047594|FG000|STARTED|Overall Study||6||
59929318|NCT03198715|76047595|FG001|STARTED|Overall Study||12||
59929319|NCT03198715|76047596|FG002|STARTED|Overall Study||12||
59929320|NCT03198715|76047597|FG003|STARTED|Overall Study||3||
59929321|NCT03198715|76047598|FG004|STARTED|Overall Study||9||
59929322|NCT03198715|76047594|FG000|COMPLETED|Overall Study||6||
59929323|NCT03198715|76047595|FG001|COMPLETED|Overall Study||11||
59929324|NCT03198715|76047596|FG002|COMPLETED|Overall Study||10||
59929325|NCT03198715|76047597|FG003|COMPLETED|Overall Study||3||
59929326|NCT03198715|76047598|FG004|COMPLETED|Overall Study||7||
59929327|NCT03198715|76047594|FG000|NOT COMPLETED|Overall Study||0||
59929328|NCT03198715|76047595|FG001|NOT COMPLETED|Overall Study||1||
59929329|NCT03198715|76047596|FG002|NOT COMPLETED|Overall Study||2||
59929330|NCT03198715|76047597|FG003|NOT COMPLETED|Overall Study||0||
59929331|NCT03198715|76047598|FG004|NOT COMPLETED|Overall Study||2||
59929332|NCT03960138|76047612|FG000|STARTED|Second TBS||20||
59929333|NCT03960138|76047613|FG001|STARTED|Second TBS||21||
59929334|NCT03960138|76047612|FG000|COMPLETED|Second TBS||16||
59929335|NCT03960138|76047613|FG001|COMPLETED|Second TBS||21||
59929336|NCT03960138|76047612|FG000|NOT COMPLETED|Second TBS||4||
59929337|NCT03960138|76047613|FG001|NOT COMPLETED|Second TBS||0||
59929338|NCT03960138|76047612|FG000|STARTED|First TBS||20||
59929339|NCT03960138|76047613|FG001|STARTED|First TBS||21||
59929340|NCT03960138|76047612|FG000|COMPLETED|First TBS||16||
59929341|NCT03960138|76047613|FG001|COMPLETED|First TBS||21||
59929342|NCT03960138|76047612|FG000|NOT COMPLETED|First TBS||4||
59929343|NCT03960138|76047613|FG001|NOT COMPLETED|First TBS||0||
59929344|NCT03088917|76047619|FG000|STARTED|Overall Study||106||
59929345|NCT03088917|76047619|FG000|COMPLETED|Overall Study||10||
59929346|NCT03088917|76047619|FG000|NOT COMPLETED|Overall Study||96||
59929347|NCT03087513|76047625|FG000|STARTED|First Intervention||40||
59929348|NCT03087513|76047625|FG000|COMPLETED|First Intervention||40||
59929349|NCT03087513|76047625|FG000|NOT COMPLETED|First Intervention||0||
59929350|NCT03087513|76047625|FG000|STARTED|Second Intervention After 3 hr Washout||40||
59929351|NCT03087513|76047625|FG000|COMPLETED|Second Intervention After 3 hr Washout||38||
59929352|NCT03087513|76047625|FG000|NOT COMPLETED|Second Intervention After 3 hr Washout||2||
59929353|NCT02917629|76047640|FG000|STARTED|Overall Study||4||
59929354|NCT02917629|76047641|FG001|STARTED|Overall Study||2||
59929355|NCT02917629|76047640|FG000|Considered Study Compliant|Overall Study||4||
59929356|NCT02917629|76047641|FG001|Considered Study Compliant|Overall Study||1||
59929357|NCT02917629|76047640|FG000|Experienced Study Drug Interruption|Overall Study||2||
59929358|NCT02917629|76047641|FG001|Experienced Study Drug Interruption|Overall Study||1||
59929359|NCT02917629|76047640|FG000|COMPLETED|Overall Study||4||
60062924|NCT01439074|76178192|FG000|NOT COMPLETED|Overall Study||9||
60062925|NCT01439074|76178193|FG001|NOT COMPLETED|Overall Study||13||
60062926|NCT01438996|76178202|FG000|STARTED|Overall Study||18||
60062927|NCT01438996|76178203|FG001|STARTED|Overall Study||13||
59517261|NCT03460990|75611044|FG000|STARTED|Overall Study||57||
59929360|NCT02917629|76047641|FG001|COMPLETED|Overall Study||1||
59929361|NCT02917629|76047640|FG000|NOT COMPLETED|Overall Study||0||
59929362|NCT02917629|76047641|FG001|NOT COMPLETED|Overall Study||1||
59929363|NCT02927847|76047650|FG000|STARTED|Overall Study||16||
59929364|NCT02927847|76047651|FG001|STARTED|Overall Study||19||
59929365|NCT02927847|76047650|FG000|COMPLETED|Overall Study||10||
59929366|NCT02927847|76047651|FG001|COMPLETED|Overall Study||16||
59929367|NCT02927847|76047650|FG000|NOT COMPLETED|Overall Study||6||
60062928|NCT01438996|76178204|FG002|STARTED|Overall Study||20||
60062929|NCT01438996|76178202|FG000|COMPLETED|Overall Study||14||
60062930|NCT01438996|76178203|FG001|COMPLETED|Overall Study||12||
59929368|NCT02927847|76047651|FG001|NOT COMPLETED|Overall Study||3||
59929369|NCT02960438|76047661|FG000|STARTED|Treatment Phase (Double-blind): 24 Weeks||56||
59929370|NCT02960438|76047662|FG001|STARTED|Treatment Phase (Double-blind): 24 Weeks||29||
60062931|NCT01438996|76178204|FG002|COMPLETED|Overall Study||20||
59761150|NCT00881712|75880820|FG001|NOT COMPLETED|Overall Study||0||
59761151|NCT00881712|75880821|FG002|NOT COMPLETED|Overall Study||0||
59761152|NCT03955471|75880829|FG000|STARTED|Overall Study||41||
59761153|NCT03955471|75880829|FG000|COMPLETED|Overall Study||1||
59929371|NCT02960438|76047663|FG002|STARTED|Treatment Phase (Double-blind): 24 Weeks||54||
60062932|NCT01438996|76178202|FG000|NOT COMPLETED|Overall Study||4||
60062933|NCT01438996|76178203|FG001|NOT COMPLETED|Overall Study||1||
60062934|NCT01438996|76178204|FG002|NOT COMPLETED|Overall Study||0||
59761154|NCT03955471|75880829|FG000|NOT COMPLETED|Overall Study||40||
59761155|NCT00880542|75880833|FG000|STARTED|Treatment Period (Sorafenib+Ifosfamide)||7||
59761156|NCT00880542|75880833|FG000|COMPLETED|Treatment Period (Sorafenib+Ifosfamide)||4||
59761157|NCT00880542|75880833|FG000|NOT COMPLETED|Treatment Period (Sorafenib+Ifosfamide)||3||
59761158|NCT00880542|75880833|FG000|STARTED|Response Evaluation Period(REP): PET/CT||4||
59761159|NCT00880542|75880833|FG000|COMPLETED|Response Evaluation Period(REP): PET/CT||4||
59761160|NCT00880542|75880833|FG000|NOT COMPLETED|Response Evaluation Period(REP): PET/CT||0||
59761161|NCT00880542|75880833|FG000|STARTED|REP: Surgical Resection||4||
59761162|NCT00880542|75880833|FG000|COMPLETED|REP: Surgical Resection||3||
59761163|NCT00880542|75880833|FG000|NOT COMPLETED|REP: Surgical Resection||1||
59761164|NCT00880542|75880833|FG000|STARTED|Post Surgical Evaluation||3||
60062935|NCT01438840|76178214|FG000|STARTED|Core Study||17||
60062936|NCT01438840|76178215|FG001|STARTED|Core Study||32||
60062937|NCT01438840|76178216|FG002|STARTED|Core Study||0||
60062938|NCT01438840|76178214|FG000|COMPLETED|Core Study||1||
60062939|NCT01438840|76178215|FG001|COMPLETED|Core Study||22||
60062940|NCT01438840|76178216|FG002|COMPLETED|Core Study||0||
60062941|NCT01438840|76178214|FG000|NOT COMPLETED|Core Study||16||
60062942|NCT01438840|76178215|FG001|NOT COMPLETED|Core Study||10||
60062943|NCT01438840|76178216|FG002|NOT COMPLETED|Core Study||0||
60062944|NCT01438840|76178214|FG000|STARTED|Extension Phase||0||
60062945|NCT01438840|76178215|FG001|STARTED|Extension Phase||0||
60062946|NCT01438840|76178216|FG002|STARTED|Extension Phase|39 participants met eligibility criteria for the Extension Phase.|39||
60062947|NCT01438840|76178214|FG000|COMPLETED|Extension Phase||0||
60062948|NCT01438840|76178215|FG001|COMPLETED|Extension Phase||0||
60062949|NCT01438840|76178216|FG002|COMPLETED|Extension Phase||29||
60062950|NCT01438840|76178214|FG000|NOT COMPLETED|Extension Phase||0||
60062951|NCT01438840|76178215|FG001|NOT COMPLETED|Extension Phase||0||
60062952|NCT01438840|76178216|FG002|NOT COMPLETED|Extension Phase||10||
60062953|NCT01471054|76178225|FG000|STARTED|Overall Study||5||
60062954|NCT01471054|76178226|FG001|STARTED|Overall Study||1||
60062955|NCT01471054|76178225|FG000|COMPLETED|Overall Study||1||
60062956|NCT01471054|76178226|FG001|COMPLETED|Overall Study||1||
60062957|NCT01471054|76178225|FG000|NOT COMPLETED|Overall Study||4||
60062958|NCT01471054|76178226|FG001|NOT COMPLETED|Overall Study||0||
60062959|NCT01978184|76178244|FG000|STARTED|Overall Study||43||
60062960|NCT01978184|76178245|FG001|STARTED|Overall Study||61||
59517262|NCT03460990|75611045|FG001|STARTED|Overall Study||54||
59517263|NCT03460990|75611044|FG000|COMPLETED|Overall Study||57||
59761165|NCT00880542|75880833|FG000|COMPLETED|Post Surgical Evaluation|none of the 3 subjects met study criteria for continuation of therapy.|3||
59929372|NCT02960438|76047664|FG003|STARTED|Treatment Phase (Double-blind): 24 Weeks||55||
59929373|NCT02960438|76047661|FG000|Treated Participants|Treatment Phase (Double-blind): 24 Weeks||54||
59929374|NCT02960438|76047662|FG001|Treated Participants|Treatment Phase (Double-blind): 24 Weeks||28||
59929375|NCT02960438|76047663|FG002|Treated Participants|Treatment Phase (Double-blind): 24 Weeks||54||
59929376|NCT02960438|76047664|FG003|Treated Participants|Treatment Phase (Double-blind): 24 Weeks||54||
59929377|NCT02960438|76047661|FG000|COMPLETED|Treatment Phase (Double-blind): 24 Weeks||47||
59929378|NCT02960438|76047662|FG001|COMPLETED|Treatment Phase (Double-blind): 24 Weeks||26||
59929379|NCT02960438|76047663|FG002|COMPLETED|Treatment Phase (Double-blind): 24 Weeks||50||
59929380|NCT02960438|76047664|FG003|COMPLETED|Treatment Phase (Double-blind): 24 Weeks||46||
59929381|NCT02960438|76047661|FG000|NOT COMPLETED|Treatment Phase (Double-blind): 24 Weeks||9||
59929382|NCT02960438|76047662|FG001|NOT COMPLETED|Treatment Phase (Double-blind): 24 Weeks||3||
60062961|NCT01978184|76178244|FG000|COMPLETED|Overall Study||30||
60062962|NCT01978184|76178245|FG001|COMPLETED|Overall Study||41||
60062963|NCT01978184|76178244|FG000|NOT COMPLETED|Overall Study||13||
60062964|NCT01978184|76178245|FG001|NOT COMPLETED|Overall Study||20||
60062965|NCT01445548|76178251|FG000|STARTED|Overall Study||6||
60062966|NCT01445548|76178251|FG000|COMPLETED|Overall Study||5||
59517264|NCT03460990|75611045|FG001|COMPLETED|Overall Study||54||
59761166|NCT00880542|75880833|FG000|NOT COMPLETED|Post Surgical Evaluation||0||
59761167|NCT00880542|75880833|FG000|STARTED|Continued Treatment Period|None of the 3 subjects from previous period met study criteria for continuation of therapy.|0||
59929383|NCT02960438|76047663|FG002|NOT COMPLETED|Treatment Phase (Double-blind): 24 Weeks||4||
59929384|NCT02960438|76047664|FG003|NOT COMPLETED|Treatment Phase (Double-blind): 24 Weeks||9||
59929385|NCT02960438|76047661|FG000|STARTED|Extension Phase (Open-label): 80 Weeks||47||
59929386|NCT02960438|76047662|FG001|STARTED|Extension Phase (Open-label): 80 Weeks||26||
60062967|NCT01445548|76178251|FG000|NOT COMPLETED|Overall Study||1||
60062968|NCT01977794|76178257|FG000|STARTED|Overall Study||100||
60062969|NCT01977794|76178258|FG001|STARTED|Overall Study||100||
60062970|NCT01977794|76178257|FG000|COMPLETED|Overall Study||92||
60062971|NCT01977794|76178258|FG001|COMPLETED|Overall Study||94||
60062972|NCT01977794|76178257|FG000|NOT COMPLETED|Overall Study||8||
60062973|NCT01977794|76178258|FG001|NOT COMPLETED|Overall Study||6||
60062974|NCT02005484|76178264|FG000|STARTED|Overall Study||6||
60062975|NCT02005484|76178264|FG000|COMPLETED|Overall Study||2||
60062976|NCT02005484|76178264|FG000|NOT COMPLETED|Overall Study||4||
60062977|NCT02005250|76178270|FG000|STARTED|Overall Study||61||
60062978|NCT02005250|76178271|FG001|STARTED|Overall Study||32||
60062979|NCT02005250|76178270|FG000|COMPLETED|Overall Study||46||
60062980|NCT02005250|76178271|FG001|COMPLETED|Overall Study||27||
60062981|NCT02005250|76178270|FG000|NOT COMPLETED|Overall Study||15||
60062982|NCT02005250|76178271|FG001|NOT COMPLETED|Overall Study||5||
60062983|NCT02024750|76178279|FG000|STARTED|Overall Study||106||
60062984|NCT02024750|76178280|FG001|STARTED|Overall Study||108||
60062985|NCT02024750|76178279|FG000|COMPLETED|Overall Study||104||
60062986|NCT02024750|76178280|FG001|COMPLETED|Overall Study||107||
60062987|NCT02024750|76178279|FG000|NOT COMPLETED|Overall Study||2||
60062988|NCT02024750|76178280|FG001|NOT COMPLETED|Overall Study||1||
60062989|NCT01597973|76178288|FG000|STARTED|Overall Study||234|Started means randomized, here.|
60062990|NCT01597973|76178289|FG001|STARTED|Overall Study||230|Started means randomized, here.|
60062991|NCT01597973|76178288|FG000|Began First Dose|Overall Study||230||
60062992|NCT01597973|76178289|FG001|Began First Dose|Overall Study||228||
60062993|NCT01597973|76178288|FG000|COMPLETED|Overall Study||214||
60062994|NCT01597973|76178289|FG001|COMPLETED|Overall Study||211||
60062995|NCT01597973|76178288|FG000|NOT COMPLETED|Overall Study||20||
60062996|NCT01597973|76178289|FG001|NOT COMPLETED|Overall Study||19||
60062997|NCT02023268|76178299|FG000|STARTED|Overall Study||52||
60062998|NCT02023268|76178300|FG001|STARTED|Overall Study||53||
60062999|NCT02023268|76178299|FG000|COMPLETED|Overall Study||52||
60063000|NCT02023268|76178300|FG001|COMPLETED|Overall Study||49||
60063001|NCT02023268|76178299|FG000|NOT COMPLETED|Overall Study||0||
60063002|NCT02023268|76178300|FG001|NOT COMPLETED|Overall Study||4||
60063003|NCT02047253|76178306|FG000|STARTED|Overall Study||28||
60063004|NCT02047253|76178306|FG000|COMPLETED|Overall Study||20||
60063005|NCT02047253|76178306|FG000|NOT COMPLETED|Overall Study||8||
60063006|NCT02096705|76178312|FG000|STARTED|Treatment||133||
60063007|NCT02096705|76178313|FG001|STARTED|Treatment||139||
60063008|NCT02096705|76178312|FG000|COMPLETED|Treatment||124||
60063009|NCT02096705|76178313|FG001|COMPLETED|Treatment||134||
60063010|NCT02096705|76178312|FG000|NOT COMPLETED|Treatment||9||
60063011|NCT02096705|76178313|FG001|NOT COMPLETED|Treatment||5||
60063012|NCT02096705|76178312|FG000|STARTED|Follow-up|5 participants in this arm did not complete the treatment period and rejoined for follow-up|129||
60063013|NCT02096705|76178313|FG001|STARTED|Follow-up|5 participants in this arm did not complete the treatment period and rejoined for follow-up|139||
60063014|NCT02096705|76178312|FG000|COMPLETED|Follow-up||125||
60063015|NCT02096705|76178313|FG001|COMPLETED|Follow-up||135||
60063016|NCT02096705|76178312|FG000|NOT COMPLETED|Follow-up||4||
60063017|NCT02096705|76178313|FG001|NOT COMPLETED|Follow-up||4||
60063018|NCT02096471|76178319|FG000|STARTED|Overall Study||19||19
60063019|NCT02096471|76178319|FG000|COMPLETED|Overall Study|Participants terminated the study if a partial response was not achieved and/or maintained.|6|This is a single group study and the units assigned data element is the target lesion.|6
60063020|NCT02096471|76178319|FG000|NOT COMPLETED|Overall Study||13||13
60063021|NCT02096003|76178325|FG000|STARTED|Overall Study||40||
60063022|NCT02096003|76178326|FG001|STARTED|Overall Study||40||
60063023|NCT02096003|76178325|FG000|COMPLETED|Overall Study||38||
60063024|NCT02096003|76178326|FG001|COMPLETED|Overall Study||37||
60063025|NCT02096003|76178325|FG000|NOT COMPLETED|Overall Study||2||
60063026|NCT02096003|76178326|FG001|NOT COMPLETED|Overall Study||3||
60063027|NCT02062385|76178336|FG000|STARTED|Overall Study||1620||
60063028|NCT02062385|76178337|FG001|STARTED|Overall Study||1620||
60063029|NCT02062385|76178338|FG002|STARTED|Overall Study||400||
60063030|NCT02062385|76178339|FG003|STARTED|Overall Study||400||
60063031|NCT02062385|76178336|FG000|Received Vaccination 1|Overall Study||1618||
60063032|NCT02062385|76178337|FG001|Received Vaccination 1|Overall Study||1619||
60063033|NCT02062385|76178338|FG002|Received Vaccination 1|Overall Study||400||
60063034|NCT02062385|76178339|FG003|Received Vaccination 1|Overall Study||400||
60063035|NCT02062385|76178336|FG000|Received Vaccination 2|Overall Study||1554||
60063036|NCT02062385|76178337|FG001|Received Vaccination 2|Overall Study||1566||
60063037|NCT02062385|76178338|FG002|Received Vaccination 2|Overall Study||392||
60063038|NCT02062385|76178339|FG003|Received Vaccination 2|Overall Study||393||
60063039|NCT02062385|76178336|FG000|Received Vaccination 3|Overall Study||1543||
60063040|NCT02062385|76178337|FG001|Received Vaccination 3|Overall Study||1554||
60063041|NCT02062385|76178338|FG002|Received Vaccination 3|Overall Study||389||
60063042|NCT02062385|76178339|FG003|Received Vaccination 3|Overall Study||392||
60063043|NCT02062385|76178336|FG000|COMPLETED|Overall Study||1542||
60063044|NCT02062385|76178337|FG001|COMPLETED|Overall Study||1555||
60063045|NCT02062385|76178338|FG002|COMPLETED|Overall Study||388||
60063046|NCT02062385|76178339|FG003|COMPLETED|Overall Study||391||
60063047|NCT02062385|76178336|FG000|NOT COMPLETED|Overall Study||78||
60063048|NCT02062385|76178337|FG001|NOT COMPLETED|Overall Study||65||
60063049|NCT02062385|76178338|FG002|NOT COMPLETED|Overall Study||12||
60063050|NCT02062385|76178339|FG003|NOT COMPLETED|Overall Study||9||
60063051|NCT02062151|76178347|FG000|STARTED|Overall Study||21||
60063052|NCT02062151|76178347|FG000|COMPLETED|Overall Study||20||
60063053|NCT02062151|76178347|FG000|NOT COMPLETED|Overall Study||1||
60063054|NCT02060903|76178353|FG000|STARTED|Overall Study||187||
60063055|NCT02060903|76178354|FG001|STARTED|Overall Study||192||
60063056|NCT02060903|76178353|FG000|COMPLETED|Overall Study||183||
60063057|NCT02060903|76178354|FG001|COMPLETED|Overall Study||185||
60063058|NCT02060903|76178353|FG000|NOT COMPLETED|Overall Study||4||
60063059|NCT02060903|76178354|FG001|NOT COMPLETED|Overall Study||7||
60063060|NCT02095691|76178360|FG000|STARTED|Overall Study|Subjects who were consented and treated with study ablation catheter.|19||
60063061|NCT02095691|76178360|FG000|COMPLETED|Overall Study|Subjects with follow up available at 12 months.|18||
59517265|NCT03460990|75611044|FG000|NOT COMPLETED|Overall Study||0||
59517266|NCT03460990|75611045|FG001|NOT COMPLETED|Overall Study||0||
59929387|NCT02960438|76047663|FG002|STARTED|Extension Phase (Open-label): 80 Weeks||50||
59929388|NCT02960438|76047664|FG003|STARTED|Extension Phase (Open-label): 80 Weeks||46||
59929389|NCT02960438|76047661|FG000|COMPLETED|Extension Phase (Open-label): 80 Weeks||36||
59929390|NCT02960438|76047662|FG001|COMPLETED|Extension Phase (Open-label): 80 Weeks||17||
59929391|NCT02960438|76047663|FG002|COMPLETED|Extension Phase (Open-label): 80 Weeks||36||
59929392|NCT02960438|76047664|FG003|COMPLETED|Extension Phase (Open-label): 80 Weeks||35||
59929393|NCT02960438|76047661|FG000|NOT COMPLETED|Extension Phase (Open-label): 80 Weeks||11||
59929394|NCT02960438|76047662|FG001|NOT COMPLETED|Extension Phase (Open-label): 80 Weeks||9||
59929395|NCT02960438|76047663|FG002|NOT COMPLETED|Extension Phase (Open-label): 80 Weeks||14||
59929396|NCT02960438|76047664|FG003|NOT COMPLETED|Extension Phase (Open-label): 80 Weeks||11||
59929397|NCT02957942|76047684|FG000|STARTED|Overall Study||7||
59929398|NCT02957942|76047685|FG001|STARTED|Overall Study|7 healthy individuals were recruited as control; 6 were recruited for practicing experiment details.|13||
59929399|NCT02957942|76047684|FG000|COMPLETED|Overall Study||7||
59929400|NCT02957942|76047685|FG001|COMPLETED|Overall Study||6||
59929401|NCT02957942|76047684|FG000|NOT COMPLETED|Overall Study||0||
59929402|NCT02957942|76047685|FG001|NOT COMPLETED|Overall Study||7||
59929403|NCT02959970|76047693|FG000|STARTED|Overall Study||17||
59929404|NCT02959970|76047694|FG001|STARTED|Overall Study||83||
59929405|NCT02959970|76047693|FG000|COMPLETED|Overall Study||15||
59929406|NCT02959970|76047694|FG001|COMPLETED|Overall Study||76||
59929407|NCT02959970|76047693|FG000|NOT COMPLETED|Overall Study||2||
59929408|NCT02959970|76047694|FG001|NOT COMPLETED|Overall Study||7||
59929409|NCT03681990|76047702|FG000|STARTED|Overall Study||28||84
59929410|NCT03681990|76047702|FG000|COMPLETED|Overall Study||28||84
59929411|NCT03681990|76047702|FG000|NOT COMPLETED|Overall Study||0||0
59929412|NCT04690413|76047711|FG000|STARTED|Overall Study||129||
59929413|NCT04690413|76047711|FG000|COMPLETED|Overall Study||124||
59929414|NCT04690413|76047711|FG000|NOT COMPLETED|Overall Study||5||
59929415|NCT02740335|76047717|FG000|STARTED|Overall Study||105||
59929416|NCT02740335|76047718|FG001|STARTED|Overall Study||103||
59929417|NCT02740335|76047717|FG000|COMPLETED|Overall Study||105||
59929418|NCT02740335|76047718|FG001|COMPLETED|Overall Study||103||
59929419|NCT02740335|76047717|FG000|NOT COMPLETED|Overall Study||0||
59929420|NCT02740335|76047718|FG001|NOT COMPLETED|Overall Study||0||
59929421|NCT05300763|76047727|FG000|STARTED|Overall Study||171||
59929422|NCT05300763|76047728|FG001|STARTED|Overall Study||171||
59929423|NCT05300763|76047727|FG000|COMPLETED|Overall Study||169||
59929424|NCT05300763|76047728|FG001|COMPLETED|Overall Study||170||
59929425|NCT05300763|76047727|FG000|NOT COMPLETED|Overall Study||2||
59929426|NCT05300763|76047728|FG001|NOT COMPLETED|Overall Study||1||
59929427|NCT01383135|76047738|FG000|STARTED|Overall Study||6||
59929428|NCT01383135|76047739|FG001|STARTED|Overall Study||8||
59929429|NCT01383135|76047740|FG002|STARTED|Overall Study||9||
59929430|NCT01383135|76047741|FG003|STARTED|Overall Study||4||
59929431|NCT01383135|76047738|FG000|COMPLETED|Overall Study||5||
59929432|NCT01383135|76047739|FG001|COMPLETED|Overall Study||8||
59929433|NCT01383135|76047740|FG002|COMPLETED|Overall Study||8||
59929434|NCT01383135|76047741|FG003|COMPLETED|Overall Study||4||
59929435|NCT01383135|76047738|FG000|NOT COMPLETED|Overall Study||1||
59929436|NCT01383135|76047739|FG001|NOT COMPLETED|Overall Study||0||
59929437|NCT01383135|76047740|FG002|NOT COMPLETED|Overall Study||1||
59929438|NCT01383135|76047741|FG003|NOT COMPLETED|Overall Study||0||
59517267|NCT01052545|75611053|FG000|STARTED|Overall Study||867||
59517268|NCT01052545|75611054|FG001|STARTED|Overall Study||731||
59929439|NCT02925312|76047754|FG000|STARTED|Overall Study||125||
59929440|NCT02925312|76047755|FG001|STARTED|Overall Study||294||
59929441|NCT02925312|76047754|FG000|COMPLETED|Overall Study||98||
59929442|NCT02925312|76047755|FG001|COMPLETED|Overall Study||294||
59929443|NCT02925312|76047754|FG000|NOT COMPLETED|Overall Study||27||
59929444|NCT02925312|76047755|FG001|NOT COMPLETED|Overall Study||0||
59929445|NCT01783041|76047763|FG000|STARTED|First 2 Weeks of Life||72||
59929446|NCT01783041|76047764|FG001|STARTED|First 2 Weeks of Life||72||
59929447|NCT01783041|76047763|FG000|COMPLETED|First 2 Weeks of Life||69||
60063062|NCT02095691|76178360|FG000|NOT COMPLETED|Overall Study||1||
60063063|NCT02095535|76178376|FG000|STARTED|Recruitment||20||
60063064|NCT02095535|76178376|FG000|COMPLETED|Recruitment||18||
60063065|NCT02095535|76178376|FG000|NOT COMPLETED|Recruitment||2||
60063066|NCT02095535|76178376|FG000|STARTED|Analysis||18||
60063067|NCT02095535|76178376|FG000|COMPLETED|Analysis||18||
60063068|NCT02095535|76178376|FG000|NOT COMPLETED|Analysis||0||
60063069|NCT02095223|76178382|FG000|STARTED|Overall Study||2||
60063070|NCT02095223|76178383|FG001|STARTED|Overall Study||2||
60063071|NCT02095223|76178382|FG000|COMPLETED|Overall Study|1 participant dropped out of this study due to the time commitment associated with participation.|1||
60063072|NCT02095223|76178383|FG001|COMPLETED|Overall Study||2||
60063073|NCT02095223|76178382|FG000|NOT COMPLETED|Overall Study||1||
59517269|NCT01052545|75611053|FG000|COMPLETED|Overall Study||867||
59517270|NCT01052545|75611054|FG001|COMPLETED|Overall Study||731||
59517271|NCT01052545|75611053|FG000|NOT COMPLETED|Overall Study||0||
60063074|NCT02095223|76178383|FG001|NOT COMPLETED|Overall Study||0||
60063075|NCT02095145|76178391|FG000|STARTED|Overall Study||15||
60063076|NCT02095145|76178392|FG001|STARTED|Overall Study||15||
60063077|NCT02095145|76178391|FG000|COMPLETED|Overall Study||14||
60063078|NCT02095145|76178392|FG001|COMPLETED|Overall Study||15||
60063079|NCT02095145|76178391|FG000|NOT COMPLETED|Overall Study||1||
60063080|NCT02095145|76178392|FG001|NOT COMPLETED|Overall Study||0||
60063081|NCT02059187|76178402|FG000|STARTED|Overall Study||265||
60063082|NCT02059187|76178403|FG001|STARTED|Overall Study||266||
60063083|NCT02059187|76178402|FG000|COMPLETED|Overall Study||240||
60063084|NCT02059187|76178403|FG001|COMPLETED|Overall Study||244||
60063085|NCT02059187|76178402|FG000|NOT COMPLETED|Overall Study||25||
60063086|NCT02059187|76178403|FG001|NOT COMPLETED|Overall Study||22||
60063087|NCT02043899|76178409|FG000|STARTED|Overall Study||36||
59929448|NCT01783041|76047764|FG001|COMPLETED|First 2 Weeks of Life||71||
59929449|NCT01783041|76047763|FG000|NOT COMPLETED|First 2 Weeks of Life||3||
59929450|NCT01783041|76047764|FG001|NOT COMPLETED|First 2 Weeks of Life||1||
59929451|NCT01783041|76047763|FG000|STARTED|NNNS Examination at Term Equivalent Age||69||
59929452|NCT01783041|76047764|FG001|STARTED|NNNS Examination at Term Equivalent Age||71||
60063088|NCT02043899|76178409|FG000|Underwent Routine [123I]mIBG Planar and SPECT/CT Imaging|Overall Study||32||
60063089|NCT02043899|76178409|FG000|Underwent [124I]mIBG PET/CT Imaging|Overall Study||9||
60063090|NCT02043899|76178409|FG000|COMPLETED|Overall Study||9||
60063091|NCT02043899|76178409|FG000|NOT COMPLETED|Overall Study||27||
60063092|NCT02043509|76178415|FG000|STARTED|Baseline to 1st Follow-up||203||
60063093|NCT02043509|76178416|FG001|STARTED|Baseline to 1st Follow-up||204||
60063094|NCT02043509|76178415|FG000|COMPLETED|Baseline to 1st Follow-up||138||
60063095|NCT02043509|76178416|FG001|COMPLETED|Baseline to 1st Follow-up||157||
59761168|NCT00880542|75880833|FG000|COMPLETED|Continued Treatment Period||0||
59761169|NCT00880542|75880833|FG000|NOT COMPLETED|Continued Treatment Period||0||
59761170|NCT00880542|75880833|FG000|STARTED|Follow-up Period|All 7 patients who started the treatment period completed the follow-up period.|7||
59761171|NCT00880542|75880833|FG000|COMPLETED|Follow-up Period||7||
59761172|NCT00880542|75880833|FG000|NOT COMPLETED|Follow-up Period||0||
59929453|NCT01783041|76047763|FG000|COMPLETED|NNNS Examination at Term Equivalent Age||60||
59929454|NCT01783041|76047764|FG001|COMPLETED|NNNS Examination at Term Equivalent Age||59||
59929455|NCT01783041|76047763|FG000|NOT COMPLETED|NNNS Examination at Term Equivalent Age||9||
59929456|NCT01783041|76047764|FG001|NOT COMPLETED|NNNS Examination at Term Equivalent Age||12||
59929457|NCT03196297|76047770|FG000|STARTED|Main Period||36|Concizumab- Main part|
59929458|NCT03196297|76047770|FG000|Full Analysis Set (FAS)|Main Period||36||
59929459|NCT03196297|76047770|FG000|Subject Analysis Set (SAS)|Main Period||36||
59929460|NCT03196297|76047770|FG000|COMPLETED|Main Period||32||
59929461|NCT03196297|76047770|FG000|NOT COMPLETED|Main Period||4||
59929462|NCT03196297|76047770|FG000|STARTED|Extension Period||32||
59929463|NCT03196297|76047770|FG000|FAS|Extension Period||32||
60063096|NCT02043509|76178415|FG000|NOT COMPLETED|Baseline to 1st Follow-up||65||
60063097|NCT02043509|76178416|FG001|NOT COMPLETED|Baseline to 1st Follow-up||47||
59517272|NCT01052545|75611054|FG001|NOT COMPLETED|Overall Study||0||
59761173|NCT00885534|75880837|FG000|STARTED|Overall Study||7||
59761174|NCT00885534|75880837|FG000|COMPLETED|Overall Study||6||
59929464|NCT03196297|76047770|FG000|SAS|Extension Period||32||
59929465|NCT03196297|76047770|FG000|COMPLETED|Extension Period||29||
60063098|NCT02043509|76178415|FG000|STARTED|Baseline to 2nd Follow-up||203|Note that participants who were lost to 1st follow-up could be present at 2nd follow-up.|
60063099|NCT02043509|76178416|FG001|STARTED|Baseline to 2nd Follow-up||204|Note that participants who were lost to 1st follow-up could be present at 2nd follow-up.|
60063100|NCT02043509|76178415|FG000|COMPLETED|Baseline to 2nd Follow-up||129||
60063101|NCT02043509|76178416|FG001|COMPLETED|Baseline to 2nd Follow-up||132||
60063102|NCT02043509|76178415|FG000|NOT COMPLETED|Baseline to 2nd Follow-up||74||
59517273|NCT03319810|75611072|FG000|STARTED|Overall Study||5||
59517274|NCT03319810|75611072|FG000|COMPLETED|Overall Study||5||
59517275|NCT03319810|75611072|FG000|NOT COMPLETED|Overall Study||0||
59517276|NCT01052701|75611078|FG000|STARTED|Overall Study||14||
59517277|NCT01052701|75611079|FG001|STARTED|Overall Study||12||
59613099|NCT01713348|75724187|FG003|COMPLETED|Overall Study||15||
59761175|NCT00885534|75880837|FG000|NOT COMPLETED|Overall Study||1||
60063103|NCT02043509|76178416|FG001|NOT COMPLETED|Baseline to 2nd Follow-up||72||
59517278|NCT01052701|75611078|FG000|COMPLETED|Overall Study||14||
59517279|NCT01052701|75611079|FG001|COMPLETED|Overall Study||12||
59517280|NCT01052701|75611078|FG000|NOT COMPLETED|Overall Study||0||
59517281|NCT01052701|75611079|FG001|NOT COMPLETED|Overall Study||0||
59929466|NCT03196297|76047770|FG000|NOT COMPLETED|Extension Period||3||
59929467|NCT03192475|76047788|FG000|STARTED|Overall Study||162||
59929468|NCT03192475|76047789|FG001|STARTED|Overall Study||160||
59929469|NCT03192475|76047788|FG000|COMPLETED|Overall Study||149||
59613100|NCT01713348|75724184|FG000|NOT COMPLETED|Overall Study||4||
59929470|NCT03192475|76047789|FG001|COMPLETED|Overall Study||151||
59929471|NCT03192475|76047788|FG000|NOT COMPLETED|Overall Study||13||
59929472|NCT03192475|76047789|FG001|NOT COMPLETED|Overall Study||9||
59929473|NCT03189745|76047798|FG000|STARTED|Overall Study||170||
59929474|NCT03189745|76047799|FG001|STARTED|Overall Study||59||
59929475|NCT03189745|76047798|FG000|COMPLETED|Overall Study||169||
60063104|NCT02058563|76178424|FG000|STARTED|Overall Study||454||
60063105|NCT02058563|76178425|FG001|STARTED|Overall Study||457||
60063106|NCT02058563|76178424|FG000|COMPLETED|Overall Study||426||
60063107|NCT02058563|76178425|FG001|COMPLETED|Overall Study||433||
60063108|NCT02058563|76178424|FG000|NOT COMPLETED|Overall Study||28||
60063109|NCT02058563|76178425|FG001|NOT COMPLETED|Overall Study||24||
60063110|NCT01622231|76178431|FG000|STARTED|Overall Study||61||
60063111|NCT01622231|76178431|FG000|COMPLETED|Overall Study||59||
60063112|NCT01622231|76178431|FG000|NOT COMPLETED|Overall Study||2||
60063113|NCT02042183|76178437|FG000|STARTED|Overall Study||404||
60063114|NCT02042183|76178438|FG001|STARTED|Overall Study||202||
60063115|NCT02042183|76178437|FG000|Safety Population|Overall Study||400|All participants who took at least one dose of double-blinded study medication.|
60063116|NCT02042183|76178438|FG001|Safety Population|Overall Study||195|All participants who took at least one dose of double-blinded study medication.|
60063117|NCT02042183|76178437|FG000|Modified Intent-to-treat (mITT)|Overall Study||399|All participants in safety population who have at least one efficacy assessment.|
60063118|NCT02042183|76178438|FG001|Modified Intent-to-treat (mITT)|Overall Study||195|All participants in safety population who have at least one efficacy assessment.|
60063119|NCT02042183|76178437|FG000|COMPLETED|Overall Study||339||
60063120|NCT02042183|76178438|FG001|COMPLETED|Overall Study||166||
60063121|NCT02042183|76178437|FG000|NOT COMPLETED|Overall Study||65||
60063122|NCT02042183|76178438|FG001|NOT COMPLETED|Overall Study||36||
60063123|NCT01977482|76178452|FG000|STARTED|Overall Study||39||
60063124|NCT01977482|76178453|FG001|STARTED|Overall Study||39||
59613101|NCT01713348|75724185|FG001|NOT COMPLETED|Overall Study||2||
59613102|NCT01713348|75724186|FG002|NOT COMPLETED|Overall Study||2||
59613103|NCT01713348|75724187|FG003|NOT COMPLETED|Overall Study||0||
59613104|NCT01737996|75724200|FG000|STARTED|Overall Study||8||
59761176|NCT00885378|75880843|FG000|STARTED|Overall Study|Number randomized.|74||
59761177|NCT00885378|75880844|FG001|STARTED|Overall Study|Number randomized.|86||
59761178|NCT00885378|75880843|FG000|COMPLETED|Overall Study||66||
59761179|NCT00885378|75880844|FG001|COMPLETED|Overall Study||78||
59761180|NCT00885378|75880843|FG000|NOT COMPLETED|Overall Study||8||
59761181|NCT00885378|75880844|FG001|NOT COMPLETED|Overall Study||8||
59761182|NCT00545779|75880850|FG000|STARTED|Overall Study||677||
59761183|NCT00545779|75880850|FG000|COMPLETED|Overall Study||633||
59761184|NCT00545779|75880850|FG000|NOT COMPLETED|Overall Study||44||
59761185|NCT04083404|75880854|FG000|STARTED|Overall Study||202||
59761186|NCT04083404|75880854|FG000|COMPLETED|Overall Study||202||
59761187|NCT04083404|75880854|FG000|NOT COMPLETED|Overall Study||0||
59761188|NCT00597714|75880860|FG000|STARTED|Overall Study||80||
59761189|NCT00597714|75880861|FG001|STARTED|Overall Study||57||
59761190|NCT00597714|75880862|FG002|STARTED|Overall Study||94||
59761191|NCT00597714|75880860|FG000|COMPLETED|Overall Study||24||
59761192|NCT00597714|75880861|FG001|COMPLETED|Overall Study||11||
59761193|NCT00597714|75880862|FG002|COMPLETED|Overall Study||84||
59761194|NCT00597714|75880860|FG000|NOT COMPLETED|Overall Study||56||
59761195|NCT00597714|75880861|FG001|NOT COMPLETED|Overall Study||46||
59761196|NCT00597714|75880862|FG002|NOT COMPLETED|Overall Study||10||
59761197|NCT03938857|75880875|FG000|STARTED|Overall Study||6||
59761198|NCT03938857|75880876|FG001|STARTED|Overall Study||12||
59761199|NCT03938857|75880877|FG002|STARTED|Overall Study||12||
59761200|NCT03938857|75880878|FG003|STARTED|Overall Study||0||
59761201|NCT03938857|75880875|FG000|COMPLETED|Overall Study||5||
59929476|NCT03189745|76047799|FG001|COMPLETED|Overall Study||58||
59929477|NCT03189745|76047798|FG000|NOT COMPLETED|Overall Study||1||
59929478|NCT03189745|76047799|FG001|NOT COMPLETED|Overall Study||1||
59929479|NCT03188263|76047807|FG000|STARTED|Overall Study||10||
59929480|NCT03188263|76047808|FG001|STARTED|Overall Study||0||
60063125|NCT01977482|76178454|FG002|STARTED|Overall Study||40||
60063126|NCT01977482|76178455|FG003|STARTED|Overall Study||39||
60063127|NCT01977482|76178456|FG004|STARTED|Overall Study||40||
60063128|NCT01977482|76178457|FG005|STARTED|Overall Study||19||
60063129|NCT01977482|76178452|FG000|COMPLETED|Overall Study||36||
59613105|NCT01737996|75724201|FG001|STARTED|Overall Study||8||
59761202|NCT03938857|75880876|FG001|COMPLETED|Overall Study||12||
59761203|NCT03938857|75880877|FG002|COMPLETED|Overall Study||12||
59761204|NCT03938857|75880878|FG003|COMPLETED|Overall Study||0||
59929481|NCT03188263|76047807|FG000|COMPLETED|Overall Study||6||
59929482|NCT03188263|76047808|FG001|COMPLETED|Overall Study||0||
59929483|NCT03188263|76047807|FG000|NOT COMPLETED|Overall Study||4||
59929484|NCT03188263|76047808|FG001|NOT COMPLETED|Overall Study||0||
59929485|NCT03188185|76047816|FG000|STARTED|Stage 1||198||
59929486|NCT03188185|76047817|FG001|STARTED|Stage 1||80||
60063130|NCT01977482|76178453|FG001|COMPLETED|Overall Study||30||
60063131|NCT01977482|76178454|FG002|COMPLETED|Overall Study||35||
60063132|NCT01977482|76178455|FG003|COMPLETED|Overall Study||35||
60063133|NCT01977482|76178456|FG004|COMPLETED|Overall Study||37||
60063134|NCT01977482|76178457|FG005|COMPLETED|Overall Study||14||
60063135|NCT01977482|76178452|FG000|NOT COMPLETED|Overall Study||3||
60063136|NCT01977482|76178453|FG001|NOT COMPLETED|Overall Study||9||
60063137|NCT01977482|76178454|FG002|NOT COMPLETED|Overall Study||5||
60063138|NCT01977482|76178455|FG003|NOT COMPLETED|Overall Study||4||
60063139|NCT01977482|76178456|FG004|NOT COMPLETED|Overall Study||3||
60063140|NCT01977482|76178457|FG005|NOT COMPLETED|Overall Study||5||
60063141|NCT02058095|76178478|FG000|STARTED|Overall Study||15||
60063142|NCT02058095|76178479|FG001|STARTED|Overall Study||7||
60063143|NCT02058095|76178478|FG000|COMPLETED|Overall Study||14||
60063144|NCT02058095|76178479|FG001|COMPLETED|Overall Study||7||
59613106|NCT01737996|75724202|FG002|STARTED|Overall Study||16||
59929487|NCT03188185|76047818|FG002|STARTED|Stage 1||0||
59613107|NCT01737996|75724200|FG000|COMPLETED|Overall Study||8||
59613108|NCT01737996|75724201|FG001|COMPLETED|Overall Study||7||
59613109|NCT01737996|75724202|FG002|COMPLETED|Overall Study|One patient withdrew consent after the first dose due to private reasons.|14||
59929488|NCT03188185|76047819|FG003|STARTED|Stage 1||0||
59929489|NCT03188185|76047816|FG000|COMPLETED|Stage 1||179||
59929490|NCT03188185|76047817|FG001|COMPLETED|Stage 1||64||
59929491|NCT03188185|76047818|FG002|COMPLETED|Stage 1||0||
59929492|NCT03188185|76047819|FG003|COMPLETED|Stage 1||0||
59929493|NCT03188185|76047816|FG000|NOT COMPLETED|Stage 1||19||
59929494|NCT03188185|76047817|FG001|NOT COMPLETED|Stage 1||16||
59929495|NCT03188185|76047818|FG002|NOT COMPLETED|Stage 1||0||
59929496|NCT03188185|76047819|FG003|NOT COMPLETED|Stage 1||0||
59929497|NCT03188185|76047816|FG000|STARTED|Stage 2||0||
59929498|NCT03188185|76047817|FG001|STARTED|Stage 2||0||
59929499|NCT03188185|76047818|FG002|STARTED|Stage 2||64||
59929500|NCT03188185|76047819|FG003|STARTED|Stage 2||63||
59929501|NCT03188185|76047816|FG000|COMPLETED|Stage 2||0||
59929502|NCT03188185|76047817|FG001|COMPLETED|Stage 2||0||
59929503|NCT03188185|76047818|FG002|COMPLETED|Stage 2||55||
59929504|NCT03188185|76047819|FG003|COMPLETED|Stage 2||57||
59929505|NCT03188185|76047816|FG000|NOT COMPLETED|Stage 2||0||
59929506|NCT03188185|76047817|FG001|NOT COMPLETED|Stage 2||0||
60063145|NCT02058095|76178478|FG000|NOT COMPLETED|Overall Study||1||
60063146|NCT02058095|76178479|FG001|NOT COMPLETED|Overall Study||0||
59613110|NCT01737996|75724200|FG000|NOT COMPLETED|Overall Study||0||
59613111|NCT01737996|75724201|FG001|NOT COMPLETED|Overall Study||1||
59613112|NCT01737996|75724202|FG002|NOT COMPLETED|Overall Study||2||
59613113|NCT01713036|75724210|FG000|STARTED|Overall Study||6||
59613114|NCT01713036|75724210|FG000|COMPLETED|Overall Study||5||
59613115|NCT01713036|75724210|FG000|NOT COMPLETED|Overall Study||1||
59613116|NCT01712334|75724220|FG000|STARTED|Treatment Period 1||44||
59929507|NCT03188185|76047818|FG002|NOT COMPLETED|Stage 2||9||
59929508|NCT03188185|76047819|FG003|NOT COMPLETED|Stage 2||6||
59929509|NCT03186781|76047835|FG000|STARTED|Overall Study||5||
59929510|NCT03186781|76047836|FG001|STARTED|Overall Study||5||
59929511|NCT03186781|76047837|FG002|STARTED|Overall Study||10||
60063147|NCT02023112|76178487|FG000|STARTED|Overall Study||85||
60063148|NCT02023112|76178488|FG001|STARTED|Overall Study||86||
60063149|NCT02023112|76178487|FG000|COMPLETED|Overall Study||83||
59929512|NCT03186781|76047838|FG003|STARTED|Overall Study||10||
59929513|NCT03186781|76047839|FG004|STARTED|Overall Study||10||
59929514|NCT03186781|76047840|FG005|STARTED|Overall Study||10||
59929515|NCT03186781|76047835|FG000|Received First Product Administration|Overall Study||5||
59929516|NCT03186781|76047836|FG001|Received First Product Administration|Overall Study||5||
59929517|NCT03186781|76047837|FG002|Received First Product Administration|Overall Study||10||
59929518|NCT03186781|76047838|FG003|Received First Product Administration|Overall Study||10||
59929519|NCT03186781|76047839|FG004|Received First Product Administration|Overall Study||10||
59929520|NCT03186781|76047840|FG005|Received First Product Administration|Overall Study||10||
59929521|NCT03186781|76047835|FG000|Received All Product Administrations|Overall Study||5||
59929522|NCT03186781|76047836|FG001|Received All Product Administrations|Overall Study||5||
59929523|NCT03186781|76047837|FG002|Received All Product Administrations|Overall Study|2nd dose not given due to unrelated intercurrent illness (n=1) and lost to follow up (n=1)|8||
59929524|NCT03186781|76047838|FG003|Received All Product Administrations|Overall Study|PI decided not to give 2nd dose to limit variation in environmental exposure to flu between subjects|9||
60063150|NCT02023112|76178488|FG001|COMPLETED|Overall Study||85||
60063151|NCT02023112|76178487|FG000|NOT COMPLETED|Overall Study||2||
60063152|NCT02023112|76178488|FG001|NOT COMPLETED|Overall Study||1||
60063153|NCT01977092|76178498|FG000|STARTED|Overall Study||149||
60063154|NCT01977092|76178499|FG001|STARTED|Overall Study||181||
60063155|NCT01977092|76178498|FG000|COMPLETED|Overall Study||118||
60063156|NCT01977092|76178499|FG001|COMPLETED|Overall Study||151||
60063157|NCT01977092|76178498|FG000|NOT COMPLETED|Overall Study||31||
60063158|NCT01977092|76178499|FG001|NOT COMPLETED|Overall Study||30||
60063159|NCT01976624|76178505|FG000|STARTED|Overall Study||756||
60063160|NCT01976624|76178505|FG000|COMPLETED|Overall Study||742||
60063161|NCT01976624|76178505|FG000|NOT COMPLETED|Overall Study||14||
60063162|NCT02041091|76178511|FG000|STARTED|Treatment||112||
60063163|NCT02041091|76178512|FG001|STARTED|Treatment||114||
60063164|NCT02041091|76178511|FG000|Received At Least One Dose of Study Drug|Treatment||112||
60063165|NCT02041091|76178512|FG001|Received At Least One Dose of Study Drug|Treatment||114||
60063166|NCT02041091|76178511|FG000|Participated in Follow Up|Treatment||106||
60063167|NCT02041091|76178512|FG001|Participated in Follow Up|Treatment||96||
60063168|NCT02041091|76178511|FG000|COMPLETED|Treatment||90||
59929525|NCT03186781|76047839|FG004|Received All Product Administrations|Overall Study|2nd dose not given due to subject decision to withdraw (n=2)|8||
59929526|NCT03186781|76047840|FG005|Received All Product Administrations|Overall Study|PI decided not to give 2nd dose to limit variation in environmental exposure to flu between subjects|9||
59929527|NCT03186781|76047835|FG000|COMPLETED|Overall Study||5||
59929528|NCT03186781|76047836|FG001|COMPLETED|Overall Study||5||
59929529|NCT03186781|76047837|FG002|COMPLETED|Overall Study||9||
59929530|NCT03186781|76047838|FG003|COMPLETED|Overall Study||10||
59929531|NCT03186781|76047839|FG004|COMPLETED|Overall Study||7||
59929532|NCT03186781|76047840|FG005|COMPLETED|Overall Study||10||
59929533|NCT03186781|76047835|FG000|NOT COMPLETED|Overall Study||0||
59929534|NCT03186781|76047836|FG001|NOT COMPLETED|Overall Study||0||
59929535|NCT03186781|76047837|FG002|NOT COMPLETED|Overall Study||1||
59929536|NCT03186781|76047838|FG003|NOT COMPLETED|Overall Study||0||
60063169|NCT02041091|76178512|FG001|COMPLETED|Treatment||91||
60063170|NCT02041091|76178511|FG000|NOT COMPLETED|Treatment||22||
60063171|NCT02041091|76178512|FG001|NOT COMPLETED|Treatment||23||
60063172|NCT02041091|76178511|FG000|STARTED|Optional Safety Extension Period|Participation was optional for the Safety Extension Period.|85||
59929537|NCT03186781|76047839|FG004|NOT COMPLETED|Overall Study||3||
59929538|NCT03186781|76047840|FG005|NOT COMPLETED|Overall Study||0||
59929539|NCT02830165|76047858|FG000|STARTED|Overall Study||11||
59929540|NCT02830165|76047858|FG000|COMPLETED|Overall Study||11||
59929541|NCT02830165|76047858|FG000|NOT COMPLETED|Overall Study||0||
59929542|NCT03184987|76047867|FG000|STARTED|Overall Study||47||
59929543|NCT03184987|76047868|FG001|STARTED|Overall Study||9||
59929544|NCT03184987|76047869|FG002|STARTED|Overall Study||55||
59929545|NCT03184987|76047867|FG000|COMPLETED|Overall Study||46||
59929546|NCT03184987|76047868|FG001|COMPLETED|Overall Study||8||
59929547|NCT03184987|76047869|FG002|COMPLETED|Overall Study||51||
59929548|NCT03184987|76047867|FG000|NOT COMPLETED|Overall Study||1||
59929549|NCT03184987|76047868|FG001|NOT COMPLETED|Overall Study||1||
59929550|NCT03184987|76047869|FG002|NOT COMPLETED|Overall Study||4||
59929551|NCT03184519|76047877|FG000|STARTED|Overall Study||156||
59929552|NCT03184519|76047877|FG000|COMPLETED|Overall Study||129||
59929553|NCT03184519|76047877|FG000|NOT COMPLETED|Overall Study||27||
59929554|NCT03184441|76047881|FG000|STARTED|Overall Study||11||
59929555|NCT03184441|76047881|FG000|COMPLETED|Overall Study|Last subject completed study|10||
60063173|NCT02041091|76178512|FG001|STARTED|Optional Safety Extension Period|Participation was optional for the Safety Extension Period.|82||
60063174|NCT02041091|76178511|FG000|COMPLETED|Optional Safety Extension Period||0||
60063175|NCT02041091|76178512|FG001|COMPLETED|Optional Safety Extension Period||0||
60063176|NCT02041091|76178511|FG000|NOT COMPLETED|Optional Safety Extension Period||85||
59929556|NCT03184441|76047881|FG000|NOT COMPLETED|Overall Study||1||
59929557|NCT03026166|76047890|FG000|STARTED|Overall Study||30||
59929558|NCT03026166|76047891|FG001|STARTED|Overall Study||12||
59929559|NCT03026166|76047890|FG000|COMPLETED|Overall Study||0||
59929560|NCT03026166|76047891|FG001|COMPLETED|Overall Study||0||
59929561|NCT03026166|76047890|FG000|NOT COMPLETED|Overall Study||30||
59929562|NCT03026166|76047891|FG001|NOT COMPLETED|Overall Study||12||
59929563|NCT03026088|76047897|FG000|STARTED|Overall Study||20||
59929564|NCT03026088|76047897|FG000|COMPLETED|Overall Study||0||
59929565|NCT03026088|76047897|FG000|NOT COMPLETED|Overall Study||20||
59929566|NCT03181789|76047905|FG000|STARTED|Overall Study||25||
59929567|NCT03181789|76047906|FG001|STARTED|Overall Study||25||
59929568|NCT03181789|76047907|FG002|STARTED|Overall Study||3||
59929569|NCT03181789|76047908|FG003|STARTED|Overall Study||3||
60063177|NCT02041091|76178512|FG001|NOT COMPLETED|Optional Safety Extension Period||82||
60063178|NCT02057549|76178526|FG000|STARTED|Overall Study||18||
60063179|NCT02057549|76178527|FG001|STARTED|Overall Study||18||
59929570|NCT03181789|76047905|FG000|Safety Population|Overall Study||25||
59929571|NCT03181789|76047906|FG001|Safety Population|Overall Study||25||
59929572|NCT03181789|76047907|FG002|Safety Population|Overall Study||3||
59929573|NCT03181789|76047908|FG003|Safety Population|Overall Study||3||
59929574|NCT03181789|76047905|FG000|COMPLETED|Overall Study||18||
59929575|NCT03181789|76047906|FG001|COMPLETED|Overall Study||22||
59929576|NCT03181789|76047907|FG002|COMPLETED|Overall Study||2||
59929577|NCT03181789|76047908|FG003|COMPLETED|Overall Study||3||
59929578|NCT03181789|76047905|FG000|NOT COMPLETED|Overall Study||7||
59929579|NCT03181789|76047906|FG001|NOT COMPLETED|Overall Study||3||
59929580|NCT03181789|76047907|FG002|NOT COMPLETED|Overall Study||1||
60063180|NCT02057549|76178526|FG000|COMPLETED|Overall Study||15||
60063181|NCT02057549|76178527|FG001|COMPLETED|Overall Study||18||
60063182|NCT02057549|76178526|FG000|NOT COMPLETED|Overall Study||3||
60063183|NCT02057549|76178527|FG001|NOT COMPLETED|Overall Study||0||
60063184|NCT02057393|76178533|FG000|STARTED|Overall Study||89||
60063185|NCT02057393|76178533|FG000|COMPLETED|Overall Study||87||
60063186|NCT02057393|76178533|FG000|NOT COMPLETED|Overall Study||2||
60063187|NCT02040779|76178540|FG000|STARTED|Overall Study||91||
60063188|NCT02040779|76178541|FG001|STARTED|Overall Study||90||
60063189|NCT02040779|76178542|FG002|STARTED|Overall Study||92||
60063190|NCT02040779|76178540|FG000|Full Analysis Set (FAS)|Overall Study||90||
60063191|NCT02040779|76178541|FG001|Full Analysis Set (FAS)|Overall Study||88||
60063192|NCT02040779|76178542|FG002|Full Analysis Set (FAS)|Overall Study||92||
60063193|NCT02040779|76178540|FG000|COMPLETED|Overall Study||79||
60063194|NCT02040779|76178541|FG001|COMPLETED|Overall Study||83||
60063195|NCT02040779|76178542|FG002|COMPLETED|Overall Study||88||
60063196|NCT02040779|76178540|FG000|NOT COMPLETED|Overall Study||12||
60063197|NCT02040779|76178541|FG001|NOT COMPLETED|Overall Study||7||
60063198|NCT02040779|76178542|FG002|NOT COMPLETED|Overall Study||4||
60063199|NCT02056301|76178552|FG000|STARTED|Overall Study||33||
60063200|NCT02056301|76178553|FG001|STARTED|Overall Study||29||
60063201|NCT02056301|76178552|FG000|COMPLETED|Overall Study||31||
60063202|NCT02056301|76178553|FG001|COMPLETED|Overall Study||23||
60063203|NCT02056301|76178552|FG000|NOT COMPLETED|Overall Study||2||
60063204|NCT02056301|76178553|FG001|NOT COMPLETED|Overall Study||6||
60063205|NCT01967732|76178561|FG000|STARTED|Washout Period of 1 Day (Day 0)||22||
60063206|NCT01967732|76178562|FG001|STARTED|Washout Period of 1 Day (Day 0)||22||
60063207|NCT01967732|76178563|FG002|STARTED|Washout Period of 1 Day (Day 0)||9||
60063208|NCT01967732|76178564|FG003|STARTED|Washout Period of 1 Day (Day 0)||9||
60063209|NCT01967732|76178561|FG000|COMPLETED|Washout Period of 1 Day (Day 0)||22||
60063210|NCT01967732|76178562|FG001|COMPLETED|Washout Period of 1 Day (Day 0)||21||
60063211|NCT01967732|76178563|FG002|COMPLETED|Washout Period of 1 Day (Day 0)||9||
60063212|NCT01967732|76178564|FG003|COMPLETED|Washout Period of 1 Day (Day 0)||9||
60063213|NCT01967732|76178561|FG000|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0||
60063214|NCT01967732|76178562|FG001|NOT COMPLETED|Washout Period of 1 Day (Day 0)||1||
60063215|NCT01967732|76178563|FG002|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0||
60063216|NCT01967732|76178564|FG003|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0||
60063217|NCT01967732|76178561|FG000|STARTED|First Intervention (Day 1)||22||
60063218|NCT01967732|76178562|FG001|STARTED|First Intervention (Day 1)||21||
60063219|NCT01967732|76178563|FG002|STARTED|First Intervention (Day 1)||9||
60063220|NCT01967732|76178564|FG003|STARTED|First Intervention (Day 1)||9||
60063221|NCT01967732|76178561|FG000|COMPLETED|First Intervention (Day 1)||22||
60063222|NCT01967732|76178562|FG001|COMPLETED|First Intervention (Day 1)|Subject discontinued from the study prior to product use|20||
60063223|NCT01967732|76178563|FG002|COMPLETED|First Intervention (Day 1)||9||
60063224|NCT01967732|76178564|FG003|COMPLETED|First Intervention (Day 1)||9||
59517282|NCT03322930|75611087|FG000|STARTED|Overall Study|recruitment of 20 patients with retinitis pigmentosa|20|recruitment of 40 patients|
59517283|NCT03322930|75611088|FG001|STARTED|Overall Study|recruitment of 20 patients with macular degeneration|20|recruitment of 40 patients|
60063225|NCT01967732|76178561|FG000|NOT COMPLETED|First Intervention (Day 1)||0||
60063226|NCT01967732|76178562|FG001|NOT COMPLETED|First Intervention (Day 1)||1||
60063227|NCT01967732|76178563|FG002|NOT COMPLETED|First Intervention (Day 1)||0||
60063228|NCT01967732|76178564|FG003|NOT COMPLETED|First Intervention (Day 1)||0||
60063229|NCT01967732|76178561|FG000|STARTED|Washout Period of 1 Day (Day 2)||22||
60063230|NCT01967732|76178562|FG001|STARTED|Washout Period of 1 Day (Day 2)||20||
60063231|NCT01967732|76178563|FG002|STARTED|Washout Period of 1 Day (Day 2)||9||
60063232|NCT01967732|76178564|FG003|STARTED|Washout Period of 1 Day (Day 2)||9||
60063233|NCT01967732|76178561|FG000|COMPLETED|Washout Period of 1 Day (Day 2)||22||
60063234|NCT01967732|76178562|FG001|COMPLETED|Washout Period of 1 Day (Day 2)||20||
59517284|NCT03322930|75611087|FG000|COMPLETED|Overall Study||20||
60063235|NCT01967732|76178563|FG002|COMPLETED|Washout Period of 1 Day (Day 2)||9||
60063236|NCT01967732|76178564|FG003|COMPLETED|Washout Period of 1 Day (Day 2)||9||
60063237|NCT01967732|76178561|FG000|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0||
59517285|NCT03322930|75611088|FG001|COMPLETED|Overall Study||20||
60063238|NCT01967732|76178562|FG001|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0||
60063239|NCT01967732|76178563|FG002|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0||
60063240|NCT01967732|76178564|FG003|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0||
60063241|NCT01967732|76178561|FG000|STARTED|Second Intervention (Day 3)||22||
60063242|NCT01967732|76178562|FG001|STARTED|Second Intervention (Day 3)||20||
60063243|NCT01967732|76178563|FG002|STARTED|Second Intervention (Day 3)||9||
60063244|NCT01967732|76178564|FG003|STARTED|Second Intervention (Day 3)||9||
60063245|NCT01967732|76178561|FG000|COMPLETED|Second Intervention (Day 3)||22||
60063246|NCT01967732|76178562|FG001|COMPLETED|Second Intervention (Day 3)||20||
60063247|NCT01967732|76178563|FG002|COMPLETED|Second Intervention (Day 3)||9||
60063248|NCT01967732|76178564|FG003|COMPLETED|Second Intervention (Day 3)||9||
60063249|NCT01967732|76178561|FG000|NOT COMPLETED|Second Intervention (Day 3)||0||
60063250|NCT01967732|76178562|FG001|NOT COMPLETED|Second Intervention (Day 3)||0||
60063251|NCT01967732|76178563|FG002|NOT COMPLETED|Second Intervention (Day 3)||0||
60063252|NCT01967732|76178564|FG003|NOT COMPLETED|Second Intervention (Day 3)||0||
60063253|NCT01967576|76178572|FG000|STARTED|Overall Study||14||
60063254|NCT01967576|76178572|FG000|COMPLETED|Overall Study||7||
60063255|NCT01967576|76178572|FG000|NOT COMPLETED|Overall Study||7||
60063256|NCT02039687|76178580|FG000|STARTED|Overall Study||16||
60063257|NCT02039687|76178581|FG001|STARTED|Overall Study||16||
60063258|NCT02039687|76178582|FG002|STARTED|Overall Study||16||
59517286|NCT03322930|75611087|FG000|NOT COMPLETED|Overall Study||0||
59517287|NCT03322930|75611088|FG001|NOT COMPLETED|Overall Study||0||
59517288|NCT03325816|75611096|FG000|STARTED|Overall Study||3||
59517289|NCT03325816|75611097|FG001|STARTED|Overall Study||6||
59517290|NCT03325816|75611096|FG000|COMPLETED|Overall Study||3||
59517291|NCT03325816|75611097|FG001|COMPLETED|Overall Study||6||
59517292|NCT03325816|75611096|FG000|NOT COMPLETED|Overall Study||0||
60063259|NCT02039687|76178583|FG003|STARTED|Overall Study||16||
60063260|NCT02039687|76178580|FG000|COMPLETED|Overall Study||16||
60063261|NCT02039687|76178581|FG001|COMPLETED|Overall Study||15||
60063262|NCT02039687|76178582|FG002|COMPLETED|Overall Study||13||
60063263|NCT02039687|76178583|FG003|COMPLETED|Overall Study||16||
60063264|NCT02039687|76178580|FG000|NOT COMPLETED|Overall Study||0||
60063265|NCT02039687|76178581|FG001|NOT COMPLETED|Overall Study||1||
60063266|NCT02039687|76178582|FG002|NOT COMPLETED|Overall Study||3||
60063267|NCT02039687|76178583|FG003|NOT COMPLETED|Overall Study||0||
60063268|NCT02003534|76178593|FG000|STARTED|Overall Study||376||
60063269|NCT02003534|76178593|FG000|COMPLETED|Overall Study||329||
60063270|NCT02003534|76178593|FG000|NOT COMPLETED|Overall Study||47||
60063271|NCT02055365|76178597|FG000|STARTED|Overall Study||10||
60063272|NCT02055365|76178597|FG000|COMPLETED|Overall Study||9||
59517293|NCT03325816|75611097|FG001|NOT COMPLETED|Overall Study||0||
59517294|NCT00986570|75611105|FG000|STARTED|Overall Study||121||
59517295|NCT00986570|75611105|FG000|COMPLETED|Overall Study||114||
59517296|NCT00986570|75611105|FG000|NOT COMPLETED|Overall Study||7||
59517297|NCT00986258|75611109|FG000|STARTED|Observation Period||136||
59517298|NCT00986258|75611109|FG000|COMPLETED|Observation Period||125||
59517299|NCT00986258|75611109|FG000|NOT COMPLETED|Observation Period||11||
59517300|NCT00986258|75611109|FG000|STARTED|Titration and Optimal Dose Period||125||
60063273|NCT02055365|76178597|FG000|NOT COMPLETED|Overall Study||1||
60063274|NCT02039375|76178608|FG000|STARTED|Overall Study||35||
60063275|NCT02039375|76178608|FG000|COMPLETED|Overall Study||33||
60063276|NCT02039375|76178608|FG000|NOT COMPLETED|Overall Study||2||
60063277|NCT02054897|76178615|FG000|STARTED|Overall Study||129||
60063278|NCT02054897|76178616|FG001|STARTED|Overall Study||130||
60063279|NCT02054897|76178617|FG002|STARTED|Overall Study||129||
59517301|NCT00986258|75611109|FG000|COMPLETED|Titration and Optimal Dose Period||102||
60063280|NCT02054897|76178615|FG000|Exposed|Overall Study||128||
60063281|NCT02054897|76178616|FG001|Exposed|Overall Study||130||
60063282|NCT02054897|76178617|FG002|Exposed|Overall Study||129||
59517302|NCT00986258|75611109|FG000|NOT COMPLETED|Titration and Optimal Dose Period||23||
59517303|NCT00986258|75611109|FG000|STARTED|Maintenance Period||102||
59517304|NCT00986258|75611109|FG000|COMPLETED|Maintenance Period||93||
59517305|NCT00986258|75611109|FG000|NOT COMPLETED|Maintenance Period||9||
59517306|NCT00986180|75611125|FG000|STARTED|Overall Study||321||
59517307|NCT00986180|75611126|FG001|STARTED|Overall Study||324||
59517308|NCT00986180|75611125|FG000|COMPLETED|Overall Study||277||
59517309|NCT00986180|75611126|FG001|COMPLETED|Overall Study||268||
59517310|NCT00986180|75611125|FG000|NOT COMPLETED|Overall Study||44||
59517311|NCT00986180|75611126|FG001|NOT COMPLETED|Overall Study||56||
59517312|NCT01053013|75611134|FG000|STARTED|Overall Study||24||
59517313|NCT01053013|75611135|FG001|STARTED|Overall Study||34||
59517314|NCT01053013|75611134|FG000|COMPLETED|Overall Study||24||
59517315|NCT01053013|75611135|FG001|COMPLETED|Overall Study||34||
59517316|NCT01053013|75611134|FG000|NOT COMPLETED|Overall Study||0||
59517317|NCT01053013|75611135|FG001|NOT COMPLETED|Overall Study||0||
59517318|NCT01054183|75611239|FG000|STARTED|Overall Study||10||
59517319|NCT01054183|75611240|FG001|STARTED|Overall Study||12||
59929581|NCT03181789|76047908|FG003|NOT COMPLETED|Overall Study||0||
59929582|NCT03024606|76047920|FG000|STARTED|Overall Study||23||
59929583|NCT03024606|76047921|FG001|STARTED|Overall Study||26||
59929584|NCT03024606|76047920|FG000|COMPLETED|Overall Study||14||
59929585|NCT03024606|76047921|FG001|COMPLETED|Overall Study||16||
59929586|NCT03024606|76047920|FG000|NOT COMPLETED|Overall Study||9||
59929587|NCT03024606|76047921|FG001|NOT COMPLETED|Overall Study||10||
59929588|NCT03180619|76047930|FG000|STARTED|Overall Study||78||
59929589|NCT03180619|76047931|FG001|STARTED|Overall Study||15||
59929590|NCT03180619|76047932|FG002|STARTED|Overall Study||31||
59929591|NCT03180619|76047930|FG000|COMPLETED|Overall Study||67||
59929592|NCT03180619|76047931|FG001|COMPLETED|Overall Study||14||
59929593|NCT03180619|76047932|FG002|COMPLETED|Overall Study||25||
59929594|NCT03180619|76047930|FG000|NOT COMPLETED|Overall Study||11||
59929595|NCT03180619|76047931|FG001|NOT COMPLETED|Overall Study||1||
59929596|NCT03180619|76047932|FG002|NOT COMPLETED|Overall Study||6||
59929597|NCT02915874|76047949|FG000|STARTED|Overall Study||44||
59929598|NCT02915874|76047950|FG001|STARTED|Overall Study||28||
59929599|NCT02915874|76047949|FG000|Week 6 Follow Up|Overall Study||41||
59929600|NCT02915874|76047950|FG001|Week 6 Follow Up|Overall Study||26||
59929601|NCT02915874|76047949|FG000|COMPLETED|Overall Study||38||
60063283|NCT02054897|76178615|FG000|COMPLETED|Overall Study||119||
60063284|NCT02054897|76178616|FG001|COMPLETED|Overall Study||123||
59517320|NCT01054183|75611239|FG000|COMPLETED|Overall Study||10||
59517321|NCT01054183|75611240|FG001|COMPLETED|Overall Study||12||
59517322|NCT01054183|75611239|FG000|NOT COMPLETED|Overall Study||0||
59517323|NCT01054183|75611240|FG001|NOT COMPLETED|Overall Study||0||
59517324|NCT01054339|75611249|FG000|STARTED|Overall Study||3||
59517325|NCT01054339|75611250|FG001|STARTED|Overall Study||3||
59929602|NCT02915874|76047950|FG001|COMPLETED|Overall Study||22||
59929603|NCT02915874|76047949|FG000|NOT COMPLETED|Overall Study||6||
59929604|NCT02915874|76047950|FG001|NOT COMPLETED|Overall Study||6||
59929605|NCT03022578|76047956|FG000|STARTED|Overall Study||4||
59929606|NCT03022578|76047956|FG000|COMPLETED|Overall Study||0||
59929607|NCT03022578|76047956|FG000|NOT COMPLETED|Overall Study||4||
59929608|NCT03022422|76047966|FG000|STARTED|Overall Study||8||
59929609|NCT03022422|76047967|FG001|STARTED|Overall Study||10||
59929610|NCT03022422|76047968|FG002|STARTED|Overall Study||23||
59929611|NCT03022422|76047969|FG003|STARTED|Overall Study||12||
59929612|NCT03022422|76047970|FG004|STARTED|Overall Study||5||
59929613|NCT03022422|76047971|FG005|STARTED|Overall Study||5||
59929614|NCT03022422|76047966|FG000|COMPLETED|Overall Study||8||
59929615|NCT03022422|76047967|FG001|COMPLETED|Overall Study||10||
59929616|NCT03022422|76047968|FG002|COMPLETED|Overall Study||20||
59929617|NCT03022422|76047969|FG003|COMPLETED|Overall Study||12||
59929618|NCT03022422|76047970|FG004|COMPLETED|Overall Study||5||
59929619|NCT03022422|76047971|FG005|COMPLETED|Overall Study||5||
59929620|NCT03022422|76047966|FG000|NOT COMPLETED|Overall Study||0||
59929621|NCT03022422|76047967|FG001|NOT COMPLETED|Overall Study||0||
59929622|NCT03022422|76047968|FG002|NOT COMPLETED|Overall Study||3||
59517326|NCT01054339|75611251|FG002|STARTED|Overall Study||3||
59517327|NCT01054339|75611249|FG000|COMPLETED|Overall Study||3||
59517328|NCT01054339|75611250|FG001|COMPLETED|Overall Study||3||
59929623|NCT03022422|76047969|FG003|NOT COMPLETED|Overall Study||0||
60063285|NCT02054897|76178617|FG002|COMPLETED|Overall Study||117||
59929624|NCT03022422|76047970|FG004|NOT COMPLETED|Overall Study||0||
59929625|NCT03022422|76047971|FG005|NOT COMPLETED|Overall Study||0||
59929626|NCT03023826|76047987|FG000|STARTED|Period 1||4||
60063286|NCT02054897|76178615|FG000|NOT COMPLETED|Overall Study||10||
60063287|NCT02054897|76178616|FG001|NOT COMPLETED|Overall Study||7||
60063288|NCT02054897|76178617|FG002|NOT COMPLETED|Overall Study||12||
60063289|NCT01976312|76178627|FG000|STARTED|Overall Study||190||
60063290|NCT01976312|76178628|FG001|STARTED|Overall Study||62||
60063291|NCT01976312|76178627|FG000|Completed 3 Months|Overall Study||186||
60063292|NCT01976312|76178628|FG001|Completed 3 Months|Overall Study||60||
60063293|NCT01976312|76178627|FG000|Discontinued Study Prior to 3 Months|Overall Study||4||
60063294|NCT01976312|76178628|FG001|Discontinued Study Prior to 3 Months|Overall Study||2||
60063295|NCT01976312|76178627|FG000|COMPLETED|Overall Study|Completed study at 12 months|173||
60063296|NCT01976312|76178628|FG001|COMPLETED|Overall Study|Completed study at 12 months|53||
60063297|NCT01976312|76178627|FG000|NOT COMPLETED|Overall Study||17||
60063298|NCT01976312|76178628|FG001|NOT COMPLETED|Overall Study||9||
60063299|NCT02039219|76178637|FG000|STARTED|Treatment||11||
60063300|NCT02039219|76178638|FG001|STARTED|Treatment||8||
60063301|NCT02039219|76178637|FG000|COMPLETED|Treatment||7||
60063302|NCT02039219|76178638|FG001|COMPLETED|Treatment||6||
60063303|NCT02039219|76178637|FG000|NOT COMPLETED|Treatment||4||
60063304|NCT02039219|76178638|FG001|NOT COMPLETED|Treatment||2||
59517329|NCT01054339|75611251|FG002|COMPLETED|Overall Study||3||
59517330|NCT01054339|75611249|FG000|NOT COMPLETED|Overall Study||0||
59929627|NCT03023826|76047988|FG001|STARTED|Period 1||4||
59929628|NCT03023826|76047989|FG002|STARTED|Period 1||5||
60063305|NCT02039219|76178637|FG000|STARTED|Follow up||7||
60063306|NCT02039219|76178638|FG001|STARTED|Follow up||6||
60063307|NCT02039219|76178637|FG000|COMPLETED|Follow up||7||
60063308|NCT02039219|76178638|FG001|COMPLETED|Follow up||5||
59929629|NCT03023826|76047990|FG003|STARTED|Period 1||4||
59929630|NCT03023826|76047991|FG004|STARTED|Period 1||4||
60063309|NCT02039219|76178637|FG000|NOT COMPLETED|Follow up||0||
60063310|NCT02039219|76178638|FG001|NOT COMPLETED|Follow up||1||
60063311|NCT02053493|76178646|FG000|STARTED|Overall Study||51||
60063312|NCT02053493|76178647|FG001|STARTED|Overall Study||59||
60063313|NCT02053493|76178646|FG000|COMPLETED|Overall Study||50||
60063314|NCT02053493|76178647|FG001|COMPLETED|Overall Study||58||
60063315|NCT02053493|76178646|FG000|NOT COMPLETED|Overall Study||1||
60063316|NCT02053493|76178647|FG001|NOT COMPLETED|Overall Study||1||
60063317|NCT02003144|76178655|FG000|STARTED|Blind Induction Phase||41||
60063318|NCT02003144|76178656|FG001|STARTED|Blind Induction Phase||78||
60063319|NCT02003144|76178655|FG000|Received at Least 1 Dose of Study Drug|Blind Induction Phase||41||
60063320|NCT02003144|76178656|FG001|Received at Least 1 Dose of Study Drug|Blind Induction Phase||78||
60063321|NCT02003144|76178655|FG000|COMPLETED|Blind Induction Phase||41||
60063322|NCT02003144|76178656|FG001|COMPLETED|Blind Induction Phase||78||
60063323|NCT02003144|76178655|FG000|NOT COMPLETED|Blind Induction Phase||0||
60063324|NCT02003144|76178656|FG001|NOT COMPLETED|Blind Induction Phase||0||
59929631|NCT03023826|76047992|FG005|STARTED|Period 1||5||
59929632|NCT03023826|76047987|FG000|Received at Least One Dose of Study Drug|Period 1||4||
59929633|NCT03023826|76047988|FG001|Received at Least One Dose of Study Drug|Period 1||4||
59929634|NCT03023826|76047989|FG002|Received at Least One Dose of Study Drug|Period 1||5||
59929635|NCT03023826|76047990|FG003|Received at Least One Dose of Study Drug|Period 1||4||
59929636|NCT03023826|76047991|FG004|Received at Least One Dose of Study Drug|Period 1||4||
59929637|NCT03023826|76047992|FG005|Received at Least One Dose of Study Drug|Period 1||5||
59929638|NCT03023826|76047987|FG000|COMPLETED|Period 1||4||
59929639|NCT03023826|76047988|FG001|COMPLETED|Period 1||4||
59929640|NCT03023826|76047989|FG002|COMPLETED|Period 1||5||
59929641|NCT03023826|76047990|FG003|COMPLETED|Period 1||4||
59929642|NCT03023826|76047991|FG004|COMPLETED|Period 1||3||
59929643|NCT03023826|76047992|FG005|COMPLETED|Period 1||5||
59929644|NCT03023826|76047987|FG000|NOT COMPLETED|Period 1||0||
59929645|NCT03023826|76047988|FG001|NOT COMPLETED|Period 1||0||
59929646|NCT03023826|76047989|FG002|NOT COMPLETED|Period 1||0||
60063325|NCT02003144|76178655|FG000|STARTED|Open Label Maintenance Phase||41||
59517331|NCT01054339|75611250|FG001|NOT COMPLETED|Overall Study||0||
59929647|NCT03023826|76047990|FG003|NOT COMPLETED|Period 1||0||
59929648|NCT03023826|76047991|FG004|NOT COMPLETED|Period 1||1||
60063326|NCT02003144|76178656|FG001|STARTED|Open Label Maintenance Phase||78||
60063327|NCT02003144|76178655|FG000|Received at Least 1 Dose of Study Drug|Open Label Maintenance Phase||41||
60063328|NCT02003144|76178656|FG001|Received at Least 1 Dose of Study Drug|Open Label Maintenance Phase||78||
60063329|NCT02003144|76178655|FG000|COMPLETED|Open Label Maintenance Phase||32||
60063330|NCT02003144|76178656|FG001|COMPLETED|Open Label Maintenance Phase||64||
60063331|NCT02003144|76178655|FG000|NOT COMPLETED|Open Label Maintenance Phase||9||
60063332|NCT02003144|76178656|FG001|NOT COMPLETED|Open Label Maintenance Phase||14||
60063333|NCT02001194|76178667|FG000|STARTED|Intervention Period (13 Weeks)|17 teams|68||
60063334|NCT02001194|76178668|FG001|STARTED|Intervention Period (13 Weeks)|20 teams|80||
59929649|NCT03023826|76047992|FG005|NOT COMPLETED|Period 1||0||
60063335|NCT02001194|76178669|FG002|STARTED|Intervention Period (13 Weeks)|19 teams|76||
60063336|NCT02001194|76178670|FG003|STARTED|Intervention Period (13 Weeks)|20 teams|80||
60063337|NCT02001194|76178667|FG000|COMPLETED|Intervention Period (13 Weeks)|16 teams|67||
60063338|NCT02001194|76178668|FG001|COMPLETED|Intervention Period (13 Weeks)|20 teams|80||
60063339|NCT02001194|76178669|FG002|COMPLETED|Intervention Period (13 Weeks)|19 teams|74||
60063340|NCT02001194|76178670|FG003|COMPLETED|Intervention Period (13 Weeks)|20 teams|78||
60063341|NCT02001194|76178667|FG000|NOT COMPLETED|Intervention Period (13 Weeks)||1||
60063342|NCT02001194|76178668|FG001|NOT COMPLETED|Intervention Period (13 Weeks)||0||
60063343|NCT02001194|76178669|FG002|NOT COMPLETED|Intervention Period (13 Weeks)||2||
60063344|NCT02001194|76178670|FG003|NOT COMPLETED|Intervention Period (13 Weeks)||2||
60063345|NCT02001194|76178667|FG000|STARTED|Follow-Up Period (13 Weeks)||67||
60063346|NCT02001194|76178668|FG001|STARTED|Follow-Up Period (13 Weeks)||80||
60063347|NCT02001194|76178669|FG002|STARTED|Follow-Up Period (13 Weeks)||74||
60063348|NCT02001194|76178670|FG003|STARTED|Follow-Up Period (13 Weeks)||78||
60063349|NCT02001194|76178667|FG000|COMPLETED|Follow-Up Period (13 Weeks)||64||
60063350|NCT02001194|76178668|FG001|COMPLETED|Follow-Up Period (13 Weeks)||78||
60063351|NCT02001194|76178669|FG002|COMPLETED|Follow-Up Period (13 Weeks)||73||
60063352|NCT02001194|76178670|FG003|COMPLETED|Follow-Up Period (13 Weeks)||78||
60063353|NCT02001194|76178667|FG000|NOT COMPLETED|Follow-Up Period (13 Weeks)||3||
60063354|NCT02001194|76178668|FG001|NOT COMPLETED|Follow-Up Period (13 Weeks)||2||
60063355|NCT02001194|76178669|FG002|NOT COMPLETED|Follow-Up Period (13 Weeks)||1||
60063356|NCT02001194|76178670|FG003|NOT COMPLETED|Follow-Up Period (13 Weeks)||0||
60063357|NCT02038907|76178694|FG000|STARTED|Overall Study||30||
60063358|NCT02038907|76178695|FG001|STARTED|Overall Study||30||
60063359|NCT02038907|76178696|FG002|STARTED|Overall Study||30||
59929650|NCT03023826|76047987|FG000|STARTED|Period 2||4||
60063360|NCT02038907|76178697|FG003|STARTED|Overall Study||31||
60063361|NCT02038907|76178698|FG004|STARTED|Overall Study||30||
60063362|NCT02038907|76178699|FG005|STARTED|Overall Study||31||
60063363|NCT02038907|76178700|FG006|STARTED|Overall Study||30||
60063364|NCT02038907|76178701|FG007|STARTED|Overall Study||32||
60063365|NCT02038907|76178702|FG008|STARTED|Overall Study||29||
60063366|NCT02038907|76178703|FG009|STARTED|Overall Study||30||
60063367|NCT02038907|76178704|FG010|STARTED|Overall Study||29||
60063368|NCT02038907|76178705|FG011|STARTED|Overall Study||28||
60063369|NCT02038907|76178706|FG012|STARTED|Overall Study||29||
60063370|NCT02038907|76178707|FG013|STARTED|Overall Study||31||
60063371|NCT02038907|76178694|FG000|COMPLETED|Overall Study||30||
60063372|NCT02038907|76178695|FG001|COMPLETED|Overall Study||30||
60063373|NCT02038907|76178696|FG002|COMPLETED|Overall Study||30||
60063374|NCT02038907|76178697|FG003|COMPLETED|Overall Study||31||
60063375|NCT02038907|76178698|FG004|COMPLETED|Overall Study||30||
60063376|NCT02038907|76178699|FG005|COMPLETED|Overall Study||31||
60063377|NCT02038907|76178700|FG006|COMPLETED|Overall Study||30||
59929651|NCT03023826|76047988|FG001|STARTED|Period 2||4||
59929652|NCT03023826|76047989|FG002|STARTED|Period 2||5||
59929653|NCT03023826|76047990|FG003|STARTED|Period 2||4||
59929654|NCT03023826|76047991|FG004|STARTED|Period 2||3||
59929655|NCT03023826|76047992|FG005|STARTED|Period 2||5||
59929656|NCT03023826|76047987|FG000|COMPLETED|Period 2||4||
59929657|NCT03023826|76047988|FG001|COMPLETED|Period 2||4||
59929658|NCT03023826|76047989|FG002|COMPLETED|Period 2||5||
59929659|NCT03023826|76047990|FG003|COMPLETED|Period 2||4||
59929660|NCT03023826|76047991|FG004|COMPLETED|Period 2||3||
59929661|NCT03023826|76047992|FG005|COMPLETED|Period 2||5||
59929662|NCT03023826|76047987|FG000|NOT COMPLETED|Period 2||0||
59929663|NCT03023826|76047988|FG001|NOT COMPLETED|Period 2||0||
59929664|NCT03023826|76047989|FG002|NOT COMPLETED|Period 2||0||
59929665|NCT03023826|76047990|FG003|NOT COMPLETED|Period 2||0||
59929666|NCT03023826|76047991|FG004|NOT COMPLETED|Period 2||0||
59929667|NCT03023826|76047992|FG005|NOT COMPLETED|Period 2||0||
59929668|NCT03023826|76047987|FG000|STARTED|Period 3||4||
59929669|NCT03023826|76047988|FG001|STARTED|Period 3||4||
59929670|NCT03023826|76047989|FG002|STARTED|Period 3||5||
59929671|NCT03023826|76047990|FG003|STARTED|Period 3||4||
59929672|NCT03023826|76047991|FG004|STARTED|Period 3||3||
59929673|NCT03023826|76047992|FG005|STARTED|Period 3||5||
59929674|NCT03023826|76047987|FG000|COMPLETED|Period 3||4||
59929675|NCT03023826|76047988|FG001|COMPLETED|Period 3||4||
60063378|NCT02038907|76178701|FG007|COMPLETED|Overall Study||32||
60063379|NCT02038907|76178702|FG008|COMPLETED|Overall Study||29||
60063380|NCT02038907|76178703|FG009|COMPLETED|Overall Study||30||
60063381|NCT02038907|76178704|FG010|COMPLETED|Overall Study||27||
60063382|NCT02038907|76178705|FG011|COMPLETED|Overall Study||28||
60063383|NCT02038907|76178706|FG012|COMPLETED|Overall Study||29||
60063384|NCT02038907|76178707|FG013|COMPLETED|Overall Study||31||
60063385|NCT02038907|76178694|FG000|NOT COMPLETED|Overall Study||0||
60063386|NCT02038907|76178695|FG001|NOT COMPLETED|Overall Study||0||
60063387|NCT02038907|76178696|FG002|NOT COMPLETED|Overall Study||0||
60063388|NCT02038907|76178697|FG003|NOT COMPLETED|Overall Study||0||
60063389|NCT02038907|76178698|FG004|NOT COMPLETED|Overall Study||0||
60063390|NCT02038907|76178699|FG005|NOT COMPLETED|Overall Study||0||
60063391|NCT02038907|76178700|FG006|NOT COMPLETED|Overall Study||0||
60063392|NCT02038907|76178701|FG007|NOT COMPLETED|Overall Study||0||
60063393|NCT02038907|76178702|FG008|NOT COMPLETED|Overall Study||0||
60063394|NCT02038907|76178703|FG009|NOT COMPLETED|Overall Study||0||
60063395|NCT02038907|76178704|FG010|NOT COMPLETED|Overall Study||2||
60063396|NCT02038907|76178705|FG011|NOT COMPLETED|Overall Study||0||
60063397|NCT02038907|76178706|FG012|NOT COMPLETED|Overall Study||0||
60063398|NCT02038907|76178707|FG013|NOT COMPLETED|Overall Study||0||
60063399|NCT02038829|76178739|FG000|STARTED|Treatment Period 1||8||
60063400|NCT02038829|76178740|FG001|STARTED|Treatment Period 1||8||
60063401|NCT02038829|76178741|FG002|STARTED|Treatment Period 1||8||
60063402|NCT02038829|76178742|FG003|STARTED|Treatment Period 1||8||
60063403|NCT02038829|76178743|FG004|STARTED|Treatment Period 1||8||
60063404|NCT02038829|76178744|FG005|STARTED|Treatment Period 1||8||
60063405|NCT02038829|76178745|FG006|STARTED|Treatment Period 1||8||
60063406|NCT02038829|76178746|FG007|STARTED|Treatment Period 1||8||
60063407|NCT02038829|76178747|FG008|STARTED|Treatment Period 1||8||
60063408|NCT02038829|76178748|FG009|STARTED|Treatment Period 1||8||
60063409|NCT02038829|76178749|FG010|STARTED|Treatment Period 1||8||
60063410|NCT02038829|76178750|FG011|STARTED|Treatment Period 1||8||
60063411|NCT02038829|76178739|FG000|COMPLETED|Treatment Period 1||8||
60063412|NCT02038829|76178740|FG001|COMPLETED|Treatment Period 1||8||
60063413|NCT02038829|76178741|FG002|COMPLETED|Treatment Period 1||8||
60063414|NCT02038829|76178742|FG003|COMPLETED|Treatment Period 1||8||
60063415|NCT02038829|76178743|FG004|COMPLETED|Treatment Period 1||8||
60063416|NCT02038829|76178744|FG005|COMPLETED|Treatment Period 1||8||
60063417|NCT02038829|76178745|FG006|COMPLETED|Treatment Period 1||8||
60063418|NCT02038829|76178746|FG007|COMPLETED|Treatment Period 1||8||
60063419|NCT02038829|76178747|FG008|COMPLETED|Treatment Period 1||8||
60063420|NCT02038829|76178748|FG009|COMPLETED|Treatment Period 1||8||
60063421|NCT02038829|76178749|FG010|COMPLETED|Treatment Period 1||8||
60063422|NCT02038829|76178750|FG011|COMPLETED|Treatment Period 1||8||
60063423|NCT02038829|76178739|FG000|NOT COMPLETED|Treatment Period 1||0||
60063424|NCT02038829|76178740|FG001|NOT COMPLETED|Treatment Period 1||0||
60063425|NCT02038829|76178741|FG002|NOT COMPLETED|Treatment Period 1||0||
60063426|NCT02038829|76178742|FG003|NOT COMPLETED|Treatment Period 1||0||
60063427|NCT02038829|76178743|FG004|NOT COMPLETED|Treatment Period 1||0||
60063428|NCT02038829|76178744|FG005|NOT COMPLETED|Treatment Period 1||0||
60063429|NCT02038829|76178745|FG006|NOT COMPLETED|Treatment Period 1||0||
60063430|NCT02038829|76178746|FG007|NOT COMPLETED|Treatment Period 1||0||
60063431|NCT02038829|76178747|FG008|NOT COMPLETED|Treatment Period 1||0||
60063432|NCT02038829|76178748|FG009|NOT COMPLETED|Treatment Period 1||0||
60063433|NCT02038829|76178749|FG010|NOT COMPLETED|Treatment Period 1||0||
60063434|NCT02038829|76178750|FG011|NOT COMPLETED|Treatment Period 1||0||
60063435|NCT02038829|76178739|FG000|STARTED|Washout Period 1||8||
60063436|NCT02038829|76178740|FG001|STARTED|Washout Period 1||8||
60063437|NCT02038829|76178741|FG002|STARTED|Washout Period 1||8||
60063438|NCT02038829|76178742|FG003|STARTED|Washout Period 1||8||
60063439|NCT02038829|76178743|FG004|STARTED|Washout Period 1||8||
59761205|NCT03938857|75880875|FG000|NOT COMPLETED|Overall Study||1||
59761206|NCT03938857|75880876|FG001|NOT COMPLETED|Overall Study||0||
59761207|NCT03938857|75880877|FG002|NOT COMPLETED|Overall Study||0||
60063440|NCT02038829|76178744|FG005|STARTED|Washout Period 1||8||
60063441|NCT02038829|76178745|FG006|STARTED|Washout Period 1||8||
60063442|NCT02038829|76178746|FG007|STARTED|Washout Period 1||8||
60063443|NCT02038829|76178747|FG008|STARTED|Washout Period 1||8||
60063444|NCT02038829|76178748|FG009|STARTED|Washout Period 1||8||
60063445|NCT02038829|76178749|FG010|STARTED|Washout Period 1||8||
60063446|NCT02038829|76178750|FG011|STARTED|Washout Period 1||8||
60063447|NCT02038829|76178739|FG000|COMPLETED|Washout Period 1||8||
60063448|NCT02038829|76178740|FG001|COMPLETED|Washout Period 1||8||
59761208|NCT03938857|75880878|FG003|NOT COMPLETED|Overall Study||0||
60063449|NCT02038829|76178741|FG002|COMPLETED|Washout Period 1||8||
60063450|NCT02038829|76178742|FG003|COMPLETED|Washout Period 1||8||
60063451|NCT02038829|76178743|FG004|COMPLETED|Washout Period 1||7||
60063452|NCT02038829|76178744|FG005|COMPLETED|Washout Period 1||8||
60063453|NCT02038829|76178745|FG006|COMPLETED|Washout Period 1||8||
60063454|NCT02038829|76178746|FG007|COMPLETED|Washout Period 1||8||
60063455|NCT02038829|76178747|FG008|COMPLETED|Washout Period 1||8||
60063456|NCT02038829|76178748|FG009|COMPLETED|Washout Period 1||8||
60063457|NCT02038829|76178749|FG010|COMPLETED|Washout Period 1||8||
60063458|NCT02038829|76178750|FG011|COMPLETED|Washout Period 1||8||
60063459|NCT02038829|76178739|FG000|NOT COMPLETED|Washout Period 1||0||
60063460|NCT02038829|76178740|FG001|NOT COMPLETED|Washout Period 1||0||
60063461|NCT02038829|76178741|FG002|NOT COMPLETED|Washout Period 1||0||
60063462|NCT02038829|76178742|FG003|NOT COMPLETED|Washout Period 1||0||
60063463|NCT02038829|76178743|FG004|NOT COMPLETED|Washout Period 1||1||
60063464|NCT02038829|76178744|FG005|NOT COMPLETED|Washout Period 1||0||
60063465|NCT02038829|76178745|FG006|NOT COMPLETED|Washout Period 1||0||
60063466|NCT02038829|76178746|FG007|NOT COMPLETED|Washout Period 1||0||
60063467|NCT02038829|76178747|FG008|NOT COMPLETED|Washout Period 1||0||
59929676|NCT03023826|76047989|FG002|COMPLETED|Period 3||5||
60063468|NCT02038829|76178748|FG009|NOT COMPLETED|Washout Period 1||0||
60063469|NCT02038829|76178749|FG010|NOT COMPLETED|Washout Period 1||0||
59517332|NCT01054339|75611251|FG002|NOT COMPLETED|Overall Study||0||
59517333|NCT01056601|75611261|FG000|STARTED|Overall Study||7||
59517334|NCT01056601|75611261|FG000|COMPLETED|Overall Study||7||
59517335|NCT01056601|75611261|FG000|NOT COMPLETED|Overall Study||0||
59517336|NCT01056913|75611265|FG000|STARTED|Overall Study||62||
59517337|NCT01056913|75611265|FG000|COMPLETED|Overall Study||62||
59517338|NCT01056913|75611265|FG000|NOT COMPLETED|Overall Study||0||
59517339|NCT01057225|75611269|FG000|STARTED|Overall Study||3||
59929677|NCT03023826|76047990|FG003|COMPLETED|Period 3||4||
59929678|NCT03023826|76047991|FG004|COMPLETED|Period 3||3||
59929679|NCT03023826|76047992|FG005|COMPLETED|Period 3||5||
59929680|NCT03023826|76047987|FG000|NOT COMPLETED|Period 3||0||
59929681|NCT03023826|76047988|FG001|NOT COMPLETED|Period 3||0||
59929682|NCT03023826|76047989|FG002|NOT COMPLETED|Period 3||0||
59929683|NCT03023826|76047990|FG003|NOT COMPLETED|Period 3||0||
59929684|NCT03023826|76047991|FG004|NOT COMPLETED|Period 3||0||
59929685|NCT03023826|76047992|FG005|NOT COMPLETED|Period 3||0||
59929686|NCT03166735|76048005|FG000|STARTED|Overall Study||33||
59929687|NCT03166735|76048006|FG001|STARTED|Overall Study||16||
59929688|NCT03166735|76048007|FG002|STARTED|Overall Study||16||
59929689|NCT03166735|76048008|FG003|STARTED|Overall Study||17||
59929690|NCT03166735|76048009|FG004|STARTED|Overall Study||32||
59929691|NCT03166735|76048005|FG000|Treated|Overall Study||32||
59929692|NCT03166735|76048006|FG001|Treated|Overall Study||16||
59929693|NCT03166735|76048007|FG002|Treated|Overall Study||16||
59929694|NCT03166735|76048008|FG003|Treated|Overall Study||17||
59929695|NCT03166735|76048009|FG004|Treated|Overall Study||32||
59929696|NCT03166735|76048005|FG000|COMPLETED|Overall Study||32||
59929697|NCT03166735|76048006|FG001|COMPLETED|Overall Study||13||
59929698|NCT03166735|76048007|FG002|COMPLETED|Overall Study||13||
59929699|NCT03166735|76048008|FG003|COMPLETED|Overall Study||16||
59929700|NCT03166735|76048009|FG004|COMPLETED|Overall Study||28||
59929701|NCT03166735|76048005|FG000|NOT COMPLETED|Overall Study||1||
59929702|NCT03166735|76048006|FG001|NOT COMPLETED|Overall Study||3||
59929703|NCT03166735|76048007|FG002|NOT COMPLETED|Overall Study||3||
59929704|NCT03166735|76048008|FG003|NOT COMPLETED|Overall Study||1||
59929705|NCT03166735|76048009|FG004|NOT COMPLETED|Overall Study||4||
60063470|NCT02038829|76178750|FG011|NOT COMPLETED|Washout Period 1||0||
60063471|NCT02038829|76178739|FG000|STARTED|Treatment Period 2||8||
59761209|NCT00884832|75880890|FG000|STARTED|Overall Study||22||
59929706|NCT03165955|76048022|FG000|STARTED|Screening/Baseline||31||
59929707|NCT03165955|76048022|FG000|COMPLETED|Screening/Baseline||28||
59929708|NCT03165955|76048022|FG000|NOT COMPLETED|Screening/Baseline||3||
59929709|NCT03165955|76048022|FG000|STARTED|Treatment||28||
59929710|NCT03165955|76048022|FG000|COMPLETED|Treatment||20||
59929711|NCT03165955|76048022|FG000|NOT COMPLETED|Treatment||8||
59929712|NCT03055494|76048028|FG000|STARTED|Overall Study||54||
59929713|NCT03055494|76048029|FG001|STARTED|Overall Study||28||
59929714|NCT03055494|76048028|FG000|COMPLETED|Overall Study||44||
59929715|NCT03055494|76048029|FG001|COMPLETED|Overall Study||27||
59929716|NCT03055494|76048028|FG000|NOT COMPLETED|Overall Study||10||
59929717|NCT03055494|76048029|FG001|NOT COMPLETED|Overall Study||1||
59517340|NCT01057225|75611270|FG001|STARTED|Overall Study||3||
59517341|NCT01057225|75611271|FG002|STARTED|Overall Study||6||
59517342|NCT01057225|75611272|FG003|STARTED|Overall Study||7||
59929718|NCT02914548|76048039|FG000|STARTED|Overall Study||67||
59929719|NCT02914548|76048040|FG001|STARTED|Overall Study||67||
59929720|NCT02914548|76048041|FG002|STARTED|Overall Study||66||
59517343|NCT01057225|75611273|FG004|STARTED|Overall Study||22||
59517344|NCT01057225|75611274|FG005|STARTED|Overall Study||23||
59517345|NCT01057225|75611269|FG000|COMPLETED|Overall Study||3||
59517346|NCT01057225|75611270|FG001|COMPLETED|Overall Study||3||
59517347|NCT01057225|75611271|FG002|COMPLETED|Overall Study||6||
59517348|NCT01057225|75611272|FG003|COMPLETED|Overall Study||7||
59517349|NCT01057225|75611273|FG004|COMPLETED|Overall Study||22||
59517350|NCT01057225|75611274|FG005|COMPLETED|Overall Study||23||
59517351|NCT01057225|75611269|FG000|NOT COMPLETED|Overall Study||0||
59517352|NCT01057225|75611270|FG001|NOT COMPLETED|Overall Study||0||
59517353|NCT01057225|75611271|FG002|NOT COMPLETED|Overall Study||0||
59929721|NCT02914548|76048039|FG000|COMPLETED|Overall Study||46||
59929722|NCT02914548|76048040|FG001|COMPLETED|Overall Study||53||
59929723|NCT02914548|76048041|FG002|COMPLETED|Overall Study||46||
59929724|NCT02914548|76048039|FG000|NOT COMPLETED|Overall Study||21||
59929725|NCT02914548|76048040|FG001|NOT COMPLETED|Overall Study||14||
59929726|NCT02914548|76048041|FG002|NOT COMPLETED|Overall Study||20||
59929727|NCT03165721|76048052|FG000|STARTED|Overall Study||7||
59929728|NCT03165721|76048053|FG001|STARTED|Overall Study||1||
59929729|NCT03165721|76048054|FG002|STARTED|Overall Study||1||
59929730|NCT03165721|76048052|FG000|COMPLETED|Overall Study||3||
59929731|NCT03165721|76048053|FG001|COMPLETED|Overall Study||1||
59929732|NCT03165721|76048054|FG002|COMPLETED|Overall Study||1||
59929733|NCT03165721|76048052|FG000|NOT COMPLETED|Overall Study||4||
59929734|NCT03165721|76048053|FG001|NOT COMPLETED|Overall Study||0||
59929735|NCT03165721|76048054|FG002|NOT COMPLETED|Overall Study||0||
59929736|NCT02224872|76048064|FG000|STARTED|Overall Study||18||
59517354|NCT01057225|75611272|FG003|NOT COMPLETED|Overall Study||0||
59517355|NCT01057225|75611273|FG004|NOT COMPLETED|Overall Study||0||
59517356|NCT01057225|75611274|FG005|NOT COMPLETED|Overall Study||0||
59517357|NCT01057381|75611291|FG000|STARTED|Overall Study||26||
59517358|NCT01057381|75611292|FG001|STARTED|Overall Study||27||
59517359|NCT01057381|75611293|FG002|STARTED|Overall Study||30||
59517360|NCT01057381|75611294|FG003|STARTED|Overall Study||26||
59517361|NCT01057381|75611291|FG000|COMPLETED|Overall Study||26||
59517362|NCT01057381|75611292|FG001|COMPLETED|Overall Study||27||
59929737|NCT02224872|76048064|FG000|COMPLETED|Overall Study||16||
59929738|NCT02224872|76048064|FG000|NOT COMPLETED|Overall Study||2||
59929739|NCT02187198|76048070|FG000|STARTED|Overall Study||5||
59929740|NCT02187198|76048071|FG001|STARTED|Overall Study||4||
59929741|NCT02187198|76048070|FG000|COMPLETED|Overall Study||4||
59929742|NCT02187198|76048071|FG001|COMPLETED|Overall Study||3||
59929743|NCT02187198|76048070|FG000|NOT COMPLETED|Overall Study||1||
59929744|NCT02187198|76048071|FG001|NOT COMPLETED|Overall Study||1||
59929745|NCT02642029|76048077|FG000|STARTED|Study Visit 1 (1 Day)|"N=11 total participants were randomized to sham for the first study visit. For study visit 1, participants could be randomized to ONE OF THREE interventions (iTBS, cTBS, or sham TBS), not one of six interventions as this participant flow section suggests. The total number randomized to sham is the number started in Sham-iTBS-cTBS PLUS the number started in Sham-cTBS-iTBS."|6||
59929746|NCT02642029|76048078|FG001|STARTED|Study Visit 1 (1 Day)|"N=11 total participants were randomized to sham for the first study visit. For study visit 1, participants could be randomized to ONE OF THREE interventions (iTBS, cTBS, or sham TBS), not one of six interventions as this participant flow section suggests. The total number randomized to sham is the number started in Sham-iTBS-cTBS PLUS the number started in Sham-cTBS-iTBS."|5||
59929747|NCT02642029|76048079|FG002|STARTED|Study Visit 1 (1 Day)|"N=7 total participants were randomized to iTBS for the first study visit. For study visit 1, participants could be randomized to ONE OF THREE interventions (iTBS, cTBS, or sham TBS), not one of six interventions as this participant flow section suggests. The total number randomized to sham is the number started in iTBS-sham-cTBS PLUS the number started in iTBS-cTBS-sham."|3||
59929748|NCT02642029|76048080|FG003|STARTED|Study Visit 1 (1 Day)|"N=7 total participants were randomized to iTBS for the first study visit. For study visit 1, participants could be randomized to ONE OF THREE interventions (iTBS, cTBS, or sham TBS), not one of six interventions as this participant flow section suggests. The total number randomized to sham is the number started in iTBS-sham-cTBS PLUS the number started in iTBS-cTBS-sham."|4||
59929749|NCT02642029|76048081|FG004|STARTED|Study Visit 1 (1 Day)|"N=8 total participants were randomized to cTBS for the first study visit. For study visit 1, participants could be randomized to ONE OF THREE interventions (iTBS, cTBS, or sham TBS), not one of six interventions as this participant flow section suggests. The total number randomized to sham is the number started in cTBS-sham-iTBS PLUS the number started in cTBS-iTBS-sham."|4||
60063472|NCT02038829|76178740|FG001|STARTED|Treatment Period 2||8||
60063473|NCT02038829|76178741|FG002|STARTED|Treatment Period 2||8||
60063474|NCT02038829|76178742|FG003|STARTED|Treatment Period 2||8||
59517363|NCT01057381|75611293|FG002|COMPLETED|Overall Study||30||
59517364|NCT01057381|75611294|FG003|COMPLETED|Overall Study||26||
59517365|NCT01057381|75611291|FG000|NOT COMPLETED|Overall Study||0||
59517366|NCT01057381|75611292|FG001|NOT COMPLETED|Overall Study||0||
59517367|NCT01057381|75611293|FG002|NOT COMPLETED|Overall Study||0||
59517368|NCT01057381|75611294|FG003|NOT COMPLETED|Overall Study||0||
59517369|NCT00986102|75611308|FG000|STARTED|Overall Study|Number of participants who received study medication|53||
59517370|NCT00986102|75611309|FG001|STARTED|Overall Study|Number of participants who received study medication|77||
59517371|NCT00986102|75611310|FG002|STARTED|Overall Study|Number of participants who received study medication|19||
59517372|NCT00986102|75611311|FG003|STARTED|Overall Study|Number of participants who received study medication|67||
59517373|NCT00986102|75611308|FG000|COMPLETED|Overall Study||52||
59517374|NCT00986102|75611309|FG001|COMPLETED|Overall Study||75||
59517375|NCT00986102|75611310|FG002|COMPLETED|Overall Study||19||
59517376|NCT00986102|75611311|FG003|COMPLETED|Overall Study||66||
59517377|NCT00986102|75611308|FG000|NOT COMPLETED|Overall Study||1||
59517378|NCT00986102|75611309|FG001|NOT COMPLETED|Overall Study||2||
59517379|NCT00986102|75611310|FG002|NOT COMPLETED|Overall Study||0||
59517380|NCT00986102|75611311|FG003|NOT COMPLETED|Overall Study||1||
59517381|NCT01058239|75611321|FG000|STARTED|Overall Study||7||
59517382|NCT01058239|75611321|FG000|COMPLETED|Overall Study||7||
59517383|NCT01058239|75611321|FG000|NOT COMPLETED|Overall Study||0||
59517384|NCT01058941|75611327|FG000|STARTED|Overall Study||34||
59517385|NCT01058941|75611328|FG001|STARTED|Overall Study||33||
59517386|NCT01058941|75611327|FG000|COMPLETED|Overall Study||25||
59517387|NCT01058941|75611328|FG001|COMPLETED|Overall Study||22||
59517388|NCT01058941|75611327|FG000|NOT COMPLETED|Overall Study||9||
59517389|NCT01058941|75611328|FG001|NOT COMPLETED|Overall Study||11||
59517390|NCT00985946|75611334|FG000|STARTED|Overall Study|Eighty-seven percent (n=13) were evaluable for response.|15||
59517391|NCT00985946|75611334|FG000|COMPLETED|Overall Study||8||
59517392|NCT00985946|75611334|FG000|NOT COMPLETED|Overall Study||7||
59517393|NCT01059877|75611340|FG000|STARTED|Overall Study||6||
59517394|NCT01059877|75611341|FG001|STARTED|Overall Study||5||
59929750|NCT02642029|76048082|FG005|STARTED|Study Visit 1 (1 Day)|"N=8 total participants were randomized to cTBS for the first study visit. For study visit 1, participants could be randomized to ONE OF THREE interventions (iTBS, cTBS, or sham TBS), not one of six interventions as this participant flow section suggests. The total number randomized to sham is the number started in cTBS-sham-iTBS PLUS the number started in cTBS-iTBS-sham."|4||
59929751|NCT02642029|76048077|FG000|COMPLETED|Study Visit 1 (1 Day)||6||
59929752|NCT02642029|76048078|FG001|COMPLETED|Study Visit 1 (1 Day)||5||
59929753|NCT02642029|76048079|FG002|COMPLETED|Study Visit 1 (1 Day)||3||
59517395|NCT01059877|75611340|FG000|COMPLETED|Overall Study||6||
59517396|NCT01059877|75611341|FG001|COMPLETED|Overall Study||3||
59517397|NCT01059877|75611340|FG000|NOT COMPLETED|Overall Study||0||
59517398|NCT01059877|75611341|FG001|NOT COMPLETED|Overall Study||2||
59517399|NCT00985790|75611349|FG000|STARTED|Overall Study|95 were primed and 203 were unprimed subjects.|298||
59929754|NCT02642029|76048080|FG003|COMPLETED|Study Visit 1 (1 Day)||4||
59929755|NCT02642029|76048081|FG004|COMPLETED|Study Visit 1 (1 Day)||4||
59929756|NCT02642029|76048082|FG005|COMPLETED|Study Visit 1 (1 Day)||4||
59929757|NCT02642029|76048077|FG000|NOT COMPLETED|Study Visit 1 (1 Day)||0||
59929758|NCT02642029|76048078|FG001|NOT COMPLETED|Study Visit 1 (1 Day)||0||
59929759|NCT02642029|76048079|FG002|NOT COMPLETED|Study Visit 1 (1 Day)||0||
59929760|NCT02642029|76048080|FG003|NOT COMPLETED|Study Visit 1 (1 Day)||0||
59929761|NCT02642029|76048081|FG004|NOT COMPLETED|Study Visit 1 (1 Day)||0||
59929762|NCT02642029|76048082|FG005|NOT COMPLETED|Study Visit 1 (1 Day)||0||
59929763|NCT02642029|76048077|FG000|STARTED|Washout 1 (≥ 36 Hours)||6||
59929764|NCT02642029|76048078|FG001|STARTED|Washout 1 (≥ 36 Hours)||5||
59929765|NCT02642029|76048079|FG002|STARTED|Washout 1 (≥ 36 Hours)||3||
59929766|NCT02642029|76048080|FG003|STARTED|Washout 1 (≥ 36 Hours)||4||
59929767|NCT02642029|76048081|FG004|STARTED|Washout 1 (≥ 36 Hours)||4||
59929768|NCT02642029|76048082|FG005|STARTED|Washout 1 (≥ 36 Hours)||4||
59929769|NCT02642029|76048077|FG000|COMPLETED|Washout 1 (≥ 36 Hours)||5||
59929770|NCT02642029|76048078|FG001|COMPLETED|Washout 1 (≥ 36 Hours)||4||
59929771|NCT02642029|76048079|FG002|COMPLETED|Washout 1 (≥ 36 Hours)||3||
60063475|NCT02038829|76178743|FG004|STARTED|Treatment Period 2||7||
59517400|NCT00985790|75611350|FG001|STARTED|Overall Study|97 were primed and 204 were unprimed subjects.|301||
59761210|NCT00884832|75880891|FG001|STARTED|Overall Study||22||
59761211|NCT00884832|75880890|FG000|COMPLETED|Overall Study||22||
59761212|NCT00884832|75880891|FG001|COMPLETED|Overall Study||21||
59761213|NCT00884832|75880890|FG000|NOT COMPLETED|Overall Study||0||
59761214|NCT00884832|75880891|FG001|NOT COMPLETED|Overall Study||1||
59761215|NCT03938545|75880901|FG000|STARTED|Overall Study||18||
59761216|NCT03938545|75880902|FG001|STARTED|Overall Study||19||
59761217|NCT03938545|75880903|FG002|STARTED|Overall Study||10||
59761218|NCT03938545|75880904|FG003|STARTED|Overall Study||18||
59761219|NCT03938545|75880901|FG000|COMPLETED|Overall Study||10||
59929772|NCT02642029|76048080|FG003|COMPLETED|Washout 1 (≥ 36 Hours)||4||
59929773|NCT02642029|76048081|FG004|COMPLETED|Washout 1 (≥ 36 Hours)||3||
59929774|NCT02642029|76048082|FG005|COMPLETED|Washout 1 (≥ 36 Hours)||4||
59929775|NCT02642029|76048077|FG000|NOT COMPLETED|Washout 1 (≥ 36 Hours)||1||
60063476|NCT02038829|76178744|FG005|STARTED|Treatment Period 2||8||
59517401|NCT00985790|75611349|FG000|COMPLETED|Overall Study||291||
59517402|NCT00985790|75611350|FG001|COMPLETED|Overall Study||293||
59517403|NCT00985790|75611349|FG000|NOT COMPLETED|Overall Study||7||
59517404|NCT00985790|75611350|FG001|NOT COMPLETED|Overall Study||8||
59517405|NCT01060345|75611361|FG000|STARTED|Overall Study||20||
59517406|NCT01060345|75611361|FG000|COMPLETED|Overall Study||20||
59517407|NCT01060345|75611361|FG000|NOT COMPLETED|Overall Study||0||
59517408|NCT02170519|75611367|FG000|STARTED|Overall Study||22||
59517409|NCT02170519|75611368|FG001|STARTED|Overall Study||5||
59761220|NCT03938545|75880902|FG001|COMPLETED|Overall Study||14||
59761221|NCT03938545|75880903|FG002|COMPLETED|Overall Study||7||
60063477|NCT02038829|76178745|FG006|STARTED|Treatment Period 2||8||
60063478|NCT02038829|76178746|FG007|STARTED|Treatment Period 2||8||
60063479|NCT02038829|76178747|FG008|STARTED|Treatment Period 2||8||
60063480|NCT02038829|76178748|FG009|STARTED|Treatment Period 2||8||
60063481|NCT02038829|76178749|FG010|STARTED|Treatment Period 2||8||
60063482|NCT02038829|76178750|FG011|STARTED|Treatment Period 2||8||
60063483|NCT02038829|76178739|FG000|COMPLETED|Treatment Period 2||7||
60063484|NCT02038829|76178740|FG001|COMPLETED|Treatment Period 2||8||
60063485|NCT02038829|76178741|FG002|COMPLETED|Treatment Period 2||8||
60063486|NCT02038829|76178742|FG003|COMPLETED|Treatment Period 2||8||
60063487|NCT02038829|76178743|FG004|COMPLETED|Treatment Period 2||7||
60063488|NCT02038829|76178744|FG005|COMPLETED|Treatment Period 2||8||
60063489|NCT02038829|76178745|FG006|COMPLETED|Treatment Period 2||8||
60063490|NCT02038829|76178746|FG007|COMPLETED|Treatment Period 2||8||
60063491|NCT02038829|76178747|FG008|COMPLETED|Treatment Period 2||8||
60063492|NCT02038829|76178748|FG009|COMPLETED|Treatment Period 2||8||
60063493|NCT02038829|76178749|FG010|COMPLETED|Treatment Period 2||7||
60063494|NCT02038829|76178750|FG011|COMPLETED|Treatment Period 2||8||
60063495|NCT02038829|76178739|FG000|NOT COMPLETED|Treatment Period 2||1||
60063496|NCT02038829|76178740|FG001|NOT COMPLETED|Treatment Period 2||0||
60063497|NCT02038829|76178741|FG002|NOT COMPLETED|Treatment Period 2||0||
60063498|NCT02038829|76178742|FG003|NOT COMPLETED|Treatment Period 2||0||
60063499|NCT02038829|76178743|FG004|NOT COMPLETED|Treatment Period 2||0||
60063500|NCT02038829|76178744|FG005|NOT COMPLETED|Treatment Period 2||0||
60063501|NCT02038829|76178745|FG006|NOT COMPLETED|Treatment Period 2||0||
60063502|NCT02038829|76178746|FG007|NOT COMPLETED|Treatment Period 2||0||
60063503|NCT02038829|76178747|FG008|NOT COMPLETED|Treatment Period 2||0||
60063504|NCT02038829|76178748|FG009|NOT COMPLETED|Treatment Period 2||0||
60063505|NCT02038829|76178749|FG010|NOT COMPLETED|Treatment Period 2||1||
60063506|NCT02038829|76178750|FG011|NOT COMPLETED|Treatment Period 2||0||
60063507|NCT02038829|76178739|FG000|STARTED|Washout Period 2||7||
60063508|NCT02038829|76178740|FG001|STARTED|Washout Period 2||8||
60063509|NCT02038829|76178741|FG002|STARTED|Washout Period 2||8||
60063510|NCT02038829|76178742|FG003|STARTED|Washout Period 2||8||
60063511|NCT02038829|76178743|FG004|STARTED|Washout Period 2||7||
60063512|NCT02038829|76178744|FG005|STARTED|Washout Period 2||8||
60063513|NCT02038829|76178745|FG006|STARTED|Washout Period 2||8||
60063514|NCT02038829|76178746|FG007|STARTED|Washout Period 2||8||
60063515|NCT02038829|76178747|FG008|STARTED|Washout Period 2||8||
60063516|NCT02038829|76178748|FG009|STARTED|Washout Period 2||8||
60063517|NCT02038829|76178749|FG010|STARTED|Washout Period 2||7||
60063518|NCT02038829|76178750|FG011|STARTED|Washout Period 2||8||
60063519|NCT02038829|76178739|FG000|COMPLETED|Washout Period 2||7||
60063520|NCT02038829|76178740|FG001|COMPLETED|Washout Period 2||8||
60063521|NCT02038829|76178741|FG002|COMPLETED|Washout Period 2||8||
60063522|NCT02038829|76178742|FG003|COMPLETED|Washout Period 2||8||
60063523|NCT02038829|76178743|FG004|COMPLETED|Washout Period 2||7||
60063524|NCT02038829|76178744|FG005|COMPLETED|Washout Period 2||7||
60063525|NCT02038829|76178745|FG006|COMPLETED|Washout Period 2||8||
60063526|NCT02038829|76178746|FG007|COMPLETED|Washout Period 2||8||
60063527|NCT02038829|76178747|FG008|COMPLETED|Washout Period 2||7||
60063528|NCT02038829|76178748|FG009|COMPLETED|Washout Period 2||8||
60063529|NCT02038829|76178749|FG010|COMPLETED|Washout Period 2||7||
60063530|NCT02038829|76178750|FG011|COMPLETED|Washout Period 2||8||
60063531|NCT02038829|76178739|FG000|NOT COMPLETED|Washout Period 2||0||
60063532|NCT02038829|76178740|FG001|NOT COMPLETED|Washout Period 2||0||
60063533|NCT02038829|76178741|FG002|NOT COMPLETED|Washout Period 2||0||
60063534|NCT02038829|76178742|FG003|NOT COMPLETED|Washout Period 2||0||
60063535|NCT02038829|76178743|FG004|NOT COMPLETED|Washout Period 2||0||
60063536|NCT02038829|76178744|FG005|NOT COMPLETED|Washout Period 2||1||
60063537|NCT02038829|76178745|FG006|NOT COMPLETED|Washout Period 2||0||
60063538|NCT02038829|76178746|FG007|NOT COMPLETED|Washout Period 2||0||
60063539|NCT02038829|76178747|FG008|NOT COMPLETED|Washout Period 2||1||
60063540|NCT02038829|76178748|FG009|NOT COMPLETED|Washout Period 2||0||
60063541|NCT02038829|76178749|FG010|NOT COMPLETED|Washout Period 2||0||
60063542|NCT02038829|76178750|FG011|NOT COMPLETED|Washout Period 2||0||
60063543|NCT02038829|76178739|FG000|STARTED|Treatment Period 3||7||
60063544|NCT02038829|76178740|FG001|STARTED|Treatment Period 3||8||
60063545|NCT02038829|76178741|FG002|STARTED|Treatment Period 3||8||
60063546|NCT02038829|76178742|FG003|STARTED|Treatment Period 3||8||
60063547|NCT02038829|76178743|FG004|STARTED|Treatment Period 3||7||
60063548|NCT02038829|76178744|FG005|STARTED|Treatment Period 3||7||
60063549|NCT02038829|76178745|FG006|STARTED|Treatment Period 3||8||
60063550|NCT02038829|76178746|FG007|STARTED|Treatment Period 3||8||
60063551|NCT02038829|76178747|FG008|STARTED|Treatment Period 3||7||
60063552|NCT02038829|76178748|FG009|STARTED|Treatment Period 3||8||
60063553|NCT02038829|76178749|FG010|STARTED|Treatment Period 3||7||
60063554|NCT02038829|76178750|FG011|STARTED|Treatment Period 3||8||
60063555|NCT02038829|76178739|FG000|COMPLETED|Treatment Period 3||7||
60063556|NCT02038829|76178740|FG001|COMPLETED|Treatment Period 3||8||
60063557|NCT02038829|76178741|FG002|COMPLETED|Treatment Period 3||8||
60063558|NCT02038829|76178742|FG003|COMPLETED|Treatment Period 3||8||
60063559|NCT02038829|76178743|FG004|COMPLETED|Treatment Period 3||7||
60063560|NCT02038829|76178744|FG005|COMPLETED|Treatment Period 3||7||
60063561|NCT02038829|76178745|FG006|COMPLETED|Treatment Period 3||8||
60063562|NCT02038829|76178746|FG007|COMPLETED|Treatment Period 3||8||
60063563|NCT02038829|76178747|FG008|COMPLETED|Treatment Period 3||7||
60063564|NCT02038829|76178748|FG009|COMPLETED|Treatment Period 3||8||
60063565|NCT02038829|76178749|FG010|COMPLETED|Treatment Period 3||7||
60063566|NCT02038829|76178750|FG011|COMPLETED|Treatment Period 3||8||
60063567|NCT02038829|76178739|FG000|NOT COMPLETED|Treatment Period 3||0||
60063568|NCT02038829|76178740|FG001|NOT COMPLETED|Treatment Period 3||0||
60063569|NCT02038829|76178741|FG002|NOT COMPLETED|Treatment Period 3||0||
60063570|NCT02038829|76178742|FG003|NOT COMPLETED|Treatment Period 3||0||
60063571|NCT02038829|76178743|FG004|NOT COMPLETED|Treatment Period 3||0||
60063572|NCT02038829|76178744|FG005|NOT COMPLETED|Treatment Period 3||0||
60063573|NCT02038829|76178745|FG006|NOT COMPLETED|Treatment Period 3||0||
60063574|NCT02038829|76178746|FG007|NOT COMPLETED|Treatment Period 3||0||
60063575|NCT02038829|76178747|FG008|NOT COMPLETED|Treatment Period 3||0||
60063576|NCT02038829|76178748|FG009|NOT COMPLETED|Treatment Period 3||0||
60063577|NCT02038829|76178749|FG010|NOT COMPLETED|Treatment Period 3||0||
60063578|NCT02038829|76178750|FG011|NOT COMPLETED|Treatment Period 3||0||
60063579|NCT02038829|76178739|FG000|STARTED|Washout Period 3||7||
60063580|NCT02038829|76178740|FG001|STARTED|Washout Period 3||8||
60063581|NCT02038829|76178741|FG002|STARTED|Washout Period 3||8||
60063582|NCT02038829|76178742|FG003|STARTED|Washout Period 3||8||
60063583|NCT02038829|76178743|FG004|STARTED|Washout Period 3||7||
60063584|NCT02038829|76178744|FG005|STARTED|Washout Period 3||7||
60063585|NCT02038829|76178745|FG006|STARTED|Washout Period 3||8||
60063586|NCT02038829|76178746|FG007|STARTED|Washout Period 3||8||
60063587|NCT02038829|76178747|FG008|STARTED|Washout Period 3||7||
60063588|NCT02038829|76178748|FG009|STARTED|Washout Period 3||8||
60063589|NCT02038829|76178749|FG010|STARTED|Washout Period 3||7||
60063590|NCT02038829|76178750|FG011|STARTED|Washout Period 3||8||
60063591|NCT02038829|76178739|FG000|COMPLETED|Washout Period 3||7||
60063592|NCT02038829|76178740|FG001|COMPLETED|Washout Period 3||8||
60063593|NCT02038829|76178741|FG002|COMPLETED|Washout Period 3||8||
60063594|NCT02038829|76178742|FG003|COMPLETED|Washout Period 3||8||
60063595|NCT02038829|76178743|FG004|COMPLETED|Washout Period 3||7||
60063596|NCT02038829|76178744|FG005|COMPLETED|Washout Period 3||7||
60063597|NCT02038829|76178745|FG006|COMPLETED|Washout Period 3||8||
60063598|NCT02038829|76178746|FG007|COMPLETED|Washout Period 3||8||
60063599|NCT02038829|76178747|FG008|COMPLETED|Washout Period 3||7||
60063600|NCT02038829|76178748|FG009|COMPLETED|Washout Period 3||8||
60063601|NCT02038829|76178749|FG010|COMPLETED|Washout Period 3||7||
60063602|NCT02038829|76178750|FG011|COMPLETED|Washout Period 3||8||
60063603|NCT02038829|76178739|FG000|NOT COMPLETED|Washout Period 3||0||
60063604|NCT02038829|76178740|FG001|NOT COMPLETED|Washout Period 3||0||
60063605|NCT02038829|76178741|FG002|NOT COMPLETED|Washout Period 3||0||
60063606|NCT02038829|76178742|FG003|NOT COMPLETED|Washout Period 3||0||
60063607|NCT02038829|76178743|FG004|NOT COMPLETED|Washout Period 3||0||
60063608|NCT02038829|76178744|FG005|NOT COMPLETED|Washout Period 3||0||
60063609|NCT02038829|76178745|FG006|NOT COMPLETED|Washout Period 3||0||
60063610|NCT02038829|76178746|FG007|NOT COMPLETED|Washout Period 3||0||
60063611|NCT02038829|76178747|FG008|NOT COMPLETED|Washout Period 3||0||
60063612|NCT02038829|76178748|FG009|NOT COMPLETED|Washout Period 3||0||
60063613|NCT02038829|76178749|FG010|NOT COMPLETED|Washout Period 3||0||
60063614|NCT02038829|76178750|FG011|NOT COMPLETED|Washout Period 3||0||
60063615|NCT02038829|76178739|FG000|STARTED|Treatment Period 4||7||
60063616|NCT02038829|76178740|FG001|STARTED|Treatment Period 4||8||
60063617|NCT02038829|76178741|FG002|STARTED|Treatment Period 4||8||
60063618|NCT02038829|76178742|FG003|STARTED|Treatment Period 4||8||
60063619|NCT02038829|76178743|FG004|STARTED|Treatment Period 4||7||
60063620|NCT02038829|76178744|FG005|STARTED|Treatment Period 4||7||
60063621|NCT02038829|76178745|FG006|STARTED|Treatment Period 4||8||
60063622|NCT02038829|76178746|FG007|STARTED|Treatment Period 4||8||
60063623|NCT02038829|76178747|FG008|STARTED|Treatment Period 4||7||
60063624|NCT02038829|76178748|FG009|STARTED|Treatment Period 4||8||
60063625|NCT02038829|76178749|FG010|STARTED|Treatment Period 4||7||
60063626|NCT02038829|76178750|FG011|STARTED|Treatment Period 4||8||
60063627|NCT02038829|76178739|FG000|COMPLETED|Treatment Period 4||7||
60063628|NCT02038829|76178740|FG001|COMPLETED|Treatment Period 4||7||
60063629|NCT02038829|76178741|FG002|COMPLETED|Treatment Period 4||8||
60063630|NCT02038829|76178742|FG003|COMPLETED|Treatment Period 4||8||
60063631|NCT02038829|76178743|FG004|COMPLETED|Treatment Period 4||7||
60063632|NCT02038829|76178744|FG005|COMPLETED|Treatment Period 4||7||
60063633|NCT02038829|76178745|FG006|COMPLETED|Treatment Period 4||8||
60063634|NCT02038829|76178746|FG007|COMPLETED|Treatment Period 4||8||
60063635|NCT02038829|76178747|FG008|COMPLETED|Treatment Period 4||7||
60063636|NCT02038829|76178748|FG009|COMPLETED|Treatment Period 4||8||
60063637|NCT02038829|76178749|FG010|COMPLETED|Treatment Period 4||7||
60063638|NCT02038829|76178750|FG011|COMPLETED|Treatment Period 4||8||
60063639|NCT02038829|76178739|FG000|NOT COMPLETED|Treatment Period 4||0||
60063640|NCT02038829|76178740|FG001|NOT COMPLETED|Treatment Period 4||1||
60063641|NCT02038829|76178741|FG002|NOT COMPLETED|Treatment Period 4||0||
60063642|NCT02038829|76178742|FG003|NOT COMPLETED|Treatment Period 4||0||
60063643|NCT02038829|76178743|FG004|NOT COMPLETED|Treatment Period 4||0||
60063644|NCT02038829|76178744|FG005|NOT COMPLETED|Treatment Period 4||0||
60063645|NCT02038829|76178745|FG006|NOT COMPLETED|Treatment Period 4||0||
60063646|NCT02038829|76178746|FG007|NOT COMPLETED|Treatment Period 4||0||
60063647|NCT02038829|76178747|FG008|NOT COMPLETED|Treatment Period 4||0||
60063648|NCT02038829|76178748|FG009|NOT COMPLETED|Treatment Period 4||0||
60063649|NCT02038829|76178749|FG010|NOT COMPLETED|Treatment Period 4||0||
60063650|NCT02038829|76178750|FG011|NOT COMPLETED|Treatment Period 4||0||
60063651|NCT02038829|76178739|FG000|STARTED|Washout Period 4||7||
60063652|NCT02038829|76178740|FG001|STARTED|Washout Period 4||7||
60063653|NCT02038829|76178741|FG002|STARTED|Washout Period 4||8||
60063654|NCT02038829|76178742|FG003|STARTED|Washout Period 4||8||
60063655|NCT02038829|76178743|FG004|STARTED|Washout Period 4||7||
60063656|NCT02038829|76178744|FG005|STARTED|Washout Period 4||7||
60063657|NCT02038829|76178745|FG006|STARTED|Washout Period 4||8||
60063658|NCT02038829|76178746|FG007|STARTED|Washout Period 4||8||
60063659|NCT02038829|76178747|FG008|STARTED|Washout Period 4||7||
60063660|NCT02038829|76178748|FG009|STARTED|Washout Period 4||8||
60063661|NCT02038829|76178749|FG010|STARTED|Washout Period 4||7||
60063662|NCT02038829|76178750|FG011|STARTED|Washout Period 4||8||
60063663|NCT02038829|76178739|FG000|COMPLETED|Washout Period 4||7||
60063664|NCT02038829|76178740|FG001|COMPLETED|Washout Period 4||7||
60063665|NCT02038829|76178741|FG002|COMPLETED|Washout Period 4||8||
60063666|NCT02038829|76178742|FG003|COMPLETED|Washout Period 4||8||
60063667|NCT02038829|76178743|FG004|COMPLETED|Washout Period 4||7||
60063668|NCT02038829|76178744|FG005|COMPLETED|Washout Period 4||7||
60063669|NCT02038829|76178745|FG006|COMPLETED|Washout Period 4||7||
60063670|NCT02038829|76178746|FG007|COMPLETED|Washout Period 4||8||
60063671|NCT02038829|76178747|FG008|COMPLETED|Washout Period 4||7||
60063672|NCT02038829|76178748|FG009|COMPLETED|Washout Period 4||8||
60063673|NCT02038829|76178749|FG010|COMPLETED|Washout Period 4||7||
60063674|NCT02038829|76178750|FG011|COMPLETED|Washout Period 4||8||
60063675|NCT02038829|76178739|FG000|NOT COMPLETED|Washout Period 4||0||
60063676|NCT02038829|76178740|FG001|NOT COMPLETED|Washout Period 4||0||
60063677|NCT02038829|76178741|FG002|NOT COMPLETED|Washout Period 4||0||
60063678|NCT02038829|76178742|FG003|NOT COMPLETED|Washout Period 4||0||
60063679|NCT02038829|76178743|FG004|NOT COMPLETED|Washout Period 4||0||
60063680|NCT02038829|76178744|FG005|NOT COMPLETED|Washout Period 4||0||
60063681|NCT02038829|76178745|FG006|NOT COMPLETED|Washout Period 4||1||
60063682|NCT02038829|76178746|FG007|NOT COMPLETED|Washout Period 4||0||
60063683|NCT02038829|76178747|FG008|NOT COMPLETED|Washout Period 4||0||
60063684|NCT02038829|76178748|FG009|NOT COMPLETED|Washout Period 4||0||
60063685|NCT02038829|76178749|FG010|NOT COMPLETED|Washout Period 4||0||
60063686|NCT02038829|76178750|FG011|NOT COMPLETED|Washout Period 4||0||
60063687|NCT02038829|76178739|FG000|STARTED|Treatment Period 5||7||
60063688|NCT02038829|76178740|FG001|STARTED|Treatment Period 5||7||
60063689|NCT02038829|76178741|FG002|STARTED|Treatment Period 5||8||
60063690|NCT02038829|76178742|FG003|STARTED|Treatment Period 5||8||
60063691|NCT02038829|76178743|FG004|STARTED|Treatment Period 5||7||
60063692|NCT02038829|76178744|FG005|STARTED|Treatment Period 5||7||
60063693|NCT02038829|76178745|FG006|STARTED|Treatment Period 5||7||
60063694|NCT02038829|76178746|FG007|STARTED|Treatment Period 5||8||
60063695|NCT02038829|76178747|FG008|STARTED|Treatment Period 5||7||
60063696|NCT02038829|76178748|FG009|STARTED|Treatment Period 5||8||
60063697|NCT02038829|76178749|FG010|STARTED|Treatment Period 5||7||
60063698|NCT02038829|76178750|FG011|STARTED|Treatment Period 5||8||
60063699|NCT02038829|76178739|FG000|COMPLETED|Treatment Period 5||7||
60063700|NCT02038829|76178740|FG001|COMPLETED|Treatment Period 5||7||
60063701|NCT02038829|76178741|FG002|COMPLETED|Treatment Period 5||8||
60063702|NCT02038829|76178742|FG003|COMPLETED|Treatment Period 5||8||
60063703|NCT02038829|76178743|FG004|COMPLETED|Treatment Period 5||7||
60063704|NCT02038829|76178744|FG005|COMPLETED|Treatment Period 5||7||
60063705|NCT02038829|76178745|FG006|COMPLETED|Treatment Period 5||7||
60063706|NCT02038829|76178746|FG007|COMPLETED|Treatment Period 5||8||
60063707|NCT02038829|76178747|FG008|COMPLETED|Treatment Period 5||7||
60063708|NCT02038829|76178748|FG009|COMPLETED|Treatment Period 5||8||
60063709|NCT02038829|76178749|FG010|COMPLETED|Treatment Period 5||7||
60063710|NCT02038829|76178750|FG011|COMPLETED|Treatment Period 5||8||
60063711|NCT02038829|76178739|FG000|NOT COMPLETED|Treatment Period 5||0||
60063712|NCT02038829|76178740|FG001|NOT COMPLETED|Treatment Period 5||0||
60063713|NCT02038829|76178741|FG002|NOT COMPLETED|Treatment Period 5||0||
60063714|NCT02038829|76178742|FG003|NOT COMPLETED|Treatment Period 5||0||
60063715|NCT02038829|76178743|FG004|NOT COMPLETED|Treatment Period 5||0||
60063716|NCT02038829|76178744|FG005|NOT COMPLETED|Treatment Period 5||0||
60063717|NCT02038829|76178745|FG006|NOT COMPLETED|Treatment Period 5||0||
60063718|NCT02038829|76178746|FG007|NOT COMPLETED|Treatment Period 5||0||
59517410|NCT02170519|75611367|FG000|COMPLETED|Overall Study||22||
59929776|NCT02642029|76048078|FG001|NOT COMPLETED|Washout 1 (≥ 36 Hours)||1||
59929777|NCT02642029|76048079|FG002|NOT COMPLETED|Washout 1 (≥ 36 Hours)||0||
59929778|NCT02642029|76048080|FG003|NOT COMPLETED|Washout 1 (≥ 36 Hours)||0||
59929779|NCT02642029|76048081|FG004|NOT COMPLETED|Washout 1 (≥ 36 Hours)||1||
59929780|NCT02642029|76048082|FG005|NOT COMPLETED|Washout 1 (≥ 36 Hours)||0||
59929781|NCT02642029|76048077|FG000|STARTED|Study Visit 2 (1 Day)|Of the 9 participants who completed sham TBS, 5 were randomized to iTBS for the second study visit.|5||
59929782|NCT02642029|76048078|FG001|STARTED|Study Visit 2 (1 Day)|Of the 9 participants who completed sham TBS, 4 were randomized to cTBS for the second study visit.|4||
59929783|NCT02642029|76048079|FG002|STARTED|Study Visit 2 (1 Day)|Of the 7 participants who completed iTBS, 3 were randomized to sham TBS for the second study visit.|3||
59929784|NCT02642029|76048080|FG003|STARTED|Study Visit 2 (1 Day)|Of the 7 participants who completed iTBS, 4 were randomized to cTBS for the second study visit.|4||
59929785|NCT02642029|76048081|FG004|STARTED|Study Visit 2 (1 Day)|Of the 7 participants who completed cTBS, 3 were randomized to sham TBS for the second study visit.|3||
59929786|NCT02642029|76048082|FG005|STARTED|Study Visit 2 (1 Day)|Of the 7 participants who completed cTBS, 4 were randomized to iTBS for the second study visit.|4||
59929787|NCT02642029|76048077|FG000|COMPLETED|Study Visit 2 (1 Day)||4||
59929788|NCT02642029|76048078|FG001|COMPLETED|Study Visit 2 (1 Day)||4||
59929789|NCT02642029|76048079|FG002|COMPLETED|Study Visit 2 (1 Day)||3||
59929790|NCT02642029|76048080|FG003|COMPLETED|Study Visit 2 (1 Day)||4||
59929791|NCT02642029|76048081|FG004|COMPLETED|Study Visit 2 (1 Day)||3||
59929792|NCT02642029|76048082|FG005|COMPLETED|Study Visit 2 (1 Day)||4||
59929793|NCT02642029|76048077|FG000|NOT COMPLETED|Study Visit 2 (1 Day)||1||
59929794|NCT02642029|76048078|FG001|NOT COMPLETED|Study Visit 2 (1 Day)||0||
59929795|NCT02642029|76048079|FG002|NOT COMPLETED|Study Visit 2 (1 Day)||0||
59929796|NCT02642029|76048080|FG003|NOT COMPLETED|Study Visit 2 (1 Day)||0||
59929797|NCT02642029|76048081|FG004|NOT COMPLETED|Study Visit 2 (1 Day)||0||
59929798|NCT02642029|76048082|FG005|NOT COMPLETED|Study Visit 2 (1 Day)||0||
59929799|NCT02642029|76048077|FG000|STARTED|Washout 2 (≥ 36 Hours)||4||
59929800|NCT02642029|76048078|FG001|STARTED|Washout 2 (≥ 36 Hours)||4||
59929801|NCT02642029|76048079|FG002|STARTED|Washout 2 (≥ 36 Hours)||3||
59929802|NCT02642029|76048080|FG003|STARTED|Washout 2 (≥ 36 Hours)||4||
59929803|NCT02642029|76048081|FG004|STARTED|Washout 2 (≥ 36 Hours)||3||
59929804|NCT02642029|76048082|FG005|STARTED|Washout 2 (≥ 36 Hours)||4||
59929805|NCT02642029|76048077|FG000|COMPLETED|Washout 2 (≥ 36 Hours)||2||
59929806|NCT02642029|76048078|FG001|COMPLETED|Washout 2 (≥ 36 Hours)||4||
59929807|NCT02642029|76048079|FG002|COMPLETED|Washout 2 (≥ 36 Hours)||3||
59929808|NCT02642029|76048080|FG003|COMPLETED|Washout 2 (≥ 36 Hours)||4||
59929809|NCT02642029|76048081|FG004|COMPLETED|Washout 2 (≥ 36 Hours)||3||
59929810|NCT02642029|76048082|FG005|COMPLETED|Washout 2 (≥ 36 Hours)||4||
59929811|NCT02642029|76048077|FG000|NOT COMPLETED|Washout 2 (≥ 36 Hours)||2||
59929812|NCT02642029|76048078|FG001|NOT COMPLETED|Washout 2 (≥ 36 Hours)||0||
59929813|NCT02642029|76048079|FG002|NOT COMPLETED|Washout 2 (≥ 36 Hours)||0||
59929814|NCT02642029|76048080|FG003|NOT COMPLETED|Washout 2 (≥ 36 Hours)||0||
59929815|NCT02642029|76048081|FG004|NOT COMPLETED|Washout 2 (≥ 36 Hours)||0||
59929816|NCT02642029|76048082|FG005|NOT COMPLETED|Washout 2 (≥ 36 Hours)||0||
59929817|NCT02642029|76048077|FG000|STARTED|Study Visit 3 (1 Day)||2||
59929818|NCT02642029|76048078|FG001|STARTED|Study Visit 3 (1 Day)||4||
59929819|NCT02642029|76048079|FG002|STARTED|Study Visit 3 (1 Day)||3||
59929820|NCT02642029|76048080|FG003|STARTED|Study Visit 3 (1 Day)||4||
59929821|NCT02642029|76048081|FG004|STARTED|Study Visit 3 (1 Day)||3||
59929822|NCT02642029|76048082|FG005|STARTED|Study Visit 3 (1 Day)||4||
59929823|NCT02642029|76048077|FG000|COMPLETED|Study Visit 3 (1 Day)||2||
59929824|NCT02642029|76048078|FG001|COMPLETED|Study Visit 3 (1 Day)||4||
59929825|NCT02642029|76048079|FG002|COMPLETED|Study Visit 3 (1 Day)||3||
59929826|NCT02642029|76048080|FG003|COMPLETED|Study Visit 3 (1 Day)||4||
59929827|NCT02642029|76048081|FG004|COMPLETED|Study Visit 3 (1 Day)||3||
59929828|NCT02642029|76048082|FG005|COMPLETED|Study Visit 3 (1 Day)||4||
59929829|NCT02642029|76048077|FG000|NOT COMPLETED|Study Visit 3 (1 Day)||0||
59929830|NCT02642029|76048078|FG001|NOT COMPLETED|Study Visit 3 (1 Day)||0||
59929831|NCT02642029|76048079|FG002|NOT COMPLETED|Study Visit 3 (1 Day)||0||
59929832|NCT02642029|76048080|FG003|NOT COMPLETED|Study Visit 3 (1 Day)||0||
59929833|NCT02642029|76048081|FG004|NOT COMPLETED|Study Visit 3 (1 Day)||0||
59929834|NCT02642029|76048082|FG005|NOT COMPLETED|Study Visit 3 (1 Day)||0||
59929835|NCT03178669|76048095|FG000|STARTED|Overall Study||40||
59929836|NCT03178669|76048096|FG001|STARTED|Overall Study||43||
59929837|NCT03178669|76048097|FG002|STARTED|Overall Study||42||
60063719|NCT02038829|76178747|FG008|NOT COMPLETED|Treatment Period 5||0||
60063720|NCT02038829|76178748|FG009|NOT COMPLETED|Treatment Period 5||0||
60063721|NCT02038829|76178749|FG010|NOT COMPLETED|Treatment Period 5||0||
60063722|NCT02038829|76178750|FG011|NOT COMPLETED|Treatment Period 5||0||
60063723|NCT02038829|76178739|FG000|STARTED|Washout Period 5||7||
60063724|NCT02038829|76178740|FG001|STARTED|Washout Period 5||7||
59517411|NCT02170519|75611368|FG001|COMPLETED|Overall Study||5||
59929838|NCT03178669|76048098|FG003|STARTED|Overall Study||42||
59929839|NCT03178669|76048099|FG004|STARTED|Overall Study||44||
60063725|NCT02038829|76178741|FG002|STARTED|Washout Period 5||8||
60063726|NCT02038829|76178742|FG003|STARTED|Washout Period 5||8||
60063727|NCT02038829|76178743|FG004|STARTED|Washout Period 5||7||
60063728|NCT02038829|76178744|FG005|STARTED|Washout Period 5||7||
60063729|NCT02038829|76178745|FG006|STARTED|Washout Period 5||7||
60063730|NCT02038829|76178746|FG007|STARTED|Washout Period 5||8||
60063731|NCT02038829|76178747|FG008|STARTED|Washout Period 5||7||
60063732|NCT02038829|76178748|FG009|STARTED|Washout Period 5||8||
60063733|NCT02038829|76178749|FG010|STARTED|Washout Period 5||7||
60063734|NCT02038829|76178750|FG011|STARTED|Washout Period 5||8||
60063735|NCT02038829|76178739|FG000|COMPLETED|Washout Period 5||7||
60063736|NCT02038829|76178740|FG001|COMPLETED|Washout Period 5||7||
60063737|NCT02038829|76178741|FG002|COMPLETED|Washout Period 5||8||
60063738|NCT02038829|76178742|FG003|COMPLETED|Washout Period 5||8||
60063739|NCT02038829|76178743|FG004|COMPLETED|Washout Period 5||7||
60063740|NCT02038829|76178744|FG005|COMPLETED|Washout Period 5||7||
60063741|NCT02038829|76178745|FG006|COMPLETED|Washout Period 5||7||
60063742|NCT02038829|76178746|FG007|COMPLETED|Washout Period 5||8||
60063743|NCT02038829|76178747|FG008|COMPLETED|Washout Period 5||7||
60063744|NCT02038829|76178748|FG009|COMPLETED|Washout Period 5||8||
60063745|NCT02038829|76178749|FG010|COMPLETED|Washout Period 5||7||
60063746|NCT02038829|76178750|FG011|COMPLETED|Washout Period 5||8||
60063747|NCT02038829|76178739|FG000|NOT COMPLETED|Washout Period 5||0||
59929840|NCT03178669|76048095|FG000|Completed Week 6|Overall Study||35|Completed Week 6|
59929841|NCT03178669|76048096|FG001|Completed Week 6|Overall Study||42|Completed Week 6|
59929842|NCT03178669|76048097|FG002|Completed Week 6|Overall Study||36|Completed Week 6|
59929843|NCT03178669|76048098|FG003|Completed Week 6|Overall Study||38|Completed Week 6|
59929844|NCT03178669|76048099|FG004|Completed Week 6|Overall Study||42|Completed Week 6|
59929845|NCT03178669|76048095|FG000|COMPLETED|Overall Study||35|Completed Week 10|
59929846|NCT03178669|76048096|FG001|COMPLETED|Overall Study||42|Completed Week 10|
59929847|NCT03178669|76048097|FG002|COMPLETED|Overall Study||35|Completed Week 10|
59929848|NCT03178669|76048098|FG003|COMPLETED|Overall Study||38|Completed Week 10|
59929849|NCT03178669|76048099|FG004|COMPLETED|Overall Study||40|Completed Week 10|
59929850|NCT03178669|76048095|FG000|NOT COMPLETED|Overall Study||5||
59929851|NCT03178669|76048096|FG001|NOT COMPLETED|Overall Study||1||
59929852|NCT03178669|76048097|FG002|NOT COMPLETED|Overall Study||7||
59929853|NCT03178669|76048098|FG003|NOT COMPLETED|Overall Study||4||
60063748|NCT02038829|76178740|FG001|NOT COMPLETED|Washout Period 5||0||
60063749|NCT02038829|76178741|FG002|NOT COMPLETED|Washout Period 5||0||
60063750|NCT02038829|76178742|FG003|NOT COMPLETED|Washout Period 5||0||
60063751|NCT02038829|76178743|FG004|NOT COMPLETED|Washout Period 5||0||
60063752|NCT02038829|76178744|FG005|NOT COMPLETED|Washout Period 5||0||
60063753|NCT02038829|76178745|FG006|NOT COMPLETED|Washout Period 5||0||
59517412|NCT02170519|75611367|FG000|NOT COMPLETED|Overall Study||0||
59517413|NCT02170519|75611368|FG001|NOT COMPLETED|Overall Study||0||
59929854|NCT03178669|76048099|FG004|NOT COMPLETED|Overall Study||4||
59929855|NCT03178201|76048111|FG000|STARTED|Overall Study||5||
59929856|NCT03178201|76048111|FG000|COMPLETED|Overall Study||0||
59929857|NCT03178201|76048111|FG000|NOT COMPLETED|Overall Study||5||
59929858|NCT03021642|76048115|FG000|STARTED|Treatment Period 1 (Day 1)||12||
59929859|NCT03021642|76048116|FG001|STARTED|Treatment Period 1 (Day 1)||12||
59929860|NCT03021642|76048115|FG000|COMPLETED|Treatment Period 1 (Day 1)||12||
59929861|NCT03021642|76048116|FG001|COMPLETED|Treatment Period 1 (Day 1)||12||
59929862|NCT03021642|76048115|FG000|NOT COMPLETED|Treatment Period 1 (Day 1)||0||
59929863|NCT03021642|76048116|FG001|NOT COMPLETED|Treatment Period 1 (Day 1)||0||
59929864|NCT03021642|76048115|FG000|STARTED|Washout Period (21 Days)||12||
59929865|NCT03021642|76048116|FG001|STARTED|Washout Period (21 Days)||12||
59929866|NCT03021642|76048115|FG000|COMPLETED|Washout Period (21 Days)||11||
59929867|NCT03021642|76048116|FG001|COMPLETED|Washout Period (21 Days)||11||
59929868|NCT03021642|76048115|FG000|NOT COMPLETED|Washout Period (21 Days)||1||
59929869|NCT03021642|76048116|FG001|NOT COMPLETED|Washout Period (21 Days)||1||
59929870|NCT03021642|76048115|FG000|STARTED|Treatment Period 2 (Day 22)||11||
59929871|NCT03021642|76048116|FG001|STARTED|Treatment Period 2 (Day 22)||11||
59929872|NCT03021642|76048115|FG000|COMPLETED|Treatment Period 2 (Day 22)||11||
59929873|NCT03021642|76048116|FG001|COMPLETED|Treatment Period 2 (Day 22)||11||
59929874|NCT03021642|76048115|FG000|NOT COMPLETED|Treatment Period 2 (Day 22)||0||
60063754|NCT02038829|76178746|FG007|NOT COMPLETED|Washout Period 5||0||
60063755|NCT02038829|76178747|FG008|NOT COMPLETED|Washout Period 5||0||
60063756|NCT02038829|76178748|FG009|NOT COMPLETED|Washout Period 5||0||
60063757|NCT02038829|76178749|FG010|NOT COMPLETED|Washout Period 5||0||
60063758|NCT02038829|76178750|FG011|NOT COMPLETED|Washout Period 5||0||
60063759|NCT02038829|76178739|FG000|STARTED|Treatment Period 6||7||
60063760|NCT02038829|76178740|FG001|STARTED|Treatment Period 6||7||
60063761|NCT02038829|76178741|FG002|STARTED|Treatment Period 6||8||
60063762|NCT02038829|76178742|FG003|STARTED|Treatment Period 6||8||
60063763|NCT02038829|76178743|FG004|STARTED|Treatment Period 6||7||
60063764|NCT02038829|76178744|FG005|STARTED|Treatment Period 6||7||
60063765|NCT02038829|76178745|FG006|STARTED|Treatment Period 6||7||
60063766|NCT02038829|76178746|FG007|STARTED|Treatment Period 6||8||
60063767|NCT02038829|76178747|FG008|STARTED|Treatment Period 6||7||
60063768|NCT02038829|76178748|FG009|STARTED|Treatment Period 6||8||
60063769|NCT02038829|76178749|FG010|STARTED|Treatment Period 6||7||
60063770|NCT02038829|76178750|FG011|STARTED|Treatment Period 6||8||
60063771|NCT02038829|76178739|FG000|COMPLETED|Treatment Period 6||7||
60063772|NCT02038829|76178740|FG001|COMPLETED|Treatment Period 6||7||
60063773|NCT02038829|76178741|FG002|COMPLETED|Treatment Period 6||7||
60063774|NCT02038829|76178742|FG003|COMPLETED|Treatment Period 6||8||
60063775|NCT02038829|76178743|FG004|COMPLETED|Treatment Period 6||7||
60063776|NCT02038829|76178744|FG005|COMPLETED|Treatment Period 6||7||
60063777|NCT02038829|76178745|FG006|COMPLETED|Treatment Period 6||7||
59517414|NCT00985712|75611377|FG000|STARTED|Overall Study||133||
59517415|NCT00985712|75611378|FG001|STARTED|Overall Study||130||
59929875|NCT03021642|76048116|FG001|NOT COMPLETED|Treatment Period 2 (Day 22)||0||
60063778|NCT02038829|76178746|FG007|COMPLETED|Treatment Period 6||8||
60063779|NCT02038829|76178747|FG008|COMPLETED|Treatment Period 6||7||
60063780|NCT02038829|76178748|FG009|COMPLETED|Treatment Period 6||8||
59929876|NCT03021564|76048124|FG000|STARTED|Overall Study||120||
60063781|NCT02038829|76178749|FG010|COMPLETED|Treatment Period 6||7||
60063782|NCT02038829|76178750|FG011|COMPLETED|Treatment Period 6||8||
59929877|NCT03021564|76048125|FG001|STARTED|Overall Study||557||
59929878|NCT03021564|76048124|FG000|COMPLETED|Overall Study||36||
59517416|NCT00985712|75611377|FG000|Received at Least One Dose of Study Drug|Overall Study||131||
59929879|NCT03021564|76048125|FG001|COMPLETED|Overall Study||89||
59929880|NCT03021564|76048124|FG000|NOT COMPLETED|Overall Study||84||
59929881|NCT03021564|76048125|FG001|NOT COMPLETED|Overall Study||468||
59517417|NCT00985712|75611378|FG001|Received at Least One Dose of Study Drug|Overall Study||130||
59517418|NCT00985712|75611377|FG000|Full Analysis Set (FAS)|Overall Study|Participants completed baseline and had at least 1 post-baseline measurement for efficacy analysis.|128||
59517419|NCT00985712|75611378|FG001|Full Analysis Set (FAS)|Overall Study|Participants completed baseline and had at least 1 post-baseline measurement for efficacy analysis.|129||
59517420|NCT00985712|75611377|FG000|COMPLETED|Overall Study||127||
59517421|NCT00985712|75611378|FG001|COMPLETED|Overall Study||123||
59761222|NCT03938545|75880904|FG003|COMPLETED|Overall Study||13||
59929882|NCT03023046|76048135|FG000|STARTED|Overall Study||54||
59929883|NCT03023046|76048135|FG000|COMPLETED|Overall Study||53||
59929884|NCT03023046|76048135|FG000|NOT COMPLETED|Overall Study||1||
59929885|NCT03019458|76048143|FG000|STARTED|Overall Study||24||
59929886|NCT03019458|76048144|FG001|STARTED|Overall Study||26||
59929887|NCT03019458|76048143|FG000|COMPLETED|Overall Study||24||
59929888|NCT03019458|76048144|FG001|COMPLETED|Overall Study||25||
59929889|NCT03019458|76048143|FG000|NOT COMPLETED|Overall Study||0||
59929890|NCT03019458|76048144|FG001|NOT COMPLETED|Overall Study||1||
59929891|NCT02923830|76048154|FG000|STARTED|Overall Study||13||
59929892|NCT02923830|76048155|FG001|STARTED|Overall Study||15||
59929893|NCT02923830|76048154|FG000|COMPLETED|Overall Study|Study terminated|0||
59929894|NCT02923830|76048155|FG001|COMPLETED|Overall Study|Study terminated|0||
59929895|NCT02923830|76048154|FG000|NOT COMPLETED|Overall Study||13||
59929896|NCT02923830|76048155|FG001|NOT COMPLETED|Overall Study||15||
59929897|NCT03021018|76048164|FG000|STARTED|Overall Study||16||
59929898|NCT03021018|76048165|FG001|STARTED|Overall Study||15||
60063783|NCT02038829|76178739|FG000|NOT COMPLETED|Treatment Period 6||0||
60063784|NCT02038829|76178740|FG001|NOT COMPLETED|Treatment Period 6||0||
60063785|NCT02038829|76178741|FG002|NOT COMPLETED|Treatment Period 6||1||
59929899|NCT03021018|76048166|FG002|STARTED|Overall Study||15||
59929900|NCT03021018|76048164|FG000|COMPLETED|Overall Study||14||
59929901|NCT03021018|76048165|FG001|COMPLETED|Overall Study||15||
59929902|NCT03021018|76048166|FG002|COMPLETED|Overall Study||15||
59929903|NCT03021018|76048164|FG000|NOT COMPLETED|Overall Study||2||
59929904|NCT03021018|76048165|FG001|NOT COMPLETED|Overall Study||0||
60063786|NCT02038829|76178742|FG003|NOT COMPLETED|Treatment Period 6||0||
60063787|NCT02038829|76178743|FG004|NOT COMPLETED|Treatment Period 6||0||
60063788|NCT02038829|76178744|FG005|NOT COMPLETED|Treatment Period 6||0||
60063789|NCT02038829|76178745|FG006|NOT COMPLETED|Treatment Period 6||0||
60063790|NCT02038829|76178746|FG007|NOT COMPLETED|Treatment Period 6||0||
60063791|NCT02038829|76178747|FG008|NOT COMPLETED|Treatment Period 6||0||
60063792|NCT02038829|76178748|FG009|NOT COMPLETED|Treatment Period 6||0||
60063793|NCT02038829|76178749|FG010|NOT COMPLETED|Treatment Period 6||0||
60063794|NCT02038829|76178750|FG011|NOT COMPLETED|Treatment Period 6||0||
60063795|NCT02038049|76178767|FG000|STARTED|Overall Study||4|All randomized patients were included in the Full Analysis (FAS) and Safety Set|
60063796|NCT02038049|76178768|FG001|STARTED|Overall Study||4|All randomized patients were included in the Full Analysis (FAS) and Safety Set|
60063797|NCT02038049|76178767|FG000|Pharmacodynamic (PD) Analysis Set|Overall Study||4|At least one dose of study drug and one evaluable PD assessment|
60063798|NCT02038049|76178768|FG001|Pharmacodynamic (PD) Analysis Set|Overall Study||4|At least one dose of study drug and one evaluable PD assessment|
60063799|NCT02038049|76178767|FG000|COMPLETED|Overall Study||3||
60063800|NCT02038049|76178768|FG001|COMPLETED|Overall Study||4||
60063801|NCT02038049|76178767|FG000|NOT COMPLETED|Overall Study||1||
60063802|NCT02038049|76178768|FG001|NOT COMPLETED|Overall Study||0||
60063803|NCT02052011|76178780|FG000|STARTED|Overall Study||21||
60063804|NCT02052011|76178781|FG001|STARTED|Overall Study||10||
60063805|NCT02052011|76178780|FG000|COMPLETED|Overall Study||17||
60063806|NCT02052011|76178781|FG001|COMPLETED|Overall Study||8||
60063807|NCT02052011|76178780|FG000|NOT COMPLETED|Overall Study||4||
60063808|NCT02052011|76178781|FG001|NOT COMPLETED|Overall Study||2||
60063809|NCT02036645|76178799|FG000|STARTED|SAD Cohorts : Study Part 1|Pooled across cohorts 1-5 (2 per cohort)|12||
60063810|NCT02036645|76178800|FG001|STARTED|SAD Cohorts : Study Part 1||3||
60063811|NCT02036645|76178801|FG002|STARTED|SAD Cohorts : Study Part 1||6||
60063812|NCT02036645|76178802|FG003|STARTED|SAD Cohorts : Study Part 1||6||
60063813|NCT02036645|76178803|FG004|STARTED|SAD Cohorts : Study Part 1||6||
60063814|NCT02036645|76178804|FG005|STARTED|SAD Cohorts : Study Part 1||6||
59517422|NCT00985712|75611377|FG000|NOT COMPLETED|Overall Study||6||
59517423|NCT00985712|75611378|FG001|NOT COMPLETED|Overall Study||7||
59517424|NCT03326986|75611387|FG000|STARTED|Overall Study||8||
59517425|NCT03326986|75611388|FG001|STARTED|Overall Study||8||
59517426|NCT03326986|75611389|FG002|STARTED|Overall Study||8||
59517427|NCT03326986|75611387|FG000|COMPLETED|Overall Study||8||
59517428|NCT03326986|75611388|FG001|COMPLETED|Overall Study||8||
59517429|NCT03326986|75611389|FG002|COMPLETED|Overall Study||8||
59517430|NCT03326986|75611387|FG000|NOT COMPLETED|Overall Study||0||
59517431|NCT03326986|75611388|FG001|NOT COMPLETED|Overall Study||0||
59517432|NCT03326986|75611389|FG002|NOT COMPLETED|Overall Study||0||
59517433|NCT03328624|75611430|FG000|STARTED|Overall Study||36||
59517434|NCT03328624|75611430|FG000|COMPLETED|Overall Study||36||
59517435|NCT03328624|75611430|FG000|NOT COMPLETED|Overall Study||0||
59517436|NCT03229252|75611437|FG000|STARTED|Overall Study||31||
60063815|NCT02036645|76178805|FG006|STARTED|SAD Cohorts : Study Part 1||6||
60063816|NCT02036645|76178806|FG007|STARTED|SAD Cohorts : Study Part 1||0||
60063817|NCT02036645|76178807|FG008|STARTED|SAD Cohorts : Study Part 1||0||
60063818|NCT02036645|76178808|FG009|STARTED|SAD Cohorts : Study Part 1||0||
60063819|NCT02036645|76178809|FG010|STARTED|SAD Cohorts : Study Part 1||0||
60063820|NCT02036645|76178810|FG011|STARTED|SAD Cohorts : Study Part 1||0||
60063821|NCT02036645|76178799|FG000|COMPLETED|SAD Cohorts : Study Part 1||12||
60063822|NCT02036645|76178800|FG001|COMPLETED|SAD Cohorts : Study Part 1||3||
60063823|NCT02036645|76178801|FG002|COMPLETED|SAD Cohorts : Study Part 1||6||
59517437|NCT03229252|75611438|FG001|STARTED|Overall Study||15||
59517438|NCT03229252|75611439|FG002|STARTED|Overall Study||45||
59517439|NCT03229252|75611437|FG000|COMPLETED|Overall Study||29||
59517440|NCT03229252|75611438|FG001|COMPLETED|Overall Study||15||
59517441|NCT03229252|75611439|FG002|COMPLETED|Overall Study||39||
59517442|NCT03229252|75611437|FG000|NOT COMPLETED|Overall Study||2||
60063824|NCT02036645|76178802|FG003|COMPLETED|SAD Cohorts : Study Part 1||5||
60063825|NCT02036645|76178803|FG004|COMPLETED|SAD Cohorts : Study Part 1||6||
60063826|NCT02036645|76178804|FG005|COMPLETED|SAD Cohorts : Study Part 1||6||
60063827|NCT02036645|76178805|FG006|COMPLETED|SAD Cohorts : Study Part 1||5||
60063828|NCT02036645|76178806|FG007|COMPLETED|SAD Cohorts : Study Part 1||0||
60063829|NCT02036645|76178807|FG008|COMPLETED|SAD Cohorts : Study Part 1||0||
60063830|NCT02036645|76178808|FG009|COMPLETED|SAD Cohorts : Study Part 1||0||
60063831|NCT02036645|76178809|FG010|COMPLETED|SAD Cohorts : Study Part 1||0||
60063832|NCT02036645|76178810|FG011|COMPLETED|SAD Cohorts : Study Part 1||0||
60063833|NCT02036645|76178799|FG000|NOT COMPLETED|SAD Cohorts : Study Part 1||0||
60063834|NCT02036645|76178800|FG001|NOT COMPLETED|SAD Cohorts : Study Part 1||0||
60063835|NCT02036645|76178801|FG002|NOT COMPLETED|SAD Cohorts : Study Part 1||0||
59517443|NCT03229252|75611438|FG001|NOT COMPLETED|Overall Study||0||
59517444|NCT03229252|75611439|FG002|NOT COMPLETED|Overall Study||6||
59517445|NCT03330262|75611449|FG000|STARTED|First Six Weeks||7||
60063836|NCT02036645|76178802|FG003|NOT COMPLETED|SAD Cohorts : Study Part 1||1||
60063837|NCT02036645|76178803|FG004|NOT COMPLETED|SAD Cohorts : Study Part 1||0||
59517446|NCT03330262|75611450|FG001|STARTED|First Six Weeks||6||
59517447|NCT03330262|75611449|FG000|COMPLETED|First Six Weeks||7||
59517448|NCT03330262|75611450|FG001|COMPLETED|First Six Weeks||6||
59517449|NCT03330262|75611449|FG000|NOT COMPLETED|First Six Weeks||0||
59517450|NCT03330262|75611450|FG001|NOT COMPLETED|First Six Weeks||0||
59517451|NCT03330262|75611449|FG000|STARTED|Second Six Weeks||7||
59517452|NCT03330262|75611450|FG001|STARTED|Second Six Weeks||6||
59517453|NCT03330262|75611449|FG000|COMPLETED|Second Six Weeks||5||
60067877|NCT01756053|76183072|FG001|COMPLETED|Period 1 (10 Days)||8||
60063838|NCT02036645|76178804|FG005|NOT COMPLETED|SAD Cohorts : Study Part 1||0||
60063839|NCT02036645|76178805|FG006|NOT COMPLETED|SAD Cohorts : Study Part 1||1||
60063840|NCT02036645|76178806|FG007|NOT COMPLETED|SAD Cohorts : Study Part 1||0||
60063841|NCT02036645|76178807|FG008|NOT COMPLETED|SAD Cohorts : Study Part 1||0||
60063842|NCT02036645|76178808|FG009|NOT COMPLETED|SAD Cohorts : Study Part 1||0||
60063843|NCT02036645|76178809|FG010|NOT COMPLETED|SAD Cohorts : Study Part 1||0||
60063844|NCT02036645|76178810|FG011|NOT COMPLETED|SAD Cohorts : Study Part 1||0||
60063845|NCT02036645|76178799|FG000|STARTED|MAD Cohorts: Study Part 2|Pooled across Cohorts 7 to 9 (2 per cohort)|0||
60063846|NCT02036645|76178800|FG001|STARTED|MAD Cohorts: Study Part 2||0||
60063847|NCT02036645|76178801|FG002|STARTED|MAD Cohorts: Study Part 2||0||
59517454|NCT03330262|75611450|FG001|COMPLETED|Second Six Weeks||5||
59517455|NCT03330262|75611449|FG000|NOT COMPLETED|Second Six Weeks||2||
59517456|NCT03330262|75611450|FG001|NOT COMPLETED|Second Six Weeks||1||
59517457|NCT03235180|75611459|FG000|STARTED|Overall Study||9||
59517458|NCT03235180|75611459|FG000|COMPLETED|Overall Study||9||
59517459|NCT03235180|75611459|FG000|NOT COMPLETED|Overall Study||0||
59517460|NCT03470740|75611465|FG000|STARTED|Overall Study||112||
59517461|NCT03470740|75611466|FG001|STARTED|Overall Study||112||
59517462|NCT03470740|75611465|FG000|COMPLETED|Overall Study||108||
60063848|NCT02036645|76178802|FG003|STARTED|MAD Cohorts: Study Part 2||0||
60063849|NCT02036645|76178803|FG004|STARTED|MAD Cohorts: Study Part 2||0||
60063850|NCT02036645|76178804|FG005|STARTED|MAD Cohorts: Study Part 2||0||
60063851|NCT02036645|76178805|FG006|STARTED|MAD Cohorts: Study Part 2||0||
60063852|NCT02036645|76178806|FG007|STARTED|MAD Cohorts: Study Part 2||8||
60063853|NCT02036645|76178807|FG008|STARTED|MAD Cohorts: Study Part 2||6||
60063854|NCT02036645|76178808|FG009|STARTED|MAD Cohorts: Study Part 2||6||
60063855|NCT02036645|76178809|FG010|STARTED|MAD Cohorts: Study Part 2||6||
60063856|NCT02036645|76178810|FG011|STARTED|MAD Cohorts: Study Part 2||6||
60063857|NCT02036645|76178799|FG000|COMPLETED|MAD Cohorts: Study Part 2||0||
60063858|NCT02036645|76178800|FG001|COMPLETED|MAD Cohorts: Study Part 2||0||
60063859|NCT02036645|76178801|FG002|COMPLETED|MAD Cohorts: Study Part 2||0||
60063860|NCT02036645|76178802|FG003|COMPLETED|MAD Cohorts: Study Part 2||0||
60063861|NCT02036645|76178803|FG004|COMPLETED|MAD Cohorts: Study Part 2||0||
60063862|NCT02036645|76178804|FG005|COMPLETED|MAD Cohorts: Study Part 2||0||
60063863|NCT02036645|76178805|FG006|COMPLETED|MAD Cohorts: Study Part 2||0||
60063864|NCT02036645|76178806|FG007|COMPLETED|MAD Cohorts: Study Part 2||8||
60063865|NCT02036645|76178807|FG008|COMPLETED|MAD Cohorts: Study Part 2||6||
60063866|NCT02036645|76178808|FG009|COMPLETED|MAD Cohorts: Study Part 2||6||
60063867|NCT02036645|76178809|FG010|COMPLETED|MAD Cohorts: Study Part 2||6||
60063868|NCT02036645|76178810|FG011|COMPLETED|MAD Cohorts: Study Part 2||6||
60063869|NCT02036645|76178799|FG000|NOT COMPLETED|MAD Cohorts: Study Part 2||0||
60063870|NCT02036645|76178800|FG001|NOT COMPLETED|MAD Cohorts: Study Part 2||0||
60063871|NCT02036645|76178801|FG002|NOT COMPLETED|MAD Cohorts: Study Part 2||0||
60063872|NCT02036645|76178802|FG003|NOT COMPLETED|MAD Cohorts: Study Part 2||0||
60063873|NCT02036645|76178803|FG004|NOT COMPLETED|MAD Cohorts: Study Part 2||0||
60063874|NCT02036645|76178804|FG005|NOT COMPLETED|MAD Cohorts: Study Part 2||0||
60063875|NCT02036645|76178805|FG006|NOT COMPLETED|MAD Cohorts: Study Part 2||0||
60063876|NCT02036645|76178806|FG007|NOT COMPLETED|MAD Cohorts: Study Part 2||0||
60063877|NCT02036645|76178807|FG008|NOT COMPLETED|MAD Cohorts: Study Part 2||0||
60063878|NCT02036645|76178808|FG009|NOT COMPLETED|MAD Cohorts: Study Part 2||0||
60063879|NCT02036645|76178809|FG010|NOT COMPLETED|MAD Cohorts: Study Part 2||0||
60063880|NCT02036645|76178810|FG011|NOT COMPLETED|MAD Cohorts: Study Part 2||0||
60063881|NCT02051933|76178850|FG000|STARTED|Overall Study||5||
60063882|NCT02051933|76178851|FG001|STARTED|Overall Study||5||
60063883|NCT02051933|76178850|FG000|COMPLETED|Overall Study||5||
59517463|NCT03470740|75611466|FG001|COMPLETED|Overall Study||106||
59517464|NCT03470740|75611465|FG000|NOT COMPLETED|Overall Study||4||
59517465|NCT03470740|75611466|FG001|NOT COMPLETED|Overall Study||6||
59517466|NCT03471832|75611473|FG000|STARTED|Overall Study||40||40
59517467|NCT03471832|75611474|FG001|STARTED|Overall Study||40||40
59517468|NCT03471832|75611473|FG000|COMPLETED|Overall Study||40||40
59517469|NCT03471832|75611474|FG001|COMPLETED|Overall Study||40||40
59517470|NCT03471832|75611473|FG000|NOT COMPLETED|Overall Study||0||0
59517471|NCT03471832|75611474|FG001|NOT COMPLETED|Overall Study||0||0
60063884|NCT02051933|76178851|FG001|COMPLETED|Overall Study||4||
60063885|NCT02051933|76178850|FG000|NOT COMPLETED|Overall Study||0||
60063886|NCT02051933|76178851|FG001|NOT COMPLETED|Overall Study||1||
60063887|NCT02050373|76178864|FG000|STARTED|Overall Study||34||
60063888|NCT02050373|76178865|FG001|STARTED|Overall Study||34||
60063889|NCT02050373|76178864|FG000|COMPLETED|Overall Study||27||
60063890|NCT02050373|76178865|FG001|COMPLETED|Overall Study||24||
60063891|NCT02050373|76178864|FG000|NOT COMPLETED|Overall Study||7||
60063892|NCT02050373|76178865|FG001|NOT COMPLETED|Overall Study||10||
60063893|NCT02049437|76178874|FG000|STARTED|Period 1||17||
60063894|NCT02049437|76178875|FG001|STARTED|Period 1||17||
59517472|NCT00985166|75611485|FG000|STARTED|Overall Study|Two randomized subjects withdrew consent before vaccination: no demographic information available.|401||
59517473|NCT00985166|75611486|FG001|STARTED|Overall Study||205||
59517474|NCT00985166|75611487|FG002|STARTED|Overall Study||195||
59517475|NCT00985166|75611485|FG000|Vaccinated at Visit 1|Overall Study||399||
60063895|NCT02049437|76178874|FG000|COMPLETED|Period 1||15||
60063896|NCT02049437|76178875|FG001|COMPLETED|Period 1|Dropout due to low trough levels|16||
60063897|NCT02049437|76178874|FG000|NOT COMPLETED|Period 1||2||
60063898|NCT02049437|76178875|FG001|NOT COMPLETED|Period 1||1||
60063899|NCT02049437|76178874|FG000|STARTED|Washout 1||15||
60063900|NCT02049437|76178875|FG001|STARTED|Washout 1||16||
60063901|NCT02049437|76178874|FG000|COMPLETED|Washout 1||15||
60063902|NCT02049437|76178875|FG001|COMPLETED|Washout 1||16||
60063903|NCT02049437|76178874|FG000|NOT COMPLETED|Washout 1||0||
60063904|NCT02049437|76178875|FG001|NOT COMPLETED|Washout 1||0||
60063905|NCT02049437|76178874|FG000|STARTED|Period 2||15||
60063906|NCT02049437|76178875|FG001|STARTED|Period 2||16||
60063907|NCT02049437|76178874|FG000|COMPLETED|Period 2||15||
60063908|NCT02049437|76178875|FG001|COMPLETED|Period 2||16||
60063909|NCT02049437|76178874|FG000|NOT COMPLETED|Period 2||0||
60063910|NCT02049437|76178875|FG001|NOT COMPLETED|Period 2||0||
60063911|NCT02049437|76178874|FG000|STARTED|Washout 2||15||
60063912|NCT02049437|76178875|FG001|STARTED|Washout 2||16||
60063913|NCT02049437|76178874|FG000|COMPLETED|Washout 2||15||
60063914|NCT02049437|76178875|FG001|COMPLETED|Washout 2||16||
59929905|NCT03021018|76048166|FG002|NOT COMPLETED|Overall Study||0||
59929906|NCT02509507|76048183|FG000|STARTED|Overall Study||23||
59929907|NCT02509507|76048184|FG001|STARTED|Overall Study||5||
59929908|NCT02509507|76048185|FG002|STARTED|Overall Study||24||
59929909|NCT02509507|76048186|FG003|STARTED|Overall Study||22||
59929910|NCT02509507|76048187|FG004|STARTED|Overall Study||10||
59929911|NCT02509507|76048188|FG005|STARTED|Overall Study||18||
59929912|NCT02509507|76048189|FG006|STARTED|Overall Study||10||
59929913|NCT02509507|76048190|FG007|STARTED|Overall Study||5||
59929914|NCT02509507|76048191|FG008|STARTED|Overall Study||10||
60063915|NCT02049437|76178874|FG000|NOT COMPLETED|Washout 2||0||
59929915|NCT02509507|76048183|FG000|Received Talimogene Laherparepvec|Overall Study||23||
60063916|NCT02049437|76178875|FG001|NOT COMPLETED|Washout 2||0||
60063917|NCT02035553|76178883|FG000|STARTED|Overall Study||91||
60063918|NCT02035553|76178884|FG001|STARTED|Overall Study||90||
60063919|NCT02035553|76178883|FG000|COMPLETED|Overall Study||73||
59929916|NCT02509507|76048184|FG001|Received Talimogene Laherparepvec|Overall Study||5||
59929917|NCT02509507|76048185|FG002|Received Talimogene Laherparepvec|Overall Study||24||
59929918|NCT02509507|76048186|FG003|Received Talimogene Laherparepvec|Overall Study||22||
59929919|NCT02509507|76048187|FG004|Received Talimogene Laherparepvec|Overall Study||10||
59929920|NCT02509507|76048188|FG005|Received Talimogene Laherparepvec|Overall Study||18||
59929921|NCT02509507|76048189|FG006|Received Talimogene Laherparepvec|Overall Study||10||
59929922|NCT02509507|76048190|FG007|Received Talimogene Laherparepvec|Overall Study||5||
59929923|NCT02509507|76048191|FG008|Received Talimogene Laherparepvec|Overall Study||10||
59929924|NCT02509507|76048183|FG000|Received Pembrolizumab|Overall Study||0||
59929925|NCT02509507|76048184|FG001|Received Pembrolizumab|Overall Study||0||
59929926|NCT02509507|76048185|FG002|Received Pembrolizumab|Overall Study||24||
59929927|NCT02509507|76048186|FG003|Received Pembrolizumab|Overall Study||22||
59929928|NCT02509507|76048187|FG004|Received Pembrolizumab|Overall Study||10||
59929929|NCT02509507|76048188|FG005|Received Pembrolizumab|Overall Study||18||
59929930|NCT02509507|76048189|FG006|Received Pembrolizumab|Overall Study||10||
59929931|NCT02509507|76048190|FG007|Received Pembrolizumab|Overall Study||5||
59929932|NCT02509507|76048191|FG008|Received Pembrolizumab|Overall Study||10||
59929933|NCT02509507|76048183|FG000|COMPLETED|Overall Study||0||
59929934|NCT02509507|76048184|FG001|COMPLETED|Overall Study||0||
59929935|NCT02509507|76048185|FG002|COMPLETED|Overall Study||0||
59929936|NCT02509507|76048186|FG003|COMPLETED|Overall Study||0||
60063920|NCT02035553|76178884|FG001|COMPLETED|Overall Study||67||
60063921|NCT02035553|76178883|FG000|NOT COMPLETED|Overall Study||18||
60063922|NCT02035553|76178884|FG001|NOT COMPLETED|Overall Study||23||
60063923|NCT01445080|76178899|FG000|STARTED|Overall Study||7||
60063924|NCT01445080|76178900|FG001|STARTED|Overall Study||5||
60063925|NCT01445080|76178901|FG002|STARTED|Overall Study||12||
60063926|NCT01445080|76178902|FG003|STARTED|Overall Study||8||
60063927|NCT01445080|76178903|FG004|STARTED|Overall Study||4||
60063928|NCT01445080|76178904|FG005|STARTED|Overall Study||9||
60063929|NCT01445080|76178905|FG006|STARTED|Overall Study||2||
60063930|NCT01445080|76178906|FG007|STARTED|Overall Study||5||
60063931|NCT01445080|76178907|FG008|STARTED|Overall Study||18||
60063932|NCT01445080|76178899|FG000|COMPLETED|Overall Study||0||
60063933|NCT01445080|76178900|FG001|COMPLETED|Overall Study||0||
60063934|NCT01445080|76178901|FG002|COMPLETED|Overall Study||0||
60063935|NCT01445080|76178902|FG003|COMPLETED|Overall Study||0||
60063936|NCT01445080|76178903|FG004|COMPLETED|Overall Study||0||
60063937|NCT01445080|76178904|FG005|COMPLETED|Overall Study||0||
60063938|NCT01445080|76178905|FG006|COMPLETED|Overall Study||0||
60063939|NCT01445080|76178906|FG007|COMPLETED|Overall Study||0||
60063940|NCT01445080|76178907|FG008|COMPLETED|Overall Study||0||
60063941|NCT01445080|76178899|FG000|NOT COMPLETED|Overall Study||7||
60063942|NCT01445080|76178900|FG001|NOT COMPLETED|Overall Study||5||
60063943|NCT01445080|76178901|FG002|NOT COMPLETED|Overall Study||12||
60063944|NCT01445080|76178902|FG003|NOT COMPLETED|Overall Study||8||
60063945|NCT01445080|76178903|FG004|NOT COMPLETED|Overall Study||4||
60063946|NCT01445080|76178904|FG005|NOT COMPLETED|Overall Study||9||
60063947|NCT01445080|76178905|FG006|NOT COMPLETED|Overall Study||2||
60063948|NCT01445080|76178906|FG007|NOT COMPLETED|Overall Study||5||
60063949|NCT01445080|76178907|FG008|NOT COMPLETED|Overall Study||18||
59517476|NCT00985166|75611486|FG001|Vaccinated at Visit 1|Overall Study||205||
59517477|NCT00985166|75611487|FG002|Vaccinated at Visit 1|Overall Study||195||
59517478|NCT00985166|75611485|FG000|COMPLETED|Overall Study||392||
59517479|NCT00985166|75611486|FG001|COMPLETED|Overall Study||201||
59517480|NCT00985166|75611487|FG002|COMPLETED|Overall Study||188||
59517481|NCT00985166|75611485|FG000|NOT COMPLETED|Overall Study||9||
59517482|NCT00985166|75611486|FG001|NOT COMPLETED|Overall Study||4||
59517483|NCT00985166|75611487|FG002|NOT COMPLETED|Overall Study||7||
59613117|NCT01712334|75724221|FG001|STARTED|Treatment Period 1||43||
59517484|NCT03235414|75611497|FG000|STARTED|Overall Study||101||
59517485|NCT03235414|75611497|FG000|COMPLETED|Overall Study||101||
59517486|NCT03235414|75611497|FG000|NOT COMPLETED|Overall Study||0||
59517487|NCT03474172|75611503|FG000|STARTED|Overall Study||30||
59517488|NCT03474172|75611504|FG001|STARTED|Overall Study||30||
59517489|NCT03474172|75611503|FG000|COMPLETED|Overall Study||30||
59517490|NCT03474172|75611504|FG001|COMPLETED|Overall Study||30||
59517491|NCT03474172|75611503|FG000|NOT COMPLETED|Overall Study||0||
59613118|NCT01712334|75724220|FG000|Received Treatment|Treatment Period 1||44||
59761223|NCT03938545|75880901|FG000|NOT COMPLETED|Overall Study||8||
59929937|NCT02509507|76048187|FG004|COMPLETED|Overall Study||0||
59761224|NCT03938545|75880902|FG001|NOT COMPLETED|Overall Study||5||
59761225|NCT03938545|75880903|FG002|NOT COMPLETED|Overall Study||3||
59929938|NCT02509507|76048188|FG005|COMPLETED|Overall Study||0||
59929939|NCT02509507|76048189|FG006|COMPLETED|Overall Study||0||
59929940|NCT02509507|76048190|FG007|COMPLETED|Overall Study||0||
59929941|NCT02509507|76048191|FG008|COMPLETED|Overall Study||0||
59929942|NCT02509507|76048183|FG000|NOT COMPLETED|Overall Study||23||
59929943|NCT02509507|76048184|FG001|NOT COMPLETED|Overall Study||5||
59929944|NCT02509507|76048185|FG002|NOT COMPLETED|Overall Study||24||
59929945|NCT02509507|76048186|FG003|NOT COMPLETED|Overall Study||22||
59929946|NCT02509507|76048187|FG004|NOT COMPLETED|Overall Study||10||
59929947|NCT02509507|76048188|FG005|NOT COMPLETED|Overall Study||18||
59929948|NCT02509507|76048189|FG006|NOT COMPLETED|Overall Study||10||
59929949|NCT02509507|76048190|FG007|NOT COMPLETED|Overall Study||5||
59929950|NCT02509507|76048191|FG008|NOT COMPLETED|Overall Study||10||
59929951|NCT03176407|76048216|FG000|STARTED|Overall Study||30||
59929952|NCT03176407|76048216|FG000|COMPLETED|Overall Study||27||
59929953|NCT03176407|76048216|FG000|NOT COMPLETED|Overall Study||3||
59929954|NCT03175549|76048224|FG000|STARTED|Overall Study||26||
59929955|NCT03175549|76048225|FG001|STARTED|Overall Study||25||
59929956|NCT03175549|76048224|FG000|COMPLETED|Overall Study||22||
59929957|NCT03175549|76048225|FG001|COMPLETED|Overall Study||21||
59929958|NCT03175549|76048224|FG000|NOT COMPLETED|Overall Study||4||
59929959|NCT03175549|76048225|FG001|NOT COMPLETED|Overall Study||4||
59929960|NCT03174925|76048233|FG000|STARTED|Overall Study||55||
59929961|NCT03174925|76048233|FG000|COMPLETED|Overall Study||52||
59929962|NCT03174925|76048233|FG000|NOT COMPLETED|Overall Study||3||
59929963|NCT02924688|76048243|FG000|STARTED|Overall Study||407||
60063950|NCT02035475|76178942|FG000|STARTED|Overall Study|120 subjects were consented for participation in the study.|120||
60063951|NCT02035475|76178942|FG000|COMPLETED|Overall Study|Six subjects did not complete the study due to withdrawal of consent.|114||
60063952|NCT02035475|76178942|FG000|NOT COMPLETED|Overall Study||6||
60063953|NCT01444456|76178948|FG000|STARTED|Overall Study||1262||
60063954|NCT01444456|76178948|FG000|Received Darbepoetin Alfa or Other ESA|Overall Study||1158||
60063955|NCT01444456|76178948|FG000|Received Darbepoetin Alfa|Overall Study||1134||
60063956|NCT01444456|76178948|FG000|COMPLETED|Overall Study|Defined as 4 weeks after last dose of ESA or chemotherapy or 13 weeks after enrolment|977||
60063957|NCT01444456|76178948|FG000|NOT COMPLETED|Overall Study||285||
60063958|NCT01438294|76178954|FG000|STARTED|Overall Study||16||
60063959|NCT01438294|76178955|FG001|STARTED|Overall Study||20||
60063960|NCT01438294|76178954|FG000|COMPLETED|Overall Study||13||
60063961|NCT01438294|76178955|FG001|COMPLETED|Overall Study||13||
60063962|NCT01438294|76178954|FG000|NOT COMPLETED|Overall Study||3||
59517492|NCT03474172|75611504|FG001|NOT COMPLETED|Overall Study||0||
59517493|NCT03474406|75611513|FG000|STARTED|Overall Study||150||
59929964|NCT02924688|76048244|FG001|STARTED|Overall Study||405||
59929965|NCT02924688|76048245|FG002|STARTED|Overall Study||406||
59929966|NCT02924688|76048246|FG003|STARTED|Overall Study||406||
59929967|NCT02924688|76048247|FG004|STARTED|Overall Study||404||
59929968|NCT02924688|76048248|FG005|STARTED|Overall Study||408||
59929969|NCT02924688|76048243|FG000|COMPLETED|Overall Study||374||
59929970|NCT02924688|76048244|FG001|COMPLETED|Overall Study||374||
59613119|NCT01712334|75724221|FG001|Received Treatment|Treatment Period 1||41||
59613120|NCT01712334|75724220|FG000|COMPLETED|Treatment Period 1||44||
59613121|NCT01712334|75724221|FG001|COMPLETED|Treatment Period 1||41||
59613122|NCT01712334|75724220|FG000|NOT COMPLETED|Treatment Period 1||0||
59613123|NCT01712334|75724221|FG001|NOT COMPLETED|Treatment Period 1||2||
59613124|NCT01712334|75724220|FG000|STARTED|Treatment Period 2||44||
59613125|NCT01712334|75724221|FG001|STARTED|Treatment Period 2||41||
59613126|NCT01712334|75724220|FG000|COMPLETED|Treatment Period 2||44||
59613127|NCT01712334|75724221|FG001|COMPLETED|Treatment Period 2||41||
59761226|NCT03938545|75880904|FG003|NOT COMPLETED|Overall Study||5||
59761227|NCT00879996|75880916|FG000|STARTED|Overall Study||28||
59929971|NCT02924688|76048245|FG002|COMPLETED|Overall Study||383||
59929972|NCT02924688|76048246|FG003|COMPLETED|Overall Study||378||
59929973|NCT02924688|76048247|FG004|COMPLETED|Overall Study||381||
59929974|NCT02924688|76048248|FG005|COMPLETED|Overall Study||384||
59929975|NCT02924688|76048243|FG000|NOT COMPLETED|Overall Study||33||
59929976|NCT02924688|76048244|FG001|NOT COMPLETED|Overall Study||31||
59929977|NCT02924688|76048245|FG002|NOT COMPLETED|Overall Study||23||
60063963|NCT01438294|76178955|FG001|NOT COMPLETED|Overall Study||7||
60063964|NCT02033759|76178963|FG000|STARTED|Overall Study||22||
59929978|NCT02924688|76048246|FG003|NOT COMPLETED|Overall Study||28||
59929979|NCT02924688|76048247|FG004|NOT COMPLETED|Overall Study||23||
59929980|NCT02924688|76048248|FG005|NOT COMPLETED|Overall Study||24||
60063965|NCT02033759|76178964|FG001|STARTED|Overall Study||21||
60063966|NCT02033759|76178963|FG000|COMPLETED|Overall Study||19||
60063967|NCT02033759|76178964|FG001|COMPLETED|Overall Study||19||
60063968|NCT02033759|76178963|FG000|NOT COMPLETED|Overall Study||3||
60063969|NCT02033759|76178964|FG001|NOT COMPLETED|Overall Study||2||
60063970|NCT01959529|76178972|FG000|STARTED|Overall Study||3818||
60063971|NCT01959529|76178973|FG001|STARTED|Overall Study||3819||
59929981|NCT03011892|76048271|FG000|STARTED|Double Blind (DB) Period||52||
59929982|NCT03011892|76048272|FG001|STARTED|Double Blind (DB) Period||51||
59613128|NCT01712334|75724220|FG000|NOT COMPLETED|Treatment Period 2||0||
59613129|NCT01712334|75724221|FG001|NOT COMPLETED|Treatment Period 2||0||
59929983|NCT03011892|76048273|FG002|STARTED|Double Blind (DB) Period||51||
59929984|NCT03011892|76048274|FG003|STARTED|Double Blind (DB) Period||51||
59929985|NCT03011892|76048275|FG004|STARTED|Double Blind (DB) Period||52||
60063972|NCT01959529|76178972|FG000|Exposed|Overall Study||3809||
60063973|NCT01959529|76178973|FG001|Exposed|Overall Study||3806||
60063974|NCT01959529|76178972|FG000|COMPLETED|Overall Study||3742||
60063975|NCT01959529|76178973|FG001|COMPLETED|Overall Study||3747||
60063976|NCT01959529|76178972|FG000|NOT COMPLETED|Overall Study||76||
60063977|NCT01959529|76178973|FG001|NOT COMPLETED|Overall Study||72||
60063978|NCT02033369|76178981|FG000|STARTED|Overall Study||26||
60063979|NCT02033369|76178982|FG001|STARTED|Overall Study||26||
60063980|NCT02033369|76178981|FG000|COMPLETED|Overall Study||21||
60063981|NCT02033369|76178982|FG001|COMPLETED|Overall Study||21||
60063982|NCT02033369|76178981|FG000|NOT COMPLETED|Overall Study||5||
60063983|NCT02033369|76178982|FG001|NOT COMPLETED|Overall Study||5||
60063984|NCT02032901|76178988|FG000|STARTED|Treatment Period (12 Weeks)||101||
60063985|NCT02032901|76178989|FG001|STARTED|Treatment Period (12 Weeks)||51||
59929986|NCT03011892|76048276|FG005|STARTED|Double Blind (DB) Period||50||
60063986|NCT02032901|76178988|FG000|COMPLETED|Treatment Period (12 Weeks)||100||
60063987|NCT02032901|76178989|FG001|COMPLETED|Treatment Period (12 Weeks)||51||
60063988|NCT02032901|76178988|FG000|NOT COMPLETED|Treatment Period (12 Weeks)||1||
60063989|NCT02032901|76178989|FG001|NOT COMPLETED|Treatment Period (12 Weeks)||0||
60063990|NCT02032901|76178988|FG000|STARTED|Follow-Up Period (24 Weeks)|Participant could enter follow up period even if the treatment period was not completed.|101||
59517494|NCT03474406|75611513|FG000|COMPLETED|Overall Study||72||
59517495|NCT03474406|75611513|FG000|NOT COMPLETED|Overall Study||78||
59517496|NCT03474874|75611517|FG000|STARTED|Overall Study||68||
59517497|NCT03474874|75611517|FG000|COMPLETED|Overall Study||54||
59517498|NCT03474874|75611517|FG000|NOT COMPLETED|Overall Study||14||
59517499|NCT03476278|75611523|FG000|STARTED|Overall Study||300||
59517500|NCT03476278|75611523|FG000|COMPLETED|Overall Study||300||
59517501|NCT03476278|75611523|FG000|NOT COMPLETED|Overall Study||0||
59761228|NCT00879996|75880917|FG001|STARTED|Overall Study||26||
60063991|NCT02032901|76178989|FG001|STARTED|Follow-Up Period (24 Weeks)||51||
60063992|NCT02032901|76178988|FG000|COMPLETED|Follow-Up Period (24 Weeks)||101||
60063993|NCT02032901|76178989|FG001|COMPLETED|Follow-Up Period (24 Weeks)||50||
60063994|NCT02032901|76178988|FG000|NOT COMPLETED|Follow-Up Period (24 Weeks)||0||
60063995|NCT02032901|76178989|FG001|NOT COMPLETED|Follow-Up Period (24 Weeks)||1||
60063996|NCT02020967|76178999|FG000|STARTED|Overall Study||367||
60063997|NCT02020967|76178999|FG000|Examined Participants|Overall Study||329||
60063998|NCT02020967|76178999|FG000|COMPLETED|Overall Study||316|Completed Participation in the Survey.|
60063999|NCT02020967|76178999|FG000|NOT COMPLETED|Overall Study||51||
60064000|NCT01986829|76179005|FG000|STARTED|Overall Study||9||
60064001|NCT01986829|76179005|FG000|COMPLETED|Overall Study||8||
60064002|NCT01986829|76179005|FG000|NOT COMPLETED|Overall Study||1||
60064003|NCT01986751|76179014|FG000|STARTED|Overall Study||10||
60064004|NCT01986751|76179015|FG001|STARTED|Overall Study||4||
60064005|NCT01986751|76179014|FG000|COMPLETED|Overall Study||0||
60064006|NCT01986751|76179015|FG001|COMPLETED|Overall Study||2||
60064007|NCT01986751|76179014|FG000|NOT COMPLETED|Overall Study||10||
59517502|NCT03335254|75611557|FG000|STARTED|Period 1||9||
59517503|NCT03335254|75611558|FG001|STARTED|Period 1||0||
59517504|NCT03335254|75611559|FG002|STARTED|Period 1||0||
59517505|NCT03335254|75611560|FG003|STARTED|Period 1||0||
60064008|NCT01986751|76179015|FG001|NOT COMPLETED|Overall Study||2||
60064009|NCT02004847|76179027|FG000|STARTED|Overall Study||24||
60064010|NCT02004847|76179028|FG001|STARTED|Overall Study||23||
60064011|NCT02004847|76179027|FG000|COMPLETED|Overall Study||23||
60064012|NCT02004847|76179028|FG001|COMPLETED|Overall Study||22||
60064013|NCT02004847|76179027|FG000|NOT COMPLETED|Overall Study||1||
60064014|NCT02004847|76179028|FG001|NOT COMPLETED|Overall Study||1||
59517506|NCT03335254|75611561|FG004|STARTED|Period 1||0||
59517507|NCT03335254|75611562|FG005|STARTED|Period 1||0||
59517508|NCT03335254|75611563|FG006|STARTED|Period 1||0||
59517509|NCT03335254|75611564|FG007|STARTED|Period 1||0||
59517510|NCT03335254|75611565|FG008|STARTED|Period 1||0||
59517511|NCT03335254|75611566|FG009|STARTED|Period 1||0||
59517512|NCT03335254|75611567|FG010|STARTED|Period 1||0||
60064015|NCT01438060|76179045|FG000|STARTED|Acute Phase: Double-blind, 10 Weeks||102||
60064016|NCT01438060|76179046|FG001|STARTED|Acute Phase: Double-blind, 10 Weeks||106||
60064017|NCT01438060|76179045|FG000|COMPLETED|Acute Phase: Double-blind, 10 Weeks||84||
60064018|NCT01438060|76179046|FG001|COMPLETED|Acute Phase: Double-blind, 10 Weeks||88||
60064019|NCT01438060|76179045|FG000|NOT COMPLETED|Acute Phase: Double-blind, 10 Weeks||18||
60064020|NCT01438060|76179046|FG001|NOT COMPLETED|Acute Phase: Double-blind, 10 Weeks||18||
60067878|NCT01756053|76183071|FG000|NOT COMPLETED|Period 1 (10 Days)||1||
59517513|NCT03335254|75611568|FG011|STARTED|Period 1||0||
59517514|NCT03335254|75611569|FG012|STARTED|Period 1||0||
59517515|NCT03335254|75611570|FG013|STARTED|Period 1||0||
59517516|NCT03335254|75611571|FG014|STARTED|Period 1||0||
59517517|NCT03335254|75611572|FG015|STARTED|Period 1||0||
59517518|NCT03335254|75611573|FG016|STARTED|Period 1||0||
59517519|NCT03335254|75611574|FG017|STARTED|Period 1||0||
59517520|NCT03335254|75611575|FG018|STARTED|Period 1||0||
59517521|NCT03335254|75611576|FG019|STARTED|Period 1||0||
60064021|NCT01438060|76179045|FG000|STARTED|Extension Phase: Week 10 to Week 130|80 out of the 84 participants entered extension phase. All were treated with open-label aripiprazole|80||
60064022|NCT01438060|76179046|FG001|STARTED|Extension Phase: Week 10 to Week 130|Of the 88 participants, who completed Acute Phase, 81 opted to enter 130-week extension phase|81||
60064023|NCT01438060|76179045|FG000|COMPLETED|Extension Phase: Week 10 to Week 130||22||
60064024|NCT01438060|76179046|FG001|COMPLETED|Extension Phase: Week 10 to Week 130||25||
60064025|NCT01438060|76179045|FG000|NOT COMPLETED|Extension Phase: Week 10 to Week 130||58||
60064026|NCT01438060|76179046|FG001|NOT COMPLETED|Extension Phase: Week 10 to Week 130||56||
60064027|NCT01438060|76179045|FG000|STARTED|On Study Beyond Week 140||0||
60064028|NCT01438060|76179046|FG001|STARTED|On Study Beyond Week 140|9 participants in France who showed improvement at Week 140 continued treatment beyond 140 weeks|9||
60064029|NCT01438060|76179045|FG000|COMPLETED|On Study Beyond Week 140||0||
60064030|NCT01438060|76179046|FG001|COMPLETED|On Study Beyond Week 140||1||
60064031|NCT01438060|76179045|FG000|NOT COMPLETED|On Study Beyond Week 140||0||
60064032|NCT01438060|76179046|FG001|NOT COMPLETED|On Study Beyond Week 140||8||
60064033|NCT01469182|76179059|FG000|STARTED|Overall Study||610||
60064034|NCT01469182|76179060|FG001|STARTED|Overall Study||304||
60064035|NCT01469182|76179059|FG000|Treated|Overall Study||609||
60064036|NCT01469182|76179060|FG001|Treated|Overall Study||304||
59929987|NCT03011892|76048277|FG006|STARTED|Double Blind (DB) Period||0||
59929988|NCT03011892|76048278|FG007|STARTED|Double Blind (DB) Period||0||
60064037|NCT01469182|76179059|FG000|COMPLETED|Overall Study||575||
60064038|NCT01469182|76179060|FG001|COMPLETED|Overall Study||298||
60064039|NCT01469182|76179059|FG000|NOT COMPLETED|Overall Study||35||
60064040|NCT01469182|76179060|FG001|NOT COMPLETED|Overall Study||6||
60064041|NCT01444378|76179066|FG000|STARTED|Overall Study|A total of 141 patients were enrolled into MOMENTUM|141||
60064042|NCT01444378|76179066|FG000|COMPLETED|Overall Study||124||
60064043|NCT01444378|76179066|FG000|NOT COMPLETED|Overall Study||17||
60064044|NCT02020889|76179075|FG000|STARTED|Overall Study||68||
60064045|NCT02020889|76179076|FG001|STARTED|Overall Study||68||
60064046|NCT02020889|76179075|FG000|COMPLETED|Overall Study||61||
60064047|NCT02020889|76179076|FG001|COMPLETED|Overall Study||65||
60064048|NCT02020889|76179075|FG000|NOT COMPLETED|Overall Study||7||
60064049|NCT02020889|76179076|FG001|NOT COMPLETED|Overall Study||3||
60064050|NCT01444300|76179084|FG000|STARTED|Overall Study||12||
60064051|NCT01444300|76179085|FG001|STARTED|Overall Study||12||
60064052|NCT01444300|76179084|FG000|COMPLETED|Overall Study||8||
60064053|NCT01444300|76179085|FG001|COMPLETED|Overall Study||12||
60064054|NCT01444300|76179084|FG000|NOT COMPLETED|Overall Study||4||
60064055|NCT01444300|76179085|FG001|NOT COMPLETED|Overall Study||0||
60064056|NCT01443364|76179092|FG000|STARTED|Overall Study||132||
60064057|NCT01443364|76179092|FG000|COMPLETED|Overall Study||91||
60064058|NCT01443364|76179092|FG000|NOT COMPLETED|Overall Study||41||
60064059|NCT02020577|76179098|FG000|STARTED|Overall Study||3||
59929989|NCT03011892|76048279|FG008|STARTED|Double Blind (DB) Period||0||
59929990|NCT03011892|76048280|FG009|STARTED|Double Blind (DB) Period||0||
59929991|NCT03011892|76048281|FG010|STARTED|Double Blind (DB) Period||0||
59929992|NCT03011892|76048282|FG011|STARTED|Double Blind (DB) Period||0||
59929993|NCT03011892|76048271|FG000|Treated in DB Period|Double Blind (DB) Period||52|One participant was randomized but did not receive study drug.|
59929994|NCT03011892|76048272|FG001|Treated in DB Period|Double Blind (DB) Period||51|One participant was randomized but did not receive study drug.|
59929995|NCT03011892|76048273|FG002|Treated in DB Period|Double Blind (DB) Period||51|One participant was randomized but did not receive study drug.|
59929996|NCT03011892|76048274|FG003|Treated in DB Period|Double Blind (DB) Period||51|One participant was randomized but did not receive study drug.|
59929997|NCT03011892|76048275|FG004|Treated in DB Period|Double Blind (DB) Period||51|One participant was randomized but did not receive study drug.|
59929998|NCT03011892|76048276|FG005|Treated in DB Period|Double Blind (DB) Period||50|One participant was randomized but did not receive study drug.|
59929999|NCT03011892|76048277|FG006|Treated in DB Period|Double Blind (DB) Period||0|One participant was randomized but did not receive study drug.|
59930000|NCT03011892|76048278|FG007|Treated in DB Period|Double Blind (DB) Period||0|One participant was randomized but did not receive study drug.|
59930001|NCT03011892|76048279|FG008|Treated in DB Period|Double Blind (DB) Period||0|One participant was randomized but did not receive study drug.|
59930002|NCT03011892|76048280|FG009|Treated in DB Period|Double Blind (DB) Period||0|One participant was randomized but did not receive study drug.|
59930003|NCT03011892|76048281|FG010|Treated in DB Period|Double Blind (DB) Period||0|One participant was randomized but did not receive study drug.|
59930004|NCT03011892|76048282|FG011|Treated in DB Period|Double Blind (DB) Period||0|One participant was randomized but did not receive study drug.|
59930005|NCT03011892|76048271|FG000|Completed Treatment Through Week 4|Double Blind (DB) Period||44||
59930006|NCT03011892|76048272|FG001|Completed Treatment Through Week 4|Double Blind (DB) Period||46||
60064060|NCT02020577|76179099|FG001|STARTED|Overall Study||55||
60064061|NCT02020577|76179098|FG000|COMPLETED|Overall Study||0||
60064062|NCT02020577|76179099|FG001|COMPLETED|Overall Study||0||
60064063|NCT02020577|76179098|FG000|NOT COMPLETED|Overall Study||3||
60064064|NCT02020577|76179099|FG001|NOT COMPLETED|Overall Study||55||
60064065|NCT02020031|76179109|FG000|STARTED|Overall Study||11||
60064066|NCT02020031|76179110|FG001|STARTED|Overall Study||11||
60064067|NCT02020031|76179109|FG000|COMPLETED|Overall Study||10||
60064068|NCT02020031|76179110|FG001|COMPLETED|Overall Study||10||
60064069|NCT02020031|76179109|FG000|NOT COMPLETED|Overall Study||1||
60064070|NCT02020031|76179110|FG001|NOT COMPLETED|Overall Study||1||
60064071|NCT04179305|76179120|FG000|STARTED|Overall Study||19||
60064072|NCT04179305|76179121|FG001|STARTED|Overall Study||14||
59930007|NCT03011892|76048273|FG002|Completed Treatment Through Week 4|Double Blind (DB) Period||48||
59930008|NCT03011892|76048274|FG003|Completed Treatment Through Week 4|Double Blind (DB) Period||47||
59930009|NCT03011892|76048275|FG004|Completed Treatment Through Week 4|Double Blind (DB) Period||49||
59930010|NCT03011892|76048276|FG005|Completed Treatment Through Week 4|Double Blind (DB) Period||49||
59930011|NCT03011892|76048277|FG006|Completed Treatment Through Week 4|Double Blind (DB) Period||0||
59930012|NCT03011892|76048278|FG007|Completed Treatment Through Week 4|Double Blind (DB) Period||0||
59930013|NCT03011892|76048279|FG008|Completed Treatment Through Week 4|Double Blind (DB) Period||0||
59930014|NCT03011892|76048280|FG009|Completed Treatment Through Week 4|Double Blind (DB) Period||0||
59930015|NCT03011892|76048281|FG010|Completed Treatment Through Week 4|Double Blind (DB) Period||0||
59930016|NCT03011892|76048282|FG011|Completed Treatment Through Week 4|Double Blind (DB) Period||0||
59930017|NCT03011892|76048271|FG000|COMPLETED|Double Blind (DB) Period||41|Completed= Number of participants who completed treatment through Week 8 in DB period.|
59930018|NCT03011892|76048272|FG001|COMPLETED|Double Blind (DB) Period||41|Completed= Number of participants who completed treatment through Week 8 in DB period.|
59930019|NCT03011892|76048273|FG002|COMPLETED|Double Blind (DB) Period||45|Completed= Number of participants who completed treatment through Week 8 in DB period.|
59930020|NCT03011892|76048274|FG003|COMPLETED|Double Blind (DB) Period||44|Completed= Number of participants who completed treatment through Week 8 in DB period.|
59930021|NCT03011892|76048275|FG004|COMPLETED|Double Blind (DB) Period||45|Completed= Number of participants who completed treatment through Week 8 in DB period.|
59930022|NCT03011892|76048276|FG005|COMPLETED|Double Blind (DB) Period||45|Completed= Number of participants who completed treatment through Week 8 in DB period.|
59930023|NCT03011892|76048277|FG006|COMPLETED|Double Blind (DB) Period||0|Completed= Number of participants who completed treatment through Week 8 in DB period.|
59930024|NCT03011892|76048278|FG007|COMPLETED|Double Blind (DB) Period||0|Completed= Number of participants who completed treatment through Week 8 in DB period.|
59930025|NCT03011892|76048279|FG008|COMPLETED|Double Blind (DB) Period||0|Completed= Number of participants who completed treatment through Week 8 in DB period.|
59930026|NCT03011892|76048280|FG009|COMPLETED|Double Blind (DB) Period||0|Completed= Number of participants who completed treatment through Week 8 in DB period.|
59930027|NCT03011892|76048281|FG010|COMPLETED|Double Blind (DB) Period||0|Completed= Number of participants who completed treatment through Week 8 in DB period.|
59930028|NCT03011892|76048282|FG011|COMPLETED|Double Blind (DB) Period||0|Completed= Number of participants who completed treatment through Week 8 in DB period.|
59930029|NCT03011892|76048271|FG000|NOT COMPLETED|Double Blind (DB) Period||11||
59930030|NCT03011892|76048272|FG001|NOT COMPLETED|Double Blind (DB) Period||10||
59930031|NCT03011892|76048273|FG002|NOT COMPLETED|Double Blind (DB) Period||6||
59930032|NCT03011892|76048274|FG003|NOT COMPLETED|Double Blind (DB) Period||7||
59930033|NCT03011892|76048275|FG004|NOT COMPLETED|Double Blind (DB) Period||7||
59930034|NCT03011892|76048276|FG005|NOT COMPLETED|Double Blind (DB) Period||5||
59930035|NCT03011892|76048277|FG006|NOT COMPLETED|Double Blind (DB) Period||0||
59930036|NCT03011892|76048278|FG007|NOT COMPLETED|Double Blind (DB) Period||0||
59930037|NCT03011892|76048279|FG008|NOT COMPLETED|Double Blind (DB) Period||0||
59930038|NCT03011892|76048280|FG009|NOT COMPLETED|Double Blind (DB) Period||0||
59930039|NCT03011892|76048281|FG010|NOT COMPLETED|Double Blind (DB) Period||0||
59930040|NCT03011892|76048282|FG011|NOT COMPLETED|Double Blind (DB) Period||0||
59930041|NCT03011892|76048271|FG000|STARTED|Open Label (OL) Period||0||
59930042|NCT03011892|76048272|FG001|STARTED|Open Label (OL) Period||0||
59930043|NCT03011892|76048273|FG002|STARTED|Open Label (OL) Period||0||
59930044|NCT03011892|76048274|FG003|STARTED|Open Label (OL) Period||0||
59930045|NCT03011892|76048275|FG004|STARTED|Open Label (OL) Period||0||
59930046|NCT03011892|76048276|FG005|STARTED|Open Label (OL) Period||0||
59930047|NCT03011892|76048277|FG006|STARTED|Open Label (OL) Period||41||
59930048|NCT03011892|76048278|FG007|STARTED|Open Label (OL) Period||40||
59930049|NCT03011892|76048279|FG008|STARTED|Open Label (OL) Period||45||
59930050|NCT03011892|76048280|FG009|STARTED|Open Label (OL) Period||41||
59930051|NCT03011892|76048281|FG010|STARTED|Open Label (OL) Period||42||
59930052|NCT03011892|76048282|FG011|STARTED|Open Label (OL) Period||43||
59930053|NCT03011892|76048271|FG000|COMPLETED|Open Label (OL) Period||0||
59930054|NCT03011892|76048272|FG001|COMPLETED|Open Label (OL) Period||0||
59930055|NCT03011892|76048273|FG002|COMPLETED|Open Label (OL) Period||0||
59930056|NCT03011892|76048274|FG003|COMPLETED|Open Label (OL) Period||0||
59930057|NCT03011892|76048275|FG004|COMPLETED|Open Label (OL) Period||0||
59930058|NCT03011892|76048276|FG005|COMPLETED|Open Label (OL) Period||0||
59930059|NCT03011892|76048277|FG006|COMPLETED|Open Label (OL) Period||34||
60064073|NCT04179305|76179122|FG002|STARTED|Overall Study||2||
60064074|NCT04179305|76179123|FG003|STARTED|Overall Study||2||
60064075|NCT04179305|76179120|FG000|Completed Patient Baseline Assessment|Overall Study||18||
60064076|NCT04179305|76179121|FG001|Completed Patient Baseline Assessment|Overall Study||13||
60064077|NCT04179305|76179122|FG002|Completed Patient Baseline Assessment|Overall Study||0||
60064078|NCT04179305|76179123|FG003|Completed Patient Baseline Assessment|Overall Study||0||
60064079|NCT04179305|76179120|FG000|Had Progression on Scan|Overall Study||13||
60064080|NCT04179305|76179121|FG001|Had Progression on Scan|Overall Study||12||
60064081|NCT04179305|76179122|FG002|Had Progression on Scan|Overall Study||0||
60064082|NCT04179305|76179123|FG003|Had Progression on Scan|Overall Study||0||
59761229|NCT00879996|75880916|FG000|COMPLETED|Overall Study||13||
59761230|NCT00879996|75880917|FG001|COMPLETED|Overall Study||13||
59761231|NCT00879996|75880916|FG000|NOT COMPLETED|Overall Study||15||
59930060|NCT03011892|76048278|FG007|COMPLETED|Open Label (OL) Period||37||
60064083|NCT04179305|76179120|FG000|Completed Post-scan Assessment|Overall Study||13||
60064084|NCT04179305|76179121|FG001|Completed Post-scan Assessment|Overall Study||11||
60064085|NCT04179305|76179122|FG002|Completed Post-scan Assessment|Overall Study||0||
59930061|NCT03011892|76048279|FG008|COMPLETED|Open Label (OL) Period||43||
59930062|NCT03011892|76048280|FG009|COMPLETED|Open Label (OL) Period||41||
59930063|NCT03011892|76048281|FG010|COMPLETED|Open Label (OL) Period||40||
59930064|NCT03011892|76048282|FG011|COMPLETED|Open Label (OL) Period||40||
59761232|NCT00879996|75880917|FG001|NOT COMPLETED|Overall Study||13||
59761233|NCT00873093|75880930|FG000|STARTED|Overall Study||4||
59761234|NCT00873093|75880931|FG001|STARTED|Overall Study||62||
59930065|NCT03011892|76048271|FG000|NOT COMPLETED|Open Label (OL) Period||0||
59930066|NCT03011892|76048272|FG001|NOT COMPLETED|Open Label (OL) Period||0||
59761235|NCT00873093|75880932|FG002|STARTED|Overall Study||49||
59930067|NCT03011892|76048273|FG002|NOT COMPLETED|Open Label (OL) Period||0||
59930068|NCT03011892|76048274|FG003|NOT COMPLETED|Open Label (OL) Period||0||
59930069|NCT03011892|76048275|FG004|NOT COMPLETED|Open Label (OL) Period||0||
59930070|NCT03011892|76048276|FG005|NOT COMPLETED|Open Label (OL) Period||0||
59930071|NCT03011892|76048277|FG006|NOT COMPLETED|Open Label (OL) Period||7||
59930072|NCT03011892|76048278|FG007|NOT COMPLETED|Open Label (OL) Period||3||
59930073|NCT03011892|76048279|FG008|NOT COMPLETED|Open Label (OL) Period||2||
59930074|NCT03011892|76048280|FG009|NOT COMPLETED|Open Label (OL) Period||0||
59930075|NCT03011892|76048281|FG010|NOT COMPLETED|Open Label (OL) Period||2||
59930076|NCT03011892|76048282|FG011|NOT COMPLETED|Open Label (OL) Period||3||
59930077|NCT03017742|76048309|FG000|STARTED|Overall Study||813||
59930078|NCT03017742|76048309|FG000|COMPLETED|Overall Study||740||
59930079|NCT03017742|76048309|FG000|NOT COMPLETED|Overall Study||73||
59930080|NCT03012828|76048319|FG000|STARTED|Overall Study||10||
59930081|NCT03012828|76048320|FG001|STARTED|Overall Study||10||
59930082|NCT03012828|76048321|FG002|STARTED|Overall Study||10||
59930083|NCT03012828|76048322|FG003|STARTED|Overall Study||10||
59930084|NCT03012828|76048323|FG004|STARTED|Overall Study||10||
59930085|NCT03012828|76048324|FG005|STARTED|Overall Study||10||
59930086|NCT03012828|76048319|FG000|COMPLETED|Overall Study||9||
59930087|NCT03012828|76048320|FG001|COMPLETED|Overall Study||10||
59930088|NCT03012828|76048321|FG002|COMPLETED|Overall Study||8||
59930089|NCT03012828|76048322|FG003|COMPLETED|Overall Study||10||
59930090|NCT03012828|76048323|FG004|COMPLETED|Overall Study||8||
59930091|NCT03012828|76048324|FG005|COMPLETED|Overall Study||8||
59930092|NCT03012828|76048319|FG000|NOT COMPLETED|Overall Study||1||
59930093|NCT03012828|76048320|FG001|NOT COMPLETED|Overall Study||0||
59930094|NCT03012828|76048321|FG002|NOT COMPLETED|Overall Study||2||
59930095|NCT03012828|76048322|FG003|NOT COMPLETED|Overall Study||0||
59930096|NCT03012828|76048323|FG004|NOT COMPLETED|Overall Study||2||
59930097|NCT03012828|76048324|FG005|NOT COMPLETED|Overall Study||2||
59930098|NCT03010254|76048342|FG000|STARTED|Overall Study||159|All randomized subjects|
59930099|NCT03010254|76048343|FG001|STARTED|Overall Study||123|All randomized subjects|
59930100|NCT03010254|76048342|FG000|Attempted Implantation|Overall Study||156||
59930101|NCT03010254|76048343|FG001|Attempted Implantation|Overall Study||120||
59930102|NCT03010254|76048342|FG000|Successful Implantation|Overall Study||156||
59930103|NCT03010254|76048343|FG001|Successful Implantation|Overall Study||120||
59930104|NCT03010254|76048342|FG000|COMPLETED|Overall Study||152||
59930105|NCT03010254|76048343|FG001|COMPLETED|Overall Study||118||
60064086|NCT04179305|76179123|FG003|Completed Post-scan Assessment|Overall Study||0||
60064087|NCT04179305|76179120|FG000|Completed Physician Demographics Survey|Overall Study||0||
60064088|NCT04179305|76179121|FG001|Completed Physician Demographics Survey|Overall Study||0||
60064089|NCT04179305|76179122|FG002|Completed Physician Demographics Survey|Overall Study||2||
60064090|NCT04179305|76179123|FG003|Completed Physician Demographics Survey|Overall Study||2||
60064091|NCT04179305|76179120|FG000|Completed Physician Oncolo-GIST Quiz|Overall Study||0||
59761236|NCT00873093|75880933|FG003|STARTED|Overall Study||23||
59930106|NCT03010254|76048342|FG000|NOT COMPLETED|Overall Study||7||
59930107|NCT03010254|76048343|FG001|NOT COMPLETED|Overall Study||5||
59930108|NCT03008460|76048358|FG000|STARTED|Overall Study||126|Randomised|
60064092|NCT04179305|76179121|FG001|Completed Physician Oncolo-GIST Quiz|Overall Study||0||
60064093|NCT04179305|76179122|FG002|Completed Physician Oncolo-GIST Quiz|Overall Study||2||
60064094|NCT04179305|76179123|FG003|Completed Physician Oncolo-GIST Quiz|Overall Study||0||
60064095|NCT04179305|76179120|FG000|Completed Physician Post-study Questionnaire|Overall Study||0||
60064096|NCT04179305|76179121|FG001|Completed Physician Post-study Questionnaire|Overall Study||0||
60064097|NCT04179305|76179122|FG002|Completed Physician Post-study Questionnaire|Overall Study||2||
60064098|NCT04179305|76179123|FG003|Completed Physician Post-study Questionnaire|Overall Study||2||
60064099|NCT04179305|76179120|FG000|COMPLETED|Overall Study||13||
60064100|NCT04179305|76179121|FG001|COMPLETED|Overall Study||11||
59930109|NCT03008460|76048359|FG001|STARTED|Overall Study||124|Randomised|
59930110|NCT03008460|76048358|FG000|COMPLETED|Overall Study||119||
60064101|NCT04179305|76179122|FG002|COMPLETED|Overall Study||2||
60064102|NCT04179305|76179123|FG003|COMPLETED|Overall Study||2||
60064103|NCT04179305|76179120|FG000|NOT COMPLETED|Overall Study||6||
60064104|NCT04179305|76179121|FG001|NOT COMPLETED|Overall Study||3||
60064105|NCT04179305|76179122|FG002|NOT COMPLETED|Overall Study||0||
60064106|NCT04179305|76179123|FG003|NOT COMPLETED|Overall Study||0||
60064107|NCT02019719|76179139|FG000|STARTED|Overall Study||19||
60064108|NCT02019719|76179140|FG001|STARTED|Overall Study||19||
60064109|NCT02019719|76179141|FG002|STARTED|Overall Study||20||
60064110|NCT02019719|76179142|FG003|STARTED|Overall Study||19||
60064111|NCT02019719|76179143|FG004|STARTED|Overall Study||20||
60064112|NCT02019719|76179139|FG000|COMPLETED|Overall Study||13||
60064113|NCT02019719|76179140|FG001|COMPLETED|Overall Study||18||
60064114|NCT02019719|76179141|FG002|COMPLETED|Overall Study||20||
60064115|NCT02019719|76179142|FG003|COMPLETED|Overall Study||17||
60064116|NCT02019719|76179143|FG004|COMPLETED|Overall Study||18||
60064117|NCT02019719|76179139|FG000|NOT COMPLETED|Overall Study||6||
60064118|NCT02019719|76179140|FG001|NOT COMPLETED|Overall Study||1||
60064119|NCT02019719|76179141|FG002|NOT COMPLETED|Overall Study||0||
60064120|NCT02019719|76179142|FG003|NOT COMPLETED|Overall Study||2||
60064121|NCT02019719|76179143|FG004|NOT COMPLETED|Overall Study||2||
60064122|NCT02030405|76179162|FG000|STARTED|Overall Study||4||
60064123|NCT02030405|76179162|FG000|COMPLETED|Overall Study||2||
60064124|NCT02030405|76179162|FG000|NOT COMPLETED|Overall Study||2||
60064125|NCT01975376|76179169|FG000|STARTED|Overall Study||8390||
60064126|NCT01975376|76179170|FG001|STARTED|Overall Study||8394||
60064127|NCT01975376|76179169|FG000|Treated|Overall Study||8374||
59930111|NCT03008460|76048359|FG001|COMPLETED|Overall Study||110||
59930112|NCT03008460|76048358|FG000|NOT COMPLETED|Overall Study||7||
59930113|NCT03008460|76048359|FG001|NOT COMPLETED|Overall Study||14||
59930114|NCT02914236|76048365|FG000|STARTED|Overall Study||50|Underwent procedure|
59930115|NCT02914236|76048365|FG000|4-week Follow-up Visit|Overall Study||50||
59930116|NCT02914236|76048365|FG000|12-week Follow-up Visit|Overall Study||50||
59930117|NCT02914236|76048365|FG000|26-week Follow-up Visit|Overall Study||49||
59930118|NCT02914236|76048365|FG000|COMPLETED|Overall Study||49||
59930119|NCT02914236|76048365|FG000|NOT COMPLETED|Overall Study||1||
59930120|NCT03003390|76048371|FG000|STARTED|Overall Study||27||
59930121|NCT03003390|76048372|FG001|STARTED|Overall Study||24||
59930122|NCT03003390|76048371|FG000|COMPLETED|Overall Study||23||
59930123|NCT03003390|76048372|FG001|COMPLETED|Overall Study||24||
59930124|NCT03003390|76048371|FG000|NOT COMPLETED|Overall Study||4||
60064128|NCT01975376|76179170|FG001|Treated|Overall Study||8386||
60064129|NCT01975376|76179169|FG000|COMPLETED|Overall Study||8164||
60064130|NCT01975376|76179170|FG001|COMPLETED|Overall Study||8177||
60064131|NCT01975376|76179169|FG000|NOT COMPLETED|Overall Study||226||
60064132|NCT01975376|76179170|FG001|NOT COMPLETED|Overall Study||217||
60064133|NCT01443130|76179182|FG000|STARTED|Overall Study||300||
60064134|NCT01443130|76179183|FG001|STARTED|Overall Study||300||
60064135|NCT01443130|76179184|FG002|STARTED|Overall Study||300||
60064136|NCT01443130|76179185|FG003|STARTED|Overall Study||270||
60064137|NCT01443130|76179186|FG004|STARTED|Overall Study||274||
60064138|NCT01443130|76179187|FG005|STARTED|Overall Study||259||
60064139|NCT01443130|76179182|FG000|COMPLETED|Overall Study||232||
60064140|NCT01443130|76179183|FG001|COMPLETED|Overall Study||231||
60064141|NCT01443130|76179184|FG002|COMPLETED|Overall Study||223||
60064142|NCT01443130|76179185|FG003|COMPLETED|Overall Study||231||
60064143|NCT01443130|76179186|FG004|COMPLETED|Overall Study||230||
60064144|NCT01443130|76179187|FG005|COMPLETED|Overall Study||225||
60064145|NCT01443130|76179182|FG000|NOT COMPLETED|Overall Study||68||
60064146|NCT01443130|76179183|FG001|NOT COMPLETED|Overall Study||69||
60064147|NCT01443130|76179184|FG002|NOT COMPLETED|Overall Study||77||
60064148|NCT01443130|76179185|FG003|NOT COMPLETED|Overall Study||39||
60064149|NCT01443130|76179186|FG004|NOT COMPLETED|Overall Study||44||
60064150|NCT01443130|76179187|FG005|NOT COMPLETED|Overall Study||34||
59930125|NCT03003390|76048372|FG001|NOT COMPLETED|Overall Study||0||
59930126|NCT03003000|76048386|FG000|STARTED|Overall Study||126|Randomized and treated|
59930127|NCT03003000|76048387|FG001|STARTED|Overall Study||253|Randomized and treated|
60064151|NCT01436500|76179203|FG000|STARTED|Overall Study||12||
60064152|NCT01436500|76179204|FG001|STARTED|Overall Study||12||
60064153|NCT01436500|76179205|FG002|STARTED|Overall Study||12||
60064154|NCT01436500|76179206|FG003|STARTED|Overall Study||6||
60064155|NCT01436500|76179207|FG004|STARTED|Overall Study||13||
60064156|NCT01436500|76179203|FG000|COMPLETED|Overall Study||9||
60064157|NCT01436500|76179204|FG001|COMPLETED|Overall Study||9||
60064158|NCT01436500|76179205|FG002|COMPLETED|Overall Study||7||
60064159|NCT01436500|76179206|FG003|COMPLETED|Overall Study||5||
60064160|NCT01436500|76179207|FG004|COMPLETED|Overall Study||9||
60064161|NCT01436500|76179203|FG000|NOT COMPLETED|Overall Study||3||
60064162|NCT01436500|76179204|FG001|NOT COMPLETED|Overall Study||3||
60064163|NCT01436500|76179205|FG002|NOT COMPLETED|Overall Study||5||
60064164|NCT01436500|76179206|FG003|NOT COMPLETED|Overall Study||1||
60064165|NCT01436500|76179207|FG004|NOT COMPLETED|Overall Study||4||
60064166|NCT01958827|76179220|FG000|STARTED|Overall Study||28||
60064167|NCT01958827|76179220|FG000|COMPLETED|Overall Study||18||
60064168|NCT01958827|76179220|FG000|NOT COMPLETED|Overall Study||10||
60064169|NCT01620086|76179226|FG000|STARTED|Overall Study||13||
60064170|NCT01620086|76179227|FG001|STARTED|Overall Study||11||
60064171|NCT01620086|76179228|FG002|STARTED|Overall Study||2||
60064172|NCT01620086|76179226|FG000|COMPLETED|Overall Study||8||
59930128|NCT03003000|76048388|FG002|STARTED|Overall Study||256|Randomized and treated|
59930129|NCT03003000|76048386|FG000|COMPLETED|Overall Study||121||
59930130|NCT03003000|76048387|FG001|COMPLETED|Overall Study||249||
59930131|NCT03003000|76048388|FG002|COMPLETED|Overall Study||251||
59930132|NCT03003000|76048386|FG000|NOT COMPLETED|Overall Study||5||
59930133|NCT03003000|76048387|FG001|NOT COMPLETED|Overall Study||4||
59930134|NCT03003000|76048388|FG002|NOT COMPLETED|Overall Study||5||
59930135|NCT03002610|76048399|FG000|STARTED|Overall Study||24||
59930136|NCT03002610|76048400|FG001|STARTED|Overall Study||50||
59930137|NCT03002610|76048401|FG002|STARTED|Overall Study||34||
59930138|NCT03002610|76048399|FG000|COMPLETED|Overall Study||18||
59930139|NCT03002610|76048400|FG001|COMPLETED|Overall Study||25||
59930140|NCT03002610|76048401|FG002|COMPLETED|Overall Study||21||
59930141|NCT03002610|76048399|FG000|NOT COMPLETED|Overall Study||6||
59930142|NCT03002610|76048400|FG001|NOT COMPLETED|Overall Study||25||
59930143|NCT03002610|76048401|FG002|NOT COMPLETED|Overall Study||13||
60064173|NCT01620086|76179227|FG001|COMPLETED|Overall Study||4||
60064174|NCT01620086|76179228|FG002|COMPLETED|Overall Study||2||
60064175|NCT01620086|76179226|FG000|NOT COMPLETED|Overall Study||5||
60064176|NCT01620086|76179227|FG001|NOT COMPLETED|Overall Study||7||
60064177|NCT01620086|76179228|FG002|NOT COMPLETED|Overall Study||0||
60064178|NCT01436110|76179240|FG000|STARTED|Overall Study|These participants were randomized to trial medication.|116||
59613130|NCT01712256|75724227|FG000|STARTED|Overall Study||33||
59613131|NCT01712256|75724227|FG000|COMPLETED|Overall Study||32||
59613132|NCT01712256|75724227|FG000|NOT COMPLETED|Overall Study||1||
59613133|NCT01712178|75724233|FG000|STARTED|Overall Study||50||
59613134|NCT01712178|75724234|FG001|STARTED|Overall Study||50||
59613135|NCT01712178|75724233|FG000|COMPLETED|Overall Study||49||
59930144|NCT03005106|76048409|FG000|STARTED|Overall Study||71||
60064179|NCT01436110|76179241|FG001|STARTED|Overall Study|These participants were randomized to trial medication.|117||
60064180|NCT01436110|76179242|FG002|STARTED|Overall Study|These participants were randomized to trial medication.|118||
60064181|NCT01436110|76179240|FG000|Intent-to-Treat Population|Overall Study|These randomized participants received at least a single dose of trial medication.|115||
60064182|NCT01436110|76179241|FG001|Intent-to-Treat Population|Overall Study|These randomized participants received at least a single dose of trial medication.|117||
60064183|NCT01436110|76179242|FG002|Intent-to-Treat Population|Overall Study|These randomized participants received at least a single dose of trial medication.|115||
59613136|NCT01712178|75724234|FG001|COMPLETED|Overall Study||47||
59930145|NCT03005106|76048409|FG000|Completed Month 3 Visit|Overall Study||64||
59930146|NCT03005106|76048409|FG000|Completed Month 12 Visit|Overall Study||51||
59930147|NCT03005106|76048409|FG000|COMPLETED|Overall Study||51||
59613137|NCT01712178|75724233|FG000|NOT COMPLETED|Overall Study||1||
59613138|NCT01712178|75724234|FG001|NOT COMPLETED|Overall Study||3||
59613139|NCT01693068|75724242|FG000|STARTED|Randomization Period||64||
59613140|NCT01693068|75724243|FG001|STARTED|Randomization Period||130||
59613141|NCT01693068|75724244|FG002|STARTED|Randomization Period||0||
59613142|NCT01693068|75724242|FG000|Treated|Randomization Period||61||
59613143|NCT01693068|75724243|FG001|Treated|Randomization Period||130||
59613144|NCT01693068|75724244|FG002|Treated|Randomization Period||0||
59613145|NCT01693068|75724242|FG000|COMPLETED|Randomization Period||62||
59613146|NCT01693068|75724243|FG001|COMPLETED|Randomization Period||125||
59613147|NCT01693068|75724244|FG002|COMPLETED|Randomization Period||0||
59613148|NCT01693068|75724242|FG000|NOT COMPLETED|Randomization Period||2||
59613149|NCT01693068|75724243|FG001|NOT COMPLETED|Randomization Period||5||
59613150|NCT01693068|75724244|FG002|NOT COMPLETED|Randomization Period||0||
59613151|NCT01693068|75724242|FG000|STARTED|Cross-over (Dacarbazine To Pimasertib)||0||
59761237|NCT00873093|75880934|FG004|STARTED|Overall Study||10||
59761238|NCT00873093|75880930|FG000|COMPLETED|Overall Study||3||
59761239|NCT00873093|75880931|FG001|COMPLETED|Overall Study||35||
59761240|NCT00873093|75880932|FG002|COMPLETED|Overall Study||33||
59761241|NCT00873093|75880933|FG003|COMPLETED|Overall Study||12||
59761242|NCT00873093|75880934|FG004|COMPLETED|Overall Study||8||
59761243|NCT00873093|75880930|FG000|NOT COMPLETED|Overall Study||1||
59761244|NCT00873093|75880931|FG001|NOT COMPLETED|Overall Study||27||
59761245|NCT00873093|75880932|FG002|NOT COMPLETED|Overall Study||16||
59761246|NCT00873093|75880933|FG003|NOT COMPLETED|Overall Study||11||
59761247|NCT00873093|75880934|FG004|NOT COMPLETED|Overall Study||2||
59761248|NCT00884286|75880958|FG000|STARTED|Overall Study||34||
59761249|NCT00884286|75880959|FG001|STARTED|Overall Study||33||
59761250|NCT00884286|75880958|FG000|COMPLETED|Overall Study||2||
59761251|NCT00884286|75880959|FG001|COMPLETED|Overall Study||0||
59761252|NCT00884286|75880958|FG000|NOT COMPLETED|Overall Study||32||
59761253|NCT00884286|75880959|FG001|NOT COMPLETED|Overall Study||33||
59761254|NCT00873015|75880970|FG000|STARTED|Overall Study||9||
59761255|NCT00873015|75880971|FG001|STARTED|Overall Study||4||
59761256|NCT00873015|75880972|FG002|STARTED|Overall Study||3||
59761257|NCT00873015|75880973|FG003|STARTED|Overall Study||3||
59761258|NCT00873015|75880970|FG000|COMPLETED|Overall Study||9||
59761259|NCT00873015|75880971|FG001|COMPLETED|Overall Study||3||
59761260|NCT00873015|75880972|FG002|COMPLETED|Overall Study||3||
59761261|NCT00873015|75880973|FG003|COMPLETED|Overall Study||3||
59761262|NCT00873015|75880970|FG000|NOT COMPLETED|Overall Study||0||
59761263|NCT00873015|75880971|FG001|NOT COMPLETED|Overall Study||1||
59761264|NCT00873015|75880972|FG002|NOT COMPLETED|Overall Study||0||
59761265|NCT00873015|75880973|FG003|NOT COMPLETED|Overall Study||0||
59761266|NCT02510885|75880982|FG000|STARTED|Overall Study||39||
59761267|NCT02510885|75880982|FG000|COMPLETED|Overall Study||39||
59761268|NCT02510885|75880982|FG000|NOT COMPLETED|Overall Study||0||
59761269|NCT03921151|75880988|FG000|STARTED|Overall Study||46||
59761270|NCT03921151|75880989|FG001|STARTED|Overall Study||44||
59761271|NCT03921151|75880988|FG000|COMPLETED|Overall Study||35||
59761272|NCT03921151|75880989|FG001|COMPLETED|Overall Study||28||
59761273|NCT03921151|75880988|FG000|NOT COMPLETED|Overall Study||11||
59761274|NCT03921151|75880989|FG001|NOT COMPLETED|Overall Study||16||
59761275|NCT04865432|75880995|FG000|STARTED|Overall Study||10||
59761276|NCT04865432|75880995|FG000|COMPLETED|Overall Study||10||
59761277|NCT04865432|75880995|FG000|NOT COMPLETED|Overall Study||0||
59761278|NCT00872001|75881001|FG000|STARTED|Overall Study||1536||
59761279|NCT00872001|75881002|FG001|STARTED|Overall Study||1544||
59761280|NCT00872001|75881001|FG000|COMPLETED|Overall Study||1400||
59761281|NCT00872001|75881002|FG001|COMPLETED|Overall Study||1413||
59613152|NCT01693068|75724243|FG001|STARTED|Cross-over (Dacarbazine To Pimasertib)||0||
59613153|NCT01693068|75724244|FG002|STARTED|Cross-over (Dacarbazine To Pimasertib)||41||
59613154|NCT01693068|75724242|FG000|Treated|Cross-over (Dacarbazine To Pimasertib)||0||
59761282|NCT00872001|75881001|FG000|NOT COMPLETED|Overall Study||136||
59761283|NCT00872001|75881002|FG001|NOT COMPLETED|Overall Study||131||
59761284|NCT00871923|75881010|FG000|STARTED|Overall Study||44||
59761285|NCT00871923|75881010|FG000|COMPLETED|Overall Study||42||
59761286|NCT00871923|75881010|FG000|NOT COMPLETED|Overall Study||2||
59761287|NCT03922945|75881017|FG000|STARTED|Overall Study||56||
59761288|NCT03922945|75881018|FG001|STARTED|Overall Study||54||
59761289|NCT03922945|75881019|FG002|STARTED|Overall Study||113||
59761290|NCT03922945|75881017|FG000|COMPLETED|Overall Study||29||
59761291|NCT03922945|75881018|FG001|COMPLETED|Overall Study||37||
59761292|NCT03922945|75881019|FG002|COMPLETED|Overall Study||73||
59761293|NCT03922945|75881017|FG000|NOT COMPLETED|Overall Study||27||
59761294|NCT03922945|75881018|FG001|NOT COMPLETED|Overall Study||17||
59761295|NCT03922945|75881019|FG002|NOT COMPLETED|Overall Study||40||
59761296|NCT03922477|75881030|FG000|STARTED|Overall Study||13||
59761297|NCT03922477|75881030|FG000|COMPLETED|Overall Study||0||
59761298|NCT03922477|75881030|FG000|NOT COMPLETED|Overall Study||13||
59761299|NCT00867165|75881036|FG000|STARTED|Overall Study||93||
59761300|NCT00867165|75881037|FG001|STARTED|Overall Study||45||
59761301|NCT00867165|75881036|FG000|COMPLETED|Overall Study||89||
59761302|NCT00867165|75881037|FG001|COMPLETED|Overall Study||45||
59930148|NCT03005106|76048409|FG000|NOT COMPLETED|Overall Study||20||
59930149|NCT01004861|76048426|FG000|STARTED|Overall Study||3||
59930150|NCT01004861|76048427|FG001|STARTED|Overall Study||6||
59930151|NCT01004861|76048428|FG002|STARTED|Overall Study||6||
59930152|NCT01004861|76048429|FG003|STARTED|Overall Study||6||
59930153|NCT01004861|76048430|FG004|STARTED|Overall Study||7||
59930154|NCT01004861|76048431|FG005|STARTED|Overall Study||6||
59930155|NCT01004861|76048432|FG006|STARTED|Overall Study||7||
59930156|NCT01004861|76048433|FG007|STARTED|Overall Study||4||
59930157|NCT01004861|76048434|FG008|STARTED|Overall Study||39||
59930158|NCT01004861|76048435|FG009|STARTED|Overall Study||11||
59930159|NCT01004861|76048436|FG010|STARTED|Overall Study||9||
59930160|NCT01004861|76048437|FG011|STARTED|Overall Study||8||
59930161|NCT01004861|76048438|FG012|STARTED|Overall Study||20||
59930162|NCT01004861|76048426|FG000|COMPLETED|Overall Study||0||
59930163|NCT01004861|76048427|FG001|COMPLETED|Overall Study||0||
59930164|NCT01004861|76048428|FG002|COMPLETED|Overall Study||0||
59930165|NCT01004861|76048429|FG003|COMPLETED|Overall Study||0||
59930166|NCT01004861|76048430|FG004|COMPLETED|Overall Study||0||
59930167|NCT01004861|76048431|FG005|COMPLETED|Overall Study||0||
59930168|NCT01004861|76048432|FG006|COMPLETED|Overall Study||0||
59930169|NCT01004861|76048433|FG007|COMPLETED|Overall Study||0||
59930170|NCT01004861|76048434|FG008|COMPLETED|Overall Study||0||
59930171|NCT01004861|76048435|FG009|COMPLETED|Overall Study||0||
59930172|NCT01004861|76048436|FG010|COMPLETED|Overall Study||0||
59930173|NCT01004861|76048437|FG011|COMPLETED|Overall Study||0||
59930174|NCT01004861|76048438|FG012|COMPLETED|Overall Study||0||
59930175|NCT01004861|76048426|FG000|NOT COMPLETED|Overall Study||3||
59930176|NCT01004861|76048427|FG001|NOT COMPLETED|Overall Study||6||
59930177|NCT01004861|76048428|FG002|NOT COMPLETED|Overall Study||6||
59613155|NCT01693068|75724243|FG001|Treated|Cross-over (Dacarbazine To Pimasertib)||0||
59930178|NCT01004861|76048429|FG003|NOT COMPLETED|Overall Study||6||
59930179|NCT01004861|76048430|FG004|NOT COMPLETED|Overall Study||7||
59930180|NCT01004861|76048431|FG005|NOT COMPLETED|Overall Study||6||
59930181|NCT01004861|76048432|FG006|NOT COMPLETED|Overall Study||7||
59517522|NCT03335254|75611557|FG000|COMPLETED|Period 1||9||
59517523|NCT03335254|75611558|FG001|COMPLETED|Period 1||0||
59517524|NCT03335254|75611559|FG002|COMPLETED|Period 1||0||
59517525|NCT03335254|75611560|FG003|COMPLETED|Period 1||0||
59517526|NCT03335254|75611561|FG004|COMPLETED|Period 1||0||
59517527|NCT03335254|75611562|FG005|COMPLETED|Period 1||0||
59930182|NCT01004861|76048433|FG007|NOT COMPLETED|Overall Study||4||
59930183|NCT01004861|76048434|FG008|NOT COMPLETED|Overall Study||39||
59930184|NCT01004861|76048435|FG009|NOT COMPLETED|Overall Study||11||
59930185|NCT01004861|76048436|FG010|NOT COMPLETED|Overall Study||9||
59930186|NCT01004861|76048437|FG011|NOT COMPLETED|Overall Study||8||
59930187|NCT01004861|76048438|FG012|NOT COMPLETED|Overall Study||20||
59930188|NCT00038675|76048470|FG000|STARTED|Overall Study||125||
59930189|NCT00038675|76048470|FG000|COMPLETED|Overall Study||125||
59930190|NCT00038675|76048470|FG000|NOT COMPLETED|Overall Study||0||
59930191|NCT02974907|76048476|FG000|STARTED|Overall Study||299||
59930192|NCT02974907|76048477|FG001|STARTED|Overall Study||302||
59930193|NCT02974907|76048476|FG000|COMPLETED|Overall Study||286||
59930194|NCT02974907|76048477|FG001|COMPLETED|Overall Study||292||
59930195|NCT02974907|76048476|FG000|NOT COMPLETED|Overall Study||13||
59930196|NCT02974907|76048477|FG001|NOT COMPLETED|Overall Study||10||
59930197|NCT03254459|76048485|FG000|STARTED|Overall Study||50||
59930198|NCT03254459|76048486|FG001|STARTED|Overall Study||50||
59930199|NCT03254459|76048485|FG000|COMPLETED|Overall Study||40||
59930200|NCT03254459|76048486|FG001|COMPLETED|Overall Study||27||
59930201|NCT03254459|76048485|FG000|NOT COMPLETED|Overall Study||10||
59930202|NCT03254459|76048486|FG001|NOT COMPLETED|Overall Study||23||
59930203|NCT02736617|76048492|FG000|STARTED|Treatment||10||
59930204|NCT02736617|76048492|FG000|COMPLETED|Treatment||7||
60064184|NCT01436110|76179240|FG000|COMPLETED|Overall Study||77||
59517528|NCT03335254|75611563|FG006|COMPLETED|Period 1||0||
59517529|NCT03335254|75611564|FG007|COMPLETED|Period 1||0||
59517530|NCT03335254|75611565|FG008|COMPLETED|Period 1||0||
59930205|NCT02736617|76048492|FG000|NOT COMPLETED|Treatment||3||
59930206|NCT02736617|76048492|FG000|STARTED|Maintenance||7||
59930207|NCT02736617|76048492|FG000|COMPLETED|Maintenance||2||
59930208|NCT02736617|76048492|FG000|NOT COMPLETED|Maintenance||5||
59930209|NCT03251963|76048499|FG000|STARTED|Overall Study||65||
59930210|NCT03251963|76048500|FG001|STARTED|Overall Study||66||
59517531|NCT03335254|75611566|FG009|COMPLETED|Period 1||0||
59517532|NCT03335254|75611567|FG010|COMPLETED|Period 1||0||
59517533|NCT03335254|75611568|FG011|COMPLETED|Period 1||0||
59517534|NCT03335254|75611569|FG012|COMPLETED|Period 1||0||
59517535|NCT03335254|75611570|FG013|COMPLETED|Period 1||0||
59517536|NCT03335254|75611571|FG014|COMPLETED|Period 1||0||
59517537|NCT03335254|75611572|FG015|COMPLETED|Period 1||0||
59517538|NCT03335254|75611573|FG016|COMPLETED|Period 1||0||
59517539|NCT03335254|75611574|FG017|COMPLETED|Period 1||0||
59517540|NCT03335254|75611575|FG018|COMPLETED|Period 1||0||
59930211|NCT03251963|76048499|FG000|COMPLETED|Overall Study||56||
59930212|NCT03251963|76048500|FG001|COMPLETED|Overall Study||61||
59761303|NCT00867165|75881036|FG000|NOT COMPLETED|Overall Study||4||
60064185|NCT01436110|76179241|FG001|COMPLETED|Overall Study||91||
60064186|NCT01436110|76179242|FG002|COMPLETED|Overall Study||95||
60064187|NCT01436110|76179240|FG000|NOT COMPLETED|Overall Study||39||
60064188|NCT01436110|76179241|FG001|NOT COMPLETED|Overall Study||26||
60064189|NCT01436110|76179242|FG002|NOT COMPLETED|Overall Study||23||
60064190|NCT01619852|76179252|FG000|STARTED|24 Hour Assessment||75||
60064191|NCT01619852|76179253|FG001|STARTED|24 Hour Assessment||75||
60064192|NCT01619852|76179252|FG000|COMPLETED|24 Hour Assessment||74||
60064193|NCT01619852|76179253|FG001|COMPLETED|24 Hour Assessment||74||
60064194|NCT01619852|76179252|FG000|NOT COMPLETED|24 Hour Assessment||1||
60064195|NCT01619852|76179253|FG001|NOT COMPLETED|24 Hour Assessment||1||
60064196|NCT01619852|76179252|FG000|STARTED|3 Month Follow up||74||
60064197|NCT01619852|76179253|FG001|STARTED|3 Month Follow up||74||
60064198|NCT01619852|76179252|FG000|COMPLETED|3 Month Follow up||43||
60064199|NCT01619852|76179253|FG001|COMPLETED|3 Month Follow up||40||
60064200|NCT01619852|76179252|FG000|NOT COMPLETED|3 Month Follow up||31||
60064201|NCT01619852|76179253|FG001|NOT COMPLETED|3 Month Follow up||34||
60064202|NCT02000882|76179260|FG000|STARTED|Overall Study||10||
60064203|NCT02000882|76179260|FG000|COMPLETED|Overall Study||4||
60064204|NCT02000882|76179260|FG000|NOT COMPLETED|Overall Study||6||
60064205|NCT01965938|76179266|FG000|STARTED|Overall Study||21||
60064206|NCT01965938|76179267|FG001|STARTED|Overall Study||20||
60064207|NCT01965938|76179266|FG000|COMPLETED|Overall Study||20||
60064208|NCT01965938|76179267|FG001|COMPLETED|Overall Study||20||
60064209|NCT01965938|76179266|FG000|NOT COMPLETED|Overall Study||1||
60064210|NCT01965938|76179267|FG001|NOT COMPLETED|Overall Study||0||
60064211|NCT01965860|76179278|FG000|STARTED|Overall Study||11||
60064212|NCT01965860|76179279|FG001|STARTED|Overall Study||10||
60064213|NCT01965860|76179280|FG002|STARTED|Overall Study||11||
60064214|NCT01965860|76179278|FG000|COMPLETED|Overall Study||9||
60064215|NCT01965860|76179279|FG001|COMPLETED|Overall Study||10||
60064216|NCT01965860|76179280|FG002|COMPLETED|Overall Study||10||
60064217|NCT01965860|76179278|FG000|NOT COMPLETED|Overall Study||2||
60064218|NCT01965860|76179279|FG001|NOT COMPLETED|Overall Study||0||
60064219|NCT01965860|76179280|FG002|NOT COMPLETED|Overall Study||1||
60064220|NCT04666051|76179290|FG000|STARTED|Overall Study||16||
60064221|NCT04666051|76179291|FG001|STARTED|Overall Study||16||
60064222|NCT04666051|76179290|FG000|COMPLETED|Overall Study||16||
60064223|NCT04666051|76179291|FG001|COMPLETED|Overall Study||16||
60064224|NCT04666051|76179290|FG000|NOT COMPLETED|Overall Study||0||
60064225|NCT04666051|76179291|FG001|NOT COMPLETED|Overall Study||0||
60064226|NCT01965704|76179301|FG000|STARTED|Overall Study||48||
60064227|NCT01965704|76179302|FG001|STARTED|Overall Study||48||
60064228|NCT01965704|76179303|FG002|STARTED|Overall Study||50||
60064229|NCT01965704|76179304|FG003|STARTED|Overall Study||50||
60064230|NCT01965704|76179301|FG000|Received Intervention|Overall Study||45||
59613156|NCT01693068|75724244|FG002|Treated|Cross-over (Dacarbazine To Pimasertib)||41||
59613157|NCT01693068|75724242|FG000|COMPLETED|Cross-over (Dacarbazine To Pimasertib)||0||
59761304|NCT00867165|75881037|FG001|NOT COMPLETED|Overall Study||0||
60064231|NCT01965704|76179302|FG001|Received Intervention|Overall Study||45||
60064232|NCT01965704|76179303|FG002|Received Intervention|Overall Study||47||
59761305|NCT00867087|75881043|FG000|STARTED|Overall Study||63||
59761306|NCT00867087|75881043|FG000|COMPLETED|Overall Study||21||
60064233|NCT01965704|76179304|FG003|Received Intervention|Overall Study||47||
60064234|NCT01965704|76179301|FG000|Analyzable Population|Overall Study||45|Received treatment and met all eligibility criteria|
60064235|NCT01965704|76179302|FG001|Analyzable Population|Overall Study||45|Received treatment and met all eligibility criteria|
60064236|NCT01965704|76179303|FG002|Analyzable Population|Overall Study||41|Received treatment and met all eligibility criteria|
60067879|NCT01756053|76183072|FG001|NOT COMPLETED|Period 1 (10 Days)||1||
60064237|NCT01965704|76179304|FG003|Analyzable Population|Overall Study||41|Received treatment and met all eligibility criteria|
60064238|NCT01965704|76179301|FG000|COMPLETED|Overall Study||45||
59517541|NCT03335254|75611576|FG019|COMPLETED|Period 1||0||
60064239|NCT01965704|76179302|FG001|COMPLETED|Overall Study||45||
60064240|NCT01965704|76179303|FG002|COMPLETED|Overall Study||45||
60064241|NCT01965704|76179304|FG003|COMPLETED|Overall Study||45||
60064242|NCT01965704|76179301|FG000|NOT COMPLETED|Overall Study||3||
60064243|NCT01965704|76179302|FG001|NOT COMPLETED|Overall Study||3||
60064244|NCT01965704|76179303|FG002|NOT COMPLETED|Overall Study||5||
60064245|NCT01965704|76179304|FG003|NOT COMPLETED|Overall Study||5||
60064246|NCT02003365|76179315|FG000|STARTED|Overall Study||10||
60064247|NCT02003365|76179316|FG001|STARTED|Overall Study||30||
60064248|NCT02003365|76179317|FG002|STARTED|Overall Study||10||
60064249|NCT02003365|76179315|FG000|COMPLETED|Overall Study||10||
60064250|NCT02003365|76179316|FG001|COMPLETED|Overall Study||30||
60064251|NCT02003365|76179317|FG002|COMPLETED|Overall Study||9||
60064252|NCT02003365|76179315|FG000|NOT COMPLETED|Overall Study||0||
60064253|NCT02003365|76179316|FG001|NOT COMPLETED|Overall Study||0||
60064254|NCT02003365|76179317|FG002|NOT COMPLETED|Overall Study||1||
60064255|NCT01975220|76179328|FG000|STARTED|Test Period 1||12||
60064256|NCT01975220|76179329|FG001|STARTED|Test Period 1||12||
60064257|NCT01975220|76179330|FG002|STARTED|Test Period 1||12||
60064258|NCT01975220|76179331|FG003|STARTED|Test Period 1||12||
60064259|NCT01975220|76179332|FG004|STARTED|Test Period 1||12||
60064260|NCT01975220|76179333|FG005|STARTED|Test Period 1||12||
60064261|NCT01975220|76179328|FG000|COMPLETED|Test Period 1||12||
60064262|NCT01975220|76179329|FG001|COMPLETED|Test Period 1||11||
60064263|NCT01975220|76179330|FG002|COMPLETED|Test Period 1||12||
60064264|NCT01975220|76179331|FG003|COMPLETED|Test Period 1||12||
60064265|NCT01975220|76179332|FG004|COMPLETED|Test Period 1||12||
60064266|NCT01975220|76179333|FG005|COMPLETED|Test Period 1||12||
59613158|NCT01693068|75724243|FG001|COMPLETED|Cross-over (Dacarbazine To Pimasertib)||0||
59613159|NCT01693068|75724244|FG002|COMPLETED|Cross-over (Dacarbazine To Pimasertib)||40||
59613160|NCT01693068|75724242|FG000|NOT COMPLETED|Cross-over (Dacarbazine To Pimasertib)||0||
59613161|NCT01693068|75724243|FG001|NOT COMPLETED|Cross-over (Dacarbazine To Pimasertib)||0||
59613162|NCT01693068|75724244|FG002|NOT COMPLETED|Cross-over (Dacarbazine To Pimasertib)||1||
59613163|NCT01691898|75724258|FG000|STARTED|Overall Study||63||
59613164|NCT01691898|75724259|FG001|STARTED|Overall Study||59||
59613165|NCT01691898|75724260|FG002|STARTED|Overall Study||20||
59613166|NCT01691898|75724261|FG003|STARTED|Overall Study||9||
59613167|NCT01691898|75724262|FG004|STARTED|Overall Study||40||
59613168|NCT01691898|75724263|FG005|STARTED|Overall Study||40||
59613169|NCT01691898|75724258|FG000|COMPLETED|Overall Study||16||
59613170|NCT01691898|75724259|FG001|COMPLETED|Overall Study||15||
59613171|NCT01691898|75724260|FG002|COMPLETED|Overall Study||11||
59613172|NCT01691898|75724261|FG003|COMPLETED|Overall Study||4||
59613173|NCT01691898|75724262|FG004|COMPLETED|Overall Study||26||
59613174|NCT01691898|75724263|FG005|COMPLETED|Overall Study||5||
59613175|NCT01691898|75724258|FG000|NOT COMPLETED|Overall Study||47||
59613176|NCT01691898|75724259|FG001|NOT COMPLETED|Overall Study||44||
59613177|NCT01691898|75724260|FG002|NOT COMPLETED|Overall Study||9||
59613178|NCT01691898|75724261|FG003|NOT COMPLETED|Overall Study||5||
60064267|NCT01975220|76179328|FG000|NOT COMPLETED|Test Period 1||0||
59517542|NCT03335254|75611557|FG000|NOT COMPLETED|Period 1||0||
59517543|NCT03335254|75611558|FG001|NOT COMPLETED|Period 1||0||
60064268|NCT01975220|76179329|FG001|NOT COMPLETED|Test Period 1||1||
60064269|NCT01975220|76179330|FG002|NOT COMPLETED|Test Period 1||0||
60064270|NCT01975220|76179331|FG003|NOT COMPLETED|Test Period 1||0||
60064271|NCT01975220|76179332|FG004|NOT COMPLETED|Test Period 1||0||
60064272|NCT01975220|76179333|FG005|NOT COMPLETED|Test Period 1||0||
60064273|NCT01975220|76179328|FG000|STARTED|Test Period 2||12||
60064274|NCT01975220|76179329|FG001|STARTED|Test Period 2||11||
60064275|NCT01975220|76179330|FG002|STARTED|Test Period 2||12||
60064276|NCT01975220|76179331|FG003|STARTED|Test Period 2||12||
59517544|NCT03335254|75611559|FG002|NOT COMPLETED|Period 1||0||
59517545|NCT03335254|75611560|FG003|NOT COMPLETED|Period 1||0||
59517546|NCT03335254|75611561|FG004|NOT COMPLETED|Period 1||0||
59517547|NCT03335254|75611562|FG005|NOT COMPLETED|Period 1||0||
59517548|NCT03335254|75611563|FG006|NOT COMPLETED|Period 1||0||
59517549|NCT03335254|75611564|FG007|NOT COMPLETED|Period 1||0||
59517550|NCT03335254|75611565|FG008|NOT COMPLETED|Period 1||0||
59613179|NCT01691898|75724262|FG004|NOT COMPLETED|Overall Study||14||
60064277|NCT01975220|76179332|FG004|STARTED|Test Period 2||12||
60064278|NCT01975220|76179333|FG005|STARTED|Test Period 2||12||
60064279|NCT01975220|76179328|FG000|COMPLETED|Test Period 2||12||
60064280|NCT01975220|76179329|FG001|COMPLETED|Test Period 2||11||
60064281|NCT01975220|76179330|FG002|COMPLETED|Test Period 2||12||
60064282|NCT01975220|76179331|FG003|COMPLETED|Test Period 2||12||
60064283|NCT01975220|76179332|FG004|COMPLETED|Test Period 2||12||
60064284|NCT01975220|76179333|FG005|COMPLETED|Test Period 2||12||
60064285|NCT01975220|76179328|FG000|NOT COMPLETED|Test Period 2||0||
60064286|NCT01975220|76179329|FG001|NOT COMPLETED|Test Period 2||0||
60064287|NCT01975220|76179330|FG002|NOT COMPLETED|Test Period 2||0||
60064288|NCT01975220|76179331|FG003|NOT COMPLETED|Test Period 2||0||
60064289|NCT01975220|76179332|FG004|NOT COMPLETED|Test Period 2||0||
60064290|NCT01975220|76179333|FG005|NOT COMPLETED|Test Period 2||0||
60064291|NCT01958437|76179350|FG000|STARTED|Overall Study||11||
60064292|NCT01958437|76179351|FG001|STARTED|Overall Study||11||
60064293|NCT01958437|76179352|FG002|STARTED|Overall Study||11||
60064294|NCT01958437|76179353|FG003|STARTED|Overall Study||11||
60064295|NCT01958437|76179350|FG000|COMPLETED|Overall Study||11||
60064296|NCT01958437|76179351|FG001|COMPLETED|Overall Study||11||
60064297|NCT01958437|76179352|FG002|COMPLETED|Overall Study||10||
60064298|NCT01958437|76179353|FG003|COMPLETED|Overall Study||10||
60064299|NCT01958437|76179350|FG000|NOT COMPLETED|Overall Study||0||
60064300|NCT01958437|76179351|FG001|NOT COMPLETED|Overall Study||0||
60064301|NCT01958437|76179352|FG002|NOT COMPLETED|Overall Study||1||
60064302|NCT01958437|76179353|FG003|NOT COMPLETED|Overall Study||1||
60064303|NCT01974752|76179372|FG000|STARTED|Overall Study||97||
60064304|NCT01974752|76179373|FG001|STARTED|Overall Study||32||
60064305|NCT01974752|76179372|FG000|COMPLETED|Overall Study||60||
60064306|NCT01974752|76179373|FG001|COMPLETED|Overall Study||17||
60064307|NCT01974752|76179372|FG000|NOT COMPLETED|Overall Study||37||
60064308|NCT01974752|76179373|FG001|NOT COMPLETED|Overall Study||15||
60064309|NCT01999946|76179382|FG000|STARTED|Overall Study||61||
59613180|NCT01691898|75724263|FG005|NOT COMPLETED|Overall Study||35||
59613181|NCT01691820|75724297|FG000|STARTED|Overall Study||210||
59613182|NCT01691820|75724298|FG001|STARTED|Overall Study||152||
59613183|NCT01691820|75724297|FG000|COMPLETED|Overall Study||184||
59613184|NCT01691820|75724298|FG001|COMPLETED|Overall Study||115||
59761307|NCT00867087|75881043|FG000|NOT COMPLETED|Overall Study||42||
59761308|NCT00545233|75881049|FG000|STARTED|Overall Study||79||
59761309|NCT00545233|75881050|FG001|STARTED|Overall Study||76||
59761310|NCT00545233|75881049|FG000|Safety Set|Overall Study||77||
59761311|NCT00545233|75881050|FG001|Safety Set|Overall Study||75||
59517551|NCT03335254|75611566|FG009|NOT COMPLETED|Period 1||0||
59517552|NCT03335254|75611567|FG010|NOT COMPLETED|Period 1||0||
59517553|NCT03335254|75611568|FG011|NOT COMPLETED|Period 1||0||
59517554|NCT03335254|75611569|FG012|NOT COMPLETED|Period 1||0||
59761312|NCT00545233|75881049|FG000|Intent-to-Treat (ITT)|Overall Study||77||
59761313|NCT00545233|75881050|FG001|Intent-to-Treat (ITT)|Overall Study||73||
59517555|NCT03335254|75611570|FG013|NOT COMPLETED|Period 1||0||
59517556|NCT03335254|75611571|FG014|NOT COMPLETED|Period 1||0||
59517557|NCT03335254|75611572|FG015|NOT COMPLETED|Period 1||0||
59761314|NCT00545233|75881049|FG000|COMPLETED|Overall Study||33||
59761315|NCT00545233|75881050|FG001|COMPLETED|Overall Study||41||
59761316|NCT00545233|75881049|FG000|NOT COMPLETED|Overall Study||46||
59761317|NCT00545233|75881050|FG001|NOT COMPLETED|Overall Study||35||
59761318|NCT02393248|75881082|FG000|STARTED|Part 1: Monotherapy Dose Escalation||3||
59761319|NCT02393248|75881083|FG001|STARTED|Part 1: Monotherapy Dose Escalation||4||
59761320|NCT02393248|75881084|FG002|STARTED|Part 1: Monotherapy Dose Escalation||3||
59761321|NCT02393248|75881085|FG003|STARTED|Part 1: Monotherapy Dose Escalation||6||
59761322|NCT02393248|75881086|FG004|STARTED|Part 1: Monotherapy Dose Escalation||6||
59761323|NCT02393248|75881087|FG005|STARTED|Part 1: Monotherapy Dose Escalation||9||
60064310|NCT01999946|76179383|FG001|STARTED|Overall Study||58||
60064311|NCT01999946|76179384|FG002|STARTED|Overall Study||79||
60064312|NCT01999946|76179382|FG000|COMPLETED|Overall Study||59||
60064313|NCT01999946|76179383|FG001|COMPLETED|Overall Study||56||
60064314|NCT01999946|76179384|FG002|COMPLETED|Overall Study||0||
60064315|NCT01999946|76179382|FG000|NOT COMPLETED|Overall Study||2||
60064316|NCT01999946|76179383|FG001|NOT COMPLETED|Overall Study||2||
60064317|NCT01999946|76179384|FG002|NOT COMPLETED|Overall Study||79||
60064318|NCT01958281|76179394|FG000|STARTED|Overall Study||10||
60064319|NCT01958281|76179395|FG001|STARTED|Overall Study||10||
60064320|NCT01958281|76179396|FG002|STARTED|Overall Study||18||
60064321|NCT01958281|76179394|FG000|COMPLETED|Overall Study||4||
59517558|NCT03335254|75611573|FG016|NOT COMPLETED|Period 1||0||
59517559|NCT03335254|75611574|FG017|NOT COMPLETED|Period 1||0||
59613185|NCT01691820|75724297|FG000|NOT COMPLETED|Overall Study||26||
59517560|NCT03335254|75611575|FG018|NOT COMPLETED|Period 1||0||
59517561|NCT03335254|75611576|FG019|NOT COMPLETED|Period 1||0||
59517562|NCT03335254|75611557|FG000|STARTED|Period 2, Day 1-15||9||
59517563|NCT03335254|75611558|FG001|STARTED|Period 2, Day 1-15||0||
59761324|NCT02393248|75881088|FG006|STARTED|Part 1: Monotherapy Dose Escalation||10||
59761325|NCT02393248|75881089|FG007|STARTED|Part 1: Monotherapy Dose Escalation||9||
60064322|NCT01958281|76179395|FG001|COMPLETED|Overall Study||6||
60064323|NCT01958281|76179396|FG002|COMPLETED|Overall Study||18||
60064324|NCT01958281|76179394|FG000|NOT COMPLETED|Overall Study||6||
60064325|NCT01958281|76179395|FG001|NOT COMPLETED|Overall Study||4||
60064326|NCT01958281|76179396|FG002|NOT COMPLETED|Overall Study||0||
60064327|NCT01958125|76179407|FG000|STARTED|Overall Study||50||
60064328|NCT01958125|76179408|FG001|STARTED|Overall Study||52||
60064329|NCT01958125|76179407|FG000|COMPLETED|Overall Study||48||
60064330|NCT01958125|76179408|FG001|COMPLETED|Overall Study||44||
60064331|NCT01958125|76179407|FG000|NOT COMPLETED|Overall Study||2||
60064332|NCT01958125|76179408|FG001|NOT COMPLETED|Overall Study||8||
60064333|NCT02002975|76179414|FG000|STARTED|Overall Study||18223||
60064334|NCT02002975|76179414|FG000|COMPLETED|Overall Study||17651||
60064335|NCT02002975|76179414|FG000|NOT COMPLETED|Overall Study||572||
60064336|NCT02001181|76179420|FG000|STARTED|Overall Study||35||
60064337|NCT02001181|76179421|FG001|STARTED|Overall Study||34||
60064338|NCT02001181|76179420|FG000|COMPLETED|Overall Study||34||
60064339|NCT02001181|76179421|FG001|COMPLETED|Overall Study||31||
60064340|NCT02001181|76179420|FG000|NOT COMPLETED|Overall Study||1||
60064341|NCT02001181|76179421|FG001|NOT COMPLETED|Overall Study||3||
60064342|NCT01999465|76179429|FG000|STARTED|Overall Study||10||
60064343|NCT01999465|76179430|FG001|STARTED|Overall Study||10||
60064344|NCT01999465|76179429|FG000|COMPLETED|Overall Study||10||
60064345|NCT01999465|76179430|FG001|COMPLETED|Overall Study||7||
60064346|NCT01999465|76179429|FG000|NOT COMPLETED|Overall Study||0||
60064347|NCT01999465|76179430|FG001|NOT COMPLETED|Overall Study||3||
60064348|NCT01982773|76179438|FG000|STARTED|Overall Study||58||
59517564|NCT03335254|75611559|FG002|STARTED|Period 2, Day 1-15||0||
59517565|NCT03335254|75611560|FG003|STARTED|Period 2, Day 1-15||0||
59517566|NCT03335254|75611561|FG004|STARTED|Period 2, Day 1-15||0||
59517567|NCT03335254|75611562|FG005|STARTED|Period 2, Day 1-15||0||
59517568|NCT03335254|75611563|FG006|STARTED|Period 2, Day 1-15||0||
59761326|NCT02393248|75881090|FG008|STARTED|Part 1: Monotherapy Dose Escalation||4||
59761327|NCT02393248|75881091|FG009|STARTED|Part 1: Monotherapy Dose Escalation||3||
59761328|NCT02393248|75881092|FG010|STARTED|Part 1: Monotherapy Dose Escalation||0||
60064349|NCT01982773|76179439|FG001|STARTED|Overall Study||60||
60064350|NCT01982773|76179438|FG000|COMPLETED|Overall Study||50||
60064351|NCT01982773|76179439|FG001|COMPLETED|Overall Study||56||
60064352|NCT01982773|76179438|FG000|NOT COMPLETED|Overall Study||8||
60064353|NCT01982773|76179439|FG001|NOT COMPLETED|Overall Study||4||
60064354|NCT01974206|76179447|FG000|STARTED|Overall Study||74||
59761329|NCT02393248|75881093|FG011|STARTED|Part 1: Monotherapy Dose Escalation||0||
60064355|NCT01974206|76179448|FG001|STARTED|Overall Study||76||
60064356|NCT01974206|76179447|FG000|Received Treatment|Overall Study||74||
60064357|NCT01974206|76179448|FG001|Received Treatment|Overall Study||75||
60064358|NCT01974206|76179447|FG000|COMPLETED|Overall Study||68||
60064359|NCT01974206|76179448|FG001|COMPLETED|Overall Study||75||
60064360|NCT01974206|76179447|FG000|NOT COMPLETED|Overall Study||6||
60064361|NCT01974206|76179448|FG001|NOT COMPLETED|Overall Study||1||
59517569|NCT03335254|75611564|FG007|STARTED|Period 2, Day 1-15||0||
59517570|NCT03335254|75611565|FG008|STARTED|Period 2, Day 1-15||0||
59517571|NCT03335254|75611566|FG009|STARTED|Period 2, Day 1-15||0||
60064362|NCT01999868|76179457|FG000|STARTED|Lead-in Phase (Week 0 - 12)||45||
60064363|NCT01999868|76179458|FG001|STARTED|Lead-in Phase (Week 0 - 12)||46||
60064364|NCT01999868|76179459|FG002|STARTED|Lead-in Phase (Week 0 - 12)||17||
60064365|NCT01999868|76179457|FG000|COMPLETED|Lead-in Phase (Week 0 - 12)||45||
60064366|NCT01999868|76179458|FG001|COMPLETED|Lead-in Phase (Week 0 - 12)||46||
60064367|NCT01999868|76179459|FG002|COMPLETED|Lead-in Phase (Week 0 - 12)||12||
60064368|NCT01999868|76179457|FG000|NOT COMPLETED|Lead-in Phase (Week 0 - 12)||0||
60064369|NCT01999868|76179458|FG001|NOT COMPLETED|Lead-in Phase (Week 0 - 12)||0||
60064370|NCT01999868|76179459|FG002|NOT COMPLETED|Lead-in Phase (Week 0 - 12)||5||
59517572|NCT03335254|75611567|FG010|STARTED|Period 2, Day 1-15||0||
59517573|NCT03335254|75611568|FG011|STARTED|Period 2, Day 1-15||0||
59517574|NCT03335254|75611569|FG012|STARTED|Period 2, Day 1-15||0||
59517575|NCT03335254|75611570|FG013|STARTED|Period 2, Day 1-15||0||
59517576|NCT03335254|75611571|FG014|STARTED|Period 2, Day 1-15||0||
60064371|NCT01999868|76179457|FG000|STARTED|Blinded Treatment Phase (Week 12 - 40)||45||
60064372|NCT01999868|76179458|FG001|STARTED|Blinded Treatment Phase (Week 12 - 40)||46||
60064373|NCT01999868|76179459|FG002|STARTED|Blinded Treatment Phase (Week 12 - 40)|Participants didn't meet eligibility requirements for randomization or withdrew prior to Week 12.|0||
60064374|NCT01999868|76179457|FG000|COMPLETED|Blinded Treatment Phase (Week 12 - 40)||27||
60064375|NCT01999868|76179458|FG001|COMPLETED|Blinded Treatment Phase (Week 12 - 40)||35||
60064376|NCT01999868|76179459|FG002|COMPLETED|Blinded Treatment Phase (Week 12 - 40)||0||
60064377|NCT01999868|76179457|FG000|NOT COMPLETED|Blinded Treatment Phase (Week 12 - 40)||18||
60064378|NCT01999868|76179458|FG001|NOT COMPLETED|Blinded Treatment Phase (Week 12 - 40)||11||
60064379|NCT01999868|76179459|FG002|NOT COMPLETED|Blinded Treatment Phase (Week 12 - 40)||0||
60064380|NCT01999868|76179457|FG000|STARTED|Blinded Observation Phase (Week 40 - 88)||27||
60064381|NCT01999868|76179458|FG001|STARTED|Blinded Observation Phase (Week 40 - 88)||35||
60064382|NCT01999868|76179459|FG002|STARTED|Blinded Observation Phase (Week 40 - 88)||0||
60064383|NCT01999868|76179457|FG000|COMPLETED|Blinded Observation Phase (Week 40 - 88)||4||
60064384|NCT01999868|76179458|FG001|COMPLETED|Blinded Observation Phase (Week 40 - 88)||6||
60064385|NCT01999868|76179459|FG002|COMPLETED|Blinded Observation Phase (Week 40 - 88)||0||
60064386|NCT01999868|76179457|FG000|NOT COMPLETED|Blinded Observation Phase (Week 40 - 88)||23||
60064387|NCT01999868|76179458|FG001|NOT COMPLETED|Blinded Observation Phase (Week 40 - 88)||29||
60064388|NCT01999868|76179459|FG002|NOT COMPLETED|Blinded Observation Phase (Week 40 - 88)||0||
60064389|NCT01957579|76179471|FG000|STARTED|Overall Study||3||
60064390|NCT01957579|76179472|FG001|STARTED|Overall Study||7||
60064391|NCT01957579|76179473|FG002|STARTED|Overall Study||4||
60064392|NCT01957579|76179474|FG003|STARTED|Overall Study||6||
60064393|NCT01957579|76179471|FG000|COMPLETED|Overall Study||3||
60064394|NCT01957579|76179472|FG001|COMPLETED|Overall Study||6||
60064395|NCT01957579|76179473|FG002|COMPLETED|Overall Study||2||
60064396|NCT01957579|76179474|FG003|COMPLETED|Overall Study||6||
60064397|NCT01957579|76179471|FG000|NOT COMPLETED|Overall Study||0||
60064398|NCT01957579|76179472|FG001|NOT COMPLETED|Overall Study||1||
60064399|NCT01957579|76179473|FG002|NOT COMPLETED|Overall Study||2||
60064400|NCT01957579|76179474|FG003|NOT COMPLETED|Overall Study||0||
60064401|NCT01999322|76179503|FG000|STARTED|Overall Study||25||
59517577|NCT03335254|75611572|FG015|STARTED|Period 2, Day 1-15||0||
59930213|NCT03251963|76048499|FG000|NOT COMPLETED|Overall Study||9||
59930214|NCT03251963|76048500|FG001|NOT COMPLETED|Overall Study||5||
60064402|NCT01999322|76179504|FG001|STARTED|Overall Study||12||
60064403|NCT01999322|76179503|FG000|COMPLETED|Overall Study||24||
59517578|NCT03335254|75611573|FG016|STARTED|Period 2, Day 1-15||0||
59517579|NCT03335254|75611574|FG017|STARTED|Period 2, Day 1-15||0||
59517580|NCT03335254|75611575|FG018|STARTED|Period 2, Day 1-15||0||
59517581|NCT03335254|75611576|FG019|STARTED|Period 2, Day 1-15||0||
59517582|NCT03335254|75611557|FG000|COMPLETED|Period 2, Day 1-15||9||
59517583|NCT03335254|75611558|FG001|COMPLETED|Period 2, Day 1-15||0||
59930215|NCT03287219|76048508|FG000|STARTED|Overall Study||24||
59930216|NCT03287219|76048509|FG001|STARTED|Overall Study||90||
59930217|NCT03287219|76048508|FG000|COMPLETED|Overall Study||24||
59930218|NCT03287219|76048509|FG001|COMPLETED|Overall Study||88||
59930219|NCT03287219|76048508|FG000|NOT COMPLETED|Overall Study||0||
59517584|NCT03335254|75611559|FG002|COMPLETED|Period 2, Day 1-15||0||
59930220|NCT03287219|76048509|FG001|NOT COMPLETED|Overall Study||2||
59930221|NCT03286751|76048548|FG000|STARTED|Period 1||7||
59930222|NCT03286751|76048549|FG001|STARTED|Period 1||7||
59930223|NCT03286751|76048550|FG002|STARTED|Period 1||7||
59930224|NCT03286751|76048551|FG003|STARTED|Period 1||7||
59930225|NCT03286751|76048552|FG004|STARTED|Period 1||7||
59930226|NCT03286751|76048553|FG005|STARTED|Period 1||7||
59930227|NCT03286751|76048548|FG000|Received at Least One Dose of Study Drug|Period 1||7||
59930228|NCT03286751|76048549|FG001|Received at Least One Dose of Study Drug|Period 1||7||
59930229|NCT03286751|76048550|FG002|Received at Least One Dose of Study Drug|Period 1||7||
59930230|NCT03286751|76048551|FG003|Received at Least One Dose of Study Drug|Period 1||7||
59930231|NCT03286751|76048552|FG004|Received at Least One Dose of Study Drug|Period 1||7||
59930232|NCT03286751|76048553|FG005|Received at Least One Dose of Study Drug|Period 1||7||
59930233|NCT03286751|76048548|FG000|COMPLETED|Period 1||7||
59930234|NCT03286751|76048549|FG001|COMPLETED|Period 1||7||
59930235|NCT03286751|76048550|FG002|COMPLETED|Period 1||7||
60064404|NCT01999322|76179504|FG001|COMPLETED|Overall Study||12||
60064405|NCT01999322|76179503|FG000|NOT COMPLETED|Overall Study||1||
60064406|NCT01999322|76179504|FG001|NOT COMPLETED|Overall Study||0||
60064407|NCT01996982|76179510|FG000|STARTED|Overall Study||7||
60064408|NCT01996982|76179510|FG000|COMPLETED|Overall Study||0||
60064409|NCT01996982|76179510|FG000|NOT COMPLETED|Overall Study||7||
60064410|NCT01965158|76179516|FG000|STARTED|Overall Study|Includes 1 participant enrolled at 2 different sites simultaneously|274||
60064411|NCT01965158|76179517|FG001|STARTED|Overall Study|Includes 1 participant enrolled at 2 different sites simultaneously|273||
60064412|NCT01965158|76179516|FG000|Received Treatment|Overall Study||272||
60064413|NCT01965158|76179517|FG001|Received Treatment|Overall Study||273||
60064414|NCT01965158|76179516|FG000|COMPLETED|Overall Study||233||
60064415|NCT01965158|76179517|FG001|COMPLETED|Overall Study||238||
60064416|NCT01965158|76179516|FG000|NOT COMPLETED|Overall Study||41||
60064417|NCT01965158|76179517|FG001|NOT COMPLETED|Overall Study||35||
60064418|NCT01964924|76179523|FG000|STARTED|Trametinib Monotherapy||37||
60064419|NCT01964924|76179524|FG001|STARTED|Trametinib Monotherapy||0||
60064420|NCT01964924|76179523|FG000|COMPLETED|Trametinib Monotherapy||18||
60064421|NCT01964924|76179524|FG001|COMPLETED|Trametinib Monotherapy||0||
60064422|NCT01964924|76179523|FG000|NOT COMPLETED|Trametinib Monotherapy||19||
60064423|NCT01964924|76179524|FG001|NOT COMPLETED|Trametinib Monotherapy||0||
60064424|NCT01964924|76179523|FG000|STARTED|Trametinib + GSK2141||0|Participants who completed Part 1 were not eligible for Part 2|
60064425|NCT01964924|76179524|FG001|STARTED|Trametinib + GSK2141|Progressed in Part 1 and therefore initiated combination treatment in Part 2|19|Participants who completed Part 1 were not eligible for Part 2|
60064426|NCT01964924|76179523|FG000|COMPLETED|Trametinib + GSK2141||0||
60064427|NCT01964924|76179524|FG001|COMPLETED|Trametinib + GSK2141||19||
60064428|NCT01964924|76179523|FG000|NOT COMPLETED|Trametinib + GSK2141||0||
60064429|NCT01964924|76179524|FG001|NOT COMPLETED|Trametinib + GSK2141||0||
60064430|NCT01964378|76179535|FG000|STARTED|Overall Study||66|All allocated participants|
60064431|NCT01964378|76179536|FG001|STARTED|Overall Study||66|All allocated participants|
60064432|NCT01964378|76179535|FG000|Participants Treated (Safety Set)|Overall Study||65||
60064433|NCT01964378|76179536|FG001|Participants Treated (Safety Set)|Overall Study|"4 Participants died during treatment, hereof 2 with withdrawal... as primary reason for discont."|61||
60064434|NCT01964378|76179535|FG000|COMPLETED|Overall Study||41||
60064435|NCT01964378|76179536|FG001|COMPLETED|Overall Study||45||
59517585|NCT03335254|75611560|FG003|COMPLETED|Period 2, Day 1-15||0||
59930236|NCT03286751|76048551|FG003|COMPLETED|Period 1||7||
59930237|NCT03286751|76048552|FG004|COMPLETED|Period 1||7||
60064436|NCT01964378|76179535|FG000|NOT COMPLETED|Overall Study||25||
60064437|NCT01964378|76179536|FG001|NOT COMPLETED|Overall Study||21||
60064438|NCT01442038|76179544|FG000|STARTED|Overall Study||1332||
60064439|NCT01442038|76179545|FG001|STARTED|Overall Study||1319||
60064440|NCT01442038|76179544|FG000|COMPLETED|Overall Study||1029||
59930238|NCT03286751|76048553|FG005|COMPLETED|Period 1||7||
59930239|NCT03286751|76048548|FG000|NOT COMPLETED|Period 1||0||
59930240|NCT03286751|76048549|FG001|NOT COMPLETED|Period 1||0||
59930241|NCT03286751|76048550|FG002|NOT COMPLETED|Period 1||0||
59930242|NCT03286751|76048551|FG003|NOT COMPLETED|Period 1||0||
59930243|NCT03286751|76048552|FG004|NOT COMPLETED|Period 1||0||
59930244|NCT03286751|76048553|FG005|NOT COMPLETED|Period 1||0||
59930245|NCT03286751|76048548|FG000|STARTED|Washout Period 1||7||
59930246|NCT03286751|76048549|FG001|STARTED|Washout Period 1||7||
59930247|NCT03286751|76048550|FG002|STARTED|Washout Period 1||7||
59930248|NCT03286751|76048551|FG003|STARTED|Washout Period 1||7||
60064441|NCT01442038|76179545|FG001|COMPLETED|Overall Study||1040||
60064442|NCT01442038|76179544|FG000|NOT COMPLETED|Overall Study||303||
60064443|NCT01442038|76179545|FG001|NOT COMPLETED|Overall Study||279||
60064444|NCT01998919|76179553|FG000|STARTED|Overall Study||79||
60064445|NCT01998919|76179554|FG001|STARTED|Overall Study||74||
60064446|NCT01998919|76179553|FG000|Randomized|Overall Study|1 participant randomized to erlotinib didn't receive study drug; analyzed in placebo for safety|78||
60064447|NCT01998919|76179554|FG001|Randomized|Overall Study|One participant withdrew consent prior to 1st dose and was excluded from safety analysis population.|76||
60064448|NCT01998919|76179553|FG000|COMPLETED|Overall Study||37||
60064449|NCT01998919|76179554|FG001|COMPLETED|Overall Study||39||
60064450|NCT01998919|76179553|FG000|NOT COMPLETED|Overall Study||42||
60064451|NCT01998919|76179554|FG001|NOT COMPLETED|Overall Study||35||
60064452|NCT01957111|76179562|FG000|STARTED|Overall Study||16||
60064453|NCT01957111|76179563|FG001|STARTED|Overall Study||16||
60064454|NCT01957111|76179562|FG000|COMPLETED|Overall Study||15||
60064455|NCT01957111|76179563|FG001|COMPLETED|Overall Study||15||
59517586|NCT03335254|75611561|FG004|COMPLETED|Period 2, Day 1-15||0||
59517587|NCT03335254|75611562|FG005|COMPLETED|Period 2, Day 1-15||0||
59517588|NCT03335254|75611563|FG006|COMPLETED|Period 2, Day 1-15||0||
59930249|NCT03286751|76048552|FG004|STARTED|Washout Period 1||7||
59930250|NCT03286751|76048553|FG005|STARTED|Washout Period 1||7||
59930251|NCT03286751|76048548|FG000|COMPLETED|Washout Period 1||7||
59930252|NCT03286751|76048549|FG001|COMPLETED|Washout Period 1||7||
59930253|NCT03286751|76048550|FG002|COMPLETED|Washout Period 1||7||
59930254|NCT03286751|76048551|FG003|COMPLETED|Washout Period 1||7||
59930255|NCT03286751|76048552|FG004|COMPLETED|Washout Period 1||6||
59930256|NCT03286751|76048553|FG005|COMPLETED|Washout Period 1||7||
59930257|NCT03286751|76048548|FG000|NOT COMPLETED|Washout Period 1||0||
59930258|NCT03286751|76048549|FG001|NOT COMPLETED|Washout Period 1||0||
59930259|NCT03286751|76048550|FG002|NOT COMPLETED|Washout Period 1||0||
59930260|NCT03286751|76048551|FG003|NOT COMPLETED|Washout Period 1||0||
59930261|NCT03286751|76048552|FG004|NOT COMPLETED|Washout Period 1||1||
59930262|NCT03286751|76048553|FG005|NOT COMPLETED|Washout Period 1||0||
59930263|NCT03286751|76048548|FG000|STARTED|Period 2||7||
59930264|NCT03286751|76048549|FG001|STARTED|Period 2||7||
59930265|NCT03286751|76048550|FG002|STARTED|Period 2||7||
59930266|NCT03286751|76048551|FG003|STARTED|Period 2||7||
59930267|NCT03286751|76048552|FG004|STARTED|Period 2||6||
59930268|NCT03286751|76048553|FG005|STARTED|Period 2||7||
59930269|NCT03286751|76048548|FG000|COMPLETED|Period 2||7||
59930270|NCT03286751|76048549|FG001|COMPLETED|Period 2||7||
59930271|NCT03286751|76048550|FG002|COMPLETED|Period 2||7||
59930272|NCT03286751|76048551|FG003|COMPLETED|Period 2||7||
59930273|NCT03286751|76048552|FG004|COMPLETED|Period 2||6||
59930274|NCT03286751|76048553|FG005|COMPLETED|Period 2||7||
59930275|NCT03286751|76048548|FG000|NOT COMPLETED|Period 2||0||
59930276|NCT03286751|76048549|FG001|NOT COMPLETED|Period 2||0||
59930277|NCT03286751|76048550|FG002|NOT COMPLETED|Period 2||0||
59930278|NCT03286751|76048551|FG003|NOT COMPLETED|Period 2||0||
59930279|NCT03286751|76048552|FG004|NOT COMPLETED|Period 2||0||
59930280|NCT03286751|76048553|FG005|NOT COMPLETED|Period 2||0||
59930281|NCT03286751|76048548|FG000|STARTED|Washout Period 2||7||
59930282|NCT03286751|76048549|FG001|STARTED|Washout Period 2||7||
59930283|NCT03286751|76048550|FG002|STARTED|Washout Period 2||7||
59930284|NCT03286751|76048551|FG003|STARTED|Washout Period 2||7||
59930285|NCT03286751|76048552|FG004|STARTED|Washout Period 2||6||
59930286|NCT03286751|76048553|FG005|STARTED|Washout Period 2||7||
59930287|NCT03286751|76048548|FG000|COMPLETED|Washout Period 2||7||
59930288|NCT03286751|76048549|FG001|COMPLETED|Washout Period 2||6||
59930289|NCT03286751|76048550|FG002|COMPLETED|Washout Period 2||7||
59930290|NCT03286751|76048551|FG003|COMPLETED|Washout Period 2||7||
59930291|NCT03286751|76048552|FG004|COMPLETED|Washout Period 2||6||
59930292|NCT03286751|76048553|FG005|COMPLETED|Washout Period 2||7||
59930293|NCT03286751|76048548|FG000|NOT COMPLETED|Washout Period 2||0||
59930294|NCT03286751|76048549|FG001|NOT COMPLETED|Washout Period 2||1||
59930295|NCT03286751|76048550|FG002|NOT COMPLETED|Washout Period 2||0||
59930296|NCT03286751|76048551|FG003|NOT COMPLETED|Washout Period 2||0||
59517589|NCT03335254|75611564|FG007|COMPLETED|Period 2, Day 1-15||0||
59930297|NCT03286751|76048552|FG004|NOT COMPLETED|Washout Period 2||0||
59517590|NCT03335254|75611565|FG008|COMPLETED|Period 2, Day 1-15||0||
59517591|NCT03335254|75611566|FG009|COMPLETED|Period 2, Day 1-15||0||
59517592|NCT03335254|75611567|FG010|COMPLETED|Period 2, Day 1-15||0||
59517593|NCT03335254|75611568|FG011|COMPLETED|Period 2, Day 1-15||0||
59517594|NCT03335254|75611569|FG012|COMPLETED|Period 2, Day 1-15||0||
59517595|NCT03335254|75611570|FG013|COMPLETED|Period 2, Day 1-15||0||
59517596|NCT03335254|75611571|FG014|COMPLETED|Period 2, Day 1-15||0||
60064456|NCT01957111|76179562|FG000|NOT COMPLETED|Overall Study||1||
60064457|NCT01957111|76179563|FG001|NOT COMPLETED|Overall Study||1||
60064458|NCT01964300|76179571|FG000|STARTED|Overall Study||7||
60064459|NCT01964300|76179572|FG001|STARTED|Overall Study||12||
60064460|NCT01964300|76179571|FG000|COMPLETED|Overall Study||1||
60064461|NCT01964300|76179572|FG001|COMPLETED|Overall Study||1||
60064462|NCT01964300|76179571|FG000|NOT COMPLETED|Overall Study||6||
60064463|NCT01964300|76179572|FG001|NOT COMPLETED|Overall Study||11||
60064464|NCT01964222|76179580|FG000|STARTED|Overall Study||101||
60064465|NCT01964222|76179581|FG001|STARTED|Overall Study||100||
60064466|NCT01964222|76179580|FG000|COMPLETED|Overall Study||86||
60064467|NCT01964222|76179581|FG001|COMPLETED|Overall Study||89||
60064468|NCT01964222|76179580|FG000|NOT COMPLETED|Overall Study||15||
60064469|NCT01964222|76179581|FG001|NOT COMPLETED|Overall Study||11||
60064470|NCT01467700|76179591|FG000|STARTED|Overall Study||115||
60064471|NCT01467700|76179592|FG001|STARTED|Overall Study||128||
60064472|NCT01467700|76179593|FG002|STARTED|Overall Study||124||
60064473|NCT01467700|76179594|FG003|STARTED|Overall Study||123||
60064474|NCT01467700|76179591|FG000|Safety Set - Received Treatment|Overall Study||115||
60064475|NCT01467700|76179592|FG001|Safety Set - Received Treatment|Overall Study||127||
60064476|NCT01467700|76179593|FG002|Safety Set - Received Treatment|Overall Study||124||
60064477|NCT01467700|76179594|FG003|Safety Set - Received Treatment|Overall Study||123||
60064478|NCT01467700|76179591|FG000|COMPLETED|Overall Study||86||
60064479|NCT01467700|76179592|FG001|COMPLETED|Overall Study||100||
60064480|NCT01467700|76179593|FG002|COMPLETED|Overall Study||97||
60064481|NCT01467700|76179594|FG003|COMPLETED|Overall Study||96||
60064482|NCT01467700|76179591|FG000|NOT COMPLETED|Overall Study||29||
60064483|NCT01467700|76179592|FG001|NOT COMPLETED|Overall Study||28||
60064484|NCT01467700|76179593|FG002|NOT COMPLETED|Overall Study||27||
60064485|NCT01467700|76179594|FG003|NOT COMPLETED|Overall Study||27||
60064486|NCT01972724|76179607|FG000|STARTED|Double-Blind||19||
60064487|NCT01972724|76179608|FG001|STARTED|Double-Blind||18||
60064488|NCT01972724|76179609|FG002|STARTED|Double-Blind||0||
60064489|NCT01972724|76179607|FG000|Intent-to-treat:Received Study Drug|Double-Blind||17||
60064490|NCT01972724|76179608|FG001|Intent-to-treat:Received Study Drug|Double-Blind||17||
60064491|NCT01972724|76179609|FG002|Intent-to-treat:Received Study Drug|Double-Blind||0||
60064492|NCT01972724|76179607|FG000|COMPLETED|Double-Blind||10||
60064493|NCT01972724|76179608|FG001|COMPLETED|Double-Blind||9||
60064494|NCT01972724|76179609|FG002|COMPLETED|Double-Blind||0||
60064495|NCT01972724|76179607|FG000|NOT COMPLETED|Double-Blind||9||
60064496|NCT01972724|76179608|FG001|NOT COMPLETED|Double-Blind||9||
60064497|NCT01972724|76179609|FG002|NOT COMPLETED|Double-Blind||0||
60064498|NCT01972724|76179607|FG000|STARTED|Open-Label||0||
60064499|NCT01972724|76179608|FG001|STARTED|Open-Label||0||
60064500|NCT01972724|76179609|FG002|STARTED|Open-Label||77||
60064501|NCT01972724|76179607|FG000|COMPLETED|Open-Label||0||
60064502|NCT01972724|76179608|FG001|COMPLETED|Open-Label||0||
60064503|NCT01972724|76179609|FG002|COMPLETED|Open-Label||72||
60064504|NCT01972724|76179607|FG000|NOT COMPLETED|Open-Label||0||
60064505|NCT01972724|76179608|FG001|NOT COMPLETED|Open-Label||0||
60064506|NCT01972724|76179609|FG002|NOT COMPLETED|Open-Label||5||
60064507|NCT01441960|76179617|FG000|STARTED|First Neuromuscular Blocking Agent:||26||
59517597|NCT03335254|75611572|FG015|COMPLETED|Period 2, Day 1-15||0||
59517598|NCT03335254|75611573|FG016|COMPLETED|Period 2, Day 1-15||0||
59517599|NCT03335254|75611574|FG017|COMPLETED|Period 2, Day 1-15||0||
59517600|NCT03335254|75611575|FG018|COMPLETED|Period 2, Day 1-15||0||
59517601|NCT03335254|75611576|FG019|COMPLETED|Period 2, Day 1-15||0||
59517602|NCT03335254|75611557|FG000|NOT COMPLETED|Period 2, Day 1-15||0||
59517603|NCT03335254|75611558|FG001|NOT COMPLETED|Period 2, Day 1-15||0||
59613186|NCT01691820|75724298|FG001|NOT COMPLETED|Overall Study||37||
59613187|NCT01711866|75724308|FG000|STARTED|Overall Study||87||
59613188|NCT01711866|75724308|FG000|COMPLETED|Overall Study||79||
59613189|NCT01711866|75724308|FG000|NOT COMPLETED|Overall Study||8||
59613190|NCT01737762|75724314|FG000|STARTED|Overall Study||77||
59761330|NCT02393248|75881094|FG012|STARTED|Part 1: Monotherapy Dose Escalation||0||
59762685|NCT00857259|75882529|FG002|NOT COMPLETED|Overall Study||1||
60064508|NCT01441960|76179618|FG001|STARTED|First Neuromuscular Blocking Agent:||19||
60064509|NCT01441960|76179617|FG000|COMPLETED|First Neuromuscular Blocking Agent:||18||
60064510|NCT01441960|76179618|FG001|COMPLETED|First Neuromuscular Blocking Agent:||13||
60064511|NCT01441960|76179617|FG000|NOT COMPLETED|First Neuromuscular Blocking Agent:||8||
60064512|NCT01441960|76179618|FG001|NOT COMPLETED|First Neuromuscular Blocking Agent:||6||
60064513|NCT01441960|76179617|FG000|STARTED|Second Neuromuscular Blocking Agent||18||
60064514|NCT01441960|76179618|FG001|STARTED|Second Neuromuscular Blocking Agent||13||
60064515|NCT01441960|76179617|FG000|COMPLETED|Second Neuromuscular Blocking Agent||18||
59613191|NCT01737762|75724315|FG001|STARTED|Overall Study||78||
59613192|NCT01737762|75724314|FG000|COMPLETED|Overall Study||57||
59613193|NCT01737762|75724315|FG001|COMPLETED|Overall Study||61||
59613194|NCT01737762|75724314|FG000|NOT COMPLETED|Overall Study||20||
59613195|NCT01737762|75724315|FG001|NOT COMPLETED|Overall Study||17||
59613196|NCT01691508|75724323|FG000|STARTED|Overall Study||66||
59613197|NCT01691508|75724324|FG001|STARTED|Overall Study||69||
59517604|NCT03335254|75611559|FG002|NOT COMPLETED|Period 2, Day 1-15||0||
59517605|NCT03335254|75611560|FG003|NOT COMPLETED|Period 2, Day 1-15||0||
59517606|NCT03335254|75611561|FG004|NOT COMPLETED|Period 2, Day 1-15||0||
59613198|NCT01691508|75724323|FG000|COMPLETED|Overall Study||62||
59613199|NCT01691508|75724324|FG001|COMPLETED|Overall Study||66||
59613200|NCT01691508|75724323|FG000|NOT COMPLETED|Overall Study||4||
59613201|NCT01691508|75724324|FG001|NOT COMPLETED|Overall Study||3||
59613202|NCT01682460|75724330|FG000|STARTED|Overall Study||15||
59613203|NCT01682460|75724330|FG000|COMPLETED|Overall Study||11||
59613204|NCT01682460|75724330|FG000|NOT COMPLETED|Overall Study||4||
59613205|NCT01691430|75724336|FG000|STARTED|Overall Study||92||
59613206|NCT01691430|75724337|FG001|STARTED|Overall Study||93||
59613207|NCT01691430|75724336|FG000|Received Medication|Overall Study||92||
60064516|NCT01441960|76179618|FG001|COMPLETED|Second Neuromuscular Blocking Agent||13||
60064517|NCT01441960|76179617|FG000|NOT COMPLETED|Second Neuromuscular Blocking Agent||0||
60064518|NCT01441960|76179618|FG001|NOT COMPLETED|Second Neuromuscular Blocking Agent||0||
60064519|NCT01955707|76179630|FG000|STARTED|Overall Study||82||
60064520|NCT01955707|76179631|FG001|STARTED|Overall Study||79||
60064521|NCT01955707|76179630|FG000|Withdrew Prior to Dosing|Overall Study||0||
60064522|NCT01955707|76179631|FG001|Withdrew Prior to Dosing|Overall Study||1||
60064523|NCT01955707|76179630|FG000|Dosed|Overall Study||82||
60064524|NCT01955707|76179631|FG001|Dosed|Overall Study||78||
60064525|NCT01955707|76179630|FG000|Received Total Volume of Study Drug|Overall Study||82||
60064526|NCT01955707|76179631|FG001|Received Total Volume of Study Drug|Overall Study||77||
60064527|NCT01955707|76179630|FG000|COMPLETED|Overall Study||62||
60064528|NCT01955707|76179631|FG001|COMPLETED|Overall Study||57||
60064529|NCT01955707|76179630|FG000|NOT COMPLETED|Overall Study||20||
60064530|NCT01955707|76179631|FG001|NOT COMPLETED|Overall Study||22||
60064531|NCT01435798|76179637|FG000|STARTED|Overall Study|Crossover design|26||
60064532|NCT01435798|76179637|FG000|0% MTD|Overall Study||25||
60064533|NCT01435798|76179637|FG000|25% MTD|Overall Study||26||
60064534|NCT01435798|76179637|FG000|50% MTD|Overall Study||25||
60064535|NCT01435798|76179637|FG000|100% MTD|Overall Study||25||
60064536|NCT01435798|76179637|FG000|COMPLETED|Overall Study|Crossover design|25||
60064537|NCT01435798|76179637|FG000|NOT COMPLETED|Overall Study||1||
60064538|NCT01972568|76179650|FG000|STARTED|Overall Study||102||
60064539|NCT01972568|76179651|FG001|STARTED|Overall Study||104||
60064540|NCT01972568|76179652|FG002|STARTED|Overall Study||100||
60064541|NCT01972568|76179650|FG000|COMPLETED|Overall Study||86||
60064542|NCT01972568|76179651|FG001|COMPLETED|Overall Study||92||
60064543|NCT01972568|76179652|FG002|COMPLETED|Overall Study||84||
60064544|NCT01972568|76179650|FG000|NOT COMPLETED|Overall Study||16||
60064545|NCT01972568|76179651|FG001|NOT COMPLETED|Overall Study||12||
60064546|NCT01972568|76179652|FG002|NOT COMPLETED|Overall Study||16||
60064547|NCT01955161|76179663|FG000|STARTED|Overall Study||310||
60064548|NCT01955161|76179664|FG001|STARTED|Overall Study||313||
60064549|NCT01955161|76179665|FG002|STARTED|Overall Study||310||
60064550|NCT01955161|76179663|FG000|Treated|Overall Study||308||
59517607|NCT03335254|75611562|FG005|NOT COMPLETED|Period 2, Day 1-15||0||
59517608|NCT03335254|75611563|FG006|NOT COMPLETED|Period 2, Day 1-15||0||
59517609|NCT03335254|75611564|FG007|NOT COMPLETED|Period 2, Day 1-15||0||
59517610|NCT03335254|75611565|FG008|NOT COMPLETED|Period 2, Day 1-15||0||
59517611|NCT03335254|75611566|FG009|NOT COMPLETED|Period 2, Day 1-15||0||
59517612|NCT03335254|75611567|FG010|NOT COMPLETED|Period 2, Day 1-15||0||
59517613|NCT03335254|75611568|FG011|NOT COMPLETED|Period 2, Day 1-15||0||
59517614|NCT03335254|75611569|FG012|NOT COMPLETED|Period 2, Day 1-15||0||
60064551|NCT01955161|76179664|FG001|Treated|Overall Study||313||
60064552|NCT01955161|76179665|FG002|Treated|Overall Study||309||
60064553|NCT01955161|76179663|FG000|COMPLETED|Overall Study||283||
59517615|NCT03335254|75611570|FG013|NOT COMPLETED|Period 2, Day 1-15||0||
60064554|NCT01955161|76179664|FG001|COMPLETED|Overall Study||288||
60064555|NCT01955161|76179665|FG002|COMPLETED|Overall Study||275||
60064556|NCT01955161|76179663|FG000|NOT COMPLETED|Overall Study||27||
59517616|NCT03335254|75611571|FG014|NOT COMPLETED|Period 2, Day 1-15||0||
60064557|NCT01955161|76179664|FG001|NOT COMPLETED|Overall Study||25||
60064558|NCT01955161|76179665|FG002|NOT COMPLETED|Overall Study||35||
59517617|NCT03335254|75611572|FG015|NOT COMPLETED|Period 2, Day 1-15||0||
59613208|NCT01691430|75724337|FG001|Received Medication|Overall Study||93||
59613209|NCT01691430|75724336|FG000|COMPLETED|Overall Study||70||
60064559|NCT01441414|76179673|FG000|STARTED|Overall Study||18||
59517618|NCT03335254|75611573|FG016|NOT COMPLETED|Period 2, Day 1-15||0||
59613210|NCT01691430|75724337|FG001|COMPLETED|Overall Study||73||
59613211|NCT01691430|75724336|FG000|NOT COMPLETED|Overall Study||22||
59613212|NCT01691430|75724337|FG001|NOT COMPLETED|Overall Study||20||
59613213|NCT01709838|75724343|FG000|STARTED|Overall Study||134||
59613214|NCT01709838|75724343|FG000|COMPLETED|Overall Study||67||
60064560|NCT01441414|76179673|FG000|COMPLETED|Overall Study||3||
60064561|NCT01441414|76179673|FG000|NOT COMPLETED|Overall Study||15||
60064562|NCT01971554|76179693|FG000|STARTED|Overall Study||9||
60064563|NCT01971554|76179694|FG001|STARTED|Overall Study||18||
60064564|NCT01971554|76179695|FG002|STARTED|Overall Study||18||
60064565|NCT01971554|76179696|FG003|STARTED|Overall Study||18||
60064566|NCT01971554|76179693|FG000|COMPLETED|Overall Study||8||
60064567|NCT01971554|76179694|FG001|COMPLETED|Overall Study||18||
60064568|NCT01971554|76179695|FG002|COMPLETED|Overall Study||18||
60064569|NCT01971554|76179696|FG003|COMPLETED|Overall Study||18||
60064570|NCT01971554|76179693|FG000|NOT COMPLETED|Overall Study||1||
60064571|NCT01971554|76179694|FG001|NOT COMPLETED|Overall Study||0||
60064572|NCT01971554|76179695|FG002|NOT COMPLETED|Overall Study||0||
60064573|NCT01971554|76179696|FG003|NOT COMPLETED|Overall Study||0||
60064574|NCT01955083|76179708|FG000|STARTED|Overall Study||15||
60064575|NCT01955083|76179709|FG001|STARTED|Overall Study||15||
60064576|NCT01955083|76179708|FG000|COMPLETED|Overall Study||14||
60064577|NCT01955083|76179709|FG001|COMPLETED|Overall Study||14||
60064578|NCT01955083|76179708|FG000|NOT COMPLETED|Overall Study||1||
60064579|NCT01955083|76179709|FG001|NOT COMPLETED|Overall Study||1||
60064580|NCT01955005|76179741|FG000|STARTED|Overall Study||30||
60064581|NCT01955005|76179742|FG001|STARTED|Overall Study||30||
60064582|NCT01955005|76179741|FG000|COMPLETED|Overall Study||27||
60064583|NCT01955005|76179742|FG001|COMPLETED|Overall Study||25||
60064584|NCT01955005|76179741|FG000|NOT COMPLETED|Overall Study||3||
60064585|NCT01955005|76179742|FG001|NOT COMPLETED|Overall Study||5||
60064586|NCT01954927|76179750|FG000|STARTED|Overall Study||45||
60064587|NCT01954927|76179751|FG001|STARTED|Overall Study||45||
60064588|NCT01954927|76179750|FG000|COMPLETED|Overall Study||42||
60064589|NCT01954927|76179751|FG001|COMPLETED|Overall Study||44||
60064590|NCT01954927|76179750|FG000|NOT COMPLETED|Overall Study||3||
60064591|NCT01954927|76179751|FG001|NOT COMPLETED|Overall Study||1||
59613215|NCT01709838|75724343|FG000|NOT COMPLETED|Overall Study||67||
59613216|NCT01682226|75724349|FG000|STARTED|Overall Study||84||
59613217|NCT01682226|75724349|FG000|COMPLETED|Overall Study||78||
59613218|NCT01682226|75724349|FG000|NOT COMPLETED|Overall Study||6||
59613219|NCT04167618|75724355|FG000|STARTED|Overall Study||1||
59613220|NCT04167618|75724356|FG001|STARTED|Overall Study||1||
59613221|NCT04167618|75724355|FG000|COMPLETED|Overall Study||0||
59613222|NCT04167618|75724356|FG001|COMPLETED|Overall Study||0||
59613223|NCT04167618|75724355|FG000|NOT COMPLETED|Overall Study||1||
59613224|NCT04167618|75724356|FG001|NOT COMPLETED|Overall Study||1||
59613225|NCT01688466|75724364|FG000|STARTED|Overall Study||17||
59613226|NCT01688466|75724365|FG001|STARTED|Overall Study||17||
59613227|NCT01688466|75724364|FG000|COMPLETED|Overall Study||15||
59613228|NCT01688466|75724365|FG001|COMPLETED|Overall Study||10||
59613229|NCT01688466|75724364|FG000|NOT COMPLETED|Overall Study||2||
59613230|NCT01688466|75724365|FG001|NOT COMPLETED|Overall Study||7||
59613231|NCT01682148|75724373|FG000|STARTED|Overall Study||44||
60064592|NCT01954771|76179760|FG000|STARTED|Overall Study||29||
60064593|NCT01954771|76179761|FG001|STARTED|Overall Study||32||
60064594|NCT01954771|76179762|FG002|STARTED|Overall Study||28||
59517619|NCT03335254|75611574|FG017|NOT COMPLETED|Period 2, Day 1-15||0||
59517620|NCT03335254|75611575|FG018|NOT COMPLETED|Period 2, Day 1-15||0||
59517621|NCT03335254|75611576|FG019|NOT COMPLETED|Period 2, Day 1-15||0||
59517622|NCT03335254|75611557|FG000|STARTED|Period 3, Day 16-25||9||
59517623|NCT03335254|75611558|FG001|STARTED|Period 3, Day 16-25||0||
59517624|NCT03335254|75611559|FG002|STARTED|Period 3, Day 16-25||0||
59517625|NCT03335254|75611560|FG003|STARTED|Period 3, Day 16-25||0||
59517626|NCT03335254|75611561|FG004|STARTED|Period 3, Day 16-25||0||
60064595|NCT01954771|76179760|FG000|COMPLETED|Overall Study||22||
60064596|NCT01954771|76179761|FG001|COMPLETED|Overall Study||29||
59517627|NCT03335254|75611562|FG005|STARTED|Period 3, Day 16-25||0||
59517628|NCT03335254|75611563|FG006|STARTED|Period 3, Day 16-25||0||
59517629|NCT03335254|75611564|FG007|STARTED|Period 3, Day 16-25||0||
59613232|NCT01682148|75724374|FG001|STARTED|Overall Study||44||
59613233|NCT01682148|75724373|FG000|COMPLETED|Overall Study||40||
59613234|NCT01682148|75724374|FG001|COMPLETED|Overall Study||41||
59613235|NCT01682148|75724373|FG000|NOT COMPLETED|Overall Study||4||
60064597|NCT01954771|76179762|FG002|COMPLETED|Overall Study||25||
60064598|NCT01954771|76179760|FG000|NOT COMPLETED|Overall Study||7||
60064599|NCT01954771|76179761|FG001|NOT COMPLETED|Overall Study||3||
59613236|NCT01682148|75724374|FG001|NOT COMPLETED|Overall Study||3||
60064600|NCT01954771|76179762|FG002|NOT COMPLETED|Overall Study||3||
60064601|NCT01997281|76179775|FG000|STARTED|Overall Study||7||
60064602|NCT01997281|76179776|FG001|STARTED|Overall Study||7||
60064603|NCT01997281|76179775|FG000|Withdrawal|Overall Study||1||
60064604|NCT01997281|76179776|FG001|Withdrawal|Overall Study||0||
60064605|NCT01997281|76179775|FG000|COMPLETED|Overall Study||6||
60064606|NCT01997281|76179776|FG001|COMPLETED|Overall Study||7||
60064607|NCT01997281|76179775|FG000|NOT COMPLETED|Overall Study||1||
60064608|NCT01997281|76179776|FG001|NOT COMPLETED|Overall Study||0||
60064609|NCT01996033|76179782|FG000|STARTED|Overall Study||25||
60064610|NCT01996033|76179782|FG000|COMPLETED|Overall Study||16||
60064611|NCT01996033|76179782|FG000|NOT COMPLETED|Overall Study||9||
60064612|NCT01953913|76179786|FG000|STARTED|Overall Study||542||
60064613|NCT01953913|76179786|FG000|Treated|Overall Study||541||
60064614|NCT01953913|76179786|FG000|COMPLETED|Overall Study||0|Not discontinued from trial medication|
60064615|NCT01953913|76179786|FG000|NOT COMPLETED|Overall Study||542||
60064616|NCT01971476|76179793|FG000|STARTED|Cohort 1: 2 to <12 Years||3||
60064617|NCT01971476|76179794|FG001|STARTED|Cohort 1: 2 to <12 Years||3||
60064618|NCT01971476|76179795|FG002|STARTED|Cohort 1: 2 to <12 Years||6||
60064619|NCT01971476|76179793|FG000|COMPLETED|Cohort 1: 2 to <12 Years||0||
60064620|NCT01971476|76179794|FG001|COMPLETED|Cohort 1: 2 to <12 Years||0||
60064621|NCT01971476|76179795|FG002|COMPLETED|Cohort 1: 2 to <12 Years||0||
60064622|NCT01971476|76179793|FG000|NOT COMPLETED|Cohort 1: 2 to <12 Years||3||
60064623|NCT01971476|76179794|FG001|NOT COMPLETED|Cohort 1: 2 to <12 Years||3||
60064624|NCT01971476|76179795|FG002|NOT COMPLETED|Cohort 1: 2 to <12 Years||6||
60064625|NCT01971476|76179793|FG000|STARTED|Cohort 2: 12 to <18 Years||6||
60064626|NCT01971476|76179794|FG001|STARTED|Cohort 2: 12 to <18 Years||4||
60064627|NCT01971476|76179795|FG002|STARTED|Cohort 2: 12 to <18 Years||0||
59517630|NCT03335254|75611565|FG008|STARTED|Period 3, Day 16-25||0||
59517631|NCT03335254|75611566|FG009|STARTED|Period 3, Day 16-25||0||
59517632|NCT03335254|75611567|FG010|STARTED|Period 3, Day 16-25||0||
59517633|NCT03335254|75611568|FG011|STARTED|Period 3, Day 16-25||0||
59517634|NCT03335254|75611569|FG012|STARTED|Period 3, Day 16-25||0||
60064628|NCT01971476|76179793|FG000|COMPLETED|Cohort 2: 12 to <18 Years||0||
60064629|NCT01971476|76179794|FG001|COMPLETED|Cohort 2: 12 to <18 Years||0||
60064630|NCT01971476|76179795|FG002|COMPLETED|Cohort 2: 12 to <18 Years||0||
60064631|NCT01971476|76179793|FG000|NOT COMPLETED|Cohort 2: 12 to <18 Years||6||
60064632|NCT01971476|76179794|FG001|NOT COMPLETED|Cohort 2: 12 to <18 Years||4||
60064633|NCT01971476|76179795|FG002|NOT COMPLETED|Cohort 2: 12 to <18 Years||0||
60064634|NCT01996904|76179814|FG000|STARTED|Overall Study||139||
60064635|NCT01996904|76179815|FG001|STARTED|Overall Study||117||
60064636|NCT01996904|76179814|FG000|COMPLETED|Overall Study||101||
60064637|NCT01996904|76179815|FG001|COMPLETED|Overall Study||90||
60064638|NCT01996904|76179814|FG000|NOT COMPLETED|Overall Study||38||
59517635|NCT03335254|75611570|FG013|STARTED|Period 3, Day 16-25||0||
59517636|NCT03335254|75611571|FG014|STARTED|Period 3, Day 16-25||0||
59517637|NCT03335254|75611572|FG015|STARTED|Period 3, Day 16-25||0||
60064639|NCT01996904|76179815|FG001|NOT COMPLETED|Overall Study||27||
60064640|NCT01970540|76179824|FG000|STARTED|Overall Study||73||
60064641|NCT01970540|76179825|FG001|STARTED|Overall Study||28||
60064642|NCT01970540|76179826|FG002|STARTED|Overall Study||19||
60064643|NCT01970540|76179824|FG000|COMPLETED|Overall Study||0||
60064644|NCT01970540|76179825|FG001|COMPLETED|Overall Study||0||
60064645|NCT01970540|76179826|FG002|COMPLETED|Overall Study||0||
59517638|NCT03335254|75611573|FG016|STARTED|Period 3, Day 16-25||0||
59517639|NCT03335254|75611574|FG017|STARTED|Period 3, Day 16-25||0||
59761331|NCT02393248|75881095|FG013|STARTED|Part 1: Monotherapy Dose Escalation||0||
59761332|NCT02393248|75881096|FG014|STARTED|Part 1: Monotherapy Dose Escalation||0||
59761333|NCT02393248|75881097|FG015|STARTED|Part 1: Monotherapy Dose Escalation||0||
59761334|NCT02393248|75881098|FG016|STARTED|Part 1: Monotherapy Dose Escalation||0||
59761335|NCT02393248|75881099|FG017|STARTED|Part 1: Monotherapy Dose Escalation||0||
59761336|NCT02393248|75881100|FG018|STARTED|Part 1: Monotherapy Dose Escalation||0||
59761337|NCT02393248|75881101|FG019|STARTED|Part 1: Monotherapy Dose Escalation||0||
59761338|NCT02393248|75881102|FG020|STARTED|Part 1: Monotherapy Dose Escalation||0||
59761339|NCT02393248|75881103|FG021|STARTED|Part 1: Monotherapy Dose Escalation||0||
59761340|NCT02393248|75881104|FG022|STARTED|Part 1: Monotherapy Dose Escalation||0||
59761341|NCT02393248|75881105|FG023|STARTED|Part 1: Monotherapy Dose Escalation||0||
59761342|NCT02393248|75881106|FG024|STARTED|Part 1: Monotherapy Dose Escalation||0||
59761343|NCT02393248|75881082|FG000|COMPLETED|Part 1: Monotherapy Dose Escalation||0||
59761344|NCT02393248|75881083|FG001|COMPLETED|Part 1: Monotherapy Dose Escalation||0||
59761345|NCT02393248|75881084|FG002|COMPLETED|Part 1: Monotherapy Dose Escalation||0||
59930298|NCT03286751|76048553|FG005|NOT COMPLETED|Washout Period 2||0||
59930299|NCT03286751|76048548|FG000|STARTED|Period 3||7||
59930300|NCT03286751|76048549|FG001|STARTED|Period 3||6||
59930301|NCT03286751|76048550|FG002|STARTED|Period 3||7||
59930302|NCT03286751|76048551|FG003|STARTED|Period 3||7||
59930303|NCT03286751|76048552|FG004|STARTED|Period 3||6||
59930304|NCT03286751|76048553|FG005|STARTED|Period 3||7||
60064646|NCT01970540|76179824|FG000|NOT COMPLETED|Overall Study||73||
60064647|NCT01970540|76179825|FG001|NOT COMPLETED|Overall Study||28||
60064648|NCT01970540|76179826|FG002|NOT COMPLETED|Overall Study||19||
59761346|NCT02393248|75881085|FG003|COMPLETED|Part 1: Monotherapy Dose Escalation||0||
59761347|NCT02393248|75881086|FG004|COMPLETED|Part 1: Monotherapy Dose Escalation||0||
59761348|NCT02393248|75881087|FG005|COMPLETED|Part 1: Monotherapy Dose Escalation||0||
59761349|NCT02393248|75881088|FG006|COMPLETED|Part 1: Monotherapy Dose Escalation||1||
59761350|NCT02393248|75881089|FG007|COMPLETED|Part 1: Monotherapy Dose Escalation||1||
59761351|NCT02393248|75881090|FG008|COMPLETED|Part 1: Monotherapy Dose Escalation||0||
59761352|NCT02393248|75881091|FG009|COMPLETED|Part 1: Monotherapy Dose Escalation||0||
59761353|NCT02393248|75881092|FG010|COMPLETED|Part 1: Monotherapy Dose Escalation||0||
59761354|NCT02393248|75881093|FG011|COMPLETED|Part 1: Monotherapy Dose Escalation||0||
59761355|NCT02393248|75881094|FG012|COMPLETED|Part 1: Monotherapy Dose Escalation||0||
59930305|NCT03286751|76048548|FG000|COMPLETED|Period 3||7||
60064649|NCT01963676|76179847|FG000|STARTED|Overall Study||14||
60064650|NCT01963676|76179848|FG001|STARTED|Overall Study||13||
60064651|NCT01963676|76179847|FG000|COMPLETED|Overall Study||13||
60064652|NCT01963676|76179848|FG001|COMPLETED|Overall Study||13||
60064653|NCT01963676|76179847|FG000|NOT COMPLETED|Overall Study||1||
59761356|NCT02393248|75881095|FG013|COMPLETED|Part 1: Monotherapy Dose Escalation||0||
59761357|NCT02393248|75881096|FG014|COMPLETED|Part 1: Monotherapy Dose Escalation||0||
59761358|NCT02393248|75881097|FG015|COMPLETED|Part 1: Monotherapy Dose Escalation||0||
59762686|NCT00868608|75882542|FG000|STARTED|Overall Study||72||
59930306|NCT03286751|76048549|FG001|COMPLETED|Period 3||6||
59930307|NCT03286751|76048550|FG002|COMPLETED|Period 3||7||
59930308|NCT03286751|76048551|FG003|COMPLETED|Period 3||7||
60064654|NCT01963676|76179848|FG001|NOT COMPLETED|Overall Study||0||
60064655|NCT01996826|76179856|FG000|STARTED|Overall Study||39||
60064656|NCT01996826|76179857|FG001|STARTED|Overall Study||36||
60064657|NCT01996826|76179856|FG000|COMPLETED|Overall Study||32||
60064658|NCT01996826|76179857|FG001|COMPLETED|Overall Study||33||
60064659|NCT01996826|76179856|FG000|NOT COMPLETED|Overall Study||7||
60064660|NCT01996826|76179857|FG001|NOT COMPLETED|Overall Study||3||
59517640|NCT03335254|75611575|FG018|STARTED|Period 3, Day 16-25||0||
59517641|NCT03335254|75611576|FG019|STARTED|Period 3, Day 16-25||0||
59517642|NCT03335254|75611557|FG000|COMPLETED|Period 3, Day 16-25||9||
59930309|NCT03286751|76048552|FG004|COMPLETED|Period 3||6||
59517643|NCT03335254|75611558|FG001|COMPLETED|Period 3, Day 16-25||0||
59930310|NCT03286751|76048553|FG005|COMPLETED|Period 3||7||
59930311|NCT03286751|76048548|FG000|NOT COMPLETED|Period 3||0||
59930312|NCT03286751|76048549|FG001|NOT COMPLETED|Period 3||0||
59930313|NCT03286751|76048550|FG002|NOT COMPLETED|Period 3||0||
59930314|NCT03286751|76048551|FG003|NOT COMPLETED|Period 3||0||
59517644|NCT03335254|75611559|FG002|COMPLETED|Period 3, Day 16-25||0||
59517645|NCT03335254|75611560|FG003|COMPLETED|Period 3, Day 16-25||0||
59761359|NCT02393248|75881098|FG016|COMPLETED|Part 1: Monotherapy Dose Escalation||0||
59761360|NCT02393248|75881099|FG017|COMPLETED|Part 1: Monotherapy Dose Escalation||0||
59761361|NCT02393248|75881100|FG018|COMPLETED|Part 1: Monotherapy Dose Escalation||0||
59930315|NCT03286751|76048552|FG004|NOT COMPLETED|Period 3||0||
59930316|NCT03286751|76048553|FG005|NOT COMPLETED|Period 3||0||
59930317|NCT03286751|76048548|FG000|STARTED|Washout Period 3||7||
59930318|NCT03286751|76048549|FG001|STARTED|Washout Period 3||6||
59930319|NCT03286751|76048550|FG002|STARTED|Washout Period 3||7||
59930320|NCT03286751|76048551|FG003|STARTED|Washout Period 3||7||
60064661|NCT01996748|76179865|FG000|STARTED|Overall Study||66||
60064662|NCT01996748|76179866|FG001|STARTED|Overall Study||69||
60064663|NCT01996748|76179865|FG000|COMPLETED|Overall Study||58||
60064664|NCT01996748|76179866|FG001|COMPLETED|Overall Study||63||
60064665|NCT01996748|76179865|FG000|NOT COMPLETED|Overall Study||8||
59517646|NCT03335254|75611561|FG004|COMPLETED|Period 3, Day 16-25||0||
59517647|NCT03335254|75611562|FG005|COMPLETED|Period 3, Day 16-25||0||
59517648|NCT03335254|75611563|FG006|COMPLETED|Period 3, Day 16-25||0||
59517649|NCT03335254|75611564|FG007|COMPLETED|Period 3, Day 16-25||0||
59517650|NCT03335254|75611565|FG008|COMPLETED|Period 3, Day 16-25||0||
59517651|NCT03335254|75611566|FG009|COMPLETED|Period 3, Day 16-25||0||
59761362|NCT02393248|75881101|FG019|COMPLETED|Part 1: Monotherapy Dose Escalation||0||
59761363|NCT02393248|75881102|FG020|COMPLETED|Part 1: Monotherapy Dose Escalation||0||
59761364|NCT02393248|75881103|FG021|COMPLETED|Part 1: Monotherapy Dose Escalation||0||
59761365|NCT02393248|75881104|FG022|COMPLETED|Part 1: Monotherapy Dose Escalation||0||
59761366|NCT02393248|75881105|FG023|COMPLETED|Part 1: Monotherapy Dose Escalation||0||
59761367|NCT02393248|75881106|FG024|COMPLETED|Part 1: Monotherapy Dose Escalation||0||
59930321|NCT03286751|76048552|FG004|STARTED|Washout Period 3||6||
59930322|NCT03286751|76048553|FG005|STARTED|Washout Period 3||7||
59930323|NCT03286751|76048548|FG000|COMPLETED|Washout Period 3||7||
59930324|NCT03286751|76048549|FG001|COMPLETED|Washout Period 3||6||
59930325|NCT03286751|76048550|FG002|COMPLETED|Washout Period 3||7||
59930326|NCT03286751|76048551|FG003|COMPLETED|Washout Period 3||7||
59930327|NCT03286751|76048552|FG004|COMPLETED|Washout Period 3||6||
59930328|NCT03286751|76048553|FG005|COMPLETED|Washout Period 3||7||
59930329|NCT03286751|76048548|FG000|NOT COMPLETED|Washout Period 3||0||
59930330|NCT03286751|76048549|FG001|NOT COMPLETED|Washout Period 3||0||
59930331|NCT03286751|76048550|FG002|NOT COMPLETED|Washout Period 3||0||
59930332|NCT03286751|76048551|FG003|NOT COMPLETED|Washout Period 3||0||
59761368|NCT02393248|75881082|FG000|NOT COMPLETED|Part 1: Monotherapy Dose Escalation||3||
59930333|NCT03286751|76048552|FG004|NOT COMPLETED|Washout Period 3||0||
59930334|NCT03286751|76048553|FG005|NOT COMPLETED|Washout Period 3||0||
59930335|NCT03286751|76048548|FG000|STARTED|Period 4||7||
59930336|NCT03286751|76048549|FG001|STARTED|Period 4||6||
59930337|NCT03286751|76048550|FG002|STARTED|Period 4||7||
59930338|NCT03286751|76048551|FG003|STARTED|Period 4||7||
59930339|NCT03286751|76048552|FG004|STARTED|Period 4||6||
59930340|NCT03286751|76048553|FG005|STARTED|Period 4||7||
59930341|NCT03286751|76048548|FG000|COMPLETED|Period 4||7||
59930342|NCT03286751|76048549|FG001|COMPLETED|Period 4||6||
59930343|NCT03286751|76048550|FG002|COMPLETED|Period 4||7||
60064666|NCT01996748|76179866|FG001|NOT COMPLETED|Overall Study||6||
60064667|NCT01621178|76179877|FG000|STARTED|Overall Study||194||
60064668|NCT01621178|76179878|FG001|STARTED|Overall Study||190||
60064669|NCT01621178|76179879|FG002|STARTED|Overall Study||193||
60064670|NCT01621178|76179877|FG000|Received at Least One Dose of Study Drug|Overall Study||194||
59930344|NCT03286751|76048551|FG003|COMPLETED|Period 4||7||
60064671|NCT01621178|76179878|FG001|Received at Least One Dose of Study Drug|Overall Study||190||
60064672|NCT01621178|76179879|FG002|Received at Least One Dose of Study Drug|Overall Study||192||
59930345|NCT03286751|76048552|FG004|COMPLETED|Period 4||6||
59930346|NCT03286751|76048553|FG005|COMPLETED|Period 4||7||
59930347|NCT03286751|76048548|FG000|NOT COMPLETED|Period 4||0||
59930348|NCT03286751|76048549|FG001|NOT COMPLETED|Period 4||0||
59930349|NCT03286751|76048550|FG002|NOT COMPLETED|Period 4||0||
59930350|NCT03286751|76048551|FG003|NOT COMPLETED|Period 4||0||
59930351|NCT03286751|76048552|FG004|NOT COMPLETED|Period 4||0||
59517652|NCT03335254|75611567|FG010|COMPLETED|Period 3, Day 16-25||0||
59517653|NCT03335254|75611568|FG011|COMPLETED|Period 3, Day 16-25||0||
59517654|NCT03335254|75611569|FG012|COMPLETED|Period 3, Day 16-25||0||
59930352|NCT03286751|76048553|FG005|NOT COMPLETED|Period 4||0||
59930353|NCT03286751|76048548|FG000|STARTED|Washout Period 4||7||
59930354|NCT03286751|76048549|FG001|STARTED|Washout Period 4||6||
59930355|NCT03286751|76048550|FG002|STARTED|Washout Period 4||7||
59517655|NCT03335254|75611570|FG013|COMPLETED|Period 3, Day 16-25||0||
59517656|NCT03335254|75611571|FG014|COMPLETED|Period 3, Day 16-25||0||
59517657|NCT03335254|75611572|FG015|COMPLETED|Period 3, Day 16-25||0||
59517658|NCT03335254|75611573|FG016|COMPLETED|Period 3, Day 16-25||0||
59517659|NCT03335254|75611574|FG017|COMPLETED|Period 3, Day 16-25||0||
59517660|NCT03335254|75611575|FG018|COMPLETED|Period 3, Day 16-25||0||
59517661|NCT03335254|75611576|FG019|COMPLETED|Period 3, Day 16-25||0||
59517662|NCT03335254|75611557|FG000|NOT COMPLETED|Period 3, Day 16-25||0||
59517663|NCT03335254|75611558|FG001|NOT COMPLETED|Period 3, Day 16-25||0||
59517664|NCT03335254|75611559|FG002|NOT COMPLETED|Period 3, Day 16-25||0||
59517665|NCT03335254|75611560|FG003|NOT COMPLETED|Period 3, Day 16-25||0||
59517666|NCT03335254|75611561|FG004|NOT COMPLETED|Period 3, Day 16-25||0||
59517667|NCT03335254|75611562|FG005|NOT COMPLETED|Period 3, Day 16-25||0||
59517668|NCT03335254|75611563|FG006|NOT COMPLETED|Period 3, Day 16-25||0||
59517669|NCT03335254|75611564|FG007|NOT COMPLETED|Period 3, Day 16-25||0||
59517670|NCT03335254|75611565|FG008|NOT COMPLETED|Period 3, Day 16-25||0||
59517671|NCT03335254|75611566|FG009|NOT COMPLETED|Period 3, Day 16-25||0||
59517672|NCT03335254|75611567|FG010|NOT COMPLETED|Period 3, Day 16-25||0||
59517673|NCT03335254|75611568|FG011|NOT COMPLETED|Period 3, Day 16-25||0||
59517674|NCT03335254|75611569|FG012|NOT COMPLETED|Period 3, Day 16-25||0||
59517675|NCT03335254|75611570|FG013|NOT COMPLETED|Period 3, Day 16-25||0||
59517676|NCT03335254|75611571|FG014|NOT COMPLETED|Period 3, Day 16-25||0||
59517677|NCT03335254|75611572|FG015|NOT COMPLETED|Period 3, Day 16-25||0||
59517678|NCT03335254|75611573|FG016|NOT COMPLETED|Period 3, Day 16-25||0||
59930356|NCT03286751|76048551|FG003|STARTED|Washout Period 4||7||
59930357|NCT03286751|76048552|FG004|STARTED|Washout Period 4||6||
59761369|NCT02393248|75881083|FG001|NOT COMPLETED|Part 1: Monotherapy Dose Escalation||4||
59761370|NCT02393248|75881084|FG002|NOT COMPLETED|Part 1: Monotherapy Dose Escalation||3||
59761371|NCT02393248|75881085|FG003|NOT COMPLETED|Part 1: Monotherapy Dose Escalation||6||
59930358|NCT03286751|76048553|FG005|STARTED|Washout Period 4||7||
59930359|NCT03286751|76048548|FG000|COMPLETED|Washout Period 4||7||
59930360|NCT03286751|76048549|FG001|COMPLETED|Washout Period 4||6||
59930361|NCT03286751|76048550|FG002|COMPLETED|Washout Period 4||7||
60064673|NCT01621178|76179877|FG000|Modified Intent to Treat Population|Overall Study||186||
59517679|NCT03335254|75611574|FG017|NOT COMPLETED|Period 3, Day 16-25||0||
59517680|NCT03335254|75611575|FG018|NOT COMPLETED|Period 3, Day 16-25||0||
59517681|NCT03335254|75611576|FG019|NOT COMPLETED|Period 3, Day 16-25||0||
59517682|NCT03335254|75611557|FG000|STARTED|Period 3, Day 26-30||9||
59517683|NCT03335254|75611558|FG001|STARTED|Period 3, Day 26-30||0||
59517684|NCT03335254|75611559|FG002|STARTED|Period 3, Day 26-30||0||
59517685|NCT03335254|75611560|FG003|STARTED|Period 3, Day 26-30||0||
59517686|NCT03335254|75611561|FG004|STARTED|Period 3, Day 26-30||0||
59517687|NCT03335254|75611562|FG005|STARTED|Period 3, Day 26-30||0||
59517688|NCT03335254|75611563|FG006|STARTED|Period 3, Day 26-30||0||
59517689|NCT03335254|75611564|FG007|STARTED|Period 3, Day 26-30||0||
59517690|NCT03335254|75611565|FG008|STARTED|Period 3, Day 26-30||0||
59517691|NCT03335254|75611566|FG009|STARTED|Period 3, Day 26-30||0||
59517692|NCT03335254|75611567|FG010|STARTED|Period 3, Day 26-30||0||
59517693|NCT03335254|75611568|FG011|STARTED|Period 3, Day 26-30||0||
59517694|NCT03335254|75611569|FG012|STARTED|Period 3, Day 26-30||0||
59517695|NCT03335254|75611570|FG013|STARTED|Period 3, Day 26-30||0||
59517696|NCT03335254|75611571|FG014|STARTED|Period 3, Day 26-30||0||
59517697|NCT03335254|75611572|FG015|STARTED|Period 3, Day 26-30||0||
59517698|NCT03335254|75611573|FG016|STARTED|Period 3, Day 26-30||0||
59517699|NCT03335254|75611574|FG017|STARTED|Period 3, Day 26-30||0||
59761372|NCT02393248|75881086|FG004|NOT COMPLETED|Part 1: Monotherapy Dose Escalation||6||
59761373|NCT02393248|75881087|FG005|NOT COMPLETED|Part 1: Monotherapy Dose Escalation||9||
59761374|NCT02393248|75881088|FG006|NOT COMPLETED|Part 1: Monotherapy Dose Escalation||9||
59761375|NCT02393248|75881089|FG007|NOT COMPLETED|Part 1: Monotherapy Dose Escalation||8||
59930362|NCT03286751|76048551|FG003|COMPLETED|Washout Period 4||7||
59930363|NCT03286751|76048552|FG004|COMPLETED|Washout Period 4||6||
59930364|NCT03286751|76048553|FG005|COMPLETED|Washout Period 4||7||
59930365|NCT03286751|76048548|FG000|NOT COMPLETED|Washout Period 4||0||
59930366|NCT03286751|76048549|FG001|NOT COMPLETED|Washout Period 4||0||
59930367|NCT03286751|76048550|FG002|NOT COMPLETED|Washout Period 4||0||
60064674|NCT01621178|76179878|FG001|Modified Intent to Treat Population|Overall Study||180||
59517700|NCT03335254|75611575|FG018|STARTED|Period 3, Day 26-30||0||
59517701|NCT03335254|75611576|FG019|STARTED|Period 3, Day 26-30||0||
59517702|NCT03335254|75611557|FG000|COMPLETED|Period 3, Day 26-30||9||
59517703|NCT03335254|75611558|FG001|COMPLETED|Period 3, Day 26-30||0||
59517704|NCT03335254|75611559|FG002|COMPLETED|Period 3, Day 26-30||0||
59517705|NCT03335254|75611560|FG003|COMPLETED|Period 3, Day 26-30||0||
59517706|NCT03335254|75611561|FG004|COMPLETED|Period 3, Day 26-30||0||
59930368|NCT03286751|76048551|FG003|NOT COMPLETED|Washout Period 4||0||
59930369|NCT03286751|76048552|FG004|NOT COMPLETED|Washout Period 4||0||
59930370|NCT03286751|76048553|FG005|NOT COMPLETED|Washout Period 4||0||
59930371|NCT03286751|76048548|FG000|STARTED|Period 5||7||
59930372|NCT03286751|76048549|FG001|STARTED|Period 5||6||
59930373|NCT03286751|76048550|FG002|STARTED|Period 5||7||
59930374|NCT03286751|76048551|FG003|STARTED|Period 5||7||
60064675|NCT01621178|76179879|FG002|Modified Intent to Treat Population|Overall Study||183||
60064676|NCT01621178|76179877|FG000|COMPLETED|Overall Study||163||
60064677|NCT01621178|76179878|FG001|COMPLETED|Overall Study||160||
60064678|NCT01621178|76179879|FG002|COMPLETED|Overall Study||157||
60064679|NCT01621178|76179877|FG000|NOT COMPLETED|Overall Study||31||
60064680|NCT01621178|76179878|FG001|NOT COMPLETED|Overall Study||30||
60064681|NCT01621178|76179879|FG002|NOT COMPLETED|Overall Study||36||
60064682|NCT01962974|76179891|FG000|STARTED|Overall Study||7||
60064683|NCT01962974|76179891|FG000|COMPLETED|Overall Study||0||
60064684|NCT01962974|76179891|FG000|NOT COMPLETED|Overall Study||7||
60064685|NCT01996592|76179895|FG000|STARTED|Overall Study||575||
60064686|NCT01996592|76179895|FG000|COMPLETED|Overall Study||530||
60064687|NCT01996592|76179895|FG000|NOT COMPLETED|Overall Study||45||
60064688|NCT01962896|76179904|FG000|STARTED|Overall Study||4||
60064689|NCT01962896|76179904|FG000|COMPLETED|Overall Study||0||
60064690|NCT01962896|76179904|FG000|NOT COMPLETED|Overall Study||4||
60064691|NCT01970462|76179911|FG000|STARTED|Overall Study||1||
60064692|NCT01970462|76179912|FG001|STARTED|Overall Study||4||
60064693|NCT01970462|76179911|FG000|COMPLETED|Overall Study||1||
60064694|NCT01970462|76179912|FG001|COMPLETED|Overall Study||2||
60064695|NCT01970462|76179911|FG000|NOT COMPLETED|Overall Study||0||
60064696|NCT01970462|76179912|FG001|NOT COMPLETED|Overall Study||2||
60064697|NCT01958671|76179921|FG000|STARTED|Overall Study||156||
60064698|NCT01958671|76179922|FG001|STARTED|Overall Study||152||
60064699|NCT01958671|76179923|FG002|STARTED|Overall Study||153||
60064700|NCT01958671|76179921|FG000|COMPLETED|Overall Study||137||
60064701|NCT01958671|76179922|FG001|COMPLETED|Overall Study||128||
59930375|NCT03286751|76048552|FG004|STARTED|Period 5||6||
60064702|NCT01958671|76179923|FG002|COMPLETED|Overall Study||121||
60064703|NCT01958671|76179921|FG000|NOT COMPLETED|Overall Study||19||
60064704|NCT01958671|76179922|FG001|NOT COMPLETED|Overall Study||24||
60064705|NCT01958671|76179923|FG002|NOT COMPLETED|Overall Study||32||
60064706|NCT01995266|76179935|FG000|STARTED|Overall Study||159||
60064707|NCT01995266|76179935|FG000|COMPLETED|Overall Study||150||
60064708|NCT01995266|76179935|FG000|NOT COMPLETED|Overall Study||9||
60064709|NCT01969058|76179941|FG000|STARTED|Overall Study||50||
60064710|NCT01969058|76179942|FG001|STARTED|Overall Study||26||
60064711|NCT01969058|76179941|FG000|COMPLETED|Overall Study||47||
60064712|NCT01969058|76179942|FG001|COMPLETED|Overall Study||26||
60064713|NCT01969058|76179941|FG000|NOT COMPLETED|Overall Study||3||
60064714|NCT01969058|76179942|FG001|NOT COMPLETED|Overall Study||0||
60064715|NCT01968980|76179950|FG000|STARTED|Overall Study||185||
60064716|NCT01968980|76179951|FG001|STARTED|Overall Study||185||
59930376|NCT03286751|76048553|FG005|STARTED|Period 5||7||
59930377|NCT03286751|76048548|FG000|COMPLETED|Period 5||7||
59930378|NCT03286751|76048549|FG001|COMPLETED|Period 5||6||
59930379|NCT03286751|76048550|FG002|COMPLETED|Period 5||7||
60064717|NCT01968980|76179950|FG000|COMPLETED|Overall Study||169||
60064718|NCT01968980|76179951|FG001|COMPLETED|Overall Study||171||
60064719|NCT01968980|76179950|FG000|NOT COMPLETED|Overall Study||16||
60064720|NCT01968980|76179951|FG001|NOT COMPLETED|Overall Study||14||
60064721|NCT01961882|76179960|FG000|STARTED|Overall Study||69||
60064722|NCT01961882|76179961|FG001|STARTED|Overall Study||65||
60064723|NCT01961882|76179960|FG000|COMPLETED|Overall Study||19||
60064724|NCT01961882|76179961|FG001|COMPLETED|Overall Study||23||
60064725|NCT01961882|76179960|FG000|NOT COMPLETED|Overall Study||50||
60064726|NCT01961882|76179961|FG001|NOT COMPLETED|Overall Study||42||
59930380|NCT03286751|76048551|FG003|COMPLETED|Period 5||7||
59930381|NCT03286751|76048552|FG004|COMPLETED|Period 5||6||
59930382|NCT03286751|76048553|FG005|COMPLETED|Period 5||7||
59930383|NCT03286751|76048548|FG000|NOT COMPLETED|Period 5||0||
59930384|NCT03286751|76048549|FG001|NOT COMPLETED|Period 5||0||
60064727|NCT01968434|76179969|FG000|STARTED|Overall Study||78||
60064728|NCT01968434|76179970|FG001|STARTED|Overall Study||72||
60064729|NCT01968434|76179969|FG000|COMPLETED|Overall Study||75||
60064730|NCT01968434|76179970|FG001|COMPLETED|Overall Study||66||
60064731|NCT01968434|76179969|FG000|NOT COMPLETED|Overall Study||3||
59517707|NCT03335254|75611562|FG005|COMPLETED|Period 3, Day 26-30||0||
59517708|NCT03335254|75611563|FG006|COMPLETED|Period 3, Day 26-30||0||
59517709|NCT03335254|75611564|FG007|COMPLETED|Period 3, Day 26-30||0||
59517710|NCT03335254|75611565|FG008|COMPLETED|Period 3, Day 26-30||0||
59517711|NCT03335254|75611566|FG009|COMPLETED|Period 3, Day 26-30||0||
59517712|NCT03335254|75611567|FG010|COMPLETED|Period 3, Day 26-30||0||
59517713|NCT03335254|75611568|FG011|COMPLETED|Period 3, Day 26-30||0||
59517714|NCT03335254|75611569|FG012|COMPLETED|Period 3, Day 26-30||0||
59930385|NCT03286751|76048550|FG002|NOT COMPLETED|Period 5||0||
60064732|NCT01968434|76179970|FG001|NOT COMPLETED|Overall Study||6||
60064733|NCT01946438|76179980|FG000|STARTED|Overall Study||52||
60064734|NCT01946438|76179981|FG001|STARTED|Overall Study||52||
60064735|NCT01946438|76179982|FG002|STARTED|Overall Study||52||
59517715|NCT03335254|75611570|FG013|COMPLETED|Period 3, Day 26-30||0||
59517716|NCT03335254|75611571|FG014|COMPLETED|Period 3, Day 26-30||0||
59517717|NCT03335254|75611572|FG015|COMPLETED|Period 3, Day 26-30||0||
59930386|NCT03286751|76048551|FG003|NOT COMPLETED|Period 5||0||
59930387|NCT03286751|76048552|FG004|NOT COMPLETED|Period 5||0||
59930388|NCT03286751|76048553|FG005|NOT COMPLETED|Period 5||0||
59517718|NCT03335254|75611573|FG016|COMPLETED|Period 3, Day 26-30||0||
59517719|NCT03335254|75611574|FG017|COMPLETED|Period 3, Day 26-30||0||
59761376|NCT02393248|75881090|FG008|NOT COMPLETED|Part 1: Monotherapy Dose Escalation||4||
59761377|NCT02393248|75881091|FG009|NOT COMPLETED|Part 1: Monotherapy Dose Escalation||3||
59761378|NCT02393248|75881092|FG010|NOT COMPLETED|Part 1: Monotherapy Dose Escalation||0||
59761379|NCT02393248|75881093|FG011|NOT COMPLETED|Part 1: Monotherapy Dose Escalation||0||
59761380|NCT02393248|75881094|FG012|NOT COMPLETED|Part 1: Monotherapy Dose Escalation||0||
59761381|NCT02393248|75881095|FG013|NOT COMPLETED|Part 1: Monotherapy Dose Escalation||0||
59930389|NCT03286751|76048548|FG000|STARTED|Washout Period 5||7||
59930390|NCT03286751|76048549|FG001|STARTED|Washout Period 5||6||
59930391|NCT03286751|76048550|FG002|STARTED|Washout Period 5||7||
59930392|NCT03286751|76048551|FG003|STARTED|Washout Period 5||7||
59930393|NCT03286751|76048552|FG004|STARTED|Washout Period 5||6||
59930394|NCT03286751|76048553|FG005|STARTED|Washout Period 5||7||
59930395|NCT03286751|76048548|FG000|COMPLETED|Washout Period 5||7||
59930396|NCT03286751|76048549|FG001|COMPLETED|Washout Period 5||6||
59930397|NCT03286751|76048550|FG002|COMPLETED|Washout Period 5||7||
59930398|NCT03286751|76048551|FG003|COMPLETED|Washout Period 5||7||
59930399|NCT03286751|76048552|FG004|COMPLETED|Washout Period 5||5||
59930400|NCT03286751|76048553|FG005|COMPLETED|Washout Period 5||7||
59930401|NCT03286751|76048548|FG000|NOT COMPLETED|Washout Period 5||0||
59930402|NCT03286751|76048549|FG001|NOT COMPLETED|Washout Period 5||0||
59930403|NCT03286751|76048550|FG002|NOT COMPLETED|Washout Period 5||0||
59930404|NCT03286751|76048551|FG003|NOT COMPLETED|Washout Period 5||0||
59930405|NCT03286751|76048552|FG004|NOT COMPLETED|Washout Period 5||1||
59930406|NCT03286751|76048553|FG005|NOT COMPLETED|Washout Period 5||0||
59930407|NCT03286751|76048548|FG000|STARTED|Period 6||7||
59930408|NCT03286751|76048549|FG001|STARTED|Period 6||6||
59930409|NCT03286751|76048550|FG002|STARTED|Period 6||7||
59930410|NCT03286751|76048551|FG003|STARTED|Period 6||7||
59930411|NCT03286751|76048552|FG004|STARTED|Period 6||5||
59930412|NCT03286751|76048553|FG005|STARTED|Period 6||7||
59930413|NCT03286751|76048548|FG000|COMPLETED|Period 6||7||
59930414|NCT03286751|76048549|FG001|COMPLETED|Period 6||6||
59930415|NCT03286751|76048550|FG002|COMPLETED|Period 6||7||
59930416|NCT03286751|76048551|FG003|COMPLETED|Period 6||7||
59930417|NCT03286751|76048552|FG004|COMPLETED|Period 6||5||
59930418|NCT03286751|76048553|FG005|COMPLETED|Period 6||7||
59930419|NCT03286751|76048548|FG000|NOT COMPLETED|Period 6||0||
59930420|NCT03286751|76048549|FG001|NOT COMPLETED|Period 6||0||
59517720|NCT03335254|75611575|FG018|COMPLETED|Period 3, Day 26-30||0||
59517721|NCT03335254|75611576|FG019|COMPLETED|Period 3, Day 26-30||0||
59930421|NCT03286751|76048550|FG002|NOT COMPLETED|Period 6||0||
59761382|NCT02393248|75881096|FG014|NOT COMPLETED|Part 1: Monotherapy Dose Escalation||0||
59761383|NCT02393248|75881097|FG015|NOT COMPLETED|Part 1: Monotherapy Dose Escalation||0||
59930422|NCT03286751|76048551|FG003|NOT COMPLETED|Period 6||0||
59930423|NCT03286751|76048552|FG004|NOT COMPLETED|Period 6||0||
60064736|NCT01946438|76179983|FG003|STARTED|Overall Study||52||
60064737|NCT01946438|76179980|FG000|COMPLETED|Overall Study||50||
60064738|NCT01946438|76179981|FG001|COMPLETED|Overall Study||52||
59930424|NCT03286751|76048553|FG005|NOT COMPLETED|Period 6||0||
59930425|NCT03249935|76048567|FG000|STARTED|Overall Study||100||
59930426|NCT03249935|76048567|FG000|COMPLETED|Overall Study||55||
59930427|NCT03249935|76048567|FG000|NOT COMPLETED|Overall Study||45||
59930428|NCT03285113|76048573|FG000|STARTED|Overall Study||10||
59930429|NCT03285113|76048573|FG000|COMPLETED|Overall Study||8||
59930430|NCT03285113|76048573|FG000|NOT COMPLETED|Overall Study||2||
59930431|NCT03000348|76048583|FG000|STARTED|Overall Study||17||
59930432|NCT03000348|76048584|FG001|STARTED|Overall Study||11||
59930433|NCT03000348|76048585|FG002|STARTED|Overall Study||15||
59930434|NCT03000348|76048586|FG003|STARTED|Overall Study||15||
59930435|NCT03000348|76048587|FG004|STARTED|Overall Study||16||
59930436|NCT03000348|76048588|FG005|STARTED|Overall Study||15||
59930437|NCT03000348|76048583|FG000|Day 14 Treatment Period|Overall Study||17||
59930438|NCT03000348|76048584|FG001|Day 14 Treatment Period|Overall Study||10||
59930439|NCT03000348|76048585|FG002|Day 14 Treatment Period|Overall Study||13||
59930440|NCT03000348|76048586|FG003|Day 14 Treatment Period|Overall Study||14||
59930441|NCT03000348|76048587|FG004|Day 14 Treatment Period|Overall Study||13||
59930442|NCT03000348|76048588|FG005|Day 14 Treatment Period|Overall Study||14||
59930443|NCT03000348|76048583|FG000|COMPLETED|Overall Study||14||
59930444|NCT03000348|76048584|FG001|COMPLETED|Overall Study||7||
59930445|NCT03000348|76048585|FG002|COMPLETED|Overall Study||11||
59930446|NCT03000348|76048586|FG003|COMPLETED|Overall Study||12||
59930447|NCT03000348|76048587|FG004|COMPLETED|Overall Study||11||
59930448|NCT03000348|76048588|FG005|COMPLETED|Overall Study||13||
59930449|NCT03000348|76048583|FG000|NOT COMPLETED|Overall Study||3||
59930450|NCT03000348|76048584|FG001|NOT COMPLETED|Overall Study||4||
59930451|NCT03000348|76048585|FG002|NOT COMPLETED|Overall Study||4||
59930452|NCT03000348|76048586|FG003|NOT COMPLETED|Overall Study||3||
59930453|NCT03000348|76048587|FG004|NOT COMPLETED|Overall Study||5||
59930454|NCT03000348|76048588|FG005|NOT COMPLETED|Overall Study||2||
59930455|NCT03283709|76048607|FG000|STARTED|Overall Study||0||
59930456|NCT03283709|76048608|FG001|STARTED|Overall Study||1||
59930457|NCT03283709|76048607|FG000|COMPLETED|Overall Study||0||
59930458|NCT03283709|76048608|FG001|COMPLETED|Overall Study||0||
59930459|NCT03283709|76048607|FG000|NOT COMPLETED|Overall Study||0||
59930460|NCT03283709|76048608|FG001|NOT COMPLETED|Overall Study||1||
59930461|NCT03247673|76048617|FG000|STARTED|Overall Study||46||
59930462|NCT03247673|76048618|FG001|STARTED|Overall Study||47||
59930463|NCT03247673|76048619|FG002|STARTED|Overall Study||48||
59930464|NCT03247673|76048617|FG000|COMPLETED|Overall Study||45||
59930465|NCT03247673|76048618|FG001|COMPLETED|Overall Study||47||
59930466|NCT03247673|76048619|FG002|COMPLETED|Overall Study||44||
59930467|NCT03247673|76048617|FG000|NOT COMPLETED|Overall Study||1||
59930468|NCT03247673|76048618|FG001|NOT COMPLETED|Overall Study||0||
59930469|NCT03247673|76048619|FG002|NOT COMPLETED|Overall Study||4||
59930470|NCT03247517|76048630|FG000|STARTED|Overall Study||104|The number of subjects reported here is based on the Safety Population (assigned treatment arm); includes subjects who were randomized and took at least one dose of study medication.|
59930471|NCT03247517|76048631|FG001|STARTED|Overall Study||98|The number of subjects reported here is based on the Safety Population (assigned treatment arm); includes subjects who were randomized and took at least one dose of study medication.|
59930472|NCT03247517|76048632|FG002|STARTED|Overall Study|One subject randomized to the 400mg/day SPN-812 arm received 200mg/day SPN-812 during the trial|106|The number of subjects reported here is based on the Safety Population (assigned treatment arm); includes subjects who were randomized and took at least one dose of study medication.|
59930473|NCT03247517|76048630|FG000|COMPLETED|Overall Study||96||
59930474|NCT03247517|76048631|FG001|COMPLETED|Overall Study||78||
60064739|NCT01946438|76179982|FG002|COMPLETED|Overall Study||51||
59517722|NCT03335254|75611557|FG000|NOT COMPLETED|Period 3, Day 26-30||0||
60064740|NCT01946438|76179983|FG003|COMPLETED|Overall Study||51||
60064741|NCT01946438|76179980|FG000|NOT COMPLETED|Overall Study||2||
60064742|NCT01946438|76179981|FG001|NOT COMPLETED|Overall Study||0||
60064743|NCT01946438|76179982|FG002|NOT COMPLETED|Overall Study||1||
60064744|NCT01946438|76179983|FG003|NOT COMPLETED|Overall Study||1||
60064745|NCT01946282|76180002|FG000|STARTED|Year 1||6565||
60064746|NCT01946282|76180003|FG001|STARTED|Year 1||1000||
60064747|NCT01946282|76180004|FG002|STARTED|Year 1||1000||
60064748|NCT01946282|76180002|FG000|COMPLETED|Year 1||2379|Number of returned FIT kits|
60064749|NCT01946282|76180003|FG001|COMPLETED|Year 1||392|Number of returned FIT kits|
60064750|NCT01946282|76180004|FG002|COMPLETED|Year 1||346|Number of returned FIT kits|
60064751|NCT01946282|76180002|FG000|NOT COMPLETED|Year 1||4186||
60064752|NCT01946282|76180003|FG001|NOT COMPLETED|Year 1||608||
60064753|NCT01946282|76180004|FG002|NOT COMPLETED|Year 1||654||
60064754|NCT01946282|76180002|FG000|STARTED|Year 2|Patients are those with Year 1 negative FIT results, or no longer met inclusion criteria.|2051||
60064755|NCT01946282|76180003|FG001|STARTED|Year 2|Patients are those with Year 1 negative FIT results, or no longer met inclusion criteria.|341||
60064756|NCT01946282|76180004|FG002|STARTED|Year 2|Patients are those with Year 1 negative FIT results, or no longer met inclusion criteria.|299||
60064757|NCT01946282|76180002|FG000|COMPLETED|Year 2||1248||
60064758|NCT01946282|76180003|FG001|COMPLETED|Year 2||210||
60064759|NCT01946282|76180004|FG002|COMPLETED|Year 2||184||
60064760|NCT01946282|76180002|FG000|NOT COMPLETED|Year 2||803||
60064761|NCT01946282|76180003|FG001|NOT COMPLETED|Year 2||131||
60064762|NCT01946282|76180004|FG002|NOT COMPLETED|Year 2||115||
60064763|NCT01946282|76180002|FG000|STARTED|Year 3|Patients are those with Year 2 negative FIT results, or no longer met inclusion criteria.|1144||
60064764|NCT01946282|76180003|FG001|STARTED|Year 3|Patients are those with Year 2 negative FIT results, or no longer met inclusion criteria.|184||
60064765|NCT01946282|76180004|FG002|STARTED|Year 3|Patients are those with Year 2 negative FIT results, or no longer met inclusion criteria.|170||
60064766|NCT01946282|76180002|FG000|COMPLETED|Year 3||856||
60064767|NCT01946282|76180003|FG001|COMPLETED|Year 3||141||
60064768|NCT01946282|76180004|FG002|COMPLETED|Year 3||140||
60064769|NCT01946282|76180002|FG000|NOT COMPLETED|Year 3||288||
60064770|NCT01946282|76180003|FG001|NOT COMPLETED|Year 3||43||
60064771|NCT01946282|76180004|FG002|NOT COMPLETED|Year 3||30||
60064772|NCT01945580|76180016|FG000|STARTED|Overall Study||228||
60064773|NCT01945580|76180017|FG001|STARTED|Overall Study||485||
60064774|NCT01945580|76180016|FG000|COMPLETED|Overall Study||176||
60064775|NCT01945580|76180017|FG001|COMPLETED|Overall Study||401||
60064776|NCT01945580|76180016|FG000|NOT COMPLETED|Overall Study||52||
60064777|NCT01945580|76180017|FG001|NOT COMPLETED|Overall Study||84||
60064778|NCT01945034|76180030|FG000|STARTED|Overall Study||67||
60064779|NCT01945034|76180031|FG001|STARTED|Overall Study||85||
60064780|NCT01945034|76180032|FG002|STARTED|Overall Study||152||
60064781|NCT01945034|76180030|FG000|COMPLETED|Overall Study||66||
60064782|NCT01945034|76180031|FG001|COMPLETED|Overall Study||80||
60064783|NCT01945034|76180032|FG002|COMPLETED|Overall Study||145||
60064784|NCT01945034|76180030|FG000|NOT COMPLETED|Overall Study||1||
60064785|NCT01945034|76180031|FG001|NOT COMPLETED|Overall Study||5||
60064786|NCT01945034|76180032|FG002|NOT COMPLETED|Overall Study||7||
60064787|NCT01960790|76180040|FG000|STARTED|Overall Study||473||
60064788|NCT01960790|76180040|FG000|COMPLETED|Overall Study||462||
60064789|NCT01960790|76180040|FG000|NOT COMPLETED|Overall Study||11||
60064790|NCT01618214|76180046|FG000|STARTED|Overall Study||172||
60064791|NCT01618214|76180047|FG001|STARTED|Overall Study||172||
60064792|NCT01618214|76180046|FG000|Exposed|Overall Study||172||
60064793|NCT01618214|76180047|FG001|Exposed|Overall Study||172||
60064794|NCT01618214|76180046|FG000|COMPLETED|Overall Study||162||
60064795|NCT01618214|76180047|FG001|COMPLETED|Overall Study||159||
60064796|NCT01618214|76180046|FG000|NOT COMPLETED|Overall Study||10||
60064797|NCT01618214|76180047|FG001|NOT COMPLETED|Overall Study||13||
60064798|NCT01917968|76180055|FG000|STARTED|Overall Study||225||
60064799|NCT01917968|76180056|FG001|STARTED|Overall Study||485||
60064800|NCT01917968|76180055|FG000|COMPLETED|Overall Study||171||
60064801|NCT01917968|76180056|FG001|COMPLETED|Overall Study||401||
59517723|NCT03335254|75611558|FG001|NOT COMPLETED|Period 3, Day 26-30||0||
59517724|NCT03335254|75611559|FG002|NOT COMPLETED|Period 3, Day 26-30||0||
59517725|NCT03335254|75611560|FG003|NOT COMPLETED|Period 3, Day 26-30||0||
59930475|NCT03247517|76048632|FG002|COMPLETED|Overall Study||92||
59930476|NCT03247517|76048630|FG000|NOT COMPLETED|Overall Study||8||
59930477|NCT03247517|76048631|FG001|NOT COMPLETED|Overall Study||20||
59930478|NCT03247517|76048632|FG002|NOT COMPLETED|Overall Study||14||
59930479|NCT03283553|76048642|FG000|STARTED|Patient Participant Flow||69||
59930480|NCT03283553|76048643|FG001|STARTED|Patient Participant Flow||63||
59930481|NCT03283553|76048642|FG000|Patient Baseline Interview|Patient Participant Flow||69||
59930482|NCT03283553|76048643|FG001|Patient Baseline Interview|Patient Participant Flow||62||
59930483|NCT03283553|76048642|FG000|Patient 3-Month Interview|Patient Participant Flow||67||
59930484|NCT03283553|76048643|FG001|Patient 3-Month Interview|Patient Participant Flow||60||
59930485|NCT03283553|76048642|FG000|Patient 9-Month Interview|Patient Participant Flow||63||
59930486|NCT03283553|76048643|FG001|Patient 9-Month Interview|Patient Participant Flow||57||
59930487|NCT03283553|76048642|FG000|Patient 12-Month Interview|Patient Participant Flow||59||
59930488|NCT03283553|76048643|FG001|Patient 12-Month Interview|Patient Participant Flow||50||
59930489|NCT03283553|76048642|FG000|COMPLETED|Patient Participant Flow||59||
59930490|NCT03283553|76048643|FG001|COMPLETED|Patient Participant Flow||50||
59930491|NCT03283553|76048642|FG000|NOT COMPLETED|Patient Participant Flow||10||
59930492|NCT03283553|76048643|FG001|NOT COMPLETED|Patient Participant Flow||13||
59930493|NCT03283553|76048642|FG000|STARTED|Care Partner Participant Flow||69|Patients and Care Partners were distinctly contacted for baseline and follow up, so the participation of one was not necessarily contingent on the participation of the other.|
59930494|NCT03283553|76048643|FG001|STARTED|Care Partner Participant Flow||63|Patients and Care Partners were distinctly contacted for baseline and follow up, so the participation of one was not necessarily contingent on the participation of the other.|
59930495|NCT03283553|76048642|FG000|Care Partner Baseline Interview|Care Partner Participant Flow||69||
59930496|NCT03283553|76048643|FG001|Care Partner Baseline Interview|Care Partner Participant Flow||63||
59930497|NCT03283553|76048642|FG000|Care Partner 3-Month Interview|Care Partner Participant Flow||69||
59930498|NCT03283553|76048643|FG001|Care Partner 3-Month Interview|Care Partner Participant Flow||60||
59930499|NCT03283553|76048642|FG000|Care Partner 9-Month Interview|Care Partner Participant Flow||64||
59930500|NCT03283553|76048643|FG001|Care Partner 9-Month Interview|Care Partner Participant Flow||55||
59930501|NCT03283553|76048642|FG000|Care Partner 12-Month Interview|Care Partner Participant Flow||59||
59930502|NCT03283553|76048643|FG001|Care Partner 12-Month Interview|Care Partner Participant Flow||48||
59930503|NCT03283553|76048642|FG000|COMPLETED|Care Partner Participant Flow||59||
59930504|NCT03283553|76048643|FG001|COMPLETED|Care Partner Participant Flow||48||
59930505|NCT03283553|76048642|FG000|NOT COMPLETED|Care Partner Participant Flow||10||
59930506|NCT03283553|76048643|FG001|NOT COMPLETED|Care Partner Participant Flow||15||
59930507|NCT03283319|76048657|FG000|STARTED|Overall Study||62||
59930508|NCT03283319|76048658|FG001|STARTED|Overall Study||60||
59930509|NCT03283319|76048659|FG002|STARTED|Overall Study||62||
59930510|NCT03283319|76048660|FG003|STARTED|Overall Study||61||
59930511|NCT03283319|76048661|FG004|STARTED|Overall Study||60||
59930512|NCT03283319|76048662|FG005|STARTED|Overall Study||61||
59930513|NCT03283319|76048657|FG000|COMPLETED|Overall Study||55||
59930514|NCT03283319|76048658|FG001|COMPLETED|Overall Study||54||
59930515|NCT03283319|76048659|FG002|COMPLETED|Overall Study||55||
59930516|NCT03283319|76048660|FG003|COMPLETED|Overall Study||54||
59930517|NCT03283319|76048661|FG004|COMPLETED|Overall Study||56||
59930518|NCT03283319|76048662|FG005|COMPLETED|Overall Study||57||
59930519|NCT03283319|76048657|FG000|NOT COMPLETED|Overall Study||7||
59930520|NCT03283319|76048658|FG001|NOT COMPLETED|Overall Study||6||
59930521|NCT03283319|76048659|FG002|NOT COMPLETED|Overall Study||7||
59930522|NCT03283319|76048660|FG003|NOT COMPLETED|Overall Study||7||
59930523|NCT03283319|76048661|FG004|NOT COMPLETED|Overall Study||4||
59517726|NCT03335254|75611561|FG004|NOT COMPLETED|Period 3, Day 26-30||0||
59517727|NCT03335254|75611562|FG005|NOT COMPLETED|Period 3, Day 26-30||0||
60064802|NCT01917968|76180055|FG000|NOT COMPLETED|Overall Study||54||
60064803|NCT01917968|76180056|FG001|NOT COMPLETED|Overall Study||84||
60064804|NCT01917656|76180071|FG000|STARTED|Overall Study||172||
60064805|NCT01917656|76180072|FG001|STARTED|Overall Study||171||
60064806|NCT01917656|76180071|FG000|Exposed|Overall Study|1 subject was withdrawn prior to exposure to trial products|171||
60064807|NCT01917656|76180072|FG001|Exposed|Overall Study|1 subject was withdrawn prior to exposure to first SU dose after randomisation|170||
60064808|NCT01917656|76180071|FG000|Exposed During Ramadan (Fasting)|Overall Study||152||
60064809|NCT01917656|76180072|FG001|Exposed During Ramadan (Fasting)|Overall Study||163||
60064810|NCT01917656|76180071|FG000|COMPLETED|Overall Study||146||
60064811|NCT01917656|76180072|FG001|COMPLETED|Overall Study||147||
60064812|NCT01917656|76180071|FG000|NOT COMPLETED|Overall Study||26||
60064813|NCT01917656|76180072|FG001|NOT COMPLETED|Overall Study||24||
60064814|NCT01944722|76180080|FG000|STARTED|Overall Study||33858||
60064815|NCT01944722|76180080|FG000|COMPLETED|Overall Study||24343||
60064816|NCT01944722|76180080|FG000|NOT COMPLETED|Overall Study||9515||
60064817|NCT01917344|76180089|FG000|STARTED|Overall Study||10||
60064818|NCT01917344|76180089|FG000|COMPLETED|Overall Study||9||
60064819|NCT01917344|76180089|FG000|NOT COMPLETED|Overall Study||1||
60064820|NCT02017535|76180097|FG000|STARTED|Overall Study||9||
60064821|NCT02017535|76180098|FG001|STARTED|Overall Study||3||
60064822|NCT02017535|76180099|FG002|STARTED|Overall Study||2||
60064823|NCT02017535|76180100|FG003|STARTED|Overall Study||1||
60064824|NCT02017535|76180097|FG000|COMPLETED|Overall Study||8||
60064825|NCT02017535|76180098|FG001|COMPLETED|Overall Study||3||
60064826|NCT02017535|76180099|FG002|COMPLETED|Overall Study||2||
60064827|NCT02017535|76180100|FG003|COMPLETED|Overall Study||1||
60064828|NCT02017535|76180097|FG000|NOT COMPLETED|Overall Study||1||
60064829|NCT02017535|76180098|FG001|NOT COMPLETED|Overall Study||0||
60064830|NCT02017535|76180099|FG002|NOT COMPLETED|Overall Study||0||
60064831|NCT02017535|76180100|FG003|NOT COMPLETED|Overall Study||0||
60064832|NCT01944098|76180112|FG000|STARTED|Overall Study||10||
60064833|NCT01944098|76180113|FG001|STARTED|Overall Study||10||
60064834|NCT01944098|76180112|FG000|COMPLETED|Overall Study||9||
60064835|NCT01944098|76180113|FG001|COMPLETED|Overall Study||10||
60064836|NCT01944098|76180112|FG000|NOT COMPLETED|Overall Study||1||
60064837|NCT01944098|76180113|FG001|NOT COMPLETED|Overall Study||0||
60064838|NCT02017223|76180119|FG000|STARTED|Overall Study||12||
60064839|NCT02017223|76180119|FG000|COMPLETED|Overall Study||10||
60064840|NCT02017223|76180119|FG000|NOT COMPLETED|Overall Study||2||
60064841|NCT01944020|76180125|FG000|STARTED|Overall Study||17||
60064842|NCT01944020|76180126|FG001|STARTED|Overall Study||12||
60064843|NCT01944020|76180125|FG000|COMPLETED|Overall Study||12||
60064844|NCT01944020|76180126|FG001|COMPLETED|Overall Study||12||
60064845|NCT01944020|76180125|FG000|NOT COMPLETED|Overall Study||5||
60064846|NCT01944020|76180126|FG001|NOT COMPLETED|Overall Study||0||
60064847|NCT01943552|76180134|FG000|STARTED|Overall Study|One patient was randomised to the placebo group, but received nebulized ipratropium bromide.|96||
60064848|NCT01943552|76180135|FG001|STARTED|Overall Study||94||
60064849|NCT01943552|76180134|FG000|COMPLETED|Overall Study||71||
60064850|NCT01943552|76180135|FG001|COMPLETED|Overall Study||69||
60064851|NCT01943552|76180134|FG000|NOT COMPLETED|Overall Study||25||
60064852|NCT01943552|76180135|FG001|NOT COMPLETED|Overall Study||25||
60064853|NCT01915940|76180143|FG000|STARTED|Pre-randomization Washout Period||169||
60064854|NCT01915940|76180144|FG001|STARTED|Pre-randomization Washout Period||0||
60064855|NCT01915940|76180145|FG002|STARTED|Pre-randomization Washout Period||0||
60064856|NCT01915940|76180143|FG000|COMPLETED|Pre-randomization Washout Period||130||
60064857|NCT01915940|76180144|FG001|COMPLETED|Pre-randomization Washout Period||0||
60064858|NCT01915940|76180145|FG002|COMPLETED|Pre-randomization Washout Period||0||
60064859|NCT01915940|76180143|FG000|NOT COMPLETED|Pre-randomization Washout Period||39||
60064860|NCT01915940|76180144|FG001|NOT COMPLETED|Pre-randomization Washout Period||0||
60064861|NCT01915940|76180145|FG002|NOT COMPLETED|Pre-randomization Washout Period||0||
60064862|NCT01915940|76180143|FG000|STARTED|Treatment Period||0||
60064863|NCT01915940|76180144|FG001|STARTED|Treatment Period||64||
60064864|NCT01915940|76180145|FG002|STARTED|Treatment Period||66||
60064865|NCT01915940|76180143|FG000|COMPLETED|Treatment Period||0||
60064866|NCT01915940|76180144|FG001|COMPLETED|Treatment Period||53||
60064867|NCT01915940|76180145|FG002|COMPLETED|Treatment Period||62||
60064868|NCT01915940|76180143|FG000|NOT COMPLETED|Treatment Period||0||
60064869|NCT01915940|76180144|FG001|NOT COMPLETED|Treatment Period||11||
60064870|NCT01915940|76180145|FG002|NOT COMPLETED|Treatment Period||4||
60064871|NCT01914926|76180153|FG000|STARTED|Overall Study||29||
60064872|NCT01914926|76180154|FG001|STARTED|Overall Study||25||
60064873|NCT01914926|76180153|FG000|COMPLETED|Overall Study||28||
60064874|NCT01914926|76180154|FG001|COMPLETED|Overall Study||24||
60064875|NCT01914926|76180153|FG000|NOT COMPLETED|Overall Study||1||
60064876|NCT01914926|76180154|FG001|NOT COMPLETED|Overall Study||1||
60064877|NCT02016755|76180160|FG000|STARTED|Overall Study||10||
60064878|NCT02016755|76180160|FG000|Completed Month 18 Clinic Visit|Overall Study||5||
60064879|NCT02016755|76180160|FG000|Completed Month 36 LTFU Questionnaire|Overall Study||3||
60064880|NCT02016755|76180160|FG000|COMPLETED|Overall Study||3||
60064881|NCT02016755|76180160|FG000|NOT COMPLETED|Overall Study||7||
60064882|NCT01942148|76180164|FG000|STARTED|Overall Study||68||
60064883|NCT01942148|76180164|FG000|COMPLETED|Overall Study||41||
60064884|NCT01942148|76180164|FG000|NOT COMPLETED|Overall Study||27||
60064885|NCT02030015|76180168|FG000|STARTED|Overall Study||16||
60064886|NCT02030015|76180168|FG000|COMPLETED|Overall Study||0||
60064887|NCT02030015|76180168|FG000|NOT COMPLETED|Overall Study||16||
60064888|NCT02029235|76180174|FG000|STARTED|Overall Study||34||
60064889|NCT02029235|76180175|FG001|STARTED|Overall Study||31||
60064890|NCT02029235|76180174|FG000|COMPLETED|Overall Study||30||
60064891|NCT02029235|76180175|FG001|COMPLETED|Overall Study||30||
60064892|NCT02029235|76180174|FG000|NOT COMPLETED|Overall Study||4||
60064893|NCT02029235|76180175|FG001|NOT COMPLETED|Overall Study||1||
60064894|NCT01617434|76180183|FG000|STARTED|Overall Study||226||
60064895|NCT01617434|76180184|FG001|STARTED|Overall Study||225||
60064896|NCT01617434|76180183|FG000|Exposed|Overall Study||225||
60064897|NCT01617434|76180184|FG001|Exposed|Overall Study||225||
59517728|NCT03335254|75611563|FG006|NOT COMPLETED|Period 3, Day 26-30||0||
59517729|NCT03335254|75611564|FG007|NOT COMPLETED|Period 3, Day 26-30||0||
59517730|NCT03335254|75611565|FG008|NOT COMPLETED|Period 3, Day 26-30||0||
59517731|NCT03335254|75611566|FG009|NOT COMPLETED|Period 3, Day 26-30||0||
59517732|NCT03335254|75611567|FG010|NOT COMPLETED|Period 3, Day 26-30||0||
59517733|NCT03335254|75611568|FG011|NOT COMPLETED|Period 3, Day 26-30||0||
59517734|NCT03335254|75611569|FG012|NOT COMPLETED|Period 3, Day 26-30||0||
59517735|NCT03335254|75611570|FG013|NOT COMPLETED|Period 3, Day 26-30||0||
59517736|NCT03335254|75611571|FG014|NOT COMPLETED|Period 3, Day 26-30||0||
59613237|NCT01681992|75724388|FG000|STARTED|Overall Study||1493||
59613238|NCT01681992|75724389|FG001|STARTED|Overall Study||1497||
60064898|NCT01617434|76180183|FG000|COMPLETED|Overall Study||191||
60064899|NCT01617434|76180184|FG001|COMPLETED|Overall Study||174||
60064900|NCT01617434|76180183|FG000|NOT COMPLETED|Overall Study||35||
60064901|NCT01617434|76180184|FG001|NOT COMPLETED|Overall Study||51||
60064902|NCT01940900|76180192|FG000|STARTED|Overall Study||311||
60064903|NCT01940900|76180193|FG001|STARTED|Overall Study||315||
60064904|NCT01940900|76180192|FG000|COMPLETED|Overall Study||282||
60064905|NCT01940900|76180193|FG001|COMPLETED|Overall Study||284||
60064906|NCT01940900|76180192|FG000|NOT COMPLETED|Overall Study||29||
60064907|NCT01940900|76180193|FG001|NOT COMPLETED|Overall Study||31||
60064908|NCT01940354|76180201|FG000|STARTED|Overall Study||110||
60064909|NCT01940354|76180202|FG001|STARTED|Overall Study||110||
60064910|NCT01940354|76180201|FG000|COMPLETED|Overall Study||106||
60064911|NCT01940354|76180202|FG001|COMPLETED|Overall Study||108||
60064912|NCT01940354|76180201|FG000|NOT COMPLETED|Overall Study||4||
60064913|NCT01940354|76180202|FG001|NOT COMPLETED|Overall Study||2||
60064914|NCT01940120|76180208|FG000|STARTED|Overall Study||78||
60064915|NCT01940120|76180208|FG000|COMPLETED|Overall Study||30||
60064916|NCT01940120|76180208|FG000|NOT COMPLETED|Overall Study||48||
59517737|NCT03335254|75611572|FG015|NOT COMPLETED|Period 3, Day 26-30||0||
59517738|NCT03335254|75611573|FG016|NOT COMPLETED|Period 3, Day 26-30||0||
59613239|NCT01681992|75724390|FG002|STARTED|Overall Study||1526||
60064917|NCT01911260|76180217|FG000|STARTED|Supplementation Period||50||
60064918|NCT01911260|76180218|FG001|STARTED|Supplementation Period||50||
60064919|NCT01911260|76180219|FG002|STARTED|Supplementation Period||49||
60064920|NCT01911260|76180220|FG003|STARTED|Supplementation Period||50||
60064921|NCT01911260|76180217|FG000|COMPLETED|Supplementation Period||40||
60064922|NCT01911260|76180218|FG001|COMPLETED|Supplementation Period||38||
60064923|NCT01911260|76180219|FG002|COMPLETED|Supplementation Period||39||
60064924|NCT01911260|76180220|FG003|COMPLETED|Supplementation Period||42||
60064925|NCT01911260|76180217|FG000|NOT COMPLETED|Supplementation Period||10||
60064926|NCT01911260|76180218|FG001|NOT COMPLETED|Supplementation Period||12||
60064927|NCT01911260|76180219|FG002|NOT COMPLETED|Supplementation Period||10||
60064928|NCT01911260|76180220|FG003|NOT COMPLETED|Supplementation Period||8||
60064929|NCT01911260|76180217|FG000|STARTED|Follow-up Period||40||
60064930|NCT01911260|76180218|FG001|STARTED|Follow-up Period||38||
60064931|NCT01911260|76180219|FG002|STARTED|Follow-up Period||39||
60064932|NCT01911260|76180220|FG003|STARTED|Follow-up Period||42||
60064933|NCT01911260|76180217|FG000|COMPLETED|Follow-up Period||27||
60064934|NCT01911260|76180218|FG001|COMPLETED|Follow-up Period||18||
60064935|NCT01911260|76180219|FG002|COMPLETED|Follow-up Period||24||
60064936|NCT01911260|76180220|FG003|COMPLETED|Follow-up Period||30||
60064937|NCT01911260|76180217|FG000|NOT COMPLETED|Follow-up Period||13||
60064938|NCT01911260|76180218|FG001|NOT COMPLETED|Follow-up Period||20||
59930524|NCT03283319|76048662|FG005|NOT COMPLETED|Overall Study||4||
59930525|NCT03282227|76048676|FG000|STARTED|Overall Study||342||
59930526|NCT03282227|76048676|FG000|Completed at Least 6 Months|Overall Study||257||
59930527|NCT03282227|76048676|FG000|COMPLETED|Overall Study||127|Completed 12 Months|
59930528|NCT03282227|76048676|FG000|NOT COMPLETED|Overall Study||215||
59930529|NCT03240575|76048684|FG000|STARTED|Overall Study||146||
59930530|NCT03240575|76048685|FG001|STARTED|Overall Study||145||
59930531|NCT03240575|76048686|FG002|STARTED|Overall Study||6||
59930532|NCT03240575|76048687|FG003|STARTED|Overall Study||5||
59930533|NCT03240575|76048684|FG000|COMPLETED|Overall Study||144||
59930534|NCT03240575|76048685|FG001|COMPLETED|Overall Study||131||
59930535|NCT03240575|76048686|FG002|COMPLETED|Overall Study||6||
59930536|NCT03240575|76048687|FG003|COMPLETED|Overall Study||3||
59930537|NCT03240575|76048684|FG000|NOT COMPLETED|Overall Study||2||
59930538|NCT03240575|76048685|FG001|NOT COMPLETED|Overall Study||14||
59930539|NCT03240575|76048686|FG002|NOT COMPLETED|Overall Study||0||
59930540|NCT03240575|76048687|FG003|NOT COMPLETED|Overall Study||2||
59930541|NCT03385265|76048699|FG000|STARTED|Overall Study||20||
59930542|NCT03385265|76048700|FG001|STARTED|Overall Study||11||
59930543|NCT03385265|76048701|FG002|STARTED|Overall Study||20||
59930544|NCT03385265|76048702|FG003|STARTED|Overall Study||11||
59930545|NCT03385265|76048699|FG000|COMPLETED|Overall Study|this is Time 3 or 33 weeks post-baseline|15||
59930546|NCT03385265|76048700|FG001|COMPLETED|Overall Study|this is Time 3 or 33 weeks post-baseline|9||
59930547|NCT03385265|76048701|FG002|COMPLETED|Overall Study|this is Time 3 or 33 weeks post-baseline|15||
59930548|NCT03385265|76048702|FG003|COMPLETED|Overall Study|this is Time 3 or 33 weeks post-baseline|9||
59930549|NCT03385265|76048699|FG000|NOT COMPLETED|Overall Study||5||
59930550|NCT03385265|76048700|FG001|NOT COMPLETED|Overall Study||2||
59930551|NCT03385265|76048701|FG002|NOT COMPLETED|Overall Study||5||
59930552|NCT03385265|76048702|FG003|NOT COMPLETED|Overall Study||2||
59930553|NCT03280121|76048714|FG000|STARTED|Overall Study||14||
59930554|NCT03280121|76048714|FG000|COMPLETED|Overall Study||8||
59930555|NCT03280121|76048714|FG000|NOT COMPLETED|Overall Study||6||
59930556|NCT03233009|76048718|FG000|STARTED|Overall Study||40||
59930557|NCT03233009|76048718|FG000|Test Product 1|Overall Study||39||
59930558|NCT03233009|76048718|FG000|Test Product 2|Overall Study||39||
59930559|NCT03233009|76048718|FG000|Test Product 3|Overall Study||39||
60064939|NCT01911260|76180219|FG002|NOT COMPLETED|Follow-up Period||15||
60064940|NCT01911260|76180220|FG003|NOT COMPLETED|Follow-up Period||12||
60064941|NCT02015819|76180234|FG000|STARTED|Overall Study||3||
60064942|NCT02015819|76180235|FG001|STARTED|Overall Study||3||
60064943|NCT02015819|76180236|FG002|STARTED|Overall Study||3||
60064944|NCT02015819|76180237|FG003|STARTED|Overall Study||7||
59930560|NCT03233009|76048718|FG000|Test Product 4|Overall Study||39||
59930561|NCT03233009|76048718|FG000|Reference Product|Overall Study||39||
59930562|NCT03233009|76048718|FG000|COMPLETED|Overall Study||39|1 participant lost to follow-up was removed from all the treatment arms.|
59930563|NCT03233009|76048718|FG000|NOT COMPLETED|Overall Study||1||
59930564|NCT04034225|76048733|FG000|STARTED|Overall Study|Study stopped prematurely. 25/60 patients enrolled.|25||
59930565|NCT04034225|76048733|FG000|COMPLETED|Overall Study||0||
59930566|NCT04034225|76048733|FG000|NOT COMPLETED|Overall Study||25||
59930567|NCT02999178|76048741|FG000|STARTED|Overall Study||332||
59930568|NCT02999178|76048742|FG001|STARTED|Overall Study||331||
59930569|NCT02999178|76048741|FG000|COMPLETED|Overall Study|On treatment at analysis cut-off date, 12-August-2019|218||
60064945|NCT02015819|76180234|FG000|COMPLETED|Overall Study||3||
59930570|NCT02999178|76048742|FG001|COMPLETED|Overall Study|On treatment at analysis cut-off date, 12-August-2019|231||
59930571|NCT02999178|76048741|FG000|NOT COMPLETED|Overall Study||114||
59930572|NCT02999178|76048742|FG001|NOT COMPLETED|Overall Study||100||
59930573|NCT02959190|76048754|FG000|STARTED|Open Label||120||
59930574|NCT02959190|76048755|FG001|STARTED|Open Label||126||
59930575|NCT02959190|76048756|FG002|STARTED|Open Label||32||
59930576|NCT02959190|76048757|FG003|STARTED|Open Label||33||
59930577|NCT02959190|76048754|FG000|Received at Least 1 Dose of Study Drug|Open Label||120||
60064946|NCT02015819|76180235|FG001|COMPLETED|Overall Study||3||
60064947|NCT02015819|76180236|FG002|COMPLETED|Overall Study||3||
60064948|NCT02015819|76180237|FG003|COMPLETED|Overall Study||6||
60064949|NCT02015819|76180234|FG000|NOT COMPLETED|Overall Study||0||
60064950|NCT02015819|76180235|FG001|NOT COMPLETED|Overall Study||0||
60064951|NCT02015819|76180236|FG002|NOT COMPLETED|Overall Study||0||
60064952|NCT02015819|76180237|FG003|NOT COMPLETED|Overall Study||1||
60064953|NCT01939496|76180254|FG000|STARTED|Overall Study||56||
60064954|NCT01939496|76180255|FG001|STARTED|Overall Study||57||
60064955|NCT01939496|76180256|FG002|STARTED|Overall Study||56||
60064956|NCT01939496|76180254|FG000|COMPLETED|Overall Study||47||
60064957|NCT01939496|76180255|FG001|COMPLETED|Overall Study||54||
60064958|NCT01939496|76180256|FG002|COMPLETED|Overall Study||54||
60064959|NCT01939496|76180254|FG000|NOT COMPLETED|Overall Study||9||
60064960|NCT01939496|76180255|FG001|NOT COMPLETED|Overall Study||3||
60064961|NCT01939496|76180256|FG002|NOT COMPLETED|Overall Study||2||
60064962|NCT01939028|76180264|FG000|STARTED|Overall Study||58||
60064963|NCT01939028|76180264|FG000|COMPLETED|Overall Study||46||
60064964|NCT01939028|76180264|FG000|NOT COMPLETED|Overall Study||12||
60064965|NCT01938716|76180268|FG000|STARTED|Overall Study||12||
60064966|NCT01938716|76180268|FG000|COMPLETED|Overall Study||8||
60064967|NCT01938716|76180268|FG000|NOT COMPLETED|Overall Study||4||
60064968|NCT01937390|76180272|FG000|STARTED|Overall Study||585||
60064969|NCT01937390|76180272|FG000|COMPLETED|Overall Study||550||
60064970|NCT01937390|76180272|FG000|NOT COMPLETED|Overall Study||35||
60064971|NCT02028767|76180276|FG000|STARTED|Treatment Period 1||16||
60064972|NCT02028767|76180277|FG001|STARTED|Treatment Period 1||16||
60064973|NCT02028767|76180276|FG000|COMPLETED|Treatment Period 1||16||
60064974|NCT02028767|76180277|FG001|COMPLETED|Treatment Period 1||16||
60064975|NCT02028767|76180276|FG000|NOT COMPLETED|Treatment Period 1||0||
60064976|NCT02028767|76180277|FG001|NOT COMPLETED|Treatment Period 1||0||
60064977|NCT02028767|76180276|FG000|STARTED|Treatment Period 2||16||
60064978|NCT02028767|76180277|FG001|STARTED|Treatment Period 2||16||
60064979|NCT02028767|76180276|FG000|COMPLETED|Treatment Period 2||14||
60064980|NCT02028767|76180277|FG001|COMPLETED|Treatment Period 2||16||
60064981|NCT02028767|76180276|FG000|NOT COMPLETED|Treatment Period 2||2||
60064982|NCT02028767|76180277|FG001|NOT COMPLETED|Treatment Period 2||0||
60064983|NCT01959932|76180286|FG000|STARTED|Overall Study||80||
60064984|NCT01959932|76180287|FG001|STARTED|Overall Study||41||
60064985|NCT01959932|76180288|FG002|STARTED|Overall Study||39||
60064986|NCT01959932|76180286|FG000|COMPLETED|Overall Study||79||
60064987|NCT01959932|76180287|FG001|COMPLETED|Overall Study||41||
59517739|NCT03335254|75611574|FG017|NOT COMPLETED|Period 3, Day 26-30||0||
59517740|NCT03335254|75611575|FG018|NOT COMPLETED|Period 3, Day 26-30||0||
59517741|NCT03335254|75611576|FG019|NOT COMPLETED|Period 3, Day 26-30||0||
59517742|NCT02226159|75611607|FG000|STARTED|Overall Study||33||
59517743|NCT02226159|75611608|FG001|STARTED|Overall Study||32||
59517744|NCT02226159|75611607|FG000|COMPLETED|Overall Study||27||
59517745|NCT02226159|75611608|FG001|COMPLETED|Overall Study||26||
59517746|NCT02226159|75611607|FG000|NOT COMPLETED|Overall Study||6||
59517747|NCT02226159|75611608|FG001|NOT COMPLETED|Overall Study||6||
59517748|NCT03335800|75611614|FG000|STARTED|Overall Study||419927||
59517749|NCT03335800|75611614|FG000|Received Irregular Pulse Notification|Overall Study||2161||
59517750|NCT03335800|75611614|FG000|Attended First Study Visit|Overall Study||945||
59517751|NCT03335800|75611614|FG000|ECG Patch Shipped|Overall Study||658||
59517752|NCT03335800|75611614|FG000|ECG Patch Returned for Analysis|Overall Study||450||
59517753|NCT03335800|75611614|FG000|Attended Second Study Visit|Overall Study||396||
59517754|NCT03335800|75611614|FG000|COMPLETED|Overall Study||396||
59517755|NCT03335800|75611614|FG000|NOT COMPLETED|Overall Study||419531||
60064988|NCT01959932|76180288|FG002|COMPLETED|Overall Study||39||
60064989|NCT01959932|76180286|FG000|NOT COMPLETED|Overall Study||1||
60064990|NCT01959932|76180287|FG001|NOT COMPLETED|Overall Study||0||
60064991|NCT01959932|76180288|FG002|NOT COMPLETED|Overall Study||0||
60064992|NCT02028065|76180300|FG000|STARTED|Randomization Through Start Treatment|Randomized|76||
60064993|NCT02028065|76180301|FG001|STARTED|Randomization Through Start Treatment|Randomized|154||
59517756|NCT03338686|75611621|FG000|STARTED|Overall Study||2||2
59517757|NCT03338686|75611622|FG001|STARTED|Overall Study||5||5
59517758|NCT03338686|75611623|FG002|STARTED|Overall Study|12 FGG implant sites and 7 CTG implant sites for this Arm/Group|7||19
60064994|NCT02028065|76180302|FG002|STARTED|Randomization Through Start Treatment|Randomized|152||
60064995|NCT02028065|76180300|FG000|COMPLETED|Randomization Through Start Treatment||75||
60064996|NCT02028065|76180301|FG001|COMPLETED|Randomization Through Start Treatment||151||
60064997|NCT02028065|76180302|FG002|COMPLETED|Randomization Through Start Treatment||149||
59517759|NCT03338686|75611621|FG000|COMPLETED|Overall Study||2||2
59517760|NCT03338686|75611622|FG001|COMPLETED|Overall Study||5||5
59517761|NCT03338686|75611623|FG002|COMPLETED|Overall Study||7||19
59517762|NCT03338686|75611621|FG000|NOT COMPLETED|Overall Study||0||0
60064998|NCT02028065|76180300|FG000|NOT COMPLETED|Randomization Through Start Treatment||1||
60064999|NCT02028065|76180301|FG001|NOT COMPLETED|Randomization Through Start Treatment||3||
60067880|NCT01756053|76183071|FG000|STARTED|Washout Period (~21 Days)||7||
59517763|NCT03338686|75611622|FG001|NOT COMPLETED|Overall Study||0||0
59517764|NCT03338686|75611623|FG002|NOT COMPLETED|Overall Study||0||0
59517765|NCT03241030|75611632|FG000|STARTED|Overall Study||50||
59517766|NCT03241030|75611633|FG001|STARTED|Overall Study||52||
59517767|NCT03241030|75611632|FG000|COMPLETED|Overall Study||49||
59517768|NCT03241030|75611633|FG001|COMPLETED|Overall Study||51||
59517769|NCT03241030|75611632|FG000|NOT COMPLETED|Overall Study||1||
59517770|NCT03241030|75611633|FG001|NOT COMPLETED|Overall Study||1||
59517771|NCT03479944|75611639|FG000|STARTED|Overall Study||55||110
59517772|NCT03479944|75611639|FG000|FLACS|Overall Study||55|left or right eye|55
59517773|NCT03479944|75611639|FG000|Conventional|Overall Study||55|fellow eye|55
59517774|NCT03479944|75611639|FG000|Full Analysis Set|Overall Study||53||106
59517775|NCT03479944|75611639|FG000|COMPLETED|Overall Study||55||110
59517776|NCT03479944|75611639|FG000|NOT COMPLETED|Overall Study||0||0
59517777|NCT03241810|75611649|FG000|STARTED|Overall Study||11||
59517778|NCT03241810|75611650|FG001|STARTED|Overall Study||11||
59517779|NCT03241810|75611649|FG000|COMPLETED|Overall Study|Safety population: includes patients receiving at least one dose of study medication.|11||
59517780|NCT03241810|75611650|FG001|COMPLETED|Overall Study|Safety population: includes patients receiving at least one dose of study medication.|11||
59517781|NCT03241810|75611649|FG000|NOT COMPLETED|Overall Study||0||
59517782|NCT03241810|75611650|FG001|NOT COMPLETED|Overall Study||0||
59517783|NCT03242590|75611657|FG000|STARTED|Overall Study||95||
59517784|NCT03242590|75611657|FG000|COMPLETED|Overall Study||95||
60065000|NCT02028065|76180302|FG002|NOT COMPLETED|Randomization Through Start Treatment||3||
60065001|NCT02028065|76180300|FG000|STARTED|Treatment Through Study Completion|Includes 1 participant randomized to sugammadex 16 mg/kg who actually received placebo|76||
60065002|NCT02028065|76180301|FG001|STARTED|Treatment Through Study Completion||151||
60065003|NCT02028065|76180302|FG002|STARTED|Treatment Through Study Completion|Does not include the 1 participant randomized to sugammadex 16 mg/kg who actually received placebo|148||
60065004|NCT02028065|76180300|FG000|Received First Dose|Treatment Through Study Completion||76||
60065005|NCT02028065|76180301|FG001|Received First Dose|Treatment Through Study Completion||151||
60065006|NCT02028065|76180302|FG002|Received First Dose|Treatment Through Study Completion||148||
60065007|NCT02028065|76180300|FG000|Received Second Dose|Treatment Through Study Completion||69||
60065008|NCT02028065|76180301|FG001|Received Second Dose|Treatment Through Study Completion||140||
60065009|NCT02028065|76180302|FG002|Received Second Dose|Treatment Through Study Completion||138||
60065010|NCT02028065|76180300|FG000|Received Third Dose|Treatment Through Study Completion||64||
60065011|NCT02028065|76180301|FG001|Received Third Dose|Treatment Through Study Completion||136||
60065012|NCT02028065|76180302|FG002|Received Third Dose|Treatment Through Study Completion||134||
60065013|NCT02028065|76180300|FG000|COMPLETED|Treatment Through Study Completion||64||
60065014|NCT02028065|76180301|FG001|COMPLETED|Treatment Through Study Completion||136||
60065015|NCT02028065|76180302|FG002|COMPLETED|Treatment Through Study Completion||134||
60065016|NCT02028065|76180300|FG000|NOT COMPLETED|Treatment Through Study Completion||12||
60065017|NCT02028065|76180301|FG001|NOT COMPLETED|Treatment Through Study Completion||15||
60065018|NCT02028065|76180302|FG002|NOT COMPLETED|Treatment Through Study Completion||14||
60065019|NCT02015195|76180317|FG000|STARTED|Overall Study||16||
60065020|NCT02015195|76180318|FG001|STARTED|Overall Study||16||
59517785|NCT03242590|75611657|FG000|NOT COMPLETED|Overall Study||0||
59517786|NCT03481270|75611663|FG000|STARTED|Overall Study||324||
59517787|NCT03481270|75611664|FG001|STARTED|Overall Study||313||
59517788|NCT03481270|75611663|FG000|COMPLETED|Overall Study||324||
59517789|NCT03481270|75611664|FG001|COMPLETED|Overall Study||313||
59517790|NCT03481270|75611663|FG000|NOT COMPLETED|Overall Study||0||
59517791|NCT03481270|75611664|FG001|NOT COMPLETED|Overall Study||0||
59517792|NCT03247738|75611672|FG000|STARTED|Overall Study||25||
59517793|NCT03247738|75611673|FG001|STARTED|Overall Study||25||
59517794|NCT03247738|75611672|FG000|COMPLETED|Overall Study||25||
60065021|NCT02015195|76180319|FG002|STARTED|Overall Study||16||
60065022|NCT02015195|76180320|FG003|STARTED|Overall Study||1||
60065023|NCT02015195|76180321|FG004|STARTED|Overall Study||16||
59517795|NCT03247738|75611673|FG001|COMPLETED|Overall Study||25||
59517796|NCT03247738|75611672|FG000|NOT COMPLETED|Overall Study||0||
59517797|NCT03247738|75611673|FG001|NOT COMPLETED|Overall Study||0||
59517798|NCT02660385|75611681|FG000|STARTED|Overall Study||100||
59517799|NCT02660385|75611682|FG001|STARTED|Overall Study||89||
59517800|NCT02660385|75611681|FG000|COMPLETED|Overall Study||91||
59517801|NCT02660385|75611682|FG001|COMPLETED|Overall Study||84||
59517802|NCT02660385|75611681|FG000|NOT COMPLETED|Overall Study||9||
59517803|NCT02660385|75611682|FG001|NOT COMPLETED|Overall Study||5||
60065024|NCT02015195|76180322|FG005|STARTED|Overall Study||16||
60065025|NCT02015195|76180323|FG006|STARTED|Overall Study||16||
60065026|NCT02015195|76180317|FG000|COMPLETED|Overall Study||16||
60065027|NCT02015195|76180318|FG001|COMPLETED|Overall Study||16||
60065028|NCT02015195|76180319|FG002|COMPLETED|Overall Study||16||
60065029|NCT02015195|76180320|FG003|COMPLETED|Overall Study||0||
60065030|NCT02015195|76180321|FG004|COMPLETED|Overall Study||16||
60065031|NCT02015195|76180322|FG005|COMPLETED|Overall Study||16||
60065032|NCT02015195|76180323|FG006|COMPLETED|Overall Study||16||
60065033|NCT02015195|76180317|FG000|NOT COMPLETED|Overall Study||0||
60065034|NCT02015195|76180318|FG001|NOT COMPLETED|Overall Study||0||
60065035|NCT02015195|76180319|FG002|NOT COMPLETED|Overall Study||0||
60065036|NCT02015195|76180320|FG003|NOT COMPLETED|Overall Study||1||
60065037|NCT02015195|76180321|FG004|NOT COMPLETED|Overall Study||0||
60065038|NCT02015195|76180322|FG005|NOT COMPLETED|Overall Study||0||
60065039|NCT02015195|76180323|FG006|NOT COMPLETED|Overall Study||0||
60065040|NCT02015039|76180340|FG000|STARTED|Overall Study||6||
60065041|NCT02015039|76180341|FG001|STARTED|Overall Study||7||
60065042|NCT02015039|76180340|FG000|COMPLETED|Overall Study||6||
60065043|NCT02015039|76180341|FG001|COMPLETED|Overall Study||6||
60065044|NCT02015039|76180340|FG000|NOT COMPLETED|Overall Study||0||
60065045|NCT02015039|76180341|FG001|NOT COMPLETED|Overall Study||1||
60065046|NCT02025725|76180349|FG000|STARTED|Overall Study||102||
59517804|NCT03341728|75611688|FG000|STARTED|Session 1||7||
59517805|NCT03341728|75611689|FG001|STARTED|Session 1||7||
59930578|NCT02959190|76048755|FG001|Received at Least 1 Dose of Study Drug|Open Label||126||
59930579|NCT02959190|76048756|FG002|Received at Least 1 Dose of Study Drug|Open Label||32||
59930580|NCT02959190|76048757|FG003|Received at Least 1 Dose of Study Drug|Open Label||33||
59930581|NCT02959190|76048754|FG000|120mg/120mg Galcanezumab - EM|Open Label||58||
59930582|NCT02959190|76048755|FG001|120mg/120mg Galcanezumab - EM|Open Label||0||
59930583|NCT02959190|76048756|FG002|120mg/120mg Galcanezumab - EM|Open Label||0||
60065047|NCT02025725|76180350|FG001|STARTED|Overall Study||103||
60065048|NCT02025725|76180349|FG000|COMPLETED|Overall Study||91||
60065049|NCT02025725|76180350|FG001|COMPLETED|Overall Study||99||
60065050|NCT02025725|76180349|FG000|NOT COMPLETED|Overall Study||11||
60065051|NCT02025725|76180350|FG001|NOT COMPLETED|Overall Study||4||
60065052|NCT02025179|76180361|FG000|STARTED|Overall Study||8||
60065053|NCT02025179|76180362|FG001|STARTED|Overall Study||9||
60065054|NCT02025179|76180363|FG002|STARTED|Overall Study||8||
60065055|NCT02025179|76180361|FG000|COMPLETED|Overall Study||8||
60065056|NCT02025179|76180362|FG001|COMPLETED|Overall Study||9||
60065057|NCT02025179|76180363|FG002|COMPLETED|Overall Study||7||
60065058|NCT02025179|76180361|FG000|NOT COMPLETED|Overall Study||0||
59517806|NCT03341728|75611688|FG000|COMPLETED|Session 1||7||
59930584|NCT02959190|76048757|FG003|120mg/120mg Galcanezumab - EM|Open Label||0||
59930585|NCT02959190|76048754|FG000|240mg/240mg Galcanezumab - EM|Open Label||0||
59930586|NCT02959190|76048755|FG001|240mg/240mg Galcanezumab - EM|Open Label||62||
60065059|NCT02025179|76180362|FG001|NOT COMPLETED|Overall Study||0||
60065060|NCT02025179|76180363|FG002|NOT COMPLETED|Overall Study||1||
60065061|NCT02013791|76180380|FG000|STARTED|Period 1||8||
59517807|NCT03341728|75611689|FG001|COMPLETED|Session 1||7||
60065062|NCT02013791|76180381|FG001|STARTED|Period 1||8||
59517808|NCT03341728|75611688|FG000|NOT COMPLETED|Session 1||0||
60065063|NCT02013791|76180382|FG002|STARTED|Period 1||4||
60065064|NCT02013791|76180383|FG003|STARTED|Period 1||8||
60065065|NCT02013791|76180384|FG004|STARTED|Period 1||4||
60065066|NCT02013791|76180385|FG005|STARTED|Period 1||8||
60065067|NCT02013791|76180386|FG006|STARTED|Period 1||4||
60065068|NCT02013791|76180387|FG007|STARTED|Period 1||8||
60065069|NCT02013791|76180388|FG008|STARTED|Period 1||3||
60065070|NCT02013791|76180380|FG000|COMPLETED|Period 1||8||
59517809|NCT03341728|75611689|FG001|NOT COMPLETED|Session 1||0||
59517810|NCT03341728|75611688|FG000|STARTED|Washout (1 Week)||7||
59517811|NCT03341728|75611689|FG001|STARTED|Washout (1 Week)||7||
59517812|NCT03341728|75611688|FG000|COMPLETED|Washout (1 Week)||7||
59517813|NCT03341728|75611689|FG001|COMPLETED|Washout (1 Week)||7||
59517814|NCT03341728|75611688|FG000|NOT COMPLETED|Washout (1 Week)||0||
59517815|NCT03341728|75611689|FG001|NOT COMPLETED|Washout (1 Week)||0||
59517816|NCT03341728|75611688|FG000|STARTED|Session 2||7||
59517817|NCT03341728|75611689|FG001|STARTED|Session 2||7||
60065071|NCT02013791|76180381|FG001|COMPLETED|Period 1||6||
59517818|NCT03341728|75611688|FG000|COMPLETED|Session 2||7||
59517819|NCT03341728|75611689|FG001|COMPLETED|Session 2||7||
59517820|NCT03341728|75611688|FG000|NOT COMPLETED|Session 2||0||
59517821|NCT03341728|75611689|FG001|NOT COMPLETED|Session 2||0||
59517822|NCT03345160|75611695|FG000|STARTED|Overall Study||7||
59517823|NCT03345160|75611695|FG000|COMPLETED|Overall Study||7||
59517824|NCT03345160|75611695|FG000|NOT COMPLETED|Overall Study||0||
59517825|NCT03345394|75611701|FG000|STARTED|Overall Study||48||
59517826|NCT03345394|75611702|FG001|STARTED|Overall Study||50||
59761384|NCT02393248|75881098|FG016|NOT COMPLETED|Part 1: Monotherapy Dose Escalation||0||
59761385|NCT02393248|75881099|FG017|NOT COMPLETED|Part 1: Monotherapy Dose Escalation||0||
60065072|NCT02013791|76180382|FG002|COMPLETED|Period 1||4||
60065073|NCT02013791|76180383|FG003|COMPLETED|Period 1||7||
60065074|NCT02013791|76180384|FG004|COMPLETED|Period 1||4||
60065075|NCT02013791|76180385|FG005|COMPLETED|Period 1||8||
60065076|NCT02013791|76180386|FG006|COMPLETED|Period 1||3||
59517827|NCT03345394|75611701|FG000|COMPLETED|Overall Study||48||
59517828|NCT03345394|75611702|FG001|COMPLETED|Overall Study||50||
59517829|NCT03345394|75611701|FG000|NOT COMPLETED|Overall Study||0||
59517830|NCT03345394|75611702|FG001|NOT COMPLETED|Overall Study||0||
59517831|NCT01567605|75611710|FG000|STARTED|Overall Study||7||
60065077|NCT02013791|76180387|FG007|COMPLETED|Period 1||7||
59517832|NCT01567605|75611711|FG001|STARTED|Overall Study||6||
59517833|NCT01567605|75611710|FG000|COMPLETED|Overall Study||7||
59517834|NCT01567605|75611711|FG001|COMPLETED|Overall Study||6||
59517835|NCT01567605|75611710|FG000|NOT COMPLETED|Overall Study||0||
59517836|NCT01567605|75611711|FG001|NOT COMPLETED|Overall Study||0||
59517837|NCT01063075|75611717|FG000|STARTED|Overall Study||2||
59517838|NCT01063075|75611718|FG001|STARTED|Overall Study||3||
59761386|NCT02393248|75881100|FG018|NOT COMPLETED|Part 1: Monotherapy Dose Escalation||0||
59761387|NCT02393248|75881101|FG019|NOT COMPLETED|Part 1: Monotherapy Dose Escalation||0||
60065078|NCT02013791|76180388|FG008|COMPLETED|Period 1||3||
59517839|NCT01063075|75611719|FG002|STARTED|Overall Study||14||
59517840|NCT01063075|75611720|FG003|STARTED|Overall Study||15||
59517841|NCT01063075|75611717|FG000|COMPLETED|Overall Study||1||
59517842|NCT01063075|75611718|FG001|COMPLETED|Overall Study||1||
59517843|NCT01063075|75611719|FG002|COMPLETED|Overall Study||9||
60065079|NCT02013791|76180380|FG000|NOT COMPLETED|Period 1||0||
60065080|NCT02013791|76180381|FG001|NOT COMPLETED|Period 1||2||
60065081|NCT02013791|76180382|FG002|NOT COMPLETED|Period 1||0||
60065082|NCT02013791|76180383|FG003|NOT COMPLETED|Period 1||1||
60065083|NCT02013791|76180384|FG004|NOT COMPLETED|Period 1||0||
60065084|NCT02013791|76180385|FG005|NOT COMPLETED|Period 1||0||
60065085|NCT02013791|76180386|FG006|NOT COMPLETED|Period 1||1||
60065086|NCT02013791|76180387|FG007|NOT COMPLETED|Period 1||1||
60065087|NCT02013791|76180388|FG008|NOT COMPLETED|Period 1||0||
60065088|NCT02013791|76180380|FG000|STARTED|Period 2||0||
60065089|NCT02013791|76180381|FG001|STARTED|Period 2||0||
60065090|NCT02013791|76180382|FG002|STARTED|Period 2||2||
60065091|NCT02013791|76180383|FG003|STARTED|Period 2||0||
60065092|NCT02013791|76180384|FG004|STARTED|Period 2||0||
60065093|NCT02013791|76180385|FG005|STARTED|Period 2||0||
60065094|NCT02013791|76180386|FG006|STARTED|Period 2||3||
59930587|NCT02959190|76048756|FG002|240mg/240mg Galcanezumab - EM|Open Label||0||
59930588|NCT02959190|76048757|FG003|240mg/240mg Galcanezumab - EM|Open Label||0||
60065095|NCT02013791|76180387|FG007|STARTED|Period 2||0||
60065096|NCT02013791|76180388|FG008|STARTED|Period 2||0||
59930589|NCT02959190|76048754|FG000|Placebo/ 120mg Galcanezumab - EM|Open Label||62||
59930590|NCT02959190|76048755|FG001|Placebo/ 120mg Galcanezumab - EM|Open Label||0||
59930591|NCT02959190|76048756|FG002|Placebo/ 120mg Galcanezumab - EM|Open Label||0||
59930592|NCT02959190|76048757|FG003|Placebo/ 120mg Galcanezumab - EM|Open Label||0||
59930593|NCT02959190|76048754|FG000|Placebo/ 240mg Galcanezumab - EM|Open Label||0||
59930594|NCT02959190|76048755|FG001|Placebo/ 240mg Galcanezumab - EM|Open Label||64||
59930595|NCT02959190|76048756|FG002|Placebo/ 240mg Galcanezumab - EM|Open Label||0||
60065097|NCT02013791|76180380|FG000|COMPLETED|Period 2||0||
59517844|NCT01063075|75611720|FG003|COMPLETED|Overall Study||14||
59517845|NCT01063075|75611717|FG000|NOT COMPLETED|Overall Study||1||
59613240|NCT01681992|75724388|FG000|COMPLETED|Overall Study||1427||
60065098|NCT02013791|76180381|FG001|COMPLETED|Period 2||0||
60065099|NCT02013791|76180382|FG002|COMPLETED|Period 2||2||
60065100|NCT02013791|76180383|FG003|COMPLETED|Period 2||0||
60065101|NCT02013791|76180384|FG004|COMPLETED|Period 2||0||
59517846|NCT01063075|75611718|FG001|NOT COMPLETED|Overall Study||2||
59517847|NCT01063075|75611719|FG002|NOT COMPLETED|Overall Study||5||
59517848|NCT01063075|75611720|FG003|NOT COMPLETED|Overall Study||1||
59517849|NCT01341405|75611733|FG000|STARTED|Overall Study||40||
59517850|NCT01341405|75611734|FG001|STARTED|Overall Study||42||
59517851|NCT01341405|75611735|FG002|STARTED|Overall Study||43||
59517852|NCT01341405|75611733|FG000|COMPLETED|Overall Study||37||
59613241|NCT01681992|75724389|FG001|COMPLETED|Overall Study||1427||
59613242|NCT01681992|75724390|FG002|COMPLETED|Overall Study||1443||
59613243|NCT01681992|75724388|FG000|NOT COMPLETED|Overall Study||66||
59613244|NCT01681992|75724389|FG001|NOT COMPLETED|Overall Study||70||
59613245|NCT01681992|75724390|FG002|NOT COMPLETED|Overall Study||83||
59613246|NCT01737840|75724400|FG000|STARTED|Overall Study||35||
59613247|NCT01737840|75724401|FG001|STARTED|Overall Study||35||
59613248|NCT01737840|75724400|FG000|COMPLETED|Overall Study||33||
59613249|NCT01737840|75724401|FG001|COMPLETED|Overall Study||33||
59613250|NCT01737840|75724400|FG000|NOT COMPLETED|Overall Study||2||
59613251|NCT01737840|75724401|FG001|NOT COMPLETED|Overall Study||2||
59613252|NCT01687998|75724411|FG000|STARTED|Overall Study||6038||
59613253|NCT01687998|75724412|FG001|STARTED|Overall Study||6054||
59613254|NCT01687998|75724411|FG000|Received at Least One Dose of Study Drug|Overall Study||6036||
59930596|NCT02959190|76048757|FG003|Placebo/ 240mg Galcanezumab - EM|Open Label||0||
59930597|NCT02959190|76048754|FG000|COMPLETED|Open Label||113||
60065102|NCT02013791|76180385|FG005|COMPLETED|Period 2||0||
60065103|NCT02013791|76180386|FG006|COMPLETED|Period 2||3||
60065104|NCT02013791|76180387|FG007|COMPLETED|Period 2||0||
60065105|NCT02013791|76180388|FG008|COMPLETED|Period 2||0||
60065106|NCT02013791|76180380|FG000|NOT COMPLETED|Period 2||0||
60065107|NCT02013791|76180381|FG001|NOT COMPLETED|Period 2||0||
60065108|NCT02013791|76180382|FG002|NOT COMPLETED|Period 2||0||
60065109|NCT02013791|76180383|FG003|NOT COMPLETED|Period 2||0||
60065110|NCT02013791|76180384|FG004|NOT COMPLETED|Period 2||0||
60065111|NCT02013791|76180385|FG005|NOT COMPLETED|Period 2||0||
60065112|NCT02013791|76180386|FG006|NOT COMPLETED|Period 2||0||
60065113|NCT02013791|76180387|FG007|NOT COMPLETED|Period 2||0||
60065114|NCT02013791|76180388|FG008|NOT COMPLETED|Period 2||0||
60065115|NCT02024867|76180411|FG000|STARTED|Overall Study||134||
60065116|NCT02024867|76180412|FG001|STARTED|Overall Study||131||
60065117|NCT02024867|76180411|FG000|COMPLETED|Overall Study||125||
60065118|NCT02024867|76180412|FG001|COMPLETED|Overall Study||124||
60065119|NCT02024867|76180411|FG000|NOT COMPLETED|Overall Study||9||
60065120|NCT02024867|76180412|FG001|NOT COMPLETED|Overall Study||7||
60065121|NCT01953601|76180421|FG000|STARTED|Part 1 (Base Study)||485||
60065122|NCT01953601|76180422|FG001|STARTED|Part 1 (Base Study)||484||
60065123|NCT01953601|76180423|FG002|STARTED|Part 1 (Base Study)||485||
59517853|NCT01341405|75611734|FG001|COMPLETED|Overall Study||39||
59517854|NCT01341405|75611735|FG002|COMPLETED|Overall Study||41||
59517855|NCT01341405|75611733|FG000|NOT COMPLETED|Overall Study||3||
59517856|NCT01341405|75611734|FG001|NOT COMPLETED|Overall Study||3||
59517857|NCT01341405|75611735|FG002|NOT COMPLETED|Overall Study||2||
59517858|NCT01064323|75611743|FG000|STARTED|Overall Study||10||
59517859|NCT01064323|75611743|FG000|COMPLETED|Overall Study||10||
59930598|NCT02959190|76048755|FG001|COMPLETED|Open Label||110||
59517860|NCT01064323|75611743|FG000|NOT COMPLETED|Overall Study||0||
59517861|NCT01064713|75611749|FG000|STARTED|Overall Study||13||
59517862|NCT01064713|75611750|FG001|STARTED|Overall Study||4||
59517863|NCT01064713|75611749|FG000|COMPLETED|Overall Study||13||
59517864|NCT01064713|75611750|FG001|COMPLETED|Overall Study||4||
59517865|NCT01064713|75611749|FG000|NOT COMPLETED|Overall Study||0||
59517866|NCT01064713|75611750|FG001|NOT COMPLETED|Overall Study||0||
59517867|NCT01065571|75611758|FG000|STARTED|Overall Study||10||
59517868|NCT01065571|75611759|FG001|STARTED|Overall Study||5||
59517869|NCT01065571|75611758|FG000|COMPLETED|Overall Study||7||
59517870|NCT01065571|75611759|FG001|COMPLETED|Overall Study||5||
59517871|NCT01065571|75611758|FG000|NOT COMPLETED|Overall Study||3||
59517872|NCT01065571|75611759|FG001|NOT COMPLETED|Overall Study||0||
59517873|NCT03248440|75611769|FG000|STARTED|Overall Study||131||
59517874|NCT03248440|75611770|FG001|STARTED|Overall Study||132||
59517875|NCT03248440|75611769|FG000|COMPLETED|Overall Study||116||
59517876|NCT03248440|75611770|FG001|COMPLETED|Overall Study||120||
59517877|NCT03248440|75611769|FG000|NOT COMPLETED|Overall Study||15||
59517878|NCT03248440|75611770|FG001|NOT COMPLETED|Overall Study||12||
59517879|NCT03487276|75611781|FG000|STARTED|Main Period (16 Weeks)||37||
59517880|NCT03487276|75611782|FG001|STARTED|Main Period (16 Weeks)||34||
59517881|NCT03487276|75611783|FG002|STARTED|Main Period (16 Weeks)||36||
59517882|NCT03487276|75611784|FG003|STARTED|Main Period (16 Weeks)||36||
59517883|NCT03487276|75611785|FG004|STARTED|Main Period (16 Weeks)||36||
59517884|NCT03487276|75611781|FG000|COMPLETED|Main Period (16 Weeks)||34||
59613255|NCT01687998|75724412|FG001|Received at Least One Dose of Study Drug|Overall Study||6052||
59930599|NCT02959190|76048756|FG002|COMPLETED|Open Label||28||
59930600|NCT02959190|76048757|FG003|COMPLETED|Open Label||27||
59930601|NCT02959190|76048754|FG000|NOT COMPLETED|Open Label||7||
59930602|NCT02959190|76048755|FG001|NOT COMPLETED|Open Label||16||
59930603|NCT02959190|76048756|FG002|NOT COMPLETED|Open Label||4||
60065124|NCT01953601|76180421|FG000|Treated|Part 1 (Base Study)||483||
60065125|NCT01953601|76180422|FG001|Treated|Part 1 (Base Study)||484||
60065126|NCT01953601|76180423|FG002|Treated|Part 1 (Base Study)||484||
60065127|NCT01953601|76180421|FG000|COMPLETED|Part 1 (Base Study)||234||
60065128|NCT01953601|76180422|FG001|COMPLETED|Part 1 (Base Study)||231||
60065129|NCT01953601|76180423|FG002|COMPLETED|Part 1 (Base Study)||239||
59930604|NCT02959190|76048757|FG003|NOT COMPLETED|Open Label||6||
59930605|NCT02959190|76048754|FG000|STARTED|Post Treatment Follow Up|Participants who discontinued open-label treatment phase had an option to enter post treatment phase|117||
60065130|NCT01953601|76180421|FG000|NOT COMPLETED|Part 1 (Base Study)||251||
60065131|NCT01953601|76180422|FG001|NOT COMPLETED|Part 1 (Base Study)||253||
59517885|NCT03487276|75611782|FG001|COMPLETED|Main Period (16 Weeks)||30||
59517886|NCT03487276|75611783|FG002|COMPLETED|Main Period (16 Weeks)||32||
59930606|NCT02959190|76048755|FG001|STARTED|Post Treatment Follow Up|Participants who discontinued open-label treatment phase had an option to enter post treatment phase|120||
59517887|NCT03487276|75611784|FG003|COMPLETED|Main Period (16 Weeks)||30||
59517888|NCT03487276|75611785|FG004|COMPLETED|Main Period (16 Weeks)|One patient completed the Main Period but was lost to follow-up afterwards and not treated in the Extension Period|31||
59517889|NCT03487276|75611781|FG000|NOT COMPLETED|Main Period (16 Weeks)||3||
59517890|NCT03487276|75611782|FG001|NOT COMPLETED|Main Period (16 Weeks)||4||
59517891|NCT03487276|75611783|FG002|NOT COMPLETED|Main Period (16 Weeks)||4||
59613256|NCT01687998|75724411|FG000|COMPLETED|Overall Study||5926||
60065132|NCT01953601|76180423|FG002|NOT COMPLETED|Part 1 (Base Study)||246||
60065133|NCT01953601|76180421|FG000|STARTED|Part 2 (Extension Study)|Number started refers only to participants completing Part 1, volunteering to continue to Part 2.|198||
60067881|NCT01756053|76183072|FG001|STARTED|Washout Period (~21 Days)||8||
60065134|NCT01953601|76180422|FG001|STARTED|Part 2 (Extension Study)|Number started refers only to participants completing Part 1, volunteering to continue to Part 2.|191||
60065135|NCT01953601|76180423|FG002|STARTED|Part 2 (Extension Study)|Number started refers only to participants completing Part 1, volunteering to continue to Part 2.|204||
60065136|NCT01953601|76180421|FG000|Treated|Part 2 (Extension Study)||197||
60065137|NCT01953601|76180422|FG001|Treated|Part 2 (Extension Study)||191||
60065138|NCT01953601|76180423|FG002|Treated|Part 2 (Extension Study)||204||
60065139|NCT01953601|76180421|FG000|COMPLETED|Part 2 (Extension Study)||0||
60065140|NCT01953601|76180422|FG001|COMPLETED|Part 2 (Extension Study)||0||
60065141|NCT01953601|76180423|FG002|COMPLETED|Part 2 (Extension Study)||0||
60065142|NCT01953601|76180421|FG000|NOT COMPLETED|Part 2 (Extension Study)||198||
60065143|NCT01953601|76180422|FG001|NOT COMPLETED|Part 2 (Extension Study)||191||
60065144|NCT01953601|76180423|FG002|NOT COMPLETED|Part 2 (Extension Study)||204||
60065145|NCT01952665|76180436|FG000|STARTED|Overall Study||37||
60065146|NCT01952665|76180437|FG001|STARTED|Overall Study||26||
60065147|NCT01952665|76180436|FG000|COMPLETED|Overall Study||31||
60065148|NCT01952665|76180437|FG001|COMPLETED|Overall Study||20||
60065149|NCT01952665|76180436|FG000|NOT COMPLETED|Overall Study||6||
60065150|NCT01952665|76180437|FG001|NOT COMPLETED|Overall Study||6||
60065151|NCT01952041|76180448|FG000|STARTED|Overall Study||62||
60065152|NCT01952041|76180449|FG001|STARTED|Overall Study||64||
60065153|NCT01952041|76180448|FG000|COMPLETED|Overall Study||45||
60065154|NCT01952041|76180449|FG001|COMPLETED|Overall Study||43||
60065155|NCT01952041|76180448|FG000|NOT COMPLETED|Overall Study||17||
60065156|NCT01952041|76180449|FG001|NOT COMPLETED|Overall Study||21||
60065157|NCT01951573|76180455|FG000|STARTED|Period 1, First 9 Hours of Wear||17||
60065158|NCT01951573|76180456|FG001|STARTED|Period 1, First 9 Hours of Wear||17||
60065159|NCT01951573|76180455|FG000|COMPLETED|Period 1, First 9 Hours of Wear||17||
60065160|NCT01951573|76180456|FG001|COMPLETED|Period 1, First 9 Hours of Wear||17||
60065161|NCT01951573|76180455|FG000|NOT COMPLETED|Period 1, First 9 Hours of Wear||0||
60065162|NCT01951573|76180456|FG001|NOT COMPLETED|Period 1, First 9 Hours of Wear||0||
60065163|NCT01951573|76180455|FG000|STARTED|Washout Period||17||
60065164|NCT01951573|76180456|FG001|STARTED|Washout Period||17||
60065165|NCT01951573|76180455|FG000|COMPLETED|Washout Period||17||
60065166|NCT01951573|76180456|FG001|COMPLETED|Washout Period||16||
60065167|NCT01951573|76180455|FG000|NOT COMPLETED|Washout Period||0||
60065168|NCT01951573|76180456|FG001|NOT COMPLETED|Washout Period||1||
60065169|NCT01951573|76180455|FG000|STARTED|Period 2, Second 9 Hours of Wear||17||
60065170|NCT01951573|76180456|FG001|STARTED|Period 2, Second 9 Hours of Wear||16||
60065171|NCT01951573|76180455|FG000|COMPLETED|Period 2, Second 9 Hours of Wear||17||
60065172|NCT01951573|76180456|FG001|COMPLETED|Period 2, Second 9 Hours of Wear||16||
60065173|NCT01951573|76180455|FG000|NOT COMPLETED|Period 2, Second 9 Hours of Wear||0||
60065174|NCT01951573|76180456|FG001|NOT COMPLETED|Period 2, Second 9 Hours of Wear||0||
60065175|NCT02023697|76180465|FG000|STARTED|Treatment Period||130|Randomized, Intent-To-Treatment (ITT)|
60065176|NCT02023697|76180466|FG001|STARTED|Treatment Period||130|Randomized, Intent-To-Treatment (ITT)|
60065177|NCT02023697|76180467|FG002|STARTED|Treatment Period||131|Randomized, Intent-To-Treatment (ITT)|
60065178|NCT02023697|76180465|FG000|Received Treatment|Treatment Period||125||
60065179|NCT02023697|76180466|FG001|Received Treatment|Treatment Period||124||
60065180|NCT02023697|76180467|FG002|Received Treatment|Treatment Period||121||
60065181|NCT02023697|76180465|FG000|COMPLETED|Treatment Period||84||
60065182|NCT02023697|76180466|FG001|COMPLETED|Treatment Period||67||
60065183|NCT02023697|76180467|FG002|COMPLETED|Treatment Period||29||
60065184|NCT02023697|76180465|FG000|NOT COMPLETED|Treatment Period||46||
60065185|NCT02023697|76180466|FG001|NOT COMPLETED|Treatment Period||63||
60065186|NCT02023697|76180467|FG002|NOT COMPLETED|Treatment Period||102||
60065187|NCT02023697|76180465|FG000|STARTED|Active Follow-up Period|Not all participants in ITT entered active follow-up.|120|Entered active follow-up|
60065188|NCT02023697|76180466|FG001|STARTED|Active Follow-up Period|Not all participants in ITT entered active follow-up.|120|Entered active follow-up|
60065189|NCT02023697|76180467|FG002|STARTED|Active Follow-up Period|Not all participants in ITT entered active follow-up.|116|Entered active follow-up|
60065190|NCT02023697|76180465|FG000|COMPLETED|Active Follow-up Period||28||
60065191|NCT02023697|76180466|FG001|COMPLETED|Active Follow-up Period||21||
60065192|NCT02023697|76180467|FG002|COMPLETED|Active Follow-up Period||17||
59519050|NCT03593902|75612910|FG000|NOT COMPLETED|Overall Study||0||
60065193|NCT02023697|76180465|FG000|NOT COMPLETED|Active Follow-up Period||92||
60065194|NCT02023697|76180466|FG001|NOT COMPLETED|Active Follow-up Period||99||
60065195|NCT02023697|76180467|FG002|NOT COMPLETED|Active Follow-up Period||99||
60065196|NCT02023697|76180465|FG000|STARTED|Long-term Follow-up Period||28||
60065197|NCT02023697|76180466|FG001|STARTED|Long-term Follow-up Period||21||
60065198|NCT02023697|76180467|FG002|STARTED|Long-term Follow-up Period||17||
60065199|NCT02023697|76180465|FG000|COMPLETED|Long-term Follow-up Period||0||
60065200|NCT02023697|76180466|FG001|COMPLETED|Long-term Follow-up Period||0||
60065201|NCT02023697|76180467|FG002|COMPLETED|Long-term Follow-up Period||0||
59517892|NCT03487276|75611784|FG003|NOT COMPLETED|Main Period (16 Weeks)||6||
59517893|NCT03487276|75611785|FG004|NOT COMPLETED|Main Period (16 Weeks)||5||
59517894|NCT03487276|75611781|FG000|STARTED|Extension Period (28 Weeks)||0||
59517895|NCT03487276|75611782|FG001|STARTED|Extension Period (28 Weeks)||0||
59517896|NCT03487276|75611783|FG002|STARTED|Extension Period (28 Weeks)||72||
59517897|NCT03487276|75611784|FG003|STARTED|Extension Period (28 Weeks)||84||
59517898|NCT03487276|75611785|FG004|STARTED|Extension Period (28 Weeks)||0||
59517899|NCT03487276|75611781|FG000|Number of Patients in Cohort 1 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0||
59517900|NCT03487276|75611782|FG001|Number of Patients in Cohort 1 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0||
59517901|NCT03487276|75611783|FG002|Number of Patients in Cohort 1 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||16||
59517902|NCT03487276|75611784|FG003|Number of Patients in Cohort 1 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||18||
59517903|NCT03487276|75611785|FG004|Number of Patients in Cohort 1 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0||
60065202|NCT02023697|76180465|FG000|NOT COMPLETED|Long-term Follow-up Period||28||
60065203|NCT02023697|76180466|FG001|NOT COMPLETED|Long-term Follow-up Period||21||
60065204|NCT02023697|76180467|FG002|NOT COMPLETED|Long-term Follow-up Period||17||
60065205|NCT01951417|76180482|FG000|STARTED|Overall Study||81||
60065206|NCT01951417|76180482|FG000|COMPLETED|Overall Study||72||
60065207|NCT01951417|76180482|FG000|NOT COMPLETED|Overall Study||9||
60065208|NCT01951261|76180492|FG000|STARTED|Overall Study||58||
60065209|NCT01951261|76180493|FG001|STARTED|Overall Study||58||
60065210|NCT01951261|76180492|FG000|Discontinued|Overall Study|"2-readmission when was at home~1-monitor failure~1-new home hospitalitation 4-missing~1-death"|9||
60065211|NCT01951261|76180493|FG001|Discontinued|Overall Study|"2-readmission when was at home~1-new home hospitalitation 3-missing"|6||
60065212|NCT01951261|76180492|FG000|COMPLETED|Overall Study||49||
60065213|NCT01951261|76180493|FG001|COMPLETED|Overall Study||52||
60065214|NCT01951261|76180492|FG000|NOT COMPLETED|Overall Study||9||
60065215|NCT01951261|76180493|FG001|NOT COMPLETED|Overall Study||6||
60065216|NCT02023151|76180499|FG000|STARTED|Overall Study||17||
59517904|NCT03487276|75611781|FG000|Number of Patients in Cohort 2 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0||
59517905|NCT03487276|75611782|FG001|Number of Patients in Cohort 2 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0||
60065217|NCT02023151|76180499|FG000|COMPLETED|Overall Study||13||
60065218|NCT02023151|76180499|FG000|NOT COMPLETED|Overall Study||4||
60065219|NCT01979185|76180505|FG000|STARTED|Period 1||15||
60065220|NCT01979185|76180506|FG001|STARTED|Period 1||15||
60065221|NCT01979185|76180505|FG000|COMPLETED|Period 1||15||
60065222|NCT01979185|76180506|FG001|COMPLETED|Period 1||15||
60065223|NCT01979185|76180505|FG000|NOT COMPLETED|Period 1||0||
60065224|NCT01979185|76180506|FG001|NOT COMPLETED|Period 1||0||
60065225|NCT01979185|76180505|FG000|STARTED|Period 2||15||
60065226|NCT01979185|76180506|FG001|STARTED|Period 2||15||
60065227|NCT01979185|76180505|FG000|COMPLETED|Period 2||15||
60065228|NCT01979185|76180506|FG001|COMPLETED|Period 2|1 subject discontinued due to a positive drug test prior to receiving Simvastatin alone in Period 2.|14||
60065229|NCT01979185|76180505|FG000|NOT COMPLETED|Period 2||0||
60065230|NCT01979185|76180506|FG001|NOT COMPLETED|Period 2||1||
60065231|NCT01946425|76180514|FG000|STARTED|Overall Study||30||
60065232|NCT01946425|76180515|FG001|STARTED|Overall Study||30||
60065233|NCT01946425|76180514|FG000|COMPLETED|Overall Study||28||
60065234|NCT01946425|76180515|FG001|COMPLETED|Overall Study||30||
60065235|NCT01946425|76180514|FG000|NOT COMPLETED|Overall Study||2||
60065236|NCT01946425|76180515|FG001|NOT COMPLETED|Overall Study||0||
60065237|NCT01946191|76180524|FG000|STARTED|Allocation||98||
60065238|NCT01946191|76180525|FG001|STARTED|Allocation||96||
60065239|NCT01946191|76180524|FG000|COMPLETED|Allocation||97||
60065240|NCT01946191|76180525|FG001|COMPLETED|Allocation||95||
60065241|NCT01946191|76180524|FG000|NOT COMPLETED|Allocation||1||
60065242|NCT01946191|76180525|FG001|NOT COMPLETED|Allocation||1||
60065243|NCT01946191|76180524|FG000|STARTED|Follow-Up, 24-mo Endpoint||97||
60065244|NCT01946191|76180525|FG001|STARTED|Follow-Up, 24-mo Endpoint||95||
60065245|NCT01946191|76180524|FG000|COMPLETED|Follow-Up, 24-mo Endpoint||80||
60065246|NCT01946191|76180525|FG001|COMPLETED|Follow-Up, 24-mo Endpoint||77||
60065247|NCT01946191|76180524|FG000|NOT COMPLETED|Follow-Up, 24-mo Endpoint||17||
60065248|NCT01946191|76180525|FG001|NOT COMPLETED|Follow-Up, 24-mo Endpoint||18||
60065249|NCT01946191|76180524|FG000|STARTED|Primary Outcome Analysis||98||
60065250|NCT01946191|76180525|FG001|STARTED|Primary Outcome Analysis||95||
60065251|NCT01946191|76180524|FG000|COMPLETED|Primary Outcome Analysis|Weight data at 24 months|80||
60065252|NCT01946191|76180525|FG001|COMPLETED|Primary Outcome Analysis|Weight data at 24 months|77||
60065253|NCT01946191|76180524|FG000|NOT COMPLETED|Primary Outcome Analysis||18||
60065254|NCT01946191|76180525|FG001|NOT COMPLETED|Primary Outcome Analysis||18||
60065255|NCT01937312|76180534|FG000|STARTED|Overall Study||94||
60065256|NCT01937312|76180535|FG001|STARTED|Overall Study||95||
59517906|NCT03487276|75611783|FG002|Number of Patients in Cohort 2 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||12||
59517907|NCT03487276|75611784|FG003|Number of Patients in Cohort 2 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||18||
59517908|NCT03487276|75611785|FG004|Number of Patients in Cohort 2 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0||
59517909|NCT03487276|75611781|FG000|Number of Patients in Cohort 3 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0||
59517910|NCT03487276|75611782|FG001|Number of Patients in Cohort 3 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0||
59517911|NCT03487276|75611783|FG002|Number of Patients in Cohort 3 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||17||
59517912|NCT03487276|75611784|FG003|Number of Patients in Cohort 3 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||15||
59517913|NCT03487276|75611785|FG004|Number of Patients in Cohort 3 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0||
59517914|NCT03487276|75611781|FG000|Number of Patients in Cohort 4 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0||
59517915|NCT03487276|75611782|FG001|Number of Patients in Cohort 4 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0||
59517916|NCT03487276|75611783|FG002|Number of Patients in Cohort 4 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||12||
59517917|NCT03487276|75611784|FG003|Number of Patients in Cohort 4 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||18||
59517918|NCT03487276|75611785|FG004|Number of Patients in Cohort 4 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0||
59517919|NCT03487276|75611781|FG000|Number of Patients in Cohort 5 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0|One patient of Cohort 5 completed the Main Period as Non-Responder but was lost to follow-up afterwards and not treated in the Extension Period|
59517920|NCT03487276|75611782|FG001|Number of Patients in Cohort 5 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0|One patient of Cohort 5 completed the Main Period as Non-Responder but was lost to follow-up afterwards and not treated in the Extension Period|
59519051|NCT00948935|75612914|FG000|STARTED|Overall Study||35||
59930607|NCT02959190|76048756|FG002|STARTED|Post Treatment Follow Up|Participants who discontinued open-label treatment phase had an option to enter post treatment phase|32||
59930608|NCT02959190|76048757|FG003|STARTED|Post Treatment Follow Up|Participants who discontinued open-label treatment phase had an option to enter post treatment phase|32||
59930609|NCT02959190|76048754|FG000|COMPLETED|Post Treatment Follow Up||114||
59930610|NCT02959190|76048755|FG001|COMPLETED|Post Treatment Follow Up||119||
59930611|NCT02959190|76048756|FG002|COMPLETED|Post Treatment Follow Up||31||
59930612|NCT02959190|76048757|FG003|COMPLETED|Post Treatment Follow Up||32||
59930613|NCT02959190|76048754|FG000|NOT COMPLETED|Post Treatment Follow Up||3||
59930614|NCT02959190|76048755|FG001|NOT COMPLETED|Post Treatment Follow Up||1||
59930615|NCT02959190|76048756|FG002|NOT COMPLETED|Post Treatment Follow Up||1||
59930616|NCT02959190|76048757|FG003|NOT COMPLETED|Post Treatment Follow Up||0||
59930617|NCT01344356|76048778|FG000|STARTED|Overall Study||1||
59930618|NCT01344356|76048779|FG001|STARTED|Overall Study||18||
59930619|NCT01344356|76048778|FG000|COMPLETED|Overall Study||1||
59930620|NCT01344356|76048779|FG001|COMPLETED|Overall Study||9||
59930621|NCT01344356|76048778|FG000|NOT COMPLETED|Overall Study||0||
59930622|NCT01344356|76048779|FG001|NOT COMPLETED|Overall Study||9||
59930623|NCT03722810|76048789|FG000|STARTED|Overall Study||157||
59930624|NCT03722810|76048790|FG001|STARTED|Overall Study||160||
59930625|NCT03722810|76048789|FG000|COMPLETED|Overall Study||150||
59930626|NCT03722810|76048790|FG001|COMPLETED|Overall Study||156||
59930627|NCT03722810|76048789|FG000|NOT COMPLETED|Overall Study||7||
59930628|NCT03722810|76048790|FG001|NOT COMPLETED|Overall Study||4||
59930629|NCT02956460|76048805|FG000|STARTED|Lens 1||30||
59930630|NCT02956460|76048806|FG001|STARTED|Lens 1||34||
59930631|NCT02956460|76048805|FG000|COMPLETED|Lens 1||29||
59930632|NCT02956460|76048806|FG001|COMPLETED|Lens 1||34||
59930633|NCT02956460|76048805|FG000|NOT COMPLETED|Lens 1||1||
59930634|NCT02956460|76048806|FG001|NOT COMPLETED|Lens 1||0||
59930635|NCT02956460|76048805|FG000|STARTED|Lens 2||29||
59930636|NCT02956460|76048806|FG001|STARTED|Lens 2||34||
59930637|NCT02956460|76048805|FG000|COMPLETED|Lens 2||29||
59930638|NCT02956460|76048806|FG001|COMPLETED|Lens 2||34||
60065257|NCT01937312|76180534|FG000|Treated|Overall Study||93||
59930639|NCT02956460|76048805|FG000|NOT COMPLETED|Lens 2||0||
59930640|NCT02956460|76048806|FG001|NOT COMPLETED|Lens 2||0||
59930641|NCT02999100|76048818|FG000|STARTED|Part 1 (up to 15 Days)||9||
59930642|NCT02999100|76048819|FG001|STARTED|Part 1 (up to 15 Days)||8||
59930643|NCT02999100|76048820|FG002|STARTED|Part 1 (up to 15 Days)||0||
59930644|NCT02999100|76048821|FG003|STARTED|Part 1 (up to 15 Days)||0||
59930645|NCT02999100|76048822|FG004|STARTED|Part 1 (up to 15 Days)||0||
59930646|NCT02999100|76048823|FG005|STARTED|Part 1 (up to 15 Days)||0||
59930647|NCT02999100|76048818|FG000|COMPLETED|Part 1 (up to 15 Days)||9||
59930648|NCT02999100|76048819|FG001|COMPLETED|Part 1 (up to 15 Days)||7||
59930649|NCT02999100|76048820|FG002|COMPLETED|Part 1 (up to 15 Days)||0||
59930650|NCT02999100|76048821|FG003|COMPLETED|Part 1 (up to 15 Days)||0||
59930651|NCT02999100|76048822|FG004|COMPLETED|Part 1 (up to 15 Days)||0||
59930652|NCT02999100|76048823|FG005|COMPLETED|Part 1 (up to 15 Days)||0||
59930653|NCT02999100|76048818|FG000|NOT COMPLETED|Part 1 (up to 15 Days)||0||
59930654|NCT02999100|76048819|FG001|NOT COMPLETED|Part 1 (up to 15 Days)||1||
59930655|NCT02999100|76048820|FG002|NOT COMPLETED|Part 1 (up to 15 Days)||0||
60065258|NCT01937312|76180535|FG001|Treated|Overall Study||95||
59517921|NCT03487276|75611783|FG002|Number of Patients in Cohort 5 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||15|One patient of Cohort 5 completed the Main Period as Non-Responder but was lost to follow-up afterwards and not treated in the Extension Period|
59517922|NCT03487276|75611784|FG003|Number of Patients in Cohort 5 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||16|One patient of Cohort 5 completed the Main Period as Non-Responder but was lost to follow-up afterwards and not treated in the Extension Period|
59517923|NCT03487276|75611785|FG004|Number of Patients in Cohort 5 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0|One patient of Cohort 5 completed the Main Period as Non-Responder but was lost to follow-up afterwards and not treated in the Extension Period|
59517924|NCT03487276|75611781|FG000|COMPLETED|Extension Period (28 Weeks)||0||
60065259|NCT01937312|76180534|FG000|COMPLETED|Overall Study||83||
60065260|NCT01937312|76180535|FG001|COMPLETED|Overall Study||92||
60065261|NCT01937312|76180534|FG000|NOT COMPLETED|Overall Study||11||
60065262|NCT01937312|76180535|FG001|NOT COMPLETED|Overall Study||3||
60065263|NCT01935128|76180542|FG000|STARTED|Overall Study||50||
60065264|NCT01935128|76180542|FG000|COMPLETED|Overall Study||43||
60065265|NCT01935128|76180542|FG000|NOT COMPLETED|Overall Study||7||
60065266|NCT01934972|76180548|FG000|STARTED|Overall Study||13||
60065267|NCT01934972|76180549|FG001|STARTED|Overall Study||11||
60065268|NCT01934972|76180548|FG000|COMPLETED|Overall Study||4||
60065269|NCT01934972|76180549|FG001|COMPLETED|Overall Study||5||
60065270|NCT01934972|76180548|FG000|NOT COMPLETED|Overall Study||9||
60065271|NCT01934972|76180549|FG001|NOT COMPLETED|Overall Study||6||
60065272|NCT01959230|76180557|FG000|STARTED|Overall Study||40||
60065273|NCT01959230|76180558|FG001|STARTED|Overall Study||20||
60065274|NCT01959230|76180557|FG000|Received at Least 1 Dose of Study Drug|Overall Study||40||
60065275|NCT01959230|76180558|FG001|Received at Least 1 Dose of Study Drug|Overall Study||20||
60065276|NCT01959230|76180557|FG000|COMPLETED|Overall Study||36||
60065277|NCT01959230|76180558|FG001|COMPLETED|Overall Study||19||
60065278|NCT01959230|76180557|FG000|NOT COMPLETED|Overall Study||4||
60065279|NCT01959230|76180558|FG001|NOT COMPLETED|Overall Study||1||
60065280|NCT01909778|76180564|FG000|STARTED|Overall Study||2||
60065281|NCT01909778|76180564|FG000|COMPLETED|Overall Study||1||
60065282|NCT01909778|76180564|FG000|NOT COMPLETED|Overall Study||1||
60065283|NCT01977937|76180572|FG000|STARTED|Overall Study||27||
60065284|NCT01977937|76180573|FG001|STARTED|Overall Study||28||
60065285|NCT01977937|76180572|FG000|COMPLETED|Overall Study||24||
60065286|NCT01977937|76180573|FG001|COMPLETED|Overall Study||26||
60065287|NCT01977937|76180572|FG000|NOT COMPLETED|Overall Study||3||
60065288|NCT01977937|76180573|FG001|NOT COMPLETED|Overall Study||2||
60065289|NCT02015663|76180581|FG000|STARTED|Overall Study||16||
60065290|NCT02015663|76180582|FG001|STARTED|Overall Study||16||
60065291|NCT02015663|76180581|FG000|COMPLETED|Overall Study||1||
60065292|NCT02015663|76180582|FG001|COMPLETED|Overall Study||4||
60065293|NCT02015663|76180581|FG000|NOT COMPLETED|Overall Study||15||
60065294|NCT02015663|76180582|FG001|NOT COMPLETED|Overall Study||12||
60065295|NCT01978093|76180591|FG000|STARTED|Overall Study||297||
60065296|NCT01978093|76180592|FG001|STARTED|Overall Study||303||
60065297|NCT01978093|76180591|FG000|COMPLETED|Overall Study||232||
60065298|NCT01978093|76180592|FG001|COMPLETED|Overall Study||230||
60065299|NCT01978093|76180591|FG000|NOT COMPLETED|Overall Study||65||
60065300|NCT01978093|76180592|FG001|NOT COMPLETED|Overall Study||73||
60065301|NCT01951105|76180604|FG000|STARTED|Overall Study||11||
60065302|NCT01951105|76180605|FG001|STARTED|Overall Study||31||
60065303|NCT01951105|76180606|FG002|STARTED|Overall Study||30||
60065304|NCT01951105|76180604|FG000|Completed 12 Weeks Treatment|Overall Study||10||
60065305|NCT01951105|76180605|FG001|Completed 12 Weeks Treatment|Overall Study||24||
59517925|NCT03487276|75611782|FG001|COMPLETED|Extension Period (28 Weeks)||0||
59517926|NCT03487276|75611783|FG002|COMPLETED|Extension Period (28 Weeks)||67||
60065306|NCT01951105|76180606|FG002|Completed 12 Weeks Treatment|Overall Study||28||
60065307|NCT01951105|76180604|FG000|COMPLETED|Overall Study||10||
60065308|NCT01951105|76180605|FG001|COMPLETED|Overall Study||21||
60065309|NCT01951105|76180606|FG002|COMPLETED|Overall Study||28||
60065310|NCT01951105|76180604|FG000|NOT COMPLETED|Overall Study||1||
60065311|NCT01951105|76180605|FG001|NOT COMPLETED|Overall Study||10||
60065312|NCT01951105|76180606|FG002|NOT COMPLETED|Overall Study||2||
60065313|NCT01958918|76180622|FG000|STARTED|Overall Study||356|patients randomized|
60065314|NCT01958918|76180623|FG001|STARTED|Overall Study||356|patients randomized|
60065315|NCT01958918|76180622|FG000|Full Analysis Set|Overall Study||353||
60065316|NCT01958918|76180623|FG001|Full Analysis Set|Overall Study||354||
60065317|NCT01958918|76180622|FG000|COMPLETED|Overall Study||313|completed overall|
60065318|NCT01958918|76180623|FG001|COMPLETED|Overall Study||314|completed overall|
60065319|NCT01958918|76180622|FG000|NOT COMPLETED|Overall Study||43||
60065320|NCT01958918|76180623|FG001|NOT COMPLETED|Overall Study||42||
60065321|NCT01945489|76180631|FG000|STARTED|Cycle 1||129||
60065322|NCT01945489|76180632|FG001|STARTED|Cycle 1||125||
60065323|NCT01945489|76180631|FG000|COMPLETED|Cycle 1||116||
60065324|NCT01945489|76180632|FG001|COMPLETED|Cycle 1||121||
60065325|NCT01945489|76180631|FG000|NOT COMPLETED|Cycle 1||13||
60065326|NCT01945489|76180632|FG001|NOT COMPLETED|Cycle 1||4||
60065327|NCT01945489|76180631|FG000|STARTED|Cycle 2|Not all participants participated in Cycle 2.|88||
60065328|NCT01945489|76180632|FG001|STARTED|Cycle 2||107||
60065329|NCT01945489|76180631|FG000|COMPLETED|Cycle 2||87||
60065330|NCT01945489|76180632|FG001|COMPLETED|Cycle 2||106||
60065331|NCT01945489|76180631|FG000|NOT COMPLETED|Cycle 2||1||
60065332|NCT01945489|76180632|FG001|NOT COMPLETED|Cycle 2||1||
60065333|NCT01934894|76180641|FG000|STARTED|Overall Study||6||
60065334|NCT01934894|76180642|FG001|STARTED|Overall Study||5||
60065335|NCT01934894|76180641|FG000|COMPLETED|Overall Study||0||
59930656|NCT02999100|76048821|FG003|NOT COMPLETED|Part 1 (up to 15 Days)||0||
59930657|NCT02999100|76048822|FG004|NOT COMPLETED|Part 1 (up to 15 Days)||0||
59930658|NCT02999100|76048823|FG005|NOT COMPLETED|Part 1 (up to 15 Days)||0||
59930659|NCT02999100|76048818|FG000|STARTED|Part 2 (Day 1): Dosing Session 1|Participants from Part 1 did not enter Part 2|0||
59930660|NCT02999100|76048819|FG001|STARTED|Part 2 (Day 1): Dosing Session 1|Participants from Part 1 did not enter Part 2|0||
59930661|NCT02999100|76048820|FG002|STARTED|Part 2 (Day 1): Dosing Session 1|New participants were enrolled in Part 2 of study|5||
59930662|NCT02999100|76048821|FG003|STARTED|Part 2 (Day 1): Dosing Session 1|New participants were enrolled in Part 2 of study|3||
59930663|NCT02999100|76048822|FG004|STARTED|Part 2 (Day 1): Dosing Session 1|New participants were enrolled in Part 2 of study|3||
59930664|NCT02999100|76048823|FG005|STARTED|Part 2 (Day 1): Dosing Session 1|New participants were enrolled in Part 2 of study|3||
59930665|NCT02999100|76048818|FG000|COMPLETED|Part 2 (Day 1): Dosing Session 1||0||
59930666|NCT02999100|76048819|FG001|COMPLETED|Part 2 (Day 1): Dosing Session 1||0||
60065336|NCT01934894|76180642|FG001|COMPLETED|Overall Study||0||
60065337|NCT01934894|76180641|FG000|NOT COMPLETED|Overall Study||6||
60065338|NCT01934894|76180642|FG001|NOT COMPLETED|Overall Study||5||
59930667|NCT02999100|76048820|FG002|COMPLETED|Part 2 (Day 1): Dosing Session 1||4||
59930668|NCT02999100|76048821|FG003|COMPLETED|Part 2 (Day 1): Dosing Session 1||3||
59930669|NCT02999100|76048822|FG004|COMPLETED|Part 2 (Day 1): Dosing Session 1||3||
60065339|NCT01950169|76180654|FG000|STARTED|Overall Study||28||
60065340|NCT01950169|76180655|FG001|STARTED|Overall Study||26||
60065341|NCT01950169|76180656|FG002|STARTED|Overall Study||25||
60065342|NCT01950169|76180654|FG000|COMPLETED|Overall Study||25||
59930670|NCT02999100|76048823|FG005|COMPLETED|Part 2 (Day 1): Dosing Session 1||2||
60065343|NCT01950169|76180655|FG001|COMPLETED|Overall Study||18||
60065344|NCT01950169|76180656|FG002|COMPLETED|Overall Study||24||
60065345|NCT01950169|76180654|FG000|NOT COMPLETED|Overall Study||3||
60065346|NCT01950169|76180655|FG001|NOT COMPLETED|Overall Study||8||
60065347|NCT01950169|76180656|FG002|NOT COMPLETED|Overall Study||1||
60065348|NCT01934504|76180669|FG000|STARTED|Overall Study||6||
60065349|NCT01934504|76180670|FG001|STARTED|Overall Study||3||
60065350|NCT01934504|76180671|FG002|STARTED|Overall Study||16||
60065351|NCT01934504|76180672|FG003|STARTED|Overall Study||8||
59930671|NCT02999100|76048818|FG000|NOT COMPLETED|Part 2 (Day 1): Dosing Session 1||0||
59930672|NCT02999100|76048819|FG001|NOT COMPLETED|Part 2 (Day 1): Dosing Session 1||0||
59930673|NCT02999100|76048820|FG002|NOT COMPLETED|Part 2 (Day 1): Dosing Session 1||1||
60065352|NCT01934504|76180669|FG000|COMPLETED|Overall Study||5||
60065353|NCT01934504|76180670|FG001|COMPLETED|Overall Study||3||
59930674|NCT02999100|76048821|FG003|NOT COMPLETED|Part 2 (Day 1): Dosing Session 1||0||
59930675|NCT02999100|76048822|FG004|NOT COMPLETED|Part 2 (Day 1): Dosing Session 1||0||
60065354|NCT01934504|76180671|FG002|COMPLETED|Overall Study||11||
60065355|NCT01934504|76180672|FG003|COMPLETED|Overall Study||1||
60065356|NCT01934504|76180669|FG000|NOT COMPLETED|Overall Study||1||
60065357|NCT01934504|76180670|FG001|NOT COMPLETED|Overall Study||0||
60065358|NCT01934504|76180671|FG002|NOT COMPLETED|Overall Study||5||
60065359|NCT01934504|76180672|FG003|NOT COMPLETED|Overall Study||7||
60065360|NCT01950013|76180685|FG000|STARTED|Overall Study||15||
60065361|NCT01950013|76180686|FG001|STARTED|Overall Study||15||
60065362|NCT01950013|76180687|FG002|STARTED|Overall Study||15||
60065363|NCT01950013|76180685|FG000|COMPLETED|Overall Study||15||
60065364|NCT01950013|76180686|FG001|COMPLETED|Overall Study||13||
60065365|NCT01950013|76180687|FG002|COMPLETED|Overall Study||15||
60065366|NCT01950013|76180685|FG000|NOT COMPLETED|Overall Study||0||
60065367|NCT01950013|76180686|FG001|NOT COMPLETED|Overall Study||2||
60065368|NCT01950013|76180687|FG002|NOT COMPLETED|Overall Study||0||
60065369|NCT01949155|76180697|FG000|STARTED|Overall Study||178||
60065370|NCT01949155|76180698|FG001|STARTED|Overall Study||88||
60065371|NCT01949155|76180697|FG000|COMPLETED|Overall Study||176||
59930676|NCT02999100|76048823|FG005|NOT COMPLETED|Part 2 (Day 1): Dosing Session 1||1||
59930677|NCT02999100|76048818|FG000|STARTED|Part 2 (Day 14): Dosing Session 2||0||
59930678|NCT02999100|76048819|FG001|STARTED|Part 2 (Day 14): Dosing Session 2||0||
59930679|NCT02999100|76048820|FG002|STARTED|Part 2 (Day 14): Dosing Session 2||4||
59930680|NCT02999100|76048821|FG003|STARTED|Part 2 (Day 14): Dosing Session 2||3||
59930681|NCT02999100|76048822|FG004|STARTED|Part 2 (Day 14): Dosing Session 2||3||
59930682|NCT02999100|76048823|FG005|STARTED|Part 2 (Day 14): Dosing Session 2||2||
59930683|NCT02999100|76048818|FG000|COMPLETED|Part 2 (Day 14): Dosing Session 2||0||
59930684|NCT02999100|76048819|FG001|COMPLETED|Part 2 (Day 14): Dosing Session 2||0||
59930685|NCT02999100|76048820|FG002|COMPLETED|Part 2 (Day 14): Dosing Session 2||4||
59930686|NCT02999100|76048821|FG003|COMPLETED|Part 2 (Day 14): Dosing Session 2||3||
59930687|NCT02999100|76048822|FG004|COMPLETED|Part 2 (Day 14): Dosing Session 2||3||
59930688|NCT02999100|76048823|FG005|COMPLETED|Part 2 (Day 14): Dosing Session 2||2||
60065372|NCT01949155|76180698|FG001|COMPLETED|Overall Study||88||
60065373|NCT01949155|76180697|FG000|NOT COMPLETED|Overall Study||2||
60065374|NCT01949155|76180698|FG001|NOT COMPLETED|Overall Study||0||
60065375|NCT01909466|76180705|FG000|STARTED|Overall Study||68||
60065376|NCT01909466|76180706|FG001|STARTED|Overall Study||73||
60065377|NCT01909466|76180705|FG000|COMPLETED|Overall Study||46||
60065378|NCT01909466|76180706|FG001|COMPLETED|Overall Study||50||
60065379|NCT01909466|76180705|FG000|NOT COMPLETED|Overall Study||22||
60065380|NCT01909466|76180706|FG001|NOT COMPLETED|Overall Study||23||
60065381|NCT01977625|76180710|FG000|STARTED|First Intervention (4 Weeks)||11||
60065382|NCT01977625|76180711|FG001|STARTED|First Intervention (4 Weeks)||7||
60065383|NCT01977625|76180710|FG000|COMPLETED|First Intervention (4 Weeks)||8||
60065384|NCT01977625|76180711|FG001|COMPLETED|First Intervention (4 Weeks)||7||
60065385|NCT01977625|76180710|FG000|NOT COMPLETED|First Intervention (4 Weeks)||3||
60065386|NCT01977625|76180711|FG001|NOT COMPLETED|First Intervention (4 Weeks)||0||
60065387|NCT01977625|76180710|FG000|STARTED|Washout (2 Weeks)||8||
60065388|NCT01977625|76180711|FG001|STARTED|Washout (2 Weeks)||7||
60065389|NCT01977625|76180710|FG000|COMPLETED|Washout (2 Weeks)||8||
60065390|NCT01977625|76180711|FG001|COMPLETED|Washout (2 Weeks)||7||
60065391|NCT01977625|76180710|FG000|NOT COMPLETED|Washout (2 Weeks)||0||
60065392|NCT01977625|76180711|FG001|NOT COMPLETED|Washout (2 Weeks)||0||
60065393|NCT01977625|76180710|FG000|STARTED|Second Intervention (4 Weeks)||8||
60065394|NCT01977625|76180711|FG001|STARTED|Second Intervention (4 Weeks)||7||
60065395|NCT01977625|76180710|FG000|COMPLETED|Second Intervention (4 Weeks)||7||
60065396|NCT01977625|76180711|FG001|COMPLETED|Second Intervention (4 Weeks)||7||
60065397|NCT01977625|76180710|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||1||
60065398|NCT01977625|76180711|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||0||
60065399|NCT01944631|76180721|FG000|STARTED|Overall Study||100||
60065400|NCT01944631|76180722|FG001|STARTED|Overall Study||100||
60065401|NCT01944631|76180721|FG000|COMPLETED|Overall Study||96||
60065402|NCT01944631|76180722|FG001|COMPLETED|Overall Study||98||
60065403|NCT01944631|76180721|FG000|NOT COMPLETED|Overall Study||4||
60065404|NCT01944631|76180722|FG001|NOT COMPLETED|Overall Study||2||
60065405|NCT01948063|76180730|FG000|STARTED|Overall Study||20||
60065406|NCT01948063|76180731|FG001|STARTED|Overall Study||21||
60065407|NCT01948063|76180730|FG000|COMPLETED|Overall Study||19||
60065408|NCT01948063|76180731|FG001|COMPLETED|Overall Study||19||
60065409|NCT01948063|76180730|FG000|NOT COMPLETED|Overall Study||1||
60065410|NCT01948063|76180731|FG001|NOT COMPLETED|Overall Study||2||
60065411|NCT01995071|76180749|FG000|STARTED|Overall Study||8|The safety population: all participants who received at least 1 dose of any study drug.|
60065412|NCT01995071|76180750|FG001|STARTED|Overall Study||8|The safety population: all participants who received at least 1 dose of any study drug.|
60065413|NCT01995071|76180751|FG002|STARTED|Overall Study||9|The safety population: all participants who received at least 1 dose of any study drug.|
60065414|NCT01995071|76180752|FG003|STARTED|Overall Study||8|The safety population: all participants who received at least 1 dose of any study drug.|
60067882|NCT01756053|76183071|FG000|COMPLETED|Washout Period (~21 Days)||7||
59517927|NCT03487276|75611784|FG003|COMPLETED|Extension Period (28 Weeks)||54||
59517928|NCT03487276|75611785|FG004|COMPLETED|Extension Period (28 Weeks)||0||
59517929|NCT03487276|75611781|FG000|NOT COMPLETED|Extension Period (28 Weeks)||0||
60065415|NCT01995071|76180753|FG004|STARTED|Overall Study||8|The safety population: all participants who received at least 1 dose of any study drug.|
60065416|NCT01995071|76180754|FG005|STARTED|Overall Study||8|The safety population: all participants who received at least 1 dose of any study drug.|
60065417|NCT01995071|76180755|FG006|STARTED|Overall Study||8|The safety population: all participants who received at least 1 dose of any study drug.|
60065418|NCT01995071|76180756|FG007|STARTED|Overall Study||8|The safety population: all participants who received at least 1 dose of any study drug.|
60065419|NCT01995071|76180757|FG008|STARTED|Overall Study||8|The safety population: all participants who received at least 1 dose of any study drug.|
60065420|NCT01995071|76180758|FG009|STARTED|Overall Study||8|The safety population: all participants who received at least 1 dose of any study drug.|
60065421|NCT01995071|76180759|FG010|STARTED|Overall Study||8|The safety population: all participants who received at least 1 dose of any study drug.|
60065422|NCT01995071|76180760|FG011|STARTED|Overall Study||0|The safety population: all participants who received at least 1 dose of any study drug.|
60065423|NCT01995071|76180749|FG000|COMPLETED|Overall Study||7||
60065424|NCT01995071|76180750|FG001|COMPLETED|Overall Study||8||
60065425|NCT01995071|76180751|FG002|COMPLETED|Overall Study||8||
60065426|NCT01995071|76180752|FG003|COMPLETED|Overall Study||8||
59517930|NCT03487276|75611782|FG001|NOT COMPLETED|Extension Period (28 Weeks)||0||
59517931|NCT03487276|75611783|FG002|NOT COMPLETED|Extension Period (28 Weeks)||5||
60065427|NCT01995071|76180753|FG004|COMPLETED|Overall Study||7||
60065428|NCT01995071|76180754|FG005|COMPLETED|Overall Study||8||
60065429|NCT01995071|76180755|FG006|COMPLETED|Overall Study||7||
60065430|NCT01995071|76180756|FG007|COMPLETED|Overall Study||6||
60065431|NCT01995071|76180757|FG008|COMPLETED|Overall Study||7||
60065432|NCT01995071|76180758|FG009|COMPLETED|Overall Study||8||
60065433|NCT01995071|76180759|FG010|COMPLETED|Overall Study||7||
60065434|NCT01995071|76180760|FG011|COMPLETED|Overall Study||0||
60065435|NCT01995071|76180749|FG000|NOT COMPLETED|Overall Study||1||
60065436|NCT01995071|76180750|FG001|NOT COMPLETED|Overall Study||0||
60065437|NCT01995071|76180751|FG002|NOT COMPLETED|Overall Study||1||
60065438|NCT01995071|76180752|FG003|NOT COMPLETED|Overall Study||0||
60065439|NCT01995071|76180753|FG004|NOT COMPLETED|Overall Study||1||
60065440|NCT01995071|76180754|FG005|NOT COMPLETED|Overall Study||0||
60065441|NCT01995071|76180755|FG006|NOT COMPLETED|Overall Study||1||
60065442|NCT01995071|76180756|FG007|NOT COMPLETED|Overall Study||2||
60065443|NCT01995071|76180757|FG008|NOT COMPLETED|Overall Study||1||
59517932|NCT03487276|75611784|FG003|NOT COMPLETED|Extension Period (28 Weeks)||30||
59517933|NCT03487276|75611785|FG004|NOT COMPLETED|Extension Period (28 Weeks)||0||
60065444|NCT01995071|76180758|FG009|NOT COMPLETED|Overall Study||0||
60065445|NCT01995071|76180759|FG010|NOT COMPLETED|Overall Study||1||
60065446|NCT01995071|76180760|FG011|NOT COMPLETED|Overall Study||0||
60065447|NCT01994837|76180792|FG000|STARTED|Overall Study||32||
60065448|NCT01994837|76180792|FG000|Treated|Overall Study||32||
60065449|NCT01994837|76180792|FG000|COMPLETED|Overall Study||0||
60065450|NCT01994837|76180792|FG000|NOT COMPLETED|Overall Study||32||
59517934|NCT03487588|75611806|FG000|STARTED|Overall Study||41||
59517935|NCT03487588|75611806|FG000|COMPLETED|Overall Study||41||
60065451|NCT02010593|76180798|FG000|STARTED|Overall Study||72||
60065452|NCT02010593|76180799|FG001|STARTED|Overall Study||24||
60065453|NCT02010593|76180798|FG000|COMPLETED|Overall Study||70||
60065454|NCT02010593|76180799|FG001|COMPLETED|Overall Study||22||
60065455|NCT02010593|76180798|FG000|NOT COMPLETED|Overall Study||2||
59517936|NCT03487588|75611806|FG000|NOT COMPLETED|Overall Study||0||
59517937|NCT03250234|75611812|FG000|STARTED|Overall Study||6||
59517938|NCT03250234|75611813|FG001|STARTED|Overall Study||6||
60065456|NCT02010593|76180799|FG001|NOT COMPLETED|Overall Study||2||
60065457|NCT01994291|76180808|FG000|STARTED|Overall Study||99||
60065458|NCT01994291|76180809|FG001|STARTED|Overall Study||43||
60065459|NCT01994291|76180810|FG002|STARTED|Overall Study||56||
60065460|NCT01994291|76180808|FG000|Received Treatment|Overall Study||99||
60065461|NCT01994291|76180809|FG001|Received Treatment|Overall Study||43||
60065462|NCT01994291|76180810|FG002|Received Treatment|Overall Study||56||
60065463|NCT01994291|76180808|FG000|COMPLETED|Overall Study||84||
60065464|NCT01994291|76180809|FG001|COMPLETED|Overall Study||36||
60065465|NCT01994291|76180810|FG002|COMPLETED|Overall Study||47||
60065466|NCT01994291|76180808|FG000|NOT COMPLETED|Overall Study||15||
60065467|NCT01994291|76180809|FG001|NOT COMPLETED|Overall Study||7||
60065468|NCT01994291|76180810|FG002|NOT COMPLETED|Overall Study||9||
60065469|NCT02094677|76180821|FG000|STARTED|Overall Study||43||
60065470|NCT02094677|76180822|FG001|STARTED|Overall Study||31||
60065471|NCT02094677|76180821|FG000|COMPLETED|Overall Study||40||
60065472|NCT02094677|76180822|FG001|COMPLETED|Overall Study||30||
60065473|NCT02094677|76180821|FG000|NOT COMPLETED|Overall Study||3||
60065474|NCT02094677|76180822|FG001|NOT COMPLETED|Overall Study||1||
60065475|NCT01993823|76180837|FG000|STARTED|Overall Study||95||
60065476|NCT01993823|76180838|FG001|STARTED|Overall Study||95||
60065477|NCT01993823|76180837|FG000|COMPLETED|Overall Study||88||
60065478|NCT01993823|76180838|FG001|COMPLETED|Overall Study||79||
60065479|NCT01993823|76180837|FG000|NOT COMPLETED|Overall Study||7||
60065480|NCT01993823|76180838|FG001|NOT COMPLETED|Overall Study||16||
60065481|NCT01993667|76180846|FG000|STARTED|Overall Study||64||
60065482|NCT01993667|76180847|FG001|STARTED|Overall Study||66||
60065483|NCT01993667|76180846|FG000|COMPLETED|Overall Study||43||
60065484|NCT01993667|76180847|FG001|COMPLETED|Overall Study||47||
60065485|NCT01993667|76180846|FG000|NOT COMPLETED|Overall Study||21||
59517939|NCT03250234|75611812|FG000|COMPLETED|Overall Study||6||
59517940|NCT03250234|75611813|FG001|COMPLETED|Overall Study||6||
59517941|NCT03250234|75611812|FG000|NOT COMPLETED|Overall Study||0||
59517942|NCT03250234|75611813|FG001|NOT COMPLETED|Overall Study||0||
59517943|NCT03489850|75611821|FG000|STARTED|Overall Study||24||
59517944|NCT03489850|75611822|FG001|STARTED|Overall Study||28||
59517945|NCT03489850|75611821|FG000|COMPLETED|Overall Study||23||
59517946|NCT03489850|75611822|FG001|COMPLETED|Overall Study||27||
59517947|NCT03489850|75611821|FG000|NOT COMPLETED|Overall Study||1||
59517948|NCT03489850|75611822|FG001|NOT COMPLETED|Overall Study||1||
59517949|NCT03490942|75611831|FG000|STARTED|Overall Study||15||
59517950|NCT03490942|75611832|FG001|STARTED|Overall Study||18||
59517951|NCT03490942|75611833|FG002|STARTED|Overall Study||16||
59517952|NCT03490942|75611831|FG000|COMPLETED|Overall Study||5||
59517953|NCT03490942|75611832|FG001|COMPLETED|Overall Study||8||
60065486|NCT01993667|76180847|FG001|NOT COMPLETED|Overall Study||19||
60065487|NCT01992107|76180856|FG000|STARTED|Overall Study||1159||
60065488|NCT01992107|76180857|FG001|STARTED|Overall Study||593||
60065489|NCT01992107|76180858|FG002|STARTED|Overall Study||581||
60065490|NCT01992107|76180856|FG000|COMPLETED|Overall Study||1091||
60065491|NCT01992107|76180857|FG001|COMPLETED|Overall Study||560||
60065492|NCT01992107|76180858|FG002|COMPLETED|Overall Study||545||
60065493|NCT01992107|76180856|FG000|NOT COMPLETED|Overall Study||68||
60065494|NCT01992107|76180857|FG001|NOT COMPLETED|Overall Study||33||
60065495|NCT01992107|76180858|FG002|NOT COMPLETED|Overall Study||36||
60065496|NCT01934192|76180887|FG000|STARTED|Overall Study||40||
60065497|NCT01934192|76180888|FG001|STARTED|Overall Study||44||
60065498|NCT01934192|76180889|FG002|STARTED|Overall Study||4||
60065499|NCT01934192|76180890|FG003|STARTED|Overall Study||4||
60065500|NCT01934192|76180887|FG000|COMPLETED|Overall Study||31||
60065501|NCT01934192|76180888|FG001|COMPLETED|Overall Study||37||
60065502|NCT01934192|76180889|FG002|COMPLETED|Overall Study||3||
60065503|NCT01934192|76180890|FG003|COMPLETED|Overall Study||3||
60065504|NCT01934192|76180887|FG000|NOT COMPLETED|Overall Study||9||
59517954|NCT03490942|75611833|FG002|COMPLETED|Overall Study||9||
59517955|NCT03490942|75611831|FG000|NOT COMPLETED|Overall Study||10||
60065505|NCT01934192|76180888|FG001|NOT COMPLETED|Overall Study||7||
60065506|NCT01934192|76180889|FG002|NOT COMPLETED|Overall Study||1||
60065507|NCT01934192|76180890|FG003|NOT COMPLETED|Overall Study||1||
60065508|NCT01933880|76180913|FG000|STARTED|Overall Study||153||
60065509|NCT01933880|76180914|FG001|STARTED|Overall Study||41||
60065510|NCT01933880|76180913|FG000|COMPLETED|Overall Study||123||
60065511|NCT01933880|76180914|FG001|COMPLETED|Overall Study||40||
60065512|NCT01933880|76180913|FG000|NOT COMPLETED|Overall Study||30||
60065513|NCT01933880|76180914|FG001|NOT COMPLETED|Overall Study||1||
60065514|NCT02008877|76180925|FG000|STARTED|Overall Study||3||
60065515|NCT02008877|76180926|FG001|STARTED|Overall Study||7||
60065516|NCT02008877|76180927|FG002|STARTED|Overall Study||10||
60065517|NCT02008877|76180925|FG000|COMPLETED|Overall Study||3||
60065518|NCT02008877|76180926|FG001|COMPLETED|Overall Study||6||
60065519|NCT02008877|76180927|FG002|COMPLETED|Overall Study||10||
60065520|NCT02008877|76180925|FG000|NOT COMPLETED|Overall Study||0||
60065521|NCT02008877|76180926|FG001|NOT COMPLETED|Overall Study||1||
60065522|NCT02008877|76180927|FG002|NOT COMPLETED|Overall Study||0||
60065523|NCT01933334|76180938|FG000|STARTED|Overall Study||32||
60065524|NCT01933334|76180939|FG001|STARTED|Overall Study||31||
60065525|NCT01933334|76180938|FG000|COMPLETED|Overall Study||27||
60065526|NCT01933334|76180939|FG001|COMPLETED|Overall Study||29||
60065527|NCT01933334|76180938|FG000|NOT COMPLETED|Overall Study||5||
60065528|NCT01933334|76180939|FG001|NOT COMPLETED|Overall Study||2||
60065529|NCT01908140|76180947|FG000|STARTED|Overall Study||468||
60065530|NCT01908140|76180948|FG001|STARTED|Overall Study||465||
60065531|NCT01908140|76180947|FG000|COMPLETED|Overall Study||402||
60065532|NCT01908140|76180948|FG001|COMPLETED|Overall Study||386||
60065533|NCT01908140|76180947|FG000|NOT COMPLETED|Overall Study||66||
60065534|NCT01908140|76180948|FG001|NOT COMPLETED|Overall Study||79||
60065535|NCT02008565|76180958|FG000|STARTED|Overall Study||86||
60065536|NCT02008565|76180959|FG001|STARTED|Overall Study||84||
60065537|NCT02008565|76180960|FG002|STARTED|Overall Study||88||
60065538|NCT02008565|76180961|FG003|STARTED|Overall Study||42||
60065539|NCT02008565|76180958|FG000|COMPLETED|Overall Study||85||
60065540|NCT02008565|76180959|FG001|COMPLETED|Overall Study||83||
60065541|NCT02008565|76180960|FG002|COMPLETED|Overall Study||86||
60065542|NCT02008565|76180961|FG003|COMPLETED|Overall Study||42||
60065543|NCT02008565|76180958|FG000|NOT COMPLETED|Overall Study||1||
60065544|NCT02008565|76180959|FG001|NOT COMPLETED|Overall Study||1||
60065545|NCT02008565|76180960|FG002|NOT COMPLETED|Overall Study||2||
60065546|NCT02008565|76180961|FG003|NOT COMPLETED|Overall Study||0||
60065547|NCT01907906|76180975|FG000|STARTED|Overall Study||16||
60065548|NCT01907906|76180976|FG001|STARTED|Overall Study||13||
60065549|NCT01907906|76180975|FG000|COMPLETED|Overall Study||12||
60065550|NCT01907906|76180976|FG001|COMPLETED|Overall Study||12||
60065551|NCT01907906|76180975|FG000|NOT COMPLETED|Overall Study||4||
60065552|NCT01907906|76180976|FG001|NOT COMPLETED|Overall Study||1||
60065553|NCT01907828|76180986|FG000|STARTED|Overall Study||39||
60065554|NCT01907828|76180987|FG001|STARTED|Overall Study||22||
60065555|NCT01907828|76180986|FG000|Underwent Procedure|Overall Study||39||
60065556|NCT01907828|76180987|FG001|Underwent Procedure|Overall Study|2 participants terminated early|20||
60065557|NCT01907828|76180986|FG000|1-month Follow-up|Overall Study|2 participants terminated early|37||
60065558|NCT01907828|76180987|FG001|1-month Follow-up|Overall Study|3 participants terminated early|17||
60065559|NCT01907828|76180986|FG000|3-month Follow-up|Overall Study|1 participant terminated early|36||
60065560|NCT01907828|76180987|FG001|3-month Follow-up|Overall Study|1 participant terminated early|16||
60065561|NCT01907828|76180986|FG000|6-month Follow-up|Overall Study|1 participant terminated early|35||
60065562|NCT01907828|76180987|FG001|6-month Follow-up|Overall Study||16||
60065563|NCT01907828|76180986|FG000|12-month Follow-up|Overall Study|1 participant terminated early|34||
60065564|NCT01907828|76180987|FG001|12-month Follow-up|Overall Study||16||
60065565|NCT01907828|76180986|FG000|24-month Follow-up|Overall Study|2 participants terminated early|32||
60065566|NCT01907828|76180987|FG001|24-month Follow-up|Overall Study||16||
60065567|NCT01907828|76180986|FG000|COMPLETED|Overall Study||32||
60065568|NCT01907828|76180987|FG001|COMPLETED|Overall Study||16||
60065569|NCT01907828|76180986|FG000|NOT COMPLETED|Overall Study||7||
60065570|NCT01907828|76180987|FG001|NOT COMPLETED|Overall Study||6||
60065571|NCT01907516|76180995|FG000|STARTED|First Intervention (3 Weeks)||50||
60065572|NCT01907516|76180996|FG001|STARTED|First Intervention (3 Weeks)||50||
60065573|NCT01907516|76180995|FG000|COMPLETED|First Intervention (3 Weeks)||40||
60065574|NCT01907516|76180996|FG001|COMPLETED|First Intervention (3 Weeks)||34||
60065575|NCT01907516|76180995|FG000|NOT COMPLETED|First Intervention (3 Weeks)||10||
60065576|NCT01907516|76180996|FG001|NOT COMPLETED|First Intervention (3 Weeks)||16||
60065577|NCT01907516|76180995|FG000|STARTED|Second Intervention (3 Weeks)||40||
60065578|NCT01907516|76180996|FG001|STARTED|Second Intervention (3 Weeks)||34||
60065579|NCT01907516|76180995|FG000|COMPLETED|Second Intervention (3 Weeks)||40||
60065580|NCT01907516|76180996|FG001|COMPLETED|Second Intervention (3 Weeks)||34||
60065581|NCT01907516|76180995|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||0||
60065582|NCT01907516|76180996|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0||
60065583|NCT01931462|76181003|FG000|STARTED|Overall Study||2||
60065584|NCT01931462|76181003|FG000|COMPLETED|Overall Study||1||
60065585|NCT01931462|76181003|FG000|NOT COMPLETED|Overall Study||1||
60065586|NCT01931150|76181009|FG000|STARTED|Overall Study||5||
59930689|NCT02999100|76048818|FG000|NOT COMPLETED|Part 2 (Day 14): Dosing Session 2||0||
59930690|NCT02999100|76048819|FG001|NOT COMPLETED|Part 2 (Day 14): Dosing Session 2||0||
59930691|NCT02999100|76048820|FG002|NOT COMPLETED|Part 2 (Day 14): Dosing Session 2||0||
59930692|NCT02999100|76048821|FG003|NOT COMPLETED|Part 2 (Day 14): Dosing Session 2||0||
59930693|NCT02999100|76048822|FG004|NOT COMPLETED|Part 2 (Day 14): Dosing Session 2||0||
59930694|NCT02999100|76048823|FG005|NOT COMPLETED|Part 2 (Day 14): Dosing Session 2||0||
59930695|NCT02749370|76048845|FG000|STARTED|Overall Study||80||
59930696|NCT02749370|76048845|FG000|COMPLETED|Overall Study||66||
59930697|NCT02749370|76048845|FG000|NOT COMPLETED|Overall Study||14||
59930698|NCT03607994|76048851|FG000|STARTED|Overall Study||10||
59930699|NCT03607994|76048852|FG001|STARTED|Overall Study||12||
59930700|NCT03607994|76048851|FG000|COMPLETED|Overall Study||9||
59930701|NCT03607994|76048852|FG001|COMPLETED|Overall Study||11||
59930702|NCT03607994|76048851|FG000|NOT COMPLETED|Overall Study||1||
59930703|NCT03607994|76048852|FG001|NOT COMPLETED|Overall Study||1||
59930704|NCT02996682|76048860|FG000|STARTED|Overall Study||51||
59930705|NCT02996682|76048861|FG001|STARTED|Overall Study||51||
59930706|NCT02996682|76048860|FG000|COMPLETED|Overall Study||51||
59930707|NCT02996682|76048861|FG001|COMPLETED|Overall Study||48||
59930708|NCT02996682|76048860|FG000|NOT COMPLETED|Overall Study||0||
59930709|NCT02996682|76048861|FG001|NOT COMPLETED|Overall Study||3||
59930710|NCT02873702|76048869|FG000|STARTED|Healing Period (up to Week 8)||20||
59930711|NCT02873702|76048870|FG001|STARTED|Healing Period (up to Week 8)||17||
59930712|NCT02873702|76048871|FG002|STARTED|Healing Period (up to Week 8)||0||
60065587|NCT01931150|76181010|FG001|STARTED|Overall Study||6||
60065588|NCT01931150|76181009|FG000|COMPLETED|Overall Study||4||
60065589|NCT01931150|76181010|FG001|COMPLETED|Overall Study||4||
60065590|NCT01931150|76181009|FG000|NOT COMPLETED|Overall Study||1||
60065591|NCT01931150|76181010|FG001|NOT COMPLETED|Overall Study||2||
60065592|NCT01930214|76181019|FG000|STARTED|Overall Study||100||
60065593|NCT01930214|76181020|FG001|STARTED|Overall Study||117||
60065594|NCT01930214|76181021|FG002|STARTED|Overall Study||133||
60065595|NCT01930214|76181019|FG000|COMPLETED|Overall Study||80||
60065596|NCT01930214|76181020|FG001|COMPLETED|Overall Study||96||
60065597|NCT01930214|76181021|FG002|COMPLETED|Overall Study||108||
60065598|NCT01930214|76181019|FG000|NOT COMPLETED|Overall Study||20||
60065599|NCT01930214|76181020|FG001|NOT COMPLETED|Overall Study||21||
60065600|NCT01930214|76181021|FG002|NOT COMPLETED|Overall Study||25||
60065601|NCT01958294|76181029|FG000|STARTED|Overall Study||12||
60065602|NCT01958294|76181029|FG000|COMPLETED|Overall Study||10||
60065603|NCT01958294|76181029|FG000|NOT COMPLETED|Overall Study||2||
60065604|NCT01906346|76181033|FG000|STARTED|Overall Study||9||
60065605|NCT01906346|76181033|FG000|COMPLETED|Overall Study||8||
60065606|NCT01906346|76181033|FG000|NOT COMPLETED|Overall Study||1||
60065607|NCT01958060|76181045|FG000|STARTED|Overall Study||10||
60065608|NCT01958060|76181046|FG001|STARTED|Overall Study||6||
59517956|NCT03490942|75611832|FG001|NOT COMPLETED|Overall Study||10||
59930713|NCT02873702|76048872|FG003|STARTED|Healing Period (up to Week 8)||0||
59930714|NCT02873702|76048869|FG000|COMPLETED|Healing Period (up to Week 8)||19||
59930715|NCT02873702|76048870|FG001|COMPLETED|Healing Period (up to Week 8)||16||
59930716|NCT02873702|76048871|FG002|COMPLETED|Healing Period (up to Week 8)||0||
59930717|NCT02873702|76048872|FG003|COMPLETED|Healing Period (up to Week 8)||0||
59930718|NCT02873702|76048869|FG000|NOT COMPLETED|Healing Period (up to Week 8)||1||
59930719|NCT02873702|76048870|FG001|NOT COMPLETED|Healing Period (up to Week 8)||1||
59930720|NCT02873702|76048871|FG002|NOT COMPLETED|Healing Period (up to Week 8)||0||
59930721|NCT02873702|76048872|FG003|NOT COMPLETED|Healing Period (up to Week 8)||0||
59930722|NCT02873702|76048869|FG000|STARTED|Maintenance Period (up to Month 6)||0||
59930723|NCT02873702|76048870|FG001|STARTED|Maintenance Period (up to Month 6)||0||
59930724|NCT02873702|76048871|FG002|STARTED|Maintenance Period (up to Month 6)||8||
59930725|NCT02873702|76048872|FG003|STARTED|Maintenance Period (up to Month 6)||8||
59930726|NCT02873702|76048869|FG000|COMPLETED|Maintenance Period (up to Month 6)||0||
59930727|NCT02873702|76048870|FG001|COMPLETED|Maintenance Period (up to Month 6)||0||
59930728|NCT02873702|76048871|FG002|COMPLETED|Maintenance Period (up to Month 6)||1||
59930729|NCT02873702|76048872|FG003|COMPLETED|Maintenance Period (up to Month 6)||6||
60065609|NCT01958060|76181047|FG002|STARTED|Overall Study||6||
60065610|NCT01958060|76181048|FG003|STARTED|Overall Study||5||
60065611|NCT01958060|76181049|FG004|STARTED|Overall Study||7||
60065612|NCT01958060|76181050|FG005|STARTED|Overall Study||1||
60065613|NCT01958060|76181045|FG000|COMPLETED|Overall Study||8||
60065614|NCT01958060|76181046|FG001|COMPLETED|Overall Study||6||
59930730|NCT02873702|76048869|FG000|NOT COMPLETED|Maintenance Period (up to Month 6)||0||
60065615|NCT01958060|76181047|FG002|COMPLETED|Overall Study||6||
60065616|NCT01958060|76181048|FG003|COMPLETED|Overall Study||5||
59930731|NCT02873702|76048870|FG001|NOT COMPLETED|Maintenance Period (up to Month 6)||0||
59930732|NCT02873702|76048871|FG002|NOT COMPLETED|Maintenance Period (up to Month 6)||7||
59930733|NCT02873702|76048872|FG003|NOT COMPLETED|Maintenance Period (up to Month 6)||2||
60067883|NCT01756053|76183072|FG001|COMPLETED|Washout Period (~21 Days)||8||
60065617|NCT01958060|76181049|FG004|COMPLETED|Overall Study|One subject in the 50 mg iv dose group did not receive complete dose of trial medication.|6||
60065618|NCT01958060|76181050|FG005|COMPLETED|Overall Study|One subject in the 100 mg iv dose group did not receive complete dose of trial medication.|1||
60065619|NCT01958060|76181045|FG000|NOT COMPLETED|Overall Study||2||
60065620|NCT01958060|76181046|FG001|NOT COMPLETED|Overall Study||0||
60065621|NCT01958060|76181047|FG002|NOT COMPLETED|Overall Study||0||
60065622|NCT01958060|76181048|FG003|NOT COMPLETED|Overall Study||0||
60065623|NCT01958060|76181049|FG004|NOT COMPLETED|Overall Study||1||
60065624|NCT01958060|76181050|FG005|NOT COMPLETED|Overall Study||0||
60065625|NCT01929980|76181069|FG000|STARTED|Overall Study||4||
59517957|NCT03490942|75611833|FG002|NOT COMPLETED|Overall Study||7||
59930734|NCT02911116|76048884|FG000|STARTED|Overall Study||5||
59930735|NCT02911116|76048885|FG001|STARTED|Overall Study||3||
60065626|NCT01929980|76181069|FG000|COMPLETED|Overall Study||3||
60065627|NCT01929980|76181069|FG000|NOT COMPLETED|Overall Study||1||
60065628|NCT01363076|76181075|FG000|STARTED|Overall Study||7||
60065629|NCT01363076|76181076|FG001|STARTED|Overall Study||13||
60065630|NCT01363076|76181075|FG000|COMPLETED|Overall Study||7||
60065631|NCT01363076|76181076|FG001|COMPLETED|Overall Study||12||
60065632|NCT01363076|76181075|FG000|NOT COMPLETED|Overall Study||0||
60065633|NCT01363076|76181076|FG001|NOT COMPLETED|Overall Study||1||
60065634|NCT01929044|76181084|FG000|STARTED|Overall Study||153||
60065635|NCT01929044|76181085|FG001|STARTED|Overall Study||146||
60065636|NCT01929044|76181084|FG000|COMPLETED|Overall Study||142||
60065637|NCT01929044|76181085|FG001|COMPLETED|Overall Study||129||
60065638|NCT01929044|76181084|FG000|NOT COMPLETED|Overall Study||11||
60065639|NCT01929044|76181085|FG001|NOT COMPLETED|Overall Study||17||
60065640|NCT01903460|76181095|FG000|STARTED|Overall Study||6||
60065641|NCT01903460|76181096|FG001|STARTED|Overall Study||8||
60065642|NCT01903460|76181097|FG002|STARTED|Overall Study||3||
60065643|NCT01903460|76181098|FG003|STARTED|Overall Study||3||
60065644|NCT01903460|76181095|FG000|COMPLETED|Overall Study||6||
60065645|NCT01903460|76181096|FG001|COMPLETED|Overall Study||8||
60065646|NCT01903460|76181097|FG002|COMPLETED|Overall Study||3||
59517958|NCT01069003|75611844|FG000|STARTED|Overall Study||399||
59930736|NCT02911116|76048884|FG000|COMPLETED|Overall Study||4||
60065647|NCT01903460|76181098|FG003|COMPLETED|Overall Study||2||
60065648|NCT01903460|76181095|FG000|NOT COMPLETED|Overall Study||0||
60065649|NCT01903460|76181096|FG001|NOT COMPLETED|Overall Study||0||
60065650|NCT01903460|76181097|FG002|NOT COMPLETED|Overall Study||0||
60065651|NCT01903460|76181098|FG003|NOT COMPLETED|Overall Study||1||
60065652|NCT01957202|76181107|FG000|STARTED|Treatment Period 1 (8 Days)||3||
60065653|NCT01957202|76181108|FG001|STARTED|Treatment Period 1 (8 Days)||6||
60065654|NCT01957202|76181109|FG002|STARTED|Treatment Period 1 (8 Days)||6||
59930737|NCT02911116|76048885|FG001|COMPLETED|Overall Study||2||
59930738|NCT02911116|76048884|FG000|NOT COMPLETED|Overall Study||1||
59930739|NCT02911116|76048885|FG001|NOT COMPLETED|Overall Study||1||
59930740|NCT02998554|76048893|FG000|STARTED|Overall Study||79||
59930741|NCT02998554|76048894|FG001|STARTED|Overall Study||77||
59930742|NCT02998554|76048893|FG000|COMPLETED|Overall Study||68||
59930743|NCT02998554|76048894|FG001|COMPLETED|Overall Study||66||
60065655|NCT01957202|76181110|FG003|STARTED|Treatment Period 1 (8 Days)||3||
60065656|NCT01957202|76181111|FG004|STARTED|Treatment Period 1 (8 Days)||3||
60065657|NCT01957202|76181112|FG005|STARTED|Treatment Period 1 (8 Days)||2||
60065658|NCT01957202|76181113|FG006|STARTED|Treatment Period 1 (8 Days)||3||
60065659|NCT01957202|76181114|FG007|STARTED|Treatment Period 1 (8 Days)||3||
60065660|NCT01957202|76181115|FG008|STARTED|Treatment Period 1 (8 Days)||3||
60065661|NCT01957202|76181116|FG009|STARTED|Treatment Period 1 (8 Days)||6||
60065662|NCT01957202|76181117|FG010|STARTED|Treatment Period 1 (8 Days)||3||
60065663|NCT01957202|76181118|FG011|STARTED|Treatment Period 1 (8 Days)||6||
60065664|NCT01957202|76181119|FG012|STARTED|Treatment Period 1 (8 Days)||3||
60065665|NCT01957202|76181120|FG013|STARTED|Treatment Period 1 (8 Days)||3||
60065666|NCT01957202|76181121|FG014|STARTED|Treatment Period 1 (8 Days)||6||
60065667|NCT01957202|76181122|FG015|STARTED|Treatment Period 1 (8 Days)||3||
60065668|NCT01957202|76181123|FG016|STARTED|Treatment Period 1 (8 Days)||6||
60065669|NCT01957202|76181124|FG017|STARTED|Treatment Period 1 (8 Days)||3||
60065670|NCT01957202|76181107|FG000|COMPLETED|Treatment Period 1 (8 Days)||3||
60065671|NCT01957202|76181108|FG001|COMPLETED|Treatment Period 1 (8 Days)||6||
60065672|NCT01957202|76181109|FG002|COMPLETED|Treatment Period 1 (8 Days)||6||
60065673|NCT01957202|76181110|FG003|COMPLETED|Treatment Period 1 (8 Days)||3||
60065674|NCT01957202|76181111|FG004|COMPLETED|Treatment Period 1 (8 Days)||3||
60065675|NCT01957202|76181112|FG005|COMPLETED|Treatment Period 1 (8 Days)||2||
60065676|NCT01957202|76181113|FG006|COMPLETED|Treatment Period 1 (8 Days)||3||
60065677|NCT01957202|76181114|FG007|COMPLETED|Treatment Period 1 (8 Days)||3||
60065678|NCT01957202|76181115|FG008|COMPLETED|Treatment Period 1 (8 Days)||3||
60065679|NCT01957202|76181116|FG009|COMPLETED|Treatment Period 1 (8 Days)||6||
60065680|NCT01957202|76181117|FG010|COMPLETED|Treatment Period 1 (8 Days)||3||
60065681|NCT01957202|76181118|FG011|COMPLETED|Treatment Period 1 (8 Days)||6||
60065682|NCT01957202|76181119|FG012|COMPLETED|Treatment Period 1 (8 Days)||3||
60065683|NCT01957202|76181120|FG013|COMPLETED|Treatment Period 1 (8 Days)||3||
60065684|NCT01957202|76181121|FG014|COMPLETED|Treatment Period 1 (8 Days)||6||
60065685|NCT01957202|76181122|FG015|COMPLETED|Treatment Period 1 (8 Days)||3||
60065686|NCT01957202|76181123|FG016|COMPLETED|Treatment Period 1 (8 Days)||6||
60065687|NCT01957202|76181124|FG017|COMPLETED|Treatment Period 1 (8 Days)||3||
60065688|NCT01957202|76181107|FG000|NOT COMPLETED|Treatment Period 1 (8 Days)||0||
60065689|NCT01957202|76181108|FG001|NOT COMPLETED|Treatment Period 1 (8 Days)||0||
59930744|NCT02998554|76048893|FG000|NOT COMPLETED|Overall Study||11||
59930745|NCT02998554|76048894|FG001|NOT COMPLETED|Overall Study||11||
59930746|NCT02996448|76048902|FG000|STARTED|Overall Study||3||
59930747|NCT02996448|76048902|FG000|COMPLETED|Overall Study||0||
59930748|NCT02996448|76048902|FG000|NOT COMPLETED|Overall Study||3||
59930749|NCT02995980|76048907|FG000|STARTED|Overall Study||128||
59930750|NCT02995980|76048907|FG000|COMPLETED|Overall Study||114||
59930751|NCT02995980|76048907|FG000|NOT COMPLETED|Overall Study||14||
59930752|NCT02872142|76048912|FG000|STARTED|Overall Study||12||
59930753|NCT02872142|76048912|FG000|COMPLETED|Overall Study||6||
59930754|NCT02872142|76048912|FG000|NOT COMPLETED|Overall Study||6||
59930755|NCT02994654|76048916|FG000|STARTED|Overall Study||12||
59930756|NCT02994654|76048916|FG000|COMPLETED|Overall Study||11||
59930757|NCT02994654|76048916|FG000|NOT COMPLETED|Overall Study||1||
59930758|NCT02870972|76048926|FG000|STARTED|Overall Study||18||
59930759|NCT02870972|76048927|FG001|STARTED|Overall Study||14||
59930760|NCT02870972|76048928|FG002|STARTED|Overall Study||14||
59930761|NCT02870972|76048929|FG003|STARTED|Overall Study||7||
59930762|NCT02870972|76048930|FG004|STARTED|Overall Study||22||
59930763|NCT02870972|76048926|FG000|COMPLETED|Overall Study||17||
60065690|NCT01957202|76181109|FG002|NOT COMPLETED|Treatment Period 1 (8 Days)||0||
60065691|NCT01957202|76181110|FG003|NOT COMPLETED|Treatment Period 1 (8 Days)||0||
60065692|NCT01957202|76181111|FG004|NOT COMPLETED|Treatment Period 1 (8 Days)||0||
60065693|NCT01957202|76181112|FG005|NOT COMPLETED|Treatment Period 1 (8 Days)||0||
60065694|NCT01957202|76181113|FG006|NOT COMPLETED|Treatment Period 1 (8 Days)||0||
60065695|NCT01957202|76181114|FG007|NOT COMPLETED|Treatment Period 1 (8 Days)||0||
60065696|NCT01957202|76181115|FG008|NOT COMPLETED|Treatment Period 1 (8 Days)||0||
60065697|NCT01957202|76181116|FG009|NOT COMPLETED|Treatment Period 1 (8 Days)||0||
60065698|NCT01957202|76181117|FG010|NOT COMPLETED|Treatment Period 1 (8 Days)||0||
59930764|NCT02870972|76048927|FG001|COMPLETED|Overall Study||14||
59930765|NCT02870972|76048928|FG002|COMPLETED|Overall Study||14||
59930766|NCT02870972|76048929|FG003|COMPLETED|Overall Study||7||
59930767|NCT02870972|76048930|FG004|COMPLETED|Overall Study||22||
59930768|NCT02870972|76048926|FG000|NOT COMPLETED|Overall Study||1||
59930769|NCT02870972|76048927|FG001|NOT COMPLETED|Overall Study||0||
59930770|NCT02870972|76048928|FG002|NOT COMPLETED|Overall Study||0||
59930771|NCT02870972|76048929|FG003|NOT COMPLETED|Overall Study||0||
59930772|NCT02870972|76048930|FG004|NOT COMPLETED|Overall Study||0||
59930773|NCT03214367|76048950|FG000|STARTED|Lead-in Period||1316||
59930774|NCT03214367|76048951|FG001|STARTED|Lead-in Period||0||
59930775|NCT03214367|76048952|FG002|STARTED|Lead-in Period||0||
60065699|NCT01957202|76181118|FG011|NOT COMPLETED|Treatment Period 1 (8 Days)||0||
60065700|NCT01957202|76181119|FG012|NOT COMPLETED|Treatment Period 1 (8 Days)||0||
60065701|NCT01957202|76181120|FG013|NOT COMPLETED|Treatment Period 1 (8 Days)||0||
60065702|NCT01957202|76181121|FG014|NOT COMPLETED|Treatment Period 1 (8 Days)||0||
60065703|NCT01957202|76181122|FG015|NOT COMPLETED|Treatment Period 1 (8 Days)||0||
60065704|NCT01957202|76181123|FG016|NOT COMPLETED|Treatment Period 1 (8 Days)||0||
60065705|NCT01957202|76181124|FG017|NOT COMPLETED|Treatment Period 1 (8 Days)||0||
60065706|NCT01957202|76181107|FG000|STARTED|Washout Period 1 (14 to 28 Days)||3||
60065707|NCT01957202|76181108|FG001|STARTED|Washout Period 1 (14 to 28 Days)||6||
60065708|NCT01957202|76181109|FG002|STARTED|Washout Period 1 (14 to 28 Days)||6||
60065709|NCT01957202|76181110|FG003|STARTED|Washout Period 1 (14 to 28 Days)||3||
60065710|NCT01957202|76181111|FG004|STARTED|Washout Period 1 (14 to 28 Days)||3||
60065711|NCT01957202|76181112|FG005|STARTED|Washout Period 1 (14 to 28 Days)||2||
60065712|NCT01957202|76181113|FG006|STARTED|Washout Period 1 (14 to 28 Days)||3||
60065713|NCT01957202|76181114|FG007|STARTED|Washout Period 1 (14 to 28 Days)||3||
60065714|NCT01957202|76181115|FG008|STARTED|Washout Period 1 (14 to 28 Days)||3||
60065715|NCT01957202|76181116|FG009|STARTED|Washout Period 1 (14 to 28 Days)||6||
60065716|NCT01957202|76181117|FG010|STARTED|Washout Period 1 (14 to 28 Days)||3||
60065717|NCT01957202|76181118|FG011|STARTED|Washout Period 1 (14 to 28 Days)||6||
60065718|NCT01957202|76181119|FG012|STARTED|Washout Period 1 (14 to 28 Days)||3||
60065719|NCT01957202|76181120|FG013|STARTED|Washout Period 1 (14 to 28 Days)||3||
60065720|NCT01957202|76181121|FG014|STARTED|Washout Period 1 (14 to 28 Days)||6||
60065721|NCT01957202|76181122|FG015|STARTED|Washout Period 1 (14 to 28 Days)||3||
60065722|NCT01957202|76181123|FG016|STARTED|Washout Period 1 (14 to 28 Days)||6||
60065723|NCT01957202|76181124|FG017|STARTED|Washout Period 1 (14 to 28 Days)||3||
60065724|NCT01957202|76181107|FG000|COMPLETED|Washout Period 1 (14 to 28 Days)||3||
60065725|NCT01957202|76181108|FG001|COMPLETED|Washout Period 1 (14 to 28 Days)||6||
60065726|NCT01957202|76181109|FG002|COMPLETED|Washout Period 1 (14 to 28 Days)||6||
60065727|NCT01957202|76181110|FG003|COMPLETED|Washout Period 1 (14 to 28 Days)||3||
60065728|NCT01957202|76181111|FG004|COMPLETED|Washout Period 1 (14 to 28 Days)||3||
60065729|NCT01957202|76181112|FG005|COMPLETED|Washout Period 1 (14 to 28 Days)||2||
60065730|NCT01957202|76181113|FG006|COMPLETED|Washout Period 1 (14 to 28 Days)||3||
60065731|NCT01957202|76181114|FG007|COMPLETED|Washout Period 1 (14 to 28 Days)||3||
60065732|NCT01957202|76181115|FG008|COMPLETED|Washout Period 1 (14 to 28 Days)||3||
60065733|NCT01957202|76181116|FG009|COMPLETED|Washout Period 1 (14 to 28 Days)||6||
60065734|NCT01957202|76181117|FG010|COMPLETED|Washout Period 1 (14 to 28 Days)||3||
60065735|NCT01957202|76181118|FG011|COMPLETED|Washout Period 1 (14 to 28 Days)||6||
60065736|NCT01957202|76181119|FG012|COMPLETED|Washout Period 1 (14 to 28 Days)||3||
60065737|NCT01957202|76181120|FG013|COMPLETED|Washout Period 1 (14 to 28 Days)||3||
60065738|NCT01957202|76181121|FG014|COMPLETED|Washout Period 1 (14 to 28 Days)||6||
60065739|NCT01957202|76181122|FG015|COMPLETED|Washout Period 1 (14 to 28 Days)||3||
60065740|NCT01957202|76181123|FG016|COMPLETED|Washout Period 1 (14 to 28 Days)||6||
60065741|NCT01957202|76181124|FG017|COMPLETED|Washout Period 1 (14 to 28 Days)||3||
60065742|NCT01957202|76181107|FG000|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0||
60065743|NCT01957202|76181108|FG001|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0||
60065744|NCT01957202|76181109|FG002|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0||
60065745|NCT01957202|76181110|FG003|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0||
60065746|NCT01957202|76181111|FG004|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0||
60065747|NCT01957202|76181112|FG005|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0||
60065748|NCT01957202|76181113|FG006|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0||
60065749|NCT01957202|76181114|FG007|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0||
60065750|NCT01957202|76181115|FG008|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0||
60065751|NCT01957202|76181116|FG009|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0||
60065752|NCT01957202|76181117|FG010|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0||
60065753|NCT01957202|76181118|FG011|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0||
60065754|NCT01957202|76181119|FG012|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0||
60065755|NCT01957202|76181120|FG013|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0||
60065756|NCT01957202|76181121|FG014|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0||
59517959|NCT01069003|75611845|FG001|STARTED|Overall Study||412||
59517960|NCT01069003|75611846|FG002|STARTED|Overall Study||1451||
59517961|NCT01069003|75611844|FG000|COMPLETED|Overall Study||353||
60065757|NCT01957202|76181122|FG015|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0||
60065758|NCT01957202|76181123|FG016|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0||
60065759|NCT01957202|76181124|FG017|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0||
60065760|NCT01957202|76181107|FG000|STARTED|Treatment Period 2 (8 Days)||3||
60065761|NCT01957202|76181108|FG001|STARTED|Treatment Period 2 (8 Days)||6||
60065762|NCT01957202|76181109|FG002|STARTED|Treatment Period 2 (8 Days)||6||
60065763|NCT01957202|76181110|FG003|STARTED|Treatment Period 2 (8 Days)||3||
60065764|NCT01957202|76181111|FG004|STARTED|Treatment Period 2 (8 Days)||3||
60065765|NCT01957202|76181112|FG005|STARTED|Treatment Period 2 (8 Days)||2||
60065766|NCT01957202|76181113|FG006|STARTED|Treatment Period 2 (8 Days)||3||
60065767|NCT01957202|76181114|FG007|STARTED|Treatment Period 2 (8 Days)||3||
59517962|NCT01069003|75611845|FG001|COMPLETED|Overall Study||358||
59517963|NCT01069003|75611846|FG002|COMPLETED|Overall Study||976||
59517964|NCT01069003|75611844|FG000|NOT COMPLETED|Overall Study||46||
59517965|NCT01069003|75611845|FG001|NOT COMPLETED|Overall Study||54||
59517966|NCT01069003|75611846|FG002|NOT COMPLETED|Overall Study||475||
59517967|NCT01069315|75611860|FG000|STARTED|Overall Study||27||
59517968|NCT01069315|75611861|FG001|STARTED|Overall Study||30||
59517969|NCT01069315|75611862|FG002|STARTED|Overall Study||28||
60065768|NCT01957202|76181115|FG008|STARTED|Treatment Period 2 (8 Days)||3||
60065769|NCT01957202|76181116|FG009|STARTED|Treatment Period 2 (8 Days)||6||
60065770|NCT01957202|76181117|FG010|STARTED|Treatment Period 2 (8 Days)||3||
60065771|NCT01957202|76181118|FG011|STARTED|Treatment Period 2 (8 Days)||6||
60065772|NCT01957202|76181119|FG012|STARTED|Treatment Period 2 (8 Days)||3||
60065773|NCT01957202|76181120|FG013|STARTED|Treatment Period 2 (8 Days)||3||
60065774|NCT01957202|76181121|FG014|STARTED|Treatment Period 2 (8 Days)||6||
59517970|NCT01069315|75611863|FG003|STARTED|Overall Study||26||
59517971|NCT01069315|75611860|FG000|COMPLETED|Overall Study||23||
59517972|NCT01069315|75611861|FG001|COMPLETED|Overall Study||24||
59517973|NCT01069315|75611862|FG002|COMPLETED|Overall Study||23||
59517974|NCT01069315|75611863|FG003|COMPLETED|Overall Study||19||
59517975|NCT01069315|75611860|FG000|NOT COMPLETED|Overall Study||4||
60065775|NCT01957202|76181122|FG015|STARTED|Treatment Period 2 (8 Days)||3||
60065776|NCT01957202|76181123|FG016|STARTED|Treatment Period 2 (8 Days)||6||
60065777|NCT01957202|76181124|FG017|STARTED|Treatment Period 2 (8 Days)||3||
60065778|NCT01957202|76181107|FG000|COMPLETED|Treatment Period 2 (8 Days)||3||
60065779|NCT01957202|76181108|FG001|COMPLETED|Treatment Period 2 (8 Days)||5||
60065780|NCT01957202|76181109|FG002|COMPLETED|Treatment Period 2 (8 Days)||6||
60065781|NCT01957202|76181110|FG003|COMPLETED|Treatment Period 2 (8 Days)||3||
60065782|NCT01957202|76181111|FG004|COMPLETED|Treatment Period 2 (8 Days)||3||
60065783|NCT01957202|76181112|FG005|COMPLETED|Treatment Period 2 (8 Days)||2||
60065784|NCT01957202|76181113|FG006|COMPLETED|Treatment Period 2 (8 Days)||3||
60065785|NCT01957202|76181114|FG007|COMPLETED|Treatment Period 2 (8 Days)||3||
60065786|NCT01957202|76181115|FG008|COMPLETED|Treatment Period 2 (8 Days)||3||
59517976|NCT01069315|75611861|FG001|NOT COMPLETED|Overall Study||6||
59517977|NCT01069315|75611862|FG002|NOT COMPLETED|Overall Study||5||
59517978|NCT01069315|75611863|FG003|NOT COMPLETED|Overall Study||7||
59517979|NCT03350542|75611877|FG000|STARTED|Overall Study||100||
60065787|NCT01957202|76181116|FG009|COMPLETED|Treatment Period 2 (8 Days)||6||
60065788|NCT01957202|76181117|FG010|COMPLETED|Treatment Period 2 (8 Days)||3||
59517980|NCT03350542|75611877|FG000|Completed 12-Month Clinical F/U|Overall Study||96||
59517981|NCT03350542|75611877|FG000|Death With no 12-month F/U|Overall Study||4||
59517982|NCT03350542|75611877|FG000|COMPLETED|Overall Study||96||
59517983|NCT03350542|75611877|FG000|NOT COMPLETED|Overall Study||4||
59517984|NCT03252964|75611881|FG000|STARTED|Overall Study||52||
59517985|NCT03252964|75611881|FG000|COMPLETED|Overall Study||20||
59517986|NCT03252964|75611881|FG000|NOT COMPLETED|Overall Study||32||
59517987|NCT01070095|75611885|FG000|STARTED|Baseline Period||19||
59517988|NCT01070095|75611886|FG001|STARTED|Baseline Period||830||
59517989|NCT01070095|75611885|FG000|COMPLETED|Baseline Period||18||
59517990|NCT01070095|75611886|FG001|COMPLETED|Baseline Period||830||
59517991|NCT01070095|75611885|FG000|NOT COMPLETED|Baseline Period||1||
59517992|NCT01070095|75611886|FG001|NOT COMPLETED|Baseline Period||0||
59517993|NCT01070095|75611885|FG000|STARTED|Intervention Period||18||
59517994|NCT01070095|75611886|FG001|STARTED|Intervention Period||890||
59517995|NCT01070095|75611885|FG000|COMPLETED|Intervention Period||18||
59517996|NCT01070095|75611886|FG001|COMPLETED|Intervention Period||890||
59517997|NCT01070095|75611885|FG000|NOT COMPLETED|Intervention Period||0||
59517998|NCT01070095|75611886|FG001|NOT COMPLETED|Intervention Period||0||
59517999|NCT01070173|75611896|FG000|STARTED|Overall Study||33||
59518000|NCT01070173|75611897|FG001|STARTED|Overall Study||8||
59518001|NCT01070173|75611898|FG002|STARTED|Overall Study||11||
59518002|NCT01070173|75611896|FG000|COMPLETED|Overall Study||33||
59518003|NCT01070173|75611897|FG001|COMPLETED|Overall Study||8||
59518004|NCT01070173|75611898|FG002|COMPLETED|Overall Study||11||
59518005|NCT01070173|75611896|FG000|NOT COMPLETED|Overall Study||0||
59518006|NCT01070173|75611897|FG001|NOT COMPLETED|Overall Study||0||
59518007|NCT01070173|75611898|FG002|NOT COMPLETED|Overall Study||0||
59518008|NCT03491800|75611909|FG000|STARTED|Overall Study||23||
59518009|NCT03491800|75611910|FG001|STARTED|Overall Study||23||
59518010|NCT03491800|75611911|FG002|STARTED|Overall Study||7||
60065789|NCT01957202|76181118|FG011|COMPLETED|Treatment Period 2 (8 Days)||6||
60065790|NCT01957202|76181119|FG012|COMPLETED|Treatment Period 2 (8 Days)||3||
60065791|NCT01957202|76181120|FG013|COMPLETED|Treatment Period 2 (8 Days)||3||
60065792|NCT01957202|76181121|FG014|COMPLETED|Treatment Period 2 (8 Days)||6||
60065793|NCT01957202|76181122|FG015|COMPLETED|Treatment Period 2 (8 Days)||3||
60065794|NCT01957202|76181123|FG016|COMPLETED|Treatment Period 2 (8 Days)||5||
60065795|NCT01957202|76181124|FG017|COMPLETED|Treatment Period 2 (8 Days)||3||
60065796|NCT01957202|76181107|FG000|NOT COMPLETED|Treatment Period 2 (8 Days)||0||
60065797|NCT01957202|76181108|FG001|NOT COMPLETED|Treatment Period 2 (8 Days)||1||
60065798|NCT01957202|76181109|FG002|NOT COMPLETED|Treatment Period 2 (8 Days)||0||
60065799|NCT01957202|76181110|FG003|NOT COMPLETED|Treatment Period 2 (8 Days)||0||
59518011|NCT03491800|75611909|FG000|COMPLETED|Overall Study||23||
59518012|NCT03491800|75611910|FG001|COMPLETED|Overall Study||23||
59518013|NCT03491800|75611911|FG002|COMPLETED|Overall Study||7||
59518014|NCT03491800|75611909|FG000|NOT COMPLETED|Overall Study||0||
59518015|NCT03491800|75611910|FG001|NOT COMPLETED|Overall Study||0||
59518016|NCT03491800|75611911|FG002|NOT COMPLETED|Overall Study||0||
59518017|NCT03256162|75611922|FG000|STARTED|Overall Study||13||
59518018|NCT03256162|75611923|FG001|STARTED|Overall Study||12||
59518019|NCT03256162|75611922|FG000|COMPLETED|Overall Study||8||
59518020|NCT03256162|75611923|FG001|COMPLETED|Overall Study||8||
59518021|NCT03256162|75611922|FG000|NOT COMPLETED|Overall Study||5||
59518022|NCT03256162|75611923|FG001|NOT COMPLETED|Overall Study||4||
59518023|NCT03493828|75611932|FG000|STARTED|Overall Study||20||
59518024|NCT03493828|75611933|FG001|STARTED|Overall Study||20||
59930776|NCT03214367|76048953|FG003|STARTED|Lead-in Period||0||
60065800|NCT01957202|76181111|FG004|NOT COMPLETED|Treatment Period 2 (8 Days)||0||
60065801|NCT01957202|76181112|FG005|NOT COMPLETED|Treatment Period 2 (8 Days)||0||
60065802|NCT01957202|76181113|FG006|NOT COMPLETED|Treatment Period 2 (8 Days)||0||
60065803|NCT01957202|76181114|FG007|NOT COMPLETED|Treatment Period 2 (8 Days)||0||
60065804|NCT01957202|76181115|FG008|NOT COMPLETED|Treatment Period 2 (8 Days)||0||
60065805|NCT01957202|76181116|FG009|NOT COMPLETED|Treatment Period 2 (8 Days)||0||
60065806|NCT01957202|76181117|FG010|NOT COMPLETED|Treatment Period 2 (8 Days)||0||
60065807|NCT01957202|76181118|FG011|NOT COMPLETED|Treatment Period 2 (8 Days)||0||
60065808|NCT01957202|76181119|FG012|NOT COMPLETED|Treatment Period 2 (8 Days)||0||
60065809|NCT01957202|76181120|FG013|NOT COMPLETED|Treatment Period 2 (8 Days)||0||
60065810|NCT01957202|76181121|FG014|NOT COMPLETED|Treatment Period 2 (8 Days)||0||
60065811|NCT01957202|76181122|FG015|NOT COMPLETED|Treatment Period 2 (8 Days)||0||
60065812|NCT01957202|76181123|FG016|NOT COMPLETED|Treatment Period 2 (8 Days)||1||
60065813|NCT01957202|76181124|FG017|NOT COMPLETED|Treatment Period 2 (8 Days)||0||
60065814|NCT01957202|76181107|FG000|STARTED|Washout Period 2 (14 to 28 Days)||3||
60065815|NCT01957202|76181108|FG001|STARTED|Washout Period 2 (14 to 28 Days)||5||
60065816|NCT01957202|76181109|FG002|STARTED|Washout Period 2 (14 to 28 Days)||6||
60065817|NCT01957202|76181110|FG003|STARTED|Washout Period 2 (14 to 28 Days)||3||
60065818|NCT01957202|76181111|FG004|STARTED|Washout Period 2 (14 to 28 Days)||3||
60065819|NCT01957202|76181112|FG005|STARTED|Washout Period 2 (14 to 28 Days)||2||
60065820|NCT01957202|76181113|FG006|STARTED|Washout Period 2 (14 to 28 Days)||3||
60065821|NCT01957202|76181114|FG007|STARTED|Washout Period 2 (14 to 28 Days)||3||
60065822|NCT01957202|76181115|FG008|STARTED|Washout Period 2 (14 to 28 Days)||3||
60065823|NCT01957202|76181116|FG009|STARTED|Washout Period 2 (14 to 28 Days)||6||
59930777|NCT03214367|76048954|FG004|STARTED|Lead-in Period||76||
59930778|NCT03214367|76048955|FG005|STARTED|Lead-in Period||0||
59930779|NCT03214367|76048956|FG006|STARTED|Lead-in Period||0||
59930780|NCT03214367|76048957|FG007|STARTED|Lead-in Period||0||
59930781|NCT03214367|76048950|FG000|COMPLETED|Lead-in Period||1222||
59930782|NCT03214367|76048951|FG001|COMPLETED|Lead-in Period||0||
59930783|NCT03214367|76048952|FG002|COMPLETED|Lead-in Period||0||
59930784|NCT03214367|76048953|FG003|COMPLETED|Lead-in Period||0||
59930785|NCT03214367|76048954|FG004|COMPLETED|Lead-in Period||74||
59930786|NCT03214367|76048955|FG005|COMPLETED|Lead-in Period||0||
59930787|NCT03214367|76048956|FG006|COMPLETED|Lead-in Period||0||
59930788|NCT03214367|76048957|FG007|COMPLETED|Lead-in Period||0||
59930789|NCT03214367|76048950|FG000|NOT COMPLETED|Lead-in Period||94||
59930790|NCT03214367|76048951|FG001|NOT COMPLETED|Lead-in Period||0||
59930791|NCT03214367|76048952|FG002|NOT COMPLETED|Lead-in Period||0||
59930792|NCT03214367|76048953|FG003|NOT COMPLETED|Lead-in Period||0||
59930793|NCT03214367|76048954|FG004|NOT COMPLETED|Lead-in Period||2||
59930794|NCT03214367|76048955|FG005|NOT COMPLETED|Lead-in Period||0||
59930795|NCT03214367|76048956|FG006|NOT COMPLETED|Lead-in Period||0||
59930796|NCT03214367|76048957|FG007|NOT COMPLETED|Lead-in Period||0||
59930797|NCT03214367|76048950|FG000|STARTED|Treatment Period|Participants received Insulin Lispro during Lead-in Period.|0||
59930798|NCT03214367|76048951|FG001|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro in Treatment Period.|442||
59930799|NCT03214367|76048952|FG002|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro in Treatment Period.|451||
59930800|NCT03214367|76048953|FG003|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro in Treatment Period.|329||
59930801|NCT03214367|76048954|FG004|STARTED|Treatment Period|Participants received Insulin Lispro during Lead-in Period.|0||
59930802|NCT03214367|76048955|FG005|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro in Treatment Period.|31||
59930803|NCT03214367|76048956|FG006|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro in Treatment Period.|21||
59930804|NCT03214367|76048957|FG007|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro in Treatment Period.|22||
59761388|NCT02393248|75881102|FG020|NOT COMPLETED|Part 1: Monotherapy Dose Escalation||0||
59761389|NCT02393248|75881103|FG021|NOT COMPLETED|Part 1: Monotherapy Dose Escalation||0||
59761390|NCT02393248|75881104|FG022|NOT COMPLETED|Part 1: Monotherapy Dose Escalation||0||
59761391|NCT02393248|75881105|FG023|NOT COMPLETED|Part 1: Monotherapy Dose Escalation||0||
59761392|NCT02393248|75881106|FG024|NOT COMPLETED|Part 1: Monotherapy Dose Escalation||0||
59930805|NCT03214367|76048950|FG000|COMPLETED|Treatment Period||0||
59930806|NCT03214367|76048951|FG001|COMPLETED|Treatment Period||408||
59930807|NCT03214367|76048952|FG002|COMPLETED|Treatment Period||418||
59930808|NCT03214367|76048953|FG003|COMPLETED|Treatment Period||310||
59930809|NCT03214367|76048954|FG004|COMPLETED|Treatment Period||0||
59930810|NCT03214367|76048955|FG005|COMPLETED|Treatment Period||28||
59930811|NCT03214367|76048956|FG006|COMPLETED|Treatment Period||19||
60065824|NCT01957202|76181117|FG010|STARTED|Washout Period 2 (14 to 28 Days)||3||
60065825|NCT01957202|76181118|FG011|STARTED|Washout Period 2 (14 to 28 Days)||6||
60065826|NCT01957202|76181119|FG012|STARTED|Washout Period 2 (14 to 28 Days)||3||
60065827|NCT01957202|76181120|FG013|STARTED|Washout Period 2 (14 to 28 Days)||3||
60065828|NCT01957202|76181121|FG014|STARTED|Washout Period 2 (14 to 28 Days)||6||
60065829|NCT01957202|76181122|FG015|STARTED|Washout Period 2 (14 to 28 Days)||3||
60065830|NCT01957202|76181123|FG016|STARTED|Washout Period 2 (14 to 28 Days)||5||
60065831|NCT01957202|76181124|FG017|STARTED|Washout Period 2 (14 to 28 Days)||3||
60065832|NCT01957202|76181107|FG000|COMPLETED|Washout Period 2 (14 to 28 Days)||3||
60065833|NCT01957202|76181108|FG001|COMPLETED|Washout Period 2 (14 to 28 Days)||5||
60065834|NCT01957202|76181109|FG002|COMPLETED|Washout Period 2 (14 to 28 Days)||6||
60065835|NCT01957202|76181110|FG003|COMPLETED|Washout Period 2 (14 to 28 Days)||3||
60065836|NCT01957202|76181111|FG004|COMPLETED|Washout Period 2 (14 to 28 Days)||3||
60065837|NCT01957202|76181112|FG005|COMPLETED|Washout Period 2 (14 to 28 Days)||2||
60065838|NCT01957202|76181113|FG006|COMPLETED|Washout Period 2 (14 to 28 Days)||3||
60065839|NCT01957202|76181114|FG007|COMPLETED|Washout Period 2 (14 to 28 Days)||3||
60065840|NCT01957202|76181115|FG008|COMPLETED|Washout Period 2 (14 to 28 Days)||3||
60065841|NCT01957202|76181116|FG009|COMPLETED|Washout Period 2 (14 to 28 Days)||6||
60065842|NCT01957202|76181117|FG010|COMPLETED|Washout Period 2 (14 to 28 Days)||3||
60065843|NCT01957202|76181118|FG011|COMPLETED|Washout Period 2 (14 to 28 Days)||6||
60065844|NCT01957202|76181119|FG012|COMPLETED|Washout Period 2 (14 to 28 Days)||3||
60065845|NCT01957202|76181120|FG013|COMPLETED|Washout Period 2 (14 to 28 Days)||3||
60065846|NCT01957202|76181121|FG014|COMPLETED|Washout Period 2 (14 to 28 Days)||6||
60065847|NCT01957202|76181122|FG015|COMPLETED|Washout Period 2 (14 to 28 Days)||3||
60065848|NCT01957202|76181123|FG016|COMPLETED|Washout Period 2 (14 to 28 Days)||5||
60065849|NCT01957202|76181124|FG017|COMPLETED|Washout Period 2 (14 to 28 Days)||3||
60065850|NCT01957202|76181107|FG000|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0||
60065851|NCT01957202|76181108|FG001|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0||
60065852|NCT01957202|76181109|FG002|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0||
60065853|NCT01957202|76181110|FG003|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0||
60065854|NCT01957202|76181111|FG004|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0||
60065855|NCT01957202|76181112|FG005|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0||
60065856|NCT01957202|76181113|FG006|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0||
60065857|NCT01957202|76181114|FG007|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0||
60065858|NCT01957202|76181115|FG008|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0||
60065859|NCT01957202|76181116|FG009|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0||
60065860|NCT01957202|76181117|FG010|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0||
60065861|NCT01957202|76181118|FG011|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0||
60065862|NCT01957202|76181119|FG012|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0||
60065863|NCT01957202|76181120|FG013|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0||
60065864|NCT01957202|76181121|FG014|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0||
60065865|NCT01957202|76181122|FG015|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0||
60065866|NCT01957202|76181123|FG016|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0||
60065867|NCT01957202|76181124|FG017|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0||
60065868|NCT01957202|76181107|FG000|STARTED|Treatment Period 3 (8 Days)||3||
60065869|NCT01957202|76181108|FG001|STARTED|Treatment Period 3 (8 Days)||5||
60065870|NCT01957202|76181109|FG002|STARTED|Treatment Period 3 (8 Days)||6||
60065871|NCT01957202|76181110|FG003|STARTED|Treatment Period 3 (8 Days)||3||
60065872|NCT01957202|76181111|FG004|STARTED|Treatment Period 3 (8 Days)||3||
60065873|NCT01957202|76181112|FG005|STARTED|Treatment Period 3 (8 Days)||2||
60065874|NCT01957202|76181113|FG006|STARTED|Treatment Period 3 (8 Days)||3||
60065875|NCT01957202|76181114|FG007|STARTED|Treatment Period 3 (8 Days)||3||
60065876|NCT01957202|76181115|FG008|STARTED|Treatment Period 3 (8 Days)||3||
60065877|NCT01957202|76181116|FG009|STARTED|Treatment Period 3 (8 Days)||6||
60065878|NCT01957202|76181117|FG010|STARTED|Treatment Period 3 (8 Days)||3||
60065879|NCT01957202|76181118|FG011|STARTED|Treatment Period 3 (8 Days)||6||
60065880|NCT01957202|76181119|FG012|STARTED|Treatment Period 3 (8 Days)||3||
60065881|NCT01957202|76181120|FG013|STARTED|Treatment Period 3 (8 Days)||3||
60065882|NCT01957202|76181121|FG014|STARTED|Treatment Period 3 (8 Days)||6||
60065883|NCT01957202|76181122|FG015|STARTED|Treatment Period 3 (8 Days)||3||
60065884|NCT01957202|76181123|FG016|STARTED|Treatment Period 3 (8 Days)||5||
60065885|NCT01957202|76181124|FG017|STARTED|Treatment Period 3 (8 Days)||3||
60065886|NCT01957202|76181107|FG000|COMPLETED|Treatment Period 3 (8 Days)||3||
60065887|NCT01957202|76181108|FG001|COMPLETED|Treatment Period 3 (8 Days)||5||
60065888|NCT01957202|76181109|FG002|COMPLETED|Treatment Period 3 (8 Days)||6||
60065889|NCT01957202|76181110|FG003|COMPLETED|Treatment Period 3 (8 Days)||3||
60065890|NCT01957202|76181111|FG004|COMPLETED|Treatment Period 3 (8 Days)||3||
60065891|NCT01957202|76181112|FG005|COMPLETED|Treatment Period 3 (8 Days)||2||
60065892|NCT01957202|76181113|FG006|COMPLETED|Treatment Period 3 (8 Days)||3||
60065893|NCT01957202|76181114|FG007|COMPLETED|Treatment Period 3 (8 Days)||3||
60065894|NCT01957202|76181115|FG008|COMPLETED|Treatment Period 3 (8 Days)||3||
60065895|NCT01957202|76181116|FG009|COMPLETED|Treatment Period 3 (8 Days)||6||
60065896|NCT01957202|76181117|FG010|COMPLETED|Treatment Period 3 (8 Days)||3||
60065897|NCT01957202|76181118|FG011|COMPLETED|Treatment Period 3 (8 Days)||6||
60065898|NCT01957202|76181119|FG012|COMPLETED|Treatment Period 3 (8 Days)||3||
60065899|NCT01957202|76181120|FG013|COMPLETED|Treatment Period 3 (8 Days)||3||
60065900|NCT01957202|76181121|FG014|COMPLETED|Treatment Period 3 (8 Days)||6||
60065901|NCT01957202|76181122|FG015|COMPLETED|Treatment Period 3 (8 Days)||3||
60065902|NCT01957202|76181123|FG016|COMPLETED|Treatment Period 3 (8 Days)||4||
60065903|NCT01957202|76181124|FG017|COMPLETED|Treatment Period 3 (8 Days)||3||
60065904|NCT01957202|76181107|FG000|NOT COMPLETED|Treatment Period 3 (8 Days)||0||
60065905|NCT01957202|76181108|FG001|NOT COMPLETED|Treatment Period 3 (8 Days)||0||
60065906|NCT01957202|76181109|FG002|NOT COMPLETED|Treatment Period 3 (8 Days)||0||
60065907|NCT01957202|76181110|FG003|NOT COMPLETED|Treatment Period 3 (8 Days)||0||
60065908|NCT01957202|76181111|FG004|NOT COMPLETED|Treatment Period 3 (8 Days)||0||
60065909|NCT01957202|76181112|FG005|NOT COMPLETED|Treatment Period 3 (8 Days)||0||
60065910|NCT01957202|76181113|FG006|NOT COMPLETED|Treatment Period 3 (8 Days)||0||
60065911|NCT01957202|76181114|FG007|NOT COMPLETED|Treatment Period 3 (8 Days)||0||
60065912|NCT01957202|76181115|FG008|NOT COMPLETED|Treatment Period 3 (8 Days)||0||
60065913|NCT01957202|76181116|FG009|NOT COMPLETED|Treatment Period 3 (8 Days)||0||
60065914|NCT01957202|76181117|FG010|NOT COMPLETED|Treatment Period 3 (8 Days)||0||
60065915|NCT01957202|76181118|FG011|NOT COMPLETED|Treatment Period 3 (8 Days)||0||
60065916|NCT01957202|76181119|FG012|NOT COMPLETED|Treatment Period 3 (8 Days)||0||
60065917|NCT01957202|76181120|FG013|NOT COMPLETED|Treatment Period 3 (8 Days)||0||
60065918|NCT01957202|76181121|FG014|NOT COMPLETED|Treatment Period 3 (8 Days)||0||
60065919|NCT01957202|76181122|FG015|NOT COMPLETED|Treatment Period 3 (8 Days)||0||
60065920|NCT01957202|76181123|FG016|NOT COMPLETED|Treatment Period 3 (8 Days)||1||
60065921|NCT01957202|76181124|FG017|NOT COMPLETED|Treatment Period 3 (8 Days)||0||
60065922|NCT01616654|76181139|FG000|STARTED|Overall Study||61||
60065923|NCT01616654|76181140|FG001|STARTED|Overall Study||61||
60065924|NCT01616654|76181141|FG002|STARTED|Overall Study||60||
60065925|NCT01616654|76181142|FG003|STARTED|Overall Study||61||
60065926|NCT01616654|76181143|FG004|STARTED|Overall Study||61||
60065927|NCT01616654|76181139|FG000|COMPLETED|Overall Study||56||
60065928|NCT01616654|76181140|FG001|COMPLETED|Overall Study||53||
60065929|NCT01616654|76181141|FG002|COMPLETED|Overall Study||50||
60065930|NCT01616654|76181142|FG003|COMPLETED|Overall Study||53||
60065931|NCT01616654|76181143|FG004|COMPLETED|Overall Study||49||
60065932|NCT01616654|76181139|FG000|NOT COMPLETED|Overall Study||5||
60065933|NCT01616654|76181140|FG001|NOT COMPLETED|Overall Study||8||
60065934|NCT01616654|76181141|FG002|NOT COMPLETED|Overall Study||10||
60065935|NCT01616654|76181142|FG003|NOT COMPLETED|Overall Study||8||
60065936|NCT01616654|76181143|FG004|NOT COMPLETED|Overall Study||12||
60065937|NCT01902290|76181158|FG000|STARTED|Overall Study||210||
60065938|NCT01902290|76181159|FG001|STARTED|Overall Study||211||
60065939|NCT01902290|76181158|FG000|Received Study Drug|Overall Study||207||
60065940|NCT01902290|76181159|FG001|Received Study Drug|Overall Study||208||
60065941|NCT01902290|76181158|FG000|COMPLETED|Overall Study||162|Completed end of study visit at week 28|
60065942|NCT01902290|76181159|FG001|COMPLETED|Overall Study||158|Completed end of study visit at week 28|
60065943|NCT01902290|76181158|FG000|NOT COMPLETED|Overall Study||48||
60065944|NCT01902290|76181159|FG001|NOT COMPLETED|Overall Study||53||
60065945|NCT01927562|76181166|FG000|STARTED|Overall Study||57||
60065946|NCT01927562|76181166|FG000|COMPLETED|Overall Study|5 at M24, 2 at M30,12 at M36 due to two protocol changes moving followups from M24 to M30 to M36|19||
60065947|NCT01927562|76181166|FG000|NOT COMPLETED|Overall Study||38||
60065948|NCT01467466|76181174|FG000|STARTED|Overall Study||1300||
60065949|NCT01467466|76181175|FG001|STARTED|Overall Study||1292||
60065950|NCT01467466|76181176|FG002|STARTED|Overall Study||1294||
60065951|NCT01467466|76181177|FG003|STARTED|Overall Study||1291||
60065952|NCT01467466|76181174|FG000|COMPLETED|Overall Study||1191||
60065953|NCT01467466|76181175|FG001|COMPLETED|Overall Study||1188||
60065954|NCT01467466|76181176|FG002|COMPLETED|Overall Study||1190||
60065955|NCT01467466|76181177|FG003|COMPLETED|Overall Study||1203||
60065956|NCT01467466|76181174|FG000|NOT COMPLETED|Overall Study||109||
60065957|NCT01467466|76181175|FG001|NOT COMPLETED|Overall Study||104||
60065958|NCT01467466|76181176|FG002|NOT COMPLETED|Overall Study||104||
60065959|NCT01467466|76181177|FG003|NOT COMPLETED|Overall Study||88||
60065960|NCT01441180|76181190|FG000|STARTED|Overall Study||10||
60065961|NCT01441180|76181191|FG001|STARTED|Overall Study||25||
60065962|NCT01441180|76181192|FG002|STARTED|Overall Study||25||
60065963|NCT01441180|76181190|FG000|COMPLETED|Overall Study||9||
60065964|NCT01441180|76181191|FG001|COMPLETED|Overall Study||24||
60065965|NCT01441180|76181192|FG002|COMPLETED|Overall Study||22||
60065966|NCT01441180|76181190|FG000|NOT COMPLETED|Overall Study||1||
60065967|NCT01441180|76181191|FG001|NOT COMPLETED|Overall Study||1||
60065968|NCT01441180|76181192|FG002|NOT COMPLETED|Overall Study||3||
60065969|NCT01441102|76181203|FG000|STARTED|Overall Study|Two participants withdrew prior to Month 6; therefore, two additional participants were enrolled.|7||
60065970|NCT01441102|76181203|FG000|COMPLETED|Overall Study||4||
60065971|NCT01441102|76181203|FG000|NOT COMPLETED|Overall Study||3||
60065972|NCT01467076|76181210|FG000|STARTED|Overall Study||3||
60065973|NCT01467076|76181211|FG001|STARTED|Overall Study||2||
60065974|NCT01467076|76181212|FG002|STARTED|Overall Study||2||
60065975|NCT01467076|76181210|FG000|COMPLETED|Overall Study||2||
60065976|NCT01467076|76181211|FG001|COMPLETED|Overall Study||2||
60065977|NCT01467076|76181212|FG002|COMPLETED|Overall Study||2||
60065978|NCT01467076|76181210|FG000|NOT COMPLETED|Overall Study||1||
60065979|NCT01467076|76181211|FG001|NOT COMPLETED|Overall Study||0||
60065980|NCT01467076|76181212|FG002|NOT COMPLETED|Overall Study||0||
60065981|NCT01466062|76181220|FG000|STARTED|Overall Study||28||
60065982|NCT01466062|76181220|FG000|COMPLETED|Overall Study||26||
60065983|NCT01466062|76181220|FG000|NOT COMPLETED|Overall Study||2||
60065984|NCT01435018|76181227|FG000|STARTED|Overall Study||135||
60065985|NCT01435018|76181228|FG001|STARTED|Overall Study||60||
60065986|NCT01435018|76181229|FG002|STARTED|Overall Study||139||
60065987|NCT01435018|76181227|FG000|COMPLETED|Overall Study||88||
60065988|NCT01435018|76181228|FG001|COMPLETED|Overall Study||26||
60065989|NCT01435018|76181229|FG002|COMPLETED|Overall Study||98||
60065990|NCT01435018|76181227|FG000|NOT COMPLETED|Overall Study||47||
60065991|NCT01435018|76181228|FG001|NOT COMPLETED|Overall Study||34||
60065992|NCT01435018|76181229|FG002|NOT COMPLETED|Overall Study||41||
60065993|NCT01419184|76181241|FG000|STARTED|Overall Study||128||
60065994|NCT01419184|76181242|FG001|STARTED|Overall Study||121||
60065995|NCT01419184|76181241|FG000|Received at Least 1 Dose of Study Drug|Overall Study||118||
60065996|NCT01419184|76181242|FG001|Received at Least 1 Dose of Study Drug|Overall Study||106||
60065997|NCT01419184|76181241|FG000|COMPLETED|Overall Study|6 participants did not complete the study due to no valid infection-related length of stay (IRLOS)|118||
60065998|NCT01419184|76181242|FG001|COMPLETED|Overall Study|13 participants did not complete the study due to no valid infection-related length of stay (IRLOS)|106||
60065999|NCT01419184|76181241|FG000|NOT COMPLETED|Overall Study||10||
60066000|NCT01419184|76181242|FG001|NOT COMPLETED|Overall Study||15||
60066001|NCT01417234|76181248|FG000|STARTED|Overall Study||30||
60066002|NCT01417234|76181248|FG000|COMPLETED|Overall Study||27||
60066003|NCT01417234|76181248|FG000|NOT COMPLETED|Overall Study||3||
60066004|NCT01417156|76181252|FG000|STARTED|Overall Study||20||
59930812|NCT03214367|76048957|FG007|COMPLETED|Treatment Period||21||
59930813|NCT03214367|76048950|FG000|NOT COMPLETED|Treatment Period||0||
59930814|NCT03214367|76048951|FG001|NOT COMPLETED|Treatment Period||34||
59930815|NCT03214367|76048952|FG002|NOT COMPLETED|Treatment Period||33||
59930816|NCT03214367|76048953|FG003|NOT COMPLETED|Treatment Period||19||
59930817|NCT03214367|76048954|FG004|NOT COMPLETED|Treatment Period||0||
59930818|NCT03214367|76048955|FG005|NOT COMPLETED|Treatment Period||3||
59930819|NCT03214367|76048956|FG006|NOT COMPLETED|Treatment Period||2||
59930820|NCT03214367|76048957|FG007|NOT COMPLETED|Treatment Period||1||
59930821|NCT02994108|76048973|FG000|STARTED|Intervention Messages||74||
59930822|NCT02994108|76048974|FG001|STARTED|Intervention Messages||76||
59930823|NCT02994108|76048973|FG000|COMPLETED|Intervention Messages||72||
59930824|NCT02994108|76048974|FG001|COMPLETED|Intervention Messages||76||
59930825|NCT02994108|76048973|FG000|NOT COMPLETED|Intervention Messages||2||
59930826|NCT02994108|76048974|FG001|NOT COMPLETED|Intervention Messages||0||
59930827|NCT02994108|76048973|FG000|STARTED|Phase 1 Assessment||72|Enrolled participants were allowed to complete follow-up even if they did not receive all messages.|
59930828|NCT02994108|76048974|FG001|STARTED|Phase 1 Assessment||76|Enrolled participants were allowed to complete follow-up even if they did not receive all messages.|
59930829|NCT02994108|76048973|FG000|COMPLETED|Phase 1 Assessment||67||
59930830|NCT02994108|76048974|FG001|COMPLETED|Phase 1 Assessment||73||
59930831|NCT02994108|76048973|FG000|NOT COMPLETED|Phase 1 Assessment||5||
59930832|NCT02994108|76048974|FG001|NOT COMPLETED|Phase 1 Assessment||3||
59930833|NCT02994108|76048973|FG000|STARTED|Phase 2 Assessment||72|Enrolled participants were allowed to complete follow-up even if they did not receive all messages.|
59930834|NCT02994108|76048974|FG001|STARTED|Phase 2 Assessment||76|Enrolled participants were allowed to complete follow-up even if they did not receive all messages.|
59930835|NCT02994108|76048973|FG000|COMPLETED|Phase 2 Assessment||63||
59930836|NCT02994108|76048974|FG001|COMPLETED|Phase 2 Assessment||69||
59930837|NCT02994108|76048973|FG000|NOT COMPLETED|Phase 2 Assessment||9||
59930838|NCT02994108|76048974|FG001|NOT COMPLETED|Phase 2 Assessment||7||
59930839|NCT03231371|76048981|FG000|STARTED|Overall Study||22||
59930840|NCT03231371|76048981|FG000|Optional and Age Limited (12 Yrs+) MRI|Overall Study||9||
59930841|NCT03231371|76048981|FG000|COMPLETED|Overall Study||9||
59930842|NCT03231371|76048981|FG000|NOT COMPLETED|Overall Study||13||
59930843|NCT02870348|76048985|FG000|STARTED|Overall Study||4||
59930844|NCT02870348|76048985|FG000|COMPLETED|Overall Study||0||
59930845|NCT02870348|76048985|FG000|NOT COMPLETED|Overall Study||4||
59930846|NCT03239873|76048991|FG000|STARTED|Overall Study||300||
59930847|NCT03239873|76048992|FG001|STARTED|Overall Study||300||
59930848|NCT03239873|76048991|FG000|Vaccination 1|Overall Study||299||
59930849|NCT03239873|76048992|FG001|Vaccination 1|Overall Study||300||
59930850|NCT03239873|76048991|FG000|Vaccination 2|Overall Study||276||
59930851|NCT03239873|76048992|FG001|Vaccination 2|Overall Study||282||
59930852|NCT03239873|76048991|FG000|COMPLETED|Overall Study||268||
59930853|NCT03239873|76048992|FG001|COMPLETED|Overall Study||273||
59930854|NCT03239873|76048991|FG000|NOT COMPLETED|Overall Study||32||
59930855|NCT03239873|76048992|FG001|NOT COMPLETED|Overall Study||27||
59930856|NCT03213509|76049000|FG000|STARTED|Overall Study||80||
60066005|NCT01417156|76181252|FG000|COMPLETED|Overall Study||6||
60066006|NCT01417156|76181252|FG000|NOT COMPLETED|Overall Study||14||
60066007|NCT01417078|76181256|FG000|STARTED|Overall Study||31||
60066008|NCT01417078|76181256|FG000|COMPLETED|Overall Study||30||
60066009|NCT01417078|76181256|FG000|NOT COMPLETED|Overall Study||1||
60066010|NCT01954394|76181264|FG000|STARTED|Overall Study|Enrolled|331||
60066011|NCT01954394|76181265|FG001|STARTED|Overall Study|Enrolled|655||
60066012|NCT01954394|76181264|FG000|Treated|Overall Study|Safety population|330||
60066013|NCT01954394|76181265|FG001|Treated|Overall Study|Safety population|655||
60066014|NCT01954394|76181264|FG000|COMPLETED|Overall Study||301||
60066015|NCT01954394|76181265|FG001|COMPLETED|Overall Study||598||
60066016|NCT01954394|76181264|FG000|NOT COMPLETED|Overall Study||30||
60066017|NCT01954394|76181265|FG001|NOT COMPLETED|Overall Study||57||
60066018|NCT01464424|76181273|FG000|STARTED|Period 1, First 6 Weeks||42||
60066019|NCT01464424|76181274|FG001|STARTED|Period 1, First 6 Weeks||42||
60066020|NCT01464424|76181273|FG000|COMPLETED|Period 1, First 6 Weeks||42||
59518025|NCT03493828|75611934|FG002|STARTED|Overall Study||20||
59518026|NCT03493828|75611932|FG000|COMPLETED|Overall Study||20||
59518027|NCT03493828|75611933|FG001|COMPLETED|Overall Study||20||
60066021|NCT01464424|76181274|FG001|COMPLETED|Period 1, First 6 Weeks||41||
60066022|NCT01464424|76181273|FG000|NOT COMPLETED|Period 1, First 6 Weeks||0||
60066023|NCT01464424|76181274|FG001|NOT COMPLETED|Period 1, First 6 Weeks||1||
60066024|NCT01464424|76181273|FG000|STARTED|Period 2, Second 6 Weeks||42||
60066025|NCT01464424|76181274|FG001|STARTED|Period 2, Second 6 Weeks||41||
60066026|NCT01464424|76181273|FG000|COMPLETED|Period 2, Second 6 Weeks||42||
60066027|NCT01464424|76181274|FG001|COMPLETED|Period 2, Second 6 Weeks||41||
60066028|NCT01464424|76181273|FG000|NOT COMPLETED|Period 2, Second 6 Weeks||0||
60066029|NCT01464424|76181274|FG001|NOT COMPLETED|Period 2, Second 6 Weeks||0||
60066030|NCT01902134|76181286|FG000|STARTED|Overall Study||159||
60066031|NCT01902134|76181287|FG001|STARTED|Overall Study||161||
60066032|NCT01902134|76181288|FG002|STARTED|Overall Study||160||
60066033|NCT01902134|76181289|FG003|STARTED|Overall Study||54||
60066034|NCT01902134|76181290|FG004|STARTED|Overall Study||53||
60066035|NCT01902134|76181291|FG005|STARTED|Overall Study||54||
60066036|NCT01902134|76181286|FG000|Single-dose Phase|Overall Study||159||
60066037|NCT01902134|76181287|FG001|Single-dose Phase|Overall Study||161||
60066038|NCT01902134|76181288|FG002|Single-dose Phase|Overall Study||160||
60066039|NCT01902134|76181289|FG003|Single-dose Phase|Overall Study||54||
60066040|NCT01902134|76181290|FG004|Single-dose Phase|Overall Study||53||
60066041|NCT01902134|76181291|FG005|Single-dose Phase|Overall Study||54||
60066042|NCT01902134|76181286|FG000|Multiple-dose Phase|Overall Study||159||
59930857|NCT03213509|76049001|FG001|STARTED|Overall Study||90||
59930858|NCT03213509|76049000|FG000|COMPLETED|Overall Study||76||
60066043|NCT01902134|76181287|FG001|Multiple-dose Phase|Overall Study||160||
60066044|NCT01902134|76181288|FG002|Multiple-dose Phase|Overall Study||160||
60066045|NCT01902134|76181289|FG003|Multiple-dose Phase|Overall Study||54||
60066046|NCT01902134|76181290|FG004|Multiple-dose Phase|Overall Study||53||
60066047|NCT01902134|76181291|FG005|Multiple-dose Phase|Overall Study||52||
60066048|NCT01902134|76181286|FG000|COMPLETED|Overall Study||151||
60066049|NCT01902134|76181287|FG001|COMPLETED|Overall Study||150||
60066050|NCT01902134|76181288|FG002|COMPLETED|Overall Study||145||
60066051|NCT01902134|76181289|FG003|COMPLETED|Overall Study||52||
60066052|NCT01902134|76181290|FG004|COMPLETED|Overall Study||46||
60066053|NCT01902134|76181291|FG005|COMPLETED|Overall Study||45||
60066054|NCT01902134|76181286|FG000|NOT COMPLETED|Overall Study||8||
60066055|NCT01902134|76181287|FG001|NOT COMPLETED|Overall Study||11||
60066056|NCT01902134|76181288|FG002|NOT COMPLETED|Overall Study||15||
59518028|NCT03493828|75611934|FG002|COMPLETED|Overall Study||20||
59518029|NCT03493828|75611932|FG000|NOT COMPLETED|Overall Study||0||
59930859|NCT03213509|76049001|FG001|COMPLETED|Overall Study||85||
59930860|NCT03213509|76049000|FG000|NOT COMPLETED|Overall Study||4||
59930861|NCT03213509|76049001|FG001|NOT COMPLETED|Overall Study||5||
59930862|NCT03239483|76049010|FG000|STARTED|Overall Study||19|one participant withdrew consent and did not receive any study product|
59930863|NCT03239483|76049011|FG001|STARTED|Overall Study||9|one participant withdrew consent and did not receive any study product|
59930864|NCT03239483|76049010|FG000|COMPLETED|Overall Study||17||
59930865|NCT03239483|76049011|FG001|COMPLETED|Overall Study||9||
60066057|NCT01902134|76181289|FG003|NOT COMPLETED|Overall Study||2||
60066058|NCT01902134|76181290|FG004|NOT COMPLETED|Overall Study||7||
60066059|NCT01902134|76181291|FG005|NOT COMPLETED|Overall Study||9||
60066060|NCT01954082|76181309|FG000|STARTED|Overall Study||317||
60066061|NCT01954082|76181310|FG001|STARTED|Overall Study||321||
60066062|NCT01954082|76181309|FG000|Treated|Overall Study|The 4 participants who were not treated either died (3) or withdrew before treatment start (1).|313||
59930866|NCT03239483|76049010|FG000|NOT COMPLETED|Overall Study||2||
59930867|NCT03239483|76049011|FG001|NOT COMPLETED|Overall Study||0||
59930868|NCT02868554|76049020|FG000|STARTED|Overall Study||10||
60066063|NCT01954082|76181310|FG001|Treated|Overall Study|The 2 participants who were not treated died before treatment start.|319||
60066064|NCT01954082|76181309|FG000|COMPLETED|Overall Study|There were 22 infants that received more doses than intended per protocol.|249||
60066065|NCT01954082|76181310|FG001|COMPLETED|Overall Study|There were 27 infants that received more doses than intended per protocol.|264||
60066066|NCT01954082|76181309|FG000|NOT COMPLETED|Overall Study||68||
60066067|NCT01954082|76181310|FG001|NOT COMPLETED|Overall Study||57||
60066068|NCT01417000|76181318|FG000|STARTED|Overall Study|62 subjects randomized into Cy/GVAX + CRS-207 arm; 61 subjects received ≥ 1 protocol-specified drug.|61|Participant flow values reflect original arm assignments and do not account for rollover subjects|
60066069|NCT01417000|76181319|FG001|STARTED|Overall Study|31 subjects randomized into Cy/GVAX arm; 29 subjects received ≥ 1 protocol-specified drug.|29|Participant flow values reflect original arm assignments and do not account for rollover subjects|
60066070|NCT01417000|76181318|FG000|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/death/study close, so no subjects completed study."|0|No predetermined study completion date or study completion event specified in protocol.|
60066071|NCT01417000|76181319|FG001|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/death/study close, so no subjects completed study."|0|No predetermined study completion date or study completion event specified in protocol.|
60066072|NCT01417000|76181318|FG000|NOT COMPLETED|Overall Study||61||
60066073|NCT01417000|76181319|FG001|NOT COMPLETED|Overall Study||29||
60066074|NCT01416610|76181325|FG000|STARTED|Overall Study||88||
60066075|NCT01416610|76181325|FG000|Intention to Treat|Overall Study||88||
60066076|NCT01416610|76181325|FG000|Safety Population|Overall Study||86||
60066077|NCT01416610|76181325|FG000|Per Protocol|Overall Study||83||
60066078|NCT01416610|76181325|FG000|Completed Treatment|Overall Study||47||
60066079|NCT01416610|76181325|FG000|Completed Follow-up|Overall Study||45||
60066080|NCT01416610|76181325|FG000|COMPLETED|Overall Study||45||
60066081|NCT01416610|76181325|FG000|NOT COMPLETED|Overall Study||43||
60066082|NCT01416142|76181333|FG000|STARTED|Cross Over at Movie Intermission||32||
60066083|NCT01416142|76181334|FG001|STARTED|Cross Over at Movie Intermission||31||
60066084|NCT01416142|76181335|FG002|STARTED|Cross Over at Movie Intermission||0||
60066085|NCT01416142|76181333|FG000|COMPLETED|Cross Over at Movie Intermission||32||
60066086|NCT01416142|76181334|FG001|COMPLETED|Cross Over at Movie Intermission||31||
60066087|NCT01416142|76181335|FG002|COMPLETED|Cross Over at Movie Intermission||0||
60066088|NCT01416142|76181333|FG000|NOT COMPLETED|Cross Over at Movie Intermission||0||
60066089|NCT01416142|76181334|FG001|NOT COMPLETED|Cross Over at Movie Intermission||0||
60066090|NCT01416142|76181335|FG002|NOT COMPLETED|Cross Over at Movie Intermission||0||
60066091|NCT01416142|76181333|FG000|STARTED|PureVision2 HD||0||
60066092|NCT01416142|76181334|FG001|STARTED|PureVision2 HD||0||
60066093|NCT01416142|76181335|FG002|STARTED|PureVision2 HD||63||
60066094|NCT01416142|76181333|FG000|COMPLETED|PureVision2 HD||0||
60066095|NCT01416142|76181334|FG001|COMPLETED|PureVision2 HD||0||
60066096|NCT01416142|76181335|FG002|COMPLETED|PureVision2 HD||62||
60066097|NCT01416142|76181333|FG000|NOT COMPLETED|PureVision2 HD||0||
59930869|NCT02868554|76049021|FG001|STARTED|Overall Study||12||
59930870|NCT02868554|76049022|FG002|STARTED|Overall Study||12||
59930871|NCT02868554|76049020|FG000|COMPLETED|Overall Study||7||
59930872|NCT02868554|76049021|FG001|COMPLETED|Overall Study||12||
59930873|NCT02868554|76049022|FG002|COMPLETED|Overall Study||11||
59930874|NCT02868554|76049020|FG000|NOT COMPLETED|Overall Study||3||
59930875|NCT02868554|76049021|FG001|NOT COMPLETED|Overall Study||0||
59930876|NCT02868554|76049022|FG002|NOT COMPLETED|Overall Study||1||
59930877|NCT01068912|76049033|FG000|STARTED|Overall Study||134||
59930878|NCT01068912|76049034|FG001|STARTED|Overall Study||195||
59930879|NCT01068912|76049035|FG002|STARTED|Overall Study||201||
59930880|NCT01068912|76049033|FG000|COMPLETED|Overall Study||123||
59930881|NCT01068912|76049034|FG001|COMPLETED|Overall Study||173||
59930882|NCT01068912|76049035|FG002|COMPLETED|Overall Study||186||
59930883|NCT01068912|76049033|FG000|NOT COMPLETED|Overall Study||11||
59930884|NCT01068912|76049034|FG001|NOT COMPLETED|Overall Study||22||
59930885|NCT01068912|76049035|FG002|NOT COMPLETED|Overall Study||15||
59930886|NCT03229109|76049047|FG000|STARTED|Overall Study||50||
59930887|NCT03229109|76049048|FG001|STARTED|Overall Study||50||
59930888|NCT03229109|76049049|FG002|STARTED|Overall Study||50||
59930889|NCT03229109|76049050|FG003|STARTED|Overall Study||51||
59930890|NCT03229109|76049047|FG000|COMPLETED|Overall Study||50||
59930891|NCT03229109|76049048|FG001|COMPLETED|Overall Study||50||
59930892|NCT03229109|76049049|FG002|COMPLETED|Overall Study||50||
59930893|NCT03229109|76049050|FG003|COMPLETED|Overall Study||50||
59930894|NCT03229109|76049047|FG000|NOT COMPLETED|Overall Study||0||
59930895|NCT03229109|76049048|FG001|NOT COMPLETED|Overall Study||0||
59930896|NCT03229109|76049049|FG002|NOT COMPLETED|Overall Study||0||
59930897|NCT03229109|76049050|FG003|NOT COMPLETED|Overall Study||1||
59930898|NCT03212261|76049060|FG000|STARTED|Overall Study|Enrolled: eligible at time of approach and signed a consent.|37||
59930899|NCT03212261|76049060|FG000|Remained Eligible|Overall Study||35||
59930900|NCT03212261|76049060|FG000|Baseline Completion|Overall Study|Lost patients: Technology difficulties (n=2), Family Emergency (n=1), Too busy (n=3), LTFU (n=1)|30|Eligible patients who completed the baseline survey|
60066098|NCT01416142|76181334|FG001|NOT COMPLETED|PureVision2 HD||0||
60066099|NCT01416142|76181335|FG002|NOT COMPLETED|PureVision2 HD||1||
60066100|NCT01415986|76181343|FG000|STARTED|Overall Study||1||
60066101|NCT01415986|76181343|FG000|COMPLETED|Overall Study|Study terminated|0||
60066102|NCT01415986|76181343|FG000|NOT COMPLETED|Overall Study||1||
60066103|NCT01415908|76181350|FG000|STARTED|Overall Study||11||
60066104|NCT01415908|76181351|FG001|STARTED|Overall Study||4||
60066105|NCT01415908|76181350|FG000|COMPLETED|Overall Study||10||
60066106|NCT01415908|76181351|FG001|COMPLETED|Overall Study||4||
60066107|NCT01415908|76181350|FG000|NOT COMPLETED|Overall Study||1||
60066108|NCT01415908|76181351|FG001|NOT COMPLETED|Overall Study||0||
60066109|NCT01415518|76181359|FG000|STARTED|Overall Study||292||
60066110|NCT01415518|76181360|FG001|STARTED|Overall Study||292||
60066111|NCT01415518|76181359|FG000|Patients Who Received Study Treatment|Overall Study||290||
60066112|NCT01415518|76181360|FG001|Patients Who Received Study Treatment|Overall Study||292||
59930901|NCT03212261|76049060|FG000|Program Initiation|Overall Study|Lost patients: Tech trouble no first visit (n=1), Too busy/no time (n=2), LTFU (n=1)|26|4 people completed the baseline survey but did not start the program|
59930902|NCT03212261|76049060|FG000|Post-intervention Survey|Overall Study|Lost to follow up (n=4)|22|# of people who completed the post-treatment survey (~8 weeks)|
59930903|NCT03212261|76049060|FG000|One Month Follow-up|Overall Study|Lost to follow up (n=1)|21|# of people who completed the one month follow-up survey (~4 weeks after intervention completion).|
59930904|NCT03212261|76049060|FG000|COMPLETED|Overall Study||21||
59930905|NCT03212261|76049060|FG000|NOT COMPLETED|Overall Study||16||
59930906|NCT02993250|76049067|FG000|STARTED|Overall Study||22||
59930907|NCT02993250|76049068|FG001|STARTED|Overall Study||11||
59930908|NCT02993250|76049067|FG000|COMPLETED|Overall Study||22||
59930909|NCT02993250|76049068|FG001|COMPLETED|Overall Study||10||
59930910|NCT02993250|76049067|FG000|NOT COMPLETED|Overall Study||0||
59930911|NCT02993250|76049068|FG001|NOT COMPLETED|Overall Study||1||
59930912|NCT02989194|76049077|FG000|STARTED|Overall Study||50||
59930913|NCT02989194|76049078|FG001|STARTED|Overall Study||50||
59930914|NCT02989194|76049079|FG002|STARTED|Overall Study||50||
59930915|NCT02989194|76049077|FG000|COMPLETED|Overall Study||49||
59930916|NCT02989194|76049078|FG001|COMPLETED|Overall Study||48||
59930917|NCT02989194|76049079|FG002|COMPLETED|Overall Study||50||
59930918|NCT02989194|76049077|FG000|NOT COMPLETED|Overall Study||1||
59930919|NCT02989194|76049078|FG001|NOT COMPLETED|Overall Study||2||
59930920|NCT02989194|76049079|FG002|NOT COMPLETED|Overall Study||0||
59930921|NCT02990910|76049100|FG000|STARTED|Overall Study||140|accorded with the inclusion criteria|
59930922|NCT02990910|76049101|FG001|STARTED|Overall Study||140|accorded with the inclusion criteria|
59930923|NCT02990910|76049100|FG000|COMPLETED|Overall Study||134|back to the wards|
59930924|NCT02990910|76049101|FG001|COMPLETED|Overall Study||130|back to the wards|
59930925|NCT02990910|76049100|FG000|NOT COMPLETED|Overall Study||6||
59930926|NCT02990910|76049101|FG001|NOT COMPLETED|Overall Study||10||
59930927|NCT03227861|76049107|FG000|STARTED|Main Study Period (Week 0 to Week 48)||109||
59930928|NCT03227861|76049107|FG000|COMPLETED|Main Study Period (Week 0 to Week 48)||97||
59930929|NCT03227861|76049107|FG000|NOT COMPLETED|Main Study Period (Week 0 to Week 48)||12||
59930930|NCT03227861|76049107|FG000|STARTED|Extension Period (Week 48 to Week 96)|17 participants were not willing to enter extension study and discontinued after main study.|80||
59930931|NCT03227861|76049107|FG000|COMPLETED|Extension Period (Week 48 to Week 96)||0||
59930932|NCT03227861|76049107|FG000|NOT COMPLETED|Extension Period (Week 48 to Week 96)||80||
60066113|NCT01415518|76181359|FG000|Pts With Correct Randomized Treatment|Overall Study|Efficacy analysis used 290 patients. Safety analysis used 290+3=293 patients.|290||
60066114|NCT01415518|76181360|FG001|Pts With Correct Randomized Treatment|Overall Study|Efficacy analysis used 292 patients. Safety analysis used 292-3=289 patients.|289||
60066115|NCT01415518|76181359|FG000|COMPLETED|Overall Study||276||
60066116|NCT01415518|76181360|FG001|COMPLETED|Overall Study||261||
60066117|NCT01415518|76181359|FG000|NOT COMPLETED|Overall Study||16||
60066118|NCT01415518|76181360|FG001|NOT COMPLETED|Overall Study||31||
60066119|NCT01393600|76181366|FG000|STARTED|Treatment Period 1 (Day 1 to 14)||9||
59930933|NCT01336712|76049113|FG000|STARTED|Overall Study||30||
59930934|NCT01336712|76049113|FG000|COMPLETED|Overall Study||27||
59930935|NCT01336712|76049113|FG000|NOT COMPLETED|Overall Study||3||
59930936|NCT03208127|76049117|FG000|STARTED|Overall Study||24||
59930937|NCT03208127|76049117|FG000|COMPLETED|Overall Study||23||
59930938|NCT03208127|76049117|FG000|NOT COMPLETED|Overall Study||1||
60066120|NCT01393600|76181367|FG001|STARTED|Treatment Period 1 (Day 1 to 14)||8||
60066121|NCT01393600|76181368|FG002|STARTED|Treatment Period 1 (Day 1 to 14)||10||
59518030|NCT03493828|75611933|FG001|NOT COMPLETED|Overall Study||0||
59761393|NCT02393248|75881082|FG000|STARTED|Part 2: Monotherapy Dose Expansion||0||
60066122|NCT01393600|76181369|FG003|STARTED|Treatment Period 1 (Day 1 to 14)||10||
60066123|NCT01393600|76181366|FG000|COMPLETED|Treatment Period 1 (Day 1 to 14)||9||
60066124|NCT01393600|76181367|FG001|COMPLETED|Treatment Period 1 (Day 1 to 14)||7||
60066125|NCT01393600|76181368|FG002|COMPLETED|Treatment Period 1 (Day 1 to 14)||9||
60066126|NCT01393600|76181369|FG003|COMPLETED|Treatment Period 1 (Day 1 to 14)||9||
60066127|NCT01393600|76181366|FG000|NOT COMPLETED|Treatment Period 1 (Day 1 to 14)||0||
60066128|NCT01393600|76181367|FG001|NOT COMPLETED|Treatment Period 1 (Day 1 to 14)||1||
60066129|NCT01393600|76181368|FG002|NOT COMPLETED|Treatment Period 1 (Day 1 to 14)||1||
60066130|NCT01393600|76181369|FG003|NOT COMPLETED|Treatment Period 1 (Day 1 to 14)||1||
60066131|NCT01393600|76181366|FG000|STARTED|Treatment Period 2 (Day 15 to 28)||9||
60066132|NCT01393600|76181367|FG001|STARTED|Treatment Period 2 (Day 15 to 28)||7||
59761394|NCT02393248|75881083|FG001|STARTED|Part 2: Monotherapy Dose Expansion||0||
59761395|NCT02393248|75881084|FG002|STARTED|Part 2: Monotherapy Dose Expansion||0||
60066133|NCT01393600|76181368|FG002|STARTED|Treatment Period 2 (Day 15 to 28)||9||
60066134|NCT01393600|76181369|FG003|STARTED|Treatment Period 2 (Day 15 to 28)||9||
60066135|NCT01393600|76181366|FG000|COMPLETED|Treatment Period 2 (Day 15 to 28)||9||
60066136|NCT01393600|76181367|FG001|COMPLETED|Treatment Period 2 (Day 15 to 28)||7||
60066137|NCT01393600|76181368|FG002|COMPLETED|Treatment Period 2 (Day 15 to 28)||7||
60066138|NCT01393600|76181369|FG003|COMPLETED|Treatment Period 2 (Day 15 to 28)||8||
60066139|NCT01393600|76181366|FG000|NOT COMPLETED|Treatment Period 2 (Day 15 to 28)||0||
60066140|NCT01393600|76181367|FG001|NOT COMPLETED|Treatment Period 2 (Day 15 to 28)||0||
60066141|NCT01393600|76181368|FG002|NOT COMPLETED|Treatment Period 2 (Day 15 to 28)||2||
59518031|NCT03493828|75611934|FG002|NOT COMPLETED|Overall Study||0||
59518032|NCT03495856|75611942|FG000|STARTED|Overall Study||23||
59518033|NCT03495856|75611942|FG000|COMPLETED|Overall Study||22||
59761396|NCT02393248|75881085|FG003|STARTED|Part 2: Monotherapy Dose Expansion||0||
59761397|NCT02393248|75881086|FG004|STARTED|Part 2: Monotherapy Dose Expansion||0||
59761398|NCT02393248|75881087|FG005|STARTED|Part 2: Monotherapy Dose Expansion||0||
59761399|NCT02393248|75881088|FG006|STARTED|Part 2: Monotherapy Dose Expansion||0||
59761400|NCT02393248|75881089|FG007|STARTED|Part 2: Monotherapy Dose Expansion||0||
59761401|NCT02393248|75881090|FG008|STARTED|Part 2: Monotherapy Dose Expansion||0||
59761402|NCT02393248|75881091|FG009|STARTED|Part 2: Monotherapy Dose Expansion||0||
59761403|NCT02393248|75881092|FG010|STARTED|Part 2: Monotherapy Dose Expansion||4||
59761404|NCT02393248|75881093|FG011|STARTED|Part 2: Monotherapy Dose Expansion||44||
59761405|NCT02393248|75881094|FG012|STARTED|Part 2: Monotherapy Dose Expansion||5||
59761406|NCT02393248|75881095|FG013|STARTED|Part 2: Monotherapy Dose Expansion||20||
59761407|NCT02393248|75881096|FG014|STARTED|Part 2: Monotherapy Dose Expansion||6||
59761408|NCT02393248|75881097|FG015|STARTED|Part 2: Monotherapy Dose Expansion||0||
59761409|NCT02393248|75881098|FG016|STARTED|Part 2: Monotherapy Dose Expansion||0||
59761410|NCT02393248|75881099|FG017|STARTED|Part 2: Monotherapy Dose Expansion||0||
59761411|NCT02393248|75881100|FG018|STARTED|Part 2: Monotherapy Dose Expansion||0||
59761412|NCT02393248|75881101|FG019|STARTED|Part 2: Monotherapy Dose Expansion||0||
59761413|NCT02393248|75881102|FG020|STARTED|Part 2: Monotherapy Dose Expansion||0||
59761414|NCT02393248|75881103|FG021|STARTED|Part 2: Monotherapy Dose Expansion||0||
59761415|NCT02393248|75881104|FG022|STARTED|Part 2: Monotherapy Dose Expansion||0||
59761416|NCT02393248|75881105|FG023|STARTED|Part 2: Monotherapy Dose Expansion||0||
59761417|NCT02393248|75881106|FG024|STARTED|Part 2: Monotherapy Dose Expansion||0||
59761418|NCT02393248|75881082|FG000|COMPLETED|Part 2: Monotherapy Dose Expansion||0||
59761419|NCT02393248|75881083|FG001|COMPLETED|Part 2: Monotherapy Dose Expansion||0||
59761420|NCT02393248|75881084|FG002|COMPLETED|Part 2: Monotherapy Dose Expansion||0||
60066142|NCT01393600|76181369|FG003|NOT COMPLETED|Treatment Period 2 (Day 15 to 28)||1||
60066143|NCT01393600|76181366|FG000|STARTED|Follow-up Period (Day 29 to 35)||9||
60066144|NCT01393600|76181367|FG001|STARTED|Follow-up Period (Day 29 to 35)||7||
60066145|NCT01393600|76181368|FG002|STARTED|Follow-up Period (Day 29 to 35)||7||
60066146|NCT01393600|76181369|FG003|STARTED|Follow-up Period (Day 29 to 35)||8||
60066147|NCT01393600|76181366|FG000|COMPLETED|Follow-up Period (Day 29 to 35)||9||
60066148|NCT01393600|76181367|FG001|COMPLETED|Follow-up Period (Day 29 to 35)||7||
59930939|NCT02865122|76049124|FG000|STARTED|Overall Study||1||
59930940|NCT02865122|76049125|FG001|STARTED|Overall Study||1||
59930941|NCT02865122|76049126|FG002|STARTED|Overall Study||0||
60066149|NCT01393600|76181368|FG002|COMPLETED|Follow-up Period (Day 29 to 35)||6||
60066150|NCT01393600|76181369|FG003|COMPLETED|Follow-up Period (Day 29 to 35)||8||
60066151|NCT01393600|76181366|FG000|NOT COMPLETED|Follow-up Period (Day 29 to 35)||0||
60066152|NCT01393600|76181367|FG001|NOT COMPLETED|Follow-up Period (Day 29 to 35)||0||
60066153|NCT01393600|76181368|FG002|NOT COMPLETED|Follow-up Period (Day 29 to 35)||1||
60066154|NCT01393600|76181369|FG003|NOT COMPLETED|Follow-up Period (Day 29 to 35)||0||
60066155|NCT01432756|76181385|FG000|STARTED|Overall Study||32||
60066156|NCT01432756|76181386|FG001|STARTED|Overall Study||34||
59930942|NCT02865122|76049124|FG000|COMPLETED|Overall Study||0||
59930943|NCT02865122|76049125|FG001|COMPLETED|Overall Study||1||
59930944|NCT02865122|76049126|FG002|COMPLETED|Overall Study||0||
59930945|NCT02865122|76049124|FG000|NOT COMPLETED|Overall Study||1||
59930946|NCT02865122|76049125|FG001|NOT COMPLETED|Overall Study||0||
59930947|NCT02865122|76049126|FG002|NOT COMPLETED|Overall Study||0||
59930948|NCT02864498|76049137|FG000|STARTED|Overall Study||105||
59930949|NCT02864498|76049138|FG001|STARTED|Overall Study||112||
59930950|NCT02864498|76049139|FG002|STARTED|Overall Study||104||
59930951|NCT02864498|76049137|FG000|COMPLETED|Overall Study||85||
59930952|NCT02864498|76049138|FG001|COMPLETED|Overall Study||87||
59930953|NCT02864498|76049139|FG002|COMPLETED|Overall Study||91||
59930954|NCT02864498|76049137|FG000|NOT COMPLETED|Overall Study||20||
59930955|NCT02864498|76049138|FG001|NOT COMPLETED|Overall Study||25||
59930956|NCT02864498|76049139|FG002|NOT COMPLETED|Overall Study||13||
59930957|NCT03238781|76049150|FG000|STARTED|Overall Study||137||
59930958|NCT03238781|76049151|FG001|STARTED|Overall Study||104||
59930959|NCT03238781|76049152|FG002|STARTED|Overall Study||102||
59930960|NCT03238781|76049150|FG000|COMPLETED|Overall Study||111||
59930961|NCT03238781|76049151|FG001|COMPLETED|Overall Study||87||
59930962|NCT03238781|76049152|FG002|COMPLETED|Overall Study||82||
59930963|NCT03238781|76049150|FG000|NOT COMPLETED|Overall Study||26||
59930964|NCT03238781|76049151|FG001|NOT COMPLETED|Overall Study||17||
59930965|NCT03238781|76049152|FG002|NOT COMPLETED|Overall Study||20||
59930966|NCT02097121|76049163|FG000|STARTED|Overall Study||19||
59930967|NCT02097121|76049164|FG001|STARTED|Overall Study||18||
59930968|NCT02097121|76049165|FG002|STARTED|Overall Study||19||
59930969|NCT02097121|76049163|FG000|Received Any Treatment|Overall Study||19||
59930970|NCT02097121|76049164|FG001|Received Any Treatment|Overall Study||17||
59930971|NCT02097121|76049165|FG002|Received Any Treatment|Overall Study||19||
59930972|NCT02097121|76049163|FG000|Actual Treatment Received in Cycle 1|Overall Study||18||
59930973|NCT02097121|76049164|FG001|Actual Treatment Received in Cycle 1|Overall Study||17||
59930974|NCT02097121|76049165|FG002|Actual Treatment Received in Cycle 1|Overall Study|One participant randomized to 25 U BOTOX received 100 U BOTOX in Cycle 1 in error|20||
59930975|NCT02097121|76049163|FG000|Actual Treatment Received in Cycle 2|Overall Study||1||
59930976|NCT02097121|76049164|FG001|Actual Treatment Received in Cycle 2|Overall Study|One participant assigned to 100 U BOTOX received 50 U BOTOX in Cycle 2 in error|17||
59930977|NCT02097121|76049165|FG002|Actual Treatment Received in Cycle 2|Overall Study|One participant assigned to 25 U BOTOX and two participants assigned to 50 U BOTOX received 100 U BOTOX in Cycle 2 in error|28||
59930978|NCT02097121|76049163|FG000|Actual Treatment Received in Cycle 3|Overall Study||2||
59930979|NCT02097121|76049164|FG001|Actual Treatment Received in Cycle 3|Overall Study||7||
59930980|NCT02097121|76049165|FG002|Actual Treatment Received in Cycle 3|Overall Study||13||
59930981|NCT02097121|76049163|FG000|Actual Treatment Received in Cycle 4|Overall Study||0||
59930982|NCT02097121|76049164|FG001|Actual Treatment Received in Cycle 4|Overall Study||1||
59930983|NCT02097121|76049165|FG002|Actual Treatment Received in Cycle 4|Overall Study||3||
59930984|NCT02097121|76049163|FG000|COMPLETED|Overall Study||12||
59930985|NCT02097121|76049164|FG001|COMPLETED|Overall Study||12||
59930986|NCT02097121|76049165|FG002|COMPLETED|Overall Study||9||
59930987|NCT02097121|76049163|FG000|NOT COMPLETED|Overall Study||7||
59930988|NCT02097121|76049164|FG001|NOT COMPLETED|Overall Study||6||
59930989|NCT02097121|76049165|FG002|NOT COMPLETED|Overall Study||10||
59930990|NCT02747420|76049194|FG000|STARTED|Overall Study||18||
59930991|NCT02747420|76049195|FG001|STARTED|Overall Study||22||
59930992|NCT02747420|76049194|FG000|COMPLETED|Overall Study||11||
59930993|NCT02747420|76049195|FG001|COMPLETED|Overall Study||18||
59930994|NCT02747420|76049194|FG000|NOT COMPLETED|Overall Study||7||
59930995|NCT02747420|76049195|FG001|NOT COMPLETED|Overall Study||4||
59930996|NCT03238001|76049201|FG000|STARTED|Visit 1 (Primary Endpoint Cohort)||436||
60066157|NCT01432756|76181387|FG002|STARTED|Overall Study||32||
60066158|NCT01432756|76181388|FG003|STARTED|Overall Study||34||
60066159|NCT01432756|76181385|FG000|COMPLETED|Overall Study||31||
59930997|NCT03238001|76049201|FG000|COMPLETED|Visit 1 (Primary Endpoint Cohort)||432||
59930998|NCT03238001|76049201|FG000|NOT COMPLETED|Visit 1 (Primary Endpoint Cohort)||4||
60066160|NCT01432756|76181386|FG001|COMPLETED|Overall Study||34||
60066161|NCT01432756|76181387|FG002|COMPLETED|Overall Study||30||
60066162|NCT01432756|76181388|FG003|COMPLETED|Overall Study||33||
60066163|NCT01432756|76181385|FG000|NOT COMPLETED|Overall Study||1||
60066164|NCT01432756|76181386|FG001|NOT COMPLETED|Overall Study||0||
60066165|NCT01432756|76181387|FG002|NOT COMPLETED|Overall Study||2||
60066166|NCT01432756|76181388|FG003|NOT COMPLETED|Overall Study||1||
60066167|NCT01432600|76181399|FG000|STARTED|Overall Study||10||
60066168|NCT01432600|76181400|FG001|STARTED|Overall Study||36||
60066169|NCT01432600|76181401|FG002|STARTED|Overall Study||34||
60066170|NCT01432600|76181399|FG000|COMPLETED|Overall Study||10||
60066171|NCT01432600|76181400|FG001|COMPLETED|Overall Study||35||
60066172|NCT01432600|76181401|FG002|COMPLETED|Overall Study||33||
60066173|NCT01432600|76181399|FG000|NOT COMPLETED|Overall Study||0||
60066174|NCT01432600|76181400|FG001|NOT COMPLETED|Overall Study||1||
60066175|NCT01432600|76181401|FG002|NOT COMPLETED|Overall Study||1||
60066176|NCT01432444|76181411|FG000|STARTED|Tolerability/Cross-titration Phase||325||
60066177|NCT01432444|76181412|FG001|STARTED|Tolerability/Cross-titration Phase||0||
60066178|NCT01432444|76181413|FG002|STARTED|Tolerability/Cross-titration Phase||0||
60066179|NCT01432444|76181411|FG000|COMPLETED|Tolerability/Cross-titration Phase||265||
60066180|NCT01432444|76181412|FG001|COMPLETED|Tolerability/Cross-titration Phase||0||
60066181|NCT01432444|76181413|FG002|COMPLETED|Tolerability/Cross-titration Phase||0||
60066182|NCT01432444|76181411|FG000|NOT COMPLETED|Tolerability/Cross-titration Phase||60||
60066183|NCT01432444|76181412|FG001|NOT COMPLETED|Tolerability/Cross-titration Phase||0||
60066184|NCT01432444|76181413|FG002|NOT COMPLETED|Tolerability/Cross-titration Phase||0||
60066185|NCT01432444|76181411|FG000|STARTED|Treatment Phase||0||
60066186|NCT01432444|76181412|FG001|STARTED|Treatment Phase||433||
60066187|NCT01432444|76181413|FG002|STARTED|Treatment Phase||0||
60066188|NCT01432444|76181411|FG000|COMPLETED|Treatment Phase||0||
60066189|NCT01432444|76181412|FG001|COMPLETED|Treatment Phase||293||
60066190|NCT01432444|76181413|FG002|COMPLETED|Treatment Phase||0||
60066191|NCT01432444|76181411|FG000|NOT COMPLETED|Treatment Phase||0||
60066192|NCT01432444|76181412|FG001|NOT COMPLETED|Treatment Phase||140||
60066193|NCT01432444|76181413|FG002|NOT COMPLETED|Treatment Phase||0||
60066194|NCT01432444|76181411|FG000|STARTED|Extension Phase||0||
60066195|NCT01432444|76181412|FG001|STARTED|Extension Phase||0||
60066196|NCT01432444|76181413|FG002|STARTED|Extension Phase||192||
60066197|NCT01432444|76181411|FG000|COMPLETED|Extension Phase||0||
60066198|NCT01432444|76181412|FG001|COMPLETED|Extension Phase||0||
60066199|NCT01432444|76181413|FG002|COMPLETED|Extension Phase||0||
60066200|NCT01432444|76181411|FG000|NOT COMPLETED|Extension Phase||0||
60066201|NCT01432444|76181412|FG001|NOT COMPLETED|Extension Phase||0||
60066202|NCT01432444|76181413|FG002|NOT COMPLETED|Extension Phase||192||
59761421|NCT02393248|75881085|FG003|COMPLETED|Part 2: Monotherapy Dose Expansion||0||
59761422|NCT02393248|75881086|FG004|COMPLETED|Part 2: Monotherapy Dose Expansion||0||
59761423|NCT02393248|75881087|FG005|COMPLETED|Part 2: Monotherapy Dose Expansion||0||
59761424|NCT02393248|75881088|FG006|COMPLETED|Part 2: Monotherapy Dose Expansion||0||
59761425|NCT02393248|75881089|FG007|COMPLETED|Part 2: Monotherapy Dose Expansion||0||
59761426|NCT02393248|75881090|FG008|COMPLETED|Part 2: Monotherapy Dose Expansion||0||
60066203|NCT01432366|76181418|FG000|STARTED|Overall Study||460||
60066204|NCT01432366|76181418|FG000|COMPLETED|Overall Study||392||
60066205|NCT01432366|76181418|FG000|NOT COMPLETED|Overall Study||68||
60066206|NCT01415440|76181425|FG000|STARTED|Overall Study||41||
60066207|NCT01415440|76181426|FG001|STARTED|Overall Study||29||
60066208|NCT01415440|76181427|FG002|STARTED|Overall Study||29||
60066209|NCT01415440|76181425|FG000|COMPLETED|Overall Study||37||
60066210|NCT01415440|76181426|FG001|COMPLETED|Overall Study||28||
60066211|NCT01415440|76181427|FG002|COMPLETED|Overall Study||27||
60066212|NCT01415440|76181425|FG000|NOT COMPLETED|Overall Study||4||
59761427|NCT02393248|75881091|FG009|COMPLETED|Part 2: Monotherapy Dose Expansion||0||
59761428|NCT02393248|75881092|FG010|COMPLETED|Part 2: Monotherapy Dose Expansion||0||
60066213|NCT01415440|76181426|FG001|NOT COMPLETED|Overall Study||1||
60066214|NCT01415440|76181427|FG002|NOT COMPLETED|Overall Study||2||
60066215|NCT02076412|76181436|FG000|STARTED|Overall Study||50||
60066216|NCT02076412|76181437|FG001|STARTED|Overall Study||24||
60066217|NCT02076412|76181436|FG000|COMPLETED|Overall Study||13||
60066218|NCT02076412|76181437|FG001|COMPLETED|Overall Study||2||
60066219|NCT02076412|76181436|FG000|NOT COMPLETED|Overall Study||37||
60066220|NCT02076412|76181437|FG001|NOT COMPLETED|Overall Study||22||
60066221|NCT01932788|76181445|FG000|STARTED|Overall Study||173||
60066222|NCT01932788|76181446|FG001|STARTED|Overall Study||169||
60066223|NCT01932788|76181445|FG000|COMPLETED|Overall Study||135||
59518034|NCT03495856|75611942|FG000|NOT COMPLETED|Overall Study||1||
59518035|NCT03496324|75611946|FG000|STARTED|Period 1||6||
59518036|NCT03496324|75611947|FG001|STARTED|Period 1||6||
59518037|NCT03496324|75611948|FG002|STARTED|Period 1||6||
59518038|NCT03496324|75611949|FG003|STARTED|Period 1||6||
59518039|NCT03496324|75611946|FG000|COMPLETED|Period 1||6||
59518040|NCT03496324|75611947|FG001|COMPLETED|Period 1||6||
59518041|NCT03496324|75611948|FG002|COMPLETED|Period 1||6||
59518042|NCT03496324|75611949|FG003|COMPLETED|Period 1||6||
59518043|NCT03496324|75611946|FG000|NOT COMPLETED|Period 1||0||
59518044|NCT03496324|75611947|FG001|NOT COMPLETED|Period 1||0||
59518045|NCT03496324|75611948|FG002|NOT COMPLETED|Period 1||0||
59518046|NCT03496324|75611949|FG003|NOT COMPLETED|Period 1||0||
59518047|NCT03496324|75611946|FG000|STARTED|Period 1: Washout (3 to 7 Days)||6||
59518048|NCT03496324|75611947|FG001|STARTED|Period 1: Washout (3 to 7 Days)||6||
59518049|NCT03496324|75611948|FG002|STARTED|Period 1: Washout (3 to 7 Days)||6||
59518050|NCT03496324|75611949|FG003|STARTED|Period 1: Washout (3 to 7 Days)||6||
59518051|NCT03496324|75611946|FG000|COMPLETED|Period 1: Washout (3 to 7 Days)||6||
59518052|NCT03496324|75611947|FG001|COMPLETED|Period 1: Washout (3 to 7 Days)||6||
59518053|NCT03496324|75611948|FG002|COMPLETED|Period 1: Washout (3 to 7 Days)||6||
59518054|NCT03496324|75611949|FG003|COMPLETED|Period 1: Washout (3 to 7 Days)||6||
59518055|NCT03496324|75611946|FG000|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0||
59518056|NCT03496324|75611947|FG001|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0||
60066224|NCT01932788|76181446|FG001|COMPLETED|Overall Study||118||
60066225|NCT01932788|76181445|FG000|NOT COMPLETED|Overall Study||38||
60066226|NCT01932788|76181446|FG001|NOT COMPLETED|Overall Study||51||
60066227|NCT01414738|76181452|FG000|STARTED|Overall Study||49|1 patient did not initiate treatment|
60066228|NCT01414738|76181452|FG000|Follow-up (3 Months)|Overall Study||18||
60066229|NCT01414738|76181452|FG000|Follow-up (6 Months)|Overall Study||8||
60066230|NCT01414738|76181452|FG000|Follow-up (9 Months)|Overall Study||5||
60066231|NCT01414738|76181452|FG000|COMPLETED|Overall Study||5||
60066232|NCT01414738|76181452|FG000|NOT COMPLETED|Overall Study||44||
60066233|NCT01414114|76181456|FG000|STARTED|Overall Study||37||
60066234|NCT01414114|76181456|FG000|COMPLETED|Overall Study|Completed 12-week treatment period|32||
60066235|NCT01414114|76181456|FG000|NOT COMPLETED|Overall Study||5||
60066236|NCT01393444|76181462|FG000|STARTED|Overall Study||6||
60066237|NCT01393444|76181462|FG000|First (1st Implanted) Subject Enrolled|Overall Study|2011: Individual with cervical spinal cord injury enrolled and was eligible. Implanted in 2011.|1||
60066238|NCT01393444|76181462|FG000|Second Subject Enrolled|Overall Study|2012: Second participant enrolled. Ineligible.|1||
59761429|NCT02393248|75881093|FG011|COMPLETED|Part 2: Monotherapy Dose Expansion||0||
59518057|NCT03496324|75611948|FG002|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0||
59518058|NCT03496324|75611949|FG003|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0||
59518059|NCT03496324|75611946|FG000|STARTED|Period 2||6||
59518060|NCT03496324|75611947|FG001|STARTED|Period 2||6||
60066239|NCT01393444|76181462|FG000|Third Subject Enrolled|Overall Study|2013: Third participant enrolled. Withdrew due to family commitments.|1||
60066240|NCT01393444|76181462|FG000|Fourth Subject Enrolled|Overall Study|2013: Fourth participant enrolled. Ineligible.|1||
60066241|NCT01393444|76181462|FG000|Fifth (2nd Implanted) Subject Enrolled|Overall Study|2013: Individual with ALS enrolled and was eligible. Implanted in 2014.|1||
60066242|NCT01393444|76181462|FG000|Sixth (3rd Implanted) Subject|Overall Study|2014: Individual with brachial plexus injury enrolled and was eligible. Implanted in 2015.|1||
60066243|NCT01393444|76181462|FG000|COMPLETED|Overall Study|2015: Third implanted subject completed the study. This fulfilled the requirements of our grant.|3||
60066244|NCT01393444|76181462|FG000|NOT COMPLETED|Overall Study||3||
60066245|NCT01431976|76181466|FG000|STARTED|Overall Study||20||
60066246|NCT01431976|76181466|FG000|COMPLETED|Overall Study||6||
60066247|NCT01431976|76181466|FG000|NOT COMPLETED|Overall Study||14||
60066248|NCT01392742|76181470|FG000|STARTED|Overall Study||443||
60066249|NCT01392742|76181470|FG000|COMPLETED|Overall Study||242||
60066250|NCT01392742|76181470|FG000|NOT COMPLETED|Overall Study||201||
60066251|NCT01413958|76181476|FG000|STARTED|Overall Study||288||
60066252|NCT01413958|76181477|FG001|STARTED|Overall Study||287||
60066253|NCT01413958|76181476|FG000|COMPLETED|Overall Study||288||
60066254|NCT01413958|76181477|FG001|COMPLETED|Overall Study||286||
60066255|NCT01413958|76181476|FG000|NOT COMPLETED|Overall Study||0||
60066256|NCT01413958|76181477|FG001|NOT COMPLETED|Overall Study||1||
60066257|NCT01413178|76181486|FG000|STARTED|Overall Study||105||
60066258|NCT01413178|76181487|FG001|STARTED|Overall Study||100||
60066259|NCT01413178|76181486|FG000|COMPLETED|Overall Study||104||
59518061|NCT03496324|75611948|FG002|STARTED|Period 2||6||
59518062|NCT03496324|75611949|FG003|STARTED|Period 2||6||
60066260|NCT01413178|76181487|FG001|COMPLETED|Overall Study||98||
60066261|NCT01413178|76181486|FG000|NOT COMPLETED|Overall Study||1||
60066262|NCT01413178|76181487|FG001|NOT COMPLETED|Overall Study||2||
60066263|NCT01799889|76181505|FG000|STARTED|Overall Study||41||
60066264|NCT01799889|76181506|FG001|STARTED|Overall Study||41||
60066265|NCT01799889|76181507|FG002|STARTED|Overall Study||44||
60066266|NCT01799889|76181508|FG003|STARTED|Overall Study||39||
60066267|NCT01799889|76181509|FG004|STARTED|Overall Study||49||
60066268|NCT01799889|76181510|FG005|STARTED|Overall Study||20||
60066269|NCT01799889|76181511|FG006|STARTED|Overall Study||21||
60066270|NCT01799889|76181512|FG007|STARTED|Overall Study||20||
60066271|NCT01799889|76181513|FG008|STARTED|Overall Study||33||
60066272|NCT01799889|76181514|FG009|STARTED|Overall Study||8||
60066273|NCT01799889|76181515|FG010|STARTED|Overall Study||7||
60066274|NCT01799889|76181516|FG011|STARTED|Overall Study||3||
60066275|NCT01799889|76181505|FG000|COMPLETED|Overall Study||0||
60066276|NCT01799889|76181506|FG001|COMPLETED|Overall Study||0||
60066277|NCT01799889|76181507|FG002|COMPLETED|Overall Study||0||
60066278|NCT01799889|76181508|FG003|COMPLETED|Overall Study||0||
60066279|NCT01799889|76181509|FG004|COMPLETED|Overall Study||0||
60066280|NCT01799889|76181510|FG005|COMPLETED|Overall Study||0||
60066281|NCT01799889|76181511|FG006|COMPLETED|Overall Study||0||
60066282|NCT01799889|76181512|FG007|COMPLETED|Overall Study||0||
60066283|NCT01799889|76181513|FG008|COMPLETED|Overall Study||0||
60066284|NCT01799889|76181514|FG009|COMPLETED|Overall Study||0||
60066285|NCT01799889|76181515|FG010|COMPLETED|Overall Study||0||
60066286|NCT01799889|76181516|FG011|COMPLETED|Overall Study||0||
60066287|NCT01799889|76181505|FG000|NOT COMPLETED|Overall Study||41||
60066288|NCT01799889|76181506|FG001|NOT COMPLETED|Overall Study||41||
60066289|NCT01799889|76181507|FG002|NOT COMPLETED|Overall Study||44||
60066290|NCT01799889|76181508|FG003|NOT COMPLETED|Overall Study||39||
60066291|NCT01799889|76181509|FG004|NOT COMPLETED|Overall Study||49||
60066292|NCT01799889|76181510|FG005|NOT COMPLETED|Overall Study||20||
60066293|NCT01799889|76181511|FG006|NOT COMPLETED|Overall Study||21||
60066294|NCT01799889|76181512|FG007|NOT COMPLETED|Overall Study||20||
60066295|NCT01799889|76181513|FG008|NOT COMPLETED|Overall Study||33||
60066296|NCT01799889|76181514|FG009|NOT COMPLETED|Overall Study||8||
60066297|NCT01799889|76181515|FG010|NOT COMPLETED|Overall Study||7||
60066298|NCT01799889|76181516|FG011|NOT COMPLETED|Overall Study||3||
60066299|NCT01412944|76181555|FG000|STARTED|IV: Per Previous CAIN457A2304 Treatment||0||
60066300|NCT01412944|76181556|FG001|STARTED|IV: Per Previous CAIN457A2304 Treatment||0||
60066301|NCT01412944|76181557|FG002|STARTED|IV: Per Previous CAIN457A2304 Treatment||15||
60066302|NCT01412944|76181558|FG003|STARTED|IV: Per Previous CAIN457A2304 Treatment||6||
60066303|NCT01412944|76181559|FG004|STARTED|IV: Per Previous CAIN457A2304 Treatment||14||
60066304|NCT01412944|76181560|FG005|STARTED|IV: Per Previous CAIN457A2304 Treatment||8||
60066305|NCT01412944|76181555|FG000|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0||
60066306|NCT01412944|76181556|FG001|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0||
60066307|NCT01412944|76181557|FG002|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||14||
60066308|NCT01412944|76181558|FG003|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||6||
60066309|NCT01412944|76181559|FG004|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||14||
60066310|NCT01412944|76181560|FG005|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||6||
60066311|NCT01412944|76181555|FG000|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0||
60066312|NCT01412944|76181556|FG001|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0||
60066313|NCT01412944|76181557|FG002|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||1||
60066314|NCT01412944|76181558|FG003|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0||
60066315|NCT01412944|76181559|FG004|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0||
60066316|NCT01412944|76181560|FG005|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||2||
60066317|NCT01412944|76181555|FG000|STARTED|IV: Per CAIN457A2307||21||
60066318|NCT01412944|76181556|FG001|STARTED|IV: Per CAIN457A2307||22||
60066319|NCT01412944|76181557|FG002|STARTED|IV: Per CAIN457A2307||0||
60066320|NCT01412944|76181558|FG003|STARTED|IV: Per CAIN457A2307||0||
60066321|NCT01412944|76181559|FG004|STARTED|IV: Per CAIN457A2307||0||
59761430|NCT02393248|75881094|FG012|COMPLETED|Part 2: Monotherapy Dose Expansion||0||
59518063|NCT03496324|75611946|FG000|COMPLETED|Period 2||6||
59518064|NCT03496324|75611947|FG001|COMPLETED|Period 2||6||
59518065|NCT03496324|75611948|FG002|COMPLETED|Period 2||6||
59518066|NCT03496324|75611949|FG003|COMPLETED|Period 2||6||
59518067|NCT03496324|75611946|FG000|NOT COMPLETED|Period 2||0||
59518068|NCT03496324|75611947|FG001|NOT COMPLETED|Period 2||0||
59761431|NCT02393248|75881095|FG013|COMPLETED|Part 2: Monotherapy Dose Expansion||0||
59761432|NCT02393248|75881096|FG014|COMPLETED|Part 2: Monotherapy Dose Expansion||1||
60066322|NCT01412944|76181560|FG005|STARTED|IV: Per CAIN457A2307||0||
60066323|NCT01412944|76181555|FG000|COMPLETED|IV: Per CAIN457A2307||20||
60066324|NCT01412944|76181556|FG001|COMPLETED|IV: Per CAIN457A2307||20||
60066325|NCT01412944|76181557|FG002|COMPLETED|IV: Per CAIN457A2307||0||
60066326|NCT01412944|76181558|FG003|COMPLETED|IV: Per CAIN457A2307||0||
60066327|NCT01412944|76181559|FG004|COMPLETED|IV: Per CAIN457A2307||0||
60066328|NCT01412944|76181560|FG005|COMPLETED|IV: Per CAIN457A2307||0||
59518069|NCT03496324|75611948|FG002|NOT COMPLETED|Period 2||0||
60066329|NCT01412944|76181555|FG000|NOT COMPLETED|IV: Per CAIN457A2307||1||
60066330|NCT01412944|76181556|FG001|NOT COMPLETED|IV: Per CAIN457A2307||2||
59518070|NCT03496324|75611949|FG003|NOT COMPLETED|Period 2||0||
59761433|NCT02393248|75881097|FG015|COMPLETED|Part 2: Monotherapy Dose Expansion||0||
60066331|NCT01412944|76181557|FG002|NOT COMPLETED|IV: Per CAIN457A2307||0||
60066332|NCT01412944|76181558|FG003|NOT COMPLETED|IV: Per CAIN457A2307||0||
60066333|NCT01412944|76181559|FG004|NOT COMPLETED|IV: Per CAIN457A2307||0||
60066334|NCT01412944|76181560|FG005|NOT COMPLETED|IV: Per CAIN457A2307||0||
60066335|NCT01412944|76181555|FG000|STARTED|Entire: IV + Maintenance||0||
60066336|NCT01412944|76181556|FG001|STARTED|Entire: IV + Maintenance||0||
60066337|NCT01412944|76181557|FG002|STARTED|Entire: IV + Maintenance||15||
60066338|NCT01412944|76181558|FG003|STARTED|Entire: IV + Maintenance||6||
60066339|NCT01412944|76181559|FG004|STARTED|Entire: IV + Maintenance||14||
60066340|NCT01412944|76181560|FG005|STARTED|Entire: IV + Maintenance||8||
60066341|NCT01412944|76181555|FG000|COMPLETED|Entire: IV + Maintenance||0||
59518071|NCT03496324|75611946|FG000|STARTED|Period 2: Washout (3 to 7 Days)||6||
59761434|NCT02393248|75881098|FG016|COMPLETED|Part 2: Monotherapy Dose Expansion||0||
59761435|NCT02393248|75881099|FG017|COMPLETED|Part 2: Monotherapy Dose Expansion||0||
60066342|NCT01412944|76181556|FG001|COMPLETED|Entire: IV + Maintenance||0||
60066343|NCT01412944|76181557|FG002|COMPLETED|Entire: IV + Maintenance||14||
59518072|NCT03496324|75611947|FG001|STARTED|Period 2: Washout (3 to 7 Days)||6||
59518073|NCT03496324|75611948|FG002|STARTED|Period 2: Washout (3 to 7 Days)||6||
60066344|NCT01412944|76181558|FG003|COMPLETED|Entire: IV + Maintenance||5||
60066345|NCT01412944|76181559|FG004|COMPLETED|Entire: IV + Maintenance||11||
60066346|NCT01412944|76181560|FG005|COMPLETED|Entire: IV + Maintenance||6||
59761436|NCT02393248|75881100|FG018|COMPLETED|Part 2: Monotherapy Dose Expansion||0||
59761437|NCT02393248|75881101|FG019|COMPLETED|Part 2: Monotherapy Dose Expansion||0||
59761438|NCT02393248|75881102|FG020|COMPLETED|Part 2: Monotherapy Dose Expansion||0||
59761439|NCT02393248|75881103|FG021|COMPLETED|Part 2: Monotherapy Dose Expansion||0||
59761440|NCT02393248|75881104|FG022|COMPLETED|Part 2: Monotherapy Dose Expansion||0||
59518074|NCT03496324|75611949|FG003|STARTED|Period 2: Washout (3 to 7 Days)||6||
59518075|NCT03496324|75611946|FG000|COMPLETED|Period 2: Washout (3 to 7 Days)||6||
59518076|NCT03496324|75611947|FG001|COMPLETED|Period 2: Washout (3 to 7 Days)||6||
59518077|NCT03496324|75611948|FG002|COMPLETED|Period 2: Washout (3 to 7 Days)||6||
59518078|NCT03496324|75611949|FG003|COMPLETED|Period 2: Washout (3 to 7 Days)||6||
59518079|NCT03496324|75611946|FG000|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0||
59518080|NCT03496324|75611947|FG001|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0||
59518081|NCT03496324|75611948|FG002|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0||
59761441|NCT02393248|75881105|FG023|COMPLETED|Part 2: Monotherapy Dose Expansion||0||
59761442|NCT02393248|75881106|FG024|COMPLETED|Part 2: Monotherapy Dose Expansion||0||
59761443|NCT02393248|75881082|FG000|NOT COMPLETED|Part 2: Monotherapy Dose Expansion||0||
59761444|NCT02393248|75881083|FG001|NOT COMPLETED|Part 2: Monotherapy Dose Expansion||0||
59761445|NCT02393248|75881084|FG002|NOT COMPLETED|Part 2: Monotherapy Dose Expansion||0||
59761446|NCT02393248|75881085|FG003|NOT COMPLETED|Part 2: Monotherapy Dose Expansion||0||
59761447|NCT02393248|75881086|FG004|NOT COMPLETED|Part 2: Monotherapy Dose Expansion||0||
59761448|NCT02393248|75881087|FG005|NOT COMPLETED|Part 2: Monotherapy Dose Expansion||0||
59761449|NCT02393248|75881088|FG006|NOT COMPLETED|Part 2: Monotherapy Dose Expansion||0||
59761450|NCT02393248|75881089|FG007|NOT COMPLETED|Part 2: Monotherapy Dose Expansion||0||
59518082|NCT03496324|75611949|FG003|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0||
59518083|NCT03496324|75611946|FG000|STARTED|Period 3||6||
59518084|NCT03496324|75611947|FG001|STARTED|Period 3||6||
59518085|NCT03496324|75611948|FG002|STARTED|Period 3||6||
59518086|NCT03496324|75611949|FG003|STARTED|Period 3||6||
59518087|NCT03496324|75611946|FG000|COMPLETED|Period 3||6||
59518088|NCT03496324|75611947|FG001|COMPLETED|Period 3||6||
59518089|NCT03496324|75611948|FG002|COMPLETED|Period 3||6||
59518090|NCT03496324|75611949|FG003|COMPLETED|Period 3||6||
59518091|NCT03496324|75611946|FG000|NOT COMPLETED|Period 3||0||
59518092|NCT03496324|75611947|FG001|NOT COMPLETED|Period 3||0||
60066347|NCT01412944|76181555|FG000|NOT COMPLETED|Entire: IV + Maintenance||0||
60066348|NCT01412944|76181556|FG001|NOT COMPLETED|Entire: IV + Maintenance||0||
60066349|NCT01412944|76181557|FG002|NOT COMPLETED|Entire: IV + Maintenance||1||
59761451|NCT02393248|75881090|FG008|NOT COMPLETED|Part 2: Monotherapy Dose Expansion||0||
59761452|NCT02393248|75881091|FG009|NOT COMPLETED|Part 2: Monotherapy Dose Expansion||0||
59761453|NCT02393248|75881092|FG010|NOT COMPLETED|Part 2: Monotherapy Dose Expansion||4||
59761454|NCT02393248|75881093|FG011|NOT COMPLETED|Part 2: Monotherapy Dose Expansion||44||
59761455|NCT02393248|75881094|FG012|NOT COMPLETED|Part 2: Monotherapy Dose Expansion||5||
59761456|NCT02393248|75881095|FG013|NOT COMPLETED|Part 2: Monotherapy Dose Expansion||20||
59761457|NCT02393248|75881096|FG014|NOT COMPLETED|Part 2: Monotherapy Dose Expansion||5||
59761458|NCT02393248|75881097|FG015|NOT COMPLETED|Part 2: Monotherapy Dose Expansion||0||
60066350|NCT01412944|76181558|FG003|NOT COMPLETED|Entire: IV + Maintenance||1||
60066351|NCT01412944|76181559|FG004|NOT COMPLETED|Entire: IV + Maintenance||3||
60066352|NCT01412944|76181560|FG005|NOT COMPLETED|Entire: IV + Maintenance||2||
60066353|NCT01412944|76181555|FG000|STARTED|Entire: IV + Maintenance||21||
60066354|NCT01412944|76181556|FG001|STARTED|Entire: IV + Maintenance||22||
60066355|NCT01412944|76181557|FG002|STARTED|Entire: IV + Maintenance||0||
59518093|NCT03496324|75611948|FG002|NOT COMPLETED|Period 3||0||
60066356|NCT01412944|76181558|FG003|STARTED|Entire: IV + Maintenance||0||
60066357|NCT01412944|76181559|FG004|STARTED|Entire: IV + Maintenance||0||
60066358|NCT01412944|76181560|FG005|STARTED|Entire: IV + Maintenance||0||
59518094|NCT03496324|75611949|FG003|NOT COMPLETED|Period 3||0||
59518095|NCT03496324|75611946|FG000|STARTED|Period 3: Washout (3 to 7 Days)||6||
60066359|NCT01412944|76181555|FG000|COMPLETED|Entire: IV + Maintenance||19||
60066360|NCT01412944|76181556|FG001|COMPLETED|Entire: IV + Maintenance||17||
60066361|NCT01412944|76181557|FG002|COMPLETED|Entire: IV + Maintenance||0||
60066362|NCT01412944|76181558|FG003|COMPLETED|Entire: IV + Maintenance||0||
60066363|NCT01412944|76181559|FG004|COMPLETED|Entire: IV + Maintenance||0||
60066364|NCT01412944|76181560|FG005|COMPLETED|Entire: IV + Maintenance||0||
60066365|NCT01412944|76181555|FG000|NOT COMPLETED|Entire: IV + Maintenance||2||
60066366|NCT01412944|76181556|FG001|NOT COMPLETED|Entire: IV + Maintenance||5||
60066367|NCT01412944|76181557|FG002|NOT COMPLETED|Entire: IV + Maintenance||0||
60066368|NCT01412944|76181558|FG003|NOT COMPLETED|Entire: IV + Maintenance||0||
60066369|NCT01412944|76181559|FG004|NOT COMPLETED|Entire: IV + Maintenance||0||
60066370|NCT01412944|76181560|FG005|NOT COMPLETED|Entire: IV + Maintenance||0||
60066371|NCT01412944|76181555|FG000|STARTED|Follow-up||0||
60066372|NCT01412944|76181556|FG001|STARTED|Follow-up||0||
60066373|NCT01412944|76181557|FG002|STARTED|Follow-up||2||
60066374|NCT01412944|76181558|FG003|STARTED|Follow-up||1||
60066375|NCT01412944|76181559|FG004|STARTED|Follow-up||2||
60066376|NCT01412944|76181560|FG005|STARTED|Follow-up||0||
60066377|NCT01412944|76181555|FG000|COMPLETED|Follow-up||0||
60066378|NCT01412944|76181556|FG001|COMPLETED|Follow-up||0||
60066379|NCT01412944|76181557|FG002|COMPLETED|Follow-up||2||
60066380|NCT01412944|76181558|FG003|COMPLETED|Follow-up||1||
60066381|NCT01412944|76181559|FG004|COMPLETED|Follow-up||2||
60066382|NCT01412944|76181560|FG005|COMPLETED|Follow-up||0||
60066383|NCT01412944|76181555|FG000|NOT COMPLETED|Follow-up||0||
60066384|NCT01412944|76181556|FG001|NOT COMPLETED|Follow-up||0||
60066385|NCT01412944|76181557|FG002|NOT COMPLETED|Follow-up||0||
59518096|NCT03496324|75611947|FG001|STARTED|Period 3: Washout (3 to 7 Days)||6||
59518097|NCT03496324|75611948|FG002|STARTED|Period 3: Washout (3 to 7 Days)||6||
59518098|NCT03496324|75611949|FG003|STARTED|Period 3: Washout (3 to 7 Days)||6||
59518099|NCT03496324|75611946|FG000|COMPLETED|Period 3: Washout (3 to 7 Days)||6||
60066386|NCT01412944|76181558|FG003|NOT COMPLETED|Follow-up||0||
59518100|NCT03496324|75611947|FG001|COMPLETED|Period 3: Washout (3 to 7 Days)||6||
59518101|NCT03496324|75611948|FG002|COMPLETED|Period 3: Washout (3 to 7 Days)||6||
59518102|NCT03496324|75611949|FG003|COMPLETED|Period 3: Washout (3 to 7 Days)||6||
59518103|NCT03496324|75611946|FG000|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0||
59761459|NCT02393248|75881098|FG016|NOT COMPLETED|Part 2: Monotherapy Dose Expansion||0||
59761460|NCT02393248|75881099|FG017|NOT COMPLETED|Part 2: Monotherapy Dose Expansion||0||
59761461|NCT02393248|75881100|FG018|NOT COMPLETED|Part 2: Monotherapy Dose Expansion||0||
59518104|NCT03496324|75611947|FG001|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0||
59762687|NCT00868608|75882543|FG001|STARTED|Overall Study||4||
60066387|NCT01412944|76181559|FG004|NOT COMPLETED|Follow-up||0||
60066388|NCT01412944|76181560|FG005|NOT COMPLETED|Follow-up||0||
60066389|NCT01798485|76181578|FG000|STARTED|Overall Study||347||
60066390|NCT01798485|76181579|FG001|STARTED|Overall Study||349||
60066391|NCT01798485|76181578|FG000|Safety Population as of 23 Dec 2015|Overall Study||338||
60066392|NCT01798485|76181579|FG001|Safety Population as of 23 Dec 2015|Overall Study||342||
60066393|NCT01798485|76181578|FG000|Randomized as of 19 October 2015|Overall Study||335||
60066394|NCT01798485|76181579|FG001|Randomized as of 19 October 2015|Overall Study||337||
60066395|NCT01798485|76181578|FG000|COMPLETED|Overall Study||1||
60066396|NCT01798485|76181579|FG001|COMPLETED|Overall Study||59||
60066397|NCT01798485|76181578|FG000|NOT COMPLETED|Overall Study||346||
60066398|NCT01798485|76181579|FG001|NOT COMPLETED|Overall Study||290||
60066399|NCT01767597|76181587|FG000|STARTED|Overall Study||500||
60066400|NCT01767597|76181588|FG001|STARTED|Overall Study||500||
60066401|NCT01767597|76181587|FG000|COMPLETED|Overall Study||496||
60066402|NCT01767597|76181588|FG001|COMPLETED|Overall Study||499||
60066403|NCT01767597|76181587|FG000|NOT COMPLETED|Overall Study||4||
60066404|NCT01767597|76181588|FG001|NOT COMPLETED|Overall Study||1||
60066405|NCT01767519|76181597|FG000|STARTED|Overall Study||145||
60066406|NCT01767519|76181598|FG001|STARTED|Overall Study||151||
60066407|NCT01767519|76181599|FG002|STARTED|Overall Study||60||
60066408|NCT01767519|76181597|FG000|COMPLETED|Overall Study||131||
60066409|NCT01767519|76181598|FG001|COMPLETED|Overall Study||138||
60066410|NCT01767519|76181599|FG002|COMPLETED|Overall Study||55||
60066411|NCT01767519|76181597|FG000|NOT COMPLETED|Overall Study||14||
60066412|NCT01767519|76181598|FG001|NOT COMPLETED|Overall Study||13||
60066413|NCT01767519|76181599|FG002|NOT COMPLETED|Overall Study||5||
60066414|NCT01797783|76181609|FG000|STARTED|Overall Study||52||
60066415|NCT01797783|76181610|FG001|STARTED|Overall Study||27||
60066416|NCT01797783|76181609|FG000|COMPLETED|Overall Study||50||
60066417|NCT01797783|76181610|FG001|COMPLETED|Overall Study||26||
60066418|NCT01797783|76181609|FG000|NOT COMPLETED|Overall Study||2||
60066419|NCT01797783|76181610|FG001|NOT COMPLETED|Overall Study||1||
60066420|NCT01766817|76181627|FG000|STARTED|Overall Study||48||
60066421|NCT01766817|76181628|FG001|STARTED|Overall Study||48||
60066422|NCT01766817|76181629|FG002|STARTED|Overall Study||47||
60066423|NCT01766817|76181627|FG000|COMPLETED|Overall Study||37||
60066424|NCT01766817|76181628|FG001|COMPLETED|Overall Study||37||
60066425|NCT01766817|76181629|FG002|COMPLETED|Overall Study||34||
60066426|NCT01766817|76181627|FG000|NOT COMPLETED|Overall Study||11||
60066427|NCT01766817|76181628|FG001|NOT COMPLETED|Overall Study||11||
60066428|NCT01766817|76181629|FG002|NOT COMPLETED|Overall Study||13||
60066429|NCT01797705|76181637|FG000|STARTED|Overall Study||33||
60066430|NCT01797705|76181637|FG000|COMPLETED|Overall Study||28||
60066431|NCT01797705|76181637|FG000|NOT COMPLETED|Overall Study||5||
60066432|NCT01797081|76181645|FG000|STARTED|Overall Study||104||
60066433|NCT01797081|76181646|FG001|STARTED|Overall Study||99||
60066434|NCT01797081|76181647|FG002|STARTED|Overall Study||48||
60066435|NCT01797081|76181648|FG003|STARTED|Overall Study||49||
60066436|NCT01797081|76181645|FG000|COMPLETED|Overall Study||90||
60066437|NCT01797081|76181646|FG001|COMPLETED|Overall Study||95||
60066438|NCT01797081|76181647|FG002|COMPLETED|Overall Study||43||
60066439|NCT01797081|76181648|FG003|COMPLETED|Overall Study||40||
60066440|NCT01797081|76181645|FG000|NOT COMPLETED|Overall Study||14||
60066441|NCT01797081|76181646|FG001|NOT COMPLETED|Overall Study||4||
60066442|NCT01797081|76181647|FG002|NOT COMPLETED|Overall Study||5||
60066443|NCT01797081|76181648|FG003|NOT COMPLETED|Overall Study||9||
60066444|NCT01794117|76181660|FG000|STARTED|Overall Study||1||
60066445|NCT01794117|76181661|FG001|STARTED|Overall Study||3||
60066446|NCT01794117|76181662|FG002|STARTED|Overall Study||2||
60066447|NCT01794117|76181663|FG003|STARTED|Overall Study||12||
60066448|NCT01794117|76181660|FG000|COMPLETED|Overall Study||0||
60066449|NCT01794117|76181661|FG001|COMPLETED|Overall Study||0||
60066450|NCT01794117|76181662|FG002|COMPLETED|Overall Study||2||
60066451|NCT01794117|76181663|FG003|COMPLETED|Overall Study||12||
60066452|NCT01794117|76181660|FG000|NOT COMPLETED|Overall Study||1||
60066453|NCT01794117|76181661|FG001|NOT COMPLETED|Overall Study||3||
60066454|NCT01794117|76181662|FG002|NOT COMPLETED|Overall Study||0||
60066455|NCT01794117|76181663|FG003|NOT COMPLETED|Overall Study||0||
60066456|NCT01766037|76181676|FG000|STARTED|Overall Study||111||
60066457|NCT01766037|76181677|FG001|STARTED|Overall Study||60||
60066458|NCT01766037|76181676|FG000|COMPLETED|Overall Study||82||
60066459|NCT01766037|76181677|FG001|COMPLETED|Overall Study||31||
60066460|NCT01766037|76181676|FG000|NOT COMPLETED|Overall Study||29||
60066461|NCT01766037|76181677|FG001|NOT COMPLETED|Overall Study||29||
60066462|NCT01765569|76181683|FG000|STARTED|Period A||29||
60066463|NCT01765569|76181683|FG000|COMPLETED|Period A||29||
60066464|NCT01765569|76181683|FG000|NOT COMPLETED|Period A||0||
60066465|NCT01765569|76181683|FG000|STARTED|Period B||29||
60066466|NCT01765569|76181683|FG000|COMPLETED|Period B||28||
60066467|NCT01765569|76181683|FG000|NOT COMPLETED|Period B||1||
60066468|NCT01765569|76181683|FG000|STARTED|Period C||28||
60066469|NCT01765569|76181683|FG000|COMPLETED|Period C||27||
60066470|NCT01765569|76181683|FG000|NOT COMPLETED|Period C||1||
60066471|NCT01609257|76181692|FG000|STARTED|Overall Study||67||
60066472|NCT01609257|76181693|FG001|STARTED|Overall Study||65||
60066473|NCT01609257|76181692|FG000|Received 2 Doses|Overall Study||63||
60066474|NCT01609257|76181693|FG001|Received 2 Doses|Overall Study||64||
59518105|NCT03496324|75611948|FG002|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0||
59518106|NCT03496324|75611949|FG003|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0||
59518107|NCT03496324|75611946|FG000|STARTED|Period 7: Period 4||6||
60066475|NCT01609257|76181692|FG000|Received Challenge Product|Overall Study||56||
60066476|NCT01609257|76181693|FG001|Received Challenge Product|Overall Study||53||
60066477|NCT01609257|76181692|FG000|COMPLETED|Overall Study||61||
60066478|NCT01609257|76181693|FG001|COMPLETED|Overall Study||57||
60066479|NCT01609257|76181692|FG000|NOT COMPLETED|Overall Study||6||
60066480|NCT01609257|76181693|FG001|NOT COMPLETED|Overall Study||8||
60066481|NCT01609023|76181702|FG000|STARTED|Overall Study||67||
60066482|NCT01609023|76181702|FG000|COMPLETED|Overall Study||34||
59518108|NCT03496324|75611947|FG001|STARTED|Period 7: Period 4||6||
59518109|NCT03496324|75611948|FG002|STARTED|Period 7: Period 4||6||
59518110|NCT03496324|75611949|FG003|STARTED|Period 7: Period 4||6||
59518111|NCT03496324|75611946|FG000|COMPLETED|Period 7: Period 4||6||
59518112|NCT03496324|75611947|FG001|COMPLETED|Period 7: Period 4||6||
59518113|NCT03496324|75611948|FG002|COMPLETED|Period 7: Period 4||6||
60066483|NCT01609023|76181702|FG000|NOT COMPLETED|Overall Study||33||
60066484|NCT01765179|76181706|FG000|STARTED|Overall Study||144||
60066485|NCT01765179|76181706|FG000|COMPLETED|Overall Study||117||
60066486|NCT01765179|76181706|FG000|NOT COMPLETED|Overall Study||27||
60066487|NCT01764945|76181718|FG000|STARTED|Overall Study||5||
60066488|NCT01764945|76181719|FG001|STARTED|Overall Study||5||
60066489|NCT01764945|76181720|FG002|STARTED|Overall Study||5||
60066490|NCT01764945|76181721|FG003|STARTED|Overall Study||5||
60066491|NCT01764945|76181722|FG004|STARTED|Overall Study||10||
60066492|NCT01764945|76181723|FG005|STARTED|Overall Study||8||
60066493|NCT01764945|76181724|FG006|STARTED|Overall Study||9||
60066494|NCT01764945|76181725|FG007|STARTED|Overall Study||9||
60066495|NCT01764945|76181718|FG000|COMPLETED|Overall Study||5||
60066496|NCT01764945|76181719|FG001|COMPLETED|Overall Study||4||
60066497|NCT01764945|76181720|FG002|COMPLETED|Overall Study||5||
60066498|NCT01764945|76181721|FG003|COMPLETED|Overall Study||5||
60066499|NCT01764945|76181722|FG004|COMPLETED|Overall Study||10||
60066500|NCT01764945|76181723|FG005|COMPLETED|Overall Study||8||
60066501|NCT01764945|76181724|FG006|COMPLETED|Overall Study||8||
60066502|NCT01764945|76181725|FG007|COMPLETED|Overall Study||9||
60066503|NCT01764945|76181718|FG000|NOT COMPLETED|Overall Study||0||
60066504|NCT01764945|76181719|FG001|NOT COMPLETED|Overall Study||1||
60066505|NCT01764945|76181720|FG002|NOT COMPLETED|Overall Study||0||
60066506|NCT01764945|76181721|FG003|NOT COMPLETED|Overall Study||0||
60066507|NCT01764945|76181722|FG004|NOT COMPLETED|Overall Study||0||
60066508|NCT01764945|76181723|FG005|NOT COMPLETED|Overall Study||0||
60066509|NCT01764945|76181724|FG006|NOT COMPLETED|Overall Study||1||
60066510|NCT01764945|76181725|FG007|NOT COMPLETED|Overall Study||0||
59518114|NCT03496324|75611949|FG003|COMPLETED|Period 7: Period 4||6||
59518115|NCT03496324|75611946|FG000|NOT COMPLETED|Period 7: Period 4||0||
59518116|NCT03496324|75611947|FG001|NOT COMPLETED|Period 7: Period 4||0||
60066511|NCT01793883|76181746|FG000|STARTED|Overall Study||213||
60066512|NCT01793883|76181747|FG001|STARTED|Overall Study||214||
60066513|NCT01793883|76181748|FG002|STARTED|Overall Study||212||
60066514|NCT01793883|76181746|FG000|COMPLETED|Overall Study||201||
60066515|NCT01793883|76181747|FG001|COMPLETED|Overall Study||204||
60066516|NCT01793883|76181748|FG002|COMPLETED|Overall Study||204||
60066517|NCT01793883|76181746|FG000|NOT COMPLETED|Overall Study||12||
60066518|NCT01793883|76181747|FG001|NOT COMPLETED|Overall Study||10||
59518117|NCT03496324|75611948|FG002|NOT COMPLETED|Period 7: Period 4||0||
59518118|NCT03496324|75611949|FG003|NOT COMPLETED|Period 7: Period 4||0||
59518119|NCT03354598|75611961|FG000|STARTED|Overall Study||835||
59518120|NCT03354598|75611962|FG001|STARTED|Overall Study||836||
59518121|NCT03354598|75611961|FG000|Microbiologic Modified Intent to Treat Resistant (Micro-MITTR) Participants|Overall Study||147||
60066519|NCT01793883|76181748|FG002|NOT COMPLETED|Overall Study||8||
60066520|NCT01792635|76181759|FG000|STARTED|Part A||6||
60066521|NCT01792635|76181760|FG001|STARTED|Part A||0||
60066522|NCT01792635|76181761|FG002|STARTED|Part A||0||
60066523|NCT01792635|76181759|FG000|COMPLETED|Part A||6||
60066524|NCT01792635|76181760|FG001|COMPLETED|Part A||0||
60066525|NCT01792635|76181761|FG002|COMPLETED|Part A||0||
60066526|NCT01792635|76181759|FG000|NOT COMPLETED|Part A||0||
60066527|NCT01792635|76181760|FG001|NOT COMPLETED|Part A||0||
60066528|NCT01792635|76181761|FG002|NOT COMPLETED|Part A||0||
60066529|NCT01792635|76181759|FG000|STARTED|Part B||0||
60066530|NCT01792635|76181760|FG001|STARTED|Part B||6||
60066531|NCT01792635|76181761|FG002|STARTED|Part B||7||
60066532|NCT01792635|76181759|FG000|COMPLETED|Part B||0||
60066533|NCT01792635|76181760|FG001|COMPLETED|Part B||2||
60066534|NCT01792635|76181761|FG002|COMPLETED|Part B||3||
60066535|NCT01792635|76181759|FG000|NOT COMPLETED|Part B||0||
60066536|NCT01792635|76181760|FG001|NOT COMPLETED|Part B||4||
60066537|NCT01792635|76181761|FG002|NOT COMPLETED|Part B||4||
60066538|NCT01953692|76181779|FG000|STARTED|Overall Study||28||
60066539|NCT01953692|76181780|FG001|STARTED|Overall Study||30||
60066540|NCT01953692|76181781|FG002|STARTED|Overall Study||31||
60066541|NCT01953692|76181782|FG003|STARTED|Overall Study||21||
60066542|NCT01953692|76181783|FG004|STARTED|Overall Study||4||
60066543|NCT01953692|76181784|FG005|STARTED|Overall Study||22||
60066544|NCT01953692|76181785|FG006|STARTED|Overall Study||42||
60066545|NCT01953692|76181786|FG007|STARTED|Overall Study||13||
60066546|NCT01953692|76181787|FG008|STARTED|Overall Study||6||
60066547|NCT01953692|76181779|FG000|COMPLETED|Overall Study||1||
60066548|NCT01953692|76181780|FG001|COMPLETED|Overall Study||5||
60066549|NCT01953692|76181781|FG002|COMPLETED|Overall Study||11||
60066550|NCT01953692|76181782|FG003|COMPLETED|Overall Study||7||
60066551|NCT01953692|76181783|FG004|COMPLETED|Overall Study||1||
60066552|NCT01953692|76181784|FG005|COMPLETED|Overall Study||4||
60066553|NCT01953692|76181785|FG006|COMPLETED|Overall Study||10||
60066554|NCT01953692|76181786|FG007|COMPLETED|Overall Study||3||
60066555|NCT01953692|76181787|FG008|COMPLETED|Overall Study||1||
60066556|NCT01953692|76181779|FG000|NOT COMPLETED|Overall Study||27||
59518122|NCT03354598|75611962|FG001|Microbiologic Modified Intent to Treat Resistant (Micro-MITTR) Participants|Overall Study||139||
59518123|NCT03354598|75611961|FG000|Microbiologic Modified Intent to Treat Susceptible (Micro-MITTS) Participants|Overall Study||370||
59518124|NCT03354598|75611962|FG001|Microbiologic Modified Intent to Treat Susceptible (Micro-MITTS) Participants|Overall Study||415||
59518125|NCT03354598|75611961|FG000|Microbiologic Modified Intent to Treat (Micro-MITT) Participants|Overall Study||517||
59518126|NCT03354598|75611962|FG001|Microbiologic Modified Intent to Treat (Micro-MITT) Participants|Overall Study||554||
59518127|NCT03354598|75611961|FG000|Modified Intent to Treat (MITT) Participants|Overall Study||785||
59518128|NCT03354598|75611962|FG001|Modified Intent to Treat (MITT) Participants|Overall Study||794||
59518129|NCT03354598|75611961|FG000|Intent to Treat (ITT) Participants|Overall Study||787||
59518130|NCT03354598|75611962|FG001|Intent to Treat (ITT) Participants|Overall Study||803||
59518131|NCT03354598|75611961|FG000|Safety Participants|Overall Study||833||
59518132|NCT03354598|75611962|FG001|Safety Participants|Overall Study||827||
59518133|NCT03354598|75611961|FG000|COMPLETED|Overall Study||755||
59518134|NCT03354598|75611962|FG001|COMPLETED|Overall Study||761||
59518135|NCT03354598|75611961|FG000|NOT COMPLETED|Overall Study||80||
59518136|NCT03354598|75611962|FG001|NOT COMPLETED|Overall Study||75||
59518137|NCT02169895|75611972|FG000|STARTED|Overall Study||4||
59518138|NCT02169895|75611973|FG001|STARTED|Overall Study||4||
59930999|NCT03238001|76049201|FG000|STARTED|Visit 2 (Secondary Endpoint Cohort)||432||
59518139|NCT02169895|75611974|FG002|STARTED|Overall Study||4||
59518140|NCT02169895|75611975|FG003|STARTED|Overall Study||4||
59518141|NCT02169895|75611972|FG000|25 mg BIA 9-1067|Overall Study||4||
59518142|NCT02169895|75611973|FG001|25 mg BIA 9-1067|Overall Study||4||
59518143|NCT02169895|75611974|FG002|25 mg BIA 9-1067|Overall Study||4||
59518144|NCT02169895|75611975|FG003|25 mg BIA 9-1067|Overall Study||4||
59518145|NCT02169895|75611972|FG000|50 mg BIA 9-1067|Overall Study||4||
59518146|NCT02169895|75611973|FG001|50 mg BIA 9-1067|Overall Study||4||
59518147|NCT02169895|75611974|FG002|50 mg BIA 9-1067|Overall Study||4||
59518148|NCT02169895|75611975|FG003|50 mg BIA 9-1067|Overall Study||4||
59518149|NCT02169895|75611972|FG000|100 mg BIA 9-1067|Overall Study||4||
59518150|NCT02169895|75611973|FG001|100 mg BIA 9-1067|Overall Study||4||
59518151|NCT02169895|75611974|FG002|100 mg BIA 9-1067|Overall Study||4||
59518152|NCT02169895|75611975|FG003|100 mg BIA 9-1067|Overall Study||2||
59518153|NCT02169895|75611972|FG000|Placebo|Overall Study||4||
59518154|NCT02169895|75611973|FG001|Placebo|Overall Study||4||
59518155|NCT02169895|75611974|FG002|Placebo|Overall Study||4||
59518156|NCT02169895|75611975|FG003|Placebo|Overall Study||4||
59518157|NCT02169895|75611972|FG000|COMPLETED|Overall Study||4||
59518158|NCT02169895|75611973|FG001|COMPLETED|Overall Study||4||
59518159|NCT02169895|75611974|FG002|COMPLETED|Overall Study||4||
59518160|NCT02169895|75611975|FG003|COMPLETED|Overall Study||2||
59931000|NCT03238001|76049201|FG000|COMPLETED|Visit 2 (Secondary Endpoint Cohort)||403||
59931001|NCT03238001|76049201|FG000|NOT COMPLETED|Visit 2 (Secondary Endpoint Cohort)||29||
60066557|NCT01953692|76181780|FG001|NOT COMPLETED|Overall Study||25||
60066558|NCT01953692|76181781|FG002|NOT COMPLETED|Overall Study||20||
60066559|NCT01953692|76181782|FG003|NOT COMPLETED|Overall Study||14||
60066560|NCT01953692|76181783|FG004|NOT COMPLETED|Overall Study||3||
60066561|NCT01953692|76181784|FG005|NOT COMPLETED|Overall Study||18||
60066562|NCT01953692|76181785|FG006|NOT COMPLETED|Overall Study||32||
60066563|NCT01953692|76181786|FG007|NOT COMPLETED|Overall Study||10||
60066564|NCT01953692|76181787|FG008|NOT COMPLETED|Overall Study||5||
59518161|NCT02169895|75611972|FG000|NOT COMPLETED|Overall Study||0||
59518162|NCT02169895|75611973|FG001|NOT COMPLETED|Overall Study||0||
59518163|NCT02169895|75611974|FG002|NOT COMPLETED|Overall Study||0||
59518164|NCT02169895|75611975|FG003|NOT COMPLETED|Overall Study||2||
59518165|NCT01072669|75611987|FG000|STARTED|Overall Study||15||
59518166|NCT01072669|75611988|FG001|STARTED|Overall Study||5||
59518167|NCT01072669|75611987|FG000|COMPLETED|Overall Study||15||
59518168|NCT01072669|75611988|FG001|COMPLETED|Overall Study||5||
59518169|NCT01072669|75611987|FG000|NOT COMPLETED|Overall Study||0||
59518170|NCT01072669|75611988|FG001|NOT COMPLETED|Overall Study||0||
59613257|NCT01687998|75724412|FG001|COMPLETED|Overall Study||5934||
59613258|NCT01687998|75724411|FG000|NOT COMPLETED|Overall Study||112||
59931002|NCT02747108|76049215|FG000|STARTED|Overall Study||253||
59518171|NCT03354754|75611996|FG000|STARTED|Overall Study||2||
59518172|NCT03354754|75611997|FG001|STARTED|Overall Study||1||
59761462|NCT02393248|75881101|FG019|NOT COMPLETED|Part 2: Monotherapy Dose Expansion||0||
59931003|NCT02747108|76049216|FG001|STARTED|Overall Study||62||
59931004|NCT02747108|76049215|FG000|COMPLETED|Overall Study||248||
59931005|NCT02747108|76049216|FG001|COMPLETED|Overall Study||60||
59931006|NCT02747108|76049215|FG000|NOT COMPLETED|Overall Study||5||
59931007|NCT02747108|76049216|FG001|NOT COMPLETED|Overall Study||2||
59931008|NCT02075671|76049232|FG000|STARTED|Overall Study||10||
59931009|NCT02075671|76049233|FG001|STARTED|Overall Study||10||
59931010|NCT02075671|76049234|FG002|STARTED|Overall Study||10||
59931011|NCT02075671|76049232|FG000|COMPLETED|Overall Study||8||
59931012|NCT02075671|76049233|FG001|COMPLETED|Overall Study||10||
59931013|NCT02075671|76049234|FG002|COMPLETED|Overall Study||6||
60066565|NCT01791153|76181821|FG000|STARTED|Part 1: Blinded Period||100||
60066566|NCT01791153|76181822|FG001|STARTED|Part 1: Blinded Period||49||
59518173|NCT03354754|75611996|FG000|COMPLETED|Overall Study||2||
59518174|NCT03354754|75611997|FG001|COMPLETED|Overall Study||1||
59518175|NCT03354754|75611996|FG000|NOT COMPLETED|Overall Study||0||
59518176|NCT03354754|75611997|FG001|NOT COMPLETED|Overall Study||0||
59518177|NCT01073449|75612003|FG000|STARTED|Overall Study||3362||
59518178|NCT01073449|75612003|FG000|COMPLETED|Overall Study||3362||
59518179|NCT01073449|75612003|FG000|NOT COMPLETED|Overall Study||0||
59518180|NCT03270436|75612009|FG000|STARTED|Baseline||213||
59518181|NCT03270436|75612010|FG001|STARTED|Baseline||167||
59518182|NCT03270436|75612009|FG000|COMPLETED|Baseline||212||
59518183|NCT03270436|75612010|FG001|COMPLETED|Baseline||166||
59518184|NCT03270436|75612009|FG000|NOT COMPLETED|Baseline||1||
59518185|NCT03270436|75612010|FG001|NOT COMPLETED|Baseline||1||
59518186|NCT03270436|75612009|FG000|STARTED|Immediate Post-Intervention||213|All enrolled participants were contacted to provide data at post-intervention whether or not they completed baseline data collection.|
59518187|NCT03270436|75612010|FG001|STARTED|Immediate Post-Intervention||167|All enrolled participants were contacted to provide data at post-intervention whether or not they completed baseline data collection.|
59518188|NCT03270436|75612009|FG000|COMPLETED|Immediate Post-Intervention||172||
59931014|NCT02075671|76049232|FG000|NOT COMPLETED|Overall Study||2||
59931015|NCT02075671|76049233|FG001|NOT COMPLETED|Overall Study||0||
59931016|NCT02075671|76049234|FG002|NOT COMPLETED|Overall Study||4||
59613259|NCT01687998|75724412|FG001|NOT COMPLETED|Overall Study||120||
59613260|NCT01681836|75724418|FG000|STARTED|First Intervention||6||
59762688|NCT00868608|75882544|FG002|STARTED|Overall Study||5||
59931017|NCT03226769|76049244|FG000|STARTED|Overall Study||29||
59931018|NCT03226769|76049245|FG001|STARTED|Overall Study||28||
59931019|NCT03226769|76049244|FG000|COMPLETED|Overall Study||29||
59931020|NCT03226769|76049245|FG001|COMPLETED|Overall Study||27||
59931021|NCT03226769|76049244|FG000|NOT COMPLETED|Overall Study||0||
59931022|NCT03226769|76049245|FG001|NOT COMPLETED|Overall Study||1||
59613261|NCT01681836|75724419|FG001|STARTED|First Intervention||5||
59613262|NCT01681836|75724418|FG000|COMPLETED|First Intervention||6||
59931023|NCT02864342|76049253|FG000|STARTED|Overall Study||70||
59931024|NCT02864342|76049254|FG001|STARTED|Overall Study||68||
59931025|NCT02864342|76049253|FG000|Full Analysis Set (FAS)|Overall Study||70|Subjects who took at least 1 inhalation of Symbicort during the treatment phase of the study.|
59931026|NCT02864342|76049254|FG001|Full Analysis Set (FAS)|Overall Study||67|Subjects who took at least 1 inhalation of Symbicort during the treatment phase of the study.|
59931027|NCT02864342|76049253|FG000|COMPLETED|Overall Study||55||
59931028|NCT02864342|76049254|FG001|COMPLETED|Overall Study||49||
59931029|NCT02864342|76049253|FG000|NOT COMPLETED|Overall Study||15||
59931030|NCT02864342|76049254|FG001|NOT COMPLETED|Overall Study||19||
59931031|NCT03237065|76049263|FG000|STARTED|Overall Study||61||
59931032|NCT03237065|76049264|FG001|STARTED|Overall Study||61||
59931033|NCT03237065|76049263|FG000|Safety Analysis Set|Overall Study|1 subject from ferric carboxymaltose group received iron isomaltoside/ferric derisomaltose in error.|62||
59931034|NCT03237065|76049264|FG001|Safety Analysis Set|Overall Study||57||
59931035|NCT03237065|76049263|FG000|COMPLETED|Overall Study||57||
59931036|NCT03237065|76049264|FG001|COMPLETED|Overall Study||57||
59931037|NCT03237065|76049263|FG000|NOT COMPLETED|Overall Study||4||
59931038|NCT03237065|76049264|FG001|NOT COMPLETED|Overall Study||4||
59931039|NCT03171415|76049275|FG000|STARTED|Overall Study||6||
59931040|NCT03171415|76049276|FG001|STARTED|Overall Study||6||
59931041|NCT03171415|76049277|FG002|STARTED|Overall Study||6||
59931042|NCT03171415|76049278|FG003|STARTED|Overall Study||6||
59931043|NCT03171415|76049279|FG004|STARTED|Overall Study||9||
59931044|NCT03171415|76049275|FG000|COMPLETED|Overall Study||6||
59931045|NCT03171415|76049276|FG001|COMPLETED|Overall Study||6||
59931046|NCT03171415|76049277|FG002|COMPLETED|Overall Study||6||
59931047|NCT03171415|76049278|FG003|COMPLETED|Overall Study||6||
59931048|NCT03171415|76049279|FG004|COMPLETED|Overall Study||7||
59931049|NCT03171415|76049275|FG000|NOT COMPLETED|Overall Study||0||
59931050|NCT03171415|76049276|FG001|NOT COMPLETED|Overall Study||0||
59931051|NCT03171415|76049277|FG002|NOT COMPLETED|Overall Study||0||
59931052|NCT03171415|76049278|FG003|NOT COMPLETED|Overall Study||0||
59931053|NCT03171415|76049279|FG004|NOT COMPLETED|Overall Study||2||
59931054|NCT03829241|76049304|FG000|STARTED|Randomization Phase (Week 1 to Week 8)||202||
59931055|NCT03829241|76049305|FG001|STARTED|Randomization Phase (Week 1 to Week 8)||200||
59931056|NCT03829241|76049304|FG000|Treated|Randomization Phase (Week 1 to Week 8)||199||
59931057|NCT03829241|76049305|FG001|Treated|Randomization Phase (Week 1 to Week 8)||191||
59931058|NCT03829241|76049304|FG000|Modified Intent-to- Treat (mITT) Participants|Randomization Phase (Week 1 to Week 8)||198|Modified intent-to-treat (mITT) participants in the randomization phase included randomized participants who received at least 1 dose of blinded study drug and provided a non-missing baseline assessment and at least 1 non-missing post-baseline efficacy assessment.|
60066567|NCT01791153|76181823|FG002|STARTED|Part 1: Blinded Period||50||
60066568|NCT01791153|76181824|FG003|STARTED|Part 1: Blinded Period||51||
60066569|NCT01791153|76181825|FG004|STARTED|Part 1: Blinded Period||0||
60066570|NCT01791153|76181826|FG005|STARTED|Part 1: Blinded Period||0||
59931059|NCT03829241|76049305|FG001|Modified Intent-to- Treat (mITT) Participants|Randomization Phase (Week 1 to Week 8)||187|Modified intent-to-treat (mITT) participants in the randomization phase included randomized participants who received at least 1 dose of blinded study drug and provided a non-missing baseline assessment and at least 1 non-missing post-baseline efficacy assessment.|
59931060|NCT03829241|76049304|FG000|COMPLETED|Randomization Phase (Week 1 to Week 8)||171||
59931061|NCT03829241|76049305|FG001|COMPLETED|Randomization Phase (Week 1 to Week 8)||158||
59931062|NCT03829241|76049304|FG000|NOT COMPLETED|Randomization Phase (Week 1 to Week 8)||31||
59931063|NCT03829241|76049305|FG001|NOT COMPLETED|Randomization Phase (Week 1 to Week 8)||42||
59931064|NCT03829241|76049304|FG000|STARTED|Extension Phase (Week 9 up to Week 48)||159|Participants who continued into the extension phase|
59931065|NCT03829241|76049305|FG001|STARTED|Extension Phase (Week 9 up to Week 48)||154|Participants who continued into the extension phase|
59931066|NCT03829241|76049304|FG000|Treated|Extension Phase (Week 9 up to Week 48)||153||
59931067|NCT03829241|76049305|FG001|Treated|Extension Phase (Week 9 up to Week 48)||149||
59931068|NCT03829241|76049304|FG000|COMPLETED|Extension Phase (Week 9 up to Week 48)||0||
59931069|NCT03829241|76049305|FG001|COMPLETED|Extension Phase (Week 9 up to Week 48)||0||
59931070|NCT03829241|76049304|FG000|NOT COMPLETED|Extension Phase (Week 9 up to Week 48)||159||
59931071|NCT03829241|76049305|FG001|NOT COMPLETED|Extension Phase (Week 9 up to Week 48)||154||
59931072|NCT03164551|76049317|FG000|STARTED|Overall Study||200||
59931073|NCT03164551|76049318|FG001|STARTED|Overall Study||208||
59931074|NCT03164551|76049317|FG000|COMPLETED|Overall Study||171||
59931075|NCT03164551|76049318|FG001|COMPLETED|Overall Study||192||
59931076|NCT03164551|76049317|FG000|NOT COMPLETED|Overall Study||29||
59931077|NCT03164551|76049318|FG001|NOT COMPLETED|Overall Study||16||
59931078|NCT02863328|76049326|FG000|STARTED|Overall Study||411|One participant was duplicate, hence removed from 'started' population.|
59931079|NCT02863328|76049327|FG001|STARTED|Overall Study||410|One participant was duplicate, hence removed from 'started' population.|
59931080|NCT02863328|76049326|FG000|Full Analysis Set (FAS)|Overall Study||411||
59931081|NCT02863328|76049327|FG001|Full Analysis Set (FAS)|Overall Study||410||
59931082|NCT02863328|76049326|FG000|Safety Analysis Set (SAS)|Overall Study||410||
59931083|NCT02863328|76049327|FG001|Safety Analysis Set (SAS)|Overall Study||409||
59931084|NCT02863328|76049326|FG000|COMPLETED|Overall Study||400||
59931085|NCT02863328|76049327|FG001|COMPLETED|Overall Study||387||
59931086|NCT02863328|76049326|FG000|NOT COMPLETED|Overall Study||11||
59931087|NCT02863328|76049327|FG001|NOT COMPLETED|Overall Study||23||
59931088|NCT03040141|76049336|FG000|STARTED|Overall Study||29||
59931089|NCT03040141|76049337|FG001|STARTED|Overall Study||30||
59931090|NCT03040141|76049338|FG002|STARTED|Overall Study||30||
59931091|NCT03040141|76049336|FG000|COMPLETED|Overall Study||25||
59931092|NCT03040141|76049337|FG001|COMPLETED|Overall Study||24||
59931093|NCT03040141|76049338|FG002|COMPLETED|Overall Study||24||
59931094|NCT03040141|76049336|FG000|NOT COMPLETED|Overall Study||4||
59931095|NCT03040141|76049337|FG001|NOT COMPLETED|Overall Study||6||
59931096|NCT03040141|76049338|FG002|NOT COMPLETED|Overall Study||6||
59931097|NCT02937701|76049352|FG000|STARTED|Day 1 to Week 22||279||
59931098|NCT02937701|76049353|FG001|STARTED|Day 1 to Week 22||279||
59931099|NCT02937701|76049354|FG002|STARTED|Day 1 to Week 22||0||
59931100|NCT02937701|76049355|FG003|STARTED|Day 1 to Week 22||0||
59931101|NCT02937701|76049356|FG004|STARTED|Day 1 to Week 22||0||
59931102|NCT02937701|76049352|FG000|Received Treatment|Day 1 to Week 22||278||
59931103|NCT02937701|76049353|FG001|Received Treatment|Day 1 to Week 22||278||
59931104|NCT02937701|76049354|FG002|Received Treatment|Day 1 to Week 22||0||
59931105|NCT02937701|76049355|FG003|Received Treatment|Day 1 to Week 22||0||
59931106|NCT02937701|76049356|FG004|Received Treatment|Day 1 to Week 22||0||
59931107|NCT02937701|76049352|FG000|COMPLETED|Day 1 to Week 22||244||
59931108|NCT02937701|76049353|FG001|COMPLETED|Day 1 to Week 22||240||
59931109|NCT02937701|76049354|FG002|COMPLETED|Day 1 to Week 22||0||
59931110|NCT02937701|76049355|FG003|COMPLETED|Day 1 to Week 22||0||
59931111|NCT02937701|76049356|FG004|COMPLETED|Day 1 to Week 22||0||
59931112|NCT02937701|76049352|FG000|NOT COMPLETED|Day 1 to Week 22||35||
59931113|NCT02937701|76049353|FG001|NOT COMPLETED|Day 1 to Week 22||39||
59931114|NCT02937701|76049354|FG002|NOT COMPLETED|Day 1 to Week 22||0||
60066571|NCT01791153|76181827|FG006|STARTED|Part 1: Blinded Period||0||
60066572|NCT01791153|76181828|FG007|STARTED|Part 1: Blinded Period||0||
60066573|NCT01791153|76181821|FG000|COMPLETED|Part 1: Blinded Period|Completed Study to Week 52|85||
60066574|NCT01791153|76181822|FG001|COMPLETED|Part 1: Blinded Period|Completed Study to Week 52|41||
60066575|NCT01791153|76181823|FG002|COMPLETED|Part 1: Blinded Period|Completed Study to Week 52|44||
60066576|NCT01791153|76181824|FG003|COMPLETED|Part 1: Blinded Period|Completed Study to Week 52|46||
60066577|NCT01791153|76181825|FG004|COMPLETED|Part 1: Blinded Period||0||
59931115|NCT02937701|76049355|FG003|NOT COMPLETED|Day 1 to Week 22||0||
59931116|NCT02937701|76049356|FG004|NOT COMPLETED|Day 1 to Week 22||0||
59931117|NCT02937701|76049352|FG000|STARTED|Week 22 to Week 50||0||
59931118|NCT02937701|76049353|FG001|STARTED|Week 22 to Week 50||0||
59931119|NCT02937701|76049354|FG002|STARTED|Week 22 to Week 50||244||
59931120|NCT02937701|76049355|FG003|STARTED|Week 22 to Week 50||121||
59931121|NCT02937701|76049356|FG004|STARTED|Week 22 to Week 50||119||
59931122|NCT02937701|76049352|FG000|COMPLETED|Week 22 to Week 50||0||
59931123|NCT02937701|76049353|FG001|COMPLETED|Week 22 to Week 50||0||
59931124|NCT02937701|76049354|FG002|COMPLETED|Week 22 to Week 50||212||
59931125|NCT02937701|76049355|FG003|COMPLETED|Week 22 to Week 50||113||
59931126|NCT02937701|76049356|FG004|COMPLETED|Week 22 to Week 50||110||
59931127|NCT02937701|76049352|FG000|NOT COMPLETED|Week 22 to Week 50||0||
59931128|NCT02937701|76049353|FG001|NOT COMPLETED|Week 22 to Week 50||0||
59931129|NCT02937701|76049354|FG002|NOT COMPLETED|Week 22 to Week 50||32||
59931130|NCT02937701|76049355|FG003|NOT COMPLETED|Week 22 to Week 50||8||
59931131|NCT02937701|76049356|FG004|NOT COMPLETED|Week 22 to Week 50||9||
59931132|NCT03169153|76049368|FG000|STARTED|Period 1, First 30 Days of Wear||42|Randomized and exposed|
59931133|NCT03169153|76049369|FG001|STARTED|Period 1, First 30 Days of Wear||39|Randomized and exposed|
59931134|NCT03169153|76049368|FG000|COMPLETED|Period 1, First 30 Days of Wear||39||
59931135|NCT03169153|76049369|FG001|COMPLETED|Period 1, First 30 Days of Wear||35||
59931136|NCT03169153|76049368|FG000|NOT COMPLETED|Period 1, First 30 Days of Wear||3||
59931137|NCT03169153|76049369|FG001|NOT COMPLETED|Period 1, First 30 Days of Wear||4||
59931138|NCT03169153|76049368|FG000|STARTED|Period 2, Second 30 Days of Wear||39||
59931139|NCT03169153|76049369|FG001|STARTED|Period 2, Second 30 Days of Wear|One subject discontinued after completing Period 1 and was not exposed in Period 2.|34||
59931140|NCT03169153|76049368|FG000|COMPLETED|Period 2, Second 30 Days of Wear||37||
59931141|NCT03169153|76049369|FG001|COMPLETED|Period 2, Second 30 Days of Wear||32||
59931142|NCT03169153|76049368|FG000|NOT COMPLETED|Period 2, Second 30 Days of Wear||2||
59931143|NCT03169153|76049369|FG001|NOT COMPLETED|Period 2, Second 30 Days of Wear||2||
59931144|NCT03168919|76049375|FG000|STARTED|Overall Study||5||
59931145|NCT03168919|76049375|FG000|COMPLETED|Overall Study||3||
60066578|NCT01791153|76181826|FG005|COMPLETED|Part 1: Blinded Period||0||
60066579|NCT01791153|76181827|FG006|COMPLETED|Part 1: Blinded Period||0||
60066580|NCT01791153|76181828|FG007|COMPLETED|Part 1: Blinded Period||0||
60066581|NCT01791153|76181821|FG000|NOT COMPLETED|Part 1: Blinded Period||15||
60066582|NCT01791153|76181822|FG001|NOT COMPLETED|Part 1: Blinded Period||8||
60066583|NCT01791153|76181823|FG002|NOT COMPLETED|Part 1: Blinded Period||6||
60066584|NCT01791153|76181824|FG003|NOT COMPLETED|Part 1: Blinded Period||5||
60066585|NCT01791153|76181825|FG004|NOT COMPLETED|Part 1: Blinded Period||0||
60066586|NCT01791153|76181826|FG005|NOT COMPLETED|Part 1: Blinded Period||0||
60066587|NCT01791153|76181827|FG006|NOT COMPLETED|Part 1: Blinded Period||0||
60066588|NCT01791153|76181828|FG007|NOT COMPLETED|Part 1: Blinded Period||0||
60066589|NCT01791153|76181821|FG000|STARTED|Part 2: Open-label Period||0||
60066590|NCT01791153|76181822|FG001|STARTED|Part 2: Open-label Period||0||
60066591|NCT01791153|76181823|FG002|STARTED|Part 2: Open-label Period||0||
59931146|NCT03168919|76049375|FG000|NOT COMPLETED|Overall Study||2||
59931147|NCT03205163|76049385|FG000|STARTED|ATP (LDC: 3 Days; HDC: 4 Days)||7||
59931148|NCT03205163|76049386|FG001|STARTED|ATP (LDC: 3 Days; HDC: 4 Days)||9||
59931149|NCT03205163|76049385|FG000|Safety Population|ATP (LDC: 3 Days; HDC: 4 Days)||7||
59931150|NCT03205163|76049386|FG001|Safety Population|ATP (LDC: 3 Days; HDC: 4 Days)||9||
59931151|NCT03205163|76049385|FG000|COMPLETED|ATP (LDC: 3 Days; HDC: 4 Days)||6||
59931152|NCT03205163|76049386|FG001|COMPLETED|ATP (LDC: 3 Days; HDC: 4 Days)||9||
59931153|NCT03205163|76049385|FG000|NOT COMPLETED|ATP (LDC: 3 Days; HDC: 4 Days)||1||
59931154|NCT03205163|76049386|FG001|NOT COMPLETED|ATP (LDC: 3 Days; HDC: 4 Days)||0||
59931155|NCT03205163|76049385|FG000|STARTED|BTP (LDC: 28 Days; HDC: 28 Days)||6||
59931156|NCT03205163|76049386|FG001|STARTED|BTP (LDC: 28 Days; HDC: 28 Days)||9||
59931157|NCT03205163|76049385|FG000|Safety Population|BTP (LDC: 28 Days; HDC: 28 Days)||6||
59931158|NCT03205163|76049386|FG001|Safety Population|BTP (LDC: 28 Days; HDC: 28 Days)||9||
59931159|NCT03205163|76049385|FG000|COMPLETED|BTP (LDC: 28 Days; HDC: 28 Days)||6||
59931160|NCT03205163|76049386|FG001|COMPLETED|BTP (LDC: 28 Days; HDC: 28 Days)||9||
59931161|NCT03205163|76049385|FG000|NOT COMPLETED|BTP (LDC: 28 Days; HDC: 28 Days)||0||
59931162|NCT03205163|76049386|FG001|NOT COMPLETED|BTP (LDC: 28 Days; HDC: 28 Days)||0||
60066592|NCT01791153|76181824|FG003|STARTED|Part 2: Open-label Period||0||
60066593|NCT01791153|76181825|FG004|STARTED|Part 2: Open-label Period||40||
60066594|NCT01791153|76181826|FG005|STARTED|Part 2: Open-label Period||58||
60066595|NCT01791153|76181827|FG006|STARTED|Part 2: Open-label Period||50||
60066596|NCT01791153|76181828|FG007|STARTED|Part 2: Open-label Period||67||
60066597|NCT01791153|76181821|FG000|COMPLETED|Part 2: Open-label Period||0||
60066598|NCT01791153|76181822|FG001|COMPLETED|Part 2: Open-label Period||0||
60066599|NCT01791153|76181823|FG002|COMPLETED|Part 2: Open-label Period||0||
60066600|NCT01791153|76181824|FG003|COMPLETED|Part 2: Open-label Period||0||
60066601|NCT01791153|76181825|FG004|COMPLETED|Part 2: Open-label Period||38||
60066602|NCT01791153|76181826|FG005|COMPLETED|Part 2: Open-label Period||54||
60066603|NCT01791153|76181827|FG006|COMPLETED|Part 2: Open-label Period||44||
60066604|NCT01791153|76181828|FG007|COMPLETED|Part 2: Open-label Period||61||
60066605|NCT01791153|76181821|FG000|NOT COMPLETED|Part 2: Open-label Period||0||
60066606|NCT01791153|76181822|FG001|NOT COMPLETED|Part 2: Open-label Period||0||
59518189|NCT03270436|75612010|FG001|COMPLETED|Immediate Post-Intervention||111||
60066607|NCT01791153|76181823|FG002|NOT COMPLETED|Part 2: Open-label Period||0||
60066608|NCT01791153|76181824|FG003|NOT COMPLETED|Part 2: Open-label Period||0||
60066609|NCT01791153|76181825|FG004|NOT COMPLETED|Part 2: Open-label Period||2||
60066610|NCT01791153|76181826|FG005|NOT COMPLETED|Part 2: Open-label Period||4||
60066611|NCT01791153|76181827|FG006|NOT COMPLETED|Part 2: Open-label Period||6||
60066612|NCT01791153|76181828|FG007|NOT COMPLETED|Part 2: Open-label Period||6||
60066613|NCT01926782|76181849|FG000|STARTED|Overall Study||157||
60066614|NCT01926782|76181850|FG001|STARTED|Overall Study||78||
60066615|NCT01926782|76181851|FG002|STARTED|Overall Study||312||
60066616|NCT01926782|76181852|FG003|STARTED|Overall Study||73||
60066617|NCT01926782|76181853|FG004|STARTED|Overall Study||37||
60066618|NCT01926782|76181854|FG005|STARTED|Overall Study||146||
60066619|NCT01926782|76181849|FG000|Treated|Overall Study||157||
60066620|NCT01926782|76181850|FG001|Treated|Overall Study||78||
60066621|NCT01926782|76181851|FG002|Treated|Overall Study||312||
60066622|NCT01926782|76181852|FG003|Treated|Overall Study||72||
60066623|NCT01926782|76181853|FG004|Treated|Overall Study||37||
60066624|NCT01926782|76181854|FG005|Treated|Overall Study||146||
60066625|NCT01926782|76181849|FG000|Completed 24 Weeks Treatment Period|Overall Study||137||
60066626|NCT01926782|76181850|FG001|Completed 24 Weeks Treatment Period|Overall Study||68||
60066627|NCT01926782|76181851|FG002|Completed 24 Weeks Treatment Period|Overall Study||285||
60066628|NCT01926782|76181852|FG003|Completed 24 Weeks Treatment Period|Overall Study||58||
59518190|NCT03270436|75612009|FG000|NOT COMPLETED|Immediate Post-Intervention||41||
59761463|NCT02393248|75881102|FG020|NOT COMPLETED|Part 2: Monotherapy Dose Expansion||0||
59518191|NCT03270436|75612010|FG001|NOT COMPLETED|Immediate Post-Intervention||56||
59518192|NCT03270436|75612009|FG000|STARTED|6 Months Post-Intervention||213|All enrolled participants were contacted to provide data at 6 months post-intervention whether or not they completed previous data collections.|
59518193|NCT03270436|75612010|FG001|STARTED|6 Months Post-Intervention||167|All enrolled participants were contacted to provide data at 6 months post-intervention whether or not they completed previous data collections.|
59518194|NCT03270436|75612009|FG000|COMPLETED|6 Months Post-Intervention||173||
59519052|NCT00948935|75612914|FG000|COMPLETED|Overall Study||35||
59761464|NCT02393248|75881103|FG021|NOT COMPLETED|Part 2: Monotherapy Dose Expansion||0||
59761465|NCT02393248|75881104|FG022|NOT COMPLETED|Part 2: Monotherapy Dose Expansion||0||
60066629|NCT01926782|76181853|FG004|Completed 24 Weeks Treatment Period|Overall Study||31||
60066630|NCT01926782|76181854|FG005|Completed 24 Weeks Treatment Period|Overall Study||120||
60066631|NCT01926782|76181849|FG000|COMPLETED|Overall Study||129||
60066632|NCT01926782|76181850|FG001|COMPLETED|Overall Study||65||
60066633|NCT01926782|76181851|FG002|COMPLETED|Overall Study||272||
60066634|NCT01926782|76181852|FG003|COMPLETED|Overall Study||53||
60066635|NCT01926782|76181853|FG004|COMPLETED|Overall Study||29||
60066636|NCT01926782|76181854|FG005|COMPLETED|Overall Study||105||
60066637|NCT01926782|76181849|FG000|NOT COMPLETED|Overall Study||28||
60066638|NCT01926782|76181850|FG001|NOT COMPLETED|Overall Study||13||
60066639|NCT01926782|76181851|FG002|NOT COMPLETED|Overall Study||40||
60066640|NCT01926782|76181852|FG003|NOT COMPLETED|Overall Study||20||
60066641|NCT01926782|76181853|FG004|NOT COMPLETED|Overall Study||8||
60066642|NCT01926782|76181854|FG005|NOT COMPLETED|Overall Study||41||
60066643|NCT01926626|76181869|FG000|STARTED|Overall Study||38||
59931163|NCT01759537|76049401|FG000|STARTED|Overall Study|This is a split mouth study. The same 48 patients started the study for both Arms. Three (3) subjects were enrolled but withdrawn and not included in the statistical analysis.|48||48
59931164|NCT01759537|76049402|FG001|STARTED|Overall Study|This is a split mouth study. The same 48 patients started the study for both Arms. Three (3) subjects were enrolled but withdrawn and not included in the statistical analysis.|48||48
59931165|NCT01759537|76049401|FG000|COMPLETED|Overall Study|This is a split mouth study. The same 35 patients completed the study for both Arms.|35||35
60066644|NCT01926626|76181869|FG000|Received Moclobemide|Overall Study||37||
60066645|NCT01926626|76181869|FG000|COMPLETED|Overall Study||16||
60066646|NCT01926626|76181869|FG000|NOT COMPLETED|Overall Study||22||
60066647|NCT01953224|76181875|FG000|STARTED|Overall Study||20||
60066648|NCT01953224|76181876|FG001|STARTED|Overall Study||20||
60066649|NCT01953224|76181875|FG000|COMPLETED|Overall Study||18||
60066650|NCT01953224|76181876|FG001|COMPLETED|Overall Study||17||
60066651|NCT01953224|76181875|FG000|NOT COMPLETED|Overall Study||2||
59518195|NCT03270436|75612010|FG001|COMPLETED|6 Months Post-Intervention||116||
59518196|NCT03270436|75612009|FG000|NOT COMPLETED|6 Months Post-Intervention||40||
59518197|NCT03270436|75612010|FG001|NOT COMPLETED|6 Months Post-Intervention||51||
59518198|NCT01074463|75612018|FG000|STARTED|First Intervention||12||
59518199|NCT01074463|75612019|FG001|STARTED|First Intervention||12||
59518200|NCT01074463|75612018|FG000|COMPLETED|First Intervention||12||
59518201|NCT01074463|75612019|FG001|COMPLETED|First Intervention||12||
59518202|NCT01074463|75612018|FG000|NOT COMPLETED|First Intervention||0||
59518203|NCT01074463|75612019|FG001|NOT COMPLETED|First Intervention||0||
59518204|NCT01074463|75612018|FG000|STARTED|Washout of 7 Days||12||
59518205|NCT01074463|75612019|FG001|STARTED|Washout of 7 Days||12||
59518206|NCT01074463|75612018|FG000|COMPLETED|Washout of 7 Days||12||
59518207|NCT01074463|75612019|FG001|COMPLETED|Washout of 7 Days||12||
59518208|NCT01074463|75612018|FG000|NOT COMPLETED|Washout of 7 Days||0||
59518209|NCT01074463|75612019|FG001|NOT COMPLETED|Washout of 7 Days||0||
60066652|NCT01953224|76181876|FG001|NOT COMPLETED|Overall Study||3||
60066653|NCT01900730|76181884|FG000|STARTED|Overall Study||3||
60066654|NCT01900730|76181885|FG001|STARTED|Overall Study||0||
60066655|NCT01900730|76181884|FG000|COMPLETED|Overall Study||1||
60066656|NCT01900730|76181885|FG001|COMPLETED|Overall Study||0||
60066657|NCT01900730|76181884|FG000|NOT COMPLETED|Overall Study||2||
60066658|NCT01900730|76181885|FG001|NOT COMPLETED|Overall Study||0||
60066659|NCT01952834|76181891|FG000|STARTED|Overall Study||21||
60066660|NCT01952834|76181891|FG000|COMPLETED|Overall Study||20||
60066661|NCT01952834|76181891|FG000|NOT COMPLETED|Overall Study||1||
60066662|NCT01952054|76181896|FG000|STARTED|Overall Study||6||
60066663|NCT01952054|76181896|FG000|COMPLETED|Overall Study||5||
60066664|NCT01952054|76181896|FG000|NOT COMPLETED|Overall Study||1||
60066665|NCT01925768|76181902|FG000|STARTED|Placebo-controlled Phase (Week 0 - 24)||109||
60066666|NCT01925768|76181903|FG001|STARTED|Placebo-controlled Phase (Week 0 - 24)||110||
60066667|NCT01925768|76181902|FG000|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||109||
59518210|NCT01074463|75612018|FG000|STARTED|Second Intervention||12||
59518211|NCT01074463|75612019|FG001|STARTED|Second Intervention||12||
59518212|NCT01074463|75612018|FG000|COMPLETED|Second Intervention||12||
59518213|NCT01074463|75612019|FG001|COMPLETED|Second Intervention||12||
59518214|NCT01074463|75612018|FG000|NOT COMPLETED|Second Intervention||0||
59518215|NCT01074463|75612019|FG001|NOT COMPLETED|Second Intervention||0||
60066668|NCT01925768|76181903|FG001|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||109||
60066669|NCT01925768|76181902|FG000|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||101||
60066670|NCT01925768|76181903|FG001|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||91||
60066671|NCT01925768|76181902|FG000|Escaped Early (EE)|Placebo-controlled Phase (Week 0 - 24)||35||
60066672|NCT01925768|76181903|FG001|Escaped Early (EE)|Placebo-controlled Phase (Week 0 - 24)||13||
60066673|NCT01925768|76181902|FG000|COMPLETED|Placebo-controlled Phase (Week 0 - 24)|3 participants who completed Week 24 did not enter the active treatment phase|98||
60066674|NCT01925768|76181903|FG001|COMPLETED|Placebo-controlled Phase (Week 0 - 24)|2 participants who completed Week 24 did not enter the active treatment phase|87||
60066675|NCT01925768|76181902|FG000|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||11||
60066676|NCT01925768|76181903|FG001|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||23||
59518216|NCT01075087|75612027|FG000|STARTED|Overall Study||9||
60066677|NCT01925768|76181902|FG000|STARTED|ActiveTreatment/Extension (Weeks 24-104)||95||
60066678|NCT01925768|76181903|FG001|STARTED|ActiveTreatment/Extension (Weeks 24-104)||85||
60066679|NCT01925768|76181902|FG000|COMPLETED|ActiveTreatment/Extension (Weeks 24-104)||75||
60066680|NCT01925768|76181903|FG001|COMPLETED|ActiveTreatment/Extension (Weeks 24-104)|Completed Apremilast treatment at Week 104|67||
59518217|NCT01075087|75612028|FG001|STARTED|Overall Study||10||
59518218|NCT01075087|75612027|FG000|COMPLETED|Overall Study||9||
59518219|NCT01075087|75612028|FG001|COMPLETED|Overall Study||10||
59518220|NCT01075087|75612027|FG000|NOT COMPLETED|Overall Study||0||
59518221|NCT01075087|75612028|FG001|NOT COMPLETED|Overall Study||0||
59518222|NCT01075399|75612034|FG000|STARTED|Overall Study|A total of 50 patients were enrolled into the study.|50||
59518223|NCT01075399|75612034|FG000|COMPLETED|Overall Study|42 of 50 patients received at least one dose and 39 of 50 patients completed two pre-treatment scan|42||
59931166|NCT01759537|76049402|FG001|COMPLETED|Overall Study|This is a split mouth study. The same 35 patients completed the study for both Arms.|35||35
59931167|NCT01759537|76049401|FG000|NOT COMPLETED|Overall Study||13||13
59931168|NCT01759537|76049402|FG001|NOT COMPLETED|Overall Study||13||13
59931169|NCT03204539|76049410|FG000|STARTED|Overall Study||0||
59931170|NCT03204539|76049411|FG001|STARTED|Overall Study||1||
59931171|NCT03204539|76049410|FG000|COMPLETED|Overall Study||0||
59931172|NCT03204539|76049411|FG001|COMPLETED|Overall Study||0||
59931173|NCT03204539|76049410|FG000|NOT COMPLETED|Overall Study||0||
59931174|NCT03204539|76049411|FG001|NOT COMPLETED|Overall Study||1||
59931175|NCT03638947|76049419|FG000|STARTED|Overall Study||130||
59931176|NCT03638947|76049420|FG001|STARTED|Overall Study||106||
59931177|NCT03638947|76049419|FG000|COMPLETED|Overall Study||130||
59931178|NCT03638947|76049420|FG001|COMPLETED|Overall Study||106||
59931179|NCT03638947|76049419|FG000|NOT COMPLETED|Overall Study||0||
59931180|NCT03638947|76049420|FG001|NOT COMPLETED|Overall Study||0||
59931181|NCT03502681|76049428|FG000|STARTED|Overall Study||3||
59931182|NCT03502681|76049429|FG001|STARTED|Overall Study||3||
59931183|NCT03502681|76049428|FG000|COMPLETED|Overall Study||0||
59931184|NCT03502681|76049429|FG001|COMPLETED|Overall Study||1||
59931185|NCT03502681|76049428|FG000|NOT COMPLETED|Overall Study||3||
59931186|NCT03502681|76049429|FG001|NOT COMPLETED|Overall Study||2||
59931187|NCT02860130|76049436|FG000|STARTED|Overall Study||17||
59931188|NCT02860130|76049437|FG001|STARTED|Overall Study||17||
59931189|NCT02860130|76049436|FG000|COMPLETED|Overall Study||10||
59931190|NCT02860130|76049437|FG001|COMPLETED|Overall Study||8||
59931191|NCT02860130|76049436|FG000|NOT COMPLETED|Overall Study||7||
59931192|NCT02860130|76049437|FG001|NOT COMPLETED|Overall Study||9||
59931193|NCT02986854|76049446|FG000|STARTED|Overall Study||301||
59931194|NCT02986854|76049447|FG001|STARTED|Overall Study||300||
59931195|NCT02986854|76049448|FG002|STARTED|Overall Study||100||
59931196|NCT02986854|76049446|FG000|COMPLETED|Overall Study||298||
59931197|NCT02986854|76049447|FG001|COMPLETED|Overall Study||288||
60066681|NCT01925768|76181902|FG000|NOT COMPLETED|ActiveTreatment/Extension (Weeks 24-104)||20||
60066682|NCT01925768|76181903|FG001|NOT COMPLETED|ActiveTreatment/Extension (Weeks 24-104)||18||
60066683|NCT01431274|76181918|FG000|STARTED|Overall Study||528||
60066684|NCT01431274|76181919|FG001|STARTED|Overall Study||525||
60066685|NCT01431274|76181920|FG002|STARTED|Overall Study||527||
60066686|NCT01431274|76181921|FG003|STARTED|Overall Study||522||
60066687|NCT01431274|76181922|FG004|STARTED|Overall Study||522||
60066688|NCT01431274|76181918|FG000|COMPLETED|Overall Study||431||
60066689|NCT01431274|76181919|FG001|COMPLETED|Overall Study||448||
60066690|NCT01431274|76181920|FG002|COMPLETED|Overall Study||455||
60066691|NCT01431274|76181921|FG003|COMPLETED|Overall Study||462||
60066692|NCT01431274|76181922|FG004|COMPLETED|Overall Study||466||
60066693|NCT01431274|76181918|FG000|NOT COMPLETED|Overall Study||97||
60066694|NCT01431274|76181919|FG001|NOT COMPLETED|Overall Study||77||
60066695|NCT01431274|76181920|FG002|NOT COMPLETED|Overall Study||72||
60066696|NCT01431274|76181921|FG003|NOT COMPLETED|Overall Study||60||
60066697|NCT01431274|76181922|FG004|NOT COMPLETED|Overall Study||56||
60066698|NCT01991795|76181936|FG000|STARTED|Overall Study||9645|Includes patients that were randomised to study drug|
60066699|NCT01991795|76181937|FG001|STARTED|Overall Study||9626|Includes patients that were randomised to study drug|
60066700|NCT01991795|76181936|FG000|COMPLETED|Overall Study||9496|Patients who did not withdrew informed consent, were not LTFU and not excluded from the analyses|
60066701|NCT01991795|76181937|FG001|COMPLETED|Overall Study||9503|Patients who did not withdrew informed consent, were not LTFU and not excluded from the analyses|
59518224|NCT01075399|75612034|FG000|NOT COMPLETED|Overall Study||8||
59931198|NCT02986854|76049448|FG002|COMPLETED|Overall Study||97||
59931199|NCT02986854|76049446|FG000|NOT COMPLETED|Overall Study||3||
59931200|NCT02986854|76049447|FG001|NOT COMPLETED|Overall Study||12||
59931201|NCT02986854|76049448|FG002|NOT COMPLETED|Overall Study||3||
59931202|NCT02887183|76049458|FG000|STARTED|Overall Study||795||
59931203|NCT02887183|76049458|FG000|Full Analysis Set|Overall Study||794||
59931204|NCT02887183|76049458|FG000|COMPLETED|Overall Study||654||
59931205|NCT02887183|76049458|FG000|NOT COMPLETED|Overall Study||141||
59931206|NCT03167359|76049462|FG000|STARTED|Overall Study||74||
59931207|NCT03167359|76049462|FG000|COMPLETED|Overall Study||72||
59931208|NCT03167359|76049462|FG000|NOT COMPLETED|Overall Study||2||
59931209|NCT01068600|76049468|FG000|STARTED|Overall Study||159||
59931210|NCT01068600|76049469|FG001|STARTED|Overall Study||159||
59931211|NCT01068600|76049468|FG000|COMPLETED|Overall Study||148||
59931212|NCT01068600|76049469|FG001|COMPLETED|Overall Study||142||
59931213|NCT01068600|76049468|FG000|NOT COMPLETED|Overall Study||11||
59931214|NCT01068600|76049469|FG001|NOT COMPLETED|Overall Study||17||
59931215|NCT01067976|76049475|FG000|STARTED|Overall Study|screened and enrolled|446||
59931216|NCT01067976|76049475|FG000|Received Treatment|Overall Study|treatment started|426||
59931217|NCT01067976|76049475|FG000|Fulfilled Requirements of FAS Population|Overall Study||390||
59931218|NCT01067976|76049475|FG000|COMPLETED|Overall Study|study course completed|424||
59931219|NCT01067976|76049475|FG000|NOT COMPLETED|Overall Study||22||
59931220|NCT02858492|76049497|FG000|STARTED|Overall Study||3||
59931221|NCT02858492|76049498|FG001|STARTED|Overall Study||15||
59931222|NCT02858492|76049499|FG002|STARTED|Overall Study||5||
59931223|NCT02858492|76049500|FG003|STARTED|Overall Study||28||
59931224|NCT02858492|76049497|FG000|COMPLETED|Overall Study||3||
59931225|NCT02858492|76049498|FG001|COMPLETED|Overall Study||14||
59931226|NCT02858492|76049499|FG002|COMPLETED|Overall Study||5||
59931227|NCT02858492|76049500|FG003|COMPLETED|Overall Study||22||
59931228|NCT02858492|76049497|FG000|NOT COMPLETED|Overall Study||0||
60066702|NCT01991795|76181936|FG000|NOT COMPLETED|Overall Study||149||
60066703|NCT01991795|76181937|FG001|NOT COMPLETED|Overall Study||123||
60066704|NCT02076100|76181950|FG000|STARTED|Overall Study||3||
59931229|NCT02858492|76049498|FG001|NOT COMPLETED|Overall Study||1||
59931230|NCT02858492|76049499|FG002|NOT COMPLETED|Overall Study||0||
59931231|NCT02858492|76049500|FG003|NOT COMPLETED|Overall Study||6||
59931232|NCT01067508|76049514|FG000|STARTED|Overall Study||10||
59931233|NCT01067508|76049515|FG001|STARTED|Overall Study||9||
59931234|NCT01067508|76049514|FG000|COMPLETED|Overall Study||10||
59931235|NCT01067508|76049515|FG001|COMPLETED|Overall Study||7||
59931236|NCT01067508|76049514|FG000|NOT COMPLETED|Overall Study||0||
59931237|NCT01067508|76049515|FG001|NOT COMPLETED|Overall Study||2||
59931238|NCT01067352|76049524|FG000|STARTED|Overall Study||9||
59931239|NCT01067352|76049525|FG001|STARTED|Overall Study||6||
59931240|NCT01067352|76049526|FG002|STARTED|Overall Study||10||
59931241|NCT01067352|76049524|FG000|COMPLETED|Overall Study||8||
59931242|NCT01067352|76049525|FG001|COMPLETED|Overall Study||3||
59931243|NCT01067352|76049526|FG002|COMPLETED|Overall Study||9||
59931244|NCT01067352|76049524|FG000|NOT COMPLETED|Overall Study||1||
59931245|NCT01067352|76049525|FG001|NOT COMPLETED|Overall Study||3||
59931246|NCT01067352|76049526|FG002|NOT COMPLETED|Overall Study||1||
59931247|NCT02986074|76049534|FG000|STARTED|First Trial Period||26||
59931248|NCT02986074|76049535|FG001|STARTED|First Trial Period||29||
59931249|NCT02986074|76049536|FG002|STARTED|First Trial Period||0||
59931250|NCT02986074|76049537|FG003|STARTED|First Trial Period||0||
59931251|NCT02986074|76049534|FG000|COMPLETED|First Trial Period||25||
59931252|NCT02986074|76049535|FG001|COMPLETED|First Trial Period||29||
59931253|NCT02986074|76049536|FG002|COMPLETED|First Trial Period||0||
59931254|NCT02986074|76049537|FG003|COMPLETED|First Trial Period||0||
59931255|NCT02986074|76049534|FG000|NOT COMPLETED|First Trial Period||1||
60066705|NCT02076100|76181951|FG001|STARTED|Overall Study||3||
60066706|NCT02076100|76181952|FG002|STARTED|Overall Study||3||
60066707|NCT02076100|76181953|FG003|STARTED|Overall Study||3||
60066708|NCT02076100|76181954|FG004|STARTED|Overall Study||3||
60066709|NCT02076100|76181955|FG005|STARTED|Overall Study||3||
60066710|NCT02076100|76181956|FG006|STARTED|Overall Study||4||
60066711|NCT02076100|76181950|FG000|COMPLETED|Overall Study||3||
60066712|NCT02076100|76181951|FG001|COMPLETED|Overall Study||3||
59931256|NCT02986074|76049535|FG001|NOT COMPLETED|First Trial Period||0||
59931257|NCT02986074|76049536|FG002|NOT COMPLETED|First Trial Period||0||
59931258|NCT02986074|76049537|FG003|NOT COMPLETED|First Trial Period||0||
59931259|NCT02986074|76049534|FG000|STARTED|Second Trial Period||25||
59931260|NCT02986074|76049535|FG001|STARTED|Second Trial Period||29||
59931261|NCT02986074|76049536|FG002|STARTED|Second Trial Period||0||
59931262|NCT02986074|76049537|FG003|STARTED|Second Trial Period||0||
59931263|NCT02986074|76049534|FG000|COMPLETED|Second Trial Period||25||
59931264|NCT02986074|76049535|FG001|COMPLETED|Second Trial Period||29||
59931265|NCT02986074|76049536|FG002|COMPLETED|Second Trial Period||0||
59931266|NCT02986074|76049537|FG003|COMPLETED|Second Trial Period||0||
59931267|NCT02986074|76049534|FG000|NOT COMPLETED|Second Trial Period||0||
59931268|NCT02986074|76049535|FG001|NOT COMPLETED|Second Trial Period||0||
59931269|NCT02986074|76049536|FG002|NOT COMPLETED|Second Trial Period||0||
60066713|NCT02076100|76181952|FG002|COMPLETED|Overall Study||3||
60066714|NCT02076100|76181953|FG003|COMPLETED|Overall Study||3||
60066715|NCT02076100|76181954|FG004|COMPLETED|Overall Study||3||
59931270|NCT02986074|76049537|FG003|NOT COMPLETED|Second Trial Period||0||
59931271|NCT02986074|76049534|FG000|STARTED|Follow up Period||0||
59931272|NCT02986074|76049535|FG001|STARTED|Follow up Period||0||
59931273|NCT02986074|76049536|FG002|STARTED|Follow up Period||21||
59931274|NCT02986074|76049537|FG003|STARTED|Follow up Period||22||
59931275|NCT02986074|76049534|FG000|3 Month Follow up|Follow up Period||0||
59931276|NCT02986074|76049535|FG001|3 Month Follow up|Follow up Period||0||
60066716|NCT02076100|76181955|FG005|COMPLETED|Overall Study||3||
60066717|NCT02076100|76181956|FG006|COMPLETED|Overall Study||4||
60066718|NCT02076100|76181950|FG000|NOT COMPLETED|Overall Study||0||
60066719|NCT02076100|76181951|FG001|NOT COMPLETED|Overall Study||0||
59518225|NCT03358576|75612040|FG000|STARTED|Overall Study||338||
60066720|NCT02076100|76181952|FG002|NOT COMPLETED|Overall Study||0||
60066721|NCT02076100|76181953|FG003|NOT COMPLETED|Overall Study||0||
60066722|NCT02076100|76181954|FG004|NOT COMPLETED|Overall Study||0||
60066723|NCT02076100|76181955|FG005|NOT COMPLETED|Overall Study||0||
60066724|NCT02076100|76181956|FG006|NOT COMPLETED|Overall Study||0||
60066725|NCT01411852|76181978|FG000|STARTED|Prehospital Intervention Phase|1 patient randomized to 2000 mL bolus arm but received 250 mL bolus. Analyzed in 2000 mL arm.|95||
60066726|NCT01411852|76181979|FG001|STARTED|Prehospital Intervention Phase|One patient was in police custody at the time of enrollment. Patient's data omitted from analyses.|96||
60066727|NCT01411852|76181978|FG000|COMPLETED|Prehospital Intervention Phase|12 patients had the intervention stopped prior to hospital arrival|83||
60066728|NCT01411852|76181979|FG001|COMPLETED|Prehospital Intervention Phase|7 patients had intervention stopped prior to hospital arrival|89||
60066729|NCT01411852|76181978|FG000|NOT COMPLETED|Prehospital Intervention Phase||12||
60066730|NCT01411852|76181979|FG001|NOT COMPLETED|Prehospital Intervention Phase||7||
60066731|NCT01411852|76181978|FG000|STARTED|Hospital Intervention Phase||83||
60066732|NCT01411852|76181979|FG001|STARTED|Hospital Intervention Phase||89||
60066733|NCT01411852|76181978|FG000|COMPLETED|Hospital Intervention Phase|24 patients had intervention stopped prior to 2 hours after arrival or hemorrhage control|59||
60066734|NCT01411852|76181979|FG001|COMPLETED|Hospital Intervention Phase|18 patients had intervention stopped prior to 2 hours after arrival or hemorrhage control|71||
60066735|NCT01411852|76181978|FG000|NOT COMPLETED|Hospital Intervention Phase||24||
60066736|NCT01411852|76181979|FG001|NOT COMPLETED|Hospital Intervention Phase||18||
60066737|NCT01411774|76181989|FG000|STARTED|Overall Study||72||
60066738|NCT01411774|76181990|FG001|STARTED|Overall Study||70||
60066739|NCT01411774|76181989|FG000|COMPLETED|Overall Study||72||
60066740|NCT01411774|76181990|FG001|COMPLETED|Overall Study||67||
60066741|NCT01411774|76181989|FG000|NOT COMPLETED|Overall Study||0||
60066742|NCT01411774|76181990|FG001|NOT COMPLETED|Overall Study||3||
60066743|NCT01411228|76181999|FG000|STARTED|Overall Study||5||
60066744|NCT01411228|76182000|FG001|STARTED|Overall Study||5||
60066745|NCT01411228|76182001|FG002|STARTED|Overall Study||5||
60066746|NCT01411228|76181999|FG000|COMPLETED|Overall Study||4||
60066747|NCT01411228|76182000|FG001|COMPLETED|Overall Study||5||
60066748|NCT01411228|76182001|FG002|COMPLETED|Overall Study||4||
60066749|NCT01411228|76181999|FG000|NOT COMPLETED|Overall Study||1||
60066750|NCT01411228|76182000|FG001|NOT COMPLETED|Overall Study||0||
60066751|NCT01411228|76182001|FG002|NOT COMPLETED|Overall Study||1||
60066752|NCT01410604|76182011|FG000|STARTED|Overall Study||15||
60066753|NCT01410604|76182012|FG001|STARTED|Overall Study||16||
60066754|NCT01410604|76182011|FG000|COMPLETED|Overall Study||12||
60066755|NCT01410604|76182012|FG001|COMPLETED|Overall Study||14||
60066756|NCT01410604|76182011|FG000|NOT COMPLETED|Overall Study||3||
60066757|NCT01410604|76182012|FG001|NOT COMPLETED|Overall Study||2||
60066758|NCT01991483|76182022|FG000|STARTED|Dose Level: Placebo||7||
60066759|NCT01991483|76182023|FG001|STARTED|Dose Level: Placebo||0||
60066760|NCT01991483|76182024|FG002|STARTED|Dose Level: Placebo||0||
60066761|NCT01991483|76182025|FG003|STARTED|Dose Level: Placebo||0||
60066762|NCT01991483|76182022|FG000|Received at Least One Dose of Study Drug|Dose Level: Placebo||7||
60066763|NCT01991483|76182023|FG001|Received at Least One Dose of Study Drug|Dose Level: Placebo||0||
60066764|NCT01991483|76182024|FG002|Received at Least One Dose of Study Drug|Dose Level: Placebo||0||
59518226|NCT03358576|75612041|FG001|STARTED|Overall Study||336||
60066765|NCT01991483|76182025|FG003|Received at Least One Dose of Study Drug|Dose Level: Placebo||0||
60066766|NCT01991483|76182022|FG000|COMPLETED|Dose Level: Placebo||7||
60066767|NCT01991483|76182023|FG001|COMPLETED|Dose Level: Placebo||0||
60066768|NCT01991483|76182024|FG002|COMPLETED|Dose Level: Placebo||0||
59931277|NCT02986074|76049536|FG002|3 Month Follow up|Follow up Period||21||
59931278|NCT02986074|76049537|FG003|3 Month Follow up|Follow up Period||21||
60066769|NCT01991483|76182025|FG003|COMPLETED|Dose Level: Placebo||0||
60066770|NCT01991483|76182022|FG000|NOT COMPLETED|Dose Level: Placebo||0||
60066771|NCT01991483|76182023|FG001|NOT COMPLETED|Dose Level: Placebo||0||
60066772|NCT01991483|76182024|FG002|NOT COMPLETED|Dose Level: Placebo||0||
60066773|NCT01991483|76182025|FG003|NOT COMPLETED|Dose Level: Placebo||0||
60066774|NCT01991483|76182022|FG000|STARTED|Dose Level 300 mg|Multiple periods were added for each dose level to represent dose escalation.|0||
60066775|NCT01991483|76182023|FG001|STARTED|Dose Level 300 mg|Multiple periods were added for each dose level to represent dose escalation.|6||
60066776|NCT01991483|76182024|FG002|STARTED|Dose Level 300 mg||0||
60066777|NCT01991483|76182025|FG003|STARTED|Dose Level 300 mg||0||
60066778|NCT01991483|76182022|FG000|Received at Least One Dose of Study Drug|Dose Level 300 mg||0||
60066779|NCT01991483|76182023|FG001|Received at Least One Dose of Study Drug|Dose Level 300 mg||6||
60066780|NCT01991483|76182024|FG002|Received at Least One Dose of Study Drug|Dose Level 300 mg||0||
59931279|NCT02986074|76049534|FG000|6 Month Follow up|Follow up Period||0||
59931280|NCT02986074|76049535|FG001|6 Month Follow up|Follow up Period||0||
59931281|NCT02986074|76049536|FG002|6 Month Follow up|Follow up Period||21||
59931282|NCT02986074|76049537|FG003|6 Month Follow up|Follow up Period||20||
59931283|NCT02986074|76049534|FG000|COMPLETED|Follow up Period||0||
59931284|NCT02986074|76049535|FG001|COMPLETED|Follow up Period||0||
59931285|NCT02986074|76049536|FG002|COMPLETED|Follow up Period||20||
59931286|NCT02986074|76049537|FG003|COMPLETED|Follow up Period||19||
59931287|NCT02986074|76049534|FG000|NOT COMPLETED|Follow up Period||0||
59931288|NCT02986074|76049535|FG001|NOT COMPLETED|Follow up Period||0||
59931289|NCT02986074|76049536|FG002|NOT COMPLETED|Follow up Period||1||
59931290|NCT02986074|76049537|FG003|NOT COMPLETED|Follow up Period||3||
59931291|NCT02920242|76049545|FG000|STARTED|Overall Study||13||
59931292|NCT02920242|76049546|FG001|STARTED|Overall Study||11||
59931293|NCT02920242|76049547|FG002|STARTED|Overall Study||4||
59931294|NCT02920242|76049545|FG000|Safety Set|Overall Study||12||
59931295|NCT02920242|76049546|FG001|Safety Set|Overall Study||11||
59931296|NCT02920242|76049547|FG002|Safety Set|Overall Study||4||
59931297|NCT02920242|76049545|FG000|COMPLETED|Overall Study||11||
59931298|NCT02920242|76049546|FG001|COMPLETED|Overall Study||11||
59931299|NCT02920242|76049547|FG002|COMPLETED|Overall Study||3||
59931300|NCT02920242|76049545|FG000|NOT COMPLETED|Overall Study||2||
59931301|NCT02920242|76049546|FG001|NOT COMPLETED|Overall Study||0||
59931302|NCT02920242|76049547|FG002|NOT COMPLETED|Overall Study||1||
59931303|NCT02985996|76049560|FG000|STARTED|Overall Study||5||
59931304|NCT02985996|76049561|FG001|STARTED|Overall Study||8||
59931305|NCT02985996|76049562|FG002|STARTED|Overall Study||10||
59931306|NCT02985996|76049563|FG003|STARTED|Overall Study||7||
59931307|NCT02985996|76049564|FG004|STARTED|Overall Study||9||
59931308|NCT02985996|76049560|FG000|COMPLETED|Overall Study||5||
59931309|NCT02985996|76049561|FG001|COMPLETED|Overall Study||7||
59931310|NCT02985996|76049562|FG002|COMPLETED|Overall Study||9||
59931311|NCT02985996|76049563|FG003|COMPLETED|Overall Study||7||
59931312|NCT02985996|76049564|FG004|COMPLETED|Overall Study||9||
59931313|NCT02985996|76049560|FG000|NOT COMPLETED|Overall Study||0||
59931314|NCT02985996|76049561|FG001|NOT COMPLETED|Overall Study||1||
60066781|NCT01991483|76182025|FG003|Received at Least One Dose of Study Drug|Dose Level 300 mg||0||
60066782|NCT01991483|76182022|FG000|COMPLETED|Dose Level 300 mg||0||
60066783|NCT01991483|76182023|FG001|COMPLETED|Dose Level 300 mg||6||
60066784|NCT01991483|76182024|FG002|COMPLETED|Dose Level 300 mg||0||
60066785|NCT01991483|76182025|FG003|COMPLETED|Dose Level 300 mg||0||
60066786|NCT01991483|76182022|FG000|NOT COMPLETED|Dose Level 300 mg||0||
60066787|NCT01991483|76182023|FG001|NOT COMPLETED|Dose Level 300 mg||0||
60066788|NCT01991483|76182024|FG002|NOT COMPLETED|Dose Level 300 mg||0||
60066789|NCT01991483|76182025|FG003|NOT COMPLETED|Dose Level 300 mg||0||
60066790|NCT01991483|76182022|FG000|STARTED|Dose Level 600 mg||0||
60066791|NCT01991483|76182023|FG001|STARTED|Dose Level 600 mg|Multiple periods were added for each dose level to represent dose escalation.|0||
59931315|NCT02985996|76049562|FG002|NOT COMPLETED|Overall Study||1||
59931316|NCT02985996|76049563|FG003|NOT COMPLETED|Overall Study||0||
59931317|NCT02985996|76049564|FG004|NOT COMPLETED|Overall Study||0||
59931318|NCT03225833|76049586|FG000|STARTED|Overall Study||16||
59931319|NCT03225833|76049587|FG001|STARTED|Overall Study||9||
59931320|NCT03225833|76049588|FG002|STARTED|Overall Study||9||
59931321|NCT03225833|76049589|FG003|STARTED|Overall Study||9||
59931322|NCT03225833|76049590|FG004|STARTED|Overall Study||8||
59931323|NCT03225833|76049591|FG005|STARTED|Overall Study||10||
59931324|NCT03225833|76049586|FG000|Single Dose Period Only|Overall Study||1||
59931325|NCT03225833|76049587|FG001|Single Dose Period Only|Overall Study||1||
59518227|NCT03358576|75612040|FG000|COMPLETED|Overall Study||312||
59518228|NCT03358576|75612041|FG001|COMPLETED|Overall Study||311||
59518229|NCT03358576|75612040|FG000|NOT COMPLETED|Overall Study||26||
59518230|NCT03358576|75612041|FG001|NOT COMPLETED|Overall Study||25||
59518231|NCT03800563|75612047|FG000|STARTED|Overall Study||20||
59518232|NCT03800563|75612047|FG000|COMPLETED|Overall Study||20||
59518233|NCT03800563|75612047|FG000|NOT COMPLETED|Overall Study||0||
59518234|NCT03362944|75612051|FG000|STARTED|First Intervention||8||
59518235|NCT03362944|75612052|FG001|STARTED|First Intervention||8||
59518236|NCT03362944|75612051|FG000|COMPLETED|First Intervention||8||
59518237|NCT03362944|75612052|FG001|COMPLETED|First Intervention||8||
59518238|NCT03362944|75612051|FG000|NOT COMPLETED|First Intervention||0||
59518239|NCT03362944|75612052|FG001|NOT COMPLETED|First Intervention||0||
59518240|NCT03362944|75612051|FG000|STARTED|Single Week Washout Period||8||
59518241|NCT03362944|75612052|FG001|STARTED|Single Week Washout Period||8||
59518242|NCT03362944|75612051|FG000|COMPLETED|Single Week Washout Period||8||
59518243|NCT03362944|75612052|FG001|COMPLETED|Single Week Washout Period||8||
59518244|NCT03362944|75612051|FG000|NOT COMPLETED|Single Week Washout Period||0||
59518245|NCT03362944|75612052|FG001|NOT COMPLETED|Single Week Washout Period||0||
59931326|NCT03225833|76049588|FG002|Single Dose Period Only|Overall Study||2||
59931327|NCT03225833|76049589|FG003|Single Dose Period Only|Overall Study||0||
59931328|NCT03225833|76049590|FG004|Single Dose Period Only|Overall Study||0||
59931329|NCT03225833|76049591|FG005|Single Dose Period Only|Overall Study||4||
59931330|NCT03225833|76049586|FG000|Multiple Dose Period Only|Overall Study||0||
59931331|NCT03225833|76049587|FG001|Multiple Dose Period Only|Overall Study||0||
59931332|NCT03225833|76049588|FG002|Multiple Dose Period Only|Overall Study||0||
59931333|NCT03225833|76049589|FG003|Multiple Dose Period Only|Overall Study||0||
59931334|NCT03225833|76049590|FG004|Multiple Dose Period Only|Overall Study||0||
59931335|NCT03225833|76049591|FG005|Multiple Dose Period Only|Overall Study||1||
59931336|NCT03225833|76049586|FG000|Single Dose and Multiple Dose Periods|Overall Study||15||
59931337|NCT03225833|76049587|FG001|Single Dose and Multiple Dose Periods|Overall Study||8||
59931338|NCT03225833|76049588|FG002|Single Dose and Multiple Dose Periods|Overall Study||7||
59931339|NCT03225833|76049589|FG003|Single Dose and Multiple Dose Periods|Overall Study||9||
59931340|NCT03225833|76049590|FG004|Single Dose and Multiple Dose Periods|Overall Study||8||
59931341|NCT03225833|76049591|FG005|Single Dose and Multiple Dose Periods|Overall Study||5||
59931342|NCT03225833|76049586|FG000|COMPLETED|Overall Study||11||
59931343|NCT03225833|76049587|FG001|COMPLETED|Overall Study||8||
59931344|NCT03225833|76049588|FG002|COMPLETED|Overall Study||7||
59931345|NCT03225833|76049589|FG003|COMPLETED|Overall Study||9||
59931346|NCT03225833|76049590|FG004|COMPLETED|Overall Study||7||
59931347|NCT03225833|76049591|FG005|COMPLETED|Overall Study||0||
59931348|NCT03225833|76049586|FG000|NOT COMPLETED|Overall Study||5||
59931349|NCT03225833|76049587|FG001|NOT COMPLETED|Overall Study||1||
59931350|NCT03225833|76049588|FG002|NOT COMPLETED|Overall Study||2||
59931351|NCT03225833|76049589|FG003|NOT COMPLETED|Overall Study||0||
59931352|NCT03225833|76049590|FG004|NOT COMPLETED|Overall Study||1||
59931353|NCT03225833|76049591|FG005|NOT COMPLETED|Overall Study||10||
59931354|NCT03203447|76049612|FG000|STARTED|Overall Study|Two patients were randomized to the Active arm, but did not receive study drug.|162||
59931355|NCT03203447|76049613|FG001|STARTED|Overall Study|One patient was randomized to the Control arm, but did not receive study drug.|163||
59931356|NCT03203447|76049612|FG000|COMPLETED|Overall Study||0||
59931357|NCT03203447|76049613|FG001|COMPLETED|Overall Study||0||
59931358|NCT03203447|76049612|FG000|NOT COMPLETED|Overall Study||162||
59931359|NCT03203447|76049613|FG001|NOT COMPLETED|Overall Study||163||
59931360|NCT02858726|76049623|FG000|STARTED|Overall Study||44||
59931361|NCT02858726|76049624|FG001|STARTED|Overall Study||42||
59931362|NCT02858726|76049625|FG002|STARTED|Overall Study||44||
59931363|NCT02858726|76049626|FG003|STARTED|Overall Study||45||
59931364|NCT02858726|76049623|FG000|COMPLETED|Overall Study||39||
59931365|NCT02858726|76049624|FG001|COMPLETED|Overall Study||35||
59518246|NCT03362944|75612051|FG000|STARTED|Second Intervention||8||
59518247|NCT03362944|75612052|FG001|STARTED|Second Intervention||8||
59518248|NCT03362944|75612051|FG000|COMPLETED|Second Intervention||8||
59931366|NCT02858726|76049625|FG002|COMPLETED|Overall Study||33||
59931367|NCT02858726|76049626|FG003|COMPLETED|Overall Study||42||
59931368|NCT02858726|76049623|FG000|NOT COMPLETED|Overall Study||5||
59518249|NCT03362944|75612052|FG001|COMPLETED|Second Intervention||8||
59518250|NCT03362944|75612051|FG000|NOT COMPLETED|Second Intervention||0||
59931369|NCT02858726|76049624|FG001|NOT COMPLETED|Overall Study||7||
59931370|NCT02858726|76049625|FG002|NOT COMPLETED|Overall Study||11||
59931371|NCT02858726|76049626|FG003|NOT COMPLETED|Overall Study||3||
59931372|NCT03203291|76049640|FG000|STARTED|Overall Study||12||
59931373|NCT03203291|76049640|FG000|COMPLETED|Overall Study||11||
59931374|NCT03203291|76049640|FG000|NOT COMPLETED|Overall Study||1||
59931375|NCT01068678|76049646|FG000|STARTED|Overall Study||230||
59931376|NCT01068678|76049647|FG001|STARTED|Overall Study||230||
60066792|NCT01991483|76182024|FG002|STARTED|Dose Level 600 mg|Multiple periods were added for each dose level to represent dose escalation.|11||
60066793|NCT01991483|76182025|FG003|STARTED|Dose Level 600 mg||0||
60066794|NCT01991483|76182022|FG000|Receive at Least One Dose of Study Drug|Dose Level 600 mg||0||
60066795|NCT01991483|76182023|FG001|Receive at Least One Dose of Study Drug|Dose Level 600 mg||0||
60066796|NCT01991483|76182024|FG002|Receive at Least One Dose of Study Drug|Dose Level 600 mg||11||
60066797|NCT01991483|76182025|FG003|Receive at Least One Dose of Study Drug|Dose Level 600 mg||0||
60066798|NCT01991483|76182022|FG000|COMPLETED|Dose Level 600 mg||0||
60066799|NCT01991483|76182023|FG001|COMPLETED|Dose Level 600 mg||0||
60066800|NCT01991483|76182024|FG002|COMPLETED|Dose Level 600 mg||9||
59931377|NCT01068678|76049646|FG000|Exposed|Overall Study|Three subjects withdrew prior to exposure to trial product.|227||
59931378|NCT01068678|76049647|FG001|Exposed|Overall Study|one subject withdrew prior to exposure to trial product|229||
59931379|NCT01068678|76049646|FG000|COMPLETED|Overall Study||192||
59931380|NCT01068678|76049647|FG001|COMPLETED|Overall Study||206||
59931381|NCT01068678|76049646|FG000|NOT COMPLETED|Overall Study||38||
60066801|NCT01991483|76182025|FG003|COMPLETED|Dose Level 600 mg||0||
60066802|NCT01991483|76182022|FG000|NOT COMPLETED|Dose Level 600 mg||0||
60066803|NCT01991483|76182023|FG001|NOT COMPLETED|Dose Level 600 mg||0||
60066804|NCT01991483|76182024|FG002|NOT COMPLETED|Dose Level 600 mg||2||
60066805|NCT01991483|76182025|FG003|NOT COMPLETED|Dose Level 600 mg||0||
60066806|NCT01991483|76182022|FG000|STARTED|Dose Level 1000 mg||0||
59931382|NCT01068678|76049647|FG001|NOT COMPLETED|Overall Study||24||
60066807|NCT01991483|76182023|FG001|STARTED|Dose Level 1000 mg||0||
60066808|NCT01991483|76182024|FG002|STARTED|Dose Level 1000 mg|Multiple periods were added for each dose level to represent dose escalation.|0||
60066809|NCT01991483|76182025|FG003|STARTED|Dose Level 1000 mg|Multiple periods were added for each dose level to represent dose escalation.|4||
60066810|NCT01991483|76182022|FG000|Received at Least One Dose of Study Drug|Dose Level 1000 mg||0||
60066811|NCT01991483|76182023|FG001|Received at Least One Dose of Study Drug|Dose Level 1000 mg||0||
60066812|NCT01991483|76182024|FG002|Received at Least One Dose of Study Drug|Dose Level 1000 mg||0||
60066813|NCT01991483|76182025|FG003|Received at Least One Dose of Study Drug|Dose Level 1000 mg||4||
60066814|NCT01991483|76182022|FG000|COMPLETED|Dose Level 1000 mg||0||
60066815|NCT01991483|76182023|FG001|COMPLETED|Dose Level 1000 mg||0||
60066816|NCT01991483|76182024|FG002|COMPLETED|Dose Level 1000 mg||0||
60066817|NCT01991483|76182025|FG003|COMPLETED|Dose Level 1000 mg||3||
60066818|NCT01991483|76182022|FG000|NOT COMPLETED|Dose Level 1000 mg||0||
60066819|NCT01991483|76182023|FG001|NOT COMPLETED|Dose Level 1000 mg||0||
60066820|NCT01991483|76182024|FG002|NOT COMPLETED|Dose Level 1000 mg||0||
60066821|NCT01991483|76182025|FG003|NOT COMPLETED|Dose Level 1000 mg||1||
60066822|NCT01410448|76182040|FG000|STARTED|Overall Study||193||
60066823|NCT01410448|76182041|FG001|STARTED|Overall Study||190||
60066824|NCT01410448|76182040|FG000|Intent-to Treat (ITT) Analysis Set|Overall Study||193||
60066825|NCT01410448|76182041|FG001|Intent-to Treat (ITT) Analysis Set|Overall Study||190||
60066826|NCT01410448|76182040|FG000|Modified ITT Analysis Set|Overall Study||161||
60066827|NCT01410448|76182041|FG001|Modified ITT Analysis Set|Overall Study||149||
60066828|NCT01410448|76182040|FG000|COMPLETED|Overall Study||181||
60066829|NCT01410448|76182041|FG001|COMPLETED|Overall Study||155||
60066830|NCT01410448|76182040|FG000|NOT COMPLETED|Overall Study||12||
60066831|NCT01410448|76182041|FG001|NOT COMPLETED|Overall Study||35||
60066832|NCT01943851|76182065|FG000|STARTED|Part 1 (Up to 86.9 Weeks)||1||
60066833|NCT01943851|76182066|FG001|STARTED|Part 1 (Up to 86.9 Weeks)||1||
60066834|NCT01943851|76182067|FG002|STARTED|Part 1 (Up to 86.9 Weeks)||1||
60066835|NCT01943851|76182068|FG003|STARTED|Part 1 (Up to 86.9 Weeks)||5||
59518251|NCT03362944|75612052|FG001|NOT COMPLETED|Second Intervention||0||
59931383|NCT03202511|76049653|FG000|STARTED|Overall Study||8||
59931384|NCT03202511|76049654|FG001|STARTED|Overall Study||7||
60066836|NCT01943851|76182069|FG004|STARTED|Part 1 (Up to 86.9 Weeks)||1||
60066837|NCT01943851|76182070|FG005|STARTED|Part 1 (Up to 86.9 Weeks)||4||
60066838|NCT01943851|76182071|FG006|STARTED|Part 1 (Up to 86.9 Weeks)||8||
60066839|NCT01943851|76182072|FG007|STARTED|Part 1 (Up to 86.9 Weeks)||18||
60066840|NCT01943851|76182073|FG008|STARTED|Part 1 (Up to 86.9 Weeks)||3||
60066841|NCT01943851|76182074|FG009|STARTED|Part 1 (Up to 86.9 Weeks)||8||
60066842|NCT01943851|76182075|FG010|STARTED|Part 1 (Up to 86.9 Weeks)||1||
60066843|NCT01943851|76182076|FG011|STARTED|Part 1 (Up to 86.9 Weeks)||7||
60066844|NCT01943851|76182077|FG012|STARTED|Part 1 (Up to 86.9 Weeks)||7||
59931385|NCT03202511|76049653|FG000|COMPLETED|Overall Study||7||
59931386|NCT03202511|76049654|FG001|COMPLETED|Overall Study||7||
59931387|NCT03202511|76049653|FG000|NOT COMPLETED|Overall Study||1||
59931388|NCT03202511|76049654|FG001|NOT COMPLETED|Overall Study||0||
59931389|NCT02960113|76049663|FG000|STARTED|Overall Study||80||
59931390|NCT02960113|76049664|FG001|STARTED|Overall Study||80||
59931391|NCT02960113|76049665|FG002|STARTED|Overall Study||80||
59931392|NCT02960113|76049663|FG000|COMPLETED|Overall Study||80||
60066845|NCT01943851|76182078|FG013|STARTED|Part 1 (Up to 86.9 Weeks)||16||
60066846|NCT01943851|76182079|FG014|STARTED|Part 1 (Up to 86.9 Weeks)||6||
60066847|NCT01943851|76182080|FG015|STARTED|Part 1 (Up to 86.9 Weeks)||0||
59931393|NCT02960113|76049664|FG001|COMPLETED|Overall Study||80||
60066848|NCT01943851|76182081|FG016|STARTED|Part 1 (Up to 86.9 Weeks)||0||
60066849|NCT01943851|76182082|FG017|STARTED|Part 1 (Up to 86.9 Weeks)||0||
60066850|NCT01943851|76182065|FG000|COMPLETED|Part 1 (Up to 86.9 Weeks)||1||
60066851|NCT01943851|76182066|FG001|COMPLETED|Part 1 (Up to 86.9 Weeks)||1||
60066852|NCT01943851|76182067|FG002|COMPLETED|Part 1 (Up to 86.9 Weeks)||1||
60066853|NCT01943851|76182068|FG003|COMPLETED|Part 1 (Up to 86.9 Weeks)||4||
60066854|NCT01943851|76182069|FG004|COMPLETED|Part 1 (Up to 86.9 Weeks)||0||
60066855|NCT01943851|76182070|FG005|COMPLETED|Part 1 (Up to 86.9 Weeks)||4||
60066856|NCT01943851|76182071|FG006|COMPLETED|Part 1 (Up to 86.9 Weeks)||7||
60066857|NCT01943851|76182072|FG007|COMPLETED|Part 1 (Up to 86.9 Weeks)||16||
60066858|NCT01943851|76182073|FG008|COMPLETED|Part 1 (Up to 86.9 Weeks)||2||
60066859|NCT01943851|76182074|FG009|COMPLETED|Part 1 (Up to 86.9 Weeks)||8||
60066860|NCT01943851|76182075|FG010|COMPLETED|Part 1 (Up to 86.9 Weeks)||1||
60066861|NCT01943851|76182076|FG011|COMPLETED|Part 1 (Up to 86.9 Weeks)||7||
60066862|NCT01943851|76182077|FG012|COMPLETED|Part 1 (Up to 86.9 Weeks)||7||
59518252|NCT03497026|75612058|FG000|STARTED|Overall Study||4||
59518253|NCT03497026|75612058|FG000|COMPLETED|Overall Study||4||
59518254|NCT03497026|75612058|FG000|NOT COMPLETED|Overall Study||0||
59518255|NCT02175979|75612064|FG000|STARTED|Overall Study||140||
59518256|NCT02175979|75612065|FG001|STARTED|Overall Study||140||
59518257|NCT02175979|75612064|FG000|COMPLETED|Overall Study||133||
59518258|NCT02175979|75612065|FG001|COMPLETED|Overall Study||132||
59518259|NCT02175979|75612064|FG000|NOT COMPLETED|Overall Study||7||
59518260|NCT02175979|75612065|FG001|NOT COMPLETED|Overall Study||8||
59518261|NCT03498196|75612071|FG000|STARTED|Overall Study||1||
59518262|NCT03498196|75612071|FG000|COMPLETED|Overall Study||1||
59518263|NCT03498196|75612071|FG000|NOT COMPLETED|Overall Study||0||
59518264|NCT03613519|75612078|FG000|STARTED|Baseline||115||
59518265|NCT03613519|75612079|FG001|STARTED|Baseline||108||
59518266|NCT03613519|75612080|FG002|STARTED|Baseline||110||
59518267|NCT03613519|75612078|FG000|COMPLETED|Baseline||113||
59613263|NCT01681836|75724419|FG001|COMPLETED|First Intervention||5||
59931394|NCT02960113|76049665|FG002|COMPLETED|Overall Study||80||
59931395|NCT02960113|76049663|FG000|NOT COMPLETED|Overall Study||0||
59931396|NCT02960113|76049664|FG001|NOT COMPLETED|Overall Study||0||
59931397|NCT02960113|76049665|FG002|NOT COMPLETED|Overall Study||0||
59931398|NCT02919696|76049675|FG000|STARTED|Overall Study||12||
59931399|NCT02919696|76049676|FG001|STARTED|Overall Study||14||
59931400|NCT02919696|76049675|FG000|Received at Least One Dose of Study Drug|Overall Study||12||
59931401|NCT02919696|76049676|FG001|Received at Least One Dose of Study Drug|Overall Study||13||
59931402|NCT02919696|76049675|FG000|PK 100 mg Abemaciclib Dose|Overall Study||5||
59931403|NCT02919696|76049676|FG001|PK 100 mg Abemaciclib Dose|Overall Study||0||
59931404|NCT02919696|76049675|FG000|PK 150 mg Abemaciclib Dose|Overall Study||0||
59931405|NCT02919696|76049676|FG001|PK 150 mg Abemaciclib Dose|Overall Study||2||
59931406|NCT02919696|76049675|FG000|Death On Treatment|Overall Study||1||
59931407|NCT02919696|76049676|FG001|Death On Treatment|Overall Study||0||
59931408|NCT02919696|76049675|FG000|Progressive Disease|Overall Study||7||
60066863|NCT01943851|76182078|FG013|COMPLETED|Part 1 (Up to 86.9 Weeks)||15||
60066864|NCT01943851|76182079|FG014|COMPLETED|Part 1 (Up to 86.9 Weeks)||6||
60066865|NCT01943851|76182080|FG015|COMPLETED|Part 1 (Up to 86.9 Weeks)||0||
60066866|NCT01943851|76182081|FG016|COMPLETED|Part 1 (Up to 86.9 Weeks)||0||
59518268|NCT03613519|75612079|FG001|COMPLETED|Baseline||85||
59518269|NCT03613519|75612080|FG002|COMPLETED|Baseline||100||
59518270|NCT03613519|75612078|FG000|NOT COMPLETED|Baseline||2||
59518271|NCT03613519|75612079|FG001|NOT COMPLETED|Baseline||23||
59518272|NCT03613519|75612080|FG002|NOT COMPLETED|Baseline||10||
59613264|NCT01681836|75724418|FG000|NOT COMPLETED|First Intervention||0||
59931409|NCT02919696|76049676|FG001|Progressive Disease|Overall Study||9||
59931410|NCT02919696|76049675|FG000|COMPLETED|Overall Study||8||
60066867|NCT01943851|76182082|FG017|COMPLETED|Part 1 (Up to 86.9 Weeks)||0||
59518273|NCT03613519|75612078|FG000|STARTED|Post -Intervention (9 Weeks)||113||
59931411|NCT02919696|76049676|FG001|COMPLETED|Overall Study||9||
59518274|NCT03613519|75612079|FG001|STARTED|Post -Intervention (9 Weeks)||85||
59518275|NCT03613519|75612080|FG002|STARTED|Post -Intervention (9 Weeks)||100||
60066868|NCT01943851|76182065|FG000|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0||
59931412|NCT02919696|76049675|FG000|NOT COMPLETED|Overall Study||4||
59931413|NCT02919696|76049676|FG001|NOT COMPLETED|Overall Study||5||
59931414|NCT02935673|76049691|FG000|STARTED|Overall Study||16||
59931415|NCT02935673|76049692|FG001|STARTED|Overall Study||27||
59931416|NCT02935673|76049693|FG002|STARTED|Overall Study||6||
59931417|NCT02935673|76049691|FG000|COMPLETED|Overall Study||15||
59931418|NCT02935673|76049692|FG001|COMPLETED|Overall Study||24||
59931419|NCT02935673|76049693|FG002|COMPLETED|Overall Study||6||
59931420|NCT02935673|76049691|FG000|NOT COMPLETED|Overall Study||1||
59931421|NCT02935673|76049692|FG001|NOT COMPLETED|Overall Study||3||
59931422|NCT02935673|76049693|FG002|NOT COMPLETED|Overall Study||0||
59931423|NCT03201809|76049705|FG000|STARTED|Overall Study||6||
59931424|NCT03201809|76049706|FG001|STARTED|Overall Study||6||
59931425|NCT03201809|76049705|FG000|COMPLETED|Overall Study||4||
59761466|NCT02393248|75881105|FG023|NOT COMPLETED|Part 2: Monotherapy Dose Expansion||0||
59761467|NCT02393248|75881106|FG024|NOT COMPLETED|Part 2: Monotherapy Dose Expansion||0||
59931426|NCT03201809|76049706|FG001|COMPLETED|Overall Study||6||
59931427|NCT03201809|76049705|FG000|NOT COMPLETED|Overall Study||2||
59931428|NCT03201809|76049706|FG001|NOT COMPLETED|Overall Study||0||
60066869|NCT01943851|76182066|FG001|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0||
60066870|NCT01943851|76182067|FG002|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0||
60066871|NCT01943851|76182068|FG003|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||1||
60066872|NCT01943851|76182069|FG004|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||1||
59761468|NCT02393248|75881082|FG000|STARTED|Part 3: Combination Therapy||0||
59761469|NCT02393248|75881083|FG001|STARTED|Part 3: Combination Therapy||0||
59761470|NCT02393248|75881084|FG002|STARTED|Part 3: Combination Therapy||0||
59761471|NCT02393248|75881085|FG003|STARTED|Part 3: Combination Therapy||0||
59761472|NCT02393248|75881086|FG004|STARTED|Part 3: Combination Therapy||0||
59761473|NCT02393248|75881087|FG005|STARTED|Part 3: Combination Therapy||0||
59761474|NCT02393248|75881088|FG006|STARTED|Part 3: Combination Therapy||0||
60066873|NCT01943851|76182070|FG005|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0||
59761475|NCT02393248|75881089|FG007|STARTED|Part 3: Combination Therapy||0||
59761476|NCT02393248|75881090|FG008|STARTED|Part 3: Combination Therapy||0||
59761477|NCT02393248|75881091|FG009|STARTED|Part 3: Combination Therapy||0||
59761478|NCT02393248|75881092|FG010|STARTED|Part 3: Combination Therapy||0||
59761479|NCT02393248|75881093|FG011|STARTED|Part 3: Combination Therapy||0||
59761480|NCT02393248|75881094|FG012|STARTED|Part 3: Combination Therapy||0||
59761481|NCT02393248|75881095|FG013|STARTED|Part 3: Combination Therapy||0||
59761482|NCT02393248|75881096|FG014|STARTED|Part 3: Combination Therapy||0||
59761483|NCT02393248|75881097|FG015|STARTED|Part 3: Combination Therapy||1||
59761484|NCT02393248|75881098|FG016|STARTED|Part 3: Combination Therapy||7||
59761485|NCT02393248|75881099|FG017|STARTED|Part 3: Combination Therapy||6||
59761486|NCT02393248|75881100|FG018|STARTED|Part 3: Combination Therapy||7||
59931429|NCT02858154|76049712|FG000|STARTED|HFNC 3-4 Hours||9||
59931430|NCT02858154|76049712|FG000|COMPLETED|HFNC 3-4 Hours||9||
59931431|NCT02858154|76049712|FG000|NOT COMPLETED|HFNC 3-4 Hours||0||
60066874|NCT01943851|76182071|FG006|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||1||
60066875|NCT01943851|76182072|FG007|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||2||
60066876|NCT01943851|76182073|FG008|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||1||
60066877|NCT01943851|76182074|FG009|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0||
59761487|NCT02393248|75881101|FG019|STARTED|Part 3: Combination Therapy||3||
59761488|NCT02393248|75881102|FG020|STARTED|Part 3: Combination Therapy||14||
59931432|NCT02858154|76049712|FG000|STARTED|Clinically Ordered PSG/Low Flow Oxygen||9||
59931433|NCT02858154|76049712|FG000|COMPLETED|Clinically Ordered PSG/Low Flow Oxygen||9||
59931434|NCT02858154|76049712|FG000|NOT COMPLETED|Clinically Ordered PSG/Low Flow Oxygen||0||
59931435|NCT02985450|76049717|FG000|STARTED|Overall Study||82||
60066878|NCT01943851|76182075|FG010|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0||
59518276|NCT03613519|75612078|FG000|COMPLETED|Post -Intervention (9 Weeks)||112||
59518277|NCT03613519|75612079|FG001|COMPLETED|Post -Intervention (9 Weeks)||79||
59518278|NCT03613519|75612080|FG002|COMPLETED|Post -Intervention (9 Weeks)||93||
59518279|NCT03613519|75612078|FG000|NOT COMPLETED|Post -Intervention (9 Weeks)||1||
59518280|NCT03613519|75612079|FG001|NOT COMPLETED|Post -Intervention (9 Weeks)||6||
59518281|NCT03613519|75612080|FG002|NOT COMPLETED|Post -Intervention (9 Weeks)||7||
59931436|NCT02985450|76049717|FG000|COMPLETED|Overall Study||75||
59931437|NCT02985450|76049717|FG000|NOT COMPLETED|Overall Study||7||
59518282|NCT03613519|75612078|FG000|STARTED|Long-term Follow-up (6 Months)||112||
59518283|NCT03613519|75612079|FG001|STARTED|Long-term Follow-up (6 Months)||79||
59518284|NCT03613519|75612080|FG002|STARTED|Long-term Follow-up (6 Months)||93||
59518285|NCT03613519|75612078|FG000|COMPLETED|Long-term Follow-up (6 Months)||112||
59518286|NCT03613519|75612079|FG001|COMPLETED|Long-term Follow-up (6 Months)||79||
59518287|NCT03613519|75612080|FG002|COMPLETED|Long-term Follow-up (6 Months)||93||
59518288|NCT03613519|75612078|FG000|NOT COMPLETED|Long-term Follow-up (6 Months)||0||
59518289|NCT03613519|75612079|FG001|NOT COMPLETED|Long-term Follow-up (6 Months)||0||
59518290|NCT03613519|75612080|FG002|NOT COMPLETED|Long-term Follow-up (6 Months)||0||
59518291|NCT03500302|75612090|FG000|STARTED|Overall Study||19||
60066879|NCT01943851|76182076|FG011|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0||
60066880|NCT01943851|76182077|FG012|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0||
60066881|NCT01943851|76182078|FG013|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||1||
60066882|NCT01943851|76182079|FG014|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0||
60066883|NCT01943851|76182080|FG015|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0||
60066884|NCT01943851|76182081|FG016|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0||
60066885|NCT01943851|76182082|FG017|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0||
59761489|NCT02393248|75881103|FG021|STARTED|Part 3: Combination Therapy||9||
59761490|NCT02393248|75881104|FG022|STARTED|Part 3: Combination Therapy||7||
59761491|NCT02393248|75881105|FG023|STARTED|Part 3: Combination Therapy||9||
59761492|NCT02393248|75881106|FG024|STARTED|Part 3: Combination Therapy||2||
59761493|NCT02393248|75881082|FG000|COMPLETED|Part 3: Combination Therapy||0||
59761494|NCT02393248|75881083|FG001|COMPLETED|Part 3: Combination Therapy||0||
59761495|NCT02393248|75881084|FG002|COMPLETED|Part 3: Combination Therapy||0||
59761496|NCT02393248|75881085|FG003|COMPLETED|Part 3: Combination Therapy||0||
59761497|NCT02393248|75881086|FG004|COMPLETED|Part 3: Combination Therapy||0||
59761498|NCT02393248|75881087|FG005|COMPLETED|Part 3: Combination Therapy||0||
59761499|NCT02393248|75881088|FG006|COMPLETED|Part 3: Combination Therapy||0||
59761500|NCT02393248|75881089|FG007|COMPLETED|Part 3: Combination Therapy||0||
59761501|NCT02393248|75881090|FG008|COMPLETED|Part 3: Combination Therapy||0||
59761502|NCT02393248|75881091|FG009|COMPLETED|Part 3: Combination Therapy||0||
59761503|NCT02393248|75881092|FG010|COMPLETED|Part 3: Combination Therapy||0||
59761504|NCT02393248|75881093|FG011|COMPLETED|Part 3: Combination Therapy||0||
59761505|NCT02393248|75881094|FG012|COMPLETED|Part 3: Combination Therapy||0||
59761506|NCT02393248|75881095|FG013|COMPLETED|Part 3: Combination Therapy||0||
59761507|NCT02393248|75881096|FG014|COMPLETED|Part 3: Combination Therapy||0||
59761508|NCT02393248|75881097|FG015|COMPLETED|Part 3: Combination Therapy||0||
59761509|NCT02393248|75881098|FG016|COMPLETED|Part 3: Combination Therapy||0||
59761510|NCT02393248|75881099|FG017|COMPLETED|Part 3: Combination Therapy||0||
59761511|NCT02393248|75881100|FG018|COMPLETED|Part 3: Combination Therapy||0||
59761512|NCT02393248|75881101|FG019|COMPLETED|Part 3: Combination Therapy||0||
59761513|NCT02393248|75881102|FG020|COMPLETED|Part 3: Combination Therapy||0||
59518292|NCT03500302|75612090|FG000|COMPLETED|Overall Study||19||
59518293|NCT03500302|75612090|FG000|NOT COMPLETED|Overall Study||0||
59518294|NCT02176837|75612094|FG000|STARTED|Overall Study||6||
59518295|NCT02176837|75612094|FG000|COMPLETED|Overall Study||0||
59931438|NCT02908464|76049726|FG000|STARTED|Overall Study||22||
59931439|NCT02908464|76049727|FG001|STARTED|Overall Study||23||
60066886|NCT01943851|76182065|FG000|STARTED|Part 2 (Up to 36.4 Weeks)||0||
60066887|NCT01943851|76182066|FG001|STARTED|Part 2 (Up to 36.4 Weeks)||0||
60066888|NCT01943851|76182067|FG002|STARTED|Part 2 (Up to 36.4 Weeks)||0||
60066889|NCT01943851|76182068|FG003|STARTED|Part 2 (Up to 36.4 Weeks)||0||
60066890|NCT01943851|76182069|FG004|STARTED|Part 2 (Up to 36.4 Weeks)||0||
60066891|NCT01943851|76182070|FG005|STARTED|Part 2 (Up to 36.4 Weeks)||0||
60066892|NCT01943851|76182071|FG006|STARTED|Part 2 (Up to 36.4 Weeks)||0||
60066893|NCT01943851|76182072|FG007|STARTED|Part 2 (Up to 36.4 Weeks)||0||
60066894|NCT01943851|76182073|FG008|STARTED|Part 2 (Up to 36.4 Weeks)||0||
59761514|NCT02393248|75881103|FG021|COMPLETED|Part 3: Combination Therapy||0||
59762689|NCT00868608|75882542|FG000|COMPLETED|Overall Study||49||
59931440|NCT02908464|76049726|FG000|COMPLETED|Overall Study||20||
59931441|NCT02908464|76049727|FG001|COMPLETED|Overall Study||20||
59931442|NCT02908464|76049726|FG000|NOT COMPLETED|Overall Study||2||
59931443|NCT02908464|76049727|FG001|NOT COMPLETED|Overall Study||3||
59931444|NCT02907216|76049736|FG000|STARTED|Overall Study||147||
60066895|NCT01943851|76182074|FG009|STARTED|Part 2 (Up to 36.4 Weeks)||0||
60066896|NCT01943851|76182075|FG010|STARTED|Part 2 (Up to 36.4 Weeks)||0||
59518296|NCT02176837|75612094|FG000|NOT COMPLETED|Overall Study||6||
59518297|NCT03501550|75612098|FG000|STARTED|Overall Study||12||
59518298|NCT03501550|75612098|FG000|COMPLETED|Overall Study||12||
59518299|NCT03501550|75612098|FG000|NOT COMPLETED|Overall Study||0||
60066897|NCT01943851|76182076|FG011|STARTED|Part 2 (Up to 36.4 Weeks)||0||
60066898|NCT01943851|76182077|FG012|STARTED|Part 2 (Up to 36.4 Weeks)||0||
60066899|NCT01943851|76182078|FG013|STARTED|Part 2 (Up to 36.4 Weeks)||0||
60066900|NCT01943851|76182079|FG014|STARTED|Part 2 (Up to 36.4 Weeks)||0||
60066901|NCT01943851|76182080|FG015|STARTED|Part 2 (Up to 36.4 Weeks)||7||
60066902|NCT01943851|76182081|FG016|STARTED|Part 2 (Up to 36.4 Weeks)||16||
60066903|NCT01943851|76182082|FG017|STARTED|Part 2 (Up to 36.4 Weeks)||1||
59518300|NCT03503578|75612102|FG000|STARTED|Overall Study||12||
59518301|NCT03503578|75612102|FG000|COMPLETED|Overall Study||12||
59518302|NCT03503578|75612102|FG000|NOT COMPLETED|Overall Study||0||
59518303|NCT03506386|75612106|FG000|STARTED|Overall Study||943||
59518304|NCT03506386|75612106|FG000|COMPLETED|Overall Study||943||
59518305|NCT03506386|75612106|FG000|NOT COMPLETED|Overall Study||0||
59518306|NCT03270514|75612112|FG000|STARTED|Overall Study||29||
59518307|NCT03270514|75612113|FG001|STARTED|Overall Study||31||
59518308|NCT03270514|75612112|FG000|COMPLETED|Overall Study||29||
59613265|NCT01681836|75724419|FG001|NOT COMPLETED|First Intervention||0||
59613266|NCT01681836|75724418|FG000|STARTED|Washout Period of 3-7 Days||6||
60066904|NCT01943851|76182065|FG000|COMPLETED|Part 2 (Up to 36.4 Weeks)||0||
59518309|NCT03270514|75612113|FG001|COMPLETED|Overall Study||31||
59518310|NCT03270514|75612112|FG000|NOT COMPLETED|Overall Study||0||
60066905|NCT01943851|76182066|FG001|COMPLETED|Part 2 (Up to 36.4 Weeks)||0||
60066906|NCT01943851|76182067|FG002|COMPLETED|Part 2 (Up to 36.4 Weeks)||0||
60066907|NCT01943851|76182068|FG003|COMPLETED|Part 2 (Up to 36.4 Weeks)||0||
60066908|NCT01943851|76182069|FG004|COMPLETED|Part 2 (Up to 36.4 Weeks)||0||
60066909|NCT01943851|76182070|FG005|COMPLETED|Part 2 (Up to 36.4 Weeks)||0||
60066910|NCT01943851|76182071|FG006|COMPLETED|Part 2 (Up to 36.4 Weeks)||0||
60066911|NCT01943851|76182072|FG007|COMPLETED|Part 2 (Up to 36.4 Weeks)||0||
60066912|NCT01943851|76182073|FG008|COMPLETED|Part 2 (Up to 36.4 Weeks)||0||
60066913|NCT01943851|76182074|FG009|COMPLETED|Part 2 (Up to 36.4 Weeks)||0||
60066914|NCT01943851|76182075|FG010|COMPLETED|Part 2 (Up to 36.4 Weeks)||0||
60066915|NCT01943851|76182076|FG011|COMPLETED|Part 2 (Up to 36.4 Weeks)||0||
60066916|NCT01943851|76182077|FG012|COMPLETED|Part 2 (Up to 36.4 Weeks)||0||
60066917|NCT01943851|76182078|FG013|COMPLETED|Part 2 (Up to 36.4 Weeks)||0||
60066918|NCT01943851|76182079|FG014|COMPLETED|Part 2 (Up to 36.4 Weeks)||0||
60066919|NCT01943851|76182080|FG015|COMPLETED|Part 2 (Up to 36.4 Weeks)||1||
60066920|NCT01943851|76182081|FG016|COMPLETED|Part 2 (Up to 36.4 Weeks)||13||
60066921|NCT01943851|76182082|FG017|COMPLETED|Part 2 (Up to 36.4 Weeks)||0||
60066922|NCT01943851|76182065|FG000|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0||
60066923|NCT01943851|76182066|FG001|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0||
60066924|NCT01943851|76182067|FG002|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0||
60066925|NCT01943851|76182068|FG003|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0||
60066926|NCT01943851|76182069|FG004|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0||
60066927|NCT01943851|76182070|FG005|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0||
60066928|NCT01943851|76182071|FG006|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0||
60066929|NCT01943851|76182072|FG007|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0||
60066930|NCT01943851|76182073|FG008|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0||
60066931|NCT01943851|76182074|FG009|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0||
60066932|NCT01943851|76182075|FG010|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0||
60066933|NCT01943851|76182076|FG011|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0||
60066934|NCT01943851|76182077|FG012|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0||
60066935|NCT01943851|76182078|FG013|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0||
60066936|NCT01943851|76182079|FG014|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0||
60066937|NCT01943851|76182080|FG015|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||6||
60066938|NCT01943851|76182081|FG016|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||3||
60066939|NCT01943851|76182082|FG017|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||1||
60066940|NCT01430104|76182123|FG000|STARTED|14-Day Lead-In Period||30||
60066941|NCT01430104|76182123|FG000|COMPLETED|14-Day Lead-In Period||30||
60066942|NCT01430104|76182123|FG000|NOT COMPLETED|14-Day Lead-In Period||0||
59613267|NCT01681836|75724419|FG001|STARTED|Washout Period of 3-7 Days||5||
59613268|NCT01681836|75724418|FG000|COMPLETED|Washout Period of 3-7 Days||6||
60066943|NCT01430104|76182123|FG000|STARTED|28-Day Teriparatide Treatment Period|1 participant withdrew from the study after completing the 14-day Lead-in Period.|29||
60066944|NCT01430104|76182123|FG000|Received at Least 1 Dose of Teriparatide|28-Day Teriparatide Treatment Period||29||
60066945|NCT01430104|76182123|FG000|COMPLETED|28-Day Teriparatide Treatment Period||28||
60066946|NCT01430104|76182123|FG000|NOT COMPLETED|28-Day Teriparatide Treatment Period||1||
60066947|NCT01990859|76182130|FG000|STARTED|Treatment (4 Doses Over 12 Weeks)||20||
60066948|NCT01990859|76182130|FG000|COMPLETED|Treatment (4 Doses Over 12 Weeks)||15||
60066949|NCT01990859|76182130|FG000|NOT COMPLETED|Treatment (4 Doses Over 12 Weeks)||5||
60066950|NCT01990859|76182130|FG000|STARTED|Week 12 to Week 24 Post Dosing Follow Up|All were entered into follow-up whether dosing was completed or not.|20||
60066951|NCT01990859|76182130|FG000|COMPLETED|Week 12 to Week 24 Post Dosing Follow Up||3||
60066952|NCT01990859|76182130|FG000|NOT COMPLETED|Week 12 to Week 24 Post Dosing Follow Up||17||
60066953|NCT01990859|76182130|FG000|STARTED|90 Day Follow Up for All Participants|All entered into 90 day follow-up whether treatment and/or post dose follow up was completed or not.|20||
60066954|NCT01990859|76182130|FG000|COMPLETED|90 Day Follow Up for All Participants||20||
59518311|NCT03270514|75612113|FG001|NOT COMPLETED|Overall Study||0||
60066955|NCT01990859|76182130|FG000|NOT COMPLETED|90 Day Follow Up for All Participants||0||
60066956|NCT02093897|76182135|FG000|STARTED|Overall Study||84|A total of 5313 CSL627 infusions were administered to 84 subjects during the study.|
60066957|NCT02093897|76182135|FG000|COMPLETED|Overall Study||65|As planned, groups were closed and subjects discontinued when 25 subjects reached 50 EDs per group.|
60066958|NCT02093897|76182135|FG000|NOT COMPLETED|Overall Study||19||
60066959|NCT01990313|76182146|FG000|STARTED|Overall Study||15||
60066960|NCT01990313|76182146|FG000|COMPLETED|Overall Study||14||
60066961|NCT01990313|76182146|FG000|NOT COMPLETED|Overall Study||1||
60066962|NCT01947517|76182152|FG000|STARTED|Overall Study||26||
60066963|NCT01947517|76182153|FG001|STARTED|Overall Study||26||
60066964|NCT01947517|76182152|FG000|COMPLETED|Overall Study||25||
60066965|NCT01947517|76182153|FG001|COMPLETED|Overall Study||25||
60066966|NCT01947517|76182152|FG000|NOT COMPLETED|Overall Study||1||
60066967|NCT01947517|76182153|FG001|NOT COMPLETED|Overall Study||1||
60066968|NCT02006927|76182159|FG000|STARTED|Overall Study||3||
60066969|NCT02006927|76182159|FG000|COMPLETED|Overall Study||0||
60066970|NCT02006927|76182159|FG000|NOT COMPLETED|Overall Study||3||
60066971|NCT01947283|76182170|FG000|STARTED|Overall Study||89||
60066972|NCT01947283|76182171|FG001|STARTED|Overall Study||68||
60066973|NCT01947283|76182172|FG002|STARTED|Overall Study||83||
60066974|NCT01947283|76182173|FG003|STARTED|Overall Study||72||
60066975|NCT01947283|76182174|FG004|STARTED|Overall Study||95||
60066976|NCT01947283|76182175|FG005|STARTED|Overall Study||34||
60066977|NCT01947283|76182176|FG006|STARTED|Overall Study||40||
60066978|NCT01947283|76182170|FG000|Baseline Assessment|Overall Study||89||
60066979|NCT01947283|76182171|FG001|Baseline Assessment|Overall Study||68||
60066980|NCT01947283|76182172|FG002|Baseline Assessment|Overall Study||83||
60066981|NCT01947283|76182173|FG003|Baseline Assessment|Overall Study||72||
60066982|NCT01947283|76182174|FG004|Baseline Assessment|Overall Study||0||
60066983|NCT01947283|76182175|FG005|Baseline Assessment|Overall Study||34||
60066984|NCT01947283|76182176|FG006|Baseline Assessment|Overall Study||40||
59518312|NCT03277378|75612121|FG000|STARTED|Overall Study||135||
59518313|NCT03277378|75612122|FG001|STARTED|Overall Study||135||
59518314|NCT03277378|75612121|FG000|Received Lead Implant|Overall Study||129||
59518315|NCT03277378|75612122|FG001|Received Lead Implant|Overall Study||123||
59518316|NCT03277378|75612121|FG000|Completed Initial Trial|Overall Study||126||
59518317|NCT03277378|75612122|FG001|Completed Initial Trial|Overall Study||122||
59518318|NCT03277378|75612121|FG000|Qualified for Permanent Implant|Overall Study||103||
59518319|NCT03277378|75612122|FG001|Qualified for Permanent Implant|Overall Study||93||
59613269|NCT01681836|75724419|FG001|COMPLETED|Washout Period of 3-7 Days||5||
59613270|NCT01681836|75724418|FG000|NOT COMPLETED|Washout Period of 3-7 Days||0||
59613271|NCT01681836|75724419|FG001|NOT COMPLETED|Washout Period of 3-7 Days||0||
59613272|NCT01681836|75724418|FG000|STARTED|Second Intervention||6||
59613273|NCT01681836|75724419|FG001|STARTED|Second Intervention||5||
59613274|NCT01681836|75724418|FG000|COMPLETED|Second Intervention||6||
59613275|NCT01681836|75724419|FG001|COMPLETED|Second Intervention||4||
59613276|NCT01681836|75724418|FG000|NOT COMPLETED|Second Intervention||0||
59613277|NCT01681836|75724419|FG001|NOT COMPLETED|Second Intervention||1||
60066985|NCT01947283|76182170|FG000|Follow-up Assessment|Overall Study||64||
60066986|NCT01947283|76182171|FG001|Follow-up Assessment|Overall Study||51||
60066987|NCT01947283|76182172|FG002|Follow-up Assessment|Overall Study||65||
60066988|NCT01947283|76182173|FG003|Follow-up Assessment|Overall Study||59||
60066989|NCT01947283|76182174|FG004|Follow-up Assessment|Overall Study||0||
60066990|NCT01947283|76182175|FG005|Follow-up Assessment|Overall Study||27||
60066991|NCT01947283|76182176|FG006|Follow-up Assessment|Overall Study||36||
60066992|NCT01947283|76182170|FG000|Clinical Recording|Overall Study||65||
60066993|NCT01947283|76182171|FG001|Clinical Recording|Overall Study||54||
60066994|NCT01947283|76182172|FG002|Clinical Recording|Overall Study||68||
59518320|NCT03277378|75612121|FG000|Not Qualified for Permanent Implant|Overall Study||19||
60066995|NCT01947283|76182173|FG003|Clinical Recording|Overall Study||57||
60066996|NCT01947283|76182174|FG004|Clinical Recording|Overall Study||0||
60066997|NCT01947283|76182175|FG005|Clinical Recording|Overall Study||0||
60066998|NCT01947283|76182176|FG006|Clinical Recording|Overall Study||0||
60066999|NCT01947283|76182170|FG000|End-of-Intervention Assessment|Overall Study||74||
60067000|NCT01947283|76182171|FG001|End-of-Intervention Assessment|Overall Study||53||
60067001|NCT01947283|76182172|FG002|End-of-Intervention Assessment|Overall Study||73||
60067002|NCT01947283|76182173|FG003|End-of-Intervention Assessment|Overall Study||66||
60067003|NCT01947283|76182174|FG004|End-of-Intervention Assessment|Overall Study||0||
60067004|NCT01947283|76182175|FG005|End-of-Intervention Assessment|Overall Study||32||
60067005|NCT01947283|76182176|FG006|End-of-Intervention Assessment|Overall Study||33||
60067006|NCT01947283|76182170|FG000|In Analysis|Overall Study||89||
60067007|NCT01947283|76182171|FG001|In Analysis|Overall Study||68||
60067008|NCT01947283|76182172|FG002|In Analysis|Overall Study||83||
60067009|NCT01947283|76182173|FG003|In Analysis|Overall Study||72||
60067010|NCT01947283|76182174|FG004|In Analysis|Overall Study||95||
60067011|NCT01947283|76182175|FG005|In Analysis|Overall Study||30||
60067012|NCT01947283|76182176|FG006|In Analysis|Overall Study||38||
60067013|NCT01947283|76182170|FG000|Completed NRCT Baseline Assessment|Overall Study||0||
60067014|NCT01947283|76182171|FG001|Completed NRCT Baseline Assessment|Overall Study||0||
60067015|NCT01947283|76182172|FG002|Completed NRCT Baseline Assessment|Overall Study||0||
60067016|NCT01947283|76182173|FG003|Completed NRCT Baseline Assessment|Overall Study||0||
60067017|NCT01947283|76182174|FG004|Completed NRCT Baseline Assessment|Overall Study||95||
60067018|NCT01947283|76182175|FG005|Completed NRCT Baseline Assessment|Overall Study||0||
60067019|NCT01947283|76182176|FG006|Completed NRCT Baseline Assessment|Overall Study||0||
60067020|NCT01947283|76182170|FG000|COMPLETED|Overall Study||60||
60067021|NCT01947283|76182171|FG001|COMPLETED|Overall Study||45||
60067022|NCT01947283|76182172|FG002|COMPLETED|Overall Study||62||
60067023|NCT01947283|76182173|FG003|COMPLETED|Overall Study||55||
60067024|NCT01947283|76182174|FG004|COMPLETED|Overall Study||95||
60067025|NCT01947283|76182175|FG005|COMPLETED|Overall Study||27||
60067026|NCT01947283|76182176|FG006|COMPLETED|Overall Study||32||
60067027|NCT01947283|76182170|FG000|NOT COMPLETED|Overall Study||29||
60067028|NCT01947283|76182171|FG001|NOT COMPLETED|Overall Study||23||
60067029|NCT01947283|76182172|FG002|NOT COMPLETED|Overall Study||21||
60067030|NCT01947283|76182173|FG003|NOT COMPLETED|Overall Study||17||
60067031|NCT01947283|76182174|FG004|NOT COMPLETED|Overall Study||0||
60067032|NCT01947283|76182175|FG005|NOT COMPLETED|Overall Study||7||
60067033|NCT01947283|76182176|FG006|NOT COMPLETED|Overall Study||8||
60067034|NCT02006693|76182195|FG000|STARTED|Overall Study||112||120
60067035|NCT02006693|76182196|FG001|STARTED|Overall Study||87||98
60067036|NCT02006693|76182195|FG000|COMPLETED|Overall Study||84||91
60067037|NCT02006693|76182196|FG001|COMPLETED|Overall Study||74||83
60067038|NCT02006693|76182195|FG000|NOT COMPLETED|Overall Study||28||29
60067039|NCT02006693|76182196|FG001|NOT COMPLETED|Overall Study||13||15
60067040|NCT01947127|76182204|FG000|STARTED|Overall Study||166||
60067041|NCT01947127|76182205|FG001|STARTED|Overall Study||292||
60067042|NCT01947127|76182204|FG000|COMPLETED|Overall Study||143||
60067043|NCT01947127|76182205|FG001|COMPLETED|Overall Study||249||
60067044|NCT01947127|76182204|FG000|NOT COMPLETED|Overall Study||23||
60067045|NCT01947127|76182205|FG001|NOT COMPLETED|Overall Study||43||
60067046|NCT01976845|76182214|FG000|STARTED|Overall Study||48||
60067047|NCT01976845|76182215|FG001|STARTED|Overall Study||48||
60067048|NCT01976845|76182216|FG002|STARTED|Overall Study||43||
60067049|NCT01976845|76182214|FG000|COMPLETED|Overall Study||40||
60067050|NCT01976845|76182215|FG001|COMPLETED|Overall Study||40||
60067051|NCT01976845|76182216|FG002|COMPLETED|Overall Study||40||
60067052|NCT01976845|76182214|FG000|NOT COMPLETED|Overall Study||8||
60067053|NCT01976845|76182215|FG001|NOT COMPLETED|Overall Study||8||
60067054|NCT01976845|76182216|FG002|NOT COMPLETED|Overall Study||3||
60067055|NCT01989689|76182226|FG000|STARTED|Baseline||11||
60067056|NCT01989689|76182227|FG001|STARTED|Baseline||13||
60067057|NCT01989689|76182226|FG000|COMPLETED|Baseline||11||
60067058|NCT01989689|76182227|FG001|COMPLETED|Baseline||13||
60067059|NCT01989689|76182226|FG000|NOT COMPLETED|Baseline||0||
60067060|NCT01989689|76182227|FG001|NOT COMPLETED|Baseline||0||
60067061|NCT01989689|76182226|FG000|STARTED|Treatment Period 1 ( 3 Months)||11||
60067062|NCT01989689|76182227|FG001|STARTED|Treatment Period 1 ( 3 Months)||13||
60067063|NCT01989689|76182226|FG000|COMPLETED|Treatment Period 1 ( 3 Months)||11||
60067064|NCT01989689|76182227|FG001|COMPLETED|Treatment Period 1 ( 3 Months)||10||
60067065|NCT01989689|76182226|FG000|NOT COMPLETED|Treatment Period 1 ( 3 Months)||0||
60067066|NCT01989689|76182227|FG001|NOT COMPLETED|Treatment Period 1 ( 3 Months)||3||
60067067|NCT01989689|76182226|FG000|STARTED|Treatment Period ( 3 Months)||11||
60067068|NCT01989689|76182227|FG001|STARTED|Treatment Period ( 3 Months)||10||
60067069|NCT01989689|76182226|FG000|COMPLETED|Treatment Period ( 3 Months)||11||
60067070|NCT01989689|76182227|FG001|COMPLETED|Treatment Period ( 3 Months)||10||
60067071|NCT01989689|76182226|FG000|NOT COMPLETED|Treatment Period ( 3 Months)||0||
60067072|NCT01989689|76182227|FG001|NOT COMPLETED|Treatment Period ( 3 Months)||0||
60067073|NCT01943539|76182235|FG000|STARTED|Overall Study||44||
60067074|NCT01943539|76182236|FG001|STARTED|Overall Study||40||
60067075|NCT01943539|76182235|FG000|COMPLETED|Overall Study||40||
60067076|NCT01943539|76182236|FG001|COMPLETED|Overall Study||40||
60067077|NCT01943539|76182235|FG000|NOT COMPLETED|Overall Study||4||
60067078|NCT01943539|76182236|FG001|NOT COMPLETED|Overall Study||0||
60067079|NCT01942993|76182243|FG000|STARTED|Overall Study||3||
60067080|NCT01942993|76182243|FG000|COMPLETED|Overall Study||1||
60067081|NCT01942993|76182243|FG000|NOT COMPLETED|Overall Study||2||
60067082|NCT01989455|76182252|FG000|STARTED|Overall Study||14||
60067083|NCT01989455|76182253|FG001|STARTED|Overall Study||14||
60067084|NCT01989455|76182254|FG002|STARTED|Overall Study||14||
60067085|NCT01989455|76182255|FG003|STARTED|Overall Study||14||
60067086|NCT01989455|76182256|FG004|STARTED|Overall Study||8||
60067087|NCT01989455|76182252|FG000|COMPLETED|Overall Study||14||
60067088|NCT01989455|76182253|FG001|COMPLETED|Overall Study||12||
60067089|NCT01989455|76182254|FG002|COMPLETED|Overall Study||13||
60067090|NCT01989455|76182255|FG003|COMPLETED|Overall Study||14||
60067091|NCT01989455|76182256|FG004|COMPLETED|Overall Study||7||
60067092|NCT01989455|76182252|FG000|NOT COMPLETED|Overall Study||0||
60067093|NCT01989455|76182253|FG001|NOT COMPLETED|Overall Study||2||
60067094|NCT01989455|76182254|FG002|NOT COMPLETED|Overall Study||1||
60067095|NCT01989455|76182255|FG003|NOT COMPLETED|Overall Study||0||
60067096|NCT01989455|76182256|FG004|NOT COMPLETED|Overall Study||1||
60067097|NCT01942837|76182272|FG000|STARTED|Overall Study||67||
60067098|NCT01942837|76182272|FG000|COMPLETED|Overall Study||0||
60067099|NCT01942837|76182272|FG000|NOT COMPLETED|Overall Study||67||
60067100|NCT01987895|76182279|FG000|STARTED|Overall Study||306||
60067101|NCT01987895|76182280|FG001|STARTED|Overall Study||326||
60067102|NCT01987895|76182279|FG000|COMPLETED|Overall Study||276|Include subjects who completed the main study + subjects who completed the re-treatment extension.|
60067103|NCT01987895|76182280|FG001|COMPLETED|Overall Study||296|Include subjects who completed the main study + subjects who completed the re-treatment extension.|
60067104|NCT01987895|76182279|FG000|NOT COMPLETED|Overall Study||30||
60067105|NCT01987895|76182280|FG001|NOT COMPLETED|Overall Study||30||
60067106|NCT02005445|76182288|FG000|STARTED|Overall Study||2||
60067107|NCT02005445|76182289|FG001|STARTED|Overall Study||2||
60067108|NCT02005445|76182288|FG000|COMPLETED|Overall Study||2||
60067109|NCT02005445|76182289|FG001|COMPLETED|Overall Study||1||
60067110|NCT02005445|76182288|FG000|NOT COMPLETED|Overall Study||0||
60067111|NCT02005445|76182289|FG001|NOT COMPLETED|Overall Study||1||
60067112|NCT01618669|76182297|FG000|STARTED|Overall Study||578||
60067113|NCT01618669|76182298|FG001|STARTED|Overall Study||569||
60067114|NCT01618669|76182297|FG000|Received Treatment|Overall Study||575||
60067115|NCT01618669|76182298|FG001|Received Treatment|Overall Study||567||
60067116|NCT01618669|76182297|FG000|COMPLETED|Overall Study||544||
60067117|NCT01618669|76182298|FG001|COMPLETED|Overall Study||546||
60067118|NCT01618669|76182297|FG000|NOT COMPLETED|Overall Study||34||
60067119|NCT01618669|76182298|FG001|NOT COMPLETED|Overall Study||23||
60067120|NCT01390948|76182319|FG000|STARTED|Overall Study||59||
60067121|NCT01390948|76182320|FG001|STARTED|Overall Study||62||
60067122|NCT01390948|76182321|FG002|STARTED|Overall Study||3||
60067123|NCT01390948|76182319|FG000|Treated|Overall Study||56||
60067124|NCT01390948|76182320|FG001|Treated|Overall Study||60||
60067125|NCT01390948|76182321|FG002|Treated|Overall Study||3||
60067126|NCT01390948|76182319|FG000|COMPLETED|Overall Study||44||
60067127|NCT01390948|76182320|FG001|COMPLETED|Overall Study||44||
60067128|NCT01390948|76182321|FG002|COMPLETED|Overall Study||2||
60067129|NCT01390948|76182319|FG000|NOT COMPLETED|Overall Study||15||
60067130|NCT01390948|76182320|FG001|NOT COMPLETED|Overall Study||18||
60067131|NCT01390948|76182321|FG002|NOT COMPLETED|Overall Study||1||
60067132|NCT02005211|76182335|FG000|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||6||
60067133|NCT02005211|76182336|FG001|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||6||
60067134|NCT02005211|76182337|FG002|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||6||
60067135|NCT02005211|76182338|FG003|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||6||
60067136|NCT02005211|76182339|FG004|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||0||
60067137|NCT02005211|76182340|FG005|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||0||
60067138|NCT02005211|76182341|FG006|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||0||
59613278|NCT01681368|75724425|FG000|STARTED|Overall Study||11||
60067139|NCT02005211|76182335|FG000|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||6||
60067140|NCT02005211|76182336|FG001|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||6||
60067141|NCT02005211|76182337|FG002|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||6||
59613279|NCT01681368|75724425|FG000|COMPLETED|Overall Study||9||
59613280|NCT01681368|75724425|FG000|NOT COMPLETED|Overall Study||2||
60067142|NCT02005211|76182338|FG003|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||6||
60067143|NCT02005211|76182339|FG004|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0||
60067144|NCT02005211|76182340|FG005|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0||
60067145|NCT02005211|76182341|FG006|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0||
60067146|NCT02005211|76182335|FG000|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0||
60067147|NCT02005211|76182336|FG001|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0||
60067148|NCT02005211|76182337|FG002|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0||
60067149|NCT02005211|76182338|FG003|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0||
60067150|NCT02005211|76182339|FG004|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0||
60067151|NCT02005211|76182340|FG005|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0||
60067152|NCT02005211|76182341|FG006|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0||
60067153|NCT02005211|76182335|FG000|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||0||
60067154|NCT02005211|76182336|FG001|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||0||
60067155|NCT02005211|76182337|FG002|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||0||
60067156|NCT02005211|76182338|FG003|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||0||
60067157|NCT02005211|76182339|FG004|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||6||
60067158|NCT02005211|76182340|FG005|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||6||
60067159|NCT02005211|76182341|FG006|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||4||
60067160|NCT02005211|76182335|FG000|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0||
60067161|NCT02005211|76182336|FG001|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0||
60067162|NCT02005211|76182337|FG002|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0||
60067163|NCT02005211|76182338|FG003|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0||
60067164|NCT02005211|76182339|FG004|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||5||
60067165|NCT02005211|76182340|FG005|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||6||
60067166|NCT02005211|76182341|FG006|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||4||
60067167|NCT02005211|76182335|FG000|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0||
60067168|NCT02005211|76182336|FG001|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0||
60067169|NCT02005211|76182337|FG002|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0||
60067170|NCT02005211|76182338|FG003|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0||
60067171|NCT02005211|76182339|FG004|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||1||
60067172|NCT02005211|76182340|FG005|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0||
60067173|NCT02005211|76182341|FG006|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0||
60067174|NCT01429792|76182364|FG000|STARTED|Overall Study||1013||
60067175|NCT01429792|76182364|FG000|Genotype 1|Overall Study||687||
60067176|NCT01429792|76182364|FG000|Genotype 2 & 3|Overall Study||305||
60067177|NCT01429792|76182364|FG000|Genotype 4|Overall Study||5||
60067178|NCT01429792|76182364|FG000|COMPLETED|Overall Study||607||
60067179|NCT01429792|76182364|FG000|NOT COMPLETED|Overall Study||406||
60067180|NCT01409434|76182368|FG000|STARTED|Overall Study||44||
60067181|NCT01409434|76182368|FG000|COMPLETED|Overall Study||40||
60067182|NCT01409434|76182368|FG000|NOT COMPLETED|Overall Study||4||
60067183|NCT01940887|76182374|FG000|STARTED|Year 1||322||
60067184|NCT01940887|76182375|FG001|STARTED|Year 1||320||
60067185|NCT01940887|76182374|FG000|COMPLETED|Year 1||283||
59931445|NCT02907216|76049737|FG001|STARTED|Overall Study||145||
59931446|NCT02907216|76049736|FG000|COMPLETED|Overall Study||146||
59931447|NCT02907216|76049737|FG001|COMPLETED|Overall Study||144||
59931448|NCT02907216|76049736|FG000|NOT COMPLETED|Overall Study||1||
60067186|NCT01940887|76182375|FG001|COMPLETED|Year 1||297||
60067187|NCT01940887|76182374|FG000|NOT COMPLETED|Year 1||39||
59761515|NCT02393248|75881104|FG022|COMPLETED|Part 3: Combination Therapy||0||
59761516|NCT02393248|75881105|FG023|COMPLETED|Part 3: Combination Therapy||1||
59761517|NCT02393248|75881106|FG024|COMPLETED|Part 3: Combination Therapy||1||
59761518|NCT02393248|75881082|FG000|NOT COMPLETED|Part 3: Combination Therapy||0||
59761519|NCT02393248|75881083|FG001|NOT COMPLETED|Part 3: Combination Therapy||0||
59761520|NCT02393248|75881084|FG002|NOT COMPLETED|Part 3: Combination Therapy||0||
59761521|NCT02393248|75881085|FG003|NOT COMPLETED|Part 3: Combination Therapy||0||
59761522|NCT02393248|75881086|FG004|NOT COMPLETED|Part 3: Combination Therapy||0||
59761523|NCT02393248|75881087|FG005|NOT COMPLETED|Part 3: Combination Therapy||0||
59761524|NCT02393248|75881088|FG006|NOT COMPLETED|Part 3: Combination Therapy||0||
59761525|NCT02393248|75881089|FG007|NOT COMPLETED|Part 3: Combination Therapy||0||
59761526|NCT02393248|75881090|FG008|NOT COMPLETED|Part 3: Combination Therapy||0||
59761527|NCT02393248|75881091|FG009|NOT COMPLETED|Part 3: Combination Therapy||0||
59931449|NCT02907216|76049737|FG001|NOT COMPLETED|Overall Study||1||
59931450|NCT02984982|76049745|FG000|STARTED|Overall Study||102||
59931451|NCT02984982|76049746|FG001|STARTED|Overall Study||104||
59931452|NCT02984982|76049745|FG000|Treated|Overall Study||102||
59931453|NCT02984982|76049746|FG001|Treated|Overall Study||103||
59931454|NCT02984982|76049745|FG000|COMPLETED|Overall Study||94||
60067188|NCT01940887|76182375|FG001|NOT COMPLETED|Year 1||23||
60067189|NCT01940887|76182374|FG000|STARTED|Year 2||283||
60067190|NCT01940887|76182375|FG001|STARTED|Year 2||297||
60067191|NCT01940887|76182374|FG000|COMPLETED|Year 2||66||
60067192|NCT01940887|76182375|FG001|COMPLETED|Year 2||75||
60067193|NCT01940887|76182374|FG000|NOT COMPLETED|Year 2||217||
60067194|NCT01940887|76182375|FG001|NOT COMPLETED|Year 2||222||
60067195|NCT01925612|76182386|FG000|STARTED|Overall Study||29||
60067196|NCT01925612|76182387|FG001|STARTED|Overall Study||22||
60067197|NCT01925612|76182388|FG002|STARTED|Overall Study||11||
60067198|NCT01925612|76182389|FG003|STARTED|Overall Study||11||
60067199|NCT01925612|76182390|FG004|STARTED|Overall Study||12||
60067200|NCT01925612|76182386|FG000|COMPLETED|Overall Study||25||
60067201|NCT01925612|76182387|FG001|COMPLETED|Overall Study||18||
60067202|NCT01925612|76182388|FG002|COMPLETED|Overall Study||10||
59761528|NCT02393248|75881092|FG010|NOT COMPLETED|Part 3: Combination Therapy||0||
59761529|NCT02393248|75881093|FG011|NOT COMPLETED|Part 3: Combination Therapy||0||
59761530|NCT02393248|75881094|FG012|NOT COMPLETED|Part 3: Combination Therapy||0||
59761531|NCT02393248|75881095|FG013|NOT COMPLETED|Part 3: Combination Therapy||0||
59761532|NCT02393248|75881096|FG014|NOT COMPLETED|Part 3: Combination Therapy||0||
59761533|NCT02393248|75881097|FG015|NOT COMPLETED|Part 3: Combination Therapy||1||
59761534|NCT02393248|75881098|FG016|NOT COMPLETED|Part 3: Combination Therapy||7||
59931455|NCT02984982|76049746|FG001|COMPLETED|Overall Study||94||
59931456|NCT02984982|76049745|FG000|NOT COMPLETED|Overall Study||8||
59931457|NCT02984982|76049746|FG001|NOT COMPLETED|Overall Study||10||
59931458|NCT02981472|76049755|FG000|STARTED|Pre-Treatment Period||129||
59761535|NCT02393248|75881099|FG017|NOT COMPLETED|Part 3: Combination Therapy||6||
59761536|NCT02393248|75881100|FG018|NOT COMPLETED|Part 3: Combination Therapy||7||
59761537|NCT02393248|75881101|FG019|NOT COMPLETED|Part 3: Combination Therapy||3||
59761538|NCT02393248|75881102|FG020|NOT COMPLETED|Part 3: Combination Therapy||14||
59761539|NCT02393248|75881103|FG021|NOT COMPLETED|Part 3: Combination Therapy||9||
59761540|NCT02393248|75881104|FG022|NOT COMPLETED|Part 3: Combination Therapy||7||
59761541|NCT02393248|75881105|FG023|NOT COMPLETED|Part 3: Combination Therapy||8||
59761542|NCT02393248|75881106|FG024|NOT COMPLETED|Part 3: Combination Therapy||1||
59761543|NCT00601484|75881169|FG000|STARTED|Overall Study||34||
59761544|NCT00601484|75881170|FG001|STARTED|Overall Study||31||
59931459|NCT02981472|76049756|FG001|STARTED|Pre-Treatment Period||63||
59931460|NCT02981472|76049755|FG000|COMPLETED|Pre-Treatment Period||126||
59931461|NCT02981472|76049756|FG001|COMPLETED|Pre-Treatment Period||62||
59931462|NCT02981472|76049755|FG000|NOT COMPLETED|Pre-Treatment Period||3||
59761545|NCT00601484|75881169|FG000|Treated|Overall Study||34||
59931463|NCT02981472|76049756|FG001|NOT COMPLETED|Pre-Treatment Period||1||
59931464|NCT02981472|76049755|FG000|STARTED|Treatment Period||126||
59931465|NCT02981472|76049756|FG001|STARTED|Treatment Period||62||
59931466|NCT02981472|76049755|FG000|COMPLETED|Treatment Period||119|completed treatment for up to 12 months or until anticoagulation is no longer needed, whichever is shorter|
59931467|NCT02981472|76049756|FG001|COMPLETED|Treatment Period||60|completed treatment for up to 12 months or until anticoagulation is no longer needed, whichever is shorter|
59931468|NCT02981472|76049755|FG000|NOT COMPLETED|Treatment Period||7||
59931469|NCT02981472|76049756|FG001|NOT COMPLETED|Treatment Period||2||
59931470|NCT02982720|76049768|FG000|STARTED|Overall Study||4||
59931471|NCT02982720|76049768|FG000|COMPLETED|Overall Study||0||
59931472|NCT02982720|76049768|FG000|NOT COMPLETED|Overall Study||4||
59931473|NCT00849667|76049775|FG000|STARTED|Overall Study||370||
60067203|NCT01925612|76182389|FG003|COMPLETED|Overall Study||10||
60067204|NCT01925612|76182390|FG004|COMPLETED|Overall Study||10||
60067205|NCT01925612|76182386|FG000|NOT COMPLETED|Overall Study||4||
60067206|NCT01925612|76182387|FG001|NOT COMPLETED|Overall Study||4||
59519053|NCT00948935|75612914|FG000|NOT COMPLETED|Overall Study||0||
59761546|NCT00601484|75881170|FG001|Treated|Overall Study||30||
59931474|NCT00849667|76049776|FG001|STARTED|Overall Study||366||
59931475|NCT00849667|76049777|FG002|STARTED|Overall Study||364||
59931476|NCT00849667|76049775|FG000|Safety Analysis Set|Overall Study||376||
59931477|NCT00849667|76049776|FG001|Safety Analysis Set|Overall Study||363||
59931478|NCT00849667|76049777|FG002|Safety Analysis Set|Overall Study||352||
59931479|NCT00849667|76049775|FG000|COMPLETED|Overall Study||0||
59931480|NCT00849667|76049776|FG001|COMPLETED|Overall Study||0||
59931481|NCT00849667|76049777|FG002|COMPLETED|Overall Study||0||
59931482|NCT00849667|76049775|FG000|NOT COMPLETED|Overall Study||370||
59931483|NCT00849667|76049776|FG001|NOT COMPLETED|Overall Study||366||
59931484|NCT00849667|76049777|FG002|NOT COMPLETED|Overall Study||364||
59931485|NCT03201419|76049796|FG000|STARTED|Overall Study||60||
59931486|NCT03201419|76049797|FG001|STARTED|Overall Study||27||
59931487|NCT03201419|76049798|FG002|STARTED|Overall Study||24||
59931488|NCT03201419|76049799|FG003|STARTED|Overall Study||14||
59931489|NCT03201419|76049800|FG004|STARTED|Overall Study||13||
59931490|NCT03201419|76049801|FG005|STARTED|Overall Study||34||
59931491|NCT03201419|76049802|FG006|STARTED|Overall Study||87||
59931492|NCT03201419|76049803|FG007|STARTED|Overall Study||26||
59931493|NCT03201419|76049804|FG008|STARTED|Overall Study||17||
59931494|NCT03201419|76049796|FG000|COMPLETED|Overall Study||52||
59931495|NCT03201419|76049797|FG001|COMPLETED|Overall Study||24||
59931496|NCT03201419|76049798|FG002|COMPLETED|Overall Study||22||
59931497|NCT03201419|76049799|FG003|COMPLETED|Overall Study||14||
59931498|NCT03201419|76049800|FG004|COMPLETED|Overall Study||12||
59931499|NCT03201419|76049801|FG005|COMPLETED|Overall Study||33||
59931500|NCT03201419|76049802|FG006|COMPLETED|Overall Study||81||
59931501|NCT03201419|76049803|FG007|COMPLETED|Overall Study||25||
59931502|NCT03201419|76049804|FG008|COMPLETED|Overall Study||15||
59931503|NCT03201419|76049796|FG000|NOT COMPLETED|Overall Study||8||
59931504|NCT03201419|76049797|FG001|NOT COMPLETED|Overall Study||3||
59931505|NCT03201419|76049798|FG002|NOT COMPLETED|Overall Study||2||
59931506|NCT03201419|76049799|FG003|NOT COMPLETED|Overall Study||0||
59931507|NCT03201419|76049800|FG004|NOT COMPLETED|Overall Study||1||
59931508|NCT03201419|76049801|FG005|NOT COMPLETED|Overall Study||1||
59931509|NCT03201419|76049802|FG006|NOT COMPLETED|Overall Study||6||
59931510|NCT03201419|76049803|FG007|NOT COMPLETED|Overall Study||1||
59931511|NCT03201419|76049804|FG008|NOT COMPLETED|Overall Study||2||
59931512|NCT01764633|76049840|FG000|STARTED|Overall Study||13780||
59931513|NCT01764633|76049841|FG001|STARTED|Overall Study||13784||
59931514|NCT01764633|76049840|FG000|Received Treatment|Overall Study||13756||
59931515|NCT01764633|76049841|FG001|Received Treatment|Overall Study||13769||
59931516|NCT01764633|76049840|FG000|COMPLETED|Overall Study||13662||
59931517|NCT01764633|76049841|FG001|COMPLETED|Overall Study||13691||
59931518|NCT01764633|76049840|FG000|NOT COMPLETED|Overall Study||118||
59931519|NCT01764633|76049841|FG001|NOT COMPLETED|Overall Study||93||
59931520|NCT02924389|76049849|FG000|STARTED|Overall Study||16||
59931521|NCT02924389|76049850|FG001|STARTED|Overall Study||6||
59931522|NCT02924389|76049849|FG000|COMPLETED|Overall Study||8||
59931523|NCT02924389|76049850|FG001|COMPLETED|Overall Study||6||
59931524|NCT02924389|76049849|FG000|NOT COMPLETED|Overall Study||8||
59931525|NCT02924389|76049850|FG001|NOT COMPLETED|Overall Study||0||
59931526|NCT03235349|76049857|FG000|STARTED|Overall Study||160||
59931527|NCT03235349|76049857|FG000|COMPLETED|Overall Study||158||
59931528|NCT03235349|76049857|FG000|NOT COMPLETED|Overall Study||2||
59931529|NCT03235115|76049861|FG000|STARTED|First Intervention (1 Hour, Visit 2)||9||
59931530|NCT03235115|76049862|FG001|STARTED|First Intervention (1 Hour, Visit 2)||6||
59931531|NCT03235115|76049863|FG002|STARTED|First Intervention (1 Hour, Visit 2)||7||
60067207|NCT01925612|76182388|FG002|NOT COMPLETED|Overall Study||1||
60067208|NCT01925612|76182389|FG003|NOT COMPLETED|Overall Study||1||
60067209|NCT01925612|76182390|FG004|NOT COMPLETED|Overall Study||2||
59761547|NCT00601484|75881169|FG000|COMPLETED|Overall Study||29||
59761548|NCT00601484|75881170|FG001|COMPLETED|Overall Study||23||
59761549|NCT00601484|75881169|FG000|NOT COMPLETED|Overall Study||5||
59761550|NCT00601484|75881170|FG001|NOT COMPLETED|Overall Study||8||
59761551|NCT00883896|75881180|FG000|STARTED|Overall Study||66||
59761552|NCT00883896|75881181|FG001|STARTED|Overall Study||39||
59761553|NCT00883896|75881182|FG002|STARTED|Overall Study||42||
59761554|NCT00883896|75881183|FG003|STARTED|Overall Study||48||
59761555|NCT00883896|75881180|FG000|COMPLETED|Overall Study||60||
59761556|NCT00883896|75881181|FG001|COMPLETED|Overall Study||39||
59761557|NCT00883896|75881182|FG002|COMPLETED|Overall Study||41||
59761558|NCT00883896|75881183|FG003|COMPLETED|Overall Study||41||
59761559|NCT00883896|75881180|FG000|NOT COMPLETED|Overall Study||6||
59761560|NCT00883896|75881181|FG001|NOT COMPLETED|Overall Study||0||
59761561|NCT00883896|75881182|FG002|NOT COMPLETED|Overall Study||1||
59761562|NCT00883896|75881183|FG003|NOT COMPLETED|Overall Study||7||
59761563|NCT00867009|75881193|FG000|STARTED|Induction Period|Participants with Stage IIIB/IV non-squamous (NS) non-small cell lung cancer (NSCLC)|113||
59931532|NCT03235115|76049864|FG003|STARTED|First Intervention (1 Hour, Visit 2)||6||
59931533|NCT03235115|76049865|FG004|STARTED|First Intervention (1 Hour, Visit 2)||6||
59931534|NCT03235115|76049866|FG005|STARTED|First Intervention (1 Hour, Visit 2)||6||
59931535|NCT03235115|76049861|FG000|COMPLETED|First Intervention (1 Hour, Visit 2)||9||
59931536|NCT03235115|76049862|FG001|COMPLETED|First Intervention (1 Hour, Visit 2)||6||
59931537|NCT03235115|76049863|FG002|COMPLETED|First Intervention (1 Hour, Visit 2)||7||
59931538|NCT03235115|76049864|FG003|COMPLETED|First Intervention (1 Hour, Visit 2)||6||
59931539|NCT03235115|76049865|FG004|COMPLETED|First Intervention (1 Hour, Visit 2)||6||
59931540|NCT03235115|76049866|FG005|COMPLETED|First Intervention (1 Hour, Visit 2)||5||
59931541|NCT03235115|76049861|FG000|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||0||
59931542|NCT03235115|76049862|FG001|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||0||
59931543|NCT03235115|76049863|FG002|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||0||
59931544|NCT03235115|76049864|FG003|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||0||
59931545|NCT03235115|76049865|FG004|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||0||
59931546|NCT03235115|76049866|FG005|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||1||
59931547|NCT03235115|76049861|FG000|STARTED|Second Intervention (1 Hour, Visit 4)||9||
59931548|NCT03235115|76049862|FG001|STARTED|Second Intervention (1 Hour, Visit 4)||6||
59931549|NCT03235115|76049863|FG002|STARTED|Second Intervention (1 Hour, Visit 4)||7||
59931550|NCT03235115|76049864|FG003|STARTED|Second Intervention (1 Hour, Visit 4)||6||
59931551|NCT03235115|76049865|FG004|STARTED|Second Intervention (1 Hour, Visit 4)||6||
59931552|NCT03235115|76049866|FG005|STARTED|Second Intervention (1 Hour, Visit 4)||5||
59931553|NCT03235115|76049861|FG000|COMPLETED|Second Intervention (1 Hour, Visit 4)||9||
59931554|NCT03235115|76049862|FG001|COMPLETED|Second Intervention (1 Hour, Visit 4)||6||
59761564|NCT00867009|75881193|FG000|Received at Least 1 Dose of Study Drug|Induction Period||113||
59761565|NCT00867009|75881193|FG000|Protocol Qualified (PQ) Population|Induction Period|Stage IIIB/IV NS-NSCLC, no concurrent chemotherapy, measurable disease, ≥1 dose study drug.|109||
59761566|NCT00867009|75881193|FG000|COMPLETED|Induction Period|Participants continued on the study in the Maintenance Period.|51||
59761567|NCT00867009|75881193|FG000|NOT COMPLETED|Induction Period||62||
59761568|NCT00867009|75881193|FG000|STARTED|Maintenance Period||51||
59761569|NCT00867009|75881193|FG000|COMPLETED|Maintenance Period|Participant was considered completed if they had PD, death, or stopped receiving study drug.|47||
59761570|NCT00867009|75881193|FG000|NOT COMPLETED|Maintenance Period||4||
59761571|NCT00601250|75881199|FG000|STARTED|Overall Study|number who started treatment|177||
59761572|NCT00601250|75881200|FG001|STARTED|Overall Study|number who started treatment. One additional patient was randomised but not treated.|523||
59761573|NCT00601250|75881199|FG000|COMPLETED|Overall Study|number who completed treatment|163||
59761574|NCT00601250|75881200|FG001|COMPLETED|Overall Study|number who completed treatment|484||
59761575|NCT00601250|75881199|FG000|NOT COMPLETED|Overall Study||14||
59761576|NCT00601250|75881200|FG001|NOT COMPLETED|Overall Study||39||
59761577|NCT00866775|75881208|FG000|STARTED|Overall Study||65||
59761578|NCT00866775|75881209|FG001|STARTED|Overall Study||128||
59761579|NCT00866775|75881208|FG000|COMPLETED|Overall Study||29||
59761580|NCT00866775|75881209|FG001|COMPLETED|Overall Study||76||
59931555|NCT03235115|76049863|FG002|COMPLETED|Second Intervention (1 Hour, Visit 4)||7||
59931556|NCT03235115|76049864|FG003|COMPLETED|Second Intervention (1 Hour, Visit 4)||6||
59931557|NCT03235115|76049865|FG004|COMPLETED|Second Intervention (1 Hour, Visit 4)||6||
59931558|NCT03235115|76049866|FG005|COMPLETED|Second Intervention (1 Hour, Visit 4)||5||
59931559|NCT03235115|76049861|FG000|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0||
59931560|NCT03235115|76049862|FG001|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0||
59931561|NCT03235115|76049863|FG002|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0||
59931562|NCT03235115|76049864|FG003|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0||
59931563|NCT03235115|76049865|FG004|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0||
59931564|NCT03235115|76049866|FG005|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0||
59931565|NCT03235115|76049861|FG000|STARTED|Third Intervention ( 1 Hour, Visit 6)||9||
59931566|NCT03235115|76049862|FG001|STARTED|Third Intervention ( 1 Hour, Visit 6)||6||
59931567|NCT03235115|76049863|FG002|STARTED|Third Intervention ( 1 Hour, Visit 6)||7||
59931568|NCT03235115|76049864|FG003|STARTED|Third Intervention ( 1 Hour, Visit 6)||6||
59931569|NCT03235115|76049865|FG004|STARTED|Third Intervention ( 1 Hour, Visit 6)||6||
59931570|NCT03235115|76049866|FG005|STARTED|Third Intervention ( 1 Hour, Visit 6)||5||
59931571|NCT03235115|76049861|FG000|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||9||
59931572|NCT03235115|76049862|FG001|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||6||
59931573|NCT03235115|76049863|FG002|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||7||
59931574|NCT03235115|76049864|FG003|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||6||
59931575|NCT03235115|76049865|FG004|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||6||
59931576|NCT03235115|76049866|FG005|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||5||
59931577|NCT03235115|76049861|FG000|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0||
59931578|NCT03235115|76049862|FG001|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0||
59931579|NCT03235115|76049863|FG002|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0||
59931580|NCT03235115|76049864|FG003|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0||
59931581|NCT03235115|76049865|FG004|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0||
59931582|NCT03235115|76049866|FG005|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0||
59931583|NCT02923531|76049874|FG000|STARTED|Overall Study||9||
59931584|NCT02923531|76049874|FG000|Received at Least 1 Dose of Study Medication|Overall Study||9||
59931585|NCT02923531|76049874|FG000|COMPLETED|Overall Study||0||
60067210|NCT02093663|76182402|FG000|STARTED|Double Blind Acute Phase (8 Weeks)||27||
60067211|NCT02093663|76182403|FG001|STARTED|Double Blind Acute Phase (8 Weeks)||26||
59518321|NCT03277378|75612122|FG001|Not Qualified for Permanent Implant|Overall Study||20||
59518322|NCT03277378|75612121|FG000|Completed Extended Trial With Tonic Stim|Overall Study||8||
59518323|NCT03277378|75612122|FG001|Completed Extended Trial With Tonic Stim|Overall Study||12||
59518324|NCT03277378|75612121|FG000|Exit Study|Overall Study||11||
59518325|NCT03277378|75612122|FG001|Exit Study|Overall Study||8||
59518326|NCT03277378|75612121|FG000|COMPLETED|Overall Study||111||
59761581|NCT00866775|75881208|FG000|NOT COMPLETED|Overall Study||36||
59761582|NCT00866775|75881209|FG001|NOT COMPLETED|Overall Study||52||
59761583|NCT03265210|75881219|FG000|STARTED|Overall Study||50||
59761584|NCT03265210|75881220|FG001|STARTED|Overall Study||23||
59931586|NCT02923531|76049874|FG000|NOT COMPLETED|Overall Study||9||
59931587|NCT02934503|76049879|FG000|STARTED|Overall Study||5||
59931588|NCT02934503|76049879|FG000|COMPLETED|Overall Study||1||
59931589|NCT02934503|76049879|FG000|NOT COMPLETED|Overall Study||4||
59931590|NCT02937545|76049885|FG000|STARTED|Overall Study||69||
59931591|NCT02937545|76049886|FG001|STARTED|Overall Study||85||
59931592|NCT02937545|76049887|FG002|STARTED|Overall Study||15||
59931593|NCT02937545|76049888|FG003|STARTED|Overall Study||21||
59931594|NCT02937545|76049885|FG000|COMPLETED|Overall Study||67||
60067212|NCT02093663|76182404|FG002|STARTED|Double Blind Acute Phase (8 Weeks)||0||
60067213|NCT02093663|76182405|FG003|STARTED|Double Blind Acute Phase (8 Weeks)||0||
59931595|NCT02937545|76049886|FG001|COMPLETED|Overall Study||83||
59931596|NCT02937545|76049887|FG002|COMPLETED|Overall Study||9||
59931597|NCT02937545|76049888|FG003|COMPLETED|Overall Study||14||
59931598|NCT02937545|76049885|FG000|NOT COMPLETED|Overall Study||2||
59931599|NCT02937545|76049886|FG001|NOT COMPLETED|Overall Study||2||
59931600|NCT02937545|76049887|FG002|NOT COMPLETED|Overall Study||6||
59761585|NCT03265210|75881219|FG000|COMPLETED|Overall Study||38||
59761586|NCT03265210|75881220|FG001|COMPLETED|Overall Study||14||
59761587|NCT03265210|75881219|FG000|NOT COMPLETED|Overall Study||12||
59761588|NCT03265210|75881220|FG001|NOT COMPLETED|Overall Study||9||
59761589|NCT00543985|75881226|FG000|STARTED|Overall Study||36||
59761590|NCT00543985|75881226|FG000|COMPLETED|Overall Study||32||
59761591|NCT00543985|75881226|FG000|NOT COMPLETED|Overall Study||4||
59761592|NCT04654351|75881233|FG000|STARTED|Overall Study||2||
59761593|NCT04654351|75881233|FG000|COMPLETED|Overall Study||2||
59761594|NCT04654351|75881233|FG000|NOT COMPLETED|Overall Study||0||
59761595|NCT00582556|75881241|FG000|STARTED|Overall Study||14||
59761596|NCT00582556|75881242|FG001|STARTED|Overall Study||15||
59761597|NCT00582556|75881243|FG002|STARTED|Overall Study||14||
59761598|NCT00582556|75881241|FG000|COMPLETED|Overall Study||14||
59761599|NCT00582556|75881242|FG001|COMPLETED|Overall Study||14||
59761600|NCT00582556|75881243|FG002|COMPLETED|Overall Study||12||
59761601|NCT00582556|75881241|FG000|NOT COMPLETED|Overall Study||0||
59761602|NCT00582556|75881242|FG001|NOT COMPLETED|Overall Study||1||
59761603|NCT00582556|75881243|FG002|NOT COMPLETED|Overall Study||2||
59761604|NCT00542269|75881255|FG000|STARTED|Overall Study||61||
59761605|NCT00542269|75881256|FG001|STARTED|Overall Study||60||
59761606|NCT00542269|75881257|FG002|STARTED|Overall Study||57||
59761607|NCT00542269|75881255|FG000|COMPLETED|Overall Study||48||
59761608|NCT00542269|75881256|FG001|COMPLETED|Overall Study||54||
59761609|NCT00542269|75881257|FG002|COMPLETED|Overall Study||51||
59761610|NCT00542269|75881255|FG000|NOT COMPLETED|Overall Study||13||
59931601|NCT02937545|76049888|FG003|NOT COMPLETED|Overall Study||7||
59931602|NCT03199391|76049899|FG000|STARTED|Overall Study||71||
59931603|NCT03199391|76049899|FG000|COMPLETED|Overall Study||55||
59931604|NCT03199391|76049899|FG000|NOT COMPLETED|Overall Study||16||
59518327|NCT03277378|75612122|FG001|COMPLETED|Overall Study||101||
59518328|NCT03277378|75612121|FG000|NOT COMPLETED|Overall Study||24||
59761611|NCT00542269|75881256|FG001|NOT COMPLETED|Overall Study||6||
59931605|NCT03198767|76049910|FG000|STARTED|Overall Study||8||
59931606|NCT03198767|76049911|FG001|STARTED|Overall Study||8||
59931607|NCT03198767|76049912|FG002|STARTED|Overall Study||8||
59931608|NCT03198767|76049913|FG003|STARTED|Overall Study||6||
59931609|NCT03198767|76049914|FG004|STARTED|Overall Study||8||
59931610|NCT03198767|76049915|FG005|STARTED|Overall Study||8||
60067214|NCT02093663|76182406|FG004|STARTED|Double Blind Acute Phase (8 Weeks)||0||
60067215|NCT02093663|76182402|FG000|COMPLETED|Double Blind Acute Phase (8 Weeks)||19||
60067216|NCT02093663|76182403|FG001|COMPLETED|Double Blind Acute Phase (8 Weeks)||22||
60067217|NCT02093663|76182404|FG002|COMPLETED|Double Blind Acute Phase (8 Weeks)||0||
60067218|NCT02093663|76182405|FG003|COMPLETED|Double Blind Acute Phase (8 Weeks)||0||
60067219|NCT02093663|76182406|FG004|COMPLETED|Double Blind Acute Phase (8 Weeks)||0||
60067220|NCT02093663|76182402|FG000|NOT COMPLETED|Double Blind Acute Phase (8 Weeks)||8||
60067221|NCT02093663|76182403|FG001|NOT COMPLETED|Double Blind Acute Phase (8 Weeks)||4||
60067222|NCT02093663|76182404|FG002|NOT COMPLETED|Double Blind Acute Phase (8 Weeks)||0||
60067223|NCT02093663|76182405|FG003|NOT COMPLETED|Double Blind Acute Phase (8 Weeks)||0||
59761612|NCT00542269|75881257|FG002|NOT COMPLETED|Overall Study||6||
59761613|NCT00866697|75881269|FG000|STARTED|Overall Study||468||
59761614|NCT00866697|75881270|FG001|STARTED|Overall Study||472||
59761615|NCT00866697|75881269|FG000|COMPLETED|Overall Study||254|Death|
59761616|NCT00866697|75881270|FG001|COMPLETED|Overall Study||244|Death|
59761617|NCT00866697|75881269|FG000|NOT COMPLETED|Overall Study||214||
59761618|NCT00866697|75881270|FG001|NOT COMPLETED|Overall Study||228||
59761619|NCT00542191|75881276|FG000|STARTED|Overall Study||21||
59931611|NCT03198767|76049916|FG006|STARTED|Overall Study||8||
59931612|NCT03198767|76049910|FG000|COMPLETED|Overall Study||8||
59931613|NCT03198767|76049911|FG001|COMPLETED|Overall Study||8||
59931614|NCT03198767|76049912|FG002|COMPLETED|Overall Study||8||
59931615|NCT03198767|76049913|FG003|COMPLETED|Overall Study||0||
59931616|NCT03198767|76049914|FG004|COMPLETED|Overall Study||8||
59931617|NCT03198767|76049915|FG005|COMPLETED|Overall Study||8||
59931618|NCT03198767|76049916|FG006|COMPLETED|Overall Study||8||
59931619|NCT03198767|76049910|FG000|NOT COMPLETED|Overall Study||0||
59931620|NCT03198767|76049911|FG001|NOT COMPLETED|Overall Study||0||
59931621|NCT03198767|76049912|FG002|NOT COMPLETED|Overall Study||0||
59931622|NCT03198767|76049913|FG003|NOT COMPLETED|Overall Study||6||
59931623|NCT03198767|76049914|FG004|NOT COMPLETED|Overall Study||0||
59931624|NCT03198767|76049915|FG005|NOT COMPLETED|Overall Study||0||
59931625|NCT03198767|76049916|FG006|NOT COMPLETED|Overall Study||0||
59931626|NCT03162055|76049933|FG000|STARTED|Overall Study||559||
59931627|NCT03162055|76049934|FG001|STARTED|Overall Study||560||
59931628|NCT03162055|76049933|FG000|Received Treatment|Overall Study||557||
59931629|NCT03162055|76049934|FG001|Received Treatment|Overall Study||560||
59761620|NCT00542191|75881276|FG000|COMPLETED|Overall Study||18||
59931630|NCT03162055|76049933|FG000|Safety Analysis Set|Overall Study||552||
59931631|NCT03162055|76049934|FG001|Safety Analysis Set|Overall Study||552||
59931632|NCT03162055|76049933|FG000|Full Analysis Set (FAS)|Overall Study||552||
59931633|NCT03162055|76049934|FG001|Full Analysis Set (FAS)|Overall Study||552||
59931634|NCT03162055|76049933|FG000|Per Protocol (PP) Analysis Set|Overall Study||506||
59931635|NCT03162055|76049934|FG001|Per Protocol (PP) Analysis Set|Overall Study||510||
59931636|NCT03162055|76049933|FG000|COMPLETED|Overall Study||497||
59931637|NCT03162055|76049934|FG001|COMPLETED|Overall Study||517||
59931638|NCT03162055|76049933|FG000|NOT COMPLETED|Overall Study||62||
59931639|NCT03162055|76049934|FG001|NOT COMPLETED|Overall Study||43||
59931640|NCT02927145|76049947|FG000|STARTED|Initial Recruitment||12||
59931641|NCT02927145|76049948|FG001|STARTED|Initial Recruitment||12||
59931642|NCT02927145|76049949|FG002|STARTED|Initial Recruitment||12||
59931643|NCT02927145|76049950|FG003|STARTED|Initial Recruitment||14||
59931644|NCT02927145|76049951|FG004|STARTED|Initial Recruitment||17||
59931645|NCT02927145|76049952|FG005|STARTED|Initial Recruitment||15||
59931646|NCT02927145|76049953|FG006|STARTED|Initial Recruitment||0||
59931647|NCT02927145|76049954|FG007|STARTED|Initial Recruitment||0||
59931648|NCT02927145|76049955|FG008|STARTED|Initial Recruitment||6||
59931649|NCT02927145|76049947|FG000|COMPLETED|Initial Recruitment||12||
59931650|NCT02927145|76049948|FG001|COMPLETED|Initial Recruitment||11||
59931651|NCT02927145|76049949|FG002|COMPLETED|Initial Recruitment||11||
59931652|NCT02927145|76049950|FG003|COMPLETED|Initial Recruitment||10||
59931653|NCT02927145|76049951|FG004|COMPLETED|Initial Recruitment||14||
59931654|NCT02927145|76049952|FG005|COMPLETED|Initial Recruitment||14||
59931655|NCT02927145|76049953|FG006|COMPLETED|Initial Recruitment||0||
59931656|NCT02927145|76049954|FG007|COMPLETED|Initial Recruitment||0||
59931657|NCT02927145|76049955|FG008|COMPLETED|Initial Recruitment||4||
59931658|NCT02927145|76049947|FG000|NOT COMPLETED|Initial Recruitment||0||
59931659|NCT02927145|76049948|FG001|NOT COMPLETED|Initial Recruitment||1||
59931660|NCT02927145|76049949|FG002|NOT COMPLETED|Initial Recruitment||1||
59931661|NCT02927145|76049950|FG003|NOT COMPLETED|Initial Recruitment||4||
59931662|NCT02927145|76049951|FG004|NOT COMPLETED|Initial Recruitment||3||
59931663|NCT02927145|76049952|FG005|NOT COMPLETED|Initial Recruitment||1||
59931664|NCT02927145|76049953|FG006|NOT COMPLETED|Initial Recruitment||0||
59931665|NCT02927145|76049954|FG007|NOT COMPLETED|Initial Recruitment||0||
59931666|NCT02927145|76049955|FG008|NOT COMPLETED|Initial Recruitment||2||
59931667|NCT02927145|76049947|FG000|STARTED|Invitation for Additional Challenge||0||
59931668|NCT02927145|76049948|FG001|STARTED|Invitation for Additional Challenge||0||
59931669|NCT02927145|76049949|FG002|STARTED|Invitation for Additional Challenge||0||
59931670|NCT02927145|76049950|FG003|STARTED|Invitation for Additional Challenge||0||
59931671|NCT02927145|76049951|FG004|STARTED|Invitation for Additional Challenge||0||
59931672|NCT02927145|76049952|FG005|STARTED|Invitation for Additional Challenge||0||
59931673|NCT02927145|76049953|FG006|STARTED|Invitation for Additional Challenge||9||
59931674|NCT02927145|76049954|FG007|STARTED|Invitation for Additional Challenge||8||
59931675|NCT02927145|76049955|FG008|STARTED|Invitation for Additional Challenge||0||
59931676|NCT02927145|76049947|FG000|COMPLETED|Invitation for Additional Challenge||0||
59931677|NCT02927145|76049948|FG001|COMPLETED|Invitation for Additional Challenge||0||
59931678|NCT02927145|76049949|FG002|COMPLETED|Invitation for Additional Challenge||0||
59931679|NCT02927145|76049950|FG003|COMPLETED|Invitation for Additional Challenge||0||
59931680|NCT02927145|76049951|FG004|COMPLETED|Invitation for Additional Challenge||0||
59931681|NCT02927145|76049952|FG005|COMPLETED|Invitation for Additional Challenge||0||
59931682|NCT02927145|76049953|FG006|COMPLETED|Invitation for Additional Challenge||8||
59931683|NCT02927145|76049954|FG007|COMPLETED|Invitation for Additional Challenge||8||
59931684|NCT02927145|76049955|FG008|COMPLETED|Invitation for Additional Challenge||0||
59931685|NCT02927145|76049947|FG000|NOT COMPLETED|Invitation for Additional Challenge||0||
59931686|NCT02927145|76049948|FG001|NOT COMPLETED|Invitation for Additional Challenge||0||
59931687|NCT02927145|76049949|FG002|NOT COMPLETED|Invitation for Additional Challenge||0||
59931688|NCT02927145|76049950|FG003|NOT COMPLETED|Invitation for Additional Challenge||0||
59931689|NCT02927145|76049951|FG004|NOT COMPLETED|Invitation for Additional Challenge||0||
59931690|NCT02927145|76049952|FG005|NOT COMPLETED|Invitation for Additional Challenge||0||
59931691|NCT02927145|76049953|FG006|NOT COMPLETED|Invitation for Additional Challenge||1||
59931692|NCT02927145|76049954|FG007|NOT COMPLETED|Invitation for Additional Challenge||0||
59931693|NCT02927145|76049955|FG008|NOT COMPLETED|Invitation for Additional Challenge||0||
59931694|NCT03688919|76049978|FG000|STARTED|Overall Study||41||
59931695|NCT03688919|76049979|FG001|STARTED|Overall Study||47||
59931696|NCT03688919|76049978|FG000|COMPLETED|Overall Study||38||
59931697|NCT03688919|76049979|FG001|COMPLETED|Overall Study||46||
59931698|NCT03688919|76049978|FG000|NOT COMPLETED|Overall Study||3||
59931699|NCT03688919|76049979|FG001|NOT COMPLETED|Overall Study||1||
59931700|NCT04646369|76049988|FG000|STARTED|Overall Study||23||
59931701|NCT04646369|76049989|FG001|STARTED|Overall Study||38||
59931702|NCT04646369|76049990|FG002|STARTED|Overall Study||39||
59931703|NCT04646369|76049988|FG000|COMPLETED|Overall Study||23||
59931704|NCT04646369|76049989|FG001|COMPLETED|Overall Study||38||
59931705|NCT04646369|76049990|FG002|COMPLETED|Overall Study||39||
59931706|NCT04646369|76049988|FG000|NOT COMPLETED|Overall Study||0||
59931707|NCT04646369|76049989|FG001|NOT COMPLETED|Overall Study||0||
59931708|NCT04646369|76049990|FG002|NOT COMPLETED|Overall Study||0||
59931709|NCT02888119|76050002|FG000|STARTED|Overall Study||11||
59931710|NCT02888119|76050003|FG001|STARTED|Overall Study||7||
59931711|NCT02888119|76050004|FG002|STARTED|Overall Study||30||
59931712|NCT02888119|76050002|FG000|COMPLETED|Overall Study||6||
59931713|NCT02888119|76050003|FG001|COMPLETED|Overall Study||3||
59931714|NCT02888119|76050004|FG002|COMPLETED|Overall Study||30||
59931715|NCT02888119|76050002|FG000|NOT COMPLETED|Overall Study||5||
59931716|NCT02888119|76050003|FG001|NOT COMPLETED|Overall Study||4||
59931717|NCT02888119|76050004|FG002|NOT COMPLETED|Overall Study||0||
59931718|NCT03197129|76050013|FG000|STARTED|Overall Study||60||
59931719|NCT03197129|76050014|FG001|STARTED|Overall Study||62||
59931720|NCT03197129|76050013|FG000|COMPLETED|Overall Study||56||
59931721|NCT03197129|76050014|FG001|COMPLETED|Overall Study||57||
59931722|NCT03197129|76050013|FG000|NOT COMPLETED|Overall Study||4||
59931723|NCT03197129|76050014|FG001|NOT COMPLETED|Overall Study||5||
59931724|NCT03196973|76050023|FG000|STARTED|Overall Study||197||
59931725|NCT03196973|76050024|FG001|STARTED|Overall Study||196||
59931726|NCT03196973|76050025|FG002|STARTED|Overall Study||100||
59931727|NCT03196973|76050023|FG000|COMPLETED|Overall Study||188||
59931728|NCT03196973|76050024|FG001|COMPLETED|Overall Study||184||
59931729|NCT03196973|76050025|FG002|COMPLETED|Overall Study||95||
59931730|NCT03196973|76050023|FG000|NOT COMPLETED|Overall Study||9||
59931731|NCT03196973|76050024|FG001|NOT COMPLETED|Overall Study||12||
59931732|NCT03196973|76050025|FG002|NOT COMPLETED|Overall Study||5||
59931733|NCT03196505|76050035|FG000|STARTED|Overall Study||115||
59931734|NCT03196505|76050036|FG001|STARTED|Overall Study||116||
59931735|NCT03196505|76050035|FG000|COMPLETED|Overall Study||89||
59931736|NCT03196505|76050036|FG001|COMPLETED|Overall Study||90||
59931737|NCT03196505|76050035|FG000|NOT COMPLETED|Overall Study||26||
59931738|NCT03196505|76050036|FG001|NOT COMPLETED|Overall Study||26||
59518329|NCT03277378|75612122|FG001|NOT COMPLETED|Overall Study||34||
59518330|NCT02178241|75612132|FG000|STARTED|Overall Study||24|Two enrolled patients did not receive any study treatment and were excluded from analysis.|
59518331|NCT02178241|75612132|FG000|COMPLETED|Overall Study||24||
59518332|NCT02178241|75612132|FG000|NOT COMPLETED|Overall Study||0||
59518333|NCT03509974|75612136|FG000|STARTED|Overall Study||14||
59518334|NCT03509974|75612136|FG000|COMPLETED|Overall Study||14||
59518335|NCT03509974|75612136|FG000|NOT COMPLETED|Overall Study||0||
59931739|NCT03196349|76050045|FG000|STARTED|Overall Study||17||
59931740|NCT03196349|76050046|FG001|STARTED|Overall Study||14||
59931741|NCT03196349|76050047|FG002|STARTED|Overall Study||13||
59931742|NCT03196349|76050045|FG000|COMPLETED|Overall Study||0||
59931743|NCT03196349|76050046|FG001|COMPLETED|Overall Study||0||
59931744|NCT03196349|76050047|FG002|COMPLETED|Overall Study||0||
59931745|NCT03196349|76050045|FG000|NOT COMPLETED|Overall Study||17||
59931746|NCT03196349|76050046|FG001|NOT COMPLETED|Overall Study||14||
59931747|NCT03196349|76050047|FG002|NOT COMPLETED|Overall Study||13||
59931748|NCT02886715|76050058|FG000|STARTED|Overall Study||442|Randomized - Safety Population|
59518336|NCT01077973|75612143|FG000|STARTED|Overall Study||41||
59518337|NCT01077973|75612144|FG001|STARTED|Overall Study||79||
59518338|NCT01077973|75612145|FG002|STARTED|Overall Study||80||
59518339|NCT01077973|75612143|FG000|COMPLETED|Overall Study||41||
59931749|NCT02886715|76050059|FG001|STARTED|Overall Study||445|Randomized - Safety Population|
59931750|NCT02886715|76050060|FG002|STARTED|Overall Study||223|Randomized - Safety Population|
59931751|NCT02886715|76050058|FG000|Modified ITT (mITT)|Overall Study||421||
59931752|NCT02886715|76050059|FG001|Modified ITT (mITT)|Overall Study||418||
59931753|NCT02886715|76050060|FG002|Modified ITT (mITT)|Overall Study||217||
59931754|NCT02886715|76050058|FG000|Per Protocol (PP) Population|Overall Study||346||
59931755|NCT02886715|76050059|FG001|Per Protocol (PP) Population|Overall Study||351||
59931756|NCT02886715|76050060|FG002|Per Protocol (PP) Population|Overall Study||176||
59931757|NCT02886715|76050058|FG000|COMPLETED|Overall Study||378||
59931758|NCT02886715|76050059|FG001|COMPLETED|Overall Study||390||
59931759|NCT02886715|76050060|FG002|COMPLETED|Overall Study||203||
59931760|NCT02886715|76050058|FG000|NOT COMPLETED|Overall Study||64||
59931761|NCT02886715|76050059|FG001|NOT COMPLETED|Overall Study||55||
59931762|NCT02886715|76050060|FG002|NOT COMPLETED|Overall Study||20||
59931763|NCT03085797|76050070|FG000|STARTED|Treatment Period (TP) (52 Weeks)||201|Data presented for ITT Population|
59931764|NCT03085797|76050071|FG001|STARTED|Treatment Period (TP) (52 Weeks)||206|Data presented for ITT Population|
59931765|NCT03085797|76050070|FG000|Completed Investigational Product (IP)|Treatment Period (TP) (52 Weeks)||167||
59931766|NCT03085797|76050071|FG001|Completed Investigational Product (IP)|Treatment Period (TP) (52 Weeks)||183||
59931767|NCT03085797|76050070|FG000|Not Completed IP|Treatment Period (TP) (52 Weeks)||34||
59931768|NCT03085797|76050071|FG001|Not Completed IP|Treatment Period (TP) (52 Weeks)||23||
59931769|NCT03085797|76050070|FG000|Withdrew IP Due to: Adverse Event|Treatment Period (TP) (52 Weeks)||4||
59931770|NCT03085797|76050071|FG001|Withdrew IP Due to: Adverse Event|Treatment Period (TP) (52 Weeks)||4||
59931771|NCT03085797|76050070|FG000|Withdrew IP Due to: Lack of Efficacy|Treatment Period (TP) (52 Weeks)||11||
59931772|NCT03085797|76050071|FG001|Withdrew IP Due to: Lack of Efficacy|Treatment Period (TP) (52 Weeks)||5||
59931773|NCT03085797|76050070|FG000|Withdrew IP Due to: Protocol Deviation|Treatment Period (TP) (52 Weeks)||1||
59931774|NCT03085797|76050071|FG001|Withdrew IP Due to: Protocol Deviation|Treatment Period (TP) (52 Weeks)||0||
59931775|NCT03085797|76050070|FG000|Withdrew IP Due to: Stopping Criteria|Treatment Period (TP) (52 Weeks)||1||
59931776|NCT03085797|76050071|FG001|Withdrew IP Due to: Stopping Criteria|Treatment Period (TP) (52 Weeks)||1||
59931777|NCT03085797|76050070|FG000|Withdrew IP Due to: Physician Decision|Treatment Period (TP) (52 Weeks)||2||
59931778|NCT03085797|76050071|FG001|Withdrew IP Due to: Physician Decision|Treatment Period (TP) (52 Weeks)||1||
59931779|NCT03085797|76050070|FG000|Withdrew IP Due to: Withdrawal by Par.|Treatment Period (TP) (52 Weeks)||15||
59931780|NCT03085797|76050071|FG001|Withdrew IP Due to: Withdrawal by Par.|Treatment Period (TP) (52 Weeks)||12||
59931781|NCT03085797|76050070|FG000|COMPLETED|Treatment Period (TP) (52 Weeks)||184||
59931782|NCT03085797|76050071|FG001|COMPLETED|Treatment Period (TP) (52 Weeks)||189||
59931783|NCT03085797|76050070|FG000|NOT COMPLETED|Treatment Period (TP) (52 Weeks)||17||
59931784|NCT03085797|76050071|FG001|NOT COMPLETED|Treatment Period (TP) (52 Weeks)||17||
59931785|NCT03085797|76050070|FG000|STARTED|No-treatment Follow-up Period (6 Months)|Only 65 Par. continued in FU to check maintenance of response after stopping treatment per protocol|65||
59931786|NCT03085797|76050071|FG001|STARTED|No-treatment Follow-up Period (6 Months)|Only 69 Par. continued in FU to check maintenance of response after stopping treatment per protocol|69||
59931787|NCT03085797|76050070|FG000|COMPLETED|No-treatment Follow-up Period (6 Months)||65||
59931788|NCT03085797|76050071|FG001|COMPLETED|No-treatment Follow-up Period (6 Months)||68||
59931789|NCT03085797|76050070|FG000|NOT COMPLETED|No-treatment Follow-up Period (6 Months)||0||
59931790|NCT03085797|76050071|FG001|NOT COMPLETED|No-treatment Follow-up Period (6 Months)||1||
59931791|NCT03157531|76050079|FG000|STARTED|Overall Study||97||
59931792|NCT03157531|76050079|FG000|Analyzed at 30 Days For MAEs|Overall Study||93||
59931793|NCT03157531|76050079|FG000|COMPLETED|Overall Study||91||
59931794|NCT03157531|76050079|FG000|NOT COMPLETED|Overall Study||6||
59931795|NCT03159091|76050085|FG000|STARTED|Overall Study||121||
59931796|NCT03159091|76050086|FG001|STARTED|Overall Study||117||
59931797|NCT03159091|76050085|FG000|COMPLETED|Overall Study||116||
59931798|NCT03159091|76050086|FG001|COMPLETED|Overall Study||113||
59931799|NCT03159091|76050085|FG000|NOT COMPLETED|Overall Study||5||
59931800|NCT03159091|76050086|FG001|NOT COMPLETED|Overall Study||4||
59931801|NCT03196193|76050094|FG000|STARTED|Overall Study||121||
59931802|NCT03196193|76050095|FG001|STARTED|Overall Study||119||
59931803|NCT03196193|76050094|FG000|COMPLETED|Overall Study||118||
59931804|NCT03196193|76050095|FG001|COMPLETED|Overall Study||119||
59931805|NCT03196193|76050094|FG000|NOT COMPLETED|Overall Study||3||
59931806|NCT03196193|76050095|FG001|NOT COMPLETED|Overall Study||0||
59931807|NCT03621761|76050104|FG000|STARTED|Overall Study||114||
59931808|NCT03621761|76050105|FG001|STARTED|Overall Study||114||
59931809|NCT03621761|76050106|FG002|STARTED|Overall Study||108||
59931810|NCT03621761|76050104|FG000|Week 8 Follow-up Timepoint|Overall Study||111||
59931811|NCT03621761|76050105|FG001|Week 8 Follow-up Timepoint|Overall Study||111||
59931812|NCT03621761|76050106|FG002|Week 8 Follow-up Timepoint|Overall Study||105||
59931813|NCT03621761|76050104|FG000|Week 12 Follow-up Timepoint|Overall Study||111||
59931814|NCT03621761|76050105|FG001|Week 12 Follow-up Timepoint|Overall Study||110||
59931815|NCT03621761|76050106|FG002|Week 12 Follow-up Timepoint|Overall Study||105||
59931816|NCT03621761|76050104|FG000|Week 24 Survey Timepoint|Overall Study||111||
59931817|NCT03621761|76050105|FG001|Week 24 Survey Timepoint|Overall Study||110||
59931818|NCT03621761|76050106|FG002|Week 24 Survey Timepoint|Overall Study||105||
59931819|NCT03621761|76050104|FG000|COMPLETED|Overall Study||111||
59931820|NCT03621761|76050105|FG001|COMPLETED|Overall Study||110||
59931821|NCT03621761|76050106|FG002|COMPLETED|Overall Study||105||
59931822|NCT03621761|76050104|FG000|NOT COMPLETED|Overall Study||3||
59931823|NCT03621761|76050105|FG001|NOT COMPLETED|Overall Study||4||
59931824|NCT03621761|76050106|FG002|NOT COMPLETED|Overall Study||3||
59931825|NCT03221387|76050114|FG000|STARTED|Overall Study||30||
59931826|NCT03221387|76050114|FG000|COMPLETED|Overall Study||28||
59931827|NCT03221387|76050114|FG000|NOT COMPLETED|Overall Study||2||
59761621|NCT00542191|75881276|FG000|NOT COMPLETED|Overall Study||3||
59761622|NCT00600938|75881282|FG000|STARTED|Core Study||98||
59761623|NCT00600938|75881283|FG001|STARTED|Core Study||99||
59761624|NCT00600938|75881284|FG002|STARTED|Core Study||0||
59761625|NCT00600938|75881285|FG003|STARTED|Core Study||0||
59931828|NCT03318861|76050123|FG000|STARTED|Overall Study||3||
59931829|NCT03318861|76050124|FG001|STARTED|Overall Study||4||
59761626|NCT00600938|75881282|FG000|Core Safety Set|Core Study||96||
59931830|NCT03318861|76050125|FG002|STARTED|Overall Study||3||
59931831|NCT03318861|76050126|FG003|STARTED|Overall Study||4||
59931832|NCT03318861|76050127|FG004|STARTED|Overall Study||3||
59931833|NCT03318861|76050123|FG000|COMPLETED|Overall Study||0||
59931834|NCT03318861|76050124|FG001|COMPLETED|Overall Study||0||
59931835|NCT03318861|76050125|FG002|COMPLETED|Overall Study||0||
59931836|NCT03318861|76050126|FG003|COMPLETED|Overall Study||0||
59931837|NCT03318861|76050127|FG004|COMPLETED|Overall Study||0||
59931838|NCT03318861|76050123|FG000|NOT COMPLETED|Overall Study||3||
59931839|NCT03318861|76050124|FG001|NOT COMPLETED|Overall Study||4||
59931840|NCT03318861|76050125|FG002|NOT COMPLETED|Overall Study||3||
59931841|NCT03318861|76050126|FG003|NOT COMPLETED|Overall Study||4||
59931842|NCT03318861|76050127|FG004|NOT COMPLETED|Overall Study||3||
59931843|NCT03084315|76050142|FG000|STARTED|Overall Study||116||
59931844|NCT03084315|76050143|FG001|STARTED|Overall Study||118||
59931845|NCT03084315|76050142|FG000|COMPLETED|Overall Study||106||
59931846|NCT03084315|76050143|FG001|COMPLETED|Overall Study||109||
59931847|NCT03084315|76050142|FG000|NOT COMPLETED|Overall Study||10||
59931848|NCT03084315|76050143|FG001|NOT COMPLETED|Overall Study||9||
59931849|NCT03187301|76050149|FG000|STARTED|Titration Period||7||
59931850|NCT03187301|76050150|FG001|STARTED|Titration Period||7||
59931851|NCT03187301|76050151|FG002|STARTED|Titration Period||7||
59931852|NCT03187301|76050152|FG003|STARTED|Titration Period||6||
59931853|NCT03187301|76050153|FG004|STARTED|Titration Period||7||
59931854|NCT03187301|76050154|FG005|STARTED|Titration Period||7||
59931855|NCT03187301|76050155|FG006|STARTED|Titration Period||7||
59931856|NCT03187301|76050149|FG000|COMPLETED|Titration Period||7||
59931857|NCT03187301|76050150|FG001|COMPLETED|Titration Period||7||
59931858|NCT03187301|76050151|FG002|COMPLETED|Titration Period||7||
59931859|NCT03187301|76050152|FG003|COMPLETED|Titration Period||6||
59931860|NCT03187301|76050153|FG004|COMPLETED|Titration Period||7||
59931861|NCT03187301|76050154|FG005|COMPLETED|Titration Period||7||
59931862|NCT03187301|76050155|FG006|COMPLETED|Titration Period||0||
59931863|NCT03187301|76050149|FG000|NOT COMPLETED|Titration Period||0||
59931864|NCT03187301|76050150|FG001|NOT COMPLETED|Titration Period||0||
59931865|NCT03187301|76050151|FG002|NOT COMPLETED|Titration Period||0||
59931866|NCT03187301|76050152|FG003|NOT COMPLETED|Titration Period||0||
59931867|NCT03187301|76050153|FG004|NOT COMPLETED|Titration Period||0||
59931868|NCT03187301|76050154|FG005|NOT COMPLETED|Titration Period||0||
59931869|NCT03187301|76050155|FG006|NOT COMPLETED|Titration Period||7||
59931870|NCT03187301|76050149|FG000|STARTED|Pre-Intervention||7||
59931871|NCT03187301|76050150|FG001|STARTED|Pre-Intervention||7||
59931872|NCT03187301|76050151|FG002|STARTED|Pre-Intervention||7||
59931873|NCT03187301|76050152|FG003|STARTED|Pre-Intervention||6||
59931874|NCT03187301|76050153|FG004|STARTED|Pre-Intervention||7||
59931875|NCT03187301|76050154|FG005|STARTED|Pre-Intervention||7||
59931876|NCT03187301|76050155|FG006|STARTED|Pre-Intervention||0||
59931877|NCT03187301|76050149|FG000|COMPLETED|Pre-Intervention||6||
59931878|NCT03187301|76050150|FG001|COMPLETED|Pre-Intervention||7||
59931879|NCT03187301|76050151|FG002|COMPLETED|Pre-Intervention||7||
59931880|NCT03187301|76050152|FG003|COMPLETED|Pre-Intervention||6||
59931881|NCT03187301|76050153|FG004|COMPLETED|Pre-Intervention||7||
59931882|NCT03187301|76050154|FG005|COMPLETED|Pre-Intervention||7||
59931883|NCT03187301|76050155|FG006|COMPLETED|Pre-Intervention||0||
59931884|NCT03187301|76050149|FG000|NOT COMPLETED|Pre-Intervention||1||
59931885|NCT03187301|76050150|FG001|NOT COMPLETED|Pre-Intervention||0||
59931886|NCT03187301|76050151|FG002|NOT COMPLETED|Pre-Intervention||0||
59931887|NCT03187301|76050152|FG003|NOT COMPLETED|Pre-Intervention||0||
59931888|NCT03187301|76050153|FG004|NOT COMPLETED|Pre-Intervention||0||
59931889|NCT03187301|76050154|FG005|NOT COMPLETED|Pre-Intervention||0||
59931890|NCT03187301|76050155|FG006|NOT COMPLETED|Pre-Intervention||0||
59931891|NCT03187301|76050149|FG000|STARTED|First Intervention||6||
59931892|NCT03187301|76050150|FG001|STARTED|First Intervention||7||
59931893|NCT03187301|76050151|FG002|STARTED|First Intervention||7||
59931894|NCT03187301|76050152|FG003|STARTED|First Intervention||6||
59931895|NCT03187301|76050153|FG004|STARTED|First Intervention||7||
59931896|NCT03187301|76050154|FG005|STARTED|First Intervention||7||
59931897|NCT03187301|76050155|FG006|STARTED|First Intervention||0||
59931898|NCT03187301|76050149|FG000|COMPLETED|First Intervention||6||
59931899|NCT03187301|76050150|FG001|COMPLETED|First Intervention||7||
59931900|NCT03187301|76050151|FG002|COMPLETED|First Intervention||7||
59931901|NCT03187301|76050152|FG003|COMPLETED|First Intervention||6||
59931902|NCT03187301|76050153|FG004|COMPLETED|First Intervention||7||
59931903|NCT03187301|76050154|FG005|COMPLETED|First Intervention||7||
59931904|NCT03187301|76050155|FG006|COMPLETED|First Intervention||0||
59931905|NCT03187301|76050149|FG000|NOT COMPLETED|First Intervention||0||
59931906|NCT03187301|76050150|FG001|NOT COMPLETED|First Intervention||0||
59931907|NCT03187301|76050151|FG002|NOT COMPLETED|First Intervention||0||
59931908|NCT03187301|76050152|FG003|NOT COMPLETED|First Intervention||0||
59931909|NCT03187301|76050153|FG004|NOT COMPLETED|First Intervention||0||
59931910|NCT03187301|76050154|FG005|NOT COMPLETED|First Intervention||0||
59931911|NCT03187301|76050155|FG006|NOT COMPLETED|First Intervention||0||
59931912|NCT03187301|76050149|FG000|STARTED|First Washout||6||
59931913|NCT03187301|76050150|FG001|STARTED|First Washout||7||
59931914|NCT03187301|76050151|FG002|STARTED|First Washout||7||
59931915|NCT03187301|76050152|FG003|STARTED|First Washout||6||
59931916|NCT03187301|76050153|FG004|STARTED|First Washout||7||
59931917|NCT03187301|76050154|FG005|STARTED|First Washout||7||
59931918|NCT03187301|76050155|FG006|STARTED|First Washout||0||
59931919|NCT03187301|76050149|FG000|COMPLETED|First Washout||6||
59931920|NCT03187301|76050150|FG001|COMPLETED|First Washout||7||
59931921|NCT03187301|76050151|FG002|COMPLETED|First Washout||7||
59931922|NCT03187301|76050152|FG003|COMPLETED|First Washout||6||
59931923|NCT03187301|76050153|FG004|COMPLETED|First Washout||7||
59931924|NCT03187301|76050154|FG005|COMPLETED|First Washout||7||
59931925|NCT03187301|76050155|FG006|COMPLETED|First Washout||0||
59931926|NCT03187301|76050149|FG000|NOT COMPLETED|First Washout||0||
59931927|NCT03187301|76050150|FG001|NOT COMPLETED|First Washout||0||
59931928|NCT03187301|76050151|FG002|NOT COMPLETED|First Washout||0||
59931929|NCT03187301|76050152|FG003|NOT COMPLETED|First Washout||0||
59931930|NCT03187301|76050153|FG004|NOT COMPLETED|First Washout||0||
59931931|NCT03187301|76050154|FG005|NOT COMPLETED|First Washout||0||
59931932|NCT03187301|76050155|FG006|NOT COMPLETED|First Washout||0||
59931933|NCT03187301|76050149|FG000|STARTED|Second Intervention||6||
59931934|NCT03187301|76050150|FG001|STARTED|Second Intervention||7||
59931935|NCT03187301|76050151|FG002|STARTED|Second Intervention||7||
59931936|NCT03187301|76050152|FG003|STARTED|Second Intervention||6||
59931937|NCT03187301|76050153|FG004|STARTED|Second Intervention||7||
59931938|NCT03187301|76050154|FG005|STARTED|Second Intervention||7||
59931939|NCT03187301|76050155|FG006|STARTED|Second Intervention||0||
59931940|NCT03187301|76050149|FG000|COMPLETED|Second Intervention||6||
59931941|NCT03187301|76050150|FG001|COMPLETED|Second Intervention||7||
59931942|NCT03187301|76050151|FG002|COMPLETED|Second Intervention||7||
59931943|NCT03187301|76050152|FG003|COMPLETED|Second Intervention||6||
59931944|NCT03187301|76050153|FG004|COMPLETED|Second Intervention||7||
59931945|NCT03187301|76050154|FG005|COMPLETED|Second Intervention||7||
59931946|NCT03187301|76050155|FG006|COMPLETED|Second Intervention||0||
59931947|NCT03187301|76050149|FG000|NOT COMPLETED|Second Intervention||0||
59931948|NCT03187301|76050150|FG001|NOT COMPLETED|Second Intervention||0||
59931949|NCT03187301|76050151|FG002|NOT COMPLETED|Second Intervention||0||
59931950|NCT03187301|76050152|FG003|NOT COMPLETED|Second Intervention||0||
59931951|NCT03187301|76050153|FG004|NOT COMPLETED|Second Intervention||0||
59931952|NCT03187301|76050154|FG005|NOT COMPLETED|Second Intervention||0||
59931953|NCT03187301|76050155|FG006|NOT COMPLETED|Second Intervention||0||
59931954|NCT03187301|76050149|FG000|STARTED|Second Washout||6||
59931955|NCT03187301|76050150|FG001|STARTED|Second Washout||7||
59931956|NCT03187301|76050151|FG002|STARTED|Second Washout||7||
59931957|NCT03187301|76050152|FG003|STARTED|Second Washout||6||
59931958|NCT03187301|76050153|FG004|STARTED|Second Washout||7||
59931959|NCT03187301|76050154|FG005|STARTED|Second Washout||7||
59931960|NCT03187301|76050155|FG006|STARTED|Second Washout||0||
59931961|NCT03187301|76050149|FG000|COMPLETED|Second Washout||6||
59931962|NCT03187301|76050150|FG001|COMPLETED|Second Washout||7||
59931963|NCT03187301|76050151|FG002|COMPLETED|Second Washout||7||
59931964|NCT03187301|76050152|FG003|COMPLETED|Second Washout||6||
59931965|NCT03187301|76050153|FG004|COMPLETED|Second Washout||7||
60067224|NCT02093663|76182406|FG004|NOT COMPLETED|Double Blind Acute Phase (8 Weeks)||0||
59931966|NCT03187301|76050154|FG005|COMPLETED|Second Washout||7||
59931967|NCT03187301|76050155|FG006|COMPLETED|Second Washout||0||
59931968|NCT03187301|76050149|FG000|NOT COMPLETED|Second Washout||0||
59931969|NCT03187301|76050150|FG001|NOT COMPLETED|Second Washout||0||
59931970|NCT03187301|76050151|FG002|NOT COMPLETED|Second Washout||0||
59931971|NCT03187301|76050152|FG003|NOT COMPLETED|Second Washout||0||
59931972|NCT03187301|76050153|FG004|NOT COMPLETED|Second Washout||0||
59931973|NCT03187301|76050154|FG005|NOT COMPLETED|Second Washout||0||
59931974|NCT03187301|76050155|FG006|NOT COMPLETED|Second Washout||0||
59931975|NCT03187301|76050149|FG000|STARTED|Third Intervention||6||
60067225|NCT02093663|76182402|FG000|STARTED|Open Label Acute Phase (8 Weeks)||0||
60067226|NCT02093663|76182403|FG001|STARTED|Open Label Acute Phase (8 Weeks)||0||
59931976|NCT03187301|76050150|FG001|STARTED|Third Intervention||7||
59931977|NCT03187301|76050151|FG002|STARTED|Third Intervention||7||
59931978|NCT03187301|76050152|FG003|STARTED|Third Intervention||6||
59931979|NCT03187301|76050153|FG004|STARTED|Third Intervention||7||
59931980|NCT03187301|76050154|FG005|STARTED|Third Intervention||7||
59931981|NCT03187301|76050155|FG006|STARTED|Third Intervention||0||
59931982|NCT03187301|76050149|FG000|COMPLETED|Third Intervention||6||
59931983|NCT03187301|76050150|FG001|COMPLETED|Third Intervention||7||
59931984|NCT03187301|76050151|FG002|COMPLETED|Third Intervention||7||
59931985|NCT03187301|76050152|FG003|COMPLETED|Third Intervention||6||
59931986|NCT03187301|76050153|FG004|COMPLETED|Third Intervention||7||
59931987|NCT03187301|76050154|FG005|COMPLETED|Third Intervention||7||
60067227|NCT02093663|76182404|FG002|STARTED|Open Label Acute Phase (8 Weeks)||18||
59931988|NCT03187301|76050155|FG006|COMPLETED|Third Intervention||0||
59931989|NCT03187301|76050149|FG000|NOT COMPLETED|Third Intervention||0||
59931990|NCT03187301|76050150|FG001|NOT COMPLETED|Third Intervention||0||
59931991|NCT03187301|76050151|FG002|NOT COMPLETED|Third Intervention||0||
59931992|NCT03187301|76050152|FG003|NOT COMPLETED|Third Intervention||0||
59931993|NCT03187301|76050153|FG004|NOT COMPLETED|Third Intervention||0||
59931994|NCT03187301|76050154|FG005|NOT COMPLETED|Third Intervention||0||
59931995|NCT03187301|76050155|FG006|NOT COMPLETED|Third Intervention||0||
59931996|NCT02946047|76050180|FG000|STARTED|Overall Study||4||
59931997|NCT02946047|76050181|FG001|STARTED|Overall Study||3||
59931998|NCT02946047|76050182|FG002|STARTED|Overall Study||3||
59931999|NCT02946047|76050183|FG003|STARTED|Overall Study||7||
59932000|NCT02946047|76050180|FG000|COMPLETED|Overall Study||3||
59932001|NCT02946047|76050181|FG001|COMPLETED|Overall Study||3||
59932002|NCT02946047|76050182|FG002|COMPLETED|Overall Study||3||
59932003|NCT02946047|76050183|FG003|COMPLETED|Overall Study||7||
59932004|NCT02946047|76050180|FG000|NOT COMPLETED|Overall Study||1||
59932005|NCT02946047|76050181|FG001|NOT COMPLETED|Overall Study||0||
59932006|NCT02946047|76050182|FG002|NOT COMPLETED|Overall Study||0||
59932007|NCT02946047|76050183|FG003|NOT COMPLETED|Overall Study||0||
59932008|NCT03077919|76050195|FG000|STARTED|Overall Study||74||
59932009|NCT03077919|76050196|FG001|STARTED|Overall Study||39||
59932010|NCT03077919|76050195|FG000|Week 2 Visit|Overall Study||74||
59932011|NCT03077919|76050196|FG001|Week 2 Visit|Overall Study||39||
59932012|NCT03077919|76050195|FG000|Week 4 Visit|Overall Study||73||
59932013|NCT03077919|76050196|FG001|Week 4 Visit|Overall Study||38||
59932014|NCT03077919|76050195|FG000|Week 6 Visit|Overall Study||73||
59932015|NCT03077919|76050196|FG001|Week 6 Visit|Overall Study||38||
59932016|NCT03077919|76050195|FG000|Week 8 Visit|Overall Study||71||
59932017|NCT03077919|76050196|FG001|Week 8 Visit|Overall Study||38||
59932018|NCT03077919|76050195|FG000|Final CAPS|Overall Study||70||
59932019|NCT03077919|76050196|FG001|Final CAPS|Overall Study||38||
59932020|NCT03077919|76050195|FG000|COMPLETED|Overall Study||70||
59932021|NCT03077919|76050196|FG001|COMPLETED|Overall Study||38||
59932022|NCT03077919|76050195|FG000|NOT COMPLETED|Overall Study||4||
59932023|NCT03077919|76050196|FG001|NOT COMPLETED|Overall Study||1||
59932024|NCT03220217|76050205|FG000|STARTED|Overall Study||8|Received 68Ga-satoreotide trizoxetan|
59932025|NCT03220217|76050206|FG001|STARTED|Overall Study||10|Received 68Ga-satoreotide trizoxetan|
59932026|NCT03220217|76050207|FG002|STARTED|Overall Study||11|Received 68Ga-satoreotide trizoxetan|
59932027|NCT03220217|76050205|FG000|COMPLETED|Overall Study||8|Completed Study|
59932028|NCT03220217|76050206|FG001|COMPLETED|Overall Study||9|Completed Study|
59932029|NCT03220217|76050207|FG002|COMPLETED|Overall Study||10|Completed Study|
59932030|NCT03220217|76050205|FG000|NOT COMPLETED|Overall Study||0||
59932031|NCT03220217|76050206|FG001|NOT COMPLETED|Overall Study||1||
59932032|NCT03220217|76050207|FG002|NOT COMPLETED|Overall Study||1||
59932033|NCT03192137|76050238|FG000|STARTED|Overall Study||173||
59932034|NCT03192137|76050239|FG001|STARTED|Overall Study||87||
59932035|NCT03192137|76050238|FG000|COMPLETED|Overall Study||123||
59932036|NCT03192137|76050239|FG001|COMPLETED|Overall Study||29||
59932037|NCT03192137|76050238|FG000|NOT COMPLETED|Overall Study||50||
59932038|NCT03192137|76050239|FG001|NOT COMPLETED|Overall Study||58||
59932039|NCT03618095|76050248|FG000|STARTED|Overall Study||274||
59932040|NCT03618095|76050249|FG001|STARTED|Overall Study||63||
59932041|NCT03618095|76050250|FG002|STARTED|Overall Study||45||
59932042|NCT03618095|76050248|FG000|COMPLETED|Overall Study||0||
59932043|NCT03618095|76050249|FG001|COMPLETED|Overall Study||0||
59932044|NCT03618095|76050250|FG002|COMPLETED|Overall Study||0||
59932045|NCT03618095|76050248|FG000|NOT COMPLETED|Overall Study||274||
59932046|NCT03618095|76050249|FG001|NOT COMPLETED|Overall Study||63||
59932047|NCT03618095|76050250|FG002|NOT COMPLETED|Overall Study||45||
59932048|NCT03881059|76050259|FG000|STARTED|Treatment Period - Part A||66||
59932049|NCT03881059|76050260|FG001|STARTED|Treatment Period - Part A||70||
59932050|NCT03881059|76050261|FG002|STARTED|Treatment Period - Part A||67||
59932051|NCT03881059|76050259|FG000|COMPLETED|Treatment Period - Part A||58||
59932052|NCT03881059|76050260|FG001|COMPLETED|Treatment Period - Part A||63||
59932053|NCT03881059|76050261|FG002|COMPLETED|Treatment Period - Part A||59||
59932054|NCT03881059|76050259|FG000|NOT COMPLETED|Treatment Period - Part A||8||
59932055|NCT03881059|76050260|FG001|NOT COMPLETED|Treatment Period - Part A||7||
59932056|NCT03881059|76050261|FG002|NOT COMPLETED|Treatment Period - Part A||8||
59932057|NCT03881059|76050259|FG000|STARTED|Treatment Period - Part B||55|Participation in Part B was optional. Some of the participants who completed Part A decided not to continue in Part B|
59932058|NCT03881059|76050260|FG001|STARTED|Treatment Period - Part B||60|Participation in Part B was optional. Some of the participants who completed Part A decided not to continue in Part B|
59932059|NCT03881059|76050261|FG002|STARTED|Treatment Period - Part B||58|Participation in Part B was optional. Some of the participants who completed Part A decided not to continue in Part B|
59932060|NCT03881059|76050259|FG000|Participants Maintaining Same Treatment as in Part A|Treatment Period - Part B||0||
59932061|NCT03881059|76050260|FG001|Participants Maintaining Same Treatment as in Part A|Treatment Period - Part B||13||
59932062|NCT03881059|76050261|FG002|Participants Maintaining Same Treatment as in Part A|Treatment Period - Part B||16||
60067228|NCT02093663|76182405|FG003|STARTED|Open Label Acute Phase (8 Weeks)||0||
59932063|NCT03881059|76050259|FG000|Participants Treated With Ustekinumab in Part B|Treatment Period - Part B||55||
59932064|NCT03881059|76050260|FG001|Participants Treated With Ustekinumab in Part B|Treatment Period - Part B||47||
59932065|NCT03881059|76050261|FG002|Participants Treated With Ustekinumab in Part B|Treatment Period - Part B||42||
59932066|NCT03881059|76050259|FG000|COMPLETED|Treatment Period - Part B||47||
59932067|NCT03881059|76050260|FG001|COMPLETED|Treatment Period - Part B||54||
59932068|NCT03881059|76050261|FG002|COMPLETED|Treatment Period - Part B||47||
59932069|NCT03881059|76050259|FG000|NOT COMPLETED|Treatment Period - Part B||8||
59932070|NCT03881059|76050260|FG001|NOT COMPLETED|Treatment Period - Part B||6||
59932071|NCT03881059|76050261|FG002|NOT COMPLETED|Treatment Period - Part B||11||
59932072|NCT02861534|76050276|FG000|STARTED|Overall Study||2526||
59932073|NCT02861534|76050277|FG001|STARTED|Overall Study||2524||
59932074|NCT02861534|76050276|FG000|Treated|Overall Study||2519||
59932075|NCT02861534|76050277|FG001|Treated|Overall Study||2515||
59932076|NCT02861534|76050276|FG000|COMPLETED|Overall Study||1952||
59932077|NCT02861534|76050277|FG001|COMPLETED|Overall Study||1937||
59932078|NCT02861534|76050276|FG000|NOT COMPLETED|Overall Study||574||
59932079|NCT02861534|76050277|FG001|NOT COMPLETED|Overall Study||587||
59932080|NCT03167255|76050285|FG000|STARTED|Overall Study||8||
59932081|NCT03167255|76050286|FG001|STARTED|Overall Study||8||
59932082|NCT03167255|76050285|FG000|COMPLETED|Overall Study||8||
59932083|NCT03167255|76050286|FG001|COMPLETED|Overall Study||8||
59932084|NCT03167255|76050285|FG000|NOT COMPLETED|Overall Study||0||
59932085|NCT03167255|76050286|FG001|NOT COMPLETED|Overall Study||0||
59932086|NCT03140969|76050298|FG000|STARTED|Overall Study||6||
59932087|NCT03140969|76050299|FG001|STARTED|Overall Study||5||
59932088|NCT03140969|76050300|FG002|STARTED|Overall Study||0||
59932089|NCT03140969|76050298|FG000|COMPLETED|Overall Study||6||
59932090|NCT03140969|76050299|FG001|COMPLETED|Overall Study||5||
59932091|NCT03140969|76050300|FG002|COMPLETED|Overall Study||0||
59932092|NCT03140969|76050298|FG000|NOT COMPLETED|Overall Study||0||
59932093|NCT03140969|76050299|FG001|NOT COMPLETED|Overall Study||0||
59932094|NCT03140969|76050300|FG002|NOT COMPLETED|Overall Study||0||
59932095|NCT03083847|76050318|FG000|STARTED|Pilot 1a||2||
59932096|NCT03083847|76050319|FG001|STARTED|Pilot 1a||0||
59932097|NCT03083847|76050320|FG002|STARTED|Pilot 1a||0||
59932098|NCT03083847|76050321|FG003|STARTED|Pilot 1a||0||
59932099|NCT03083847|76050322|FG004|STARTED|Pilot 1a||0||
59932100|NCT03083847|76050323|FG005|STARTED|Pilot 1a||0||
59932101|NCT03083847|76050324|FG006|STARTED|Pilot 1a||0||
59932102|NCT03083847|76050325|FG007|STARTED|Pilot 1a||0||
59932103|NCT03083847|76050326|FG008|STARTED|Pilot 1a||0||
59932104|NCT03083847|76050327|FG009|STARTED|Pilot 1a||0||
59932105|NCT03083847|76050318|FG000|COMPLETED|Pilot 1a||2||
59932106|NCT03083847|76050319|FG001|COMPLETED|Pilot 1a||0||
59932107|NCT03083847|76050320|FG002|COMPLETED|Pilot 1a||0||
59932108|NCT03083847|76050321|FG003|COMPLETED|Pilot 1a||0||
59932109|NCT03083847|76050322|FG004|COMPLETED|Pilot 1a||0||
59932110|NCT03083847|76050323|FG005|COMPLETED|Pilot 1a||0||
59932111|NCT03083847|76050324|FG006|COMPLETED|Pilot 1a||0||
59932112|NCT03083847|76050325|FG007|COMPLETED|Pilot 1a||0||
59932113|NCT03083847|76050326|FG008|COMPLETED|Pilot 1a||0||
59932114|NCT03083847|76050327|FG009|COMPLETED|Pilot 1a||0||
59932115|NCT03083847|76050318|FG000|NOT COMPLETED|Pilot 1a||0||
59932116|NCT03083847|76050319|FG001|NOT COMPLETED|Pilot 1a||0||
59932117|NCT03083847|76050320|FG002|NOT COMPLETED|Pilot 1a||0||
59932118|NCT03083847|76050321|FG003|NOT COMPLETED|Pilot 1a||0||
59932119|NCT03083847|76050322|FG004|NOT COMPLETED|Pilot 1a||0||
59932120|NCT03083847|76050323|FG005|NOT COMPLETED|Pilot 1a||0||
59932121|NCT03083847|76050324|FG006|NOT COMPLETED|Pilot 1a||0||
59932122|NCT03083847|76050325|FG007|NOT COMPLETED|Pilot 1a||0||
59932123|NCT03083847|76050326|FG008|NOT COMPLETED|Pilot 1a||0||
59932124|NCT03083847|76050327|FG009|NOT COMPLETED|Pilot 1a||0||
59932125|NCT03083847|76050318|FG000|STARTED|Pilot Ib & 5a||0||
59932126|NCT03083847|76050319|FG001|STARTED|Pilot Ib & 5a||2||
59932127|NCT03083847|76050320|FG002|STARTED|Pilot Ib & 5a||2||
59932128|NCT03083847|76050321|FG003|STARTED|Pilot Ib & 5a||0||
59932129|NCT03083847|76050322|FG004|STARTED|Pilot Ib & 5a||0||
59932130|NCT03083847|76050323|FG005|STARTED|Pilot Ib & 5a||0||
59932131|NCT03083847|76050324|FG006|STARTED|Pilot Ib & 5a||0||
59932132|NCT03083847|76050325|FG007|STARTED|Pilot Ib & 5a||0||
59932133|NCT03083847|76050326|FG008|STARTED|Pilot Ib & 5a||0||
59932134|NCT03083847|76050327|FG009|STARTED|Pilot Ib & 5a||0||
59932135|NCT03083847|76050318|FG000|COMPLETED|Pilot Ib & 5a||0||
59932136|NCT03083847|76050319|FG001|COMPLETED|Pilot Ib & 5a||2||
59932137|NCT03083847|76050320|FG002|COMPLETED|Pilot Ib & 5a||2||
59932138|NCT03083847|76050321|FG003|COMPLETED|Pilot Ib & 5a||0||
59932139|NCT03083847|76050322|FG004|COMPLETED|Pilot Ib & 5a||0||
59932140|NCT03083847|76050323|FG005|COMPLETED|Pilot Ib & 5a||0||
59932141|NCT03083847|76050324|FG006|COMPLETED|Pilot Ib & 5a||0||
59932142|NCT03083847|76050325|FG007|COMPLETED|Pilot Ib & 5a||0||
59932143|NCT03083847|76050326|FG008|COMPLETED|Pilot Ib & 5a||0||
59932144|NCT03083847|76050327|FG009|COMPLETED|Pilot Ib & 5a||0||
59932145|NCT03083847|76050318|FG000|NOT COMPLETED|Pilot Ib & 5a||0||
59932146|NCT03083847|76050319|FG001|NOT COMPLETED|Pilot Ib & 5a||0||
59932147|NCT03083847|76050320|FG002|NOT COMPLETED|Pilot Ib & 5a||0||
59932148|NCT03083847|76050321|FG003|NOT COMPLETED|Pilot Ib & 5a||0||
59932149|NCT03083847|76050322|FG004|NOT COMPLETED|Pilot Ib & 5a||0||
59932150|NCT03083847|76050323|FG005|NOT COMPLETED|Pilot Ib & 5a||0||
59932151|NCT03083847|76050324|FG006|NOT COMPLETED|Pilot Ib & 5a||0||
59932152|NCT03083847|76050325|FG007|NOT COMPLETED|Pilot Ib & 5a||0||
59932153|NCT03083847|76050326|FG008|NOT COMPLETED|Pilot Ib & 5a||0||
59932154|NCT03083847|76050327|FG009|NOT COMPLETED|Pilot Ib & 5a||0||
59932155|NCT03083847|76050318|FG000|STARTED|Pilot 1d & 5b||0||
59932156|NCT03083847|76050319|FG001|STARTED|Pilot 1d & 5b||0||
59932157|NCT03083847|76050320|FG002|STARTED|Pilot 1d & 5b||0||
59932158|NCT03083847|76050321|FG003|STARTED|Pilot 1d & 5b||4||
59932159|NCT03083847|76050322|FG004|STARTED|Pilot 1d & 5b||4||
59932160|NCT03083847|76050323|FG005|STARTED|Pilot 1d & 5b||0||
59932161|NCT03083847|76050324|FG006|STARTED|Pilot 1d & 5b||0||
59932162|NCT03083847|76050325|FG007|STARTED|Pilot 1d & 5b||0||
59932163|NCT03083847|76050326|FG008|STARTED|Pilot 1d & 5b||0||
59932164|NCT03083847|76050327|FG009|STARTED|Pilot 1d & 5b||0||
59932165|NCT03083847|76050318|FG000|COMPLETED|Pilot 1d & 5b||0||
59932166|NCT03083847|76050319|FG001|COMPLETED|Pilot 1d & 5b||0||
59932167|NCT03083847|76050320|FG002|COMPLETED|Pilot 1d & 5b||0||
59932168|NCT03083847|76050321|FG003|COMPLETED|Pilot 1d & 5b||4||
59932169|NCT03083847|76050322|FG004|COMPLETED|Pilot 1d & 5b||4||
59932170|NCT03083847|76050323|FG005|COMPLETED|Pilot 1d & 5b||0||
59932171|NCT03083847|76050324|FG006|COMPLETED|Pilot 1d & 5b||0||
59932172|NCT03083847|76050325|FG007|COMPLETED|Pilot 1d & 5b||0||
59932173|NCT03083847|76050326|FG008|COMPLETED|Pilot 1d & 5b||0||
59932174|NCT03083847|76050327|FG009|COMPLETED|Pilot 1d & 5b||0||
59932175|NCT03083847|76050318|FG000|NOT COMPLETED|Pilot 1d & 5b||0||
59932176|NCT03083847|76050319|FG001|NOT COMPLETED|Pilot 1d & 5b||0||
59932177|NCT03083847|76050320|FG002|NOT COMPLETED|Pilot 1d & 5b||0||
59932178|NCT03083847|76050321|FG003|NOT COMPLETED|Pilot 1d & 5b||0||
59932179|NCT03083847|76050322|FG004|NOT COMPLETED|Pilot 1d & 5b||0||
59932180|NCT03083847|76050323|FG005|NOT COMPLETED|Pilot 1d & 5b||0||
59932181|NCT03083847|76050324|FG006|NOT COMPLETED|Pilot 1d & 5b||0||
59932182|NCT03083847|76050325|FG007|NOT COMPLETED|Pilot 1d & 5b||0||
59932183|NCT03083847|76050326|FG008|NOT COMPLETED|Pilot 1d & 5b||0||
59932184|NCT03083847|76050327|FG009|NOT COMPLETED|Pilot 1d & 5b||0||
59932185|NCT03083847|76050318|FG000|STARTED|Main||0||
59932186|NCT03083847|76050319|FG001|STARTED|Main||0||
59932187|NCT03083847|76050320|FG002|STARTED|Main||0||
59932188|NCT03083847|76050321|FG003|STARTED|Main||0||
59932189|NCT03083847|76050322|FG004|STARTED|Main||0||
59932190|NCT03083847|76050323|FG005|STARTED|Main||9||
59932191|NCT03083847|76050324|FG006|STARTED|Main||10||
59932192|NCT03083847|76050325|FG007|STARTED|Main||10||
59932193|NCT03083847|76050326|FG008|STARTED|Main||4||
59932194|NCT03083847|76050327|FG009|STARTED|Main||8||
59932195|NCT03083847|76050318|FG000|COMPLETED|Main||0||
59932196|NCT03083847|76050319|FG001|COMPLETED|Main||0||
59932197|NCT03083847|76050320|FG002|COMPLETED|Main||0||
59932198|NCT03083847|76050321|FG003|COMPLETED|Main||0||
59932199|NCT03083847|76050322|FG004|COMPLETED|Main||0||
59932200|NCT03083847|76050323|FG005|COMPLETED|Main||8||
59932201|NCT03083847|76050324|FG006|COMPLETED|Main||9||
59932202|NCT03083847|76050325|FG007|COMPLETED|Main||6||
59932203|NCT03083847|76050326|FG008|COMPLETED|Main||4||
59932204|NCT03083847|76050327|FG009|COMPLETED|Main||8||
59932205|NCT03083847|76050318|FG000|NOT COMPLETED|Main||0||
59932206|NCT03083847|76050319|FG001|NOT COMPLETED|Main||0||
59932207|NCT03083847|76050320|FG002|NOT COMPLETED|Main||0||
60067229|NCT02093663|76182406|FG004|STARTED|Open Label Acute Phase (8 Weeks)||0||
59932208|NCT03083847|76050321|FG003|NOT COMPLETED|Main||0||
59932209|NCT03083847|76050322|FG004|NOT COMPLETED|Main||0||
59932210|NCT03083847|76050323|FG005|NOT COMPLETED|Main||1||
59932211|NCT03083847|76050324|FG006|NOT COMPLETED|Main||1||
59932212|NCT03083847|76050325|FG007|NOT COMPLETED|Main||4||
59932213|NCT03083847|76050326|FG008|NOT COMPLETED|Main||0||
59932214|NCT03083847|76050327|FG009|NOT COMPLETED|Main||0||
59932215|NCT03082677|76050355|FG000|STARTED|Overall Study||20||
59932216|NCT03082677|76050355|FG000|COMPLETED|Overall Study||18||
59932217|NCT03082677|76050355|FG000|NOT COMPLETED|Overall Study||2||
59932218|NCT03136055|76050361|FG000|STARTED|Overall Study||14||
59932219|NCT03136055|76050362|FG001|STARTED|Overall Study||22||
59932220|NCT03136055|76050361|FG000|COMPLETED|Overall Study||14||
59932221|NCT03136055|76050362|FG001|COMPLETED|Overall Study||22||
59932222|NCT03136055|76050361|FG000|NOT COMPLETED|Overall Study||0||
59932223|NCT03136055|76050362|FG001|NOT COMPLETED|Overall Study||0||
59932224|NCT02858180|76050370|FG000|STARTED|Overall Study||10||
59932225|NCT02858180|76050371|FG001|STARTED|Overall Study||5||
59932226|NCT02858180|76050370|FG000|COMPLETED|Overall Study|Completed a 12-week course of therapy.|10||
59932227|NCT02858180|76050371|FG001|COMPLETED|Overall Study|Completed a 12-week course of therapy.|3||
59932228|NCT02858180|76050370|FG000|NOT COMPLETED|Overall Study||0||
59932229|NCT02858180|76050371|FG001|NOT COMPLETED|Overall Study||2||
59932230|NCT03082599|76050379|FG000|STARTED|Overall Study||40||
59932231|NCT03082599|76050380|FG001|STARTED|Overall Study||39||
59932232|NCT03082599|76050379|FG000|COMPLETED|Overall Study||39||
59932233|NCT03082599|76050380|FG001|COMPLETED|Overall Study||39||
59932234|NCT03082599|76050379|FG000|NOT COMPLETED|Overall Study||1||
59932235|NCT03082599|76050380|FG001|NOT COMPLETED|Overall Study||0||
59932236|NCT01346501|76050388|FG000|STARTED|Overall Study||79||
59932237|NCT01346501|76050389|FG001|STARTED|Overall Study||93||
59932238|NCT01346501|76050388|FG000|COMPLETED|Overall Study||68||
59932239|NCT01346501|76050389|FG001|COMPLETED|Overall Study||80||
59932240|NCT01346501|76050388|FG000|NOT COMPLETED|Overall Study||11||
59932241|NCT01346501|76050389|FG001|NOT COMPLETED|Overall Study||13||
59932242|NCT03160885|76050399|FG000|STARTED|Initial Treatment Period||593||
59932243|NCT03160885|76050400|FG001|STARTED|Initial Treatment Period||201||
59932244|NCT03160885|76050401|FG002|STARTED|Initial Treatment Period||0||
59932245|NCT03160885|76050402|FG003|STARTED|Initial Treatment Period||0||
59932246|NCT03160885|76050403|FG004|STARTED|Initial Treatment Period||0||
59932247|NCT03160885|76050404|FG005|STARTED|Initial Treatment Period||0||
59932248|NCT03160885|76050405|FG006|STARTED|Initial Treatment Period||0||
59932249|NCT03160885|76050399|FG000|COMPLETED|Initial Treatment Period||558||
59932250|NCT03160885|76050400|FG001|COMPLETED|Initial Treatment Period||179||
59932251|NCT03160885|76050401|FG002|COMPLETED|Initial Treatment Period||0||
59932252|NCT03160885|76050402|FG003|COMPLETED|Initial Treatment Period||0||
59932253|NCT03160885|76050403|FG004|COMPLETED|Initial Treatment Period||0||
59932254|NCT03160885|76050404|FG005|COMPLETED|Initial Treatment Period||0||
59932255|NCT03160885|76050405|FG006|COMPLETED|Initial Treatment Period||0||
59932256|NCT03160885|76050399|FG000|NOT COMPLETED|Initial Treatment Period||35||
59932257|NCT03160885|76050400|FG001|NOT COMPLETED|Initial Treatment Period||22||
59932258|NCT03160885|76050401|FG002|NOT COMPLETED|Initial Treatment Period||0||
59932259|NCT03160885|76050402|FG003|NOT COMPLETED|Initial Treatment Period||0||
59932260|NCT03160885|76050403|FG004|NOT COMPLETED|Initial Treatment Period||0||
59932261|NCT03160885|76050404|FG005|NOT COMPLETED|Initial Treatment Period||0||
59932262|NCT03160885|76050405|FG006|NOT COMPLETED|Initial Treatment Period||0||
59932263|NCT03160885|76050399|FG000|STARTED|Open-label Treatment||0||
59932264|NCT03160885|76050400|FG001|STARTED|Open-label Treatment||0||
59932265|NCT03160885|76050401|FG002|STARTED|Open-label Treatment||0||
59932266|NCT03160885|76050402|FG003|STARTED|Open-label Treatment||0||
59932267|NCT03160885|76050403|FG004|STARTED|Open-label Treatment||0||
59932268|NCT03160885|76050404|FG005|STARTED|Open-label Treatment||0||
59932269|NCT03160885|76050405|FG006|STARTED|Open-label Treatment||560||
59932270|NCT03160885|76050399|FG000|COMPLETED|Open-label Treatment||0||
59932271|NCT03160885|76050400|FG001|COMPLETED|Open-label Treatment||0||
59932272|NCT03160885|76050401|FG002|COMPLETED|Open-label Treatment||0||
59932273|NCT03160885|76050402|FG003|COMPLETED|Open-label Treatment||0||
59932274|NCT03160885|76050403|FG004|COMPLETED|Open-label Treatment||0||
59932275|NCT03160885|76050404|FG005|COMPLETED|Open-label Treatment||0||
59932276|NCT03160885|76050405|FG006|COMPLETED|Open-label Treatment||423||
59932277|NCT03160885|76050399|FG000|NOT COMPLETED|Open-label Treatment||0||
59932278|NCT03160885|76050400|FG001|NOT COMPLETED|Open-label Treatment||0||
59932279|NCT03160885|76050401|FG002|NOT COMPLETED|Open-label Treatment||0||
59932280|NCT03160885|76050402|FG003|NOT COMPLETED|Open-label Treatment||0||
59932281|NCT03160885|76050403|FG004|NOT COMPLETED|Open-label Treatment||0||
59932282|NCT03160885|76050404|FG005|NOT COMPLETED|Open-label Treatment||0||
59932283|NCT03160885|76050405|FG006|NOT COMPLETED|Open-label Treatment||137||
59932284|NCT03160885|76050399|FG000|STARTED|Maintenance Treatment Period||0||
59932285|NCT03160885|76050400|FG001|STARTED|Maintenance Treatment Period||0||
59932286|NCT03160885|76050401|FG002|STARTED|Maintenance Treatment Period||91||
59932287|NCT03160885|76050402|FG003|STARTED|Maintenance Treatment Period||90||
59932288|NCT03160885|76050403|FG004|STARTED|Maintenance Treatment Period||46||
59932289|NCT03160885|76050404|FG005|STARTED|Maintenance Treatment Period||31||
59932290|NCT03160885|76050405|FG006|STARTED|Maintenance Treatment Period||0||
59932291|NCT03160885|76050399|FG000|COMPLETED|Maintenance Treatment Period||0||
59932292|NCT03160885|76050400|FG001|COMPLETED|Maintenance Treatment Period||0||
59932293|NCT03160885|76050401|FG002|COMPLETED|Maintenance Treatment Period||52||
59932294|NCT03160885|76050402|FG003|COMPLETED|Maintenance Treatment Period||50||
59932295|NCT03160885|76050403|FG004|COMPLETED|Maintenance Treatment Period||15||
59932296|NCT03160885|76050404|FG005|COMPLETED|Maintenance Treatment Period||16||
59932297|NCT03160885|76050405|FG006|COMPLETED|Maintenance Treatment Period||0||
59932298|NCT03160885|76050399|FG000|NOT COMPLETED|Maintenance Treatment Period||0||
60067230|NCT02093663|76182402|FG000|Participants Entered OLA Via DBA|Open Label Acute Phase (8 Weeks)||0||
60067231|NCT02093663|76182403|FG001|Participants Entered OLA Via DBA|Open Label Acute Phase (8 Weeks)||0||
59932299|NCT03160885|76050400|FG001|NOT COMPLETED|Maintenance Treatment Period||0||
59932300|NCT03160885|76050401|FG002|NOT COMPLETED|Maintenance Treatment Period||39||
59932301|NCT03160885|76050402|FG003|NOT COMPLETED|Maintenance Treatment Period||40||
60067232|NCT02093663|76182404|FG002|Participants Entered OLA Via DBA|Open Label Acute Phase (8 Weeks)||18||
59932302|NCT03160885|76050403|FG004|NOT COMPLETED|Maintenance Treatment Period||31||
59932303|NCT03160885|76050404|FG005|NOT COMPLETED|Maintenance Treatment Period||15||
59932304|NCT03160885|76050405|FG006|NOT COMPLETED|Maintenance Treatment Period||0||
59932305|NCT03181451|76050425|FG000|STARTED|Overall Study||12||
59932306|NCT03181451|76050426|FG001|STARTED|Overall Study||13||
59932307|NCT03181451|76050427|FG002|STARTED|Overall Study||12||
59932308|NCT03181451|76050425|FG000|COMPLETED|Overall Study||12||
59932309|NCT03181451|76050426|FG001|COMPLETED|Overall Study||11||
59932310|NCT03181451|76050427|FG002|COMPLETED|Overall Study||12||
59932311|NCT03181451|76050425|FG000|NOT COMPLETED|Overall Study||0||
59932312|NCT03181451|76050426|FG001|NOT COMPLETED|Overall Study||2||
59932313|NCT03181451|76050427|FG002|NOT COMPLETED|Overall Study||0||
59932314|NCT00406783|76050439|FG000|STARTED|Overall Study||276||
59932315|NCT00406783|76050440|FG001|STARTED|Overall Study||271||
59932316|NCT00406783|76050439|FG000|COMPLETED|Overall Study||262||
59932317|NCT00406783|76050440|FG001|COMPLETED|Overall Study||256||
59932318|NCT00406783|76050439|FG000|NOT COMPLETED|Overall Study||14||
59932319|NCT00406783|76050440|FG001|NOT COMPLETED|Overall Study||15||
59932320|NCT03179891|76050446|FG000|STARTED|First Intervention||13||
59932321|NCT03179891|76050447|FG001|STARTED|First Intervention||22||
59932322|NCT03179891|76050446|FG000|COMPLETED|First Intervention||11||
59932323|NCT03179891|76050447|FG001|COMPLETED|First Intervention||20||
59932324|NCT03179891|76050446|FG000|NOT COMPLETED|First Intervention||2||
59932325|NCT03179891|76050447|FG001|NOT COMPLETED|First Intervention||2||
59932326|NCT03179891|76050446|FG000|STARTED|Second Intervention (After 14 Days)||11||
59932327|NCT03179891|76050447|FG001|STARTED|Second Intervention (After 14 Days)||20||
59932328|NCT03179891|76050446|FG000|COMPLETED|Second Intervention (After 14 Days)||11||
59932329|NCT03179891|76050447|FG001|COMPLETED|Second Intervention (After 14 Days)||20||
59932330|NCT03179891|76050446|FG000|NOT COMPLETED|Second Intervention (After 14 Days)||0||
59932331|NCT03179891|76050447|FG001|NOT COMPLETED|Second Intervention (After 14 Days)||0||
59932332|NCT02973815|76050458|FG000|STARTED|Post Intervention|58 parent/child dyads|116||
59932333|NCT02973815|76050459|FG001|STARTED|Post Intervention|56 parent/child dyads|112||
59932334|NCT02973815|76050458|FG000|COMPLETED|Post Intervention|54 parent/child dyads|108||
59932335|NCT02973815|76050459|FG001|COMPLETED|Post Intervention|44 parent/child dyads|88||
59932336|NCT02973815|76050458|FG000|NOT COMPLETED|Post Intervention||8||
59932337|NCT02973815|76050459|FG001|NOT COMPLETED|Post Intervention||24||
59932338|NCT02973815|76050458|FG000|STARTED|Follow-up|54 parent/child dyads|108||
59932339|NCT02973815|76050459|FG001|STARTED|Follow-up|44 parent/child dyads|88||
59932340|NCT02973815|76050458|FG000|COMPLETED|Follow-up|53 parent/child dyads|106||
59932341|NCT02973815|76050459|FG001|COMPLETED|Follow-up|44 parent/child dyads|88||
59932342|NCT02973815|76050458|FG000|NOT COMPLETED|Follow-up||2||
59932343|NCT02973815|76050459|FG001|NOT COMPLETED|Follow-up||0||
59932344|NCT03160573|76050469|FG000|STARTED|First Sequence (3 Weeks)||23||
59932345|NCT03160573|76050470|FG001|STARTED|First Sequence (3 Weeks)||26||
59932346|NCT03160573|76050471|FG002|STARTED|First Sequence (3 Weeks)||25||
59932347|NCT03160573|76050472|FG003|STARTED|First Sequence (3 Weeks)||25||
59932348|NCT03160573|76050469|FG000|COMPLETED|First Sequence (3 Weeks)||22||
59932349|NCT03160573|76050470|FG001|COMPLETED|First Sequence (3 Weeks)||23||
59932350|NCT03160573|76050471|FG002|COMPLETED|First Sequence (3 Weeks)||23||
59932351|NCT03160573|76050472|FG003|COMPLETED|First Sequence (3 Weeks)||23||
59932352|NCT03160573|76050469|FG000|NOT COMPLETED|First Sequence (3 Weeks)||1||
59932353|NCT03160573|76050470|FG001|NOT COMPLETED|First Sequence (3 Weeks)||3||
59932354|NCT03160573|76050471|FG002|NOT COMPLETED|First Sequence (3 Weeks)||2||
59932355|NCT03160573|76050472|FG003|NOT COMPLETED|First Sequence (3 Weeks)||2||
59932356|NCT03160573|76050469|FG000|STARTED|Washout (2 Weeks)||22||
59932357|NCT03160573|76050470|FG001|STARTED|Washout (2 Weeks)||23||
59932358|NCT03160573|76050471|FG002|STARTED|Washout (2 Weeks)||23||
59932359|NCT03160573|76050472|FG003|STARTED|Washout (2 Weeks)||23||
59932360|NCT03160573|76050469|FG000|COMPLETED|Washout (2 Weeks)||22||
59932361|NCT03160573|76050470|FG001|COMPLETED|Washout (2 Weeks)||23||
59932362|NCT03160573|76050471|FG002|COMPLETED|Washout (2 Weeks)||23||
59932363|NCT03160573|76050472|FG003|COMPLETED|Washout (2 Weeks)||23||
59932364|NCT03160573|76050469|FG000|NOT COMPLETED|Washout (2 Weeks)||0||
59932365|NCT03160573|76050470|FG001|NOT COMPLETED|Washout (2 Weeks)||0||
59932366|NCT03160573|76050471|FG002|NOT COMPLETED|Washout (2 Weeks)||0||
59932367|NCT03160573|76050472|FG003|NOT COMPLETED|Washout (2 Weeks)||0||
59932368|NCT03160573|76050469|FG000|STARTED|Second Sequence (3 Weeks)||22||
59932369|NCT03160573|76050470|FG001|STARTED|Second Sequence (3 Weeks)||23||
59932370|NCT03160573|76050471|FG002|STARTED|Second Sequence (3 Weeks)||23||
59932371|NCT03160573|76050472|FG003|STARTED|Second Sequence (3 Weeks)||23||
59932372|NCT03160573|76050469|FG000|COMPLETED|Second Sequence (3 Weeks)||22||
59932373|NCT03160573|76050470|FG001|COMPLETED|Second Sequence (3 Weeks)||23||
59932374|NCT03160573|76050471|FG002|COMPLETED|Second Sequence (3 Weeks)||23||
59932375|NCT03160573|76050472|FG003|COMPLETED|Second Sequence (3 Weeks)||23||
59932376|NCT03160573|76050469|FG000|NOT COMPLETED|Second Sequence (3 Weeks)||0||
59932377|NCT03160573|76050470|FG001|NOT COMPLETED|Second Sequence (3 Weeks)||0||
59932378|NCT03160573|76050471|FG002|NOT COMPLETED|Second Sequence (3 Weeks)||0||
59932379|NCT03160573|76050472|FG003|NOT COMPLETED|Second Sequence (3 Weeks)||0||
59932380|NCT02736227|76050485|FG000|STARTED|Overall Study||5||
59932381|NCT02736227|76050486|FG001|STARTED|Overall Study||15||
59932382|NCT02736227|76050487|FG002|STARTED|Overall Study||8||
59932383|NCT02736227|76050485|FG000|COMPLETED|Overall Study||5||
59932384|NCT02736227|76050486|FG001|COMPLETED|Overall Study||15||
59932385|NCT02736227|76050487|FG002|COMPLETED|Overall Study||0||
59932386|NCT02736227|76050485|FG000|NOT COMPLETED|Overall Study||0||
59932387|NCT02736227|76050486|FG001|NOT COMPLETED|Overall Study||0||
59932388|NCT02736227|76050487|FG002|NOT COMPLETED|Overall Study||8||
59932389|NCT03176459|76050496|FG000|STARTED|Overall Study||96|Subject 263-0203 was randomized to bupivacaine HCl but received EXPAREL 266 mg. Subject 263-0203 is included in the IR bupivacaine group in this table.|
59932390|NCT03176459|76050497|FG001|STARTED|Overall Study||90|Subject 263-0203 was randomized to bupivacaine HCl but received EXPAREL 266 mg. Subject 263-0203 is included in the IR bupivacaine group in this table.|
59932391|NCT03176459|76050496|FG000|COMPLETED|Overall Study||91||
59932392|NCT03176459|76050497|FG001|COMPLETED|Overall Study||83||
59932393|NCT03176459|76050496|FG000|NOT COMPLETED|Overall Study||5||
59932394|NCT03176459|76050497|FG001|NOT COMPLETED|Overall Study||7||
59932395|NCT03155269|76050505|FG000|STARTED|Overall Study||57||
59932396|NCT03155269|76050506|FG001|STARTED|Overall Study||57||
59932397|NCT03155269|76050505|FG000|COMPLETED|Overall Study||52||
59932398|NCT03155269|76050506|FG001|COMPLETED|Overall Study||50||
59932399|NCT03155269|76050505|FG000|NOT COMPLETED|Overall Study||5||
59932400|NCT03155269|76050506|FG001|NOT COMPLETED|Overall Study||7||
59932401|NCT02906670|76050522|FG000|STARTED|Cohort 1, QW||1||
59932402|NCT02906670|76050523|FG001|STARTED|Cohort 1, QW||0||
59932403|NCT02906670|76050524|FG002|STARTED|Cohort 1, QW||0||
59932404|NCT02906670|76050525|FG003|STARTED|Cohort 1, QW||0||
59932405|NCT02906670|76050526|FG004|STARTED|Cohort 1, QW||0||
59932406|NCT02906670|76050527|FG005|STARTED|Cohort 1, QW||0||
60067233|NCT02093663|76182405|FG003|Participants Entered OLA Via DBA|Open Label Acute Phase (8 Weeks)||0||
59932407|NCT02906670|76050528|FG006|STARTED|Cohort 1, QW||0||
59932408|NCT02906670|76050529|FG007|STARTED|Cohort 1, QW||0||
59932409|NCT02906670|76050530|FG008|STARTED|Cohort 1, QW||0||
59932410|NCT02906670|76050531|FG009|STARTED|Cohort 1, QW||0||
59932411|NCT02906670|76050522|FG000|COMPLETED|Cohort 1, QW||0||
59932412|NCT02906670|76050523|FG001|COMPLETED|Cohort 1, QW||0||
59932413|NCT02906670|76050524|FG002|COMPLETED|Cohort 1, QW||0||
59932414|NCT02906670|76050525|FG003|COMPLETED|Cohort 1, QW||0||
59932415|NCT02906670|76050526|FG004|COMPLETED|Cohort 1, QW||0||
59932416|NCT02906670|76050527|FG005|COMPLETED|Cohort 1, QW||0||
59932417|NCT02906670|76050528|FG006|COMPLETED|Cohort 1, QW||0||
59932418|NCT02906670|76050529|FG007|COMPLETED|Cohort 1, QW||0||
59932419|NCT02906670|76050530|FG008|COMPLETED|Cohort 1, QW||0||
59932420|NCT02906670|76050531|FG009|COMPLETED|Cohort 1, QW||0||
59932421|NCT02906670|76050522|FG000|NOT COMPLETED|Cohort 1, QW||1||
59932422|NCT02906670|76050523|FG001|NOT COMPLETED|Cohort 1, QW||0||
59932423|NCT02906670|76050524|FG002|NOT COMPLETED|Cohort 1, QW||0||
59932424|NCT02906670|76050525|FG003|NOT COMPLETED|Cohort 1, QW||0||
59932425|NCT02906670|76050526|FG004|NOT COMPLETED|Cohort 1, QW||0||
59932426|NCT02906670|76050527|FG005|NOT COMPLETED|Cohort 1, QW||0||
59932427|NCT02906670|76050528|FG006|NOT COMPLETED|Cohort 1, QW||0||
59932428|NCT02906670|76050529|FG007|NOT COMPLETED|Cohort 1, QW||0||
59932429|NCT02906670|76050530|FG008|NOT COMPLETED|Cohort 1, QW||0||
59932430|NCT02906670|76050531|FG009|NOT COMPLETED|Cohort 1, QW||0||
59932431|NCT02906670|76050522|FG000|STARTED|Cohort 2, QW||0||
59932432|NCT02906670|76050523|FG001|STARTED|Cohort 2, QW||1||
59932433|NCT02906670|76050524|FG002|STARTED|Cohort 2, QW||0||
60067234|NCT02093663|76182406|FG004|Participants Entered OLA Via DBA|Open Label Acute Phase (8 Weeks)||0||
60067235|NCT02093663|76182402|FG000|COMPLETED|Open Label Acute Phase (8 Weeks)||0||
60067236|NCT02093663|76182403|FG001|COMPLETED|Open Label Acute Phase (8 Weeks)||0||
60067237|NCT02093663|76182404|FG002|COMPLETED|Open Label Acute Phase (8 Weeks)||12||
60067238|NCT02093663|76182405|FG003|COMPLETED|Open Label Acute Phase (8 Weeks)||0||
59932434|NCT02906670|76050525|FG003|STARTED|Cohort 2, QW||0||
59932435|NCT02906670|76050526|FG004|STARTED|Cohort 2, QW||0||
59932436|NCT02906670|76050527|FG005|STARTED|Cohort 2, QW||0||
59932437|NCT02906670|76050528|FG006|STARTED|Cohort 2, QW||0||
59932438|NCT02906670|76050529|FG007|STARTED|Cohort 2, QW||0||
59932439|NCT02906670|76050530|FG008|STARTED|Cohort 2, QW||0||
59932440|NCT02906670|76050531|FG009|STARTED|Cohort 2, QW||0||
59932441|NCT02906670|76050522|FG000|COMPLETED|Cohort 2, QW||0||
59932442|NCT02906670|76050523|FG001|COMPLETED|Cohort 2, QW||0||
59932443|NCT02906670|76050524|FG002|COMPLETED|Cohort 2, QW||0||
59932444|NCT02906670|76050525|FG003|COMPLETED|Cohort 2, QW||0||
59932445|NCT02906670|76050526|FG004|COMPLETED|Cohort 2, QW||0||
59932446|NCT02906670|76050527|FG005|COMPLETED|Cohort 2, QW||0||
59932447|NCT02906670|76050528|FG006|COMPLETED|Cohort 2, QW||0||
59932448|NCT02906670|76050529|FG007|COMPLETED|Cohort 2, QW||0||
59932449|NCT02906670|76050530|FG008|COMPLETED|Cohort 2, QW||0||
59932450|NCT02906670|76050531|FG009|COMPLETED|Cohort 2, QW||0||
59932451|NCT02906670|76050522|FG000|NOT COMPLETED|Cohort 2, QW||0||
59932452|NCT02906670|76050523|FG001|NOT COMPLETED|Cohort 2, QW||1||
59932453|NCT02906670|76050524|FG002|NOT COMPLETED|Cohort 2, QW||0||
59932454|NCT02906670|76050525|FG003|NOT COMPLETED|Cohort 2, QW||0||
59932455|NCT02906670|76050526|FG004|NOT COMPLETED|Cohort 2, QW||0||
59932456|NCT02906670|76050527|FG005|NOT COMPLETED|Cohort 2, QW||0||
59932457|NCT02906670|76050528|FG006|NOT COMPLETED|Cohort 2, QW||0||
59932458|NCT02906670|76050529|FG007|NOT COMPLETED|Cohort 2, QW||0||
59932459|NCT02906670|76050530|FG008|NOT COMPLETED|Cohort 2, QW||0||
59932460|NCT02906670|76050531|FG009|NOT COMPLETED|Cohort 2, QW||0||
59932461|NCT02906670|76050522|FG000|STARTED|Cohort 3, QW||0||
59932462|NCT02906670|76050523|FG001|STARTED|Cohort 3, QW||0||
59932463|NCT02906670|76050524|FG002|STARTED|Cohort 3, QW||4||
59932464|NCT02906670|76050525|FG003|STARTED|Cohort 3, QW||0||
59932465|NCT02906670|76050526|FG004|STARTED|Cohort 3, QW||0||
59932466|NCT02906670|76050527|FG005|STARTED|Cohort 3, QW||0||
59932467|NCT02906670|76050528|FG006|STARTED|Cohort 3, QW||0||
59932468|NCT02906670|76050529|FG007|STARTED|Cohort 3, QW||0||
59932469|NCT02906670|76050530|FG008|STARTED|Cohort 3, QW||0||
59932470|NCT02906670|76050531|FG009|STARTED|Cohort 3, QW||0||
59932471|NCT02906670|76050522|FG000|COMPLETED|Cohort 3, QW||0||
59932472|NCT02906670|76050523|FG001|COMPLETED|Cohort 3, QW||0||
59932473|NCT02906670|76050524|FG002|COMPLETED|Cohort 3, QW||0||
59932474|NCT02906670|76050525|FG003|COMPLETED|Cohort 3, QW||0||
59932475|NCT02906670|76050526|FG004|COMPLETED|Cohort 3, QW||0||
59932476|NCT02906670|76050527|FG005|COMPLETED|Cohort 3, QW||0||
59932477|NCT02906670|76050528|FG006|COMPLETED|Cohort 3, QW||0||
59932478|NCT02906670|76050529|FG007|COMPLETED|Cohort 3, QW||0||
59932479|NCT02906670|76050530|FG008|COMPLETED|Cohort 3, QW||0||
59932480|NCT02906670|76050531|FG009|COMPLETED|Cohort 3, QW||0||
59932481|NCT02906670|76050522|FG000|NOT COMPLETED|Cohort 3, QW||0||
59932482|NCT02906670|76050523|FG001|NOT COMPLETED|Cohort 3, QW||0||
59932483|NCT02906670|76050524|FG002|NOT COMPLETED|Cohort 3, QW||4||
59932484|NCT02906670|76050525|FG003|NOT COMPLETED|Cohort 3, QW||0||
59932485|NCT02906670|76050526|FG004|NOT COMPLETED|Cohort 3, QW||0||
59932486|NCT02906670|76050527|FG005|NOT COMPLETED|Cohort 3, QW||0||
59932487|NCT02906670|76050528|FG006|NOT COMPLETED|Cohort 3, QW||0||
59932488|NCT02906670|76050529|FG007|NOT COMPLETED|Cohort 3, QW||0||
59932489|NCT02906670|76050530|FG008|NOT COMPLETED|Cohort 3, QW||0||
59932490|NCT02906670|76050531|FG009|NOT COMPLETED|Cohort 3, QW||0||
59932491|NCT02906670|76050522|FG000|STARTED|Cohort 4, Q2W||0||
59932492|NCT02906670|76050523|FG001|STARTED|Cohort 4, Q2W||0||
59932493|NCT02906670|76050524|FG002|STARTED|Cohort 4, Q2W||0||
59932494|NCT02906670|76050525|FG003|STARTED|Cohort 4, Q2W||0||
59932495|NCT02906670|76050526|FG004|STARTED|Cohort 4, Q2W||0||
59932496|NCT02906670|76050527|FG005|STARTED|Cohort 4, Q2W||3||
59932497|NCT02906670|76050528|FG006|STARTED|Cohort 4, Q2W||0||
59932498|NCT02906670|76050529|FG007|STARTED|Cohort 4, Q2W||0||
59932499|NCT02906670|76050530|FG008|STARTED|Cohort 4, Q2W||0||
60067239|NCT02093663|76182406|FG004|COMPLETED|Open Label Acute Phase (8 Weeks)||0||
60067240|NCT02093663|76182402|FG000|NOT COMPLETED|Open Label Acute Phase (8 Weeks)||0||
60067241|NCT02093663|76182403|FG001|NOT COMPLETED|Open Label Acute Phase (8 Weeks)||0||
60067242|NCT02093663|76182404|FG002|NOT COMPLETED|Open Label Acute Phase (8 Weeks)||6||
60067243|NCT02093663|76182405|FG003|NOT COMPLETED|Open Label Acute Phase (8 Weeks)||0||
60067244|NCT02093663|76182406|FG004|NOT COMPLETED|Open Label Acute Phase (8 Weeks)||0||
60067245|NCT02093663|76182402|FG000|STARTED|Double Blind Maintenance Phase(26 Weeks)||0||
60067246|NCT02093663|76182403|FG001|STARTED|Double Blind Maintenance Phase(26 Weeks)||0||
60067247|NCT02093663|76182404|FG002|STARTED|Double Blind Maintenance Phase(26 Weeks)||0||
60067248|NCT02093663|76182405|FG003|STARTED|Double Blind Maintenance Phase(26 Weeks)||42||
60067249|NCT02093663|76182406|FG004|STARTED|Double Blind Maintenance Phase(26 Weeks)||45||
60067250|NCT02093663|76182402|FG000|Participants Entered Directly to DBM|Double Blind Maintenance Phase(26 Weeks)||0||
60067251|NCT02093663|76182403|FG001|Participants Entered Directly to DBM|Double Blind Maintenance Phase(26 Weeks)||0||
60067252|NCT02093663|76182404|FG002|Participants Entered Directly to DBM|Double Blind Maintenance Phase(26 Weeks)||0||
60067253|NCT02093663|76182405|FG003|Participants Entered Directly to DBM|Double Blind Maintenance Phase(26 Weeks)||26||
60067254|NCT02093663|76182406|FG004|Participants Entered Directly to DBM|Double Blind Maintenance Phase(26 Weeks)||26||
60067255|NCT02093663|76182402|FG000|Participants Entered DBM Via DBA|Double Blind Maintenance Phase(26 Weeks)||0||
60067256|NCT02093663|76182403|FG001|Participants Entered DBM Via DBA|Double Blind Maintenance Phase(26 Weeks)||0||
60067257|NCT02093663|76182404|FG002|Participants Entered DBM Via DBA|Double Blind Maintenance Phase(26 Weeks)||0||
60067258|NCT02093663|76182405|FG003|Participants Entered DBM Via DBA|Double Blind Maintenance Phase(26 Weeks)||12||
60067259|NCT02093663|76182406|FG004|Participants Entered DBM Via DBA|Double Blind Maintenance Phase(26 Weeks)||15||
60067260|NCT02093663|76182402|FG000|Participants Entered DBM Via OLA|Double Blind Maintenance Phase(26 Weeks)||0||
59932500|NCT02906670|76050531|FG009|STARTED|Cohort 4, Q2W||0||
60067261|NCT02093663|76182403|FG001|Participants Entered DBM Via OLA|Double Blind Maintenance Phase(26 Weeks)||0||
59932501|NCT02906670|76050522|FG000|COMPLETED|Cohort 4, Q2W||0||
59932502|NCT02906670|76050523|FG001|COMPLETED|Cohort 4, Q2W||0||
59932503|NCT02906670|76050524|FG002|COMPLETED|Cohort 4, Q2W||0||
59932504|NCT02906670|76050525|FG003|COMPLETED|Cohort 4, Q2W||0||
59932505|NCT02906670|76050526|FG004|COMPLETED|Cohort 4, Q2W||0||
59932506|NCT02906670|76050527|FG005|COMPLETED|Cohort 4, Q2W||0||
59932507|NCT02906670|76050528|FG006|COMPLETED|Cohort 4, Q2W||0||
59932508|NCT02906670|76050529|FG007|COMPLETED|Cohort 4, Q2W||0||
59932509|NCT02906670|76050530|FG008|COMPLETED|Cohort 4, Q2W||0||
59932510|NCT02906670|76050531|FG009|COMPLETED|Cohort 4, Q2W||0||
59932511|NCT02906670|76050522|FG000|NOT COMPLETED|Cohort 4, Q2W||0||
59932512|NCT02906670|76050523|FG001|NOT COMPLETED|Cohort 4, Q2W||0||
59932513|NCT02906670|76050524|FG002|NOT COMPLETED|Cohort 4, Q2W||0||
59932514|NCT02906670|76050525|FG003|NOT COMPLETED|Cohort 4, Q2W||0||
59932515|NCT02906670|76050526|FG004|NOT COMPLETED|Cohort 4, Q2W||0||
59932516|NCT02906670|76050527|FG005|NOT COMPLETED|Cohort 4, Q2W||3||
59932517|NCT02906670|76050528|FG006|NOT COMPLETED|Cohort 4, Q2W||0||
59932518|NCT02906670|76050529|FG007|NOT COMPLETED|Cohort 4, Q2W||0||
59932519|NCT02906670|76050530|FG008|NOT COMPLETED|Cohort 4, Q2W||0||
59932520|NCT02906670|76050531|FG009|NOT COMPLETED|Cohort 4, Q2W||0||
59932521|NCT02906670|76050522|FG000|STARTED|Cohort 5, Q2W||0||
59932522|NCT02906670|76050523|FG001|STARTED|Cohort 5, Q2W||0||
59932523|NCT02906670|76050524|FG002|STARTED|Cohort 5, Q2W||0||
59932524|NCT02906670|76050525|FG003|STARTED|Cohort 5, Q2W||0||
59932525|NCT02906670|76050526|FG004|STARTED|Cohort 5, Q2W||0||
59932526|NCT02906670|76050527|FG005|STARTED|Cohort 5, Q2W||0||
59932527|NCT02906670|76050528|FG006|STARTED|Cohort 5, Q2W||7||
59932528|NCT02906670|76050529|FG007|STARTED|Cohort 5, Q2W||0||
59932529|NCT02906670|76050530|FG008|STARTED|Cohort 5, Q2W||0||
59932530|NCT02906670|76050531|FG009|STARTED|Cohort 5, Q2W||0||
59932531|NCT02906670|76050522|FG000|COMPLETED|Cohort 5, Q2W||0||
59932532|NCT02906670|76050523|FG001|COMPLETED|Cohort 5, Q2W||0||
59932533|NCT02906670|76050524|FG002|COMPLETED|Cohort 5, Q2W||0||
59932534|NCT02906670|76050525|FG003|COMPLETED|Cohort 5, Q2W||0||
59932535|NCT02906670|76050526|FG004|COMPLETED|Cohort 5, Q2W||0||
59932536|NCT02906670|76050527|FG005|COMPLETED|Cohort 5, Q2W||0||
59932537|NCT02906670|76050528|FG006|COMPLETED|Cohort 5, Q2W||0||
59932538|NCT02906670|76050529|FG007|COMPLETED|Cohort 5, Q2W||0||
59932539|NCT02906670|76050530|FG008|COMPLETED|Cohort 5, Q2W||0||
59932540|NCT02906670|76050531|FG009|COMPLETED|Cohort 5, Q2W||0||
59932541|NCT02906670|76050522|FG000|NOT COMPLETED|Cohort 5, Q2W||0||
59932542|NCT02906670|76050523|FG001|NOT COMPLETED|Cohort 5, Q2W||0||
59932543|NCT02906670|76050524|FG002|NOT COMPLETED|Cohort 5, Q2W||0||
59932544|NCT02906670|76050525|FG003|NOT COMPLETED|Cohort 5, Q2W||0||
59932545|NCT02906670|76050526|FG004|NOT COMPLETED|Cohort 5, Q2W||0||
59932546|NCT02906670|76050527|FG005|NOT COMPLETED|Cohort 5, Q2W||0||
59932547|NCT02906670|76050528|FG006|NOT COMPLETED|Cohort 5, Q2W||7||
59932548|NCT02906670|76050529|FG007|NOT COMPLETED|Cohort 5, Q2W||0||
59932549|NCT02906670|76050530|FG008|NOT COMPLETED|Cohort 5, Q2W||0||
59932550|NCT02906670|76050531|FG009|NOT COMPLETED|Cohort 5, Q2W||0||
59932551|NCT02906670|76050522|FG000|STARTED|Cohort 5P, Q2W||0||
59932552|NCT02906670|76050523|FG001|STARTED|Cohort 5P, Q2W||0||
59932553|NCT02906670|76050524|FG002|STARTED|Cohort 5P, Q2W||0||
59932554|NCT02906670|76050525|FG003|STARTED|Cohort 5P, Q2W||0||
59932555|NCT02906670|76050526|FG004|STARTED|Cohort 5P, Q2W||0||
59932556|NCT02906670|76050527|FG005|STARTED|Cohort 5P, Q2W||0||
59932557|NCT02906670|76050528|FG006|STARTED|Cohort 5P, Q2W||0||
59932558|NCT02906670|76050529|FG007|STARTED|Cohort 5P, Q2W||3||
59932559|NCT02906670|76050530|FG008|STARTED|Cohort 5P, Q2W||0||
59932560|NCT02906670|76050531|FG009|STARTED|Cohort 5P, Q2W||0||
59932561|NCT02906670|76050522|FG000|COMPLETED|Cohort 5P, Q2W||0||
59932562|NCT02906670|76050523|FG001|COMPLETED|Cohort 5P, Q2W||0||
59932563|NCT02906670|76050524|FG002|COMPLETED|Cohort 5P, Q2W||0||
59932564|NCT02906670|76050525|FG003|COMPLETED|Cohort 5P, Q2W||0||
59932565|NCT02906670|76050526|FG004|COMPLETED|Cohort 5P, Q2W||0||
59932566|NCT02906670|76050527|FG005|COMPLETED|Cohort 5P, Q2W||0||
59932567|NCT02906670|76050528|FG006|COMPLETED|Cohort 5P, Q2W||0||
59932568|NCT02906670|76050529|FG007|COMPLETED|Cohort 5P, Q2W||0||
59932569|NCT02906670|76050530|FG008|COMPLETED|Cohort 5P, Q2W||0||
59932570|NCT02906670|76050531|FG009|COMPLETED|Cohort 5P, Q2W||0||
59932571|NCT02906670|76050522|FG000|NOT COMPLETED|Cohort 5P, Q2W||0||
60067262|NCT02093663|76182404|FG002|Participants Entered DBM Via OLA|Double Blind Maintenance Phase(26 Weeks)||0||
60067263|NCT02093663|76182405|FG003|Participants Entered DBM Via OLA|Double Blind Maintenance Phase(26 Weeks)||4||
60067264|NCT02093663|76182406|FG004|Participants Entered DBM Via OLA|Double Blind Maintenance Phase(26 Weeks)||4||
59932572|NCT02906670|76050523|FG001|NOT COMPLETED|Cohort 5P, Q2W||0||
59932573|NCT02906670|76050524|FG002|NOT COMPLETED|Cohort 5P, Q2W||0||
60067265|NCT02093663|76182402|FG000|COMPLETED|Double Blind Maintenance Phase(26 Weeks)||0||
59932574|NCT02906670|76050525|FG003|NOT COMPLETED|Cohort 5P, Q2W||0||
59932575|NCT02906670|76050526|FG004|NOT COMPLETED|Cohort 5P, Q2W||0||
59932576|NCT02906670|76050527|FG005|NOT COMPLETED|Cohort 5P, Q2W||0||
59932577|NCT02906670|76050528|FG006|NOT COMPLETED|Cohort 5P, Q2W||0||
60067266|NCT02093663|76182403|FG001|COMPLETED|Double Blind Maintenance Phase(26 Weeks)||0||
60067267|NCT02093663|76182404|FG002|COMPLETED|Double Blind Maintenance Phase(26 Weeks)||0||
59932578|NCT02906670|76050529|FG007|NOT COMPLETED|Cohort 5P, Q2W||3||
59932579|NCT02906670|76050530|FG008|NOT COMPLETED|Cohort 5P, Q2W||0||
59932580|NCT02906670|76050531|FG009|NOT COMPLETED|Cohort 5P, Q2W||0||
59932581|NCT02906670|76050522|FG000|STARTED|Cohort 6P, Q2W||0||
59932582|NCT02906670|76050523|FG001|STARTED|Cohort 6P, Q2W||0||
59932583|NCT02906670|76050524|FG002|STARTED|Cohort 6P, Q2W||0||
59932584|NCT02906670|76050525|FG003|STARTED|Cohort 6P, Q2W||0||
59932585|NCT02906670|76050526|FG004|STARTED|Cohort 6P, Q2W||0||
59932586|NCT02906670|76050527|FG005|STARTED|Cohort 6P, Q2W||0||
59932587|NCT02906670|76050528|FG006|STARTED|Cohort 6P, Q2W||0||
59932588|NCT02906670|76050529|FG007|STARTED|Cohort 6P, Q2W||0||
59932589|NCT02906670|76050530|FG008|STARTED|Cohort 6P, Q2W||4||
59932590|NCT02906670|76050531|FG009|STARTED|Cohort 6P, Q2W||0||
59932591|NCT02906670|76050522|FG000|COMPLETED|Cohort 6P, Q2W||0||
59932592|NCT02906670|76050523|FG001|COMPLETED|Cohort 6P, Q2W||0||
59932593|NCT02906670|76050524|FG002|COMPLETED|Cohort 6P, Q2W||0||
59932594|NCT02906670|76050525|FG003|COMPLETED|Cohort 6P, Q2W||0||
59932595|NCT02906670|76050526|FG004|COMPLETED|Cohort 6P, Q2W||0||
59932596|NCT02906670|76050527|FG005|COMPLETED|Cohort 6P, Q2W||0||
59932597|NCT02906670|76050528|FG006|COMPLETED|Cohort 6P, Q2W||0||
59932598|NCT02906670|76050529|FG007|COMPLETED|Cohort 6P, Q2W||0||
59932599|NCT02906670|76050530|FG008|COMPLETED|Cohort 6P, Q2W||0||
59932600|NCT02906670|76050531|FG009|COMPLETED|Cohort 6P, Q2W||0||
59932601|NCT02906670|76050522|FG000|NOT COMPLETED|Cohort 6P, Q2W||0||
59932602|NCT02906670|76050523|FG001|NOT COMPLETED|Cohort 6P, Q2W||0||
59932603|NCT02906670|76050524|FG002|NOT COMPLETED|Cohort 6P, Q2W||0||
59932604|NCT02906670|76050525|FG003|NOT COMPLETED|Cohort 6P, Q2W||0||
59932605|NCT02906670|76050526|FG004|NOT COMPLETED|Cohort 6P, Q2W||0||
59932606|NCT02906670|76050527|FG005|NOT COMPLETED|Cohort 6P, Q2W||0||
59932607|NCT02906670|76050528|FG006|NOT COMPLETED|Cohort 6P, Q2W||0||
59932608|NCT02906670|76050529|FG007|NOT COMPLETED|Cohort 6P, Q2W||0||
59932609|NCT02906670|76050530|FG008|NOT COMPLETED|Cohort 6P, Q2W||4||
59932610|NCT02906670|76050531|FG009|NOT COMPLETED|Cohort 6P, Q2W||0||
59932611|NCT02906670|76050522|FG000|STARTED|Cohort 4P, QW||0||
59932612|NCT02906670|76050523|FG001|STARTED|Cohort 4P, QW||0||
59932613|NCT02906670|76050524|FG002|STARTED|Cohort 4P, QW||0||
59932614|NCT02906670|76050525|FG003|STARTED|Cohort 4P, QW||3||
59932615|NCT02906670|76050526|FG004|STARTED|Cohort 4P, QW||0||
59932616|NCT02906670|76050527|FG005|STARTED|Cohort 4P, QW||0||
59932617|NCT02906670|76050528|FG006|STARTED|Cohort 4P, QW||0||
59932618|NCT02906670|76050529|FG007|STARTED|Cohort 4P, QW||0||
59932619|NCT02906670|76050530|FG008|STARTED|Cohort 4P, QW||0||
59932620|NCT02906670|76050531|FG009|STARTED|Cohort 4P, QW||0||
59932621|NCT02906670|76050522|FG000|COMPLETED|Cohort 4P, QW||0||
59932622|NCT02906670|76050523|FG001|COMPLETED|Cohort 4P, QW||0||
59932623|NCT02906670|76050524|FG002|COMPLETED|Cohort 4P, QW||0||
59932624|NCT02906670|76050525|FG003|COMPLETED|Cohort 4P, QW||0||
59932625|NCT02906670|76050526|FG004|COMPLETED|Cohort 4P, QW||0||
59932626|NCT02906670|76050527|FG005|COMPLETED|Cohort 4P, QW||0||
59932627|NCT02906670|76050528|FG006|COMPLETED|Cohort 4P, QW||0||
59932628|NCT02906670|76050529|FG007|COMPLETED|Cohort 4P, QW||0||
59518340|NCT01077973|75612144|FG001|COMPLETED|Overall Study||79||
59518341|NCT01077973|75612145|FG002|COMPLETED|Overall Study||80||
59932629|NCT02906670|76050530|FG008|COMPLETED|Cohort 4P, QW||0||
59932630|NCT02906670|76050531|FG009|COMPLETED|Cohort 4P, QW||0||
59932631|NCT02906670|76050522|FG000|NOT COMPLETED|Cohort 4P, QW||0||
59932632|NCT02906670|76050523|FG001|NOT COMPLETED|Cohort 4P, QW||0||
59932633|NCT02906670|76050524|FG002|NOT COMPLETED|Cohort 4P, QW||0||
59932634|NCT02906670|76050525|FG003|NOT COMPLETED|Cohort 4P, QW||3||
59932635|NCT02906670|76050526|FG004|NOT COMPLETED|Cohort 4P, QW||0||
59932636|NCT02906670|76050527|FG005|NOT COMPLETED|Cohort 4P, QW||0||
59932637|NCT02906670|76050528|FG006|NOT COMPLETED|Cohort 4P, QW||0||
59932638|NCT02906670|76050529|FG007|NOT COMPLETED|Cohort 4P, QW||0||
59932639|NCT02906670|76050530|FG008|NOT COMPLETED|Cohort 4P, QW||0||
59932640|NCT02906670|76050531|FG009|NOT COMPLETED|Cohort 4P, QW||0||
59932641|NCT02906670|76050522|FG000|STARTED|Cohort 7P, Q2W||0||
59932642|NCT02906670|76050523|FG001|STARTED|Cohort 7P, Q2W||0||
59932643|NCT02906670|76050524|FG002|STARTED|Cohort 7P, Q2W||0||
59932644|NCT02906670|76050525|FG003|STARTED|Cohort 7P, Q2W||0||
59932645|NCT02906670|76050526|FG004|STARTED|Cohort 7P, Q2W||0||
59932646|NCT02906670|76050527|FG005|STARTED|Cohort 7P, Q2W||0||
59932647|NCT02906670|76050528|FG006|STARTED|Cohort 7P, Q2W||0||
59932648|NCT02906670|76050529|FG007|STARTED|Cohort 7P, Q2W||0||
59932649|NCT02906670|76050530|FG008|STARTED|Cohort 7P, Q2W||0||
59932650|NCT02906670|76050531|FG009|STARTED|Cohort 7P, Q2W||3||
59932651|NCT02906670|76050522|FG000|COMPLETED|Cohort 7P, Q2W||0||
59932652|NCT02906670|76050523|FG001|COMPLETED|Cohort 7P, Q2W||0||
59932653|NCT02906670|76050524|FG002|COMPLETED|Cohort 7P, Q2W||0||
59932654|NCT02906670|76050525|FG003|COMPLETED|Cohort 7P, Q2W||0||
59932655|NCT02906670|76050526|FG004|COMPLETED|Cohort 7P, Q2W||0||
59518342|NCT01077973|75612143|FG000|NOT COMPLETED|Overall Study||0||
59932656|NCT02906670|76050527|FG005|COMPLETED|Cohort 7P, Q2W||0||
59932657|NCT02906670|76050528|FG006|COMPLETED|Cohort 7P, Q2W||0||
59932658|NCT02906670|76050529|FG007|COMPLETED|Cohort 7P, Q2W||0||
59932659|NCT02906670|76050530|FG008|COMPLETED|Cohort 7P, Q2W||0||
59932660|NCT02906670|76050531|FG009|COMPLETED|Cohort 7P, Q2W||0||
59932661|NCT02906670|76050522|FG000|NOT COMPLETED|Cohort 7P, Q2W||0||
59932662|NCT02906670|76050523|FG001|NOT COMPLETED|Cohort 7P, Q2W||0||
59932663|NCT02906670|76050524|FG002|NOT COMPLETED|Cohort 7P, Q2W||0||
59932664|NCT02906670|76050525|FG003|NOT COMPLETED|Cohort 7P, Q2W||0||
59932665|NCT02906670|76050526|FG004|NOT COMPLETED|Cohort 7P, Q2W||0||
59932666|NCT02906670|76050527|FG005|NOT COMPLETED|Cohort 7P, Q2W||0||
59932667|NCT02906670|76050528|FG006|NOT COMPLETED|Cohort 7P, Q2W||0||
59932668|NCT02906670|76050529|FG007|NOT COMPLETED|Cohort 7P, Q2W||0||
59518343|NCT01077973|75612144|FG001|NOT COMPLETED|Overall Study||0||
59932669|NCT02906670|76050530|FG008|NOT COMPLETED|Cohort 7P, Q2W||0||
59932670|NCT02906670|76050531|FG009|NOT COMPLETED|Cohort 7P, Q2W||3||
59932671|NCT02906670|76050522|FG000|STARTED|Cohort 5P, QW||0||
59932672|NCT02906670|76050523|FG001|STARTED|Cohort 5P, QW||0||
59932673|NCT02906670|76050524|FG002|STARTED|Cohort 5P, QW||0||
59932674|NCT02906670|76050525|FG003|STARTED|Cohort 5P, QW||0||
59932675|NCT02906670|76050526|FG004|STARTED|Cohort 5P, QW||3||
59932676|NCT02906670|76050527|FG005|STARTED|Cohort 5P, QW||0||
59932677|NCT02906670|76050528|FG006|STARTED|Cohort 5P, QW||0||
59932678|NCT02906670|76050529|FG007|STARTED|Cohort 5P, QW||0||
59932679|NCT02906670|76050530|FG008|STARTED|Cohort 5P, QW||0||
59932680|NCT02906670|76050531|FG009|STARTED|Cohort 5P, QW||0||
59932681|NCT02906670|76050522|FG000|COMPLETED|Cohort 5P, QW||0||
59932682|NCT02906670|76050523|FG001|COMPLETED|Cohort 5P, QW||0||
59932683|NCT02906670|76050524|FG002|COMPLETED|Cohort 5P, QW||0||
59932684|NCT02906670|76050525|FG003|COMPLETED|Cohort 5P, QW||0||
59932685|NCT02906670|76050526|FG004|COMPLETED|Cohort 5P, QW||0||
59932686|NCT02906670|76050527|FG005|COMPLETED|Cohort 5P, QW||0||
59932687|NCT02906670|76050528|FG006|COMPLETED|Cohort 5P, QW||0||
59932688|NCT02906670|76050529|FG007|COMPLETED|Cohort 5P, QW||0||
59932689|NCT02906670|76050530|FG008|COMPLETED|Cohort 5P, QW||0||
59932690|NCT02906670|76050531|FG009|COMPLETED|Cohort 5P, QW||0||
59932691|NCT02906670|76050522|FG000|NOT COMPLETED|Cohort 5P, QW||0||
59932692|NCT02906670|76050523|FG001|NOT COMPLETED|Cohort 5P, QW||0||
59932693|NCT02906670|76050524|FG002|NOT COMPLETED|Cohort 5P, QW||0||
59932694|NCT02906670|76050525|FG003|NOT COMPLETED|Cohort 5P, QW||0||
59932695|NCT02906670|76050526|FG004|NOT COMPLETED|Cohort 5P, QW||3||
59932696|NCT02906670|76050527|FG005|NOT COMPLETED|Cohort 5P, QW||0||
59932697|NCT02906670|76050528|FG006|NOT COMPLETED|Cohort 5P, QW||0||
59932698|NCT02906670|76050529|FG007|NOT COMPLETED|Cohort 5P, QW||0||
59932699|NCT02906670|76050530|FG008|NOT COMPLETED|Cohort 5P, QW||0||
59932700|NCT02906670|76050531|FG009|NOT COMPLETED|Cohort 5P, QW||0||
59932701|NCT02906358|76050583|FG000|STARTED|Overall Study||58||
59932702|NCT02906358|76050584|FG001|STARTED|Overall Study||53||
59932703|NCT02906358|76050583|FG000|Completed 3 Month Measures|Overall Study||36||
59932704|NCT02906358|76050584|FG001|Completed 3 Month Measures|Overall Study||33||
59932705|NCT02906358|76050583|FG000|COMPLETED|Overall Study||36|Includes participants who completed the entire program and 6 month measures|
59932706|NCT02906358|76050584|FG001|COMPLETED|Overall Study||31|Includes participants who completed the entire program and 6 month measures|
59932707|NCT02906358|76050583|FG000|NOT COMPLETED|Overall Study||22||
59932708|NCT02906358|76050584|FG001|NOT COMPLETED|Overall Study||22||
59932709|NCT02186834|76050590|FG000|STARTED|Dose Escalation||6||
59932710|NCT02186834|76050591|FG001|STARTED|Dose Escalation||3||
59932711|NCT02186834|76050592|FG002|STARTED|Dose Escalation||0||
59932712|NCT02186834|76050593|FG003|STARTED|Dose Escalation||7||
59932713|NCT02186834|76050594|FG004|STARTED|Dose Escalation||4||
59932714|NCT02186834|76050595|FG005|STARTED|Dose Escalation||0||
59932715|NCT02186834|76050590|FG000|COMPLETED|Dose Escalation||6||
59932716|NCT02186834|76050591|FG001|COMPLETED|Dose Escalation||3||
59932717|NCT02186834|76050592|FG002|COMPLETED|Dose Escalation||0||
59932718|NCT02186834|76050593|FG003|COMPLETED|Dose Escalation||6||
59932719|NCT02186834|76050594|FG004|COMPLETED|Dose Escalation||4||
59932720|NCT02186834|76050595|FG005|COMPLETED|Dose Escalation||0||
59932721|NCT02186834|76050590|FG000|NOT COMPLETED|Dose Escalation||0||
59932722|NCT02186834|76050591|FG001|NOT COMPLETED|Dose Escalation||0||
59932723|NCT02186834|76050592|FG002|NOT COMPLETED|Dose Escalation||0||
59932724|NCT02186834|76050593|FG003|NOT COMPLETED|Dose Escalation||1||
59932725|NCT02186834|76050594|FG004|NOT COMPLETED|Dose Escalation||0||
59932726|NCT02186834|76050595|FG005|NOT COMPLETED|Dose Escalation||0||
59932727|NCT02186834|76050590|FG000|STARTED|Treatment at RP2D||0||
59932728|NCT02186834|76050591|FG001|STARTED|Treatment at RP2D||0||
59932729|NCT02186834|76050592|FG002|STARTED|Treatment at RP2D||0||
59932730|NCT02186834|76050593|FG003|STARTED|Treatment at RP2D||0||
59932731|NCT02186834|76050594|FG004|STARTED|Treatment at RP2D||0||
59932732|NCT02186834|76050595|FG005|STARTED|Treatment at RP2D||14||
59932733|NCT02186834|76050590|FG000|COMPLETED|Treatment at RP2D||0||
59932734|NCT02186834|76050591|FG001|COMPLETED|Treatment at RP2D||0||
59932735|NCT02186834|76050592|FG002|COMPLETED|Treatment at RP2D||0||
60067268|NCT02093663|76182405|FG003|COMPLETED|Double Blind Maintenance Phase(26 Weeks)||32||
59932736|NCT02186834|76050593|FG003|COMPLETED|Treatment at RP2D||0||
59932737|NCT02186834|76050594|FG004|COMPLETED|Treatment at RP2D||0||
59932738|NCT02186834|76050595|FG005|COMPLETED|Treatment at RP2D||13||
59932739|NCT02186834|76050590|FG000|NOT COMPLETED|Treatment at RP2D||0||
59932740|NCT02186834|76050591|FG001|NOT COMPLETED|Treatment at RP2D||0||
59932741|NCT02186834|76050592|FG002|NOT COMPLETED|Treatment at RP2D||0||
60067269|NCT02093663|76182406|FG004|COMPLETED|Double Blind Maintenance Phase(26 Weeks)||34||
59932742|NCT02186834|76050593|FG003|NOT COMPLETED|Treatment at RP2D||0||
59932743|NCT02186834|76050594|FG004|NOT COMPLETED|Treatment at RP2D||0||
59932744|NCT02186834|76050595|FG005|NOT COMPLETED|Treatment at RP2D||1||
59932745|NCT03144687|76050606|FG000|STARTED|Overall Study||13||
59932746|NCT03144687|76050607|FG001|STARTED|Overall Study||10||
59932747|NCT03144687|76050606|FG000|COMPLETED|Overall Study||10||
59932748|NCT03144687|76050607|FG001|COMPLETED|Overall Study||3||
59932749|NCT03144687|76050606|FG000|NOT COMPLETED|Overall Study||3||
59932750|NCT03144687|76050607|FG001|NOT COMPLETED|Overall Study||7||
59932751|NCT03080961|76050617|FG000|STARTED|Overall Study||46||
59932752|NCT03080961|76050617|FG000|COMPLETED|Overall Study||43||
59932753|NCT03080961|76050617|FG000|NOT COMPLETED|Overall Study||3||
59932754|NCT01538966|76050629|FG000|STARTED|Overall Study||23||
59932755|NCT01538966|76050630|FG001|STARTED|Overall Study||26||
59932756|NCT01538966|76050631|FG002|STARTED|Overall Study||27||
59932757|NCT01538966|76050629|FG000|COMPLETED|Overall Study||15||
59932758|NCT01538966|76050630|FG001|COMPLETED|Overall Study||14||
59932759|NCT01538966|76050631|FG002|COMPLETED|Overall Study||23||
59932760|NCT01538966|76050629|FG000|NOT COMPLETED|Overall Study||8||
59932761|NCT01538966|76050630|FG001|NOT COMPLETED|Overall Study||12||
59932762|NCT01538966|76050631|FG002|NOT COMPLETED|Overall Study||4||
59932763|NCT02905266|76050641|FG000|STARTED|Treatment Phase Part 1||53|Randomized and treated|
59932764|NCT02905266|76050642|FG001|STARTED|Treatment Phase Part 1||53|Randomized and treated|
59932765|NCT02905266|76050641|FG000|COMPLETED|Treatment Phase Part 1||24|Completed = Continuing in study|
59932766|NCT02905266|76050642|FG001|COMPLETED|Treatment Phase Part 1||30|Completed = Continuing in study|
59932767|NCT02905266|76050641|FG000|NOT COMPLETED|Treatment Phase Part 1||29||
59932768|NCT02905266|76050642|FG001|NOT COMPLETED|Treatment Phase Part 1||23||
59932769|NCT02905266|76050641|FG000|STARTED|Transition From Part 1 to Part 2||24||
59932770|NCT02905266|76050642|FG001|STARTED|Transition From Part 1 to Part 2||30||
59932771|NCT02905266|76050641|FG000|COMPLETED|Transition From Part 1 to Part 2||20||
59932772|NCT02905266|76050642|FG001|COMPLETED|Transition From Part 1 to Part 2||22||
59932773|NCT02905266|76050641|FG000|NOT COMPLETED|Transition From Part 1 to Part 2||4||
59932774|NCT02905266|76050642|FG001|NOT COMPLETED|Transition From Part 1 to Part 2||8||
59932775|NCT02905266|76050641|FG000|STARTED|Maintenance Phase Part 2||20||
59932776|NCT02905266|76050642|FG001|STARTED|Maintenance Phase Part 2||22||
59932777|NCT02905266|76050641|FG000|COMPLETED|Maintenance Phase Part 2||8||
59932778|NCT02905266|76050642|FG001|COMPLETED|Maintenance Phase Part 2||14||
59932779|NCT02905266|76050641|FG000|NOT COMPLETED|Maintenance Phase Part 2||12||
59932780|NCT02905266|76050642|FG001|NOT COMPLETED|Maintenance Phase Part 2||8||
59932781|NCT02982018|76050650|FG000|STARTED|Overall Study||67||
59932782|NCT02982018|76050651|FG001|STARTED|Overall Study||64||
59932783|NCT02982018|76050650|FG000|COMPLETED|Overall Study||62||
59932784|NCT02982018|76050651|FG001|COMPLETED|Overall Study||61||
59932785|NCT02982018|76050650|FG000|NOT COMPLETED|Overall Study||5||
59932786|NCT02982018|76050651|FG001|NOT COMPLETED|Overall Study||3||
59932787|NCT03080493|76050659|FG000|STARTED|Overall Study||61||
59932788|NCT03080493|76050660|FG001|STARTED|Overall Study||60||
59932789|NCT03080493|76050659|FG000|COMPLETED|Overall Study||60||
59932790|NCT03080493|76050660|FG001|COMPLETED|Overall Study||58||
59932791|NCT03080493|76050659|FG000|NOT COMPLETED|Overall Study||1||
59932792|NCT03080493|76050660|FG001|NOT COMPLETED|Overall Study||2||
59932793|NCT01339910|76050668|FG000|STARTED|Overall Study||135||
59932794|NCT01339910|76050669|FG001|STARTED|Overall Study||137||
59932795|NCT01339910|76050668|FG000|COMPLETED|Overall Study||132||
59932796|NCT01339910|76050669|FG001|COMPLETED|Overall Study||133||
59932797|NCT01339910|76050668|FG000|NOT COMPLETED|Overall Study||3||
59932798|NCT01339910|76050669|FG001|NOT COMPLETED|Overall Study||4||
59932799|NCT02981082|76050677|FG000|STARTED|Overall Study||4||
59932800|NCT02981082|76050678|FG001|STARTED|Overall Study||2||
59932801|NCT02981082|76050677|FG000|COMPLETED|Overall Study||1||
59932802|NCT02981082|76050678|FG001|COMPLETED|Overall Study||1||
59932803|NCT02981082|76050677|FG000|NOT COMPLETED|Overall Study||3||
59932804|NCT02981082|76050678|FG001|NOT COMPLETED|Overall Study||1||
59932805|NCT01066104|76050686|FG000|STARTED|Overall Study||14||
59932806|NCT01066104|76050687|FG001|STARTED|Overall Study||13||
59932807|NCT01066104|76050686|FG000|COMPLETED|Overall Study||12||
59932808|NCT01066104|76050687|FG001|COMPLETED|Overall Study||12||
59932809|NCT01066104|76050686|FG000|NOT COMPLETED|Overall Study||2||
59932810|NCT01066104|76050687|FG001|NOT COMPLETED|Overall Study||1||
59932811|NCT02736968|76050698|FG000|STARTED|Overall Study||0||
59932812|NCT02736968|76050699|FG001|STARTED|Overall Study||1||
59932813|NCT02736968|76050700|FG002|STARTED|Overall Study||17||
59932814|NCT02736968|76050701|FG003|STARTED|Overall Study||16||
59932815|NCT02736968|76050702|FG004|STARTED|Overall Study||0||
59932816|NCT02736968|76050703|FG005|STARTED|Overall Study||0||
59932817|NCT02736968|76050704|FG006|STARTED|Overall Study||30||
59932818|NCT02736968|76050705|FG007|STARTED|Overall Study||29||
59932819|NCT02736968|76050698|FG000|COMPLETED|Overall Study||0||
59932820|NCT02736968|76050699|FG001|COMPLETED|Overall Study||1||
59932821|NCT02736968|76050700|FG002|COMPLETED|Overall Study||17||
59932822|NCT02736968|76050701|FG003|COMPLETED|Overall Study||16||
59932823|NCT02736968|76050702|FG004|COMPLETED|Overall Study||0||
59932824|NCT02736968|76050703|FG005|COMPLETED|Overall Study||0||
59932825|NCT02736968|76050704|FG006|COMPLETED|Overall Study||22||
59932826|NCT02736968|76050705|FG007|COMPLETED|Overall Study||27||
59932827|NCT02736968|76050698|FG000|NOT COMPLETED|Overall Study||0||
59932828|NCT02736968|76050699|FG001|NOT COMPLETED|Overall Study||0||
59932829|NCT02736968|76050700|FG002|NOT COMPLETED|Overall Study||0||
59932830|NCT02736968|76050701|FG003|NOT COMPLETED|Overall Study||0||
59932831|NCT02736968|76050702|FG004|NOT COMPLETED|Overall Study||0||
59932832|NCT02736968|76050703|FG005|NOT COMPLETED|Overall Study||0||
59932833|NCT02736968|76050704|FG006|NOT COMPLETED|Overall Study||8||
59932834|NCT02736968|76050705|FG007|NOT COMPLETED|Overall Study||2||
59932835|NCT02980224|76050718|FG000|STARTED|Overall Study||89||
59932836|NCT02980224|76050719|FG001|STARTED|Overall Study||91||
59932837|NCT02980224|76050718|FG000|COMPLETED|Overall Study||85||
59932838|NCT02980224|76050719|FG001|COMPLETED|Overall Study||88||
59932839|NCT02980224|76050718|FG000|NOT COMPLETED|Overall Study||4||
59932840|NCT02980224|76050719|FG001|NOT COMPLETED|Overall Study||3||
59932841|NCT02591615|76050729|FG000|STARTED|Arm B Pembro Lead in Phase||9||
59932842|NCT02591615|76050730|FG001|STARTED|Arm B Pembro Lead in Phase||34||
59932843|NCT02591615|76050731|FG002|STARTED|Arm B Pembro Lead in Phase||11||
59932844|NCT02591615|76050732|FG003|STARTED|Arm B Pembro Lead in Phase||37||
59932845|NCT02591615|76050729|FG000|COMPLETED|Arm B Pembro Lead in Phase||9||
59932846|NCT02591615|76050730|FG001|COMPLETED|Arm B Pembro Lead in Phase||34||
59932847|NCT02591615|76050731|FG002|COMPLETED|Arm B Pembro Lead in Phase||10||
59932848|NCT02591615|76050732|FG003|COMPLETED|Arm B Pembro Lead in Phase||37||
59932849|NCT02591615|76050729|FG000|NOT COMPLETED|Arm B Pembro Lead in Phase||0||
59932850|NCT02591615|76050730|FG001|NOT COMPLETED|Arm B Pembro Lead in Phase||0||
59932851|NCT02591615|76050731|FG002|NOT COMPLETED|Arm B Pembro Lead in Phase||1||
59932852|NCT02591615|76050732|FG003|NOT COMPLETED|Arm B Pembro Lead in Phase||0||
59932853|NCT02591615|76050729|FG000|STARTED|Platinum Doublet Arm A, MK-3475 Arm B||9||
59932854|NCT02591615|76050730|FG001|STARTED|Platinum Doublet Arm A, MK-3475 Arm B||34||
59932855|NCT02591615|76050731|FG002|STARTED|Platinum Doublet Arm A, MK-3475 Arm B||10||
59932856|NCT02591615|76050732|FG003|STARTED|Platinum Doublet Arm A, MK-3475 Arm B||37||
59932857|NCT02591615|76050729|FG000|COMPLETED|Platinum Doublet Arm A, MK-3475 Arm B||4||
59932858|NCT02591615|76050730|FG001|COMPLETED|Platinum Doublet Arm A, MK-3475 Arm B||25||
59932859|NCT02591615|76050731|FG002|COMPLETED|Platinum Doublet Arm A, MK-3475 Arm B||6||
59932860|NCT02591615|76050732|FG003|COMPLETED|Platinum Doublet Arm A, MK-3475 Arm B||20||
59932861|NCT02591615|76050729|FG000|NOT COMPLETED|Platinum Doublet Arm A, MK-3475 Arm B||5||
59932862|NCT02591615|76050730|FG001|NOT COMPLETED|Platinum Doublet Arm A, MK-3475 Arm B||9||
59932863|NCT02591615|76050731|FG002|NOT COMPLETED|Platinum Doublet Arm A, MK-3475 Arm B||4||
59932864|NCT02591615|76050732|FG003|NOT COMPLETED|Platinum Doublet Arm A, MK-3475 Arm B||17||
59932865|NCT02591615|76050729|FG000|STARTED|MK-3475 Arm A, Platinum Doublet Arm B||4||
59932866|NCT02591615|76050730|FG001|STARTED|MK-3475 Arm A, Platinum Doublet Arm B||25||
59932867|NCT02591615|76050731|FG002|STARTED|MK-3475 Arm A, Platinum Doublet Arm B||6||
59932868|NCT02591615|76050732|FG003|STARTED|MK-3475 Arm A, Platinum Doublet Arm B||20||
59932869|NCT02591615|76050729|FG000|COMPLETED|MK-3475 Arm A, Platinum Doublet Arm B||2||
59932870|NCT02591615|76050730|FG001|COMPLETED|MK-3475 Arm A, Platinum Doublet Arm B||17||
59932871|NCT02591615|76050731|FG002|COMPLETED|MK-3475 Arm A, Platinum Doublet Arm B||4||
59932872|NCT02591615|76050732|FG003|COMPLETED|MK-3475 Arm A, Platinum Doublet Arm B||18||
59932873|NCT02591615|76050729|FG000|NOT COMPLETED|MK-3475 Arm A, Platinum Doublet Arm B||2||
59932874|NCT02591615|76050730|FG001|NOT COMPLETED|MK-3475 Arm A, Platinum Doublet Arm B||8||
59932875|NCT02591615|76050731|FG002|NOT COMPLETED|MK-3475 Arm A, Platinum Doublet Arm B||2||
59932876|NCT02591615|76050732|FG003|NOT COMPLETED|MK-3475 Arm A, Platinum Doublet Arm B||2||
59932877|NCT02591615|76050729|FG000|STARTED|Maintenance MK-3475||2||
59932878|NCT02591615|76050730|FG001|STARTED|Maintenance MK-3475||17||
59932879|NCT02591615|76050731|FG002|STARTED|Maintenance MK-3475||4||
59932880|NCT02591615|76050732|FG003|STARTED|Maintenance MK-3475||18||
59932881|NCT02591615|76050729|FG000|COMPLETED|Maintenance MK-3475||0||
59932882|NCT02591615|76050730|FG001|COMPLETED|Maintenance MK-3475||3||
59932883|NCT02591615|76050731|FG002|COMPLETED|Maintenance MK-3475||1||
59932884|NCT02591615|76050732|FG003|COMPLETED|Maintenance MK-3475||7||
59932885|NCT02591615|76050729|FG000|NOT COMPLETED|Maintenance MK-3475||2||
59932886|NCT02591615|76050730|FG001|NOT COMPLETED|Maintenance MK-3475||14||
59932887|NCT02591615|76050731|FG002|NOT COMPLETED|Maintenance MK-3475||3||
59932888|NCT02591615|76050732|FG003|NOT COMPLETED|Maintenance MK-3475||11||
59932889|NCT03077607|76050747|FG000|STARTED|Period 1 (15 Days)||19||
59932890|NCT03077607|76050748|FG001|STARTED|Period 1 (15 Days)||17||
59932891|NCT03077607|76050747|FG000|Treated (With Any Study Drug)|Period 1 (15 Days)||19||
59932892|NCT03077607|76050748|FG001|Treated (With Any Study Drug)|Period 1 (15 Days)||17||
59932893|NCT03077607|76050747|FG000|Received Talazoparib|Period 1 (15 Days)||19||
59932894|NCT03077607|76050748|FG001|Received Talazoparib|Period 1 (15 Days)||17||
59932895|NCT03077607|76050747|FG000|COMPLETED|Period 1 (15 Days)||17||
59932896|NCT03077607|76050748|FG001|COMPLETED|Period 1 (15 Days)||17||
59932897|NCT03077607|76050747|FG000|NOT COMPLETED|Period 1 (15 Days)||2||
59932898|NCT03077607|76050748|FG001|NOT COMPLETED|Period 1 (15 Days)||0||
59932899|NCT03077607|76050747|FG000|STARTED|Period 2 (Arm A:21 Days; Arm B:23 Days)||17||
59932900|NCT03077607|76050748|FG001|STARTED|Period 2 (Arm A:21 Days; Arm B:23 Days)||17||
59932901|NCT03077607|76050747|FG000|Treated (With Any Study Drug)|Period 2 (Arm A:21 Days; Arm B:23 Days)||17||
59932902|NCT03077607|76050748|FG001|Treated (With Any Study Drug)|Period 2 (Arm A:21 Days; Arm B:23 Days)||17||
59932903|NCT03077607|76050747|FG000|Received Talazoparib|Period 2 (Arm A:21 Days; Arm B:23 Days)||15||
59932904|NCT03077607|76050748|FG001|Received Talazoparib|Period 2 (Arm A:21 Days; Arm B:23 Days)||15||
59932905|NCT03077607|76050747|FG000|COMPLETED|Period 2 (Arm A:21 Days; Arm B:23 Days)||14||
59932906|NCT03077607|76050748|FG001|COMPLETED|Period 2 (Arm A:21 Days; Arm B:23 Days)||15||
59932907|NCT03077607|76050747|FG000|NOT COMPLETED|Period 2 (Arm A:21 Days; Arm B:23 Days)||3||
59932908|NCT03077607|76050748|FG001|NOT COMPLETED|Period 2 (Arm A:21 Days; Arm B:23 Days)||2||
59932909|NCT02977572|76050767|FG000|STARTED|Overall Study||58||
59932910|NCT02977572|76050768|FG001|STARTED|Overall Study||56||
59932911|NCT02977572|76050767|FG000|COMPLETED|Overall Study||56||
59932912|NCT02977572|76050768|FG001|COMPLETED|Overall Study||54||
59932913|NCT02977572|76050767|FG000|NOT COMPLETED|Overall Study||2||
59932914|NCT02977572|76050768|FG001|NOT COMPLETED|Overall Study||2||
59932915|NCT02746874|76050780|FG000|STARTED|Overall Study||35||
59932916|NCT02746874|76050781|FG001|STARTED|Overall Study||35||
59932917|NCT02746874|76050780|FG000|COMPLETED|Overall Study||35||
59932918|NCT02746874|76050781|FG001|COMPLETED|Overall Study||32||
59932919|NCT02746874|76050780|FG000|NOT COMPLETED|Overall Study||0||
59932920|NCT02746874|76050781|FG001|NOT COMPLETED|Overall Study||3||
59932921|NCT03217175|76050787|FG000|STARTED|Overall Study||4||
59932922|NCT03217175|76050788|FG001|STARTED|Overall Study||1||
59932923|NCT03217175|76050787|FG000|COMPLETED|Overall Study||0||
59932924|NCT03217175|76050788|FG001|COMPLETED|Overall Study||0||
59932925|NCT03217175|76050787|FG000|NOT COMPLETED|Overall Study||4||
59932926|NCT03217175|76050788|FG001|NOT COMPLETED|Overall Study||1||
59932927|NCT01062126|76050794|FG000|STARTED|Overall Study||3389||
59932928|NCT01062126|76050794|FG000|COMPLETED|Overall Study||2856||
59932929|NCT01062126|76050794|FG000|NOT COMPLETED|Overall Study||533||
59932930|NCT02522429|76050798|FG000|STARTED|Overall Study|Acute: 13 Chronic: 10|23||
59932931|NCT02522429|76050798|FG000|COMPLETED|Overall Study|Acute: 4 Chronic: 7|11||
59932932|NCT02522429|76050798|FG000|NOT COMPLETED|Overall Study||12||
59932933|NCT02974140|76050802|FG000|STARTED|Overall Study||39||78
59932934|NCT02974140|76050802|FG000|CRS (Left or Right Eye)|Overall Study||38|Cataract surgery using Cataract Refractive Suite, as randomized|38
59932935|NCT02974140|76050802|FG000|Manual (Fellow Eye)|Overall Study||38|Cataract surgery using standard manual technique|38
59932936|NCT02974140|76050802|FG000|COMPLETED|Overall Study||0||0
59932937|NCT02974140|76050802|FG000|NOT COMPLETED|Overall Study||39||78
59932938|NCT02974842|76050809|FG000|STARTED|Overall Study|Participants|50||
59932939|NCT02974842|76050809|FG000|COMPLETED|Overall Study||42||
59932940|NCT02974842|76050809|FG000|NOT COMPLETED|Overall Study||8||
59932941|NCT03172481|76050815|FG000|STARTED|Open-label||156||
59932942|NCT03172481|76050816|FG001|STARTED|Open-label||0||
59932943|NCT03172481|76050815|FG000|COMPLETED|Open-label||148||
59932944|NCT03172481|76050816|FG001|COMPLETED|Open-label||0||
59932945|NCT03172481|76050815|FG000|NOT COMPLETED|Open-label||8||
59932946|NCT03172481|76050816|FG001|NOT COMPLETED|Open-label||0||
59932947|NCT03172481|76050815|FG000|STARTED|Double-blind||75|From 148 subjects who completed the Open-label period, 75 randomly received PRC-063|
59932948|NCT03172481|76050816|FG001|STARTED|Double-blind|From 148 subjects who completed the Open-label period, 73 randomly received Placebo|73|From 148 subjects who completed the Open-label period, 75 randomly received PRC-063|
59932949|NCT03172481|76050815|FG000|COMPLETED|Double-blind||74||
59932950|NCT03172481|76050816|FG001|COMPLETED|Double-blind||73||
59932951|NCT03172481|76050815|FG000|NOT COMPLETED|Double-blind||1||
59761627|NCT00600938|75881283|FG001|Core Safety Set|Core Study||91||
59761628|NCT00600938|75881284|FG002|Core Safety Set|Core Study||0||
59932952|NCT03172481|76050816|FG001|NOT COMPLETED|Double-blind||0||
59932953|NCT02855450|76050824|FG000|STARTED|Overall Study||40||
59932954|NCT02855450|76050825|FG001|STARTED|Overall Study||20||
59761629|NCT00600938|75881285|FG003|Core Safety Set|Core Study||0||
59761630|NCT00600938|75881282|FG000|Per Protocol Set (PPS)|Core Study||91||
59761631|NCT00600938|75881283|FG001|Per Protocol Set (PPS)|Core Study||81||
59761632|NCT00600938|75881284|FG002|Per Protocol Set (PPS)|Core Study||0||
59761633|NCT00600938|75881285|FG003|Per Protocol Set (PPS)|Core Study||0||
59761634|NCT00600938|75881282|FG000|COMPLETED|Core Study||82||
59761635|NCT00600938|75881283|FG001|COMPLETED|Core Study||78||
59761636|NCT00600938|75881284|FG002|COMPLETED|Core Study||0||
59932955|NCT02855450|76050824|FG000|COMPLETED|Overall Study||35||
59932956|NCT02855450|76050825|FG001|COMPLETED|Overall Study||20||
59932957|NCT02855450|76050824|FG000|NOT COMPLETED|Overall Study||5||
59932958|NCT02855450|76050825|FG001|NOT COMPLETED|Overall Study||0||
59932959|NCT03172325|76050833|FG000|STARTED|Overall Study||68||
59932960|NCT03172325|76050834|FG001|STARTED|Overall Study||68||
59932961|NCT03172325|76050833|FG000|COMPLETED|Overall Study||64||
59932962|NCT03172325|76050834|FG001|COMPLETED|Overall Study||64||
59932963|NCT03172325|76050833|FG000|NOT COMPLETED|Overall Study||4||
59932964|NCT03172325|76050834|FG001|NOT COMPLETED|Overall Study||4||
59932965|NCT03085017|76050842|FG000|STARTED|Overall Study||30||
59932966|NCT03085017|76050843|FG001|STARTED|Overall Study||27||
59761637|NCT00600938|75881285|FG003|COMPLETED|Core Study||0||
59761638|NCT00600938|75881282|FG000|NOT COMPLETED|Core Study||16||
59761639|NCT00600938|75881283|FG001|NOT COMPLETED|Core Study||21||
59761640|NCT00600938|75881284|FG002|NOT COMPLETED|Core Study||0||
59761641|NCT00600938|75881285|FG003|NOT COMPLETED|Core Study||0||
59761642|NCT00600938|75881282|FG000|STARTED|Extension Study|Of the 82 patients who completed the ICL core, 74 continued on the ICL ext. phase; 1 went to ICL-DFO|74||
59762619|NCT00866307|75882445|FG002|NOT COMPLETED|Consolidation/Maintenance||16||
59932967|NCT03085017|76050842|FG000|COMPLETED|Overall Study||30||
59932968|NCT03085017|76050843|FG001|COMPLETED|Overall Study||24||
59932969|NCT03085017|76050842|FG000|NOT COMPLETED|Overall Study||0||
59932970|NCT03085017|76050843|FG001|NOT COMPLETED|Overall Study||3||
59932971|NCT03215771|76050849|FG000|STARTED|Overall Study||16||
59932972|NCT03215771|76050849|FG000|Stroke Subjects|Overall Study||8||
59932973|NCT03215771|76050849|FG000|TBI Subjects|Overall Study||8||
59932974|NCT03215771|76050849|FG000|COMPLETED|Overall Study||13||
59932975|NCT03215771|76050849|FG000|NOT COMPLETED|Overall Study||3||
59932976|NCT02745392|76050858|FG000|STARTED|Overall Study||91||
59932977|NCT02745392|76050859|FG001|STARTED|Overall Study||90||
59932978|NCT02745392|76050860|FG002|STARTED|Overall Study||92||
59932979|NCT02745392|76050861|FG003|STARTED|Overall Study||92||
59932980|NCT02745392|76050858|FG000|COMPLETED|Overall Study||91||
59932981|NCT02745392|76050859|FG001|COMPLETED|Overall Study||89||
59932982|NCT02745392|76050860|FG002|COMPLETED|Overall Study||92||
59932983|NCT02745392|76050861|FG003|COMPLETED|Overall Study||92||
59932984|NCT02745392|76050858|FG000|NOT COMPLETED|Overall Study||0||
59932985|NCT02745392|76050859|FG001|NOT COMPLETED|Overall Study||1||
59932986|NCT02745392|76050860|FG002|NOT COMPLETED|Overall Study||0||
59932987|NCT02745392|76050861|FG003|NOT COMPLETED|Overall Study||0||
59932988|NCT03076515|76050873|FG000|STARTED|Overall Study||58||
59932989|NCT03076515|76050874|FG001|STARTED|Overall Study||62||
59932990|NCT03076515|76050873|FG000|COMPLETED|Overall Study||33||
59932991|NCT03076515|76050874|FG001|COMPLETED|Overall Study||33||
59932992|NCT03076515|76050873|FG000|NOT COMPLETED|Overall Study||25||
59932993|NCT03076515|76050874|FG001|NOT COMPLETED|Overall Study||29||
59932994|NCT03170609|76050887|FG000|STARTED|Overall Study||53||
59932995|NCT03170609|76050888|FG001|STARTED|Overall Study||52||
59932996|NCT03170609|76050889|FG002|STARTED|Overall Study||52||
59932997|NCT03170609|76050890|FG003|STARTED|Overall Study||52||
59932998|NCT03170609|76050891|FG004|STARTED|Overall Study||52||
59932999|NCT03170609|76050892|FG005|STARTED|Overall Study||52||
59933000|NCT03170609|76050893|FG006|STARTED|Overall Study||52||
59933001|NCT03170609|76050887|FG000|Vaccinated|Overall Study||52||
59933002|NCT03170609|76050888|FG001|Vaccinated|Overall Study||52||
59933003|NCT03170609|76050889|FG002|Vaccinated|Overall Study||52||
59933004|NCT03170609|76050890|FG003|Vaccinated|Overall Study||52||
59933005|NCT03170609|76050891|FG004|Vaccinated|Overall Study||52||
59933006|NCT03170609|76050892|FG005|Vaccinated|Overall Study||52||
59933007|NCT03170609|76050893|FG006|Vaccinated|Overall Study||52||
59933008|NCT03170609|76050887|FG000|COMPLETED|Overall Study||50||
59933009|NCT03170609|76050888|FG001|COMPLETED|Overall Study||50||
59933010|NCT03170609|76050889|FG002|COMPLETED|Overall Study||46||
59933011|NCT03170609|76050890|FG003|COMPLETED|Overall Study||50||
59933012|NCT03170609|76050891|FG004|COMPLETED|Overall Study||51||
59933013|NCT03170609|76050892|FG005|COMPLETED|Overall Study||50||
59933014|NCT03170609|76050893|FG006|COMPLETED|Overall Study||51||
59933015|NCT03170609|76050887|FG000|NOT COMPLETED|Overall Study||3||
59933016|NCT03170609|76050888|FG001|NOT COMPLETED|Overall Study||2||
59933017|NCT03170609|76050889|FG002|NOT COMPLETED|Overall Study||6||
59933018|NCT03170609|76050890|FG003|NOT COMPLETED|Overall Study||2||
59933019|NCT03170609|76050891|FG004|NOT COMPLETED|Overall Study||1||
59933020|NCT03170609|76050892|FG005|NOT COMPLETED|Overall Study||2||
59933021|NCT03170609|76050893|FG006|NOT COMPLETED|Overall Study||1||
59933022|NCT01141712|76050909|FG000|STARTED|Overall Study||43||
59933023|NCT01141712|76050909|FG000|COMPLETED|Overall Study||40||
59933024|NCT01141712|76050909|FG000|NOT COMPLETED|Overall Study||3||
59933025|NCT00145145|76050913|FG000|STARTED|Overall Study||1||
59933026|NCT00145145|76050913|FG000|COMPLETED|Overall Study||1||
59933027|NCT00145145|76050913|FG000|NOT COMPLETED|Overall Study||0||
59933028|NCT03219333|76050919|FG000|STARTED|Overall Study||128||
59933029|NCT03219333|76050920|FG001|STARTED|Overall Study||91||
59933030|NCT03219333|76050919|FG000|Treated|Overall Study||125||
59933031|NCT03219333|76050920|FG001|Treated|Overall Study||89||
59933032|NCT03219333|76050919|FG000|COMPLETED|Overall Study|Cohort 1 Completed includes 4 participants on treatment and 19 participants in follow-up.|23|Participants still on treatment or in long term follow-up as of data cut-off date 08-Sep-2020.|
59933033|NCT03219333|76050920|FG001|COMPLETED|Overall Study|Cohort 2 Completed includes 16 participants on treatment and 26 participants in follow-up.|42|Participants still on treatment or in long term follow-up as of data cut-off date 08-Sep-2020.|
59933034|NCT03219333|76050919|FG000|NOT COMPLETED|Overall Study||105||
59933035|NCT03219333|76050920|FG001|NOT COMPLETED|Overall Study||49||
59933036|NCT03168867|76050928|FG000|STARTED|Overall Study||74||
59933037|NCT03168867|76050929|FG001|STARTED|Overall Study||75||
59933038|NCT03168867|76050928|FG000|COMPLETED|Overall Study||73||
59933039|NCT03168867|76050929|FG001|COMPLETED|Overall Study||70||
59933040|NCT03168867|76050928|FG000|NOT COMPLETED|Overall Study||1||
59933041|NCT03168867|76050929|FG001|NOT COMPLETED|Overall Study||5||
59933042|NCT01064622|76050938|FG000|STARTED|Lead-in Phase I||0||
59933043|NCT01064622|76050939|FG001|STARTED|Lead-in Phase I||7||
59933044|NCT01064622|76050938|FG000|COMPLETED|Lead-in Phase I||0||
59933045|NCT01064622|76050939|FG001|COMPLETED|Lead-in Phase I||7||
59933046|NCT01064622|76050938|FG000|NOT COMPLETED|Lead-in Phase I||0||
59933047|NCT01064622|76050939|FG001|NOT COMPLETED|Lead-in Phase I||0||
59933048|NCT01064622|76050938|FG000|STARTED|Randomized Phase II||55||
59933049|NCT01064622|76050939|FG001|STARTED|Randomized Phase II||56||
59933050|NCT01064622|76050938|FG000|COMPLETED|Randomized Phase II||53||
59933051|NCT01064622|76050939|FG001|COMPLETED|Randomized Phase II||53||
59933052|NCT01064622|76050938|FG000|NOT COMPLETED|Randomized Phase II||2||
59933053|NCT01064622|76050939|FG001|NOT COMPLETED|Randomized Phase II||3||
59933054|NCT01064622|76050938|FG000|STARTED|Crossover of Arm I|Among 53 patients, 45 had disease progression; however 23 elected not to crossover to vismodegib.|22||
59933055|NCT01064622|76050939|FG001|STARTED|Crossover of Arm I||0||
59933056|NCT01064622|76050938|FG000|COMPLETED|Crossover of Arm I||22||
59933057|NCT01064622|76050939|FG001|COMPLETED|Crossover of Arm I||0||
59933058|NCT01064622|76050938|FG000|NOT COMPLETED|Crossover of Arm I||0||
59933059|NCT01064622|76050939|FG001|NOT COMPLETED|Crossover of Arm I||0||
59933060|NCT04163718|76050948|FG000|STARTED|Overall Study||12||
59933061|NCT04163718|76050948|FG000|COMPLETED|Overall Study||0||
59933062|NCT04163718|76050948|FG000|NOT COMPLETED|Overall Study||12||
59933063|NCT01063764|76050952|FG000|STARTED|1st Period (From Week 8 to Week 22)||73||
59933064|NCT01063764|76050952|FG000|COMPLETED|1st Period (From Week 8 to Week 22)|62 subjects completed the First Period, but 7 of these subjects did not enter the Second Period.|62||
59933065|NCT01063764|76050952|FG000|NOT COMPLETED|1st Period (From Week 8 to Week 22)||11||
59933066|NCT01063764|76050952|FG000|STARTED|2nd Period (Week 22 to the End of Study)|7 subjects who completed Period 1 did not enter the Second Period.|55||
59933067|NCT01063764|76050952|FG000|COMPLETED|2nd Period (Week 22 to the End of Study)||35||
59933068|NCT01063764|76050952|FG000|NOT COMPLETED|2nd Period (Week 22 to the End of Study)||20||
59933069|NCT02880189|76050956|FG000|STARTED|Overall Study||21||
59933070|NCT02880189|76050956|FG000|COMPLETED|Overall Study||21||
59933071|NCT02880189|76050956|FG000|NOT COMPLETED|Overall Study||0||
59933072|NCT03075891|76050962|FG000|STARTED|Overall Study||135||
59933073|NCT03075891|76050963|FG001|STARTED|Overall Study||138||
59933074|NCT03075891|76050962|FG000|COMPLETED|Overall Study||126||
59933075|NCT03075891|76050963|FG001|COMPLETED|Overall Study||125||
59933076|NCT03075891|76050962|FG000|NOT COMPLETED|Overall Study||9||
59933077|NCT03075891|76050963|FG001|NOT COMPLETED|Overall Study||13||
59933078|NCT02013167|76050973|FG000|STARTED|Overall Study||134||
59933079|NCT02013167|76050974|FG001|STARTED|Overall Study||271||
59933080|NCT02013167|76050973|FG000|Received Treatment|Overall Study||109||
59933081|NCT02013167|76050974|FG001|Received Treatment|Overall Study||267||
59933082|NCT02013167|76050973|FG000|COMPLETED|Overall Study|Indicates participants continuing study at time of data cut-off|33||
59933083|NCT02013167|76050974|FG001|COMPLETED|Overall Study|Indicates participants continuing study at time of data cut-off; 22 were receiving treatment|93||
59933084|NCT02013167|76050973|FG000|NOT COMPLETED|Overall Study||101||
59933085|NCT02013167|76050974|FG001|NOT COMPLETED|Overall Study||178||
59933086|NCT01063062|76050983|FG000|STARTED|Overall Study||30||
59933087|NCT01063062|76050984|FG001|STARTED|Overall Study||77||
59933088|NCT01063062|76050983|FG000|Received Study Drug|Overall Study||29||
59933089|NCT01063062|76050984|FG001|Received Study Drug|Overall Study||76||
59933090|NCT01063062|76050983|FG000|COMPLETED|Overall Study||22||
59933091|NCT01063062|76050984|FG001|COMPLETED|Overall Study||65||
59933092|NCT01063062|76050983|FG000|NOT COMPLETED|Overall Study||8||
59933093|NCT01063062|76050984|FG001|NOT COMPLETED|Overall Study||12||
59933094|NCT02973048|76050993|FG000|STARTED|Overall Study||20||
59933095|NCT02973048|76050994|FG001|STARTED|Overall Study||20||
59933096|NCT02973048|76050993|FG000|COMPLETED|Overall Study||19||
59933097|NCT02973048|76050994|FG001|COMPLETED|Overall Study||17||
59933098|NCT02973048|76050993|FG000|NOT COMPLETED|Overall Study||1||
59933099|NCT02973048|76050994|FG001|NOT COMPLETED|Overall Study||3||
59933100|NCT02932943|76051002|FG000|STARTED|Overall Study||227||
59933101|NCT02932943|76051003|FG001|STARTED|Overall Study||231||
59933102|NCT02932943|76051002|FG000|COMPLETED|Overall Study||222||
59933103|NCT02932943|76051003|FG001|COMPLETED|Overall Study||224||
59933104|NCT02932943|76051002|FG000|NOT COMPLETED|Overall Study||5||
59933105|NCT02932943|76051003|FG001|NOT COMPLETED|Overall Study||7||
59933106|NCT01550315|76051011|FG000|STARTED|Overall Study||7||
59933107|NCT01550315|76051012|FG001|STARTED|Overall Study||7||
59933108|NCT01550315|76051013|FG002|STARTED|Overall Study||6||
59933109|NCT01550315|76051014|FG003|STARTED|Overall Study||7||
59933110|NCT01550315|76051011|FG000|COMPLETED|Overall Study||7||
59933111|NCT01550315|76051012|FG001|COMPLETED|Overall Study||7||
59933112|NCT01550315|76051013|FG002|COMPLETED|Overall Study||6||
59761643|NCT00600938|75881283|FG001|STARTED|Extension Study|Of the 78 patients who completed the DFO core, 29 went on DFO ext. phase; 42 went to the DFO-ICL|29||
59761644|NCT00600938|75881284|FG002|STARTED|Extension Study|Of the 78 patients who completed the DFO core, 29 went on DFO ext. phase; 42 went to the DFO-ICL|42||
59762620|NCT00531427|75882453|FG000|STARTED|Overall Study||282||
59933113|NCT01550315|76051014|FG003|COMPLETED|Overall Study||7||
59933114|NCT01550315|76051011|FG000|NOT COMPLETED|Overall Study||0||
59933115|NCT01550315|76051012|FG001|NOT COMPLETED|Overall Study||0||
59933116|NCT01550315|76051013|FG002|NOT COMPLETED|Overall Study||0||
59933117|NCT01550315|76051014|FG003|NOT COMPLETED|Overall Study||0||
59933118|NCT02972658|76051028|FG000|STARTED|Overall Study||76||
59518344|NCT01077973|75612145|FG002|NOT COMPLETED|Overall Study||0||
59933119|NCT02972658|76051029|FG001|STARTED|Overall Study||139||
59933120|NCT02972658|76051030|FG002|STARTED|Overall Study||75||
59933121|NCT02972658|76051031|FG003|STARTED|Overall Study||131||
59933122|NCT02972658|76051028|FG000|Received at Least 1 Dose of Study Drug|Overall Study||76||
59933123|NCT02972658|76051029|FG001|Received at Least 1 Dose of Study Drug|Overall Study||139||
59933124|NCT02972658|76051030|FG002|Received at Least 1 Dose of Study Drug|Overall Study||74||
59933125|NCT02972658|76051031|FG003|Received at Least 1 Dose of Study Drug|Overall Study||131||
59933126|NCT02972658|76051028|FG000|COMPLETED|Overall Study||0||
59933127|NCT02972658|76051029|FG001|COMPLETED|Overall Study|"1 participant was incorrectly marked as Completed rather than study terminated by Sponsor."|1||
60067270|NCT02093663|76182402|FG000|NOT COMPLETED|Double Blind Maintenance Phase(26 Weeks)||0||
60067271|NCT02093663|76182403|FG001|NOT COMPLETED|Double Blind Maintenance Phase(26 Weeks)||0||
60067272|NCT02093663|76182404|FG002|NOT COMPLETED|Double Blind Maintenance Phase(26 Weeks)||0||
59933128|NCT02972658|76051030|FG002|COMPLETED|Overall Study||0||
59933129|NCT02972658|76051031|FG003|COMPLETED|Overall Study||0||
59933130|NCT02972658|76051028|FG000|NOT COMPLETED|Overall Study||76||
59933131|NCT02972658|76051029|FG001|NOT COMPLETED|Overall Study||138||
59933132|NCT02972658|76051030|FG002|NOT COMPLETED|Overall Study||75||
59933133|NCT02972658|76051031|FG003|NOT COMPLETED|Overall Study||131||
59933134|NCT02853032|76051043|FG000|STARTED|Overall Study||60||
59933135|NCT02853032|76051044|FG001|STARTED|Overall Study||59||
59933136|NCT02853032|76051043|FG000|COMPLETED|Overall Study|"Evaluable = 10 or more irTMS sessions Completers = 15 or more irTMS sessions"|51||
59933137|NCT02853032|76051044|FG001|COMPLETED|Overall Study|"Evaluable = 10 or more irTMS sessions Completers = 15 or more irTMS sessions"|56||
59933138|NCT02853032|76051043|FG000|NOT COMPLETED|Overall Study||9||
59933139|NCT02853032|76051044|FG001|NOT COMPLETED|Overall Study||3||
59933140|NCT02232087|76051052|FG000|STARTED|Overall Study||9||
59933141|NCT02232087|76051053|FG001|STARTED|Overall Study||10||
59933142|NCT02232087|76051054|FG002|STARTED|Overall Study||8||
59933143|NCT02232087|76051055|FG003|STARTED|Overall Study||8||
59933144|NCT02232087|76051056|FG004|STARTED|Overall Study||8||
59933145|NCT02232087|76051057|FG005|STARTED|Overall Study||9||
59933146|NCT02232087|76051052|FG000|COMPLETED|Overall Study||7||
59933147|NCT02232087|76051053|FG001|COMPLETED|Overall Study||8||
59933148|NCT02232087|76051054|FG002|COMPLETED|Overall Study||8||
59933149|NCT02232087|76051055|FG003|COMPLETED|Overall Study||7||
59933150|NCT02232087|76051056|FG004|COMPLETED|Overall Study||7||
59933151|NCT02232087|76051057|FG005|COMPLETED|Overall Study||6||
59933152|NCT02232087|76051052|FG000|NOT COMPLETED|Overall Study||2||
59933153|NCT02232087|76051053|FG001|NOT COMPLETED|Overall Study||2||
59933154|NCT02232087|76051054|FG002|NOT COMPLETED|Overall Study||0||
59933155|NCT02232087|76051055|FG003|NOT COMPLETED|Overall Study||1||
59933156|NCT02232087|76051056|FG004|NOT COMPLETED|Overall Study||1||
59933157|NCT02232087|76051057|FG005|NOT COMPLETED|Overall Study||3||
59933158|NCT03168425|76051078|FG000|STARTED|Overall Study||94||
59933159|NCT03168425|76051079|FG001|STARTED|Overall Study||96||
59933160|NCT03168425|76051078|FG000|COMPLETED|Overall Study||87||
59933161|NCT03168425|76051079|FG001|COMPLETED|Overall Study||85||
59933162|NCT03168425|76051078|FG000|NOT COMPLETED|Overall Study||7||
59933163|NCT03168425|76051079|FG001|NOT COMPLETED|Overall Study||11||
59933164|NCT00004445|76051086|FG000|STARTED|Overall Study||18||
59933165|NCT00004445|76051086|FG000|COMPLETED|Overall Study||15||
59933166|NCT00004445|76051086|FG000|NOT COMPLETED|Overall Study||3||
59933167|NCT02972502|76051092|FG000|STARTED|Overall Study||35||
59933168|NCT02972502|76051093|FG001|STARTED|Overall Study||31||
59933169|NCT02972502|76051092|FG000|COMPLETED|Overall Study||31||
59933170|NCT02972502|76051093|FG001|COMPLETED|Overall Study||29||
59933171|NCT02972502|76051092|FG000|NOT COMPLETED|Overall Study||4||
59933172|NCT02972502|76051093|FG001|NOT COMPLETED|Overall Study||2||
59933173|NCT02971800|76051099|FG000|STARTED|Overall Study||37||
59933174|NCT02971800|76051099|FG000|COMPLETED|Overall Study||30||
59933175|NCT02971800|76051099|FG000|NOT COMPLETED|Overall Study||7||
59933176|NCT03163667|76051105|FG000|STARTED|Overall Study||23||
59933177|NCT03163667|76051106|FG001|STARTED|Overall Study||46||
59933178|NCT03163667|76051105|FG000|COMPLETED|Overall Study||0||
59933179|NCT03163667|76051106|FG001|COMPLETED|Overall Study||0||
59933180|NCT03163667|76051105|FG000|NOT COMPLETED|Overall Study||23||
59933181|NCT03163667|76051106|FG001|NOT COMPLETED|Overall Study||46||
59933182|NCT03167411|76051114|FG000|STARTED|Overall Study||10||
59933183|NCT03167411|76051115|FG001|STARTED|Overall Study||10||
59933184|NCT03167411|76051114|FG000|COMPLETED|Overall Study||10||
59933185|NCT03167411|76051115|FG001|COMPLETED|Overall Study||9||
59933186|NCT03167411|76051114|FG000|NOT COMPLETED|Overall Study||0||
59933187|NCT03167411|76051115|FG001|NOT COMPLETED|Overall Study||1||
59933188|NCT01952847|76051125|FG000|STARTED|Overall Study||27||
59933189|NCT01952847|76051126|FG001|STARTED|Overall Study||26||
59933190|NCT01952847|76051127|FG002|STARTED|Overall Study||7||
59933191|NCT01952847|76051128|FG003|STARTED|Overall Study||7||
59933192|NCT01952847|76051125|FG000|COMPLETED|Overall Study||25||
59933193|NCT01952847|76051126|FG001|COMPLETED|Overall Study||24||
59933194|NCT01952847|76051127|FG002|COMPLETED|Overall Study||7||
59933195|NCT01952847|76051128|FG003|COMPLETED|Overall Study||6||
59933196|NCT01952847|76051125|FG000|NOT COMPLETED|Overall Study||2||
59933197|NCT01952847|76051126|FG001|NOT COMPLETED|Overall Study||2||
59933198|NCT01952847|76051127|FG002|NOT COMPLETED|Overall Study||0||
59933199|NCT01952847|76051128|FG003|NOT COMPLETED|Overall Study||1||
59933200|NCT01560585|76051140|FG000|STARTED|Overall Study||3||
59933201|NCT01560585|76051140|FG000|Screened|Overall Study|3 subjects screend and started treatment in open label|3||
59951226|NCT03771664|76070158|FG000|Full Analysis Set (FAS)|Overall Study||43|FAS included all randomized participants with valid baseline and at least one post-baseline efficacy evaluation.|
59933202|NCT01560585|76051140|FG000|COMPLETED|Overall Study|Study stopped due to adverse events One subject had transient loss of consciousness - possibly related to treatment One subject declined rapidly and found to have glioblastoma- not rrelated to treatment|0||
59933203|NCT01560585|76051140|FG000|NOT COMPLETED|Overall Study||3||
59933204|NCT03075501|76051147|FG000|STARTED|Overall Study||89||
59933205|NCT03075501|76051148|FG001|STARTED|Overall Study||44||
59933206|NCT03075501|76051147|FG000|COMPLETED|Overall Study||74||
59933207|NCT03075501|76051148|FG001|COMPLETED|Overall Study||35||
59933208|NCT03075501|76051147|FG000|NOT COMPLETED|Overall Study||15||
59933209|NCT03075501|76051148|FG001|NOT COMPLETED|Overall Study||9||
59933210|NCT02317991|76051155|FG000|STARTED|Overall Study||65||
59933211|NCT02317991|76051155|FG000|COMPLETED|Overall Study||0||
59933212|NCT02317991|76051155|FG000|NOT COMPLETED|Overall Study||65||
59933213|NCT03075267|76051162|FG000|STARTED|Overall Study||32||
59933214|NCT03075267|76051163|FG001|STARTED|Overall Study||32||
59933215|NCT03075267|76051164|FG002|STARTED|Overall Study||32||
59933216|NCT03075267|76051162|FG000|COMPLETED|Overall Study||31||
59933217|NCT03075267|76051163|FG001|COMPLETED|Overall Study||32||
59933218|NCT03075267|76051164|FG002|COMPLETED|Overall Study||32||
59933219|NCT03075267|76051162|FG000|NOT COMPLETED|Overall Study||1||
59933220|NCT03075267|76051163|FG001|NOT COMPLETED|Overall Study||0||
59933221|NCT03075267|76051164|FG002|NOT COMPLETED|Overall Study||0||
59933222|NCT03074331|76051172|FG000|STARTED|Overall Study||130||
59933223|NCT03074331|76051172|FG000|COMPLETED|Overall Study||123||
59933224|NCT03074331|76051172|FG000|NOT COMPLETED|Overall Study||7||
59933225|NCT02260193|76051179|FG000|STARTED|Overall Study||30||
59933226|NCT02260193|76051180|FG001|STARTED|Overall Study||33||
59933227|NCT02260193|76051181|FG002|STARTED|Overall Study||31||
59933228|NCT02260193|76051179|FG000|COMPLETED|Overall Study||24||
59933229|NCT02260193|76051180|FG001|COMPLETED|Overall Study||24||
59933230|NCT02260193|76051181|FG002|COMPLETED|Overall Study||21||
59933231|NCT02260193|76051179|FG000|NOT COMPLETED|Overall Study||6||
59933232|NCT02260193|76051180|FG001|NOT COMPLETED|Overall Study||9||
59933233|NCT02260193|76051181|FG002|NOT COMPLETED|Overall Study||10||
59933234|NCT02849678|76051191|FG000|STARTED|Overall Study||20||
59933235|NCT02849678|76051192|FG001|STARTED|Overall Study||24||
59933236|NCT02849678|76051191|FG000|COMPLETED|Overall Study||17||
59933237|NCT02849678|76051192|FG001|COMPLETED|Overall Study||18||
59933238|NCT02849678|76051191|FG000|NOT COMPLETED|Overall Study||3||
59933239|NCT02849678|76051192|FG001|NOT COMPLETED|Overall Study||6||
59933240|NCT01596257|76051200|FG000|STARTED|Overall Study||61||
59933241|NCT01596257|76051201|FG001|STARTED|Overall Study||55||
59933242|NCT01596257|76051200|FG000|COMPLETED|Overall Study||38||
59933243|NCT01596257|76051201|FG001|COMPLETED|Overall Study||36||
59933244|NCT01596257|76051200|FG000|NOT COMPLETED|Overall Study||23||
59933245|NCT01596257|76051201|FG001|NOT COMPLETED|Overall Study||19||
59933246|NCT04577781|76051211|FG000|STARTED|Overall Study||16||
59933247|NCT04577781|76051212|FG001|STARTED|Overall Study||12||
59933248|NCT04577781|76051211|FG000|COMPLETED|Overall Study||13||
59933249|NCT04577781|76051212|FG001|COMPLETED|Overall Study||10||
59933250|NCT04577781|76051211|FG000|NOT COMPLETED|Overall Study||3||
59933251|NCT04577781|76051212|FG001|NOT COMPLETED|Overall Study||2||
59933252|NCT02737826|76051219|FG000|STARTED|Phase I - Buprenorphine Initiation||27||
59933253|NCT02737826|76051220|FG001|STARTED|Phase I - Buprenorphine Initiation||0||
59933254|NCT02737826|76051221|FG002|STARTED|Phase I - Buprenorphine Initiation||0||
59933255|NCT02737826|76051219|FG000|COMPLETED|Phase I - Buprenorphine Initiation||27||
59933256|NCT02737826|76051220|FG001|COMPLETED|Phase I - Buprenorphine Initiation||0||
59933257|NCT02737826|76051221|FG002|COMPLETED|Phase I - Buprenorphine Initiation||0||
59933258|NCT02737826|76051219|FG000|NOT COMPLETED|Phase I - Buprenorphine Initiation||0||
59933259|NCT02737826|76051220|FG001|NOT COMPLETED|Phase I - Buprenorphine Initiation||0||
59933260|NCT02737826|76051221|FG002|NOT COMPLETED|Phase I - Buprenorphine Initiation||0||
59933261|NCT02737826|76051219|FG000|STARTED|Phase II - Randomization + Taper||0||
59933262|NCT02737826|76051220|FG001|STARTED|Phase II - Randomization + Taper||13||
59933263|NCT02737826|76051221|FG002|STARTED|Phase II - Randomization + Taper||14||
59933264|NCT02737826|76051219|FG000|COMPLETED|Phase II - Randomization + Taper||0||
59933265|NCT02737826|76051220|FG001|COMPLETED|Phase II - Randomization + Taper||1||
59933266|NCT02737826|76051221|FG002|COMPLETED|Phase II - Randomization + Taper||0||
59933267|NCT02737826|76051219|FG000|NOT COMPLETED|Phase II - Randomization + Taper||0||
59933268|NCT02737826|76051220|FG001|NOT COMPLETED|Phase II - Randomization + Taper||12||
59933269|NCT02737826|76051221|FG002|NOT COMPLETED|Phase II - Randomization + Taper||14||
59933270|NCT03367715|76051244|FG000|STARTED|Overall Study||10||
59933271|NCT03367715|76051244|FG000|COMPLETED|Overall Study||10||
59933272|NCT03367715|76051244|FG000|NOT COMPLETED|Overall Study||0||
59933273|NCT03070431|76051248|FG000|STARTED|Overall Study||44||
59933274|NCT03070431|76051248|FG000|COMPLETED|Overall Study||40||
59933275|NCT03070431|76051248|FG000|NOT COMPLETED|Overall Study||4||
59933276|NCT01071395|76051259|FG000|STARTED|Overall Study||36||
59933277|NCT01071395|76051260|FG001|STARTED|Overall Study||32||
59933278|NCT01071395|76051259|FG000|COMPLETED|Overall Study||31||
59933279|NCT01071395|76051260|FG001|COMPLETED|Overall Study||30||
59933280|NCT01071395|76051259|FG000|NOT COMPLETED|Overall Study||5||
59933281|NCT01071395|76051260|FG001|NOT COMPLETED|Overall Study||2||
59933282|NCT02970942|76051270|FG000|STARTED|Overall Study||80||
59933283|NCT02970942|76051271|FG001|STARTED|Overall Study||78||
59933284|NCT02970942|76051272|FG002|STARTED|Overall Study||82||
59933285|NCT02970942|76051273|FG003|STARTED|Overall Study||80||
59933286|NCT02970942|76051270|FG000|Full Analysis Set|Overall Study||80||
59933287|NCT02970942|76051271|FG001|Full Analysis Set|Overall Study||78||
59933288|NCT02970942|76051272|FG002|Full Analysis Set|Overall Study||82||
59933289|NCT02970942|76051273|FG003|Full Analysis Set|Overall Study||80||
59933290|NCT02970942|76051270|FG000|Safety Analysis Set|Overall Study||80||
59933291|NCT02970942|76051271|FG001|Safety Analysis Set|Overall Study||78||
59933292|NCT02970942|76051272|FG002|Safety Analysis Set|Overall Study||81||
59933293|NCT02970942|76051273|FG003|Safety Analysis Set|Overall Study||80||
59933294|NCT02970942|76051270|FG000|Exposed|Overall Study||80||
59933295|NCT02970942|76051271|FG001|Exposed|Overall Study||78||
59933296|NCT02970942|76051272|FG002|Exposed|Overall Study||81||
59933297|NCT02970942|76051273|FG003|Exposed|Overall Study||80||
59933298|NCT02970942|76051270|FG000|COMPLETED|Overall Study||76||
59933299|NCT02970942|76051271|FG001|COMPLETED|Overall Study||72||
59933300|NCT02970942|76051272|FG002|COMPLETED|Overall Study||77||
59933301|NCT02970942|76051273|FG003|COMPLETED|Overall Study||77||
59933302|NCT02970942|76051270|FG000|NOT COMPLETED|Overall Study||4||
59933303|NCT02970942|76051271|FG001|NOT COMPLETED|Overall Study||6||
59933304|NCT02970942|76051272|FG002|NOT COMPLETED|Overall Study||5||
59933305|NCT02970942|76051273|FG003|NOT COMPLETED|Overall Study||3||
59933306|NCT03073005|76051287|FG000|STARTED|Overall Study||33||
59933307|NCT03073005|76051288|FG001|STARTED|Overall Study||37||
59933308|NCT03073005|76051289|FG002|STARTED|Overall Study||36||
59933309|NCT03073005|76051290|FG003|STARTED|Overall Study||37||
59933310|NCT03073005|76051287|FG000|Received Initial Training|Overall Study|29 pairs (29 patients plus their caregivers)|29||
59933311|NCT03073005|76051288|FG001|Received Initial Training|Overall Study||29||
59933312|NCT03073005|76051289|FG002|Received Initial Training|Overall Study|33 pairs (33 patients plus their caregivers)|33||
59933313|NCT03073005|76051290|FG003|Received Initial Training|Overall Study||33||
59933314|NCT03073005|76051287|FG000|COMPLETED|Overall Study|25 pairs (25 patients plus their caregivers)|25|Completed entire protocol thru discharge testing|
59933315|NCT03073005|76051288|FG001|COMPLETED|Overall Study||25|Completed entire protocol thru discharge testing|
59933316|NCT03073005|76051289|FG002|COMPLETED|Overall Study|24 pairs (24 patients plus their caregivers)|24|Completed entire protocol thru discharge testing|
59933317|NCT03073005|76051290|FG003|COMPLETED|Overall Study||24|Completed entire protocol thru discharge testing|
59933318|NCT03073005|76051287|FG000|NOT COMPLETED|Overall Study||8||
59933319|NCT03073005|76051288|FG001|NOT COMPLETED|Overall Study||12||
59933320|NCT03073005|76051289|FG002|NOT COMPLETED|Overall Study||12||
59933321|NCT03073005|76051290|FG003|NOT COMPLETED|Overall Study||13||
59933322|NCT02849171|76051303|FG000|STARTED|Overall Study||8||
59933323|NCT02849171|76051303|FG000|COMPLETED|Overall Study||6||
59933324|NCT02849171|76051303|FG000|NOT COMPLETED|Overall Study||2||
59933325|NCT03888885|76051309|FG000|STARTED|Overall Study||208||
60067273|NCT02093663|76182405|FG003|NOT COMPLETED|Double Blind Maintenance Phase(26 Weeks)||10||
60067274|NCT02093663|76182406|FG004|NOT COMPLETED|Double Blind Maintenance Phase(26 Weeks)||11||
60067275|NCT01408888|76182423|FG000|STARTED|First Intervention||18||
60067276|NCT01408888|76182424|FG001|STARTED|First Intervention||11||
59933326|NCT03888885|76051310|FG001|STARTED|Overall Study||202||
59933327|NCT03888885|76051309|FG000|Post-intervention|Overall Study||191||
59933328|NCT03888885|76051310|FG001|Post-intervention|Overall Study||190||
59933329|NCT03888885|76051309|FG000|COMPLETED|Overall Study||188||
59933330|NCT03888885|76051310|FG001|COMPLETED|Overall Study||184||
59933331|NCT03888885|76051309|FG000|NOT COMPLETED|Overall Study||20||
59933332|NCT03888885|76051310|FG001|NOT COMPLETED|Overall Study||18||
59933333|NCT02848664|76051316|FG000|STARTED|Overall Study||11||
59933334|NCT02848664|76051316|FG000|COMPLETED|Overall Study||7||
59933335|NCT02848664|76051316|FG000|NOT COMPLETED|Overall Study||4||
59933336|NCT02969382|76051326|FG000|STARTED|Overall Study||125||
59933337|NCT02969382|76051327|FG001|STARTED|Overall Study||120||
59933338|NCT02969382|76051326|FG000|Subjects Continued Into Extension Study|Overall Study||79||
59933339|NCT02969382|76051327|FG001|Subjects Continued Into Extension Study|Overall Study||78||
59933340|NCT02969382|76051326|FG000|COMPLETED|Overall Study||99||
59933341|NCT02969382|76051327|FG001|COMPLETED|Overall Study||94||
59933342|NCT02969382|76051326|FG000|NOT COMPLETED|Overall Study||26||
59933343|NCT02969382|76051327|FG001|NOT COMPLETED|Overall Study||26||
59933344|NCT01989104|76051338|FG000|STARTED|Overall Study||25||
59933345|NCT01989104|76051339|FG001|STARTED|Overall Study||25||
59933346|NCT01989104|76051340|FG002|STARTED|Overall Study||25||
59933347|NCT01989104|76051341|FG003|STARTED|Overall Study||24||
59933348|NCT01989104|76051342|FG004|STARTED|Overall Study||24||
59933349|NCT01989104|76051338|FG000|COMPLETED|Overall Study||22||
59933350|NCT01989104|76051339|FG001|COMPLETED|Overall Study||25||
59933351|NCT01989104|76051340|FG002|COMPLETED|Overall Study||25||
59933352|NCT01989104|76051341|FG003|COMPLETED|Overall Study||24||
59933353|NCT01989104|76051342|FG004|COMPLETED|Overall Study||24||
59933354|NCT01989104|76051338|FG000|NOT COMPLETED|Overall Study||3||
59933355|NCT01989104|76051339|FG001|NOT COMPLETED|Overall Study||0||
59933356|NCT01989104|76051340|FG002|NOT COMPLETED|Overall Study||0||
59933357|NCT01989104|76051341|FG003|NOT COMPLETED|Overall Study||0||
59933358|NCT01989104|76051342|FG004|NOT COMPLETED|Overall Study||0||
59933359|NCT02903238|76051354|FG000|STARTED|Overall Study||21||
59933360|NCT02903238|76051354|FG000|COMPLETED|Overall Study||17||
59933361|NCT02903238|76051354|FG000|NOT COMPLETED|Overall Study||4||
59933362|NCT02847260|76051359|FG000|STARTED|Overall Study||39||
59933363|NCT02847260|76051359|FG000|COMPLETED|Overall Study||32||
59933364|NCT02847260|76051359|FG000|NOT COMPLETED|Overall Study||7||
59933365|NCT02968563|76051365|FG000|STARTED|Overall Study||5||
59933366|NCT02968563|76051366|FG001|STARTED|Overall Study||30||
59933367|NCT02968563|76051365|FG000|COMPLETED|Overall Study||4||
59933368|NCT02968563|76051366|FG001|COMPLETED|Overall Study||22||
59933369|NCT02968563|76051365|FG000|NOT COMPLETED|Overall Study||1||
59933370|NCT02968563|76051366|FG001|NOT COMPLETED|Overall Study||8||
59933371|NCT02904096|76051374|FG000|STARTED|Overall Study||130||
59933372|NCT02904096|76051375|FG001|STARTED|Overall Study||126||
59933373|NCT02904096|76051374|FG000|COMPLETED|Overall Study||111||
59933374|NCT02904096|76051375|FG001|COMPLETED|Overall Study||105||
59933375|NCT02904096|76051374|FG000|NOT COMPLETED|Overall Study||19||
59933376|NCT02904096|76051375|FG001|NOT COMPLETED|Overall Study||21||
59933377|NCT02586675|76051381|FG000|STARTED|Overall Study||7||
59933378|NCT02586675|76051381|FG000|COMPLETED|Overall Study||7||
59933379|NCT02586675|76051381|FG000|NOT COMPLETED|Overall Study||0||
59933380|NCT03161405|76051385|FG000|STARTED|First Intervention Period (3 Days)||12||
59933381|NCT03161405|76051385|FG000|COMPLETED|First Intervention Period (3 Days)||12||
59933382|NCT03161405|76051385|FG000|NOT COMPLETED|First Intervention Period (3 Days)||0||
59933383|NCT03161405|76051385|FG000|STARTED|Washout Period (at Least 4 Days)||12||
59933384|NCT03161405|76051385|FG000|COMPLETED|Washout Period (at Least 4 Days)||12||
59933385|NCT03161405|76051385|FG000|NOT COMPLETED|Washout Period (at Least 4 Days)||0||
59933386|NCT03161405|76051385|FG000|STARTED|Second Intervention Period (6 Days)||12||
59933387|NCT03161405|76051385|FG000|COMPLETED|Second Intervention Period (6 Days)||11||
59933388|NCT03161405|76051385|FG000|NOT COMPLETED|Second Intervention Period (6 Days)||1||
59933389|NCT01813929|76051394|FG000|STARTED|Overall Study||5||
59933390|NCT01813929|76051395|FG001|STARTED|Overall Study||12||
59933391|NCT01813929|76051394|FG000|Completed Intervention 1|Overall Study||5||
59933392|NCT01813929|76051395|FG001|Completed Intervention 1|Overall Study||12||
59933393|NCT01813929|76051394|FG000|Completed Washout (2weeks up to 2 Months)|Overall Study||5||
59933394|NCT01813929|76051395|FG001|Completed Washout (2weeks up to 2 Months)|Overall Study||11||
59933395|NCT01813929|76051394|FG000|Started Intervention 2|Overall Study||5||
59933396|NCT01813929|76051395|FG001|Started Intervention 2|Overall Study||11||
59933397|NCT01813929|76051394|FG000|COMPLETED|Overall Study||5||
59933398|NCT01813929|76051395|FG001|COMPLETED|Overall Study||11||
59933399|NCT01813929|76051394|FG000|NOT COMPLETED|Overall Study||0||
59933400|NCT01813929|76051395|FG001|NOT COMPLETED|Overall Study||1||
59933401|NCT01502085|76051401|FG000|STARTED|Overall Study||25||
59933402|NCT01502085|76051401|FG000|COMPLETED|Overall Study||25||
59933403|NCT01502085|76051401|FG000|NOT COMPLETED|Overall Study||0||
59933404|NCT02901054|76051405|FG000|STARTED|Overall Study|19 consented, 3 withdrew prior to intervention, 1 received study drug but surgery was cancelled.|19||
59933405|NCT02901054|76051405|FG000|COMPLETED|Overall Study||15||
59933406|NCT02901054|76051405|FG000|NOT COMPLETED|Overall Study||4||
59933407|NCT03068715|76051411|FG000|STARTED|Overall Study||15||
59933408|NCT03068715|76051412|FG001|STARTED|Overall Study||15||
59933409|NCT03068715|76051411|FG000|COMPLETED|Overall Study||14||
59933410|NCT03068715|76051412|FG001|COMPLETED|Overall Study||15||
59933411|NCT03068715|76051411|FG000|NOT COMPLETED|Overall Study||1||
59933412|NCT03068715|76051412|FG001|NOT COMPLETED|Overall Study||0||
59933413|NCT02966340|76051420|FG000|STARTED|Overall Study||37||
59933414|NCT02966340|76051421|FG001|STARTED|Overall Study||33||
59933415|NCT02966340|76051420|FG000|COMPLETED|Overall Study||34||
59933416|NCT02966340|76051421|FG001|COMPLETED|Overall Study||30||
59933417|NCT02966340|76051420|FG000|NOT COMPLETED|Overall Study||3||
59933418|NCT02966340|76051421|FG001|NOT COMPLETED|Overall Study||3||
59933419|NCT03067311|76051429|FG000|STARTED|Overall Study||19||
59933420|NCT03067311|76051430|FG001|STARTED|Overall Study||19||
59933421|NCT03067311|76051429|FG000|COMPLETED|Overall Study||17||
59933422|NCT03067311|76051430|FG001|COMPLETED|Overall Study||17||
59933423|NCT03067311|76051429|FG000|NOT COMPLETED|Overall Study||2||
59933424|NCT03067311|76051430|FG001|NOT COMPLETED|Overall Study||2||
59933425|NCT04380519|76051439|FG000|STARTED|Overall Study||124||
59933426|NCT04380519|76051440|FG001|STARTED|Overall Study||124||
59933427|NCT04380519|76051441|FG002|STARTED|Overall Study||124||
59933428|NCT04380519|76051439|FG000|Intent-to-Treat (ITT)|Overall Study||124||
59933429|NCT04380519|76051440|FG001|Intent-to-Treat (ITT)|Overall Study||124||
59933430|NCT04380519|76051441|FG002|Intent-to-Treat (ITT)|Overall Study||124||
59933431|NCT04380519|76051439|FG000|Modified Intent-to-Treat (mITT)|Overall Study||115||
59933432|NCT04380519|76051440|FG001|Modified Intent-to-Treat (mITT)|Overall Study||119||
59933433|NCT04380519|76051441|FG002|Modified Intent-to-Treat (mITT)|Overall Study||118||
59933434|NCT04380519|76051439|FG000|Safety Population|Overall Study||123||
59933435|NCT04380519|76051440|FG001|Safety Population|Overall Study||124||
59933436|NCT04380519|76051441|FG002|Safety Population|Overall Study||124||
59933437|NCT04380519|76051439|FG000|COMPLETED|Overall Study||106||
59933438|NCT04380519|76051440|FG001|COMPLETED|Overall Study||113||
59933439|NCT04380519|76051441|FG002|COMPLETED|Overall Study||117||
59933440|NCT04380519|76051439|FG000|NOT COMPLETED|Overall Study||18||
59933441|NCT04380519|76051440|FG001|NOT COMPLETED|Overall Study||11||
59933442|NCT04380519|76051441|FG002|NOT COMPLETED|Overall Study||7||
59933443|NCT02847182|76051451|FG000|STARTED|Overall Study||119||
59933444|NCT02847182|76051452|FG001|STARTED|Overall Study||61||
59933445|NCT02847182|76051451|FG000|First Intervention (6 Months)|Overall Study||119||
59933446|NCT02847182|76051452|FG001|First Intervention (6 Months)|Overall Study||61||
59933447|NCT02847182|76051451|FG000|Second Intervention (6 Months)|Overall Study||61||
59933448|NCT02847182|76051452|FG001|Second Intervention (6 Months)|Overall Study||119||
59933449|NCT02847182|76051451|FG000|COMPLETED|Overall Study||119||
59933450|NCT02847182|76051452|FG001|COMPLETED|Overall Study||60||
59933451|NCT02847182|76051451|FG000|NOT COMPLETED|Overall Study||0||
59933452|NCT02847182|76051452|FG001|NOT COMPLETED|Overall Study||1||
59933453|NCT02846558|76051468|FG000|STARTED|Overall Study||15||
59933454|NCT02846558|76051469|FG001|STARTED|Overall Study||12||
59933455|NCT02846558|76051470|FG002|STARTED|Overall Study||14||
59933456|NCT02846558|76051471|FG003|STARTED|Overall Study||13||
59933457|NCT02846558|76051468|FG000|Baseline Study Visit|Overall Study||10||
59613281|NCT01681212|75724429|FG000|STARTED|Overall Study|Enrolled|21||
59613282|NCT01681212|75724429|FG000|Received Treatment|Overall Study||15||
59613283|NCT01681212|75724429|FG000|COMPLETED|Overall Study|Completed=patients who received treatment; not completed=patients who did not receive treatment|15||
59933458|NCT02846558|76051469|FG001|Baseline Study Visit|Overall Study||9||
59933459|NCT02846558|76051470|FG002|Baseline Study Visit|Overall Study||14||
59933460|NCT02846558|76051471|FG003|Baseline Study Visit|Overall Study||12||
59933461|NCT02846558|76051468|FG000|3 Month Study Visit|Overall Study||7||
59933462|NCT02846558|76051469|FG001|3 Month Study Visit|Overall Study||8||
59933463|NCT02846558|76051470|FG002|3 Month Study Visit|Overall Study||12||
59933464|NCT02846558|76051471|FG003|3 Month Study Visit|Overall Study||11||
59933465|NCT02846558|76051468|FG000|COMPLETED|Overall Study||7||
59933466|NCT02846558|76051469|FG001|COMPLETED|Overall Study||8||
59933467|NCT02846558|76051470|FG002|COMPLETED|Overall Study||12||
59933468|NCT02846558|76051471|FG003|COMPLETED|Overall Study||11||
59933469|NCT02846558|76051468|FG000|NOT COMPLETED|Overall Study||8||
59933470|NCT02846558|76051469|FG001|NOT COMPLETED|Overall Study||4||
59933471|NCT02846558|76051470|FG002|NOT COMPLETED|Overall Study||2||
59613284|NCT01681212|75724429|FG000|NOT COMPLETED|Overall Study||6||
59933472|NCT02846558|76051471|FG003|NOT COMPLETED|Overall Study||2||
59933473|NCT04362813|76051490|FG000|STARTED|Overall Study||227|Ranomized participants|
59933474|NCT04362813|76051491|FG001|STARTED|Overall Study||227|Ranomized participants|
59933475|NCT04362813|76051490|FG000|Safety Set|Overall Study||225|The Safety Set included all participants who received at least one dose of double-blind treatment|
59933476|NCT04362813|76051491|FG001|Safety Set|Overall Study||223|The Safety Set included all participants who received at least one dose of double-blind treatment|
59933477|NCT04362813|76051490|FG000|Completed Day 29|Overall Study||211||
59933478|NCT04362813|76051491|FG001|Completed Day 29|Overall Study||206||
59933479|NCT04362813|76051490|FG000|COMPLETED|Overall Study||209||
59933480|NCT04362813|76051491|FG001|COMPLETED|Overall Study||202||
59933481|NCT04362813|76051490|FG000|NOT COMPLETED|Overall Study||18||
59933482|NCT04362813|76051491|FG001|NOT COMPLETED|Overall Study||25||
59933483|NCT02966028|76051500|FG000|STARTED|Overall Study||92||
59933484|NCT02966028|76051501|FG001|STARTED|Overall Study||91||
59933485|NCT02966028|76051502|FG002|STARTED|Overall Study||91||
59933486|NCT02966028|76051500|FG000|COMPLETED|Overall Study||68||
59933487|NCT02966028|76051501|FG001|COMPLETED|Overall Study||57||
59933488|NCT02966028|76051502|FG002|COMPLETED|Overall Study||60||
59933489|NCT02966028|76051500|FG000|NOT COMPLETED|Overall Study||24||
59613285|NCT01687296|75724435|FG000|STARTED|Overall Study||123||
59613286|NCT01687296|75724436|FG001|STARTED|Overall Study||128||
59613287|NCT01687296|75724435|FG000|COMPLETED|Overall Study||116||
59613288|NCT01687296|75724436|FG001|COMPLETED|Overall Study||123||
59613289|NCT01687296|75724435|FG000|NOT COMPLETED|Overall Study||7||
59613290|NCT01687296|75724436|FG001|NOT COMPLETED|Overall Study||5||
59613291|NCT02071914|75724445|FG000|STARTED|Overall Study||27||
59613292|NCT02071914|75724446|FG001|STARTED|Overall Study||27||
59933490|NCT02966028|76051501|FG001|NOT COMPLETED|Overall Study||34||
59933491|NCT02966028|76051502|FG002|NOT COMPLETED|Overall Study||31||
59613293|NCT02071914|75724447|FG002|STARTED|Overall Study||27||
59933492|NCT02925741|76051516|FG000|STARTED|Overall Study||1637||
59933493|NCT02925741|76051517|FG001|STARTED|Overall Study||1706||
59933494|NCT02925741|76051516|FG000|COMPLETED|Overall Study||1626||
59933495|NCT02925741|76051517|FG001|COMPLETED|Overall Study||1706||
59933496|NCT02925741|76051516|FG000|NOT COMPLETED|Overall Study||11||
59933497|NCT02925741|76051517|FG001|NOT COMPLETED|Overall Study||0||
59933498|NCT02964312|76051526|FG000|STARTED|Overall Study||166||
59933499|NCT02964312|76051526|FG000|1-Month Follow-up|Overall Study||164||
59933500|NCT02964312|76051526|FG000|3-Month Follow-up|Overall Study||159||
59933501|NCT02964312|76051526|FG000|6-Month Follow-up|Overall Study||152||
59933502|NCT02964312|76051526|FG000|12-Month Follow-up|Overall Study||139||
59933503|NCT02964312|76051526|FG000|18-Month Follow-up|Overall Study||112|The 18-mo and 24-mo follow-up visits required participants to sign an new consent to participate.|
59933504|NCT02964312|76051526|FG000|24-Month Follow-up|Overall Study||102||
59933505|NCT02964312|76051526|FG000|COMPLETED|Overall Study||102||
59933506|NCT02964312|76051526|FG000|NOT COMPLETED|Overall Study||64||
59933507|NCT03959592|76051535|FG000|STARTED|Overall Study||3||
59933508|NCT03959592|76051536|FG001|STARTED|Overall Study||5||
59933509|NCT03959592|76051535|FG000|COMPLETED|Overall Study||3||
59933510|NCT03959592|76051536|FG001|COMPLETED|Overall Study||5||
59933511|NCT03959592|76051535|FG000|NOT COMPLETED|Overall Study||0||
59933512|NCT03959592|76051536|FG001|NOT COMPLETED|Overall Study||0||
59933513|NCT04087395|76051542|FG000|STARTED|Overall Study||30||
59933514|NCT04087395|76051542|FG000|COMPLETED|Overall Study||30||
59933515|NCT04087395|76051542|FG000|NOT COMPLETED|Overall Study||0||
59933516|NCT02899962|76051550|FG000|STARTED|Open-label Phase||650||
59933517|NCT02899962|76051551|FG001|STARTED|Open-label Phase||0||
59933518|NCT02899962|76051552|FG002|STARTED|Open-label Phase||0||
59933519|NCT02899962|76051550|FG000|COMPLETED|Open-label Phase||623||
59933520|NCT02899962|76051551|FG001|COMPLETED|Open-label Phase||0||
59933521|NCT02899962|76051552|FG002|COMPLETED|Open-label Phase||0||
59933522|NCT02899962|76051550|FG000|NOT COMPLETED|Open-label Phase||27||
59933523|NCT02899962|76051551|FG001|NOT COMPLETED|Open-label Phase||0||
59933524|NCT02899962|76051552|FG002|NOT COMPLETED|Open-label Phase||0||
59933525|NCT02899962|76051550|FG000|STARTED|Maintenance Phase||0||
59933526|NCT02899962|76051551|FG001|STARTED|Maintenance Phase||272||
59933527|NCT02899962|76051552|FG002|STARTED|Maintenance Phase||273||
59933528|NCT02899962|76051550|FG000|COMPLETED|Maintenance Phase||0||
59933529|NCT02899962|76051551|FG001|COMPLETED|Maintenance Phase||131||
59933530|NCT02899962|76051552|FG002|COMPLETED|Maintenance Phase||120||
59933531|NCT02899962|76051550|FG000|NOT COMPLETED|Maintenance Phase||0||
59933532|NCT02899962|76051551|FG001|NOT COMPLETED|Maintenance Phase||141||
59933533|NCT02899962|76051552|FG002|NOT COMPLETED|Maintenance Phase||153||
59933534|NCT02899338|76051561|FG000|STARTED|Overall Study||81||
59933535|NCT02899338|76051562|FG001|STARTED|Overall Study||81||
59933536|NCT02899338|76051561|FG000|COMPLETED|Overall Study||78||
59933537|NCT02899338|76051562|FG001|COMPLETED|Overall Study||79||
59933538|NCT02899338|76051561|FG000|NOT COMPLETED|Overall Study||3||
59933539|NCT02899338|76051562|FG001|NOT COMPLETED|Overall Study||2||
59933540|NCT03066609|76051571|FG000|STARTED|INDUCTION||136||
59933541|NCT03066609|76051572|FG001|STARTED|INDUCTION||272||
59933542|NCT03066609|76051573|FG002|STARTED|INDUCTION||135||
59933543|NCT03066609|76051574|FG003|STARTED|INDUCTION||0||
59933544|NCT03066609|76051571|FG000|COMPLETED|INDUCTION||134||
59933545|NCT03066609|76051572|FG001|COMPLETED|INDUCTION||270||
59933546|NCT03066609|76051573|FG002|COMPLETED|INDUCTION||133||
59933547|NCT03066609|76051574|FG003|COMPLETED|INDUCTION||0||
59933548|NCT03066609|76051571|FG000|NOT COMPLETED|INDUCTION||2||
59933549|NCT03066609|76051572|FG001|NOT COMPLETED|INDUCTION||2||
59933550|NCT03066609|76051573|FG002|NOT COMPLETED|INDUCTION||2||
59933551|NCT03066609|76051574|FG003|NOT COMPLETED|INDUCTION||0||
59933552|NCT03066609|76051571|FG000|STARTED|MAINTENANCE||134||
59933553|NCT03066609|76051572|FG001|STARTED|MAINTENANCE||270||
59933554|NCT03066609|76051573|FG002|STARTED|MAINTENANCE||4||
59933555|NCT03066609|76051574|FG003|STARTED|MAINTENANCE||129||
59933556|NCT03066609|76051571|FG000|COMPLETED|MAINTENANCE||127||
59933557|NCT03066609|76051572|FG001|COMPLETED|MAINTENANCE||266||
59933558|NCT03066609|76051573|FG002|COMPLETED|MAINTENANCE||2||
59933559|NCT03066609|76051574|FG003|COMPLETED|MAINTENANCE||126||
59933560|NCT03066609|76051571|FG000|NOT COMPLETED|MAINTENANCE||7||
59933561|NCT03066609|76051572|FG001|NOT COMPLETED|MAINTENANCE||4||
59933562|NCT03066609|76051573|FG002|NOT COMPLETED|MAINTENANCE||2||
59933563|NCT03066609|76051574|FG003|NOT COMPLETED|MAINTENANCE||3||
59933564|NCT03066609|76051571|FG000|STARTED|OVERALL STUDY||136||
59933565|NCT03066609|76051572|FG001|STARTED|OVERALL STUDY||272||
59933566|NCT03066609|76051573|FG002|STARTED|OVERALL STUDY||6||
59933567|NCT03066609|76051574|FG003|STARTED|OVERALL STUDY||129||
59933568|NCT03066609|76051571|FG000|COMPLETED|OVERALL STUDY||126||
59933569|NCT03066609|76051572|FG001|COMPLETED|OVERALL STUDY||264||
59933570|NCT03066609|76051573|FG002|COMPLETED|OVERALL STUDY||2||
59933571|NCT03066609|76051574|FG003|COMPLETED|OVERALL STUDY||124||
59933572|NCT03066609|76051571|FG000|NOT COMPLETED|OVERALL STUDY||10||
59933573|NCT03066609|76051572|FG001|NOT COMPLETED|OVERALL STUDY||8||
59933574|NCT03066609|76051573|FG002|NOT COMPLETED|OVERALL STUDY||4||
59933575|NCT03066609|76051574|FG003|NOT COMPLETED|OVERALL STUDY||5||
59933576|NCT03611790|76051585|FG000|STARTED|Overall Study||30||
59933577|NCT03611790|76051585|FG000|COMPLETED|Overall Study||30||
59933578|NCT03611790|76051585|FG000|NOT COMPLETED|Overall Study||0||
59933579|NCT02964234|76051591|FG000|STARTED|Overall Study||76||
59933580|NCT02964234|76051592|FG001|STARTED|Overall Study||69||
59933581|NCT02964234|76051591|FG000|COMPLETED|Overall Study||54||
59933582|NCT02964234|76051592|FG001|COMPLETED|Overall Study||56||
59933583|NCT02964234|76051591|FG000|NOT COMPLETED|Overall Study||22||
59933584|NCT02964234|76051592|FG001|NOT COMPLETED|Overall Study||13||
59933585|NCT01345188|76051598|FG000|STARTED|Randomization Ranolazine/Placebo 6 Weeks||28||
59933586|NCT01345188|76051598|FG000|COMPLETED|Randomization Ranolazine/Placebo 6 Weeks||26||
59933587|NCT01345188|76051598|FG000|NOT COMPLETED|Randomization Ranolazine/Placebo 6 Weeks||2||
59933588|NCT01345188|76051598|FG000|STARTED|Crossover Ranolazine/Placebo 6 Weeks||26||
59933589|NCT01345188|76051598|FG000|COMPLETED|Crossover Ranolazine/Placebo 6 Weeks||25||
59933590|NCT01345188|76051598|FG000|NOT COMPLETED|Crossover Ranolazine/Placebo 6 Weeks||1||
59933591|NCT03852459|76051607|FG000|STARTED|Overall Study||126||
59933592|NCT03852459|76051608|FG001|STARTED|Overall Study||125||
59933593|NCT03852459|76051607|FG000|COMPLETED|Overall Study||123||
59933594|NCT03852459|76051608|FG001|COMPLETED|Overall Study||122||
59933595|NCT03852459|76051607|FG000|NOT COMPLETED|Overall Study||3||
59933596|NCT03852459|76051608|FG001|NOT COMPLETED|Overall Study||3||
59933597|NCT02896296|76051614|FG000|STARTED|Overall Study||208||
59933598|NCT02896296|76051614|FG000|COMPLETED|Overall Study||166||
59933599|NCT02896296|76051614|FG000|NOT COMPLETED|Overall Study||42||
59933600|NCT03740919|76051621|FG000|STARTED|Lead-in Period||751||
59933601|NCT03740919|76051622|FG001|STARTED|Lead-in Period||0||
59933602|NCT03740919|76051623|FG002|STARTED|Lead-in Period||0||
59933603|NCT03740919|76051624|FG003|STARTED|Lead-in Period||0||
59933604|NCT03740919|76051621|FG000|Received at Least One Dose of Study Drug|Lead-in Period||751||
59933605|NCT03740919|76051622|FG001|Received at Least One Dose of Study Drug|Lead-in Period||0||
59933606|NCT03740919|76051623|FG002|Received at Least One Dose of Study Drug|Lead-in Period||0||
59933607|NCT03740919|76051624|FG003|Received at Least One Dose of Study Drug|Lead-in Period||0||
59933608|NCT03740919|76051621|FG000|COMPLETED|Lead-in Period||716||
59933609|NCT03740919|76051622|FG001|COMPLETED|Lead-in Period||0||
59933610|NCT03740919|76051623|FG002|COMPLETED|Lead-in Period||0||
59933611|NCT03740919|76051624|FG003|COMPLETED|Lead-in Period||0||
59933612|NCT03740919|76051621|FG000|NOT COMPLETED|Lead-in Period||35||
59933613|NCT03740919|76051622|FG001|NOT COMPLETED|Lead-in Period||0||
59933614|NCT03740919|76051623|FG002|NOT COMPLETED|Lead-in Period||0||
59933615|NCT03740919|76051624|FG003|NOT COMPLETED|Lead-in Period||0||
59933616|NCT03740919|76051621|FG000|STARTED|Treatment Period||0|After completion of Lead-in Period, participants were randomized to either blinded LY900014 or Humalog or open-label LY900014.|
59933617|NCT03740919|76051622|FG001|STARTED|Treatment Period|Participants were randomized from Lead-in Period to Insulin Lispro (Humalog).|298|After completion of Lead-in Period, participants were randomized to either blinded LY900014 or Humalog or open-label LY900014.|
59933618|NCT03740919|76051623|FG002|STARTED|Treatment Period|Participants were randomized from Lead-in Period to LY900014.|280|After completion of Lead-in Period, participants were randomized to either blinded LY900014 or Humalog or open-label LY900014.|
59933619|NCT03740919|76051624|FG003|STARTED|Treatment Period|Participants were randomized from Lead-in Period to open-label LY900014.|138|After completion of Lead-in Period, participants were randomized to either blinded LY900014 or Humalog or open-label LY900014.|
59933620|NCT03740919|76051621|FG000|Received at Least One Dose of Study Drug|Treatment Period||0||
59933621|NCT03740919|76051622|FG001|Received at Least One Dose of Study Drug|Treatment Period||298||
59933622|NCT03740919|76051623|FG002|Received at Least One Dose of Study Drug|Treatment Period||280||
59933623|NCT03740919|76051624|FG003|Received at Least One Dose of Study Drug|Treatment Period||138||
59933624|NCT03740919|76051621|FG000|COMPLETED|Treatment Period||0||
59933625|NCT03740919|76051622|FG001|COMPLETED|Treatment Period||288||
59933626|NCT03740919|76051623|FG002|COMPLETED|Treatment Period||266||
59933627|NCT03740919|76051624|FG003|COMPLETED|Treatment Period||135||
59933628|NCT03740919|76051621|FG000|NOT COMPLETED|Treatment Period||0||
59933629|NCT03740919|76051622|FG001|NOT COMPLETED|Treatment Period||10||
59933630|NCT03740919|76051623|FG002|NOT COMPLETED|Treatment Period||14||
59933631|NCT03740919|76051624|FG003|NOT COMPLETED|Treatment Period||3||
59933632|NCT01335685|76051639|FG000|STARTED|Overall Study||7||
59933633|NCT01335685|76051640|FG001|STARTED|Overall Study||4||
59933634|NCT01335685|76051641|FG002|STARTED|Overall Study||3||
59933635|NCT01335685|76051642|FG003|STARTED|Overall Study||26||
59933636|NCT01335685|76051643|FG004|STARTED|Overall Study||5||
59933637|NCT01335685|76051644|FG005|STARTED|Overall Study||6||
59933638|NCT01335685|76051645|FG006|STARTED|Overall Study||4||
59933639|NCT01335685|76051646|FG007|STARTED|Overall Study||6||
59933640|NCT01335685|76051639|FG000|COMPLETED|Overall Study||4||
59933641|NCT01335685|76051640|FG001|COMPLETED|Overall Study||3||
59933642|NCT01335685|76051641|FG002|COMPLETED|Overall Study||1||
59933643|NCT01335685|76051642|FG003|COMPLETED|Overall Study||15||
59933644|NCT01335685|76051643|FG004|COMPLETED|Overall Study||5||
59933645|NCT01335685|76051644|FG005|COMPLETED|Overall Study||1||
59933646|NCT01335685|76051645|FG006|COMPLETED|Overall Study||2||
59933647|NCT01335685|76051646|FG007|COMPLETED|Overall Study||3||
59933648|NCT01335685|76051639|FG000|NOT COMPLETED|Overall Study||3||
59933649|NCT01335685|76051640|FG001|NOT COMPLETED|Overall Study||1||
59933650|NCT01335685|76051641|FG002|NOT COMPLETED|Overall Study||2||
59933651|NCT01335685|76051642|FG003|NOT COMPLETED|Overall Study||11||
59933652|NCT01335685|76051643|FG004|NOT COMPLETED|Overall Study||0||
60067277|NCT01408888|76182423|FG000|Received at Least 1 Dose of Drug|First Intervention||18||
59933653|NCT01335685|76051644|FG005|NOT COMPLETED|Overall Study||5||
60067278|NCT01408888|76182424|FG001|Received at Least 1 Dose of Drug|First Intervention||11||
59933654|NCT01335685|76051645|FG006|NOT COMPLETED|Overall Study||2||
59933655|NCT01335685|76051646|FG007|NOT COMPLETED|Overall Study||3||
60067279|NCT01408888|76182423|FG000|COMPLETED|First Intervention||18||
59933656|NCT02926209|76051669|FG000|STARTED|Study Cohort|Training cohort patients Aer-O-Scope as first followed by a conventional colonoscopy|42||
59933657|NCT02926209|76051670|FG001|STARTED|Study Cohort||37||
59933658|NCT02926209|76051669|FG000|COMPLETED|Study Cohort||41||
59933659|NCT02926209|76051670|FG001|COMPLETED|Study Cohort||37||
59933660|NCT02926209|76051669|FG000|NOT COMPLETED|Study Cohort||1||
59933661|NCT02926209|76051670|FG001|NOT COMPLETED|Study Cohort||0||
59933662|NCT02926209|76051669|FG000|STARTED|Training Cohort - First Patients||20||
59933663|NCT02926209|76051670|FG001|STARTED|Training Cohort - First Patients||0||
59933664|NCT02926209|76051669|FG000|COMPLETED|Training Cohort - First Patients||20||
59933665|NCT02926209|76051670|FG001|COMPLETED|Training Cohort - First Patients||0||
59933666|NCT02926209|76051669|FG000|NOT COMPLETED|Training Cohort - First Patients||0||
59933667|NCT02926209|76051670|FG001|NOT COMPLETED|Training Cohort - First Patients||0||
59933668|NCT03066999|76051679|FG000|STARTED|Overall Study||2||
59933669|NCT03066999|76051680|FG001|STARTED|Overall Study||3||
59933670|NCT03066999|76051679|FG000|COMPLETED|Overall Study||2||
59933671|NCT03066999|76051680|FG001|COMPLETED|Overall Study||1||
59933672|NCT03066999|76051679|FG000|NOT COMPLETED|Overall Study||0||
59933673|NCT03066999|76051680|FG001|NOT COMPLETED|Overall Study||2||
59933674|NCT01482195|76051687|FG000|STARTED|Overall Study||6||
59933675|NCT01482195|76051687|FG000|One Year Results|Overall Study||6||
59933676|NCT01482195|76051687|FG000|COMPLETED|Overall Study||6||
59933677|NCT01482195|76051687|FG000|NOT COMPLETED|Overall Study||0||
59933678|NCT02963922|76051694|FG000|STARTED|Overall Study||198||
59933679|NCT02963922|76051695|FG001|STARTED|Overall Study||198||
59933680|NCT02963922|76051694|FG000|COMPLETED|Overall Study||166||
59933681|NCT02963922|76051695|FG001|COMPLETED|Overall Study||168||
59933682|NCT02963922|76051694|FG000|NOT COMPLETED|Overall Study||32||
59933683|NCT02963922|76051695|FG001|NOT COMPLETED|Overall Study||30||
59933684|NCT02881567|76051701|FG000|STARTED|Overall Study||41||
59933685|NCT02881567|76051701|FG000|COMPLETED|Overall Study||23||
59933686|NCT02881567|76051701|FG000|NOT COMPLETED|Overall Study||18||
59933687|NCT02962674|76051705|FG000|STARTED|Overall Study|"Although a total of 49 subjects were consented to participate in the study, three (3) of those subjects are not included in the study analysis as they did not actually receive treatment. These 3 subjects could not be treated because of their anatomy and therefore are considered treatment attempts. The final enrollment number (treated subjects only)is 46 subjects."|49|All subjects that signed an informed consent form.|
59933688|NCT02962674|76051705|FG000|3 Month Endpoint|Overall Study|All treated subjects that completed the 3-month endpoint visit per protocol.|46||
59933689|NCT02962674|76051705|FG000|12 Month Durability|Overall Study|All subjects that completed the 12-month follow-up visit per protocol.|46||
59933690|NCT02962674|76051705|FG000|24 Month Durability|Overall Study|All subjects that completed the 24-month follow-up visit. Note that at the time of study termination, all subjects would have reached this milestone.|32||
59933691|NCT02962674|76051705|FG000|36 Month Durability|Overall Study|All subjects that completed the 36-month follow-up visit. Note that at the time of study termination, not all subjects would have reached this milestone depending on time of enrollment.|18||
59933692|NCT02962674|76051705|FG000|48 Month Durability|Overall Study|All subjects that completed the 48-month follow-up visit. Note that at the time of study termination, not all subjects would have reached this milestone depending on time of enrollment.|4||
59933693|NCT02962674|76051705|FG000|COMPLETED|Overall Study|Study was terminated by sponsor prior to reaching 60 Month study completion mainly due to COVID-19 effects on subject follow-up.|0||
59933694|NCT02962674|76051705|FG000|NOT COMPLETED|Overall Study||49||
59933695|NCT02962908|76051715|FG000|STARTED|Overall Study||58||
59933696|NCT02962908|76051716|FG001|STARTED|Overall Study||58||
59933697|NCT02962908|76051717|FG002|STARTED|Overall Study||32||
59933698|NCT02962908|76051718|FG003|STARTED|Overall Study||27||
59933699|NCT02962908|76051715|FG000|COMPLETED|Overall Study||58||
59933700|NCT02962908|76051716|FG001|COMPLETED|Overall Study||50||
59933701|NCT02962908|76051717|FG002|COMPLETED|Overall Study||32||
59933702|NCT02962908|76051718|FG003|COMPLETED|Overall Study||24||
59933703|NCT02962908|76051715|FG000|NOT COMPLETED|Overall Study||0||
59933704|NCT02962908|76051716|FG001|NOT COMPLETED|Overall Study||8||
59933705|NCT02962908|76051717|FG002|NOT COMPLETED|Overall Study||0||
59933706|NCT02962908|76051718|FG003|NOT COMPLETED|Overall Study||3||
59933707|NCT02962284|76051736|FG000|STARTED|Overall Study||9||
59933708|NCT02962284|76051737|FG001|STARTED|Overall Study||11||
59933709|NCT02962284|76051736|FG000|COMPLETED|Overall Study||4||
59933710|NCT02962284|76051737|FG001|COMPLETED|Overall Study||8||
59933711|NCT02962284|76051736|FG000|NOT COMPLETED|Overall Study||5||
59933712|NCT02962284|76051737|FG001|NOT COMPLETED|Overall Study||3||
59933713|NCT01344876|76051745|FG000|STARTED|Overall Study||4||
59933714|NCT01344876|76051746|FG001|STARTED|Overall Study||3||
59933715|NCT01344876|76051747|FG002|STARTED|Overall Study||4||
59933716|NCT01344876|76051748|FG003|STARTED|Overall Study||6||
59933717|NCT01344876|76051749|FG004|STARTED|Overall Study||3||
59933718|NCT01344876|76051745|FG000|COMPLETED|Overall Study||3||
60067280|NCT01408888|76182424|FG001|COMPLETED|First Intervention||8||
60067281|NCT01408888|76182423|FG000|NOT COMPLETED|First Intervention||0||
59761645|NCT00600938|75881285|FG003|STARTED|Extension Study|Of the 82 patients who completed the ICL core, 74 continued on the ICL ext. phase; 1 went to ICL-DFO|1||
59933719|NCT01344876|76051746|FG001|COMPLETED|Overall Study||3||
59933720|NCT01344876|76051747|FG002|COMPLETED|Overall Study||3||
60067282|NCT01408888|76182424|FG001|NOT COMPLETED|First Intervention||3||
59933721|NCT01344876|76051748|FG003|COMPLETED|Overall Study||3||
59933722|NCT01344876|76051749|FG004|COMPLETED|Overall Study||2||
59933723|NCT01344876|76051745|FG000|NOT COMPLETED|Overall Study||1||
59933724|NCT01344876|76051746|FG001|NOT COMPLETED|Overall Study||0||
59933725|NCT01344876|76051747|FG002|NOT COMPLETED|Overall Study||1||
59933726|NCT01344876|76051748|FG003|NOT COMPLETED|Overall Study||3||
59933727|NCT01344876|76051749|FG004|NOT COMPLETED|Overall Study||1||
59933728|NCT02846324|76051766|FG000|STARTED|Overall Study||9||
59933729|NCT02846324|76051767|FG001|STARTED|Overall Study||6||
59933730|NCT02846324|76051768|FG002|STARTED|Overall Study||14||
59933731|NCT02846324|76051769|FG003|STARTED|Overall Study||10||
59933732|NCT02846324|76051766|FG000|Completed Study Treatment|Overall Study||7||
59933733|NCT02846324|76051767|FG001|Completed Study Treatment|Overall Study||5||
59933734|NCT02846324|76051768|FG002|Completed Study Treatment|Overall Study||11||
59933735|NCT02846324|76051769|FG003|Completed Study Treatment|Overall Study||10||
59933736|NCT02846324|76051766|FG000|COMPLETED|Overall Study||7|Completed Study|
59933737|NCT02846324|76051767|FG001|COMPLETED|Overall Study||6|Completed Study|
59933738|NCT02846324|76051768|FG002|COMPLETED|Overall Study||10|Completed Study|
59933739|NCT02846324|76051769|FG003|COMPLETED|Overall Study||10|Completed Study|
59933740|NCT02846324|76051766|FG000|NOT COMPLETED|Overall Study||2||
59933741|NCT02846324|76051767|FG001|NOT COMPLETED|Overall Study||0||
59933742|NCT02846324|76051768|FG002|NOT COMPLETED|Overall Study||4||
59933743|NCT02846324|76051769|FG003|NOT COMPLETED|Overall Study||0||
59933744|NCT03161093|76051794|FG000|STARTED|Overall Study||354||
59933745|NCT03161093|76051795|FG001|STARTED|Overall Study||1063||
59933746|NCT03161093|76051796|FG002|STARTED|Overall Study||551||
59933747|NCT03161093|76051797|FG003|STARTED|Overall Study||1054||
59933748|NCT03161093|76051798|FG004|STARTED|Overall Study||145||
59933749|NCT03161093|76051799|FG005|STARTED|Overall Study||140||
59933750|NCT03161093|76051794|FG000|As Treated|Overall Study||352||
59933751|NCT03161093|76051795|FG001|As Treated|Overall Study||1056||
59933752|NCT03161093|76051796|FG002|As Treated|Overall Study||554||
59933753|NCT03161093|76051797|FG003|As Treated|Overall Study||1052||
59933754|NCT03161093|76051798|FG004|As Treated|Overall Study||145||
59933755|NCT03161093|76051799|FG005|As Treated|Overall Study||139||
59933756|NCT03161093|76051794|FG000|COMPLETED|Overall Study||299||
59933757|NCT03161093|76051795|FG001|COMPLETED|Overall Study||919||
59933758|NCT03161093|76051796|FG002|COMPLETED|Overall Study||465||
59933759|NCT03161093|76051797|FG003|COMPLETED|Overall Study||867||
59933760|NCT03161093|76051798|FG004|COMPLETED|Overall Study||102||
59933761|NCT03161093|76051799|FG005|COMPLETED|Overall Study||99||
59933762|NCT03161093|76051794|FG000|NOT COMPLETED|Overall Study||55||
59933763|NCT03161093|76051795|FG001|NOT COMPLETED|Overall Study||144||
59933764|NCT03161093|76051796|FG002|NOT COMPLETED|Overall Study||86||
59933765|NCT03161093|76051797|FG003|NOT COMPLETED|Overall Study||187||
59933766|NCT03161093|76051798|FG004|NOT COMPLETED|Overall Study||43||
59933767|NCT03161093|76051799|FG005|NOT COMPLETED|Overall Study||41||
59933768|NCT02847650|76051820|FG000|STARTED|Overall Study||29||
60067283|NCT01408888|76182423|FG000|STARTED|Washout of at Least 21 Days||18||
59933769|NCT02847650|76051821|FG001|STARTED|Overall Study||28||
59933770|NCT02847650|76051820|FG000|COMPLETED|Overall Study||25||
59933771|NCT02847650|76051821|FG001|COMPLETED|Overall Study||22||
59933772|NCT02847650|76051820|FG000|NOT COMPLETED|Overall Study||4||
59933773|NCT02847650|76051821|FG001|NOT COMPLETED|Overall Study||6||
59933774|NCT02847494|76051829|FG000|STARTED|Overall Study||109||
59933775|NCT02847494|76051830|FG001|STARTED|Overall Study||111||
59933776|NCT02847494|76051829|FG000|COMPLETED|Overall Study||101||
59933777|NCT02847494|76051830|FG001|COMPLETED|Overall Study||106||
59933778|NCT02847494|76051829|FG000|NOT COMPLETED|Overall Study||8||
59933779|NCT02847494|76051830|FG001|NOT COMPLETED|Overall Study||5||
59933780|NCT02554253|76051838|FG000|STARTED|Overall Study||26||
59933781|NCT02554253|76051839|FG001|STARTED|Overall Study||26||
59933782|NCT02554253|76051838|FG000|COMPLETED|Overall Study||25||
59933783|NCT02554253|76051839|FG001|COMPLETED|Overall Study||24||
59933784|NCT02554253|76051838|FG000|NOT COMPLETED|Overall Study||1||
59933785|NCT02554253|76051839|FG001|NOT COMPLETED|Overall Study||2||
59933786|NCT03157583|76051846|FG000|STARTED|Overall Study||8||
59933787|NCT03157583|76051846|FG000|COMPLETED|Overall Study||7||
59933788|NCT03157583|76051846|FG000|NOT COMPLETED|Overall Study||1||
59933789|NCT02842736|76051864|FG000|STARTED|Overall Study|Treated|242||
59933790|NCT02842736|76051864|FG000|Known Month 12 Outcome|Overall Study||230||
60067284|NCT01408888|76182424|FG001|STARTED|Washout of at Least 21 Days||8||
59933791|NCT02842736|76051864|FG000|24 Month Visit Performed|Overall Study||210||
59933792|NCT02842736|76051864|FG000|COMPLETED|Overall Study|36 Month Visit Completed|201||
59933793|NCT02842736|76051864|FG000|NOT COMPLETED|Overall Study||41||
59933794|NCT01307033|76051870|FG000|STARTED|8-week Double-blind Period||144||
59933795|NCT01307033|76051871|FG001|STARTED|8-week Double-blind Period||134||
59933796|NCT01307033|76051872|FG002|STARTED|8-week Double-blind Period||0||
59933797|NCT01307033|76051873|FG003|STARTED|8-week Double-blind Period||0||
59933798|NCT01307033|76051870|FG000|COMPLETED|8-week Double-blind Period||131||
59933799|NCT01307033|76051871|FG001|COMPLETED|8-week Double-blind Period||127||
59933800|NCT01307033|76051872|FG002|COMPLETED|8-week Double-blind Period||0||
59933801|NCT01307033|76051873|FG003|COMPLETED|8-week Double-blind Period||0||
59933802|NCT01307033|76051870|FG000|NOT COMPLETED|8-week Double-blind Period||13||
59933803|NCT01307033|76051871|FG001|NOT COMPLETED|8-week Double-blind Period||7||
59933804|NCT01307033|76051872|FG002|NOT COMPLETED|8-week Double-blind Period||0||
59933805|NCT01307033|76051873|FG003|NOT COMPLETED|8-week Double-blind Period||0||
59933806|NCT01307033|76051870|FG000|STARTED|44-week Open-label Extension||0||
59933807|NCT01307033|76051871|FG001|STARTED|44-week Open-label Extension||0||
59933808|NCT01307033|76051872|FG002|STARTED|44-week Open-label Extension||131||
59933809|NCT01307033|76051873|FG003|STARTED|44-week Open-label Extension||127||
59933810|NCT01307033|76051870|FG000|COMPLETED|44-week Open-label Extension||0||
59933811|NCT01307033|76051871|FG001|COMPLETED|44-week Open-label Extension||0||
59933812|NCT01307033|76051872|FG002|COMPLETED|44-week Open-label Extension||120||
59933813|NCT01307033|76051873|FG003|COMPLETED|44-week Open-label Extension||115||
59933814|NCT01307033|76051870|FG000|NOT COMPLETED|44-week Open-label Extension||0||
59933815|NCT01307033|76051871|FG001|NOT COMPLETED|44-week Open-label Extension||0||
59933816|NCT01307033|76051872|FG002|NOT COMPLETED|44-week Open-label Extension||11||
59933817|NCT01307033|76051873|FG003|NOT COMPLETED|44-week Open-label Extension||12||
59933818|NCT02844920|76051885|FG000|STARTED|Overall Study||37||
59933819|NCT02844920|76051885|FG000|Completed Without Evaluable Videos|Overall Study|Participants with completed the follow-up but without evaluable hysteroscopy videos|1||
59933820|NCT02844920|76051885|FG000|Completed With Evaluable Videos|Overall Study|Participants with completed the follow-up and evaluable hysteroscopy videos|34||
59933821|NCT02844920|76051885|FG000|Completed, Eval. Data, Opposing Fibroids|Overall Study|Participants with completed the follow-up, evaluable hysteroscopy videos, and opposing fibroids|6||
59933822|NCT02844920|76051885|FG000|COMPLETED|Overall Study|Participants with completed the follow-up|35||
59933823|NCT02844920|76051885|FG000|NOT COMPLETED|Overall Study||2||
59933824|NCT03158311|76051892|FG000|STARTED|Overall Study||474|All participants who were assigned a randomization number|
59933825|NCT03158311|76051893|FG001|STARTED|Overall Study||476|All participants who were assigned a randomization number|
59933826|NCT03158311|76051894|FG002|STARTED|Overall Study||476|All participants who were assigned a randomization number|
59933827|NCT03158311|76051892|FG000|Full Analysis Set (FAS)|Overall Study||474|All the participants in the randomization set who received at least one dose of the study medication|
59933828|NCT03158311|76051893|FG001|Full Analysis Set (FAS)|Overall Study||476|All the participants in the randomization set who received at least one dose of the study medication|
59933829|NCT03158311|76051894|FG002|Full Analysis Set (FAS)|Overall Study||475|All the participants in the randomization set who received at least one dose of the study medication|
59933830|NCT03158311|76051892|FG000|Safety Set (SAF)|Overall Study||474|All the participants who received at least one dose of the study medication|
59933831|NCT03158311|76051893|FG001|Safety Set (SAF)|Overall Study||476|All the participants who received at least one dose of the study medication|
59933832|NCT03158311|76051894|FG002|Safety Set (SAF)|Overall Study||475|All the participants who received at least one dose of the study medication|
59933833|NCT03158311|76051892|FG000|COMPLETED|Overall Study||452||
59933834|NCT03158311|76051893|FG001|COMPLETED|Overall Study||460||
59933835|NCT03158311|76051894|FG002|COMPLETED|Overall Study||448||
59933836|NCT03158311|76051892|FG000|NOT COMPLETED|Overall Study||22||
59933837|NCT03158311|76051893|FG001|NOT COMPLETED|Overall Study||16||
59933838|NCT03158311|76051894|FG002|NOT COMPLETED|Overall Study||28||
59933839|NCT01391234|76051902|FG000|STARTED|Overall Study||28||
59933840|NCT01391234|76051902|FG000|COMPLETED|Overall Study||28||
59933841|NCT01391234|76051902|FG000|NOT COMPLETED|Overall Study||0||
59933842|NCT01336621|76051906|FG000|STARTED|Primary Reporting Phase (Upto 5.8 Years)||98||
59933843|NCT01336621|76051906|FG000|COMPLETED|Primary Reporting Phase (Upto 5.8 Years)||0||
59933844|NCT01336621|76051906|FG000|NOT COMPLETED|Primary Reporting Phase (Upto 5.8 Years)||98||
59933845|NCT01336621|76051906|FG000|STARTED|SFUCP (up to 2.6 Years)||9||
59933846|NCT01336621|76051906|FG000|COMPLETED|SFUCP (up to 2.6 Years)||0||
59933847|NCT01336621|76051906|FG000|NOT COMPLETED|SFUCP (up to 2.6 Years)||9||
59933848|NCT00383435|76051918|FG000|STARTED|26-Week Double-Blind Treatment Period||217||
59933849|NCT00383435|76051919|FG001|STARTED|26-Week Double-Blind Treatment Period||207||
59933850|NCT00383435|76051920|FG002|STARTED|26-Week Double-Blind Treatment Period||210||
59933851|NCT00383435|76051921|FG003|STARTED|26-Week Double-Blind Treatment Period||209||
59933852|NCT00383435|76051922|FG004|STARTED|26-Week Double-Blind Treatment Period||212||
59933853|NCT00383435|76051918|FG000|COMPLETED|26-Week Double-Blind Treatment Period||176||
59933854|NCT00383435|76051919|FG001|COMPLETED|26-Week Double-Blind Treatment Period||169||
59933855|NCT00383435|76051920|FG002|COMPLETED|26-Week Double-Blind Treatment Period||164||
59933856|NCT00383435|76051921|FG003|COMPLETED|26-Week Double-Blind Treatment Period||172||
59933857|NCT00383435|76051922|FG004|COMPLETED|26-Week Double-Blind Treatment Period||159||
59933858|NCT00383435|76051918|FG000|NOT COMPLETED|26-Week Double-Blind Treatment Period||41||
59933859|NCT00383435|76051919|FG001|NOT COMPLETED|26-Week Double-Blind Treatment Period||38||
59933860|NCT00383435|76051920|FG002|NOT COMPLETED|26-Week Double-Blind Treatment Period||46||
59933861|NCT00383435|76051921|FG003|NOT COMPLETED|26-Week Double-Blind Treatment Period||37||
59933862|NCT00383435|76051922|FG004|NOT COMPLETED|26-Week Double-Blind Treatment Period||53||
59933863|NCT00383435|76051918|FG000|STARTED|26-Week Treatment Safety Extension||131||
60067285|NCT01408888|76182423|FG000|COMPLETED|Washout of at Least 21 Days||18||
60067286|NCT01408888|76182424|FG001|COMPLETED|Washout of at Least 21 Days||8||
59933864|NCT00383435|76051919|FG001|STARTED|26-Week Treatment Safety Extension||130||
59933865|NCT00383435|76051920|FG002|STARTED|26-Week Treatment Safety Extension||124||
59933866|NCT00383435|76051921|FG003|STARTED|26-Week Treatment Safety Extension||131||
59933867|NCT00383435|76051922|FG004|STARTED|26-Week Treatment Safety Extension||13||
59933868|NCT00383435|76051918|FG000|COMPLETED|26-Week Treatment Safety Extension||117||
59933869|NCT00383435|76051919|FG001|COMPLETED|26-Week Treatment Safety Extension||121||
59933870|NCT00383435|76051920|FG002|COMPLETED|26-Week Treatment Safety Extension||108||
59933871|NCT00383435|76051921|FG003|COMPLETED|26-Week Treatment Safety Extension||116||
59933872|NCT00383435|76051922|FG004|COMPLETED|26-Week Treatment Safety Extension||10||
59933873|NCT00383435|76051918|FG000|NOT COMPLETED|26-Week Treatment Safety Extension||14||
59933874|NCT00383435|76051919|FG001|NOT COMPLETED|26-Week Treatment Safety Extension||9||
59933875|NCT00383435|76051920|FG002|NOT COMPLETED|26-Week Treatment Safety Extension||16||
59933876|NCT00383435|76051921|FG003|NOT COMPLETED|26-Week Treatment Safety Extension||15||
59933877|NCT00383435|76051922|FG004|NOT COMPLETED|26-Week Treatment Safety Extension||3||
59933878|NCT03157037|76051934|FG000|STARTED|Overall Study||15||
59933879|NCT03157037|76051934|FG000|COMPLETED|Overall Study||14||
59933880|NCT03157037|76051934|FG000|NOT COMPLETED|Overall Study||1||
59933881|NCT03067610|76051945|FG000|STARTED|Overall Study||72||
59933882|NCT03067610|76051945|FG000|COMPLETED|Overall Study||72||
59933883|NCT03067610|76051945|FG000|NOT COMPLETED|Overall Study||0||
59933884|NCT00381485|76051956|FG000|STARTED|Open-Label Run-In Period||834||
59933885|NCT00381485|76051957|FG001|STARTED|Open-Label Run-In Period||0||
59933886|NCT00381485|76051958|FG002|STARTED|Open-Label Run-In Period||0||
59933887|NCT00381485|76051959|FG003|STARTED|Open-Label Run-In Period||0||
59933888|NCT00381485|76051956|FG000|COMPLETED|Open-Label Run-In Period||728||
59933889|NCT00381485|76051957|FG001|COMPLETED|Open-Label Run-In Period||0||
59933890|NCT00381485|76051958|FG002|COMPLETED|Open-Label Run-In Period||0||
59933891|NCT00381485|76051959|FG003|COMPLETED|Open-Label Run-In Period||0||
59933892|NCT00381485|76051956|FG000|NOT COMPLETED|Open-Label Run-In Period||106||
59933893|NCT00381485|76051957|FG001|NOT COMPLETED|Open-Label Run-In Period||0||
59933894|NCT00381485|76051958|FG002|NOT COMPLETED|Open-Label Run-In Period||0||
59933895|NCT00381485|76051959|FG003|NOT COMPLETED|Open-Label Run-In Period||0||
59933896|NCT00381485|76051956|FG000|STARTED|Double-Blind Treatment Period||0||
59933897|NCT00381485|76051957|FG001|STARTED|Double-Blind Treatment Period||255||
59933898|NCT00381485|76051958|FG002|STARTED|Double-Blind Treatment Period||233||
59933899|NCT00381485|76051959|FG003|STARTED|Double-Blind Treatment Period||240||
59933900|NCT00381485|76051956|FG000|COMPLETED|Double-Blind Treatment Period||0||
59933901|NCT00381485|76051957|FG001|COMPLETED|Double-Blind Treatment Period||228||
59933902|NCT00381485|76051958|FG002|COMPLETED|Double-Blind Treatment Period||208||
59933903|NCT00381485|76051959|FG003|COMPLETED|Double-Blind Treatment Period||207||
59933904|NCT00381485|76051956|FG000|NOT COMPLETED|Double-Blind Treatment Period||0||
59933905|NCT00381485|76051957|FG001|NOT COMPLETED|Double-Blind Treatment Period||27||
59933906|NCT00381485|76051958|FG002|NOT COMPLETED|Double-Blind Treatment Period||25||
59933907|NCT00381485|76051959|FG003|NOT COMPLETED|Double-Blind Treatment Period||33||
59933908|NCT02840474|76051970|FG000|STARTED|Overall Study||7||
59933909|NCT02840474|76051971|FG001|STARTED|Overall Study||9||
59933910|NCT02840474|76051970|FG000|Received Study Product|Overall Study||7||
59933911|NCT02840474|76051971|FG001|Received Study Product|Overall Study||9||
59933912|NCT02840474|76051970|FG000|COMPLETED|Overall Study||6||
59933913|NCT02840474|76051971|FG001|COMPLETED|Overall Study||9||
59933914|NCT02840474|76051970|FG000|NOT COMPLETED|Overall Study||1||
59933915|NCT02840474|76051971|FG001|NOT COMPLETED|Overall Study||0||
59933916|NCT03155945|76051979|FG000|STARTED|Overall Study||6||
59933917|NCT03155945|76051980|FG001|STARTED|Overall Study||8||
59933918|NCT03155945|76051979|FG000|COMPLETED|Overall Study||6||
59933919|NCT03155945|76051980|FG001|COMPLETED|Overall Study||5||
59933920|NCT03155945|76051979|FG000|NOT COMPLETED|Overall Study||0||
59933921|NCT03155945|76051980|FG001|NOT COMPLETED|Overall Study||3||
59933922|NCT03160703|76051990|FG000|STARTED|Overall Study||55||
59933923|NCT03160703|76051991|FG001|STARTED|Overall Study||55||
60067287|NCT01408888|76182423|FG000|NOT COMPLETED|Washout of at Least 21 Days||0||
59613294|NCT02071914|75724445|FG000|COMPLETED|Overall Study||27||
59933924|NCT03160703|76051992|FG002|STARTED|Overall Study||55||
59933925|NCT03160703|76051993|FG003|STARTED|Overall Study||55||
59933926|NCT03160703|76051990|FG000|COMPLETED|Overall Study||55||
59933927|NCT03160703|76051991|FG001|COMPLETED|Overall Study||55||
59933928|NCT03160703|76051992|FG002|COMPLETED|Overall Study||55||
59933929|NCT03160703|76051993|FG003|COMPLETED|Overall Study||54||
59933930|NCT03160703|76051990|FG000|NOT COMPLETED|Overall Study||0||
59933931|NCT03160703|76051991|FG001|NOT COMPLETED|Overall Study||0||
59933932|NCT03160703|76051992|FG002|NOT COMPLETED|Overall Study||0||
60067288|NCT01408888|76182424|FG001|NOT COMPLETED|Washout of at Least 21 Days||0||
60067289|NCT01408888|76182423|FG000|STARTED|Second Intervention||18||
59933933|NCT03160703|76051993|FG003|NOT COMPLETED|Overall Study||1||
59933934|NCT03159611|76052005|FG000|STARTED|Overall Study||95||
59933935|NCT03159611|76052006|FG001|STARTED|Overall Study||87||
59933936|NCT03159611|76052005|FG000|COMPLETED|Overall Study||72||
59933937|NCT03159611|76052006|FG001|COMPLETED|Overall Study||72||
59933938|NCT03159611|76052005|FG000|NOT COMPLETED|Overall Study||23||
59933939|NCT03159611|76052006|FG001|NOT COMPLETED|Overall Study||15||
59933940|NCT03159455|76052018|FG000|STARTED|Overall Study||9||
59933941|NCT03159455|76052019|FG001|STARTED|Overall Study||9||
59933942|NCT03159455|76052020|FG002|STARTED|Overall Study||9||
59933943|NCT03159455|76052021|FG003|STARTED|Overall Study||9||
59933944|NCT03159455|76052022|FG004|STARTED|Overall Study||3||
59933945|NCT03159455|76052023|FG005|STARTED|Overall Study||9||
59933946|NCT03159455|76052018|FG000|COMPLETED|Overall Study||9||
59933947|NCT03159455|76052019|FG001|COMPLETED|Overall Study||9||
59933948|NCT03159455|76052020|FG002|COMPLETED|Overall Study||9||
59933949|NCT03159455|76052021|FG003|COMPLETED|Overall Study||9||
59933950|NCT03159455|76052022|FG004|COMPLETED|Overall Study||3||
59933951|NCT03159455|76052023|FG005|COMPLETED|Overall Study||8||
59933952|NCT03159455|76052018|FG000|NOT COMPLETED|Overall Study||0||
59933953|NCT03159455|76052019|FG001|NOT COMPLETED|Overall Study||0||
59933954|NCT03159455|76052020|FG002|NOT COMPLETED|Overall Study||0||
59933955|NCT03159455|76052021|FG003|NOT COMPLETED|Overall Study||0||
59933956|NCT03159455|76052022|FG004|NOT COMPLETED|Overall Study||0||
59933957|NCT03159455|76052023|FG005|NOT COMPLETED|Overall Study||1||
59933958|NCT02838134|76052043|FG000|STARTED|Overall Study||50||
59933959|NCT02838134|76052044|FG001|STARTED|Overall Study||51||
59933960|NCT02838134|76052043|FG000|COMPLETED|Overall Study||48||
59933961|NCT02838134|76052044|FG001|COMPLETED|Overall Study||48||
59933962|NCT02838134|76052043|FG000|NOT COMPLETED|Overall Study||2||
59933963|NCT02838134|76052044|FG001|NOT COMPLETED|Overall Study||3||
59933964|NCT03150589|76052052|FG000|STARTED|Overall Study||351||
59933965|NCT03150589|76052053|FG001|STARTED|Overall Study||354||
59933966|NCT03150589|76052052|FG000|COMPLETED|Overall Study||307||
59933967|NCT03150589|76052053|FG001|COMPLETED|Overall Study||327||
59933968|NCT03150589|76052052|FG000|NOT COMPLETED|Overall Study||44||
59933969|NCT03150589|76052053|FG001|NOT COMPLETED|Overall Study||27||
59933970|NCT02835092|76052062|FG000|STARTED|Overall Study||66||
59933971|NCT02835092|76052063|FG001|STARTED|Overall Study||65||
59933972|NCT02835092|76052064|FG002|STARTED|Overall Study||67||
59933973|NCT02835092|76052062|FG000|COMPLETED|Overall Study||63||
59933974|NCT02835092|76052063|FG001|COMPLETED|Overall Study||57||
59933975|NCT02835092|76052064|FG002|COMPLETED|Overall Study||64||
59933976|NCT02835092|76052062|FG000|NOT COMPLETED|Overall Study||3||
59933977|NCT02835092|76052063|FG001|NOT COMPLETED|Overall Study||8||
59933978|NCT02835092|76052064|FG002|NOT COMPLETED|Overall Study||3||
59933979|NCT03145207|76052072|FG000|STARTED|Overall Study|The same 12 volunteers completed each of the seven study sessions.|14||
59933980|NCT03145207|76052072|FG000|COMPLETED|Overall Study||12||
59933981|NCT03145207|76052072|FG000|NOT COMPLETED|Overall Study||2||
59933982|NCT02836652|76052089|FG000|STARTED|Overall Study||35||
59933983|NCT02836652|76052090|FG001|STARTED|Overall Study||37||
59933984|NCT02836652|76052089|FG000|As-treated Population|Overall Study||31|Cohort of subjects on treatment medication.|
59933985|NCT02836652|76052090|FG001|As-treated Population|Overall Study||34|Cohort of subjects on treatment medication.|
59933986|NCT02836652|76052089|FG000|COMPLETED|Overall Study||17||
59933987|NCT02836652|76052090|FG001|COMPLETED|Overall Study||18||
59933988|NCT02836652|76052089|FG000|NOT COMPLETED|Overall Study||18||
59933989|NCT02836652|76052090|FG001|NOT COMPLETED|Overall Study||19||
59933990|NCT02836496|76052098|FG000|STARTED|Overall Study||54||
59933991|NCT02836496|76052099|FG001|STARTED|Overall Study||54||
59933992|NCT02836496|76052098|FG000|COMPLETED|Overall Study||52||
59933993|NCT02836496|76052099|FG001|COMPLETED|Overall Study||52||
59933994|NCT02836496|76052098|FG000|NOT COMPLETED|Overall Study||2||
59933995|NCT02836496|76052099|FG001|NOT COMPLETED|Overall Study||2||
59933996|NCT04213807|76052108|FG000|STARTED|Overall Study||5||
59933997|NCT04213807|76052109|FG001|STARTED|Overall Study||6||
59933998|NCT04213807|76052110|FG002|STARTED|Overall Study||7||
59933999|NCT04213807|76052108|FG000|COMPLETED|Overall Study||5||
59934000|NCT04213807|76052109|FG001|COMPLETED|Overall Study||6||
59934001|NCT04213807|76052110|FG002|COMPLETED|Overall Study||6||
59934002|NCT04213807|76052108|FG000|NOT COMPLETED|Overall Study||0||
59934003|NCT04213807|76052109|FG001|NOT COMPLETED|Overall Study||0||
59934004|NCT04213807|76052110|FG002|NOT COMPLETED|Overall Study||1||
59613295|NCT02071914|75724446|FG001|COMPLETED|Overall Study||27||
59934005|NCT04172467|76052120|FG000|STARTED|Overall Study||1086||
59934006|NCT04172467|76052120|FG000|COMPLETED|Overall Study||1086||
59613296|NCT02071914|75724447|FG002|COMPLETED|Overall Study||27||
59613297|NCT02071914|75724445|FG000|NOT COMPLETED|Overall Study||0||
59934007|NCT04172467|76052120|FG000|NOT COMPLETED|Overall Study||0||
59934008|NCT00577577|76052129|FG000|STARTED|Overall Study||34||
59934009|NCT00577577|76052130|FG001|STARTED|Overall Study||35||
59934010|NCT00577577|76052129|FG000|Received Treatment|Overall Study||34||
59934011|NCT00577577|76052130|FG001|Received Treatment|Overall Study||35||
59934012|NCT00577577|76052129|FG000|COMPLETED|Overall Study||29||
59934013|NCT00577577|76052130|FG001|COMPLETED|Overall Study||30||
59934014|NCT00577577|76052129|FG000|NOT COMPLETED|Overall Study||5||
59613298|NCT02071914|75724446|FG001|NOT COMPLETED|Overall Study||0||
59934015|NCT00577577|76052130|FG001|NOT COMPLETED|Overall Study||5||
59934016|NCT02833844|76052138|FG000|STARTED|Double-Blind Period||157|Randomized|
59934017|NCT02833844|76052139|FG001|STARTED|Double-Blind Period||310|Randomized|
59761646|NCT00600938|75881282|FG000|Extension Safety Set|Extension Study|1 patient did not receive drug in the ext. phase but received drug in the core phase|73||
59761647|NCT00600938|75881283|FG001|Extension Safety Set|Extension Study||29||
59761648|NCT00600938|75881284|FG002|Extension Safety Set|Extension Study||42||
59761649|NCT00600938|75881285|FG003|Extension Safety Set|Extension Study||1||
59934018|NCT02833844|76052138|FG000|Randomized and Treated|Double-Blind Period||157||
59934019|NCT02833844|76052139|FG001|Randomized and Treated|Double-Blind Period||307||
59934020|NCT02833844|76052138|FG000|COMPLETED|Double-Blind Period|completed double-blind period|155||
59934021|NCT02833844|76052139|FG001|COMPLETED|Double-Blind Period|completed double-blind period|303||
59934022|NCT02833844|76052138|FG000|NOT COMPLETED|Double-Blind Period||2||
59934023|NCT02833844|76052139|FG001|NOT COMPLETED|Double-Blind Period||7||
59934024|NCT02833844|76052138|FG000|STARTED|Open-Label Period|3 participants did not continue to open-label period|152||
59934025|NCT02833844|76052139|FG001|STARTED|Open-Label Period||303||
59934026|NCT02833844|76052138|FG000|Received Open-Label Study Drug|Open-Label Period||152||
59934027|NCT02833844|76052139|FG001|Received Open-Label Study Drug|Open-Label Period||299||
59934028|NCT02833844|76052138|FG000|COMPLETED|Open-Label Period||150||
59934029|NCT02833844|76052139|FG001|COMPLETED|Open-Label Period||301||
59934030|NCT02833844|76052138|FG000|NOT COMPLETED|Open-Label Period||2||
59934031|NCT02833844|76052139|FG001|NOT COMPLETED|Open-Label Period||2||
59934032|NCT01341782|76052149|FG000|STARTED|Overall Study||127||
59934033|NCT01341782|76052150|FG001|STARTED|Overall Study||128||
59934034|NCT01341782|76052149|FG000|COMPLETED|Overall Study||112||
59934035|NCT01341782|76052150|FG001|COMPLETED|Overall Study||114||
59934036|NCT01341782|76052149|FG000|NOT COMPLETED|Overall Study||15||
59934037|NCT01341782|76052150|FG001|NOT COMPLETED|Overall Study||14||
59934038|NCT01341470|76052162|FG000|STARTED|Overall Study||6||
59934039|NCT01341470|76052163|FG001|STARTED|Overall Study||9||
59934040|NCT01341470|76052164|FG002|STARTED|Overall Study||10||
59934041|NCT01341470|76052165|FG003|STARTED|Overall Study||10||
59934042|NCT01341470|76052166|FG004|STARTED|Overall Study||2||
59934043|NCT01341470|76052167|FG005|STARTED|Overall Study||10||
59934044|NCT01341470|76052162|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6||
59934045|NCT01341470|76052163|FG001|Received at Least 1 Dose of Study Drug|Overall Study||9||
59934046|NCT01341470|76052164|FG002|Received at Least 1 Dose of Study Drug|Overall Study||10||
59934047|NCT01341470|76052165|FG003|Received at Least 1 Dose of Study Drug|Overall Study||10||
59934048|NCT01341470|76052166|FG004|Received at Least 1 Dose of Study Drug|Overall Study||2||
59934049|NCT01341470|76052167|FG005|Received at Least 1 Dose of Study Drug|Overall Study||10||
59934050|NCT01341470|76052162|FG000|COMPLETED|Overall Study||6||
59934051|NCT01341470|76052163|FG001|COMPLETED|Overall Study||9||
59934052|NCT01341470|76052164|FG002|COMPLETED|Overall Study||9||
59934053|NCT01341470|76052165|FG003|COMPLETED|Overall Study||9||
59934054|NCT01341470|76052166|FG004|COMPLETED|Overall Study||2||
59934055|NCT01341470|76052167|FG005|COMPLETED|Overall Study||9||
59934056|NCT01341470|76052162|FG000|NOT COMPLETED|Overall Study||0||
59934057|NCT01341470|76052163|FG001|NOT COMPLETED|Overall Study||0||
59934058|NCT01341470|76052164|FG002|NOT COMPLETED|Overall Study||1||
59934059|NCT01341470|76052165|FG003|NOT COMPLETED|Overall Study||1||
59934060|NCT01341470|76052166|FG004|NOT COMPLETED|Overall Study||0||
59934061|NCT01341470|76052167|FG005|NOT COMPLETED|Overall Study||1||
59934062|NCT03143101|76052186|FG000|STARTED|Overall Study||67||
59934063|NCT03143101|76052187|FG001|STARTED|Overall Study||66||
59934064|NCT03143101|76052188|FG002|STARTED|Overall Study||67||
59934065|NCT03143101|76052186|FG000|COMPLETED|Overall Study||65||
59934066|NCT03143101|76052187|FG001|COMPLETED|Overall Study||63||
59934067|NCT03143101|76052188|FG002|COMPLETED|Overall Study||67||
59934068|NCT03143101|76052186|FG000|NOT COMPLETED|Overall Study||2||
59934069|NCT03143101|76052187|FG001|NOT COMPLETED|Overall Study||3||
59934070|NCT03143101|76052188|FG002|NOT COMPLETED|Overall Study||0||
59934071|NCT00871351|76052199|FG000|STARTED|Overall Study||47||
59934072|NCT00871351|76052200|FG001|STARTED|Overall Study||46||
59934073|NCT00871351|76052201|FG002|STARTED|Overall Study||32||
59934074|NCT00871351|76052199|FG000|COMPLETED|Overall Study||43||
59934075|NCT00871351|76052200|FG001|COMPLETED|Overall Study||45||
59934076|NCT00871351|76052201|FG002|COMPLETED|Overall Study||32||
59934077|NCT00871351|76052199|FG000|NOT COMPLETED|Overall Study||4||
59934078|NCT00871351|76052200|FG001|NOT COMPLETED|Overall Study||1||
59934079|NCT00871351|76052201|FG002|NOT COMPLETED|Overall Study||0||
59518345|NCT03514420|75612155|FG000|STARTED|Overall Study||4||
59518346|NCT03514420|75612155|FG000|COMPLETED|Overall Study||4||
59518347|NCT03514420|75612155|FG000|NOT COMPLETED|Overall Study||0||
59518348|NCT01078207|75612159|FG000|STARTED|Overall Study||100||
59518349|NCT01078207|75612159|FG000|COMPLETED|Overall Study||100||
59518350|NCT01078207|75612159|FG000|NOT COMPLETED|Overall Study||0||
59518351|NCT03369340|75612163|FG000|STARTED|Day 2||3||
59761650|NCT00600938|75881282|FG000|COMPLETED|Extension Study||65||
59934080|NCT02745080|76052211|FG000|STARTED|Overall Study||426|All randomized patients were included in the Full Analysis Set (FAS) and Safety Analysis Set (SAF)|
59518352|NCT03369340|75612164|FG001|STARTED|Day 2||3||
59518353|NCT03369340|75612165|FG002|STARTED|Day 2||3||
59518354|NCT03369340|75612166|FG003|STARTED|Day 2||3||
59518355|NCT03369340|75612167|FG004|STARTED|Day 2||3||
59934081|NCT02745080|76052212|FG001|STARTED|Overall Study||427|All randomized patients were included in the Full Analysis Set (FAS) and Safety Analysis Set (SAF)|
59934082|NCT02745080|76052211|FG000|COMPLETED|Overall Study||371||
59934083|NCT02745080|76052212|FG001|COMPLETED|Overall Study||338||
59934084|NCT02745080|76052211|FG000|NOT COMPLETED|Overall Study||55||
59934085|NCT02745080|76052212|FG001|NOT COMPLETED|Overall Study||89||
59934086|NCT00521599|76052222|FG000|STARTED|Overall Study||268||
59934087|NCT00521599|76052223|FG001|STARTED|Overall Study||268||
59934088|NCT00521599|76052224|FG002|STARTED|Overall Study||136||
59934089|NCT00521599|76052222|FG000|COMPLETED|Overall Study||243||
59934090|NCT00521599|76052223|FG001|COMPLETED|Overall Study||239||
59934091|NCT00521599|76052224|FG002|COMPLETED|Overall Study||100||
59934092|NCT00521599|76052222|FG000|NOT COMPLETED|Overall Study||25||
59934093|NCT00521599|76052223|FG001|NOT COMPLETED|Overall Study||29||
59934094|NCT00521599|76052224|FG002|NOT COMPLETED|Overall Study||36||
59934095|NCT00442897|76052235|FG000|STARTED|Base Study (12 Week Follow-up)||118||
59934096|NCT00442897|76052236|FG001|STARTED|Base Study (12 Week Follow-up)||111||
59934097|NCT00442897|76052235|FG000|COMPLETED|Base Study (12 Week Follow-up)||101||
59934098|NCT00442897|76052236|FG001|COMPLETED|Base Study (12 Week Follow-up)||99||
59934099|NCT00442897|76052235|FG000|NOT COMPLETED|Base Study (12 Week Follow-up)||17||
59934100|NCT00442897|76052236|FG001|NOT COMPLETED|Base Study (12 Week Follow-up)||12||
59934101|NCT00442897|76052235|FG000|STARTED|24 Weeks Follow-up (3 Centers)|66 Patients did not continue in the additional 12 week extension, for the 24 weeks follow-up period.|35||
59934102|NCT00442897|76052236|FG001|STARTED|24 Weeks Follow-up (3 Centers)|65 Patients did not continue in the additional 12 week extension, for the 24 weeks follow-up period.|34||
59934103|NCT00442897|76052235|FG000|COMPLETED|24 Weeks Follow-up (3 Centers)||29||
59934104|NCT00442897|76052236|FG001|COMPLETED|24 Weeks Follow-up (3 Centers)||28||
59934105|NCT00442897|76052235|FG000|NOT COMPLETED|24 Weeks Follow-up (3 Centers)||6||
59934106|NCT00442897|76052236|FG001|NOT COMPLETED|24 Weeks Follow-up (3 Centers)||6||
59934107|NCT02834390|76052244|FG000|STARTED|Induction Phase||4||
59934108|NCT02834390|76052245|FG001|STARTED|Induction Phase||3||
59934109|NCT02834390|76052244|FG000|COMPLETED|Induction Phase||2||
59934110|NCT02834390|76052245|FG001|COMPLETED|Induction Phase||1||
59934111|NCT02834390|76052244|FG000|NOT COMPLETED|Induction Phase||2||
59934112|NCT02834390|76052245|FG001|NOT COMPLETED|Induction Phase||2||
59934113|NCT02834390|76052244|FG000|STARTED|Consolidation Phase||2||
59934114|NCT02834390|76052245|FG001|STARTED|Consolidation Phase||1||
59934115|NCT02834390|76052244|FG000|COMPLETED|Consolidation Phase||1||
59934116|NCT02834390|76052245|FG001|COMPLETED|Consolidation Phase||0||
59934117|NCT02834390|76052244|FG000|NOT COMPLETED|Consolidation Phase||1||
59934118|NCT02834390|76052245|FG001|NOT COMPLETED|Consolidation Phase||1||
59934119|NCT03141151|76052253|FG000|STARTED|Overall Study||59||
59934120|NCT03141151|76052254|FG001|STARTED|Overall Study||58||
59934121|NCT03141151|76052253|FG000|COMPLETED|Overall Study||53||
59934122|NCT03141151|76052254|FG001|COMPLETED|Overall Study||54||
59934123|NCT03141151|76052253|FG000|NOT COMPLETED|Overall Study||6||
59934124|NCT03141151|76052254|FG001|NOT COMPLETED|Overall Study||4||
59934125|NCT01358708|76052262|FG000|STARTED|Double-Blind Treatment Phase||13||
59934126|NCT01358708|76052263|FG001|STARTED|Double-Blind Treatment Phase||13||
59934127|NCT01358708|76052262|FG000|Randomized|Double-Blind Treatment Phase||13||
59934128|NCT01358708|76052263|FG001|Randomized|Double-Blind Treatment Phase||13||
59934129|NCT01358708|76052262|FG000|Received Study Medication|Double-Blind Treatment Phase|For 1 subject, unused med not returned to the site and intake of study medication not confirmed.|12||
59934130|NCT01358708|76052263|FG001|Received Study Medication|Double-Blind Treatment Phase||13||
59934131|NCT01358708|76052262|FG000|COMPLETED|Double-Blind Treatment Phase||10||
59934132|NCT01358708|76052263|FG001|COMPLETED|Double-Blind Treatment Phase||13||
59934133|NCT01358708|76052262|FG000|NOT COMPLETED|Double-Blind Treatment Phase||3||
59934134|NCT01358708|76052263|FG001|NOT COMPLETED|Double-Blind Treatment Phase||0||
59934135|NCT01358708|76052262|FG000|STARTED|Open-Label Treatment Phase|Number of subjects on LACTEOL® during double-blind treatment and entering the Open-Label Phase|5||
59934136|NCT01358708|76052263|FG001|STARTED|Open-Label Treatment Phase|Number of subjects on PLACEBO during double-blind treatment and entering the Open-Label Phase|12||
59934137|NCT01358708|76052262|FG000|COMPLETED|Open-Label Treatment Phase||5||
59934138|NCT01358708|76052263|FG001|COMPLETED|Open-Label Treatment Phase||12||
59934139|NCT01358708|76052262|FG000|NOT COMPLETED|Open-Label Treatment Phase||0||
59934140|NCT01358708|76052263|FG001|NOT COMPLETED|Open-Label Treatment Phase||0||
59934141|NCT01356602|76052276|FG000|STARTED|Overall Study||133||
59934142|NCT01356602|76052277|FG001|STARTED|Overall Study||132||
59934143|NCT01356602|76052278|FG002|STARTED|Overall Study||132||
60067290|NCT01408888|76182424|FG001|STARTED|Second Intervention||8||
60067291|NCT01408888|76182423|FG000|COMPLETED|Second Intervention||16||
60067292|NCT01408888|76182424|FG001|COMPLETED|Second Intervention||8||
60067293|NCT01408888|76182423|FG000|NOT COMPLETED|Second Intervention||2||
60067294|NCT01408888|76182424|FG001|NOT COMPLETED|Second Intervention||0||
60067295|NCT01918033|76182443|FG000|STARTED|Overall Study||203||
60067296|NCT01918033|76182444|FG001|STARTED|Overall Study||203||
60067297|NCT01918033|76182445|FG002|STARTED|Overall Study||202||
60067298|NCT01918033|76182443|FG000|Treated|Overall Study|One randomized participant did not receive study drug.|202||
60067299|NCT01918033|76182444|FG001|Treated|Overall Study||203||
59934144|NCT01356602|76052276|FG000|Safety Set|Overall Study|In this arm, 1 patient had only 3 placebo injections and 3 patients also took other active drug.|133||
59934145|NCT01356602|76052277|FG001|Safety Set|Overall Study|In this arm, 3 patients also took other active drug.|133||
59934146|NCT01356602|76052278|FG002|Safety Set|Overall Study|In this arm, 3 patients also took other active drug.|133||
59934147|NCT01356602|76052276|FG000|Full Analysis Set|Overall Study||131||
59934148|NCT01356602|76052277|FG001|Full Analysis Set|Overall Study||129||
59934149|NCT01356602|76052278|FG002|Full Analysis Set|Overall Study||129||
59934150|NCT01356602|76052276|FG000|COMPLETED|Overall Study||124||
59934151|NCT01356602|76052277|FG001|COMPLETED|Overall Study||117||
59934152|NCT01356602|76052278|FG002|COMPLETED|Overall Study||108||
59934153|NCT01356602|76052276|FG000|NOT COMPLETED|Overall Study||9||
59934154|NCT01356602|76052277|FG001|NOT COMPLETED|Overall Study||15||
59934155|NCT01356602|76052278|FG002|NOT COMPLETED|Overall Study||24||
59934156|NCT02830880|76052286|FG000|STARTED|Overall Study||7||
59934157|NCT02830880|76052286|FG000|Completed Visit After Cyle 1|Overall Study||7||
59934158|NCT02830880|76052286|FG000|COMPLETED|Overall Study||4|Completed visit after Cycle 6|
59934159|NCT02830880|76052286|FG000|NOT COMPLETED|Overall Study||3||
59934160|NCT03141307|76052292|FG000|STARTED|In-Hospital||471||
59934161|NCT03141307|76052293|FG001|STARTED|In-Hospital||240||
59934162|NCT03141307|76052292|FG000|COMPLETED|In-Hospital||467||
59934163|NCT03141307|76052293|FG001|COMPLETED|In-Hospital||238||
59934164|NCT03141307|76052292|FG000|NOT COMPLETED|In-Hospital||4||
59934165|NCT03141307|76052293|FG001|NOT COMPLETED|In-Hospital||2||
59934166|NCT03141307|76052292|FG000|STARTED|Follow-Up||467||
59934167|NCT03141307|76052293|FG001|STARTED|Follow-Up||238||
59934168|NCT03141307|76052292|FG000|COMPLETED|Follow-Up||370||
59934169|NCT03141307|76052293|FG001|COMPLETED|Follow-Up||184||
59934170|NCT03141307|76052292|FG000|NOT COMPLETED|Follow-Up||97||
59934171|NCT03141307|76052293|FG001|NOT COMPLETED|Follow-Up||54||
59934172|NCT02825420|76052301|FG000|STARTED|Overall Study||131||
60067300|NCT01918033|76182445|FG002|Treated|Overall Study|One randomized participant did not receive study drug.|201||
60067301|NCT01918033|76182443|FG000|COMPLETED|Overall Study||198||
60067302|NCT01918033|76182444|FG001|COMPLETED|Overall Study||201||
60067303|NCT01918033|76182445|FG002|COMPLETED|Overall Study||199||
60067304|NCT01918033|76182443|FG000|NOT COMPLETED|Overall Study||5||
60067305|NCT01918033|76182444|FG001|NOT COMPLETED|Overall Study||2||
60067306|NCT01918033|76182445|FG002|NOT COMPLETED|Overall Study||3||
60067307|NCT01408732|76182453|FG000|STARTED|Overall Study||9||
60067308|NCT01408732|76182454|FG001|STARTED|Overall Study||9||
60067309|NCT01408732|76182453|FG000|COMPLETED|Overall Study||7||
60067310|NCT01408732|76182454|FG001|COMPLETED|Overall Study||7||
60067311|NCT01408732|76182453|FG000|NOT COMPLETED|Overall Study||2||
60067312|NCT01408732|76182454|FG001|NOT COMPLETED|Overall Study||2||
60067313|NCT01390402|76182460|FG000|STARTED|Overall Study||6||
60067314|NCT01390402|76182460|FG000|COMPLETED|Overall Study||1||
60067315|NCT01390402|76182460|FG000|NOT COMPLETED|Overall Study||5||
60067316|NCT01976299|76182466|FG000|STARTED|Overall Study||292|Subjects that signed consent and were randomized.|
60067317|NCT01976299|76182467|FG001|STARTED|Overall Study||286|Subjects that signed consent and were randomized.|
60067318|NCT01976299|76182466|FG000|Completed Procedure|Overall Study||283||
60067319|NCT01976299|76182467|FG001|Completed Procedure|Overall Study||284||
60067320|NCT01976299|76182466|FG000|COMPLETED|Overall Study|9 subjects did not proceed onto procedure in this arm.|269||
60067321|NCT01976299|76182467|FG001|COMPLETED|Overall Study|2 subjects did not proceed onto procedure in this arm.|280||
60067322|NCT01976299|76182466|FG000|NOT COMPLETED|Overall Study||23||
59934173|NCT02825420|76052302|FG001|STARTED|Overall Study||89||
59934174|NCT02825420|76052301|FG000|COMPLETED|Overall Study||88||
59934175|NCT02825420|76052302|FG001|COMPLETED|Overall Study||72||
59934176|NCT02825420|76052301|FG000|NOT COMPLETED|Overall Study||43||
59934177|NCT02825420|76052302|FG001|NOT COMPLETED|Overall Study||17||
59934178|NCT02829944|76052315|FG000|STARTED|Overall Study||44||
59934179|NCT02829944|76052316|FG001|STARTED|Overall Study||40||
59934180|NCT02829944|76052315|FG000|COMPLETED|Overall Study||38||
59934181|NCT02829944|76052316|FG001|COMPLETED|Overall Study||33||
59934182|NCT02829944|76052315|FG000|NOT COMPLETED|Overall Study||6||
59934183|NCT02829944|76052316|FG001|NOT COMPLETED|Overall Study||7||
59934184|NCT02824562|76052324|FG000|STARTED|Overall Study||22||
59934185|NCT02824562|76052325|FG001|STARTED|Overall Study||22||
59934186|NCT02824562|76052324|FG000|COMPLETED|Overall Study||19||
59934187|NCT02824562|76052325|FG001|COMPLETED|Overall Study||17||
59934188|NCT02824562|76052324|FG000|NOT COMPLETED|Overall Study||3||
59934189|NCT02824562|76052325|FG001|NOT COMPLETED|Overall Study||5||
59934190|NCT02744066|76052333|FG000|STARTED|Overall Study||25||
60067323|NCT01976299|76182467|FG001|NOT COMPLETED|Overall Study||6||
60067324|NCT01428076|76182475|FG000|STARTED|Overall Study||9||
59934191|NCT02744066|76052334|FG001|STARTED|Overall Study||30||
59934192|NCT02744066|76052333|FG000|COMPLETED|Overall Study||25||
59934193|NCT02744066|76052334|FG001|COMPLETED|Overall Study||25||
59934194|NCT02744066|76052333|FG000|NOT COMPLETED|Overall Study||0||
59934195|NCT02744066|76052334|FG001|NOT COMPLETED|Overall Study||5||
59934196|NCT01338818|76052342|FG000|STARTED|Overall Study||298||
59934197|NCT01338818|76052342|FG000|COMPLETED|Overall Study||262||
59934198|NCT01338818|76052342|FG000|NOT COMPLETED|Overall Study||36||
59934199|NCT02823470|76052348|FG000|STARTED|Overall Study||9||
59934200|NCT02823470|76052349|FG001|STARTED|Overall Study||15||
59934201|NCT02823470|76052348|FG000|COMPLETED|Overall Study||0||
59934202|NCT02823470|76052349|FG001|COMPLETED|Overall Study||0||
59761651|NCT00600938|75881283|FG001|COMPLETED|Extension Study||24||
59761652|NCT00600938|75881284|FG002|COMPLETED|Extension Study||33||
59761653|NCT00600938|75881285|FG003|COMPLETED|Extension Study||0||
59761654|NCT00600938|75881282|FG000|NOT COMPLETED|Extension Study||9||
59761655|NCT00600938|75881283|FG001|NOT COMPLETED|Extension Study||5||
59761656|NCT00600938|75881284|FG002|NOT COMPLETED|Extension Study||9||
59761657|NCT00600938|75881285|FG003|NOT COMPLETED|Extension Study||1||
59761658|NCT04671017|75881313|FG000|STARTED|Overall Study||51||
59761659|NCT04671017|75881314|FG001|STARTED|Overall Study||51||
59761660|NCT04671017|75881315|FG002|STARTED|Overall Study||51||
59761661|NCT04671017|75881313|FG000|COMPLETED|Overall Study||51||
59761662|NCT04671017|75881314|FG001|COMPLETED|Overall Study||51||
59761663|NCT04671017|75881315|FG002|COMPLETED|Overall Study||51||
59761664|NCT04671017|75881313|FG000|NOT COMPLETED|Overall Study||0||
59761665|NCT04671017|75881314|FG001|NOT COMPLETED|Overall Study||0||
59761666|NCT04671017|75881315|FG002|NOT COMPLETED|Overall Study||0||
59761667|NCT00543439|75881326|FG000|STARTED|Period 1||10||
59761668|NCT00543439|75881327|FG001|STARTED|Period 1||29||
59761669|NCT00543439|75881328|FG002|STARTED|Period 1||27||
59761670|NCT00543439|75881326|FG000|Treated|Period 1||9||
59761671|NCT00543439|75881327|FG001|Treated|Period 1||29||
59761672|NCT00543439|75881328|FG002|Treated|Period 1||27||
59761673|NCT00543439|75881326|FG000|COMPLETED|Period 1||9||
59761674|NCT00543439|75881327|FG001|COMPLETED|Period 1||26||
59761675|NCT00543439|75881328|FG002|COMPLETED|Period 1||25||
59761676|NCT00543439|75881326|FG000|NOT COMPLETED|Period 1||1||
59934203|NCT02823470|76052348|FG000|NOT COMPLETED|Overall Study||9||
59934204|NCT02823470|76052349|FG001|NOT COMPLETED|Overall Study||15||
59934205|NCT01371656|76052360|FG000|STARTED|Overall Study||314||
59934206|NCT01371656|76052361|FG001|STARTED|Overall Study||310||
59934207|NCT01371656|76052360|FG000|COMPLETED|Overall Study||250||
59934208|NCT01371656|76052361|FG001|COMPLETED|Overall Study||296||
59934209|NCT01371656|76052360|FG000|NOT COMPLETED|Overall Study||64||
59934210|NCT01371656|76052361|FG001|NOT COMPLETED|Overall Study||14||
59934211|NCT01354106|76052367|FG000|STARTED|Overall Study||26||
59934212|NCT01354106|76052367|FG000|COMPLETED|Overall Study||24||
59934213|NCT01354106|76052367|FG000|NOT COMPLETED|Overall Study||2||
59934214|NCT01354028|76052373|FG000|STARTED|Overall Study||15||
59934215|NCT01354028|76052374|FG001|STARTED|Overall Study||15||
59934216|NCT01354028|76052373|FG000|COMPLETED|Overall Study||13||
59934217|NCT01354028|76052374|FG001|COMPLETED|Overall Study||10||
59934218|NCT01354028|76052373|FG000|NOT COMPLETED|Overall Study||2||
59934219|NCT01354028|76052374|FG001|NOT COMPLETED|Overall Study||5||
59934220|NCT01354964|76052388|FG000|STARTED|Overall Study||11||
59934221|NCT01354964|76052389|FG001|STARTED|Overall Study||8||
59934222|NCT01354964|76052388|FG000|COMPLETED|Overall Study||7||
59934223|NCT01354964|76052389|FG001|COMPLETED|Overall Study||7||
59934224|NCT01354964|76052388|FG000|NOT COMPLETED|Overall Study||4||
59934225|NCT01354964|76052389|FG001|NOT COMPLETED|Overall Study||1||
59934226|NCT01354496|76052399|FG000|STARTED|Period 1||6||
59934227|NCT01354496|76052400|FG001|STARTED|Period 1||6||
59934228|NCT01354496|76052401|FG002|STARTED|Period 1||6||
59934229|NCT01354496|76052402|FG003|STARTED|Period 1||6||
59934230|NCT01354496|76052403|FG004|STARTED|Period 1||5||
59934231|NCT01354496|76052404|FG005|STARTED|Period 1||6||
59934232|NCT01354496|76052399|FG000|Received at Least 1 Dose of Study Drug|Period 1||6||
59761677|NCT00543439|75881327|FG001|NOT COMPLETED|Period 1||3||
59761678|NCT00543439|75881328|FG002|NOT COMPLETED|Period 1||2||
59761679|NCT00543439|75881326|FG000|STARTED|Period 2||9||
59761680|NCT00543439|75881327|FG001|STARTED|Period 2||26||
59761681|NCT00543439|75881328|FG002|STARTED|Period 2||25||
59761682|NCT00543439|75881326|FG000|COMPLETED|Period 2||8||
59761683|NCT00543439|75881327|FG001|COMPLETED|Period 2||25||
59761684|NCT00543439|75881328|FG002|COMPLETED|Period 2||23||
59761685|NCT00543439|75881326|FG000|NOT COMPLETED|Period 2||1||
59761686|NCT00543439|75881327|FG001|NOT COMPLETED|Period 2||1||
59761687|NCT00543439|75881328|FG002|NOT COMPLETED|Period 2||2||
59761688|NCT00582166|75881345|FG000|STARTED|Overall Study||18||
59761689|NCT00582166|75881345|FG000|COMPLETED|Overall Study||16||
59761690|NCT00582166|75881345|FG000|NOT COMPLETED|Overall Study||2||
59761691|NCT00601172|75881351|FG000|STARTED|Overall Study||355||
59934233|NCT01354496|76052400|FG001|Received at Least 1 Dose of Study Drug|Period 1||6||
59934234|NCT01354496|76052401|FG002|Received at Least 1 Dose of Study Drug|Period 1||6||
59934235|NCT01354496|76052402|FG003|Received at Least 1 Dose of Study Drug|Period 1||6||
59934236|NCT01354496|76052403|FG004|Received at Least 1 Dose of Study Drug|Period 1||5||
59934237|NCT01354496|76052404|FG005|Received at Least 1 Dose of Study Drug|Period 1||6||
59934238|NCT01354496|76052399|FG000|COMPLETED|Period 1||6||
59934239|NCT01354496|76052400|FG001|COMPLETED|Period 1||6||
59934240|NCT01354496|76052401|FG002|COMPLETED|Period 1||4||
59934241|NCT01354496|76052402|FG003|COMPLETED|Period 1||6||
59934242|NCT01354496|76052403|FG004|COMPLETED|Period 1||5||
59934243|NCT01354496|76052404|FG005|COMPLETED|Period 1||6||
59934244|NCT01354496|76052399|FG000|NOT COMPLETED|Period 1||0||
59934245|NCT01354496|76052400|FG001|NOT COMPLETED|Period 1||0||
59934246|NCT01354496|76052401|FG002|NOT COMPLETED|Period 1||2||
59934247|NCT01354496|76052402|FG003|NOT COMPLETED|Period 1||0||
59934248|NCT01354496|76052403|FG004|NOT COMPLETED|Period 1||0||
59934249|NCT01354496|76052404|FG005|NOT COMPLETED|Period 1||0||
59934250|NCT01354496|76052399|FG000|STARTED|Washout (at Least 14 Days)||6||
59934251|NCT01354496|76052400|FG001|STARTED|Washout (at Least 14 Days)||6||
59934252|NCT01354496|76052401|FG002|STARTED|Washout (at Least 14 Days)||4||
59934253|NCT01354496|76052402|FG003|STARTED|Washout (at Least 14 Days)||6||
59934254|NCT01354496|76052403|FG004|STARTED|Washout (at Least 14 Days)||5||
59934255|NCT01354496|76052404|FG005|STARTED|Washout (at Least 14 Days)||6||
59934256|NCT01354496|76052399|FG000|COMPLETED|Washout (at Least 14 Days)||6||
59934257|NCT01354496|76052400|FG001|COMPLETED|Washout (at Least 14 Days)||6||
59934258|NCT01354496|76052401|FG002|COMPLETED|Washout (at Least 14 Days)||4||
59934259|NCT01354496|76052402|FG003|COMPLETED|Washout (at Least 14 Days)||6||
59934260|NCT01354496|76052403|FG004|COMPLETED|Washout (at Least 14 Days)||5||
59934261|NCT01354496|76052404|FG005|COMPLETED|Washout (at Least 14 Days)||6||
59934262|NCT01354496|76052399|FG000|NOT COMPLETED|Washout (at Least 14 Days)||0||
59934263|NCT01354496|76052400|FG001|NOT COMPLETED|Washout (at Least 14 Days)||0||
59934264|NCT01354496|76052401|FG002|NOT COMPLETED|Washout (at Least 14 Days)||0||
59934265|NCT01354496|76052402|FG003|NOT COMPLETED|Washout (at Least 14 Days)||0||
59934266|NCT01354496|76052403|FG004|NOT COMPLETED|Washout (at Least 14 Days)||0||
59934267|NCT01354496|76052404|FG005|NOT COMPLETED|Washout (at Least 14 Days)||0||
59934268|NCT01354496|76052399|FG000|STARTED|Period 2||6||
59934269|NCT01354496|76052400|FG001|STARTED|Period 2||6||
60067325|NCT01428076|76182476|FG001|STARTED|Overall Study||12||
60067326|NCT01428076|76182475|FG000|COMPLETED|Overall Study||9||
60067327|NCT01428076|76182476|FG001|COMPLETED|Overall Study||11||
60067328|NCT01428076|76182475|FG000|NOT COMPLETED|Overall Study||0||
60067329|NCT01428076|76182476|FG001|NOT COMPLETED|Overall Study||1||
60067330|NCT01900652|76182486|FG000|STARTED|Overall Study||83||
59934270|NCT01354496|76052401|FG002|STARTED|Period 2||4||
59934271|NCT01354496|76052402|FG003|STARTED|Period 2||6||
59934272|NCT01354496|76052403|FG004|STARTED|Period 2||5||
59934273|NCT01354496|76052404|FG005|STARTED|Period 2||6||
59934274|NCT01354496|76052399|FG000|COMPLETED|Period 2||6||
59934275|NCT01354496|76052400|FG001|COMPLETED|Period 2||6||
59934276|NCT01354496|76052401|FG002|COMPLETED|Period 2||4||
59934277|NCT01354496|76052402|FG003|COMPLETED|Period 2||5||
59934278|NCT01354496|76052403|FG004|COMPLETED|Period 2||5||
59934279|NCT01354496|76052404|FG005|COMPLETED|Period 2||6||
59934280|NCT01354496|76052399|FG000|NOT COMPLETED|Period 2||0||
59934281|NCT01354496|76052400|FG001|NOT COMPLETED|Period 2||0||
59934282|NCT01354496|76052401|FG002|NOT COMPLETED|Period 2||0||
59934283|NCT01354496|76052402|FG003|NOT COMPLETED|Period 2||1||
59934284|NCT01354496|76052403|FG004|NOT COMPLETED|Period 2||0||
59934285|NCT01354496|76052404|FG005|NOT COMPLETED|Period 2||0||
59934286|NCT01354496|76052399|FG000|STARTED|Washout (at Least 14 Days)||6||
59934287|NCT01354496|76052400|FG001|STARTED|Washout (at Least 14 Days)||6||
59934288|NCT01354496|76052401|FG002|STARTED|Washout (at Least 14 Days)||4||
59934289|NCT01354496|76052402|FG003|STARTED|Washout (at Least 14 Days)||5||
59934290|NCT01354496|76052403|FG004|STARTED|Washout (at Least 14 Days)||5||
59934291|NCT01354496|76052404|FG005|STARTED|Washout (at Least 14 Days)||6||
59934292|NCT01354496|76052399|FG000|COMPLETED|Washout (at Least 14 Days)||6||
59934293|NCT01354496|76052400|FG001|COMPLETED|Washout (at Least 14 Days)||5||
59934294|NCT01354496|76052401|FG002|COMPLETED|Washout (at Least 14 Days)||4||
59934295|NCT01354496|76052402|FG003|COMPLETED|Washout (at Least 14 Days)||4||
59934296|NCT01354496|76052403|FG004|COMPLETED|Washout (at Least 14 Days)||5||
59934297|NCT01354496|76052404|FG005|COMPLETED|Washout (at Least 14 Days)||6||
59934298|NCT01354496|76052399|FG000|NOT COMPLETED|Washout (at Least 14 Days)||0||
60067331|NCT01900652|76182487|FG001|STARTED|Overall Study||28||
59934299|NCT01354496|76052400|FG001|NOT COMPLETED|Washout (at Least 14 Days)||1||
59934300|NCT01354496|76052401|FG002|NOT COMPLETED|Washout (at Least 14 Days)||0||
59934301|NCT01354496|76052402|FG003|NOT COMPLETED|Washout (at Least 14 Days)||1||
59934302|NCT01354496|76052403|FG004|NOT COMPLETED|Washout (at Least 14 Days)||0||
59934303|NCT01354496|76052404|FG005|NOT COMPLETED|Washout (at Least 14 Days)||0||
59934304|NCT01354496|76052399|FG000|STARTED|Period 3||6||
59934305|NCT01354496|76052400|FG001|STARTED|Period 3||5||
59934306|NCT01354496|76052401|FG002|STARTED|Period 3||4||
59934307|NCT01354496|76052402|FG003|STARTED|Period 3||4||
59934308|NCT01354496|76052403|FG004|STARTED|Period 3||5||
59934309|NCT01354496|76052404|FG005|STARTED|Period 3||6||
59934310|NCT01354496|76052399|FG000|COMPLETED|Period 3||6||
59934311|NCT01354496|76052400|FG001|COMPLETED|Period 3||5||
59934312|NCT01354496|76052401|FG002|COMPLETED|Period 3||4||
59934313|NCT01354496|76052402|FG003|COMPLETED|Period 3||4||
59934314|NCT01354496|76052403|FG004|COMPLETED|Period 3||5||
59934315|NCT01354496|76052404|FG005|COMPLETED|Period 3||6||
59934316|NCT01354496|76052399|FG000|NOT COMPLETED|Period 3||0||
59934317|NCT01354496|76052400|FG001|NOT COMPLETED|Period 3||0||
59934318|NCT01354496|76052401|FG002|NOT COMPLETED|Period 3||0||
59934319|NCT01354496|76052402|FG003|NOT COMPLETED|Period 3||0||
59934320|NCT01354496|76052403|FG004|NOT COMPLETED|Period 3||0||
59934321|NCT01354496|76052404|FG005|NOT COMPLETED|Period 3||0||
59934322|NCT02822222|76052427|FG000|STARTED|Overall Study||16|Number started means number randomized to treatment at Day 4.|
59934323|NCT02822222|76052428|FG001|STARTED|Overall Study||6|Number started means number randomized to treatment at Day 4.|
59934324|NCT02822222|76052427|FG000|COMPLETED|Overall Study||15||
59934325|NCT02822222|76052428|FG001|COMPLETED|Overall Study||6||
59934326|NCT02822222|76052427|FG000|NOT COMPLETED|Overall Study||1||
59934327|NCT02822222|76052428|FG001|NOT COMPLETED|Overall Study||0||
59934328|NCT02821910|76052440|FG000|STARTED|Overall Study||7||
59934329|NCT02821910|76052441|FG001|STARTED|Overall Study||8||
59934330|NCT02821910|76052442|FG002|STARTED|Overall Study||10||
59934331|NCT02821910|76052443|FG003|STARTED|Overall Study||10||
59934332|NCT02821910|76052444|FG004|STARTED|Overall Study||7||
59934333|NCT02821910|76052445|FG005|STARTED|Overall Study||8||
59934334|NCT02821910|76052440|FG000|COMPLETED|Overall Study||6||
59934335|NCT02821910|76052441|FG001|COMPLETED|Overall Study||8||
59934336|NCT02821910|76052442|FG002|COMPLETED|Overall Study||8||
59934337|NCT02821910|76052443|FG003|COMPLETED|Overall Study||10||
59934338|NCT02821910|76052444|FG004|COMPLETED|Overall Study||7||
59934339|NCT02821910|76052445|FG005|COMPLETED|Overall Study||7||
59934340|NCT02821910|76052440|FG000|NOT COMPLETED|Overall Study||1||
59934341|NCT02821910|76052441|FG001|NOT COMPLETED|Overall Study||0||
59934342|NCT02821910|76052442|FG002|NOT COMPLETED|Overall Study||2||
59934343|NCT02821910|76052443|FG003|NOT COMPLETED|Overall Study||0||
59934344|NCT02821910|76052444|FG004|NOT COMPLETED|Overall Study||0||
59934345|NCT02821910|76052445|FG005|NOT COMPLETED|Overall Study||1||
59934346|NCT02817776|76052459|FG000|STARTED|Overall Study|33 excluded prior to procedure. 348 had study catheter inserted (Safety Population)|381||
59934347|NCT02817776|76052459|FG000|COMPLETED|Overall Study||293||
59934348|NCT02817776|76052459|FG000|NOT COMPLETED|Overall Study||88||
59934349|NCT03138655|76052471|FG000|STARTED|Overall Study||10||
59934350|NCT03138655|76052472|FG001|STARTED|Overall Study||9||
59934351|NCT03138655|76052473|FG002|STARTED|Overall Study||11||
59934352|NCT03138655|76052474|FG003|STARTED|Overall Study||10||
59934353|NCT03138655|76052475|FG004|STARTED|Overall Study||13||
59934354|NCT03138655|76052476|FG005|STARTED|Overall Study||12||
59934355|NCT03138655|76052477|FG006|STARTED|Overall Study||12||
59934356|NCT03138655|76052478|FG007|STARTED|Overall Study||12||
59934357|NCT03138655|76052471|FG000|COMPLETED|Overall Study||7||
59934358|NCT03138655|76052472|FG001|COMPLETED|Overall Study||7||
59934359|NCT03138655|76052473|FG002|COMPLETED|Overall Study||9||
59934360|NCT03138655|76052474|FG003|COMPLETED|Overall Study||7||
59934361|NCT03138655|76052475|FG004|COMPLETED|Overall Study||11||
59934362|NCT03138655|76052476|FG005|COMPLETED|Overall Study||7||
59934363|NCT03138655|76052477|FG006|COMPLETED|Overall Study||9||
59934364|NCT03138655|76052478|FG007|COMPLETED|Overall Study||10||
59934365|NCT03138655|76052471|FG000|NOT COMPLETED|Overall Study||3||
59934366|NCT03138655|76052472|FG001|NOT COMPLETED|Overall Study||2||
59934367|NCT03138655|76052473|FG002|NOT COMPLETED|Overall Study||2||
59934368|NCT03138655|76052474|FG003|NOT COMPLETED|Overall Study||3||
59934369|NCT03138655|76052475|FG004|NOT COMPLETED|Overall Study||2||
59934370|NCT03138655|76052476|FG005|NOT COMPLETED|Overall Study||5||
59934371|NCT03138655|76052477|FG006|NOT COMPLETED|Overall Study||3||
59934372|NCT03138655|76052478|FG007|NOT COMPLETED|Overall Study||2||
59934373|NCT02820038|76052504|FG000|STARTED|Overall Study||78|Numbers are those who completed baseline data collection and given access to intervention materials|
59934374|NCT02820038|76052505|FG001|STARTED|Overall Study||77|Numbers are those who completed baseline data collection and given access to intervention materials|
59934375|NCT02820038|76052506|FG002|STARTED|Overall Study||65|Numbers are those who completed baseline data collection and given access to intervention materials|
60067332|NCT01900652|76182486|FG000|Post-Erlotinib Progression Tumor Sample|Overall Study||66||
59934376|NCT02820038|76052507|FG003|STARTED|Overall Study||66|Numbers are those who completed baseline data collection and given access to intervention materials|
59934377|NCT02820038|76052504|FG000|COMPLETED|Overall Study||68||
59934378|NCT02820038|76052505|FG001|COMPLETED|Overall Study||52||
59934379|NCT02820038|76052506|FG002|COMPLETED|Overall Study||60||
59934380|NCT02820038|76052507|FG003|COMPLETED|Overall Study||44||
59934381|NCT02820038|76052504|FG000|NOT COMPLETED|Overall Study||10||
59934382|NCT02820038|76052505|FG001|NOT COMPLETED|Overall Study||25||
59934383|NCT02820038|76052506|FG002|NOT COMPLETED|Overall Study||5||
59934384|NCT02820038|76052507|FG003|NOT COMPLETED|Overall Study||22||
59934385|NCT02819804|76052518|FG000|STARTED|Complete Cycle 1 (28 Days)||1||
59934386|NCT02819804|76052518|FG000|COMPLETED|Complete Cycle 1 (28 Days)||0||
59934387|NCT02819804|76052518|FG000|NOT COMPLETED|Complete Cycle 1 (28 Days)||1||
59934388|NCT02819804|76052518|FG000|STARTED|Start Cycle 2 and Beyond||0||
59934389|NCT02819804|76052518|FG000|COMPLETED|Start Cycle 2 and Beyond||0||
59934390|NCT02819804|76052518|FG000|NOT COMPLETED|Start Cycle 2 and Beyond||0||
59934391|NCT02819804|76052518|FG000|STARTED|Follow-up for 1 Year||1|All patients that are treated on the study go into the follow-up period.|
59934392|NCT02819804|76052518|FG000|COMPLETED|Follow-up for 1 Year||1||
59934393|NCT02819804|76052518|FG000|NOT COMPLETED|Follow-up for 1 Year||0||
59934394|NCT02819726|76052525|FG000|STARTED|Part A (All Participants)||98|Received at least 1 infusion of study treatment in Part A|
59934395|NCT02819726|76052526|FG001|STARTED|Part A (All Participants)||98|Received at least 1 infusion of study treatment in Part A|
59934396|NCT02819726|76052527|FG002|STARTED|Part A (All Participants)||98|Received at least 1 infusion of study treatment in Part A|
59934397|NCT02819726|76052528|FG003|STARTED|Part A (All Participants)||0|Received at least 1 infusion of study treatment in Part A|
59934398|NCT02819726|76052525|FG000|COMPLETED|Part A (All Participants)||92||
59934399|NCT02819726|76052526|FG001|COMPLETED|Part A (All Participants)||88||
59934400|NCT02819726|76052527|FG002|COMPLETED|Part A (All Participants)||87||
59934401|NCT02819726|76052528|FG003|COMPLETED|Part A (All Participants)||0||
59934402|NCT02819726|76052525|FG000|NOT COMPLETED|Part A (All Participants)||6||
59934403|NCT02819726|76052526|FG001|NOT COMPLETED|Part A (All Participants)||10||
59934404|NCT02819726|76052527|FG002|NOT COMPLETED|Part A (All Participants)||11||
59934405|NCT02819726|76052528|FG003|NOT COMPLETED|Part A (All Participants)||0||
59934406|NCT02819726|76052525|FG000|STARTED|Part B (All Participants)|19 participants who completed Part A were not eligible for Part B|73|Received at least 1 infusion of treatment in Part B. 220 participants were re-treated in Part B|
59934407|NCT02819726|76052526|FG001|STARTED|Part B (All Participants)|18 participants completing Part A were not eligible for Part B|70|Received at least 1 infusion of treatment in Part B. 220 participants were re-treated in Part B|
59934408|NCT02819726|76052527|FG002|STARTED|Part B (All Participants)|5 participants completing Part A were ineligible for Part B.|39|Received at least 1 infusion of treatment in Part B. 220 participants were re-treated in Part B|
59934409|NCT02819726|76052528|FG003|STARTED|Part B (All Participants)|5 participants completing Part A were ineligible for Part B.|38|Received at least 1 infusion of treatment in Part B. 220 participants were re-treated in Part B|
59934410|NCT02819726|76052525|FG000|COMPLETED|Part B (All Participants)||70||
59934411|NCT02819726|76052526|FG001|COMPLETED|Part B (All Participants)||68||
59934412|NCT02819726|76052527|FG002|COMPLETED|Part B (All Participants)||35||
59934413|NCT02819726|76052528|FG003|COMPLETED|Part B (All Participants)||36||
59934414|NCT02819726|76052525|FG000|NOT COMPLETED|Part B (All Participants)||3||
59934415|NCT02819726|76052526|FG001|NOT COMPLETED|Part B (All Participants)||2||
59934416|NCT02819726|76052527|FG002|NOT COMPLETED|Part B (All Participants)||4||
59934417|NCT02819726|76052528|FG003|NOT COMPLETED|Part B (All Participants)||2||
59934418|NCT02816138|76052536|FG000|STARTED|Overall Study||15||
59934419|NCT02816138|76052536|FG000|COMPLETED|Overall Study||14||
59934420|NCT02816138|76052536|FG000|NOT COMPLETED|Overall Study||1||
59934421|NCT02815670|76052540|FG000|STARTED|Overall Study||1||
59934422|NCT02815670|76052540|FG000|COMPLETED|Overall Study||0||
59934423|NCT02815670|76052540|FG000|NOT COMPLETED|Overall Study||1||
59934424|NCT02809976|76052544|FG000|STARTED|Overall Study||11||
59934425|NCT02809976|76052544|FG000|COMPLETED|Overall Study||9||
59934426|NCT02809976|76052544|FG000|NOT COMPLETED|Overall Study||2||
59934427|NCT02880865|76052550|FG000|STARTED|Overall Study||314||
59934428|NCT02880865|76052551|FG001|STARTED|Overall Study||314||
59934429|NCT02880865|76052550|FG000|Received MMR Dose 1|Overall Study||314||
59934430|NCT02880865|76052551|FG001|Received MMR Dose 1|Overall Study||314||
59934431|NCT02880865|76052550|FG000|Received CD-JEV|Overall Study||314||
59934432|NCT02880865|76052551|FG001|Received CD-JEV|Overall Study||309||
59934433|NCT02880865|76052550|FG000|Received MMR Dose 2|Overall Study||313||
59934434|NCT02880865|76052551|FG001|Received MMR Dose 2|Overall Study||311||
59934435|NCT02880865|76052550|FG000|COMPLETED|Overall Study||313||
59934436|NCT02880865|76052551|FG001|COMPLETED|Overall Study||311||
59934437|NCT02880865|76052550|FG000|NOT COMPLETED|Overall Study||1||
59934438|NCT02880865|76052551|FG001|NOT COMPLETED|Overall Study||3||
59934439|NCT01854385|76052578|FG000|STARTED|Pre-Treatment||40||
59934440|NCT01854385|76052578|FG000|COMPLETED|Pre-Treatment||17||
59934441|NCT01854385|76052578|FG000|NOT COMPLETED|Pre-Treatment||23||
59934442|NCT01854385|76052578|FG000|STARTED|Treatment||17||
59934443|NCT01854385|76052578|FG000|COMPLETED|Treatment||16||
60067333|NCT01900652|76182487|FG001|Post-Erlotinib Progression Tumor Sample|Overall Study||23||
60067334|NCT01900652|76182486|FG000|COMPLETED|Overall Study||75||
59613299|NCT02071914|75724447|FG002|NOT COMPLETED|Overall Study||0||
59613300|NCT01568892|75724457|FG000|STARTED|Double-blind Phase||14||
59613301|NCT01568892|75724458|FG001|STARTED|Double-blind Phase||16||
59613302|NCT01568892|75724457|FG000|COMPLETED|Double-blind Phase||14||
59934444|NCT01854385|76052578|FG000|NOT COMPLETED|Treatment||1||
59934445|NCT02809118|76052585|FG000|STARTED|Overall Study||18||
59934446|NCT02809118|76052586|FG001|STARTED|Overall Study||19||
59934447|NCT02809118|76052587|FG002|STARTED|Overall Study||19||
59934448|NCT02809118|76052585|FG000|COMPLETED|Overall Study||18||
59934449|NCT02809118|76052586|FG001|COMPLETED|Overall Study||18||
59934450|NCT02809118|76052587|FG002|COMPLETED|Overall Study||18||
59934451|NCT02809118|76052585|FG000|NOT COMPLETED|Overall Study||0||
59934452|NCT02809118|76052586|FG001|NOT COMPLETED|Overall Study||1||
59934453|NCT02809118|76052587|FG002|NOT COMPLETED|Overall Study||1||
59934454|NCT03604159|76052597|FG000|STARTED|Overall Study||26||
60067335|NCT01900652|76182487|FG001|COMPLETED|Overall Study||25||
60067336|NCT01900652|76182486|FG000|NOT COMPLETED|Overall Study||8||
60067337|NCT01900652|76182487|FG001|NOT COMPLETED|Overall Study||3||
59613303|NCT01568892|75724458|FG001|COMPLETED|Double-blind Phase||16||
59934455|NCT03604159|76052598|FG001|STARTED|Overall Study||26||
59934456|NCT03604159|76052597|FG000|COMPLETED|Overall Study||20||
59934457|NCT03604159|76052598|FG001|COMPLETED|Overall Study||19||
59934458|NCT03604159|76052597|FG000|NOT COMPLETED|Overall Study||6||
59934459|NCT03604159|76052598|FG001|NOT COMPLETED|Overall Study||7||
59934460|NCT02808338|76052604|FG000|STARTED|Screening||25||
59934461|NCT02808338|76052604|FG000|COMPLETED|Screening||15||
59934462|NCT02808338|76052604|FG000|NOT COMPLETED|Screening||10||
59934463|NCT02808338|76052604|FG000|STARTED|Overnight In-lab Polysomonography||15||
59934464|NCT02808338|76052604|FG000|Modified Philips BiPAP ASV|Overnight In-lab Polysomonography||13||
59934465|NCT02808338|76052604|FG000|ResMed S7 VPAP Adapt|Overnight In-lab Polysomonography||13||
59934466|NCT02808338|76052604|FG000|Philips BiPAP AutoSV Advanced System One|Overnight In-lab Polysomonography||12||
59934467|NCT02808338|76052604|FG000|ResMed S9 VPAP Adapt|Overnight In-lab Polysomonography||12||
59934468|NCT02808338|76052604|FG000|COMPLETED|Overnight In-lab Polysomonography||13||
59934469|NCT02808338|76052604|FG000|NOT COMPLETED|Overnight In-lab Polysomonography||2||
59934470|NCT02808338|76052604|FG000|STARTED|Take Home Period||13||
59934471|NCT02808338|76052604|FG000|COMPLETED|Take Home Period||13||
59934472|NCT02808338|76052604|FG000|NOT COMPLETED|Take Home Period||0||
59934473|NCT02807948|76052615|FG000|STARTED|Overall Study||132||
59934474|NCT02807948|76052616|FG001|STARTED|Overall Study||57||
59934475|NCT02807948|76052615|FG000|COMPLETED|Overall Study||131||
59934476|NCT02807948|76052616|FG001|COMPLETED|Overall Study||57||
59934477|NCT02807948|76052615|FG000|NOT COMPLETED|Overall Study||1||
59934478|NCT02807948|76052616|FG001|NOT COMPLETED|Overall Study||0||
59934479|NCT02879383|76052625|FG000|STARTED|First 24 Weeks||39||
59934480|NCT02879383|76052626|FG001|STARTED|First 24 Weeks||37||
59934481|NCT02879383|76052627|FG002|STARTED|First 24 Weeks||17||
59934482|NCT02879383|76052628|FG003|STARTED|First 24 Weeks||16||
59934483|NCT02879383|76052625|FG000|COMPLETED|First 24 Weeks||39||
59934484|NCT02879383|76052626|FG001|COMPLETED|First 24 Weeks||36||
59934485|NCT02879383|76052627|FG002|COMPLETED|First 24 Weeks||17||
59761692|NCT00601172|75881352|FG001|STARTED|Overall Study||355||
59761693|NCT00601172|75881351|FG000|COMPLETED|Overall Study||214||
59761694|NCT00601172|75881352|FG001|COMPLETED|Overall Study||228||
59761695|NCT00601172|75881351|FG000|NOT COMPLETED|Overall Study||141||
59934486|NCT02879383|76052628|FG003|COMPLETED|First 24 Weeks||16||
59934487|NCT02879383|76052625|FG000|NOT COMPLETED|First 24 Weeks||0||
59934488|NCT02879383|76052626|FG001|NOT COMPLETED|First 24 Weeks||1||
59934489|NCT02879383|76052627|FG002|NOT COMPLETED|First 24 Weeks||0||
59934490|NCT02879383|76052628|FG003|NOT COMPLETED|First 24 Weeks||0||
59934491|NCT02879383|76052625|FG000|STARTED|Second 24 Weeks (Crossover for Sham)||33||
60067338|NCT02093351|76182501|FG000|STARTED|Part A||30||
60067339|NCT02093351|76182502|FG001|STARTED|Part A||23||
60067340|NCT02093351|76182503|FG002|STARTED|Part A||26||
59761696|NCT00601172|75881352|FG001|NOT COMPLETED|Overall Study||127||
59761697|NCT00582010|75881361|FG000|STARTED|Overall Study||40||
59761698|NCT00582010|75881362|FG001|STARTED|Overall Study||40||
59761699|NCT00582010|75881361|FG000|COMPLETED|Overall Study||40||
59761700|NCT00582010|75881362|FG001|COMPLETED|Overall Study||39||
59761701|NCT00582010|75881361|FG000|NOT COMPLETED|Overall Study||0||
59761702|NCT00582010|75881362|FG001|NOT COMPLETED|Overall Study||1||
59761703|NCT02340676|75881368|FG000|STARTED|Overall Study||25||
59761704|NCT02340676|75881368|FG000|COMPLETED|Overall Study||25||
59761705|NCT02340676|75881368|FG000|NOT COMPLETED|Overall Study||0||
59761706|NCT00580840|75881372|FG000|STARTED|Run-in|620 subjects were screened for the study with 333 being enrolled.|333||
59761707|NCT00580840|75881373|FG001|STARTED|Run-in||0||
59761708|NCT00580840|75881374|FG002|STARTED|Run-in||0||
59761709|NCT00580840|75881375|FG003|STARTED|Run-in||0||
59761710|NCT00580840|75881372|FG000|COMPLETED|Run-in|Of the 209 randomized participants, 208 are in the Full Analysis Set (FAS).|209||
59761711|NCT00580840|75881373|FG001|COMPLETED|Run-in||0||
59761712|NCT00580840|75881374|FG002|COMPLETED|Run-in||0||
59761713|NCT00580840|75881375|FG003|COMPLETED|Run-in||0||
59761714|NCT00580840|75881372|FG000|NOT COMPLETED|Run-in||124||
59761715|NCT00580840|75881373|FG001|NOT COMPLETED|Run-in||0||
59761716|NCT00580840|75881374|FG002|NOT COMPLETED|Run-in||0||
59761717|NCT00580840|75881375|FG003|NOT COMPLETED|Run-in||0||
59761718|NCT00580840|75881372|FG000|STARTED|Double-Blind||0||
59761719|NCT00580840|75881373|FG001|STARTED|Double-Blind||70||
59761720|NCT00580840|75881374|FG002|STARTED|Double-Blind||70||
59761721|NCT00580840|75881375|FG003|STARTED|Double-Blind||69||
59761722|NCT00580840|75881372|FG000|COMPLETED|Double-Blind||0||
59761723|NCT00580840|75881373|FG001|COMPLETED|Double-Blind||63||
59761724|NCT00580840|75881374|FG002|COMPLETED|Double-Blind||61||
59934492|NCT02879383|76052626|FG001|STARTED|Second 24 Weeks (Crossover for Sham)||0||
59934493|NCT02879383|76052627|FG002|STARTED|Second 24 Weeks (Crossover for Sham)||4||
59934494|NCT02879383|76052628|FG003|STARTED|Second 24 Weeks (Crossover for Sham)||0||
59934495|NCT02879383|76052625|FG000|COMPLETED|Second 24 Weeks (Crossover for Sham)||33||
59934496|NCT02879383|76052626|FG001|COMPLETED|Second 24 Weeks (Crossover for Sham)||0||
60067341|NCT02093351|76182504|FG003|STARTED|Part A||0||
60067342|NCT02093351|76182501|FG000|Completing Treatment Period 1|Part A||29||
59761725|NCT00580840|75881375|FG003|COMPLETED|Double-Blind||54||
59761726|NCT00580840|75881372|FG000|NOT COMPLETED|Double-Blind||0||
59761727|NCT00580840|75881373|FG001|NOT COMPLETED|Double-Blind||7||
59761728|NCT00580840|75881374|FG002|NOT COMPLETED|Double-Blind||9||
59761729|NCT00580840|75881375|FG003|NOT COMPLETED|Double-Blind||15||
59761730|NCT00879684|75881385|FG000|STARTED|Stage 1: Dose Escalation||3||
59761731|NCT00879684|75881386|FG001|STARTED|Stage 1: Dose Escalation||3||
59761732|NCT00879684|75881387|FG002|STARTED|Stage 1: Dose Escalation||3||
59761733|NCT00879684|75881388|FG003|STARTED|Stage 1: Dose Escalation||6||
59761734|NCT00879684|75881389|FG004|STARTED|Stage 1: Dose Escalation||3||
59761735|NCT00879684|75881390|FG005|STARTED|Stage 1: Dose Escalation||3||
59761736|NCT00879684|75881391|FG006|STARTED|Stage 1: Dose Escalation||0||
59761737|NCT00879684|75881385|FG000|COMPLETED|Stage 1: Dose Escalation||0||
59761738|NCT00879684|75881386|FG001|COMPLETED|Stage 1: Dose Escalation||0||
59761739|NCT00879684|75881387|FG002|COMPLETED|Stage 1: Dose Escalation||0||
59761740|NCT00879684|75881388|FG003|COMPLETED|Stage 1: Dose Escalation||0||
59761741|NCT00879684|75881389|FG004|COMPLETED|Stage 1: Dose Escalation||0||
59761742|NCT00879684|75881390|FG005|COMPLETED|Stage 1: Dose Escalation||0||
59761743|NCT00879684|75881391|FG006|COMPLETED|Stage 1: Dose Escalation||0||
59761744|NCT00879684|75881385|FG000|NOT COMPLETED|Stage 1: Dose Escalation||3||
59934497|NCT02879383|76052627|FG002|COMPLETED|Second 24 Weeks (Crossover for Sham)||4||
59934498|NCT02879383|76052628|FG003|COMPLETED|Second 24 Weeks (Crossover for Sham)||0||
59934499|NCT02879383|76052625|FG000|NOT COMPLETED|Second 24 Weeks (Crossover for Sham)||0||
59934500|NCT02879383|76052626|FG001|NOT COMPLETED|Second 24 Weeks (Crossover for Sham)||0||
59934501|NCT02879383|76052627|FG002|NOT COMPLETED|Second 24 Weeks (Crossover for Sham)||0||
59934502|NCT02879383|76052628|FG003|NOT COMPLETED|Second 24 Weeks (Crossover for Sham)||0||
59934503|NCT02049710|76052642|FG000|STARTED|Overall Study||653||
59934504|NCT02049710|76052643|FG001|STARTED|Overall Study||664||
59934505|NCT02049710|76052642|FG000|COMPLETED|Overall Study||334||
59934506|NCT02049710|76052643|FG001|COMPLETED|Overall Study||340||
59934507|NCT02049710|76052642|FG000|NOT COMPLETED|Overall Study||319||
59934508|NCT02049710|76052643|FG001|NOT COMPLETED|Overall Study||324||
59934509|NCT01543633|76052649|FG000|STARTED|Overall Study||36||
59934510|NCT01543633|76052649|FG000|COMPLETED|Overall Study||17||
59934511|NCT01543633|76052649|FG000|NOT COMPLETED|Overall Study||19||
59934512|NCT03494647|76052655|FG000|STARTED|Overall Study||21||
59934513|NCT03494647|76052656|FG001|STARTED|Overall Study||22||
59934514|NCT03494647|76052655|FG000|COMPLETED|Overall Study||16||
59934515|NCT03494647|76052656|FG001|COMPLETED|Overall Study||16||
59934516|NCT03494647|76052655|FG000|NOT COMPLETED|Overall Study||5||
59934517|NCT03494647|76052656|FG001|NOT COMPLETED|Overall Study||6||
59934518|NCT02806232|76052671|FG000|STARTED|Overall Study||60||
59934519|NCT02806232|76052672|FG001|STARTED|Overall Study||60||
59934520|NCT02806232|76052673|FG002|STARTED|Overall Study||60||
59934521|NCT02806232|76052674|FG003|STARTED|Overall Study||60||
59934522|NCT02806232|76052675|FG004|STARTED|Overall Study||60||
59934523|NCT02806232|76052676|FG005|STARTED|Overall Study||60||
59934524|NCT02806232|76052677|FG006|STARTED|Overall Study||60||
59934525|NCT02806232|76052678|FG007|STARTED|Overall Study||20||
59934526|NCT02806232|76052679|FG008|STARTED|Overall Study||4||
59934527|NCT02806232|76052671|FG000|COMPLETED|Overall Study||59||
59934528|NCT02806232|76052672|FG001|COMPLETED|Overall Study||56||
59934529|NCT02806232|76052673|FG002|COMPLETED|Overall Study||59||
59934530|NCT02806232|76052674|FG003|COMPLETED|Overall Study||60||
59934531|NCT02806232|76052675|FG004|COMPLETED|Overall Study||58||
59934532|NCT02806232|76052676|FG005|COMPLETED|Overall Study||58||
59934533|NCT02806232|76052677|FG006|COMPLETED|Overall Study||60||
59934534|NCT02806232|76052678|FG007|COMPLETED|Overall Study||20||
59934535|NCT02806232|76052679|FG008|COMPLETED|Overall Study||4||
59934536|NCT02806232|76052671|FG000|NOT COMPLETED|Overall Study||1||
59934537|NCT02806232|76052672|FG001|NOT COMPLETED|Overall Study||4||
59934538|NCT02806232|76052673|FG002|NOT COMPLETED|Overall Study||1||
59934539|NCT02806232|76052674|FG003|NOT COMPLETED|Overall Study||0||
59934540|NCT02806232|76052675|FG004|NOT COMPLETED|Overall Study||2||
59934541|NCT02806232|76052676|FG005|NOT COMPLETED|Overall Study||2||
59934542|NCT02806232|76052677|FG006|NOT COMPLETED|Overall Study||0||
59761745|NCT00879684|75881386|FG001|NOT COMPLETED|Stage 1: Dose Escalation||3||
59761746|NCT00879684|75881387|FG002|NOT COMPLETED|Stage 1: Dose Escalation||3||
59934543|NCT02806232|76052678|FG007|NOT COMPLETED|Overall Study||0||
59761747|NCT00879684|75881388|FG003|NOT COMPLETED|Stage 1: Dose Escalation||6||
59761748|NCT00879684|75881389|FG004|NOT COMPLETED|Stage 1: Dose Escalation||3||
59761749|NCT00879684|75881390|FG005|NOT COMPLETED|Stage 1: Dose Escalation||3||
59761750|NCT00879684|75881391|FG006|NOT COMPLETED|Stage 1: Dose Escalation||0||
59761751|NCT00879684|75881385|FG000|STARTED|Stage 2: Expanded Cohort||0||
59761752|NCT00879684|75881386|FG001|STARTED|Stage 2: Expanded Cohort||0||
59934544|NCT02806232|76052679|FG008|NOT COMPLETED|Overall Study||0||
59934545|NCT02807402|76052699|FG000|STARTED|Overall Study||522||
59934546|NCT02807402|76052699|FG000|COMPLETED|Overall Study||516|HCV ribonucleic acid (RNA) treatment assessment performed at least 10 weeks post-treatment|
59934547|NCT02807402|76052699|FG000|NOT COMPLETED|Overall Study||6||
59934548|NCT02960490|76052713|FG000|STARTED|Treatment Phase(Double-blind): 12 Weeks||34||
59934549|NCT02960490|76052714|FG001|STARTED|Treatment Phase(Double-blind): 12 Weeks||32||
59934550|NCT02960490|76052715|FG002|STARTED|Treatment Phase(Double-blind): 12 Weeks||0||
59934551|NCT02960490|76052716|FG003|STARTED|Treatment Phase(Double-blind): 12 Weeks||0||
59934552|NCT02960490|76052717|FG004|STARTED|Treatment Phase(Double-blind): 12 Weeks||0||
59934553|NCT02960490|76052718|FG005|STARTED|Treatment Phase(Double-blind): 12 Weeks||0||
59934554|NCT02960490|76052719|FG006|STARTED|Treatment Phase(Double-blind): 12 Weeks||0||
59934555|NCT02960490|76052720|FG007|STARTED|Treatment Phase(Double-blind): 12 Weeks||0||
59934556|NCT02960490|76052721|FG008|STARTED|Treatment Phase(Double-blind): 12 Weeks||0||
59934557|NCT02960490|76052722|FG009|STARTED|Treatment Phase(Double-blind): 12 Weeks||0||
59934558|NCT02960490|76052713|FG000|Treated|Treatment Phase(Double-blind): 12 Weeks||33||
59934559|NCT02960490|76052714|FG001|Treated|Treatment Phase(Double-blind): 12 Weeks||31||
59934560|NCT02960490|76052715|FG002|Treated|Treatment Phase(Double-blind): 12 Weeks||0||
59934561|NCT02960490|76052716|FG003|Treated|Treatment Phase(Double-blind): 12 Weeks||0||
59934562|NCT02960490|76052717|FG004|Treated|Treatment Phase(Double-blind): 12 Weeks||0||
59934563|NCT02960490|76052718|FG005|Treated|Treatment Phase(Double-blind): 12 Weeks||0||
59934564|NCT02960490|76052719|FG006|Treated|Treatment Phase(Double-blind): 12 Weeks||0||
59934565|NCT02960490|76052720|FG007|Treated|Treatment Phase(Double-blind): 12 Weeks||0||
59934566|NCT02960490|76052721|FG008|Treated|Treatment Phase(Double-blind): 12 Weeks||0||
59934567|NCT02960490|76052722|FG009|Treated|Treatment Phase(Double-blind): 12 Weeks||0||
59934568|NCT02960490|76052713|FG000|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||33||
59934569|NCT02960490|76052714|FG001|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||31||
59934570|NCT02960490|76052715|FG002|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||0||
59934571|NCT02960490|76052716|FG003|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||0||
59934572|NCT02960490|76052717|FG004|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||0||
59934573|NCT02960490|76052718|FG005|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||0||
59934574|NCT02960490|76052719|FG006|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||0||
59934575|NCT02960490|76052720|FG007|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||0||
59934576|NCT02960490|76052721|FG008|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||0||
59934577|NCT02960490|76052722|FG009|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||0||
59934578|NCT02960490|76052713|FG000|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||33||
59934579|NCT02960490|76052714|FG001|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||31||
59934580|NCT02960490|76052715|FG002|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||0||
59934581|NCT02960490|76052716|FG003|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||0||
59934582|NCT02960490|76052717|FG004|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||0||
59934583|NCT02960490|76052718|FG005|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||0||
59934584|NCT02960490|76052719|FG006|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||0||
59934585|NCT02960490|76052720|FG007|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||0||
59934586|NCT02960490|76052721|FG008|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||0||
59934587|NCT02960490|76052722|FG009|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||0||
59934588|NCT02960490|76052713|FG000|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||29||
59934589|NCT02960490|76052714|FG001|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||26||
59934590|NCT02960490|76052715|FG002|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0||
59934591|NCT02960490|76052716|FG003|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0||
59934592|NCT02960490|76052717|FG004|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0||
59934593|NCT02960490|76052718|FG005|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0||
59934594|NCT02960490|76052719|FG006|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0||
59934595|NCT02960490|76052720|FG007|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0||
59934596|NCT02960490|76052721|FG008|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0||
59934597|NCT02960490|76052722|FG009|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0||
59934598|NCT02960490|76052713|FG000|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||5||
59934599|NCT02960490|76052714|FG001|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||6||
59934600|NCT02960490|76052715|FG002|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0||
59934601|NCT02960490|76052716|FG003|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0||
59934602|NCT02960490|76052717|FG004|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0||
59934603|NCT02960490|76052718|FG005|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0||
59934604|NCT02960490|76052719|FG006|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0||
59934605|NCT02960490|76052720|FG007|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0||
59761753|NCT00879684|75881387|FG002|STARTED|Stage 2: Expanded Cohort||0||
59761754|NCT00879684|75881388|FG003|STARTED|Stage 2: Expanded Cohort||0||
59761755|NCT00879684|75881389|FG004|STARTED|Stage 2: Expanded Cohort||0||
59761756|NCT00879684|75881390|FG005|STARTED|Stage 2: Expanded Cohort||0||
59761757|NCT00879684|75881391|FG006|STARTED|Stage 2: Expanded Cohort||13||
59761758|NCT00879684|75881385|FG000|COMPLETED|Stage 2: Expanded Cohort||0||
59761759|NCT00879684|75881386|FG001|COMPLETED|Stage 2: Expanded Cohort||0||
59761760|NCT00879684|75881387|FG002|COMPLETED|Stage 2: Expanded Cohort||0||
59761761|NCT00879684|75881388|FG003|COMPLETED|Stage 2: Expanded Cohort||0||
60067343|NCT02093351|76182502|FG001|Completing Treatment Period 1|Part A||22||
59761762|NCT00879684|75881389|FG004|COMPLETED|Stage 2: Expanded Cohort||0||
59761763|NCT00879684|75881390|FG005|COMPLETED|Stage 2: Expanded Cohort||0||
59761764|NCT00879684|75881391|FG006|COMPLETED|Stage 2: Expanded Cohort||0||
59934606|NCT02960490|76052721|FG008|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0||
59934607|NCT02960490|76052722|FG009|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0||
59934608|NCT02960490|76052713|FG000|STARTED|Re-randomized Participants: 12 Weeks||0||
59934609|NCT02960490|76052714|FG001|STARTED|Re-randomized Participants: 12 Weeks||0||
59934610|NCT02960490|76052715|FG002|STARTED|Re-randomized Participants: 12 Weeks||15||
59934611|NCT02960490|76052716|FG003|STARTED|Re-randomized Participants: 12 Weeks||14||
59934612|NCT02960490|76052717|FG004|STARTED|Re-randomized Participants: 12 Weeks||14||
59934613|NCT02960490|76052718|FG005|STARTED|Re-randomized Participants: 12 Weeks||12||
59934614|NCT02960490|76052719|FG006|STARTED|Re-randomized Participants: 12 Weeks||0||
59934615|NCT02960490|76052720|FG007|STARTED|Re-randomized Participants: 12 Weeks||0||
59934616|NCT02960490|76052721|FG008|STARTED|Re-randomized Participants: 12 Weeks||0||
59934617|NCT02960490|76052722|FG009|STARTED|Re-randomized Participants: 12 Weeks||0||
59934618|NCT02960490|76052713|FG000|Treated|Re-randomized Participants: 12 Weeks||0||
59934619|NCT02960490|76052714|FG001|Treated|Re-randomized Participants: 12 Weeks||0||
59934620|NCT02960490|76052715|FG002|Treated|Re-randomized Participants: 12 Weeks||15||
59934621|NCT02960490|76052716|FG003|Treated|Re-randomized Participants: 12 Weeks||14||
59934622|NCT02960490|76052717|FG004|Treated|Re-randomized Participants: 12 Weeks||14||
59934623|NCT02960490|76052718|FG005|Treated|Re-randomized Participants: 12 Weeks||12||
59934624|NCT02960490|76052719|FG006|Treated|Re-randomized Participants: 12 Weeks||0||
59934625|NCT02960490|76052720|FG007|Treated|Re-randomized Participants: 12 Weeks||0||
59934626|NCT02960490|76052721|FG008|Treated|Re-randomized Participants: 12 Weeks||0||
59934627|NCT02960490|76052722|FG009|Treated|Re-randomized Participants: 12 Weeks||0||
59934628|NCT02960490|76052713|FG000|FAS|Re-randomized Participants: 12 Weeks||0||
59934629|NCT02960490|76052714|FG001|FAS|Re-randomized Participants: 12 Weeks||0||
59934630|NCT02960490|76052715|FG002|FAS|Re-randomized Participants: 12 Weeks||15||
59934631|NCT02960490|76052716|FG003|FAS|Re-randomized Participants: 12 Weeks||14||
59934632|NCT02960490|76052717|FG004|FAS|Re-randomized Participants: 12 Weeks||14||
59934633|NCT02960490|76052718|FG005|FAS|Re-randomized Participants: 12 Weeks||12||
59934634|NCT02960490|76052719|FG006|FAS|Re-randomized Participants: 12 Weeks||0||
59934635|NCT02960490|76052720|FG007|FAS|Re-randomized Participants: 12 Weeks||0||
59934636|NCT02960490|76052721|FG008|FAS|Re-randomized Participants: 12 Weeks||0||
59934637|NCT02960490|76052722|FG009|FAS|Re-randomized Participants: 12 Weeks||0||
59934638|NCT02960490|76052713|FG000|SAS|Re-randomized Participants: 12 Weeks||0||
59934639|NCT02960490|76052714|FG001|SAS|Re-randomized Participants: 12 Weeks||0||
59934640|NCT02960490|76052715|FG002|SAS|Re-randomized Participants: 12 Weeks||15||
59934641|NCT02960490|76052716|FG003|SAS|Re-randomized Participants: 12 Weeks||14||
59934642|NCT02960490|76052717|FG004|SAS|Re-randomized Participants: 12 Weeks||14||
59934643|NCT02960490|76052718|FG005|SAS|Re-randomized Participants: 12 Weeks||12||
59934644|NCT02960490|76052719|FG006|SAS|Re-randomized Participants: 12 Weeks||0||
59934645|NCT02960490|76052720|FG007|SAS|Re-randomized Participants: 12 Weeks||0||
59934646|NCT02960490|76052721|FG008|SAS|Re-randomized Participants: 12 Weeks||0||
59934647|NCT02960490|76052722|FG009|SAS|Re-randomized Participants: 12 Weeks||0||
59934648|NCT02960490|76052713|FG000|COMPLETED|Re-randomized Participants: 12 Weeks||0||
59934649|NCT02960490|76052714|FG001|COMPLETED|Re-randomized Participants: 12 Weeks||0||
59934650|NCT02960490|76052715|FG002|COMPLETED|Re-randomized Participants: 12 Weeks||13||
59934651|NCT02960490|76052716|FG003|COMPLETED|Re-randomized Participants: 12 Weeks||12||
59934652|NCT02960490|76052717|FG004|COMPLETED|Re-randomized Participants: 12 Weeks||13||
59934653|NCT02960490|76052718|FG005|COMPLETED|Re-randomized Participants: 12 Weeks||10||
59934654|NCT02960490|76052719|FG006|COMPLETED|Re-randomized Participants: 12 Weeks||0||
59934655|NCT02960490|76052720|FG007|COMPLETED|Re-randomized Participants: 12 Weeks||0||
60067344|NCT02093351|76182503|FG002|Completing Treatment Period 1|Part A||23||
60067345|NCT02093351|76182504|FG003|Completing Treatment Period 1|Part A||0||
59934656|NCT02960490|76052721|FG008|COMPLETED|Re-randomized Participants: 12 Weeks||0||
59934657|NCT02960490|76052722|FG009|COMPLETED|Re-randomized Participants: 12 Weeks||0||
59934658|NCT02960490|76052713|FG000|NOT COMPLETED|Re-randomized Participants: 12 Weeks||0||
59934659|NCT02960490|76052714|FG001|NOT COMPLETED|Re-randomized Participants: 12 Weeks||0||
59934660|NCT02960490|76052715|FG002|NOT COMPLETED|Re-randomized Participants: 12 Weeks||2||
59934661|NCT02960490|76052716|FG003|NOT COMPLETED|Re-randomized Participants: 12 Weeks||2||
59934662|NCT02960490|76052717|FG004|NOT COMPLETED|Re-randomized Participants: 12 Weeks||1||
59934663|NCT02960490|76052718|FG005|NOT COMPLETED|Re-randomized Participants: 12 Weeks||2||
59934664|NCT02960490|76052719|FG006|NOT COMPLETED|Re-randomized Participants: 12 Weeks||0||
59934665|NCT02960490|76052720|FG007|NOT COMPLETED|Re-randomized Participants: 12 Weeks||0||
59934666|NCT02960490|76052721|FG008|NOT COMPLETED|Re-randomized Participants: 12 Weeks||0||
59934667|NCT02960490|76052722|FG009|NOT COMPLETED|Re-randomized Participants: 12 Weeks||0||
59934668|NCT02960490|76052713|FG000|STARTED|Extension Phase(Open-label): 80 Weeks||0||
59934669|NCT02960490|76052714|FG001|STARTED|Extension Phase(Open-label): 80 Weeks||0||
59934670|NCT02960490|76052715|FG002|STARTED|Extension Phase(Open-label): 80 Weeks||0||
59934671|NCT02960490|76052716|FG003|STARTED|Extension Phase(Open-label): 80 Weeks||0||
59934672|NCT02960490|76052717|FG004|STARTED|Extension Phase(Open-label): 80 Weeks||0||
59934673|NCT02960490|76052718|FG005|STARTED|Extension Phase(Open-label): 80 Weeks||0||
60067346|NCT02093351|76182501|FG000|Completing Treatment Period 2|Part A||29||
59934674|NCT02960490|76052719|FG006|STARTED|Extension Phase(Open-label): 80 Weeks||13||
59934675|NCT02960490|76052720|FG007|STARTED|Extension Phase(Open-label): 80 Weeks|One Participant who completed Core Treatment Phase (Placebo Then E6011 400 mg arm) had inadequate therapeutic effect at Week 24, hence did not started Extension phase.|11||
59934676|NCT02960490|76052721|FG008|STARTED|Extension Phase(Open-label): 80 Weeks||13||
59934677|NCT02960490|76052722|FG009|STARTED|Extension Phase(Open-label): 80 Weeks||10||
59934678|NCT02960490|76052713|FG000|Treated|Extension Phase(Open-label): 80 Weeks||0||
59934679|NCT02960490|76052714|FG001|Treated|Extension Phase(Open-label): 80 Weeks||0||
59934680|NCT02960490|76052715|FG002|Treated|Extension Phase(Open-label): 80 Weeks||0||
59934681|NCT02960490|76052716|FG003|Treated|Extension Phase(Open-label): 80 Weeks||0||
59934682|NCT02960490|76052717|FG004|Treated|Extension Phase(Open-label): 80 Weeks||0||
59934683|NCT02960490|76052718|FG005|Treated|Extension Phase(Open-label): 80 Weeks||0||
59934684|NCT02960490|76052719|FG006|Treated|Extension Phase(Open-label): 80 Weeks||13||
59934685|NCT02960490|76052720|FG007|Treated|Extension Phase(Open-label): 80 Weeks||11||
59934686|NCT02960490|76052721|FG008|Treated|Extension Phase(Open-label): 80 Weeks||13||
59934687|NCT02960490|76052722|FG009|Treated|Extension Phase(Open-label): 80 Weeks||10||
59934688|NCT02960490|76052713|FG000|FAS|Extension Phase(Open-label): 80 Weeks||0||
59934689|NCT02960490|76052714|FG001|FAS|Extension Phase(Open-label): 80 Weeks||0||
59934690|NCT02960490|76052715|FG002|FAS|Extension Phase(Open-label): 80 Weeks||0||
59934691|NCT02960490|76052716|FG003|FAS|Extension Phase(Open-label): 80 Weeks||0||
59934692|NCT02960490|76052717|FG004|FAS|Extension Phase(Open-label): 80 Weeks||0||
59934693|NCT02960490|76052718|FG005|FAS|Extension Phase(Open-label): 80 Weeks||0||
59934694|NCT02960490|76052719|FG006|FAS|Extension Phase(Open-label): 80 Weeks||13||
59934695|NCT02960490|76052720|FG007|FAS|Extension Phase(Open-label): 80 Weeks||11||
59934696|NCT02960490|76052721|FG008|FAS|Extension Phase(Open-label): 80 Weeks||13||
59934697|NCT02960490|76052722|FG009|FAS|Extension Phase(Open-label): 80 Weeks||10||
59934698|NCT02960490|76052713|FG000|SAS|Extension Phase(Open-label): 80 Weeks||0||
59934699|NCT02960490|76052714|FG001|SAS|Extension Phase(Open-label): 80 Weeks||0||
59934700|NCT02960490|76052715|FG002|SAS|Extension Phase(Open-label): 80 Weeks||0||
59934701|NCT02960490|76052716|FG003|SAS|Extension Phase(Open-label): 80 Weeks||0||
59934702|NCT02960490|76052717|FG004|SAS|Extension Phase(Open-label): 80 Weeks||0||
59934703|NCT02960490|76052718|FG005|SAS|Extension Phase(Open-label): 80 Weeks||0||
59934704|NCT02960490|76052719|FG006|SAS|Extension Phase(Open-label): 80 Weeks||13||
59934705|NCT02960490|76052720|FG007|SAS|Extension Phase(Open-label): 80 Weeks||11||
59934706|NCT02960490|76052721|FG008|SAS|Extension Phase(Open-label): 80 Weeks||13||
59934707|NCT02960490|76052722|FG009|SAS|Extension Phase(Open-label): 80 Weeks||10||
59934708|NCT02960490|76052713|FG000|COMPLETED|Extension Phase(Open-label): 80 Weeks||0||
59934709|NCT02960490|76052714|FG001|COMPLETED|Extension Phase(Open-label): 80 Weeks||0||
59934710|NCT02960490|76052715|FG002|COMPLETED|Extension Phase(Open-label): 80 Weeks||0||
59934711|NCT02960490|76052716|FG003|COMPLETED|Extension Phase(Open-label): 80 Weeks||0||
59934712|NCT02960490|76052717|FG004|COMPLETED|Extension Phase(Open-label): 80 Weeks||0||
59934713|NCT02960490|76052718|FG005|COMPLETED|Extension Phase(Open-label): 80 Weeks||0||
59934714|NCT02960490|76052719|FG006|COMPLETED|Extension Phase(Open-label): 80 Weeks||4||
59934715|NCT02960490|76052720|FG007|COMPLETED|Extension Phase(Open-label): 80 Weeks||5||
59934716|NCT02960490|76052721|FG008|COMPLETED|Extension Phase(Open-label): 80 Weeks||9||
59934717|NCT02960490|76052722|FG009|COMPLETED|Extension Phase(Open-label): 80 Weeks||3||
59934718|NCT02960490|76052713|FG000|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||0||
59934719|NCT02960490|76052714|FG001|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||0||
59934720|NCT02960490|76052715|FG002|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||0||
59934721|NCT02960490|76052716|FG003|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||0||
59934722|NCT02960490|76052717|FG004|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||0||
59934723|NCT02960490|76052718|FG005|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||0||
59934724|NCT02960490|76052719|FG006|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||9||
59934725|NCT02960490|76052720|FG007|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||6||
59934726|NCT02960490|76052721|FG008|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||4||
59934727|NCT02960490|76052722|FG009|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||7||
59934728|NCT02804750|76052746|FG000|STARTED|Period 1||17||
59934729|NCT02804750|76052747|FG001|STARTED|Period 1||18||
59934730|NCT02804750|76052746|FG000|COMPLETED|Period 1||17||
59934731|NCT02804750|76052747|FG001|COMPLETED|Period 1||15||
59934732|NCT02804750|76052746|FG000|NOT COMPLETED|Period 1||0||
59934733|NCT02804750|76052747|FG001|NOT COMPLETED|Period 1||3||
59934734|NCT02804750|76052746|FG000|STARTED|Period 2||17||
59934735|NCT02804750|76052747|FG001|STARTED|Period 2||15||
59934736|NCT02804750|76052746|FG000|COMPLETED|Period 2||16||
59934737|NCT02804750|76052747|FG001|COMPLETED|Period 2||15||
59934738|NCT02804750|76052746|FG000|NOT COMPLETED|Period 2||1||
59934739|NCT02804750|76052747|FG001|NOT COMPLETED|Period 2||0||
59934740|NCT02804750|76052746|FG000|STARTED|Period 3||16||
59934741|NCT02804750|76052747|FG001|STARTED|Period 3||15||
59934742|NCT02804750|76052746|FG000|COMPLETED|Period 3||16||
59934743|NCT02804750|76052747|FG001|COMPLETED|Period 3||13||
59934744|NCT02804750|76052746|FG000|NOT COMPLETED|Period 3||0||
59934745|NCT02804750|76052747|FG001|NOT COMPLETED|Period 3||2||
60067347|NCT02093351|76182502|FG001|Completing Treatment Period 2|Part A||21||
59934746|NCT02804750|76052746|FG000|STARTED|Period 4|Per-protocol, Group 1 did not participate in Period 4.|0||
59934747|NCT02804750|76052747|FG001|STARTED|Period 4|One participant completed Period 3 but did not start Period 4 due to a pre-scheduled surgery.|12||
59934748|NCT02804750|76052746|FG000|COMPLETED|Period 4||0||
59934749|NCT02804750|76052747|FG001|COMPLETED|Period 4||7||
59934750|NCT02804750|76052746|FG000|NOT COMPLETED|Period 4||0||
59934751|NCT02804750|76052747|FG001|NOT COMPLETED|Period 4||5||
59934752|NCT02959866|76052755|FG000|STARTED|Overall Study||59||
59934753|NCT02959866|76052755|FG000|Telephone Interview at 1 Month Follow-up|Overall Study||59||
59934754|NCT02959866|76052755|FG000|COMPLETED|Overall Study||58||
59934755|NCT02959866|76052755|FG000|NOT COMPLETED|Overall Study||1||
59934756|NCT02748512|76052762|FG000|STARTED|Overall Study||14||27
59934757|NCT02748512|76052763|FG001|STARTED|Overall Study||12||11
59934758|NCT02748512|76052762|FG000|COMPLETED|Overall Study||13|14 subjects had 1 study eye treated and 12 subjects had 2 study eyes treated|26
59934759|NCT02748512|76052763|FG001|COMPLETED|Overall Study||11|14 subjects had 1 study eye treated and 12 subjects had 2 study eyes treated|10
59934760|NCT02748512|76052762|FG000|NOT COMPLETED|Overall Study||1||1
59934761|NCT02748512|76052763|FG001|NOT COMPLETED|Overall Study||1||1
59934762|NCT02748356|76052769|FG000|STARTED|Overall Study||7||
59934763|NCT02748356|76052769|FG000|COMPLETED|Overall Study||6||
59934764|NCT02748356|76052769|FG000|NOT COMPLETED|Overall Study||1||
59934765|NCT03439657|76052775|FG000|STARTED|Overall Study||449||
59934766|NCT03439657|76052776|FG001|STARTED|Overall Study||463||
59934767|NCT03439657|76052775|FG000|COMPLETED|Overall Study||442||
59934768|NCT03439657|76052776|FG001|COMPLETED|Overall Study||459||
59934769|NCT03439657|76052775|FG000|NOT COMPLETED|Overall Study||7||
59934770|NCT03439657|76052776|FG001|NOT COMPLETED|Overall Study||4||
59934771|NCT02803580|76052784|FG000|STARTED|Overall Study||209||
59934772|NCT02803580|76052784|FG000|COMPLETED|Overall Study||173||
59934773|NCT02803580|76052784|FG000|NOT COMPLETED|Overall Study||36||
59934774|NCT02878213|76052788|FG000|STARTED|Overall Study||39||
59934775|NCT02878213|76052788|FG000|COMPLETED|Overall Study||36||
59934776|NCT02878213|76052788|FG000|NOT COMPLETED|Overall Study||3||
59934777|NCT02802878|76052795|FG000|STARTED|Overall Study||21||
59934778|NCT02802878|76052796|FG001|STARTED|Overall Study||21||
59934779|NCT02802878|76052795|FG000|COMPLETED|Overall Study||17||
59934780|NCT02802878|76052796|FG001|COMPLETED|Overall Study||18||
59934781|NCT02802878|76052795|FG000|NOT COMPLETED|Overall Study||4||
59934782|NCT02802878|76052796|FG001|NOT COMPLETED|Overall Study||3||
59934783|NCT02801396|76052802|FG000|STARTED|Period 1||17||
59934784|NCT02801396|76052803|FG001|STARTED|Period 1||17||
59934785|NCT02801396|76052804|FG002|STARTED|Period 1||17||
59934786|NCT02801396|76052805|FG003|STARTED|Period 1||16||
59934787|NCT02801396|76052806|FG004|STARTED|Period 1||17||
59934788|NCT02801396|76052807|FG005|STARTED|Period 1||17||
59934789|NCT02801396|76052802|FG000|COMPLETED|Period 1||17||
59934790|NCT02801396|76052803|FG001|COMPLETED|Period 1||17||
59934791|NCT02801396|76052804|FG002|COMPLETED|Period 1||17||
59934792|NCT02801396|76052805|FG003|COMPLETED|Period 1||16||
59934793|NCT02801396|76052806|FG004|COMPLETED|Period 1||16||
59934794|NCT02801396|76052807|FG005|COMPLETED|Period 1||17||
59934795|NCT02801396|76052802|FG000|NOT COMPLETED|Period 1||0||
59934796|NCT02801396|76052803|FG001|NOT COMPLETED|Period 1||0||
59934797|NCT02801396|76052804|FG002|NOT COMPLETED|Period 1||0||
59934798|NCT02801396|76052805|FG003|NOT COMPLETED|Period 1||0||
59934799|NCT02801396|76052806|FG004|NOT COMPLETED|Period 1||1||
59934800|NCT02801396|76052807|FG005|NOT COMPLETED|Period 1||0||
59934801|NCT02801396|76052802|FG000|STARTED|Period 2||17||
59934802|NCT02801396|76052803|FG001|STARTED|Period 2||17||
59934803|NCT02801396|76052804|FG002|STARTED|Period 2||17||
59934804|NCT02801396|76052805|FG003|STARTED|Period 2||16||
59934805|NCT02801396|76052806|FG004|STARTED|Period 2||16||
59934806|NCT02801396|76052807|FG005|STARTED|Period 2||17||
59934807|NCT02801396|76052802|FG000|COMPLETED|Period 2||17||
59934808|NCT02801396|76052803|FG001|COMPLETED|Period 2||17||
59934809|NCT02801396|76052804|FG002|COMPLETED|Period 2||17||
60067348|NCT02093351|76182503|FG002|Completing Treatment Period 2|Part A||23||
59934810|NCT02801396|76052805|FG003|COMPLETED|Period 2||16||
59934811|NCT02801396|76052806|FG004|COMPLETED|Period 2||16||
59934812|NCT02801396|76052807|FG005|COMPLETED|Period 2||17||
59934813|NCT02801396|76052802|FG000|NOT COMPLETED|Period 2||0||
59934814|NCT02801396|76052803|FG001|NOT COMPLETED|Period 2||0||
59934815|NCT02801396|76052804|FG002|NOT COMPLETED|Period 2||0||
59934816|NCT02801396|76052805|FG003|NOT COMPLETED|Period 2||0||
59934817|NCT02801396|76052806|FG004|NOT COMPLETED|Period 2||0||
59934818|NCT02801396|76052807|FG005|NOT COMPLETED|Period 2||0||
59934819|NCT02801396|76052802|FG000|STARTED|Period 3||17||
59934820|NCT02801396|76052803|FG001|STARTED|Period 3||17||
59934821|NCT02801396|76052804|FG002|STARTED|Period 3||17||
59934822|NCT02801396|76052805|FG003|STARTED|Period 3||16||
59934823|NCT02801396|76052806|FG004|STARTED|Period 3||16||
59934824|NCT02801396|76052807|FG005|STARTED|Period 3||17||
59934825|NCT02801396|76052802|FG000|COMPLETED|Period 3||17||
59934826|NCT02801396|76052803|FG001|COMPLETED|Period 3||17||
59934827|NCT02801396|76052804|FG002|COMPLETED|Period 3||17||
59934828|NCT02801396|76052805|FG003|COMPLETED|Period 3||16||
59934829|NCT02801396|76052806|FG004|COMPLETED|Period 3||16||
59934830|NCT02801396|76052807|FG005|COMPLETED|Period 3||17||
59934831|NCT02801396|76052802|FG000|NOT COMPLETED|Period 3||0||
59934832|NCT02801396|76052803|FG001|NOT COMPLETED|Period 3||0||
59934833|NCT02801396|76052804|FG002|NOT COMPLETED|Period 3||0||
59934834|NCT02801396|76052805|FG003|NOT COMPLETED|Period 3||0||
59934835|NCT02801396|76052806|FG004|NOT COMPLETED|Period 3||0||
59934836|NCT02801396|76052807|FG005|NOT COMPLETED|Period 3||0||
59934837|NCT02800928|76052815|FG000|STARTED|Overall Study||9||
59934838|NCT02800928|76052816|FG001|STARTED|Overall Study||8||
59934839|NCT02800928|76052815|FG000|COMPLETED|Overall Study||7||
59934840|NCT02800928|76052816|FG001|COMPLETED|Overall Study||6||
59934841|NCT02800928|76052815|FG000|NOT COMPLETED|Overall Study||2||
59934842|NCT02800928|76052816|FG001|NOT COMPLETED|Overall Study||2||
59934843|NCT03148691|76052825|FG000|STARTED|Overall Study||50||
59934844|NCT03148691|76052826|FG001|STARTED|Overall Study||103||
59934845|NCT03148691|76052827|FG002|STARTED|Overall Study||100||
59934846|NCT03148691|76052825|FG000|COMPLETED|Overall Study||47||
59934847|NCT03148691|76052826|FG001|COMPLETED|Overall Study||101||
59934848|NCT03148691|76052827|FG002|COMPLETED|Overall Study||92||
59934849|NCT03148691|76052825|FG000|NOT COMPLETED|Overall Study||3||
59934850|NCT03148691|76052826|FG001|NOT COMPLETED|Overall Study||2||
59934851|NCT03148691|76052827|FG002|NOT COMPLETED|Overall Study||8||
59934852|NCT03148067|76052835|FG000|STARTED|Overall Study||225||
59934853|NCT03148067|76052835|FG000|COMPLETED|Overall Study||221||
59934854|NCT03148067|76052835|FG000|NOT COMPLETED|Overall Study||4||
59934855|NCT04739735|76052842|FG000|STARTED|Overall Study||25||
59934856|NCT04739735|76052843|FG001|STARTED|Overall Study||25||
59934857|NCT04739735|76052842|FG000|COMPLETED|Overall Study||25||
59934858|NCT04739735|76052843|FG001|COMPLETED|Overall Study||25||
59934859|NCT04739735|76052842|FG000|NOT COMPLETED|Overall Study||0||
59934860|NCT04739735|76052843|FG001|NOT COMPLETED|Overall Study||0||
59934861|NCT03146741|76052849|FG000|STARTED|Overall Study||20||
59934862|NCT03146741|76052849|FG000|COMPLETED|Overall Study||10||
59934863|NCT03146741|76052849|FG000|NOT COMPLETED|Overall Study||10||
59934864|NCT03150719|76052855|FG000|STARTED|Overall Study||47||
59934865|NCT03150719|76052856|FG001|STARTED|Overall Study||50||
59934866|NCT03150719|76052855|FG000|COMPLETED|Overall Study||46||
59934867|NCT03150719|76052856|FG001|COMPLETED|Overall Study||48||
59934868|NCT03150719|76052855|FG000|NOT COMPLETED|Overall Study||1||
59934869|NCT03150719|76052856|FG001|NOT COMPLETED|Overall Study||2||
59934870|NCT04039217|76052862|FG000|STARTED|Overall Study||20||
59934871|NCT04039217|76052862|FG000|Started Study Arm A.1|Overall Study||4||
59934872|NCT04039217|76052862|FG000|Completed Study Arm A.1|Overall Study||4||
59934873|NCT04039217|76052862|FG000|Started Study Arm A.2|Overall Study||4||
59934874|NCT04039217|76052862|FG000|Completed Study Arm A.2|Overall Study||4||
59934875|NCT04039217|76052862|FG000|Started Study Arm A.3|Overall Study||4||
59934876|NCT04039217|76052862|FG000|Completed Study Arm A.3|Overall Study||4||
59934877|NCT04039217|76052862|FG000|Started Study Arm B.1|Overall Study||4||
59934878|NCT04039217|76052862|FG000|Completed Study Arm B.1|Overall Study||4||
59934879|NCT04039217|76052862|FG000|Started Study Arm B.2|Overall Study||4||
59934880|NCT04039217|76052862|FG000|Completed Study Arm B.2|Overall Study||4||
59934881|NCT04039217|76052862|FG000|Started Study Arm C.1|Overall Study||5||
59934882|NCT04039217|76052862|FG000|Completed Study Arm C.1|Overall Study||4||
59934883|NCT04039217|76052862|FG000|Started Study Arm C.2|Overall Study||0||
59934884|NCT04039217|76052862|FG000|Completed Study Arm C.2|Overall Study||0||
59934885|NCT04039217|76052862|FG000|COMPLETED|Overall Study||19||
59934886|NCT04039217|76052862|FG000|NOT COMPLETED|Overall Study||1||
59934887|NCT00982111|76052872|FG000|STARTED|Overall Study||315||
59934888|NCT00982111|76052873|FG001|STARTED|Overall Study||318||
59934889|NCT00982111|76052872|FG000|Received at Least 1 Dose of Study Drug|Overall Study||304||
59934890|NCT00982111|76052873|FG001|Received at Least 1 Dose of Study Drug|Overall Study||312||
59934891|NCT00982111|76052872|FG000|Death Due to Any Cause|Overall Study||236||
59934892|NCT00982111|76052873|FG001|Death Due to Any Cause|Overall Study||246||
59934893|NCT00982111|76052872|FG000|COMPLETED|Overall Study||236||
59934894|NCT00982111|76052873|FG001|COMPLETED|Overall Study||246||
59934895|NCT00982111|76052872|FG000|NOT COMPLETED|Overall Study||79||
59934896|NCT00982111|76052873|FG001|NOT COMPLETED|Overall Study||72||
59934897|NCT02957682|76052882|FG000|STARTED|Overall Study||1088|Randomized|
59934898|NCT02957682|76052883|FG001|STARTED|Overall Study||1088|Randomized|
59934899|NCT02957682|76052882|FG000|Randomized and Treated|Overall Study||1085||
59934900|NCT02957682|76052883|FG001|Randomized and Treated|Overall Study||1086||
59934901|NCT02957682|76052882|FG000|COMPLETED|Overall Study||890|Completed 96-week study treatment period|
59934902|NCT02957682|76052883|FG001|COMPLETED|Overall Study||919|Completed 96-week study treatment period|
59934903|NCT02957682|76052882|FG000|NOT COMPLETED|Overall Study||198||
59934904|NCT02957682|76052883|FG001|NOT COMPLETED|Overall Study||169||
59934905|NCT03057951|76052891|FG000|STARTED|Overall Study||2991|Randomised|
59934906|NCT03057951|76052892|FG001|STARTED|Overall Study||2997|Randomised|
59934907|NCT03057951|76052891|FG000|Treated|Overall Study||2989||
59934908|NCT03057951|76052892|FG001|Treated|Overall Study||2996||
59934909|NCT03057951|76052891|FG000|COMPLETED|Overall Study||2046|Patients who did not prematurely discontinue from trial medication|
59934910|NCT03057951|76052892|FG001|COMPLETED|Overall Study||2051|Patients who did not prematurely discontinue from trial medication|
59934911|NCT03057951|76052891|FG000|NOT COMPLETED|Overall Study||945||
59934912|NCT03057951|76052892|FG001|NOT COMPLETED|Overall Study||946||
59934913|NCT03146663|76052900|FG000|STARTED|Overall Study||25||
59934914|NCT03146663|76052901|FG001|STARTED|Overall Study||28||
59934915|NCT03146663|76052900|FG000|COMPLETED|Overall Study||24||
59934916|NCT03146663|76052901|FG001|COMPLETED|Overall Study||27||
59934917|NCT03146663|76052900|FG000|NOT COMPLETED|Overall Study||1||
59934918|NCT03146663|76052901|FG001|NOT COMPLETED|Overall Study||1||
59934919|NCT02956278|76052911|FG000|STARTED|Overall Study||15||
59934920|NCT02956278|76052912|FG001|STARTED|Overall Study||9||
59934921|NCT02956278|76052913|FG002|STARTED|Overall Study||3||
59934922|NCT02956278|76052911|FG000|COMPLETED|Overall Study||9||
59934923|NCT02956278|76052912|FG001|COMPLETED|Overall Study||7||
59934924|NCT02956278|76052913|FG002|COMPLETED|Overall Study||3||
59934925|NCT02956278|76052911|FG000|NOT COMPLETED|Overall Study||6||
59934926|NCT02956278|76052912|FG001|NOT COMPLETED|Overall Study||2||
59934927|NCT02956278|76052913|FG002|NOT COMPLETED|Overall Study||0||
59934928|NCT02957136|76052923|FG000|STARTED|Overall Study||95||
59934929|NCT02957136|76052924|FG001|STARTED|Overall Study||99||
59934930|NCT02957136|76052923|FG000|COMPLETED|Overall Study||93||
59934931|NCT02957136|76052924|FG001|COMPLETED|Overall Study||98||
59934932|NCT02957136|76052923|FG000|NOT COMPLETED|Overall Study||2||
59934933|NCT02957136|76052924|FG001|NOT COMPLETED|Overall Study||1||
59934934|NCT03150485|76052930|FG000|STARTED|Overall Study||2||
59934935|NCT03150485|76052931|FG001|STARTED|Overall Study||9||
59934936|NCT03150485|76052932|FG002|STARTED|Overall Study||4||
59934937|NCT03150485|76052933|FG003|STARTED|Overall Study||5||
59934938|NCT03150485|76052934|FG004|STARTED|Overall Study||2||
59934939|NCT03150485|76052935|FG005|STARTED|Overall Study||1||
59934940|NCT03150485|76052930|FG000|COMPLETED|Overall Study||2||
59934941|NCT03150485|76052931|FG001|COMPLETED|Overall Study||8||
59934942|NCT03150485|76052932|FG002|COMPLETED|Overall Study||4||
59934943|NCT03150485|76052933|FG003|COMPLETED|Overall Study||5||
59934944|NCT03150485|76052934|FG004|COMPLETED|Overall Study||2||
59934945|NCT03150485|76052935|FG005|COMPLETED|Overall Study||1||
59934946|NCT03150485|76052930|FG000|NOT COMPLETED|Overall Study||0||
59934947|NCT03150485|76052931|FG001|NOT COMPLETED|Overall Study||1||
59934948|NCT03150485|76052932|FG002|NOT COMPLETED|Overall Study||0||
59934949|NCT03150485|76052933|FG003|NOT COMPLETED|Overall Study||0||
59934950|NCT03150485|76052934|FG004|NOT COMPLETED|Overall Study||0||
59934951|NCT03150485|76052935|FG005|NOT COMPLETED|Overall Study||0||
59934952|NCT03134911|76052942|FG000|STARTED|Overall Study||535||
59934953|NCT03134911|76052942|FG000|COMPLETED|Overall Study||501||
59934954|NCT03134911|76052942|FG000|NOT COMPLETED|Overall Study||34||
59934955|NCT02291445|76052952|FG000|STARTED|Overall Study||4||
59518356|NCT03369340|75612168|FG005|STARTED|Day 2||3||
59518357|NCT03369340|75612163|FG000|COMPLETED|Day 2||3||
59518358|NCT03369340|75612164|FG001|COMPLETED|Day 2||3||
59518359|NCT03369340|75612165|FG002|COMPLETED|Day 2||3||
59518360|NCT03369340|75612166|FG003|COMPLETED|Day 2||3||
59518361|NCT03369340|75612167|FG004|COMPLETED|Day 2||3||
59518362|NCT03369340|75612168|FG005|COMPLETED|Day 2||3||
59934956|NCT02291445|76052953|FG001|STARTED|Overall Study||4||
59934957|NCT02291445|76052952|FG000|COMPLETED|Overall Study||4||
59934958|NCT02291445|76052953|FG001|COMPLETED|Overall Study||4||
59934959|NCT02291445|76052952|FG000|NOT COMPLETED|Overall Study||0||
59934960|NCT02291445|76052953|FG001|NOT COMPLETED|Overall Study||0||
59934961|NCT03134599|76052961|FG000|STARTED|Week 1||10||
59934962|NCT03134599|76052962|FG001|STARTED|Week 1||10||
59934963|NCT03134599|76052963|FG002|STARTED|Week 1||10||
59934964|NCT03134599|76052964|FG003|STARTED|Week 1||11||
59934965|NCT03134599|76052965|FG004|STARTED|Week 1||10||
59934966|NCT03134599|76052966|FG005|STARTED|Week 1||9||
59934967|NCT03134599|76052961|FG000|COMPLETED|Week 1||10||
59934968|NCT03134599|76052962|FG001|COMPLETED|Week 1||10||
59934969|NCT03134599|76052963|FG002|COMPLETED|Week 1||10||
59934970|NCT03134599|76052964|FG003|COMPLETED|Week 1||11||
59934971|NCT03134599|76052965|FG004|COMPLETED|Week 1||9||
59934972|NCT03134599|76052966|FG005|COMPLETED|Week 1||9||
59934973|NCT03134599|76052961|FG000|NOT COMPLETED|Week 1||0||
59934974|NCT03134599|76052962|FG001|NOT COMPLETED|Week 1||0||
59934975|NCT03134599|76052963|FG002|NOT COMPLETED|Week 1||0||
59934976|NCT03134599|76052964|FG003|NOT COMPLETED|Week 1||0||
59934977|NCT03134599|76052965|FG004|NOT COMPLETED|Week 1||1||
59934978|NCT03134599|76052966|FG005|NOT COMPLETED|Week 1||0||
59518363|NCT03369340|75612163|FG000|NOT COMPLETED|Day 2||0||
59518364|NCT03369340|75612164|FG001|NOT COMPLETED|Day 2||0||
59934979|NCT03134599|76052961|FG000|STARTED|Week 2||10||
59934980|NCT03134599|76052962|FG001|STARTED|Week 2||10||
59934981|NCT03134599|76052963|FG002|STARTED|Week 2||10||
59934982|NCT03134599|76052964|FG003|STARTED|Week 2||11||
59934983|NCT03134599|76052965|FG004|STARTED|Week 2||9||
59934984|NCT03134599|76052966|FG005|STARTED|Week 2||9||
59934985|NCT03134599|76052961|FG000|COMPLETED|Week 2||9||
59934986|NCT03134599|76052962|FG001|COMPLETED|Week 2||10||
59934987|NCT03134599|76052963|FG002|COMPLETED|Week 2||10||
59934988|NCT03134599|76052964|FG003|COMPLETED|Week 2||10||
59934989|NCT03134599|76052965|FG004|COMPLETED|Week 2||8||
59934990|NCT03134599|76052966|FG005|COMPLETED|Week 2||9||
59934991|NCT03134599|76052961|FG000|NOT COMPLETED|Week 2||1||
59934992|NCT03134599|76052962|FG001|NOT COMPLETED|Week 2||0||
59934993|NCT03134599|76052963|FG002|NOT COMPLETED|Week 2||0||
59934994|NCT03134599|76052964|FG003|NOT COMPLETED|Week 2||1||
59934995|NCT03134599|76052965|FG004|NOT COMPLETED|Week 2||1||
59934996|NCT03134599|76052966|FG005|NOT COMPLETED|Week 2||0||
59934997|NCT03134599|76052961|FG000|STARTED|Week 3||9||
59934998|NCT03134599|76052962|FG001|STARTED|Week 3||10||
59934999|NCT03134599|76052963|FG002|STARTED|Week 3||10||
59935000|NCT03134599|76052964|FG003|STARTED|Week 3||10||
59935001|NCT03134599|76052965|FG004|STARTED|Week 3||8||
59935002|NCT03134599|76052966|FG005|STARTED|Week 3||9||
59935003|NCT03134599|76052961|FG000|COMPLETED|Week 3||9||
59935004|NCT03134599|76052962|FG001|COMPLETED|Week 3||10||
59935005|NCT03134599|76052963|FG002|COMPLETED|Week 3||10||
59935006|NCT03134599|76052964|FG003|COMPLETED|Week 3||9||
59935007|NCT03134599|76052965|FG004|COMPLETED|Week 3||8||
59935008|NCT03134599|76052966|FG005|COMPLETED|Week 3||8||
59935009|NCT03134599|76052961|FG000|NOT COMPLETED|Week 3||0||
59935010|NCT03134599|76052962|FG001|NOT COMPLETED|Week 3||0||
59935011|NCT03134599|76052963|FG002|NOT COMPLETED|Week 3||0||
59935012|NCT03134599|76052964|FG003|NOT COMPLETED|Week 3||1||
59935013|NCT03134599|76052965|FG004|NOT COMPLETED|Week 3||0||
59935014|NCT03134599|76052966|FG005|NOT COMPLETED|Week 3||1||
59935015|NCT03153137|76052976|FG000|STARTED|Overall Study||69||
59935016|NCT03153137|76052977|FG001|STARTED|Overall Study||68||
59935017|NCT03153137|76052976|FG000|COMPLETED|Overall Study||66||
59935018|NCT03153137|76052977|FG001|COMPLETED|Overall Study||64||
59935019|NCT03153137|76052976|FG000|NOT COMPLETED|Overall Study||3||
59935020|NCT03153137|76052977|FG001|NOT COMPLETED|Overall Study||4||
59935021|NCT03136861|76052990|FG000|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||285|All randomized patients were included in the Full Analysis Set (FAS) and Safety Analysis Set (SAF).|
59935022|NCT03136861|76052991|FG001|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||95|All randomized patients were included in the Full Analysis Set (FAS) and Safety Analysis Set (SAF).|
59935023|NCT03136861|76052992|FG002|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0|All randomized patients were included in the Full Analysis Set (FAS) and Safety Analysis Set (SAF).|
59935024|NCT03136861|76052993|FG003|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0|All randomized patients were included in the Full Analysis Set (FAS) and Safety Analysis Set (SAF).|
59935025|NCT03136861|76052994|FG004|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0|All randomized patients were included in the Full Analysis Set (FAS) and Safety Analysis Set (SAF).|
59935026|NCT03136861|76052995|FG005|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0|All randomized patients were included in the Full Analysis Set (FAS) and Safety Analysis Set (SAF).|
59935027|NCT03136861|76052996|FG006|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0|All randomized patients were included in the Full Analysis Set (FAS) and Safety Analysis Set (SAF).|
59935028|NCT03136861|76052990|FG000|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||278||
59935029|NCT03136861|76052991|FG001|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||89||
59935030|NCT03136861|76052992|FG002|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0||
59935031|NCT03136861|76052993|FG003|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0||
59935032|NCT03136861|76052994|FG004|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0||
59935033|NCT03136861|76052995|FG005|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0||
59935034|NCT03136861|76052996|FG006|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0||
59935035|NCT03136861|76052990|FG000|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||7||
59935036|NCT03136861|76052991|FG001|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||6||
59935037|NCT03136861|76052992|FG002|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0||
59935038|NCT03136861|76052993|FG003|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0||
59935039|NCT03136861|76052994|FG004|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0||
59935040|NCT03136861|76052995|FG005|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0||
59935041|NCT03136861|76052996|FG006|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0||
59935042|NCT03136861|76052990|FG000|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0|All randomized patients were included in the Full Analysis Set (FAS) and Safety Analysis Set (SAF).|
59935043|NCT03136861|76052991|FG001|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0|All randomized patients were included in the Full Analysis Set (FAS) and Safety Analysis Set (SAF).|
59935044|NCT03136861|76052992|FG002|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||90|All randomized patients were included in the Full Analysis Set (FAS) and Safety Analysis Set (SAF).|
59935045|NCT03136861|76052993|FG003|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||94|All randomized patients were included in the Full Analysis Set (FAS) and Safety Analysis Set (SAF).|
59935046|NCT03136861|76052994|FG004|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||94|All randomized patients were included in the Full Analysis Set (FAS) and Safety Analysis Set (SAF).|
59935047|NCT03136861|76052995|FG005|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||45|All randomized patients were included in the Full Analysis Set (FAS) and Safety Analysis Set (SAF).|
59935048|NCT03136861|76052996|FG006|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||44|All randomized patients were included in the Full Analysis Set (FAS) and Safety Analysis Set (SAF).|
59935049|NCT03136861|76052990|FG000|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0||
59935050|NCT03136861|76052991|FG001|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0||
59935051|NCT03136861|76052992|FG002|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||88||
59935052|NCT03136861|76052993|FG003|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||93||
59935053|NCT03136861|76052994|FG004|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||92||
59935054|NCT03136861|76052995|FG005|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||45||
59935055|NCT03136861|76052996|FG006|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||43||
59935056|NCT03136861|76052990|FG000|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0||
59935057|NCT03136861|76052991|FG001|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0||
59935058|NCT03136861|76052992|FG002|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||2||
59935059|NCT03136861|76052993|FG003|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||1||
59935060|NCT03136861|76052994|FG004|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||2||
59935061|NCT03136861|76052995|FG005|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0||
59935062|NCT03136861|76052996|FG006|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||1||
59935063|NCT02666183|76053010|FG000|STARTED|Overall Study||137||
59935064|NCT02666183|76053011|FG001|STARTED|Overall Study||141||
59935065|NCT02666183|76053012|FG002|STARTED|Overall Study||119||
59935066|NCT02666183|76053010|FG000|COMPLETED|Overall Study||103||
59935067|NCT02666183|76053011|FG001|COMPLETED|Overall Study||106||
59935068|NCT02666183|76053012|FG002|COMPLETED|Overall Study||93||
59935069|NCT02666183|76053010|FG000|NOT COMPLETED|Overall Study||34||
59935070|NCT02666183|76053011|FG001|NOT COMPLETED|Overall Study||35||
59935071|NCT02666183|76053012|FG002|NOT COMPLETED|Overall Study||26||
59935072|NCT03316950|76053024|FG000|STARTED|Initial Intervention (1 to 3 Months)||12||
59935073|NCT03316950|76053025|FG001|STARTED|Initial Intervention (1 to 3 Months)||12||
59935074|NCT03316950|76053026|FG002|STARTED|Initial Intervention (1 to 3 Months)||23||
59935075|NCT03316950|76053027|FG003|STARTED|Initial Intervention (1 to 3 Months)||0||
59935076|NCT03316950|76053024|FG000|COMPLETED|Initial Intervention (1 to 3 Months)||9||
59935077|NCT03316950|76053025|FG001|COMPLETED|Initial Intervention (1 to 3 Months)||8||
59935078|NCT03316950|76053026|FG002|COMPLETED|Initial Intervention (1 to 3 Months)||14||
59935079|NCT03316950|76053027|FG003|COMPLETED|Initial Intervention (1 to 3 Months)||0||
59935080|NCT03316950|76053024|FG000|NOT COMPLETED|Initial Intervention (1 to 3 Months)||3||
59935081|NCT03316950|76053025|FG001|NOT COMPLETED|Initial Intervention (1 to 3 Months)||4||
59935082|NCT03316950|76053026|FG002|NOT COMPLETED|Initial Intervention (1 to 3 Months)||9||
59935083|NCT03316950|76053027|FG003|NOT COMPLETED|Initial Intervention (1 to 3 Months)||0||
59935084|NCT03316950|76053024|FG000|STARTED|Dual Intervention (6 to 8 Months)||0||
59935085|NCT03316950|76053025|FG001|STARTED|Dual Intervention (6 to 8 Months)||0||
59935086|NCT03316950|76053026|FG002|STARTED|Dual Intervention (6 to 8 Months)||0||
59935087|NCT03316950|76053027|FG003|STARTED|Dual Intervention (6 to 8 Months)||14||
59935088|NCT03316950|76053024|FG000|COMPLETED|Dual Intervention (6 to 8 Months)||0||
59935089|NCT03316950|76053025|FG001|COMPLETED|Dual Intervention (6 to 8 Months)||0||
59935090|NCT03316950|76053026|FG002|COMPLETED|Dual Intervention (6 to 8 Months)||0||
59935091|NCT03316950|76053027|FG003|COMPLETED|Dual Intervention (6 to 8 Months)||14||
59935092|NCT03316950|76053024|FG000|NOT COMPLETED|Dual Intervention (6 to 8 Months)||0||
59935093|NCT03316950|76053025|FG001|NOT COMPLETED|Dual Intervention (6 to 8 Months)||0||
59935094|NCT03316950|76053026|FG002|NOT COMPLETED|Dual Intervention (6 to 8 Months)||0||
59935095|NCT03316950|76053027|FG003|NOT COMPLETED|Dual Intervention (6 to 8 Months)||0||
59935096|NCT03139279|76053041|FG000|STARTED|Overall Study||58||
59935097|NCT03139279|76053042|FG001|STARTED|Overall Study||56||
59935098|NCT03139279|76053041|FG000|COMPLETED|Overall Study||51||
59935099|NCT03139279|76053042|FG001|COMPLETED|Overall Study||50||
59935100|NCT03139279|76053041|FG000|NOT COMPLETED|Overall Study||7||
59935101|NCT03139279|76053042|FG001|NOT COMPLETED|Overall Study||6||
59935102|NCT01370642|76053051|FG000|STARTED|Overall Study||98||
59935103|NCT01370642|76053052|FG001|STARTED|Overall Study||98||
59935104|NCT01370642|76053053|FG002|STARTED|Overall Study||98||
59935105|NCT01370642|76053051|FG000|FAS Population|Overall Study||98||
59935106|NCT01370642|76053052|FG001|FAS Population|Overall Study||97||
60067349|NCT02093351|76182504|FG003|Completing Treatment Period 2|Part A||0||
60067350|NCT02093351|76182501|FG000|Completing Treatment Period 3|Part A||28||
60067351|NCT02093351|76182502|FG001|Completing Treatment Period 3|Part A||21||
60067352|NCT02093351|76182503|FG002|Completing Treatment Period 3|Part A||23||
60067353|NCT02093351|76182504|FG003|Completing Treatment Period 3|Part A||0||
59935107|NCT01370642|76053053|FG002|FAS Population|Overall Study||98||
59935108|NCT01370642|76053051|FG000|COMPLETED|Overall Study||90||
59935109|NCT01370642|76053052|FG001|COMPLETED|Overall Study||92||
59935110|NCT01370642|76053053|FG002|COMPLETED|Overall Study||69||
59935111|NCT01370642|76053051|FG000|NOT COMPLETED|Overall Study||8||
59935112|NCT01370642|76053052|FG001|NOT COMPLETED|Overall Study||6||
59935113|NCT01370642|76053053|FG002|NOT COMPLETED|Overall Study||29||
59935114|NCT02873208|76053061|FG000|STARTED|Overall Study||265||
60067354|NCT02093351|76182501|FG000|COMPLETED|Part A||28||
59935115|NCT02873208|76053061|FG000|COMPLETED|Overall Study||167||
59935116|NCT02873208|76053061|FG000|NOT COMPLETED|Overall Study||98||
59935117|NCT03138967|76053067|FG000|STARTED|Overall Study||26||
59761765|NCT00879684|75881385|FG000|NOT COMPLETED|Stage 2: Expanded Cohort||0||
59761766|NCT00879684|75881386|FG001|NOT COMPLETED|Stage 2: Expanded Cohort||0||
59761767|NCT00879684|75881387|FG002|NOT COMPLETED|Stage 2: Expanded Cohort||0||
59761768|NCT00879684|75881388|FG003|NOT COMPLETED|Stage 2: Expanded Cohort||0||
59761769|NCT00879684|75881389|FG004|NOT COMPLETED|Stage 2: Expanded Cohort||0||
59762621|NCT00531427|75882454|FG001|STARTED|Overall Study||285||
59935118|NCT03138967|76053068|FG001|STARTED|Overall Study||28||
59935119|NCT03138967|76053067|FG000|Post-operative Day(POD) 1 Follow-up|Overall Study||25||
59935120|NCT03138967|76053068|FG001|Post-operative Day(POD) 1 Follow-up|Overall Study||25||
59935121|NCT03138967|76053067|FG000|Post-operative Day(POD) 7 Follow-up|Overall Study||25||
59935122|NCT03138967|76053068|FG001|Post-operative Day(POD) 7 Follow-up|Overall Study||24||
59935123|NCT03138967|76053067|FG000|COMPLETED|Overall Study||25||
59935124|NCT03138967|76053068|FG001|COMPLETED|Overall Study||24||
59935125|NCT03138967|76053067|FG000|NOT COMPLETED|Overall Study||1||
59935126|NCT03138967|76053068|FG001|NOT COMPLETED|Overall Study||4||
59935127|NCT01547117|76053078|FG000|STARTED|Overall Study||12||
59935128|NCT01547117|76053079|FG001|STARTED|Overall Study||5||
59935129|NCT01547117|76053080|FG002|STARTED|Overall Study||10||
59935130|NCT01547117|76053081|FG003|STARTED|Overall Study||11||
59935131|NCT01547117|76053078|FG000|Phase 1 Baseline Labs|Overall Study||12||
59935132|NCT01547117|76053079|FG001|Phase 1 Baseline Labs|Overall Study|1 healthy control was unable to find time to schedule study|4||
59935133|NCT01547117|76053080|FG002|Phase 1 Baseline Labs|Overall Study|2 patients with POTS did not discontinue medication that was prohibited by protocol.|8||
59935134|NCT01547117|76053081|FG003|Phase 1 Baseline Labs|Overall Study|1 patient with POTS did not discontinue medication that was prohibited by protocol, 1 patient was unable to find time to schedule the study, 1 was noted to be too old to participate, and 1 became pregnant between enrollment and the start of phase 1.|7||
59935135|NCT01547117|76053078|FG000|Phase 1-150 mEq Sodium/Day|Overall Study||12||
59935136|NCT01547117|76053079|FG001|Phase 1-150 mEq Sodium/Day|Overall Study||4||
59935137|NCT01547117|76053080|FG002|Phase 1-150 mEq Sodium/Day|Overall Study||8||
59935138|NCT01547117|76053081|FG003|Phase 1-150 mEq Sodium/Day|Overall Study||7||
59935139|NCT01547117|76053078|FG000|Phase 1-start Low Sodium or High Sodium Diet|Overall Study||12||
59935140|NCT01547117|76053079|FG001|Phase 1-start Low Sodium or High Sodium Diet|Overall Study||4||
59935141|NCT01547117|76053080|FG002|Phase 1-start Low Sodium or High Sodium Diet|Overall Study||8||
59935142|NCT01547117|76053081|FG003|Phase 1-start Low Sodium or High Sodium Diet|Overall Study||7||
59935143|NCT01547117|76053078|FG000|Phase 1-finish|Overall Study|1 healthy control withdrew with migraines during phase 1 (low Na+).|11||
59935144|NCT01547117|76053079|FG001|Phase 1-finish|Overall Study|2 healthy controls withdrew during phase 1 (high Na+): 1 unable to tolerate study diet and another with difficulty cooperating with investigators..|2||
59935145|NCT01547117|76053080|FG002|Phase 1-finish|Overall Study||8||
59935146|NCT01547117|76053081|FG003|Phase 1-finish|Overall Study|1 patient with POTS withdrew during phase 1 due to a family illness.|6||
59935147|NCT01547117|76053078|FG000|Phase 2-150 mEq Sodium/Day|Overall Study||11||
59935148|NCT01547117|76053079|FG001|Phase 2-150 mEq Sodium/Day|Overall Study||2||
59935149|NCT01547117|76053080|FG002|Phase 2-150 mEq Sodium/Day|Overall Study||8||
59935150|NCT01547117|76053081|FG003|Phase 2-150 mEq Sodium/Day|Overall Study||6||
59935151|NCT01547117|76053078|FG000|Phase 2-start Low Sodium or High Sodium Diet|Overall Study||11||
59935152|NCT01547117|76053079|FG001|Phase 2-start Low Sodium or High Sodium Diet|Overall Study||2||
59935153|NCT01547117|76053080|FG002|Phase 2-start Low Sodium or High Sodium Diet|Overall Study||8||
59935154|NCT01547117|76053081|FG003|Phase 2-start Low Sodium or High Sodium Diet|Overall Study||6||
59935155|NCT01547117|76053078|FG000|Phase 2-finish|Overall Study||11||
59935156|NCT01547117|76053079|FG001|Phase 2-finish|Overall Study||2||
59935157|NCT01547117|76053080|FG002|Phase 2-finish|Overall Study||8||
59935158|NCT01547117|76053081|FG003|Phase 2-finish|Overall Study||6||
59935159|NCT01547117|76053078|FG000|COMPLETED|Overall Study||11||
59935160|NCT01547117|76053079|FG001|COMPLETED|Overall Study||2||
59935161|NCT01547117|76053080|FG002|COMPLETED|Overall Study||8||
59935162|NCT01547117|76053081|FG003|COMPLETED|Overall Study||6||
59935163|NCT01547117|76053078|FG000|NOT COMPLETED|Overall Study||1||
59935164|NCT01547117|76053079|FG001|NOT COMPLETED|Overall Study||3||
59935165|NCT01547117|76053080|FG002|NOT COMPLETED|Overall Study||2||
59613304|NCT01568892|75724457|FG000|NOT COMPLETED|Double-blind Phase||0||
59613305|NCT01568892|75724458|FG001|NOT COMPLETED|Double-blind Phase||0||
59613306|NCT01568892|75724457|FG000|STARTED|Open-label Phase|One participant completing the DB Phase withdrew on Day 8 and did not enter the Open-label Phase.|13||
59613307|NCT01568892|75724458|FG001|STARTED|Open-label Phase||16||
59613308|NCT01568892|75724457|FG000|COMPLETED|Open-label Phase||7||
59935166|NCT01547117|76053081|FG003|NOT COMPLETED|Overall Study||5||
59935167|NCT03136159|76053109|FG000|STARTED|Overall Study||190||
59935168|NCT03136159|76053110|FG001|STARTED|Overall Study||190||
59935169|NCT03136159|76053109|FG000|COMPLETED|Overall Study||185||
60067355|NCT02093351|76182502|FG001|COMPLETED|Part A||21||
59935170|NCT03136159|76053110|FG001|COMPLETED|Overall Study||190||
59935171|NCT03136159|76053109|FG000|NOT COMPLETED|Overall Study||5||
59935172|NCT03136159|76053110|FG001|NOT COMPLETED|Overall Study||0||
60067356|NCT02093351|76182503|FG002|COMPLETED|Part A||23||
60067357|NCT02093351|76182504|FG003|COMPLETED|Part A||0||
60067358|NCT02093351|76182501|FG000|NOT COMPLETED|Part A||2||
59935173|NCT01986933|76053121|FG000|STARTED|Placebo-controlled (Part A)||53|Patients were randomly assigned (1:1:1:1:1 ratio) to one of four active treatment groups and one placebo group in double-blind fashion.|
59935174|NCT01986933|76053122|FG001|STARTED|Placebo-controlled (Part A)||53|Patients were randomly assigned (1:1:1:1:1 ratio) to one of four active treatment groups and one placebo group in double-blind fashion.|
60067359|NCT02093351|76182502|FG001|NOT COMPLETED|Part A||2||
60067360|NCT02093351|76182503|FG002|NOT COMPLETED|Part A||3||
60067361|NCT02093351|76182504|FG003|NOT COMPLETED|Part A||0||
59935175|NCT01986933|76053123|FG002|STARTED|Placebo-controlled (Part A)||54|Patients were randomly assigned (1:1:1:1:1 ratio) to one of four active treatment groups and one placebo group in double-blind fashion.|
59935176|NCT01986933|76053124|FG003|STARTED|Placebo-controlled (Part A)||52|Patients were randomly assigned (1:1:1:1:1 ratio) to one of four active treatment groups and one placebo group in double-blind fashion.|
59935177|NCT01986933|76053125|FG004|STARTED|Placebo-controlled (Part A)||52|Patients were randomly assigned (1:1:1:1:1 ratio) to one of four active treatment groups and one placebo group in double-blind fashion.|
59935178|NCT01986933|76053121|FG000|COMPLETED|Placebo-controlled (Part A)||44||
59935179|NCT01986933|76053122|FG001|COMPLETED|Placebo-controlled (Part A)||44||
59935180|NCT01986933|76053123|FG002|COMPLETED|Placebo-controlled (Part A)||45||
59935181|NCT01986933|76053124|FG003|COMPLETED|Placebo-controlled (Part A)||45||
59935182|NCT01986933|76053125|FG004|COMPLETED|Placebo-controlled (Part A)||38||
59935183|NCT01986933|76053121|FG000|NOT COMPLETED|Placebo-controlled (Part A)||9||
59935184|NCT01986933|76053122|FG001|NOT COMPLETED|Placebo-controlled (Part A)||9||
59935185|NCT01986933|76053123|FG002|NOT COMPLETED|Placebo-controlled (Part A)||9||
59935186|NCT01986933|76053124|FG003|NOT COMPLETED|Placebo-controlled (Part A)||7||
59935187|NCT01986933|76053125|FG004|NOT COMPLETED|Placebo-controlled (Part A)||14||
59935188|NCT01986933|76053121|FG000|STARTED|Active-to-active (Part B)||0|Data from patients who were randomized to Nemoliozumab groups in Part A and initiated Part B were analyzed.|
59935189|NCT01986933|76053122|FG001|STARTED|Active-to-active (Part B)||41|Data from patients who were randomized to Nemoliozumab groups in Part A and initiated Part B were analyzed.|
59935190|NCT01986933|76053123|FG002|STARTED|Active-to-active (Part B)||38|Data from patients who were randomized to Nemoliozumab groups in Part A and initiated Part B were analyzed.|
59935191|NCT01986933|76053124|FG003|STARTED|Active-to-active (Part B)||39|Data from patients who were randomized to Nemoliozumab groups in Part A and initiated Part B were analyzed.|
59935192|NCT01986933|76053125|FG004|STARTED|Active-to-active (Part B)||35|Data from patients who were randomized to Nemoliozumab groups in Part A and initiated Part B were analyzed.|
59935193|NCT01986933|76053121|FG000|COMPLETED|Active-to-active (Part B)||0||
59935194|NCT01986933|76053122|FG001|COMPLETED|Active-to-active (Part B)||31||
59935195|NCT01986933|76053123|FG002|COMPLETED|Active-to-active (Part B)||28||
59935196|NCT01986933|76053124|FG003|COMPLETED|Active-to-active (Part B)||30||
59935197|NCT01986933|76053125|FG004|COMPLETED|Active-to-active (Part B)||19||
59935198|NCT01986933|76053121|FG000|NOT COMPLETED|Active-to-active (Part B)||0||
59935199|NCT01986933|76053122|FG001|NOT COMPLETED|Active-to-active (Part B)||10||
59935200|NCT01986933|76053123|FG002|NOT COMPLETED|Active-to-active (Part B)||10||
59935201|NCT01986933|76053124|FG003|NOT COMPLETED|Active-to-active (Part B)||9||
59935202|NCT01986933|76053125|FG004|NOT COMPLETED|Active-to-active (Part B)||16||
59935203|NCT01986933|76053121|FG000|STARTED|Placebo-to-active (Part B)||0|Data from patients who were randomized to placebo group in Part A and initiated Part B were analyzed.|
59935204|NCT01986933|76053122|FG001|STARTED|Placebo-to-active (Part B)|Patients in the initial placebo group were re-randomized into Nemoliozumab groups (0.1, 0.5 or 2.0 mg/kg Q4W) in Part B.|13|Data from patients who were randomized to placebo group in Part A and initiated Part B were analyzed.|
59935205|NCT01986933|76053123|FG002|STARTED|Placebo-to-active (Part B)|Patients in the initial placebo group were re-randomized into Nemoliozumab groups (0.1, 0.5 or 2.0 mg/kg Q4W) in Part B.|12|Data from patients who were randomized to placebo group in Part A and initiated Part B were analyzed.|
59935206|NCT01986933|76053124|FG003|STARTED|Placebo-to-active (Part B)|Patients in the initial placebo group were re-randomized into Nemoliozumab groups (0.1, 0.5 or 2.0 mg/kg Q4W) in Part B.|13|Data from patients who were randomized to placebo group in Part A and initiated Part B were analyzed.|
59935207|NCT01986933|76053125|FG004|STARTED|Placebo-to-active (Part B)|Patients in the initial placebo group were not re-randomized into Nemoliozumab (2.0 mg/kg) Q8W group in Part B.|0|Data from patients who were randomized to placebo group in Part A and initiated Part B were analyzed.|
59935208|NCT01986933|76053121|FG000|COMPLETED|Placebo-to-active (Part B)||0||
59935209|NCT01986933|76053122|FG001|COMPLETED|Placebo-to-active (Part B)||8||
59935210|NCT01986933|76053123|FG002|COMPLETED|Placebo-to-active (Part B)||7||
59935211|NCT01986933|76053124|FG003|COMPLETED|Placebo-to-active (Part B)||8||
59935212|NCT01986933|76053125|FG004|COMPLETED|Placebo-to-active (Part B)||0||
59935213|NCT01986933|76053121|FG000|NOT COMPLETED|Placebo-to-active (Part B)||0||
59935214|NCT01986933|76053122|FG001|NOT COMPLETED|Placebo-to-active (Part B)||5||
59935215|NCT01986933|76053123|FG002|NOT COMPLETED|Placebo-to-active (Part B)||5||
59935216|NCT01986933|76053124|FG003|NOT COMPLETED|Placebo-to-active (Part B)||5||
59935217|NCT01986933|76053125|FG004|NOT COMPLETED|Placebo-to-active (Part B)||0||
59935218|NCT01986075|76053147|FG000|STARTED|Initial CBT + CM (Pre-randomization)||0||
59935219|NCT01986075|76053148|FG001|STARTED|Initial CBT + CM (Pre-randomization)||0||
59935220|NCT01986075|76053149|FG002|STARTED|Initial CBT + CM (Pre-randomization)||145||
59935221|NCT01986075|76053147|FG000|COMPLETED|Initial CBT + CM (Pre-randomization)||0||
59935222|NCT01986075|76053148|FG001|COMPLETED|Initial CBT + CM (Pre-randomization)||0||
59935223|NCT01986075|76053149|FG002|COMPLETED|Initial CBT + CM (Pre-randomization)||86||
59935224|NCT01986075|76053147|FG000|NOT COMPLETED|Initial CBT + CM (Pre-randomization)||0||
59761770|NCT00879684|75881390|FG005|NOT COMPLETED|Stage 2: Expanded Cohort||0||
59761771|NCT00879684|75881391|FG006|NOT COMPLETED|Stage 2: Expanded Cohort||13||
59761772|NCT00581776|75881410|FG000|STARTED|Overall Study||30||
59761773|NCT00581776|75881410|FG000|COMPLETED|Overall Study|3 subjects did not complete the planned induction chemotherapy.|27||
59761774|NCT00581776|75881410|FG000|NOT COMPLETED|Overall Study||3||
59761775|NCT00883740|75881414|FG000|STARTED|First Intervention||60||
59935225|NCT01986075|76053148|FG001|NOT COMPLETED|Initial CBT + CM (Pre-randomization)||0||
59518365|NCT03369340|75612165|FG002|NOT COMPLETED|Day 2||0||
59518366|NCT03369340|75612166|FG003|NOT COMPLETED|Day 2||0||
59518367|NCT03369340|75612167|FG004|NOT COMPLETED|Day 2||0||
59518368|NCT03369340|75612168|FG005|NOT COMPLETED|Day 2||0||
59935226|NCT01986075|76053149|FG002|NOT COMPLETED|Initial CBT + CM (Pre-randomization)||59||
59935227|NCT01986075|76053147|FG000|STARTED|Randomized Intervention||45||
59935228|NCT01986075|76053148|FG001|STARTED|Randomized Intervention||41||
59935229|NCT01986075|76053149|FG002|STARTED|Randomized Intervention||0||
59935230|NCT01986075|76053147|FG000|COMPLETED|Randomized Intervention||30||
59935231|NCT01986075|76053148|FG001|COMPLETED|Randomized Intervention||27||
59935232|NCT01986075|76053149|FG002|COMPLETED|Randomized Intervention||0||
59935233|NCT01986075|76053147|FG000|NOT COMPLETED|Randomized Intervention||15||
59935234|NCT01986075|76053148|FG001|NOT COMPLETED|Randomized Intervention||14||
59935235|NCT01986075|76053149|FG002|NOT COMPLETED|Randomized Intervention||0||
59935236|NCT04753710|76053158|FG000|STARTED|Overall||67||
59935237|NCT04753710|76053159|FG001|STARTED|Overall||29||
59935238|NCT04753710|76053158|FG000|COMPLETED|Overall||67||
59935239|NCT04753710|76053159|FG001|COMPLETED|Overall||29||
59935240|NCT04753710|76053158|FG000|NOT COMPLETED|Overall||0||
59935241|NCT04753710|76053159|FG001|NOT COMPLETED|Overall||0||
59935242|NCT04753710|76053158|FG000|STARTED|First Phase||27||
59935243|NCT04753710|76053159|FG001|STARTED|First Phase||9||
59935244|NCT04753710|76053158|FG000|COMPLETED|First Phase||27||
59935245|NCT04753710|76053159|FG001|COMPLETED|First Phase||9||
59935246|NCT04753710|76053158|FG000|NOT COMPLETED|First Phase||0||
59935247|NCT04753710|76053159|FG001|NOT COMPLETED|First Phase||0||
59935248|NCT04753710|76053158|FG000|STARTED|Second Phase||40||
59935249|NCT04753710|76053159|FG001|STARTED|Second Phase||20||
59935250|NCT04753710|76053158|FG000|COMPLETED|Second Phase||40||
59935251|NCT04753710|76053159|FG001|COMPLETED|Second Phase||20||
59935252|NCT04753710|76053158|FG000|NOT COMPLETED|Second Phase||0||
59935253|NCT04753710|76053159|FG001|NOT COMPLETED|Second Phase||0||
59935254|NCT00394355|76053169|FG000|STARTED|Overall Study||140||
59935255|NCT00394355|76053170|FG001|STARTED|Overall Study||137||
59935256|NCT00394355|76053171|FG002|STARTED|Overall Study||147||
59935257|NCT00394355|76053172|FG003|STARTED|Overall Study||142||
59935258|NCT00394355|76053169|FG000|COMPLETED|Overall Study||105||
59935259|NCT00394355|76053170|FG001|COMPLETED|Overall Study||103||
59935260|NCT00394355|76053171|FG002|COMPLETED|Overall Study||109||
59935261|NCT00394355|76053172|FG003|COMPLETED|Overall Study||111||
59935262|NCT00394355|76053169|FG000|NOT COMPLETED|Overall Study||35||
59935263|NCT00394355|76053170|FG001|NOT COMPLETED|Overall Study||34||
59935264|NCT00394355|76053171|FG002|NOT COMPLETED|Overall Study||38||
59935265|NCT00394355|76053172|FG003|NOT COMPLETED|Overall Study||31||
59935266|NCT02797808|76053184|FG000|STARTED|Overall Study||23||
59935267|NCT02797808|76053185|FG001|STARTED|Overall Study||18||
59935268|NCT02797808|76053184|FG000|COMPLETED|Overall Study||16||
59935269|NCT02797808|76053185|FG001|COMPLETED|Overall Study||15||
59935270|NCT02797808|76053184|FG000|NOT COMPLETED|Overall Study||7||
59935271|NCT02797808|76053185|FG001|NOT COMPLETED|Overall Study||3||
59935272|NCT02796560|76053193|FG000|STARTED|Overall Study||38||
59935273|NCT02796560|76053194|FG001|STARTED|Overall Study||38||
59935274|NCT02796560|76053193|FG000|COMPLETED|Overall Study||34||
59935275|NCT02796560|76053194|FG001|COMPLETED|Overall Study||36||
59935276|NCT02796560|76053193|FG000|NOT COMPLETED|Overall Study||4||
59935277|NCT02796560|76053194|FG001|NOT COMPLETED|Overall Study||2||
59935278|NCT00344487|76053200|FG000|STARTED|Overall Study||3||
59935279|NCT00344487|76053200|FG000|COMPLETED|Overall Study|One subject was withdrawn at month 9 because he was considered an immunologic failure on study.|2||
59935280|NCT00344487|76053200|FG000|NOT COMPLETED|Overall Study||1||
59935281|NCT02871492|76053209|FG000|STARTED|Overall Study||73||
59935282|NCT02871492|76053210|FG001|STARTED|Overall Study||73||
59935283|NCT02871492|76053211|FG002|STARTED|Overall Study||77||
59935284|NCT02871492|76053209|FG000|COMPLETED|Overall Study||67||
59935285|NCT02871492|76053210|FG001|COMPLETED|Overall Study||70||
59935286|NCT02871492|76053211|FG002|COMPLETED|Overall Study||71||
59935287|NCT02871492|76053209|FG000|NOT COMPLETED|Overall Study||6||
59935288|NCT02871492|76053210|FG001|NOT COMPLETED|Overall Study||3||
59935289|NCT02871492|76053211|FG002|NOT COMPLETED|Overall Study||6||
60067362|NCT02093351|76182501|FG000|STARTED|Part B|Only the Olaparib (Part B) arm is applicable for this period.|0||
59518369|NCT03369340|75612163|FG000|STARTED|Day 3||3||
59518370|NCT03369340|75612164|FG001|STARTED|Day 3||3||
59518371|NCT03369340|75612165|FG002|STARTED|Day 3||3||
59935290|NCT03143855|76053221|FG000|STARTED|Overall Study||17||
59935291|NCT03143855|76053222|FG001|STARTED|Overall Study||10||
59935292|NCT03143855|76053221|FG000|COMPLETED|Overall Study||12||
59935293|NCT03143855|76053222|FG001|COMPLETED|Overall Study||6||
59935294|NCT03143855|76053221|FG000|NOT COMPLETED|Overall Study||5||
59935295|NCT03143855|76053222|FG001|NOT COMPLETED|Overall Study||4||
59935296|NCT02878603|76053230|FG000|STARTED|Overall Study||29||
59935297|NCT02878603|76053231|FG001|STARTED|Overall Study||75||
59518372|NCT03369340|75612166|FG003|STARTED|Day 3||3||
59935298|NCT02878603|76053230|FG000|COMPLETED|Overall Study||23||
59935299|NCT02878603|76053231|FG001|COMPLETED|Overall Study||70||
59935300|NCT02878603|76053230|FG000|NOT COMPLETED|Overall Study||6||
59935301|NCT02878603|76053231|FG001|NOT COMPLETED|Overall Study||5||
59935302|NCT01370408|76053237|FG000|STARTED|Overall Study||85||
59935303|NCT01370408|76053237|FG000|COMPLETED|Overall Study||76||
59935304|NCT01370408|76053237|FG000|NOT COMPLETED|Overall Study||9||
59935305|NCT03294109|76053243|FG000|STARTED|Overall Study||46||
59935306|NCT03294109|76053244|FG001|STARTED|Overall Study||57||
59935307|NCT03294109|76053243|FG000|Underwent Surgery|Overall Study||40||
59935308|NCT03294109|76053244|FG001|Underwent Surgery|Overall Study||52||
59935309|NCT03294109|76053243|FG000|COMPLETED|Overall Study||40||
59935310|NCT03294109|76053244|FG001|COMPLETED|Overall Study||52||
59935311|NCT03294109|76053243|FG000|NOT COMPLETED|Overall Study||6||
59935312|NCT03294109|76053244|FG001|NOT COMPLETED|Overall Study||5||
59935313|NCT03963011|76053253|FG000|STARTED|Overall Study||8||
59935314|NCT03963011|76053254|FG001|STARTED|Overall Study||6||
59935315|NCT03963011|76053253|FG000|COMPLETED|Overall Study||8||
59935316|NCT03963011|76053254|FG001|COMPLETED|Overall Study||6||
59935317|NCT03963011|76053253|FG000|NOT COMPLETED|Overall Study||0||
59935318|NCT03963011|76053254|FG001|NOT COMPLETED|Overall Study||0||
59935319|NCT03132805|76053263|FG000|STARTED|Overall Study||1629|Students and teachers enrolled within participating schools|16
59935320|NCT03132805|76053264|FG001|STARTED|Overall Study||1792|Students and teachers enrolled within participating schools|16
59935321|NCT03132805|76053265|FG002|STARTED|Overall Study||1812|Students and teachers enrolled within participating schools|16
59935322|NCT03132805|76053263|FG000|Students|Overall Study||1527||16
59935323|NCT03132805|76053264|FG001|Students|Overall Study||1694||16
59935324|NCT03132805|76053265|FG002|Students|Overall Study||1702||16
59935325|NCT03132805|76053263|FG000|Teachers|Overall Study||102||16
59935326|NCT03132805|76053264|FG001|Teachers|Overall Study||98||16
59935327|NCT03132805|76053265|FG002|Teachers|Overall Study||110||16
59935328|NCT03132805|76053263|FG000|Baseline Data Collection (Students)|Overall Study||1442||16
59935329|NCT03132805|76053264|FG001|Baseline Data Collection (Students)|Overall Study||1603||16
59935330|NCT03132805|76053265|FG002|Baseline Data Collection (Students)|Overall Study||1617||16
59935331|NCT03132805|76053263|FG000|Post-test Data Collection (Students)|Overall Study||1395||16
59935332|NCT03132805|76053264|FG001|Post-test Data Collection (Students)|Overall Study||1564||16
59935333|NCT03132805|76053265|FG002|Post-test Data Collection (Students)|Overall Study||1609||16
59935334|NCT03132805|76053263|FG000|Baseline Data Collection (Teachers)|Overall Study||102||16
59935335|NCT03132805|76053264|FG001|Baseline Data Collection (Teachers)|Overall Study||91||16
59935336|NCT03132805|76053265|FG002|Baseline Data Collection (Teachers)|Overall Study||99||16
59935337|NCT03132805|76053263|FG000|Post-test Data Collection (Teachers)|Overall Study||92||16
59935338|NCT03132805|76053264|FG001|Post-test Data Collection (Teachers)|Overall Study||87||16
59935339|NCT03132805|76053265|FG002|Post-test Data Collection (Teachers)|Overall Study||90||16
59935340|NCT03132805|76053263|FG000|COMPLETED|Overall Study||1487|Students and teachers enrolled within participating schools who were assessed at post-test|16
59935341|NCT03132805|76053264|FG001|COMPLETED|Overall Study||1651|Students and teachers enrolled within participating schools who were assessed at post-test|16
59935342|NCT03132805|76053265|FG002|COMPLETED|Overall Study||1699|Students and teachers enrolled within participating schools who were assessed at post-test|16
59935343|NCT03132805|76053263|FG000|NOT COMPLETED|Overall Study||142||0
59935344|NCT03132805|76053264|FG001|NOT COMPLETED|Overall Study||141||0
59935345|NCT03132805|76053265|FG002|NOT COMPLETED|Overall Study||113||0
59935346|NCT02793128|76053273|FG000|STARTED|Overall Study||71||
59935347|NCT02793128|76053273|FG000|COMPLETED|Overall Study||62||
59935348|NCT02793128|76053273|FG000|NOT COMPLETED|Overall Study||9||
59935349|NCT03142451|76053287|FG000|STARTED|Overall Study||495||
59935350|NCT03142451|76053288|FG001|STARTED|Overall Study||256||
59935351|NCT03142451|76053287|FG000|COMPLETED|Overall Study||437||
59935352|NCT03142451|76053288|FG001|COMPLETED|Overall Study||232||
59935353|NCT03142451|76053287|FG000|NOT COMPLETED|Overall Study||58||
59935354|NCT03142451|76053288|FG001|NOT COMPLETED|Overall Study||24||
59935355|NCT03141905|76053296|FG000|STARTED|Overall Study||176||
59935356|NCT03141905|76053297|FG001|STARTED|Overall Study||166||
59935357|NCT03141905|76053296|FG000|COMPLETED|Overall Study||152||
59935358|NCT03141905|76053297|FG001|COMPLETED|Overall Study||147||
59935359|NCT03141905|76053296|FG000|NOT COMPLETED|Overall Study||24||
59935360|NCT03141905|76053297|FG001|NOT COMPLETED|Overall Study||19||
59935361|NCT01370018|76053304|FG000|STARTED|Overall Study||4||
59935362|NCT01370018|76053304|FG000|COMPLETED|Overall Study||3||
59935363|NCT01370018|76053304|FG000|NOT COMPLETED|Overall Study||1||
59935364|NCT04034355|76053310|FG000|STARTED|Overall Study||151||
59935365|NCT04034355|76053311|FG001|STARTED|Overall Study||150||
59935366|NCT04034355|76053310|FG000|Treated|Overall Study||147||
59935367|NCT04034355|76053311|FG001|Treated|Overall Study||150||
59935368|NCT04034355|76053310|FG000|COMPLETED|Overall Study||117||
59935369|NCT04034355|76053311|FG001|COMPLETED|Overall Study||115||
59935370|NCT04034355|76053310|FG000|NOT COMPLETED|Overall Study||34||
59935371|NCT04034355|76053311|FG001|NOT COMPLETED|Overall Study||35||
59935372|NCT02304991|76053319|FG000|STARTED|Overall Study||25||
59935373|NCT02304991|76053320|FG001|STARTED|Overall Study||25||
59935374|NCT02304991|76053319|FG000|COMPLETED|Overall Study||18||
59935375|NCT02304991|76053320|FG001|COMPLETED|Overall Study||15||
59935376|NCT02304991|76053319|FG000|NOT COMPLETED|Overall Study||7||
59935377|NCT02304991|76053320|FG001|NOT COMPLETED|Overall Study||10||
59935378|NCT01336764|76053328|FG000|STARTED|Overall Study||12||
59935379|NCT01336764|76053329|FG001|STARTED|Overall Study||10||
59935380|NCT01336764|76053328|FG000|COMPLETED|Overall Study||7||
59935381|NCT01336764|76053329|FG001|COMPLETED|Overall Study||5||
59935382|NCT01336764|76053328|FG000|NOT COMPLETED|Overall Study||5||
59935383|NCT01336764|76053329|FG001|NOT COMPLETED|Overall Study||5||
59935384|NCT01336608|76053338|FG000|STARTED|2-week, Single-blind Run-In Period||559||
59935385|NCT01336608|76053339|FG001|STARTED|2-week, Single-blind Run-In Period||0||
59935386|NCT01336608|76053340|FG002|STARTED|2-week, Single-blind Run-In Period||0||
59935387|NCT01336608|76053341|FG003|STARTED|2-week, Single-blind Run-In Period||0||
59935388|NCT01336608|76053338|FG000|COMPLETED|2-week, Single-blind Run-In Period||444||
59935389|NCT01336608|76053339|FG001|COMPLETED|2-week, Single-blind Run-In Period||0||
59935390|NCT01336608|76053340|FG002|COMPLETED|2-week, Single-blind Run-In Period||0||
59935391|NCT01336608|76053341|FG003|COMPLETED|2-week, Single-blind Run-In Period||0||
59935392|NCT01336608|76053338|FG000|NOT COMPLETED|2-week, Single-blind Run-In Period||115||
59935393|NCT01336608|76053339|FG001|NOT COMPLETED|2-week, Single-blind Run-In Period||0||
59935394|NCT01336608|76053340|FG002|NOT COMPLETED|2-week, Single-blind Run-In Period||0||
59935395|NCT01336608|76053341|FG003|NOT COMPLETED|2-week, Single-blind Run-In Period||0||
59935396|NCT01336608|76053338|FG000|STARTED|24-week, Double-blind Treatment Period||0||
59935397|NCT01336608|76053339|FG001|STARTED|24-week, Double-blind Treatment Period||141||
59935398|NCT01336608|76053340|FG002|STARTED|24-week, Double-blind Treatment Period||154||
59935399|NCT01336608|76053341|FG003|STARTED|24-week, Double-blind Treatment Period||135||
59935400|NCT01336608|76053338|FG000|Completed the Treatment Period|24-week, Double-blind Treatment Period||0||
59935401|NCT01336608|76053339|FG001|Completed the Treatment Period|24-week, Double-blind Treatment Period|Par. were considered to have completed the TP if they attended Visit 6 (Week 24).|96||
59935402|NCT01336608|76053340|FG002|Completed the Treatment Period|24-week, Double-blind Treatment Period|Par. were considered to have completed the TP if they attended Visit 6 (Week 24).|124||
59935403|NCT01336608|76053341|FG003|Completed the Treatment Period|24-week, Double-blind Treatment Period|Par. were considered to have completed the TP if they attended Visit 6 (Week 24).|110||
59935404|NCT01336608|76053338|FG000|COMPLETED|24-week, Double-blind Treatment Period||0||
59935405|NCT01336608|76053339|FG001|COMPLETED|24-week, Double-blind Treatment Period|Par. completed study if attended Wk 24, had 1-wk follow-up contact and no early withdrawal.|97||
59935406|NCT01336608|76053340|FG002|COMPLETED|24-week, Double-blind Treatment Period|Par. completed study if attended Wk 24, had 1-wk follow-up contact and no early withdrawal.|124||
59935407|NCT01336608|76053341|FG003|COMPLETED|24-week, Double-blind Treatment Period|Par. completed study if attended Wk 24, had 1-wk follow-up contact and no early withdrawal.|111||
59935408|NCT01336608|76053338|FG000|NOT COMPLETED|24-week, Double-blind Treatment Period||0||
59935409|NCT01336608|76053339|FG001|NOT COMPLETED|24-week, Double-blind Treatment Period||44||
59935410|NCT01336608|76053340|FG002|NOT COMPLETED|24-week, Double-blind Treatment Period||30||
59935411|NCT01336608|76053341|FG003|NOT COMPLETED|24-week, Double-blind Treatment Period||24||
59935412|NCT03691727|76053351|FG000|STARTED|Overall Study||18||
59935413|NCT03691727|76053352|FG001|STARTED|Overall Study||12||
59935414|NCT03691727|76053351|FG000|COMPLETED|Overall Study||16||
59935415|NCT03691727|76053352|FG001|COMPLETED|Overall Study||11||
59935416|NCT03691727|76053351|FG000|NOT COMPLETED|Overall Study||2||
59935417|NCT03691727|76053352|FG001|NOT COMPLETED|Overall Study||1||
59935418|NCT01346371|76053360|FG000|STARTED|Overall Study||20||
59935419|NCT01346371|76053361|FG001|STARTED|Overall Study||20||
59935420|NCT01346371|76053360|FG000|COMPLETED|Overall Study||18||
59935421|NCT01346371|76053361|FG001|COMPLETED|Overall Study||20||
60067363|NCT02093351|76182502|FG001|STARTED|Part B|Only the Olaparib (Part B) arm is applicable for this period.|0||
59935422|NCT01346371|76053360|FG000|NOT COMPLETED|Overall Study||2||
59935423|NCT01346371|76053361|FG001|NOT COMPLETED|Overall Study||0||
59935424|NCT03672227|76053369|FG000|STARTED|Overall Study||112||
60067364|NCT02093351|76182503|FG002|STARTED|Part B|Only the Olaparib (Part B) arm is applicable for this period.|0||
60067365|NCT02093351|76182504|FG003|STARTED|Part B|Eligible patients completing Part A entered Part B for continued access to olaparib.|69||
60067366|NCT02093351|76182501|FG000|COMPLETED|Part B||0||
60067367|NCT02093351|76182502|FG001|COMPLETED|Part B||0||
59935425|NCT03672227|76053370|FG001|STARTED|Overall Study||52||
59935426|NCT03672227|76053369|FG000|Teachers Started|Overall Study||8||
59935427|NCT03672227|76053370|FG001|Teachers Started|Overall Study||6||
59935428|NCT03672227|76053369|FG000|Children Started|Overall Study||52||
59935429|NCT03672227|76053370|FG001|Children Started|Overall Study||23||
59935430|NCT03672227|76053369|FG000|Parents Started|Overall Study||52||
59935431|NCT03672227|76053370|FG001|Parents Started|Overall Study||23||
59935432|NCT03672227|76053369|FG000|COMPLETED|Overall Study||105||
59935433|NCT03672227|76053370|FG001|COMPLETED|Overall Study||52||
59935434|NCT03672227|76053369|FG000|NOT COMPLETED|Overall Study||7||
59935435|NCT03672227|76053370|FG001|NOT COMPLETED|Overall Study||0||
59935436|NCT03644849|76053379|FG000|STARTED|Overall Study||24||
59935437|NCT03644849|76053380|FG001|STARTED|Overall Study||24||
59935438|NCT03644849|76053379|FG000|COMPLETED|Overall Study||23||
59935439|NCT03644849|76053380|FG001|COMPLETED|Overall Study||21||
59935440|NCT03644849|76053379|FG000|NOT COMPLETED|Overall Study||1||
59935441|NCT03644849|76053380|FG001|NOT COMPLETED|Overall Study||3||
59935442|NCT03131479|76053391|FG000|STARTED|Overall Study||10||
59935443|NCT03131479|76053392|FG001|STARTED|Overall Study||10||
59935444|NCT03131479|76053393|FG002|STARTED|Overall Study||11||
59935445|NCT03131479|76053394|FG003|STARTED|Overall Study||12||
59935446|NCT03131479|76053395|FG004|STARTED|Overall Study||10||
59935447|NCT03131479|76053391|FG000|Safety Analysis Set (SS)|Overall Study||10|All subjects that received study drug|
59935448|NCT03131479|76053392|FG001|Safety Analysis Set (SS)|Overall Study||10|All subjects that received study drug|
59935449|NCT03131479|76053393|FG002|Safety Analysis Set (SS)|Overall Study||11|All subjects that received study drug|
59935450|NCT03131479|76053394|FG003|Safety Analysis Set (SS)|Overall Study||12|All subjects that received study drug|
59935451|NCT03131479|76053395|FG004|Safety Analysis Set (SS)|Overall Study||10|All subjects that received study drug|
59935452|NCT03131479|76053391|FG000|Pharmacokinetic Analysis Set (PAS)|Overall Study||10|At least one dose of study drug and had at least 1 valid PK concentration measurement|
59935453|NCT03131479|76053392|FG001|Pharmacokinetic Analysis Set (PAS)|Overall Study||10|At least one dose of study drug and had at least 1 valid PK concentration measurement|
59935454|NCT03131479|76053393|FG002|Pharmacokinetic Analysis Set (PAS)|Overall Study||11|At least one dose of study drug and had at least 1 valid PK concentration measurement|
59935455|NCT03131479|76053394|FG003|Pharmacokinetic Analysis Set (PAS)|Overall Study||12|At least one dose of study drug and had at least 1 valid PK concentration measurement|
59935456|NCT03131479|76053395|FG004|Pharmacokinetic Analysis Set (PAS)|Overall Study||10|At least one dose of study drug and had at least 1 valid PK concentration measurement|
59935457|NCT03131479|76053391|FG000|Pharcodynamic Analysis Set (PD)|Overall Study||10|At least one dose of study drug and had at least 1 valid post baseline PD|
59935458|NCT03131479|76053392|FG001|Pharcodynamic Analysis Set (PD)|Overall Study||10|At least one dose of study drug and had at least 1 valid post baseline PD|
59935459|NCT03131479|76053393|FG002|Pharcodynamic Analysis Set (PD)|Overall Study||11|At least one dose of study drug and had at least 1 valid post baseline PD|
59935460|NCT03131479|76053394|FG003|Pharcodynamic Analysis Set (PD)|Overall Study||12|At least one dose of study drug and had at least 1 valid post baseline PD|
59935461|NCT03131479|76053395|FG004|Pharcodynamic Analysis Set (PD)|Overall Study||10|At least one dose of study drug and had at least 1 valid post baseline PD|
59935462|NCT03131479|76053391|FG000|COMPLETED|Overall Study||10||
59935463|NCT03131479|76053392|FG001|COMPLETED|Overall Study||10||
59935464|NCT03131479|76053393|FG002|COMPLETED|Overall Study||10||
59935465|NCT03131479|76053394|FG003|COMPLETED|Overall Study||10||
59935466|NCT03131479|76053395|FG004|COMPLETED|Overall Study||10||
59935467|NCT03131479|76053391|FG000|NOT COMPLETED|Overall Study||0||
59935468|NCT03131479|76053392|FG001|NOT COMPLETED|Overall Study||0||
59935469|NCT03131479|76053393|FG002|NOT COMPLETED|Overall Study||1||
59935470|NCT03131479|76053394|FG003|NOT COMPLETED|Overall Study||2||
59935471|NCT03131479|76053395|FG004|NOT COMPLETED|Overall Study||0||
59935472|NCT03602885|76053409|FG000|STARTED|Overall Study||5||
59935473|NCT03602885|76053410|FG001|STARTED|Overall Study||5||
59935474|NCT03602885|76053409|FG000|COMPLETED|Overall Study||2|Early closure for failure to accrue|
59935475|NCT03602885|76053410|FG001|COMPLETED|Overall Study||5|Early closure for failure to accrue|
59935476|NCT03602885|76053409|FG000|NOT COMPLETED|Overall Study||3||
59935477|NCT03602885|76053410|FG001|NOT COMPLETED|Overall Study||0||
59935478|NCT02880761|76053418|FG000|STARTED|Overall Study||103||
59935479|NCT02880761|76053419|FG001|STARTED|Overall Study||106||
59935480|NCT02880761|76053418|FG000|COMPLETED|Overall Study||87||
59935481|NCT02880761|76053419|FG001|COMPLETED|Overall Study||85||
59935482|NCT02880761|76053418|FG000|NOT COMPLETED|Overall Study||16||
59935483|NCT02880761|76053419|FG001|NOT COMPLETED|Overall Study||21||
59935484|NCT02930941|76053427|FG000|STARTED|Overall Study||17||
59935485|NCT02930941|76053428|FG001|STARTED|Overall Study||18||
59935486|NCT02930941|76053427|FG000|COMPLETED|Overall Study||16||
60067368|NCT02093351|76182503|FG002|COMPLETED|Part B||0||
60067369|NCT02093351|76182504|FG003|COMPLETED|Part B||6||
60067370|NCT02093351|76182501|FG000|NOT COMPLETED|Part B||0||
60067371|NCT02093351|76182502|FG001|NOT COMPLETED|Part B||0||
60067372|NCT02093351|76182503|FG002|NOT COMPLETED|Part B||0||
60067373|NCT02093351|76182504|FG003|NOT COMPLETED|Part B||63||
60067374|NCT02078284|76182524|FG000|STARTED|Overall Study||5||
60067375|NCT02078284|76182525|FG001|STARTED|Overall Study||7||
59935487|NCT02930941|76053428|FG001|COMPLETED|Overall Study||16||
59935488|NCT02930941|76053427|FG000|NOT COMPLETED|Overall Study||1||
59935489|NCT02930941|76053428|FG001|NOT COMPLETED|Overall Study||2||
59935490|NCT03137537|76053440|FG000|STARTED|Overall Study||12||
59935491|NCT03137537|76053441|FG001|STARTED|Overall Study||11||
59935492|NCT03137537|76053440|FG000|COMPLETED|Overall Study||12||
60067376|NCT02078284|76182526|FG002|STARTED|Overall Study||6||
60067377|NCT02078284|76182527|FG003|STARTED|Overall Study||6||
60067378|NCT02078284|76182528|FG004|STARTED|Overall Study||4||
60067379|NCT02078284|76182524|FG000|COMPLETED|Overall Study||5||
60067380|NCT02078284|76182525|FG001|COMPLETED|Overall Study||7||
60067381|NCT02078284|76182526|FG002|COMPLETED|Overall Study||6||
59935493|NCT03137537|76053441|FG001|COMPLETED|Overall Study||10||
59935494|NCT03137537|76053440|FG000|NOT COMPLETED|Overall Study||0||
59935495|NCT03137537|76053441|FG001|NOT COMPLETED|Overall Study||1||
59935496|NCT03137459|76053449|FG000|STARTED|2-month Assessment||455||
59935497|NCT03137459|76053450|FG001|STARTED|2-month Assessment||454||
59935498|NCT03137459|76053449|FG000|COMPLETED|2-month Assessment||387||
59935499|NCT03137459|76053450|FG001|COMPLETED|2-month Assessment||412||
59935500|NCT03137459|76053449|FG000|NOT COMPLETED|2-month Assessment||68||
59935501|NCT03137459|76053450|FG001|NOT COMPLETED|2-month Assessment||42||
59935502|NCT03137459|76053449|FG000|STARTED|4-month Assessment||442||
59935503|NCT03137459|76053450|FG001|STARTED|4-month Assessment||451||
59935504|NCT03137459|76053449|FG000|COMPLETED|4-month Assessment||364||
59935505|NCT03137459|76053450|FG001|COMPLETED|4-month Assessment||405||
59935506|NCT03137459|76053449|FG000|NOT COMPLETED|4-month Assessment||78||
59935507|NCT03137459|76053450|FG001|NOT COMPLETED|4-month Assessment||46||
59935508|NCT03137459|76053449|FG000|STARTED|6-months||434||
59935509|NCT03137459|76053450|FG001|STARTED|6-months||447||
59935510|NCT03137459|76053449|FG000|COMPLETED|6-months||413||
59935511|NCT03137459|76053450|FG001|COMPLETED|6-months||430||
59935512|NCT03137459|76053449|FG000|NOT COMPLETED|6-months||21||
59935513|NCT03137459|76053450|FG001|NOT COMPLETED|6-months||17||
59935514|NCT03131713|76053459|FG000|STARTED|Overall Study||50||
59935515|NCT03131713|76053460|FG001|STARTED|Overall Study|1 intervention subject was added on after the protocol was initiated.|51||
59935516|NCT03131713|76053459|FG000|COMPLETED|Overall Study||45||
59935517|NCT03131713|76053460|FG001|COMPLETED|Overall Study||51||
59935518|NCT03131713|76053459|FG000|NOT COMPLETED|Overall Study||5||
59935519|NCT03131713|76053460|FG001|NOT COMPLETED|Overall Study||0||
59935520|NCT02930005|76053468|FG000|STARTED|Overall Study||2||
59935521|NCT02930005|76053469|FG001|STARTED|Overall Study||6||
59935522|NCT02930005|76053468|FG000|Completed 2 Weeks|Overall Study||2||
59935523|NCT02930005|76053469|FG001|Completed 2 Weeks|Overall Study||2||
59935524|NCT02930005|76053468|FG000|COMPLETED|Overall Study||1|Completed the 8 week study|
59935525|NCT02930005|76053469|FG001|COMPLETED|Overall Study||1|Completed the 8 week study|
59935526|NCT02930005|76053468|FG000|NOT COMPLETED|Overall Study||1||
59935527|NCT02930005|76053469|FG001|NOT COMPLETED|Overall Study||5||
59935528|NCT03637491|76053479|FG000|STARTED|Overall Study||10||
59935529|NCT03637491|76053480|FG001|STARTED|Overall Study||12||
59935530|NCT03637491|76053481|FG002|STARTED|Overall Study||7||
59935531|NCT03637491|76053482|FG003|STARTED|Overall Study||6||
59935532|NCT03637491|76053479|FG000|Received Treatment|Overall Study||10||
59935533|NCT03637491|76053480|FG001|Received Treatment|Overall Study||12||
59935534|NCT03637491|76053481|FG002|Received Treatment|Overall Study||7||
59935535|NCT03637491|76053482|FG003|Received Treatment|Overall Study||6||
59935536|NCT03637491|76053479|FG000|COMPLETED|Overall Study||0||
59935537|NCT03637491|76053480|FG001|COMPLETED|Overall Study||0||
59935538|NCT03637491|76053481|FG002|COMPLETED|Overall Study||0||
59935539|NCT03637491|76053482|FG003|COMPLETED|Overall Study||0||
59935540|NCT03637491|76053479|FG000|NOT COMPLETED|Overall Study||10||
59935541|NCT03637491|76053480|FG001|NOT COMPLETED|Overall Study||12||
59935542|NCT03637491|76053481|FG002|NOT COMPLETED|Overall Study||7||
59935543|NCT03637491|76053482|FG003|NOT COMPLETED|Overall Study||6||
59935544|NCT03040661|76053497|FG000|STARTED|Overall Study||35||
59935545|NCT03040661|76053498|FG001|STARTED|Overall Study||35||
59935546|NCT03040661|76053497|FG000|COMPLETED|Overall Study||35||
59935547|NCT03040661|76053498|FG001|COMPLETED|Overall Study||35||
59935548|NCT03040661|76053497|FG000|NOT COMPLETED|Overall Study||0||
59935549|NCT03040661|76053498|FG001|NOT COMPLETED|Overall Study||0||
59935550|NCT01733147|76053506|FG000|STARTED|Overall Study||30||
59935551|NCT01733147|76053507|FG001|STARTED|Overall Study||30||
59935552|NCT01733147|76053506|FG000|COMPLETED|Overall Study||30||
59935553|NCT01733147|76053507|FG001|COMPLETED|Overall Study||30||
59935554|NCT01733147|76053506|FG000|NOT COMPLETED|Overall Study||0||
59935555|NCT01733147|76053507|FG001|NOT COMPLETED|Overall Study||0||
59935556|NCT03334539|76053516|FG000|STARTED|Overall Study||50||
59935557|NCT03334539|76053517|FG001|STARTED|Overall Study||50||
59935558|NCT03334539|76053518|FG002|STARTED|Overall Study||50||
59935559|NCT03334539|76053516|FG000|COMPLETED|Overall Study||46||
59935560|NCT03334539|76053517|FG001|COMPLETED|Overall Study||43||
59935561|NCT03334539|76053518|FG002|COMPLETED|Overall Study||49||
59935562|NCT03334539|76053516|FG000|NOT COMPLETED|Overall Study||4||
59935563|NCT03334539|76053517|FG001|NOT COMPLETED|Overall Study||7||
59935564|NCT03334539|76053518|FG002|NOT COMPLETED|Overall Study||1||
59935565|NCT03137303|76053533|FG000|STARTED|T0: Time of Enrollment - Baseline Visit||231||
59935566|NCT03137303|76053534|FG001|STARTED|T0: Time of Enrollment - Baseline Visit||171||
59935567|NCT03137303|76053533|FG000|COMPLETED|T0: Time of Enrollment - Baseline Visit||231||
59935568|NCT03137303|76053534|FG001|COMPLETED|T0: Time of Enrollment - Baseline Visit||171||
59935569|NCT03137303|76053533|FG000|NOT COMPLETED|T0: Time of Enrollment - Baseline Visit||0||
59935570|NCT03137303|76053534|FG001|NOT COMPLETED|T0: Time of Enrollment - Baseline Visit||0||
59935571|NCT03137303|76053533|FG000|STARTED|T1: 3-month Follow-up||231||
59935572|NCT03137303|76053534|FG001|STARTED|T1: 3-month Follow-up||171||
59935573|NCT03137303|76053533|FG000|COMPLETED|T1: 3-month Follow-up||225||
59935574|NCT03137303|76053534|FG001|COMPLETED|T1: 3-month Follow-up||161||
59935575|NCT03137303|76053533|FG000|NOT COMPLETED|T1: 3-month Follow-up||6||
59935576|NCT03137303|76053534|FG001|NOT COMPLETED|T1: 3-month Follow-up||10||
59935577|NCT03137303|76053533|FG000|STARTED|T2: 6-month Follow-up||230||
59935578|NCT03137303|76053534|FG001|STARTED|T2: 6-month Follow-up||167||
59935579|NCT03137303|76053533|FG000|COMPLETED|T2: 6-month Follow-up||225||
59935580|NCT03137303|76053534|FG001|COMPLETED|T2: 6-month Follow-up||162||
59935581|NCT03137303|76053533|FG000|NOT COMPLETED|T2: 6-month Follow-up||5||
59935582|NCT03137303|76053534|FG001|NOT COMPLETED|T2: 6-month Follow-up||5||
59935583|NCT03137303|76053533|FG000|STARTED|T3: 9-month Follow-up||230||
59935584|NCT03137303|76053534|FG001|STARTED|T3: 9-month Follow-up||167||
59935585|NCT03137303|76053533|FG000|COMPLETED|T3: 9-month Follow-up||225||
59935586|NCT03137303|76053534|FG001|COMPLETED|T3: 9-month Follow-up||163||
59935587|NCT03137303|76053533|FG000|NOT COMPLETED|T3: 9-month Follow-up||5||
59935588|NCT03137303|76053534|FG001|NOT COMPLETED|T3: 9-month Follow-up||4||
59935589|NCT03137303|76053533|FG000|STARTED|T4: 12-month Follow-up||229||
59935590|NCT03137303|76053534|FG001|STARTED|T4: 12-month Follow-up||167||
59935591|NCT03137303|76053533|FG000|COMPLETED|T4: 12-month Follow-up||222||
59935592|NCT03137303|76053534|FG001|COMPLETED|T4: 12-month Follow-up||162||
59935593|NCT03137303|76053533|FG000|NOT COMPLETED|T4: 12-month Follow-up||7||
59935594|NCT03137303|76053534|FG001|NOT COMPLETED|T4: 12-month Follow-up||5||
59935595|NCT03296553|76053542|FG000|STARTED|Overall Study||20||
59935596|NCT03296553|76053543|FG001|STARTED|Overall Study||20||
59935597|NCT03296553|76053542|FG000|COMPLETED|Overall Study||18||
59935598|NCT03296553|76053543|FG001|COMPLETED|Overall Study||19||
59935599|NCT03296553|76053542|FG000|NOT COMPLETED|Overall Study||2||
59935600|NCT03296553|76053543|FG001|NOT COMPLETED|Overall Study||1||
59935601|NCT03131167|76053562|FG000|STARTED|Overall Study||6||
59935602|NCT03131167|76053563|FG001|STARTED|Overall Study||5||
59935603|NCT03131167|76053564|FG002|STARTED|Overall Study||5||
59935604|NCT03131167|76053565|FG003|STARTED|Overall Study||5||
59935605|NCT03131167|76053566|FG004|STARTED|Overall Study||6||
59935606|NCT03131167|76053567|FG005|STARTED|Overall Study||5||
59935607|NCT03131167|76053568|FG006|STARTED|Overall Study||5||
59935608|NCT03131167|76053569|FG007|STARTED|Overall Study||5||
59935609|NCT03131167|76053570|FG008|STARTED|Overall Study||2||
59935610|NCT03131167|76053571|FG009|STARTED|Overall Study||5||
59935611|NCT03131167|76053572|FG010|STARTED|Overall Study||4||
59935612|NCT03131167|76053573|FG011|STARTED|Overall Study||5||
59935613|NCT03131167|76053574|FG012|STARTED|Overall Study||5||
59935614|NCT03131167|76053562|FG000|COMPLETED|Overall Study||6||
59935615|NCT03131167|76053563|FG001|COMPLETED|Overall Study||5||
59935616|NCT03131167|76053564|FG002|COMPLETED|Overall Study||5||
59935617|NCT03131167|76053565|FG003|COMPLETED|Overall Study||5||
59935618|NCT03131167|76053566|FG004|COMPLETED|Overall Study||6||
59935619|NCT03131167|76053567|FG005|COMPLETED|Overall Study||4||
59935620|NCT03131167|76053568|FG006|COMPLETED|Overall Study||5||
59935621|NCT03131167|76053569|FG007|COMPLETED|Overall Study||5||
59935622|NCT03131167|76053570|FG008|COMPLETED|Overall Study||2||
59935623|NCT03131167|76053571|FG009|COMPLETED|Overall Study||5||
59935624|NCT03131167|76053572|FG010|COMPLETED|Overall Study||4||
59935625|NCT03131167|76053573|FG011|COMPLETED|Overall Study||5||
59935626|NCT03131167|76053574|FG012|COMPLETED|Overall Study||5||
59935627|NCT03131167|76053562|FG000|NOT COMPLETED|Overall Study||0||
59935628|NCT03131167|76053563|FG001|NOT COMPLETED|Overall Study||0||
59761776|NCT00883740|75881415|FG001|STARTED|First Intervention||59||
59761777|NCT00883740|75881414|FG000|COMPLETED|First Intervention|1 participant not crossed to period 2 but continued on period 1, sponsor terminated as noncompliance|53||
59761778|NCT00883740|75881415|FG001|COMPLETED|First Intervention||51||
59761779|NCT00883740|75881414|FG000|NOT COMPLETED|First Intervention||7||
59761780|NCT00883740|75881415|FG001|NOT COMPLETED|First Intervention||8||
59762622|NCT00531427|75882453|FG000|COMPLETED|Overall Study||209||
59762623|NCT00531427|75882454|FG001|COMPLETED|Overall Study||191||
59935629|NCT03131167|76053564|FG002|NOT COMPLETED|Overall Study||0||
59935630|NCT03131167|76053565|FG003|NOT COMPLETED|Overall Study||0||
59935631|NCT03131167|76053566|FG004|NOT COMPLETED|Overall Study||0||
59935632|NCT03131167|76053567|FG005|NOT COMPLETED|Overall Study||1||
59935633|NCT03131167|76053568|FG006|NOT COMPLETED|Overall Study||0||
59935634|NCT03131167|76053569|FG007|NOT COMPLETED|Overall Study||0||
59935635|NCT03131167|76053570|FG008|NOT COMPLETED|Overall Study||0||
59935636|NCT03131167|76053571|FG009|NOT COMPLETED|Overall Study||0||
59935637|NCT03131167|76053572|FG010|NOT COMPLETED|Overall Study||0||
59935638|NCT03131167|76053573|FG011|NOT COMPLETED|Overall Study||0||
59935639|NCT03131167|76053574|FG012|NOT COMPLETED|Overall Study||0||
59935640|NCT03060447|76053605|FG000|STARTED|Overall Study||17||
59935641|NCT03060447|76053606|FG001|STARTED|Overall Study||8||
59935642|NCT03060447|76053605|FG000|COMPLETED|Overall Study||15||
59935643|NCT03060447|76053606|FG001|COMPLETED|Overall Study||8||
59935644|NCT03060447|76053605|FG000|NOT COMPLETED|Overall Study||2||
59935645|NCT03060447|76053606|FG001|NOT COMPLETED|Overall Study||0||
59935646|NCT01712789|76053618|FG000|STARTED|Overall Study||682||
59935647|NCT01712789|76053618|FG000|Received Study Treatment|Overall Study||676||
59935648|NCT01712789|76053618|FG000|COMPLETED|Overall Study||0|"Completed = did not discontinue treatment~Note: Reason for Not Completed below equates to Reason for Treatment Discontinuation"|
59935649|NCT01712789|76053618|FG000|NOT COMPLETED|Overall Study||682||
59935650|NCT03074318|76053626|FG000|STARTED|Overall Study||6||
59935651|NCT03074318|76053627|FG001|STARTED|Overall Study||7||
59935652|NCT03074318|76053628|FG002|STARTED|Overall Study||6||
59935653|NCT03074318|76053629|FG003|STARTED|Overall Study||16||
59935654|NCT03074318|76053626|FG000|COMPLETED|Overall Study||2||
59935655|NCT03074318|76053627|FG001|COMPLETED|Overall Study||2||
59935656|NCT03074318|76053628|FG002|COMPLETED|Overall Study||0||
59935657|NCT03074318|76053629|FG003|COMPLETED|Overall Study||0||
59935658|NCT03074318|76053626|FG000|NOT COMPLETED|Overall Study||4||
59935659|NCT03074318|76053627|FG001|NOT COMPLETED|Overall Study||5||
59935660|NCT03074318|76053628|FG002|NOT COMPLETED|Overall Study||6||
59935661|NCT03074318|76053629|FG003|NOT COMPLETED|Overall Study||16||
59935662|NCT03135119|76053650|FG000|STARTED|Overall Study||16||
59935663|NCT03135119|76053651|FG001|STARTED|Overall Study||17||
59935664|NCT03135119|76053650|FG000|COMPLETED|Overall Study||11||
59935665|NCT03135119|76053651|FG001|COMPLETED|Overall Study||14||
59935666|NCT03135119|76053650|FG000|NOT COMPLETED|Overall Study||5||
59935667|NCT03135119|76053651|FG001|NOT COMPLETED|Overall Study||3||
59935668|NCT01369784|76053657|FG000|STARTED|Overall Study||158||
59935669|NCT01369784|76053657|FG000|COMPLETED|Overall Study||146||
59935670|NCT01369784|76053657|FG000|NOT COMPLETED|Overall Study||12||
59935671|NCT03353675|76053661|FG000|STARTED|Overall Study||44||
59935672|NCT03353675|76053661|FG000|COMPLETED|Overall Study||40||
59935673|NCT03353675|76053661|FG000|NOT COMPLETED|Overall Study||4||
59935674|NCT03137069|76053671|FG000|STARTED|Overall Study||13||
59935675|NCT03137069|76053672|FG001|STARTED|Overall Study||28||
59935676|NCT03137069|76053673|FG002|STARTED|Overall Study||23||
59935677|NCT03137069|76053674|FG003|STARTED|Overall Study||23||
59935678|NCT03137069|76053675|FG004|STARTED|Overall Study||24||
59935679|NCT03137069|76053676|FG005|STARTED|Overall Study||23||
59935680|NCT03137069|76053671|FG000|COMPLETED|Overall Study||12||
59935681|NCT03137069|76053672|FG001|COMPLETED|Overall Study||22||
59935682|NCT03137069|76053673|FG002|COMPLETED|Overall Study||20||
59935683|NCT03137069|76053674|FG003|COMPLETED|Overall Study||17||
59935684|NCT03137069|76053675|FG004|COMPLETED|Overall Study||22||
59935685|NCT03137069|76053676|FG005|COMPLETED|Overall Study||21||
59935686|NCT03137069|76053671|FG000|NOT COMPLETED|Overall Study||1||
59935687|NCT03137069|76053672|FG001|NOT COMPLETED|Overall Study||6||
59935688|NCT03137069|76053673|FG002|NOT COMPLETED|Overall Study||3||
59935689|NCT03137069|76053674|FG003|NOT COMPLETED|Overall Study||6||
59935690|NCT03137069|76053675|FG004|NOT COMPLETED|Overall Study||2||
59935691|NCT03137069|76053676|FG005|NOT COMPLETED|Overall Study||2||
59935692|NCT02792504|76053694|FG000|STARTED|Overall Study||669||
59935693|NCT02792504|76053694|FG000|Safety Analysis Set|Overall Study||639||
59935694|NCT02792504|76053694|FG000|Efficacy Analysis Set|Overall Study||390||
59935695|NCT02792504|76053694|FG000|COMPLETED|Overall Study||639||
59935696|NCT02792504|76053694|FG000|NOT COMPLETED|Overall Study||30||
59935697|NCT03124459|76053704|FG000|STARTED|Part 1-Open Label Dose Escalation||6|Participants in the Part 2 double-blind placebo controlled portion of the study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study.|
59935698|NCT03124459|76053705|FG001|STARTED|Part 1-Open Label Dose Escalation||6|Participants in the Part 2 double-blind placebo controlled portion of the study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study.|
59935699|NCT03124459|76053706|FG002|STARTED|Part 1-Open Label Dose Escalation||6|Participants in the Part 2 double-blind placebo controlled portion of the study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study.|
59935700|NCT03124459|76053707|FG003|STARTED|Part 1-Open Label Dose Escalation|Patients in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study.|0|Participants in the Part 2 double-blind placebo controlled portion of the study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study.|
59935701|NCT03124459|76053708|FG004|STARTED|Part 1-Open Label Dose Escalation|Patients in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study.|0|Participants in the Part 2 double-blind placebo controlled portion of the study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study.|
59935702|NCT03124459|76053709|FG005|STARTED|Part 1-Open Label Dose Escalation|Patients in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study. Participants that completed the double-blind portion of the study then moved into this Part 2 open-label portion of the study.|0|Participants in the Part 2 double-blind placebo controlled portion of the study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study.|
59935703|NCT03124459|76053704|FG000|COMPLETED|Part 1-Open Label Dose Escalation||6||
59935704|NCT03124459|76053705|FG001|COMPLETED|Part 1-Open Label Dose Escalation||6||
59935705|NCT03124459|76053706|FG002|COMPLETED|Part 1-Open Label Dose Escalation||6||
59935706|NCT03124459|76053707|FG003|COMPLETED|Part 1-Open Label Dose Escalation|Patients in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study.|0||
60067382|NCT02078284|76182527|FG003|COMPLETED|Overall Study||6||
60067383|NCT02078284|76182528|FG004|COMPLETED|Overall Study||4||
60067384|NCT02078284|76182524|FG000|NOT COMPLETED|Overall Study||0||
60067385|NCT02078284|76182525|FG001|NOT COMPLETED|Overall Study||0||
60067386|NCT02078284|76182526|FG002|NOT COMPLETED|Overall Study||0||
59935707|NCT03124459|76053708|FG004|COMPLETED|Part 1-Open Label Dose Escalation|Patients in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study.|0||
59935708|NCT03124459|76053709|FG005|COMPLETED|Part 1-Open Label Dose Escalation|Patients in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study. Participants that completed the double-blind portion of the study then moved into this Part 2 open-label portion of the study.|0||
59935709|NCT03124459|76053704|FG000|NOT COMPLETED|Part 1-Open Label Dose Escalation||0||
59935710|NCT03124459|76053705|FG001|NOT COMPLETED|Part 1-Open Label Dose Escalation||0||
59935711|NCT03124459|76053706|FG002|NOT COMPLETED|Part 1-Open Label Dose Escalation||0||
59935712|NCT03124459|76053707|FG003|NOT COMPLETED|Part 1-Open Label Dose Escalation||0||
59935713|NCT03124459|76053708|FG004|NOT COMPLETED|Part 1-Open Label Dose Escalation||0||
59935714|NCT03124459|76053709|FG005|NOT COMPLETED|Part 1-Open Label Dose Escalation||0||
59935715|NCT03124459|76053704|FG000|STARTED|Phase 2- Randomized Doubled-blind|Participants in Part 1 Open-Label Dose escalation portion of the study were not the same participants that participated in the double-blind placebo controlled study.|0|Participants in Part 1 Open-Label Dose escalation portion of the study were not the same participants that participated in the double-blind placebo controlled study.|
59935716|NCT03124459|76053705|FG001|STARTED|Phase 2- Randomized Doubled-blind|Participants in Part 1 Open-Label Dose escalation portion of the study were not the same participants that participated in the double-blind placebo controlled study.|0|Participants in Part 1 Open-Label Dose escalation portion of the study were not the same participants that participated in the double-blind placebo controlled study.|
59935717|NCT03124459|76053706|FG002|STARTED|Phase 2- Randomized Doubled-blind|Participants in Part 1 Open-Label Dose escalation portion of the study were not the same participants that participated in the double-blind placebo controlled study.|0|Participants in Part 1 Open-Label Dose escalation portion of the study were not the same participants that participated in the double-blind placebo controlled study.|
59935718|NCT03124459|76053707|FG003|STARTED|Phase 2- Randomized Doubled-blind|Participants in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study.|21|Participants in Part 1 Open-Label Dose escalation portion of the study were not the same participants that participated in the double-blind placebo controlled study.|
59935719|NCT03124459|76053708|FG004|STARTED|Phase 2- Randomized Doubled-blind|Participants in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study.|24|Participants in Part 1 Open-Label Dose escalation portion of the study were not the same participants that participated in the double-blind placebo controlled study.|
59935720|NCT03124459|76053709|FG005|STARTED|Phase 2- Randomized Doubled-blind|Participants in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study. Participants that completed the double-blind portion of the study then moved into this Part 2 open-label portion of the study.|0|Participants in Part 1 Open-Label Dose escalation portion of the study were not the same participants that participated in the double-blind placebo controlled study.|
59935721|NCT03124459|76053704|FG000|COMPLETED|Phase 2- Randomized Doubled-blind||0||
59935722|NCT03124459|76053705|FG001|COMPLETED|Phase 2- Randomized Doubled-blind||0||
59935723|NCT03124459|76053706|FG002|COMPLETED|Phase 2- Randomized Doubled-blind||0||
59935724|NCT03124459|76053707|FG003|COMPLETED|Phase 2- Randomized Doubled-blind||9||
59935725|NCT03124459|76053708|FG004|COMPLETED|Phase 2- Randomized Doubled-blind||5||
59935726|NCT03124459|76053709|FG005|COMPLETED|Phase 2- Randomized Doubled-blind||0||
59935727|NCT03124459|76053704|FG000|NOT COMPLETED|Phase 2- Randomized Doubled-blind||0||
59935728|NCT03124459|76053705|FG001|NOT COMPLETED|Phase 2- Randomized Doubled-blind||0||
59935729|NCT03124459|76053706|FG002|NOT COMPLETED|Phase 2- Randomized Doubled-blind||0||
59935730|NCT03124459|76053707|FG003|NOT COMPLETED|Phase 2- Randomized Doubled-blind||12||
59935731|NCT03124459|76053708|FG004|NOT COMPLETED|Phase 2- Randomized Doubled-blind||19||
59935732|NCT03124459|76053709|FG005|NOT COMPLETED|Phase 2- Randomized Doubled-blind||0||
59935733|NCT03124459|76053704|FG000|STARTED|Part 2- Open Label ACE-083||0|Participants in Part 1 Open-Label Dose escalation portion of the study were not the same participants that participated in the double-blind placebo controlled study. Participants that completed the Part 2 double-blind placebo controlled portion of the study were able to move into the open-label portion of the study.|
59935734|NCT03124459|76053705|FG001|STARTED|Part 2- Open Label ACE-083||0|Participants in Part 1 Open-Label Dose escalation portion of the study were not the same participants that participated in the double-blind placebo controlled study. Participants that completed the Part 2 double-blind placebo controlled portion of the study were able to move into the open-label portion of the study.|
59935735|NCT03124459|76053706|FG002|STARTED|Part 2- Open Label ACE-083||0|Participants in Part 1 Open-Label Dose escalation portion of the study were not the same participants that participated in the double-blind placebo controlled study. Participants that completed the Part 2 double-blind placebo controlled portion of the study were able to move into the open-label portion of the study.|
59935736|NCT03124459|76053707|FG003|STARTED|Part 2- Open Label ACE-083|Participants in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study. Participants that completed the double-blind placebo controlled portion of Part 2, moved into the open-label portion part 2 study.|0|Participants in Part 1 Open-Label Dose escalation portion of the study were not the same participants that participated in the double-blind placebo controlled study. Participants that completed the Part 2 double-blind placebo controlled portion of the study were able to move into the open-label portion of the study.|
59951227|NCT03771664|76070159|FG001|Full Analysis Set (FAS)|Overall Study||43|FAS included all randomized participants with valid baseline and at least one post-baseline efficacy evaluation.|
60067387|NCT02078284|76182527|FG003|NOT COMPLETED|Overall Study||0||
60067388|NCT02078284|76182528|FG004|NOT COMPLETED|Overall Study||0||
59935737|NCT03124459|76053708|FG004|STARTED|Part 2- Open Label ACE-083|Participants in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study. Participants that completed the double-blind placebo controlled portion of Part 2, moved into the open-label portion part 2 study.|0|Participants in Part 1 Open-Label Dose escalation portion of the study were not the same participants that participated in the double-blind placebo controlled study. Participants that completed the Part 2 double-blind placebo controlled portion of the study were able to move into the open-label portion of the study.|
59935738|NCT03124459|76053709|FG005|STARTED|Part 2- Open Label ACE-083|The open-label portion of Part 2 are the participants that were enrolled in and completed the double-blind placebo-controlled portion of Part 2.|40|Participants in Part 1 Open-Label Dose escalation portion of the study were not the same participants that participated in the double-blind placebo controlled study. Participants that completed the Part 2 double-blind placebo controlled portion of the study were able to move into the open-label portion of the study.|
59935739|NCT03124459|76053704|FG000|COMPLETED|Part 2- Open Label ACE-083||0||
59935740|NCT03124459|76053705|FG001|COMPLETED|Part 2- Open Label ACE-083||0||
59935741|NCT03124459|76053706|FG002|COMPLETED|Part 2- Open Label ACE-083||0||
59935742|NCT03124459|76053707|FG003|COMPLETED|Part 2- Open Label ACE-083||0||
59935743|NCT03124459|76053708|FG004|COMPLETED|Part 2- Open Label ACE-083||0||
59935744|NCT03124459|76053709|FG005|COMPLETED|Part 2- Open Label ACE-083||17||
59935745|NCT03124459|76053704|FG000|NOT COMPLETED|Part 2- Open Label ACE-083||0||
59935746|NCT03124459|76053705|FG001|NOT COMPLETED|Part 2- Open Label ACE-083||0||
59935747|NCT03124459|76053706|FG002|NOT COMPLETED|Part 2- Open Label ACE-083||0||
59935748|NCT03124459|76053707|FG003|NOT COMPLETED|Part 2- Open Label ACE-083||0||
59935749|NCT03124459|76053708|FG004|NOT COMPLETED|Part 2- Open Label ACE-083||0||
59935750|NCT03124459|76053709|FG005|NOT COMPLETED|Part 2- Open Label ACE-083||23||
59935751|NCT03134183|76053724|FG000|STARTED|Overall Study||36||
59935752|NCT03134183|76053725|FG001|STARTED|Overall Study||34||
59935753|NCT03134183|76053724|FG000|COMPLETED|Overall Study||35||
59935754|NCT03134183|76053725|FG001|COMPLETED|Overall Study||33||
59935755|NCT03134183|76053724|FG000|NOT COMPLETED|Overall Study||1||
59935756|NCT03134183|76053725|FG001|NOT COMPLETED|Overall Study||1||
59935757|NCT03136367|76053734|FG000|STARTED|T1 Consultation||66||
59935758|NCT03136367|76053735|FG001|STARTED|T1 Consultation||248||
59935759|NCT03136367|76053736|FG002|STARTED|T1 Consultation||257||
59935760|NCT03136367|76053734|FG000|COMPLETED|T1 Consultation|received the intervention|64||
59935761|NCT03136367|76053735|FG001|COMPLETED|T1 Consultation||241||
59935762|NCT03136367|76053736|FG002|COMPLETED|T1 Consultation||256||
59935763|NCT03136367|76053734|FG000|NOT COMPLETED|T1 Consultation||2||
59935764|NCT03136367|76053735|FG001|NOT COMPLETED|T1 Consultation||7||
59935765|NCT03136367|76053736|FG002|NOT COMPLETED|T1 Consultation||1||
59935766|NCT03136367|76053734|FG000|STARTED|T2 Post-consultation||64||
59935767|NCT03136367|76053735|FG001|STARTED|T2 Post-consultation||241||
59935768|NCT03136367|76053736|FG002|STARTED|T2 Post-consultation||256||
59935769|NCT03136367|76053734|FG000|COMPLETED|T2 Post-consultation||61||
59935770|NCT03136367|76053735|FG001|COMPLETED|T2 Post-consultation||235||
59935771|NCT03136367|76053736|FG002|COMPLETED|T2 Post-consultation||225||
59935772|NCT03136367|76053734|FG000|NOT COMPLETED|T2 Post-consultation||3||
59935773|NCT03136367|76053735|FG001|NOT COMPLETED|T2 Post-consultation||6||
59935774|NCT03136367|76053736|FG002|NOT COMPLETED|T2 Post-consultation||31||
59935775|NCT03136367|76053734|FG000|STARTED|T3 1 Week After Surgery||61||
59935776|NCT03136367|76053735|FG001|STARTED|T3 1 Week After Surgery||235||
59935777|NCT03136367|76053736|FG002|STARTED|T3 1 Week After Surgery||225||
59935778|NCT03136367|76053734|FG000|COMPLETED|T3 1 Week After Surgery||51||
59935779|NCT03136367|76053735|FG001|COMPLETED|T3 1 Week After Surgery||203||
59935780|NCT03136367|76053736|FG002|COMPLETED|T3 1 Week After Surgery||194||
59935781|NCT03136367|76053734|FG000|NOT COMPLETED|T3 1 Week After Surgery||10||
59935782|NCT03136367|76053735|FG001|NOT COMPLETED|T3 1 Week After Surgery||32||
59935783|NCT03136367|76053736|FG002|NOT COMPLETED|T3 1 Week After Surgery||31||
59935784|NCT03136367|76053734|FG000|STARTED|T4 12 Weeks After Surgery||51||
59935785|NCT03136367|76053735|FG001|STARTED|T4 12 Weeks After Surgery||203||
59935786|NCT03136367|76053736|FG002|STARTED|T4 12 Weeks After Surgery||194||
59935787|NCT03136367|76053734|FG000|COMPLETED|T4 12 Weeks After Surgery||49||
59935788|NCT03136367|76053735|FG001|COMPLETED|T4 12 Weeks After Surgery||198||
59935789|NCT03136367|76053736|FG002|COMPLETED|T4 12 Weeks After Surgery||185||
59935790|NCT03136367|76053734|FG000|NOT COMPLETED|T4 12 Weeks After Surgery||2||
59935791|NCT03136367|76053735|FG001|NOT COMPLETED|T4 12 Weeks After Surgery||5||
59935792|NCT03136367|76053736|FG002|NOT COMPLETED|T4 12 Weeks After Surgery||9||
59935793|NCT03136367|76053734|FG000|STARTED|T5 1 Year After Surgery||49||
59935794|NCT03136367|76053735|FG001|STARTED|T5 1 Year After Surgery||198||
59935795|NCT03136367|76053736|FG002|STARTED|T5 1 Year After Surgery||185||
59935796|NCT03136367|76053734|FG000|COMPLETED|T5 1 Year After Surgery||13||
59935797|NCT03136367|76053735|FG001|COMPLETED|T5 1 Year After Surgery||62||
59935798|NCT03136367|76053736|FG002|COMPLETED|T5 1 Year After Surgery||56||
59935799|NCT03136367|76053734|FG000|NOT COMPLETED|T5 1 Year After Surgery||36||
59935800|NCT03136367|76053735|FG001|NOT COMPLETED|T5 1 Year After Surgery||136||
59935801|NCT03136367|76053736|FG002|NOT COMPLETED|T5 1 Year After Surgery||129||
59935802|NCT03124381|76053749|FG000|STARTED|Overall Study||65||
59935803|NCT03124381|76053750|FG001|STARTED|Overall Study||61||
60067389|NCT02092961|76182543|FG000|STARTED|Overall Study|Patients who received treatment|33||
59935804|NCT03124381|76053749|FG000|COMPLETED|Overall Study||56||
59935805|NCT03124381|76053750|FG001|COMPLETED|Overall Study||55||
59935806|NCT03124381|76053749|FG000|NOT COMPLETED|Overall Study||9||
59935807|NCT03124381|76053750|FG001|NOT COMPLETED|Overall Study||6||
59935808|NCT03133793|76053760|FG000|STARTED|Overall Study||39||
59935809|NCT03133793|76053761|FG001|STARTED|Overall Study||39||
59935810|NCT03133793|76053762|FG002|STARTED|Overall Study||37||
59935811|NCT03133793|76053763|FG003|STARTED|Overall Study||38||
59935812|NCT03133793|76053760|FG000|COMPLETED|Overall Study||38||
59935813|NCT03133793|76053761|FG001|COMPLETED|Overall Study||35||
59935814|NCT03133793|76053762|FG002|COMPLETED|Overall Study||33||
59935815|NCT03133793|76053763|FG003|COMPLETED|Overall Study||33||
59935816|NCT03133793|76053760|FG000|NOT COMPLETED|Overall Study||1||
59935817|NCT03133793|76053761|FG001|NOT COMPLETED|Overall Study||4||
59935818|NCT03133793|76053762|FG002|NOT COMPLETED|Overall Study||4||
59935819|NCT03133793|76053763|FG003|NOT COMPLETED|Overall Study||5||
59935820|NCT02747238|76053779|FG000|STARTED|Overall Study||12||
59935821|NCT02747238|76053780|FG001|STARTED|Overall Study||20||
59935822|NCT02747238|76053779|FG000|COMPLETED|Overall Study||9||
59935823|NCT02747238|76053780|FG001|COMPLETED|Overall Study||14||
59935824|NCT02747238|76053779|FG000|NOT COMPLETED|Overall Study||3||
59935825|NCT02747238|76053780|FG001|NOT COMPLETED|Overall Study||6||
59935826|NCT03133481|76053788|FG000|STARTED|Overall Study||45||
59935827|NCT03133481|76053789|FG001|STARTED|Overall Study||49||
59935828|NCT03133481|76053788|FG000|COMPLETED|Overall Study||45||
59935829|NCT03133481|76053789|FG001|COMPLETED|Overall Study||45||
59935830|NCT03133481|76053788|FG000|NOT COMPLETED|Overall Study||0||
59935831|NCT03133481|76053789|FG001|NOT COMPLETED|Overall Study||4||
59935832|NCT02864316|76053797|FG000|STARTED|Overall Study||2||
59935833|NCT02864316|76053798|FG001|STARTED|Overall Study||2||
59935834|NCT02864316|76053797|FG000|COMPLETED|Overall Study||0||
59935835|NCT02864316|76053798|FG001|COMPLETED|Overall Study||0||
59935836|NCT02864316|76053797|FG000|NOT COMPLETED|Overall Study||2||
59935837|NCT02864316|76053798|FG001|NOT COMPLETED|Overall Study||2||
59935838|NCT02862600|76053804|FG000|STARTED|Period 1--Perhexiline-low Target Range|First subject underwent baseline functional assessment and perhexiline dosing on August 22, 2016|35|Target range 100-300 ng/mL|
59935839|NCT02862600|76053804|FG000|COMPLETED|Period 1--Perhexiline-low Target Range|Study terminated on April 26, 2017 due to lack of efficacy.|22|Period and study terminated|
59935840|NCT02862600|76053804|FG000|NOT COMPLETED|Period 1--Perhexiline-low Target Range||13||
59935841|NCT02862600|76053804|FG000|STARTED|Period 2--Perhexiline-high Target Range|First subject completed Period 1 and moved into Period 2 perhexiline dosing on October 17, 2016|22|Target range 300-500 ng/mL|
60067390|NCT02092961|76182544|FG001|STARTED|Overall Study|Patients who received treatment|28||
59518373|NCT03369340|75612167|FG004|STARTED|Day 3||3||
59518374|NCT03369340|75612168|FG005|STARTED|Day 3||3||
59518375|NCT03369340|75612163|FG000|COMPLETED|Day 3||3||
59518376|NCT03369340|75612164|FG001|COMPLETED|Day 3||3||
59518377|NCT03369340|75612165|FG002|COMPLETED|Day 3||3||
59518378|NCT03369340|75612166|FG003|COMPLETED|Day 3||3||
59518379|NCT03369340|75612167|FG004|COMPLETED|Day 3||3||
59518380|NCT03369340|75612168|FG005|COMPLETED|Day 3||3||
59518381|NCT03369340|75612163|FG000|NOT COMPLETED|Day 3||0||
59518382|NCT03369340|75612164|FG001|NOT COMPLETED|Day 3||0||
59518383|NCT03369340|75612165|FG002|NOT COMPLETED|Day 3||0||
59518384|NCT03369340|75612166|FG003|NOT COMPLETED|Day 3||0||
59518385|NCT03369340|75612167|FG004|NOT COMPLETED|Day 3||0||
59518386|NCT03369340|75612168|FG005|NOT COMPLETED|Day 3||0||
59518387|NCT03369340|75612163|FG000|STARTED|Day 4||3||
59518388|NCT03369340|75612164|FG001|STARTED|Day 4||3||
59518389|NCT03369340|75612165|FG002|STARTED|Day 4||3||
59518390|NCT03369340|75612166|FG003|STARTED|Day 4||3||
59518391|NCT03369340|75612167|FG004|STARTED|Day 4||3||
59518392|NCT03369340|75612168|FG005|STARTED|Day 4||3||
59518393|NCT03369340|75612163|FG000|COMPLETED|Day 4||3||
59518394|NCT03369340|75612164|FG001|COMPLETED|Day 4||3||
59518395|NCT03369340|75612165|FG002|COMPLETED|Day 4||3||
59518396|NCT03369340|75612166|FG003|COMPLETED|Day 4||3||
59935842|NCT02862600|76053804|FG000|COMPLETED|Period 2--Perhexiline-high Target Range|Study terminated on April 26, 2017 due to lack of efficacy in first 15 subjects completing Period 2.|15|Period and study termination|
59935843|NCT02862600|76053804|FG000|NOT COMPLETED|Period 2--Perhexiline-high Target Range||7||
59935844|NCT02864082|76053812|FG000|STARTED|Overall Study||10||
59935845|NCT02864082|76053813|FG001|STARTED|Overall Study||9||
59935846|NCT02864082|76053812|FG000|COMPLETED|Overall Study||7||
59935847|NCT02864082|76053813|FG001|COMPLETED|Overall Study||5||
59935848|NCT02864082|76053812|FG000|NOT COMPLETED|Overall Study||3||
59935849|NCT02864082|76053813|FG001|NOT COMPLETED|Overall Study||4||
59935850|NCT02792192|76053837|FG000|STARTED|Overall Study||12||
59935851|NCT02792192|76053838|FG001|STARTED|Overall Study||12||
59935852|NCT02792192|76053839|FG002|STARTED|Overall Study||0||
59935853|NCT02792192|76053840|FG003|STARTED|Overall Study||0||
59935854|NCT02792192|76053837|FG000|COMPLETED|Overall Study||0||
59935855|NCT02792192|76053838|FG001|COMPLETED|Overall Study||1||
59935856|NCT02792192|76053839|FG002|COMPLETED|Overall Study||0||
59935857|NCT02792192|76053840|FG003|COMPLETED|Overall Study||0||
59935858|NCT02792192|76053837|FG000|NOT COMPLETED|Overall Study||12||
59935859|NCT02792192|76053838|FG001|NOT COMPLETED|Overall Study||11||
59518397|NCT03369340|75612167|FG004|COMPLETED|Day 4||3||
59518398|NCT03369340|75612168|FG005|COMPLETED|Day 4||3||
59518399|NCT03369340|75612163|FG000|NOT COMPLETED|Day 4||0||
59518400|NCT03369340|75612164|FG001|NOT COMPLETED|Day 4||0||
59518401|NCT03369340|75612165|FG002|NOT COMPLETED|Day 4||0||
59518402|NCT03369340|75612166|FG003|NOT COMPLETED|Day 4||0||
59518403|NCT03369340|75612167|FG004|NOT COMPLETED|Day 4||0||
59518404|NCT03369340|75612168|FG005|NOT COMPLETED|Day 4||0||
59518405|NCT01078363|75612180|FG000|STARTED|Overall Study||47||
59518406|NCT01078363|75612181|FG001|STARTED|Overall Study||49||
59518407|NCT01078363|75612180|FG000|COMPLETED|Overall Study||47||
59518408|NCT01078363|75612181|FG001|COMPLETED|Overall Study||49||
59518409|NCT01078363|75612180|FG000|NOT COMPLETED|Overall Study||0||
59518410|NCT01078363|75612181|FG001|NOT COMPLETED|Overall Study||0||
59518411|NCT03370042|75612191|FG000|STARTED|Overall Study||10||10
59518412|NCT03370042|75612192|FG001|STARTED|Overall Study||10||10
59518413|NCT03370042|75612191|FG000|COMPLETED|Overall Study||10||10
59518414|NCT03370042|75612192|FG001|COMPLETED|Overall Study||10||10
59518415|NCT03370042|75612191|FG000|NOT COMPLETED|Overall Study||0||0
59518416|NCT03370042|75612192|FG001|NOT COMPLETED|Overall Study||0||0
59518417|NCT03371836|75612202|FG000|STARTED|Overall Study||20||
59518418|NCT03371836|75612202|FG000|COMPLETED|Overall Study||18||
59518419|NCT03371836|75612202|FG000|NOT COMPLETED|Overall Study||2||
59518420|NCT01078753|75612208|FG000|STARTED|Treatment Period I||45||
59518421|NCT01078753|75612209|FG001|STARTED|Treatment Period I||44||
59518422|NCT01078753|75612208|FG000|Full Analysis Set|Treatment Period I|One patient was excluded from the full analysis set due to failure to satisfy the entry criteria.|44||
59518423|NCT01078753|75612209|FG001|Full Analysis Set|Treatment Period I||44||
59518424|NCT01078753|75612208|FG000|COMPLETED|Treatment Period I||45||
59518425|NCT01078753|75612209|FG001|COMPLETED|Treatment Period I||44||
59613309|NCT01568892|75724458|FG001|COMPLETED|Open-label Phase||13||
59613310|NCT01568892|75724457|FG000|NOT COMPLETED|Open-label Phase||6||
59613311|NCT01568892|75724458|FG001|NOT COMPLETED|Open-label Phase||3||
59613312|NCT01568112|75724469|FG000|STARTED|Overall Study||44||
59613313|NCT01568112|75724470|FG001|STARTED|Overall Study||44||
59935860|NCT02792192|76053839|FG002|NOT COMPLETED|Overall Study||0||
59935861|NCT02792192|76053840|FG003|NOT COMPLETED|Overall Study||0||
59935862|NCT02964507|76053859|FG000|STARTED|Overall Study||33||
59935863|NCT02964507|76053860|FG001|STARTED|Overall Study||12||
59613314|NCT01568112|75724471|FG002|STARTED|Overall Study||43||
59613315|NCT01568112|75724472|FG003|STARTED|Overall Study||42||
59935864|NCT02964507|76053861|FG002|STARTED|Overall Study||42||
59935865|NCT02964507|76053862|FG003|STARTED|Overall Study||7||
59935866|NCT02964507|76053863|FG004|STARTED|Overall Study||18||
59935867|NCT02964507|76053864|FG005|STARTED|Overall Study||11||
59935868|NCT02964507|76053865|FG006|STARTED|Overall Study||0||
59935869|NCT02964507|76053866|FG007|STARTED|Overall Study||0||
59935870|NCT02964507|76053859|FG000|COMPLETED|Overall Study||7||
59935871|NCT02964507|76053860|FG001|COMPLETED|Overall Study||1||
59935872|NCT02964507|76053861|FG002|COMPLETED|Overall Study||17||
59935873|NCT02964507|76053862|FG003|COMPLETED|Overall Study||1||
59935874|NCT02964507|76053863|FG004|COMPLETED|Overall Study||2||
59935875|NCT02964507|76053864|FG005|COMPLETED|Overall Study||3||
59613316|NCT01568112|75724469|FG000|COMPLETED|Overall Study||39||
59935876|NCT02964507|76053865|FG006|COMPLETED|Overall Study||0||
59935877|NCT02964507|76053866|FG007|COMPLETED|Overall Study||0||
59935878|NCT02964507|76053859|FG000|NOT COMPLETED|Overall Study||26||
59518426|NCT01078753|75612208|FG000|NOT COMPLETED|Treatment Period I||0||
59518427|NCT01078753|75612209|FG001|NOT COMPLETED|Treatment Period I||0||
59518428|NCT01078753|75612208|FG000|STARTED|Treatment Period II|Desmopressin 120 µg - 4 participants Desmopressin 240 µg - 41 participants|45||
59518429|NCT01078753|75612209|FG001|STARTED|Treatment Period II||44||
59518430|NCT01078753|75612208|FG000|Full Analysis Set|Treatment Period II|One patient was excluded from the full analysis set due to failure to satisfy the entry criteria.|44||
59613317|NCT01568112|75724470|FG001|COMPLETED|Overall Study||36||
59613318|NCT01568112|75724471|FG002|COMPLETED|Overall Study||36||
59613319|NCT01568112|75724472|FG003|COMPLETED|Overall Study||30||
59613320|NCT01568112|75724469|FG000|NOT COMPLETED|Overall Study||5||
59613321|NCT01568112|75724470|FG001|NOT COMPLETED|Overall Study||8||
59518431|NCT01078753|75612209|FG001|Full Analysis Set|Treatment Period II||44||
59518432|NCT01078753|75612208|FG000|COMPLETED|Treatment Period II||45||
59518433|NCT01078753|75612209|FG001|COMPLETED|Treatment Period II||44||
59518434|NCT01078753|75612208|FG000|NOT COMPLETED|Treatment Period II||0||
59613322|NCT01568112|75724471|FG002|NOT COMPLETED|Overall Study||7||
59613323|NCT01568112|75724472|FG003|NOT COMPLETED|Overall Study||12||
59613324|NCT01568034|75724483|FG000|STARTED|Overall Study||2||
59613325|NCT01568034|75724484|FG001|STARTED|Overall Study||2||
59518435|NCT01078753|75612209|FG001|NOT COMPLETED|Treatment Period II||0||
59518436|NCT03372382|75612217|FG000|STARTED|Overall Study||85||
59613326|NCT01568034|75724485|FG002|STARTED|Overall Study||3||
59935879|NCT02964507|76053860|FG001|NOT COMPLETED|Overall Study||11||
59935880|NCT02964507|76053861|FG002|NOT COMPLETED|Overall Study||25||
59935881|NCT02964507|76053862|FG003|NOT COMPLETED|Overall Study||6||
59935882|NCT02964507|76053863|FG004|NOT COMPLETED|Overall Study||16||
59935883|NCT02964507|76053864|FG005|NOT COMPLETED|Overall Study||8||
59935884|NCT02964507|76053865|FG006|NOT COMPLETED|Overall Study||0||
59935885|NCT02964507|76053866|FG007|NOT COMPLETED|Overall Study||0||
59935886|NCT03170869|76053885|FG000|STARTED|Overall Study||11||
59935887|NCT03170869|76053885|FG000|COMPLETED|Overall Study||3||
59935888|NCT03170869|76053885|FG000|NOT COMPLETED|Overall Study||8||
59935889|NCT02440464|76053892|FG000|STARTED|Overall Study||21||
59935890|NCT02440464|76053893|FG001|STARTED|Overall Study||22||
59935891|NCT02440464|76053892|FG000|COMPLETED|Overall Study||18||
59935892|NCT02440464|76053893|FG001|COMPLETED|Overall Study||20||
59935893|NCT02440464|76053892|FG000|NOT COMPLETED|Overall Study||3||
59935894|NCT02440464|76053893|FG001|NOT COMPLETED|Overall Study||2||
59935895|NCT03103321|76053904|FG000|STARTED|Overall Study||25||
59935896|NCT03103321|76053905|FG001|STARTED|Overall Study||39||
59935897|NCT03103321|76053906|FG002|STARTED|Overall Study||44||
59935898|NCT03103321|76053907|FG003|STARTED|Overall Study||50||
59935899|NCT03103321|76053904|FG000|COMPLETED|Overall Study||24||
59935900|NCT03103321|76053905|FG001|COMPLETED|Overall Study||38||
59935901|NCT03103321|76053906|FG002|COMPLETED|Overall Study||43||
59935902|NCT03103321|76053907|FG003|COMPLETED|Overall Study||50||
59935903|NCT03103321|76053904|FG000|NOT COMPLETED|Overall Study||1||
59935904|NCT03103321|76053905|FG001|NOT COMPLETED|Overall Study||1||
59935905|NCT03103321|76053906|FG002|NOT COMPLETED|Overall Study||1||
59935906|NCT03103321|76053907|FG003|NOT COMPLETED|Overall Study||0||
59935907|NCT03131453|76053920|FG000|STARTED|Overall Study||456||
59935908|NCT03131453|76053921|FG001|STARTED|Overall Study||233||
59935909|NCT03131453|76053922|FG002|STARTED|Overall Study||456||
59935910|NCT03131453|76053920|FG000|Patient Misrandomized|Overall Study||1||
59935911|NCT03131453|76053921|FG001|Patient Misrandomized|Overall Study||0||
59935912|NCT03131453|76053922|FG002|Patient Misrandomized|Overall Study||0||
59935913|NCT03131453|76053920|FG000|COMPLETED|Overall Study||0||
59935914|NCT03131453|76053921|FG001|COMPLETED|Overall Study||0||
59935915|NCT03131453|76053922|FG002|COMPLETED|Overall Study||0||
59935916|NCT03131453|76053920|FG000|NOT COMPLETED|Overall Study||456||
59935917|NCT03131453|76053921|FG001|NOT COMPLETED|Overall Study||233||
59935918|NCT03131453|76053922|FG002|NOT COMPLETED|Overall Study||456||
59935919|NCT02673151|76053930|FG000|STARTED|Overall Study||61||
59935920|NCT02673151|76053930|FG000|COMPLETED|Overall Study||61||
59935921|NCT02673151|76053930|FG000|NOT COMPLETED|Overall Study||0||
59935922|NCT02942277|76053950|FG000|STARTED|Year 1||5||
59935923|NCT02942277|76053951|FG001|STARTED|Year 1||10||
59935924|NCT02942277|76053952|FG002|STARTED|Year 1||5||
59935925|NCT02942277|76053953|FG003|STARTED|Year 1||10||
59935926|NCT02942277|76053954|FG004|STARTED|Year 1||56||
59935927|NCT02942277|76053955|FG005|STARTED|Year 1||61||
59935928|NCT02942277|76053956|FG006|STARTED|Year 1||5||
59761781|NCT00883740|75881414|FG000|STARTED|Taper and Washout Period (2 Weeks)|1 participant not crossed to period 2 but continued on period 1, sponsor terminated as noncompliance|54||
59935929|NCT02942277|76053957|FG007|STARTED|Year 1||10||
59935930|NCT02942277|76053958|FG008|STARTED|Year 1||10||
59761782|NCT00883740|75881415|FG001|STARTED|Taper and Washout Period (2 Weeks)||51||
59761783|NCT00883740|75881414|FG000|COMPLETED|Taper and Washout Period (2 Weeks)||54||
59761784|NCT00883740|75881415|FG001|COMPLETED|Taper and Washout Period (2 Weeks)||51||
59935931|NCT02942277|76053959|FG009|STARTED|Year 1||10||
59935932|NCT02942277|76053960|FG010|STARTED|Year 1||119||
59935933|NCT02942277|76053950|FG000|COMPLETED|Year 1||5||
59935934|NCT02942277|76053951|FG001|COMPLETED|Year 1||8||
59935935|NCT02942277|76053952|FG002|COMPLETED|Year 1||5||
59935936|NCT02942277|76053953|FG003|COMPLETED|Year 1||9||
59935937|NCT02942277|76053954|FG004|COMPLETED|Year 1||49||
59935938|NCT02942277|76053955|FG005|COMPLETED|Year 1||51||
59935939|NCT02942277|76053956|FG006|COMPLETED|Year 1||5||
59935940|NCT02942277|76053957|FG007|COMPLETED|Year 1||9||
59935941|NCT02942277|76053958|FG008|COMPLETED|Year 1||10||
59935942|NCT02942277|76053959|FG009|COMPLETED|Year 1||10||
59935943|NCT02942277|76053960|FG010|COMPLETED|Year 1||104||
59935944|NCT02942277|76053950|FG000|NOT COMPLETED|Year 1||0||
59935945|NCT02942277|76053951|FG001|NOT COMPLETED|Year 1||2||
59935946|NCT02942277|76053952|FG002|NOT COMPLETED|Year 1||0||
59935947|NCT02942277|76053953|FG003|NOT COMPLETED|Year 1||1||
59935948|NCT02942277|76053954|FG004|NOT COMPLETED|Year 1||7||
59935949|NCT02942277|76053955|FG005|NOT COMPLETED|Year 1||10||
59935950|NCT02942277|76053956|FG006|NOT COMPLETED|Year 1||0||
59935951|NCT02942277|76053957|FG007|NOT COMPLETED|Year 1||1||
59935952|NCT02942277|76053958|FG008|NOT COMPLETED|Year 1||0||
59935953|NCT02942277|76053959|FG009|NOT COMPLETED|Year 1||0||
59935954|NCT02942277|76053960|FG010|NOT COMPLETED|Year 1||15||
59935955|NCT02942277|76053950|FG000|STARTED|Year 2||5||
59935956|NCT02942277|76053951|FG001|STARTED|Year 2||8||
59935957|NCT02942277|76053952|FG002|STARTED|Year 2||5||
59935958|NCT02942277|76053953|FG003|STARTED|Year 2||9||
59935959|NCT02942277|76053954|FG004|STARTED|Year 2||49||
59935960|NCT02942277|76053955|FG005|STARTED|Year 2||51||
59935961|NCT02942277|76053956|FG006|STARTED|Year 2||5||
59935962|NCT02942277|76053957|FG007|STARTED|Year 2||9||
59935963|NCT02942277|76053958|FG008|STARTED|Year 2||10||
59935964|NCT02942277|76053959|FG009|STARTED|Year 2||10||
59935965|NCT02942277|76053960|FG010|STARTED|Year 2||104||
59935966|NCT02942277|76053950|FG000|COMPLETED|Year 2||5||
59935967|NCT02942277|76053951|FG001|COMPLETED|Year 2||7||
59935968|NCT02942277|76053952|FG002|COMPLETED|Year 2||4||
59935969|NCT02942277|76053953|FG003|COMPLETED|Year 2||8||
59935970|NCT02942277|76053954|FG004|COMPLETED|Year 2||36||
59935971|NCT02942277|76053955|FG005|COMPLETED|Year 2||40||
59935972|NCT02942277|76053956|FG006|COMPLETED|Year 2||4||
59935973|NCT02942277|76053957|FG007|COMPLETED|Year 2||8||
59935974|NCT02942277|76053958|FG008|COMPLETED|Year 2||10||
59935975|NCT02942277|76053959|FG009|COMPLETED|Year 2||9||
59935976|NCT02942277|76053960|FG010|COMPLETED|Year 2||79||
59935977|NCT02942277|76053950|FG000|NOT COMPLETED|Year 2||0||
59935978|NCT02942277|76053951|FG001|NOT COMPLETED|Year 2||1||
59935979|NCT02942277|76053952|FG002|NOT COMPLETED|Year 2||1||
59935980|NCT02942277|76053953|FG003|NOT COMPLETED|Year 2||1||
59935981|NCT02942277|76053954|FG004|NOT COMPLETED|Year 2||13||
59935982|NCT02942277|76053955|FG005|NOT COMPLETED|Year 2||11||
59935983|NCT02942277|76053956|FG006|NOT COMPLETED|Year 2||1||
59935984|NCT02942277|76053957|FG007|NOT COMPLETED|Year 2||1||
59935985|NCT02942277|76053958|FG008|NOT COMPLETED|Year 2||0||
59935986|NCT02942277|76053959|FG009|NOT COMPLETED|Year 2||1||
59935987|NCT02942277|76053960|FG010|NOT COMPLETED|Year 2||25||
59935988|NCT02296801|76053991|FG000|STARTED|Overall Study||103||
59935989|NCT02296801|76053992|FG001|STARTED|Overall Study||68||
59935990|NCT02296801|76053993|FG002|STARTED|Overall Study||69||
59935991|NCT02296801|76053994|FG003|STARTED|Overall Study||67||
59935992|NCT02296801|76053991|FG000|COMPLETED|Overall Study||83||
59935993|NCT02296801|76053992|FG001|COMPLETED|Overall Study||53||
59935994|NCT02296801|76053993|FG002|COMPLETED|Overall Study||50||
59935995|NCT02296801|76053994|FG003|COMPLETED|Overall Study||58||
59935996|NCT02296801|76053991|FG000|NOT COMPLETED|Overall Study||20||
59935997|NCT02296801|76053992|FG001|NOT COMPLETED|Overall Study||15||
59935998|NCT02296801|76053993|FG002|NOT COMPLETED|Overall Study||19||
59935999|NCT02296801|76053994|FG003|NOT COMPLETED|Overall Study||9||
59936000|NCT02859324|76054011|FG000|STARTED|Overall Study||7||
59761785|NCT00883740|75881414|FG000|NOT COMPLETED|Taper and Washout Period (2 Weeks)||0||
59761786|NCT00883740|75881415|FG001|NOT COMPLETED|Taper and Washout Period (2 Weeks)||0||
59761787|NCT00883740|75881414|FG000|STARTED|Second Intervention|1 participant not crossed to period 2 but continued on period 1, sponsor terminated as noncompliance|53||
59761788|NCT00883740|75881415|FG001|STARTED|Second Intervention||51||
59761789|NCT00883740|75881414|FG000|COMPLETED|Second Intervention||52||
59761790|NCT00883740|75881415|FG001|COMPLETED|Second Intervention||50||
59761791|NCT00883740|75881414|FG000|NOT COMPLETED|Second Intervention||1||
59761792|NCT00883740|75881415|FG001|NOT COMPLETED|Second Intervention||1||
59761793|NCT00597012|75881423|FG000|STARTED|Overall Study||174||
59761794|NCT00597012|75881424|FG001|STARTED|Overall Study||177||
59936001|NCT02859324|76054012|FG001|STARTED|Overall Study||9||
59936002|NCT02859324|76054013|FG002|STARTED|Overall Study||5||
59936003|NCT02859324|76054011|FG000|COMPLETED|Overall Study||0|Completed = Did not discontinue study|
59936004|NCT02859324|76054012|FG001|COMPLETED|Overall Study||0|Completed = Did not discontinue study|
59936005|NCT02859324|76054013|FG002|COMPLETED|Overall Study||0|Completed = Did not discontinue study|
59936006|NCT02859324|76054011|FG000|NOT COMPLETED|Overall Study||7||
59936007|NCT02859324|76054012|FG001|NOT COMPLETED|Overall Study||9||
59936008|NCT02859324|76054013|FG002|NOT COMPLETED|Overall Study||5||
59936009|NCT02143063|76054024|FG000|STARTED|Overall Study||61||
59936010|NCT02143063|76054025|FG001|STARTED|Overall Study||105||
59936011|NCT02143063|76054026|FG002|STARTED|Overall Study||108||
59936012|NCT02143063|76054024|FG000|COMPLETED|Overall Study||45||
59936013|NCT02143063|76054025|FG001|COMPLETED|Overall Study||75||
59936014|NCT02143063|76054026|FG002|COMPLETED|Overall Study||78||
59936015|NCT02143063|76054024|FG000|NOT COMPLETED|Overall Study||16||
59936016|NCT02143063|76054025|FG001|NOT COMPLETED|Overall Study||30||
59936017|NCT02143063|76054026|FG002|NOT COMPLETED|Overall Study||30||
59761795|NCT00597012|75881423|FG000|COMPLETED|Overall Study||161||
59761796|NCT00597012|75881424|FG001|COMPLETED|Overall Study||169||
59761797|NCT00597012|75881423|FG000|NOT COMPLETED|Overall Study||13||
59761798|NCT00597012|75881424|FG001|NOT COMPLETED|Overall Study||8||
59761799|NCT00542815|75881435|FG000|STARTED|Overall Study||432||
59761800|NCT00542815|75881436|FG001|STARTED|Overall Study||76||
59761801|NCT00542815|75881437|FG002|STARTED|Overall Study||124||
59761802|NCT00542815|75881435|FG000|COMPLETED|Overall Study||326||
59761803|NCT00542815|75881436|FG001|COMPLETED|Overall Study||44||
59761804|NCT00542815|75881437|FG002|COMPLETED|Overall Study||92||
59761805|NCT00542815|75881435|FG000|NOT COMPLETED|Overall Study||106||
59761806|NCT00542815|75881436|FG001|NOT COMPLETED|Overall Study||32||
59761807|NCT00542815|75881437|FG002|NOT COMPLETED|Overall Study||32||
59936018|NCT02859246|76054034|FG000|STARTED|Overall Study|15 subjects were enrolled into study|15||
59936019|NCT02859246|76054034|FG000|COMPLETED|Overall Study|10 subjects completed the study|10||
59936020|NCT02859246|76054034|FG000|NOT COMPLETED|Overall Study||5||
59936021|NCT02921997|76054042|FG000|STARTED|Overall Study||10||
59936022|NCT02921997|76054043|FG001|STARTED|Overall Study||10||
59936023|NCT02921997|76054044|FG002|STARTED|Overall Study||10||
59936024|NCT02921997|76054042|FG000|COMPLETED|Overall Study||10||
59936025|NCT02921997|76054043|FG001|COMPLETED|Overall Study||10||
59936026|NCT02921997|76054044|FG002|COMPLETED|Overall Study||10||
59936027|NCT02921997|76054042|FG000|NOT COMPLETED|Overall Study||0||
59518437|NCT03372382|75612218|FG001|STARTED|Overall Study||85||
59761808|NCT00542425|75881450|FG000|STARTED|Initial 24 Weeks||46||
59761809|NCT00542425|75881451|FG001|STARTED|Initial 24 Weeks||43||
59761810|NCT00542425|75881452|FG002|STARTED|Initial 24 Weeks||43||
59761811|NCT00542425|75881453|FG003|STARTED|Initial 24 Weeks||45||
59761812|NCT00542425|75881454|FG004|STARTED|Initial 24 Weeks||45||
59761813|NCT00542425|75881450|FG000|COMPLETED|Initial 24 Weeks||42||
59761814|NCT00542425|75881451|FG001|COMPLETED|Initial 24 Weeks||33||
59761815|NCT00542425|75881452|FG002|COMPLETED|Initial 24 Weeks||36||
59761816|NCT00542425|75881453|FG003|COMPLETED|Initial 24 Weeks||34||
59761817|NCT00542425|75881454|FG004|COMPLETED|Initial 24 Weeks||39||
59761818|NCT00542425|75881450|FG000|NOT COMPLETED|Initial 24 Weeks||4||
59761819|NCT00542425|75881451|FG001|NOT COMPLETED|Initial 24 Weeks||10||
59761820|NCT00542425|75881452|FG002|NOT COMPLETED|Initial 24 Weeks||7||
59761821|NCT00542425|75881453|FG003|NOT COMPLETED|Initial 24 Weeks||11||
59761822|NCT00542425|75881454|FG004|NOT COMPLETED|Initial 24 Weeks||6||
59761823|NCT00542425|75881450|FG000|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|11||
59761824|NCT00542425|75881451|FG001|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|13||
59761825|NCT00542425|75881452|FG002|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|10||
59761826|NCT00542425|75881453|FG003|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|7||
59761827|NCT00542425|75881454|FG004|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|14||
59761828|NCT00542425|75881450|FG000|COMPLETED|Extended 24 Weeks of Treatment||10||
59761829|NCT00542425|75881451|FG001|COMPLETED|Extended 24 Weeks of Treatment||11||
59761830|NCT00542425|75881452|FG002|COMPLETED|Extended 24 Weeks of Treatment||8||
59761831|NCT00542425|75881453|FG003|COMPLETED|Extended 24 Weeks of Treatment||6||
59761832|NCT00542425|75881454|FG004|COMPLETED|Extended 24 Weeks of Treatment||13||
59761833|NCT00542425|75881450|FG000|NOT COMPLETED|Extended 24 Weeks of Treatment||1||
59761834|NCT00542425|75881451|FG001|NOT COMPLETED|Extended 24 Weeks of Treatment||2||
59761835|NCT00542425|75881452|FG002|NOT COMPLETED|Extended 24 Weeks of Treatment||2||
59761836|NCT00542425|75881453|FG003|NOT COMPLETED|Extended 24 Weeks of Treatment||1||
59761837|NCT00542425|75881454|FG004|NOT COMPLETED|Extended 24 Weeks of Treatment||1||
59761838|NCT00541099|75881466|FG000|STARTED|Overall Study||11||
59761839|NCT00541099|75881466|FG000|COMPLETED|Overall Study||8||
59761840|NCT00541099|75881466|FG000|NOT COMPLETED|Overall Study||3||
59761841|NCT00580606|75881472|FG000|STARTED|Double Blind (DB)||20||
59761842|NCT00580606|75881473|FG001|STARTED|Double Blind (DB)||20||
59761843|NCT00580606|75881472|FG000|Had Week 44 Oral Food Challenge|Double Blind (DB)||18||
59761844|NCT00580606|75881473|FG001|Had Week 44 Oral Food Challenge|Double Blind (DB)||19||
59761845|NCT00580606|75881472|FG000|COMPLETED|Double Blind (DB)|Completed: Participants who were assessed for the primary outcome measure.|20||
59761846|NCT00580606|75881473|FG001|COMPLETED|Double Blind (DB)|Completed: Participants who were assessed for the primary outcome measure.|20||
59761847|NCT00580606|75881472|FG000|NOT COMPLETED|Double Blind (DB)||0||
59761848|NCT00580606|75881473|FG001|NOT COMPLETED|Double Blind (DB)||0||
59761849|NCT00580606|75881472|FG000|STARTED|Open Label (OL)|2 participants discontinued dosing before Open Label (OL) period.|18||
59761850|NCT00580606|75881473|FG001|STARTED|Open Label (OL)|1 participant discontinued dosing before OL period; 2 passed Week 44 OFC & ineligible to crossover.|17||
59761851|NCT00580606|75881472|FG000|Had Week 44 Oral Food Challenge|Open Label (OL)|The Week 44 OFC for Low Dose Peanut SLIT was done at the end of the DB Period, not the OL period.|0||
59761852|NCT00580606|75881473|FG001|Had Week 44 Oral Food Challenge|Open Label (OL)|After 44 weeks of OL high dose SLIT; 1 additional participant declined Week 44 OFC in OL period.|12||
59761853|NCT00580606|75881472|FG000|Had Week 68 Oral Food Challenge|Open Label (OL)||15||
59761854|NCT00580606|75881473|FG001|Had Week 68 Oral Food Challenge|Open Label (OL)||12||
59761855|NCT00580606|75881472|FG000|Had Week 116 Oral Food Challenge|Open Label (OL)||13||
59761856|NCT00580606|75881473|FG001|Had Week 116 Oral Food Challenge|Open Label (OL)||6||
59761857|NCT00580606|75881472|FG000|Had Week 164 Oral Food Challenge|Open Label (OL)||9||
59761858|NCT00580606|75881473|FG001|Had Week 164 Oral Food Challenge|Open Label (OL)||5||
59761859|NCT00580606|75881472|FG000|Had Week 172 Oral Food Challenge|Open Label (OL)||2||
59761860|NCT00580606|75881473|FG001|Had Week 172 Oral Food Challenge|Open Label (OL)||2||
59518438|NCT03372382|75612217|FG000|COMPLETED|Overall Study||76||
59518439|NCT03372382|75612218|FG001|COMPLETED|Overall Study||81||
59936028|NCT02921997|76054043|FG001|NOT COMPLETED|Overall Study||0||
59936029|NCT02921997|76054044|FG002|NOT COMPLETED|Overall Study||0||
59936030|NCT01083433|76054057|FG000|STARTED|Overall Study||22||
59936031|NCT01083433|76054058|FG001|STARTED|Overall Study||23||
59936032|NCT01083433|76054059|FG002|STARTED|Overall Study||23||
59936033|NCT01083433|76054057|FG000|COMPLETED|Overall Study||20||
59936034|NCT01083433|76054058|FG001|COMPLETED|Overall Study||17||
59936035|NCT01083433|76054059|FG002|COMPLETED|Overall Study||18||
59936036|NCT01083433|76054057|FG000|NOT COMPLETED|Overall Study||2||
59936037|NCT01083433|76054058|FG001|NOT COMPLETED|Overall Study||6||
59936038|NCT01083433|76054059|FG002|NOT COMPLETED|Overall Study||5||
59936039|NCT02791490|76054073|FG000|STARTED|Overall Study||229||
59936040|NCT02791490|76054074|FG001|STARTED|Overall Study||229||
59936041|NCT02791490|76054073|FG000|COMPLETED|Overall Study||226||
59936042|NCT02791490|76054074|FG001|COMPLETED|Overall Study||221||
59936043|NCT02791490|76054073|FG000|NOT COMPLETED|Overall Study||3||
59936044|NCT02791490|76054074|FG001|NOT COMPLETED|Overall Study||8||
59936045|NCT02833935|76054082|FG000|STARTED|Overall Study||12||
59936046|NCT02833935|76054083|FG001|STARTED|Overall Study||12||
59936047|NCT02833935|76054082|FG000|COMPLETED|Overall Study||10||
59936048|NCT02833935|76054083|FG001|COMPLETED|Overall Study||12||
59936049|NCT02833935|76054082|FG000|NOT COMPLETED|Overall Study||2||
59936050|NCT02833935|76054083|FG001|NOT COMPLETED|Overall Study||0||
59936051|NCT02507973|76054089|FG000|STARTED|Overall Study||8||
59936052|NCT02507973|76054089|FG000|COMPLETED|Overall Study||7||
59936053|NCT02507973|76054089|FG000|NOT COMPLETED|Overall Study||1||
59936054|NCT02425644|76054097|FG000|STARTED|Overall Study||567||
59936055|NCT02425644|76054098|FG001|STARTED|Overall Study||566||
59936056|NCT02425644|76054097|FG000|Treated|Overall Study||565||
59936057|NCT02425644|76054098|FG001|Treated|Overall Study||566||
59936058|NCT02425644|76054097|FG000|COMPLETED|Overall Study||490||
59936059|NCT02425644|76054098|FG001|COMPLETED|Overall Study||495||
59936060|NCT02425644|76054097|FG000|NOT COMPLETED|Overall Study||77||
59936061|NCT02425644|76054098|FG001|NOT COMPLETED|Overall Study||71||
59936062|NCT04174521|76054104|FG000|STARTED|Overall Study|A unit is defined as a mother-child pair; each unit was comprised of two participants: the mother and the child.|20670||
59936063|NCT04174521|76054104|FG000|COMPLETED|Overall Study|This was a retrospective observational study so there really was no drop-out.|20670||
59936064|NCT04174521|76054104|FG000|NOT COMPLETED|Overall Study||0||
59936065|NCT02861664|76054110|FG000|STARTED|Overall Study||67||
59936066|NCT02861664|76054111|FG001|STARTED|Overall Study||68||
59936067|NCT02861664|76054110|FG000|COMPLETED|Overall Study||67||
59761861|NCT00580606|75881472|FG000|COMPLETED|Open Label (OL)|Completed dosing & final Wk 164 desensitization OFC & Wk 172 tolerance OFC (if passed Wk 164 OFC).|9||
59762624|NCT00531427|75882453|FG000|NOT COMPLETED|Overall Study||73||
59936068|NCT02861664|76054111|FG001|COMPLETED|Overall Study||67||
59936069|NCT02861664|76054110|FG000|NOT COMPLETED|Overall Study||0||
59936070|NCT02861664|76054111|FG001|NOT COMPLETED|Overall Study||1||
59936071|NCT01307787|76054119|FG000|STARTED|Overall Study||19||
59936072|NCT01307787|76054120|FG001|STARTED|Overall Study||15||
59936073|NCT01307787|76054119|FG000|T1= After 9 Weeks Post Intervention|Overall Study||18||
59936074|NCT01307787|76054120|FG001|T1= After 9 Weeks Post Intervention|Overall Study||15||
59936075|NCT01307787|76054119|FG000|T2= After 22 Weeks at Follow-up|Overall Study||17||
59936076|NCT01307787|76054120|FG001|T2= After 22 Weeks at Follow-up|Overall Study||15||
59936077|NCT01307787|76054119|FG000|COMPLETED|Overall Study||17||
59936078|NCT01307787|76054120|FG001|COMPLETED|Overall Study||15||
59936079|NCT01307787|76054119|FG000|NOT COMPLETED|Overall Study||2||
59936080|NCT01307787|76054120|FG001|NOT COMPLETED|Overall Study||0||
59936081|NCT03284853|76054133|FG000|STARTED|Overall Study||218||
59936082|NCT03284853|76054134|FG001|STARTED|Overall Study||212||
59936083|NCT03284853|76054133|FG000|Intent-to-Treat Population|Overall Study||218|All randomized participants who received at least one dose of study medication.|
59936084|NCT03284853|76054134|FG001|Intent-to-Treat Population|Overall Study||212|All randomized participants who received at least one dose of study medication.|
59936085|NCT03284853|76054133|FG000|Per-Protocol Population|Overall Study||169|Subset of the ITT Population, includes participants (and their visits) who did not have major protocol violations likely to seriously affect the primary outcome of the study as judged by a masked evaluation prior to the unmasking of the study treatment.|
59936086|NCT03284853|76054134|FG001|Per-Protocol Population|Overall Study||170|Subset of the ITT Population, includes participants (and their visits) who did not have major protocol violations likely to seriously affect the primary outcome of the study as judged by a masked evaluation prior to the unmasking of the study treatment.|
59936087|NCT03284853|76054133|FG000|Safety Population|Overall Study||218|All randomized participants who received at least one dose of study medication.|
59936088|NCT03284853|76054134|FG001|Safety Population|Overall Study||212|All randomized participants who received at least one dose of study medication.|
60067391|NCT02092961|76182545|FG002|STARTED|Overall Study|Patients who received treatment|29||
59936089|NCT03284853|76054133|FG000|COMPLETED|Overall Study||163||
59936090|NCT03284853|76054134|FG001|COMPLETED|Overall Study||199||
59936091|NCT03284853|76054133|FG000|NOT COMPLETED|Overall Study||55||
59936092|NCT03284853|76054134|FG001|NOT COMPLETED|Overall Study||13||
60067392|NCT02092961|76182543|FG000|Randomised But Did Not Receive Treatment|Overall Study|Study stopped|1||
59936093|NCT01218555|76054140|FG000|STARTED|Overall Study||3||
59518440|NCT03372382|75612217|FG000|NOT COMPLETED|Overall Study||9||
59936094|NCT01218555|76054141|FG001|STARTED|Overall Study||3||
59936095|NCT01218555|76054142|FG002|STARTED|Overall Study||5||
59936096|NCT01218555|76054143|FG003|STARTED|Overall Study||3||
59936097|NCT01218555|76054144|FG004|STARTED|Overall Study||8||
59936098|NCT01218555|76054145|FG005|STARTED|Overall Study||22||
59936099|NCT01218555|76054140|FG000|COMPLETED|Overall Study||3||
59936100|NCT01218555|76054141|FG001|COMPLETED|Overall Study||3||
59936101|NCT01218555|76054142|FG002|COMPLETED|Overall Study||5||
59936102|NCT01218555|76054143|FG003|COMPLETED|Overall Study||3||
59936103|NCT01218555|76054144|FG004|COMPLETED|Overall Study||8||
59936104|NCT01218555|76054145|FG005|COMPLETED|Overall Study||22||
59936105|NCT01218555|76054140|FG000|NOT COMPLETED|Overall Study||0||
59936106|NCT01218555|76054141|FG001|NOT COMPLETED|Overall Study||0||
59936107|NCT01218555|76054142|FG002|NOT COMPLETED|Overall Study||0||
59936108|NCT01218555|76054143|FG003|NOT COMPLETED|Overall Study||0||
59936109|NCT01218555|76054144|FG004|NOT COMPLETED|Overall Study||0||
59936110|NCT01218555|76054145|FG005|NOT COMPLETED|Overall Study||0||
59936111|NCT01111305|76054151|FG000|STARTED|Overall Study||4||
59936112|NCT01111305|76054152|FG001|STARTED|Overall Study||4||
59936113|NCT01111305|76054151|FG000|COMPLETED|Overall Study||4||
59936114|NCT01111305|76054152|FG001|COMPLETED|Overall Study||4||
59936115|NCT01111305|76054151|FG000|NOT COMPLETED|Overall Study||0||
59936116|NCT01111305|76054152|FG001|NOT COMPLETED|Overall Study||0||
59936117|NCT04497415|76054162|FG000|STARTED|Overall Study||229|Pre-intervention assessment (day 1)|
59936118|NCT04497415|76054163|FG001|STARTED|Overall Study||121|Pre-intervention assessment (day 1)|
59936119|NCT04497415|76054162|FG000|Post-intervention Assessment (Day 1)|Overall Study||229||
59936120|NCT04497415|76054163|FG001|Post-intervention Assessment (Day 1)|Overall Study||121||
59936121|NCT04497415|76054162|FG000|First Follow-up Assessment (Day 14)|Overall Study||195||
59936122|NCT04497415|76054163|FG001|First Follow-up Assessment (Day 14)|Overall Study||102||
59936123|NCT04497415|76054162|FG000|COMPLETED|Overall Study||186|Second follow-up assessment (day 30)|
59936124|NCT04497415|76054163|FG001|COMPLETED|Overall Study||94|Second follow-up assessment (day 30)|
59936125|NCT04497415|76054162|FG000|NOT COMPLETED|Overall Study||43||
59936126|NCT04497415|76054163|FG001|NOT COMPLETED|Overall Study||27||
59936127|NCT03125941|76054171|FG000|STARTED|Overall Study||65||
59936128|NCT03125941|76054172|FG001|STARTED|Overall Study||65||
59936129|NCT03125941|76054171|FG000|Post-randomization Exclusion|Overall Study|procedure changed, did not receive intervention|1||
59936130|NCT03125941|76054172|FG001|Post-randomization Exclusion|Overall Study|procedure changed, did not receive intervention|2||
59936131|NCT03125941|76054171|FG000|COMPLETED|Overall Study||64||
59936132|NCT03125941|76054172|FG001|COMPLETED|Overall Study||63||
59936133|NCT03125941|76054171|FG000|NOT COMPLETED|Overall Study||1||
59936134|NCT03125941|76054172|FG001|NOT COMPLETED|Overall Study||2||
59936135|NCT02774889|76054180|FG000|STARTED|Overall Study||23||
59936136|NCT02774889|76054181|FG001|STARTED|Overall Study||22||
59936137|NCT02774889|76054180|FG000|COMPLETED|Overall Study||21||
59936138|NCT02774889|76054181|FG001|COMPLETED|Overall Study||21||
59936139|NCT02774889|76054180|FG000|NOT COMPLETED|Overall Study||2||
59936140|NCT02774889|76054181|FG001|NOT COMPLETED|Overall Study||1||
59936141|NCT03125629|76054189|FG000|STARTED|Overall Study||53||
59936142|NCT03125629|76054189|FG000|COMPLETED|Overall Study||50||
59936143|NCT03125629|76054189|FG000|NOT COMPLETED|Overall Study||3||
59936144|NCT03125395|76054201|FG000|STARTED|Overall Study||57||
59936145|NCT03125395|76054201|FG000|Study 115B FAS|Overall Study||60|Participants enrolled and exposed to any amount of study drug in parent study VX15-809-115.|
59936146|NCT03125395|76054201|FG000|Study 116 FAS|Overall Study||57|Participants enrolled and exposed to any amount of study drug in current study VX16-809-116.|
59936147|NCT03125395|76054201|FG000|Study 116 LCI Substudy Set|Overall Study||31||
59936148|NCT03125395|76054201|FG000|COMPLETED|Overall Study||47||
59936149|NCT03125395|76054201|FG000|NOT COMPLETED|Overall Study||10||
59936150|NCT02721069|76054205|FG000|STARTED|Overall Study||175||
59936151|NCT02721069|76054205|FG000|COMPLETED|Overall Study||117||
59936152|NCT02721069|76054205|FG000|NOT COMPLETED|Overall Study||58||
59936153|NCT00261807|76054215|FG000|STARTED|Overall Study||25||
59936154|NCT00261807|76054215|FG000|COMPLETED|Overall Study||18||
59936155|NCT00261807|76054215|FG000|NOT COMPLETED|Overall Study||7||
59936156|NCT02820753|76054222|FG000|STARTED|Baseline||256||
59936157|NCT02820753|76054223|FG001|STARTED|Baseline||421||
59936158|NCT02820753|76054222|FG000|COMPLETED|Baseline||256||
59936159|NCT02820753|76054223|FG001|COMPLETED|Baseline||421||
59936160|NCT02820753|76054222|FG000|NOT COMPLETED|Baseline||0||
59936161|NCT02820753|76054223|FG001|NOT COMPLETED|Baseline||0||
59936162|NCT02820753|76054222|FG000|STARTED|2 Month||256||
59936163|NCT02820753|76054223|FG001|STARTED|2 Month||421||
59936164|NCT02820753|76054222|FG000|COMPLETED|2 Month||178||
59936165|NCT02820753|76054223|FG001|COMPLETED|2 Month||379||
59936166|NCT02820753|76054222|FG000|NOT COMPLETED|2 Month||78||
59936167|NCT02820753|76054223|FG001|NOT COMPLETED|2 Month||42||
59936168|NCT02820753|76054222|FG000|STARTED|6 Month||253||
59936169|NCT02820753|76054223|FG001|STARTED|6 Month||418||
59936170|NCT02820753|76054222|FG000|COMPLETED|6 Month||150||
59936171|NCT02820753|76054223|FG001|COMPLETED|6 Month||307||
59936172|NCT02820753|76054222|FG000|NOT COMPLETED|6 Month||103||
59936173|NCT02820753|76054223|FG001|NOT COMPLETED|6 Month||111||
59936174|NCT02861586|76054237|FG000|STARTED|Overall Study||51||
59936175|NCT02861586|76054238|FG001|STARTED|Overall Study||18||
59936176|NCT02861586|76054239|FG002|STARTED|Overall Study||47||
59936177|NCT02861586|76054240|FG003|STARTED|Overall Study||16||
59936178|NCT02861586|76054241|FG004|STARTED|Overall Study||47||
59936179|NCT02861586|76054242|FG005|STARTED|Overall Study||50||
59936180|NCT02861586|76054243|FG006|STARTED|Overall Study||18||
59936181|NCT02861586|76054244|FG007|STARTED|Overall Study||16||
59936182|NCT02861586|76054237|FG000|COMPLETED|Overall Study||47||
59936183|NCT02861586|76054238|FG001|COMPLETED|Overall Study||15||
59936184|NCT02861586|76054239|FG002|COMPLETED|Overall Study||46||
59936185|NCT02861586|76054240|FG003|COMPLETED|Overall Study||16||
59936186|NCT02861586|76054241|FG004|COMPLETED|Overall Study||47||
59936187|NCT02861586|76054242|FG005|COMPLETED|Overall Study||45||
59936188|NCT02861586|76054243|FG006|COMPLETED|Overall Study||17||
59936189|NCT02861586|76054244|FG007|COMPLETED|Overall Study||16||
59936190|NCT02861586|76054237|FG000|NOT COMPLETED|Overall Study||4||
59936191|NCT02861586|76054238|FG001|NOT COMPLETED|Overall Study||3||
59936192|NCT02861586|76054239|FG002|NOT COMPLETED|Overall Study||1||
59936193|NCT02861586|76054240|FG003|NOT COMPLETED|Overall Study||0||
59936194|NCT02861586|76054241|FG004|NOT COMPLETED|Overall Study||0||
59936195|NCT02861586|76054242|FG005|NOT COMPLETED|Overall Study||5||
59936196|NCT02861586|76054243|FG006|NOT COMPLETED|Overall Study||1||
59936197|NCT02861586|76054244|FG007|NOT COMPLETED|Overall Study||0||
59936198|NCT02384421|76054267|FG000|STARTED|Overall Study||22||
59936199|NCT02384421|76054267|FG000|COMPLETED|Overall Study||22||
59936200|NCT02384421|76054267|FG000|NOT COMPLETED|Overall Study||0||
59936201|NCT01377753|76054274|FG000|STARTED|Overall Study||15||
59936202|NCT01377753|76054274|FG000|COMPLETED|Overall Study||15||
59936203|NCT01377753|76054274|FG000|NOT COMPLETED|Overall Study||0||
59936204|NCT04964193|76054278|FG000|STARTED|1st Intervention||12||
59936205|NCT04964193|76054279|FG001|STARTED|1st Intervention||12||
59936206|NCT04964193|76054278|FG000|COMPLETED|1st Intervention||12||
59936207|NCT04964193|76054279|FG001|COMPLETED|1st Intervention||12||
59936208|NCT04964193|76054278|FG000|NOT COMPLETED|1st Intervention||0||
59936209|NCT04964193|76054279|FG001|NOT COMPLETED|1st Intervention||0||
59936210|NCT04964193|76054278|FG000|STARTED|Washout = Three Weeks||12||
59936211|NCT04964193|76054279|FG001|STARTED|Washout = Three Weeks||12||
59936212|NCT04964193|76054278|FG000|COMPLETED|Washout = Three Weeks||12||
59936213|NCT04964193|76054279|FG001|COMPLETED|Washout = Three Weeks||12||
59936214|NCT04964193|76054278|FG000|NOT COMPLETED|Washout = Three Weeks||0||
59936215|NCT04964193|76054279|FG001|NOT COMPLETED|Washout = Three Weeks||0||
59936216|NCT04964193|76054278|FG000|STARTED|2nd Intervention||12||
59936217|NCT04964193|76054279|FG001|STARTED|2nd Intervention||12||
59936218|NCT04964193|76054278|FG000|COMPLETED|2nd Intervention||12||
59936219|NCT04964193|76054279|FG001|COMPLETED|2nd Intervention||12||
59936220|NCT04964193|76054278|FG000|NOT COMPLETED|2nd Intervention||0||
59936221|NCT04964193|76054279|FG001|NOT COMPLETED|2nd Intervention||0||
59936222|NCT03124537|76054287|FG000|STARTED|Overall Study||41||
59936223|NCT03124537|76054288|FG001|STARTED|Overall Study||45||
59936224|NCT03124537|76054287|FG000|COMPLETED|Overall Study||31||
59936225|NCT03124537|76054288|FG001|COMPLETED|Overall Study||32||
59936226|NCT03124537|76054287|FG000|NOT COMPLETED|Overall Study||10||
59936227|NCT03124537|76054288|FG001|NOT COMPLETED|Overall Study||13||
59936228|NCT03118297|76054296|FG000|STARTED|Overall Study||32||
60067393|NCT02092961|76182544|FG001|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/study stopped|5||
59936229|NCT03118297|76054297|FG001|STARTED|Overall Study||33||
59936230|NCT03118297|76054296|FG000|COMPLETED|Overall Study||32||
59936231|NCT03118297|76054297|FG001|COMPLETED|Overall Study||31||
59936232|NCT03118297|76054296|FG000|NOT COMPLETED|Overall Study||0||
59936233|NCT03118297|76054297|FG001|NOT COMPLETED|Overall Study||2||
59936234|NCT03117361|76054303|FG000|STARTED|Overall Study||10||
59936235|NCT03117361|76054303|FG000|COMPLETED|Overall Study||0||
59936236|NCT03117361|76054303|FG000|NOT COMPLETED|Overall Study||10||
59936237|NCT01368614|76054307|FG000|STARTED|Screening Period||90||
59936238|NCT01368614|76054308|FG001|STARTED|Screening Period||0||
59936239|NCT01368614|76054309|FG002|STARTED|Screening Period||0||
59936240|NCT01368614|76054310|FG003|STARTED|Screening Period||0||
59936241|NCT01368614|76054307|FG000|COMPLETED|Screening Period||32||
59936242|NCT01368614|76054308|FG001|COMPLETED|Screening Period||0||
59936243|NCT01368614|76054309|FG002|COMPLETED|Screening Period||0||
59936244|NCT01368614|76054310|FG003|COMPLETED|Screening Period||0||
59936245|NCT01368614|76054307|FG000|NOT COMPLETED|Screening Period||58||
59936246|NCT01368614|76054308|FG001|NOT COMPLETED|Screening Period||0||
59936247|NCT01368614|76054309|FG002|NOT COMPLETED|Screening Period||0||
59936248|NCT01368614|76054310|FG003|NOT COMPLETED|Screening Period||0||
59936249|NCT01368614|76054307|FG000|STARTED|Study Period||0||
59936250|NCT01368614|76054308|FG001|STARTED|Study Period||11||
59936251|NCT01368614|76054309|FG002|STARTED|Study Period||10||
59936252|NCT01368614|76054310|FG003|STARTED|Study Period||11||
59936253|NCT01368614|76054307|FG000|COMPLETED|Study Period||0||
59936254|NCT01368614|76054308|FG001|COMPLETED|Study Period||10||
59936255|NCT01368614|76054309|FG002|COMPLETED|Study Period||8||
59936256|NCT01368614|76054310|FG003|COMPLETED|Study Period||8||
59936257|NCT01368614|76054307|FG000|NOT COMPLETED|Study Period||0||
59936258|NCT01368614|76054308|FG001|NOT COMPLETED|Study Period||1||
59936259|NCT01368614|76054309|FG002|NOT COMPLETED|Study Period||2||
59936260|NCT01368614|76054310|FG003|NOT COMPLETED|Study Period||3||
59936261|NCT03053427|76054320|FG000|STARTED|Overall Study||186||
59936262|NCT03053427|76054321|FG001|STARTED|Overall Study||189||
59936263|NCT03053427|76054320|FG000|COMPLETED|Overall Study||173||
59936264|NCT03053427|76054321|FG001|COMPLETED|Overall Study||173||
59936265|NCT03053427|76054320|FG000|NOT COMPLETED|Overall Study||13||
59936266|NCT03053427|76054321|FG001|NOT COMPLETED|Overall Study||16||
59936267|NCT02373241|76054329|FG000|STARTED|Overall Study||0||
59936268|NCT02373241|76054330|FG001|STARTED|Overall Study||1||
59936269|NCT02373241|76054329|FG000|COMPLETED|Overall Study||0||
59936270|NCT02373241|76054330|FG001|COMPLETED|Overall Study||1||
59936271|NCT02373241|76054329|FG000|NOT COMPLETED|Overall Study||0||
59936272|NCT02373241|76054330|FG001|NOT COMPLETED|Overall Study||0||
59936273|NCT03052959|76054338|FG000|STARTED|Overall Study||59||5
59936274|NCT03052959|76054339|FG001|STARTED|Overall Study||66||5
59936275|NCT03052959|76054338|FG000|COMPLETED|Overall Study||55||5
59936276|NCT03052959|76054339|FG001|COMPLETED|Overall Study||61||5
59936277|NCT03052959|76054338|FG000|NOT COMPLETED|Overall Study||4||0
59936278|NCT03052959|76054339|FG001|NOT COMPLETED|Overall Study||5||0
59936279|NCT03120013|76054346|FG000|STARTED|First Intervention (2 Weeks)||10||
59936280|NCT03120013|76054347|FG001|STARTED|First Intervention (2 Weeks)||11||
59936281|NCT03120013|76054346|FG000|Received Intervention|First Intervention (2 Weeks)||10||
59936282|NCT03120013|76054347|FG001|Received Intervention|First Intervention (2 Weeks)||11||
59936283|NCT03120013|76054346|FG000|COMPLETED|First Intervention (2 Weeks)||10||
59936284|NCT03120013|76054347|FG001|COMPLETED|First Intervention (2 Weeks)||10||
59936285|NCT03120013|76054346|FG000|NOT COMPLETED|First Intervention (2 Weeks)||0||
59936286|NCT03120013|76054347|FG001|NOT COMPLETED|First Intervention (2 Weeks)||1||
59936287|NCT03120013|76054346|FG000|STARTED|Washout (6 Months)||10||
59936288|NCT03120013|76054347|FG001|STARTED|Washout (6 Months)||10||
59936289|NCT03120013|76054346|FG000|COMPLETED|Washout (6 Months)||10||
59936290|NCT03120013|76054347|FG001|COMPLETED|Washout (6 Months)||10||
59936291|NCT03120013|76054346|FG000|NOT COMPLETED|Washout (6 Months)||0||
59936292|NCT03120013|76054347|FG001|NOT COMPLETED|Washout (6 Months)||0||
59936293|NCT03120013|76054346|FG000|STARTED|Second Intervention (2 Weeks)||10||
59936294|NCT03120013|76054347|FG001|STARTED|Second Intervention (2 Weeks)||10||
59936295|NCT03120013|76054346|FG000|COMPLETED|Second Intervention (2 Weeks)||10||
59936296|NCT03120013|76054347|FG001|COMPLETED|Second Intervention (2 Weeks)||10||
59936297|NCT03120013|76054346|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||0||
59936298|NCT03120013|76054347|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||0||
59936299|NCT01845649|76054355|FG000|STARTED|Overall Study||273||
59936300|NCT01845649|76054356|FG001|STARTED|Overall Study||277||
59936301|NCT01845649|76054355|FG000|Safety Population|Overall Study||271||
59936302|NCT01845649|76054356|FG001|Safety Population|Overall Study||277||
59936303|NCT01845649|76054355|FG000|Modified Intent-to-treat (mITT) Population|Overall Study||233||
59936304|NCT01845649|76054356|FG001|Modified Intent-to-treat (mITT) Population|Overall Study||239||
59936305|NCT01845649|76054355|FG000|COMPLETED|Overall Study||242||
59936306|NCT01845649|76054356|FG001|COMPLETED|Overall Study||255||
59936307|NCT01845649|76054355|FG000|NOT COMPLETED|Overall Study||31||
59936308|NCT01845649|76054356|FG001|NOT COMPLETED|Overall Study||22||
59936309|NCT01345929|76054364|FG000|STARTED|Overall Study||533||
59936310|NCT01345929|76054365|FG001|STARTED|Overall Study||535||
59936311|NCT01345929|76054364|FG000|COMPLETED|Overall Study||512||
59936312|NCT01345929|76054365|FG001|COMPLETED|Overall Study||516||
59936313|NCT01345929|76054364|FG000|NOT COMPLETED|Overall Study||21||
59936314|NCT01345929|76054365|FG001|NOT COMPLETED|Overall Study||19||
59936315|NCT01343901|76054371|FG000|STARTED|Overall Study||210||
59936316|NCT01343901|76054371|FG000|Efficacy Population|Overall Study||205||
59936317|NCT01343901|76054371|FG000|COMPLETED|Overall Study||97||
59936318|NCT01343901|76054371|FG000|NOT COMPLETED|Overall Study||113||
59936319|NCT03053271|76054375|FG000|STARTED|Overall Study||4||
59936320|NCT03053271|76054375|FG000|COMPLETED|Overall Study|All completed the open-label dose escalation, but did not meet criteria for randomization|0||
59936321|NCT03053271|76054375|FG000|NOT COMPLETED|Overall Study||4||
59936322|NCT01343823|76054383|FG000|STARTED|Overall Study||20||
59936323|NCT01343823|76054384|FG001|STARTED|Overall Study||20||
59936324|NCT01343823|76054385|FG002|STARTED|Overall Study||19||
59936325|NCT01343823|76054386|FG003|STARTED|Overall Study||20||
59936326|NCT01343823|76054383|FG000|COMPLETED|Overall Study||18||
59936327|NCT01343823|76054384|FG001|COMPLETED|Overall Study||20||
59936328|NCT01343823|76054385|FG002|COMPLETED|Overall Study||19||
59936329|NCT01343823|76054386|FG003|COMPLETED|Overall Study||19||
59936330|NCT01343823|76054383|FG000|NOT COMPLETED|Overall Study||2||
59936331|NCT01343823|76054384|FG001|NOT COMPLETED|Overall Study||0||
59936332|NCT01343823|76054385|FG002|NOT COMPLETED|Overall Study||0||
59936333|NCT01343823|76054386|FG003|NOT COMPLETED|Overall Study||1||
59936334|NCT01318083|76054399|FG000|STARTED|Overall Study||105||
59936335|NCT01318083|76054400|FG001|STARTED|Overall Study||104||
59936336|NCT01318083|76054401|FG002|STARTED|Overall Study||103||
59936337|NCT01318083|76054399|FG000|COMPLETED|Overall Study||99||
59936338|NCT01318083|76054400|FG001|COMPLETED|Overall Study||102||
59936339|NCT01318083|76054401|FG002|COMPLETED|Overall Study||98||
59936340|NCT01318083|76054399|FG000|NOT COMPLETED|Overall Study||6||
59936341|NCT01318083|76054400|FG001|NOT COMPLETED|Overall Study||2||
59936342|NCT01318083|76054401|FG002|NOT COMPLETED|Overall Study||5||
59936343|NCT01376323|76054414|FG000|STARTED|Overall Study||20||
59936344|NCT01376323|76054415|FG001|STARTED|Overall Study||18||
59936345|NCT01376323|76054416|FG002|STARTED|Overall Study||19||
59936346|NCT01376323|76054417|FG003|STARTED|Overall Study||19||
59936347|NCT01376323|76054418|FG004|STARTED|Overall Study||18||
59936348|NCT01376323|76054414|FG000|COMPLETED|Overall Study||18||
59936349|NCT01376323|76054415|FG001|COMPLETED|Overall Study||17||
59936350|NCT01376323|76054416|FG002|COMPLETED|Overall Study||16||
59936351|NCT01376323|76054417|FG003|COMPLETED|Overall Study||14||
59936352|NCT01376323|76054418|FG004|COMPLETED|Overall Study||17||
59936353|NCT01376323|76054414|FG000|NOT COMPLETED|Overall Study||2||
59936354|NCT01376323|76054415|FG001|NOT COMPLETED|Overall Study||1||
59936355|NCT01376323|76054416|FG002|NOT COMPLETED|Overall Study||3||
59936356|NCT01376323|76054417|FG003|NOT COMPLETED|Overall Study||5||
59936357|NCT01376323|76054418|FG004|NOT COMPLETED|Overall Study||1||
59936358|NCT04975321|76054443|FG000|STARTED|Overall Study||25||70
59936359|NCT04975321|76054444|FG001|STARTED|Overall Study||26||80
59936360|NCT04975321|76054445|FG002|STARTED|Overall Study||25||70
59936361|NCT04975321|76054443|FG000|COMPLETED|Overall Study||15||40
59936362|NCT04975321|76054444|FG001|COMPLETED|Overall Study||15||47
59936363|NCT04975321|76054445|FG002|COMPLETED|Overall Study||17||48
59936364|NCT04975321|76054443|FG000|NOT COMPLETED|Overall Study||10||30
59936365|NCT04975321|76054444|FG001|NOT COMPLETED|Overall Study||11||33
59936366|NCT04975321|76054445|FG002|NOT COMPLETED|Overall Study||8||22
59936367|NCT03725293|76054455|FG000|STARTED|Overall Study||106||
59936368|NCT03725293|76054456|FG001|STARTED|Overall Study||106||
59936369|NCT03725293|76054455|FG000|COMPLETED|Overall Study||94||
59936370|NCT03725293|76054456|FG001|COMPLETED|Overall Study||97||
59936371|NCT03725293|76054455|FG000|NOT COMPLETED|Overall Study||12||
59936372|NCT03725293|76054456|FG001|NOT COMPLETED|Overall Study||9||
59936373|NCT01368536|76054465|FG000|STARTED|Overall Study||138||
59936374|NCT01368536|76054466|FG001|STARTED|Overall Study||137||
59936375|NCT01368536|76054467|FG002|STARTED|Overall Study||142||
59936376|NCT01368536|76054465|FG000|Full Analysis Set|Overall Study||138||
59936377|NCT01368536|76054466|FG001|Full Analysis Set|Overall Study||137||
59936378|NCT01368536|76054467|FG002|Full Analysis Set|Overall Study|One patient was excluded from efficacy analysis as there was no post baseline data|141||
59936379|NCT01368536|76054465|FG000|COMPLETED|Overall Study||87||
59936380|NCT01368536|76054466|FG001|COMPLETED|Overall Study||78||
60067394|NCT02092961|76182545|FG002|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled|1||
59936381|NCT01368536|76054467|FG002|COMPLETED|Overall Study||83||
59936382|NCT01368536|76054465|FG000|NOT COMPLETED|Overall Study||51||
59936383|NCT01368536|76054466|FG001|NOT COMPLETED|Overall Study||59||
59936384|NCT01368536|76054467|FG002|NOT COMPLETED|Overall Study||59||
59936385|NCT03051165|76054476|FG000|STARTED|Overall Study||13||
59936386|NCT03051165|76054476|FG000|Completed Some Baseline Assessments|Overall Study||1|Baseline assessments refer to clinical assessments; demographic information was collected for all.|
59936387|NCT03051165|76054476|FG000|Completed Some Day 105 Assessments|Overall Study||1|Day 105 assessments occur just prior to HGNS treatment withdrawal.|
59936388|NCT03051165|76054476|FG000|Began HGNS Treatment Withdrawal|Overall Study||0||
59936389|NCT03051165|76054476|FG000|Completed Some Day 137 Assessments|Overall Study||0|Day 137 assessments occur after 30 days of HGNS treatment withdrawal.|
59936390|NCT03051165|76054476|FG000|COMPLETED|Overall Study||0||
59936391|NCT03051165|76054476|FG000|NOT COMPLETED|Overall Study||13||
59936392|NCT01319929|76054482|FG000|STARTED|First Treatment Period (4 Weeks)||20||
59936393|NCT01319929|76054483|FG001|STARTED|First Treatment Period (4 Weeks)||19||
59936394|NCT01319929|76054482|FG000|COMPLETED|First Treatment Period (4 Weeks)||17||
59936395|NCT01319929|76054483|FG001|COMPLETED|First Treatment Period (4 Weeks)||17||
59936396|NCT01319929|76054482|FG000|NOT COMPLETED|First Treatment Period (4 Weeks)||3||
59936397|NCT01319929|76054483|FG001|NOT COMPLETED|First Treatment Period (4 Weeks)||2||
59936398|NCT01319929|76054482|FG000|STARTED|Washout Period (3 Weeks)||17||
59936399|NCT01319929|76054483|FG001|STARTED|Washout Period (3 Weeks)||17||
59936400|NCT01319929|76054482|FG000|COMPLETED|Washout Period (3 Weeks)||17||
59936401|NCT01319929|76054483|FG001|COMPLETED|Washout Period (3 Weeks)||17||
59936402|NCT01319929|76054482|FG000|NOT COMPLETED|Washout Period (3 Weeks)||0||
59936403|NCT01319929|76054483|FG001|NOT COMPLETED|Washout Period (3 Weeks)||0||
59936404|NCT01319929|76054482|FG000|STARTED|Second Treatment Period (4 Weeks)||17||
59936405|NCT01319929|76054483|FG001|STARTED|Second Treatment Period (4 Weeks)||17||
59936406|NCT01319929|76054482|FG000|COMPLETED|Second Treatment Period (4 Weeks)||16||
59936407|NCT01319929|76054483|FG001|COMPLETED|Second Treatment Period (4 Weeks)||16||
59936408|NCT01319929|76054482|FG000|NOT COMPLETED|Second Treatment Period (4 Weeks)||1||
59936409|NCT01319929|76054483|FG001|NOT COMPLETED|Second Treatment Period (4 Weeks)||1||
59936410|NCT03110185|76054492|FG000|STARTED|Overall Study||27||
59936411|NCT03110185|76054493|FG001|STARTED|Overall Study||64||
59936412|NCT03110185|76054492|FG000|COMPLETED|Overall Study||17||
59936413|NCT03110185|76054493|FG001|COMPLETED|Overall Study||33||
59936414|NCT03110185|76054492|FG000|NOT COMPLETED|Overall Study||10||
59936415|NCT03110185|76054493|FG001|NOT COMPLETED|Overall Study||31||
59936416|NCT02858076|76054504|FG000|STARTED|Overall Study||100||
59936417|NCT02858076|76054505|FG001|STARTED|Overall Study||105||
59936418|NCT02858076|76054504|FG000|COMPLETED|Overall Study||90||
59936419|NCT02858076|76054505|FG001|COMPLETED|Overall Study||87||
59936420|NCT02858076|76054504|FG000|NOT COMPLETED|Overall Study||10||
59936421|NCT02858076|76054505|FG001|NOT COMPLETED|Overall Study||18||
59936422|NCT04594759|76054513|FG000|STARTED|Overall Study||22||
59936423|NCT04594759|76054513|FG000|COMPLETED|Overall Study||19||
59936424|NCT04594759|76054513|FG000|NOT COMPLETED|Overall Study||3||
59936425|NCT02856282|76054517|FG000|STARTED|Overall Study||46||
59936426|NCT02856282|76054517|FG000|COMPLETED|Overall Study||45||
59936427|NCT02856282|76054517|FG000|NOT COMPLETED|Overall Study||1||
59936428|NCT03833817|76054523|FG000|STARTED|Overall Study||14||
59936429|NCT03833817|76054524|FG001|STARTED|Overall Study||14||
59936430|NCT03833817|76054523|FG000|COMPLETED|Overall Study|*Note: Whereas 8 patients completed the study, 1 additional patient was able to be included in the analysis of most patient outcome measures as they completed the applicable assessments for those measures prior to being lost to follow-up.|8||
59936431|NCT03833817|76054524|FG001|COMPLETED|Overall Study||8||
59936432|NCT03833817|76054523|FG000|NOT COMPLETED|Overall Study||6||
59936433|NCT03833817|76054524|FG001|NOT COMPLETED|Overall Study||6||
59936434|NCT03119701|76054532|FG000|STARTED|6-day Dosing||29||
59936435|NCT03119701|76054533|FG001|STARTED|6-day Dosing||11||
59936436|NCT03119701|76054532|FG000|COMPLETED|6-day Dosing||22||
59936437|NCT03119701|76054533|FG001|COMPLETED|6-day Dosing||8||
59936438|NCT03119701|76054532|FG000|NOT COMPLETED|6-day Dosing||7||
59936439|NCT03119701|76054533|FG001|NOT COMPLETED|6-day Dosing||3||
59936440|NCT03119701|76054532|FG000|STARTED|Mid-term (Final) Follow-up at D90|3 patients who discontinued study drug due to adverse events were also followed up.|25||
59936441|NCT03119701|76054533|FG001|STARTED|Mid-term (Final) Follow-up at D90|2 patients who did not receive 6 doses were also followed up.|10||
59936442|NCT03119701|76054532|FG000|COMPLETED|Mid-term (Final) Follow-up at D90||22||
59936443|NCT03119701|76054533|FG001|COMPLETED|Mid-term (Final) Follow-up at D90||9||
59936444|NCT03119701|76054532|FG000|NOT COMPLETED|Mid-term (Final) Follow-up at D90||3||
59936445|NCT03119701|76054533|FG001|NOT COMPLETED|Mid-term (Final) Follow-up at D90||1||
59936446|NCT03717129|76054539|FG000|STARTED|Genvoya Oral Dose (1 Week)||12||
59936447|NCT03717129|76054539|FG000|COMPLETED|Genvoya Oral Dose (1 Week)||12||
59936448|NCT03717129|76054539|FG000|NOT COMPLETED|Genvoya Oral Dose (1 Week)||0||
59936449|NCT03717129|76054539|FG000|STARTED|Washout (2 Weeks)||12||
59936450|NCT03717129|76054539|FG000|COMPLETED|Washout (2 Weeks)||12||
59936451|NCT03717129|76054539|FG000|NOT COMPLETED|Washout (2 Weeks)||0||
59936452|NCT03717129|76054539|FG000|STARTED|Genvoya Crushed Dose (1 Week)||12||
59936453|NCT03717129|76054539|FG000|COMPLETED|Genvoya Crushed Dose (1 Week)||12||
59936454|NCT03717129|76054539|FG000|NOT COMPLETED|Genvoya Crushed Dose (1 Week)||0||
59936455|NCT02679781|76054547|FG000|STARTED|Overall Study||37||
59936456|NCT02679781|76054548|FG001|STARTED|Overall Study||33||
59761862|NCT00580606|75881473|FG001|COMPLETED|Open Label (OL)|Completed dosing & final Wk 164 desensitization OFC & Wk 172 tolerance OFC (if passed Wk 164 OFC).|5||
59761863|NCT00580606|75881472|FG000|NOT COMPLETED|Open Label (OL)||9||
59761864|NCT00580606|75881473|FG001|NOT COMPLETED|Open Label (OL)||12||
59761865|NCT00579982|75881487|FG000|STARTED|Overall Study||97||
59761866|NCT00579982|75881487|FG000|COMPLETED|Overall Study||89||
59761867|NCT00579982|75881487|FG000|NOT COMPLETED|Overall Study||8||
59761868|NCT00596466|75881491|FG000|STARTED|Overall Study||75||
59761869|NCT00596466|75881491|FG000|Enrolled, Treated|Overall Study||73||
59761870|NCT00596466|75881491|FG000|COMPLETED|Overall Study||58||
59761871|NCT00596466|75881491|FG000|NOT COMPLETED|Overall Study||17||
59761872|NCT00596934|75881495|FG000|STARTED|Overall Study||9||
59761873|NCT00596934|75881495|FG000|COMPLETED|Overall Study||7||
59761874|NCT00596934|75881495|FG000|NOT COMPLETED|Overall Study||2||
59936457|NCT02679781|76054547|FG000|COMPLETED|Overall Study||30||
59936458|NCT02679781|76054548|FG001|COMPLETED|Overall Study||30||
59936459|NCT02679781|76054547|FG000|NOT COMPLETED|Overall Study||7||
59936460|NCT02679781|76054548|FG001|NOT COMPLETED|Overall Study||3||
59936461|NCT02624869|76054557|FG000|STARTED|Overall Study||49||
59936462|NCT02624869|76054558|FG001|STARTED|Overall Study||101||
59936463|NCT02624869|76054559|FG002|STARTED|Overall Study||13||
59936464|NCT02624869|76054557|FG000|Received Study Drug|Overall Study||49||
59936465|NCT02624869|76054558|FG001|Received Study Drug|Overall Study||101||
59936466|NCT02624869|76054559|FG002|Received Study Drug|Overall Study||12||
59761875|NCT03911401|75881504|FG000|STARTED|Overall Study||83||
59761876|NCT03911401|75881505|FG001|STARTED|Overall Study||85||
59761877|NCT03911401|75881506|FG002|STARTED|Overall Study||83||
59761878|NCT03911401|75881504|FG000|COMPLETED|Overall Study||76||
59936467|NCT02624869|76054557|FG000|COMPLETED|Overall Study||48||
59936468|NCT02624869|76054558|FG001|COMPLETED|Overall Study||98||
59936469|NCT02624869|76054559|FG002|COMPLETED|Overall Study||11||
59936470|NCT02624869|76054557|FG000|NOT COMPLETED|Overall Study||1||
59936471|NCT02624869|76054558|FG001|NOT COMPLETED|Overall Study||3||
59936472|NCT02624869|76054559|FG002|NOT COMPLETED|Overall Study||2||
59936473|NCT03318393|76054570|FG000|STARTED|Overall Study||14||
59936474|NCT03318393|76054571|FG001|STARTED|Overall Study||16||
59936475|NCT03318393|76054570|FG000|COMPLETED|Overall Study||14||
59761879|NCT03911401|75881505|FG001|COMPLETED|Overall Study||76||
59761880|NCT03911401|75881506|FG002|COMPLETED|Overall Study||58||
59761881|NCT03911401|75881504|FG000|NOT COMPLETED|Overall Study||7||
59761882|NCT03911401|75881505|FG001|NOT COMPLETED|Overall Study||9||
59761883|NCT03911401|75881506|FG002|NOT COMPLETED|Overall Study||25||
59761884|NCT00579670|75881519|FG000|STARTED|Overall Study|Full Analysis Set (FAS): at least 1 dose study medication and at least 1 efficacy measurement|15||
59761885|NCT00579670|75881520|FG001|STARTED|Overall Study||57||
59936476|NCT03318393|76054571|FG001|COMPLETED|Overall Study||16||
59936477|NCT03318393|76054570|FG000|NOT COMPLETED|Overall Study||0||
59936478|NCT03318393|76054571|FG001|NOT COMPLETED|Overall Study||0||
59936479|NCT03110029|76054579|FG000|STARTED|Overall Study||7||
59936480|NCT03110029|76054580|FG001|STARTED|Overall Study||6||
59936481|NCT03110029|76054579|FG000|COMPLETED|Overall Study||6||
59936482|NCT03110029|76054580|FG001|COMPLETED|Overall Study||5||
59936483|NCT03110029|76054579|FG000|NOT COMPLETED|Overall Study||1||
59936484|NCT03110029|76054580|FG001|NOT COMPLETED|Overall Study||1||
59936485|NCT04207749|76054588|FG000|STARTED|Overall Study||78||156
59936486|NCT04207749|76054589|FG001|STARTED|Overall Study||156||312
59936487|NCT04207749|76054588|FG000|COMPLETED|Overall Study||74||148
59936488|NCT04207749|76054589|FG001|COMPLETED|Overall Study||149||298
59936489|NCT04207749|76054588|FG000|NOT COMPLETED|Overall Study||4||8
59936490|NCT04207749|76054589|FG001|NOT COMPLETED|Overall Study||7||14
59936491|NCT03043365|76054600|FG000|STARTED|Weeks 0 to Week 8||20||
59936492|NCT03043365|76054601|FG001|STARTED|Weeks 0 to Week 8||17||
59936493|NCT03043365|76054600|FG000|COMPLETED|Weeks 0 to Week 8||17||
59936494|NCT03043365|76054601|FG001|COMPLETED|Weeks 0 to Week 8||14||
59936495|NCT03043365|76054600|FG000|NOT COMPLETED|Weeks 0 to Week 8||3||
59936496|NCT03043365|76054601|FG001|NOT COMPLETED|Weeks 0 to Week 8||3||
59936497|NCT03043365|76054600|FG000|STARTED|Week 8 to Week 16 - Washout Period||17||
59936498|NCT03043365|76054601|FG001|STARTED|Week 8 to Week 16 - Washout Period||14||
59936499|NCT03043365|76054600|FG000|COMPLETED|Week 8 to Week 16 - Washout Period||16||
59936500|NCT03043365|76054601|FG001|COMPLETED|Week 8 to Week 16 - Washout Period||14||
59936501|NCT03043365|76054600|FG000|NOT COMPLETED|Week 8 to Week 16 - Washout Period||1||
59936502|NCT03043365|76054601|FG001|NOT COMPLETED|Week 8 to Week 16 - Washout Period||0||
59936503|NCT03043365|76054600|FG000|STARTED|Week 16 to Week 24||16||
59936504|NCT03043365|76054601|FG001|STARTED|Week 16 to Week 24||14||
59936505|NCT03043365|76054600|FG000|COMPLETED|Week 16 to Week 24||16||
59936506|NCT03043365|76054601|FG001|COMPLETED|Week 16 to Week 24||14||
60067395|NCT02092961|76182543|FG000|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|12||
60067396|NCT02092961|76182544|FG001|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|14||
60067397|NCT02092961|76182545|FG002|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|13||
60067398|NCT02092961|76182543|FG000|NOT COMPLETED|Overall Study||21||
60067399|NCT02092961|76182544|FG001|NOT COMPLETED|Overall Study||14||
60067400|NCT02092961|76182545|FG002|NOT COMPLETED|Overall Study||16||
60067401|NCT01898078|76182556|FG000|STARTED|Overall Study||13||
60067402|NCT01898078|76182557|FG001|STARTED|Overall Study||13||
59613327|NCT01568034|75724486|FG003|STARTED|Overall Study||3||
59761886|NCT00579670|75881521|FG002|STARTED|Overall Study||88||
59761887|NCT00579670|75881522|FG003|STARTED|Overall Study||285||
59761888|NCT00579670|75881523|FG004|STARTED|Overall Study||5||
59761889|NCT00579670|75881519|FG000|Population: Within SmPC (Started)|Overall Study|"Within summary of product characteristics (SmPC): FAS subjects who received all doses Within SmPC"|15||
59761890|NCT00579670|75881520|FG001|Population: Within SmPC (Started)|Overall Study||56||
59761891|NCT00579670|75881521|FG002|Population: Within SmPC (Started)|Overall Study||83||
59761892|NCT00579670|75881522|FG003|Population: Within SmPC (Started)|Overall Study||159||
59761893|NCT00579670|75881523|FG004|Population: Within SmPC (Started)|Overall Study|"Ziprasidone Unknown reporting group is not applicable to the Within SmPC population"|0||
59761894|NCT00579670|75881519|FG000|Population: Within SmPC (Completed)|Overall Study|Not Completed (DC): Subject died N=1; Adverse Event (AE) N=1|13||
59761895|NCT00579670|75881520|FG001|Population: Within SmPC (Completed)|Overall Study|DC: Lost to follow-up (LTFU) N=1|55||
59761896|NCT00579670|75881521|FG002|Population: Within SmPC (Completed)|Overall Study|DC: AE N=1; Lack of efficacy N=1; Other unspecified N=1; Withdrawal by subject N=1|79||
59761897|NCT00579670|75881522|FG003|Population: Within SmPC (Completed)|Overall Study|DC: AE N=2; Lack of efficacy N=5; LTFU N=3; Other unspecified N=2|147||
59761898|NCT00579670|75881523|FG004|Population: Within SmPC (Completed)|Overall Study||0||
59761899|NCT00579670|75881519|FG000|COMPLETED|Overall Study||13||
59761900|NCT00579670|75881520|FG001|COMPLETED|Overall Study||56||
59761901|NCT00579670|75881521|FG002|COMPLETED|Overall Study||84||
59761902|NCT00579670|75881522|FG003|COMPLETED|Overall Study||263||
59761903|NCT00579670|75881523|FG004|COMPLETED|Overall Study||5||
59936507|NCT03043365|76054600|FG000|NOT COMPLETED|Week 16 to Week 24||0||
59936508|NCT03043365|76054601|FG001|NOT COMPLETED|Week 16 to Week 24||0||
59936509|NCT03108157|76054611|FG000|STARTED|Overall Study||176||
59936510|NCT03108157|76054612|FG001|STARTED|Overall Study||176||
59936511|NCT03108157|76054611|FG000|COMPLETED|Overall Study||161||
59936512|NCT03108157|76054612|FG001|COMPLETED|Overall Study||172||
59936513|NCT03108157|76054611|FG000|NOT COMPLETED|Overall Study||15||
59936514|NCT03108157|76054612|FG001|NOT COMPLETED|Overall Study||4||
59936515|NCT04421131|76054619|FG000|STARTED|Overall Study||110||
59936516|NCT04421131|76054619|FG000|Referred to a Follow up Screening|Overall Study||17||
59936517|NCT04421131|76054619|FG000|COMPLETED|Overall Study||102||
59936518|NCT04421131|76054619|FG000|NOT COMPLETED|Overall Study||8||
59936519|NCT04167345|76054628|FG000|STARTED|Overall Study||10||
59936520|NCT04167345|76054629|FG001|STARTED|Overall Study||4||
59936521|NCT04167345|76054630|FG002|STARTED|Overall Study||3||
59936522|NCT04167345|76054631|FG003|STARTED|Overall Study||13||
59936523|NCT04167345|76054632|FG004|STARTED|Overall Study||18||
59936524|NCT04167345|76054628|FG000|COMPLETED|Overall Study||9||
59936525|NCT04167345|76054629|FG001|COMPLETED|Overall Study||3||
59936526|NCT04167345|76054630|FG002|COMPLETED|Overall Study||3||
59936527|NCT04167345|76054631|FG003|COMPLETED|Overall Study||13||
59936528|NCT04167345|76054632|FG004|COMPLETED|Overall Study||18||
59936529|NCT04167345|76054628|FG000|NOT COMPLETED|Overall Study||1||
59936530|NCT04167345|76054629|FG001|NOT COMPLETED|Overall Study||1||
59936531|NCT04167345|76054630|FG002|NOT COMPLETED|Overall Study||0||
59936532|NCT04167345|76054631|FG003|NOT COMPLETED|Overall Study||0||
59936533|NCT04167345|76054632|FG004|NOT COMPLETED|Overall Study||0||
59936534|NCT02854800|76054651|FG000|STARTED|Overall Study||32||
59936535|NCT02854800|76054652|FG001|STARTED|Overall Study||28||
59936536|NCT02854800|76054653|FG002|STARTED|Overall Study||14||
59936537|NCT02854800|76054651|FG000|COMPLETED|Overall Study||12||
59936538|NCT02854800|76054652|FG001|COMPLETED|Overall Study||15||
59936539|NCT02854800|76054653|FG002|COMPLETED|Overall Study||8||
59936540|NCT02854800|76054651|FG000|NOT COMPLETED|Overall Study||20||
59936541|NCT02854800|76054652|FG001|NOT COMPLETED|Overall Study||13||
59936542|NCT02854800|76054653|FG002|NOT COMPLETED|Overall Study||6||
59936543|NCT02931539|76054666|FG000|STARTED|Period 1: Treatment Phase||117||
59936544|NCT02931539|76054667|FG001|STARTED|Period 1: Treatment Phase||235||
59936545|NCT02931539|76054668|FG002|STARTED|Period 1: Treatment Phase||0||
59936546|NCT02931539|76054666|FG000|Treated Participants|Period 1: Treatment Phase||116||
59936547|NCT02931539|76054667|FG001|Treated Participants|Period 1: Treatment Phase||234||
59936548|NCT02931539|76054668|FG002|Treated Participants|Period 1: Treatment Phase||0||
59936549|NCT02931539|76054666|FG000|IAT (Ganciclovir/ Valganciclovir)|Period 1: Treatment Phase||56||
59936550|NCT02931539|76054667|FG001|IAT (Ganciclovir/ Valganciclovir)|Period 1: Treatment Phase||0||
59936551|NCT02931539|76054668|FG002|IAT (Ganciclovir/ Valganciclovir)|Period 1: Treatment Phase||0||
59936552|NCT02931539|76054666|FG000|IAT (Foscarnet)|Period 1: Treatment Phase||47||
59936553|NCT02931539|76054667|FG001|IAT (Foscarnet)|Period 1: Treatment Phase||0||
59936554|NCT02931539|76054668|FG002|IAT (Foscarnet)|Period 1: Treatment Phase||0||
59936555|NCT02931539|76054666|FG000|IAT (Cidofovir)|Period 1: Treatment Phase||6||
59936556|NCT02931539|76054667|FG001|IAT (Cidofovir)|Period 1: Treatment Phase||0||
59936557|NCT02931539|76054668|FG002|IAT (Cidofovir)|Period 1: Treatment Phase||0||
59936558|NCT02931539|76054666|FG000|IAT (Foscarnet + Valganciclovir/Ganciclovir)|Period 1: Treatment Phase||7||
59936559|NCT02931539|76054667|FG001|IAT (Foscarnet + Valganciclovir/Ganciclovir)|Period 1: Treatment Phase||0||
59936560|NCT02931539|76054668|FG002|IAT (Foscarnet + Valganciclovir/Ganciclovir)|Period 1: Treatment Phase||0||
59936561|NCT02931539|76054666|FG000|COMPLETED|Period 1: Treatment Phase||58||
59936562|NCT02931539|76054667|FG001|COMPLETED|Period 1: Treatment Phase||199||
59936563|NCT02931539|76054668|FG002|COMPLETED|Period 1: Treatment Phase||0||
59936564|NCT02931539|76054666|FG000|NOT COMPLETED|Period 1: Treatment Phase||59||
59936565|NCT02931539|76054667|FG001|NOT COMPLETED|Period 1: Treatment Phase||36||
59936566|NCT02931539|76054668|FG002|NOT COMPLETED|Period 1: Treatment Phase||0||
59936567|NCT02931539|76054666|FG000|STARTED|Period 2: Maribavir Rescue Therapy||0||
59936568|NCT02931539|76054667|FG001|STARTED|Period 2: Maribavir Rescue Therapy||0||
59936569|NCT02931539|76054668|FG002|STARTED|Period 2: Maribavir Rescue Therapy||22||
59936570|NCT02931539|76054666|FG000|COMPLETED|Period 2: Maribavir Rescue Therapy||0||
59936571|NCT02931539|76054667|FG001|COMPLETED|Period 2: Maribavir Rescue Therapy||0||
59936572|NCT02931539|76054668|FG002|COMPLETED|Period 2: Maribavir Rescue Therapy||20||
59936573|NCT02931539|76054666|FG000|NOT COMPLETED|Period 2: Maribavir Rescue Therapy||0||
59936574|NCT02931539|76054667|FG001|NOT COMPLETED|Period 2: Maribavir Rescue Therapy||0||
59936575|NCT02931539|76054668|FG002|NOT COMPLETED|Period 2: Maribavir Rescue Therapy||2||
59936576|NCT04042077|76054685|FG000|STARTED|Overall Study||134||
59936577|NCT04042077|76054686|FG001|STARTED|Overall Study||132||
59936578|NCT04042077|76054685|FG000|Vancomycin IV|Overall Study||0||
59936579|NCT04042077|76054686|FG001|Vancomycin IV|Overall Study||2||
59936580|NCT04042077|76054685|FG000|Linezolid IV, With the Option to Switch to Linezolid Oral|Overall Study||0||
59936581|NCT04042077|76054686|FG001|Linezolid IV, With the Option to Switch to Linezolid Oral|Overall Study||8||
59936582|NCT04042077|76054685|FG000|Piperacillin/Tazobactam IV|Overall Study||0||
59936583|NCT04042077|76054686|FG001|Piperacillin/Tazobactam IV|Overall Study||68||
59936584|NCT04042077|76054685|FG000|Tigecycline IV|Overall Study||0||
59936585|NCT04042077|76054686|FG001|Tigecycline IV|Overall Study||54||
59936586|NCT04042077|76054685|FG000|COMPLETED|Overall Study||127||
59936587|NCT04042077|76054686|FG001|COMPLETED|Overall Study||127||
59936588|NCT04042077|76054685|FG000|NOT COMPLETED|Overall Study||7||
59936589|NCT04042077|76054686|FG001|NOT COMPLETED|Overall Study||5||
59936590|NCT03936699|76054700|FG000|STARTED|Overall Study||83||
59936591|NCT03936699|76054701|FG001|STARTED|Overall Study||78||
59936592|NCT03936699|76054700|FG000|COMPLETED|Overall Study||61||
59936593|NCT03936699|76054701|FG001|COMPLETED|Overall Study||55||
59936594|NCT03936699|76054700|FG000|NOT COMPLETED|Overall Study||22||
59613328|NCT01568034|75724483|FG000|25 mg BIA 9-1067|Overall Study||2||
59936595|NCT03936699|76054701|FG001|NOT COMPLETED|Overall Study||23||
59936596|NCT02853318|76054707|FG000|STARTED|Overall Study||40||
59936597|NCT02853318|76054707|FG000|COMPLETED|Overall Study||39||
59936598|NCT02853318|76054707|FG000|NOT COMPLETED|Overall Study||1||
59936599|NCT02404155|76054711|FG000|STARTED|Overall Study||274||
59936600|NCT02404155|76054711|FG000|COMPLETED|Overall Study||227||
59936601|NCT02404155|76054711|FG000|NOT COMPLETED|Overall Study||47||
59936602|NCT03113071|76054717|FG000|STARTED|Overall Study||1||
59936603|NCT03113071|76054718|FG001|STARTED|Overall Study||0||
59936604|NCT03113071|76054717|FG000|COMPLETED|Overall Study||0||
59936605|NCT03113071|76054718|FG001|COMPLETED|Overall Study||0||
59936606|NCT03113071|76054717|FG000|NOT COMPLETED|Overall Study||1||
59936607|NCT03113071|76054718|FG001|NOT COMPLETED|Overall Study||0||
59936608|NCT03050307|76054726|FG000|STARTED|Overall Study||115||
59936609|NCT03050307|76054727|FG001|STARTED|Overall Study||119||
59936610|NCT03050307|76054726|FG000|COMPLETED|Overall Study||107||
59936611|NCT03050307|76054727|FG001|COMPLETED|Overall Study||110||
59936612|NCT03050307|76054726|FG000|NOT COMPLETED|Overall Study||8||
59936613|NCT03050307|76054727|FG001|NOT COMPLETED|Overall Study||9||
59936614|NCT02400723|76054737|FG000|STARTED|Overall Study||27||
59936615|NCT02400723|76054738|FG001|STARTED|Overall Study||29||
59936616|NCT02400723|76054737|FG000|COMPLETED|Overall Study||22||
59936617|NCT02400723|76054738|FG001|COMPLETED|Overall Study||24||
59936618|NCT02400723|76054737|FG000|NOT COMPLETED|Overall Study||5||
59936619|NCT02400723|76054738|FG001|NOT COMPLETED|Overall Study||5||
59936620|NCT03256045|76054744|FG000|STARTED|Overall Study||9||
59936621|NCT03256045|76054744|FG000|COMPLETED|Overall Study||9||
59936622|NCT03256045|76054744|FG000|NOT COMPLETED|Overall Study||0||
59936623|NCT03118765|76054753|FG000|STARTED|Overall Study||30||
59936624|NCT03118765|76054754|FG001|STARTED|Overall Study||32||
60067403|NCT01898078|76182556|FG000|COMPLETED|Overall Study|Completed treatment|7||
60067404|NCT01898078|76182557|FG001|COMPLETED|Overall Study|Completed treatment|5||
60067405|NCT01898078|76182556|FG000|NOT COMPLETED|Overall Study||6||
59936625|NCT03118765|76054755|FG002|STARTED|Overall Study||31||
59936626|NCT03118765|76054756|FG003|STARTED|Overall Study||32||
59936627|NCT03118765|76054757|FG004|STARTED|Overall Study||30||
59936628|NCT03118765|76054753|FG000|COMPLETED|Overall Study||26||
59936629|NCT03118765|76054754|FG001|COMPLETED|Overall Study||30||
59936630|NCT03118765|76054755|FG002|COMPLETED|Overall Study||26||
59936631|NCT03118765|76054756|FG003|COMPLETED|Overall Study||29||
59936632|NCT03118765|76054757|FG004|COMPLETED|Overall Study||28||
59936633|NCT03118765|76054753|FG000|NOT COMPLETED|Overall Study||4||
59936634|NCT03118765|76054754|FG001|NOT COMPLETED|Overall Study||2||
59936635|NCT03118765|76054755|FG002|NOT COMPLETED|Overall Study||5||
59936636|NCT03118765|76054756|FG003|NOT COMPLETED|Overall Study||3||
59936637|NCT03118765|76054757|FG004|NOT COMPLETED|Overall Study||2||
59936638|NCT05222880|76054772|FG000|STARTED|Overall Study||139||
59936639|NCT05222880|76054772|FG000|COMPLETED|Overall Study||136||
59936640|NCT05222880|76054772|FG000|NOT COMPLETED|Overall Study||3||
59936641|NCT05110014|76054778|FG000|STARTED|Overall Study||12239||
59936642|NCT05110014|76054779|FG001|STARTED|Overall Study||10787||
59936643|NCT05110014|76054778|FG000|COMPLETED|Overall Study||12239||
59936644|NCT05110014|76054779|FG001|COMPLETED|Overall Study||10787||
59936645|NCT05110014|76054778|FG000|NOT COMPLETED|Overall Study||0||
60067406|NCT01898078|76182557|FG001|NOT COMPLETED|Overall Study||8||
60067407|NCT01987817|76182567|FG000|STARTED|Overall Study||29||
60067408|NCT01987817|76182568|FG001|STARTED|Overall Study||27||
60067409|NCT01987817|76182567|FG000|COMPLETED|Overall Study||23||
60067410|NCT01987817|76182568|FG001|COMPLETED|Overall Study||26||
60067411|NCT01987817|76182567|FG000|NOT COMPLETED|Overall Study||6||
60067412|NCT01987817|76182568|FG001|NOT COMPLETED|Overall Study||1||
59613329|NCT01568034|75724484|FG001|25 mg BIA 9-1067|Overall Study||2||
59936646|NCT05110014|76054779|FG001|NOT COMPLETED|Overall Study||0||
59936647|NCT04810962|76054789|FG000|STARTED|Overall Study||185||
59936648|NCT04810962|76054790|FG001|STARTED|Overall Study||185||
59936649|NCT04810962|76054789|FG000|COMPLETED|Overall Study||179||
59936650|NCT04810962|76054790|FG001|COMPLETED|Overall Study||179||
59936651|NCT04810962|76054789|FG000|NOT COMPLETED|Overall Study||6||
59936652|NCT04810962|76054790|FG001|NOT COMPLETED|Overall Study||6||
59936653|NCT04805983|76054802|FG000|STARTED|Overall Study||6||
59936654|NCT04805983|76054803|FG001|STARTED|Overall Study||6||
59936655|NCT04805983|76054804|FG002|STARTED|Overall Study||6||
59936656|NCT04805983|76054805|FG003|STARTED|Overall Study||6||
59936657|NCT04805983|76054806|FG004|STARTED|Overall Study||6||
59936658|NCT04805983|76054807|FG005|STARTED|Overall Study||6||
59936659|NCT04805983|76054802|FG000|Completed Baseline (Study Day 1)|Overall Study||6||
59936660|NCT04805983|76054803|FG001|Completed Baseline (Study Day 1)|Overall Study||6||
59936661|NCT04805983|76054804|FG002|Completed Baseline (Study Day 1)|Overall Study||6||
59761904|NCT00579670|75881519|FG000|NOT COMPLETED|Overall Study||2||
59761905|NCT00579670|75881520|FG001|NOT COMPLETED|Overall Study||1||
59761906|NCT00579670|75881521|FG002|NOT COMPLETED|Overall Study||4||
59936662|NCT04805983|76054805|FG003|Completed Baseline (Study Day 1)|Overall Study||6||
59936663|NCT04805983|76054806|FG004|Completed Baseline (Study Day 1)|Overall Study||6||
59936664|NCT04805983|76054807|FG005|Completed Baseline (Study Day 1)|Overall Study||6||
59936665|NCT04805983|76054802|FG000|Completed Inpatient Treatment (Study Day 3)|Overall Study||6||
59936666|NCT04805983|76054803|FG001|Completed Inpatient Treatment (Study Day 3)|Overall Study||6||
59936667|NCT04805983|76054804|FG002|Completed Inpatient Treatment (Study Day 3)|Overall Study||6||
59936668|NCT04805983|76054805|FG003|Completed Inpatient Treatment (Study Day 3)|Overall Study||6||
59936669|NCT04805983|76054806|FG004|Completed Inpatient Treatment (Study Day 3)|Overall Study||6||
59936670|NCT04805983|76054807|FG005|Completed Inpatient Treatment (Study Day 3)|Overall Study||6||
59936671|NCT04805983|76054802|FG000|Completed In-Clinic Follow-Up (Study Day 4)|Overall Study||6||
59936672|NCT04805983|76054803|FG001|Completed In-Clinic Follow-Up (Study Day 4)|Overall Study||6||
59936673|NCT04805983|76054804|FG002|Completed In-Clinic Follow-Up (Study Day 4)|Overall Study||6||
59936674|NCT04805983|76054805|FG003|Completed In-Clinic Follow-Up (Study Day 4)|Overall Study||6||
59936675|NCT04805983|76054806|FG004|Completed In-Clinic Follow-Up (Study Day 4)|Overall Study||6||
59936676|NCT04805983|76054807|FG005|Completed In-Clinic Follow-Up (Study Day 4)|Overall Study||6||
59936677|NCT04805983|76054802|FG000|Completed Phone Visit Follow-Up (Study Day 5)|Overall Study||6||
59936678|NCT04805983|76054803|FG001|Completed Phone Visit Follow-Up (Study Day 5)|Overall Study||6||
59936679|NCT04805983|76054804|FG002|Completed Phone Visit Follow-Up (Study Day 5)|Overall Study||6||
59936680|NCT04805983|76054805|FG003|Completed Phone Visit Follow-Up (Study Day 5)|Overall Study||6||
59936681|NCT04805983|76054806|FG004|Completed Phone Visit Follow-Up (Study Day 5)|Overall Study||6||
59936682|NCT04805983|76054807|FG005|Completed Phone Visit Follow-Up (Study Day 5)|Overall Study||6||
59936683|NCT04805983|76054802|FG000|Completed In-Clinic Final Follow- Up/Completed Protocol (Study Day 7)|Overall Study||6||
59936684|NCT04805983|76054803|FG001|Completed In-Clinic Final Follow- Up/Completed Protocol (Study Day 7)|Overall Study||6||
59936685|NCT04805983|76054804|FG002|Completed In-Clinic Final Follow- Up/Completed Protocol (Study Day 7)|Overall Study||6||
59936686|NCT04805983|76054805|FG003|Completed In-Clinic Final Follow- Up/Completed Protocol (Study Day 7)|Overall Study||6||
59936687|NCT04805983|76054806|FG004|Completed In-Clinic Final Follow- Up/Completed Protocol (Study Day 7)|Overall Study||6||
59936688|NCT04805983|76054807|FG005|Completed In-Clinic Final Follow- Up/Completed Protocol (Study Day 7)|Overall Study||6||
59936689|NCT04805983|76054802|FG000|COMPLETED|Overall Study||6||
59936690|NCT04805983|76054803|FG001|COMPLETED|Overall Study||6||
59936691|NCT04805983|76054804|FG002|COMPLETED|Overall Study||6||
59936692|NCT04805983|76054805|FG003|COMPLETED|Overall Study||6||
59936693|NCT04805983|76054806|FG004|COMPLETED|Overall Study||6||
59936694|NCT04805983|76054807|FG005|COMPLETED|Overall Study||6||
59936695|NCT04805983|76054802|FG000|NOT COMPLETED|Overall Study||0||
59936696|NCT04805983|76054803|FG001|NOT COMPLETED|Overall Study||0||
59936697|NCT04805983|76054804|FG002|NOT COMPLETED|Overall Study||0||
59936698|NCT04805983|76054805|FG003|NOT COMPLETED|Overall Study||0||
59936699|NCT04805983|76054806|FG004|NOT COMPLETED|Overall Study||0||
59936700|NCT04805983|76054807|FG005|NOT COMPLETED|Overall Study||0||
59936701|NCT04606134|76054823|FG000|STARTED|Overall Study||6||
59936702|NCT04606134|76054824|FG001|STARTED|Overall Study||4||
59936703|NCT04606134|76054823|FG000|COMPLETED|Overall Study||6||
59936704|NCT04606134|76054824|FG001|COMPLETED|Overall Study||3||
59936705|NCT04606134|76054823|FG000|NOT COMPLETED|Overall Study||0||
59936706|NCT04606134|76054824|FG001|NOT COMPLETED|Overall Study||1||
59936707|NCT04426825|76054830|FG000|STARTED|Overall Study||23||
59936708|NCT04426825|76054830|FG000|COMPLETED|Overall Study||0||
59936709|NCT04426825|76054830|FG000|NOT COMPLETED|Overall Study||23||
59936710|NCT04399538|76054839|FG000|STARTED|Double-Blind Treatment||15||
59936711|NCT04399538|76054840|FG001|STARTED|Double-Blind Treatment||15||
59936712|NCT04399538|76054841|FG002|STARTED|Double-Blind Treatment||13||
59936713|NCT04399538|76054842|FG003|STARTED|Double-Blind Treatment||18||
59936714|NCT04399538|76054843|FG004|STARTED|Double-Blind Treatment||14||
59936715|NCT04399538|76054839|FG000|COMPLETED|Double-Blind Treatment||15||
59518441|NCT03372382|75612218|FG001|NOT COMPLETED|Overall Study||4||
59518442|NCT03372928|75612226|FG000|STARTED|First Intervention (5 d Energy Deficit)||10||
59518443|NCT03372928|75612227|FG001|STARTED|First Intervention (5 d Energy Deficit)||10||
59518444|NCT03372928|75612226|FG000|COMPLETED|First Intervention (5 d Energy Deficit)||10||
59518445|NCT03372928|75612227|FG001|COMPLETED|First Intervention (5 d Energy Deficit)||10||
59518446|NCT03372928|75612226|FG000|NOT COMPLETED|First Intervention (5 d Energy Deficit)||0||
59518447|NCT03372928|75612227|FG001|NOT COMPLETED|First Intervention (5 d Energy Deficit)||0||
59761907|NCT00579670|75881522|FG003|NOT COMPLETED|Overall Study||22||
59761908|NCT00579670|75881523|FG004|NOT COMPLETED|Overall Study||0||
59761909|NCT03909295|75881547|FG000|STARTED|Overall Study||52||
59761910|NCT03909295|75881547|FG000|Safety Set (SAF)|Overall Study||52|All subjects who received at least one dose of study drug|
59761911|NCT03909295|75881547|FG000|COMPLETED|Overall Study||0||
59761912|NCT03909295|75881547|FG000|NOT COMPLETED|Overall Study||52||
59761913|NCT00599924|75881558|FG000|STARTED|Overall Study||4||
59936716|NCT04399538|76054840|FG001|COMPLETED|Double-Blind Treatment||15||
59936717|NCT04399538|76054841|FG002|COMPLETED|Double-Blind Treatment||13||
59936718|NCT04399538|76054842|FG003|COMPLETED|Double-Blind Treatment||17||
59936719|NCT04399538|76054843|FG004|COMPLETED|Double-Blind Treatment||12||
59936720|NCT04399538|76054839|FG000|NOT COMPLETED|Double-Blind Treatment||0||
59936721|NCT04399538|76054840|FG001|NOT COMPLETED|Double-Blind Treatment||0||
59936722|NCT04399538|76054841|FG002|NOT COMPLETED|Double-Blind Treatment||0||
59936723|NCT04399538|76054842|FG003|NOT COMPLETED|Double-Blind Treatment||1||
59936724|NCT04399538|76054843|FG004|NOT COMPLETED|Double-Blind Treatment||2||
59936725|NCT04399538|76054839|FG000|STARTED|Follow-Up||15||
59936726|NCT04399538|76054840|FG001|STARTED|Follow-Up||15||
59936727|NCT04399538|76054841|FG002|STARTED|Follow-Up||13||
59936728|NCT04399538|76054842|FG003|STARTED|Follow-Up||17||
59936729|NCT04399538|76054843|FG004|STARTED|Follow-Up||13||
59936730|NCT04399538|76054839|FG000|COMPLETED|Follow-Up||15||
59936731|NCT04399538|76054840|FG001|COMPLETED|Follow-Up||15||
59936732|NCT04399538|76054841|FG002|COMPLETED|Follow-Up||13||
59936733|NCT04399538|76054842|FG003|COMPLETED|Follow-Up||15||
59936734|NCT04399538|76054843|FG004|COMPLETED|Follow-Up||12||
59936735|NCT04399538|76054839|FG000|NOT COMPLETED|Follow-Up||0||
59936736|NCT04399538|76054840|FG001|NOT COMPLETED|Follow-Up||0||
59936737|NCT04399538|76054841|FG002|NOT COMPLETED|Follow-Up||0||
59936738|NCT04399538|76054842|FG003|NOT COMPLETED|Follow-Up||2||
59936739|NCT04399538|76054843|FG004|NOT COMPLETED|Follow-Up||1||
59936740|NCT04342091|76054855|FG000|STARTED|Overall Study||6||
59936741|NCT04342091|76054855|FG000|COMPLETED|Overall Study||6||
59936742|NCT04342091|76054855|FG000|NOT COMPLETED|Overall Study||0||
59936743|NCT03643796|76054861|FG000|STARTED|Overall Study||15||
59936744|NCT03643796|76054862|FG001|STARTED|Overall Study||17||
59936745|NCT03643796|76054861|FG000|COMPLETED|Overall Study||15||
59936746|NCT03643796|76054862|FG001|COMPLETED|Overall Study||17||
59936747|NCT03643796|76054861|FG000|NOT COMPLETED|Overall Study||0||
59936748|NCT03643796|76054862|FG001|NOT COMPLETED|Overall Study||0||
59936749|NCT03436433|76054875|FG000|STARTED|Overall Study||1||
59936750|NCT03436433|76054876|FG001|STARTED|Overall Study||2||
59761914|NCT00599924|75881559|FG001|STARTED|Overall Study||9||
59761915|NCT00599924|75881560|FG002|STARTED|Overall Study||5||
59761916|NCT00599924|75881561|FG003|STARTED|Overall Study||12||
59761917|NCT00599924|75881562|FG004|STARTED|Overall Study||9||
59761918|NCT00599924|75881563|FG005|STARTED|Overall Study||6||
59761919|NCT00599924|75881564|FG006|STARTED|Overall Study||8||
59761920|NCT00599924|75881558|FG000|COMPLETED|Overall Study||1||
59761921|NCT00599924|75881559|FG001|COMPLETED|Overall Study||4||
59936751|NCT03436433|76054877|FG002|STARTED|Overall Study||1||
59936752|NCT03436433|76054875|FG000|COMPLETED|Overall Study||1||
59936753|NCT03436433|76054876|FG001|COMPLETED|Overall Study||2||
59936754|NCT03436433|76054877|FG002|COMPLETED|Overall Study||1||
59936755|NCT03436433|76054875|FG000|NOT COMPLETED|Overall Study||0||
59936756|NCT03436433|76054876|FG001|NOT COMPLETED|Overall Study||0||
60067413|NCT01940497|76182577|FG000|STARTED|Overall Study||121||
60067414|NCT01940497|76182578|FG001|STARTED|Overall Study||119||
59936757|NCT03436433|76054877|FG002|NOT COMPLETED|Overall Study||0||
59936758|NCT03284307|76054885|FG000|STARTED|Overall Study||35||
60067415|NCT01940497|76182577|FG000|Treated|Overall Study||115||
60067416|NCT01940497|76182578|FG001|Treated|Overall Study||113||
60067417|NCT01940497|76182577|FG000|Treated: Adjuvant|Overall Study||95||
60067418|NCT01940497|76182578|FG001|Treated: Adjuvant|Overall Study||92||
60067419|NCT01940497|76182577|FG000|Treated: Neoadjuvant|Overall Study||20||
59936759|NCT03284307|76054885|FG000|Completed Sedation and/or Sleep Visit|Overall Study||27||
59936760|NCT03284307|76054885|FG000|Completed Sedation Visit|Overall Study||21||
59951228|NCT03771664|76070158|FG000|Safety Set|Overall Study||43|Safety set included all participants who received at least 1 dose of double-blind study drug.|
59951229|NCT03771664|76070159|FG001|Safety Set|Overall Study||43|Safety set included all participants who received at least 1 dose of double-blind study drug.|
59951230|NCT03771664|76070158|FG000|COMPLETED|Overall Study||40||
59761922|NCT00599924|75881560|FG002|COMPLETED|Overall Study||3||
59761923|NCT00599924|75881561|FG003|COMPLETED|Overall Study||4||
59761924|NCT00599924|75881562|FG004|COMPLETED|Overall Study||3||
59761925|NCT00599924|75881563|FG005|COMPLETED|Overall Study||2||
59761926|NCT00599924|75881564|FG006|COMPLETED|Overall Study||3||
59761927|NCT00599924|75881558|FG000|NOT COMPLETED|Overall Study||3||
59761928|NCT00599924|75881559|FG001|NOT COMPLETED|Overall Study||5||
59761929|NCT00599924|75881560|FG002|NOT COMPLETED|Overall Study||2||
59951231|NCT03771664|76070159|FG001|COMPLETED|Overall Study||39||
59936761|NCT03284307|76054885|FG000|Sleep|Overall Study||15|Participants were fitted with a saline gel EEG cap and a pre-sleep recording was collected. After the pre-sleep recording, participants laid down within 30 minutes of their usual bedtime and were left to sleep for 2-3 hours. Then, the participant was woken up every 15-30 minutes to answer standardized wake report form questions. After awaking a final time, the participant repeated 10 minutes of awake eyes open and eyes closed recordings and a predictive coding cognitive task on a computer.|
59936762|NCT03284307|76054885|FG000|Dexmedetomidine|Overall Study||20|Rapid infusion of 3.0 mg kg-1 h-1 was administered over a 10 min period followed by a 0.5 mg kg-1 h-1 maintenance infusion to achieve the first drug step. The second drug step was similarly achieved by a 10 min infusion of 3.0 mg kg-1 h-1 followed by a 1.5 mg kg-1 h-1 maintenance infusion. Duration of drug exposure was limited to 4 hours.|
59936763|NCT03284307|76054885|FG000|Ketamine|Overall Study||15|Ketamine was titrated using up to a 4.5mg/kg bolus over 10 minutes followed by 0.1-0.5mg/min intravenous infusion with 5 minutes between increments and titrated to desired observed alertness/sedation level. Short-lived emergence delirium (confusion on awakening) may occur on emergence from ketamine anesthesia and this will be managed through standard clinical practice including administration of midazolam (up to 4mg IV) if required. Duration of drug exposure was limited to 4 hours.|
59936764|NCT03284307|76054885|FG000|Propofol|Overall Study||6|A target-controlled infusion model used to predict plasma concentrations of propofol at 0.5 mcg/mL increments allowing 5-minutes to equilibrate between any step change. Dosing will be confined to FDA approved limits with up to a 2.5mg/kg bolus over 1 to 3 minute followed by an infusion of 50-200mcg/kg/min titrated to the desired observed alertness/sedation levels. Drug exposure was limited to 4 hours.|
59936765|NCT03284307|76054885|FG000|Midazolam|Overall Study|No midazolam visit was ever conducted because no interested participants had reached that step of the drug sequence after it was added to the protocol in November of 2019.This was in large part due to the shutdown of in-person research activities in March of 2020 from the COVID-19 pandemic.|0|Initial boluses of up to 0.35mg/kg followed by doses up to 0.1mg/kg/h as a maintenance infusion. Duration of drug exposure was limited to 4 hours.|
59936766|NCT03284307|76054885|FG000|COMPLETED|Overall Study||27||
59936767|NCT03284307|76054885|FG000|NOT COMPLETED|Overall Study||8||
59936768|NCT03094832|76054902|FG000|STARTED|Overall Study||17||
59936769|NCT03094832|76054903|FG001|STARTED|Overall Study||22||
59936770|NCT03094832|76054904|FG002|STARTED|Overall Study||1||
59936771|NCT03094832|76054905|FG003|STARTED|Overall Study||8||
59936772|NCT03094832|76054906|FG004|STARTED|Overall Study||2||
59936773|NCT03094832|76054902|FG000|Treated|Overall Study||17||
59936774|NCT03094832|76054903|FG001|Treated|Overall Study||22||
59936775|NCT03094832|76054904|FG002|Treated|Overall Study||1||
59936776|NCT03094832|76054905|FG003|Treated|Overall Study||8||
59936777|NCT03094832|76054906|FG004|Treated|Overall Study||1||
59936778|NCT03094832|76054902|FG000|COMPLETED|Overall Study||2||
59936779|NCT03094832|76054903|FG001|COMPLETED|Overall Study||2||
59936780|NCT03094832|76054904|FG002|COMPLETED|Overall Study||0||
59936781|NCT03094832|76054905|FG003|COMPLETED|Overall Study||0||
59936782|NCT03094832|76054906|FG004|COMPLETED|Overall Study||0||
59936783|NCT03094832|76054902|FG000|NOT COMPLETED|Overall Study||15||
59936784|NCT03094832|76054903|FG001|NOT COMPLETED|Overall Study||20||
59936785|NCT03094832|76054904|FG002|NOT COMPLETED|Overall Study||1||
59936786|NCT03094832|76054905|FG003|NOT COMPLETED|Overall Study||8||
59936787|NCT03094832|76054906|FG004|NOT COMPLETED|Overall Study||2||
59936788|NCT03036579|76054920|FG000|STARTED|Baseline|some participants had 2 teeth restored with crowns|41||50
59936789|NCT03036579|76054921|FG001|STARTED|Baseline|some participants had two teeth restored with crowns|32||50
59936790|NCT03036579|76054920|FG000|COMPLETED|Baseline||41||50
59936791|NCT03036579|76054921|FG001|COMPLETED|Baseline||32||50
59936792|NCT03036579|76054920|FG000|NOT COMPLETED|Baseline||0||0
59936793|NCT03036579|76054921|FG001|NOT COMPLETED|Baseline||0||0
59936794|NCT03036579|76054920|FG000|STARTED|6 Months||41||50
59936795|NCT03036579|76054921|FG001|STARTED|6 Months||32||50
59936796|NCT03036579|76054920|FG000|COMPLETED|6 Months||41||50
59936797|NCT03036579|76054921|FG001|COMPLETED|6 Months||32||50
59936798|NCT03036579|76054920|FG000|NOT COMPLETED|6 Months||0||0
59936799|NCT03036579|76054921|FG001|NOT COMPLETED|6 Months||0||0
59936800|NCT03036579|76054920|FG000|STARTED|1 Year||41||50
59936801|NCT03036579|76054921|FG001|STARTED|1 Year||32||50
59936802|NCT03036579|76054920|FG000|COMPLETED|1 Year||41||50
59936803|NCT03036579|76054921|FG001|COMPLETED|1 Year||32||50
59936804|NCT03036579|76054920|FG000|NOT COMPLETED|1 Year||0||0
59936805|NCT03036579|76054921|FG001|NOT COMPLETED|1 Year||0||0
59936806|NCT03036579|76054920|FG000|STARTED|2 Years||41||50
59936807|NCT03036579|76054921|FG001|STARTED|2 Years||32||50
59936808|NCT03036579|76054920|FG000|COMPLETED|2 Years||40||49
59936809|NCT03036579|76054921|FG001|COMPLETED|2 Years||32||50
59936810|NCT03036579|76054920|FG000|NOT COMPLETED|2 Years||1||1
59936811|NCT03036579|76054921|FG001|NOT COMPLETED|2 Years||0||0
59936812|NCT03036579|76054920|FG000|STARTED|3 Years|The participant lost to follow up in year 2 participated in year 3 which is why the number of participants to start in year 3 does not equal those who completed year 2.|41||50
59936813|NCT03036579|76054921|FG001|STARTED|3 Years||32||50
59936814|NCT03036579|76054920|FG000|COMPLETED|3 Years||41||50
59936815|NCT03036579|76054921|FG001|COMPLETED|3 Years||31||49
59936816|NCT03036579|76054920|FG000|NOT COMPLETED|3 Years||0||0
59936817|NCT03036579|76054921|FG001|NOT COMPLETED|3 Years||1||1
59936818|NCT02867761|76054929|FG000|STARTED|Overall Study||261||
59936819|NCT02867761|76054930|FG001|STARTED|Overall Study||274||
59936820|NCT02867761|76054929|FG000|COMPLETED|Overall Study||233||
59936821|NCT02867761|76054930|FG001|COMPLETED|Overall Study||248||
59936822|NCT02867761|76054929|FG000|NOT COMPLETED|Overall Study||28||
59936823|NCT02867761|76054930|FG001|NOT COMPLETED|Overall Study||26||
59936824|NCT02858050|76054938|FG000|STARTED|Overall Study||20||
59936825|NCT02858050|76054939|FG001|STARTED|Overall Study||20||
59936826|NCT02858050|76054938|FG000|COMPLETED|Overall Study||20||
59936827|NCT02858050|76054939|FG001|COMPLETED|Overall Study||20||
59936828|NCT02858050|76054938|FG000|NOT COMPLETED|Overall Study||0||
59936829|NCT02858050|76054939|FG001|NOT COMPLETED|Overall Study||0||
59936830|NCT02719990|76054945|FG000|STARTED|Overall Study||36||
59936831|NCT02719990|76054945|FG000|Received at Least 1 Dose of Study Drug|Overall Study||36||
59936832|NCT02719990|76054945|FG000|COMPLETED|Overall Study||0||
59936833|NCT02719990|76054945|FG000|NOT COMPLETED|Overall Study||36||
59936834|NCT02494583|76054952|FG000|STARTED|Overall Study||256||
59936835|NCT02494583|76054953|FG001|STARTED|Overall Study||257||
59936836|NCT02494583|76054954|FG002|STARTED|Overall Study||250||
59936837|NCT02494583|76054952|FG000|Received First Course of Pembrolizumab|Overall Study|1 participant randomized to the pembro combo arm received pembrolizumab monotherapy by mistake.|254||
59936838|NCT02494583|76054953|FG001|Received First Course of Pembrolizumab|Overall Study||250||
59936839|NCT02494583|76054954|FG002|Received First Course of Pembrolizumab|Overall Study||244||
59936840|NCT02494583|76054952|FG000|Received Second Course of Pembrolizumab|Overall Study||4||
59936841|NCT02494583|76054953|FG001|Received Second Course of Pembrolizumab|Overall Study||5||
59936842|NCT02494583|76054954|FG002|Received Second Course of Pembrolizumab|Overall Study||0||
59936843|NCT02494583|76054952|FG000|COMPLETED|Overall Study||0||
59936844|NCT02494583|76054953|FG001|COMPLETED|Overall Study||0||
59936845|NCT02494583|76054954|FG002|COMPLETED|Overall Study||0||
59936846|NCT02494583|76054952|FG000|NOT COMPLETED|Overall Study||256||
59936847|NCT02494583|76054953|FG001|NOT COMPLETED|Overall Study||257||
59936848|NCT02494583|76054954|FG002|NOT COMPLETED|Overall Study||250||
59936849|NCT02322814|76054969|FG000|STARTED|Overall Study||16||
59936850|NCT02322814|76054970|FG001|STARTED|Overall Study||43||
59936851|NCT02322814|76054971|FG002|STARTED|Overall Study||47||
59936852|NCT02322814|76054972|FG003|STARTED|Overall Study||32||
59936853|NCT02322814|76054973|FG004|STARTED|Overall Study||31||
59936854|NCT02322814|76054969|FG000|COMPLETED|Overall Study||0||
59936855|NCT02322814|76054970|FG001|COMPLETED|Overall Study||0||
59936856|NCT02322814|76054971|FG002|COMPLETED|Overall Study||0||
59936857|NCT02322814|76054972|FG003|COMPLETED|Overall Study||0||
59936858|NCT02322814|76054973|FG004|COMPLETED|Overall Study||0||
59936859|NCT02322814|76054969|FG000|NOT COMPLETED|Overall Study||16||
59936860|NCT02322814|76054970|FG001|NOT COMPLETED|Overall Study||43||
59936861|NCT02322814|76054971|FG002|NOT COMPLETED|Overall Study||47||
59936862|NCT02322814|76054972|FG003|NOT COMPLETED|Overall Study||32||
59936863|NCT02322814|76054973|FG004|NOT COMPLETED|Overall Study||31||
59936864|NCT01333033|76054995|FG000|STARTED|Overall Study||72||
59936865|NCT01333033|76054996|FG001|STARTED|Overall Study||39||
59936866|NCT01333033|76054997|FG002|STARTED|Overall Study||64||
59936867|NCT01333033|76054998|FG003|STARTED|Overall Study||50||
59936868|NCT01333033|76054999|FG004|STARTED|Overall Study||14||
59936869|NCT01333033|76055000|FG005|STARTED|Overall Study||18||
59936870|NCT01333033|76054995|FG000|COMPLETED|Overall Study||72||
59936871|NCT01333033|76054996|FG001|COMPLETED|Overall Study||39||
59936872|NCT01333033|76054997|FG002|COMPLETED|Overall Study||64||
59936873|NCT01333033|76054998|FG003|COMPLETED|Overall Study||50||
59936874|NCT01333033|76054999|FG004|COMPLETED|Overall Study||0||
59936875|NCT01333033|76055000|FG005|COMPLETED|Overall Study||0||
59936876|NCT01333033|76054995|FG000|NOT COMPLETED|Overall Study||0||
59936877|NCT01333033|76054996|FG001|NOT COMPLETED|Overall Study||0||
59936878|NCT01333033|76054997|FG002|NOT COMPLETED|Overall Study||0||
59936879|NCT01333033|76054998|FG003|NOT COMPLETED|Overall Study||0||
59936880|NCT01333033|76054999|FG004|NOT COMPLETED|Overall Study||14||
59936881|NCT01333033|76055000|FG005|NOT COMPLETED|Overall Study||18||
59936882|NCT01192776|76055022|FG000|STARTED|Overall Study||95||
59936883|NCT01192776|76055023|FG001|STARTED|Overall Study||90||
59936884|NCT01192776|76055024|FG002|STARTED|Overall Study||96||
59936885|NCT01192776|76055025|FG003|STARTED|Overall Study||83||
59936886|NCT01192776|76055022|FG000|Died Prior to Discharge|Overall Study||7||
59936887|NCT01192776|76055023|FG001|Died Prior to Discharge|Overall Study||13||
59936888|NCT01192776|76055024|FG002|Died Prior to Discharge|Overall Study||15||
59936889|NCT01192776|76055025|FG003|Died Prior to Discharge|Overall Study||14||
59936890|NCT01192776|76055022|FG000|Died After Discharge|Overall Study||1||
59936891|NCT01192776|76055023|FG001|Died After Discharge|Overall Study||2||
59936892|NCT01192776|76055024|FG002|Died After Discharge|Overall Study||3||
59936893|NCT01192776|76055025|FG003|Died After Discharge|Overall Study||1||
59936894|NCT01192776|76055022|FG000|COMPLETED|Overall Study||84||
59936895|NCT01192776|76055023|FG001|COMPLETED|Overall Study||69||
59936896|NCT01192776|76055024|FG002|COMPLETED|Overall Study||75||
59936897|NCT01192776|76055025|FG003|COMPLETED|Overall Study||63||
59936898|NCT01192776|76055022|FG000|NOT COMPLETED|Overall Study||11||
59936899|NCT01192776|76055023|FG001|NOT COMPLETED|Overall Study||21||
59936900|NCT01192776|76055024|FG002|NOT COMPLETED|Overall Study||21||
59936901|NCT01192776|76055025|FG003|NOT COMPLETED|Overall Study||20||
59936902|NCT00547196|76055042|FG000|STARTED|Overall Study||5||
59936903|NCT00547196|76055043|FG001|STARTED|Overall Study||0||
59936904|NCT00547196|76055044|FG002|STARTED|Overall Study||1||
59936905|NCT00547196|76055045|FG003|STARTED|Overall Study||2||
59936906|NCT00547196|76055046|FG004|STARTED|Overall Study||2||
59936907|NCT00547196|76055042|FG000|COMPLETED|Overall Study||5||
59936908|NCT00547196|76055043|FG001|COMPLETED|Overall Study||0||
59936909|NCT00547196|76055044|FG002|COMPLETED|Overall Study||1||
59936910|NCT00547196|76055045|FG003|COMPLETED|Overall Study||2||
59936911|NCT00547196|76055046|FG004|COMPLETED|Overall Study||2||
59936912|NCT00547196|76055042|FG000|NOT COMPLETED|Overall Study||0||
59936913|NCT00547196|76055043|FG001|NOT COMPLETED|Overall Study||0||
59936914|NCT00547196|76055044|FG002|NOT COMPLETED|Overall Study||0||
59936915|NCT00547196|76055045|FG003|NOT COMPLETED|Overall Study||0||
59936916|NCT00547196|76055046|FG004|NOT COMPLETED|Overall Study||0||
59936917|NCT01367834|76055058|FG000|STARTED|Overall Study||11||
59936918|NCT01367834|76055059|FG001|STARTED|Overall Study||6||
59936919|NCT01367834|76055058|FG000|COMPLETED|Overall Study||9||
59936920|NCT01367834|76055059|FG001|COMPLETED|Overall Study||3||
59936921|NCT01367834|76055058|FG000|NOT COMPLETED|Overall Study||2||
59936922|NCT01367834|76055059|FG001|NOT COMPLETED|Overall Study||3||
59936923|NCT03106753|76055067|FG000|STARTED|Overall Study||17||
59936924|NCT03106753|76055068|FG001|STARTED|Overall Study||17||
59936925|NCT03106753|76055067|FG000|COMPLETED|Overall Study||17||
59936926|NCT03106753|76055068|FG001|COMPLETED|Overall Study||16||
59936927|NCT03106753|76055067|FG000|NOT COMPLETED|Overall Study||0||
59936928|NCT03106753|76055068|FG001|NOT COMPLETED|Overall Study||1||
59613330|NCT01568034|75724485|FG002|25 mg BIA 9-1067|Overall Study||3||
59613331|NCT01568034|75724486|FG003|25 mg BIA 9-1067|Overall Study||3||
59613332|NCT01568034|75724483|FG000|50 mg BIA 9-1067|Overall Study||2||
59613333|NCT01568034|75724484|FG001|50 mg BIA 9-1067|Overall Study||2||
59613334|NCT01568034|75724485|FG002|50 mg BIA 9-1067|Overall Study||3||
59613335|NCT01568034|75724486|FG003|50 mg BIA 9-1067|Overall Study||3||
59936929|NCT03045081|76055078|FG000|STARTED|Overall Study||51||
59936930|NCT03045081|76055079|FG001|STARTED|Overall Study||48||
59936931|NCT03045081|76055078|FG000|COMPLETED|Overall Study||45||
59936932|NCT03045081|76055079|FG001|COMPLETED|Overall Study||37||
59518448|NCT03372928|75612226|FG000|STARTED|Washout (14 d)||10||
59518449|NCT03372928|75612227|FG001|STARTED|Washout (14 d)||10||
59518450|NCT03372928|75612226|FG000|COMPLETED|Washout (14 d)||10||
59518451|NCT03372928|75612227|FG001|COMPLETED|Washout (14 d)||9||
59518452|NCT03372928|75612226|FG000|NOT COMPLETED|Washout (14 d)||0||
59936933|NCT03045081|76055078|FG000|NOT COMPLETED|Overall Study||6||
59936934|NCT03045081|76055079|FG001|NOT COMPLETED|Overall Study||11||
59936935|NCT03107377|76055087|FG000|STARTED|Overall Study||426||
59936936|NCT03107377|76055088|FG001|STARTED|Overall Study||434||
59936937|NCT03107377|76055087|FG000|COMPLETED|Overall Study||335||
59936938|NCT03107377|76055088|FG001|COMPLETED|Overall Study||335||
59936939|NCT03107377|76055087|FG000|NOT COMPLETED|Overall Study||91||
59936940|NCT03107377|76055088|FG001|NOT COMPLETED|Overall Study||99||
59936941|NCT02545283|76055096|FG000|STARTED|Overall Study||149||
59936942|NCT02545283|76055097|FG001|STARTED|Overall Study||298||
59936943|NCT02545283|76055096|FG000|Received Treatment|Overall Study||149||
59936944|NCT02545283|76055097|FG001|Received Treatment|Overall Study||292||
59613336|NCT01568034|75724483|FG000|100 mg BIA 9-1067|Overall Study||2||
59936945|NCT02545283|76055096|FG000|Safety Follow Up|Overall Study|I participant was not treated and 1 participant entered from the Idasanutlin arm|149||
59936946|NCT02545283|76055097|FG001|Safety Follow Up|Overall Study|5 participants were not treated, 1 participant did not receive Idasanutlin and was moved to the Placebo arm|292||
59936947|NCT02545283|76055096|FG000|COMPLETED|Overall Study||0||
59936948|NCT02545283|76055097|FG001|COMPLETED|Overall Study||0||
59936949|NCT02545283|76055096|FG000|NOT COMPLETED|Overall Study||149||
59936950|NCT02545283|76055097|FG001|NOT COMPLETED|Overall Study||298||
59936951|NCT03282565|76055108|FG000|STARTED|Overall Study||10||
59936952|NCT03282565|76055109|FG001|STARTED|Overall Study||10||
60067420|NCT01940497|76182578|FG001|Treated: Neoadjuvant|Overall Study||21||
59518453|NCT03372928|75612227|FG001|NOT COMPLETED|Washout (14 d)||1||
59518454|NCT03372928|75612226|FG000|STARTED|Second Intervention (5 d Energy Deficit)||10||
59518455|NCT03372928|75612227|FG001|STARTED|Second Intervention (5 d Energy Deficit)||9||
59613337|NCT01568034|75724484|FG001|100 mg BIA 9-1067|Overall Study||2||
59613338|NCT01568034|75724485|FG002|100 mg BIA 9-1067|Overall Study||3||
59936953|NCT03282565|76055110|FG002|STARTED|Overall Study||10||
59936954|NCT03282565|76055108|FG000|COMPLETED|Overall Study||10||
59936955|NCT03282565|76055109|FG001|COMPLETED|Overall Study||8||
59936956|NCT03282565|76055110|FG002|COMPLETED|Overall Study||8||
59936957|NCT03282565|76055108|FG000|NOT COMPLETED|Overall Study||0||
59936958|NCT03282565|76055109|FG001|NOT COMPLETED|Overall Study||2||
59936959|NCT03282565|76055110|FG002|NOT COMPLETED|Overall Study||2||
59613339|NCT01568034|75724486|FG003|100 mg BIA 9-1067|Overall Study||3||
59936960|NCT02875613|76055118|FG000|STARTED|Overall Study||5||
59936961|NCT02875613|76055118|FG000|COMPLETED|Overall Study||4||
59936962|NCT02875613|76055118|FG000|NOT COMPLETED|Overall Study||1||
59936963|NCT02823457|76055122|FG000|STARTED|Overall Study||20||
59936964|NCT02823457|76055122|FG000|COMPLETED|Overall Study||15||
59936965|NCT02823457|76055122|FG000|NOT COMPLETED|Overall Study||5||
59936966|NCT02815267|76055128|FG000|STARTED|Double-Blind Phase||307||
59936967|NCT02815267|76055129|FG001|STARTED|Double-Blind Phase||159||
59936968|NCT02815267|76055128|FG000|COMPLETED|Double-Blind Phase||274||
59936969|NCT02815267|76055129|FG001|COMPLETED|Double-Blind Phase||128||
59936970|NCT02815267|76055128|FG000|NOT COMPLETED|Double-Blind Phase||33||
59936971|NCT02815267|76055129|FG001|NOT COMPLETED|Double-Blind Phase||31||
59936972|NCT02815267|76055128|FG000|STARTED|Open-Label Phase||193||
59936973|NCT02815267|76055129|FG001|STARTED|Open-Label Phase||91||
59936974|NCT02815267|76055128|FG000|COMPLETED|Open-Label Phase||122||
59936975|NCT02815267|76055129|FG001|COMPLETED|Open-Label Phase||50||
59936976|NCT02815267|76055128|FG000|NOT COMPLETED|Open-Label Phase||71||
59936977|NCT02815267|76055129|FG001|NOT COMPLETED|Open-Label Phase||41||
59936978|NCT02930837|76055139|FG000|STARTED|Overall Study|Started are treated patients|120||
59936979|NCT02930837|76055139|FG000|COMPLETED|Overall Study|Completed the trial|108||
59936980|NCT02930837|76055139|FG000|NOT COMPLETED|Overall Study||12||
59936981|NCT01343277|76055145|FG000|STARTED|Overall Study||384||
59936982|NCT01343277|76055146|FG001|STARTED|Overall Study||193||
59936983|NCT01343277|76055145|FG000|Treated|Overall Study||378||
59936984|NCT01343277|76055146|FG001|Treated|Overall Study||172||
59936985|NCT01343277|76055145|FG000|COMPLETED|Overall Study||0||
59936986|NCT01343277|76055146|FG001|COMPLETED|Overall Study||0||
59936987|NCT01343277|76055145|FG000|NOT COMPLETED|Overall Study||384||
59936988|NCT01343277|76055146|FG001|NOT COMPLETED|Overall Study||193||
59936989|NCT03135899|76055160|FG000|STARTED|Overall Study||1||
59936990|NCT03135899|76055161|FG001|STARTED|Overall Study||1||
59936991|NCT03135899|76055162|FG002|STARTED|Overall Study||1||
59936992|NCT03135899|76055163|FG003|STARTED|Overall Study||1||
59936993|NCT03135899|76055164|FG004|STARTED|Overall Study||8||
59936994|NCT03135899|76055165|FG005|STARTED|Overall Study||9||
59936995|NCT03135899|76055166|FG006|STARTED|Overall Study||8||
59936996|NCT03135899|76055167|FG007|STARTED|Overall Study||8||
59936997|NCT03135899|76055160|FG000|COMPLETED|Overall Study||1||
59936998|NCT03135899|76055161|FG001|COMPLETED|Overall Study||1||
59936999|NCT03135899|76055162|FG002|COMPLETED|Overall Study||1||
59937000|NCT03135899|76055163|FG003|COMPLETED|Overall Study||1||
59937001|NCT03135899|76055164|FG004|COMPLETED|Overall Study||8||
59937002|NCT03135899|76055165|FG005|COMPLETED|Overall Study||7||
59937003|NCT03135899|76055166|FG006|COMPLETED|Overall Study||7||
59937004|NCT03135899|76055167|FG007|COMPLETED|Overall Study||8||
59937005|NCT03135899|76055160|FG000|NOT COMPLETED|Overall Study||0||
59937006|NCT03135899|76055161|FG001|NOT COMPLETED|Overall Study||0||
59937007|NCT03135899|76055162|FG002|NOT COMPLETED|Overall Study||0||
59937008|NCT03135899|76055163|FG003|NOT COMPLETED|Overall Study||0||
59937009|NCT03135899|76055164|FG004|NOT COMPLETED|Overall Study||0||
59937010|NCT03135899|76055165|FG005|NOT COMPLETED|Overall Study||2||
59937011|NCT03135899|76055166|FG006|NOT COMPLETED|Overall Study||1||
59937012|NCT03135899|76055167|FG007|NOT COMPLETED|Overall Study||0||
59937013|NCT02487979|76055181|FG000|STARTED|Overall Study||22||
59937014|NCT02487979|76055181|FG000|COMPLETED|Overall Study||1||
59937015|NCT02487979|76055181|FG000|NOT COMPLETED|Overall Study||21||
59937016|NCT04579549|76055185|FG000|STARTED|Overall Study||464||
59937017|NCT04579549|76055185|FG000|Number of Individuals Trained In COVID-19 Assay|Overall Study||11||
59937018|NCT04579549|76055185|FG000|COMPLETED|Overall Study||464||
59937019|NCT04579549|76055185|FG000|NOT COMPLETED|Overall Study||0||
59937020|NCT03103087|76055192|FG000|STARTED|Overall Study||126||
59937021|NCT03103087|76055193|FG001|STARTED|Overall Study||127||
59937022|NCT03103087|76055194|FG002|STARTED|Overall Study||129||
59937023|NCT03103087|76055192|FG000|COMPLETED|Overall Study||102||
59937024|NCT03103087|76055193|FG001|COMPLETED|Overall Study||98||
59937025|NCT03103087|76055194|FG002|COMPLETED|Overall Study||102||
59937026|NCT03103087|76055192|FG000|NOT COMPLETED|Overall Study||24||
59937027|NCT03103087|76055193|FG001|NOT COMPLETED|Overall Study||29||
59937028|NCT03103087|76055194|FG002|NOT COMPLETED|Overall Study||27||
59937029|NCT03131999|76055206|FG000|STARTED|Overall Study||8||
59937030|NCT03131999|76055207|FG001|STARTED|Overall Study||8||
59937031|NCT03131999|76055206|FG000|COMPLETED|Overall Study||8||
59937032|NCT03131999|76055207|FG001|COMPLETED|Overall Study||7||
59937033|NCT03131999|76055206|FG000|NOT COMPLETED|Overall Study||0||
59937034|NCT03131999|76055207|FG001|NOT COMPLETED|Overall Study||1||
59937035|NCT02055053|76055215|FG000|STARTED|Overall Study||35||
59937036|NCT02055053|76055216|FG001|STARTED|Overall Study||35||
59937037|NCT02055053|76055215|FG000|COMPLETED|Overall Study||35||
59937038|NCT02055053|76055216|FG001|COMPLETED|Overall Study||35||
59937039|NCT02055053|76055215|FG000|NOT COMPLETED|Overall Study||0||
59937040|NCT02055053|76055216|FG001|NOT COMPLETED|Overall Study||0||
59937041|NCT02263885|76055222|FG000|STARTED|Overall Study||20||
59937042|NCT02263885|76055222|FG000|COMPLETED|Overall Study||10||
59937043|NCT02263885|76055222|FG000|NOT COMPLETED|Overall Study||10||
59937044|NCT02000219|76055227|FG000|STARTED|14-Week Study Period||12||
59937045|NCT02000219|76055227|FG000|COMPLETED|14-Week Study Period||9||
59937046|NCT02000219|76055227|FG000|NOT COMPLETED|14-Week Study Period||3||
59937047|NCT02000219|76055227|FG000|STARTED|Continuation Period||8|One patient chose not to enter the continuation period, and returned to their home country|
59937048|NCT02000219|76055227|FG000|COMPLETED|Continuation Period||3||
59937049|NCT02000219|76055227|FG000|NOT COMPLETED|Continuation Period||5||
59937050|NCT03101371|76055233|FG000|STARTED|Overall Study||48||
59937051|NCT03101371|76055234|FG001|STARTED|Overall Study||51||
59937052|NCT03101371|76055233|FG000|COMPLETED|Overall Study||45||
59937053|NCT03101371|76055234|FG001|COMPLETED|Overall Study||45||
59937054|NCT03101371|76055233|FG000|NOT COMPLETED|Overall Study||3||
59937055|NCT03101371|76055234|FG001|NOT COMPLETED|Overall Study||6||
59937056|NCT02850276|76055240|FG000|STARTED|Overall Study||76||
59937057|NCT02850276|76055240|FG000|COMPLETED|Overall Study||15||
59937058|NCT02850276|76055240|FG000|NOT COMPLETED|Overall Study||61||
59937059|NCT02783768|76055245|FG000|STARTED|Overall Study||6||
59937060|NCT02783768|76055246|FG001|STARTED|Overall Study||5||
59937061|NCT02783768|76055245|FG000|COMPLETED|Overall Study||5||
59937062|NCT02783768|76055246|FG001|COMPLETED|Overall Study||5||
59937063|NCT02783768|76055245|FG000|NOT COMPLETED|Overall Study||1||
59937064|NCT02783768|76055246|FG001|NOT COMPLETED|Overall Study||0||
59937065|NCT03131687|76055258|FG000|STARTED|Overall Study||51||
59937066|NCT03131687|76055259|FG001|STARTED|Overall Study||53||
59937067|NCT03131687|76055260|FG002|STARTED|Overall Study||55||
59937068|NCT03131687|76055261|FG003|STARTED|Overall Study||52||
59937069|NCT03131687|76055262|FG004|STARTED|Overall Study||53||
59937070|NCT03131687|76055263|FG005|STARTED|Overall Study||54||
59518456|NCT03372928|75612226|FG000|COMPLETED|Second Intervention (5 d Energy Deficit)||10||
59761930|NCT00599924|75881561|FG003|NOT COMPLETED|Overall Study||8||
59761931|NCT00599924|75881562|FG004|NOT COMPLETED|Overall Study||6||
59761932|NCT00599924|75881563|FG005|NOT COMPLETED|Overall Study||4||
59761933|NCT00599924|75881564|FG006|NOT COMPLETED|Overall Study||5||
59937071|NCT03131687|76055258|FG000|Received at Least One Dose of Study Drug|Overall Study||51||
59937072|NCT03131687|76055259|FG001|Received at Least One Dose of Study Drug|Overall Study||52||
59937073|NCT03131687|76055260|FG002|Received at Least One Dose of Study Drug|Overall Study||55||
59937074|NCT03131687|76055261|FG003|Received at Least One Dose of Study Drug|Overall Study||51||
59937075|NCT03131687|76055262|FG004|Received at Least One Dose of Study Drug|Overall Study||53||
59937076|NCT03131687|76055263|FG005|Received at Least One Dose of Study Drug|Overall Study||54||
59937077|NCT03131687|76055258|FG000|COMPLETED|Overall Study||45||
59937078|NCT03131687|76055259|FG001|COMPLETED|Overall Study||44||
59937079|NCT03131687|76055260|FG002|COMPLETED|Overall Study||52||
59937080|NCT03131687|76055261|FG003|COMPLETED|Overall Study||48||
59937081|NCT03131687|76055262|FG004|COMPLETED|Overall Study||45||
59937082|NCT03131687|76055263|FG005|COMPLETED|Overall Study||49||
59937083|NCT03131687|76055258|FG000|NOT COMPLETED|Overall Study||6||
59937084|NCT03131687|76055259|FG001|NOT COMPLETED|Overall Study||9||
59937085|NCT03131687|76055260|FG002|NOT COMPLETED|Overall Study||3||
59937086|NCT03131687|76055261|FG003|NOT COMPLETED|Overall Study||4||
59937087|NCT03131687|76055262|FG004|NOT COMPLETED|Overall Study||8||
59937088|NCT03131687|76055263|FG005|NOT COMPLETED|Overall Study||5||
59937089|NCT03101293|76055292|FG000|STARTED|Intervention Period 1||7||
59937090|NCT03101293|76055293|FG001|STARTED|Intervention Period 1||8||
59937091|NCT03101293|76055292|FG000|COMPLETED|Intervention Period 1||7||
59937092|NCT03101293|76055293|FG001|COMPLETED|Intervention Period 1||8||
59937093|NCT03101293|76055292|FG000|NOT COMPLETED|Intervention Period 1||0||
59937094|NCT03101293|76055293|FG001|NOT COMPLETED|Intervention Period 1||0||
59937095|NCT03101293|76055292|FG000|STARTED|Washout Period (at Least 7 Days)||7||
59937096|NCT03101293|76055293|FG001|STARTED|Washout Period (at Least 7 Days)||8||
59937097|NCT03101293|76055292|FG000|COMPLETED|Washout Period (at Least 7 Days)||6||
59937098|NCT03101293|76055293|FG001|COMPLETED|Washout Period (at Least 7 Days)||8||
59937099|NCT03101293|76055292|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||1||
59937100|NCT03101293|76055293|FG001|NOT COMPLETED|Washout Period (at Least 7 Days)||0||
59937101|NCT03101293|76055292|FG000|STARTED|Intervention Period 2||6||
59937102|NCT03101293|76055293|FG001|STARTED|Intervention Period 2||8||
59937103|NCT03101293|76055292|FG000|COMPLETED|Intervention Period 2||6||
59937104|NCT03101293|76055293|FG001|COMPLETED|Intervention Period 2||8||
59937105|NCT03101293|76055292|FG000|NOT COMPLETED|Intervention Period 2||0||
60067421|NCT01940497|76182577|FG000|COMPLETED|Overall Study||100|Completed Treatment Period|
59761934|NCT00581542|75881587|FG000|STARTED|Overall Study||62||
59937106|NCT03101293|76055293|FG001|NOT COMPLETED|Intervention Period 2||0||
59937107|NCT02850978|76055299|FG000|STARTED|Overall Study||1335|Strated are registered|
59937108|NCT02850978|76055299|FG000|Case Report Form (CRF) Collected|Overall Study||1308||
59937109|NCT02850978|76055299|FG000|Treated|Overall Study||1308||
59937110|NCT02850978|76055299|FG000|COMPLETED|Overall Study||909||
59937111|NCT02850978|76055299|FG000|NOT COMPLETED|Overall Study||426||
59937112|NCT03135431|76055305|FG000|STARTED|Overall Study||20||
59937113|NCT03135431|76055306|FG001|STARTED|Overall Study||20||
59937114|NCT03135431|76055305|FG000|COMPLETED|Overall Study||18||
59937115|NCT03135431|76055306|FG001|COMPLETED|Overall Study||20||
59937116|NCT03135431|76055305|FG000|NOT COMPLETED|Overall Study||2||
59937117|NCT03135431|76055306|FG001|NOT COMPLETED|Overall Study||0||
59937118|NCT03767634|76055315|FG000|STARTED|Overall Study||62145||
59937119|NCT03767634|76055316|FG001|STARTED|Overall Study|8,146 neonates were included in the matched propensity score analysis|19080||
59937120|NCT03767634|76055317|FG002|STARTED|Overall Study|8,146 neonates were included in the matched propensity score analysis|16282||
59937121|NCT03767634|76055315|FG000|COMPLETED|Overall Study||62145||
59937122|NCT03767634|76055316|FG001|COMPLETED|Overall Study|8,146 neonates were included in the matched propensity score analysis|19080||
59937123|NCT03767634|76055317|FG002|COMPLETED|Overall Study|8,146 neonates were included in the matched propensity score analysis|16282||
59937124|NCT03767634|76055315|FG000|NOT COMPLETED|Overall Study||0||
59937125|NCT03767634|76055316|FG001|NOT COMPLETED|Overall Study||0||
59937126|NCT03767634|76055317|FG002|NOT COMPLETED|Overall Study||0||
59937127|NCT04534517|76055328|FG000|STARTED|Overall Study||114||
59937128|NCT04534517|76055328|FG000|COMPLETED|Overall Study||110||
59937129|NCT04534517|76055328|FG000|NOT COMPLETED|Overall Study||4||
59937130|NCT02831257|76055332|FG000|STARTED|Overall Study||18||
59937131|NCT02831257|76055332|FG000|COMPLETED|Overall Study||6||
59937132|NCT02831257|76055332|FG000|NOT COMPLETED|Overall Study||12||
59937133|NCT03100825|76055336|FG000|STARTED|Overall Study||94||
59937134|NCT03100825|76055336|FG000|COMPLETED|Overall Study||86||
59937135|NCT03100825|76055336|FG000|NOT COMPLETED|Overall Study||8||
59937136|NCT02250534|76055343|FG000|STARTED|Overall Study||254||
59937137|NCT02250534|76055344|FG001|STARTED|Overall Study||235||
59937138|NCT02250534|76055345|FG002|STARTED|Overall Study||286||
59937139|NCT02250534|76055343|FG000|COMPLETED|Overall Study||218||
59937140|NCT02250534|76055344|FG001|COMPLETED|Overall Study||190||
59937141|NCT02250534|76055345|FG002|COMPLETED|Overall Study||224||
59937142|NCT02250534|76055343|FG000|NOT COMPLETED|Overall Study||36||
59937143|NCT02250534|76055344|FG001|NOT COMPLETED|Overall Study||45||
59937144|NCT02250534|76055345|FG002|NOT COMPLETED|Overall Study||62||
59937145|NCT02848326|76055359|FG000|STARTED|Treatment Period||186||
59937146|NCT02848326|76055360|FG001|STARTED|Treatment Period||94||
59937147|NCT02848326|76055361|FG002|STARTED|Treatment Period||185||
59937148|NCT02848326|76055362|FG003|STARTED|Treatment Period||187||
59937149|NCT02848326|76055363|FG004|STARTED|Treatment Period||89||
59937150|NCT02848326|76055364|FG005|STARTED|Treatment Period||93||
59937151|NCT02848326|76055359|FG000|Safety Population: Received Study Drug|Treatment Period||186||
59937152|NCT02848326|76055360|FG001|Safety Population: Received Study Drug|Treatment Period||93||
59937153|NCT02848326|76055361|FG002|Safety Population: Received Study Drug|Treatment Period||183||
59937154|NCT02848326|76055362|FG003|Safety Population: Received Study Drug|Treatment Period||186||
59937155|NCT02848326|76055363|FG004|Safety Population: Received Study Drug|Treatment Period||86||
59937156|NCT02848326|76055364|FG005|Safety Population: Received Study Drug|Treatment Period||91||
59937157|NCT02848326|76055359|FG000|COMPLETED|Treatment Period||148||
59937158|NCT02848326|76055360|FG001|COMPLETED|Treatment Period||80||
59937159|NCT02848326|76055361|FG002|COMPLETED|Treatment Period||149||
59937160|NCT02848326|76055362|FG003|COMPLETED|Treatment Period||164||
59937161|NCT02848326|76055363|FG004|COMPLETED|Treatment Period||70||
59937162|NCT02848326|76055364|FG005|COMPLETED|Treatment Period||73||
59937163|NCT02848326|76055359|FG000|NOT COMPLETED|Treatment Period||38||
59937164|NCT02848326|76055360|FG001|NOT COMPLETED|Treatment Period||14||
59937165|NCT02848326|76055361|FG002|NOT COMPLETED|Treatment Period||36||
59937166|NCT02848326|76055362|FG003|NOT COMPLETED|Treatment Period||23||
59937167|NCT02848326|76055363|FG004|NOT COMPLETED|Treatment Period||19||
59937168|NCT02848326|76055364|FG005|NOT COMPLETED|Treatment Period||20||
59937169|NCT02848326|76055359|FG000|STARTED|Safety Follow-up Period||161||
59937170|NCT02848326|76055360|FG001|STARTED|Safety Follow-up Period||84||
59937171|NCT02848326|76055361|FG002|STARTED|Safety Follow-up Period||156||
59937172|NCT02848326|76055362|FG003|STARTED|Safety Follow-up Period||169||
59937173|NCT02848326|76055363|FG004|STARTED|Safety Follow-up Period||77||
59937174|NCT02848326|76055364|FG005|STARTED|Safety Follow-up Period||82||
59937175|NCT02848326|76055359|FG000|COMPLETED|Safety Follow-up Period||157||
59937176|NCT02848326|76055360|FG001|COMPLETED|Safety Follow-up Period||83||
59937177|NCT02848326|76055361|FG002|COMPLETED|Safety Follow-up Period||153||
59937178|NCT02848326|76055362|FG003|COMPLETED|Safety Follow-up Period||169||
59937179|NCT02848326|76055363|FG004|COMPLETED|Safety Follow-up Period||76||
59937180|NCT02848326|76055364|FG005|COMPLETED|Safety Follow-up Period||77||
59937181|NCT02848326|76055359|FG000|NOT COMPLETED|Safety Follow-up Period||4||
59937182|NCT02848326|76055360|FG001|NOT COMPLETED|Safety Follow-up Period||1||
59937183|NCT02848326|76055361|FG002|NOT COMPLETED|Safety Follow-up Period||3||
59937184|NCT02848326|76055362|FG003|NOT COMPLETED|Safety Follow-up Period||0||
59937185|NCT02848326|76055363|FG004|NOT COMPLETED|Safety Follow-up Period||1||
59937186|NCT02848326|76055364|FG005|NOT COMPLETED|Safety Follow-up Period||5||
59518457|NCT03372928|75612227|FG001|COMPLETED|Second Intervention (5 d Energy Deficit)||9||
59937187|NCT03128723|76055378|FG000|STARTED|Overall Study||45||
59937188|NCT03128723|76055378|FG000|COMPLETED|Overall Study||43||
59937189|NCT03128723|76055378|FG000|NOT COMPLETED|Overall Study||2||
59937190|NCT03128411|76055382|FG000|STARTED|Treatment Phase||60||
59937191|NCT03128411|76055382|FG000|Received Treatment|Treatment Phase||60||
59937192|NCT03128411|76055382|FG000|COMPLETED|Treatment Phase||36||
59937193|NCT03128411|76055382|FG000|NOT COMPLETED|Treatment Phase||24||
59937194|NCT03128411|76055382|FG000|STARTED|Long Term Follow-up Phase|Participants who discontinued treatment phase, entered in long term follow up phase.|24||
59937195|NCT03128411|76055382|FG000|COMPLETED|Long Term Follow-up Phase||22||
59937196|NCT03128411|76055382|FG000|NOT COMPLETED|Long Term Follow-up Phase||2||
59937197|NCT02847858|76055388|FG000|STARTED|Overall Study||693||
59937198|NCT02847858|76055389|FG001|STARTED|Overall Study||667||
59937199|NCT02847858|76055388|FG000|COMPLETED|Overall Study||292||
59937200|NCT02847858|76055389|FG001|COMPLETED|Overall Study||398||
59937201|NCT02847858|76055388|FG000|NOT COMPLETED|Overall Study||401||
59937202|NCT02847858|76055389|FG001|NOT COMPLETED|Overall Study||269||
59937203|NCT03124199|76055400|FG000|STARTED|Overall Study||40||
59937204|NCT03124199|76055400|FG000|COMPLETED|Overall Study||36||
59937205|NCT03124199|76055400|FG000|NOT COMPLETED|Overall Study||4||
59937206|NCT04465916|76055406|FG000|STARTED|Overall Study||19||
59937207|NCT04465916|76055407|FG001|STARTED|Overall Study||7||
59937208|NCT04465916|76055406|FG000|COMPLETED|Overall Study||19||
59937209|NCT04465916|76055407|FG001|COMPLETED|Overall Study||6||
59937210|NCT04465916|76055406|FG000|NOT COMPLETED|Overall Study||0||
59937211|NCT04465916|76055407|FG001|NOT COMPLETED|Overall Study||1||
59937212|NCT05090852|76055413|FG000|STARTED|Overall Study||31||
59937213|NCT05090852|76055413|FG000|COMPLETED|Overall Study||26||
59937214|NCT05090852|76055413|FG000|NOT COMPLETED|Overall Study||5||
59937215|NCT04408586|76055419|FG000|STARTED|Overall Study||42||
59937216|NCT04408586|76055420|FG001|STARTED|Overall Study||38||
59937217|NCT04408586|76055419|FG000|COMPLETED|Overall Study||42||
59937218|NCT04408586|76055420|FG001|COMPLETED|Overall Study||38||
59937219|NCT04408586|76055419|FG000|NOT COMPLETED|Overall Study||0||
59937220|NCT04408586|76055420|FG001|NOT COMPLETED|Overall Study||0||
59937221|NCT00075816|76055428|FG000|STARTED|Overall Study||278||
59937222|NCT00075816|76055429|FG001|STARTED|Overall Study||273||
59937223|NCT00075816|76055428|FG000|COMPLETED|Overall Study||264||
59937224|NCT00075816|76055429|FG001|COMPLETED|Overall Study||262||
59937225|NCT00075816|76055428|FG000|NOT COMPLETED|Overall Study||14||
59937226|NCT00075816|76055429|FG001|NOT COMPLETED|Overall Study||11||
59937227|NCT04039022|76055437|FG000|STARTED|Overall Study||876||
59937228|NCT04039022|76055437|FG000|COMPLETED|Overall Study||53||
59937229|NCT04039022|76055437|FG000|NOT COMPLETED|Overall Study||823||
59937230|NCT00109772|76055443|FG000|STARTED|Double-blind Treatment||90||
59937231|NCT00109772|76055444|FG001|STARTED|Double-blind Treatment||94||
60067422|NCT01940497|76182578|FG001|COMPLETED|Overall Study||101|Completed Treatment Period|
59518458|NCT03372928|75612226|FG000|NOT COMPLETED|Second Intervention (5 d Energy Deficit)||0||
59519054|NCT01116895|75612922|FG000|STARTED|Overall Study||16||
59937232|NCT00109772|76055443|FG000|Safety and ITT Population|Double-blind Treatment|Safety: at least one dose of study drug ITT: treated and at least one post dose diary measurement|87||
59937233|NCT00109772|76055444|FG001|Safety and ITT Population|Double-blind Treatment|Safety: at least one dose of study drug ITT: treated and at least one post dose diary measurement|93||
59937234|NCT00109772|76055443|FG000|COMPLETED|Double-blind Treatment||68||
59937235|NCT00109772|76055444|FG001|COMPLETED|Double-blind Treatment||79||
59937236|NCT00109772|76055443|FG000|NOT COMPLETED|Double-blind Treatment||22||
59937237|NCT00109772|76055444|FG001|NOT COMPLETED|Double-blind Treatment||15||
59937238|NCT00109772|76055443|FG000|STARTED|Open-label Extension|Four double-blind participants did not continue into the open-label extension|64||
59937239|NCT00109772|76055444|FG001|STARTED|Open-label Extension|One double-blind participant did not continue into the open-label extension|78||
59937240|NCT00109772|76055443|FG000|COMPLETED|Open-label Extension|Participants who were active in extension period when the sponsor terminated the study.|19||
59937241|NCT00109772|76055444|FG001|COMPLETED|Open-label Extension|Participants who were active in extension period when the sponsor terminated the study.|29||
59937242|NCT00109772|76055443|FG000|NOT COMPLETED|Open-label Extension||45||
59937243|NCT00109772|76055444|FG001|NOT COMPLETED|Open-label Extension||49||
59937244|NCT02783066|76055450|FG000|STARTED|Overall Study||16||
59937245|NCT02783066|76055450|FG000|COMPLETED|Overall Study|complete 4-week pulseflow offloading wearing test|3||
59937246|NCT02783066|76055450|FG000|NOT COMPLETED|Overall Study||13||
59937247|NCT01371305|76055461|FG000|STARTED|Overall Study||6||
59937248|NCT01371305|76055462|FG001|STARTED|Overall Study||6||
59937249|NCT01371305|76055463|FG002|STARTED|Overall Study||6||
59937250|NCT01371305|76055464|FG003|STARTED|Overall Study||7||
59937251|NCT01371305|76055465|FG004|STARTED|Overall Study||6||
59937252|NCT01371305|76055466|FG005|STARTED|Overall Study||10||
59937253|NCT01371305|76055461|FG000|COMPLETED|Overall Study||6||
59937254|NCT01371305|76055462|FG001|COMPLETED|Overall Study||6||
59937255|NCT01371305|76055463|FG002|COMPLETED|Overall Study||6||
59937256|NCT01371305|76055464|FG003|COMPLETED|Overall Study||5||
59937257|NCT01371305|76055465|FG004|COMPLETED|Overall Study||2||
59937258|NCT01371305|76055466|FG005|COMPLETED|Overall Study||8||
59937259|NCT01371305|76055461|FG000|NOT COMPLETED|Overall Study||0||
59937260|NCT01371305|76055462|FG001|NOT COMPLETED|Overall Study||0||
59937261|NCT01371305|76055463|FG002|NOT COMPLETED|Overall Study||0||
59937262|NCT01371305|76055464|FG003|NOT COMPLETED|Overall Study||2||
59937263|NCT01371305|76055465|FG004|NOT COMPLETED|Overall Study||4||
59937264|NCT01371305|76055466|FG005|NOT COMPLETED|Overall Study||2||
59937265|NCT00109928|76055481|FG000|STARTED|Overall Study||34||
59937266|NCT00109928|76055481|FG000|Eligible|Overall Study||33||
59937267|NCT00109928|76055481|FG000|Eligible and Began Protocol Therapy|Overall Study||33||
59937268|NCT00109928|76055481|FG000|COMPLETED|Overall Study||21||
59937269|NCT00109928|76055481|FG000|NOT COMPLETED|Overall Study||13||
59937270|NCT00109850|76055486|FG000|STARTED|Overall Study||22||
59937271|NCT00109850|76055486|FG000|Eligible|Overall Study||21||
59937272|NCT00109850|76055486|FG000|Eligible and Began Protocol Therapy|Overall Study||21||
59937273|NCT00109850|76055486|FG000|COMPLETED|Overall Study||18||
59937274|NCT00109850|76055486|FG000|NOT COMPLETED|Overall Study||4||
59937275|NCT01342926|76055494|FG000|STARTED|Overall Study||46||
59937276|NCT01342926|76055495|FG001|STARTED|Overall Study||46||
59937277|NCT01342926|76055496|FG002|STARTED|Overall Study||48||
59937278|NCT01342926|76055497|FG003|STARTED|Overall Study||51||
59937279|NCT01342926|76055494|FG000|COMPLETED|Overall Study||37||
59937280|NCT01342926|76055495|FG001|COMPLETED|Overall Study||31||
59937281|NCT01342926|76055496|FG002|COMPLETED|Overall Study||34||
59937282|NCT01342926|76055497|FG003|COMPLETED|Overall Study||39||
59937283|NCT01342926|76055494|FG000|NOT COMPLETED|Overall Study||9||
59937284|NCT01342926|76055495|FG001|NOT COMPLETED|Overall Study||15||
59937285|NCT01342926|76055496|FG002|NOT COMPLETED|Overall Study||14||
59937286|NCT01342926|76055497|FG003|NOT COMPLETED|Overall Study||12||
59937287|NCT01810016|76055510|FG000|STARTED|Overall Study||5||
59937288|NCT01810016|76055511|FG001|STARTED|Overall Study||2||
59937289|NCT01810016|76055512|FG002|STARTED|Overall Study||1||
59937290|NCT01810016|76055510|FG000|COMPLETED|Overall Study||4||
59937291|NCT01810016|76055511|FG001|COMPLETED|Overall Study||1||
59937292|NCT01810016|76055512|FG002|COMPLETED|Overall Study||0||
59937293|NCT01810016|76055510|FG000|NOT COMPLETED|Overall Study||1||
59937294|NCT01810016|76055511|FG001|NOT COMPLETED|Overall Study||1||
59937295|NCT01810016|76055512|FG002|NOT COMPLETED|Overall Study||1||
59937296|NCT02843178|76055524|FG000|STARTED|Overall Study||86||
59937297|NCT02843178|76055525|FG001|STARTED|Overall Study||90||
59937298|NCT02843178|76055526|FG002|STARTED|Overall Study||92||
59937299|NCT02843178|76055527|FG003|STARTED|Overall Study||91||
59937300|NCT02843178|76055524|FG000|COMPLETED|Overall Study||78||
59937301|NCT02843178|76055525|FG001|COMPLETED|Overall Study||82||
59937302|NCT02843178|76055526|FG002|COMPLETED|Overall Study||85||
59937303|NCT02843178|76055527|FG003|COMPLETED|Overall Study||87||
59937304|NCT02843178|76055524|FG000|NOT COMPLETED|Overall Study||8||
59937305|NCT02843178|76055525|FG001|NOT COMPLETED|Overall Study||8||
59937306|NCT02843178|76055526|FG002|NOT COMPLETED|Overall Study||7||
59937307|NCT02843178|76055527|FG003|NOT COMPLETED|Overall Study||4||
59937308|NCT03123185|76055551|FG000|STARTED|Overall Study||12||
59937309|NCT03123185|76055552|FG001|STARTED|Overall Study||8||
59937310|NCT03123185|76055553|FG002|STARTED|Overall Study||6||
59937311|NCT03123185|76055554|FG003|STARTED|Overall Study||5||
59937312|NCT03123185|76055555|FG004|STARTED|Overall Study||6||
59937313|NCT03123185|76055556|FG005|STARTED|Overall Study||6||
59937314|NCT03123185|76055557|FG006|STARTED|Overall Study||6||
59937315|NCT03123185|76055558|FG007|STARTED|Overall Study||6||
59937316|NCT03123185|76055559|FG008|STARTED|Overall Study||6||
59937317|NCT03123185|76055560|FG009|STARTED|Overall Study||6||
59937318|NCT03123185|76055561|FG010|STARTED|Overall Study||6||
59937319|NCT03123185|76055562|FG011|STARTED|Overall Study||6||
59937320|NCT03123185|76055563|FG012|STARTED|Overall Study||6||
59937321|NCT03123185|76055564|FG013|STARTED|Overall Study||6||
59937322|NCT03123185|76055551|FG000|COMPLETED|Overall Study||12||
59937323|NCT03123185|76055552|FG001|COMPLETED|Overall Study||8||
59937324|NCT03123185|76055553|FG002|COMPLETED|Overall Study||6||
59937325|NCT03123185|76055554|FG003|COMPLETED|Overall Study||5||
59937326|NCT03123185|76055555|FG004|COMPLETED|Overall Study||6||
59937327|NCT03123185|76055556|FG005|COMPLETED|Overall Study||6||
59937328|NCT03123185|76055557|FG006|COMPLETED|Overall Study||6||
59937329|NCT03123185|76055558|FG007|COMPLETED|Overall Study||6||
59937330|NCT03123185|76055559|FG008|COMPLETED|Overall Study||6||
59937331|NCT03123185|76055560|FG009|COMPLETED|Overall Study||6||
59937332|NCT03123185|76055561|FG010|COMPLETED|Overall Study||6||
59937333|NCT03123185|76055562|FG011|COMPLETED|Overall Study||6||
59937334|NCT03123185|76055563|FG012|COMPLETED|Overall Study||5||
59937335|NCT03123185|76055564|FG013|COMPLETED|Overall Study||6||
59937336|NCT03123185|76055551|FG000|NOT COMPLETED|Overall Study||0||
59937337|NCT03123185|76055552|FG001|NOT COMPLETED|Overall Study||0||
59937338|NCT03123185|76055553|FG002|NOT COMPLETED|Overall Study||0||
59937339|NCT03123185|76055554|FG003|NOT COMPLETED|Overall Study||0||
59937340|NCT03123185|76055555|FG004|NOT COMPLETED|Overall Study||0||
59937341|NCT03123185|76055556|FG005|NOT COMPLETED|Overall Study||0||
59937342|NCT03123185|76055557|FG006|NOT COMPLETED|Overall Study||0||
59937343|NCT03123185|76055558|FG007|NOT COMPLETED|Overall Study||0||
59937344|NCT03123185|76055559|FG008|NOT COMPLETED|Overall Study||0||
59937345|NCT03123185|76055560|FG009|NOT COMPLETED|Overall Study||0||
59937346|NCT03123185|76055561|FG010|NOT COMPLETED|Overall Study||0||
59937347|NCT03123185|76055562|FG011|NOT COMPLETED|Overall Study||0||
59937348|NCT03123185|76055563|FG012|NOT COMPLETED|Overall Study||1||
59937349|NCT03123185|76055564|FG013|NOT COMPLETED|Overall Study||0||
59937350|NCT03123068|76055614|FG000|STARTED|Overall Study||22||
59937351|NCT03123068|76055615|FG001|STARTED|Overall Study||20||
59937352|NCT03123068|76055614|FG000|COMPLETED|Overall Study||22||
59937353|NCT03123068|76055615|FG001|COMPLETED|Overall Study||20||
59937354|NCT03123068|76055614|FG000|NOT COMPLETED|Overall Study||0||
59937355|NCT03123068|76055615|FG001|NOT COMPLETED|Overall Study||0||
59937356|NCT02842866|76055623|FG000|STARTED|Overall Study||451|Randomized|
59937357|NCT02842866|76055624|FG001|STARTED|Overall Study||455|Randomized|
59937358|NCT02842866|76055623|FG000|Vaccinated|Overall Study||448||
59937359|NCT02842866|76055624|FG001|Vaccinated|Overall Study||453||
59937360|NCT02842866|76055623|FG000|COMPLETED|Overall Study||444||
59937361|NCT02842866|76055624|FG001|COMPLETED|Overall Study||452||
59937362|NCT02842866|76055623|FG000|NOT COMPLETED|Overall Study||7||
59937363|NCT02842866|76055624|FG001|NOT COMPLETED|Overall Study||3||
59937364|NCT01316913|76055634|FG000|STARTED|Overall Study||222||
59937365|NCT01316913|76055635|FG001|STARTED|Overall Study||217||
59937366|NCT01316913|76055636|FG002|STARTED|Overall Study||215||
59937367|NCT01316913|76055637|FG003|STARTED|Overall Study||215||
59613340|NCT01568034|75724483|FG000|Placebo|Overall Study||1||
59613341|NCT01568034|75724484|FG001|Placebo|Overall Study||2||
59613342|NCT01568034|75724485|FG002|Placebo|Overall Study||3||
59613343|NCT01568034|75724486|FG003|Placebo|Overall Study||3||
59613344|NCT01568034|75724483|FG000|COMPLETED|Overall Study||1||
59613345|NCT01568034|75724484|FG001|COMPLETED|Overall Study||2||
59613346|NCT01568034|75724485|FG002|COMPLETED|Overall Study||3||
59613347|NCT01568034|75724486|FG003|COMPLETED|Overall Study||3||
59613348|NCT01568034|75724483|FG000|NOT COMPLETED|Overall Study||1||
59613349|NCT01568034|75724484|FG001|NOT COMPLETED|Overall Study||0||
59613350|NCT01568034|75724485|FG002|NOT COMPLETED|Overall Study||0||
59613351|NCT01568034|75724486|FG003|NOT COMPLETED|Overall Study||0||
59613352|NCT01687218|75724502|FG000|STARTED|Overall Study||33||
59613353|NCT01687218|75724503|FG001|STARTED|Overall Study||32||
59613354|NCT01687218|75724504|FG002|STARTED|Overall Study||31||
59613355|NCT01687218|75724505|FG003|STARTED|Overall Study||34||
59937368|NCT01316913|76055634|FG000|COMPLETED|Overall Study||165||
59937369|NCT01316913|76055635|FG001|COMPLETED|Overall Study||163||
59937370|NCT01316913|76055636|FG002|COMPLETED|Overall Study||166||
59937371|NCT01316913|76055637|FG003|COMPLETED|Overall Study||176||
59937372|NCT01316913|76055634|FG000|NOT COMPLETED|Overall Study||57||
59937373|NCT01316913|76055635|FG001|NOT COMPLETED|Overall Study||54||
59937374|NCT01316913|76055636|FG002|NOT COMPLETED|Overall Study||49||
59937375|NCT01316913|76055637|FG003|NOT COMPLETED|Overall Study||39||
59937376|NCT02875067|76055648|FG000|STARTED|Overall Study||6||
59937377|NCT02875067|76055648|FG000|COMPLETED|Overall Study||0||
59937378|NCT02875067|76055648|FG000|NOT COMPLETED|Overall Study||6||
59937379|NCT02781506|76055652|FG000|STARTED|Overall Study||7||
59937380|NCT02781506|76055652|FG000|COMPLETED|Overall Study||2||
59937381|NCT02781506|76055652|FG000|NOT COMPLETED|Overall Study||5||
59937382|NCT03132753|76055658|FG000|STARTED|Baseline - 6 Month Follow-Up||46||
59937383|NCT03132753|76055659|FG001|STARTED|Baseline - 6 Month Follow-Up||54||
59937384|NCT03132753|76055658|FG000|COMPLETED|Baseline - 6 Month Follow-Up||19||
59937385|NCT03132753|76055659|FG001|COMPLETED|Baseline - 6 Month Follow-Up||22||
59937386|NCT03132753|76055658|FG000|NOT COMPLETED|Baseline - 6 Month Follow-Up||27||
59937387|NCT03132753|76055659|FG001|NOT COMPLETED|Baseline - 6 Month Follow-Up||32||
59937388|NCT03132753|76055658|FG000|STARTED|6 Month Follow-Up - 12 Month Follow-Up||19||
59937389|NCT03132753|76055659|FG001|STARTED|6 Month Follow-Up - 12 Month Follow-Up||22||
59937390|NCT03132753|76055658|FG000|COMPLETED|6 Month Follow-Up - 12 Month Follow-Up||13||
59937391|NCT03132753|76055659|FG001|COMPLETED|6 Month Follow-Up - 12 Month Follow-Up||20||
59937392|NCT03132753|76055658|FG000|NOT COMPLETED|6 Month Follow-Up - 12 Month Follow-Up||6||
59937393|NCT03132753|76055659|FG001|NOT COMPLETED|6 Month Follow-Up - 12 Month Follow-Up||2||
60067423|NCT01940497|76182577|FG000|NOT COMPLETED|Overall Study||21||
60067424|NCT01940497|76182578|FG001|NOT COMPLETED|Overall Study||18||
59613356|NCT01687218|75724506|FG004|STARTED|Overall Study||33||
59937394|NCT01468454|76055665|FG000|STARTED|Overall Study||128||
59937395|NCT01468454|76055665|FG000|PETs Completed|Overall Study||128||
59937396|NCT01468454|76055665|FG000|Had Both PET and Surgery|Overall Study||119||
59937397|NCT01468454|76055665|FG000|COMPLETED|Overall Study||119||
59937398|NCT01468454|76055665|FG000|NOT COMPLETED|Overall Study||9||
59937399|NCT03067077|76055670|FG000|STARTED|Overall Study||44||44
59937400|NCT03067077|76055671|FG001|STARTED|Overall Study||44||44
59937401|NCT03067077|76055670|FG000|Received Surgery|Overall Study||40||40
59937402|NCT03067077|76055671|FG001|Received Surgery|Overall Study||39||39
59613357|NCT01687218|75724507|FG005|STARTED|Overall Study||32||
59937403|NCT03067077|76055670|FG000|COMPLETED|Overall Study||37||37
59937404|NCT03067077|76055671|FG001|COMPLETED|Overall Study||37||37
59937405|NCT03067077|76055670|FG000|NOT COMPLETED|Overall Study||7||7
59937406|NCT03067077|76055671|FG001|NOT COMPLETED|Overall Study||7||7
59937407|NCT03096847|76055680|FG000|STARTED|Overall Study||319|participants who started treatment|
60067425|NCT01924754|76182598|FG000|STARTED|Overall Study||50||
60067426|NCT01924754|76182599|FG001|STARTED|Overall Study||50||
59937408|NCT03096847|76055681|FG001|STARTED|Overall Study||26|participants who started treatment|
59937409|NCT03096847|76055682|FG002|STARTED|Overall Study||157|participants who started treatment|
59937410|NCT03096847|76055680|FG000|Full Analysis Set|Overall Study||307||
59937411|NCT03096847|76055681|FG001|Full Analysis Set|Overall Study||26||
59937412|NCT03096847|76055682|FG002|Full Analysis Set|Overall Study||154||
59937413|NCT03096847|76055680|FG000|COMPLETED|Overall Study|Only the primary reason for disc. is included in this table.|100|Completed study|
59937414|NCT03096847|76055681|FG001|COMPLETED|Overall Study|Only the primary reason for disc. is included in this table.|6|Completed study|
59937415|NCT03096847|76055682|FG002|COMPLETED|Overall Study|Only the primary reason for disc. is included in this table.|19|Completed study|
59937416|NCT03096847|76055680|FG000|NOT COMPLETED|Overall Study||219||
59937417|NCT03096847|76055681|FG001|NOT COMPLETED|Overall Study||20||
59937418|NCT03096847|76055682|FG002|NOT COMPLETED|Overall Study||138||
59937419|NCT01365182|76055701|FG000|STARTED|Overall Study||91||
59937420|NCT01365182|76055702|FG001|STARTED|Overall Study||94||
59937421|NCT01365182|76055703|FG002|STARTED|Overall Study||94||
59937422|NCT01365182|76055701|FG000|COMPLETED|Overall Study||81||
59937423|NCT01365182|76055702|FG001|COMPLETED|Overall Study||81||
59937424|NCT01365182|76055703|FG002|COMPLETED|Overall Study||82||
59937425|NCT01365182|76055701|FG000|NOT COMPLETED|Overall Study||10||
59937426|NCT01365182|76055702|FG001|NOT COMPLETED|Overall Study||13||
59937427|NCT01365182|76055703|FG002|NOT COMPLETED|Overall Study||12||
59937428|NCT03019575|76055714|FG000|STARTED|Overall Study||17||
59937429|NCT03019575|76055714|FG000|COMPLETED|Overall Study||17||
59937430|NCT03019575|76055714|FG000|NOT COMPLETED|Overall Study||0||
59937431|NCT03128099|76055721|FG000|STARTED|Overall Study||21||
59937432|NCT03128099|76055722|FG001|STARTED|Overall Study||4||
59937433|NCT03128099|76055723|FG002|STARTED|Overall Study||22||
59937434|NCT03128099|76055721|FG000|Hour 1 (Low Dose) Started|Overall Study||21||
59937435|NCT03128099|76055722|FG001|Hour 1 (Low Dose) Started|Overall Study||4||
59937436|NCT03128099|76055723|FG002|Hour 1 (Low Dose) Started|Overall Study||22||
59937437|NCT03128099|76055721|FG000|Hour 1 (Low Dose) Completed|Overall Study||19||
59937438|NCT03128099|76055722|FG001|Hour 1 (Low Dose) Completed|Overall Study||4||
59937439|NCT03128099|76055723|FG002|Hour 1 (Low Dose) Completed|Overall Study||21||
59937440|NCT03128099|76055721|FG000|Hour 2 (High Dose)Started|Overall Study|Hour 2 of training not available to these participants|0||
59937441|NCT03128099|76055722|FG001|Hour 2 (High Dose)Started|Overall Study||4||
59937442|NCT03128099|76055723|FG002|Hour 2 (High Dose)Started|Overall Study|Hour 2 of training not available to these participants|0||
59937443|NCT03128099|76055721|FG000|Hour 2 (High Dose) Completed|Overall Study||0||
59937444|NCT03128099|76055722|FG001|Hour 2 (High Dose) Completed|Overall Study||0||
59937445|NCT03128099|76055723|FG002|Hour 2 (High Dose) Completed|Overall Study||0||
59937446|NCT03128099|76055721|FG000|COMPLETED|Overall Study||19||
59937447|NCT03128099|76055722|FG001|COMPLETED|Overall Study|hour 2 training was completed by 0 participants|0||
59937448|NCT03128099|76055723|FG002|COMPLETED|Overall Study||21||
59937449|NCT03128099|76055721|FG000|NOT COMPLETED|Overall Study||2||
59937450|NCT03128099|76055722|FG001|NOT COMPLETED|Overall Study||4||
59937451|NCT03128099|76055723|FG002|NOT COMPLETED|Overall Study||1||
59937452|NCT02886494|76055731|FG000|STARTED|Overall Study||60||
59937453|NCT02886494|76055732|FG001|STARTED|Overall Study||20||
59937454|NCT02886494|76055731|FG000|COMPLETED|Overall Study||43||
59937455|NCT02886494|76055732|FG001|COMPLETED|Overall Study||16||
59937456|NCT02886494|76055731|FG000|NOT COMPLETED|Overall Study||17||
59937457|NCT02886494|76055732|FG001|NOT COMPLETED|Overall Study||4||
59937458|NCT00204477|76055743|FG000|STARTED|Baseline||161||
59937459|NCT00204477|76055744|FG001|STARTED|Baseline||160||
59937460|NCT00204477|76055743|FG000|COMPLETED|Baseline||161||
59937461|NCT00204477|76055744|FG001|COMPLETED|Baseline||160||
59937462|NCT00204477|76055743|FG000|NOT COMPLETED|Baseline||0||
59937463|NCT00204477|76055744|FG001|NOT COMPLETED|Baseline||0||
59937464|NCT00204477|76055743|FG000|STARTED|One Year After Diet||128|Picked up the diet|
59937465|NCT00204477|76055744|FG001|STARTED|One Year After Diet||125|Picked up the diet|
59937466|NCT00204477|76055743|FG000|COMPLETED|One Year After Diet||86|Complete 1 year of diet|
59937467|NCT00204477|76055744|FG001|COMPLETED|One Year After Diet||87|Complete 1 year of diet|
59937468|NCT00204477|76055743|FG000|NOT COMPLETED|One Year After Diet||42||
59937469|NCT00204477|76055744|FG001|NOT COMPLETED|One Year After Diet||38||
59937470|NCT00204477|76055743|FG000|STARTED|Two Years After Diet||55|Complete full 2nd year of diet.|
59937471|NCT00204477|76055744|FG001|STARTED|Two Years After Diet||62|Complete full 2nd year of diet.|
59937472|NCT00204477|76055743|FG000|COMPLETED|Two Years After Diet||39||
59937473|NCT00204477|76055744|FG001|COMPLETED|Two Years After Diet||49||
59937474|NCT00204477|76055743|FG000|NOT COMPLETED|Two Years After Diet||16||
59937475|NCT00204477|76055744|FG001|NOT COMPLETED|Two Years After Diet||13||
59937476|NCT02846532|76055753|FG000|STARTED|Overall Study||12||
59937477|NCT02846532|76055754|FG001|STARTED|Overall Study||66||
59937478|NCT02846532|76055755|FG002|STARTED|Overall Study||34||
59937479|NCT02846532|76055753|FG000|COMPLETED|Overall Study||11||
59937480|NCT02846532|76055754|FG001|COMPLETED|Overall Study||63||
59937481|NCT02846532|76055755|FG002|COMPLETED|Overall Study||33||
59937482|NCT02846532|76055753|FG000|NOT COMPLETED|Overall Study||1||
59937483|NCT02846532|76055754|FG001|NOT COMPLETED|Overall Study||3||
59937484|NCT02846532|76055755|FG002|NOT COMPLETED|Overall Study||1||
59937485|NCT02659605|76055765|FG000|STARTED|Overall Study||40||
59937486|NCT02659605|76055766|FG001|STARTED|Overall Study||34||
59937487|NCT02659605|76055765|FG000|COMPLETED|Overall Study||31||
59937488|NCT02659605|76055766|FG001|COMPLETED|Overall Study||30||
59937489|NCT02659605|76055765|FG000|NOT COMPLETED|Overall Study||9||
59937490|NCT02659605|76055766|FG001|NOT COMPLETED|Overall Study||4||
59937491|NCT00842348|76055774|FG000|STARTED|Patients Randomised in Study 726||101||
59937492|NCT00842348|76055775|FG001|STARTED|Patients Randomised in Study 726||103||
59937493|NCT00842348|76055774|FG000|COMPLETED|Patients Randomised in Study 726|41 patients had stable disease and 1 patient had progressive disease.|42||
59937494|NCT00842348|76055775|FG001|COMPLETED|Patients Randomised in Study 726|15 patients had stable disease and 32 patients had progressive disease.|47||
59937495|NCT00842348|76055774|FG000|NOT COMPLETED|Patients Randomised in Study 726||59||
59937496|NCT00842348|76055775|FG001|NOT COMPLETED|Patients Randomised in Study 726||56||
59937497|NCT00842348|76055774|FG000|STARTED|Study 729||42||
59937498|NCT00842348|76055775|FG001|STARTED|Study 729||47||
59937499|NCT00842348|76055774|FG000|COMPLETED|Study 729|Enrolled in Study 729 and received at least one dose of open label lanreotide Autogel.|16||
59937500|NCT00842348|76055775|FG001|COMPLETED|Study 729|Enrolled in Study 729 and received at least one dose of open label lanreotide Autogel.|9||
59937501|NCT00842348|76055774|FG000|NOT COMPLETED|Study 729||26||
59937502|NCT00842348|76055775|FG001|NOT COMPLETED|Study 729||38||
59937503|NCT03095599|76055787|FG000|STARTED|Overall Study||741||
59937504|NCT03095599|76055788|FG001|STARTED|Overall Study||148||
59937505|NCT03095599|76055787|FG000|Withdrawal Before Vaccination|Overall Study||1|Voluntary withdrawal.|
59937506|NCT03095599|76055788|FG001|Withdrawal Before Vaccination|Overall Study||0|Voluntary withdrawal.|
59937507|NCT03095599|76055787|FG000|Vaccinated|Overall Study||740||
59937508|NCT03095599|76055788|FG001|Vaccinated|Overall Study||148||
59937509|NCT03095599|76055787|FG000|COMPLETED|Overall Study||738||
59937510|NCT03095599|76055788|FG001|COMPLETED|Overall Study||148||
59937511|NCT03095599|76055787|FG000|NOT COMPLETED|Overall Study||3||
59937512|NCT03095599|76055788|FG001|NOT COMPLETED|Overall Study||0||
59937513|NCT03095521|76055798|FG000|STARTED|Overall Study||115|231 screened, 3 excluded (breach in incl. criteria (2) and no hematology analyses (1)|
59937514|NCT03095521|76055799|FG001|STARTED|Overall Study||113|231 screened, 3 excluded (breach in incl. criteria (2) and no hematology analyses (1)|
59937515|NCT03095521|76055798|FG000|Intent to Treat Population ITT|Overall Study||115||
59937516|NCT03095521|76055799|FG001|Intent to Treat Population ITT|Overall Study||113||
59937517|NCT03095521|76055798|FG000|Per Protocol Population PP|Overall Study||113||
59937518|NCT03095521|76055799|FG001|Per Protocol Population PP|Overall Study||107||
59937519|NCT03095521|76055798|FG000|Safety Population|Overall Study||115||
59937520|NCT03095521|76055799|FG001|Safety Population|Overall Study||113||
59937521|NCT03095521|76055798|FG000|COMPLETED|Overall Study||115||
59937522|NCT03095521|76055799|FG001|COMPLETED|Overall Study||111||
59937523|NCT03095521|76055798|FG000|NOT COMPLETED|Overall Study||0||
59937524|NCT03095521|76055799|FG001|NOT COMPLETED|Overall Study||2||
59937525|NCT03033875|76055808|FG000|STARTED|Overall Study||96||
59937526|NCT03033875|76055809|FG001|STARTED|Overall Study||111||
59937527|NCT03033875|76055810|FG002|STARTED|Overall Study||54||
59937528|NCT03033875|76055808|FG000|Completed Month 3 Assessment|Overall Study||71||
59937529|NCT03033875|76055809|FG001|Completed Month 3 Assessment|Overall Study||83||
59937530|NCT03033875|76055810|FG002|Completed Month 3 Assessment|Overall Study||43||
59937531|NCT03033875|76055808|FG000|Completed Month 6 Assessment|Overall Study||73||
59937532|NCT03033875|76055809|FG001|Completed Month 6 Assessment|Overall Study||81||
59937533|NCT03033875|76055810|FG002|Completed Month 6 Assessment|Overall Study||46||
59937534|NCT03033875|76055808|FG000|COMPLETED|Overall Study||77||
59937535|NCT03033875|76055809|FG001|COMPLETED|Overall Study||87||
59937536|NCT03033875|76055810|FG002|COMPLETED|Overall Study||42||
59937537|NCT03033875|76055808|FG000|NOT COMPLETED|Overall Study||19||
59937538|NCT03033875|76055809|FG001|NOT COMPLETED|Overall Study||24||
59937539|NCT03033875|76055810|FG002|NOT COMPLETED|Overall Study||12||
59937540|NCT02935595|76055818|FG000|STARTED|Overall Study||5||
59937541|NCT02935595|76055818|FG000|COMPLETED|Overall Study||4||
59937542|NCT02935595|76055818|FG000|NOT COMPLETED|Overall Study||1||
59937543|NCT01968785|76055824|FG000|STARTED|Overall Study||2||
59937544|NCT01968785|76055825|FG001|STARTED|Overall Study||0||
59937545|NCT01968785|76055824|FG000|COMPLETED|Overall Study||1||
59519055|NCT01116895|75612923|FG001|STARTED|Overall Study||15||
59937546|NCT01968785|76055825|FG001|COMPLETED|Overall Study||0||
59937547|NCT01968785|76055824|FG000|NOT COMPLETED|Overall Study||1||
59937548|NCT01968785|76055825|FG001|NOT COMPLETED|Overall Study||0||
59937549|NCT03095287|76055831|FG000|STARTED|Overall Study||2||
59937550|NCT03095287|76055831|FG000|COMPLETED|Overall Study||0||
59937551|NCT03095287|76055831|FG000|NOT COMPLETED|Overall Study||2||
59937552|NCT01335581|76055837|FG000|STARTED|Overall Study||9||
59937553|NCT01335581|76055838|FG001|STARTED|Overall Study||9||
59937554|NCT01335581|76055837|FG000|COMPLETED|Overall Study||5||
59937555|NCT01335581|76055838|FG001|COMPLETED|Overall Study||3||
59937556|NCT01335581|76055837|FG000|NOT COMPLETED|Overall Study||4||
59937557|NCT01335581|76055838|FG001|NOT COMPLETED|Overall Study||6||
59937558|NCT01209923|76055844|FG000|STARTED|Overall Study||362||
59937559|NCT01209923|76055844|FG000|COMPLETED|Overall Study||362||
59937560|NCT01209923|76055844|FG000|NOT COMPLETED|Overall Study||0||
59937561|NCT02839746|76055849|FG000|STARTED|Overall Study||671||
59937562|NCT02839746|76055849|FG000|COMPLETED|Overall Study||659||
59937563|NCT02839746|76055849|FG000|NOT COMPLETED|Overall Study||12||
59937564|NCT00033293|76055855|FG000|STARTED|Overall Study||26||
59937565|NCT00033293|76055856|FG001|STARTED|Overall Study||27||
59937566|NCT00033293|76055855|FG000|COMPLETED|Overall Study||16||
59937567|NCT00033293|76055856|FG001|COMPLETED|Overall Study||9||
59937568|NCT00033293|76055855|FG000|NOT COMPLETED|Overall Study||10||
59937569|NCT00033293|76055856|FG001|NOT COMPLETED|Overall Study||18||
59937570|NCT02039674|76055878|FG000|STARTED|Overall Study||13||
59937571|NCT02039674|76055879|FG001|STARTED|Overall Study||12||
59937572|NCT02039674|76055880|FG002|STARTED|Overall Study||12||
59937573|NCT02039674|76055881|FG003|STARTED|Overall Study||13||
59937574|NCT02039674|76055882|FG004|STARTED|Overall Study||12||
59937575|NCT02039674|76055883|FG005|STARTED|Overall Study||12||
59937576|NCT02039674|76055884|FG006|STARTED|Overall Study||3||
59937577|NCT02039674|76055885|FG007|STARTED|Overall Study||3||
59937578|NCT02039674|76055886|FG008|STARTED|Overall Study||12||
59937579|NCT02039674|76055887|FG009|STARTED|Overall Study||12||
59937580|NCT02039674|76055888|FG010|STARTED|Overall Study||7||
59937581|NCT02039674|76055889|FG011|STARTED|Overall Study||60||
59937582|NCT02039674|76055890|FG012|STARTED|Overall Study||63||
59937583|NCT02039674|76055891|FG013|STARTED|Overall Study||33||
59937584|NCT02039674|76055878|FG000|Treated|Overall Study||13||
59937585|NCT02039674|76055879|FG001|Treated|Overall Study||12||
59937586|NCT02039674|76055880|FG002|Treated|Overall Study||11||
59937587|NCT02039674|76055881|FG003|Treated|Overall Study||13||
59937588|NCT02039674|76055882|FG004|Treated|Overall Study||12||
59937589|NCT02039674|76055883|FG005|Treated|Overall Study||12||
59937590|NCT02039674|76055884|FG006|Treated|Overall Study||3||
59937591|NCT02039674|76055885|FG007|Treated|Overall Study||3||
59937592|NCT02039674|76055886|FG008|Treated|Overall Study||12||
59937593|NCT02039674|76055887|FG009|Treated|Overall Study||12||
59937594|NCT02039674|76055888|FG010|Treated|Overall Study||7||
59937595|NCT02039674|76055889|FG011|Treated|Overall Study||59||
59937596|NCT02039674|76055890|FG012|Treated|Overall Study||62||
59937597|NCT02039674|76055891|FG013|Treated|Overall Study||33||
59937598|NCT02039674|76055878|FG000|Received Second Course of Pembrolizumab|Overall Study||2||
59937599|NCT02039674|76055879|FG001|Received Second Course of Pembrolizumab|Overall Study||0||
59937600|NCT02039674|76055880|FG002|Received Second Course of Pembrolizumab|Overall Study||0||
59937601|NCT02039674|76055881|FG003|Received Second Course of Pembrolizumab|Overall Study||1||
59937602|NCT02039674|76055882|FG004|Received Second Course of Pembrolizumab|Overall Study||0||
59937603|NCT02039674|76055883|FG005|Received Second Course of Pembrolizumab|Overall Study||0||
59937604|NCT02039674|76055884|FG006|Received Second Course of Pembrolizumab|Overall Study||0||
59937605|NCT02039674|76055885|FG007|Received Second Course of Pembrolizumab|Overall Study||0||
59937606|NCT02039674|76055886|FG008|Received Second Course of Pembrolizumab|Overall Study||0||
59937607|NCT02039674|76055887|FG009|Received Second Course of Pembrolizumab|Overall Study||1||
59937608|NCT02039674|76055888|FG010|Received Second Course of Pembrolizumab|Overall Study||0||
59937609|NCT02039674|76055889|FG011|Received Second Course of Pembrolizumab|Overall Study||2||
59937610|NCT02039674|76055890|FG012|Received Second Course of Pembrolizumab|Overall Study||0||
59937611|NCT02039674|76055891|FG013|Received Second Course of Pembrolizumab|Overall Study||0||
59937612|NCT02039674|76055878|FG000|Switched Over to Pembrolizumab|Overall Study||0||
59937613|NCT02039674|76055879|FG001|Switched Over to Pembrolizumab|Overall Study||0||
59937614|NCT02039674|76055880|FG002|Switched Over to Pembrolizumab|Overall Study||0||
59937615|NCT02039674|76055881|FG003|Switched Over to Pembrolizumab|Overall Study||0||
59937616|NCT02039674|76055882|FG004|Switched Over to Pembrolizumab|Overall Study||0||
59937617|NCT02039674|76055883|FG005|Switched Over to Pembrolizumab|Overall Study||0||
59937618|NCT02039674|76055884|FG006|Switched Over to Pembrolizumab|Overall Study||0||
59937619|NCT02039674|76055885|FG007|Switched Over to Pembrolizumab|Overall Study||0||
59937620|NCT02039674|76055886|FG008|Switched Over to Pembrolizumab|Overall Study||0||
59937621|NCT02039674|76055887|FG009|Switched Over to Pembrolizumab|Overall Study||0||
59937622|NCT02039674|76055888|FG010|Switched Over to Pembrolizumab|Overall Study||0||
59937623|NCT02039674|76055889|FG011|Switched Over to Pembrolizumab|Overall Study||0||
59937624|NCT02039674|76055890|FG012|Switched Over to Pembrolizumab|Overall Study||28||
59937625|NCT02039674|76055891|FG013|Switched Over to Pembrolizumab|Overall Study||0||
59937626|NCT02039674|76055878|FG000|COMPLETED|Overall Study||0||
59937627|NCT02039674|76055879|FG001|COMPLETED|Overall Study||0||
59937628|NCT02039674|76055880|FG002|COMPLETED|Overall Study||0||
59937629|NCT02039674|76055881|FG003|COMPLETED|Overall Study||0||
59937630|NCT02039674|76055882|FG004|COMPLETED|Overall Study||0||
59937631|NCT02039674|76055883|FG005|COMPLETED|Overall Study||0||
59937632|NCT02039674|76055884|FG006|COMPLETED|Overall Study||0||
59937633|NCT02039674|76055885|FG007|COMPLETED|Overall Study||0||
59937634|NCT02039674|76055886|FG008|COMPLETED|Overall Study||0||
59937635|NCT02039674|76055887|FG009|COMPLETED|Overall Study||0||
59937636|NCT02039674|76055888|FG010|COMPLETED|Overall Study||0||
59937637|NCT02039674|76055889|FG011|COMPLETED|Overall Study||0||
59937638|NCT02039674|76055890|FG012|COMPLETED|Overall Study||0||
59937639|NCT02039674|76055891|FG013|COMPLETED|Overall Study||0||
59937640|NCT02039674|76055878|FG000|NOT COMPLETED|Overall Study||13||
59937641|NCT02039674|76055879|FG001|NOT COMPLETED|Overall Study||12||
59937642|NCT02039674|76055880|FG002|NOT COMPLETED|Overall Study||12||
59937643|NCT02039674|76055881|FG003|NOT COMPLETED|Overall Study||13||
59937644|NCT02039674|76055882|FG004|NOT COMPLETED|Overall Study||12||
59937645|NCT02039674|76055883|FG005|NOT COMPLETED|Overall Study||12||
59937646|NCT02039674|76055884|FG006|NOT COMPLETED|Overall Study||3||
59937647|NCT02039674|76055885|FG007|NOT COMPLETED|Overall Study||3||
59937648|NCT02039674|76055886|FG008|NOT COMPLETED|Overall Study||12||
59937649|NCT02039674|76055887|FG009|NOT COMPLETED|Overall Study||12||
59937650|NCT02039674|76055888|FG010|NOT COMPLETED|Overall Study||7||
59937651|NCT02039674|76055889|FG011|NOT COMPLETED|Overall Study||60||
59937652|NCT02039674|76055890|FG012|NOT COMPLETED|Overall Study||63||
59937653|NCT02039674|76055891|FG013|NOT COMPLETED|Overall Study||33||
59937654|NCT03126227|76055931|FG000|STARTED|Overall Study||338||
59937655|NCT03126227|76055932|FG001|STARTED|Overall Study||168||
59937656|NCT03126227|76055931|FG000|COMPLETED|Overall Study||260||
59937657|NCT03126227|76055932|FG001|COMPLETED|Overall Study||158||
59937658|NCT03126227|76055931|FG000|NOT COMPLETED|Overall Study||78||
59937659|NCT03126227|76055932|FG001|NOT COMPLETED|Overall Study||10||
59937660|NCT03099187|76055940|FG000|STARTED|Double-blind Treatment||127||
59937661|NCT03099187|76055941|FG001|STARTED|Double-blind Treatment||126||
59937662|NCT03099187|76055942|FG002|STARTED|Double-blind Treatment||0||
59937663|NCT03099187|76055943|FG003|STARTED|Double-blind Treatment||0||
59937664|NCT03099187|76055940|FG000|COMPLETED|Double-blind Treatment||94||
59937665|NCT03099187|76055941|FG001|COMPLETED|Double-blind Treatment||110||
59937666|NCT03099187|76055942|FG002|COMPLETED|Double-blind Treatment||0||
59937667|NCT03099187|76055943|FG003|COMPLETED|Double-blind Treatment||0||
59937668|NCT03099187|76055940|FG000|NOT COMPLETED|Double-blind Treatment||33||
59937669|NCT03099187|76055941|FG001|NOT COMPLETED|Double-blind Treatment||16||
59937670|NCT03099187|76055942|FG002|NOT COMPLETED|Double-blind Treatment||0||
59937671|NCT03099187|76055943|FG003|NOT COMPLETED|Double-blind Treatment||0||
59937672|NCT03099187|76055940|FG000|STARTED|12-month Safety Follow-up||0||
59937673|NCT03099187|76055941|FG001|STARTED|12-month Safety Follow-up||0||
59937674|NCT03099187|76055942|FG002|STARTED|12-month Safety Follow-up||94||
59937675|NCT03099187|76055943|FG003|STARTED|12-month Safety Follow-up||110||
59937676|NCT03099187|76055940|FG000|COMPLETED|12-month Safety Follow-up||0||
59937677|NCT03099187|76055941|FG001|COMPLETED|12-month Safety Follow-up||0||
59937678|NCT03099187|76055942|FG002|COMPLETED|12-month Safety Follow-up||75||
59937679|NCT03099187|76055943|FG003|COMPLETED|12-month Safety Follow-up||84||
59937680|NCT03099187|76055940|FG000|NOT COMPLETED|12-month Safety Follow-up||0||
59937681|NCT03099187|76055941|FG001|NOT COMPLETED|12-month Safety Follow-up||0||
59937682|NCT03099187|76055942|FG002|NOT COMPLETED|12-month Safety Follow-up||19||
59937683|NCT03099187|76055943|FG003|NOT COMPLETED|12-month Safety Follow-up||26||
59937684|NCT04535453|76055965|FG000|STARTED|Overall Study||86||
59937685|NCT04535453|76055966|FG001|STARTED|Overall Study||81||
59937686|NCT04535453|76055967|FG002|STARTED|Overall Study||75||
59937687|NCT04535453|76055968|FG003|STARTED|Overall Study||74||
59937688|NCT04535453|76055969|FG004|STARTED|Overall Study||81||
59937689|NCT04535453|76055970|FG005|STARTED|Overall Study||26||
59937690|NCT04535453|76055971|FG006|STARTED|Overall Study||56||
59937691|NCT04535453|76055972|FG007|STARTED|Overall Study||27||
59937692|NCT04535453|76055973|FG008|STARTED|Overall Study||53||
59937693|NCT04535453|76055974|FG009|STARTED|Overall Study||25||
59937694|NCT04535453|76055975|FG010|STARTED|Overall Study||30||
59937695|NCT04535453|76055976|FG011|STARTED|Overall Study||3||
59937696|NCT04535453|76055965|FG000|COMPLETED|Overall Study||82||
59937697|NCT04535453|76055966|FG001|COMPLETED|Overall Study||73||
59937698|NCT04535453|76055967|FG002|COMPLETED|Overall Study||70||
59937699|NCT04535453|76055968|FG003|COMPLETED|Overall Study||70||
59937700|NCT04535453|76055969|FG004|COMPLETED|Overall Study||75||
59937701|NCT04535453|76055970|FG005|COMPLETED|Overall Study||24||
59937702|NCT04535453|76055971|FG006|COMPLETED|Overall Study||54||
59937703|NCT04535453|76055972|FG007|COMPLETED|Overall Study||25||
59937704|NCT04535453|76055973|FG008|COMPLETED|Overall Study||50||
59937705|NCT04535453|76055974|FG009|COMPLETED|Overall Study||23||
59937706|NCT04535453|76055975|FG010|COMPLETED|Overall Study||30||
59937707|NCT04535453|76055976|FG011|COMPLETED|Overall Study||2||
59937708|NCT04535453|76055965|FG000|NOT COMPLETED|Overall Study||4||
59937709|NCT04535453|76055966|FG001|NOT COMPLETED|Overall Study||8||
59518459|NCT03372928|75612227|FG001|NOT COMPLETED|Second Intervention (5 d Energy Deficit)||0||
59937710|NCT04535453|76055967|FG002|NOT COMPLETED|Overall Study||5||
59937711|NCT04535453|76055968|FG003|NOT COMPLETED|Overall Study||4||
59937712|NCT04535453|76055969|FG004|NOT COMPLETED|Overall Study||6||
59937713|NCT04535453|76055970|FG005|NOT COMPLETED|Overall Study||2||
59937714|NCT04535453|76055971|FG006|NOT COMPLETED|Overall Study||2||
59937715|NCT04535453|76055972|FG007|NOT COMPLETED|Overall Study||2||
59937716|NCT04535453|76055973|FG008|NOT COMPLETED|Overall Study||3||
59937717|NCT04535453|76055974|FG009|NOT COMPLETED|Overall Study||2||
59937718|NCT04535453|76055975|FG010|NOT COMPLETED|Overall Study||0||
59937719|NCT04535453|76055976|FG011|NOT COMPLETED|Overall Study||1||
59937720|NCT04463069|76056019|FG000|STARTED|Overall Study||41||
59937721|NCT04463069|76056020|FG001|STARTED|Overall Study||45||
59937722|NCT04463069|76056019|FG000|COMPLETED|Overall Study||39||
59937723|NCT04463069|76056020|FG001|COMPLETED|Overall Study||22||
59937724|NCT04463069|76056019|FG000|NOT COMPLETED|Overall Study||2||
59937725|NCT04463069|76056020|FG001|NOT COMPLETED|Overall Study||23||
59937726|NCT03521687|76056026|FG000|STARTED|Overall Study||20||
59937727|NCT03521687|76056026|FG000|COMPLETED|Overall Study||15||
59937728|NCT03521687|76056026|FG000|NOT COMPLETED|Overall Study||5||
59937729|NCT03125915|76056034|FG000|STARTED|Baseline and Intervention||32||
59937730|NCT03125915|76056035|FG001|STARTED|Baseline and Intervention||40||
59937731|NCT03125915|76056036|FG002|STARTED|Baseline and Intervention||34||
59937732|NCT03125915|76056037|FG003|STARTED|Baseline and Intervention||34||
59937733|NCT03125915|76056034|FG000|COMPLETED|Baseline and Intervention||32||
59937734|NCT03125915|76056035|FG001|COMPLETED|Baseline and Intervention||40||
59937735|NCT03125915|76056036|FG002|COMPLETED|Baseline and Intervention||34||
59937736|NCT03125915|76056037|FG003|COMPLETED|Baseline and Intervention||34||
59937737|NCT03125915|76056034|FG000|NOT COMPLETED|Baseline and Intervention||0||
59937738|NCT03125915|76056035|FG001|NOT COMPLETED|Baseline and Intervention||0||
59937739|NCT03125915|76056036|FG002|NOT COMPLETED|Baseline and Intervention||0||
59937740|NCT03125915|76056037|FG003|NOT COMPLETED|Baseline and Intervention||0||
59937741|NCT03125915|76056034|FG000|STARTED|1 Month Follow up||32||
59937742|NCT03125915|76056035|FG001|STARTED|1 Month Follow up||40||
59937743|NCT03125915|76056036|FG002|STARTED|1 Month Follow up||34||
59937744|NCT03125915|76056037|FG003|STARTED|1 Month Follow up||34||
59937745|NCT03125915|76056034|FG000|COMPLETED|1 Month Follow up||29||
59937746|NCT03125915|76056035|FG001|COMPLETED|1 Month Follow up||37||
59937747|NCT03125915|76056036|FG002|COMPLETED|1 Month Follow up||32||
59937748|NCT03125915|76056037|FG003|COMPLETED|1 Month Follow up||31||
59937749|NCT03125915|76056034|FG000|NOT COMPLETED|1 Month Follow up||3||
59937750|NCT03125915|76056035|FG001|NOT COMPLETED|1 Month Follow up||3||
59937751|NCT03125915|76056036|FG002|NOT COMPLETED|1 Month Follow up||2||
59937752|NCT03125915|76056037|FG003|NOT COMPLETED|1 Month Follow up||3||
59937753|NCT03125915|76056034|FG000|STARTED|3 Month Follow-up||32||
59937754|NCT03125915|76056035|FG001|STARTED|3 Month Follow-up||40||
59937755|NCT03125915|76056036|FG002|STARTED|3 Month Follow-up||34||
59937756|NCT03125915|76056037|FG003|STARTED|3 Month Follow-up||34||
59937757|NCT03125915|76056034|FG000|COMPLETED|3 Month Follow-up||26||
59937758|NCT03125915|76056035|FG001|COMPLETED|3 Month Follow-up||36||
59937759|NCT03125915|76056036|FG002|COMPLETED|3 Month Follow-up||30||
59937760|NCT03125915|76056037|FG003|COMPLETED|3 Month Follow-up||32||
59937761|NCT03125915|76056034|FG000|NOT COMPLETED|3 Month Follow-up||6||
59937762|NCT03125915|76056035|FG001|NOT COMPLETED|3 Month Follow-up||4||
59937763|NCT03125915|76056036|FG002|NOT COMPLETED|3 Month Follow-up||4||
59937764|NCT03125915|76056037|FG003|NOT COMPLETED|3 Month Follow-up||2||
59937765|NCT03125915|76056034|FG000|STARTED|6 Month Follow-up||32||
59937766|NCT03125915|76056035|FG001|STARTED|6 Month Follow-up||40||
59937767|NCT03125915|76056036|FG002|STARTED|6 Month Follow-up||34||
59761935|NCT00581542|75881588|FG001|STARTED|Overall Study||62||
59761936|NCT00581542|75881587|FG000|COMPLETED|Overall Study||51||
59761937|NCT00581542|75881588|FG001|COMPLETED|Overall Study||39||
59761938|NCT00581542|75881587|FG000|NOT COMPLETED|Overall Study||11||
59761939|NCT00581542|75881588|FG001|NOT COMPLETED|Overall Study||23||
59761940|NCT03912337|75881598|FG000|STARTED|Overall Study||15||
59937768|NCT03125915|76056037|FG003|STARTED|6 Month Follow-up||34||
59937769|NCT03125915|76056034|FG000|COMPLETED|6 Month Follow-up||25||
59937770|NCT03125915|76056035|FG001|COMPLETED|6 Month Follow-up||37||
59937771|NCT03125915|76056036|FG002|COMPLETED|6 Month Follow-up||28||
59937772|NCT03125915|76056037|FG003|COMPLETED|6 Month Follow-up||31||
59937773|NCT03125915|76056034|FG000|NOT COMPLETED|6 Month Follow-up||7||
59937774|NCT03125915|76056035|FG001|NOT COMPLETED|6 Month Follow-up||3||
59937775|NCT03125915|76056036|FG002|NOT COMPLETED|6 Month Follow-up||6||
59937776|NCT03125915|76056037|FG003|NOT COMPLETED|6 Month Follow-up||3||
59937777|NCT03122171|76056047|FG000|STARTED|Overall Study||6||
59937778|NCT03122171|76056047|FG000|COMPLETED|Overall Study||5||
59937779|NCT03122171|76056047|FG000|NOT COMPLETED|Overall Study||1||
59937780|NCT01427725|76056051|FG000|STARTED|Overall Study||579||
59937781|NCT01427725|76056051|FG000|Collected CRFs|Overall Study|Not collected Case Report Forms (CRFs) of 17 patients.|562||
59937782|NCT01427725|76056051|FG000|Safety Analysis Set|Overall Study|Analysis of safety data. 9 patients dropped out, could not confirm existence of Adverse Events.|553||
59937783|NCT01427725|76056051|FG000|COMPLETED|Overall Study|Among the patients in the safety analysis set, 175 patients discontinued the survey.|378||
59937784|NCT01427725|76056051|FG000|NOT COMPLETED|Overall Study||201||
59937785|NCT02839200|76056062|FG000|STARTED|Overall Study||60||
59937786|NCT02839200|76056063|FG001|STARTED|Overall Study||59||
59937787|NCT02839200|76056064|FG002|STARTED|Overall Study||60||
59937788|NCT02839200|76056065|FG003|STARTED|Overall Study||61||
59937789|NCT02839200|76056066|FG004|STARTED|Overall Study||60||
59937790|NCT02839200|76056067|FG005|STARTED|Overall Study||60||
59937791|NCT02839200|76056062|FG000|COMPLETED|Overall Study||56||
59937792|NCT02839200|76056063|FG001|COMPLETED|Overall Study||58||
59761941|NCT03912337|75881599|FG001|STARTED|Overall Study||14||
59761942|NCT03912337|75881598|FG000|COMPLETED|Overall Study||13||
59937793|NCT02839200|76056064|FG002|COMPLETED|Overall Study||59||
59937794|NCT02839200|76056065|FG003|COMPLETED|Overall Study||61||
59937795|NCT02839200|76056066|FG004|COMPLETED|Overall Study||58||
59937796|NCT02839200|76056067|FG005|COMPLETED|Overall Study||59||
59937797|NCT02839200|76056062|FG000|NOT COMPLETED|Overall Study||4||
59937798|NCT02839200|76056063|FG001|NOT COMPLETED|Overall Study||1||
59937799|NCT02839200|76056064|FG002|NOT COMPLETED|Overall Study||1||
59937800|NCT02839200|76056065|FG003|NOT COMPLETED|Overall Study||0||
59937801|NCT02839200|76056066|FG004|NOT COMPLETED|Overall Study||2||
59937802|NCT02839200|76056067|FG005|NOT COMPLETED|Overall Study||1||
59937803|NCT03118739|76056083|FG000|STARTED|Overall Study||32||
59937804|NCT03118739|76056084|FG001|STARTED|Overall Study||28||
59937805|NCT03118739|76056083|FG000|Completed 12 Weeks of Treatment|Overall Study||26||
59937806|NCT03118739|76056084|FG001|Completed 12 Weeks of Treatment|Overall Study||25||
59937807|NCT03118739|76056083|FG000|Completed 24 Weeks of Treatment|Overall Study||24||
59937808|NCT03118739|76056084|FG001|Completed 24 Weeks of Treatment|Overall Study||25||
59937809|NCT03118739|76056083|FG000|COMPLETED|Overall Study||25||
59937810|NCT03118739|76056084|FG001|COMPLETED|Overall Study||24||
59937811|NCT03118739|76056083|FG000|NOT COMPLETED|Overall Study||7||
59937812|NCT03118739|76056084|FG001|NOT COMPLETED|Overall Study||4||
59937813|NCT03094195|76056093|FG000|STARTED|Double-Blind Treatment Period (DB)||43||
59937814|NCT03094195|76056094|FG001|STARTED|Double-Blind Treatment Period (DB)||43||
59937815|NCT03094195|76056095|FG002|STARTED|Double-Blind Treatment Period (DB)||43||
59937816|NCT03094195|76056096|FG003|STARTED|Double-Blind Treatment Period (DB)||0||
59937817|NCT03094195|76056097|FG004|STARTED|Double-Blind Treatment Period (DB)||0||
59937818|NCT03094195|76056098|FG005|STARTED|Double-Blind Treatment Period (DB)||0||
59937819|NCT03094195|76056099|FG006|STARTED|Double-Blind Treatment Period (DB)||0||
59937820|NCT03094195|76056100|FG007|STARTED|Double-Blind Treatment Period (DB)||0||
59937821|NCT03094195|76056093|FG000|COMPLETED|Double-Blind Treatment Period (DB)||28|Study completers completed the treatment phase regardless of completion of study treatment.|
59937822|NCT03094195|76056094|FG001|COMPLETED|Double-Blind Treatment Period (DB)||30|Study completers completed the treatment phase regardless of completion of study treatment.|
59937823|NCT03094195|76056095|FG002|COMPLETED|Double-Blind Treatment Period (DB)||29|Study completers completed the treatment phase regardless of completion of study treatment.|
59937824|NCT03094195|76056096|FG003|COMPLETED|Double-Blind Treatment Period (DB)||0|Study completers completed the treatment phase regardless of completion of study treatment.|
59937825|NCT03094195|76056097|FG004|COMPLETED|Double-Blind Treatment Period (DB)||0|Study completers completed the treatment phase regardless of completion of study treatment.|
59937826|NCT03094195|76056098|FG005|COMPLETED|Double-Blind Treatment Period (DB)||0|Study completers completed the treatment phase regardless of completion of study treatment.|
59937827|NCT03094195|76056099|FG006|COMPLETED|Double-Blind Treatment Period (DB)||0|Study completers completed the treatment phase regardless of completion of study treatment.|
59937828|NCT03094195|76056100|FG007|COMPLETED|Double-Blind Treatment Period (DB)||0|Study completers completed the treatment phase regardless of completion of study treatment.|
59937829|NCT03094195|76056093|FG000|NOT COMPLETED|Double-Blind Treatment Period (DB)||15||
59937830|NCT03094195|76056094|FG001|NOT COMPLETED|Double-Blind Treatment Period (DB)||13||
59937831|NCT03094195|76056095|FG002|NOT COMPLETED|Double-Blind Treatment Period (DB)||14||
59937832|NCT03094195|76056096|FG003|NOT COMPLETED|Double-Blind Treatment Period (DB)||0||
59937833|NCT03094195|76056097|FG004|NOT COMPLETED|Double-Blind Treatment Period (DB)||0||
59937834|NCT03094195|76056098|FG005|NOT COMPLETED|Double-Blind Treatment Period (DB)||0||
59937835|NCT03094195|76056099|FG006|NOT COMPLETED|Double-Blind Treatment Period (DB)||0||
59937836|NCT03094195|76056100|FG007|NOT COMPLETED|Double-Blind Treatment Period (DB)||0||
59937837|NCT03094195|76056093|FG000|STARTED|Treatment Withdrawal Period (TW)||0||
59937838|NCT03094195|76056094|FG001|STARTED|Treatment Withdrawal Period (TW)||0||
59937839|NCT03094195|76056095|FG002|STARTED|Treatment Withdrawal Period (TW)||0||
59937840|NCT03094195|76056096|FG003|STARTED|Treatment Withdrawal Period (TW)||13||
59937841|NCT03094195|76056097|FG004|STARTED|Treatment Withdrawal Period (TW)||13||
59937842|NCT03094195|76056098|FG005|STARTED|Treatment Withdrawal Period (TW)||15||
59937843|NCT03094195|76056099|FG006|STARTED|Treatment Withdrawal Period (TW)||13||
59937844|NCT03094195|76056100|FG007|STARTED|Treatment Withdrawal Period (TW)||26||
59937845|NCT03094195|76056093|FG000|COMPLETED|Treatment Withdrawal Period (TW)||0||
59937846|NCT03094195|76056094|FG001|COMPLETED|Treatment Withdrawal Period (TW)||0||
59937847|NCT03094195|76056095|FG002|COMPLETED|Treatment Withdrawal Period (TW)||0||
59937848|NCT03094195|76056096|FG003|COMPLETED|Treatment Withdrawal Period (TW)||13||
59937849|NCT03094195|76056097|FG004|COMPLETED|Treatment Withdrawal Period (TW)||13||
59937850|NCT03094195|76056098|FG005|COMPLETED|Treatment Withdrawal Period (TW)||15||
59937851|NCT03094195|76056099|FG006|COMPLETED|Treatment Withdrawal Period (TW)||13||
59937852|NCT03094195|76056100|FG007|COMPLETED|Treatment Withdrawal Period (TW)||26||
59937853|NCT03094195|76056093|FG000|NOT COMPLETED|Treatment Withdrawal Period (TW)||0||
59937854|NCT03094195|76056094|FG001|NOT COMPLETED|Treatment Withdrawal Period (TW)||0||
59937855|NCT03094195|76056095|FG002|NOT COMPLETED|Treatment Withdrawal Period (TW)||0||
59937856|NCT03094195|76056096|FG003|NOT COMPLETED|Treatment Withdrawal Period (TW)||0||
59937857|NCT03094195|76056097|FG004|NOT COMPLETED|Treatment Withdrawal Period (TW)||0||
59937858|NCT03094195|76056098|FG005|NOT COMPLETED|Treatment Withdrawal Period (TW)||0||
59937859|NCT03094195|76056099|FG006|NOT COMPLETED|Treatment Withdrawal Period (TW)||0||
59937860|NCT03094195|76056100|FG007|NOT COMPLETED|Treatment Withdrawal Period (TW)||0||
59937861|NCT02835690|76056121|FG000|STARTED|Overall Study||14||
59937862|NCT02835690|76056122|FG001|STARTED|Overall Study||15||
59937863|NCT02835690|76056123|FG002|STARTED|Overall Study||15||
59937864|NCT02835690|76056121|FG000|Received First Course of Pembrolizumab|Overall Study||14||
59937865|NCT02835690|76056122|FG001|Received First Course of Pembrolizumab|Overall Study||13||
59937866|NCT02835690|76056123|FG002|Received First Course of Pembrolizumab|Overall Study||15||
59937867|NCT02835690|76056121|FG000|Received Second Course of Pembrolizumab|Overall Study||1||
59937868|NCT02835690|76056122|FG001|Received Second Course of Pembrolizumab|Overall Study||0||
59937869|NCT02835690|76056123|FG002|Received Second Course of Pembrolizumab|Overall Study||0||
59937870|NCT02835690|76056121|FG000|COMPLETED|Overall Study||0||
59937871|NCT02835690|76056122|FG001|COMPLETED|Overall Study||0||
59937872|NCT02835690|76056123|FG002|COMPLETED|Overall Study||0||
59937873|NCT02835690|76056121|FG000|NOT COMPLETED|Overall Study||14||
59937874|NCT02835690|76056122|FG001|NOT COMPLETED|Overall Study||15||
59937875|NCT02835690|76056123|FG002|NOT COMPLETED|Overall Study||15||
59937876|NCT02837952|76056134|FG000|STARTED|Overall Study||41||
59937877|NCT02837952|76056135|FG001|STARTED|Overall Study||82||
59937878|NCT02837952|76056134|FG000|COMPLETED|Overall Study||36||
59937879|NCT02837952|76056135|FG001|COMPLETED|Overall Study||76||
59937880|NCT02837952|76056134|FG000|NOT COMPLETED|Overall Study||5||
59937881|NCT02837952|76056135|FG001|NOT COMPLETED|Overall Study||6||
59937882|NCT02832167|76056141|FG000|STARTED|Treatment Period 1||239||
59937883|NCT02832167|76056141|FG000|COMPLETED|Treatment Period 1||110||
59937884|NCT02832167|76056141|FG000|NOT COMPLETED|Treatment Period 1||129||
59937885|NCT02832167|76056141|FG000|STARTED|Transition From Period 1 to Period 2||110||
59937886|NCT02832167|76056141|FG000|COMPLETED|Transition From Period 1 to Period 2||103|Completed = moved to Treatment Period 2|
59937887|NCT02832167|76056141|FG000|NOT COMPLETED|Transition From Period 1 to Period 2||7||
59937888|NCT02832167|76056141|FG000|STARTED|Treatment Period 2||103||
59937889|NCT02832167|76056141|FG000|COMPLETED|Treatment Period 2||19||
59937890|NCT02832167|76056141|FG000|NOT COMPLETED|Treatment Period 2||84||
59937891|NCT02674529|76056147|FG000|STARTED|Overall Study||25||
59937892|NCT02674529|76056148|FG001|STARTED|Overall Study||29||
59937893|NCT02674529|76056147|FG000|COMPLETED|Overall Study||22||
59937894|NCT02674529|76056148|FG001|COMPLETED|Overall Study||24||
59937895|NCT02674529|76056147|FG000|NOT COMPLETED|Overall Study||3||
59937896|NCT02674529|76056148|FG001|NOT COMPLETED|Overall Study||5||
59937897|NCT02626949|76056159|FG000|STARTED|Randomization, Pre-Enrollment||56||
59937898|NCT02626949|76056160|FG001|STARTED|Randomization, Pre-Enrollment||58||
59937899|NCT02626949|76056159|FG000|COMPLETED|Randomization, Pre-Enrollment||40||
59937900|NCT02626949|76056160|FG001|COMPLETED|Randomization, Pre-Enrollment||44||
59937901|NCT02626949|76056159|FG000|NOT COMPLETED|Randomization, Pre-Enrollment||16||
59937902|NCT02626949|76056160|FG001|NOT COMPLETED|Randomization, Pre-Enrollment||14||
59937903|NCT02626949|76056159|FG000|STARTED|Enrolled||40||
59937904|NCT02626949|76056160|FG001|STARTED|Enrolled||44||
59937905|NCT02626949|76056159|FG000|COMPLETED|Enrolled||30||
59937906|NCT02626949|76056160|FG001|COMPLETED|Enrolled||36||
59937907|NCT02626949|76056159|FG000|NOT COMPLETED|Enrolled||10||
59937908|NCT02626949|76056160|FG001|NOT COMPLETED|Enrolled||8||
59937909|NCT03116399|76056168|FG000|STARTED|Overall Study||128||
59937910|NCT03116399|76056169|FG001|STARTED|Overall Study||120||
59937911|NCT03116399|76056168|FG000|6-month|Overall Study||98||
59937912|NCT03116399|76056169|FG001|6-month|Overall Study||108||
59937913|NCT03116399|76056168|FG000|9-month|Overall Study||91||
59937914|NCT03116399|76056169|FG001|9-month|Overall Study||101||
59937915|NCT03116399|76056168|FG000|COMPLETED|Overall Study||88||
59937916|NCT03116399|76056169|FG001|COMPLETED|Overall Study||96||
59937917|NCT03116399|76056168|FG000|NOT COMPLETED|Overall Study||40||
59937918|NCT03116399|76056169|FG001|NOT COMPLETED|Overall Study||24||
59937919|NCT03097861|76056178|FG000|STARTED|Overall Study||145||
59937920|NCT03097861|76056179|FG001|STARTED|Overall Study||276||
59937921|NCT03097861|76056180|FG002|STARTED|Overall Study||131||
59937922|NCT03097861|76056178|FG000|Safety Population|Overall Study||143|Randomized and took at least one dose of study drug, by treatment actually received|
59937923|NCT03097861|76056179|FG001|Safety Population|Overall Study||275|Randomized and took at least one dose of study drug, by treatment actually received|
59937924|NCT03097861|76056180|FG002|Safety Population|Overall Study||130|Randomized and took at least one dose of study drug, by treatment actually received|
59937925|NCT03097861|76056178|FG000|Modified Intent to Treat|Overall Study||143|As randomized, received at least one dose of study drug and had at least one diary entry|
59937926|NCT03097861|76056179|FG001|Modified Intent to Treat|Overall Study||275|As randomized, received at least one dose of study drug and had at least one diary entry|
59937927|NCT03097861|76056180|FG002|Modified Intent to Treat|Overall Study||130|As randomized, received at least one dose of study drug and had at least one diary entry|
59937928|NCT03097861|76056178|FG000|Completers|Overall Study||129|Completed the entire treatment period with a recorded primary endpoint|
59937929|NCT03097861|76056179|FG001|Completers|Overall Study||255|Completed the entire treatment period with a recorded primary endpoint|
59937930|NCT03097861|76056180|FG002|Completers|Overall Study||121|Completed the entire treatment period with a recorded primary endpoint|
59937931|NCT03097861|76056178|FG000|Per-protocol Population (PP)|Overall Study||126|Main population for efficacy analysis|
59937932|NCT03097861|76056179|FG001|Per-protocol Population (PP)|Overall Study||234|Main population for efficacy analysis|
59937933|NCT03097861|76056180|FG002|Per-protocol Population (PP)|Overall Study||113|Main population for efficacy analysis|
59937934|NCT03097861|76056178|FG000|COMPLETED|Overall Study||138||
59937935|NCT03097861|76056179|FG001|COMPLETED|Overall Study||254||
59937936|NCT03097861|76056180|FG002|COMPLETED|Overall Study||122||
59937937|NCT03097861|76056178|FG000|NOT COMPLETED|Overall Study||7||
59937938|NCT03097861|76056179|FG001|NOT COMPLETED|Overall Study||22||
59937939|NCT03097861|76056180|FG002|NOT COMPLETED|Overall Study||9||
59937940|NCT03215914|76056190|FG000|STARTED|Overall Study||10||
59937941|NCT03215914|76056190|FG000|COMPLETED|Overall Study||10||
59937942|NCT03215914|76056190|FG000|NOT COMPLETED|Overall Study||0||
59937943|NCT01816139|76056196|FG000|STARTED|Overall Study||289||
59937944|NCT01816139|76056197|FG001|STARTED|Overall Study||287||
59937945|NCT01816139|76056196|FG000|Safety Population|Overall Study||287||
59937946|NCT01816139|76056197|FG001|Safety Population|Overall Study||286||
59937947|NCT01816139|76056196|FG000|Modified Intent-to-treat (mITT) Population|Overall Study||240||
59937948|NCT01816139|76056197|FG001|Modified Intent-to-treat (mITT) Population|Overall Study||248||
59937949|NCT01816139|76056196|FG000|COMPLETED|Overall Study||261||
59937950|NCT01816139|76056197|FG001|COMPLETED|Overall Study||265||
59937951|NCT01816139|76056196|FG000|NOT COMPLETED|Overall Study||28||
59937952|NCT01816139|76056197|FG001|NOT COMPLETED|Overall Study||22||
59937953|NCT03764735|76056206|FG000|STARTED|Overall Study||151||
59937954|NCT03764735|76056207|FG001|STARTED|Overall Study||150||
59937955|NCT03764735|76056208|FG002|STARTED|Overall Study||151||
59937956|NCT03764735|76056206|FG000|COMPLETED|Overall Study||147||
59937957|NCT03764735|76056207|FG001|COMPLETED|Overall Study||144||
59937958|NCT03764735|76056208|FG002|COMPLETED|Overall Study||147||
59937959|NCT03764735|76056206|FG000|NOT COMPLETED|Overall Study||4||
59937960|NCT03764735|76056207|FG001|NOT COMPLETED|Overall Study||6||
59937961|NCT03764735|76056208|FG002|NOT COMPLETED|Overall Study||4||
59937962|NCT03907540|76056216|FG000|STARTED|Overall Study||5||
59937963|NCT03907540|76056216|FG000|Completed Part 1|Overall Study||5||
59937964|NCT03907540|76056216|FG000|Completed Part 2|Overall Study||5||
59937965|NCT03907540|76056216|FG000|COMPLETED|Overall Study||5||
59937966|NCT03907540|76056216|FG000|NOT COMPLETED|Overall Study||0||
59937967|NCT03904108|76056229|FG000|STARTED|Overall Study||3||
59937968|NCT03904108|76056229|FG000|COMPLETED|Overall Study||3||
59937969|NCT03904108|76056229|FG000|NOT COMPLETED|Overall Study||0||
59937970|NCT02833350|76056240|FG000|STARTED|Overall Study||40|SAF population|
59937971|NCT02833350|76056241|FG001|STARTED|Overall Study||109|SAF population|
59937972|NCT02833350|76056242|FG002|STARTED|Overall Study||110|SAF population|
59937973|NCT02833350|76056243|FG003|STARTED|Overall Study||110|SAF population|
59937974|NCT02833350|76056244|FG004|STARTED|Overall Study||111|SAF population|
59937975|NCT02833350|76056245|FG005|STARTED|Overall Study||49|SAF population|
59937976|NCT02833350|76056246|FG006|STARTED|Overall Study||49|SAF population|
59937977|NCT02833350|76056240|FG000|Randomized|Overall Study||40|ITT population|
59937978|NCT02833350|76056241|FG001|Randomized|Overall Study||109|ITT population|
59937979|NCT02833350|76056242|FG002|Randomized|Overall Study||110|ITT population|
59937980|NCT02833350|76056243|FG003|Randomized|Overall Study||110|ITT population|
59937981|NCT02833350|76056244|FG004|Randomized|Overall Study||111|ITT population|
59937982|NCT02833350|76056245|FG005|Randomized|Overall Study||48|ITT population|
59937983|NCT02833350|76056246|FG006|Randomized|Overall Study||50|ITT population|
59937984|NCT02833350|76056240|FG000|COMPLETED|Overall Study||37||
59937985|NCT02833350|76056241|FG001|COMPLETED|Overall Study||100||
59937986|NCT02833350|76056242|FG002|COMPLETED|Overall Study||102||
59761943|NCT03912337|75881599|FG001|COMPLETED|Overall Study||13||
59761944|NCT03912337|75881598|FG000|NOT COMPLETED|Overall Study||2||
59761945|NCT03912337|75881599|FG001|NOT COMPLETED|Overall Study||1||
59761946|NCT02121652|75881607|FG000|STARTED|Overall Study||20||
59761947|NCT02121652|75881608|FG001|STARTED|Overall Study||20||
59761948|NCT02121652|75881607|FG000|COMPLETED|Overall Study||14||
59761949|NCT02121652|75881608|FG001|COMPLETED|Overall Study||16||
59761950|NCT02121652|75881607|FG000|NOT COMPLETED|Overall Study||6||
59761951|NCT02121652|75881608|FG001|NOT COMPLETED|Overall Study||4||
59937987|NCT02833350|76056243|FG003|COMPLETED|Overall Study||102||
59937988|NCT02833350|76056244|FG004|COMPLETED|Overall Study||108||
59937989|NCT02833350|76056245|FG005|COMPLETED|Overall Study||48||
59937990|NCT02833350|76056246|FG006|COMPLETED|Overall Study||44||
59937991|NCT02833350|76056240|FG000|NOT COMPLETED|Overall Study||3||
59937992|NCT02833350|76056241|FG001|NOT COMPLETED|Overall Study||9||
59937993|NCT02833350|76056242|FG002|NOT COMPLETED|Overall Study||8||
59937994|NCT02833350|76056243|FG003|NOT COMPLETED|Overall Study||8||
59937995|NCT02833350|76056244|FG004|NOT COMPLETED|Overall Study||3||
59937996|NCT02833350|76056245|FG005|NOT COMPLETED|Overall Study||1||
59937997|NCT02833350|76056246|FG006|NOT COMPLETED|Overall Study||5||
59937998|NCT01343043|76056269|FG000|STARTED|Overall Study||15||
59761952|NCT00595920|75881614|FG000|STARTED|Overall Study||116||
59937999|NCT01343043|76056270|FG001|STARTED|Overall Study||14||
59938000|NCT01343043|76056271|FG002|STARTED|Overall Study||5||
59938001|NCT01343043|76056272|FG003|STARTED|Overall Study||16||
59938002|NCT01343043|76056269|FG000|Received T-cell Infusion|Overall Study||12||
59938003|NCT01343043|76056270|FG001|Received T-cell Infusion|Overall Study||13||
59938004|NCT01343043|76056271|FG002|Received T-cell Infusion|Overall Study||5||
59938005|NCT01343043|76056272|FG003|Received T-cell Infusion|Overall Study||15||
59938006|NCT01343043|76056269|FG000|COMPLETED|Overall Study||12||
59938007|NCT01343043|76056270|FG001|COMPLETED|Overall Study||13||
59938008|NCT01343043|76056271|FG002|COMPLETED|Overall Study||5||
59938009|NCT01343043|76056272|FG003|COMPLETED|Overall Study||15||
59938010|NCT01343043|76056269|FG000|NOT COMPLETED|Overall Study||3||
59938011|NCT01343043|76056270|FG001|NOT COMPLETED|Overall Study||1||
59938012|NCT01343043|76056271|FG002|NOT COMPLETED|Overall Study||0||
59938013|NCT01343043|76056272|FG003|NOT COMPLETED|Overall Study||1||
59938014|NCT03548987|76056287|FG000|STARTED|Run-in Period (Week 0 to Week 20)||902||
59938015|NCT03548987|76056288|FG001|STARTED|Run-in Period (Week 0 to Week 20)||0||
59938016|NCT03548987|76056287|FG000|Safety Analysis Set (SAS)|Run-in Period (Week 0 to Week 20)||902||
59938017|NCT03548987|76056288|FG001|Safety Analysis Set (SAS)|Run-in Period (Week 0 to Week 20)||0||
59938018|NCT03548987|76056287|FG000|COMPLETED|Run-in Period (Week 0 to Week 20)||803||
59938019|NCT03548987|76056288|FG001|COMPLETED|Run-in Period (Week 0 to Week 20)||0||
59938020|NCT03548987|76056287|FG000|NOT COMPLETED|Run-in Period (Week 0 to Week 20)||99||
59938021|NCT03548987|76056288|FG001|NOT COMPLETED|Run-in Period (Week 0 to Week 20)||0||
59938022|NCT03548987|76056287|FG000|STARTED|Maintenance Period (Week 20 to Week 68)||535||
59938023|NCT03548987|76056288|FG001|STARTED|Maintenance Period (Week 20 to Week 68)||268||
59938024|NCT03548987|76056287|FG000|Full Analysis Set (FAS)|Maintenance Period (Week 20 to Week 68)||535||
59938025|NCT03548987|76056288|FG001|Full Analysis Set (FAS)|Maintenance Period (Week 20 to Week 68)||268||
59938026|NCT03548987|76056287|FG000|COMPLETED|Maintenance Period (Week 20 to Week 68)||504||
59938027|NCT03548987|76056288|FG001|COMPLETED|Maintenance Period (Week 20 to Week 68)||237||
59938028|NCT03548987|76056287|FG000|NOT COMPLETED|Maintenance Period (Week 20 to Week 68)||31||
59938029|NCT03548987|76056288|FG001|NOT COMPLETED|Maintenance Period (Week 20 to Week 68)||31||
59938030|NCT01358760|76056298|FG000|STARTED|Overall Study||152||
59938031|NCT01358760|76056299|FG001|STARTED|Overall Study||148||
59938032|NCT01358760|76056300|FG002|STARTED|Overall Study||150||
59938033|NCT01358760|76056298|FG000|Safety Population|Overall Study||150||
59938034|NCT01358760|76056299|FG001|Safety Population|Overall Study||143||
59938035|NCT01358760|76056300|FG002|Safety Population|Overall Study||148||
59938036|NCT01358760|76056298|FG000|ITT Population|Overall Study||139||
59938037|NCT01358760|76056299|FG001|ITT Population|Overall Study||134||
59938038|NCT01358760|76056300|FG002|ITT Population|Overall Study||134||
59938039|NCT01358760|76056298|FG000|COMPLETED|Overall Study||130||
59938040|NCT01358760|76056299|FG001|COMPLETED|Overall Study||128||
59938041|NCT01358760|76056300|FG002|COMPLETED|Overall Study||125||
59938042|NCT01358760|76056298|FG000|NOT COMPLETED|Overall Study||22||
59938043|NCT01358760|76056299|FG001|NOT COMPLETED|Overall Study||20||
59938044|NCT01358760|76056300|FG002|NOT COMPLETED|Overall Study||25||
59938045|NCT01341990|76056310|FG000|STARTED|Overall Study||35||
59938046|NCT01341990|76056311|FG001|STARTED|Overall Study||33||
59938047|NCT01341990|76056310|FG000|COMPLETED|Overall Study||32||
59938048|NCT01341990|76056311|FG001|COMPLETED|Overall Study||32||
59938049|NCT01341990|76056310|FG000|NOT COMPLETED|Overall Study||3||
59938050|NCT01341990|76056311|FG001|NOT COMPLETED|Overall Study||1||
59938051|NCT03048747|76056317|FG000|STARTED|Overall Study||16||
59938052|NCT03048747|76056317|FG000|COMPLETED|Overall Study||11||
59938053|NCT03048747|76056317|FG000|NOT COMPLETED|Overall Study||5||
59938054|NCT03670277|76056324|FG000|STARTED|Overall Study||20||
59938055|NCT03670277|76056325|FG001|STARTED|Overall Study||8||
59938056|NCT03670277|76056324|FG000|COMPLETED|Overall Study||20||
59938057|NCT03670277|76056325|FG001|COMPLETED|Overall Study||8||
59938058|NCT03670277|76056324|FG000|NOT COMPLETED|Overall Study||0||
59938059|NCT03670277|76056325|FG001|NOT COMPLETED|Overall Study||0||
59938060|NCT03263195|76056338|FG000|STARTED|Overall Study||174||
59938061|NCT03263195|76056339|FG001|STARTED|Overall Study||0||
59938062|NCT03263195|76056340|FG002|STARTED|Overall Study||0||
59938063|NCT03263195|76056341|FG003|STARTED|Overall Study||26||
59938064|NCT03263195|76056342|FG004|STARTED|Overall Study||170||
59938065|NCT03263195|76056343|FG005|STARTED|Overall Study||0||
59938066|NCT03263195|76056344|FG006|STARTED|Overall Study||0||
59938067|NCT03263195|76056345|FG007|STARTED|Overall Study||25||
59938068|NCT03263195|76056338|FG000|COMPLETED|Overall Study||168||
59938069|NCT03263195|76056339|FG001|COMPLETED|Overall Study||0||
59938070|NCT03263195|76056340|FG002|COMPLETED|Overall Study||0||
59938071|NCT03263195|76056341|FG003|COMPLETED|Overall Study||23||
59938072|NCT03263195|76056342|FG004|COMPLETED|Overall Study||155||
59938073|NCT03263195|76056343|FG005|COMPLETED|Overall Study||0||
59938074|NCT03263195|76056344|FG006|COMPLETED|Overall Study||0||
59938075|NCT03263195|76056345|FG007|COMPLETED|Overall Study||19||
59938076|NCT03263195|76056338|FG000|NOT COMPLETED|Overall Study||6||
59938077|NCT03263195|76056339|FG001|NOT COMPLETED|Overall Study||0||
59938078|NCT03263195|76056340|FG002|NOT COMPLETED|Overall Study||0||
59938079|NCT03263195|76056341|FG003|NOT COMPLETED|Overall Study||3||
59938080|NCT03263195|76056342|FG004|NOT COMPLETED|Overall Study||15||
59938081|NCT03263195|76056343|FG005|NOT COMPLETED|Overall Study||0||
59938082|NCT03263195|76056344|FG006|NOT COMPLETED|Overall Study||0||
59938083|NCT03263195|76056345|FG007|NOT COMPLETED|Overall Study||6||
59938084|NCT03287687|76056370|FG000|STARTED|Overall Study||88||89
59938085|NCT03287687|76056371|FG001|STARTED|Overall Study||90||91
59938086|NCT03287687|76056370|FG000|Procedures|Overall Study||88||89
59938087|NCT03287687|76056371|FG001|Procedures|Overall Study||90||91
59938088|NCT03287687|76056370|FG000|COMPLETED|Overall Study||88||89
59938089|NCT03287687|76056371|FG001|COMPLETED|Overall Study||90||91
59938090|NCT03287687|76056370|FG000|NOT COMPLETED|Overall Study||0||0
59938091|NCT03287687|76056371|FG001|NOT COMPLETED|Overall Study||0||0
59938092|NCT01991067|76056379|FG000|STARTED|Overall Study||19||
59938093|NCT01991067|76056380|FG001|STARTED|Overall Study||15||
59938094|NCT01991067|76056379|FG000|COMPLETED|Overall Study||13||
59938095|NCT01991067|76056380|FG001|COMPLETED|Overall Study||10||
59938096|NCT01991067|76056379|FG000|NOT COMPLETED|Overall Study||6||
59938097|NCT01991067|76056380|FG001|NOT COMPLETED|Overall Study||5||
59938098|NCT01709331|76056386|FG000|STARTED|Overall Study||18||
59938099|NCT01709331|76056386|FG000|COMPLETED|Overall Study||17||
59938100|NCT01709331|76056386|FG000|NOT COMPLETED|Overall Study||1||
59938101|NCT03255083|76056394|FG000|STARTED|Overall Study||6||
59938102|NCT03255083|76056395|FG001|STARTED|Overall Study||3||
59938103|NCT03255083|76056396|FG002|STARTED|Overall Study||3||
59938104|NCT03255083|76056397|FG003|STARTED|Overall Study||1||
59938105|NCT03255083|76056394|FG000|COMPLETED|Overall Study||0||
59938106|NCT03255083|76056395|FG001|COMPLETED|Overall Study||0||
59938107|NCT03255083|76056396|FG002|COMPLETED|Overall Study||0||
59938108|NCT03255083|76056397|FG003|COMPLETED|Overall Study||0||
59938109|NCT03255083|76056394|FG000|NOT COMPLETED|Overall Study||6||
59938110|NCT03255083|76056395|FG001|NOT COMPLETED|Overall Study||3||
59938111|NCT03255083|76056396|FG002|NOT COMPLETED|Overall Study||3||
59938112|NCT03255083|76056397|FG003|NOT COMPLETED|Overall Study||1||
59938113|NCT01665118|76056407|FG000|STARTED|Overall Study||44||88
59938114|NCT01665118|76056407|FG000|Thigh Treated With RF|Overall Study||44||44
59938115|NCT01665118|76056407|FG000|Untreated Thigh|Overall Study||44||44
59938116|NCT01665118|76056407|FG000|COMPLETED|Overall Study||26||52
59938117|NCT01665118|76056407|FG000|NOT COMPLETED|Overall Study||18||36
59938118|NCT04552587|76056413|FG000|STARTED|Overall Study||50||
59938119|NCT04552587|76056413|FG000|Patients|Overall Study||23||
59938120|NCT04552587|76056413|FG000|Caregivers|Overall Study||23||
59938121|NCT04552587|76056413|FG000|COMPLETED|Overall Study|N= 23 Patients, 23 Caregivers|46||
59938122|NCT04552587|76056413|FG000|NOT COMPLETED|Overall Study||4||
59938123|NCT01316055|76056429|FG000|STARTED|Overall Study||13||
59938124|NCT01316055|76056430|FG001|STARTED|Overall Study||17||
59938125|NCT01316055|76056431|FG002|STARTED|Overall Study||12||
59938126|NCT01316055|76056429|FG000|COMPLETED|Overall Study||12||
59938127|NCT01316055|76056430|FG001|COMPLETED|Overall Study||17||
59938128|NCT01316055|76056431|FG002|COMPLETED|Overall Study||12||
60067427|NCT01924754|76182600|FG002|STARTED|Overall Study||50||
60067428|NCT01924754|76182598|FG000|COMPLETED|Overall Study||49||
60067429|NCT01924754|76182599|FG001|COMPLETED|Overall Study||47||
60067430|NCT01924754|76182600|FG002|COMPLETED|Overall Study||47||
59938129|NCT01316055|76056429|FG000|NOT COMPLETED|Overall Study||1||
59938130|NCT01316055|76056430|FG001|NOT COMPLETED|Overall Study||0||
59938131|NCT01316055|76056431|FG002|NOT COMPLETED|Overall Study||0||
59938132|NCT01340976|76056448|FG000|STARTED|Overall Study||4||
59938133|NCT01340976|76056449|FG001|STARTED|Overall Study||3||
59938134|NCT01340976|76056450|FG002|STARTED|Overall Study||7||
59938135|NCT01340976|76056451|FG003|STARTED|Overall Study||5||
59938136|NCT01340976|76056452|FG004|STARTED|Overall Study||7||
59938137|NCT01340976|76056453|FG005|STARTED|Overall Study||7||
59938138|NCT01340976|76056448|FG000|Received at Least 1 Dose of Study Drug|Overall Study||4||
59938139|NCT01340976|76056449|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3||
59938140|NCT01340976|76056450|FG002|Received at Least 1 Dose of Study Drug|Overall Study||7||
59938141|NCT01340976|76056451|FG003|Received at Least 1 Dose of Study Drug|Overall Study||5||
59938142|NCT01340976|76056452|FG004|Received at Least 1 Dose of Study Drug|Overall Study||7||
59938143|NCT01340976|76056453|FG005|Received at Least 1 Dose of Study Drug|Overall Study||7||
59938144|NCT01340976|76056448|FG000|COMPLETED|Overall Study||0||
59518460|NCT03373162|75612238|FG000|STARTED|Overall Study||10||
59938145|NCT01340976|76056449|FG001|COMPLETED|Overall Study||1||
59938146|NCT01340976|76056450|FG002|COMPLETED|Overall Study||4||
59938147|NCT01340976|76056451|FG003|COMPLETED|Overall Study||2||
59938148|NCT01340976|76056452|FG004|COMPLETED|Overall Study||5||
59938149|NCT01340976|76056453|FG005|COMPLETED|Overall Study||6||
59938150|NCT01340976|76056448|FG000|NOT COMPLETED|Overall Study||4||
59938151|NCT01340976|76056449|FG001|NOT COMPLETED|Overall Study||2||
59938152|NCT01340976|76056450|FG002|NOT COMPLETED|Overall Study||3||
59938153|NCT01340976|76056451|FG003|NOT COMPLETED|Overall Study||3||
59938154|NCT01340976|76056452|FG004|NOT COMPLETED|Overall Study||2||
60067431|NCT01924754|76182598|FG000|NOT COMPLETED|Overall Study||1||
60067432|NCT01924754|76182599|FG001|NOT COMPLETED|Overall Study||3||
60067433|NCT01924754|76182600|FG002|NOT COMPLETED|Overall Study||3||
59938155|NCT01340976|76056453|FG005|NOT COMPLETED|Overall Study||1||
59938156|NCT01680016|76056475|FG000|STARTED|Overall Study||121||
59938157|NCT01680016|76056476|FG001|STARTED|Overall Study||122||
59938158|NCT01680016|76056477|FG002|STARTED|Overall Study||201||
59938159|NCT01680016|76056478|FG003|STARTED|Overall Study||200||
59938160|NCT01680016|76056475|FG000|COMPLETED|Overall Study||115||
59938161|NCT01680016|76056476|FG001|COMPLETED|Overall Study||114||
59938162|NCT01680016|76056477|FG002|COMPLETED|Overall Study||196||
59938163|NCT01680016|76056478|FG003|COMPLETED|Overall Study||195||
59938164|NCT01680016|76056475|FG000|NOT COMPLETED|Overall Study||6||
59938165|NCT01680016|76056476|FG001|NOT COMPLETED|Overall Study||8||
59938166|NCT01680016|76056477|FG002|NOT COMPLETED|Overall Study||5||
59938167|NCT01680016|76056478|FG003|NOT COMPLETED|Overall Study||5||
59938168|NCT01340898|76056503|FG000|STARTED|Primary Phase||376||
59938169|NCT01340898|76056504|FG001|STARTED|Primary Phase||187||
59938170|NCT01340898|76056505|FG002|STARTED|Primary Phase||187||
59938171|NCT01340898|76056503|FG000|COMPLETED|Primary Phase||360||
59938172|NCT01340898|76056504|FG001|COMPLETED|Primary Phase||178||
59938173|NCT01340898|76056505|FG002|COMPLETED|Primary Phase||181||
59938174|NCT01340898|76056503|FG000|NOT COMPLETED|Primary Phase||16||
59938175|NCT01340898|76056504|FG001|NOT COMPLETED|Primary Phase||9||
59938176|NCT01340898|76056505|FG002|NOT COMPLETED|Primary Phase||6||
59938177|NCT01340898|76056503|FG000|STARTED|Booster Phase||342||
59938178|NCT01340898|76056504|FG001|STARTED|Booster Phase||166||
59761953|NCT00595920|75881614|FG000|Patients Dosed|Overall Study|116 patients enrolled; however, only 38 received at least 1 dose.|38||
59761954|NCT00595920|75881614|FG000|COMPLETED|Overall Study||0||
59761955|NCT00595920|75881614|FG000|NOT COMPLETED|Overall Study||116||
59761956|NCT00595764|75881620|FG000|STARTED|Overall Study||71||
59761957|NCT00595764|75881621|FG001|STARTED|Overall Study||70||
59761958|NCT00595764|75881620|FG000|COMPLETED|Overall Study||32||
59761959|NCT00595764|75881621|FG001|COMPLETED|Overall Study||27||
59761960|NCT00595764|75881620|FG000|NOT COMPLETED|Overall Study||39||
59761961|NCT00595764|75881621|FG001|NOT COMPLETED|Overall Study||43||
59761962|NCT04466215|75881629|FG000|STARTED|Overall Study||25||
59761963|NCT04466215|75881630|FG001|STARTED|Overall Study||25||
59938179|NCT01340898|76056505|FG002|STARTED|Booster Phase||170||
59938180|NCT01340898|76056503|FG000|COMPLETED|Booster Phase||332||
59938181|NCT01340898|76056504|FG001|COMPLETED|Booster Phase||164||
59938182|NCT01340898|76056505|FG002|COMPLETED|Booster Phase||163||
59938183|NCT01340898|76056503|FG000|NOT COMPLETED|Booster Phase||10||
59938184|NCT01340898|76056504|FG001|NOT COMPLETED|Booster Phase||2||
59938185|NCT01340898|76056505|FG002|NOT COMPLETED|Booster Phase||7||
59938186|NCT02426749|76056517|FG000|STARTED|Overall Study||12||
59938187|NCT02426749|76056518|FG001|STARTED|Overall Study||10||
59938188|NCT02426749|76056517|FG000|COMPLETED|Overall Study||9||
59938189|NCT02426749|76056518|FG001|COMPLETED|Overall Study||9||
59938190|NCT02426749|76056517|FG000|NOT COMPLETED|Overall Study||3||
59938191|NCT02426749|76056518|FG001|NOT COMPLETED|Overall Study||1||
59938192|NCT03097315|76056526|FG000|STARTED|Overall Study||38||
59938193|NCT03097315|76056526|FG000|Intention-to-Treat Population|Overall Study||38|Defined as all patients eligible to be treated with CLS-TA (i.e., patients who did not fail screening and entered the study).|
59938194|NCT03097315|76056526|FG000|Safety Population|Overall Study||38|Defined as all patients who entered the study and were administered at least one dose of CLS-TA.|
59938195|NCT03097315|76056526|FG000|COMPLETED|Overall Study||37||
59938196|NCT03097315|76056526|FG000|NOT COMPLETED|Overall Study||1||
59938197|NCT03039699|76056532|FG000|STARTED|Overall Study||127||
59938198|NCT03039699|76056533|FG001|STARTED|Overall Study||132||
59938199|NCT03039699|76056532|FG000|COMPLETED|Overall Study||105||
59938200|NCT03039699|76056533|FG001|COMPLETED|Overall Study||97||
59938201|NCT03039699|76056532|FG000|NOT COMPLETED|Overall Study||22||
59938202|NCT03039699|76056533|FG001|NOT COMPLETED|Overall Study||35||
59938203|NCT02833974|76056541|FG000|STARTED|Overall Study||14||
59938204|NCT02833974|76056542|FG001|STARTED|Overall Study||22||
59938205|NCT02833974|76056541|FG000|COMPLETED|Overall Study||13||
59938206|NCT02833974|76056542|FG001|COMPLETED|Overall Study||19||
59938207|NCT02833974|76056541|FG000|NOT COMPLETED|Overall Study||1||
59938208|NCT02833974|76056542|FG001|NOT COMPLETED|Overall Study||3||
59938209|NCT03093415|76056551|FG000|STARTED|Assessed for Eligibility --> Enrollment||165||
59938210|NCT03093415|76056552|FG001|STARTED|Assessed for Eligibility --> Enrollment||135||
59938211|NCT03093415|76056553|FG002|STARTED|Assessed for Eligibility --> Enrollment||50||
59938212|NCT03093415|76056551|FG000|COMPLETED|Assessed for Eligibility --> Enrollment||25||
59938213|NCT03093415|76056552|FG001|COMPLETED|Assessed for Eligibility --> Enrollment||25||
59938214|NCT03093415|76056553|FG002|COMPLETED|Assessed for Eligibility --> Enrollment||50||
59938215|NCT03093415|76056551|FG000|NOT COMPLETED|Assessed for Eligibility --> Enrollment||140||
59938216|NCT03093415|76056552|FG001|NOT COMPLETED|Assessed for Eligibility --> Enrollment||110||
59938217|NCT03093415|76056553|FG002|NOT COMPLETED|Assessed for Eligibility --> Enrollment||0||
59761964|NCT04466215|75881629|FG000|COMPLETED|Overall Study||25||
59761965|NCT04466215|75881630|FG001|COMPLETED|Overall Study||25||
59938218|NCT03093415|76056551|FG000|STARTED|Enrollment to SVR12 Results|Pre-specified 25 participants to were enrolled.|25||
59938219|NCT03093415|76056552|FG001|STARTED|Enrollment to SVR12 Results|Pre-specified 25 participants to were enrolled.|25||
59951232|NCT03771664|76070158|FG000|NOT COMPLETED|Overall Study||3||
59938220|NCT03093415|76056553|FG002|STARTED|Enrollment to SVR12 Results|Prespecified 50 participants enrolled.|50||
59938221|NCT03093415|76056551|FG000|COMPLETED|Enrollment to SVR12 Results||24||
59938222|NCT03093415|76056552|FG001|COMPLETED|Enrollment to SVR12 Results||17||
59938223|NCT03093415|76056553|FG002|COMPLETED|Enrollment to SVR12 Results||47||
59938224|NCT03093415|76056551|FG000|NOT COMPLETED|Enrollment to SVR12 Results||1||
59938225|NCT03093415|76056552|FG001|NOT COMPLETED|Enrollment to SVR12 Results||8||
59938226|NCT03093415|76056553|FG002|NOT COMPLETED|Enrollment to SVR12 Results||3||
59938227|NCT01358526|76056563|FG000|STARTED|Open-label Titration Period||1095||
59938228|NCT01358526|76056564|FG001|STARTED|Open-label Titration Period||0||
59938229|NCT01358526|76056565|FG002|STARTED|Open-label Titration Period||0||
59938230|NCT01358526|76056563|FG000|COMPLETED|Open-label Titration Period|1 subject was randomized but never received double-blind treatment: Randomized Safety Population=600|601||
59938231|NCT01358526|76056564|FG001|COMPLETED|Open-label Titration Period||0||
59938232|NCT01358526|76056565|FG002|COMPLETED|Open-label Titration Period||0||
59938233|NCT01358526|76056563|FG000|NOT COMPLETED|Open-label Titration Period||494||
59938234|NCT01358526|76056564|FG001|NOT COMPLETED|Open-label Titration Period||0||
59938235|NCT01358526|76056565|FG002|NOT COMPLETED|Open-label Titration Period||0||
59938236|NCT01358526|76056563|FG000|STARTED|Double-blind Phase||0||
59938237|NCT01358526|76056564|FG001|STARTED|Double-blind Phase|1 subject was randomized but never received double-blind treatment: Randomized Safety Population=600|298||
59938238|NCT01358526|76056565|FG002|STARTED|Double-blind Phase|1 subject was randomized but never received double-blind treatment: Randomized Safety Population=600|302||
59938239|NCT01358526|76056563|FG000|COMPLETED|Double-blind Phase||0||
59938240|NCT01358526|76056564|FG001|COMPLETED|Double-blind Phase||218||
59938241|NCT01358526|76056565|FG002|COMPLETED|Double-blind Phase||181||
59938242|NCT01358526|76056563|FG000|NOT COMPLETED|Double-blind Phase||0||
59938243|NCT01358526|76056564|FG001|NOT COMPLETED|Double-blind Phase||80||
59938244|NCT01358526|76056565|FG002|NOT COMPLETED|Double-blind Phase||121||
59938245|NCT02830776|76056572|FG000|STARTED|Overall Study||15||
59938246|NCT02830776|76056572|FG000|COMPLETED|Overall Study||14||
59938247|NCT02830776|76056572|FG000|NOT COMPLETED|Overall Study||1||
59938248|NCT03039621|76056579|FG000|STARTED|Overall Study||143||
59938249|NCT03039621|76056580|FG001|STARTED|Overall Study||144||
59938250|NCT03039621|76056579|FG000|COMPLETED|Overall Study||131||
59938251|NCT03039621|76056580|FG001|COMPLETED|Overall Study||128||
59938252|NCT03039621|76056579|FG000|NOT COMPLETED|Overall Study||12||
59938253|NCT03039621|76056580|FG001|NOT COMPLETED|Overall Study||16||
59938254|NCT03041181|76056588|FG000|STARTED|Overall Study||1||
59938255|NCT03041181|76056589|FG001|STARTED|Overall Study||2||
59938256|NCT03041181|76056588|FG000|COMPLETED|Overall Study||0||
59938257|NCT03041181|76056589|FG001|COMPLETED|Overall Study||0||
59938258|NCT03041181|76056588|FG000|NOT COMPLETED|Overall Study||1||
59938259|NCT03041181|76056589|FG001|NOT COMPLETED|Overall Study||2||
59938260|NCT02828436|76056595|FG000|STARTED|Period 1||0||
59938261|NCT02828436|76056596|FG001|STARTED|Period 1||9||
59938262|NCT02828436|76056595|FG000|COMPLETED|Period 1||0||
59938263|NCT02828436|76056596|FG001|COMPLETED|Period 1||5||
59938264|NCT02828436|76056595|FG000|NOT COMPLETED|Period 1||0||
59938265|NCT02828436|76056596|FG001|NOT COMPLETED|Period 1||4||
59938266|NCT02828436|76056595|FG000|STARTED|Period 2||9||
59938267|NCT02828436|76056596|FG001|STARTED|Period 2||0||
59938268|NCT02828436|76056595|FG000|COMPLETED|Period 2||1||
59938269|NCT02828436|76056596|FG001|COMPLETED|Period 2||0||
59938270|NCT02828436|76056595|FG000|NOT COMPLETED|Period 2||8||
59938271|NCT02828436|76056596|FG001|NOT COMPLETED|Period 2||0||
59938272|NCT04059159|76056602|FG000|STARTED|Overall Study||8||
59938273|NCT04059159|76056602|FG000|COMPLETED|Overall Study||3||
59938274|NCT04059159|76056602|FG000|NOT COMPLETED|Overall Study||5||
59938275|NCT02828124|76056610|FG000|STARTED|Overall Study||1||
59938276|NCT02828124|76056611|FG001|STARTED|Overall Study||2||
59938277|NCT02828124|76056612|FG002|STARTED|Overall Study||1||
59938278|NCT02828124|76056613|FG003|STARTED|Overall Study||6||
59938279|NCT02828124|76056610|FG000|COMPLETED|Overall Study||0||
59938280|NCT02828124|76056611|FG001|COMPLETED|Overall Study||0||
59938281|NCT02828124|76056612|FG002|COMPLETED|Overall Study||0||
59938282|NCT02828124|76056613|FG003|COMPLETED|Overall Study||0||
59938283|NCT02828124|76056610|FG000|NOT COMPLETED|Overall Study||1||
59938284|NCT02828124|76056611|FG001|NOT COMPLETED|Overall Study||2||
59938285|NCT02828124|76056612|FG002|NOT COMPLETED|Overall Study||1||
59938286|NCT02828124|76056613|FG003|NOT COMPLETED|Overall Study||6||
59938287|NCT02829996|76056628|FG000|STARTED|Overall Study||39||
59938288|NCT02829996|76056629|FG001|STARTED|Overall Study||39||
59938289|NCT02829996|76056630|FG002|STARTED|Overall Study||40||
59938290|NCT02829996|76056631|FG003|STARTED|Overall Study||41||
59938291|NCT02829996|76056632|FG004|STARTED|Overall Study||42||
59938292|NCT02829996|76056628|FG000|COMPLETED|Overall Study||38||
59938293|NCT02829996|76056629|FG001|COMPLETED|Overall Study||39||
59938294|NCT02829996|76056630|FG002|COMPLETED|Overall Study||40||
59938295|NCT02829996|76056631|FG003|COMPLETED|Overall Study||41||
59938296|NCT02829996|76056632|FG004|COMPLETED|Overall Study||42||
59938297|NCT02829996|76056628|FG000|NOT COMPLETED|Overall Study||1||
59938298|NCT02829996|76056629|FG001|NOT COMPLETED|Overall Study||0||
59938299|NCT02829996|76056630|FG002|NOT COMPLETED|Overall Study||0||
59938300|NCT02829996|76056631|FG003|NOT COMPLETED|Overall Study||0||
59938301|NCT02829996|76056632|FG004|NOT COMPLETED|Overall Study||0||
59938302|NCT02827500|76056646|FG000|STARTED|Overall Study||52||
59938303|NCT02827500|76056647|FG001|STARTED|Overall Study||52||
59938304|NCT02827500|76056646|FG000|COMPLETED|Overall Study||33||
59938305|NCT02827500|76056647|FG001|COMPLETED|Overall Study||45||
59938306|NCT02827500|76056646|FG000|NOT COMPLETED|Overall Study||19||
59938307|NCT02827500|76056647|FG001|NOT COMPLETED|Overall Study||7||
59938308|NCT02826798|76056658|FG000|STARTED|Overall Study||25||
59938309|NCT02826798|76056659|FG001|STARTED|Overall Study||26||
59938310|NCT02826798|76056660|FG002|STARTED|Overall Study||26||
59938311|NCT02826798|76056661|FG003|STARTED|Overall Study||25||
59938312|NCT02826798|76056662|FG004|STARTED|Overall Study||26||
59938313|NCT02826798|76056658|FG000|COMPLETED|Overall Study||25||
59938314|NCT02826798|76056659|FG001|COMPLETED|Overall Study||25||
59938315|NCT02826798|76056660|FG002|COMPLETED|Overall Study||26||
59938316|NCT02826798|76056661|FG003|COMPLETED|Overall Study||24||
59938317|NCT02826798|76056662|FG004|COMPLETED|Overall Study||26||
59938318|NCT02826798|76056658|FG000|NOT COMPLETED|Overall Study||0||
59938319|NCT02826798|76056659|FG001|NOT COMPLETED|Overall Study||1||
59938320|NCT02826798|76056660|FG002|NOT COMPLETED|Overall Study||0||
59938321|NCT02826798|76056661|FG003|NOT COMPLETED|Overall Study||1||
59938322|NCT02826798|76056662|FG004|NOT COMPLETED|Overall Study||0||
59938323|NCT02829138|76056676|FG000|STARTED|Overall Study||29||
59938324|NCT02829138|76056677|FG001|STARTED|Overall Study||28||
59938325|NCT02829138|76056676|FG000|COMPLETED|Overall Study||28||
59938326|NCT02829138|76056677|FG001|COMPLETED|Overall Study||28||
59938327|NCT02829138|76056676|FG000|NOT COMPLETED|Overall Study||1||
59938328|NCT02829138|76056677|FG001|NOT COMPLETED|Overall Study||0||
59938329|NCT02825550|76056683|FG000|STARTED|Overall Study||13||
59938330|NCT02825550|76056683|FG000|COMPLETED|Overall Study||12||
59938331|NCT02825550|76056683|FG000|NOT COMPLETED|Overall Study||1||
59938332|NCT02744040|76056692|FG000|STARTED|Overall Study||28||
59938333|NCT02744040|76056693|FG001|STARTED|Overall Study||51||
59938334|NCT02744040|76056694|FG002|STARTED|Overall Study||72||
59938335|NCT02744040|76056692|FG000|COMPLETED|Overall Study||22||
59938336|NCT02744040|76056693|FG001|COMPLETED|Overall Study||40||
59938337|NCT02744040|76056694|FG002|COMPLETED|Overall Study||50||
59938338|NCT02744040|76056692|FG000|NOT COMPLETED|Overall Study||6||
59938339|NCT02744040|76056693|FG001|NOT COMPLETED|Overall Study||11||
59938340|NCT02744040|76056694|FG002|NOT COMPLETED|Overall Study||22||
59938341|NCT02743962|76056704|FG000|STARTED|Overall Study||5||
59938342|NCT02743962|76056705|FG001|STARTED|Overall Study||5||
59938343|NCT02743962|76056704|FG000|COMPLETED|Overall Study||4||
59938344|NCT02743962|76056705|FG001|COMPLETED|Overall Study||5||
59938345|NCT02743962|76056704|FG000|NOT COMPLETED|Overall Study||1||
59938346|NCT02743962|76056705|FG001|NOT COMPLETED|Overall Study||0||
59938347|NCT03094416|76056714|FG000|STARTED|Run-in||66||
59938348|NCT03094416|76056714|FG000|COMPLETED|Run-in||47||
59938349|NCT03094416|76056714|FG000|NOT COMPLETED|Run-in||19||
59938350|NCT03094416|76056714|FG000|STARTED|Treatment Period||47||
59938351|NCT03094416|76056714|FG000|COMPLETED|Treatment Period||45||
59938352|NCT03094416|76056714|FG000|NOT COMPLETED|Treatment Period||2||
59938353|NCT03041025|76056722|FG000|STARTED|Overall Study||8||
59938354|NCT03041025|76056723|FG001|STARTED|Overall Study||3||
59938355|NCT03041025|76056724|FG002|STARTED|Overall Study||24||
59938356|NCT03041025|76056722|FG000|COMPLETED|Overall Study||7||
59938357|NCT03041025|76056723|FG001|COMPLETED|Overall Study||3||
59938358|NCT03041025|76056724|FG002|COMPLETED|Overall Study||22||
59938359|NCT03041025|76056722|FG000|NOT COMPLETED|Overall Study||1||
59938360|NCT03041025|76056723|FG001|NOT COMPLETED|Overall Study||0||
59938361|NCT03041025|76056724|FG002|NOT COMPLETED|Overall Study||2||
59938362|NCT01338870|76056741|FG000|STARTED|Overall Study||50||
59938363|NCT01338870|76056742|FG001|STARTED|Overall Study||49||
59938364|NCT01338870|76056743|FG002|STARTED|Overall Study||50||
59938365|NCT01338870|76056744|FG003|STARTED|Overall Study||50||
59938366|NCT01338870|76056745|FG004|STARTED|Overall Study||52||
59938367|NCT01338870|76056746|FG005|STARTED|Overall Study||50||
59938368|NCT01338870|76056741|FG000|COMPLETED|Overall Study||41||
59938369|NCT01338870|76056742|FG001|COMPLETED|Overall Study||37||
59938370|NCT01338870|76056743|FG002|COMPLETED|Overall Study||39||
59938371|NCT01338870|76056744|FG003|COMPLETED|Overall Study||41||
59938372|NCT01338870|76056745|FG004|COMPLETED|Overall Study||46||
59938373|NCT01338870|76056746|FG005|COMPLETED|Overall Study||44||
59938374|NCT01338870|76056741|FG000|NOT COMPLETED|Overall Study||9||
59938375|NCT01338870|76056742|FG001|NOT COMPLETED|Overall Study||12||
59938376|NCT01338870|76056743|FG002|NOT COMPLETED|Overall Study||11||
59938377|NCT01338870|76056744|FG003|NOT COMPLETED|Overall Study||9||
59938378|NCT01338870|76056745|FG004|NOT COMPLETED|Overall Study||6||
59938379|NCT01338870|76056746|FG005|NOT COMPLETED|Overall Study||6||
59938380|NCT02824224|76056762|FG000|STARTED|Overall Study||19||
59938381|NCT02824224|76056763|FG001|STARTED|Overall Study||18||
59938382|NCT02824224|76056762|FG000|COMPLETED|Overall Study||17||
59938383|NCT02824224|76056763|FG001|COMPLETED|Overall Study||17||
59938384|NCT02824224|76056762|FG000|NOT COMPLETED|Overall Study||2||
59938385|NCT02824224|76056763|FG001|NOT COMPLETED|Overall Study||1||
59938386|NCT01338792|76056769|FG000|STARTED|Overall Study||47||
59938387|NCT01338792|76056769|FG000|COMPLETED|Overall Study||43||
59938388|NCT01338792|76056769|FG000|NOT COMPLETED|Overall Study||4||
59938389|NCT01314105|76056775|FG000|STARTED|Overall Study||7||
59938390|NCT01314105|76056776|FG001|STARTED|Overall Study||12||
59938391|NCT01314105|76056775|FG000|COMPLETED|Overall Study||0||
59938392|NCT01314105|76056776|FG001|COMPLETED|Overall Study||0||
59938393|NCT01314105|76056775|FG000|NOT COMPLETED|Overall Study||7||
59938394|NCT01314105|76056776|FG001|NOT COMPLETED|Overall Study||12||
59938395|NCT03040713|76056784|FG000|STARTED|Overall Study||16||
59938396|NCT03040713|76056784|FG000|COMPLETED|Overall Study||13||
59938397|NCT03040713|76056784|FG000|NOT COMPLETED|Overall Study||3||
59938398|NCT01966471|76056790|FG000|STARTED|Overall Study||918||
59938399|NCT01966471|76056791|FG001|STARTED|Overall Study||928||
59938400|NCT01966471|76056790|FG000|COMPLETED|Overall Study||0||
59938401|NCT01966471|76056791|FG001|COMPLETED|Overall Study|There is a difference in the death count displayed here and in the All-Cause Mortality section under Adverse Events. The difference relates to a participant that died and who was randomized to the AC-KP arm, but never received trastuzumab emtansine. Consequently they were assigned to the AC-THP for safety analyses. This death counts in the AC-KP arm when summary is based on the ITT population, but counts in the AC-THP arm when the summary on the safety population.|0||
59938402|NCT01966471|76056790|FG000|NOT COMPLETED|Overall Study||918||
59938403|NCT01966471|76056791|FG001|NOT COMPLETED|Overall Study||928||
59938404|NCT05224843|76056797|FG000|STARTED|Overall Study||80||
59938405|NCT05224843|76056797|FG000|COMPLETED|Overall Study||80||
59938406|NCT05224843|76056797|FG000|NOT COMPLETED|Overall Study||0||
59938407|NCT03227471|76056820|FG000|STARTED|Overall Study||9||
59938408|NCT03227471|76056821|FG001|STARTED|Overall Study||30||
59938409|NCT03227471|76056822|FG002|STARTED|Overall Study||8||
59938410|NCT03227471|76056823|FG003|STARTED|Overall Study||7||
59938411|NCT03227471|76056824|FG004|STARTED|Overall Study||25||
59938412|NCT03227471|76056825|FG005|STARTED|Overall Study||6||
59938413|NCT03227471|76056826|FG006|STARTED|Overall Study||17||
59938414|NCT03227471|76056827|FG007|STARTED|Overall Study||12||
59938415|NCT03227471|76056828|FG008|STARTED|Overall Study||10||
59938416|NCT03227471|76056829|FG009|STARTED|Overall Study||22||
59938417|NCT03227471|76056830|FG010|STARTED|Overall Study||21||
59938418|NCT03227471|76056831|FG011|STARTED|Overall Study||7||
59938419|NCT03227471|76056832|FG012|STARTED|Overall Study||21||
59938420|NCT03227471|76056833|FG013|STARTED|Overall Study||8||
59938421|NCT03227471|76056834|FG014|STARTED|Overall Study||22||
59938422|NCT03227471|76056820|FG000|Safety Set|Overall Study||9|Received at least 1 dose of study drug.|
59938423|NCT03227471|76056821|FG001|Safety Set|Overall Study||30|Received at least 1 dose of study drug.|
59938424|NCT03227471|76056822|FG002|Safety Set|Overall Study||8|Received at least 1 dose of study drug.|
59938425|NCT03227471|76056823|FG003|Safety Set|Overall Study||7|Received at least 1 dose of study drug.|
59938426|NCT03227471|76056824|FG004|Safety Set|Overall Study||25|Received at least 1 dose of study drug.|
59938427|NCT03227471|76056825|FG005|Safety Set|Overall Study||6|Received at least 1 dose of study drug.|
59938428|NCT03227471|76056826|FG006|Safety Set|Overall Study||17|Received at least 1 dose of study drug.|
59938429|NCT03227471|76056827|FG007|Safety Set|Overall Study||12|Received at least 1 dose of study drug.|
59938430|NCT03227471|76056828|FG008|Safety Set|Overall Study||10|Received at least 1 dose of study drug.|
59938431|NCT03227471|76056829|FG009|Safety Set|Overall Study||22|Received at least 1 dose of study drug.|
59938432|NCT03227471|76056830|FG010|Safety Set|Overall Study||21|Received at least 1 dose of study drug.|
59938433|NCT03227471|76056831|FG011|Safety Set|Overall Study||7|Received at least 1 dose of study drug.|
59938434|NCT03227471|76056832|FG012|Safety Set|Overall Study||21|Received at least 1 dose of study drug.|
59938435|NCT03227471|76056833|FG013|Safety Set|Overall Study||8|Received at least 1 dose of study drug.|
59938436|NCT03227471|76056834|FG014|Safety Set|Overall Study||21|Received at least 1 dose of study drug.|
59938437|NCT03227471|76056820|FG000|COMPLETED|Overall Study||9||
59938438|NCT03227471|76056821|FG001|COMPLETED|Overall Study||30||
59938439|NCT03227471|76056822|FG002|COMPLETED|Overall Study||8||
59938440|NCT03227471|76056823|FG003|COMPLETED|Overall Study||7||
59938441|NCT03227471|76056824|FG004|COMPLETED|Overall Study||24||
59938442|NCT03227471|76056825|FG005|COMPLETED|Overall Study||6||
59938443|NCT03227471|76056826|FG006|COMPLETED|Overall Study||17||
59938444|NCT03227471|76056827|FG007|COMPLETED|Overall Study||12||
59938445|NCT03227471|76056828|FG008|COMPLETED|Overall Study||10||
59938446|NCT03227471|76056829|FG009|COMPLETED|Overall Study||22||
59938447|NCT03227471|76056830|FG010|COMPLETED|Overall Study||21||
59938448|NCT03227471|76056831|FG011|COMPLETED|Overall Study||7||
59938449|NCT03227471|76056832|FG012|COMPLETED|Overall Study||20||
59938450|NCT03227471|76056833|FG013|COMPLETED|Overall Study||8||
59938451|NCT03227471|76056834|FG014|COMPLETED|Overall Study||21||
59938452|NCT03227471|76056820|FG000|NOT COMPLETED|Overall Study||0||
59938453|NCT03227471|76056821|FG001|NOT COMPLETED|Overall Study||0||
59938454|NCT03227471|76056822|FG002|NOT COMPLETED|Overall Study||0||
59938455|NCT03227471|76056823|FG003|NOT COMPLETED|Overall Study||0||
59938456|NCT03227471|76056824|FG004|NOT COMPLETED|Overall Study||1||
59938457|NCT03227471|76056825|FG005|NOT COMPLETED|Overall Study||0||
59938458|NCT03227471|76056826|FG006|NOT COMPLETED|Overall Study||0||
59938459|NCT03227471|76056827|FG007|NOT COMPLETED|Overall Study||0||
59938460|NCT03227471|76056828|FG008|NOT COMPLETED|Overall Study||0||
59938461|NCT03227471|76056829|FG009|NOT COMPLETED|Overall Study||0||
59938462|NCT03227471|76056830|FG010|NOT COMPLETED|Overall Study||0||
59938463|NCT03227471|76056831|FG011|NOT COMPLETED|Overall Study||0||
59938464|NCT03227471|76056832|FG012|NOT COMPLETED|Overall Study||1||
59938465|NCT03227471|76056833|FG013|NOT COMPLETED|Overall Study||0||
59938466|NCT03227471|76056834|FG014|NOT COMPLETED|Overall Study||1||
59938467|NCT01354314|76056899|FG000|STARTED|Overall Study||12||
59938468|NCT01354314|76056900|FG001|STARTED|Overall Study||11||
59938469|NCT01354314|76056901|FG002|STARTED|Overall Study||11||
59938470|NCT01354314|76056902|FG003|STARTED|Overall Study||11||
59938471|NCT01354314|76056899|FG000|Completed (ITT)|Overall Study||11|Completed trial with evaluable data for intention to treat analysis.|
59938472|NCT01354314|76056900|FG001|Completed (ITT)|Overall Study||11|Completed trial with evaluable data for intention to treat analysis.|
59938473|NCT01354314|76056901|FG002|Completed (ITT)|Overall Study||9|Completed trial with evaluable data for intention to treat analysis.|
59938474|NCT01354314|76056902|FG003|Completed (ITT)|Overall Study||10|Completed trial with evaluable data for intention to treat analysis.|
59938475|NCT01354314|76056899|FG000|COMPLETED|Overall Study||6|Per protocol: evaluable outcome measures and 90+ percent of target study treatment total dose.|
59938476|NCT01354314|76056900|FG001|COMPLETED|Overall Study||8|Per protocol: evaluable outcome measures and 90+ percent of target study treatment total dose.|
59938477|NCT01354314|76056901|FG002|COMPLETED|Overall Study||3|Per protocol: evaluable outcome measures and 90+ percent of target study treatment total dose.|
59938478|NCT01354314|76056902|FG003|COMPLETED|Overall Study||5|Per protocol: evaluable outcome measures and 90+ percent of target study treatment total dose.|
59938479|NCT01354314|76056899|FG000|NOT COMPLETED|Overall Study||6||
59938480|NCT01354314|76056900|FG001|NOT COMPLETED|Overall Study||3||
59938481|NCT01354314|76056901|FG002|NOT COMPLETED|Overall Study||8||
59938482|NCT01354314|76056902|FG003|NOT COMPLETED|Overall Study||6||
59938483|NCT03194321|76056914|FG000|STARTED|Overall Study||20||
59938484|NCT03194321|76056914|FG000|COMPLETED|Overall Study||17||
59938485|NCT03194321|76056914|FG000|NOT COMPLETED|Overall Study||3||
59938486|NCT01354938|76056918|FG000|STARTED|Overall Study||220||
59938487|NCT01354938|76056918|FG000|COMPLETED|Overall Study||219||
59938488|NCT01354938|76056918|FG000|NOT COMPLETED|Overall Study||1||
59938489|NCT02516969|76056924|FG000|STARTED|Overall Study||3||
59938490|NCT02516969|76056925|FG001|STARTED|Overall Study||4||
59938491|NCT02516969|76056924|FG000|COMPLETED|Overall Study||3||
59938492|NCT02516969|76056925|FG001|COMPLETED|Overall Study||4||
59938493|NCT02516969|76056924|FG000|NOT COMPLETED|Overall Study||0||
59938494|NCT02516969|76056925|FG001|NOT COMPLETED|Overall Study||0||
59938495|NCT03092791|76056941|FG000|STARTED|Overall Study||20||
59938496|NCT03092791|76056942|FG001|STARTED|Overall Study||20||
59938497|NCT03092791|76056943|FG002|STARTED|Overall Study||30||
59938498|NCT03092791|76056944|FG003|STARTED|Overall Study||30||
59938499|NCT03092791|76056945|FG004|STARTED|Overall Study||60||
59938500|NCT03092791|76056946|FG005|STARTED|Overall Study||60||
59938501|NCT03092791|76056947|FG006|STARTED|Overall Study||60||
59938502|NCT03092791|76056948|FG007|STARTED|Overall Study||60||
59938503|NCT03092791|76056941|FG000|COMPLETED|Overall Study||20||
59938504|NCT03092791|76056942|FG001|COMPLETED|Overall Study||20||
59938505|NCT03092791|76056943|FG002|COMPLETED|Overall Study||30||
59938506|NCT03092791|76056944|FG003|COMPLETED|Overall Study||30||
59938507|NCT03092791|76056945|FG004|COMPLETED|Overall Study||0||
59938508|NCT03092791|76056946|FG005|COMPLETED|Overall Study||0||
59938509|NCT03092791|76056947|FG006|COMPLETED|Overall Study||0||
59938510|NCT03092791|76056948|FG007|COMPLETED|Overall Study||0||
59938511|NCT03092791|76056941|FG000|NOT COMPLETED|Overall Study||0||
59938512|NCT03092791|76056942|FG001|NOT COMPLETED|Overall Study||0||
59938513|NCT03092791|76056943|FG002|NOT COMPLETED|Overall Study||0||
59938514|NCT03092791|76056944|FG003|NOT COMPLETED|Overall Study||0||
59938515|NCT03092791|76056945|FG004|NOT COMPLETED|Overall Study||60||
59938516|NCT03092791|76056946|FG005|NOT COMPLETED|Overall Study||60||
59938517|NCT03092791|76056947|FG006|NOT COMPLETED|Overall Study||60||
59938518|NCT03092791|76056948|FG007|NOT COMPLETED|Overall Study||60||
59938519|NCT04569253|76056966|FG000|STARTED|Overall Study||65||130
59938520|NCT04569253|76056966|FG000|Control Flanks|Overall Study||65||65
59938521|NCT04569253|76056966|FG000|Treatment Flanks|Overall Study||65||65
59938522|NCT04569253|76056966|FG000|COMPLETED|Overall Study||57||114
59938523|NCT04569253|76056966|FG000|NOT COMPLETED|Overall Study||8||16
59938524|NCT02505425|76056975|FG000|STARTED|Overall Study||208||
59938525|NCT02505425|76056976|FG001|STARTED|Overall Study||207||
59938526|NCT02505425|76056977|FG002|STARTED|Overall Study||82||
59938527|NCT02505425|76056978|FG003|STARTED|Overall Study||76||
59938528|NCT02505425|76056975|FG000|COMPLETED|Overall Study||120||
59938529|NCT02505425|76056976|FG001|COMPLETED|Overall Study||125||
59938530|NCT02505425|76056977|FG002|COMPLETED|Overall Study||32||
59938531|NCT02505425|76056978|FG003|COMPLETED|Overall Study||50||
59938532|NCT02505425|76056975|FG000|NOT COMPLETED|Overall Study||88||
59938533|NCT02505425|76056976|FG001|NOT COMPLETED|Overall Study||82||
59938534|NCT02505425|76056977|FG002|NOT COMPLETED|Overall Study||50||
59938535|NCT02505425|76056978|FG003|NOT COMPLETED|Overall Study||26||
59938536|NCT03089047|76056990|FG000|STARTED|Overall Study||2||
59938537|NCT03089047|76056991|FG001|STARTED|Overall Study||2||
59938538|NCT03089047|76056990|FG000|COMPLETED|Overall Study||1||
59938539|NCT03089047|76056991|FG001|COMPLETED|Overall Study||2||
59938540|NCT03089047|76056990|FG000|NOT COMPLETED|Overall Study||1||
59938541|NCT03089047|76056991|FG001|NOT COMPLETED|Overall Study||0||
59938542|NCT01371006|76056999|FG000|STARTED|Overall Study||14||
59938543|NCT01371006|76057000|FG001|STARTED|Overall Study||15||
59938544|NCT01371006|76056999|FG000|COMPLETED|Overall Study||13||
59938545|NCT01371006|76057000|FG001|COMPLETED|Overall Study||15||
59938546|NCT01371006|76056999|FG000|NOT COMPLETED|Overall Study||1||
59938547|NCT01371006|76057000|FG001|NOT COMPLETED|Overall Study||0||
59938548|NCT02288897|76057028|FG000|STARTED|Overall Study||12||
59938549|NCT02288897|76057029|FG001|STARTED|Overall Study||8||
59938550|NCT02288897|76057028|FG000|COMPLETED|Overall Study||12||
59938551|NCT02288897|76057029|FG001|COMPLETED|Overall Study||8||
59938552|NCT02288897|76057028|FG000|NOT COMPLETED|Overall Study||0||
59938553|NCT02288897|76057029|FG001|NOT COMPLETED|Overall Study||0||
59938554|NCT01371552|76057035|FG000|STARTED|Part 1, First 3 Days||19||
59938555|NCT01371552|76057036|FG001|STARTED|Part 1, First 3 Days||17||
59938556|NCT01371552|76057037|FG002|STARTED|Part 1, First 3 Days||20||
59938557|NCT01371552|76057038|FG003|STARTED|Part 1, First 3 Days||20||
59938558|NCT01371552|76057039|FG004|STARTED|Part 1, First 3 Days||15||
59938559|NCT01371552|76057040|FG005|STARTED|Part 1, First 3 Days||18||
59938560|NCT01371552|76057035|FG000|COMPLETED|Part 1, First 3 Days||19||
59938561|NCT01371552|76057036|FG001|COMPLETED|Part 1, First 3 Days||17||
59938562|NCT01371552|76057037|FG002|COMPLETED|Part 1, First 3 Days||19||
59938563|NCT01371552|76057038|FG003|COMPLETED|Part 1, First 3 Days||20||
59938564|NCT01371552|76057039|FG004|COMPLETED|Part 1, First 3 Days||15||
59938565|NCT01371552|76057040|FG005|COMPLETED|Part 1, First 3 Days||18||
59938566|NCT01371552|76057035|FG000|NOT COMPLETED|Part 1, First 3 Days||0||
59938567|NCT01371552|76057036|FG001|NOT COMPLETED|Part 1, First 3 Days||0||
59938568|NCT01371552|76057037|FG002|NOT COMPLETED|Part 1, First 3 Days||1||
59938569|NCT01371552|76057038|FG003|NOT COMPLETED|Part 1, First 3 Days||0||
59938570|NCT01371552|76057039|FG004|NOT COMPLETED|Part 1, First 3 Days||0||
59938571|NCT01371552|76057040|FG005|NOT COMPLETED|Part 1, First 3 Days||0||
59938572|NCT01371552|76057035|FG000|STARTED|Part 1, Second 3 Days||19||
59938573|NCT01371552|76057036|FG001|STARTED|Part 1, Second 3 Days||17||
59938574|NCT01371552|76057037|FG002|STARTED|Part 1, Second 3 Days|1 subject discontinued after First 3 days due to positive slit lamp findings unrelated to lens wear|18||
59938575|NCT01371552|76057038|FG003|STARTED|Part 1, Second 3 Days||20||
59938576|NCT01371552|76057039|FG004|STARTED|Part 1, Second 3 Days||15||
59938577|NCT01371552|76057040|FG005|STARTED|Part 1, Second 3 Days||18||
59938578|NCT01371552|76057035|FG000|COMPLETED|Part 1, Second 3 Days|One subject did not complete period due to discomfort but continued to next, as allowed by protocol|18||
59938579|NCT01371552|76057036|FG001|COMPLETED|Part 1, Second 3 Days||17||
59938580|NCT01371552|76057037|FG002|COMPLETED|Part 1, Second 3 Days||18||
59938581|NCT01371552|76057038|FG003|COMPLETED|Part 1, Second 3 Days||20||
59938582|NCT01371552|76057039|FG004|COMPLETED|Part 1, Second 3 Days||15||
59938583|NCT01371552|76057040|FG005|COMPLETED|Part 1, Second 3 Days||18||
59938584|NCT01371552|76057035|FG000|NOT COMPLETED|Part 1, Second 3 Days||1||
59938585|NCT01371552|76057036|FG001|NOT COMPLETED|Part 1, Second 3 Days||0||
59938586|NCT01371552|76057037|FG002|NOT COMPLETED|Part 1, Second 3 Days||0||
59938587|NCT01371552|76057038|FG003|NOT COMPLETED|Part 1, Second 3 Days||0||
59938588|NCT01371552|76057039|FG004|NOT COMPLETED|Part 1, Second 3 Days||0||
59938589|NCT01371552|76057040|FG005|NOT COMPLETED|Part 1, Second 3 Days||0||
59938590|NCT01371552|76057035|FG000|STARTED|Part 1, Third 3 Days||19||
59938591|NCT01371552|76057036|FG001|STARTED|Part 1, Third 3 Days||17||
59938592|NCT01371552|76057037|FG002|STARTED|Part 1, Third 3 Days||18||
59938593|NCT01371552|76057038|FG003|STARTED|Part 1, Third 3 Days||20||
59938594|NCT01371552|76057039|FG004|STARTED|Part 1, Third 3 Days||15||
59938595|NCT01371552|76057040|FG005|STARTED|Part 1, Third 3 Days||18||
59938596|NCT01371552|76057035|FG000|COMPLETED|Part 1, Third 3 Days||19||
59938597|NCT01371552|76057036|FG001|COMPLETED|Part 1, Third 3 Days||17||
59938598|NCT01371552|76057037|FG002|COMPLETED|Part 1, Third 3 Days||18||
59938599|NCT01371552|76057038|FG003|COMPLETED|Part 1, Third 3 Days||20||
59938600|NCT01371552|76057039|FG004|COMPLETED|Part 1, Third 3 Days|One subject did not complete period due to randomization error, but continued into Part 2.|14||
59938601|NCT01371552|76057040|FG005|COMPLETED|Part 1, Third 3 Days|One subject did not complete period due to discomfort, but continued into Part 2.|17||
59938602|NCT01371552|76057035|FG000|NOT COMPLETED|Part 1, Third 3 Days||0||
59938603|NCT01371552|76057036|FG001|NOT COMPLETED|Part 1, Third 3 Days||0||
59938604|NCT01371552|76057037|FG002|NOT COMPLETED|Part 1, Third 3 Days||0||
59938605|NCT01371552|76057038|FG003|NOT COMPLETED|Part 1, Third 3 Days||0||
59938606|NCT01371552|76057039|FG004|NOT COMPLETED|Part 1, Third 3 Days||1||
59938607|NCT01371552|76057040|FG005|NOT COMPLETED|Part 1, Third 3 Days||1||
59951233|NCT03771664|76070159|FG001|NOT COMPLETED|Overall Study||5||
59938608|NCT01371552|76057035|FG000|STARTED|Part 2, One Week|One participant discontinued between Part 1 and Part 2 due to inconvenience|18||
59938609|NCT01371552|76057036|FG001|STARTED|Part 2, One Week||17||
59938610|NCT01371552|76057037|FG002|STARTED|Part 2, One Week||18||
59938611|NCT01371552|76057038|FG003|STARTED|Part 2, One Week||20||
59938612|NCT01371552|76057039|FG004|STARTED|Part 2, One Week||15||
59938613|NCT01371552|76057040|FG005|STARTED|Part 2, One Week||18||
59938614|NCT01371552|76057035|FG000|COMPLETED|Part 2, One Week||18||
59518461|NCT03373162|75612238|FG000|COMPLETED|Overall Study||10||
59518462|NCT03373162|75612238|FG000|NOT COMPLETED|Overall Study||0||
59518463|NCT03373240|75612245|FG000|STARTED|Overall Study||22||
59518464|NCT03373240|75612246|FG001|STARTED|Overall Study||24||
59518465|NCT03373240|75612245|FG000|4-week Post Treatment|Overall Study||14||
59518466|NCT03373240|75612246|FG001|4-week Post Treatment|Overall Study||23||
59518467|NCT03373240|75612245|FG000|COMPLETED|Overall Study|This is the 1-month post follow-up|11||
59518468|NCT03373240|75612246|FG001|COMPLETED|Overall Study|This is the 1-month post follow-up|20||
59518469|NCT03373240|75612245|FG000|NOT COMPLETED|Overall Study||11||
59518470|NCT03373240|75612246|FG001|NOT COMPLETED|Overall Study||4||
59518471|NCT03374176|75612254|FG000|STARTED|Overall Study||21||
59518472|NCT03374176|75612255|FG001|STARTED|Overall Study||21||
59518473|NCT03374176|75612254|FG000|COMPLETED|Overall Study||21||
59518474|NCT03374176|75612255|FG001|COMPLETED|Overall Study||21||
59518475|NCT03374176|75612254|FG000|NOT COMPLETED|Overall Study||0||
59518476|NCT03374176|75612255|FG001|NOT COMPLETED|Overall Study||0||
59518477|NCT03281200|75612261|FG000|STARTED|Overall Study||172|Started are the treated with entry criteria met|
59518478|NCT03281200|75612261|FG000|COMPLETED|Overall Study||172||
59518479|NCT03281200|75612261|FG000|NOT COMPLETED|Overall Study||0||
59518480|NCT03514966|75612267|FG000|STARTED|Overall Study||40||
59518481|NCT03514966|75612268|FG001|STARTED|Overall Study||43||
59518482|NCT03514966|75612267|FG000|COMPLETED|Overall Study||40||
59518483|NCT03514966|75612268|FG001|COMPLETED|Overall Study||43||
59518484|NCT03514966|75612267|FG000|NOT COMPLETED|Overall Study||0||
59518485|NCT03514966|75612268|FG001|NOT COMPLETED|Overall Study||0||
59518486|NCT03520348|75612276|FG000|STARTED|Overall Study||12||
59518487|NCT03520348|75612277|FG001|STARTED|Overall Study||12||
59518488|NCT03520348|75612276|FG000|COMPLETED|Overall Study||12||
59518489|NCT03520348|75612277|FG001|COMPLETED|Overall Study||12||
59518490|NCT03520348|75612276|FG000|NOT COMPLETED|Overall Study||0||
59518491|NCT03520348|75612277|FG001|NOT COMPLETED|Overall Study||0||
59518492|NCT03282682|75612286|FG000|STARTED|Overall Study||6||
59518493|NCT03282682|75612287|FG001|STARTED|Overall Study||8||
59518494|NCT03282682|75612288|FG002|STARTED|Overall Study||8||
59761966|NCT04466215|75881629|FG000|NOT COMPLETED|Overall Study||0||
59518495|NCT03282682|75612286|FG000|COMPLETED|Overall Study||6||
59518496|NCT03282682|75612287|FG001|COMPLETED|Overall Study||8||
59938615|NCT01371552|76057036|FG001|COMPLETED|Part 2, One Week||17||
59938616|NCT01371552|76057037|FG002|COMPLETED|Part 2, One Week||18||
59938617|NCT01371552|76057038|FG003|COMPLETED|Part 2, One Week||20||
59938618|NCT01371552|76057039|FG004|COMPLETED|Part 2, One Week||15||
59938619|NCT01371552|76057040|FG005|COMPLETED|Part 2, One Week||18||
59938620|NCT01371552|76057035|FG000|NOT COMPLETED|Part 2, One Week||0||
59938621|NCT01371552|76057036|FG001|NOT COMPLETED|Part 2, One Week||0||
59938622|NCT01371552|76057037|FG002|NOT COMPLETED|Part 2, One Week||0||
59938623|NCT01371552|76057038|FG003|NOT COMPLETED|Part 2, One Week||0||
59938624|NCT01371552|76057039|FG004|NOT COMPLETED|Part 2, One Week||0||
59938625|NCT01371552|76057040|FG005|NOT COMPLETED|Part 2, One Week||0||
59938626|NCT02819310|76057049|FG000|STARTED|Overall Study||330||
59938627|NCT02819310|76057049|FG000|COMPLETED|Overall Study||221||
59938628|NCT02819310|76057049|FG000|NOT COMPLETED|Overall Study||109||
59938629|NCT03087643|76057055|FG000|STARTED|Overall Study||26||
59938630|NCT03087643|76057056|FG001|STARTED|Overall Study||25||
59938631|NCT03087643|76057055|FG000|COMPLETED|Overall Study||22||
59938632|NCT03087643|76057056|FG001|COMPLETED|Overall Study||19||
59938633|NCT03087643|76057055|FG000|NOT COMPLETED|Overall Study||4||
59938634|NCT03087643|76057056|FG001|NOT COMPLETED|Overall Study||6||
59938635|NCT02821962|76057064|FG000|STARTED|Overall Study||19||
59938636|NCT02821962|76057065|FG001|STARTED|Overall Study||21||
59938637|NCT02821962|76057064|FG000|COMPLETED|Overall Study||17||
59518497|NCT03282682|75612288|FG002|COMPLETED|Overall Study||8||
59518498|NCT03282682|75612286|FG000|NOT COMPLETED|Overall Study||0||
59938638|NCT02821962|76057065|FG001|COMPLETED|Overall Study||21||
59938639|NCT02821962|76057064|FG000|NOT COMPLETED|Overall Study||2||
59938640|NCT02821962|76057065|FG001|NOT COMPLETED|Overall Study||0||
59938641|NCT03092479|76057073|FG000|STARTED|Overall Study||24||
59938642|NCT03092479|76057074|FG001|STARTED|Overall Study||26||
59938643|NCT03092479|76057073|FG000|COMPLETED|Overall Study||17||
59518499|NCT03282682|75612287|FG001|NOT COMPLETED|Overall Study||0||
59518500|NCT03282682|75612288|FG002|NOT COMPLETED|Overall Study||0||
59518501|NCT03380026|75612296|FG000|STARTED|Overall Study||28||
59519056|NCT01116895|75612924|FG002|STARTED|Overall Study||18||
59761967|NCT04466215|75881630|FG001|NOT COMPLETED|Overall Study||0||
59519057|NCT01116895|75612925|FG003|STARTED|Overall Study||14||
59938644|NCT03092479|76057074|FG001|COMPLETED|Overall Study||24||
59938645|NCT03092479|76057073|FG000|NOT COMPLETED|Overall Study||7||
59938646|NCT03092479|76057074|FG001|NOT COMPLETED|Overall Study||2||
59938647|NCT03086551|76057082|FG000|STARTED|First Intervention||5||
59938648|NCT03086551|76057083|FG001|STARTED|First Intervention||5||
59938649|NCT03086551|76057082|FG000|COMPLETED|First Intervention||4||
59938650|NCT03086551|76057083|FG001|COMPLETED|First Intervention||4||
59938651|NCT03086551|76057082|FG000|NOT COMPLETED|First Intervention||1||
59938652|NCT03086551|76057083|FG001|NOT COMPLETED|First Intervention||1||
59938653|NCT03086551|76057082|FG000|STARTED|Washout||4||
59938654|NCT03086551|76057083|FG001|STARTED|Washout||4||
59938655|NCT03086551|76057082|FG000|COMPLETED|Washout||1||
59938656|NCT03086551|76057083|FG001|COMPLETED|Washout||1||
59938657|NCT03086551|76057082|FG000|NOT COMPLETED|Washout||3||
59938658|NCT03086551|76057083|FG001|NOT COMPLETED|Washout||3||
59938659|NCT03086551|76057082|FG000|STARTED|Second Intervention||1||
59938660|NCT03086551|76057083|FG001|STARTED|Second Intervention||1||
59938661|NCT03086551|76057082|FG000|COMPLETED|Second Intervention||1||
59938662|NCT03086551|76057083|FG001|COMPLETED|Second Intervention||1||
59938663|NCT03086551|76057082|FG000|NOT COMPLETED|Second Intervention||0||
59938664|NCT03086551|76057083|FG001|NOT COMPLETED|Second Intervention||0||
59938665|NCT03265249|76057091|FG000|STARTED|Overall Study||12||
59938666|NCT03265249|76057092|FG001|STARTED|Overall Study||15||
59938667|NCT03265249|76057091|FG000|COMPLETED|Overall Study||12||
59938668|NCT03265249|76057092|FG001|COMPLETED|Overall Study||14||
59938669|NCT03265249|76057091|FG000|NOT COMPLETED|Overall Study||0||
59938670|NCT03265249|76057092|FG001|NOT COMPLETED|Overall Study||1||
59938671|NCT02951767|76057098|FG000|STARTED|Overall Study||119||
59938672|NCT02951767|76057098|FG000|COMPLETED|Overall Study||0||
59938673|NCT02951767|76057098|FG000|NOT COMPLETED|Overall Study||119||
59938674|NCT03093181|76057105|FG000|STARTED|Overall Study||44||
59938675|NCT03093181|76057106|FG001|STARTED|Overall Study||44||
59938676|NCT03093181|76057107|FG002|STARTED|Overall Study||44||
59938677|NCT03093181|76057105|FG000|COMPLETED|Overall Study||41||
59938678|NCT03093181|76057106|FG001|COMPLETED|Overall Study||42||
59938679|NCT03093181|76057107|FG002|COMPLETED|Overall Study||41||
59938680|NCT03093181|76057105|FG000|NOT COMPLETED|Overall Study||3||
59938681|NCT03093181|76057106|FG001|NOT COMPLETED|Overall Study||2||
59938682|NCT03093181|76057107|FG002|NOT COMPLETED|Overall Study||3||
59938683|NCT03091777|76057118|FG000|STARTED|Overall Study||289||
59938684|NCT03091777|76057119|FG001|STARTED|Overall Study||288||
59938685|NCT03091777|76057120|FG002|STARTED|Overall Study||294||
59938686|NCT03091777|76057118|FG000|COMPLETED|Overall Study||257||
59938687|NCT03091777|76057119|FG001|COMPLETED|Overall Study||255||
59938688|NCT03091777|76057120|FG002|COMPLETED|Overall Study||257||
59938689|NCT03091777|76057118|FG000|NOT COMPLETED|Overall Study||32||
59938690|NCT03091777|76057119|FG001|NOT COMPLETED|Overall Study||33||
59938691|NCT03091777|76057120|FG002|NOT COMPLETED|Overall Study||37||
59938692|NCT02818998|76057131|FG000|STARTED|Overall Study||155||
59938693|NCT02818998|76057132|FG001|STARTED|Overall Study||154||
59938694|NCT02818998|76057133|FG002|STARTED|Overall Study||154||
59938695|NCT02818998|76057131|FG000|Completed Week 52 Visit|Overall Study||144||
59938696|NCT02818998|76057132|FG001|Completed Week 52 Visit|Overall Study||146||
59938697|NCT02818998|76057133|FG002|Completed Week 52 Visit|Overall Study||140||
59938698|NCT02818998|76057131|FG000|COMPLETED|Overall Study||137|Completed Week 100 visit|
59938699|NCT02818998|76057132|FG001|COMPLETED|Overall Study||138|Completed Week 100 visit|
59938700|NCT02818998|76057133|FG002|COMPLETED|Overall Study||136|Completed Week 100 visit|
59938701|NCT02818998|76057131|FG000|NOT COMPLETED|Overall Study||18||
59938702|NCT02818998|76057132|FG001|NOT COMPLETED|Overall Study||16||
59938703|NCT02818998|76057133|FG002|NOT COMPLETED|Overall Study||18||
59938704|NCT02821416|76057143|FG000|STARTED|Overall Study||23||
59938705|NCT02821416|76057144|FG001|STARTED|Overall Study||23||
59938706|NCT02821416|76057143|FG000|COMPLETED|Overall Study||20||
59938707|NCT02821416|76057144|FG001|COMPLETED|Overall Study||22||
59938708|NCT02821416|76057143|FG000|NOT COMPLETED|Overall Study||3||
59938709|NCT02821416|76057144|FG001|NOT COMPLETED|Overall Study||1||
59938710|NCT03108521|76057153|FG000|STARTED|Overall Study||83||
59938711|NCT03108521|76057154|FG001|STARTED|Overall Study||36||
59938712|NCT03108521|76057153|FG000|COMPLETED|Overall Study||71||
59938713|NCT03108521|76057154|FG001|COMPLETED|Overall Study||36||
59938714|NCT03108521|76057153|FG000|NOT COMPLETED|Overall Study||12||
59938715|NCT03108521|76057154|FG001|NOT COMPLETED|Overall Study||0||
59938716|NCT04343989|76057167|FG000|STARTED|Overall Study||78||
59938717|NCT04343989|76057168|FG001|STARTED|Overall Study||26||
59938718|NCT04343989|76057169|FG002|STARTED|Overall Study||74||
59938719|NCT04343989|76057167|FG000|COMPLETED|Overall Study||78||
59938720|NCT04343989|76057168|FG001|COMPLETED|Overall Study||26||
59938721|NCT04343989|76057169|FG002|COMPLETED|Overall Study||74||
59938722|NCT04343989|76057167|FG000|NOT COMPLETED|Overall Study||0||
59938723|NCT04343989|76057168|FG001|NOT COMPLETED|Overall Study||0||
59938724|NCT04343989|76057169|FG002|NOT COMPLETED|Overall Study||0||
59938725|NCT02817828|76057177|FG000|STARTED|Overall Study||1553||
59938726|NCT02817828|76057177|FG000|COMPLETED|Overall Study||1218||
59938727|NCT02817828|76057177|FG000|NOT COMPLETED|Overall Study||335||
59951234|NCT03743415|76070175|FG000|STARTED|Overall Study||166||
59951235|NCT03743415|76070176|FG001|STARTED|Overall Study||44||
59938728|NCT02817906|76057188|FG000|STARTED|Overall Study|87 patients were randomized but only 86 received study drug. The number completed and discontinued is based on the 86 patients that received study drug.|86|Part A-Number of subjects treated|
59938729|NCT02817906|76057189|FG001|STARTED|Overall Study|90 patients were randomized but only 89 received study drug. The number completed and discontinued is based on 89 patients that received study drug.|89|Part A-Number of subjects treated|
59938730|NCT02817906|76057188|FG000|COMPLETED|Overall Study||70|Part A|
59938731|NCT02817906|76057189|FG001|COMPLETED|Overall Study||84|Part A|
59938732|NCT02817906|76057188|FG000|NOT COMPLETED|Overall Study||16||
59938733|NCT02817906|76057189|FG001|NOT COMPLETED|Overall Study||5||
59938734|NCT04338971|76057195|FG000|STARTED|Overall Study||24||
59938735|NCT04338971|76057195|FG000|COMPLETED|Overall Study||17||
59938736|NCT04338971|76057195|FG000|NOT COMPLETED|Overall Study||7||
59938737|NCT02817594|76057200|FG000|STARTED|Overall Study||51||
59938738|NCT02817594|76057200|FG000|Received Treatment|Overall Study||50||
59938739|NCT02817594|76057200|FG000|COMPLETED|Overall Study||48|Completed defined as having an HCV RNA assessment performed at least 10 weeks post-treatment|
59938740|NCT02817594|76057200|FG000|NOT COMPLETED|Overall Study||3||
59938741|NCT02813694|76057210|FG000|STARTED|Overall Study|Intent to Treat Analysis Set|370||
59938742|NCT02813694|76057211|FG001|STARTED|Overall Study|Intent to Treat Analysis Set|368||
59938743|NCT02813694|76057210|FG000|COMPLETED|Overall Study||353|Completed Study (Late Follow Up Assessment)|
59938744|NCT02813694|76057211|FG001|COMPLETED|Overall Study|Completed Study (Late Follow Up Assessment)|354|Completed Study (Late Follow Up Assessment)|
59938745|NCT02813694|76057210|FG000|NOT COMPLETED|Overall Study||17||
59938746|NCT02813694|76057211|FG001|NOT COMPLETED|Overall Study||14||
59938747|NCT03103919|76057219|FG000|STARTED|Overall Study||20||
59938748|NCT03103919|76057220|FG001|STARTED|Overall Study||19||
59938749|NCT03103919|76057219|FG000|COMPLETED|Overall Study||18||
59938750|NCT03103919|76057220|FG001|COMPLETED|Overall Study||17||
59938751|NCT03103919|76057219|FG000|NOT COMPLETED|Overall Study||2||
59938752|NCT03103919|76057220|FG001|NOT COMPLETED|Overall Study||2||
59938753|NCT02810964|76057230|FG000|STARTED|Placebo Run-In Phase (2 Weeks)||32||
59938754|NCT02810964|76057231|FG001|STARTED|Placebo Run-In Phase (2 Weeks)||32||
59938755|NCT02810964|76057230|FG000|COMPLETED|Placebo Run-In Phase (2 Weeks)||32||
59938756|NCT02810964|76057231|FG001|COMPLETED|Placebo Run-In Phase (2 Weeks)||32||
59938757|NCT02810964|76057230|FG000|NOT COMPLETED|Placebo Run-In Phase (2 Weeks)||0||
59938758|NCT02810964|76057231|FG001|NOT COMPLETED|Placebo Run-In Phase (2 Weeks)||0||
59938759|NCT02810964|76057230|FG000|STARTED|Double-Blind Treatment Phase (16 Weeks)||32||
59938760|NCT02810964|76057231|FG001|STARTED|Double-Blind Treatment Phase (16 Weeks)||32||
59938761|NCT02810964|76057230|FG000|COMPLETED|Double-Blind Treatment Phase (16 Weeks)||29||
59938762|NCT02810964|76057231|FG001|COMPLETED|Double-Blind Treatment Phase (16 Weeks)||29||
59938763|NCT02810964|76057230|FG000|NOT COMPLETED|Double-Blind Treatment Phase (16 Weeks)||3||
59938764|NCT02810964|76057231|FG001|NOT COMPLETED|Double-Blind Treatment Phase (16 Weeks)||3||
59938765|NCT03103763|76057240|FG000|STARTED|Overall Study||44||
59938766|NCT03103763|76057241|FG001|STARTED|Overall Study||44||
59938767|NCT03103763|76057242|FG002|STARTED|Overall Study||44||
59938768|NCT03103763|76057240|FG000|COMPLETED|Overall Study||29||
59938769|NCT03103763|76057241|FG001|COMPLETED|Overall Study||36||
59938770|NCT03103763|76057242|FG002|COMPLETED|Overall Study||37||
59938771|NCT03103763|76057240|FG000|NOT COMPLETED|Overall Study||15||
59938772|NCT03103763|76057241|FG001|NOT COMPLETED|Overall Study||8||
59938773|NCT03103763|76057242|FG002|NOT COMPLETED|Overall Study||7||
59938774|NCT04011475|76057253|FG000|STARTED|Overall Study||239||
59938775|NCT04011475|76057254|FG001|STARTED|Overall Study||937||
59938776|NCT04011475|76057255|FG002|STARTED|Overall Study||441||
59938777|NCT04011475|76057253|FG000|Propensity Score Matched Cohort|Overall Study||114|Eligible patients matching via propensity score to balance the baseline characteristics between study groups.|
59938778|NCT04011475|76057254|FG001|Propensity Score Matched Cohort|Overall Study||114|Eligible patients matching via propensity score to balance the baseline characteristics between study groups.|
59938779|NCT04011475|76057255|FG002|Propensity Score Matched Cohort|Overall Study||114|Eligible patients matching via propensity score to balance the baseline characteristics between study groups.|
59938780|NCT04011475|76057253|FG000|COMPLETED|Overall Study||239||
59938781|NCT04011475|76057254|FG001|COMPLETED|Overall Study||937||
59938782|NCT04011475|76057255|FG002|COMPLETED|Overall Study||441||
59938783|NCT04011475|76057253|FG000|NOT COMPLETED|Overall Study||0||
59938784|NCT04011475|76057254|FG001|NOT COMPLETED|Overall Study||0||
59938785|NCT04011475|76057255|FG002|NOT COMPLETED|Overall Study||0||
59938786|NCT03101267|76057266|FG000|STARTED|Primary Study Period||50||
59938787|NCT03101267|76057267|FG001|STARTED|Primary Study Period||50||
59938788|NCT03101267|76057268|FG002|STARTED|Primary Study Period||50||
59938789|NCT03101267|76057266|FG000|COMPLETED|Primary Study Period||47||
59938790|NCT03101267|76057267|FG001|COMPLETED|Primary Study Period||48||
59938791|NCT03101267|76057268|FG002|COMPLETED|Primary Study Period||47||
59938792|NCT03101267|76057266|FG000|NOT COMPLETED|Primary Study Period||3||
59519058|NCT01116895|75612922|FG000|COMPLETED|Overall Study||12||
59938793|NCT03101267|76057267|FG001|NOT COMPLETED|Primary Study Period||2||
59938794|NCT03101267|76057268|FG002|NOT COMPLETED|Primary Study Period||3||
59938795|NCT03101267|76057266|FG000|STARTED|Pollinosis Symptoms Survey Period||47||
59938796|NCT03101267|76057267|FG001|STARTED|Pollinosis Symptoms Survey Period||48||
59938797|NCT03101267|76057268|FG002|STARTED|Pollinosis Symptoms Survey Period||47||
59938798|NCT03101267|76057266|FG000|COMPLETED|Pollinosis Symptoms Survey Period||47||
59938799|NCT03101267|76057267|FG001|COMPLETED|Pollinosis Symptoms Survey Period||48||
59938800|NCT03101267|76057268|FG002|COMPLETED|Pollinosis Symptoms Survey Period||47||
59938801|NCT03101267|76057266|FG000|NOT COMPLETED|Pollinosis Symptoms Survey Period||0||
59938802|NCT03101267|76057267|FG001|NOT COMPLETED|Pollinosis Symptoms Survey Period||0||
59938803|NCT03101267|76057268|FG002|NOT COMPLETED|Pollinosis Symptoms Survey Period||0||
59938804|NCT02810418|76057283|FG000|STARTED|Arm A Dose Escalation||6||
59938805|NCT02810418|76057284|FG001|STARTED|Arm A Dose Escalation||8||
59938806|NCT02810418|76057285|FG002|STARTED|Arm A Dose Escalation||0||
59938807|NCT02810418|76057286|FG003|STARTED|Arm A Dose Escalation||0||
59938808|NCT02810418|76057287|FG004|STARTED|Arm A Dose Escalation||0||
59938809|NCT02810418|76057288|FG005|STARTED|Arm A Dose Escalation||0||
59938810|NCT02810418|76057289|FG006|STARTED|Arm A Dose Escalation||0||
59938811|NCT02810418|76057283|FG000|COMPLETED|Arm A Dose Escalation||4||
59938812|NCT02810418|76057284|FG001|COMPLETED|Arm A Dose Escalation||7||
59938813|NCT02810418|76057285|FG002|COMPLETED|Arm A Dose Escalation||0||
59938814|NCT02810418|76057286|FG003|COMPLETED|Arm A Dose Escalation||0||
59938815|NCT02810418|76057287|FG004|COMPLETED|Arm A Dose Escalation||0||
59938816|NCT02810418|76057288|FG005|COMPLETED|Arm A Dose Escalation||0||
59938817|NCT02810418|76057289|FG006|COMPLETED|Arm A Dose Escalation||0||
59938818|NCT02810418|76057283|FG000|NOT COMPLETED|Arm A Dose Escalation||2||
59938819|NCT02810418|76057284|FG001|NOT COMPLETED|Arm A Dose Escalation||1||
59938820|NCT02810418|76057285|FG002|NOT COMPLETED|Arm A Dose Escalation||0||
59938821|NCT02810418|76057286|FG003|NOT COMPLETED|Arm A Dose Escalation||0||
59938822|NCT02810418|76057287|FG004|NOT COMPLETED|Arm A Dose Escalation||0||
59938823|NCT02810418|76057288|FG005|NOT COMPLETED|Arm A Dose Escalation||0||
59938824|NCT02810418|76057289|FG006|NOT COMPLETED|Arm A Dose Escalation||0||
59938825|NCT02810418|76057283|FG000|STARTED|Dose Expansion||0||
59938826|NCT02810418|76057284|FG001|STARTED|Dose Expansion||8||
59938827|NCT02810418|76057285|FG002|STARTED|Dose Expansion||6||
59938828|NCT02810418|76057286|FG003|STARTED|Dose Expansion||0||
59938829|NCT02810418|76057287|FG004|STARTED|Dose Expansion||0||
59938830|NCT02810418|76057288|FG005|STARTED|Dose Expansion||0||
59938831|NCT02810418|76057289|FG006|STARTED|Dose Expansion||0||
59938832|NCT02810418|76057283|FG000|COMPLETED|Dose Expansion||0||
59938833|NCT02810418|76057284|FG001|COMPLETED|Dose Expansion||7||
59938834|NCT02810418|76057285|FG002|COMPLETED|Dose Expansion||3||
59938835|NCT02810418|76057286|FG003|COMPLETED|Dose Expansion||0||
59938836|NCT02810418|76057287|FG004|COMPLETED|Dose Expansion||0||
59938837|NCT02810418|76057288|FG005|COMPLETED|Dose Expansion||0||
59938838|NCT02810418|76057289|FG006|COMPLETED|Dose Expansion||0||
59938839|NCT02810418|76057283|FG000|NOT COMPLETED|Dose Expansion||0||
59938840|NCT02810418|76057284|FG001|NOT COMPLETED|Dose Expansion||1||
59938841|NCT02810418|76057285|FG002|NOT COMPLETED|Dose Expansion||3||
59938842|NCT02810418|76057286|FG003|NOT COMPLETED|Dose Expansion||0||
59938843|NCT02810418|76057287|FG004|NOT COMPLETED|Dose Expansion||0||
59938844|NCT02810418|76057288|FG005|NOT COMPLETED|Dose Expansion||0||
59938845|NCT02810418|76057289|FG006|NOT COMPLETED|Dose Expansion||0||
59938846|NCT02810418|76057283|FG000|STARTED|Arm B Dose Escalation||0||
59938847|NCT02810418|76057284|FG001|STARTED|Arm B Dose Escalation||0||
59938848|NCT02810418|76057285|FG002|STARTED|Arm B Dose Escalation||0||
59938849|NCT02810418|76057286|FG003|STARTED|Arm B Dose Escalation||6||
59938850|NCT02810418|76057287|FG004|STARTED|Arm B Dose Escalation||3||
59938851|NCT02810418|76057288|FG005|STARTED|Arm B Dose Escalation||6||
59938852|NCT02810418|76057289|FG006|STARTED|Arm B Dose Escalation||0||
59938853|NCT02810418|76057283|FG000|COMPLETED|Arm B Dose Escalation||0||
59938854|NCT02810418|76057284|FG001|COMPLETED|Arm B Dose Escalation||0||
59938855|NCT02810418|76057285|FG002|COMPLETED|Arm B Dose Escalation||0||
59938856|NCT02810418|76057286|FG003|COMPLETED|Arm B Dose Escalation||6||
59519059|NCT01116895|75612923|FG001|COMPLETED|Overall Study||8||
59938857|NCT02810418|76057287|FG004|COMPLETED|Arm B Dose Escalation||2||
59938858|NCT02810418|76057288|FG005|COMPLETED|Arm B Dose Escalation||4||
59938859|NCT02810418|76057289|FG006|COMPLETED|Arm B Dose Escalation||0||
59938860|NCT02810418|76057283|FG000|NOT COMPLETED|Arm B Dose Escalation||0||
59938861|NCT02810418|76057284|FG001|NOT COMPLETED|Arm B Dose Escalation||0||
59938862|NCT02810418|76057285|FG002|NOT COMPLETED|Arm B Dose Escalation||0||
59938863|NCT02810418|76057286|FG003|NOT COMPLETED|Arm B Dose Escalation||0||
59938864|NCT02810418|76057287|FG004|NOT COMPLETED|Arm B Dose Escalation||1||
59938865|NCT02810418|76057288|FG005|NOT COMPLETED|Arm B Dose Escalation||2||
59938866|NCT02810418|76057289|FG006|NOT COMPLETED|Arm B Dose Escalation||0||
59938867|NCT02810418|76057283|FG000|STARTED|Arm B Combination Therapy||0||
59938868|NCT02810418|76057284|FG001|STARTED|Arm B Combination Therapy||0||
59938869|NCT02810418|76057285|FG002|STARTED|Arm B Combination Therapy||0||
59938870|NCT02810418|76057286|FG003|STARTED|Arm B Combination Therapy||0||
59938871|NCT02810418|76057287|FG004|STARTED|Arm B Combination Therapy||0||
59938872|NCT02810418|76057288|FG005|STARTED|Arm B Combination Therapy||0||
59938873|NCT02810418|76057289|FG006|STARTED|Arm B Combination Therapy||5||
59938874|NCT02810418|76057283|FG000|COMPLETED|Arm B Combination Therapy||0||
59938875|NCT02810418|76057284|FG001|COMPLETED|Arm B Combination Therapy||0||
59938876|NCT02810418|76057285|FG002|COMPLETED|Arm B Combination Therapy||0||
59938877|NCT02810418|76057286|FG003|COMPLETED|Arm B Combination Therapy||0||
59938878|NCT02810418|76057287|FG004|COMPLETED|Arm B Combination Therapy||0||
59938879|NCT02810418|76057288|FG005|COMPLETED|Arm B Combination Therapy||0||
59938880|NCT02810418|76057289|FG006|COMPLETED|Arm B Combination Therapy||5||
59938881|NCT02810418|76057283|FG000|NOT COMPLETED|Arm B Combination Therapy||0||
59938882|NCT02810418|76057284|FG001|NOT COMPLETED|Arm B Combination Therapy||0||
59938883|NCT02810418|76057285|FG002|NOT COMPLETED|Arm B Combination Therapy||0||
59938884|NCT02810418|76057286|FG003|NOT COMPLETED|Arm B Combination Therapy||0||
59938885|NCT02810418|76057287|FG004|NOT COMPLETED|Arm B Combination Therapy||0||
59938886|NCT02810418|76057288|FG005|NOT COMPLETED|Arm B Combination Therapy||0||
59938887|NCT02810418|76057289|FG006|NOT COMPLETED|Arm B Combination Therapy||0||
59938888|NCT02810340|76057355|FG000|STARTED|Overall Study||20||
59761968|NCT03652909|75881636|FG000|STARTED|Overall Study||32||
59761969|NCT03652909|75881636|FG000|COMPLETED|Overall Study||32||
59761970|NCT03652909|75881636|FG000|NOT COMPLETED|Overall Study||0||
59761971|NCT00581308|75881641|FG000|STARTED|Pre Discharge||215||
59761972|NCT00581308|75881641|FG000|COMPLETED|Pre Discharge||213||
59761973|NCT00581308|75881641|FG000|NOT COMPLETED|Pre Discharge||2||
59938889|NCT02810340|76057356|FG001|STARTED|Overall Study||20||
59938890|NCT02810340|76057357|FG002|STARTED|Overall Study||20||
59938891|NCT02810340|76057355|FG000|COMPLETED|Overall Study||19||
59938892|NCT02810340|76057356|FG001|COMPLETED|Overall Study||19||
59938893|NCT02810340|76057357|FG002|COMPLETED|Overall Study||19||
59938894|NCT02810340|76057355|FG000|NOT COMPLETED|Overall Study||1||
59938895|NCT02810340|76057356|FG001|NOT COMPLETED|Overall Study||1||
59938896|NCT02810340|76057357|FG002|NOT COMPLETED|Overall Study||1||
59938897|NCT02817516|76057369|FG000|STARTED|Overall Study||6||
59938898|NCT02817516|76057370|FG001|STARTED|Overall Study||6||
59938899|NCT02817516|76057371|FG002|STARTED|Overall Study||6||
59938900|NCT02817516|76057372|FG003|STARTED|Overall Study||6||
59938901|NCT02817516|76057369|FG000|COMPLETED|Overall Study||6||
59938902|NCT02817516|76057370|FG001|COMPLETED|Overall Study||6||
59938903|NCT02817516|76057371|FG002|COMPLETED|Overall Study||5||
59938904|NCT02817516|76057372|FG003|COMPLETED|Overall Study||6||
59938905|NCT02817516|76057369|FG000|NOT COMPLETED|Overall Study||0||
59938906|NCT02817516|76057370|FG001|NOT COMPLETED|Overall Study||0||
59938907|NCT02817516|76057371|FG002|NOT COMPLETED|Overall Study||1||
59938908|NCT02817516|76057372|FG003|NOT COMPLETED|Overall Study||0||
59938909|NCT02928029|76057387|FG000|STARTED|Overall Study||3||
59938910|NCT02928029|76057388|FG001|STARTED|Overall Study||4||
59938911|NCT02928029|76057387|FG000|COMPLETED|Overall Study||0||
59938912|NCT02928029|76057388|FG001|COMPLETED|Overall Study||0||
59938913|NCT02928029|76057387|FG000|NOT COMPLETED|Overall Study||3||
59938914|NCT02928029|76057388|FG001|NOT COMPLETED|Overall Study||4||
59938915|NCT02806986|76057394|FG000|STARTED|Treatment Stage 1||61||
59938916|NCT02806986|76057394|FG000|COMPLETED|Treatment Stage 1||60||
59938917|NCT02806986|76057394|FG000|NOT COMPLETED|Treatment Stage 1||1||
59938918|NCT02806986|76057394|FG000|STARTED|Treatment Stage 2||60||
59938919|NCT02806986|76057394|FG000|COMPLETED|Treatment Stage 2||55||
59938920|NCT02806986|76057394|FG000|NOT COMPLETED|Treatment Stage 2||5||
59938921|NCT03095651|76057410|FG000|STARTED|Overall Study||6||
59938922|NCT03095651|76057411|FG001|STARTED|Overall Study||6||
59938923|NCT03095651|76057412|FG002|STARTED|Overall Study||0||
59938924|NCT03095651|76057413|FG003|STARTED|Overall Study||4||
59938925|NCT03095651|76057414|FG004|STARTED|Overall Study||0||
59938926|NCT03095651|76057415|FG005|STARTED|Overall Study||7||
59938927|NCT03095651|76057416|FG006|STARTED|Overall Study||6||
59938928|NCT03095651|76057417|FG007|STARTED|Overall Study||4||
59938929|NCT03095651|76057410|FG000|COMPLETED|Overall Study||5||
59938930|NCT03095651|76057411|FG001|COMPLETED|Overall Study||5||
59938931|NCT03095651|76057412|FG002|COMPLETED|Overall Study||0||
59938932|NCT03095651|76057413|FG003|COMPLETED|Overall Study||3||
59938933|NCT03095651|76057414|FG004|COMPLETED|Overall Study||0||
59938934|NCT03095651|76057415|FG005|COMPLETED|Overall Study||6||
59938935|NCT03095651|76057416|FG006|COMPLETED|Overall Study||6||
59938936|NCT03095651|76057417|FG007|COMPLETED|Overall Study||4||
59938937|NCT03095651|76057410|FG000|NOT COMPLETED|Overall Study||1||
59938938|NCT03095651|76057411|FG001|NOT COMPLETED|Overall Study||1||
59938939|NCT03095651|76057412|FG002|NOT COMPLETED|Overall Study||0||
59938940|NCT03095651|76057413|FG003|NOT COMPLETED|Overall Study||1||
59938941|NCT03095651|76057414|FG004|NOT COMPLETED|Overall Study||0||
59938942|NCT03095651|76057415|FG005|NOT COMPLETED|Overall Study||1||
59938943|NCT03095651|76057416|FG006|NOT COMPLETED|Overall Study||0||
59938944|NCT03095651|76057417|FG007|NOT COMPLETED|Overall Study||0||
59938945|NCT02808312|76057440|FG000|STARTED|Overall Study||10||
59938946|NCT02808312|76057441|FG001|STARTED|Overall Study||10||
59938947|NCT02808312|76057442|FG002|STARTED|Overall Study||17||
59938948|NCT02808312|76057443|FG003|STARTED|Overall Study||10||
59938949|NCT02808312|76057444|FG004|STARTED|Overall Study||10||
59938950|NCT02808312|76057440|FG000|COMPLETED|Overall Study||10||
59938951|NCT02808312|76057441|FG001|COMPLETED|Overall Study||10||
59938952|NCT02808312|76057442|FG002|COMPLETED|Overall Study||16||
59938953|NCT02808312|76057443|FG003|COMPLETED|Overall Study||10||
59938954|NCT02808312|76057444|FG004|COMPLETED|Overall Study||10||
59938955|NCT02808312|76057440|FG000|NOT COMPLETED|Overall Study||0||
59938956|NCT02808312|76057441|FG001|NOT COMPLETED|Overall Study||0||
59938957|NCT02808312|76057442|FG002|NOT COMPLETED|Overall Study||1||
59938958|NCT02808312|76057443|FG003|NOT COMPLETED|Overall Study||0||
59938959|NCT02808312|76057444|FG004|NOT COMPLETED|Overall Study||0||
59938960|NCT03099161|76057464|FG000|STARTED|Overall Study||3||
59938961|NCT03099161|76057465|FG001|STARTED|Overall Study||4||
59938962|NCT03099161|76057466|FG002|STARTED|Overall Study||3||
59938963|NCT03099161|76057464|FG000|COMPLETED|Overall Study||0||
59938964|NCT03099161|76057465|FG001|COMPLETED|Overall Study||0||
59938965|NCT03099161|76057466|FG002|COMPLETED|Overall Study||0||
59938966|NCT03099161|76057464|FG000|NOT COMPLETED|Overall Study||3||
59938967|NCT03099161|76057465|FG001|NOT COMPLETED|Overall Study||4||
59938968|NCT03099161|76057466|FG002|NOT COMPLETED|Overall Study||3||
59938969|NCT03095027|76057474|FG000|STARTED|Period 1, First Week of Wear||27|As Treated; 1 subject randomized to stenfilcon A/FID122819 exposed to FID122819/stenfilcon A instead|
59938970|NCT03095027|76057475|FG001|STARTED|Period 1, First Week of Wear||24|As Treated; 1 subject randomized to stenfilcon A/FID122819 exposed to FID122819/stenfilcon A instead|
59938971|NCT03095027|76057474|FG000|COMPLETED|Period 1, First Week of Wear||27||
59938972|NCT03095027|76057475|FG001|COMPLETED|Period 1, First Week of Wear||24||
59938973|NCT03095027|76057474|FG000|NOT COMPLETED|Period 1, First Week of Wear||0||
59938974|NCT03095027|76057475|FG001|NOT COMPLETED|Period 1, First Week of Wear||0||
59938975|NCT03095027|76057474|FG000|STARTED|Period 2, Second Week of Wear||27||
59938976|NCT03095027|76057475|FG001|STARTED|Period 2, Second Week of Wear||24||
59938977|NCT03095027|76057474|FG000|COMPLETED|Period 2, Second Week of Wear||26||
59938978|NCT03095027|76057475|FG001|COMPLETED|Period 2, Second Week of Wear||24||
59938979|NCT03095027|76057474|FG000|NOT COMPLETED|Period 2, Second Week of Wear||1||
59938980|NCT03095027|76057475|FG001|NOT COMPLETED|Period 2, Second Week of Wear||0||
59938981|NCT04227197|76057483|FG000|STARTED|Randomization||117||
59938982|NCT04227197|76057484|FG001|STARTED|Randomization||113||
59938983|NCT04227197|76057483|FG000|COMPLETED|Randomization||115||
59938984|NCT04227197|76057484|FG001|COMPLETED|Randomization||113||
59938985|NCT04227197|76057483|FG000|NOT COMPLETED|Randomization||2||
59938986|NCT04227197|76057484|FG001|NOT COMPLETED|Randomization||0||
59938987|NCT04227197|76057483|FG000|STARTED|Primary Care Provider (PCP) Visit||115||
59938988|NCT04227197|76057484|FG001|STARTED|Primary Care Provider (PCP) Visit||113||
59938989|NCT04227197|76057483|FG000|COMPLETED|Primary Care Provider (PCP) Visit||113||
59938990|NCT04227197|76057484|FG001|COMPLETED|Primary Care Provider (PCP) Visit||113||
59518502|NCT03380026|75612296|FG000|Half of Body Assigned to Treatment With Valchlor Only|Overall Study||28|Side of body from each patient assigned to treatment with Valchlor only, assigned randomly at enrollment.|
59518503|NCT03380026|75612296|FG000|Half of Body Assigned to Treatment With Valchlor and Triamcinolone Acetonide|Overall Study||28|Side of body from each patient assigned to treatment with both Valchlor and Triamcinolone, assigned randomly at enrollment.|
59518504|NCT03380026|75612296|FG000|COMPLETED|Overall Study||25||
59518505|NCT03380026|75612296|FG000|NOT COMPLETED|Overall Study||3||
59518506|NCT03380572|75612305|FG000|STARTED|Overall Study||20||
59518507|NCT03380572|75612306|FG001|STARTED|Overall Study||20||
59518508|NCT03380572|75612305|FG000|COMPLETED|Overall Study||20||
59518509|NCT03380572|75612306|FG001|COMPLETED|Overall Study||20||
59518510|NCT03380572|75612305|FG000|NOT COMPLETED|Overall Study||0||
59518511|NCT03380572|75612306|FG001|NOT COMPLETED|Overall Study||0||
59518512|NCT01079143|75612316|FG000|STARTED|Overall Study||36||
59518513|NCT01079143|75612317|FG001|STARTED|Overall Study||60||
59518514|NCT01079143|75612318|FG002|STARTED|Overall Study||39||
59518515|NCT01079143|75612319|FG003|STARTED|Overall Study||59||
59518516|NCT01079143|75612316|FG000|Exposed|Overall Study||36||
59518517|NCT01079143|75612317|FG001|Exposed|Overall Study||60||
59518518|NCT01079143|75612318|FG002|Exposed|Overall Study||39||
59518519|NCT01079143|75612319|FG003|Exposed|Overall Study||59||
59518520|NCT01079143|75612316|FG000|Month 3 (M3) Biopsies|Overall Study||36||
59518521|NCT01079143|75612317|FG001|Month 3 (M3) Biopsies|Overall Study|1 patient was excluded due to an IF/TA Grade of III at the M3 Biopsy|59||
59518522|NCT01079143|75612318|FG002|Month 3 (M3) Biopsies|Overall Study||39||
59518523|NCT01079143|75612319|FG003|Month 3 (M3) Biopsies|Overall Study||59||
59938991|NCT04227197|76057483|FG000|NOT COMPLETED|Primary Care Provider (PCP) Visit||2||
59938992|NCT04227197|76057484|FG001|NOT COMPLETED|Primary Care Provider (PCP) Visit||0||
59938993|NCT04227197|76057483|FG000|STARTED|2-week Follow-up Survey for Caregivers||113||
59938994|NCT04227197|76057484|FG001|STARTED|2-week Follow-up Survey for Caregivers||113||
59938995|NCT04227197|76057483|FG000|COMPLETED|2-week Follow-up Survey for Caregivers||101||
59938996|NCT04227197|76057484|FG001|COMPLETED|2-week Follow-up Survey for Caregivers||108||
59938997|NCT04227197|76057483|FG000|NOT COMPLETED|2-week Follow-up Survey for Caregivers||12||
59938998|NCT04227197|76057484|FG001|NOT COMPLETED|2-week Follow-up Survey for Caregivers||5||
59938999|NCT04227197|76057483|FG000|STARTED|2-week Follow-up Survey for PCP's||114||
59939000|NCT04227197|76057484|FG001|STARTED|2-week Follow-up Survey for PCP's||113||
59939001|NCT04227197|76057483|FG000|COMPLETED|2-week Follow-up Survey for PCP's||94||
59939002|NCT04227197|76057484|FG001|COMPLETED|2-week Follow-up Survey for PCP's||88||
59939003|NCT04227197|76057483|FG000|NOT COMPLETED|2-week Follow-up Survey for PCP's||20||
59939004|NCT04227197|76057484|FG001|NOT COMPLETED|2-week Follow-up Survey for PCP's||25||
59939005|NCT04227197|76057483|FG000|STARTED|7-month Follow-up Survey for Caregivers||114||
59939006|NCT04227197|76057484|FG001|STARTED|7-month Follow-up Survey for Caregivers||113||
59939007|NCT04227197|76057483|FG000|COMPLETED|7-month Follow-up Survey for Caregivers||103||
59939008|NCT04227197|76057484|FG001|COMPLETED|7-month Follow-up Survey for Caregivers||110||
59939009|NCT04227197|76057483|FG000|NOT COMPLETED|7-month Follow-up Survey for Caregivers||11||
59939010|NCT04227197|76057484|FG001|NOT COMPLETED|7-month Follow-up Survey for Caregivers||3||
59939011|NCT03080935|76057495|FG000|STARTED|Overall Study||745||
59939012|NCT03080935|76057496|FG001|STARTED|Overall Study||855||
59939013|NCT03080935|76057495|FG000|COMPLETED|Overall Study||695||
59939014|NCT03080935|76057496|FG001|COMPLETED|Overall Study||786||
59939015|NCT03080935|76057495|FG000|NOT COMPLETED|Overall Study||50||
59939016|NCT03080935|76057496|FG001|NOT COMPLETED|Overall Study||69||
59939017|NCT04434131|76057502|FG000|STARTED|Overall Study||12||
59939018|NCT04434131|76057502|FG000|COMPLETED|Overall Study||12||
59939019|NCT04434131|76057502|FG000|NOT COMPLETED|Overall Study||0||
59939020|NCT02921789|76057508|FG000|STARTED|Overall Study||34||
59939021|NCT02921789|76057509|FG001|STARTED|Overall Study||29||
59939022|NCT02921789|76057508|FG000|Randomized and Took Study Drug|Overall Study||34||
59939023|NCT02921789|76057509|FG001|Randomized and Took Study Drug|Overall Study||29||
59939024|NCT02921789|76057508|FG000|COMPLETED|Overall Study||26||
59939025|NCT02921789|76057509|FG001|COMPLETED|Overall Study||25||
59939026|NCT02921789|76057508|FG000|NOT COMPLETED|Overall Study||8||
59939027|NCT02921789|76057509|FG001|NOT COMPLETED|Overall Study||4||
59939028|NCT03943823|76057517|FG000|STARTED|Overall Study||2||
59939029|NCT03943823|76057518|FG001|STARTED|Overall Study||2||
59939030|NCT03943823|76057517|FG000|COMPLETED|Overall Study||1||
59939031|NCT03943823|76057518|FG001|COMPLETED|Overall Study||2||
59939032|NCT03943823|76057517|FG000|NOT COMPLETED|Overall Study||1||
59939033|NCT03943823|76057518|FG001|NOT COMPLETED|Overall Study||0||
59939034|NCT03097289|76057524|FG000|STARTED|Overall Study||32||
59939035|NCT03097289|76057524|FG000|COMPLETED|Overall Study||26||
59939036|NCT03097289|76057524|FG000|NOT COMPLETED|Overall Study||6||
59939037|NCT02419742|76057531|FG000|STARTED|Overall Study||58||
59939038|NCT02419742|76057532|FG001|STARTED|Overall Study||52||
59939039|NCT02419742|76057531|FG000|COMPLETED|Overall Study||53||
59939040|NCT02419742|76057532|FG001|COMPLETED|Overall Study||50||
59939041|NCT02419742|76057531|FG000|NOT COMPLETED|Overall Study||5||
59939042|NCT02419742|76057532|FG001|NOT COMPLETED|Overall Study||2||
59939043|NCT02409290|76057542|FG000|STARTED|Overall Study||32||
59939044|NCT02409290|76057543|FG001|STARTED|Overall Study||202||
59939045|NCT02409290|76057544|FG002|STARTED|Overall Study||211||
59939046|NCT02409290|76057545|FG003|STARTED|Overall Study||143||
59939047|NCT02409290|76057542|FG000|COMPLETED|Overall Study||0||
59939048|NCT02409290|76057543|FG001|COMPLETED|Overall Study||187||
59939049|NCT02409290|76057544|FG002|COMPLETED|Overall Study||196||
59939050|NCT02409290|76057545|FG003|COMPLETED|Overall Study||134||
59939051|NCT02409290|76057542|FG000|NOT COMPLETED|Overall Study||32||
59939052|NCT02409290|76057543|FG001|NOT COMPLETED|Overall Study||15||
59939053|NCT02409290|76057544|FG002|NOT COMPLETED|Overall Study||15||
59939054|NCT02409290|76057545|FG003|NOT COMPLETED|Overall Study||9||
59939055|NCT02898077|76057557|FG000|STARTED|Overall Study||294||
59939056|NCT02898077|76057558|FG001|STARTED|Overall Study||146||
59939057|NCT02898077|76057557|FG000|Received at Least 1 Dose of Study Drug|Overall Study||293||
59939058|NCT02898077|76057558|FG001|Received at Least 1 Dose of Study Drug|Overall Study||145||
59939059|NCT02898077|76057557|FG000|COMPLETED|Overall Study||246||
59939060|NCT02898077|76057558|FG001|COMPLETED|Overall Study||123||
59939061|NCT02898077|76057557|FG000|NOT COMPLETED|Overall Study||48||
59939062|NCT02898077|76057558|FG001|NOT COMPLETED|Overall Study||23||
59939063|NCT03097133|76057566|FG000|STARTED|Overall Study||115||
59939064|NCT03097133|76057567|FG001|STARTED|Overall Study||115||
59761974|NCT00581308|75881641|FG000|STARTED|Month 1||213||
59761975|NCT00581308|75881641|FG000|COMPLETED|Month 1||205||
59761976|NCT00581308|75881641|FG000|NOT COMPLETED|Month 1||8||
59761977|NCT00581308|75881641|FG000|STARTED|Month 6||205||
59761978|NCT00581308|75881641|FG000|COMPLETED|Month 6||202||
59939065|NCT03097133|76057566|FG000|Treated|Overall Study||113||
59939066|NCT03097133|76057567|FG001|Treated|Overall Study||114||
59939067|NCT03097133|76057566|FG000|COMPLETED|Overall Study||85||
59939068|NCT03097133|76057567|FG001|COMPLETED|Overall Study||81||
59939069|NCT03097133|76057566|FG000|NOT COMPLETED|Overall Study||30||
59939070|NCT03097133|76057567|FG001|NOT COMPLETED|Overall Study||34||
59939071|NCT03889639|76057581|FG000|STARTED|Overall Study||16||
59939072|NCT03889639|76057582|FG001|STARTED|Overall Study||16||
59939073|NCT03889639|76057583|FG002|STARTED|Overall Study||16||
59939074|NCT03889639|76057584|FG003|STARTED|Overall Study||16||
59761979|NCT00581308|75881641|FG000|NOT COMPLETED|Month 6||3||
59939075|NCT03889639|76057585|FG004|STARTED|Overall Study||17||
59939076|NCT03889639|76057586|FG005|STARTED|Overall Study||16||
59939077|NCT03889639|76057587|FG006|STARTED|Overall Study||17||
59939078|NCT03889639|76057588|FG007|STARTED|Overall Study||16||
59939079|NCT03889639|76057581|FG000|COMPLETED|Overall Study||16||
59939080|NCT03889639|76057582|FG001|COMPLETED|Overall Study||16||
59939081|NCT03889639|76057583|FG002|COMPLETED|Overall Study||16||
59761980|NCT00581308|75881641|FG000|STARTED|Month 12||202||
59761981|NCT00581308|75881641|FG000|COMPLETED|Month 12||182||
59761982|NCT00581308|75881641|FG000|NOT COMPLETED|Month 12||20||
59761983|NCT00581308|75881641|FG000|STARTED|24 Months||182||
59939082|NCT03889639|76057584|FG003|COMPLETED|Overall Study||16||
59939083|NCT03889639|76057585|FG004|COMPLETED|Overall Study||17||
59939084|NCT03889639|76057586|FG005|COMPLETED|Overall Study||16||
59939085|NCT03889639|76057587|FG006|COMPLETED|Overall Study||17||
59939086|NCT03889639|76057588|FG007|COMPLETED|Overall Study||15||
59939087|NCT03889639|76057581|FG000|NOT COMPLETED|Overall Study||0||
59939088|NCT03889639|76057582|FG001|NOT COMPLETED|Overall Study||0||
59939089|NCT03889639|76057583|FG002|NOT COMPLETED|Overall Study||0||
59939090|NCT03889639|76057584|FG003|NOT COMPLETED|Overall Study||0||
59939091|NCT03889639|76057585|FG004|NOT COMPLETED|Overall Study||0||
59939092|NCT03889639|76057586|FG005|NOT COMPLETED|Overall Study||0||
59939093|NCT03889639|76057587|FG006|NOT COMPLETED|Overall Study||0||
59939094|NCT03889639|76057588|FG007|NOT COMPLETED|Overall Study||1||
59939095|NCT03265145|76057611|FG000|STARTED|Overall Study||356||
59939096|NCT03265145|76057612|FG001|STARTED|Overall Study||358||
59939097|NCT03265145|76057611|FG000|COMPLETED|Overall Study||285|12 Month Study Observation Period|
59939098|NCT03265145|76057612|FG001|COMPLETED|Overall Study||302|12 Month Study Observation Period|
59939099|NCT03265145|76057611|FG000|NOT COMPLETED|Overall Study||71||
59939100|NCT03265145|76057612|FG001|NOT COMPLETED|Overall Study||56||
59939101|NCT05779397|76057619|FG000|STARTED|Overall Study||68||
59939102|NCT05779397|76057619|FG000|COMPLETED|Overall Study||68||
59939103|NCT05779397|76057619|FG000|NOT COMPLETED|Overall Study||0||
59939104|NCT05674344|76057623|FG000|STARTED|Overall Study||170||
59939105|NCT05674344|76057623|FG000|COMPLETED|Overall Study||146||
59939106|NCT05674344|76057623|FG000|NOT COMPLETED|Overall Study||24||
59939107|NCT05502081|76057630|FG000|STARTED|Overall Study||53||
59939108|NCT05502081|76057631|FG001|STARTED|Overall Study||106||
59939109|NCT05502081|76057632|FG002|STARTED|Overall Study||106||
59939110|NCT05502081|76057630|FG000|COMPLETED|Overall Study||53||
59939111|NCT05502081|76057631|FG001|COMPLETED|Overall Study||106||
59939112|NCT05502081|76057632|FG002|COMPLETED|Overall Study||106||
59939113|NCT05502081|76057630|FG000|NOT COMPLETED|Overall Study||0||
59939114|NCT05502081|76057631|FG001|NOT COMPLETED|Overall Study||0||
59939115|NCT05502081|76057632|FG002|NOT COMPLETED|Overall Study||0||
59939116|NCT04970342|76057640|FG000|STARTED|Treatment Visit 1 (1 Day)||2||
59939117|NCT04970342|76057641|FG001|STARTED|Treatment Visit 1 (1 Day)||2||
59939118|NCT04970342|76057642|FG002|STARTED|Treatment Visit 1 (1 Day)||1||
59939119|NCT04970342|76057643|FG003|STARTED|Treatment Visit 1 (1 Day)||1||
59939120|NCT04970342|76057644|FG004|STARTED|Treatment Visit 1 (1 Day)||1||
59939121|NCT04970342|76057645|FG005|STARTED|Treatment Visit 1 (1 Day)||1||
59939122|NCT04970342|76057640|FG000|COMPLETED|Treatment Visit 1 (1 Day)||2||
59939123|NCT04970342|76057641|FG001|COMPLETED|Treatment Visit 1 (1 Day)||2||
59939124|NCT04970342|76057642|FG002|COMPLETED|Treatment Visit 1 (1 Day)||1||
59939125|NCT04970342|76057643|FG003|COMPLETED|Treatment Visit 1 (1 Day)||1||
59939126|NCT04970342|76057644|FG004|COMPLETED|Treatment Visit 1 (1 Day)||1||
59939127|NCT04970342|76057645|FG005|COMPLETED|Treatment Visit 1 (1 Day)||1||
59939128|NCT04970342|76057640|FG000|NOT COMPLETED|Treatment Visit 1 (1 Day)||0||
59939129|NCT04970342|76057641|FG001|NOT COMPLETED|Treatment Visit 1 (1 Day)||0||
59939130|NCT04970342|76057642|FG002|NOT COMPLETED|Treatment Visit 1 (1 Day)||0||
59939131|NCT04970342|76057643|FG003|NOT COMPLETED|Treatment Visit 1 (1 Day)||0||
59939132|NCT04970342|76057644|FG004|NOT COMPLETED|Treatment Visit 1 (1 Day)||0||
59939133|NCT04970342|76057645|FG005|NOT COMPLETED|Treatment Visit 1 (1 Day)||0||
59939134|NCT04970342|76057640|FG000|STARTED|Washout (7 Days)||2||
59939135|NCT04970342|76057641|FG001|STARTED|Washout (7 Days)||2||
59939136|NCT04970342|76057642|FG002|STARTED|Washout (7 Days)||1||
59939137|NCT04970342|76057643|FG003|STARTED|Washout (7 Days)||1||
59939138|NCT04970342|76057644|FG004|STARTED|Washout (7 Days)||1||
59939139|NCT04970342|76057645|FG005|STARTED|Washout (7 Days)||1||
59939140|NCT04970342|76057640|FG000|COMPLETED|Washout (7 Days)||2||
59939141|NCT04970342|76057641|FG001|COMPLETED|Washout (7 Days)||2||
60067434|NCT01924364|76182611|FG000|STARTED|Overall Study||7||
60067435|NCT01924364|76182611|FG000|COMPLETED|Overall Study||4||
59939142|NCT04970342|76057642|FG002|COMPLETED|Washout (7 Days)||1||
59939143|NCT04970342|76057643|FG003|COMPLETED|Washout (7 Days)||1||
60067436|NCT01924364|76182611|FG000|NOT COMPLETED|Overall Study||3||
60067437|NCT01987505|76182628|FG000|STARTED|Overall Study||140||
60067438|NCT01987505|76182628|FG000|COMPLETED|Overall Study||106||
59761984|NCT00581308|75881641|FG000|COMPLETED|24 Months||176||
59761985|NCT00581308|75881641|FG000|NOT COMPLETED|24 Months||6||
59939144|NCT04970342|76057644|FG004|COMPLETED|Washout (7 Days)||1||
59939145|NCT04970342|76057645|FG005|COMPLETED|Washout (7 Days)||1||
59939146|NCT04970342|76057640|FG000|NOT COMPLETED|Washout (7 Days)||0||
60067439|NCT01987505|76182628|FG000|NOT COMPLETED|Overall Study||34||
60067440|NCT01923896|76182636|FG000|STARTED|Overall Study||8||
59761986|NCT00581308|75881641|FG000|STARTED|36 Months||176||
59939147|NCT04970342|76057641|FG001|NOT COMPLETED|Washout (7 Days)||0||
59939148|NCT04970342|76057642|FG002|NOT COMPLETED|Washout (7 Days)||0||
60067441|NCT01923896|76182637|FG001|STARTED|Overall Study||8||
60067442|NCT01923896|76182636|FG000|COMPLETED|Overall Study||7||
59939149|NCT04970342|76057643|FG003|NOT COMPLETED|Washout (7 Days)||0||
59939150|NCT04970342|76057644|FG004|NOT COMPLETED|Washout (7 Days)||0||
59939151|NCT04970342|76057645|FG005|NOT COMPLETED|Washout (7 Days)||0||
59939152|NCT04970342|76057640|FG000|STARTED|Treatment Visit 2 (1 Day)||2||
59939153|NCT04970342|76057641|FG001|STARTED|Treatment Visit 2 (1 Day)||2||
59939154|NCT04970342|76057642|FG002|STARTED|Treatment Visit 2 (1 Day)||1||
59939155|NCT04970342|76057643|FG003|STARTED|Treatment Visit 2 (1 Day)||1||
59939156|NCT04970342|76057644|FG004|STARTED|Treatment Visit 2 (1 Day)||1||
59939157|NCT04970342|76057645|FG005|STARTED|Treatment Visit 2 (1 Day)||1||
59939158|NCT04970342|76057640|FG000|COMPLETED|Treatment Visit 2 (1 Day)||2||
59939159|NCT04970342|76057641|FG001|COMPLETED|Treatment Visit 2 (1 Day)||2||
59939160|NCT04970342|76057642|FG002|COMPLETED|Treatment Visit 2 (1 Day)||1||
59939161|NCT04970342|76057643|FG003|COMPLETED|Treatment Visit 2 (1 Day)||1||
59939162|NCT04970342|76057644|FG004|COMPLETED|Treatment Visit 2 (1 Day)||1||
59939163|NCT04970342|76057645|FG005|COMPLETED|Treatment Visit 2 (1 Day)||1||
59939164|NCT04970342|76057640|FG000|NOT COMPLETED|Treatment Visit 2 (1 Day)||0||
59939165|NCT04970342|76057641|FG001|NOT COMPLETED|Treatment Visit 2 (1 Day)||0||
59939166|NCT04970342|76057642|FG002|NOT COMPLETED|Treatment Visit 2 (1 Day)||0||
59939167|NCT04970342|76057643|FG003|NOT COMPLETED|Treatment Visit 2 (1 Day)||0||
59939168|NCT04970342|76057644|FG004|NOT COMPLETED|Treatment Visit 2 (1 Day)||0||
59939169|NCT04970342|76057645|FG005|NOT COMPLETED|Treatment Visit 2 (1 Day)||0||
59939170|NCT04970342|76057640|FG000|STARTED|Washout (7 Days)||2||
59939171|NCT04970342|76057641|FG001|STARTED|Washout (7 Days)||2||
59939172|NCT04970342|76057642|FG002|STARTED|Washout (7 Days)||1||
59939173|NCT04970342|76057643|FG003|STARTED|Washout (7 Days)||1||
59939174|NCT04970342|76057644|FG004|STARTED|Washout (7 Days)||1||
59939175|NCT04970342|76057645|FG005|STARTED|Washout (7 Days)||1||
59939176|NCT04970342|76057640|FG000|COMPLETED|Washout (7 Days)||2||
59939177|NCT04970342|76057641|FG001|COMPLETED|Washout (7 Days)||2||
59939178|NCT04970342|76057642|FG002|COMPLETED|Washout (7 Days)||1||
59939179|NCT04970342|76057643|FG003|COMPLETED|Washout (7 Days)||1||
59939180|NCT04970342|76057644|FG004|COMPLETED|Washout (7 Days)||1||
59939181|NCT04970342|76057645|FG005|COMPLETED|Washout (7 Days)||1||
59939182|NCT04970342|76057640|FG000|NOT COMPLETED|Washout (7 Days)||0||
59939183|NCT04970342|76057641|FG001|NOT COMPLETED|Washout (7 Days)||0||
59939184|NCT04970342|76057642|FG002|NOT COMPLETED|Washout (7 Days)||0||
59939185|NCT04970342|76057643|FG003|NOT COMPLETED|Washout (7 Days)||0||
59939186|NCT04970342|76057644|FG004|NOT COMPLETED|Washout (7 Days)||0||
59939187|NCT04970342|76057645|FG005|NOT COMPLETED|Washout (7 Days)||0||
59939188|NCT04970342|76057640|FG000|STARTED|Treatment Visit 3 (1 Day)||2||
59939189|NCT04970342|76057641|FG001|STARTED|Treatment Visit 3 (1 Day)||2||
59939190|NCT04970342|76057642|FG002|STARTED|Treatment Visit 3 (1 Day)||1||
59939191|NCT04970342|76057643|FG003|STARTED|Treatment Visit 3 (1 Day)||1||
59939192|NCT04970342|76057644|FG004|STARTED|Treatment Visit 3 (1 Day)||1||
59939193|NCT04970342|76057645|FG005|STARTED|Treatment Visit 3 (1 Day)||1||
59939194|NCT04970342|76057640|FG000|COMPLETED|Treatment Visit 3 (1 Day)||2||
59939195|NCT04970342|76057641|FG001|COMPLETED|Treatment Visit 3 (1 Day)||2||
59939196|NCT04970342|76057642|FG002|COMPLETED|Treatment Visit 3 (1 Day)||1||
59939197|NCT04970342|76057643|FG003|COMPLETED|Treatment Visit 3 (1 Day)||1||
59939198|NCT04970342|76057644|FG004|COMPLETED|Treatment Visit 3 (1 Day)||1||
59939199|NCT04970342|76057645|FG005|COMPLETED|Treatment Visit 3 (1 Day)||1||
59939200|NCT04970342|76057640|FG000|NOT COMPLETED|Treatment Visit 3 (1 Day)||0||
59939201|NCT04970342|76057641|FG001|NOT COMPLETED|Treatment Visit 3 (1 Day)||0||
59939202|NCT04970342|76057642|FG002|NOT COMPLETED|Treatment Visit 3 (1 Day)||0||
59939203|NCT04970342|76057643|FG003|NOT COMPLETED|Treatment Visit 3 (1 Day)||0||
59939204|NCT04970342|76057644|FG004|NOT COMPLETED|Treatment Visit 3 (1 Day)||0||
59939205|NCT04970342|76057645|FG005|NOT COMPLETED|Treatment Visit 3 (1 Day)||0||
59939206|NCT04507464|76057655|FG000|STARTED|Overall Study||20||
59939207|NCT04507464|76057656|FG001|STARTED|Overall Study||19||
59939208|NCT04507464|76057655|FG000|COMPLETED|Overall Study||19||
59939209|NCT04507464|76057656|FG001|COMPLETED|Overall Study||19||
59939210|NCT04507464|76057655|FG000|NOT COMPLETED|Overall Study||1||
59939211|NCT04507464|76057656|FG001|NOT COMPLETED|Overall Study||0||
59939212|NCT04441892|76057664|FG000|STARTED|Overall Study||28||
59939213|NCT04441892|76057665|FG001|STARTED|Overall Study||5||
59939214|NCT04441892|76057664|FG000|COMPLETED|Overall Study||28||
59939215|NCT04441892|76057665|FG001|COMPLETED|Overall Study||5||
59939216|NCT04441892|76057664|FG000|NOT COMPLETED|Overall Study||0||
59939217|NCT04441892|76057665|FG001|NOT COMPLETED|Overall Study||0||
59939218|NCT04436497|76057673|FG000|STARTED|Overall Study||122||
59939219|NCT04436497|76057674|FG001|STARTED|Overall Study||40||
59939220|NCT04436497|76057673|FG000|COMPLETED|Overall Study||88||
59939221|NCT04436497|76057674|FG001|COMPLETED|Overall Study||29||
59939222|NCT04436497|76057673|FG000|NOT COMPLETED|Overall Study||34||
59939223|NCT04436497|76057674|FG001|NOT COMPLETED|Overall Study||11||
59939224|NCT04424641|76057689|FG000|STARTED|Overall Study||1||
59939225|NCT04424641|76057690|FG001|STARTED|Overall Study||4||
59939226|NCT04424641|76057691|FG002|STARTED|Overall Study||7||
59939227|NCT04424641|76057692|FG003|STARTED|Overall Study||7||
59939228|NCT04424641|76057693|FG004|STARTED|Overall Study||6||
59939229|NCT04424641|76057694|FG005|STARTED|Overall Study||2||
59939230|NCT04424641|76057695|FG006|STARTED|Overall Study||4||
59939231|NCT04424641|76057696|FG007|STARTED|Overall Study||6||
59939232|NCT04424641|76057689|FG000|COMPLETED|Overall Study||0||
59939233|NCT04424641|76057690|FG001|COMPLETED|Overall Study||0||
59939234|NCT04424641|76057691|FG002|COMPLETED|Overall Study||0||
59939235|NCT04424641|76057692|FG003|COMPLETED|Overall Study||0||
59939236|NCT04424641|76057693|FG004|COMPLETED|Overall Study||0||
59939237|NCT04424641|76057694|FG005|COMPLETED|Overall Study||0||
59939238|NCT04424641|76057695|FG006|COMPLETED|Overall Study||0||
59939239|NCT04424641|76057696|FG007|COMPLETED|Overall Study||0||
59939240|NCT04424641|76057689|FG000|NOT COMPLETED|Overall Study||1||
59939241|NCT04424641|76057690|FG001|NOT COMPLETED|Overall Study||4||
59939242|NCT04424641|76057691|FG002|NOT COMPLETED|Overall Study||7||
59939243|NCT04424641|76057692|FG003|NOT COMPLETED|Overall Study||7||
59939244|NCT04424641|76057693|FG004|NOT COMPLETED|Overall Study||6||
59939245|NCT04424641|76057694|FG005|NOT COMPLETED|Overall Study||2||
59939246|NCT04424641|76057695|FG006|NOT COMPLETED|Overall Study||4||
59939247|NCT04424641|76057696|FG007|NOT COMPLETED|Overall Study||6||
59939248|NCT04414345|76057716|FG000|STARTED|Overall Study||120||
59939249|NCT04414345|76057717|FG001|STARTED|Overall Study||41||
59939250|NCT04414345|76057716|FG000|COMPLETED|Overall Study||110||
59939251|NCT04414345|76057717|FG001|COMPLETED|Overall Study||35||
59939252|NCT04414345|76057716|FG000|NOT COMPLETED|Overall Study||10||
59939253|NCT04414345|76057717|FG001|NOT COMPLETED|Overall Study||6||
59939254|NCT04276090|76057725|FG000|STARTED|Overall Study||17||
59939255|NCT04276090|76057726|FG001|STARTED|Overall Study||4||
59939256|NCT04276090|76057725|FG000|COMPLETED|Overall Study||16||
59939257|NCT04276090|76057726|FG001|COMPLETED|Overall Study||4||
59939258|NCT04276090|76057725|FG000|NOT COMPLETED|Overall Study||1||
59939259|NCT04276090|76057726|FG001|NOT COMPLETED|Overall Study||0||
59939260|NCT04244370|76057732|FG000|STARTED|Overall Study||50||
59939261|NCT04244370|76057732|FG000|COMPLETED|Overall Study||49||
59939262|NCT04244370|76057732|FG000|NOT COMPLETED|Overall Study||1||
59939263|NCT04105842|76057736|FG000|STARTED|Overall Study||37||
59939264|NCT04105842|76057736|FG000|COMPLETED|Overall Study||35||
59939265|NCT04105842|76057736|FG000|NOT COMPLETED|Overall Study||2||
59939266|NCT04088734|76057743|FG000|STARTED|Overall Study||5||
59939267|NCT04088734|76057743|FG000|COMPLETED|Overall Study||0||
59939268|NCT04088734|76057743|FG000|NOT COMPLETED|Overall Study||5||
59939269|NCT04081688|76057747|FG000|STARTED|Overall Study||16||
59939270|NCT04081688|76057747|FG000|COMPLETED|Overall Study||16||
59939271|NCT04081688|76057747|FG000|NOT COMPLETED|Overall Study||0||
59939272|NCT04041609|76057754|FG000|STARTED|Overall Study||24||
59939273|NCT04041609|76057755|FG001|STARTED|Overall Study||23||
59939274|NCT04041609|76057756|FG002|STARTED|Overall Study||24||
59939275|NCT04041609|76057754|FG000|COMPLETED|Overall Study||17||
59939276|NCT04041609|76057755|FG001|COMPLETED|Overall Study||15||
59939277|NCT04041609|76057756|FG002|COMPLETED|Overall Study||17||
59939278|NCT04041609|76057754|FG000|NOT COMPLETED|Overall Study||7||
59939279|NCT04041609|76057755|FG001|NOT COMPLETED|Overall Study||8||
59939280|NCT04041609|76057756|FG002|NOT COMPLETED|Overall Study||7||
59939281|NCT03868787|76057766|FG000|STARTED|Overall Study||37||
59939282|NCT03868787|76057767|FG001|STARTED|Overall Study||37||
59939283|NCT03868787|76057766|FG000|COMPLETED|Overall Study||35||
59939284|NCT03868787|76057767|FG001|COMPLETED|Overall Study||36||
59939285|NCT03868787|76057766|FG000|NOT COMPLETED|Overall Study||2||
59939286|NCT03868787|76057767|FG001|NOT COMPLETED|Overall Study||1||
59939287|NCT03856320|76057775|FG000|STARTED|Overall Study||20||
59939288|NCT03856320|76057776|FG001|STARTED|Overall Study||22||
59939289|NCT03856320|76057775|FG000|COMPLETED|Overall Study||20||
59939290|NCT03856320|76057776|FG001|COMPLETED|Overall Study||20||
59939291|NCT03856320|76057775|FG000|NOT COMPLETED|Overall Study||0||
59939292|NCT03856320|76057776|FG001|NOT COMPLETED|Overall Study||2||
59939293|NCT03804671|76057782|FG000|STARTED|Overall Study||6||
59939294|NCT03804671|76057782|FG000|COMPLETED|Overall Study||6||
59939295|NCT03804671|76057782|FG000|NOT COMPLETED|Overall Study||0||
59939296|NCT03669133|76057789|FG000|STARTED|Overall Study||1||
59939297|NCT03669133|76057790|FG001|STARTED|Overall Study||1||
59939298|NCT03669133|76057789|FG000|COMPLETED|Overall Study||1||
59939299|NCT03669133|76057790|FG001|COMPLETED|Overall Study||1||
59939300|NCT03669133|76057789|FG000|NOT COMPLETED|Overall Study||0||
59939301|NCT03669133|76057790|FG001|NOT COMPLETED|Overall Study||0||
59939302|NCT03457701|76057798|FG000|STARTED|Treatment Period 1 (up to Day 28)||7|Randomized|
59939303|NCT03457701|76057799|FG001|STARTED|Treatment Period 1 (up to Day 28)||8|Randomized|
59939304|NCT03457701|76057798|FG000|Safety Population|Treatment Period 1 (up to Day 28)||7||
59939305|NCT03457701|76057799|FG001|Safety Population|Treatment Period 1 (up to Day 28)||7||
59939306|NCT03457701|76057798|FG000|COMPLETED|Treatment Period 1 (up to Day 28)||6||
59939307|NCT03457701|76057799|FG001|COMPLETED|Treatment Period 1 (up to Day 28)||7||
59939308|NCT03457701|76057798|FG000|NOT COMPLETED|Treatment Period 1 (up to Day 28)||1||
59939309|NCT03457701|76057799|FG001|NOT COMPLETED|Treatment Period 1 (up to Day 28)||1||
59939310|NCT03457701|76057798|FG000|STARTED|Treatment Period 2 (Up to Day 28)||6||
59939311|NCT03457701|76057799|FG001|STARTED|Treatment Period 2 (Up to Day 28)||7||
59939312|NCT03457701|76057798|FG000|COMPLETED|Treatment Period 2 (Up to Day 28)||6||
59939313|NCT03457701|76057799|FG001|COMPLETED|Treatment Period 2 (Up to Day 28)||6||
59939314|NCT03457701|76057798|FG000|NOT COMPLETED|Treatment Period 2 (Up to Day 28)||0||
59939315|NCT03457701|76057799|FG001|NOT COMPLETED|Treatment Period 2 (Up to Day 28)||1||
59939316|NCT03403231|76057823|FG000|STARTED|Overall Study||9||
59939317|NCT03403231|76057824|FG001|STARTED|Overall Study||9||
59939318|NCT03403231|76057825|FG002|STARTED|Overall Study||9||
59939319|NCT03403231|76057826|FG003|STARTED|Overall Study||9||
59939320|NCT03403231|76057827|FG004|STARTED|Overall Study||9||
59939321|NCT03403231|76057828|FG005|STARTED|Overall Study||9||
59939322|NCT03403231|76057829|FG006|STARTED|Overall Study||9||
59939323|NCT03403231|76057830|FG007|STARTED|Overall Study||9||
59939324|NCT03403231|76057831|FG008|STARTED|Overall Study||9||
59939325|NCT03403231|76057832|FG009|STARTED|Overall Study||9||
59939326|NCT03403231|76057833|FG010|STARTED|Overall Study||9||
59939327|NCT03403231|76057834|FG011|STARTED|Overall Study||9||
59939328|NCT03403231|76057835|FG012|STARTED|Overall Study||9||
59939329|NCT03403231|76057836|FG013|STARTED|Overall Study||9||
59939330|NCT03403231|76057837|FG014|STARTED|Overall Study||9||
59939331|NCT03403231|76057838|FG015|STARTED|Overall Study||9||
59939332|NCT03403231|76057823|FG000|COMPLETED|Overall Study||9||
59939333|NCT03403231|76057824|FG001|COMPLETED|Overall Study||9||
59939334|NCT03403231|76057825|FG002|COMPLETED|Overall Study||9||
59939335|NCT03403231|76057826|FG003|COMPLETED|Overall Study||9||
59939336|NCT03403231|76057827|FG004|COMPLETED|Overall Study||9||
59939337|NCT03403231|76057828|FG005|COMPLETED|Overall Study||9||
59939338|NCT03403231|76057829|FG006|COMPLETED|Overall Study||9||
59939339|NCT03403231|76057830|FG007|COMPLETED|Overall Study||9||
59939340|NCT03403231|76057831|FG008|COMPLETED|Overall Study||9||
59939341|NCT03403231|76057832|FG009|COMPLETED|Overall Study||9||
59939342|NCT03403231|76057833|FG010|COMPLETED|Overall Study||9||
59939343|NCT03403231|76057834|FG011|COMPLETED|Overall Study||9||
59939344|NCT03403231|76057835|FG012|COMPLETED|Overall Study||9||
59939345|NCT03403231|76057836|FG013|COMPLETED|Overall Study||9||
59939346|NCT03403231|76057837|FG014|COMPLETED|Overall Study||9||
59939347|NCT03403231|76057838|FG015|COMPLETED|Overall Study||9||
59939348|NCT03403231|76057823|FG000|NOT COMPLETED|Overall Study||0||
59939349|NCT03403231|76057824|FG001|NOT COMPLETED|Overall Study||0||
59939350|NCT03403231|76057825|FG002|NOT COMPLETED|Overall Study||0||
59939351|NCT03403231|76057826|FG003|NOT COMPLETED|Overall Study||0||
59939352|NCT03403231|76057827|FG004|NOT COMPLETED|Overall Study||0||
59939353|NCT03403231|76057828|FG005|NOT COMPLETED|Overall Study||0||
59939354|NCT03403231|76057829|FG006|NOT COMPLETED|Overall Study||0||
59939355|NCT03403231|76057830|FG007|NOT COMPLETED|Overall Study||0||
59939356|NCT03403231|76057831|FG008|NOT COMPLETED|Overall Study||0||
59939357|NCT03403231|76057832|FG009|NOT COMPLETED|Overall Study||0||
59939358|NCT03403231|76057833|FG010|NOT COMPLETED|Overall Study||0||
59939359|NCT03403231|76057834|FG011|NOT COMPLETED|Overall Study||0||
59939360|NCT03403231|76057835|FG012|NOT COMPLETED|Overall Study||0||
59939361|NCT03403231|76057836|FG013|NOT COMPLETED|Overall Study||0||
59939362|NCT03403231|76057837|FG014|NOT COMPLETED|Overall Study||0||
59939363|NCT03403231|76057838|FG015|NOT COMPLETED|Overall Study||0||
59939364|NCT03078946|76057874|FG000|STARTED|Overall Study||30||
59939365|NCT03078946|76057875|FG001|STARTED|Overall Study||30||
59939366|NCT03078946|76057874|FG000|COMPLETED|Overall Study||30||
59939367|NCT03078946|76057875|FG001|COMPLETED|Overall Study||30||
59939368|NCT03078946|76057874|FG000|NOT COMPLETED|Overall Study||0||
59939369|NCT03078946|76057875|FG001|NOT COMPLETED|Overall Study||0||
59939370|NCT02915601|76057883|FG000|STARTED|Overall Study||55||
59939371|NCT02915601|76057884|FG001|STARTED|Overall Study||54||
59939372|NCT02915601|76057883|FG000|COMPLETED|Overall Study||44||
59939373|NCT02915601|76057884|FG001|COMPLETED|Overall Study||46||
59939374|NCT02915601|76057883|FG000|NOT COMPLETED|Overall Study||11||
59939375|NCT02915601|76057884|FG001|NOT COMPLETED|Overall Study||8||
59939376|NCT02694978|76057892|FG000|STARTED|Overall Study||1006||
59939377|NCT02694978|76057893|FG001|STARTED|Overall Study||1008||
59939378|NCT02694978|76057892|FG000|Received at Least 1 Dose of Study Drug|Overall Study||997||
59939379|NCT02694978|76057893|FG001|Received at Least 1 Dose of Study Drug|Overall Study||1000||
59939380|NCT02694978|76057892|FG000|COMPLETED|Overall Study||935|Completed=received at least 1 dose of study drug and returned for final study visit (Week 5).|
59939381|NCT02694978|76057893|FG001|COMPLETED|Overall Study||948|Completed=received at least 1 dose of study drug and returned for final study visit (Week 5).|
59939382|NCT02694978|76057892|FG000|NOT COMPLETED|Overall Study||71||
59939383|NCT02694978|76057893|FG001|NOT COMPLETED|Overall Study||60||
59939384|NCT02563002|76057901|FG000|STARTED|Overall Study||153||
59939385|NCT02563002|76057902|FG001|STARTED|Overall Study||154||
59939386|NCT02563002|76057901|FG000|Treated|Overall Study||153||
59939387|NCT02563002|76057902|FG001|Treated|Overall Study||143||
59613358|NCT01687218|75724502|FG000|COMPLETED|Overall Study||30||
59613359|NCT01687218|75724503|FG001|COMPLETED|Overall Study||29||
59613360|NCT01687218|75724504|FG002|COMPLETED|Overall Study||30||
59613361|NCT01687218|75724505|FG003|COMPLETED|Overall Study||32||
59613362|NCT01687218|75724506|FG004|COMPLETED|Overall Study||32||
59613363|NCT01687218|75724507|FG005|COMPLETED|Overall Study||32||
59613364|NCT01687218|75724502|FG000|NOT COMPLETED|Overall Study||3||
59613365|NCT01687218|75724503|FG001|NOT COMPLETED|Overall Study||3||
59613366|NCT01687218|75724504|FG002|NOT COMPLETED|Overall Study||1||
59613367|NCT01687218|75724505|FG003|NOT COMPLETED|Overall Study||2||
59613368|NCT01687218|75724506|FG004|NOT COMPLETED|Overall Study||1||
59761987|NCT00581308|75881641|FG000|COMPLETED|36 Months||170||
59939388|NCT02563002|76057901|FG000|Received Second Course of Pembrolizumab|Overall Study||8||
59939389|NCT02563002|76057902|FG001|Received Second Course of Pembrolizumab|Overall Study||4||
59939390|NCT02563002|76057901|FG000|Switched Over to Pembrolizumab|Overall Study||0||
59939391|NCT02563002|76057902|FG001|Switched Over to Pembrolizumab|Overall Study||56||
59939392|NCT02563002|76057901|FG000|COMPLETED|Overall Study||0||
59939393|NCT02563002|76057902|FG001|COMPLETED|Overall Study||0||
59939394|NCT02563002|76057901|FG000|NOT COMPLETED|Overall Study||153||
59939395|NCT02563002|76057902|FG001|NOT COMPLETED|Overall Study||154||
59939396|NCT02454933|76057913|FG000|STARTED|Overall Study||17|Actual treatment received|
59939397|NCT02454933|76057914|FG001|STARTED|Overall Study|2 subjects switched to osimertinib monotherapy Cycle 1 Day 1|12|Actual treatment received|
59939398|NCT02454933|76057913|FG000|Treatment Group Randomised to|Overall Study||15||
59939399|NCT02454933|76057914|FG001|Treatment Group Randomised to|Overall Study||14||
59939400|NCT02454933|76057913|FG000|COMPLETED|Overall Study||9|Subjects ongoing study at primary analysis data cut-off|
59939401|NCT02454933|76057914|FG001|COMPLETED|Overall Study||4|Subjects ongoing study at primary analysis data cut-off|
59939402|NCT02454933|76057913|FG000|NOT COMPLETED|Overall Study||8||
59939403|NCT02454933|76057914|FG001|NOT COMPLETED|Overall Study||8||
59939404|NCT02430480|76057919|FG000|STARTED|Overall Study||39||
59939405|NCT02430480|76057919|FG000|COMPLETED|Overall Study||36||
59939406|NCT02430480|76057919|FG000|NOT COMPLETED|Overall Study||3||
59939407|NCT02207439|76057926|FG000|STARTED|Nelfinavir Lead-In||17||
59939408|NCT02207439|76057926|FG000|COMPLETED|Nelfinavir Lead-In||17||
59939409|NCT02207439|76057926|FG000|NOT COMPLETED|Nelfinavir Lead-In||0||
59939410|NCT02207439|76057926|FG000|STARTED|Chemoradiotherapy With Nelfinavir||17||
59939411|NCT02207439|76057926|FG000|COMPLETED|Chemoradiotherapy With Nelfinavir||17||
59939412|NCT02207439|76057926|FG000|NOT COMPLETED|Chemoradiotherapy With Nelfinavir||0||
59939413|NCT01796197|76057931|FG000|STARTED|Overall Study||23||
59939414|NCT01796197|76057931|FG000|COMPLETED|Overall Study||21||
59939415|NCT01796197|76057931|FG000|NOT COMPLETED|Overall Study||2||
59939416|NCT01205048|76057937|FG000|STARTED|Overall Study||170||
59939417|NCT01205048|76057937|FG000|Emervel Classic Lidocaine in Left NLF Followed by Juvederm Ultra in Right NLF|Overall Study||84||
59939418|NCT01205048|76057937|FG000|Juvederm Ultra in Left NLF Followed by Emervel Classic Lidocaine in Right NLF|Overall Study||86||
59939419|NCT01205048|76057937|FG000|COMPLETED|Overall Study||149||
59939420|NCT01205048|76057937|FG000|NOT COMPLETED|Overall Study||21||
59939421|NCT01052779|76057945|FG000|STARTED|Overall Study||80||
59939422|NCT01052779|76057946|FG001|STARTED|Overall Study||82||
59939423|NCT01052779|76057945|FG000|Received at Least 1 Dose of Study Drug|Overall Study||80||
59939424|NCT01052779|76057946|FG001|Received at Least 1 Dose of Study Drug|Overall Study||81||
59939425|NCT01052779|76057945|FG000|COMPLETED|Overall Study||75||
59939426|NCT01052779|76057946|FG001|COMPLETED|Overall Study||73||
59939427|NCT01052779|76057945|FG000|NOT COMPLETED|Overall Study||5||
59939428|NCT01052779|76057946|FG001|NOT COMPLETED|Overall Study||9||
59939429|NCT00743262|76057952|FG000|STARTED|Overall Study||15||
59939430|NCT00743262|76057952|FG000|COMPLETED|Overall Study||15||
59939431|NCT00743262|76057952|FG000|NOT COMPLETED|Overall Study||0||
59939432|NCT00591370|76057956|FG000|STARTED|Overall Study||51||
59939433|NCT00591370|76057956|FG000|COMPLETED|Overall Study||49||
59939434|NCT00591370|76057956|FG000|NOT COMPLETED|Overall Study||2||
59939435|NCT03064763|76057960|FG000|STARTED|Overall Study||18||
59939436|NCT03064763|76057960|FG000|Received Treatment|Overall Study||18||
59761988|NCT00581308|75881641|FG000|NOT COMPLETED|36 Months||6||
59761989|NCT00581308|75881641|FG000|STARTED|48 Months||170||
59761990|NCT00581308|75881641|FG000|COMPLETED|48 Months||161||
59761991|NCT00581308|75881641|FG000|NOT COMPLETED|48 Months||9||
59939437|NCT03064763|76057960|FG000|COMPLETED|Overall Study||9||
59939438|NCT03064763|76057960|FG000|NOT COMPLETED|Overall Study||9||
59761992|NCT00581308|75881641|FG000|STARTED|60 Months||161||
59613369|NCT01687218|75724507|FG005|NOT COMPLETED|Overall Study||0||
59613370|NCT01686828|75724519|FG000|STARTED|Overall Study||13||
59613371|NCT01686828|75724520|FG001|STARTED|Overall Study||14||
59939439|NCT02782676|76057964|FG000|STARTED|Overall Study||211||211
59761993|NCT00581308|75881641|FG000|COMPLETED|60 Months||158||
59939440|NCT02782676|76057965|FG001|STARTED|Overall Study||210||210
59939441|NCT02782676|76057964|FG000|COMPLETED|Overall Study||211||211
59939442|NCT02782676|76057965|FG001|COMPLETED|Overall Study||209||209
59939443|NCT02782676|76057964|FG000|NOT COMPLETED|Overall Study||0||0
59939444|NCT02782676|76057965|FG001|NOT COMPLETED|Overall Study||1||1
59939445|NCT02471339|76057973|FG000|STARTED|Overall Study||32||
59939446|NCT02471339|76057974|FG001|STARTED|Overall Study||34||
59939447|NCT02471339|76057973|FG000|COMPLETED|Overall Study||30||
59939448|NCT02471339|76057974|FG001|COMPLETED|Overall Study||34||
59939449|NCT02471339|76057973|FG000|NOT COMPLETED|Overall Study||2||
59939450|NCT02471339|76057974|FG001|NOT COMPLETED|Overall Study||0||
59939451|NCT00107978|76057982|FG000|STARTED|Overall Study||458||
59939452|NCT00107978|76057983|FG001|STARTED|Overall Study||481||
59939453|NCT00107978|76057982|FG000|COMPLETED|Overall Study||425||
59939454|NCT00107978|76057983|FG001|COMPLETED|Overall Study||431||
59939455|NCT00107978|76057982|FG000|NOT COMPLETED|Overall Study||33||
59939456|NCT00107978|76057983|FG001|NOT COMPLETED|Overall Study||50||
59939457|NCT02781818|76057992|FG000|STARTED|Overall Study||20||24
59939458|NCT02781818|76057993|FG001|STARTED|Overall Study||18||22
59939459|NCT02781818|76057994|FG002|STARTED|Overall Study||17||21
59939460|NCT02781818|76057992|FG000|COMPLETED|Overall Study||16||18
59939461|NCT02781818|76057993|FG001|COMPLETED|Overall Study||16||20
59939462|NCT02781818|76057994|FG002|COMPLETED|Overall Study||16||20
59939463|NCT02781818|76057992|FG000|NOT COMPLETED|Overall Study||4||6
59939464|NCT02781818|76057993|FG001|NOT COMPLETED|Overall Study||2||2
59939465|NCT02781818|76057994|FG002|NOT COMPLETED|Overall Study||1||1
59939466|NCT02927873|76058008|FG000|STARTED|Overall Study||11||
59939467|NCT02927873|76058009|FG001|STARTED|Overall Study||14||
59939468|NCT02927873|76058010|FG002|STARTED|Overall Study||18||
59939469|NCT02927873|76058011|FG003|STARTED|Overall Study||11||
59939470|NCT02927873|76058012|FG004|STARTED|Overall Study||11||
59939471|NCT02927873|76058013|FG005|STARTED|Overall Study||17||
59939472|NCT02927873|76058008|FG000|COMPLETED|Overall Study||9||
59939473|NCT02927873|76058009|FG001|COMPLETED|Overall Study||11||
59939474|NCT02927873|76058010|FG002|COMPLETED|Overall Study||18||
59939475|NCT02927873|76058011|FG003|COMPLETED|Overall Study||11||
59939476|NCT02927873|76058012|FG004|COMPLETED|Overall Study||11||
59939477|NCT02927873|76058013|FG005|COMPLETED|Overall Study||16||
59939478|NCT02927873|76058008|FG000|NOT COMPLETED|Overall Study||2||
59939479|NCT02927873|76058009|FG001|NOT COMPLETED|Overall Study||3||
59939480|NCT02927873|76058010|FG002|NOT COMPLETED|Overall Study||0||
59939481|NCT02927873|76058011|FG003|NOT COMPLETED|Overall Study||0||
59939482|NCT02927873|76058012|FG004|NOT COMPLETED|Overall Study||0||
59939483|NCT02927873|76058013|FG005|NOT COMPLETED|Overall Study||1||
59939484|NCT01220999|76058032|FG000|STARTED|Overall Study||2||
59939485|NCT01220999|76058033|FG001|STARTED|Overall Study||4||
59939486|NCT01220999|76058034|FG002|STARTED|Overall Study||5||
59939487|NCT01220999|76058035|FG003|STARTED|Overall Study||3||
59939488|NCT01220999|76058036|FG004|STARTED|Overall Study||5||
59939489|NCT01220999|76058032|FG000|COMPLETED|Overall Study||2|Completed Cycle 1 (through Day 43) as planned|
59939490|NCT01220999|76058033|FG001|COMPLETED|Overall Study||4|Completed Cycle 1 (through Day 43) as planned|
59939491|NCT01220999|76058034|FG002|COMPLETED|Overall Study||4|Completed Cycle 1 (through Day 43) as planned|
59939492|NCT01220999|76058035|FG003|COMPLETED|Overall Study||3|Completed Cycle 1 (through Day 43) as planned|
59939493|NCT01220999|76058036|FG004|COMPLETED|Overall Study||5|Completed Cycle 1 (through Day 43) as planned|
59939494|NCT01220999|76058032|FG000|NOT COMPLETED|Overall Study||0||
59939495|NCT01220999|76058033|FG001|NOT COMPLETED|Overall Study||0||
59939496|NCT01220999|76058034|FG002|NOT COMPLETED|Overall Study||1||
59939497|NCT01220999|76058035|FG003|NOT COMPLETED|Overall Study||0||
59939498|NCT01220999|76058036|FG004|NOT COMPLETED|Overall Study||0||
59939499|NCT00142415|76058054|FG000|STARTED|Overall Study||3||
59939500|NCT00142415|76058055|FG001|STARTED|Overall Study||3||
59939501|NCT00142415|76058056|FG002|STARTED|Overall Study||6||
59939502|NCT00142415|76058057|FG003|STARTED|Overall Study||3||
59939503|NCT00142415|76058058|FG004|STARTED|Overall Study||3||
59939504|NCT00142415|76058059|FG005|STARTED|Overall Study||8||
59939505|NCT00142415|76058054|FG000|COMPLETED|Overall Study||3|Defined as completion of Cycle 1 (ie, received 111-In-DOTA-cG250 and 177-Lu-DOTA-cG250)|
59939506|NCT00142415|76058055|FG001|COMPLETED|Overall Study||3|Defined as completion of Cycle 1 (ie, received 111-In-DOTA-cG250 and 177-Lu-DOTA-cG250)|
59939507|NCT00142415|76058056|FG002|COMPLETED|Overall Study||6|Defined as completion of Cycle 1 (ie, received 111-In-DOTA-cG250 and 177-Lu-DOTA-cG250)|
59939508|NCT00142415|76058057|FG003|COMPLETED|Overall Study||3|Defined as completion of Cycle 1 (ie, received 111-In-DOTA-cG250 and 177-Lu-DOTA-cG250)|
59939509|NCT00142415|76058058|FG004|COMPLETED|Overall Study||2|Defined as completion of Cycle 1 (ie, received 111-In-DOTA-cG250 and 177-Lu-DOTA-cG250)|
59939510|NCT00142415|76058059|FG005|COMPLETED|Overall Study||6|Defined as completion of Cycle 1 (ie, received 111-In-DOTA-cG250 and 177-Lu-DOTA-cG250)|
59939511|NCT00142415|76058054|FG000|NOT COMPLETED|Overall Study||0||
59939512|NCT00142415|76058055|FG001|NOT COMPLETED|Overall Study||0||
59939513|NCT00142415|76058056|FG002|NOT COMPLETED|Overall Study||0||
59939514|NCT00142415|76058057|FG003|NOT COMPLETED|Overall Study||0||
59939515|NCT00142415|76058058|FG004|NOT COMPLETED|Overall Study||1||
59939516|NCT00142415|76058059|FG005|NOT COMPLETED|Overall Study||2||
59939517|NCT01825187|76058077|FG000|STARTED|Overall Study||25||
59939518|NCT01825187|76058078|FG001|STARTED|Overall Study||25||
59939519|NCT01825187|76058079|FG002|STARTED|Overall Study||25||
59939520|NCT01825187|76058077|FG000|COMPLETED|Overall Study||24||
59939521|NCT01825187|76058078|FG001|COMPLETED|Overall Study||24||
59939522|NCT01825187|76058079|FG002|COMPLETED|Overall Study||24||
59939523|NCT01825187|76058077|FG000|NOT COMPLETED|Overall Study||1||
59939524|NCT01825187|76058078|FG001|NOT COMPLETED|Overall Study||1||
59939525|NCT01825187|76058079|FG002|NOT COMPLETED|Overall Study||1||
59939526|NCT02781584|76058101|FG000|STARTED|Pre-treatment Phase||0||
59939527|NCT02781584|76058102|FG001|STARTED|Pre-treatment Phase||0||
59939528|NCT02781584|76058103|FG002|STARTED|Pre-treatment Phase||0||
59939529|NCT02781584|76058104|FG003|STARTED|Pre-treatment Phase||0||
59939530|NCT02781584|76058105|FG004|STARTED|Pre-treatment Phase||0||
59939531|NCT02781584|76058106|FG005|STARTED|Pre-treatment Phase||0||
59939532|NCT02781584|76058107|FG006|STARTED|Pre-treatment Phase||0||
59939533|NCT02781584|76058108|FG007|STARTED|Pre-treatment Phase||0||
59939534|NCT02781584|76058109|FG008|STARTED|Pre-treatment Phase||0||
59939535|NCT02781584|76058110|FG009|STARTED|Pre-treatment Phase||15||
59939536|NCT02781584|76058111|FG010|STARTED|Pre-treatment Phase||16||
59939537|NCT02781584|76058112|FG011|STARTED|Pre-treatment Phase||33||
59939538|NCT02781584|76058113|FG012|STARTED|Pre-treatment Phase||33||
59939539|NCT02781584|76058101|FG000|COMPLETED|Pre-treatment Phase||0||
59939540|NCT02781584|76058102|FG001|COMPLETED|Pre-treatment Phase||0||
59939541|NCT02781584|76058103|FG002|COMPLETED|Pre-treatment Phase||0||
59939542|NCT02781584|76058104|FG003|COMPLETED|Pre-treatment Phase||0||
59939543|NCT02781584|76058105|FG004|COMPLETED|Pre-treatment Phase||0||
59939544|NCT02781584|76058106|FG005|COMPLETED|Pre-treatment Phase||0||
59939545|NCT02781584|76058107|FG006|COMPLETED|Pre-treatment Phase||0||
59939546|NCT02781584|76058108|FG007|COMPLETED|Pre-treatment Phase||0||
59939547|NCT02781584|76058109|FG008|COMPLETED|Pre-treatment Phase||0||
59939548|NCT02781584|76058110|FG009|COMPLETED|Pre-treatment Phase||15||
59939549|NCT02781584|76058111|FG010|COMPLETED|Pre-treatment Phase||16||
59939550|NCT02781584|76058112|FG011|COMPLETED|Pre-treatment Phase||30||
59939551|NCT02781584|76058113|FG012|COMPLETED|Pre-treatment Phase||32||
59939552|NCT02781584|76058101|FG000|NOT COMPLETED|Pre-treatment Phase||0||
59939553|NCT02781584|76058102|FG001|NOT COMPLETED|Pre-treatment Phase||0||
59939554|NCT02781584|76058103|FG002|NOT COMPLETED|Pre-treatment Phase||0||
59939555|NCT02781584|76058104|FG003|NOT COMPLETED|Pre-treatment Phase||0||
59939556|NCT02781584|76058105|FG004|NOT COMPLETED|Pre-treatment Phase||0||
59939557|NCT02781584|76058106|FG005|NOT COMPLETED|Pre-treatment Phase||0||
59939558|NCT02781584|76058107|FG006|NOT COMPLETED|Pre-treatment Phase||0||
59939559|NCT02781584|76058108|FG007|NOT COMPLETED|Pre-treatment Phase||0||
59939560|NCT02781584|76058109|FG008|NOT COMPLETED|Pre-treatment Phase||0||
59939561|NCT02781584|76058110|FG009|NOT COMPLETED|Pre-treatment Phase||0||
59939562|NCT02781584|76058111|FG010|NOT COMPLETED|Pre-treatment Phase||0||
59939563|NCT02781584|76058112|FG011|NOT COMPLETED|Pre-treatment Phase||3||
59939564|NCT02781584|76058113|FG012|NOT COMPLETED|Pre-treatment Phase||1||
59939565|NCT02781584|76058101|FG000|STARTED|Treatment Phase|Only participants in Cohorts 10-13 received pre-treatment.|10||
59939566|NCT02781584|76058102|FG001|STARTED|Treatment Phase|Only participants in Cohorts 10-13 received pre-treatment.|10||
59939567|NCT02781584|76058103|FG002|STARTED|Treatment Phase|Only participants in Cohorts 10-13 received pre-treatment.|10||
59939568|NCT02781584|76058104|FG003|STARTED|Treatment Phase|Only participants in Cohorts 10-13 received pre-treatment.|20||
59939569|NCT02781584|76058105|FG004|STARTED|Treatment Phase|Only participants in Cohorts 10-13 received pre-treatment.|20||
59939570|NCT02781584|76058106|FG005|STARTED|Treatment Phase|Only participants in Cohorts 10-13 received pre-treatment.|20||
59939571|NCT02781584|76058107|FG006|STARTED|Treatment Phase|Only participants in Cohorts 10-13 received pre-treatment.|10||
59939572|NCT02781584|76058108|FG007|STARTED|Treatment Phase|Only participants in Cohorts 10-13 received pre-treatment.|10||
59939573|NCT02781584|76058109|FG008|STARTED|Treatment Phase|Only participants in Cohorts 10-13 received pre-treatment.|13||
59939574|NCT02781584|76058110|FG009|STARTED|Treatment Phase||15||
59939575|NCT02781584|76058111|FG010|STARTED|Treatment Phase||16||
59939576|NCT02781584|76058112|FG011|STARTED|Treatment Phase||30||
59939577|NCT02781584|76058113|FG012|STARTED|Treatment Phase||32||
59939578|NCT02781584|76058101|FG000|COMPLETED|Treatment Phase||10||
59939579|NCT02781584|76058102|FG001|COMPLETED|Treatment Phase||10||
59939580|NCT02781584|76058103|FG002|COMPLETED|Treatment Phase||10||
59939581|NCT02781584|76058104|FG003|COMPLETED|Treatment Phase||20||
59939582|NCT02781584|76058105|FG004|COMPLETED|Treatment Phase||20||
59939583|NCT02781584|76058106|FG005|COMPLETED|Treatment Phase||19||
59939584|NCT02781584|76058107|FG006|COMPLETED|Treatment Phase||10||
59939585|NCT02781584|76058108|FG007|COMPLETED|Treatment Phase||9||
59939586|NCT02781584|76058109|FG008|COMPLETED|Treatment Phase||13||
59939587|NCT02781584|76058110|FG009|COMPLETED|Treatment Phase||15||
59939588|NCT02781584|76058111|FG010|COMPLETED|Treatment Phase||15||
59939589|NCT02781584|76058112|FG011|COMPLETED|Treatment Phase||28||
59939590|NCT02781584|76058113|FG012|COMPLETED|Treatment Phase||32||
59939591|NCT02781584|76058101|FG000|NOT COMPLETED|Treatment Phase||0||
59939592|NCT02781584|76058102|FG001|NOT COMPLETED|Treatment Phase||0||
59939593|NCT02781584|76058103|FG002|NOT COMPLETED|Treatment Phase||0||
59939594|NCT02781584|76058104|FG003|NOT COMPLETED|Treatment Phase||0||
59939595|NCT02781584|76058105|FG004|NOT COMPLETED|Treatment Phase||0||
59939596|NCT02781584|76058106|FG005|NOT COMPLETED|Treatment Phase||1||
59939597|NCT02781584|76058107|FG006|NOT COMPLETED|Treatment Phase||0||
59939598|NCT02781584|76058108|FG007|NOT COMPLETED|Treatment Phase||1||
59939599|NCT02781584|76058109|FG008|NOT COMPLETED|Treatment Phase||0||
59939600|NCT02781584|76058110|FG009|NOT COMPLETED|Treatment Phase||0||
59939601|NCT02781584|76058111|FG010|NOT COMPLETED|Treatment Phase||1||
59939602|NCT02781584|76058112|FG011|NOT COMPLETED|Treatment Phase||2||
59939603|NCT02781584|76058113|FG012|NOT COMPLETED|Treatment Phase||0||
59939604|NCT02776670|76058143|FG000|STARTED|Overall Study||117|Randomized and treated|
59939605|NCT02776670|76058144|FG001|STARTED|Overall Study||114|Randomized and treated|
59939606|NCT02776670|76058143|FG000|Full Analysis Set (FAS)|Overall Study||117|All randomized subjects who had at least 1 post-baseline primary endpoint (ie, TFBUT) assessment.|
59939607|NCT02776670|76058144|FG001|Full Analysis Set (FAS)|Overall Study||114|All randomized subjects who had at least 1 post-baseline primary endpoint (ie, TFBUT) assessment.|
59939608|NCT02776670|76058143|FG000|Per Protocol Analysis Set (PPS)|Overall Study||115|Subjects in FAS who satisfied all inclusion/exclusion criteria and had no major protocol deviations|
59939609|NCT02776670|76058144|FG001|Per Protocol Analysis Set (PPS)|Overall Study||113|Subjects in FAS who satisfied all inclusion/exclusion criteria and had no major protocol deviations|
59939610|NCT02776670|76058143|FG000|Safety Analysis Set|Overall Study||117|All subjects exposed to post-randomization study treatment|
59939611|NCT02776670|76058144|FG001|Safety Analysis Set|Overall Study||114|All subjects exposed to post-randomization study treatment|
59939612|NCT02776670|76058143|FG000|COMPLETED|Overall Study||117|All subjects who completed the study whether on study treatment or not|
59939613|NCT02776670|76058144|FG001|COMPLETED|Overall Study||108|All subjects who completed the study whether on study treatment or not|
59939614|NCT02776670|76058143|FG000|NOT COMPLETED|Overall Study||0||
59939615|NCT02776670|76058144|FG001|NOT COMPLETED|Overall Study||6||
59939616|NCT01307423|76058153|FG000|STARTED|Placebo-controlled Phase (Week 0 - 24)||176||
59939617|NCT01307423|76058154|FG001|STARTED|Placebo-controlled Phase (Week 0 - 24)||175||
59939618|NCT01307423|76058155|FG002|STARTED|Placebo-controlled Phase (Week 0 - 24)||177||
59939619|NCT01307423|76058156|FG003|STARTED|Placebo-controlled Phase (Week 0 - 24)||0||
59939620|NCT01307423|76058157|FG004|STARTED|Placebo-controlled Phase (Week 0 - 24)||0||
59939621|NCT01307423|76058158|FG005|STARTED|Placebo-controlled Phase (Week 0 - 24)||0||
59939622|NCT01307423|76058159|FG006|STARTED|Placebo-controlled Phase (Week 0 - 24)||0||
59939623|NCT01307423|76058160|FG007|STARTED|Placebo-controlled Phase (Week 0 - 24)||0||
59939624|NCT01307423|76058161|FG008|STARTED|Placebo-controlled Phase (Week 0 - 24)||0||
59939625|NCT01307423|76058153|FG000|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||176||
59939626|NCT01307423|76058154|FG001|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||175||
59939627|NCT01307423|76058155|FG002|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||175||
59939628|NCT01307423|76058156|FG003|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0||
59939629|NCT01307423|76058157|FG004|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0||
59939630|NCT01307423|76058158|FG005|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0||
59939631|NCT01307423|76058159|FG006|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0||
59939632|NCT01307423|76058160|FG007|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0||
59939633|NCT01307423|76058161|FG008|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0||
59939634|NCT01307423|76058153|FG000|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||166||
59939635|NCT01307423|76058154|FG001|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||168||
59939636|NCT01307423|76058155|FG002|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||166||
59939637|NCT01307423|76058156|FG003|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0||
59939638|NCT01307423|76058157|FG004|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0||
59939639|NCT01307423|76058158|FG005|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0||
59939640|NCT01307423|76058159|FG006|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0||
59939641|NCT01307423|76058160|FG007|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0||
59939642|NCT01307423|76058161|FG008|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0||
59939643|NCT01307423|76058153|FG000|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|One participant who escaped early did not complete Week 24|103||
59939644|NCT01307423|76058154|FG001|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||73||
59939645|NCT01307423|76058155|FG002|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||79||
59939646|NCT01307423|76058156|FG003|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0||
59939647|NCT01307423|76058157|FG004|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0||
59939648|NCT01307423|76058158|FG005|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0||
59939649|NCT01307423|76058159|FG006|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0||
59939650|NCT01307423|76058160|FG007|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0||
59939651|NCT01307423|76058161|FG008|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0||
59939652|NCT01307423|76058153|FG000|COMPLETED|Placebo-controlled Phase (Week 0 - 24)|Two participants did not escape early and finished Week 24 did not enter the active treatment phase|156||
59939653|NCT01307423|76058154|FG001|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||160||
59939654|NCT01307423|76058155|FG002|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||155||
59939655|NCT01307423|76058156|FG003|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0||
59939656|NCT01307423|76058157|FG004|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0||
59939657|NCT01307423|76058158|FG005|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0||
59939658|NCT01307423|76058159|FG006|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0||
59939659|NCT01307423|76058160|FG007|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0||
59939660|NCT01307423|76058161|FG008|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0||
59939661|NCT01307423|76058153|FG000|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||20||
59939662|NCT01307423|76058154|FG001|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||15||
59939663|NCT01307423|76058155|FG002|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||22||
59939664|NCT01307423|76058156|FG003|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0||
59939665|NCT01307423|76058157|FG004|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0||
59939666|NCT01307423|76058158|FG005|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0||
59939667|NCT01307423|76058159|FG006|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0||
59939668|NCT01307423|76058160|FG007|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0||
59939669|NCT01307423|76058161|FG008|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0||
59939670|NCT01307423|76058153|FG000|STARTED|Active Treatment Phase (Week 25-52)||0||
59939671|NCT01307423|76058154|FG001|STARTED|Active Treatment Phase (Week 25-52)|Nine participants who completed Week 24 did not enter active treatment phase|151||
59939672|NCT01307423|76058155|FG002|STARTED|Active Treatment Phase (Week 25-52)|Five participants who completed Week 24 did not enter active treatment phase|150||
59939673|NCT01307423|76058156|FG003|STARTED|Active Treatment Phase (Week 25-52)|Four participants who escaped early and completed Week 24 did not enter the active treatment phase.|46||
59939674|NCT01307423|76058157|FG004|STARTED|Active Treatment Phase (Week 25-52)||26||
59939675|NCT01307423|76058158|FG005|STARTED|Active Treatment Phase (Week 25-52)|Six participants who escaped early and completed Week 24 did not enter the active treatment phase|46||
59939676|NCT01307423|76058159|FG006|STARTED|Active Treatment Phase (Week 25-52)||26||
59939677|NCT01307423|76058160|FG007|STARTED|Active Treatment Phase (Week 25-52)||0||
59939678|NCT01307423|76058161|FG008|STARTED|Active Treatment Phase (Week 25-52)||0||
59939679|NCT01307423|76058153|FG000|COMPLETED|Active Treatment Phase (Week 25-52)||0||
59939680|NCT01307423|76058154|FG001|COMPLETED|Active Treatment Phase (Week 25-52)||132||
59939681|NCT01307423|76058155|FG002|COMPLETED|Active Treatment Phase (Week 25-52)||141||
59939682|NCT01307423|76058156|FG003|COMPLETED|Active Treatment Phase (Week 25-52)||38||
59939683|NCT01307423|76058157|FG004|COMPLETED|Active Treatment Phase (Week 25-52)||23||
59939684|NCT01307423|76058158|FG005|COMPLETED|Active Treatment Phase (Week 25-52)||43||
59939685|NCT01307423|76058159|FG006|COMPLETED|Active Treatment Phase (Week 25-52)||25||
59939686|NCT01307423|76058160|FG007|COMPLETED|Active Treatment Phase (Week 25-52)||0||
59939687|NCT01307423|76058161|FG008|COMPLETED|Active Treatment Phase (Week 25-52)||0||
59939688|NCT01307423|76058153|FG000|NOT COMPLETED|Active Treatment Phase (Week 25-52)||0||
59939689|NCT01307423|76058154|FG001|NOT COMPLETED|Active Treatment Phase (Week 25-52)||19||
59939690|NCT01307423|76058155|FG002|NOT COMPLETED|Active Treatment Phase (Week 25-52)||9||
59939691|NCT01307423|76058156|FG003|NOT COMPLETED|Active Treatment Phase (Week 25-52)||8||
59939692|NCT01307423|76058157|FG004|NOT COMPLETED|Active Treatment Phase (Week 25-52)||3||
59939693|NCT01307423|76058158|FG005|NOT COMPLETED|Active Treatment Phase (Week 25-52)||3||
59939694|NCT01307423|76058159|FG006|NOT COMPLETED|Active Treatment Phase (Week 25-52)||1||
59939695|NCT01307423|76058160|FG007|NOT COMPLETED|Active Treatment Phase (Week 25-52)||0||
59939696|NCT01307423|76058161|FG008|NOT COMPLETED|Active Treatment Phase (Week 25-52)||0||
59939697|NCT01307423|76058153|FG000|STARTED|Long-term Safety Phase (Year 2)||0||
59939698|NCT01307423|76058154|FG001|STARTED|Long-term Safety Phase (Year 2)|10 participants who completed Week 52 did not enter the long-term safety phase|122||
59939699|NCT01307423|76058155|FG002|STARTED|Long-term Safety Phase (Year 2)|7 participants who completed Week 52 did not enter the long-term safety phase|134||
59939700|NCT01307423|76058156|FG003|STARTED|Long-term Safety Phase (Year 2)||0||
59939701|NCT01307423|76058157|FG004|STARTED|Long-term Safety Phase (Year 2)||0||
59939702|NCT01307423|76058158|FG005|STARTED|Long-term Safety Phase (Year 2)||0||
59939703|NCT01307423|76058159|FG006|STARTED|Long-term Safety Phase (Year 2)||0||
59939704|NCT01307423|76058160|FG007|STARTED|Long-term Safety Phase (Year 2)|Patients from the PBO/APR 20 mg EE and XO are combined;15 patients finished Wk 52;no entry into LTSP|57||
59939705|NCT01307423|76058161|FG008|STARTED|Long-term Safety Phase (Year 2)|Patients from the PBO/APR 30 mg EE and XO are combined;5 patients finished Wk 52;no entry into LTSP|67||
59939706|NCT01307423|76058153|FG000|COMPLETED|Long-term Safety Phase (Year 2)||0||
59939707|NCT01307423|76058154|FG001|COMPLETED|Long-term Safety Phase (Year 2)||99||
59939708|NCT01307423|76058155|FG002|COMPLETED|Long-term Safety Phase (Year 2)||109||
59939709|NCT01307423|76058156|FG003|COMPLETED|Long-term Safety Phase (Year 2)||0||
59939710|NCT01307423|76058157|FG004|COMPLETED|Long-term Safety Phase (Year 2)||0||
59939711|NCT01307423|76058158|FG005|COMPLETED|Long-term Safety Phase (Year 2)||0||
59939712|NCT01307423|76058159|FG006|COMPLETED|Long-term Safety Phase (Year 2)||0||
59939713|NCT01307423|76058160|FG007|COMPLETED|Long-term Safety Phase (Year 2)||48||
59951236|NCT03743415|76070177|FG002|STARTED|Overall Study||44||
59939714|NCT01307423|76058161|FG008|COMPLETED|Long-term Safety Phase (Year 2)||60||
59939715|NCT01307423|76058153|FG000|NOT COMPLETED|Long-term Safety Phase (Year 2)||0||
59939716|NCT01307423|76058154|FG001|NOT COMPLETED|Long-term Safety Phase (Year 2)||23||
59939717|NCT01307423|76058155|FG002|NOT COMPLETED|Long-term Safety Phase (Year 2)||25||
59939718|NCT01307423|76058156|FG003|NOT COMPLETED|Long-term Safety Phase (Year 2)||0||
59939719|NCT01307423|76058157|FG004|NOT COMPLETED|Long-term Safety Phase (Year 2)||0||
59939720|NCT01307423|76058158|FG005|NOT COMPLETED|Long-term Safety Phase (Year 2)||0||
59939721|NCT01307423|76058159|FG006|NOT COMPLETED|Long-term Safety Phase (Year 2)||0||
59939722|NCT01307423|76058160|FG007|NOT COMPLETED|Long-term Safety Phase (Year 2)||9||
59939723|NCT01307423|76058161|FG008|NOT COMPLETED|Long-term Safety Phase (Year 2)||7||
59939724|NCT01307423|76058153|FG000|STARTED|Long-term Safety Phase (Year 3)||0|The PBO/APR 20 mg and 30 mg EE and XO patients from week 24-52 are combined within the LTSP|
59939725|NCT01307423|76058154|FG001|STARTED|Long-term Safety Phase (Year 3)||99|The PBO/APR 20 mg and 30 mg EE and XO patients from week 24-52 are combined within the LTSP|
59939726|NCT01307423|76058155|FG002|STARTED|Long-term Safety Phase (Year 3)||109|The PBO/APR 20 mg and 30 mg EE and XO patients from week 24-52 are combined within the LTSP|
59939727|NCT01307423|76058156|FG003|STARTED|Long-term Safety Phase (Year 3)||0|The PBO/APR 20 mg and 30 mg EE and XO patients from week 24-52 are combined within the LTSP|
59939728|NCT01307423|76058157|FG004|STARTED|Long-term Safety Phase (Year 3)||0|The PBO/APR 20 mg and 30 mg EE and XO patients from week 24-52 are combined within the LTSP|
59939729|NCT01307423|76058158|FG005|STARTED|Long-term Safety Phase (Year 3)||0|The PBO/APR 20 mg and 30 mg EE and XO patients from week 24-52 are combined within the LTSP|
59939730|NCT01307423|76058159|FG006|STARTED|Long-term Safety Phase (Year 3)||0|The PBO/APR 20 mg and 30 mg EE and XO patients from week 24-52 are combined within the LTSP|
59939731|NCT01307423|76058160|FG007|STARTED|Long-term Safety Phase (Year 3)||48|The PBO/APR 20 mg and 30 mg EE and XO patients from week 24-52 are combined within the LTSP|
59939732|NCT01307423|76058161|FG008|STARTED|Long-term Safety Phase (Year 3)||60|The PBO/APR 20 mg and 30 mg EE and XO patients from week 24-52 are combined within the LTSP|
59939733|NCT01307423|76058153|FG000|COMPLETED|Long-term Safety Phase (Year 3)||0||
59939734|NCT01307423|76058154|FG001|COMPLETED|Long-term Safety Phase (Year 3)||90||
59939735|NCT01307423|76058155|FG002|COMPLETED|Long-term Safety Phase (Year 3)||91||
59939736|NCT01307423|76058156|FG003|COMPLETED|Long-term Safety Phase (Year 3)||0||
59939737|NCT01307423|76058157|FG004|COMPLETED|Long-term Safety Phase (Year 3)||0||
59939738|NCT01307423|76058158|FG005|COMPLETED|Long-term Safety Phase (Year 3)||0||
59939739|NCT01307423|76058159|FG006|COMPLETED|Long-term Safety Phase (Year 3)||0||
59939740|NCT01307423|76058160|FG007|COMPLETED|Long-term Safety Phase (Year 3)||40||
59939741|NCT01307423|76058161|FG008|COMPLETED|Long-term Safety Phase (Year 3)||49||
59939742|NCT01307423|76058153|FG000|NOT COMPLETED|Long-term Safety Phase (Year 3)||0||
59939743|NCT01307423|76058154|FG001|NOT COMPLETED|Long-term Safety Phase (Year 3)||9||
59939744|NCT01307423|76058155|FG002|NOT COMPLETED|Long-term Safety Phase (Year 3)||18||
59939745|NCT01307423|76058156|FG003|NOT COMPLETED|Long-term Safety Phase (Year 3)||0||
59939746|NCT01307423|76058157|FG004|NOT COMPLETED|Long-term Safety Phase (Year 3)||0||
59939747|NCT01307423|76058158|FG005|NOT COMPLETED|Long-term Safety Phase (Year 3)||0||
59939748|NCT01307423|76058159|FG006|NOT COMPLETED|Long-term Safety Phase (Year 3)||0||
59939749|NCT01307423|76058160|FG007|NOT COMPLETED|Long-term Safety Phase (Year 3)||8||
59939750|NCT01307423|76058161|FG008|NOT COMPLETED|Long-term Safety Phase (Year 3)||11||
59939751|NCT01307423|76058153|FG000|STARTED|Long-term Safety Phase (Year 4)||0|The PBO/APR 20 mg and 30 mg EE and XO patients from week 24-52 are combined within the LTSP|
59939752|NCT01307423|76058154|FG001|STARTED|Long-term Safety Phase (Year 4)|1 participant who completed Year 3 did not continue treatment in Year 4|89|The PBO/APR 20 mg and 30 mg EE and XO patients from week 24-52 are combined within the LTSP|
59939753|NCT01307423|76058155|FG002|STARTED|Long-term Safety Phase (Year 4)||91|The PBO/APR 20 mg and 30 mg EE and XO patients from week 24-52 are combined within the LTSP|
59939754|NCT01307423|76058156|FG003|STARTED|Long-term Safety Phase (Year 4)||0|The PBO/APR 20 mg and 30 mg EE and XO patients from week 24-52 are combined within the LTSP|
59939755|NCT01307423|76058157|FG004|STARTED|Long-term Safety Phase (Year 4)||0|The PBO/APR 20 mg and 30 mg EE and XO patients from week 24-52 are combined within the LTSP|
59939756|NCT01307423|76058158|FG005|STARTED|Long-term Safety Phase (Year 4)||0|The PBO/APR 20 mg and 30 mg EE and XO patients from week 24-52 are combined within the LTSP|
59939757|NCT01307423|76058159|FG006|STARTED|Long-term Safety Phase (Year 4)||0|The PBO/APR 20 mg and 30 mg EE and XO patients from week 24-52 are combined within the LTSP|
59939758|NCT01307423|76058160|FG007|STARTED|Long-term Safety Phase (Year 4)||40|The PBO/APR 20 mg and 30 mg EE and XO patients from week 24-52 are combined within the LTSP|
59939759|NCT01307423|76058161|FG008|STARTED|Long-term Safety Phase (Year 4)||49|The PBO/APR 20 mg and 30 mg EE and XO patients from week 24-52 are combined within the LTSP|
59939760|NCT01307423|76058153|FG000|COMPLETED|Long-term Safety Phase (Year 4)||0||
59939761|NCT01307423|76058154|FG001|COMPLETED|Long-term Safety Phase (Year 4)||81||
59939762|NCT01307423|76058155|FG002|COMPLETED|Long-term Safety Phase (Year 4)||86||
59939763|NCT01307423|76058156|FG003|COMPLETED|Long-term Safety Phase (Year 4)||0||
60067443|NCT01923896|76182637|FG001|COMPLETED|Overall Study||8||
60067444|NCT01923896|76182636|FG000|NOT COMPLETED|Overall Study||1||
60067445|NCT01923896|76182637|FG001|NOT COMPLETED|Overall Study||0||
60067446|NCT02004353|76182643|FG000|STARTED|Overall Study||1518||
60067447|NCT02004353|76182643|FG000|COMPLETED|Overall Study||184||
60067448|NCT02004353|76182643|FG000|NOT COMPLETED|Overall Study||1334||
59519060|NCT01116895|75612924|FG002|COMPLETED|Overall Study||14||
59519061|NCT01116895|75612925|FG003|COMPLETED|Overall Study||11||
59939764|NCT01307423|76058157|FG004|COMPLETED|Long-term Safety Phase (Year 4)||0||
59939765|NCT01307423|76058158|FG005|COMPLETED|Long-term Safety Phase (Year 4)||0||
59939766|NCT01307423|76058159|FG006|COMPLETED|Long-term Safety Phase (Year 4)||0||
59939767|NCT01307423|76058160|FG007|COMPLETED|Long-term Safety Phase (Year 4)||38||
59939768|NCT01307423|76058161|FG008|COMPLETED|Long-term Safety Phase (Year 4)||44||
59939769|NCT01307423|76058153|FG000|NOT COMPLETED|Long-term Safety Phase (Year 4)||0||
59939770|NCT01307423|76058154|FG001|NOT COMPLETED|Long-term Safety Phase (Year 4)||8||
59939771|NCT01307423|76058155|FG002|NOT COMPLETED|Long-term Safety Phase (Year 4)||5||
59939772|NCT01307423|76058156|FG003|NOT COMPLETED|Long-term Safety Phase (Year 4)||0||
59939773|NCT01307423|76058157|FG004|NOT COMPLETED|Long-term Safety Phase (Year 4)||0||
59939774|NCT01307423|76058158|FG005|NOT COMPLETED|Long-term Safety Phase (Year 4)||0||
59939775|NCT01307423|76058159|FG006|NOT COMPLETED|Long-term Safety Phase (Year 4)||0||
59939776|NCT01307423|76058160|FG007|NOT COMPLETED|Long-term Safety Phase (Year 4)||2||
59939777|NCT01307423|76058161|FG008|NOT COMPLETED|Long-term Safety Phase (Year 4)||5||
59939778|NCT01307423|76058153|FG000|STARTED|Long-term Safety Phase (Year 5)||0|The PBO/APR 20 mg and 30 mg EE and XO patients from week 24-52 are combined within the LTSP|
59939779|NCT01307423|76058154|FG001|STARTED|Long-term Safety Phase (Year 5)||81|The PBO/APR 20 mg and 30 mg EE and XO patients from week 24-52 are combined within the LTSP|
59939780|NCT01307423|76058155|FG002|STARTED|Long-term Safety Phase (Year 5)||86|The PBO/APR 20 mg and 30 mg EE and XO patients from week 24-52 are combined within the LTSP|
59939781|NCT01307423|76058156|FG003|STARTED|Long-term Safety Phase (Year 5)||0|The PBO/APR 20 mg and 30 mg EE and XO patients from week 24-52 are combined within the LTSP|
59939782|NCT01307423|76058157|FG004|STARTED|Long-term Safety Phase (Year 5)||0|The PBO/APR 20 mg and 30 mg EE and XO patients from week 24-52 are combined within the LTSP|
59939783|NCT01307423|76058158|FG005|STARTED|Long-term Safety Phase (Year 5)||0|The PBO/APR 20 mg and 30 mg EE and XO patients from week 24-52 are combined within the LTSP|
59939784|NCT01307423|76058159|FG006|STARTED|Long-term Safety Phase (Year 5)||0|The PBO/APR 20 mg and 30 mg EE and XO patients from week 24-52 are combined within the LTSP|
59518524|NCT01079143|75612316|FG000|Month 12 (M12) Biopsies|Overall Study|Only 26 out of 36 participants in this group had graft biopsy that was eligible for analysis.|26||
59518525|NCT01079143|75612317|FG001|Month 12 (M12) Biopsies|Overall Study||43||
59518526|NCT01079143|75612318|FG002|Month 12 (M12) Biopsies|Overall Study|Only 32 out of 39 participants in this group had graft biopsy that was eligible for analysis.|32||
59518527|NCT01079143|75612319|FG003|Month 12 (M12) Biopsies|Overall Study|Only 53 out of 59 participants in this group had graft biopsy that was eligible for analysis.|53||
59518528|NCT01079143|75612316|FG000|M3 and M12 Biopsies|Overall Study|Only 26 out of 36 participants in this group had graft biopsy that was eligible for analysis.|26||
59518529|NCT01079143|75612317|FG001|M3 and M12 Biopsies|Overall Study||43||
59518530|NCT01079143|75612318|FG002|M3 and M12 Biopsies|Overall Study|Only 32 out of 39 participants in this group had graft biopsy that was eligible for analysis.|32||
59518531|NCT01079143|75612319|FG003|M3 and M12 Biopsies|Overall Study|Only 53 out of 59 participants in this group had graft biopsy that was eligible for analysis.|53||
59518532|NCT01079143|75612316|FG000|COMPLETED|Overall Study||27||
59939785|NCT01307423|76058160|FG007|STARTED|Long-term Safety Phase (Year 5)||38|The PBO/APR 20 mg and 30 mg EE and XO patients from week 24-52 are combined within the LTSP|
59939786|NCT01307423|76058161|FG008|STARTED|Long-term Safety Phase (Year 5)||44|The PBO/APR 20 mg and 30 mg EE and XO patients from week 24-52 are combined within the LTSP|
59939787|NCT01307423|76058153|FG000|COMPLETED|Long-term Safety Phase (Year 5)||0||
59939788|NCT01307423|76058154|FG001|COMPLETED|Long-term Safety Phase (Year 5)||71||
59939789|NCT01307423|76058155|FG002|COMPLETED|Long-term Safety Phase (Year 5)||80||
59939790|NCT01307423|76058156|FG003|COMPLETED|Long-term Safety Phase (Year 5)||0||
59939791|NCT01307423|76058157|FG004|COMPLETED|Long-term Safety Phase (Year 5)||0||
59939792|NCT01307423|76058158|FG005|COMPLETED|Long-term Safety Phase (Year 5)||0||
59939793|NCT01307423|76058159|FG006|COMPLETED|Long-term Safety Phase (Year 5)||0||
59939794|NCT01307423|76058160|FG007|COMPLETED|Long-term Safety Phase (Year 5)||37||
59939795|NCT01307423|76058161|FG008|COMPLETED|Long-term Safety Phase (Year 5)||41||
59939796|NCT01307423|76058153|FG000|NOT COMPLETED|Long-term Safety Phase (Year 5)||0||
59939797|NCT01307423|76058154|FG001|NOT COMPLETED|Long-term Safety Phase (Year 5)||10||
59939798|NCT01307423|76058155|FG002|NOT COMPLETED|Long-term Safety Phase (Year 5)||6||
59939799|NCT01307423|76058156|FG003|NOT COMPLETED|Long-term Safety Phase (Year 5)||0||
59939800|NCT01307423|76058157|FG004|NOT COMPLETED|Long-term Safety Phase (Year 5)||0||
59939801|NCT01307423|76058158|FG005|NOT COMPLETED|Long-term Safety Phase (Year 5)||0||
59939802|NCT01307423|76058159|FG006|NOT COMPLETED|Long-term Safety Phase (Year 5)||0||
59939803|NCT01307423|76058160|FG007|NOT COMPLETED|Long-term Safety Phase (Year 5)||1||
59939804|NCT01307423|76058161|FG008|NOT COMPLETED|Long-term Safety Phase (Year 5)||3||
59939805|NCT02778074|76058195|FG000|STARTED|Overall Study||72||
59939806|NCT02778074|76058196|FG001|STARTED|Overall Study||72||
59939807|NCT02778074|76058195|FG000|COMPLETED|Overall Study||65||
59939808|NCT02778074|76058196|FG001|COMPLETED|Overall Study||62||
59939809|NCT02778074|76058195|FG000|NOT COMPLETED|Overall Study||7||
59939810|NCT02778074|76058196|FG001|NOT COMPLETED|Overall Study||10||
59939811|NCT00911183|76058204|FG000|STARTED|Overall Study||47||
59939812|NCT00911183|76058205|FG001|STARTED|Overall Study||20||
59939813|NCT00911183|76058204|FG000|COMPLETED|Overall Study||47||
59939814|NCT00911183|76058205|FG001|COMPLETED|Overall Study||20||
59518533|NCT01079143|75612317|FG001|COMPLETED|Overall Study||43||
59518534|NCT01079143|75612318|FG002|COMPLETED|Overall Study||34||
59939815|NCT00911183|76058204|FG000|NOT COMPLETED|Overall Study||0||
59939816|NCT00911183|76058205|FG001|NOT COMPLETED|Overall Study||0||
59939817|NCT02775344|76058213|FG000|STARTED|Overall Study||40||
59939818|NCT02775344|76058214|FG001|STARTED|Overall Study||40||
59939819|NCT02775344|76058213|FG000|COMPLETED|Overall Study||37||
59939820|NCT02775344|76058214|FG001|COMPLETED|Overall Study||38||
59939821|NCT02775344|76058213|FG000|NOT COMPLETED|Overall Study||3||
59939822|NCT02775344|76058214|FG001|NOT COMPLETED|Overall Study||2||
59939823|NCT02777918|76058222|FG000|STARTED|Overall Study||53||
59939824|NCT02777918|76058223|FG001|STARTED|Overall Study||47||
59939825|NCT02777918|76058222|FG000|COMPLETED|Overall Study||50||
59939826|NCT02777918|76058223|FG001|COMPLETED|Overall Study||43||
59939827|NCT02777918|76058222|FG000|NOT COMPLETED|Overall Study||3||
59939828|NCT02777918|76058223|FG001|NOT COMPLETED|Overall Study||4||
59939829|NCT02927795|76058229|FG000|STARTED|Overall Study||257||
59939830|NCT02927795|76058229|FG000|Treated|Overall Study||253||
59939831|NCT02927795|76058229|FG000|COMPLETED|Overall Study||234||
59939832|NCT02927795|76058229|FG000|NOT COMPLETED|Overall Study||23||
59939833|NCT02767856|76058235|FG000|STARTED|Overall Study||18||
59939834|NCT02767856|76058236|FG001|STARTED|Overall Study||14||
59939835|NCT02767856|76058235|FG000|COMPLETED|Overall Study||7||
59939836|NCT02767856|76058236|FG001|COMPLETED|Overall Study||12||
59939837|NCT02767856|76058235|FG000|NOT COMPLETED|Overall Study||11||
59939838|NCT02767856|76058236|FG001|NOT COMPLETED|Overall Study||2||
59939839|NCT03087851|76058245|FG000|STARTED|Overall Study||20||
59939840|NCT03087851|76058246|FG001|STARTED|Overall Study||20||
59939841|NCT03087851|76058247|FG002|STARTED|Overall Study||21||
59939842|NCT03087851|76058245|FG000|COMPLETED|Overall Study||20||
59939843|NCT03087851|76058246|FG001|COMPLETED|Overall Study||19||
59939844|NCT03087851|76058247|FG002|COMPLETED|Overall Study||19||
59939845|NCT03087851|76058245|FG000|NOT COMPLETED|Overall Study||0||
59939846|NCT03087851|76058246|FG001|NOT COMPLETED|Overall Study||1||
59939847|NCT03087851|76058247|FG002|NOT COMPLETED|Overall Study||2||
59939848|NCT03092375|76058259|FG000|STARTED|Overall Study||78||
59939849|NCT03092375|76058260|FG001|STARTED|Overall Study||49||
59939850|NCT03092375|76058261|FG002|STARTED|Overall Study||21||
59939851|NCT03092375|76058262|FG003|STARTED|Overall Study||29||
59939852|NCT03092375|76058259|FG000|COMPLETED|Overall Study||78||
59939853|NCT03092375|76058260|FG001|COMPLETED|Overall Study||48||
59939854|NCT03092375|76058261|FG002|COMPLETED|Overall Study||20||
59939855|NCT03092375|76058262|FG003|COMPLETED|Overall Study||29||
59939856|NCT03092375|76058259|FG000|NOT COMPLETED|Overall Study||0||
59939857|NCT03092375|76058260|FG001|NOT COMPLETED|Overall Study||1||
59939858|NCT03092375|76058261|FG002|NOT COMPLETED|Overall Study||1||
59939859|NCT03092375|76058262|FG003|NOT COMPLETED|Overall Study||0||
59939860|NCT01995513|76058279|FG000|STARTED|Period 1: First Open Label Treatment||509||
59939861|NCT01995513|76058280|FG001|STARTED|Period 1: First Open Label Treatment||0||
59939862|NCT01995513|76058281|FG002|STARTED|Period 1: First Open Label Treatment||0||
59939863|NCT01995513|76058282|FG003|STARTED|Period 1: First Open Label Treatment||0||
59939864|NCT01995513|76058279|FG000|COMPLETED|Period 1: First Open Label Treatment||264||
59939865|NCT01995513|76058280|FG001|COMPLETED|Period 1: First Open Label Treatment||0||
59939866|NCT01995513|76058281|FG002|COMPLETED|Period 1: First Open Label Treatment||0||
59939867|NCT01995513|76058282|FG003|COMPLETED|Period 1: First Open Label Treatment||0||
59939868|NCT01995513|76058279|FG000|NOT COMPLETED|Period 1: First Open Label Treatment||245||
59939869|NCT01995513|76058280|FG001|NOT COMPLETED|Period 1: First Open Label Treatment||0||
59939870|NCT01995513|76058281|FG002|NOT COMPLETED|Period 1: First Open Label Treatment||0||
59939871|NCT01995513|76058282|FG003|NOT COMPLETED|Period 1: First Open Label Treatment||0||
59939872|NCT01995513|76058279|FG000|STARTED|Period 1: Second Open Label Treatment||0||
59939873|NCT01995513|76058280|FG001|STARTED|Period 1: Second Open Label Treatment||13||
59939874|NCT01995513|76058281|FG002|STARTED|Period 1: Second Open Label Treatment||0||
59939875|NCT01995513|76058282|FG003|STARTED|Period 1: Second Open Label Treatment||0||
59939876|NCT01995513|76058279|FG000|COMPLETED|Period 1: Second Open Label Treatment||0||
59939877|NCT01995513|76058280|FG001|COMPLETED|Period 1: Second Open Label Treatment||0||
59939878|NCT01995513|76058281|FG002|COMPLETED|Period 1: Second Open Label Treatment||0||
59939879|NCT01995513|76058282|FG003|COMPLETED|Period 1: Second Open Label Treatment||0||
59939880|NCT01995513|76058279|FG000|NOT COMPLETED|Period 1: Second Open Label Treatment||0||
59939881|NCT01995513|76058280|FG001|NOT COMPLETED|Period 1: Second Open Label Treatment||13||
59939882|NCT01995513|76058281|FG002|NOT COMPLETED|Period 1: Second Open Label Treatment||0||
59939883|NCT01995513|76058282|FG003|NOT COMPLETED|Period 1: Second Open Label Treatment||0||
59939884|NCT01995513|76058279|FG000|STARTED|Period 2: Double Blind Treatment||0||
59939885|NCT01995513|76058280|FG001|STARTED|Period 2: Double Blind Treatment||0||
59939886|NCT01995513|76058281|FG002|STARTED|Period 2: Double Blind Treatment||126||
59939887|NCT01995513|76058282|FG003|STARTED|Period 2: Double Blind Treatment||125||
59939888|NCT01995513|76058279|FG000|Treated|Period 2: Double Blind Treatment||0||
59939889|NCT01995513|76058280|FG001|Treated|Period 2: Double Blind Treatment||0||
59939890|NCT01995513|76058281|FG002|Treated|Period 2: Double Blind Treatment||125||
59939891|NCT01995513|76058282|FG003|Treated|Period 2: Double Blind Treatment||124||
59939892|NCT01995513|76058279|FG000|COMPLETED|Period 2: Double Blind Treatment||0||
59939893|NCT01995513|76058280|FG001|COMPLETED|Period 2: Double Blind Treatment||0||
59939894|NCT01995513|76058281|FG002|COMPLETED|Period 2: Double Blind Treatment||0||
59939895|NCT01995513|76058282|FG003|COMPLETED|Period 2: Double Blind Treatment||0||
59939896|NCT01995513|76058279|FG000|NOT COMPLETED|Period 2: Double Blind Treatment||0||
59939897|NCT01995513|76058280|FG001|NOT COMPLETED|Period 2: Double Blind Treatment||0||
59939898|NCT01995513|76058281|FG002|NOT COMPLETED|Period 2: Double Blind Treatment||126||
59939899|NCT01995513|76058282|FG003|NOT COMPLETED|Period 2: Double Blind Treatment||125||
59939900|NCT02927171|76058298|FG000|STARTED|Overall Study||53||
59939901|NCT02927171|76058299|FG001|STARTED|Overall Study||51||
59939902|NCT02927171|76058298|FG000|COMPLETED|Overall Study||53||
59939903|NCT02927171|76058299|FG001|COMPLETED|Overall Study||50||
59939904|NCT02927171|76058298|FG000|NOT COMPLETED|Overall Study||0||
59939905|NCT02927171|76058299|FG001|NOT COMPLETED|Overall Study||1||
59939906|NCT03087617|76058309|FG000|STARTED|Overall Study||79||
59939907|NCT03087617|76058310|FG001|STARTED|Overall Study||80||
59939908|NCT03087617|76058311|FG002|STARTED|Overall Study||82||
59939909|NCT03087617|76058312|FG003|STARTED|Overall Study||80||
59939910|NCT03087617|76058309|FG000|COMPLETED|Overall Study||47||
59939911|NCT03087617|76058310|FG001|COMPLETED|Overall Study||50||
59939912|NCT03087617|76058311|FG002|COMPLETED|Overall Study||52||
59939913|NCT03087617|76058312|FG003|COMPLETED|Overall Study||41||
59939914|NCT03087617|76058309|FG000|NOT COMPLETED|Overall Study||32||
59939915|NCT03087617|76058310|FG001|NOT COMPLETED|Overall Study||30||
59939916|NCT03087617|76058311|FG002|NOT COMPLETED|Overall Study||30||
59939917|NCT03087617|76058312|FG003|NOT COMPLETED|Overall Study||39||
59939918|NCT00103610|76058324|FG000|STARTED|Overall Study||150||
59939919|NCT00103610|76058325|FG001|STARTED|Overall Study||148||
59939920|NCT00103610|76058324|FG000|COMPLETED|Overall Study||112||
59939921|NCT00103610|76058325|FG001|COMPLETED|Overall Study||68||
59939922|NCT00103610|76058324|FG000|NOT COMPLETED|Overall Study||38||
59939923|NCT00103610|76058325|FG001|NOT COMPLETED|Overall Study||80||
59939924|NCT03091439|76058334|FG000|STARTED|Overall Study||1||
59939925|NCT03091439|76058335|FG001|STARTED|Overall Study||0||
59939926|NCT03091439|76058334|FG000|COMPLETED|Overall Study||0||
59939927|NCT03091439|76058335|FG001|COMPLETED|Overall Study||0||
59939928|NCT03091439|76058334|FG000|NOT COMPLETED|Overall Study||1||
59939929|NCT03091439|76058335|FG001|NOT COMPLETED|Overall Study||0||
59939930|NCT03086447|76058343|FG000|STARTED|Overall Study||132||
59939931|NCT03086447|76058344|FG001|STARTED|Overall Study||130||
59939932|NCT03086447|76058343|FG000|COMPLETED|Overall Study||121||
59939933|NCT03086447|76058344|FG001|COMPLETED|Overall Study||110||
59939934|NCT03086447|76058343|FG000|NOT COMPLETED|Overall Study||11||
59939935|NCT03086447|76058344|FG001|NOT COMPLETED|Overall Study||20||
59939936|NCT03104413|76058353|FG000|STARTED|Induction Period 1||207||
59939937|NCT03104413|76058354|FG001|STARTED|Induction Period 1||206||
59939938|NCT03104413|76058355|FG002|STARTED|Induction Period 1||205||
59939939|NCT03104413|76058356|FG003|STARTED|Induction Period 1||0||
59939940|NCT03104413|76058357|FG004|STARTED|Induction Period 1||0||
59939941|NCT03104413|76058358|FG005|STARTED|Induction Period 1||0||
59939942|NCT03104413|76058359|FG006|STARTED|Induction Period 1||0||
59939943|NCT03104413|76058353|FG000|COMPLETED|Induction Period 1||186||
59939944|NCT03104413|76058354|FG001|COMPLETED|Induction Period 1||202||
59939945|NCT03104413|76058355|FG002|COMPLETED|Induction Period 1||199||
59939946|NCT03104413|76058356|FG003|COMPLETED|Induction Period 1||0||
59939947|NCT03104413|76058357|FG004|COMPLETED|Induction Period 1||0||
59939948|NCT03104413|76058358|FG005|COMPLETED|Induction Period 1||0||
59939949|NCT03104413|76058359|FG006|COMPLETED|Induction Period 1||0||
59939950|NCT03104413|76058353|FG000|NOT COMPLETED|Induction Period 1||21||
59939951|NCT03104413|76058354|FG001|NOT COMPLETED|Induction Period 1||4||
59939952|NCT03104413|76058355|FG002|NOT COMPLETED|Induction Period 1||6||
59939953|NCT03104413|76058356|FG003|NOT COMPLETED|Induction Period 1||0||
59939954|NCT03104413|76058357|FG004|NOT COMPLETED|Induction Period 1||0||
59939955|NCT03104413|76058358|FG005|NOT COMPLETED|Induction Period 1||0||
60067449|NCT01938625|76182649|FG000|STARTED|Overall Study||10||
60067450|NCT01938625|76182650|FG001|STARTED|Overall Study||25||
59939956|NCT03104413|76058359|FG006|NOT COMPLETED|Induction Period 1||0||
59939957|NCT03104413|76058353|FG000|STARTED|Induction Period 2||0||
59939958|NCT03104413|76058354|FG001|STARTED|Induction Period 2||0||
59939959|NCT03104413|76058355|FG002|STARTED|Induction Period 2||0||
59939960|NCT03104413|76058356|FG003|STARTED|Induction Period 2||41||
59939961|NCT03104413|76058357|FG004|STARTED|Induction Period 2||42||
59939962|NCT03104413|76058358|FG005|STARTED|Induction Period 2||42||
59939963|NCT03104413|76058359|FG006|STARTED|Induction Period 2||86||
59939964|NCT03104413|76058353|FG000|COMPLETED|Induction Period 2||0||
59939965|NCT03104413|76058354|FG001|COMPLETED|Induction Period 2||0||
59939966|NCT03104413|76058355|FG002|COMPLETED|Induction Period 2||0||
59939967|NCT03104413|76058356|FG003|COMPLETED|Induction Period 2||39||
59939968|NCT03104413|76058357|FG004|COMPLETED|Induction Period 2||39||
59939969|NCT03104413|76058358|FG005|COMPLETED|Induction Period 2||38||
59939970|NCT03104413|76058359|FG006|COMPLETED|Induction Period 2||76||
59939971|NCT03104413|76058353|FG000|NOT COMPLETED|Induction Period 2||0||
59939972|NCT03104413|76058354|FG001|NOT COMPLETED|Induction Period 2||0||
59939973|NCT03104413|76058355|FG002|NOT COMPLETED|Induction Period 2||0||
59939974|NCT03104413|76058356|FG003|NOT COMPLETED|Induction Period 2||2||
59939975|NCT03104413|76058357|FG004|NOT COMPLETED|Induction Period 2||3||
59939976|NCT03104413|76058358|FG005|NOT COMPLETED|Induction Period 2||4||
59939977|NCT03104413|76058359|FG006|NOT COMPLETED|Induction Period 2||10||
59939978|NCT03083639|76058375|FG000|STARTED|Intervention Period 1 (1 Day)||26||
59939979|NCT03083639|76058376|FG001|STARTED|Intervention Period 1 (1 Day)||26||
59939980|NCT03083639|76058375|FG000|COMPLETED|Intervention Period 1 (1 Day)||26||
59939981|NCT03083639|76058376|FG001|COMPLETED|Intervention Period 1 (1 Day)||26||
59939982|NCT03083639|76058375|FG000|NOT COMPLETED|Intervention Period 1 (1 Day)||0||
59939983|NCT03083639|76058376|FG001|NOT COMPLETED|Intervention Period 1 (1 Day)||0||
59939984|NCT03083639|76058375|FG000|STARTED|Washout Period (at Least 6 Days)||26||
59939985|NCT03083639|76058376|FG001|STARTED|Washout Period (at Least 6 Days)||26||
59939986|NCT03083639|76058375|FG000|COMPLETED|Washout Period (at Least 6 Days)||25||
59939987|NCT03083639|76058376|FG001|COMPLETED|Washout Period (at Least 6 Days)||25||
59939988|NCT03083639|76058375|FG000|NOT COMPLETED|Washout Period (at Least 6 Days)||1||
59939989|NCT03083639|76058376|FG001|NOT COMPLETED|Washout Period (at Least 6 Days)||1||
59939990|NCT03083639|76058375|FG000|STARTED|Intervention Period 2 (1 Day)||25||
59939991|NCT03083639|76058376|FG001|STARTED|Intervention Period 2 (1 Day)||25||
59939992|NCT03083639|76058375|FG000|COMPLETED|Intervention Period 2 (1 Day)||25||
59939993|NCT03083639|76058376|FG001|COMPLETED|Intervention Period 2 (1 Day)||25||
59939994|NCT03083639|76058375|FG000|NOT COMPLETED|Intervention Period 2 (1 Day)||0||
59939995|NCT03083639|76058376|FG001|NOT COMPLETED|Intervention Period 2 (1 Day)||0||
59939996|NCT02927431|76058385|FG000|STARTED|Overall Study||2||
59939997|NCT02927431|76058386|FG001|STARTED|Overall Study||4||
59939998|NCT02927431|76058387|FG002|STARTED|Overall Study||4||
59939999|NCT02927431|76058385|FG000|COMPLETED|Overall Study||2||
59940000|NCT02927431|76058386|FG001|COMPLETED|Overall Study||4||
59940001|NCT02927431|76058387|FG002|COMPLETED|Overall Study||3||
59940002|NCT02927431|76058385|FG000|NOT COMPLETED|Overall Study||0||
59940003|NCT02927431|76058386|FG001|NOT COMPLETED|Overall Study||0||
59940004|NCT02927431|76058387|FG002|NOT COMPLETED|Overall Study||1||
59940005|NCT03083483|76058400|FG000|STARTED|Overall Study||24||
59940006|NCT03083483|76058401|FG001|STARTED|Overall Study||22||
59940007|NCT03083483|76058402|FG002|STARTED|Overall Study||23||
59940008|NCT03083483|76058400|FG000|COMPLETED|Overall Study||20||
59940009|NCT03083483|76058401|FG001|COMPLETED|Overall Study||20||
59940010|NCT03083483|76058402|FG002|COMPLETED|Overall Study||20||
59940011|NCT03083483|76058400|FG000|NOT COMPLETED|Overall Study||4||
59940012|NCT03083483|76058401|FG001|NOT COMPLETED|Overall Study||2||
59940013|NCT03083483|76058402|FG002|NOT COMPLETED|Overall Study||3||
59940014|NCT03085927|76058414|FG000|STARTED|Overall Study||69|Numbers listed reflect child/parents in a dyad. Arm 1=138 individuals Arm 2=134|
59940015|NCT03085927|76058415|FG001|STARTED|Overall Study||67|Numbers listed reflect child/parents in a dyad. Arm 1=138 individuals Arm 2=134|
59940016|NCT03085927|76058414|FG000|Study Sessions|Overall Study|"Off Study reasons:~Child toxicity/side effects (n=1) Dyad withdrew (n=1) Dyad lost to follow-up (n=2)"|65|Arm 1=130 individuals Arm 2=126 individuals|
59940017|NCT03085927|76058415|FG001|Study Sessions|Overall Study|"Off Study reasons:~Dyad withdrew (n=3) Dyad became ineligible (n=1)"|63|Arm 1=130 individuals Arm 2=126 individuals|
59940018|NCT03085927|76058414|FG000|Time 2 Measures|Overall Study||65|Arm 1=130 individuals Arm 2=124 individuals|
59940019|NCT03085927|76058415|FG001|Time 2 Measures|Overall Study|"Off Study reasons:~Dyad withdrew (n=1)"|62|Arm 1=130 individuals Arm 2=124 individuals|
59940020|NCT03085927|76058414|FG000|COMPLETED|Overall Study|"Off Study reasons:~Death of child (n=1) Dyad lost to follow up (n=1)"|63|Arm 1=126 individuals Arm 2=122 individuals|
59940021|NCT03085927|76058415|FG001|COMPLETED|Overall Study|"Off Study reason:~Dyad lost to follow up (n=1)"|61|Arm 1=126 individuals Arm 2=122 individuals|
59940022|NCT03085927|76058414|FG000|NOT COMPLETED|Overall Study||6||
59940023|NCT03085927|76058415|FG001|NOT COMPLETED|Overall Study||6||
59940024|NCT04392583|76058423|FG000|STARTED|Overall Study||40||
59940025|NCT04392583|76058423|FG000|COMPLETED|Overall Study||39||
59940026|NCT04392583|76058423|FG000|NOT COMPLETED|Overall Study||1||
59940027|NCT04497987|76058429|FG000|STARTED|Overall Study||592||
59940028|NCT04497987|76058430|FG001|STARTED|Overall Study||588||
59940029|NCT04497987|76058429|FG000|Received at Least One Dose of Study Drug|Overall Study||587||
59940030|NCT04497987|76058430|FG001|Received at Least One Dose of Study Drug|Overall Study||588||
59940031|NCT04497987|76058429|FG000|Prevention Population|Overall Study||485||
59940032|NCT04497987|76058430|FG001|Prevention Population|Overall Study||487||
59940033|NCT04497987|76058429|FG000|Treatment Population|Overall Study||68||
59940034|NCT04497987|76058430|FG001|Treatment Population|Overall Study||66||
59940035|NCT04497987|76058429|FG000|Serology Positive|Overall Study||36||
59940036|NCT04497987|76058430|FG001|Serology Positive|Overall Study||35||
59940037|NCT04497987|76058429|FG000|COMPLETED|Overall Study||493||
59940038|NCT04497987|76058430|FG001|COMPLETED|Overall Study||521||
59940039|NCT04497987|76058429|FG000|NOT COMPLETED|Overall Study||99||
59940040|NCT04497987|76058430|FG001|NOT COMPLETED|Overall Study||67||
59940041|NCT00974571|76058440|FG000|STARTED|Overall Study||630||
59940042|NCT00974571|76058441|FG001|STARTED|Overall Study||122||
59940043|NCT00974571|76058442|FG002|STARTED|Overall Study||613||
59940044|NCT00974571|76058440|FG000|COMPLETED|Overall Study||562||
59940045|NCT00974571|76058441|FG001|COMPLETED|Overall Study||106||
59940046|NCT00974571|76058442|FG002|COMPLETED|Overall Study||530||
59940047|NCT00974571|76058440|FG000|NOT COMPLETED|Overall Study||68||
59940048|NCT00974571|76058441|FG001|NOT COMPLETED|Overall Study||16||
59940049|NCT00974571|76058442|FG002|NOT COMPLETED|Overall Study||83||
59940050|NCT02766608|76058455|FG000|STARTED|Overall Study||655|mITT Population|
59940051|NCT02766608|76058456|FG001|STARTED|Overall Study||637|mITT Population|
59940052|NCT02766608|76058457|FG002|STARTED|Overall Study||644|mITT Population|
59940053|NCT02766608|76058458|FG003|STARTED|Overall Study||206|mITT Population|
59940054|NCT02766608|76058459|FG004|STARTED|Overall Study||219|mITT Population|
59940055|NCT02766608|76058455|FG000|COMPLETED|Overall Study||576|Completed Treatment|
59940056|NCT02766608|76058456|FG001|COMPLETED|Overall Study||567|Completed Treatment|
59940057|NCT02766608|76058457|FG002|COMPLETED|Overall Study||554|Completed Treatment|
59940058|NCT02766608|76058458|FG003|COMPLETED|Overall Study||169|Completed Treatment|
59940059|NCT02766608|76058459|FG004|COMPLETED|Overall Study||190|Completed Treatment|
59940060|NCT02766608|76058455|FG000|NOT COMPLETED|Overall Study||79||
59940061|NCT02766608|76058456|FG001|NOT COMPLETED|Overall Study||70||
59940062|NCT02766608|76058457|FG002|NOT COMPLETED|Overall Study||90||
59940063|NCT02766608|76058458|FG003|NOT COMPLETED|Overall Study||37||
59940064|NCT02766608|76058459|FG004|NOT COMPLETED|Overall Study||29||
59940065|NCT00960141|76058477|FG000|STARTED|Overall Study||333||
59940066|NCT00960141|76058478|FG001|STARTED|Overall Study||326||
59940067|NCT00960141|76058479|FG002|STARTED|Overall Study||170||
59940068|NCT00960141|76058477|FG000|COMPLETED|Overall Study||323||
59940069|NCT00960141|76058478|FG001|COMPLETED|Overall Study||309||
59940070|NCT00960141|76058479|FG002|COMPLETED|Overall Study||163||
59940071|NCT00960141|76058477|FG000|NOT COMPLETED|Overall Study||10||
59940072|NCT00960141|76058478|FG001|NOT COMPLETED|Overall Study||17||
59940073|NCT00960141|76058479|FG002|NOT COMPLETED|Overall Study||7||
59940074|NCT02771522|76058487|FG000|STARTED|Overall Study|119 teeth imaged with the Calcivis System from 30 patients|30|Patients attending baseline visit at de-bond and imaged with Calcivis System|119
59940075|NCT02771522|76058487|FG000|COMPLETED|Overall Study|87 teeth imaged with the Calcivis System fro 22 patients|22|Patients attending final visit at 8 weeks post de-bond and imaged with Calcivis System|87
59940076|NCT02771522|76058487|FG000|NOT COMPLETED|Overall Study||8||32
59940077|NCT00759655|76058496|FG000|STARTED|Overall Study||1||
59940078|NCT00759655|76058496|FG000|COMPLETED|Overall Study||0||
59940079|NCT00759655|76058496|FG000|NOT COMPLETED|Overall Study||1||
59940080|NCT02771366|76058502|FG000|STARTED|Period 1||15||
59940081|NCT02771366|76058503|FG001|STARTED|Period 1||15||
59940082|NCT02771366|76058502|FG000|COMPLETED|Period 1||15||
59940083|NCT02771366|76058503|FG001|COMPLETED|Period 1||13||
59518535|NCT01079143|75612319|FG003|COMPLETED|Overall Study||54||
59518536|NCT01079143|75612316|FG000|NOT COMPLETED|Overall Study||9||
59518537|NCT01079143|75612317|FG001|NOT COMPLETED|Overall Study||17||
59518538|NCT01079143|75612318|FG002|NOT COMPLETED|Overall Study||5||
59518539|NCT01079143|75612319|FG003|NOT COMPLETED|Overall Study||5||
59518540|NCT03284398|75612335|FG000|STARTED|Overall Study||2753||
59940084|NCT02771366|76058502|FG000|NOT COMPLETED|Period 1||0||
59940085|NCT02771366|76058503|FG001|NOT COMPLETED|Period 1||2||
59940086|NCT02771366|76058502|FG000|STARTED|Period 2 (Crossover)||15||
59940087|NCT02771366|76058503|FG001|STARTED|Period 2 (Crossover)||13||
59940088|NCT02771366|76058502|FG000|COMPLETED|Period 2 (Crossover)||13||
59940089|NCT02771366|76058503|FG001|COMPLETED|Period 2 (Crossover)||13||
59940090|NCT02771366|76058502|FG000|NOT COMPLETED|Period 2 (Crossover)||2||
59940091|NCT02771366|76058503|FG001|NOT COMPLETED|Period 2 (Crossover)||0||
59940092|NCT03396471|76058510|FG000|STARTED|Study Treatment - Up to 22 Months||14||
59940093|NCT03396471|76058510|FG000|COMPLETED|Study Treatment - Up to 22 Months||0||
59940094|NCT03396471|76058510|FG000|NOT COMPLETED|Study Treatment - Up to 22 Months||14||
59940095|NCT03396471|76058510|FG000|STARTED|Follow up - Up to 2 Years||14|Treatment and Follow-up are sequential time periods. All subjects from the Treatment time period continue to the follow-up time period, regardless of their completion status.|
59940096|NCT03396471|76058510|FG000|COMPLETED|Follow up - Up to 2 Years||0||
59940097|NCT03396471|76058510|FG000|NOT COMPLETED|Follow up - Up to 2 Years||14||
60067451|NCT01938625|76182649|FG000|COMPLETED|Overall Study||10||
59518541|NCT03284398|75612336|FG001|STARTED|Overall Study||970||
59940098|NCT00103142|76058516|FG000|STARTED|Overall Study||36||
59940099|NCT00103142|76058517|FG001|STARTED|Overall Study||37||
59940100|NCT00103142|76058516|FG000|COMPLETED|Overall Study||33||
60067452|NCT01938625|76182650|FG001|COMPLETED|Overall Study||23||
59518542|NCT03284398|75612335|FG000|COMPLETED|Overall Study||2753|Retrospective data collection: all patients under study intervention during the predefined period|
59940101|NCT00103142|76058517|FG001|COMPLETED|Overall Study||36||
59940102|NCT00103142|76058516|FG000|NOT COMPLETED|Overall Study||3||
59940103|NCT00103142|76058517|FG001|NOT COMPLETED|Overall Study||1||
59940104|NCT00943683|76058527|FG000|STARTED|Overall Study||81||
59940105|NCT00943683|76058528|FG001|STARTED|Overall Study||175||
59940106|NCT00943683|76058527|FG000|COMPLETED|Overall Study||74||
59940107|NCT00943683|76058528|FG001|COMPLETED|Overall Study||169||
59940108|NCT00943683|76058527|FG000|NOT COMPLETED|Overall Study||7||
59940109|NCT00943683|76058528|FG001|NOT COMPLETED|Overall Study||6||
59940110|NCT00911547|76058538|FG000|STARTED|Overall Study|Efficacy in last 10 wks to minimize confounding effect of beclo in 1st 4 wks & allow beclo washout.|48||
59940111|NCT00911547|76058539|FG001|STARTED|Overall Study|Efficacy in last 10 wks to minimize confounding effect of beclo in 1st 4 wks & allow beclo washout.|201||
59940112|NCT00911547|76058540|FG002|STARTED|Overall Study|Efficacy analyses were over the 16 weeks of treatment.|200||
59940113|NCT00911547|76058541|FG003|STARTED|Overall Study|Efficacy analyses were over the 16 weeks of treatment.|193||
59940114|NCT00911547|76058538|FG000|COMPLETED|Overall Study||37||
59940115|NCT00911547|76058539|FG001|COMPLETED|Overall Study||159||
59940116|NCT00911547|76058540|FG002|COMPLETED|Overall Study||178||
59940117|NCT00911547|76058541|FG003|COMPLETED|Overall Study||177||
59940118|NCT00911547|76058538|FG000|NOT COMPLETED|Overall Study||11||
59940119|NCT00911547|76058539|FG001|NOT COMPLETED|Overall Study||42||
59940120|NCT00911547|76058540|FG002|NOT COMPLETED|Overall Study||22||
59940121|NCT00911547|76058541|FG003|NOT COMPLETED|Overall Study||16||
59940122|NCT00899379|76058556|FG000|STARTED|Overall Study|Patients who were allocated study drug|95||
59940123|NCT00899379|76058557|FG001|STARTED|Overall Study|Patients who were allocated study drug|95||
59940124|NCT00899379|76058558|FG002|STARTED|Overall Study|Patients who were allocated study drug|95||
59940125|NCT00899379|76058559|FG003|STARTED|Overall Study|Patients who were allocated study drug|94||
59940126|NCT00899379|76058560|FG004|STARTED|Overall Study|Patients who were allocated study drug|94||
59940127|NCT00899379|76058556|FG000|Patients Treated|Overall Study|Patients who took study drug|83||
59940128|NCT00899379|76058557|FG001|Patients Treated|Overall Study|Patients who took study drug|82||
59940129|NCT00899379|76058558|FG002|Patients Treated|Overall Study|Patients who took study drug|84||
59940130|NCT00899379|76058559|FG003|Patients Treated|Overall Study|Patients who took study drug|77||
59940131|NCT00899379|76058560|FG004|Patients Treated|Overall Study|Patients who took study drug|81||
59940132|NCT00899379|76058556|FG000|Patients Not Treated|Overall Study|Patients who did not take study drug|12||
59940133|NCT00899379|76058557|FG001|Patients Not Treated|Overall Study|Patients who did not take study drug|13||
59940134|NCT00899379|76058558|FG002|Patients Not Treated|Overall Study|Patients who did not take study drug|11||
59940135|NCT00899379|76058559|FG003|Patients Not Treated|Overall Study|Patients who did not take study drug|17||
59940136|NCT00899379|76058560|FG004|Patients Not Treated|Overall Study|Patients who did not take study drug|13||
59940137|NCT00899379|76058556|FG000|COMPLETED|Overall Study|Patients who took study drug and completed the study|61||
59940138|NCT00899379|76058557|FG001|COMPLETED|Overall Study|Patients who took study drug and completed the study|66||
59940139|NCT00899379|76058558|FG002|COMPLETED|Overall Study|Patients who took study drug and completed the study|66||
59940140|NCT00899379|76058559|FG003|COMPLETED|Overall Study|Patients who took study drug and completed the study|57||
59940141|NCT00899379|76058560|FG004|COMPLETED|Overall Study|Patients who took study drug and completed the study|63||
59940142|NCT00899379|76058556|FG000|NOT COMPLETED|Overall Study||34||
59940143|NCT00899379|76058557|FG001|NOT COMPLETED|Overall Study||29||
59940144|NCT00899379|76058558|FG002|NOT COMPLETED|Overall Study||29||
59761994|NCT00581308|75881641|FG000|NOT COMPLETED|60 Months||3||
59761995|NCT00877890|75881650|FG000|STARTED|Overall Study||129||
59761996|NCT00877890|75881651|FG001|STARTED|Overall Study||125||
59761997|NCT00877890|75881650|FG000|Intent to Treat (ITT)|Overall Study||129||
59761998|NCT00877890|75881651|FG001|Intent to Treat (ITT)|Overall Study||123||
59761999|NCT00877890|75881650|FG000|COMPLETED|Overall Study||109||
59762000|NCT00877890|75881651|FG001|COMPLETED|Overall Study||95||
59762001|NCT00877890|75881650|FG000|NOT COMPLETED|Overall Study||20||
59762002|NCT00877890|75881651|FG001|NOT COMPLETED|Overall Study||30||
59762003|NCT03474679|75881661|FG000|STARTED|Overall Study||19||
59762004|NCT03474679|75881661|FG000|COMPLETED|Overall Study||11||
59762005|NCT03474679|75881661|FG000|NOT COMPLETED|Overall Study||8||
59762006|NCT03905863|75881667|FG000|STARTED|Overall Study||64||
59762007|NCT03905863|75881668|FG001|STARTED|Overall Study||81||
59762008|NCT03905863|75881667|FG000|COMPLETED|Overall Study||59||
59762009|NCT03905863|75881668|FG001|COMPLETED|Overall Study||69||
59762010|NCT03905863|75881667|FG000|NOT COMPLETED|Overall Study||5||
59762011|NCT03905863|75881668|FG001|NOT COMPLETED|Overall Study||12||
59762012|NCT04067011|75881677|FG000|STARTED|Overall Study||70||
59940145|NCT00899379|76058559|FG003|NOT COMPLETED|Overall Study||37||
59940146|NCT00899379|76058560|FG004|NOT COMPLETED|Overall Study||31||
59940147|NCT04326439|76058568|FG000|STARTED|Overall Study||5||
59762013|NCT04067011|75881678|FG001|STARTED|Overall Study||71||
59762014|NCT04067011|75881679|FG002|STARTED|Overall Study||69||
59762015|NCT04067011|75881677|FG000|COMPLETED|Overall Study||51||
59762016|NCT04067011|75881678|FG001|COMPLETED|Overall Study||58||
59762017|NCT04067011|75881679|FG002|COMPLETED|Overall Study||61||
59762018|NCT04067011|75881677|FG000|NOT COMPLETED|Overall Study||19||
59762019|NCT04067011|75881678|FG001|NOT COMPLETED|Overall Study||13||
59762020|NCT04067011|75881679|FG002|NOT COMPLETED|Overall Study||8||
59762021|NCT04488575|75881691|FG000|STARTED|Overall Study||7||
59762022|NCT04488575|75881692|FG001|STARTED|Overall Study||9||
59762023|NCT04488575|75881691|FG000|COMPLETED|Overall Study||7||
59762024|NCT04488575|75881692|FG001|COMPLETED|Overall Study||4||
59762025|NCT04488575|75881691|FG000|NOT COMPLETED|Overall Study||0||
59762026|NCT04488575|75881692|FG001|NOT COMPLETED|Overall Study||5||
59762027|NCT03475004|75881701|FG000|STARTED|Overall Study||11||
59762028|NCT03475004|75881702|FG001|STARTED|Overall Study||21||
59762029|NCT03475004|75881703|FG002|STARTED|Overall Study||21||
59762030|NCT03475004|75881701|FG000|COMPLETED|Overall Study||10||
59762031|NCT03475004|75881702|FG001|COMPLETED|Overall Study||20||
59762032|NCT03475004|75881703|FG002|COMPLETED|Overall Study||20||
59762033|NCT03475004|75881701|FG000|NOT COMPLETED|Overall Study||1||
59762034|NCT03475004|75881702|FG001|NOT COMPLETED|Overall Study||1||
59762035|NCT03475004|75881703|FG002|NOT COMPLETED|Overall Study||1||
59762036|NCT03993691|75881717|FG000|STARTED|Overall Study||30||
59762037|NCT03993691|75881717|FG000|COMPLETED|Overall Study||30||
59762038|NCT03993691|75881717|FG000|NOT COMPLETED|Overall Study||0||
59762039|NCT00539305|75881723|FG000|STARTED|Overall Study||10||
59762040|NCT00539305|75881724|FG001|STARTED|Overall Study||12||
59762041|NCT00539305|75881723|FG000|COMPLETED|Overall Study||9||
59762042|NCT00539305|75881724|FG001|COMPLETED|Overall Study||10||
59762043|NCT00539305|75881723|FG000|NOT COMPLETED|Overall Study||1||
59762044|NCT00539305|75881724|FG001|NOT COMPLETED|Overall Study||2||
59762045|NCT04460027|75881732|FG000|STARTED|Overall Study||88||
59762046|NCT04460027|75881733|FG001|STARTED|Overall Study||92||
59762047|NCT04460027|75881732|FG000|COMPLETED|Overall Study||71||
59762048|NCT04460027|75881733|FG001|COMPLETED|Overall Study||81||
59762049|NCT04460027|75881732|FG000|NOT COMPLETED|Overall Study||17||
59762050|NCT04460027|75881733|FG001|NOT COMPLETED|Overall Study||11||
59762051|NCT04159714|75881742|FG000|STARTED|Overall Study||1||
59762052|NCT04159714|75881743|FG001|STARTED|Overall Study||0||
59762053|NCT04159714|75881742|FG000|COMPLETED|Overall Study||1||
59762054|NCT04159714|75881743|FG001|COMPLETED|Overall Study||0||
59762055|NCT04159714|75881742|FG000|NOT COMPLETED|Overall Study||0||
59762056|NCT04159714|75881743|FG001|NOT COMPLETED|Overall Study||0||
59762057|NCT04469465|75881751|FG000|STARTED|Overall Study||57||
59762058|NCT04469465|75881752|FG001|STARTED|Overall Study||29||
59762059|NCT04469465|75881751|FG000|Received at Least 1 Dose of Study Drug|Overall Study||57||
59940148|NCT04326439|76058569|FG001|STARTED|Overall Study||3||
59940149|NCT04326439|76058568|FG000|COMPLETED|Overall Study||3||
59940150|NCT04326439|76058569|FG001|COMPLETED|Overall Study||0||
59940151|NCT04326439|76058568|FG000|NOT COMPLETED|Overall Study||2||
59940152|NCT04326439|76058569|FG001|NOT COMPLETED|Overall Study||3||
59518543|NCT03284398|75612336|FG001|COMPLETED|Overall Study||970|Retrospective data collection: all patients under study intervention during the predefined period|
59518544|NCT03284398|75612335|FG000|NOT COMPLETED|Overall Study||0||
59518545|NCT03284398|75612336|FG001|NOT COMPLETED|Overall Study||0||
59518546|NCT03381742|75612352|FG000|STARTED|Overall Study||525||
59518547|NCT03381742|75612353|FG001|STARTED|Overall Study||501||
59518548|NCT03381742|75612354|FG002|STARTED|Overall Study||1511||
59518549|NCT03381742|75612355|FG003|STARTED|Overall Study||506||
59518550|NCT03381742|75612352|FG000|COMPLETED|Overall Study||525||
59518551|NCT03381742|75612353|FG001|COMPLETED|Overall Study||501||
59940153|NCT00145795|76058583|FG000|STARTED|Overall Study||10||
59940154|NCT00145795|76058584|FG001|STARTED|Overall Study||10||
59940155|NCT00145795|76058583|FG000|COMPLETED|Overall Study|1 patient discontinued early due to grade II gastrointestinal symptoms.|9||
59940156|NCT00145795|76058584|FG001|COMPLETED|Overall Study||10||
59940157|NCT00145795|76058583|FG000|NOT COMPLETED|Overall Study||1||
59940158|NCT00145795|76058584|FG001|NOT COMPLETED|Overall Study||0||
59518552|NCT03381742|75612354|FG002|COMPLETED|Overall Study||1511||
59518553|NCT03381742|75612355|FG003|COMPLETED|Overall Study||506||
59518554|NCT03381742|75612352|FG000|NOT COMPLETED|Overall Study||0||
59762060|NCT04469465|75881752|FG001|Received at Least 1 Dose of Study Drug|Overall Study||29||
59762061|NCT04469465|75881751|FG000|Interim Efficacy Analysis Set|Overall Study||42|Per the prespecified plan for interim analysis, the first 75% of randomized participants formed the Interim Analysis Set for efficacy analysis.|
59762062|NCT04469465|75881752|FG001|Interim Efficacy Analysis Set|Overall Study||21|Per the prespecified plan for interim analysis, the first 75% of randomized participants formed the Interim Analysis Set for efficacy analysis.|
59762063|NCT04469465|75881751|FG000|COMPLETED|Overall Study||48|Completed TP1|
59762064|NCT04469465|75881752|FG001|COMPLETED|Overall Study||23|Completed TP1|
59762065|NCT04469465|75881751|FG000|NOT COMPLETED|Overall Study||9||
59762066|NCT04469465|75881752|FG001|NOT COMPLETED|Overall Study||6||
59762067|NCT00877032|75881765|FG000|STARTED|Overall Study||6||
59762068|NCT00877032|75881766|FG001|STARTED|Overall Study||6||
59762069|NCT00877032|75881767|FG002|STARTED|Overall Study||6||
59762070|NCT00877032|75881768|FG003|STARTED|Overall Study||7||
59762071|NCT00877032|75881769|FG004|STARTED|Overall Study||6||
59762072|NCT00877032|75881770|FG005|STARTED|Overall Study||6||
59762073|NCT00877032|75881771|FG006|STARTED|Overall Study||20||
59940159|NCT02771210|76058592|FG000|STARTED|Period 1||102||
59940160|NCT02771210|76058593|FG001|STARTED|Period 1||102||
59940161|NCT02771210|76058592|FG000|COMPLETED|Period 1||91||
59940162|NCT02771210|76058593|FG001|COMPLETED|Period 1||84||
59940163|NCT02771210|76058592|FG000|NOT COMPLETED|Period 1||11||
59940164|NCT02771210|76058593|FG001|NOT COMPLETED|Period 1||18||
59940165|NCT02771210|76058592|FG000|STARTED|Period 2||91|Completed treatment period 1 and continued to treatment period 2|
59940166|NCT02771210|76058593|FG001|STARTED|Period 2||84|Completed treatment period 1 and continued to treatment period 2|
59940167|NCT02771210|76058592|FG000|COMPLETED|Period 2||89||
59940168|NCT02771210|76058593|FG001|COMPLETED|Period 2||81||
59940169|NCT02771210|76058592|FG000|NOT COMPLETED|Period 2||2||
59940170|NCT02771210|76058593|FG001|NOT COMPLETED|Period 2||3||
59940171|NCT00898677|76058603|FG000|STARTED|Overall Study||180||
59940172|NCT00898677|76058604|FG001|STARTED|Overall Study||455||
59940173|NCT00898677|76058605|FG002|STARTED|Overall Study||455||
59940174|NCT00898677|76058606|FG003|STARTED|Overall Study||178||
59940175|NCT00898677|76058603|FG000|Patients Treated|Overall Study|Patients Not Treated: 16|164||
59940176|NCT00898677|76058604|FG001|Patients Treated|Overall Study|Patients Not Treated: 68|387||
59940177|NCT00898677|76058605|FG002|Patients Treated|Overall Study|Patients Not Treated: 67|388||
59940178|NCT00898677|76058606|FG003|Patients Treated|Overall Study|Patients Not Treated: 18|160||
59940179|NCT00898677|76058603|FG000|COMPLETED|Overall Study||163||
59940180|NCT00898677|76058604|FG001|COMPLETED|Overall Study||386||
59940181|NCT00898677|76058605|FG002|COMPLETED|Overall Study||383||
59940182|NCT00898677|76058606|FG003|COMPLETED|Overall Study||159||
59940183|NCT00898677|76058603|FG000|NOT COMPLETED|Overall Study||17||
59940184|NCT00898677|76058604|FG001|NOT COMPLETED|Overall Study||69||
59940185|NCT00898677|76058605|FG002|NOT COMPLETED|Overall Study||72||
59940186|NCT00898677|76058606|FG003|NOT COMPLETED|Overall Study||19||
59940187|NCT02770820|76058616|FG000|STARTED|Overall Study||7||
59940188|NCT02770820|76058616|FG000|COMPLETED|Overall Study||4||
59940189|NCT02770820|76058616|FG000|NOT COMPLETED|Overall Study||3||
59940190|NCT03082729|76058620|FG000|STARTED|Overall Study||70||
59940191|NCT03082729|76058620|FG000|Per Protocol Population Week 16|Overall Study||60||
59940192|NCT03082729|76058620|FG000|COMPLETED|Overall Study||39||
59940193|NCT03082729|76058620|FG000|NOT COMPLETED|Overall Study||31||
59940194|NCT02764190|76058632|FG000|STARTED|Overall Study||167||
59940195|NCT02764190|76058633|FG001|STARTED|Overall Study||135||
59940196|NCT02764190|76058632|FG000|1 Day Follow-up|Overall Study||161||
59940197|NCT02764190|76058633|FG001|1 Day Follow-up|Overall Study||131||
59940198|NCT02764190|76058632|FG000|3 Month Follow-up|Overall Study||156||
59940199|NCT02764190|76058633|FG001|3 Month Follow-up|Overall Study||128||
59940200|NCT02764190|76058632|FG000|6 Month Follow-up|Overall Study||155||
59940201|NCT02764190|76058633|FG001|6 Month Follow-up|Overall Study||128||
59940202|NCT02764190|76058632|FG000|12 Month Follow-up|Overall Study||150||
59940203|NCT02764190|76058633|FG001|12 Month Follow-up|Overall Study||122||
59940204|NCT02764190|76058632|FG000|COMPLETED|Overall Study||150||
59940205|NCT02764190|76058633|FG001|COMPLETED|Overall Study||122||
59940206|NCT02764190|76058632|FG000|NOT COMPLETED|Overall Study||17||
59940207|NCT02764190|76058633|FG001|NOT COMPLETED|Overall Study||13||
59940208|NCT03077659|76058642|FG000|STARTED|Overall Study||3||
59940209|NCT03077659|76058643|FG001|STARTED|Overall Study||3||
59940210|NCT03077659|76058644|FG002|STARTED|Overall Study||10||
59940211|NCT03077659|76058642|FG000|COMPLETED|Overall Study||3||
59940212|NCT03077659|76058643|FG001|COMPLETED|Overall Study||3||
59940213|NCT03077659|76058644|FG002|COMPLETED|Overall Study||9||
59940214|NCT03077659|76058642|FG000|NOT COMPLETED|Overall Study||0||
59518555|NCT03381742|75612353|FG001|NOT COMPLETED|Overall Study||0||
59518556|NCT03381742|75612354|FG002|NOT COMPLETED|Overall Study||0||
59940215|NCT03077659|76058643|FG001|NOT COMPLETED|Overall Study||0||
59940216|NCT03077659|76058644|FG002|NOT COMPLETED|Overall Study||1||
59940217|NCT02807883|76058655|FG000|STARTED|Overall Study||23||
59940218|NCT02807883|76058655|FG000|COMPLETED|Overall Study||21||
59940219|NCT02807883|76058655|FG000|NOT COMPLETED|Overall Study||2||
59940220|NCT03082261|76058659|FG000|STARTED|Overall Study||269||
59940221|NCT03082261|76058659|FG000|COMPLETED|Overall Study||149||
59940222|NCT03082261|76058659|FG000|NOT COMPLETED|Overall Study||120||
59940223|NCT00102440|76058666|FG000|STARTED|Overall Study||256||
59940224|NCT00102440|76058667|FG001|STARTED|Overall Study||251||
59940225|NCT00102440|76058668|FG002|STARTED|Overall Study||253||
59940226|NCT00102440|76058666|FG000|COMPLETED|Overall Study||168||
59940227|NCT00102440|76058667|FG001|COMPLETED|Overall Study||153||
59940228|NCT00102440|76058668|FG002|COMPLETED|Overall Study||187||
59940229|NCT00102440|76058666|FG000|NOT COMPLETED|Overall Study||88||
59940230|NCT00102440|76058667|FG001|NOT COMPLETED|Overall Study||98||
59940231|NCT00102440|76058668|FG002|NOT COMPLETED|Overall Study||66||
59940232|NCT03909607|76058679|FG000|STARTED|Overall Study||40||
59940233|NCT03909607|76058680|FG001|STARTED|Overall Study||40||
59940234|NCT03909607|76058681|FG002|STARTED|Overall Study||40||
59940235|NCT03909607|76058679|FG000|COMPLETED|Overall Study||35||
59940236|NCT03909607|76058680|FG001|COMPLETED|Overall Study||36||
59940237|NCT03909607|76058681|FG002|COMPLETED|Overall Study||38||
59940238|NCT03909607|76058679|FG000|NOT COMPLETED|Overall Study||5||
59940239|NCT03909607|76058680|FG001|NOT COMPLETED|Overall Study||4||
59940240|NCT03909607|76058681|FG002|NOT COMPLETED|Overall Study||2||
59940241|NCT02762084|76058692|FG000|STARTED|Overall Study||6||
59940242|NCT02762084|76058693|FG001|STARTED|Overall Study||6||
59940243|NCT02762084|76058694|FG002|STARTED|Overall Study||5||
59940244|NCT02762084|76058692|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6||
59940245|NCT02762084|76058693|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6||
59940246|NCT02762084|76058694|FG002|Received at Least 1 Dose of Study Drug|Overall Study||5||
59940247|NCT02762084|76058692|FG000|By Tumor Per Protocol Population (PP)|Overall Study||6|All treatment-targeted tumors except those biopsied and those that did not meet protocol criteria.|
59940248|NCT02762084|76058693|FG001|By Tumor Per Protocol Population (PP)|Overall Study||6|All treatment-targeted tumors except those biopsied and those that did not meet protocol criteria.|
59940249|NCT02762084|76058694|FG002|By Tumor Per Protocol Population (PP)|Overall Study||4|All treatment-targeted tumors except those biopsied and those that did not meet protocol criteria.|
59940250|NCT02762084|76058692|FG000|COMPLETED|Overall Study||5||
59940251|NCT02762084|76058693|FG001|COMPLETED|Overall Study||6||
59940252|NCT02762084|76058694|FG002|COMPLETED|Overall Study||4||
59940253|NCT02762084|76058692|FG000|NOT COMPLETED|Overall Study||1||
59940254|NCT02762084|76058693|FG001|NOT COMPLETED|Overall Study||0||
59940255|NCT02762084|76058694|FG002|NOT COMPLETED|Overall Study||1||
59940256|NCT02763644|76058706|FG000|STARTED|Overall Study||3||
59940257|NCT02763644|76058707|FG001|STARTED|Overall Study||4||
59940258|NCT02763644|76058706|FG000|COMPLETED|Overall Study||0||
59940259|NCT02763644|76058707|FG001|COMPLETED|Overall Study||2||
59940260|NCT02763644|76058706|FG000|NOT COMPLETED|Overall Study||3||
59940261|NCT02763644|76058707|FG001|NOT COMPLETED|Overall Study||2||
59940262|NCT02807844|76058725|FG000|STARTED|Overall Study||6||
59940263|NCT02807844|76058726|FG001|STARTED|Overall Study||12||
59940264|NCT02807844|76058727|FG002|STARTED|Overall Study||12||
59940265|NCT02807844|76058728|FG003|STARTED|Overall Study||13||
59940266|NCT02807844|76058729|FG004|STARTED|Overall Study||6||
59940267|NCT02807844|76058730|FG005|STARTED|Overall Study||11||
59940268|NCT02807844|76058731|FG006|STARTED|Overall Study||20||
59940269|NCT02807844|76058732|FG007|STARTED|Overall Study||20||
59940270|NCT02807844|76058733|FG008|STARTED|Overall Study||21||
59940271|NCT02807844|76058734|FG009|STARTED|Overall Study||20||
59940272|NCT02807844|76058725|FG000|COMPLETED|Overall Study||0||
59940273|NCT02807844|76058726|FG001|COMPLETED|Overall Study||0||
59940274|NCT02807844|76058727|FG002|COMPLETED|Overall Study||0||
59940275|NCT02807844|76058728|FG003|COMPLETED|Overall Study||0||
59940276|NCT02807844|76058729|FG004|COMPLETED|Overall Study||0||
59940277|NCT02807844|76058730|FG005|COMPLETED|Overall Study||0||
59940278|NCT02807844|76058731|FG006|COMPLETED|Overall Study||0||
59940279|NCT02807844|76058732|FG007|COMPLETED|Overall Study||0||
59940280|NCT02807844|76058733|FG008|COMPLETED|Overall Study||0||
59940281|NCT02807844|76058734|FG009|COMPLETED|Overall Study||0||
59940282|NCT02807844|76058725|FG000|NOT COMPLETED|Overall Study||6||
59940283|NCT02807844|76058726|FG001|NOT COMPLETED|Overall Study||12||
59613372|NCT01686828|75724521|FG002|STARTED|Overall Study||13||
59940284|NCT02807844|76058727|FG002|NOT COMPLETED|Overall Study||12||
59940285|NCT02807844|76058728|FG003|NOT COMPLETED|Overall Study||13||
59940286|NCT02807844|76058729|FG004|NOT COMPLETED|Overall Study||6||
59940287|NCT02807844|76058730|FG005|NOT COMPLETED|Overall Study||11||
59940288|NCT02807844|76058731|FG006|NOT COMPLETED|Overall Study||20||
59940289|NCT02807844|76058732|FG007|NOT COMPLETED|Overall Study||20||
59940290|NCT02807844|76058733|FG008|NOT COMPLETED|Overall Study||21||
59940291|NCT02807844|76058734|FG009|NOT COMPLETED|Overall Study||20||
59940292|NCT02763254|76058760|FG000|STARTED|Overall Study||1||
59940293|NCT02763254|76058760|FG000|COMPLETED|Overall Study||0||
59940294|NCT02763254|76058760|FG000|NOT COMPLETED|Overall Study||1||
59940295|NCT02805972|76058766|FG000|STARTED|Intervention Visit 1||23||
59940296|NCT02805972|76058767|FG001|STARTED|Intervention Visit 1||18||
59940297|NCT02805972|76058766|FG000|COMPLETED|Intervention Visit 1||23||
59940298|NCT02805972|76058767|FG001|COMPLETED|Intervention Visit 1||18||
59940299|NCT02805972|76058766|FG000|NOT COMPLETED|Intervention Visit 1||0||
60067453|NCT01938625|76182649|FG000|NOT COMPLETED|Overall Study||0||
60067454|NCT01938625|76182650|FG001|NOT COMPLETED|Overall Study||2||
60067455|NCT01975675|76182660|FG000|STARTED|Overall Study||83||
60067456|NCT01975675|76182661|FG001|STARTED|Overall Study||83||
60067457|NCT01975675|76182662|FG002|STARTED|Overall Study||88||
60067458|NCT01975675|76182663|FG003|STARTED|Overall Study||87||
60067459|NCT01975675|76182660|FG000|COMPLETED|Overall Study||83||
60067460|NCT01975675|76182661|FG001|COMPLETED|Overall Study||82||
59613373|NCT01686828|75724522|FG003|STARTED|Overall Study||13||
59940300|NCT02805972|76058767|FG001|NOT COMPLETED|Intervention Visit 1||0||
59940301|NCT02805972|76058766|FG000|STARTED|Washout Period||23||
59940302|NCT02805972|76058767|FG001|STARTED|Washout Period||18||
59940303|NCT02805972|76058766|FG000|COMPLETED|Washout Period||20||
59940304|NCT02805972|76058767|FG001|COMPLETED|Washout Period||18||
59940305|NCT02805972|76058766|FG000|NOT COMPLETED|Washout Period||3||
59940306|NCT02805972|76058767|FG001|NOT COMPLETED|Washout Period||0||
59940307|NCT02805972|76058766|FG000|STARTED|Intervention Visit 2||20||
59940308|NCT02805972|76058767|FG001|STARTED|Intervention Visit 2||18||
59940309|NCT02805972|76058766|FG000|COMPLETED|Intervention Visit 2||20||
59940310|NCT02805972|76058767|FG001|COMPLETED|Intervention Visit 2||18||
59940311|NCT02805972|76058766|FG000|NOT COMPLETED|Intervention Visit 2||0||
60067461|NCT01975675|76182662|FG002|COMPLETED|Overall Study||88||
59940312|NCT02805972|76058767|FG001|NOT COMPLETED|Intervention Visit 2||0||
59940313|NCT03032523|76058785|FG000|STARTED|Overall Study||15||
59940314|NCT03032523|76058786|FG001|STARTED|Overall Study||6||
59940315|NCT03032523|76058785|FG000|COMPLETED|Overall Study||12||
59940316|NCT03032523|76058786|FG001|COMPLETED|Overall Study||4||
59940317|NCT03032523|76058785|FG000|NOT COMPLETED|Overall Study||3||
59940318|NCT03032523|76058786|FG001|NOT COMPLETED|Overall Study||2||
59940319|NCT03031899|76058793|FG000|STARTED|Overall Study||27||41
59940320|NCT03031899|76058793|FG000|COMPLETED|Overall Study||25|one patient had not quit the habit, another lesion disappeared 2 patients (3 lesions) were excluded|38
59940321|NCT03031899|76058793|FG000|NOT COMPLETED|Overall Study||2||3
59940322|NCT03086369|76058806|FG000|STARTED|Overall Study||3||
59940323|NCT03086369|76058807|FG001|STARTED|Overall Study||7||
59940324|NCT03086369|76058808|FG002|STARTED|Overall Study||12||
59940325|NCT03086369|76058809|FG003|STARTED|Overall Study||82||
59940326|NCT03086369|76058810|FG004|STARTED|Overall Study||80||
59940327|NCT03086369|76058806|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3||
59940328|NCT03086369|76058807|FG001|Received at Least 1 Dose of Study Drug|Overall Study||7||
59940329|NCT03086369|76058808|FG002|Received at Least 1 Dose of Study Drug|Overall Study||12||
59940330|NCT03086369|76058809|FG003|Received at Least 1 Dose of Study Drug|Overall Study||81||
59940331|NCT03086369|76058810|FG004|Received at Least 1 Dose of Study Drug|Overall Study||78||
59940332|NCT03086369|76058806|FG000|COMPLETED|Overall Study||2||
59940333|NCT03086369|76058807|FG001|COMPLETED|Overall Study||7||
59940334|NCT03086369|76058808|FG002|COMPLETED|Overall Study||12||
59940335|NCT03086369|76058809|FG003|COMPLETED|Overall Study||73||
59940336|NCT03086369|76058810|FG004|COMPLETED|Overall Study||73||
59940337|NCT03086369|76058806|FG000|NOT COMPLETED|Overall Study||1||
59940338|NCT03086369|76058807|FG001|NOT COMPLETED|Overall Study||0||
59940339|NCT03086369|76058808|FG002|NOT COMPLETED|Overall Study||0||
59940340|NCT03086369|76058809|FG003|NOT COMPLETED|Overall Study||9||
59940341|NCT03086369|76058810|FG004|NOT COMPLETED|Overall Study||7||
59940342|NCT00101582|76058826|FG000|STARTED|Overall Study||94||
59940343|NCT00101582|76058827|FG001|STARTED|Overall Study||94||
59940344|NCT00101582|76058826|FG000|Received Study Drug|Overall Study||91||
59940345|NCT00101582|76058827|FG001|Received Study Drug|Overall Study||94||
59940346|NCT00101582|76058826|FG000|COMPLETED|Overall Study|Participants who completed the acute oral mucositis evaluation phase|83||
59940347|NCT00101582|76058827|FG001|COMPLETED|Overall Study|Participants who completed the acute oral mucositis evaluation phase|79||
59940348|NCT00101582|76058826|FG000|NOT COMPLETED|Overall Study||11||
59940349|NCT00101582|76058827|FG001|NOT COMPLETED|Overall Study||15||
59940350|NCT03238677|76058839|FG000|STARTED|Overall Study||9||
59940351|NCT03238677|76058840|FG001|STARTED|Overall Study||9||
59940352|NCT03238677|76058841|FG002|STARTED|Overall Study||10||
59940353|NCT03238677|76058842|FG003|STARTED|Overall Study||9||
59940354|NCT03238677|76058843|FG004|STARTED|Overall Study||10||
59940355|NCT03238677|76058844|FG005|STARTED|Overall Study||9||
59940356|NCT03238677|76058839|FG000|COMPLETED|Overall Study||7||
59940357|NCT03238677|76058840|FG001|COMPLETED|Overall Study||7||
59940358|NCT03238677|76058841|FG002|COMPLETED|Overall Study||8||
59940359|NCT03238677|76058842|FG003|COMPLETED|Overall Study||8||
59940360|NCT03238677|76058843|FG004|COMPLETED|Overall Study||9||
59940361|NCT03238677|76058844|FG005|COMPLETED|Overall Study||9||
59940362|NCT03238677|76058839|FG000|NOT COMPLETED|Overall Study||2||
59940363|NCT03238677|76058840|FG001|NOT COMPLETED|Overall Study||2||
59940364|NCT03238677|76058841|FG002|NOT COMPLETED|Overall Study||2||
59940365|NCT03238677|76058842|FG003|NOT COMPLETED|Overall Study||1||
59940366|NCT03238677|76058843|FG004|NOT COMPLETED|Overall Study||1||
59940367|NCT03238677|76058844|FG005|NOT COMPLETED|Overall Study||0||
59940368|NCT03086135|76058858|FG000|STARTED|Overall Study||51||
59940369|NCT03086135|76058858|FG000|COMPLETED|Overall Study||48||
59940370|NCT03086135|76058858|FG000|NOT COMPLETED|Overall Study||3||
59940371|NCT04494867|76058864|FG000|STARTED|Overall Study||10||
59940372|NCT04494867|76058865|FG001|STARTED|Overall Study||10||
59940373|NCT04494867|76058864|FG000|COMPLETED|Overall Study||7||
59940374|NCT04494867|76058865|FG001|COMPLETED|Overall Study||6||
59940375|NCT04494867|76058864|FG000|NOT COMPLETED|Overall Study||3||
59940376|NCT04494867|76058865|FG001|NOT COMPLETED|Overall Study||4||
59940377|NCT02762708|76058875|FG000|STARTED|Study 1 - RYGB vs Caloric Restriction||3||
59940378|NCT02762708|76058876|FG001|STARTED|Study 1 - RYGB vs Caloric Restriction||9||
59940379|NCT02762708|76058877|FG002|STARTED|Study 1 - RYGB vs Caloric Restriction||0||
59940380|NCT02762708|76058878|FG003|STARTED|Study 1 - RYGB vs Caloric Restriction||0||
59940381|NCT02762708|76058875|FG000|COMPLETED|Study 1 - RYGB vs Caloric Restriction||3||
59940382|NCT02762708|76058876|FG001|COMPLETED|Study 1 - RYGB vs Caloric Restriction||7||
59940383|NCT02762708|76058877|FG002|COMPLETED|Study 1 - RYGB vs Caloric Restriction||0||
59940384|NCT02762708|76058878|FG003|COMPLETED|Study 1 - RYGB vs Caloric Restriction||0||
59940385|NCT02762708|76058875|FG000|NOT COMPLETED|Study 1 - RYGB vs Caloric Restriction||0||
60067462|NCT01975675|76182663|FG003|COMPLETED|Overall Study||87||
60067463|NCT01975675|76182660|FG000|NOT COMPLETED|Overall Study||0||
59940386|NCT02762708|76058876|FG001|NOT COMPLETED|Study 1 - RYGB vs Caloric Restriction||2||
59951237|NCT03743415|76070178|FG003|STARTED|Overall Study||97||
60067464|NCT01975675|76182661|FG001|NOT COMPLETED|Overall Study||1||
59940387|NCT02762708|76058877|FG002|NOT COMPLETED|Study 1 - RYGB vs Caloric Restriction||0||
59940388|NCT02762708|76058878|FG003|NOT COMPLETED|Study 1 - RYGB vs Caloric Restriction||0||
59940389|NCT02762708|76058875|FG000|STARTED|Study 2 - Exendin (9,39) Amide Study||0||
59940390|NCT02762708|76058876|FG001|STARTED|Study 2 - Exendin (9,39) Amide Study||0||
59940391|NCT02762708|76058877|FG002|STARTED|Study 2 - Exendin (9,39) Amide Study||1||
59940392|NCT02762708|76058878|FG003|STARTED|Study 2 - Exendin (9,39) Amide Study||0||
59940393|NCT02762708|76058875|FG000|COMPLETED|Study 2 - Exendin (9,39) Amide Study||0||
59940394|NCT02762708|76058876|FG001|COMPLETED|Study 2 - Exendin (9,39) Amide Study||0||
59940395|NCT02762708|76058877|FG002|COMPLETED|Study 2 - Exendin (9,39) Amide Study||1||
59940396|NCT02762708|76058878|FG003|COMPLETED|Study 2 - Exendin (9,39) Amide Study||0||
59940397|NCT02762708|76058875|FG000|NOT COMPLETED|Study 2 - Exendin (9,39) Amide Study||0||
59940398|NCT02762708|76058876|FG001|NOT COMPLETED|Study 2 - Exendin (9,39) Amide Study||0||
59940399|NCT02762708|76058877|FG002|NOT COMPLETED|Study 2 - Exendin (9,39) Amide Study||0||
59940400|NCT02762708|76058878|FG003|NOT COMPLETED|Study 2 - Exendin (9,39) Amide Study||0||
59940401|NCT02760602|76058890|FG000|STARTED|Overall Study||13||
59940402|NCT02760602|76058891|FG001|STARTED|Overall Study||13||
59940403|NCT02760602|76058890|FG000|COMPLETED|Overall Study||0||
59940404|NCT02760602|76058891|FG001|COMPLETED|Overall Study||0||
59940405|NCT02760602|76058890|FG000|NOT COMPLETED|Overall Study||13||
59940406|NCT02760602|76058891|FG001|NOT COMPLETED|Overall Study||13||
59940407|NCT00210249|76058897|FG000|STARTED|Overall Study||364||
59940408|NCT00210249|76058897|FG000|COMPLETED|Overall Study||348||
59940409|NCT00210249|76058897|FG000|NOT COMPLETED|Overall Study||16||
59940410|NCT03086057|76058905|FG000|STARTED|Stage 1: PrEP Uptake||55||
59940411|NCT03086057|76058906|FG001|STARTED|Stage 1: PrEP Uptake||55||
59940412|NCT03086057|76058907|FG002|STARTED|Stage 1: PrEP Uptake|This intervention was not provided until Stage 2|0||
59940413|NCT03086057|76058908|FG003|STARTED|Stage 1: PrEP Uptake|This intervention was not provided until Stage 2|0||
59940414|NCT03086057|76058905|FG000|COMPLETED|Stage 1: PrEP Uptake||44||
59940415|NCT03086057|76058906|FG001|COMPLETED|Stage 1: PrEP Uptake||45||
59940416|NCT03086057|76058907|FG002|COMPLETED|Stage 1: PrEP Uptake||0||
59940417|NCT03086057|76058908|FG003|COMPLETED|Stage 1: PrEP Uptake||0||
59940418|NCT03086057|76058905|FG000|NOT COMPLETED|Stage 1: PrEP Uptake||11||
59940419|NCT03086057|76058906|FG001|NOT COMPLETED|Stage 1: PrEP Uptake||10||
59940420|NCT03086057|76058907|FG002|NOT COMPLETED|Stage 1: PrEP Uptake||0||
59940421|NCT03086057|76058908|FG003|NOT COMPLETED|Stage 1: PrEP Uptake||0||
59940422|NCT03086057|76058905|FG000|STARTED|Stage 2: PrEP Adherence|This was only provided in Stage 1|0||
59940423|NCT03086057|76058906|FG001|STARTED|Stage 2: PrEP Adherence|This was only provided in Stage 1|0||
59940424|NCT03086057|76058907|FG002|STARTED|Stage 2: PrEP Adherence|Only individuals who completed Stage 1 AND initiated PrEP were randomized in Stage 2.|17||
59940425|NCT03086057|76058908|FG003|STARTED|Stage 2: PrEP Adherence|Only individuals who completed Stage 1 AND initiated PrEP were randomized in Stage 2.|18||
59940426|NCT03086057|76058905|FG000|COMPLETED|Stage 2: PrEP Adherence||0||
59940427|NCT03086057|76058906|FG001|COMPLETED|Stage 2: PrEP Adherence||0||
59940428|NCT03086057|76058907|FG002|COMPLETED|Stage 2: PrEP Adherence||11||
59940429|NCT03086057|76058908|FG003|COMPLETED|Stage 2: PrEP Adherence||16||
59940430|NCT03086057|76058905|FG000|NOT COMPLETED|Stage 2: PrEP Adherence||0||
59940431|NCT03086057|76058906|FG001|NOT COMPLETED|Stage 2: PrEP Adherence||0||
59940432|NCT03086057|76058907|FG002|NOT COMPLETED|Stage 2: PrEP Adherence||6||
59940433|NCT03086057|76058908|FG003|NOT COMPLETED|Stage 2: PrEP Adherence||2||
59940434|NCT02759120|76058920|FG000|STARTED|Overall Study||254||
59940435|NCT02759120|76058921|FG001|STARTED|Overall Study||259||
59940436|NCT02759120|76058920|FG000|COMPLETED|Overall Study||169||
59940437|NCT02759120|76058921|FG001|COMPLETED|Overall Study||180||
59940438|NCT02759120|76058920|FG000|NOT COMPLETED|Overall Study||85||
59940439|NCT02759120|76058921|FG001|NOT COMPLETED|Overall Study||79||
59940440|NCT03697161|76058930|FG000|STARTED|Overall Study||7||
59940441|NCT03697161|76058931|FG001|STARTED|Overall Study||8||
59940442|NCT03697161|76058932|FG002|STARTED|Overall Study||8||
59940443|NCT03697161|76058930|FG000|COMPLETED|Overall Study||6||
59940444|NCT03697161|76058931|FG001|COMPLETED|Overall Study||7||
59940445|NCT03697161|76058932|FG002|COMPLETED|Overall Study||7||
59940446|NCT03697161|76058930|FG000|NOT COMPLETED|Overall Study||1||
59940447|NCT03697161|76058931|FG001|NOT COMPLETED|Overall Study||1||
59940448|NCT03697161|76058932|FG002|NOT COMPLETED|Overall Study||1||
59940449|NCT00101192|76058940|FG000|STARTED|Overall Study||76||
59940450|NCT00101192|76058940|FG000|COMPLETED|Overall Study||69||
59940451|NCT00101192|76058940|FG000|NOT COMPLETED|Overall Study||7||
59940452|NCT03031431|76058944|FG000|STARTED|Overall Study||130||204
59940453|NCT03031431|76058944|FG000|COMPLETED|Overall Study||129||203
59940454|NCT03031431|76058944|FG000|NOT COMPLETED|Overall Study||1||1
59940455|NCT03029247|76058950|FG000|STARTED|Acute Challenge 1 (Day 1)||45||
59940456|NCT03029247|76058951|FG001|STARTED|Acute Challenge 1 (Day 1)||43||
59940457|NCT03029247|76058950|FG000|COMPLETED|Acute Challenge 1 (Day 1)||45||
59940458|NCT03029247|76058951|FG001|COMPLETED|Acute Challenge 1 (Day 1)||43||
59940459|NCT03029247|76058950|FG000|NOT COMPLETED|Acute Challenge 1 (Day 1)||0||
59940460|NCT03029247|76058951|FG001|NOT COMPLETED|Acute Challenge 1 (Day 1)||0||
59940461|NCT03029247|76058950|FG000|STARTED|Hgb Maintenance Phase (8 Weeks)||45||
59940462|NCT03029247|76058951|FG001|STARTED|Hgb Maintenance Phase (8 Weeks)||43||
59940463|NCT03029247|76058950|FG000|COMPLETED|Hgb Maintenance Phase (8 Weeks)||32||
59940464|NCT03029247|76058951|FG001|COMPLETED|Hgb Maintenance Phase (8 Weeks)||36||
59940465|NCT03029247|76058950|FG000|NOT COMPLETED|Hgb Maintenance Phase (8 Weeks)||13||
59940466|NCT03029247|76058951|FG001|NOT COMPLETED|Hgb Maintenance Phase (8 Weeks)||7||
59940467|NCT03029247|76058950|FG000|STARTED|Acute Challenge 2 (Day 57)||32||
59940468|NCT03029247|76058951|FG001|STARTED|Acute Challenge 2 (Day 57)||36||
59940469|NCT03029247|76058950|FG000|COMPLETED|Acute Challenge 2 (Day 57)||32||
59940470|NCT03029247|76058951|FG001|COMPLETED|Acute Challenge 2 (Day 57)||36||
59940471|NCT03029247|76058950|FG000|NOT COMPLETED|Acute Challenge 2 (Day 57)||0||
59940472|NCT03029247|76058951|FG001|NOT COMPLETED|Acute Challenge 2 (Day 57)||0||
59940473|NCT03029247|76058950|FG000|STARTED|Follow-up Period (14 Days)||32||
59940474|NCT03029247|76058951|FG001|STARTED|Follow-up Period (14 Days)||36||
59940475|NCT03029247|76058950|FG000|COMPLETED|Follow-up Period (14 Days)||32||
59940476|NCT03029247|76058951|FG001|COMPLETED|Follow-up Period (14 Days)||36||
59940477|NCT03029247|76058950|FG000|NOT COMPLETED|Follow-up Period (14 Days)||0||
59940478|NCT03029247|76058951|FG001|NOT COMPLETED|Follow-up Period (14 Days)||0||
59940479|NCT04313283|76058957|FG000|STARTED|Overall Study||19||
59940480|NCT04313283|76058957|FG000|COMPLETED|Overall Study||15||
59940481|NCT04313283|76058957|FG000|NOT COMPLETED|Overall Study||4||
59940482|NCT02754440|76058965|FG000|STARTED|Overall Study||99||
59940483|NCT02754440|76058966|FG001|STARTED|Overall Study||101||
59940484|NCT02754440|76058967|FG002|STARTED|Overall Study||100||
59940485|NCT02754440|76058968|FG003|STARTED|Overall Study||35||
59940486|NCT02754440|76058965|FG000|COMPLETED|Overall Study||93||
59940487|NCT02754440|76058966|FG001|COMPLETED|Overall Study||93||
59940488|NCT02754440|76058967|FG002|COMPLETED|Overall Study||93||
59940489|NCT02754440|76058968|FG003|COMPLETED|Overall Study||0||
59940490|NCT02754440|76058965|FG000|NOT COMPLETED|Overall Study||6||
59940491|NCT02754440|76058966|FG001|NOT COMPLETED|Overall Study||8||
59940492|NCT02754440|76058967|FG002|NOT COMPLETED|Overall Study||7||
59940493|NCT02754440|76058968|FG003|NOT COMPLETED|Overall Study||35||
59940494|NCT02753816|76058980|FG000|STARTED|Overall Study||7||9
59940495|NCT02753816|76058981|FG001|STARTED|Overall Study||11||11
59940496|NCT02753816|76058982|FG002|STARTED|Overall Study||7||22
59940497|NCT02753816|76058980|FG000|Tranexamic Acid|Overall Study||7||9
59940498|NCT02753816|76058981|FG001|Tranexamic Acid|Overall Study||0||0
59940499|NCT02753816|76058982|FG002|Tranexamic Acid|Overall Study||7||12
59940500|NCT02753816|76058980|FG000|Placebo|Overall Study||0||0
59940501|NCT02753816|76058981|FG001|Placebo|Overall Study||11||11
59940502|NCT02753816|76058982|FG002|Placebo|Overall Study||7||10
59940503|NCT02753816|76058980|FG000|COMPLETED|Overall Study||7||9
59940504|NCT02753816|76058981|FG001|COMPLETED|Overall Study||10||10
59940505|NCT02753816|76058982|FG002|COMPLETED|Overall Study||7||22
59940506|NCT02753816|76058980|FG000|NOT COMPLETED|Overall Study||0||0
59940507|NCT02753816|76058981|FG001|NOT COMPLETED|Overall Study||1||1
59940508|NCT02753816|76058982|FG002|NOT COMPLETED|Overall Study||0||0
59940509|NCT02752802|76058990|FG000|STARTED|Overall Study||48||
59940510|NCT02752802|76058991|FG001|STARTED|Overall Study||48||
59940511|NCT02752802|76058990|FG000|COMPLETED|Overall Study||47||
59940512|NCT02752802|76058991|FG001|COMPLETED|Overall Study||48||
59940513|NCT02752802|76058990|FG000|NOT COMPLETED|Overall Study||1||
59940514|NCT02752802|76058991|FG001|NOT COMPLETED|Overall Study||0||
59940515|NCT03682653|76059001|FG000|STARTED|Overall Study||10898||
59518557|NCT03381742|75612355|FG003|NOT COMPLETED|Overall Study||0||
59940516|NCT03682653|76059002|FG001|STARTED|Overall Study||10934||
59940517|NCT03682653|76059001|FG000|Received Allocated Treatment|Overall Study||10898||
59940518|NCT03682653|76059002|FG001|Received Allocated Treatment|Overall Study||10928||
59518558|NCT01079299|75612367|FG000|STARTED|Overall Study||27||
59518559|NCT01079299|75612368|FG001|STARTED|Overall Study||25||
59518560|NCT01079299|75612367|FG000|COMPLETED|Overall Study||27||
59518561|NCT01079299|75612368|FG001|COMPLETED|Overall Study||25||
59940519|NCT03682653|76059001|FG000|Day 21|Overall Study||10069||
59940520|NCT03682653|76059002|FG001|Day 21|Overall Study||10119||
59940521|NCT03682653|76059001|FG000|3 Months|Overall Study||10273||
59940522|NCT03682653|76059002|FG001|3 Months|Overall Study||10356||
59940523|NCT03682653|76059001|FG000|COMPLETED|Overall Study||9606|6 Months (primary endpoint)|
59940524|NCT03682653|76059002|FG001|COMPLETED|Overall Study||9684|6 Months (primary endpoint)|
59940525|NCT03682653|76059001|FG000|NOT COMPLETED|Overall Study||1292||
59940526|NCT03682653|76059002|FG001|NOT COMPLETED|Overall Study||1250||
59940527|NCT02756078|76059008|FG000|STARTED|Period 1||85||
59940528|NCT02756078|76059009|FG001|STARTED|Period 1||86||
59940529|NCT02756078|76059008|FG000|COMPLETED|Period 1||76||
59940530|NCT02756078|76059009|FG001|COMPLETED|Period 1||64||
59940531|NCT02756078|76059008|FG000|NOT COMPLETED|Period 1||9||
59940532|NCT02756078|76059009|FG001|NOT COMPLETED|Period 1||22||
59940533|NCT02756078|76059008|FG000|STARTED|Period 2||76||
59940534|NCT02756078|76059009|FG001|STARTED|Period 2||64||
59940535|NCT02756078|76059008|FG000|COMPLETED|Period 2||70||
59940536|NCT02756078|76059009|FG001|COMPLETED|Period 2||57||
59940537|NCT02756078|76059008|FG000|NOT COMPLETED|Period 2||6||
59940538|NCT02756078|76059009|FG001|NOT COMPLETED|Period 2||7||
59940539|NCT02752958|76059015|FG000|STARTED|Overall Study||75||
59940540|NCT02752958|76059015|FG000|COMPLETED|Overall Study||66||
59940541|NCT02752958|76059015|FG000|NOT COMPLETED|Overall Study||9||
59940542|NCT02805660|76059028|FG000|STARTED|Overall Study||5||
59940543|NCT02805660|76059029|FG001|STARTED|Overall Study||4||
59940544|NCT02805660|76059030|FG002|STARTED|Overall Study||11||
59940545|NCT02805660|76059031|FG003|STARTED|Overall Study||18||
59940546|NCT02805660|76059032|FG004|STARTED|Overall Study||3||
59940547|NCT02805660|76059033|FG005|STARTED|Overall Study||23||
59940548|NCT02805660|76059034|FG006|STARTED|Overall Study||19||
59940549|NCT02805660|76059028|FG000|COMPLETED|Overall Study||0||
59940550|NCT02805660|76059029|FG001|COMPLETED|Overall Study||0||
59940551|NCT02805660|76059030|FG002|COMPLETED|Overall Study||0||
59940552|NCT02805660|76059031|FG003|COMPLETED|Overall Study||0||
59940553|NCT02805660|76059032|FG004|COMPLETED|Overall Study||0||
59940554|NCT02805660|76059033|FG005|COMPLETED|Overall Study||0||
59940555|NCT02805660|76059034|FG006|COMPLETED|Overall Study||0||
59940556|NCT02805660|76059028|FG000|NOT COMPLETED|Overall Study||5||
59940557|NCT02805660|76059029|FG001|NOT COMPLETED|Overall Study||4||
59940558|NCT02805660|76059030|FG002|NOT COMPLETED|Overall Study||11||
59940559|NCT02805660|76059031|FG003|NOT COMPLETED|Overall Study||18||
59940560|NCT02805660|76059032|FG004|NOT COMPLETED|Overall Study||3||
59940561|NCT02805660|76059033|FG005|NOT COMPLETED|Overall Study||23||
59940562|NCT02805660|76059034|FG006|NOT COMPLETED|Overall Study||19||
59940563|NCT02807376|76059065|FG000|STARTED|Overall Study||139||
59940564|NCT02807376|76059066|FG001|STARTED|Overall Study||131||
59940565|NCT02807376|76059065|FG000|COMPLETED|Overall Study||136||
59940566|NCT02807376|76059066|FG001|COMPLETED|Overall Study||130||
59940567|NCT02807376|76059065|FG000|NOT COMPLETED|Overall Study||3||
59940568|NCT02807376|76059066|FG001|NOT COMPLETED|Overall Study||1||
59940569|NCT02804178|76059072|FG000|STARTED|Overall Study||10||
59940570|NCT02804178|76059072|FG000|COMPLETED|Overall Study||9||
59940571|NCT02804178|76059072|FG000|NOT COMPLETED|Overall Study||1||
59940572|NCT02917941|76059076|FG000|STARTED|Treatment Period||34||
59940573|NCT02917941|76059076|FG000|COMPLETED|Treatment Period||10||
59940574|NCT02917941|76059076|FG000|NOT COMPLETED|Treatment Period||24||
59940575|NCT02917941|76059076|FG000|STARTED|Survival Follow-up Period||31|Out of 34 Participants, 31 entered the Follow-up Period.|
59940576|NCT02917941|76059076|FG000|COMPLETED|Survival Follow-up Period||26||
59940577|NCT02917941|76059076|FG000|NOT COMPLETED|Survival Follow-up Period||5||
59940578|NCT01333956|76059084|FG000|STARTED|Overall Study||30||
59940579|NCT01333956|76059085|FG001|STARTED|Overall Study||30||
59940580|NCT01333956|76059086|FG002|STARTED|Overall Study||30||
59940581|NCT01333956|76059087|FG003|STARTED|Overall Study||30||
59940582|NCT01333956|76059084|FG000|COMPLETED|Overall Study||28||
59940583|NCT01333956|76059085|FG001|COMPLETED|Overall Study||26||
59940584|NCT01333956|76059086|FG002|COMPLETED|Overall Study||29||
59940585|NCT01333956|76059087|FG003|COMPLETED|Overall Study||28||
59940586|NCT01333956|76059084|FG000|NOT COMPLETED|Overall Study||2||
59940587|NCT01333956|76059085|FG001|NOT COMPLETED|Overall Study||4||
59940588|NCT01333956|76059086|FG002|NOT COMPLETED|Overall Study||1||
59940589|NCT01333956|76059087|FG003|NOT COMPLETED|Overall Study||2||
59940590|NCT01333722|76059100|FG000|STARTED|Overall Study||51||
59940591|NCT01333722|76059101|FG001|STARTED|Overall Study||49||
59940592|NCT01333722|76059100|FG000|COMPLETED|Overall Study||51||
59940593|NCT01333722|76059101|FG001|COMPLETED|Overall Study||46||
59940594|NCT01333722|76059100|FG000|NOT COMPLETED|Overall Study||0||
59940595|NCT01333722|76059101|FG001|NOT COMPLETED|Overall Study||3||
59940596|NCT01370694|76059109|FG000|STARTED|Overall Study||7||
59940597|NCT01370694|76059109|FG000|COMPLETED|Overall Study||1||
59940598|NCT01370694|76059109|FG000|NOT COMPLETED|Overall Study||6||
59940599|NCT03315143|76059115|FG000|STARTED|Overall Study||5292||
60067465|NCT01975675|76182662|FG002|NOT COMPLETED|Overall Study||0||
59940600|NCT03315143|76059116|FG001|STARTED|Overall Study||5292||
59940601|NCT03315143|76059115|FG000|Randomized and Treated|Overall Study||5291||
59940602|NCT03315143|76059116|FG001|Randomized and Treated|Overall Study||5286||
59940603|NCT03315143|76059115|FG000|COMPLETED|Overall Study||0||
59940604|NCT03315143|76059116|FG001|COMPLETED|Overall Study||0||
59518562|NCT01079299|75612367|FG000|NOT COMPLETED|Overall Study||0||
59518563|NCT01079299|75612368|FG001|NOT COMPLETED|Overall Study||0||
59518564|NCT03530098|75612376|FG000|STARTED|Overall Study||939||
59518565|NCT03530098|75612377|FG001|STARTED|Overall Study||964||
59940605|NCT03315143|76059115|FG000|NOT COMPLETED|Overall Study||5292||
59940606|NCT03315143|76059116|FG001|NOT COMPLETED|Overall Study||5292||
59940607|NCT02797080|76059122|FG000|STARTED|Overall Study||38||
59940608|NCT02797080|76059122|FG000|COMPLETED|Overall Study||36||
59940609|NCT02797080|76059122|FG000|NOT COMPLETED|Overall Study||2||
59940610|NCT02915835|76059128|FG000|STARTED|Overall Study||9||
59940611|NCT02915835|76059129|FG001|STARTED|Overall Study||8||
59940612|NCT02915835|76059128|FG000|COMPLETED|Overall Study||8||
59940613|NCT02915835|76059129|FG001|COMPLETED|Overall Study||7||
59940614|NCT02915835|76059128|FG000|NOT COMPLETED|Overall Study||1||
59940615|NCT02915835|76059129|FG001|NOT COMPLETED|Overall Study||1||
59940616|NCT01370616|76059137|FG000|STARTED|Overall Study|Participants randomized|282||
59940617|NCT01370616|76059138|FG001|STARTED|Overall Study|Participants randomized|283||
59940618|NCT01370616|76059137|FG000|Treated|Overall Study||275||
59940619|NCT01370616|76059138|FG001|Treated|Overall Study||275||
59940620|NCT01370616|76059137|FG000|COMPLETED|Overall Study||220||
59940621|NCT01370616|76059138|FG001|COMPLETED|Overall Study||216||
59940622|NCT01370616|76059137|FG000|NOT COMPLETED|Overall Study||62||
59940623|NCT01370616|76059138|FG001|NOT COMPLETED|Overall Study||67||
59940624|NCT03798756|76059144|FG000|STARTED|Overall Study||9274||
59940625|NCT03798756|76059144|FG000|COMPLETED|Overall Study||9274||
59940626|NCT03798756|76059144|FG000|NOT COMPLETED|Overall Study||0||
59940627|NCT02916927|76059151|FG000|STARTED|Overall Study||31||
59940628|NCT02916927|76059152|FG001|STARTED|Overall Study||31||
59940629|NCT02916927|76059151|FG000|Received Study Drug|Overall Study||31||
60067466|NCT01975675|76182663|FG003|NOT COMPLETED|Overall Study||0||
60067467|NCT01975285|76182675|FG000|STARTED|Overall Study||30||
60067468|NCT01975285|76182676|FG001|STARTED|Overall Study||30||
60067469|NCT01975285|76182675|FG000|COMPLETED|Overall Study||28||
60067470|NCT01975285|76182676|FG001|COMPLETED|Overall Study||28||
60067471|NCT01975285|76182675|FG000|NOT COMPLETED|Overall Study||2||
59518566|NCT03530098|75612376|FG000|Ground-truth Labeled|Overall Study||741|Ground-truth labeled: exam was interpreted by a panel of 4 radiologists and their interpretations were averaged to determine a final label.|
59518567|NCT03530098|75612377|FG001|Ground-truth Labeled|Overall Study||794|Ground-truth labeled: exam was interpreted by a panel of 4 radiologists and their interpretations were averaged to determine a final label.|
59518568|NCT03530098|75612376|FG000|Primary Analysis Set|Overall Study||739|Primary analysis set: Participants with ground-truth labeled exam results and no bone deformity.|
59519062|NCT01116895|75612922|FG000|NOT COMPLETED|Overall Study||4||
59940630|NCT02916927|76059152|FG001|Received Study Drug|Overall Study||29||
59940631|NCT02916927|76059151|FG000|COMPLETED|Overall Study||30||
59940632|NCT02916927|76059152|FG001|COMPLETED|Overall Study|1 participant was in radiology for the 45 and 60 minute time points.|28||
59940633|NCT02916927|76059151|FG000|NOT COMPLETED|Overall Study||1||
59940634|NCT02916927|76059152|FG001|NOT COMPLETED|Overall Study||3||
59940635|NCT02916693|76059158|FG000|STARTED|Overall Study||20||
59940636|NCT02916693|76059158|FG000|COMPLETED|Overall Study||13||
59940637|NCT02916693|76059158|FG000|NOT COMPLETED|Overall Study||7||
59940638|NCT02574455|76059168|FG000|STARTED|Overall Study||267||
59940639|NCT02574455|76059169|FG001|STARTED|Overall Study||262||
59940640|NCT02574455|76059168|FG000|Enrolled and Treated|Overall Study||258||
59940641|NCT02574455|76059169|FG001|Enrolled and Treated|Overall Study||224||
59940642|NCT02574455|76059168|FG000|COMPLETED|Overall Study||0||
59940643|NCT02574455|76059169|FG001|COMPLETED|Overall Study||0||
59940644|NCT02574455|76059168|FG000|NOT COMPLETED|Overall Study||267||
59940645|NCT02574455|76059169|FG001|NOT COMPLETED|Overall Study||262||
59940646|NCT02795832|76059181|FG000|STARTED|Overall Study||8||
59940647|NCT02795832|76059182|FG001|STARTED|Overall Study||4||
59940648|NCT02795832|76059183|FG002|STARTED|Overall Study||8||
59940649|NCT02795832|76059184|FG003|STARTED|Overall Study||3||
59940650|NCT02795832|76059185|FG004|STARTED|Overall Study||20||
59940651|NCT02795832|76059186|FG005|STARTED|Overall Study||10||
59940652|NCT02795832|76059181|FG000|COMPLETED|Overall Study||8||
59940653|NCT02795832|76059182|FG001|COMPLETED|Overall Study||4||
59940654|NCT02795832|76059183|FG002|COMPLETED|Overall Study||8||
59940655|NCT02795832|76059184|FG003|COMPLETED|Overall Study||3||
60067472|NCT01975285|76182676|FG001|NOT COMPLETED|Overall Study||2||
60067473|NCT01974895|76182684|FG000|STARTED|Overall Study||158||
59940656|NCT02795832|76059185|FG004|COMPLETED|Overall Study||20||
59940657|NCT02795832|76059186|FG005|COMPLETED|Overall Study||7||
59940658|NCT02795832|76059181|FG000|NOT COMPLETED|Overall Study||0||
59940659|NCT02795832|76059182|FG001|NOT COMPLETED|Overall Study||0||
59940660|NCT02795832|76059183|FG002|NOT COMPLETED|Overall Study||0||
59940661|NCT02795832|76059184|FG003|NOT COMPLETED|Overall Study||0||
59940662|NCT02795832|76059185|FG004|NOT COMPLETED|Overall Study||0||
59940663|NCT02795832|76059186|FG005|NOT COMPLETED|Overall Study||3||
59940664|NCT02794974|76059210|FG000|STARTED|Overall Study||14||
59940665|NCT02794974|76059211|FG001|STARTED|Overall Study||15||
59940666|NCT02794974|76059210|FG000|COMPLETED|Overall Study||14||
59940667|NCT02794974|76059211|FG001|COMPLETED|Overall Study||14||
59940668|NCT02794974|76059210|FG000|NOT COMPLETED|Overall Study||0||
59940669|NCT02794974|76059211|FG001|NOT COMPLETED|Overall Study||1||
59940670|NCT02419417|76059228|FG000|STARTED|Overall Study||5||
59940671|NCT02419417|76059229|FG001|STARTED|Overall Study||4||
59940672|NCT02419417|76059230|FG002|STARTED|Overall Study||13||
59940673|NCT02419417|76059231|FG003|STARTED|Overall Study||10||
59518569|NCT03530098|75612377|FG001|Primary Analysis Set|Overall Study||792|Primary analysis set: Participants with ground-truth labeled exam results and no bone deformity.|
59518570|NCT03530098|75612376|FG000|COMPLETED|Overall Study||939||
59518571|NCT03530098|75612377|FG001|COMPLETED|Overall Study||964||
59518572|NCT03530098|75612376|FG000|NOT COMPLETED|Overall Study||0||
59518573|NCT03530098|75612377|FG001|NOT COMPLETED|Overall Study||0||
59940674|NCT02419417|76059232|FG004|STARTED|Overall Study||13||
59940675|NCT02419417|76059233|FG005|STARTED|Overall Study||4||
59940676|NCT02419417|76059234|FG006|STARTED|Overall Study||4||
59940677|NCT02419417|76059235|FG007|STARTED|Overall Study||6||
59940678|NCT02419417|76059236|FG008|STARTED|Overall Study||13||
59940679|NCT02419417|76059237|FG009|STARTED|Overall Study||10||
59940680|NCT02419417|76059238|FG010|STARTED|Overall Study||1||
59940681|NCT02419417|76059228|FG000|COMPLETED|Overall Study||0||
59940682|NCT02419417|76059229|FG001|COMPLETED|Overall Study||0||
59940683|NCT02419417|76059230|FG002|COMPLETED|Overall Study||0||
59940684|NCT02419417|76059231|FG003|COMPLETED|Overall Study||0||
59940685|NCT02419417|76059232|FG004|COMPLETED|Overall Study||0||
59940686|NCT02419417|76059233|FG005|COMPLETED|Overall Study||0||
60067474|NCT01974895|76182685|FG001|STARTED|Overall Study||156||
59518574|NCT03386110|75612386|FG000|STARTED|Overall Study||56||
59518575|NCT03386110|75612387|FG001|STARTED|Overall Study||44||
59518576|NCT03386110|75612386|FG000|COMPLETED|Overall Study||41||
59518577|NCT03386110|75612387|FG001|COMPLETED|Overall Study||38||
59518578|NCT03386110|75612386|FG000|NOT COMPLETED|Overall Study||15||
59518579|NCT03386110|75612387|FG001|NOT COMPLETED|Overall Study||6||
59518580|NCT01082575|75612393|FG000|STARTED|Overall Study||100||
59518581|NCT01082575|75612393|FG000|COMPLETED|Overall Study||100||
59940687|NCT02419417|76059234|FG006|COMPLETED|Overall Study||0||
59940688|NCT02419417|76059235|FG007|COMPLETED|Overall Study||0||
59940689|NCT02419417|76059236|FG008|COMPLETED|Overall Study||0||
59940690|NCT02419417|76059237|FG009|COMPLETED|Overall Study||0||
59940691|NCT02419417|76059238|FG010|COMPLETED|Overall Study||0||
59940692|NCT02419417|76059228|FG000|NOT COMPLETED|Overall Study||5||
59940693|NCT02419417|76059229|FG001|NOT COMPLETED|Overall Study||4||
59940694|NCT02419417|76059230|FG002|NOT COMPLETED|Overall Study||13||
59940695|NCT02419417|76059231|FG003|NOT COMPLETED|Overall Study||10||
59940696|NCT02419417|76059232|FG004|NOT COMPLETED|Overall Study||13||
59940697|NCT02419417|76059233|FG005|NOT COMPLETED|Overall Study||4||
59940698|NCT02419417|76059234|FG006|NOT COMPLETED|Overall Study||4||
59940699|NCT02419417|76059235|FG007|NOT COMPLETED|Overall Study||6||
59940700|NCT02419417|76059236|FG008|NOT COMPLETED|Overall Study||13||
59940701|NCT02419417|76059237|FG009|NOT COMPLETED|Overall Study||10||
59940702|NCT02419417|76059238|FG010|NOT COMPLETED|Overall Study||1||
59940703|NCT02342275|76059269|FG000|STARTED|Overall Study||190||
59940704|NCT02342275|76059270|FG001|STARTED|Overall Study||187||
59940705|NCT02342275|76059269|FG000|COMPLETED|Overall Study||184||
59940706|NCT02342275|76059270|FG001|COMPLETED|Overall Study||182||
59940707|NCT02342275|76059269|FG000|NOT COMPLETED|Overall Study||6||
59940708|NCT02342275|76059270|FG001|NOT COMPLETED|Overall Study||5||
59940709|NCT00777491|76059279|FG000|STARTED|Overall Study||35||
59940710|NCT00777491|76059280|FG001|STARTED|Overall Study||35||
59940711|NCT00777491|76059279|FG000|Eligible|Overall Study||33||
59940712|NCT00777491|76059280|FG001|Eligible|Overall Study||33||
59940713|NCT00777491|76059279|FG000|Has 3-year Efficacy Data|Overall Study||27|Eligible and has 3-year distant metastasis status|
59940714|NCT00777491|76059280|FG001|Has 3-year Efficacy Data|Overall Study||25|Eligible and has 3-year distant metastasis status|
59940715|NCT00777491|76059279|FG000|Started Induction Therapy|Overall Study||33|Eligible and started induction therapy|
59940716|NCT00777491|76059280|FG001|Started Induction Therapy|Overall Study||33|Eligible and started induction therapy|
59940717|NCT00777491|76059279|FG000|Started Consolidation Therapy|Overall Study||29|Eligible and started consolidation therapy|
59940718|NCT00777491|76059280|FG001|Started Consolidation Therapy|Overall Study||25|Eligible and started consolidation therapy|
59940719|NCT00777491|76059279|FG000|Started Adjuvant Therapy|Overall Study||32|Eligible and started adjuvant therapy|
59940720|NCT00777491|76059280|FG001|Started Adjuvant Therapy|Overall Study||31|Eligible and started adjuvant therapy|
59940721|NCT00777491|76059279|FG000|Has Adverse Event Data (Treatment)|Overall Study||33|Eligible and has adverse event data during treatment|
59940722|NCT00777491|76059280|FG001|Has Adverse Event Data (Treatment)|Overall Study||33|Eligible and has adverse event data during treatment|
59613374|NCT01686828|75724519|FG000|COMPLETED|Overall Study||12||
59613375|NCT01686828|75724520|FG001|COMPLETED|Overall Study||13||
59613376|NCT01686828|75724521|FG002|COMPLETED|Overall Study||12||
59613377|NCT01686828|75724522|FG003|COMPLETED|Overall Study||13||
59940723|NCT00777491|76059279|FG000|Has Adverse Event Data (Late)|Overall Study||32|Eligible and has adverse event data between end of treatment to 180 days after end of treatment|
59940724|NCT00777491|76059280|FG001|Has Adverse Event Data (Late)|Overall Study||31|Eligible and has adverse event data between end of treatment to 180 days after end of treatment|
59940725|NCT00777491|76059279|FG000|Has 3 Year AUASI Data|Overall Study||6|Eligible and has baseline and 3-year American Urological Association Symptom Index (AUASI) scores|
59940726|NCT00777491|76059280|FG001|Has 3 Year AUASI Data|Overall Study||6|Eligible and has baseline and 3-year American Urological Association Symptom Index (AUASI) scores|
59940727|NCT00777491|76059279|FG000|COMPLETED|Overall Study||33|Subjects contributing any data to analysis are considered to have completed the study|
59940728|NCT00777491|76059280|FG001|COMPLETED|Overall Study||33|Subjects contributing any data to analysis are considered to have completed the study|
59940729|NCT00777491|76059279|FG000|NOT COMPLETED|Overall Study||2||
59940730|NCT00777491|76059280|FG001|NOT COMPLETED|Overall Study||2||
59940731|NCT03430531|76059286|FG000|STARTED|Overall Study||6||
59940732|NCT03430531|76059286|FG000|COMPLETED|Overall Study||6||
59940733|NCT03430531|76059286|FG000|NOT COMPLETED|Overall Study||0||
59940734|NCT02066532|76059290|FG000|STARTED|Phase I||9||
59940735|NCT02066532|76059291|FG001|STARTED|Phase I||1||
59940736|NCT02066532|76059292|FG002|STARTED|Phase I||0||
59940737|NCT02066532|76059293|FG003|STARTED|Phase I||0||
59940738|NCT02066532|76059290|FG000|COMPLETED|Phase I||9||
59940739|NCT02066532|76059291|FG001|COMPLETED|Phase I||1||
59940740|NCT02066532|76059292|FG002|COMPLETED|Phase I||0||
59940741|NCT02066532|76059293|FG003|COMPLETED|Phase I||0||
59940742|NCT02066532|76059290|FG000|NOT COMPLETED|Phase I||0||
59940743|NCT02066532|76059291|FG001|NOT COMPLETED|Phase I||0||
59940744|NCT02066532|76059292|FG002|NOT COMPLETED|Phase I||0||
59940745|NCT02066532|76059293|FG003|NOT COMPLETED|Phase I||0||
59940746|NCT02066532|76059290|FG000|STARTED|Phase II||27||
59940747|NCT02066532|76059291|FG001|STARTED|Phase II||0||
59940748|NCT02066532|76059292|FG002|STARTED|Phase II||0||
59940749|NCT02066532|76059293|FG003|STARTED|Phase II||0||
59940750|NCT02066532|76059290|FG000|COMPLETED|Phase II||26||
59940751|NCT02066532|76059291|FG001|COMPLETED|Phase II||0||
59940752|NCT02066532|76059292|FG002|COMPLETED|Phase II||0||
59940753|NCT02066532|76059293|FG003|COMPLETED|Phase II||0||
59940754|NCT02066532|76059290|FG000|NOT COMPLETED|Phase II||1||
59940755|NCT02066532|76059291|FG001|NOT COMPLETED|Phase II||0||
59940756|NCT02066532|76059292|FG002|NOT COMPLETED|Phase II||0||
59940757|NCT02066532|76059293|FG003|NOT COMPLETED|Phase II||0||
59940758|NCT03077711|76059300|FG000|STARTED|Overall Study||47||
59940759|NCT03077711|76059301|FG001|STARTED|Overall Study||45||
59940760|NCT03077711|76059300|FG000|COMPLETED|Overall Study||43||
59940761|NCT03077711|76059301|FG001|COMPLETED|Overall Study||43||
59940762|NCT03077711|76059300|FG000|NOT COMPLETED|Overall Study||4||
59940763|NCT03077711|76059301|FG001|NOT COMPLETED|Overall Study||2||
59940764|NCT04374019|76059313|FG000|STARTED|Overall Study||1||
59940765|NCT04374019|76059314|FG001|STARTED|Overall Study||1||
59940766|NCT04374019|76059315|FG002|STARTED|Overall Study||6||
59940767|NCT04374019|76059316|FG003|STARTED|Overall Study||5||
59940768|NCT04374019|76059313|FG000|COMPLETED|Overall Study||1||
59940769|NCT04374019|76059314|FG001|COMPLETED|Overall Study||1||
59940770|NCT04374019|76059315|FG002|COMPLETED|Overall Study||5||
59940771|NCT04374019|76059316|FG003|COMPLETED|Overall Study||5||
59940772|NCT04374019|76059313|FG000|NOT COMPLETED|Overall Study||0||
59940773|NCT04374019|76059314|FG001|NOT COMPLETED|Overall Study||0||
59940774|NCT04374019|76059315|FG002|NOT COMPLETED|Overall Study||1||
59940775|NCT04374019|76059316|FG003|NOT COMPLETED|Overall Study||0||
59940776|NCT04311463|76059328|FG000|STARTED|Period 1 (Up to Day 3)||19||
59940777|NCT04311463|76059329|FG001|STARTED|Period 1 (Up to Day 3)||19||
59940778|NCT04311463|76059328|FG000|COMPLETED|Period 1 (Up to Day 3)||18||
59613378|NCT01686828|75724519|FG000|NOT COMPLETED|Overall Study||1||
59940779|NCT04311463|76059329|FG001|COMPLETED|Period 1 (Up to Day 3)||19||
59940780|NCT04311463|76059328|FG000|NOT COMPLETED|Period 1 (Up to Day 3)||1||
59940781|NCT04311463|76059329|FG001|NOT COMPLETED|Period 1 (Up to Day 3)||0||
59940782|NCT04311463|76059328|FG000|STARTED|Washout Period (Up to Day 7)||18||
59940783|NCT04311463|76059329|FG001|STARTED|Washout Period (Up to Day 7)||19||
59613379|NCT01686828|75724520|FG001|NOT COMPLETED|Overall Study||1||
59940784|NCT04311463|76059328|FG000|COMPLETED|Washout Period (Up to Day 7)||17||
59940785|NCT04311463|76059329|FG001|COMPLETED|Washout Period (Up to Day 7)||18||
59940786|NCT04311463|76059328|FG000|NOT COMPLETED|Washout Period (Up to Day 7)||1||
59940787|NCT04311463|76059329|FG001|NOT COMPLETED|Washout Period (Up to Day 7)||1||
59940788|NCT04311463|76059328|FG000|STARTED|Period 2 (Up to Day 3)||17||
59940789|NCT04311463|76059329|FG001|STARTED|Period 2 (Up to Day 3)||18||
59940790|NCT04311463|76059328|FG000|COMPLETED|Period 2 (Up to Day 3)||15||
59940791|NCT04311463|76059329|FG001|COMPLETED|Period 2 (Up to Day 3)||17||
59940792|NCT04311463|76059328|FG000|NOT COMPLETED|Period 2 (Up to Day 3)||2||
59940793|NCT04311463|76059329|FG001|NOT COMPLETED|Period 2 (Up to Day 3)||1||
59940794|NCT03174353|76059336|FG000|STARTED|Overall Study||114||
59940795|NCT03174353|76059336|FG000|COMPLETED|Overall Study||98||
59940796|NCT03174353|76059336|FG000|NOT COMPLETED|Overall Study||16||
59940797|NCT01370538|76059342|FG000|STARTED|Overall Study||170||
59940798|NCT01370538|76059343|FG001|STARTED|Overall Study||171||
59940799|NCT01370538|76059342|FG000|Patients Who Received Treatment|Overall Study||165||
59940800|NCT01370538|76059343|FG001|Patients Who Received Treatment|Overall Study||161||
59940801|NCT01370538|76059342|FG000|Patients Who Completed Treatment|Overall Study||151||
59940802|NCT01370538|76059343|FG001|Patients Who Completed Treatment|Overall Study||152||
59940803|NCT01370538|76059342|FG000|COMPLETED|Overall Study||151||
59940804|NCT01370538|76059343|FG001|COMPLETED|Overall Study||152||
59940805|NCT01370538|76059342|FG000|NOT COMPLETED|Overall Study||19||
59940806|NCT01370538|76059343|FG001|NOT COMPLETED|Overall Study||19||
59940807|NCT03248297|76059352|FG000|STARTED|Overall Study||253||
59940808|NCT03248297|76059353|FG001|STARTED|Overall Study||253||
59940809|NCT03248297|76059354|FG002|STARTED|Overall Study||250||
59940810|NCT03248297|76059352|FG000|COMPLETED|Overall Study||253||
59940811|NCT03248297|76059353|FG001|COMPLETED|Overall Study||253||
59940812|NCT03248297|76059354|FG002|COMPLETED|Overall Study||250||
59940813|NCT03248297|76059352|FG000|NOT COMPLETED|Overall Study||0||
59940814|NCT03248297|76059353|FG001|NOT COMPLETED|Overall Study||0||
59940815|NCT03248297|76059354|FG002|NOT COMPLETED|Overall Study||0||
59940816|NCT03402841|76059362|FG000|STARTED|Overall Study||279||
59940817|NCT03402841|76059362|FG000|COMPLETED|Overall Study||128||
59940818|NCT03402841|76059362|FG000|NOT COMPLETED|Overall Study||151||
59940819|NCT04175509|76059368|FG000|STARTED|Overall Study||19||
59940820|NCT04175509|76059369|FG001|STARTED|Overall Study||21||
59940821|NCT04175509|76059368|FG000|COMPLETED|Overall Study||17||
59940822|NCT04175509|76059369|FG001|COMPLETED|Overall Study||19||
59940823|NCT04175509|76059368|FG000|NOT COMPLETED|Overall Study||2||
59940824|NCT04175509|76059369|FG001|NOT COMPLETED|Overall Study||2||
59940825|NCT02881957|76059377|FG000|STARTED|Overall Study||136||
59940826|NCT02881957|76059378|FG001|STARTED|Overall Study||138||
59940827|NCT02881957|76059377|FG000|COMPLETED|Overall Study||133||
59940828|NCT02881957|76059378|FG001|COMPLETED|Overall Study||134||
59940829|NCT02881957|76059377|FG000|NOT COMPLETED|Overall Study||3||
59940830|NCT02881957|76059378|FG001|NOT COMPLETED|Overall Study||4||
59940831|NCT03022461|76059384|FG000|STARTED|Overall Study||25||
59940832|NCT03022461|76059384|FG000|COMPLETED|Overall Study||22||
59940833|NCT03022461|76059384|FG000|NOT COMPLETED|Overall Study||3||
59940834|NCT02750930|76059389|FG000|STARTED|Overall Study||8||
59940835|NCT02750930|76059389|FG000|COMPLETED|Overall Study||0||
59940836|NCT02750930|76059389|FG000|NOT COMPLETED|Overall Study||8||
59940837|NCT03078907|76059395|FG000|STARTED|Overall Study||53||
59940838|NCT03078907|76059396|FG001|STARTED|Overall Study||55||
59940839|NCT03078907|76059395|FG000|COMPLETED|Overall Study||50||
59940840|NCT03078907|76059396|FG001|COMPLETED|Overall Study||54||
59940841|NCT03078907|76059395|FG000|NOT COMPLETED|Overall Study||3||
59940842|NCT03078907|76059396|FG001|NOT COMPLETED|Overall Study||1||
59940843|NCT03249714|76059404|FG000|STARTED|Double-blind Treatment (Core Part)||43||
59940844|NCT03249714|76059405|FG001|STARTED|Double-blind Treatment (Core Part)||21||
59940845|NCT03249714|76059404|FG000|COMPLETED|Double-blind Treatment (Core Part)||40||
59940846|NCT03249714|76059405|FG001|COMPLETED|Double-blind Treatment (Core Part)||19||
59940847|NCT03249714|76059404|FG000|NOT COMPLETED|Double-blind Treatment (Core Part)||3||
59940848|NCT03249714|76059405|FG001|NOT COMPLETED|Double-blind Treatment (Core Part)||2||
59940849|NCT03249714|76059404|FG000|STARTED|Open-label Treatment (Extension Part)||40||
59518582|NCT01082575|75612393|FG000|NOT COMPLETED|Overall Study||0||
59518583|NCT03578926|75612397|FG000|STARTED|First Intervention||21||
59940850|NCT03249714|76059405|FG001|STARTED|Open-label Treatment (Extension Part)||19||
59940851|NCT03249714|76059404|FG000|COMPLETED|Open-label Treatment (Extension Part)||38||
59940852|NCT03249714|76059405|FG001|COMPLETED|Open-label Treatment (Extension Part)||19||
59940853|NCT03249714|76059404|FG000|NOT COMPLETED|Open-label Treatment (Extension Part)||2||
59940854|NCT03249714|76059405|FG001|NOT COMPLETED|Open-label Treatment (Extension Part)||0||
59518584|NCT03578926|75612398|FG001|STARTED|First Intervention||23||
59518585|NCT03578926|75612397|FG000|COMPLETED|First Intervention||21||
59518586|NCT03578926|75612398|FG001|COMPLETED|First Intervention||23||
59940855|NCT02925117|76059431|FG000|STARTED|Period 1 (Weeks 0 - 16)||41||
59940856|NCT02925117|76059432|FG001|STARTED|Period 1 (Weeks 0 - 16)||42||
59940857|NCT02925117|76059433|FG002|STARTED|Period 1 (Weeks 0 - 16)||42||
59940858|NCT02925117|76059434|FG003|STARTED|Period 1 (Weeks 0 - 16)||42||
59940859|NCT02925117|76059435|FG004|STARTED|Period 1 (Weeks 0 - 16)||0||
59940860|NCT02925117|76059436|FG005|STARTED|Period 1 (Weeks 0 - 16)||0||
59940861|NCT02925117|76059437|FG006|STARTED|Period 1 (Weeks 0 - 16)||0||
59940862|NCT02925117|76059438|FG007|STARTED|Period 1 (Weeks 0 - 16)||0||
59940863|NCT02925117|76059439|FG008|STARTED|Period 1 (Weeks 0 - 16)||0||
59940864|NCT02925117|76059440|FG009|STARTED|Period 1 (Weeks 0 - 16)||0||
59940865|NCT02925117|76059441|FG010|STARTED|Period 1 (Weeks 0 - 16)||0||
59940866|NCT02925117|76059442|FG011|STARTED|Period 1 (Weeks 0 - 16)||0||
59940867|NCT02925117|76059431|FG000|Received Treatment|Period 1 (Weeks 0 - 16)||40||
59940868|NCT02925117|76059432|FG001|Received Treatment|Period 1 (Weeks 0 - 16)||42||
59940869|NCT02925117|76059433|FG002|Received Treatment|Period 1 (Weeks 0 - 16)||42||
59940870|NCT02925117|76059434|FG003|Received Treatment|Period 1 (Weeks 0 - 16)||42||
59940871|NCT02925117|76059435|FG004|Received Treatment|Period 1 (Weeks 0 - 16)||0||
59940872|NCT02925117|76059436|FG005|Received Treatment|Period 1 (Weeks 0 - 16)||0||
59940873|NCT02925117|76059437|FG006|Received Treatment|Period 1 (Weeks 0 - 16)||0||
59940874|NCT02925117|76059438|FG007|Received Treatment|Period 1 (Weeks 0 - 16)||0||
59940875|NCT02925117|76059439|FG008|Received Treatment|Period 1 (Weeks 0 - 16)||0||
59940876|NCT02925117|76059440|FG009|Received Treatment|Period 1 (Weeks 0 - 16)||0||
59940877|NCT02925117|76059441|FG010|Received Treatment|Period 1 (Weeks 0 - 16)||0||
59940878|NCT02925117|76059442|FG011|Received Treatment|Period 1 (Weeks 0 - 16)||0||
59940879|NCT02925117|76059431|FG000|COMPLETED|Period 1 (Weeks 0 - 16)||23||
59940880|NCT02925117|76059432|FG001|COMPLETED|Period 1 (Weeks 0 - 16)||31||
59940881|NCT02925117|76059433|FG002|COMPLETED|Period 1 (Weeks 0 - 16)||37||
59940882|NCT02925117|76059434|FG003|COMPLETED|Period 1 (Weeks 0 - 16)||39||
59940883|NCT02925117|76059435|FG004|COMPLETED|Period 1 (Weeks 0 - 16)||0||
59940884|NCT02925117|76059436|FG005|COMPLETED|Period 1 (Weeks 0 - 16)||0||
59940885|NCT02925117|76059437|FG006|COMPLETED|Period 1 (Weeks 0 - 16)||0||
59940886|NCT02925117|76059438|FG007|COMPLETED|Period 1 (Weeks 0 - 16)||0||
59940887|NCT02925117|76059439|FG008|COMPLETED|Period 1 (Weeks 0 - 16)||0||
59940888|NCT02925117|76059440|FG009|COMPLETED|Period 1 (Weeks 0 - 16)||0||
59940889|NCT02925117|76059441|FG010|COMPLETED|Period 1 (Weeks 0 - 16)||0||
59940890|NCT02925117|76059442|FG011|COMPLETED|Period 1 (Weeks 0 - 16)||0||
59940891|NCT02925117|76059431|FG000|NOT COMPLETED|Period 1 (Weeks 0 - 16)||18||
59940892|NCT02925117|76059432|FG001|NOT COMPLETED|Period 1 (Weeks 0 - 16)||11||
59940893|NCT02925117|76059433|FG002|NOT COMPLETED|Period 1 (Weeks 0 - 16)||5||
59940894|NCT02925117|76059434|FG003|NOT COMPLETED|Period 1 (Weeks 0 - 16)||3||
59940895|NCT02925117|76059435|FG004|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0||
59940896|NCT02925117|76059436|FG005|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0||
59940897|NCT02925117|76059437|FG006|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0||
59940898|NCT02925117|76059438|FG007|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0||
59940899|NCT02925117|76059439|FG008|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0||
59940900|NCT02925117|76059440|FG009|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0||
59940901|NCT02925117|76059441|FG010|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0||
59940902|NCT02925117|76059442|FG011|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0||
59940903|NCT02925117|76059431|FG000|STARTED|Period 2 (Weeks 16 - 88)||0|Four participants completed Week 16 but were not re-randomized into Period 2.|
59940904|NCT02925117|76059432|FG001|STARTED|Period 2 (Weeks 16 - 88)||0|Four participants completed Week 16 but were not re-randomized into Period 2.|
59940905|NCT02925117|76059433|FG002|STARTED|Period 2 (Weeks 16 - 88)||0|Four participants completed Week 16 but were not re-randomized into Period 2.|
59940906|NCT02925117|76059434|FG003|STARTED|Period 2 (Weeks 16 - 88)||0|Four participants completed Week 16 but were not re-randomized into Period 2.|
59940907|NCT02925117|76059435|FG004|STARTED|Period 2 (Weeks 16 - 88)||10|Four participants completed Week 16 but were not re-randomized into Period 2.|
59940908|NCT02925117|76059436|FG005|STARTED|Period 2 (Weeks 16 - 88)||10|Four participants completed Week 16 but were not re-randomized into Period 2.|
59940909|NCT02925117|76059437|FG006|STARTED|Period 2 (Weeks 16 - 88)||15|Four participants completed Week 16 but were not re-randomized into Period 2.|
59940910|NCT02925117|76059438|FG007|STARTED|Period 2 (Weeks 16 - 88)||16|Four participants completed Week 16 but were not re-randomized into Period 2.|
59940911|NCT02925117|76059439|FG008|STARTED|Period 2 (Weeks 16 - 88)||19|Four participants completed Week 16 but were not re-randomized into Period 2.|
59940912|NCT02925117|76059440|FG009|STARTED|Period 2 (Weeks 16 - 88)||18|Four participants completed Week 16 but were not re-randomized into Period 2.|
59940913|NCT02925117|76059441|FG010|STARTED|Period 2 (Weeks 16 - 88)||19|Four participants completed Week 16 but were not re-randomized into Period 2.|
59940914|NCT02925117|76059442|FG011|STARTED|Period 2 (Weeks 16 - 88)||19|Four participants completed Week 16 but were not re-randomized into Period 2.|
59940915|NCT02925117|76059431|FG000|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||0||
59940916|NCT02925117|76059432|FG001|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||0||
59940917|NCT02925117|76059433|FG002|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||0||
59940918|NCT02925117|76059434|FG003|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||0||
59940919|NCT02925117|76059435|FG004|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||8||
59940920|NCT02925117|76059436|FG005|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||1||
59940921|NCT02925117|76059437|FG006|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||13||
59940922|NCT02925117|76059438|FG007|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||12||
59518587|NCT03578926|75612397|FG000|NOT COMPLETED|First Intervention||0||
59518588|NCT03578926|75612398|FG001|NOT COMPLETED|First Intervention||0||
59940923|NCT02925117|76059439|FG008|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||17||
59940924|NCT02925117|76059440|FG009|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||12||
59940925|NCT02925117|76059441|FG010|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||14||
59940926|NCT02925117|76059442|FG011|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||4||
59940927|NCT02925117|76059431|FG000|COMPLETED|Period 2 (Weeks 16 - 88)||0||
59940928|NCT02925117|76059432|FG001|COMPLETED|Period 2 (Weeks 16 - 88)||0||
59940929|NCT02925117|76059433|FG002|COMPLETED|Period 2 (Weeks 16 - 88)||0||
59951238|NCT03743415|76070179|FG004|STARTED|Overall Study||166||
59518589|NCT03578926|75612397|FG000|STARTED|Second Intervention||23||
59940930|NCT02925117|76059434|FG003|COMPLETED|Period 2 (Weeks 16 - 88)||0||
59940931|NCT02925117|76059435|FG004|COMPLETED|Period 2 (Weeks 16 - 88)||8||
59940932|NCT02925117|76059436|FG005|COMPLETED|Period 2 (Weeks 16 - 88)||5||
59940933|NCT02925117|76059437|FG006|COMPLETED|Period 2 (Weeks 16 - 88)||9||
59940934|NCT02925117|76059438|FG007|COMPLETED|Period 2 (Weeks 16 - 88)||11||
59940935|NCT02925117|76059439|FG008|COMPLETED|Period 2 (Weeks 16 - 88)||13||
59940936|NCT02925117|76059440|FG009|COMPLETED|Period 2 (Weeks 16 - 88)||12||
59940937|NCT02925117|76059441|FG010|COMPLETED|Period 2 (Weeks 16 - 88)||11||
59940938|NCT02925117|76059442|FG011|COMPLETED|Period 2 (Weeks 16 - 88)||14||
59940939|NCT02925117|76059431|FG000|NOT COMPLETED|Period 2 (Weeks 16 - 88)||0||
59940940|NCT02925117|76059432|FG001|NOT COMPLETED|Period 2 (Weeks 16 - 88)||0||
59940941|NCT02925117|76059433|FG002|NOT COMPLETED|Period 2 (Weeks 16 - 88)||0||
59940942|NCT02925117|76059434|FG003|NOT COMPLETED|Period 2 (Weeks 16 - 88)||0||
59940943|NCT02925117|76059435|FG004|NOT COMPLETED|Period 2 (Weeks 16 - 88)||2||
59940944|NCT02925117|76059436|FG005|NOT COMPLETED|Period 2 (Weeks 16 - 88)||5||
59518590|NCT03578926|75612398|FG001|STARTED|Second Intervention||21||
59518591|NCT03578926|75612397|FG000|COMPLETED|Second Intervention||23||
59518592|NCT03578926|75612398|FG001|COMPLETED|Second Intervention||21||
59518593|NCT03578926|75612397|FG000|NOT COMPLETED|Second Intervention||0||
59518594|NCT03578926|75612398|FG001|NOT COMPLETED|Second Intervention||0||
59518595|NCT01083199|75612406|FG000|STARTED|Overall Study||10||
59518596|NCT01083199|75612406|FG000|COMPLETED|Overall Study||10||
59518597|NCT01083199|75612406|FG000|NOT COMPLETED|Overall Study||0||
59518598|NCT03388294|75612413|FG000|STARTED|Overall Study||42||21
59518599|NCT03388294|75612414|FG001|STARTED|Overall Study||30||15
59518600|NCT03388294|75612413|FG000|Posttest 1|Overall Study||38||19
59518601|NCT03388294|75612414|FG001|Posttest 1|Overall Study||30||15
59518602|NCT03388294|75612413|FG000|Posttest 2|Overall Study||38||19
59518603|NCT03388294|75612414|FG001|Posttest 2|Overall Study||30||15
59518604|NCT03388294|75612413|FG000|COMPLETED|Overall Study||38||19
59518605|NCT03388294|75612414|FG001|COMPLETED|Overall Study||30||15
59518606|NCT03388294|75612413|FG000|NOT COMPLETED|Overall Study||4||2
59518607|NCT03388294|75612414|FG001|NOT COMPLETED|Overall Study||0||0
59518608|NCT02171611|75612420|FG000|STARTED|Overall Study||5||
59518609|NCT02171611|75612421|FG001|STARTED|Overall Study||5||
59518610|NCT02171611|75612422|FG002|STARTED|Overall Study||5||
59518611|NCT02171611|75612423|FG003|STARTED|Overall Study||5||
59518612|NCT02171611|75612424|FG004|STARTED|Overall Study||5||
59518613|NCT02171611|75612425|FG005|STARTED|Overall Study||5||
59518614|NCT02171611|75612420|FG000|COMPLETED|Overall Study||5||
59518615|NCT02171611|75612421|FG001|COMPLETED|Overall Study||5||
59518616|NCT02171611|75612422|FG002|COMPLETED|Overall Study||5||
59940945|NCT02925117|76059437|FG006|NOT COMPLETED|Period 2 (Weeks 16 - 88)||6||
59940946|NCT02925117|76059438|FG007|NOT COMPLETED|Period 2 (Weeks 16 - 88)||5||
59940947|NCT02925117|76059439|FG008|NOT COMPLETED|Period 2 (Weeks 16 - 88)||6||
59940948|NCT02925117|76059440|FG009|NOT COMPLETED|Period 2 (Weeks 16 - 88)||6||
59940949|NCT02925117|76059441|FG010|NOT COMPLETED|Period 2 (Weeks 16 - 88)||8||
59940950|NCT02925117|76059442|FG011|NOT COMPLETED|Period 2 (Weeks 16 - 88)||5||
59940951|NCT03075163|76059466|FG000|STARTED|Overall Study||150||
59940952|NCT03075163|76059467|FG001|STARTED|Overall Study||150||
59940953|NCT03075163|76059466|FG000|COMPLETED|Overall Study||12||
59940954|NCT03075163|76059467|FG001|COMPLETED|Overall Study||12||
59940955|NCT03075163|76059466|FG000|NOT COMPLETED|Overall Study||138||
59940956|NCT03075163|76059467|FG001|NOT COMPLETED|Overall Study||138||
59940957|NCT03078751|76059475|FG000|STARTED|Overall Study||26||
59940958|NCT03078751|76059476|FG001|STARTED|Overall Study||28||
59940959|NCT03078751|76059475|FG000|Untreated Participants|Overall Study||0||
59940960|NCT03078751|76059476|FG001|Untreated Participants|Overall Study||4||
59940961|NCT03078751|76059475|FG000|Safety Set|Overall Study||26||
59940962|NCT03078751|76059476|FG001|Safety Set|Overall Study||24||
59940963|NCT03078751|76059475|FG000|COMPLETED|Overall Study||13||
59940964|NCT03078751|76059476|FG001|COMPLETED|Overall Study||0||
59940965|NCT03078751|76059475|FG000|NOT COMPLETED|Overall Study||13||
59940966|NCT03078751|76059476|FG001|NOT COMPLETED|Overall Study||28||
59940967|NCT03709771|76059486|FG000|STARTED|Overall Study||0||
59518617|NCT02171611|75612423|FG003|COMPLETED|Overall Study||5||
59518618|NCT02171611|75612424|FG004|COMPLETED|Overall Study||5||
59518619|NCT02171611|75612425|FG005|COMPLETED|Overall Study||5||
59518620|NCT02171611|75612420|FG000|NOT COMPLETED|Overall Study||0||
59518621|NCT02171611|75612421|FG001|NOT COMPLETED|Overall Study||0||
59518622|NCT02171611|75612422|FG002|NOT COMPLETED|Overall Study||0||
59518623|NCT02171611|75612423|FG003|NOT COMPLETED|Overall Study||0||
59518624|NCT02171611|75612424|FG004|NOT COMPLETED|Overall Study||0||
59518625|NCT02171611|75612425|FG005|NOT COMPLETED|Overall Study||0||
59518626|NCT03389854|75612437|FG000|STARTED|Overall Study||28||
59518627|NCT03389854|75612438|FG001|STARTED|Overall Study||27||
59518628|NCT03389854|75612439|FG002|STARTED|Overall Study||28||
59518629|NCT03389854|75612440|FG003|STARTED|Overall Study||27||
59518630|NCT03389854|75612437|FG000|COMPLETED|Overall Study||27||
59518631|NCT03389854|75612438|FG001|COMPLETED|Overall Study||21||
59518632|NCT03389854|75612439|FG002|COMPLETED|Overall Study||23||
59518633|NCT03389854|75612440|FG003|COMPLETED|Overall Study||19||
59940968|NCT03709771|76059487|FG001|STARTED|Overall Study||1||
59940969|NCT03709771|76059488|FG002|STARTED|Overall Study||1||
59940970|NCT03709771|76059489|FG003|STARTED|Overall Study||0||
59940971|NCT03709771|76059486|FG000|COMPLETED|Overall Study||0||
59940972|NCT03709771|76059487|FG001|COMPLETED|Overall Study||1||
59940973|NCT03709771|76059488|FG002|COMPLETED|Overall Study||0||
59940974|NCT03709771|76059489|FG003|COMPLETED|Overall Study||0||
59940975|NCT03709771|76059486|FG000|NOT COMPLETED|Overall Study||0||
59940976|NCT03709771|76059487|FG001|NOT COMPLETED|Overall Study||0||
59940977|NCT03709771|76059488|FG002|NOT COMPLETED|Overall Study||1||
59940978|NCT03709771|76059489|FG003|NOT COMPLETED|Overall Study||0||
59940979|NCT02924883|76059501|FG000|STARTED|Overall Study||133||
59940980|NCT02924883|76059502|FG001|STARTED|Overall Study||69||
59940981|NCT02924883|76059501|FG000|COMPLETED|Overall Study||0||
59940982|NCT02924883|76059502|FG001|COMPLETED|Overall Study||0||
59940983|NCT02924883|76059501|FG000|NOT COMPLETED|Overall Study||133||
59940984|NCT02924883|76059502|FG001|NOT COMPLETED|Overall Study||69||
59940985|NCT03373435|76059512|FG000|STARTED|Treatment Period 1 (14 Days)||8||
59940986|NCT03373435|76059513|FG001|STARTED|Treatment Period 1 (14 Days)||10||
59940987|NCT03373435|76059512|FG000|COMPLETED|Treatment Period 1 (14 Days)||8||
59940988|NCT03373435|76059513|FG001|COMPLETED|Treatment Period 1 (14 Days)||10||
59940989|NCT03373435|76059512|FG000|NOT COMPLETED|Treatment Period 1 (14 Days)||0||
59940990|NCT03373435|76059513|FG001|NOT COMPLETED|Treatment Period 1 (14 Days)||0||
59940991|NCT03373435|76059512|FG000|STARTED|Treatment Period 2 (14 Days)||8||
59940992|NCT03373435|76059513|FG001|STARTED|Treatment Period 2 (14 Days)||10||
59940993|NCT03373435|76059512|FG000|COMPLETED|Treatment Period 2 (14 Days)||8||
59940994|NCT03373435|76059513|FG001|COMPLETED|Treatment Period 2 (14 Days)||10||
59940995|NCT03373435|76059512|FG000|NOT COMPLETED|Treatment Period 2 (14 Days)||0||
59940996|NCT03373435|76059513|FG001|NOT COMPLETED|Treatment Period 2 (14 Days)||0||
59940997|NCT03373435|76059512|FG000|STARTED|Treatment Period 3 (14 Days)||8||
59940998|NCT03373435|76059513|FG001|STARTED|Treatment Period 3 (14 Days)||10||
59940999|NCT03373435|76059512|FG000|COMPLETED|Treatment Period 3 (14 Days)||8||
59941000|NCT03373435|76059513|FG001|COMPLETED|Treatment Period 3 (14 Days)||10||
59941001|NCT03373435|76059512|FG000|NOT COMPLETED|Treatment Period 3 (14 Days)||0||
59941002|NCT03373435|76059513|FG001|NOT COMPLETED|Treatment Period 3 (14 Days)||0||
59941003|NCT01369680|76059525|FG000|STARTED|Overall Study||3||
59941004|NCT01369680|76059526|FG001|STARTED|Overall Study||3||
59941005|NCT01369680|76059527|FG002|STARTED|Overall Study||3||
59941006|NCT01369680|76059528|FG003|STARTED|Overall Study||3||
59941007|NCT01369680|76059525|FG000|COMPLETED|Overall Study||3||
59941008|NCT01369680|76059526|FG001|COMPLETED|Overall Study||3||
59941009|NCT01369680|76059527|FG002|COMPLETED|Overall Study||2||
59941010|NCT01369680|76059528|FG003|COMPLETED|Overall Study||1||
59941011|NCT01369680|76059525|FG000|NOT COMPLETED|Overall Study||0||
59941012|NCT01369680|76059526|FG001|NOT COMPLETED|Overall Study||0||
59941013|NCT01369680|76059527|FG002|NOT COMPLETED|Overall Study||1||
59941014|NCT01369680|76059528|FG003|NOT COMPLETED|Overall Study||2||
59941015|NCT03240679|76059551|FG000|STARTED|Overall Study||1||
59941016|NCT03240679|76059552|FG001|STARTED|Overall Study||2||
59941017|NCT03240679|76059551|FG000|COMPLETED|Overall Study||1||
59941018|NCT03240679|76059552|FG001|COMPLETED|Overall Study||2||
59941019|NCT03240679|76059551|FG000|NOT COMPLETED|Overall Study||0||
59941020|NCT03240679|76059552|FG001|NOT COMPLETED|Overall Study||0||
59941021|NCT03074149|76059560|FG000|STARTED|Overall Study||96||
59941022|NCT03074149|76059561|FG001|STARTED|Overall Study||205||
59941023|NCT03074149|76059560|FG000|COMPLETED|Overall Study||64||
59941024|NCT03074149|76059561|FG001|COMPLETED|Overall Study||125||
59941025|NCT03074149|76059560|FG000|NOT COMPLETED|Overall Study||32||
59941026|NCT03074149|76059561|FG001|NOT COMPLETED|Overall Study||80||
59941027|NCT02751320|76059569|FG000|STARTED|Overall Study||45||
59941028|NCT02751320|76059569|FG000|Received Test Product 1|Overall Study||29||
59941029|NCT02751320|76059569|FG000|Received Test Prodcut 2|Overall Study||28||
59941030|NCT02751320|76059569|FG000|Received Test Prodcut 3|Overall Study||28||
59941031|NCT02751320|76059569|FG000|Received Reference Product 1|Overall Study||29||
59941032|NCT02751320|76059569|FG000|Received Reference Product 2|Overall Study||28||
59941033|NCT02751320|76059569|FG000|Received Reference Product 3|Overall Study||28||
59941034|NCT02751320|76059569|FG000|COMPLETED|Overall Study||42||
59941035|NCT02751320|76059569|FG000|NOT COMPLETED|Overall Study||3||
59941036|NCT02206035|76059597|FG000|STARTED|Overall Study||45||
59941037|NCT02206035|76059598|FG001|STARTED|Overall Study||130||
59941038|NCT02206035|76059599|FG002|STARTED|Overall Study||204||
59941039|NCT02206035|76059597|FG000|COMPLETED|Overall Study||35||
59941040|NCT02206035|76059598|FG001|COMPLETED|Overall Study||130||
59941041|NCT02206035|76059599|FG002|COMPLETED|Overall Study||29||
59941042|NCT02206035|76059597|FG000|NOT COMPLETED|Overall Study||10||
59941043|NCT02206035|76059598|FG001|NOT COMPLETED|Overall Study||0||
59941044|NCT02206035|76059599|FG002|NOT COMPLETED|Overall Study||175||
59941045|NCT02746471|76059606|FG000|STARTED|Overall Study||1604||
59941046|NCT02746471|76059606|FG000|COMPLETED|Overall Study||442||
59941047|NCT02746471|76059606|FG000|NOT COMPLETED|Overall Study||1162||
59941048|NCT02591953|76059613|FG000|STARTED|Overall Study||12||
59941049|NCT02591953|76059614|FG001|STARTED|Overall Study||10||
59941050|NCT02591953|76059613|FG000|COMPLETED|Overall Study||6||
59941051|NCT02591953|76059614|FG001|COMPLETED|Overall Study||4||
59941052|NCT02591953|76059613|FG000|NOT COMPLETED|Overall Study||6||
59941053|NCT02591953|76059614|FG001|NOT COMPLETED|Overall Study||6||
59941054|NCT03073213|76059622|FG000|STARTED|Single Dose Period||12||
59941055|NCT03073213|76059623|FG001|STARTED|Single Dose Period||0||
59941056|NCT03073213|76059624|FG002|STARTED|Single Dose Period||0||
59941057|NCT03073213|76059622|FG000|COMPLETED|Single Dose Period||12||
59941058|NCT03073213|76059623|FG001|COMPLETED|Single Dose Period||0||
59941059|NCT03073213|76059624|FG002|COMPLETED|Single Dose Period||0||
59941060|NCT03073213|76059622|FG000|NOT COMPLETED|Single Dose Period||0||
59941061|NCT03073213|76059623|FG001|NOT COMPLETED|Single Dose Period||0||
59941062|NCT03073213|76059624|FG002|NOT COMPLETED|Single Dose Period||0||
59941063|NCT03073213|76059622|FG000|STARTED|Multiple Dose Period||0||
59941064|NCT03073213|76059623|FG001|STARTED|Multiple Dose Period|Participants who completed single dose had option to enroll into multiple dose.|14||
59941065|NCT03073213|76059624|FG002|STARTED|Multiple Dose Period|Participants who completed single dose had option to enroll into multiple dose.|15||
59941066|NCT03073213|76059622|FG000|Participants Enrolled From Single Dose|Multiple Dose Period||0||
59941067|NCT03073213|76059623|FG001|Participants Enrolled From Single Dose|Multiple Dose Period||7||
59941068|NCT03073213|76059624|FG002|Participants Enrolled From Single Dose|Multiple Dose Period||2||
59941069|NCT03073213|76059622|FG000|COMPLETED|Multiple Dose Period||0||
59941070|NCT03073213|76059623|FG001|COMPLETED|Multiple Dose Period||14||
59941071|NCT03073213|76059624|FG002|COMPLETED|Multiple Dose Period||14||
59941072|NCT03073213|76059622|FG000|NOT COMPLETED|Multiple Dose Period||0||
59941073|NCT03073213|76059623|FG001|NOT COMPLETED|Multiple Dose Period||0||
59941074|NCT03073213|76059624|FG002|NOT COMPLETED|Multiple Dose Period||1||
59941075|NCT03070483|76059633|FG000|STARTED|Overall Study||5|First person was screened March 25, 2018|
59941076|NCT03070483|76059633|FG000|COMPLETED|Overall Study||3|Completed the trial|
59941077|NCT03070483|76059633|FG000|NOT COMPLETED|Overall Study||2||
59941078|NCT02231762|76059638|FG000|STARTED|Combination Phase||57||
59941079|NCT02231762|76059639|FG001|STARTED|Combination Phase|This arm was not included in period 1 (combination phase).|0||
59941080|NCT02231762|76059640|FG002|STARTED|Combination Phase|This arm was not included in period 1 (combination phase).|0||
59941081|NCT02231762|76059641|FG003|STARTED|Combination Phase|This arm was not included in period 1 (combination phase).|0||
59941082|NCT02231762|76059638|FG000|COMPLETED|Combination Phase||37||
59941083|NCT02231762|76059639|FG001|COMPLETED|Combination Phase||0||
59941084|NCT02231762|76059640|FG002|COMPLETED|Combination Phase||0||
59941085|NCT02231762|76059641|FG003|COMPLETED|Combination Phase||0||
59941086|NCT02231762|76059638|FG000|NOT COMPLETED|Combination Phase||20||
59941087|NCT02231762|76059639|FG001|NOT COMPLETED|Combination Phase||0||
59941088|NCT02231762|76059640|FG002|NOT COMPLETED|Combination Phase||0||
59941089|NCT02231762|76059641|FG003|NOT COMPLETED|Combination Phase||0||
59941090|NCT02231762|76059638|FG000|STARTED|Maintenance Phase|This arm was not included in period 2 (maintenance phase).|0||
59941091|NCT02231762|76059639|FG001|STARTED|Maintenance Phase|The 37 subjects completing period 1 were split between the 3 arms in period 2.|11||
59941092|NCT02231762|76059640|FG002|STARTED|Maintenance Phase|The 37 subjects completing period 1 were split between the 3 arms in period 2.|14||
59941093|NCT02231762|76059641|FG003|STARTED|Maintenance Phase|The 37 subjects completing period 1 were split between the 3 arms in period 2.|12||
59941094|NCT02231762|76059638|FG000|COMPLETED|Maintenance Phase||0||
59941095|NCT02231762|76059639|FG001|COMPLETED|Maintenance Phase||8||
59941096|NCT02231762|76059640|FG002|COMPLETED|Maintenance Phase||9||
59941097|NCT02231762|76059641|FG003|COMPLETED|Maintenance Phase||7||
59941098|NCT02231762|76059638|FG000|NOT COMPLETED|Maintenance Phase||0||
59941099|NCT02231762|76059639|FG001|NOT COMPLETED|Maintenance Phase||3||
59941100|NCT02231762|76059640|FG002|NOT COMPLETED|Maintenance Phase||5||
59941101|NCT02231762|76059641|FG003|NOT COMPLETED|Maintenance Phase||5||
59941102|NCT03023397|76059658|FG000|STARTED|Run-In||8||
59941103|NCT03023397|76059659|FG001|STARTED|Run-In||3||
59518634|NCT03389854|75612437|FG000|NOT COMPLETED|Overall Study||1||
59941104|NCT03023397|76059660|FG002|STARTED|Run-In||1||
59941105|NCT03023397|76059658|FG000|COMPLETED|Run-In||6||
59518635|NCT03389854|75612438|FG001|NOT COMPLETED|Overall Study||6||
59941106|NCT03023397|76059659|FG001|COMPLETED|Run-In||3||
59941107|NCT03023397|76059660|FG002|COMPLETED|Run-In||1||
59941108|NCT03023397|76059658|FG000|NOT COMPLETED|Run-In||2||
59941109|NCT03023397|76059659|FG001|NOT COMPLETED|Run-In||0||
59941110|NCT03023397|76059660|FG002|NOT COMPLETED|Run-In||0||
59941111|NCT03023397|76059658|FG000|STARTED|Main Study||6||
59941112|NCT03023397|76059659|FG001|STARTED|Main Study||3||
59941113|NCT03023397|76059660|FG002|STARTED|Main Study||1||
59941114|NCT03023397|76059658|FG000|COMPLETED|Main Study||6||
59941115|NCT03023397|76059659|FG001|COMPLETED|Main Study||3||
59941116|NCT03023397|76059660|FG002|COMPLETED|Main Study||1||
59941117|NCT03023397|76059658|FG000|NOT COMPLETED|Main Study||0||
59941118|NCT03023397|76059659|FG001|NOT COMPLETED|Main Study||0||
59941119|NCT03023397|76059660|FG002|NOT COMPLETED|Main Study||0||
59941120|NCT04325906|76059671|FG000|STARTED|Overall Study||112||
59941121|NCT04325906|76059672|FG001|STARTED|Overall Study||112||
59941122|NCT04325906|76059671|FG000|COMPLETED|Overall Study||110||
59941123|NCT04325906|76059672|FG001|COMPLETED|Overall Study||112||
59941124|NCT04325906|76059671|FG000|NOT COMPLETED|Overall Study||2||
59941125|NCT04325906|76059672|FG001|NOT COMPLETED|Overall Study||0||
59941126|NCT03068455|76059680|FG000|STARTED|Pre-treatment Period||920|Started = Randomized|
59941127|NCT03068455|76059681|FG001|STARTED|Pre-treatment Period||924|Started = Randomized|
59941128|NCT03068455|76059680|FG000|COMPLETED|Pre-treatment Period||916|Completed = Treated|
59941129|NCT03068455|76059681|FG001|COMPLETED|Pre-treatment Period||917|Completed = Treated|
59941130|NCT03068455|76059680|FG000|NOT COMPLETED|Pre-treatment Period||4||
59941131|NCT03068455|76059681|FG001|NOT COMPLETED|Pre-treatment Period||7||
59941132|NCT03068455|76059680|FG000|STARTED|Treatment Period||916|Started = Treated|
59941133|NCT03068455|76059681|FG001|STARTED|Treatment Period||917|Started = Treated|
59941134|NCT03068455|76059680|FG000|COMPLETED|Treatment Period||364|Completed = Finished treatment period|
59941135|NCT03068455|76059681|FG001|COMPLETED|Treatment Period||561|Completed = Finished treatment period|
59941136|NCT03068455|76059680|FG000|NOT COMPLETED|Treatment Period||552||
59941137|NCT03068455|76059681|FG001|NOT COMPLETED|Treatment Period||356||
59941138|NCT03067987|76059689|FG000|STARTED|Overall Study||50||
59941139|NCT03067987|76059690|FG001|STARTED|Overall Study||53||
59941140|NCT03067987|76059689|FG000|COMPLETED|Overall Study||40||
59941141|NCT03067987|76059690|FG001|COMPLETED|Overall Study||40||
59941142|NCT03067987|76059689|FG000|NOT COMPLETED|Overall Study||10||
59941143|NCT03067987|76059690|FG001|NOT COMPLETED|Overall Study||13||
59941144|NCT04035200|76059699|FG000|STARTED|Overall Study||38||
59941145|NCT04035200|76059700|FG001|STARTED|Overall Study||38||
59941146|NCT04035200|76059701|FG002|STARTED|Overall Study||38||
59941147|NCT04035200|76059699|FG000|COMPLETED|Overall Study||36||
59941148|NCT04035200|76059700|FG001|COMPLETED|Overall Study||31||
59941149|NCT04035200|76059701|FG002|COMPLETED|Overall Study||34||
59941150|NCT04035200|76059699|FG000|NOT COMPLETED|Overall Study||2||
59941151|NCT04035200|76059700|FG001|NOT COMPLETED|Overall Study||7||
59941152|NCT04035200|76059701|FG002|NOT COMPLETED|Overall Study||4||
59941153|NCT03197870|76059712|FG000|STARTED|Overall Study||55||
59941154|NCT03197870|76059713|FG001|STARTED|Overall Study||55||
59941155|NCT03197870|76059714|FG002|STARTED|Overall Study||57||
59941156|NCT03197870|76059712|FG000|COMPLETED|Overall Study||41||
59941157|NCT03197870|76059713|FG001|COMPLETED|Overall Study||45||
59941158|NCT03197870|76059714|FG002|COMPLETED|Overall Study||51||
59941159|NCT03197870|76059712|FG000|NOT COMPLETED|Overall Study||14||
59941160|NCT03197870|76059713|FG001|NOT COMPLETED|Overall Study||10||
59941161|NCT03197870|76059714|FG002|NOT COMPLETED|Overall Study||6||
59941162|NCT04889222|76059725|FG000|STARTED|Overall Study||54||
59941163|NCT04889222|76059725|FG000|COMPLETED|Overall Study||38||
59941164|NCT04889222|76059725|FG000|NOT COMPLETED|Overall Study||16||
59941165|NCT03911102|76059733|FG000|STARTED|Overall Study||15||
59941166|NCT03911102|76059734|FG001|STARTED|Overall Study||17||
59941167|NCT03911102|76059735|FG002|STARTED|Overall Study||15||
59941168|NCT03911102|76059736|FG003|STARTED|Overall Study||16||
59941169|NCT03911102|76059733|FG000|COMPLETED|Overall Study||14||
59941170|NCT03911102|76059734|FG001|COMPLETED|Overall Study||16||
59941171|NCT03911102|76059735|FG002|COMPLETED|Overall Study||12||
59941172|NCT03911102|76059736|FG003|COMPLETED|Overall Study||16||
59941173|NCT03911102|76059733|FG000|NOT COMPLETED|Overall Study||1||
59941174|NCT03911102|76059734|FG001|NOT COMPLETED|Overall Study||1||
59941175|NCT03911102|76059735|FG002|NOT COMPLETED|Overall Study||3||
59941176|NCT03911102|76059736|FG003|NOT COMPLETED|Overall Study||0||
59941177|NCT03881852|76059748|FG000|STARTED|Overall Study||11||
59941178|NCT03881852|76059749|FG001|STARTED|Overall Study||10||
59941179|NCT03881852|76059748|FG000|Dosed With AXS-12|Overall Study||11||
59941180|NCT03881852|76059749|FG001|Dosed With AXS-12|Overall Study||10||
59941181|NCT03881852|76059748|FG000|Dosed With Placebo|Overall Study||10||
59941182|NCT03881852|76059749|FG001|Dosed With Placebo|Overall Study||10||
59941183|NCT03881852|76059748|FG000|COMPLETED|Overall Study||10||
59941184|NCT03881852|76059749|FG001|COMPLETED|Overall Study||10||
59941185|NCT03881852|76059748|FG000|NOT COMPLETED|Overall Study||1||
59941186|NCT03881852|76059749|FG001|NOT COMPLETED|Overall Study||0||
59941187|NCT03067441|76059757|FG000|STARTED|Overall Study||492||
59941188|NCT03067441|76059758|FG001|STARTED|Overall Study||970||
59941189|NCT03067441|76059757|FG000|COMPLETED|Overall Study||459||
59941190|NCT03067441|76059758|FG001|COMPLETED|Overall Study||913||
59941191|NCT03067441|76059757|FG000|NOT COMPLETED|Overall Study||33||
59941192|NCT03067441|76059758|FG001|NOT COMPLETED|Overall Study||57||
59941193|NCT02600923|76059767|FG000|STARTED|Overall Study||131||
59941194|NCT02600923|76059767|FG000|Treated|Overall Study||130||
59941195|NCT02600923|76059767|FG000|COMPLETED|Overall Study||0||
59941196|NCT02600923|76059767|FG000|NOT COMPLETED|Overall Study||131||
59941197|NCT03070171|76059773|FG000|STARTED|Treatment Period 1 + Washout||80||
59941198|NCT03070171|76059774|FG001|STARTED|Treatment Period 1 + Washout||80||
59941199|NCT03070171|76059773|FG000|COMPLETED|Treatment Period 1 + Washout||80||
59941200|NCT03070171|76059774|FG001|COMPLETED|Treatment Period 1 + Washout||80||
59941201|NCT03070171|76059773|FG000|NOT COMPLETED|Treatment Period 1 + Washout||0||
59941202|NCT03070171|76059774|FG001|NOT COMPLETED|Treatment Period 1 + Washout||0||
59941203|NCT03070171|76059773|FG000|STARTED|Treatment Period 2 + Washout||80||
59941204|NCT03070171|76059774|FG001|STARTED|Treatment Period 2 + Washout||80||
59941205|NCT03070171|76059773|FG000|COMPLETED|Treatment Period 2 + Washout||80||
59941206|NCT03070171|76059774|FG001|COMPLETED|Treatment Period 2 + Washout||79||
59941207|NCT03070171|76059773|FG000|NOT COMPLETED|Treatment Period 2 + Washout||0||
59941208|NCT03070171|76059774|FG001|NOT COMPLETED|Treatment Period 2 + Washout||1||
59941209|NCT03070171|76059773|FG000|STARTED|Treatment Period 3 + Washout||80||
59941210|NCT03070171|76059774|FG001|STARTED|Treatment Period 3 + Washout||79||
59941211|NCT03070171|76059773|FG000|COMPLETED|Treatment Period 3 + Washout||80||
59941212|NCT03070171|76059774|FG001|COMPLETED|Treatment Period 3 + Washout||79||
59941213|NCT03070171|76059773|FG000|NOT COMPLETED|Treatment Period 3 + Washout||0||
59941214|NCT03070171|76059774|FG001|NOT COMPLETED|Treatment Period 3 + Washout||0||
59941215|NCT03070171|76059773|FG000|STARTED|Treatment Period 4 + Washout||80||
59941216|NCT03070171|76059774|FG001|STARTED|Treatment Period 4 + Washout||79||
59941217|NCT03070171|76059773|FG000|COMPLETED|Treatment Period 4 + Washout||80||
59941218|NCT03070171|76059774|FG001|COMPLETED|Treatment Period 4 + Washout||78||
59941219|NCT03070171|76059773|FG000|NOT COMPLETED|Treatment Period 4 + Washout||0||
59941220|NCT03070171|76059774|FG001|NOT COMPLETED|Treatment Period 4 + Washout||1||
59941221|NCT03644017|76059780|FG000|STARTED|Overall Study||46||
59941222|NCT03644017|76059780|FG000|COMPLETED|Overall Study||39||
59941223|NCT03644017|76059780|FG000|NOT COMPLETED|Overall Study||7||
59941224|NCT00158054|76059786|FG000|STARTED|Overall Study||80||
59941225|NCT00158054|76059787|FG001|STARTED|Overall Study||77||
59941226|NCT00158054|76059786|FG000|COMPLETED|Overall Study||70||
59941227|NCT00158054|76059787|FG001|COMPLETED|Overall Study||74||
59941228|NCT00158054|76059786|FG000|NOT COMPLETED|Overall Study||10||
59941229|NCT00158054|76059787|FG001|NOT COMPLETED|Overall Study||3||
59941230|NCT01337960|76059796|FG000|STARTED|Overall Study||14||
59941231|NCT01337960|76059797|FG001|STARTED|Overall Study||14||
59941232|NCT01337960|76059798|FG002|STARTED|Overall Study||6||
59941233|NCT01337960|76059796|FG000|COMPLETED|Overall Study||12||
59941234|NCT01337960|76059797|FG001|COMPLETED|Overall Study||14||
59941235|NCT01337960|76059798|FG002|COMPLETED|Overall Study||6||
59941236|NCT01337960|76059796|FG000|NOT COMPLETED|Overall Study||2||
59941237|NCT01337960|76059797|FG001|NOT COMPLETED|Overall Study||0||
59941238|NCT01337960|76059798|FG002|NOT COMPLETED|Overall Study||0||
59941239|NCT03077737|76059808|FG000|STARTED|Week 6 (10 Weeks After Enrollment)||97||
59941240|NCT03077737|76059809|FG001|STARTED|Week 6 (10 Weeks After Enrollment)||93||
59941241|NCT03077737|76059808|FG000|COMPLETED|Week 6 (10 Weeks After Enrollment)||89||
59941242|NCT03077737|76059809|FG001|COMPLETED|Week 6 (10 Weeks After Enrollment)||79||
59941243|NCT03077737|76059808|FG000|NOT COMPLETED|Week 6 (10 Weeks After Enrollment)||8||
59941244|NCT03077737|76059809|FG001|NOT COMPLETED|Week 6 (10 Weeks After Enrollment)||14||
59941245|NCT03077737|76059808|FG000|STARTED|Week 14 (18 Weeks After Enrollment)||97||
59941246|NCT03077737|76059809|FG001|STARTED|Week 14 (18 Weeks After Enrollment)||93||
59941247|NCT03077737|76059808|FG000|COMPLETED|Week 14 (18 Weeks After Enrollment)||83||
59941248|NCT03077737|76059809|FG001|COMPLETED|Week 14 (18 Weeks After Enrollment)||76||
59941249|NCT03077737|76059808|FG000|NOT COMPLETED|Week 14 (18 Weeks After Enrollment)||14||
59941250|NCT03077737|76059809|FG001|NOT COMPLETED|Week 14 (18 Weeks After Enrollment)||17||
59941251|NCT03077737|76059808|FG000|STARTED|Week 28 (32 Weeks After Enrollment)||49|Due to project timeline constraints, only the first 96 participants enrolled in the study were followed for 32 weeks.|
59941252|NCT03077737|76059809|FG001|STARTED|Week 28 (32 Weeks After Enrollment)||47|Due to project timeline constraints, only the first 96 participants enrolled in the study were followed for 32 weeks.|
59941253|NCT03077737|76059808|FG000|COMPLETED|Week 28 (32 Weeks After Enrollment)||39||
59941254|NCT03077737|76059809|FG001|COMPLETED|Week 28 (32 Weeks After Enrollment)||40||
59941255|NCT03077737|76059808|FG000|NOT COMPLETED|Week 28 (32 Weeks After Enrollment)||10||
59941256|NCT03077737|76059809|FG001|NOT COMPLETED|Week 28 (32 Weeks After Enrollment)||7||
59941257|NCT02750306|76059817|FG000|STARTED|Overall Study||142||
59941258|NCT02750306|76059818|FG001|STARTED|Overall Study||143||
59941259|NCT02750306|76059817|FG000|COMPLETED|Overall Study||136||
59941260|NCT02750306|76059818|FG001|COMPLETED|Overall Study||141||
59941261|NCT02750306|76059817|FG000|NOT COMPLETED|Overall Study||6||
59941262|NCT02750306|76059818|FG001|NOT COMPLETED|Overall Study||2||
59941263|NCT01816165|76059826|FG000|STARTED|Overall Study||5||
59941264|NCT01816165|76059827|FG001|STARTED|Overall Study||4||
59941265|NCT01816165|76059828|FG002|STARTED|Overall Study||5||
59941266|NCT01816165|76059829|FG003|STARTED|Overall Study||4||
59941267|NCT01816165|76059826|FG000|Completed Intervention 1|Overall Study||4||
59941268|NCT01816165|76059827|FG001|Completed Intervention 1|Overall Study||4||
59941269|NCT01816165|76059828|FG002|Completed Intervention 1|Overall Study||5||
59941270|NCT01816165|76059829|FG003|Completed Intervention 1|Overall Study||4||
59941271|NCT01816165|76059826|FG000|Completed ~2 Week Washout|Overall Study||4||
59941272|NCT01816165|76059827|FG001|Completed ~2 Week Washout|Overall Study||4||
59941273|NCT01816165|76059828|FG002|Completed ~2 Week Washout|Overall Study||5||
59941274|NCT01816165|76059829|FG003|Completed ~2 Week Washout|Overall Study||4||
59941275|NCT01816165|76059826|FG000|Started Second Intervention|Overall Study||4||
59941276|NCT01816165|76059827|FG001|Started Second Intervention|Overall Study||4||
59941277|NCT01816165|76059828|FG002|Started Second Intervention|Overall Study||5||
59941278|NCT01816165|76059829|FG003|Started Second Intervention|Overall Study||4||
59941279|NCT01816165|76059826|FG000|COMPLETED|Overall Study||4||
59941280|NCT01816165|76059827|FG001|COMPLETED|Overall Study||4||
59941281|NCT01816165|76059828|FG002|COMPLETED|Overall Study||5||
59941282|NCT01816165|76059829|FG003|COMPLETED|Overall Study||4||
59941283|NCT01816165|76059826|FG000|NOT COMPLETED|Overall Study||1||
59941284|NCT01816165|76059827|FG001|NOT COMPLETED|Overall Study||0||
59941285|NCT01816165|76059828|FG002|NOT COMPLETED|Overall Study||0||
59941286|NCT01816165|76059829|FG003|NOT COMPLETED|Overall Study||0||
59941287|NCT03890588|76059851|FG000|STARTED|Overall Study||2923||16
59941288|NCT03890588|76059852|FG001|STARTED|Overall Study||3372||16
59941289|NCT03890588|76059851|FG000|COMPLETED|Overall Study||2923||16
59941290|NCT03890588|76059852|FG001|COMPLETED|Overall Study||3372||16
59941291|NCT03890588|76059851|FG000|NOT COMPLETED|Overall Study||0||0
59941292|NCT03890588|76059852|FG001|NOT COMPLETED|Overall Study||0||0
59941293|NCT01677988|76059858|FG000|STARTED|Overall Study||3||
59941294|NCT01677988|76059858|FG000|COMPLETED|Overall Study||1||
59941295|NCT01677988|76059858|FG000|NOT COMPLETED|Overall Study||2||
59941296|NCT02926573|76059865|FG000|STARTED|Overall Study||55||
59941297|NCT02926573|76059866|FG001|STARTED|Overall Study||55||
59941298|NCT02926573|76059865|FG000|COMPLETED|Overall Study||44||
59941299|NCT02926573|76059866|FG001|COMPLETED|Overall Study||46||
59941300|NCT02926573|76059865|FG000|NOT COMPLETED|Overall Study||11||
59941301|NCT02926573|76059866|FG001|NOT COMPLETED|Overall Study||9||
59941302|NCT00158860|76059874|FG000|STARTED|Overall Study||128||
59941303|NCT00158860|76059875|FG001|STARTED|Overall Study||255||
59941304|NCT00158860|76059874|FG000|COMPLETED|Overall Study||93||
59941305|NCT00158860|76059875|FG001|COMPLETED|Overall Study||184||
59941306|NCT00158860|76059874|FG000|NOT COMPLETED|Overall Study||35||
59941307|NCT00158860|76059875|FG001|NOT COMPLETED|Overall Study||71||
59941308|NCT03067129|76059886|FG000|STARTED|Overall Study||47||
59941309|NCT03067129|76059887|FG001|STARTED|Overall Study||29||
59941310|NCT03067129|76059888|FG002|STARTED|Overall Study||27||
59941311|NCT03067129|76059889|FG003|STARTED|Overall Study||24||
59941312|NCT03067129|76059886|FG000|Intense Pharmacokinetic Portion|Overall Study||14|Includes participants who provided IPK samples by age group|
59941313|NCT03067129|76059887|FG001|Intense Pharmacokinetic Portion|Overall Study|Six participants received the initial proposed dose and 13 received the final proposed dose regimen.|19|Includes participants who provided IPK samples by age group|
59941314|NCT03067129|76059888|FG002|Intense Pharmacokinetic Portion|Overall Study|Six participants received the initial proposed dose and 12 received the final proposed dose regimen.|18|Includes participants who provided IPK samples by age group|
59941315|NCT03067129|76059889|FG003|Intense Pharmacokinetic Portion|Overall Study|Five participants received the initial proposed dose and 13 received the final proposed dose regimen.|18|Includes participants who provided IPK samples by age group|
59941316|NCT03067129|76059886|FG000|COMPLETED|Overall Study||42||
59941317|NCT03067129|76059887|FG001|COMPLETED|Overall Study||24||
59941318|NCT03067129|76059888|FG002|COMPLETED|Overall Study||22||
59941319|NCT03067129|76059889|FG003|COMPLETED|Overall Study||18||
59941320|NCT03067129|76059886|FG000|NOT COMPLETED|Overall Study||5||
59941321|NCT03067129|76059887|FG001|NOT COMPLETED|Overall Study||5||
59941322|NCT03067129|76059888|FG002|NOT COMPLETED|Overall Study||5||
59518636|NCT03389854|75612439|FG002|NOT COMPLETED|Overall Study||5||
59762074|NCT00877032|75881765|FG000|Treated|Overall Study||6||
59762075|NCT00877032|75881766|FG001|Treated|Overall Study||6||
59762076|NCT00877032|75881767|FG002|Treated|Overall Study||6||
59762077|NCT00877032|75881768|FG003|Treated|Overall Study||6||
59762078|NCT00877032|75881769|FG004|Treated|Overall Study||6||
59762079|NCT00877032|75881770|FG005|Treated|Overall Study||6||
59762080|NCT00877032|75881771|FG006|Treated|Overall Study||18||
59762081|NCT00877032|75881765|FG000|COMPLETED|Overall Study||6||
59762082|NCT00877032|75881766|FG001|COMPLETED|Overall Study||6||
59762083|NCT00877032|75881767|FG002|COMPLETED|Overall Study||6||
59762084|NCT00877032|75881768|FG003|COMPLETED|Overall Study||6||
59762085|NCT00877032|75881769|FG004|COMPLETED|Overall Study||6||
59762086|NCT00877032|75881770|FG005|COMPLETED|Overall Study||6||
59762087|NCT00877032|75881771|FG006|COMPLETED|Overall Study||18||
59941323|NCT03067129|76059889|FG003|NOT COMPLETED|Overall Study||6||
59941324|NCT01679236|76059911|FG000|STARTED|Overall Study||30||
59941325|NCT01679236|76059912|FG001|STARTED|Overall Study||25||
59941326|NCT01679236|76059911|FG000|COMPLETED|Overall Study||15||
59941327|NCT01679236|76059912|FG001|COMPLETED|Overall Study||10||
59762088|NCT00877032|75881765|FG000|NOT COMPLETED|Overall Study||0||
59762089|NCT00877032|75881766|FG001|NOT COMPLETED|Overall Study||0||
59762090|NCT00877032|75881767|FG002|NOT COMPLETED|Overall Study||0||
59762091|NCT00877032|75881768|FG003|NOT COMPLETED|Overall Study||1||
59762092|NCT00877032|75881769|FG004|NOT COMPLETED|Overall Study||0||
59941328|NCT01679236|76059911|FG000|NOT COMPLETED|Overall Study||15||
59941329|NCT01679236|76059912|FG001|NOT COMPLETED|Overall Study||15||
59941330|NCT01679002|76059921|FG000|STARTED|Overall Study||4||
59941331|NCT01679002|76059922|FG001|STARTED|Overall Study||4||
59941332|NCT01679002|76059923|FG002|STARTED|Overall Study||4||
59941333|NCT01679002|76059921|FG000|BIA 2-093 900 mg Once-daily Period|Overall Study||4||
59941334|NCT01679002|76059922|FG001|BIA 2-093 900 mg Once-daily Period|Overall Study||3||
59941335|NCT01679002|76059923|FG002|BIA 2-093 900 mg Once-daily Period|Overall Study||4||
59941336|NCT01679002|76059921|FG000|BIA 2-093 450 mg Twice-daily Period|Overall Study||4||
59941337|NCT01679002|76059922|FG001|BIA 2-093 450 mg Twice-daily Period|Overall Study||4||
59941338|NCT01679002|76059923|FG002|BIA 2-093 450 mg Twice-daily Period|Overall Study||4||
59941339|NCT01679002|76059921|FG000|Oxcarbazepine 450 mg Twice-daily Period|Overall Study||3||
59941340|NCT01679002|76059922|FG001|Oxcarbazepine 450 mg Twice-daily Period|Overall Study||4||
59941341|NCT01679002|76059923|FG002|Oxcarbazepine 450 mg Twice-daily Period|Overall Study||4||
59941342|NCT01679002|76059921|FG000|COMPLETED|Overall Study||3||
59941343|NCT01679002|76059922|FG001|COMPLETED|Overall Study||3||
59941344|NCT01679002|76059923|FG002|COMPLETED|Overall Study||4||
59941345|NCT01679002|76059921|FG000|NOT COMPLETED|Overall Study||1||
59941346|NCT01679002|76059922|FG001|NOT COMPLETED|Overall Study||1||
59941347|NCT01679002|76059923|FG002|NOT COMPLETED|Overall Study||0||
59941348|NCT04409509|76059933|FG000|STARTED|Overall Study||61||
59941349|NCT04409509|76059934|FG001|STARTED|Overall Study||63||
59941350|NCT04409509|76059933|FG000|COMPLETED|Overall Study||48||
59941351|NCT04409509|76059934|FG001|COMPLETED|Overall Study||43||
59941352|NCT04409509|76059933|FG000|NOT COMPLETED|Overall Study||13||
59941353|NCT04409509|76059934|FG001|NOT COMPLETED|Overall Study||20||
59941354|NCT01678924|76059945|FG000|STARTED|Overall Study||64||
59941355|NCT01678924|76059946|FG001|STARTED|Overall Study||63||
59941356|NCT01678924|76059947|FG002|STARTED|Overall Study||30||
59762093|NCT00877032|75881770|FG005|NOT COMPLETED|Overall Study||0||
59762094|NCT00877032|75881771|FG006|NOT COMPLETED|Overall Study||2||
59762095|NCT03318809|75881789|FG000|STARTED|Overall Study||6||
59762096|NCT03318809|75881790|FG001|STARTED|Overall Study||6||
59762097|NCT03318809|75881789|FG000|COMPLETED|Overall Study||6||
59762098|NCT03318809|75881790|FG001|COMPLETED|Overall Study||6||
59941357|NCT01678924|76059948|FG003|STARTED|Overall Study||123||
59941358|NCT01678924|76059945|FG000|COMPLETED|Overall Study||54||
59941359|NCT01678924|76059946|FG001|COMPLETED|Overall Study||51||
59941360|NCT01678924|76059947|FG002|COMPLETED|Overall Study||28||
59941361|NCT01678924|76059948|FG003|COMPLETED|Overall Study||105||
59941362|NCT01678924|76059945|FG000|NOT COMPLETED|Overall Study||10||
59941363|NCT01678924|76059946|FG001|NOT COMPLETED|Overall Study||12||
59941364|NCT01678924|76059947|FG002|NOT COMPLETED|Overall Study||2||
59941365|NCT01678924|76059948|FG003|NOT COMPLETED|Overall Study||18||
59941366|NCT02925793|76059962|FG000|STARTED|Overall Study||106||
59941367|NCT02925793|76059963|FG001|STARTED|Overall Study||110||
59941368|NCT02925793|76059964|FG002|STARTED|Overall Study||111||
59941369|NCT02925793|76059962|FG000|COMPLETED|Overall Study||81||
59941370|NCT02925793|76059963|FG001|COMPLETED|Overall Study||81||
59941371|NCT02925793|76059964|FG002|COMPLETED|Overall Study||83||
59941372|NCT02925793|76059962|FG000|NOT COMPLETED|Overall Study||25||
59941373|NCT02925793|76059963|FG001|NOT COMPLETED|Overall Study||29||
59941374|NCT02925793|76059964|FG002|NOT COMPLETED|Overall Study||28||
59941375|NCT03071263|76059974|FG000|STARTED|Overall Study||147||
59941376|NCT03071263|76059975|FG001|STARTED|Overall Study||148||
59941377|NCT03071263|76059974|FG000|COMPLETED|Overall Study||144||
59941378|NCT03071263|76059975|FG001|COMPLETED|Overall Study||141||
59941379|NCT03071263|76059974|FG000|NOT COMPLETED|Overall Study||3||
59941380|NCT03071263|76059975|FG001|NOT COMPLETED|Overall Study||7||
59941381|NCT04069585|76059981|FG000|STARTED|Overall Study||30||
59941382|NCT04069585|76059981|FG000|COMPLETED|Overall Study||30||
59941383|NCT04069585|76059981|FG000|NOT COMPLETED|Overall Study||0||
59941384|NCT00157196|76059987|FG000|STARTED|Overall Study||22||
59941385|NCT00157196|76059987|FG000|COMPLETED|Overall Study||13||
59941386|NCT00157196|76059987|FG000|NOT COMPLETED|Overall Study||9||
59941387|NCT03066193|76059991|FG000|STARTED|Overall Study||17||
59941388|NCT03066193|76059991|FG000|COMPLETED|Overall Study||16||
59941389|NCT03066193|76059991|FG000|NOT COMPLETED|Overall Study||1||
59941390|NCT03922321|76059995|FG000|STARTED|Overall Study||7||
59941391|NCT03922321|76059995|FG000|COMPLETED|Overall Study||5||
59941392|NCT03922321|76059995|FG000|NOT COMPLETED|Overall Study||2||
59762099|NCT03318809|75881789|FG000|NOT COMPLETED|Overall Study||0||
59941393|NCT01677910|76060002|FG000|STARTED|Double-Blind Treatment Period||45||
59941394|NCT01677910|76060003|FG001|STARTED|Double-Blind Treatment Period||45||
59941395|NCT01677910|76060004|FG002|STARTED|Double-Blind Treatment Period||45||
59941396|NCT01677910|76060005|FG003|STARTED|Double-Blind Treatment Period||0||
59941397|NCT01677910|76060002|FG000|COMPLETED|Double-Blind Treatment Period||38||
59941398|NCT01677910|76060003|FG001|COMPLETED|Double-Blind Treatment Period||42||
59941399|NCT01677910|76060004|FG002|COMPLETED|Double-Blind Treatment Period||38||
59941400|NCT01677910|76060005|FG003|COMPLETED|Double-Blind Treatment Period||0||
59941401|NCT01677910|76060002|FG000|NOT COMPLETED|Double-Blind Treatment Period||7||
59941402|NCT01677910|76060003|FG001|NOT COMPLETED|Double-Blind Treatment Period||3||
59941403|NCT01677910|76060004|FG002|NOT COMPLETED|Double-Blind Treatment Period||7||
59941404|NCT01677910|76060005|FG003|NOT COMPLETED|Double-Blind Treatment Period||0||
59941405|NCT01677910|76060002|FG000|STARTED|Open-Label Extension Period (OLE)||0||
59941406|NCT01677910|76060003|FG001|STARTED|Open-Label Extension Period (OLE)||0||
59941407|NCT01677910|76060004|FG002|STARTED|Open-Label Extension Period (OLE)||0||
59941408|NCT01677910|76060005|FG003|STARTED|Open-Label Extension Period (OLE)||115||
59941409|NCT01677910|76060002|FG000|COMPLETED|Open-Label Extension Period (OLE)||0||
59941410|NCT01677910|76060003|FG001|COMPLETED|Open-Label Extension Period (OLE)||0||
59941411|NCT01677910|76060004|FG002|COMPLETED|Open-Label Extension Period (OLE)||0||
59941412|NCT01677910|76060005|FG003|COMPLETED|Open-Label Extension Period (OLE)||79||
59941413|NCT01677910|76060002|FG000|NOT COMPLETED|Open-Label Extension Period (OLE)||0||
59941414|NCT01677910|76060003|FG001|NOT COMPLETED|Open-Label Extension Period (OLE)||0||
59941415|NCT01677910|76060004|FG002|NOT COMPLETED|Open-Label Extension Period (OLE)||0||
59941416|NCT01677910|76060005|FG003|NOT COMPLETED|Open-Label Extension Period (OLE)||36||
59941417|NCT03911713|76060020|FG000|STARTED|Overall Study||12||
59941418|NCT03911713|76060021|FG001|STARTED|Overall Study||6||
59941419|NCT03911713|76060022|FG002|STARTED|Overall Study||11||
59941420|NCT03911713|76060023|FG003|STARTED|Overall Study||24||
59941421|NCT03911713|76060024|FG004|STARTED|Overall Study||24||
59941422|NCT03911713|76060020|FG000|Full Analysis Set|Overall Study||11|Received at least 1 dose of study drug in treatment period.|
59941423|NCT03911713|76060021|FG001|Full Analysis Set|Overall Study||6|Received at least 1 dose of study drug in treatment period.|
59941424|NCT03911713|76060022|FG002|Full Analysis Set|Overall Study||11|Received at least 1 dose of study drug in treatment period.|
59941425|NCT03911713|76060023|FG003|Full Analysis Set|Overall Study||23|Received at least 1 dose of study drug in treatment period.|
59941426|NCT03911713|76060024|FG004|Full Analysis Set|Overall Study||24|Received at least 1 dose of study drug in treatment period.|
59941427|NCT03911713|76060020|FG000|COMPLETED|Overall Study||11||
59941428|NCT03911713|76060021|FG001|COMPLETED|Overall Study||4||
59941429|NCT03911713|76060022|FG002|COMPLETED|Overall Study||11||
59941430|NCT03911713|76060023|FG003|COMPLETED|Overall Study||22||
59941431|NCT03911713|76060024|FG004|COMPLETED|Overall Study||24||
59941432|NCT03911713|76060020|FG000|NOT COMPLETED|Overall Study||1||
59941433|NCT03911713|76060021|FG001|NOT COMPLETED|Overall Study||2||
59941434|NCT03911713|76060022|FG002|NOT COMPLETED|Overall Study||0||
59941435|NCT03911713|76060023|FG003|NOT COMPLETED|Overall Study||2||
59941436|NCT03911713|76060024|FG004|NOT COMPLETED|Overall Study||0||
59941437|NCT03065023|76060042|FG000|STARTED|Overall Study||3||
59941438|NCT03065023|76060043|FG001|STARTED|Overall Study||3||
59941439|NCT03065023|76060044|FG002|STARTED|Overall Study||3||
59941440|NCT03065023|76060045|FG003|STARTED|Overall Study||6||
59941441|NCT03065023|76060046|FG004|STARTED|Overall Study|Group B not started for business reasons.|0||
59941442|NCT03065023|76060042|FG000|COMPLETED|Overall Study||1||
59941443|NCT03065023|76060043|FG001|COMPLETED|Overall Study||1||
59941444|NCT03065023|76060044|FG002|COMPLETED|Overall Study||2||
59941445|NCT03065023|76060045|FG003|COMPLETED|Overall Study||3||
59941446|NCT03065023|76060046|FG004|COMPLETED|Overall Study||0||
59941447|NCT03065023|76060042|FG000|NOT COMPLETED|Overall Study||2||
59941448|NCT03065023|76060043|FG001|NOT COMPLETED|Overall Study||2||
59941449|NCT03065023|76060044|FG002|NOT COMPLETED|Overall Study||1||
59941450|NCT03065023|76060045|FG003|NOT COMPLETED|Overall Study||3||
59941451|NCT03065023|76060046|FG004|NOT COMPLETED|Overall Study||0||
59941452|NCT03614923|76060059|FG000|STARTED|Overall Study||35||
59941453|NCT03614923|76060060|FG001|STARTED|Overall Study||35||
59941454|NCT03614923|76060061|FG002|STARTED|Overall Study||35||
59941455|NCT03614923|76060059|FG000|COMPLETED|Overall Study||30||
59941456|NCT03614923|76060060|FG001|COMPLETED|Overall Study||30||
59941457|NCT03614923|76060061|FG002|COMPLETED|Overall Study||30||
59941458|NCT03614923|76060059|FG000|NOT COMPLETED|Overall Study||5||
59941459|NCT03614923|76060060|FG001|NOT COMPLETED|Overall Study||5||
59941460|NCT03614923|76060061|FG002|NOT COMPLETED|Overall Study||5||
59941461|NCT05169424|76060071|FG000|STARTED|Overall Study||3996||
59941462|NCT05169424|76060072|FG001|STARTED|Overall Study||5121||
59941463|NCT05169424|76060071|FG000|Propensity Score Matching|Overall Study||2951||
59941464|NCT05169424|76060072|FG001|Propensity Score Matching|Overall Study||2951||
59941465|NCT05169424|76060071|FG000|COMPLETED|Overall Study||3996||
59941466|NCT05169424|76060072|FG001|COMPLETED|Overall Study||5121||
59941467|NCT05169424|76060071|FG000|NOT COMPLETED|Overall Study||0||
59941468|NCT05169424|76060072|FG001|NOT COMPLETED|Overall Study||0||
59941469|NCT05098509|76060083|FG000|STARTED|Overall Study||1||
59941470|NCT05098509|76060084|FG001|STARTED|Overall Study||1||
59941471|NCT05098509|76060085|FG002|STARTED|Overall Study||2||
59941472|NCT05098509|76060086|FG003|STARTED|Overall Study||0||
59941473|NCT05098509|76060083|FG000|Received 1 Dose of Study Drug|Overall Study||1||
59941474|NCT05098509|76060084|FG001|Received 1 Dose of Study Drug|Overall Study||1||
59941475|NCT05098509|76060085|FG002|Received 1 Dose of Study Drug|Overall Study||2||
59941476|NCT05098509|76060086|FG003|Received 1 Dose of Study Drug|Overall Study||0||
59941477|NCT05098509|76060083|FG000|COMPLETED|Overall Study||0||
59941478|NCT05098509|76060084|FG001|COMPLETED|Overall Study||0||
59941479|NCT05098509|76060085|FG002|COMPLETED|Overall Study||0||
59941480|NCT05098509|76060086|FG003|COMPLETED|Overall Study||0||
59941481|NCT05098509|76060083|FG000|NOT COMPLETED|Overall Study||1||
59941482|NCT05098509|76060084|FG001|NOT COMPLETED|Overall Study||1||
59941483|NCT05098509|76060085|FG002|NOT COMPLETED|Overall Study||2||
59941484|NCT05098509|76060086|FG003|NOT COMPLETED|Overall Study||0||
59941485|NCT04962698|76060096|FG000|STARTED|Motor Imagery||19||
59941486|NCT04962698|76060097|FG001|STARTED|Motor Imagery||6||
59941487|NCT04962698|76060096|FG000|COMPLETED|Motor Imagery||18||
59941488|NCT04962698|76060097|FG001|COMPLETED|Motor Imagery||4||
59941489|NCT04962698|76060096|FG000|NOT COMPLETED|Motor Imagery||1||
59941490|NCT04962698|76060097|FG001|NOT COMPLETED|Motor Imagery||2||
59941491|NCT04962698|76060096|FG000|STARTED|Kinesthetic MI||19||
59941492|NCT04962698|76060097|FG001|STARTED|Kinesthetic MI||0||
59941493|NCT04962698|76060096|FG000|COMPLETED|Kinesthetic MI||18||
59941494|NCT04962698|76060097|FG001|COMPLETED|Kinesthetic MI||0||
59941495|NCT04962698|76060096|FG000|NOT COMPLETED|Kinesthetic MI||1||
59941496|NCT04962698|76060097|FG001|NOT COMPLETED|Kinesthetic MI||0||
59941497|NCT04962698|76060096|FG000|STARTED|Robotic-hand Interaction With MI||19||
59941498|NCT04962698|76060097|FG001|STARTED|Robotic-hand Interaction With MI||6||
59941499|NCT04962698|76060096|FG000|COMPLETED|Robotic-hand Interaction With MI||18||
59941500|NCT04962698|76060097|FG001|COMPLETED|Robotic-hand Interaction With MI||4||
59941501|NCT04962698|76060096|FG000|NOT COMPLETED|Robotic-hand Interaction With MI||1||
59941502|NCT04962698|76060097|FG001|NOT COMPLETED|Robotic-hand Interaction With MI||2||
59941503|NCT04962698|76060096|FG000|STARTED|Robotic-hand Interaction Without MI||19||
59941504|NCT04962698|76060097|FG001|STARTED|Robotic-hand Interaction Without MI||0||
59941505|NCT04962698|76060096|FG000|COMPLETED|Robotic-hand Interaction Without MI||18||
59941506|NCT04962698|76060097|FG001|COMPLETED|Robotic-hand Interaction Without MI||0||
59941507|NCT04962698|76060096|FG000|NOT COMPLETED|Robotic-hand Interaction Without MI||1||
59941508|NCT04962698|76060097|FG001|NOT COMPLETED|Robotic-hand Interaction Without MI||0||
59941509|NCT04962698|76060096|FG000|STARTED|Virtual-hand Interaction||19||
59941510|NCT04962698|76060097|FG001|STARTED|Virtual-hand Interaction||0||
59941511|NCT04962698|76060096|FG000|COMPLETED|Virtual-hand Interaction||18||
59941512|NCT04962698|76060097|FG001|COMPLETED|Virtual-hand Interaction||0||
59941513|NCT04962698|76060096|FG000|NOT COMPLETED|Virtual-hand Interaction||1||
59941514|NCT04962698|76060097|FG001|NOT COMPLETED|Virtual-hand Interaction||0||
59941515|NCT04962698|76060096|FG000|STARTED|Robotic Action Observation||19||
59941516|NCT04962698|76060097|FG001|STARTED|Robotic Action Observation||0||
59941517|NCT04962698|76060096|FG000|COMPLETED|Robotic Action Observation||18||
59941518|NCT04962698|76060097|FG001|COMPLETED|Robotic Action Observation||0||
59941519|NCT04962698|76060096|FG000|NOT COMPLETED|Robotic Action Observation||1||
59941520|NCT04962698|76060097|FG001|NOT COMPLETED|Robotic Action Observation||0||
59941521|NCT04962698|76060096|FG000|STARTED|Rest||19||
59941522|NCT04962698|76060097|FG001|STARTED|Rest||6||
59941523|NCT04962698|76060096|FG000|COMPLETED|Rest||18||
59941524|NCT04962698|76060097|FG001|COMPLETED|Rest||4||
59941525|NCT04962698|76060096|FG000|NOT COMPLETED|Rest||1||
59941526|NCT04962698|76060097|FG001|NOT COMPLETED|Rest||2||
59941527|NCT04609514|76060106|FG000|STARTED|Overall Study||22||
59941528|NCT04609514|76060107|FG001|STARTED|Overall Study||21||
59941529|NCT04609514|76060106|FG000|Per Protocol Week 4|Overall Study||20||
59941530|NCT04609514|76060107|FG001|Per Protocol Week 4|Overall Study||14||
59941531|NCT04609514|76060106|FG000|Per Protocol Week 8|Overall Study||18||
59941532|NCT04609514|76060107|FG001|Per Protocol Week 8|Overall Study||12||
59518637|NCT03389854|75612440|FG003|NOT COMPLETED|Overall Study||8||
59518638|NCT01083667|75612454|FG000|STARTED|Overall Study|enrolled|32||
59762100|NCT03318809|75881790|FG001|NOT COMPLETED|Overall Study||0||
59762101|NCT02772965|75881798|FG000|STARTED|Overall Study||162||
59762102|NCT02772965|75881799|FG001|STARTED|Overall Study||144||
59762103|NCT02772965|75881798|FG000|Randomized|Overall Study||162||
59762104|NCT02772965|75881799|FG001|Randomized|Overall Study||144||
59762105|NCT02772965|75881798|FG000|Withdrew Before Receiving Drug|Overall Study||6||
59762106|NCT02772965|75881799|FG001|Withdrew Before Receiving Drug|Overall Study||3||
59762107|NCT02772965|75881798|FG000|Modified Intent to Treat|Overall Study||156||
59762108|NCT02772965|75881799|FG001|Modified Intent to Treat|Overall Study||141||
59762109|NCT02772965|75881798|FG000|COMPLETED|Overall Study||140||
59762110|NCT02772965|75881799|FG001|COMPLETED|Overall Study||126||
59762111|NCT02772965|75881798|FG000|NOT COMPLETED|Overall Study||22||
59762112|NCT02772965|75881799|FG001|NOT COMPLETED|Overall Study||18||
59762113|NCT00538681|75881810|FG000|STARTED|Overall Study||9||
59762114|NCT00538681|75881811|FG001|STARTED|Overall Study||4||
59762115|NCT00538681|75881812|FG002|STARTED|Overall Study||11||
59762116|NCT00538681|75881813|FG003|STARTED|Overall Study|One (1) participant received pemetrexed and cisplatin only before the study was closed.|11||
59762117|NCT00538681|75881810|FG000|Received ≥1 Dose of Any Study Drug|Overall Study||9||
59941533|NCT04609514|76060106|FG000|Per Protocol Week 12|Overall Study||15||
59941534|NCT04609514|76060107|FG001|Per Protocol Week 12|Overall Study||12||
59941535|NCT04609514|76060106|FG000|Survey or Text Per Protocol Week 12|Overall Study||2||
59941536|NCT04609514|76060107|FG001|Survey or Text Per Protocol Week 12|Overall Study||3||
59941537|NCT04609514|76060106|FG000|COMPLETED|Overall Study||17||
59941538|NCT04609514|76060107|FG001|COMPLETED|Overall Study||15||
59941539|NCT04609514|76060106|FG000|NOT COMPLETED|Overall Study||5||
59941540|NCT04609514|76060107|FG001|NOT COMPLETED|Overall Study||6||
59762118|NCT00538681|75881811|FG001|Received ≥1 Dose of Any Study Drug|Overall Study||4||
59762119|NCT00538681|75881812|FG002|Received ≥1 Dose of Any Study Drug|Overall Study||11||
59762120|NCT00538681|75881813|FG003|Received ≥1 Dose of Any Study Drug|Overall Study||11||
59762121|NCT00538681|75881810|FG000|COMPLETED|Overall Study||0||
59941541|NCT04467840|76060116|FG000|STARTED|Overall Study||237|ITT populaion|
59941542|NCT04467840|76060117|FG001|STARTED|Overall Study||238|ITT populaion|
59941543|NCT04467840|76060116|FG000|mITT Population|Overall Study||230||
59941544|NCT04467840|76060117|FG001|mITT Population|Overall Study||233||
59941545|NCT04467840|76060116|FG000|COMPLETED|Overall Study||186||
59941546|NCT04467840|76060117|FG001|COMPLETED|Overall Study||186||
59941547|NCT04467840|76060116|FG000|NOT COMPLETED|Overall Study||51||
59941548|NCT04467840|76060117|FG001|NOT COMPLETED|Overall Study||52||
59941549|NCT04295499|76060127|FG000|STARTED|Overall Study|July 22, 2020|50||
59941550|NCT04295499|76060128|FG001|STARTED|Overall Study|July 22, 2020|25||
59941551|NCT04295499|76060127|FG000|COMPLETED|Overall Study|January 28, 2021|48||
59941552|NCT04295499|76060128|FG001|COMPLETED|Overall Study|January 28, 2021|25||
59941553|NCT04295499|76060127|FG000|NOT COMPLETED|Overall Study||2||
59941554|NCT04295499|76060128|FG001|NOT COMPLETED|Overall Study||0||
59941555|NCT04021290|76060136|FG000|STARTED|Randomized Phase (Day1 to Week 52)||246||
59941556|NCT04021290|76060137|FG001|STARTED|Randomized Phase (Day1 to Week 52)||247||
59941557|NCT04021290|76060138|FG002|STARTED|Randomized Phase (Day1 to Week 52)||0||
59941558|NCT04021290|76060136|FG000|COMPLETED|Randomized Phase (Day1 to Week 52)||136||
59941559|NCT04021290|76060137|FG001|COMPLETED|Randomized Phase (Day1 to Week 52)||229||
59941560|NCT04021290|76060138|FG002|COMPLETED|Randomized Phase (Day1 to Week 52)||0||
59941561|NCT04021290|76060136|FG000|NOT COMPLETED|Randomized Phase (Day1 to Week 52)||110||
59941562|NCT04021290|76060137|FG001|NOT COMPLETED|Randomized Phase (Day1 to Week 52)||18||
59941563|NCT04021290|76060138|FG002|NOT COMPLETED|Randomized Phase (Day1 to Week 52)||0||
59941564|NCT04021290|76060136|FG000|STARTED|Continuation Phase (Week 52 to Week 132)|This consist of participants who got transferred to continuation phase.|0||
59941565|NCT04021290|76060137|FG001|STARTED|Continuation Phase (Week 52 to Week 132)|Participants did not receive CAR in continuation phase.|0||
59941566|NCT04021290|76060138|FG002|STARTED|Continuation Phase (Week 52 to Week 132)|Transferred to continuation phase|96||
59941567|NCT04021290|76060136|FG000|COMPLETED|Continuation Phase (Week 52 to Week 132)||0||
59941568|NCT04021290|76060137|FG001|COMPLETED|Continuation Phase (Week 52 to Week 132)||0||
59941569|NCT04021290|76060138|FG002|COMPLETED|Continuation Phase (Week 52 to Week 132)||91||
59941570|NCT04021290|76060136|FG000|NOT COMPLETED|Continuation Phase (Week 52 to Week 132)||0||
59941571|NCT04021290|76060137|FG001|NOT COMPLETED|Continuation Phase (Week 52 to Week 132)||0||
59941572|NCT04021290|76060138|FG002|NOT COMPLETED|Continuation Phase (Week 52 to Week 132)||5||
59941573|NCT03630705|76060150|FG000|STARTED|Overall Study||200||
59941574|NCT03630705|76060151|FG001|STARTED|Overall Study||100||
59941575|NCT03630705|76060152|FG002|STARTED|Overall Study||150||
59941576|NCT03630705|76060153|FG003|STARTED|Overall Study||75||
59941577|NCT03630705|76060150|FG000|Vaccinated at the Age of 2 Months|Overall Study||200||
59941578|NCT03630705|76060151|FG001|Vaccinated at the Age of 2 Months|Overall Study||100||
59941579|NCT03630705|76060152|FG002|Vaccinated at the Age of 2 Months|Overall Study||150||
59941580|NCT03630705|76060153|FG003|Vaccinated at the Age of 2 Months|Overall Study||75||
59941581|NCT03630705|76060150|FG000|Vaccinated at the Age of 3 Months|Overall Study||0|Group 1 and 2 participants did not receive any vaccination at the age of 3 months.|
59941582|NCT03630705|76060151|FG001|Vaccinated at the Age of 3 Months|Overall Study||0|Group 1 and 2 participants did not receive any vaccination at the age of 3 months.|
59941583|NCT03630705|76060152|FG002|Vaccinated at the Age of 3 Months|Overall Study||149|Group 1 and 2 participants did not receive any vaccination at the age of 3 months.|
59941584|NCT03630705|76060153|FG003|Vaccinated at the Age of 3 Months|Overall Study||75|Group 1 and 2 participants did not receive any vaccination at the age of 3 months.|
59941585|NCT03630705|76060150|FG000|Vaccinated at the Age of 4 Months|Overall Study||195|Group 3 and 4 participants did not receive any vaccination at the age of 4 months.|
59941586|NCT03630705|76060151|FG001|Vaccinated at the Age of 4 Months|Overall Study||96|Group 3 and 4 participants did not receive any vaccination at the age of 4 months.|
59941587|NCT03630705|76060152|FG002|Vaccinated at the Age of 4 Months|Overall Study||0|Group 3 and 4 participants did not receive any vaccination at the age of 4 months.|
59941588|NCT03630705|76060153|FG003|Vaccinated at the Age of 4 Months|Overall Study||0|Group 3 and 4 participants did not receive any vaccination at the age of 4 months.|
59762122|NCT00538681|75881811|FG001|COMPLETED|Overall Study||0||
59762123|NCT00538681|75881812|FG002|COMPLETED|Overall Study||0||
59762124|NCT00538681|75881813|FG003|COMPLETED|Overall Study||0||
59762125|NCT00538681|75881810|FG000|NOT COMPLETED|Overall Study||9||
59762126|NCT00538681|75881811|FG001|NOT COMPLETED|Overall Study||4||
59762127|NCT00538681|75881812|FG002|NOT COMPLETED|Overall Study||11||
59762128|NCT00538681|75881813|FG003|NOT COMPLETED|Overall Study||11||
59762129|NCT00876018|75881827|FG000|STARTED|Overall Study||100||
59762130|NCT00876018|75881828|FG001|STARTED|Overall Study||100||
59762131|NCT00876018|75881829|FG002|STARTED|Overall Study||100||
59762132|NCT00876018|75881827|FG000|COMPLETED|Overall Study||95||
59762133|NCT00876018|75881828|FG001|COMPLETED|Overall Study||95||
59762134|NCT00876018|75881829|FG002|COMPLETED|Overall Study||97||
59762135|NCT00876018|75881827|FG000|NOT COMPLETED|Overall Study||5||
59762136|NCT00876018|75881828|FG001|NOT COMPLETED|Overall Study||5||
59941589|NCT03630705|76060150|FG000|Vaccinated at the Age of 4.5 Months|Overall Study||0|Group 1 and 2 participants did not receive any vaccination at the age of 4.5 months.|
59941590|NCT03630705|76060151|FG001|Vaccinated at the Age of 4.5 Months|Overall Study||0|Group 1 and 2 participants did not receive any vaccination at the age of 4.5 months.|
59941591|NCT03630705|76060152|FG002|Vaccinated at the Age of 4.5 Months|Overall Study||149|Group 1 and 2 participants did not receive any vaccination at the age of 4.5 months.|
59941592|NCT03630705|76060153|FG003|Vaccinated at the Age of 4.5 Months|Overall Study||75|Group 1 and 2 participants did not receive any vaccination at the age of 4.5 months.|
59941593|NCT03630705|76060150|FG000|Vaccinated at the Age of 6 Months|Overall Study||194||
59941594|NCT03630705|76060151|FG001|Vaccinated at the Age of 6 Months|Overall Study||95||
59941595|NCT03630705|76060152|FG002|Vaccinated at the Age of 6 Months|Overall Study||149||
59941596|NCT03630705|76060153|FG003|Vaccinated at the Age of 6 Months|Overall Study||75||
59941597|NCT03630705|76060150|FG000|Vaccinated at the Age of 12 Months|Overall Study||192||
59941598|NCT03630705|76060151|FG001|Vaccinated at the Age of 12 Months|Overall Study||92||
59941599|NCT03630705|76060152|FG002|Vaccinated at the Age of 12 Months|Overall Study||148||
59941600|NCT03630705|76060153|FG003|Vaccinated at the Age of 12 Months|Overall Study||75||
59941601|NCT03630705|76060150|FG000|Safety Analysis Set|Overall Study|One participant of arm 'Group 2: Menveo® (Mexico)' received MenACYW Conjugate vaccine at the age of 2 months and thus included in the safety analysis of arm 'Group 1: MenACYW Conjugate Vaccine (Mexico)'.|201|Safety analysis set (SafAS) included those participants who had received at least 1 dose of the study vaccine and had any safety data available. All participants had their safety analyzed after each dose according to the vaccine they actually received at that dose.|
59941602|NCT03630705|76060151|FG001|Safety Analysis Set|Overall Study||99|Safety analysis set (SafAS) included those participants who had received at least 1 dose of the study vaccine and had any safety data available. All participants had their safety analyzed after each dose according to the vaccine they actually received at that dose.|
59941603|NCT03630705|76060152|FG002|Safety Analysis Set|Overall Study||150|Safety analysis set (SafAS) included those participants who had received at least 1 dose of the study vaccine and had any safety data available. All participants had their safety analyzed after each dose according to the vaccine they actually received at that dose.|
59941604|NCT03630705|76060153|FG003|Safety Analysis Set|Overall Study||75|Safety analysis set (SafAS) included those participants who had received at least 1 dose of the study vaccine and had any safety data available. All participants had their safety analyzed after each dose according to the vaccine they actually received at that dose.|
59941605|NCT03630705|76060150|FG000|COMPLETED|Overall Study||190||
59941606|NCT03630705|76060151|FG001|COMPLETED|Overall Study||92||
59941607|NCT03630705|76060152|FG002|COMPLETED|Overall Study||148||
59941608|NCT03630705|76060153|FG003|COMPLETED|Overall Study||75||
59941609|NCT03630705|76060150|FG000|NOT COMPLETED|Overall Study||10||
59941610|NCT03630705|76060151|FG001|NOT COMPLETED|Overall Study||8||
59941611|NCT03630705|76060152|FG002|NOT COMPLETED|Overall Study||2||
59941612|NCT03630705|76060153|FG003|NOT COMPLETED|Overall Study||0||
59941613|NCT03539458|76060170|FG000|STARTED|Overall Study||11||
59941614|NCT03539458|76060170|FG000|COMPLETED|Overall Study||10||
59941615|NCT03539458|76060170|FG000|NOT COMPLETED|Overall Study||1||
59941616|NCT03534180|76060174|FG000|STARTED|Overall Study||9||
59941617|NCT03534180|76060174|FG000|COMPLETED|Overall Study||8||
59941618|NCT03534180|76060174|FG000|NOT COMPLETED|Overall Study||1||
59941619|NCT03494166|76060184|FG000|STARTED|Overall Study||71||
59941620|NCT03494166|76060185|FG001|STARTED|Overall Study||204||
59941621|NCT03494166|76060186|FG002|STARTED|Overall Study||30||
59941622|NCT03494166|76060187|FG003|STARTED|Overall Study||31||
59941623|NCT03494166|76060188|FG004|STARTED|Overall Study||93||
59941624|NCT03494166|76060189|FG005|STARTED|Overall Study||17||
59941625|NCT03494166|76060184|FG000|COMPLETED|Overall Study||58||
59941626|NCT03494166|76060185|FG001|COMPLETED|Overall Study||195||
59941627|NCT03494166|76060186|FG002|COMPLETED|Overall Study||28||
59941628|NCT03494166|76060187|FG003|COMPLETED|Overall Study||23||
59941629|NCT03494166|76060188|FG004|COMPLETED|Overall Study||72||
59941630|NCT03494166|76060189|FG005|COMPLETED|Overall Study||0||
59941631|NCT03494166|76060184|FG000|NOT COMPLETED|Overall Study||13||
59941632|NCT03494166|76060185|FG001|NOT COMPLETED|Overall Study||9||
59941633|NCT03494166|76060186|FG002|NOT COMPLETED|Overall Study||2||
59941634|NCT03494166|76060187|FG003|NOT COMPLETED|Overall Study||8||
59941635|NCT03494166|76060188|FG004|NOT COMPLETED|Overall Study||21||
59941636|NCT03494166|76060189|FG005|NOT COMPLETED|Overall Study||17||
59941637|NCT03377816|76060202|FG000|STARTED|Overall Study||157||
59941638|NCT03377816|76060203|FG001|STARTED|Overall Study||161||
59941639|NCT03377816|76060202|FG000|COMPLETED|Overall Study||107||
59941640|NCT03377816|76060203|FG001|COMPLETED|Overall Study||108||
59941641|NCT03377816|76060202|FG000|NOT COMPLETED|Overall Study||50||
59941642|NCT03377816|76060203|FG001|NOT COMPLETED|Overall Study||53||
59941643|NCT03367156|76060211|FG000|STARTED|Overall Study||85||
59941644|NCT03367156|76060212|FG001|STARTED|Overall Study||43||
59941645|NCT03367156|76060211|FG000|Completed 7 Days|Overall Study||76||
59941646|NCT03367156|76060212|FG001|Completed 7 Days|Overall Study||38||
59941647|NCT03367156|76060211|FG000|Completed 14 Days|Overall Study||61||
59941648|NCT03367156|76060212|FG001|Completed 14 Days|Overall Study||35||
59941649|NCT03367156|76060211|FG000|COMPLETED|Overall Study||61||
59941650|NCT03367156|76060212|FG001|COMPLETED|Overall Study||35||
59941651|NCT03367156|76060211|FG000|NOT COMPLETED|Overall Study||24||
59941652|NCT03367156|76060212|FG001|NOT COMPLETED|Overall Study||8||
59941653|NCT03302299|76060220|FG000|STARTED|Overall Study||302||
59941654|NCT03302299|76060220|FG000|Completed 3 Month Visit|Overall Study||295||
59941655|NCT03302299|76060220|FG000|Completed 6 Month Visit|Overall Study||289||
59941656|NCT03302299|76060220|FG000|COMPLETED|Overall Study||301|Completed study enrollment and initiated isoniazid (INH) course.|
59941657|NCT03302299|76060220|FG000|NOT COMPLETED|Overall Study||1||
59941658|NCT03262935|76060227|FG000|STARTED|Overall Study||291||
59941659|NCT03262935|76060228|FG001|STARTED|Overall Study||146||
59941660|NCT03262935|76060227|FG000|COMPLETED|Overall Study||0||
59941661|NCT03262935|76060228|FG001|COMPLETED|Overall Study||0||
59941662|NCT03262935|76060227|FG000|NOT COMPLETED|Overall Study||291||
59941663|NCT03262935|76060228|FG001|NOT COMPLETED|Overall Study||146||
59941664|NCT03200847|76060234|FG000|STARTED|Overall Study||26||
59941665|NCT03200847|76060234|FG000|COMPLETED|Overall Study||25||
59941666|NCT03200847|76060234|FG000|NOT COMPLETED|Overall Study||1||
59941667|NCT02964078|76060238|FG000|STARTED|Overall Study||27||
59941668|NCT02964078|76060238|FG000|COMPLETED|Overall Study||27||
59941669|NCT02964078|76060238|FG000|NOT COMPLETED|Overall Study||0||
59941670|NCT02953457|76060245|FG000|STARTED|Overall Study||10||
59941671|NCT02953457|76060246|FG001|STARTED|Overall Study||20||
59941672|NCT02953457|76060247|FG002|STARTED|Overall Study||10||
59941673|NCT02953457|76060245|FG000|COMPLETED|Overall Study||10||
59941674|NCT02953457|76060246|FG001|COMPLETED|Overall Study||20||
59941675|NCT02953457|76060247|FG002|COMPLETED|Overall Study||10||
59941676|NCT02953457|76060245|FG000|NOT COMPLETED|Overall Study||0||
59941677|NCT02953457|76060246|FG001|NOT COMPLETED|Overall Study||0||
59941678|NCT02953457|76060247|FG002|NOT COMPLETED|Overall Study||0||
59941679|NCT02948426|76060262|FG000|STARTED|Overall Study||3||
59941680|NCT02948426|76060263|FG001|STARTED|Overall Study||6||
59941681|NCT02948426|76060264|FG002|STARTED|Overall Study||3||
59941682|NCT02948426|76060265|FG003|STARTED|Overall Study||6||
59941683|NCT02948426|76060262|FG000|COMPLETED|Overall Study||3||
59941684|NCT02948426|76060263|FG001|COMPLETED|Overall Study||6||
59941685|NCT02948426|76060264|FG002|COMPLETED|Overall Study||3||
59941686|NCT02948426|76060265|FG003|COMPLETED|Overall Study||6||
59941687|NCT02948426|76060262|FG000|NOT COMPLETED|Overall Study||0||
59941688|NCT02948426|76060263|FG001|NOT COMPLETED|Overall Study||0||
59941689|NCT02948426|76060264|FG002|NOT COMPLETED|Overall Study||0||
59941690|NCT02948426|76060265|FG003|NOT COMPLETED|Overall Study||0||
59941691|NCT02603562|76060277|FG000|STARTED|Overall Study||8||
59941692|NCT02603562|76060277|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8||
59941693|NCT02603562|76060277|FG000|COMPLETED|Overall Study||7||
59941694|NCT02603562|76060277|FG000|NOT COMPLETED|Overall Study||1||
59941695|NCT02586727|76060283|FG000|STARTED|Overall Study||20||
59941696|NCT02586727|76060284|FG001|STARTED|Overall Study||20||
59941697|NCT02586727|76060283|FG000|COMPLETED|Overall Study||19||
59941698|NCT02586727|76060284|FG001|COMPLETED|Overall Study||20||
59941699|NCT02586727|76060283|FG000|NOT COMPLETED|Overall Study||1||
59941700|NCT02586727|76060284|FG001|NOT COMPLETED|Overall Study||0||
59941701|NCT02579239|76060292|FG000|STARTED|Overall Study||4||
59941702|NCT02579239|76060293|FG001|STARTED|Overall Study||14||
59941703|NCT02579239|76060292|FG000|Received at Least 1 Dose of Study Drug|Overall Study||4||
59941704|NCT02579239|76060293|FG001|Received at Least 1 Dose of Study Drug|Overall Study||14||
59613380|NCT01686828|75724521|FG002|NOT COMPLETED|Overall Study||1||
59941705|NCT02579239|76060292|FG000|COMPLETED|Overall Study||4||
59941706|NCT02579239|76060293|FG001|COMPLETED|Overall Study||14||
59941707|NCT02579239|76060292|FG000|NOT COMPLETED|Overall Study||0||
59941708|NCT02579239|76060293|FG001|NOT COMPLETED|Overall Study||0||
59941709|NCT02458690|76060301|FG000|STARTED|Overall Study||107||
59941710|NCT02458690|76060302|FG001|STARTED|Overall Study||109||
59941711|NCT02458690|76060301|FG000|COMPLETED|Overall Study||99||
59941712|NCT02458690|76060302|FG001|COMPLETED|Overall Study||100||
59941713|NCT02458690|76060301|FG000|NOT COMPLETED|Overall Study||8||
59941714|NCT02458690|76060302|FG001|NOT COMPLETED|Overall Study||9||
59941715|NCT02339909|76060311|FG000|STARTED|Overall Study||524||
59941716|NCT02339909|76060312|FG001|STARTED|Overall Study||375||
59941717|NCT02339909|76060313|FG002|STARTED|Overall Study||375||
59941718|NCT02339909|76060311|FG000|COMPLETED|Overall Study||435||
59941719|NCT02339909|76060312|FG001|COMPLETED|Overall Study||312||
59941720|NCT02339909|76060313|FG002|COMPLETED|Overall Study||304||
59941721|NCT02339909|76060311|FG000|NOT COMPLETED|Overall Study||89||
59941722|NCT02339909|76060312|FG001|NOT COMPLETED|Overall Study||63||
59941723|NCT02339909|76060313|FG002|NOT COMPLETED|Overall Study||71||
59941724|NCT02076113|76060323|FG000|STARTED|Overall Study||63||
59941725|NCT02076113|76060324|FG001|STARTED|Overall Study||100||
59941726|NCT02076113|76060323|FG000|Surgery as Randomized|Overall Study|1 patient underwent dorsal fusion surgery|62||
59941727|NCT02076113|76060324|FG001|Surgery as Randomized|Overall Study|4 patients underwent ventral fusion surgery|96||
59941728|NCT02076113|76060323|FG000|3-Month Follow-up|Overall Study|5 missed follow-up visit; 2 lost to follow-up|56||
59941729|NCT02076113|76060324|FG001|3-Month Follow-up|Overall Study|9 missed follow-up appointment; 1 lost to follow-up|90||
59941730|NCT02076113|76060323|FG000|6-Month Follow-up|Overall Study|7 missed follow-up visit; 3 lost to follow-up|53||
59941731|NCT02076113|76060324|FG001|6-Month Follow-up|Overall Study|7 missed follow-up visit; 1 lost to follow-up; 1 deceased|91||
59941732|NCT02076113|76060323|FG000|1-Year Follow-up|Overall Study|3 lost to follow-up|60||
59941733|NCT02076113|76060324|FG001|1-Year Follow-up|Overall Study|2 missed follow-up visit; 1 lost to follow-up; 2 deceased|95||
59941734|NCT02076113|76060323|FG000|2-Year Follow-up|Overall Study|5 missed follow-up visit; 4 lost to follow-up; 2 withdrew consent; 1 deceased|51||
59941735|NCT02076113|76060324|FG001|2-Year Follow-up|Overall Study|14 missed follow-up visit; 1 lost to follow-up; 3 withdrew consent; 3 deceased|79||
59941736|NCT02076113|76060323|FG000|COMPLETED|Overall Study||56||
59941737|NCT02076113|76060324|FG001|COMPLETED|Overall Study||93||
59941738|NCT02076113|76060323|FG000|NOT COMPLETED|Overall Study||7||
59941739|NCT02076113|76060324|FG001|NOT COMPLETED|Overall Study||7||
59941740|NCT01701674|76060333|FG000|STARTED|Overall Study||13||
59941741|NCT01701674|76060333|FG000|COMPLETED|Overall Study||12||
59941742|NCT01701674|76060333|FG000|NOT COMPLETED|Overall Study||1||
59941743|NCT01586910|76060339|FG000|STARTED|Overall Study||879||
59941744|NCT01586910|76060340|FG001|STARTED|Overall Study||867||
59941745|NCT01586910|76060339|FG000|COMPLETED|Overall Study||864||
59941746|NCT01586910|76060340|FG001|COMPLETED|Overall Study||796||
59941747|NCT01586910|76060339|FG000|NOT COMPLETED|Overall Study||15||
59941748|NCT01586910|76060340|FG001|NOT COMPLETED|Overall Study||71||
59941749|NCT01496976|76060348|FG000|STARTED|Overall Study||45||
59941750|NCT01496976|76060348|FG000|COMPLETED|Overall Study||44||
59518639|NCT01083667|75612454|FG000|COMPLETED|Overall Study|22 completed to visit 9, the last visit on study.|22||
59518640|NCT01083667|75612454|FG000|NOT COMPLETED|Overall Study||10||
59518641|NCT01083901|75612461|FG000|STARTED|Overall Study||13||
59941751|NCT01496976|76060348|FG000|NOT COMPLETED|Overall Study||1||
59941752|NCT01401907|76060354|FG000|STARTED|Overall Study||175||
59941753|NCT01401907|76060355|FG001|STARTED|Overall Study||175||
59941754|NCT01401907|76060354|FG000|12 Week Outcomes|Overall Study||148||
59941755|NCT01401907|76060355|FG001|12 Week Outcomes|Overall Study||153||
59941756|NCT01401907|76060354|FG000|COMPLETED|Overall Study||118|24 week outcomes|
59941757|NCT01401907|76060355|FG001|COMPLETED|Overall Study||124|24 week outcomes|
59941758|NCT01401907|76060354|FG000|NOT COMPLETED|Overall Study||57||
59941759|NCT01401907|76060355|FG001|NOT COMPLETED|Overall Study||51||
59941760|NCT02915016|76060371|FG000|STARTED|Overall Study||30||
59941761|NCT02915016|76060372|FG001|STARTED|Overall Study||50||
59941762|NCT02915016|76060373|FG002|STARTED|Overall Study||50||
59941763|NCT02915016|76060374|FG003|STARTED|Overall Study||30||
59941764|NCT02915016|76060375|FG004|STARTED|Overall Study||50||
59941765|NCT02915016|76060376|FG005|STARTED|Overall Study||50||
59941766|NCT02915016|76060377|FG006|STARTED|Overall Study||50||
59941767|NCT02915016|76060378|FG007|STARTED|Overall Study||24||
59941768|NCT02915016|76060371|FG000|Month 6.5 Immunogenicity Timepoint|Overall Study||23|HIV uninfected at Month 6.5 and specimen available for assays|
59941769|NCT02915016|76060372|FG001|Month 6.5 Immunogenicity Timepoint|Overall Study||49|HIV uninfected at Month 6.5 and specimen available for assays|
59941770|NCT02915016|76060373|FG002|Month 6.5 Immunogenicity Timepoint|Overall Study||46|HIV uninfected at Month 6.5 and specimen available for assays|
59941771|NCT02915016|76060374|FG003|Month 6.5 Immunogenicity Timepoint|Overall Study||26|HIV uninfected at Month 6.5 and specimen available for assays|
59941772|NCT02915016|76060375|FG004|Month 6.5 Immunogenicity Timepoint|Overall Study||43|HIV uninfected at Month 6.5 and specimen available for assays|
59941773|NCT02915016|76060376|FG005|Month 6.5 Immunogenicity Timepoint|Overall Study||42|HIV uninfected at Month 6.5 and specimen available for assays|
59941774|NCT02915016|76060377|FG006|Month 6.5 Immunogenicity Timepoint|Overall Study||42|HIV uninfected at Month 6.5 and specimen available for assays|
59941775|NCT02915016|76060378|FG007|Month 6.5 Immunogenicity Timepoint|Overall Study||21|HIV uninfected at Month 6.5 and specimen available for assays|
59941776|NCT02915016|76060371|FG000|COMPLETED|Overall Study||23||
59941777|NCT02915016|76060372|FG001|COMPLETED|Overall Study||47||
59941778|NCT02915016|76060373|FG002|COMPLETED|Overall Study||42||
59941779|NCT02915016|76060374|FG003|COMPLETED|Overall Study||26||
59941780|NCT02915016|76060375|FG004|COMPLETED|Overall Study||43||
59941781|NCT02915016|76060376|FG005|COMPLETED|Overall Study||44||
59941782|NCT02915016|76060377|FG006|COMPLETED|Overall Study||38||
59941783|NCT02915016|76060378|FG007|COMPLETED|Overall Study||20||
59941784|NCT02915016|76060371|FG000|NOT COMPLETED|Overall Study||7||
59941785|NCT02915016|76060372|FG001|NOT COMPLETED|Overall Study||3||
59518642|NCT01083901|75612462|FG001|STARTED|Overall Study||8||
59518643|NCT01083901|75612463|FG002|STARTED|Overall Study||13||
59518644|NCT01083901|75612461|FG000|COMPLETED|Overall Study||12||
59518645|NCT01083901|75612462|FG001|COMPLETED|Overall Study||6||
59518646|NCT01083901|75612463|FG002|COMPLETED|Overall Study||11||
59518647|NCT01083901|75612461|FG000|NOT COMPLETED|Overall Study||1||
59518648|NCT01083901|75612462|FG001|NOT COMPLETED|Overall Study||2||
59941786|NCT02915016|76060373|FG002|NOT COMPLETED|Overall Study||8||
59941787|NCT02915016|76060374|FG003|NOT COMPLETED|Overall Study||4||
59941788|NCT02915016|76060375|FG004|NOT COMPLETED|Overall Study||7||
59941789|NCT02915016|76060376|FG005|NOT COMPLETED|Overall Study||6||
59941790|NCT02915016|76060377|FG006|NOT COMPLETED|Overall Study||12||
59941791|NCT02915016|76060378|FG007|NOT COMPLETED|Overall Study||4||
59941792|NCT03323749|76060398|FG000|STARTED|Double-blind Period||109||
59518649|NCT01083901|75612463|FG002|NOT COMPLETED|Overall Study||2||
59518650|NCT03533374|75612473|FG000|STARTED|Overall Study||54||
59518651|NCT03533374|75612474|FG001|STARTED|Overall Study||46||
59518652|NCT03533374|75612473|FG000|COMPLETED|Overall Study||54||
59518653|NCT03533374|75612474|FG001|COMPLETED|Overall Study||46||
59941793|NCT03323749|76060399|FG001|STARTED|Double-blind Period||109||
59941794|NCT03323749|76060398|FG000|COMPLETED|Double-blind Period||102||
59941795|NCT03323749|76060399|FG001|COMPLETED|Double-blind Period||103||
59941796|NCT03323749|76060398|FG000|NOT COMPLETED|Double-blind Period||7||
59941797|NCT03323749|76060399|FG001|NOT COMPLETED|Double-blind Period||6||
59941798|NCT03323749|76060398|FG000|STARTED|Open-Label Period||93|A total of 196 subjects enrolled in Part 2 of the trial: 93 from the elamipretide group in Part 1, and 103 from the placebo group in Part 1. No subjects completed the trial: it was terminated early due to the Sponsor's decision.|
59941799|NCT03323749|76060399|FG001|STARTED|Open-Label Period||103|A total of 196 subjects enrolled in Part 2 of the trial: 93 from the elamipretide group in Part 1, and 103 from the placebo group in Part 1. No subjects completed the trial: it was terminated early due to the Sponsor's decision.|
59941800|NCT03323749|76060398|FG000|COMPLETED|Open-Label Period||0||
59941801|NCT03323749|76060399|FG001|COMPLETED|Open-Label Period||0||
59941802|NCT03323749|76060398|FG000|NOT COMPLETED|Open-Label Period||93||
59941803|NCT03323749|76060399|FG001|NOT COMPLETED|Open-Label Period||103||
59941804|NCT03240601|76060411|FG000|STARTED|Overall Study||9||
59941805|NCT03240601|76060412|FG001|STARTED|Overall Study||9||
59941806|NCT03240601|76060411|FG000|COMPLETED|Overall Study||8||
59941807|NCT03240601|76060412|FG001|COMPLETED|Overall Study||8||
59941808|NCT03240601|76060411|FG000|NOT COMPLETED|Overall Study||1||
59941809|NCT03240601|76060412|FG001|NOT COMPLETED|Overall Study||1||
59941810|NCT02208024|76060418|FG000|STARTED|Overall Study||18||
59941811|NCT02208024|76060418|FG000|COMPLETED|Overall Study||17||
59941812|NCT02208024|76060418|FG000|NOT COMPLETED|Overall Study||1||
59941813|NCT02660086|76060424|FG000|STARTED|Overall Study- 12-month||299||
59941814|NCT02660086|76060425|FG001|STARTED|Overall Study- 12-month||303||
59941815|NCT02660086|76060424|FG000|COMPLETED|Overall Study- 12-month||273||
59941816|NCT02660086|76060425|FG001|COMPLETED|Overall Study- 12-month||274||
59941817|NCT02660086|76060424|FG000|NOT COMPLETED|Overall Study- 12-month||26||
59941818|NCT02660086|76060425|FG001|NOT COMPLETED|Overall Study- 12-month||29||
59941819|NCT02660086|76060424|FG000|STARTED|Overall Study: 24-month Follow-up||281||
59941820|NCT02660086|76060425|FG001|STARTED|Overall Study: 24-month Follow-up||278||
59941821|NCT02660086|76060424|FG000|COMPLETED|Overall Study: 24-month Follow-up||255||
59941822|NCT02660086|76060425|FG001|COMPLETED|Overall Study: 24-month Follow-up||254||
59941823|NCT02660086|76060424|FG000|NOT COMPLETED|Overall Study: 24-month Follow-up||26||
59941824|NCT02660086|76060425|FG001|NOT COMPLETED|Overall Study: 24-month Follow-up||24||
59941825|NCT01678144|76060431|FG000|STARTED|Stage 1: MAR Classic||7||7
59941826|NCT01678144|76060431|FG000|COMPLETED|Stage 1: MAR Classic||6||6
59941827|NCT01678144|76060431|FG000|NOT COMPLETED|Stage 1: MAR Classic||1||1
59941828|NCT01678144|76060431|FG000|STARTED|Stage 2: MAR Regular and MAR Expanded||5||5
59941829|NCT01678144|76060431|FG000|COMPLETED|Stage 2: MAR Regular and MAR Expanded||5||5
59941830|NCT01678144|76060431|FG000|NOT COMPLETED|Stage 2: MAR Regular and MAR Expanded||0||0
59941831|NCT00153920|76060435|FG000|STARTED|Overall Study||66||
59941832|NCT00153920|76060435|FG000|Eligible and Treated|Overall Study||64||
59941833|NCT00153920|76060435|FG000|COMPLETED|Overall Study||36||
59941834|NCT00153920|76060435|FG000|NOT COMPLETED|Overall Study||30||
59941835|NCT02660242|76060439|FG000|STARTED|Control||16||
59941836|NCT02660242|76060439|FG000|COMPLETED|Control||16||
59941837|NCT02660242|76060439|FG000|NOT COMPLETED|Control||0||
59941838|NCT02660242|76060439|FG000|STARTED|Basal Insulin Reduction||16||
59941839|NCT02660242|76060439|FG000|COMPLETED|Basal Insulin Reduction||16||
59941840|NCT02660242|76060439|FG000|NOT COMPLETED|Basal Insulin Reduction||0||
59941841|NCT02660242|76060439|FG000|STARTED|Glucose Tabs|16 participants were randomized but only 15 completed all 4 periods.|16||
59941842|NCT02660242|76060439|FG000|COMPLETED|Glucose Tabs||15||
59941843|NCT02660242|76060439|FG000|NOT COMPLETED|Glucose Tabs||1||
59941844|NCT02660242|76060439|FG000|STARTED|Glucagon Injection|16 participants were randomized but only 15 completed all 4 periods.|16||
59941845|NCT02660242|76060439|FG000|COMPLETED|Glucagon Injection||15||
59941846|NCT02660242|76060439|FG000|NOT COMPLETED|Glucagon Injection||1||
59941847|NCT03072043|76060455|FG000|STARTED|Overall Study||3||
59518654|NCT03533374|75612473|FG000|NOT COMPLETED|Overall Study||0||
59941848|NCT03072043|76060456|FG001|STARTED|Overall Study||3||
59941849|NCT03072043|76060457|FG002|STARTED|Overall Study||49||
59941850|NCT03072043|76060455|FG000|COMPLETED|Overall Study||3||
59941851|NCT03072043|76060456|FG001|COMPLETED|Overall Study||3||
59941852|NCT03072043|76060457|FG002|COMPLETED|Overall Study||40||
59941853|NCT03072043|76060455|FG000|NOT COMPLETED|Overall Study||0||
59941854|NCT03072043|76060456|FG001|NOT COMPLETED|Overall Study||0||
59941855|NCT03072043|76060457|FG002|NOT COMPLETED|Overall Study||9||
59941856|NCT03069313|76060469|FG000|STARTED|Overall Study||41||
59941857|NCT03069313|76060469|FG000|COMPLETED|Overall Study||36||
59941858|NCT03069313|76060469|FG000|NOT COMPLETED|Overall Study||5||
59941859|NCT03068767|76060475|FG000|STARTED|Overall Study|from August 2017 to September 2018|75||
59941860|NCT03068767|76060476|FG001|STARTED|Overall Study|from August 2017 to September 2018|74||
59941861|NCT03068767|76060475|FG000|COMPLETED|Overall Study|December 2018|65||
59518655|NCT03533374|75612474|FG001|NOT COMPLETED|Overall Study||0||
59941862|NCT03068767|76060476|FG001|COMPLETED|Overall Study|December 2018|71||
59941863|NCT03068767|76060475|FG000|NOT COMPLETED|Overall Study||10||
59518656|NCT01083979|75612480|FG000|STARTED|Overall Study||1||
59941864|NCT03068767|76060476|FG001|NOT COMPLETED|Overall Study||3||
59941865|NCT03020745|76060490|FG000|STARTED|Part 1 (Up to 60 Days)||3||
59941866|NCT03020745|76060491|FG001|STARTED|Part 1 (Up to 60 Days)||3||
59941867|NCT03020745|76060492|FG002|STARTED|Part 1 (Up to 60 Days)|No participants were enrolled in this arm as per decision made by the dose escalation committee.|0||
59941868|NCT03020745|76060493|FG003|STARTED|Part 1 (Up to 60 Days)||6||
59941869|NCT03020745|76060494|FG004|STARTED|Part 1 (Up to 60 Days)|No participants were enrolled in this arm as per decision made by the dose escalation committee.|0||
59941870|NCT03020745|76060495|FG005|STARTED|Part 1 (Up to 60 Days)||0||
59941871|NCT03020745|76060496|FG006|STARTED|Part 1 (Up to 60 Days)||0||
59941872|NCT03020745|76060497|FG007|STARTED|Part 1 (Up to 60 Days)||0||
59941873|NCT03020745|76060498|FG008|STARTED|Part 1 (Up to 60 Days)||0||
59941874|NCT03020745|76060499|FG009|STARTED|Part 1 (Up to 60 Days)||0||
59941875|NCT03020745|76060490|FG000|COMPLETED|Part 1 (Up to 60 Days)||3||
59941876|NCT03020745|76060491|FG001|COMPLETED|Part 1 (Up to 60 Days)||3||
59941877|NCT03020745|76060492|FG002|COMPLETED|Part 1 (Up to 60 Days)||0||
59941878|NCT03020745|76060493|FG003|COMPLETED|Part 1 (Up to 60 Days)||6||
59941879|NCT03020745|76060494|FG004|COMPLETED|Part 1 (Up to 60 Days)||0||
59941880|NCT03020745|76060495|FG005|COMPLETED|Part 1 (Up to 60 Days)||0||
59941881|NCT03020745|76060496|FG006|COMPLETED|Part 1 (Up to 60 Days)||0||
59941882|NCT03020745|76060497|FG007|COMPLETED|Part 1 (Up to 60 Days)||0||
59941883|NCT03020745|76060498|FG008|COMPLETED|Part 1 (Up to 60 Days)||0||
59941884|NCT03020745|76060499|FG009|COMPLETED|Part 1 (Up to 60 Days)||0||
59941885|NCT03020745|76060490|FG000|NOT COMPLETED|Part 1 (Up to 60 Days)||0||
59941886|NCT03020745|76060491|FG001|NOT COMPLETED|Part 1 (Up to 60 Days)||0||
59941887|NCT03020745|76060492|FG002|NOT COMPLETED|Part 1 (Up to 60 Days)||0||
59941888|NCT03020745|76060493|FG003|NOT COMPLETED|Part 1 (Up to 60 Days)||0||
59941889|NCT03020745|76060494|FG004|NOT COMPLETED|Part 1 (Up to 60 Days)||0||
59941890|NCT03020745|76060495|FG005|NOT COMPLETED|Part 1 (Up to 60 Days)||0||
59941891|NCT03020745|76060496|FG006|NOT COMPLETED|Part 1 (Up to 60 Days)||0||
59941892|NCT03020745|76060497|FG007|NOT COMPLETED|Part 1 (Up to 60 Days)||0||
59941893|NCT03020745|76060498|FG008|NOT COMPLETED|Part 1 (Up to 60 Days)||0||
59941894|NCT03020745|76060499|FG009|NOT COMPLETED|Part 1 (Up to 60 Days)||0||
59941895|NCT03020745|76060490|FG000|STARTED|Part 2 (Up to 169 Days)||0||
59941896|NCT03020745|76060491|FG001|STARTED|Part 2 (Up to 169 Days)||0||
59941897|NCT03020745|76060492|FG002|STARTED|Part 2 (Up to 169 Days)||0||
59941898|NCT03020745|76060493|FG003|STARTED|Part 2 (Up to 169 Days)||0||
59941899|NCT03020745|76060494|FG004|STARTED|Part 2 (Up to 169 Days)||0||
59941900|NCT03020745|76060495|FG005|STARTED|Part 2 (Up to 169 Days)||10||
59941901|NCT03020745|76060496|FG006|STARTED|Part 2 (Up to 169 Days)||6||
59941902|NCT03020745|76060497|FG007|STARTED|Part 2 (Up to 169 Days)||20||
59941903|NCT03020745|76060498|FG008|STARTED|Part 2 (Up to 169 Days)||15||
59941904|NCT03020745|76060499|FG009|STARTED|Part 2 (Up to 169 Days)||15||
59941905|NCT03020745|76060490|FG000|COMPLETED|Part 2 (Up to 169 Days)||0||
59941906|NCT03020745|76060491|FG001|COMPLETED|Part 2 (Up to 169 Days)||0||
59941907|NCT03020745|76060492|FG002|COMPLETED|Part 2 (Up to 169 Days)||0||
59941908|NCT03020745|76060493|FG003|COMPLETED|Part 2 (Up to 169 Days)||0||
59941909|NCT03020745|76060494|FG004|COMPLETED|Part 2 (Up to 169 Days)||0||
59941910|NCT03020745|76060495|FG005|COMPLETED|Part 2 (Up to 169 Days)||10||
59941911|NCT03020745|76060496|FG006|COMPLETED|Part 2 (Up to 169 Days)||6||
59941912|NCT03020745|76060497|FG007|COMPLETED|Part 2 (Up to 169 Days)||19||
59941913|NCT03020745|76060498|FG008|COMPLETED|Part 2 (Up to 169 Days)||14||
59941914|NCT03020745|76060499|FG009|COMPLETED|Part 2 (Up to 169 Days)||15||
59941915|NCT03020745|76060490|FG000|NOT COMPLETED|Part 2 (Up to 169 Days)||0||
59941916|NCT03020745|76060491|FG001|NOT COMPLETED|Part 2 (Up to 169 Days)||0||
59941917|NCT03020745|76060492|FG002|NOT COMPLETED|Part 2 (Up to 169 Days)||0||
59941918|NCT03020745|76060493|FG003|NOT COMPLETED|Part 2 (Up to 169 Days)||0||
59941919|NCT03020745|76060494|FG004|NOT COMPLETED|Part 2 (Up to 169 Days)||0||
59941920|NCT03020745|76060495|FG005|NOT COMPLETED|Part 2 (Up to 169 Days)||0||
59941921|NCT03020745|76060496|FG006|NOT COMPLETED|Part 2 (Up to 169 Days)||0||
59941922|NCT03020745|76060497|FG007|NOT COMPLETED|Part 2 (Up to 169 Days)||1||
59941923|NCT03020745|76060498|FG008|NOT COMPLETED|Part 2 (Up to 169 Days)||1||
59941924|NCT03020745|76060499|FG009|NOT COMPLETED|Part 2 (Up to 169 Days)||0||
59518657|NCT01083979|75612480|FG000|COMPLETED|Overall Study||1||
59941925|NCT03020745|76060490|FG000|STARTED|Part 2:Optional FU (Up to 450 Days)||0||
59941926|NCT03020745|76060491|FG001|STARTED|Part 2:Optional FU (Up to 450 Days)||0||
59941927|NCT03020745|76060492|FG002|STARTED|Part 2:Optional FU (Up to 450 Days)||0||
59941928|NCT03020745|76060493|FG003|STARTED|Part 2:Optional FU (Up to 450 Days)||0||
59941929|NCT03020745|76060494|FG004|STARTED|Part 2:Optional FU (Up to 450 Days)||0||
59941930|NCT03020745|76060495|FG005|STARTED|Part 2:Optional FU (Up to 450 Days)||10||
59941931|NCT03020745|76060496|FG006|STARTED|Part 2:Optional FU (Up to 450 Days)|1 participant didn't enter into optional follow-up period.|5||
59518658|NCT01083979|75612480|FG000|NOT COMPLETED|Overall Study||0||
59518659|NCT03585790|75612486|FG000|STARTED|First Intervention (1 Week)||23|First intervention|
59941932|NCT03020745|76060497|FG007|STARTED|Part 2:Optional FU (Up to 450 Days)|2 participants didn't enter into optional follow-up period.|17||
59951239|NCT03743415|76070180|FG005|STARTED|Overall Study||44||
59518660|NCT03585790|75612487|FG001|STARTED|First Intervention (1 Week)||22|First intervention|
59518661|NCT03585790|75612486|FG000|COMPLETED|First Intervention (1 Week)||23||
59941933|NCT03020745|76060498|FG008|STARTED|Part 2:Optional FU (Up to 450 Days)|1 participant did not enter into optional follow-up period|13||
59941934|NCT03020745|76060499|FG009|STARTED|Part 2:Optional FU (Up to 450 Days)||15||
59941935|NCT03020745|76060490|FG000|COMPLETED|Part 2:Optional FU (Up to 450 Days)||0||
59941936|NCT03020745|76060491|FG001|COMPLETED|Part 2:Optional FU (Up to 450 Days)||0||
59941937|NCT03020745|76060492|FG002|COMPLETED|Part 2:Optional FU (Up to 450 Days)||0||
59941938|NCT03020745|76060493|FG003|COMPLETED|Part 2:Optional FU (Up to 450 Days)||0||
59941939|NCT03020745|76060494|FG004|COMPLETED|Part 2:Optional FU (Up to 450 Days)||0||
59941940|NCT03020745|76060495|FG005|COMPLETED|Part 2:Optional FU (Up to 450 Days)||9||
59941941|NCT03020745|76060496|FG006|COMPLETED|Part 2:Optional FU (Up to 450 Days)||5||
59941942|NCT03020745|76060497|FG007|COMPLETED|Part 2:Optional FU (Up to 450 Days)||17||
59941943|NCT03020745|76060498|FG008|COMPLETED|Part 2:Optional FU (Up to 450 Days)||10||
59941944|NCT03020745|76060499|FG009|COMPLETED|Part 2:Optional FU (Up to 450 Days)||15||
59941945|NCT03020745|76060490|FG000|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0||
59941946|NCT03020745|76060491|FG001|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0||
59941947|NCT03020745|76060492|FG002|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0||
59941948|NCT03020745|76060493|FG003|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0||
59941949|NCT03020745|76060494|FG004|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0||
59941950|NCT03020745|76060495|FG005|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||1||
59941951|NCT03020745|76060496|FG006|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0||
59941952|NCT03020745|76060497|FG007|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0||
59941953|NCT03020745|76060498|FG008|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||3||
59941954|NCT03020745|76060499|FG009|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0||
59941955|NCT02946853|76060525|FG000|STARTED|Overall Study||13||
59941956|NCT02946853|76060526|FG001|STARTED|Overall Study||13||
59941957|NCT02946853|76060525|FG000|COMPLETED|Overall Study||12||
59941958|NCT02946853|76060526|FG001|COMPLETED|Overall Study||13||
59941959|NCT02946853|76060525|FG000|NOT COMPLETED|Overall Study||1||
59941960|NCT02946853|76060526|FG001|NOT COMPLETED|Overall Study||0||
59941961|NCT03019965|76060534|FG000|STARTED|Overall Study||211||
59941962|NCT03019965|76060535|FG001|STARTED|Overall Study||215||
59941963|NCT03019965|76060534|FG000|COMPLETED|Overall Study||201||
59941964|NCT03019965|76060535|FG001|COMPLETED|Overall Study||202||
59941965|NCT03019965|76060534|FG000|NOT COMPLETED|Overall Study||10||
59941966|NCT03019965|76060535|FG001|NOT COMPLETED|Overall Study||13||
59941967|NCT01468831|76060543|FG000|STARTED|Overall Study||4||4
59941968|NCT01468831|76060544|FG001|STARTED|Overall Study||5||5
59941969|NCT01468831|76060543|FG000|Month 12 (Primary Outcome)|Overall Study||4||4
59941970|NCT01468831|76060544|FG001|Month 12 (Primary Outcome)|Overall Study||4||4
59941971|NCT01468831|76060543|FG000|COMPLETED|Overall Study||4||4
59941972|NCT01468831|76060544|FG001|COMPLETED|Overall Study||4||4
59941973|NCT01468831|76060543|FG000|NOT COMPLETED|Overall Study||0||0
59941974|NCT01468831|76060544|FG001|NOT COMPLETED|Overall Study||1||1
59941975|NCT01675882|76060554|FG000|STARTED|Overall Study||53||
59941976|NCT01675882|76060555|FG001|STARTED|Overall Study||56||
59941977|NCT01675882|76060556|FG002|STARTED|Overall Study||56||
59941978|NCT01675882|76060557|FG003|STARTED|Overall Study||56||
59941979|NCT01675882|76060554|FG000|COMPLETED|Overall Study||51||
59941980|NCT01675882|76060555|FG001|COMPLETED|Overall Study||49||
59941981|NCT01675882|76060556|FG002|COMPLETED|Overall Study||53||
59941982|NCT01675882|76060557|FG003|COMPLETED|Overall Study||54||
59941983|NCT01675882|76060554|FG000|NOT COMPLETED|Overall Study||2||
59941984|NCT01675882|76060555|FG001|NOT COMPLETED|Overall Study||7||
59941985|NCT01675882|76060556|FG002|NOT COMPLETED|Overall Study||3||
59941986|NCT01675882|76060557|FG003|NOT COMPLETED|Overall Study||2||
59941987|NCT03018249|76060569|FG000|STARTED|Overall Study||25||
59941988|NCT03018249|76060570|FG001|STARTED|Overall Study||25||
59762137|NCT00876018|75881829|FG002|NOT COMPLETED|Overall Study||3||
59762138|NCT02226367|75881841|FG000|STARTED|Overall Study||46||
59941989|NCT03018249|76060569|FG000|COMPLETED|Overall Study||23||
59941990|NCT03018249|76060570|FG001|COMPLETED|Overall Study||23||
59941991|NCT03018249|76060569|FG000|NOT COMPLETED|Overall Study||2||
59941992|NCT03018249|76060570|FG001|NOT COMPLETED|Overall Study||2||
59941993|NCT00912158|76060579|FG000|STARTED|Overall Study||44||
59941994|NCT00912158|76060580|FG001|STARTED|Overall Study||44||
59941995|NCT00912158|76060581|FG002|STARTED|Overall Study||41||
59941996|NCT00912158|76060579|FG000|COMPLETED|Overall Study||44||
59941997|NCT00912158|76060580|FG001|COMPLETED|Overall Study||44||
59941998|NCT00912158|76060581|FG002|COMPLETED|Overall Study||41||
59941999|NCT00912158|76060579|FG000|NOT COMPLETED|Overall Study||0||
59762139|NCT02226367|75881842|FG001|STARTED|Overall Study||56||
59762140|NCT02226367|75881841|FG000|COMPLETED|Overall Study||37||
59942000|NCT00912158|76060580|FG001|NOT COMPLETED|Overall Study||0||
59942001|NCT00912158|76060581|FG002|NOT COMPLETED|Overall Study||0||
59942002|NCT02923245|76060588|FG000|STARTED|Overall Study||60||
59942003|NCT02923245|76060589|FG001|STARTED|Overall Study||60||
59942004|NCT02923245|76060588|FG000|COMPLETED|Overall Study||58||
59942005|NCT02923245|76060589|FG001|COMPLETED|Overall Study||59||
59942006|NCT02923245|76060588|FG000|NOT COMPLETED|Overall Study||2||
59942007|NCT02923245|76060589|FG001|NOT COMPLETED|Overall Study||1||
59762141|NCT02226367|75881842|FG001|COMPLETED|Overall Study||49||
59942008|NCT00908648|76060598|FG000|STARTED|Overall Study||108||
59942009|NCT00908648|76060599|FG001|STARTED|Overall Study||103||
59942010|NCT00908648|76060598|FG000|COMPLETED|Overall Study||108||
59942011|NCT00908648|76060599|FG001|COMPLETED|Overall Study||103||
59942012|NCT00908648|76060598|FG000|NOT COMPLETED|Overall Study||0||
59942013|NCT00908648|76060599|FG001|NOT COMPLETED|Overall Study||0||
59942014|NCT00905606|76060605|FG000|STARTED|Period 1||15||
59942015|NCT00905606|76060606|FG001|STARTED|Period 1||15||
59942016|NCT00905606|76060605|FG000|COMPLETED|Period 1||15||
59942017|NCT00905606|76060606|FG001|COMPLETED|Period 1||14||
59942018|NCT00905606|76060605|FG000|NOT COMPLETED|Period 1||0||
59942019|NCT00905606|76060606|FG001|NOT COMPLETED|Period 1||1||
59942020|NCT00905606|76060605|FG000|STARTED|Washout||15||
59942021|NCT00905606|76060606|FG001|STARTED|Washout||14||
59942022|NCT00905606|76060605|FG000|COMPLETED|Washout||14||
59942023|NCT00905606|76060606|FG001|COMPLETED|Washout||14||
59942024|NCT00905606|76060605|FG000|NOT COMPLETED|Washout||1||
59942025|NCT00905606|76060606|FG001|NOT COMPLETED|Washout||0||
59942026|NCT00905606|76060605|FG000|STARTED|Period 2||14||
59942027|NCT00905606|76060606|FG001|STARTED|Period 2||14||
59942028|NCT00905606|76060605|FG000|COMPLETED|Period 2||14||
59942029|NCT00905606|76060606|FG001|COMPLETED|Period 2||14||
59942030|NCT00905606|76060605|FG000|NOT COMPLETED|Period 2||0||
59942031|NCT00905606|76060606|FG001|NOT COMPLETED|Period 2||0||
59942032|NCT01676896|76060613|FG000|STARTED|Overall Study||96||
59942033|NCT01676896|76060614|FG001|STARTED|Overall Study||96||
59942034|NCT01676896|76060615|FG002|STARTED|Overall Study||100||
59942035|NCT01676896|76060613|FG000|COMPLETED|Overall Study||84||
59942036|NCT01676896|76060614|FG001|COMPLETED|Overall Study||89||
59942037|NCT01676896|76060615|FG002|COMPLETED|Overall Study||81||
59942038|NCT01676896|76060613|FG000|NOT COMPLETED|Overall Study||12||
59942039|NCT01676896|76060614|FG001|NOT COMPLETED|Overall Study||7||
59942040|NCT01676896|76060615|FG002|NOT COMPLETED|Overall Study||19||
59942041|NCT03017235|76060625|FG000|STARTED|Overall Study||456||
59942042|NCT03017235|76060626|FG001|STARTED|Overall Study||461||
59942043|NCT03017235|76060625|FG000|COMPLETED|Overall Study||444||
59942044|NCT03017235|76060626|FG001|COMPLETED|Overall Study||447||
59942045|NCT03017235|76060625|FG000|NOT COMPLETED|Overall Study||12||
59942046|NCT03017235|76060626|FG001|NOT COMPLETED|Overall Study||14||
59942047|NCT03017079|76060634|FG000|STARTED|Overall Study||20||
59942048|NCT03017079|76060635|FG001|STARTED|Overall Study||20||
59942049|NCT03017079|76060634|FG000|COMPLETED|Overall Study||14|Death:defined as death within 3 days of enrollment|
59942050|NCT03017079|76060635|FG001|COMPLETED|Overall Study||14|Death:defined as death within 3 days of enrollment|
59942051|NCT03017079|76060634|FG000|NOT COMPLETED|Overall Study||6||
59942052|NCT03017079|76060635|FG001|NOT COMPLETED|Overall Study||6||
59942053|NCT03015363|76060648|FG000|STARTED|Overall Study||37||
59942054|NCT03015363|76060648|FG000|COMPLETED|Overall Study||20||
59942055|NCT03015363|76060648|FG000|NOT COMPLETED|Overall Study||17||
59942056|NCT02880371|76060660|FG000|STARTED|Phase 1b||6||
59942057|NCT02880371|76060661|FG001|STARTED|Phase 1b||7||
59942058|NCT02880371|76060662|FG002|STARTED|Phase 1b||7||
59942059|NCT02880371|76060663|FG003|STARTED|Phase 1b||1||
59942060|NCT02880371|76060664|FG004|STARTED|Phase 1b||0||
59942061|NCT02880371|76060665|FG005|STARTED|Phase 1b||0||
59942062|NCT02880371|76060666|FG006|STARTED|Phase 1b||0||
59942063|NCT02880371|76060667|FG007|STARTED|Phase 1b||0||
59942064|NCT02880371|76060660|FG000|Treated|Phase 1b||6||
59942065|NCT02880371|76060661|FG001|Treated|Phase 1b||6||
59942066|NCT02880371|76060662|FG002|Treated|Phase 1b||7||
59942067|NCT02880371|76060663|FG003|Treated|Phase 1b||1||
59942068|NCT02880371|76060664|FG004|Treated|Phase 1b||0||
59942069|NCT02880371|76060665|FG005|Treated|Phase 1b||0||
59942070|NCT02880371|76060666|FG006|Treated|Phase 1b||0||
59942071|NCT02880371|76060667|FG007|Treated|Phase 1b||0||
59942072|NCT02880371|76060660|FG000|COMPLETED|Phase 1b||0||
59942073|NCT02880371|76060661|FG001|COMPLETED|Phase 1b||0||
59942074|NCT02880371|76060662|FG002|COMPLETED|Phase 1b||1||
59942075|NCT02880371|76060663|FG003|COMPLETED|Phase 1b||0||
59942076|NCT02880371|76060664|FG004|COMPLETED|Phase 1b||0||
59942077|NCT02880371|76060665|FG005|COMPLETED|Phase 1b||0||
59942078|NCT02880371|76060666|FG006|COMPLETED|Phase 1b||0||
59942079|NCT02880371|76060667|FG007|COMPLETED|Phase 1b||0||
59942080|NCT02880371|76060660|FG000|NOT COMPLETED|Phase 1b||6||
59942081|NCT02880371|76060661|FG001|NOT COMPLETED|Phase 1b||7||
59942082|NCT02880371|76060662|FG002|NOT COMPLETED|Phase 1b||6||
59942083|NCT02880371|76060663|FG003|NOT COMPLETED|Phase 1b||1||
59942084|NCT02880371|76060664|FG004|NOT COMPLETED|Phase 1b||0||
59942085|NCT02880371|76060665|FG005|NOT COMPLETED|Phase 1b||0||
59942086|NCT02880371|76060666|FG006|NOT COMPLETED|Phase 1b||0||
59942087|NCT02880371|76060667|FG007|NOT COMPLETED|Phase 1b||0||
59942088|NCT02880371|76060660|FG000|STARTED|Phase 2|Participants of Phase 1b were different from Phase 2.|0||
59942089|NCT02880371|76060661|FG001|STARTED|Phase 2|Participants of Phase 1b were different from Phase 2.|0||
59942090|NCT02880371|76060662|FG002|STARTED|Phase 2|Participants of Phase 1b were different from Phase 2.|0||
59942091|NCT02880371|76060663|FG003|STARTED|Phase 2|Participants of Phase 1b were different from Phase 2.|0||
59942092|NCT02880371|76060664|FG004|STARTED|Phase 2|Participants enrolled for Phase 2 were different from participants enrolled for Phase 1b.|2||
59942093|NCT02880371|76060665|FG005|STARTED|Phase 2|Participants enrolled for Phase 2 were different from participants enrolled for Phase 1b.|20||
59942094|NCT02880371|76060666|FG006|STARTED|Phase 2|Participants enrolled for Phase 2 were different from participants enrolled for Phase 1b.|28||
59942095|NCT02880371|76060667|FG007|STARTED|Phase 2|Participants enrolled for Phase 2 were different from participants enrolled for Phase 1b.|11||
59942096|NCT02880371|76060660|FG000|Treated|Phase 2||0||
59942097|NCT02880371|76060661|FG001|Treated|Phase 2||0||
59942098|NCT02880371|76060662|FG002|Treated|Phase 2||0||
59942099|NCT02880371|76060663|FG003|Treated|Phase 2||0||
59942100|NCT02880371|76060664|FG004|Treated|Phase 2||2||
59942101|NCT02880371|76060665|FG005|Treated|Phase 2||19||
59942102|NCT02880371|76060666|FG006|Treated|Phase 2||27||
59942103|NCT02880371|76060667|FG007|Treated|Phase 2||11||
59942104|NCT02880371|76060660|FG000|COMPLETED|Phase 2||0||
59942105|NCT02880371|76060661|FG001|COMPLETED|Phase 2||0||
59942106|NCT02880371|76060662|FG002|COMPLETED|Phase 2||0||
59942107|NCT02880371|76060663|FG003|COMPLETED|Phase 2||0||
59942108|NCT02880371|76060664|FG004|COMPLETED|Phase 2||0||
59942109|NCT02880371|76060665|FG005|COMPLETED|Phase 2||0||
59942110|NCT02880371|76060666|FG006|COMPLETED|Phase 2||0||
59942111|NCT02880371|76060667|FG007|COMPLETED|Phase 2||0||
59942112|NCT02880371|76060660|FG000|NOT COMPLETED|Phase 2||0||
59942113|NCT02880371|76060661|FG001|NOT COMPLETED|Phase 2||0||
59942114|NCT02880371|76060662|FG002|NOT COMPLETED|Phase 2||0||
59942115|NCT02880371|76060663|FG003|NOT COMPLETED|Phase 2||0||
59942116|NCT02880371|76060664|FG004|NOT COMPLETED|Phase 2||2||
59942117|NCT02880371|76060665|FG005|NOT COMPLETED|Phase 2||20||
59942118|NCT02880371|76060666|FG006|NOT COMPLETED|Phase 2||28||
59942119|NCT02880371|76060667|FG007|NOT COMPLETED|Phase 2||11||
59942120|NCT02837029|76060690|FG000|STARTED|Screening||15||
59942121|NCT02837029|76060691|FG001|STARTED|Screening||12||
59942122|NCT02837029|76060692|FG002|STARTED|Screening||0||
59942123|NCT02837029|76060690|FG000|COMPLETED|Screening||8||
59942124|NCT02837029|76060691|FG001|COMPLETED|Screening||9||
59942125|NCT02837029|76060692|FG002|COMPLETED|Screening||0||
59942126|NCT02837029|76060690|FG000|NOT COMPLETED|Screening||7||
59942127|NCT02837029|76060691|FG001|NOT COMPLETED|Screening||3||
59942128|NCT02837029|76060692|FG002|NOT COMPLETED|Screening||0||
59942129|NCT02837029|76060690|FG000|STARTED|Induction Treatment With Y90||8||
59942130|NCT02837029|76060691|FG001|STARTED|Induction Treatment With Y90||9||
59942131|NCT02837029|76060692|FG002|STARTED|Induction Treatment With Y90||0||
59942132|NCT02837029|76060690|FG000|COMPLETED|Induction Treatment With Y90||8||
59942133|NCT02837029|76060691|FG001|COMPLETED|Induction Treatment With Y90||9||
59942134|NCT02837029|76060692|FG002|COMPLETED|Induction Treatment With Y90||0||
59942135|NCT02837029|76060690|FG000|NOT COMPLETED|Induction Treatment With Y90||0||
59942136|NCT02837029|76060691|FG001|NOT COMPLETED|Induction Treatment With Y90||0||
59942137|NCT02837029|76060692|FG002|NOT COMPLETED|Induction Treatment With Y90||0||
59942138|NCT02837029|76060690|FG000|STARTED|Cycle 1 (DLT Monitoring Period)||8||
59942139|NCT02837029|76060691|FG001|STARTED|Cycle 1 (DLT Monitoring Period)||9||
59942140|NCT02837029|76060692|FG002|STARTED|Cycle 1 (DLT Monitoring Period)||0||
59942141|NCT02837029|76060690|FG000|Received Nivolumab Dose|Cycle 1 (DLT Monitoring Period)||6||
59942142|NCT02837029|76060691|FG001|Received Nivolumab Dose|Cycle 1 (DLT Monitoring Period)||7||
59942143|NCT02837029|76060692|FG002|Received Nivolumab Dose|Cycle 1 (DLT Monitoring Period)||0||
59942144|NCT02837029|76060690|FG000|COMPLETED|Cycle 1 (DLT Monitoring Period)||6||
59942145|NCT02837029|76060691|FG001|COMPLETED|Cycle 1 (DLT Monitoring Period)||6||
59942146|NCT02837029|76060692|FG002|COMPLETED|Cycle 1 (DLT Monitoring Period)||0||
59942147|NCT02837029|76060690|FG000|NOT COMPLETED|Cycle 1 (DLT Monitoring Period)||2||
59942148|NCT02837029|76060691|FG001|NOT COMPLETED|Cycle 1 (DLT Monitoring Period)||3||
59942149|NCT02837029|76060692|FG002|NOT COMPLETED|Cycle 1 (DLT Monitoring Period)||0||
60067475|NCT01974895|76182684|FG000|COMPLETED|Overall Study||143||
60067476|NCT01974895|76182685|FG001|COMPLETED|Overall Study||141||
60067477|NCT01974895|76182684|FG000|NOT COMPLETED|Overall Study||15||
59942150|NCT02837029|76060690|FG000|STARTED|Cycle 2 and Beyond||6||
59942151|NCT02837029|76060691|FG001|STARTED|Cycle 2 and Beyond||6||
59942152|NCT02837029|76060692|FG002|STARTED|Cycle 2 and Beyond||0||
60067478|NCT01974895|76182685|FG001|NOT COMPLETED|Overall Study||15||
59942153|NCT02837029|76060690|FG000|COMPLETED|Cycle 2 and Beyond||5||
59942154|NCT02837029|76060691|FG001|COMPLETED|Cycle 2 and Beyond||6||
59942155|NCT02837029|76060692|FG002|COMPLETED|Cycle 2 and Beyond||0||
59942156|NCT02837029|76060690|FG000|NOT COMPLETED|Cycle 2 and Beyond||1||
59942157|NCT02837029|76060691|FG001|NOT COMPLETED|Cycle 2 and Beyond||0||
59942158|NCT02837029|76060692|FG002|NOT COMPLETED|Cycle 2 and Beyond||0||
59942159|NCT02837029|76060690|FG000|STARTED|2 Year Follow-up|All patients who receive at least one dose of nivolumab go into follow-up.|6||
59942160|NCT02837029|76060691|FG001|STARTED|2 Year Follow-up|All patients who receive at least one dose of nivolumab go into follow-up.|7||
59942161|NCT02837029|76060692|FG002|STARTED|2 Year Follow-up||0||
59942162|NCT02837029|76060690|FG000|COMPLETED|2 Year Follow-up||0||
59942163|NCT02837029|76060691|FG001|COMPLETED|2 Year Follow-up||0||
59942164|NCT02837029|76060692|FG002|COMPLETED|2 Year Follow-up||0||
59942165|NCT02837029|76060690|FG000|NOT COMPLETED|2 Year Follow-up||6||
59942166|NCT02837029|76060691|FG001|NOT COMPLETED|2 Year Follow-up||7||
59942167|NCT02837029|76060692|FG002|NOT COMPLETED|2 Year Follow-up||0||
59942168|NCT03010527|76060704|FG000|STARTED|Overall Study||15||
59942169|NCT03010527|76060705|FG001|STARTED|Overall Study||111||
59942170|NCT03010527|76060706|FG002|STARTED|Overall Study||91||
59942171|NCT03010527|76060704|FG000|COMPLETED|Overall Study||15||
59942172|NCT03010527|76060705|FG001|COMPLETED|Overall Study||92||
59942173|NCT03010527|76060706|FG002|COMPLETED|Overall Study||75||
59942174|NCT03010527|76060704|FG000|NOT COMPLETED|Overall Study||0||
59942175|NCT03010527|76060705|FG001|NOT COMPLETED|Overall Study||19||
59942176|NCT03010527|76060706|FG002|NOT COMPLETED|Overall Study||16||
59942177|NCT00803114|76060725|FG000|STARTED|Overall Study||113||
59942178|NCT00803114|76060726|FG001|STARTED|Overall Study||115||
59942179|NCT00803114|76060725|FG000|COMPLETED|Overall Study||113||
59942180|NCT00803114|76060726|FG001|COMPLETED|Overall Study||115||
59942181|NCT00803114|76060725|FG000|NOT COMPLETED|Overall Study||0||
59942182|NCT00803114|76060726|FG001|NOT COMPLETED|Overall Study||0||
59942183|NCT00799292|76060732|FG000|STARTED|Overall Study||29||
59942184|NCT00799292|76060733|FG001|STARTED|Overall Study||29||
59942185|NCT00799292|76060732|FG000|COMPLETED|Overall Study||29||
59942186|NCT00799292|76060733|FG001|COMPLETED|Overall Study||29||
59942187|NCT00799292|76060732|FG000|NOT COMPLETED|Overall Study||0||
59942188|NCT00799292|76060733|FG001|NOT COMPLETED|Overall Study||0||
59942189|NCT00794924|76060739|FG000|STARTED|Overall Study|14 patients refused to start the study|174||
59942190|NCT00794924|76060740|FG001|STARTED|Overall Study|14 patients refused to start the study|171||
59942191|NCT00794924|76060739|FG000|COMPLETED|Overall Study||114||
59942192|NCT00794924|76060740|FG001|COMPLETED|Overall Study||101||
59942193|NCT00794924|76060739|FG000|NOT COMPLETED|Overall Study||60||
59942194|NCT00794924|76060740|FG001|NOT COMPLETED|Overall Study||70||
59942195|NCT02914275|76060746|FG000|STARTED|Overall Study||1687|(Randomized)|
59942196|NCT02914275|76060747|FG001|STARTED|Overall Study||563|(Randomized)|
59942197|NCT02914275|76060746|FG000|Included in Clinical Database / FAS|Overall Study||1684||
59942198|NCT02914275|76060747|FG001|Included in Clinical Database / FAS|Overall Study||563||
59942199|NCT02914275|76060746|FG000|COMPLETED|Overall Study||1566||
59942200|NCT02914275|76060747|FG001|COMPLETED|Overall Study||521||
59942201|NCT02914275|76060746|FG000|NOT COMPLETED|Overall Study||121||
59942202|NCT02914275|76060747|FG001|NOT COMPLETED|Overall Study||42||
59942203|NCT00792116|76060759|FG000|STARTED|Overall Study||53||
59942204|NCT00792116|76060760|FG001|STARTED|Overall Study||55||
59942205|NCT00792116|76060759|FG000|COMPLETED|Overall Study||52||
59942206|NCT00792116|76060760|FG001|COMPLETED|Overall Study||54||
59942207|NCT00792116|76060759|FG000|NOT COMPLETED|Overall Study||1||
59942208|NCT00792116|76060760|FG001|NOT COMPLETED|Overall Study||1||
59942209|NCT01773395|76060766|FG000|STARTED|Overall Study||64||
59942210|NCT01773395|76060767|FG001|STARTED|Overall Study||59||
59942211|NCT01773395|76060766|FG000|COMPLETED|Overall Study||30||
59942212|NCT01773395|76060767|FG001|COMPLETED|Overall Study||27||
59942213|NCT01773395|76060766|FG000|NOT COMPLETED|Overall Study||34||
59942214|NCT01773395|76060767|FG001|NOT COMPLETED|Overall Study||32||
59942215|NCT00489827|76060775|FG000|STARTED|Overall Study||430||
59942216|NCT00489827|76060776|FG001|STARTED|Overall Study||435||
59942217|NCT00489827|76060775|FG000|COMPLETED|Overall Study||428||
59942218|NCT00489827|76060776|FG001|COMPLETED|Overall Study||433||
59942219|NCT00489827|76060775|FG000|NOT COMPLETED|Overall Study||2||
59942220|NCT00489827|76060776|FG001|NOT COMPLETED|Overall Study||2||
59942221|NCT02604433|76060784|FG000|STARTED|Overall Study||224|Participants randomized|
59942222|NCT02604433|76060785|FG001|STARTED|Overall Study||112|Participants randomized|
59942223|NCT02604433|76060784|FG000|Participants Treated|Overall Study||223|All participants who received at least 1 dose of study drug|
59942224|NCT02604433|76060785|FG001|Participants Treated|Overall Study||109|All participants who received at least 1 dose of study drug|
59942225|NCT02604433|76060784|FG000|Completed 24 Weeks of Treatment|Overall Study||211||
59942226|NCT02604433|76060785|FG001|Completed 24 Weeks of Treatment|Overall Study||102||
59942227|NCT02604433|76060784|FG000|Completed 48 Weeks of Treatment|Overall Study||202||
59942228|NCT02604433|76060785|FG001|Completed 48 Weeks of Treatment|Overall Study||96||
59942229|NCT02604433|76060784|FG000|Completed 96 Weeks of Treatment|Overall Study||155||
59942230|NCT02604433|76060785|FG001|Completed 96 Weeks of Treatment|Overall Study||3||
59942231|NCT02604433|76060784|FG000|Completed 144 Weeks of Treatment|Overall Study||125||
59942232|NCT02604433|76060785|FG001|Completed 144 Weeks of Treatment|Overall Study||0||
59942233|NCT02604433|76060784|FG000|Completed 192 Weeks of Treatment|Overall Study||6||
59942234|NCT02604433|76060785|FG001|Completed 192 Weeks of Treatment|Overall Study||0||
59942235|NCT02604433|76060784|FG000|COMPLETED|Overall Study||6|Completed study per original protocol|
59942236|NCT02604433|76060785|FG001|COMPLETED|Overall Study||6|Completed study per original protocol|
59942237|NCT02604433|76060784|FG000|NOT COMPLETED|Overall Study||218||
59942238|NCT02604433|76060785|FG001|NOT COMPLETED|Overall Study||106||
59942239|NCT02659150|76060791|FG000|STARTED|Subject Enrollment||16||
59942240|NCT02659150|76060791|FG000|COMPLETED|Subject Enrollment||11||
59942241|NCT02659150|76060791|FG000|NOT COMPLETED|Subject Enrollment||5||
59942242|NCT02659150|76060791|FG000|STARTED|Baseline Imaging||11||
59942243|NCT02659150|76060791|FG000|COMPLETED|Baseline Imaging||9||
59942244|NCT02659150|76060791|FG000|NOT COMPLETED|Baseline Imaging||2||
59942245|NCT02659150|76060791|FG000|STARTED|Study Drug Dosing||9||
59942246|NCT02659150|76060791|FG000|COMPLETED|Study Drug Dosing||8||
59942247|NCT02659150|76060791|FG000|NOT COMPLETED|Study Drug Dosing||1||
59942248|NCT02659150|76060791|FG000|STARTED|Follow-up Imaging||8||
59942249|NCT02659150|76060791|FG000|COMPLETED|Follow-up Imaging||8||
59942250|NCT02659150|76060791|FG000|NOT COMPLETED|Follow-up Imaging||0||
59942251|NCT03006393|76060798|FG000|STARTED|Overall Study||21||
59942252|NCT03006393|76060799|FG001|STARTED|Overall Study||21||
59942253|NCT03006393|76060798|FG000|COMPLETED|Overall Study||20||
59942254|NCT03006393|76060799|FG001|COMPLETED|Overall Study||18||
59942255|NCT03006393|76060798|FG000|NOT COMPLETED|Overall Study||1||
59942256|NCT03006393|76060799|FG001|NOT COMPLETED|Overall Study||3||
59942257|NCT01383109|76060805|FG000|STARTED|Overall Study||6||
59942258|NCT01383109|76060805|FG000|COMPLETED|Overall Study||6||
59942259|NCT01383109|76060805|FG000|NOT COMPLETED|Overall Study||0||
59942260|NCT00882440|76060816|FG000|STARTED|Overall Study||78||
59942261|NCT00882440|76060817|FG001|STARTED|Overall Study||80||
59942262|NCT00882440|76060818|FG002|STARTED|Overall Study||82||
59942263|NCT00882440|76060819|FG003|STARTED|Overall Study||79||
59942264|NCT00882440|76060820|FG004|STARTED|Overall Study||90||
59942265|NCT00882440|76060821|FG005|STARTED|Overall Study||84||
59942266|NCT00882440|76060822|FG006|STARTED|Overall Study||83||
59942267|NCT00882440|76060816|FG000|COMPLETED|Overall Study||67||
59942268|NCT00882440|76060817|FG001|COMPLETED|Overall Study||72||
59942269|NCT00882440|76060818|FG002|COMPLETED|Overall Study||75||
59942270|NCT00882440|76060819|FG003|COMPLETED|Overall Study||76||
59942271|NCT00882440|76060820|FG004|COMPLETED|Overall Study||80||
59942272|NCT00882440|76060821|FG005|COMPLETED|Overall Study||77||
59942273|NCT00882440|76060822|FG006|COMPLETED|Overall Study||79||
59942274|NCT00882440|76060816|FG000|NOT COMPLETED|Overall Study||11||
59942275|NCT00882440|76060817|FG001|NOT COMPLETED|Overall Study||8||
59942276|NCT00882440|76060818|FG002|NOT COMPLETED|Overall Study||7||
59942277|NCT00882440|76060819|FG003|NOT COMPLETED|Overall Study||3||
59942278|NCT00882440|76060820|FG004|NOT COMPLETED|Overall Study||10||
59942279|NCT00882440|76060821|FG005|NOT COMPLETED|Overall Study||7||
59942280|NCT00882440|76060822|FG006|NOT COMPLETED|Overall Study||4||
59942281|NCT03005067|76060833|FG000|STARTED|Overall Study||90||
59942282|NCT03005067|76060834|FG001|STARTED|Overall Study||81||
59942283|NCT03005067|76060833|FG000|COMPLETED|Overall Study||80||
59942284|NCT03005067|76060834|FG001|COMPLETED|Overall Study||74||
59942285|NCT03005067|76060833|FG000|NOT COMPLETED|Overall Study||10||
59942286|NCT03005067|76060834|FG001|NOT COMPLETED|Overall Study||7||
59942287|NCT02658448|76060840|FG000|STARTED|Overall Study||19||
59942288|NCT02658448|76060840|FG000|COMPLETED|Overall Study|One patient was lost to follow-up after enrollment and prior to visit 1|18||
59942289|NCT02658448|76060840|FG000|NOT COMPLETED|Overall Study||1||
59613381|NCT01686828|75724522|FG003|NOT COMPLETED|Overall Study||0||
59613382|NCT01686438|75724539|FG000|STARTED|Overall Study||15||
59613383|NCT01686438|75724540|FG001|STARTED|Overall Study||35||
59942290|NCT00870818|76060849|FG000|STARTED|Overall Study||32||
59942291|NCT00870818|76060850|FG001|STARTED|Overall Study||73||
59942292|NCT00870818|76060851|FG002|STARTED|Overall Study||38||
59942293|NCT00870818|76060852|FG003|STARTED|Overall Study||38||
59942294|NCT00870818|76060853|FG004|STARTED|Overall Study||38||
59942295|NCT00870818|76060849|FG000|Completed 6 Months|Overall Study||31||
59942296|NCT00870818|76060850|FG001|Completed 6 Months|Overall Study||22||
59942297|NCT00870818|76060851|FG002|Completed 6 Months|Overall Study||13||
59942298|NCT00870818|76060852|FG003|Completed 6 Months|Overall Study||13||
59942299|NCT00870818|76060853|FG004|Completed 6 Months|Overall Study||11||
59942300|NCT00870818|76060849|FG000|Completed 12 Months|Overall Study||27||
59942301|NCT00870818|76060850|FG001|Completed 12 Months|Overall Study||2||
59942302|NCT00870818|76060851|FG002|Completed 12 Months|Overall Study||3||
59942303|NCT00870818|76060852|FG003|Completed 12 Months|Overall Study||2||
59942304|NCT00870818|76060853|FG004|Completed 12 Months|Overall Study||2||
59942305|NCT00870818|76060849|FG000|Completed 18 Months|Overall Study||5||
59942306|NCT00870818|76060850|FG001|Completed 18 Months|Overall Study||0||
59942307|NCT00870818|76060851|FG002|Completed 18 Months|Overall Study||0||
59942308|NCT00870818|76060852|FG003|Completed 18 Months|Overall Study||0||
59942309|NCT00870818|76060853|FG004|Completed 18 Months|Overall Study||0||
59942310|NCT00870818|76060849|FG000|Completed 21 Months|Overall Study||1||
59942311|NCT00870818|76060850|FG001|Completed 21 Months|Overall Study||0||
59942312|NCT00870818|76060851|FG002|Completed 21 Months|Overall Study||0||
59942313|NCT00870818|76060852|FG003|Completed 21 Months|Overall Study||0||
59942314|NCT00870818|76060853|FG004|Completed 21 Months|Overall Study||0||
59942315|NCT00870818|76060849|FG000|COMPLETED|Overall Study||0||
59942316|NCT00870818|76060850|FG001|COMPLETED|Overall Study||0||
59942317|NCT00870818|76060851|FG002|COMPLETED|Overall Study||0||
59942318|NCT00870818|76060852|FG003|COMPLETED|Overall Study||0||
59942319|NCT00870818|76060853|FG004|COMPLETED|Overall Study||0||
59942320|NCT00870818|76060849|FG000|NOT COMPLETED|Overall Study||32||
59942321|NCT00870818|76060850|FG001|NOT COMPLETED|Overall Study||73||
59942322|NCT00870818|76060851|FG002|NOT COMPLETED|Overall Study||38||
59942323|NCT00870818|76060852|FG003|NOT COMPLETED|Overall Study||38||
59942324|NCT00870818|76060853|FG004|NOT COMPLETED|Overall Study||38||
59942325|NCT03075761|76060867|FG000|STARTED|Overall Study||11||
59942326|NCT03075761|76060868|FG001|STARTED|Overall Study||12||
59942327|NCT03075761|76060867|FG000|COMPLETED|Overall Study||10||
59942328|NCT03075761|76060868|FG001|COMPLETED|Overall Study||6||
59942329|NCT03075761|76060867|FG000|NOT COMPLETED|Overall Study||1||
59942330|NCT03075761|76060868|FG001|NOT COMPLETED|Overall Study||6||
59942331|NCT03000075|76060882|FG000|STARTED|Part A||58||
59942332|NCT03000075|76060883|FG001|STARTED|Part A||58||
59942333|NCT03000075|76060884|FG002|STARTED|Part A||55||
59942334|NCT03000075|76060885|FG003|STARTED|Part A||0||
59942335|NCT03000075|76060886|FG004|STARTED|Part A||0||
59942336|NCT03000075|76060887|FG005|STARTED|Part A||0||
59942337|NCT03000075|76060888|FG006|STARTED|Part A||0||
59942338|NCT03000075|76060882|FG000|COMPLETED|Part A||54||
59942339|NCT03000075|76060883|FG001|COMPLETED|Part A||58||
59942340|NCT03000075|76060884|FG002|COMPLETED|Part A||55||
59942341|NCT03000075|76060885|FG003|COMPLETED|Part A||0||
59942342|NCT03000075|76060886|FG004|COMPLETED|Part A||0||
59942343|NCT03000075|76060887|FG005|COMPLETED|Part A||0||
59942344|NCT03000075|76060888|FG006|COMPLETED|Part A||0||
59942345|NCT03000075|76060882|FG000|NOT COMPLETED|Part A||4||
59942346|NCT03000075|76060883|FG001|NOT COMPLETED|Part A||0||
59942347|NCT03000075|76060884|FG002|NOT COMPLETED|Part A||0||
59942348|NCT03000075|76060885|FG003|NOT COMPLETED|Part A||0||
60067479|NCT01974817|76182691|FG000|STARTED|Overall Study||25||
60067480|NCT01974817|76182691|FG000|COMPLETED|Overall Study||17||
60067481|NCT01974817|76182691|FG000|NOT COMPLETED|Overall Study||8||
60067482|NCT01915849|76182699|FG000|STARTED|Treatment Period 1 (4 Days)||5||
60067483|NCT01915849|76182700|FG001|STARTED|Treatment Period 1 (4 Days)||3||
60067484|NCT01915849|76182701|FG002|STARTED|Treatment Period 1 (4 Days)||3||
60067485|NCT01915849|76182702|FG003|STARTED|Treatment Period 1 (4 Days)||3||
60067486|NCT01915849|76182699|FG000|COMPLETED|Treatment Period 1 (4 Days)||3||
60067487|NCT01915849|76182700|FG001|COMPLETED|Treatment Period 1 (4 Days)||3||
60067488|NCT01915849|76182701|FG002|COMPLETED|Treatment Period 1 (4 Days)||3||
60067489|NCT01915849|76182702|FG003|COMPLETED|Treatment Period 1 (4 Days)||3||
60067490|NCT01915849|76182699|FG000|NOT COMPLETED|Treatment Period 1 (4 Days)||2||
60067491|NCT01915849|76182700|FG001|NOT COMPLETED|Treatment Period 1 (4 Days)||0||
60067492|NCT01915849|76182701|FG002|NOT COMPLETED|Treatment Period 1 (4 Days)||0||
60067493|NCT01915849|76182702|FG003|NOT COMPLETED|Treatment Period 1 (4 Days)||0||
59942349|NCT03000075|76060886|FG004|NOT COMPLETED|Part A||0||
59942350|NCT03000075|76060887|FG005|NOT COMPLETED|Part A||0||
59942351|NCT03000075|76060888|FG006|NOT COMPLETED|Part A||0||
59942352|NCT03000075|76060882|FG000|STARTED|Part B||0||
59942353|NCT03000075|76060883|FG001|STARTED|Part B||0||
59942354|NCT03000075|76060884|FG002|STARTED|Part B||0||
59942355|NCT03000075|76060885|FG003|STARTED|Part B|Participants who received placebo in Part A received risankizumab 75 mg in Part B|27||
59942356|NCT03000075|76060886|FG004|STARTED|Part B|Participants who received placebo in Part A received risankizumab 150 mg in Part B|27||
59942357|NCT03000075|76060887|FG005|STARTED|Part B|Participants who received risankizumab 75 mg in Part A received risankizumab 75 mg in Part B|58||
59942358|NCT03000075|76060888|FG006|STARTED|Part B|Participants who received risankizumab 150 mg in Part A received risankizumab 150 mg in Part B|55||
59942359|NCT03000075|76060882|FG000|COMPLETED|Part B||0||
59942360|NCT03000075|76060883|FG001|COMPLETED|Part B||0||
59942361|NCT03000075|76060884|FG002|COMPLETED|Part B||0||
59942362|NCT03000075|76060885|FG003|COMPLETED|Part B||27||
59942363|NCT03000075|76060886|FG004|COMPLETED|Part B||26||
59942364|NCT03000075|76060887|FG005|COMPLETED|Part B||56||
59942365|NCT03000075|76060888|FG006|COMPLETED|Part B||54||
59942366|NCT03000075|76060882|FG000|NOT COMPLETED|Part B||0||
59942367|NCT03000075|76060883|FG001|NOT COMPLETED|Part B||0||
59942368|NCT03000075|76060884|FG002|NOT COMPLETED|Part B||0||
59942369|NCT03000075|76060885|FG003|NOT COMPLETED|Part B||0||
59942370|NCT03000075|76060886|FG004|NOT COMPLETED|Part B||1||
59942371|NCT03000075|76060887|FG005|NOT COMPLETED|Part B||2||
59942372|NCT03000075|76060888|FG006|NOT COMPLETED|Part B||1||
59942373|NCT03073109|76060906|FG000|STARTED|Overall Study||100||
59942374|NCT03073109|76060907|FG001|STARTED|Overall Study||70||
59942375|NCT03073109|76060906|FG000|COMPLETED|Overall Study||90||
59942376|NCT03073109|76060907|FG001|COMPLETED|Overall Study||68||
59942377|NCT03073109|76060906|FG000|NOT COMPLETED|Overall Study||10||
59942378|NCT03073109|76060907|FG001|NOT COMPLETED|Overall Study||2||
59942379|NCT02371889|76060929|FG000|STARTED|Overall Study||85||
59942380|NCT02371889|76060930|FG001|STARTED|Overall Study||85||
59942381|NCT02371889|76060929|FG000|COMPLETED|Overall Study||66||
59942382|NCT02371889|76060930|FG001|COMPLETED|Overall Study||71||
59942383|NCT02371889|76060929|FG000|NOT COMPLETED|Overall Study||19||
59942384|NCT02371889|76060930|FG001|NOT COMPLETED|Overall Study||14||
59942385|NCT03072875|76060940|FG000|STARTED|Overall Study||26||
59942386|NCT03072875|76060940|FG000|COMPLETED|Overall Study||25||
59942387|NCT03072875|76060940|FG000|NOT COMPLETED|Overall Study||1||
59942388|NCT04250077|76060948|FG000|STARTED|Overall Study||15||
59942389|NCT04250077|76060949|FG001|STARTED|Overall Study||15||
59942390|NCT04250077|76060950|FG002|STARTED|Overall Study||15||
59942391|NCT04250077|76060948|FG000|COMPLETED|Overall Study||13||
59942392|NCT04250077|76060949|FG001|COMPLETED|Overall Study||11||
59942393|NCT04250077|76060950|FG002|COMPLETED|Overall Study||15||
59942394|NCT04250077|76060948|FG000|NOT COMPLETED|Overall Study||2||
59942395|NCT04250077|76060949|FG001|NOT COMPLETED|Overall Study||4||
59942396|NCT04250077|76060950|FG002|NOT COMPLETED|Overall Study||0||
59942397|NCT00859430|76060962|FG000|STARTED|First Intervention||11||
59942398|NCT00859430|76060963|FG001|STARTED|First Intervention||11||
59942399|NCT00859430|76060962|FG000|COMPLETED|First Intervention||11||
59942400|NCT00859430|76060963|FG001|COMPLETED|First Intervention||10||
59942401|NCT00859430|76060962|FG000|NOT COMPLETED|First Intervention||0||
59942402|NCT00859430|76060963|FG001|NOT COMPLETED|First Intervention||1||
59942403|NCT00859430|76060962|FG000|STARTED|Second Intervention||11||
59942404|NCT00859430|76060963|FG001|STARTED|Second Intervention||10||
59942405|NCT00859430|76060962|FG000|COMPLETED|Second Intervention||11||
59942406|NCT00859430|76060963|FG001|COMPLETED|Second Intervention||10||
59942407|NCT00859430|76060962|FG000|NOT COMPLETED|Second Intervention||0||
59942408|NCT00859430|76060963|FG001|NOT COMPLETED|Second Intervention||0||
59942409|NCT00856934|76060970|FG000|STARTED|Overall Study||15||
59942410|NCT00856934|76060971|FG001|STARTED|Overall Study||15||
59942411|NCT00856934|76060972|FG002|STARTED|Overall Study||15||
59942412|NCT00856934|76060970|FG000|COMPLETED|Overall Study||15||
59942413|NCT00856934|76060971|FG001|COMPLETED|Overall Study||15||
59942414|NCT00856934|76060972|FG002|COMPLETED|Overall Study||15||
59942415|NCT00856934|76060970|FG000|NOT COMPLETED|Overall Study||0||
59942416|NCT00856934|76060971|FG001|NOT COMPLETED|Overall Study||0||
59942417|NCT00856934|76060972|FG002|NOT COMPLETED|Overall Study||0||
59942418|NCT02913105|76060980|FG000|STARTED|Overall Study||37||
59942419|NCT02913105|76060981|FG001|STARTED|Overall Study||44||
59942420|NCT02913105|76060982|FG002|STARTED|Overall Study||40||
59942421|NCT02913105|76060980|FG000|COMPLETED|Overall Study||22||
59942422|NCT02913105|76060981|FG001|COMPLETED|Overall Study||39||
59942423|NCT02913105|76060982|FG002|COMPLETED|Overall Study||33||
59613384|NCT01686438|75724541|FG002|STARTED|Overall Study||37||
59613385|NCT01686438|75724539|FG000|2-Week Follow Up|Overall Study||12||
59942424|NCT02913105|76060980|FG000|NOT COMPLETED|Overall Study||15||
59942425|NCT02913105|76060981|FG001|NOT COMPLETED|Overall Study||5||
59942426|NCT02913105|76060982|FG002|NOT COMPLETED|Overall Study||7||
59942427|NCT00840866|76060993|FG000|STARTED|First Intervention||20||
59942428|NCT00840866|76060994|FG001|STARTED|First Intervention||19||
59942429|NCT00840866|76060993|FG000|COMPLETED|First Intervention||20||
59942430|NCT00840866|76060994|FG001|COMPLETED|First Intervention||19||
59942431|NCT00840866|76060993|FG000|NOT COMPLETED|First Intervention||0||
59942432|NCT00840866|76060994|FG001|NOT COMPLETED|First Intervention||0||
59613386|NCT01686438|75724540|FG001|2-Week Follow Up|Overall Study||31||
59762142|NCT02226367|75881841|FG000|NOT COMPLETED|Overall Study||9||
59942433|NCT00840866|76060993|FG000|STARTED|Washout of 7 Days||20||
59942434|NCT00840866|76060994|FG001|STARTED|Washout of 7 Days||19||
59942435|NCT00840866|76060993|FG000|COMPLETED|Washout of 7 Days||20||
59613387|NCT01686438|75724541|FG002|2-Week Follow Up|Overall Study||27||
59942436|NCT00840866|76060994|FG001|COMPLETED|Washout of 7 Days||19||
59942437|NCT00840866|76060993|FG000|NOT COMPLETED|Washout of 7 Days||0||
59942438|NCT00840866|76060994|FG001|NOT COMPLETED|Washout of 7 Days||0||
59942439|NCT00840866|76060993|FG000|STARTED|Second Intervention||20||
59942440|NCT00840866|76060994|FG001|STARTED|Second Intervention||19||
59942441|NCT00840866|76060993|FG000|COMPLETED|Second Intervention||20||
59942442|NCT00840866|76060994|FG001|COMPLETED|Second Intervention||19||
59942443|NCT00840866|76060993|FG000|NOT COMPLETED|Second Intervention||0||
59942444|NCT00840866|76060994|FG001|NOT COMPLETED|Second Intervention||0||
59942445|NCT00840632|76061000|FG000|STARTED|First Intervention||20||
59942446|NCT00840632|76061001|FG001|STARTED|First Intervention||20||
59942447|NCT00840632|76061000|FG000|COMPLETED|First Intervention||20||
59942448|NCT00840632|76061001|FG001|COMPLETED|First Intervention||19||
59942449|NCT00840632|76061000|FG000|NOT COMPLETED|First Intervention||0||
59942450|NCT00840632|76061001|FG001|NOT COMPLETED|First Intervention||1||
59942451|NCT00840632|76061000|FG000|STARTED|Washout||20||
59942452|NCT00840632|76061001|FG001|STARTED|Washout||19||
59942453|NCT00840632|76061000|FG000|COMPLETED|Washout||19||
59942454|NCT00840632|76061001|FG001|COMPLETED|Washout||18||
59942455|NCT00840632|76061000|FG000|NOT COMPLETED|Washout||1||
59942456|NCT00840632|76061001|FG001|NOT COMPLETED|Washout||1||
59942457|NCT00840632|76061000|FG000|STARTED|Second Intervention||19||
59942458|NCT00840632|76061001|FG001|STARTED|Second Intervention||18||
59942459|NCT00840632|76061000|FG000|COMPLETED|Second Intervention||19||
59942460|NCT00840632|76061001|FG001|COMPLETED|Second Intervention||18||
59942461|NCT00840632|76061000|FG000|NOT COMPLETED|Second Intervention||0||
59942462|NCT00840632|76061001|FG001|NOT COMPLETED|Second Intervention||0||
59942463|NCT00840476|76061007|FG000|STARTED|First Intervention||14||
59942464|NCT00840476|76061008|FG001|STARTED|First Intervention||14||
59942465|NCT00840476|76061007|FG000|COMPLETED|First Intervention||14||
59942466|NCT00840476|76061008|FG001|COMPLETED|First Intervention||14||
59942467|NCT00840476|76061007|FG000|NOT COMPLETED|First Intervention||0||
59942468|NCT00840476|76061008|FG001|NOT COMPLETED|First Intervention||0||
59942469|NCT00840476|76061007|FG000|STARTED|Washout: 14 Days||14||
59942470|NCT00840476|76061008|FG001|STARTED|Washout: 14 Days||14||
59942471|NCT00840476|76061007|FG000|COMPLETED|Washout: 14 Days||14||
59942472|NCT00840476|76061008|FG001|COMPLETED|Washout: 14 Days||14||
59942473|NCT00840476|76061007|FG000|NOT COMPLETED|Washout: 14 Days||0||
59942474|NCT00840476|76061008|FG001|NOT COMPLETED|Washout: 14 Days||0||
59942475|NCT00840476|76061007|FG000|STARTED|Second Intervention||14||
59942476|NCT00840476|76061008|FG001|STARTED|Second Intervention||14||
59942477|NCT00840476|76061007|FG000|COMPLETED|Second Intervention||14||
59942478|NCT00840476|76061008|FG001|COMPLETED|Second Intervention||14||
59942479|NCT00840476|76061007|FG000|NOT COMPLETED|Second Intervention||0||
59942480|NCT00840476|76061008|FG001|NOT COMPLETED|Second Intervention||0||
59942481|NCT03961009|76061012|FG000|STARTED|Overall Study||47||
59942482|NCT03961009|76061012|FG000|COMPLETED|Overall Study||47||
59942483|NCT03961009|76061012|FG000|NOT COMPLETED|Overall Study||0||
59942484|NCT01602562|76061018|FG000|STARTED|Overall Study||21||
59942485|NCT01602562|76061019|FG001|STARTED|Overall Study||19||
59942486|NCT01602562|76061018|FG000|COMPLETED|Overall Study||16||
59942487|NCT01602562|76061019|FG001|COMPLETED|Overall Study||16||
59942488|NCT01602562|76061018|FG000|NOT COMPLETED|Overall Study||5||
59942489|NCT01602562|76061019|FG001|NOT COMPLETED|Overall Study||3||
59942490|NCT01945775|76061028|FG000|STARTED|Overall Study||287||
59518662|NCT03585790|75612487|FG001|COMPLETED|First Intervention (1 Week)||22||
59518663|NCT03585790|75612486|FG000|NOT COMPLETED|First Intervention (1 Week)||0||
59942491|NCT01945775|76061029|FG001|STARTED|Overall Study||144||
59942492|NCT01945775|76061028|FG000|Treated|Overall Study||286||
59942493|NCT01945775|76061029|FG001|Treated|Overall Study||126||
59942494|NCT01945775|76061028|FG000|COMPLETED|Overall Study||0||
59942495|NCT01945775|76061029|FG001|COMPLETED|Overall Study||0||
59942496|NCT01945775|76061028|FG000|NOT COMPLETED|Overall Study||287||
59942497|NCT01945775|76061029|FG001|NOT COMPLETED|Overall Study||144||
59942498|NCT00839930|76061037|FG000|STARTED|First Intervention||15||
59942499|NCT00839930|76061038|FG001|STARTED|First Intervention||15||
59942500|NCT00839930|76061037|FG000|COMPLETED|First Intervention||15||
59942501|NCT00839930|76061038|FG001|COMPLETED|First Intervention||15||
59942502|NCT00839930|76061037|FG000|NOT COMPLETED|First Intervention||0||
59942503|NCT00839930|76061038|FG001|NOT COMPLETED|First Intervention||0||
59942504|NCT00839930|76061037|FG000|STARTED|Washout: 7 Days||15||
59942505|NCT00839930|76061038|FG001|STARTED|Washout: 7 Days||15||
59942506|NCT00839930|76061037|FG000|COMPLETED|Washout: 7 Days||15||
59518664|NCT03585790|75612487|FG001|NOT COMPLETED|First Intervention (1 Week)||0||
59942507|NCT00839930|76061038|FG001|COMPLETED|Washout: 7 Days||15||
59942508|NCT00839930|76061037|FG000|NOT COMPLETED|Washout: 7 Days||0||
59942509|NCT00839930|76061038|FG001|NOT COMPLETED|Washout: 7 Days||0||
59942510|NCT00839930|76061037|FG000|STARTED|Second Intervention||15||
59518665|NCT03585790|75612486|FG000|STARTED|Second Intervention (1 Week)||23||
59942511|NCT00839930|76061038|FG001|STARTED|Second Intervention||15||
59942512|NCT00839930|76061037|FG000|COMPLETED|Second Intervention||15||
59942513|NCT00839930|76061038|FG001|COMPLETED|Second Intervention||15||
59942514|NCT00839930|76061037|FG000|NOT COMPLETED|Second Intervention||0||
59942515|NCT00839930|76061038|FG001|NOT COMPLETED|Second Intervention||0||
59942516|NCT00838136|76061044|FG000|STARTED|First Intervention||16||
59942517|NCT00838136|76061045|FG001|STARTED|First Intervention||16||
59942518|NCT00838136|76061044|FG000|COMPLETED|First Intervention||16||
59942519|NCT00838136|76061045|FG001|COMPLETED|First Intervention||16||
59942520|NCT00838136|76061044|FG000|NOT COMPLETED|First Intervention||0||
59942521|NCT00838136|76061045|FG001|NOT COMPLETED|First Intervention||0||
59942522|NCT00838136|76061044|FG000|STARTED|Second Intervention||16||
59942523|NCT00838136|76061045|FG001|STARTED|Second Intervention||16||
59942524|NCT00838136|76061044|FG000|COMPLETED|Second Intervention||16||
59518666|NCT03585790|75612487|FG001|STARTED|Second Intervention (1 Week)||22||
59518667|NCT03585790|75612486|FG000|COMPLETED|Second Intervention (1 Week)||23||
59942525|NCT00838136|76061045|FG001|COMPLETED|Second Intervention||15||
59942526|NCT00838136|76061044|FG000|NOT COMPLETED|Second Intervention||0||
59942527|NCT00838136|76061045|FG001|NOT COMPLETED|Second Intervention||1||
59942528|NCT03702439|76061049|FG000|STARTED|Overall Study||408||
59942529|NCT03702439|76061049|FG000|COMPLETED|Overall Study||408||
59942530|NCT03702439|76061049|FG000|NOT COMPLETED|Overall Study||0||
59942531|NCT03072719|76061057|FG000|STARTED|Overall Study||60||
59942532|NCT03072719|76061058|FG001|STARTED|Overall Study||60||
59942533|NCT03072719|76061057|FG000|COMPLETED|Overall Study||59||
59942534|NCT03072719|76061058|FG001|COMPLETED|Overall Study||59||
59942535|NCT03072719|76061057|FG000|NOT COMPLETED|Overall Study||1||
59942536|NCT03072719|76061058|FG001|NOT COMPLETED|Overall Study||1||
59942537|NCT00835796|76061066|FG000|STARTED|First Intervention||10||
59942538|NCT00835796|76061067|FG001|STARTED|First Intervention||10||
59942539|NCT00835796|76061066|FG000|COMPLETED|First Intervention||10||
59518668|NCT03585790|75612487|FG001|COMPLETED|Second Intervention (1 Week)||22||
59518669|NCT03585790|75612486|FG000|NOT COMPLETED|Second Intervention (1 Week)||0||
59518670|NCT03585790|75612487|FG001|NOT COMPLETED|Second Intervention (1 Week)||0||
59942540|NCT00835796|76061067|FG001|COMPLETED|First Intervention||9||
59942541|NCT00835796|76061066|FG000|NOT COMPLETED|First Intervention||0||
59942542|NCT00835796|76061067|FG001|NOT COMPLETED|First Intervention||1||
59942543|NCT00835796|76061066|FG000|STARTED|Washout||10||
59942544|NCT00835796|76061067|FG001|STARTED|Washout||9||
59942545|NCT00835796|76061066|FG000|COMPLETED|Washout||10||
59942546|NCT00835796|76061067|FG001|COMPLETED|Washout||9||
59942547|NCT00835796|76061066|FG000|NOT COMPLETED|Washout||0||
59942548|NCT00835796|76061067|FG001|NOT COMPLETED|Washout||0||
59942549|NCT00835796|76061066|FG000|STARTED|Second Intervention||10||
59942550|NCT00835796|76061067|FG001|STARTED|Second Intervention||9||
59942551|NCT00835796|76061066|FG000|COMPLETED|Second Intervention||10||
59942552|NCT00835796|76061067|FG001|COMPLETED|Second Intervention||9||
59942553|NCT00835796|76061066|FG000|NOT COMPLETED|Second Intervention||0||
59942554|NCT00835796|76061067|FG001|NOT COMPLETED|Second Intervention||0||
59942555|NCT00835640|76061073|FG000|STARTED|First Intervention||12||
59942556|NCT00835640|76061074|FG001|STARTED|First Intervention||12||
59942557|NCT00835640|76061073|FG000|COMPLETED|First Intervention||12||
59942558|NCT00835640|76061074|FG001|COMPLETED|First Intervention||12||
59942559|NCT00835640|76061073|FG000|NOT COMPLETED|First Intervention||0||
59518671|NCT00942305|75612504|FG000|STARTED|Overall Study||30||
59518672|NCT00942305|75612505|FG001|STARTED|Overall Study||10||
59942560|NCT00835640|76061074|FG001|NOT COMPLETED|First Intervention||0||
59942561|NCT00835640|76061073|FG000|STARTED|Washout of 7 Days||12||
59942562|NCT00835640|76061074|FG001|STARTED|Washout of 7 Days||12||
59942563|NCT00835640|76061073|FG000|COMPLETED|Washout of 7 Days||12||
59942564|NCT00835640|76061074|FG001|COMPLETED|Washout of 7 Days||12||
59942565|NCT00835640|76061073|FG000|NOT COMPLETED|Washout of 7 Days||0||
59942566|NCT00835640|76061074|FG001|NOT COMPLETED|Washout of 7 Days||0||
59942567|NCT00835640|76061073|FG000|STARTED|Second Intervention||12||
59942568|NCT00835640|76061074|FG001|STARTED|Second Intervention||12||
59942569|NCT00835640|76061073|FG000|COMPLETED|Second Intervention||11||
59942570|NCT00835640|76061074|FG001|COMPLETED|Second Intervention||12||
59942571|NCT00835640|76061073|FG000|NOT COMPLETED|Second Intervention||1||
59942572|NCT00835640|76061074|FG001|NOT COMPLETED|Second Intervention||0||
59942573|NCT02942017|76061080|FG000|STARTED|Overall Study||54||
59942574|NCT02942017|76061081|FG001|STARTED|Overall Study||54||
59942575|NCT02942017|76061080|FG000|Treated|Overall Study||53||
59942576|NCT02942017|76061081|FG001|Treated|Overall Study||51||
59942577|NCT02942017|76061080|FG000|COMPLETED|Overall Study||52||
59942578|NCT02942017|76061081|FG001|COMPLETED|Overall Study||48||
59942579|NCT02942017|76061080|FG000|NOT COMPLETED|Overall Study||2||
59942580|NCT02942017|76061081|FG001|NOT COMPLETED|Overall Study||6||
59942581|NCT00835484|76061089|FG000|STARTED|First Intervention||16||
59942582|NCT00835484|76061090|FG001|STARTED|First Intervention||16||
59942583|NCT00835484|76061089|FG000|COMPLETED|First Intervention||16||
59942584|NCT00835484|76061090|FG001|COMPLETED|First Intervention||16||
59942585|NCT00835484|76061089|FG000|NOT COMPLETED|First Intervention||0||
59942586|NCT00835484|76061090|FG001|NOT COMPLETED|First Intervention||0||
59942587|NCT00835484|76061089|FG000|STARTED|Washout of 7 Days||16||
59942588|NCT00835484|76061090|FG001|STARTED|Washout of 7 Days||16||
59942589|NCT00835484|76061089|FG000|COMPLETED|Washout of 7 Days||16||
59942590|NCT00835484|76061090|FG001|COMPLETED|Washout of 7 Days||16||
59942591|NCT00835484|76061089|FG000|NOT COMPLETED|Washout of 7 Days||0||
59942592|NCT00835484|76061090|FG001|NOT COMPLETED|Washout of 7 Days||0||
59942593|NCT00835484|76061089|FG000|STARTED|Second Intervention||16||
59942594|NCT00835484|76061090|FG001|STARTED|Second Intervention||16||
59942595|NCT00835484|76061089|FG000|COMPLETED|Second Intervention||16||
59942596|NCT00835484|76061090|FG001|COMPLETED|Second Intervention||16||
59942597|NCT00835484|76061089|FG000|NOT COMPLETED|Second Intervention||0||
59942598|NCT00835484|76061090|FG001|NOT COMPLETED|Second Intervention||0||
59942599|NCT00835406|76061096|FG000|STARTED|Period: First Intervention||70||
59942600|NCT00835406|76061097|FG001|STARTED|Period: First Intervention||70||
59942601|NCT00835406|76061096|FG000|COMPLETED|Period: First Intervention||68||
59942602|NCT00835406|76061097|FG001|COMPLETED|Period: First Intervention||69||
59942603|NCT00835406|76061096|FG000|NOT COMPLETED|Period: First Intervention||2||
59942604|NCT00835406|76061097|FG001|NOT COMPLETED|Period: First Intervention||1||
59942605|NCT00835406|76061096|FG000|STARTED|Period: Washout of 7 Days||68||
59942606|NCT00835406|76061097|FG001|STARTED|Period: Washout of 7 Days||69||
59942607|NCT00835406|76061096|FG000|COMPLETED|Period: Washout of 7 Days||68||
59942608|NCT00835406|76061097|FG001|COMPLETED|Period: Washout of 7 Days||67||
59942609|NCT00835406|76061096|FG000|NOT COMPLETED|Period: Washout of 7 Days||0||
59942610|NCT00835406|76061097|FG001|NOT COMPLETED|Period: Washout of 7 Days||2||
59942611|NCT00835406|76061096|FG000|STARTED|Period: Second Intervention||68||
59942612|NCT00835406|76061097|FG001|STARTED|Period: Second Intervention||67||
59942613|NCT00835406|76061096|FG000|COMPLETED|Period: Second Intervention||68||
59942614|NCT00835406|76061097|FG001|COMPLETED|Period: Second Intervention||67||
59942615|NCT00835406|76061096|FG000|NOT COMPLETED|Period: Second Intervention||0||
59942616|NCT00835406|76061097|FG001|NOT COMPLETED|Period: Second Intervention||0||
59942617|NCT00835172|76061103|FG000|STARTED|First Intervention||16||
59942618|NCT00835172|76061104|FG001|STARTED|First Intervention||16||
59942619|NCT00835172|76061103|FG000|COMPLETED|First Intervention||16||
59942620|NCT00835172|76061104|FG001|COMPLETED|First Intervention||16||
59942621|NCT00835172|76061103|FG000|NOT COMPLETED|First Intervention||0||
60067494|NCT01915849|76182699|FG000|STARTED|Treatment Period 2 (4 Days)||3||
60067495|NCT01915849|76182700|FG001|STARTED|Treatment Period 2 (4 Days)||3||
59942622|NCT00835172|76061104|FG001|NOT COMPLETED|First Intervention||0||
59942623|NCT00835172|76061103|FG000|STARTED|Washout||16||
59942624|NCT00835172|76061104|FG001|STARTED|Washout||16||
59942625|NCT00835172|76061103|FG000|COMPLETED|Washout||16||
59942626|NCT00835172|76061104|FG001|COMPLETED|Washout||15||
59942627|NCT00835172|76061103|FG000|NOT COMPLETED|Washout||0||
59942628|NCT00835172|76061104|FG001|NOT COMPLETED|Washout||1||
59942629|NCT00835172|76061103|FG000|STARTED|Second Intervention||16||
59942630|NCT00835172|76061104|FG001|STARTED|Second Intervention||15||
59942631|NCT00835172|76061103|FG000|COMPLETED|Second Intervention||16||
60067496|NCT01915849|76182701|FG002|STARTED|Treatment Period 2 (4 Days)||3||
59942632|NCT00835172|76061104|FG001|COMPLETED|Second Intervention||15||
59942633|NCT00835172|76061103|FG000|NOT COMPLETED|Second Intervention||0||
59942634|NCT00835172|76061104|FG001|NOT COMPLETED|Second Intervention||0||
59942635|NCT01676116|76061110|FG000|STARTED|Overall Study||292||
59942636|NCT01676116|76061111|FG001|STARTED|Overall Study||146||
59942637|NCT01676116|76061110|FG000|COMPLETED|Overall Study||276||
59942638|NCT01676116|76061111|FG001|COMPLETED|Overall Study||117||
59942639|NCT01676116|76061110|FG000|NOT COMPLETED|Overall Study||16||
59942640|NCT01676116|76061111|FG001|NOT COMPLETED|Overall Study||29||
59942641|NCT00740480|76061117|FG000|STARTED|Overall Study||25||
59942642|NCT00740480|76061117|FG000|COMPLETED|Overall Study||23||
59942643|NCT00740480|76061117|FG000|NOT COMPLETED|Overall Study||2||
59942644|NCT02743520|76061120|FG000|STARTED|Overall Study||86||
59942645|NCT02743520|76061120|FG000|COMPLETED|Overall Study||85||
59942646|NCT02743520|76061120|FG000|NOT COMPLETED|Overall Study||1||
59942647|NCT04178993|76061126|FG000|STARTED|Overall Study||4||
59942648|NCT04178993|76061127|FG001|STARTED|Overall Study||4||
59942649|NCT04178993|76061126|FG000|COMPLETED|Overall Study||3||
59942650|NCT04178993|76061127|FG001|COMPLETED|Overall Study||4||
59942651|NCT04178993|76061126|FG000|NOT COMPLETED|Overall Study||1||
59942652|NCT04178993|76061127|FG001|NOT COMPLETED|Overall Study||0||
59942653|NCT03001557|76061139|FG000|STARTED|Core Phase||12||
59942654|NCT03001557|76061140|FG001|STARTED|Core Phase||12||
59942655|NCT03001557|76061141|FG002|STARTED|Core Phase||14||
59942656|NCT03001557|76061142|FG003|STARTED|Core Phase||13||
59942657|NCT03001557|76061143|FG004|STARTED|Core Phase||12||
59942658|NCT03001557|76061144|FG005|STARTED|Core Phase||0||
59942659|NCT03001557|76061145|FG006|STARTED|Core Phase||0||
59942660|NCT03001557|76061146|FG007|STARTED|Core Phase||0||
59942661|NCT03001557|76061139|FG000|Treated|Core Phase||12||
59942662|NCT03001557|76061140|FG001|Treated|Core Phase||12||
59942663|NCT03001557|76061141|FG002|Treated|Core Phase||13||
59942664|NCT03001557|76061142|FG003|Treated|Core Phase||13||
59942665|NCT03001557|76061143|FG004|Treated|Core Phase||12||
59942666|NCT03001557|76061144|FG005|Treated|Core Phase||0||
59942667|NCT03001557|76061145|FG006|Treated|Core Phase||0||
59942668|NCT03001557|76061146|FG007|Treated|Core Phase||0||
59942669|NCT03001557|76061139|FG000|COMPLETED|Core Phase||12||
59942670|NCT03001557|76061140|FG001|COMPLETED|Core Phase||12||
59942671|NCT03001557|76061141|FG002|COMPLETED|Core Phase||13||
59942672|NCT03001557|76061142|FG003|COMPLETED|Core Phase||13||
59942673|NCT03001557|76061143|FG004|COMPLETED|Core Phase||12||
59942674|NCT03001557|76061144|FG005|COMPLETED|Core Phase||0||
59942675|NCT03001557|76061145|FG006|COMPLETED|Core Phase||0||
59942676|NCT03001557|76061146|FG007|COMPLETED|Core Phase||0||
59942677|NCT03001557|76061139|FG000|NOT COMPLETED|Core Phase||0||
59942678|NCT03001557|76061140|FG001|NOT COMPLETED|Core Phase||0||
59942679|NCT03001557|76061141|FG002|NOT COMPLETED|Core Phase||1||
59942680|NCT03001557|76061142|FG003|NOT COMPLETED|Core Phase||0||
59942681|NCT03001557|76061143|FG004|NOT COMPLETED|Core Phase||0||
59942682|NCT03001557|76061144|FG005|NOT COMPLETED|Core Phase||0||
59942683|NCT03001557|76061145|FG006|NOT COMPLETED|Core Phase||0||
59942684|NCT03001557|76061146|FG007|NOT COMPLETED|Core Phase||0||
59942685|NCT03001557|76061139|FG000|STARTED|Extension Phase||0||
59942686|NCT03001557|76061140|FG001|STARTED|Extension Phase||0||
59942687|NCT03001557|76061141|FG002|STARTED|Extension Phase||0||
59942688|NCT03001557|76061142|FG003|STARTED|Extension Phase||0||
59942689|NCT03001557|76061143|FG004|STARTED|Extension Phase||0||
59942690|NCT03001557|76061144|FG005|STARTED|Extension Phase||5||
59942691|NCT03001557|76061145|FG006|STARTED|Extension Phase||14||
59942692|NCT03001557|76061146|FG007|STARTED|Extension Phase||6||
59942693|NCT03001557|76061139|FG000|COMPLETED|Extension Phase||0||
59942694|NCT03001557|76061140|FG001|COMPLETED|Extension Phase||0||
59942695|NCT03001557|76061141|FG002|COMPLETED|Extension Phase||0||
59942696|NCT03001557|76061142|FG003|COMPLETED|Extension Phase||0||
59942697|NCT03001557|76061143|FG004|COMPLETED|Extension Phase||0||
59942698|NCT03001557|76061144|FG005|COMPLETED|Extension Phase||0||
59942699|NCT03001557|76061145|FG006|COMPLETED|Extension Phase||0||
59942700|NCT03001557|76061146|FG007|COMPLETED|Extension Phase||0||
59942701|NCT03001557|76061139|FG000|NOT COMPLETED|Extension Phase||0||
59942702|NCT03001557|76061140|FG001|NOT COMPLETED|Extension Phase||0||
59942703|NCT03001557|76061141|FG002|NOT COMPLETED|Extension Phase||0||
59942704|NCT03001557|76061142|FG003|NOT COMPLETED|Extension Phase||0||
59942705|NCT03001557|76061143|FG004|NOT COMPLETED|Extension Phase||0||
59942706|NCT03001557|76061144|FG005|NOT COMPLETED|Extension Phase||5||
59942707|NCT03001557|76061145|FG006|NOT COMPLETED|Extension Phase||14||
59942708|NCT03001557|76061146|FG007|NOT COMPLETED|Extension Phase||6||
59942709|NCT04365985|76061171|FG000|STARTED|Overall Study||9||
59942710|NCT04365985|76061172|FG001|STARTED|Overall Study||9||
59942711|NCT04365985|76061173|FG002|STARTED|Overall Study||52||
59942712|NCT04365985|76061171|FG000|COMPLETED|Overall Study||9||
59942713|NCT04365985|76061172|FG001|COMPLETED|Overall Study||9||
59942714|NCT04365985|76061173|FG002|COMPLETED|Overall Study||52||
59942715|NCT04365985|76061171|FG000|NOT COMPLETED|Overall Study||0||
59942716|NCT04365985|76061172|FG001|NOT COMPLETED|Overall Study||0||
59942717|NCT04365985|76061173|FG002|NOT COMPLETED|Overall Study||0||
59942718|NCT00830336|76061183|FG000|STARTED|First Intervention||40||
59942719|NCT00830336|76061184|FG001|STARTED|First Intervention||40||
59942720|NCT00830336|76061183|FG000|COMPLETED|First Intervention||40||
59942721|NCT00830336|76061184|FG001|COMPLETED|First Intervention||40||
59942722|NCT00830336|76061183|FG000|NOT COMPLETED|First Intervention||0||
59942723|NCT00830336|76061184|FG001|NOT COMPLETED|First Intervention||0||
59942724|NCT00830336|76061183|FG000|STARTED|Washout: 21 Days||40||
59518673|NCT00942305|75612506|FG002|STARTED|Overall Study||29||
59518674|NCT00942305|75612507|FG003|STARTED|Overall Study||10||
59518675|NCT00942305|75612508|FG004|STARTED|Overall Study||39||
59942725|NCT00830336|76061184|FG001|STARTED|Washout: 21 Days||40||
59942726|NCT00830336|76061183|FG000|COMPLETED|Washout: 21 Days||39||
59942727|NCT00830336|76061184|FG001|COMPLETED|Washout: 21 Days||40||
59942728|NCT00830336|76061183|FG000|NOT COMPLETED|Washout: 21 Days||1||
59942729|NCT00830336|76061184|FG001|NOT COMPLETED|Washout: 21 Days||0||
59942730|NCT00830336|76061183|FG000|STARTED|Second Intervention||39||
59942731|NCT00830336|76061184|FG001|STARTED|Second Intervention||40||
59942732|NCT00830336|76061183|FG000|COMPLETED|Second Intervention||39||
59518676|NCT00942305|75612509|FG005|STARTED|Overall Study||14||
59942733|NCT00830336|76061184|FG001|COMPLETED|Second Intervention||40||
59942734|NCT00830336|76061183|FG000|NOT COMPLETED|Second Intervention||0||
59942735|NCT00830336|76061184|FG001|NOT COMPLETED|Second Intervention||0||
59942736|NCT00830258|76061190|FG000|STARTED|First Intervention||30||
59942737|NCT00830258|76061191|FG001|STARTED|First Intervention||30||
59942738|NCT00830258|76061190|FG000|COMPLETED|First Intervention||29||
59942739|NCT00830258|76061191|FG001|COMPLETED|First Intervention||30||
59942740|NCT00830258|76061190|FG000|NOT COMPLETED|First Intervention||1||
59942741|NCT00830258|76061191|FG001|NOT COMPLETED|First Intervention||0||
59942742|NCT00830258|76061190|FG000|STARTED|Washout: 7 Days||29||
59942743|NCT00830258|76061191|FG001|STARTED|Washout: 7 Days||30||
59942744|NCT00830258|76061190|FG000|COMPLETED|Washout: 7 Days||28||
59942745|NCT00830258|76061191|FG001|COMPLETED|Washout: 7 Days||30||
59942746|NCT00830258|76061190|FG000|NOT COMPLETED|Washout: 7 Days||1||
59942747|NCT00830258|76061191|FG001|NOT COMPLETED|Washout: 7 Days||0||
59942748|NCT00830258|76061190|FG000|STARTED|Second Intervention||28||
59942749|NCT00830258|76061191|FG001|STARTED|Second Intervention||30||
59942750|NCT00830258|76061190|FG000|COMPLETED|Second Intervention||28||
59942751|NCT00830258|76061191|FG001|COMPLETED|Second Intervention||30||
59942752|NCT00830258|76061190|FG000|NOT COMPLETED|Second Intervention||0||
60067497|NCT01915849|76182702|FG003|STARTED|Treatment Period 2 (4 Days)||3||
59518677|NCT00942305|75612510|FG006|STARTED|Overall Study||30||
59518678|NCT00942305|75612511|FG007|STARTED|Overall Study||10||
59942753|NCT00830258|76061191|FG001|NOT COMPLETED|Second Intervention||0||
59942754|NCT03349775|76061197|FG000|STARTED|Overall Study||10||
59942755|NCT03349775|76061198|FG001|STARTED|Overall Study||11||
59942756|NCT03349775|76061197|FG000|COMPLETED|Overall Study||8||
59942757|NCT03349775|76061198|FG001|COMPLETED|Overall Study||7||
59942758|NCT03349775|76061197|FG000|NOT COMPLETED|Overall Study||2||
59942759|NCT03349775|76061198|FG001|NOT COMPLETED|Overall Study||4||
59942760|NCT00830024|76061206|FG000|STARTED|First Intervention||18||
59942761|NCT00830024|76061207|FG001|STARTED|First Intervention||18||
59942762|NCT00830024|76061206|FG000|COMPLETED|First Intervention||18||
59942763|NCT00830024|76061207|FG001|COMPLETED|First Intervention||18||
59942764|NCT00830024|76061206|FG000|NOT COMPLETED|First Intervention||0||
59942765|NCT00830024|76061207|FG001|NOT COMPLETED|First Intervention||0||
59942766|NCT00830024|76061206|FG000|STARTED|Washout: 7 Days||18||
59942767|NCT00830024|76061207|FG001|STARTED|Washout: 7 Days||18||
59942768|NCT00830024|76061206|FG000|COMPLETED|Washout: 7 Days||17||
59942769|NCT00830024|76061207|FG001|COMPLETED|Washout: 7 Days||18||
59942770|NCT00830024|76061206|FG000|NOT COMPLETED|Washout: 7 Days||1||
59942771|NCT00830024|76061207|FG001|NOT COMPLETED|Washout: 7 Days||0||
59942772|NCT00830024|76061206|FG000|STARTED|Second Intervention||17||
59942773|NCT00830024|76061207|FG001|STARTED|Second Intervention||18||
59942774|NCT00830024|76061206|FG000|COMPLETED|Second Intervention||17||
59942775|NCT00830024|76061207|FG001|COMPLETED|Second Intervention||18||
59942776|NCT00830024|76061206|FG000|NOT COMPLETED|Second Intervention||0||
59942777|NCT00830024|76061207|FG001|NOT COMPLETED|Second Intervention||0||
59942778|NCT00829868|76061213|FG000|STARTED|First Intervention||21||
59942779|NCT00829868|76061214|FG001|STARTED|First Intervention||21||
59942780|NCT00829868|76061213|FG000|COMPLETED|First Intervention||21||
59942781|NCT00829868|76061214|FG001|COMPLETED|First Intervention||21||
59942782|NCT00829868|76061213|FG000|NOT COMPLETED|First Intervention||0||
59942783|NCT00829868|76061214|FG001|NOT COMPLETED|First Intervention||0||
59942784|NCT00829868|76061213|FG000|STARTED|Washout||21||
59942785|NCT00829868|76061214|FG001|STARTED|Washout||21||
59942786|NCT00829868|76061213|FG000|COMPLETED|Washout||20||
59942787|NCT00829868|76061214|FG001|COMPLETED|Washout||21||
59942788|NCT00829868|76061213|FG000|NOT COMPLETED|Washout||1||
59942789|NCT00829868|76061214|FG001|NOT COMPLETED|Washout||0||
59942790|NCT00829868|76061213|FG000|STARTED|Second Intervention||20||
59942791|NCT00829868|76061214|FG001|STARTED|Second Intervention||21||
59942792|NCT00829868|76061213|FG000|COMPLETED|Second Intervention||20||
59942793|NCT00829868|76061214|FG001|COMPLETED|Second Intervention||21||
59942794|NCT00829868|76061213|FG000|NOT COMPLETED|Second Intervention||0||
59942795|NCT00829868|76061214|FG001|NOT COMPLETED|Second Intervention||0||
59942796|NCT00829790|76061220|FG000|STARTED|First Intervention||15||
59942797|NCT00829790|76061221|FG001|STARTED|First Intervention||15||
59942798|NCT00829790|76061220|FG000|COMPLETED|First Intervention||15||
59942799|NCT00829790|76061221|FG001|COMPLETED|First Intervention||15||
59942800|NCT00829790|76061220|FG000|NOT COMPLETED|First Intervention||0||
59942801|NCT00829790|76061221|FG001|NOT COMPLETED|First Intervention||0||
59942802|NCT00829790|76061220|FG000|STARTED|Washout of 14 Days||15||
59942803|NCT00829790|76061221|FG001|STARTED|Washout of 14 Days||15||
59942804|NCT00829790|76061220|FG000|COMPLETED|Washout of 14 Days||15||
59942805|NCT00829790|76061221|FG001|COMPLETED|Washout of 14 Days||14||
59942806|NCT00829790|76061220|FG000|NOT COMPLETED|Washout of 14 Days||0||
59942807|NCT00829790|76061221|FG001|NOT COMPLETED|Washout of 14 Days||1||
59942808|NCT00829790|76061220|FG000|STARTED|Second Intervention||15||
59942809|NCT00829790|76061221|FG001|STARTED|Second Intervention||14||
59518679|NCT00942305|75612512|FG008|STARTED|Overall Study||50||
59942810|NCT00829790|76061220|FG000|COMPLETED|Second Intervention||15||
59942811|NCT00829790|76061221|FG001|COMPLETED|Second Intervention||14||
59942812|NCT00829790|76061220|FG000|NOT COMPLETED|Second Intervention||0||
59942813|NCT00829790|76061221|FG001|NOT COMPLETED|Second Intervention||0||
60067498|NCT01915849|76182699|FG000|COMPLETED|Treatment Period 2 (4 Days)||3||
60067499|NCT01915849|76182700|FG001|COMPLETED|Treatment Period 2 (4 Days)||3||
60067500|NCT01915849|76182701|FG002|COMPLETED|Treatment Period 2 (4 Days)||3||
60067501|NCT01915849|76182702|FG003|COMPLETED|Treatment Period 2 (4 Days)||3||
59942814|NCT03207815|76061227|FG000|STARTED|Overall Study||38||
59942815|NCT03207815|76061228|FG001|STARTED|Overall Study||36||
59942816|NCT03207815|76061227|FG000|COMPLETED|Overall Study||30||
59942817|NCT03207815|76061228|FG001|COMPLETED|Overall Study||29||
59942818|NCT03207815|76061227|FG000|NOT COMPLETED|Overall Study||8||
59942819|NCT03207815|76061228|FG001|NOT COMPLETED|Overall Study||7||
59942820|NCT02911935|76061236|FG000|STARTED|Overall Study||101||
59942821|NCT02911935|76061237|FG001|STARTED|Overall Study||99||
59942822|NCT02911935|76061236|FG000|COMPLETED|Overall Study||96||
59942823|NCT02911935|76061237|FG001|COMPLETED|Overall Study||92||
59942824|NCT02911935|76061236|FG000|NOT COMPLETED|Overall Study||5||
59942825|NCT02911935|76061237|FG001|NOT COMPLETED|Overall Study||7||
59942826|NCT00829712|76061245|FG000|STARTED|First Intervention||12||
59942827|NCT00829712|76061246|FG001|STARTED|First Intervention||12||
60067502|NCT01915849|76182699|FG000|NOT COMPLETED|Treatment Period 2 (4 Days)||0||
59942828|NCT00829712|76061245|FG000|COMPLETED|First Intervention||12||
59942829|NCT00829712|76061246|FG001|COMPLETED|First Intervention||12||
59942830|NCT00829712|76061245|FG000|NOT COMPLETED|First Intervention||0||
59942831|NCT00829712|76061246|FG001|NOT COMPLETED|First Intervention||0||
59942832|NCT00829712|76061245|FG000|STARTED|Washout of 7 Days||12||
59942833|NCT00829712|76061246|FG001|STARTED|Washout of 7 Days||12||
59942834|NCT00829712|76061245|FG000|COMPLETED|Washout of 7 Days||12||
59942835|NCT00829712|76061246|FG001|COMPLETED|Washout of 7 Days||11||
59942836|NCT00829712|76061245|FG000|NOT COMPLETED|Washout of 7 Days||0||
59942837|NCT00829712|76061246|FG001|NOT COMPLETED|Washout of 7 Days||1||
59942838|NCT00829712|76061245|FG000|STARTED|Second Intervention||12||
59942839|NCT00829712|76061246|FG001|STARTED|Second Intervention||11||
59942840|NCT00829712|76061245|FG000|COMPLETED|Second Intervention||12||
59942841|NCT00829712|76061246|FG001|COMPLETED|Second Intervention||11||
59942842|NCT00829712|76061245|FG000|NOT COMPLETED|Second Intervention||0||
59942843|NCT00829712|76061246|FG001|NOT COMPLETED|Second Intervention||0||
59942844|NCT04306211|76061252|FG000|STARTED|Overall Study||6||
59942845|NCT04306211|76061253|FG001|STARTED|Overall Study||5||
59942846|NCT04306211|76061252|FG000|COMPLETED|Overall Study||6||
59942847|NCT04306211|76061253|FG001|COMPLETED|Overall Study||5||
59942848|NCT04306211|76061252|FG000|NOT COMPLETED|Overall Study||0||
59942849|NCT04306211|76061253|FG001|NOT COMPLETED|Overall Study||0||
59942850|NCT03069989|76061261|FG000|STARTED|Dosing Period 1 (Up to 2 Days)||3||
59942851|NCT03069989|76061262|FG001|STARTED|Dosing Period 1 (Up to 2 Days)||5||
59942852|NCT03069989|76061261|FG000|COMPLETED|Dosing Period 1 (Up to 2 Days)||3||
59942853|NCT03069989|76061262|FG001|COMPLETED|Dosing Period 1 (Up to 2 Days)||5||
59942854|NCT03069989|76061261|FG000|NOT COMPLETED|Dosing Period 1 (Up to 2 Days)||0||
59942855|NCT03069989|76061262|FG001|NOT COMPLETED|Dosing Period 1 (Up to 2 Days)||0||
59942856|NCT03069989|76061261|FG000|STARTED|Wash Out Period (Up to 28 Days))||3||
59942857|NCT03069989|76061262|FG001|STARTED|Wash Out Period (Up to 28 Days))||5||
59942858|NCT03069989|76061261|FG000|COMPLETED|Wash Out Period (Up to 28 Days))||3||
59942859|NCT03069989|76061262|FG001|COMPLETED|Wash Out Period (Up to 28 Days))||5||
59942860|NCT03069989|76061261|FG000|NOT COMPLETED|Wash Out Period (Up to 28 Days))||0||
59942861|NCT03069989|76061262|FG001|NOT COMPLETED|Wash Out Period (Up to 28 Days))||0||
59942862|NCT03069989|76061261|FG000|STARTED|Dosing Period 2 (Up to 16 Days)||3||
59942863|NCT03069989|76061262|FG001|STARTED|Dosing Period 2 (Up to 16 Days)||5||
59942864|NCT03069989|76061261|FG000|COMPLETED|Dosing Period 2 (Up to 16 Days)||2||
59942865|NCT03069989|76061262|FG001|COMPLETED|Dosing Period 2 (Up to 16 Days)||5||
59942866|NCT03069989|76061261|FG000|NOT COMPLETED|Dosing Period 2 (Up to 16 Days)||1||
59942867|NCT03069989|76061262|FG001|NOT COMPLETED|Dosing Period 2 (Up to 16 Days)||0||
59942868|NCT04826731|76061271|FG000|STARTED|Overall Study||10||
59942869|NCT04826731|76061272|FG001|STARTED|Overall Study||4||
59942870|NCT04826731|76061271|FG000|COMPLETED|Overall Study|All patients were initially accepted as the study group per study design, with those unable to utilize respiratory exerciser (n=4) were later removed to standard care group.|10||
59942871|NCT04826731|76061272|FG001|COMPLETED|Overall Study|Patients who could not use the respiratory exerciser (n=2) or refused to do so (n=2) were accepted as the control group.|4||
59942872|NCT04826731|76061271|FG000|NOT COMPLETED|Overall Study||0||
59942873|NCT04826731|76061272|FG001|NOT COMPLETED|Overall Study||0||
59942874|NCT04231409|76061280|FG000|STARTED|Overall Study||5||
59942875|NCT04231409|76061281|FG001|STARTED|Overall Study||4||
59942876|NCT04231409|76061280|FG000|COMPLETED|Overall Study||0||
59942877|NCT04231409|76061281|FG001|COMPLETED|Overall Study||0||
59942878|NCT04231409|76061280|FG000|NOT COMPLETED|Overall Study||5||
59942879|NCT04231409|76061281|FG001|NOT COMPLETED|Overall Study||4||
59942880|NCT02698163|76061289|FG000|STARTED|Overall Study||1||
59942881|NCT02698163|76061290|FG001|STARTED|Overall Study||3||
59942882|NCT02698163|76061289|FG000|COMPLETED|Overall Study||1||
59942883|NCT02698163|76061290|FG001|COMPLETED|Overall Study||2||
59942884|NCT02698163|76061289|FG000|NOT COMPLETED|Overall Study||0||
59942885|NCT02698163|76061290|FG001|NOT COMPLETED|Overall Study||1||
60067503|NCT01915849|76182700|FG001|NOT COMPLETED|Treatment Period 2 (4 Days)||0||
60067504|NCT01915849|76182701|FG002|NOT COMPLETED|Treatment Period 2 (4 Days)||0||
59942886|NCT03817190|76061298|FG000|STARTED|Overall Study||110||
59942887|NCT03817190|76061299|FG001|STARTED|Overall Study||109||
59942888|NCT03817190|76061298|FG000|COMPLETED|Overall Study||50||
59942889|NCT03817190|76061299|FG001|COMPLETED|Overall Study||50||
59942890|NCT03817190|76061298|FG000|NOT COMPLETED|Overall Study||60||
59942891|NCT03817190|76061299|FG001|NOT COMPLETED|Overall Study||59||
59942892|NCT04507321|76061305|FG000|STARTED|Treatment Period 1 (8 Days)||5||
59942893|NCT04507321|76061305|FG000|COMPLETED|Treatment Period 1 (8 Days)||5||
59942894|NCT04507321|76061305|FG000|NOT COMPLETED|Treatment Period 1 (8 Days)||0||
59942895|NCT04507321|76061305|FG000|STARTED|Treatment Period 2 (8 Days)||5||
59942896|NCT04507321|76061305|FG000|COMPLETED|Treatment Period 2 (8 Days)||5||
59942897|NCT04507321|76061305|FG000|NOT COMPLETED|Treatment Period 2 (8 Days)||0||
59942898|NCT03797222|76061318|FG000|STARTED|Overall Study||14||
59942899|NCT03797222|76061318|FG000|COMPLETED|Overall Study||13||
59942900|NCT03797222|76061318|FG000|NOT COMPLETED|Overall Study||1||
59942901|NCT02742818|76061328|FG000|STARTED|Overall Study||25||
59942902|NCT02742818|76061329|FG001|STARTED|Overall Study||25||
59942903|NCT02742818|76061328|FG000|COMPLETED|Overall Study||25||
59942904|NCT02742818|76061329|FG001|COMPLETED|Overall Study||23||
59942905|NCT02742818|76061328|FG000|NOT COMPLETED|Overall Study||0||
59942906|NCT02742818|76061329|FG001|NOT COMPLETED|Overall Study||2||
59942907|NCT03069365|76061337|FG000|STARTED|Overall Study||101||
60067505|NCT01915849|76182702|FG003|NOT COMPLETED|Treatment Period 2 (4 Days)||0||
59942908|NCT03069365|76061337|FG000|COMPLETED|Overall Study||100||
59942909|NCT03069365|76061337|FG000|NOT COMPLETED|Overall Study||1||
59942910|NCT03065933|76061341|FG000|STARTED|Overall Study||5||
59942911|NCT03065933|76061341|FG000|COMPLETED|Overall Study||0||
59942912|NCT03065933|76061341|FG000|NOT COMPLETED|Overall Study||5||
59942913|NCT04256629|76061351|FG000|STARTED|Overall Study||4||
59942914|NCT04256629|76061352|FG001|STARTED|Overall Study||4||
59942915|NCT04256629|76061353|FG002|STARTED|Overall Study||4||
59942916|NCT04256629|76061354|FG003|STARTED|Overall Study||4||
59942917|NCT04256629|76061355|FG004|STARTED|Overall Study||4||
59942918|NCT04256629|76061356|FG005|STARTED|Overall Study||4||
59942919|NCT04256629|76061351|FG000|COMPLETED|Overall Study||4||
59942920|NCT04256629|76061352|FG001|COMPLETED|Overall Study||3||
59942921|NCT04256629|76061353|FG002|COMPLETED|Overall Study||4||
59942922|NCT04256629|76061354|FG003|COMPLETED|Overall Study||4||
59942923|NCT04256629|76061355|FG004|COMPLETED|Overall Study||4||
59942924|NCT04256629|76061356|FG005|COMPLETED|Overall Study||3||
59942925|NCT04256629|76061351|FG000|NOT COMPLETED|Overall Study||0||
59942926|NCT04256629|76061352|FG001|NOT COMPLETED|Overall Study||1||
59942927|NCT04256629|76061353|FG002|NOT COMPLETED|Overall Study||0||
59942928|NCT04256629|76061354|FG003|NOT COMPLETED|Overall Study||0||
59942929|NCT04256629|76061355|FG004|NOT COMPLETED|Overall Study||0||
59942930|NCT04256629|76061356|FG005|NOT COMPLETED|Overall Study||1||
59942931|NCT01346293|76061366|FG000|STARTED|Overall Study||2743||
59942932|NCT01346293|76061367|FG001|STARTED|Overall Study||629||
59942933|NCT01346293|76061366|FG000|COMPLETED|Overall Study||2676||
59942934|NCT01346293|76061367|FG001|COMPLETED|Overall Study||608||
59942935|NCT01346293|76061366|FG000|NOT COMPLETED|Overall Study||67||
59942936|NCT01346293|76061367|FG001|NOT COMPLETED|Overall Study||21||
59942937|NCT03060902|76061377|FG000|STARTED|Overall Study||46||
59942938|NCT03060902|76061378|FG001|STARTED|Overall Study||47||
59942939|NCT03060902|76061377|FG000|COMPLETED|Overall Study||23||
59942940|NCT03060902|76061378|FG001|COMPLETED|Overall Study||47||
59942941|NCT03060902|76061377|FG000|NOT COMPLETED|Overall Study||23||
59942942|NCT03060902|76061378|FG001|NOT COMPLETED|Overall Study||0||
59942943|NCT03502187|76061387|FG000|STARTED|Overall Study||43||
59942944|NCT03502187|76061388|FG001|STARTED|Overall Study||43||
59942945|NCT03502187|76061389|FG002|STARTED|Overall Study||42||
59942946|NCT03502187|76061387|FG000|COMPLETED|Overall Study||34||
59942947|NCT03502187|76061388|FG001|COMPLETED|Overall Study||36||
59942948|NCT03502187|76061389|FG002|COMPLETED|Overall Study||34||
59942949|NCT03502187|76061387|FG000|NOT COMPLETED|Overall Study||9||
59942950|NCT03502187|76061388|FG001|NOT COMPLETED|Overall Study||7||
59942951|NCT03502187|76061389|FG002|NOT COMPLETED|Overall Study||8||
59942952|NCT03058705|76061397|FG000|STARTED|Overall Study||10||
59942953|NCT03058705|76061397|FG000|COMPLETED|Overall Study||6||
59942954|NCT03058705|76061397|FG000|NOT COMPLETED|Overall Study||4||
59942955|NCT02998671|76061406|FG000|STARTED|Period 1||21||
59942956|NCT02998671|76061407|FG001|STARTED|Period 1||13||
59942957|NCT02998671|76061408|FG002|STARTED|Period 1||6||
59942958|NCT02998671|76061409|FG003|STARTED|Period 1||8||
59942959|NCT02998671|76061410|FG004|STARTED|Period 1||4||
59942960|NCT02998671|76061406|FG000|COMPLETED|Period 1||17||
59942961|NCT02998671|76061407|FG001|COMPLETED|Period 1||10||
59942962|NCT02998671|76061408|FG002|COMPLETED|Period 1||6||
59942963|NCT02998671|76061409|FG003|COMPLETED|Period 1||8||
59942964|NCT02998671|76061410|FG004|COMPLETED|Period 1||0||
59518680|NCT00942305|75612513|FG009|STARTED|Overall Study||17||
59942965|NCT02998671|76061406|FG000|NOT COMPLETED|Period 1||4||
59942966|NCT02998671|76061407|FG001|NOT COMPLETED|Period 1||3||
59942967|NCT02998671|76061408|FG002|NOT COMPLETED|Period 1||0||
59942968|NCT02998671|76061409|FG003|NOT COMPLETED|Period 1||0||
59942969|NCT02998671|76061410|FG004|NOT COMPLETED|Period 1||4||
59942970|NCT02998671|76061406|FG000|STARTED|Period 2||17||
59942971|NCT02998671|76061407|FG001|STARTED|Period 2||10||
59942972|NCT02998671|76061408|FG002|STARTED|Period 2||6||
59942973|NCT02998671|76061409|FG003|STARTED|Period 2||8||
59942974|NCT02998671|76061410|FG004|STARTED|Period 2||0||
59942975|NCT02998671|76061406|FG000|COMPLETED|Period 2||14||
59518681|NCT00942305|75612504|FG000|COMPLETED|Overall Study||7||
59518682|NCT00942305|75612505|FG001|COMPLETED|Overall Study||5||
59942976|NCT02998671|76061407|FG001|COMPLETED|Period 2||3||
59942977|NCT02998671|76061408|FG002|COMPLETED|Period 2||5||
59942978|NCT02998671|76061409|FG003|COMPLETED|Period 2||4||
59942979|NCT02998671|76061410|FG004|COMPLETED|Period 2||0||
59518683|NCT00942305|75612506|FG002|COMPLETED|Overall Study||14||
59942980|NCT02998671|76061406|FG000|NOT COMPLETED|Period 2||3||
59942981|NCT02998671|76061407|FG001|NOT COMPLETED|Period 2||7||
59942982|NCT02998671|76061408|FG002|NOT COMPLETED|Period 2||1||
59942983|NCT02998671|76061409|FG003|NOT COMPLETED|Period 2||4||
59942984|NCT02998671|76061410|FG004|NOT COMPLETED|Period 2||0||
59942985|NCT02660827|76061430|FG000|STARTED|From Study to End of Continued Access||151||
59942986|NCT02660827|76061430|FG000|COMPLETED|From Study to End of Continued Access||120||
59942987|NCT02660827|76061430|FG000|NOT COMPLETED|From Study to End of Continued Access||31||
59942988|NCT02660827|76061430|FG000|STARTED|Period 1: Study Period||151||
59942989|NCT02660827|76061430|FG000|COMPLETED|Period 1: Study Period||150||
59942990|NCT02660827|76061430|FG000|NOT COMPLETED|Period 1: Study Period||1||
59942991|NCT02660827|76061430|FG000|STARTED|Period 2: Continued Access Period||145||
59942992|NCT02660827|76061430|FG000|COMPLETED|Period 2: Continued Access Period||120||
59942993|NCT02660827|76061430|FG000|NOT COMPLETED|Period 2: Continued Access Period||25||
59942994|NCT00491738|76061439|FG000|STARTED|Overall Study||7||
59942995|NCT00491738|76061440|FG001|STARTED|Overall Study||9||
59942996|NCT00491738|76061439|FG000|COMPLETED|Overall Study||7||
59942997|NCT00491738|76061440|FG001|COMPLETED|Overall Study||9||
59942998|NCT00491738|76061439|FG000|NOT COMPLETED|Overall Study||0||
59942999|NCT00491738|76061440|FG001|NOT COMPLETED|Overall Study||0||
59943000|NCT00479258|76061446|FG000|STARTED|Overall Study||0||
59943001|NCT00479258|76061447|FG001|STARTED|Overall Study||0||
59943002|NCT00479258|76061446|FG000|COMPLETED|Overall Study||0||
59943003|NCT00479258|76061447|FG001|COMPLETED|Overall Study||0||
59943004|NCT00479258|76061446|FG000|NOT COMPLETED|Overall Study||0||
59943005|NCT00479258|76061447|FG001|NOT COMPLETED|Overall Study||0||
59943006|NCT01069419|76061451|FG000|STARTED|Overall Study||1117||
59943007|NCT01069419|76061451|FG000|Safety Set|Overall Study||1111||
59943008|NCT01069419|76061451|FG000|Full Analysis Set|Overall Study||851||
59943009|NCT01069419|76061451|FG000|COMPLETED|Overall Study||402||
59943010|NCT01069419|76061451|FG000|NOT COMPLETED|Overall Study||715||
59943011|NCT01069341|76061455|FG000|STARTED|Overall Study||4||
59943012|NCT01069341|76061455|FG000|COMPLETED|Overall Study||3||
59943013|NCT01069341|76061455|FG000|NOT COMPLETED|Overall Study||1||
59943014|NCT02996097|76061459|FG000|STARTED|Overall Study||30||30
59943015|NCT02996097|76061460|FG001|STARTED|Overall Study||30||30
59943016|NCT02996097|76061459|FG000|Per Protocol Population|Overall Study||22||22
59943017|NCT02996097|76061460|FG001|Per Protocol Population|Overall Study||22||22
59943018|NCT02996097|76061459|FG000|COMPLETED|Overall Study||19||19
59943019|NCT02996097|76061460|FG001|COMPLETED|Overall Study||19||19
59943020|NCT02996097|76061459|FG000|NOT COMPLETED|Overall Study||11||11
59943021|NCT02996097|76061460|FG001|NOT COMPLETED|Overall Study||11||11
59943022|NCT04053699|76061465|FG000|STARTED|Full Analysis Set||56||
59943023|NCT04053699|76061465|FG000|COMPLETED|Full Analysis Set||51||
59943024|NCT04053699|76061465|FG000|NOT COMPLETED|Full Analysis Set||5||
59943025|NCT04053699|76061465|FG000|STARTED|Per Protocol Set||42||
59943026|NCT04053699|76061465|FG000|COMPLETED|Per Protocol Set||42||
59943027|NCT04053699|76061465|FG000|NOT COMPLETED|Per Protocol Set||0||
59943028|NCT02992899|76061476|FG000|STARTED|Overall Study||27||
59943029|NCT02992899|76061477|FG001|STARTED|Overall Study||29||
59943030|NCT02992899|76061476|FG000|COMPLETED|Overall Study||25||
59943031|NCT02992899|76061477|FG001|COMPLETED|Overall Study||26||
59943032|NCT02992899|76061476|FG000|NOT COMPLETED|Overall Study||2||
59943033|NCT02992899|76061477|FG001|NOT COMPLETED|Overall Study||3||
59943034|NCT01602484|76061485|FG000|STARTED|Overall Study||25||
59943035|NCT01602484|76061486|FG001|STARTED|Overall Study||25||
59943036|NCT01602484|76061485|FG000|COMPLETED|Overall Study||25||
59943037|NCT01602484|76061486|FG001|COMPLETED|Overall Study||24||
59943038|NCT01602484|76061485|FG000|NOT COMPLETED|Overall Study||0||
59943039|NCT01602484|76061486|FG001|NOT COMPLETED|Overall Study||1||
59943040|NCT04530604|76061492|FG000|STARTED|Overall Study||12||
59943041|NCT04530604|76061492|FG000|Completed Dosing|Overall Study||10|"One participant discontinued defibrotide early when a pre-therapy blood culture became positive for potential pathogen while the participant was on study therapy. The patient discontinued study at that time but was still evaluable for toxicity and response.~Another stopped defibrotide when endotracheal aspirate grew oral flora and H. influenza."|
59943042|NCT04530604|76061492|FG000|COMPLETED|Overall Study||12||
59943043|NCT04530604|76061492|FG000|NOT COMPLETED|Overall Study||0||
59943044|NCT02989389|76061506|FG000|STARTED|Period 1||3||
59943045|NCT02989389|76061507|FG001|STARTED|Period 1||4||
59943046|NCT02989389|76061508|FG002|STARTED|Period 1||3||
59943047|NCT02989389|76061509|FG003|STARTED|Period 1||3||
59943048|NCT02989389|76061510|FG004|STARTED|Period 1||3||
59943049|NCT02989389|76061511|FG005|STARTED|Period 1||3||
59943050|NCT02989389|76061512|FG006|STARTED|Period 1||6||
59943051|NCT02989389|76061513|FG007|STARTED|Period 1||5||
59943052|NCT02989389|76061514|FG008|STARTED|Period 1||6||
59518684|NCT00942305|75612507|FG003|COMPLETED|Overall Study||4||
59943053|NCT02989389|76061515|FG009|STARTED|Period 1||6||
59943054|NCT02989389|76061506|FG000|Received at Least 1 Dose of Study Drug|Period 1||3||
59943055|NCT02989389|76061507|FG001|Received at Least 1 Dose of Study Drug|Period 1||4||
59943056|NCT02989389|76061508|FG002|Received at Least 1 Dose of Study Drug|Period 1||3||
59943057|NCT02989389|76061509|FG003|Received at Least 1 Dose of Study Drug|Period 1||3||
59943058|NCT02989389|76061510|FG004|Received at Least 1 Dose of Study Drug|Period 1||3||
59943059|NCT02989389|76061511|FG005|Received at Least 1 Dose of Study Drug|Period 1||3||
59943060|NCT02989389|76061512|FG006|Received at Least 1 Dose of Study Drug|Period 1||6||
59943061|NCT02989389|76061513|FG007|Received at Least 1 Dose of Study Drug|Period 1||5||
59943062|NCT02989389|76061514|FG008|Received at Least 1 Dose of Study Drug|Period 1||6||
59943063|NCT02989389|76061515|FG009|Received at Least 1 Dose of Study Drug|Period 1||6||
59943064|NCT02989389|76061506|FG000|COMPLETED|Period 1||3||
59943065|NCT02989389|76061507|FG001|COMPLETED|Period 1||3||
59943066|NCT02989389|76061508|FG002|COMPLETED|Period 1||3||
59943067|NCT02989389|76061509|FG003|COMPLETED|Period 1||3||
59943068|NCT02989389|76061510|FG004|COMPLETED|Period 1||3||
59943069|NCT02989389|76061511|FG005|COMPLETED|Period 1||3||
59518685|NCT00942305|75612508|FG004|COMPLETED|Overall Study||14||
59518686|NCT00942305|75612509|FG005|COMPLETED|Overall Study||9||
59518687|NCT00942305|75612510|FG006|COMPLETED|Overall Study||6||
59943070|NCT02989389|76061512|FG006|COMPLETED|Period 1||6||
59943071|NCT02989389|76061513|FG007|COMPLETED|Period 1||5||
59943072|NCT02989389|76061514|FG008|COMPLETED|Period 1||5||
59943073|NCT02989389|76061515|FG009|COMPLETED|Period 1||6||
59943074|NCT02989389|76061506|FG000|NOT COMPLETED|Period 1||0||
59943075|NCT02989389|76061507|FG001|NOT COMPLETED|Period 1||1||
59943076|NCT02989389|76061508|FG002|NOT COMPLETED|Period 1||0||
59943077|NCT02989389|76061509|FG003|NOT COMPLETED|Period 1||0||
59943078|NCT02989389|76061510|FG004|NOT COMPLETED|Period 1||0||
59943079|NCT02989389|76061511|FG005|NOT COMPLETED|Period 1||0||
59943080|NCT02989389|76061512|FG006|NOT COMPLETED|Period 1||0||
59943081|NCT02989389|76061513|FG007|NOT COMPLETED|Period 1||0||
59943082|NCT02989389|76061514|FG008|NOT COMPLETED|Period 1||1||
59943083|NCT02989389|76061515|FG009|NOT COMPLETED|Period 1||0||
59943084|NCT02989389|76061506|FG000|STARTED|Period 2||3||
59943085|NCT02989389|76061507|FG001|STARTED|Period 2||3||
59943086|NCT02989389|76061508|FG002|STARTED|Period 2||3||
59943087|NCT02989389|76061509|FG003|STARTED|Period 2||3||
59943088|NCT02989389|76061510|FG004|STARTED|Period 2||3||
59943089|NCT02989389|76061511|FG005|STARTED|Period 2||3||
59943090|NCT02989389|76061512|FG006|STARTED|Period 2|Part B was planned as a single period study.|0||
59943091|NCT02989389|76061513|FG007|STARTED|Period 2|Part B was planned as a single period study.|0||
59943092|NCT02989389|76061514|FG008|STARTED|Period 2|Part B was planned as a single period study.|0||
59943093|NCT02989389|76061515|FG009|STARTED|Period 2|Part B was planned as a single period study.|0||
59943094|NCT02989389|76061506|FG000|COMPLETED|Period 2||3||
59943095|NCT02989389|76061507|FG001|COMPLETED|Period 2||3||
59943096|NCT02989389|76061508|FG002|COMPLETED|Period 2||3||
59943097|NCT02989389|76061509|FG003|COMPLETED|Period 2||3||
59943098|NCT02989389|76061510|FG004|COMPLETED|Period 2||3||
59943099|NCT02989389|76061511|FG005|COMPLETED|Period 2||3||
59943100|NCT02989389|76061512|FG006|COMPLETED|Period 2||0||
59943101|NCT02989389|76061513|FG007|COMPLETED|Period 2||0||
59943102|NCT02989389|76061514|FG008|COMPLETED|Period 2||0||
59943103|NCT02989389|76061515|FG009|COMPLETED|Period 2||0||
59943104|NCT02989389|76061506|FG000|NOT COMPLETED|Period 2||0||
59943105|NCT02989389|76061507|FG001|NOT COMPLETED|Period 2||0||
59943106|NCT02989389|76061508|FG002|NOT COMPLETED|Period 2||0||
59943107|NCT02989389|76061509|FG003|NOT COMPLETED|Period 2||0||
59943108|NCT02989389|76061510|FG004|NOT COMPLETED|Period 2||0||
59943109|NCT02989389|76061511|FG005|NOT COMPLETED|Period 2||0||
59943110|NCT02989389|76061512|FG006|NOT COMPLETED|Period 2||0||
59943111|NCT02989389|76061513|FG007|NOT COMPLETED|Period 2||0||
59943112|NCT02989389|76061514|FG008|NOT COMPLETED|Period 2||0||
59943113|NCT02989389|76061515|FG009|NOT COMPLETED|Period 2||0||
59943114|NCT02989389|76061506|FG000|STARTED|Period 3||3||
59943115|NCT02989389|76061507|FG001|STARTED|Period 3||3||
59943116|NCT02989389|76061508|FG002|STARTED|Period 3||3||
59943117|NCT02989389|76061509|FG003|STARTED|Period 3||3||
59943118|NCT02989389|76061510|FG004|STARTED|Period 3||3||
59943119|NCT02989389|76061511|FG005|STARTED|Period 3||3||
59943120|NCT02989389|76061512|FG006|STARTED|Period 3||0||
59943121|NCT02989389|76061513|FG007|STARTED|Period 3||0||
59943122|NCT02989389|76061514|FG008|STARTED|Period 3||0||
59943123|NCT02989389|76061515|FG009|STARTED|Period 3||0||
59943124|NCT02989389|76061506|FG000|COMPLETED|Period 3||3||
59943125|NCT02989389|76061507|FG001|COMPLETED|Period 3||3||
59943126|NCT02989389|76061508|FG002|COMPLETED|Period 3||3||
59518688|NCT00942305|75612511|FG007|COMPLETED|Overall Study||5||
59518689|NCT00942305|75612512|FG008|COMPLETED|Overall Study||25||
59518690|NCT00942305|75612513|FG009|COMPLETED|Overall Study||7||
59518691|NCT00942305|75612504|FG000|NOT COMPLETED|Overall Study||23||
59518692|NCT00942305|75612505|FG001|NOT COMPLETED|Overall Study||5||
59518693|NCT00942305|75612506|FG002|NOT COMPLETED|Overall Study||15||
59518694|NCT00942305|75612507|FG003|NOT COMPLETED|Overall Study||6||
59518695|NCT00942305|75612508|FG004|NOT COMPLETED|Overall Study||25||
59518696|NCT00942305|75612509|FG005|NOT COMPLETED|Overall Study||5||
59518697|NCT00942305|75612510|FG006|NOT COMPLETED|Overall Study||24||
59943127|NCT02989389|76061509|FG003|COMPLETED|Period 3||3||
59943128|NCT02989389|76061510|FG004|COMPLETED|Period 3||3||
59943129|NCT02989389|76061511|FG005|COMPLETED|Period 3||3||
59943130|NCT02989389|76061512|FG006|COMPLETED|Period 3||0||
59943131|NCT02989389|76061513|FG007|COMPLETED|Period 3||0||
59943132|NCT02989389|76061514|FG008|COMPLETED|Period 3||0||
59943133|NCT02989389|76061515|FG009|COMPLETED|Period 3||0||
59943134|NCT02989389|76061506|FG000|NOT COMPLETED|Period 3||0||
59943135|NCT02989389|76061507|FG001|NOT COMPLETED|Period 3||0||
59943136|NCT02989389|76061508|FG002|NOT COMPLETED|Period 3||0||
59943137|NCT02989389|76061509|FG003|NOT COMPLETED|Period 3||0||
59943138|NCT02989389|76061510|FG004|NOT COMPLETED|Period 3||0||
59943139|NCT02989389|76061511|FG005|NOT COMPLETED|Period 3||0||
59943140|NCT02989389|76061512|FG006|NOT COMPLETED|Period 3||0||
59943141|NCT02989389|76061513|FG007|NOT COMPLETED|Period 3||0||
59943142|NCT02989389|76061514|FG008|NOT COMPLETED|Period 3||0||
59943143|NCT02989389|76061515|FG009|NOT COMPLETED|Period 3||0||
59943144|NCT02653300|76061555|FG000|STARTED|Overall Study||10||
59943145|NCT02653300|76061555|FG000|COMPLETED|Overall Study||8||
59943146|NCT02653300|76061555|FG000|NOT COMPLETED|Overall Study||2||
59943147|NCT00430508|76061563|FG000|STARTED|Overall Study||140||
59943148|NCT00430508|76061564|FG001|STARTED|Overall Study||278||
59943149|NCT00430508|76061565|FG002|STARTED|Overall Study||279||
59943150|NCT00430508|76061566|FG003|STARTED|Overall Study||274||
59943151|NCT00430508|76061563|FG000|COMPLETED|Overall Study||137||
59943152|NCT00430508|76061564|FG001|COMPLETED|Overall Study||272||
59943153|NCT00430508|76061565|FG002|COMPLETED|Overall Study||266||
59943154|NCT00430508|76061566|FG003|COMPLETED|Overall Study||269||
59943155|NCT00430508|76061563|FG000|NOT COMPLETED|Overall Study||3||
59943156|NCT00430508|76061564|FG001|NOT COMPLETED|Overall Study||6||
59943157|NCT00430508|76061565|FG002|NOT COMPLETED|Overall Study||13||
59943158|NCT00430508|76061566|FG003|NOT COMPLETED|Overall Study||5||
59943159|NCT02988219|76061574|FG000|STARTED|Overall Study||25||
59943160|NCT02988219|76061575|FG001|STARTED|Overall Study||25||
59943161|NCT02988219|76061574|FG000|COMPLETED|Overall Study||24||
59943162|NCT02988219|76061575|FG001|COMPLETED|Overall Study||22||
59943163|NCT02988219|76061574|FG000|NOT COMPLETED|Overall Study||1||
59943164|NCT02988219|76061575|FG001|NOT COMPLETED|Overall Study||3||
59943165|NCT01346059|76061583|FG000|STARTED|Overall Study||1||
59943166|NCT01346059|76061584|FG001|STARTED|Overall Study||1||
59943167|NCT01346059|76061583|FG000|COMPLETED|Overall Study||0||
59943168|NCT01346059|76061584|FG001|COMPLETED|Overall Study||1||
59943169|NCT01346059|76061583|FG000|NOT COMPLETED|Overall Study||1||
59943170|NCT01346059|76061584|FG001|NOT COMPLETED|Overall Study||0||
59943171|NCT01318915|76061590|FG000|STARTED|Overall Study||10||
59943172|NCT01318915|76061590|FG000|COMPLETED|Overall Study||9||
59943173|NCT01318915|76061590|FG000|NOT COMPLETED|Overall Study||1||
59943174|NCT02987205|76061596|FG000|STARTED|Overall Study||163||
59943175|NCT02987205|76061596|FG000|Treated - Bilateral NLF Injection|Overall Study||163||
59943176|NCT02987205|76061596|FG000|COMPLETED|Overall Study|Treatment is bilateral, subject lost to Restylane AE was lost to further Revanesse Ultra treatment|159||
59943177|NCT02987205|76061596|FG000|NOT COMPLETED|Overall Study||4||
59943178|NCT04368364|76061605|FG000|STARTED|Overall Study||1||
59943179|NCT04368364|76061606|FG001|STARTED|Overall Study||1||
59943180|NCT04368364|76061607|FG002|STARTED|Overall Study||1||
59943181|NCT04368364|76061605|FG000|COMPLETED|Overall Study||1||
59943182|NCT04368364|76061606|FG001|COMPLETED|Overall Study||1||
59943183|NCT04368364|76061607|FG002|COMPLETED|Overall Study||1||
59943184|NCT04368364|76061605|FG000|NOT COMPLETED|Overall Study||0||
59943185|NCT04368364|76061606|FG001|NOT COMPLETED|Overall Study||0||
59943186|NCT04368364|76061607|FG002|NOT COMPLETED|Overall Study||0||
59943187|NCT02926937|76061618|FG000|STARTED|Overall Study||150||
59943188|NCT02926937|76061619|FG001|STARTED|Overall Study||142||
59943189|NCT02926937|76061620|FG002|STARTED|Overall Study||107||
59943190|NCT02926937|76061618|FG000|COMPLETED|Overall Study||131||
59943191|NCT02926937|76061619|FG001|COMPLETED|Overall Study||127||
59943192|NCT02926937|76061620|FG002|COMPLETED|Overall Study||96||
59943193|NCT02926937|76061618|FG000|NOT COMPLETED|Overall Study||19||
59943194|NCT02926937|76061619|FG001|NOT COMPLETED|Overall Study||15||
59943195|NCT02926937|76061620|FG002|NOT COMPLETED|Overall Study||11||
59943196|NCT00151892|76061631|FG000|STARTED|Overall Study||416||
59943197|NCT00151892|76061632|FG001|STARTED|Overall Study||413||
59943198|NCT00151892|76061631|FG000|COMPLETED|Overall Study||340||
59943199|NCT00151892|76061632|FG001|COMPLETED|Overall Study||330||
59943200|NCT00151892|76061631|FG000|NOT COMPLETED|Overall Study||76||
59943201|NCT00151892|76061632|FG001|NOT COMPLETED|Overall Study||83||
59943202|NCT02740127|76061640|FG000|STARTED|Overall Study||24||
59943203|NCT02740127|76061641|FG001|STARTED|Overall Study||28||
59943204|NCT02740127|76061640|FG000|COMPLETED|Overall Study||24||
59943205|NCT02740127|76061641|FG001|COMPLETED|Overall Study||28||
59943206|NCT02740127|76061640|FG000|NOT COMPLETED|Overall Study||0||
59943207|NCT02740127|76061641|FG001|NOT COMPLETED|Overall Study||0||
59943208|NCT00654992|76061649|FG000|STARTED|Overall Study||36||
59943209|NCT00654992|76061650|FG001|STARTED|Overall Study||35||
59518698|NCT00942305|75612511|FG007|NOT COMPLETED|Overall Study||5||
59943210|NCT00654992|76061649|FG000|COMPLETED|Overall Study||36||
59943211|NCT00654992|76061650|FG001|COMPLETED|Overall Study||35||
59943212|NCT00654992|76061649|FG000|NOT COMPLETED|Overall Study||0||
59943213|NCT00654992|76061650|FG001|NOT COMPLETED|Overall Study||0||
59943214|NCT03055195|76061656|FG000|STARTED|Overall Study||16||
59943215|NCT03055195|76061657|FG001|STARTED|Overall Study||18||
59943216|NCT03055195|76061656|FG000|COMPLETED|Overall Study||4||
59943217|NCT03055195|76061657|FG001|COMPLETED|Overall Study||4||
59943218|NCT03055195|76061656|FG000|NOT COMPLETED|Overall Study||12||
59518699|NCT00942305|75612512|FG008|NOT COMPLETED|Overall Study||25||
59518700|NCT00942305|75612513|FG009|NOT COMPLETED|Overall Study||10||
59518701|NCT01084759|75612535|FG000|STARTED|Overall Study||16||
59518702|NCT01084759|75612535|FG000|COMPLETED|Overall Study||14||
59518703|NCT01084759|75612535|FG000|NOT COMPLETED|Overall Study||2||
59943219|NCT03055195|76061657|FG001|NOT COMPLETED|Overall Study||14||
59943220|NCT02921919|76061665|FG000|STARTED|Overall Study||66||
59943221|NCT02921919|76061666|FG001|STARTED|Overall Study||52||
59943222|NCT02921919|76061665|FG000|Treated|Overall Study||66||
59943223|NCT02921919|76061666|FG001|Treated|Overall Study||52||
59943224|NCT02921919|76061665|FG000|COMPLETED|Overall Study||0||
59943225|NCT02921919|76061666|FG001|COMPLETED|Overall Study||0||
59943226|NCT02921919|76061665|FG000|NOT COMPLETED|Overall Study||66||
59943227|NCT02921919|76061666|FG001|NOT COMPLETED|Overall Study||52||
59943228|NCT02737553|76061674|FG000|STARTED|Overall Study||49||
59943229|NCT02737553|76061675|FG001|STARTED|Overall Study||48||
59943230|NCT02737553|76061674|FG000|COMPLETED|Overall Study||49||
59943231|NCT02737553|76061675|FG001|COMPLETED|Overall Study||48||
59943232|NCT02737553|76061674|FG000|NOT COMPLETED|Overall Study||0||
59943233|NCT02737553|76061675|FG001|NOT COMPLETED|Overall Study||0||
59943234|NCT00393068|76061682|FG000|STARTED|Overall Study||62||
59943235|NCT00393068|76061682|FG000|COMPLETED|Overall Study||44||
59943236|NCT00393068|76061682|FG000|NOT COMPLETED|Overall Study||18||
59943237|NCT02910219|76061688|FG000|STARTED|Overall Study||27||
59943238|NCT02910219|76061689|FG001|STARTED|Overall Study||26||
59943239|NCT02910219|76061688|FG000|COMPLETED|Overall Study||26||
59943240|NCT02910219|76061689|FG001|COMPLETED|Overall Study||25||
59943241|NCT02910219|76061688|FG000|NOT COMPLETED|Overall Study||1||
59943242|NCT02910219|76061689|FG001|NOT COMPLETED|Overall Study||1||
59943243|NCT01068717|76061695|FG000|STARTED|Period 1: Treatment Schedule Phase 1||7||
59943244|NCT01068717|76061696|FG001|STARTED|Period 1: Treatment Schedule Phase 1||6||
59943245|NCT01068717|76061697|FG002|STARTED|Period 1: Treatment Schedule Phase 1||7||
59943246|NCT01068717|76061698|FG003|STARTED|Period 1: Treatment Schedule Phase 1||7||
59943247|NCT01068717|76061695|FG000|COMPLETED|Period 1: Treatment Schedule Phase 1|Patient who withdrew returned for Treatment Periods 3 and 4.|6||
59943248|NCT01068717|76061696|FG001|COMPLETED|Period 1: Treatment Schedule Phase 1||6||
59943249|NCT01068717|76061697|FG002|COMPLETED|Period 1: Treatment Schedule Phase 1||7||
59943250|NCT01068717|76061698|FG003|COMPLETED|Period 1: Treatment Schedule Phase 1||7||
59762143|NCT02226367|75881842|FG001|NOT COMPLETED|Overall Study||7||
59762144|NCT03885934|75881854|FG000|STARTED|Overall Study||64||
59762145|NCT03885934|75881855|FG001|STARTED|Overall Study||64||
59762146|NCT03885934|75881856|FG002|STARTED|Overall Study||62||
59762147|NCT03885934|75881857|FG003|STARTED|Overall Study||64||
59762148|NCT03885934|75881858|FG004|STARTED|Overall Study||177||
59762149|NCT03885934|75881859|FG005|STARTED|Overall Study||175||
59762150|NCT03885934|75881854|FG000|PCV Dose 1|Overall Study||64||
59943251|NCT01068717|76061695|FG000|NOT COMPLETED|Period 1: Treatment Schedule Phase 1||1||
59943252|NCT01068717|76061696|FG001|NOT COMPLETED|Period 1: Treatment Schedule Phase 1||0||
59943253|NCT01068717|76061697|FG002|NOT COMPLETED|Period 1: Treatment Schedule Phase 1||0||
59943254|NCT01068717|76061698|FG003|NOT COMPLETED|Period 1: Treatment Schedule Phase 1||0||
59943255|NCT01068717|76061695|FG000|STARTED|Period 2: Treatment Schedule Phase 2||6||
59943256|NCT01068717|76061696|FG001|STARTED|Period 2: Treatment Schedule Phase 2||6||
59518704|NCT01110187|75612541|FG000|STARTED|Overall Study||7||
59518705|NCT01110187|75612542|FG001|STARTED|Overall Study||4||
59762151|NCT03885934|75881855|FG001|PCV Dose 1|Overall Study||64||
59762152|NCT03885934|75881856|FG002|PCV Dose 1|Overall Study||62||
59762153|NCT03885934|75881857|FG003|PCV Dose 1|Overall Study||64||
59762154|NCT03885934|75881858|FG004|PCV Dose 1|Overall Study||177||
59518706|NCT01110187|75612541|FG000|COMPLETED|Overall Study|completed 7 day treatment|7||
59518707|NCT01110187|75612542|FG001|COMPLETED|Overall Study|completed 7 day treatment|4||
59518708|NCT01110187|75612541|FG000|NOT COMPLETED|Overall Study||0||
59762155|NCT03885934|75881859|FG005|PCV Dose 1|Overall Study||175||
59762156|NCT03885934|75881854|FG000|PCV Dose 2|Overall Study||63||
59762157|NCT03885934|75881855|FG001|PCV Dose 2|Overall Study||64||
59762158|NCT03885934|75881856|FG002|PCV Dose 2|Overall Study||62||
59762159|NCT03885934|75881857|FG003|PCV Dose 2|Overall Study||64||
59943257|NCT01068717|76061697|FG002|STARTED|Period 2: Treatment Schedule Phase 2||7||
59943258|NCT01068717|76061698|FG003|STARTED|Period 2: Treatment Schedule Phase 2||7||
59943259|NCT01068717|76061695|FG000|COMPLETED|Period 2: Treatment Schedule Phase 2||6||
59943260|NCT01068717|76061696|FG001|COMPLETED|Period 2: Treatment Schedule Phase 2||6||
59943261|NCT01068717|76061697|FG002|COMPLETED|Period 2: Treatment Schedule Phase 2||7||
59943262|NCT01068717|76061698|FG003|COMPLETED|Period 2: Treatment Schedule Phase 2||7||
59943263|NCT01068717|76061695|FG000|NOT COMPLETED|Period 2: Treatment Schedule Phase 2||0||
59943264|NCT01068717|76061696|FG001|NOT COMPLETED|Period 2: Treatment Schedule Phase 2||0||
59943265|NCT01068717|76061697|FG002|NOT COMPLETED|Period 2: Treatment Schedule Phase 2||0||
59943266|NCT01068717|76061698|FG003|NOT COMPLETED|Period 2: Treatment Schedule Phase 2||0||
59943267|NCT01068717|76061695|FG000|STARTED|Period 3: Treatment Schedule Phase 3|Patient who withdrew during Treatment Period 1 returned for Treatment Periods 3 and 4.|7||
59943268|NCT01068717|76061696|FG001|STARTED|Period 3: Treatment Schedule Phase 3||6||
59943269|NCT01068717|76061697|FG002|STARTED|Period 3: Treatment Schedule Phase 3||7||
59943270|NCT01068717|76061698|FG003|STARTED|Period 3: Treatment Schedule Phase 3||7||
59943271|NCT01068717|76061695|FG000|COMPLETED|Period 3: Treatment Schedule Phase 3||7||
59943272|NCT01068717|76061696|FG001|COMPLETED|Period 3: Treatment Schedule Phase 3||6||
59943273|NCT01068717|76061697|FG002|COMPLETED|Period 3: Treatment Schedule Phase 3||7||
59943274|NCT01068717|76061698|FG003|COMPLETED|Period 3: Treatment Schedule Phase 3||7||
59943275|NCT01068717|76061695|FG000|NOT COMPLETED|Period 3: Treatment Schedule Phase 3||0||
59943276|NCT01068717|76061696|FG001|NOT COMPLETED|Period 3: Treatment Schedule Phase 3||0||
59943277|NCT01068717|76061697|FG002|NOT COMPLETED|Period 3: Treatment Schedule Phase 3||0||
59943278|NCT01068717|76061698|FG003|NOT COMPLETED|Period 3: Treatment Schedule Phase 3||0||
59943279|NCT01068717|76061695|FG000|STARTED|Period 4: Treatment Schedule Phase 4|Patient who withdrew during Treatment Period 1 returned for Treatment Periods 3 and 4.|7||
59943280|NCT01068717|76061696|FG001|STARTED|Period 4: Treatment Schedule Phase 4||6||
59943281|NCT01068717|76061697|FG002|STARTED|Period 4: Treatment Schedule Phase 4||7||
59943282|NCT01068717|76061698|FG003|STARTED|Period 4: Treatment Schedule Phase 4||7||
59943283|NCT01068717|76061695|FG000|COMPLETED|Period 4: Treatment Schedule Phase 4||7||
59943284|NCT01068717|76061696|FG001|COMPLETED|Period 4: Treatment Schedule Phase 4||6||
59943285|NCT01068717|76061697|FG002|COMPLETED|Period 4: Treatment Schedule Phase 4||7||
59943286|NCT01068717|76061698|FG003|COMPLETED|Period 4: Treatment Schedule Phase 4||7||
59943287|NCT01068717|76061695|FG000|NOT COMPLETED|Period 4: Treatment Schedule Phase 4||0||
59943288|NCT01068717|76061696|FG001|NOT COMPLETED|Period 4: Treatment Schedule Phase 4||0||
59943289|NCT01068717|76061697|FG002|NOT COMPLETED|Period 4: Treatment Schedule Phase 4||0||
59943290|NCT01068717|76061698|FG003|NOT COMPLETED|Period 4: Treatment Schedule Phase 4||0||
59943291|NCT02921763|76061712|FG000|STARTED|Overall Study||60||
59943292|NCT02921763|76061712|FG000|COMPLETED|Overall Study||42||
59943293|NCT02921763|76061712|FG000|NOT COMPLETED|Overall Study||18||
59943294|NCT01318135|76061734|FG000|STARTED|Enrolled - Long-Term Extension Study||99||
59943295|NCT01318135|76061735|FG001|STARTED|Enrolled - Long-Term Extension Study||102||
59943296|NCT01318135|76061736|FG002|STARTED|Enrolled - Long-Term Extension Study||46||
59943297|NCT01318135|76061737|FG003|STARTED|Enrolled - Long-Term Extension Study||49||
59943298|NCT01318135|76061738|FG004|STARTED|Enrolled - Long-Term Extension Study||91||
59943299|NCT01318135|76061739|FG005|STARTED|Enrolled - Long-Term Extension Study||90||
59943300|NCT01318135|76061740|FG006|STARTED|Enrolled - Long-Term Extension Study||50||
59943301|NCT01318135|76061741|FG007|STARTED|Enrolled - Long-Term Extension Study||49||
59943302|NCT01318135|76061734|FG000|COMPLETED|Enrolled - Long-Term Extension Study||97||
59943303|NCT01318135|76061735|FG001|COMPLETED|Enrolled - Long-Term Extension Study||102||
59943304|NCT01318135|76061736|FG002|COMPLETED|Enrolled - Long-Term Extension Study||46||
59943305|NCT01318135|76061737|FG003|COMPLETED|Enrolled - Long-Term Extension Study||49||
59943306|NCT01318135|76061738|FG004|COMPLETED|Enrolled - Long-Term Extension Study||91||
59943307|NCT01318135|76061739|FG005|COMPLETED|Enrolled - Long-Term Extension Study||90||
59943308|NCT01318135|76061740|FG006|COMPLETED|Enrolled - Long-Term Extension Study||50||
59943309|NCT01318135|76061741|FG007|COMPLETED|Enrolled - Long-Term Extension Study||49||
59943310|NCT01318135|76061734|FG000|NOT COMPLETED|Enrolled - Long-Term Extension Study||2||
59943311|NCT01318135|76061735|FG001|NOT COMPLETED|Enrolled - Long-Term Extension Study||0||
59943312|NCT01318135|76061736|FG002|NOT COMPLETED|Enrolled - Long-Term Extension Study||0||
59943313|NCT01318135|76061737|FG003|NOT COMPLETED|Enrolled - Long-Term Extension Study||0||
59943314|NCT01318135|76061738|FG004|NOT COMPLETED|Enrolled - Long-Term Extension Study||0||
59943315|NCT01318135|76061739|FG005|NOT COMPLETED|Enrolled - Long-Term Extension Study||0||
59943316|NCT01318135|76061740|FG006|NOT COMPLETED|Enrolled - Long-Term Extension Study||0||
59943317|NCT01318135|76061741|FG007|NOT COMPLETED|Enrolled - Long-Term Extension Study||0||
59943318|NCT01318135|76061734|FG000|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-005 but not entered OCT-005 are excluded in Participant Flow.|97||
59943319|NCT01318135|76061735|FG001|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-005 but not entered OCT-005 are excluded in Participant Flow.|102||
59943320|NCT01318135|76061736|FG002|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-005 but not entered OCT-005 are excluded in Participant Flow.|46||
59943321|NCT01318135|76061737|FG003|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-005 but not entered OCT-005 are excluded in Participant Flow.|49||
59943322|NCT01318135|76061738|FG004|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-006 but not entered OCT-005 are excluded in Participant Flow.|90||
59943323|NCT01318135|76061739|FG005|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-006 but not entered OCT-005 are excluded in Participant Flow.|87||
59943324|NCT01318135|76061740|FG006|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-006 but not entered OCT-005 are excluded in Participant Flow.|50||
59943325|NCT01318135|76061741|FG007|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-006 but not entered OCT-005 are excluded in Participant Flow.|49||
59943326|NCT01318135|76061734|FG000|COMPLETED|Entered - Long-Term Extension Study|296 participants enrolled and 294 completed glimepiride add-on study and entered the present study.|80||
59943327|NCT01318135|76061735|FG001|COMPLETED|Entered - Long-Term Extension Study|296 participants enrolled and 294 completed glimepiride add-on study and entered the present study.|89||
59943328|NCT01318135|76061736|FG002|COMPLETED|Entered - Long-Term Extension Study|296 participants enrolled and 294 completed glimepiride add-on study and entered the present study.|38||
59943329|NCT01318135|76061737|FG003|COMPLETED|Entered - Long-Term Extension Study|296 participants enrolled and 294 completed glimepiride add-on study and entered the present study.|42||
59943330|NCT01318135|76061738|FG004|COMPLETED|Entered - Long-Term Extension Study|280 participants enrolled and 276 completed metformin add-on study and entered the present study.|81||
59943331|NCT01318135|76061739|FG005|COMPLETED|Entered - Long-Term Extension Study|280 participants enrolled and 276 completed metformin add-on study and entered the present study.|83||
59943332|NCT01318135|76061740|FG006|COMPLETED|Entered - Long-Term Extension Study|280 participants enrolled and 276 completed metformin add-on study and entered the present study.|49||
59943333|NCT01318135|76061741|FG007|COMPLETED|Entered - Long-Term Extension Study|280 participants enrolled and 276 completed metformin add-on study and entered the present study.|46||
59943334|NCT01318135|76061734|FG000|NOT COMPLETED|Entered - Long-Term Extension Study||17||
59943335|NCT01318135|76061735|FG001|NOT COMPLETED|Entered - Long-Term Extension Study||13||
59943336|NCT01318135|76061736|FG002|NOT COMPLETED|Entered - Long-Term Extension Study||8||
59943337|NCT01318135|76061737|FG003|NOT COMPLETED|Entered - Long-Term Extension Study||7||
59943338|NCT01318135|76061738|FG004|NOT COMPLETED|Entered - Long-Term Extension Study||9||
59943339|NCT01318135|76061739|FG005|NOT COMPLETED|Entered - Long-Term Extension Study||4||
59943340|NCT01318135|76061740|FG006|NOT COMPLETED|Entered - Long-Term Extension Study||1||
59943341|NCT01318135|76061741|FG007|NOT COMPLETED|Entered - Long-Term Extension Study||3||
59943342|NCT02922153|76061753|FG000|STARTED|Overall Study||65||
59943343|NCT02922153|76061754|FG001|STARTED|Overall Study||19||
59943344|NCT02922153|76061753|FG000|COMPLETED|Overall Study||55||
59943345|NCT02922153|76061754|FG001|COMPLETED|Overall Study||17||
59943346|NCT02922153|76061753|FG000|NOT COMPLETED|Overall Study||10||
59943347|NCT02922153|76061754|FG001|NOT COMPLETED|Overall Study||2||
59943348|NCT02920983|76061760|FG000|STARTED|Dispense 1||8||
59943349|NCT02920983|76061761|FG001|STARTED|Dispense 1||10||
59943350|NCT02920983|76061762|FG002|STARTED|Dispense 1||7||
59943351|NCT02920983|76061763|FG003|STARTED|Dispense 1||6||
59943352|NCT02920983|76061764|FG004|STARTED|Dispense 1||13||
59943353|NCT02920983|76061765|FG005|STARTED|Dispense 1||7||
59943354|NCT02920983|76061760|FG000|COMPLETED|Dispense 1||8||
59943355|NCT02920983|76061761|FG001|COMPLETED|Dispense 1||10||
59943356|NCT02920983|76061762|FG002|COMPLETED|Dispense 1||7||
59943357|NCT02920983|76061763|FG003|COMPLETED|Dispense 1||6||
59943358|NCT02920983|76061764|FG004|COMPLETED|Dispense 1||12||
59943359|NCT02920983|76061765|FG005|COMPLETED|Dispense 1||7||
59943360|NCT02920983|76061760|FG000|NOT COMPLETED|Dispense 1||0||
59943361|NCT02920983|76061761|FG001|NOT COMPLETED|Dispense 1||0||
59943362|NCT02920983|76061762|FG002|NOT COMPLETED|Dispense 1||0||
59943363|NCT02920983|76061763|FG003|NOT COMPLETED|Dispense 1||0||
59943364|NCT02920983|76061764|FG004|NOT COMPLETED|Dispense 1||1||
59943365|NCT02920983|76061765|FG005|NOT COMPLETED|Dispense 1||0||
59943366|NCT02920983|76061760|FG000|STARTED|Dispense 2||8||
59943367|NCT02920983|76061761|FG001|STARTED|Dispense 2||10||
59943368|NCT02920983|76061762|FG002|STARTED|Dispense 2||7||
59943369|NCT02920983|76061763|FG003|STARTED|Dispense 2||6||
59943370|NCT02920983|76061764|FG004|STARTED|Dispense 2||13||
59943371|NCT02920983|76061765|FG005|STARTED|Dispense 2||7||
59943372|NCT02920983|76061760|FG000|COMPLETED|Dispense 2||7||
59943373|NCT02920983|76061761|FG001|COMPLETED|Dispense 2||10||
59943374|NCT02920983|76061762|FG002|COMPLETED|Dispense 2||7||
59943375|NCT02920983|76061763|FG003|COMPLETED|Dispense 2||6||
59943376|NCT02920983|76061764|FG004|COMPLETED|Dispense 2||12||
59943377|NCT02920983|76061765|FG005|COMPLETED|Dispense 2||7||
59943378|NCT02920983|76061760|FG000|NOT COMPLETED|Dispense 2||1||
59943379|NCT02920983|76061761|FG001|NOT COMPLETED|Dispense 2||0||
59943380|NCT02920983|76061762|FG002|NOT COMPLETED|Dispense 2||0||
59943381|NCT02920983|76061763|FG003|NOT COMPLETED|Dispense 2||0||
59943382|NCT02920983|76061764|FG004|NOT COMPLETED|Dispense 2||1||
59943383|NCT02920983|76061765|FG005|NOT COMPLETED|Dispense 2||0||
59943384|NCT02920983|76061760|FG000|STARTED|Dispense 3||8||
59943385|NCT02920983|76061761|FG001|STARTED|Dispense 3||10||
59943386|NCT02920983|76061762|FG002|STARTED|Dispense 3||7||
59943387|NCT02920983|76061763|FG003|STARTED|Dispense 3||6||
59943388|NCT02920983|76061764|FG004|STARTED|Dispense 3||13||
59943389|NCT02920983|76061765|FG005|STARTED|Dispense 3||7||
59943390|NCT02920983|76061760|FG000|COMPLETED|Dispense 3||7||
59943391|NCT02920983|76061761|FG001|COMPLETED|Dispense 3||9||
59943392|NCT02920983|76061762|FG002|COMPLETED|Dispense 3||7||
59943393|NCT02920983|76061763|FG003|COMPLETED|Dispense 3||6||
59943394|NCT02920983|76061764|FG004|COMPLETED|Dispense 3||12||
59943395|NCT02920983|76061765|FG005|COMPLETED|Dispense 3||7||
59943396|NCT02920983|76061760|FG000|NOT COMPLETED|Dispense 3||1||
59943397|NCT02920983|76061761|FG001|NOT COMPLETED|Dispense 3||1||
59943398|NCT02920983|76061762|FG002|NOT COMPLETED|Dispense 3||0||
59943399|NCT02920983|76061763|FG003|NOT COMPLETED|Dispense 3||0||
59943400|NCT02920983|76061764|FG004|NOT COMPLETED|Dispense 3||1||
59943401|NCT02920983|76061765|FG005|NOT COMPLETED|Dispense 3||0||
59943402|NCT02654002|76061782|FG000|STARTED|Overall Study||12||
59943403|NCT02654002|76061783|FG001|STARTED|Overall Study||12||
59943404|NCT02654002|76061784|FG002|STARTED|Overall Study||12||
59943405|NCT02654002|76061785|FG003|STARTED|Overall Study||12||
59943406|NCT02654002|76061786|FG004|STARTED|Overall Study||12||
59943407|NCT02654002|76061787|FG005|STARTED|Overall Study||12||
59943408|NCT02654002|76061788|FG006|STARTED|Overall Study||12||
59943409|NCT02654002|76061789|FG007|STARTED|Overall Study||12||
59943410|NCT02654002|76061790|FG008|STARTED|Overall Study||24||
59943411|NCT02654002|76061782|FG000|COMPLETED|Overall Study||12||
59943412|NCT02654002|76061783|FG001|COMPLETED|Overall Study||12||
59943413|NCT02654002|76061784|FG002|COMPLETED|Overall Study||12||
59943414|NCT02654002|76061785|FG003|COMPLETED|Overall Study||12||
59943415|NCT02654002|76061786|FG004|COMPLETED|Overall Study||12||
59943416|NCT02654002|76061787|FG005|COMPLETED|Overall Study||11||
59943417|NCT02654002|76061788|FG006|COMPLETED|Overall Study||11||
59943418|NCT02654002|76061789|FG007|COMPLETED|Overall Study||11||
59943419|NCT02654002|76061790|FG008|COMPLETED|Overall Study||24||
59943420|NCT02654002|76061782|FG000|NOT COMPLETED|Overall Study||0||
59943421|NCT02654002|76061783|FG001|NOT COMPLETED|Overall Study||0||
59943422|NCT02654002|76061784|FG002|NOT COMPLETED|Overall Study||0||
59943423|NCT02654002|76061785|FG003|NOT COMPLETED|Overall Study||0||
59943424|NCT02654002|76061786|FG004|NOT COMPLETED|Overall Study||0||
59943425|NCT02654002|76061787|FG005|NOT COMPLETED|Overall Study||1||
59943426|NCT02654002|76061788|FG006|NOT COMPLETED|Overall Study||1||
59943427|NCT02654002|76061789|FG007|NOT COMPLETED|Overall Study||1||
59943428|NCT02654002|76061790|FG008|NOT COMPLETED|Overall Study||0||
59943429|NCT01675492|76061825|FG000|STARTED|Overall Study||84|Number of patients and eyes (units) treated|149
59943430|NCT01675492|76061825|FG000|COMPLETED|Overall Study||42|# subjects and eyes completed 24M visit. 149 eyes of 84 subjects completed 3M visit - approval basis|75
59943431|NCT01675492|76061825|FG000|NOT COMPLETED|Overall Study||42||74
59943432|NCT03924622|76061836|FG000|STARTED|Overall Study||12||
59943433|NCT03924622|76061837|FG001|STARTED|Overall Study||12||
59943434|NCT03924622|76061838|FG002|STARTED|Overall Study||12||
59943435|NCT03924622|76061839|FG003|STARTED|Overall Study||12||
59943436|NCT03924622|76061840|FG004|STARTED|Overall Study||12||
59943437|NCT03924622|76061841|FG005|STARTED|Overall Study||12||
59943438|NCT03924622|76061836|FG000|COMPLETED|Overall Study||10||
59943439|NCT03924622|76061837|FG001|COMPLETED|Overall Study||9||
59943440|NCT03924622|76061838|FG002|COMPLETED|Overall Study||9||
59943441|NCT03924622|76061839|FG003|COMPLETED|Overall Study||8||
59943442|NCT03924622|76061840|FG004|COMPLETED|Overall Study||9||
59943443|NCT03924622|76061841|FG005|COMPLETED|Overall Study||9||
59943444|NCT03924622|76061836|FG000|NOT COMPLETED|Overall Study||2||
59943445|NCT03924622|76061837|FG001|NOT COMPLETED|Overall Study||3||
59943446|NCT03924622|76061838|FG002|NOT COMPLETED|Overall Study||3||
59943447|NCT03924622|76061839|FG003|NOT COMPLETED|Overall Study||4||
59943448|NCT03924622|76061840|FG004|NOT COMPLETED|Overall Study||3||
59943449|NCT03924622|76061841|FG005|NOT COMPLETED|Overall Study||3||
59943450|NCT04044664|76061858|FG000|STARTED|Stage 1||103||
59943451|NCT04044664|76061859|FG001|STARTED|Stage 1||26||
59943452|NCT04044664|76061860|FG002|STARTED|Stage 1||23||
59943453|NCT04044664|76061858|FG000|COMPLETED|Stage 1||86||
59943454|NCT04044664|76061859|FG001|COMPLETED|Stage 1||19||
59943455|NCT04044664|76061860|FG002|COMPLETED|Stage 1||20||
59943456|NCT04044664|76061858|FG000|NOT COMPLETED|Stage 1||17||
59943457|NCT04044664|76061859|FG001|NOT COMPLETED|Stage 1||7||
59943458|NCT04044664|76061860|FG002|NOT COMPLETED|Stage 1||3||
59943459|NCT04044664|76061858|FG000|STARTED|Stage 2||76||
59943460|NCT04044664|76061859|FG001|STARTED|Stage 2||26||
59943461|NCT04044664|76061860|FG002|STARTED|Stage 2||22||
59943462|NCT04044664|76061858|FG000|From Placebo, Responder|Stage 2||20||
59943463|NCT04044664|76061859|FG001|From Placebo, Responder|Stage 2||13||
59943464|NCT04044664|76061860|FG002|From Placebo, Responder|Stage 2||11||
59943465|NCT04044664|76061858|FG000|From Placebo, Non-Responder|Stage 2||18||
59943466|NCT04044664|76061859|FG001|From Placebo, Non-Responder|Stage 2||13||
59943467|NCT04044664|76061860|FG002|From Placebo, Non-Responder|Stage 2||11||
59943468|NCT04044664|76061858|FG000|From NYX-783 (10 mg or 50 mg)|Stage 2||38||
59943469|NCT04044664|76061859|FG001|From NYX-783 (10 mg or 50 mg)|Stage 2||0||
59943470|NCT04044664|76061860|FG002|From NYX-783 (10 mg or 50 mg)|Stage 2||0||
59943471|NCT04044664|76061858|FG000|COMPLETED|Stage 2||67||
59943472|NCT04044664|76061859|FG001|COMPLETED|Stage 2||24||
59943473|NCT04044664|76061860|FG002|COMPLETED|Stage 2||21||
59943474|NCT04044664|76061858|FG000|NOT COMPLETED|Stage 2||9||
59943475|NCT04044664|76061859|FG001|NOT COMPLETED|Stage 2||2||
59943476|NCT04044664|76061860|FG002|NOT COMPLETED|Stage 2||1||
59943477|NCT00150176|76061870|FG000|STARTED|Overall Study|subjects who were screened and received at least one dose of double-blind trial medication|194||
59943478|NCT00150176|76061871|FG001|STARTED|Overall Study|subjects who were screened and received at least one dose of double-blind trial medication|192||
59943479|NCT00150176|76061870|FG000|COMPLETED|Overall Study||135||
59943480|NCT00150176|76061871|FG001|COMPLETED|Overall Study||72||
59943481|NCT00150176|76061870|FG000|NOT COMPLETED|Overall Study||59||
59943482|NCT00150176|76061871|FG001|NOT COMPLETED|Overall Study||120||
59943483|NCT02985879|76061881|FG000|STARTED|Overall Study||126||
59943484|NCT02985879|76061882|FG001|STARTED|Overall Study||127||
59943485|NCT02985879|76061883|FG002|STARTED|Overall Study||125||
59943486|NCT02985879|76061881|FG000|COMPLETED|Overall Study||50||
59943487|NCT02985879|76061882|FG001|COMPLETED|Overall Study||52||
59943488|NCT02985879|76061883|FG002|COMPLETED|Overall Study||48||
59943489|NCT02985879|76061881|FG000|NOT COMPLETED|Overall Study||76||
59943490|NCT02985879|76061882|FG001|NOT COMPLETED|Overall Study||75||
59943491|NCT02985879|76061883|FG002|NOT COMPLETED|Overall Study||77||
59943492|NCT01067469|76061899|FG000|STARTED|Overall Study||36||
59943493|NCT01067469|76061900|FG001|STARTED|Overall Study||35||
59762160|NCT03885934|75881858|FG004|PCV Dose 2|Overall Study||0||
59762161|NCT03885934|75881859|FG005|PCV Dose 2|Overall Study||0||
59762162|NCT03885934|75881854|FG000|PCV Dose 3|Overall Study||63||
59762163|NCT03885934|75881855|FG001|PCV Dose 3|Overall Study||64||
59762164|NCT03885934|75881856|FG002|PCV Dose 3|Overall Study||0||
59762165|NCT03885934|75881857|FG003|PCV Dose 3|Overall Study||0||
59762166|NCT03885934|75881858|FG004|PCV Dose 3|Overall Study||0||
59762167|NCT03885934|75881859|FG005|PCV Dose 3|Overall Study||0||
59762168|NCT03885934|75881854|FG000|COMPLETED|Overall Study||63||
59762169|NCT03885934|75881855|FG001|COMPLETED|Overall Study||64||
59943494|NCT01067469|76061899|FG000|90 mg/m^2|Overall Study||0||
59943495|NCT01067469|76061900|FG001|90 mg/m^2|Overall Study||12||
59943496|NCT01067469|76061899|FG000|75 mg/m^2|Overall Study||0||
59943497|NCT01067469|76061900|FG001|75 mg/m^2|Overall Study||21||
59943498|NCT01067469|76061899|FG000|COMPLETED|Overall Study||36||
59943499|NCT01067469|76061900|FG001|COMPLETED|Overall Study||33||
59762170|NCT03885934|75881856|FG002|COMPLETED|Overall Study||62||
59762171|NCT03885934|75881857|FG003|COMPLETED|Overall Study||64||
59762172|NCT03885934|75881858|FG004|COMPLETED|Overall Study||177||
59762173|NCT03885934|75881859|FG005|COMPLETED|Overall Study||175||
59762174|NCT03885934|75881854|FG000|NOT COMPLETED|Overall Study||1||
59762175|NCT03885934|75881855|FG001|NOT COMPLETED|Overall Study||0||
59943500|NCT01067469|76061899|FG000|NOT COMPLETED|Overall Study||0||
59943501|NCT01067469|76061900|FG001|NOT COMPLETED|Overall Study||2||
59943502|NCT02985021|76061906|FG000|STARTED|Overall Study||2||
59762176|NCT03885934|75881856|FG002|NOT COMPLETED|Overall Study||0||
59762177|NCT03885934|75881857|FG003|NOT COMPLETED|Overall Study||0||
60067506|NCT01915849|76182699|FG000|STARTED|Treatment Period 3 (4 Days)||3||
60067507|NCT01915849|76182700|FG001|STARTED|Treatment Period 3 (4 Days)||3||
59943503|NCT02985021|76061906|FG000|COMPLETED|Overall Study||1|Achievement of complete response or 10 cycles of therapy. Patient achieved complete response. One patient did not complete therapy due to inability to comply with study procedures|
59943504|NCT02985021|76061906|FG000|NOT COMPLETED|Overall Study||1||
59943505|NCT01066923|76061914|FG000|STARTED|Overall Study||28||
59943506|NCT01066923|76061915|FG001|STARTED|Overall Study||32||
59943507|NCT01066923|76061916|FG002|STARTED|Overall Study||33||
59943508|NCT01066923|76061917|FG003|STARTED|Overall Study||31||
59943509|NCT01066923|76061914|FG000|Platelet Closure Time|Overall Study||25||
59943510|NCT01066923|76061915|FG001|Platelet Closure Time|Overall Study||29||
59943511|NCT01066923|76061916|FG002|Platelet Closure Time|Overall Study||25||
59943512|NCT01066923|76061917|FG003|Platelet Closure Time|Overall Study||23||
59943513|NCT01066923|76061914|FG000|Vascular Function|Overall Study||13||
59943514|NCT01066923|76061915|FG001|Vascular Function|Overall Study||14||
59943515|NCT01066923|76061916|FG002|Vascular Function|Overall Study||12||
59943516|NCT01066923|76061917|FG003|Vascular Function|Overall Study||13||
59943517|NCT01066923|76061914|FG000|Activation of Coagulation|Overall Study||0||
59943518|NCT01066923|76061915|FG001|Activation of Coagulation|Overall Study||0||
59943519|NCT01066923|76061916|FG002|Activation of Coagulation|Overall Study||0||
59943520|NCT01066923|76061917|FG003|Activation of Coagulation|Overall Study||0||
59943521|NCT01066923|76061914|FG000|Retinal Imaging|Overall Study||0||
59943522|NCT01066923|76061915|FG001|Retinal Imaging|Overall Study||0||
59943523|NCT01066923|76061916|FG002|Retinal Imaging|Overall Study||0||
59943524|NCT01066923|76061917|FG003|Retinal Imaging|Overall Study||0||
59943525|NCT01066923|76061914|FG000|COMPLETED|Overall Study||25||
59943526|NCT01066923|76061915|FG001|COMPLETED|Overall Study||29||
59943527|NCT01066923|76061916|FG002|COMPLETED|Overall Study||25||
59943528|NCT01066923|76061917|FG003|COMPLETED|Overall Study||23||
59943529|NCT01066923|76061914|FG000|NOT COMPLETED|Overall Study||3||
60067508|NCT01915849|76182701|FG002|STARTED|Treatment Period 3 (4 Days)||3||
59518709|NCT01110187|75612542|FG001|NOT COMPLETED|Overall Study||0||
59518710|NCT01110421|75612552|FG000|STARTED|Overall Study||5||
59518711|NCT01110421|75612553|FG001|STARTED|Overall Study||2||
59943530|NCT01066923|76061915|FG001|NOT COMPLETED|Overall Study||3||
59943531|NCT01066923|76061916|FG002|NOT COMPLETED|Overall Study||8||
59943532|NCT01066923|76061917|FG003|NOT COMPLETED|Overall Study||8||
59943533|NCT04216264|76061929|FG000|STARTED|Overall Study||7||
59943534|NCT04216264|76061930|FG001|STARTED|Overall Study||7||
59943535|NCT04216264|76061931|FG002|STARTED|Overall Study||7||
59943536|NCT04216264|76061932|FG003|STARTED|Overall Study||7||
59943537|NCT04216264|76061929|FG000|COMPLETED|Overall Study||5||
59943538|NCT04216264|76061930|FG001|COMPLETED|Overall Study||5||
59943539|NCT04216264|76061931|FG002|COMPLETED|Overall Study||2||
59943540|NCT04216264|76061932|FG003|COMPLETED|Overall Study||2||
59943541|NCT04216264|76061929|FG000|NOT COMPLETED|Overall Study||2||
59943542|NCT04216264|76061930|FG001|NOT COMPLETED|Overall Study||2||
59943543|NCT04216264|76061931|FG002|NOT COMPLETED|Overall Study||5||
59943544|NCT04216264|76061932|FG003|NOT COMPLETED|Overall Study||5||
59943545|NCT02919267|76061942|FG000|STARTED|Overall Study||10||
59943546|NCT02919267|76061943|FG001|STARTED|Overall Study||12||
59943547|NCT02919267|76061944|FG002|STARTED|Overall Study||13||
59943548|NCT02919267|76061945|FG003|STARTED|Overall Study||14||
59943549|NCT02919267|76061942|FG000|COMPLETED|Overall Study||10||
59943550|NCT02919267|76061943|FG001|COMPLETED|Overall Study||9||
59943551|NCT02919267|76061944|FG002|COMPLETED|Overall Study||10||
59943552|NCT02919267|76061945|FG003|COMPLETED|Overall Study||10||
59943553|NCT02919267|76061942|FG000|NOT COMPLETED|Overall Study||0||
59943554|NCT02919267|76061943|FG001|NOT COMPLETED|Overall Study||3||
59943555|NCT02919267|76061944|FG002|NOT COMPLETED|Overall Study||3||
59943556|NCT02919267|76061945|FG003|NOT COMPLETED|Overall Study||4||
59943557|NCT01368900|76061955|FG000|STARTED|Overall Study||68||
59943558|NCT01368900|76061955|FG000|COMPLETED|Overall Study||61||
59943559|NCT01368900|76061955|FG000|NOT COMPLETED|Overall Study||7||
59943560|NCT02910063|76061961|FG000|STARTED|Phase 2||41||
59943561|NCT02910063|76061962|FG001|STARTED|Phase 2|Participants in this Phase 3 arm were not included in the Phase 2 period.|0||
59943562|NCT02910063|76061963|FG002|STARTED|Phase 2|Participants in this Phase 3 arm were not included in the Phase 2 period.|0||
59943563|NCT02910063|76061961|FG000|Started Cycle 1|Phase 2||41||
59519063|NCT01116895|75612923|FG001|NOT COMPLETED|Overall Study||7||
59943564|NCT02910063|76061962|FG001|Started Cycle 1|Phase 2||0||
59943565|NCT02910063|76061963|FG002|Started Cycle 1|Phase 2||0||
59943566|NCT02910063|76061961|FG000|Started Optional Cycle 2|Phase 2||4||
59943567|NCT02910063|76061962|FG001|Started Optional Cycle 2|Phase 2||0||
60067509|NCT01915849|76182702|FG003|STARTED|Treatment Period 3 (4 Days)||3||
59943568|NCT02910063|76061963|FG002|Started Optional Cycle 2|Phase 2||0||
59943569|NCT02910063|76061961|FG000|COMPLETED|Phase 2||13||
59943570|NCT02910063|76061962|FG001|COMPLETED|Phase 2||0||
59943571|NCT02910063|76061963|FG002|COMPLETED|Phase 2||0||
59943572|NCT02910063|76061961|FG000|NOT COMPLETED|Phase 2||28||
59943573|NCT02910063|76061962|FG001|NOT COMPLETED|Phase 2||0||
59943574|NCT02910063|76061963|FG002|NOT COMPLETED|Phase 2||0||
59943575|NCT02910063|76061961|FG000|STARTED|Phase 3|Participants in this Phase 2 arm were not included in the Phase 3 period.|0||
59943576|NCT02910063|76061962|FG001|STARTED|Phase 3||0||
59943577|NCT02910063|76061963|FG002|STARTED|Phase 3||0||
59943578|NCT02910063|76061961|FG000|COMPLETED|Phase 3||0||
59943579|NCT02910063|76061962|FG001|COMPLETED|Phase 3||0||
59943580|NCT02910063|76061963|FG002|COMPLETED|Phase 3||0||
59943581|NCT02910063|76061961|FG000|NOT COMPLETED|Phase 3||0||
59943582|NCT02910063|76061962|FG001|NOT COMPLETED|Phase 3||0||
59943583|NCT02910063|76061963|FG002|NOT COMPLETED|Phase 3||0||
59943584|NCT02909907|76061974|FG000|STARTED|Overall Study||10||
59943585|NCT02909907|76061975|FG001|STARTED|Overall Study||10||
59943586|NCT02909907|76061974|FG000|COMPLETED|Overall Study||10||
59943587|NCT02909907|76061975|FG001|COMPLETED|Overall Study||9||
59943588|NCT02909907|76061974|FG000|NOT COMPLETED|Overall Study||0||
59943589|NCT02909907|76061975|FG001|NOT COMPLETED|Overall Study||1||
59943590|NCT02651194|76061981|FG000|STARTED|Overall Study||104||
59943591|NCT02651194|76061981|FG000|COMPLETED|Overall Study||99||
59943592|NCT02651194|76061981|FG000|NOT COMPLETED|Overall Study||5||
59943593|NCT02907177|76061987|FG000|STARTED|Overall Study||68||
59943594|NCT02907177|76061988|FG001|STARTED|Overall Study||68||
59943595|NCT02907177|76061987|FG000|Treated|Overall Study||67||
59943596|NCT02907177|76061988|FG001|Treated|Overall Study||68||
59943597|NCT02907177|76061987|FG000|Randomized Analysis Set|Overall Study||68||
59943598|NCT02907177|76061988|FG001|Randomized Analysis Set|Overall Study||68||
59943599|NCT02907177|76061987|FG000|COMPLETED|Overall Study||0||
59943600|NCT02907177|76061988|FG001|COMPLETED|Overall Study||0||
59943601|NCT02907177|76061987|FG000|NOT COMPLETED|Overall Study||68||
59943602|NCT02907177|76061988|FG001|NOT COMPLETED|Overall Study||68||
59943603|NCT02652442|76061994|FG000|STARTED|Centrifugation - Distance||6||
59943604|NCT02652442|76061994|FG000|COMPLETED|Centrifugation - Distance||5||
59943605|NCT02652442|76061994|FG000|NOT COMPLETED|Centrifugation - Distance||1||
59943606|NCT02652442|76061994|FG000|STARTED|Centrifugation - Duration||5||
59943607|NCT02652442|76061994|FG000|COMPLETED|Centrifugation - Duration||5||
59943608|NCT02652442|76061994|FG000|NOT COMPLETED|Centrifugation - Duration||0||
59943609|NCT02652442|76061994|FG000|STARTED|Centrifugation - Schedule||5||
59943610|NCT02652442|76061994|FG000|COMPLETED|Centrifugation - Schedule||5||
59943611|NCT02652442|76061994|FG000|NOT COMPLETED|Centrifugation - Schedule||0||
59943612|NCT02906709|76062008|FG000|STARTED|Phase A (Week 0 to Week 16)||123||
59943613|NCT02906709|76062009|FG001|STARTED|Phase A (Week 0 to Week 16)||61||
59943614|NCT02906709|76062008|FG000|COMPLETED|Phase A (Week 0 to Week 16)||122||
59943615|NCT02906709|76062009|FG001|COMPLETED|Phase A (Week 0 to Week 16)||58||
59943616|NCT02906709|76062008|FG000|NOT COMPLETED|Phase A (Week 0 to Week 16)||1||
59943617|NCT02906709|76062009|FG001|NOT COMPLETED|Phase A (Week 0 to Week 16)||3||
59943618|NCT02906709|76062008|FG000|STARTED|Phase B (Extension, Week 17 to Week 52)||122||
59943619|NCT02906709|76062009|FG001|STARTED|Phase B (Extension, Week 17 to Week 52)||58||
59943620|NCT02906709|76062008|FG000|COMPLETED|Phase B (Extension, Week 17 to Week 52)||117||
59943621|NCT02906709|76062009|FG001|COMPLETED|Phase B (Extension, Week 17 to Week 52)||58||
59943622|NCT02906709|76062008|FG000|NOT COMPLETED|Phase B (Extension, Week 17 to Week 52)||5||
59943623|NCT02906709|76062009|FG001|NOT COMPLETED|Phase B (Extension, Week 17 to Week 52)||0||
59943624|NCT00318656|76062023|FG000|STARTED|Overall Study||12||
59943625|NCT00318656|76062024|FG001|STARTED|Overall Study||11||
59943626|NCT00318656|76062023|FG000|COMPLETED|Overall Study||12||
59943627|NCT00318656|76062024|FG001|COMPLETED|Overall Study|1 patient received by error avandamet treatment and 1 patient did not receive any treatment.|9||
59943628|NCT00318656|76062023|FG000|NOT COMPLETED|Overall Study||0||
59943629|NCT00318656|76062024|FG001|NOT COMPLETED|Overall Study||2||
59943630|NCT02908347|76062030|FG000|STARTED|Overall Study||23||
59943631|NCT02908347|76062031|FG001|STARTED|Overall Study||23||
59943632|NCT02908347|76062030|FG000|COMPLETED|Overall Study||22||
59943633|NCT02908347|76062031|FG001|COMPLETED|Overall Study||22||
59943634|NCT02908347|76062030|FG000|NOT COMPLETED|Overall Study||1||
59943635|NCT02908347|76062031|FG001|NOT COMPLETED|Overall Study||1||
59943636|NCT02983305|76062053|FG000|STARTED|Overall Study||12||
59943637|NCT02983305|76062054|FG001|STARTED|Overall Study||10||
59943638|NCT02983305|76062053|FG000|COMPLETED|Overall Study||10|Participants were deemed to have not completed the study if they contributed incomplete data.|
59943639|NCT02983305|76062054|FG001|COMPLETED|Overall Study||10|Participants were deemed to have not completed the study if they contributed incomplete data.|
59943640|NCT02983305|76062053|FG000|NOT COMPLETED|Overall Study||2||
59943641|NCT02983305|76062054|FG001|NOT COMPLETED|Overall Study||0||
59943642|NCT03663166|76062060|FG000|STARTED|Overall Study||19||
59943643|NCT03663166|76062060|FG000|COMPLETED|Overall Study||18||
59943644|NCT03663166|76062060|FG000|NOT COMPLETED|Overall Study||1||
59943645|NCT02983227|76062067|FG000|STARTED|Overall Study||410||
59943646|NCT02983227|76062068|FG001|STARTED|Overall Study||86||
59943647|NCT02983227|76062067|FG000|COMPLETED|Overall Study||351||
59943648|NCT02983227|76062068|FG001|COMPLETED|Overall Study||72||
59943649|NCT02983227|76062067|FG000|NOT COMPLETED|Overall Study||59||
59943650|NCT02983227|76062068|FG001|NOT COMPLETED|Overall Study||14||
59943651|NCT00301262|76062076|FG000|STARTED|Double Blind Phase (DB)||94||
59943652|NCT00301262|76062077|FG001|STARTED|Double Blind Phase (DB)||82||
59943653|NCT00301262|76062076|FG000|COMPLETED|Double Blind Phase (DB)||84||
59943654|NCT00301262|76062077|FG001|COMPLETED|Double Blind Phase (DB)||69||
59943655|NCT00301262|76062076|FG000|NOT COMPLETED|Double Blind Phase (DB)||10||
59943656|NCT00301262|76062077|FG001|NOT COMPLETED|Double Blind Phase (DB)||13||
59943657|NCT00301262|76062076|FG000|STARTED|Open Label Phase (OL)||83||
59943658|NCT00301262|76062077|FG001|STARTED|Open Label Phase (OL)||69||
59943659|NCT00301262|76062076|FG000|COMPLETED|Open Label Phase (OL)||79||
59943660|NCT00301262|76062077|FG001|COMPLETED|Open Label Phase (OL)||67||
59943661|NCT00301262|76062076|FG000|NOT COMPLETED|Open Label Phase (OL)||4||
59943662|NCT00301262|76062077|FG001|NOT COMPLETED|Open Label Phase (OL)||2||
59762178|NCT03885934|75881858|FG004|NOT COMPLETED|Overall Study||0||
59762179|NCT03885934|75881859|FG005|NOT COMPLETED|Overall Study||0||
59762180|NCT04417894|75881875|FG000|STARTED|Overall Study||66||
59762181|NCT04417894|75881876|FG001|STARTED|Overall Study||67||
59762182|NCT04417894|75881875|FG000|COMPLETED|Overall Study||53||
59762183|NCT04417894|75881876|FG001|COMPLETED|Overall Study||60||
59943663|NCT02905149|76062104|FG000|STARTED|Overall Study||30||
59943664|NCT02905149|76062105|FG001|STARTED|Overall Study||30||
59943665|NCT02905149|76062104|FG000|COMPLETED|Overall Study||28||
59943666|NCT02905149|76062105|FG001|COMPLETED|Overall Study||30||
59943667|NCT02905149|76062104|FG000|NOT COMPLETED|Overall Study||2||
59943668|NCT02905149|76062105|FG001|NOT COMPLETED|Overall Study||0||
59943669|NCT02790606|76062111|FG000|STARTED|Overall Study||110||
59943670|NCT02790606|76062111|FG000|COMPLETED|Overall Study||75|The Milestone is all participants who completed the study (24-month Follow-Up).|
59943671|NCT02790606|76062111|FG000|NOT COMPLETED|Overall Study||35||
59943672|NCT03077620|76062119|FG000|STARTED|Overall Study||14||
59943673|NCT03077620|76062120|FG001|STARTED|Overall Study||14||
59762184|NCT04417894|75881875|FG000|NOT COMPLETED|Overall Study||13||
59943674|NCT03077620|76062121|FG002|STARTED|Overall Study||14||
59943675|NCT03077620|76062122|FG003|STARTED|Overall Study||6||
59943676|NCT03077620|76062119|FG000|COMPLETED|Overall Study||13||
59943677|NCT03077620|76062120|FG001|COMPLETED|Overall Study||13||
59943678|NCT03077620|76062121|FG002|COMPLETED|Overall Study||12||
59518712|NCT01110421|75612552|FG000|COMPLETED|Overall Study|Includes 1 participant who discontinued study drug due to an adverse event of empyema on Days 9-13.|5||
59943679|NCT03077620|76062122|FG003|COMPLETED|Overall Study||6||
59943680|NCT03077620|76062119|FG000|NOT COMPLETED|Overall Study||1||
59943681|NCT03077620|76062120|FG001|NOT COMPLETED|Overall Study||1||
59943682|NCT03077620|76062121|FG002|NOT COMPLETED|Overall Study||2||
59943683|NCT03077620|76062122|FG003|NOT COMPLETED|Overall Study||0||
59943684|NCT01883817|76062134|FG000|STARTED|Overall Study||14||
59943685|NCT01883817|76062135|FG001|STARTED|Overall Study||16||
59943686|NCT01883817|76062134|FG000|COMPLETED|Overall Study||10||
59943687|NCT01883817|76062135|FG001|COMPLETED|Overall Study||9||
59943688|NCT01883817|76062134|FG000|NOT COMPLETED|Overall Study||4||
59943689|NCT01883817|76062135|FG001|NOT COMPLETED|Overall Study||7||
59943690|NCT02982213|76062143|FG000|STARTED|Overall Study||75||
59943691|NCT02982213|76062144|FG001|STARTED|Overall Study||75||
59943692|NCT02982213|76062143|FG000|COMPLETED|Overall Study||70||
59943693|NCT02982213|76062144|FG001|COMPLETED|Overall Study||74||
59943694|NCT02982213|76062143|FG000|NOT COMPLETED|Overall Study||5||
59943695|NCT02982213|76062144|FG001|NOT COMPLETED|Overall Study||1||
59943696|NCT02649634|76062152|FG000|STARTED|Overall Study||69||
59943697|NCT02649634|76062153|FG001|STARTED|Overall Study||66||
59943698|NCT02649634|76062152|FG000|COMPLETED|Overall Study||66||
60067510|NCT01915849|76182699|FG000|COMPLETED|Treatment Period 3 (4 Days)||3||
59943699|NCT02649634|76062153|FG001|COMPLETED|Overall Study||60||
59943700|NCT02649634|76062152|FG000|NOT COMPLETED|Overall Study||3||
59943701|NCT02649634|76062153|FG001|NOT COMPLETED|Overall Study||6||
59943702|NCT01066143|76062159|FG000|STARTED|Overall Study||8||
59943703|NCT01066143|76062159|FG000|COMPLETED|Overall Study||0||
59943704|NCT01066143|76062159|FG000|NOT COMPLETED|Overall Study||8||
59943705|NCT02980107|76062165|FG000|STARTED|Overall Study||105||
59943706|NCT02980107|76062166|FG001|STARTED|Overall Study||107||
59518713|NCT01110421|75612553|FG001|COMPLETED|Overall Study||2||
59943707|NCT02980107|76062165|FG000|COMPLETED|Overall Study||54||
59943708|NCT02980107|76062166|FG001|COMPLETED|Overall Study||45||
59943709|NCT02980107|76062165|FG000|NOT COMPLETED|Overall Study||51||
60067511|NCT01915849|76182700|FG001|COMPLETED|Treatment Period 3 (4 Days)||3||
60067512|NCT01915849|76182701|FG002|COMPLETED|Treatment Period 3 (4 Days)||3||
59762185|NCT04417894|75881876|FG001|NOT COMPLETED|Overall Study||7||
59762186|NCT00875706|75881889|FG000|STARTED|Overall Study||8||
59762187|NCT00875706|75881890|FG001|STARTED|Overall Study||24||
59762188|NCT00875706|75881891|FG002|STARTED|Overall Study||13||
59762189|NCT00875706|75881889|FG000|COMPLETED|Overall Study||7||
59762190|NCT00875706|75881890|FG001|COMPLETED|Overall Study||24||
59762191|NCT00875706|75881891|FG002|COMPLETED|Overall Study||13||
59762192|NCT00875706|75881889|FG000|NOT COMPLETED|Overall Study||1||
59943710|NCT02980107|76062166|FG001|NOT COMPLETED|Overall Study||62||
59943711|NCT02652130|76062172|FG000|STARTED|Overall Study||32||
59943712|NCT02652130|76062172|FG000|COMPLETED|Overall Study||31||
59943713|NCT02652130|76062172|FG000|NOT COMPLETED|Overall Study||1||
59943714|NCT02979639|76062176|FG000|STARTED|Overall Study||401||
59943715|NCT02979639|76062176|FG000|COMPLETED|Overall Study||387||
59943716|NCT02979639|76062176|FG000|NOT COMPLETED|Overall Study||14||
59943717|NCT01674634|76062180|FG000|STARTED|Overall Study||715||
59943718|NCT01674634|76062180|FG000|COMPLETED|Overall Study||709||
59943719|NCT01674634|76062180|FG000|NOT COMPLETED|Overall Study||6||
59943720|NCT02979249|76062188|FG000|STARTED|Overall Study||16||
59943721|NCT02979249|76062188|FG000|COMPLETED|Overall Study||10||
59943722|NCT02979249|76062188|FG000|NOT COMPLETED|Overall Study||6||
59943723|NCT02112552|76062192|FG000|STARTED|Overall Study||3||
59943724|NCT02112552|76062192|FG000|COMPLETED|Overall Study||1||
59943725|NCT02112552|76062192|FG000|NOT COMPLETED|Overall Study||2||
59943726|NCT02976519|76062203|FG000|STARTED|Treatment Period 1 (Part 1 and Part 2)||8|Started are treated|
59943727|NCT02976519|76062204|FG001|STARTED|Treatment Period 1 (Part 1 and Part 2)||8|Started are treated|
59943728|NCT02976519|76062205|FG002|STARTED|Treatment Period 1 (Part 1 and Part 2)||8|Started are treated|
59943729|NCT02976519|76062206|FG003|STARTED|Treatment Period 1 (Part 1 and Part 2)||8|Started are treated|
59943730|NCT02976519|76062207|FG004|STARTED|Treatment Period 1 (Part 1 and Part 2)||8|Started are treated|
59943731|NCT02976519|76062208|FG005|STARTED|Treatment Period 1 (Part 1 and Part 2)||12|Started are treated|
59943732|NCT02976519|76062209|FG006|STARTED|Treatment Period 1 (Part 1 and Part 2)||12|Started are treated|
59943733|NCT02976519|76062203|FG000|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||8||
59943734|NCT02976519|76062204|FG001|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||7||
59943735|NCT02976519|76062205|FG002|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||8||
59943736|NCT02976519|76062206|FG003|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||7||
59943737|NCT02976519|76062207|FG004|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||8||
59943738|NCT02976519|76062208|FG005|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||12||
59943739|NCT02976519|76062209|FG006|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||12||
59943740|NCT02976519|76062203|FG000|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||0||
59943741|NCT02976519|76062204|FG001|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||1||
59943742|NCT02976519|76062205|FG002|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||0||
59943743|NCT02976519|76062206|FG003|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||1||
59943744|NCT02976519|76062207|FG004|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||0||
59943745|NCT02976519|76062208|FG005|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||0||
59943746|NCT02976519|76062209|FG006|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||0||
59943747|NCT02976519|76062203|FG000|STARTED|Wash-out Period (Part 2 Only)||0||
59943748|NCT02976519|76062204|FG001|STARTED|Wash-out Period (Part 2 Only)||0||
59943749|NCT02976519|76062205|FG002|STARTED|Wash-out Period (Part 2 Only)||0||
59943750|NCT02976519|76062206|FG003|STARTED|Wash-out Period (Part 2 Only)||0||
59943751|NCT02976519|76062207|FG004|STARTED|Wash-out Period (Part 2 Only)||0||
59943752|NCT02976519|76062208|FG005|STARTED|Wash-out Period (Part 2 Only)||12||
59943753|NCT02976519|76062209|FG006|STARTED|Wash-out Period (Part 2 Only)||12||
59943754|NCT02976519|76062203|FG000|COMPLETED|Wash-out Period (Part 2 Only)||0||
59943755|NCT02976519|76062204|FG001|COMPLETED|Wash-out Period (Part 2 Only)||0||
59943756|NCT02976519|76062205|FG002|COMPLETED|Wash-out Period (Part 2 Only)||0||
59943757|NCT02976519|76062206|FG003|COMPLETED|Wash-out Period (Part 2 Only)||0||
59943758|NCT02976519|76062207|FG004|COMPLETED|Wash-out Period (Part 2 Only)||0||
59943759|NCT02976519|76062208|FG005|COMPLETED|Wash-out Period (Part 2 Only)||12||
59943760|NCT02976519|76062209|FG006|COMPLETED|Wash-out Period (Part 2 Only)||10||
59943761|NCT02976519|76062203|FG000|NOT COMPLETED|Wash-out Period (Part 2 Only)||0||
59943762|NCT02976519|76062204|FG001|NOT COMPLETED|Wash-out Period (Part 2 Only)||0||
59943763|NCT02976519|76062205|FG002|NOT COMPLETED|Wash-out Period (Part 2 Only)||0||
59943764|NCT02976519|76062206|FG003|NOT COMPLETED|Wash-out Period (Part 2 Only)||0||
59943765|NCT02976519|76062207|FG004|NOT COMPLETED|Wash-out Period (Part 2 Only)||0||
59943766|NCT02976519|76062208|FG005|NOT COMPLETED|Wash-out Period (Part 2 Only)||0||
59943767|NCT02976519|76062209|FG006|NOT COMPLETED|Wash-out Period (Part 2 Only)||2||
59943768|NCT02976519|76062203|FG000|STARTED|Treatment Period 2 (Part 2 Only)||0||
59943769|NCT02976519|76062204|FG001|STARTED|Treatment Period 2 (Part 2 Only)||0||
59943770|NCT02976519|76062205|FG002|STARTED|Treatment Period 2 (Part 2 Only)||0||
59943771|NCT02976519|76062206|FG003|STARTED|Treatment Period 2 (Part 2 Only)||0||
59943772|NCT02976519|76062207|FG004|STARTED|Treatment Period 2 (Part 2 Only)||0||
59943773|NCT02976519|76062208|FG005|STARTED|Treatment Period 2 (Part 2 Only)||12||
59943774|NCT02976519|76062209|FG006|STARTED|Treatment Period 2 (Part 2 Only)||10||
59943775|NCT02976519|76062203|FG000|COMPLETED|Treatment Period 2 (Part 2 Only)||0||
59943776|NCT02976519|76062204|FG001|COMPLETED|Treatment Period 2 (Part 2 Only)||0||
59943777|NCT02976519|76062205|FG002|COMPLETED|Treatment Period 2 (Part 2 Only)||0||
59943778|NCT02976519|76062206|FG003|COMPLETED|Treatment Period 2 (Part 2 Only)||0||
59943779|NCT02976519|76062207|FG004|COMPLETED|Treatment Period 2 (Part 2 Only)||0||
59943780|NCT02976519|76062208|FG005|COMPLETED|Treatment Period 2 (Part 2 Only)||12||
59943781|NCT02976519|76062209|FG006|COMPLETED|Treatment Period 2 (Part 2 Only)||9||
59943782|NCT02976519|76062203|FG000|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||0||
59943783|NCT02976519|76062204|FG001|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||0||
59943784|NCT02976519|76062205|FG002|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||0||
59943785|NCT02976519|76062206|FG003|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||0||
59943786|NCT02976519|76062207|FG004|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||0||
59943787|NCT02976519|76062208|FG005|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||0||
59943788|NCT02976519|76062209|FG006|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||1||
59943789|NCT04565353|76062249|FG000|STARTED|Overall Study||3742||
59943790|NCT04565353|76062250|FG001|STARTED|Overall Study||3737||
59943791|NCT04565353|76062251|FG002|STARTED|Overall Study||3709||
59943792|NCT04565353|76062252|FG003|STARTED|Overall Study||3735||
59943793|NCT04565353|76062253|FG004|STARTED|Overall Study||3758||
59943794|NCT04565353|76062254|FG005|STARTED|Overall Study||3769||
59943795|NCT04565353|76062255|FG006|STARTED|Overall Study||3719||
59943796|NCT04565353|76062256|FG007|STARTED|Overall Study||3732||
59943797|NCT04565353|76062257|FG008|STARTED|Overall Study||3728||
59943798|NCT04565353|76062258|FG009|STARTED|Overall Study||3777||
59943799|NCT04565353|76062259|FG010|STARTED|Overall Study||3672||
59943800|NCT04565353|76062260|FG011|STARTED|Overall Study||3751||
59943801|NCT04565353|76062261|FG012|STARTED|Overall Study||3737||
59943802|NCT04565353|76062262|FG013|STARTED|Overall Study||3714||
59943803|NCT04565353|76062263|FG014|STARTED|Overall Study||3773||
59943804|NCT04565353|76062264|FG015|STARTED|Overall Study||3739||
59943805|NCT04565353|76062265|FG016|STARTED|Overall Study||3776||
59943806|NCT04565353|76062266|FG017|STARTED|Overall Study||3744||
59943807|NCT04565353|76062267|FG018|STARTED|Overall Study||3741||
59943808|NCT04565353|76062268|FG019|STARTED|Overall Study||3758||
59943809|NCT04565353|76062249|FG000|COMPLETED|Overall Study||3742||
59943810|NCT04565353|76062250|FG001|COMPLETED|Overall Study||3688||
59943811|NCT04565353|76062251|FG002|COMPLETED|Overall Study||3670||
59943812|NCT04565353|76062252|FG003|COMPLETED|Overall Study||3693||
59943813|NCT04565353|76062253|FG004|COMPLETED|Overall Study||3717||
59943814|NCT04565353|76062254|FG005|COMPLETED|Overall Study||3716||
59943815|NCT04565353|76062255|FG006|COMPLETED|Overall Study||3665||
59943816|NCT04565353|76062256|FG007|COMPLETED|Overall Study||3693||
59943817|NCT04565353|76062257|FG008|COMPLETED|Overall Study||3662||
59943818|NCT04565353|76062258|FG009|COMPLETED|Overall Study||3734||
59943819|NCT04565353|76062259|FG010|COMPLETED|Overall Study||3623||
59943820|NCT04565353|76062260|FG011|COMPLETED|Overall Study||3710||
59943821|NCT04565353|76062261|FG012|COMPLETED|Overall Study||3685||
59943822|NCT04565353|76062262|FG013|COMPLETED|Overall Study||3664||
59943823|NCT04565353|76062263|FG014|COMPLETED|Overall Study||3736||
59943824|NCT04565353|76062264|FG015|COMPLETED|Overall Study||3690||
59943825|NCT04565353|76062265|FG016|COMPLETED|Overall Study||3734||
59943826|NCT04565353|76062266|FG017|COMPLETED|Overall Study||3696||
59943827|NCT04565353|76062267|FG018|COMPLETED|Overall Study||3698||
59943828|NCT04565353|76062268|FG019|COMPLETED|Overall Study||3712||
59943829|NCT04565353|76062249|FG000|NOT COMPLETED|Overall Study||0||
59943830|NCT04565353|76062250|FG001|NOT COMPLETED|Overall Study||49||
59943831|NCT04565353|76062251|FG002|NOT COMPLETED|Overall Study||39||
59943832|NCT04565353|76062252|FG003|NOT COMPLETED|Overall Study||42||
59943833|NCT04565353|76062253|FG004|NOT COMPLETED|Overall Study||41||
59943834|NCT04565353|76062254|FG005|NOT COMPLETED|Overall Study||53||
59943835|NCT04565353|76062255|FG006|NOT COMPLETED|Overall Study||54||
59943836|NCT04565353|76062256|FG007|NOT COMPLETED|Overall Study||39||
59943837|NCT04565353|76062257|FG008|NOT COMPLETED|Overall Study||66||
59943838|NCT04565353|76062258|FG009|NOT COMPLETED|Overall Study||43||
59943839|NCT04565353|76062259|FG010|NOT COMPLETED|Overall Study||49||
59943840|NCT04565353|76062260|FG011|NOT COMPLETED|Overall Study||41||
59943841|NCT04565353|76062261|FG012|NOT COMPLETED|Overall Study||52||
59943842|NCT04565353|76062262|FG013|NOT COMPLETED|Overall Study||50||
59943843|NCT04565353|76062263|FG014|NOT COMPLETED|Overall Study||37||
59943844|NCT04565353|76062264|FG015|NOT COMPLETED|Overall Study||49||
59943845|NCT04565353|76062265|FG016|NOT COMPLETED|Overall Study||42||
59943846|NCT04565353|76062266|FG017|NOT COMPLETED|Overall Study||48||
59943847|NCT04565353|76062267|FG018|NOT COMPLETED|Overall Study||43||
59943848|NCT04565353|76062268|FG019|NOT COMPLETED|Overall Study||46||
59943849|NCT02975973|76062314|FG000|STARTED|Overall Study||1||
59943850|NCT02975973|76062315|FG001|STARTED|Overall Study||2||
59943851|NCT02975973|76062316|FG002|STARTED|Overall Study||1||
59943852|NCT02975973|76062317|FG003|STARTED|Overall Study||4||
59943853|NCT02975973|76062314|FG000|COMPLETED|Overall Study||0||
59943854|NCT02975973|76062315|FG001|COMPLETED|Overall Study||1||
59943855|NCT02975973|76062316|FG002|COMPLETED|Overall Study||0||
59943856|NCT02975973|76062317|FG003|COMPLETED|Overall Study||4||
59943857|NCT02975973|76062314|FG000|NOT COMPLETED|Overall Study||1||
59943858|NCT02975973|76062315|FG001|NOT COMPLETED|Overall Study||1||
59943859|NCT02975973|76062316|FG002|NOT COMPLETED|Overall Study||1||
59943860|NCT02975973|76062317|FG003|NOT COMPLETED|Overall Study||0||
59943861|NCT01362322|76062329|FG000|STARTED|Overall Study||335||
59943862|NCT01362322|76062330|FG001|STARTED|Overall Study||336||
59943863|NCT01362322|76062329|FG000|COMPLETED|Overall Study||330||
59943864|NCT01362322|76062330|FG001|COMPLETED|Overall Study||329||
59943865|NCT01362322|76062329|FG000|NOT COMPLETED|Overall Study||5||
59943866|NCT01362322|76062330|FG001|NOT COMPLETED|Overall Study||7||
59943867|NCT02918877|76062338|FG000|STARTED|Overall Study||24||
59943868|NCT02918877|76062339|FG001|STARTED|Overall Study||25||
59943869|NCT02918877|76062338|FG000|COMPLETED|Overall Study||18||
59943870|NCT02918877|76062339|FG001|COMPLETED|Overall Study||22||
59943871|NCT02918877|76062338|FG000|NOT COMPLETED|Overall Study||6||
59943872|NCT02918877|76062339|FG001|NOT COMPLETED|Overall Study||3||
59943873|NCT01674712|76062350|FG000|STARTED|Overall Study||114||
59943874|NCT01674712|76062351|FG001|STARTED|Overall Study||117||
59943875|NCT01674712|76062352|FG002|STARTED|Overall Study||115||
59943876|NCT01674712|76062353|FG003|STARTED|Overall Study||116||
59943877|NCT01674712|76062354|FG004|STARTED|Overall Study||113||
59943878|NCT01674712|76062350|FG000|Full Analysis Subject Sample|Overall Study||109||
59943879|NCT01674712|76062351|FG001|Full Analysis Subject Sample|Overall Study||114||
59943880|NCT01674712|76062352|FG002|Full Analysis Subject Sample|Overall Study||110||
59943881|NCT01674712|76062353|FG003|Full Analysis Subject Sample|Overall Study||112||
59943882|NCT01674712|76062354|FG004|Full Analysis Subject Sample|Overall Study||111||
59943883|NCT01674712|76062350|FG000|Safety Subject Sample|Overall Study||111||
59943884|NCT01674712|76062351|FG001|Safety Subject Sample|Overall Study||117||
59943885|NCT01674712|76062352|FG002|Safety Subject Sample|Overall Study||113||
59943886|NCT01674712|76062353|FG003|Safety Subject Sample|Overall Study||115||
59943887|NCT01674712|76062354|FG004|Safety Subject Sample|Overall Study||112||
59943888|NCT01674712|76062350|FG000|COMPLETED|Overall Study||104||
59943889|NCT01674712|76062351|FG001|COMPLETED|Overall Study||108||
59943890|NCT01674712|76062352|FG002|COMPLETED|Overall Study||106||
59943891|NCT01674712|76062353|FG003|COMPLETED|Overall Study||108||
59943892|NCT01674712|76062354|FG004|COMPLETED|Overall Study||102||
59943893|NCT01674712|76062350|FG000|NOT COMPLETED|Overall Study||10||
59943894|NCT01674712|76062351|FG001|NOT COMPLETED|Overall Study||9||
59943895|NCT01674712|76062352|FG002|NOT COMPLETED|Overall Study||9||
59943896|NCT01674712|76062353|FG003|NOT COMPLETED|Overall Study||8||
59943897|NCT01674712|76062354|FG004|NOT COMPLETED|Overall Study||11||
59943898|NCT01368432|76062368|FG000|STARTED|Overall Study||6||
59943899|NCT01368432|76062369|FG001|STARTED|Overall Study||8||
59943900|NCT01368432|76062368|FG000|COMPLETED|Overall Study||6||
59943901|NCT01368432|76062369|FG001|COMPLETED|Overall Study||7||
59943902|NCT01368432|76062368|FG000|NOT COMPLETED|Overall Study||0||
59943903|NCT01368432|76062369|FG001|NOT COMPLETED|Overall Study||1||
59943904|NCT01063881|76062392|FG000|STARTED|Overall Study||147||
59943905|NCT01063881|76062393|FG001|STARTED|Overall Study||125||
59943906|NCT01063881|76062394|FG002|STARTED|Overall Study||13||
59943907|NCT01063881|76062392|FG000|COMPLETED|Overall Study||92||
59943908|NCT01063881|76062393|FG001|COMPLETED|Overall Study||114||
59943909|NCT01063881|76062394|FG002|COMPLETED|Overall Study||12||
59943910|NCT01063881|76062392|FG000|NOT COMPLETED|Overall Study||55||
60067513|NCT01915849|76182702|FG003|COMPLETED|Treatment Period 3 (4 Days)||3||
60067514|NCT01915849|76182699|FG000|NOT COMPLETED|Treatment Period 3 (4 Days)||0||
60067515|NCT01915849|76182700|FG001|NOT COMPLETED|Treatment Period 3 (4 Days)||0||
60067516|NCT01915849|76182701|FG002|NOT COMPLETED|Treatment Period 3 (4 Days)||0||
60067517|NCT01915849|76182702|FG003|NOT COMPLETED|Treatment Period 3 (4 Days)||0||
60067518|NCT01915849|76182699|FG000|STARTED|Treatment Period 4 (4 Days)||3||
60067519|NCT01915849|76182700|FG001|STARTED|Treatment Period 4 (4 Days)||3||
60067520|NCT01915849|76182701|FG002|STARTED|Treatment Period 4 (4 Days)||3||
60067521|NCT01915849|76182702|FG003|STARTED|Treatment Period 4 (4 Days)||3||
60067522|NCT01915849|76182699|FG000|COMPLETED|Treatment Period 4 (4 Days)||3||
60067523|NCT01915849|76182700|FG001|COMPLETED|Treatment Period 4 (4 Days)||3||
60067524|NCT01915849|76182701|FG002|COMPLETED|Treatment Period 4 (4 Days)||3||
60067525|NCT01915849|76182702|FG003|COMPLETED|Treatment Period 4 (4 Days)||3||
60067526|NCT01915849|76182699|FG000|NOT COMPLETED|Treatment Period 4 (4 Days)||0||
60067527|NCT01915849|76182700|FG001|NOT COMPLETED|Treatment Period 4 (4 Days)||0||
60067528|NCT01915849|76182701|FG002|NOT COMPLETED|Treatment Period 4 (4 Days)||0||
60067529|NCT01915849|76182702|FG003|NOT COMPLETED|Treatment Period 4 (4 Days)||0||
59943911|NCT01063881|76062393|FG001|NOT COMPLETED|Overall Study||11||
59943912|NCT01063881|76062394|FG002|NOT COMPLETED|Overall Study||1||
60067530|NCT01915771|76182712|FG000|STARTED|Day 1||15||
60067531|NCT01915771|76182712|FG000|COMPLETED|Day 1||14||
60067532|NCT01915771|76182712|FG000|NOT COMPLETED|Day 1||1||
60067533|NCT01915771|76182712|FG000|STARTED|Day 15||14||
60067534|NCT01915771|76182712|FG000|COMPLETED|Day 15||13||
59943913|NCT01062555|76062411|FG000|STARTED|Phase 1||266||
59943914|NCT01062555|76062412|FG001|STARTED|Phase 1||261||
59943915|NCT01062555|76062413|FG002|STARTED|Phase 1||0||
59943916|NCT01062555|76062414|FG003|STARTED|Phase 1||0||
59943917|NCT01062555|76062411|FG000|COMPLETED|Phase 1||243||
60067535|NCT01915771|76182712|FG000|NOT COMPLETED|Day 15||1||
60067536|NCT01938391|76182720|FG000|STARTED|Baseline||25||
59943918|NCT01062555|76062412|FG001|COMPLETED|Phase 1||235||
59943919|NCT01062555|76062413|FG002|COMPLETED|Phase 1||0||
59943920|NCT01062555|76062414|FG003|COMPLETED|Phase 1||0||
59943921|NCT01062555|76062411|FG000|NOT COMPLETED|Phase 1||23||
59943922|NCT01062555|76062412|FG001|NOT COMPLETED|Phase 1||26||
59943923|NCT01062555|76062413|FG002|NOT COMPLETED|Phase 1||0||
59943924|NCT01062555|76062414|FG003|NOT COMPLETED|Phase 1||0||
59943925|NCT01062555|76062411|FG000|STARTED|Phase 2||0||
59943926|NCT01062555|76062412|FG001|STARTED|Phase 2||0||
59943927|NCT01062555|76062413|FG002|STARTED|Phase 2||86||
59943928|NCT01062555|76062414|FG003|STARTED|Phase 2||87||
59943929|NCT01062555|76062411|FG000|COMPLETED|Phase 2||0||
59943930|NCT01062555|76062412|FG001|COMPLETED|Phase 2||0||
59943931|NCT01062555|76062413|FG002|COMPLETED|Phase 2||71||
59943932|NCT01062555|76062414|FG003|COMPLETED|Phase 2||53||
59943933|NCT01062555|76062411|FG000|NOT COMPLETED|Phase 2||0||
59943934|NCT01062555|76062412|FG001|NOT COMPLETED|Phase 2||0||
59943935|NCT01062555|76062413|FG002|NOT COMPLETED|Phase 2||15||
59943936|NCT01062555|76062414|FG003|NOT COMPLETED|Phase 2||34||
59943937|NCT01064817|76062426|FG000|STARTED|All Study Treatment Days 1-9||62||
59943938|NCT01064817|76062427|FG001|STARTED|All Study Treatment Days 1-9||62||
59943939|NCT01064817|76062426|FG000|COMPLETED|All Study Treatment Days 1-9||62||
59943940|NCT01064817|76062427|FG001|COMPLETED|All Study Treatment Days 1-9||62||
59943941|NCT01064817|76062426|FG000|NOT COMPLETED|All Study Treatment Days 1-9||0||
59943942|NCT01064817|76062427|FG001|NOT COMPLETED|All Study Treatment Days 1-9||0||
59943943|NCT01064817|76062426|FG000|STARTED|Study Completion||62||
59943944|NCT01064817|76062427|FG001|STARTED|Study Completion||62||
59943945|NCT01064817|76062426|FG000|COMPLETED|Study Completion||60||
59943946|NCT01064817|76062427|FG001|COMPLETED|Study Completion||62||
59943947|NCT01064817|76062426|FG000|NOT COMPLETED|Study Completion||2||
59943948|NCT01064817|76062427|FG001|NOT COMPLETED|Study Completion||0||
59943949|NCT01368276|76062435|FG000|STARTED|Overall Study||3||
59943950|NCT01368276|76062436|FG001|STARTED|Overall Study||28||
59943951|NCT01368276|76062435|FG000|COMPLETED|Overall Study||2||
59943952|NCT01368276|76062436|FG001|COMPLETED|Overall Study||18||
59943953|NCT01368276|76062435|FG000|NOT COMPLETED|Overall Study||1||
59943954|NCT01368276|76062436|FG001|NOT COMPLETED|Overall Study||10||
59943955|NCT01064739|76062442|FG000|STARTED|Fixed Sodium Study Diet|14 participants consumed the fixed-sodium study diet prior to the fava bean supplement study day.|14||
59943956|NCT01064739|76062442|FG000|COMPLETED|Fixed Sodium Study Diet||14||
59943957|NCT01064739|76062442|FG000|NOT COMPLETED|Fixed Sodium Study Diet||0||
59943958|NCT01064739|76062442|FG000|STARTED|Fixed Sodium Diet + Fava Beans||14||
59943959|NCT01064739|76062442|FG000|COMPLETED|Fixed Sodium Diet + Fava Beans|1 participant withdrew with blood in his urine on the fava bean study day.|13||
59943960|NCT01064739|76062442|FG000|NOT COMPLETED|Fixed Sodium Diet + Fava Beans||1||
59943961|NCT01061775|76062452|FG000|STARTED|Overall Study||19||
59943962|NCT01061775|76062452|FG000|COMPLETED|Overall Study||16||
59943963|NCT01061775|76062452|FG000|NOT COMPLETED|Overall Study||3||
59943964|NCT02651116|76062459|FG000|STARTED|Overall Study||68||
59943965|NCT02651116|76062460|FG001|STARTED|Overall Study||63||
59943966|NCT02651116|76062459|FG000|Treated|Overall Study||68||
59943967|NCT02651116|76062460|FG001|Treated|Overall Study||63||
59943968|NCT02651116|76062459|FG000|COMPLETED|Overall Study||67||
59943969|NCT02651116|76062460|FG001|COMPLETED|Overall Study||62||
59943970|NCT02651116|76062459|FG000|NOT COMPLETED|Overall Study||1||
59943971|NCT02651116|76062460|FG001|NOT COMPLETED|Overall Study||1||
59943972|NCT01061385|76062468|FG000|STARTED|Overall Study||21||
59943973|NCT01061385|76062469|FG001|STARTED|Overall Study||9||
59943974|NCT01061385|76062468|FG000|COMPLETED|Overall Study||20||
59943975|NCT01061385|76062469|FG001|COMPLETED|Overall Study||8||
59943976|NCT01061385|76062468|FG000|NOT COMPLETED|Overall Study||1||
59943977|NCT01061385|76062469|FG001|NOT COMPLETED|Overall Study||1||
59943978|NCT02973477|76062478|FG000|STARTED|First Intervention||19||
59943979|NCT02973477|76062479|FG001|STARTED|First Intervention||26||
59943980|NCT02973477|76062478|FG000|COMPLETED|First Intervention||19||
59943981|NCT02973477|76062479|FG001|COMPLETED|First Intervention||24||
59943982|NCT02973477|76062478|FG000|NOT COMPLETED|First Intervention||0||
59943983|NCT02973477|76062479|FG001|NOT COMPLETED|First Intervention||2||
59943984|NCT02973477|76062478|FG000|STARTED|Washout||19||
59943985|NCT02973477|76062479|FG001|STARTED|Washout||24||
59943986|NCT02973477|76062478|FG000|COMPLETED|Washout||18||
59943987|NCT02973477|76062479|FG001|COMPLETED|Washout||24||
59943988|NCT02973477|76062478|FG000|NOT COMPLETED|Washout||1||
59943989|NCT02973477|76062479|FG001|NOT COMPLETED|Washout||0||
59943990|NCT02973477|76062478|FG000|STARTED|Second Intervention||18||
59943991|NCT02973477|76062479|FG001|STARTED|Second Intervention||24||
59943992|NCT02973477|76062478|FG000|COMPLETED|Second Intervention||17||
59943993|NCT02973477|76062479|FG001|COMPLETED|Second Intervention||24||
59943994|NCT02973477|76062478|FG000|NOT COMPLETED|Second Intervention||1||
59943995|NCT02973477|76062479|FG001|NOT COMPLETED|Second Intervention||0||
59943996|NCT02788656|76062493|FG000|STARTED|Overall Study||2||
59943997|NCT02788656|76062494|FG001|STARTED|Overall Study||2||
59943998|NCT02788656|76062493|FG000|COMPLETED|Overall Study||1||
59943999|NCT02788656|76062494|FG001|COMPLETED|Overall Study||2||
59944000|NCT02788656|76062493|FG000|NOT COMPLETED|Overall Study||1||
59944001|NCT02788656|76062494|FG001|NOT COMPLETED|Overall Study||0||
59944002|NCT00283868|76062502|FG000|STARTED|Overall Study||111||
59944003|NCT00283868|76062503|FG001|STARTED|Overall Study||111||
59944004|NCT00283868|76062502|FG000|COMPLETED|Overall Study||104||
59944005|NCT00283868|76062503|FG001|COMPLETED|Overall Study||103||
59944006|NCT00283868|76062502|FG000|NOT COMPLETED|Overall Study||7||
59944007|NCT00283868|76062503|FG001|NOT COMPLETED|Overall Study||8||
59944008|NCT02973087|76062509|FG000|STARTED|Overall Study||13||
59944009|NCT02973087|76062510|FG001|STARTED|Overall Study||10||
59944010|NCT02973087|76062509|FG000|COMPLETED|Overall Study||9||
59944011|NCT02973087|76062510|FG001|COMPLETED|Overall Study||8||
59944012|NCT02973087|76062509|FG000|NOT COMPLETED|Overall Study||4||
59944013|NCT02973087|76062510|FG001|NOT COMPLETED|Overall Study||2||
59944014|NCT01525329|76062519|FG000|STARTED|Overall Study||4||
59944015|NCT01525329|76062520|FG001|STARTED|Overall Study||14||
59944016|NCT01525329|76062519|FG000|COMPLETED|Overall Study||4||
59944017|NCT01525329|76062520|FG001|COMPLETED|Overall Study||14||
59944018|NCT01525329|76062519|FG000|NOT COMPLETED|Overall Study||0||
59944019|NCT01525329|76062520|FG001|NOT COMPLETED|Overall Study||0||
59944020|NCT00271544|76062530|FG000|STARTED|Overall Study|Total number of subjects enrolled.|190||
59944021|NCT00271544|76062530|FG000|Implant Attempted|Overall Study|Total number of subjects completed baseline and underwent system implant attempt.|186||
59944022|NCT00271544|76062530|FG000|Model 4196 Lead Attempted|Overall Study|Total number of subjects attempted Model 4196 lead.|177||
59944023|NCT00271544|76062530|FG000|COMPLETED|Overall Study|Total number subjects successfully implanted 4196 lead.|170||
59944024|NCT00271544|76062530|FG000|NOT COMPLETED|Overall Study||20||
59944025|NCT05342532|76062548|FG000|STARTED|Overall Study||58||
59944026|NCT05342532|76062549|FG001|STARTED|Overall Study||54||
59944027|NCT05342532|76062548|FG000|COMPLETED|Overall Study||43||
59944028|NCT05342532|76062549|FG001|COMPLETED|Overall Study||19||
59944029|NCT05342532|76062548|FG000|NOT COMPLETED|Overall Study||15||
59944030|NCT05342532|76062549|FG001|NOT COMPLETED|Overall Study||35||
59944031|NCT02984943|76062555|FG000|STARTED|Overall Study||14||
59944032|NCT02984943|76062555|FG000|COMPLETED|Overall Study||10||
59944033|NCT02984943|76062555|FG000|NOT COMPLETED|Overall Study||4||
59944034|NCT02787408|76062559|FG000|STARTED|Overall Study||25||
59944035|NCT02787408|76062559|FG000|COMPLETED|Overall Study||7||
59944036|NCT02787408|76062559|FG000|NOT COMPLETED|Overall Study||18||
59944037|NCT02971605|76062563|FG000|STARTED|Overall Study||13||
59944038|NCT02971605|76062563|FG000|COMPLETED|Overall Study||12||
59944039|NCT02971605|76062563|FG000|NOT COMPLETED|Overall Study||1||
59944040|NCT03054337|76062575|FG000|STARTED|Primary Efficacy Period (6 Weeks)||12||
59944041|NCT03054337|76062576|FG001|STARTED|Primary Efficacy Period (6 Weeks)||12||
59944042|NCT03054337|76062577|FG002|STARTED|Primary Efficacy Period (6 Weeks)||13||
59944043|NCT03054337|76062578|FG003|STARTED|Primary Efficacy Period (6 Weeks)||5||
59944044|NCT03054337|76062579|FG004|STARTED|Primary Efficacy Period (6 Weeks)||4||
59762193|NCT00875706|75881890|FG001|NOT COMPLETED|Overall Study||0||
59762194|NCT00875706|75881891|FG002|NOT COMPLETED|Overall Study||0||
59762195|NCT04399889|75881902|FG000|STARTED|Overall Study||10||
59762196|NCT04399889|75881903|FG001|STARTED|Overall Study||1||
59762197|NCT04399889|75881904|FG002|STARTED|Overall Study||1||
59944045|NCT03054337|76062580|FG005|STARTED|Primary Efficacy Period (6 Weeks)||5||
59944046|NCT03054337|76062575|FG000|COMPLETED|Primary Efficacy Period (6 Weeks)||12||
59944047|NCT03054337|76062576|FG001|COMPLETED|Primary Efficacy Period (6 Weeks)||12||
59944048|NCT03054337|76062577|FG002|COMPLETED|Primary Efficacy Period (6 Weeks)||13||
59944049|NCT03054337|76062578|FG003|COMPLETED|Primary Efficacy Period (6 Weeks)||5||
59944050|NCT03054337|76062579|FG004|COMPLETED|Primary Efficacy Period (6 Weeks)||4||
59944051|NCT03054337|76062580|FG005|COMPLETED|Primary Efficacy Period (6 Weeks)||5||
59944052|NCT03054337|76062575|FG000|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||0||
59944053|NCT03054337|76062576|FG001|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||0||
59944054|NCT03054337|76062577|FG002|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||0||
59944055|NCT03054337|76062578|FG003|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||0||
59944056|NCT03054337|76062579|FG004|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||0||
59944057|NCT03054337|76062580|FG005|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||0||
59944058|NCT03054337|76062575|FG000|STARTED|Dose Adjustment and Maintenance Period||12||
59944059|NCT03054337|76062576|FG001|STARTED|Dose Adjustment and Maintenance Period||12||
59944060|NCT03054337|76062577|FG002|STARTED|Dose Adjustment and Maintenance Period||13||
59944061|NCT03054337|76062578|FG003|STARTED|Dose Adjustment and Maintenance Period||5||
59944062|NCT03054337|76062579|FG004|STARTED|Dose Adjustment and Maintenance Period||4||
59944063|NCT03054337|76062580|FG005|STARTED|Dose Adjustment and Maintenance Period||5||
59944064|NCT03054337|76062575|FG000|COMPLETED|Dose Adjustment and Maintenance Period||11||
59762198|NCT04399889|75881902|FG000|COMPLETED|Overall Study||5||
59762199|NCT04399889|75881903|FG001|COMPLETED|Overall Study||0||
59762200|NCT04399889|75881904|FG002|COMPLETED|Overall Study||0||
59944065|NCT03054337|76062576|FG001|COMPLETED|Dose Adjustment and Maintenance Period||10||
59944066|NCT03054337|76062577|FG002|COMPLETED|Dose Adjustment and Maintenance Period||12||
59944067|NCT03054337|76062578|FG003|COMPLETED|Dose Adjustment and Maintenance Period||5||
59944068|NCT03054337|76062579|FG004|COMPLETED|Dose Adjustment and Maintenance Period||4||
59762201|NCT04399889|75881902|FG000|NOT COMPLETED|Overall Study||5||
59944069|NCT03054337|76062580|FG005|COMPLETED|Dose Adjustment and Maintenance Period||4||
59944070|NCT03054337|76062575|FG000|NOT COMPLETED|Dose Adjustment and Maintenance Period||1||
59944071|NCT03054337|76062576|FG001|NOT COMPLETED|Dose Adjustment and Maintenance Period||2||
59944072|NCT03054337|76062577|FG002|NOT COMPLETED|Dose Adjustment and Maintenance Period||1||
59944073|NCT03054337|76062578|FG003|NOT COMPLETED|Dose Adjustment and Maintenance Period||0||
59944074|NCT03054337|76062579|FG004|NOT COMPLETED|Dose Adjustment and Maintenance Period||0||
59944075|NCT03054337|76062580|FG005|NOT COMPLETED|Dose Adjustment and Maintenance Period||1||
59944076|NCT02609737|76062607|FG000|STARTED|Overall Study||20||
59944077|NCT02609737|76062607|FG000|COMPLETED|Overall Study||20||
59944078|NCT02609737|76062607|FG000|NOT COMPLETED|Overall Study||0||
59944079|NCT01060059|76062613|FG000|STARTED|Overall Study||444||
59944080|NCT01060059|76062614|FG001|STARTED|Overall Study||438||
59944081|NCT01060059|76062613|FG000|COMPLETED|Overall Study||377||
59944082|NCT01060059|76062614|FG001|COMPLETED|Overall Study||371||
59944083|NCT01060059|76062613|FG000|NOT COMPLETED|Overall Study||67||
59944084|NCT01060059|76062614|FG001|NOT COMPLETED|Overall Study||67||
59944085|NCT00790803|76062622|FG000|STARTED|Overall Study||5||
59944086|NCT00790803|76062622|FG000|COMPLETED|Overall Study||5||
59944087|NCT00790803|76062622|FG000|NOT COMPLETED|Overall Study||0||
59944088|NCT02648932|76062628|FG000|STARTED|Overall Study||5||
59944089|NCT02648932|76062629|FG001|STARTED|Overall Study||4||
59944090|NCT02648932|76062628|FG000|COMPLETED|Overall Study||2||
59944091|NCT02648932|76062629|FG001|COMPLETED|Overall Study||3||
59944092|NCT02648932|76062628|FG000|NOT COMPLETED|Overall Study||3||
59944093|NCT02648932|76062629|FG001|NOT COMPLETED|Overall Study||1||
59944094|NCT02122458|76062642|FG000|STARTED|Overall Study||12||
59944095|NCT02122458|76062643|FG001|STARTED|Overall Study||18||
59944096|NCT02122458|76062644|FG002|STARTED|Overall Study||7||
59944097|NCT02122458|76062645|FG003|STARTED|Overall Study||82||
59944098|NCT02122458|76062646|FG004|STARTED|Overall Study||45||
59944099|NCT02122458|76062647|FG005|STARTED|Overall Study||43||
59944100|NCT02122458|76062648|FG006|STARTED|Overall Study||19||
59944101|NCT02122458|76062642|FG000|COMPLETED|Overall Study||9||
59944102|NCT02122458|76062643|FG001|COMPLETED|Overall Study||13||
59944103|NCT02122458|76062644|FG002|COMPLETED|Overall Study||7||
59944104|NCT02122458|76062645|FG003|COMPLETED|Overall Study||67||
59944105|NCT02122458|76062646|FG004|COMPLETED|Overall Study||31||
59944106|NCT02122458|76062647|FG005|COMPLETED|Overall Study||23||
59944107|NCT02122458|76062648|FG006|COMPLETED|Overall Study||18||
59944108|NCT02122458|76062642|FG000|NOT COMPLETED|Overall Study||3||
59944109|NCT02122458|76062643|FG001|NOT COMPLETED|Overall Study||5||
59944110|NCT02122458|76062644|FG002|NOT COMPLETED|Overall Study||0||
59944111|NCT02122458|76062645|FG003|NOT COMPLETED|Overall Study||15||
59944112|NCT02122458|76062646|FG004|NOT COMPLETED|Overall Study||14||
59944113|NCT02122458|76062647|FG005|NOT COMPLETED|Overall Study||20||
59944114|NCT02122458|76062648|FG006|NOT COMPLETED|Overall Study||1||
59944115|NCT02903511|76062664|FG000|STARTED|Overall Study||26||
59944116|NCT02903511|76062665|FG001|STARTED|Overall Study||25||
59944117|NCT02903511|76062664|FG000|Received Intervention|Overall Study||25||
59944118|NCT02903511|76062665|FG001|Received Intervention|Overall Study||25||
59944119|NCT02903511|76062664|FG000|COMPLETED|Overall Study||22||
59944120|NCT02903511|76062665|FG001|COMPLETED|Overall Study||23||
60067537|NCT01938391|76182720|FG000|COMPLETED|Baseline||25||
60067538|NCT01938391|76182720|FG000|NOT COMPLETED|Baseline||0||
59944121|NCT02903511|76062664|FG000|NOT COMPLETED|Overall Study||4||
59944122|NCT02903511|76062665|FG001|NOT COMPLETED|Overall Study||2||
59944123|NCT00147290|76062673|FG000|STARTED|Overall Study||266||
59944124|NCT00147290|76062674|FG001|STARTED|Overall Study||260||
60067539|NCT01938391|76182720|FG000|STARTED|2 Week Follow up||25||
60067540|NCT01938391|76182720|FG000|COMPLETED|2 Week Follow up||25||
60067541|NCT01938391|76182720|FG000|NOT COMPLETED|2 Week Follow up||0||
60067542|NCT01938391|76182720|FG000|STARTED|6 Month Follow up||25||
60067543|NCT01938391|76182720|FG000|COMPLETED|6 Month Follow up||24||
60067544|NCT01938391|76182720|FG000|NOT COMPLETED|6 Month Follow up||1||
59944125|NCT00147290|76062673|FG000|COMPLETED|Overall Study||266||
59944126|NCT00147290|76062674|FG001|COMPLETED|Overall Study||260||
59944127|NCT00147290|76062673|FG000|NOT COMPLETED|Overall Study||0||
59944128|NCT00147290|76062674|FG001|NOT COMPLETED|Overall Study||0||
59944129|NCT03830359|76062678|FG000|STARTED|Overall Study||62||
59944130|NCT03830359|76062678|FG000|COMPLETED|Overall Study||62||
59944131|NCT03830359|76062678|FG000|NOT COMPLETED|Overall Study||0||
59944132|NCT01368042|76062682|FG000|STARTED|Overall Study||265||
59944133|NCT01368042|76062682|FG000|COMPLETED|Overall Study||235||
59944134|NCT01368042|76062682|FG000|NOT COMPLETED|Overall Study||30||
59944135|NCT00126776|76062688|FG000|STARTED|Overall Study||372||
59944136|NCT00126776|76062689|FG001|STARTED|Overall Study||371||
59944137|NCT00126776|76062688|FG000|COMPLETED|Overall Study||372||
59944138|NCT00126776|76062689|FG001|COMPLETED|Overall Study||371||
59944139|NCT00126776|76062688|FG000|NOT COMPLETED|Overall Study||0||
59944140|NCT00126776|76062689|FG001|NOT COMPLETED|Overall Study||0||
59944141|NCT01674010|76062693|FG000|STARTED|Open Treatment Phase 1||309||
59944142|NCT01674010|76062694|FG001|STARTED|Open Treatment Phase 1||0||
60067545|NCT01938391|76182720|FG000|STARTED|12 Month Follow up||24||
59944143|NCT01674010|76062695|FG002|STARTED|Open Treatment Phase 1||0||
59944144|NCT01674010|76062693|FG000|COMPLETED|Open Treatment Phase 1||129||
59944145|NCT01674010|76062694|FG001|COMPLETED|Open Treatment Phase 1||0||
59944146|NCT01674010|76062695|FG002|COMPLETED|Open Treatment Phase 1||0||
59944147|NCT01674010|76062693|FG000|NOT COMPLETED|Open Treatment Phase 1||180||
59944148|NCT01674010|76062694|FG001|NOT COMPLETED|Open Treatment Phase 1||0||
59944149|NCT01674010|76062695|FG002|NOT COMPLETED|Open Treatment Phase 1||0||
59944150|NCT01674010|76062693|FG000|STARTED|Randomization Phase 2||0||
59944151|NCT01674010|76062694|FG001|STARTED|Randomization Phase 2||65||
59944152|NCT01674010|76062695|FG002|STARTED|Randomization Phase 2||64||
59944153|NCT01674010|76062693|FG000|COMPLETED|Randomization Phase 2||0||
59944154|NCT01674010|76062694|FG001|COMPLETED|Randomization Phase 2||3||
59944155|NCT01674010|76062695|FG002|COMPLETED|Randomization Phase 2||3||
59944156|NCT01674010|76062693|FG000|NOT COMPLETED|Randomization Phase 2||0||
59944157|NCT01674010|76062694|FG001|NOT COMPLETED|Randomization Phase 2||62||
59944158|NCT01674010|76062695|FG002|NOT COMPLETED|Randomization Phase 2||61||
59944159|NCT01345669|76062705|FG000|STARTED|Overall Study||411||
59944160|NCT01345669|76062706|FG001|STARTED|Overall Study||206||
59944161|NCT01345669|76062705|FG000|COMPLETED|Overall Study||124||
59944162|NCT01345669|76062706|FG001|COMPLETED|Overall Study||87||
59944163|NCT01345669|76062705|FG000|NOT COMPLETED|Overall Study||287||
59944164|NCT01345669|76062706|FG001|NOT COMPLETED|Overall Study||119||
59944165|NCT05334212|76062712|FG000|STARTED|Overall Study||7||
59944166|NCT05334212|76062712|FG000|COMPLETED|Overall Study||0||
59944167|NCT05334212|76062712|FG000|NOT COMPLETED|Overall Study||7||
59944168|NCT01673854|76062716|FG000|STARTED|Vem 1 Phase (Vemurafenib, 960 mg)||46||
59944169|NCT01673854|76062716|FG000|COMPLETED|Vem 1 Phase (Vemurafenib, 960 mg)||46||
59944170|NCT01673854|76062716|FG000|NOT COMPLETED|Vem 1 Phase (Vemurafenib, 960 mg)||0||
59944171|NCT01673854|76062716|FG000|STARTED|Ipilimumab Phase (Ipilimumab, 10 mg/kg)||46||
59944172|NCT01673854|76062716|FG000|COMPLETED|Ipilimumab Phase (Ipilimumab, 10 mg/kg)||19||
59944173|NCT01673854|76062716|FG000|NOT COMPLETED|Ipilimumab Phase (Ipilimumab, 10 mg/kg)||27||
59944174|NCT01673854|76062716|FG000|STARTED|Vem 2 Phase (Vemurafenib Retreatment)||19||
59944175|NCT01673854|76062716|FG000|COMPLETED|Vem 2 Phase (Vemurafenib Retreatment)||0||
59944176|NCT01673854|76062716|FG000|NOT COMPLETED|Vem 2 Phase (Vemurafenib Retreatment)||19||
59944177|NCT01343407|76062720|FG000|STARTED|First Treatment Period (Part 2)||2|Allergen challenge was done 1 hour after dosing on Day 5 of each treatment period.|
59944178|NCT01343407|76062721|FG001|STARTED|First Treatment Period (Part 2)||2|Allergen challenge was done 1 hour after dosing on Day 5 of each treatment period.|
59944179|NCT01343407|76062722|FG002|STARTED|First Treatment Period (Part 2)||3|Allergen challenge was done 1 hour after dosing on Day 5 of each treatment period.|
59944180|NCT01343407|76062723|FG003|STARTED|First Treatment Period (Part 2)||3|Allergen challenge was done 1 hour after dosing on Day 5 of each treatment period.|
59944181|NCT01343407|76062724|FG004|STARTED|First Treatment Period (Part 2)||3|Allergen challenge was done 1 hour after dosing on Day 5 of each treatment period.|
59944182|NCT01343407|76062725|FG005|STARTED|First Treatment Period (Part 2)||3|Allergen challenge was done 1 hour after dosing on Day 5 of each treatment period.|
59944183|NCT01343407|76062720|FG000|COMPLETED|First Treatment Period (Part 2)||2||
59944184|NCT01343407|76062721|FG001|COMPLETED|First Treatment Period (Part 2)||2||
59944185|NCT01343407|76062722|FG002|COMPLETED|First Treatment Period (Part 2)||3||
59944186|NCT01343407|76062723|FG003|COMPLETED|First Treatment Period (Part 2)||3||
59944187|NCT01343407|76062724|FG004|COMPLETED|First Treatment Period (Part 2)||3||
59944188|NCT01343407|76062725|FG005|COMPLETED|First Treatment Period (Part 2)||3||
59944189|NCT01343407|76062720|FG000|NOT COMPLETED|First Treatment Period (Part 2)||0||
59944190|NCT01343407|76062721|FG001|NOT COMPLETED|First Treatment Period (Part 2)||0||
59944191|NCT01343407|76062722|FG002|NOT COMPLETED|First Treatment Period (Part 2)||0||
59944192|NCT01343407|76062723|FG003|NOT COMPLETED|First Treatment Period (Part 2)||0||
59944193|NCT01343407|76062724|FG004|NOT COMPLETED|First Treatment Period (Part 2)||0||
59944194|NCT01343407|76062725|FG005|NOT COMPLETED|First Treatment Period (Part 2)||0||
59944195|NCT01343407|76062720|FG000|STARTED|First Washout (Part 2)||2||
59944196|NCT01343407|76062721|FG001|STARTED|First Washout (Part 2)||2||
59944197|NCT01343407|76062722|FG002|STARTED|First Washout (Part 2)||3||
59944198|NCT01343407|76062723|FG003|STARTED|First Washout (Part 2)||3||
59944199|NCT01343407|76062724|FG004|STARTED|First Washout (Part 2)||3||
59944200|NCT01343407|76062725|FG005|STARTED|First Washout (Part 2)||3||
59944201|NCT01343407|76062720|FG000|COMPLETED|First Washout (Part 2)||2||
59944202|NCT01343407|76062721|FG001|COMPLETED|First Washout (Part 2)||2||
59944203|NCT01343407|76062722|FG002|COMPLETED|First Washout (Part 2)||3||
59944204|NCT01343407|76062723|FG003|COMPLETED|First Washout (Part 2)||3||
59944205|NCT01343407|76062724|FG004|COMPLETED|First Washout (Part 2)||3||
59944206|NCT01343407|76062725|FG005|COMPLETED|First Washout (Part 2)||3||
59944207|NCT01343407|76062720|FG000|NOT COMPLETED|First Washout (Part 2)||0||
59944208|NCT01343407|76062721|FG001|NOT COMPLETED|First Washout (Part 2)||0||
59944209|NCT01343407|76062722|FG002|NOT COMPLETED|First Washout (Part 2)||0||
59944210|NCT01343407|76062723|FG003|NOT COMPLETED|First Washout (Part 2)||0||
59944211|NCT01343407|76062724|FG004|NOT COMPLETED|First Washout (Part 2)||0||
59944212|NCT01343407|76062725|FG005|NOT COMPLETED|First Washout (Part 2)||0||
59944213|NCT01343407|76062720|FG000|STARTED|Second Treatment Period (Part 2)||2|Allergen challenge was done 1 hour after dosing on Day 5 of each treatment period.|
59944214|NCT01343407|76062721|FG001|STARTED|Second Treatment Period (Part 2)||2|Allergen challenge was done 1 hour after dosing on Day 5 of each treatment period.|
59944215|NCT01343407|76062722|FG002|STARTED|Second Treatment Period (Part 2)||3|Allergen challenge was done 1 hour after dosing on Day 5 of each treatment period.|
59944216|NCT01343407|76062723|FG003|STARTED|Second Treatment Period (Part 2)||3|Allergen challenge was done 1 hour after dosing on Day 5 of each treatment period.|
59944217|NCT01343407|76062724|FG004|STARTED|Second Treatment Period (Part 2)||3|Allergen challenge was done 1 hour after dosing on Day 5 of each treatment period.|
59944218|NCT01343407|76062725|FG005|STARTED|Second Treatment Period (Part 2)||3|Allergen challenge was done 1 hour after dosing on Day 5 of each treatment period.|
59944219|NCT01343407|76062720|FG000|COMPLETED|Second Treatment Period (Part 2)||2||
59944220|NCT01343407|76062721|FG001|COMPLETED|Second Treatment Period (Part 2)||2||
59944221|NCT01343407|76062722|FG002|COMPLETED|Second Treatment Period (Part 2)||2||
59944222|NCT01343407|76062723|FG003|COMPLETED|Second Treatment Period (Part 2)||3||
59944223|NCT01343407|76062724|FG004|COMPLETED|Second Treatment Period (Part 2)||3||
59944224|NCT01343407|76062725|FG005|COMPLETED|Second Treatment Period (Part 2)||3||
59944225|NCT01343407|76062720|FG000|NOT COMPLETED|Second Treatment Period (Part 2)||0||
59944226|NCT01343407|76062721|FG001|NOT COMPLETED|Second Treatment Period (Part 2)||0||
59944227|NCT01343407|76062722|FG002|NOT COMPLETED|Second Treatment Period (Part 2)||1||
59944228|NCT01343407|76062723|FG003|NOT COMPLETED|Second Treatment Period (Part 2)||0||
59944229|NCT01343407|76062724|FG004|NOT COMPLETED|Second Treatment Period (Part 2)||0||
59944230|NCT01343407|76062725|FG005|NOT COMPLETED|Second Treatment Period (Part 2)||0||
59944231|NCT01343407|76062720|FG000|STARTED|Second Washout (Part 2)||2||
59944232|NCT01343407|76062721|FG001|STARTED|Second Washout (Part 2)||2||
59944233|NCT01343407|76062722|FG002|STARTED|Second Washout (Part 2)||2||
59944234|NCT01343407|76062723|FG003|STARTED|Second Washout (Part 2)||3||
59944235|NCT01343407|76062724|FG004|STARTED|Second Washout (Part 2)||3||
59944236|NCT01343407|76062725|FG005|STARTED|Second Washout (Part 2)||3||
59944237|NCT01343407|76062720|FG000|COMPLETED|Second Washout (Part 2)||2||
59944238|NCT01343407|76062721|FG001|COMPLETED|Second Washout (Part 2)||2||
59944239|NCT01343407|76062722|FG002|COMPLETED|Second Washout (Part 2)||1||
59944240|NCT01343407|76062723|FG003|COMPLETED|Second Washout (Part 2)||3||
59944241|NCT01343407|76062724|FG004|COMPLETED|Second Washout (Part 2)||3||
59944242|NCT01343407|76062725|FG005|COMPLETED|Second Washout (Part 2)||3||
59944243|NCT01343407|76062720|FG000|NOT COMPLETED|Second Washout (Part 2)||0||
59944244|NCT01343407|76062721|FG001|NOT COMPLETED|Second Washout (Part 2)||0||
59944245|NCT01343407|76062722|FG002|NOT COMPLETED|Second Washout (Part 2)||1||
59944246|NCT01343407|76062723|FG003|NOT COMPLETED|Second Washout (Part 2)||0||
59944247|NCT01343407|76062724|FG004|NOT COMPLETED|Second Washout (Part 2)||0||
59944248|NCT01343407|76062725|FG005|NOT COMPLETED|Second Washout (Part 2)||0||
59944249|NCT01343407|76062720|FG000|STARTED|Third Treatment Period (Part 2)||2|Allergen challenge was done 1 hour after dosing on Day 5 of each treatment period.|
59944250|NCT01343407|76062721|FG001|STARTED|Third Treatment Period (Part 2)||2|Allergen challenge was done 1 hour after dosing on Day 5 of each treatment period.|
59944251|NCT01343407|76062722|FG002|STARTED|Third Treatment Period (Part 2)||1|Allergen challenge was done 1 hour after dosing on Day 5 of each treatment period.|
59944252|NCT01343407|76062723|FG003|STARTED|Third Treatment Period (Part 2)||3|Allergen challenge was done 1 hour after dosing on Day 5 of each treatment period.|
59944253|NCT01343407|76062724|FG004|STARTED|Third Treatment Period (Part 2)||3|Allergen challenge was done 1 hour after dosing on Day 5 of each treatment period.|
59944254|NCT01343407|76062725|FG005|STARTED|Third Treatment Period (Part 2)||3|Allergen challenge was done 1 hour after dosing on Day 5 of each treatment period.|
59944255|NCT01343407|76062720|FG000|COMPLETED|Third Treatment Period (Part 2)||2||
59944256|NCT01343407|76062721|FG001|COMPLETED|Third Treatment Period (Part 2)||2||
59944257|NCT01343407|76062722|FG002|COMPLETED|Third Treatment Period (Part 2)||1||
59944258|NCT01343407|76062723|FG003|COMPLETED|Third Treatment Period (Part 2)||3||
59944259|NCT01343407|76062724|FG004|COMPLETED|Third Treatment Period (Part 2)||3||
59944260|NCT01343407|76062725|FG005|COMPLETED|Third Treatment Period (Part 2)||3||
59944261|NCT01343407|76062720|FG000|NOT COMPLETED|Third Treatment Period (Part 2)||0||
59944262|NCT01343407|76062721|FG001|NOT COMPLETED|Third Treatment Period (Part 2)||0||
59944263|NCT01343407|76062722|FG002|NOT COMPLETED|Third Treatment Period (Part 2)||0||
59944264|NCT01343407|76062723|FG003|NOT COMPLETED|Third Treatment Period (Part 2)||0||
59944265|NCT01343407|76062724|FG004|NOT COMPLETED|Third Treatment Period (Part 2)||0||
59944266|NCT01343407|76062725|FG005|NOT COMPLETED|Third Treatment Period (Part 2)||0||
59944267|NCT01367886|76062733|FG000|STARTED|Overall Study||21||
59944268|NCT01367886|76062733|FG000|COMPLETED|Overall Study||14||
59944269|NCT01367886|76062733|FG000|NOT COMPLETED|Overall Study||7||
59944270|NCT01673698|76062740|FG000|STARTED|Overall Study||187||
59944271|NCT01673698|76062741|FG001|STARTED|Overall Study||139||
59944272|NCT01673698|76062740|FG000|COMPLETED|Overall Study||136||
59944273|NCT01673698|76062741|FG001|COMPLETED|Overall Study||126||
59944274|NCT01673698|76062740|FG000|NOT COMPLETED|Overall Study||51||
59944275|NCT01673698|76062741|FG001|NOT COMPLETED|Overall Study||13||
59944276|NCT02786004|76062750|FG000|STARTED|Overall Study||14||
59944277|NCT02786004|76062751|FG001|STARTED|Overall Study||10||
59944278|NCT02786004|76062750|FG000|COMPLETED|Overall Study||14||
59944279|NCT02786004|76062751|FG001|COMPLETED|Overall Study||9||
59944280|NCT02786004|76062750|FG000|NOT COMPLETED|Overall Study||0||
59944281|NCT02786004|76062751|FG001|NOT COMPLETED|Overall Study||1||
59944282|NCT03051607|76062759|FG000|STARTED|Overall Study||66||
59944283|NCT03051607|76062759|FG000|COMPLETED|Overall Study||0||
59944284|NCT03051607|76062759|FG000|NOT COMPLETED|Overall Study||66||
59762202|NCT04399889|75881903|FG001|NOT COMPLETED|Overall Study||1||
59762203|NCT04399889|75881904|FG002|NOT COMPLETED|Overall Study||1||
59944285|NCT01062399|76062768|FG000|STARTED|Overall Study||8||
59944286|NCT01062399|76062769|FG001|STARTED|Overall Study||10||
59944287|NCT01062399|76062770|FG002|STARTED|Overall Study||8||
59944288|NCT01062399|76062771|FG003|STARTED|Overall Study||89||
59944289|NCT01062399|76062772|FG004|STARTED|Overall Study||92||
59944290|NCT01062399|76062768|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analyses are considered to have completed the study.|8||
59944291|NCT01062399|76062769|FG001|COMPLETED|Overall Study||9||
59944292|NCT01062399|76062770|FG002|COMPLETED|Overall Study||8||
59944293|NCT01062399|76062771|FG003|COMPLETED|Overall Study||83||
59944294|NCT01062399|76062772|FG004|COMPLETED|Overall Study||88||
59944295|NCT01062399|76062768|FG000|NOT COMPLETED|Overall Study||0||
59944296|NCT01062399|76062769|FG001|NOT COMPLETED|Overall Study||1||
59944297|NCT01062399|76062770|FG002|NOT COMPLETED|Overall Study||0||
59944298|NCT01062399|76062771|FG003|NOT COMPLETED|Overall Study||6||
59944299|NCT01062399|76062772|FG004|NOT COMPLETED|Overall Study||4||
59944300|NCT01317277|76062786|FG000|STARTED|Overall Study||50||
59944301|NCT01317277|76062787|FG001|STARTED|Overall Study||25||
59944302|NCT01317277|76062786|FG000|COMPLETED|Overall Study||43||
59944303|NCT01317277|76062787|FG001|COMPLETED|Overall Study||23||
59944304|NCT01317277|76062786|FG000|NOT COMPLETED|Overall Study||7||
59944305|NCT01317277|76062787|FG001|NOT COMPLETED|Overall Study||2||
59944306|NCT04820686|76062796|FG000|STARTED|Overall Study||32||
59944307|NCT04820686|76062797|FG001|STARTED|Overall Study||16||
59944308|NCT04820686|76062798|FG002|STARTED|Overall Study||17||
59944309|NCT04820686|76062796|FG000|COMPLETED|Overall Study||2||
59944310|NCT04820686|76062797|FG001|COMPLETED|Overall Study||0||
59944311|NCT04820686|76062798|FG002|COMPLETED|Overall Study||0||
59944312|NCT04820686|76062796|FG000|NOT COMPLETED|Overall Study||30||
59944313|NCT04820686|76062797|FG001|NOT COMPLETED|Overall Study||16||
59762204|NCT00837265|75881919|FG000|STARTED|Pilot Phase||11||
59762205|NCT00837265|75881920|FG001|STARTED|Pilot Phase||21||
59762206|NCT00837265|75881921|FG002|STARTED|Pilot Phase||20||
59762207|NCT00837265|75881922|FG003|STARTED|Pilot Phase||26||
59762208|NCT00837265|75881923|FG004|STARTED|Pilot Phase||0||
59762209|NCT00837265|75881924|FG005|STARTED|Pilot Phase||0||
59762210|NCT00837265|75881925|FG006|STARTED|Pilot Phase||0||
59762211|NCT00837265|75881919|FG000|Modified Intent-to-treat (mITT) Population|Pilot Phase||10|All participants who were randomized into the study and received at least 1 dose of assigned study drug.|
59762212|NCT00837265|75881920|FG001|Modified Intent-to-treat (mITT) Population|Pilot Phase|1 participant was randomized to this arm but was treated with pegfilgrastim. This participant was included in the pegfilgrastim group for safety analyses.|21|All participants who were randomized into the study and received at least 1 dose of assigned study drug.|
59762213|NCT00837265|75881921|FG002|Modified Intent-to-treat (mITT) Population|Pilot Phase||20|All participants who were randomized into the study and received at least 1 dose of assigned study drug.|
59762214|NCT00837265|75881922|FG003|Modified Intent-to-treat (mITT) Population|Pilot Phase||25|All participants who were randomized into the study and received at least 1 dose of assigned study drug.|
59762215|NCT00837265|75881923|FG004|Modified Intent-to-treat (mITT) Population|Pilot Phase||0|All participants who were randomized into the study and received at least 1 dose of assigned study drug.|
59762216|NCT00837265|75881924|FG005|Modified Intent-to-treat (mITT) Population|Pilot Phase||0|All participants who were randomized into the study and received at least 1 dose of assigned study drug.|
59944314|NCT04820686|76062798|FG002|NOT COMPLETED|Overall Study||17||
59944315|NCT02740478|76062813|FG000|STARTED|Overall Study|Volunteers recruited until quantity 20 completed the study|21||
59944316|NCT02740478|76062813|FG000|COMPLETED|Overall Study|One volunteer was very high BMI and uncomfortable lying still during the recordings: test stopped.|20||
59944317|NCT02740478|76062813|FG000|NOT COMPLETED|Overall Study||1||
59944318|NCT02969655|76062819|FG000|STARTED|Overall Study||136||
59944319|NCT02969655|76062820|FG001|STARTED|Overall Study||135||
59944320|NCT02969655|76062819|FG000|COMPLETED|Overall Study||115||
59944321|NCT02969655|76062820|FG001|COMPLETED|Overall Study||120||
59944322|NCT02969655|76062819|FG000|NOT COMPLETED|Overall Study||21||
59944323|NCT02969655|76062820|FG001|NOT COMPLETED|Overall Study||15||
59944324|NCT01317199|76062831|FG000|STARTED|Dose-escalation Phase 1||14||
59944325|NCT01317199|76062832|FG001|STARTED|Dose-escalation Phase 1||0||
59944326|NCT01317199|76062833|FG002|STARTED|Dose-escalation Phase 1||0||
59944327|NCT01317199|76062834|FG003|STARTED|Dose-escalation Phase 1||0||
59944328|NCT01317199|76062831|FG000|Cycle 1: 500mg MPX Once Daily for 28 Day|Dose-escalation Phase 1||2||
59944329|NCT01317199|76062832|FG001|Cycle 1: 500mg MPX Once Daily for 28 Day|Dose-escalation Phase 1||0||
59944330|NCT01317199|76062833|FG002|Cycle 1: 500mg MPX Once Daily for 28 Day|Dose-escalation Phase 1||0||
59944331|NCT01317199|76062834|FG003|Cycle 1: 500mg MPX Once Daily for 28 Day|Dose-escalation Phase 1||0||
59944332|NCT01317199|76062831|FG000|Cycle 2: 1000mg MPX Daily for 28 Days|Dose-escalation Phase 1||2||
59944333|NCT01317199|76062832|FG001|Cycle 2: 1000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0||
59944334|NCT01317199|76062833|FG002|Cycle 2: 1000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0||
59944335|NCT01317199|76062834|FG003|Cycle 2: 1000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0||
59944336|NCT01317199|76062831|FG000|Cycle 3: 2000mg MPX Daily for 28 Days|Dose-escalation Phase 1||2||
59944337|NCT01317199|76062832|FG001|Cycle 3: 2000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0||
59944338|NCT01317199|76062833|FG002|Cycle 3: 2000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0||
59944339|NCT01317199|76062834|FG003|Cycle 3: 2000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0||
59944340|NCT01317199|76062831|FG000|Cycle 4: 3000mg MPX Daily for 28 Days|Dose-escalation Phase 1||2||
59944341|NCT01317199|76062832|FG001|Cycle 4: 3000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0||
59944342|NCT01317199|76062833|FG002|Cycle 4: 3000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0||
59944343|NCT01317199|76062834|FG003|Cycle 4: 3000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0||
59944344|NCT01317199|76062831|FG000|Cycle 5: 4000mg MPX Daily for 28 Days|Dose-escalation Phase 1||6||
59944345|NCT01317199|76062832|FG001|Cycle 5: 4000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0||
59944346|NCT01317199|76062833|FG002|Cycle 5: 4000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0||
59944347|NCT01317199|76062834|FG003|Cycle 5: 4000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0||
59944348|NCT01317199|76062831|FG000|COMPLETED|Dose-escalation Phase 1||7||
59944349|NCT01317199|76062832|FG001|COMPLETED|Dose-escalation Phase 1||0||
59944350|NCT01317199|76062833|FG002|COMPLETED|Dose-escalation Phase 1||0||
59944351|NCT01317199|76062834|FG003|COMPLETED|Dose-escalation Phase 1||0||
59944352|NCT01317199|76062831|FG000|NOT COMPLETED|Dose-escalation Phase 1||7||
59944353|NCT01317199|76062832|FG001|NOT COMPLETED|Dose-escalation Phase 1||0||
59944354|NCT01317199|76062833|FG002|NOT COMPLETED|Dose-escalation Phase 1||0||
59944355|NCT01317199|76062834|FG003|NOT COMPLETED|Dose-escalation Phase 1||0||
59944356|NCT01317199|76062831|FG000|STARTED|Randomized Phase 2||0||
59944357|NCT01317199|76062832|FG001|STARTED|Randomized Phase 2||24||
59944358|NCT01317199|76062833|FG002|STARTED|Randomized Phase 2||56||
59944359|NCT01317199|76062834|FG003|STARTED|Randomized Phase 2||49||
59944360|NCT01317199|76062831|FG000|COMPLETED|Randomized Phase 2||0||
59944361|NCT01317199|76062832|FG001|COMPLETED|Randomized Phase 2||13||
59944362|NCT01317199|76062833|FG002|COMPLETED|Randomized Phase 2||35||
59944363|NCT01317199|76062834|FG003|COMPLETED|Randomized Phase 2||32||
59944364|NCT01317199|76062831|FG000|NOT COMPLETED|Randomized Phase 2||0||
59944365|NCT01317199|76062832|FG001|NOT COMPLETED|Randomized Phase 2||11||
59944366|NCT01317199|76062833|FG002|NOT COMPLETED|Randomized Phase 2||21||
59944367|NCT01317199|76062834|FG003|NOT COMPLETED|Randomized Phase 2||17||
59944368|NCT02648698|76062853|FG000|STARTED|Overall Study||60||
59944369|NCT02648698|76062854|FG001|STARTED|Overall Study||60||
59944370|NCT02648698|76062853|FG000|COMPLETED|Overall Study||59||
59944371|NCT02648698|76062854|FG001|COMPLETED|Overall Study||55||
59944372|NCT02648698|76062853|FG000|NOT COMPLETED|Overall Study||1||
59944373|NCT02648698|76062854|FG001|NOT COMPLETED|Overall Study||5||
59944374|NCT02970669|76062862|FG000|STARTED|Double-blind Period||70|Randomized|
59944375|NCT02970669|76062863|FG001|STARTED|Double-blind Period||70|Randomized|
59944376|NCT02970669|76062862|FG000|COMPLETED|Double-blind Period||62||
59944377|NCT02970669|76062863|FG001|COMPLETED|Double-blind Period||64||
59944378|NCT02970669|76062862|FG000|NOT COMPLETED|Double-blind Period||8||
59944379|NCT02970669|76062863|FG001|NOT COMPLETED|Double-blind Period||6||
59944380|NCT02970669|76062862|FG000|STARTED|Open-label Period||62||
59944381|NCT02970669|76062863|FG001|STARTED|Open-label Period||64||
59944382|NCT02970669|76062862|FG000|COMPLETED|Open-label Period||58||
59944383|NCT02970669|76062863|FG001|COMPLETED|Open-label Period||62||
59944384|NCT02970669|76062862|FG000|NOT COMPLETED|Open-label Period||4||
59944385|NCT02970669|76062863|FG001|NOT COMPLETED|Open-label Period||2||
59944386|NCT02902965|76062871|FG000|STARTED|Overall Study||74||
59944387|NCT02902965|76062871|FG000|COMPLETED|Overall Study||64||
59944388|NCT02902965|76062871|FG000|NOT COMPLETED|Overall Study||10||
59944389|NCT02902809|76062876|FG000|STARTED|Overall Study||28||
59944390|NCT02902809|76062876|FG000|Treatment Received|Overall Study||28||
59944391|NCT02902809|76062876|FG000|Treatment Completed|Overall Study||2||
59944392|NCT02902809|76062876|FG000|COMPLETED|Overall Study||0||
59944393|NCT02902809|76062876|FG000|NOT COMPLETED|Overall Study||28||
59944394|NCT01362244|76062882|FG000|STARTED|Overall Study||54||
59944395|NCT01362244|76062883|FG001|STARTED|Overall Study||51||
59944396|NCT01362244|76062882|FG000|COMPLETED|Overall Study||22||
59944397|NCT01362244|76062883|FG001|COMPLETED|Overall Study||19||
59944398|NCT01362244|76062882|FG000|NOT COMPLETED|Overall Study||32||
59944399|NCT01362244|76062883|FG001|NOT COMPLETED|Overall Study||32||
59944400|NCT02969187|76062891|FG000|STARTED|Overall Study||63||
59944401|NCT02969187|76062892|FG001|STARTED|Overall Study||63||
59944402|NCT02969187|76062891|FG000|COMPLETED|Overall Study||51||
59944403|NCT02969187|76062892|FG001|COMPLETED|Overall Study||50||
59944404|NCT02969187|76062891|FG000|NOT COMPLETED|Overall Study||12||
59944405|NCT02969187|76062892|FG001|NOT COMPLETED|Overall Study||13||
59944406|NCT03050359|76062902|FG000|STARTED|Overall Study||265||
59944407|NCT03050359|76062903|FG001|STARTED|Overall Study||268||
59944408|NCT03050359|76062902|FG000|COMPLETED|Overall Study||248||
59944409|NCT03050359|76062903|FG001|COMPLETED|Overall Study||248||
59944410|NCT03050359|76062902|FG000|NOT COMPLETED|Overall Study||17||
59944411|NCT03050359|76062903|FG001|NOT COMPLETED|Overall Study||20||
59944412|NCT02785770|76062911|FG000|STARTED|Intervention Period 1 (1 Day)||11||
59944413|NCT02785770|76062912|FG001|STARTED|Intervention Period 1 (1 Day)||11||
59944414|NCT02785770|76062913|FG002|STARTED|Intervention Period 1 (1 Day)||11||
59944415|NCT02785770|76062914|FG003|STARTED|Intervention Period 1 (1 Day)||11||
59944416|NCT02785770|76062911|FG000|COMPLETED|Intervention Period 1 (1 Day)||11||
59944417|NCT02785770|76062912|FG001|COMPLETED|Intervention Period 1 (1 Day)||11||
59944418|NCT02785770|76062913|FG002|COMPLETED|Intervention Period 1 (1 Day)||11||
59944419|NCT02785770|76062914|FG003|COMPLETED|Intervention Period 1 (1 Day)||11||
59944420|NCT02785770|76062911|FG000|NOT COMPLETED|Intervention Period 1 (1 Day)||0||
59944421|NCT02785770|76062912|FG001|NOT COMPLETED|Intervention Period 1 (1 Day)||0||
59944422|NCT02785770|76062913|FG002|NOT COMPLETED|Intervention Period 1 (1 Day)||0||
59944423|NCT02785770|76062914|FG003|NOT COMPLETED|Intervention Period 1 (1 Day)||0||
59944424|NCT02785770|76062911|FG000|STARTED|Washout Period 1 (7 Days)||11||
59944425|NCT02785770|76062912|FG001|STARTED|Washout Period 1 (7 Days)||11||
59944426|NCT02785770|76062913|FG002|STARTED|Washout Period 1 (7 Days)||11||
59944427|NCT02785770|76062914|FG003|STARTED|Washout Period 1 (7 Days)||11||
59944428|NCT02785770|76062911|FG000|COMPLETED|Washout Period 1 (7 Days)||11||
59944429|NCT02785770|76062912|FG001|COMPLETED|Washout Period 1 (7 Days)||11||
59944430|NCT02785770|76062913|FG002|COMPLETED|Washout Period 1 (7 Days)||11||
59944431|NCT02785770|76062914|FG003|COMPLETED|Washout Period 1 (7 Days)||11||
59944432|NCT02785770|76062911|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0||
59944433|NCT02785770|76062912|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0||
59944434|NCT02785770|76062913|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0||
59944435|NCT02785770|76062914|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0||
59944436|NCT02785770|76062911|FG000|STARTED|Intervention Period 2 (1 Day)||11||
59944437|NCT02785770|76062912|FG001|STARTED|Intervention Period 2 (1 Day)||11||
59944438|NCT02785770|76062913|FG002|STARTED|Intervention Period 2 (1 Day)||11||
59944439|NCT02785770|76062914|FG003|STARTED|Intervention Period 2 (1 Day)||11||
59944440|NCT02785770|76062911|FG000|COMPLETED|Intervention Period 2 (1 Day)||11||
59944441|NCT02785770|76062912|FG001|COMPLETED|Intervention Period 2 (1 Day)||10||
59944442|NCT02785770|76062913|FG002|COMPLETED|Intervention Period 2 (1 Day)||10||
59944443|NCT02785770|76062914|FG003|COMPLETED|Intervention Period 2 (1 Day)||11||
59944444|NCT02785770|76062911|FG000|NOT COMPLETED|Intervention Period 2 (1 Day)||0||
59944445|NCT02785770|76062912|FG001|NOT COMPLETED|Intervention Period 2 (1 Day)||1||
59944446|NCT02785770|76062913|FG002|NOT COMPLETED|Intervention Period 2 (1 Day)||1||
59944447|NCT02785770|76062914|FG003|NOT COMPLETED|Intervention Period 2 (1 Day)||0||
59944448|NCT02785770|76062911|FG000|STARTED|Washout Period 2 (7 Days)||11||
59944449|NCT02785770|76062912|FG001|STARTED|Washout Period 2 (7 Days)||10||
59944450|NCT02785770|76062913|FG002|STARTED|Washout Period 2 (7 Days)||10||
59944451|NCT02785770|76062914|FG003|STARTED|Washout Period 2 (7 Days)||11||
59944452|NCT02785770|76062911|FG000|COMPLETED|Washout Period 2 (7 Days)||11||
59944453|NCT02785770|76062912|FG001|COMPLETED|Washout Period 2 (7 Days)||10||
59944454|NCT02785770|76062913|FG002|COMPLETED|Washout Period 2 (7 Days)||10||
59944455|NCT02785770|76062914|FG003|COMPLETED|Washout Period 2 (7 Days)||11||
59944456|NCT02785770|76062911|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0||
59944457|NCT02785770|76062912|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0||
59944458|NCT02785770|76062913|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0||
59944459|NCT02785770|76062914|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0||
59944460|NCT02785770|76062911|FG000|STARTED|Intervention Period 3 (1 Day)||11||
59944461|NCT02785770|76062912|FG001|STARTED|Intervention Period 3 (1 Day)||10||
59944462|NCT02785770|76062913|FG002|STARTED|Intervention Period 3 (1 Day)||10||
59944463|NCT02785770|76062914|FG003|STARTED|Intervention Period 3 (1 Day)||11||
59944464|NCT02785770|76062911|FG000|COMPLETED|Intervention Period 3 (1 Day)||11||
59944465|NCT02785770|76062912|FG001|COMPLETED|Intervention Period 3 (1 Day)||10||
59944466|NCT02785770|76062913|FG002|COMPLETED|Intervention Period 3 (1 Day)||10||
59944467|NCT02785770|76062914|FG003|COMPLETED|Intervention Period 3 (1 Day)||10||
59944468|NCT02785770|76062911|FG000|NOT COMPLETED|Intervention Period 3 (1 Day)||0||
59944469|NCT02785770|76062912|FG001|NOT COMPLETED|Intervention Period 3 (1 Day)||0||
59944470|NCT02785770|76062913|FG002|NOT COMPLETED|Intervention Period 3 (1 Day)||0||
59944471|NCT02785770|76062914|FG003|NOT COMPLETED|Intervention Period 3 (1 Day)||1||
59944472|NCT02785770|76062911|FG000|STARTED|Washout Period 3 (7 Days)||11||
59944473|NCT02785770|76062912|FG001|STARTED|Washout Period 3 (7 Days)||10||
59944474|NCT02785770|76062913|FG002|STARTED|Washout Period 3 (7 Days)||10||
59944475|NCT02785770|76062914|FG003|STARTED|Washout Period 3 (7 Days)||10||
59944476|NCT02785770|76062911|FG000|COMPLETED|Washout Period 3 (7 Days)||11||
59944477|NCT02785770|76062912|FG001|COMPLETED|Washout Period 3 (7 Days)||10||
59944478|NCT02785770|76062913|FG002|COMPLETED|Washout Period 3 (7 Days)||10||
59944479|NCT02785770|76062914|FG003|COMPLETED|Washout Period 3 (7 Days)||10||
59944480|NCT02785770|76062911|FG000|NOT COMPLETED|Washout Period 3 (7 Days)||0||
59944481|NCT02785770|76062912|FG001|NOT COMPLETED|Washout Period 3 (7 Days)||0||
59944482|NCT02785770|76062913|FG002|NOT COMPLETED|Washout Period 3 (7 Days)||0||
59944483|NCT02785770|76062914|FG003|NOT COMPLETED|Washout Period 3 (7 Days)||0||
59944484|NCT02785770|76062911|FG000|STARTED|Intervention Period 4 (1 Day)||11||
59944485|NCT02785770|76062912|FG001|STARTED|Intervention Period 4 (1 Day)||10||
59944486|NCT02785770|76062913|FG002|STARTED|Intervention Period 4 (1 Day)||10||
59944487|NCT02785770|76062914|FG003|STARTED|Intervention Period 4 (1 Day)||10||
59944488|NCT02785770|76062911|FG000|COMPLETED|Intervention Period 4 (1 Day)||11||
59944489|NCT02785770|76062912|FG001|COMPLETED|Intervention Period 4 (1 Day)||10||
59762217|NCT00837265|75881925|FG006|Modified Intent-to-treat (mITT) Population|Pilot Phase||0|All participants who were randomized into the study and received at least 1 dose of assigned study drug.|
59762218|NCT00837265|75881919|FG000|COMPLETED|Pilot Phase||8||
59762219|NCT00837265|75881920|FG001|COMPLETED|Pilot Phase||18||
59762220|NCT00837265|75881921|FG002|COMPLETED|Pilot Phase||17||
59762221|NCT00837265|75881922|FG003|COMPLETED|Pilot Phase||22||
59762222|NCT00837265|75881923|FG004|COMPLETED|Pilot Phase||0||
59762223|NCT00837265|75881924|FG005|COMPLETED|Pilot Phase||0||
59762224|NCT00837265|75881925|FG006|COMPLETED|Pilot Phase||0||
59762225|NCT00837265|75881919|FG000|NOT COMPLETED|Pilot Phase||3||
59762226|NCT00837265|75881920|FG001|NOT COMPLETED|Pilot Phase||3||
59762227|NCT00837265|75881921|FG002|NOT COMPLETED|Pilot Phase||3||
59762228|NCT00837265|75881922|FG003|NOT COMPLETED|Pilot Phase||4||
59762229|NCT00837265|75881923|FG004|NOT COMPLETED|Pilot Phase||0||
59762230|NCT00837265|75881924|FG005|NOT COMPLETED|Pilot Phase||0||
59762231|NCT00837265|75881925|FG006|NOT COMPLETED|Pilot Phase||0||
59762232|NCT00837265|75881919|FG000|STARTED|Main Phase||0||
59762233|NCT00837265|75881920|FG001|STARTED|Main Phase||0||
59762234|NCT00837265|75881921|FG002|STARTED|Main Phase||0||
59762235|NCT00837265|75881922|FG003|STARTED|Main Phase||0||
59762236|NCT00837265|75881923|FG004|STARTED|Main Phase||86||
59762237|NCT00837265|75881924|FG005|STARTED|Main Phase||84||
59762238|NCT00837265|75881925|FG006|STARTED|Main Phase||86||
59762239|NCT00837265|75881919|FG000|Received at Least 1 Dose of Study Drug|Main Phase||0||
59762240|NCT00837265|75881920|FG001|Received at Least 1 Dose of Study Drug|Main Phase||0||
59762241|NCT00837265|75881921|FG002|Received at Least 1 Dose of Study Drug|Main Phase||0||
59762242|NCT00837265|75881922|FG003|Received at Least 1 Dose of Study Drug|Main Phase||0||
59762243|NCT00837265|75881923|FG004|Received at Least 1 Dose of Study Drug|Main Phase||85||
59762244|NCT00837265|75881924|FG005|Received at Least 1 Dose of Study Drug|Main Phase||84||
59762245|NCT00837265|75881925|FG006|Received at Least 1 Dose of Study Drug|Main Phase||86||
59762246|NCT00837265|75881919|FG000|COMPLETED|Main Phase||0||
59762247|NCT00837265|75881920|FG001|COMPLETED|Main Phase||0||
59762248|NCT00837265|75881921|FG002|COMPLETED|Main Phase||0||
59944490|NCT02785770|76062913|FG002|COMPLETED|Intervention Period 4 (1 Day)||10||
59944491|NCT02785770|76062914|FG003|COMPLETED|Intervention Period 4 (1 Day)||10||
59944492|NCT02785770|76062911|FG000|NOT COMPLETED|Intervention Period 4 (1 Day)||0||
59944493|NCT02785770|76062912|FG001|NOT COMPLETED|Intervention Period 4 (1 Day)||0||
59944494|NCT02785770|76062913|FG002|NOT COMPLETED|Intervention Period 4 (1 Day)||0||
59944495|NCT02785770|76062914|FG003|NOT COMPLETED|Intervention Period 4 (1 Day)||0||
59944496|NCT02965833|76062927|FG000|STARTED|Period 1, First 30 Days of Wear||67||
59944497|NCT02965833|76062928|FG001|STARTED|Period 1, First 30 Days of Wear||54||
59944498|NCT02965833|76062927|FG000|COMPLETED|Period 1, First 30 Days of Wear||64||
59944499|NCT02965833|76062928|FG001|COMPLETED|Period 1, First 30 Days of Wear||52||
59944500|NCT02965833|76062927|FG000|NOT COMPLETED|Period 1, First 30 Days of Wear||3||
59944501|NCT02965833|76062928|FG001|NOT COMPLETED|Period 1, First 30 Days of Wear||2||
59944502|NCT02965833|76062927|FG000|STARTED|Period 2, Second 30 Days of Wear||64||
59944503|NCT02965833|76062928|FG001|STARTED|Period 2, Second 30 Days of Wear||52||
59944504|NCT02965833|76062927|FG000|COMPLETED|Period 2, Second 30 Days of Wear||62||
59944505|NCT02965833|76062928|FG001|COMPLETED|Period 2, Second 30 Days of Wear||52||
59944506|NCT02965833|76062927|FG000|NOT COMPLETED|Period 2, Second 30 Days of Wear||2||
59944507|NCT02965833|76062928|FG001|NOT COMPLETED|Period 2, Second 30 Days of Wear||0||
59944508|NCT02968173|76062934|FG000|STARTED|Overall Study||50||
59944509|NCT02968173|76062934|FG000|COMPLETED|Overall Study||49||
59944510|NCT02968173|76062934|FG000|NOT COMPLETED|Overall Study||1||
59944511|NCT02785458|76062941|FG000|STARTED|Baseline||526||
59944512|NCT02785458|76062942|FG001|STARTED|Baseline||479||
59944513|NCT02785458|76062941|FG000|COMPLETED|Baseline||526||
59944514|NCT02785458|76062942|FG001|COMPLETED|Baseline||479||
59944515|NCT02785458|76062941|FG000|NOT COMPLETED|Baseline||0||
59944516|NCT02785458|76062942|FG001|NOT COMPLETED|Baseline||0||
59944517|NCT02785458|76062941|FG000|STARTED|1 Month||526||
59944518|NCT02785458|76062942|FG001|STARTED|1 Month||479||
59944519|NCT02785458|76062941|FG000|COMPLETED|1 Month||443||
59944520|NCT02785458|76062942|FG001|COMPLETED|1 Month||404||
59762249|NCT00837265|75881922|FG003|COMPLETED|Main Phase||0||
59762250|NCT00837265|75881923|FG004|COMPLETED|Main Phase||76||
59762251|NCT00837265|75881924|FG005|COMPLETED|Main Phase||79||
59762252|NCT00837265|75881925|FG006|COMPLETED|Main Phase||83||
59762253|NCT00837265|75881919|FG000|NOT COMPLETED|Main Phase||0||
59762254|NCT00837265|75881920|FG001|NOT COMPLETED|Main Phase||0||
59762255|NCT00837265|75881921|FG002|NOT COMPLETED|Main Phase||0||
59762256|NCT00837265|75881922|FG003|NOT COMPLETED|Main Phase||0||
59762257|NCT00837265|75881923|FG004|NOT COMPLETED|Main Phase||10||
59944521|NCT02785458|76062941|FG000|NOT COMPLETED|1 Month||83||
59944522|NCT02785458|76062942|FG001|NOT COMPLETED|1 Month||75||
59944523|NCT02785458|76062941|FG000|STARTED|3 Months||443||
59944524|NCT02785458|76062942|FG001|STARTED|3 Months||404||
59944525|NCT02785458|76062941|FG000|COMPLETED|3 Months||315||
59944526|NCT02785458|76062942|FG001|COMPLETED|3 Months||293||
59762258|NCT00837265|75881924|FG005|NOT COMPLETED|Main Phase||5||
59762259|NCT00837265|75881925|FG006|NOT COMPLETED|Main Phase||3||
59944527|NCT02785458|76062941|FG000|NOT COMPLETED|3 Months||128||
59944528|NCT02785458|76062942|FG001|NOT COMPLETED|3 Months||111||
59944529|NCT02784834|76062948|FG000|STARTED|Overall Study||2||
59944530|NCT02784834|76062948|FG000|COMPLETED|Overall Study||1||
59944531|NCT02784834|76062948|FG000|NOT COMPLETED|Overall Study||1||
59944532|NCT02966223|76062952|FG000|STARTED|Overall Study||20||
59944533|NCT02966223|76062952|FG000|COMPLETED|Overall Study||5||
59944534|NCT02966223|76062952|FG000|NOT COMPLETED|Overall Study||15||
59944535|NCT03049735|76062959|FG000|STARTED|Overall Study||128||
59944536|NCT03049735|76062960|FG001|STARTED|Overall Study||132||
59944537|NCT03049735|76062961|FG002|STARTED|Overall Study||128||
59944538|NCT03049735|76062959|FG000|Received at Least 1 Dose of Study Drug|Overall Study||128||
59944539|NCT03049735|76062960|FG001|Received at Least 1 Dose of Study Drug|Overall Study||132||
59944540|NCT03049735|76062961|FG002|Received at Least 1 Dose of Study Drug|Overall Study||127||
59944541|NCT03049735|76062959|FG000|COMPLETED|Overall Study||100||
59944542|NCT03049735|76062960|FG001|COMPLETED|Overall Study||103||
59944543|NCT03049735|76062961|FG002|COMPLETED|Overall Study||105||
59944544|NCT03049735|76062959|FG000|NOT COMPLETED|Overall Study||28||
59944545|NCT03049735|76062960|FG001|NOT COMPLETED|Overall Study||29||
59944546|NCT03049735|76062961|FG002|NOT COMPLETED|Overall Study||23||
59944547|NCT01295944|76062969|FG000|STARTED|Overall Study||35||
59944548|NCT01295944|76062969|FG000|COMPLETED|Overall Study||17||
59944549|NCT01295944|76062969|FG000|NOT COMPLETED|Overall Study||18||
59944550|NCT02965599|76062975|FG000|STARTED|Overall Study||2||
59944551|NCT02965599|76062976|FG001|STARTED|Overall Study||1||
59944552|NCT02965599|76062975|FG000|COMPLETED|Overall Study||1||
59944553|NCT02965599|76062976|FG001|COMPLETED|Overall Study||1||
59944554|NCT02965599|76062975|FG000|NOT COMPLETED|Overall Study||1||
59944555|NCT02965599|76062976|FG001|NOT COMPLETED|Overall Study||0||
59944556|NCT02898597|76062985|FG000|STARTED|Overall Study||25||
59944557|NCT02898597|76062986|FG001|STARTED|Overall Study||24||
59944558|NCT02898597|76062985|FG000|COMPLETED|Overall Study||21||
59944559|NCT02898597|76062986|FG001|COMPLETED|Overall Study||12||
59944560|NCT02898597|76062985|FG000|NOT COMPLETED|Overall Study||4||
59944561|NCT02898597|76062986|FG001|NOT COMPLETED|Overall Study||12||
59944562|NCT02899377|76062994|FG000|STARTED|Overall Study||13||
59944563|NCT02899377|76062995|FG001|STARTED|Overall Study||12||
59944564|NCT02899377|76062994|FG000|COMPLETED|Overall Study||12||
59944565|NCT02899377|76062995|FG001|COMPLETED|Overall Study||12||
59944566|NCT02899377|76062994|FG000|NOT COMPLETED|Overall Study||1||
59944567|NCT02899377|76062995|FG001|NOT COMPLETED|Overall Study||0||
59944568|NCT01316887|76063006|FG000|STARTED|Overall Study||109||
59944569|NCT01316887|76063007|FG001|STARTED|Overall Study||227||
59944570|NCT01316887|76063008|FG002|STARTED|Overall Study||226||
59944571|NCT01316887|76063006|FG000|COMPLETED|Overall Study||66||
59944572|NCT01316887|76063007|FG001|COMPLETED|Overall Study||133||
59944573|NCT01316887|76063008|FG002|COMPLETED|Overall Study||143||
59944574|NCT01316887|76063006|FG000|NOT COMPLETED|Overall Study||43||
59518714|NCT01110421|75612552|FG000|NOT COMPLETED|Overall Study||0||
59518715|NCT01110421|75612553|FG001|NOT COMPLETED|Overall Study||0||
59518716|NCT01110499|75612567|FG000|STARTED|Overall Study||14||
59518717|NCT01110499|75612568|FG001|STARTED|Overall Study||14||
59762260|NCT00594516|75881938|FG000|STARTED|Open Label (OL): Tapentadol IR|one patient was enrolled but lost to follow up at the start of open label therefore was not included|116||
59944575|NCT01316887|76063007|FG001|NOT COMPLETED|Overall Study||94||
59944576|NCT01316887|76063008|FG002|NOT COMPLETED|Overall Study||83||
59944577|NCT02897349|76063019|FG000|STARTED|Overall Study||102|Started are randomized/ treated|
59944578|NCT02897349|76063020|FG001|STARTED|Overall Study||104|Started are randomized/ treated|
59944579|NCT02897349|76063019|FG000|COMPLETED|Overall Study||97||
59944580|NCT02897349|76063020|FG001|COMPLETED|Overall Study||98||
60067546|NCT01938391|76182720|FG000|COMPLETED|12 Month Follow up||22||
59518718|NCT01110499|75612569|FG002|STARTED|Overall Study||14||
59518719|NCT01110499|75612570|FG003|STARTED|Overall Study||14||
59518720|NCT01110499|75612571|FG004|STARTED|Overall Study||14||
59518721|NCT01110499|75612572|FG005|STARTED|Overall Study||14||
59518722|NCT01110499|75612573|FG006|STARTED|Overall Study||39||
59518723|NCT01110499|75612574|FG007|STARTED|Overall Study||40||
59518724|NCT01110499|75612567|FG000|COMPLETED|Overall Study||14||
59518725|NCT01110499|75612568|FG001|COMPLETED|Overall Study||14||
59944581|NCT02897349|76063019|FG000|NOT COMPLETED|Overall Study||5||
59944582|NCT02897349|76063020|FG001|NOT COMPLETED|Overall Study||6||
59944583|NCT03699748|76063028|FG000|STARTED|Overall Study||80||
59944584|NCT03699748|76063029|FG001|STARTED|Overall Study||80||
59944585|NCT03699748|76063028|FG000|Completed Baseline Survey|Overall Study||80||
59944586|NCT03699748|76063029|FG001|Completed Baseline Survey|Overall Study||80||
59944587|NCT03699748|76063028|FG000|Completed 4 Month Survey|Overall Study||74||
59944588|NCT03699748|76063029|FG001|Completed 4 Month Survey|Overall Study||71||
59944589|NCT03699748|76063028|FG000|Completed 12 Month Survey|Overall Study||59||
59944590|NCT03699748|76063029|FG001|Completed 12 Month Survey|Overall Study||57||
59944591|NCT03699748|76063028|FG000|COMPLETED|Overall Study||58||
59944592|NCT03699748|76063029|FG001|COMPLETED|Overall Study||57||
59944593|NCT03699748|76063028|FG000|NOT COMPLETED|Overall Study||22||
59944594|NCT03699748|76063029|FG001|NOT COMPLETED|Overall Study||23||
59944595|NCT03047551|76063037|FG000|STARTED|Overall Study||319||
59944596|NCT03047551|76063038|FG001|STARTED|Overall Study||315||
59944597|NCT03047551|76063037|FG000|COMPLETED|Overall Study||317||
59944598|NCT03047551|76063038|FG001|COMPLETED|Overall Study||312||
59944599|NCT03047551|76063037|FG000|NOT COMPLETED|Overall Study||2||
59944600|NCT03047551|76063038|FG001|NOT COMPLETED|Overall Study||3||
59944601|NCT02964741|76063047|FG000|STARTED|Overall Study||15||
59944602|NCT02964741|76063048|FG001|STARTED|Overall Study||13||
59944603|NCT02964741|76063049|FG002|STARTED|Overall Study||12||
59944604|NCT02964741|76063047|FG000|COMPLETED|Overall Study||13||
59944605|NCT02964741|76063048|FG001|COMPLETED|Overall Study||12||
59944606|NCT02964741|76063049|FG002|COMPLETED|Overall Study||12||
59944607|NCT02964741|76063047|FG000|NOT COMPLETED|Overall Study||2||
59944608|NCT02964741|76063048|FG001|NOT COMPLETED|Overall Study||1||
59944609|NCT02964741|76063049|FG002|NOT COMPLETED|Overall Study||0||
59944610|NCT01316419|76063055|FG000|STARTED|Overall Study||2089||
59944611|NCT01316419|76063055|FG000|COMPLETED|Overall Study||1824||
59944612|NCT01316419|76063055|FG000|NOT COMPLETED|Overall Study||265||
59944613|NCT02964039|76063062|FG000|STARTED|Overall Study||18||
59944614|NCT02964039|76063063|FG001|STARTED|Overall Study||18||
59944615|NCT02964039|76063064|FG002|STARTED|Overall Study||18||
59944616|NCT02964039|76063062|FG000|Received Allocated Intervention|Overall Study||15||
59944617|NCT02964039|76063063|FG001|Received Allocated Intervention|Overall Study||17||
59944618|NCT02964039|76063064|FG002|Received Allocated Intervention|Overall Study||14||
59944619|NCT02964039|76063062|FG000|COMPLETED|Overall Study||14|Re-assessed after 12-week follow-up period|
59944620|NCT02964039|76063063|FG001|COMPLETED|Overall Study||17|Re-assessed after 12-week follow-up period|
59944621|NCT02964039|76063064|FG002|COMPLETED|Overall Study||13|Re-assessed after 12-week follow-up period|
59944622|NCT02964039|76063062|FG000|NOT COMPLETED|Overall Study||4||
59944623|NCT02964039|76063063|FG001|NOT COMPLETED|Overall Study||1||
59944624|NCT02964039|76063064|FG002|NOT COMPLETED|Overall Study||5||
59944625|NCT02897115|76063074|FG000|STARTED|Overall Study||14||
59944626|NCT02897115|76063075|FG001|STARTED|Overall Study||8||
59944627|NCT02897115|76063074|FG000|COMPLETED|Overall Study||3||
59944628|NCT02897115|76063075|FG001|COMPLETED|Overall Study||0||
59944629|NCT02897115|76063074|FG000|NOT COMPLETED|Overall Study||11||
59944630|NCT02897115|76063075|FG001|NOT COMPLETED|Overall Study||8||
59944631|NCT02896569|76063083|FG000|STARTED|Overall Study||25||
59944632|NCT02896569|76063084|FG001|STARTED|Overall Study||24||
59944633|NCT02896569|76063083|FG000|COMPLETED|Overall Study||21||
59944634|NCT02896569|76063084|FG001|COMPLETED|Overall Study||19||
59944635|NCT02896569|76063083|FG000|NOT COMPLETED|Overall Study||4||
59944636|NCT02896569|76063084|FG001|NOT COMPLETED|Overall Study||5||
59944637|NCT04030195|76063093|FG000|STARTED|Overall Study||8|One participant who was retreated was dosed with Dose Level 3 at both initial and retreatment dosing. For the purposes of calculating and reporting participant flow and efficacy outcomes, the participant who was dosed twice was counted as 2 individual participants.|
59944638|NCT04030195|76063094|FG001|STARTED|Overall Study||3|One participant who was retreated was dosed with Dose Level 3 at both initial and retreatment dosing. For the purposes of calculating and reporting participant flow and efficacy outcomes, the participant who was dosed twice was counted as 2 individual participants.|
59944639|NCT04030195|76063095|FG002|STARTED|Overall Study||7|One participant who was retreated was dosed with Dose Level 3 at both initial and retreatment dosing. For the purposes of calculating and reporting participant flow and efficacy outcomes, the participant who was dosed twice was counted as 2 individual participants.|
59944640|NCT04030195|76063093|FG000|Participants in Demographic Population|Overall Study||8||
59944641|NCT04030195|76063094|FG001|Participants in Demographic Population|Overall Study||3||
59944642|NCT04030195|76063095|FG002|Participants in Demographic Population|Overall Study||6||
59944643|NCT04030195|76063093|FG000|Participants in Safety Population|Overall Study||8||
59944644|NCT04030195|76063094|FG001|Participants in Safety Population|Overall Study||3||
59944645|NCT04030195|76063095|FG002|Participants in Safety Population|Overall Study||6||
59944646|NCT04030195|76063093|FG000|Participants Re-treated|Overall Study||0||
59944647|NCT04030195|76063094|FG001|Participants Re-treated|Overall Study||0||
59944648|NCT04030195|76063095|FG002|Participants Re-treated|Overall Study||1||
59944649|NCT04030195|76063093|FG000|Participants in Efficacy Population|Overall Study||8||
59944650|NCT04030195|76063094|FG001|Participants in Efficacy Population|Overall Study||3||
59944651|NCT04030195|76063095|FG002|Participants in Efficacy Population|Overall Study||7||
59944652|NCT04030195|76063093|FG000|COMPLETED|Overall Study||6||
59944653|NCT04030195|76063094|FG001|COMPLETED|Overall Study||3||
59944654|NCT04030195|76063095|FG002|COMPLETED|Overall Study||7||
59944655|NCT04030195|76063093|FG000|NOT COMPLETED|Overall Study||2||
59944656|NCT04030195|76063094|FG001|NOT COMPLETED|Overall Study||0||
59944657|NCT04030195|76063095|FG002|NOT COMPLETED|Overall Study||0||
59944658|NCT01673620|76063106|FG000|STARTED|Overall Study||47||
59944659|NCT01673620|76063107|FG001|STARTED|Overall Study||22||
59944660|NCT01673620|76063106|FG000|COMPLETED|Overall Study||46||
59944661|NCT01673620|76063107|FG001|COMPLETED|Overall Study||22||
59944662|NCT01673620|76063106|FG000|NOT COMPLETED|Overall Study||1||
59944663|NCT01673620|76063107|FG001|NOT COMPLETED|Overall Study||0||
59944664|NCT00432094|76063113|FG000|STARTED|Overall Study||14||
59944665|NCT00432094|76063114|FG001|STARTED|Overall Study||9||
60067547|NCT01938391|76182720|FG000|NOT COMPLETED|12 Month Follow up||2||
59944666|NCT00432094|76063113|FG000|COMPLETED|Overall Study||14||
59944667|NCT00432094|76063114|FG001|COMPLETED|Overall Study||9||
59944668|NCT00432094|76063113|FG000|NOT COMPLETED|Overall Study||0||
59944669|NCT00432094|76063114|FG001|NOT COMPLETED|Overall Study||0||
59944670|NCT03044197|76063121|FG000|STARTED|Overall Study||12||
59944671|NCT03044197|76063122|FG001|STARTED|Overall Study||12||
59944672|NCT03044197|76063121|FG000|COMPLETED|Overall Study||9||
59944673|NCT03044197|76063122|FG001|COMPLETED|Overall Study||11||
59944674|NCT03044197|76063121|FG000|NOT COMPLETED|Overall Study||3||
59944675|NCT03044197|76063122|FG001|NOT COMPLETED|Overall Study||1||
59944676|NCT00072358|76063128|FG000|STARTED|Overall Study||291||
59944677|NCT00072358|76063128|FG000|COMPLETED|Overall Study||291||
59944678|NCT00072358|76063128|FG000|NOT COMPLETED|Overall Study||0||
59944679|NCT03990766|76063134|FG000|STARTED|Overall Study||14||
59944680|NCT03990766|76063135|FG001|STARTED|Overall Study||13||
59944681|NCT03990766|76063134|FG000|COMPLETED|Overall Study||12||
59944682|NCT03990766|76063135|FG001|COMPLETED|Overall Study||10||
59944683|NCT03990766|76063134|FG000|NOT COMPLETED|Overall Study||2||
59944684|NCT03990766|76063135|FG001|NOT COMPLETED|Overall Study||3||
59944685|NCT02807350|76063143|FG000|STARTED|Overall Study||196||
59944686|NCT02807350|76063144|FG001|STARTED|Overall Study||190||
59944687|NCT02807350|76063143|FG000|6 mo Follow Up Visit|Overall Study||188||
59944688|NCT02807350|76063144|FG001|6 mo Follow Up Visit|Overall Study||171||
59944689|NCT02807350|76063143|FG000|12 mo Follow Up Visit|Overall Study||189||
59944690|NCT02807350|76063144|FG001|12 mo Follow Up Visit|Overall Study||169||
59944691|NCT02807350|76063143|FG000|15 mo Follow Up Visit|Overall Study||180||
59944692|NCT02807350|76063144|FG001|15 mo Follow Up Visit|Overall Study||153||
59944693|NCT02807350|76063143|FG000|COMPLETED|Overall Study||176||
59944694|NCT02807350|76063144|FG001|COMPLETED|Overall Study||155||
59944695|NCT02807350|76063143|FG000|NOT COMPLETED|Overall Study||20||
59944696|NCT02807350|76063144|FG001|NOT COMPLETED|Overall Study||35||
59944697|NCT03043651|76063150|FG000|STARTED|Overall Study||48||
59944698|NCT03043651|76063150|FG000|COMPLETED|Overall Study||0||
59944699|NCT03043651|76063150|FG000|NOT COMPLETED|Overall Study||48||
59944700|NCT03536143|76063154|FG000|STARTED|Overall Study|The numbers of wounds selected for each subject were 2 in Phase 1 (2 subjects, B-VEC: Placebo = 1:1), 3 in Phase 2a and 2b (9 subjects, B-VEC: Placebo = 2:1), and 2 in Phase 2c (1 subject, B-VEC: Placebo = 1:1). The total wounds selected for this study were 33 (=2x2+9x3+2x1), in which 21 received B-VEC and 12 received Placebo.|12||33
59944701|NCT03536143|76063154|FG000|B-VEC|Overall Study||12||21
59944702|NCT03536143|76063154|FG000|Placebo|Overall Study||12||12
59944703|NCT03536143|76063154|FG000|COMPLETED|Overall Study||11||31
59944704|NCT03536143|76063154|FG000|NOT COMPLETED|Overall Study||1||2
59944705|NCT01344759|76063164|FG000|STARTED|Overall Study||30||
59944706|NCT01344759|76063165|FG001|STARTED|Overall Study||30||
59944707|NCT01344759|76063164|FG000|COMPLETED|Overall Study||30||
59944708|NCT01344759|76063165|FG001|COMPLETED|Overall Study|Two of the original DEX group subjects were removed, due to receiving dexmedetomidine and propofol.|28||
59944709|NCT01344759|76063164|FG000|NOT COMPLETED|Overall Study||0||
59944710|NCT01344759|76063165|FG001|NOT COMPLETED|Overall Study||2||
59944711|NCT05584176|76063179|FG000|STARTED|Overall Study||298||
59944712|NCT05584176|76063180|FG001|STARTED|Overall Study||34||
59944713|NCT05584176|76063179|FG000|COMPLETED|Overall Study||298||
59944714|NCT05584176|76063180|FG001|COMPLETED|Overall Study||34||
59944715|NCT05584176|76063179|FG000|NOT COMPLETED|Overall Study||0||
59944716|NCT05584176|76063180|FG001|NOT COMPLETED|Overall Study||0||
59944717|NCT05027451|76063188|FG000|STARTED|Overall Study||7||
59944718|NCT05027451|76063189|FG001|STARTED|Overall Study||2||
59944719|NCT05027451|76063188|FG000|COMPLETED|Overall Study||6||
59944720|NCT05027451|76063189|FG001|COMPLETED|Overall Study||1||
59944721|NCT05027451|76063188|FG000|NOT COMPLETED|Overall Study||1||
59944722|NCT05027451|76063189|FG001|NOT COMPLETED|Overall Study||1||
59944723|NCT05000047|76063195|FG000|STARTED|Overall Study||30||
59944724|NCT05000047|76063195|FG000|COMPLETED|Overall Study||30||
59944725|NCT05000047|76063195|FG000|NOT COMPLETED|Overall Study||0||
59944726|NCT04810247|76063212|FG000|STARTED|Overall Study||46||
59944727|NCT04810247|76063212|FG000|COMPLETED|Overall Study||39||
59944728|NCT04810247|76063212|FG000|NOT COMPLETED|Overall Study||7||
60067548|NCT01915303|76182724|FG000|STARTED|Core Phase||68||
60067549|NCT01915303|76182724|FG000|COMPLETED|Core Phase||52||
60067550|NCT01915303|76182724|FG000|NOT COMPLETED|Core Phase||16||
59944732|NCT04549454|76063227|FG000|STARTED|T1 to T2||134|Note that the participant flow reported here reflects the period between the student baseline (July 2021 [T1]) and first follow-up (October 2021 [T2]) surveys. Thus, the number of participants reported during this period reflects the number of students who completed the surveys between T1 and T2. Students, not parents, are the ones who reported on outcomes. Parent data was not collected and therefore we could not include them in the Participant Flow.|
59944733|NCT04549454|76063228|FG001|STARTED|T1 to T2||132|Note that the participant flow reported here reflects the period between the student baseline (July 2021 [T1]) and first follow-up (October 2021 [T2]) surveys. Thus, the number of participants reported during this period reflects the number of students who completed the surveys between T1 and T2. Students, not parents, are the ones who reported on outcomes. Parent data was not collected and therefore we could not include them in the Participant Flow.|
59944734|NCT04549454|76063227|FG000|COMPLETED|T1 to T2||112||
60067551|NCT01915303|76182724|FG000|STARTED|Extension Phase||29||
60067552|NCT01915303|76182724|FG000|COMPLETED|Extension Phase||12||
59944735|NCT04549454|76063228|FG001|COMPLETED|T1 to T2||106||
59944736|NCT04549454|76063227|FG000|NOT COMPLETED|T1 to T2||22||
59944737|NCT04549454|76063228|FG001|NOT COMPLETED|T1 to T2||26||
59944738|NCT04549454|76063227|FG000|STARTED|T1 to T3||134|Note that the participant flow reported here reflects the period between the student baseline (July 2021 [T1]) and second follow-up (February 2022 [T3]) surveys. Thus, the number of participants reported during this period reflects the number of students who completed the surveys between T1 and T3. Students, not parents, are the ones who reported on outcomes. Parent data was not collected and therefore we could not include them in the Participant Flow.|
59944739|NCT04549454|76063228|FG001|STARTED|T1 to T3||132|Note that the participant flow reported here reflects the period between the student baseline (July 2021 [T1]) and second follow-up (February 2022 [T3]) surveys. Thus, the number of participants reported during this period reflects the number of students who completed the surveys between T1 and T3. Students, not parents, are the ones who reported on outcomes. Parent data was not collected and therefore we could not include them in the Participant Flow.|
59944740|NCT04549454|76063227|FG000|COMPLETED|T1 to T3||103||
59944741|NCT04549454|76063228|FG001|COMPLETED|T1 to T3||96||
59944742|NCT04549454|76063227|FG000|NOT COMPLETED|T1 to T3||31||
59944743|NCT04549454|76063228|FG001|NOT COMPLETED|T1 to T3||36||
59944744|NCT04504331|76063236|FG000|STARTED|Dose Level 1 (up to 18 28-day Cycles+FU)||3||
59944745|NCT04504331|76063237|FG001|STARTED|Dose Level 1 (up to 18 28-day Cycles+FU)||0||
59944746|NCT04504331|76063238|FG002|STARTED|Dose Level 1 (up to 18 28-day Cycles+FU)||0||
59944747|NCT04504331|76063236|FG000|Completed at Least 6 Treatment Cycles|Dose Level 1 (up to 18 28-day Cycles+FU)||3||
59944748|NCT04504331|76063237|FG001|Completed at Least 6 Treatment Cycles|Dose Level 1 (up to 18 28-day Cycles+FU)||0||
59944749|NCT04504331|76063238|FG002|Completed at Least 6 Treatment Cycles|Dose Level 1 (up to 18 28-day Cycles+FU)||0||
59944750|NCT04504331|76063236|FG000|COMPLETED|Dose Level 1 (up to 18 28-day Cycles+FU)||3||
59944751|NCT04504331|76063237|FG001|COMPLETED|Dose Level 1 (up to 18 28-day Cycles+FU)||0||
59944752|NCT04504331|76063238|FG002|COMPLETED|Dose Level 1 (up to 18 28-day Cycles+FU)||0||
59944753|NCT04504331|76063236|FG000|NOT COMPLETED|Dose Level 1 (up to 18 28-day Cycles+FU)||0||
59944754|NCT04504331|76063237|FG001|NOT COMPLETED|Dose Level 1 (up to 18 28-day Cycles+FU)||0||
59944755|NCT04504331|76063238|FG002|NOT COMPLETED|Dose Level 1 (up to 18 28-day Cycles+FU)||0||
59944756|NCT04504331|76063236|FG000|STARTED|Dose Level 2 (up to 18 28-day Cycles+FU)||0||
59944757|NCT04504331|76063237|FG001|STARTED|Dose Level 2 (up to 18 28-day Cycles+FU)||1||
59944758|NCT04504331|76063238|FG002|STARTED|Dose Level 2 (up to 18 28-day Cycles+FU)||0||
59944759|NCT04504331|76063236|FG000|Completed at Least 6 Treatment Cycles|Dose Level 2 (up to 18 28-day Cycles+FU)||0||
59944760|NCT04504331|76063237|FG001|Completed at Least 6 Treatment Cycles|Dose Level 2 (up to 18 28-day Cycles+FU)||0||
59944761|NCT04504331|76063238|FG002|Completed at Least 6 Treatment Cycles|Dose Level 2 (up to 18 28-day Cycles+FU)||0||
59944762|NCT04504331|76063236|FG000|COMPLETED|Dose Level 2 (up to 18 28-day Cycles+FU)||0||
59944763|NCT04504331|76063237|FG001|COMPLETED|Dose Level 2 (up to 18 28-day Cycles+FU)||1||
59944764|NCT04504331|76063238|FG002|COMPLETED|Dose Level 2 (up to 18 28-day Cycles+FU)||0||
59944765|NCT04504331|76063236|FG000|NOT COMPLETED|Dose Level 2 (up to 18 28-day Cycles+FU)||0||
59944766|NCT04504331|76063237|FG001|NOT COMPLETED|Dose Level 2 (up to 18 28-day Cycles+FU)||0||
59944767|NCT04504331|76063238|FG002|NOT COMPLETED|Dose Level 2 (up to 18 28-day Cycles+FU)||0||
59944768|NCT04313985|76063246|FG000|STARTED|Treatment Period 1 (1 Week)||2||
59762261|NCT00594516|75881939|FG001|STARTED|Open Label (OL): Tapentadol IR||0||
59762262|NCT00594516|75881940|FG002|STARTED|Open Label (OL): Tapentadol IR||0||
59762263|NCT00594516|75881938|FG000|COMPLETED|Open Label (OL): Tapentadol IR||87||
59762264|NCT00594516|75881939|FG001|COMPLETED|Open Label (OL): Tapentadol IR||0||
59762265|NCT00594516|75881940|FG002|COMPLETED|Open Label (OL): Tapentadol IR||0||
59762266|NCT00594516|75881938|FG000|NOT COMPLETED|Open Label (OL): Tapentadol IR||29||
59762267|NCT00594516|75881939|FG001|NOT COMPLETED|Open Label (OL): Tapentadol IR||0||
59944769|NCT04313985|76063247|FG001|STARTED|Treatment Period 1 (1 Week)||2||
59944770|NCT04313985|76063246|FG000|COMPLETED|Treatment Period 1 (1 Week)||2||
59944771|NCT04313985|76063247|FG001|COMPLETED|Treatment Period 1 (1 Week)||2||
59944772|NCT04313985|76063246|FG000|NOT COMPLETED|Treatment Period 1 (1 Week)||0||
59944773|NCT04313985|76063247|FG001|NOT COMPLETED|Treatment Period 1 (1 Week)||0||
59944774|NCT04313985|76063246|FG000|STARTED|Treatment Period 2 (1 Week)||2||
59944775|NCT04313985|76063247|FG001|STARTED|Treatment Period 2 (1 Week)||2||
59944776|NCT04313985|76063246|FG000|COMPLETED|Treatment Period 2 (1 Week)||2||
59944777|NCT04313985|76063247|FG001|COMPLETED|Treatment Period 2 (1 Week)||2||
59944778|NCT04313985|76063246|FG000|NOT COMPLETED|Treatment Period 2 (1 Week)||0||
59944779|NCT04313985|76063247|FG001|NOT COMPLETED|Treatment Period 2 (1 Week)||0||
59944780|NCT04313985|76063246|FG000|STARTED|Follow-up Period (1 Week)||2||
59944781|NCT04313985|76063247|FG001|STARTED|Follow-up Period (1 Week)||2||
59944782|NCT04313985|76063246|FG000|COMPLETED|Follow-up Period (1 Week)||2||
59944783|NCT04313985|76063247|FG001|COMPLETED|Follow-up Period (1 Week)||2||
59944784|NCT04313985|76063246|FG000|NOT COMPLETED|Follow-up Period (1 Week)||0||
60067553|NCT01915303|76182724|FG000|NOT COMPLETED|Extension Phase||17||
60067554|NCT01987427|76182731|FG000|STARTED|Overall Study||78||
59762268|NCT00594516|75881940|FG002|NOT COMPLETED|Open Label (OL): Tapentadol IR||0||
60067555|NCT01987427|76182732|FG001|STARTED|Overall Study||78||
60067556|NCT01987427|76182733|FG002|STARTED|Overall Study||79||
59762269|NCT00594516|75881938|FG000|STARTED|DB: Tapentadol IR to ER & ER to IR||0||
59762270|NCT00594516|75881939|FG001|STARTED|DB: Tapentadol IR to ER & ER to IR||44||
59944785|NCT04313985|76063247|FG001|NOT COMPLETED|Follow-up Period (1 Week)||0||
59944786|NCT03990870|76063255|FG000|STARTED|Overall Study||16||
59944787|NCT03990870|76063256|FG001|STARTED|Overall Study||8||
59944788|NCT03990870|76063255|FG000|COMPLETED|Overall Study||13||
59944789|NCT03990870|76063256|FG001|COMPLETED|Overall Study||7||
59944790|NCT03990870|76063255|FG000|NOT COMPLETED|Overall Study||3||
59944791|NCT03990870|76063256|FG001|NOT COMPLETED|Overall Study||1||
59944792|NCT03679117|76063264|FG000|STARTED|Overall Study||15||
59944793|NCT03679117|76063265|FG001|STARTED|Overall Study||14||
59944794|NCT03679117|76063264|FG000|COMPLETED|Overall Study||12||
59944795|NCT03679117|76063265|FG001|COMPLETED|Overall Study||14||
59944796|NCT03679117|76063264|FG000|NOT COMPLETED|Overall Study||3||
59944797|NCT03679117|76063265|FG001|NOT COMPLETED|Overall Study||0||
59944798|NCT03519256|76063275|FG000|STARTED|Overall Study||16||
59944799|NCT03519256|76063276|FG001|STARTED|Overall Study||26||
59944800|NCT03519256|76063277|FG002|STARTED|Overall Study||17||
59944801|NCT03519256|76063278|FG003|STARTED|Overall Study||10||
59944802|NCT03519256|76063275|FG000|Safety-Lead In Phase|Overall Study||0||
59944803|NCT03519256|76063276|FG001|Safety-Lead In Phase|Overall Study||10||
59944804|NCT03519256|76063277|FG002|Safety-Lead In Phase|Overall Study||0||
59944805|NCT03519256|76063278|FG003|Safety-Lead In Phase|Overall Study||10||
59944806|NCT03519256|76063275|FG000|COMPLETED|Overall Study||6||
59944807|NCT03519256|76063276|FG001|COMPLETED|Overall Study||15||
59944808|NCT03519256|76063277|FG002|COMPLETED|Overall Study||2||
59944809|NCT03519256|76063278|FG003|COMPLETED|Overall Study||3||
59944810|NCT03519256|76063275|FG000|NOT COMPLETED|Overall Study||10||
59944811|NCT03519256|76063276|FG001|NOT COMPLETED|Overall Study||11||
59944812|NCT03519256|76063277|FG002|NOT COMPLETED|Overall Study||15||
59944813|NCT03519256|76063278|FG003|NOT COMPLETED|Overall Study||7||
59944814|NCT03458000|76063290|FG000|STARTED|Overall Study||13||
59944815|NCT03458000|76063291|FG001|STARTED|Overall Study||11||
59944816|NCT03458000|76063290|FG000|COMPLETED|Overall Study||13||
59944817|NCT03458000|76063291|FG001|COMPLETED|Overall Study||11||
59944818|NCT03458000|76063290|FG000|NOT COMPLETED|Overall Study||0||
59944819|NCT03458000|76063291|FG001|NOT COMPLETED|Overall Study||0||
59944820|NCT03009110|76063300|FG000|STARTED|Overall Study||816||
59944821|NCT03009110|76063301|FG001|STARTED|Overall Study||808||
59944822|NCT03009110|76063300|FG000|COMPLETED|Overall Study||806||
59944823|NCT03009110|76063301|FG001|COMPLETED|Overall Study||802||
59944824|NCT03009110|76063300|FG000|NOT COMPLETED|Overall Study||10||
59944825|NCT03009110|76063301|FG001|NOT COMPLETED|Overall Study||6||
59944826|NCT02918721|76063307|FG000|STARTED|Overall Study||70||
59944827|NCT02918721|76063307|FG000|COMPLETED|Overall Study||70||
59944828|NCT02918721|76063307|FG000|NOT COMPLETED|Overall Study||0||
59944829|NCT02799602|76063314|FG000|STARTED|Overall Study||652||
59944830|NCT02799602|76063315|FG001|STARTED|Overall Study||654||
59944831|NCT02799602|76063314|FG000|COMPLETED|Overall Study||299||
59944832|NCT02799602|76063315|FG001|COMPLETED|Overall Study||125||
59944833|NCT02799602|76063314|FG000|NOT COMPLETED|Overall Study||353||
59944834|NCT02799602|76063315|FG001|NOT COMPLETED|Overall Study||529||
59944835|NCT02788903|76063323|FG000|STARTED|Overall Study||567908||
59944836|NCT02788903|76063324|FG001|STARTED|Overall Study||2054256||
59944837|NCT02788903|76063323|FG000|COMPLETED|Overall Study||567908||
59944838|NCT02788903|76063324|FG001|COMPLETED|Overall Study||2054256||
59944839|NCT02788903|76063323|FG000|NOT COMPLETED|Overall Study||0||
59944840|NCT02788903|76063324|FG001|NOT COMPLETED|Overall Study||0||
59944841|NCT02243709|76063332|FG000|STARTED|Phase 1||12||
59944842|NCT02243709|76063333|FG001|STARTED|Phase 1||20||
59944843|NCT02243709|76063332|FG000|COMPLETED|Phase 1||11||
59944844|NCT02243709|76063333|FG001|COMPLETED|Phase 1||17||
59944845|NCT02243709|76063332|FG000|NOT COMPLETED|Phase 1||1||
59944846|NCT02243709|76063333|FG001|NOT COMPLETED|Phase 1||3||
59944847|NCT02243709|76063332|FG000|STARTED|Phase 2: Crossover to Opposite Condition||11||
59944848|NCT02243709|76063333|FG001|STARTED|Phase 2: Crossover to Opposite Condition||17||
59944849|NCT02243709|76063332|FG000|COMPLETED|Phase 2: Crossover to Opposite Condition||11||
59944850|NCT02243709|76063333|FG001|COMPLETED|Phase 2: Crossover to Opposite Condition||17||
59944851|NCT02243709|76063332|FG000|NOT COMPLETED|Phase 2: Crossover to Opposite Condition||0||
59944852|NCT02243709|76063333|FG001|NOT COMPLETED|Phase 2: Crossover to Opposite Condition||0||
59944853|NCT01891396|76063345|FG000|STARTED|Overall Study||149||
59944854|NCT01891396|76063346|FG001|STARTED|Overall Study||150||
59944855|NCT01891396|76063347|FG002|STARTED|Overall Study||69||
59944856|NCT01891396|76063345|FG000|Received Study Injection|Overall Study||149||
59944857|NCT01891396|76063346|FG001|Received Study Injection|Overall Study||150||
59944858|NCT01891396|76063347|FG002|Received Study Injection|Overall Study||69||
59944859|NCT01891396|76063345|FG000|COMPLETED|Overall Study||145||
59944860|NCT01891396|76063346|FG001|COMPLETED|Overall Study||145||
59944861|NCT01891396|76063347|FG002|COMPLETED|Overall Study||66||
59944862|NCT01891396|76063345|FG000|NOT COMPLETED|Overall Study||4||
59944863|NCT01891396|76063346|FG001|NOT COMPLETED|Overall Study||5||
59944864|NCT01891396|76063347|FG002|NOT COMPLETED|Overall Study||3||
59944865|NCT01746225|76063362|FG000|STARTED|Overall Study||83||
59944866|NCT01746225|76063363|FG001|STARTED|Overall Study||86||
59944867|NCT01746225|76063364|FG002|STARTED|Overall Study||86||
59944868|NCT01746225|76063362|FG000|COMPLETED|Overall Study||43||
59944869|NCT01746225|76063363|FG001|COMPLETED|Overall Study||40||
59944870|NCT01746225|76063364|FG002|COMPLETED|Overall Study||43||
59944871|NCT01746225|76063362|FG000|NOT COMPLETED|Overall Study||40||
59944872|NCT01746225|76063363|FG001|NOT COMPLETED|Overall Study||46||
59944873|NCT01746225|76063364|FG002|NOT COMPLETED|Overall Study||43||
59762271|NCT00594516|75881940|FG002|STARTED|DB: Tapentadol IR to ER & ER to IR||43||
59762272|NCT00594516|75881938|FG000|COMPLETED|DB: Tapentadol IR to ER & ER to IR||0||
59762273|NCT00594516|75881939|FG001|COMPLETED|DB: Tapentadol IR to ER & ER to IR||37||
59762274|NCT00594516|75881940|FG002|COMPLETED|DB: Tapentadol IR to ER & ER to IR||35||
59762275|NCT00594516|75881938|FG000|NOT COMPLETED|DB: Tapentadol IR to ER & ER to IR||0||
59762276|NCT00594516|75881939|FG001|NOT COMPLETED|DB: Tapentadol IR to ER & ER to IR||7||
59762277|NCT00594516|75881940|FG002|NOT COMPLETED|DB: Tapentadol IR to ER & ER to IR||8||
59762278|NCT00538291|75881944|FG000|STARTED|Overall Study||13||
59762279|NCT00538291|75881944|FG000|COMPLETED|Overall Study||10||
59762280|NCT00538291|75881944|FG000|NOT COMPLETED|Overall Study||3||
59944874|NCT01650545|76063374|FG000|STARTED|Overall Study||11||
59944875|NCT01650545|76063375|FG001|STARTED|Overall Study||10||
59944876|NCT01650545|76063374|FG000|COMPLETED|Overall Study||11||
59944877|NCT01650545|76063375|FG001|COMPLETED|Overall Study||10||
59944878|NCT01650545|76063374|FG000|NOT COMPLETED|Overall Study||0||
59944879|NCT01650545|76063375|FG001|NOT COMPLETED|Overall Study||0||
59944880|NCT01471522|76063385|FG000|STARTED|Overall Study||2588||
59944881|NCT01471522|76063386|FG001|STARTED|Overall Study||2591||
59944882|NCT01471522|76063385|FG000|COMPLETED|Overall Study||2524||
59944883|NCT01471522|76063386|FG001|COMPLETED|Overall Study||2543||
59944884|NCT01471522|76063385|FG000|NOT COMPLETED|Overall Study||64||
59944885|NCT01471522|76063386|FG001|NOT COMPLETED|Overall Study||48||
59944886|NCT01191008|76063393|FG000|STARTED|Overall Study||633||
59944887|NCT01191008|76063393|FG000|COMPLETED|Overall Study||618||
59944888|NCT01191008|76063393|FG000|NOT COMPLETED|Overall Study||15||
59944889|NCT00821587|76063399|FG000|STARTED|Overall Study||20||
59944890|NCT00821587|76063400|FG001|STARTED|Overall Study||19||
59944891|NCT00821587|76063399|FG000|COMPLETED|Overall Study||20||
59944892|NCT00821587|76063400|FG001|COMPLETED|Overall Study||18||
59944893|NCT00821587|76063399|FG000|NOT COMPLETED|Overall Study||0||
59944894|NCT00821587|76063400|FG001|NOT COMPLETED|Overall Study||1||
59944895|NCT00645801|76063408|FG000|STARTED|Overall Study||77||
59944896|NCT00645801|76063409|FG001|STARTED|Overall Study||81||
59944897|NCT00645801|76063408|FG000|COMPLETED|Overall Study||57||
59944898|NCT00645801|76063409|FG001|COMPLETED|Overall Study||66||
59944899|NCT00645801|76063408|FG000|NOT COMPLETED|Overall Study||20||
59944900|NCT00645801|76063409|FG001|NOT COMPLETED|Overall Study||15||
59944901|NCT00424099|76063423|FG000|STARTED|Overall Study||45||
59944902|NCT00424099|76063424|FG001|STARTED|Overall Study||47||
59944903|NCT00424099|76063425|FG002|STARTED|Overall Study||50||
59944904|NCT00424099|76063426|FG003|STARTED|Overall Study||48||
59944905|NCT00424099|76063423|FG000|COMPLETED|Overall Study||38||
59944906|NCT00424099|76063424|FG001|COMPLETED|Overall Study||31||
59944907|NCT00424099|76063425|FG002|COMPLETED|Overall Study||38||
59944908|NCT00424099|76063426|FG003|COMPLETED|Overall Study||35||
59944909|NCT00424099|76063423|FG000|NOT COMPLETED|Overall Study||7||
59944910|NCT00424099|76063424|FG001|NOT COMPLETED|Overall Study||16||
59944911|NCT00424099|76063425|FG002|NOT COMPLETED|Overall Study||12||
59944912|NCT00424099|76063426|FG003|NOT COMPLETED|Overall Study||13||
59944913|NCT03316573|76063436|FG000|STARTED|Overall Study||18||
59944914|NCT03316573|76063436|FG000|COMPLETED|Overall Study||18||
59944915|NCT03316573|76063436|FG000|NOT COMPLETED|Overall Study||0||
59944916|NCT02963493|76063440|FG000|STARTED|Overall Study||157||
59944917|NCT02963493|76063440|FG000|COMPLETED|Overall Study||157|Study completion for assessment of endpoints|
59944918|NCT02963493|76063440|FG000|NOT COMPLETED|Overall Study||0||
59944919|NCT02988661|76063453|FG000|STARTED|Overall Study||168||
59944920|NCT02988661|76063454|FG001|STARTED|Overall Study||531||
59944921|NCT02988661|76063453|FG000|COMPLETED|Overall Study||165||
59944922|NCT02988661|76063454|FG001|COMPLETED|Overall Study||447||
59944923|NCT02988661|76063453|FG000|NOT COMPLETED|Overall Study||3||
59762281|NCT00594906|75881950|FG000|STARTED|Overall Study||7||
59762282|NCT00594906|75881951|FG001|STARTED|Overall Study||3||
59762283|NCT00594906|75881950|FG000|COMPLETED|Overall Study||6||
59762284|NCT00594906|75881951|FG001|COMPLETED|Overall Study||1||
59762285|NCT00594906|75881950|FG000|NOT COMPLETED|Overall Study||1||
59762286|NCT00594906|75881951|FG001|NOT COMPLETED|Overall Study||2||
59762287|NCT00537979|75881959|FG000|STARTED|Overall Study||38||
59762288|NCT00537979|75881960|FG001|STARTED|Overall Study||109||
59762289|NCT00537979|75881959|FG000|COMPLETED|Overall Study||32||
59762290|NCT00537979|75881960|FG001|COMPLETED|Overall Study||89||
59944924|NCT02988661|76063454|FG001|NOT COMPLETED|Overall Study||84||
59762291|NCT00537979|75881959|FG000|NOT COMPLETED|Overall Study||6||
59944925|NCT03738397|76063462|FG000|STARTED|Overall Study||344||
59944926|NCT03738397|76063463|FG001|STARTED|Overall Study||348||
59944927|NCT03738397|76063462|FG000|COMPLETED|Overall Study||320||
59944928|NCT03738397|76063463|FG001|COMPLETED|Overall Study||318||
59944929|NCT03738397|76063462|FG000|NOT COMPLETED|Overall Study||24||
59944930|NCT03738397|76063463|FG001|NOT COMPLETED|Overall Study||30||
59951240|NCT03743415|76070181|FG006|STARTED|Overall Study||44||
59944931|NCT02960217|76063471|FG000|STARTED|Maintenance Phase: Treatment Period 1||22|Randomized and treated|
59944932|NCT02960217|76063472|FG001|STARTED|Maintenance Phase: Treatment Period 1||21|Randomized and treated|
59944933|NCT02960217|76063471|FG000|COMPLETED|Maintenance Phase: Treatment Period 1||21||
59944934|NCT02960217|76063472|FG001|COMPLETED|Maintenance Phase: Treatment Period 1||21||
59944935|NCT02960217|76063471|FG000|NOT COMPLETED|Maintenance Phase: Treatment Period 1||1||
59944936|NCT02960217|76063472|FG001|NOT COMPLETED|Maintenance Phase: Treatment Period 1||0||
59944937|NCT02960217|76063471|FG000|STARTED|Maintenance Phase: Crossover Washout||21||
59944938|NCT02960217|76063472|FG001|STARTED|Maintenance Phase: Crossover Washout||21||
59944939|NCT02960217|76063471|FG000|COMPLETED|Maintenance Phase: Crossover Washout||21||
59944940|NCT02960217|76063472|FG001|COMPLETED|Maintenance Phase: Crossover Washout||21||
59944941|NCT02960217|76063471|FG000|NOT COMPLETED|Maintenance Phase: Crossover Washout||0||
59944942|NCT02960217|76063472|FG001|NOT COMPLETED|Maintenance Phase: Crossover Washout||0||
59944943|NCT02960217|76063471|FG000|STARTED|Maintenance Phase: Treatment Period 2||21||
59944944|NCT02960217|76063472|FG001|STARTED|Maintenance Phase: Treatment Period 2||21||
59944945|NCT02960217|76063471|FG000|COMPLETED|Maintenance Phase: Treatment Period 2||20||
59944946|NCT02960217|76063472|FG001|COMPLETED|Maintenance Phase: Treatment Period 2||18||
59944947|NCT02960217|76063471|FG000|NOT COMPLETED|Maintenance Phase: Treatment Period 2||1||
59944948|NCT02960217|76063472|FG001|NOT COMPLETED|Maintenance Phase: Treatment Period 2||3||
59944949|NCT02960217|76063471|FG000|STARTED|Open-Label Extension Phase||20||
59944950|NCT02960217|76063472|FG001|STARTED|Open-Label Extension Phase|5 participants completed the double blind period but did not continue in the open label period.|13||
59944951|NCT02960217|76063471|FG000|COMPLETED|Open-Label Extension Phase||0||
59944952|NCT02960217|76063472|FG001|COMPLETED|Open-Label Extension Phase||0||
59944953|NCT02960217|76063471|FG000|NOT COMPLETED|Open-Label Extension Phase||20||
59944954|NCT02960217|76063472|FG001|NOT COMPLETED|Open-Label Extension Phase||13||
59944955|NCT02959983|76063484|FG000|STARTED|Overall Study||172||
59944956|NCT02959983|76063485|FG001|STARTED|Overall Study||174||
59944957|NCT02959983|76063484|FG000|COMPLETED|Overall Study||146||
59944958|NCT02959983|76063485|FG001|COMPLETED|Overall Study||149||
59944959|NCT02959983|76063484|FG000|NOT COMPLETED|Overall Study||26||
59944960|NCT02959983|76063485|FG001|NOT COMPLETED|Overall Study||25||
59944961|NCT01344447|76063491|FG000|STARTED|Overall Study|Participant received study drug; Safety analysis set|479||
59944962|NCT01344447|76063491|FG000|Fulfilled Requirement of FAS Population|Overall Study|Full Analysis Set (FAS)|457||
59944963|NCT01344447|76063491|FG000|COMPLETED|Overall Study||471||
59944964|NCT01344447|76063491|FG000|NOT COMPLETED|Overall Study||8||
59944965|NCT03513068|76063501|FG000|STARTED|Overall Study||54||
59944966|NCT03513068|76063502|FG001|STARTED|Overall Study||54||
59944967|NCT03513068|76063501|FG000|COMPLETED|Overall Study||49||
59944968|NCT03513068|76063502|FG001|COMPLETED|Overall Study||48||
59944969|NCT03513068|76063501|FG000|NOT COMPLETED|Overall Study||5||
59944970|NCT03513068|76063502|FG001|NOT COMPLETED|Overall Study||6||
59944971|NCT01348425|76063510|FG000|STARTED|Overall Study||31||
59944972|NCT01348425|76063511|FG001|STARTED|Overall Study||14||
59762292|NCT00537979|75881960|FG001|NOT COMPLETED|Overall Study||20||
59944973|NCT01348425|76063510|FG000|COMPLETED|Overall Study||30||
59944974|NCT01348425|76063511|FG001|COMPLETED|Overall Study||13||
59944975|NCT01348425|76063510|FG000|NOT COMPLETED|Overall Study||1||
59944976|NCT01348425|76063511|FG001|NOT COMPLETED|Overall Study||1||
59944977|NCT03041701|76063519|FG000|STARTED|Ph I: Dose Level 1 and 2 Dose Escalation||7||
59944978|NCT03041701|76063520|FG001|STARTED|Ph I: Dose Level 1 and 2 Dose Escalation||6||
59944979|NCT03041701|76063521|FG002|STARTED|Ph I: Dose Level 1 and 2 Dose Escalation||0||
59944980|NCT03041701|76063519|FG000|COMPLETED|Ph I: Dose Level 1 and 2 Dose Escalation||6||
59944981|NCT03041701|76063520|FG001|COMPLETED|Ph I: Dose Level 1 and 2 Dose Escalation||5||
59944982|NCT03041701|76063521|FG002|COMPLETED|Ph I: Dose Level 1 and 2 Dose Escalation||0||
59944983|NCT03041701|76063519|FG000|NOT COMPLETED|Ph I: Dose Level 1 and 2 Dose Escalation||1||
59944984|NCT03041701|76063520|FG001|NOT COMPLETED|Ph I: Dose Level 1 and 2 Dose Escalation||1||
59944985|NCT03041701|76063521|FG002|NOT COMPLETED|Ph I: Dose Level 1 and 2 Dose Escalation||0||
59944986|NCT03041701|76063519|FG000|STARTED|Ph 2:Dose Level 1 Maximum Tolerated Dose||0||
59944987|NCT03041701|76063520|FG001|STARTED|Ph 2:Dose Level 1 Maximum Tolerated Dose||0||
59518726|NCT01110499|75612569|FG002|COMPLETED|Overall Study||14||
59944988|NCT03041701|76063521|FG002|STARTED|Ph 2:Dose Level 1 Maximum Tolerated Dose||1||
59944989|NCT03041701|76063519|FG000|COMPLETED|Ph 2:Dose Level 1 Maximum Tolerated Dose||0||
59944990|NCT03041701|76063520|FG001|COMPLETED|Ph 2:Dose Level 1 Maximum Tolerated Dose||0||
59944991|NCT03041701|76063521|FG002|COMPLETED|Ph 2:Dose Level 1 Maximum Tolerated Dose||0||
59944992|NCT03041701|76063519|FG000|NOT COMPLETED|Ph 2:Dose Level 1 Maximum Tolerated Dose||0||
59944993|NCT03041701|76063520|FG001|NOT COMPLETED|Ph 2:Dose Level 1 Maximum Tolerated Dose||0||
59944994|NCT03041701|76063521|FG002|NOT COMPLETED|Ph 2:Dose Level 1 Maximum Tolerated Dose||1||
59944995|NCT02956629|76063538|FG000|STARTED|Overall Study||78||
59944996|NCT02956629|76063539|FG001|STARTED|Overall Study||47||
59944997|NCT02956629|76063540|FG002|STARTED|Overall Study||61||
59944998|NCT02956629|76063541|FG003|STARTED|Overall Study||56||
59944999|NCT02956629|76063542|FG004|STARTED|Overall Study||18||
59945000|NCT02956629|76063543|FG005|STARTED|Overall Study||22||
59945001|NCT02956629|76063538|FG000|COMPLETED|Overall Study||73||
59945002|NCT02956629|76063539|FG001|COMPLETED|Overall Study||41||
59945003|NCT02956629|76063540|FG002|COMPLETED|Overall Study||57||
59945004|NCT02956629|76063541|FG003|COMPLETED|Overall Study||55||
59945005|NCT02956629|76063542|FG004|COMPLETED|Overall Study||18||
59945006|NCT02956629|76063543|FG005|COMPLETED|Overall Study||21||
59945007|NCT02956629|76063538|FG000|NOT COMPLETED|Overall Study||5||
59945008|NCT02956629|76063539|FG001|NOT COMPLETED|Overall Study||6||
59945009|NCT02956629|76063540|FG002|NOT COMPLETED|Overall Study||4||
59945010|NCT02956629|76063541|FG003|NOT COMPLETED|Overall Study||1||
59945011|NCT02956629|76063542|FG004|NOT COMPLETED|Overall Study||0||
59945012|NCT02956629|76063543|FG005|NOT COMPLETED|Overall Study||1||
59945013|NCT01348347|76063560|FG000|STARTED|Overall Study||3||
59945014|NCT01348347|76063561|FG001|STARTED|Overall Study||6||
59945015|NCT01348347|76063562|FG002|STARTED|Overall Study||6||
59945016|NCT01348347|76063560|FG000|COMPLETED|Overall Study||0||
59945017|NCT01348347|76063561|FG001|COMPLETED|Overall Study||0||
59945018|NCT01348347|76063562|FG002|COMPLETED|Overall Study||0||
59945019|NCT01348347|76063560|FG000|NOT COMPLETED|Overall Study||3||
59945020|NCT01348347|76063561|FG001|NOT COMPLETED|Overall Study||6||
59945021|NCT01348347|76063562|FG002|NOT COMPLETED|Overall Study||6||
59945022|NCT02959671|76063571|FG000|STARTED|Overall Study||34||
59945023|NCT02959671|76063571|FG000|COMPLETED|Overall Study||29||
59945024|NCT02959671|76063571|FG000|NOT COMPLETED|Overall Study||5||
59945025|NCT01597258|76063575|FG000|STARTED|Overall Study||2029||
59945026|NCT01597258|76063575|FG000|COMPLETED|Overall Study||2028||
59945027|NCT01597258|76063575|FG000|NOT COMPLETED|Overall Study||1||
59945028|NCT02958267|76063581|FG000|STARTED|Enrollment||17||
59945029|NCT02958267|76063582|FG001|STARTED|Enrollment||15||
59945030|NCT02958267|76063581|FG000|COMPLETED|Enrollment||17||
59945031|NCT02958267|76063582|FG001|COMPLETED|Enrollment||15||
59945032|NCT02958267|76063581|FG000|NOT COMPLETED|Enrollment||0||
59945033|NCT02958267|76063582|FG001|NOT COMPLETED|Enrollment||0||
59945034|NCT02958267|76063581|FG000|STARTED|Enrollment to Actual Treatment Complete||17||
59945035|NCT02958267|76063582|FG001|STARTED|Enrollment to Actual Treatment Complete||15||
59945036|NCT02958267|76063581|FG000|COMPLETED|Enrollment to Actual Treatment Complete||15||
59945037|NCT02958267|76063582|FG001|COMPLETED|Enrollment to Actual Treatment Complete||15||
59945038|NCT02958267|76063581|FG000|NOT COMPLETED|Enrollment to Actual Treatment Complete||2||
59945039|NCT02958267|76063582|FG001|NOT COMPLETED|Enrollment to Actual Treatment Complete||0||
59945040|NCT02958267|76063581|FG000|STARTED|Follow-up Visits||15||
59945041|NCT02958267|76063582|FG001|STARTED|Follow-up Visits||15||
59945042|NCT02958267|76063581|FG000|3 Month Follow-up|Follow-up Visits||15||
59945043|NCT02958267|76063582|FG001|3 Month Follow-up|Follow-up Visits||15||
59945044|NCT02958267|76063581|FG000|6 Month Follow-up|Follow-up Visits||14||
59945045|NCT02958267|76063582|FG001|6 Month Follow-up|Follow-up Visits||14||
59945046|NCT02958267|76063581|FG000|12 Month Follow-up|Follow-up Visits||13||
59945047|NCT02958267|76063582|FG001|12 Month Follow-up|Follow-up Visits||14||
59945048|NCT02958267|76063581|FG000|COMPLETED|Follow-up Visits||13||
59945049|NCT02958267|76063582|FG001|COMPLETED|Follow-up Visits||14||
59945050|NCT02958267|76063581|FG000|NOT COMPLETED|Follow-up Visits||2||
59945051|NCT02958267|76063582|FG001|NOT COMPLETED|Follow-up Visits||1||
59945052|NCT01952574|76063592|FG000|STARTED|Double-blind Treatment Phase||160||
59945053|NCT01952574|76063593|FG001|STARTED|Double-blind Treatment Phase||108||
59945054|NCT01952574|76063594|FG002|STARTED|Double-blind Treatment Phase||108||
59945055|NCT01952574|76063595|FG003|STARTED|Double-blind Treatment Phase||107||
59945056|NCT01952574|76063596|FG004|STARTED|Double-blind Treatment Phase||0||
59945057|NCT01952574|76063597|FG005|STARTED|Double-blind Treatment Phase||0||
59945058|NCT01952574|76063598|FG006|STARTED|Double-blind Treatment Phase||0||
59945059|NCT01952574|76063592|FG000|Received Study Drug|Double-blind Treatment Phase||153||
59945060|NCT01952574|76063593|FG001|Received Study Drug|Double-blind Treatment Phase||108||
59945061|NCT01952574|76063594|FG002|Received Study Drug|Double-blind Treatment Phase||105||
59945062|NCT01952574|76063595|FG003|Received Study Drug|Double-blind Treatment Phase||106||
60067557|NCT01987427|76182731|FG000|COMPLETED|Overall Study||64||
60067558|NCT01987427|76182732|FG001|COMPLETED|Overall Study||68||
59945063|NCT01952574|76063596|FG004|Received Study Drug|Double-blind Treatment Phase||0||
59945064|NCT01952574|76063597|FG005|Received Study Drug|Double-blind Treatment Phase||0||
59945065|NCT01952574|76063598|FG006|Received Study Drug|Double-blind Treatment Phase||0||
59945066|NCT01952574|76063592|FG000|COMPLETED|Double-blind Treatment Phase||143|Completed double-blind treatment phase|
59945067|NCT01952574|76063593|FG001|COMPLETED|Double-blind Treatment Phase||105|Completed double-blind treatment phase|
59945068|NCT01952574|76063594|FG002|COMPLETED|Double-blind Treatment Phase||99|Completed double-blind treatment phase|
59945069|NCT01952574|76063595|FG003|COMPLETED|Double-blind Treatment Phase||101|Completed double-blind treatment phase|
59945070|NCT01952574|76063596|FG004|COMPLETED|Double-blind Treatment Phase||0|Completed double-blind treatment phase|
59945071|NCT01952574|76063597|FG005|COMPLETED|Double-blind Treatment Phase||0|Completed double-blind treatment phase|
59945072|NCT01952574|76063598|FG006|COMPLETED|Double-blind Treatment Phase||0|Completed double-blind treatment phase|
59945073|NCT01952574|76063592|FG000|NOT COMPLETED|Double-blind Treatment Phase||17||
59945074|NCT01952574|76063593|FG001|NOT COMPLETED|Double-blind Treatment Phase||3||
59945075|NCT01952574|76063594|FG002|NOT COMPLETED|Double-blind Treatment Phase||9||
59945076|NCT01952574|76063595|FG003|NOT COMPLETED|Double-blind Treatment Phase||6||
59945077|NCT01952574|76063596|FG004|NOT COMPLETED|Double-blind Treatment Phase||0||
59945078|NCT01952574|76063597|FG005|NOT COMPLETED|Double-blind Treatment Phase||0||
59945079|NCT01952574|76063598|FG006|NOT COMPLETED|Double-blind Treatment Phase||0||
59945080|NCT01952574|76063592|FG000|STARTED|Open-label Treatment Phase||0|Participants enrolled in Norway did not participate in the OLTP. In addition 12 participants who completed the DBTP withdrew consent prior to entering the OLTP.|
59945081|NCT01952574|76063593|FG001|STARTED|Open-label Treatment Phase||0|Participants enrolled in Norway did not participate in the OLTP. In addition 12 participants who completed the DBTP withdrew consent prior to entering the OLTP.|
59945082|NCT01952574|76063594|FG002|STARTED|Open-label Treatment Phase||0|Participants enrolled in Norway did not participate in the OLTP. In addition 12 participants who completed the DBTP withdrew consent prior to entering the OLTP.|
59945083|NCT01952574|76063595|FG003|STARTED|Open-label Treatment Phase||0|Participants enrolled in Norway did not participate in the OLTP. In addition 12 participants who completed the DBTP withdrew consent prior to entering the OLTP.|
59945084|NCT01952574|76063596|FG004|STARTED|Open-label Treatment Phase||383|Participants enrolled in Norway did not participate in the OLTP. In addition 12 participants who completed the DBTP withdrew consent prior to entering the OLTP.|
59945085|NCT01952574|76063597|FG005|STARTED|Open-label Treatment Phase||0|Participants enrolled in Norway did not participate in the OLTP. In addition 12 participants who completed the DBTP withdrew consent prior to entering the OLTP.|
59945086|NCT01952574|76063598|FG006|STARTED|Open-label Treatment Phase||0|Participants enrolled in Norway did not participate in the OLTP. In addition 12 participants who completed the DBTP withdrew consent prior to entering the OLTP.|
59945087|NCT01952574|76063592|FG000|Received 70 mg Erenumab|Open-label Treatment Phase||0||
59945088|NCT01952574|76063593|FG001|Received 70 mg Erenumab|Open-label Treatment Phase||0||
59945089|NCT01952574|76063594|FG002|Received 70 mg Erenumab|Open-label Treatment Phase||0||
59945090|NCT01952574|76063595|FG003|Received 70 mg Erenumab|Open-label Treatment Phase||0||
59945091|NCT01952574|76063596|FG004|Received 70 mg Erenumab|Open-label Treatment Phase||383||
59945092|NCT01952574|76063597|FG005|Received 70 mg Erenumab|Open-label Treatment Phase||0||
59945093|NCT01952574|76063598|FG006|Received 70 mg Erenumab|Open-label Treatment Phase||0||
59945094|NCT01952574|76063592|FG000|Received 140 mg Erenumab|Open-label Treatment Phase||0||
59945095|NCT01952574|76063593|FG001|Received 140 mg Erenumab|Open-label Treatment Phase||0||
59945096|NCT01952574|76063594|FG002|Received 140 mg Erenumab|Open-label Treatment Phase||0||
59945097|NCT01952574|76063595|FG003|Received 140 mg Erenumab|Open-label Treatment Phase||0||
59945098|NCT01952574|76063596|FG004|Received 140 mg Erenumab|Open-label Treatment Phase||250||
59945099|NCT01952574|76063597|FG005|Received 140 mg Erenumab|Open-label Treatment Phase||0||
59945100|NCT01952574|76063598|FG006|Received 140 mg Erenumab|Open-label Treatment Phase||0||
59945101|NCT01952574|76063592|FG000|COMPLETED|Open-label Treatment Phase||0||
59945102|NCT01952574|76063593|FG001|COMPLETED|Open-label Treatment Phase||0||
59945103|NCT01952574|76063594|FG002|COMPLETED|Open-label Treatment Phase||0||
59945104|NCT01952574|76063595|FG003|COMPLETED|Open-label Treatment Phase||0||
59945105|NCT01952574|76063596|FG004|COMPLETED|Open-label Treatment Phase||221||
59945106|NCT01952574|76063597|FG005|COMPLETED|Open-label Treatment Phase||0||
59945107|NCT01952574|76063598|FG006|COMPLETED|Open-label Treatment Phase||0||
59945108|NCT01952574|76063592|FG000|NOT COMPLETED|Open-label Treatment Phase||0||
59945109|NCT01952574|76063593|FG001|NOT COMPLETED|Open-label Treatment Phase||0||
59945110|NCT01952574|76063594|FG002|NOT COMPLETED|Open-label Treatment Phase||0||
59945111|NCT01952574|76063595|FG003|NOT COMPLETED|Open-label Treatment Phase||0||
59945112|NCT01952574|76063596|FG004|NOT COMPLETED|Open-label Treatment Phase||162||
59945113|NCT01952574|76063597|FG005|NOT COMPLETED|Open-label Treatment Phase||0||
59945114|NCT01952574|76063598|FG006|NOT COMPLETED|Open-label Treatment Phase||0||
59945115|NCT01952574|76063592|FG000|STARTED|Clinical Home Use Substudy||0||
59945116|NCT01952574|76063593|FG001|STARTED|Clinical Home Use Substudy||0||
59945117|NCT01952574|76063594|FG002|STARTED|Clinical Home Use Substudy||0||
59945118|NCT01952574|76063595|FG003|STARTED|Clinical Home Use Substudy||0||
59945119|NCT01952574|76063596|FG004|STARTED|Clinical Home Use Substudy||0||
59945120|NCT01952574|76063597|FG005|STARTED|Clinical Home Use Substudy||42||
59945121|NCT01952574|76063598|FG006|STARTED|Clinical Home Use Substudy||41||
59945122|NCT01952574|76063592|FG000|COMPLETED|Clinical Home Use Substudy||0||
59945123|NCT01952574|76063593|FG001|COMPLETED|Clinical Home Use Substudy||0||
59945124|NCT01952574|76063594|FG002|COMPLETED|Clinical Home Use Substudy||0||
59945125|NCT01952574|76063595|FG003|COMPLETED|Clinical Home Use Substudy||0||
59945126|NCT01952574|76063596|FG004|COMPLETED|Clinical Home Use Substudy||0||
59945127|NCT01952574|76063597|FG005|COMPLETED|Clinical Home Use Substudy||39||
59945128|NCT01952574|76063598|FG006|COMPLETED|Clinical Home Use Substudy||40||
59945129|NCT01952574|76063592|FG000|NOT COMPLETED|Clinical Home Use Substudy||0||
59945130|NCT01952574|76063593|FG001|NOT COMPLETED|Clinical Home Use Substudy||0||
59945131|NCT01952574|76063594|FG002|NOT COMPLETED|Clinical Home Use Substudy||0||
59945132|NCT01952574|76063595|FG003|NOT COMPLETED|Clinical Home Use Substudy||0||
59945133|NCT01952574|76063596|FG004|NOT COMPLETED|Clinical Home Use Substudy||0||
59945134|NCT01952574|76063597|FG005|NOT COMPLETED|Clinical Home Use Substudy||3||
59945135|NCT01952574|76063598|FG006|NOT COMPLETED|Clinical Home Use Substudy||1||
59945136|NCT02959437|76063627|FG000|STARTED|Overall Study||62||
59945137|NCT02959437|76063628|FG001|STARTED|Overall Study||8||
59945138|NCT02959437|76063629|FG002|STARTED|Overall Study|Due to early termination of the trial Treatment groups B and C were not dosed.|0||
59945139|NCT02959437|76063630|FG003|STARTED|Overall Study|Due to early termination of the trial Treatment groups B and C were not dosed.|0||
59945140|NCT02959437|76063627|FG000|COMPLETED|Overall Study||0||
59945141|NCT02959437|76063628|FG001|COMPLETED|Overall Study||0||
59945142|NCT02959437|76063629|FG002|COMPLETED|Overall Study||0||
59945143|NCT02959437|76063630|FG003|COMPLETED|Overall Study||0||
59945144|NCT02959437|76063627|FG000|NOT COMPLETED|Overall Study||62||
59945145|NCT02959437|76063628|FG001|NOT COMPLETED|Overall Study||8||
59945146|NCT02959437|76063629|FG002|NOT COMPLETED|Overall Study||0||
59945147|NCT02959437|76063630|FG003|NOT COMPLETED|Overall Study||0||
59945148|NCT02957331|76063643|FG000|STARTED|Overall Study||14||
59945149|NCT02957331|76063644|FG001|STARTED|Overall Study||12||
59945150|NCT02957331|76063643|FG000|COMPLETED|Overall Study||13||
59945151|NCT02957331|76063644|FG001|COMPLETED|Overall Study||12||
59945152|NCT02957331|76063643|FG000|NOT COMPLETED|Overall Study||1||
59945153|NCT02957331|76063644|FG001|NOT COMPLETED|Overall Study||0||
59945154|NCT05212883|76063650|FG000|STARTED|Overall Study||2778||
59945155|NCT05212883|76063650|FG000|COMPLETED|Overall Study||2653||
59945156|NCT05212883|76063650|FG000|NOT COMPLETED|Overall Study||125||
59945157|NCT05198713|76063654|FG000|STARTED|Overall Study||15||
59945158|NCT05198713|76063654|FG000|COMPLETED|Overall Study||15||
59945159|NCT05198713|76063654|FG000|NOT COMPLETED|Overall Study||0||
59945160|NCT04995055|76063658|FG000|STARTED|Period 1||17||
59945161|NCT04995055|76063659|FG001|STARTED|Period 1||18||
59945162|NCT04995055|76063658|FG000|COMPLETED|Period 1||12||
59945163|NCT04995055|76063659|FG001|COMPLETED|Period 1||13||
59945164|NCT04995055|76063658|FG000|NOT COMPLETED|Period 1||5||
59945165|NCT04995055|76063659|FG001|NOT COMPLETED|Period 1||5||
59945166|NCT04995055|76063658|FG000|STARTED|Period 2||12||
59945167|NCT04995055|76063659|FG001|STARTED|Period 2||13||
59945168|NCT04995055|76063658|FG000|COMPLETED|Period 2||12||
59945169|NCT04995055|76063659|FG001|COMPLETED|Period 2||13||
59945170|NCT04995055|76063658|FG000|NOT COMPLETED|Period 2||0||
59518727|NCT01110499|75612570|FG003|COMPLETED|Overall Study||14||
59518728|NCT01110499|75612571|FG004|COMPLETED|Overall Study||14||
59518729|NCT01110499|75612572|FG005|COMPLETED|Overall Study||14||
59518730|NCT01110499|75612573|FG006|COMPLETED|Overall Study||39||
59518731|NCT01110499|75612574|FG007|COMPLETED|Overall Study||40||
59518732|NCT01110499|75612567|FG000|NOT COMPLETED|Overall Study||0||
59518733|NCT01110499|75612568|FG001|NOT COMPLETED|Overall Study||0||
59518734|NCT01110499|75612569|FG002|NOT COMPLETED|Overall Study||0||
59518735|NCT01110499|75612570|FG003|NOT COMPLETED|Overall Study||0||
59518736|NCT01110499|75612571|FG004|NOT COMPLETED|Overall Study||0||
59518737|NCT01110499|75612572|FG005|NOT COMPLETED|Overall Study||0||
59518738|NCT01110499|75612573|FG006|NOT COMPLETED|Overall Study||0||
59518739|NCT01110499|75612574|FG007|NOT COMPLETED|Overall Study||0||
59518740|NCT01110967|75612594|FG000|STARTED|Overall Study||40||
59518741|NCT01110967|75612594|FG000|Surgery|Overall Study||40||
60067559|NCT01987427|76182733|FG002|COMPLETED|Overall Study||59||
60067560|NCT01987427|76182731|FG000|NOT COMPLETED|Overall Study||14||
60067561|NCT01987427|76182732|FG001|NOT COMPLETED|Overall Study||10||
59518742|NCT01110967|75612594|FG000|1 Month Follow up|Overall Study||26||
59518743|NCT01110967|75612594|FG000|3 Months Follow up|Overall Study||28||
59518744|NCT01110967|75612594|FG000|6 Months Follow up|Overall Study||24||
59945171|NCT04995055|76063659|FG001|NOT COMPLETED|Period 2||0||
59945172|NCT04785144|76063675|FG000|STARTED|Overall Study||25||
60067562|NCT01987427|76182733|FG002|NOT COMPLETED|Overall Study||20||
59518745|NCT01110967|75612594|FG000|12 Months Follow up|Overall Study||31||
59518746|NCT01110967|75612594|FG000|COMPLETED|Overall Study||31||
59518747|NCT01110967|75612594|FG000|NOT COMPLETED|Overall Study||9||
59518748|NCT01112293|75612598|FG000|STARTED|Overall Study||14||
59518749|NCT01112293|75612598|FG000|COMPLETED|Overall Study||14||
59518750|NCT01112293|75612598|FG000|NOT COMPLETED|Overall Study||0||
59518751|NCT02174419|75612605|FG000|STARTED|Overall Study||22||
59518752|NCT02174419|75612606|FG001|STARTED|Overall Study||18||
59518753|NCT02174419|75612607|FG002|STARTED|Overall Study||22||
59945173|NCT04785144|76063676|FG001|STARTED|Overall Study||23||
59945174|NCT04785144|76063677|FG002|STARTED|Overall Study||5||
59945175|NCT04785144|76063678|FG003|STARTED|Overall Study||6||
59945176|NCT04785144|76063679|FG004|STARTED|Overall Study||12||
60067563|NCT01937299|76182743|FG000|STARTED|Overall Study||117||
59945177|NCT04785144|76063680|FG005|STARTED|Overall Study||13||
59945178|NCT04785144|76063681|FG006|STARTED|Overall Study||13||
59945179|NCT04785144|76063682|FG007|STARTED|Overall Study||12||
59945180|NCT04785144|76063683|FG008|STARTED|Overall Study||13||
59945181|NCT04785144|76063684|FG009|STARTED|Overall Study||13||
59945182|NCT04785144|76063675|FG000|COMPLETED|Overall Study||20||
59945183|NCT04785144|76063676|FG001|COMPLETED|Overall Study||22||
59945184|NCT04785144|76063677|FG002|COMPLETED|Overall Study||5||
59945185|NCT04785144|76063678|FG003|COMPLETED|Overall Study||6||
59945186|NCT04785144|76063679|FG004|COMPLETED|Overall Study||11||
59945187|NCT04785144|76063680|FG005|COMPLETED|Overall Study||9||
59945188|NCT04785144|76063681|FG006|COMPLETED|Overall Study||9||
59945189|NCT04785144|76063682|FG007|COMPLETED|Overall Study||10||
59945190|NCT04785144|76063683|FG008|COMPLETED|Overall Study||8||
59945191|NCT04785144|76063684|FG009|COMPLETED|Overall Study||10||
59945192|NCT04785144|76063675|FG000|NOT COMPLETED|Overall Study||5||
59945193|NCT04785144|76063676|FG001|NOT COMPLETED|Overall Study||1||
59945194|NCT04785144|76063677|FG002|NOT COMPLETED|Overall Study||0||
59945195|NCT04785144|76063678|FG003|NOT COMPLETED|Overall Study||0||
59945196|NCT04785144|76063679|FG004|NOT COMPLETED|Overall Study||1||
59945197|NCT04785144|76063680|FG005|NOT COMPLETED|Overall Study||4||
59945198|NCT04785144|76063681|FG006|NOT COMPLETED|Overall Study||4||
59945199|NCT04785144|76063682|FG007|NOT COMPLETED|Overall Study||2||
59945200|NCT04785144|76063683|FG008|NOT COMPLETED|Overall Study||5||
59945201|NCT04785144|76063684|FG009|NOT COMPLETED|Overall Study||3||
59945202|NCT04743635|76063727|FG000|STARTED|Overall Study||68||
59945203|NCT04743635|76063728|FG001|STARTED|Overall Study||6||
59945204|NCT04743635|76063727|FG000|COMPLETED|Overall Study||66||
59945205|NCT04743635|76063728|FG001|COMPLETED|Overall Study||6||
59945206|NCT04743635|76063727|FG000|NOT COMPLETED|Overall Study||2||
59945207|NCT04743635|76063728|FG001|NOT COMPLETED|Overall Study||0||
59945208|NCT04712110|76063735|FG000|STARTED|Overall Study||50||
59945209|NCT04712110|76063736|FG001|STARTED|Overall Study||150||
59945210|NCT04712110|76063735|FG000|COMPLETED|Overall Study||4||
59945211|NCT04712110|76063736|FG001|COMPLETED|Overall Study||131||
59945212|NCT04712110|76063735|FG000|NOT COMPLETED|Overall Study||46||
59945213|NCT04712110|76063736|FG001|NOT COMPLETED|Overall Study||19||
59945214|NCT04218799|76063742|FG000|STARTED|Overall Study||7||
59945215|NCT04218799|76063742|FG000|COMPLETED|Overall Study||7||
59945216|NCT04218799|76063742|FG000|NOT COMPLETED|Overall Study||0||
59945217|NCT03877510|76063746|FG000|STARTED|Overall Study||419||
59945218|NCT03877510|76063746|FG000|COMPLETED|Overall Study||352||
59945219|NCT03877510|76063746|FG000|NOT COMPLETED|Overall Study||67||
59945220|NCT03846427|76063750|FG000|STARTED|Overall Study||68||
59945221|NCT03846427|76063750|FG000|COMPLETED|Overall Study||51||
59945222|NCT03846427|76063750|FG000|NOT COMPLETED|Overall Study||17||
59945223|NCT04305236|76063754|FG000|STARTED|Overall Study||1||
59945224|NCT04305236|76063754|FG000|COMPLETED|Overall Study||1||
59945225|NCT04305236|76063754|FG000|NOT COMPLETED|Overall Study||0||
59945226|NCT03761537|76063760|FG000|STARTED|Overall Study||140||
59945227|NCT03761537|76063761|FG001|STARTED|Overall Study||137||
59945228|NCT03761537|76063760|FG000|COMPLETED|Overall Study||125||
59945229|NCT03761537|76063761|FG001|COMPLETED|Overall Study||120||
59945230|NCT03761537|76063760|FG000|NOT COMPLETED|Overall Study||15||
59945231|NCT03761537|76063761|FG001|NOT COMPLETED|Overall Study||17||
59945232|NCT03706079|76063779|FG000|STARTED|Predecessor Study||529||
59945233|NCT03706079|76063780|FG001|STARTED|Predecessor Study||532||
59945234|NCT03706079|76063781|FG002|STARTED|Predecessor Study|Not Applicable for predecessor period|0||
59945235|NCT03706079|76063782|FG003|STARTED|Predecessor Study||74||
59945236|NCT03706079|76063783|FG004|STARTED|Predecessor Study||76||
59945237|NCT03706079|76063784|FG005|STARTED|Predecessor Study|Not Applicable for predecessor period|0||
59945238|NCT03706079|76063779|FG000|Received Treatment|Predecessor Study||528||
59945239|NCT03706079|76063780|FG001|Received Treatment|Predecessor Study||531||
59945240|NCT03706079|76063781|FG002|Received Treatment|Predecessor Study|Not Applicable for predecessor period|0||
59945241|NCT03706079|76063782|FG003|Received Treatment|Predecessor Study||74||
59945242|NCT03706079|76063783|FG004|Received Treatment|Predecessor Study||76||
59945243|NCT03706079|76063784|FG005|Received Treatment|Predecessor Study|Not Applicable for predecessor period|0||
59945244|NCT03706079|76063779|FG000|COMPLETED|Predecessor Study||513||
59945245|NCT03706079|76063780|FG001|COMPLETED|Predecessor Study||509||
59945246|NCT03706079|76063781|FG002|COMPLETED|Predecessor Study|Not Applicable for predecessor period|0||
59945247|NCT03706079|76063782|FG003|COMPLETED|Predecessor Study||68||
59945248|NCT03706079|76063783|FG004|COMPLETED|Predecessor Study||73||
59945249|NCT03706079|76063784|FG005|COMPLETED|Predecessor Study|Not Applicable for predecessor period|0||
59945250|NCT03706079|76063779|FG000|NOT COMPLETED|Predecessor Study||16||
59945251|NCT03706079|76063780|FG001|NOT COMPLETED|Predecessor Study||23||
59945252|NCT03706079|76063781|FG002|NOT COMPLETED|Predecessor Study||0||
59945253|NCT03706079|76063782|FG003|NOT COMPLETED|Predecessor Study||6||
59945254|NCT03706079|76063783|FG004|NOT COMPLETED|Predecessor Study||3||
59945255|NCT03706079|76063784|FG005|NOT COMPLETED|Predecessor Study||0||
59945256|NCT03706079|76063779|FG000|STARTED|Long Term Extension (DESTINATION)||415||
59945257|NCT03706079|76063780|FG001|STARTED|Long Term Extension (DESTINATION)||206||
59945258|NCT03706079|76063781|FG002|STARTED|Long Term Extension (DESTINATION)||206||
59945259|NCT03706079|76063782|FG003|STARTED|Long Term Extension (DESTINATION)||60||
59945260|NCT03706079|76063783|FG004|STARTED|Long Term Extension (DESTINATION)||32||
59945261|NCT03706079|76063784|FG005|STARTED|Long Term Extension (DESTINATION)||32||
59945262|NCT03706079|76063779|FG000|Received Treatment|Long Term Extension (DESTINATION)||415||
59945263|NCT03706079|76063780|FG001|Received Treatment|Long Term Extension (DESTINATION)||206||
59945264|NCT03706079|76063781|FG002|Received Treatment|Long Term Extension (DESTINATION)||205||
59945265|NCT03706079|76063782|FG003|Received Treatment|Long Term Extension (DESTINATION)||60||
59945266|NCT03706079|76063783|FG004|Received Treatment|Long Term Extension (DESTINATION)||32||
59945267|NCT03706079|76063784|FG005|Received Treatment|Long Term Extension (DESTINATION)||32||
59945268|NCT03706079|76063779|FG000|COMPLETED|Long Term Extension (DESTINATION)||400||
59945269|NCT03706079|76063780|FG001|COMPLETED|Long Term Extension (DESTINATION)||200||
59945270|NCT03706079|76063781|FG002|COMPLETED|Long Term Extension (DESTINATION)||198||
59945271|NCT03706079|76063782|FG003|COMPLETED|Long Term Extension (DESTINATION)||58||
59945272|NCT03706079|76063783|FG004|COMPLETED|Long Term Extension (DESTINATION)||28||
59945273|NCT03706079|76063784|FG005|COMPLETED|Long Term Extension (DESTINATION)||31||
59945274|NCT03706079|76063779|FG000|NOT COMPLETED|Long Term Extension (DESTINATION)||15||
59945275|NCT03706079|76063780|FG001|NOT COMPLETED|Long Term Extension (DESTINATION)||6||
59945276|NCT03706079|76063781|FG002|NOT COMPLETED|Long Term Extension (DESTINATION)||8||
59945277|NCT03706079|76063782|FG003|NOT COMPLETED|Long Term Extension (DESTINATION)||2||
59945278|NCT03706079|76063783|FG004|NOT COMPLETED|Long Term Extension (DESTINATION)||4||
59945279|NCT03706079|76063784|FG005|NOT COMPLETED|Long Term Extension (DESTINATION)||1||
59945280|NCT03657160|76063798|FG000|STARTED|Overall Study||169||
59945281|NCT03657160|76063799|FG001|STARTED|Overall Study||174||
59945282|NCT03657160|76063798|FG000|Safety Analysis Set|Overall Study||165|Safety Analysis Set included all participants who received at least 1 dose of study drug.|
59945283|NCT03657160|76063799|FG001|Safety Analysis Set|Overall Study||169|Safety Analysis Set included all participants who received at least 1 dose of study drug.|
59945284|NCT03657160|76063798|FG000|Full Analysis Set|Overall Study||165|Full Analysis Set included all participants who were randomized, received at least 1 dose of the treatment, and under-went allo-HSCT.|
59945285|NCT03657160|76063799|FG001|Full Analysis Set|Overall Study||168|Full Analysis Set included all participants who were randomized, received at least 1 dose of the treatment, and under-went allo-HSCT.|
59945286|NCT03657160|76063798|FG000|COMPLETED|Overall Study||98|Participants who completed the 182 days treatment period and the long term follow-up (6 months after the last dose of study drug).|
59945287|NCT03657160|76063799|FG001|COMPLETED|Overall Study||117|Participants who completed the 182 days treatment period and the long term follow-up (6 months after the last dose of study drug).|
59945288|NCT03657160|76063798|FG000|NOT COMPLETED|Overall Study||71||
59945289|NCT03657160|76063799|FG001|NOT COMPLETED|Overall Study||57||
59945290|NCT03635320|76063809|FG000|STARTED|Overall Study||94|Participated in randomization|
59945291|NCT03635320|76063810|FG001|STARTED|Overall Study||94|Participated in randomization|
59945292|NCT03635320|76063809|FG000|FAS|Overall Study|1 subject was not implanted the device|93|Full Analysis Set (FAS): The data set constituted by all subjects who participate in the randomized study and receive the product (implant).|
59945293|NCT03635320|76063810|FG001|FAS|Overall Study|2 subjects were not implant the device|92|Full Analysis Set (FAS): The data set constituted by all subjects who participate in the randomized study and receive the product (implant).|
59945294|NCT03635320|76063809|FG000|PPS|Overall Study|11 subjects early discontinued and didn't complete the trial which were excluded from PPS, 1 subject had a risk of unblinding, which was excluded from the PPS.|81|Per Protocol Set (PPS): A set of subjects that complete the trial, excluding those with serious protocol violation affecting the primary efficacy endpoints.|
59945295|NCT03635320|76063810|FG001|PPS|Overall Study|6 subjects early discontinued and didn't complete the trial which were excluded from PPS, 1 subject didn't undergo the evaluation or laboratory examination required by the clinical trial, 1 subject violated the inclusion/exclusion criteria and 1 subject used the device beyond the scope of the specifications, which were excluded from the PPS.|83|Per Protocol Set (PPS): A set of subjects that complete the trial, excluding those with serious protocol violation affecting the primary efficacy endpoints.|
59945296|NCT03635320|76063809|FG000|COMPLETED|Overall Study||82|Completed the study visits|
59945297|NCT03635320|76063810|FG001|COMPLETED|Overall Study||86|Completed the study visits|
59945298|NCT03635320|76063809|FG000|NOT COMPLETED|Overall Study||12||
59945299|NCT03635320|76063810|FG001|NOT COMPLETED|Overall Study||8||
59945300|NCT03623620|76063818|FG000|STARTED|Overall Study||249||
59945301|NCT03623620|76063819|FG001|STARTED|Overall Study||251||
59945302|NCT03623620|76063818|FG000|COMPLETED|Overall Study||249||
59945303|NCT03623620|76063819|FG001|COMPLETED|Overall Study||251||
59945304|NCT03623620|76063818|FG000|NOT COMPLETED|Overall Study||0||
59945305|NCT03623620|76063819|FG001|NOT COMPLETED|Overall Study||0||
59945306|NCT03508726|76063827|FG000|STARTED|Overall Study||6||
59945307|NCT03508726|76063828|FG001|STARTED|Overall Study||19||
59945308|NCT03508726|76063827|FG000|COMPLETED|Overall Study||6||
59945309|NCT03508726|76063828|FG001|COMPLETED|Overall Study||18||
59945310|NCT03508726|76063827|FG000|NOT COMPLETED|Overall Study||0||
59945311|NCT03508726|76063828|FG001|NOT COMPLETED|Overall Study||1||
59945312|NCT03499964|76063837|FG000|STARTED|Overall Study||79||
59945313|NCT03499964|76063838|FG001|STARTED|Overall Study||48||
59945314|NCT03499964|76063837|FG000|COMPLETED|Overall Study||68||
59945315|NCT03499964|76063838|FG001|COMPLETED|Overall Study||21||
59945316|NCT03499964|76063837|FG000|NOT COMPLETED|Overall Study||11||
59613388|NCT01686438|75724539|FG000|3-Month Follow Up|Overall Study||7||
59613389|NCT01686438|75724540|FG001|3-Month Follow Up|Overall Study||21||
59945317|NCT03499964|76063838|FG001|NOT COMPLETED|Overall Study||27||
59945318|NCT03279692|76063844|FG000|STARTED|Overall Study||26||
59945319|NCT03279692|76063844|FG000|COMPLETED|Overall Study||25||
59945320|NCT03279692|76063844|FG000|NOT COMPLETED|Overall Study||1||
59945321|NCT03152929|76063850|FG000|STARTED|Overall Study||40||
59945322|NCT03152929|76063851|FG001|STARTED|Overall Study||49||
59945323|NCT03152929|76063850|FG000|COMPLETED|Overall Study||40||
59945324|NCT03152929|76063851|FG001|COMPLETED|Overall Study||49||
59945325|NCT03152929|76063850|FG000|NOT COMPLETED|Overall Study||0||
59945326|NCT03152929|76063851|FG001|NOT COMPLETED|Overall Study||0||
59945327|NCT03001882|76063861|FG000|STARTED|Overall Study||30||
59945328|NCT03001882|76063862|FG001|STARTED|Overall Study||28||
59945329|NCT03001882|76063863|FG002|STARTED|Overall Study||2||
59945330|NCT03001882|76063864|FG003|STARTED|Overall Study||170||
59945331|NCT03001882|76063861|FG000|COMPLETED|Overall Study||1|Continuing in treatment period|
59945332|NCT03001882|76063862|FG001|COMPLETED|Overall Study||1|Continuing in treatment period|
59945333|NCT03001882|76063863|FG002|COMPLETED|Overall Study||0|Continuing in treatment period|
59518754|NCT02174419|75612605|FG000|COMPLETED|Overall Study||18||
59945334|NCT03001882|76063864|FG003|COMPLETED|Overall Study||0|Continuing in treatment period|
59945335|NCT03001882|76063861|FG000|NOT COMPLETED|Overall Study||29||
59945336|NCT03001882|76063862|FG001|NOT COMPLETED|Overall Study||27||
59945337|NCT03001882|76063863|FG002|NOT COMPLETED|Overall Study||2||
59945338|NCT03001882|76063864|FG003|NOT COMPLETED|Overall Study||170||
59945339|NCT02985151|76063881|FG000|STARTED|Original Randomization||25||
59945340|NCT02985151|76063882|FG001|STARTED|Original Randomization||26||
59945341|NCT02985151|76063881|FG000|COMPLETED|Original Randomization||25||
59945342|NCT02985151|76063882|FG001|COMPLETED|Original Randomization||25||
59945343|NCT02985151|76063881|FG000|NOT COMPLETED|Original Randomization||0||
59945344|NCT02985151|76063882|FG001|NOT COMPLETED|Original Randomization||1||
59945345|NCT02985151|76063881|FG000|STARTED|Crossover From Low to High Energy||0||
59945346|NCT02985151|76063882|FG001|STARTED|Crossover From Low to High Energy||10||
59945347|NCT02985151|76063881|FG000|COMPLETED|Crossover From Low to High Energy||0||
59945348|NCT02985151|76063882|FG001|COMPLETED|Crossover From Low to High Energy||10||
59945349|NCT02985151|76063881|FG000|NOT COMPLETED|Crossover From Low to High Energy||0||
59945350|NCT02985151|76063882|FG001|NOT COMPLETED|Crossover From Low to High Energy||0||
59945351|NCT02981966|76063892|FG000|STARTED|Overall Study||13||
59945352|NCT02981966|76063893|FG001|STARTED|Overall Study||7||
59945353|NCT02981966|76063894|FG002|STARTED|Overall Study||8||
59945354|NCT02981966|76063895|FG003|STARTED|Overall Study||4||
59945355|NCT02981966|76063892|FG000|COMPLETED|Overall Study||13||
59945356|NCT02981966|76063893|FG001|COMPLETED|Overall Study||7||
59945357|NCT02981966|76063894|FG002|COMPLETED|Overall Study||8||
59945358|NCT02981966|76063895|FG003|COMPLETED|Overall Study||4||
59945359|NCT02981966|76063892|FG000|NOT COMPLETED|Overall Study||0||
59945360|NCT02981966|76063893|FG001|NOT COMPLETED|Overall Study||0||
59945361|NCT02981966|76063894|FG002|NOT COMPLETED|Overall Study||0||
59945362|NCT02981966|76063895|FG003|NOT COMPLETED|Overall Study||0||
59945363|NCT02740179|76063907|FG000|STARTED|Overall Study||20||
59945364|NCT02740179|76063908|FG001|STARTED|Overall Study||20||
59945365|NCT02740179|76063907|FG000|COMPLETED|Overall Study||14||
59945366|NCT02740179|76063908|FG001|COMPLETED|Overall Study||19||
59945367|NCT02740179|76063907|FG000|NOT COMPLETED|Overall Study||6||
60067564|NCT01937299|76182744|FG001|STARTED|Overall Study||116||
59518755|NCT02174419|75612606|FG001|COMPLETED|Overall Study||12||
59518756|NCT02174419|75612607|FG002|COMPLETED|Overall Study||20||
59518757|NCT02174419|75612605|FG000|NOT COMPLETED|Overall Study||4||
59518758|NCT02174419|75612606|FG001|NOT COMPLETED|Overall Study||6||
59945368|NCT02740179|76063908|FG001|NOT COMPLETED|Overall Study||1||
59945369|NCT02650986|76063918|FG000|STARTED|Overall Study||3||
59945370|NCT02650986|76063919|FG001|STARTED|Overall Study||3||
59945371|NCT02650986|76063920|FG002|STARTED|Overall Study||3||
59945372|NCT02650986|76063921|FG003|STARTED|Overall Study||6||
59945373|NCT02650986|76063918|FG000|COMPLETED|Overall Study||3||
59945374|NCT02650986|76063919|FG001|COMPLETED|Overall Study||3||
59945375|NCT02650986|76063920|FG002|COMPLETED|Overall Study||3||
59945376|NCT02650986|76063921|FG003|COMPLETED|Overall Study||6||
59945377|NCT02650986|76063918|FG000|NOT COMPLETED|Overall Study||0||
59945378|NCT02650986|76063919|FG001|NOT COMPLETED|Overall Study||0||
59945379|NCT02650986|76063920|FG002|NOT COMPLETED|Overall Study||0||
59945380|NCT02650986|76063921|FG003|NOT COMPLETED|Overall Study||0||
59945381|NCT02619409|76063936|FG000|STARTED|Overall Study||6||
59945382|NCT02619409|76063937|FG001|STARTED|Overall Study||6||
59945383|NCT02619409|76063938|FG002|STARTED|Overall Study||6||
59945384|NCT02619409|76063939|FG003|STARTED|Overall Study||6||
59945385|NCT02619409|76063940|FG004|STARTED|Overall Study||6||
59518759|NCT02174419|75612607|FG002|NOT COMPLETED|Overall Study||2||
59518760|NCT00942851|75612617|FG000|STARTED|Overall Study||12||
59518761|NCT00942851|75612618|FG001|STARTED|Overall Study||12||
59518762|NCT00942851|75612617|FG000|COMPLETED|Overall Study||12||
59518763|NCT00942851|75612618|FG001|COMPLETED|Overall Study||11||
59945386|NCT02619409|76063936|FG000|COMPLETED|Overall Study||6||
59518764|NCT00942851|75612617|FG000|NOT COMPLETED|Overall Study||0||
59945387|NCT02619409|76063937|FG001|COMPLETED|Overall Study||6||
59945388|NCT02619409|76063938|FG002|COMPLETED|Overall Study||6||
59945389|NCT02619409|76063939|FG003|COMPLETED|Overall Study||6||
59945390|NCT02619409|76063940|FG004|COMPLETED|Overall Study||6||
59945391|NCT02619409|76063936|FG000|NOT COMPLETED|Overall Study||0||
59945392|NCT02619409|76063937|FG001|NOT COMPLETED|Overall Study||0||
59945393|NCT02619409|76063938|FG002|NOT COMPLETED|Overall Study||0||
59945394|NCT02619409|76063939|FG003|NOT COMPLETED|Overall Study||0||
59945395|NCT02619409|76063940|FG004|NOT COMPLETED|Overall Study||0||
59945396|NCT02603432|76063954|FG000|STARTED|Overall Study||350||
59945397|NCT02603432|76063955|FG001|STARTED|Overall Study||350||
59945398|NCT02603432|76063954|FG000|COMPLETED|Overall Study||0||
59945399|NCT02603432|76063955|FG001|COMPLETED|Overall Study||0||
59945400|NCT02603432|76063954|FG000|NOT COMPLETED|Overall Study||350||
59945401|NCT02603432|76063955|FG001|NOT COMPLETED|Overall Study||350||
59945402|NCT02582866|76063961|FG000|STARTED|Overall Study||106||
59945403|NCT02582866|76063961|FG000|COMPLETED|Overall Study||84||
59945404|NCT02582866|76063961|FG000|NOT COMPLETED|Overall Study||22||
59945405|NCT02098161|76063965|FG000|STARTED|Overall Study||50||
59945406|NCT02098161|76063965|FG000|COMPLETED|Overall Study||50||
59945407|NCT02098161|76063965|FG000|NOT COMPLETED|Overall Study||0||
59945408|NCT01734928|76063971|FG000|STARTED|Randomization||281||
59945409|NCT01734928|76063972|FG001|STARTED|Randomization||278||
59945410|NCT01734928|76063971|FG000|COMPLETED|Randomization||278||
59945411|NCT01734928|76063972|FG001|COMPLETED|Randomization||270||
59945412|NCT01734928|76063971|FG000|NOT COMPLETED|Randomization||3||
59945413|NCT01734928|76063972|FG001|NOT COMPLETED|Randomization||8||
59945414|NCT01734928|76063971|FG000|STARTED|Treatment Period||278||
59945415|NCT01734928|76063972|FG001|STARTED|Treatment Period||270||
59945416|NCT01734928|76063971|FG000|COMPLETED|Treatment Period||0||
59945417|NCT01734928|76063972|FG001|COMPLETED|Treatment Period||0||
59945418|NCT01734928|76063971|FG000|NOT COMPLETED|Treatment Period||278||
59945419|NCT01734928|76063972|FG001|NOT COMPLETED|Treatment Period||270||
59945420|NCT00667459|76063980|FG000|STARTED|Overall Study||280||
59945421|NCT00667459|76063981|FG001|STARTED|Overall Study||265||
59945422|NCT00667459|76063980|FG000|COMPLETED|Overall Study||272||
59945423|NCT00667459|76063981|FG001|COMPLETED|Overall Study||220||
59945424|NCT00667459|76063980|FG000|NOT COMPLETED|Overall Study||8||
59945425|NCT00667459|76063981|FG001|NOT COMPLETED|Overall Study||45||
59945426|NCT00546429|76063987|FG000|STARTED|Overall Study|2 subjects did not have a preoperative Merle D'Aubigne score.|62||
59945427|NCT00546429|76063987|FG000|COMPLETED|Overall Study||32||
59945428|NCT00546429|76063987|FG000|NOT COMPLETED|Overall Study||30||
59945429|NCT00453544|76063995|FG000|STARTED|Overall Study||62||
59945430|NCT00453544|76063996|FG001|STARTED|Overall Study||55||
59945431|NCT00453544|76063997|FG002|STARTED|Overall Study||68||
59945432|NCT00453544|76063998|FG003|STARTED|Overall Study||67||
59945433|NCT00453544|76063995|FG000|COMPLETED|Overall Study||60||
59945434|NCT00453544|76063996|FG001|COMPLETED|Overall Study||54||
59945435|NCT00453544|76063997|FG002|COMPLETED|Overall Study||68||
59945436|NCT00453544|76063998|FG003|COMPLETED|Overall Study||66||
59945437|NCT00453544|76063995|FG000|NOT COMPLETED|Overall Study||2||
59945438|NCT00453544|76063996|FG001|NOT COMPLETED|Overall Study||1||
59945439|NCT00453544|76063997|FG002|NOT COMPLETED|Overall Study||0||
59945440|NCT00453544|76063998|FG003|NOT COMPLETED|Overall Study||1||
59945441|NCT02646124|76064022|FG000|STARTED|Overall Study||57||
59945442|NCT02646124|76064023|FG001|STARTED|Overall Study||57||
59945443|NCT02646124|76064022|FG000|COMPLETED|Overall Study||57||
59945444|NCT02646124|76064023|FG001|COMPLETED|Overall Study||55||
59945445|NCT02646124|76064022|FG000|NOT COMPLETED|Overall Study||0||
59945446|NCT02646124|76064023|FG001|NOT COMPLETED|Overall Study||2||
59945447|NCT01597492|76064031|FG000|STARTED|Overall Study||34||
59945448|NCT01597492|76064032|FG001|STARTED|Overall Study||45||
59945449|NCT01597492|76064031|FG000|COMPLETED|Overall Study||28||
59945450|NCT01597492|76064032|FG001|COMPLETED|Overall Study||41||
59945451|NCT01597492|76064031|FG000|NOT COMPLETED|Overall Study||6||
59945452|NCT01597492|76064032|FG001|NOT COMPLETED|Overall Study||4||
59945453|NCT03423602|76064038|FG000|STARTED|Overall Study||75||84
59945454|NCT03423602|76064038|FG000|Discharge|Overall Study|One subject died prior to discharge: due to cerebral infarction following cardiac arrest, not related to the study device. Four subjects were excluded from the study with no further follow-up due to not being implanted with a study device.|70||77
59945455|NCT03423602|76064038|FG000|1-month Follow-up|Overall Study|Two subjects voluntarily withdrew their consent to remain in the study. One subject was excluded from the study post discharge examination due to unrelated groin surgery. One subject was not followed-up at 1-month due to unrelated gastrointestinal complications (and subsequently withdrew from the study prior to 3-month follow-up); Three subjects missed their 1-month follow-up, however remained in the study and attended their 3-month follow-up assessment.|66||71
59945456|NCT03423602|76064038|FG000|3-month Follow-up|Overall Study|Two subjects voluntarily withdrew their consent to remain in the study. One subject was lost to follow-up|63||72
59945457|NCT03423602|76064038|FG000|COMPLETED|Overall Study||63||72
59945458|NCT03423602|76064038|FG000|NOT COMPLETED|Overall Study||12||12
59945459|NCT00109590|76064045|FG000|STARTED|Overall Study||57||
59945460|NCT00109590|76064046|FG001|STARTED|Overall Study||58||
59945461|NCT00109590|76064047|FG002|STARTED|Overall Study||60||
60067565|NCT01937299|76182743|FG000|COMPLETED|Overall Study||103||
60067566|NCT01937299|76182744|FG001|COMPLETED|Overall Study||112||
59945462|NCT00109590|76064045|FG000|RECEIVED TREATMENT|Overall Study||56||
59945463|NCT00109590|76064046|FG001|RECEIVED TREATMENT|Overall Study||56||
59945464|NCT00109590|76064047|FG002|RECEIVED TREATMENT|Overall Study||57||
59945465|NCT00109590|76064045|FG000|COMPLETED|Overall Study||55||
59945466|NCT00109590|76064046|FG001|COMPLETED|Overall Study||56||
59945467|NCT00109590|76064047|FG002|COMPLETED|Overall Study||56||
59945468|NCT00109590|76064045|FG000|NOT COMPLETED|Overall Study||2||
59945469|NCT00109590|76064046|FG001|NOT COMPLETED|Overall Study||2||
59945470|NCT00109590|76064047|FG002|NOT COMPLETED|Overall Study||4||
59945471|NCT02781558|76064071|FG000|STARTED|Overall Study||101||
59945472|NCT02781558|76064072|FG001|STARTED|Overall Study||103||
59945473|NCT02781558|76064071|FG000|COMPLETED|Overall Study||98||
59945474|NCT02781558|76064072|FG001|COMPLETED|Overall Study||101||
59945475|NCT02781558|76064071|FG000|NOT COMPLETED|Overall Study||3||
59945476|NCT02781558|76064072|FG001|NOT COMPLETED|Overall Study||2||
59945477|NCT03041311|76064081|FG000|STARTED|Overall Study||54||
59945478|NCT03041311|76064082|FG001|STARTED|Overall Study||53||
59945479|NCT03041311|76064081|FG000|COMPLETED|Overall Study||0||
59945480|NCT03041311|76064082|FG001|COMPLETED|Overall Study||0||
59945481|NCT03041311|76064081|FG000|NOT COMPLETED|Overall Study||54||
59945482|NCT03041311|76064082|FG001|NOT COMPLETED|Overall Study||53||
59945483|NCT02644096|76064098|FG000|STARTED|Overall Study||93||
59945484|NCT02644096|76064099|FG001|STARTED|Overall Study||82||
59945485|NCT02644096|76064098|FG000|2 Week Interview|Overall Study|Not done in control group|0||
59945486|NCT02644096|76064099|FG001|2 Week Interview|Overall Study||68||
59945487|NCT02644096|76064098|FG000|10 Week Interview|Overall Study|Not done in control group|0||
59945488|NCT02644096|76064099|FG001|10 Week Interview|Overall Study||59||
59945489|NCT02644096|76064098|FG000|12 Week SF-36 Questionnaire|Overall Study||68||
59945490|NCT02644096|76064099|FG001|12 Week SF-36 Questionnaire|Overall Study||59||
59945491|NCT02644096|76064098|FG000|9 Month SF-36 Questionnaire|Overall Study||65||
59945492|NCT02644096|76064099|FG001|9 Month SF-36 Questionnaire|Overall Study||57||
59945493|NCT02644096|76064098|FG000|COMPLETED|Overall Study||65||
59945494|NCT02644096|76064099|FG001|COMPLETED|Overall Study||57||
59945495|NCT02644096|76064098|FG000|NOT COMPLETED|Overall Study||28||
59945496|NCT02644096|76064099|FG001|NOT COMPLETED|Overall Study||25||
59945497|NCT02643628|76064107|FG000|STARTED|Overall Study||21||
59945498|NCT02643628|76064108|FG001|STARTED|Overall Study||23||
59945499|NCT02643628|76064107|FG000|COMPLETED|Overall Study||20||
59945500|NCT02643628|76064108|FG001|COMPLETED|Overall Study||17||
59945501|NCT02643628|76064107|FG000|NOT COMPLETED|Overall Study||1||
59945502|NCT02643628|76064108|FG001|NOT COMPLETED|Overall Study||6||
59945503|NCT02643472|76064118|FG000|STARTED|Overall Study||150||
59945504|NCT02643472|76064119|FG001|STARTED|Overall Study||150||
59945505|NCT02643472|76064118|FG000|COMPLETED|Overall Study||123||
59945506|NCT02643472|76064119|FG001|COMPLETED|Overall Study|One participant completed CESD-10 but not other measures at 12 months; n=115 for other measures.|116||
59945507|NCT02643472|76064118|FG000|NOT COMPLETED|Overall Study||27||
59945508|NCT02643472|76064119|FG001|NOT COMPLETED|Overall Study||34||
59945509|NCT02738840|76064127|FG000|STARTED|Overall Study||56||
59945510|NCT02738840|76064127|FG000|COMPLETED|Overall Study||48||
59945511|NCT02738840|76064127|FG000|NOT COMPLETED|Overall Study||8||
59945512|NCT02643394|76064133|FG000|STARTED|Overall Study||55||
59945513|NCT02643394|76064134|FG001|STARTED|Overall Study||55||
59945514|NCT02643394|76064133|FG000|COMPLETED|Overall Study||51||
59945515|NCT02643394|76064134|FG001|COMPLETED|Overall Study||50||
59945516|NCT02643394|76064133|FG000|NOT COMPLETED|Overall Study||4||
59945517|NCT02643394|76064134|FG001|NOT COMPLETED|Overall Study||5||
59945518|NCT03538158|76064142|FG000|STARTED|Overall Study||92||
59945519|NCT03538158|76064143|FG001|STARTED|Overall Study||89||
59945520|NCT03538158|76064142|FG000|12 Week Intervention Phase|Overall Study||82||
59945521|NCT03538158|76064143|FG001|12 Week Intervention Phase|Overall Study||82||
59945522|NCT03538158|76064142|FG000|12 Week Maintenance Phase|Overall Study||77||
60067567|NCT01937299|76182743|FG000|NOT COMPLETED|Overall Study||14||
59945523|NCT03538158|76064143|FG001|12 Week Maintenance Phase|Overall Study||81||
59945524|NCT03538158|76064142|FG000|COMPLETED|Overall Study||77||
59945525|NCT03538158|76064143|FG001|COMPLETED|Overall Study||81||
59945526|NCT03538158|76064142|FG000|NOT COMPLETED|Overall Study||15||
59945527|NCT03538158|76064143|FG001|NOT COMPLETED|Overall Study||8||
59945528|NCT02643082|76064149|FG000|STARTED|Period 1||10||
59945529|NCT02643082|76064150|FG001|STARTED|Period 1||10||
59945530|NCT02643082|76064149|FG000|COMPLETED|Period 1||9||
59945531|NCT02643082|76064150|FG001|COMPLETED|Period 1||10||
59945532|NCT02643082|76064149|FG000|NOT COMPLETED|Period 1||1||
59945533|NCT02643082|76064150|FG001|NOT COMPLETED|Period 1||0||
59945534|NCT02643082|76064149|FG000|STARTED|Washout||9||
59945535|NCT02643082|76064150|FG001|STARTED|Washout||10||
59945536|NCT02643082|76064149|FG000|COMPLETED|Washout||9||
59945537|NCT02643082|76064150|FG001|COMPLETED|Washout||10||
59945538|NCT02643082|76064149|FG000|NOT COMPLETED|Washout||0||
59945539|NCT02643082|76064150|FG001|NOT COMPLETED|Washout||0||
59945540|NCT02643082|76064149|FG000|STARTED|Period 2||9||
59945541|NCT02643082|76064150|FG001|STARTED|Period 2||10||
59945542|NCT02643082|76064149|FG000|COMPLETED|Period 2||9||
59945543|NCT02643082|76064150|FG001|COMPLETED|Period 2||10||
59945544|NCT02643082|76064149|FG000|NOT COMPLETED|Period 2||0||
59945545|NCT02643082|76064150|FG001|NOT COMPLETED|Period 2||0||
59945546|NCT00353496|76064159|FG000|STARTED|Overall Study||101||
59945547|NCT00353496|76064160|FG001|STARTED|Overall Study||103||
59945548|NCT00353496|76064159|FG000|COMPLETED|Overall Study|Patients who completed specified assessments or met primary efficacy endpoint criteria for an event.|85||
59945549|NCT00353496|76064160|FG001|COMPLETED|Overall Study||86||
59945550|NCT00353496|76064159|FG000|NOT COMPLETED|Overall Study||16||
59945551|NCT00353496|76064160|FG001|NOT COMPLETED|Overall Study||17||
59945552|NCT03473977|76064169|FG000|STARTED|Overall Study||13||
59945553|NCT03473977|76064170|FG001|STARTED|Overall Study||13||
59945554|NCT03473977|76064169|FG000|COMPLETED|Overall Study||13||
59945555|NCT03473977|76064170|FG001|COMPLETED|Overall Study||13||
59945556|NCT03473977|76064169|FG000|NOT COMPLETED|Overall Study||0||
59945557|NCT03473977|76064170|FG001|NOT COMPLETED|Overall Study||0||
59945558|NCT01361464|76064176|FG000|STARTED|Overall Study||21||
59945559|NCT01361464|76064176|FG000|COMPLETED|Overall Study||18||
59945560|NCT01361464|76064176|FG000|NOT COMPLETED|Overall Study||3||
59945561|NCT03486912|76064184|FG000|STARTED|Randomized (Pre-Treatment)||39||
59945562|NCT03486912|76064185|FG001|STARTED|Randomized (Pre-Treatment)||38||
59945563|NCT03486912|76064186|FG002|STARTED|Randomized (Pre-Treatment)||39||
59945564|NCT03486912|76064187|FG003|STARTED|Randomized (Pre-Treatment)||39||
59945565|NCT03486912|76064184|FG000|COMPLETED|Randomized (Pre-Treatment)||39|Moved to treatment period|
59945566|NCT03486912|76064185|FG001|COMPLETED|Randomized (Pre-Treatment)||37|Moved to treatment period|
59945567|NCT03486912|76064186|FG002|COMPLETED|Randomized (Pre-Treatment)||39|Moved to treatment period|
59945568|NCT03486912|76064187|FG003|COMPLETED|Randomized (Pre-Treatment)||39|Moved to treatment period|
59945569|NCT03486912|76064184|FG000|NOT COMPLETED|Randomized (Pre-Treatment)||0||
59945570|NCT03486912|76064185|FG001|NOT COMPLETED|Randomized (Pre-Treatment)||1||
59945571|NCT03486912|76064186|FG002|NOT COMPLETED|Randomized (Pre-Treatment)||0||
59945572|NCT03486912|76064187|FG003|NOT COMPLETED|Randomized (Pre-Treatment)||0||
59945573|NCT03486912|76064184|FG000|STARTED|Treatment Period||39||
59945574|NCT03486912|76064185|FG001|STARTED|Treatment Period||37||
59945575|NCT03486912|76064186|FG002|STARTED|Treatment Period||39||
59945576|NCT03486912|76064187|FG003|STARTED|Treatment Period||39||
59945577|NCT03486912|76064184|FG000|COMPLETED|Treatment Period||35||
59945578|NCT03486912|76064185|FG001|COMPLETED|Treatment Period||31||
59945579|NCT03486912|76064186|FG002|COMPLETED|Treatment Period||34||
59945580|NCT03486912|76064187|FG003|COMPLETED|Treatment Period||34||
59945581|NCT03486912|76064184|FG000|NOT COMPLETED|Treatment Period||4||
59945582|NCT03486912|76064185|FG001|NOT COMPLETED|Treatment Period||6||
59945583|NCT03486912|76064186|FG002|NOT COMPLETED|Treatment Period||5||
59945584|NCT03486912|76064187|FG003|NOT COMPLETED|Treatment Period||5||
59945585|NCT02642614|76064201|FG000|STARTED|Overall Study||30||
59945586|NCT02642614|76064202|FG001|STARTED|Overall Study||30||
59945587|NCT02642614|76064203|FG002|STARTED|Overall Study||30||
59945588|NCT02642614|76064204|FG003|STARTED|Overall Study||30||
59945589|NCT02642614|76064201|FG000|COMPLETED|Overall Study||27||
59945590|NCT02642614|76064202|FG001|COMPLETED|Overall Study||28||
59945591|NCT02642614|76064203|FG002|COMPLETED|Overall Study||28||
59945592|NCT02642614|76064204|FG003|COMPLETED|Overall Study||28||
60067568|NCT01937299|76182744|FG001|NOT COMPLETED|Overall Study||4||
60067569|NCT02003963|76182753|FG000|STARTED|Overall Study||22||
60067570|NCT02003963|76182754|FG001|STARTED|Overall Study||19||
60067571|NCT02003963|76182753|FG000|COMPLETED|Overall Study|2 participants dropped out: 1 due to lack of interest and 1 due to a mental health hospitalization.|20||
60067572|NCT02003963|76182754|FG001|COMPLETED|Overall Study|1 participant was removed from analysis for completing final visit outside of visit window.|18||
60067573|NCT02003963|76182753|FG000|NOT COMPLETED|Overall Study||2||
60067574|NCT02003963|76182754|FG001|NOT COMPLETED|Overall Study||1||
60067575|NCT01606761|76182765|FG000|STARTED|Prior to Week 24||294||
60067576|NCT01606761|76182766|FG001|STARTED|Prior to Week 24||292||
60067577|NCT01606761|76182767|FG002|STARTED|Prior to Week 24||292||
60067578|NCT01606761|76182768|FG003|STARTED|Prior to Week 24||0||
60067579|NCT01606761|76182769|FG004|STARTED|Prior to Week 24||0||
60067580|NCT01606761|76182765|FG000|Participants Re-randomized at Week 18|Prior to Week 24|Out of 94, 46 were re-randomized to sirukumab 50 mg and 48 were re-randomized to 100 mg group.|94||
60067581|NCT01606761|76182766|FG001|Participants Re-randomized at Week 18|Prior to Week 24||0||
59945593|NCT02642614|76064201|FG000|NOT COMPLETED|Overall Study||3||
59945594|NCT02642614|76064202|FG001|NOT COMPLETED|Overall Study||2||
59945595|NCT02642614|76064203|FG002|NOT COMPLETED|Overall Study||2||
59945596|NCT02642614|76064204|FG003|NOT COMPLETED|Overall Study||2||
59945597|NCT02781324|76064219|FG000|STARTED|Overall Study||33||
59945598|NCT02781324|76064220|FG001|STARTED|Overall Study||33||
59945599|NCT02781324|76064219|FG000|COMPLETED|Overall Study||31||
59945600|NCT02781324|76064220|FG001|COMPLETED|Overall Study||31||
59945601|NCT02781324|76064219|FG000|NOT COMPLETED|Overall Study||2||
59945602|NCT02781324|76064220|FG001|NOT COMPLETED|Overall Study||2||
59945603|NCT03292146|76064230|FG000|STARTED|Baseline to 12 Months||20||
59945604|NCT03292146|76064231|FG001|STARTED|Baseline to 12 Months||10||
59945605|NCT03292146|76064230|FG000|COMPLETED|Baseline to 12 Months||18||
59945606|NCT03292146|76064231|FG001|COMPLETED|Baseline to 12 Months||9||
59945607|NCT03292146|76064230|FG000|NOT COMPLETED|Baseline to 12 Months||2||
59945608|NCT03292146|76064231|FG001|NOT COMPLETED|Baseline to 12 Months||1||
59945609|NCT03292146|76064230|FG000|STARTED|12 Months to 24 Months||18||
59945610|NCT03292146|76064231|FG001|STARTED|12 Months to 24 Months||9||
59945611|NCT03292146|76064230|FG000|COMPLETED|12 Months to 24 Months||15||
59945612|NCT03292146|76064231|FG001|COMPLETED|12 Months to 24 Months||6||
59945613|NCT03292146|76064230|FG000|NOT COMPLETED|12 Months to 24 Months||3||
59945614|NCT03292146|76064231|FG001|NOT COMPLETED|12 Months to 24 Months||3||
59945615|NCT01360996|76064240|FG000|STARTED|Overall Study||20||
59945616|NCT01360996|76064241|FG001|STARTED|Overall Study||21||
59945617|NCT01360996|76064242|FG002|STARTED|Overall Study||23||
59945618|NCT01360996|76064240|FG000|COMPLETED|Overall Study||14||
59945619|NCT01360996|76064241|FG001|COMPLETED|Overall Study||18||
59945620|NCT01360996|76064242|FG002|COMPLETED|Overall Study||21||
59945621|NCT01360996|76064240|FG000|NOT COMPLETED|Overall Study||6||
59945622|NCT01360996|76064241|FG001|NOT COMPLETED|Overall Study||3||
59945623|NCT01360996|76064242|FG002|NOT COMPLETED|Overall Study||2||
59945624|NCT02639338|76064251|FG000|STARTED|Overall Study||110||
59945625|NCT02639338|76064252|FG001|STARTED|Overall Study||110||
59945626|NCT02639338|76064251|FG000|COMPLETED|Overall Study||106||
59945627|NCT02639338|76064252|FG001|COMPLETED|Overall Study||105||
59945628|NCT02639338|76064251|FG000|NOT COMPLETED|Overall Study||4||
59945629|NCT02639338|76064252|FG001|NOT COMPLETED|Overall Study||5||
59945630|NCT01754857|76064258|FG000|STARTED|Overall Study||36||
59945631|NCT01754857|76064258|FG000|COMPLETED|Overall Study||17||
59945632|NCT01754857|76064258|FG000|NOT COMPLETED|Overall Study||19||
59945633|NCT02900352|76064264|FG000|STARTED|Overall Study||77||
59945634|NCT02900352|76064265|FG001|STARTED|Overall Study||79||
59945635|NCT02900352|76064264|FG000|COMPLETED|Overall Study||49||
59945636|NCT02900352|76064265|FG001|COMPLETED|Overall Study||62||
59945637|NCT02900352|76064264|FG000|NOT COMPLETED|Overall Study||28||
59945638|NCT02900352|76064265|FG001|NOT COMPLETED|Overall Study||17||
59945639|NCT03040687|76064274|FG000|STARTED|Overall Study||20||
59945640|NCT03040687|76064275|FG001|STARTED|Overall Study||20||
59945641|NCT03040687|76064276|FG002|STARTED|Overall Study||20||
59945642|NCT03040687|76064274|FG000|COMPLETED|Overall Study||19||
59945643|NCT03040687|76064275|FG001|COMPLETED|Overall Study||20||
59945644|NCT03040687|76064276|FG002|COMPLETED|Overall Study||20||
59945645|NCT03040687|76064274|FG000|NOT COMPLETED|Overall Study||1||
59945646|NCT03040687|76064275|FG001|NOT COMPLETED|Overall Study||0||
59945647|NCT03040687|76064276|FG002|NOT COMPLETED|Overall Study||0||
59945648|NCT03042559|76064286|FG000|STARTED|Overall Study||22||
59945649|NCT03042559|76064287|FG001|STARTED|Overall Study||21||
59945650|NCT03042559|76064286|FG000|COMPLETED|Overall Study||21||
59945651|NCT03042559|76064287|FG001|COMPLETED|Overall Study||20||
59945652|NCT03042559|76064286|FG000|NOT COMPLETED|Overall Study||1||
59945653|NCT03042559|76064287|FG001|NOT COMPLETED|Overall Study||1||
59945654|NCT02780856|76064293|FG000|STARTED|Overall Study||110|Attended Visit 1 when teeth were imaged with the Calcivis System|176
59945655|NCT02780856|76064293|FG000|COMPLETED|Overall Study||109|Attended Visit 2 - no images taken at this visit|176
59945656|NCT02780856|76064293|FG000|NOT COMPLETED|Overall Study||1||0
59945657|NCT02749045|76064300|FG000|STARTED|Overall Study||27||
59945658|NCT02749045|76064300|FG000|COMPLETED|Overall Study||27||
59945659|NCT02749045|76064300|FG000|NOT COMPLETED|Overall Study||0||
60067582|NCT01606761|76182767|FG002|Participants Re-randomized at Week 18|Prior to Week 24||0||
59945660|NCT02321540|76064306|FG000|STARTED|Overall Study||3||
59945661|NCT02321540|76064307|FG001|STARTED|Overall Study||10||
59945662|NCT02321540|76064306|FG000|COMPLETED|Overall Study||0||
59945663|NCT02321540|76064307|FG001|COMPLETED|Overall Study||0||
59945664|NCT02321540|76064306|FG000|NOT COMPLETED|Overall Study||3||
59945665|NCT02321540|76064307|FG001|NOT COMPLETED|Overall Study||10||
59945666|NCT02777190|76064321|FG000|STARTED|Overall Study||17||
59945667|NCT02777190|76064322|FG001|STARTED|Overall Study||17||
59945668|NCT02777190|76064321|FG000|COMPLETED|Overall Study||16||
59945669|NCT02777190|76064322|FG001|COMPLETED|Overall Study||11||
59945670|NCT02777190|76064321|FG000|NOT COMPLETED|Overall Study||1||
59945671|NCT02777190|76064322|FG001|NOT COMPLETED|Overall Study||6||
59945672|NCT02432209|76064330|FG000|STARTED|Overall Study||188||
59945673|NCT02432209|76064331|FG001|STARTED|Overall Study||191||
59945674|NCT02432209|76064330|FG000|COMPLETED|Overall Study||157||
59945675|NCT02432209|76064331|FG001|COMPLETED|Overall Study||151||
59945676|NCT02432209|76064330|FG000|NOT COMPLETED|Overall Study||31||
59945677|NCT02432209|76064331|FG001|NOT COMPLETED|Overall Study||40||
59945678|NCT00108732|76064337|FG000|STARTED|Step 1 (Vaccinia/Fowlpox/GM-CSF)||50||
59945679|NCT00108732|76064337|FG000|Eligible and Treated|Step 1 (Vaccinia/Fowlpox/GM-CSF)||40||
59945680|NCT00108732|76064337|FG000|COMPLETED|Step 1 (Vaccinia/Fowlpox/GM-CSF)||36||
59945681|NCT00108732|76064337|FG000|NOT COMPLETED|Step 1 (Vaccinia/Fowlpox/GM-CSF)||14||
59945682|NCT00108732|76064337|FG000|STARTED|Step 2 (Androgen Ablation and Vaccine)||31||
59945683|NCT00108732|76064337|FG000|COMPLETED|Step 2 (Androgen Ablation and Vaccine)||26||
59945684|NCT00108732|76064337|FG000|NOT COMPLETED|Step 2 (Androgen Ablation and Vaccine)||5||
59945685|NCT00107952|76064343|FG000|STARTED|Overall Study||381||
59945686|NCT00107952|76064344|FG001|STARTED|Overall Study||380||
59945687|NCT00107952|76064343|FG000|COMPLETED|Overall Study||286||
59945688|NCT00107952|76064344|FG001|COMPLETED|Overall Study||299||
59945689|NCT00107952|76064343|FG000|NOT COMPLETED|Overall Study||95||
59945690|NCT00107952|76064344|FG001|NOT COMPLETED|Overall Study||81||
59945691|NCT02354118|76064352|FG000|STARTED|Overall Study||222||
59945692|NCT02354118|76064353|FG001|STARTED|Overall Study||214||
59945693|NCT02354118|76064352|FG000|COMPLETED|Overall Study||222||
59945694|NCT02354118|76064353|FG001|COMPLETED|Overall Study||214||
59945695|NCT02354118|76064352|FG000|NOT COMPLETED|Overall Study||0||
59945696|NCT02354118|76064353|FG001|NOT COMPLETED|Overall Study||0||
59945697|NCT01366638|76064362|FG000|STARTED|Overall Study||24||
59945698|NCT01366638|76064363|FG001|STARTED|Overall Study||29||
59945699|NCT01366638|76064364|FG002|STARTED|Overall Study||26||
59945700|NCT01366638|76064362|FG000|COMPLETED|Overall Study||23||
59945701|NCT01366638|76064363|FG001|COMPLETED|Overall Study||29||
59945702|NCT01366638|76064364|FG002|COMPLETED|Overall Study||20||
59945703|NCT01366638|76064362|FG000|NOT COMPLETED|Overall Study||1||
59945704|NCT01366638|76064363|FG001|NOT COMPLETED|Overall Study||0||
59945705|NCT01366638|76064364|FG002|NOT COMPLETED|Overall Study||6||
59945706|NCT02780700|76064372|FG000|STARTED|Overall Study||1||
59945707|NCT02780700|76064372|FG000|COMPLETED|Overall Study||0||
59945708|NCT02780700|76064372|FG000|NOT COMPLETED|Overall Study||1||
59945709|NCT04537910|76064380|FG000|STARTED|Overall Study||6||
59945710|NCT04537910|76064381|FG001|STARTED|Overall Study||5||
59945711|NCT04537910|76064382|FG002|STARTED|Overall Study||7||
59945712|NCT04537910|76064383|FG003|STARTED|Overall Study||7||
59945713|NCT04537910|76064380|FG000|Received at Least One Dose of Study Drug|Overall Study||6||
59945714|NCT04537910|76064381|FG001|Received at Least One Dose of Study Drug|Overall Study||5||
59945715|NCT04537910|76064382|FG002|Received at Least One Dose of Study Drug|Overall Study||7||
59945716|NCT04537910|76064383|FG003|Received at Least One Dose of Study Drug|Overall Study||7||
59945717|NCT04537910|76064380|FG000|COMPLETED|Overall Study||6||
59945718|NCT04537910|76064381|FG001|COMPLETED|Overall Study||5||
59945719|NCT04537910|76064382|FG002|COMPLETED|Overall Study||7||
59945720|NCT04537910|76064383|FG003|COMPLETED|Overall Study||7||
59945721|NCT04537910|76064380|FG000|NOT COMPLETED|Overall Study||0||
59945722|NCT04537910|76064381|FG001|NOT COMPLETED|Overall Study||0||
59945723|NCT04537910|76064382|FG002|NOT COMPLETED|Overall Study||0||
59945724|NCT04537910|76064383|FG003|NOT COMPLETED|Overall Study||0||
59945725|NCT04821362|76064395|FG000|STARTED|Overall Study||90||
59945726|NCT04821362|76064396|FG001|STARTED|Overall Study||90||
59945727|NCT04821362|76064397|FG002|STARTED|Overall Study||90||
59945728|NCT04821362|76064395|FG000|COMPLETED|Overall Study||90||
59945729|NCT04821362|76064396|FG001|COMPLETED|Overall Study||90||
60067583|NCT01606761|76182768|FG003|Participants Re-randomized at Week 18|Prior to Week 24||0||
60067584|NCT01606761|76182769|FG004|Participants Re-randomized at Week 18|Prior to Week 24||0||
60067585|NCT01606761|76182765|FG000|COMPLETED|Prior to Week 24||252||
60067586|NCT01606761|76182766|FG001|COMPLETED|Prior to Week 24||237||
60067587|NCT01606761|76182767|FG002|COMPLETED|Prior to Week 24||245||
60067588|NCT01606761|76182768|FG003|COMPLETED|Prior to Week 24||0||
60067589|NCT01606761|76182769|FG004|COMPLETED|Prior to Week 24||0||
59945730|NCT04821362|76064397|FG002|COMPLETED|Overall Study||90||
59945731|NCT04821362|76064395|FG000|NOT COMPLETED|Overall Study||0||
59945732|NCT04821362|76064396|FG001|NOT COMPLETED|Overall Study||0||
59945733|NCT04821362|76064397|FG002|NOT COMPLETED|Overall Study||0||
60067590|NCT01606761|76182765|FG000|NOT COMPLETED|Prior to Week 24||42||
59945734|NCT04230122|76064410|FG000|STARTED|Overall Study||3||
59945735|NCT04230122|76064411|FG001|STARTED|Overall Study||1||
59945736|NCT04230122|76064410|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3||
60067591|NCT01606761|76182766|FG001|NOT COMPLETED|Prior to Week 24||55||
60067592|NCT01606761|76182767|FG002|NOT COMPLETED|Prior to Week 24||47||
59945737|NCT04230122|76064411|FG001|Received at Least 1 Dose of Study Drug|Overall Study||1||
59945738|NCT04230122|76064410|FG000|COMPLETED|Overall Study||2||
59945739|NCT04230122|76064411|FG001|COMPLETED|Overall Study||1||
59945740|NCT04230122|76064410|FG000|NOT COMPLETED|Overall Study||1||
59945741|NCT04230122|76064411|FG001|NOT COMPLETED|Overall Study||0||
59945742|NCT02780388|76064422|FG000|STARTED|Overall Study||15||
59945743|NCT02780388|76064423|FG001|STARTED|Overall Study||8||
59945744|NCT02780388|76064424|FG002|STARTED|Overall Study||10||
59945745|NCT02780388|76064425|FG003|STARTED|Overall Study||12||
59945746|NCT02780388|76064426|FG004|STARTED|Overall Study||12||
59945747|NCT02780388|76064422|FG000|COMPLETED|Overall Study||14||
59945748|NCT02780388|76064423|FG001|COMPLETED|Overall Study||6||
59945749|NCT02780388|76064424|FG002|COMPLETED|Overall Study||10||
59945750|NCT02780388|76064425|FG003|COMPLETED|Overall Study||12||
59945751|NCT02780388|76064426|FG004|COMPLETED|Overall Study||12||
59945752|NCT02780388|76064422|FG000|NOT COMPLETED|Overall Study||1||
59945753|NCT02780388|76064423|FG001|NOT COMPLETED|Overall Study||2||
59945754|NCT02780388|76064424|FG002|NOT COMPLETED|Overall Study||0||
59945755|NCT02780388|76064425|FG003|NOT COMPLETED|Overall Study||0||
59945756|NCT02780388|76064426|FG004|NOT COMPLETED|Overall Study||0||
59945757|NCT03491462|76064444|FG000|STARTED|Overall Study|The 160 participants in the modified intention-to-treat (mITT) population excludes 3 participants in the edaravone sub-population (participants on minimum 6 months' stable treatment with edaravone and who otherwise fulfil the eligibility criteria)|160||
59945758|NCT03491462|76064445|FG001|STARTED|Overall Study|The 79 participants in the modified intention-to-treat (mITT) population excludes 3 participants in the edaravone sub-population (participants on minimum 6 months' stable treatment with edaravone and who otherwise fulfil the eligibility criteria)|79||
59945759|NCT03491462|76064444|FG000|COMPLETED|Overall Study|Participants who reached a survival endpoint (PAV / tracheostomy / death) during the study were recorded as completers|122||
59945760|NCT03491462|76064445|FG001|COMPLETED|Overall Study|Participants who reached a survival endpoint (PAV / tracheostomy / death) during the study were recorded as completers|63||
59945761|NCT03491462|76064444|FG000|NOT COMPLETED|Overall Study||38||
59945762|NCT03491462|76064445|FG001|NOT COMPLETED|Overall Study||16||
59945763|NCT02224573|76064453|FG000|STARTED|Treatment Phase||315||
59945764|NCT02224573|76064454|FG001|STARTED|Treatment Phase||366||
59945765|NCT02224573|76064453|FG000|COMPLETED|Treatment Phase||170||
59945766|NCT02224573|76064454|FG001|COMPLETED|Treatment Phase||243||
59945767|NCT02224573|76064453|FG000|NOT COMPLETED|Treatment Phase||145||
59945768|NCT02224573|76064454|FG001|NOT COMPLETED|Treatment Phase||123||
59945769|NCT02224573|76064453|FG000|STARTED|Taper Phase|The number of participants to start the Taper Phase is not equal to the number who completed the Treatment Phase because not all participants tapered IMP.|79||
59945770|NCT02224573|76064454|FG001|STARTED|Taper Phase|The number of participants to start the Taper Phase is not equal to the number who completed the Treatment Phase because not all participants tapered IMP.|71||
59945771|NCT02224573|76064453|FG000|COMPLETED|Taper Phase||76||
59945772|NCT02224573|76064454|FG001|COMPLETED|Taper Phase||67||
59945773|NCT02224573|76064453|FG000|NOT COMPLETED|Taper Phase||3||
59945774|NCT02224573|76064454|FG001|NOT COMPLETED|Taper Phase||4||
59945775|NCT01360840|76064464|FG000|STARTED|Overall Study||60||
59945776|NCT01360840|76064465|FG001|STARTED|Overall Study||60||
59945777|NCT01360840|76064466|FG002|STARTED|Overall Study||60||
59945778|NCT01360840|76064464|FG000|COMPLETED|Overall Study||50||
59945779|NCT01360840|76064465|FG001|COMPLETED|Overall Study||50||
59945780|NCT01360840|76064466|FG002|COMPLETED|Overall Study||51||
59945781|NCT01360840|76064464|FG000|NOT COMPLETED|Overall Study||10||
59945782|NCT01360840|76064465|FG001|NOT COMPLETED|Overall Study||10||
59945783|NCT01360840|76064466|FG002|NOT COMPLETED|Overall Study||9||
59945784|NCT03350984|76064478|FG000|STARTED|Overall Study||39||
59945785|NCT03350984|76064479|FG001|STARTED|Overall Study||36||
59945786|NCT03350984|76064478|FG000|COMPLETED|Overall Study||31||
59945787|NCT03350984|76064479|FG001|COMPLETED|Overall Study||28||
59945788|NCT03350984|76064478|FG000|NOT COMPLETED|Overall Study||8||
59945789|NCT03350984|76064479|FG001|NOT COMPLETED|Overall Study||8||
59945790|NCT03504423|76064487|FG000|STARTED|Overall Study||266||
59945791|NCT03504423|76064488|FG001|STARTED|Overall Study||262||
59945792|NCT03504423|76064487|FG000|COMPLETED|Overall Study||259||
59945793|NCT03504423|76064488|FG001|COMPLETED|Overall Study||235||
59945794|NCT03504423|76064487|FG000|NOT COMPLETED|Overall Study||7||
59945795|NCT03504423|76064488|FG001|NOT COMPLETED|Overall Study||27||
59945796|NCT05176717|76064497|FG000|STARTED|Overall Study||1||
59945797|NCT05176717|76064498|FG001|STARTED|Overall Study||2||
59945798|NCT05176717|76064499|FG002|STARTED|Overall Study||2||
59945799|NCT05176717|76064497|FG000|COMPLETED|Overall Study||0||
59945800|NCT05176717|76064498|FG001|COMPLETED|Overall Study||0||
59945801|NCT05176717|76064499|FG002|COMPLETED|Overall Study||0||
59945802|NCT05176717|76064497|FG000|NOT COMPLETED|Overall Study||1||
59945803|NCT05176717|76064498|FG001|NOT COMPLETED|Overall Study||2||
59945804|NCT05176717|76064499|FG002|NOT COMPLETED|Overall Study||2||
59945805|NCT02770248|76064509|FG000|STARTED|Overall Study||62||
59945806|NCT02770248|76064510|FG001|STARTED|Overall Study||63||
59945807|NCT02770248|76064509|FG000|COMPLETED|Overall Study||62||
59945808|NCT02770248|76064510|FG001|COMPLETED|Overall Study||61||
59945809|NCT02770248|76064509|FG000|NOT COMPLETED|Overall Study||0||
59945810|NCT02770248|76064510|FG001|NOT COMPLETED|Overall Study||2||
59945811|NCT01344369|76064518|FG000|STARTED|First Intervention||18||
59945812|NCT01344369|76064519|FG001|STARTED|First Intervention||18||
59945813|NCT01344369|76064518|FG000|COMPLETED|First Intervention||18||
59945814|NCT01344369|76064519|FG001|COMPLETED|First Intervention||18||
59945815|NCT01344369|76064518|FG000|NOT COMPLETED|First Intervention||0||
59945816|NCT01344369|76064519|FG001|NOT COMPLETED|First Intervention||0||
59945817|NCT01344369|76064518|FG000|STARTED|Washout of 28 Days||18||
59945818|NCT01344369|76064519|FG001|STARTED|Washout of 28 Days||18||
59945819|NCT01344369|76064518|FG000|COMPLETED|Washout of 28 Days||17||
59945820|NCT01344369|76064519|FG001|COMPLETED|Washout of 28 Days||17||
59945821|NCT01344369|76064518|FG000|NOT COMPLETED|Washout of 28 Days||1||
59945822|NCT01344369|76064519|FG001|NOT COMPLETED|Washout of 28 Days||1||
59945823|NCT01344369|76064518|FG000|STARTED|Second Intervention||17||
59945824|NCT01344369|76064519|FG001|STARTED|Second Intervention||17||
59945825|NCT01344369|76064518|FG000|COMPLETED|Second Intervention||17||
59945826|NCT01344369|76064519|FG001|COMPLETED|Second Intervention||16||
59945827|NCT01344369|76064518|FG000|NOT COMPLETED|Second Intervention||0||
59945828|NCT01344369|76064519|FG001|NOT COMPLETED|Second Intervention||1||
59945829|NCT03179462|76064528|FG000|STARTED|Overall Study||9||
59945830|NCT03179462|76064529|FG001|STARTED|Overall Study||10||
59945831|NCT03179462|76064530|FG002|STARTED|Overall Study||8||
59945832|NCT03179462|76064528|FG000|COMPLETED|Overall Study||8||
59945833|NCT03179462|76064529|FG001|COMPLETED|Overall Study||8||
59945834|NCT03179462|76064530|FG002|COMPLETED|Overall Study||8||
59945835|NCT03179462|76064528|FG000|NOT COMPLETED|Overall Study||1||
59945836|NCT03179462|76064529|FG001|NOT COMPLETED|Overall Study||2||
59945837|NCT03179462|76064530|FG002|NOT COMPLETED|Overall Study||0||
59945838|NCT01314703|76064538|FG000|STARTED|Overall Study||35||
59945839|NCT01314703|76064538|FG000|Signed Informed Consent|Overall Study||35||
59945840|NCT01314703|76064538|FG000|Completed Screen Visit|Overall Study||33||
59945841|NCT01314703|76064538|FG000|Completed Treatment Visit|Overall Study||27||
59945842|NCT01314703|76064538|FG000|Completed Study|Overall Study||27||
59945843|NCT01314703|76064538|FG000|Excluded Prior to Screening Baseline|Overall Study||2||
59945844|NCT01314703|76064538|FG000|Non Qualified Bacterial Screening Counts|Overall Study||3||
59945845|NCT01314703|76064538|FG000|Discontinued When Enrollment Completed|Overall Study||3||
59945846|NCT01314703|76064538|FG000|COMPLETED|Overall Study||27||
59945847|NCT01314703|76064538|FG000|NOT COMPLETED|Overall Study||8||
59945848|NCT01360762|76064543|FG000|STARTED|Main Study Period (12-month Treatment)||74||
59945849|NCT01360762|76064543|FG000|COMPLETED|Main Study Period (12-month Treatment)||45||
59945850|NCT01360762|76064543|FG000|NOT COMPLETED|Main Study Period (12-month Treatment)||29||
59945851|NCT01360762|76064543|FG000|STARTED|Whole Study Period||74|Treatment period and extended treatment period and follow-up period|
59945852|NCT01360762|76064543|FG000|COMPLETED|Whole Study Period||38||
59945853|NCT01360762|76064543|FG000|NOT COMPLETED|Whole Study Period||36||
59945854|NCT04382924|76064550|FG000|STARTED|Overall Study||52||
59945855|NCT04382924|76064551|FG001|STARTED|Overall Study||56||
59945856|NCT04382924|76064552|FG002|STARTED|Overall Study||60||
59945857|NCT04382924|76064550|FG000|COMPLETED|Overall Study||44||
59945858|NCT04382924|76064551|FG001|COMPLETED|Overall Study||46||
59945859|NCT04382924|76064552|FG002|COMPLETED|Overall Study||48||
59945860|NCT04382924|76064550|FG000|NOT COMPLETED|Overall Study||8||
59945861|NCT04382924|76064551|FG001|NOT COMPLETED|Overall Study||10||
59945862|NCT04382924|76064552|FG002|NOT COMPLETED|Overall Study||12||
59945863|NCT00002601|76064560|FG000|STARTED|Overall Study||13||
59945864|NCT00002601|76064560|FG000|COMPLETED|Overall Study||13||
59945865|NCT00002601|76064560|FG000|NOT COMPLETED|Overall Study||0||
59945866|NCT03044431|76064566|FG000|STARTED|Overall Study||207||
59945867|NCT03044431|76064566|FG000|COMPLETED|Overall Study||148||
59945868|NCT03044431|76064566|FG000|NOT COMPLETED|Overall Study||59||
59945869|NCT02770170|76064574|FG000|STARTED|Overall Study||21||
59945870|NCT02770170|76064575|FG001|STARTED|Overall Study||20||
59945871|NCT02770170|76064576|FG002|STARTED|Overall Study||40||
59945872|NCT02770170|76064577|FG003|STARTED|Overall Study||40||
59945873|NCT02770170|76064574|FG000|COMPLETED|Overall Study||14||
59945874|NCT02770170|76064575|FG001|COMPLETED|Overall Study||17||
59945875|NCT02770170|76064576|FG002|COMPLETED|Overall Study||35||
59945876|NCT02770170|76064577|FG003|COMPLETED|Overall Study||33||
59945877|NCT02770170|76064574|FG000|NOT COMPLETED|Overall Study||7||
59945878|NCT02770170|76064575|FG001|NOT COMPLETED|Overall Study||3||
59945879|NCT02770170|76064576|FG002|NOT COMPLETED|Overall Study||5||
59945880|NCT02770170|76064577|FG003|NOT COMPLETED|Overall Study||7||
59945881|NCT02769858|76064587|FG000|STARTED|Overall Study||10||
59945882|NCT02769858|76064587|FG000|COMPLETED|Overall Study||8||
59945883|NCT02769858|76064587|FG000|NOT COMPLETED|Overall Study||2||
59945884|NCT02769624|76064591|FG000|STARTED|Overall Study||7||
59945885|NCT02769624|76064592|FG001|STARTED|Overall Study||8||
59945886|NCT02769624|76064591|FG000|COMPLETED|Overall Study||7||
59945887|NCT02769624|76064592|FG001|COMPLETED|Overall Study||7||
59945888|NCT02769624|76064591|FG000|NOT COMPLETED|Overall Study||0||
59945889|NCT02769624|76064592|FG001|NOT COMPLETED|Overall Study||1||
59945890|NCT03446768|76064600|FG000|STARTED|Overall Study||141||
59945891|NCT03446768|76064601|FG001|STARTED|Overall Study||153||
59945892|NCT03446768|76064600|FG000|COMPLETED|Overall Study||141||
59945893|NCT03446768|76064601|FG001|COMPLETED|Overall Study||152||
59945894|NCT03446768|76064600|FG000|NOT COMPLETED|Overall Study||0||
59945895|NCT03446768|76064601|FG001|NOT COMPLETED|Overall Study||1||
59945896|NCT02676284|76064607|FG000|STARTED|Overall Study||36||
59945897|NCT02676284|76064607|FG000|COMPLETED|Overall Study||35||
59945898|NCT02676284|76064607|FG000|NOT COMPLETED|Overall Study||1||
59945899|NCT02769312|76064613|FG000|STARTED|Double-Blind (0-2 Weeks)||25||
59945900|NCT02769312|76064614|FG001|STARTED|Double-Blind (0-2 Weeks)||25||
59945901|NCT02769312|76064613|FG000|COMPLETED|Double-Blind (0-2 Weeks)||23||
59945902|NCT02769312|76064614|FG001|COMPLETED|Double-Blind (0-2 Weeks)||24||
59945903|NCT02769312|76064613|FG000|NOT COMPLETED|Double-Blind (0-2 Weeks)||2||
59945904|NCT02769312|76064614|FG001|NOT COMPLETED|Double-Blind (0-2 Weeks)||1||
59945905|NCT02769312|76064613|FG000|STARTED|Unblinded (Optional 2-4 Weeks)|2 participants chose not to continue with the unblinded period.|21|Optional unblinded period. All participants received 2 weeks of active stimulation.|
59945906|NCT02769312|76064614|FG001|STARTED|Unblinded (Optional 2-4 Weeks)||24|Optional unblinded period. All participants received 2 weeks of active stimulation.|
59945907|NCT02769312|76064613|FG000|COMPLETED|Unblinded (Optional 2-4 Weeks)||20||
59762293|NCT00537823|75881969|FG000|STARTED|Overall Study||7||
59762294|NCT00537823|75881970|FG001|STARTED|Overall Study||2||
59762295|NCT00537823|75881969|FG000|COMPLETED|Overall Study||5||
59945908|NCT02769312|76064614|FG001|COMPLETED|Unblinded (Optional 2-4 Weeks)||23||
59945909|NCT02769312|76064613|FG000|NOT COMPLETED|Unblinded (Optional 2-4 Weeks)||1||
59945910|NCT02769312|76064614|FG001|NOT COMPLETED|Unblinded (Optional 2-4 Weeks)||1||
59945911|NCT02769312|76064613|FG000|STARTED|Follow-up||23|1 month following the end of intervention.|
59945912|NCT02769312|76064614|FG001|STARTED|Follow-up||24|1 month following the end of intervention.|
59945913|NCT02769312|76064613|FG000|COMPLETED|Follow-up||22|Participants did not have to complete the unblinded period to complete the follow-up period.|
59945914|NCT02769312|76064614|FG001|COMPLETED|Follow-up||23|Participants did not have to complete the unblinded period to complete the follow-up period.|
59945915|NCT02769312|76064613|FG000|NOT COMPLETED|Follow-up||1||
59945916|NCT02769312|76064614|FG001|NOT COMPLETED|Follow-up||1||
59945917|NCT01673386|76064621|FG000|STARTED|Overall Study||27||
59945918|NCT01673386|76064622|FG001|STARTED|Overall Study||31||
59945919|NCT01673386|76064621|FG000|COMPLETED|Overall Study|Of 2 subjects, 1 subject discontinued tivozanib early, completed planned treatment with sunitinib.|2||
59945920|NCT01673386|76064622|FG001|COMPLETED|Overall Study|Of 4 subjects, 3 subjects discontinued sunitinib early, completed planned treatment with tivozanib.|4||
59945921|NCT01673386|76064621|FG000|NOT COMPLETED|Overall Study||25||
59945922|NCT01673386|76064622|FG001|NOT COMPLETED|Overall Study||27||
59945923|NCT00103740|76064630|FG000|STARTED|Period 1 - Core||92||
59945924|NCT00103740|76064631|FG001|STARTED|Period 1 - Core||93||
59945925|NCT00103740|76064630|FG000|COMPLETED|Period 1 - Core||85||
59945926|NCT00103740|76064631|FG001|COMPLETED|Period 1 - Core||89||
59945927|NCT00103740|76064630|FG000|NOT COMPLETED|Period 1 - Core||7||
59945928|NCT00103740|76064631|FG001|NOT COMPLETED|Period 1 - Core||4||
59945929|NCT00103740|76064630|FG000|STARTED|Period 2 - Extended Observation Period||78||
59945930|NCT00103740|76064631|FG001|STARTED|Period 2 - Extended Observation Period||63||
59945931|NCT00103740|76064630|FG000|COMPLETED|Period 2 - Extended Observation Period|Includes patients retreated for Paget's disease and patients discontinued when sponsor ended study|9||
59945932|NCT00103740|76064631|FG001|COMPLETED|Period 2 - Extended Observation Period|Includes patients retreated for Paget's disease and patients discontinued when sponsor ended study|27||
59613390|NCT01686438|75724541|FG002|3-Month Follow Up|Overall Study||17||
59613391|NCT01686438|75724539|FG000|6-Month Follow Up|Overall Study||7||
59613392|NCT01686438|75724540|FG001|6-Month Follow Up|Overall Study||26||
59945933|NCT00103740|76064630|FG000|NOT COMPLETED|Period 2 - Extended Observation Period||69||
59945934|NCT00103740|76064631|FG001|NOT COMPLETED|Period 2 - Extended Observation Period||36||
59945935|NCT01281644|76064637|FG000|STARTED|Overall Study||23||
59945936|NCT01281644|76064637|FG000|COMPLETED|Overall Study||18||
59945937|NCT01281644|76064637|FG000|NOT COMPLETED|Overall Study||5||
59945938|NCT02869893|76064643|FG000|STARTED|Overall Study||57||
59945939|NCT02869893|76064643|FG000|COMPLETED|Overall Study||50||
59945940|NCT02869893|76064643|FG000|NOT COMPLETED|Overall Study||7||
59945941|NCT03617289|76064650|FG000|STARTED|Overall Study||18||
59945942|NCT03617289|76064651|FG001|STARTED|Overall Study||19||
59945943|NCT03617289|76064650|FG000|COMPLETED|Overall Study||18||
59945944|NCT03617289|76064651|FG001|COMPLETED|Overall Study||19||
59945945|NCT03617289|76064650|FG000|NOT COMPLETED|Overall Study||0||
59945946|NCT03617289|76064651|FG001|NOT COMPLETED|Overall Study||0||
59762296|NCT00537823|75881970|FG001|COMPLETED|Overall Study||2||
59762297|NCT00537823|75881969|FG000|NOT COMPLETED|Overall Study||2||
59762298|NCT00537823|75881970|FG001|NOT COMPLETED|Overall Study||0||
59945947|NCT00363038|76064658|FG000|STARTED|Overall Study||16||
59945948|NCT00363038|76064658|FG000|COMPLETED|Overall Study||16||
59945949|NCT00363038|76064658|FG000|NOT COMPLETED|Overall Study||0||
59945950|NCT02872311|76064667|FG000|STARTED|Overall Study||59||
59945951|NCT02872311|76064668|FG001|STARTED|Overall Study||60||
59945952|NCT02872311|76064669|FG002|STARTED|Overall Study||20||
59945953|NCT02872311|76064670|FG003|STARTED|Overall Study||20||
59945954|NCT02872311|76064671|FG004|STARTED|Overall Study||20||
59945955|NCT02872311|76064667|FG000|COMPLETED|Overall Study||55||
59945956|NCT02872311|76064668|FG001|COMPLETED|Overall Study||58||
59945957|NCT02872311|76064669|FG002|COMPLETED|Overall Study||19||
59945958|NCT02872311|76064670|FG003|COMPLETED|Overall Study||20||
59945959|NCT02872311|76064671|FG004|COMPLETED|Overall Study||20||
59945960|NCT02872311|76064667|FG000|NOT COMPLETED|Overall Study||4||
59945961|NCT02872311|76064668|FG001|NOT COMPLETED|Overall Study||2||
59945962|NCT02872311|76064669|FG002|NOT COMPLETED|Overall Study||1||
59945963|NCT02872311|76064670|FG003|NOT COMPLETED|Overall Study||0||
59945964|NCT02872311|76064671|FG004|NOT COMPLETED|Overall Study||0||
59945965|NCT02871375|76064699|FG000|STARTED|Period 1, First 14 Days of Wear||89||
59945966|NCT02871375|76064700|FG001|STARTED|Period 1, First 14 Days of Wear||77||
59945967|NCT02871375|76064699|FG000|COMPLETED|Period 1, First 14 Days of Wear||89||
59945968|NCT02871375|76064700|FG001|COMPLETED|Period 1, First 14 Days of Wear||76||
59945969|NCT02871375|76064699|FG000|NOT COMPLETED|Period 1, First 14 Days of Wear||0||
59945970|NCT02871375|76064700|FG001|NOT COMPLETED|Period 1, First 14 Days of Wear||1||
59945971|NCT02871375|76064699|FG000|STARTED|Period 2, Second 14 Days of Wear||89||
59945972|NCT02871375|76064700|FG001|STARTED|Period 2, Second 14 Days of Wear||76||
59945973|NCT02871375|76064699|FG000|COMPLETED|Period 2, Second 14 Days of Wear||89||
59945974|NCT02871375|76064700|FG001|COMPLETED|Period 2, Second 14 Days of Wear||76||
59945975|NCT02871375|76064699|FG000|NOT COMPLETED|Period 2, Second 14 Days of Wear||0||
59945976|NCT02871375|76064700|FG001|NOT COMPLETED|Period 2, Second 14 Days of Wear||0||
59945977|NCT02867709|76064711|FG000|STARTED|Treatment Period||563||
59945978|NCT02867709|76064712|FG001|STARTED|Treatment Period||561||
59945979|NCT02867709|76064713|FG002|STARTED|Treatment Period||562||
59945980|NCT02867709|76064711|FG000|Safety Population: Received Study Drug|Treatment Period||499||
59945981|NCT02867709|76064712|FG001|Safety Population: Received Study Drug|Treatment Period||478||
59945982|NCT02867709|76064713|FG002|Safety Population: Received Study Drug|Treatment Period||488||
59945983|NCT02867709|76064711|FG000|COMPLETED|Treatment Period||493||
59945984|NCT02867709|76064712|FG001|COMPLETED|Treatment Period||474||
59945985|NCT02867709|76064713|FG002|COMPLETED|Treatment Period||487||
59945986|NCT02867709|76064711|FG000|NOT COMPLETED|Treatment Period||70||
59945987|NCT02867709|76064712|FG001|NOT COMPLETED|Treatment Period||87||
59945988|NCT02867709|76064713|FG002|NOT COMPLETED|Treatment Period||75||
59945989|NCT02867709|76064711|FG000|STARTED|Safety Follow-up Period||493||
59945990|NCT02867709|76064712|FG001|STARTED|Safety Follow-up Period||474||
59945991|NCT02867709|76064713|FG002|STARTED|Safety Follow-up Period||487||
59945992|NCT02867709|76064711|FG000|COMPLETED|Safety Follow-up Period||482||
59945993|NCT02867709|76064712|FG001|COMPLETED|Safety Follow-up Period||459||
59945994|NCT02867709|76064713|FG002|COMPLETED|Safety Follow-up Period||473||
59945995|NCT02867709|76064711|FG000|NOT COMPLETED|Safety Follow-up Period||11||
59945996|NCT02867709|76064712|FG001|NOT COMPLETED|Safety Follow-up Period||15||
59945997|NCT02867709|76064713|FG002|NOT COMPLETED|Safety Follow-up Period||14||
59945998|NCT03044353|76064724|FG000|STARTED|Overall Study||6||
59945999|NCT03044353|76064725|FG001|STARTED|Overall Study||1||
59946000|NCT03044353|76064726|FG002|STARTED|Overall Study|No participant was enrolled in Group-3 due to early termination of the study.|0||
59946001|NCT03044353|76064724|FG000|COMPLETED|Overall Study||6||
59946002|NCT03044353|76064725|FG001|COMPLETED|Overall Study||0||
59946003|NCT03044353|76064726|FG002|COMPLETED|Overall Study||0||
59946004|NCT03044353|76064724|FG000|NOT COMPLETED|Overall Study||0||
59946005|NCT03044353|76064725|FG001|NOT COMPLETED|Overall Study||1||
59946006|NCT03044353|76064726|FG002|NOT COMPLETED|Overall Study||0||
59946007|NCT01361308|76064735|FG000|STARTED|Overall Study||306||
59946008|NCT01361308|76064736|FG001|STARTED|Overall Study||308||
59946009|NCT01361308|76064735|FG000|COMPLETED|Overall Study||271||
59946010|NCT01361308|76064736|FG001|COMPLETED|Overall Study||278||
59946011|NCT01361308|76064735|FG000|NOT COMPLETED|Overall Study||35||
59946012|NCT01361308|76064736|FG001|NOT COMPLETED|Overall Study||30||
59946013|NCT05043142|76064742|FG000|STARTED|Overall Study||3632||
59762299|NCT00537277|75881977|FG000|STARTED|Overall Study||161||
59762300|NCT00537277|75881977|FG000|Exposed to Trial Drug|Overall Study|One subject not exposed to trial drug, and thus not included in full analysis set (FAS)|160||
59762301|NCT00537277|75881977|FG000|COMPLETED|Overall Study||112||
59762302|NCT00537277|75881977|FG000|NOT COMPLETED|Overall Study||49||
59762303|NCT00537199|75881981|FG000|STARTED|Overall Study||1||
59762304|NCT00537199|75881981|FG000|COMPLETED|Overall Study||0||
59762305|NCT00537199|75881981|FG000|NOT COMPLETED|Overall Study||1||
59762306|NCT03898063|75881987|FG000|STARTED|Overall Study||74||
59762307|NCT03898063|75881988|FG001|STARTED|Overall Study||74||
59762308|NCT03898063|75881987|FG000|COMPLETED|Overall Study||64||
59946014|NCT05043142|76064742|FG000|COMPLETED|Overall Study||3443||
59946015|NCT05043142|76064742|FG000|NOT COMPLETED|Overall Study||189||
59946016|NCT02872935|76064748|FG000|STARTED|Overall Study||11||
59946017|NCT02872935|76064749|FG001|STARTED|Overall Study||11||
59946018|NCT02872935|76064748|FG000|COMPLETED|Overall Study||11||
59946019|NCT02872935|76064749|FG001|COMPLETED|Overall Study|One subject consented but did no proceed with the study.|10||
59946020|NCT02872935|76064748|FG000|NOT COMPLETED|Overall Study||0||
59946021|NCT02872935|76064749|FG001|NOT COMPLETED|Overall Study||1||
59946022|NCT00103662|76064757|FG000|STARTED|Overall Study||148||
59946023|NCT00103662|76064758|FG001|STARTED|Overall Study||154||
59946024|NCT00103662|76064757|FG000|COMPLETED|Overall Study|1 participant was wrongly terminated due to 'other'; the participant stayed on study until death.|129||
59946025|NCT00103662|76064758|FG001|COMPLETED|Overall Study|1 participant was wrongly terminated due to 'other'; the participant stayed on study until death.|121||
59762309|NCT03898063|75881988|FG001|COMPLETED|Overall Study||66||
59762310|NCT03898063|75881987|FG000|NOT COMPLETED|Overall Study||10||
59946026|NCT00103662|76064757|FG000|NOT COMPLETED|Overall Study||19||
59762311|NCT03898063|75881988|FG001|NOT COMPLETED|Overall Study||8||
59762312|NCT00873912|75881996|FG000|STARTED|Overall Study||240||
59762313|NCT00873912|75881997|FG001|STARTED|Overall Study||60||
59762314|NCT00873912|75881996|FG000|COMPLETED|Overall Study||237||
59762315|NCT00873912|75881997|FG001|COMPLETED|Overall Study||60||
59946027|NCT00103662|76064758|FG001|NOT COMPLETED|Overall Study||33||
59946028|NCT02865915|76064766|FG000|STARTED|Overall Study||25||
59946029|NCT02865915|76064767|FG001|STARTED|Overall Study||30||
59946030|NCT02865915|76064766|FG000|COMPLETED|Overall Study|Study terminated prior to completion by any subject|0||
59946031|NCT02865915|76064767|FG001|COMPLETED|Overall Study|Study terminated prior to completion by any subject|0||
59946032|NCT02865915|76064766|FG000|NOT COMPLETED|Overall Study||25||
59946033|NCT02865915|76064767|FG001|NOT COMPLETED|Overall Study||30||
59946034|NCT00104676|76064775|FG000|STARTED|Overall Study||98||
59946035|NCT00104676|76064776|FG001|STARTED|Overall Study||105||
59946036|NCT00104676|76064775|FG000|COMPLETED|Overall Study||91||
59946037|NCT00104676|76064776|FG001|COMPLETED|Overall Study||91||
59946038|NCT00104676|76064775|FG000|NOT COMPLETED|Overall Study||7||
59946039|NCT00104676|76064776|FG001|NOT COMPLETED|Overall Study||14||
59946040|NCT00354835|76064784|FG000|STARTED|Overall Study||239||
59946041|NCT00354835|76064785|FG001|STARTED|Overall Study||242||
59946042|NCT00354835|76064784|FG000|COMPLETED|Overall Study||187||
59946043|NCT00354835|76064785|FG001|COMPLETED|Overall Study||181||
59946044|NCT00354835|76064784|FG000|NOT COMPLETED|Overall Study||52||
59946045|NCT00354835|76064785|FG001|NOT COMPLETED|Overall Study||61||
59762316|NCT00873912|75881996|FG000|NOT COMPLETED|Overall Study||3||
59946046|NCT02768298|76064808|FG000|STARTED|Overall Study||103||
59946047|NCT02768298|76064809|FG001|STARTED|Overall Study||98||
59518765|NCT00942851|75612618|FG001|NOT COMPLETED|Overall Study||1||
59518766|NCT01085539|75612628|FG000|STARTED|Sat Secs Off--No Alarm Evaluation||50||
59518767|NCT01085539|75612628|FG000|COMPLETED|Sat Secs Off--No Alarm Evaluation||50||
59518768|NCT01085539|75612628|FG000|NOT COMPLETED|Sat Secs Off--No Alarm Evaluation||0||
59518769|NCT01085539|75612628|FG000|STARTED|10 Sat Secs--10 Second Alarm Evaluation||50||
59762317|NCT00873912|75881997|FG001|NOT COMPLETED|Overall Study||0||
59946048|NCT02768298|76064808|FG000|COMPLETED|Overall Study||99||
59946049|NCT02768298|76064809|FG001|COMPLETED|Overall Study||91||
59946050|NCT02768298|76064808|FG000|NOT COMPLETED|Overall Study||4||
59946051|NCT02768298|76064809|FG001|NOT COMPLETED|Overall Study||7||
59946052|NCT02775864|76064819|FG000|STARTED|Overall Study||26014||
59946053|NCT02775864|76064820|FG001|STARTED|Overall Study||31117||
59946054|NCT02775864|76064821|FG002|STARTED|Overall Study||11941||
59946055|NCT02775864|76064822|FG003|STARTED|Overall Study||12849||
59946056|NCT02775864|76064819|FG000|COMPLETED|Overall Study||22772||
59946057|NCT02775864|76064820|FG001|COMPLETED|Overall Study||26218||
59946058|NCT02775864|76064821|FG002|COMPLETED|Overall Study||10081||
59946059|NCT02775864|76064822|FG003|COMPLETED|Overall Study||10765||
59946060|NCT02775864|76064819|FG000|NOT COMPLETED|Overall Study||3242||
59946061|NCT02775864|76064820|FG001|NOT COMPLETED|Overall Study||4899||
59946062|NCT02775864|76064821|FG002|NOT COMPLETED|Overall Study||1860||
59946063|NCT02775864|76064822|FG003|NOT COMPLETED|Overall Study||2084||
59946064|NCT02964273|76064835|FG000|STARTED|Phase A: Double-blind Period (12 Months)||48||
59946065|NCT02964273|76064836|FG001|STARTED|Phase A: Double-blind Period (12 Months)||43||
59946066|NCT02964273|76064837|FG002|STARTED|Phase A: Double-blind Period (12 Months)||0||
59946067|NCT02964273|76064838|FG003|STARTED|Phase A: Double-blind Period (12 Months)||0||
59946068|NCT02964273|76064835|FG000|Dense Pharmacokinetic/Pharmacodynamic (PK/PD) Population|Phase A: Double-blind Period (12 Months)||12|The Dense PK/PD Population included a subset of participants half on tolvaptan and half on placebo, in the 12 to 17 year old age group who had dense PK sampling after at least 1 month on IMP.|
59946069|NCT02964273|76064836|FG001|Dense Pharmacokinetic/Pharmacodynamic (PK/PD) Population|Phase A: Double-blind Period (12 Months)||8|The Dense PK/PD Population included a subset of participants half on tolvaptan and half on placebo, in the 12 to 17 year old age group who had dense PK sampling after at least 1 month on IMP.|
59946070|NCT02964273|76064837|FG002|Dense Pharmacokinetic/Pharmacodynamic (PK/PD) Population|Phase A: Double-blind Period (12 Months)||0|The Dense PK/PD Population included a subset of participants half on tolvaptan and half on placebo, in the 12 to 17 year old age group who had dense PK sampling after at least 1 month on IMP.|
59946071|NCT02964273|76064838|FG003|Dense Pharmacokinetic/Pharmacodynamic (PK/PD) Population|Phase A: Double-blind Period (12 Months)||0|The Dense PK/PD Population included a subset of participants half on tolvaptan and half on placebo, in the 12 to 17 year old age group who had dense PK sampling after at least 1 month on IMP.|
59946072|NCT02964273|76064835|FG000|COMPLETED|Phase A: Double-blind Period (12 Months)||44||
59518770|NCT01085539|75612628|FG000|COMPLETED|10 Sat Secs--10 Second Alarm Evaluation||50||
59518771|NCT01085539|75612628|FG000|NOT COMPLETED|10 Sat Secs--10 Second Alarm Evaluation||0||
59518772|NCT01085539|75612628|FG000|STARTED|25 Sat Secs--25 Second Alarm Evaluation||50||
59518773|NCT01085539|75612628|FG000|COMPLETED|25 Sat Secs--25 Second Alarm Evaluation||50||
59518774|NCT01085539|75612628|FG000|NOT COMPLETED|25 Sat Secs--25 Second Alarm Evaluation||0||
59518775|NCT01085539|75612628|FG000|STARTED|50 Sat Secs--50 Second Alarm Evaluation||50||
59518776|NCT01085539|75612628|FG000|COMPLETED|50 Sat Secs--50 Second Alarm Evaluation||50||
59518777|NCT01085539|75612628|FG000|NOT COMPLETED|50 Sat Secs--50 Second Alarm Evaluation||0||
59762318|NCT04494841|75882003|FG000|STARTED|Overall Study||20||
59762319|NCT04494841|75882003|FG000|COMPLETED|Overall Study||20||
59762320|NCT04494841|75882003|FG000|NOT COMPLETED|Overall Study||0||
59946073|NCT02964273|76064836|FG001|COMPLETED|Phase A: Double-blind Period (12 Months)||40||
59946074|NCT02964273|76064837|FG002|COMPLETED|Phase A: Double-blind Period (12 Months)||0||
59946075|NCT02964273|76064838|FG003|COMPLETED|Phase A: Double-blind Period (12 Months)||0||
59946076|NCT02964273|76064835|FG000|NOT COMPLETED|Phase A: Double-blind Period (12 Months)||4||
59946077|NCT02964273|76064836|FG001|NOT COMPLETED|Phase A: Double-blind Period (12 Months)||3||
59946078|NCT02964273|76064837|FG002|NOT COMPLETED|Phase A: Double-blind Period (12 Months)||0||
59946079|NCT02964273|76064838|FG003|NOT COMPLETED|Phase A: Double-blind Period (12 Months)||0||
59946080|NCT02964273|76064835|FG000|STARTED|Phase B: Open-label Period (24 Months)||0||
59946081|NCT02964273|76064836|FG001|STARTED|Phase B: Open-label Period (24 Months)||0||
59946082|NCT02964273|76064837|FG002|STARTED|Phase B: Open-label Period (24 Months)|2 Phase A: Tolvaptan completers did not enter Phase B.|42||
59946083|NCT02964273|76064838|FG003|STARTED|Phase B: Open-label Period (24 Months)|1 Phase A: Placebo completer did not enter Phase B.|39||
59946084|NCT02964273|76064835|FG000|COMPLETED|Phase B: Open-label Period (24 Months)||0||
59946085|NCT02964273|76064836|FG001|COMPLETED|Phase B: Open-label Period (24 Months)||0||
59946086|NCT02964273|76064837|FG002|COMPLETED|Phase B: Open-label Period (24 Months)||36||
59946087|NCT02964273|76064838|FG003|COMPLETED|Phase B: Open-label Period (24 Months)||33||
59946088|NCT02964273|76064835|FG000|NOT COMPLETED|Phase B: Open-label Period (24 Months)||0||
59946089|NCT02964273|76064836|FG001|NOT COMPLETED|Phase B: Open-label Period (24 Months)||0||
59946090|NCT02964273|76064837|FG002|NOT COMPLETED|Phase B: Open-label Period (24 Months)||6||
59946091|NCT02964273|76064838|FG003|NOT COMPLETED|Phase B: Open-label Period (24 Months)||6||
59946092|NCT02773446|76064857|FG000|STARTED|First Admission||7||
59946093|NCT02773446|76064858|FG001|STARTED|First Admission||7||
59946094|NCT02773446|76064859|FG002|STARTED|First Admission||7||
59946095|NCT02773446|76064860|FG003|STARTED|First Admission||7||
59946096|NCT02773446|76064861|FG004|STARTED|First Admission||0||
59946097|NCT02773446|76064862|FG005|STARTED|First Admission||0||
59946098|NCT02773446|76064857|FG000|COMPLETED|First Admission||6||
59946099|NCT02773446|76064858|FG001|COMPLETED|First Admission||7||
59946100|NCT02773446|76064859|FG002|COMPLETED|First Admission||7||
59946101|NCT02773446|76064860|FG003|COMPLETED|First Admission||6||
59946102|NCT02773446|76064861|FG004|COMPLETED|First Admission||0||
59946103|NCT02773446|76064862|FG005|COMPLETED|First Admission||0||
59946104|NCT02773446|76064857|FG000|NOT COMPLETED|First Admission||1||
59946105|NCT02773446|76064858|FG001|NOT COMPLETED|First Admission||0||
59946106|NCT02773446|76064859|FG002|NOT COMPLETED|First Admission||0||
59946107|NCT02773446|76064860|FG003|NOT COMPLETED|First Admission||1||
59946108|NCT02773446|76064861|FG004|NOT COMPLETED|First Admission||0||
59946109|NCT02773446|76064862|FG005|NOT COMPLETED|First Admission||0||
59946110|NCT02773446|76064857|FG000|STARTED|Second Admission||0||
59946111|NCT02773446|76064858|FG001|STARTED|Second Admission||0||
59946112|NCT02773446|76064859|FG002|STARTED|Second Admission||0||
59946113|NCT02773446|76064860|FG003|STARTED|Second Admission||0||
59518778|NCT01085539|75612628|FG000|STARTED|100Sat Secs-100 Second Alarm Evaluation||50||
59518779|NCT01085539|75612628|FG000|COMPLETED|100Sat Secs-100 Second Alarm Evaluation||50||
59518780|NCT01085539|75612628|FG000|NOT COMPLETED|100Sat Secs-100 Second Alarm Evaluation||0||
59518781|NCT01086475|75612634|FG000|STARTED|Overall Study||34||
59518782|NCT01086475|75612635|FG001|STARTED|Overall Study||33||
59518783|NCT01086475|75612634|FG000|COMPLETED|Overall Study||34||
59762625|NCT00531427|75882454|FG001|NOT COMPLETED|Overall Study||94||
59946114|NCT02773446|76064861|FG004|STARTED|Second Admission||11||
59946115|NCT02773446|76064862|FG005|STARTED|Second Admission||19||
59946116|NCT02773446|76064857|FG000|COMPLETED|Second Admission||0||
59946117|NCT02773446|76064858|FG001|COMPLETED|Second Admission||0||
59946118|NCT02773446|76064859|FG002|COMPLETED|Second Admission||0||
59946119|NCT02773446|76064860|FG003|COMPLETED|Second Admission||0||
59946120|NCT02773446|76064861|FG004|COMPLETED|Second Admission||11||
59946121|NCT02773446|76064862|FG005|COMPLETED|Second Admission||19||
59518784|NCT01086475|75612635|FG001|COMPLETED|Overall Study||33||
59518785|NCT01086475|75612634|FG000|NOT COMPLETED|Overall Study||0||
59518786|NCT01086475|75612635|FG001|NOT COMPLETED|Overall Study||0||
59518787|NCT01112683|75612643|FG000|STARTED|Overall Study||19||
59518788|NCT01112683|75612644|FG001|STARTED|Overall Study||20||
59518789|NCT01112683|75612643|FG000|COMPLETED|Overall Study||18||
59518790|NCT01112683|75612644|FG001|COMPLETED|Overall Study||19||
59518791|NCT01112683|75612643|FG000|NOT COMPLETED|Overall Study||1||
59518792|NCT01112683|75612644|FG001|NOT COMPLETED|Overall Study||1||
59518793|NCT01113385|75612650|FG000|STARTED|Overall Study||7||
59518794|NCT01113385|75612650|FG000|COMPLETED|Overall Study||7||
59946122|NCT02773446|76064857|FG000|NOT COMPLETED|Second Admission||0||
59946123|NCT02773446|76064858|FG001|NOT COMPLETED|Second Admission||0||
59946124|NCT02773446|76064859|FG002|NOT COMPLETED|Second Admission||0||
59946125|NCT02773446|76064860|FG003|NOT COMPLETED|Second Admission||0||
59518795|NCT01113385|75612650|FG000|NOT COMPLETED|Overall Study||0||
59518796|NCT01087801|75612656|FG000|STARTED|Overall Study||30||
59518797|NCT01087801|75612657|FG001|STARTED|Overall Study||34||
59518798|NCT01087801|75612656|FG000|COMPLETED|Overall Study||26||
59518799|NCT01087801|75612657|FG001|COMPLETED|Overall Study||29||
59946126|NCT02773446|76064861|FG004|NOT COMPLETED|Second Admission||0||
59946127|NCT02773446|76064862|FG005|NOT COMPLETED|Second Admission||0||
59946128|NCT02773368|76064881|FG000|STARTED|Overall Study||210||
59946129|NCT02773368|76064882|FG001|STARTED|Overall Study||210||
59946130|NCT02773368|76064881|FG000|Exposed|Overall Study||209||
59946131|NCT02773368|76064882|FG001|Exposed|Overall Study||210||
59946132|NCT02773368|76064881|FG000|COMPLETED|Overall Study||200||
59946133|NCT02773368|76064882|FG001|COMPLETED|Overall Study||206||
59946134|NCT02773368|76064881|FG000|NOT COMPLETED|Overall Study||10||
59946135|NCT02773368|76064882|FG001|NOT COMPLETED|Overall Study||4||
59946136|NCT01336647|76064891|FG000|STARTED|Overall Study||46||
59946137|NCT01336647|76064892|FG001|STARTED|Overall Study||49||
59946138|NCT01336647|76064893|FG002|STARTED|Overall Study||47||
59946139|NCT01336647|76064891|FG000|COMPLETED|Overall Study||42||
59946140|NCT01336647|76064892|FG001|COMPLETED|Overall Study||48||
59946141|NCT01336647|76064893|FG002|COMPLETED|Overall Study||44||
59946142|NCT01336647|76064891|FG000|NOT COMPLETED|Overall Study||4||
59946143|NCT01336647|76064892|FG001|NOT COMPLETED|Overall Study||1||
59946144|NCT01336647|76064893|FG002|NOT COMPLETED|Overall Study||3||
59946145|NCT01336569|76064903|FG000|STARTED|Overall Study||49||
59946146|NCT01336569|76064903|FG000|COMPLETED|Overall Study||45||
59946147|NCT01336569|76064903|FG000|NOT COMPLETED|Overall Study||4||
59946148|NCT02772978|76064907|FG000|STARTED|Overall Study|First participant enrolled|10|First participant enrolled|
59946149|NCT02772978|76064908|FG001|STARTED|Overall Study||9|First participant enrolled|
59946150|NCT02772978|76064907|FG000|COMPLETED|Overall Study|Last participant enrolled|9|Last participant enrolled|
59946151|NCT02772978|76064908|FG001|COMPLETED|Overall Study||8|Last participant enrolled|
59946152|NCT02772978|76064907|FG000|NOT COMPLETED|Overall Study||1||
59946153|NCT02772978|76064908|FG001|NOT COMPLETED|Overall Study||1||
59946154|NCT00104052|76064913|FG000|STARTED|Overall Study||107||
59946155|NCT00104052|76064913|FG000|COMPLETED|Overall Study||78||
59946156|NCT00104052|76064913|FG000|NOT COMPLETED|Overall Study||29||
59946157|NCT02777970|76064920|FG000|STARTED|Overall Study||261||
59946158|NCT02777970|76064921|FG001|STARTED|Overall Study||262||
59946159|NCT02777970|76064922|FG002|STARTED|Overall Study||131||
59946160|NCT02777970|76064920|FG000|COMPLETED|Overall Study||260||
59946161|NCT02777970|76064921|FG001|COMPLETED|Overall Study||261||
59946162|NCT02777970|76064922|FG002|COMPLETED|Overall Study||131||
59946163|NCT02777970|76064920|FG000|NOT COMPLETED|Overall Study||1||
59946164|NCT02777970|76064921|FG001|NOT COMPLETED|Overall Study||1||
59946165|NCT02777970|76064922|FG002|NOT COMPLETED|Overall Study||0||
59946166|NCT03037489|76064934|FG000|STARTED|Overall Study||46||
59946167|NCT03037489|76064935|FG001|STARTED|Overall Study||4||
59946168|NCT03037489|76064934|FG000|COMPLETED|Overall Study||39||
59946169|NCT03037489|76064935|FG001|COMPLETED|Overall Study||4||
59946170|NCT03037489|76064934|FG000|NOT COMPLETED|Overall Study||7||
59946171|NCT03037489|76064935|FG001|NOT COMPLETED|Overall Study||0||
59946172|NCT01336023|76064944|FG000|STARTED|Week 0 to Week 26||414||
59946173|NCT01336023|76064945|FG001|STARTED|Week 0 to Week 26||834||
59946174|NCT01336023|76064946|FG002|STARTED|Week 0 to Week 26||415||
59946175|NCT01336023|76064944|FG000|Exposed|Week 0 to Week 26|1 subject withdrew before exposure to trial drug and was not included in the analysis|413||
59946176|NCT01336023|76064945|FG001|Exposed|Week 0 to Week 26|8 subjects withdrew before exposure to trial drug and were not included in the analysis|826||
59946177|NCT01336023|76064946|FG002|Exposed|Week 0 to Week 26|2 subjects withdrew before exposure to trial drug and were not included in the analysis|413||
59946178|NCT01336023|76064944|FG000|COMPLETED|Week 0 to Week 26||366||
59946179|NCT01336023|76064945|FG001|COMPLETED|Week 0 to Week 26||736||
59946180|NCT01336023|76064946|FG002|COMPLETED|Week 0 to Week 26||342||
59946181|NCT01336023|76064944|FG000|NOT COMPLETED|Week 0 to Week 26||48||
59946182|NCT01336023|76064945|FG001|NOT COMPLETED|Week 0 to Week 26||98||
59946183|NCT01336023|76064946|FG002|NOT COMPLETED|Week 0 to Week 26||73||
59946184|NCT01336023|76064944|FG000|STARTED|Week 27 to 52|From the main trial, 33 subjects were not enrolled in the extension (week 27-52).|333||
59946185|NCT01336023|76064945|FG001|STARTED|Week 27 to 52|From the main trial, 71 subjects were not enrolled in the extension (week 27-52).|665||
59946186|NCT01336023|76064946|FG002|STARTED|Week 27 to 52|From the main trial, 29 subjects were not enrolled in the extension (week 27-52).|313||
59946187|NCT01336023|76064944|FG000|COMPLETED|Week 27 to 52||305||
59946188|NCT01336023|76064945|FG001|COMPLETED|Week 27 to 52||621||
59946189|NCT01336023|76064946|FG002|COMPLETED|Week 27 to 52||285||
59946190|NCT01336023|76064944|FG000|NOT COMPLETED|Week 27 to 52||28||
59946191|NCT01336023|76064945|FG001|NOT COMPLETED|Week 27 to 52||44||
60067593|NCT01606761|76182768|FG003|NOT COMPLETED|Prior to Week 24||0||
59946192|NCT01336023|76064946|FG002|NOT COMPLETED|Week 27 to 52||28||
59946193|NCT03039283|76064954|FG000|STARTED|Overall Study||162||
59946194|NCT03039283|76064954|FG000|COMPLETED|Overall Study||160||
59946195|NCT03039283|76064954|FG000|NOT COMPLETED|Overall Study||2||
59946196|NCT01518517|76064961|FG000|STARTED|Overall Study||29||
59946197|NCT01518517|76064962|FG001|STARTED|Overall Study||30||
59946198|NCT01518517|76064963|FG002|STARTED|Overall Study||26||
59946199|NCT01518517|76064961|FG000|COMPLETED|Overall Study||1||
59946200|NCT01518517|76064962|FG001|COMPLETED|Overall Study||3||
59946201|NCT01518517|76064963|FG002|COMPLETED|Overall Study||0||
59946202|NCT01518517|76064961|FG000|NOT COMPLETED|Overall Study||28||
59946203|NCT01518517|76064962|FG001|NOT COMPLETED|Overall Study||27||
59946204|NCT01518517|76064963|FG002|NOT COMPLETED|Overall Study||26||
59946205|NCT02863575|76064976|FG000|STARTED|Overall Study||161||
59946206|NCT02863575|76064977|FG001|STARTED|Overall Study||161||
59946207|NCT02863575|76064978|FG002|STARTED|Overall Study||52||
59946208|NCT02863575|76064976|FG000|COMPLETED|Overall Study||160||
59946209|NCT02863575|76064977|FG001|COMPLETED|Overall Study||159||
59946210|NCT02863575|76064978|FG002|COMPLETED|Overall Study||51||
59946211|NCT02863575|76064976|FG000|NOT COMPLETED|Overall Study||1||
59946212|NCT02863575|76064977|FG001|NOT COMPLETED|Overall Study||2||
59946213|NCT02863575|76064978|FG002|NOT COMPLETED|Overall Study||1||
59946214|NCT01227187|76064990|FG000|STARTED|Overall Study||1||
59946215|NCT01227187|76064991|FG001|STARTED|Overall Study||3||
59946216|NCT01227187|76064992|FG002|STARTED|Overall Study||3||
59946217|NCT01227187|76064993|FG003|STARTED|Overall Study||5||
59946218|NCT01227187|76064990|FG000|COMPLETED|Overall Study||1||
59946219|NCT01227187|76064991|FG001|COMPLETED|Overall Study||3||
59946220|NCT01227187|76064992|FG002|COMPLETED|Overall Study||3||
59946221|NCT01227187|76064993|FG003|COMPLETED|Overall Study||4||
59946222|NCT01227187|76064990|FG000|NOT COMPLETED|Overall Study||0||
59946223|NCT01227187|76064991|FG001|NOT COMPLETED|Overall Study||0||
59946224|NCT01227187|76064992|FG002|NOT COMPLETED|Overall Study||0||
59946225|NCT01227187|76064993|FG003|NOT COMPLETED|Overall Study||1||
59946226|NCT01077817|76065003|FG000|STARTED|Overall Study|STARTED and COMPLETED is the number of participants meeting incl./excl. criteria in the GPRD.|684815||
59946227|NCT01077817|76065003|FG000|COMPLETED|Overall Study||684815||
59946228|NCT01077817|76065003|FG000|NOT COMPLETED|Overall Study||0||
59946229|NCT02638012|76065014|FG000|STARTED|Overall Study||8||
59946230|NCT02638012|76065014|FG000|COMPLETED|Overall Study||7||
59946231|NCT02638012|76065014|FG000|NOT COMPLETED|Overall Study||1||
59946232|NCT00103506|76065020|FG000|STARTED|Overall Study||322||
59946233|NCT00103506|76065021|FG001|STARTED|Overall Study||324||
59946234|NCT00103506|76065020|FG000|COMPLETED|Overall Study||0||
59946235|NCT00103506|76065021|FG001|COMPLETED|Overall Study||0||
59946236|NCT00103506|76065020|FG000|NOT COMPLETED|Overall Study||322||
59946237|NCT00103506|76065021|FG001|NOT COMPLETED|Overall Study||324||
59946238|NCT02765490|76065029|FG000|STARTED|Overall Study||183||
59946239|NCT02765490|76065030|FG001|STARTED|Overall Study||182||
59946240|NCT02765490|76065029|FG000|COMPLETED|Overall Study||182||
59946241|NCT02765490|76065030|FG001|COMPLETED|Overall Study||179||
59946242|NCT02765490|76065029|FG000|NOT COMPLETED|Overall Study||1||
59946243|NCT02765490|76065030|FG001|NOT COMPLETED|Overall Study||3||
59946244|NCT02639182|76065038|FG000|STARTED|Overall Study||67||
59946245|NCT02639182|76065039|FG001|STARTED|Overall Study||66||
59946246|NCT02639182|76065038|FG000|Treated|Overall Study||66||
59946247|NCT02639182|76065039|FG001|Treated|Overall Study||65||
59946248|NCT02639182|76065038|FG000|COMPLETED|Overall Study||0||
59946249|NCT02639182|76065039|FG001|COMPLETED|Overall Study||0||
59946250|NCT02639182|76065038|FG000|NOT COMPLETED|Overall Study||67||
59946251|NCT02639182|76065039|FG001|NOT COMPLETED|Overall Study||66||
59946252|NCT02863419|76065048|FG000|STARTED|Overall Study||285||
59946253|NCT02863419|76065049|FG001|STARTED|Overall Study||284||
59946254|NCT02863419|76065050|FG002|STARTED|Overall Study||142||
59946255|NCT02863419|76065048|FG000|Full Analysis Set (FAS)|Overall Study||285||
59946256|NCT02863419|76065049|FG001|Full Analysis Set (FAS)|Overall Study||284||
59946257|NCT02863419|76065050|FG002|Full Analysis Set (FAS)|Overall Study||142||
59946258|NCT02863419|76065048|FG000|Safety Analysis Set (SAS)|Overall Study||285||
59946259|NCT02863419|76065049|FG001|Safety Analysis Set (SAS)|Overall Study||284||
59946260|NCT02863419|76065050|FG002|Safety Analysis Set (SAS)|Overall Study||142||
59946261|NCT02863419|76065048|FG000|COMPLETED|Overall Study||277||
59946262|NCT02863419|76065049|FG001|COMPLETED|Overall Study||274||
59946263|NCT02863419|76065050|FG002|COMPLETED|Overall Study||134||
59946264|NCT02863419|76065048|FG000|NOT COMPLETED|Overall Study||8||
59946265|NCT02863419|76065049|FG001|NOT COMPLETED|Overall Study||10||
59946266|NCT02863419|76065050|FG002|NOT COMPLETED|Overall Study||8||
59946267|NCT02765100|76065060|FG000|STARTED|Overall Study||9||
59946268|NCT02765100|76065061|FG001|STARTED|Overall Study||12||
59946269|NCT02765100|76065060|FG000|COMPLETED|Overall Study||8||
59946270|NCT02765100|76065061|FG001|COMPLETED|Overall Study||10||
59946271|NCT02765100|76065060|FG000|NOT COMPLETED|Overall Study||1||
59946272|NCT02765100|76065061|FG001|NOT COMPLETED|Overall Study||2||
59946273|NCT02761980|76065071|FG000|STARTED|Overall Study||29||
59946274|NCT02761980|76065072|FG001|STARTED|Overall Study||87||
59946275|NCT02761980|76065073|FG002|STARTED|Overall Study||87||
59946276|NCT02761980|76065074|FG003|STARTED|Overall Study||87||
59946277|NCT02761980|76065071|FG000|COMPLETED|Overall Study||25||
59946278|NCT02761980|76065072|FG001|COMPLETED|Overall Study||80||
59946279|NCT02761980|76065073|FG002|COMPLETED|Overall Study||81||
59946280|NCT02761980|76065074|FG003|COMPLETED|Overall Study||81||
59946281|NCT02761980|76065071|FG000|NOT COMPLETED|Overall Study||4||
59946282|NCT02761980|76065072|FG001|NOT COMPLETED|Overall Study||7||
59946283|NCT02761980|76065073|FG002|NOT COMPLETED|Overall Study||6||
59946284|NCT02761980|76065074|FG003|NOT COMPLETED|Overall Study||6||
59946285|NCT04570605|76065086|FG000|STARTED|Overall Study||15||
59946286|NCT04570605|76065087|FG001|STARTED|Overall Study||15||
59946287|NCT04570605|76065086|FG000|COMPLETED|Overall Study||11||
59946288|NCT04570605|76065087|FG001|COMPLETED|Overall Study||13||
59946289|NCT04570605|76065086|FG000|NOT COMPLETED|Overall Study||4||
59946290|NCT04570605|76065087|FG001|NOT COMPLETED|Overall Study||2||
59946291|NCT02862171|76065093|FG000|STARTED|Overall Study||941||
59946292|NCT02862171|76065093|FG000|COMPLETED|Overall Study||848||
59946293|NCT02862171|76065093|FG000|NOT COMPLETED|Overall Study||93||
59946294|NCT02638948|76065101|FG000|STARTED|Overall Study||75||
59946295|NCT02638948|76065102|FG001|STARTED|Overall Study||73||
59946296|NCT02638948|76065103|FG002|STARTED|Overall Study||73||
59946297|NCT02638948|76065104|FG003|STARTED|Overall Study||26||
59946298|NCT02638948|76065101|FG000|COMPLETED|Overall Study||66||
59946299|NCT02638948|76065102|FG001|COMPLETED|Overall Study||62||
59946300|NCT02638948|76065103|FG002|COMPLETED|Overall Study||66||
59946301|NCT02638948|76065104|FG003|COMPLETED|Overall Study||18||
59946302|NCT02638948|76065101|FG000|NOT COMPLETED|Overall Study||9||
59946303|NCT02638948|76065102|FG001|NOT COMPLETED|Overall Study||11||
59946304|NCT02638948|76065103|FG002|NOT COMPLETED|Overall Study||7||
59946305|NCT02638948|76065104|FG003|NOT COMPLETED|Overall Study||8||
59946306|NCT00102960|76065120|FG000|STARTED|Overall Study||125||
59946307|NCT00102960|76065121|FG001|STARTED|Overall Study||126||
59946308|NCT00102960|76065122|FG002|STARTED|Overall Study||126||
59946309|NCT00102960|76065120|FG000|COMPLETED|Overall Study||95||
59946310|NCT00102960|76065121|FG001|COMPLETED|Overall Study||103||
59946311|NCT00102960|76065122|FG002|COMPLETED|Overall Study||98||
59946312|NCT00102960|76065120|FG000|NOT COMPLETED|Overall Study||30||
59946313|NCT00102960|76065121|FG001|NOT COMPLETED|Overall Study||23||
59946314|NCT00102960|76065122|FG002|NOT COMPLETED|Overall Study||28||
59946315|NCT02858895|76065134|FG000|STARTED|Overall Study||47||
59946316|NCT02858895|76065134|FG000|Intent to Treat/Safety Population|Overall Study|Intent-to-Treat and Safety populations were identical and consisted of all subjects who signed an informed consent form and received any amount of study drug.|47||
59946317|NCT02858895|76065134|FG000|Per Protocol Population|Overall Study|Per-Protocol Population consisted of all subjects in the Intent to Treat Population who had no major protocol violation during the study. Efficacy analyses were conducted on this population in support of the primary efficacy results.|44||
59946318|NCT02858895|76065134|FG000|COMPLETED|Overall Study|Patients who completed the study were those who completed active study follow up to Day 360|8||
59946319|NCT02858895|76065134|FG000|NOT COMPLETED|Overall Study||39||
59946320|NCT02637856|76065145|FG000|STARTED|Main Study (Baseline to Week 100)||608||
59946321|NCT02637856|76065146|FG001|STARTED|Main Study (Baseline to Week 100)||0||
59946322|NCT02637856|76065145|FG000|COMPLETED|Main Study (Baseline to Week 100)||389||
59946323|NCT02637856|76065146|FG001|COMPLETED|Main Study (Baseline to Week 100)||0||
59946324|NCT02637856|76065145|FG000|NOT COMPLETED|Main Study (Baseline to Week 100)||219||
59946325|NCT02637856|76065146|FG001|NOT COMPLETED|Main Study (Baseline to Week 100)||0||
59946326|NCT02637856|76065145|FG000|STARTED|Sub-Study (Week 72 to Week 100)||0||
59946327|NCT02637856|76065146|FG001|STARTED|Sub-Study (Week 72 to Week 100)||129||
59946328|NCT02637856|76065145|FG000|COMPLETED|Sub-Study (Week 72 to Week 100)||0||
59946329|NCT02637856|76065146|FG001|COMPLETED|Sub-Study (Week 72 to Week 100)||125||
59946330|NCT02637856|76065145|FG000|NOT COMPLETED|Sub-Study (Week 72 to Week 100)||0||
59946331|NCT02637856|76065146|FG001|NOT COMPLETED|Sub-Study (Week 72 to Week 100)||4||
59946332|NCT02858037|76065152|FG000|STARTED|Overall Study||1456||
59946333|NCT02858037|76065152|FG000|Exposed Primary Cohort|Overall Study||1368||
59946334|NCT02858037|76065152|FG000|COMPLETED|Overall Study||1404||
59946335|NCT02858037|76065152|FG000|NOT COMPLETED|Overall Study||52||
59946336|NCT02856555|76065159|FG000|STARTED|Overall Study||51||
59946337|NCT02856555|76065160|FG001|STARTED|Overall Study||50||
59946338|NCT02856555|76065161|FG002|STARTED|Overall Study||26||
59946339|NCT02856555|76065159|FG000|COMPLETED|Overall Study||46||
59946340|NCT02856555|76065160|FG001|COMPLETED|Overall Study||46||
59946341|NCT02856555|76065161|FG002|COMPLETED|Overall Study||26||
59946342|NCT02856555|76065159|FG000|NOT COMPLETED|Overall Study||5||
59946343|NCT02856555|76065160|FG001|NOT COMPLETED|Overall Study||4||
59946344|NCT02856555|76065161|FG002|NOT COMPLETED|Overall Study||0||
59946345|NCT01242267|76065173|FG000|STARTED|Overall Study||3||
59946346|NCT01242267|76065174|FG001|STARTED|Overall Study||3||
59946347|NCT01242267|76065175|FG002|STARTED|Overall Study||3||
59946348|NCT01242267|76065176|FG003|STARTED|Overall Study||20||
59946349|NCT01242267|76065173|FG000|COMPLETED|Overall Study||3||
59946350|NCT01242267|76065174|FG001|COMPLETED|Overall Study||3||
59946351|NCT01242267|76065175|FG002|COMPLETED|Overall Study||3||
59946352|NCT01242267|76065176|FG003|COMPLETED|Overall Study||20||
59946353|NCT01242267|76065173|FG000|NOT COMPLETED|Overall Study||0||
59946354|NCT01242267|76065174|FG001|NOT COMPLETED|Overall Study||0||
59946355|NCT01242267|76065175|FG002|NOT COMPLETED|Overall Study||0||
59946356|NCT01242267|76065176|FG003|NOT COMPLETED|Overall Study||0||
59946357|NCT01741480|76065192|FG000|STARTED|Overall Study||285||
59946358|NCT01741480|76065193|FG001|STARTED|Overall Study||286||
59946359|NCT01741480|76065192|FG000|COMPLETED|Overall Study||285||
59946360|NCT01741480|76065193|FG001|COMPLETED|Overall Study||286||
59946361|NCT01741480|76065192|FG000|NOT COMPLETED|Overall Study||0||
59946362|NCT01741480|76065193|FG001|NOT COMPLETED|Overall Study||0||
59946363|NCT02637232|76065199|FG000|STARTED|Overall Study||301||
59946364|NCT02637232|76065199|FG000|COMPLETED|Overall Study||246||
59946365|NCT02637232|76065199|FG000|NOT COMPLETED|Overall Study||55||
59946366|NCT02855541|76065203|FG000|STARTED|Overall Study||25||
59946367|NCT02855541|76065203|FG000|COMPLETED|Overall Study||21||
59946368|NCT02855541|76065203|FG000|NOT COMPLETED|Overall Study||4||
59946369|NCT02635984|76065209|FG000|STARTED|Overall Study||53||
59946370|NCT02635984|76065210|FG001|STARTED|Overall Study||55||
59946371|NCT02635984|76065209|FG000|COMPLETED|Overall Study||50||
59946372|NCT02635984|76065210|FG001|COMPLETED|Overall Study||51||
59946373|NCT02635984|76065209|FG000|NOT COMPLETED|Overall Study||3||
59946374|NCT02635984|76065210|FG001|NOT COMPLETED|Overall Study||4||
59946375|NCT01147653|76065218|FG000|STARTED|Year 1||32||
59946376|NCT01147653|76065219|FG001|STARTED|Year 1||31||
59946377|NCT01147653|76065218|FG000|COMPLETED|Year 1||32||
59946378|NCT01147653|76065219|FG001|COMPLETED|Year 1||31||
59946379|NCT01147653|76065218|FG000|NOT COMPLETED|Year 1||0||
59946380|NCT01147653|76065219|FG001|NOT COMPLETED|Year 1||0||
59946381|NCT01147653|76065218|FG000|STARTED|Year 2||32||
59946382|NCT01147653|76065219|FG001|STARTED|Year 2||31||
59946383|NCT01147653|76065218|FG000|COMPLETED|Year 2||30||
59946384|NCT01147653|76065219|FG001|COMPLETED|Year 2||28||
59946385|NCT01147653|76065218|FG000|NOT COMPLETED|Year 2||2||
59946386|NCT01147653|76065219|FG001|NOT COMPLETED|Year 2||3||
59946387|NCT02747043|76065240|FG000|STARTED|Overall Study||128||
59946388|NCT02747043|76065241|FG001|STARTED|Overall Study||128||
59946389|NCT02747043|76065240|FG000|Treated|Overall Study||128||
59946390|NCT02747043|76065241|FG001|Treated|Overall Study||126||
59946391|NCT02747043|76065240|FG000|COMPLETED|Overall Study||118|Completed Week 28|
59946392|NCT02747043|76065241|FG001|COMPLETED|Overall Study||123|Completed Week 28|
59946393|NCT02747043|76065240|FG000|NOT COMPLETED|Overall Study||10||
59946394|NCT02747043|76065241|FG001|NOT COMPLETED|Overall Study||5||
59946395|NCT02637076|76065249|FG000|STARTED|Overall Study||2||
59946396|NCT02637076|76065250|FG001|STARTED|Overall Study||15||
59946397|NCT02637076|76065249|FG000|COMPLETED|Overall Study||1||
59946398|NCT02637076|76065250|FG001|COMPLETED|Overall Study||10||
59946399|NCT02637076|76065249|FG000|NOT COMPLETED|Overall Study||1||
59946400|NCT02637076|76065250|FG001|NOT COMPLETED|Overall Study||5||
59946401|NCT02854605|76065259|FG000|STARTED|Overall Study||56||
59946402|NCT02854605|76065260|FG001|STARTED|Overall Study||56||
59946403|NCT02854605|76065261|FG002|STARTED|Overall Study||28||
59946404|NCT02854605|76065259|FG000|COMPLETED|Overall Study||53||
59946405|NCT02854605|76065260|FG001|COMPLETED|Overall Study||49||
59946406|NCT02854605|76065261|FG002|COMPLETED|Overall Study||24||
59946407|NCT02854605|76065259|FG000|NOT COMPLETED|Overall Study||3||
59946408|NCT02854605|76065260|FG001|NOT COMPLETED|Overall Study||7||
59946409|NCT02854605|76065261|FG002|NOT COMPLETED|Overall Study||4||
59946410|NCT05485662|76065269|FG000|STARTED|Phase 1 Allocation||8||
59946411|NCT05485662|76065270|FG001|STARTED|Phase 1 Allocation||7||
59946412|NCT05485662|76065269|FG000|COMPLETED|Phase 1 Allocation||8||
59946413|NCT05485662|76065270|FG001|COMPLETED|Phase 1 Allocation||7||
59946414|NCT05485662|76065269|FG000|NOT COMPLETED|Phase 1 Allocation||0||
59946415|NCT05485662|76065270|FG001|NOT COMPLETED|Phase 1 Allocation||0||
59946416|NCT05485662|76065269|FG000|STARTED|Washout Period||8||
59946417|NCT05485662|76065270|FG001|STARTED|Washout Period||7||
59946418|NCT05485662|76065269|FG000|COMPLETED|Washout Period||8||
59946419|NCT05485662|76065270|FG001|COMPLETED|Washout Period||7||
59946420|NCT05485662|76065269|FG000|NOT COMPLETED|Washout Period||0||
59946421|NCT05485662|76065270|FG001|NOT COMPLETED|Washout Period||0||
59946422|NCT05485662|76065269|FG000|STARTED|Phase 2 Allocation||7||
59946423|NCT05485662|76065270|FG001|STARTED|Phase 2 Allocation||8||
59946424|NCT05485662|76065269|FG000|COMPLETED|Phase 2 Allocation||7||
59946425|NCT05485662|76065270|FG001|COMPLETED|Phase 2 Allocation||8||
59946426|NCT05485662|76065269|FG000|NOT COMPLETED|Phase 2 Allocation||0||
59946427|NCT05485662|76065270|FG001|NOT COMPLETED|Phase 2 Allocation||0||
59946428|NCT05059977|76065279|FG000|STARTED|Overall Study||8||
59946429|NCT05059977|76065280|FG001|STARTED|Overall Study||8||
59946430|NCT05059977|76065281|FG002|STARTED|Overall Study||8||
59946431|NCT05059977|76065279|FG000|COMPLETED|Overall Study||8||
59946432|NCT05059977|76065280|FG001|COMPLETED|Overall Study||8||
59946433|NCT05059977|76065281|FG002|COMPLETED|Overall Study||7||
59946434|NCT05059977|76065279|FG000|NOT COMPLETED|Overall Study||0||
59946435|NCT05059977|76065280|FG001|NOT COMPLETED|Overall Study||0||
59518800|NCT01087801|75612656|FG000|NOT COMPLETED|Overall Study||4||
59946436|NCT05059977|76065281|FG002|NOT COMPLETED|Overall Study||1||
59946437|NCT04985773|76065289|FG000|STARTED|Overall Study||200||
59946438|NCT04985773|76065289|FG000|COMPLETED|Overall Study||199||
59946439|NCT04985773|76065289|FG000|NOT COMPLETED|Overall Study||1||
59946440|NCT04803305|76065295|FG000|STARTED|Part A: 6-week Double-blind Treatment||6||
59946441|NCT04803305|76065296|FG001|STARTED|Part A: 6-week Double-blind Treatment||12||
59946442|NCT04803305|76065295|FG000|COMPLETED|Part A: 6-week Double-blind Treatment||5||
59946443|NCT04803305|76065296|FG001|COMPLETED|Part A: 6-week Double-blind Treatment||9||
59946444|NCT04803305|76065295|FG000|NOT COMPLETED|Part A: 6-week Double-blind Treatment||1||
59946445|NCT04803305|76065296|FG001|NOT COMPLETED|Part A: 6-week Double-blind Treatment||3||
59946446|NCT04803305|76065295|FG000|STARTED|Part B: OLT Period up to 18 Weeks||5||
59946447|NCT04803305|76065296|FG001|STARTED|Part B: OLT Period up to 18 Weeks||9||
59946448|NCT04803305|76065295|FG000|COMPLETED|Part B: OLT Period up to 18 Weeks||2||
59946449|NCT04803305|76065296|FG001|COMPLETED|Part B: OLT Period up to 18 Weeks||5||
59946450|NCT04803305|76065295|FG000|NOT COMPLETED|Part B: OLT Period up to 18 Weeks||3||
59946451|NCT04803305|76065296|FG001|NOT COMPLETED|Part B: OLT Period up to 18 Weeks||4||
59946452|NCT04795908|76065305|FG000|STARTED|Overall Study||3||
59946453|NCT04795908|76065305|FG000|COMPLETED|Overall Study||3||
59946454|NCT04795908|76065305|FG000|NOT COMPLETED|Overall Study||0||
59946455|NCT04607135|76065314|FG000|STARTED|Overall Study||34||
59946456|NCT04607135|76065314|FG000|Acoustic Radiation Force Impulse (ARFI)|Overall Study||30||
59946457|NCT04607135|76065314|FG000|MR-ultrasound Fusion|Overall Study||29||
59946458|NCT04607135|76065314|FG000|Systematic Sampling|Overall Study||30||
59946459|NCT04607135|76065314|FG000|COMPLETED|Overall Study||29||
59946460|NCT04607135|76065314|FG000|NOT COMPLETED|Overall Study||5||
59946461|NCT04586127|76065322|FG000|STARTED|Overall Study||26||
59946462|NCT04586127|76065322|FG000|COMPLETED|Overall Study||21||
59946463|NCT04586127|76065322|FG000|NOT COMPLETED|Overall Study||5||
59946464|NCT04525885|76065329|FG000|STARTED|Overall Study||68||
59946465|NCT04525885|76065330|FG001|STARTED|Overall Study||27||
59946466|NCT04525885|76065331|FG002|STARTED|Overall Study||66||
59946467|NCT04525885|76065329|FG000|Number Treated|Overall Study||67||
59946468|NCT04525885|76065330|FG001|Number Treated|Overall Study||27||
59946469|NCT04525885|76065331|FG002|Number Treated|Overall Study||66||
59946470|NCT04525885|76065329|FG000|COMPLETED|Overall Study||52||
59946471|NCT04525885|76065330|FG001|COMPLETED|Overall Study||21||
59946472|NCT04525885|76065331|FG002|COMPLETED|Overall Study||45||
59946473|NCT04525885|76065329|FG000|NOT COMPLETED|Overall Study||16||
59946474|NCT04525885|76065330|FG001|NOT COMPLETED|Overall Study||6||
59946475|NCT04525885|76065331|FG002|NOT COMPLETED|Overall Study||21||
59946476|NCT04426006|76065344|FG000|STARTED|Inclusion||526||
59946477|NCT04426006|76065344|FG000|COMPLETED|Inclusion||517|Participants who completed the self-administered questionnaire and had blood sample at inclusion|
59946478|NCT04426006|76065344|FG000|NOT COMPLETED|Inclusion||9||
59946479|NCT04426006|76065344|FG000|STARTED|3 Months||517||
59946480|NCT04426006|76065344|FG000|COMPLETED|3 Months||500||
59946481|NCT04426006|76065344|FG000|NOT COMPLETED|3 Months||17||
59946482|NCT04426006|76065344|FG000|STARTED|12 Months||500||
59946483|NCT04426006|76065344|FG000|COMPLETED|12 Months||462||
59946484|NCT04426006|76065344|FG000|NOT COMPLETED|12 Months||38||
59946485|NCT03959241|76065351|FG000|STARTED|Overall Study||214||
59946486|NCT03959241|76065352|FG001|STARTED|Overall Study||217||
59946487|NCT03959241|76065351|FG000|COMPLETED|Overall Study||203||
59946488|NCT03959241|76065352|FG001|COMPLETED|Overall Study||208||
59946489|NCT03959241|76065351|FG000|NOT COMPLETED|Overall Study||11||
59946490|NCT03959241|76065352|FG001|NOT COMPLETED|Overall Study||9||
59946491|NCT03720990|76065358|FG000|STARTED|Overall Study||12||
59946492|NCT03720990|76065358|FG000|COMPLETED|Overall Study||12||
59946493|NCT03720990|76065358|FG000|NOT COMPLETED|Overall Study||0||
59946494|NCT03705169|76065372|FG000|STARTED|Overall Study||4||
59946495|NCT03705169|76065373|FG001|STARTED|Overall Study||4||
59946496|NCT03705169|76065374|FG002|STARTED|Overall Study||4||
59946497|NCT03705169|76065375|FG003|STARTED|Overall Study||11||
59946498|NCT03705169|76065376|FG004|STARTED|Overall Study||10||
59946499|NCT03705169|76065377|FG005|STARTED|Overall Study||5||
59946500|NCT03705169|76065378|FG006|STARTED|Overall Study||2||
59946501|NCT03705169|76065379|FG007|STARTED|Overall Study||4||
59946502|NCT03705169|76065380|FG008|STARTED|Overall Study||4||
59946503|NCT03705169|76065381|FG009|STARTED|Overall Study||4||
59946504|NCT03705169|76065372|FG000|Participants Receiving First Dose|Overall Study||4||
59946505|NCT03705169|76065373|FG001|Participants Receiving First Dose|Overall Study||4||
59946506|NCT03705169|76065374|FG002|Participants Receiving First Dose|Overall Study||4||
59946507|NCT03705169|76065375|FG003|Participants Receiving First Dose|Overall Study||10||
59946508|NCT03705169|76065376|FG004|Participants Receiving First Dose|Overall Study||10||
59946509|NCT03705169|76065377|FG005|Participants Receiving First Dose|Overall Study||5||
59946510|NCT03705169|76065378|FG006|Participants Receiving First Dose|Overall Study||2||
59946511|NCT03705169|76065379|FG007|Participants Receiving First Dose|Overall Study||4||
59946512|NCT03705169|76065380|FG008|Participants Receiving First Dose|Overall Study||4||
59946513|NCT03705169|76065381|FG009|Participants Receiving First Dose|Overall Study||4||
59946514|NCT03705169|76065372|FG000|COMPLETED|Overall Study||4||
59946515|NCT03705169|76065373|FG001|COMPLETED|Overall Study||4||
59946516|NCT03705169|76065374|FG002|COMPLETED|Overall Study||4||
59946517|NCT03705169|76065375|FG003|COMPLETED|Overall Study||5||
59946518|NCT03705169|76065376|FG004|COMPLETED|Overall Study||10||
59946519|NCT03705169|76065377|FG005|COMPLETED|Overall Study||3||
59946520|NCT03705169|76065378|FG006|COMPLETED|Overall Study||1||
59946521|NCT03705169|76065379|FG007|COMPLETED|Overall Study||4||
59946522|NCT03705169|76065380|FG008|COMPLETED|Overall Study||4||
59946523|NCT03705169|76065381|FG009|COMPLETED|Overall Study||3||
59946524|NCT03705169|76065372|FG000|NOT COMPLETED|Overall Study||0||
59946525|NCT03705169|76065373|FG001|NOT COMPLETED|Overall Study||0||
59946526|NCT03705169|76065374|FG002|NOT COMPLETED|Overall Study||0||
59946527|NCT03705169|76065375|FG003|NOT COMPLETED|Overall Study||6||
59946528|NCT03705169|76065376|FG004|NOT COMPLETED|Overall Study||0||
59946529|NCT03705169|76065377|FG005|NOT COMPLETED|Overall Study||2||
59946530|NCT03705169|76065378|FG006|NOT COMPLETED|Overall Study||1||
59946531|NCT03705169|76065379|FG007|NOT COMPLETED|Overall Study||0||
59946532|NCT03705169|76065380|FG008|NOT COMPLETED|Overall Study||0||
59946533|NCT03705169|76065381|FG009|NOT COMPLETED|Overall Study||1||
59946534|NCT03414684|76065418|FG000|STARTED|First-course Treatment|39 patients were randomized to Arm A|39||
59946535|NCT03414684|76065419|FG001|STARTED|First-course Treatment|39 patients were randomized to Arm B|39||
59946536|NCT03414684|76065418|FG000|Started Treatment|First-course Treatment||37||
59946537|NCT03414684|76065419|FG001|Started Treatment|First-course Treatment||38||
59946538|NCT03414684|76065418|FG000|COMPLETED|First-course Treatment|"There was no completion of treatment, per protocol. Patients were to remain on treatment until:~Disease progression~Complete response (and treated for at least 24 weeks, with at least two treatments occurring beyond the date when the initial CR was declared)~Intercurrent illness~Unacceptable adverse event(s)~Withdrawal of consent~General/specific changes in the patient's condition that render the patient unacceptable for further treatment"|0||
59946539|NCT03414684|76065419|FG001|COMPLETED|First-course Treatment|"There was no completion of treatment, per protocol. Patients were to remain on treatment until:~Disease progression~Complete response (and treated for at least 24 weeks, with at least two treatments occurring beyond the date when the initial CR was declared)~Intercurrent illness~Unacceptable adverse event(s)~Withdrawal of consent~General/specific changes in the patient's condition that render the patient unacceptable for further treatment"|0||
59946540|NCT03414684|76065418|FG000|NOT COMPLETED|First-course Treatment||39||
59946541|NCT03414684|76065419|FG001|NOT COMPLETED|First-course Treatment||39||
59946542|NCT03414684|76065418|FG000|STARTED|Crossover Treatment||0||
59946543|NCT03414684|76065419|FG001|STARTED|Crossover Treatment||18||
59946544|NCT03414684|76065418|FG000|COMPLETED|Crossover Treatment||0||
59946545|NCT03414684|76065419|FG001|COMPLETED|Crossover Treatment|"There was no completion of treatment, per protocol. Patients were to remain on treatment until:~Disease progression~Complete response (and treated for at least 24 weeks, with at least two treatments occurring beyond the date when the initial CR was declared)~Intercurrent illness~Unacceptable adverse event(s)~Withdrawal of consent~General/specific changes in the patient's condition that render the patient unacceptable for further treatment"|0||
59946546|NCT03414684|76065418|FG000|NOT COMPLETED|Crossover Treatment||0||
59946547|NCT03414684|76065419|FG001|NOT COMPLETED|Crossover Treatment||18||
59946548|NCT03346083|76065429|FG000|STARTED|Overall Study||3||
59946549|NCT03346083|76065430|FG001|STARTED|Overall Study||18||
59946550|NCT03346083|76065429|FG000|Received At Least 1 Dose Of Study Drug|Overall Study||3||
59946551|NCT03346083|76065430|FG001|Received At Least 1 Dose Of Study Drug|Overall Study||18||
59946552|NCT03346083|76065429|FG000|Evaluated Through Day 7 Follow-up|Overall Study||3||
59946553|NCT03346083|76065430|FG001|Evaluated Through Day 7 Follow-up|Overall Study||18||
59946554|NCT03346083|76065429|FG000|COMPLETED|Overall Study||3||
59946555|NCT03346083|76065430|FG001|COMPLETED|Overall Study||18||
59946556|NCT03346083|76065429|FG000|NOT COMPLETED|Overall Study||0||
59946557|NCT03346083|76065430|FG001|NOT COMPLETED|Overall Study||0||
59946558|NCT03298451|76065440|FG000|STARTED|Overall Study||389|Randomized|
59946559|NCT03298451|76065441|FG001|STARTED|Overall Study||393|Randomized|
59946560|NCT03298451|76065442|FG002|STARTED|Overall Study||153|Randomized|
59946561|NCT03298451|76065443|FG003|STARTED|Overall Study||389|Randomized|
59946562|NCT03298451|76065440|FG000|Received Treatment|Overall Study||386|One participant in T300+D and one in T75+D arm didn't receive Treme and were analyzed under the Durva mono arm in the safety analysis set|
59946563|NCT03298451|76065441|FG001|Received Treatment|Overall Study||389|One participant in T300+D and one in T75+D arm didn't receive Treme and were analyzed under the Durva mono arm in the safety analysis set|
59946564|NCT03298451|76065442|FG002|Received Treatment|Overall Study||153|One participant in T300+D and one in T75+D arm didn't receive Treme and were analyzed under the Durva mono arm in the safety analysis set|
59946565|NCT03298451|76065443|FG003|Received Treatment|Overall Study||374|One participant in T300+D and one in T75+D arm didn't receive Treme and were analyzed under the Durva mono arm in the safety analysis set|
59946566|NCT03298451|76065440|FG000|COMPLETED|Overall Study||104|Completed final analysis and ongoing in long-term follow-up|
59946567|NCT03298451|76065441|FG001|COMPLETED|Overall Study||125|Completed final analysis and ongoing in long-term follow-up|
59946568|NCT03298451|76065442|FG002|COMPLETED|Overall Study||30|Completed final analysis and ongoing in long-term follow-up|
59946569|NCT03298451|76065443|FG003|COMPLETED|Overall Study||82|Completed final analysis and ongoing in long-term follow-up|
59946570|NCT03298451|76065440|FG000|NOT COMPLETED|Overall Study||285||
59946571|NCT03298451|76065441|FG001|NOT COMPLETED|Overall Study||268||
59946572|NCT03298451|76065442|FG002|NOT COMPLETED|Overall Study||123||
59946573|NCT03298451|76065443|FG003|NOT COMPLETED|Overall Study||307||
59946574|NCT02988375|76065455|FG000|STARTED|Overall Study||946||
59946575|NCT02988375|76065456|FG001|STARTED|Overall Study||439||
59946576|NCT02988375|76065455|FG000|COMPLETED|Overall Study|non-completed subjects consist entirely of participants who were randomized, but failed to initiate the treatment or who stopped doing the dcbti treatment prior to completion of the study.|358||
59946577|NCT02988375|76065456|FG001|COMPLETED|Overall Study|non-completed subjects consist entirely of participants who were randomized, but failed to initiate the treatment or who stopped doing the control treatment prior to completion of the study.|300||
59946578|NCT02988375|76065455|FG000|NOT COMPLETED|Overall Study||588||
59946579|NCT02988375|76065456|FG001|NOT COMPLETED|Overall Study||139||
59946580|NCT02876757|76065464|FG000|STARTED|Overall Study||93197||
59946581|NCT02876757|76065465|FG001|STARTED|Overall Study||93197||
60067594|NCT01606761|76182769|FG004|NOT COMPLETED|Prior to Week 24||0||
60067595|NCT01606761|76182765|FG000|STARTED|Week 24 to Week 52||0||
60067596|NCT01606761|76182766|FG001|STARTED|Week 24 to Week 52||237||
60067597|NCT01606761|76182767|FG002|STARTED|Week 24 to Week 52||245||
59946582|NCT02876757|76065464|FG000|COMPLETED|Overall Study||93197||
59946583|NCT02876757|76065465|FG001|COMPLETED|Overall Study||93197||
59946584|NCT02876757|76065464|FG000|NOT COMPLETED|Overall Study||0||
59946585|NCT02876757|76065465|FG001|NOT COMPLETED|Overall Study||0||
59518801|NCT01087801|75612657|FG001|NOT COMPLETED|Overall Study||5||
59518802|NCT01114555|75612663|FG000|STARTED|Overall Study||34||
59946586|NCT02586857|76065473|FG000|STARTED|Overall Study||15||
59946587|NCT02586857|76065474|FG001|STARTED|Overall Study||9||
59946588|NCT02586857|76065473|FG000|Enrolled|Overall Study||15||
59946589|NCT02586857|76065474|FG001|Enrolled|Overall Study||9||
59946590|NCT02586857|76065473|FG000|Received Study Medication|Overall Study||15||
59946591|NCT02586857|76065474|FG001|Received Study Medication|Overall Study||9||
59946592|NCT02586857|76065473|FG000|Discontinued Study|Overall Study||14||
59946593|NCT02586857|76065474|FG001|Discontinued Study|Overall Study||9||
59946594|NCT02586857|76065473|FG000|COMPLETED|Overall Study||14||
59946595|NCT02586857|76065474|FG001|COMPLETED|Overall Study||9||
59946596|NCT02586857|76065473|FG000|NOT COMPLETED|Overall Study||1||
59946597|NCT02586857|76065474|FG001|NOT COMPLETED|Overall Study||0||
59946598|NCT02288247|76065480|FG000|STARTED|Period 1: OL Treatment (Max: 315 Weeks)||688||
59946599|NCT02288247|76065481|FG001|STARTED|Period 1: OL Treatment (Max: 315 Weeks)||0||
59946600|NCT02288247|76065480|FG000|Treated|Period 1: OL Treatment (Max: 315 Weeks)||687||
59946601|NCT02288247|76065481|FG001|Treated|Period 1: OL Treatment (Max: 315 Weeks)||0||
59946602|NCT02288247|76065480|FG000|COMPLETED|Period 1: OL Treatment (Max: 315 Weeks)||41|Completed participants are those who did not have a treatment discontinuation.|
59946603|NCT02288247|76065481|FG001|COMPLETED|Period 1: OL Treatment (Max: 315 Weeks)||0|Completed participants are those who did not have a treatment discontinuation.|
59946604|NCT02288247|76065480|FG000|NOT COMPLETED|Period 1: OL Treatment (Max: 315 Weeks)||647||
59946605|NCT02288247|76065481|FG001|NOT COMPLETED|Period 1: OL Treatment (Max: 315 Weeks)||0||
59946606|NCT02288247|76065480|FG000|STARTED|Period 2: DB Treatment (Max: 180 Weeks)|137 participants from period 1 were randomized to period 2.|137||
59946607|NCT02288247|76065481|FG001|STARTED|Period 2: DB Treatment (Max: 180 Weeks)|136 participants from period 1 were randomized to period 2.|136||
59946608|NCT02288247|76065480|FG000|Treated|Period 2: DB Treatment (Max: 180 Weeks)||136||
59946609|NCT02288247|76065481|FG001|Treated|Period 2: DB Treatment (Max: 180 Weeks)||135||
59946610|NCT02288247|76065480|FG000|COMPLETED|Period 2: DB Treatment (Max: 180 Weeks)||1|Completed participants are those who did not have a treatment discontinuation. Not completed participants discontinued treatment but are still ongoing the study.|
59946611|NCT02288247|76065481|FG001|COMPLETED|Period 2: DB Treatment (Max: 180 Weeks)||1|Completed participants are those who did not have a treatment discontinuation. Not completed participants discontinued treatment but are still ongoing the study.|
59946612|NCT02288247|76065480|FG000|NOT COMPLETED|Period 2: DB Treatment (Max: 180 Weeks)||136||
59946613|NCT02288247|76065481|FG001|NOT COMPLETED|Period 2: DB Treatment (Max: 180 Weeks)||135||
59946614|NCT02244463|76065495|FG000|STARTED|Period 1: PI DL1 Dose Escalation||3||
59946615|NCT02244463|76065496|FG001|STARTED|Period 1: PI DL1 Dose Escalation||0||
59946616|NCT02244463|76065497|FG002|STARTED|Period 1: PI DL1 Dose Escalation||0||
59946617|NCT02244463|76065498|FG003|STARTED|Period 1: PI DL1 Dose Escalation||0||
59946618|NCT02244463|76065499|FG004|STARTED|Period 1: PI DL1 Dose Escalation||0||
59946619|NCT02244463|76065500|FG005|STARTED|Period 1: PI DL1 Dose Escalation||0||
59946620|NCT02244463|76065495|FG000|COMPLETED|Period 1: PI DL1 Dose Escalation||0|Given treatment duration is not fixed, all participants are considered as 'Non Completed' and reason off-treatment provided.|
59946621|NCT02244463|76065496|FG001|COMPLETED|Period 1: PI DL1 Dose Escalation||0|Given treatment duration is not fixed, all participants are considered as 'Non Completed' and reason off-treatment provided.|
59946622|NCT02244463|76065497|FG002|COMPLETED|Period 1: PI DL1 Dose Escalation||0|Given treatment duration is not fixed, all participants are considered as 'Non Completed' and reason off-treatment provided.|
59946623|NCT02244463|76065498|FG003|COMPLETED|Period 1: PI DL1 Dose Escalation||0|Given treatment duration is not fixed, all participants are considered as 'Non Completed' and reason off-treatment provided.|
59946624|NCT02244463|76065499|FG004|COMPLETED|Period 1: PI DL1 Dose Escalation||0|Given treatment duration is not fixed, all participants are considered as 'Non Completed' and reason off-treatment provided.|
59946625|NCT02244463|76065500|FG005|COMPLETED|Period 1: PI DL1 Dose Escalation||0|Given treatment duration is not fixed, all participants are considered as 'Non Completed' and reason off-treatment provided.|
59946626|NCT02244463|76065495|FG000|NOT COMPLETED|Period 1: PI DL1 Dose Escalation||3||
59946627|NCT02244463|76065496|FG001|NOT COMPLETED|Period 1: PI DL1 Dose Escalation||0||
59946628|NCT02244463|76065497|FG002|NOT COMPLETED|Period 1: PI DL1 Dose Escalation||0||
59946629|NCT02244463|76065498|FG003|NOT COMPLETED|Period 1: PI DL1 Dose Escalation||0||
59946630|NCT02244463|76065499|FG004|NOT COMPLETED|Period 1: PI DL1 Dose Escalation||0||
59946631|NCT02244463|76065500|FG005|NOT COMPLETED|Period 1: PI DL1 Dose Escalation||0||
59946632|NCT02244463|76065495|FG000|STARTED|Period 2: PI DL2 Dose Escalation||0|The 'NOTE' here is an error: Each subsequent period in the PI study involves new participants.|
59518803|NCT01114555|75612663|FG000|COMPLETED|Overall Study||34||
59518804|NCT01114555|75612663|FG000|NOT COMPLETED|Overall Study||0||
59518805|NCT01114945|75612671|FG000|STARTED|Overall Study||30||
59518806|NCT01114945|75612672|FG001|STARTED|Overall Study||30||
59518807|NCT01114945|75612673|FG002|STARTED|Overall Study||30||
59518808|NCT01114945|75612674|FG003|STARTED|Overall Study||31||
59518809|NCT01114945|75612671|FG000|COMPLETED|Overall Study||30||
59518810|NCT01114945|75612672|FG001|COMPLETED|Overall Study||30||
59946633|NCT02244463|76065496|FG001|STARTED|Period 2: PI DL2 Dose Escalation||3|The 'NOTE' here is an error: Each subsequent period in the PI study involves new participants.|
59946634|NCT02244463|76065497|FG002|STARTED|Period 2: PI DL2 Dose Escalation||0|The 'NOTE' here is an error: Each subsequent period in the PI study involves new participants.|
59946635|NCT02244463|76065498|FG003|STARTED|Period 2: PI DL2 Dose Escalation||0|The 'NOTE' here is an error: Each subsequent period in the PI study involves new participants.|
59946636|NCT02244463|76065499|FG004|STARTED|Period 2: PI DL2 Dose Escalation||0|The 'NOTE' here is an error: Each subsequent period in the PI study involves new participants.|
59946637|NCT02244463|76065500|FG005|STARTED|Period 2: PI DL2 Dose Escalation||0|The 'NOTE' here is an error: Each subsequent period in the PI study involves new participants.|
59946638|NCT02244463|76065495|FG000|COMPLETED|Period 2: PI DL2 Dose Escalation||0|Given treatment duration is not fixed, all participants are considered as 'Non Completed' and reason off-treatment provided.|
59946639|NCT02244463|76065496|FG001|COMPLETED|Period 2: PI DL2 Dose Escalation||0|Given treatment duration is not fixed, all participants are considered as 'Non Completed' and reason off-treatment provided.|
59946640|NCT02244463|76065497|FG002|COMPLETED|Period 2: PI DL2 Dose Escalation||0|Given treatment duration is not fixed, all participants are considered as 'Non Completed' and reason off-treatment provided.|
59946641|NCT02244463|76065498|FG003|COMPLETED|Period 2: PI DL2 Dose Escalation||0|Given treatment duration is not fixed, all participants are considered as 'Non Completed' and reason off-treatment provided.|
59946642|NCT02244463|76065499|FG004|COMPLETED|Period 2: PI DL2 Dose Escalation||0|Given treatment duration is not fixed, all participants are considered as 'Non Completed' and reason off-treatment provided.|
59946643|NCT02244463|76065500|FG005|COMPLETED|Period 2: PI DL2 Dose Escalation||0|Given treatment duration is not fixed, all participants are considered as 'Non Completed' and reason off-treatment provided.|
59946644|NCT02244463|76065495|FG000|NOT COMPLETED|Period 2: PI DL2 Dose Escalation||0||
59946645|NCT02244463|76065496|FG001|NOT COMPLETED|Period 2: PI DL2 Dose Escalation||3||
59946646|NCT02244463|76065497|FG002|NOT COMPLETED|Period 2: PI DL2 Dose Escalation||0||
59946647|NCT02244463|76065498|FG003|NOT COMPLETED|Period 2: PI DL2 Dose Escalation||0||
59946648|NCT02244463|76065499|FG004|NOT COMPLETED|Period 2: PI DL2 Dose Escalation||0||
59946649|NCT02244463|76065500|FG005|NOT COMPLETED|Period 2: PI DL2 Dose Escalation||0||
59946650|NCT02244463|76065495|FG000|STARTED|Period 3: PI DL3 Dose Escalation||0|The 'NOTE' here is an error: Each subsequent period in the PI study involves new participants.|
59946651|NCT02244463|76065496|FG001|STARTED|Period 3: PI DL3 Dose Escalation||0|The 'NOTE' here is an error: Each subsequent period in the PI study involves new participants.|
59946652|NCT02244463|76065497|FG002|STARTED|Period 3: PI DL3 Dose Escalation||3|The 'NOTE' here is an error: Each subsequent period in the PI study involves new participants.|
59946653|NCT02244463|76065498|FG003|STARTED|Period 3: PI DL3 Dose Escalation||0|The 'NOTE' here is an error: Each subsequent period in the PI study involves new participants.|
59946654|NCT02244463|76065499|FG004|STARTED|Period 3: PI DL3 Dose Escalation||0|The 'NOTE' here is an error: Each subsequent period in the PI study involves new participants.|
59946655|NCT02244463|76065500|FG005|STARTED|Period 3: PI DL3 Dose Escalation||0|The 'NOTE' here is an error: Each subsequent period in the PI study involves new participants.|
59946656|NCT02244463|76065495|FG000|COMPLETED|Period 3: PI DL3 Dose Escalation||0|Given treatment duration is not fixed, all participants are considered as 'Non Completed' and reason off-treatment provided.|
59946657|NCT02244463|76065496|FG001|COMPLETED|Period 3: PI DL3 Dose Escalation||0|Given treatment duration is not fixed, all participants are considered as 'Non Completed' and reason off-treatment provided.|
59946658|NCT02244463|76065497|FG002|COMPLETED|Period 3: PI DL3 Dose Escalation||0|Given treatment duration is not fixed, all participants are considered as 'Non Completed' and reason off-treatment provided.|
59946659|NCT02244463|76065498|FG003|COMPLETED|Period 3: PI DL3 Dose Escalation||0|Given treatment duration is not fixed, all participants are considered as 'Non Completed' and reason off-treatment provided.|
59946660|NCT02244463|76065499|FG004|COMPLETED|Period 3: PI DL3 Dose Escalation||0|Given treatment duration is not fixed, all participants are considered as 'Non Completed' and reason off-treatment provided.|
59946661|NCT02244463|76065500|FG005|COMPLETED|Period 3: PI DL3 Dose Escalation||0|Given treatment duration is not fixed, all participants are considered as 'Non Completed' and reason off-treatment provided.|
59946662|NCT02244463|76065495|FG000|NOT COMPLETED|Period 3: PI DL3 Dose Escalation||0||
59946663|NCT02244463|76065496|FG001|NOT COMPLETED|Period 3: PI DL3 Dose Escalation||0||
59946664|NCT02244463|76065497|FG002|NOT COMPLETED|Period 3: PI DL3 Dose Escalation||3||
59946665|NCT02244463|76065498|FG003|NOT COMPLETED|Period 3: PI DL3 Dose Escalation||0||
59946666|NCT02244463|76065499|FG004|NOT COMPLETED|Period 3: PI DL3 Dose Escalation||0||
59946667|NCT02244463|76065500|FG005|NOT COMPLETED|Period 3: PI DL3 Dose Escalation||0||
59946668|NCT02244463|76065495|FG000|STARTED|Period 4: PI DL3 Dose Expansion||0|The 'NOTE' here is an error: Each subsequent period in the PI study involves new participants.|
59946669|NCT02244463|76065496|FG001|STARTED|Period 4: PI DL3 Dose Expansion||0|The 'NOTE' here is an error: Each subsequent period in the PI study involves new participants.|
59946670|NCT02244463|76065497|FG002|STARTED|Period 4: PI DL3 Dose Expansion||0|The 'NOTE' here is an error: Each subsequent period in the PI study involves new participants.|
59946671|NCT02244463|76065498|FG003|STARTED|Period 4: PI DL3 Dose Expansion||10|The 'NOTE' here is an error: Each subsequent period in the PI study involves new participants.|
59951241|NCT03743415|76070182|FG007|STARTED|Overall Study||97||
60067598|NCT01606761|76182768|FG003|STARTED|Week 24 to Week 52|Participants re-randomized at Week 18 (46) and Week 24 (80) were included.|126||
60067599|NCT01606761|76182769|FG004|STARTED|Week 24 to Week 52|Participants re-randomized at Week 18 (48) and Week 24 (78) were included.|126||
60067600|NCT01606761|76182765|FG000|Treated|Week 24 to Week 52||0||
60067601|NCT01606761|76182766|FG001|Treated|Week 24 to Week 52||237||
60067602|NCT01606761|76182767|FG002|Treated|Week 24 to Week 52||245||
59946672|NCT02244463|76065499|FG004|STARTED|Period 4: PI DL3 Dose Expansion||0|The 'NOTE' here is an error: Each subsequent period in the PI study involves new participants.|
59946673|NCT02244463|76065500|FG005|STARTED|Period 4: PI DL3 Dose Expansion||0|The 'NOTE' here is an error: Each subsequent period in the PI study involves new participants.|
59946674|NCT02244463|76065495|FG000|COMPLETED|Period 4: PI DL3 Dose Expansion||0|Given treatment duration is not fixed, all participants are considered as 'Non Completed' and reason off-treatment provided.|
59946675|NCT02244463|76065496|FG001|COMPLETED|Period 4: PI DL3 Dose Expansion||0|Given treatment duration is not fixed, all participants are considered as 'Non Completed' and reason off-treatment provided.|
59946676|NCT02244463|76065497|FG002|COMPLETED|Period 4: PI DL3 Dose Expansion||0|Given treatment duration is not fixed, all participants are considered as 'Non Completed' and reason off-treatment provided.|
59946677|NCT02244463|76065498|FG003|COMPLETED|Period 4: PI DL3 Dose Expansion||0|Given treatment duration is not fixed, all participants are considered as 'Non Completed' and reason off-treatment provided.|
59946678|NCT02244463|76065499|FG004|COMPLETED|Period 4: PI DL3 Dose Expansion||0|Given treatment duration is not fixed, all participants are considered as 'Non Completed' and reason off-treatment provided.|
59946679|NCT02244463|76065500|FG005|COMPLETED|Period 4: PI DL3 Dose Expansion||0|Given treatment duration is not fixed, all participants are considered as 'Non Completed' and reason off-treatment provided.|
59946680|NCT02244463|76065495|FG000|NOT COMPLETED|Period 4: PI DL3 Dose Expansion||0||
59946681|NCT02244463|76065496|FG001|NOT COMPLETED|Period 4: PI DL3 Dose Expansion||0||
59946682|NCT02244463|76065497|FG002|NOT COMPLETED|Period 4: PI DL3 Dose Expansion||0||
59946683|NCT02244463|76065498|FG003|NOT COMPLETED|Period 4: PI DL3 Dose Expansion||10||
59946684|NCT02244463|76065499|FG004|NOT COMPLETED|Period 4: PI DL3 Dose Expansion||0||
59946685|NCT02244463|76065500|FG005|NOT COMPLETED|Period 4: PI DL3 Dose Expansion||0||
59946686|NCT02244463|76065495|FG000|STARTED|Period 5: Phase II||0|The 'NOTE' here is an error: the PII study total sample size is unrelated to the previous PI study. Per design, all participants treated at the maximum tolerated dose would be enrolled in the PII study. In the ATC and DTC PII cohorts, there were n=6 and n=7 participants, respectively, who received the RP2D in the PI study (DL3 escalation and expansion). There were n=12 (ATC) and n=15 (DTC) participants who subsequently enrolled in the PII study.|
59946687|NCT02244463|76065496|FG001|STARTED|Period 5: Phase II||0|The 'NOTE' here is an error: the PII study total sample size is unrelated to the previous PI study. Per design, all participants treated at the maximum tolerated dose would be enrolled in the PII study. In the ATC and DTC PII cohorts, there were n=6 and n=7 participants, respectively, who received the RP2D in the PI study (DL3 escalation and expansion). There were n=12 (ATC) and n=15 (DTC) participants who subsequently enrolled in the PII study.|
59946688|NCT02244463|76065497|FG002|STARTED|Period 5: Phase II||0|The 'NOTE' here is an error: the PII study total sample size is unrelated to the previous PI study. Per design, all participants treated at the maximum tolerated dose would be enrolled in the PII study. In the ATC and DTC PII cohorts, there were n=6 and n=7 participants, respectively, who received the RP2D in the PI study (DL3 escalation and expansion). There were n=12 (ATC) and n=15 (DTC) participants who subsequently enrolled in the PII study.|
59946689|NCT02244463|76065498|FG003|STARTED|Period 5: Phase II||0|The 'NOTE' here is an error: the PII study total sample size is unrelated to the previous PI study. Per design, all participants treated at the maximum tolerated dose would be enrolled in the PII study. In the ATC and DTC PII cohorts, there were n=6 and n=7 participants, respectively, who received the RP2D in the PI study (DL3 escalation and expansion). There were n=12 (ATC) and n=15 (DTC) participants who subsequently enrolled in the PII study.|
59946690|NCT02244463|76065499|FG004|STARTED|Period 5: Phase II||18|The 'NOTE' here is an error: the PII study total sample size is unrelated to the previous PI study. Per design, all participants treated at the maximum tolerated dose would be enrolled in the PII study. In the ATC and DTC PII cohorts, there were n=6 and n=7 participants, respectively, who received the RP2D in the PI study (DL3 escalation and expansion). There were n=12 (ATC) and n=15 (DTC) participants who subsequently enrolled in the PII study.|
59946691|NCT02244463|76065500|FG005|STARTED|Period 5: Phase II||22|The 'NOTE' here is an error: the PII study total sample size is unrelated to the previous PI study. Per design, all participants treated at the maximum tolerated dose would be enrolled in the PII study. In the ATC and DTC PII cohorts, there were n=6 and n=7 participants, respectively, who received the RP2D in the PI study (DL3 escalation and expansion). There were n=12 (ATC) and n=15 (DTC) participants who subsequently enrolled in the PII study.|
59946692|NCT02244463|76065495|FG000|COMPLETED|Period 5: Phase II||0|Given treatment duration is not fixed, all participants are considered as 'Non Completed' and reason off-treatment provided.|
59946693|NCT02244463|76065496|FG001|COMPLETED|Period 5: Phase II||0|Given treatment duration is not fixed, all participants are considered as 'Non Completed' and reason off-treatment provided.|
59946694|NCT02244463|76065497|FG002|COMPLETED|Period 5: Phase II||0|Given treatment duration is not fixed, all participants are considered as 'Non Completed' and reason off-treatment provided.|
59946695|NCT02244463|76065498|FG003|COMPLETED|Period 5: Phase II||0|Given treatment duration is not fixed, all participants are considered as 'Non Completed' and reason off-treatment provided.|
59946696|NCT02244463|76065499|FG004|COMPLETED|Period 5: Phase II||0|Given treatment duration is not fixed, all participants are considered as 'Non Completed' and reason off-treatment provided.|
59946697|NCT02244463|76065500|FG005|COMPLETED|Period 5: Phase II||0|Given treatment duration is not fixed, all participants are considered as 'Non Completed' and reason off-treatment provided.|
59946698|NCT02244463|76065495|FG000|NOT COMPLETED|Period 5: Phase II||0||
59946699|NCT02244463|76065496|FG001|NOT COMPLETED|Period 5: Phase II||0||
59946700|NCT02244463|76065497|FG002|NOT COMPLETED|Period 5: Phase II||0||
59946701|NCT02244463|76065498|FG003|NOT COMPLETED|Period 5: Phase II||0||
59946702|NCT02244463|76065499|FG004|NOT COMPLETED|Period 5: Phase II||18||
59946703|NCT02244463|76065500|FG005|NOT COMPLETED|Period 5: Phase II||22||
59946704|NCT02038777|76065537|FG000|STARTED|Overall Study||3||
59946705|NCT02038777|76065538|FG001|STARTED|Overall Study||5||
59946706|NCT02038777|76065539|FG002|STARTED|Overall Study||6||
59946707|NCT02038777|76065540|FG003|STARTED|Overall Study||6||
59946708|NCT02038777|76065541|FG004|STARTED|Overall Study||6||
59946709|NCT02038777|76065542|FG005|STARTED|Overall Study||6||
59946710|NCT02038777|76065543|FG006|STARTED|Overall Study||1||
59946711|NCT02038777|76065544|FG007|STARTED|Overall Study||15||
59946712|NCT02038777|76065537|FG000|Treated (Safety Set)|Overall Study||3||
59946713|NCT02038777|76065538|FG001|Treated (Safety Set)|Overall Study||4||
59946714|NCT02038777|76065539|FG002|Treated (Safety Set)|Overall Study||6||
59946715|NCT02038777|76065540|FG003|Treated (Safety Set)|Overall Study||6||
59946716|NCT02038777|76065541|FG004|Treated (Safety Set)|Overall Study||6||
59946717|NCT02038777|76065542|FG005|Treated (Safety Set)|Overall Study||6||
59946718|NCT02038777|76065543|FG006|Treated (Safety Set)|Overall Study||1||
59946719|NCT02038777|76065544|FG007|Treated (Safety Set)|Overall Study||15||
59946720|NCT02038777|76065537|FG000|COMPLETED|Overall Study||2||
59946721|NCT02038777|76065538|FG001|COMPLETED|Overall Study||1||
59946722|NCT02038777|76065539|FG002|COMPLETED|Overall Study||3||
59946723|NCT02038777|76065540|FG003|COMPLETED|Overall Study||2||
59946724|NCT02038777|76065541|FG004|COMPLETED|Overall Study||3||
59946725|NCT02038777|76065542|FG005|COMPLETED|Overall Study||2||
59946726|NCT02038777|76065543|FG006|COMPLETED|Overall Study||1||
59946727|NCT02038777|76065544|FG007|COMPLETED|Overall Study||5||
59946728|NCT02038777|76065537|FG000|NOT COMPLETED|Overall Study||1||
59946729|NCT02038777|76065538|FG001|NOT COMPLETED|Overall Study||4||
59946730|NCT02038777|76065539|FG002|NOT COMPLETED|Overall Study||3||
59946731|NCT02038777|76065540|FG003|NOT COMPLETED|Overall Study||4||
59946732|NCT02038777|76065541|FG004|NOT COMPLETED|Overall Study||3||
59946733|NCT02038777|76065542|FG005|NOT COMPLETED|Overall Study||4||
59946734|NCT02038777|76065543|FG006|NOT COMPLETED|Overall Study||0||
59946735|NCT02038777|76065544|FG007|NOT COMPLETED|Overall Study||10||
59946736|NCT01991457|76065561|FG000|STARTED|Overall Study||19||
59946737|NCT01991457|76065561|FG000|COMPLETED|Overall Study||19||
59946738|NCT01991457|76065561|FG000|NOT COMPLETED|Overall Study||0||
59946739|NCT04992442|76065566|FG000|STARTED|Treatment Period 1||6||
59946740|NCT04992442|76065566|FG000|COMPLETED|Treatment Period 1||6||
59946741|NCT04992442|76065566|FG000|NOT COMPLETED|Treatment Period 1||0||
59946742|NCT04992442|76065566|FG000|STARTED|Washout Period||6||
59946743|NCT04992442|76065566|FG000|COMPLETED|Washout Period||6||
59946744|NCT04992442|76065566|FG000|NOT COMPLETED|Washout Period||0||
59946745|NCT04992442|76065566|FG000|STARTED|Treatment Period 2||6||
59946746|NCT04992442|76065566|FG000|COMPLETED|Treatment Period 2||6||
59946747|NCT04992442|76065566|FG000|NOT COMPLETED|Treatment Period 2||0||
59946748|NCT02853435|76065581|FG000|STARTED|Part 1a, Period 1 (3 Days)||9||
59946749|NCT02853435|76065582|FG001|STARTED|Part 1a, Period 1 (3 Days)||9||
59946750|NCT02853435|76065583|FG002|STARTED|Part 1a, Period 1 (3 Days)||8||
59946751|NCT02853435|76065584|FG003|STARTED|Part 1a, Period 1 (3 Days)||0||
59946752|NCT02853435|76065585|FG004|STARTED|Part 1a, Period 1 (3 Days)||0||
59946753|NCT02853435|76065586|FG005|STARTED|Part 1a, Period 1 (3 Days)||0||
59946754|NCT02853435|76065581|FG000|COMPLETED|Part 1a, Period 1 (3 Days)||9||
59946755|NCT02853435|76065582|FG001|COMPLETED|Part 1a, Period 1 (3 Days)||9||
59946756|NCT02853435|76065583|FG002|COMPLETED|Part 1a, Period 1 (3 Days)||8||
59946757|NCT02853435|76065584|FG003|COMPLETED|Part 1a, Period 1 (3 Days)||0||
59946758|NCT02853435|76065585|FG004|COMPLETED|Part 1a, Period 1 (3 Days)||0||
59946759|NCT02853435|76065586|FG005|COMPLETED|Part 1a, Period 1 (3 Days)||0||
59946760|NCT02853435|76065581|FG000|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0||
59946761|NCT02853435|76065582|FG001|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0||
59946762|NCT02853435|76065583|FG002|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0||
59946763|NCT02853435|76065584|FG003|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0||
59946764|NCT02853435|76065585|FG004|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0||
59946765|NCT02853435|76065586|FG005|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0||
59946766|NCT02853435|76065581|FG000|STARTED|Part 1a, Washout Period 1 (3 Days)||9||
59946767|NCT02853435|76065582|FG001|STARTED|Part 1a, Washout Period 1 (3 Days)||9||
59946768|NCT02853435|76065583|FG002|STARTED|Part 1a, Washout Period 1 (3 Days)||8||
59946769|NCT02853435|76065584|FG003|STARTED|Part 1a, Washout Period 1 (3 Days)||0||
59762321|NCT03823300|75882009|FG000|STARTED|Overall Study||331|Intent-to-Treat (ITT) Population|
59762322|NCT03823300|75882010|FG001|STARTED|Overall Study||327|Intent-to-Treat (ITT) Population|
59762323|NCT03823300|75882009|FG000|Received at Least One Dose of Study Drug|Overall Study||331|Safety Population|
59946770|NCT02853435|76065585|FG004|STARTED|Part 1a, Washout Period 1 (3 Days)||0||
59946771|NCT02853435|76065586|FG005|STARTED|Part 1a, Washout Period 1 (3 Days)||0||
59946772|NCT02853435|76065581|FG000|COMPLETED|Part 1a, Washout Period 1 (3 Days)||9||
59946773|NCT02853435|76065582|FG001|COMPLETED|Part 1a, Washout Period 1 (3 Days)||9||
59946774|NCT02853435|76065583|FG002|COMPLETED|Part 1a, Washout Period 1 (3 Days)||8||
59946775|NCT02853435|76065584|FG003|COMPLETED|Part 1a, Washout Period 1 (3 Days)||0||
59946776|NCT02853435|76065585|FG004|COMPLETED|Part 1a, Washout Period 1 (3 Days)||0||
59946777|NCT02853435|76065586|FG005|COMPLETED|Part 1a, Washout Period 1 (3 Days)||0||
59946778|NCT02853435|76065581|FG000|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0||
59762324|NCT03823300|75882010|FG001|Received at Least One Dose of Study Drug|Overall Study||326|Safety Population|
59762626|NCT00871728|75882461|FG000|STARTED|Overall Study||132||
59946779|NCT02853435|76065582|FG001|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0||
59946780|NCT02853435|76065583|FG002|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0||
59946781|NCT02853435|76065584|FG003|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0||
59946782|NCT02853435|76065585|FG004|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0||
59946783|NCT02853435|76065586|FG005|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0||
59946784|NCT02853435|76065581|FG000|STARTED|Part 1a, Period 2 (3 Days)||9||
59946785|NCT02853435|76065582|FG001|STARTED|Part 1a, Period 2 (3 Days)||9||
59946786|NCT02853435|76065583|FG002|STARTED|Part 1a, Period 2 (3 Days)||8||
59946787|NCT02853435|76065584|FG003|STARTED|Part 1a, Period 2 (3 Days)||0||
59946788|NCT02853435|76065585|FG004|STARTED|Part 1a, Period 2 (3 Days)||0||
59946789|NCT02853435|76065586|FG005|STARTED|Part 1a, Period 2 (3 Days)||0||
59946790|NCT02853435|76065581|FG000|COMPLETED|Part 1a, Period 2 (3 Days)||9||
59946791|NCT02853435|76065582|FG001|COMPLETED|Part 1a, Period 2 (3 Days)||9||
59946792|NCT02853435|76065583|FG002|COMPLETED|Part 1a, Period 2 (3 Days)||8||
59946793|NCT02853435|76065584|FG003|COMPLETED|Part 1a, Period 2 (3 Days)||0||
59946794|NCT02853435|76065585|FG004|COMPLETED|Part 1a, Period 2 (3 Days)||0||
59946795|NCT02853435|76065586|FG005|COMPLETED|Part 1a, Period 2 (3 Days)||0||
59946796|NCT02853435|76065581|FG000|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0||
59946797|NCT02853435|76065582|FG001|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0||
59946798|NCT02853435|76065583|FG002|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0||
59946799|NCT02853435|76065584|FG003|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0||
59946800|NCT02853435|76065585|FG004|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0||
59946801|NCT02853435|76065586|FG005|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0||
59946802|NCT02853435|76065581|FG000|STARTED|Part 1a, Washout Period 2 (3 Days)||9||
59946803|NCT02853435|76065582|FG001|STARTED|Part 1a, Washout Period 2 (3 Days)||9||
59946804|NCT02853435|76065583|FG002|STARTED|Part 1a, Washout Period 2 (3 Days)||8||
59946805|NCT02853435|76065584|FG003|STARTED|Part 1a, Washout Period 2 (3 Days)||0||
59946806|NCT02853435|76065585|FG004|STARTED|Part 1a, Washout Period 2 (3 Days)||0||
59946807|NCT02853435|76065586|FG005|STARTED|Part 1a, Washout Period 2 (3 Days)||0||
59946808|NCT02853435|76065581|FG000|COMPLETED|Part 1a, Washout Period 2 (3 Days)||9||
59946809|NCT02853435|76065582|FG001|COMPLETED|Part 1a, Washout Period 2 (3 Days)||9||
59946810|NCT02853435|76065583|FG002|COMPLETED|Part 1a, Washout Period 2 (3 Days)||8||
59946811|NCT02853435|76065584|FG003|COMPLETED|Part 1a, Washout Period 2 (3 Days)||0||
59946812|NCT02853435|76065585|FG004|COMPLETED|Part 1a, Washout Period 2 (3 Days)||0||
59946813|NCT02853435|76065586|FG005|COMPLETED|Part 1a, Washout Period 2 (3 Days)||0||
59946814|NCT02853435|76065581|FG000|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0||
59946815|NCT02853435|76065582|FG001|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0||
59946816|NCT02853435|76065583|FG002|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0||
59946817|NCT02853435|76065584|FG003|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0||
59946818|NCT02853435|76065585|FG004|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0||
59946819|NCT02853435|76065586|FG005|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0||
59946820|NCT02853435|76065581|FG000|STARTED|Part 1a, Period 3 (3 Days)||9||
59946821|NCT02853435|76065582|FG001|STARTED|Part 1a, Period 3 (3 Days)||9||
59946822|NCT02853435|76065583|FG002|STARTED|Part 1a, Period 3 (3 Days)||8||
59946823|NCT02853435|76065584|FG003|STARTED|Part 1a, Period 3 (3 Days)||0||
59946824|NCT02853435|76065585|FG004|STARTED|Part 1a, Period 3 (3 Days)||0||
59946825|NCT02853435|76065586|FG005|STARTED|Part 1a, Period 3 (3 Days)||0||
59946826|NCT02853435|76065581|FG000|COMPLETED|Part 1a, Period 3 (3 Days)||9||
59946827|NCT02853435|76065582|FG001|COMPLETED|Part 1a, Period 3 (3 Days)||9||
59946828|NCT02853435|76065583|FG002|COMPLETED|Part 1a, Period 3 (3 Days)||8||
59946829|NCT02853435|76065584|FG003|COMPLETED|Part 1a, Period 3 (3 Days)||0||
59946830|NCT02853435|76065585|FG004|COMPLETED|Part 1a, Period 3 (3 Days)||0||
59946831|NCT02853435|76065586|FG005|COMPLETED|Part 1a, Period 3 (3 Days)||0||
59946832|NCT02853435|76065581|FG000|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0||
59946833|NCT02853435|76065582|FG001|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0||
59946834|NCT02853435|76065583|FG002|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0||
59946835|NCT02853435|76065584|FG003|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0||
59946836|NCT02853435|76065585|FG004|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0||
59946837|NCT02853435|76065586|FG005|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0||
60067603|NCT01606761|76182768|FG003|Treated|Week 24 to Week 52||124||
59946838|NCT02853435|76065581|FG000|STARTED|Part 2, Period 1 (3 Days)||0||
59946839|NCT02853435|76065582|FG001|STARTED|Part 2, Period 1 (3 Days)||0||
59946840|NCT02853435|76065583|FG002|STARTED|Part 2, Period 1 (3 Days)||0||
59946841|NCT02853435|76065584|FG003|STARTED|Part 2, Period 1 (3 Days)||10||
59946842|NCT02853435|76065585|FG004|STARTED|Part 2, Period 1 (3 Days)||0||
59946843|NCT02853435|76065586|FG005|STARTED|Part 2, Period 1 (3 Days)||0||
59946844|NCT02853435|76065581|FG000|COMPLETED|Part 2, Period 1 (3 Days)||0||
59946845|NCT02853435|76065582|FG001|COMPLETED|Part 2, Period 1 (3 Days)||0||
59946846|NCT02853435|76065583|FG002|COMPLETED|Part 2, Period 1 (3 Days)||0||
59946847|NCT02853435|76065584|FG003|COMPLETED|Part 2, Period 1 (3 Days)||10||
59946848|NCT02853435|76065585|FG004|COMPLETED|Part 2, Period 1 (3 Days)||0||
59946849|NCT02853435|76065586|FG005|COMPLETED|Part 2, Period 1 (3 Days)||0||
59946850|NCT02853435|76065581|FG000|NOT COMPLETED|Part 2, Period 1 (3 Days)||0||
59946851|NCT02853435|76065582|FG001|NOT COMPLETED|Part 2, Period 1 (3 Days)||0||
59946852|NCT02853435|76065583|FG002|NOT COMPLETED|Part 2, Period 1 (3 Days)||0||
59946853|NCT02853435|76065584|FG003|NOT COMPLETED|Part 2, Period 1 (3 Days)||0||
59946854|NCT02853435|76065585|FG004|NOT COMPLETED|Part 2, Period 1 (3 Days)||0||
59946855|NCT02853435|76065586|FG005|NOT COMPLETED|Part 2, Period 1 (3 Days)||0||
59946856|NCT02853435|76065581|FG000|STARTED|Part 2, Washout Period 1 (3 Days)||0||
59946857|NCT02853435|76065582|FG001|STARTED|Part 2, Washout Period 1 (3 Days)||0||
59946858|NCT02853435|76065583|FG002|STARTED|Part 2, Washout Period 1 (3 Days)||0||
59946859|NCT02853435|76065584|FG003|STARTED|Part 2, Washout Period 1 (3 Days)||10||
59946860|NCT02853435|76065585|FG004|STARTED|Part 2, Washout Period 1 (3 Days)||0||
59946861|NCT02853435|76065586|FG005|STARTED|Part 2, Washout Period 1 (3 Days)||0||
59946862|NCT02853435|76065581|FG000|COMPLETED|Part 2, Washout Period 1 (3 Days)||0||
59946863|NCT02853435|76065582|FG001|COMPLETED|Part 2, Washout Period 1 (3 Days)||0||
59946864|NCT02853435|76065583|FG002|COMPLETED|Part 2, Washout Period 1 (3 Days)||0||
59946865|NCT02853435|76065584|FG003|COMPLETED|Part 2, Washout Period 1 (3 Days)||10||
59946866|NCT02853435|76065585|FG004|COMPLETED|Part 2, Washout Period 1 (3 Days)||0||
59946867|NCT02853435|76065586|FG005|COMPLETED|Part 2, Washout Period 1 (3 Days)||0||
59946868|NCT02853435|76065581|FG000|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0||
59946869|NCT02853435|76065582|FG001|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0||
59946870|NCT02853435|76065583|FG002|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0||
59946871|NCT02853435|76065584|FG003|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0||
59946872|NCT02853435|76065585|FG004|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0||
59946873|NCT02853435|76065586|FG005|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0||
59946874|NCT02853435|76065581|FG000|STARTED|Part 2, Period 2 (3 Days)||0||
59946875|NCT02853435|76065582|FG001|STARTED|Part 2, Period 2 (3 Days)||0||
59946876|NCT02853435|76065583|FG002|STARTED|Part 2, Period 2 (3 Days)||0||
59946877|NCT02853435|76065584|FG003|STARTED|Part 2, Period 2 (3 Days)||10||
59946878|NCT02853435|76065585|FG004|STARTED|Part 2, Period 2 (3 Days)||0||
59946879|NCT02853435|76065586|FG005|STARTED|Part 2, Period 2 (3 Days)||0||
59946880|NCT02853435|76065581|FG000|COMPLETED|Part 2, Period 2 (3 Days)||0||
59946881|NCT02853435|76065582|FG001|COMPLETED|Part 2, Period 2 (3 Days)||0||
59946882|NCT02853435|76065583|FG002|COMPLETED|Part 2, Period 2 (3 Days)||0||
59946883|NCT02853435|76065584|FG003|COMPLETED|Part 2, Period 2 (3 Days)||10||
59946884|NCT02853435|76065585|FG004|COMPLETED|Part 2, Period 2 (3 Days)||0||
59946885|NCT02853435|76065586|FG005|COMPLETED|Part 2, Period 2 (3 Days)||0||
59946886|NCT02853435|76065581|FG000|NOT COMPLETED|Part 2, Period 2 (3 Days)||0||
59946887|NCT02853435|76065582|FG001|NOT COMPLETED|Part 2, Period 2 (3 Days)||0||
59946888|NCT02853435|76065583|FG002|NOT COMPLETED|Part 2, Period 2 (3 Days)||0||
59946889|NCT02853435|76065584|FG003|NOT COMPLETED|Part 2, Period 2 (3 Days)||0||
59946890|NCT02853435|76065585|FG004|NOT COMPLETED|Part 2, Period 2 (3 Days)||0||
59946891|NCT02853435|76065586|FG005|NOT COMPLETED|Part 2, Period 2 (3 Days)||0||
59946892|NCT02853435|76065581|FG000|STARTED|Part 3, Period 1 (3 Days)||0||
59946893|NCT02853435|76065582|FG001|STARTED|Part 3, Period 1 (3 Days)||0||
59946894|NCT02853435|76065583|FG002|STARTED|Part 3, Period 1 (3 Days)||0||
60067604|NCT01606761|76182769|FG004|Treated|Week 24 to Week 52||126||
60067605|NCT01606761|76182765|FG000|COMPLETED|Week 24 to Week 52||0||
60067606|NCT01606761|76182766|FG001|COMPLETED|Week 24 to Week 52||204||
59946895|NCT02853435|76065584|FG003|STARTED|Part 3, Period 1 (3 Days)||0||
59946896|NCT02853435|76065585|FG004|STARTED|Part 3, Period 1 (3 Days)||10||
59946897|NCT02853435|76065586|FG005|STARTED|Part 3, Period 1 (3 Days)||2||
59946898|NCT02853435|76065581|FG000|COMPLETED|Part 3, Period 1 (3 Days)||0||
59946899|NCT02853435|76065582|FG001|COMPLETED|Part 3, Period 1 (3 Days)||0||
59946900|NCT02853435|76065583|FG002|COMPLETED|Part 3, Period 1 (3 Days)||0||
59946901|NCT02853435|76065584|FG003|COMPLETED|Part 3, Period 1 (3 Days)||0||
59946902|NCT02853435|76065585|FG004|COMPLETED|Part 3, Period 1 (3 Days)||10||
59946903|NCT02853435|76065586|FG005|COMPLETED|Part 3, Period 1 (3 Days)||2||
59946904|NCT02853435|76065581|FG000|NOT COMPLETED|Part 3, Period 1 (3 Days)||0||
59946905|NCT02853435|76065582|FG001|NOT COMPLETED|Part 3, Period 1 (3 Days)||0||
59946906|NCT02853435|76065583|FG002|NOT COMPLETED|Part 3, Period 1 (3 Days)||0||
59946907|NCT02853435|76065584|FG003|NOT COMPLETED|Part 3, Period 1 (3 Days)||0||
59946908|NCT02853435|76065585|FG004|NOT COMPLETED|Part 3, Period 1 (3 Days)||0||
59946909|NCT02853435|76065586|FG005|NOT COMPLETED|Part 3, Period 1 (3 Days)||0||
59946910|NCT02853435|76065581|FG000|STARTED|Part 3, Washout Period 1 (3 Days)||0||
59946911|NCT02853435|76065582|FG001|STARTED|Part 3, Washout Period 1 (3 Days)||0||
59946912|NCT02853435|76065583|FG002|STARTED|Part 3, Washout Period 1 (3 Days)||0||
59946913|NCT02853435|76065584|FG003|STARTED|Part 3, Washout Period 1 (3 Days)||0||
59946914|NCT02853435|76065585|FG004|STARTED|Part 3, Washout Period 1 (3 Days)||10||
59946915|NCT02853435|76065586|FG005|STARTED|Part 3, Washout Period 1 (3 Days)||2||
59946916|NCT02853435|76065581|FG000|COMPLETED|Part 3, Washout Period 1 (3 Days)||0||
59946917|NCT02853435|76065582|FG001|COMPLETED|Part 3, Washout Period 1 (3 Days)||0||
59946918|NCT02853435|76065583|FG002|COMPLETED|Part 3, Washout Period 1 (3 Days)||0||
59946919|NCT02853435|76065584|FG003|COMPLETED|Part 3, Washout Period 1 (3 Days)||0||
59946920|NCT02853435|76065585|FG004|COMPLETED|Part 3, Washout Period 1 (3 Days)||10||
59946921|NCT02853435|76065586|FG005|COMPLETED|Part 3, Washout Period 1 (3 Days)||2||
59946922|NCT02853435|76065581|FG000|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0||
59946923|NCT02853435|76065582|FG001|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0||
59946924|NCT02853435|76065583|FG002|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0||
59946925|NCT02853435|76065584|FG003|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0||
59946926|NCT02853435|76065585|FG004|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0||
59946927|NCT02853435|76065586|FG005|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0||
59946928|NCT02853435|76065581|FG000|STARTED|Part 3, Period 2 (3 Days)||0||
59946929|NCT02853435|76065582|FG001|STARTED|Part 3, Period 2 (3 Days)||0||
59946930|NCT02853435|76065583|FG002|STARTED|Part 3, Period 2 (3 Days)||0||
59946931|NCT02853435|76065584|FG003|STARTED|Part 3, Period 2 (3 Days)||0||
59946932|NCT02853435|76065585|FG004|STARTED|Part 3, Period 2 (3 Days)||10||
59946933|NCT02853435|76065586|FG005|STARTED|Part 3, Period 2 (3 Days)||2||
59946934|NCT02853435|76065581|FG000|COMPLETED|Part 3, Period 2 (3 Days)||0||
59946935|NCT02853435|76065582|FG001|COMPLETED|Part 3, Period 2 (3 Days)||0||
59946936|NCT02853435|76065583|FG002|COMPLETED|Part 3, Period 2 (3 Days)||0||
59946937|NCT02853435|76065584|FG003|COMPLETED|Part 3, Period 2 (3 Days)||0||
59946938|NCT02853435|76065585|FG004|COMPLETED|Part 3, Period 2 (3 Days)||10||
59946939|NCT02853435|76065586|FG005|COMPLETED|Part 3, Period 2 (3 Days)||2||
59946940|NCT02853435|76065581|FG000|NOT COMPLETED|Part 3, Period 2 (3 Days)||0||
59946941|NCT02853435|76065582|FG001|NOT COMPLETED|Part 3, Period 2 (3 Days)||0||
59946942|NCT02853435|76065583|FG002|NOT COMPLETED|Part 3, Period 2 (3 Days)||0||
59946943|NCT02853435|76065584|FG003|NOT COMPLETED|Part 3, Period 2 (3 Days)||0||
59946944|NCT02853435|76065585|FG004|NOT COMPLETED|Part 3, Period 2 (3 Days)||0||
59946945|NCT02853435|76065586|FG005|NOT COMPLETED|Part 3, Period 2 (3 Days)||0||
59946946|NCT02853435|76065581|FG000|STARTED|Part 3, Washout Period 2 (3 Days)||0||
59946947|NCT02853435|76065582|FG001|STARTED|Part 3, Washout Period 2 (3 Days)||0||
59946948|NCT02853435|76065583|FG002|STARTED|Part 3, Washout Period 2 (3 Days)||0||
59946949|NCT02853435|76065584|FG003|STARTED|Part 3, Washout Period 2 (3 Days)||0||
59946950|NCT02853435|76065585|FG004|STARTED|Part 3, Washout Period 2 (3 Days)||10||
59946951|NCT02853435|76065586|FG005|STARTED|Part 3, Washout Period 2 (3 Days)||2||
59946952|NCT02853435|76065581|FG000|COMPLETED|Part 3, Washout Period 2 (3 Days)||0||
59946953|NCT02853435|76065582|FG001|COMPLETED|Part 3, Washout Period 2 (3 Days)||0||
59946954|NCT02853435|76065583|FG002|COMPLETED|Part 3, Washout Period 2 (3 Days)||0||
59946955|NCT02853435|76065584|FG003|COMPLETED|Part 3, Washout Period 2 (3 Days)||0||
59946956|NCT02853435|76065585|FG004|COMPLETED|Part 3, Washout Period 2 (3 Days)||9||
59946957|NCT02853435|76065586|FG005|COMPLETED|Part 3, Washout Period 2 (3 Days)||2||
59946958|NCT02853435|76065581|FG000|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||0||
59946959|NCT02853435|76065582|FG001|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||0||
59946960|NCT02853435|76065583|FG002|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||0||
59946961|NCT02853435|76065584|FG003|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||0||
59946962|NCT02853435|76065585|FG004|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||1||
59946963|NCT02853435|76065586|FG005|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||0||
59946964|NCT02853435|76065581|FG000|STARTED|Part 3, Period 3 (3 Days)||0||
59946965|NCT02853435|76065582|FG001|STARTED|Part 3, Period 3 (3 Days)||0||
59946966|NCT02853435|76065583|FG002|STARTED|Part 3, Period 3 (3 Days)||0||
59946967|NCT02853435|76065584|FG003|STARTED|Part 3, Period 3 (3 Days)||0||
59946968|NCT02853435|76065585|FG004|STARTED|Part 3, Period 3 (3 Days)||9||
59946969|NCT02853435|76065586|FG005|STARTED|Part 3, Period 3 (3 Days)||2||
59946970|NCT02853435|76065581|FG000|COMPLETED|Part 3, Period 3 (3 Days)||0||
59946971|NCT02853435|76065582|FG001|COMPLETED|Part 3, Period 3 (3 Days)||0||
59946972|NCT02853435|76065583|FG002|COMPLETED|Part 3, Period 3 (3 Days)||0||
59946973|NCT02853435|76065584|FG003|COMPLETED|Part 3, Period 3 (3 Days)||0||
59946974|NCT02853435|76065585|FG004|COMPLETED|Part 3, Period 3 (3 Days)||9||
59946975|NCT02853435|76065586|FG005|COMPLETED|Part 3, Period 3 (3 Days)||2||
59946976|NCT02853435|76065581|FG000|NOT COMPLETED|Part 3, Period 3 (3 Days)||0||
59946977|NCT02853435|76065582|FG001|NOT COMPLETED|Part 3, Period 3 (3 Days)||0||
59946978|NCT02853435|76065583|FG002|NOT COMPLETED|Part 3, Period 3 (3 Days)||0||
59946979|NCT02853435|76065584|FG003|NOT COMPLETED|Part 3, Period 3 (3 Days)||0||
59946980|NCT02853435|76065585|FG004|NOT COMPLETED|Part 3, Period 3 (3 Days)||0||
59946981|NCT02853435|76065586|FG005|NOT COMPLETED|Part 3, Period 3 (3 Days)||0||
59946982|NCT02635204|76065618|FG000|STARTED|Overall Study||178||
59946983|NCT02635204|76065619|FG001|STARTED|Overall Study||89||
59946984|NCT02635204|76065618|FG000|COMPLETED|Overall Study||176||
59946985|NCT02635204|76065619|FG001|COMPLETED|Overall Study||88||
59946986|NCT02635204|76065618|FG000|NOT COMPLETED|Overall Study||2||
59946987|NCT02635204|76065619|FG001|NOT COMPLETED|Overall Study||1||
59946988|NCT00102804|76065627|FG000|STARTED|Overall Study||441||
59946989|NCT00102804|76065628|FG001|STARTED|Overall Study||222||
59946990|NCT00102804|76065627|FG000|Received at Least 1 Dose of Study Drug|Overall Study||434||
59946991|NCT00102804|76065628|FG001|Received at Least 1 Dose of Study Drug|Overall Study|Four participants randomized to placebo received pemetrexed.|222||
59946992|NCT00102804|76065627|FG000|COMPLETED|Overall Study||0||
59946993|NCT00102804|76065628|FG001|COMPLETED|Overall Study||0||
59946994|NCT00102804|76065627|FG000|NOT COMPLETED|Overall Study||441||
59946995|NCT00102804|76065628|FG001|NOT COMPLETED|Overall Study||222||
59946996|NCT01814072|76065666|FG000|STARTED|Overall Study||18||
59946997|NCT01814072|76065667|FG001|STARTED|Overall Study||18||
59946998|NCT01814072|76065668|FG002|STARTED|Overall Study||18||
59946999|NCT01814072|76065669|FG003|STARTED|Overall Study||18||
59947000|NCT01814072|76065670|FG004|STARTED|Overall Study||18||
59947001|NCT01814072|76065671|FG005|STARTED|Overall Study||18||
59947002|NCT01814072|76065672|FG006|STARTED|Overall Study||18||
59947003|NCT01814072|76065673|FG007|STARTED|Overall Study||18||
59947004|NCT01814072|76065674|FG008|STARTED|Overall Study||19||
59947005|NCT01814072|76065675|FG009|STARTED|Overall Study||18||
59947006|NCT01814072|76065676|FG010|STARTED|Overall Study||18||
59947007|NCT01814072|76065677|FG011|STARTED|Overall Study||18||
59947008|NCT01814072|76065678|FG012|STARTED|Overall Study||18||
59947009|NCT01814072|76065679|FG013|STARTED|Overall Study||18||
59947010|NCT01814072|76065680|FG014|STARTED|Overall Study||18||
59947011|NCT01814072|76065681|FG015|STARTED|Overall Study||18||
59947012|NCT01814072|76065682|FG016|STARTED|Overall Study||17||
59947013|NCT01814072|76065683|FG017|STARTED|Overall Study||18||
59947014|NCT01814072|76065684|FG018|STARTED|Overall Study||17||
59947015|NCT01814072|76065685|FG019|STARTED|Overall Study||16||
59947016|NCT01814072|76065686|FG020|STARTED|Overall Study||16||
59947017|NCT01814072|76065687|FG021|STARTED|Overall Study||17||
59947018|NCT01814072|76065688|FG022|STARTED|Overall Study||17||
59947019|NCT01814072|76065689|FG023|STARTED|Overall Study||18||
59947020|NCT01814072|76065690|FG024|STARTED|Overall Study||17||
59947021|NCT01814072|76065691|FG025|STARTED|Overall Study||16||
59947022|NCT01814072|76065692|FG026|STARTED|Overall Study||18||
59947023|NCT01814072|76065693|FG027|STARTED|Overall Study||17||
59947024|NCT01814072|76065694|FG028|STARTED|Overall Study||18||
59947025|NCT01814072|76065695|FG029|STARTED|Overall Study||17||
59947026|NCT01814072|76065696|FG030|STARTED|Overall Study||17||
59947027|NCT01814072|76065697|FG031|STARTED|Overall Study||17||
59947028|NCT01814072|76065666|FG000|3-mo Visit|Overall Study||15||
59947029|NCT01814072|76065667|FG001|3-mo Visit|Overall Study||18||
59947030|NCT01814072|76065668|FG002|3-mo Visit|Overall Study||16||
59947031|NCT01814072|76065669|FG003|3-mo Visit|Overall Study||18||
59947032|NCT01814072|76065670|FG004|3-mo Visit|Overall Study||15||
59947033|NCT01814072|76065671|FG005|3-mo Visit|Overall Study||15||
59947034|NCT01814072|76065672|FG006|3-mo Visit|Overall Study||16||
59947035|NCT01814072|76065673|FG007|3-mo Visit|Overall Study||18||
59947036|NCT01814072|76065674|FG008|3-mo Visit|Overall Study||18||
59947037|NCT01814072|76065675|FG009|3-mo Visit|Overall Study||15||
59947038|NCT01814072|76065676|FG010|3-mo Visit|Overall Study||18||
59947039|NCT01814072|76065677|FG011|3-mo Visit|Overall Study||17||
59947040|NCT01814072|76065678|FG012|3-mo Visit|Overall Study||16||
59947041|NCT01814072|76065679|FG013|3-mo Visit|Overall Study||16||
59947042|NCT01814072|76065680|FG014|3-mo Visit|Overall Study||16||
59947043|NCT01814072|76065681|FG015|3-mo Visit|Overall Study||16||
59947044|NCT01814072|76065682|FG016|3-mo Visit|Overall Study||16||
59947045|NCT01814072|76065683|FG017|3-mo Visit|Overall Study||16||
60067607|NCT01606761|76182767|FG002|COMPLETED|Week 24 to Week 52||212||
60067608|NCT01606761|76182768|FG003|COMPLETED|Week 24 to Week 52||109||
59518811|NCT01114945|75612673|FG002|COMPLETED|Overall Study||30||
59947046|NCT01814072|76065684|FG018|3-mo Visit|Overall Study||14||
60067609|NCT01606761|76182769|FG004|COMPLETED|Week 24 to Week 52||106||
60067610|NCT01606761|76182765|FG000|NOT COMPLETED|Week 24 to Week 52||0||
60067611|NCT01606761|76182766|FG001|NOT COMPLETED|Week 24 to Week 52||33||
60067612|NCT01606761|76182767|FG002|NOT COMPLETED|Week 24 to Week 52||33||
59518812|NCT01114945|75612674|FG003|COMPLETED|Overall Study||31||
59518813|NCT01114945|75612671|FG000|NOT COMPLETED|Overall Study||0||
59518814|NCT01114945|75612672|FG001|NOT COMPLETED|Overall Study||0||
59518815|NCT01114945|75612673|FG002|NOT COMPLETED|Overall Study||0||
59947047|NCT01814072|76065685|FG019|3-mo Visit|Overall Study||13||
59947048|NCT01814072|76065686|FG020|3-mo Visit|Overall Study||15||
59947049|NCT01814072|76065687|FG021|3-mo Visit|Overall Study||17||
59947050|NCT01814072|76065688|FG022|3-mo Visit|Overall Study||15||
59947051|NCT01814072|76065689|FG023|3-mo Visit|Overall Study||18||
59947052|NCT01814072|76065690|FG024|3-mo Visit|Overall Study||13||
59947053|NCT01814072|76065691|FG025|3-mo Visit|Overall Study||14||
60067613|NCT01606761|76182768|FG003|NOT COMPLETED|Week 24 to Week 52||17||
60067614|NCT01606761|76182769|FG004|NOT COMPLETED|Week 24 to Week 52||20||
60067615|NCT01606761|76182765|FG000|STARTED|Safety Follow-up Period (Week 52-68)||28||
60067616|NCT01606761|76182766|FG001|STARTED|Safety Follow-up Period (Week 52-68)||65||
60067617|NCT01606761|76182767|FG002|STARTED|Safety Follow-up Period (Week 52-68)||62||
59518816|NCT01114945|75612674|FG003|NOT COMPLETED|Overall Study||0||
59947054|NCT01814072|76065692|FG026|3-mo Visit|Overall Study||17||
59947055|NCT01814072|76065693|FG027|3-mo Visit|Overall Study||14||
59947056|NCT01814072|76065694|FG028|3-mo Visit|Overall Study||15||
59947057|NCT01814072|76065695|FG029|3-mo Visit|Overall Study||16||
59947058|NCT01814072|76065696|FG030|3-mo Visit|Overall Study||16||
59947059|NCT01814072|76065697|FG031|3-mo Visit|Overall Study||17||
59947060|NCT01814072|76065666|FG000|Intent to Treat|Overall Study||4||
59947061|NCT01814072|76065667|FG001|Intent to Treat|Overall Study||2||
59947062|NCT01814072|76065668|FG002|Intent to Treat|Overall Study||3||
59947063|NCT01814072|76065669|FG003|Intent to Treat|Overall Study||0||
59947064|NCT01814072|76065670|FG004|Intent to Treat|Overall Study||4||
59947065|NCT01814072|76065671|FG005|Intent to Treat|Overall Study||6||
59947066|NCT01814072|76065672|FG006|Intent to Treat|Overall Study||4||
59947067|NCT01814072|76065673|FG007|Intent to Treat|Overall Study||1||
59947068|NCT01814072|76065674|FG008|Intent to Treat|Overall Study||3||
59947069|NCT01814072|76065675|FG009|Intent to Treat|Overall Study||5||
59947070|NCT01814072|76065676|FG010|Intent to Treat|Overall Study||1||
59947071|NCT01814072|76065677|FG011|Intent to Treat|Overall Study||2||
59947072|NCT01814072|76065678|FG012|Intent to Treat|Overall Study||3||
59947073|NCT01814072|76065679|FG013|Intent to Treat|Overall Study||2||
59947074|NCT01814072|76065680|FG014|Intent to Treat|Overall Study||3||
59947075|NCT01814072|76065681|FG015|Intent to Treat|Overall Study||2||
59947076|NCT01814072|76065682|FG016|Intent to Treat|Overall Study||3||
59947077|NCT01814072|76065683|FG017|Intent to Treat|Overall Study||1||
59947078|NCT01814072|76065684|FG018|Intent to Treat|Overall Study||3||
59947079|NCT01814072|76065685|FG019|Intent to Treat|Overall Study||5||
59947080|NCT01814072|76065686|FG020|Intent to Treat|Overall Study||2||
59947081|NCT01814072|76065687|FG021|Intent to Treat|Overall Study||1||
59947082|NCT01814072|76065688|FG022|Intent to Treat|Overall Study||4||
59947083|NCT01814072|76065689|FG023|Intent to Treat|Overall Study||1||
59947084|NCT01814072|76065690|FG024|Intent to Treat|Overall Study||6||
59947085|NCT01814072|76065691|FG025|Intent to Treat|Overall Study||2||
59947086|NCT01814072|76065692|FG026|Intent to Treat|Overall Study||2||
59613393|NCT01686438|75724541|FG002|6-Month Follow Up|Overall Study||24||
59613394|NCT01686438|75724539|FG000|COMPLETED|Overall Study||7||
59613395|NCT01686438|75724540|FG001|COMPLETED|Overall Study||26||
59613396|NCT01686438|75724541|FG002|COMPLETED|Overall Study||24||
59613397|NCT01686438|75724539|FG000|NOT COMPLETED|Overall Study||8||
59613398|NCT01686438|75724540|FG001|NOT COMPLETED|Overall Study||9||
59613399|NCT01686438|75724541|FG002|NOT COMPLETED|Overall Study||13||
59613400|NCT01593696|75724555|FG000|STARTED|Dose Escalation||16||
59613401|NCT01593696|75724556|FG001|STARTED|Dose Escalation||5||
59613402|NCT01593696|75724557|FG002|STARTED|Dose Escalation||0||
59613403|NCT01593696|75724558|FG003|STARTED|Dose Escalation||0||
59947087|NCT01814072|76065693|FG027|Intent to Treat|Overall Study||4||
59947088|NCT01814072|76065694|FG028|Intent to Treat|Overall Study||4||
59947089|NCT01814072|76065695|FG029|Intent to Treat|Overall Study||3||
59947090|NCT01814072|76065696|FG030|Intent to Treat|Overall Study||2||
59947091|NCT01814072|76065697|FG031|Intent to Treat|Overall Study||0||
59947092|NCT01814072|76065666|FG000|COMPLETED|Overall Study||14||
59947093|NCT01814072|76065667|FG001|COMPLETED|Overall Study||16||
59947094|NCT01814072|76065668|FG002|COMPLETED|Overall Study||15||
59947095|NCT01814072|76065669|FG003|COMPLETED|Overall Study||18||
59947096|NCT01814072|76065670|FG004|COMPLETED|Overall Study||14||
59613404|NCT01593696|75724555|FG000|Prior Transplant|Dose Escalation||7||
59613405|NCT01593696|75724556|FG001|Prior Transplant|Dose Escalation||1||
59613406|NCT01593696|75724557|FG002|Prior Transplant|Dose Escalation||0||
59613407|NCT01593696|75724558|FG003|Prior Transplant|Dose Escalation||0||
59947097|NCT01814072|76065671|FG005|COMPLETED|Overall Study||12||
59947098|NCT01814072|76065672|FG006|COMPLETED|Overall Study||14||
59947099|NCT01814072|76065673|FG007|COMPLETED|Overall Study||17||
59947100|NCT01814072|76065674|FG008|COMPLETED|Overall Study||16||
59947101|NCT01814072|76065675|FG009|COMPLETED|Overall Study||13||
59947102|NCT01814072|76065676|FG010|COMPLETED|Overall Study||17||
59947103|NCT01814072|76065677|FG011|COMPLETED|Overall Study||16||
59947104|NCT01814072|76065678|FG012|COMPLETED|Overall Study||15||
59947105|NCT01814072|76065679|FG013|COMPLETED|Overall Study||16||
59947106|NCT01814072|76065680|FG014|COMPLETED|Overall Study||15||
59947107|NCT01814072|76065681|FG015|COMPLETED|Overall Study||16||
59947108|NCT01814072|76065682|FG016|COMPLETED|Overall Study||14||
59947109|NCT01814072|76065683|FG017|COMPLETED|Overall Study||17||
59947110|NCT01814072|76065684|FG018|COMPLETED|Overall Study||14||
59947111|NCT01814072|76065685|FG019|COMPLETED|Overall Study||11||
59613408|NCT01593696|75724555|FG000|No Prior Transplant|Dose Escalation||9||
59947112|NCT01814072|76065686|FG020|COMPLETED|Overall Study||14||
59947113|NCT01814072|76065687|FG021|COMPLETED|Overall Study||16||
59947114|NCT01814072|76065688|FG022|COMPLETED|Overall Study||13||
59947115|NCT01814072|76065689|FG023|COMPLETED|Overall Study||17||
59947116|NCT01814072|76065690|FG024|COMPLETED|Overall Study||11||
59947117|NCT01814072|76065691|FG025|COMPLETED|Overall Study||14||
59947118|NCT01814072|76065692|FG026|COMPLETED|Overall Study||16||
59947119|NCT01814072|76065693|FG027|COMPLETED|Overall Study||13||
59947120|NCT01814072|76065694|FG028|COMPLETED|Overall Study||14||
59947121|NCT01814072|76065695|FG029|COMPLETED|Overall Study||14||
59947122|NCT01814072|76065696|FG030|COMPLETED|Overall Study||15||
59947123|NCT01814072|76065697|FG031|COMPLETED|Overall Study||17||
59947124|NCT01814072|76065666|FG000|NOT COMPLETED|Overall Study||4||
59947125|NCT01814072|76065667|FG001|NOT COMPLETED|Overall Study||2||
59947126|NCT01814072|76065668|FG002|NOT COMPLETED|Overall Study||3||
59947127|NCT01814072|76065669|FG003|NOT COMPLETED|Overall Study||0||
59947128|NCT01814072|76065670|FG004|NOT COMPLETED|Overall Study||4||
59947129|NCT01814072|76065671|FG005|NOT COMPLETED|Overall Study||6||
59947130|NCT01814072|76065672|FG006|NOT COMPLETED|Overall Study||4||
59947131|NCT01814072|76065673|FG007|NOT COMPLETED|Overall Study||1||
59947132|NCT01814072|76065674|FG008|NOT COMPLETED|Overall Study||3||
59947133|NCT01814072|76065675|FG009|NOT COMPLETED|Overall Study||5||
59947134|NCT01814072|76065676|FG010|NOT COMPLETED|Overall Study||1||
59947135|NCT01814072|76065677|FG011|NOT COMPLETED|Overall Study||2||
59947136|NCT01814072|76065678|FG012|NOT COMPLETED|Overall Study||3||
59947137|NCT01814072|76065679|FG013|NOT COMPLETED|Overall Study||2||
59947138|NCT01814072|76065680|FG014|NOT COMPLETED|Overall Study||3||
59947139|NCT01814072|76065681|FG015|NOT COMPLETED|Overall Study||2||
59947140|NCT01814072|76065682|FG016|NOT COMPLETED|Overall Study||3||
59947141|NCT01814072|76065683|FG017|NOT COMPLETED|Overall Study||1||
59947142|NCT01814072|76065684|FG018|NOT COMPLETED|Overall Study||3||
59947143|NCT01814072|76065685|FG019|NOT COMPLETED|Overall Study||5||
59947144|NCT01814072|76065686|FG020|NOT COMPLETED|Overall Study||2||
59947145|NCT01814072|76065687|FG021|NOT COMPLETED|Overall Study||1||
59947146|NCT01814072|76065688|FG022|NOT COMPLETED|Overall Study||4||
59947147|NCT01814072|76065689|FG023|NOT COMPLETED|Overall Study||1||
59947148|NCT01814072|76065690|FG024|NOT COMPLETED|Overall Study||6||
59947149|NCT01814072|76065691|FG025|NOT COMPLETED|Overall Study||2||
59947150|NCT01814072|76065692|FG026|NOT COMPLETED|Overall Study||2||
59947151|NCT01814072|76065693|FG027|NOT COMPLETED|Overall Study||4||
59947152|NCT01814072|76065694|FG028|NOT COMPLETED|Overall Study||4||
59947153|NCT01814072|76065695|FG029|NOT COMPLETED|Overall Study||3||
59947154|NCT01814072|76065696|FG030|NOT COMPLETED|Overall Study||2||
59947155|NCT01814072|76065697|FG031|NOT COMPLETED|Overall Study||0||
59947156|NCT03038113|76065752|FG000|STARTED|Overall Study||8||
59947157|NCT03038113|76065753|FG001|STARTED|Overall Study||8||
59947158|NCT03038113|76065754|FG002|STARTED|Overall Study||8||
59947159|NCT03038113|76065755|FG003|STARTED|Overall Study||8||
59947160|NCT03038113|76065756|FG004|STARTED|Overall Study||8||
59762325|NCT03823300|75882009|FG000|Completed up to Week 48|Overall Study||321|Primary Completion Date Cutoff|
59762326|NCT03823300|75882010|FG001|Completed up to Week 48|Overall Study||309|Primary Completion Date Cutoff|
59762327|NCT03823300|75882009|FG000|COMPLETED|Overall Study||297||
59762328|NCT03823300|75882010|FG001|COMPLETED|Overall Study||273||
59762329|NCT03823300|75882009|FG000|NOT COMPLETED|Overall Study||34||
59762330|NCT03823300|75882010|FG001|NOT COMPLETED|Overall Study||54||
59762331|NCT00537745|75882016|FG000|STARTED|Overall Study|There were three screen fails and two early terminations.|14||
59947161|NCT03038113|76065757|FG005|STARTED|Overall Study||8||
59947162|NCT03038113|76065758|FG006|STARTED|Overall Study||12||
59947163|NCT03038113|76065759|FG007|STARTED|Overall Study||6||
59947164|NCT03038113|76065760|FG008|STARTED|Overall Study||7||
59947165|NCT03038113|76065761|FG009|STARTED|Overall Study||6||
59947166|NCT03038113|76065762|FG010|STARTED|Overall Study||14||
59947167|NCT03038113|76065763|FG011|STARTED|Overall Study||7||
59947168|NCT03038113|76065764|FG012|STARTED|Overall Study||4||
59947169|NCT03038113|76065765|FG013|STARTED|Overall Study||15||
59947170|NCT03038113|76065752|FG000|COMPLETED|Overall Study||8||
59947171|NCT03038113|76065753|FG001|COMPLETED|Overall Study||8||
59947172|NCT03038113|76065754|FG002|COMPLETED|Overall Study||7||
59947173|NCT03038113|76065755|FG003|COMPLETED|Overall Study||8||
59947174|NCT03038113|76065756|FG004|COMPLETED|Overall Study||8||
59947175|NCT03038113|76065757|FG005|COMPLETED|Overall Study||8||
59947176|NCT03038113|76065758|FG006|COMPLETED|Overall Study||11||
59947177|NCT03038113|76065759|FG007|COMPLETED|Overall Study||6||
59947178|NCT03038113|76065760|FG008|COMPLETED|Overall Study||7||
59947179|NCT03038113|76065761|FG009|COMPLETED|Overall Study||6||
59947180|NCT03038113|76065762|FG010|COMPLETED|Overall Study||14||
59947181|NCT03038113|76065763|FG011|COMPLETED|Overall Study||7||
59947182|NCT03038113|76065764|FG012|COMPLETED|Overall Study||4||
59947183|NCT03038113|76065765|FG013|COMPLETED|Overall Study||14||
59947184|NCT03038113|76065752|FG000|NOT COMPLETED|Overall Study||0||
59947185|NCT03038113|76065753|FG001|NOT COMPLETED|Overall Study||0||
59947186|NCT03038113|76065754|FG002|NOT COMPLETED|Overall Study||1||
59947187|NCT03038113|76065755|FG003|NOT COMPLETED|Overall Study||0||
59518817|NCT01115101|75612687|FG000|STARTED|Overall Study||113||
59518818|NCT01115101|75612688|FG001|STARTED|Overall Study||126||
59518819|NCT01115101|75612687|FG000|COMPLETED|Overall Study||113||
59518820|NCT01115101|75612688|FG001|COMPLETED|Overall Study||126||
59947188|NCT03038113|76065756|FG004|NOT COMPLETED|Overall Study||0||
59947189|NCT03038113|76065757|FG005|NOT COMPLETED|Overall Study||0||
59947190|NCT03038113|76065758|FG006|NOT COMPLETED|Overall Study||1||
59947191|NCT03038113|76065759|FG007|NOT COMPLETED|Overall Study||0||
59947192|NCT03038113|76065760|FG008|NOT COMPLETED|Overall Study||0||
59947193|NCT03038113|76065761|FG009|NOT COMPLETED|Overall Study||0||
59947194|NCT03038113|76065762|FG010|NOT COMPLETED|Overall Study||0||
59947195|NCT03038113|76065763|FG011|NOT COMPLETED|Overall Study||0||
59947196|NCT03038113|76065764|FG012|NOT COMPLETED|Overall Study||0||
59947197|NCT03038113|76065765|FG013|NOT COMPLETED|Overall Study||1||
59947198|NCT00968149|76065814|FG000|STARTED|Overall Study||280||
59947199|NCT00968149|76065815|FG001|STARTED|Overall Study||133||
59947200|NCT00968149|76065814|FG000|COMPLETED|Overall Study||269||
59947201|NCT00968149|76065815|FG001|COMPLETED|Overall Study||127||
59947202|NCT00968149|76065814|FG000|NOT COMPLETED|Overall Study||11||
59947203|NCT00968149|76065815|FG001|NOT COMPLETED|Overall Study||6||
59947204|NCT00963469|76065824|FG000|STARTED|Overall Study||451||
59947205|NCT00963469|76065825|FG001|STARTED|Overall Study||448||
59947206|NCT00963469|76065826|FG002|STARTED|Overall Study||180||
59947207|NCT00963469|76065824|FG000|COMPLETED|Overall Study||410||
59947208|NCT00963469|76065825|FG001|COMPLETED|Overall Study||420||
59947209|NCT00963469|76065826|FG002|COMPLETED|Overall Study||170||
59947210|NCT00963469|76065824|FG000|NOT COMPLETED|Overall Study||41||
59947211|NCT00963469|76065825|FG001|NOT COMPLETED|Overall Study||28||
59947212|NCT00963469|76065826|FG002|NOT COMPLETED|Overall Study||10||
59947213|NCT00897949|76065837|FG000|STARTED|Overall Study|Patients who were allocated study drug|554||
59947214|NCT00897949|76065838|FG001|STARTED|Overall Study|Patients who were allocated study drug|549||
59947215|NCT00897949|76065839|FG002|STARTED|Overall Study|Patients who were allocated study drug|370||
59947216|NCT00897949|76065837|FG000|Patients Treated|Overall Study|Patients who took study drug|458||
59947217|NCT00897949|76065838|FG001|Patients Treated|Overall Study|Patients who took study drug|456||
59947218|NCT00897949|76065839|FG002|Patients Treated|Overall Study|Patients who took study drug|304||
59947219|NCT00897949|76065837|FG000|COMPLETED|Overall Study|Patients who took study drug and completed the study|450||
59947220|NCT00897949|76065838|FG001|COMPLETED|Overall Study|Patients who took study drug and completed the study|446||
59947221|NCT00897949|76065839|FG002|COMPLETED|Overall Study|Patients who took study drug and completed the study|301||
59947222|NCT00897949|76065837|FG000|NOT COMPLETED|Overall Study||104||
59947223|NCT00897949|76065838|FG001|NOT COMPLETED|Overall Study||103||
59947224|NCT00897949|76065839|FG002|NOT COMPLETED|Overall Study||69||
59947225|NCT02760810|76065853|FG000|STARTED|Overall Study||30||
59947226|NCT02760810|76065853|FG000|COMPLETED|Overall Study||29||
59947227|NCT02760810|76065853|FG000|NOT COMPLETED|Overall Study||1||
59947228|NCT02760654|76065859|FG000|STARTED|Overall Study||30|Randomized|
59947229|NCT02760654|76065860|FG001|STARTED|Overall Study||30|Randomized|
59947230|NCT02760654|76065859|FG000|COMPLETED|Overall Study||23||
59947231|NCT02760654|76065860|FG001|COMPLETED|Overall Study||24||
59947232|NCT02760654|76065859|FG000|NOT COMPLETED|Overall Study||7||
59947233|NCT02760654|76065860|FG001|NOT COMPLETED|Overall Study||6||
59947234|NCT00725491|76065868|FG000|STARTED|Overall Study|Intent-to-Treat Group|113||
59947235|NCT00725491|76065869|FG001|STARTED|Overall Study|Intent-to-Treat Group|120||
59947236|NCT00725491|76065868|FG000|COMPLETED|Overall Study||104||
59947237|NCT00725491|76065869|FG001|COMPLETED|Overall Study||102||
59947238|NCT00725491|76065868|FG000|NOT COMPLETED|Overall Study||9||
59947239|NCT00725491|76065869|FG001|NOT COMPLETED|Overall Study||18||
59947240|NCT02634580|76065879|FG000|STARTED|Double-blind Treatment Period||10||
59947241|NCT02634580|76065880|FG001|STARTED|Double-blind Treatment Period||11||
59947242|NCT02634580|76065881|FG002|STARTED|Double-blind Treatment Period||19||
59947243|NCT02634580|76065882|FG003|STARTED|Double-blind Treatment Period||21||
59947244|NCT02634580|76065879|FG000|COMPLETED|Double-blind Treatment Period||9|Completed double-blind treatment period|
59947245|NCT02634580|76065880|FG001|COMPLETED|Double-blind Treatment Period||11|Completed double-blind treatment period|
59947246|NCT02634580|76065881|FG002|COMPLETED|Double-blind Treatment Period||18|Completed double-blind treatment period|
59947247|NCT02634580|76065882|FG003|COMPLETED|Double-blind Treatment Period||20|Completed double-blind treatment period|
59947248|NCT02634580|76065879|FG000|NOT COMPLETED|Double-blind Treatment Period||1||
59947249|NCT02634580|76065880|FG001|NOT COMPLETED|Double-blind Treatment Period||0||
59947250|NCT02634580|76065881|FG002|NOT COMPLETED|Double-blind Treatment Period||1||
59947251|NCT02634580|76065882|FG003|NOT COMPLETED|Double-blind Treatment Period||1||
59947252|NCT02634580|76065879|FG000|STARTED|Open-label Extension Period||9||
59947253|NCT02634580|76065880|FG001|STARTED|Open-label Extension Period||11||
59947254|NCT02634580|76065881|FG002|STARTED|Open-label Extension Period||18||
59947255|NCT02634580|76065882|FG003|STARTED|Open-label Extension Period|Includes 1 participant who did not complete the double-blind period but had study visits during OLE|21||
59947256|NCT02634580|76065879|FG000|Received Open-label Treatment|Open-label Extension Period||9||
59947257|NCT02634580|76065880|FG001|Received Open-label Treatment|Open-label Extension Period||11||
59947258|NCT02634580|76065881|FG002|Received Open-label Treatment|Open-label Extension Period||18||
59947259|NCT02634580|76065882|FG003|Received Open-label Treatment|Open-label Extension Period||20||
59947260|NCT02634580|76065879|FG000|COMPLETED|Open-label Extension Period||9|Completed study|
59947261|NCT02634580|76065880|FG001|COMPLETED|Open-label Extension Period||10|Completed study|
59947262|NCT02634580|76065881|FG002|COMPLETED|Open-label Extension Period||18|Completed study|
59947263|NCT02634580|76065882|FG003|COMPLETED|Open-label Extension Period||20|Completed study|
59947264|NCT02634580|76065879|FG000|NOT COMPLETED|Open-label Extension Period||0||
59947265|NCT02634580|76065880|FG001|NOT COMPLETED|Open-label Extension Period||1||
59947266|NCT02634580|76065881|FG002|NOT COMPLETED|Open-label Extension Period||0||
59947267|NCT02634580|76065882|FG003|NOT COMPLETED|Open-label Extension Period||1||
59947268|NCT02225366|76065893|FG000|STARTED|Overall Study||2||
59947269|NCT02225366|76065894|FG001|STARTED|Overall Study||1||
59947270|NCT02225366|76065893|FG000|COMPLETED|Overall Study||1||
59947271|NCT02225366|76065894|FG001|COMPLETED|Overall Study||1||
59947272|NCT02225366|76065893|FG000|NOT COMPLETED|Overall Study||1||
59947273|NCT02225366|76065894|FG001|NOT COMPLETED|Overall Study||0||
59947274|NCT00697255|76065902|FG000|STARTED|Stage 1a||5||
59947275|NCT00697255|76065903|FG001|STARTED|Stage 1a||0||
59947276|NCT00697255|76065902|FG000|COMPLETED|Stage 1a|Participants who completed 1a received hCG bolus injection and did not proceed further in the trial|2||
59947277|NCT00697255|76065903|FG001|COMPLETED|Stage 1a||0||
59947278|NCT00697255|76065902|FG000|NOT COMPLETED|Stage 1a||3||
59947279|NCT00697255|76065903|FG001|NOT COMPLETED|Stage 1a||0||
59947280|NCT00697255|76065902|FG000|STARTED|Stage 1b||0||
59947281|NCT00697255|76065903|FG001|STARTED|Stage 1b|After enrollment in Stage 1a completed, a new cohort of participants enrolled in Stage 1b.|3||
59947282|NCT00697255|76065902|FG000|COMPLETED|Stage 1b||0||
59947283|NCT00697255|76065903|FG001|COMPLETED|Stage 1b|Participants who completed 1b received hCG bolus injection and did not proceed further in the trial|1||
59947284|NCT00697255|76065902|FG000|NOT COMPLETED|Stage 1b||0||
59947285|NCT00697255|76065903|FG001|NOT COMPLETED|Stage 1b||2||
59947286|NCT05350423|76065911|FG000|STARTED|Overall Study||54||
59947287|NCT05350423|76065912|FG001|STARTED|Overall Study||54||
59947288|NCT05350423|76065911|FG000|COMPLETED|Overall Study||46||
59947289|NCT05350423|76065912|FG001|COMPLETED|Overall Study||45||
59947290|NCT05350423|76065911|FG000|NOT COMPLETED|Overall Study||8||
59947291|NCT05350423|76065912|FG001|NOT COMPLETED|Overall Study||9||
59947292|NCT04896385|76065920|FG000|STARTED|24-Week Double-Blind Period||41||
59947293|NCT04896385|76065921|FG001|STARTED|24-Week Double-Blind Period||19||
59947294|NCT04896385|76065922|FG002|STARTED|24-Week Double-Blind Period||0||
59947295|NCT04896385|76065923|FG003|STARTED|24-Week Double-Blind Period||0||
59947296|NCT04896385|76065920|FG000|COMPLETED|24-Week Double-Blind Period||37||
59947297|NCT04896385|76065921|FG001|COMPLETED|24-Week Double-Blind Period||14||
59947298|NCT04896385|76065922|FG002|COMPLETED|24-Week Double-Blind Period||0||
59947299|NCT04896385|76065923|FG003|COMPLETED|24-Week Double-Blind Period||0||
59947300|NCT04896385|76065920|FG000|NOT COMPLETED|24-Week Double-Blind Period||4||
59947301|NCT04896385|76065921|FG001|NOT COMPLETED|24-Week Double-Blind Period||5||
59947302|NCT04896385|76065922|FG002|NOT COMPLETED|24-Week Double-Blind Period||0||
59947303|NCT04896385|76065923|FG003|NOT COMPLETED|24-Week Double-Blind Period||0||
59947304|NCT04896385|76065920|FG000|STARTED|28-Week Treatment-Extension Period||0||
59947305|NCT04896385|76065921|FG001|STARTED|28-Week Treatment-Extension Period||0||
59947306|NCT04896385|76065922|FG002|STARTED|28-Week Treatment-Extension Period||37||
59947307|NCT04896385|76065923|FG003|STARTED|28-Week Treatment-Extension Period||14||
59947308|NCT04896385|76065920|FG000|COMPLETED|28-Week Treatment-Extension Period||0||
59947309|NCT04896385|76065921|FG001|COMPLETED|28-Week Treatment-Extension Period||0||
59947310|NCT04896385|76065922|FG002|COMPLETED|28-Week Treatment-Extension Period||27||
59947311|NCT04896385|76065923|FG003|COMPLETED|28-Week Treatment-Extension Period||9||
59947312|NCT04896385|76065920|FG000|NOT COMPLETED|28-Week Treatment-Extension Period||0||
59947313|NCT04896385|76065921|FG001|NOT COMPLETED|28-Week Treatment-Extension Period||0||
59947314|NCT04896385|76065922|FG002|NOT COMPLETED|28-Week Treatment-Extension Period||10||
59947315|NCT04896385|76065923|FG003|NOT COMPLETED|28-Week Treatment-Extension Period||5||
59947316|NCT04866303|76065935|FG000|STARTED|Overall Study||136|Total randomized|
59947317|NCT04866303|76065936|FG001|STARTED|Overall Study||137|Total randomized|
59947318|NCT04866303|76065935|FG000|Withdrawal or Lost to Follow Up|Overall Study||4||
59947319|NCT04866303|76065936|FG001|Withdrawal or Lost to Follow Up|Overall Study||1||
59947320|NCT04866303|76065935|FG000|COMPLETED|Overall Study||132||
59947321|NCT04866303|76065936|FG001|COMPLETED|Overall Study||136||
59947322|NCT04866303|76065935|FG000|NOT COMPLETED|Overall Study||4||
59947323|NCT04866303|76065936|FG001|NOT COMPLETED|Overall Study||1||
59947324|NCT04359823|76065944|FG000|STARTED|Overall Study||17||
59947325|NCT04359823|76065945|FG001|STARTED|Overall Study||14||
59947326|NCT04359823|76065944|FG000|COMPLETED|Overall Study||17||
59947327|NCT04359823|76065945|FG001|COMPLETED|Overall Study||12||
59947328|NCT04359823|76065944|FG000|NOT COMPLETED|Overall Study||0||
59947329|NCT04359823|76065945|FG001|NOT COMPLETED|Overall Study||2||
59947330|NCT04229446|76065964|FG000|STARTED|Overall Study||134||
59947331|NCT04229446|76065965|FG001|STARTED|Overall Study||142||
59947332|NCT04229446|76065964|FG000|COMPLETED|Overall Study||117||
59947333|NCT04229446|76065965|FG001|COMPLETED|Overall Study||124||
59947334|NCT04229446|76065964|FG000|NOT COMPLETED|Overall Study||17||
59947335|NCT04229446|76065965|FG001|NOT COMPLETED|Overall Study||18||
59947336|NCT04133168|76065973|FG000|STARTED|FROzEN AF Clinical Study|63 Roll-In subjects; 336 Non Roll-In subjects; 5 consent ineligible|404||
59947337|NCT04133168|76065973|FG000|Procedure|FROzEN AF Clinical Study|Treatment = 325; Attempt = 1|326||
59947338|NCT04133168|76065973|FG000|Pre-Discharge|FROzEN AF Clinical Study||325||
59947339|NCT04133168|76065973|FG000|7 Day Follow Up|FROzEN AF Clinical Study|Missed =3|321||
59947340|NCT04133168|76065973|FG000|3 Month Follow Up|FROzEN AF Clinical Study|Missed=6|315||
59947341|NCT04133168|76065973|FG000|6 Month Follow Up|FROzEN AF Clinical Study|Missed = 9|310||
59947342|NCT04133168|76065973|FG000|12 Month Follow Up|FROzEN AF Clinical Study||308||
59947343|NCT04133168|76065973|FG000|COMPLETED|FROzEN AF Clinical Study||308||
59947344|NCT04133168|76065973|FG000|NOT COMPLETED|FROzEN AF Clinical Study||96||
59947345|NCT04133168|76065973|FG000|STARTED|POLARx FIT Substudy|Treatment = 50 Consent Ineligible = 1 Intent = 3|54||
59947346|NCT04133168|76065973|FG000|Pre-Discharge|POLARx FIT Substudy||50||
59947347|NCT04133168|76065973|FG000|3 Month Follow Up|POLARx FIT Substudy||50||
59947348|NCT04133168|76065973|FG000|6 Month Follow Up|POLARx FIT Substudy||50||
59947349|NCT04133168|76065973|FG000|12 Month Follow Up|POLARx FIT Substudy||49||
59947350|NCT04133168|76065973|FG000|COMPLETED|POLARx FIT Substudy||49||
59947351|NCT04133168|76065973|FG000|NOT COMPLETED|POLARx FIT Substudy||5||
59947352|NCT03828357|76065985|FG000|STARTED|Overall Study||15||
59947353|NCT03828357|76065986|FG001|STARTED|Overall Study||15||
59947354|NCT03828357|76065987|FG002|STARTED|Overall Study||15||
59947355|NCT03828357|76065988|FG003|STARTED|Overall Study||15||
59947356|NCT03828357|76065985|FG000|COMPLETED|Overall Study||14||
59947357|NCT03828357|76065986|FG001|COMPLETED|Overall Study||14||
59947358|NCT03828357|76065987|FG002|COMPLETED|Overall Study||15||
59947359|NCT03828357|76065988|FG003|COMPLETED|Overall Study||12||
59947360|NCT03828357|76065985|FG000|NOT COMPLETED|Overall Study||1||
59947361|NCT03828357|76065986|FG001|NOT COMPLETED|Overall Study||1||
59947362|NCT03828357|76065987|FG002|NOT COMPLETED|Overall Study||0||
59947363|NCT03828357|76065988|FG003|NOT COMPLETED|Overall Study||3||
59947364|NCT03701763|76066000|FG000|STARTED|Placebo-controlled Phase||82||
59947365|NCT03701763|76066001|FG001|STARTED|Placebo-controlled Phase||163||
59947366|NCT03701763|76066002|FG002|STARTED|Placebo-controlled Phase|This arm was not included in the Placebo-controlled Phase.|0||
59947367|NCT03701763|76066003|FG003|STARTED|Placebo-controlled Phase|This arm was not included in the Placebo-controlled Phase.|0||
59947368|NCT03701763|76066000|FG000|Took at Least 1 Dose of Investigational Product (IP)|Placebo-controlled Phase||80||
59947369|NCT03701763|76066001|FG001|Took at Least 1 Dose of Investigational Product (IP)|Placebo-controlled Phase||163||
59947370|NCT03701763|76066002|FG002|Took at Least 1 Dose of Investigational Product (IP)|Placebo-controlled Phase|This arm was not included in the Placebo-controlled Phase.|0||
59947371|NCT03701763|76066003|FG003|Took at Least 1 Dose of Investigational Product (IP)|Placebo-controlled Phase|This arm was not included in the Placebo-controlled Phase.|0||
59947372|NCT03701763|76066000|FG000|COMPLETED|Placebo-controlled Phase||72||
59947373|NCT03701763|76066001|FG001|COMPLETED|Placebo-controlled Phase||149||
59947374|NCT03701763|76066002|FG002|COMPLETED|Placebo-controlled Phase|This arm was not included in the Placebo-controlled Phase.|0||
59947375|NCT03701763|76066003|FG003|COMPLETED|Placebo-controlled Phase|This arm was not included in the Placebo-controlled Phase.|0||
59947376|NCT03701763|76066000|FG000|NOT COMPLETED|Placebo-controlled Phase||10||
59947377|NCT03701763|76066001|FG001|NOT COMPLETED|Placebo-controlled Phase||14||
59947378|NCT03701763|76066002|FG002|NOT COMPLETED|Placebo-controlled Phase||0||
59947379|NCT03701763|76066003|FG003|NOT COMPLETED|Placebo-controlled Phase||0||
59947380|NCT03701763|76066000|FG000|STARTED|Apremilast Extension Phase|This arm was not included in the Apremilast Extension Phase.|0||
59947381|NCT03701763|76066001|FG001|STARTED|Apremilast Extension Phase|This arm was not included in the Apremilast Extension Phase.|0||
59947382|NCT03701763|76066002|FG002|STARTED|Apremilast Extension Phase||72||
59947383|NCT03701763|76066003|FG003|STARTED|Apremilast Extension Phase||149||
59518821|NCT01115101|75612687|FG000|NOT COMPLETED|Overall Study||0||
59518822|NCT01115101|75612688|FG001|NOT COMPLETED|Overall Study||0||
59518823|NCT00943631|75612696|FG000|STARTED|Overall Study||202||
59518824|NCT00943631|75612697|FG001|STARTED|Overall Study||204||
59951242|NCT03743415|76070183|FG008|STARTED|Overall Study||23||
59518825|NCT00943631|75612696|FG000|COMPLETED|Overall Study||198||
59518826|NCT00943631|75612697|FG001|COMPLETED|Overall Study||202||
59518827|NCT00943631|75612696|FG000|NOT COMPLETED|Overall Study||4||
59947384|NCT03701763|76066000|FG000|Received Apremilast 20mg BID in Either Placebo-controlled or Apremilast Extension Phases (Week 0-52)|Apremilast Extension Phase|This arm was not included in the Apremilast Extension Phase.|0||
59947385|NCT03701763|76066001|FG001|Received Apremilast 20mg BID in Either Placebo-controlled or Apremilast Extension Phases (Week 0-52)|Apremilast Extension Phase|This arm was not included in the Apremilast Extension Phase.|0||
59947386|NCT03701763|76066002|FG002|Received Apremilast 20mg BID in Either Placebo-controlled or Apremilast Extension Phases (Week 0-52)|Apremilast Extension Phase||36||
59947387|NCT03701763|76066003|FG003|Received Apremilast 20mg BID in Either Placebo-controlled or Apremilast Extension Phases (Week 0-52)|Apremilast Extension Phase||80||
59947388|NCT03701763|76066000|FG000|Received Apremilast 30mg BID in Either Placebo-controlled or Apremilast Extension Phases (Week 0-52)|Apremilast Extension Phase|This arm was not included in the Apremilast Extension Phase.|0||
59947389|NCT03701763|76066001|FG001|Received Apremilast 30mg BID in Either Placebo-controlled or Apremilast Extension Phases (Week 0-52)|Apremilast Extension Phase|This arm was not included in the Apremilast Extension Phase.|0||
59947390|NCT03701763|76066002|FG002|Received Apremilast 30mg BID in Either Placebo-controlled or Apremilast Extension Phases (Week 0-52)|Apremilast Extension Phase||36||
59947391|NCT03701763|76066003|FG003|Received Apremilast 30mg BID in Either Placebo-controlled or Apremilast Extension Phases (Week 0-52)|Apremilast Extension Phase||83||
59947392|NCT03701763|76066000|FG000|Took at Least 1 Dose of IP|Apremilast Extension Phase|This arm was not included in the Apremilast Extension Phase.|0||
59947393|NCT03701763|76066001|FG001|Took at Least 1 Dose of IP|Apremilast Extension Phase|This arm was not included in the Apremilast Extension Phase.|0||
59947394|NCT03701763|76066002|FG002|Took at Least 1 Dose of IP|Apremilast Extension Phase||72||
59947395|NCT03701763|76066003|FG003|Took at Least 1 Dose of IP|Apremilast Extension Phase||149||
59947396|NCT03701763|76066000|FG000|COMPLETED|Apremilast Extension Phase|This arm was not included in the Apremilast Extension Phase.|0||
59947397|NCT03701763|76066001|FG001|COMPLETED|Apremilast Extension Phase|This arm was not included in the Apremilast Extension Phase.|0||
59947398|NCT03701763|76066002|FG002|COMPLETED|Apremilast Extension Phase||61||
59947399|NCT03701763|76066003|FG003|COMPLETED|Apremilast Extension Phase||125||
59947400|NCT03701763|76066000|FG000|NOT COMPLETED|Apremilast Extension Phase||0||
59947401|NCT03701763|76066001|FG001|NOT COMPLETED|Apremilast Extension Phase||0||
59947402|NCT03701763|76066002|FG002|NOT COMPLETED|Apremilast Extension Phase||11||
59947403|NCT03701763|76066003|FG003|NOT COMPLETED|Apremilast Extension Phase||24||
59947404|NCT03701763|76066000|FG000|STARTED|14-Week Observational Follow-up Phase||1||
59947405|NCT03701763|76066001|FG001|STARTED|14-Week Observational Follow-up Phase||4||
59947406|NCT03701763|76066002|FG002|STARTED|14-Week Observational Follow-up Phase||14||
59947407|NCT03701763|76066003|FG003|STARTED|14-Week Observational Follow-up Phase||26||
59947408|NCT03701763|76066000|FG000|COMPLETED|14-Week Observational Follow-up Phase||1||
59947409|NCT03701763|76066001|FG001|COMPLETED|14-Week Observational Follow-up Phase||3||
59947410|NCT03701763|76066002|FG002|COMPLETED|14-Week Observational Follow-up Phase||11||
59947411|NCT03701763|76066003|FG003|COMPLETED|14-Week Observational Follow-up Phase||23||
59947412|NCT03701763|76066000|FG000|NOT COMPLETED|14-Week Observational Follow-up Phase||0||
59947413|NCT03701763|76066001|FG001|NOT COMPLETED|14-Week Observational Follow-up Phase||1||
59947414|NCT03701763|76066002|FG002|NOT COMPLETED|14-Week Observational Follow-up Phase||3||
59947415|NCT03701763|76066003|FG003|NOT COMPLETED|14-Week Observational Follow-up Phase||3||
59947416|NCT03641378|76066029|FG000|STARTED|Overall Study||180||
59947417|NCT03641378|76066030|FG001|STARTED|Overall Study||180||
59947418|NCT03641378|76066031|FG002|STARTED|Overall Study||101||
59947419|NCT03641378|76066032|FG003|STARTED|Overall Study||85||
59947420|NCT03641378|76066029|FG000|COMPLETED|Overall Study||173||
59947421|NCT03641378|76066030|FG001|COMPLETED|Overall Study||160||
59947422|NCT03641378|76066031|FG002|COMPLETED|Overall Study||87||
59947423|NCT03641378|76066032|FG003|COMPLETED|Overall Study||79||
59947424|NCT03641378|76066029|FG000|NOT COMPLETED|Overall Study||7||
59947425|NCT03641378|76066030|FG001|NOT COMPLETED|Overall Study||20||
59947426|NCT03641378|76066031|FG002|NOT COMPLETED|Overall Study||14||
59947427|NCT03641378|76066032|FG003|NOT COMPLETED|Overall Study||6||
59947428|NCT03575897|76066042|FG000|STARTED|Overall Study||25||
59947429|NCT03575897|76066043|FG001|STARTED|Overall Study||25||
59947430|NCT03575897|76066042|FG000|COMPLETED|Overall Study||13||
59947431|NCT03575897|76066043|FG001|COMPLETED|Overall Study||12||
59947432|NCT03575897|76066042|FG000|NOT COMPLETED|Overall Study||12||
59947433|NCT03575897|76066043|FG001|NOT COMPLETED|Overall Study||13||
59947434|NCT03439748|76066051|FG000|STARTED|Overall Study||42||
59947435|NCT03439748|76066052|FG001|STARTED|Overall Study||43||
59947436|NCT03439748|76066051|FG000|Week 5 Assessment|Overall Study||36||
59947437|NCT03439748|76066052|FG001|Week 5 Assessment|Overall Study||37||
59947438|NCT03439748|76066051|FG000|Week 10 Assessment|Overall Study||32||
59947439|NCT03439748|76066052|FG001|Week 10 Assessment|Overall Study||29||
59947440|NCT03439748|76066051|FG000|COMPLETED|Overall Study||31||
59947441|NCT03439748|76066052|FG001|COMPLETED|Overall Study||26||
59947442|NCT03439748|76066051|FG000|NOT COMPLETED|Overall Study||11||
59947443|NCT03439748|76066052|FG001|NOT COMPLETED|Overall Study||17||
59947444|NCT03433001|76066058|FG000|STARTED|Overall Study||295||
59947445|NCT03433001|76066058|FG000|COMPLETED|Overall Study||66||
59947446|NCT03433001|76066058|FG000|NOT COMPLETED|Overall Study||229||
59947447|NCT03412565|76066066|FG000|STARTED|Overall Study||67||
59947448|NCT03412565|76066067|FG001|STARTED|Overall Study||67||
59947449|NCT03412565|76066068|FG002|STARTED|Overall Study||65||
59947450|NCT03412565|76066069|FG003|STARTED|Overall Study||66||
59947451|NCT03412565|76066066|FG000|COMPLETED|Overall Study||66||
59947452|NCT03412565|76066067|FG001|COMPLETED|Overall Study||19||
59947453|NCT03412565|76066068|FG002|COMPLETED|Overall Study||14||
59947454|NCT03412565|76066069|FG003|COMPLETED|Overall Study||15||
59947455|NCT03412565|76066066|FG000|NOT COMPLETED|Overall Study||1||
59947456|NCT03412565|76066067|FG001|NOT COMPLETED|Overall Study||48||
59947457|NCT03412565|76066068|FG002|NOT COMPLETED|Overall Study||51||
59613409|NCT01593696|75724556|FG001|No Prior Transplant|Dose Escalation||4||
59947458|NCT03412565|76066069|FG003|NOT COMPLETED|Overall Study||51||
59947459|NCT03330847|76066085|FG000|STARTED|Overall Study||114||
59947460|NCT03330847|76066086|FG001|STARTED|Overall Study||112||
59947461|NCT03330847|76066087|FG002|STARTED|Overall Study||47||
59947462|NCT03330847|76066085|FG000|COMPLETED|Overall Study||52||
59947463|NCT03330847|76066086|FG001|COMPLETED|Overall Study||47||
59947464|NCT03330847|76066087|FG002|COMPLETED|Overall Study||32||
59947465|NCT03330847|76066085|FG000|NOT COMPLETED|Overall Study||62||
59947466|NCT03330847|76066086|FG001|NOT COMPLETED|Overall Study||65||
59947467|NCT03330847|76066087|FG002|NOT COMPLETED|Overall Study||15||
59518828|NCT00943631|75612697|FG001|NOT COMPLETED|Overall Study||2||
59947468|NCT03314935|76066112|FG000|STARTED|Phase 1||8||
59947469|NCT03314935|76066113|FG001|STARTED|Phase 1||6||
59947470|NCT03314935|76066114|FG002|STARTED|Phase 1||6||
59947471|NCT03314935|76066115|FG003|STARTED|Phase 1||7||
59947472|NCT03314935|76066116|FG004|STARTED|Phase 1||4||
59947473|NCT03314935|76066117|FG005|STARTED|Phase 1||4||
59947474|NCT03314935|76066118|FG006|STARTED|Phase 1||7||
59947475|NCT03314935|76066119|FG007|STARTED|Phase 1||5||
59947476|NCT03314935|76066120|FG008|STARTED|Phase 1||7||
59947477|NCT03314935|76066121|FG009|STARTED|Phase 1||0||
59947478|NCT03314935|76066122|FG010|STARTED|Phase 1||0||
59947479|NCT03314935|76066123|FG011|STARTED|Phase 1||0||
59947480|NCT03314935|76066124|FG012|STARTED|Phase 1||0||
59947481|NCT03314935|76066125|FG013|STARTED|Phase 1||0||
59947482|NCT03314935|76066126|FG014|STARTED|Phase 1||0||
59947483|NCT03314935|76066112|FG000|COMPLETED|Phase 1||0||
59947484|NCT03314935|76066113|FG001|COMPLETED|Phase 1||0||
59947485|NCT03314935|76066114|FG002|COMPLETED|Phase 1||0||
59947486|NCT03314935|76066115|FG003|COMPLETED|Phase 1||0||
59947487|NCT03314935|76066116|FG004|COMPLETED|Phase 1||0||
59947488|NCT03314935|76066117|FG005|COMPLETED|Phase 1||0||
59947489|NCT03314935|76066118|FG006|COMPLETED|Phase 1||0||
59947490|NCT03314935|76066119|FG007|COMPLETED|Phase 1||0||
59947491|NCT03314935|76066120|FG008|COMPLETED|Phase 1||0||
59947492|NCT03314935|76066121|FG009|COMPLETED|Phase 1||0||
59947493|NCT03314935|76066122|FG010|COMPLETED|Phase 1||0||
59947494|NCT03314935|76066123|FG011|COMPLETED|Phase 1||0||
59947495|NCT03314935|76066124|FG012|COMPLETED|Phase 1||0||
59947496|NCT03314935|76066125|FG013|COMPLETED|Phase 1||0||
59947497|NCT03314935|76066126|FG014|COMPLETED|Phase 1||0||
59947498|NCT03314935|76066112|FG000|NOT COMPLETED|Phase 1||8||
59947499|NCT03314935|76066113|FG001|NOT COMPLETED|Phase 1||6||
59947500|NCT03314935|76066114|FG002|NOT COMPLETED|Phase 1||6||
59947501|NCT03314935|76066115|FG003|NOT COMPLETED|Phase 1||7||
59947502|NCT03314935|76066116|FG004|NOT COMPLETED|Phase 1||4||
59947503|NCT03314935|76066117|FG005|NOT COMPLETED|Phase 1||4||
59947504|NCT03314935|76066118|FG006|NOT COMPLETED|Phase 1||7||
59947505|NCT03314935|76066119|FG007|NOT COMPLETED|Phase 1||5||
59947506|NCT03314935|76066120|FG008|NOT COMPLETED|Phase 1||7||
59947507|NCT03314935|76066121|FG009|NOT COMPLETED|Phase 1||0||
59947508|NCT03314935|76066122|FG010|NOT COMPLETED|Phase 1||0||
59947509|NCT03314935|76066123|FG011|NOT COMPLETED|Phase 1||0||
59947510|NCT03314935|76066124|FG012|NOT COMPLETED|Phase 1||0||
59947511|NCT03314935|76066125|FG013|NOT COMPLETED|Phase 1||0||
59947512|NCT03314935|76066126|FG014|NOT COMPLETED|Phase 1||0||
59947513|NCT03314935|76066112|FG000|STARTED|Phase 2||0||
59947514|NCT03314935|76066113|FG001|STARTED|Phase 2||0||
59947515|NCT03314935|76066114|FG002|STARTED|Phase 2||0||
59947516|NCT03314935|76066115|FG003|STARTED|Phase 2||0||
59947517|NCT03314935|76066116|FG004|STARTED|Phase 2||0||
59947518|NCT03314935|76066117|FG005|STARTED|Phase 2||0||
59947519|NCT03314935|76066118|FG006|STARTED|Phase 2||0||
59947520|NCT03314935|76066119|FG007|STARTED|Phase 2||0||
59947521|NCT03314935|76066120|FG008|STARTED|Phase 2||0||
59947522|NCT03314935|76066121|FG009|STARTED|Phase 2||8||
59947523|NCT03314935|76066122|FG010|STARTED|Phase 2||33||
59947524|NCT03314935|76066123|FG011|STARTED|Phase 2||9||
59947525|NCT03314935|76066124|FG012|STARTED|Phase 2||11||
59947526|NCT03314935|76066125|FG013|STARTED|Phase 2||10||
59947527|NCT03314935|76066126|FG014|STARTED|Phase 2||24||
59947528|NCT03314935|76066112|FG000|COMPLETED|Phase 2||0||
59947529|NCT03314935|76066113|FG001|COMPLETED|Phase 2||0||
59947530|NCT03314935|76066114|FG002|COMPLETED|Phase 2||0||
59947531|NCT03314935|76066115|FG003|COMPLETED|Phase 2||0||
59947532|NCT03314935|76066116|FG004|COMPLETED|Phase 2||0||
59947533|NCT03314935|76066117|FG005|COMPLETED|Phase 2||0||
59947534|NCT03314935|76066118|FG006|COMPLETED|Phase 2||0||
59947535|NCT03314935|76066119|FG007|COMPLETED|Phase 2||0||
59947536|NCT03314935|76066120|FG008|COMPLETED|Phase 2||0||
59947537|NCT03314935|76066121|FG009|COMPLETED|Phase 2||0||
59947538|NCT03314935|76066122|FG010|COMPLETED|Phase 2||0||
59947539|NCT03314935|76066123|FG011|COMPLETED|Phase 2||0||
59947540|NCT03314935|76066124|FG012|COMPLETED|Phase 2||0||
59947541|NCT03314935|76066125|FG013|COMPLETED|Phase 2||0||
59947542|NCT03314935|76066126|FG014|COMPLETED|Phase 2||0||
59947543|NCT03314935|76066112|FG000|NOT COMPLETED|Phase 2||0||
59947544|NCT03314935|76066113|FG001|NOT COMPLETED|Phase 2||0||
59518829|NCT00947765|75612705|FG000|STARTED|Overall Study||30||
59947545|NCT03314935|76066114|FG002|NOT COMPLETED|Phase 2||0||
59947546|NCT03314935|76066115|FG003|NOT COMPLETED|Phase 2||0||
59947547|NCT03314935|76066116|FG004|NOT COMPLETED|Phase 2||0||
59947548|NCT03314935|76066117|FG005|NOT COMPLETED|Phase 2||0||
59947549|NCT03314935|76066118|FG006|NOT COMPLETED|Phase 2||0||
59947550|NCT03314935|76066119|FG007|NOT COMPLETED|Phase 2||0||
59947551|NCT03314935|76066120|FG008|NOT COMPLETED|Phase 2||0||
59947552|NCT03314935|76066121|FG009|NOT COMPLETED|Phase 2||8||
59947553|NCT03314935|76066122|FG010|NOT COMPLETED|Phase 2||33||
59947554|NCT03314935|76066123|FG011|NOT COMPLETED|Phase 2||9||
59947555|NCT03314935|76066124|FG012|NOT COMPLETED|Phase 2||11||
59947556|NCT03314935|76066125|FG013|NOT COMPLETED|Phase 2||10||
59947557|NCT03314935|76066126|FG014|NOT COMPLETED|Phase 2||24||
59947558|NCT03169361|76066169|FG000|STARTED|Overall Study||774||
59947559|NCT03169361|76066169|FG000|COMPLETED|Overall Study||742||
59947560|NCT03169361|76066169|FG000|NOT COMPLETED|Overall Study||32||
59947561|NCT03054129|76066175|FG000|STARTED|Overall Study||21||
59947562|NCT03054129|76066176|FG001|STARTED|Overall Study||21||
59947563|NCT03054129|76066175|FG000|COMPLETED|Overall Study||19||
59947564|NCT03054129|76066176|FG001|COMPLETED|Overall Study||20||
59947565|NCT03054129|76066175|FG000|NOT COMPLETED|Overall Study||2||
59947566|NCT03054129|76066176|FG001|NOT COMPLETED|Overall Study||1||
59947567|NCT03031847|76066186|FG000|STARTED|Overall Study||22||
59947568|NCT03031847|76066187|FG001|STARTED|Overall Study||20||
59947569|NCT03031847|76066188|FG002|STARTED|Overall Study||18||
59947570|NCT03031847|76066189|FG003|STARTED|Overall Study||42||
59947571|NCT03031847|76066186|FG000|COMPLETED|Overall Study||20||
59947572|NCT03031847|76066187|FG001|COMPLETED|Overall Study||18||
59947573|NCT03031847|76066188|FG002|COMPLETED|Overall Study||14||
59947574|NCT03031847|76066189|FG003|COMPLETED|Overall Study||36||
59947575|NCT03031847|76066186|FG000|NOT COMPLETED|Overall Study||2||
59947576|NCT03031847|76066187|FG001|NOT COMPLETED|Overall Study||2||
59947577|NCT03031847|76066188|FG002|NOT COMPLETED|Overall Study||4||
59947578|NCT03031847|76066189|FG003|NOT COMPLETED|Overall Study||6||
59947579|NCT02831764|76066201|FG000|STARTED|Double-blind Phase (Day1 to Week 96)|Randomized|360||
59947580|NCT02831764|76066202|FG001|STARTED|Double-blind Phase (Day1 to Week 96)|Randomized|362||
59947581|NCT02831764|76066203|FG002|STARTED|Double-blind Phase (Day1 to Week 96)||0||
59947582|NCT02831764|76066204|FG003|STARTED|Double-blind Phase (Day1 to Week 96)||0||
59947583|NCT02831764|76066205|FG004|STARTED|Double-blind Phase (Day1 to Week 96)||0||
59947584|NCT02831764|76066201|FG000|Intent-to-Treat Exposed|Double-blind Phase (Day1 to Week 96)||360||
59947585|NCT02831764|76066202|FG001|Intent-to-Treat Exposed|Double-blind Phase (Day1 to Week 96)||359||
59947586|NCT02831764|76066203|FG002|Intent-to-Treat Exposed|Double-blind Phase (Day1 to Week 96)||0||
59947587|NCT02831764|76066204|FG003|Intent-to-Treat Exposed|Double-blind Phase (Day1 to Week 96)||0||
59947588|NCT02831764|76066205|FG004|Intent-to-Treat Exposed|Double-blind Phase (Day1 to Week 96)||0||
59947589|NCT02831764|76066201|FG000|COMPLETED|Double-blind Phase (Day1 to Week 96)||319||
59947590|NCT02831764|76066202|FG001|COMPLETED|Double-blind Phase (Day1 to Week 96)||327||
59947591|NCT02831764|76066203|FG002|COMPLETED|Double-blind Phase (Day1 to Week 96)||0||
59947592|NCT02831764|76066204|FG003|COMPLETED|Double-blind Phase (Day1 to Week 96)||0||
59947593|NCT02831764|76066205|FG004|COMPLETED|Double-blind Phase (Day1 to Week 96)||0||
59947594|NCT02831764|76066201|FG000|NOT COMPLETED|Double-blind Phase (Day1 to Week 96)||41||
59947595|NCT02831764|76066202|FG001|NOT COMPLETED|Double-blind Phase (Day1 to Week 96)||35||
59947596|NCT02831764|76066203|FG002|NOT COMPLETED|Double-blind Phase (Day1 to Week 96)||0||
59947597|NCT02831764|76066204|FG003|NOT COMPLETED|Double-blind Phase (Day1 to Week 96)||0||
59947598|NCT02831764|76066205|FG004|NOT COMPLETED|Double-blind Phase (Day1 to Week 96)||0||
59947599|NCT02831764|76066201|FG000|STARTED|Open-label Phase (Week 96 to Week 148)||0||
59947600|NCT02831764|76066202|FG001|STARTED|Open-label Phase (Week 96 to Week 148)||0||
59947601|NCT02831764|76066203|FG002|STARTED|Open-label Phase (Week 96 to Week 148)||319||
59947602|NCT02831764|76066204|FG003|STARTED|Open-label Phase (Week 96 to Week 148)||327||
59947603|NCT02831764|76066205|FG004|STARTED|Open-label Phase (Week 96 to Week 148)||0||
59947604|NCT02831764|76066201|FG000|COMPLETED|Open-label Phase (Week 96 to Week 148)||0||
59947605|NCT02831764|76066202|FG001|COMPLETED|Open-label Phase (Week 96 to Week 148)||0||
59947606|NCT02831764|76066203|FG002|COMPLETED|Open-label Phase (Week 96 to Week 148)||301||
59947607|NCT02831764|76066204|FG003|COMPLETED|Open-label Phase (Week 96 to Week 148)||300||
59947608|NCT02831764|76066205|FG004|COMPLETED|Open-label Phase (Week 96 to Week 148)||0||
59947609|NCT02831764|76066201|FG000|NOT COMPLETED|Open-label Phase (Week 96 to Week 148)||0||
59947610|NCT02831764|76066202|FG001|NOT COMPLETED|Open-label Phase (Week 96 to Week 148)||0||
59947611|NCT02831764|76066203|FG002|NOT COMPLETED|Open-label Phase (Week 96 to Week 148)||18||
59947612|NCT02831764|76066204|FG003|NOT COMPLETED|Open-label Phase (Week 96 to Week 148)||27||
59947613|NCT02831764|76066205|FG004|NOT COMPLETED|Open-label Phase (Week 96 to Week 148)||0||
59947614|NCT02831764|76066201|FG000|STARTED|Continuation Phase(Week 148 to Week 280)||0||
59947615|NCT02831764|76066202|FG001|STARTED|Continuation Phase(Week 148 to Week 280)||0||
59947616|NCT02831764|76066203|FG002|STARTED|Continuation Phase(Week 148 to Week 280)||0||
59947617|NCT02831764|76066204|FG003|STARTED|Continuation Phase(Week 148 to Week 280)||0||
59947618|NCT02831764|76066205|FG004|STARTED|Continuation Phase(Week 148 to Week 280)|252 participants from the Open-label Phase entered in the Continuation Phase|252||
59947619|NCT02831764|76066201|FG000|COMPLETED|Continuation Phase(Week 148 to Week 280)||0||
59947620|NCT02831764|76066202|FG001|COMPLETED|Continuation Phase(Week 148 to Week 280)||0||
59947621|NCT02831764|76066203|FG002|COMPLETED|Continuation Phase(Week 148 to Week 280)||0||
59947622|NCT02831764|76066204|FG003|COMPLETED|Continuation Phase(Week 148 to Week 280)||0||
59947623|NCT02831764|76066205|FG004|COMPLETED|Continuation Phase(Week 148 to Week 280)||239||
59947624|NCT02831764|76066201|FG000|NOT COMPLETED|Continuation Phase(Week 148 to Week 280)||0||
59947625|NCT02831764|76066202|FG001|NOT COMPLETED|Continuation Phase(Week 148 to Week 280)||0||
59947626|NCT02831764|76066203|FG002|NOT COMPLETED|Continuation Phase(Week 148 to Week 280)||0||
59947627|NCT02831764|76066204|FG003|NOT COMPLETED|Continuation Phase(Week 148 to Week 280)||0||
59947628|NCT02831764|76066205|FG004|NOT COMPLETED|Continuation Phase(Week 148 to Week 280)||13||
59947629|NCT02396199|76066214|FG000|STARTED|Overall Study||80||
59947630|NCT02396199|76066214|FG000|Started 6-Month|Overall Study||79||
59947631|NCT02396199|76066214|FG000|Completed 6-Month|Overall Study||76||
59947632|NCT02396199|76066214|FG000|Started 12-Month|Overall Study||76||
59947633|NCT02396199|76066214|FG000|COMPLETED|Overall Study||75||
59947634|NCT02396199|76066214|FG000|NOT COMPLETED|Overall Study||5||
59947635|NCT02061345|76066220|FG000|STARTED|Overall Study||6||
59947636|NCT02061345|76066221|FG001|STARTED|Overall Study||5||
59947637|NCT02061345|76066220|FG000|COMPLETED|Overall Study||6||
59947638|NCT02061345|76066221|FG001|COMPLETED|Overall Study||5||
59947639|NCT02061345|76066220|FG000|NOT COMPLETED|Overall Study||0||
59947640|NCT02061345|76066221|FG001|NOT COMPLETED|Overall Study||0||
59947641|NCT01665144|76066229|FG000|STARTED|Overall Study||1105||
59947642|NCT01665144|76066230|FG001|STARTED|Overall Study||546||
59947643|NCT01665144|76066229|FG000|Safety Set|Overall Study||1099||
59947644|NCT01665144|76066230|FG001|Safety Set|Overall Study||546||
59947645|NCT01665144|76066229|FG000|Full Analysis Set|Overall Study||1099||
59947646|NCT01665144|76066230|FG001|Full Analysis Set|Overall Study||546||
59947647|NCT01665144|76066229|FG000|COMPLETED|Overall Study||903||
59947648|NCT01665144|76066230|FG001|COMPLETED|Overall Study||424||
59947649|NCT01665144|76066229|FG000|NOT COMPLETED|Overall Study||202||
59947650|NCT01665144|76066230|FG001|NOT COMPLETED|Overall Study||122||
59947651|NCT01661881|76066236|FG000|STARTED|Overall Study||23||
59947652|NCT01661881|76066236|FG000|COMPLETED|Overall Study||22||
59947653|NCT01661881|76066236|FG000|NOT COMPLETED|Overall Study||1||
59947654|NCT01353313|76066242|FG000|STARTED|Overall Study||398||
59947655|NCT01353313|76066243|FG001|STARTED|Overall Study||402||
59947656|NCT01353313|76066242|FG000|Completed Assessment for Neurodevelopmental Impairment|Overall Study||321||
59947657|NCT01353313|76066243|FG001|Completed Assessment for Neurodevelopmental Impairment|Overall Study||318||
59947658|NCT01353313|76066242|FG000|Died After Discharge|Overall Study||8||
59947659|NCT01353313|76066243|FG001|Died After Discharge|Overall Study||6||
59947660|NCT01353313|76066242|FG000|Died Before Discharge|Overall Study||35||
59947661|NCT01353313|76066243|FG001|Died Before Discharge|Overall Study||40||
59947662|NCT01353313|76066242|FG000|Survived to Discharge|Overall Study||363||
59947663|NCT01353313|76066243|FG001|Survived to Discharge|Overall Study||362||
59947664|NCT01353313|76066242|FG000|COMPLETED|Overall Study||364|Complete data for Neurodevelopmental Impairment or died|
59947665|NCT01353313|76066243|FG001|COMPLETED|Overall Study||364|Complete data for Neurodevelopmental Impairment or died|
59947666|NCT01353313|76066242|FG000|NOT COMPLETED|Overall Study||34||
59947667|NCT01353313|76066243|FG001|NOT COMPLETED|Overall Study||38||
59947668|NCT02764320|76066251|FG000|STARTED|Overall Study||361||
59947669|NCT02764320|76066252|FG001|STARTED|Overall Study||359||
59947670|NCT02764320|76066251|FG000|COMPLETED|Overall Study||310||
59947671|NCT02764320|76066252|FG001|COMPLETED|Overall Study||310||
59947672|NCT02764320|76066251|FG000|NOT COMPLETED|Overall Study||51||
59947673|NCT02764320|76066252|FG001|NOT COMPLETED|Overall Study||49||
59947674|NCT02851407|76066260|FG000|STARTED|Overall Study||190||
59947675|NCT02851407|76066261|FG001|STARTED|Overall Study||182||
59947676|NCT02851407|76066260|FG000|COMPLETED|Overall Study||120||
59947677|NCT02851407|76066261|FG001|COMPLETED|Overall Study||121||
59947678|NCT02851407|76066260|FG000|NOT COMPLETED|Overall Study||70||
59947679|NCT02851407|76066261|FG001|NOT COMPLETED|Overall Study||61||
59947680|NCT02636608|76066267|FG000|STARTED|Overall Study||244||
59947681|NCT02636608|76066267|FG000|Received Treatment|Overall Study||243||
59947682|NCT02636608|76066267|FG000|COMPLETED|Overall Study||233|Completed defined as having an HCV RNA assessment performed at least 10 weeks post-treatment|
59947683|NCT02636608|76066267|FG000|NOT COMPLETED|Overall Study||11||
59947684|NCT02759562|76066276|FG000|STARTED|Double-Blind Treatment Period (8 Weeks)||3||
59947685|NCT02759562|76066277|FG001|STARTED|Double-Blind Treatment Period (8 Weeks)||3||
60067618|NCT01606761|76182768|FG003|STARTED|Safety Follow-up Period (Week 52-68)||9||
59947686|NCT02759562|76066276|FG000|COMPLETED|Double-Blind Treatment Period (8 Weeks)||3||
59947687|NCT02759562|76066277|FG001|COMPLETED|Double-Blind Treatment Period (8 Weeks)||3||
59947688|NCT02759562|76066276|FG000|NOT COMPLETED|Double-Blind Treatment Period (8 Weeks)||0||
59947689|NCT02759562|76066277|FG001|NOT COMPLETED|Double-Blind Treatment Period (8 Weeks)||0||
59947690|NCT02759562|76066276|FG000|STARTED|Open-Label Treatment Period||2|2 participants completed the Double-Blind Phase, but did not enter in the Open-Label Phase.|
59947691|NCT02759562|76066277|FG001|STARTED|Open-Label Treatment Period||2|2 participants completed the Double-Blind Phase, but did not enter in the Open-Label Phase.|
59947692|NCT02759562|76066276|FG000|COMPLETED|Open-Label Treatment Period||0||
59947693|NCT02759562|76066277|FG001|COMPLETED|Open-Label Treatment Period||0||
59947694|NCT02759562|76066276|FG000|NOT COMPLETED|Open-Label Treatment Period||2||
59947695|NCT02759562|76066277|FG001|NOT COMPLETED|Open-Label Treatment Period||2||
59947696|NCT02746575|76066284|FG000|STARTED|Overall Study||70||
59947697|NCT02746575|76066284|FG000|COMPLETED|Overall Study||20||
59947698|NCT02746575|76066284|FG000|NOT COMPLETED|Overall Study||50||
59947699|NCT03625466|76066290|FG000|STARTED|Placebo-controlled Period (48 Weeks)||16||
59947700|NCT03625466|76066291|FG001|STARTED|Placebo-controlled Period (48 Weeks)||35||
59947701|NCT03625466|76066292|FG002|STARTED|Placebo-controlled Period (48 Weeks)||0||
60067619|NCT01606761|76182769|FG004|STARTED|Safety Follow-up Period (Week 52-68)||19||
60067620|NCT01606761|76182765|FG000|Safety Population|Safety Follow-up Period (Week 52-68)||28||
59947702|NCT03625466|76066290|FG000|COMPLETED|Placebo-controlled Period (48 Weeks)||16||
59947703|NCT03625466|76066291|FG001|COMPLETED|Placebo-controlled Period (48 Weeks)||33||
59947704|NCT03625466|76066292|FG002|COMPLETED|Placebo-controlled Period (48 Weeks)||0||
59947705|NCT03625466|76066290|FG000|NOT COMPLETED|Placebo-controlled Period (48 Weeks)||0||
59947706|NCT03625466|76066291|FG001|NOT COMPLETED|Placebo-controlled Period (48 Weeks)||2||
59947707|NCT03625466|76066292|FG002|NOT COMPLETED|Placebo-controlled Period (48 Weeks)||0||
59947708|NCT03625466|76066290|FG000|STARTED|Open-label Period (48 Weeks)||0||
59947709|NCT03625466|76066291|FG001|STARTED|Open-label Period (48 Weeks)||0||
59947710|NCT03625466|76066292|FG002|STARTED|Open-label Period (48 Weeks)||49||
59947711|NCT03625466|76066290|FG000|COMPLETED|Open-label Period (48 Weeks)||0||
59947712|NCT03625466|76066291|FG001|COMPLETED|Open-label Period (48 Weeks)||0||
59947713|NCT03625466|76066292|FG002|COMPLETED|Open-label Period (48 Weeks)||48||
59947714|NCT03625466|76066290|FG000|NOT COMPLETED|Open-label Period (48 Weeks)||0||
59947715|NCT03625466|76066291|FG001|NOT COMPLETED|Open-label Period (48 Weeks)||0||
59947716|NCT03625466|76066292|FG002|NOT COMPLETED|Open-label Period (48 Weeks)||1||
59947717|NCT02853123|76066299|FG000|STARTED|Treatment Period 1||52||
59947718|NCT02853123|76066300|FG001|STARTED|Treatment Period 1||54||
59947719|NCT02853123|76066299|FG000|COMPLETED|Treatment Period 1||52||
59947720|NCT02853123|76066300|FG001|COMPLETED|Treatment Period 1||51||
59947721|NCT02853123|76066299|FG000|NOT COMPLETED|Treatment Period 1||0||
59947722|NCT02853123|76066300|FG001|NOT COMPLETED|Treatment Period 1||3||
59947723|NCT02853123|76066299|FG000|STARTED|Washout Period||52||
59947724|NCT02853123|76066300|FG001|STARTED|Washout Period||51||
59947725|NCT02853123|76066299|FG000|COMPLETED|Washout Period||51||
59947726|NCT02853123|76066300|FG001|COMPLETED|Washout Period||48||
59947727|NCT02853123|76066299|FG000|NOT COMPLETED|Washout Period||1||
59947728|NCT02853123|76066300|FG001|NOT COMPLETED|Washout Period||3||
59947729|NCT02853123|76066299|FG000|STARTED|Treatment Period 2||51||
59947730|NCT02853123|76066300|FG001|STARTED|Treatment Period 2||48||
59947731|NCT02853123|76066299|FG000|COMPLETED|Treatment Period 2||51||
59947732|NCT02853123|76066300|FG001|COMPLETED|Treatment Period 2||48||
59947733|NCT02853123|76066299|FG000|NOT COMPLETED|Treatment Period 2||0||
59947734|NCT02853123|76066300|FG001|NOT COMPLETED|Treatment Period 2||0||
59947735|NCT02634346|76066310|FG000|STARTED|Overall Study||134||
59947736|NCT02634346|76066311|FG001|STARTED|Overall Study||133||
59947737|NCT02634346|76066312|FG002|STARTED|Overall Study||134||
59947738|NCT02634346|76066310|FG000|COMPLETED|Overall Study||122||
59947739|NCT02634346|76066311|FG001|COMPLETED|Overall Study||119||
59947740|NCT02634346|76066312|FG002|COMPLETED|Overall Study||111||
59947741|NCT02634346|76066310|FG000|NOT COMPLETED|Overall Study||12||
59947742|NCT02634346|76066311|FG001|NOT COMPLETED|Overall Study||14||
59947743|NCT02634346|76066312|FG002|NOT COMPLETED|Overall Study||23||
59947744|NCT00849147|76066320|FG000|STARTED|Overall Study||55||
59947745|NCT00849147|76066320|FG000|COMPLETED|Overall Study||50||
59947746|NCT00849147|76066320|FG000|NOT COMPLETED|Overall Study||5||
59947747|NCT00101166|76066324|FG000|STARTED|Overall Study||28||
59947748|NCT00101166|76066324|FG000|COMPLETED|Overall Study||18||
59947749|NCT00101166|76066324|FG000|NOT COMPLETED|Overall Study||10||
59947750|NCT02759016|76066330|FG000|STARTED|Overall Study||4|Assigned to combination treatment BI 836826 and ibrutinib|
59947751|NCT02759016|76066331|FG001|STARTED|Overall Study||3|Assigned to combination treatment BI 836826 and ibrutinib|
59947752|NCT02759016|76066330|FG000|Treated With BI 836826 and Ibrutinib|Overall Study||3||
59947753|NCT02759016|76066331|FG001|Treated With BI 836826 and Ibrutinib|Overall Study||3||
59947754|NCT02759016|76066330|FG000|COMPLETED|Overall Study||0||
59947755|NCT02759016|76066331|FG001|COMPLETED|Overall Study||0||
59947756|NCT02759016|76066330|FG000|NOT COMPLETED|Overall Study||4||
59947757|NCT02759016|76066331|FG001|NOT COMPLETED|Overall Study||3||
59947758|NCT02852967|76066343|FG000|STARTED|Overall Study||23||
59947759|NCT02852967|76066344|FG001|STARTED|Overall Study||22||
59947760|NCT02852967|76066345|FG002|STARTED|Overall Study||21||
59947761|NCT02852967|76066346|FG003|STARTED|Overall Study||26||
59947762|NCT02852967|76066347|FG004|STARTED|Overall Study||18||
59947763|NCT02852967|76066343|FG000|Completed Period 1: Double-blind|Overall Study||14||
59947764|NCT02852967|76066344|FG001|Completed Period 1: Double-blind|Overall Study||15||
59947765|NCT02852967|76066345|FG002|Completed Period 1: Double-blind|Overall Study||17||
59947766|NCT02852967|76066346|FG003|Completed Period 1: Double-blind|Overall Study||16||
59947767|NCT02852967|76066347|FG004|Completed Period 1: Double-blind|Overall Study||10||
59947768|NCT02852967|76066343|FG000|Completed Period 2: Open-label|Overall Study||11||
59947769|NCT02852967|76066344|FG001|Completed Period 2: Open-label|Overall Study||8||
59947770|NCT02852967|76066345|FG002|Completed Period 2: Open-label|Overall Study||13||
59947771|NCT02852967|76066346|FG003|Completed Period 2: Open-label|Overall Study||11||
59947772|NCT02852967|76066347|FG004|Completed Period 2: Open-label|Overall Study||14||
59947773|NCT02852967|76066343|FG000|COMPLETED|Overall Study||9||
59947774|NCT02852967|76066344|FG001|COMPLETED|Overall Study||6||
59947775|NCT02852967|76066345|FG002|COMPLETED|Overall Study||9||
59947776|NCT02852967|76066346|FG003|COMPLETED|Overall Study||4||
59947777|NCT02852967|76066347|FG004|COMPLETED|Overall Study||2||
59518830|NCT00947765|75612706|FG001|STARTED|Overall Study||30||
59947778|NCT02852967|76066343|FG000|NOT COMPLETED|Overall Study||14||
59947779|NCT02852967|76066344|FG001|NOT COMPLETED|Overall Study||16||
59947780|NCT02852967|76066345|FG002|NOT COMPLETED|Overall Study||12||
59947781|NCT02852967|76066346|FG003|NOT COMPLETED|Overall Study||22||
59947782|NCT02852967|76066347|FG004|NOT COMPLETED|Overall Study||16||
59947783|NCT03593044|76066367|FG000|STARTED|Overall Study||31||
59947784|NCT03593044|76066367|FG000|COMPLETED|Overall Study||31||
59947785|NCT03593044|76066367|FG000|NOT COMPLETED|Overall Study||0||
59947786|NCT02762994|76066375|FG000|STARTED|Overall Study||31||
59947787|NCT02762994|76066376|FG001|STARTED|Overall Study||31||
59947788|NCT02762994|76066377|FG002|STARTED|Overall Study||30||
59947789|NCT02762994|76066378|FG003|STARTED|Overall Study||28||
59947790|NCT02762994|76066375|FG000|COMPLETED|Overall Study||30||
59947791|NCT02762994|76066376|FG001|COMPLETED|Overall Study||30||
59947792|NCT02762994|76066377|FG002|COMPLETED|Overall Study||28||
59947793|NCT02762994|76066378|FG003|COMPLETED|Overall Study||26||
59947794|NCT02762994|76066375|FG000|NOT COMPLETED|Overall Study||1||
59947795|NCT02762994|76066376|FG001|NOT COMPLETED|Overall Study||1||
59947796|NCT02762994|76066377|FG002|NOT COMPLETED|Overall Study||2||
59947797|NCT02762994|76066378|FG003|NOT COMPLETED|Overall Study||2||
59947798|NCT02852265|76066394|FG000|STARTED|1-month Follow-up||10||
59947799|NCT02852265|76066395|FG001|STARTED|1-month Follow-up||10||
59947800|NCT02852265|76066394|FG000|COMPLETED|1-month Follow-up||10||
59947801|NCT02852265|76066395|FG001|COMPLETED|1-month Follow-up||10||
59947802|NCT02852265|76066394|FG000|NOT COMPLETED|1-month Follow-up||0||
59947803|NCT02852265|76066395|FG001|NOT COMPLETED|1-month Follow-up||0||
59947804|NCT02852265|76066394|FG000|STARTED|3-month Follow-up||10||
59947805|NCT02852265|76066395|FG001|STARTED|3-month Follow-up||10||
59947806|NCT02852265|76066394|FG000|COMPLETED|3-month Follow-up||9||
59947807|NCT02852265|76066395|FG001|COMPLETED|3-month Follow-up||9||
59947808|NCT02852265|76066394|FG000|NOT COMPLETED|3-month Follow-up||1||
59947809|NCT02852265|76066395|FG001|NOT COMPLETED|3-month Follow-up||1||
59947810|NCT02852265|76066394|FG000|STARTED|6-month Follow-up||9||
59947811|NCT02852265|76066395|FG001|STARTED|6-month Follow-up||9||
59518831|NCT00947765|75612705|FG000|COMPLETED|Overall Study||30||
59518832|NCT00947765|75612706|FG001|COMPLETED|Overall Study||30||
59947812|NCT02852265|76066394|FG000|COMPLETED|6-month Follow-up||9||
59947813|NCT02852265|76066395|FG001|COMPLETED|6-month Follow-up||9||
59947814|NCT02852265|76066394|FG000|NOT COMPLETED|6-month Follow-up||0||
59947815|NCT02852265|76066395|FG001|NOT COMPLETED|6-month Follow-up||0||
59947816|NCT02633800|76066407|FG000|STARTED|Overall Study||44||
59947817|NCT02633800|76066408|FG001|STARTED|Overall Study||43||
59947818|NCT02633800|76066407|FG000|COMPLETED|Overall Study||0||
59947819|NCT02633800|76066408|FG001|COMPLETED|Overall Study||0||
59947820|NCT02633800|76066407|FG000|NOT COMPLETED|Overall Study||44||
59947821|NCT02633800|76066408|FG001|NOT COMPLETED|Overall Study||43||
59947822|NCT03829657|76066417|FG000|STARTED|OL Treatment Period (Week 1 to Week 16)||85||
59947823|NCT03829657|76066418|FG001|STARTED|OL Treatment Period (Week 1 to Week 16)||85||
59947824|NCT03829657|76066419|FG002|STARTED|OL Treatment Period (Week 1 to Week 16)||33||
59947825|NCT03829657|76066420|FG003|STARTED|OL Treatment Period (Week 1 to Week 16)||0||
59947826|NCT03829657|76066421|FG004|STARTED|OL Treatment Period (Week 1 to Week 16)||0||
59947827|NCT03829657|76066417|FG000|COMPLETED|OL Treatment Period (Week 1 to Week 16)||52||
59947828|NCT03829657|76066418|FG001|COMPLETED|OL Treatment Period (Week 1 to Week 16)||64||
59947829|NCT03829657|76066419|FG002|COMPLETED|OL Treatment Period (Week 1 to Week 16)||12||
59947830|NCT03829657|76066420|FG003|COMPLETED|OL Treatment Period (Week 1 to Week 16)||0||
59947831|NCT03829657|76066421|FG004|COMPLETED|OL Treatment Period (Week 1 to Week 16)||0||
59947832|NCT03829657|76066417|FG000|NOT COMPLETED|OL Treatment Period (Week 1 to Week 16)||33||
59947833|NCT03829657|76066418|FG001|NOT COMPLETED|OL Treatment Period (Week 1 to Week 16)||21||
59947834|NCT03829657|76066419|FG002|NOT COMPLETED|OL Treatment Period (Week 1 to Week 16)||21||
59947835|NCT03829657|76066420|FG003|NOT COMPLETED|OL Treatment Period (Week 1 to Week 16)||0||
59947836|NCT03829657|76066421|FG004|NOT COMPLETED|OL Treatment Period (Week 1 to Week 16)||0||
59947837|NCT03829657|76066417|FG000|STARTED|RW Treatment Period (Week 16 to Week 24)||0||
59947838|NCT03829657|76066418|FG001|STARTED|RW Treatment Period (Week 16 to Week 24)||0||
59947839|NCT03829657|76066419|FG002|STARTED|RW Treatment Period (Week 16 to Week 24)||0||
59947840|NCT03829657|76066420|FG003|STARTED|RW Treatment Period (Week 16 to Week 24)||64||
59947841|NCT03829657|76066421|FG004|STARTED|RW Treatment Period (Week 16 to Week 24)||64||
59518833|NCT00947765|75612705|FG000|NOT COMPLETED|Overall Study||0||
59947842|NCT03829657|76066417|FG000|COMPLETED|RW Treatment Period (Week 16 to Week 24)||0||
59947843|NCT03829657|76066418|FG001|COMPLETED|RW Treatment Period (Week 16 to Week 24)||0||
59947844|NCT03829657|76066419|FG002|COMPLETED|RW Treatment Period (Week 16 to Week 24)||0||
59947845|NCT03829657|76066420|FG003|COMPLETED|RW Treatment Period (Week 16 to Week 24)||61||
59947846|NCT03829657|76066421|FG004|COMPLETED|RW Treatment Period (Week 16 to Week 24)||58||
59947847|NCT03829657|76066417|FG000|NOT COMPLETED|RW Treatment Period (Week 16 to Week 24)||0||
59947848|NCT03829657|76066418|FG001|NOT COMPLETED|RW Treatment Period (Week 16 to Week 24)||0||
59947849|NCT03829657|76066419|FG002|NOT COMPLETED|RW Treatment Period (Week 16 to Week 24)||0||
59947850|NCT03829657|76066420|FG003|NOT COMPLETED|RW Treatment Period (Week 16 to Week 24)||3||
59947851|NCT03829657|76066421|FG004|NOT COMPLETED|RW Treatment Period (Week 16 to Week 24)||6||
59947852|NCT03035227|76066432|FG000|STARTED|Overall Study||1||
59947853|NCT03035227|76066433|FG001|STARTED|Overall Study||1||
59947854|NCT03035227|76066432|FG000|COMPLETED|Overall Study|study stopped due to PI leaving institution|0||
59947855|NCT03035227|76066433|FG001|COMPLETED|Overall Study|study stopped due to PI leaving institution|0||
59947856|NCT03035227|76066432|FG000|NOT COMPLETED|Overall Study||1||
59947857|NCT03035227|76066433|FG001|NOT COMPLETED|Overall Study||1||
59947858|NCT00100932|76066443|FG000|STARTED|Overall Study|Represents all enrolled pts; counts in demographic section represents ITT/Safety Population.|78||
59947859|NCT00100932|76066444|FG001|STARTED|Overall Study|Represents all enrolled pts; counts in demographic section represents ITT/Safety Population.|28||
59947860|NCT00100932|76066443|FG000|COMPLETED|Overall Study||5||
59947861|NCT00100932|76066444|FG001|COMPLETED|Overall Study||1||
59947862|NCT00100932|76066443|FG000|NOT COMPLETED|Overall Study||73||
59947863|NCT00100932|76066444|FG001|NOT COMPLETED|Overall Study||27||
59947864|NCT03180307|76066452|FG000|STARTED|Overall Study||134||
59947865|NCT03180307|76066453|FG001|STARTED|Overall Study||6||
59947866|NCT03180307|76066452|FG000|Safety Analysis Set|Overall Study||134|All subjects received study drug prior to randomization. A total of 150 subjects received study drug, 10 of which were not randomized to either arm. These 10 subjects withdrew to the study prior to randomization but are included in the Safety Analysis Set.|
59947867|NCT03180307|76066453|FG001|Safety Analysis Set|Overall Study||16|All subjects received study drug prior to randomization. A total of 150 subjects received study drug, 10 of which were not randomized to either arm. These 10 subjects withdrew to the study prior to randomization but are included in the Safety Analysis Set.|
59947868|NCT03180307|76066452|FG000|Full Analysis Set/ Intent to Image Set|Overall Study||134||
59947869|NCT03180307|76066453|FG001|Full Analysis Set/ Intent to Image Set|Overall Study||0||
59947870|NCT03180307|76066452|FG000|Per Protocol Analysis Set|Overall Study||106||
59947871|NCT03180307|76066453|FG001|Per Protocol Analysis Set|Overall Study||0||
59947872|NCT03180307|76066452|FG000|Pharmacokinetic Analysis Set|Overall Study||122||
59947873|NCT03180307|76066453|FG001|Pharmacokinetic Analysis Set|Overall Study||6||
59947874|NCT03180307|76066452|FG000|COMPLETED|Overall Study||128||
59947875|NCT03180307|76066453|FG001|COMPLETED|Overall Study||6||
59947876|NCT03180307|76066452|FG000|NOT COMPLETED|Overall Study||6||
59947877|NCT03180307|76066453|FG001|NOT COMPLETED|Overall Study||0||
59947878|NCT02848833|76066457|FG000|STARTED|Overall Study||3368||
59947879|NCT02848833|76066457|FG000|COMPLETED|Overall Study||3231|All Participants whose case report forms (CRFs) were retrieved during the re-examination period and who did not violate the inclusion/exclusion criteria.|
59947880|NCT02848833|76066457|FG000|NOT COMPLETED|Overall Study||137||
59947881|NCT03361189|76066463|FG000|STARTED|Overall Study||2||
59947882|NCT03361189|76066464|FG001|STARTED|Overall Study||2||
59947883|NCT03361189|76066463|FG000|Completed Test Period 1 Completed|Overall Study||1||
59947884|NCT03361189|76066464|FG001|Completed Test Period 1 Completed|Overall Study||1||
59947885|NCT03361189|76066463|FG000|Test Period 2 Begun|Overall Study||1||
59947886|NCT03361189|76066464|FG001|Test Period 2 Begun|Overall Study||1||
59947887|NCT03361189|76066463|FG000|COMPLETED|Overall Study||1||
59947888|NCT03361189|76066464|FG001|COMPLETED|Overall Study||1||
59947889|NCT03361189|76066463|FG000|NOT COMPLETED|Overall Study||1||
59947890|NCT03361189|76066464|FG001|NOT COMPLETED|Overall Study||1||
59947891|NCT00092131|76066472|FG000|STARTED|Treatment Period I|1 patient discontinued due to influenza which started in washout (11 days after Period I medication)|25||
59947892|NCT00092131|76066473|FG001|STARTED|Treatment Period I||26||
59947893|NCT00092131|76066472|FG000|COMPLETED|Treatment Period I||24||
59947894|NCT00092131|76066473|FG001|COMPLETED|Treatment Period I||26||
59947895|NCT00092131|76066472|FG000|NOT COMPLETED|Treatment Period I||1||
59947896|NCT00092131|76066473|FG001|NOT COMPLETED|Treatment Period I||0||
59947897|NCT00092131|76066472|FG000|STARTED|Treatment Period II||24||
59947898|NCT00092131|76066473|FG001|STARTED|Treatment Period II|1 patient discontinued after taking Period II study medication, due to asthma exacerbation|26||
59947899|NCT00092131|76066472|FG000|COMPLETED|Treatment Period II||24||
59947900|NCT00092131|76066473|FG001|COMPLETED|Treatment Period II||25||
59947901|NCT00092131|76066472|FG000|NOT COMPLETED|Treatment Period II||0||
59947902|NCT00092131|76066473|FG001|NOT COMPLETED|Treatment Period II||1||
59947903|NCT02668783|76066481|FG000|STARTED|Overall Study||13||
59947904|NCT02668783|76066482|FG001|STARTED|Overall Study||12||
59947905|NCT02668783|76066481|FG000|Treated|Overall Study||13||
59947906|NCT02668783|76066482|FG001|Treated|Overall Study||11||
59947907|NCT02668783|76066481|FG000|COMPLETED|Overall Study||0||
59947908|NCT02668783|76066482|FG001|COMPLETED|Overall Study||0||
60067621|NCT01606761|76182766|FG001|Safety Population|Safety Follow-up Period (Week 52-68)||65||
59947909|NCT02668783|76066481|FG000|NOT COMPLETED|Overall Study||13||
59947910|NCT02668783|76066482|FG001|NOT COMPLETED|Overall Study||12||
59947911|NCT00101010|76066488|FG000|STARTED|Overall Study||80||
59947912|NCT00101010|76066488|FG000|COMPLETED|Overall Study||79||
59947913|NCT00101010|76066488|FG000|NOT COMPLETED|Overall Study||1||
59947914|NCT02848599|76066494|FG000|STARTED|Overall Study||42||
59947915|NCT02848599|76066495|FG001|STARTED|Overall Study||44||
59947916|NCT02848599|76066494|FG000|COMPLETED|Overall Study||35||
59947917|NCT02848599|76066495|FG001|COMPLETED|Overall Study||35||
59947918|NCT02848599|76066494|FG000|NOT COMPLETED|Overall Study||7||
59947919|NCT02848599|76066495|FG001|NOT COMPLETED|Overall Study||9||
59947920|NCT02995369|76066507|FG000|STARTED|Overall Study||8||
59947921|NCT02995369|76066508|FG001|STARTED|Overall Study||8||
59947922|NCT02995369|76066509|FG002|STARTED|Overall Study||8||
59947923|NCT02995369|76066510|FG003|STARTED|Overall Study||8||
59947924|NCT02995369|76066507|FG000|COMPLETED|Overall Study||8||
59947925|NCT02995369|76066508|FG001|COMPLETED|Overall Study||8||
59947926|NCT02995369|76066509|FG002|COMPLETED|Overall Study||8||
59947927|NCT02995369|76066510|FG003|COMPLETED|Overall Study||8||
59947928|NCT02995369|76066507|FG000|NOT COMPLETED|Overall Study||0||
59947929|NCT02995369|76066508|FG001|NOT COMPLETED|Overall Study||0||
59947930|NCT02995369|76066509|FG002|NOT COMPLETED|Overall Study||0||
59947931|NCT02995369|76066510|FG003|NOT COMPLETED|Overall Study||0||
59947932|NCT00778999|76066526|FG000|STARTED|Overall Study||223||
59947933|NCT00778999|76066527|FG001|STARTED|Overall Study||219||
59947934|NCT00778999|76066526|FG000|COMPLETED|Overall Study||195||
59947935|NCT00778999|76066527|FG001|COMPLETED|Overall Study||185||
59947936|NCT00778999|76066526|FG000|NOT COMPLETED|Overall Study||28||
59947937|NCT00778999|76066527|FG001|NOT COMPLETED|Overall Study||34||
59947938|NCT02631850|76066537|FG000|STARTED|Treatment Period|One participant was withdrawn during treatment because medical records review revealed that the motor deficit was due to an old orthopedic injury and not stroke. This participant had experienced a Transient Ischemic Attack, but no stroke that resulted in lasting neurological motor deficit. 40 participants were thus analyzed for this group in the intent-to-treat analysis even though 41 began treatment.|41||
59947939|NCT02631850|76066538|FG001|STARTED|Treatment Period||44||
59947940|NCT02631850|76066539|FG002|STARTED|Treatment Period||45||
59947941|NCT02631850|76066540|FG003|STARTED|Treatment Period||38||
59947942|NCT02631850|76066537|FG000|COMPLETED|Treatment Period||38||
59947943|NCT02631850|76066538|FG001|COMPLETED|Treatment Period||38||
59947944|NCT02631850|76066539|FG002|COMPLETED|Treatment Period||41||
59947945|NCT02631850|76066540|FG003|COMPLETED|Treatment Period||33||
59947946|NCT02631850|76066537|FG000|NOT COMPLETED|Treatment Period||3||
59947947|NCT02631850|76066538|FG001|NOT COMPLETED|Treatment Period||6||
59947948|NCT02631850|76066539|FG002|NOT COMPLETED|Treatment Period||4||
59947949|NCT02631850|76066540|FG003|NOT COMPLETED|Treatment Period||5||
59947950|NCT02631850|76066537|FG000|STARTED|6 Month Follow up||38||
59947951|NCT02631850|76066538|FG001|STARTED|6 Month Follow up||38||
59947952|NCT02631850|76066539|FG002|STARTED|6 Month Follow up||41||
59947953|NCT02631850|76066540|FG003|STARTED|6 Month Follow up||33||
59947954|NCT02631850|76066537|FG000|COMPLETED|6 Month Follow up||31||
59518834|NCT00947765|75612706|FG001|NOT COMPLETED|Overall Study||0||
59518835|NCT01089517|75612715|FG000|STARTED|Overall Study||148||
59518836|NCT01089517|75612716|FG001|STARTED|Overall Study||149||
59518837|NCT01089517|75612717|FG002|STARTED|Overall Study||152||
59518838|NCT01089517|75612715|FG000|COMPLETED|Overall Study||144||
59518839|NCT01089517|75612716|FG001|COMPLETED|Overall Study||144||
59518840|NCT01089517|75612717|FG002|COMPLETED|Overall Study||147||
59518841|NCT01089517|75612715|FG000|NOT COMPLETED|Overall Study||4||
59947955|NCT02631850|76066538|FG001|COMPLETED|6 Month Follow up||25||
59947956|NCT02631850|76066539|FG002|COMPLETED|6 Month Follow up||35||
59947957|NCT02631850|76066540|FG003|COMPLETED|6 Month Follow up||22||
59947958|NCT02631850|76066537|FG000|NOT COMPLETED|6 Month Follow up||7||
59947959|NCT02631850|76066538|FG001|NOT COMPLETED|6 Month Follow up||13||
59947960|NCT02631850|76066539|FG002|NOT COMPLETED|6 Month Follow up||6||
59947961|NCT02631850|76066540|FG003|NOT COMPLETED|6 Month Follow up||11||
59947962|NCT00103038|76066551|FG000|STARTED|Overall Study||155||
59947963|NCT00103038|76066551|FG000|COMPLETED|Overall Study||142||
59947964|NCT00103038|76066551|FG000|NOT COMPLETED|Overall Study||13||
59947965|NCT00620035|76066558|FG000|STARTED|Overall Study||301||
59947966|NCT00620035|76066558|FG000|COMPLETED|Overall Study||156||
59947967|NCT00620035|76066558|FG000|NOT COMPLETED|Overall Study||145||
59947968|NCT03034057|76066562|FG000|STARTED|Overall Study||169||
59947969|NCT03034057|76066562|FG000|COMPLETED|Overall Study||114||
59947970|NCT03034057|76066562|FG000|NOT COMPLETED|Overall Study||55||
59947971|NCT02757768|76066568|FG000|STARTED|Overall Study||356||
59947972|NCT02757768|76066569|FG001|STARTED|Overall Study||359||
59947973|NCT02757768|76066568|FG000|Treated|Overall Study||352||
59947974|NCT02757768|76066569|FG001|Treated|Overall Study||354||
59947975|NCT02757768|76066568|FG000|COMPLETED|Overall Study||323||
59947976|NCT02757768|76066569|FG001|COMPLETED|Overall Study||331||
59947977|NCT02757768|76066568|FG000|NOT COMPLETED|Overall Study||33||
59947978|NCT02757768|76066569|FG001|NOT COMPLETED|Overall Study||28||
59947979|NCT05225389|76066577|FG000|STARTED|Overall Study||8||
59947980|NCT05225389|76066577|FG000|COMPLETED|Overall Study||5||
59947981|NCT05225389|76066577|FG000|NOT COMPLETED|Overall Study||3||
59947982|NCT02753946|76066583|FG000|STARTED|Overall Study||233|465 were randomized but 1 randomized patient had adverse event prior to dosing|
59947983|NCT02753946|76066584|FG001|STARTED|Overall Study||231|465 were randomized but 1 randomized patient had adverse event prior to dosing|
59947984|NCT02753946|76066583|FG000|COMPLETED|Overall Study||219||
59947985|NCT02753946|76066584|FG001|COMPLETED|Overall Study||222||
59947986|NCT02753946|76066583|FG000|NOT COMPLETED|Overall Study||14||
59947987|NCT02753946|76066584|FG001|NOT COMPLETED|Overall Study||9||
59947988|NCT02756832|76066590|FG000|STARTED|Overall Study||1409||
59947989|NCT02756832|76066590|FG000|Received Therapy|Overall Study||1393||
59947990|NCT02756832|76066590|FG000|Included in Efficacy and Safety Analysis|Overall Study||1399||
59947991|NCT02756832|76066590|FG000|COMPLETED|Overall Study||1356||
59947992|NCT02756832|76066590|FG000|NOT COMPLETED|Overall Study||53||
59947993|NCT00106080|76066596|FG000|STARTED|Overall Study||194||
59947994|NCT00106080|76066597|FG001|STARTED|Overall Study||182||
59947995|NCT00106080|76066596|FG000|COMPLETED|Overall Study||151||
59947996|NCT00106080|76066597|FG001|COMPLETED|Overall Study||155||
59947997|NCT00106080|76066596|FG000|NOT COMPLETED|Overall Study||43||
59947998|NCT00106080|76066597|FG001|NOT COMPLETED|Overall Study||27||
59947999|NCT02633020|76066605|FG000|STARTED|Overall Study||19||
59948000|NCT02633020|76066606|FG001|STARTED|Overall Study||9||
59948001|NCT02633020|76066605|FG000|COMPLETED|Overall Study||18||
59948002|NCT02633020|76066606|FG001|COMPLETED|Overall Study||9||
59948003|NCT02633020|76066605|FG000|NOT COMPLETED|Overall Study||1||
59948004|NCT02633020|76066606|FG001|NOT COMPLETED|Overall Study||0||
59948005|NCT00106626|76066616|FG000|STARTED|Overall Study||13||
59948006|NCT00106626|76066617|FG001|STARTED|Overall Study||9||
59948007|NCT00106626|76066618|FG002|STARTED|Overall Study||14||
59948008|NCT00106626|76066619|FG003|STARTED|Overall Study||16||
59948009|NCT00106626|76066616|FG000|COMPLETED|Overall Study||3||
59948010|NCT00106626|76066617|FG001|COMPLETED|Overall Study||3||
59948011|NCT00106626|76066618|FG002|COMPLETED|Overall Study||2||
59948012|NCT00106626|76066619|FG003|COMPLETED|Overall Study||3||
59948013|NCT00106626|76066616|FG000|NOT COMPLETED|Overall Study||10||
59948014|NCT00106626|76066617|FG001|NOT COMPLETED|Overall Study||6||
59948015|NCT00106626|76066618|FG002|NOT COMPLETED|Overall Study||12||
59948016|NCT00106626|76066619|FG003|NOT COMPLETED|Overall Study||13||
59948017|NCT02632786|76066636|FG000|STARTED|Overall Study||66||
59948018|NCT02632786|76066637|FG001|STARTED|Overall Study||63||
59948019|NCT02632786|76066636|FG000|Informed Consent Obtained|Overall Study||66||
59948020|NCT02632786|76066637|FG001|Informed Consent Obtained|Overall Study||63||
59948021|NCT02632786|76066636|FG000|Randomized and Dosed|Overall Study||66||
59948022|NCT02632786|76066637|FG001|Randomized and Dosed|Overall Study||63||
59948023|NCT02632786|76066636|FG000|COMPLETED|Overall Study||55||
59948024|NCT02632786|76066637|FG001|COMPLETED|Overall Study||56||
59948025|NCT02632786|76066636|FG000|NOT COMPLETED|Overall Study||11||
59948026|NCT02632786|76066637|FG001|NOT COMPLETED|Overall Study||7||
60067622|NCT01606761|76182767|FG002|Safety Population|Safety Follow-up Period (Week 52-68)||62||
60067623|NCT01606761|76182768|FG003|Safety Population|Safety Follow-up Period (Week 52-68)||7||
60067624|NCT01606761|76182769|FG004|Safety Population|Safety Follow-up Period (Week 52-68)||19||
60067625|NCT01606761|76182765|FG000|COMPLETED|Safety Follow-up Period (Week 52-68)||24||
59948027|NCT02755818|76066648|FG000|STARTED|Overall Study||30||
59948028|NCT02755818|76066649|FG001|STARTED|Overall Study||2||
59948029|NCT02755818|76066650|FG002|STARTED|Overall Study||2||
59948030|NCT02755818|76066651|FG003|STARTED|Overall Study||17||
59948031|NCT02755818|76066648|FG000|COMPLETED|Overall Study||30||
59948032|NCT02755818|76066649|FG001|COMPLETED|Overall Study||2||
59948033|NCT02755818|76066650|FG002|COMPLETED|Overall Study||1||
59948034|NCT02755818|76066651|FG003|COMPLETED|Overall Study||14||
59948035|NCT02755818|76066648|FG000|NOT COMPLETED|Overall Study||0||
60067626|NCT01606761|76182766|FG001|COMPLETED|Safety Follow-up Period (Week 52-68)||55||
60067627|NCT01606761|76182767|FG002|COMPLETED|Safety Follow-up Period (Week 52-68)||45||
60067628|NCT01606761|76182768|FG003|COMPLETED|Safety Follow-up Period (Week 52-68)||7||
59948036|NCT02755818|76066649|FG001|NOT COMPLETED|Overall Study||0||
59948037|NCT02755818|76066650|FG002|NOT COMPLETED|Overall Study||1||
60067629|NCT01606761|76182769|FG004|COMPLETED|Safety Follow-up Period (Week 52-68)||11||
60067630|NCT01606761|76182765|FG000|NOT COMPLETED|Safety Follow-up Period (Week 52-68)||4||
59948038|NCT02755818|76066651|FG003|NOT COMPLETED|Overall Study||3||
59948039|NCT03033745|76066666|FG000|STARTED|Overall Study||15||
59948040|NCT03033745|76066667|FG001|STARTED|Overall Study||18||
59948041|NCT03033745|76066668|FG002|STARTED|Overall Study||16||
59948042|NCT03033745|76066666|FG000|COMPLETED|Overall Study||14||
59948043|NCT03033745|76066667|FG001|COMPLETED|Overall Study||17||
59948044|NCT03033745|76066668|FG002|COMPLETED|Overall Study||14||
59948045|NCT03033745|76066666|FG000|NOT COMPLETED|Overall Study||1||
59948046|NCT03033745|76066667|FG001|NOT COMPLETED|Overall Study||1||
59948047|NCT03033745|76066668|FG002|NOT COMPLETED|Overall Study||2||
59948048|NCT01672294|76066687|FG000|STARTED|Overall Study||71||
59948049|NCT01672294|76066688|FG001|STARTED|Overall Study||71||
59948050|NCT01672294|76066689|FG002|STARTED|Overall Study||72||
59948051|NCT01672294|76066690|FG003|STARTED|Overall Study||72||
59948052|NCT01672294|76066687|FG000|COMPLETED|Overall Study||65||
59948053|NCT01672294|76066688|FG001|COMPLETED|Overall Study||50||
59948054|NCT01672294|76066689|FG002|COMPLETED|Overall Study||61||
59948055|NCT01672294|76066690|FG003|COMPLETED|Overall Study||59||
59948056|NCT01672294|76066687|FG000|NOT COMPLETED|Overall Study||6||
59948057|NCT01672294|76066688|FG001|NOT COMPLETED|Overall Study||21||
59948058|NCT01672294|76066689|FG002|NOT COMPLETED|Overall Study||11||
59948059|NCT01672294|76066690|FG003|NOT COMPLETED|Overall Study||13||
59948060|NCT02755116|76066702|FG000|STARTED|Overall Study||74||
59948061|NCT02755116|76066703|FG001|STARTED|Overall Study||70||
59948062|NCT02755116|76066702|FG000|COMPLETED|Overall Study||71||
59948063|NCT02755116|76066703|FG001|COMPLETED|Overall Study||69||
59948064|NCT02755116|76066702|FG000|NOT COMPLETED|Overall Study||3||
59948065|NCT02755116|76066703|FG001|NOT COMPLETED|Overall Study||1||
59948066|NCT02754492|76066713|FG000|STARTED|Overall Study||97||
59948067|NCT02754492|76066714|FG001|STARTED|Overall Study||95||
59948068|NCT02754492|76066715|FG002|STARTED|Overall Study||95||
59948069|NCT02754492|76066716|FG003|STARTED|Overall Study||23||
59948070|NCT02754492|76066713|FG000|COMPLETED|Overall Study||93||
59948071|NCT02754492|76066714|FG001|COMPLETED|Overall Study||93||
59948072|NCT02754492|76066715|FG002|COMPLETED|Overall Study||93||
59948073|NCT02754492|76066716|FG003|COMPLETED|Overall Study||0||
59948074|NCT02754492|76066713|FG000|NOT COMPLETED|Overall Study||4||
59948075|NCT02754492|76066714|FG001|NOT COMPLETED|Overall Study||2||
59948076|NCT02754492|76066715|FG002|NOT COMPLETED|Overall Study||2||
59948077|NCT02754492|76066716|FG003|NOT COMPLETED|Overall Study||23||
59948078|NCT04068688|76066735|FG000|STARTED|Overall Study||17||
59948079|NCT04068688|76066736|FG001|STARTED|Overall Study||17||
59948080|NCT04068688|76066737|FG002|STARTED|Overall Study||2||
59948081|NCT04068688|76066738|FG003|STARTED|Overall Study||2||
59948082|NCT04068688|76066739|FG004|STARTED|Overall Study||12||
59948083|NCT04068688|76066740|FG005|STARTED|Overall Study||12||
59948084|NCT04068688|76066741|FG006|STARTED|Overall Study||2||
59948085|NCT04068688|76066742|FG007|STARTED|Overall Study||1||
59948086|NCT04068688|76066743|FG008|STARTED|Overall Study||4||
59948087|NCT04068688|76066744|FG009|STARTED|Overall Study||3||
59948088|NCT04068688|76066735|FG000|COMPLETED|Overall Study||8||
59948089|NCT04068688|76066736|FG001|COMPLETED|Overall Study||8||
59948090|NCT04068688|76066737|FG002|COMPLETED|Overall Study||2||
59948091|NCT04068688|76066738|FG003|COMPLETED|Overall Study||2||
59948092|NCT04068688|76066739|FG004|COMPLETED|Overall Study||7||
59948093|NCT04068688|76066740|FG005|COMPLETED|Overall Study||7||
59948094|NCT04068688|76066741|FG006|COMPLETED|Overall Study||2||
59948095|NCT04068688|76066742|FG007|COMPLETED|Overall Study||1||
59948096|NCT04068688|76066743|FG008|COMPLETED|Overall Study||3||
59948097|NCT04068688|76066744|FG009|COMPLETED|Overall Study||3||
59948098|NCT04068688|76066735|FG000|NOT COMPLETED|Overall Study||9||
59948099|NCT04068688|76066736|FG001|NOT COMPLETED|Overall Study||9||
59948100|NCT04068688|76066737|FG002|NOT COMPLETED|Overall Study||0||
59948101|NCT04068688|76066738|FG003|NOT COMPLETED|Overall Study||0||
59948102|NCT04068688|76066739|FG004|NOT COMPLETED|Overall Study||5||
59948103|NCT04068688|76066740|FG005|NOT COMPLETED|Overall Study||5||
59948104|NCT04068688|76066741|FG006|NOT COMPLETED|Overall Study||0||
59948105|NCT04068688|76066742|FG007|NOT COMPLETED|Overall Study||0||
59948106|NCT04068688|76066743|FG008|NOT COMPLETED|Overall Study||1||
59948107|NCT04068688|76066744|FG009|NOT COMPLETED|Overall Study||0||
59948108|NCT01671748|76066772|FG000|STARTED|4 Week run-in Phase||47||
59948109|NCT01671748|76066773|FG001|STARTED|4 Week run-in Phase||0||
59948110|NCT01671748|76066772|FG000|COMPLETED|4 Week run-in Phase||36||
59948111|NCT01671748|76066773|FG001|COMPLETED|4 Week run-in Phase||0||
59948112|NCT01671748|76066772|FG000|NOT COMPLETED|4 Week run-in Phase||11||
59948113|NCT01671748|76066773|FG001|NOT COMPLETED|4 Week run-in Phase||0||
59948114|NCT01671748|76066772|FG000|STARTED|12 Week Treatment Phase||19||
59948115|NCT01671748|76066773|FG001|STARTED|12 Week Treatment Phase||17||
59948116|NCT01671748|76066772|FG000|COMPLETED|12 Week Treatment Phase||19||
59948117|NCT01671748|76066773|FG001|COMPLETED|12 Week Treatment Phase||17||
59948118|NCT01671748|76066772|FG000|NOT COMPLETED|12 Week Treatment Phase||0||
59948119|NCT01671748|76066773|FG001|NOT COMPLETED|12 Week Treatment Phase||0||
59948120|NCT02657889|76066783|FG000|STARTED|Phase 1: (Up to a Maximum of 22 Months)||7||
59948121|NCT02657889|76066784|FG001|STARTED|Phase 1: (Up to a Maximum of 22 Months)||7||
59948122|NCT02657889|76066785|FG002|STARTED|Phase 1: (Up to a Maximum of 22 Months)||0||
59948123|NCT02657889|76066786|FG003|STARTED|Phase 1: (Up to a Maximum of 22 Months)||0||
59948124|NCT02657889|76066783|FG000|COMPLETED|Phase 1: (Up to a Maximum of 22 Months)||0||
59948125|NCT02657889|76066784|FG001|COMPLETED|Phase 1: (Up to a Maximum of 22 Months)||0||
59948126|NCT02657889|76066785|FG002|COMPLETED|Phase 1: (Up to a Maximum of 22 Months)||0||
59948127|NCT02657889|76066786|FG003|COMPLETED|Phase 1: (Up to a Maximum of 22 Months)||0||
59948128|NCT02657889|76066783|FG000|NOT COMPLETED|Phase 1: (Up to a Maximum of 22 Months)||7||
59951243|NCT03743415|76070184|FG009|STARTED|Overall Study||23||
59948129|NCT02657889|76066784|FG001|NOT COMPLETED|Phase 1: (Up to a Maximum of 22 Months)||7||
59948130|NCT02657889|76066785|FG002|NOT COMPLETED|Phase 1: (Up to a Maximum of 22 Months)||0||
59948131|NCT02657889|76066786|FG003|NOT COMPLETED|Phase 1: (Up to a Maximum of 22 Months)||0||
59948132|NCT02657889|76066783|FG000|STARTED|Phase 2: (Up to a Maximum of 54 Months)||0||
59948133|NCT02657889|76066784|FG001|STARTED|Phase 2: (Up to a Maximum of 54 Months)||0||
59948134|NCT02657889|76066785|FG002|STARTED|Phase 2: (Up to a Maximum of 54 Months)||53||
59762332|NCT00537745|75882016|FG000|Began Intervention|Overall Study||11||
59762333|NCT00537745|75882016|FG000|COMPLETED|Overall Study||9||
59762334|NCT00537745|75882016|FG000|NOT COMPLETED|Overall Study||5||
59762335|NCT00874848|75882023|FG000|STARTED|Overall Study||59||
59762336|NCT00874848|75882024|FG001|STARTED|Overall Study||29||
59948135|NCT02657889|76066786|FG003|STARTED|Phase 2: (Up to a Maximum of 54 Months)||55||
59948136|NCT02657889|76066783|FG000|COMPLETED|Phase 2: (Up to a Maximum of 54 Months)||0||
59948137|NCT02657889|76066784|FG001|COMPLETED|Phase 2: (Up to a Maximum of 54 Months)||0||
59948138|NCT02657889|76066785|FG002|COMPLETED|Phase 2: (Up to a Maximum of 54 Months)||0||
59948139|NCT02657889|76066786|FG003|COMPLETED|Phase 2: (Up to a Maximum of 54 Months)||0||
59948140|NCT02657889|76066783|FG000|NOT COMPLETED|Phase 2: (Up to a Maximum of 54 Months)||0||
59948141|NCT02657889|76066784|FG001|NOT COMPLETED|Phase 2: (Up to a Maximum of 54 Months)||0||
59948142|NCT02657889|76066785|FG002|NOT COMPLETED|Phase 2: (Up to a Maximum of 54 Months)||53||
59948143|NCT02657889|76066786|FG003|NOT COMPLETED|Phase 2: (Up to a Maximum of 54 Months)||55||
59948144|NCT03034915|76066801|FG000|STARTED|Overall Study||812||
59948145|NCT03034915|76066802|FG001|STARTED|Overall Study||804||
59948146|NCT03034915|76066803|FG002|STARTED|Overall Study||809||
59948147|NCT03034915|76066801|FG000|COMPLETED|Overall Study||717||
59948148|NCT03034915|76066802|FG001|COMPLETED|Overall Study||650||
59948149|NCT03034915|76066803|FG002|COMPLETED|Overall Study||683||
59948150|NCT03034915|76066801|FG000|NOT COMPLETED|Overall Study||95||
59948151|NCT03034915|76066802|FG001|NOT COMPLETED|Overall Study||154||
59948152|NCT03034915|76066803|FG002|NOT COMPLETED|Overall Study||126||
59948153|NCT02631538|76066815|FG000|STARTED|Treatment Period (Up to Week 52)||13||
59948154|NCT02631538|76066816|FG001|STARTED|Treatment Period (Up to Week 52)||24||
59948155|NCT02631538|76066817|FG002|STARTED|Treatment Period (Up to Week 52)||24||
59948156|NCT02631538|76066818|FG003|STARTED|Treatment Period (Up to Week 52)||25||
59762337|NCT00874848|75882023|FG000|Discontinued|Overall Study||59||
59762338|NCT00874848|75882024|FG001|Discontinued|Overall Study||28||
59762339|NCT00874848|75882023|FG000|COMPLETED|Overall Study|Pts who completed 18 tx cycles without progressive disease were defined as completing treatment.|0||
59762340|NCT00874848|75882024|FG001|COMPLETED|Overall Study|Pts who completed 18 tx cycles without progressive disease were defined as completing treatment.|1||
59762341|NCT00874848|75882023|FG000|NOT COMPLETED|Overall Study||59||
59762342|NCT00874848|75882024|FG001|NOT COMPLETED|Overall Study||28||
59762343|NCT00578812|75882032|FG000|STARTED|Overall Study|Does not include investigational training patients (78 STARTED, 76 COMPLETED, 2 Not Treated).|224||
59762344|NCT00578812|75882033|FG001|STARTED|Overall Study||192||
59762345|NCT00578812|75882032|FG000|COMPLETED|Overall Study|Modified Intent-to-Treat (treated patients; analyzed as randomized).|218||
59762346|NCT00578812|75882033|FG001|COMPLETED|Overall Study||185||
59762347|NCT00578812|75882032|FG000|NOT COMPLETED|Overall Study||6||
59762348|NCT00578812|75882033|FG001|NOT COMPLETED|Overall Study||7||
59762349|NCT04043806|75882040|FG000|STARTED|Overall Study||458||
59762350|NCT04043806|75882040|FG000|Safety Set|Overall Study|Safety Set is defined as all participants who received at least 1 dose of study drug.|457||
59762351|NCT04043806|75882040|FG000|COMPLETED|Overall Study||412||
59762352|NCT04043806|75882040|FG000|NOT COMPLETED|Overall Study||46||
59762353|NCT00536809|75882045|FG000|STARTED|Phase I (Dose-finding Phase)||10||
59762354|NCT00536809|75882045|FG000|COMPLETED|Phase I (Dose-finding Phase)||10||
59762355|NCT00536809|75882045|FG000|NOT COMPLETED|Phase I (Dose-finding Phase)||0||
59762356|NCT00536809|75882045|FG000|STARTED|Phase II||2||
59762357|NCT00536809|75882045|FG000|COMPLETED|Phase II||0||
59762358|NCT00536809|75882045|FG000|NOT COMPLETED|Phase II||2||
59762359|NCT03722836|75882049|FG000|STARTED|Overall Study||708||
59762360|NCT03722836|75882049|FG000|COMPLETED|Overall Study||708||
59762361|NCT03722836|75882049|FG000|NOT COMPLETED|Overall Study||0||
59762362|NCT00536731|75882056|FG000|STARTED|Overall Study||253||
59762363|NCT00536731|75882057|FG001|STARTED|Overall Study||246||
59762364|NCT00536731|75882058|FG002|STARTED|Overall Study||243||
59948157|NCT02631538|76066815|FG000|COMPLETED|Treatment Period (Up to Week 52)||9||
59948158|NCT02631538|76066816|FG001|COMPLETED|Treatment Period (Up to Week 52)||17||
59948159|NCT02631538|76066817|FG002|COMPLETED|Treatment Period (Up to Week 52)||19||
59948160|NCT02631538|76066818|FG003|COMPLETED|Treatment Period (Up to Week 52)||17||
59762365|NCT00536731|75882056|FG000|COMPLETED|Overall Study||249||
59762366|NCT00536731|75882057|FG001|COMPLETED|Overall Study||241||
59762367|NCT00536731|75882058|FG002|COMPLETED|Overall Study||238||
59762368|NCT00536731|75882056|FG000|NOT COMPLETED|Overall Study||4||
59762369|NCT00536731|75882057|FG001|NOT COMPLETED|Overall Study||5||
59762370|NCT00536731|75882058|FG002|NOT COMPLETED|Overall Study||5||
59762371|NCT00536575|75882066|FG000|STARTED|Overall Study||13||
59762372|NCT00536575|75882066|FG000|COMPLETED|Overall Study||11||
59762373|NCT00536575|75882066|FG000|NOT COMPLETED|Overall Study||2||
59762374|NCT03214250|75882077|FG000|STARTED|Overall Study||7||
59948161|NCT02631538|76066815|FG000|NOT COMPLETED|Treatment Period (Up to Week 52)||4||
59948162|NCT02631538|76066816|FG001|NOT COMPLETED|Treatment Period (Up to Week 52)||7||
59948163|NCT02631538|76066817|FG002|NOT COMPLETED|Treatment Period (Up to Week 52)||5||
59948164|NCT02631538|76066818|FG003|NOT COMPLETED|Treatment Period (Up to Week 52)||8||
59948165|NCT02631538|76066815|FG000|STARTED|General Follow-up (GFU) (Up to Week 68)||9||
59948166|NCT02631538|76066816|FG001|STARTED|General Follow-up (GFU) (Up to Week 68)||17||
59948167|NCT02631538|76066817|FG002|STARTED|General Follow-up (GFU) (Up to Week 68)||19||
59948168|NCT02631538|76066818|FG003|STARTED|General Follow-up (GFU) (Up to Week 68)||17||
59948169|NCT02631538|76066815|FG000|COMPLETED|General Follow-up (GFU) (Up to Week 68)||8||
59948170|NCT02631538|76066816|FG001|COMPLETED|General Follow-up (GFU) (Up to Week 68)||17||
59948171|NCT02631538|76066817|FG002|COMPLETED|General Follow-up (GFU) (Up to Week 68)||19||
59948172|NCT02631538|76066818|FG003|COMPLETED|General Follow-up (GFU) (Up to Week 68)||16||
59948173|NCT02631538|76066815|FG000|NOT COMPLETED|General Follow-up (GFU) (Up to Week 68)||1||
59948174|NCT02631538|76066816|FG001|NOT COMPLETED|General Follow-up (GFU) (Up to Week 68)||0||
59948175|NCT02631538|76066817|FG002|NOT COMPLETED|General Follow-up (GFU) (Up to Week 68)||0||
59948176|NCT02631538|76066818|FG003|NOT COMPLETED|General Follow-up (GFU) (Up to Week 68)||1||
59948177|NCT04421508|76066830|FG000|STARTED|Overall Study||95||
59948178|NCT04421508|76066831|FG001|STARTED|Overall Study||96||
59948179|NCT04421508|76066830|FG000|COMPLETED|Overall Study||91||
59948180|NCT04421508|76066831|FG001|COMPLETED|Overall Study||95||
59948181|NCT04421508|76066830|FG000|NOT COMPLETED|Overall Study||4||
59948182|NCT04421508|76066831|FG001|NOT COMPLETED|Overall Study||1||
59948183|NCT04587271|76066843|FG000|STARTED|Overall Study||25||
59948184|NCT04587271|76066844|FG001|STARTED|Overall Study||25||
59948185|NCT04587271|76066845|FG002|STARTED|Overall Study||0||
59948186|NCT04587271|76066846|FG003|STARTED|Overall Study||25||
59948187|NCT04587271|76066847|FG004|STARTED|Overall Study||25||
59948188|NCT04587271|76066848|FG005|STARTED|Overall Study||0||
59948189|NCT04587271|76066843|FG000|COMPLETED|Overall Study||23||
59948190|NCT04587271|76066844|FG001|COMPLETED|Overall Study||23||
59948191|NCT04587271|76066845|FG002|COMPLETED|Overall Study||0||
59948192|NCT04587271|76066846|FG003|COMPLETED|Overall Study||22||
59948193|NCT04587271|76066847|FG004|COMPLETED|Overall Study||23||
59948194|NCT04587271|76066848|FG005|COMPLETED|Overall Study||0||
59948195|NCT04587271|76066843|FG000|NOT COMPLETED|Overall Study||2||
59948196|NCT04587271|76066844|FG001|NOT COMPLETED|Overall Study||2||
59948197|NCT04587271|76066845|FG002|NOT COMPLETED|Overall Study||0||
59948198|NCT04587271|76066846|FG003|NOT COMPLETED|Overall Study||3||
59948199|NCT04587271|76066847|FG004|NOT COMPLETED|Overall Study||2||
59948200|NCT04587271|76066848|FG005|NOT COMPLETED|Overall Study||0||
59948201|NCT02631148|76066863|FG000|STARTED|Overall Study||12||
59948202|NCT02631148|76066864|FG001|STARTED|Overall Study||0||
59948203|NCT02631148|76066863|FG000|COMPLETED|Overall Study||2|2 completed visits, however blood samples did not undergo analysis and other measurements were not analyzed.|
59948204|NCT02631148|76066864|FG001|COMPLETED|Overall Study||0|2 completed visits, however blood samples did not undergo analysis and other measurements were not analyzed.|
59948205|NCT02631148|76066863|FG000|NOT COMPLETED|Overall Study||10||
59948206|NCT02631148|76066864|FG001|NOT COMPLETED|Overall Study||0||
59948207|NCT02753400|76066872|FG000|STARTED|Overall Study||12||
59948208|NCT02753400|76066873|FG001|STARTED|Overall Study||12||
59948209|NCT02753400|76066872|FG000|COMPLETED|Overall Study||7||
59948210|NCT02753400|76066873|FG001|COMPLETED|Overall Study||11||
59948211|NCT02753400|76066872|FG000|NOT COMPLETED|Overall Study||5||
59948212|NCT02753400|76066873|FG001|NOT COMPLETED|Overall Study||1||
59948213|NCT02238639|76066881|FG000|STARTED|Overall Study||374||
59948214|NCT02238639|76066882|FG001|STARTED|Overall Study||372||
59948215|NCT02238639|76066881|FG000|COMPLETED|Overall Study||370||
59948216|NCT02238639|76066882|FG001|COMPLETED|Overall Study||367||
59948217|NCT02238639|76066881|FG000|NOT COMPLETED|Overall Study||4||
59948218|NCT02238639|76066882|FG001|NOT COMPLETED|Overall Study||5||
59948219|NCT03943147|76066890|FG000|STARTED|Open-Label MMF Run-in (Part A)||16||
59948220|NCT03943147|76066891|FG001|STARTED|Open-Label MMF Run-in (Part A)||0||
59948221|NCT03943147|76066890|FG000|COMPLETED|Open-Label MMF Run-in (Part A)||6||
59948222|NCT03943147|76066891|FG001|COMPLETED|Open-Label MMF Run-in (Part A)||0||
59948223|NCT03943147|76066890|FG000|NOT COMPLETED|Open-Label MMF Run-in (Part A)||10||
59948224|NCT03943147|76066891|FG001|NOT COMPLETED|Open-Label MMF Run-in (Part A)||0||
59948225|NCT03943147|76066890|FG000|STARTED|Blinded Treatment (Part B)||5||
59948226|NCT03943147|76066891|FG001|STARTED|Blinded Treatment (Part B)||1||
60067631|NCT01606761|76182766|FG001|NOT COMPLETED|Safety Follow-up Period (Week 52-68)||10||
59948227|NCT03943147|76066890|FG000|COMPLETED|Blinded Treatment (Part B)||2||
59948228|NCT03943147|76066891|FG001|COMPLETED|Blinded Treatment (Part B)||1||
59948229|NCT03943147|76066890|FG000|NOT COMPLETED|Blinded Treatment (Part B)||3||
59948230|NCT03943147|76066891|FG001|NOT COMPLETED|Blinded Treatment (Part B)||0||
59948231|NCT03703258|76066898|FG000|STARTED|Overall Study||20||
59948232|NCT03703258|76066899|FG001|STARTED|Overall Study||21||
59948233|NCT03703258|76066898|FG000|COMPLETED|Overall Study|Completed at least one of two follow-up assessments|20||
59948234|NCT03703258|76066899|FG001|COMPLETED|Overall Study|Completed at least one of two follow-up assessments|21||
59948235|NCT03703258|76066898|FG000|NOT COMPLETED|Overall Study||0||
59948236|NCT03703258|76066899|FG001|NOT COMPLETED|Overall Study||0||
59948237|NCT03730987|76066909|FG000|STARTED|Overall Study||61||
59948238|NCT03730987|76066910|FG001|STARTED|Overall Study||61||
59948239|NCT03730987|76066911|FG002|STARTED|Overall Study||61||
59948240|NCT03730987|76066912|FG003|STARTED|Overall Study||61||
59948241|NCT03730987|76066909|FG000|COMPLETED|Overall Study||59||
59948242|NCT03730987|76066910|FG001|COMPLETED|Overall Study||61||
59948243|NCT03730987|76066911|FG002|COMPLETED|Overall Study||59||
59948244|NCT03730987|76066912|FG003|COMPLETED|Overall Study||61||
59948245|NCT03730987|76066909|FG000|NOT COMPLETED|Overall Study||2||
59948246|NCT03730987|76066910|FG001|NOT COMPLETED|Overall Study||0||
59948247|NCT03730987|76066911|FG002|NOT COMPLETED|Overall Study||2||
59948248|NCT03730987|76066912|FG003|NOT COMPLETED|Overall Study||0||
59948249|NCT02844543|76066923|FG000|STARTED|Overall Study||155||
59948250|NCT02844543|76066923|FG000|COMPLETED|Overall Study||150||
59948251|NCT02844543|76066923|FG000|NOT COMPLETED|Overall Study||5||
59948252|NCT03034135|76066927|FG000|STARTED|Overall Study||23||
59948253|NCT03034135|76066927|FG000|COMPLETED|Overall Study||21||
59948254|NCT03034135|76066927|FG000|NOT COMPLETED|Overall Study||2||
59948255|NCT01671280|76066931|FG000|STARTED|Overall Study|The number is enrollment.|403||
59948256|NCT01671280|76066931|FG000|COMPLETED|Overall Study||401||
59948257|NCT01671280|76066931|FG000|NOT COMPLETED|Overall Study||2||
59948258|NCT01405963|76066937|FG000|STARTED|Overall Study||15||
59948259|NCT01405963|76066938|FG001|STARTED|Overall Study||16||
59948260|NCT01405963|76066937|FG000|COMPLETED|Overall Study||13||
59948261|NCT01405963|76066938|FG001|COMPLETED|Overall Study||14||
59948262|NCT01405963|76066937|FG000|NOT COMPLETED|Overall Study||2||
59948263|NCT01405963|76066938|FG001|NOT COMPLETED|Overall Study||2||
59948264|NCT03952546|76066947|FG000|STARTED|Overall Study||82||
59948265|NCT03952546|76066948|FG001|STARTED|Overall Study||82||
59948266|NCT03952546|76066947|FG000|COMPLETED|Overall Study||82||
59948267|NCT03952546|76066948|FG001|COMPLETED|Overall Study||82||
59948268|NCT03952546|76066947|FG000|NOT COMPLETED|Overall Study||0||
59948269|NCT03952546|76066948|FG001|NOT COMPLETED|Overall Study||0||
59948270|NCT02628418|76066958|FG000|STARTED|Overall Study||15||
59948271|NCT02628418|76066959|FG001|STARTED|Overall Study||15||
59948272|NCT02628418|76066958|FG000|COMPLETED|Overall Study||14||
59948273|NCT02628418|76066959|FG001|COMPLETED|Overall Study||13||
59948274|NCT02628418|76066958|FG000|NOT COMPLETED|Overall Study||1||
59948275|NCT02628418|76066959|FG001|NOT COMPLETED|Overall Study||2||
59948276|NCT03027609|76066973|FG000|STARTED|Overall Study|Safety and ITT population|79||
59948277|NCT03027609|76066974|FG001|STARTED|Overall Study|Safety and ITT population|79||
59948278|NCT03027609|76066973|FG000|COMPLETED|Overall Study|Safety and ITT population|49||
59948279|NCT03027609|76066974|FG001|COMPLETED|Overall Study|Safety and ITT population|62||
59948280|NCT03027609|76066973|FG000|NOT COMPLETED|Overall Study||30||
59948281|NCT03027609|76066974|FG001|NOT COMPLETED|Overall Study||17||
59948282|NCT02752776|76066987|FG000|STARTED|Overall Study||663||
59948283|NCT02752776|76066988|FG001|STARTED|Overall Study||673||
59948284|NCT02752776|76066989|FG002|STARTED|Overall Study||324||
60067632|NCT01606761|76182767|FG002|NOT COMPLETED|Safety Follow-up Period (Week 52-68)||17||
59948285|NCT02752776|76066987|FG000|COMPLETED|Overall Study||611||
59948286|NCT02752776|76066988|FG001|COMPLETED|Overall Study||597||
59948287|NCT02752776|76066989|FG002|COMPLETED|Overall Study||276||
59948288|NCT02752776|76066987|FG000|NOT COMPLETED|Overall Study||52||
59948289|NCT02752776|76066988|FG001|NOT COMPLETED|Overall Study||76||
59948290|NCT02752776|76066989|FG002|NOT COMPLETED|Overall Study||48||
59948291|NCT01342965|76067001|FG000|STARTED|Overall Study||110||
59948292|NCT01342965|76067002|FG001|STARTED|Overall Study||107||
59948293|NCT01342965|76067001|FG000|Received Treatment|Overall Study||110||
59948294|NCT01342965|76067002|FG001|Received Treatment|Overall Study||104||
59948295|NCT01342965|76067001|FG000|COMPLETED|Overall Study||1||
59948296|NCT01342965|76067002|FG001|COMPLETED|Overall Study||0||
59948297|NCT01342965|76067001|FG000|NOT COMPLETED|Overall Study||109||
59948298|NCT01342965|76067002|FG001|NOT COMPLETED|Overall Study||107||
59948299|NCT02629822|76067008|FG000|STARTED|Base Study||10||
59948300|NCT02629822|76067008|FG000|COMPLETED|Base Study||7||
59948301|NCT02629822|76067008|FG000|NOT COMPLETED|Base Study||3||
59948302|NCT02629822|76067008|FG000|STARTED|Extension Study|Enrollment in Extension Study was voluntary.|6||
59948303|NCT02629822|76067008|FG000|COMPLETED|Extension Study||4||
59948304|NCT02629822|76067008|FG000|NOT COMPLETED|Extension Study||2||
59948305|NCT03462706|76067017|FG000|STARTED|Overall Study||60||
59948306|NCT03462706|76067018|FG001|STARTED|Overall Study||63||
59948307|NCT03462706|76067019|FG002|STARTED|Overall Study||58||
59948308|NCT03462706|76067020|FG003|STARTED|Overall Study||57||
59948309|NCT03462706|76067017|FG000|COMPLETED|Overall Study||59||
59948310|NCT03462706|76067018|FG001|COMPLETED|Overall Study||63||
59948311|NCT03462706|76067019|FG002|COMPLETED|Overall Study||57||
59948312|NCT03462706|76067020|FG003|COMPLETED|Overall Study||56||
59948313|NCT03462706|76067017|FG000|NOT COMPLETED|Overall Study||1||
59948314|NCT03462706|76067018|FG001|NOT COMPLETED|Overall Study||0||
59948315|NCT03462706|76067019|FG002|NOT COMPLETED|Overall Study||1||
59948316|NCT03462706|76067020|FG003|NOT COMPLETED|Overall Study||1||
59948317|NCT02840253|76067030|FG000|STARTED|Overall Study||23||
59948318|NCT02840253|76067030|FG000|COMPLETED|Overall Study||19||
59948319|NCT02840253|76067030|FG000|NOT COMPLETED|Overall Study||4||
59948320|NCT02752074|76067036|FG000|STARTED|Overall Study||354||
59948321|NCT02752074|76067037|FG001|STARTED|Overall Study||352||
59948322|NCT02752074|76067036|FG000|Treated|Overall Study||353||
59948323|NCT02752074|76067037|FG001|Treated|Overall Study||352||
59948324|NCT02752074|76067036|FG000|COMPLETED|Overall Study||198||
59948325|NCT02752074|76067037|FG001|COMPLETED|Overall Study||209||
59948326|NCT02752074|76067036|FG000|NOT COMPLETED|Overall Study||156||
59948327|NCT02752074|76067037|FG001|NOT COMPLETED|Overall Study||143||
59948328|NCT02835495|76067045|FG000|STARTED|Overall Study|26 randomized, however, one had to withdraw pre-intervention initiation due to cancer diagnosis.|26||
59948329|NCT02835495|76067046|FG001|STARTED|Overall Study||25||
59948330|NCT02835495|76067045|FG000|Intervention Start|Overall Study||25||
59948331|NCT02835495|76067046|FG001|Intervention Start|Overall Study||25||
59948332|NCT02835495|76067045|FG000|COMPLETED|Overall Study||21||
59948333|NCT02835495|76067046|FG001|COMPLETED|Overall Study||23||
59948334|NCT02835495|76067045|FG000|NOT COMPLETED|Overall Study||5||
59948335|NCT02835495|76067046|FG001|NOT COMPLETED|Overall Study||2||
59948336|NCT02835339|76067056|FG000|STARTED|Overall Study||31||
59948337|NCT02835339|76067057|FG001|STARTED|Overall Study||35||
59948338|NCT02835339|76067056|FG000|COMPLETED|Overall Study||18||
59948339|NCT02835339|76067057|FG001|COMPLETED|Overall Study||19||
59948340|NCT02835339|76067056|FG000|NOT COMPLETED|Overall Study||13||
59948341|NCT02835339|76067057|FG001|NOT COMPLETED|Overall Study||16||
59948342|NCT02832063|76067065|FG000|STARTED|Overall Study||186||
59948343|NCT02832063|76067066|FG001|STARTED|Overall Study||186||
59948344|NCT02832063|76067065|FG000|COMPLETED|Overall Study||152||
59948345|NCT02832063|76067066|FG001|COMPLETED|Overall Study||148||
59948346|NCT02832063|76067065|FG000|NOT COMPLETED|Overall Study||34||
59948347|NCT02832063|76067066|FG001|NOT COMPLETED|Overall Study||38||
59948348|NCT03699085|76067074|FG000|STARTED|Overall Study||20||
59948349|NCT03699085|76067075|FG001|STARTED|Overall Study||20||
59948350|NCT03699085|76067074|FG000|COMPLETED|Overall Study||20||
59948351|NCT03699085|76067075|FG001|COMPLETED|Overall Study||20||
59948352|NCT03699085|76067074|FG000|NOT COMPLETED|Overall Study||0||
59948353|NCT03699085|76067075|FG001|NOT COMPLETED|Overall Study||0||
59948354|NCT04412707|76067085|FG000|STARTED|Cycle 1||14||
59948355|NCT04412707|76067086|FG001|STARTED|Cycle 1||13||
59948356|NCT04412707|76067085|FG000|Discontinued|Cycle 1||1||
59948357|NCT04412707|76067086|FG001|Discontinued|Cycle 1||5||
59948358|NCT04412707|76067085|FG000|COMPLETED|Cycle 1||13||
59948359|NCT04412707|76067086|FG001|COMPLETED|Cycle 1||8||
59948360|NCT04412707|76067085|FG000|NOT COMPLETED|Cycle 1||1||
59948361|NCT04412707|76067086|FG001|NOT COMPLETED|Cycle 1||5||
59948362|NCT04412707|76067085|FG000|STARTED|Cycle 2||13||
59948363|NCT04412707|76067086|FG001|STARTED|Cycle 2||8||
59948364|NCT04412707|76067085|FG000|Discontinued|Cycle 2||3||
59948365|NCT04412707|76067086|FG001|Discontinued|Cycle 2||1||
59948366|NCT04412707|76067085|FG000|COMPLETED|Cycle 2||10||
59948367|NCT04412707|76067086|FG001|COMPLETED|Cycle 2||7||
59948368|NCT04412707|76067085|FG000|NOT COMPLETED|Cycle 2||3||
59948369|NCT04412707|76067086|FG001|NOT COMPLETED|Cycle 2||1||
59948370|NCT04412707|76067085|FG000|STARTED|Cycle 3 to End of Study (EOS)||10||
59948371|NCT04412707|76067086|FG001|STARTED|Cycle 3 to End of Study (EOS)||7||
59948372|NCT04412707|76067085|FG000|Ongoing in Study at Data Cut|Cycle 3 to End of Study (EOS)||0||
59948373|NCT04412707|76067086|FG001|Ongoing in Study at Data Cut|Cycle 3 to End of Study (EOS)||0||
59948374|NCT04412707|76067085|FG000|Discontinued Study in Cycle 3 or Later|Cycle 3 to End of Study (EOS)||10||
59948375|NCT04412707|76067086|FG001|Discontinued Study in Cycle 3 or Later|Cycle 3 to End of Study (EOS)||7||
59948376|NCT04412707|76067085|FG000|COMPLETED|Cycle 3 to End of Study (EOS)||0||
59948377|NCT04412707|76067086|FG001|COMPLETED|Cycle 3 to End of Study (EOS)||0||
59948378|NCT04412707|76067085|FG000|NOT COMPLETED|Cycle 3 to End of Study (EOS)||10||
60067633|NCT01606761|76182768|FG003|NOT COMPLETED|Safety Follow-up Period (Week 52-68)||2||
60067634|NCT01606761|76182769|FG004|NOT COMPLETED|Safety Follow-up Period (Week 52-68)||8||
59948379|NCT04412707|76067086|FG001|NOT COMPLETED|Cycle 3 to End of Study (EOS)||7||
59948380|NCT01358721|76067105|FG000|STARTED|Overall Study||22||
59948381|NCT01358721|76067106|FG001|STARTED|Overall Study||22||
59948382|NCT01358721|76067107|FG002|STARTED|Overall Study||23||
59948383|NCT01358721|76067108|FG003|STARTED|Overall Study||24||
59948384|NCT01358721|76067105|FG000|COMPLETED|Overall Study||1|Completed = continuing in the treatment period|
59948385|NCT01358721|76067106|FG001|COMPLETED|Overall Study||0|Completed = continuing in the treatment period|
59948386|NCT01358721|76067107|FG002|COMPLETED|Overall Study||1|Completed = continuing in the treatment period|
59948387|NCT01358721|76067108|FG003|COMPLETED|Overall Study||0|Completed = continuing in the treatment period|
60067635|NCT01790295|76182784|FG000|STARTED|Overall Study||21||
60067636|NCT01790295|76182784|FG000|COMPLETED|Overall Study||10||
59948388|NCT01358721|76067105|FG000|NOT COMPLETED|Overall Study||21||
59948389|NCT01358721|76067106|FG001|NOT COMPLETED|Overall Study||22||
59948390|NCT01358721|76067107|FG002|NOT COMPLETED|Overall Study||22||
59948391|NCT01358721|76067108|FG003|NOT COMPLETED|Overall Study||24||
59948392|NCT01341639|76067120|FG000|STARTED|Infant Series||628|All Randomized Participants|
60067637|NCT01790295|76182784|FG000|NOT COMPLETED|Overall Study||11||
59948393|NCT01341639|76067121|FG001|STARTED|Infant Series||622|All Randomized Participants|
59948394|NCT01341639|76067120|FG000|Site 0048 Excluded|Infant Series||611|Participants from Site 0048 were excluded from all analyses due to major findings in study conduct.|
59948395|NCT01341639|76067121|FG001|Site 0048 Excluded|Infant Series||606|Participants from Site 0048 were excluded from all analyses due to major findings in study conduct.|
59948396|NCT01341639|76067120|FG000|Treated|Infant Series||610||
59948397|NCT01341639|76067121|FG001|Treated|Infant Series||605||
59948398|NCT01341639|76067120|FG000|COMPLETED|Infant Series||599||
59948399|NCT01341639|76067121|FG001|COMPLETED|Infant Series||590||
59948400|NCT01341639|76067120|FG000|NOT COMPLETED|Infant Series||29||
59948401|NCT01341639|76067121|FG001|NOT COMPLETED|Infant Series||32||
59948402|NCT01341639|76067120|FG000|STARTED|Interim Period||599||
59948403|NCT01341639|76067121|FG001|STARTED|Interim Period||590||
59948404|NCT01341639|76067120|FG000|COMPLETED|Interim Period||591||
59948405|NCT01341639|76067121|FG001|COMPLETED|Interim Period||581||
59948406|NCT01341639|76067120|FG000|NOT COMPLETED|Interim Period||8||
59948407|NCT01341639|76067121|FG001|NOT COMPLETED|Interim Period||9||
59948408|NCT01341639|76067120|FG000|STARTED|Toddler Dose|One participant randomized to the PR5I group mistakenly received INFANRIX™ hexa instead|590||
59948409|NCT01341639|76067121|FG001|STARTED|Toddler Dose|One participant randomized to the PR5I group mistakenly received INFANRIX™ hexa instead|582||
59948410|NCT01341639|76067120|FG000|COMPLETED|Toddler Dose||539||
59948411|NCT01341639|76067121|FG001|COMPLETED|Toddler Dose||548||
59948412|NCT01341639|76067120|FG000|NOT COMPLETED|Toddler Dose||51||
59948413|NCT01341639|76067121|FG001|NOT COMPLETED|Toddler Dose||34||
59948414|NCT01341639|76067120|FG000|STARTED|Post-Treatment||539||
59948415|NCT01341639|76067121|FG001|STARTED|Post-Treatment||548||
59948416|NCT01341639|76067120|FG000|COMPLETED|Post-Treatment||539||
59948417|NCT01341639|76067121|FG001|COMPLETED|Post-Treatment||545||
59948418|NCT01341639|76067120|FG000|NOT COMPLETED|Post-Treatment||0||
59948419|NCT01341639|76067121|FG001|NOT COMPLETED|Post-Treatment||3||
59948420|NCT02628028|76067135|FG000|STARTED|Dosing Period||9||
59948421|NCT02628028|76067136|FG001|STARTED|Dosing Period||9||
59948422|NCT02628028|76067137|FG002|STARTED|Dosing Period||10||
59948423|NCT02628028|76067138|FG003|STARTED|Dosing Period||8||
59948424|NCT02628028|76067139|FG004|STARTED|Dosing Period||62||
59948425|NCT02628028|76067140|FG005|STARTED|Dosing Period||63||
59948426|NCT02628028|76067141|FG006|STARTED|Dosing Period||62||
59948427|NCT02628028|76067142|FG007|STARTED|Dosing Period||63||
59948428|NCT02628028|76067135|FG000|Received at Least 1dose of Study Drug|Dosing Period||9||
59948429|NCT02628028|76067136|FG001|Received at Least 1dose of Study Drug|Dosing Period||9||
59948430|NCT02628028|76067137|FG002|Received at Least 1dose of Study Drug|Dosing Period||10||
59948431|NCT02628028|76067138|FG003|Received at Least 1dose of Study Drug|Dosing Period||8||
59948432|NCT02628028|76067139|FG004|Received at Least 1dose of Study Drug|Dosing Period||62||
59948433|NCT02628028|76067140|FG005|Received at Least 1dose of Study Drug|Dosing Period||63||
59948434|NCT02628028|76067141|FG006|Received at Least 1dose of Study Drug|Dosing Period||62||
59613410|NCT01593696|75724557|FG002|No Prior Transplant|Dose Escalation||0||
59948435|NCT02628028|76067142|FG007|Received at Least 1dose of Study Drug|Dosing Period||63||
59948436|NCT02628028|76067135|FG000|COMPLETED|Dosing Period||9||
59948437|NCT02628028|76067136|FG001|COMPLETED|Dosing Period||9||
59948438|NCT02628028|76067137|FG002|COMPLETED|Dosing Period||9||
59948439|NCT02628028|76067138|FG003|COMPLETED|Dosing Period||8||
59948440|NCT02628028|76067139|FG004|COMPLETED|Dosing Period||46||
59948441|NCT02628028|76067140|FG005|COMPLETED|Dosing Period||49||
59948442|NCT02628028|76067141|FG006|COMPLETED|Dosing Period||46||
59948443|NCT02628028|76067142|FG007|COMPLETED|Dosing Period||48||
59948444|NCT02628028|76067135|FG000|NOT COMPLETED|Dosing Period||0||
59613411|NCT01593696|75724558|FG003|No Prior Transplant|Dose Escalation||0||
59613412|NCT01593696|75724555|FG000|COMPLETED|Dose Escalation||14||
59613413|NCT01593696|75724556|FG001|COMPLETED|Dose Escalation||5||
59613414|NCT01593696|75724557|FG002|COMPLETED|Dose Escalation||0||
59613415|NCT01593696|75724558|FG003|COMPLETED|Dose Escalation||0||
59613416|NCT01593696|75724555|FG000|NOT COMPLETED|Dose Escalation||2||
59613417|NCT01593696|75724556|FG001|NOT COMPLETED|Dose Escalation||0||
59948445|NCT02628028|76067136|FG001|NOT COMPLETED|Dosing Period||0||
59948446|NCT02628028|76067137|FG002|NOT COMPLETED|Dosing Period||1||
59948447|NCT02628028|76067138|FG003|NOT COMPLETED|Dosing Period||0||
59948448|NCT02628028|76067139|FG004|NOT COMPLETED|Dosing Period||16||
59948449|NCT02628028|76067140|FG005|NOT COMPLETED|Dosing Period||14||
59948450|NCT02628028|76067141|FG006|NOT COMPLETED|Dosing Period||16||
59948451|NCT02628028|76067142|FG007|NOT COMPLETED|Dosing Period||15||
59948452|NCT02628028|76067135|FG000|STARTED|Long-term Extension (LTE) Period|LTE period included participants who completed Part B of the study.|0||
59948453|NCT02628028|76067136|FG001|STARTED|Long-term Extension (LTE) Period|LTE period included participants who completed Part B of the study.|0||
59948454|NCT02628028|76067137|FG002|STARTED|Long-term Extension (LTE) Period|LTE period included participants who completed Part B of the study.|0||
59948455|NCT02628028|76067138|FG003|STARTED|Long-term Extension (LTE) Period|LTE period included participants who completed Part B of the study.|0||
59948456|NCT02628028|76067139|FG004|STARTED|Long-term Extension (LTE) Period|Part B LTE was optional;42 participants completed part B placebo period,re-randomized to LTE period.|0||
59948457|NCT02628028|76067140|FG005|STARTED|Long-term Extension (LTE) Period|Part B LTE was optional;14 participants completed part B placebo period,re-randomized to LTE period.|61||
59948458|NCT02628028|76067141|FG006|STARTED|Long-term Extension (LTE) Period|Part B LTE was optional;14 participants completed part B placebo period,re-randomized to LTE period.|58||
59948459|NCT02628028|76067142|FG007|STARTED|Long-term Extension (LTE) Period|Part B LTE was optional;14 participants completed part B placebo period,re-randomized to LTE period.|61||
59948460|NCT02628028|76067135|FG000|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||0||
59948461|NCT02628028|76067136|FG001|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||0||
59948462|NCT02628028|76067137|FG002|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||0||
59948463|NCT02628028|76067138|FG003|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||0||
59948464|NCT02628028|76067139|FG004|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||0||
59948465|NCT02628028|76067140|FG005|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||14||
59948466|NCT02628028|76067141|FG006|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||14||
59948467|NCT02628028|76067142|FG007|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||14||
59948468|NCT02628028|76067135|FG000|COMPLETED|Long-term Extension (LTE) Period||0||
59948469|NCT02628028|76067136|FG001|COMPLETED|Long-term Extension (LTE) Period||0||
59948470|NCT02628028|76067137|FG002|COMPLETED|Long-term Extension (LTE) Period||0||
59948471|NCT02628028|76067138|FG003|COMPLETED|Long-term Extension (LTE) Period||0||
59948472|NCT02628028|76067139|FG004|COMPLETED|Long-term Extension (LTE) Period||0||
59948473|NCT02628028|76067140|FG005|COMPLETED|Long-term Extension (LTE) Period||1||
59948474|NCT02628028|76067141|FG006|COMPLETED|Long-term Extension (LTE) Period||0||
59948475|NCT02628028|76067142|FG007|COMPLETED|Long-term Extension (LTE) Period||0||
59948476|NCT02628028|76067135|FG000|NOT COMPLETED|Long-term Extension (LTE) Period||0||
59948477|NCT02628028|76067136|FG001|NOT COMPLETED|Long-term Extension (LTE) Period||0||
59948478|NCT02628028|76067137|FG002|NOT COMPLETED|Long-term Extension (LTE) Period||0||
59948479|NCT02628028|76067138|FG003|NOT COMPLETED|Long-term Extension (LTE) Period||0||
59948480|NCT02628028|76067139|FG004|NOT COMPLETED|Long-term Extension (LTE) Period||0||
59948481|NCT02628028|76067140|FG005|NOT COMPLETED|Long-term Extension (LTE) Period||60||
59948482|NCT02628028|76067141|FG006|NOT COMPLETED|Long-term Extension (LTE) Period||58||
59948483|NCT02628028|76067142|FG007|NOT COMPLETED|Long-term Extension (LTE) Period||61||
59948484|NCT03977701|76067174|FG000|STARTED|Overall Study||0||
59948485|NCT03977701|76067175|FG001|STARTED|Overall Study||0||
59948486|NCT03977701|76067176|FG002|STARTED|Overall Study||7||
59948487|NCT03977701|76067177|FG003|STARTED|Overall Study||0||
59948488|NCT03977701|76067178|FG004|STARTED|Overall Study||0||
59948489|NCT03977701|76067179|FG005|STARTED|Overall Study||1||
59948490|NCT03977701|76067180|FG006|STARTED|Overall Study||10||
59948491|NCT03977701|76067181|FG007|STARTED|Overall Study||1||
59948492|NCT03977701|76067182|FG008|STARTED|Overall Study||0||
59948493|NCT03977701|76067183|FG009|STARTED|Overall Study||0||
59948494|NCT03977701|76067174|FG000|COMPLETED|Overall Study||0||
59948495|NCT03977701|76067175|FG001|COMPLETED|Overall Study||0||
59948496|NCT03977701|76067176|FG002|COMPLETED|Overall Study||7||
59948497|NCT03977701|76067177|FG003|COMPLETED|Overall Study||0||
59948498|NCT03977701|76067178|FG004|COMPLETED|Overall Study||0||
59948499|NCT03977701|76067179|FG005|COMPLETED|Overall Study||0||
59948500|NCT03977701|76067180|FG006|COMPLETED|Overall Study||10||
59948501|NCT03977701|76067181|FG007|COMPLETED|Overall Study||0||
59948502|NCT03977701|76067182|FG008|COMPLETED|Overall Study||0||
59948503|NCT03977701|76067183|FG009|COMPLETED|Overall Study||0||
59948504|NCT03977701|76067174|FG000|NOT COMPLETED|Overall Study||0||
59948505|NCT03977701|76067175|FG001|NOT COMPLETED|Overall Study||0||
59948506|NCT03977701|76067176|FG002|NOT COMPLETED|Overall Study||0||
59948507|NCT03977701|76067177|FG003|NOT COMPLETED|Overall Study||0||
59948508|NCT03977701|76067178|FG004|NOT COMPLETED|Overall Study||0||
59948509|NCT03977701|76067179|FG005|NOT COMPLETED|Overall Study||1||
59948510|NCT03977701|76067180|FG006|NOT COMPLETED|Overall Study||0||
59948511|NCT03977701|76067181|FG007|NOT COMPLETED|Overall Study||1||
59948512|NCT03977701|76067182|FG008|NOT COMPLETED|Overall Study||0||
59948513|NCT03977701|76067183|FG009|NOT COMPLETED|Overall Study||0||
59948514|NCT02197104|76067205|FG000|STARTED|Overall Study||10||
59948515|NCT02197104|76067205|FG000|COMPLETED|Overall Study||9||
59948516|NCT02197104|76067205|FG000|NOT COMPLETED|Overall Study||1||
59948517|NCT03975595|76067211|FG000|STARTED|Overall Study||21||
59948518|NCT03975595|76067212|FG001|STARTED|Overall Study||23||
59948519|NCT03975595|76067211|FG000|COMPLETED|Overall Study||15||
59948520|NCT03975595|76067212|FG001|COMPLETED|Overall Study||14||
59948521|NCT03975595|76067211|FG000|NOT COMPLETED|Overall Study||6||
59948522|NCT03975595|76067212|FG001|NOT COMPLETED|Overall Study||9||
59948523|NCT02814526|76067222|FG000|STARTED|Overall Study||148||
59948524|NCT02814526|76067223|FG001|STARTED|Overall Study||148||
59948525|NCT02814526|76067222|FG000|COMPLETED|Overall Study||115|Completed = number of participants randomized to AX or SBR and completed 12 months of supervised exercise sessions|
59948526|NCT02814526|76067223|FG001|COMPLETED|Overall Study||118|Completed = number of participants randomized to AX or SBR and completed 12 months of supervised exercise sessions|
59948527|NCT02814526|76067222|FG000|NOT COMPLETED|Overall Study||33||
59948528|NCT02814526|76067223|FG001|NOT COMPLETED|Overall Study||30||
59948529|NCT02329834|76067231|FG000|STARTED|Overall Study||8||
59948530|NCT02329834|76067232|FG001|STARTED|Overall Study||9||
59948531|NCT02329834|76067231|FG000|COMPLETED|Overall Study||7||
59948532|NCT02329834|76067232|FG001|COMPLETED|Overall Study||9||
59948533|NCT02329834|76067231|FG000|NOT COMPLETED|Overall Study||1||
59948534|NCT02329834|76067232|FG001|NOT COMPLETED|Overall Study||0||
59948535|NCT01340937|76067243|FG000|STARTED|Period 1: Infant Series||800||
59948536|NCT01340937|76067244|FG001|STARTED|Period 1: Infant Series||797||
59948537|NCT01340937|76067245|FG002|STARTED|Period 1: Infant Series||809||
59948538|NCT01340937|76067246|FG003|STARTED|Period 1: Infant Series||402||
59948539|NCT01340937|76067243|FG000|COMPLETED|Period 1: Infant Series||742||
59948540|NCT01340937|76067244|FG001|COMPLETED|Period 1: Infant Series||737||
59948541|NCT01340937|76067245|FG002|COMPLETED|Period 1: Infant Series||753||
59948542|NCT01340937|76067246|FG003|COMPLETED|Period 1: Infant Series||370||
59948543|NCT01340937|76067243|FG000|NOT COMPLETED|Period 1: Infant Series||58||
59948544|NCT01340937|76067244|FG001|NOT COMPLETED|Period 1: Infant Series||60||
59948545|NCT01340937|76067245|FG002|NOT COMPLETED|Period 1: Infant Series||56||
59948546|NCT01340937|76067246|FG003|NOT COMPLETED|Period 1: Infant Series||32||
59948547|NCT01340937|76067243|FG000|STARTED|Period 2: Interim Period||742||
59948548|NCT01340937|76067244|FG001|STARTED|Period 2: Interim Period||737||
59948549|NCT01340937|76067245|FG002|STARTED|Period 2: Interim Period||753||
59948550|NCT01340937|76067246|FG003|STARTED|Period 2: Interim Period||370||
59948551|NCT01340937|76067243|FG000|COMPLETED|Period 2: Interim Period||675||
59948552|NCT01340937|76067244|FG001|COMPLETED|Period 2: Interim Period||658||
59948553|NCT01340937|76067245|FG002|COMPLETED|Period 2: Interim Period||669||
59948554|NCT01340937|76067246|FG003|COMPLETED|Period 2: Interim Period||329||
59948555|NCT01340937|76067243|FG000|NOT COMPLETED|Period 2: Interim Period||67||
59948556|NCT01340937|76067244|FG001|NOT COMPLETED|Period 2: Interim Period||79||
59948557|NCT01340937|76067245|FG002|NOT COMPLETED|Period 2: Interim Period||84||
59948558|NCT01340937|76067246|FG003|NOT COMPLETED|Period 2: Interim Period||41||
59948559|NCT01340937|76067243|FG000|STARTED|Period 3: Toddler Vaccinations||675||
59948560|NCT01340937|76067244|FG001|STARTED|Period 3: Toddler Vaccinations||658||
59948561|NCT01340937|76067245|FG002|STARTED|Period 3: Toddler Vaccinations||669||
59948562|NCT01340937|76067246|FG003|STARTED|Period 3: Toddler Vaccinations||329||
59948563|NCT01340937|76067243|FG000|COMPLETED|Period 3: Toddler Vaccinations||666||
59948564|NCT01340937|76067244|FG001|COMPLETED|Period 3: Toddler Vaccinations||641||
59948565|NCT01340937|76067245|FG002|COMPLETED|Period 3: Toddler Vaccinations||660||
59948566|NCT01340937|76067246|FG003|COMPLETED|Period 3: Toddler Vaccinations||319||
59948567|NCT01340937|76067243|FG000|NOT COMPLETED|Period 3: Toddler Vaccinations||9||
59948568|NCT01340937|76067244|FG001|NOT COMPLETED|Period 3: Toddler Vaccinations||17||
59948569|NCT01340937|76067245|FG002|NOT COMPLETED|Period 3: Toddler Vaccinations||9||
59948570|NCT01340937|76067246|FG003|NOT COMPLETED|Period 3: Toddler Vaccinations||10||
59948571|NCT03028129|76067264|FG000|STARTED|Overall Study||258||
59948572|NCT03028129|76067265|FG001|STARTED|Overall Study||209||
59948573|NCT03028129|76067264|FG000|COMPLETED|Overall Study||132||
59948574|NCT03028129|76067265|FG001|COMPLETED|Overall Study||122||
59948575|NCT03028129|76067264|FG000|NOT COMPLETED|Overall Study||126||
59948576|NCT03028129|76067265|FG001|NOT COMPLETED|Overall Study||87||
59948577|NCT03026257|76067277|FG000|STARTED|Overall Study||60|Randomized and treated, as randomized|
59948578|NCT03026257|76067278|FG001|STARTED|Overall Study||64|Randomized and treated, as randomized|
59948579|NCT03026257|76067279|FG002|STARTED|Overall Study||34|Randomized and treated, as randomized|
59948580|NCT03026257|76067280|FG003|STARTED|Overall Study||25|Randomized and treated, as randomized|
59948581|NCT03026257|76067281|FG004|STARTED|Overall Study||23|Randomized and treated, as randomized|
59948582|NCT03026257|76067282|FG005|STARTED|Overall Study||46|Randomized and treated, as randomized|
59948583|NCT03026257|76067277|FG000|Treated|Overall Study||58|Randomized and treated, as treated|
59948584|NCT03026257|76067278|FG001|Treated|Overall Study||65|Randomized and treated, as treated|
59948585|NCT03026257|76067279|FG002|Treated|Overall Study||35|Randomized and treated, as treated|
59948586|NCT03026257|76067280|FG003|Treated|Overall Study||24|Randomized and treated, as treated|
59948587|NCT03026257|76067281|FG004|Treated|Overall Study||23|Randomized and treated, as treated|
59948588|NCT03026257|76067282|FG005|Treated|Overall Study||47|Randomized and treated, as treated|
59948589|NCT03026257|76067277|FG000|COMPLETED|Overall Study||54||
59948590|NCT03026257|76067278|FG001|COMPLETED|Overall Study||63||
59948591|NCT03026257|76067279|FG002|COMPLETED|Overall Study||34||
59948592|NCT03026257|76067280|FG003|COMPLETED|Overall Study||24||
59948593|NCT03026257|76067281|FG004|COMPLETED|Overall Study||22||
59948594|NCT03026257|76067282|FG005|COMPLETED|Overall Study||46||
59948595|NCT03026257|76067277|FG000|NOT COMPLETED|Overall Study||6||
59948596|NCT03026257|76067278|FG001|NOT COMPLETED|Overall Study||1||
59948597|NCT03026257|76067279|FG002|NOT COMPLETED|Overall Study||0||
59948598|NCT03026257|76067280|FG003|NOT COMPLETED|Overall Study||1||
59948599|NCT03026257|76067281|FG004|NOT COMPLETED|Overall Study||1||
59948600|NCT03026257|76067282|FG005|NOT COMPLETED|Overall Study||0||
59948601|NCT01670188|76067298|FG000|STARTED|Overall Study||38||
59948602|NCT01670188|76067299|FG001|STARTED|Overall Study||40||
59948603|NCT01670188|76067298|FG000|COMPLETED|Overall Study||38||
59948604|NCT01670188|76067299|FG001|COMPLETED|Overall Study||39||
59948605|NCT01670188|76067298|FG000|NOT COMPLETED|Overall Study||0||
59948606|NCT01670188|76067299|FG001|NOT COMPLETED|Overall Study||1||
59948607|NCT01933048|76067307|FG000|STARTED|Overall Study||548||
59948608|NCT01933048|76067308|FG001|STARTED|Overall Study||529||
59948609|NCT01933048|76067307|FG000|COMPLETED|Overall Study||523||
59948610|NCT01933048|76067308|FG001|COMPLETED|Overall Study||501||
59948611|NCT01933048|76067307|FG000|NOT COMPLETED|Overall Study||25||
59948612|NCT01933048|76067308|FG001|NOT COMPLETED|Overall Study||28||
59948613|NCT02751450|76067319|FG000|STARTED|Overall Study||117||
59948614|NCT02751450|76067320|FG001|STARTED|Overall Study||116||
59948615|NCT02751450|76067319|FG000|COMPLETED|Overall Study||116||
59948616|NCT02751450|76067320|FG001|COMPLETED|Overall Study||116||
59948617|NCT02751450|76067319|FG000|NOT COMPLETED|Overall Study||1||
59948618|NCT02751450|76067320|FG001|NOT COMPLETED|Overall Study||0||
59948619|NCT01358175|76067331|FG000|STARTED|Overall Study||124||
59948620|NCT01358175|76067332|FG001|STARTED|Overall Study||125||
59948621|NCT01358175|76067333|FG002|STARTED|Overall Study||122||
59948622|NCT01358175|76067331|FG000|COMPLETED|Overall Study||103||
59948623|NCT01358175|76067332|FG001|COMPLETED|Overall Study||97||
59948624|NCT01358175|76067333|FG002|COMPLETED|Overall Study||90||
59948625|NCT01358175|76067331|FG000|NOT COMPLETED|Overall Study||21||
59948626|NCT01358175|76067332|FG001|NOT COMPLETED|Overall Study||28||
59948627|NCT01358175|76067333|FG002|NOT COMPLETED|Overall Study||32||
59948628|NCT04116229|76067347|FG000|STARTED|Overall Study||10||
59948629|NCT04116229|76067348|FG001|STARTED|Overall Study||10||
59948630|NCT04116229|76067347|FG000|COMPLETED|Overall Study||8||
59948631|NCT04116229|76067348|FG001|COMPLETED|Overall Study||6||
59948632|NCT04116229|76067347|FG000|NOT COMPLETED|Overall Study||2||
59948633|NCT04116229|76067348|FG001|NOT COMPLETED|Overall Study||4||
59948634|NCT02210832|76067357|FG000|STARTED|Overall Study||91||
59948635|NCT02210832|76067358|FG001|STARTED|Overall Study||85||
59948636|NCT02210832|76067359|FG002|STARTED|Overall Study||81||
59948637|NCT02210832|76067357|FG000|COMPLETED|Overall Study||62|Defined as completed week-48 postpartum assessment.|
59948638|NCT02210832|76067358|FG001|COMPLETED|Overall Study||49|Defined as completed week-48 postpartum assessment.|
59948639|NCT02210832|76067359|FG002|COMPLETED|Overall Study||63|Defined as completed week-48 postpartum assessment.|
59948640|NCT02210832|76067357|FG000|NOT COMPLETED|Overall Study||29||
59948641|NCT02210832|76067358|FG001|NOT COMPLETED|Overall Study||36||
59948642|NCT02210832|76067359|FG002|NOT COMPLETED|Overall Study||18||
59948643|NCT02833077|76067372|FG000|STARTED|Overall Study||144||
59948644|NCT02833077|76067373|FG001|STARTED|Overall Study||48||
59948645|NCT02833077|76067372|FG000|Participants Treated|Overall Study||144||
59948646|NCT02833077|76067373|FG001|Participants Treated|Overall Study||38||
59948647|NCT02833077|76067372|FG000|COMPLETED|Overall Study||127||
59948648|NCT02833077|76067373|FG001|COMPLETED|Overall Study|Includes participants who completed the study but did not receive the optional treatment.|40||
59948649|NCT02833077|76067372|FG000|NOT COMPLETED|Overall Study||17||
59948650|NCT02833077|76067373|FG001|NOT COMPLETED|Overall Study||8||
59948651|NCT01355679|76067380|FG000|STARTED|Overall Study||16||
59948652|NCT01355679|76067380|FG000|COMPLETED|Overall Study||14||
59948653|NCT01355679|76067380|FG000|NOT COMPLETED|Overall Study||2||
59948654|NCT02832375|76067387|FG000|STARTED|Overall Study||121||
59948655|NCT02832375|76067388|FG001|STARTED|Overall Study||121||
60067638|NCT01597557|76182791|FG000|STARTED|Overall Study||132||
59948656|NCT02832375|76067387|FG000|COMPLETED|Overall Study||119||
59948657|NCT02832375|76067388|FG001|COMPLETED|Overall Study||121||
59948658|NCT02832375|76067387|FG000|NOT COMPLETED|Overall Study||2||
59948659|NCT02832375|76067388|FG001|NOT COMPLETED|Overall Study||0||
59948660|NCT02925403|76067397|FG000|STARTED|Overall Study||8||
59948661|NCT02925403|76067398|FG001|STARTED|Overall Study||5||
59948662|NCT02925403|76067397|FG000|COMPLETED|Overall Study||8||
59948663|NCT02925403|76067398|FG001|COMPLETED|Overall Study||4||
59948664|NCT02925403|76067397|FG000|NOT COMPLETED|Overall Study||0||
59948665|NCT02925403|76067398|FG001|NOT COMPLETED|Overall Study||1||
59948666|NCT02626780|76067404|FG000|STARTED|Overall Study||7||
59948667|NCT02626780|76067404|FG000|Withdrew From Study|Overall Study||3||
60067639|NCT01597557|76182792|FG001|STARTED|Overall Study||129||
59948668|NCT02626780|76067404|FG000|COMPLETED|Overall Study||4||
59948669|NCT02626780|76067404|FG000|NOT COMPLETED|Overall Study||3||
59948670|NCT01363401|76067410|FG000|STARTED|Overall Study|"Including 8 subjects of Phase 1 safety assessment. (Called Modified ITT in this clinical trials)"|41||
59948671|NCT01363401|76067411|FG001|STARTED|Overall Study||31||
59948672|NCT01363401|76067410|FG000|COMPLETED|Overall Study||39||
59948673|NCT01363401|76067411|FG001|COMPLETED|Overall Study||27||
59948674|NCT01363401|76067410|FG000|NOT COMPLETED|Overall Study||2||
60067640|NCT01597557|76182791|FG000|COMPLETED|Overall Study||128||
59948675|NCT01363401|76067411|FG001|NOT COMPLETED|Overall Study||4||
59948676|NCT02831673|76067419|FG000|STARTED|Double-blind (Day 1 to Week 96)||359|Randomized|
59948677|NCT02831673|76067420|FG001|STARTED|Double-blind (Day 1 to Week 96)||360|Randomized|
59948678|NCT02831673|76067421|FG002|STARTED|Double-blind (Day 1 to Week 96)||0|Randomized|
59948679|NCT02831673|76067422|FG003|STARTED|Double-blind (Day 1 to Week 96)||0|Randomized|
59948680|NCT02831673|76067423|FG004|STARTED|Double-blind (Day 1 to Week 96)||0|Randomized|
59948681|NCT02831673|76067419|FG000|Intent to Treat Exposed|Double-blind (Day 1 to Week 96)||356||
59948682|NCT02831673|76067420|FG001|Intent to Treat Exposed|Double-blind (Day 1 to Week 96)||358||
59948683|NCT02831673|76067421|FG002|Intent to Treat Exposed|Double-blind (Day 1 to Week 96)||0||
59948684|NCT02831673|76067422|FG003|Intent to Treat Exposed|Double-blind (Day 1 to Week 96)||0||
59948685|NCT02831673|76067423|FG004|Intent to Treat Exposed|Double-blind (Day 1 to Week 96)||0||
59948686|NCT02831673|76067419|FG000|COMPLETED|Double-blind (Day 1 to Week 96)||301||
59948687|NCT02831673|76067420|FG001|COMPLETED|Double-blind (Day 1 to Week 96)||320||
59948688|NCT02831673|76067421|FG002|COMPLETED|Double-blind (Day 1 to Week 96)||0||
59948689|NCT02831673|76067422|FG003|COMPLETED|Double-blind (Day 1 to Week 96)||0||
59948690|NCT02831673|76067423|FG004|COMPLETED|Double-blind (Day 1 to Week 96)||0||
59948691|NCT02831673|76067419|FG000|NOT COMPLETED|Double-blind (Day 1 to Week 96)||58||
59948692|NCT02831673|76067420|FG001|NOT COMPLETED|Double-blind (Day 1 to Week 96)||40||
59948693|NCT02831673|76067421|FG002|NOT COMPLETED|Double-blind (Day 1 to Week 96)||0||
59948694|NCT02831673|76067422|FG003|NOT COMPLETED|Double-blind (Day 1 to Week 96)||0||
59948695|NCT02831673|76067423|FG004|NOT COMPLETED|Double-blind (Day 1 to Week 96)||0||
59948696|NCT02831673|76067419|FG000|STARTED|Open-label Phase (Week 96 to Week 148)||0||
59948697|NCT02831673|76067420|FG001|STARTED|Open-label Phase (Week 96 to Week 148)||0||
59948698|NCT02831673|76067421|FG002|STARTED|Open-label Phase (Week 96 to Week 148)||301||
59948699|NCT02831673|76067422|FG003|STARTED|Open-label Phase (Week 96 to Week 148)|One participant who withdrew right after completion of double blind not 'Entered' open label phase.|319||
59948700|NCT02831673|76067423|FG004|STARTED|Open-label Phase (Week 96 to Week 148)||0||
59948701|NCT02831673|76067419|FG000|COMPLETED|Open-label Phase (Week 96 to Week 148)||0||
59948702|NCT02831673|76067420|FG001|COMPLETED|Open-label Phase (Week 96 to Week 148)||0||
59948703|NCT02831673|76067421|FG002|COMPLETED|Open-label Phase (Week 96 to Week 148)||281||
59948704|NCT02831673|76067422|FG003|COMPLETED|Open-label Phase (Week 96 to Week 148)||294||
59948705|NCT02831673|76067423|FG004|COMPLETED|Open-label Phase (Week 96 to Week 148)||0||
59948706|NCT02831673|76067419|FG000|NOT COMPLETED|Open-label Phase (Week 96 to Week 148)||0||
59948707|NCT02831673|76067420|FG001|NOT COMPLETED|Open-label Phase (Week 96 to Week 148)||0||
59948708|NCT02831673|76067421|FG002|NOT COMPLETED|Open-label Phase (Week 96 to Week 148)||20||
59948709|NCT02831673|76067422|FG003|NOT COMPLETED|Open-label Phase (Week 96 to Week 148)||25||
59948710|NCT02831673|76067423|FG004|NOT COMPLETED|Open-label Phase (Week 96 to Week 148)||0||
59948711|NCT02831673|76067419|FG000|STARTED|Continuation Phase(Week 148 to Week 280)||0||
59948712|NCT02831673|76067420|FG001|STARTED|Continuation Phase(Week 148 to Week 280)||0||
59948713|NCT02831673|76067421|FG002|STARTED|Continuation Phase(Week 148 to Week 280)||0||
59948714|NCT02831673|76067422|FG003|STARTED|Continuation Phase(Week 148 to Week 280)||0||
59948715|NCT02831673|76067423|FG004|STARTED|Continuation Phase(Week 148 to Week 280)|233 participants from the Open-label Phase entered in the Continuation Phase|233||
59948716|NCT02831673|76067419|FG000|COMPLETED|Continuation Phase(Week 148 to Week 280)||0||
59948717|NCT02831673|76067420|FG001|COMPLETED|Continuation Phase(Week 148 to Week 280)||0||
59948718|NCT02831673|76067421|FG002|COMPLETED|Continuation Phase(Week 148 to Week 280)||0||
59948719|NCT02831673|76067422|FG003|COMPLETED|Continuation Phase(Week 148 to Week 280)||0||
59948720|NCT02831673|76067423|FG004|COMPLETED|Continuation Phase(Week 148 to Week 280)||212||
59948721|NCT02831673|76067419|FG000|NOT COMPLETED|Continuation Phase(Week 148 to Week 280)||0||
59948722|NCT02831673|76067420|FG001|NOT COMPLETED|Continuation Phase(Week 148 to Week 280)||0||
59948723|NCT02831673|76067421|FG002|NOT COMPLETED|Continuation Phase(Week 148 to Week 280)||0||
59948724|NCT02831673|76067422|FG003|NOT COMPLETED|Continuation Phase(Week 148 to Week 280)||0||
59948725|NCT02831673|76067423|FG004|NOT COMPLETED|Continuation Phase(Week 148 to Week 280)||21||
59948726|NCT02830893|76067441|FG000|STARTED|Overall Study||12||
59948727|NCT02830893|76067442|FG001|STARTED|Overall Study||11||
59948728|NCT02830893|76067441|FG000|COMPLETED|Overall Study||11||
59948729|NCT02830893|76067442|FG001|COMPLETED|Overall Study||8||
59948730|NCT02830893|76067441|FG000|NOT COMPLETED|Overall Study||1||
59948731|NCT02830893|76067442|FG001|NOT COMPLETED|Overall Study||3||
59948732|NCT02625922|76067450|FG000|STARTED|Overall Study||14||
59948733|NCT02625922|76067451|FG001|STARTED|Overall Study||12||
59948734|NCT02625922|76067450|FG000|Completed Treatment Period 1|Overall Study||12||
59948735|NCT02625922|76067451|FG001|Completed Treatment Period 1|Overall Study||10||
59948736|NCT02625922|76067450|FG000|Completed Treatment Period 2|Overall Study||11||
59948737|NCT02625922|76067451|FG001|Completed Treatment Period 2|Overall Study||8||
59948738|NCT02625922|76067450|FG000|COMPLETED|Overall Study||12||
59948739|NCT02625922|76067451|FG001|COMPLETED|Overall Study||10||
59948740|NCT02625922|76067450|FG000|NOT COMPLETED|Overall Study||2||
59948741|NCT02625922|76067451|FG001|NOT COMPLETED|Overall Study||2||
59948742|NCT03350035|76067463|FG000|STARTED|Overall Study||5||
59948743|NCT03350035|76067464|FG001|STARTED|Overall Study||4||
59948744|NCT03350035|76067465|FG002|STARTED|Overall Study||8||
59948745|NCT03350035|76067463|FG000|COMPLETED|Overall Study||3||
59948746|NCT03350035|76067464|FG001|COMPLETED|Overall Study||4||
59948747|NCT03350035|76067465|FG002|COMPLETED|Overall Study||7||
59948748|NCT03350035|76067463|FG000|NOT COMPLETED|Overall Study||2||
59948749|NCT03350035|76067464|FG001|NOT COMPLETED|Overall Study||0||
59948750|NCT03350035|76067465|FG002|NOT COMPLETED|Overall Study||1||
59948751|NCT04426656|76067475|FG000|STARTED|Overall Study||24||
59948752|NCT04426656|76067476|FG001|STARTED|Overall Study||46||
59948753|NCT04426656|76067475|FG000|COMPLETED|Overall Study||21||
59948754|NCT04426656|76067476|FG001|COMPLETED|Overall Study||43||
59948755|NCT04426656|76067475|FG000|NOT COMPLETED|Overall Study||3||
59948756|NCT04426656|76067476|FG001|NOT COMPLETED|Overall Study||3||
59948757|NCT02845297|76067484|FG000|STARTED|Phase 1 (2 Years)||40||
59948758|NCT02845297|76067485|FG001|STARTED|Phase 1 (2 Years)||0||
59948759|NCT02845297|76067484|FG000|COMPLETED|Phase 1 (2 Years)||40||
59948760|NCT02845297|76067485|FG001|COMPLETED|Phase 1 (2 Years)||0||
59948761|NCT02845297|76067484|FG000|NOT COMPLETED|Phase 1 (2 Years)||0||
59948762|NCT02845297|76067485|FG001|NOT COMPLETED|Phase 1 (2 Years)||0||
59948763|NCT02845297|76067484|FG000|STARTED|Phase (2 Years)||0||
59948764|NCT02845297|76067485|FG001|STARTED|Phase (2 Years)||27||
59948765|NCT02845297|76067484|FG000|COMPLETED|Phase (2 Years)||0||
59948766|NCT02845297|76067485|FG001|COMPLETED|Phase (2 Years)||27||
59948767|NCT02845297|76067484|FG000|NOT COMPLETED|Phase (2 Years)||0||
59948768|NCT02845297|76067485|FG001|NOT COMPLETED|Phase (2 Years)||0||
59948769|NCT01358331|76067499|FG000|STARTED|Overall Study||2||
59948770|NCT01358331|76067500|FG001|STARTED|Overall Study||3||
59948771|NCT01358331|76067501|FG002|STARTED|Overall Study||4||
59948772|NCT01358331|76067502|FG003|STARTED|Overall Study||3||
59948773|NCT01358331|76067503|FG004|STARTED|Overall Study||7||
59948774|NCT01358331|76067504|FG005|STARTED|Overall Study||6||
59948775|NCT01358331|76067499|FG000|COMPLETED|Overall Study||0||
59948776|NCT01358331|76067500|FG001|COMPLETED|Overall Study||0||
59948777|NCT01358331|76067501|FG002|COMPLETED|Overall Study||0||
59948778|NCT01358331|76067502|FG003|COMPLETED|Overall Study||0||
59948779|NCT01358331|76067503|FG004|COMPLETED|Overall Study||0||
59948780|NCT01358331|76067504|FG005|COMPLETED|Overall Study||0||
59948781|NCT01358331|76067499|FG000|NOT COMPLETED|Overall Study||2||
59948782|NCT01358331|76067500|FG001|NOT COMPLETED|Overall Study||3||
59948783|NCT01358331|76067501|FG002|NOT COMPLETED|Overall Study||4||
59948784|NCT01358331|76067502|FG003|NOT COMPLETED|Overall Study||3||
59613418|NCT01593696|75724557|FG002|NOT COMPLETED|Dose Escalation||0||
59613419|NCT01593696|75724558|FG003|NOT COMPLETED|Dose Escalation||0||
59613420|NCT01593696|75724555|FG000|STARTED|Dose Expansion||0||
59613421|NCT01593696|75724556|FG001|STARTED|Dose Expansion||0||
59948785|NCT01358331|76067503|FG004|NOT COMPLETED|Overall Study||7||
59948786|NCT01358331|76067504|FG005|NOT COMPLETED|Overall Study||6||
59948787|NCT02828241|76067520|FG000|STARTED|Overall Study||38||
59948788|NCT02828241|76067521|FG001|STARTED|Overall Study||23||
59948789|NCT02828241|76067520|FG000|COMPLETED|Overall Study||30||
59948790|NCT02828241|76067521|FG001|COMPLETED|Overall Study||21||
59613422|NCT01593696|75724557|FG002|STARTED|Dose Expansion||16||
59613423|NCT01593696|75724558|FG003|STARTED|Dose Expansion||16||
59613424|NCT01593696|75724555|FG000|COMPLETED|Dose Expansion||0||
59948791|NCT02828241|76067520|FG000|NOT COMPLETED|Overall Study||8||
59948792|NCT02828241|76067521|FG001|NOT COMPLETED|Overall Study||2||
59948793|NCT01355523|76067530|FG000|STARTED|Overall Study||28||
59948794|NCT01355523|76067531|FG001|STARTED|Overall Study||26||
59948795|NCT01355523|76067530|FG000|COMPLETED|Overall Study||27||
59948796|NCT01355523|76067531|FG001|COMPLETED|Overall Study||16||
59948797|NCT01355523|76067530|FG000|NOT COMPLETED|Overall Study||1||
59948798|NCT01355523|76067531|FG001|NOT COMPLETED|Overall Study||10||
59948799|NCT02625220|76067537|FG000|STARTED|Overall Study||170||
59948800|NCT02625220|76067537|FG000|COMPLETED|Overall Study||163||
59948801|NCT02625220|76067537|FG000|NOT COMPLETED|Overall Study||7||
59948802|NCT02826603|76067543|FG000|STARTED|Overall Study||550||
59948803|NCT02826603|76067544|FG001|STARTED|Overall Study||552||
59948804|NCT02826603|76067543|FG000|COMPLETED|Overall Study||489||
59948805|NCT02826603|76067544|FG001|COMPLETED|Overall Study||488||
59948806|NCT02826603|76067543|FG000|NOT COMPLETED|Overall Study||61||
59948807|NCT02826603|76067544|FG001|NOT COMPLETED|Overall Study||64||
59948808|NCT05887388|76067551|FG000|STARTED|Overall Study||38||
59948809|NCT05887388|76067551|FG000|Patients Started|Overall Study||19||
59948810|NCT05887388|76067551|FG000|Caregivers Started|Overall Study||19||
59948811|NCT05887388|76067551|FG000|COMPLETED|Overall Study||38||
59948812|NCT05887388|76067551|FG000|NOT COMPLETED|Overall Study||0||
59948813|NCT05270460|76067560|FG000|STARTED|Overall Study||9||
59948814|NCT05270460|76067561|FG001|STARTED|Overall Study||8||
59948815|NCT05270460|76067562|FG002|STARTED|Overall Study||8||
59948816|NCT05270460|76067560|FG000|COMPLETED|Overall Study||9||
59948817|NCT05270460|76067561|FG001|COMPLETED|Overall Study||6||
59948818|NCT05270460|76067562|FG002|COMPLETED|Overall Study||8||
59948819|NCT05270460|76067560|FG000|NOT COMPLETED|Overall Study||0||
59948820|NCT05270460|76067561|FG001|NOT COMPLETED|Overall Study||2||
59948821|NCT05270460|76067562|FG002|NOT COMPLETED|Overall Study||0||
59948822|NCT05126836|76067572|FG000|STARTED|Overall Study||12||
59948823|NCT05126836|76067573|FG001|STARTED|Overall Study||13||
59948824|NCT05126836|76067572|FG000|COMPLETED|Overall Study||11||
59948825|NCT05126836|76067573|FG001|COMPLETED|Overall Study||12||
59948826|NCT05126836|76067572|FG000|NOT COMPLETED|Overall Study||1||
59948827|NCT05126836|76067573|FG001|NOT COMPLETED|Overall Study||1||
59948828|NCT04622592|76067587|FG000|STARTED|Overall Study||19||
59948829|NCT04622592|76067588|FG001|STARTED|Overall Study||9||
59948830|NCT04622592|76067589|FG002|STARTED|Overall Study||42||
59948831|NCT04622592|76067590|FG003|STARTED|Overall Study||19||
59948832|NCT04622592|76067591|FG004|STARTED|Overall Study||23||
59948833|NCT04622592|76067592|FG005|STARTED|Overall Study||13||
59948834|NCT04622592|76067593|FG006|STARTED|Overall Study||41||
59948835|NCT04622592|76067594|FG007|STARTED|Overall Study||43||
59948836|NCT04622592|76067587|FG000|Vaccinated|Overall Study||19||
59948837|NCT04622592|76067588|FG001|Vaccinated|Overall Study||9||
59948838|NCT04622592|76067589|FG002|Vaccinated|Overall Study||42||
59948839|NCT04622592|76067590|FG003|Vaccinated|Overall Study||19||
59948840|NCT04622592|76067591|FG004|Vaccinated|Overall Study||23||
59948841|NCT04622592|76067592|FG005|Vaccinated|Overall Study||13||
59948842|NCT04622592|76067593|FG006|Vaccinated|Overall Study||41||
59948843|NCT04622592|76067594|FG007|Vaccinated|Overall Study||43||
59948844|NCT04622592|76067587|FG000|COMPLETED|Overall Study||18||
59948845|NCT04622592|76067588|FG001|COMPLETED|Overall Study||9||
59948846|NCT04622592|76067589|FG002|COMPLETED|Overall Study||38||
59948847|NCT04622592|76067590|FG003|COMPLETED|Overall Study||16||
59948848|NCT04622592|76067591|FG004|COMPLETED|Overall Study||21||
59948849|NCT04622592|76067592|FG005|COMPLETED|Overall Study||13||
59948850|NCT04622592|76067593|FG006|COMPLETED|Overall Study||38||
59948851|NCT04622592|76067594|FG007|COMPLETED|Overall Study||36||
59948852|NCT04622592|76067587|FG000|NOT COMPLETED|Overall Study||1||
59948853|NCT04622592|76067588|FG001|NOT COMPLETED|Overall Study||0||
59948854|NCT04622592|76067589|FG002|NOT COMPLETED|Overall Study||4||
59948855|NCT04622592|76067590|FG003|NOT COMPLETED|Overall Study||3||
59948856|NCT04622592|76067591|FG004|NOT COMPLETED|Overall Study||2||
59948857|NCT04622592|76067592|FG005|NOT COMPLETED|Overall Study||0||
59948858|NCT04622592|76067593|FG006|NOT COMPLETED|Overall Study||3||
59948859|NCT04622592|76067594|FG007|NOT COMPLETED|Overall Study||7||
59948860|NCT04523220|76067615|FG000|STARTED|Main Treatment Period||234|Randomized|
59948861|NCT04523220|76067616|FG001|STARTED|Main Treatment Period||235|Randomized|
59948862|NCT04523220|76067617|FG002|STARTED|Main Treatment Period||235|Randomized|
59948863|NCT04523220|76067615|FG000|Treated|Main Treatment Period||224||
59948864|NCT04523220|76067616|FG001|Treated|Main Treatment Period||232||
59948865|NCT04523220|76067617|FG002|Treated|Main Treatment Period||230||
59948866|NCT04523220|76067615|FG000|COMPLETED|Main Treatment Period||194||
59948867|NCT04523220|76067616|FG001|COMPLETED|Main Treatment Period||199||
59948868|NCT04523220|76067617|FG002|COMPLETED|Main Treatment Period||206||
59948869|NCT04523220|76067615|FG000|NOT COMPLETED|Main Treatment Period||40||
59948870|NCT04523220|76067616|FG001|NOT COMPLETED|Main Treatment Period||36||
59948871|NCT04523220|76067617|FG002|NOT COMPLETED|Main Treatment Period||29||
59948872|NCT04523220|76067615|FG000|STARTED|Extension Treatment Period||194||
59948873|NCT04523220|76067616|FG001|STARTED|Extension Treatment Period||199||
59948874|NCT04523220|76067617|FG002|STARTED|Extension Treatment Period||206||
59948875|NCT04523220|76067615|FG000|COMPLETED|Extension Treatment Period||174||
59948876|NCT04523220|76067616|FG001|COMPLETED|Extension Treatment Period||178||
59948877|NCT04523220|76067617|FG002|COMPLETED|Extension Treatment Period||176||
59948878|NCT04523220|76067615|FG000|NOT COMPLETED|Extension Treatment Period||20||
59948879|NCT04523220|76067616|FG001|NOT COMPLETED|Extension Treatment Period||21||
59948880|NCT04523220|76067617|FG002|NOT COMPLETED|Extension Treatment Period||30||
59948881|NCT04233671|76067627|FG000|STARTED|Overall Study||13||
59948882|NCT04233671|76067628|FG001|STARTED|Overall Study||8||
59948883|NCT04233671|76067627|FG000|COMPLETED|Overall Study||8||
59948884|NCT04233671|76067628|FG001|COMPLETED|Overall Study||4||
59948885|NCT04233671|76067627|FG000|NOT COMPLETED|Overall Study||5||
59948886|NCT04233671|76067628|FG001|NOT COMPLETED|Overall Study||4||
59948887|NCT04227145|76067639|FG000|STARTED|Baseline and Post-Intervention Surveys||48||
59948888|NCT04227145|76067640|FG001|STARTED|Baseline and Post-Intervention Surveys||50||
59948889|NCT04227145|76067639|FG000|COMPLETED|Baseline and Post-Intervention Surveys||48||
59948890|NCT04227145|76067640|FG001|COMPLETED|Baseline and Post-Intervention Surveys||50||
59948891|NCT04227145|76067639|FG000|NOT COMPLETED|Baseline and Post-Intervention Surveys||0||
59948892|NCT04227145|76067640|FG001|NOT COMPLETED|Baseline and Post-Intervention Surveys||0||
59948893|NCT04227145|76067639|FG000|STARTED|Two-week Follow-up||38||
59948894|NCT04227145|76067640|FG001|STARTED|Two-week Follow-up||31||
59948895|NCT04227145|76067639|FG000|COMPLETED|Two-week Follow-up||38||
59948896|NCT04227145|76067640|FG001|COMPLETED|Two-week Follow-up||31||
59948897|NCT04227145|76067639|FG000|NOT COMPLETED|Two-week Follow-up||0||
59948898|NCT04227145|76067640|FG001|NOT COMPLETED|Two-week Follow-up||0||
59948899|NCT04227145|76067639|FG000|STARTED|One-month Follow-up||37||
59948900|NCT04227145|76067640|FG001|STARTED|One-month Follow-up||37||
59948901|NCT04227145|76067639|FG000|COMPLETED|One-month Follow-up||37||
59948902|NCT04227145|76067640|FG001|COMPLETED|One-month Follow-up||37||
59948903|NCT04227145|76067639|FG000|NOT COMPLETED|One-month Follow-up||0||
59948904|NCT04227145|76067640|FG001|NOT COMPLETED|One-month Follow-up||0||
59948905|NCT04227145|76067639|FG000|STARTED|Three-month Follow-up||36||
59948906|NCT04227145|76067640|FG001|STARTED|Three-month Follow-up||22||
59948907|NCT04227145|76067639|FG000|COMPLETED|Three-month Follow-up||36||
59948908|NCT04227145|76067640|FG001|COMPLETED|Three-month Follow-up||22||
59948909|NCT04227145|76067639|FG000|NOT COMPLETED|Three-month Follow-up||0||
59948910|NCT04227145|76067640|FG001|NOT COMPLETED|Three-month Follow-up||0||
59948911|NCT04222088|76067648|FG000|STARTED|Overall Study||84||
59948912|NCT04222088|76067649|FG001|STARTED|Overall Study||75||
59948913|NCT04222088|76067648|FG000|COMPLETED|Overall Study||75||
59948914|NCT04222088|76067649|FG001|COMPLETED|Overall Study||74||
59948915|NCT04222088|76067648|FG000|NOT COMPLETED|Overall Study||9||
59948916|NCT04222088|76067649|FG001|NOT COMPLETED|Overall Study||1||
59948917|NCT03978520|76067660|FG000|STARTED|Overall Study||75||
59948918|NCT03978520|76067661|FG001|STARTED|Overall Study||68||
59948919|NCT03978520|76067662|FG002|STARTED|Overall Study||62||
59948920|NCT03978520|76067663|FG003|STARTED|Overall Study||69||
59948921|NCT03978520|76067664|FG004|STARTED|Overall Study||67||
59948922|NCT03978520|76067660|FG000|COMPLETED|Overall Study||52||
59948923|NCT03978520|76067661|FG001|COMPLETED|Overall Study||52||
59948924|NCT03978520|76067662|FG002|COMPLETED|Overall Study||51||
59948925|NCT03978520|76067663|FG003|COMPLETED|Overall Study||24||
59948926|NCT03978520|76067664|FG004|COMPLETED|Overall Study||29||
59948927|NCT03978520|76067660|FG000|NOT COMPLETED|Overall Study||23||
59948928|NCT03978520|76067661|FG001|NOT COMPLETED|Overall Study||16||
59948929|NCT03978520|76067662|FG002|NOT COMPLETED|Overall Study||11||
59948930|NCT03978520|76067663|FG003|NOT COMPLETED|Overall Study||45||
59948931|NCT03978520|76067664|FG004|NOT COMPLETED|Overall Study||38||
59948932|NCT03929393|76067676|FG000|STARTED|Overall Study||86||
59948933|NCT03929393|76067677|FG001|STARTED|Overall Study||90||
59948934|NCT03929393|76067676|FG000|COMPLETED|Overall Study||82||
59948935|NCT03929393|76067677|FG001|COMPLETED|Overall Study||80||
59948936|NCT03929393|76067676|FG000|NOT COMPLETED|Overall Study||4||
59948937|NCT03929393|76067677|FG001|NOT COMPLETED|Overall Study||10||
59948938|NCT03874715|76067685|FG000|STARTED|Overall Study||104||
59948939|NCT03874715|76067686|FG001|STARTED|Overall Study||106||
59948940|NCT03874715|76067685|FG000|Treated|Overall Study||104||
59948941|NCT03874715|76067686|FG001|Treated|Overall Study||106||
59948942|NCT03874715|76067685|FG000|Safety Population|Overall Study||99|Safety population included all randomized participants who received at least one dose of investigational medicinal product (IMP) and analyzed according to the treatment actually received.|
59948943|NCT03874715|76067686|FG001|Safety Population|Overall Study|Five participants randomized to switching arm discontinued IMP during the first treatment of NovoLog before switching to SAR341402, thus included in the non-switching arm for the safety analysis.|111|Safety population included all randomized participants who received at least one dose of investigational medicinal product (IMP) and analyzed according to the treatment actually received.|
59948944|NCT03874715|76067685|FG000|Anti-insulin Antibody (AIA) Population|Overall Study||98|AIA population included all participants who received at least one dose of IMP and with at least one AIA sample available for analysis, and were analyzed according to the treatment actually received|
59948945|NCT03874715|76067686|FG001|Anti-insulin Antibody (AIA) Population|Overall Study|Five participants randomized to switching arm discontinued IMP during the first treatment of NovoLog before switching to SAR341402, thus included in the non-switching arm for the AIA evaluations.|107|AIA population included all participants who received at least one dose of IMP and with at least one AIA sample available for analysis, and were analyzed according to the treatment actually received|
59948946|NCT03874715|76067685|FG000|COMPLETED|Overall Study||95||
59948947|NCT03874715|76067686|FG001|COMPLETED|Overall Study||105||
59948948|NCT03874715|76067685|FG000|NOT COMPLETED|Overall Study||9||
59948949|NCT03874715|76067686|FG001|NOT COMPLETED|Overall Study||1||
59948950|NCT03801356|76067692|FG000|STARTED|Overall Study||11||
59948951|NCT03801356|76067692|FG000|COMPLETED|Overall Study||11||
59948952|NCT03801356|76067692|FG000|NOT COMPLETED|Overall Study||0||
59948953|NCT03502200|76067698|FG000|STARTED|Overall Study||175||
59948954|NCT03502200|76067699|FG001|STARTED|Overall Study||175||
59948955|NCT03502200|76067698|FG000|COMPLETED|Overall Study||132||
59948956|NCT03502200|76067699|FG001|COMPLETED|Overall Study||127||
59948957|NCT03502200|76067698|FG000|NOT COMPLETED|Overall Study||43||
59948958|NCT03502200|76067699|FG001|NOT COMPLETED|Overall Study||48||
59948959|NCT03336242|76067707|FG000|STARTED|Overall Study||10||
59948960|NCT03336242|76067708|FG001|STARTED|Overall Study||10||
59948961|NCT03336242|76067707|FG000|COMPLETED|Overall Study||10||
59948962|NCT03336242|76067708|FG001|COMPLETED|Overall Study||9||
59948963|NCT03336242|76067707|FG000|NOT COMPLETED|Overall Study||0||
59948964|NCT03336242|76067708|FG001|NOT COMPLETED|Overall Study||1||
59948965|NCT03334435|76067719|FG000|STARTED|Overall Study||91||
59948966|NCT03334435|76067720|FG001|STARTED|Overall Study||45||
59948967|NCT03334435|76067721|FG002|STARTED|Overall Study||519||
59948968|NCT03334435|76067722|FG003|STARTED|Overall Study||743||
59948969|NCT03334435|76067723|FG004|STARTED|Overall Study||247||
59948970|NCT03334435|76067719|FG000|RPR|Overall Study||91||
59948971|NCT03334435|76067720|FG001|RPR|Overall Study||45||
59948972|NCT03334435|76067721|FG002|RPR|Overall Study||108||
59948973|NCT03334435|76067722|FG003|RPR|Overall Study||134||
59948974|NCT03334435|76067723|FG004|RPR|Overall Study||0||
59948975|NCT03334435|76067719|FG000|NR|Overall Study||0||
59948976|NCT03334435|76067720|FG001|NR|Overall Study||0||
59948977|NCT03334435|76067721|FG002|NR|Overall Study||411||
59948978|NCT03334435|76067722|FG003|NR|Overall Study||609||
59948979|NCT03334435|76067723|FG004|NR|Overall Study||0||
59948980|NCT03334435|76067719|FG000|COMPLETED|Overall Study||2|The study is still ongoing and this represents participants who completed or discontinued at Week 52.|
59948981|NCT03334435|76067720|FG001|COMPLETED|Overall Study||2|The study is still ongoing and this represents participants who completed or discontinued at Week 52.|
59948982|NCT03334435|76067721|FG002|COMPLETED|Overall Study||12|The study is still ongoing and this represents participants who completed or discontinued at Week 52.|
59948983|NCT03334435|76067722|FG003|COMPLETED|Overall Study||15|The study is still ongoing and this represents participants who completed or discontinued at Week 52.|
59948984|NCT03334435|76067723|FG004|COMPLETED|Overall Study||5|The study is still ongoing and this represents participants who completed or discontinued at Week 52.|
59948985|NCT03334435|76067719|FG000|NOT COMPLETED|Overall Study||89||
59948986|NCT03334435|76067720|FG001|NOT COMPLETED|Overall Study||43||
59948987|NCT03334435|76067721|FG002|NOT COMPLETED|Overall Study||507||
59948988|NCT03334435|76067722|FG003|NOT COMPLETED|Overall Study||728||
59948989|NCT03334435|76067723|FG004|NOT COMPLETED|Overall Study||242||
59948990|NCT03239496|76067757|FG000|STARTED|Overall Study||200||
59948991|NCT03239496|76067758|FG001|STARTED|Overall Study||178||
59948992|NCT03239496|76067759|FG002|STARTED|Overall Study||178||
59948993|NCT03239496|76067760|FG003|STARTED|Overall Study||217||
59948994|NCT03239496|76067757|FG000|COMPLETED|Overall Study||186||
59948995|NCT03239496|76067758|FG001|COMPLETED|Overall Study||168||
59948996|NCT03239496|76067759|FG002|COMPLETED|Overall Study||166||
59948997|NCT03239496|76067760|FG003|COMPLETED|Overall Study||203||
59948998|NCT03239496|76067757|FG000|NOT COMPLETED|Overall Study||14||
59948999|NCT03239496|76067758|FG001|NOT COMPLETED|Overall Study||10||
59949000|NCT03239496|76067759|FG002|NOT COMPLETED|Overall Study||12||
59949001|NCT03239496|76067760|FG003|NOT COMPLETED|Overall Study||14||
59949002|NCT03151083|76067777|FG000|STARTED|Overall Study||27||
59949003|NCT03151083|76067778|FG001|STARTED|Overall Study||20||
59949004|NCT03151083|76067779|FG002|STARTED|Overall Study||30||
59949005|NCT03151083|76067777|FG000|COMPLETED|Overall Study||25||
59949006|NCT03151083|76067778|FG001|COMPLETED|Overall Study||19||
60067641|NCT01597557|76182792|FG001|COMPLETED|Overall Study||126||
60067642|NCT01597557|76182791|FG000|NOT COMPLETED|Overall Study||4||
60067643|NCT01597557|76182792|FG001|NOT COMPLETED|Overall Study||3||
59949007|NCT03151083|76067779|FG002|COMPLETED|Overall Study||26||
59949008|NCT03151083|76067777|FG000|NOT COMPLETED|Overall Study||2||
59949009|NCT03151083|76067778|FG001|NOT COMPLETED|Overall Study||1||
59949010|NCT03151083|76067779|FG002|NOT COMPLETED|Overall Study||4||
59949011|NCT02942979|76067789|FG000|STARTED|Step 0||108||
59949012|NCT02942979|76067790|FG001|STARTED|Step 0||0||
59949013|NCT02942979|76067789|FG000|COMPLETED|Step 0||108||
59949014|NCT02942979|76067790|FG001|COMPLETED|Step 0|This is a stepped wedge design - all participants received both MISSION Implementation as Usual and Facilitation|0||
59949015|NCT02942979|76067789|FG000|NOT COMPLETED|Step 0||0||
59949016|NCT02942979|76067790|FG001|NOT COMPLETED|Step 0||0||
59949017|NCT02942979|76067789|FG000|STARTED|Step 1||15||
59949018|NCT02942979|76067790|FG001|STARTED|Step 1||93||
59949019|NCT02942979|76067789|FG000|COMPLETED|Step 1||15||
59949020|NCT02942979|76067790|FG001|COMPLETED|Step 1||93||
59949021|NCT02942979|76067789|FG000|NOT COMPLETED|Step 1||0||
59949022|NCT02942979|76067790|FG001|NOT COMPLETED|Step 1||0||
59949023|NCT02942979|76067789|FG000|STARTED|Step 2||0||
59949024|NCT02942979|76067790|FG001|STARTED|Step 2||108||
59949025|NCT02942979|76067789|FG000|COMPLETED|Step 2||0||
59949026|NCT02942979|76067790|FG001|COMPLETED|Step 2||108||
59949027|NCT02942979|76067789|FG000|NOT COMPLETED|Step 2||0||
59949028|NCT02942979|76067790|FG001|NOT COMPLETED|Step 2||0||
59949029|NCT02919449|76067796|FG000|STARTED|Overall Study||2||
59949030|NCT02919449|76067796|FG000|COMPLETED|Overall Study||0||
59949031|NCT02919449|76067796|FG000|NOT COMPLETED|Overall Study||2||
59949032|NCT02769832|76067800|FG000|STARTED|Overall Study||32||
59949033|NCT02769832|76067800|FG000|COMPLETED|Overall Study||2||
59949034|NCT02769832|76067800|FG000|NOT COMPLETED|Overall Study||30||
59949035|NCT02530970|76067805|FG000|STARTED|Overall Study||1025||
59949036|NCT02530970|76067805|FG000|COMPLETED|Overall Study||891||
59949037|NCT02530970|76067805|FG000|NOT COMPLETED|Overall Study||134||
59949038|NCT02418156|76067809|FG000|STARTED|Overall Study||38||
59949039|NCT02418156|76067809|FG000|COMPLETED|Overall Study||21||
59949040|NCT02418156|76067809|FG000|NOT COMPLETED|Overall Study||17||
59949041|NCT02324543|76067819|FG000|STARTED|Overall Study||6||
59949042|NCT02324543|76067820|FG001|STARTED|Overall Study||6||
59949043|NCT02324543|76067821|FG002|STARTED|Overall Study||3||
59949044|NCT02324543|76067822|FG003|STARTED|Overall Study||4||
59949045|NCT02324543|76067823|FG004|STARTED|Overall Study||4||
59949046|NCT02324543|76067824|FG005|STARTED|Overall Study||24||
59949047|NCT02324543|76067819|FG000|COMPLETED|Overall Study||6||
59949048|NCT02324543|76067820|FG001|COMPLETED|Overall Study||6||
59949049|NCT02324543|76067821|FG002|COMPLETED|Overall Study||3||
59949050|NCT02324543|76067822|FG003|COMPLETED|Overall Study||4||
59949051|NCT02324543|76067823|FG004|COMPLETED|Overall Study||4||
59949052|NCT02324543|76067824|FG005|COMPLETED|Overall Study||24||
59949053|NCT02324543|76067819|FG000|NOT COMPLETED|Overall Study||0||
59949054|NCT02324543|76067820|FG001|NOT COMPLETED|Overall Study||0||
59949055|NCT02324543|76067821|FG002|NOT COMPLETED|Overall Study||0||
59949056|NCT02324543|76067822|FG003|NOT COMPLETED|Overall Study||0||
59949057|NCT02324543|76067823|FG004|NOT COMPLETED|Overall Study||0||
59949058|NCT02324543|76067824|FG005|NOT COMPLETED|Overall Study||0||
59949059|NCT02073331|76067834|FG000|STARTED|Overall Study||1420||
59949060|NCT02073331|76067834|FG000|COMPLETED|Overall Study||1420||
59949061|NCT02073331|76067834|FG000|NOT COMPLETED|Overall Study||0||
59949062|NCT02055638|76067840|FG000|STARTED|Overall Study||49||
59949063|NCT02055638|76067841|FG001|STARTED|Overall Study||48||
59949064|NCT02055638|76067840|FG000|COMPLETED|Overall Study||39||
59949065|NCT02055638|76067841|FG001|COMPLETED|Overall Study||40||
59949066|NCT02055638|76067840|FG000|NOT COMPLETED|Overall Study||10||
59949067|NCT02055638|76067841|FG001|NOT COMPLETED|Overall Study||8||
59949068|NCT01850524|76067849|FG000|STARTED|Overall Study||354||
59949069|NCT01850524|76067850|FG001|STARTED|Overall Study||351||
59949070|NCT01850524|76067849|FG000|Intent-to-Treat (ITT) Population|Overall Study||354||
59949071|NCT01850524|76067850|FG001|Intent-to-Treat (ITT) Population|Overall Study||351||
59949072|NCT01850524|76067849|FG000|Safety Population|Overall Study|1 participant in this arm who withdrew from the study was not included in the safety population.|349|Includes all treated participants. Participants were analyzed as treated.|
59949073|NCT01850524|76067850|FG001|Safety Population|Overall Study|Included 4 participants from placebo who received ixazomib; 1 participant who withdrew was excluded.|354|Includes all treated participants. Participants were analyzed as treated.|
59949074|NCT01850524|76067849|FG000|Participants Completed Study Treatment Per Protocol|Overall Study||283|Includes participants who completed treatment per protocol until disease progression or until discontinuation for unacceptable toxicity, withdrawal of consent, or death.|
59949075|NCT01850524|76067850|FG001|Participants Completed Study Treatment Per Protocol|Overall Study||284|Includes participants who completed treatment per protocol until disease progression or until discontinuation for unacceptable toxicity, withdrawal of consent, or death.|
59949076|NCT01850524|76067849|FG000|Per Protocol (PP) Population|Overall Study||293||
59949077|NCT01850524|76067850|FG001|Per Protocol (PP) Population|Overall Study||296||
59949078|NCT01850524|76067849|FG000|Participants With Exposure of ≥ 19 Cycles|Overall Study||189||
59949079|NCT01850524|76067850|FG001|Participants With Exposure of ≥ 19 Cycles|Overall Study||191||
59949080|NCT01850524|76067849|FG000|Response-evaluable Population|Overall Study||347|"Includes all participants in the ITT population who receive at least 1 dose of any study drug, have measurable disease at baseline, and at least~1 post baseline response assessment assessed by an Independent Review Committee (IRC)."|
59949081|NCT01850524|76067850|FG001|Response-evaluable Population|Overall Study||335|"Includes all participants in the ITT population who receive at least 1 dose of any study drug, have measurable disease at baseline, and at least~1 post baseline response assessment assessed by an Independent Review Committee (IRC)."|
59949082|NCT01850524|76067849|FG000|COMPLETED|Overall Study||183|Completed=who completed the study.|
59949083|NCT01850524|76067850|FG001|COMPLETED|Overall Study||178|Completed=who completed the study.|
59949084|NCT01850524|76067849|FG000|NOT COMPLETED|Overall Study||171||
59949085|NCT01850524|76067850|FG001|NOT COMPLETED|Overall Study||173||
59949086|NCT01609842|76067867|FG000|STARTED|Pre-Intervention Control||0||
59949087|NCT01609842|76067868|FG001|STARTED|Pre-Intervention Control|Intervention sites patients prior to enrollment period who did not receive the intervention|6081||
59949088|NCT01609842|76067867|FG000|COMPLETED|Pre-Intervention Control||0||
59949089|NCT01609842|76067868|FG001|COMPLETED|Pre-Intervention Control||6081||
59949090|NCT01609842|76067867|FG000|NOT COMPLETED|Pre-Intervention Control||0||
59949091|NCT01609842|76067868|FG001|NOT COMPLETED|Pre-Intervention Control||0||
59949092|NCT01609842|76067867|FG000|STARTED|Post-Intervention Control||0||
59949093|NCT01609842|76067868|FG001|STARTED|Post-Intervention Control|Intervention sites patients after enrollment period ended who did not receive the intervention.|2917||
59949094|NCT01609842|76067867|FG000|COMPLETED|Post-Intervention Control||0||
59949095|NCT01609842|76067868|FG001|COMPLETED|Post-Intervention Control||2917||
59949096|NCT01609842|76067867|FG000|NOT COMPLETED|Post-Intervention Control||0||
59949097|NCT01609842|76067868|FG001|NOT COMPLETED|Post-Intervention Control||0||
59949098|NCT01609842|76067867|FG000|STARTED|Concurrent Intervention Control||708||
59949099|NCT01609842|76067868|FG001|STARTED|Concurrent Intervention Control|Nonintervention sites patients during the period prior and post enrollment at the intervention sites|4869||
59949100|NCT01609842|76067867|FG000|COMPLETED|Concurrent Intervention Control||706||
59949101|NCT01609842|76067868|FG001|COMPLETED|Concurrent Intervention Control||4869||
59949102|NCT01609842|76067867|FG000|NOT COMPLETED|Concurrent Intervention Control||2||
59949103|NCT01609842|76067868|FG001|NOT COMPLETED|Concurrent Intervention Control||0||
59949104|NCT01569594|76067878|FG000|STARTED|Overall Study||230||
59949105|NCT01569594|76067878|FG000|COMPLETED|Overall Study||163||
59949106|NCT01569594|76067878|FG000|NOT COMPLETED|Overall Study||67||
59949107|NCT00593840|76067882|FG000|STARTED|Overall Study||73||
59949108|NCT00593840|76067882|FG000|COMPLETED|Overall Study||72||
59949109|NCT00593840|76067882|FG000|NOT COMPLETED|Overall Study||1||
59949110|NCT00576979|76067895|FG000|STARTED|Overall Study||3||
59949111|NCT00576979|76067896|FG001|STARTED|Overall Study||3||
59949112|NCT00576979|76067897|FG002|STARTED|Overall Study||9||
59949113|NCT00576979|76067898|FG003|STARTED|Overall Study||6||
59949114|NCT00576979|76067899|FG004|STARTED|Overall Study||6||
59949115|NCT00576979|76067900|FG005|STARTED|Overall Study||6||
59949116|NCT00576979|76067901|FG006|STARTED|Overall Study||6||
59949117|NCT00576979|76067902|FG007|STARTED|Overall Study||6||
59949118|NCT00576979|76067903|FG008|STARTED|Overall Study||6||
59949119|NCT00576979|76067895|FG000|COMPLETED|Overall Study||3||
59949120|NCT00576979|76067896|FG001|COMPLETED|Overall Study||3||
59949121|NCT00576979|76067897|FG002|COMPLETED|Overall Study||9||
59949122|NCT00576979|76067898|FG003|COMPLETED|Overall Study||6||
59949123|NCT00576979|76067899|FG004|COMPLETED|Overall Study||6||
59949124|NCT00576979|76067900|FG005|COMPLETED|Overall Study||6||
59949125|NCT00576979|76067901|FG006|COMPLETED|Overall Study||6||
59949126|NCT00576979|76067902|FG007|COMPLETED|Overall Study||6||
59949127|NCT00576979|76067903|FG008|COMPLETED|Overall Study||6||
59949128|NCT00576979|76067895|FG000|NOT COMPLETED|Overall Study||0||
59613425|NCT01593696|75724556|FG001|COMPLETED|Dose Expansion||0||
59613426|NCT01593696|75724557|FG002|COMPLETED|Dose Expansion||15||
59613427|NCT01593696|75724558|FG003|COMPLETED|Dose Expansion||16||
59613428|NCT01593696|75724555|FG000|NOT COMPLETED|Dose Expansion||0||
59949129|NCT00576979|76067896|FG001|NOT COMPLETED|Overall Study||0||
59949130|NCT00576979|76067897|FG002|NOT COMPLETED|Overall Study||0||
59949131|NCT00576979|76067898|FG003|NOT COMPLETED|Overall Study||0||
59949132|NCT00576979|76067899|FG004|NOT COMPLETED|Overall Study||0||
59949133|NCT00576979|76067900|FG005|NOT COMPLETED|Overall Study||0||
59949134|NCT00576979|76067901|FG006|NOT COMPLETED|Overall Study||0||
59949135|NCT00576979|76067902|FG007|NOT COMPLETED|Overall Study||0||
59949136|NCT00576979|76067903|FG008|NOT COMPLETED|Overall Study||0||
59949137|NCT01329900|76067915|FG000|STARTED|Overall Study||50||
59949138|NCT01329900|76067915|FG000|COMPLETED|Overall Study||49||
59949139|NCT01329900|76067915|FG000|NOT COMPLETED|Overall Study||1||
59949140|NCT02825043|76067919|FG000|STARTED|Overall Study||6||
59949141|NCT02825043|76067919|FG000|COMPLETED|Overall Study||2||
59949142|NCT02825043|76067919|FG000|NOT COMPLETED|Overall Study||4||
59949143|NCT03825393|76067925|FG000|STARTED|Overall Study||100||
59949144|NCT03825393|76067926|FG001|STARTED|Overall Study||100||
59949145|NCT03825393|76067925|FG000|COMPLETED|Overall Study||100||
59949146|NCT03825393|76067926|FG001|COMPLETED|Overall Study||100||
59949147|NCT03825393|76067925|FG000|NOT COMPLETED|Overall Study||0||
59949148|NCT03825393|76067926|FG001|NOT COMPLETED|Overall Study||0||
59949149|NCT02750592|76067934|FG000|STARTED|Overall Study||30||
59949150|NCT02750592|76067934|FG000|COMPLETED|Overall Study||25||
59949151|NCT02750592|76067934|FG000|NOT COMPLETED|Overall Study||5||
59949152|NCT02624986|76067946|FG000|STARTED|Overall Study||2|Intent-to-Treat (ITT) Population|
59949153|NCT02624986|76067947|FG001|STARTED|Overall Study||3|Intent-to-Treat (ITT) Population|
59949154|NCT02624986|76067948|FG002|STARTED|Overall Study||2|Intent-to-Treat (ITT) Population|
59949155|NCT02624986|76067949|FG003|STARTED|Overall Study||3|Intent-to-Treat (ITT) Population|
59949156|NCT02624986|76067950|FG004|STARTED|Overall Study||4|Intent-to-Treat (ITT) Population|
59949157|NCT02624986|76067951|FG005|STARTED|Overall Study||2|Intent-to-Treat (ITT) Population|
59949158|NCT02624986|76067952|FG006|STARTED|Overall Study||4|Intent-to-Treat (ITT) Population|
59949159|NCT02624986|76067953|FG007|STARTED|Overall Study||5|Intent-to-Treat (ITT) Population|
59613429|NCT01593696|75724556|FG001|NOT COMPLETED|Dose Expansion||0||
59949160|NCT02624986|76067946|FG000|Received Any Study Treatment|Overall Study||1|Safety Population|
59949161|NCT02624986|76067947|FG001|Received Any Study Treatment|Overall Study||3|Safety Population|
59949162|NCT02624986|76067948|FG002|Received Any Study Treatment|Overall Study||2|Safety Population|
59949163|NCT02624986|76067949|FG003|Received Any Study Treatment|Overall Study||3|Safety Population|
59613430|NCT01593696|75724557|FG002|NOT COMPLETED|Dose Expansion||1||
59949164|NCT02624986|76067950|FG004|Received Any Study Treatment|Overall Study||4|Safety Population|
59949165|NCT02624986|76067951|FG005|Received Any Study Treatment|Overall Study||2|Safety Population|
59949166|NCT02624986|76067952|FG006|Received Any Study Treatment|Overall Study||4|Safety Population|
59949167|NCT02624986|76067953|FG007|Received Any Study Treatment|Overall Study||5|Safety Population|
59949168|NCT02624986|76067946|FG000|COMPLETED|Overall Study||0||
59949169|NCT02624986|76067947|FG001|COMPLETED|Overall Study||0||
59949170|NCT02624986|76067948|FG002|COMPLETED|Overall Study||0||
59949171|NCT02624986|76067949|FG003|COMPLETED|Overall Study||0||
59949172|NCT02624986|76067950|FG004|COMPLETED|Overall Study||0||
59949173|NCT02624986|76067951|FG005|COMPLETED|Overall Study||0||
59949174|NCT02624986|76067952|FG006|COMPLETED|Overall Study||0||
59949175|NCT02624986|76067953|FG007|COMPLETED|Overall Study||0||
59949176|NCT02624986|76067946|FG000|NOT COMPLETED|Overall Study||2||
60067884|NCT01756053|76183071|FG000|NOT COMPLETED|Washout Period (~21 Days)||0||
59762375|NCT03214250|75882078|FG001|STARTED|Overall Study||7||
59762376|NCT03214250|75882079|FG002|STARTED|Overall Study||8||
59762377|NCT03214250|75882080|FG003|STARTED|Overall Study||8||
59762378|NCT03214250|75882081|FG004|STARTED|Overall Study||37||
59762379|NCT03214250|75882082|FG005|STARTED|Overall Study||31||
59762380|NCT03214250|75882083|FG006|STARTED|Overall Study||31||
59762381|NCT03214250|75882077|FG000|COMPLETED|Overall Study||0|"Per the protocol, completed status is defined as completing 5 years of survival follow-up from the time a patient has discontinued treatment."|
59762382|NCT03214250|75882078|FG001|COMPLETED|Overall Study||0|"Per the protocol, completed status is defined as completing 5 years of survival follow-up from the time a patient has discontinued treatment."|
59762383|NCT03214250|75882079|FG002|COMPLETED|Overall Study||0|"Per the protocol, completed status is defined as completing 5 years of survival follow-up from the time a patient has discontinued treatment."|
59762384|NCT03214250|75882080|FG003|COMPLETED|Overall Study||0|"Per the protocol, completed status is defined as completing 5 years of survival follow-up from the time a patient has discontinued treatment."|
59762385|NCT03214250|75882081|FG004|COMPLETED|Overall Study||0|"Per the protocol, completed status is defined as completing 5 years of survival follow-up from the time a patient has discontinued treatment."|
59762386|NCT03214250|75882082|FG005|COMPLETED|Overall Study||0|"Per the protocol, completed status is defined as completing 5 years of survival follow-up from the time a patient has discontinued treatment."|
59762387|NCT03214250|75882083|FG006|COMPLETED|Overall Study||0|"Per the protocol, completed status is defined as completing 5 years of survival follow-up from the time a patient has discontinued treatment."|
59762388|NCT03214250|75882077|FG000|NOT COMPLETED|Overall Study||7||
59762389|NCT03214250|75882078|FG001|NOT COMPLETED|Overall Study||7||
59762390|NCT03214250|75882079|FG002|NOT COMPLETED|Overall Study||8||
59762391|NCT03214250|75882080|FG003|NOT COMPLETED|Overall Study||8||
59762392|NCT03214250|75882081|FG004|NOT COMPLETED|Overall Study||37||
59762393|NCT03214250|75882082|FG005|NOT COMPLETED|Overall Study||31||
59762394|NCT03214250|75882083|FG006|NOT COMPLETED|Overall Study||31||
59762395|NCT00874770|75882107|FG000|STARTED|Overall Study||12||
59762396|NCT00874770|75882108|FG001|STARTED|Overall Study||12||
59762397|NCT00874770|75882109|FG002|STARTED|Overall Study||12||
59762398|NCT00874770|75882110|FG003|STARTED|Overall Study||12||
59762399|NCT00874770|75882107|FG000|COMPLETED|Overall Study||7||
59762400|NCT00874770|75882108|FG001|COMPLETED|Overall Study||11||
59762401|NCT00874770|75882109|FG002|COMPLETED|Overall Study||8||
59762402|NCT00874770|75882110|FG003|COMPLETED|Overall Study||7||
59762403|NCT00874770|75882107|FG000|NOT COMPLETED|Overall Study||5||
59762404|NCT00874770|75882108|FG001|NOT COMPLETED|Overall Study||1||
59762405|NCT00874770|75882109|FG002|NOT COMPLETED|Overall Study||4||
59762406|NCT00874770|75882110|FG003|NOT COMPLETED|Overall Study||5||
59762407|NCT00536263|75882133|FG000|STARTED|Overall Study||225||
59762408|NCT00536263|75882134|FG001|STARTED|Overall Study||221||
59762409|NCT00536263|75882135|FG002|STARTED|Overall Study|One (1) participant withdrawn from study for non-compliance.|225||
59762410|NCT00536263|75882133|FG000|COMPLETED|Overall Study||214||
59762411|NCT00536263|75882134|FG001|COMPLETED|Overall Study||207||
59762412|NCT00536263|75882135|FG002|COMPLETED|Overall Study||204||
59762413|NCT00536263|75882133|FG000|NOT COMPLETED|Overall Study||11||
59762414|NCT00536263|75882134|FG001|NOT COMPLETED|Overall Study||14||
59762415|NCT00536263|75882135|FG002|NOT COMPLETED|Overall Study||21||
59762416|NCT00578344|75882143|FG000|STARTED|Overall Study||8||
59762417|NCT00578344|75882143|FG000|COMPLETED|Overall Study||6||
59762418|NCT00578344|75882143|FG000|NOT COMPLETED|Overall Study||2||
59762419|NCT00873366|75882147|FG000|STARTED|Overall Study||77||
59762420|NCT00873366|75882147|FG000|COMPLETED|Overall Study||71||
59762421|NCT00873366|75882147|FG000|NOT COMPLETED|Overall Study||6||
59762422|NCT00536107|75882153|FG000|STARTED|Overall Study||8||
59762423|NCT00536107|75882154|FG001|STARTED|Overall Study||6||
59762424|NCT00536107|75882153|FG000|COMPLETED|Overall Study||0||
59762425|NCT00536107|75882154|FG001|COMPLETED|Overall Study||0||
59762426|NCT00536107|75882153|FG000|NOT COMPLETED|Overall Study||8||
59762427|NCT00536107|75882154|FG001|NOT COMPLETED|Overall Study||6||
59762428|NCT01022138|75882160|FG000|STARTED|Overall Study||43||
59762429|NCT01022138|75882160|FG000|COMPLETED|Overall Study||31||
59762430|NCT01022138|75882160|FG000|NOT COMPLETED|Overall Study||12||
59762431|NCT03638011|75882167|FG000|STARTED|Overall Study||38||
59762432|NCT03638011|75882168|FG001|STARTED|Overall Study||33||
59762433|NCT03638011|75882167|FG000|COMPLETED|Overall Study||38||
59762434|NCT03638011|75882168|FG001|COMPLETED|Overall Study||33||
59762435|NCT03638011|75882167|FG000|NOT COMPLETED|Overall Study||0||
59949177|NCT02624986|76067947|FG001|NOT COMPLETED|Overall Study||3||
59949178|NCT02624986|76067948|FG002|NOT COMPLETED|Overall Study||2||
59949179|NCT02624986|76067949|FG003|NOT COMPLETED|Overall Study||3||
59949180|NCT02624986|76067950|FG004|NOT COMPLETED|Overall Study||4||
59949181|NCT02624986|76067951|FG005|NOT COMPLETED|Overall Study||2||
59949182|NCT02624986|76067952|FG006|NOT COMPLETED|Overall Study||4||
59949183|NCT02624986|76067953|FG007|NOT COMPLETED|Overall Study||5||
59949184|NCT02587598|76067986|FG000|STARTED|Overall Study||4||
59949185|NCT02587598|76067987|FG001|STARTED|Overall Study||11||
59949186|NCT02587598|76067988|FG002|STARTED|Overall Study||4||
59949187|NCT02587598|76067989|FG003|STARTED|Overall Study||21||
59949188|NCT02587598|76067990|FG004|STARTED|Overall Study||12||
59949189|NCT02587598|76067991|FG005|STARTED|Overall Study||6||
59949190|NCT02587598|76067992|FG006|STARTED|Overall Study||6||
59949191|NCT02587598|76067993|FG007|STARTED|Overall Study||7||
59949192|NCT02587598|76067994|FG008|STARTED|Overall Study||9||
59949193|NCT02587598|76067995|FG009|STARTED|Overall Study||3||
59949194|NCT02587598|76067996|FG010|STARTED|Overall Study||14||
59949195|NCT02587598|76067986|FG000|COMPLETED|Overall Study|All participants discontinued study treatment and withdrew from the study.|0|All participants in each arm discontinued study treatment and withdrew from the study.|
59949196|NCT02587598|76067987|FG001|COMPLETED|Overall Study|All participants discontinued study treatment and withdrew from the study.|0|All participants in each arm discontinued study treatment and withdrew from the study.|
59949197|NCT02587598|76067988|FG002|COMPLETED|Overall Study|All participants discontinued study treatment and withdrew from the study.|0|All participants in each arm discontinued study treatment and withdrew from the study.|
59949198|NCT02587598|76067989|FG003|COMPLETED|Overall Study|All participants discontinued study treatment and withdrew from the study.|0|All participants in each arm discontinued study treatment and withdrew from the study.|
59949199|NCT02587598|76067990|FG004|COMPLETED|Overall Study|All participants discontinued study treatment and withdrew from the study.|0|All participants in each arm discontinued study treatment and withdrew from the study.|
59949200|NCT02587598|76067991|FG005|COMPLETED|Overall Study|All participants discontinued study treatment and withdrew from the study.|0|All participants in each arm discontinued study treatment and withdrew from the study.|
59949201|NCT02587598|76067992|FG006|COMPLETED|Overall Study|All participants discontinued study treatment and withdrew from the study.|0|All participants in each arm discontinued study treatment and withdrew from the study.|
59949202|NCT02587598|76067993|FG007|COMPLETED|Overall Study|All participants discontinued study treatment and withdrew from the study.|0|All participants in each arm discontinued study treatment and withdrew from the study.|
59949203|NCT02587598|76067994|FG008|COMPLETED|Overall Study|All participants discontinued study treatment and withdrew from the study.|0|All participants in each arm discontinued study treatment and withdrew from the study.|
59949204|NCT02587598|76067995|FG009|COMPLETED|Overall Study|All participants discontinued study treatment and withdrew from the study.|0|All participants in each arm discontinued study treatment and withdrew from the study.|
59949205|NCT02587598|76067996|FG010|COMPLETED|Overall Study|All participants discontinued study treatment and withdrew from the study.|0|All participants in each arm discontinued study treatment and withdrew from the study.|
59949206|NCT02587598|76067986|FG000|NOT COMPLETED|Overall Study||4||
59949207|NCT02587598|76067987|FG001|NOT COMPLETED|Overall Study||11||
59949208|NCT02587598|76067988|FG002|NOT COMPLETED|Overall Study||4||
59949209|NCT02587598|76067989|FG003|NOT COMPLETED|Overall Study||21||
59949210|NCT02587598|76067990|FG004|NOT COMPLETED|Overall Study||12||
59949211|NCT02587598|76067991|FG005|NOT COMPLETED|Overall Study||6||
59949212|NCT02587598|76067992|FG006|NOT COMPLETED|Overall Study||6||
59949213|NCT02587598|76067993|FG007|NOT COMPLETED|Overall Study||7||
60067644|NCT01760733|76182798|FG000|STARTED|Waiting List|All patients included started in the waiting list group.|289||
59613431|NCT01593696|75724558|FG003|NOT COMPLETED|Dose Expansion||0||
59949214|NCT02587598|76067994|FG008|NOT COMPLETED|Overall Study||9||
59949215|NCT02587598|76067995|FG009|NOT COMPLETED|Overall Study||3||
59949216|NCT02587598|76067996|FG010|NOT COMPLETED|Overall Study||14||
59949217|NCT02485574|76068032|FG000|STARTED|Overall Study||69||
59949218|NCT02485574|76068032|FG000|COMPLETED|Overall Study||65||
59949219|NCT02485574|76068032|FG000|NOT COMPLETED|Overall Study||4||
59949220|NCT02624284|76068044|FG000|STARTED|Overall Study||49|Only participants who attended their first session of tDCS are included in this number.|
59949221|NCT02624284|76068045|FG001|STARTED|Overall Study||53|Only participants who attended their first session of tDCS are included in this number.|
59949222|NCT02624284|76068046|FG002|STARTED|Overall Study||47|Only participants who attended their first session of tDCS are included in this number.|
59949223|NCT02624284|76068044|FG000|COMPLETED|Overall Study||35||
59949224|NCT02624284|76068045|FG001|COMPLETED|Overall Study||35||
59949225|NCT02624284|76068046|FG002|COMPLETED|Overall Study||36||
59949226|NCT02624284|76068044|FG000|NOT COMPLETED|Overall Study||14||
59949227|NCT02624284|76068045|FG001|NOT COMPLETED|Overall Study||18||
59949228|NCT02624284|76068046|FG002|NOT COMPLETED|Overall Study||11||
59949229|NCT02738450|76068058|FG000|STARTED|Overall Study||6||
59949230|NCT02738450|76068059|FG001|STARTED|Overall Study||6||
59949231|NCT02738450|76068060|FG002|STARTED|Overall Study||4||
59949232|NCT02738450|76068058|FG000|COMPLETED|Overall Study||6||
59949233|NCT02738450|76068059|FG001|COMPLETED|Overall Study||4||
59949234|NCT02738450|76068060|FG002|COMPLETED|Overall Study||4||
59949235|NCT02738450|76068058|FG000|NOT COMPLETED|Overall Study||0||
59762436|NCT03638011|75882168|FG001|NOT COMPLETED|Overall Study||0||
59762437|NCT00885482|75882174|FG000|STARTED|Overall Study||40||
59762438|NCT00885482|75882174|FG000|COMPLETED|Overall Study||36||
59949236|NCT02738450|76068059|FG001|NOT COMPLETED|Overall Study||2||
59949237|NCT02738450|76068060|FG002|NOT COMPLETED|Overall Study||0||
59949238|NCT02624050|76068071|FG000|STARTED|Overall Study||26||
59949239|NCT02624050|76068072|FG001|STARTED|Overall Study||25||
59949240|NCT02624050|76068071|FG000|COMPLETED|Overall Study||20||
59949241|NCT02624050|76068072|FG001|COMPLETED|Overall Study||25||
59949242|NCT02624050|76068071|FG000|NOT COMPLETED|Overall Study||6||
59949243|NCT02624050|76068072|FG001|NOT COMPLETED|Overall Study||0||
59949244|NCT04689932|76068078|FG000|STARTED|Overall Study||12||
59949245|NCT04689932|76068078|FG000|COMPLETED|Overall Study||12||
59949246|NCT04689932|76068078|FG000|NOT COMPLETED|Overall Study||0||
59949247|NCT01338987|76068088|FG000|STARTED|Overall Study||12||
59949248|NCT01338987|76068089|FG001|STARTED|Overall Study||9||
59949249|NCT01338987|76068090|FG002|STARTED|Overall Study||22||
59949250|NCT01338987|76068091|FG003|STARTED|Overall Study||31||
59949251|NCT01338987|76068092|FG004|STARTED|Overall Study||2||
59949252|NCT01338987|76068088|FG000|COMPLETED|Overall Study||10||
59949253|NCT01338987|76068089|FG001|COMPLETED|Overall Study||8||
59949254|NCT01338987|76068090|FG002|COMPLETED|Overall Study||20||
59949255|NCT01338987|76068091|FG003|COMPLETED|Overall Study||31||
59949256|NCT01338987|76068092|FG004|COMPLETED|Overall Study||2||
59949257|NCT01338987|76068088|FG000|NOT COMPLETED|Overall Study||2||
59949258|NCT01338987|76068089|FG001|NOT COMPLETED|Overall Study||1||
59949259|NCT01338987|76068090|FG002|NOT COMPLETED|Overall Study||2||
59949260|NCT01338987|76068091|FG003|NOT COMPLETED|Overall Study||0||
59949261|NCT01338987|76068092|FG004|NOT COMPLETED|Overall Study||0||
59949262|NCT03706430|76068106|FG000|STARTED|Overall Study||63||
59949263|NCT03706430|76068106|FG000|COMPLETED|Overall Study||48||
59949264|NCT03706430|76068106|FG000|NOT COMPLETED|Overall Study||15||
59949265|NCT03368066|76068110|FG000|STARTED|Overall Study||58||
59949266|NCT03368066|76068111|FG001|STARTED|Overall Study||37||
59949267|NCT03368066|76068110|FG000|COMPLETED|Overall Study||58||
59949268|NCT03368066|76068111|FG001|COMPLETED|Overall Study||37||
59949269|NCT03368066|76068110|FG000|NOT COMPLETED|Overall Study||0||
59949270|NCT03368066|76068111|FG001|NOT COMPLETED|Overall Study||0||
59949271|NCT02481986|76068119|FG000|STARTED|Overall Study||108||
59949272|NCT02481986|76068120|FG001|STARTED|Overall Study||115||
59949273|NCT02481986|76068119|FG000|COMPLETED|Overall Study||103||
59949274|NCT02481986|76068120|FG001|COMPLETED|Overall Study||106||
59949275|NCT02481986|76068119|FG000|NOT COMPLETED|Overall Study||5||
59949276|NCT02481986|76068120|FG001|NOT COMPLETED|Overall Study||9||
59949277|NCT02738138|76068128|FG000|STARTED|Overall Study||137||
59949278|NCT02738138|76068129|FG001|STARTED|Overall Study||16||
59949279|NCT02738138|76068128|FG000|COMPLETED|Overall Study||134||
59949280|NCT02738138|76068129|FG001|COMPLETED|Overall Study||15||
59949281|NCT02738138|76068128|FG000|NOT COMPLETED|Overall Study||3||
60067645|NCT01760733|76182798|FG000|COMPLETED|Waiting List|217 patients have been transplanted|217||
59762439|NCT00885482|75882174|FG000|NOT COMPLETED|Overall Study||4||
59762440|NCT00585715|75882180|FG000|STARTED|Overall Study||11||
59762441|NCT00585715|75882181|FG001|STARTED|Overall Study||11||
59762442|NCT00585715|75882180|FG000|COMPLETED|Overall Study||8||
59762443|NCT00585715|75882181|FG001|COMPLETED|Overall Study||11||
59762444|NCT00585715|75882180|FG000|NOT COMPLETED|Overall Study||3||
59762445|NCT00585715|75882181|FG001|NOT COMPLETED|Overall Study||0||
59949282|NCT02738138|76068129|FG001|NOT COMPLETED|Overall Study||1||
59949283|NCT01355289|76068138|FG000|STARTED|Core Study||17||
59949284|NCT01355289|76068139|FG001|STARTED|Core Study||16||
59949285|NCT01355289|76068140|FG002|STARTED|Core Study||18||
59949286|NCT01355289|76068141|FG003|STARTED|Core Study||14||
59949287|NCT01355289|76068142|FG004|STARTED|Core Study||0||
59949288|NCT01355289|76068138|FG000|COMPLETED|Core Study||16||
59949289|NCT01355289|76068139|FG001|COMPLETED|Core Study||16||
59949290|NCT01355289|76068140|FG002|COMPLETED|Core Study||18||
59949291|NCT01355289|76068141|FG003|COMPLETED|Core Study||12||
59949292|NCT01355289|76068142|FG004|COMPLETED|Core Study||0||
59949293|NCT01355289|76068138|FG000|NOT COMPLETED|Core Study||1||
59949294|NCT01355289|76068139|FG001|NOT COMPLETED|Core Study||0||
60067646|NCT01760733|76182798|FG000|NOT COMPLETED|Waiting List||72||
59762446|NCT00585247|75882189|FG000|STARTED|Overall Study||14||
59762447|NCT00585247|75882190|FG001|STARTED|Overall Study||13||
59949295|NCT01355289|76068140|FG002|NOT COMPLETED|Core Study||0||
59949296|NCT01355289|76068141|FG003|NOT COMPLETED|Core Study||2||
59949297|NCT01355289|76068142|FG004|NOT COMPLETED|Core Study||0||
59949298|NCT01355289|76068138|FG000|STARTED|Open Label Extension||0||
59949299|NCT01355289|76068139|FG001|STARTED|Open Label Extension||0||
59949300|NCT01355289|76068140|FG002|STARTED|Open Label Extension||0||
59949301|NCT01355289|76068141|FG003|STARTED|Open Label Extension||0||
59949302|NCT01355289|76068142|FG004|STARTED|Open Label Extension||62||
59949303|NCT01355289|76068138|FG000|COMPLETED|Open Label Extension||0||
59949304|NCT01355289|76068139|FG001|COMPLETED|Open Label Extension||0||
59949305|NCT01355289|76068140|FG002|COMPLETED|Open Label Extension||0||
59949306|NCT01355289|76068141|FG003|COMPLETED|Open Label Extension||0||
59949307|NCT01355289|76068142|FG004|COMPLETED|Open Label Extension||28||
59949308|NCT01355289|76068138|FG000|NOT COMPLETED|Open Label Extension||0||
59949309|NCT01355289|76068139|FG001|NOT COMPLETED|Open Label Extension||0||
59949310|NCT01355289|76068140|FG002|NOT COMPLETED|Open Label Extension||0||
59949311|NCT01355289|76068141|FG003|NOT COMPLETED|Open Label Extension||0||
59949312|NCT01355289|76068142|FG004|NOT COMPLETED|Open Label Extension||34||
59949313|NCT02737592|76068155|FG000|STARTED|Overall Study||34||
59949314|NCT02737592|76068155|FG000|COMPLETED|Overall Study||33||
59949315|NCT02737592|76068155|FG000|NOT COMPLETED|Overall Study||1||
59949316|NCT00308516|76068161|FG000|STARTED|Overall Study||35||
59949317|NCT00308516|76068162|FG001|STARTED|Overall Study||31||
59949318|NCT00308516|76068161|FG000|COMPLETED|Overall Study||6||
59949319|NCT00308516|76068162|FG001|COMPLETED|Overall Study||10||
59949320|NCT00308516|76068161|FG000|NOT COMPLETED|Overall Study||29||
59949321|NCT00308516|76068162|FG001|NOT COMPLETED|Overall Study||21||
59949322|NCT04331366|76068168|FG000|STARTED|Overall Study||2||
59949323|NCT04331366|76068168|FG000|COMPLETED|Overall Study||2||
59949324|NCT04331366|76068168|FG000|NOT COMPLETED|Overall Study||0||
59949325|NCT03063164|76068172|FG000|STARTED|Overall Study||7||7
59949326|NCT03063164|76068173|FG001|STARTED|Overall Study||7||7
59949327|NCT03063164|76068172|FG000|COMPLETED|Overall Study||7||7
59949328|NCT03063164|76068173|FG001|COMPLETED|Overall Study||7||7
59949329|NCT03063164|76068172|FG000|NOT COMPLETED|Overall Study||0||0
59949330|NCT03063164|76068173|FG001|NOT COMPLETED|Overall Study||0||0
59949331|NCT02737358|76068182|FG000|STARTED|Overall Study||55||
59949332|NCT02737358|76068183|FG001|STARTED|Overall Study||59||
59949333|NCT02737358|76068182|FG000|COMPLETED|Overall Study||46||
59949334|NCT02737358|76068183|FG001|COMPLETED|Overall Study||44||
59949335|NCT02737358|76068182|FG000|NOT COMPLETED|Overall Study||9||
59949336|NCT02737358|76068183|FG001|NOT COMPLETED|Overall Study||15||
59949337|NCT01354431|76068192|FG000|STARTED|Pre-Treatment Period||60||
59949338|NCT01354431|76068193|FG001|STARTED|Pre-Treatment Period||54||
59949339|NCT01354431|76068194|FG002|STARTED|Pre-Treatment Period||54||
59949340|NCT01354431|76068192|FG000|COMPLETED|Pre-Treatment Period||59|Completed = Moved to Treatment Period|
59949341|NCT01354431|76068193|FG001|COMPLETED|Pre-Treatment Period||54|Completed = Moved to Treatment Period|
59949342|NCT01354431|76068194|FG002|COMPLETED|Pre-Treatment Period||54|Completed = Moved to Treatment Period|
59949343|NCT01354431|76068192|FG000|NOT COMPLETED|Pre-Treatment Period||1||
59949344|NCT01354431|76068193|FG001|NOT COMPLETED|Pre-Treatment Period||0||
59949345|NCT01354431|76068194|FG002|NOT COMPLETED|Pre-Treatment Period||0||
59949346|NCT01354431|76068192|FG000|STARTED|Treatment Period||59||
59949347|NCT01354431|76068193|FG001|STARTED|Treatment Period||54||
59949348|NCT01354431|76068194|FG002|STARTED|Treatment Period||54||
59949349|NCT01354431|76068192|FG000|COMPLETED|Treatment Period||0||
59949350|NCT01354431|76068193|FG001|COMPLETED|Treatment Period||0||
59949351|NCT01354431|76068194|FG002|COMPLETED|Treatment Period||0||
59949352|NCT01354431|76068192|FG000|NOT COMPLETED|Treatment Period||59||
59949353|NCT01354431|76068193|FG001|NOT COMPLETED|Treatment Period||54||
59949354|NCT01354431|76068194|FG002|NOT COMPLETED|Treatment Period||54||
59949355|NCT02736578|76068204|FG000|STARTED|Overall Study||6||
59949356|NCT02736578|76068205|FG001|STARTED|Overall Study||2||
59949357|NCT02736578|76068204|FG000|COMPLETED|Overall Study||5||
59949358|NCT02736578|76068205|FG001|COMPLETED|Overall Study||2||
59949359|NCT02736578|76068204|FG000|NOT COMPLETED|Overall Study||1||
59949360|NCT02736578|76068205|FG001|NOT COMPLETED|Overall Study||0||
59949361|NCT02622724|76068217|FG000|STARTED|Overall Study||144|Subjects that received atleast 1 dose of study treatment|
59949362|NCT02622724|76068218|FG001|STARTED|Overall Study||152|Subjects that received atleast 1 dose of study treatment|
59949363|NCT02622724|76068217|FG000|Subjects Randomised|Overall Study||146||
59949364|NCT02622724|76068218|FG001|Subjects Randomised|Overall Study||155||
59949365|NCT02622724|76068217|FG000|Short-Term Follow-Up (Day 28)|Overall Study||105||
59949366|NCT02622724|76068218|FG001|Short-Term Follow-Up (Day 28)|Overall Study||115||
59949367|NCT02622724|76068217|FG000|Long-Term Follow-Up (Day 90)|Overall Study||96||
59949368|NCT02622724|76068218|FG001|Long-Term Follow-Up (Day 90)|Overall Study||101||
59949369|NCT02622724|76068217|FG000|Long-Term Follow-Up (Day 180)|Overall Study||73|The study was terminated early|
59949370|NCT02622724|76068218|FG001|Long-Term Follow-Up (Day 180)|Overall Study||74|The study was terminated early|
59949371|NCT02622724|76068217|FG000|COMPLETED|Overall Study||51|Extended Follow-Up (Day 360), but study was terminated early|
59949372|NCT02622724|76068218|FG001|COMPLETED|Overall Study||49|Extended Follow-Up (Day 360), but study was terminated early|
59949373|NCT02622724|76068217|FG000|NOT COMPLETED|Overall Study||93||
59949374|NCT02622724|76068218|FG001|NOT COMPLETED|Overall Study||103||
59949375|NCT01354353|76068236|FG000|STARTED|Overall Study||16||
59949376|NCT01354353|76068237|FG001|STARTED|Overall Study|Included in this arm are six participants who erroneously received oral 80 mg LY2140023 BID.|12||
59949377|NCT01354353|76068238|FG002|STARTED|Overall Study||11||
59949378|NCT01354353|76068239|FG003|STARTED|Overall Study||12||
59949379|NCT01354353|76068240|FG004|STARTED|Overall Study||12||
59949380|NCT01354353|76068241|FG005|STARTED|Overall Study||12||
59949381|NCT01354353|76068236|FG000|Received at Least One Dose of Study Drug|Overall Study||16||
59949382|NCT01354353|76068237|FG001|Received at Least One Dose of Study Drug|Overall Study||11||
59949383|NCT01354353|76068238|FG002|Received at Least One Dose of Study Drug|Overall Study||10||
59949384|NCT01354353|76068239|FG003|Received at Least One Dose of Study Drug|Overall Study||11||
59949385|NCT01354353|76068240|FG004|Received at Least One Dose of Study Drug|Overall Study||11||
59949386|NCT01354353|76068241|FG005|Received at Least One Dose of Study Drug|Overall Study||11||
59949387|NCT01354353|76068236|FG000|COMPLETED|Overall Study||13||
59949388|NCT01354353|76068237|FG001|COMPLETED|Overall Study||11||
59949389|NCT01354353|76068238|FG002|COMPLETED|Overall Study||9||
59949390|NCT01354353|76068239|FG003|COMPLETED|Overall Study||7||
59949391|NCT01354353|76068240|FG004|COMPLETED|Overall Study||11||
59949392|NCT01354353|76068241|FG005|COMPLETED|Overall Study||6||
59949393|NCT01354353|76068236|FG000|NOT COMPLETED|Overall Study||3||
59949394|NCT01354353|76068237|FG001|NOT COMPLETED|Overall Study||1||
59949395|NCT01354353|76068238|FG002|NOT COMPLETED|Overall Study||2||
59949396|NCT01354353|76068239|FG003|NOT COMPLETED|Overall Study||5||
59949397|NCT01354353|76068240|FG004|NOT COMPLETED|Overall Study||1||
59949398|NCT01354353|76068241|FG005|NOT COMPLETED|Overall Study||6||
59949399|NCT02622568|76068264|FG000|STARTED|Overall Study||14||
59949400|NCT02622568|76068265|FG001|STARTED|Overall Study||14||
59949401|NCT02622568|76068264|FG000|COMPLETED|Overall Study||9||
59949402|NCT02622568|76068265|FG001|COMPLETED|Overall Study||9||
59949403|NCT02622568|76068264|FG000|NOT COMPLETED|Overall Study||5||
59949404|NCT02622568|76068265|FG001|NOT COMPLETED|Overall Study||5||
59949405|NCT01354899|76068271|FG000|STARTED|Overall Study||24||
59949406|NCT01354899|76068271|FG000|COMPLETED|Overall Study||21||
59949407|NCT01354899|76068271|FG000|NOT COMPLETED|Overall Study||3||
59949408|NCT01353963|76068275|FG000|STARTED|Overall Study||13||
59949409|NCT01353963|76068275|FG000|COMPLETED|Overall Study||11||
59949410|NCT01353963|76068275|FG000|NOT COMPLETED|Overall Study||2||
59949411|NCT04927858|76068279|FG000|STARTED|Overall Study||460558||
59949412|NCT04927858|76068279|FG000|Treated With Empagliflozin|Overall Study||16985|Patients with Type 2 Diabetes Mellitus (T2DM) who were initiated on Empagliflozin between 1st of January 2015 and 31st of December 2017, who had at least one registration in the Swedish National Diabetes Register (NDR).|
59949413|NCT04927858|76068279|FG000|COMPLETED|Overall Study||460558||
59949414|NCT04927858|76068279|FG000|NOT COMPLETED|Overall Study||0||
59949415|NCT02820597|76068284|FG000|STARTED|Overall Study||27||
59949416|NCT02820597|76068284|FG000|1-day Post Treatment|Overall Study||27||
59949417|NCT02820597|76068284|FG000|7-day Post Treatment|Overall Study||27||
59949418|NCT02820597|76068284|FG000|30-day Post Treatment|Overall Study||27||
59949419|NCT02820597|76068284|FG000|90-day Post Treatment|Overall Study|2 participants missed the 90-day visit, 1 participant was lost to follow-up.|24||
59949420|NCT02820597|76068284|FG000|180-day Post Treatment|Overall Study|3 participants missed the 180-day visit, 3 participants were lost to follow-up.|21|Initially, study was complete upon 90 days follow-up, the 180-day visit was added later.|
59949421|NCT02820597|76068284|FG000|COMPLETED|Overall Study|12 participants were lost to follow-up.|15|Initially, study was complete upon 90 days follow-up, the 365-day visit was added later.|
59949422|NCT02820597|76068284|FG000|NOT COMPLETED|Overall Study||12||
59949423|NCT02822235|76068290|FG000|STARTED|Cross-sectional Phase (Day 1)||264||
59949424|NCT02822235|76068291|FG001|STARTED|Cross-sectional Phase (Day 1)||143||
59949425|NCT02822235|76068290|FG000|COMPLETED|Cross-sectional Phase (Day 1)||118|Participants with moderate to severe IBD at Day 1|
59949426|NCT02822235|76068291|FG001|COMPLETED|Cross-sectional Phase (Day 1)||36|Participants with moderate to severe IBD at Day 1|
59949427|NCT02822235|76068290|FG000|NOT COMPLETED|Cross-sectional Phase (Day 1)||146||
59949428|NCT02822235|76068291|FG001|NOT COMPLETED|Cross-sectional Phase (Day 1)||107||
59949429|NCT02822235|76068290|FG000|STARTED|Prospective Phase (Day 1 up to Month 12)||118||
59949430|NCT02822235|76068291|FG001|STARTED|Prospective Phase (Day 1 up to Month 12)||36||
59949431|NCT02822235|76068290|FG000|COMPLETED|Prospective Phase (Day 1 up to Month 12)||107||
59949432|NCT02822235|76068291|FG001|COMPLETED|Prospective Phase (Day 1 up to Month 12)||34||
59949433|NCT02822235|76068290|FG000|NOT COMPLETED|Prospective Phase (Day 1 up to Month 12)||11||
59949434|NCT02822235|76068291|FG001|NOT COMPLETED|Prospective Phase (Day 1 up to Month 12)||2||
59949435|NCT02817555|76068306|FG000|STARTED|Overall Study||24||
59949436|NCT02817555|76068307|FG001|STARTED|Overall Study||26||
59949437|NCT02817555|76068306|FG000|COMPLETED|Overall Study||21||
59949438|NCT02817555|76068307|FG001|COMPLETED|Overall Study||21||
59949439|NCT02817555|76068306|FG000|NOT COMPLETED|Overall Study||3||
59949440|NCT02817555|76068307|FG001|NOT COMPLETED|Overall Study||5||
59949441|NCT02817087|76068315|FG000|STARTED|Overall Study||16||
59949442|NCT02817087|76068316|FG001|STARTED|Overall Study||15||
59949443|NCT02817087|76068315|FG000|COMPLETED|Overall Study|1 pt was withdrawn early d/t concurrent disease. One pt. withdrew ICF d/t transportation concerns|14||
59949444|NCT02817087|76068316|FG001|COMPLETED|Overall Study||15||
59949445|NCT02817087|76068315|FG000|NOT COMPLETED|Overall Study||2||
59949446|NCT02817087|76068316|FG001|NOT COMPLETED|Overall Study||0||
59949447|NCT02813577|76068322|FG000|STARTED|Overall Study||4||
59949448|NCT02813577|76068322|FG000|COMPLETED|Overall Study|Study was terminated and only some results at 1 month follow up are available.|0||
59949449|NCT02813577|76068322|FG000|NOT COMPLETED|Overall Study||4||
59949450|NCT02815293|76068329|FG000|STARTED|Overall Study||10||
59949451|NCT02815293|76068330|FG001|STARTED|Overall Study||8||
59949452|NCT02815293|76068331|FG002|STARTED|Overall Study||18||
59949453|NCT02815293|76068329|FG000|COMPLETED|Overall Study||0||
59949454|NCT02815293|76068330|FG001|COMPLETED|Overall Study||0||
59949455|NCT02815293|76068331|FG002|COMPLETED|Overall Study||0||
59949456|NCT02815293|76068329|FG000|NOT COMPLETED|Overall Study||10||
59949457|NCT02815293|76068330|FG001|NOT COMPLETED|Overall Study||8||
59949458|NCT02815293|76068331|FG002|NOT COMPLETED|Overall Study||18||
59949459|NCT02813421|76068339|FG000|STARTED|Overall Study||5||
59949460|NCT02813421|76068340|FG001|STARTED|Overall Study||6||
59949461|NCT02813421|76068339|FG000|COMPLETED|Overall Study||3||
59949462|NCT02813421|76068340|FG001|COMPLETED|Overall Study||3||
59949463|NCT02813421|76068339|FG000|NOT COMPLETED|Overall Study||2||
59949464|NCT02813421|76068340|FG001|NOT COMPLETED|Overall Study||3||
59949465|NCT03672188|76068361|FG000|STARTED|Overall Study||6||
59949466|NCT03672188|76068362|FG001|STARTED|Overall Study||6||
59949467|NCT03672188|76068363|FG002|STARTED|Overall Study||6||
59949468|NCT03672188|76068364|FG003|STARTED|Overall Study||8||
59949469|NCT03672188|76068365|FG004|STARTED|Overall Study||6||
59949470|NCT03672188|76068366|FG005|STARTED|Overall Study||6||
59949471|NCT03672188|76068367|FG006|STARTED|Overall Study||12||
59949472|NCT03672188|76068368|FG007|STARTED|Overall Study||3||
59949473|NCT03672188|76068369|FG008|STARTED|Overall Study||6||
59949474|NCT03672188|76068370|FG009|STARTED|Overall Study||6||
59949475|NCT03672188|76068371|FG010|STARTED|Overall Study||3||
59949476|NCT03672188|76068372|FG011|STARTED|Overall Study||3||
59949477|NCT03672188|76068373|FG012|STARTED|Overall Study||3||
59949478|NCT03672188|76068374|FG013|STARTED|Overall Study||6||
59949479|NCT03672188|76068375|FG014|STARTED|Overall Study||2||
59949480|NCT03672188|76068361|FG000|Dosed|Overall Study||6||
59949481|NCT03672188|76068362|FG001|Dosed|Overall Study||6||
59949482|NCT03672188|76068363|FG002|Dosed|Overall Study||6||
59949483|NCT03672188|76068364|FG003|Dosed|Overall Study|1 subject was not dosed and therefore not included in any analyses.|7||
59949484|NCT03672188|76068365|FG004|Dosed|Overall Study||6||
59949485|NCT03672188|76068366|FG005|Dosed|Overall Study||6||
59949486|NCT03672188|76068367|FG006|Dosed|Overall Study||12||
59949487|NCT03672188|76068368|FG007|Dosed|Overall Study||3||
59949488|NCT03672188|76068369|FG008|Dosed|Overall Study||6||
59949489|NCT03672188|76068370|FG009|Dosed|Overall Study||6||
59949490|NCT03672188|76068371|FG010|Dosed|Overall Study||3||
59949491|NCT03672188|76068372|FG011|Dosed|Overall Study||3||
59949492|NCT03672188|76068373|FG012|Dosed|Overall Study||3||
59949493|NCT03672188|76068374|FG013|Dosed|Overall Study||6||
59949494|NCT03672188|76068375|FG014|Dosed|Overall Study||2||
59949495|NCT03672188|76068361|FG000|COMPLETED|Overall Study||6||
59949496|NCT03672188|76068362|FG001|COMPLETED|Overall Study||6||
59949497|NCT03672188|76068363|FG002|COMPLETED|Overall Study|1 Subject could not attend last follow up (Week 12 visit)|5||
59949498|NCT03672188|76068364|FG003|COMPLETED|Overall Study||5||
59949499|NCT03672188|76068365|FG004|COMPLETED|Overall Study||6||
59949500|NCT03672188|76068366|FG005|COMPLETED|Overall Study||6||
59949501|NCT03672188|76068367|FG006|COMPLETED|Overall Study||12||
59949502|NCT03672188|76068368|FG007|COMPLETED|Overall Study||3||
59949503|NCT03672188|76068369|FG008|COMPLETED|Overall Study||6||
59949504|NCT03672188|76068370|FG009|COMPLETED|Overall Study||6||
59949505|NCT03672188|76068371|FG010|COMPLETED|Overall Study||3||
59949506|NCT03672188|76068372|FG011|COMPLETED|Overall Study||3||
59949507|NCT03672188|76068373|FG012|COMPLETED|Overall Study|1 non-treatment related SAE of suicide during follow up period|2||
59949508|NCT03672188|76068374|FG013|COMPLETED|Overall Study||6||
59949509|NCT03672188|76068375|FG014|COMPLETED|Overall Study||2||
59949510|NCT03672188|76068361|FG000|NOT COMPLETED|Overall Study||0||
59949511|NCT03672188|76068362|FG001|NOT COMPLETED|Overall Study||0||
59949512|NCT03672188|76068363|FG002|NOT COMPLETED|Overall Study||1||
59949513|NCT03672188|76068364|FG003|NOT COMPLETED|Overall Study||3||
59949514|NCT03672188|76068365|FG004|NOT COMPLETED|Overall Study||0||
59949515|NCT03672188|76068366|FG005|NOT COMPLETED|Overall Study||0||
59949516|NCT03672188|76068367|FG006|NOT COMPLETED|Overall Study||0||
59949517|NCT03672188|76068368|FG007|NOT COMPLETED|Overall Study||0||
59949518|NCT03672188|76068369|FG008|NOT COMPLETED|Overall Study||0||
59949519|NCT03672188|76068370|FG009|NOT COMPLETED|Overall Study||0||
59949520|NCT03672188|76068371|FG010|NOT COMPLETED|Overall Study||0||
59949521|NCT03672188|76068372|FG011|NOT COMPLETED|Overall Study||0||
59949522|NCT03672188|76068373|FG012|NOT COMPLETED|Overall Study||1||
59949523|NCT03672188|76068374|FG013|NOT COMPLETED|Overall Study||0||
59949524|NCT03672188|76068375|FG014|NOT COMPLETED|Overall Study||0||
59949525|NCT02620384|76068443|FG000|STARTED|Overall Study||70||
59949526|NCT02620384|76068444|FG001|STARTED|Overall Study||73||
59949527|NCT02620384|76068443|FG000|COMPLETED|Overall Study|Per protocol design patients must receive both doses of investigational product to be in analysis.|66||
59949528|NCT02620384|76068444|FG001|COMPLETED|Overall Study|Per protocol design patients must receive both doses of investigational product to be in analysis.|66||
59949529|NCT02620384|76068443|FG000|NOT COMPLETED|Overall Study||4||
59949530|NCT02620384|76068444|FG001|NOT COMPLETED|Overall Study||7||
59949531|NCT03915860|76068450|FG000|STARTED|Overall Study||47||
59949532|NCT03915860|76068450|FG000|Treated|Overall Study||46||
59949533|NCT03915860|76068450|FG000|COMPLETED|Overall Study||33||
59949534|NCT03915860|76068450|FG000|NOT COMPLETED|Overall Study||14||
59949535|NCT05134974|76068456|FG000|STARTED|Overall Study||124||
59949536|NCT05134974|76068457|FG001|STARTED|Overall Study||244||
59949537|NCT05134974|76068456|FG000|COMPLETED|Overall Study||124||
59949538|NCT05134974|76068457|FG001|COMPLETED|Overall Study||244||
59949539|NCT05134974|76068456|FG000|NOT COMPLETED|Overall Study||0||
59613432|NCT01592760|75724571|FG000|STARTED|Perioperative to Discharge||90||
59613433|NCT01592760|75724572|FG001|STARTED|Perioperative to Discharge||90||
59762448|NCT00585247|75882189|FG000|COMPLETED|Overall Study||14||
59762449|NCT00585247|75882190|FG001|COMPLETED|Overall Study||13||
59762450|NCT00585247|75882189|FG000|NOT COMPLETED|Overall Study||0||
59949540|NCT05134974|76068457|FG001|NOT COMPLETED|Overall Study||0||
59949541|NCT05047211|76068465|FG000|STARTED|Overall Study||20||
59949542|NCT05047211|76068466|FG001|STARTED|Overall Study||20||
59949543|NCT05047211|76068465|FG000|COMPLETED|Overall Study||12||
59949544|NCT05047211|76068466|FG001|COMPLETED|Overall Study||15||
59949545|NCT05047211|76068465|FG000|NOT COMPLETED|Overall Study||8||
59949546|NCT05047211|76068466|FG001|NOT COMPLETED|Overall Study||5||
59949547|NCT04958642|76068475|FG000|STARTED|Overall Study||18||
59949548|NCT04958642|76068476|FG001|STARTED|Overall Study||13||
59949549|NCT04958642|76068477|FG002|STARTED|Overall Study||35||
59949550|NCT04958642|76068475|FG000|Received at Least 1 Dose of Study Drug|Overall Study||18||
59949551|NCT04958642|76068476|FG001|Received at Least 1 Dose of Study Drug|Overall Study||13||
59949552|NCT04958642|76068477|FG002|Received at Least 1 Dose of Study Drug|Overall Study||35||
59949553|NCT04958642|76068475|FG000|COMPLETED|Overall Study||0||
59949554|NCT04958642|76068476|FG001|COMPLETED|Overall Study||0||
59949555|NCT04958642|76068477|FG002|COMPLETED|Overall Study||0||
59949556|NCT04958642|76068475|FG000|NOT COMPLETED|Overall Study||18||
59949557|NCT04958642|76068476|FG001|NOT COMPLETED|Overall Study||13||
59949558|NCT04958642|76068477|FG002|NOT COMPLETED|Overall Study||35||
59949559|NCT04439357|76068485|FG000|STARTED|Overall Study||4||
59949560|NCT04439357|76068485|FG000|Eligible and Started Protocol Therapy|Overall Study||4|This is the primary analysis population.|
59949561|NCT04439357|76068485|FG000|COMPLETED|Overall Study||0||
59949562|NCT04439357|76068485|FG000|NOT COMPLETED|Overall Study||4||
59949563|NCT04321343|76068493|FG000|STARTED|Overall Study||25||
59949564|NCT04321343|76068494|FG001|STARTED|Overall Study||32||
59949565|NCT04321343|76068495|FG002|STARTED|Overall Study||30||
59949566|NCT04321343|76068496|FG003|STARTED|Overall Study||30||
59949567|NCT04321343|76068493|FG000|Completed the Double-blind Period|Overall Study||21||
59949568|NCT04321343|76068494|FG001|Completed the Double-blind Period|Overall Study||23||
59949569|NCT04321343|76068495|FG002|Completed the Double-blind Period|Overall Study||27||
59949570|NCT04321343|76068496|FG003|Completed the Double-blind Period|Overall Study||24||
59949571|NCT04321343|76068493|FG000|COMPLETED|Overall Study||21||
59949572|NCT04321343|76068494|FG001|COMPLETED|Overall Study||23||
59949573|NCT04321343|76068495|FG002|COMPLETED|Overall Study||27||
59949574|NCT04321343|76068496|FG003|COMPLETED|Overall Study||23||
59949575|NCT04321343|76068493|FG000|NOT COMPLETED|Overall Study||4||
59949576|NCT04321343|76068494|FG001|NOT COMPLETED|Overall Study||9||
59949577|NCT04321343|76068495|FG002|NOT COMPLETED|Overall Study||3||
59949578|NCT04321343|76068496|FG003|NOT COMPLETED|Overall Study||7||
59613434|NCT01592760|75724573|FG002|STARTED|Perioperative to Discharge||45||
59613435|NCT01592760|75724571|FG000|COMPLETED|Perioperative to Discharge||90||
59613436|NCT01592760|75724572|FG001|COMPLETED|Perioperative to Discharge||90||
59762451|NCT00585247|75882190|FG001|NOT COMPLETED|Overall Study||0||
59762452|NCT00885170|75882198|FG000|STARTED|Overall Study||124||
59762453|NCT00885170|75882199|FG001|STARTED|Overall Study||122||
59762454|NCT00885170|75882198|FG000|Treated|Overall Study||122||
59762455|NCT00885170|75882199|FG001|Treated|Overall Study||121||
59762456|NCT00885170|75882198|FG000|COMPLETED|Overall Study||86||
59949579|NCT04274153|76068506|FG000|STARTED|Overall Study||225||
59949580|NCT04274153|76068506|FG000|COMPLETED|Overall Study||169||
59949581|NCT04274153|76068506|FG000|NOT COMPLETED|Overall Study||56||
59949582|NCT04238754|76068510|FG000|STARTED|First Intervention||2||
59949583|NCT04238754|76068511|FG001|STARTED|First Intervention||1||
59949584|NCT04238754|76068510|FG000|COMPLETED|First Intervention||2||
59949585|NCT04238754|76068511|FG001|COMPLETED|First Intervention||1||
59949586|NCT04238754|76068510|FG000|NOT COMPLETED|First Intervention||0||
59949587|NCT04238754|76068511|FG001|NOT COMPLETED|First Intervention||0||
59949588|NCT04238754|76068510|FG000|STARTED|Washout - 1 Week||2||
59949589|NCT04238754|76068511|FG001|STARTED|Washout - 1 Week||1||
59949590|NCT04238754|76068510|FG000|COMPLETED|Washout - 1 Week||1||
59949591|NCT04238754|76068511|FG001|COMPLETED|Washout - 1 Week||1||
59949592|NCT04238754|76068510|FG000|NOT COMPLETED|Washout - 1 Week||1||
59949593|NCT04238754|76068511|FG001|NOT COMPLETED|Washout - 1 Week||0||
59949594|NCT04238754|76068510|FG000|STARTED|Second Intervention||1||
59949595|NCT04238754|76068511|FG001|STARTED|Second Intervention||1||
59949596|NCT04238754|76068510|FG000|COMPLETED|Second Intervention||1||
59949597|NCT04238754|76068511|FG001|COMPLETED|Second Intervention||1||
59949598|NCT04238754|76068510|FG000|NOT COMPLETED|Second Intervention||0||
59949599|NCT04238754|76068511|FG001|NOT COMPLETED|Second Intervention||0||
59949600|NCT04208958|76068519|FG000|STARTED|Overall Study||56||
59949601|NCT04208958|76068519|FG000|Gastric/GEJ Adenocarcinoma|Overall Study||20||
59949602|NCT04208958|76068519|FG000|Melanoma|Overall Study||20||
59949603|NCT04208958|76068519|FG000|CRC-MSS|Overall Study||14||
59949604|NCT04208958|76068519|FG000|Not Treated With VE800|Overall Study||2||
59949605|NCT04208958|76068519|FG000|COMPLETED|Overall Study||0||
59949606|NCT04208958|76068519|FG000|NOT COMPLETED|Overall Study||56||
59949607|NCT04150068|76068533|FG000|STARTED|Functional Mono/Oral Lead-in (14 Days)||24||
59949608|NCT04150068|76068534|FG001|STARTED|Functional Mono/Oral Lead-in (14 Days)||12||
59949609|NCT04150068|76068535|FG002|STARTED|Functional Mono/Oral Lead-in (14 Days)||36||
59949610|NCT04150068|76068533|FG000|COMPLETED|Functional Mono/Oral Lead-in (14 Days)||24||
59949611|NCT04150068|76068534|FG001|COMPLETED|Functional Mono/Oral Lead-in (14 Days)||12||
59949612|NCT04150068|76068535|FG002|COMPLETED|Functional Mono/Oral Lead-in (14 Days)||36||
59949613|NCT04150068|76068533|FG000|NOT COMPLETED|Functional Mono/Oral Lead-in (14 Days)||0||
59949614|NCT04150068|76068534|FG001|NOT COMPLETED|Functional Mono/Oral Lead-in (14 Days)||0||
59949615|NCT04150068|76068535|FG002|NOT COMPLETED|Functional Mono/Oral Lead-in (14 Days)||0||
59949616|NCT04150068|76068533|FG000|STARTED|Maintenance Period (Week 26 Analysis)||24|Received Day 1 subcutaneous lenacapavir injection.|
59949617|NCT04150068|76068534|FG001|STARTED|Maintenance Period (Week 26 Analysis)||12|Received Day 1 subcutaneous lenacapavir injection.|
59949618|NCT04150068|76068535|FG002|STARTED|Maintenance Period (Week 26 Analysis)||36|Received Day 1 subcutaneous lenacapavir injection.|
59949619|NCT04150068|76068533|FG000|COMPLETED|Maintenance Period (Week 26 Analysis)||0||
59949620|NCT04150068|76068534|FG001|COMPLETED|Maintenance Period (Week 26 Analysis)||0||
59949621|NCT04150068|76068535|FG002|COMPLETED|Maintenance Period (Week 26 Analysis)||0||
59949622|NCT04150068|76068533|FG000|NOT COMPLETED|Maintenance Period (Week 26 Analysis)||24||
59949623|NCT04150068|76068534|FG001|NOT COMPLETED|Maintenance Period (Week 26 Analysis)||12||
59949624|NCT04150068|76068535|FG002|NOT COMPLETED|Maintenance Period (Week 26 Analysis)||36||
59949625|NCT03920293|76068544|FG000|STARTED|Overall Study||86||
59949626|NCT03920293|76068545|FG001|STARTED|Overall Study||89||
59949627|NCT03920293|76068544|FG000|Received at Least 1 Dose of Study Drug|Overall Study||86||
59949628|NCT03920293|76068545|FG001|Received at Least 1 Dose of Study Drug|Overall Study||89||
59949629|NCT03920293|76068544|FG000|COMPLETED|Overall Study||79||
59949630|NCT03920293|76068545|FG001|COMPLETED|Overall Study||83||
59949631|NCT03920293|76068544|FG000|NOT COMPLETED|Overall Study||7||
59949632|NCT03920293|76068545|FG001|NOT COMPLETED|Overall Study||6||
59949633|NCT03791619|76068553|FG000|STARTED|Overall Study||260||
59949634|NCT03791619|76068554|FG001|STARTED|Overall Study||215||
59949635|NCT03791619|76068553|FG000|COMPLETED|Overall Study||256||
59949636|NCT03791619|76068554|FG001|COMPLETED|Overall Study||209||
59949637|NCT03791619|76068553|FG000|NOT COMPLETED|Overall Study||4||
59949638|NCT03791619|76068554|FG001|NOT COMPLETED|Overall Study||6||
59949639|NCT03398070|76068560|FG000|STARTED|Overall Study||30||
59949640|NCT03398070|76068560|FG000|COMPLETED|Overall Study||22||
59949641|NCT03398070|76068560|FG000|NOT COMPLETED|Overall Study||8||
59949642|NCT03317496|76068568|FG000|STARTED|Phase 1b Lead-in: Treatment||6||
59949643|NCT03317496|76068569|FG001|STARTED|Phase 1b Lead-in: Treatment||13||
59949644|NCT03317496|76068570|FG002|STARTED|Phase 1b Lead-in: Treatment||6||
59949645|NCT03317496|76068571|FG003|STARTED|Phase 1b Lead-in: Treatment||6||
59949646|NCT03317496|76068572|FG004|STARTED|Phase 1b Lead-in: Treatment||0||
59949647|NCT03317496|76068568|FG000|COMPLETED|Phase 1b Lead-in: Treatment||0||
59949648|NCT03317496|76068569|FG001|COMPLETED|Phase 1b Lead-in: Treatment||0||
59949649|NCT03317496|76068570|FG002|COMPLETED|Phase 1b Lead-in: Treatment||0||
59949650|NCT03317496|76068571|FG003|COMPLETED|Phase 1b Lead-in: Treatment||0||
59949651|NCT03317496|76068572|FG004|COMPLETED|Phase 1b Lead-in: Treatment||0||
59949652|NCT03317496|76068568|FG000|NOT COMPLETED|Phase 1b Lead-in: Treatment||6||
59949653|NCT03317496|76068569|FG001|NOT COMPLETED|Phase 1b Lead-in: Treatment||13||
59949654|NCT03317496|76068570|FG002|NOT COMPLETED|Phase 1b Lead-in: Treatment||6||
59949655|NCT03317496|76068571|FG003|NOT COMPLETED|Phase 1b Lead-in: Treatment||6||
59949656|NCT03317496|76068572|FG004|NOT COMPLETED|Phase 1b Lead-in: Treatment||0||
59949657|NCT03317496|76068568|FG000|STARTED|Phase 1b Lead-in: Follow-up|Eligible participants entered follow-up period following discontinuation of study treatment|6||
59949658|NCT03317496|76068569|FG001|STARTED|Phase 1b Lead-in: Follow-up|Eligible participants entered follow-up period following discontinuation of study treatment|12||
59949659|NCT03317496|76068570|FG002|STARTED|Phase 1b Lead-in: Follow-up|Eligible participants entered follow-up period following discontinuation of study treatment|5||
59949660|NCT03317496|76068571|FG003|STARTED|Phase 1b Lead-in: Follow-up|Eligible participants entered follow-up period following discontinuation of study treatment|6||
59949661|NCT03317496|76068572|FG004|STARTED|Phase 1b Lead-in: Follow-up||0||
59949662|NCT03317496|76068568|FG000|COMPLETED|Phase 1b Lead-in: Follow-up||0||
59949663|NCT03317496|76068569|FG001|COMPLETED|Phase 1b Lead-in: Follow-up||0||
59949664|NCT03317496|76068570|FG002|COMPLETED|Phase 1b Lead-in: Follow-up||0||
59949665|NCT03317496|76068571|FG003|COMPLETED|Phase 1b Lead-in: Follow-up||0||
59949666|NCT03317496|76068572|FG004|COMPLETED|Phase 1b Lead-in: Follow-up||0||
59949667|NCT03317496|76068568|FG000|NOT COMPLETED|Phase 1b Lead-in: Follow-up||6||
59949668|NCT03317496|76068569|FG001|NOT COMPLETED|Phase 1b Lead-in: Follow-up||12||
59949669|NCT03317496|76068570|FG002|NOT COMPLETED|Phase 1b Lead-in: Follow-up||5||
59949670|NCT03317496|76068571|FG003|NOT COMPLETED|Phase 1b Lead-in: Follow-up||6||
59949671|NCT03317496|76068572|FG004|NOT COMPLETED|Phase 1b Lead-in: Follow-up||0||
59949672|NCT03317496|76068568|FG000|STARTED|Phase 2: Treatment||0||
59949673|NCT03317496|76068569|FG001|STARTED|Phase 2: Treatment||0||
59949674|NCT03317496|76068570|FG002|STARTED|Phase 2: Treatment||0||
59949675|NCT03317496|76068571|FG003|STARTED|Phase 2: Treatment||0||
59949676|NCT03317496|76068572|FG004|STARTED|Phase 2: Treatment|Additional participants were enrolled in Phase 2|35||
59949677|NCT03317496|76068568|FG000|COMPLETED|Phase 2: Treatment||0||
59949678|NCT03317496|76068569|FG001|COMPLETED|Phase 2: Treatment||0||
59949679|NCT03317496|76068570|FG002|COMPLETED|Phase 2: Treatment||0||
59949680|NCT03317496|76068571|FG003|COMPLETED|Phase 2: Treatment||0||
59949681|NCT03317496|76068572|FG004|COMPLETED|Phase 2: Treatment||0||
59949682|NCT03317496|76068568|FG000|NOT COMPLETED|Phase 2: Treatment||0||
59949683|NCT03317496|76068569|FG001|NOT COMPLETED|Phase 2: Treatment||0||
59949684|NCT03317496|76068570|FG002|NOT COMPLETED|Phase 2: Treatment||0||
59949685|NCT03317496|76068571|FG003|NOT COMPLETED|Phase 2: Treatment||0||
59949686|NCT03317496|76068572|FG004|NOT COMPLETED|Phase 2: Treatment||35||
59949687|NCT03317496|76068568|FG000|STARTED|Phase 2: Follow-up||0||
59949688|NCT03317496|76068569|FG001|STARTED|Phase 2: Follow-up||0||
59949689|NCT03317496|76068570|FG002|STARTED|Phase 2: Follow-up||0||
59949690|NCT03317496|76068571|FG003|STARTED|Phase 2: Follow-up||0||
59949691|NCT03317496|76068572|FG004|STARTED|Phase 2: Follow-up|Eligible participants entered follow-up period following discontinuation of study treatment|33||
59949692|NCT03317496|76068568|FG000|COMPLETED|Phase 2: Follow-up||0||
59949693|NCT03317496|76068569|FG001|COMPLETED|Phase 2: Follow-up||0||
59949694|NCT03317496|76068570|FG002|COMPLETED|Phase 2: Follow-up||0||
59949695|NCT03317496|76068571|FG003|COMPLETED|Phase 2: Follow-up||0||
59949696|NCT03317496|76068572|FG004|COMPLETED|Phase 2: Follow-up||0||
59949697|NCT03317496|76068568|FG000|NOT COMPLETED|Phase 2: Follow-up||0||
59949698|NCT03317496|76068569|FG001|NOT COMPLETED|Phase 2: Follow-up||0||
59949699|NCT03317496|76068570|FG002|NOT COMPLETED|Phase 2: Follow-up||0||
59949700|NCT03317496|76068571|FG003|NOT COMPLETED|Phase 2: Follow-up||0||
59949701|NCT03317496|76068572|FG004|NOT COMPLETED|Phase 2: Follow-up||33||
59949702|NCT02880319|76068585|FG000|STARTED|Overall Study||98||
59949703|NCT02880319|76068586|FG001|STARTED|Overall Study|The re-irradiation cohort is 44 instead of 50 because it excluded those who were lost to follow up and/or completed the surveys at time points different from protocol specified.|44||
59949704|NCT02880319|76068585|FG000|COMPLETED|Overall Study||98||
59949705|NCT02880319|76068586|FG001|COMPLETED|Overall Study|The re-irradiation cohort is 44 instead of 50 because it excluded those who were lost to follow up and/or completed the surveys at time points different from protocol specified.|44||
59949706|NCT02880319|76068585|FG000|NOT COMPLETED|Overall Study||0||
59949707|NCT02880319|76068586|FG001|NOT COMPLETED|Overall Study||0||
59949708|NCT02836249|76068594|FG000|STARTED|Overall Study||123||
59949709|NCT02836249|76068595|FG001|STARTED|Overall Study||58||
59949710|NCT02836249|76068594|FG000|COMPLETED|Overall Study||0||
59949711|NCT02836249|76068595|FG001|COMPLETED|Overall Study||0||
59949712|NCT02836249|76068594|FG000|NOT COMPLETED|Overall Study||123||
59949713|NCT02836249|76068595|FG001|NOT COMPLETED|Overall Study||58||
59949714|NCT02568566|76068601|FG000|STARTED|Overall Study||201||
59949715|NCT02568566|76068601|FG000|COMPLETED|Overall Study||187||
59949716|NCT02568566|76068601|FG000|NOT COMPLETED|Overall Study||14||
59949717|NCT01849562|76068608|FG000|STARTED|Overall Study||10||
59949718|NCT01849562|76068609|FG001|STARTED|Overall Study||10||
59949719|NCT01849562|76068610|FG002|STARTED|Overall Study||10||
59762457|NCT00885170|75882199|FG001|COMPLETED|Overall Study||99||
59762458|NCT00885170|75882198|FG000|NOT COMPLETED|Overall Study||38||
59762459|NCT00885170|75882199|FG001|NOT COMPLETED|Overall Study||23||
59762460|NCT02644525|75882209|FG000|STARTED|Group 1||2||
59762461|NCT02644525|75882210|FG001|STARTED|Group 1||5||
59762462|NCT02644525|75882211|FG002|STARTED|Group 1||0||
59762463|NCT02644525|75882212|FG003|STARTED|Group 1||0||
59762464|NCT02644525|75882209|FG000|COMPLETED|Group 1||2||
59762465|NCT02644525|75882210|FG001|COMPLETED|Group 1||5||
59762466|NCT02644525|75882211|FG002|COMPLETED|Group 1||0||
59762467|NCT02644525|75882212|FG003|COMPLETED|Group 1||0||
59762468|NCT02644525|75882209|FG000|NOT COMPLETED|Group 1||0||
59762469|NCT02644525|75882210|FG001|NOT COMPLETED|Group 1||0||
59762470|NCT02644525|75882211|FG002|NOT COMPLETED|Group 1||0||
59762471|NCT02644525|75882212|FG003|NOT COMPLETED|Group 1||0||
59762472|NCT02644525|75882209|FG000|STARTED|Group 2||2||
59762473|NCT02644525|75882210|FG001|STARTED|Group 2||0||
59762474|NCT02644525|75882211|FG002|STARTED|Group 2||5||
59762475|NCT02644525|75882212|FG003|STARTED|Group 2||0||
59762476|NCT02644525|75882209|FG000|COMPLETED|Group 2||2||
59762477|NCT02644525|75882210|FG001|COMPLETED|Group 2||0||
59949720|NCT01849562|76068608|FG000|COMPLETED|Overall Study||8||
59949721|NCT01849562|76068609|FG001|COMPLETED|Overall Study||10||
59949722|NCT01849562|76068610|FG002|COMPLETED|Overall Study||10||
59949723|NCT01849562|76068608|FG000|NOT COMPLETED|Overall Study||2||
59762478|NCT02644525|75882211|FG002|COMPLETED|Group 2||5||
59949724|NCT01849562|76068609|FG001|NOT COMPLETED|Overall Study||0||
59949725|NCT01849562|76068610|FG002|NOT COMPLETED|Overall Study||0||
59949726|NCT01700179|76068619|FG000|STARTED|Overall Study||8||
59949727|NCT01700179|76068619|FG000|COMPLETED|Overall Study||6||
59949728|NCT01700179|76068619|FG000|NOT COMPLETED|Overall Study||2||
59949729|NCT01474200|76068625|FG000|STARTED|Overall Study||110||
59949730|NCT01474200|76068626|FG001|STARTED|Overall Study||114||
59949731|NCT01474200|76068625|FG000|COMPLETED|Overall Study||81||
59949732|NCT01474200|76068626|FG001|COMPLETED|Overall Study||84||
59949733|NCT01474200|76068625|FG000|NOT COMPLETED|Overall Study||29||
59949734|NCT01474200|76068626|FG001|NOT COMPLETED|Overall Study||30||
59949735|NCT00665223|76068635|FG000|STARTED|Randomized Phase (26 Weeks)||144||
59949736|NCT00665223|76068636|FG001|STARTED|Randomized Phase (26 Weeks)||148||
59949737|NCT00665223|76068637|FG002|STARTED|Randomized Phase (26 Weeks)||145||
59949738|NCT00665223|76068635|FG000|Received at Least 1 Dose of Study Drug|Randomized Phase (26 Weeks)||144||
59949739|NCT00665223|76068636|FG001|Received at Least 1 Dose of Study Drug|Randomized Phase (26 Weeks)||148||
59949740|NCT00665223|76068637|FG002|Received at Least 1 Dose of Study Drug|Randomized Phase (26 Weeks)||145||
59949741|NCT00665223|76068635|FG000|COMPLETED|Randomized Phase (26 Weeks)||126||
59949742|NCT00665223|76068636|FG001|COMPLETED|Randomized Phase (26 Weeks)||136||
59949743|NCT00665223|76068637|FG002|COMPLETED|Randomized Phase (26 Weeks)||124||
59949744|NCT00665223|76068635|FG000|NOT COMPLETED|Randomized Phase (26 Weeks)||18||
59949745|NCT00665223|76068636|FG001|NOT COMPLETED|Randomized Phase (26 Weeks)||12||
59949746|NCT00665223|76068637|FG002|NOT COMPLETED|Randomized Phase (26 Weeks)||21||
59949747|NCT00665223|76068635|FG000|STARTED|Open-Label Period (26 Weeks)||113||
59949748|NCT00665223|76068636|FG001|STARTED|Open-Label Period (26 Weeks)||125||
59949749|NCT00665223|76068637|FG002|STARTED|Open-Label Period (26 Weeks)||115||
59949750|NCT00665223|76068635|FG000|COMPLETED|Open-Label Period (26 Weeks)||97||
59949751|NCT00665223|76068636|FG001|COMPLETED|Open-Label Period (26 Weeks)||108||
59949752|NCT00665223|76068637|FG002|COMPLETED|Open-Label Period (26 Weeks)||100||
59949753|NCT00665223|76068635|FG000|NOT COMPLETED|Open-Label Period (26 Weeks)||16||
59949754|NCT00665223|76068636|FG001|NOT COMPLETED|Open-Label Period (26 Weeks)||17||
59949755|NCT00665223|76068637|FG002|NOT COMPLETED|Open-Label Period (26 Weeks)||15||
59949756|NCT03786380|76068658|FG000|STARTED|Overall Study||35||
59949757|NCT03786380|76068659|FG001|STARTED|Overall Study||22||
59949758|NCT03786380|76068660|FG002|STARTED|Overall Study||54||
59949759|NCT03786380|76068661|FG003|STARTED|Overall Study||63||
59949760|NCT03786380|76068662|FG004|STARTED|Overall Study||28||
59949761|NCT03786380|76068658|FG000|Safety Population|Overall Study||35|Safety Population included all participants who received ≥1 administration of study treatment.|
59949762|NCT03786380|76068659|FG001|Safety Population|Overall Study||22|Safety Population included all participants who received ≥1 administration of study treatment.|
59949763|NCT03786380|76068660|FG002|Safety Population|Overall Study||54|Safety Population included all participants who received ≥1 administration of study treatment.|
59949764|NCT03786380|76068661|FG003|Safety Population|Overall Study||62|Safety Population included all participants who received ≥1 administration of study treatment.|
59949765|NCT03786380|76068662|FG004|Safety Population|Overall Study||28|Safety Population included all participants who received ≥1 administration of study treatment.|
59949766|NCT03786380|76068658|FG000|COMPLETED|Overall Study||0||
59949767|NCT03786380|76068659|FG001|COMPLETED|Overall Study||0||
59949768|NCT03786380|76068660|FG002|COMPLETED|Overall Study||0||
59949769|NCT03786380|76068661|FG003|COMPLETED|Overall Study||0||
59949770|NCT03786380|76068662|FG004|COMPLETED|Overall Study||0||
59949771|NCT03786380|76068658|FG000|NOT COMPLETED|Overall Study||35||
59949772|NCT03786380|76068659|FG001|NOT COMPLETED|Overall Study||22||
59949773|NCT03786380|76068660|FG002|NOT COMPLETED|Overall Study||54||
59949774|NCT03786380|76068661|FG003|NOT COMPLETED|Overall Study||63||
59949775|NCT03786380|76068662|FG004|NOT COMPLETED|Overall Study||28||
59949776|NCT02626000|76068674|FG000|STARTED|Overall Study||36||
59949777|NCT02626000|76068674|FG000|COMPLETED|Overall Study||6||
59949778|NCT02626000|76068674|FG000|NOT COMPLETED|Overall Study||30||
59762479|NCT02644525|75882212|FG003|COMPLETED|Group 2||0||
59949779|NCT03769376|76068681|FG000|STARTED|Overall Study||20||
59949780|NCT03769376|76068682|FG001|STARTED|Overall Study||18||
59949781|NCT03769376|76068681|FG000|COMPLETED|Overall Study||13||
59949782|NCT03769376|76068682|FG001|COMPLETED|Overall Study||11||
59949783|NCT03769376|76068681|FG000|NOT COMPLETED|Overall Study||7||
59949784|NCT03769376|76068682|FG001|NOT COMPLETED|Overall Study||7||
59949785|NCT02736890|76068690|FG000|STARTED|First 12 Weeks||5||
59949786|NCT02736890|76068691|FG001|STARTED|First 12 Weeks||3||
59949787|NCT02736890|76068690|FG000|COMPLETED|First 12 Weeks||5||
59949788|NCT02736890|76068691|FG001|COMPLETED|First 12 Weeks||3||
59949789|NCT02736890|76068690|FG000|NOT COMPLETED|First 12 Weeks||0||
59949790|NCT02736890|76068691|FG001|NOT COMPLETED|First 12 Weeks||0||
59949791|NCT02736890|76068690|FG000|STARTED|Crossover Next 12 Weeks||5||
59949792|NCT02736890|76068691|FG001|STARTED|Crossover Next 12 Weeks||3||
59949793|NCT02736890|76068690|FG000|COMPLETED|Crossover Next 12 Weeks||3||
59949794|NCT02736890|76068691|FG001|COMPLETED|Crossover Next 12 Weeks||1||
59949795|NCT02736890|76068690|FG000|NOT COMPLETED|Crossover Next 12 Weeks||2||
59762480|NCT02644525|75882209|FG000|NOT COMPLETED|Group 2||0||
59762481|NCT02644525|75882210|FG001|NOT COMPLETED|Group 2||0||
59949796|NCT02736890|76068691|FG001|NOT COMPLETED|Crossover Next 12 Weeks||2||
59949797|NCT02779556|76068699|FG000|STARTED|Baseline||394||
59949798|NCT02779556|76068700|FG001|STARTED|Baseline||362||
59949799|NCT02779556|76068699|FG000|COMPLETED|Baseline||393||
59949800|NCT02779556|76068700|FG001|COMPLETED|Baseline||362||
59949801|NCT02779556|76068699|FG000|NOT COMPLETED|Baseline||1||
59949802|NCT02779556|76068700|FG001|NOT COMPLETED|Baseline||0||
59949803|NCT02779556|76068699|FG000|STARTED|3 Months||393||
59949804|NCT02779556|76068700|FG001|STARTED|3 Months||362||
59949805|NCT02779556|76068699|FG000|COMPLETED|3 Months||326||
59949806|NCT02779556|76068700|FG001|COMPLETED|3 Months||314||
59949807|NCT02779556|76068699|FG000|NOT COMPLETED|3 Months||67||
59949808|NCT02779556|76068700|FG001|NOT COMPLETED|3 Months||48||
59949809|NCT02779556|76068699|FG000|STARTED|6 Month|Those who were not lost to follow-up but missed the visit from the previous period were allowed to continue in the study and complete future interviews (314+19=333 Enhanced Usual Care).|353||
59949810|NCT02779556|76068700|FG001|STARTED|6 Month|Those who were not lost to follow-up but missed the visit from the previous period were allowed to continue in the study and complete future interviews (326+27=353 Intervention).|333||
59949811|NCT02779556|76068699|FG000|COMPLETED|6 Month||320||
59949812|NCT02779556|76068700|FG001|COMPLETED|6 Month||294||
59949813|NCT02779556|76068699|FG000|NOT COMPLETED|6 Month||33||
59949814|NCT02779556|76068700|FG001|NOT COMPLETED|6 Month||39||
59949815|NCT02779556|76068699|FG000|STARTED|6 Month HbA1c|All enrolled participants were eligible for the analysis of clinical values regardless of completion of 3 and 6 month interviews.|394||
59949816|NCT02779556|76068700|FG001|STARTED|6 Month HbA1c|All enrolled participants were eligible for the analysis of clinical values regardless of completion of 3 and 6 month interviews.|362||
59949817|NCT02779556|76068699|FG000|COMPLETED|6 Month HbA1c||325||
59949818|NCT02779556|76068700|FG001|COMPLETED|6 Month HbA1c||312||
59949819|NCT02779556|76068699|FG000|NOT COMPLETED|6 Month HbA1c||69||
59949820|NCT02779556|76068700|FG001|NOT COMPLETED|6 Month HbA1c||50||
59949821|NCT02779556|76068699|FG000|STARTED|12 Month HbA1c|All enrolled participants were eligible for the analysis of clinical values regardless of completion of 3 and 6 month interviews.|394||
59949822|NCT02779556|76068700|FG001|STARTED|12 Month HbA1c|All enrolled participants were eligible for the analysis of clinical values regardless of completion of 3 and 6 month interviews.|362||
59949823|NCT02779556|76068699|FG000|COMPLETED|12 Month HbA1c||256||
59949824|NCT02779556|76068700|FG001|COMPLETED|12 Month HbA1c||260||
59949825|NCT02779556|76068699|FG000|NOT COMPLETED|12 Month HbA1c||138||
59949826|NCT02779556|76068700|FG001|NOT COMPLETED|12 Month HbA1c||102||
59949827|NCT01669798|76068706|FG000|STARTED|Overall Study||32||
59949828|NCT01669798|76068706|FG000|COMPLETED|Overall Study||27||
59949829|NCT01669798|76068706|FG000|NOT COMPLETED|Overall Study||5||
59949830|NCT02334722|76068712|FG000|STARTED|Overall Study||40||
59949831|NCT02334722|76068713|FG001|STARTED|Overall Study||41||
59949832|NCT02334722|76068712|FG000|COMPLETED|Overall Study||33||
59949833|NCT02334722|76068713|FG001|COMPLETED|Overall Study||34||
59949834|NCT02334722|76068712|FG000|NOT COMPLETED|Overall Study||7||
59949835|NCT02334722|76068713|FG001|NOT COMPLETED|Overall Study||7||
59949836|NCT01952288|76068721|FG000|STARTED|Overall Study||3||
59949837|NCT01952288|76068722|FG001|STARTED|Overall Study||2||
59949838|NCT01952288|76068721|FG000|COMPLETED|Overall Study||3||
59949839|NCT01952288|76068722|FG001|COMPLETED|Overall Study||2||
59949840|NCT01952288|76068721|FG000|NOT COMPLETED|Overall Study||0||
59949841|NCT01952288|76068722|FG001|NOT COMPLETED|Overall Study||0||
59518842|NCT01089517|75612716|FG001|NOT COMPLETED|Overall Study||5||
59518843|NCT01089517|75612717|FG002|NOT COMPLETED|Overall Study||5||
59518844|NCT01089595|75612727|FG000|STARTED|Overall Study||2||
59518845|NCT01089595|75612728|FG001|STARTED|Overall Study||3||
59518846|NCT01089595|75612727|FG000|COMPLETED|Overall Study||2||
59518847|NCT01089595|75612728|FG001|COMPLETED|Overall Study||3||
59518848|NCT01089595|75612727|FG000|NOT COMPLETED|Overall Study||0||
59518849|NCT01089595|75612728|FG001|NOT COMPLETED|Overall Study||0||
59949842|NCT00812708|76068728|FG000|STARTED|Overall Study|6 patients withdrew from the study before being taken to the operating room.|72||
59949843|NCT00812708|76068728|FG000|Taken to Surgery for Device Implantation|Overall Study|2 patients could not be implanted because of intraoperative complications.|66||
59949844|NCT00812708|76068728|FG000|COMPLETED|Overall Study||64||
59949845|NCT00812708|76068728|FG000|NOT COMPLETED|Overall Study||8||
59949846|NCT00563576|76068735|FG000|STARTED|Overall Study||35||
59949847|NCT00563576|76068736|FG001|STARTED|Overall Study||36||
59949848|NCT00563576|76068735|FG000|COMPLETED|Overall Study||21||
59949849|NCT00563576|76068736|FG001|COMPLETED|Overall Study||22||
59949850|NCT00563576|76068735|FG000|NOT COMPLETED|Overall Study||14||
59949851|NCT00563576|76068736|FG001|NOT COMPLETED|Overall Study||14||
59949852|NCT03761810|76068744|FG000|STARTED|Overall Study||290||
59949853|NCT03761810|76068745|FG001|STARTED|Overall Study||144||
59949854|NCT03761810|76068744|FG000|Received at Least 1 Dose of Study Drug|Overall Study||281||
59949855|NCT03761810|76068745|FG001|Received at Least 1 Dose of Study Drug|Overall Study||138||
59949856|NCT03761810|76068744|FG000|COMPLETED|Overall Study||242||
59949857|NCT03761810|76068745|FG001|COMPLETED|Overall Study||132||
59518850|NCT01089751|75612738|FG000|STARTED|Overall Study||163||
59518851|NCT01089751|75612739|FG001|STARTED|Overall Study||159||
59518852|NCT01089751|75612738|FG000|COMPLETED|Overall Study||129||
59949858|NCT03761810|76068744|FG000|NOT COMPLETED|Overall Study||48||
59949859|NCT03761810|76068745|FG001|NOT COMPLETED|Overall Study||12||
59949860|NCT04312256|76068751|FG000|STARTED|Overall Study||81||
59949861|NCT04312256|76068751|FG000|COMPLETED|Overall Study||81||
59949862|NCT04312256|76068751|FG000|NOT COMPLETED|Overall Study||0||
59949863|NCT02811159|76068756|FG000|STARTED|Treatment Course 1||20||
59949864|NCT02811159|76068756|FG000|COMPLETED|Treatment Course 1||19||
59949865|NCT02811159|76068756|FG000|NOT COMPLETED|Treatment Course 1||1||
59949866|NCT02811159|76068756|FG000|STARTED|Treatment Course 2|Not all participants who completed the Treatment Course 1 entered the Treatment Course 2.|4||
59949867|NCT02811159|76068756|FG000|COMPLETED|Treatment Course 2||4||
59949868|NCT02811159|76068756|FG000|NOT COMPLETED|Treatment Course 2||0||
59949869|NCT01889186|76068762|FG000|STARTED|Overall Study||107||
59949870|NCT01889186|76068763|FG001|STARTED|Overall Study||51||
59949871|NCT01889186|76068762|FG000|COMPLETED|Overall Study||0||
59949872|NCT01889186|76068763|FG001|COMPLETED|Overall Study||0||
59949873|NCT01889186|76068762|FG000|NOT COMPLETED|Overall Study||107||
59949874|NCT01889186|76068763|FG001|NOT COMPLETED|Overall Study||51||
59949875|NCT01510184|76068773|FG000|STARTED|Overall Study||36||
59949876|NCT01510184|76068774|FG001|STARTED|Overall Study||43||
59949877|NCT01510184|76068773|FG000|COMPLETED|Overall Study||6||
59949878|NCT01510184|76068774|FG001|COMPLETED|Overall Study||8||
59949879|NCT01510184|76068773|FG000|NOT COMPLETED|Overall Study||30||
59949880|NCT01510184|76068774|FG001|NOT COMPLETED|Overall Study||35||
59949881|NCT04349150|76068780|FG000|STARTED|Overall Study||31||
59949882|NCT04349150|76068780|FG000|COMPLETED|Overall Study||27||
59949883|NCT04349150|76068780|FG000|NOT COMPLETED|Overall Study||4||
59949884|NCT04101890|76068784|FG000|STARTED|Routine Diaper Care||5||
59949885|NCT04101890|76068784|FG000|COMPLETED|Routine Diaper Care||5||
59949886|NCT04101890|76068784|FG000|NOT COMPLETED|Routine Diaper Care||0||
59949887|NCT04101890|76068784|FG000|STARTED|Diaper Care With Theraworx||5||
59949888|NCT04101890|76068784|FG000|COMPLETED|Diaper Care With Theraworx||5||
59949889|NCT04101890|76068784|FG000|NOT COMPLETED|Diaper Care With Theraworx||0||
59949890|NCT03993314|76068792|FG000|STARTED|Overall Study||9||
59949891|NCT03993314|76068793|FG001|STARTED|Overall Study||6||
59949892|NCT03993314|76068792|FG000|COMPLETED|Overall Study||9||
60067647|NCT01760733|76182798|FG000|STARTED|Transplanted||217|By Sept 15 2019, 217 patients have received a kidney transplant|
60067648|NCT01760733|76182798|FG000|COMPLETED|Transplanted||0|By Sept 15 2019, 8 patients have died after kidney transplantation|
59949893|NCT03993314|76068793|FG001|COMPLETED|Overall Study||6||
59949894|NCT03993314|76068792|FG000|NOT COMPLETED|Overall Study||0||
59949895|NCT03993314|76068793|FG001|NOT COMPLETED|Overall Study||0||
59949896|NCT02809833|76068799|FG000|STARTED|Overall Study||850||
59949897|NCT02809833|76068799|FG000|COMPLETED|Overall Study||550||
59949898|NCT02809833|76068799|FG000|NOT COMPLETED|Overall Study||300||
59949899|NCT02797262|76068805|FG000|STARTED|Overall Study||65||
59949900|NCT02797262|76068806|FG001|STARTED|Overall Study||65||
59949901|NCT02797262|76068805|FG000|Baseline|Overall Study||54||
59949902|NCT02797262|76068806|FG001|Baseline|Overall Study||58||
59949903|NCT02797262|76068805|FG000|COMPLETED|Overall Study||45||
59949904|NCT02797262|76068806|FG001|COMPLETED|Overall Study||54||
59949905|NCT02797262|76068805|FG000|NOT COMPLETED|Overall Study||20||
59949906|NCT02797262|76068806|FG001|NOT COMPLETED|Overall Study||11||
59949907|NCT02809053|76068814|FG000|STARTED|Overall Study||157||
59949908|NCT02809053|76068815|FG001|STARTED|Overall Study||158||
59949909|NCT02809053|76068814|FG000|Completed Treatment|Overall Study||156|Received at least one infusion of study drug.|
59949910|NCT02809053|76068815|FG001|Completed Treatment|Overall Study||156|Received at least one infusion of study drug.|
59949911|NCT02809053|76068814|FG000|COMPLETED|Overall Study||150|Completed Week 28 (Primary Analysis cut-off)|
59949912|NCT02809053|76068815|FG001|COMPLETED|Overall Study||152|Completed Week 28 (Primary Analysis cut-off)|
59949913|NCT02809053|76068814|FG000|NOT COMPLETED|Overall Study||7||
59949914|NCT02809053|76068815|FG001|NOT COMPLETED|Overall Study||6||
59949915|NCT02808975|76068823|FG000|STARTED|Overall Study||103||
59949916|NCT02808975|76068824|FG001|STARTED|Overall Study||103||
59949917|NCT02808975|76068823|FG000|COMPLETED|Overall Study||81||
59949918|NCT02808975|76068824|FG001|COMPLETED|Overall Study||84||
59949919|NCT02808975|76068823|FG000|NOT COMPLETED|Overall Study||22||
59949920|NCT02808975|76068824|FG001|NOT COMPLETED|Overall Study||19||
59949921|NCT02976038|76068830|FG000|STARTED|Overall Study||28||
59949922|NCT02976038|76068830|FG000|COMPLETED|Overall Study||0||
59949923|NCT02976038|76068830|FG000|NOT COMPLETED|Overall Study||28||
59949924|NCT02124824|76068846|FG000|STARTED|Overall Study||15||
60067649|NCT01760733|76182798|FG000|NOT COMPLETED|Transplanted||217||
60067650|NCT01914757|76182806|FG000|STARTED|Overall Study||425||
59949925|NCT02124824|76068847|FG001|STARTED|Overall Study||15||
59949926|NCT02124824|76068846|FG000|COMPLETED|Overall Study||15||
59949927|NCT02124824|76068847|FG001|COMPLETED|Overall Study||15||
59949928|NCT02124824|76068846|FG000|NOT COMPLETED|Overall Study||0||
59949929|NCT02124824|76068847|FG001|NOT COMPLETED|Overall Study||0||
59949930|NCT02808819|76068855|FG000|STARTED|Overall Study||220||
59949931|NCT02808819|76068856|FG001|STARTED|Overall Study||226||
59949932|NCT02808819|76068855|FG000|Treated|Overall Study||220||
59949933|NCT02808819|76068856|FG001|Treated|Overall Study||226||
59949934|NCT02808819|76068855|FG000|COMPLETED|Overall Study||189||
59949935|NCT02808819|76068856|FG001|COMPLETED|Overall Study||195||
59949936|NCT02808819|76068855|FG000|NOT COMPLETED|Overall Study||31||
59949937|NCT02808819|76068856|FG001|NOT COMPLETED|Overall Study||31||
59949938|NCT02808429|76068866|FG000|STARTED|Overall Study||5||
59949939|NCT02808429|76068867|FG001|STARTED|Overall Study||6||
59949940|NCT02808429|76068868|FG002|STARTED|Overall Study||5||
59949941|NCT02808429|76068866|FG000|COMPLETED|Overall Study||2||
59949942|NCT02808429|76068867|FG001|COMPLETED|Overall Study||5||
59949943|NCT02808429|76068868|FG002|COMPLETED|Overall Study||3||
59949944|NCT02808429|76068866|FG000|NOT COMPLETED|Overall Study||3||
59949945|NCT02808429|76068867|FG001|NOT COMPLETED|Overall Study||1||
59949946|NCT02808429|76068868|FG002|NOT COMPLETED|Overall Study||2||
59949947|NCT01594762|76068878|FG000|STARTED|Overall Study||97||
59949948|NCT01594762|76068879|FG001|STARTED|Overall Study||103||
59949949|NCT01594762|76068878|FG000|COMPLETED|Overall Study||86||
59949950|NCT01594762|76068879|FG001|COMPLETED|Overall Study||93||
59949951|NCT01594762|76068878|FG000|NOT COMPLETED|Overall Study||11||
59949952|NCT01594762|76068879|FG001|NOT COMPLETED|Overall Study||10||
59949953|NCT02615470|76068887|FG000|STARTED|Overall Study||58||30
59949954|NCT02615470|76068888|FG001|STARTED|Overall Study||62||32
59949955|NCT02615470|76068887|FG000|Completed the Baseline Surveys|Overall Study||46||27
59949956|NCT02615470|76068888|FG001|Completed the Baseline Surveys|Overall Study||47||25
59949957|NCT02615470|76068887|FG000|COMPLETED|Overall Study||37|Completed the 6-month survey|22
59949958|NCT02615470|76068888|FG001|COMPLETED|Overall Study||30|Completed the 6-month survey|15
59949959|NCT02615470|76068887|FG000|NOT COMPLETED|Overall Study||21||8
59949960|NCT02615470|76068888|FG001|NOT COMPLETED|Overall Study||32||17
59949961|NCT02806947|76068896|FG000|STARTED|Overall Study||58||
59949962|NCT02806947|76068897|FG001|STARTED|Overall Study||64||
59949963|NCT02806947|76068896|FG000|COMPLETED|Overall Study||53||
59949964|NCT02806947|76068897|FG001|COMPLETED|Overall Study||63||
59949965|NCT02806947|76068896|FG000|NOT COMPLETED|Overall Study||5||
59949966|NCT02806947|76068897|FG001|NOT COMPLETED|Overall Study||1||
59949967|NCT02806713|76068905|FG000|STARTED|Overall Study||46||
59949968|NCT02806713|76068906|FG001|STARTED|Overall Study||46||
59949969|NCT02806713|76068905|FG000|COMPLETED|Overall Study||44||
59949970|NCT02806713|76068906|FG001|COMPLETED|Overall Study||44||
59949971|NCT02806713|76068905|FG000|NOT COMPLETED|Overall Study||2||
59949972|NCT02806713|76068906|FG001|NOT COMPLETED|Overall Study||2||
59949973|NCT02807493|76068914|FG000|STARTED|Overall Study||174||
59949974|NCT02807493|76068915|FG001|STARTED|Overall Study||173||
59949975|NCT02807493|76068914|FG000|COMPLETED|Overall Study||87||
59949976|NCT02807493|76068915|FG001|COMPLETED|Overall Study||121||
59949977|NCT02807493|76068914|FG000|NOT COMPLETED|Overall Study||87||
59949978|NCT02807493|76068915|FG001|NOT COMPLETED|Overall Study||52||
59949979|NCT02807259|76068923|FG000|STARTED|Baseline (3 Months)||405||24
59949980|NCT02807259|76068924|FG001|STARTED|Baseline (3 Months)||404||23
59949981|NCT02807259|76068923|FG000|COMPLETED|Baseline (3 Months)||328||24
59949982|NCT02807259|76068924|FG001|COMPLETED|Baseline (3 Months)||292||23
59949983|NCT02807259|76068923|FG000|NOT COMPLETED|Baseline (3 Months)||77||0
59949984|NCT02807259|76068924|FG001|NOT COMPLETED|Baseline (3 Months)||112||0
59949985|NCT02807259|76068923|FG000|STARTED|Midline (3 Months)||352||24
59949986|NCT02807259|76068924|FG001|STARTED|Midline (3 Months)||223||23
59949987|NCT02807259|76068923|FG000|COMPLETED|Midline (3 Months)||322||24
60067651|NCT01914757|76182807|FG001|STARTED|Overall Study||441||
60067652|NCT01914757|76182808|FG002|STARTED|Overall Study||440||
59949988|NCT02807259|76068924|FG001|COMPLETED|Midline (3 Months)||189||23
59949989|NCT02807259|76068923|FG000|NOT COMPLETED|Midline (3 Months)||30||0
59949990|NCT02807259|76068924|FG001|NOT COMPLETED|Midline (3 Months)||34||0
59949991|NCT02807259|76068923|FG000|STARTED|Endline (3 Months)||323||24
59949992|NCT02807259|76068924|FG001|STARTED|Endline (3 Months)||346||23
59949993|NCT02807259|76068923|FG000|COMPLETED|Endline (3 Months)||288||24
59949994|NCT02807259|76068924|FG001|COMPLETED|Endline (3 Months)||259||23
59949995|NCT02807259|76068923|FG000|NOT COMPLETED|Endline (3 Months)||35||0
59949996|NCT02807259|76068924|FG001|NOT COMPLETED|Endline (3 Months)||87||0
59949997|NCT02802345|76068934|FG000|STARTED|Overall Study||136||
59949998|NCT02802345|76068935|FG001|STARTED|Overall Study||138||
59949999|NCT02802345|76068934|FG000|Treated|Overall Study||136||
59950000|NCT02802345|76068935|FG001|Treated|Overall Study||137||
59950001|NCT02802345|76068934|FG000|COMPLETED|Overall Study||104|Completed Nintedanib treatment|
59950002|NCT02802345|76068935|FG001|COMPLETED|Overall Study||108|Completed Nintedanib treatment|
60067653|NCT01914757|76182806|FG000|COMPLETED|Overall Study||389||
60067654|NCT01914757|76182807|FG001|COMPLETED|Overall Study||390||
60067655|NCT01914757|76182808|FG002|COMPLETED|Overall Study||402||
59518853|NCT01089751|75612739|FG001|COMPLETED|Overall Study||132||
59950003|NCT02802345|76068934|FG000|NOT COMPLETED|Overall Study||32||
59950004|NCT02802345|76068935|FG001|NOT COMPLETED|Overall Study||30||
59950005|NCT02801877|76068945|FG000|STARTED|Overall Study||74||
59950006|NCT02801877|76068946|FG001|STARTED|Overall Study||75||
59950007|NCT02801877|76068947|FG002|STARTED|Overall Study||76||
59950008|NCT02801877|76068948|FG003|STARTED|Overall Study||76||
59950009|NCT02801877|76068945|FG000|COMPLETED|Overall Study||71||
59950010|NCT02801877|76068946|FG001|COMPLETED|Overall Study||74||
59950011|NCT02801877|76068947|FG002|COMPLETED|Overall Study||70||
59950012|NCT02801877|76068948|FG003|COMPLETED|Overall Study||76||
60067656|NCT01914757|76182806|FG000|NOT COMPLETED|Overall Study||36||
59950013|NCT02801877|76068945|FG000|NOT COMPLETED|Overall Study||3||
59950014|NCT02801877|76068946|FG001|NOT COMPLETED|Overall Study||1||
59950015|NCT02801877|76068947|FG002|NOT COMPLETED|Overall Study||6||
59950016|NCT02801877|76068948|FG003|NOT COMPLETED|Overall Study||0||
59950017|NCT02805309|76068961|FG000|STARTED|Overall Study||18||
59950018|NCT02805309|76068962|FG001|STARTED|Overall Study||17||
59950019|NCT02805309|76068963|FG002|STARTED|Overall Study||19||
59950020|NCT02805309|76068961|FG000|COMPLETED|Overall Study||16||
59950021|NCT02805309|76068962|FG001|COMPLETED|Overall Study||13||
59950022|NCT02805309|76068963|FG002|COMPLETED|Overall Study||16||
59950023|NCT02805309|76068961|FG000|NOT COMPLETED|Overall Study||2||
59950024|NCT02805309|76068962|FG001|NOT COMPLETED|Overall Study||4||
59950025|NCT02805309|76068963|FG002|NOT COMPLETED|Overall Study||3||
59950026|NCT02804763|76068975|FG000|STARTED|Double-Blind Period (Week 1 to Week 24)||45||
59950027|NCT02804763|76068976|FG001|STARTED|Double-Blind Period (Week 1 to Week 24)||45||
59950028|NCT02804763|76068977|FG002|STARTED|Double-Blind Period (Week 1 to Week 24)||45||
59950029|NCT02804763|76068978|FG003|STARTED|Double-Blind Period (Week 1 to Week 24)||47||
59950030|NCT02804763|76068975|FG000|Completed Week 24|Double-Blind Period (Week 1 to Week 24)||44||
59950031|NCT02804763|76068976|FG001|Completed Week 24|Double-Blind Period (Week 1 to Week 24)||45||
59950032|NCT02804763|76068977|FG002|Completed Week 24|Double-Blind Period (Week 1 to Week 24)||44||
59950033|NCT02804763|76068978|FG003|Completed Week 24|Double-Blind Period (Week 1 to Week 24)||45||
59950034|NCT02804763|76068975|FG000|Finished Wk24 Began Observational Period|Double-Blind Period (Week 1 to Week 24)||44||
59950035|NCT02804763|76068976|FG001|Finished Wk24 Began Observational Period|Double-Blind Period (Week 1 to Week 24)||44||
59950036|NCT02804763|76068977|FG002|Finished Wk24 Began Observational Period|Double-Blind Period (Week 1 to Week 24)||44||
59950037|NCT02804763|76068978|FG003|Finished Wk24 Began Observational Period|Double-Blind Period (Week 1 to Week 24)||45||
59950038|NCT02804763|76068975|FG000|COMPLETED|Double-Blind Period (Week 1 to Week 24)||44||
59950039|NCT02804763|76068976|FG001|COMPLETED|Double-Blind Period (Week 1 to Week 24)||44||
59950040|NCT02804763|76068977|FG002|COMPLETED|Double-Blind Period (Week 1 to Week 24)||44||
59950041|NCT02804763|76068978|FG003|COMPLETED|Double-Blind Period (Week 1 to Week 24)||45||
59950042|NCT02804763|76068975|FG000|NOT COMPLETED|Double-Blind Period (Week 1 to Week 24)||1||
59950043|NCT02804763|76068976|FG001|NOT COMPLETED|Double-Blind Period (Week 1 to Week 24)||1||
59950044|NCT02804763|76068977|FG002|NOT COMPLETED|Double-Blind Period (Week 1 to Week 24)||1||
59950045|NCT02804763|76068978|FG003|NOT COMPLETED|Double-Blind Period (Week 1 to Week 24)||2||
59950046|NCT02804763|76068975|FG000|STARTED|Observational Period (Wk 24 to Wk 48)||44||
59950047|NCT02804763|76068976|FG001|STARTED|Observational Period (Wk 24 to Wk 48)||44||
59950048|NCT02804763|76068977|FG002|STARTED|Observational Period (Wk 24 to Wk 48)||44||
59950049|NCT02804763|76068978|FG003|STARTED|Observational Period (Wk 24 to Wk 48)||45||
59950050|NCT02804763|76068975|FG000|COMPLETED|Observational Period (Wk 24 to Wk 48)||38||
59950051|NCT02804763|76068976|FG001|COMPLETED|Observational Period (Wk 24 to Wk 48)||43||
59950052|NCT02804763|76068977|FG002|COMPLETED|Observational Period (Wk 24 to Wk 48)||41||
59950053|NCT02804763|76068978|FG003|COMPLETED|Observational Period (Wk 24 to Wk 48)||42||
59950054|NCT02804763|76068975|FG000|NOT COMPLETED|Observational Period (Wk 24 to Wk 48)||6||
59950055|NCT02804763|76068976|FG001|NOT COMPLETED|Observational Period (Wk 24 to Wk 48)||1||
59950056|NCT02804763|76068977|FG002|NOT COMPLETED|Observational Period (Wk 24 to Wk 48)||3||
59950057|NCT02804763|76068978|FG003|NOT COMPLETED|Observational Period (Wk 24 to Wk 48)||3||
59950058|NCT02748057|76068994|FG000|STARTED|Overall Study||114||
59950059|NCT02748057|76068995|FG001|STARTED|Overall Study||21||
59950060|NCT02748057|76068994|FG000|COMPLETED|Overall Study||109||
59950061|NCT02748057|76068995|FG001|COMPLETED|Overall Study||19||
59950062|NCT02748057|76068994|FG000|NOT COMPLETED|Overall Study||5||
59950063|NCT02748057|76068995|FG001|NOT COMPLETED|Overall Study||2||
59950064|NCT02748213|76069003|FG000|STARTED|Overall Study||113||
59950065|NCT02748213|76069004|FG001|STARTED|Overall Study||112||
59950066|NCT02748213|76069003|FG000|Treated|Overall Study||112||
59950067|NCT02748213|76069004|FG001|Treated|Overall Study||110||
59950068|NCT02748213|76069003|FG000|COMPLETED|Overall Study|"*The reason Refused Treatment also includes those who did not cooperate or withdrew consent."|0||
59950069|NCT02748213|76069004|FG001|COMPLETED|Overall Study||0||
59950070|NCT02748213|76069003|FG000|NOT COMPLETED|Overall Study||113||
59950071|NCT02748213|76069004|FG001|NOT COMPLETED|Overall Study||112||
59950072|NCT02613910|76069010|FG000|STARTED|Overall Study||1||
59950073|NCT02613910|76069010|FG000|COMPLETED|Overall Study||0||
59950074|NCT02613910|76069010|FG000|NOT COMPLETED|Overall Study||1||
59950075|NCT02802735|76069017|FG000|STARTED|Overall Study||4||
59950076|NCT02802735|76069018|FG001|STARTED|Overall Study||4||
59950077|NCT02802735|76069019|FG002|STARTED|Overall Study||4||
59950078|NCT02802735|76069020|FG003|STARTED|Overall Study||12||
59950079|NCT02802735|76069021|FG004|STARTED|Overall Study||4||
59950080|NCT02802735|76069017|FG000|COMPLETED|Overall Study||4||
59950081|NCT02802735|76069018|FG001|COMPLETED|Overall Study||3||
59950082|NCT02802735|76069019|FG002|COMPLETED|Overall Study||4||
59950083|NCT02802735|76069020|FG003|COMPLETED|Overall Study||12||
59950084|NCT02802735|76069021|FG004|COMPLETED|Overall Study||4||
59950085|NCT02802735|76069017|FG000|NOT COMPLETED|Overall Study||0||
59950086|NCT02802735|76069018|FG001|NOT COMPLETED|Overall Study||1||
59950087|NCT02802735|76069019|FG002|NOT COMPLETED|Overall Study||0||
59950088|NCT02802735|76069020|FG003|NOT COMPLETED|Overall Study||0||
59950089|NCT02802735|76069021|FG004|NOT COMPLETED|Overall Study||0||
59950090|NCT02273362|76069039|FG000|STARTED|Overall Study||5||
59950091|NCT02273362|76069040|FG001|STARTED|Overall Study||6||
59518854|NCT01089751|75612738|FG000|NOT COMPLETED|Overall Study||34||
59518855|NCT01089751|75612739|FG001|NOT COMPLETED|Overall Study||27||
59518856|NCT01090921|75612745|FG000|STARTED|Overall Study||50||
59950092|NCT02273362|76069041|FG002|STARTED|Overall Study||14||
59950093|NCT02273362|76069039|FG000|COMPLETED|Overall Study||5||
59950094|NCT02273362|76069040|FG001|COMPLETED|Overall Study||6||
59950095|NCT02273362|76069041|FG002|COMPLETED|Overall Study||14||
59950096|NCT02273362|76069039|FG000|NOT COMPLETED|Overall Study||0||
59950097|NCT02273362|76069040|FG001|NOT COMPLETED|Overall Study||0||
59950098|NCT02273362|76069041|FG002|NOT COMPLETED|Overall Study||0||
59950099|NCT02799381|76069051|FG000|STARTED|Overall Study||33||
59950100|NCT02799381|76069052|FG001|STARTED|Overall Study||28||
59950101|NCT02799381|76069051|FG000|COMPLETED|Overall Study||29||
59950102|NCT02799381|76069052|FG001|COMPLETED|Overall Study||25||
59950103|NCT02799381|76069051|FG000|NOT COMPLETED|Overall Study||4||
59950104|NCT02799381|76069052|FG001|NOT COMPLETED|Overall Study||3||
59950105|NCT01333059|76069060|FG000|STARTED|Overall Study||14||
59950106|NCT01333059|76069061|FG001|STARTED|Overall Study||11||
59950107|NCT01333059|76069060|FG000|COMPLETED|Overall Study||8||
59950108|NCT01333059|76069061|FG001|COMPLETED|Overall Study||8||
59950109|NCT01333059|76069060|FG000|NOT COMPLETED|Overall Study||6||
59950110|NCT01333059|76069061|FG001|NOT COMPLETED|Overall Study||3||
59950111|NCT01370733|76069071|FG000|STARTED|Overall Study||103||
59950112|NCT01370733|76069072|FG001|STARTED|Overall Study||99||
59950113|NCT01370733|76069071|FG000|COMPLETED|Overall Study||86||
59518857|NCT01090921|75612745|FG000|COMPLETED|Overall Study||23||
59950114|NCT01370733|76069072|FG001|COMPLETED|Overall Study||77||
59950115|NCT01370733|76069071|FG000|NOT COMPLETED|Overall Study||17||
59950116|NCT01370733|76069072|FG001|NOT COMPLETED|Overall Study||22||
59950117|NCT02613364|76069081|FG000|STARTED|Overall Study||251||
59950118|NCT02613364|76069082|FG001|STARTED|Overall Study||238||
59950119|NCT02613364|76069083|FG002|STARTED|Overall Study||251||
59950120|NCT02613364|76069081|FG000|COMPLETED|Overall Study||185||
59950121|NCT02613364|76069082|FG001|COMPLETED|Overall Study||148||
59950122|NCT02613364|76069083|FG002|COMPLETED|Overall Study||175||
59950123|NCT02613364|76069081|FG000|NOT COMPLETED|Overall Study||66||
59950124|NCT02613364|76069082|FG001|NOT COMPLETED|Overall Study||90||
59950125|NCT02613364|76069083|FG002|NOT COMPLETED|Overall Study||76||
59950126|NCT01370655|76069103|FG000|STARTED|Period 1||7||
59950127|NCT01370655|76069104|FG001|STARTED|Period 1||7||
59950128|NCT01370655|76069105|FG002|STARTED|Period 1||3||
59950129|NCT01370655|76069106|FG003|STARTED|Period 1||3||
59950130|NCT01370655|76069107|FG004|STARTED|Period 1||3||
59950131|NCT01370655|76069108|FG005|STARTED|Period 1||4||
59950132|NCT01370655|76069109|FG006|STARTED|Period 1||4||
59950133|NCT01370655|76069110|FG007|STARTED|Period 1||4||
60067657|NCT01914757|76182807|FG001|NOT COMPLETED|Overall Study||51||
60067658|NCT01914757|76182808|FG002|NOT COMPLETED|Overall Study||38||
60067659|NCT02003573|76182819|FG000|STARTED|Overall Study|Started are treated patients|3||
60067660|NCT02003573|76182820|FG001|STARTED|Overall Study|Started are treated patients|4||
60067661|NCT02003573|76182821|FG002|STARTED|Overall Study|Started are treated patients|6||
59518858|NCT01090921|75612745|FG000|NOT COMPLETED|Overall Study||27||
59518859|NCT03537274|75612753|FG000|STARTED|Overall Study||315||
59518860|NCT03537274|75612754|FG001|STARTED|Overall Study||298||
59518861|NCT03537274|75612755|FG002|STARTED|Overall Study||304||
59518862|NCT03537274|75612756|FG003|STARTED|Overall Study||307||
59518863|NCT03537274|75612753|FG000|Treated|Overall Study||315||
59518864|NCT03537274|75612754|FG001|Treated|Overall Study||297||
59518865|NCT03537274|75612755|FG002|Treated|Overall Study||304||
59518866|NCT03537274|75612756|FG003|Treated|Overall Study||303||
59518867|NCT03537274|75612753|FG000|COMPLETED|Overall Study||255||
59518868|NCT03537274|75612754|FG001|COMPLETED|Overall Study||229||
59950134|NCT01370655|76069111|FG008|STARTED|Period 1||3||
59950135|NCT01370655|76069112|FG009|STARTED|Period 1||2||
59950136|NCT01370655|76069113|FG010|STARTED|Period 1||3||
59518869|NCT03537274|75612755|FG002|COMPLETED|Overall Study||228||
59518870|NCT03537274|75612756|FG003|COMPLETED|Overall Study||231||
59950137|NCT01370655|76069114|FG011|STARTED|Period 1||3||
59950138|NCT01370655|76069103|FG000|COMPLETED|Period 1||5||
59950139|NCT01370655|76069104|FG001|COMPLETED|Period 1||7||
59950140|NCT01370655|76069105|FG002|COMPLETED|Period 1||3||
59950141|NCT01370655|76069106|FG003|COMPLETED|Period 1||3||
59950142|NCT01370655|76069107|FG004|COMPLETED|Period 1||3||
59950143|NCT01370655|76069108|FG005|COMPLETED|Period 1||4||
59950144|NCT01370655|76069109|FG006|COMPLETED|Period 1||3||
59950145|NCT01370655|76069110|FG007|COMPLETED|Period 1||4||
59950146|NCT01370655|76069111|FG008|COMPLETED|Period 1||3||
59950147|NCT01370655|76069112|FG009|COMPLETED|Period 1||2||
59950148|NCT01370655|76069113|FG010|COMPLETED|Period 1||3||
59950149|NCT01370655|76069114|FG011|COMPLETED|Period 1||3||
59950150|NCT01370655|76069103|FG000|NOT COMPLETED|Period 1||2||
59950151|NCT01370655|76069104|FG001|NOT COMPLETED|Period 1||0||
59950152|NCT01370655|76069105|FG002|NOT COMPLETED|Period 1||0||
59950153|NCT01370655|76069106|FG003|NOT COMPLETED|Period 1||0||
59950154|NCT01370655|76069107|FG004|NOT COMPLETED|Period 1||0||
59950155|NCT01370655|76069108|FG005|NOT COMPLETED|Period 1||0||
59950156|NCT01370655|76069109|FG006|NOT COMPLETED|Period 1||1||
59950157|NCT01370655|76069110|FG007|NOT COMPLETED|Period 1||0||
59950158|NCT01370655|76069111|FG008|NOT COMPLETED|Period 1||0||
59950159|NCT01370655|76069112|FG009|NOT COMPLETED|Period 1||0||
59950160|NCT01370655|76069113|FG010|NOT COMPLETED|Period 1||0||
59950161|NCT01370655|76069114|FG011|NOT COMPLETED|Period 1||0||
59950162|NCT01370655|76069103|FG000|STARTED|Period 2||5||
59950163|NCT01370655|76069104|FG001|STARTED|Period 2||7||
59950164|NCT01370655|76069105|FG002|STARTED|Period 2||3||
59950165|NCT01370655|76069106|FG003|STARTED|Period 2||3||
59950166|NCT01370655|76069107|FG004|STARTED|Period 2||3||
59950167|NCT01370655|76069108|FG005|STARTED|Period 2||4||
59950168|NCT01370655|76069109|FG006|STARTED|Period 2||3||
59950169|NCT01370655|76069110|FG007|STARTED|Period 2||4||
59950170|NCT01370655|76069111|FG008|STARTED|Period 2||3||
59950171|NCT01370655|76069112|FG009|STARTED|Period 2||2||
59950172|NCT01370655|76069113|FG010|STARTED|Period 2||3||
59950173|NCT01370655|76069114|FG011|STARTED|Period 2||3||
59950174|NCT01370655|76069103|FG000|COMPLETED|Period 2||5||
59950175|NCT01370655|76069104|FG001|COMPLETED|Period 2||7||
59950176|NCT01370655|76069105|FG002|COMPLETED|Period 2||1||
59950177|NCT01370655|76069106|FG003|COMPLETED|Period 2||3||
59950178|NCT01370655|76069107|FG004|COMPLETED|Period 2||2||
59950179|NCT01370655|76069108|FG005|COMPLETED|Period 2||4||
59950180|NCT01370655|76069109|FG006|COMPLETED|Period 2||2||
59950181|NCT01370655|76069110|FG007|COMPLETED|Period 2||3||
59950182|NCT01370655|76069111|FG008|COMPLETED|Period 2||1||
59950183|NCT01370655|76069112|FG009|COMPLETED|Period 2||2||
59950184|NCT01370655|76069113|FG010|COMPLETED|Period 2||2||
59950185|NCT01370655|76069114|FG011|COMPLETED|Period 2||3||
59950186|NCT01370655|76069103|FG000|NOT COMPLETED|Period 2||0||
59950187|NCT01370655|76069104|FG001|NOT COMPLETED|Period 2||0||
59950188|NCT01370655|76069105|FG002|NOT COMPLETED|Period 2||2||
59950189|NCT01370655|76069106|FG003|NOT COMPLETED|Period 2||0||
59950190|NCT01370655|76069107|FG004|NOT COMPLETED|Period 2||1||
59950191|NCT01370655|76069108|FG005|NOT COMPLETED|Period 2||0||
59950192|NCT01370655|76069109|FG006|NOT COMPLETED|Period 2||1||
59950193|NCT01370655|76069110|FG007|NOT COMPLETED|Period 2||1||
59950194|NCT01370655|76069111|FG008|NOT COMPLETED|Period 2||2||
59950195|NCT01370655|76069112|FG009|NOT COMPLETED|Period 2||0||
59950196|NCT01370655|76069113|FG010|NOT COMPLETED|Period 2||1||
59950197|NCT01370655|76069114|FG011|NOT COMPLETED|Period 2||0||
59950198|NCT02612194|76069127|FG000|STARTED|Overall Study||6||
59950199|NCT02612194|76069128|FG001|STARTED|Overall Study||0||
59950200|NCT02612194|76069129|FG002|STARTED|Overall Study||2||
59950201|NCT02612194|76069127|FG000|COMPLETED|Overall Study||0||
59950202|NCT02612194|76069128|FG001|COMPLETED|Overall Study||0||
59950203|NCT02612194|76069129|FG002|COMPLETED|Overall Study||0||
59950204|NCT02612194|76069127|FG000|NOT COMPLETED|Overall Study||6||
59950205|NCT02612194|76069128|FG001|NOT COMPLETED|Overall Study||0||
59950206|NCT02612194|76069129|FG002|NOT COMPLETED|Overall Study||2||
59950207|NCT02798211|76069139|FG000|STARTED|Period 1||103|Screened patients=349 Screen passed patient=271 Screened failure=78 Randomized=103|
59950208|NCT02798211|76069140|FG001|STARTED|Period 1||103|Screened patients=349 Screen passed patient=271 Screened failure=78 Randomized=103|
59950209|NCT02798211|76069141|FG002|STARTED|Period 1||52|Screened patients=349 Screen passed patient=271 Screened failure=78 Randomized=103|
59950210|NCT02798211|76069142|FG003|STARTED|Period 1||0|Screened patients=349 Screen passed patient=271 Screened failure=78 Randomized=103|
59950211|NCT02798211|76069143|FG004|STARTED|Period 1||0|Screened patients=349 Screen passed patient=271 Screened failure=78 Randomized=103|
59950212|NCT02798211|76069144|FG005|STARTED|Period 1||0|Screened patients=349 Screen passed patient=271 Screened failure=78 Randomized=103|
59950213|NCT02798211|76069139|FG000|COMPLETED|Period 1||97||
59950214|NCT02798211|76069140|FG001|COMPLETED|Period 1||93||
59950215|NCT02798211|76069141|FG002|COMPLETED|Period 1||46||
59950216|NCT02798211|76069142|FG003|COMPLETED|Period 1||0||
59950217|NCT02798211|76069143|FG004|COMPLETED|Period 1||0||
59950218|NCT02798211|76069144|FG005|COMPLETED|Period 1||0||
59950219|NCT02798211|76069139|FG000|NOT COMPLETED|Period 1||6||
59950220|NCT02798211|76069140|FG001|NOT COMPLETED|Period 1||10||
59950221|NCT02798211|76069141|FG002|NOT COMPLETED|Period 1||6||
59950222|NCT02798211|76069142|FG003|NOT COMPLETED|Period 1||0||
59950223|NCT02798211|76069143|FG004|NOT COMPLETED|Period 1||0||
59950224|NCT02798211|76069144|FG005|NOT COMPLETED|Period 1||0||
59950225|NCT02798211|76069139|FG000|STARTED|Period 2||97|Completed treatment period 1 and continued to treatment period 2|
59950226|NCT02798211|76069140|FG001|STARTED|Period 2||0|Completed treatment period 1 and continued to treatment period 2|
59950227|NCT02798211|76069141|FG002|STARTED|Period 2||0|Completed treatment period 1 and continued to treatment period 2|
59950228|NCT02798211|76069142|FG003|STARTED|Period 2||50|Completed treatment period 1 and continued to treatment period 2|
59950229|NCT02798211|76069143|FG004|STARTED|Period 2||42|Completed treatment period 1 and continued to treatment period 2|
59950230|NCT02798211|76069144|FG005|STARTED|Period 2||46|Completed treatment period 1 and continued to treatment period 2|
59950231|NCT02798211|76069139|FG000|COMPLETED|Period 2||83|Completed treatment period 2|
59950232|NCT02798211|76069140|FG001|COMPLETED|Period 2||0|Completed treatment period 2|
59950233|NCT02798211|76069141|FG002|COMPLETED|Period 2||0|Completed treatment period 2|
59950234|NCT02798211|76069142|FG003|COMPLETED|Period 2||43|Completed treatment period 2|
59950235|NCT02798211|76069143|FG004|COMPLETED|Period 2||34|Completed treatment period 2|
59950236|NCT02798211|76069144|FG005|COMPLETED|Period 2||40|Completed treatment period 2|
59950237|NCT02798211|76069139|FG000|NOT COMPLETED|Period 2||14||
59950238|NCT02798211|76069140|FG001|NOT COMPLETED|Period 2||0||
59950239|NCT02798211|76069141|FG002|NOT COMPLETED|Period 2||0||
59950240|NCT02798211|76069142|FG003|NOT COMPLETED|Period 2||7||
59950241|NCT02798211|76069143|FG004|NOT COMPLETED|Period 2||8||
59950242|NCT02798211|76069144|FG005|NOT COMPLETED|Period 2||6||
59950243|NCT02799069|76069159|FG000|STARTED|Overall Study||76|randomized|
59950244|NCT02799069|76069160|FG001|STARTED|Overall Study||248|randomized|
59950245|NCT02799069|76069161|FG002|STARTED|Overall Study||247|randomized|
59950246|NCT02799069|76069159|FG000|ITT/Safety|Overall Study||76||
59950247|NCT02799069|76069160|FG001|ITT/Safety|Overall Study||248||
59950248|NCT02799069|76069161|FG002|ITT/Safety|Overall Study|1 subject received medication without Illumination and thus was excluded from ITT/safety population|246||
59950249|NCT02799069|76069159|FG000|COMPLETED|Overall Study||68||
59950250|NCT02799069|76069160|FG001|COMPLETED|Overall Study||241||
59950251|NCT02799069|76069161|FG002|COMPLETED|Overall Study||240||
59950252|NCT02799069|76069159|FG000|NOT COMPLETED|Overall Study||8||
59950253|NCT02799069|76069160|FG001|NOT COMPLETED|Overall Study||7||
59950254|NCT02799069|76069161|FG002|NOT COMPLETED|Overall Study||7||
59950255|NCT01669174|76069171|FG000|STARTED|Overall Study||33||
59950256|NCT01669174|76069172|FG001|STARTED|Overall Study||34||
59950257|NCT01669174|76069171|FG000|COMPLETED|Overall Study||27||
59950258|NCT01669174|76069172|FG001|COMPLETED|Overall Study||28||
59950259|NCT01669174|76069171|FG000|NOT COMPLETED|Overall Study||6||
59950260|NCT01669174|76069172|FG001|NOT COMPLETED|Overall Study||6||
59950261|NCT02798835|76069181|FG000|STARTED|Overall Study||60||
59950262|NCT02798835|76069182|FG001|STARTED|Overall Study||60||
59950263|NCT02798835|76069183|FG002|STARTED|Overall Study||60||
59950264|NCT02798835|76069181|FG000|COMPLETED|Overall Study||60||
59950265|NCT02798835|76069182|FG001|COMPLETED|Overall Study||60||
59950266|NCT02798835|76069183|FG002|COMPLETED|Overall Study||57||
59950267|NCT02798835|76069181|FG000|NOT COMPLETED|Overall Study||0||
59950268|NCT02798835|76069182|FG001|NOT COMPLETED|Overall Study||0||
59950269|NCT02798835|76069183|FG002|NOT COMPLETED|Overall Study||3||
59950270|NCT02611882|76069194|FG000|STARTED|Overall Study||75||
59950271|NCT02611882|76069195|FG001|STARTED|Overall Study||150||
59950272|NCT02611882|76069196|FG002|STARTED|Overall Study||0||
59950273|NCT02611882|76069194|FG000|Completed Surgery Per Protocol|Overall Study||42|Applies only to participants in the preRP group|
59950274|NCT02611882|76069195|FG001|Completed Surgery Per Protocol|Overall Study||0|Applies only to participants in the preRP group|
59950275|NCT02611882|76069196|FG002|Completed Surgery Per Protocol|Overall Study||0|Applies only to participants in the preRP group|
59950276|NCT02611882|76069194|FG000|COMPLETED|Overall Study||42||
59950277|NCT02611882|76069195|FG001|COMPLETED|Overall Study||150||
59950278|NCT02611882|76069196|FG002|COMPLETED|Overall Study||0||
59950279|NCT02611882|76069194|FG000|NOT COMPLETED|Overall Study||33||
59950280|NCT02611882|76069195|FG001|NOT COMPLETED|Overall Study||0||
59950281|NCT02611882|76069196|FG002|NOT COMPLETED|Overall Study||0||
59950282|NCT02796963|76069207|FG000|STARTED|Overall Study||383||2
59950283|NCT02796963|76069208|FG001|STARTED|Overall Study||328||2
59950284|NCT02796963|76069209|FG002|STARTED|Overall Study||316||2
59950285|NCT02796963|76069210|FG003|STARTED|Overall Study||354||2
59950286|NCT02796963|76069207|FG000|First Follow up|Overall Study||293||2
59950287|NCT02796963|76069208|FG001|First Follow up|Overall Study||279||2
59950288|NCT02796963|76069209|FG002|First Follow up|Overall Study||257||2
59950289|NCT02796963|76069210|FG003|First Follow up|Overall Study||291||2
59950290|NCT02796963|76069207|FG000|Second Follow up|Overall Study||280||2
59950291|NCT02796963|76069208|FG001|Second Follow up|Overall Study||260||2
59950292|NCT02796963|76069209|FG002|Second Follow up|Overall Study||255||2
59950293|NCT02796963|76069210|FG003|Second Follow up|Overall Study||293||2
59950294|NCT02796963|76069207|FG000|Third Follow up|Overall Study||276||2
59950295|NCT02796963|76069208|FG001|Third Follow up|Overall Study||237||2
59950296|NCT02796963|76069209|FG002|Third Follow up|Overall Study||245||2
59950297|NCT02796963|76069210|FG003|Third Follow up|Overall Study||286||2
59950298|NCT02796963|76069207|FG000|Fourth Follow up|Overall Study||275||2
59950299|NCT02796963|76069208|FG001|Fourth Follow up|Overall Study||233||2
59950300|NCT02796963|76069209|FG002|Fourth Follow up|Overall Study||236||2
59950301|NCT02796963|76069210|FG003|Fourth Follow up|Overall Study||263||2
59950302|NCT02796963|76069207|FG000|HIV Sero Converted|Overall Study||19||2
59950303|NCT02796963|76069208|FG001|HIV Sero Converted|Overall Study||19||2
59950304|NCT02796963|76069209|FG002|HIV Sero Converted|Overall Study||11||2
59950305|NCT02796963|76069210|FG003|HIV Sero Converted|Overall Study||19||2
59950306|NCT02796963|76069207|FG000|COMPLETED|Overall Study||294||2
59950307|NCT02796963|76069208|FG001|COMPLETED|Overall Study||252||2
59950308|NCT02796963|76069209|FG002|COMPLETED|Overall Study||247||2
59950309|NCT02796963|76069210|FG003|COMPLETED|Overall Study||282||2
59950310|NCT02796963|76069207|FG000|NOT COMPLETED|Overall Study||89||0
59950311|NCT02796963|76069208|FG001|NOT COMPLETED|Overall Study||76||0
59950312|NCT02796963|76069209|FG002|NOT COMPLETED|Overall Study||69||0
59950313|NCT02796963|76069210|FG003|NOT COMPLETED|Overall Study||72||0
59950314|NCT02796651|76069220|FG000|STARTED|Overall Study||132||
59950315|NCT02796651|76069220|FG000|Formoterol Fumarate (FF) 6 μg|Overall Study||107|Participants had 1 puff each from 2 identical Pressair DPI (FF 6μg & placebo) in morning & evening|
59950316|NCT02796651|76069220|FG000|Formoterol Fumarate (FF) 12 μg|Overall Study||121|Participants had 1 puff each from 2 identical Pressair DPI (FF 12μg & placebo) in morning & evening|
59950317|NCT02796651|76069220|FG000|Formoterol Fumarate (FF) 24 μg|Overall Study||105|Participants had 1 puff each from 2 identical Pressair DPI (FF 24μg & placebo) in morning & evening|
59950318|NCT02796651|76069220|FG000|Perforomist 20 μg|Overall Study||118|Participants took 1 vial of Perforomist 20μg oral nebulization solution in morning & evening|
59950319|NCT02796651|76069220|FG000|Perforomist 40 μg|Overall Study||108|Participants took 1 dose of 2 vials of Perforomist 20μg oral nebulization solution on Day 1 morning|
59950320|NCT02796651|76069220|FG000|Placebo (Lactose Monohydrate)|Overall Study||38|Participants had 1 puff from Pressair DPI (FF 6/12/24 μg matching placebo) in morning & evening|
59950321|NCT02796651|76069220|FG000|COMPLETED|Overall Study||106||
59950322|NCT02796651|76069220|FG000|NOT COMPLETED|Overall Study||26||
59950323|NCT02613208|76069235|FG000|STARTED|Overall Study||111||
59950324|NCT02613208|76069235|FG000|COMPLETED|Overall Study||64||
59950325|NCT02613208|76069235|FG000|NOT COMPLETED|Overall Study||47||
59950326|NCT01668784|76069241|FG000|STARTED|Randomized (Pre-treatment)||410||
59950327|NCT01668784|76069242|FG001|STARTED|Randomized (Pre-treatment)||411||
59950328|NCT01668784|76069241|FG000|COMPLETED|Randomized (Pre-treatment)||406||
59950329|NCT01668784|76069242|FG001|COMPLETED|Randomized (Pre-treatment)||397||
59950330|NCT01668784|76069241|FG000|NOT COMPLETED|Randomized (Pre-treatment)||4||
59950331|NCT01668784|76069242|FG001|NOT COMPLETED|Randomized (Pre-treatment)||14||
59950332|NCT01668784|76069241|FG000|STARTED|Treatment Period||406||
59950333|NCT01668784|76069242|FG001|STARTED|Treatment Period||397||
59950334|NCT01668784|76069241|FG000|COMPLETED|Treatment Period||0||
59950335|NCT01668784|76069242|FG001|COMPLETED|Treatment Period||0||
59950336|NCT01668784|76069241|FG000|NOT COMPLETED|Treatment Period||406||
59950337|NCT01668784|76069242|FG001|NOT COMPLETED|Treatment Period||397||
59950338|NCT02750514|76069253|FG000|STARTED|Track 1||40||
59950339|NCT02750514|76069254|FG001|STARTED|Track 1||4||
59950340|NCT02750514|76069255|FG002|STARTED|Track 1||0||
59950341|NCT02750514|76069256|FG003|STARTED|Track 1||3||
59950342|NCT02750514|76069257|FG004|STARTED|Track 1||0||
59950343|NCT02750514|76069253|FG000|COMPLETED|Track 1|3 participants were re-randomized to track 3 (2 part.) or track 5 (1 part.)|13||
59950344|NCT02750514|76069254|FG001|COMPLETED|Track 1||2||
59950345|NCT02750514|76069255|FG002|COMPLETED|Track 1||0||
59950346|NCT02750514|76069256|FG003|COMPLETED|Track 1||1||
59950347|NCT02750514|76069257|FG004|COMPLETED|Track 1||0||
59950348|NCT02750514|76069253|FG000|NOT COMPLETED|Track 1||27||
59950349|NCT02750514|76069254|FG001|NOT COMPLETED|Track 1||2||
59950350|NCT02750514|76069255|FG002|NOT COMPLETED|Track 1||0||
59950351|NCT02750514|76069256|FG003|NOT COMPLETED|Track 1||2||
59950352|NCT02750514|76069257|FG004|NOT COMPLETED|Track 1||0||
59950353|NCT02750514|76069253|FG000|STARTED|Track 2||9||
59950354|NCT02750514|76069254|FG001|STARTED|Track 2||8||
59950355|NCT02750514|76069255|FG002|STARTED|Track 2||2||
59950356|NCT02750514|76069256|FG003|STARTED|Track 2||12||
59950357|NCT02750514|76069257|FG004|STARTED|Track 2||0||
59950358|NCT02750514|76069253|FG000|COMPLETED|Track 2|2 participants were re-randomized to track 3 (1 part.) or track 5 (1 part.)|3||
59950359|NCT02750514|76069254|FG001|COMPLETED|Track 2||0||
59950360|NCT02750514|76069255|FG002|COMPLETED|Track 2||0||
59950361|NCT02750514|76069256|FG003|COMPLETED|Track 2|1 participant was re-randomized to track 5|5||
59950362|NCT02750514|76069257|FG004|COMPLETED|Track 2||0||
59950363|NCT02750514|76069253|FG000|NOT COMPLETED|Track 2||6||
59950364|NCT02750514|76069254|FG001|NOT COMPLETED|Track 2||8||
59950365|NCT02750514|76069255|FG002|NOT COMPLETED|Track 2||2||
59950366|NCT02750514|76069256|FG003|NOT COMPLETED|Track 2||7||
59950367|NCT02750514|76069257|FG004|NOT COMPLETED|Track 2||0||
59950368|NCT02750514|76069253|FG000|STARTED|Track 3||0||
59950369|NCT02750514|76069254|FG001|STARTED|Track 3|2 participants had prior treatment in track 1 (1 part.) or track 2 (1 part.)|41||
59950370|NCT02750514|76069255|FG002|STARTED|Track 3|1 participant had prior treatment in track 3|16||
59950371|NCT02750514|76069256|FG003|STARTED|Track 3|5 participants had prior treatment in track 1 (1 part.) or track 3 (4 part.)|18||
59950372|NCT02750514|76069257|FG004|STARTED|Track 3||0||
59950373|NCT02750514|76069253|FG000|COMPLETED|Track 3||0||
59950374|NCT02750514|76069254|FG001|COMPLETED|Track 3|6 participants were re-randomized to track 3 (5 part.) or to track 5 (1 part.)|5||
59950375|NCT02750514|76069255|FG002|COMPLETED|Track 3||1||
59950376|NCT02750514|76069256|FG003|COMPLETED|Track 3|1 participant was re-randomized to track 5|2||
59950377|NCT02750514|76069257|FG004|COMPLETED|Track 3||0||
59950378|NCT02750514|76069253|FG000|NOT COMPLETED|Track 3||0||
59950379|NCT02750514|76069254|FG001|NOT COMPLETED|Track 3||36||
59950380|NCT02750514|76069255|FG002|NOT COMPLETED|Track 3||15||
59950381|NCT02750514|76069256|FG003|NOT COMPLETED|Track 3||16||
59950382|NCT02750514|76069257|FG004|NOT COMPLETED|Track 3||0||
59950383|NCT02750514|76069253|FG000|STARTED|Track 4||0||
59950384|NCT02750514|76069254|FG001|STARTED|Track 4||53||
59950385|NCT02750514|76069255|FG002|STARTED|Track 4||0||
59950386|NCT02750514|76069256|FG003|STARTED|Track 4||60||
59950387|NCT02750514|76069257|FG004|STARTED|Track 4||0||
59950388|NCT02750514|76069253|FG000|COMPLETED|Track 4||0||
59950389|NCT02750514|76069254|FG001|COMPLETED|Track 4|1 participant was re-randomized to track 5|2||
59950390|NCT02750514|76069255|FG002|COMPLETED|Track 4||0||
59950391|NCT02750514|76069256|FG003|COMPLETED|Track 4||18||
59950392|NCT02750514|76069257|FG004|COMPLETED|Track 4||0||
59950393|NCT02750514|76069253|FG000|NOT COMPLETED|Track 4||0||
59950394|NCT02750514|76069254|FG001|NOT COMPLETED|Track 4||51||
59950395|NCT02750514|76069255|FG002|NOT COMPLETED|Track 4||0||
59950396|NCT02750514|76069256|FG003|NOT COMPLETED|Track 4||42||
59950397|NCT02750514|76069257|FG004|NOT COMPLETED|Track 4||0||
59950398|NCT02750514|76069253|FG000|STARTED|Track 5||0||
59950399|NCT02750514|76069254|FG001|STARTED|Track 5||0||
59950400|NCT02750514|76069255|FG002|STARTED|Track 5||0||
59950401|NCT02750514|76069256|FG003|STARTED|Track 5||0||
59950402|NCT02750514|76069257|FG004|STARTED|Track 5|6 participants had prior treatment in track 1 (1 part.), 2 (2 part.), 3 (2 part.) or 4 (1 part.)|43||
59950403|NCT02750514|76069253|FG000|COMPLETED|Track 5||0||
59950404|NCT02750514|76069254|FG001|COMPLETED|Track 5||0||
59950405|NCT02750514|76069255|FG002|COMPLETED|Track 5||0||
59950406|NCT02750514|76069256|FG003|COMPLETED|Track 5||0||
59950407|NCT02750514|76069257|FG004|COMPLETED|Track 5||0||
59950408|NCT02750514|76069253|FG000|NOT COMPLETED|Track 5||0||
59950409|NCT02750514|76069254|FG001|NOT COMPLETED|Track 5||0||
59950410|NCT02750514|76069255|FG002|NOT COMPLETED|Track 5||0||
59950411|NCT02750514|76069256|FG003|NOT COMPLETED|Track 5||0||
59950412|NCT02750514|76069257|FG004|NOT COMPLETED|Track 5||43||
59950413|NCT03340974|76069281|FG000|STARTED|Active Protocol Treatment||18||
59950414|NCT03340974|76069282|FG001|STARTED|Active Protocol Treatment||6||
59950415|NCT03340974|76069283|FG002|STARTED|Active Protocol Treatment||6||
59950416|NCT03340974|76069284|FG003|STARTED|Active Protocol Treatment||12||
59950417|NCT03340974|76069281|FG000|COMPLETED|Active Protocol Treatment||18|Completed 12 month Follow up Period|
59950418|NCT03340974|76069282|FG001|COMPLETED|Active Protocol Treatment||6|Completed 12 month Follow up Period|
59950419|NCT03340974|76069283|FG002|COMPLETED|Active Protocol Treatment||6|Completed 12 month Follow up Period|
59950420|NCT03340974|76069284|FG003|COMPLETED|Active Protocol Treatment||12|Completed 12 month Follow up Period|
59950421|NCT03340974|76069281|FG000|NOT COMPLETED|Active Protocol Treatment||0||
59950422|NCT03340974|76069282|FG001|NOT COMPLETED|Active Protocol Treatment||0||
59950423|NCT03340974|76069283|FG002|NOT COMPLETED|Active Protocol Treatment||0||
59950424|NCT03340974|76069284|FG003|NOT COMPLETED|Active Protocol Treatment||0||
59950425|NCT03340974|76069281|FG000|STARTED|Completion of Study -Long Term Follow up||18||
59950426|NCT03340974|76069282|FG001|STARTED|Completion of Study -Long Term Follow up||6||
59950427|NCT03340974|76069283|FG002|STARTED|Completion of Study -Long Term Follow up||6||
59950428|NCT03340974|76069284|FG003|STARTED|Completion of Study -Long Term Follow up||12||
59950429|NCT03340974|76069281|FG000|COMPLETED|Completion of Study -Long Term Follow up||0||
59950430|NCT03340974|76069282|FG001|COMPLETED|Completion of Study -Long Term Follow up||0||
59950431|NCT03340974|76069283|FG002|COMPLETED|Completion of Study -Long Term Follow up||0||
59950432|NCT03340974|76069284|FG003|COMPLETED|Completion of Study -Long Term Follow up||0||
59950433|NCT03340974|76069281|FG000|NOT COMPLETED|Completion of Study -Long Term Follow up||18||
59950434|NCT03340974|76069282|FG001|NOT COMPLETED|Completion of Study -Long Term Follow up||6||
59950435|NCT03340974|76069283|FG002|NOT COMPLETED|Completion of Study -Long Term Follow up||6||
59950436|NCT03340974|76069284|FG003|NOT COMPLETED|Completion of Study -Long Term Follow up||12||
59950437|NCT02612428|76069300|FG000|STARTED|VTL-308||78||
59950438|NCT02612428|76069301|FG001|STARTED|VTL-308||73||
59950439|NCT02612428|76069300|FG000|COMPLETED|VTL-308||64||
59950440|NCT02612428|76069301|FG001|COMPLETED|VTL-308||56||
59950441|NCT02612428|76069300|FG000|NOT COMPLETED|VTL-308||14||
59950442|NCT02612428|76069301|FG001|NOT COMPLETED|VTL-308||17||
60067662|NCT02003573|76182819|FG000|COMPLETED|Overall Study||0||
60067663|NCT02003573|76182820|FG001|COMPLETED|Overall Study||0||
60067664|NCT02003573|76182821|FG002|COMPLETED|Overall Study||0||
60067665|NCT02003573|76182819|FG000|NOT COMPLETED|Overall Study||3||
59950443|NCT02612428|76069300|FG000|STARTED|VTL-308E||64||
59950444|NCT02612428|76069301|FG001|STARTED|VTL-308E||56||
59950445|NCT02612428|76069300|FG000|COMPLETED|VTL-308E||53||
59950446|NCT02612428|76069301|FG001|COMPLETED|VTL-308E||49||
59950447|NCT02612428|76069300|FG000|NOT COMPLETED|VTL-308E||11||
59950448|NCT02612428|76069301|FG001|NOT COMPLETED|VTL-308E||7||
59950449|NCT03679884|76069312|FG000|STARTED|Overall Study||142|DB treatment period|
59950450|NCT03679884|76069313|FG001|STARTED|Overall Study||268|DB treatment period|
59950451|NCT03679884|76069314|FG002|STARTED|Overall Study||137|DB treatment period|
59950452|NCT03679884|76069315|FG003|STARTED|Overall Study||128|DB treatment period|
59950453|NCT03679884|76069316|FG004|STARTED|Overall Study||126|DB treatment period|
59950454|NCT03679884|76069312|FG000|COMPLETED|Overall Study||99|DB treatment period|
59950455|NCT03679884|76069313|FG001|COMPLETED|Overall Study||190|DB treatment period|
59950456|NCT03679884|76069314|FG002|COMPLETED|Overall Study||93|DB treatment period|
59950457|NCT03679884|76069315|FG003|COMPLETED|Overall Study||78|DB treatment period|
59950458|NCT03679884|76069316|FG004|COMPLETED|Overall Study||90|DB treatment period|
59950459|NCT03679884|76069312|FG000|NOT COMPLETED|Overall Study||43||
60067666|NCT02003573|76182820|FG001|NOT COMPLETED|Overall Study||4||
59518871|NCT03537274|75612753|FG000|NOT COMPLETED|Overall Study||60||
59950460|NCT03679884|76069313|FG001|NOT COMPLETED|Overall Study||78||
59950461|NCT03679884|76069314|FG002|NOT COMPLETED|Overall Study||44||
59950462|NCT03679884|76069315|FG003|NOT COMPLETED|Overall Study||50||
59950463|NCT03679884|76069316|FG004|NOT COMPLETED|Overall Study||36||
59950464|NCT01329978|76069331|FG000|STARTED|Sofosbuvir+PEG+RBV Treatment Period||52||
59950465|NCT01329978|76069332|FG001|STARTED|Sofosbuvir+PEG+RBV Treatment Period||125||
59950466|NCT01329978|76069333|FG002|STARTED|Sofosbuvir+PEG+RBV Treatment Period||155||
59950467|NCT01329978|76069334|FG003|STARTED|Sofosbuvir+PEG+RBV Treatment Period||0||
59950468|NCT01329978|76069335|FG004|STARTED|Sofosbuvir+PEG+RBV Treatment Period||0||
59950469|NCT01329978|76069331|FG000|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period|Participants in this group were not re-randomized for further treatment|48||
59950470|NCT01329978|76069332|FG001|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period|Participants in this group were not re-randomized for further treatment|112||
59950471|NCT01329978|76069333|FG002|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period|150 participants were re-randomized after 12 weeks of treatment.|150||
59950472|NCT01329978|76069334|FG003|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||0||
59950473|NCT01329978|76069335|FG004|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||0||
59950474|NCT01329978|76069331|FG000|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||4||
59950475|NCT01329978|76069332|FG001|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||13||
59950476|NCT01329978|76069333|FG002|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||5||
59950477|NCT01329978|76069334|FG003|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||0||
59950478|NCT01329978|76069335|FG004|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||0||
59950479|NCT01329978|76069331|FG000|STARTED|Rerandomization Treatment Period||0||
59950480|NCT01329978|76069332|FG001|STARTED|Rerandomization Treatment Period||0||
59950481|NCT01329978|76069333|FG002|STARTED|Rerandomization Treatment Period||0||
59950482|NCT01329978|76069334|FG003|STARTED|Rerandomization Treatment Period|This group includes participants rerandomized from the SOF+PEG+RBV 12 week/Rerandomization Group.|75||
59950483|NCT01329978|76069335|FG004|STARTED|Rerandomization Treatment Period|This group includes participants rerandomized from the SOF+PEG+RBV 12 week/Rerandomization Group.|75||
59950484|NCT01329978|76069331|FG000|COMPLETED|Rerandomization Treatment Period||0||
59950485|NCT01329978|76069332|FG001|COMPLETED|Rerandomization Treatment Period||0||
59950486|NCT01329978|76069333|FG002|COMPLETED|Rerandomization Treatment Period||0||
59950487|NCT01329978|76069334|FG003|COMPLETED|Rerandomization Treatment Period||70||
59950488|NCT01329978|76069335|FG004|COMPLETED|Rerandomization Treatment Period||71||
59950489|NCT01329978|76069331|FG000|NOT COMPLETED|Rerandomization Treatment Period||0||
59950490|NCT01329978|76069332|FG001|NOT COMPLETED|Rerandomization Treatment Period||0||
59950491|NCT01329978|76069333|FG002|NOT COMPLETED|Rerandomization Treatment Period||0||
59950492|NCT01329978|76069334|FG003|NOT COMPLETED|Rerandomization Treatment Period||5||
59950493|NCT01329978|76069335|FG004|NOT COMPLETED|Rerandomization Treatment Period||4||
59950494|NCT01338012|76069347|FG000|STARTED|Overall Study||8||
59950495|NCT01338012|76069347|FG000|COMPLETED|Overall Study||0||
59950496|NCT01338012|76069347|FG000|NOT COMPLETED|Overall Study||8||
59613437|NCT01592760|75724573|FG002|COMPLETED|Perioperative to Discharge||45||
59613438|NCT01592760|75724571|FG000|NOT COMPLETED|Perioperative to Discharge||0||
59613439|NCT01592760|75724572|FG001|NOT COMPLETED|Perioperative to Discharge||0||
59950497|NCT04905498|76069353|FG000|STARTED|Overall Study||19||
59950498|NCT04905498|76069354|FG001|STARTED|Overall Study||30||
59950499|NCT04905498|76069353|FG000|COMPLETED|Overall Study||18||
59950500|NCT04905498|76069354|FG001|COMPLETED|Overall Study||28||
59950501|NCT04905498|76069353|FG000|NOT COMPLETED|Overall Study||1||
59950502|NCT04905498|76069354|FG001|NOT COMPLETED|Overall Study||2||
59950503|NCT02607280|76069362|FG000|STARTED|Overall Study||30||
59950504|NCT02607280|76069363|FG001|STARTED|Overall Study||5||
59950505|NCT02607280|76069362|FG000|Received Study Drug|Overall Study||30||
59950506|NCT02607280|76069363|FG001|Received Study Drug|Overall Study||5||
59950507|NCT02607280|76069362|FG000|COMPLETED|Overall Study||26||
59950508|NCT02607280|76069363|FG001|COMPLETED|Overall Study||4||
59950509|NCT02607280|76069362|FG000|NOT COMPLETED|Overall Study||4||
59950510|NCT02607280|76069363|FG001|NOT COMPLETED|Overall Study||1||
59950511|NCT02202434|76069373|FG000|STARTED|Overall Study||607||
59950512|NCT02202434|76069374|FG001|STARTED|Overall Study||305||
59950513|NCT02202434|76069375|FG002|STARTED|Overall Study||102||
59950514|NCT02202434|76069376|FG003|STARTED|Overall Study||295||
59950515|NCT02202434|76069373|FG000|COMPLETED|Overall Study||498||
59950516|NCT02202434|76069374|FG001|COMPLETED|Overall Study||236||
59950517|NCT02202434|76069375|FG002|COMPLETED|Overall Study||87||
59950518|NCT02202434|76069376|FG003|COMPLETED|Overall Study||258||
59950519|NCT02202434|76069373|FG000|NOT COMPLETED|Overall Study||109||
59950520|NCT02202434|76069374|FG001|NOT COMPLETED|Overall Study||69||
59950521|NCT02202434|76069375|FG002|NOT COMPLETED|Overall Study||15||
59950522|NCT02202434|76069376|FG003|NOT COMPLETED|Overall Study||37||
59950523|NCT02784288|76069386|FG000|STARTED|Overall Study||34||
59950524|NCT02784288|76069386|FG000|COMPLETED|Overall Study||33||
59950525|NCT02784288|76069386|FG000|NOT COMPLETED|Overall Study||1||
59950526|NCT01230242|76069391|FG000|STARTED|Overall Study||4||
59950527|NCT01230242|76069391|FG000|COMPLETED|Overall Study||1||
59950528|NCT01230242|76069391|FG000|NOT COMPLETED|Overall Study||3||
59950529|NCT02608450|76069397|FG000|STARTED|Overall Study||353||
59950530|NCT02608450|76069398|FG001|STARTED|Overall Study||355||
59950531|NCT02608450|76069397|FG000|COMPLETED|Overall Study||287||
59950532|NCT02608450|76069398|FG001|COMPLETED|Overall Study||290||
59950533|NCT02608450|76069397|FG000|NOT COMPLETED|Overall Study||66||
59950534|NCT02608450|76069398|FG001|NOT COMPLETED|Overall Study||65||
59950535|NCT04918784|76069406|FG000|STARTED|Overall Study||25||
59950536|NCT04918784|76069407|FG001|STARTED|Overall Study||21||
59950537|NCT04918784|76069406|FG000|COMPLETED|Overall Study||19||
59950538|NCT04918784|76069407|FG001|COMPLETED|Overall Study||18||
59950539|NCT04918784|76069406|FG000|NOT COMPLETED|Overall Study||6||
59950540|NCT04918784|76069407|FG001|NOT COMPLETED|Overall Study||3||
59950541|NCT04867434|76069416|FG000|STARTED|Overall Study||50||
59950542|NCT04867434|76069417|FG001|STARTED|Overall Study||53||
59950543|NCT04867434|76069418|FG002|STARTED|Overall Study||48||
59950544|NCT04867434|76069416|FG000|COMPLETED|Overall Study||50||
59950545|NCT04867434|76069417|FG001|COMPLETED|Overall Study||49||
59950546|NCT04867434|76069418|FG002|COMPLETED|Overall Study||47||
59950547|NCT04867434|76069416|FG000|NOT COMPLETED|Overall Study||0||
59950548|NCT04867434|76069417|FG001|NOT COMPLETED|Overall Study||4||
59950549|NCT04867434|76069418|FG002|NOT COMPLETED|Overall Study||1||
59950550|NCT04859868|76069426|FG000|STARTED|First Experimental Visit (1.5 Hour)||5||
59950551|NCT04859868|76069427|FG001|STARTED|First Experimental Visit (1.5 Hour)||5||
59950552|NCT04859868|76069428|FG002|STARTED|First Experimental Visit (1.5 Hour)||5||
59950553|NCT04859868|76069429|FG003|STARTED|First Experimental Visit (1.5 Hour)||4||
59950554|NCT04859868|76069430|FG004|STARTED|First Experimental Visit (1.5 Hour)||5||
59950555|NCT04859868|76069431|FG005|STARTED|First Experimental Visit (1.5 Hour)||5||
59950556|NCT04859868|76069426|FG000|COMPLETED|First Experimental Visit (1.5 Hour)||5||
59950557|NCT04859868|76069427|FG001|COMPLETED|First Experimental Visit (1.5 Hour)||5||
59950558|NCT04859868|76069428|FG002|COMPLETED|First Experimental Visit (1.5 Hour)||5||
59950559|NCT04859868|76069429|FG003|COMPLETED|First Experimental Visit (1.5 Hour)||4||
59950560|NCT04859868|76069430|FG004|COMPLETED|First Experimental Visit (1.5 Hour)||5||
59950561|NCT04859868|76069431|FG005|COMPLETED|First Experimental Visit (1.5 Hour)||5||
59950562|NCT04859868|76069426|FG000|NOT COMPLETED|First Experimental Visit (1.5 Hour)||0||
59950563|NCT04859868|76069427|FG001|NOT COMPLETED|First Experimental Visit (1.5 Hour)||0||
59950564|NCT04859868|76069428|FG002|NOT COMPLETED|First Experimental Visit (1.5 Hour)||0||
59950565|NCT04859868|76069429|FG003|NOT COMPLETED|First Experimental Visit (1.5 Hour)||0||
59950566|NCT04859868|76069430|FG004|NOT COMPLETED|First Experimental Visit (1.5 Hour)||0||
59950567|NCT04859868|76069431|FG005|NOT COMPLETED|First Experimental Visit (1.5 Hour)||0||
59950568|NCT04859868|76069426|FG000|STARTED|Second Experimental Visit (1.5 Hour)||4||
59950569|NCT04859868|76069427|FG001|STARTED|Second Experimental Visit (1.5 Hour)||5||
59950570|NCT04859868|76069428|FG002|STARTED|Second Experimental Visit (1.5 Hour)||5||
59950571|NCT04859868|76069429|FG003|STARTED|Second Experimental Visit (1.5 Hour)||4||
59950572|NCT04859868|76069430|FG004|STARTED|Second Experimental Visit (1.5 Hour)||4||
59950573|NCT04859868|76069431|FG005|STARTED|Second Experimental Visit (1.5 Hour)||5||
59950574|NCT04859868|76069426|FG000|COMPLETED|Second Experimental Visit (1.5 Hour)||4||
59950575|NCT04859868|76069427|FG001|COMPLETED|Second Experimental Visit (1.5 Hour)||5||
59950576|NCT04859868|76069428|FG002|COMPLETED|Second Experimental Visit (1.5 Hour)||5||
59950577|NCT04859868|76069429|FG003|COMPLETED|Second Experimental Visit (1.5 Hour)||4||
59950578|NCT04859868|76069430|FG004|COMPLETED|Second Experimental Visit (1.5 Hour)||4||
59950579|NCT04859868|76069431|FG005|COMPLETED|Second Experimental Visit (1.5 Hour)||5||
59950580|NCT04859868|76069426|FG000|NOT COMPLETED|Second Experimental Visit (1.5 Hour)||0||
59950581|NCT04859868|76069427|FG001|NOT COMPLETED|Second Experimental Visit (1.5 Hour)||0||
59950582|NCT04859868|76069428|FG002|NOT COMPLETED|Second Experimental Visit (1.5 Hour)||0||
59950583|NCT04859868|76069429|FG003|NOT COMPLETED|Second Experimental Visit (1.5 Hour)||0||
59950584|NCT04859868|76069430|FG004|NOT COMPLETED|Second Experimental Visit (1.5 Hour)||0||
59950585|NCT04859868|76069431|FG005|NOT COMPLETED|Second Experimental Visit (1.5 Hour)||0||
59950586|NCT04859868|76069426|FG000|STARTED|Third Experimental Visit (1.5 Hour)||4||
59950587|NCT04859868|76069427|FG001|STARTED|Third Experimental Visit (1.5 Hour)||5||
59950588|NCT04859868|76069428|FG002|STARTED|Third Experimental Visit (1.5 Hour)||5||
59950589|NCT04859868|76069429|FG003|STARTED|Third Experimental Visit (1.5 Hour)||4||
59950590|NCT04859868|76069430|FG004|STARTED|Third Experimental Visit (1.5 Hour)||4||
59950591|NCT04859868|76069431|FG005|STARTED|Third Experimental Visit (1.5 Hour)||5||
59950592|NCT04859868|76069426|FG000|COMPLETED|Third Experimental Visit (1.5 Hour)||4||
59950593|NCT04859868|76069427|FG001|COMPLETED|Third Experimental Visit (1.5 Hour)||5||
59950594|NCT04859868|76069428|FG002|COMPLETED|Third Experimental Visit (1.5 Hour)||5||
59950595|NCT04859868|76069429|FG003|COMPLETED|Third Experimental Visit (1.5 Hour)||4||
59950596|NCT04859868|76069430|FG004|COMPLETED|Third Experimental Visit (1.5 Hour)||4||
59950597|NCT04859868|76069431|FG005|COMPLETED|Third Experimental Visit (1.5 Hour)||5||
59950598|NCT04859868|76069426|FG000|NOT COMPLETED|Third Experimental Visit (1.5 Hour)||0||
59950599|NCT04859868|76069427|FG001|NOT COMPLETED|Third Experimental Visit (1.5 Hour)||0||
59950600|NCT04859868|76069428|FG002|NOT COMPLETED|Third Experimental Visit (1.5 Hour)||0||
59950601|NCT04859868|76069429|FG003|NOT COMPLETED|Third Experimental Visit (1.5 Hour)||0||
59950602|NCT04859868|76069430|FG004|NOT COMPLETED|Third Experimental Visit (1.5 Hour)||0||
59950603|NCT04859868|76069431|FG005|NOT COMPLETED|Third Experimental Visit (1.5 Hour)||0||
59950604|NCT04786444|76069440|FG000|STARTED|Overall Study||136||
59950605|NCT04786444|76069441|FG001|STARTED|Overall Study||137||
59950606|NCT04786444|76069442|FG002|STARTED|Overall Study||135||
59950607|NCT04786444|76069440|FG000|COMPLETED|Overall Study||121||
59950608|NCT04786444|76069441|FG001|COMPLETED|Overall Study||120||
59950609|NCT04786444|76069442|FG002|COMPLETED|Overall Study||123||
59950610|NCT04786444|76069440|FG000|NOT COMPLETED|Overall Study||15||
59950611|NCT04786444|76069441|FG001|NOT COMPLETED|Overall Study||17||
59950612|NCT04786444|76069442|FG002|NOT COMPLETED|Overall Study||12||
59950613|NCT04744155|76069452|FG000|STARTED|Overall Study||25||
59950614|NCT04744155|76069453|FG001|STARTED|Overall Study||12||
59950615|NCT04744155|76069452|FG000|COMPLETED|Overall Study||25||
59950616|NCT04744155|76069453|FG001|COMPLETED|Overall Study||10||
59950617|NCT04744155|76069452|FG000|NOT COMPLETED|Overall Study||0||
59950618|NCT04744155|76069453|FG001|NOT COMPLETED|Overall Study||2||
59950619|NCT04692155|76069459|FG000|STARTED|Overall Study||1||
59950620|NCT04692155|76069459|FG000|COMPLETED|Overall Study||0||
59950621|NCT04692155|76069459|FG000|NOT COMPLETED|Overall Study||1||
59950622|NCT04499963|76069465|FG000|STARTED|Overall Study||50||
59950623|NCT04499963|76069466|FG001|STARTED|Overall Study||50||
59950624|NCT04499963|76069465|FG000|COMPLETED|Overall Study||35||
59950625|NCT04499963|76069466|FG001|COMPLETED|Overall Study||50||
59950626|NCT04499963|76069465|FG000|NOT COMPLETED|Overall Study||15||
59950627|NCT04499963|76069466|FG001|NOT COMPLETED|Overall Study||0||
59950628|NCT04366050|76069474|FG000|STARTED|Overall Study||79||
59950629|NCT04366050|76069475|FG001|STARTED|Overall Study||35||
59950630|NCT04366050|76069474|FG000|COMPLETED|Overall Study||68||
59950631|NCT04366050|76069475|FG001|COMPLETED|Overall Study||32||
59950632|NCT04366050|76069474|FG000|NOT COMPLETED|Overall Study||11||
59950633|NCT04366050|76069475|FG001|NOT COMPLETED|Overall Study||3||
59950634|NCT04330482|76069483|FG000|STARTED|Overall Study||20||
59950635|NCT04330482|76069484|FG001|STARTED|Overall Study||20||
59950636|NCT04330482|76069483|FG000|COMPLETED|Overall Study||18||
59950637|NCT04330482|76069484|FG001|COMPLETED|Overall Study||16||
59950638|NCT04330482|76069483|FG000|NOT COMPLETED|Overall Study||2||
59950639|NCT04330482|76069484|FG001|NOT COMPLETED|Overall Study||4||
59950640|NCT04325503|76069490|FG000|STARTED|Overall Study||14||
59950641|NCT04325503|76069490|FG000|COMPLETED|Overall Study||11||
59950642|NCT04325503|76069490|FG000|NOT COMPLETED|Overall Study||3||
59950643|NCT04205240|76069494|FG000|STARTED|Overall Study||1||
60067667|NCT02003573|76182821|FG002|NOT COMPLETED|Overall Study||6||
60067668|NCT01914679|76182831|FG000|STARTED|Overall Study||17||
60067669|NCT01914679|76182831|FG000|Began 12 Week Actual RINCE Treatment|Overall Study||17||
60067670|NCT01914679|76182831|FG000|COMPLETED|Overall Study||12||
60067671|NCT01914679|76182831|FG000|NOT COMPLETED|Overall Study||5||
60067672|NCT01789281|76182837|FG000|STARTED|Overall Study||22||
60067673|NCT01789281|76182838|FG001|STARTED|Overall Study||12||
60067674|NCT01789281|76182837|FG000|COMPLETED|Overall Study||0||
60067675|NCT01789281|76182838|FG001|COMPLETED|Overall Study||2||
60067676|NCT01789281|76182837|FG000|NOT COMPLETED|Overall Study||22||
59950644|NCT04205240|76069494|FG000|COMPLETED|Overall Study||1||
59950645|NCT04205240|76069494|FG000|NOT COMPLETED|Overall Study||0||
59950646|NCT04109222|76069501|FG000|STARTED|Overall Study||30|Vaccinated participants.|
60067677|NCT01789281|76182838|FG001|NOT COMPLETED|Overall Study||10||
60067678|NCT01923740|76182847|FG000|STARTED|Overall Study||227||
60067679|NCT01923740|76182848|FG001|STARTED|Overall Study||232||
60067680|NCT01923740|76182847|FG000|COMPLETED|Overall Study||221||
60067681|NCT01923740|76182848|FG001|COMPLETED|Overall Study||223||
60067682|NCT01923740|76182847|FG000|NOT COMPLETED|Overall Study||6||
60067683|NCT01923740|76182848|FG001|NOT COMPLETED|Overall Study||9||
60067684|NCT01789203|76182856|FG000|STARTED|Overall Study||133||
60067685|NCT01789203|76182857|FG001|STARTED|Overall Study||67||
60067686|NCT01789203|76182856|FG000|COMPLETED|Overall Study||124||
60067687|NCT01789203|76182857|FG001|COMPLETED|Overall Study||63||
60067688|NCT01789203|76182856|FG000|NOT COMPLETED|Overall Study||9||
60067689|NCT01789203|76182857|FG001|NOT COMPLETED|Overall Study||4||
60067690|NCT01789047|76182867|FG000|STARTED|Overall Study||21||
60067691|NCT01789047|76182868|FG001|STARTED|Overall Study||21||
60067692|NCT01789047|76182867|FG000|COMPLETED|Overall Study||17||
60067693|NCT01789047|76182868|FG001|COMPLETED|Overall Study||17||
59950647|NCT04109222|76069502|FG001|STARTED|Overall Study||30|Vaccinated participants.|
59950648|NCT04109222|76069503|FG002|STARTED|Overall Study||30|Vaccinated participants.|
59950649|NCT04109222|76069501|FG000|COMPLETED|Overall Study||29||
59950650|NCT04109222|76069502|FG001|COMPLETED|Overall Study||30||
59950651|NCT04109222|76069503|FG002|COMPLETED|Overall Study||30||
59950652|NCT04109222|76069501|FG000|NOT COMPLETED|Overall Study||1||
59950653|NCT04109222|76069502|FG001|NOT COMPLETED|Overall Study||0||
59950654|NCT04109222|76069503|FG002|NOT COMPLETED|Overall Study||0||
59950655|NCT04080544|76069511|FG000|STARTED|Overall Study||125||
59950656|NCT04080544|76069511|FG000|COMPLETED|Overall Study||125||
59950657|NCT04080544|76069511|FG000|NOT COMPLETED|Overall Study||0||
59950658|NCT03729869|76069520|FG000|STARTED|Overall Study||40||
59950659|NCT03729869|76069521|FG001|STARTED|Overall Study||42||
60067694|NCT01789047|76182867|FG000|NOT COMPLETED|Overall Study||4||
60067695|NCT01789047|76182868|FG001|NOT COMPLETED|Overall Study||4||
59950660|NCT03729869|76069522|FG002|STARTED|Overall Study||35||
59950661|NCT03729869|76069523|FG003|STARTED|Overall Study||31||
59950662|NCT03729869|76069520|FG000|COMPLETED|Overall Study||39||
59950663|NCT03729869|76069521|FG001|COMPLETED|Overall Study||41||
59950664|NCT03729869|76069522|FG002|COMPLETED|Overall Study||35||
59950665|NCT03729869|76069523|FG003|COMPLETED|Overall Study||31||
59950666|NCT03729869|76069520|FG000|NOT COMPLETED|Overall Study||1||
59950667|NCT03729869|76069521|FG001|NOT COMPLETED|Overall Study||1||
59950668|NCT03729869|76069522|FG002|NOT COMPLETED|Overall Study||0||
59950669|NCT03729869|76069523|FG003|NOT COMPLETED|Overall Study||0||
59950670|NCT03687658|76069535|FG000|STARTED|Overall Study||67||
59950671|NCT03687658|76069536|FG001|STARTED|Overall Study||24||
59950672|NCT03687658|76069535|FG000|Completed 1st Scan|Overall Study||52||
59950673|NCT03687658|76069536|FG001|Completed 1st Scan|Overall Study||20||
59950674|NCT03687658|76069535|FG000|Completed 2nd Scan|Overall Study||46||
59950675|NCT03687658|76069536|FG001|Completed 2nd Scan|Overall Study||10||
59950676|NCT03687658|76069535|FG000|COMPLETED|Overall Study||46||
59950677|NCT03687658|76069536|FG001|COMPLETED|Overall Study||10||
59950678|NCT03687658|76069535|FG000|NOT COMPLETED|Overall Study||21||
59950679|NCT03687658|76069536|FG001|NOT COMPLETED|Overall Study||14||
59950680|NCT03573297|76069542|FG000|STARTED|Open Label Treatment Period||896|Treated|
59950681|NCT03573297|76069543|FG001|STARTED|Open Label Treatment Period||0|Treated|
59950682|NCT03573297|76069544|FG002|STARTED|Open Label Treatment Period||0|Treated|
59950683|NCT03573297|76069545|FG003|STARTED|Open Label Treatment Period||0|Treated|
59950684|NCT03573297|76069542|FG000|COMPLETED|Open Label Treatment Period||440||
59950685|NCT03573297|76069543|FG001|COMPLETED|Open Label Treatment Period||0||
59950686|NCT03573297|76069544|FG002|COMPLETED|Open Label Treatment Period||0||
59950687|NCT03573297|76069545|FG003|COMPLETED|Open Label Treatment Period||0||
59950688|NCT03573297|76069542|FG000|NOT COMPLETED|Open Label Treatment Period||456||
59950689|NCT03573297|76069543|FG001|NOT COMPLETED|Open Label Treatment Period||0||
59950690|NCT03573297|76069544|FG002|NOT COMPLETED|Open Label Treatment Period||0||
59950691|NCT03573297|76069545|FG003|NOT COMPLETED|Open Label Treatment Period||0||
59950692|NCT03573297|76069542|FG000|STARTED|Double-Blind Treatment Period||0|Randomized into Double-Blind Period|
59950693|NCT03573297|76069543|FG001|STARTED|Double-Blind Treatment Period||145|Randomized into Double-Blind Period|
59950694|NCT03573297|76069544|FG002|STARTED|Double-Blind Treatment Period||147|Randomized into Double-Blind Period|
59950695|NCT03573297|76069545|FG003|STARTED|Double-Blind Treatment Period||148|Randomized into Double-Blind Period|
59950696|NCT03573297|76069542|FG000|Randomized and Treated in Double-Blind Treatment Period|Double-Blind Treatment Period||0||
59950697|NCT03573297|76069543|FG001|Randomized and Treated in Double-Blind Treatment Period|Double-Blind Treatment Period||145||
59950698|NCT03573297|76069544|FG002|Randomized and Treated in Double-Blind Treatment Period|Double-Blind Treatment Period||144||
59950699|NCT03573297|76069545|FG003|Randomized and Treated in Double-Blind Treatment Period|Double-Blind Treatment Period||147||
59950700|NCT03573297|76069542|FG000|COMPLETED|Double-Blind Treatment Period||0||
59950701|NCT03573297|76069543|FG001|COMPLETED|Double-Blind Treatment Period||79||
59950702|NCT03573297|76069544|FG002|COMPLETED|Double-Blind Treatment Period||82||
59950703|NCT03573297|76069545|FG003|COMPLETED|Double-Blind Treatment Period||84||
59950704|NCT03573297|76069542|FG000|NOT COMPLETED|Double-Blind Treatment Period||0||
59950705|NCT03573297|76069543|FG001|NOT COMPLETED|Double-Blind Treatment Period||66||
59950706|NCT03573297|76069544|FG002|NOT COMPLETED|Double-Blind Treatment Period||65||
59950707|NCT03573297|76069545|FG003|NOT COMPLETED|Double-Blind Treatment Period||64||
59950708|NCT03536884|76069556|FG000|STARTED|Initial Treatment Period Week 0-16||373||
59950709|NCT03536884|76069557|FG001|STARTED|Initial Treatment Period Week 0-16||370||
59950710|NCT03536884|76069558|FG002|STARTED|Initial Treatment Period Week 0-16||0||
59950711|NCT03536884|76069559|FG003|STARTED|Initial Treatment Period Week 0-16||0||
59950712|NCT03536884|76069560|FG004|STARTED|Initial Treatment Period Week 0-16||0||
59950713|NCT03536884|76069556|FG000|COMPLETED|Initial Treatment Period Week 0-16||362||
59950714|NCT03536884|76069557|FG001|COMPLETED|Initial Treatment Period Week 0-16||354||
59950715|NCT03536884|76069558|FG002|COMPLETED|Initial Treatment Period Week 0-16||0||
59950716|NCT03536884|76069559|FG003|COMPLETED|Initial Treatment Period Week 0-16||0||
59950717|NCT03536884|76069560|FG004|COMPLETED|Initial Treatment Period Week 0-16||0||
59950718|NCT03536884|76069556|FG000|NOT COMPLETED|Initial Treatment Period Week 0-16||11||
59950719|NCT03536884|76069557|FG001|NOT COMPLETED|Initial Treatment Period Week 0-16||16||
59950720|NCT03536884|76069558|FG002|NOT COMPLETED|Initial Treatment Period Week 0-16||0||
59950721|NCT03536884|76069559|FG003|NOT COMPLETED|Initial Treatment Period Week 0-16||0||
59950722|NCT03536884|76069560|FG004|NOT COMPLETED|Initial Treatment Period Week 0-16||0||
59950723|NCT03536884|76069556|FG000|STARTED|Maintenance Treatment Period Week 16-48||0||
59950724|NCT03536884|76069557|FG001|STARTED|Maintenance Treatment Period Week 16-48||0||
59950725|NCT03536884|76069558|FG002|STARTED|Maintenance Treatment Period Week 16-48||215||
59950726|NCT03536884|76069559|FG003|STARTED|Maintenance Treatment Period Week 16-48||147||
59950727|NCT03536884|76069560|FG004|STARTED|Maintenance Treatment Period Week 16-48||354||
59950728|NCT03536884|76069556|FG000|COMPLETED|Maintenance Treatment Period Week 16-48||0||
59950729|NCT03536884|76069557|FG001|COMPLETED|Maintenance Treatment Period Week 16-48||0||
59950730|NCT03536884|76069558|FG002|COMPLETED|Maintenance Treatment Period Week 16-48||205||
59950731|NCT03536884|76069559|FG003|COMPLETED|Maintenance Treatment Period Week 16-48||138||
59519088|NCT00939731|75612966|FG000|NOT COMPLETED|First Intervention Period||0||
59709497|NCT00907153|75828243|FG000|STARTED|Overall Study||13||
59951532|NCT02607930|76070543|FG000|STARTED|Open-Label B/F/TAF Extension Phase|At the End of Blinded Treatment Visit, participants were given the option to receive B/F/TAF FDC in an OL extension phase for up to 96 weeks.|0||
59951533|NCT02607930|76070544|FG001|STARTED|Open-Label B/F/TAF Extension Phase|At the End of Blinded Treatment Visit, participants were given the option to receive B/F/TAF FDC in an OL extension phase for up to 96 weeks.|0||
59951534|NCT02607930|76070545|FG002|STARTED|Open-Label B/F/TAF Extension Phase|10 participants from B/F/TAF arm did not enter the Open-Label Extension Phase.|252||
59951535|NCT02607930|76070546|FG003|STARTED|Open-Label B/F/TAF Extension Phase|8 participants from the ABC/DTG/3TC arm did not enter the Open-Label Extension Phase.|254||
59951536|NCT02607930|76070543|FG000|COMPLETED|Open-Label B/F/TAF Extension Phase||0||
60067920|NCT01784211|76183110|FG004|Received at Least 1 Dose of Study Drug|Part A (Days 1-15)||0||
60067921|NCT01784211|76183111|FG005|Received at Least 1 Dose of Study Drug|Part A (Days 1-15)||0||
60067922|NCT01784211|76183106|FG000|Entered Part B|Part A (Days 1-15)|Participants who completed Part A and met certain criteria had the option of continuing to Part B.|19||
60067923|NCT01784211|76183107|FG001|Entered Part B|Part A (Days 1-15)|Participants who completed Part A and met certain criteria had the option of continuing to Part B.|21||
60067924|NCT01784211|76183108|FG002|Entered Part B|Part A (Days 1-15)||0||
60067925|NCT01784211|76183109|FG003|Entered Part B|Part A (Days 1-15)||0||
60067926|NCT01784211|76183110|FG004|Entered Part B|Part A (Days 1-15)||0||
60067927|NCT01784211|76183111|FG005|Entered Part B|Part A (Days 1-15)||0||
60067928|NCT01784211|76183106|FG000|COMPLETED|Part A (Days 1-15)||35||
60067929|NCT01784211|76183107|FG001|COMPLETED|Part A (Days 1-15)||36||
60067930|NCT01784211|76183108|FG002|COMPLETED|Part A (Days 1-15)||0||
60067931|NCT01784211|76183109|FG003|COMPLETED|Part A (Days 1-15)||0||
60067932|NCT01784211|76183110|FG004|COMPLETED|Part A (Days 1-15)||0||
60067933|NCT01784211|76183111|FG005|COMPLETED|Part A (Days 1-15)||0||
60067934|NCT01784211|76183106|FG000|NOT COMPLETED|Part A (Days 1-15)||3||
60067935|NCT01784211|76183107|FG001|NOT COMPLETED|Part A (Days 1-15)||2||
60067936|NCT01784211|76183108|FG002|NOT COMPLETED|Part A (Days 1-15)||0||
60067937|NCT01784211|76183109|FG003|NOT COMPLETED|Part A (Days 1-15)||0||
60067938|NCT01784211|76183110|FG004|NOT COMPLETED|Part A (Days 1-15)||0||
60067939|NCT01784211|76183111|FG005|NOT COMPLETED|Part A (Days 1-15)||0||
60067940|NCT01784211|76183106|FG000|STARTED|Part B (Days 16-21)|Participants who completed Part A and met certain criteria had the option of continuing to Part B.|0||
60067941|NCT01784211|76183107|FG001|STARTED|Part B (Days 16-21)|Participants who completed Part A and met certain criteria had the option of continuing to Part B.|0||
60067942|NCT01784211|76183108|FG002|STARTED|Part B (Days 16-21)||10||
60067943|NCT01784211|76183109|FG003|STARTED|Part B (Days 16-21)||9||
60067944|NCT01784211|76183110|FG004|STARTED|Part B (Days 16-21)||11||
60067945|NCT01784211|76183111|FG005|STARTED|Part B (Days 16-21)||10||
60067946|NCT01784211|76183106|FG000|COMPLETED|Part B (Days 16-21)||0||
60067947|NCT01784211|76183107|FG001|COMPLETED|Part B (Days 16-21)||0||
60067948|NCT01784211|76183108|FG002|COMPLETED|Part B (Days 16-21)||10||
60067949|NCT01784211|76183109|FG003|COMPLETED|Part B (Days 16-21)||9||
60067950|NCT01784211|76183110|FG004|COMPLETED|Part B (Days 16-21)||11||
60067951|NCT01784211|76183111|FG005|COMPLETED|Part B (Days 16-21)||10||
60067952|NCT01784211|76183106|FG000|NOT COMPLETED|Part B (Days 16-21)||0||
60067953|NCT01784211|76183107|FG001|NOT COMPLETED|Part B (Days 16-21)||0||
60067954|NCT01784211|76183108|FG002|NOT COMPLETED|Part B (Days 16-21)||0||
60067955|NCT01784211|76183109|FG003|NOT COMPLETED|Part B (Days 16-21)||0||
60067956|NCT01784211|76183110|FG004|NOT COMPLETED|Part B (Days 16-21)||0||
60067957|NCT01784211|76183111|FG005|NOT COMPLETED|Part B (Days 16-21)||0||
60067958|NCT01783821|76183125|FG000|STARTED|Overall Study||30||
60067959|NCT01783821|76183126|FG001|STARTED|Overall Study||31||
60067960|NCT01783821|76183125|FG000|COMPLETED|Overall Study||29||
60067961|NCT01783821|76183126|FG001|COMPLETED|Overall Study||30||
60067962|NCT01783821|76183125|FG000|NOT COMPLETED|Overall Study||1||
60067963|NCT01783821|76183126|FG001|NOT COMPLETED|Overall Study||1||
60067964|NCT01783743|76183134|FG000|STARTED|Screening of Subjects by CTA During MDA||13509||18
60067965|NCT01783743|76183135|FG001|STARTED|Screening of Subjects by CTA During MDA||13964||18
60067966|NCT01783743|76183134|FG000|COMPLETED|Screening of Subjects by CTA During MDA||10082||18
60067967|NCT01783743|76183135|FG001|COMPLETED|Screening of Subjects by CTA During MDA||9525||18
60067968|NCT01783743|76183134|FG000|NOT COMPLETED|Screening of Subjects by CTA During MDA||3427||0
60067969|NCT01783743|76183135|FG001|NOT COMPLETED|Screening of Subjects by CTA During MDA||4439||0
60067970|NCT01783743|76183134|FG000|STARTED|Rescreening of Subjects by Senior Grader||13509||18
60067971|NCT01783743|76183135|FG001|STARTED|Rescreening of Subjects by Senior Grader||13964||18
60067972|NCT01783743|76183134|FG000|TT Positive Cases Screened by CTA|Rescreening of Subjects by Senior Grader||46||18
60067973|NCT01783743|76183135|FG001|TT Positive Cases Screened by CTA|Rescreening of Subjects by Senior Grader||409||18
60067974|NCT01783743|76183134|FG000|Random Sample From Non TT Cases by CTA|Rescreening of Subjects by Senior Grader||1721||18
60067975|NCT01783743|76183135|FG001|Random Sample From Non TT Cases by CTA|Rescreening of Subjects by Senior Grader||1786||18
60067976|NCT01783743|76183134|FG000|Random Sample From Subject Absent at MDA|Rescreening of Subjects by Senior Grader||846||18
60067977|NCT01783743|76183135|FG001|Random Sample From Subject Absent at MDA|Rescreening of Subjects by Senior Grader||849||18
60067978|NCT01783743|76183134|FG000|COMPLETED|Rescreening of Subjects by Senior Grader||2613||18
60067979|NCT01783743|76183135|FG001|COMPLETED|Rescreening of Subjects by Senior Grader||3044||18
60067980|NCT01783743|76183134|FG000|NOT COMPLETED|Rescreening of Subjects by Senior Grader||10896||0
60067981|NCT01783743|76183135|FG001|NOT COMPLETED|Rescreening of Subjects by Senior Grader||10920||0
60067982|NCT01608321|76183143|FG000|STARTED|Overall Study||13||
60067983|NCT01608321|76183144|FG001|STARTED|Overall Study||4||
60067984|NCT01608321|76183143|FG000|COMPLETED|Overall Study||12||
60067985|NCT01608321|76183144|FG001|COMPLETED|Overall Study||4||
60067986|NCT01608321|76183143|FG000|NOT COMPLETED|Overall Study||1||
60067987|NCT01608321|76183144|FG001|NOT COMPLETED|Overall Study||0||
60067988|NCT01608087|76183153|FG000|STARTED|Overall Study||30||
60067989|NCT01608087|76183154|FG001|STARTED|Overall Study||30||
60067990|NCT01608087|76183155|FG002|STARTED|Overall Study||31||
60067991|NCT01608087|76183153|FG000|COMPLETED|Overall Study||30||
60067992|NCT01608087|76183154|FG001|COMPLETED|Overall Study||28||
60067993|NCT01608087|76183155|FG002|COMPLETED|Overall Study||31||
60067994|NCT01608087|76183153|FG000|NOT COMPLETED|Overall Study||0||
60067995|NCT01608087|76183154|FG001|NOT COMPLETED|Overall Study||2||
60067996|NCT01608087|76183155|FG002|NOT COMPLETED|Overall Study||0||
60067997|NCT01912963|76183166|FG000|STARTED|Overall Study||6||
60067998|NCT01912963|76183167|FG001|STARTED|Overall Study||19||
60067999|NCT01912963|76183168|FG002|STARTED|Overall Study||7||
60068000|NCT01912963|76183166|FG000|COMPLETED|Overall Study||0|Since treatment was not of fixed duration, all participants were considered 'Not Completed'.|
60068001|NCT01912963|76183167|FG001|COMPLETED|Overall Study||0|Since treatment was not of fixed duration, all participants were considered 'Not Completed'.|
60068002|NCT01912963|76183168|FG002|COMPLETED|Overall Study||0|Since treatment was not of fixed duration, all participants were considered 'Not Completed'.|
59519089|NCT00939731|75612967|FG001|NOT COMPLETED|First Intervention Period||0||
59519090|NCT00939731|75612966|FG000|STARTED|Washout Period (at Least 14 Days)||12||
59519091|NCT00939731|75612967|FG001|STARTED|Washout Period (at Least 14 Days)||12||
59519092|NCT00939731|75612966|FG000|COMPLETED|Washout Period (at Least 14 Days)||12||
59519093|NCT00939731|75612967|FG001|COMPLETED|Washout Period (at Least 14 Days)||12||
59519094|NCT00939731|75612966|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0||
59519095|NCT00939731|75612967|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0||
59519096|NCT00939731|75612966|FG000|STARTED|Second Intervention Period||12||
59519097|NCT00939731|75612967|FG001|STARTED|Second Intervention Period||12||
59519098|NCT00939731|75612966|FG000|COMPLETED|Second Intervention Period||12||
59519099|NCT00939731|75612967|FG001|COMPLETED|Second Intervention Period||12||
59519100|NCT00939731|75612966|FG000|NOT COMPLETED|Second Intervention Period||0||
59519101|NCT00939731|75612967|FG001|NOT COMPLETED|Second Intervention Period||0||
59519102|NCT00633945|75612973|FG000|STARTED|Overall Study||5||
59519103|NCT00633945|75612973|FG000|COMPLETED|Overall Study||3||
59519104|NCT00633945|75612973|FG000|NOT COMPLETED|Overall Study||2||
60068003|NCT01912963|76183166|FG000|NOT COMPLETED|Overall Study||6||
60068004|NCT01912963|76183167|FG001|NOT COMPLETED|Overall Study||19||
60068005|NCT01912963|76183168|FG002|NOT COMPLETED|Overall Study||7||
60068006|NCT01754727|76183176|FG000|STARTED|Overall Study||452||
60068007|NCT01754727|76183176|FG000|COMPLETED|Overall Study||450||
60068008|NCT01754727|76183176|FG000|NOT COMPLETED|Overall Study||2||
60068009|NCT01912807|76183182|FG000|STARTED|Overall Study|Enrolment phase: Recruiting of participants started December 11, 2013|150||
60068010|NCT01912807|76183183|FG001|STARTED|Overall Study|Enrolment phase: Recruitment of participants started December 11, 2013|150||
59613517|NCT01592292|75724647|FG000|Standard Population Set (SPS)|Overall Study|Excluding participants with change of administration drug or suspension of drug administration.|31||
59613518|NCT01592292|75724648|FG001|Standard Population Set (SPS)|Overall Study||10||
59613519|NCT01592292|75724649|FG002|Standard Population Set (SPS)|Overall Study||7||
60068011|NCT01912807|76183182|FG000|Randomized|Overall Study||144|10 participants were excluded as did not meet the eligibility criteria|
60068012|NCT01912807|76183183|FG001|Randomized|Overall Study||146|10 participants were excluded as did not meet the eligibility criteria|
60068013|NCT01912807|76183182|FG000|COMPLETED|Overall Study|"n=108 completed study and immediate follow up~n=36 participants were lost to follow up at 24 hr"|108||
60068014|NCT01912807|76183183|FG001|COMPLETED|Overall Study|"n=109 completed study and immediate follow up~n=37 participants were lost to follow up at 24 hr"|109||
60068015|NCT01912807|76183182|FG000|NOT COMPLETED|Overall Study||42||
60068016|NCT01912807|76183183|FG001|NOT COMPLETED|Overall Study||41||
60068017|NCT01782885|76183191|FG000|STARTED|Overall Study||36||
60068018|NCT01782885|76183192|FG001|STARTED|Overall Study||39||
60068019|NCT01782885|76183191|FG000|COMPLETED|Overall Study||32||
60068020|NCT01782885|76183192|FG001|COMPLETED|Overall Study||33||
59519105|NCT01118845|75612979|FG000|STARTED|Overall Study||59||
59519106|NCT01118845|75612979|FG000|COMPLETED|Overall Study||17||
59519107|NCT01118845|75612979|FG000|NOT COMPLETED|Overall Study||42||
59519108|NCT01120405|75612985|FG000|STARTED|Overall Study||298||
59519109|NCT01120405|75612986|FG001|STARTED|Overall Study||302||
59519110|NCT01120405|75612985|FG000|COMPLETED|Overall Study||271||
59519111|NCT01120405|75612986|FG001|COMPLETED|Overall Study||269||
59519112|NCT01120405|75612985|FG000|NOT COMPLETED|Overall Study||27||
60068021|NCT01782885|76183191|FG000|NOT COMPLETED|Overall Study||4||
60068022|NCT01782885|76183192|FG001|NOT COMPLETED|Overall Study||6||
60068023|NCT01912729|76183200|FG000|STARTED|Overall Study||20||
60068024|NCT01912729|76183201|FG001|STARTED|Overall Study||20||
60068025|NCT01912729|76183200|FG000|COMPLETED|Overall Study||20||
59519113|NCT01120405|75612986|FG001|NOT COMPLETED|Overall Study||33||
59519114|NCT03399370|75612996|FG000|STARTED|Overall Study||781||
59519115|NCT03399370|75612997|FG001|STARTED|Overall Study||780||
59613520|NCT01592292|75724650|FG003|Standard Population Set (SPS)|Overall Study||7||
59613521|NCT01592292|75724647|FG000|COMPLETED|Overall Study|Participants who completed 12 months visit.|40||
59613522|NCT01592292|75724648|FG001|COMPLETED|Overall Study||15||
59613523|NCT01592292|75724649|FG002|COMPLETED|Overall Study||10||
59519116|NCT03399370|75612996|FG000|COMPLETED|Overall Study||721||
59519117|NCT03399370|75612997|FG001|COMPLETED|Overall Study||694||
59519118|NCT03399370|75612996|FG000|NOT COMPLETED|Overall Study||60||
59613524|NCT01592292|75724650|FG003|COMPLETED|Overall Study||10||
60068026|NCT01912729|76183201|FG001|COMPLETED|Overall Study||19||
60068027|NCT01912729|76183200|FG000|NOT COMPLETED|Overall Study||0||
60068028|NCT01912729|76183201|FG001|NOT COMPLETED|Overall Study||1||
60068029|NCT01754493|76183207|FG000|STARTED|Overall Study||17||
60068030|NCT01754493|76183207|FG000|COMPLETED|Overall Study||10||
60068031|NCT01754493|76183207|FG000|NOT COMPLETED|Overall Study||7||
60068032|NCT01972789|76183213|FG000|STARTED|Overall Study||174||
60068033|NCT01972789|76183214|FG001|STARTED|Overall Study||175||
60068034|NCT01972789|76183213|FG000|COMPLETED|Overall Study||134||
60068035|NCT01972789|76183214|FG001|COMPLETED|Overall Study||145||
60068036|NCT01972789|76183213|FG000|NOT COMPLETED|Overall Study||40||
60068037|NCT01972789|76183214|FG001|NOT COMPLETED|Overall Study||30||
60068038|NCT01934335|76183222|FG000|STARTED|Overall Study||7||
60068039|NCT01934335|76183223|FG001|STARTED|Overall Study||5||
60068040|NCT01934335|76183222|FG000|COMPLETED|Overall Study||6||
60068041|NCT01934335|76183223|FG001|COMPLETED|Overall Study||4||
60068042|NCT01934335|76183222|FG000|NOT COMPLETED|Overall Study||1||
60068043|NCT01934335|76183223|FG001|NOT COMPLETED|Overall Study||1||
60068044|NCT01912339|76183231|FG000|STARTED|Blinded (0 to 3 Months)||136||
60068045|NCT01912339|76183232|FG001|STARTED|Blinded (0 to 3 Months)||61||
60068046|NCT01912339|76183233|FG002|STARTED|Blinded (0 to 3 Months)||0||
60068047|NCT01912339|76183231|FG000|COMPLETED|Blinded (0 to 3 Months)||134||
60068048|NCT01912339|76183232|FG001|COMPLETED|Blinded (0 to 3 Months)||61||
60068049|NCT01912339|76183233|FG002|COMPLETED|Blinded (0 to 3 Months)||0||
60068050|NCT01912339|76183231|FG000|NOT COMPLETED|Blinded (0 to 3 Months)||2||
60068051|NCT01912339|76183232|FG001|NOT COMPLETED|Blinded (0 to 3 Months)||0||
60068052|NCT01912339|76183233|FG002|NOT COMPLETED|Blinded (0 to 3 Months)||0||
60068053|NCT01912339|76183231|FG000|STARTED|Unblinded (3 to 6 Months/Crossover)||134||
60068054|NCT01912339|76183232|FG001|STARTED|Unblinded (3 to 6 Months/Crossover)||61||
60068055|NCT01912339|76183233|FG002|STARTED|Unblinded (3 to 6 Months/Crossover)||0||
60068056|NCT01912339|76183231|FG000|COMPLETED|Unblinded (3 to 6 Months/Crossover)|Still in study|133||
60068057|NCT01912339|76183232|FG001|COMPLETED|Unblinded (3 to 6 Months/Crossover)|Of the 61 subjects, there were 53 crossover subjects and 8 that completed their study participation.|61||
60068058|NCT01912339|76183233|FG002|COMPLETED|Unblinded (3 to 6 Months/Crossover)|Still in study|0||
60068059|NCT01912339|76183231|FG000|NOT COMPLETED|Unblinded (3 to 6 Months/Crossover)||1||
60068060|NCT01912339|76183232|FG001|NOT COMPLETED|Unblinded (3 to 6 Months/Crossover)||0||
60068061|NCT01912339|76183233|FG002|NOT COMPLETED|Unblinded (3 to 6 Months/Crossover)||0||
60068062|NCT01912339|76183231|FG000|STARTED|Unblinded (6 Months/Crossover to 5 Yrs)||133||
60068063|NCT01912339|76183232|FG001|STARTED|Unblinded (6 Months/Crossover to 5 Yrs)|All subjects for the control group either completed study or crossed over.|0||
60068064|NCT01912339|76183233|FG002|STARTED|Unblinded (6 Months/Crossover to 5 Yrs)|Control subjects that have crossed over.|53||
60068065|NCT01912339|76183231|FG000|COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||0||
60068066|NCT01912339|76183232|FG001|COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||0||
60068067|NCT01912339|76183233|FG002|COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||0||
60068068|NCT01912339|76183231|FG000|NOT COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||133||
60068069|NCT01912339|76183232|FG001|NOT COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||0||
60068070|NCT01912339|76183233|FG002|NOT COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||53||
60068071|NCT01911793|76183241|FG000|STARTED|Overall Study||1||
60068072|NCT01911793|76183242|FG001|STARTED|Overall Study||5||
60068073|NCT01911793|76183241|FG000|COMPLETED|Overall Study||0||
60068074|NCT01911793|76183242|FG001|COMPLETED|Overall Study||0||
60068075|NCT01911793|76183241|FG000|NOT COMPLETED|Overall Study||1||
60068076|NCT01911793|76183242|FG001|NOT COMPLETED|Overall Study||5||
60068077|NCT01933789|76183257|FG000|STARTED|Overall Study||65||
60068078|NCT01933789|76183258|FG001|STARTED|Overall Study||67||
60068079|NCT01933789|76183259|FG002|STARTED|Overall Study||2||
60068080|NCT01933789|76183260|FG003|STARTED|Overall Study||2||
60068081|NCT01933789|76183261|FG004|STARTED|Overall Study||249||
60068082|NCT01933789|76183262|FG005|STARTED|Overall Study||288||
60068083|NCT01933789|76183263|FG006|STARTED|Overall Study||58||
60068084|NCT01933789|76183264|FG007|STARTED|Overall Study||61||
60068085|NCT01933789|76183265|FG008|STARTED|Overall Study||25||
60068086|NCT01933789|76183257|FG000|Had Target Visit|Overall Study|Had target visit(s) completed before clinician or patient withdrawal|61||
60068087|NCT01933789|76183258|FG001|Had Target Visit|Overall Study|Had target visit(s) completed before clinician or patient withdrawal|65||
60068088|NCT01933789|76183259|FG002|Had Target Visit|Overall Study||2||
59519119|NCT03399370|75612997|FG001|NOT COMPLETED|Overall Study||86||
59519120|NCT00950729|75613004|FG000|STARTED|Driving With Running Shoes|March 2007|48||
59519121|NCT00950729|75613004|FG000|COMPLETED|Driving With Running Shoes|June 2007|48||
60068089|NCT01933789|76183260|FG003|Had Target Visit|Overall Study||2||
60068090|NCT01933789|76183261|FG004|Had Target Visit|Overall Study||228||
60068091|NCT01933789|76183262|FG005|Had Target Visit|Overall Study||266||
60068092|NCT01933789|76183263|FG006|Had Target Visit|Overall Study||0||
60068093|NCT01933789|76183264|FG007|Had Target Visit|Overall Study||0||
60068094|NCT01933789|76183265|FG008|Had Target Visit|Overall Study||0||
60068095|NCT01933789|76183257|FG000|Completed After-visit Survey|Overall Study|Number reflects individual clinicians who returned surveys for up to 6 enrolled patients|57||
59519122|NCT00950729|75613004|FG000|NOT COMPLETED|Driving With Running Shoes||0||
59519123|NCT00950729|75613004|FG000|STARTED|Driving With Plaster Cast||48||
59519124|NCT00950729|75613004|FG000|COMPLETED|Driving With Plaster Cast||48||
59519125|NCT00950729|75613004|FG000|NOT COMPLETED|Driving With Plaster Cast||0||
59519126|NCT00950729|75613004|FG000|STARTED|Driving With Aircast||48||
59519127|NCT00950729|75613004|FG000|COMPLETED|Driving With Aircast||48||
59519128|NCT00950729|75613004|FG000|NOT COMPLETED|Driving With Aircast||0||
59519129|NCT03597178|75613008|FG000|STARTED|Overall Study||14||
59519130|NCT03597178|75613008|FG000|COMPLETED|Overall Study||14||
59519131|NCT03597178|75613008|FG000|NOT COMPLETED|Overall Study||0||
59519132|NCT03544216|75613014|FG000|STARTED|Overall Study||42||
59519133|NCT03544216|75613015|FG001|STARTED|Overall Study||42||
59519134|NCT03544216|75613014|FG000|COMPLETED|Overall Study||42||
59519135|NCT03544216|75613015|FG001|COMPLETED|Overall Study||42||
59951537|NCT02607930|76070544|FG001|COMPLETED|Open-Label B/F/TAF Extension Phase||0||
59951538|NCT02607930|76070545|FG002|COMPLETED|Open-Label B/F/TAF Extension Phase||218||
59951539|NCT02607930|76070546|FG003|COMPLETED|Open-Label B/F/TAF Extension Phase||221||
59519136|NCT03544216|75613014|FG000|NOT COMPLETED|Overall Study||0||
59519137|NCT03544216|75613015|FG001|NOT COMPLETED|Overall Study||0||
59519138|NCT01120639|75613026|FG000|STARTED|Overall Study||6||
59519139|NCT01120639|75613027|FG001|STARTED|Overall Study||6||
59519140|NCT01120639|75613028|FG002|STARTED|Overall Study||6||
59519141|NCT01120639|75613029|FG003|STARTED|Overall Study||12||
59519142|NCT01120639|75613026|FG000|COMPLETED|Overall Study||6||
59951540|NCT02607930|76070543|FG000|NOT COMPLETED|Open-Label B/F/TAF Extension Phase||0||
59951541|NCT02607930|76070544|FG001|NOT COMPLETED|Open-Label B/F/TAF Extension Phase||0||
59951542|NCT02607930|76070545|FG002|NOT COMPLETED|Open-Label B/F/TAF Extension Phase||34||
59951543|NCT02607930|76070546|FG003|NOT COMPLETED|Open-Label B/F/TAF Extension Phase||33||
59951544|NCT02056782|76070556|FG000|STARTED|Overall Study||12||
59951545|NCT02056782|76070556|FG000|COMPLETED|Overall Study||10||
59951546|NCT02056782|76070556|FG000|NOT COMPLETED|Overall Study||2||
59951547|NCT01733888|76070564|FG000|STARTED|Overall Study||20||
59951548|NCT01733888|76070565|FG001|STARTED|Overall Study||20||
59951549|NCT01733888|76070566|FG002|STARTED|Overall Study||20||
59951550|NCT01733888|76070567|FG003|STARTED|Overall Study||20||
59951551|NCT01733888|76070564|FG000|COMPLETED|Overall Study||20||
59951552|NCT01733888|76070565|FG001|COMPLETED|Overall Study||20||
59951553|NCT01733888|76070566|FG002|COMPLETED|Overall Study||20||
59951554|NCT01733888|76070567|FG003|COMPLETED|Overall Study||20||
59951555|NCT01733888|76070564|FG000|NOT COMPLETED|Overall Study||0||
59951556|NCT01733888|76070565|FG001|NOT COMPLETED|Overall Study||0||
59951557|NCT01733888|76070566|FG002|NOT COMPLETED|Overall Study||0||
59951558|NCT01733888|76070567|FG003|NOT COMPLETED|Overall Study||0||
59951559|NCT02736188|76070577|FG000|STARTED|Overall Study||142||
59951560|NCT02736188|76070577|FG000|COMPLETED|Overall Study||0||
59951561|NCT02736188|76070577|FG000|NOT COMPLETED|Overall Study||142||
59951562|NCT00154284|76070585|FG000|STARTED|Overall Study|"Started indicates Safety Population (randomized patients and treated after randomization.)"|59||
59951563|NCT00154284|76070586|FG001|STARTED|Overall Study||55||
59951564|NCT00154284|76070585|FG000|Intent to Treat (ITT) Population|Overall Study||57||
59951565|NCT00154284|76070586|FG001|Intent to Treat (ITT) Population|Overall Study||53||
59951566|NCT00154284|76070585|FG000|COMPLETED|Overall Study|"Completed means patients completed on study medication.All patients of both arms completed study."|52||
59951567|NCT00154284|76070586|FG001|COMPLETED|Overall Study||42||
59951568|NCT00154284|76070585|FG000|NOT COMPLETED|Overall Study||7||
59951569|NCT00154284|76070586|FG001|NOT COMPLETED|Overall Study||13||
59951570|NCT02735096|76070594|FG000|STARTED|Overall Study||4||
59951571|NCT02735096|76070594|FG000|COMPLETED|Overall Study||3||
59951572|NCT02735096|76070594|FG000|NOT COMPLETED|Overall Study||1||
59951573|NCT00911274|76070600|FG000|STARTED|Period 1||27||
59951574|NCT00911274|76070601|FG001|STARTED|Period 1||26||
59951575|NCT00911274|76070600|FG000|COMPLETED|Period 1||27||
59951576|NCT00911274|76070601|FG001|COMPLETED|Period 1||26||
59951577|NCT00911274|76070600|FG000|NOT COMPLETED|Period 1||0||
59951578|NCT00911274|76070601|FG001|NOT COMPLETED|Period 1||0||
59951579|NCT00911274|76070600|FG000|STARTED|Period 2||27||
59951580|NCT00911274|76070601|FG001|STARTED|Period 2||26||
59951581|NCT00911274|76070600|FG000|COMPLETED|Period 2||27||
59951582|NCT00911274|76070601|FG001|COMPLETED|Period 2||26||
59951583|NCT00911274|76070600|FG000|NOT COMPLETED|Period 2||0||
59951584|NCT00911274|76070601|FG001|NOT COMPLETED|Period 2||0||
59951585|NCT00905346|76070607|FG000|STARTED|Period 1||12||
59951586|NCT00905346|76070608|FG001|STARTED|Period 1||12||
59951587|NCT00905346|76070607|FG000|COMPLETED|Period 1||11||
59519143|NCT01120639|75613027|FG001|COMPLETED|Overall Study||6||
59519144|NCT01120639|75613028|FG002|COMPLETED|Overall Study||6||
59519145|NCT01120639|75613029|FG003|COMPLETED|Overall Study||12||
59519146|NCT01120639|75613026|FG000|NOT COMPLETED|Overall Study||0||
59519147|NCT01120639|75613027|FG001|NOT COMPLETED|Overall Study||0||
59951588|NCT00905346|76070608|FG001|COMPLETED|Period 1||12||
59951589|NCT00905346|76070607|FG000|NOT COMPLETED|Period 1||1||
59951590|NCT00905346|76070608|FG001|NOT COMPLETED|Period 1||0||
59951591|NCT00905346|76070607|FG000|STARTED|Period 2|one subject withdrew prior to Pd. 2 dosing|10||
59951592|NCT00905346|76070608|FG001|STARTED|Period 2|one subject withdrew prior to Pd. 2 dosing|11||
60068096|NCT01933789|76183258|FG001|Completed After-visit Survey|Overall Study|Number reflects individual clinicians who returned surveys for up to 6 enrolled patients|64||
60068097|NCT01933789|76183259|FG002|Completed After-visit Survey|Overall Study|Number reflects individual IP Team members who returned surveys for up to 6 enrolled patients|2||
60068098|NCT01933789|76183260|FG003|Completed After-visit Survey|Overall Study|Number reflects individual IP Team members who returned surveys for up to 6 enrolled patients|1||
60068099|NCT01933789|76183261|FG004|Completed After-visit Survey|Overall Study||0||
60068100|NCT01933789|76183262|FG005|Completed After-visit Survey|Overall Study||0||
60068101|NCT01933789|76183263|FG006|Completed After-visit Survey|Overall Study||0||
60068102|NCT01933789|76183264|FG007|Completed After-visit Survey|Overall Study||0||
60068103|NCT01933789|76183265|FG008|Completed After-visit Survey|Overall Study||0||
60068104|NCT01933789|76183257|FG000|Completed 2-Week Survey|Overall Study||0||
60068105|NCT01933789|76183258|FG001|Completed 2-Week Survey|Overall Study||0||
60068106|NCT01933789|76183259|FG002|Completed 2-Week Survey|Overall Study||0||
60068107|NCT01933789|76183260|FG003|Completed 2-Week Survey|Overall Study||0||
60068108|NCT01933789|76183261|FG004|Completed 2-Week Survey|Overall Study||184||
60068109|NCT01933789|76183262|FG005|Completed 2-Week Survey|Overall Study||215||
60068110|NCT01933789|76183263|FG006|Completed 2-Week Survey|Overall Study||0||
60068111|NCT01933789|76183264|FG007|Completed 2-Week Survey|Overall Study||0||
60068112|NCT01933789|76183265|FG008|Completed 2-Week Survey|Overall Study||0||
60068113|NCT01933789|76183257|FG000|Completed 3-Month Survey|Overall Study||0||
60068114|NCT01933789|76183258|FG001|Completed 3-Month Survey|Overall Study||0||
60068115|NCT01933789|76183259|FG002|Completed 3-Month Survey|Overall Study||0||
60068116|NCT01933789|76183260|FG003|Completed 3-Month Survey|Overall Study||0||
60068117|NCT01933789|76183261|FG004|Completed 3-Month Survey|Overall Study||176||
60068118|NCT01933789|76183262|FG005|Completed 3-Month Survey|Overall Study||211||
60068119|NCT01933789|76183263|FG006|Completed 3-Month Survey|Overall Study||37||
60068120|NCT01933789|76183264|FG007|Completed 3-Month Survey|Overall Study||43||
60068121|NCT01933789|76183265|FG008|Completed 3-Month Survey|Overall Study||0||
60068122|NCT01933789|76183257|FG000|Completed 6-Month Survey|Overall Study||0||
60068123|NCT01933789|76183258|FG001|Completed 6-Month Survey|Overall Study||0||
60068124|NCT01933789|76183259|FG002|Completed 6-Month Survey|Overall Study||0||
59762690|NCT00868608|75882543|FG001|COMPLETED|Overall Study||1||
59762691|NCT00868608|75882544|FG002|COMPLETED|Overall Study||0||
59762692|NCT00868608|75882542|FG000|NOT COMPLETED|Overall Study||23||
60068125|NCT01933789|76183260|FG003|Completed 6-Month Survey|Overall Study||0||
60068126|NCT01933789|76183261|FG004|Completed 6-Month Survey|Overall Study||160||
60068127|NCT01933789|76183262|FG005|Completed 6-Month Survey|Overall Study||188||
60068128|NCT01933789|76183263|FG006|Completed 6-Month Survey|Overall Study||35||
60068129|NCT01933789|76183264|FG007|Completed 6-Month Survey|Overall Study||40||
60068130|NCT01933789|76183265|FG008|Completed 6-Month Survey|Overall Study||0||
60068131|NCT01933789|76183257|FG000|Qualitative Interviews|Overall Study||0||
60068132|NCT01933789|76183258|FG001|Qualitative Interviews|Overall Study||0||
60068133|NCT01933789|76183259|FG002|Qualitative Interviews|Overall Study||0||
60068134|NCT01933789|76183260|FG003|Qualitative Interviews|Overall Study||0||
60068135|NCT01933789|76183261|FG004|Qualitative Interviews|Overall Study||0||
60068136|NCT01933789|76183262|FG005|Qualitative Interviews|Overall Study||0||
59762693|NCT00868608|75882543|FG001|NOT COMPLETED|Overall Study||3||
59762694|NCT00868608|75882544|FG002|NOT COMPLETED|Overall Study||5||
59762695|NCT00856635|75882554|FG000|STARTED|Overall Study||22||
59762696|NCT00856635|75882555|FG001|STARTED|Overall Study||22||
59762697|NCT00856635|75882554|FG000|Received Study Drug|Overall Study||20||
60068137|NCT01933789|76183263|FG006|Qualitative Interviews|Overall Study||0||
60068138|NCT01933789|76183264|FG007|Qualitative Interviews|Overall Study||0||
60068139|NCT01933789|76183265|FG008|Qualitative Interviews|Overall Study||25||
60068140|NCT01933789|76183257|FG000|COMPLETED|Overall Study||59||
60068141|NCT01933789|76183258|FG001|COMPLETED|Overall Study||66||
60068142|NCT01933789|76183259|FG002|COMPLETED|Overall Study||2||
60068143|NCT01933789|76183260|FG003|COMPLETED|Overall Study||1||
59762698|NCT00856635|75882555|FG001|Received Study Drug|Overall Study||20||
59762699|NCT00856635|75882554|FG000|COMPLETED|Overall Study||12||
59762700|NCT00856635|75882555|FG001|COMPLETED|Overall Study||14||
59762701|NCT00856635|75882554|FG000|NOT COMPLETED|Overall Study||10||
59762702|NCT00856635|75882555|FG001|NOT COMPLETED|Overall Study||8||
59762703|NCT00856557|75882565|FG000|STARTED|Overall Study||62||
59762704|NCT00856557|75882566|FG001|STARTED|Overall Study||76||
59519148|NCT01120639|75613028|FG002|NOT COMPLETED|Overall Study||0||
59519149|NCT01120639|75613029|FG003|NOT COMPLETED|Overall Study||0||
59519150|NCT00951821|75613041|FG000|STARTED|Overall Study||16||
59519151|NCT00951821|75613042|FG001|STARTED|Overall Study||8||
59519152|NCT00951821|75613041|FG000|COMPLETED|Overall Study||16||
59519153|NCT00951821|75613042|FG001|COMPLETED|Overall Study||8||
59951593|NCT00905346|76070607|FG000|COMPLETED|Period 2||10||
59951594|NCT00905346|76070608|FG001|COMPLETED|Period 2||11||
59951595|NCT00905346|76070607|FG000|NOT COMPLETED|Period 2||0||
59951596|NCT00905346|76070608|FG001|NOT COMPLETED|Period 2||0||
59951597|NCT03928392|76070614|FG000|STARTED|Overall Study||7||
60068144|NCT01933789|76183261|FG004|COMPLETED|Overall Study||190||
60068145|NCT01933789|76183262|FG005|COMPLETED|Overall Study||221||
60068146|NCT01933789|76183263|FG006|COMPLETED|Overall Study||43||
60068147|NCT01933789|76183264|FG007|COMPLETED|Overall Study||47||
60068148|NCT01933789|76183265|FG008|COMPLETED|Overall Study||25||
60068149|NCT01933789|76183257|FG000|NOT COMPLETED|Overall Study||6||
60068150|NCT01933789|76183258|FG001|NOT COMPLETED|Overall Study||1||
60068151|NCT01933789|76183259|FG002|NOT COMPLETED|Overall Study||0||
60068152|NCT01933789|76183260|FG003|NOT COMPLETED|Overall Study||1||
60068153|NCT01933789|76183261|FG004|NOT COMPLETED|Overall Study||59||
60068154|NCT01933789|76183262|FG005|NOT COMPLETED|Overall Study||67||
60068155|NCT01933789|76183263|FG006|NOT COMPLETED|Overall Study||15||
60068156|NCT01933789|76183264|FG007|NOT COMPLETED|Overall Study||14||
60068157|NCT01933789|76183265|FG008|NOT COMPLETED|Overall Study||0||
60068158|NCT01910389|76183287|FG000|STARTED|Overall Study||15||
60068159|NCT01910389|76183288|FG001|STARTED|Overall Study||8||
60068160|NCT01910389|76183287|FG000|COMPLETED|Overall Study||0||
60068161|NCT01910389|76183288|FG001|COMPLETED|Overall Study||0||
60068162|NCT01910389|76183287|FG000|NOT COMPLETED|Overall Study||15||
60068163|NCT01910389|76183288|FG001|NOT COMPLETED|Overall Study||8||
60068164|NCT01970995|76183297|FG000|STARTED|Confinement Period (Population at Day 5)||78||
60068165|NCT01970995|76183298|FG001|STARTED|Confinement Period (Population at Day 5)||42||
60068166|NCT01970995|76183299|FG002|STARTED|Confinement Period (Population at Day 5)||40||
60068167|NCT01970995|76183297|FG000|COMPLETED|Confinement Period (Population at Day 5)||77||
60068168|NCT01970995|76183298|FG001|COMPLETED|Confinement Period (Population at Day 5)||41||
60068169|NCT01970995|76183299|FG002|COMPLETED|Confinement Period (Population at Day 5)||39||
60068170|NCT01970995|76183297|FG000|NOT COMPLETED|Confinement Period (Population at Day 5)||1||
60068171|NCT01970995|76183298|FG001|NOT COMPLETED|Confinement Period (Population at Day 5)||1||
60068172|NCT01970995|76183299|FG002|NOT COMPLETED|Confinement Period (Population at Day 5)||1||
60068173|NCT01970995|76183297|FG000|STARTED|End of Study (Population at Day 90)||77||
60068174|NCT01970995|76183298|FG001|STARTED|End of Study (Population at Day 90)||41||
60068175|NCT01970995|76183299|FG002|STARTED|End of Study (Population at Day 90)||39||
60068176|NCT01970995|76183297|FG000|COMPLETED|End of Study (Population at Day 90)||76||
60068177|NCT01970995|76183298|FG001|COMPLETED|End of Study (Population at Day 90)||41||
60068178|NCT01970995|76183299|FG002|COMPLETED|End of Study (Population at Day 90)||38||
60068179|NCT01970995|76183297|FG000|NOT COMPLETED|End of Study (Population at Day 90)||1||
60068180|NCT01970995|76183298|FG001|NOT COMPLETED|End of Study (Population at Day 90)||0||
60068181|NCT01970995|76183299|FG002|NOT COMPLETED|End of Study (Population at Day 90)||1||
60068182|NCT01970527|76183309|FG000|STARTED|Pre-treatment/Baseline||9||
60068183|NCT01970527|76183310|FG001|STARTED|Pre-treatment/Baseline||14||
60068184|NCT01970527|76183309|FG000|COMPLETED|Pre-treatment/Baseline||8||
60068185|NCT01970527|76183310|FG001|COMPLETED|Pre-treatment/Baseline||14||
60068186|NCT01970527|76183309|FG000|NOT COMPLETED|Pre-treatment/Baseline||1||
60068187|NCT01970527|76183310|FG001|NOT COMPLETED|Pre-treatment/Baseline||0||
59519154|NCT00951821|75613041|FG000|NOT COMPLETED|Overall Study||0||
59519155|NCT00951821|75613042|FG001|NOT COMPLETED|Overall Study||0||
59519156|NCT03599986|75613048|FG000|STARTED|Overall Study||398||
59613525|NCT01592292|75724647|FG000|NOT COMPLETED|Overall Study||6||
59951598|NCT03928392|76070615|FG001|STARTED|Overall Study||8||
59951599|NCT03928392|76070614|FG000|COMPLETED|Overall Study||7||
59951600|NCT03928392|76070615|FG001|COMPLETED|Overall Study||8||
60068188|NCT01970527|76183309|FG000|STARTED|Treatment||8||
60068189|NCT01970527|76183310|FG001|STARTED|Treatment||14||
60068190|NCT01970527|76183309|FG000|COMPLETED|Treatment||8||
60068191|NCT01970527|76183310|FG001|COMPLETED|Treatment||11||
59519157|NCT03599986|75613048|FG000|COMPLETED|Overall Study||366||
59519158|NCT03599986|75613048|FG000|NOT COMPLETED|Overall Study||32||
59519159|NCT01095757|75613053|FG000|STARTED|Overall Study||45||
59519160|NCT01095757|75613053|FG000|COMPLETED|Overall Study||45||
59519161|NCT01095757|75613053|FG000|NOT COMPLETED|Overall Study||0||
59613526|NCT01592292|75724648|FG001|NOT COMPLETED|Overall Study||5||
59951601|NCT03928392|76070614|FG000|NOT COMPLETED|Overall Study||0||
59519162|NCT03549598|75613058|FG000|STARTED|Overall Study||15||
59613527|NCT01592292|75724649|FG002|NOT COMPLETED|Overall Study||3||
59951602|NCT03928392|76070615|FG001|NOT COMPLETED|Overall Study||0||
59951603|NCT01328444|76070621|FG000|STARTED|Treatment Period 1 (12 Weeks)||94||
59951604|NCT01328444|76070622|FG001|STARTED|Treatment Period 1 (12 Weeks)||26||
60068192|NCT01970527|76183309|FG000|NOT COMPLETED|Treatment||0||
60068193|NCT01970527|76183310|FG001|NOT COMPLETED|Treatment||3||
60068194|NCT01970527|76183309|FG000|STARTED|Follow-up Clinic Visit||8||
60068195|NCT01970527|76183310|FG001|STARTED|Follow-up Clinic Visit||11||
60068196|NCT01970527|76183309|FG000|COMPLETED|Follow-up Clinic Visit||7||
60068197|NCT01970527|76183310|FG001|COMPLETED|Follow-up Clinic Visit||8||
60068198|NCT01970527|76183309|FG000|NOT COMPLETED|Follow-up Clinic Visit||1||
60068199|NCT01970527|76183310|FG001|NOT COMPLETED|Follow-up Clinic Visit||3||
60068200|NCT01931995|76183321|FG000|STARTED|First Intervention (1 Day)||23||
60068201|NCT01931995|76183322|FG001|STARTED|First Intervention (1 Day)||22||
60068202|NCT01931995|76183321|FG000|COMPLETED|First Intervention (1 Day)||19||
60068203|NCT01931995|76183322|FG001|COMPLETED|First Intervention (1 Day)||18||
60068204|NCT01931995|76183321|FG000|NOT COMPLETED|First Intervention (1 Day)||4||
60068205|NCT01931995|76183322|FG001|NOT COMPLETED|First Intervention (1 Day)||4||
60068206|NCT01931995|76183321|FG000|STARTED|Washout (at Least 6 Days)||19||
60068207|NCT01931995|76183322|FG001|STARTED|Washout (at Least 6 Days)||18||
60068208|NCT01931995|76183321|FG000|COMPLETED|Washout (at Least 6 Days)||19||
60068209|NCT01931995|76183322|FG001|COMPLETED|Washout (at Least 6 Days)||18||
60068210|NCT01931995|76183321|FG000|NOT COMPLETED|Washout (at Least 6 Days)||0||
60068211|NCT01931995|76183322|FG001|NOT COMPLETED|Washout (at Least 6 Days)||0||
60068212|NCT01931995|76183321|FG000|STARTED|Second Intervention (1 Day)||18||
60068213|NCT01931995|76183322|FG001|STARTED|Second Intervention (1 Day)||19||
60068214|NCT01931995|76183321|FG000|COMPLETED|Second Intervention (1 Day)||18||
60068215|NCT01931995|76183322|FG001|COMPLETED|Second Intervention (1 Day)||19||
60068216|NCT01931995|76183321|FG000|NOT COMPLETED|Second Intervention (1 Day)||0||
60068217|NCT01931995|76183322|FG001|NOT COMPLETED|Second Intervention (1 Day)||0||
60068218|NCT01408576|76183331|FG000|STARTED|Overall Study||244||
60068219|NCT01408576|76183332|FG001|STARTED|Overall Study||498||
60068220|NCT01408576|76183333|FG002|STARTED|Overall Study||508||
60068221|NCT01408576|76183331|FG000|COMPLETED|Overall Study||56||
60068222|NCT01408576|76183332|FG001|COMPLETED|Overall Study||0||
60068223|NCT01408576|76183333|FG002|COMPLETED|Overall Study||0||
60068224|NCT01408576|76183331|FG000|NOT COMPLETED|Overall Study||188||
60068225|NCT01408576|76183332|FG001|NOT COMPLETED|Overall Study||498||
60068226|NCT01408576|76183333|FG002|NOT COMPLETED|Overall Study||508||
60068227|NCT01427920|76183355|FG000|STARTED|Overall Study||174||
60068228|NCT01427920|76183356|FG001|STARTED|Overall Study||174||
60068229|NCT01427920|76183355|FG000|Exposed|Overall Study||174||
60068230|NCT01427920|76183356|FG001|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|173||
60068231|NCT01427920|76183355|FG000|COMPLETED|Overall Study||165||
60068232|NCT01427920|76183356|FG001|COMPLETED|Overall Study||157||
60068233|NCT01427920|76183355|FG000|NOT COMPLETED|Overall Study||9||
60068234|NCT01427920|76183356|FG001|NOT COMPLETED|Overall Study||17||
60068235|NCT01427608|76183364|FG000|STARTED|Overall Study||64||
60068236|NCT01427608|76183365|FG001|STARTED|Overall Study||62||
60068237|NCT01427608|76183364|FG000|COMPLETED|Overall Study||43||
60068238|NCT01427608|76183365|FG001|COMPLETED|Overall Study||24||
60068239|NCT01427608|76183364|FG000|NOT COMPLETED|Overall Study||21||
60068240|NCT01427608|76183365|FG001|NOT COMPLETED|Overall Study||38||
60068241|NCT01408030|76183377|FG000|STARTED|Treatment Phase (on Drug)||29||
60068242|NCT01408030|76183378|FG001|STARTED|Treatment Phase (on Drug)||31||
60068243|NCT01408030|76183379|FG002|STARTED|Treatment Phase (on Drug)||33||
60068244|NCT01408030|76183380|FG003|STARTED|Treatment Phase (on Drug)||28||
60068245|NCT01408030|76183377|FG000|COMPLETED|Treatment Phase (on Drug)||26||
60068246|NCT01408030|76183378|FG001|COMPLETED|Treatment Phase (on Drug)||24||
60068247|NCT01408030|76183379|FG002|COMPLETED|Treatment Phase (on Drug)||32||
60068248|NCT01408030|76183380|FG003|COMPLETED|Treatment Phase (on Drug)||25||
60068249|NCT01408030|76183377|FG000|NOT COMPLETED|Treatment Phase (on Drug)||3||
60068250|NCT01408030|76183378|FG001|NOT COMPLETED|Treatment Phase (on Drug)||7||
60068251|NCT01408030|76183379|FG002|NOT COMPLETED|Treatment Phase (on Drug)||1||
60068252|NCT01408030|76183380|FG003|NOT COMPLETED|Treatment Phase (on Drug)||3||
60068253|NCT01408030|76183377|FG000|STARTED|Observation Phase (Off Drug)||26||
60068254|NCT01408030|76183378|FG001|STARTED|Observation Phase (Off Drug)||24||
60068255|NCT01408030|76183379|FG002|STARTED|Observation Phase (Off Drug)||32||
60068256|NCT01408030|76183380|FG003|STARTED|Observation Phase (Off Drug)||25||
60068257|NCT01408030|76183377|FG000|COMPLETED|Observation Phase (Off Drug)||22||
60068258|NCT01408030|76183378|FG001|COMPLETED|Observation Phase (Off Drug)||18||
60068259|NCT01408030|76183379|FG002|COMPLETED|Observation Phase (Off Drug)||26||
60068260|NCT01408030|76183380|FG003|COMPLETED|Observation Phase (Off Drug)||21||
60068261|NCT01408030|76183377|FG000|NOT COMPLETED|Observation Phase (Off Drug)||4||
60068262|NCT01408030|76183378|FG001|NOT COMPLETED|Observation Phase (Off Drug)||6||
60068263|NCT01408030|76183379|FG002|NOT COMPLETED|Observation Phase (Off Drug)||6||
60068264|NCT01408030|76183380|FG003|NOT COMPLETED|Observation Phase (Off Drug)||4||
60068265|NCT01897532|76183392|FG000|STARTED|Discontinuation From Treatment||3492|Randomised|
60068266|NCT01897532|76183393|FG001|STARTED|Discontinuation From Treatment||3499|Randomised|
60068267|NCT01897532|76183392|FG000|Treated|Discontinuation From Treatment||3485||
60068268|NCT01897532|76183393|FG001|Treated|Discontinuation From Treatment||3494||
60068269|NCT01897532|76183392|FG000|COMPLETED|Discontinuation From Treatment||2530|Not prematurely discontinued from trial medication|
60068270|NCT01897532|76183393|FG001|COMPLETED|Discontinuation From Treatment||2660|Not prematurely discontinued from trial medication|
60068271|NCT01897532|76183392|FG000|NOT COMPLETED|Discontinuation From Treatment||962||
60068272|NCT01897532|76183393|FG001|NOT COMPLETED|Discontinuation From Treatment||839||
60068273|NCT01897532|76183392|FG000|STARTED|Discontinuation From Trial||3492|Randomised|
60068274|NCT01897532|76183393|FG001|STARTED|Discontinuation From Trial||3499|Randomised|
60068275|NCT01897532|76183392|FG000|Treated|Discontinuation From Trial||3485||
60068276|NCT01897532|76183393|FG001|Treated|Discontinuation From Trial||3494||
60068277|NCT01897532|76183392|FG000|COMPLETED|Discontinuation From Trial||3430|Completed the trial or died|
60068278|NCT01897532|76183393|FG001|COMPLETED|Discontinuation From Trial||3458|Completed the trial or died|
60068279|NCT01897532|76183392|FG000|NOT COMPLETED|Discontinuation From Trial||62||
60068280|NCT01897532|76183393|FG001|NOT COMPLETED|Discontinuation From Trial||41||
60068281|NCT01923428|76183403|FG000|STARTED|Overall Study||88||
60068282|NCT01923428|76183404|FG001|STARTED|Overall Study||89||
60068283|NCT01923428|76183405|FG002|STARTED|Overall Study||89||
60068284|NCT01923428|76183406|FG003|STARTED|Overall Study||90||
60068285|NCT01923428|76183403|FG000|COMPLETED|Overall Study||69||
60068286|NCT01923428|76183404|FG001|COMPLETED|Overall Study||77||
60068287|NCT01923428|76183405|FG002|COMPLETED|Overall Study||78||
60068288|NCT01923428|76183406|FG003|COMPLETED|Overall Study||80||
60068289|NCT01923428|76183403|FG000|NOT COMPLETED|Overall Study||19||
60068290|NCT01923428|76183404|FG001|NOT COMPLETED|Overall Study||12||
60068291|NCT01923428|76183405|FG002|NOT COMPLETED|Overall Study||11||
60068292|NCT01923428|76183406|FG003|NOT COMPLETED|Overall Study||10||
60068293|NCT01896986|76183418|FG000|STARTED|Overall Study||14||
60068294|NCT01896986|76183419|FG001|STARTED|Overall Study||23||
60068295|NCT01896986|76183418|FG000|COMPLETED|Overall Study||0||
60068296|NCT01896986|76183419|FG001|COMPLETED|Overall Study||0||
60068297|NCT01896986|76183418|FG000|NOT COMPLETED|Overall Study||14||
60068298|NCT01896986|76183419|FG001|NOT COMPLETED|Overall Study||23||
60068299|NCT01896128|76183427|FG000|STARTED|Overall Study||8||
60068300|NCT01896128|76183428|FG001|STARTED|Overall Study||11||
60068301|NCT01896128|76183427|FG000|COMPLETED|Overall Study||5||
60068302|NCT01896128|76183428|FG001|COMPLETED|Overall Study||8||
60068303|NCT01896128|76183427|FG000|NOT COMPLETED|Overall Study||3||
60068304|NCT01896128|76183428|FG001|NOT COMPLETED|Overall Study||3||
60068305|NCT01949870|76183434|FG000|STARTED|Overall Study||6||
60068306|NCT01949870|76183434|FG000|Received Treatment|Overall Study||4||
60068307|NCT01949870|76183434|FG000|COMPLETED|Overall Study||0||
60068308|NCT01949870|76183434|FG000|NOT COMPLETED|Overall Study||6||
60068309|NCT01949480|76183440|FG000|STARTED|Overall Study||20||
60068310|NCT01949480|76183441|FG001|STARTED|Overall Study||22||
60068311|NCT01949480|76183440|FG000|COMPLETED|Overall Study||15||
60068312|NCT01949480|76183441|FG001|COMPLETED|Overall Study||14||
60068313|NCT01949480|76183440|FG000|NOT COMPLETED|Overall Study||5||
60068314|NCT01949480|76183441|FG001|NOT COMPLETED|Overall Study||8||
60068315|NCT01949090|76183452|FG000|STARTED|Overall Study||60||
60068316|NCT01949090|76183453|FG001|STARTED|Overall Study||60||
60068317|NCT01949090|76183454|FG002|STARTED|Overall Study||60||
60068318|NCT01949090|76183455|FG003|STARTED|Overall Study||60||
60068319|NCT01949090|76183456|FG004|STARTED|Overall Study||120||
60068320|NCT01949090|76183452|FG000|COMPLETED|Overall Study||56||
60068321|NCT01949090|76183453|FG001|COMPLETED|Overall Study||58||
60068322|NCT01949090|76183454|FG002|COMPLETED|Overall Study||58||
60068323|NCT01949090|76183455|FG003|COMPLETED|Overall Study||59||
60068324|NCT01949090|76183456|FG004|COMPLETED|Overall Study||116||
60068325|NCT01949090|76183452|FG000|NOT COMPLETED|Overall Study||4||
60068326|NCT01949090|76183453|FG001|NOT COMPLETED|Overall Study||2||
60068327|NCT01949090|76183454|FG002|NOT COMPLETED|Overall Study||2||
60068328|NCT01949090|76183455|FG003|NOT COMPLETED|Overall Study||1||
60068329|NCT01949090|76183456|FG004|NOT COMPLETED|Overall Study||4||
60068330|NCT01948076|76183471|FG000|STARTED|Overall Study||20||
60068331|NCT01948076|76183472|FG001|STARTED|Overall Study||20||
60068332|NCT01948076|76183471|FG000|COMPLETED|Overall Study||20||
60068333|NCT01948076|76183472|FG001|COMPLETED|Overall Study||19||
60068334|NCT01948076|76183471|FG000|NOT COMPLETED|Overall Study||0||
60068335|NCT01948076|76183472|FG001|NOT COMPLETED|Overall Study||1||
60068336|NCT01922258|76183482|FG000|STARTED|Overall Study||133||
60068337|NCT01922258|76183483|FG001|STARTED|Overall Study||137||
60068338|NCT01922258|76183482|FG000|COMPLETED|Overall Study||117||
60068339|NCT01922258|76183483|FG001|COMPLETED|Overall Study||121||
60068340|NCT01922258|76183482|FG000|NOT COMPLETED|Overall Study||16||
60068341|NCT01922258|76183483|FG001|NOT COMPLETED|Overall Study||16||
60068342|NCT01406938|76183491|FG000|STARTED|Induction Period||482||
60068343|NCT01406938|76183492|FG001|STARTED|Induction Period||484||
60068344|NCT01406938|76183493|FG002|STARTED|Induction Period||0||
60068345|NCT01406938|76183494|FG003|STARTED|Induction Period||0||
60068346|NCT01406938|76183495|FG004|STARTED|Induction Period||0||
60068347|NCT01406938|76183496|FG005|STARTED|Induction Period||0||
60068348|NCT01406938|76183491|FG000|FAS:Patients Assigned Study Treatment|Induction Period||482||
60068349|NCT01406938|76183492|FG001|FAS:Patients Assigned Study Treatment|Induction Period||483||
60068350|NCT01406938|76183493|FG002|FAS:Patients Assigned Study Treatment|Induction Period||0||
60068351|NCT01406938|76183494|FG003|FAS:Patients Assigned Study Treatment|Induction Period||0||
60068352|NCT01406938|76183495|FG004|FAS:Patients Assigned Study Treatment|Induction Period||0||
60068353|NCT01406938|76183496|FG005|FAS:Patients Assigned Study Treatment|Induction Period||0||
60068354|NCT01406938|76183491|FG000|COMPLETED|Induction Period||464||
60068355|NCT01406938|76183492|FG001|COMPLETED|Induction Period||464||
60068356|NCT01406938|76183493|FG002|COMPLETED|Induction Period||0||
60068357|NCT01406938|76183494|FG003|COMPLETED|Induction Period||0||
60068358|NCT01406938|76183495|FG004|COMPLETED|Induction Period||0||
60068359|NCT01406938|76183496|FG005|COMPLETED|Induction Period||0||
60068360|NCT01406938|76183491|FG000|NOT COMPLETED|Induction Period||18||
60068361|NCT01406938|76183492|FG001|NOT COMPLETED|Induction Period||20||
60068362|NCT01406938|76183493|FG002|NOT COMPLETED|Induction Period||0||
60068363|NCT01406938|76183494|FG003|NOT COMPLETED|Induction Period||0||
60068364|NCT01406938|76183495|FG004|NOT COMPLETED|Induction Period||0||
60068365|NCT01406938|76183496|FG005|NOT COMPLETED|Induction Period||0||
60068366|NCT01406938|76183491|FG000|STARTED|Maintenance Period||0||
60068367|NCT01406938|76183492|FG001|STARTED|Maintenance Period||0||
60068368|NCT01406938|76183493|FG002|STARTED|Maintenance Period||203||
60068369|NCT01406938|76183494|FG003|STARTED|Maintenance Period||217||
60068370|NCT01406938|76183495|FG004|STARTED|Maintenance Period||206||
60068371|NCT01406938|76183496|FG005|STARTED|Maintenance Period||217||
60068372|NCT01406938|76183491|FG000|FAS: Patients Assigned Treatment Drug|Maintenance Period||0||
60068373|NCT01406938|76183492|FG001|FAS: Patients Assigned Treatment Drug|Maintenance Period||0||
60068374|NCT01406938|76183493|FG002|FAS: Patients Assigned Treatment Drug|Maintenance Period||203||
60068375|NCT01406938|76183494|FG003|FAS: Patients Assigned Treatment Drug|Maintenance Period||216||
60068376|NCT01406938|76183495|FG004|FAS: Patients Assigned Treatment Drug|Maintenance Period||206||
60068377|NCT01406938|76183496|FG005|FAS: Patients Assigned Treatment Drug|Maintenance Period||217||
60068378|NCT01406938|76183491|FG000|COMPLETED|Maintenance Period||0||
60068379|NCT01406938|76183492|FG001|COMPLETED|Maintenance Period||0||
60068380|NCT01406938|76183493|FG002|COMPLETED|Maintenance Period||186||
60068381|NCT01406938|76183494|FG003|COMPLETED|Maintenance Period||199||
60068382|NCT01406938|76183495|FG004|COMPLETED|Maintenance Period||181||
60068383|NCT01406938|76183496|FG005|COMPLETED|Maintenance Period||201||
60068384|NCT01406938|76183491|FG000|NOT COMPLETED|Maintenance Period||0||
60068385|NCT01406938|76183492|FG001|NOT COMPLETED|Maintenance Period||0||
60068386|NCT01406938|76183493|FG002|NOT COMPLETED|Maintenance Period||17||
60068387|NCT01406938|76183494|FG003|NOT COMPLETED|Maintenance Period||18||
60068388|NCT01406938|76183495|FG004|NOT COMPLETED|Maintenance Period||25||
60068389|NCT01406938|76183496|FG005|NOT COMPLETED|Maintenance Period||16||
60068390|NCT01406938|76183491|FG000|STARTED|Follow up||26||
60068391|NCT01406938|76183492|FG001|STARTED|Follow up||23||
60068392|NCT01406938|76183493|FG002|STARTED|Follow up||40||
60068393|NCT01406938|76183494|FG003|STARTED|Follow up||39||
60068394|NCT01406938|76183495|FG004|STARTED|Follow up||40||
60068395|NCT01406938|76183496|FG005|STARTED|Follow up||35||
60068396|NCT01406938|76183491|FG000|COMPLETED|Follow up||18||
60068397|NCT01406938|76183492|FG001|COMPLETED|Follow up||18||
60068398|NCT01406938|76183493|FG002|COMPLETED|Follow up||32||
60068399|NCT01406938|76183494|FG003|COMPLETED|Follow up||36||
60068400|NCT01406938|76183495|FG004|COMPLETED|Follow up||31||
60068401|NCT01406938|76183496|FG005|COMPLETED|Follow up||32||
60068402|NCT01406938|76183491|FG000|NOT COMPLETED|Follow up||8||
60068403|NCT01406938|76183492|FG001|NOT COMPLETED|Follow up||5||
60068404|NCT01406938|76183493|FG002|NOT COMPLETED|Follow up||8||
60068405|NCT01406938|76183494|FG003|NOT COMPLETED|Follow up||3||
60068406|NCT01406938|76183495|FG004|NOT COMPLETED|Follow up||9||
60068407|NCT01406938|76183496|FG005|NOT COMPLETED|Follow up||3||
60068408|NCT01405924|76183516|FG000|STARTED|Overall Study||111||
60068409|NCT01405924|76183516|FG000|COMPLETED|Overall Study||101||
60068410|NCT01405924|76183516|FG000|NOT COMPLETED|Overall Study||10||
60068411|NCT01426438|76183524|FG000|STARTED|Overall Study||50||
60068412|NCT01426438|76183525|FG001|STARTED|Overall Study||49||
60068413|NCT01426438|76183524|FG000|COMPLETED|Overall Study||35||
60068414|NCT01426438|76183525|FG001|COMPLETED|Overall Study||39||
60068415|NCT01426438|76183524|FG000|NOT COMPLETED|Overall Study||15||
60068416|NCT01426438|76183525|FG001|NOT COMPLETED|Overall Study||10||
60068417|NCT01425814|76183531|FG000|STARTED|Period 1||12||
60068418|NCT01425814|76183532|FG001|STARTED|Period 1||11||
60068419|NCT01425814|76183533|FG002|STARTED|Period 1||12||
60068420|NCT01425814|76183534|FG003|STARTED|Period 1||10||
60068421|NCT01425814|76183535|FG004|STARTED|Period 1||12||
60068422|NCT01425814|76183536|FG005|STARTED|Period 1||13||
60068423|NCT01425814|76183531|FG000|COMPLETED|Period 1||12||
60068424|NCT01425814|76183532|FG001|COMPLETED|Period 1||10||
60068425|NCT01425814|76183533|FG002|COMPLETED|Period 1||12||
60068426|NCT01425814|76183534|FG003|COMPLETED|Period 1||10||
60068427|NCT01425814|76183535|FG004|COMPLETED|Period 1||12||
60068428|NCT01425814|76183536|FG005|COMPLETED|Period 1||13||
60068429|NCT01425814|76183531|FG000|NOT COMPLETED|Period 1||0||
60068430|NCT01425814|76183532|FG001|NOT COMPLETED|Period 1||1||
60068431|NCT01425814|76183533|FG002|NOT COMPLETED|Period 1||0||
60068432|NCT01425814|76183534|FG003|NOT COMPLETED|Period 1||0||
60068433|NCT01425814|76183535|FG004|NOT COMPLETED|Period 1||0||
60068434|NCT01425814|76183536|FG005|NOT COMPLETED|Period 1||0||
60068435|NCT01425814|76183531|FG000|STARTED|Period 2||12||
60068436|NCT01425814|76183532|FG001|STARTED|Period 2||10||
60068437|NCT01425814|76183533|FG002|STARTED|Period 2||12||
60068438|NCT01425814|76183534|FG003|STARTED|Period 2||10||
60068439|NCT01425814|76183535|FG004|STARTED|Period 2||12||
60068440|NCT01425814|76183536|FG005|STARTED|Period 2||13||
60068441|NCT01425814|76183531|FG000|COMPLETED|Period 2||12||
60068442|NCT01425814|76183532|FG001|COMPLETED|Period 2||9||
60068443|NCT01425814|76183533|FG002|COMPLETED|Period 2||12||
60068444|NCT01425814|76183534|FG003|COMPLETED|Period 2||10||
60068445|NCT01425814|76183535|FG004|COMPLETED|Period 2||12||
60068446|NCT01425814|76183536|FG005|COMPLETED|Period 2||13||
60068447|NCT01425814|76183531|FG000|NOT COMPLETED|Period 2||0||
60068448|NCT01425814|76183532|FG001|NOT COMPLETED|Period 2||1||
60068449|NCT01425814|76183533|FG002|NOT COMPLETED|Period 2||0||
60068450|NCT01425814|76183534|FG003|NOT COMPLETED|Period 2||0||
60068451|NCT01425814|76183535|FG004|NOT COMPLETED|Period 2||0||
60068452|NCT01425814|76183536|FG005|NOT COMPLETED|Period 2||0||
60068453|NCT01425814|76183531|FG000|STARTED|Period 3||12||
60068454|NCT01425814|76183532|FG001|STARTED|Period 3||9||
60068455|NCT01425814|76183533|FG002|STARTED|Period 3||12||
60068456|NCT01425814|76183534|FG003|STARTED|Period 3||10||
60068457|NCT01425814|76183535|FG004|STARTED|Period 3||12||
60068458|NCT01425814|76183536|FG005|STARTED|Period 3||13||
60068459|NCT01425814|76183531|FG000|COMPLETED|Period 3||12||
60068460|NCT01425814|76183532|FG001|COMPLETED|Period 3||9||
60068461|NCT01425814|76183533|FG002|COMPLETED|Period 3||12||
60068462|NCT01425814|76183534|FG003|COMPLETED|Period 3||10||
60068463|NCT01425814|76183535|FG004|COMPLETED|Period 3||12||
60068464|NCT01425814|76183536|FG005|COMPLETED|Period 3||12||
60068465|NCT01425814|76183531|FG000|NOT COMPLETED|Period 3||0||
60068466|NCT01425814|76183532|FG001|NOT COMPLETED|Period 3||0||
60068467|NCT01425814|76183533|FG002|NOT COMPLETED|Period 3||0||
60068468|NCT01425814|76183534|FG003|NOT COMPLETED|Period 3||0||
60068469|NCT01425814|76183535|FG004|NOT COMPLETED|Period 3||0||
60068470|NCT01425814|76183536|FG005|NOT COMPLETED|Period 3||1||
60068471|NCT01425814|76183531|FG000|STARTED|Period 4||12||
60068472|NCT01425814|76183532|FG001|STARTED|Period 4||9||
60068473|NCT01425814|76183533|FG002|STARTED|Period 4||12||
60068474|NCT01425814|76183534|FG003|STARTED|Period 4||10||
60068475|NCT01425814|76183535|FG004|STARTED|Period 4||12||
60068476|NCT01425814|76183536|FG005|STARTED|Period 4||12||
60068477|NCT01425814|76183531|FG000|COMPLETED|Period 4||11||
60068478|NCT01425814|76183532|FG001|COMPLETED|Period 4||9||
60068479|NCT01425814|76183533|FG002|COMPLETED|Period 4||11||
60068480|NCT01425814|76183534|FG003|COMPLETED|Period 4||10||
60068481|NCT01425814|76183535|FG004|COMPLETED|Period 4||12||
60068482|NCT01425814|76183536|FG005|COMPLETED|Period 4||12||
60068483|NCT01425814|76183531|FG000|NOT COMPLETED|Period 4||1||
60068484|NCT01425814|76183532|FG001|NOT COMPLETED|Period 4||0||
60068485|NCT01425814|76183533|FG002|NOT COMPLETED|Period 4||1||
60068486|NCT01425814|76183534|FG003|NOT COMPLETED|Period 4||0||
60068487|NCT01425814|76183535|FG004|NOT COMPLETED|Period 4||0||
60068488|NCT01425814|76183536|FG005|NOT COMPLETED|Period 4||0||
60068489|NCT01425814|76183531|FG000|STARTED|Period 5||11||
60068490|NCT01425814|76183532|FG001|STARTED|Period 5||9||
60068491|NCT01425814|76183533|FG002|STARTED|Period 5||11||
60068492|NCT01425814|76183534|FG003|STARTED|Period 5||10||
60068493|NCT01425814|76183535|FG004|STARTED|Period 5||12||
60068494|NCT01425814|76183536|FG005|STARTED|Period 5||12||
60068495|NCT01425814|76183531|FG000|COMPLETED|Period 5||11||
60068496|NCT01425814|76183532|FG001|COMPLETED|Period 5||9||
60068497|NCT01425814|76183533|FG002|COMPLETED|Period 5||10||
60068498|NCT01425814|76183534|FG003|COMPLETED|Period 5||10||
60068499|NCT01425814|76183535|FG004|COMPLETED|Period 5||12||
60068500|NCT01425814|76183536|FG005|COMPLETED|Period 5||11||
60068501|NCT01425814|76183531|FG000|NOT COMPLETED|Period 5||0||
60068502|NCT01425814|76183532|FG001|NOT COMPLETED|Period 5||0||
60068503|NCT01425814|76183533|FG002|NOT COMPLETED|Period 5||1||
60068504|NCT01425814|76183534|FG003|NOT COMPLETED|Period 5||0||
60068505|NCT01425814|76183535|FG004|NOT COMPLETED|Period 5||0||
60068506|NCT01425814|76183536|FG005|NOT COMPLETED|Period 5||1||
60068507|NCT01782495|76183561|FG000|STARTED|Overall Study||34||
60068508|NCT01782495|76183562|FG001|STARTED|Overall Study||27||
60068509|NCT01782495|76183563|FG002|STARTED|Overall Study||13||
60068510|NCT01782495|76183564|FG003|STARTED|Overall Study||4||
60068511|NCT01782495|76183565|FG004|STARTED|Overall Study||2||
60068512|NCT01782495|76183566|FG005|STARTED|Overall Study||22||
60068513|NCT01782495|76183567|FG006|STARTED|Overall Study||12||
60068514|NCT01782495|76183568|FG007|STARTED|Overall Study||9||
60068515|NCT01782495|76183569|FG008|STARTED|Overall Study||3||
60068516|NCT01782495|76183570|FG009|STARTED|Overall Study||2||
60068517|NCT01782495|76183571|FG010|STARTED|Overall Study||1||
60068518|NCT01782495|76183561|FG000|COMPLETED|Overall Study||34||
60068519|NCT01782495|76183562|FG001|COMPLETED|Overall Study||26||
60068520|NCT01782495|76183563|FG002|COMPLETED|Overall Study||13||
60068521|NCT01782495|76183564|FG003|COMPLETED|Overall Study||4||
60068522|NCT01782495|76183565|FG004|COMPLETED|Overall Study||2||
60068523|NCT01782495|76183566|FG005|COMPLETED|Overall Study||22||
60068524|NCT01782495|76183567|FG006|COMPLETED|Overall Study||12||
60068525|NCT01782495|76183568|FG007|COMPLETED|Overall Study||6||
60068526|NCT01782495|76183569|FG008|COMPLETED|Overall Study||3||
60068527|NCT01782495|76183570|FG009|COMPLETED|Overall Study||2||
60068528|NCT01782495|76183571|FG010|COMPLETED|Overall Study||1||
60068529|NCT01782495|76183561|FG000|NOT COMPLETED|Overall Study||0||
60068530|NCT01782495|76183562|FG001|NOT COMPLETED|Overall Study||1||
60068531|NCT01782495|76183563|FG002|NOT COMPLETED|Overall Study||0||
60068532|NCT01782495|76183564|FG003|NOT COMPLETED|Overall Study||0||
60068533|NCT01782495|76183565|FG004|NOT COMPLETED|Overall Study||0||
60068534|NCT01782495|76183566|FG005|NOT COMPLETED|Overall Study||0||
60068535|NCT01782495|76183567|FG006|NOT COMPLETED|Overall Study||0||
60068536|NCT01782495|76183568|FG007|NOT COMPLETED|Overall Study||3||
60068537|NCT01782495|76183569|FG008|NOT COMPLETED|Overall Study||0||
60068538|NCT01782495|76183570|FG009|NOT COMPLETED|Overall Study||0||
60068539|NCT01782495|76183571|FG010|NOT COMPLETED|Overall Study||0||
60068540|NCT01922102|76183598|FG000|STARTED|Overall Study||182||
60068541|NCT01922102|76183599|FG001|STARTED|Overall Study||184||
60068542|NCT01922102|76183600|FG002|STARTED|Overall Study||91||
60068543|NCT01922102|76183598|FG000|COMPLETED|Overall Study||173||
60068544|NCT01922102|76183599|FG001|COMPLETED|Overall Study||175||
60068545|NCT01922102|76183600|FG002|COMPLETED|Overall Study||83||
60068546|NCT01922102|76183598|FG000|NOT COMPLETED|Overall Study||9||
60068547|NCT01922102|76183599|FG001|NOT COMPLETED|Overall Study||9||
60068548|NCT01922102|76183600|FG002|NOT COMPLETED|Overall Study||8||
60068549|NCT01405768|76183614|FG000|STARTED|Overall Study||28||
60068550|NCT01405768|76183615|FG001|STARTED|Overall Study||28||
60068551|NCT01405768|76183614|FG000|COMPLETED|Overall Study||24||
60068552|NCT01405768|76183615|FG001|COMPLETED|Overall Study||28||
60068553|NCT01405768|76183614|FG000|NOT COMPLETED|Overall Study||4||
60068554|NCT01405768|76183615|FG001|NOT COMPLETED|Overall Study||0||
60068555|NCT01913353|76183623|FG000|STARTED|Overall Study||221|Randomized including subjects not vaccinated|
60068556|NCT01913353|76183624|FG001|STARTED|Overall Study||219|Randomized including subjects not vaccinated|
60068557|NCT01913353|76183623|FG000|COMPLETED|Overall Study||189|Active trial phase|
60068558|NCT01913353|76183624|FG001|COMPLETED|Overall Study||204|Active trial phase|
60068559|NCT01913353|76183623|FG000|NOT COMPLETED|Overall Study||32||
60068560|NCT01913353|76183624|FG001|NOT COMPLETED|Overall Study||15||
60068561|NCT01754259|76183639|FG000|STARTED|Overall Study||23||
60068562|NCT01754259|76183640|FG001|STARTED|Overall Study||24||
60068563|NCT01754259|76183639|FG000|COMPLETED|Overall Study||18||
60068564|NCT01754259|76183640|FG001|COMPLETED|Overall Study||18||
60068565|NCT01754259|76183639|FG000|NOT COMPLETED|Overall Study||5||
60068566|NCT01754259|76183640|FG001|NOT COMPLETED|Overall Study||6||
60068567|NCT01405456|76183648|FG000|STARTED|Overall Study||25||
60068568|NCT01405456|76183649|FG001|STARTED|Overall Study||21||
60068569|NCT01405456|76183648|FG000|COMPLETED|Overall Study||22||
60068570|NCT01405456|76183649|FG001|COMPLETED|Overall Study||20||
60068571|NCT01405456|76183648|FG000|NOT COMPLETED|Overall Study||3||
60068572|NCT01405456|76183649|FG001|NOT COMPLETED|Overall Study||1||
60068573|NCT01404988|76183658|FG000|STARTED|Overall Study||33||
60068574|NCT01404988|76183659|FG001|STARTED|Overall Study||33||
60068575|NCT01404988|76183660|FG002|STARTED|Overall Study||33||
60068576|NCT01404988|76183658|FG000|COMPLETED|Overall Study||27||
60068577|NCT01404988|76183659|FG001|COMPLETED|Overall Study||29||
60068578|NCT01404988|76183660|FG002|COMPLETED|Overall Study||30||
60068579|NCT01404988|76183658|FG000|NOT COMPLETED|Overall Study||6||
60068580|NCT01404988|76183659|FG001|NOT COMPLETED|Overall Study||4||
60068581|NCT01404988|76183660|FG002|NOT COMPLETED|Overall Study||3||
60068582|NCT01389232|76183671|FG000|STARTED|Overall Study||100||
60068583|NCT01389232|76183671|FG000|COMPLETED|Overall Study||81||
60068584|NCT01389232|76183671|FG000|NOT COMPLETED|Overall Study||19||
60068585|NCT01404208|76183687|FG000|STARTED|Overall Study||70||
60068586|NCT01404208|76183688|FG001|STARTED|Overall Study||72||
60068587|NCT01404208|76183687|FG000|COMPLETED|Overall Study||67||
60068588|NCT01404208|76183688|FG001|COMPLETED|Overall Study||72||
60068589|NCT01404208|76183687|FG000|NOT COMPLETED|Overall Study||3||
60068590|NCT01404208|76183688|FG001|NOT COMPLETED|Overall Study||0||
60068591|NCT01617668|76183696|FG000|STARTED|Overall Study||51||
60068592|NCT01617668|76183697|FG001|STARTED|Overall Study|54 patients were randomized and only 50 received study treatment.|50||
60068593|NCT01617668|76183698|FG002|STARTED|Overall Study||55||
60068594|NCT01617668|76183699|FG003|STARTED|Overall Study|55 patients were randomized and only 53 received study treatment.|53||
60068595|NCT01617668|76183696|FG000|Randomized Patients|Overall Study||51||
60068596|NCT01617668|76183697|FG001|Randomized Patients|Overall Study||54||
60068597|NCT01617668|76183698|FG002|Randomized Patients|Overall Study||55||
60068598|NCT01617668|76183699|FG003|Randomized Patients|Overall Study||55||
60068599|NCT01617668|76183696|FG000|COMPLETED|Overall Study||38||
60068600|NCT01617668|76183697|FG001|COMPLETED|Overall Study||41||
60068601|NCT01617668|76183698|FG002|COMPLETED|Overall Study||32||
60068602|NCT01617668|76183699|FG003|COMPLETED|Overall Study||38||
60068603|NCT01617668|76183696|FG000|NOT COMPLETED|Overall Study||13||
60068604|NCT01617668|76183697|FG001|NOT COMPLETED|Overall Study||9||
60068605|NCT01617668|76183698|FG002|NOT COMPLETED|Overall Study||23||
60068606|NCT01617668|76183699|FG003|NOT COMPLETED|Overall Study||15||
60068607|NCT01425268|76183715|FG000|STARTED|Overall Study|106 Subjects Randomized to AeroForm Arm / 98 Subjects Treated (Implanted)|106||
60068608|NCT01425268|76183716|FG001|STARTED|Overall Study|52 Subjects Randomized to Saline Arm / 52 Subjects Treated (Implanted)|52||
60068609|NCT01425268|76183715|FG000|COMPLETED|Overall Study||98||
60068610|NCT01425268|76183716|FG001|COMPLETED|Overall Study||52||
60068611|NCT01425268|76183715|FG000|NOT COMPLETED|Overall Study||8||
60068612|NCT01425268|76183716|FG001|NOT COMPLETED|Overall Study||0||
60068613|NCT01425190|76183725|FG000|STARTED|Overall Study||16||
60068614|NCT01425190|76183726|FG001|STARTED|Overall Study|The study was terminated prior to enrolling participants in Cohort 2.|0||
60068615|NCT01425190|76183727|FG002|STARTED|Overall Study|The study was terminated prior to enrolling participants in Cohort 3.|0||
60068616|NCT01425190|76183725|FG000|COMPLETED|Overall Study||15||
60068617|NCT01425190|76183726|FG001|COMPLETED|Overall Study||0||
60068618|NCT01425190|76183727|FG002|COMPLETED|Overall Study||0||
60068619|NCT01425190|76183725|FG000|NOT COMPLETED|Overall Study||1||
60068620|NCT01425190|76183726|FG001|NOT COMPLETED|Overall Study||0||
60068621|NCT01425190|76183727|FG002|NOT COMPLETED|Overall Study||0||
60068622|NCT01388530|76183735|FG000|STARTED|Overall Study||25||
60068623|NCT01388530|76183735|FG000|COMPLETED|Overall Study||20||
60068624|NCT01388530|76183735|FG000|NOT COMPLETED|Overall Study||5||
60068625|NCT01895270|76183741|FG000|STARTED|Study Medications Induction (W1-4)||11||
60068626|NCT01895270|76183742|FG001|STARTED|Study Medications Induction (W1-4)||14||
60068627|NCT01895270|76183741|FG000|COMPLETED|Study Medications Induction (W1-4)||5||
60068628|NCT01895270|76183742|FG001|COMPLETED|Study Medications Induction (W1-4)||8||
60068629|NCT01895270|76183741|FG000|NOT COMPLETED|Study Medications Induction (W1-4)||6||
60068630|NCT01895270|76183742|FG001|NOT COMPLETED|Study Medications Induction (W1-4)||6||
60068631|NCT01895270|76183741|FG000|STARTED|Buprenorphine Taper (W5 to W6D3)||5||
60068632|NCT01895270|76183742|FG001|STARTED|Buprenorphine Taper (W5 to W6D3)|1 subject missed meds prior to bup taper so did not start this phase|7||
60068633|NCT01895270|76183741|FG000|COMPLETED|Buprenorphine Taper (W5 to W6D3)||2||
60068634|NCT01895270|76183742|FG001|COMPLETED|Buprenorphine Taper (W5 to W6D3)||2||
60068635|NCT01895270|76183741|FG000|NOT COMPLETED|Buprenorphine Taper (W5 to W6D3)||3||
60068636|NCT01895270|76183742|FG001|NOT COMPLETED|Buprenorphine Taper (W5 to W6D3)||5||
60068637|NCT01895270|76183741|FG000|STARTED|Isradipine Taper (W7-8)||2||
60068638|NCT01895270|76183742|FG001|STARTED|Isradipine Taper (W7-8)||2||
60068639|NCT01895270|76183741|FG000|COMPLETED|Isradipine Taper (W7-8)||2||
60068640|NCT01895270|76183742|FG001|COMPLETED|Isradipine Taper (W7-8)||0||
60068641|NCT01895270|76183741|FG000|NOT COMPLETED|Isradipine Taper (W7-8)||0||
60068642|NCT01895270|76183742|FG001|NOT COMPLETED|Isradipine Taper (W7-8)||2||
60068643|NCT01424722|76183748|FG000|STARTED|Overall Study||2258||
60068644|NCT01424722|76183748|FG000|COMPLETED|Overall Study||0||
60068645|NCT01424722|76183748|FG000|NOT COMPLETED|Overall Study||2258||
60068646|NCT01424644|76183754|FG000|STARTED|Overall Study||402||
60068647|NCT01424644|76183755|FG001|STARTED|Overall Study||399||
60068648|NCT01424644|76183754|FG000|COMPLETED|Overall Study||369||
60068649|NCT01424644|76183755|FG001|COMPLETED|Overall Study||372||
60068650|NCT01424644|76183754|FG000|NOT COMPLETED|Overall Study||33||
60068651|NCT01424644|76183755|FG001|NOT COMPLETED|Overall Study||27||
60068652|NCT01920854|76183768|FG000|STARTED|Overall Study||12||
60068653|NCT01920854|76183769|FG001|STARTED|Overall Study||6||
60068654|NCT01920854|76183770|FG002|STARTED|Overall Study||6||
60068655|NCT01920854|76183771|FG003|STARTED|Overall Study||6||
60068656|NCT01920854|76183772|FG004|STARTED|Overall Study||6||
60068657|NCT01920854|76183773|FG005|STARTED|Overall Study||6||
60068658|NCT01920854|76183774|FG006|STARTED|Overall Study||6||
60068659|NCT01920854|76183768|FG000|COMPLETED|Overall Study||11||
60068660|NCT01920854|76183769|FG001|COMPLETED|Overall Study||6||
60068661|NCT01920854|76183770|FG002|COMPLETED|Overall Study||6||
60068662|NCT01920854|76183771|FG003|COMPLETED|Overall Study||6||
60068663|NCT01920854|76183772|FG004|COMPLETED|Overall Study||5||
60068664|NCT01920854|76183773|FG005|COMPLETED|Overall Study||6||
60068665|NCT01920854|76183774|FG006|COMPLETED|Overall Study||5||
60068666|NCT01920854|76183768|FG000|NOT COMPLETED|Overall Study||1||
60068667|NCT01920854|76183769|FG001|NOT COMPLETED|Overall Study||0||
60068668|NCT01920854|76183770|FG002|NOT COMPLETED|Overall Study||0||
60068669|NCT01920854|76183771|FG003|NOT COMPLETED|Overall Study||0||
60068670|NCT01920854|76183772|FG004|NOT COMPLETED|Overall Study||1||
60068671|NCT01920854|76183773|FG005|NOT COMPLETED|Overall Study||0||
60068672|NCT01920854|76183774|FG006|NOT COMPLETED|Overall Study||1||
60068673|NCT01403194|76183809|FG000|STARTED|Overall Study||11||
60068674|NCT01403194|76183809|FG000|COMPLETED|Overall Study||1||
60068675|NCT01403194|76183809|FG000|NOT COMPLETED|Overall Study||10||
60068676|NCT01403116|76183815|FG000|STARTED|Overall Study||161||
60068677|NCT01403116|76183816|FG001|STARTED|Overall Study||160||
60068678|NCT01403116|76183815|FG000|Randomized|Overall Study||162||
60068679|NCT01403116|76183816|FG001|Randomized|Overall Study||163||
60068680|NCT01403116|76183815|FG000|Randomized in Error/ No Treatment Recvd|Overall Study||1||
60068681|NCT01403116|76183816|FG001|Randomized in Error/ No Treatment Recvd|Overall Study||3||
60068682|NCT01403116|76183815|FG000|COMPLETED|Overall Study||129||
60068683|NCT01403116|76183816|FG001|COMPLETED|Overall Study||133||
60068684|NCT01403116|76183815|FG000|NOT COMPLETED|Overall Study||32||
60068685|NCT01403116|76183816|FG001|NOT COMPLETED|Overall Study||27||
60068686|NCT01402570|76183822|FG000|STARTED|Overall Study||20||
60068687|NCT01402570|76183822|FG000|COMPLETED|Overall Study||19||
60068688|NCT01402570|76183822|FG000|NOT COMPLETED|Overall Study||1||
60068689|NCT01753401|76183829|FG000|STARTED|Double-blind Period (8 Weeks)||12||
60068690|NCT01753401|76183830|FG001|STARTED|Double-blind Period (8 Weeks)||26||
60068691|NCT01753401|76183831|FG002|STARTED|Double-blind Period (8 Weeks)|This arm was not included in the double-blind period|0||
60068692|NCT01753401|76183832|FG003|STARTED|Double-blind Period (8 Weeks)|This arm was not included in the double-blind period|0||
60068693|NCT01753401|76183829|FG000|Modified Intent to Treat (mITT)|Double-blind Period (8 Weeks)||11||
60068694|NCT01753401|76183830|FG001|Modified Intent to Treat (mITT)|Double-blind Period (8 Weeks)||25||
60068695|NCT01753401|76183831|FG002|Modified Intent to Treat (mITT)|Double-blind Period (8 Weeks)||0||
60068696|NCT01753401|76183832|FG003|Modified Intent to Treat (mITT)|Double-blind Period (8 Weeks)||0||
60068697|NCT01753401|76183829|FG000|COMPLETED|Double-blind Period (8 Weeks)||11||
60068698|NCT01753401|76183830|FG001|COMPLETED|Double-blind Period (8 Weeks)||22||
60068699|NCT01753401|76183831|FG002|COMPLETED|Double-blind Period (8 Weeks)||0||
60068700|NCT01753401|76183832|FG003|COMPLETED|Double-blind Period (8 Weeks)||0||
60068701|NCT01753401|76183829|FG000|NOT COMPLETED|Double-blind Period (8 Weeks)||1||
60068702|NCT01753401|76183830|FG001|NOT COMPLETED|Double-blind Period (8 Weeks)||4||
60068703|NCT01753401|76183831|FG002|NOT COMPLETED|Double-blind Period (8 Weeks)||0||
60068704|NCT01753401|76183832|FG003|NOT COMPLETED|Double-blind Period (8 Weeks)||0||
60068705|NCT01753401|76183829|FG000|STARTED|Open Label Period (44 Weeks)|This arm was not included in the open label period|0||
60068706|NCT01753401|76183830|FG001|STARTED|Open Label Period (44 Weeks)|This arm was not included in the open label period|0||
60068707|NCT01753401|76183831|FG002|STARTED|Open Label Period (44 Weeks)||11||
60068708|NCT01753401|76183832|FG003|STARTED|Open Label Period (44 Weeks)||22||
60068709|NCT01753401|76183829|FG000|mITT|Open Label Period (44 Weeks)||0||
60068710|NCT01753401|76183830|FG001|mITT|Open Label Period (44 Weeks)||0||
60068711|NCT01753401|76183831|FG002|mITT|Open Label Period (44 Weeks)||11||
60068712|NCT01753401|76183832|FG003|mITT|Open Label Period (44 Weeks)||22||
60068713|NCT01753401|76183829|FG000|Safety Analysis Set|Open Label Period (44 Weeks)||0||
60068714|NCT01753401|76183830|FG001|Safety Analysis Set|Open Label Period (44 Weeks)||0||
60068715|NCT01753401|76183831|FG002|Safety Analysis Set|Open Label Period (44 Weeks)||11||
60068716|NCT01753401|76183832|FG003|Safety Analysis Set|Open Label Period (44 Weeks)||22||
60068717|NCT01753401|76183829|FG000|COMPLETED|Open Label Period (44 Weeks)||0||
60068718|NCT01753401|76183830|FG001|COMPLETED|Open Label Period (44 Weeks)||0||
60068719|NCT01753401|76183831|FG002|COMPLETED|Open Label Period (44 Weeks)||7||
60068720|NCT01753401|76183832|FG003|COMPLETED|Open Label Period (44 Weeks)||13||
60068721|NCT01753401|76183829|FG000|NOT COMPLETED|Open Label Period (44 Weeks)||0||
60068722|NCT01753401|76183830|FG001|NOT COMPLETED|Open Label Period (44 Weeks)||0||
60068723|NCT01753401|76183831|FG002|NOT COMPLETED|Open Label Period (44 Weeks)||4||
60068724|NCT01753401|76183832|FG003|NOT COMPLETED|Open Label Period (44 Weeks)||9||
60068725|NCT01618916|76183848|FG000|STARTED|Overall Study||12||
60068726|NCT01618916|76183849|FG001|STARTED|Overall Study||10||
60068727|NCT01618916|76183850|FG002|STARTED|Overall Study||11||
60068728|NCT01618916|76183851|FG003|STARTED|Overall Study||9||
60068729|NCT01618916|76183852|FG004|STARTED|Overall Study||5||
60068730|NCT01618916|76183853|FG005|STARTED|Overall Study||4||
60068731|NCT01618916|76183848|FG000|Received At Least 1 Dose of Study Drug|Overall Study||12||
60068732|NCT01618916|76183849|FG001|Received At Least 1 Dose of Study Drug|Overall Study||10||
60068733|NCT01618916|76183850|FG002|Received At Least 1 Dose of Study Drug|Overall Study||11||
60068734|NCT01618916|76183851|FG003|Received At Least 1 Dose of Study Drug|Overall Study||9||
60068735|NCT01618916|76183852|FG004|Received At Least 1 Dose of Study Drug|Overall Study||5||
60068736|NCT01618916|76183853|FG005|Received At Least 1 Dose of Study Drug|Overall Study||4||
60068737|NCT01618916|76183848|FG000|COMPLETED|Overall Study||10||
60068738|NCT01618916|76183849|FG001|COMPLETED|Overall Study||9||
60068739|NCT01618916|76183850|FG002|COMPLETED|Overall Study||10||
60068740|NCT01618916|76183851|FG003|COMPLETED|Overall Study||7||
60068741|NCT01618916|76183852|FG004|COMPLETED|Overall Study||4||
60068742|NCT01618916|76183853|FG005|COMPLETED|Overall Study||4||
60068743|NCT01618916|76183848|FG000|NOT COMPLETED|Overall Study||2||
60068744|NCT01618916|76183849|FG001|NOT COMPLETED|Overall Study||1||
60068745|NCT01618916|76183850|FG002|NOT COMPLETED|Overall Study||1||
60068746|NCT01618916|76183851|FG003|NOT COMPLETED|Overall Study||2||
60068747|NCT01618916|76183852|FG004|NOT COMPLETED|Overall Study||1||
60068748|NCT01618916|76183853|FG005|NOT COMPLETED|Overall Study||0||
60068749|NCT01753323|76183869|FG000|STARTED|Overall Study||11||
60068750|NCT01753323|76183870|FG001|STARTED|Overall Study||10||
60068751|NCT01753323|76183871|FG002|STARTED|Overall Study||22||
60068752|NCT01753323|76183869|FG000|Pharmacodynamic (PD) Set|Overall Study||10||
60068753|NCT01753323|76183870|FG001|Pharmacodynamic (PD) Set|Overall Study||10||
60068754|NCT01753323|76183871|FG002|Pharmacodynamic (PD) Set|Overall Study||21||
60068755|NCT01753323|76183869|FG000|Pharmacokinetic(PK) Set|Overall Study||10||
60068756|NCT01753323|76183870|FG001|Pharmacokinetic(PK) Set|Overall Study||10||
60068757|NCT01753323|76183871|FG002|Pharmacokinetic(PK) Set|Overall Study||21||
60068758|NCT01753323|76183869|FG000|Safety Set|Overall Study||11||
60068759|NCT01753323|76183870|FG001|Safety Set|Overall Study||10||
60068760|NCT01753323|76183871|FG002|Safety Set|Overall Study||22||
60068761|NCT01753323|76183869|FG000|Intent-to-treat Analysis Set|Overall Study||11||
60068762|NCT01753323|76183870|FG001|Intent-to-treat Analysis Set|Overall Study||10||
60068763|NCT01753323|76183871|FG002|Intent-to-treat Analysis Set|Overall Study||22||
60068764|NCT01753323|76183869|FG000|COMPLETED|Overall Study||10||
60068765|NCT01753323|76183870|FG001|COMPLETED|Overall Study||10||
60068766|NCT01753323|76183871|FG002|COMPLETED|Overall Study||13||
60068767|NCT01753323|76183869|FG000|NOT COMPLETED|Overall Study||1||
60068768|NCT01753323|76183870|FG001|NOT COMPLETED|Overall Study||0||
60068769|NCT01753323|76183871|FG002|NOT COMPLETED|Overall Study||9||
60068770|NCT01894568|76183882|FG000|STARTED|Overall Study||192||
60068771|NCT01894568|76183883|FG001|STARTED|Overall Study||196||
60068772|NCT01894568|76183882|FG000|Received at Least 1 Dose of Study Drug|Overall Study||192||
60068773|NCT01894568|76183883|FG001|Received at Least 1 Dose of Study Drug|Overall Study||196||
60068774|NCT01894568|76183882|FG000|COMPLETED|Overall Study||182||
60068775|NCT01894568|76183883|FG001|COMPLETED|Overall Study||186||
60068776|NCT01894568|76183882|FG000|NOT COMPLETED|Overall Study||10||
60068777|NCT01894568|76183883|FG001|NOT COMPLETED|Overall Study||10||
60068778|NCT01618838|76183890|FG000|STARTED|Overall Study||4||
60068779|NCT01618838|76183890|FG000|COMPLETED|Overall Study||0||
60068780|NCT01618838|76183890|FG000|NOT COMPLETED|Overall Study||4||
60068781|NCT01920152|76183897|FG000|STARTED|Overall Study||19||20
60068782|NCT01920152|76183898|FG001|STARTED|Overall Study||15||16
60068783|NCT01920152|76183897|FG000|COMPLETED|Overall Study||18||19
60068784|NCT01920152|76183898|FG001|COMPLETED|Overall Study||13||14
60068785|NCT01920152|76183897|FG000|NOT COMPLETED|Overall Study||1||1
60068786|NCT01920152|76183898|FG001|NOT COMPLETED|Overall Study||2||2
60068787|NCT01752933|76183906|FG000|STARTED|Treatment|Includes all patients who received any treatment|4|"Reason Not Completed shown below are reasons for treatment discontinuation"|
60068788|NCT01752933|76183907|FG001|STARTED|Treatment|Includes all patients who received any treatment|46|"Reason Not Completed shown below are reasons for treatment discontinuation"|
60068789|NCT01752933|76183906|FG000|COMPLETED|Treatment|Completion not applicable for this survival study|0|Treatment continued as long as patient was benefitting from treatment with manageable side effects|
60068790|NCT01752933|76183907|FG001|COMPLETED|Treatment|Completion not applicable for this survival study|0|Treatment continued as long as patient was benefitting from treatment with manageable side effects|
60068791|NCT01752933|76183906|FG000|NOT COMPLETED|Treatment||4||
60068792|NCT01752933|76183907|FG001|NOT COMPLETED|Treatment||46||
60068793|NCT01752933|76183906|FG000|STARTED|Overall Study and Follow-up|Includes all patients who received any treatment|4|"Reason Not Completed shown below are reasons for study discontinuation"|
60068794|NCT01752933|76183907|FG001|STARTED|Overall Study and Follow-up|Includes all patients who received any treatment|46|"Reason Not Completed shown below are reasons for study discontinuation"|
60103545|NCT01247272|76221779|FG001|NOT COMPLETED|Washout of 28 Days||0||
60103546|NCT01247272|76221778|FG000|STARTED|Second Intervention||13||
60103547|NCT01247272|76221779|FG001|STARTED|Second Intervention||13||
60103548|NCT01247272|76221778|FG000|COMPLETED|Second Intervention||13||
60103549|NCT01247272|76221779|FG001|COMPLETED|Second Intervention||13||
60103550|NCT01247272|76221778|FG000|NOT COMPLETED|Second Intervention||0||
60103551|NCT01247272|76221779|FG001|NOT COMPLETED|Second Intervention||0||
60103552|NCT01290484|76221785|FG000|STARTED|Overall Study||7||
60103553|NCT01290484|76221785|FG000|COMPLETED|Overall Study||7||
60103554|NCT01290484|76221785|FG000|NOT COMPLETED|Overall Study||0||
60103555|NCT01247428|76221789|FG000|STARTED|Overall Study||30||
60103556|NCT01247428|76221789|FG000|COMPLETED|Overall Study||30||
60068795|NCT01752933|76183906|FG000|COMPLETED|Overall Study and Follow-up|Completion not applicable for this survival study|0||
60068796|NCT01752933|76183907|FG001|COMPLETED|Overall Study and Follow-up|Completion not applicable for this survival study|0||
60068797|NCT01752933|76183906|FG000|NOT COMPLETED|Overall Study and Follow-up||4||
60068798|NCT01752933|76183907|FG001|NOT COMPLETED|Overall Study and Follow-up||46||
60068799|NCT01752855|76183916|FG000|STARTED|Overall Study||44||
60068800|NCT01752855|76183917|FG001|STARTED|Overall Study||44||
60068801|NCT01752855|76183916|FG000|COMPLETED|Overall Study||43||
60068802|NCT01752855|76183917|FG001|COMPLETED|Overall Study||40||
60068803|NCT01752855|76183916|FG000|NOT COMPLETED|Overall Study||1||
60068804|NCT01752855|76183917|FG001|NOT COMPLETED|Overall Study||4||
60068805|NCT01402492|76183926|FG000|STARTED|Overall Study||100||
60068806|NCT01402492|76183927|FG001|STARTED|Overall Study||100||
60068807|NCT01402492|76183928|FG002|STARTED|Overall Study||102||
60068808|NCT01402492|76183926|FG000|COMPLETED|Overall Study||79||
60068809|NCT01402492|76183927|FG001|COMPLETED|Overall Study||83||
60068810|NCT01402492|76183928|FG002|COMPLETED|Overall Study||86||
60068811|NCT01402492|76183926|FG000|NOT COMPLETED|Overall Study||21||
60068812|NCT01402492|76183927|FG001|NOT COMPLETED|Overall Study||17||
60068813|NCT01402492|76183928|FG002|NOT COMPLETED|Overall Study||16||
60068814|NCT01402102|76183938|FG000|STARTED|Overall Study||30||
60068815|NCT01402102|76183939|FG001|STARTED|Overall Study||30||
60068816|NCT01402102|76183938|FG000|COMPLETED|Overall Study||28||
60068817|NCT01402102|76183939|FG001|COMPLETED|Overall Study||27||
60068818|NCT01402102|76183938|FG000|NOT COMPLETED|Overall Study||2||
60068819|NCT01402102|76183939|FG001|NOT COMPLETED|Overall Study||3||
60068820|NCT01423084|76183949|FG000|STARTED|Overall Study||170||
60068821|NCT01423084|76183950|FG001|STARTED|Overall Study||174||
60068822|NCT01423084|76183949|FG000|COMPLETED|Overall Study||168||
60068823|NCT01423084|76183950|FG001|COMPLETED|Overall Study||170||
60068824|NCT01423084|76183949|FG000|NOT COMPLETED|Overall Study||2||
60068825|NCT01423084|76183950|FG001|NOT COMPLETED|Overall Study||4||
60068826|NCT01894256|76183960|FG000|STARTED|Part A||15||
60068827|NCT01894256|76183961|FG001|STARTED|Part A||15||
60068828|NCT01894256|76183962|FG002|STARTED|Part A||14||
60068829|NCT01894256|76183960|FG000|COMPLETED|Part A||15||
60068830|NCT01894256|76183961|FG001|COMPLETED|Part A||14||
60068831|NCT01894256|76183962|FG002|COMPLETED|Part A||14||
60068832|NCT01894256|76183960|FG000|NOT COMPLETED|Part A||0||
60068833|NCT01894256|76183961|FG001|NOT COMPLETED|Part A||1||
60068834|NCT01894256|76183962|FG002|NOT COMPLETED|Part A||0||
60068835|NCT01894256|76183960|FG000|STARTED|Part B||15||
60068836|NCT01894256|76183961|FG001|STARTED|Part B||14||
60068837|NCT01894256|76183962|FG002|STARTED|Part B||14||
60068838|NCT01894256|76183960|FG000|COMPLETED|Part B||0||
60068839|NCT01894256|76183961|FG001|COMPLETED|Part B||0||
60068840|NCT01894256|76183962|FG002|COMPLETED|Part B||0||
60068841|NCT01894256|76183960|FG000|NOT COMPLETED|Part B||15||
60068842|NCT01894256|76183961|FG001|NOT COMPLETED|Part B||14||
60068843|NCT01894256|76183962|FG002|NOT COMPLETED|Part B||14||
60068844|NCT01780935|76183975|FG000|STARTED|Overall Study||335||
60068845|NCT01780935|76183976|FG001|STARTED|Overall Study||336||
60068846|NCT01780935|76183975|FG000|Safety Set|Overall Study||334||
60068847|NCT01780935|76183976|FG001|Safety Set|Overall Study||336||
60068848|NCT01780935|76183975|FG000|COMPLETED|Overall Study||0||
60068849|NCT01780935|76183976|FG001|COMPLETED|Overall Study||0||
60068850|NCT01780935|76183975|FG000|NOT COMPLETED|Overall Study||335||
60068851|NCT01780935|76183976|FG001|NOT COMPLETED|Overall Study||336||
60068852|NCT01894100|76183984|FG000|STARTED|Overall Study||15||
60068853|NCT01894100|76183985|FG001|STARTED|Overall Study||15||
60068854|NCT01894100|76183984|FG000|COMPLETED|Overall Study||12||
60068855|NCT01894100|76183985|FG001|COMPLETED|Overall Study||14||
60068856|NCT01894100|76183984|FG000|NOT COMPLETED|Overall Study||3||
60068857|NCT01894100|76183985|FG001|NOT COMPLETED|Overall Study||1||
60068858|NCT02334982|76183998|FG000|STARTED|Overall Study||6||
60068859|NCT02334982|76183999|FG001|STARTED|Overall Study||5||
60068860|NCT02334982|76184000|FG002|STARTED|Overall Study||6||
60068861|NCT02334982|76184001|FG003|STARTED|Overall Study||6||
60068862|NCT02334982|76184002|FG004|STARTED|Overall Study||6||
60068863|NCT02334982|76184003|FG005|STARTED|Overall Study||6||
60068864|NCT02334982|76184004|FG006|STARTED|Overall Study||12||
60068865|NCT02334982|76183998|FG000|COMPLETED|Overall Study||6||
60068866|NCT02334982|76183999|FG001|COMPLETED|Overall Study||5||
60068867|NCT02334982|76184000|FG002|COMPLETED|Overall Study||6||
60068868|NCT02334982|76184001|FG003|COMPLETED|Overall Study||6||
60068869|NCT02334982|76184002|FG004|COMPLETED|Overall Study||6||
60068870|NCT02334982|76184003|FG005|COMPLETED|Overall Study||6||
60068871|NCT02334982|76184004|FG006|COMPLETED|Overall Study||12||
60068872|NCT02334982|76183998|FG000|NOT COMPLETED|Overall Study||0||
60068873|NCT02334982|76183999|FG001|NOT COMPLETED|Overall Study||0||
60068874|NCT02334982|76184000|FG002|NOT COMPLETED|Overall Study||0||
60068875|NCT02334982|76184001|FG003|NOT COMPLETED|Overall Study||0||
60068876|NCT02334982|76184002|FG004|NOT COMPLETED|Overall Study||0||
60068877|NCT02334982|76184003|FG005|NOT COMPLETED|Overall Study||0||
60068878|NCT02334982|76184004|FG006|NOT COMPLETED|Overall Study||0||
60068879|NCT01401478|76184031|FG000|STARTED|Overall Study||86||
60068880|NCT01401478|76184031|FG000|COMPLETED|Overall Study||55||
60068881|NCT01401478|76184031|FG000|NOT COMPLETED|Overall Study||31||
60068882|NCT01422850|76184035|FG000|STARTED|Overall Study||21||
59519163|NCT03549598|75613058|FG000|COMPLETED|Overall Study||15||
59519164|NCT03549598|75613058|FG000|NOT COMPLETED|Overall Study||0||
59519165|NCT01034527|75613066|FG000|STARTED|Overall Study||307||
59519166|NCT01034527|75613067|FG001|STARTED|Overall Study||216||
59519167|NCT01034527|75613066|FG000|COMPLETED|Overall Study||307||
60068883|NCT01422850|76184035|FG000|Week 4 - First Treatment|Overall Study||21||
60068884|NCT01422850|76184035|FG000|Week 5|Overall Study|One patient withdrawn by PI due to progressive disease|20||
60068885|NCT01422850|76184035|FG000|Week 9 - Second Treatment|Overall Study||20||
60068886|NCT01422850|76184035|FG000|Week 14 - Third Treatment|Overall Study|One patient withdrawn by PI and referred to external radiotherapy due to progressive disease.|19||
60068887|NCT01422850|76184035|FG000|Week 15|Overall Study|One patient withdrawn by PI due to increased PSA. Started bicalutamide treatment.|18||
60068888|NCT01422850|76184035|FG000|COMPLETED|Overall Study||18||
60068889|NCT01422850|76184035|FG000|NOT COMPLETED|Overall Study||3||
60068890|NCT01422538|76184044|FG000|STARTED|Overall Study||10||
60068891|NCT01422538|76184045|FG001|STARTED|Overall Study||10||
60068892|NCT01422538|76184046|FG002|STARTED|Overall Study||10||
60068893|NCT01422538|76184044|FG000|COMPLETED|Overall Study||10||
60068894|NCT01422538|76184045|FG001|COMPLETED|Overall Study||8||
60068895|NCT01422538|76184046|FG002|COMPLETED|Overall Study||8||
60068896|NCT01422538|76184044|FG000|NOT COMPLETED|Overall Study||0||
60068897|NCT01422538|76184045|FG001|NOT COMPLETED|Overall Study||2||
60068898|NCT01422538|76184046|FG002|NOT COMPLETED|Overall Study||2||
60068899|NCT01422382|76184055|FG000|STARTED|NK-104 4mg Once Daily (QD)||28||
60068900|NCT01422382|76184055|FG000|COMPLETED|NK-104 4mg Once Daily (QD)||28||
60068901|NCT01422382|76184055|FG000|NOT COMPLETED|NK-104 4mg Once Daily (QD)||0||
60068902|NCT01422382|76184055|FG000|STARTED|Diltiazem 240 mg QD||28||
60068903|NCT01422382|76184055|FG000|COMPLETED|Diltiazem 240 mg QD||28||
60068904|NCT01422382|76184055|FG000|NOT COMPLETED|Diltiazem 240 mg QD||0||
60068905|NCT01422382|76184055|FG000|STARTED|NK-104 4mg QD and Diltiazem 240 mg QD||28||
60068906|NCT01422382|76184055|FG000|COMPLETED|NK-104 4mg QD and Diltiazem 240 mg QD||27||
60068907|NCT01422382|76184055|FG000|NOT COMPLETED|NK-104 4mg QD and Diltiazem 240 mg QD||1||
60068908|NCT01401322|76184059|FG000|STARTED|Overall Study||5||
60068909|NCT01401322|76184059|FG000|COMPLETED|Overall Study||3||
60068910|NCT01401322|76184059|FG000|NOT COMPLETED|Overall Study||2||
60068911|NCT01387594|76184065|FG000|STARTED|Overall Study||10||
60068912|NCT01387594|76184066|FG001|STARTED|Overall Study||39||
60068913|NCT01387594|76184065|FG000|COMPLETED|Overall Study||10||
60068914|NCT01387594|76184066|FG001|COMPLETED|Overall Study||36||
60068915|NCT01387594|76184065|FG000|NOT COMPLETED|Overall Study||0||
60068916|NCT01387594|76184066|FG001|NOT COMPLETED|Overall Study||3||
60068917|NCT01401010|76184077|FG000|STARTED|Overall Study||6||
60068918|NCT01401010|76184078|FG001|STARTED|Overall Study||6||
60068919|NCT01401010|76184077|FG000|COMPLETED|Overall Study||5||
60068920|NCT01401010|76184078|FG001|COMPLETED|Overall Study||6||
60068921|NCT01401010|76184077|FG000|NOT COMPLETED|Overall Study||1||
60068922|NCT01401010|76184078|FG001|NOT COMPLETED|Overall Study||0||
60068923|NCT01400932|76184091|FG000|STARTED|Overall Study||178||
60068924|NCT01400932|76184092|FG001|STARTED|Overall Study||182||
59519168|NCT01034527|75613067|FG001|COMPLETED|Overall Study||216||
59519169|NCT01034527|75613066|FG000|NOT COMPLETED|Overall Study||0||
60068925|NCT01400932|76184091|FG000|COMPLETED|Overall Study||164||
60068926|NCT01400932|76184092|FG001|COMPLETED|Overall Study||167||
60068927|NCT01400932|76184091|FG000|NOT COMPLETED|Overall Study||14||
60068928|NCT01400932|76184092|FG001|NOT COMPLETED|Overall Study||15||
60068929|NCT01400698|76184102|FG000|STARTED|Overall Study||23||
60068930|NCT01400698|76184103|FG001|STARTED|Overall Study||23||
60068931|NCT01400698|76184104|FG002|STARTED|Overall Study||2||
60068932|NCT01400698|76184105|FG003|STARTED|Overall Study||14||
60068933|NCT01400698|76184106|FG004|STARTED|Overall Study||14||
60068934|NCT01400698|76184107|FG005|STARTED|Overall Study||15||
60068935|NCT01400698|76184102|FG000|COMPLETED|Overall Study||8||
60068936|NCT01400698|76184103|FG001|COMPLETED|Overall Study||12||
60068937|NCT01400698|76184104|FG002|COMPLETED|Overall Study||0||
60068938|NCT01400698|76184105|FG003|COMPLETED|Overall Study||6||
59519170|NCT01034527|75613067|FG001|NOT COMPLETED|Overall Study||0||
59519171|NCT01096771|75613075|FG000|STARTED|Overall Study||7||
59519172|NCT01096771|75613076|FG001|STARTED|Overall Study||7||
59519173|NCT01096771|75613075|FG000|COMPLETED|Overall Study||7||
59519174|NCT01096771|75613076|FG001|COMPLETED|Overall Study||7||
60068939|NCT01400698|76184106|FG004|COMPLETED|Overall Study||7||
60068940|NCT01400698|76184107|FG005|COMPLETED|Overall Study||9||
60068941|NCT01400698|76184102|FG000|NOT COMPLETED|Overall Study||15||
59519175|NCT01096771|75613075|FG000|NOT COMPLETED|Overall Study||0||
59519176|NCT01096771|75613076|FG001|NOT COMPLETED|Overall Study||0||
60068942|NCT01400698|76184103|FG001|NOT COMPLETED|Overall Study||11||
60068943|NCT01400698|76184104|FG002|NOT COMPLETED|Overall Study||2||
60068944|NCT01400698|76184105|FG003|NOT COMPLETED|Overall Study||8||
60068945|NCT01400698|76184106|FG004|NOT COMPLETED|Overall Study||7||
60068946|NCT01400698|76184107|FG005|NOT COMPLETED|Overall Study||6||
60068947|NCT01890746|76184119|FG000|STARTED|Overall Study||74||
60068948|NCT01890746|76184120|FG001|STARTED|Overall Study||74||
60068949|NCT01890746|76184119|FG000|COMPLETED|Overall Study||22||
60068950|NCT01890746|76184120|FG001|COMPLETED|Overall Study||33||
60068951|NCT01890746|76184119|FG000|NOT COMPLETED|Overall Study||52||
60068952|NCT01890746|76184120|FG001|NOT COMPLETED|Overall Study||41||
60068953|NCT01422304|76184128|FG000|STARTED|Overall Study|Randomized|598||
60068954|NCT01422304|76184129|FG001|STARTED|Overall Study|Randomized|600||
60068955|NCT01422304|76184128|FG000|Treated|Overall Study||595||
60068956|NCT01422304|76184129|FG001|Treated|Overall Study|1 given sugammadex; thus All Participants as Treated (APaT) Ns are 596 Sugammadex, 588 Usual Care|589||
60068957|NCT01422304|76184128|FG000|COMPLETED|Overall Study||574||
60068958|NCT01422304|76184129|FG001|COMPLETED|Overall Study||563||
60068959|NCT01422304|76184128|FG000|NOT COMPLETED|Overall Study||24||
60068960|NCT01422304|76184129|FG001|NOT COMPLETED|Overall Study||37||
60068961|NCT01387516|76184139|FG000|STARTED|Overall Study||80||
60068962|NCT01387516|76184140|FG001|STARTED|Overall Study||68||
60068963|NCT01387516|76184141|FG002|STARTED|Overall Study||79||
60068964|NCT01387516|76184142|FG003|STARTED|Overall Study||69||
60068965|NCT01387516|76184139|FG000|COMPLETED|Overall Study||75||
60068966|NCT01387516|76184140|FG001|COMPLETED|Overall Study||63||
60068967|NCT01387516|76184141|FG002|COMPLETED|Overall Study||75||
60068968|NCT01387516|76184142|FG003|COMPLETED|Overall Study||65||
60068969|NCT01387516|76184139|FG000|NOT COMPLETED|Overall Study||5||
60068970|NCT01387516|76184140|FG001|NOT COMPLETED|Overall Study||5||
60068971|NCT01387516|76184141|FG002|NOT COMPLETED|Overall Study||4||
60068972|NCT01387516|76184142|FG003|NOT COMPLETED|Overall Study||4||
60068973|NCT03812146|76184154|FG000|STARTED|Overall Study||33||
60068974|NCT03812146|76184155|FG001|STARTED|Overall Study||30||
60068975|NCT03812146|76184154|FG000|COMPLETED|Overall Study||26||
60068976|NCT03812146|76184155|FG001|COMPLETED|Overall Study||29||
60068977|NCT03812146|76184154|FG000|NOT COMPLETED|Overall Study||7||
60068978|NCT03812146|76184155|FG001|NOT COMPLETED|Overall Study||1||
60068979|NCT01421134|76184163|FG000|STARTED|Overall Study||109||
60068980|NCT01421134|76184164|FG001|STARTED|Overall Study||102||
60068981|NCT01421134|76184163|FG000|COMPLETED|Overall Study||102||
60068982|NCT01421134|76184164|FG001|COMPLETED|Overall Study||87||
60068983|NCT01421134|76184163|FG000|NOT COMPLETED|Overall Study||7||
60068984|NCT01421134|76184164|FG001|NOT COMPLETED|Overall Study||15||
60068985|NCT01894022|76184172|FG000|STARTED|Overall Study||9||
60068986|NCT01894022|76184173|FG001|STARTED|Overall Study||10||
60068987|NCT01894022|76184172|FG000|COMPLETED|Overall Study||0||
60068988|NCT01894022|76184173|FG001|COMPLETED|Overall Study||0||
60068989|NCT01894022|76184172|FG000|NOT COMPLETED|Overall Study||9||
60068990|NCT01894022|76184173|FG001|NOT COMPLETED|Overall Study||10||
60068991|NCT01615328|76184182|FG000|STARTED|Overall Study||42||
60068992|NCT01615328|76184183|FG001|STARTED|Overall Study||43||
60068993|NCT01615328|76184182|FG000|COMPLETED|Overall Study||39||
60068994|NCT01615328|76184183|FG001|COMPLETED|Overall Study||38||
60068995|NCT01615328|76184182|FG000|NOT COMPLETED|Overall Study||3||
60068996|NCT01615328|76184183|FG001|NOT COMPLETED|Overall Study||5||
60068997|NCT01890512|76184193|FG000|STARTED|Overall Study||20||
60068998|NCT01890512|76184193|FG000|COMPLETED|Overall Study||17||
60068999|NCT01890512|76184193|FG000|NOT COMPLETED|Overall Study||3||
60069000|NCT01387282|76184199|FG000|STARTED|Overall Study||330||
60069001|NCT01387282|76184200|FG001|STARTED|Overall Study||165||
60069002|NCT01387282|76184199|FG000|ITT Population|Overall Study||330||
60069003|NCT01387282|76184200|FG001|ITT Population|Overall Study||165||
60069004|NCT01387282|76184199|FG000|MITT Population|Overall Study||268||
60069005|NCT01387282|76184200|FG001|MITT Population|Overall Study||136||
60069006|NCT01387282|76184199|FG000|Safety Population|Overall Study||330||
60069007|NCT01387282|76184200|FG001|Safety Population|Overall Study||161||
60069008|NCT01387282|76184199|FG000|COMPLETED|Overall Study||233|A patient was considered to have completed the study if the patient completed Week 12/Day 85 Visit.|
60069009|NCT01387282|76184200|FG001|COMPLETED|Overall Study||118|A patient was considered to have completed the study if the patient completed Week 12/Day 85 Visit.|
60069010|NCT01387282|76184199|FG000|NOT COMPLETED|Overall Study||97||
60069011|NCT01387282|76184200|FG001|NOT COMPLETED|Overall Study||47||
60069012|NCT01386970|76184208|FG000|STARTED|Overall Study||20||
60069013|NCT01386970|76184209|FG001|STARTED|Overall Study||23||
60069014|NCT01386970|76184208|FG000|COMPLETED|Overall Study||16||
60069015|NCT01386970|76184209|FG001|COMPLETED|Overall Study||21||
60069016|NCT01386970|76184208|FG000|NOT COMPLETED|Overall Study||4||
60069017|NCT01386970|76184209|FG001|NOT COMPLETED|Overall Study||2||
60069018|NCT01890434|76184217|FG000|STARTED|Overall Study||478|Treated with gadobutrol|
60069019|NCT01890434|76184217|FG000|Evaluated for Efficacy|Overall Study||389||
60069020|NCT01890434|76184217|FG000|COMPLETED|Overall Study||458|Follow-up (FU) completed|
60069021|NCT01890434|76184217|FG000|NOT COMPLETED|Overall Study||20||
60069022|NCT01385566|76184227|FG000|STARTED|Overall Study||52||
60069023|NCT01385566|76184228|FG001|STARTED|Overall Study||34||
60069024|NCT01385566|76184229|FG002|STARTED|Overall Study||34||
60069025|NCT01385566|76184230|FG003|STARTED|Overall Study||35||
60069026|NCT01385566|76184231|FG004|STARTED|Overall Study||34||
60069027|NCT01385566|76184232|FG005|STARTED|Overall Study||34||
60069028|NCT01385566|76184227|FG000|COMPLETED|Overall Study||51||
60069029|NCT01385566|76184228|FG001|COMPLETED|Overall Study||34||
60069030|NCT01385566|76184229|FG002|COMPLETED|Overall Study||34||
60069031|NCT01385566|76184230|FG003|COMPLETED|Overall Study||34||
60069032|NCT01385566|76184231|FG004|COMPLETED|Overall Study||34||
60069033|NCT01385566|76184232|FG005|COMPLETED|Overall Study||34||
60069034|NCT01385566|76184227|FG000|NOT COMPLETED|Overall Study||1||
60069035|NCT01385566|76184228|FG001|NOT COMPLETED|Overall Study||0||
60069036|NCT01385566|76184229|FG002|NOT COMPLETED|Overall Study||0||
60069037|NCT01385566|76184230|FG003|NOT COMPLETED|Overall Study||1||
60069038|NCT01385566|76184231|FG004|NOT COMPLETED|Overall Study||0||
60069039|NCT01385566|76184232|FG005|NOT COMPLETED|Overall Study||0||
60069040|NCT01780545|76184250|FG000|STARTED|Overall Study||99||
60069041|NCT01780545|76184251|FG001|STARTED|Overall Study||101||
60069042|NCT01780545|76184250|FG000|COMPLETED|Overall Study||95||
60069043|NCT01780545|76184251|FG001|COMPLETED|Overall Study||99||
60069044|NCT01780545|76184250|FG000|NOT COMPLETED|Overall Study||4||
60069045|NCT01780545|76184251|FG001|NOT COMPLETED|Overall Study||2||
60069046|NCT01780389|76184260|FG000|STARTED|Overall Study||5||
60069047|NCT01780389|76184260|FG000|COMPLETED|Overall Study|One patient discontinued due to adverse event.|4||
60069048|NCT01780389|76184260|FG000|NOT COMPLETED|Overall Study||1||
60069049|NCT01778985|76184267|FG000|STARTED|Overall Study||15||
60069050|NCT01778985|76184268|FG001|STARTED|Overall Study||15||
60069051|NCT01778985|76184267|FG000|COMPLETED|Overall Study||8||
60069052|NCT01778985|76184268|FG001|COMPLETED|Overall Study||12||
60069053|NCT01778985|76184267|FG000|NOT COMPLETED|Overall Study||7||
60069054|NCT01778985|76184268|FG001|NOT COMPLETED|Overall Study||3||
60069055|NCT01778751|76184276|FG000|STARTED|Overall Study||25||
60069056|NCT01778751|76184277|FG001|STARTED|Overall Study||25||
60069057|NCT01778751|76184276|FG000|COMPLETED|Overall Study||23||
60069058|NCT01778751|76184277|FG001|COMPLETED|Overall Study||23||
60069059|NCT01778751|76184276|FG000|NOT COMPLETED|Overall Study||2||
60069060|NCT01778751|76184277|FG001|NOT COMPLETED|Overall Study||2||
60069061|NCT01865084|76184286|FG000|STARTED|Double Blind Period (DB)||116||
60069062|NCT01865084|76184287|FG001|STARTED|Double Blind Period (DB)||102||
60069063|NCT01865084|76184288|FG002|STARTED|Double Blind Period (DB)||113||
60069064|NCT01865084|76184286|FG000|Received at Least One Dose of Study Drug|Double Blind Period (DB)||116||
60069065|NCT01865084|76184287|FG001|Received at Least One Dose of Study Drug|Double Blind Period (DB)||102||
60069066|NCT01865084|76184288|FG002|Received at Least One Dose of Study Drug|Double Blind Period (DB)||112||
60069067|NCT01865084|76184286|FG000|COMPLETED|Double Blind Period (DB)||111||
60069068|NCT01865084|76184287|FG001|COMPLETED|Double Blind Period (DB)|One participant stopped therapy during the DB period but remained in the study for follow-up.|98||
60069069|NCT01865084|76184288|FG002|COMPLETED|Double Blind Period (DB)||107||
60069070|NCT01865084|76184286|FG000|NOT COMPLETED|Double Blind Period (DB)||5||
60069071|NCT01865084|76184287|FG001|NOT COMPLETED|Double Blind Period (DB)||4||
60069072|NCT01865084|76184288|FG002|NOT COMPLETED|Double Blind Period (DB)||6||
60069073|NCT01865084|76184286|FG000|STARTED|Open Label Extension (OLE) Period|Participants who were on Placebo during the double blind period were assigned tadalafil during OLE.|0||
60069074|NCT01865084|76184287|FG001|STARTED|Open Label Extension (OLE) Period|Participants who were on Placebo during the double blind period were assigned tadalafil during OLE.|150||
60069075|NCT01865084|76184288|FG002|STARTED|Open Label Extension (OLE) Period|Participants who were on Placebo during the double blind period were assigned tadalafil during OLE.|165||
60069076|NCT01865084|76184286|FG000|COMPLETED|Open Label Extension (OLE) Period||0||
60069077|NCT01865084|76184287|FG001|COMPLETED|Open Label Extension (OLE) Period||139||
60069078|NCT01865084|76184288|FG002|COMPLETED|Open Label Extension (OLE) Period||158||
60069079|NCT01865084|76184286|FG000|NOT COMPLETED|Open Label Extension (OLE) Period||0||
60069080|NCT01865084|76184287|FG001|NOT COMPLETED|Open Label Extension (OLE) Period||11||
60069081|NCT01865084|76184288|FG002|NOT COMPLETED|Open Label Extension (OLE) Period||7||
60069082|NCT01778127|76184303|FG000|STARTED|Overall Study||33||
60069083|NCT01778127|76184304|FG001|STARTED|Overall Study||33||
60069084|NCT01778127|76184305|FG002|STARTED|Overall Study||32||
60069085|NCT01778127|76184303|FG000|COMPLETED|Overall Study||25||
60069086|NCT01778127|76184304|FG001|COMPLETED|Overall Study||31||
60069087|NCT01778127|76184305|FG002|COMPLETED|Overall Study||26||
60069088|NCT01778127|76184303|FG000|NOT COMPLETED|Overall Study||8||
60069089|NCT01778127|76184304|FG001|NOT COMPLETED|Overall Study||2||
60069090|NCT01778127|76184305|FG002|NOT COMPLETED|Overall Study||6||
60069091|NCT01892540|76184316|FG000|STARTED|Overall Study||15||
60069092|NCT01892540|76184317|FG001|STARTED|Overall Study||0||
60069093|NCT01892540|76184318|FG002|STARTED|Overall Study||28||
60069094|NCT01892540|76184316|FG000|COMPLETED|Overall Study||15||
60069095|NCT01892540|76184317|FG001|COMPLETED|Overall Study||0||
60069096|NCT01892540|76184318|FG002|COMPLETED|Overall Study||25||
60069097|NCT01892540|76184316|FG000|NOT COMPLETED|Overall Study||0||
60069098|NCT01892540|76184317|FG001|NOT COMPLETED|Overall Study||0||
60069099|NCT01892540|76184318|FG002|NOT COMPLETED|Overall Study||3||
60069100|NCT01385098|76184326|FG000|STARTED|Overall Study||37||
60069101|NCT01385098|76184326|FG000|COMPLETED|Overall Study|14 subjects did not complete. 4 subjects loss to follow-up & 10 subjects could not tolerate suppl.|23||
60069102|NCT01385098|76184326|FG000|NOT COMPLETED|Overall Study||14||
60069103|NCT01398514|76184334|FG000|STARTED|Overall Study||26||
60069104|NCT01398514|76184335|FG001|STARTED|Overall Study||26||
60069105|NCT01398514|76184334|FG000|COMPLETED|Overall Study||18||
60069106|NCT01398514|76184335|FG001|COMPLETED|Overall Study||20||
60069107|NCT01398514|76184334|FG000|NOT COMPLETED|Overall Study||8||
60069108|NCT01398514|76184335|FG001|NOT COMPLETED|Overall Study||6||
60069109|NCT01398358|76184346|FG000|STARTED|Overall Study||218||
59519177|NCT00951899|75613084|FG000|STARTED|Overall Study||19||
59519178|NCT00951899|75613085|FG001|STARTED|Overall Study||19||
60069110|NCT01398358|76184347|FG001|STARTED|Overall Study||224||
59519179|NCT00951899|75613084|FG000|COMPLETED|Overall Study||19||
59951605|NCT01328444|76070623|FG002|STARTED|Treatment Period 1 (12 Weeks)||28||
59951606|NCT01328444|76070624|FG003|STARTED|Treatment Period 1 (12 Weeks)||41||
59951607|NCT01328444|76070625|FG004|STARTED|Treatment Period 1 (12 Weeks)||81||
59951608|NCT01328444|76070626|FG005|STARTED|Treatment Period 1 (12 Weeks)||78||
59951609|NCT01328444|76070621|FG000|COMPLETED|Treatment Period 1 (12 Weeks)||83||
59951610|NCT01328444|76070622|FG001|COMPLETED|Treatment Period 1 (12 Weeks)||21||
59951611|NCT01328444|76070623|FG002|COMPLETED|Treatment Period 1 (12 Weeks)||25||
59951612|NCT01328444|76070624|FG003|COMPLETED|Treatment Period 1 (12 Weeks)||33||
59951613|NCT01328444|76070625|FG004|COMPLETED|Treatment Period 1 (12 Weeks)||67||
60069111|NCT01398358|76184348|FG002|STARTED|Overall Study||255||
60069112|NCT01398358|76184346|FG000|COMPLETED|Overall Study||203||
60069113|NCT01398358|76184347|FG001|COMPLETED|Overall Study||201||
60069114|NCT01398358|76184348|FG002|COMPLETED|Overall Study||234||
60069115|NCT01398358|76184346|FG000|NOT COMPLETED|Overall Study||15||
60069116|NCT01398358|76184347|FG001|NOT COMPLETED|Overall Study||23||
60069117|NCT01398358|76184348|FG002|NOT COMPLETED|Overall Study||21||
60069118|NCT01778049|76184358|FG000|STARTED|Open Label Treatment Period||354||
60069119|NCT01778049|76184359|FG001|STARTED|Open Label Treatment Period||355||
60069120|NCT01778049|76184360|FG002|STARTED|Open Label Treatment Period||0||
60069121|NCT01778049|76184361|FG003|STARTED|Open Label Treatment Period||0||
60069122|NCT01778049|76184362|FG004|STARTED|Open Label Treatment Period||0||
60069123|NCT01778049|76184363|FG005|STARTED|Open Label Treatment Period||0||
60069124|NCT01778049|76184358|FG000|COMPLETED|Open Label Treatment Period||256||
60069125|NCT01778049|76184359|FG001|COMPLETED|Open Label Treatment Period||226||
60069126|NCT01778049|76184360|FG002|COMPLETED|Open Label Treatment Period||0||
60069127|NCT01778049|76184361|FG003|COMPLETED|Open Label Treatment Period||0||
60069128|NCT01778049|76184362|FG004|COMPLETED|Open Label Treatment Period||0||
60069129|NCT01778049|76184363|FG005|COMPLETED|Open Label Treatment Period||0||
60069130|NCT01778049|76184358|FG000|NOT COMPLETED|Open Label Treatment Period||98||
60069131|NCT01778049|76184359|FG001|NOT COMPLETED|Open Label Treatment Period||129||
60069132|NCT01778049|76184360|FG002|NOT COMPLETED|Open Label Treatment Period||0||
60069133|NCT01778049|76184361|FG003|NOT COMPLETED|Open Label Treatment Period||0||
60069134|NCT01778049|76184362|FG004|NOT COMPLETED|Open Label Treatment Period||0||
60069135|NCT01778049|76184363|FG005|NOT COMPLETED|Open Label Treatment Period||0||
60069136|NCT01778049|76184358|FG000|STARTED|Double Blind Treatment Period||0||
60069137|NCT01778049|76184359|FG001|STARTED|Double Blind Treatment Period||0||
60069138|NCT01778049|76184360|FG002|STARTED|Double Blind Treatment Period||126||
60069139|NCT01778049|76184361|FG003|STARTED|Double Blind Treatment Period||130||
60069140|NCT01778049|76184362|FG004|STARTED|Double Blind Treatment Period||114||
59762705|NCT00856557|75882565|FG000|Received Intervention/Control|Overall Study||62||
59762706|NCT00856557|75882566|FG001|Received Intervention/Control|Overall Study||76||
59762707|NCT00856557|75882565|FG000|Tested With Standardized Patients|Overall Study||62||
59519180|NCT00951899|75613085|FG001|COMPLETED|Overall Study||19||
59519181|NCT00951899|75613084|FG000|NOT COMPLETED|Overall Study||0||
59519182|NCT00951899|75613085|FG001|NOT COMPLETED|Overall Study||0||
59519183|NCT01035151|75613093|FG000|STARTED|Overall Study||209||
59519184|NCT01035151|75613094|FG001|STARTED|Overall Study||200||
59519185|NCT01035151|75613093|FG000|COMPLETED|Overall Study||188||
59519186|NCT01035151|75613094|FG001|COMPLETED|Overall Study||185||
59519187|NCT01035151|75613093|FG000|NOT COMPLETED|Overall Study||21||
59519188|NCT01035151|75613094|FG001|NOT COMPLETED|Overall Study||15||
59519189|NCT01097395|75613102|FG000|STARTED|Overall Study||17||
59519190|NCT01097395|75613103|FG001|STARTED|Overall Study||18||
59519191|NCT01097395|75613102|FG000|COMPLETED|Overall Study||14||
59519192|NCT01097395|75613103|FG001|COMPLETED|Overall Study||14||
59519193|NCT01097395|75613102|FG000|NOT COMPLETED|Overall Study||3||
59762708|NCT00856557|75882566|FG001|Tested With Standardized Patients|Overall Study||76||
59762709|NCT00856557|75882565|FG000|With Patients With Contextual Flags|Overall Study||50||
59951614|NCT01328444|76070626|FG005|COMPLETED|Treatment Period 1 (12 Weeks)||72||
59519194|NCT01097395|75613103|FG001|NOT COMPLETED|Overall Study||4||
59519195|NCT01036009|75613111|FG000|STARTED|Overall Study||17||
59519196|NCT01036009|75613112|FG001|STARTED|Overall Study||26||
59519197|NCT01036009|75613111|FG000|COMPLETED|Overall Study||17||
59519198|NCT01036009|75613112|FG001|COMPLETED|Overall Study||26||
59519199|NCT01036009|75613111|FG000|NOT COMPLETED|Overall Study||0||
59519200|NCT01036009|75613112|FG001|NOT COMPLETED|Overall Study||0||
59519201|NCT02180893|75613121|FG000|STARTED|Overall Study||30||
59519202|NCT02180893|75613122|FG001|STARTED|Overall Study||30||
59519203|NCT02180893|75613121|FG000|COMPLETED|Overall Study||27||
59951615|NCT01328444|76070621|FG000|NOT COMPLETED|Treatment Period 1 (12 Weeks)||11||
59951616|NCT01328444|76070622|FG001|NOT COMPLETED|Treatment Period 1 (12 Weeks)||5||
59951617|NCT01328444|76070623|FG002|NOT COMPLETED|Treatment Period 1 (12 Weeks)||3||
59951618|NCT01328444|76070624|FG003|NOT COMPLETED|Treatment Period 1 (12 Weeks)||8||
59951619|NCT01328444|76070625|FG004|NOT COMPLETED|Treatment Period 1 (12 Weeks)||14||
59951620|NCT01328444|76070626|FG005|NOT COMPLETED|Treatment Period 1 (12 Weeks)||6||
59951621|NCT01328444|76070621|FG000|STARTED|Washout Period (14 Days)||83||
59951622|NCT01328444|76070622|FG001|STARTED|Washout Period (14 Days)||21||
59951623|NCT01328444|76070623|FG002|STARTED|Washout Period (14 Days)||25||
59951624|NCT01328444|76070624|FG003|STARTED|Washout Period (14 Days)||33||
59951625|NCT01328444|76070625|FG004|STARTED|Washout Period (14 Days)||67||
59951626|NCT01328444|76070626|FG005|STARTED|Washout Period (14 Days)||72||
59951627|NCT01328444|76070621|FG000|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|82||
59951628|NCT01328444|76070622|FG001|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|20||
59951629|NCT01328444|76070623|FG002|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|25||
59994813|NCT03268811|76110628|FG001|COMPLETED|Overall Study||1||
59519204|NCT02180893|75613122|FG001|COMPLETED|Overall Study||23||
59994814|NCT03268811|76110627|FG000|NOT COMPLETED|Overall Study||0||
59994815|NCT03268811|76110628|FG001|NOT COMPLETED|Overall Study||1||
59994816|NCT02732015|76110637|FG000|STARTED|Overall Study||9||
59519205|NCT02180893|75613121|FG000|NOT COMPLETED|Overall Study||3||
59994817|NCT02732015|76110638|FG001|STARTED|Overall Study||27||
59994818|NCT02732015|76110637|FG000|COMPLETED|Overall Study||9||
59994819|NCT02732015|76110638|FG001|COMPLETED|Overall Study||26||
59994820|NCT02732015|76110637|FG000|NOT COMPLETED|Overall Study||0||
59994821|NCT02732015|76110638|FG001|NOT COMPLETED|Overall Study||1||
59994822|NCT03093701|76110647|FG000|STARTED|Overall Study||10||
59994823|NCT03093701|76110648|FG001|STARTED|Overall Study||10||
59994824|NCT03093701|76110649|FG002|STARTED|Overall Study||11||
59994825|NCT03093701|76110650|FG003|STARTED|Overall Study||0||
59994826|NCT03093701|76110647|FG000|COMPLETED|Overall Study||10||
59994827|NCT03093701|76110648|FG001|COMPLETED|Overall Study||7||
59994828|NCT03093701|76110649|FG002|COMPLETED|Overall Study||11||
59994829|NCT03093701|76110650|FG003|COMPLETED|Overall Study||0||
59994830|NCT03093701|76110647|FG000|NOT COMPLETED|Overall Study||0||
59994831|NCT03093701|76110648|FG001|NOT COMPLETED|Overall Study||3||
59994832|NCT03093701|76110649|FG002|NOT COMPLETED|Overall Study||0||
59994833|NCT03093701|76110650|FG003|NOT COMPLETED|Overall Study||0||
59994834|NCT01441115|76110658|FG000|STARTED|Overall Study||2||
59994835|NCT01441115|76110658|FG000|COMPLETED|Overall Study||1||
59994836|NCT01441115|76110658|FG000|NOT COMPLETED|Overall Study||1||
59994837|NCT02006147|76110669|FG000|STARTED|Overall Study||5||
59994838|NCT02006147|76110670|FG001|STARTED|Overall Study||9||
59994839|NCT02006147|76110671|FG002|STARTED|Overall Study||0||
59994840|NCT02006147|76110672|FG003|STARTED|Overall Study||0||
59994841|NCT02006147|76110669|FG000|COMPLETED|Overall Study||3||
59994842|NCT02006147|76110670|FG001|COMPLETED|Overall Study||7||
59994843|NCT02006147|76110671|FG002|COMPLETED|Overall Study||0||
59994844|NCT02006147|76110672|FG003|COMPLETED|Overall Study||0||
59994845|NCT02006147|76110669|FG000|NOT COMPLETED|Overall Study||2||
59994846|NCT02006147|76110670|FG001|NOT COMPLETED|Overall Study||2||
59994847|NCT02006147|76110671|FG002|NOT COMPLETED|Overall Study||0||
59994848|NCT02006147|76110672|FG003|NOT COMPLETED|Overall Study||0||
59994849|NCT02732119|76110683|FG000|STARTED|Phase I||8||
59994850|NCT02732119|76110684|FG001|STARTED|Phase I||10||
59994851|NCT02732119|76110685|FG002|STARTED|Phase I||7||
59994852|NCT02732119|76110686|FG003|STARTED|Phase I||0||
59994853|NCT02732119|76110687|FG004|STARTED|Phase I||0||
59994854|NCT02732119|76110683|FG000|COMPLETED|Phase I||0||
59994855|NCT02732119|76110684|FG001|COMPLETED|Phase I||0||
59994856|NCT02732119|76110685|FG002|COMPLETED|Phase I||0||
59994857|NCT02732119|76110686|FG003|COMPLETED|Phase I||0||
59994858|NCT02732119|76110687|FG004|COMPLETED|Phase I||0||
59994859|NCT02732119|76110683|FG000|NOT COMPLETED|Phase I||8||
59994860|NCT02732119|76110684|FG001|NOT COMPLETED|Phase I||10||
59994861|NCT02732119|76110685|FG002|NOT COMPLETED|Phase I||7||
59994862|NCT02732119|76110686|FG003|NOT COMPLETED|Phase I||0||
59994863|NCT02732119|76110687|FG004|NOT COMPLETED|Phase I||0||
59994864|NCT02732119|76110683|FG000|STARTED|Phase II||0||
60069141|NCT01778049|76184363|FG005|STARTED|Double Blind Treatment Period||112||
60069142|NCT01778049|76184358|FG000|COMPLETED|Double Blind Treatment Period||0||
60069143|NCT01778049|76184359|FG001|COMPLETED|Double Blind Treatment Period||0||
60069144|NCT01778049|76184360|FG002|COMPLETED|Double Blind Treatment Period||111||
60069145|NCT01778049|76184361|FG003|COMPLETED|Double Blind Treatment Period||118||
60069146|NCT01778049|76184362|FG004|COMPLETED|Double Blind Treatment Period||102||
60069147|NCT01778049|76184363|FG005|COMPLETED|Double Blind Treatment Period||105||
60069148|NCT01778049|76184358|FG000|NOT COMPLETED|Double Blind Treatment Period||0||
60069149|NCT01778049|76184359|FG001|NOT COMPLETED|Double Blind Treatment Period||0||
60069150|NCT01778049|76184360|FG002|NOT COMPLETED|Double Blind Treatment Period||15||
60069151|NCT01778049|76184361|FG003|NOT COMPLETED|Double Blind Treatment Period||12||
60069152|NCT01778049|76184362|FG004|NOT COMPLETED|Double Blind Treatment Period||12||
60069153|NCT01778049|76184363|FG005|NOT COMPLETED|Double Blind Treatment Period||7||
60069154|NCT01777581|76184377|FG000|STARTED|Overall Study|Includes one subject screened/consented but not assigned to either arm.|8||
59951630|NCT01328444|76070624|FG003|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|32||
59951631|NCT01328444|76070625|FG004|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|66||
59951632|NCT01328444|76070626|FG005|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|68||
59951633|NCT01328444|76070621|FG000|NOT COMPLETED|Washout Period (14 Days)||1||
59951634|NCT01328444|76070622|FG001|NOT COMPLETED|Washout Period (14 Days)||1||
59951635|NCT01328444|76070623|FG002|NOT COMPLETED|Washout Period (14 Days)||0||
59951636|NCT01328444|76070624|FG003|NOT COMPLETED|Washout Period (14 Days)||1||
59951637|NCT01328444|76070625|FG004|NOT COMPLETED|Washout Period (14 Days)||1||
59951638|NCT01328444|76070626|FG005|NOT COMPLETED|Washout Period (14 Days)||4||
59951639|NCT01328444|76070621|FG000|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|76||
59951640|NCT01328444|76070622|FG001|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|23||
59951641|NCT01328444|76070623|FG002|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|22||
59951642|NCT01328444|76070624|FG003|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|35||
59951643|NCT01328444|76070625|FG004|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|71||
59951644|NCT01328444|76070626|FG005|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|66||
59951645|NCT01328444|76070621|FG000|COMPLETED|Treatment Period 2 (12 Weeks)||65||
59951646|NCT01328444|76070622|FG001|COMPLETED|Treatment Period 2 (12 Weeks)||22||
59951647|NCT01328444|76070623|FG002|COMPLETED|Treatment Period 2 (12 Weeks)||19||
59951648|NCT01328444|76070624|FG003|COMPLETED|Treatment Period 2 (12 Weeks)||30||
59951649|NCT01328444|76070625|FG004|COMPLETED|Treatment Period 2 (12 Weeks)||63||
59951650|NCT01328444|76070626|FG005|COMPLETED|Treatment Period 2 (12 Weeks)||59||
59951651|NCT01328444|76070621|FG000|NOT COMPLETED|Treatment Period 2 (12 Weeks)||11||
59951652|NCT01328444|76070622|FG001|NOT COMPLETED|Treatment Period 2 (12 Weeks)||1||
59951653|NCT01328444|76070623|FG002|NOT COMPLETED|Treatment Period 2 (12 Weeks)||3||
59951654|NCT01328444|76070624|FG003|NOT COMPLETED|Treatment Period 2 (12 Weeks)||5||
59951655|NCT01328444|76070625|FG004|NOT COMPLETED|Treatment Period 2 (12 Weeks)||8||
59951656|NCT01328444|76070626|FG005|NOT COMPLETED|Treatment Period 2 (12 Weeks)||7||
59951657|NCT00887250|76070643|FG000|STARTED|Overall Study||116||
59951658|NCT00887250|76070644|FG001|STARTED|Overall Study||127||
59951659|NCT00887250|76070645|FG002|STARTED|Overall Study||123||
59951660|NCT00887250|76070643|FG000|COMPLETED|Overall Study||98||
59951661|NCT00887250|76070644|FG001|COMPLETED|Overall Study||115||
60069155|NCT01777581|76184378|FG001|STARTED|Overall Study|Includes one subject screened/consented but not assigned to either arm.|5||
60069156|NCT01777581|76184377|FG000|COMPLETED|Overall Study||5||
60069157|NCT01777581|76184378|FG001|COMPLETED|Overall Study||3||
60069158|NCT01777581|76184377|FG000|NOT COMPLETED|Overall Study||3||
60069159|NCT01777581|76184378|FG001|NOT COMPLETED|Overall Study||2||
60069160|NCT01864148|76184389|FG000|STARTED|Overall Study||93||
60069161|NCT01864148|76184390|FG001|STARTED|Overall Study||45||
60069162|NCT01864148|76184391|FG002|STARTED|Overall Study||95||
60069163|NCT01864148|76184392|FG003|STARTED|Overall Study||94||
60069164|NCT01864148|76184393|FG004|STARTED|Overall Study||92||
60069165|NCT01864148|76184389|FG000|Randomized and Dosed|Overall Study||93||
60069166|NCT01864148|76184390|FG001|Randomized and Dosed|Overall Study||45||
60069167|NCT01864148|76184391|FG002|Randomized and Dosed|Overall Study||95||
60069168|NCT01864148|76184392|FG003|Randomized and Dosed|Overall Study||93||
59951662|NCT00887250|76070645|FG002|COMPLETED|Overall Study||110||
60069169|NCT01864148|76184393|FG004|Randomized and Dosed|Overall Study||92||
60069170|NCT01864148|76184389|FG000|COMPLETED|Overall Study||73||
60069171|NCT01864148|76184390|FG001|COMPLETED|Overall Study||40||
60069172|NCT01864148|76184391|FG002|COMPLETED|Overall Study||84||
60069173|NCT01864148|76184392|FG003|COMPLETED|Overall Study||68||
60069174|NCT01864148|76184393|FG004|COMPLETED|Overall Study||69||
60069175|NCT01864148|76184389|FG000|NOT COMPLETED|Overall Study||20||
60069176|NCT01864148|76184390|FG001|NOT COMPLETED|Overall Study||5||
60069177|NCT01864148|76184391|FG002|NOT COMPLETED|Overall Study||11||
60069178|NCT01864148|76184392|FG003|NOT COMPLETED|Overall Study||26||
60069179|NCT01864148|76184393|FG004|NOT COMPLETED|Overall Study||23||
60069180|NCT01751139|76184410|FG000|STARTED|Overall Study||3300||
60069181|NCT01751139|76184410|FG000|COMPLETED|Overall Study||1033||
60069182|NCT01751139|76184410|FG000|NOT COMPLETED|Overall Study||2267||
60069183|NCT01890122|76184418|FG000|STARTED|Overall Study|Started = Enrolled set which included all participants who signed informed consent.|162||
60069184|NCT01890122|76184419|FG001|STARTED|Overall Study||163||
60069185|NCT01890122|76184420|FG002|STARTED|Overall Study||159||
60069186|NCT01890122|76184421|FG003|STARTED|Overall Study||163||
60069187|NCT01890122|76184418|FG000|Treated|Overall Study|Treated = Randomized participants who received at least one dose of study drug.|161||
60069188|NCT01890122|76184419|FG001|Treated|Overall Study||162||
60069189|NCT01890122|76184420|FG002|Treated|Overall Study||159||
60069190|NCT01890122|76184421|FG003|Treated|Overall Study||163||
60069191|NCT01890122|76184418|FG000|COMPLETED|Overall Study||135||
60069192|NCT01890122|76184419|FG001|COMPLETED|Overall Study||126||
60069193|NCT01890122|76184420|FG002|COMPLETED|Overall Study||146||
60069194|NCT01890122|76184421|FG003|COMPLETED|Overall Study||104||
60069195|NCT01890122|76184418|FG000|NOT COMPLETED|Overall Study||27||
60069196|NCT01890122|76184419|FG001|NOT COMPLETED|Overall Study||37||
60069197|NCT01890122|76184420|FG002|NOT COMPLETED|Overall Study||13||
60069198|NCT01890122|76184421|FG003|NOT COMPLETED|Overall Study||59||
60069199|NCT01397890|76184433|FG000|STARTED|Overall Study||287||
60069200|NCT01397890|76184434|FG001|STARTED|Overall Study||291||
60069201|NCT01397890|76184433|FG000|Post-baseline Efficacy Data Collected|Overall Study|'Full Analysis Set' used for efficacy analysis|287||
60069202|NCT01397890|76184434|FG001|Post-baseline Efficacy Data Collected|Overall Study|'Full Analysis Set' used for efficacy analysis|290||
60069203|NCT01397890|76184433|FG000|Received Correct Randomized Treatment|Overall Study|'Safety Analysis Set' =287+3-1=289. 3 and 1 pts in respective groups received opposite treatment.|286||
60069204|NCT01397890|76184434|FG001|Received Correct Randomized Treatment|Overall Study|'Safety Analysis Set' =291+1-3=289.|287||
60069205|NCT01397890|76184433|FG000|COMPLETED|Overall Study||264||
60069206|NCT01397890|76184434|FG001|COMPLETED|Overall Study||260||
60069207|NCT01397890|76184433|FG000|NOT COMPLETED|Overall Study||23||
60069208|NCT01397890|76184434|FG001|NOT COMPLETED|Overall Study||31||
60069209|NCT01777269|76184442|FG000|STARTED|Overall Study||246||
60069210|NCT01777269|76184443|FG001|STARTED|Overall Study||243||
60069211|NCT01777269|76184442|FG000|COMPLETED|Overall Study||191||
60069212|NCT01777269|76184443|FG001|COMPLETED|Overall Study||184||
60069213|NCT01777269|76184442|FG000|NOT COMPLETED|Overall Study||55||
60069214|NCT01777269|76184443|FG001|NOT COMPLETED|Overall Study||59||
60069215|NCT04016272|76184451|FG000|STARTED|Overall Study||61||
60069216|NCT04016272|76184452|FG001|STARTED|Overall Study||62||
60069217|NCT04016272|76184451|FG000|COMPLETED|Overall Study||60||
60069218|NCT04016272|76184452|FG001|COMPLETED|Overall Study||60||
60069219|NCT04016272|76184451|FG000|NOT COMPLETED|Overall Study||1||
60069220|NCT04016272|76184452|FG001|NOT COMPLETED|Overall Study||2||
60069221|NCT01751061|76184460|FG000|STARTED|Overall Study||210||
60069222|NCT01751061|76184461|FG001|STARTED|Overall Study||206||
60069223|NCT01751061|76184460|FG000|COMPLETED|Overall Study||154||
60069224|NCT01751061|76184461|FG001|COMPLETED|Overall Study||172||
60069225|NCT01751061|76184460|FG000|NOT COMPLETED|Overall Study||56||
60069226|NCT01751061|76184461|FG001|NOT COMPLETED|Overall Study||34||
60069227|NCT01777191|76184469|FG000|STARTED|Treatment Period (Per) (Week 0-Week 12)||102||
60069228|NCT01777191|76184470|FG001|STARTED|Treatment Period (Per) (Week 0-Week 12)||102||
60069229|NCT01777191|76184469|FG000|COMPLETED|Treatment Period (Per) (Week 0-Week 12)||96||
60069230|NCT01777191|76184470|FG001|COMPLETED|Treatment Period (Per) (Week 0-Week 12)||94||
60069231|NCT01777191|76184469|FG000|NOT COMPLETED|Treatment Period (Per) (Week 0-Week 12)||6||
60069232|NCT01777191|76184470|FG001|NOT COMPLETED|Treatment Period (Per) (Week 0-Week 12)||8||
60069233|NCT01777191|76184469|FG000|STARTED|Safety Extension Per (Week 12-Week 48)|Participation in the safety extension period was optional.|94||
60069234|NCT01777191|76184470|FG001|STARTED|Safety Extension Per (Week 12-Week 48)|Participation in the safety extension period was optional.|91||
60069235|NCT01777191|76184469|FG000|COMPLETED|Safety Extension Per (Week 12-Week 48)||85||
60069236|NCT01777191|76184470|FG001|COMPLETED|Safety Extension Per (Week 12-Week 48)||78||
60069237|NCT01777191|76184469|FG000|NOT COMPLETED|Safety Extension Per (Week 12-Week 48)||9||
60069238|NCT01777191|76184470|FG001|NOT COMPLETED|Safety Extension Per (Week 12-Week 48)||13||
60069239|NCT01896050|76184481|FG000|STARTED|Overall Study||93||
60069240|NCT01896050|76184482|FG001|STARTED|Overall Study||22||
60069241|NCT01896050|76184481|FG000|COMPLETED|Overall Study|This includes only patients who remained on the same aromatase inhibitor medication for 12 months|55||
60069242|NCT01896050|76184482|FG001|COMPLETED|Overall Study||20||
60069243|NCT01896050|76184481|FG000|NOT COMPLETED|Overall Study||38||
60069244|NCT01896050|76184482|FG001|NOT COMPLETED|Overall Study||2||
60069245|NCT01775787|76184490|FG000|STARTED|First 7-10 Days||13||
60069246|NCT01775787|76184491|FG001|STARTED|First 7-10 Days||14||
60069247|NCT01775787|76184490|FG000|COMPLETED|First 7-10 Days||12||
60069248|NCT01775787|76184491|FG001|COMPLETED|First 7-10 Days||8||
60069249|NCT01775787|76184490|FG000|NOT COMPLETED|First 7-10 Days||1||
60069250|NCT01775787|76184491|FG001|NOT COMPLETED|First 7-10 Days||6||
60069251|NCT01775787|76184490|FG000|STARTED|Second 7-10 Days||12||
60069252|NCT01775787|76184491|FG001|STARTED|Second 7-10 Days||8||
60069253|NCT01775787|76184490|FG000|COMPLETED|Second 7-10 Days||12||
60069254|NCT01775787|76184491|FG001|COMPLETED|Second 7-10 Days||6||
60069255|NCT01775787|76184490|FG000|NOT COMPLETED|Second 7-10 Days||0||
60069256|NCT01775787|76184491|FG001|NOT COMPLETED|Second 7-10 Days||2||
60069257|NCT01775553|76184499|FG000|STARTED|Overall Study||13||
60069258|NCT01775553|76184499|FG000|COMPLETED|Overall Study||0||
60069259|NCT01775553|76184499|FG000|NOT COMPLETED|Overall Study||13||
60069260|NCT01775475|76184505|FG000|STARTED|Overall Study||4||
60069261|NCT01775475|76184506|FG001|STARTED|Overall Study||3||
60069262|NCT01775475|76184505|FG000|COMPLETED|Overall Study||1||
60069263|NCT01775475|76184506|FG001|COMPLETED|Overall Study||0||
60069264|NCT01775475|76184505|FG000|NOT COMPLETED|Overall Study||3||
59519206|NCT02180893|75613122|FG001|NOT COMPLETED|Overall Study||7||
59519207|NCT01122901|75613130|FG000|STARTED|Overall Study||40||
59519208|NCT01122901|75613131|FG001|STARTED|Overall Study||7||
59519209|NCT01122901|75613130|FG000|COMPLETED|Overall Study||40||
59519210|NCT01122901|75613131|FG001|COMPLETED|Overall Study||7||
59519211|NCT01122901|75613130|FG000|NOT COMPLETED|Overall Study||0||
59519212|NCT01122901|75613131|FG001|NOT COMPLETED|Overall Study||0||
60069265|NCT01775475|76184506|FG001|NOT COMPLETED|Overall Study||3||
60069266|NCT01774929|76184512|FG000|STARTED|Overall Study||35||
60069267|NCT01774929|76184512|FG000|COMPLETED|Overall Study||32||
60069268|NCT01774929|76184512|FG000|NOT COMPLETED|Overall Study||3||
60069269|NCT01888874|76184523|FG000|STARTED|Period 1 (Baseline up to Week 12)||86||
60069270|NCT01888874|76184524|FG001|STARTED|Period 1 (Baseline up to Week 12)||82||
60069271|NCT01888874|76184525|FG002|STARTED|Period 1 (Baseline up to Week 12)||85||
59519213|NCT01097785|75613144|FG000|STARTED|Cycle 1 (30 Days)||6||
59519214|NCT01097785|75613145|FG001|STARTED|Cycle 1 (30 Days)||6||
59519215|NCT01097785|75613144|FG000|COMPLETED|Cycle 1 (30 Days)||6||
59519216|NCT01097785|75613145|FG001|COMPLETED|Cycle 1 (30 Days)||6||
59519217|NCT01097785|75613144|FG000|NOT COMPLETED|Cycle 1 (30 Days)||0||
59519218|NCT01097785|75613145|FG001|NOT COMPLETED|Cycle 1 (30 Days)||0||
59519219|NCT01097785|75613144|FG000|STARTED|Washout (2 Weeks)||6||
59519220|NCT01097785|75613145|FG001|STARTED|Washout (2 Weeks)||6||
59519221|NCT01097785|75613144|FG000|COMPLETED|Washout (2 Weeks)||6||
59519222|NCT01097785|75613145|FG001|COMPLETED|Washout (2 Weeks)||6||
59519223|NCT01097785|75613144|FG000|NOT COMPLETED|Washout (2 Weeks)||0||
59519224|NCT01097785|75613145|FG001|NOT COMPLETED|Washout (2 Weeks)||0||
59519225|NCT01097785|75613144|FG000|STARTED|Cycle 3 (30 Days)||6||
59519226|NCT01097785|75613145|FG001|STARTED|Cycle 3 (30 Days)||6||
59519227|NCT01097785|75613144|FG000|COMPLETED|Cycle 3 (30 Days)||6||
59519228|NCT01097785|75613145|FG001|COMPLETED|Cycle 3 (30 Days)||6||
59519229|NCT01097785|75613144|FG000|NOT COMPLETED|Cycle 3 (30 Days)||0||
59519230|NCT01097785|75613145|FG001|NOT COMPLETED|Cycle 3 (30 Days)||0||
59519231|NCT01098253|75613154|FG000|STARTED|Overall Study||94||
59519232|NCT01098253|75613155|FG001|STARTED|Overall Study||88||
59519233|NCT01098253|75613154|FG000|COMPLETED|Overall Study||92||
59519234|NCT01098253|75613155|FG001|COMPLETED|Overall Study||88||
59519235|NCT01098253|75613154|FG000|NOT COMPLETED|Overall Study||2||
60069272|NCT01888874|76184526|FG003|STARTED|Period 1 (Baseline up to Week 12)||86||
60069273|NCT01888874|76184527|FG004|STARTED|Period 1 (Baseline up to Week 12)||86||
60069274|NCT01888874|76184528|FG005|STARTED|Period 1 (Baseline up to Week 12)||85||
60069275|NCT01888874|76184529|FG006|STARTED|Period 1 (Baseline up to Week 12)||84||
60069276|NCT01888874|76184523|FG000|COMPLETED|Period 1 (Baseline up to Week 12)||83||
60069277|NCT01888874|76184524|FG001|COMPLETED|Period 1 (Baseline up to Week 12)||76||
60069278|NCT01888874|76184525|FG002|COMPLETED|Period 1 (Baseline up to Week 12)||78||
60069279|NCT01888874|76184526|FG003|COMPLETED|Period 1 (Baseline up to Week 12)||80||
60069280|NCT01888874|76184527|FG004|COMPLETED|Period 1 (Baseline up to Week 12)||77||
60069281|NCT01888874|76184528|FG005|COMPLETED|Period 1 (Baseline up to Week 12)||80||
60069282|NCT01888874|76184529|FG006|COMPLETED|Period 1 (Baseline up to Week 12)||83||
60069283|NCT01888874|76184523|FG000|NOT COMPLETED|Period 1 (Baseline up to Week 12)||3||
60069284|NCT01888874|76184524|FG001|NOT COMPLETED|Period 1 (Baseline up to Week 12)||6||
60069285|NCT01888874|76184525|FG002|NOT COMPLETED|Period 1 (Baseline up to Week 12)||7||
59519236|NCT01098253|75613155|FG001|NOT COMPLETED|Overall Study||0||
59519237|NCT00940589|75613163|FG000|STARTED|Overall Study||39||
59519238|NCT00940589|75613164|FG001|STARTED|Overall Study||34||
59519239|NCT00940589|75613163|FG000|COMPLETED|Overall Study||31||
59519240|NCT00940589|75613164|FG001|COMPLETED|Overall Study||29||
59519241|NCT00940589|75613163|FG000|NOT COMPLETED|Overall Study||8||
59519242|NCT00940589|75613164|FG001|NOT COMPLETED|Overall Study||5||
59519243|NCT03603106|75613181|FG000|STARTED|Overall Study||6||
59519244|NCT03603106|75613182|FG001|STARTED|Overall Study||6||
59519245|NCT03603106|75613183|FG002|STARTED|Overall Study||6||
59519246|NCT03603106|75613184|FG003|STARTED|Overall Study||6||
59519247|NCT03603106|75613185|FG004|STARTED|Overall Study||6||
59519248|NCT03603106|75613186|FG005|STARTED|Overall Study||6||
60069286|NCT01888874|76184526|FG003|NOT COMPLETED|Period 1 (Baseline up to Week 12)||6||
60069287|NCT01888874|76184527|FG004|NOT COMPLETED|Period 1 (Baseline up to Week 12)||9||
60069288|NCT01888874|76184528|FG005|NOT COMPLETED|Period 1 (Baseline up to Week 12)||5||
60069289|NCT01888874|76184529|FG006|NOT COMPLETED|Period 1 (Baseline up to Week 12)||1||
59519249|NCT03603106|75613187|FG006|STARTED|Overall Study||18||
59519250|NCT03603106|75613188|FG007|STARTED|Overall Study||3||
59519251|NCT03603106|75613189|FG008|STARTED|Overall Study||3||
59519252|NCT03603106|75613190|FG009|STARTED|Overall Study||3||
60069290|NCT01888874|76184523|FG000|STARTED|Period 2 (Week 13 to Week 24)|Nonresponders from Placebo group moved to 100 mg QD(15 participants) and 50 mg BID(15 participants).|53||
60069291|NCT01888874|76184524|FG001|STARTED|Period 2 (Week 13 to Week 24)|Nonresponders from 50 mg QD group moved to 100 mg QD group (19 participants).|57||
60103557|NCT01247428|76221789|FG000|NOT COMPLETED|Overall Study||0||
59519253|NCT03603106|75613191|FG010|STARTED|Overall Study||3||
59519254|NCT03603106|75613181|FG000|COMPLETED|Overall Study||6||
59519255|NCT03603106|75613182|FG001|COMPLETED|Overall Study||6||
59519256|NCT03603106|75613183|FG002|COMPLETED|Overall Study||6||
59519257|NCT03603106|75613184|FG003|COMPLETED|Overall Study||6||
59519258|NCT03603106|75613185|FG004|COMPLETED|Overall Study||6||
59519259|NCT03603106|75613186|FG005|COMPLETED|Overall Study||6||
59519260|NCT03603106|75613187|FG006|COMPLETED|Overall Study||18||
59519261|NCT03603106|75613188|FG007|COMPLETED|Overall Study||3||
59519262|NCT03603106|75613189|FG008|COMPLETED|Overall Study||3||
59519263|NCT03603106|75613190|FG009|COMPLETED|Overall Study||3||
59519264|NCT03603106|75613191|FG010|COMPLETED|Overall Study||3||
59519265|NCT03603106|75613181|FG000|NOT COMPLETED|Overall Study||0||
59519266|NCT03603106|75613182|FG001|NOT COMPLETED|Overall Study||0||
59519267|NCT03603106|75613183|FG002|NOT COMPLETED|Overall Study||0||
59519268|NCT03603106|75613184|FG003|NOT COMPLETED|Overall Study||0||
59951663|NCT00887250|76070643|FG000|NOT COMPLETED|Overall Study||18||
59951664|NCT00887250|76070644|FG001|NOT COMPLETED|Overall Study||12||
59951665|NCT00887250|76070645|FG002|NOT COMPLETED|Overall Study||13||
59519269|NCT03603106|75613185|FG004|NOT COMPLETED|Overall Study||0||
59519270|NCT03603106|75613186|FG005|NOT COMPLETED|Overall Study||0||
59519271|NCT03603106|75613187|FG006|NOT COMPLETED|Overall Study||0||
59519272|NCT03603106|75613188|FG007|NOT COMPLETED|Overall Study||0||
59613528|NCT01592292|75724650|FG003|NOT COMPLETED|Overall Study||1||
59613529|NCT01590888|75724659|FG000|STARTED|Overall Study||36||
59613530|NCT01590888|75724660|FG001|STARTED|Overall Study||38||
59613531|NCT01590888|75724661|FG002|STARTED|Overall Study||35||
59613532|NCT01590888|75724659|FG000|COMPLETED|Overall Study||32||
59613533|NCT01590888|75724660|FG001|COMPLETED|Overall Study||38||
59951666|NCT02599402|76070650|FG000|STARTED|Overall Study||533||
59951667|NCT02599402|76070650|FG000|COMPLETED|Overall Study||0||
59951668|NCT02599402|76070650|FG000|NOT COMPLETED|Overall Study||533||
59951669|NCT00872430|76070682|FG000|STARTED|First Intervention||10||
59951670|NCT00872430|76070683|FG001|STARTED|First Intervention||10||
59951671|NCT00872430|76070682|FG000|COMPLETED|First Intervention||10||
60069292|NCT01888874|76184525|FG002|STARTED|Period 2 (Week 13 to Week 24)|Nonresponders from Placebo(15 participants) and 50 mg QD (19 participants) moved to 100 mg QD group.|112||
60069293|NCT01888874|76184526|FG003|STARTED|Period 2 (Week 13 to Week 24)||80||
59951672|NCT00872430|76070683|FG001|COMPLETED|First Intervention||10||
59951673|NCT00872430|76070682|FG000|NOT COMPLETED|First Intervention||0||
59519273|NCT03603106|75613189|FG008|NOT COMPLETED|Overall Study||0||
59519274|NCT03603106|75613190|FG009|NOT COMPLETED|Overall Study||0||
59519275|NCT03603106|75613191|FG010|NOT COMPLETED|Overall Study||0||
59519276|NCT02574078|75613237|FG000|STARTED|Pre-Treatment Period||13|Started = Randomized (entering treatment)|
59519277|NCT02574078|75613238|FG001|STARTED|Pre-Treatment Period||6|Started = Randomized (entering treatment)|
59519278|NCT02574078|75613239|FG002|STARTED|Pre-Treatment Period||9|Started = Randomized (entering treatment)|
59519279|NCT02574078|75613240|FG003|STARTED|Pre-Treatment Period||35|Started = Randomized (entering treatment)|
59519280|NCT02574078|75613241|FG004|STARTED|Pre-Treatment Period||34|Started = Randomized (entering treatment)|
59519281|NCT02574078|75613242|FG005|STARTED|Pre-Treatment Period||35|Started = Randomized (entering treatment)|
59519282|NCT02574078|75613243|FG006|STARTED|Pre-Treatment Period||18|Started = Randomized (entering treatment)|
59519283|NCT02574078|75613244|FG007|STARTED|Pre-Treatment Period||17|Started = Randomized (entering treatment)|
59519284|NCT02574078|75613245|FG008|STARTED|Pre-Treatment Period||26|Started = Randomized (entering treatment)|
59519285|NCT02574078|75613246|FG009|STARTED|Pre-Treatment Period||26|Started = Randomized (entering treatment)|
59519286|NCT02574078|75613247|FG010|STARTED|Pre-Treatment Period||53|Started = Randomized (entering treatment)|
59951674|NCT00872430|76070683|FG001|NOT COMPLETED|First Intervention||0||
59951675|NCT00872430|76070682|FG000|STARTED|Washout Period||10||
59613534|NCT01590888|75724661|FG002|COMPLETED|Overall Study||34||
59613535|NCT01590888|75724659|FG000|NOT COMPLETED|Overall Study||4||
59951676|NCT00872430|76070683|FG001|STARTED|Washout Period||10||
60069294|NCT01888874|76184527|FG004|STARTED|Period 2 (Week 13 to Week 24)|Nonresponders from 25 mg BID group moved to 50 mg BID group (17 participants).|60||
60069295|NCT01888874|76184528|FG005|STARTED|Period 2 (Week 13 to Week 24)|Nonresponders from Placebo(15 participants) and 25 mg BID(17 participants) moved to 50 mg BID group.|112||
60069296|NCT01888874|76184529|FG006|STARTED|Period 2 (Week 13 to Week 24)||83||
60069297|NCT01888874|76184523|FG000|COMPLETED|Period 2 (Week 13 to Week 24)||50||
60069298|NCT01888874|76184524|FG001|COMPLETED|Period 2 (Week 13 to Week 24)||55||
60069299|NCT01888874|76184525|FG002|COMPLETED|Period 2 (Week 13 to Week 24)||104||
60069300|NCT01888874|76184526|FG003|COMPLETED|Period 2 (Week 13 to Week 24)||78||
60069301|NCT01888874|76184527|FG004|COMPLETED|Period 2 (Week 13 to Week 24)||57||
60069302|NCT01888874|76184528|FG005|COMPLETED|Period 2 (Week 13 to Week 24)||109||
60069303|NCT01888874|76184529|FG006|COMPLETED|Period 2 (Week 13 to Week 24)||80||
60069304|NCT01888874|76184523|FG000|NOT COMPLETED|Period 2 (Week 13 to Week 24)||3||
60069305|NCT01888874|76184524|FG001|NOT COMPLETED|Period 2 (Week 13 to Week 24)||2||
60069306|NCT01888874|76184525|FG002|NOT COMPLETED|Period 2 (Week 13 to Week 24)||8||
60069307|NCT01888874|76184526|FG003|NOT COMPLETED|Period 2 (Week 13 to Week 24)||2||
60069308|NCT01888874|76184527|FG004|NOT COMPLETED|Period 2 (Week 13 to Week 24)||3||
60069309|NCT01888874|76184528|FG005|NOT COMPLETED|Period 2 (Week 13 to Week 24)||3||
60069310|NCT01888874|76184529|FG006|NOT COMPLETED|Period 2 (Week 13 to Week 24)||3||
60069311|NCT01749735|76184548|FG000|STARTED|Overall Study||2||
60069312|NCT01749735|76184549|FG001|STARTED|Overall Study||0||
60069313|NCT01749735|76184548|FG000|COMPLETED|Overall Study||1||
60069314|NCT01749735|76184549|FG001|COMPLETED|Overall Study||0||
60069315|NCT01749735|76184548|FG000|NOT COMPLETED|Overall Study||1||
60069316|NCT01749735|76184549|FG001|NOT COMPLETED|Overall Study||0||
60069317|NCT01749033|76184558|FG000|STARTED|Overall Study||150||
60069318|NCT01749033|76184559|FG001|STARTED|Overall Study||150||
60069319|NCT01749033|76184560|FG002|STARTED|Overall Study||150||
60069320|NCT01749033|76184558|FG000|COMPLETED|Overall Study||147||
60069321|NCT01749033|76184559|FG001|COMPLETED|Overall Study||145||
60069322|NCT01749033|76184560|FG002|COMPLETED|Overall Study||149||
60069323|NCT01749033|76184558|FG000|NOT COMPLETED|Overall Study||3||
60069324|NCT01749033|76184559|FG001|NOT COMPLETED|Overall Study||5||
60069325|NCT01749033|76184560|FG002|NOT COMPLETED|Overall Study||1||
60069326|NCT01774305|76184571|FG000|STARTED|Overall Study||71||
60069327|NCT01774305|76184572|FG001|STARTED|Overall Study||71||
60069328|NCT01774305|76184571|FG000|COMPLETED|Overall Study||70||
60069329|NCT01774305|76184572|FG001|COMPLETED|Overall Study||71||
60069330|NCT01774305|76184571|FG000|NOT COMPLETED|Overall Study||1||
60069331|NCT01774305|76184572|FG001|NOT COMPLETED|Overall Study||0||
60069332|NCT01737021|76184580|FG000|STARTED|Overall Study||22||
60069333|NCT01737021|76184581|FG001|STARTED|Overall Study||9||
60069334|NCT01737021|76184580|FG000|COMPLETED|Overall Study||17||
60069335|NCT01737021|76184581|FG001|COMPLETED|Overall Study||6||
60069336|NCT01737021|76184580|FG000|NOT COMPLETED|Overall Study||5||
60069337|NCT01737021|76184581|FG001|NOT COMPLETED|Overall Study||3||
60069338|NCT01397422|76184591|FG000|STARTED|Overall Study||22||
60069339|NCT01397422|76184592|FG001|STARTED|Overall Study||20||
60069340|NCT01397422|76184593|FG002|STARTED|Overall Study|Of the 3 participants who discontinued, 1 withdrew due to both an AE and an eGFR < 50 mL/min/1.73m^2|21||
60069341|NCT01397422|76184594|FG003|STARTED|Overall Study||20||
60069342|NCT01397422|76184591|FG000|COMPLETED|Overall Study||20||
60069343|NCT01397422|76184592|FG001|COMPLETED|Overall Study||17||
60069344|NCT01397422|76184593|FG002|COMPLETED|Overall Study|AE = adverse event; eGFR = estimated glomerular filtration rate|18||
60069345|NCT01397422|76184594|FG003|COMPLETED|Overall Study||12||
60069346|NCT01397422|76184591|FG000|NOT COMPLETED|Overall Study||2||
60069347|NCT01397422|76184592|FG001|NOT COMPLETED|Overall Study||3||
60069348|NCT01397422|76184593|FG002|NOT COMPLETED|Overall Study||3||
60069349|NCT01397422|76184594|FG003|NOT COMPLETED|Overall Study||8||
60069350|NCT01736553|76184608|FG000|STARTED|Overall Study||26||
60069351|NCT01736553|76184609|FG001|STARTED|Overall Study||27||
60069352|NCT01736553|76184608|FG000|COMPLETED|Overall Study||7||
60069353|NCT01736553|76184609|FG001|COMPLETED|Overall Study||23||
60069354|NCT01736553|76184608|FG000|NOT COMPLETED|Overall Study||19||
60069355|NCT01736553|76184609|FG001|NOT COMPLETED|Overall Study||4||
60069356|NCT01888640|76184636|FG000|STARTED|Overall Study||103||
60069357|NCT01888640|76184637|FG001|STARTED|Overall Study||99||
60069358|NCT01888640|76184638|FG002|STARTED|Overall Study||99||
60069359|NCT01888640|76184636|FG000|COMPLETED|Overall Study||76|Per Protocol, completed visit 3|
60069360|NCT01888640|76184637|FG001|COMPLETED|Overall Study||68|Per Protocol, completed visit 3|
60069361|NCT01888640|76184638|FG002|COMPLETED|Overall Study||94|Per Protocol, completed visit 3|
60069362|NCT01888640|76184636|FG000|NOT COMPLETED|Overall Study||27||
60069363|NCT01888640|76184637|FG001|NOT COMPLETED|Overall Study||31||
60069364|NCT01888640|76184638|FG002|NOT COMPLETED|Overall Study||5||
60069365|NCT01736475|76184651|FG000|STARTED|Overall Study||121||
60069366|NCT01736475|76184652|FG001|STARTED|Overall Study||17||
60069367|NCT01736475|76184651|FG000|COMPLETED|Overall Study||109||
60069368|NCT01736475|76184652|FG001|COMPLETED|Overall Study||17||
60069369|NCT01736475|76184651|FG000|NOT COMPLETED|Overall Study||12||
60069370|NCT01736475|76184652|FG001|NOT COMPLETED|Overall Study||0||
60069371|NCT01863758|76184669|FG000|STARTED|Pharmacokinetic Assessment||66||
60069372|NCT01863758|76184669|FG000|COMPLETED|Pharmacokinetic Assessment||66||
60069373|NCT01863758|76184669|FG000|NOT COMPLETED|Pharmacokinetic Assessment||0||
60069374|NCT01863758|76184669|FG000|STARTED|Prophylactic Treatment-Phase I||66||
60069375|NCT01863758|76184669|FG000|COMPLETED|Prophylactic Treatment-Phase I||66||
60069376|NCT01863758|76184669|FG000|NOT COMPLETED|Prophylactic Treatment-Phase I||0||
60069377|NCT01863758|76184669|FG000|STARTED|Prophylactic Treatment-Phase II||66||
60069378|NCT01863758|76184669|FG000|COMPLETED|Prophylactic Treatment-Phase II||64||
60069379|NCT01863758|76184669|FG000|NOT COMPLETED|Prophylactic Treatment-Phase II||2||
60069380|NCT01863680|76184673|FG000|STARTED|Overall Study||178||
60069381|NCT01863680|76184673|FG000|Subjects Started COS Treatment|Overall Study||169||
60069382|NCT01863680|76184673|FG000|Subjects Received hCG Injection|Overall Study||162||
60069383|NCT01863680|76184673|FG000|Subjects Received Study Drug|Overall Study||149||
60069384|NCT01863680|76184673|FG000|Subjects Who Have Undergone IVF/ET|Overall Study||123||
60069385|NCT01863680|76184673|FG000|COMPLETED|Overall Study||121||
60069386|NCT01863680|76184673|FG000|NOT COMPLETED|Overall Study||57||
60069387|NCT01747629|76184679|FG000|STARTED|Overall Study||85||
60069388|NCT01747629|76184680|FG001|STARTED|Overall Study||75||
60069389|NCT01747629|76184679|FG000|Treated|Overall Study|Safety set and full analysis set|84||
60069390|NCT01747629|76184680|FG001|Treated|Overall Study|Safety set and full analysis set|75||
60069391|NCT01747629|76184679|FG000|COMPLETED|Overall Study||77||
60069392|NCT01747629|76184680|FG001|COMPLETED|Overall Study||69||
60069393|NCT01747629|76184679|FG000|NOT COMPLETED|Overall Study||8||
60069394|NCT01747629|76184680|FG001|NOT COMPLETED|Overall Study||6||
60069395|NCT01863368|76184688|FG000|STARTED|Phase I, Day 0 to Day 35||46||
60069396|NCT01863368|76184689|FG001|STARTED|Phase I, Day 0 to Day 35||48||
60069397|NCT01863368|76184688|FG000|Treated|Phase I, Day 0 to Day 35||46||
60069398|NCT01863368|76184689|FG001|Treated|Phase I, Day 0 to Day 35||47||
60069399|NCT01863368|76184688|FG000|COMPLETED|Phase I, Day 0 to Day 35||43||
60069400|NCT01863368|76184689|FG001|COMPLETED|Phase I, Day 0 to Day 35||41||
60069401|NCT01863368|76184688|FG000|NOT COMPLETED|Phase I, Day 0 to Day 35||3||
60069402|NCT01863368|76184689|FG001|NOT COMPLETED|Phase I, Day 0 to Day 35||7||
60069403|NCT01863368|76184688|FG000|STARTED|Phase II, Day 35 to Day 90||43||
60069404|NCT01863368|76184689|FG001|STARTED|Phase II, Day 35 to Day 90||41||
60069405|NCT01863368|76184688|FG000|COMPLETED|Phase II, Day 35 to Day 90||41||
60069406|NCT01863368|76184689|FG001|COMPLETED|Phase II, Day 35 to Day 90||41||
60069407|NCT01863368|76184688|FG000|NOT COMPLETED|Phase II, Day 35 to Day 90||2||
60069408|NCT01863368|76184689|FG001|NOT COMPLETED|Phase II, Day 35 to Day 90||0||
60069409|NCT01886690|76184698|FG000|STARTED|Overall Study||75||
60069410|NCT01886690|76184699|FG001|STARTED|Overall Study||73||
60069411|NCT01886690|76184698|FG000|COMPLETED|Overall Study||75||
60069412|NCT01886690|76184699|FG001|COMPLETED|Overall Study||71||
60069413|NCT01886690|76184698|FG000|NOT COMPLETED|Overall Study||0||
60069414|NCT01886690|76184699|FG001|NOT COMPLETED|Overall Study||2||
60069415|NCT01886378|76184705|FG000|STARTED|Overall Study||29||
60069416|NCT01886378|76184705|FG000|Completed 24 Weeks of UX007 Treatment|Overall Study||25||
60069417|NCT01886378|76184705|FG000|COMPLETED|Overall Study||24||
60069418|NCT01886378|76184705|FG000|NOT COMPLETED|Overall Study||5||
60069419|NCT01886300|76184709|FG000|STARTED|Overall Study||16||
60069420|NCT01886300|76184709|FG000|COMPLETED|Overall Study||0||
60069421|NCT01886300|76184709|FG000|NOT COMPLETED|Overall Study||16||
60069422|NCT01885208|76184715|FG000|STARTED|Overall Study||406||
60069423|NCT01885208|76184716|FG001|STARTED|Overall Study||407||
60069424|NCT01885208|76184715|FG000|Exposed|Overall Study||404||
60069425|NCT01885208|76184716|FG001|Exposed|Overall Study||405||
60069426|NCT01885208|76184715|FG000|Premature Discontinuation of Treatment|Overall Study|Subjects who prematurely discontinued treatment were allowed to continue participation in the trial.|82||
60069427|NCT01885208|76184716|FG001|Premature Discontinuation of Treatment|Overall Study|Subjects who prematurely discontinued treatment were allowed to continue participation in the trial.|85||
60069428|NCT01885208|76184715|FG000|COMPLETED|Overall Study||374||
60069429|NCT01885208|76184716|FG001|COMPLETED|Overall Study||369||
60069430|NCT01885208|76184715|FG000|NOT COMPLETED|Overall Study||32||
60069431|NCT01885208|76184716|FG001|NOT COMPLETED|Overall Study||38||
60069432|NCT01859702|76184722|FG000|STARTED|Overall Study||36||
60069433|NCT01859702|76184722|FG000|COMPLETED|Overall Study||31||
60069434|NCT01859702|76184722|FG000|NOT COMPLETED|Overall Study||5||
60069435|NCT01835132|76184726|FG000|STARTED|Initial Phase||8||
60069436|NCT01835132|76184726|FG000|COMPLETED|Initial Phase||6||
60069437|NCT01835132|76184726|FG000|NOT COMPLETED|Initial Phase||2||
60069438|NCT01835132|76184726|FG000|STARTED|1st Extension Phase||6||
60069439|NCT01835132|76184726|FG000|COMPLETED|1st Extension Phase|Completed 52 Weeks|6||
60069440|NCT01835132|76184726|FG000|NOT COMPLETED|1st Extension Phase||0||
60069441|NCT01835132|76184726|FG000|STARTED|2nd Extension Phase - As Needed (PRN)|PRN extension - Participants starting this phase may not equal those who completed the 1st extension|3||
60069442|NCT01835132|76184726|FG000|COMPLETED|2nd Extension Phase - As Needed (PRN)||3||
60069443|NCT01835132|76184726|FG000|NOT COMPLETED|2nd Extension Phase - As Needed (PRN)||0||
60069444|NCT01747551|76184732|FG000|STARTED|Overall Study||43||
60069445|NCT01747551|76184733|FG001|STARTED|Overall Study||21||
60069446|NCT01747551|76184732|FG000|COMPLETED|Overall Study||0||
60069447|NCT01747551|76184733|FG001|COMPLETED|Overall Study||0||
60069448|NCT01747551|76184732|FG000|NOT COMPLETED|Overall Study||43||
60069449|NCT01747551|76184733|FG001|NOT COMPLETED|Overall Study||21||
60069450|NCT01736397|76184741|FG000|STARTED|Overall Study||75||
60069451|NCT01736397|76184742|FG001|STARTED|Overall Study||74||
60069452|NCT01736397|76184741|FG000|COMPLETED|Overall Study||61||
60069453|NCT01736397|76184742|FG001|COMPLETED|Overall Study||50||
60069454|NCT01736397|76184741|FG000|NOT COMPLETED|Overall Study||14||
60069455|NCT01736397|76184742|FG001|NOT COMPLETED|Overall Study||24||
60069456|NCT01859390|76184750|FG000|STARTED|Overall Study||36|Randomized|
60069457|NCT01859390|76184751|FG001|STARTED|Overall Study||37|Randomized|
60069458|NCT01859390|76184750|FG000|Withdrawals|Overall Study||2|Participants can withdraw anytime prior to their Week 18 follow-up visit.|
60069459|NCT01859390|76184751|FG001|Withdrawals|Overall Study||2|Participants can withdraw anytime prior to their Week 18 follow-up visit.|
60069460|NCT01859390|76184750|FG000|COMPLETED|Overall Study||35|Based on availability of Week 16 sputum myeloperoxidase (MPO) measurement (primary endpoint)|
60069461|NCT01859390|76184751|FG001|COMPLETED|Overall Study||30|Based on availability of Week 16 sputum myeloperoxidase (MPO) measurement (primary endpoint)|
60069462|NCT01859390|76184750|FG000|NOT COMPLETED|Overall Study||1||
60069463|NCT01859390|76184751|FG001|NOT COMPLETED|Overall Study||7||
60069464|NCT01858766|76184776|FG000|STARTED|Overall Study||27||
60069465|NCT01858766|76184777|FG001|STARTED|Overall Study||28||
60069466|NCT01858766|76184778|FG002|STARTED|Overall Study||11||
60069467|NCT01858766|76184779|FG003|STARTED|Overall Study||10||
60069468|NCT01858766|76184780|FG004|STARTED|Overall Study||27||
60069469|NCT01858766|76184781|FG005|STARTED|Overall Study||28||
60069470|NCT01858766|76184782|FG006|STARTED|Overall Study||7||
60069471|NCT01858766|76184783|FG007|STARTED|Overall Study||7||
60069472|NCT01858766|76184784|FG008|STARTED|Overall Study||1||
60069473|NCT01858766|76184785|FG009|STARTED|Overall Study||4||
60069474|NCT01858766|76184786|FG010|STARTED|Overall Study||5||
60069475|NCT01858766|76184787|FG011|STARTED|Overall Study||30||
60069476|NCT01858766|76184788|FG012|STARTED|Overall Study||30||
60069477|NCT01858766|76184789|FG013|STARTED|Overall Study||29||
60069478|NCT01858766|76184790|FG014|STARTED|Overall Study||31||
60069479|NCT01858766|76184791|FG015|STARTED|Overall Study||26||
60069480|NCT01858766|76184792|FG016|STARTED|Overall Study||25||
60069481|NCT01858766|76184793|FG017|STARTED|Overall Study||27||
60069482|NCT01858766|76184794|FG018|STARTED|Overall Study||26||
60069483|NCT01858766|76184776|FG000|COMPLETED|Overall Study||26||
59519287|NCT02574078|75613248|FG011|STARTED|Pre-Treatment Period||56|Started = Randomized (entering treatment)|
59519288|NCT02574078|75613249|FG012|STARTED|Pre-Treatment Period||13|Started = Randomized (entering treatment)|
60069484|NCT01858766|76184777|FG001|COMPLETED|Overall Study||28||
60069485|NCT01858766|76184778|FG002|COMPLETED|Overall Study||10||
60069486|NCT01858766|76184779|FG003|COMPLETED|Overall Study||10||
60069487|NCT01858766|76184780|FG004|COMPLETED|Overall Study||26||
60069488|NCT01858766|76184781|FG005|COMPLETED|Overall Study||24||
60069489|NCT01858766|76184782|FG006|COMPLETED|Overall Study||7||
60069490|NCT01858766|76184783|FG007|COMPLETED|Overall Study||5||
60069491|NCT01858766|76184784|FG008|COMPLETED|Overall Study||1||
60069492|NCT01858766|76184785|FG009|COMPLETED|Overall Study||4||
60069493|NCT01858766|76184786|FG010|COMPLETED|Overall Study||5||
60069494|NCT01858766|76184787|FG011|COMPLETED|Overall Study||25||
60069495|NCT01858766|76184788|FG012|COMPLETED|Overall Study||25||
60069496|NCT01858766|76184789|FG013|COMPLETED|Overall Study||26||
60069497|NCT01858766|76184790|FG014|COMPLETED|Overall Study||23||
60069498|NCT01858766|76184791|FG015|COMPLETED|Overall Study||20||
60069499|NCT01858766|76184792|FG016|COMPLETED|Overall Study||22||
60069500|NCT01858766|76184793|FG017|COMPLETED|Overall Study||23||
60069501|NCT01858766|76184794|FG018|COMPLETED|Overall Study||22||
60069502|NCT01858766|76184776|FG000|NOT COMPLETED|Overall Study||1||
60069503|NCT01858766|76184777|FG001|NOT COMPLETED|Overall Study||0||
60069504|NCT01858766|76184778|FG002|NOT COMPLETED|Overall Study||1||
60069505|NCT01858766|76184779|FG003|NOT COMPLETED|Overall Study||0||
60069506|NCT01858766|76184780|FG004|NOT COMPLETED|Overall Study||1||
60069507|NCT01858766|76184781|FG005|NOT COMPLETED|Overall Study||4||
60069508|NCT01858766|76184782|FG006|NOT COMPLETED|Overall Study||0||
60069509|NCT01858766|76184783|FG007|NOT COMPLETED|Overall Study||2||
59519289|NCT02574078|75613237|FG000|COMPLETED|Pre-Treatment Period||13|Finished = Treated|
59519290|NCT02574078|75613238|FG001|COMPLETED|Pre-Treatment Period||6|Finished = Treated|
60069510|NCT01858766|76184784|FG008|NOT COMPLETED|Overall Study||0||
60069511|NCT01858766|76184785|FG009|NOT COMPLETED|Overall Study||0||
60069512|NCT01858766|76184786|FG010|NOT COMPLETED|Overall Study||0||
60069513|NCT01858766|76184787|FG011|NOT COMPLETED|Overall Study||5||
60069514|NCT01858766|76184788|FG012|NOT COMPLETED|Overall Study||5||
60069515|NCT01858766|76184789|FG013|NOT COMPLETED|Overall Study||3||
60069516|NCT01858766|76184790|FG014|NOT COMPLETED|Overall Study||8||
60069517|NCT01858766|76184791|FG015|NOT COMPLETED|Overall Study||6||
60069518|NCT01858766|76184792|FG016|NOT COMPLETED|Overall Study||3||
60069519|NCT01858766|76184793|FG017|NOT COMPLETED|Overall Study||4||
60069520|NCT01858766|76184794|FG018|NOT COMPLETED|Overall Study||4||
60069521|NCT01734993|76184827|FG000|STARTED|Overall Study||11||
60069522|NCT01734993|76184827|FG000|COMPLETED|Overall Study||9||
60069523|NCT01734993|76184827|FG000|NOT COMPLETED|Overall Study||2||
60069524|NCT01745367|76184834|FG000|STARTED|Overall Study||8||
60069525|NCT01745367|76184835|FG001|STARTED|Overall Study||22||
60069526|NCT01745367|76184834|FG000|Treated|Overall Study||8||
60069527|NCT01745367|76184835|FG001|Treated|Overall Study||21||
60069528|NCT01745367|76184834|FG000|COMPLETED|Overall Study||0||
60069529|NCT01745367|76184835|FG001|COMPLETED|Overall Study||0||
60069530|NCT01745367|76184834|FG000|NOT COMPLETED|Overall Study||8||
60069531|NCT01745367|76184835|FG001|NOT COMPLETED|Overall Study||22||
60069532|NCT01733121|76184843|FG000|STARTED|Double-Blind Period (Week 0 to 6)||51||
60069533|NCT01733121|76184844|FG001|STARTED|Double-Blind Period (Week 0 to 6)||51||
60069534|NCT01733121|76184843|FG000|COMPLETED|Double-Blind Period (Week 0 to 6)||44||
60069535|NCT01733121|76184844|FG001|COMPLETED|Double-Blind Period (Week 0 to 6)||46||
60069536|NCT01733121|76184843|FG000|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||7||
60069537|NCT01733121|76184844|FG001|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||5||
60069538|NCT01733121|76184843|FG000|STARTED|Follow-Up Period (Week 6 to 8)||44||
60069539|NCT01733121|76184844|FG001|STARTED|Follow-Up Period (Week 6 to 8)||46||
60069540|NCT01733121|76184843|FG000|COMPLETED|Follow-Up Period (Week 6 to 8)||44||
60069541|NCT01733121|76184844|FG001|COMPLETED|Follow-Up Period (Week 6 to 8)||46||
60069542|NCT01733121|76184843|FG000|NOT COMPLETED|Follow-Up Period (Week 6 to 8)||0||
60069543|NCT01733121|76184844|FG001|NOT COMPLETED|Follow-Up Period (Week 6 to 8)||0||
60069544|NCT01744977|76184854|FG000|STARTED|Overall Study||120||
60069545|NCT01744977|76184855|FG001|STARTED|Overall Study||120||
60069546|NCT01744977|76184854|FG000|6 Month Completed|Overall Study||113||
60069547|NCT01744977|76184855|FG001|6 Month Completed|Overall Study||115||
60069548|NCT01744977|76184854|FG000|COMPLETED|Overall Study||109||
60069549|NCT01744977|76184855|FG001|COMPLETED|Overall Study||115||
60069550|NCT01744977|76184854|FG000|NOT COMPLETED|Overall Study||11||
60069551|NCT01744977|76184855|FG001|NOT COMPLETED|Overall Study||5||
60069552|NCT01383928|76184864|FG000|STARTED|Overall Study||7||
60069553|NCT01383928|76184865|FG001|STARTED|Overall Study||7||
60069554|NCT01383928|76184866|FG002|STARTED|Overall Study||50||
60069555|NCT01383928|76184864|FG000|COMPLETED|Overall Study||2|Completed=participants who completed 16 cycles per protocol and entered Maintenance phase.|
60069556|NCT01383928|76184865|FG001|COMPLETED|Overall Study||0|Completed=participants who completed 16 cycles per protocol and entered Maintenance phase.|
60069557|NCT01383928|76184866|FG002|COMPLETED|Overall Study||10|Completed=participants who completed 16 cycles per protocol and entered Maintenance phase.|
60069558|NCT01383928|76184864|FG000|NOT COMPLETED|Overall Study||5||
60069559|NCT01383928|76184865|FG001|NOT COMPLETED|Overall Study||7||
60069560|NCT01383928|76184866|FG002|NOT COMPLETED|Overall Study||40||
60069561|NCT01382602|76184878|FG000|STARTED|Overall Study||93||
60069562|NCT01382602|76184879|FG001|STARTED|Overall Study||50||
60069563|NCT01382602|76184878|FG000|COMPLETED|Overall Study||93||
60069564|NCT01382602|76184879|FG001|COMPLETED|Overall Study||46||
60069565|NCT01382602|76184878|FG000|NOT COMPLETED|Overall Study||0||
60069566|NCT01382602|76184879|FG001|NOT COMPLETED|Overall Study||4||
60069567|NCT04801420|76184888|FG000|STARTED|Overall Study||208||
60069568|NCT04801420|76184889|FG001|STARTED|Overall Study||209||
60069569|NCT04801420|76184890|FG002|STARTED|Overall Study||208||
60069570|NCT04801420|76184888|FG000|COMPLETED|Overall Study||0||
60069571|NCT04801420|76184889|FG001|COMPLETED|Overall Study||0||
60069572|NCT04801420|76184890|FG002|COMPLETED|Overall Study||0||
60069573|NCT04801420|76184888|FG000|NOT COMPLETED|Overall Study||208||
60069574|NCT04801420|76184889|FG001|NOT COMPLETED|Overall Study||209||
60069575|NCT04801420|76184890|FG002|NOT COMPLETED|Overall Study||208||
60069576|NCT04294472|76184905|FG000|STARTED|Overall Study||8||
60069577|NCT04294472|76184906|FG001|STARTED|Overall Study||11||
60069578|NCT04294472|76184907|FG002|STARTED|Overall Study||11||
60069579|NCT04294472|76184905|FG000|COMPLETED|Overall Study||8||
60069580|NCT04294472|76184906|FG001|COMPLETED|Overall Study||9||
60069581|NCT04294472|76184907|FG002|COMPLETED|Overall Study||9||
60069582|NCT04294472|76184905|FG000|NOT COMPLETED|Overall Study||0||
60069583|NCT04294472|76184906|FG001|NOT COMPLETED|Overall Study||2||
60069584|NCT04294472|76184907|FG002|NOT COMPLETED|Overall Study||2||
60069585|NCT04233918|76184917|FG000|STARTED|Period 1: Part A and B||6||
60069586|NCT04233918|76184918|FG001|STARTED|Period 1: Part A and B||14||
60069587|NCT04233918|76184919|FG002|STARTED|Period 1: Part A and B||0||
60069588|NCT04233918|76184917|FG000|COMPLETED|Period 1: Part A and B||6||
60069589|NCT04233918|76184918|FG001|COMPLETED|Period 1: Part A and B||14||
60069590|NCT04233918|76184919|FG002|COMPLETED|Period 1: Part A and B||0||
60069591|NCT04233918|76184917|FG000|NOT COMPLETED|Period 1: Part A and B||0||
60069592|NCT04233918|76184918|FG001|NOT COMPLETED|Period 1: Part A and B||0||
60069593|NCT04233918|76184919|FG002|NOT COMPLETED|Period 1: Part A and B||0||
60069594|NCT04233918|76184917|FG000|STARTED|Part C (Extension Period)|Participants who completed Part A or Part B were enrolled and treated in Part C.|0||
60069595|NCT04233918|76184918|FG001|STARTED|Part C (Extension Period)|Participants who completed Part A or Part B were enrolled and treated in Part C.|0||
60069596|NCT04233918|76184919|FG002|STARTED|Part C (Extension Period)|Participants who completed Part A or Part B were enrolled and treated in Part C.|19||
60069597|NCT04233918|76184917|FG000|COMPLETED|Part C (Extension Period)||0||
60069598|NCT04233918|76184918|FG001|COMPLETED|Part C (Extension Period)||0||
60069599|NCT04233918|76184919|FG002|COMPLETED|Part C (Extension Period)||4||
60069600|NCT04233918|76184917|FG000|NOT COMPLETED|Part C (Extension Period)||0||
60069601|NCT04233918|76184918|FG001|NOT COMPLETED|Part C (Extension Period)||0||
60069602|NCT04233918|76184919|FG002|NOT COMPLETED|Part C (Extension Period)||15||
60069603|NCT04060251|76184931|FG000|STARTED|Overall Study|Due to limitations caused by COVID, enrollment targets could not be met.|8||
60069604|NCT04060251|76184932|FG001|STARTED|Overall Study|Due to limitations caused by COVID, enrollment targets could not be met.|6||
60069605|NCT04060251|76184933|FG002|STARTED|Overall Study|Due to limitations caused by COVID, enrollment targets could not be met.|7||
60069606|NCT04060251|76184931|FG000|COMPLETED|Overall Study|Due to limitations caused by COVID, enrollment targets could not be met.|0||
60069607|NCT04060251|76184932|FG001|COMPLETED|Overall Study|Due to limitations caused by COVID, enrollment targets could not be met.|0||
60069608|NCT04060251|76184933|FG002|COMPLETED|Overall Study|Due to limitations caused by COVID, enrollment targets could not be met.|0||
60069609|NCT04060251|76184931|FG000|NOT COMPLETED|Overall Study||8||
60069610|NCT04060251|76184932|FG001|NOT COMPLETED|Overall Study||6||
60069611|NCT04060251|76184933|FG002|NOT COMPLETED|Overall Study||7||
60069612|NCT04048876|76184945|FG000|STARTED|Placebo Controlled Phase||13||
60069613|NCT04048876|76184946|FG001|STARTED|Placebo Controlled Phase||15||
60069614|NCT04048876|76184947|FG002|STARTED|Placebo Controlled Phase||13||
60069615|NCT04048876|76184948|FG003|STARTED|Placebo Controlled Phase||15||
60069616|NCT04048876|76184945|FG000|Continuing to Follow Up|Placebo Controlled Phase||7||
60069617|NCT04048876|76184946|FG001|Continuing to Follow Up|Placebo Controlled Phase||12||
60069618|NCT04048876|76184947|FG002|Continuing to Follow Up|Placebo Controlled Phase||8||
60069619|NCT04048876|76184948|FG003|Continuing to Follow Up|Placebo Controlled Phase||11||
60069620|NCT04048876|76184945|FG000|COMPLETED|Placebo Controlled Phase||2|= continuing to active treatment phase|
60069621|NCT04048876|76184946|FG001|COMPLETED|Placebo Controlled Phase||0|= continuing to active treatment phase|
60069622|NCT04048876|76184947|FG002|COMPLETED|Placebo Controlled Phase||3|= continuing to active treatment phase|
60069623|NCT04048876|76184948|FG003|COMPLETED|Placebo Controlled Phase||2|= continuing to active treatment phase|
60069624|NCT04048876|76184945|FG000|NOT COMPLETED|Placebo Controlled Phase||11||
60069625|NCT04048876|76184946|FG001|NOT COMPLETED|Placebo Controlled Phase||15||
60069626|NCT04048876|76184947|FG002|NOT COMPLETED|Placebo Controlled Phase||10||
60069627|NCT04048876|76184948|FG003|NOT COMPLETED|Placebo Controlled Phase||13||
60069628|NCT04048876|76184945|FG000|STARTED|Active Treatment Phase||2||
60069629|NCT04048876|76184946|FG001|STARTED|Active Treatment Phase||0||
60069630|NCT04048876|76184947|FG002|STARTED|Active Treatment Phase||3||
60069631|NCT04048876|76184948|FG003|STARTED|Active Treatment Phase||2||
60069632|NCT04048876|76184945|FG000|Placebo to CC-90001 200mg|Active Treatment Phase||0|Participants who received placebo in the placebo-controlled phase and then received CC-90001 200mg in active treatment phase|
60069633|NCT04048876|76184946|FG001|Placebo to CC-90001 200mg|Active Treatment Phase||0|Participants who received placebo in the placebo-controlled phase and then received CC-90001 200mg in active treatment phase|
60069634|NCT04048876|76184947|FG002|Placebo to CC-90001 200mg|Active Treatment Phase||0|Participants who received placebo in the placebo-controlled phase and then received CC-90001 200mg in active treatment phase|
60069635|NCT04048876|76184948|FG003|Placebo to CC-90001 200mg|Active Treatment Phase||1|Participants who received placebo in the placebo-controlled phase and then received CC-90001 200mg in active treatment phase|
60069636|NCT04048876|76184945|FG000|Placebo to CC-90001 400mg|Active Treatment Phase||0|Participants who received placebo in the placebo-controlled phase and then received CC-90001 400mg in active treatment phase.|
60069637|NCT04048876|76184946|FG001|Placebo to CC-90001 400mg|Active Treatment Phase||0|Participants who received placebo in the placebo-controlled phase and then received CC-90001 400mg in active treatment phase.|
60069638|NCT04048876|76184947|FG002|Placebo to CC-90001 400mg|Active Treatment Phase||0|Participants who received placebo in the placebo-controlled phase and then received CC-90001 400mg in active treatment phase.|
60069639|NCT04048876|76184948|FG003|Placebo to CC-90001 400mg|Active Treatment Phase||1|Participants who received placebo in the placebo-controlled phase and then received CC-90001 400mg in active treatment phase.|
60069640|NCT04048876|76184945|FG000|COMPLETED|Active Treatment Phase||0||
60069641|NCT04048876|76184946|FG001|COMPLETED|Active Treatment Phase||0||
60069642|NCT04048876|76184947|FG002|COMPLETED|Active Treatment Phase||0||
60069643|NCT04048876|76184948|FG003|COMPLETED|Active Treatment Phase||0||
60069644|NCT04048876|76184945|FG000|NOT COMPLETED|Active Treatment Phase||2||
60069645|NCT04048876|76184946|FG001|NOT COMPLETED|Active Treatment Phase||0||
60069646|NCT04048876|76184947|FG002|NOT COMPLETED|Active Treatment Phase||3||
60069647|NCT04048876|76184948|FG003|NOT COMPLETED|Active Treatment Phase||2||
60069648|NCT03944785|76184963|FG000|STARTED|2 Month Study Completion||2|Participants were prospectively followed for 2 months.|
60069649|NCT03944785|76184964|FG001|STARTED|2 Month Study Completion||34|Participants were prospectively followed for 2 months.|
60069650|NCT03944785|76184965|FG002|STARTED|2 Month Study Completion||128|Participants were prospectively followed for 2 months.|
60069651|NCT03944785|76184963|FG000|COMPLETED|2 Month Study Completion||2||
60069652|NCT03944785|76184964|FG001|COMPLETED|2 Month Study Completion||30||
60069653|NCT03944785|76184965|FG002|COMPLETED|2 Month Study Completion||123||
60069654|NCT03944785|76184963|FG000|NOT COMPLETED|2 Month Study Completion||0||
60069655|NCT03944785|76184964|FG001|NOT COMPLETED|2 Month Study Completion||4||
60069656|NCT03944785|76184965|FG002|NOT COMPLETED|2 Month Study Completion||5||
60069657|NCT03944785|76184963|FG000|STARTED|4 Month Study Optional Extension||1|Continued participation for 4 additional months as an optional extension to the original 2 months.|
60069658|NCT03944785|76184964|FG001|STARTED|4 Month Study Optional Extension||10|Continued participation for 4 additional months as an optional extension to the original 2 months.|
60069659|NCT03944785|76184965|FG002|STARTED|4 Month Study Optional Extension||64|Continued participation for 4 additional months as an optional extension to the original 2 months.|
60069660|NCT03944785|76184963|FG000|COMPLETED|4 Month Study Optional Extension||0||
60069661|NCT03944785|76184964|FG001|COMPLETED|4 Month Study Optional Extension||8||
60069662|NCT03944785|76184965|FG002|COMPLETED|4 Month Study Optional Extension||41||
60069663|NCT03944785|76184963|FG000|NOT COMPLETED|4 Month Study Optional Extension||1||
60069664|NCT03944785|76184964|FG001|NOT COMPLETED|4 Month Study Optional Extension||2||
60069665|NCT03944785|76184965|FG002|NOT COMPLETED|4 Month Study Optional Extension||23||
60069666|NCT03921424|76184975|FG000|STARTED|Overall Study||203||
60069667|NCT03921424|76184976|FG001|STARTED|Overall Study||204||
60069668|NCT03921424|76184975|FG000|Vaccination 1 - (Day 1)|Overall Study||203||
60069669|NCT03921424|76184976|FG001|Vaccination 1 - (Day 1)|Overall Study||204||
60069670|NCT03921424|76184975|FG000|Vaccination 2 - (Week 8)|Overall Study||203||
60069671|NCT03921424|76184976|FG001|Vaccination 2 - (Week 8)|Overall Study|Two participants did not receive Vaccination 2.|202||
60069672|NCT03921424|76184975|FG000|COMPLETED|Overall Study||203||
60069673|NCT03921424|76184976|FG001|COMPLETED|Overall Study||201||
60069674|NCT03921424|76184975|FG000|NOT COMPLETED|Overall Study||0||
60069675|NCT03921424|76184976|FG001|NOT COMPLETED|Overall Study||3||
60069676|NCT03896230|76184987|FG000|STARTED|Overall Study||5||
60069677|NCT03896230|76184988|FG001|STARTED|Overall Study||4||
60069678|NCT03896230|76184989|FG002|STARTED|Overall Study||2||
60069679|NCT03896230|76184987|FG000|COMPLETED|Overall Study||5||
60069680|NCT03896230|76184988|FG001|COMPLETED|Overall Study||4||
60069681|NCT03896230|76184989|FG002|COMPLETED|Overall Study||2||
60069682|NCT03896230|76184987|FG000|NOT COMPLETED|Overall Study||0||
60069683|NCT03896230|76184988|FG001|NOT COMPLETED|Overall Study||0||
60069684|NCT03896230|76184989|FG002|NOT COMPLETED|Overall Study||0||
60069685|NCT03852628|76184999|FG000|STARTED|Overall Study||35||
60069686|NCT03852628|76185000|FG001|STARTED|Overall Study||34||
60069687|NCT03852628|76184999|FG000|COMPLETED|Overall Study||22||
60069688|NCT03852628|76185000|FG001|COMPLETED|Overall Study||22||
60069689|NCT03852628|76184999|FG000|NOT COMPLETED|Overall Study||13||
60069690|NCT03852628|76185000|FG001|NOT COMPLETED|Overall Study||12||
60069691|NCT03602976|76185006|FG000|STARTED|Overall Study||7||
60069692|NCT03602976|76185006|FG000|COMPLETED|Overall Study||6||
60069693|NCT03602976|76185006|FG000|NOT COMPLETED|Overall Study||1||
60069694|NCT03421496|76185015|FG000|STARTED|Overall Study||0||
60069695|NCT03421496|76185016|FG001|STARTED|Overall Study||0||
60069696|NCT03421496|76185015|FG000|COMPLETED|Overall Study||0||
60069697|NCT03421496|76185016|FG001|COMPLETED|Overall Study||0||
60069698|NCT03421496|76185015|FG000|NOT COMPLETED|Overall Study||0||
60069699|NCT03421496|76185016|FG001|NOT COMPLETED|Overall Study||0||
60069700|NCT03278106|76185022|FG000|STARTED|Overall Study||28||
60069701|NCT03278106|76185022|FG000|COMPLETED|Overall Study||27||
60069702|NCT03278106|76185022|FG000|NOT COMPLETED|Overall Study||1||
60069703|NCT03214198|76185026|FG000|STARTED|Overall Study||1304||
60069704|NCT03214198|76185026|FG000|COMPLETED|Overall Study||1268||
60069705|NCT03214198|76185026|FG000|NOT COMPLETED|Overall Study||36||
60069706|NCT03052608|76185032|FG000|STARTED|Treatment Phase||149||
60069707|NCT03052608|76185033|FG001|STARTED|Treatment Phase||147||
60069708|NCT03052608|76185032|FG000|COMPLETED|Treatment Phase||26|"Completed refers to participants with confirmed RECIST version 1.1 defined disease progression assessed by the blinded independent central review or investigator."|
60069709|NCT03052608|76185033|FG001|COMPLETED|Treatment Phase||83|"Completed refers to participants with confirmed RECIST version 1.1 defined disease progression assessed by the blinded independent central review or investigator."|
60069710|NCT03052608|76185032|FG000|NOT COMPLETED|Treatment Phase||123||
60069711|NCT03052608|76185033|FG001|NOT COMPLETED|Treatment Phase||64||
60069712|NCT03052608|76185032|FG000|STARTED|Long-Term Follow-up Phase||149|The long-term follow-up phase included the post-treatment follow-up and the survival follow-up. Participants who started the long-term follow-up phase consisted of participants in both the post-treatment follow-up and the survival follow-up.|
60069713|NCT03052608|76185033|FG001|STARTED|Long-Term Follow-up Phase||147|The long-term follow-up phase included the post-treatment follow-up and the survival follow-up. Participants who started the long-term follow-up phase consisted of participants in both the post-treatment follow-up and the survival follow-up.|
60069714|NCT03052608|76185032|FG000|COMPLETED|Long-Term Follow-up Phase||0||
60069715|NCT03052608|76185033|FG001|COMPLETED|Long-Term Follow-up Phase||0||
60069716|NCT03052608|76185032|FG000|NOT COMPLETED|Long-Term Follow-up Phase||149||
60069717|NCT03052608|76185033|FG001|NOT COMPLETED|Long-Term Follow-up Phase||147||
60069718|NCT02914639|76185041|FG000|STARTED|Overall Study||23||
60069719|NCT02914639|76185042|FG001|STARTED|Overall Study||21||
60069720|NCT02914639|76185041|FG000|COMPLETED|Overall Study||23||
60069721|NCT02914639|76185042|FG001|COMPLETED|Overall Study||19||
60069722|NCT02914639|76185041|FG000|NOT COMPLETED|Overall Study||0||
60069723|NCT02914639|76185042|FG001|NOT COMPLETED|Overall Study||2||
60069724|NCT02865018|76185049|FG000|STARTED|Overall Study||16||
60069725|NCT02865018|76185049|FG000|COMPLETED|Overall Study||15||
60069726|NCT02865018|76185049|FG000|NOT COMPLETED|Overall Study||1||
60069727|NCT02790736|76185055|FG000|STARTED|Overall Study||5||
60069728|NCT02790736|76185056|FG001|STARTED|Overall Study||1||
60069729|NCT02790736|76185055|FG000|COMPLETED|Overall Study||5||
60069730|NCT02790736|76185056|FG001|COMPLETED|Overall Study||1||
60069731|NCT02790736|76185055|FG000|NOT COMPLETED|Overall Study||0||
60069732|NCT02790736|76185056|FG001|NOT COMPLETED|Overall Study||0||
60069733|NCT02704208|76185064|FG000|STARTED|Overall Study||202||
60069734|NCT02704208|76185065|FG001|STARTED|Overall Study||199||
60069735|NCT02704208|76185064|FG000|COMPLETED|Overall Study||160||
60069736|NCT02704208|76185065|FG001|COMPLETED|Overall Study||162||
60069737|NCT02704208|76185064|FG000|NOT COMPLETED|Overall Study||42||
60069738|NCT02704208|76185065|FG001|NOT COMPLETED|Overall Study||37||
60069739|NCT02516670|76185073|FG000|STARTED|Overall Study||34||
60069740|NCT02516670|76185074|FG001|STARTED|Overall Study||16||
60069741|NCT02516670|76185073|FG000|COMPLETED|Overall Study||34||
60069742|NCT02516670|76185074|FG001|COMPLETED|Overall Study||16||
60069743|NCT02516670|76185073|FG000|NOT COMPLETED|Overall Study||0||
60069744|NCT02516670|76185074|FG001|NOT COMPLETED|Overall Study||0||
60069745|NCT02315898|76185084|FG000|STARTED|Overall Study||10||
60069746|NCT02315898|76185085|FG001|STARTED|Overall Study||8||
60069747|NCT02315898|76185086|FG002|STARTED|Overall Study||9||
60069748|NCT02315898|76185087|FG003|STARTED|Overall Study||13||
60069749|NCT02315898|76185084|FG000|COMPLETED|Overall Study||8||
60069750|NCT02315898|76185085|FG001|COMPLETED|Overall Study||8||
60069751|NCT02315898|76185086|FG002|COMPLETED|Overall Study||9||
60069752|NCT02315898|76185087|FG003|COMPLETED|Overall Study||12||
60069753|NCT02315898|76185084|FG000|NOT COMPLETED|Overall Study||2||
60069754|NCT02315898|76185085|FG001|NOT COMPLETED|Overall Study||0||
60069755|NCT02315898|76185086|FG002|NOT COMPLETED|Overall Study||0||
60069756|NCT02315898|76185087|FG003|NOT COMPLETED|Overall Study||1||
60069757|NCT02157883|76185094|FG000|STARTED|Part A: Day 1-5 (AZD9291 Alone)||39||
60069758|NCT02157883|76185094|FG000|COMPLETED|Part A: Day 1-5 (AZD9291 Alone)||39||
60069759|NCT02157883|76185094|FG000|NOT COMPLETED|Part A: Day 1-5 (AZD9291 Alone)||0||
60069760|NCT02157883|76185094|FG000|STARTED|Part A: Day 6-18 (AZD9291+Itraconozole)||39||
60069761|NCT02157883|76185094|FG000|COMPLETED|Part A: Day 6-18 (AZD9291+Itraconozole)||38||
60069762|NCT02157883|76185094|FG000|NOT COMPLETED|Part A: Day 6-18 (AZD9291+Itraconozole)||1||
60069763|NCT02157883|76185094|FG000|STARTED|Part B: Day 19 to End Part B (AZD9291)||38||
60069764|NCT02157883|76185094|FG000|COMPLETED|Part B: Day 19 to End Part B (AZD9291)||16||
60069765|NCT02157883|76185094|FG000|NOT COMPLETED|Part B: Day 19 to End Part B (AZD9291)||22||
60069766|NCT02071290|76185103|FG000|STARTED|Overall Study||25||
60069767|NCT02071290|76185104|FG001|STARTED|Overall Study||25||
60069768|NCT02071290|76185103|FG000|COMPLETED|Overall Study||21||
60069769|NCT02071290|76185104|FG001|COMPLETED|Overall Study||18||
60069770|NCT02071290|76185103|FG000|NOT COMPLETED|Overall Study||4||
60069771|NCT02071290|76185104|FG001|NOT COMPLETED|Overall Study||7||
60069772|NCT02066181|76185112|FG000|STARTED|Overall Study||50||
60069773|NCT02066181|76185113|FG001|STARTED|Overall Study||37||
60069774|NCT02066181|76185112|FG000|Crossed Over|Overall Study||0||
60069775|NCT02066181|76185113|FG001|Crossed Over|Overall Study||28||
60069776|NCT02066181|76185112|FG000|COMPLETED|Overall Study||49||
60069777|NCT02066181|76185113|FG001|COMPLETED|Overall Study||36||
60069778|NCT02066181|76185112|FG000|NOT COMPLETED|Overall Study||1||
60069779|NCT02066181|76185113|FG001|NOT COMPLETED|Overall Study||1||
60069780|NCT01970865|76185139|FG000|STARTED|Overall Study||3||
60069781|NCT01970865|76185140|FG001|STARTED|Overall Study||3||
60069782|NCT01970865|76185141|FG002|STARTED|Overall Study||3||
60069783|NCT01970865|76185142|FG003|STARTED|Overall Study||13||
60069784|NCT01970865|76185143|FG004|STARTED|Overall Study||17||
60069785|NCT01970865|76185144|FG005|STARTED|Overall Study||3||
60069786|NCT01970865|76185145|FG006|STARTED|Overall Study||3||
60069787|NCT01970865|76185146|FG007|STARTED|Overall Study||3||
60069788|NCT01970865|76185147|FG008|STARTED|Overall Study||3||
60069789|NCT01970865|76185148|FG009|STARTED|Overall Study||4||
60069790|NCT01970865|76185149|FG010|STARTED|Overall Study||30||
60069791|NCT01970865|76185150|FG011|STARTED|Overall Study||27||
60069792|NCT01970865|76185151|FG012|STARTED|Overall Study||60||
60069793|NCT01970865|76185152|FG013|STARTED|Overall Study||66||
60069794|NCT01970865|76185153|FG014|STARTED|Overall Study||46||
60069795|NCT01970865|76185154|FG015|STARTED|Overall Study||47||
60069796|NCT01970865|76185155|FG016|STARTED|Overall Study||3||
60069797|NCT01970865|76185139|FG000|Received Treatment|Overall Study||3||
60069798|NCT01970865|76185140|FG001|Received Treatment|Overall Study||3||
60069799|NCT01970865|76185141|FG002|Received Treatment|Overall Study||3||
60069800|NCT01970865|76185142|FG003|Received Treatment|Overall Study||12||
60069801|NCT01970865|76185143|FG004|Received Treatment|Overall Study||17||
60069802|NCT01970865|76185144|FG005|Received Treatment|Overall Study||3||
60069803|NCT01970865|76185145|FG006|Received Treatment|Overall Study||3||
60069804|NCT01970865|76185146|FG007|Received Treatment|Overall Study||3||
60069805|NCT01970865|76185147|FG008|Received Treatment|Overall Study||3||
60069806|NCT01970865|76185148|FG009|Received Treatment|Overall Study||4||
60069807|NCT01970865|76185149|FG010|Received Treatment|Overall Study||30||
60069808|NCT01970865|76185150|FG011|Received Treatment|Overall Study||27||
60069809|NCT01970865|76185151|FG012|Received Treatment|Overall Study||60||
60069810|NCT01970865|76185152|FG013|Received Treatment|Overall Study||65||
60069811|NCT01970865|76185153|FG014|Received Treatment|Overall Study||46||
60069812|NCT01970865|76185154|FG015|Received Treatment|Overall Study||47||
60069813|NCT01970865|76185155|FG016|Received Treatment|Overall Study||3||
60069814|NCT01970865|76185139|FG000|COMPLETED|Overall Study||0||
60069815|NCT01970865|76185140|FG001|COMPLETED|Overall Study||0||
60069816|NCT01970865|76185141|FG002|COMPLETED|Overall Study||0||
60069817|NCT01970865|76185142|FG003|COMPLETED|Overall Study||0||
60069818|NCT01970865|76185143|FG004|COMPLETED|Overall Study||0||
60069819|NCT01970865|76185144|FG005|COMPLETED|Overall Study||0||
60069820|NCT01970865|76185145|FG006|COMPLETED|Overall Study||0||
60069821|NCT01970865|76185146|FG007|COMPLETED|Overall Study||0||
60069822|NCT01970865|76185147|FG008|COMPLETED|Overall Study||0||
60069823|NCT01970865|76185148|FG009|COMPLETED|Overall Study||0||
60069824|NCT01970865|76185149|FG010|COMPLETED|Overall Study||0||
60069825|NCT01970865|76185150|FG011|COMPLETED|Overall Study||0||
60069826|NCT01970865|76185151|FG012|COMPLETED|Overall Study||0||
60069827|NCT01970865|76185152|FG013|COMPLETED|Overall Study||0||
60069828|NCT01970865|76185153|FG014|COMPLETED|Overall Study||0||
60069829|NCT01970865|76185154|FG015|COMPLETED|Overall Study||0||
60069830|NCT01970865|76185155|FG016|COMPLETED|Overall Study||0||
60069831|NCT01970865|76185139|FG000|NOT COMPLETED|Overall Study||3||
60069832|NCT01970865|76185140|FG001|NOT COMPLETED|Overall Study||3||
60069833|NCT01970865|76185141|FG002|NOT COMPLETED|Overall Study||3||
60069834|NCT01970865|76185142|FG003|NOT COMPLETED|Overall Study||13||
60069835|NCT01970865|76185143|FG004|NOT COMPLETED|Overall Study||17||
60069836|NCT01970865|76185144|FG005|NOT COMPLETED|Overall Study||3||
60069837|NCT01970865|76185145|FG006|NOT COMPLETED|Overall Study||3||
60069838|NCT01970865|76185146|FG007|NOT COMPLETED|Overall Study||3||
60069839|NCT01970865|76185147|FG008|NOT COMPLETED|Overall Study||3||
60069840|NCT01970865|76185148|FG009|NOT COMPLETED|Overall Study||4||
60069841|NCT01970865|76185149|FG010|NOT COMPLETED|Overall Study||30||
60069842|NCT01970865|76185150|FG011|NOT COMPLETED|Overall Study||27||
60069843|NCT01970865|76185151|FG012|NOT COMPLETED|Overall Study||60||
60069844|NCT01970865|76185152|FG013|NOT COMPLETED|Overall Study||66||
60069845|NCT01970865|76185153|FG014|NOT COMPLETED|Overall Study||46||
60069846|NCT01970865|76185154|FG015|NOT COMPLETED|Overall Study||47||
60069847|NCT01970865|76185155|FG016|NOT COMPLETED|Overall Study||3||
60069848|NCT01843751|76185218|FG000|STARTED|Overall Study||11||
60069849|NCT01843751|76185219|FG001|STARTED|Overall Study||10||
60069850|NCT01843751|76185218|FG000|COMPLETED|Overall Study||0||
60069851|NCT01843751|76185219|FG001|COMPLETED|Overall Study||3||
60069852|NCT01843751|76185218|FG000|NOT COMPLETED|Overall Study||11||
60069853|NCT01843751|76185219|FG001|NOT COMPLETED|Overall Study||7||
60069854|NCT01711541|76185230|FG000|STARTED|Overall Study||4||
60069855|NCT01711541|76185231|FG001|STARTED|Overall Study||4||
60069856|NCT01711541|76185232|FG002|STARTED|Overall Study||3||
60069857|NCT01711541|76185233|FG003|STARTED|Overall Study||6||
60069858|NCT01711541|76185234|FG004|STARTED|Overall Study||7||
60069859|NCT01711541|76185230|FG000|COMPLETED|Overall Study||4||
60069860|NCT01711541|76185231|FG001|COMPLETED|Overall Study||3||
60069861|NCT01711541|76185232|FG002|COMPLETED|Overall Study||3||
60069862|NCT01711541|76185233|FG003|COMPLETED|Overall Study||5||
60069863|NCT01711541|76185234|FG004|COMPLETED|Overall Study||7||
60069864|NCT01711541|76185230|FG000|NOT COMPLETED|Overall Study||0||
60069865|NCT01711541|76185231|FG001|NOT COMPLETED|Overall Study||1||
60069866|NCT01711541|76185232|FG002|NOT COMPLETED|Overall Study||0||
60069867|NCT01711541|76185233|FG003|NOT COMPLETED|Overall Study||1||
60069868|NCT01711541|76185234|FG004|NOT COMPLETED|Overall Study||0||
60069869|NCT00134030|76185255|FG000|STARTED|Overall Study||359||
60069870|NCT00134030|76185256|FG001|STARTED|Overall Study||357||
60069871|NCT00134030|76185257|FG002|STARTED|Overall Study||310||
60069872|NCT00134030|76185258|FG003|STARTED|Overall Study||308||
60069873|NCT00134030|76185255|FG000|COMPLETED|Overall Study||359||
60069874|NCT00134030|76185256|FG001|COMPLETED|Overall Study||357||
60069875|NCT00134030|76185257|FG002|COMPLETED|Overall Study||310||
60069876|NCT00134030|76185258|FG003|COMPLETED|Overall Study||308||
60069877|NCT00134030|76185255|FG000|NOT COMPLETED|Overall Study||0||
60069878|NCT00134030|76185256|FG001|NOT COMPLETED|Overall Study||0||
60069879|NCT00134030|76185257|FG002|NOT COMPLETED|Overall Study||0||
59762710|NCT00856557|75882566|FG001|With Patients With Contextual Flags|Overall Study||60||
60069880|NCT00134030|76185258|FG003|NOT COMPLETED|Overall Study||0||
60069881|NCT01382446|76185270|FG000|STARTED|Overall Study||33||
60069882|NCT01382446|76185271|FG001|STARTED|Overall Study||33||
60069883|NCT01382446|76185270|FG000|COMPLETED|Overall Study||30||
60069884|NCT01382446|76185271|FG001|COMPLETED|Overall Study||29||
60069885|NCT01382446|76185270|FG000|NOT COMPLETED|Overall Study||3||
60069886|NCT01382446|76185271|FG001|NOT COMPLETED|Overall Study||4||
60069887|NCT01382212|76185277|FG000|STARTED|Overall Study||13||
60069888|NCT01382212|76185277|FG000|COMPLETED|Overall Study||11||
60069889|NCT01382212|76185277|FG000|NOT COMPLETED|Overall Study||2||
60069890|NCT01381900|76185284|FG000|STARTED|Overall Study||226||
60069891|NCT01381900|76185285|FG001|STARTED|Overall Study||223||
60069892|NCT01381900|76185286|FG002|STARTED|Overall Study||227||
60069893|NCT01381900|76185284|FG000|COMPLETED|Overall Study||217||
60069894|NCT01381900|76185285|FG001|COMPLETED|Overall Study||214||
60069895|NCT01381900|76185286|FG002|COMPLETED|Overall Study||215||
60069896|NCT01381900|76185284|FG000|NOT COMPLETED|Overall Study||9||
60069897|NCT01381900|76185285|FG001|NOT COMPLETED|Overall Study||9||
60069898|NCT01381900|76185286|FG002|NOT COMPLETED|Overall Study||12||
60069899|NCT01744665|76185294|FG000|STARTED|Monitoring Phase||59||
60069900|NCT01744665|76185294|FG000|COMPLETED|Monitoring Phase||41||
60069901|NCT01744665|76185294|FG000|NOT COMPLETED|Monitoring Phase||18||
60069902|NCT01744665|76185294|FG000|STARTED|Consolidation Phase||41||
60069903|NCT01744665|76185294|FG000|COMPLETED|Consolidation Phase||22||
60069904|NCT01744665|76185294|FG000|NOT COMPLETED|Consolidation Phase||19||
60069905|NCT01744665|76185294|FG000|STARTED|Treatment Free Remission Phase||32||
60069906|NCT01744665|76185294|FG000|COMPLETED|Treatment Free Remission Phase||32||
60069907|NCT01744665|76185294|FG000|NOT COMPLETED|Treatment Free Remission Phase||0||
60069908|NCT01744665|76185294|FG000|STARTED|Re-initiation Phase||17||
60069909|NCT01744665|76185294|FG000|COMPLETED|Re-initiation Phase||4||
60069910|NCT01744665|76185294|FG000|NOT COMPLETED|Re-initiation Phase||13||
60069911|NCT01744197|76185303|FG000|STARTED|Overall Study||32||
60069912|NCT01744197|76185304|FG001|STARTED|Overall Study||29||
60069913|NCT01744197|76185303|FG000|COMPLETED|Overall Study||28||
60069914|NCT01744197|76185304|FG001|COMPLETED|Overall Study||26||
60069915|NCT01744197|76185303|FG000|NOT COMPLETED|Overall Study||4||
60069916|NCT01744197|76185304|FG001|NOT COMPLETED|Overall Study||3||
60069917|NCT01732107|76185310|FG000|STARTED|Overall Study||13||
60069918|NCT01732107|76185310|FG000|COMPLETED|Overall Study||0||
60069919|NCT01732107|76185310|FG000|NOT COMPLETED|Overall Study||13||
60069920|NCT01743027|76185318|FG000|STARTED|Overall Study||98||
60069921|NCT01743027|76185319|FG001|STARTED|Overall Study||99||
60069922|NCT01743027|76185320|FG002|STARTED|Overall Study||99||
60069923|NCT01743027|76185321|FG003|STARTED|Overall Study||49||
60069924|NCT01743027|76185318|FG000|COMPLETED|Overall Study||93||
60069925|NCT01743027|76185319|FG001|COMPLETED|Overall Study||94||
60069926|NCT01743027|76185320|FG002|COMPLETED|Overall Study||90||
60069927|NCT01743027|76185321|FG003|COMPLETED|Overall Study||48||
60069928|NCT01743027|76185318|FG000|NOT COMPLETED|Overall Study||5||
60069929|NCT01743027|76185319|FG001|NOT COMPLETED|Overall Study||5||
60069930|NCT01743027|76185320|FG002|NOT COMPLETED|Overall Study||9||
60069931|NCT01743027|76185321|FG003|NOT COMPLETED|Overall Study||1||
60069932|NCT01380730|76185339|FG000|STARTED|Overall Study||78||
60069933|NCT01380730|76185340|FG001|STARTED|Overall Study||79||
60069934|NCT01380730|76185341|FG002|STARTED|Overall Study||79||
60069935|NCT01380730|76185342|FG003|STARTED|Overall Study||79||
60069936|NCT01380730|76185343|FG004|STARTED|Overall Study||78||
60069937|NCT01380730|76185344|FG005|STARTED|Overall Study||79||
60069938|NCT01380730|76185345|FG006|STARTED|Overall Study||79||
60069939|NCT01380730|76185346|FG007|STARTED|Overall Study||80||
60069940|NCT01380730|76185339|FG000|Received Treatment|Overall Study||78||
60069941|NCT01380730|76185340|FG001|Received Treatment|Overall Study|2 participants did not receive treatment but were followed until the end of study|77||
59762711|NCT00856557|75882565|FG000|COMPLETED|Overall Study||50||
59762712|NCT00856557|75882566|FG001|COMPLETED|Overall Study||60||
60069942|NCT01380730|76185341|FG002|Received Treatment|Overall Study||79||
60069943|NCT01380730|76185342|FG003|Received Treatment|Overall Study||79||
60069944|NCT01380730|76185343|FG004|Received Treatment|Overall Study||78||
60069945|NCT01380730|76185344|FG005|Received Treatment|Overall Study||79||
60069946|NCT01380730|76185345|FG006|Received Treatment|Overall Study||79||
60069947|NCT01380730|76185346|FG007|Received Treatment|Overall Study||80||
60069948|NCT01380730|76185339|FG000|COMPLETED|Overall Study||78||
60069949|NCT01380730|76185340|FG001|COMPLETED|Overall Study||79||
60069950|NCT01380730|76185341|FG002|COMPLETED|Overall Study||79||
60069951|NCT01380730|76185342|FG003|COMPLETED|Overall Study||79||
60069952|NCT01380730|76185343|FG004|COMPLETED|Overall Study||77||
60069953|NCT01380730|76185344|FG005|COMPLETED|Overall Study||79||
60069954|NCT01380730|76185345|FG006|COMPLETED|Overall Study||79||
60069955|NCT01380730|76185346|FG007|COMPLETED|Overall Study||80||
60069956|NCT01380730|76185339|FG000|NOT COMPLETED|Overall Study||0||
60069957|NCT01380730|76185340|FG001|NOT COMPLETED|Overall Study||0||
60069958|NCT01380730|76185341|FG002|NOT COMPLETED|Overall Study||0||
60069959|NCT01380730|76185342|FG003|NOT COMPLETED|Overall Study||0||
60069960|NCT01380730|76185343|FG004|NOT COMPLETED|Overall Study||1||
60069961|NCT01380730|76185344|FG005|NOT COMPLETED|Overall Study||0||
60069962|NCT01380730|76185345|FG006|NOT COMPLETED|Overall Study||0||
60069963|NCT01380730|76185346|FG007|NOT COMPLETED|Overall Study||0||
60069964|NCT01395784|76185364|FG000|STARTED|Overall Study||32||
60069965|NCT01395784|76185364|FG000|COMPLETED|Overall Study||17||
60069966|NCT01395784|76185364|FG000|NOT COMPLETED|Overall Study||15||
60069967|NCT01380184|76185368|FG000|STARTED|Part 1 (19 Days)||15||
60069968|NCT01380184|76185368|FG000|COMPLETED|Part 1 (19 Days)||14||
60069969|NCT01380184|76185368|FG000|NOT COMPLETED|Part 1 (19 Days)||1||
60069970|NCT01380184|76185368|FG000|STARTED|Washout Period (≥2 Days)||14||
60069971|NCT01380184|76185368|FG000|COMPLETED|Washout Period (≥2 Days)||14||
60069972|NCT01380184|76185368|FG000|NOT COMPLETED|Washout Period (≥2 Days)||0||
60069973|NCT01380184|76185368|FG000|STARTED|Part 2||14||
60069974|NCT01380184|76185368|FG000|COMPLETED|Part 2||0||
60069975|NCT01380184|76185368|FG000|NOT COMPLETED|Part 2||14||
60069976|NCT01395394|76185375|FG000|STARTED|Baseline Study Visit||4||
60069977|NCT01395394|76185376|FG001|STARTED|Baseline Study Visit||3||
60069978|NCT01395394|76185377|FG002|STARTED|Baseline Study Visit||5||
60069979|NCT01395394|76185375|FG000|COMPLETED|Baseline Study Visit||3||
60069980|NCT01395394|76185376|FG001|COMPLETED|Baseline Study Visit||3||
60069981|NCT01395394|76185377|FG002|COMPLETED|Baseline Study Visit||5||
60069982|NCT01395394|76185375|FG000|NOT COMPLETED|Baseline Study Visit||1||
60069983|NCT01395394|76185376|FG001|NOT COMPLETED|Baseline Study Visit||0||
60069984|NCT01395394|76185377|FG002|NOT COMPLETED|Baseline Study Visit||0||
60069985|NCT01395394|76185375|FG000|STARTED|Study Visit 2 (Non-responders Only)||3||
60069986|NCT01395394|76185376|FG001|STARTED|Study Visit 2 (Non-responders Only)||0||
60069987|NCT01395394|76185377|FG002|STARTED|Study Visit 2 (Non-responders Only)||0||
60069988|NCT01395394|76185375|FG000|COMPLETED|Study Visit 2 (Non-responders Only)||3||
60069989|NCT01395394|76185376|FG001|COMPLETED|Study Visit 2 (Non-responders Only)||0||
60069990|NCT01395394|76185377|FG002|COMPLETED|Study Visit 2 (Non-responders Only)||0||
60069991|NCT01395394|76185375|FG000|NOT COMPLETED|Study Visit 2 (Non-responders Only)||0||
60069992|NCT01395394|76185376|FG001|NOT COMPLETED|Study Visit 2 (Non-responders Only)||0||
60069993|NCT01395394|76185377|FG002|NOT COMPLETED|Study Visit 2 (Non-responders Only)||0||
60069994|NCT01395316|76185385|FG000|STARTED|Overall Study||8||
60069995|NCT01395316|76185385|FG000|COMPLETED|Overall Study||5||
60069996|NCT01395316|76185385|FG000|NOT COMPLETED|Overall Study||3||
60069997|NCT01742091|76185395|FG000|STARTED|Overall Study||9||
60069998|NCT01742091|76185396|FG001|STARTED|Overall Study||11||
60069999|NCT01742091|76185397|FG002|STARTED|Overall Study||10||
60070000|NCT01742091|76185398|FG003|STARTED|Overall Study||9||
60070001|NCT01742091|76185399|FG004|STARTED|Overall Study||8||
60070002|NCT01742091|76185400|FG005|STARTED|Overall Study||12||
60070003|NCT01742091|76185395|FG000|RECEIVED STUDY DRUG|Overall Study||9||
60070004|NCT01742091|76185396|FG001|RECEIVED STUDY DRUG|Overall Study||11||
60070005|NCT01742091|76185397|FG002|RECEIVED STUDY DRUG|Overall Study||10||
60070006|NCT01742091|76185398|FG003|RECEIVED STUDY DRUG|Overall Study||9||
60070007|NCT01742091|76185399|FG004|RECEIVED STUDY DRUG|Overall Study||8||
60070008|NCT01742091|76185400|FG005|RECEIVED STUDY DRUG|Overall Study||12||
60070009|NCT01742091|76185395|FG000|COMPLETED|Overall Study||9||
60070010|NCT01742091|76185396|FG001|COMPLETED|Overall Study||11||
59519291|NCT02574078|75613239|FG002|COMPLETED|Pre-Treatment Period||9|Finished = Treated|
59519292|NCT02574078|75613240|FG003|COMPLETED|Pre-Treatment Period||35|Finished = Treated|
59519293|NCT02574078|75613241|FG004|COMPLETED|Pre-Treatment Period||34|Finished = Treated|
59519294|NCT02574078|75613242|FG005|COMPLETED|Pre-Treatment Period||34|Finished = Treated|
59519295|NCT02574078|75613243|FG006|COMPLETED|Pre-Treatment Period||14|Finished = Treated|
59519296|NCT02574078|75613244|FG007|COMPLETED|Pre-Treatment Period||14|Finished = Treated|
59519297|NCT02574078|75613245|FG008|COMPLETED|Pre-Treatment Period||25|Finished = Treated|
60070011|NCT01742091|76185397|FG002|COMPLETED|Overall Study||10||
60070012|NCT01742091|76185398|FG003|COMPLETED|Overall Study||8||
60070013|NCT01742091|76185399|FG004|COMPLETED|Overall Study||7||
60070014|NCT01742091|76185400|FG005|COMPLETED|Overall Study||10||
60070015|NCT01742091|76185395|FG000|NOT COMPLETED|Overall Study||0||
60070016|NCT01742091|76185396|FG001|NOT COMPLETED|Overall Study||0||
60070017|NCT01742091|76185397|FG002|NOT COMPLETED|Overall Study||0||
60070018|NCT01742091|76185398|FG003|NOT COMPLETED|Overall Study||1||
60070019|NCT01742091|76185399|FG004|NOT COMPLETED|Overall Study||1||
60070020|NCT01742091|76185400|FG005|NOT COMPLETED|Overall Study||2||
60070021|NCT01731951|76185420|FG000|STARTED|Overall Study||19||
60070022|NCT01731951|76185421|FG001|STARTED|Overall Study||16||
60070023|NCT01731951|76185422|FG002|STARTED|Overall Study||9||
60070024|NCT01731951|76185423|FG003|STARTED|Overall Study||9||
60070025|NCT01731951|76185424|FG004|STARTED|Overall Study||18||
60070026|NCT01731951|76185425|FG005|STARTED|Overall Study||9||
60070027|NCT01731951|76185420|FG000|COMPLETED|Overall Study||2||
60070028|NCT01731951|76185421|FG001|COMPLETED|Overall Study||1||
60070029|NCT01731951|76185422|FG002|COMPLETED|Overall Study||0||
60070030|NCT01731951|76185423|FG003|COMPLETED|Overall Study||0||
60070031|NCT01731951|76185424|FG004|COMPLETED|Overall Study||6||
60070032|NCT01731951|76185425|FG005|COMPLETED|Overall Study||0||
60070033|NCT01731951|76185420|FG000|NOT COMPLETED|Overall Study||17||
60070034|NCT01731951|76185421|FG001|NOT COMPLETED|Overall Study||15||
60070035|NCT01731951|76185422|FG002|NOT COMPLETED|Overall Study||9||
60070036|NCT01731951|76185423|FG003|NOT COMPLETED|Overall Study||9||
60070037|NCT01731951|76185424|FG004|NOT COMPLETED|Overall Study||12||
60070038|NCT01731951|76185425|FG005|NOT COMPLETED|Overall Study||9||
60070039|NCT01731171|76185445|FG000|STARTED|Overall Study||33||
60070040|NCT01731171|76185446|FG001|STARTED|Overall Study||33||
60070041|NCT01731171|76185445|FG000|COMPLETED|Overall Study||26||
60070042|NCT01731171|76185446|FG001|COMPLETED|Overall Study||26||
60070043|NCT01731171|76185445|FG000|NOT COMPLETED|Overall Study||7||
60070044|NCT01731171|76185446|FG001|NOT COMPLETED|Overall Study||7||
60070045|NCT01741701|76185454|FG000|STARTED|Overall Study||18||
60070046|NCT01741701|76185455|FG001|STARTED|Overall Study||15||
60070047|NCT01741701|76185454|FG000|COMPLETED|Overall Study||13||
60070048|NCT01741701|76185455|FG001|COMPLETED|Overall Study||13||
60070049|NCT01741701|76185454|FG000|NOT COMPLETED|Overall Study||5||
60070050|NCT01741701|76185455|FG001|NOT COMPLETED|Overall Study||2||
60070051|NCT01741545|76185463|FG000|STARTED|Treatment Period||12||
60070052|NCT01741545|76185464|FG001|STARTED|Treatment Period||39||
60070053|NCT01741545|76185463|FG000|COMPLETED|Treatment Period||11||
60070054|NCT01741545|76185464|FG001|COMPLETED|Treatment Period||35||
60070055|NCT01741545|76185463|FG000|NOT COMPLETED|Treatment Period||1||
60070056|NCT01741545|76185464|FG001|NOT COMPLETED|Treatment Period||4||
60070057|NCT01741545|76185463|FG000|STARTED|Follow-up Period (24 Weeks)|1 participant re-joined Cohort A in follow-up period.|12||
60070058|NCT01741545|76185464|FG001|STARTED|Follow-up Period (24 Weeks)|4 participants re-joined Cohort B in follow-up period.|39||
60070059|NCT01741545|76185463|FG000|COMPLETED|Follow-up Period (24 Weeks)||11||
60070060|NCT01741545|76185464|FG001|COMPLETED|Follow-up Period (24 Weeks)||37||
60070061|NCT01741545|76185463|FG000|NOT COMPLETED|Follow-up Period (24 Weeks)||1||
60070062|NCT01741545|76185464|FG001|NOT COMPLETED|Follow-up Period (24 Weeks)||2||
60070063|NCT01884350|76185472|FG000|STARTED|Primary Efficacy Analysis Set (24 Weeks)||583|"Primary Efficacy Analysis set:~All randomized patients."|
60070064|NCT01884350|76185473|FG001|STARTED|Primary Efficacy Analysis Set (24 Weeks)||579|"Primary Efficacy Analysis set:~All randomized patients."|
60070065|NCT01884350|76185474|FG002|STARTED|Primary Efficacy Analysis Set (24 Weeks)|Participants were not randomized to this arm until after initial 24-week period|0|"Primary Efficacy Analysis set:~All randomized patients."|
60070066|NCT01884350|76185472|FG000|Safety Analysis Set|Primary Efficacy Analysis Set (24 Weeks)||604|All randomized patients who received any study drug.|
60070067|NCT01884350|76185473|FG001|Safety Analysis Set|Primary Efficacy Analysis Set (24 Weeks)||558|All randomized patients who received any study drug.|
60070068|NCT01884350|76185474|FG002|Safety Analysis Set|Primary Efficacy Analysis Set (24 Weeks)||0|All randomized patients who received any study drug.|
60070069|NCT01884350|76185472|FG000|COMPLETED|Primary Efficacy Analysis Set (24 Weeks)||529||
60070070|NCT01884350|76185473|FG001|COMPLETED|Primary Efficacy Analysis Set (24 Weeks)||525||
59613536|NCT01590888|75724660|FG001|NOT COMPLETED|Overall Study||0||
59613537|NCT01590888|75724661|FG002|NOT COMPLETED|Overall Study||1||
59613538|NCT01565928|75724669|FG000|STARTED|Overall Study||22||
59613539|NCT01565928|75724669|FG000|COMPLETED|Overall Study||0||
60070071|NCT01884350|76185474|FG002|COMPLETED|Primary Efficacy Analysis Set (24 Weeks)||0||
60070072|NCT01884350|76185472|FG000|NOT COMPLETED|Primary Efficacy Analysis Set (24 Weeks)||54||
60070073|NCT01884350|76185473|FG001|NOT COMPLETED|Primary Efficacy Analysis Set (24 Weeks)||54||
60070074|NCT01884350|76185474|FG002|NOT COMPLETED|Primary Efficacy Analysis Set (24 Weeks)||0||
60070075|NCT01884350|76185472|FG000|STARTED|Primary Efficacy Analysis Set (48 Weeks)||583|Primary Efficacy Analysis Set. 1 completed initial period but was not rand. to 2nd 24-week period|
60070076|NCT01884350|76185473|FG001|STARTED|Primary Efficacy Analysis Set (48 Weeks)|After 24 weeks participants were randomized to continue AEP or stop AEP and revert to SOC.|263|Primary Efficacy Analysis Set. 1 completed initial period but was not rand. to 2nd 24-week period|
60070077|NCT01884350|76185474|FG002|STARTED|Primary Efficacy Analysis Set (48 Weeks)|After 24 weeks participants were randomized to continue AEP or stop AEP and revert to SOC.|261|Primary Efficacy Analysis Set. 1 completed initial period but was not rand. to 2nd 24-week period|
60103558|NCT03518619|76221793|FG000|STARTED|Overall Study||20||
60070078|NCT01884350|76185472|FG000|Safety Analysis Set|Primary Efficacy Analysis Set (48 Weeks)||604|All randomized patients who received any study drug.|
60070079|NCT01884350|76185473|FG001|Safety Analysis Set|Primary Efficacy Analysis Set (48 Weeks)||308|All randomized patients who received any study drug.|
60070080|NCT01884350|76185474|FG002|Safety Analysis Set|Primary Efficacy Analysis Set (48 Weeks)||223|All randomized patients who received any study drug.|
60070081|NCT01884350|76185472|FG000|COMPLETED|Primary Efficacy Analysis Set (48 Weeks)||503||
60070082|NCT01884350|76185473|FG001|COMPLETED|Primary Efficacy Analysis Set (48 Weeks)||250||
60070083|NCT01884350|76185474|FG002|COMPLETED|Primary Efficacy Analysis Set (48 Weeks)||250||
60070084|NCT01884350|76185472|FG000|NOT COMPLETED|Primary Efficacy Analysis Set (48 Weeks)||80||
60070085|NCT01884350|76185473|FG001|NOT COMPLETED|Primary Efficacy Analysis Set (48 Weeks)||13||
60070086|NCT01884350|76185474|FG002|NOT COMPLETED|Primary Efficacy Analysis Set (48 Weeks)||11||
60070087|NCT01614795|76185488|FG000|STARTED|Overall Study||11||
60070088|NCT01614795|76185489|FG001|STARTED|Overall Study||12||
60070089|NCT01614795|76185490|FG002|STARTED|Overall Study||11||
60070090|NCT01614795|76185491|FG003|STARTED|Overall Study||12||
60070091|NCT01614795|76185488|FG000|COMPLETED|Overall Study||0||
60070092|NCT01614795|76185489|FG001|COMPLETED|Overall Study||0||
60070093|NCT01614795|76185490|FG002|COMPLETED|Overall Study||0||
60070094|NCT01614795|76185491|FG003|COMPLETED|Overall Study||0||
60070095|NCT01614795|76185488|FG000|NOT COMPLETED|Overall Study||11||
60070096|NCT01614795|76185489|FG001|NOT COMPLETED|Overall Study||12||
60070097|NCT01614795|76185490|FG002|NOT COMPLETED|Overall Study||11||
60070098|NCT01614795|76185491|FG003|NOT COMPLETED|Overall Study||12||
60070099|NCT01834586|76185502|FG000|STARTED|Overall Study||30||
60070100|NCT01834586|76185502|FG000|COMPLETED|Overall Study||29||
60070101|NCT01834586|76185502|FG000|NOT COMPLETED|Overall Study||1||
60070102|NCT01614249|76185508|FG000|STARTED|Overall Study|Participants received every two-weeks supply and monitored regularly on cell-phone and face-to-face.|107||
60070103|NCT01614249|76185509|FG001|STARTED|Overall Study|Participants received every two-week supply and monitored regularly on cell-phone and face-to-face.|109||
60070104|NCT01614249|76185508|FG000|At Week-4|Overall Study|Participants received every two-week supply and monitored regularly on cell-phone and face-to-face.|98||
60070105|NCT01614249|76185509|FG001|At Week-4|Overall Study|Participants received every two-week supply and monitored regularly on cell-phone and face-to-face.|92||
60070106|NCT01614249|76185508|FG000|At Week-8 (End of Study Period)|Overall Study|End of study data collected for all participants who completed the 8-week trial period.|96||
60070107|NCT01614249|76185509|FG001|At Week-8 (End of Study Period)|Overall Study|End of study data collected for all participants who completed the 8-week trial period.|86||
60070108|NCT01614249|76185508|FG000|COMPLETED|Overall Study|End of study data analyzed for only participants who completed the 8-week trial period.|96||
60070109|NCT01614249|76185509|FG001|COMPLETED|Overall Study|End of study data analyzed for only participants who completed the 8-week trial period.|86||
60070110|NCT01614249|76185508|FG000|NOT COMPLETED|Overall Study||11||
60070111|NCT01614249|76185509|FG001|NOT COMPLETED|Overall Study||23||
60070112|NCT01597778|76185517|FG000|STARTED|Overall Study||186||
60070113|NCT01597778|76185518|FG001|STARTED|Overall Study||182||
60070114|NCT01597778|76185517|FG000|COMPLETED|Overall Study||172||
60070115|NCT01597778|76185518|FG001|COMPLETED|Overall Study||153||
60070116|NCT01597778|76185517|FG000|NOT COMPLETED|Overall Study||14||
60070117|NCT01597778|76185518|FG001|NOT COMPLETED|Overall Study||29||
60070118|NCT01614093|76185524|FG000|STARTED|Overall Study||17||
60070119|NCT01614093|76185524|FG000|COMPLETED|Overall Study||16||
60070120|NCT01614093|76185524|FG000|NOT COMPLETED|Overall Study||1||
60070121|NCT01834274|76185531|FG000|STARTED|Overall Study||50||
60070122|NCT01834274|76185532|FG001|STARTED|Overall Study||46||
60070123|NCT01834274|76185531|FG000|COMPLETED|Overall Study||3||
60070124|NCT01834274|76185532|FG001|COMPLETED|Overall Study||5||
60070125|NCT01834274|76185531|FG000|NOT COMPLETED|Overall Study||47||
60070126|NCT01834274|76185532|FG001|NOT COMPLETED|Overall Study||41||
60070127|NCT01739595|76185541|FG000|STARTED|Overall Study||112||
60070128|NCT01739595|76185542|FG001|STARTED|Overall Study||22||
60070129|NCT01739595|76185543|FG002|STARTED|Overall Study||47||
60070130|NCT01739595|76185541|FG000|COMPLETED|Overall Study||99||
60070131|NCT01739595|76185542|FG001|COMPLETED|Overall Study||21||
60070132|NCT01739595|76185543|FG002|COMPLETED|Overall Study||45||
60070133|NCT01739595|76185541|FG000|NOT COMPLETED|Overall Study||13||
60070134|NCT01739595|76185542|FG001|NOT COMPLETED|Overall Study||1||
60070135|NCT01739595|76185543|FG002|NOT COMPLETED|Overall Study||2||
60070136|NCT01833494|76185550|FG000|STARTED|Overall Study||161||
60070137|NCT01833494|76185550|FG000|COMPLETED|Overall Study||116||
60070138|NCT01833494|76185550|FG000|NOT COMPLETED|Overall Study||45||
60070139|NCT01738971|76185557|FG000|STARTED|Overall Study|54 participants recruited to this arm|54||
60070140|NCT01738971|76185558|FG001|STARTED|Overall Study|58 participants recruited to this arm|58||
60070141|NCT01738971|76185559|FG002|STARTED|Overall Study|56 participants recruited to this arm|56||
60070142|NCT01738971|76185557|FG000|COMPLETED|Overall Study|35 participants successfully contacted to complete telephone follow-up at 6-8 weeks.|35||
60070143|NCT01738971|76185558|FG001|COMPLETED|Overall Study|28 participants successfully contacted to complete telephone follow-up at 6-8 weeks.|28||
60070144|NCT01738971|76185559|FG002|COMPLETED|Overall Study|39 participants successfully contacted to complete telephone follow-up at 6-8 weeks.|39||
60070145|NCT01738971|76185557|FG000|NOT COMPLETED|Overall Study||19||
60070146|NCT01738971|76185558|FG001|NOT COMPLETED|Overall Study||30||
60070147|NCT01738971|76185559|FG002|NOT COMPLETED|Overall Study||17||
60070148|NCT01738581|76185569|FG000|STARTED|Overall Study||5||
60070149|NCT01738581|76185570|FG001|STARTED|Overall Study||4||
59613540|NCT01565928|75724669|FG000|NOT COMPLETED|Overall Study||22||
59613541|NCT01565850|75724678|FG000|STARTED|Overall Study||103||
60070150|NCT01738581|76185569|FG000|COMPLETED|Overall Study||4||
60070151|NCT01738581|76185570|FG001|COMPLETED|Overall Study||4||
60070152|NCT01738581|76185569|FG000|NOT COMPLETED|Overall Study||1||
60070153|NCT01738581|76185570|FG001|NOT COMPLETED|Overall Study||0||
60070154|NCT01738503|76185582|FG000|STARTED|Induction/Stabilization (Days -14 to -1)||124||
60070155|NCT01738503|76185583|FG001|STARTED|Induction/Stabilization (Days -14 to -1)||0||
60070156|NCT01738503|76185584|FG002|STARTED|Induction/Stabilization (Days -14 to -1)||0||
59613542|NCT01565850|75724679|FG001|STARTED|Overall Study||50||
59613543|NCT01565850|75724678|FG000|COMPLETED|Overall Study||83||
60070157|NCT01738503|76185585|FG003|STARTED|Induction/Stabilization (Days -14 to -1)||0||
60070158|NCT01738503|76185586|FG004|STARTED|Induction/Stabilization (Days -14 to -1)||0||
60070159|NCT01738503|76185587|FG005|STARTED|Induction/Stabilization (Days -14 to -1)||0||
60070160|NCT01738503|76185588|FG006|STARTED|Induction/Stabilization (Days -14 to -1)||0||
60070161|NCT01738503|76185582|FG000|COMPLETED|Induction/Stabilization (Days -14 to -1)||89||
60070162|NCT01738503|76185583|FG001|COMPLETED|Induction/Stabilization (Days -14 to -1)||0||
60070163|NCT01738503|76185584|FG002|COMPLETED|Induction/Stabilization (Days -14 to -1)||0||
60070164|NCT01738503|76185585|FG003|COMPLETED|Induction/Stabilization (Days -14 to -1)||0||
60070165|NCT01738503|76185586|FG004|COMPLETED|Induction/Stabilization (Days -14 to -1)||0||
60070166|NCT01738503|76185587|FG005|COMPLETED|Induction/Stabilization (Days -14 to -1)||0||
60070167|NCT01738503|76185588|FG006|COMPLETED|Induction/Stabilization (Days -14 to -1)||0||
60070168|NCT01738503|76185582|FG000|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||35||
60070169|NCT01738503|76185583|FG001|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0||
60070170|NCT01738503|76185584|FG002|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0||
60070171|NCT01738503|76185585|FG003|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0||
60070172|NCT01738503|76185586|FG004|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0||
60070173|NCT01738503|76185587|FG005|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0||
60070174|NCT01738503|76185588|FG006|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0||
60070175|NCT01738503|76185582|FG000|STARTED|Treatment Period||0||
60070176|NCT01738503|76185583|FG001|STARTED|Treatment Period||15||
60070177|NCT01738503|76185584|FG002|STARTED|Treatment Period||15||
60070178|NCT01738503|76185585|FG003|STARTED|Treatment Period||15||
60070179|NCT01738503|76185586|FG004|STARTED|Treatment Period||15||
60070180|NCT01738503|76185587|FG005|STARTED|Treatment Period||15||
60070181|NCT01738503|76185588|FG006|STARTED|Treatment Period||14||
60070182|NCT01738503|76185582|FG000|COMPLETED|Treatment Period||0||
60070183|NCT01738503|76185583|FG001|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|10||
60070184|NCT01738503|76185584|FG002|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|10||
60070185|NCT01738503|76185585|FG003|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|9||
60070186|NCT01738503|76185586|FG004|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|7||
60070187|NCT01738503|76185587|FG005|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|9||
60070188|NCT01738503|76185588|FG006|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|6||
60070189|NCT01738503|76185582|FG000|NOT COMPLETED|Treatment Period||0||
60070190|NCT01738503|76185583|FG001|NOT COMPLETED|Treatment Period||5||
60070191|NCT01738503|76185584|FG002|NOT COMPLETED|Treatment Period||5||
60070192|NCT01738503|76185585|FG003|NOT COMPLETED|Treatment Period||6||
60070193|NCT01738503|76185586|FG004|NOT COMPLETED|Treatment Period||8||
60070194|NCT01738503|76185587|FG005|NOT COMPLETED|Treatment Period||6||
60070195|NCT01738503|76185588|FG006|NOT COMPLETED|Treatment Period||8||
60070196|NCT01738503|76185582|FG000|STARTED|PET Imaging Sub-study||0||
60070197|NCT01738503|76185583|FG001|STARTED|PET Imaging Sub-study||0||
60070198|NCT01738503|76185584|FG002|STARTED|PET Imaging Sub-study||0||
60070199|NCT01738503|76185585|FG003|STARTED|PET Imaging Sub-study||0||
60070200|NCT01738503|76185586|FG004|STARTED|PET Imaging Sub-study||0||
60070201|NCT01738503|76185587|FG005|STARTED|PET Imaging Sub-study||3||
60070202|NCT01738503|76185588|FG006|STARTED|PET Imaging Sub-study||2||
59613544|NCT01565850|75724679|FG001|COMPLETED|Overall Study||42||
59613545|NCT01565850|75724678|FG000|NOT COMPLETED|Overall Study||20||
59613546|NCT01565850|75724679|FG001|NOT COMPLETED|Overall Study||8||
59613547|NCT01565694|75724685|FG000|STARTED|Dose-Titration Period||76||
60070203|NCT01738503|76185582|FG000|COMPLETED|PET Imaging Sub-study||0||
60070204|NCT01738503|76185583|FG001|COMPLETED|PET Imaging Sub-study||0||
60070205|NCT01738503|76185584|FG002|COMPLETED|PET Imaging Sub-study||0||
60070206|NCT01738503|76185585|FG003|COMPLETED|PET Imaging Sub-study||0||
60070207|NCT01738503|76185586|FG004|COMPLETED|PET Imaging Sub-study||0||
60070208|NCT01738503|76185587|FG005|COMPLETED|PET Imaging Sub-study|Completion defined as a total of 12 injections plus all PET images|1||
60070209|NCT01738503|76185588|FG006|COMPLETED|PET Imaging Sub-study|Completion defined as a total of 6 injections plus all PET images|1||
60070210|NCT01738503|76185582|FG000|NOT COMPLETED|PET Imaging Sub-study||0||
60070211|NCT01738503|76185583|FG001|NOT COMPLETED|PET Imaging Sub-study||0||
60070212|NCT01738503|76185584|FG002|NOT COMPLETED|PET Imaging Sub-study||0||
59519298|NCT02574078|75613246|FG009|COMPLETED|Pre-Treatment Period||26|Finished = Treated|
59519299|NCT02574078|75613247|FG010|COMPLETED|Pre-Treatment Period||49|Finished = Treated|
59951677|NCT00872430|76070682|FG000|COMPLETED|Washout Period||10||
59951678|NCT00872430|76070683|FG001|COMPLETED|Washout Period||10||
59951679|NCT00872430|76070682|FG000|NOT COMPLETED|Washout Period||0||
59951680|NCT00872430|76070683|FG001|NOT COMPLETED|Washout Period||0||
59951681|NCT00872430|76070682|FG000|STARTED|Second Intervention||10||
59519300|NCT02574078|75613248|FG011|COMPLETED|Pre-Treatment Period||55|Finished = Treated|
59519301|NCT02574078|75613249|FG012|COMPLETED|Pre-Treatment Period||13|Finished = Treated|
59951682|NCT00872430|76070683|FG001|STARTED|Second Intervention||10||
59951683|NCT00872430|76070682|FG000|COMPLETED|Second Intervention||10||
59951684|NCT00872430|76070683|FG001|COMPLETED|Second Intervention||10||
59951685|NCT00872430|76070682|FG000|NOT COMPLETED|Second Intervention||0||
59951686|NCT00872430|76070683|FG001|NOT COMPLETED|Second Intervention||0||
59951687|NCT02734862|76070690|FG000|STARTED|Part A||35|"The Intent-to-Treat (ITT) population analyzed consisted of all subjects randomized to treatment. Subjects were analyzed based on the treatment group to which they were randomized.~In Part A, subjects were randomized in a 1:1:1 ratio to receive rezafungin treatment Group 1, rezafungin Treatment Group 2 (defined below), or IV caspofungin Group 3. Enrollment into Part A closed and Part B began."|
59951688|NCT02734862|76070691|FG001|STARTED|Part A||36|"The Intent-to-Treat (ITT) population analyzed consisted of all subjects randomized to treatment. Subjects were analyzed based on the treatment group to which they were randomized.~In Part A, subjects were randomized in a 1:1:1 ratio to receive rezafungin treatment Group 1, rezafungin Treatment Group 2 (defined below), or IV caspofungin Group 3. Enrollment into Part A closed and Part B began."|
59951689|NCT02734862|76070692|FG002|STARTED|Part A||36|"The Intent-to-Treat (ITT) population analyzed consisted of all subjects randomized to treatment. Subjects were analyzed based on the treatment group to which they were randomized.~In Part A, subjects were randomized in a 1:1:1 ratio to receive rezafungin treatment Group 1, rezafungin Treatment Group 2 (defined below), or IV caspofungin Group 3. Enrollment into Part A closed and Part B began."|
59951690|NCT02734862|76070690|FG000|COMPLETED|Part A||23||
59951691|NCT02734862|76070691|FG001|COMPLETED|Part A||28||
59951692|NCT02734862|76070692|FG002|COMPLETED|Part A||22||
59519302|NCT02574078|75613237|FG000|NOT COMPLETED|Pre-Treatment Period||0||
59519303|NCT02574078|75613238|FG001|NOT COMPLETED|Pre-Treatment Period||0||
59519304|NCT02574078|75613239|FG002|NOT COMPLETED|Pre-Treatment Period||0||
59519305|NCT02574078|75613240|FG003|NOT COMPLETED|Pre-Treatment Period||0||
59519306|NCT02574078|75613241|FG004|NOT COMPLETED|Pre-Treatment Period||0||
59519307|NCT02574078|75613242|FG005|NOT COMPLETED|Pre-Treatment Period||1||
59519308|NCT02574078|75613243|FG006|NOT COMPLETED|Pre-Treatment Period||4||
59519309|NCT02574078|75613244|FG007|NOT COMPLETED|Pre-Treatment Period||3||
59519310|NCT02574078|75613245|FG008|NOT COMPLETED|Pre-Treatment Period||1||
59519311|NCT02574078|75613246|FG009|NOT COMPLETED|Pre-Treatment Period||0||
59519312|NCT02574078|75613247|FG010|NOT COMPLETED|Pre-Treatment Period||4||
59519313|NCT02574078|75613248|FG011|NOT COMPLETED|Pre-Treatment Period||1||
59519314|NCT02574078|75613249|FG012|NOT COMPLETED|Pre-Treatment Period||0||
60070213|NCT01738503|76185585|FG003|NOT COMPLETED|PET Imaging Sub-study||0||
60070214|NCT01738503|76185586|FG004|NOT COMPLETED|PET Imaging Sub-study||0||
60070215|NCT01738503|76185587|FG005|NOT COMPLETED|PET Imaging Sub-study||2||
60070216|NCT01738503|76185588|FG006|NOT COMPLETED|PET Imaging Sub-study||1||
60070217|NCT01738191|76185612|FG000|STARTED|Overall Study||15||
60070218|NCT01738191|76185613|FG001|STARTED|Overall Study||15||
60070219|NCT01738191|76185612|FG000|COMPLETED|Overall Study||11||
60070220|NCT01738191|76185613|FG001|COMPLETED|Overall Study||14||
60070221|NCT01738191|76185612|FG000|NOT COMPLETED|Overall Study||4||
60070222|NCT01738191|76185613|FG001|NOT COMPLETED|Overall Study||1||
60070223|NCT01737879|76185619|FG000|STARTED|Overall Study||41||
60070224|NCT01737879|76185619|FG000|Received Peginesatide|Overall Study||34||
60070225|NCT01737879|76185619|FG000|Transitioned to Epoetin Alfa|Overall Study||0||
60070226|NCT01737879|76185619|FG000|COMPLETED|Overall Study||0||
60070227|NCT01737879|76185619|FG000|NOT COMPLETED|Overall Study||41||
60070228|NCT01879683|76185623|FG000|STARTED|Overall Study||10||
60070229|NCT01879683|76185623|FG000|COMPLETED|Overall Study||9||
60070230|NCT01879683|76185623|FG000|NOT COMPLETED|Overall Study||1||
60070231|NCT01605825|76185629|FG000|STARTED|Overall Study||55||
60070232|NCT01605825|76185630|FG001|STARTED|Overall Study||28||
60070233|NCT01605825|76185629|FG000|COMPLETED|Overall Study||45||
60070234|NCT01605825|76185630|FG001|COMPLETED|Overall Study||25||
60070235|NCT01605825|76185629|FG000|NOT COMPLETED|Overall Study||10||
60070236|NCT01605825|76185630|FG001|NOT COMPLETED|Overall Study||3||
60070237|NCT01727505|76185636|FG000|STARTED|First 24 Hours||14||
60070238|NCT01727505|76185637|FG001|STARTED|First 24 Hours||12||
60070239|NCT01727505|76185636|FG000|COMPLETED|First 24 Hours||14||
60070240|NCT01727505|76185637|FG001|COMPLETED|First 24 Hours||11||
60070241|NCT01727505|76185636|FG000|NOT COMPLETED|First 24 Hours||0||
60070242|NCT01727505|76185637|FG001|NOT COMPLETED|First 24 Hours||1||
60070243|NCT01727505|76185636|FG000|STARTED|Second 24 Hours||14||
60070244|NCT01727505|76185637|FG001|STARTED|Second 24 Hours||11||
60070245|NCT01727505|76185636|FG000|COMPLETED|Second 24 Hours||14||
60070246|NCT01727505|76185637|FG001|COMPLETED|Second 24 Hours||10||
60070247|NCT01727505|76185636|FG000|NOT COMPLETED|Second 24 Hours||0||
60070248|NCT01727505|76185637|FG001|NOT COMPLETED|Second 24 Hours||1||
60070249|NCT01726803|76185645|FG000|STARTED|Overall Study||112||
60070250|NCT01726803|76185646|FG001|STARTED|Overall Study||108||
60070251|NCT01726803|76185645|FG000|COMPLETED|Overall Study||105||
60070252|NCT01726803|76185646|FG001|COMPLETED|Overall Study||107||
60070253|NCT01726803|76185645|FG000|NOT COMPLETED|Overall Study||7||
60070254|NCT01726803|76185646|FG001|NOT COMPLETED|Overall Study||1||
60070255|NCT01726335|76185652|FG000|STARTED|Overall Study||53||
60070256|NCT01726335|76185652|FG000|COMPLETED|Overall Study||29||
60070257|NCT01726335|76185652|FG000|NOT COMPLETED|Overall Study||24||
60070258|NCT01877421|76185688|FG000|STARTED|Phase 1||2||
60070259|NCT01877421|76185689|FG001|STARTED|Phase 1||1||
60070260|NCT01877421|76185690|FG002|STARTED|Phase 1||4||
60070261|NCT01877421|76185691|FG003|STARTED|Phase 1||2||
60070262|NCT01877421|76185692|FG004|STARTED|Phase 1||4||
60070263|NCT01877421|76185693|FG005|STARTED|Phase 1||2||
60070264|NCT01877421|76185694|FG006|STARTED|Phase 1||4||
60070265|NCT01877421|76185695|FG007|STARTED|Phase 1||2||
60070266|NCT01877421|76185696|FG008|STARTED|Phase 1||7||
60070267|NCT01877421|76185697|FG009|STARTED|Phase 1||3||
60070268|NCT01877421|76185698|FG010|STARTED|Phase 1||7||
60070269|NCT01877421|76185699|FG011|STARTED|Phase 1||3||
60070270|NCT01877421|76185700|FG012|STARTED|Phase 1||7||
60070271|NCT01877421|76185701|FG013|STARTED|Phase 1||3||
60070272|NCT01877421|76185702|FG014|STARTED|Phase 1||7||
60070273|NCT01877421|76185703|FG015|STARTED|Phase 1||3||
60070274|NCT01877421|76185704|FG016|STARTED|Phase 1||7||
60070275|NCT01877421|76185705|FG017|STARTED|Phase 1||3||
60070276|NCT01877421|76185688|FG000|COMPLETED|Phase 1||2||
59519315|NCT02574078|75613237|FG000|STARTED|Treatment Period||13|Started = Treated|
60070277|NCT01877421|76185689|FG001|COMPLETED|Phase 1||1||
60070278|NCT01877421|76185690|FG002|COMPLETED|Phase 1||4||
60070279|NCT01877421|76185691|FG003|COMPLETED|Phase 1||2||
60070280|NCT01877421|76185692|FG004|COMPLETED|Phase 1||4||
60070281|NCT01877421|76185693|FG005|COMPLETED|Phase 1||2||
60070282|NCT01877421|76185694|FG006|COMPLETED|Phase 1||4||
60070283|NCT01877421|76185695|FG007|COMPLETED|Phase 1||2||
60070284|NCT01877421|76185696|FG008|COMPLETED|Phase 1||7||
60070285|NCT01877421|76185697|FG009|COMPLETED|Phase 1||3||
60070286|NCT01877421|76185698|FG010|COMPLETED|Phase 1||7||
60070287|NCT01877421|76185699|FG011|COMPLETED|Phase 1||3||
60070288|NCT01877421|76185700|FG012|COMPLETED|Phase 1||7||
60070289|NCT01877421|76185701|FG013|COMPLETED|Phase 1||3||
60070290|NCT01877421|76185702|FG014|COMPLETED|Phase 1||7||
60070291|NCT01877421|76185703|FG015|COMPLETED|Phase 1||3||
60070292|NCT01877421|76185704|FG016|COMPLETED|Phase 1||7||
60070293|NCT01877421|76185705|FG017|COMPLETED|Phase 1||3||
60070294|NCT01877421|76185688|FG000|NOT COMPLETED|Phase 1||0||
60070295|NCT01877421|76185689|FG001|NOT COMPLETED|Phase 1||0||
60070296|NCT01877421|76185690|FG002|NOT COMPLETED|Phase 1||0||
60070297|NCT01877421|76185691|FG003|NOT COMPLETED|Phase 1||0||
60070298|NCT01877421|76185692|FG004|NOT COMPLETED|Phase 1||0||
60070299|NCT01877421|76185693|FG005|NOT COMPLETED|Phase 1||0||
60070300|NCT01877421|76185694|FG006|NOT COMPLETED|Phase 1||0||
60070301|NCT01877421|76185695|FG007|NOT COMPLETED|Phase 1||0||
60070302|NCT01877421|76185696|FG008|NOT COMPLETED|Phase 1||0||
60070303|NCT01877421|76185697|FG009|NOT COMPLETED|Phase 1||0||
60070304|NCT01877421|76185698|FG010|NOT COMPLETED|Phase 1||0||
60070305|NCT01877421|76185699|FG011|NOT COMPLETED|Phase 1||0||
60070306|NCT01877421|76185700|FG012|NOT COMPLETED|Phase 1||0||
60070307|NCT01877421|76185701|FG013|NOT COMPLETED|Phase 1||0||
60070308|NCT01877421|76185702|FG014|NOT COMPLETED|Phase 1||0||
60070309|NCT01877421|76185703|FG015|NOT COMPLETED|Phase 1||0||
60070310|NCT01877421|76185704|FG016|NOT COMPLETED|Phase 1||0||
60070311|NCT01877421|76185705|FG017|NOT COMPLETED|Phase 1||0||
60070312|NCT01877421|76185688|FG000|STARTED|Phase 2||0||
60070313|NCT01877421|76185689|FG001|STARTED|Phase 2||0||
60070314|NCT01877421|76185690|FG002|STARTED|Phase 2||4||
60070315|NCT01877421|76185691|FG003|STARTED|Phase 2||2||
60070316|NCT01877421|76185692|FG004|STARTED|Phase 2||7||
60070317|NCT01877421|76185693|FG005|STARTED|Phase 2||3||
60070318|NCT01877421|76185694|FG006|STARTED|Phase 2||7||
60070319|NCT01877421|76185695|FG007|STARTED|Phase 2||2||
60070320|NCT01877421|76185696|FG008|STARTED|Phase 2||6||
60070321|NCT01877421|76185697|FG009|STARTED|Phase 2||3||
60070322|NCT01877421|76185698|FG010|STARTED|Phase 2||7||
60070323|NCT01877421|76185699|FG011|STARTED|Phase 2||3||
60070324|NCT01877421|76185700|FG012|STARTED|Phase 2||7||
60070325|NCT01877421|76185701|FG013|STARTED|Phase 2||3||
60070326|NCT01877421|76185702|FG014|STARTED|Phase 2||7||
60070327|NCT01877421|76185703|FG015|STARTED|Phase 2||3||
60070328|NCT01877421|76185704|FG016|STARTED|Phase 2||0||
60070329|NCT01877421|76185705|FG017|STARTED|Phase 2||0||
60070330|NCT01877421|76185688|FG000|COMPLETED|Phase 2||0||
60070331|NCT01877421|76185689|FG001|COMPLETED|Phase 2||0||
60070332|NCT01877421|76185690|FG002|COMPLETED|Phase 2||4||
60070333|NCT01877421|76185691|FG003|COMPLETED|Phase 2||2||
60070334|NCT01877421|76185692|FG004|COMPLETED|Phase 2||7||
60070335|NCT01877421|76185693|FG005|COMPLETED|Phase 2||3||
60070336|NCT01877421|76185694|FG006|COMPLETED|Phase 2||6||
60070337|NCT01877421|76185695|FG007|COMPLETED|Phase 2||2||
60070338|NCT01877421|76185696|FG008|COMPLETED|Phase 2||5||
60070339|NCT01877421|76185697|FG009|COMPLETED|Phase 2||3||
60070340|NCT01877421|76185698|FG010|COMPLETED|Phase 2||5||
60070341|NCT01877421|76185699|FG011|COMPLETED|Phase 2||3||
60070342|NCT01877421|76185700|FG012|COMPLETED|Phase 2||6||
60070343|NCT01877421|76185701|FG013|COMPLETED|Phase 2||3||
60070344|NCT01877421|76185702|FG014|COMPLETED|Phase 2||7||
60070345|NCT01877421|76185703|FG015|COMPLETED|Phase 2||2||
60070346|NCT01877421|76185704|FG016|COMPLETED|Phase 2||0||
60070347|NCT01877421|76185705|FG017|COMPLETED|Phase 2||0||
60070348|NCT01877421|76185688|FG000|NOT COMPLETED|Phase 2||0||
60070349|NCT01877421|76185689|FG001|NOT COMPLETED|Phase 2||0||
60070350|NCT01877421|76185690|FG002|NOT COMPLETED|Phase 2||0||
60070351|NCT01877421|76185691|FG003|NOT COMPLETED|Phase 2||0||
60070352|NCT01877421|76185692|FG004|NOT COMPLETED|Phase 2||0||
60070353|NCT01877421|76185693|FG005|NOT COMPLETED|Phase 2||0||
60070354|NCT01877421|76185694|FG006|NOT COMPLETED|Phase 2||1||
60070355|NCT01877421|76185695|FG007|NOT COMPLETED|Phase 2||0||
60070356|NCT01877421|76185696|FG008|NOT COMPLETED|Phase 2||1||
60070357|NCT01877421|76185697|FG009|NOT COMPLETED|Phase 2||0||
60070358|NCT01877421|76185698|FG010|NOT COMPLETED|Phase 2||2||
60070359|NCT01877421|76185699|FG011|NOT COMPLETED|Phase 2||0||
60070360|NCT01877421|76185700|FG012|NOT COMPLETED|Phase 2||1||
60070361|NCT01877421|76185701|FG013|NOT COMPLETED|Phase 2||0||
60070362|NCT01877421|76185702|FG014|NOT COMPLETED|Phase 2||0||
60070363|NCT01877421|76185703|FG015|NOT COMPLETED|Phase 2||1||
60070364|NCT01877421|76185704|FG016|NOT COMPLETED|Phase 2||0||
60070365|NCT01877421|76185705|FG017|NOT COMPLETED|Phase 2||0||
60070366|NCT01726023|76185787|FG000|STARTED|Overall Study||219||
60070367|NCT01726023|76185788|FG001|STARTED|Overall Study||222||
60070368|NCT01726023|76185787|FG000|COMPLETED|Overall Study||190||
60070369|NCT01726023|76185788|FG001|COMPLETED|Overall Study||196||
60070370|NCT01726023|76185787|FG000|NOT COMPLETED|Overall Study||29||
60070371|NCT01726023|76185788|FG001|NOT COMPLETED|Overall Study||26||
60070372|NCT01877265|76185801|FG000|STARTED|Treatment Period 1||3||
60070373|NCT01877265|76185802|FG001|STARTED|Treatment Period 1||3||
60070374|NCT01877265|76185803|FG002|STARTED|Treatment Period 1||3||
60070375|NCT01877265|76185804|FG003|STARTED|Treatment Period 1||3||
60070376|NCT01877265|76185805|FG004|STARTED|Treatment Period 1||3||
60070377|NCT01877265|76185806|FG005|STARTED|Treatment Period 1||3||
60070378|NCT01877265|76185801|FG000|Received at Least One Dose of Study Drug|Treatment Period 1||3||
60070379|NCT01877265|76185802|FG001|Received at Least One Dose of Study Drug|Treatment Period 1||3||
60070380|NCT01877265|76185803|FG002|Received at Least One Dose of Study Drug|Treatment Period 1||3||
60070381|NCT01877265|76185804|FG003|Received at Least One Dose of Study Drug|Treatment Period 1||3||
60070382|NCT01877265|76185805|FG004|Received at Least One Dose of Study Drug|Treatment Period 1||3||
60070383|NCT01877265|76185806|FG005|Received at Least One Dose of Study Drug|Treatment Period 1||3||
60070384|NCT01877265|76185801|FG000|COMPLETED|Treatment Period 1||3||
60070385|NCT01877265|76185802|FG001|COMPLETED|Treatment Period 1||3||
60070386|NCT01877265|76185803|FG002|COMPLETED|Treatment Period 1||2||
60070387|NCT01877265|76185804|FG003|COMPLETED|Treatment Period 1||3||
60070388|NCT01877265|76185805|FG004|COMPLETED|Treatment Period 1||3||
60070389|NCT01877265|76185806|FG005|COMPLETED|Treatment Period 1||3||
60070390|NCT01877265|76185801|FG000|NOT COMPLETED|Treatment Period 1||0||
60070391|NCT01877265|76185802|FG001|NOT COMPLETED|Treatment Period 1||0||
60070392|NCT01877265|76185803|FG002|NOT COMPLETED|Treatment Period 1||1||
60070393|NCT01877265|76185804|FG003|NOT COMPLETED|Treatment Period 1||0||
60070394|NCT01877265|76185805|FG004|NOT COMPLETED|Treatment Period 1||0||
60070395|NCT01877265|76185806|FG005|NOT COMPLETED|Treatment Period 1||0||
60070396|NCT01877265|76185801|FG000|STARTED|Washout Period 1 (at Least 14 Days)||3||
60070397|NCT01877265|76185802|FG001|STARTED|Washout Period 1 (at Least 14 Days)||3||
60070398|NCT01877265|76185803|FG002|STARTED|Washout Period 1 (at Least 14 Days)||2||
60070399|NCT01877265|76185804|FG003|STARTED|Washout Period 1 (at Least 14 Days)||3||
60070400|NCT01877265|76185805|FG004|STARTED|Washout Period 1 (at Least 14 Days)||3||
60070401|NCT01877265|76185806|FG005|STARTED|Washout Period 1 (at Least 14 Days)||3||
60070402|NCT01877265|76185801|FG000|COMPLETED|Washout Period 1 (at Least 14 Days)||3||
60070403|NCT01877265|76185802|FG001|COMPLETED|Washout Period 1 (at Least 14 Days)||3||
60070404|NCT01877265|76185803|FG002|COMPLETED|Washout Period 1 (at Least 14 Days)||2||
60070405|NCT01877265|76185804|FG003|COMPLETED|Washout Period 1 (at Least 14 Days)||3||
60070406|NCT01877265|76185805|FG004|COMPLETED|Washout Period 1 (at Least 14 Days)||3||
60070407|NCT01877265|76185806|FG005|COMPLETED|Washout Period 1 (at Least 14 Days)||3||
60070408|NCT01877265|76185801|FG000|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0||
60070409|NCT01877265|76185802|FG001|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0||
60070410|NCT01877265|76185803|FG002|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0||
60070411|NCT01877265|76185804|FG003|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0||
60070412|NCT01877265|76185805|FG004|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0||
60070413|NCT01877265|76185806|FG005|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0||
60070414|NCT01877265|76185801|FG000|STARTED|Treatment Period 2||3||
60070415|NCT01877265|76185802|FG001|STARTED|Treatment Period 2||3||
60070416|NCT01877265|76185803|FG002|STARTED|Treatment Period 2||2||
60070417|NCT01877265|76185804|FG003|STARTED|Treatment Period 2||3||
60070418|NCT01877265|76185805|FG004|STARTED|Treatment Period 2||3||
60070419|NCT01877265|76185806|FG005|STARTED|Treatment Period 2||3||
60070420|NCT01877265|76185801|FG000|Received at Least One Dose of Study Drug|Treatment Period 2||3||
60070421|NCT01877265|76185802|FG001|Received at Least One Dose of Study Drug|Treatment Period 2||3||
60070422|NCT01877265|76185803|FG002|Received at Least One Dose of Study Drug|Treatment Period 2||2||
60070423|NCT01877265|76185804|FG003|Received at Least One Dose of Study Drug|Treatment Period 2||3||
60070424|NCT01877265|76185805|FG004|Received at Least One Dose of Study Drug|Treatment Period 2||3||
60070425|NCT01877265|76185806|FG005|Received at Least One Dose of Study Drug|Treatment Period 2||3||
60070426|NCT01877265|76185801|FG000|COMPLETED|Treatment Period 2||3||
60070427|NCT01877265|76185802|FG001|COMPLETED|Treatment Period 2||3||
60070428|NCT01877265|76185803|FG002|COMPLETED|Treatment Period 2||2||
60070429|NCT01877265|76185804|FG003|COMPLETED|Treatment Period 2||3||
60070430|NCT01877265|76185805|FG004|COMPLETED|Treatment Period 2||3||
60070431|NCT01877265|76185806|FG005|COMPLETED|Treatment Period 2||3||
60070432|NCT01877265|76185801|FG000|NOT COMPLETED|Treatment Period 2||0||
60070433|NCT01877265|76185802|FG001|NOT COMPLETED|Treatment Period 2||0||
60070434|NCT01877265|76185803|FG002|NOT COMPLETED|Treatment Period 2||0||
60070435|NCT01877265|76185804|FG003|NOT COMPLETED|Treatment Period 2||0||
60070436|NCT01877265|76185805|FG004|NOT COMPLETED|Treatment Period 2||0||
60070437|NCT01877265|76185806|FG005|NOT COMPLETED|Treatment Period 2||0||
60070438|NCT01877265|76185801|FG000|STARTED|Washout Period 2 (at Least 14 Days)||3||
60070439|NCT01877265|76185802|FG001|STARTED|Washout Period 2 (at Least 14 Days)||3||
60070440|NCT01877265|76185803|FG002|STARTED|Washout Period 2 (at Least 14 Days)||2||
60070441|NCT01877265|76185804|FG003|STARTED|Washout Period 2 (at Least 14 Days)||3||
60070442|NCT01877265|76185805|FG004|STARTED|Washout Period 2 (at Least 14 Days)||3||
60070443|NCT01877265|76185806|FG005|STARTED|Washout Period 2 (at Least 14 Days)||3||
60070444|NCT01877265|76185801|FG000|COMPLETED|Washout Period 2 (at Least 14 Days)||3||
60070445|NCT01877265|76185802|FG001|COMPLETED|Washout Period 2 (at Least 14 Days)||3||
60070446|NCT01877265|76185803|FG002|COMPLETED|Washout Period 2 (at Least 14 Days)||2||
60070447|NCT01877265|76185804|FG003|COMPLETED|Washout Period 2 (at Least 14 Days)||3||
60070448|NCT01877265|76185805|FG004|COMPLETED|Washout Period 2 (at Least 14 Days)||3||
60070449|NCT01877265|76185806|FG005|COMPLETED|Washout Period 2 (at Least 14 Days)||2||
60070450|NCT01877265|76185801|FG000|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||0||
60070451|NCT01877265|76185802|FG001|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||0||
60070452|NCT01877265|76185803|FG002|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||0||
60070453|NCT01877265|76185804|FG003|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||0||
60070454|NCT01877265|76185805|FG004|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||0||
60070455|NCT01877265|76185806|FG005|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||1||
60070456|NCT01877265|76185801|FG000|STARTED|Treatment Period 3||3||
60070457|NCT01877265|76185802|FG001|STARTED|Treatment Period 3||3||
60070458|NCT01877265|76185803|FG002|STARTED|Treatment Period 3||2||
60070459|NCT01877265|76185804|FG003|STARTED|Treatment Period 3||3||
60070460|NCT01877265|76185805|FG004|STARTED|Treatment Period 3||3||
60070461|NCT01877265|76185806|FG005|STARTED|Treatment Period 3||2||
60070462|NCT01877265|76185801|FG000|Received at Least One Dose of Study Drug|Treatment Period 3||3||
60070463|NCT01877265|76185802|FG001|Received at Least One Dose of Study Drug|Treatment Period 3||3||
60070464|NCT01877265|76185803|FG002|Received at Least One Dose of Study Drug|Treatment Period 3||2||
60070465|NCT01877265|76185804|FG003|Received at Least One Dose of Study Drug|Treatment Period 3||3||
60070466|NCT01877265|76185805|FG004|Received at Least One Dose of Study Drug|Treatment Period 3||3||
60070467|NCT01877265|76185806|FG005|Received at Least One Dose of Study Drug|Treatment Period 3||2||
60070468|NCT01877265|76185801|FG000|COMPLETED|Treatment Period 3||2||
60070469|NCT01877265|76185802|FG001|COMPLETED|Treatment Period 3||3||
60070470|NCT01877265|76185803|FG002|COMPLETED|Treatment Period 3||2||
60070471|NCT01877265|76185804|FG003|COMPLETED|Treatment Period 3||3||
60070472|NCT01877265|76185805|FG004|COMPLETED|Treatment Period 3||3||
60070473|NCT01877265|76185806|FG005|COMPLETED|Treatment Period 3||2||
60070474|NCT01877265|76185801|FG000|NOT COMPLETED|Treatment Period 3||1||
60070475|NCT01877265|76185802|FG001|NOT COMPLETED|Treatment Period 3||0||
60070476|NCT01877265|76185803|FG002|NOT COMPLETED|Treatment Period 3||0||
60070477|NCT01877265|76185804|FG003|NOT COMPLETED|Treatment Period 3||0||
60070478|NCT01877265|76185805|FG004|NOT COMPLETED|Treatment Period 3||0||
60070479|NCT01877265|76185806|FG005|NOT COMPLETED|Treatment Period 3||0||
60070480|NCT01877187|76185817|FG000|STARTED|Overall Study|21 HCC, 18 non-HCC|39||
60070481|NCT01877187|76185817|FG000|Completed 30 Day f/u|Overall Study|18 HCC, 17 non-HCC|35||
60070482|NCT01877187|76185817|FG000|Completed 90 Day f/u|Overall Study|11 HCC, 9 non-HCC|20||
60070483|NCT01877187|76185817|FG000|COMPLETED|Overall Study|10 HCC, 7 non-HCC|17|Completed 180 day f/u|
60070484|NCT01877187|76185817|FG000|NOT COMPLETED|Overall Study||22||
60070485|NCT01858532|76185828|FG000|STARTED|Overall Study||1325||
60070486|NCT01858532|76185829|FG001|STARTED|Overall Study||1323||
60070487|NCT01858532|76185830|FG002|STARTED|Overall Study||509||
60070488|NCT01858532|76185831|FG003|STARTED|Overall Study||511||
60070489|NCT01858532|76185828|FG000|COMPLETED|Overall Study||1144||
60070490|NCT01858532|76185829|FG001|COMPLETED|Overall Study||1131||
60070491|NCT01858532|76185830|FG002|COMPLETED|Overall Study||411||
60070492|NCT01858532|76185831|FG003|COMPLETED|Overall Study||418||
60070493|NCT01858532|76185828|FG000|NOT COMPLETED|Overall Study||181||
60070494|NCT01858532|76185829|FG001|NOT COMPLETED|Overall Study||192||
60070495|NCT01858532|76185830|FG002|NOT COMPLETED|Overall Study||98||
60070496|NCT01858532|76185831|FG003|NOT COMPLETED|Overall Study||93||
60070497|NCT01883492|76185843|FG000|STARTED|Overall Study||75||
60070498|NCT01883492|76185844|FG001|STARTED|Overall Study||78||
60070499|NCT01883492|76185843|FG000|COMPLETED|Overall Study||62||
60070500|NCT01883492|76185844|FG001|COMPLETED|Overall Study||67||
60070501|NCT01883492|76185843|FG000|NOT COMPLETED|Overall Study||13||
60070502|NCT01883492|76185844|FG001|NOT COMPLETED|Overall Study||11||
60070503|NCT01832480|76185852|FG000|STARTED|Overall Study||311||
60070504|NCT01832480|76185853|FG001|STARTED|Overall Study||312||
60070505|NCT01832480|76185852|FG000|COMPLETED|Overall Study||270||
60070506|NCT01832480|76185853|FG001|COMPLETED|Overall Study||270||
60070507|NCT01832480|76185852|FG000|NOT COMPLETED|Overall Study||41||
60070508|NCT01832480|76185853|FG001|NOT COMPLETED|Overall Study||42||
60070509|NCT01858376|76185859|FG000|STARTED|Overall Study||24||
60070510|NCT01858376|76185859|FG000|COMPLETED|Overall Study||20||
60070511|NCT01858376|76185859|FG000|NOT COMPLETED|Overall Study||4||
60070512|NCT01831856|76185865|FG000|STARTED|Overall Study||67||
60070513|NCT01831856|76185866|FG001|STARTED|Overall Study||67||
60070514|NCT01831856|76185865|FG000|COMPLETED|Overall Study||33||
60070515|NCT01831856|76185866|FG001|COMPLETED|Overall Study||30||
60070516|NCT01831856|76185865|FG000|NOT COMPLETED|Overall Study||34||
60070517|NCT01831856|76185866|FG001|NOT COMPLETED|Overall Study||37||
60070518|NCT01831544|76185872|FG000|STARTED|Overall Study||11||
60070519|NCT01831544|76185872|FG000|COMPLETED|Overall Study||8||
60070520|NCT01831544|76185872|FG000|NOT COMPLETED|Overall Study||3||
60070521|NCT01857206|76185878|FG000|STARTED|Overall Study||1372||
60070522|NCT01857206|76185879|FG001|STARTED|Overall Study||683||
60070523|NCT01857206|76185878|FG000|COMPLETED|Overall Study||1359||
60070524|NCT01857206|76185879|FG001|COMPLETED|Overall Study||673||
60070525|NCT01857206|76185878|FG000|NOT COMPLETED|Overall Study||13||
60070526|NCT01857206|76185879|FG001|NOT COMPLETED|Overall Study||10||
60070527|NCT01882088|76185889|FG000|STARTED|Overall Study|35 patients were provided with psyllium in 5.0 sachets, 3 sachets per day for 10 days|35||
60070528|NCT01882088|76185889|FG000|COMPLETED|Overall Study||30||
60070529|NCT01882088|76185889|FG000|NOT COMPLETED|Overall Study||5||
60070530|NCT01881776|76185896|FG000|STARTED|Overall Study||24||
60070531|NCT01881776|76185897|FG001|STARTED|Overall Study||24||
60070532|NCT01881776|76185898|FG002|STARTED|Overall Study||22||
60070533|NCT01881776|76185896|FG000|COMPLETED|Overall Study||23||
60070534|NCT01881776|76185897|FG001|COMPLETED|Overall Study||20||
60070535|NCT01881776|76185898|FG002|COMPLETED|Overall Study||20||
60070536|NCT01881776|76185896|FG000|NOT COMPLETED|Overall Study||1||
60070537|NCT01881776|76185897|FG001|NOT COMPLETED|Overall Study||4||
60070538|NCT01881776|76185898|FG002|NOT COMPLETED|Overall Study||2||
60070539|NCT01708161|76185912|FG000|STARTED|Overall Study||4||
60070540|NCT01708161|76185913|FG001|STARTED|Overall Study||10||
60070541|NCT01708161|76185914|FG002|STARTED|Overall Study||10||
60070542|NCT01708161|76185915|FG003|STARTED|Overall Study||16||
60070543|NCT01708161|76185916|FG004|STARTED|Overall Study||6||
60070544|NCT01708161|76185917|FG005|STARTED|Overall Study||1||
60070545|NCT01708161|76185912|FG000|COMPLETED|Overall Study||0||
60070546|NCT01708161|76185913|FG001|COMPLETED|Overall Study||0||
60070547|NCT01708161|76185914|FG002|COMPLETED|Overall Study||0||
60070548|NCT01708161|76185915|FG003|COMPLETED|Overall Study||0||
60070549|NCT01708161|76185916|FG004|COMPLETED|Overall Study||0||
60070550|NCT01708161|76185917|FG005|COMPLETED|Overall Study||0||
60070551|NCT01708161|76185912|FG000|NOT COMPLETED|Overall Study||4||
60070552|NCT01708161|76185913|FG001|NOT COMPLETED|Overall Study||10||
60070553|NCT01708161|76185914|FG002|NOT COMPLETED|Overall Study||10||
60070554|NCT01708161|76185915|FG003|NOT COMPLETED|Overall Study||16||
60070555|NCT01708161|76185916|FG004|NOT COMPLETED|Overall Study||6||
60070556|NCT01708161|76185917|FG005|NOT COMPLETED|Overall Study||1||
60070557|NCT01707693|76185933|FG000|STARTED|Overall Study Allocation||59|Allocated to Intervention and Control Arms Time 1 measures|
60070558|NCT01707693|76185934|FG001|STARTED|Overall Study Allocation||62|Allocated to Intervention and Control Arms Time 1 measures|
60070559|NCT01707693|76185933|FG000|COMPLETED|Overall Study Allocation||46|Participants that completed both Time 1 (baseline) and Time 2 Measures (3 month)|
60070560|NCT01707693|76185934|FG001|COMPLETED|Overall Study Allocation||54|Participants that completed both Time 1 (baseline) and Time 2 Measures (3 month)|
60070561|NCT01707693|76185933|FG000|NOT COMPLETED|Overall Study Allocation||13||
60070562|NCT01707693|76185934|FG001|NOT COMPLETED|Overall Study Allocation||8||
60070563|NCT01707693|76185933|FG000|STARTED|Time 3 Measures @ 6 Mth||46||
60070564|NCT01707693|76185934|FG001|STARTED|Time 3 Measures @ 6 Mth||54||
60070565|NCT01707693|76185933|FG000|COMPLETED|Time 3 Measures @ 6 Mth||46||
60070566|NCT01707693|76185934|FG001|COMPLETED|Time 3 Measures @ 6 Mth||49||
60070567|NCT01707693|76185933|FG000|NOT COMPLETED|Time 3 Measures @ 6 Mth||0||
60070568|NCT01707693|76185934|FG001|NOT COMPLETED|Time 3 Measures @ 6 Mth||5||
60070569|NCT01722669|76185947|FG000|STARTED|Overall Study||5||
60070570|NCT01722669|76185948|FG001|STARTED|Overall Study||5||
60070571|NCT01722669|76185949|FG002|STARTED|Overall Study||5||
60070572|NCT01722669|76185950|FG003|STARTED|Overall Study||5||
60070573|NCT01722669|76185951|FG004|STARTED|Overall Study||10||
60070574|NCT01722669|76185952|FG005|STARTED|Overall Study|Antiphospholipid Antibody (ARM D): 6 evaluable and 2 withdrew consent without any data collected|8||
60070575|NCT01722669|76185947|FG000|COMPLETED|Overall Study||5||
60070576|NCT01722669|76185948|FG001|COMPLETED|Overall Study||5||
60070577|NCT01722669|76185949|FG002|COMPLETED|Overall Study||5||
60070578|NCT01722669|76185950|FG003|COMPLETED|Overall Study||5||
60070579|NCT01722669|76185951|FG004|COMPLETED|Overall Study||10||
60070580|NCT01722669|76185952|FG005|COMPLETED|Overall Study||6||
60070581|NCT01722669|76185947|FG000|NOT COMPLETED|Overall Study||0||
60070582|NCT01722669|76185948|FG001|NOT COMPLETED|Overall Study||0||
60070583|NCT01722669|76185949|FG002|NOT COMPLETED|Overall Study||0||
60070584|NCT01722669|76185950|FG003|NOT COMPLETED|Overall Study||0||
60070585|NCT01722669|76185951|FG004|NOT COMPLETED|Overall Study||0||
60070586|NCT01722669|76185952|FG005|NOT COMPLETED|Overall Study||2||
60070587|NCT01707147|76185972|FG000|STARTED|Overall Study||3219|Number of patients in case report form (CRF) collection|
60070588|NCT01707147|76185972|FG000|COMPLETED|Overall Study||3119|Number of patients in safety analysis set|
60070589|NCT01707147|76185972|FG000|NOT COMPLETED|Overall Study||100||
60070590|NCT01876251|76185979|FG000|STARTED|Overall Study||15||
60070591|NCT01876251|76185980|FG001|STARTED|Overall Study||3||
60070592|NCT01876251|76185981|FG002|STARTED|Overall Study||11||
60070593|NCT01876251|76185979|FG000|COMPLETED|Overall Study||0||
60070594|NCT01876251|76185980|FG001|COMPLETED|Overall Study||0||
60070595|NCT01876251|76185981|FG002|COMPLETED|Overall Study||0||
60070596|NCT01876251|76185979|FG000|NOT COMPLETED|Overall Study||15||
60070597|NCT01876251|76185980|FG001|NOT COMPLETED|Overall Study||3||
60070598|NCT01876251|76185981|FG002|NOT COMPLETED|Overall Study||11||
60070599|NCT01875471|76185992|FG000|STARTED|Overall Study||137||
60070600|NCT01875471|76185993|FG001|STARTED|Overall Study||138||
60070601|NCT01875471|76185992|FG000|Completed Per Protocol|Overall Study||127||
60070602|NCT01875471|76185993|FG001|Completed Per Protocol|Overall Study||123||
60070603|NCT01875471|76185992|FG000|COMPLETED|Overall Study||136||
60070604|NCT01875471|76185993|FG001|COMPLETED|Overall Study||137||
60070605|NCT01875471|76185992|FG000|NOT COMPLETED|Overall Study||1||
60070606|NCT01875471|76185993|FG001|NOT COMPLETED|Overall Study||1||
60070607|NCT01875237|76186001|FG000|STARTED|Overall Study||2||
60070608|NCT01875237|76186002|FG001|STARTED|Overall Study||1||
60070609|NCT01875237|76186001|FG000|COMPLETED|Overall Study||0||
60070610|NCT01875237|76186002|FG001|COMPLETED|Overall Study||1||
60070611|NCT01875237|76186001|FG000|NOT COMPLETED|Overall Study||2||
60070612|NCT01875237|76186002|FG001|NOT COMPLETED|Overall Study||0||
60070613|NCT01874535|76186012|FG000|STARTED|Overall Study||207||
60070614|NCT01874535|76186013|FG001|STARTED|Overall Study||201||
60070615|NCT01874535|76186012|FG000|COMPLETED|Overall Study||152||
60070616|NCT01874535|76186013|FG001|COMPLETED|Overall Study||157||
60070617|NCT01874535|76186012|FG000|NOT COMPLETED|Overall Study||55||
60070618|NCT01874535|76186013|FG001|NOT COMPLETED|Overall Study||44||
60070619|NCT01722045|76186019|FG000|STARTED|Overall Study||154||
60070620|NCT01722045|76186019|FG000|COMPLETED|Overall Study||126||
60070621|NCT01722045|76186019|FG000|NOT COMPLETED|Overall Study||28||
60070622|NCT01721109|76186023|FG000|STARTED|Overall Study||50||
60070623|NCT01721109|76186023|FG000|COMPLETED|Overall Study|34 participants transitioned to commercial Stribild or to an individual patient use (IPU) program|43||
60070624|NCT01721109|76186023|FG000|NOT COMPLETED|Overall Study||7||
60070625|NCT01874145|76186029|FG000|STARTED|Core Period||101||
60070626|NCT01874145|76186030|FG001|STARTED|Core Period||108||
60070627|NCT01874145|76186029|FG000|Full Analysis Set|Core Period||100||
60070628|NCT01874145|76186030|FG001|Full Analysis Set|Core Period||108||
60070629|NCT01874145|76186029|FG000|COMPLETED|Core Period||98||
60070630|NCT01874145|76186030|FG001|COMPLETED|Core Period||101||
60070631|NCT01874145|76186029|FG000|NOT COMPLETED|Core Period||3||
60070632|NCT01874145|76186030|FG001|NOT COMPLETED|Core Period||7||
60070633|NCT01874145|76186029|FG000|STARTED|Extension Period|Switchers|97||
60070634|NCT01874145|76186030|FG001|STARTED|Extension Period|Non-Switchers|101||
60070635|NCT01874145|76186029|FG000|Full Analysis Set|Extension Period||95||
60070636|NCT01874145|76186030|FG001|Full Analysis Set|Extension Period||101||
60070637|NCT01874145|76186029|FG000|COMPLETED|Extension Period||91||
60070638|NCT01874145|76186030|FG001|COMPLETED|Extension Period||97||
60070639|NCT01874145|76186029|FG000|NOT COMPLETED|Extension Period||6||
60070640|NCT01874145|76186030|FG001|NOT COMPLETED|Extension Period||4||
60070641|NCT01720797|76186042|FG000|STARTED|Overall Study||12||
60070642|NCT01720797|76186043|FG001|STARTED|Overall Study||9||
60070643|NCT01720797|76186042|FG000|COMPLETED|Overall Study||9||
60070644|NCT01720797|76186043|FG001|COMPLETED|Overall Study||9||
60070645|NCT01720797|76186042|FG000|NOT COMPLETED|Overall Study||3||
60070646|NCT01720797|76186043|FG001|NOT COMPLETED|Overall Study||0||
60070647|NCT01831466|76186061|FG000|STARTED|Overall Study|Treated|71||
60070648|NCT01831466|76186062|FG001|STARTED|Overall Study|Treated|70||
60070649|NCT01831466|76186063|FG002|STARTED|Overall Study|Treated|71||
60070650|NCT01831466|76186064|FG003|STARTED|Overall Study|Treated|70||
60070651|NCT01831466|76186065|FG004|STARTED|Overall Study|Treated|74||
60070652|NCT01831466|76186066|FG005|STARTED|Overall Study|Treated|74||
60070653|NCT01831466|76186067|FG006|STARTED|Overall Study|Treated|7||
60070654|NCT01831466|76186068|FG007|STARTED|Overall Study|Treated|7||
60070655|NCT01831466|76186069|FG008|STARTED|Overall Study|Treated|7||
60070656|NCT01831466|76186070|FG009|STARTED|Overall Study|Treated|7||
60070657|NCT01831466|76186071|FG010|STARTED|Overall Study|Treated|6||
60070658|NCT01831466|76186072|FG011|STARTED|Overall Study|Treated|7||
60070659|NCT01831466|76186061|FG000|COMPLETED|Overall Study||55||
60070660|NCT01831466|76186062|FG001|COMPLETED|Overall Study||52||
60070661|NCT01831466|76186063|FG002|COMPLETED|Overall Study||48||
60070662|NCT01831466|76186064|FG003|COMPLETED|Overall Study||51||
60070663|NCT01831466|76186065|FG004|COMPLETED|Overall Study||57||
60070664|NCT01831466|76186066|FG005|COMPLETED|Overall Study||48||
60070665|NCT01831466|76186067|FG006|COMPLETED|Overall Study||6||
60070666|NCT01831466|76186068|FG007|COMPLETED|Overall Study||5||
60070667|NCT01831466|76186069|FG008|COMPLETED|Overall Study||4||
60070668|NCT01831466|76186070|FG009|COMPLETED|Overall Study||2||
60070669|NCT01831466|76186071|FG010|COMPLETED|Overall Study||4||
60070670|NCT01831466|76186072|FG011|COMPLETED|Overall Study||3||
60070671|NCT01831466|76186061|FG000|NOT COMPLETED|Overall Study||16||
60070672|NCT01831466|76186062|FG001|NOT COMPLETED|Overall Study||18||
60070673|NCT01831466|76186063|FG002|NOT COMPLETED|Overall Study||23||
60070674|NCT01831466|76186064|FG003|NOT COMPLETED|Overall Study||19||
60070675|NCT01831466|76186065|FG004|NOT COMPLETED|Overall Study||17||
60070676|NCT01831466|76186066|FG005|NOT COMPLETED|Overall Study||26||
60070677|NCT01831466|76186067|FG006|NOT COMPLETED|Overall Study||1||
60070678|NCT01831466|76186068|FG007|NOT COMPLETED|Overall Study||2||
60070679|NCT01831466|76186069|FG008|NOT COMPLETED|Overall Study||3||
60070680|NCT01831466|76186070|FG009|NOT COMPLETED|Overall Study||5||
60070681|NCT01831466|76186071|FG010|NOT COMPLETED|Overall Study||2||
60070682|NCT01831466|76186072|FG011|NOT COMPLETED|Overall Study||4||
60070683|NCT01881620|76186092|FG000|STARTED|Overall Study||109||
60070684|NCT01881620|76186092|FG000|COMPLETED|Overall Study|Eligible patients with PET-CT scanner performed AND interpretation of 2 pairs of observors available|105||
60070685|NCT01881620|76186092|FG000|NOT COMPLETED|Overall Study||4||
60070686|NCT01830920|76186101|FG000|STARTED|Overall Study||126||
60070687|NCT01830920|76186102|FG001|STARTED|Overall Study||46||
60070688|NCT01830920|76186103|FG002|STARTED|Overall Study||48||
60070689|NCT01830920|76186104|FG003|STARTED|Overall Study||125||
60070690|NCT01830920|76186105|FG004|STARTED|Overall Study||107||
60070691|NCT01830920|76186101|FG000|Received Allocated Drug|Overall Study||115||
60070692|NCT01830920|76186102|FG001|Received Allocated Drug|Overall Study||45||
60070693|NCT01830920|76186103|FG002|Received Allocated Drug|Overall Study||47||
60070694|NCT01830920|76186104|FG003|Received Allocated Drug|Overall Study||119||
60070695|NCT01830920|76186105|FG004|Received Allocated Drug|Overall Study||105||
60070696|NCT01830920|76186101|FG000|COMPLETED|Overall Study||105||
60070697|NCT01830920|76186102|FG001|COMPLETED|Overall Study||40||
60070698|NCT01830920|76186103|FG002|COMPLETED|Overall Study||40||
60070699|NCT01830920|76186104|FG003|COMPLETED|Overall Study||109||
60070700|NCT01830920|76186105|FG004|COMPLETED|Overall Study||99||
60070701|NCT01830920|76186101|FG000|NOT COMPLETED|Overall Study||21||
60070702|NCT01830920|76186102|FG001|NOT COMPLETED|Overall Study||6||
60070703|NCT01830920|76186103|FG002|NOT COMPLETED|Overall Study||8||
60070704|NCT01830920|76186104|FG003|NOT COMPLETED|Overall Study||16||
60070705|NCT01830920|76186105|FG004|NOT COMPLETED|Overall Study||8||
60070706|NCT01881230|76186120|FG000|STARTED|Overall Study||61||
60070707|NCT01881230|76186121|FG001|STARTED|Overall Study||64||
60070708|NCT01881230|76186122|FG002|STARTED|Overall Study||66||
60070709|NCT01881230|76186120|FG000|Safety Population|Overall Study|Safety Population = randomized who received at least 1 dose of Investigational Product (IP)|60||
60070710|NCT01881230|76186121|FG001|Safety Population|Overall Study|Safety Population = randomized who received at least 1 dose of IP|64||
60070711|NCT01881230|76186122|FG002|Safety Population|Overall Study|Safety Population = randomized who received at least 1 dose of IP|64||
60070712|NCT01881230|76186120|FG000|Treatment Discontinued|Overall Study|Treatment Duration=PD, toxicity, radiation/removal of lesions, consent withdrawal, doctor decision|60||
60070713|NCT01881230|76186121|FG001|Treatment Discontinued|Overall Study|Treatment Duration=PD, toxicity, radiation/removal of lesions, consent withdrawal, doctor decision|64||
60070714|NCT01881230|76186122|FG002|Treatment Discontinued|Overall Study|Treatment Duration=PD, toxicity, radiation/removal of lesions, consent withdrawal, doctor decision|64||
60070715|NCT01881230|76186120|FG000|COMPLETED|Overall Study|Not applicable according to the study design|0||
60070716|NCT01881230|76186121|FG001|COMPLETED|Overall Study|Not applicable according to the study design|0||
60070717|NCT01881230|76186122|FG002|COMPLETED|Overall Study|Not applicable according to the study design|0||
60070718|NCT01881230|76186120|FG000|NOT COMPLETED|Overall Study||61||
60070719|NCT01881230|76186121|FG001|NOT COMPLETED|Overall Study||64||
60070720|NCT01881230|76186122|FG002|NOT COMPLETED|Overall Study||66||
60070721|NCT01856582|76186130|FG000|STARTED|Overall Study||23||
60070722|NCT01856582|76186130|FG000|COMPLETED|Overall Study||22||
60070723|NCT01856582|76186130|FG000|NOT COMPLETED|Overall Study||1||
60070724|NCT01829360|76186138|FG000|STARTED|Overall Study||8||
60070725|NCT01829360|76186139|FG001|STARTED|Overall Study||9||
60070726|NCT01829360|76186140|FG002|STARTED|Overall Study||10||
60070727|NCT01829360|76186141|FG003|STARTED|Overall Study||8||
60070728|NCT01829360|76186138|FG000|COMPLETED|Overall Study||8||
60070729|NCT01829360|76186139|FG001|COMPLETED|Overall Study||9||
60070730|NCT01829360|76186140|FG002|COMPLETED|Overall Study||9||
60070731|NCT01829360|76186141|FG003|COMPLETED|Overall Study||8||
60070732|NCT01829360|76186138|FG000|NOT COMPLETED|Overall Study||0||
59519316|NCT02574078|75613238|FG001|STARTED|Treatment Period||6|Started = Treated|
59519317|NCT02574078|75613239|FG002|STARTED|Treatment Period||9|Started = Treated|
59519318|NCT02574078|75613240|FG003|STARTED|Treatment Period||35|Started = Treated|
59519319|NCT02574078|75613241|FG004|STARTED|Treatment Period||34|Started = Treated|
60070733|NCT01829360|76186139|FG001|NOT COMPLETED|Overall Study||0||
60070734|NCT01829360|76186140|FG002|NOT COMPLETED|Overall Study||1||
60070735|NCT01829360|76186141|FG003|NOT COMPLETED|Overall Study||0||
60070736|NCT01856114|76186157|FG000|STARTED|Overall Study||11||
60070737|NCT01856114|76186158|FG001|STARTED|Overall Study||11||
60070738|NCT01856114|76186157|FG000|COMPLETED|Overall Study||9||
60070739|NCT01856114|76186158|FG001|COMPLETED|Overall Study||11||
60070740|NCT01856114|76186157|FG000|NOT COMPLETED|Overall Study||2||
60070741|NCT01856114|76186158|FG001|NOT COMPLETED|Overall Study||0||
60070742|NCT01855958|76186166|FG000|STARTED|Overall Study||13||
60070743|NCT01855958|76186167|FG001|STARTED|Overall Study||13||
60070744|NCT01855958|76186166|FG000|COMPLETED|Overall Study||12||
60070745|NCT01855958|76186167|FG001|COMPLETED|Overall Study||13||
60070746|NCT01855958|76186166|FG000|NOT COMPLETED|Overall Study||1||
60070747|NCT01855958|76186167|FG001|NOT COMPLETED|Overall Study||0||
60070748|NCT01855412|76186178|FG000|STARTED|Overall Study||501||
60070749|NCT01855412|76186179|FG001|STARTED|Overall Study||603||
60070750|NCT01855412|76186180|FG002|STARTED|Overall Study||100||
60070751|NCT01855412|76186178|FG000|COMPLETED|Overall Study||289||
60070752|NCT01855412|76186179|FG001|COMPLETED|Overall Study||260||
60070753|NCT01855412|76186180|FG002|COMPLETED|Overall Study||24||
60070754|NCT01855412|76186178|FG000|NOT COMPLETED|Overall Study||212||
60070755|NCT01855412|76186179|FG001|NOT COMPLETED|Overall Study||343||
60070756|NCT01855412|76186180|FG002|NOT COMPLETED|Overall Study||76||
60070757|NCT01614470|76186196|FG000|STARTED|Part 1: Treatment Period 1 (8 Weeks)||20||
60070758|NCT01614470|76186197|FG001|STARTED|Part 1: Treatment Period 1 (8 Weeks)||19||
60070759|NCT01614470|76186198|FG002|STARTED|Part 1: Treatment Period 1 (8 Weeks)||0||
60070760|NCT01614470|76186196|FG000|COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||18||
60070761|NCT01614470|76186197|FG001|COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||18||
60070762|NCT01614470|76186198|FG002|COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||0||
60070763|NCT01614470|76186196|FG000|NOT COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||2||
60070764|NCT01614470|76186197|FG001|NOT COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||1||
60070765|NCT01614470|76186198|FG002|NOT COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||0||
60070766|NCT01614470|76186196|FG000|STARTED|Part 1: Washout Period (4 to 8 Weeks)||18||
60070767|NCT01614470|76186197|FG001|STARTED|Part 1: Washout Period (4 to 8 Weeks)||18||
60070768|NCT01614470|76186198|FG002|STARTED|Part 1: Washout Period (4 to 8 Weeks)||0||
60070769|NCT01614470|76186196|FG000|COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||18||
60070770|NCT01614470|76186197|FG001|COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||18||
60070771|NCT01614470|76186198|FG002|COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||0||
60070772|NCT01614470|76186196|FG000|NOT COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||0||
60070773|NCT01614470|76186197|FG001|NOT COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||0||
60070774|NCT01614470|76186198|FG002|NOT COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||0||
60070775|NCT01614470|76186196|FG000|STARTED|Part 1: Treatment Period 2 (8 Weeks)||18||
60070776|NCT01614470|76186197|FG001|STARTED|Part 1: Treatment Period 2 (8 Weeks)||18||
60070777|NCT01614470|76186198|FG002|STARTED|Part 1: Treatment Period 2 (8 Weeks)||0||
60070778|NCT01614470|76186196|FG000|COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||18||
60070779|NCT01614470|76186197|FG001|COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||18||
60070780|NCT01614470|76186198|FG002|COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||0||
60070781|NCT01614470|76186196|FG000|NOT COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||0||
60070782|NCT01614470|76186197|FG001|NOT COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||0||
60070783|NCT01614470|76186198|FG002|NOT COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||0||
60070784|NCT01614470|76186196|FG000|STARTED|Part 2: Open-label Period (16 Weeks)||0||
59519320|NCT02574078|75613242|FG005|STARTED|Treatment Period||34|Started = Treated|
59519321|NCT02574078|75613243|FG006|STARTED|Treatment Period||14|Started = Treated|
59519322|NCT02574078|75613244|FG007|STARTED|Treatment Period||14|Started = Treated|
59519323|NCT02574078|75613245|FG008|STARTED|Treatment Period||25|Started = Treated|
59519324|NCT02574078|75613246|FG009|STARTED|Treatment Period||26|Started = Treated|
59519325|NCT02574078|75613247|FG010|STARTED|Treatment Period||49|Started = Treated|
59519326|NCT02574078|75613248|FG011|STARTED|Treatment Period||55|Started = Treated|
59519327|NCT02574078|75613249|FG012|STARTED|Treatment Period||13|Started = Treated|
60070785|NCT01614470|76186197|FG001|STARTED|Part 2: Open-label Period (16 Weeks)||0||
60070786|NCT01614470|76186198|FG002|STARTED|Part 2: Open-label Period (16 Weeks)||36||
60070787|NCT01614470|76186196|FG000|COMPLETED|Part 2: Open-label Period (16 Weeks)||0||
60070788|NCT01614470|76186197|FG001|COMPLETED|Part 2: Open-label Period (16 Weeks)||0||
60070789|NCT01614470|76186198|FG002|COMPLETED|Part 2: Open-label Period (16 Weeks)||36||
59519328|NCT02574078|75613237|FG000|COMPLETED|Treatment Period||3||
59519329|NCT02574078|75613238|FG001|COMPLETED|Treatment Period||0||
59519330|NCT02574078|75613239|FG002|COMPLETED|Treatment Period||0||
60070790|NCT01614470|76186196|FG000|NOT COMPLETED|Part 2: Open-label Period (16 Weeks)||0||
60070791|NCT01614470|76186197|FG001|NOT COMPLETED|Part 2: Open-label Period (16 Weeks)||0||
60070792|NCT01614470|76186198|FG002|NOT COMPLETED|Part 2: Open-label Period (16 Weeks)||0||
60070793|NCT01880528|76186209|FG000|STARTED|Overall Study||12||
60070794|NCT01880528|76186210|FG001|STARTED|Overall Study||11||
60070795|NCT01880528|76186209|FG000|COMPLETED|Overall Study||11|Evaluable for primary endpoint|
60070796|NCT01880528|76186210|FG001|COMPLETED|Overall Study||10|Evaluable for primary endpoint|
60070797|NCT01880528|76186209|FG000|NOT COMPLETED|Overall Study||1||
60070798|NCT01880528|76186210|FG001|NOT COMPLETED|Overall Study||1||
60070799|NCT01854944|76186219|FG000|STARTED|Overall Study||4||
60070800|NCT01854944|76186220|FG001|STARTED|Overall Study||4||
60070801|NCT01854944|76186221|FG002|STARTED|Overall Study||4||
60070802|NCT01854944|76186219|FG000|COMPLETED|Overall Study||4||
60070803|NCT01854944|76186220|FG001|COMPLETED|Overall Study||4||
60070804|NCT01854944|76186221|FG002|COMPLETED|Overall Study||3||
60070805|NCT01854944|76186219|FG000|NOT COMPLETED|Overall Study||0||
60070806|NCT01854944|76186220|FG001|NOT COMPLETED|Overall Study||0||
60070807|NCT01854944|76186221|FG002|NOT COMPLETED|Overall Study||1||
60070808|NCT01829048|76186248|FG000|STARTED|Overall Study||6||
60070809|NCT01829048|76186249|FG001|STARTED|Overall Study||8||
60070810|NCT01829048|76186250|FG002|STARTED|Overall Study||7||
60070811|NCT01829048|76186251|FG003|STARTED|Overall Study||14||
60070812|NCT01829048|76186252|FG004|STARTED|Overall Study||2||
60070813|NCT01829048|76186248|FG000|COMPLETED|Overall Study||6||
60070814|NCT01829048|76186249|FG001|COMPLETED|Overall Study||8||
60070815|NCT01829048|76186250|FG002|COMPLETED|Overall Study||7||
60070816|NCT01829048|76186251|FG003|COMPLETED|Overall Study||12||
60070817|NCT01829048|76186252|FG004|COMPLETED|Overall Study||2||
60070818|NCT01829048|76186248|FG000|NOT COMPLETED|Overall Study||0||
60070819|NCT01829048|76186249|FG001|NOT COMPLETED|Overall Study||0||
60070820|NCT01829048|76186250|FG002|NOT COMPLETED|Overall Study||0||
60070821|NCT01829048|76186251|FG003|NOT COMPLETED|Overall Study||2||
60070822|NCT01829048|76186252|FG004|NOT COMPLETED|Overall Study||0||
60070823|NCT01854710|76186265|FG000|STARTED|Overall Study||10||
60070824|NCT01854710|76186266|FG001|STARTED|Overall Study||10||
60070825|NCT01854710|76186267|FG002|STARTED|Overall Study||10||
60070826|NCT01854710|76186268|FG003|STARTED|Overall Study||10||
60070827|NCT01854710|76186269|FG004|STARTED|Overall Study||10||
60070828|NCT01854710|76186270|FG005|STARTED|Overall Study||10||
60070829|NCT01854710|76186265|FG000|COMPLETED|Overall Study||6||
60070830|NCT01854710|76186266|FG001|COMPLETED|Overall Study||7||
60070831|NCT01854710|76186267|FG002|COMPLETED|Overall Study||8||
60070832|NCT01854710|76186268|FG003|COMPLETED|Overall Study||8||
60070833|NCT01854710|76186269|FG004|COMPLETED|Overall Study||8||
60070834|NCT01854710|76186270|FG005|COMPLETED|Overall Study||8||
60070835|NCT01854710|76186265|FG000|NOT COMPLETED|Overall Study||4||
60070836|NCT01854710|76186266|FG001|NOT COMPLETED|Overall Study||3||
60070837|NCT01854710|76186267|FG002|NOT COMPLETED|Overall Study||2||
60070838|NCT01854710|76186268|FG003|NOT COMPLETED|Overall Study||2||
60070839|NCT01854710|76186269|FG004|NOT COMPLETED|Overall Study||2||
60070840|NCT01854710|76186270|FG005|NOT COMPLETED|Overall Study||2||
60070841|NCT01828034|76186284|FG000|STARTED|Overall Study||3||
60070842|NCT01828034|76186285|FG001|STARTED|Overall Study||6||
60070843|NCT01828034|76186286|FG002|STARTED|Overall Study||3||
60070844|NCT01828034|76186287|FG003|STARTED|Overall Study||30||
60070845|NCT01828034|76186284|FG000|COMPLETED|Overall Study||3||
60070846|NCT01828034|76186285|FG001|COMPLETED|Overall Study||6||
60070847|NCT01828034|76186286|FG002|COMPLETED|Overall Study||3||
60070848|NCT01828034|76186287|FG003|COMPLETED|Overall Study||29||
60070849|NCT01828034|76186284|FG000|NOT COMPLETED|Overall Study||0||
60070850|NCT01828034|76186285|FG001|NOT COMPLETED|Overall Study||0||
60070851|NCT01828034|76186286|FG002|NOT COMPLETED|Overall Study||0||
60070852|NCT01828034|76186287|FG003|NOT COMPLETED|Overall Study||1||
60070853|NCT01853696|76186296|FG000|STARTED|Overall Study||84||
60070854|NCT01853696|76186297|FG001|STARTED|Overall Study||83||
60070855|NCT01853696|76186296|FG000|COMPLETED|Overall Study||78||
60070856|NCT01853696|76186297|FG001|COMPLETED|Overall Study||78||
60070857|NCT01853696|76186296|FG000|NOT COMPLETED|Overall Study||6||
60070858|NCT01853696|76186297|FG001|NOT COMPLETED|Overall Study||5||
60070859|NCT01871805|76186309|FG000|STARTED|Phase I||7||
60070860|NCT01871805|76186310|FG001|STARTED|Phase I||7||
60070861|NCT01871805|76186311|FG002|STARTED|Phase I||13||
60070862|NCT01871805|76186312|FG003|STARTED|Phase I||7||
60070863|NCT01871805|76186313|FG004|STARTED|Phase I||13||
60070864|NCT01871805|76186314|FG005|STARTED|Phase I||0||
60070865|NCT01871805|76186309|FG000|COMPLETED|Phase I||0||
60070866|NCT01871805|76186310|FG001|COMPLETED|Phase I||0||
60070867|NCT01871805|76186311|FG002|COMPLETED|Phase I||0||
60070868|NCT01871805|76186312|FG003|COMPLETED|Phase I||0||
60070869|NCT01871805|76186313|FG004|COMPLETED|Phase I||0||
60070870|NCT01871805|76186314|FG005|COMPLETED|Phase I||0||
60070871|NCT01871805|76186309|FG000|NOT COMPLETED|Phase I||7||
60070872|NCT01871805|76186310|FG001|NOT COMPLETED|Phase I||7||
60070873|NCT01871805|76186311|FG002|NOT COMPLETED|Phase I||13||
60070874|NCT01871805|76186312|FG003|NOT COMPLETED|Phase I||7||
60070875|NCT01871805|76186313|FG004|NOT COMPLETED|Phase I||13||
60070876|NCT01871805|76186314|FG005|NOT COMPLETED|Phase I||0||
60070877|NCT01871805|76186309|FG000|STARTED|Phase II||0||
60070878|NCT01871805|76186310|FG001|STARTED|Phase II||0||
60070879|NCT01871805|76186311|FG002|STARTED|Phase II||0||
60070880|NCT01871805|76186312|FG003|STARTED|Phase II||0||
60070881|NCT01871805|76186313|FG004|STARTED|Phase II||0||
59519331|NCT02574078|75613240|FG003|COMPLETED|Treatment Period||7||
59519332|NCT02574078|75613241|FG004|COMPLETED|Treatment Period||3||
59519333|NCT02574078|75613242|FG005|COMPLETED|Treatment Period||1||
59519334|NCT02574078|75613243|FG006|COMPLETED|Treatment Period||2||
59519335|NCT02574078|75613244|FG007|COMPLETED|Treatment Period||2||
59519336|NCT02574078|75613245|FG008|COMPLETED|Treatment Period||1||
59519337|NCT02574078|75613246|FG009|COMPLETED|Treatment Period||9||
59519338|NCT02574078|75613247|FG010|COMPLETED|Treatment Period||4||
59519339|NCT02574078|75613248|FG011|COMPLETED|Treatment Period||8||
59519340|NCT02574078|75613249|FG012|COMPLETED|Treatment Period||0||
59519341|NCT02574078|75613237|FG000|NOT COMPLETED|Treatment Period||10||
59519342|NCT02574078|75613238|FG001|NOT COMPLETED|Treatment Period||6||
59519343|NCT02574078|75613239|FG002|NOT COMPLETED|Treatment Period||9||
59519344|NCT02574078|75613240|FG003|NOT COMPLETED|Treatment Period||28||
59519345|NCT02574078|75613241|FG004|NOT COMPLETED|Treatment Period||31||
59519346|NCT02574078|75613242|FG005|NOT COMPLETED|Treatment Period||33||
59519347|NCT02574078|75613243|FG006|NOT COMPLETED|Treatment Period||12||
59519348|NCT02574078|75613244|FG007|NOT COMPLETED|Treatment Period||12||
59519349|NCT02574078|75613245|FG008|NOT COMPLETED|Treatment Period||24||
59519350|NCT02574078|75613246|FG009|NOT COMPLETED|Treatment Period||17||
59519351|NCT02574078|75613247|FG010|NOT COMPLETED|Treatment Period||45||
59519352|NCT02574078|75613248|FG011|NOT COMPLETED|Treatment Period||47||
59519353|NCT02574078|75613249|FG012|NOT COMPLETED|Treatment Period||13||
59519354|NCT03605914|75613282|FG000|STARTED|Overall Study||57||
59519355|NCT03605914|75613283|FG001|STARTED|Overall Study||43||
59519356|NCT03605914|75613282|FG000|Completed Day 1 Assessment|Overall Study||31||
59519357|NCT03605914|75613283|FG001|Completed Day 1 Assessment|Overall Study||26||
59519358|NCT03605914|75613282|FG000|Completed Day 2 Assessment|Overall Study||32||
59519359|NCT03605914|75613283|FG001|Completed Day 2 Assessment|Overall Study||27||
60070882|NCT01871805|76186314|FG005|STARTED|Phase II||87||
60070883|NCT01871805|76186309|FG000|COMPLETED|Phase II||0||
60070884|NCT01871805|76186310|FG001|COMPLETED|Phase II||0||
60070885|NCT01871805|76186311|FG002|COMPLETED|Phase II||0||
60070886|NCT01871805|76186312|FG003|COMPLETED|Phase II||0||
60070887|NCT01871805|76186313|FG004|COMPLETED|Phase II||0||
59519360|NCT03605914|75613282|FG000|Completed Day 3 Assessment|Overall Study||31||
59519361|NCT03605914|75613283|FG001|Completed Day 3 Assessment|Overall Study||28||
59519362|NCT03605914|75613282|FG000|Completed Day 5 Assessment|Overall Study||30||
59519363|NCT03605914|75613283|FG001|Completed Day 5 Assessment|Overall Study||24||
60070888|NCT01871805|76186314|FG005|COMPLETED|Phase II||0||
60070889|NCT01871805|76186309|FG000|NOT COMPLETED|Phase II||0||
60070890|NCT01871805|76186310|FG001|NOT COMPLETED|Phase II||0||
60070891|NCT01871805|76186311|FG002|NOT COMPLETED|Phase II||0||
60070892|NCT01871805|76186312|FG003|NOT COMPLETED|Phase II||0||
59519364|NCT03605914|75613282|FG000|COMPLETED|Overall Study||30||
60070893|NCT01871805|76186313|FG004|NOT COMPLETED|Phase II||0||
60070894|NCT01871805|76186314|FG005|NOT COMPLETED|Phase II||87||
60070895|NCT01719861|76186345|FG000|STARTED|Cycle 1||6||
60070896|NCT01719861|76186345|FG000|COMPLETED|Cycle 1||2||
60070897|NCT01719861|76186345|FG000|NOT COMPLETED|Cycle 1||4||
60070898|NCT01719861|76186345|FG000|STARTED|Cycle 2||2||
60070899|NCT01719861|76186345|FG000|COMPLETED|Cycle 2||1||
60070900|NCT01719861|76186345|FG000|NOT COMPLETED|Cycle 2||1||
60070901|NCT01853618|76186355|FG000|STARTED|Overall Study||8||
60070902|NCT01853618|76186356|FG001|STARTED|Overall Study||12||
60070903|NCT01853618|76186357|FG002|STARTED|Overall Study||12||
60070904|NCT01853618|76186358|FG003|STARTED|Overall Study||9||
60070905|NCT01853618|76186359|FG004|STARTED|Overall Study||20||
60070906|NCT01853618|76186355|FG000|COMPLETED|Overall Study||6||
60070907|NCT01853618|76186356|FG001|COMPLETED|Overall Study||10||
60070908|NCT01853618|76186357|FG002|COMPLETED|Overall Study||10||
60070909|NCT01853618|76186358|FG003|COMPLETED|Overall Study||8||
60070910|NCT01853618|76186359|FG004|COMPLETED|Overall Study||17||
60070911|NCT01853618|76186355|FG000|NOT COMPLETED|Overall Study||2||
60070912|NCT01853618|76186356|FG001|NOT COMPLETED|Overall Study||2||
60070913|NCT01853618|76186357|FG002|NOT COMPLETED|Overall Study||2||
60070914|NCT01853618|76186358|FG003|NOT COMPLETED|Overall Study||1||
60070915|NCT01853618|76186359|FG004|NOT COMPLETED|Overall Study||3||
60070916|NCT01853462|76186374|FG000|STARTED|Overall Study||11||
60070917|NCT01853462|76186375|FG001|STARTED|Overall Study||11||
60070918|NCT01853462|76186374|FG000|COMPLETED|Overall Study||10||
60070919|NCT01853462|76186375|FG001|COMPLETED|Overall Study||10||
60070920|NCT01853462|76186374|FG000|NOT COMPLETED|Overall Study||1||
60070921|NCT01853462|76186375|FG001|NOT COMPLETED|Overall Study||1||
60070922|NCT01719783|76186385|FG000|STARTED|Dose 1||30||
60070923|NCT01719783|76186386|FG001|STARTED|Dose 1||10||
60070924|NCT01719783|76186385|FG000|COMPLETED|Dose 1||30||
60070925|NCT01719783|76186386|FG001|COMPLETED|Dose 1||10||
60070926|NCT01719783|76186385|FG000|NOT COMPLETED|Dose 1||0||
60070927|NCT01719783|76186386|FG001|NOT COMPLETED|Dose 1||0||
60070928|NCT01719783|76186385|FG000|STARTED|Dose 2||30||
60070929|NCT01719783|76186386|FG001|STARTED|Dose 2||10||
60070930|NCT01719783|76186385|FG000|COMPLETED|Dose 2||29||
60070931|NCT01719783|76186386|FG001|COMPLETED|Dose 2||10||
60070932|NCT01719783|76186385|FG000|NOT COMPLETED|Dose 2||1||
60070933|NCT01719783|76186386|FG001|NOT COMPLETED|Dose 2||0||
60070934|NCT01853384|76186414|FG000|STARTED|Randomized||131||
60070935|NCT01853384|76186415|FG001|STARTED|Randomized||121||
60070936|NCT01853384|76186414|FG000|COMPLETED|Randomized||69||
60070937|NCT01853384|76186415|FG001|COMPLETED|Randomized||75||
60070938|NCT01853384|76186414|FG000|NOT COMPLETED|Randomized||62||
60070939|NCT01853384|76186415|FG001|NOT COMPLETED|Randomized||46||
60070940|NCT01853384|76186414|FG000|STARTED|Enrolled in Follow up Period||96||
60070941|NCT01853384|76186415|FG001|STARTED|Enrolled in Follow up Period||94||
60070942|NCT01853384|76186414|FG000|Not Enrolled in Follow-up|Enrolled in Follow up Period||35||
60070943|NCT01853384|76186415|FG001|Not Enrolled in Follow-up|Enrolled in Follow up Period||27||
60070944|NCT01853384|76186414|FG000|COMPLETED|Enrolled in Follow up Period||96||
60070945|NCT01853384|76186415|FG001|COMPLETED|Enrolled in Follow up Period||94||
60070946|NCT01853384|76186414|FG000|NOT COMPLETED|Enrolled in Follow up Period||0||
60070947|NCT01853384|76186415|FG001|NOT COMPLETED|Enrolled in Follow up Period||0||
60070948|NCT01853384|76186414|FG000|STARTED|Completed Follow up Visit 1||96||
60070949|NCT01853384|76186415|FG001|STARTED|Completed Follow up Visit 1||94||
60070950|NCT01853384|76186414|FG000|COMPLETED|Completed Follow up Visit 1||82||
60070951|NCT01853384|76186415|FG001|COMPLETED|Completed Follow up Visit 1||85||
60070952|NCT01853384|76186414|FG000|NOT COMPLETED|Completed Follow up Visit 1||14||
60070953|NCT01853384|76186415|FG001|NOT COMPLETED|Completed Follow up Visit 1||9||
60070954|NCT01853384|76186414|FG000|STARTED|Completed Follow up Visit 2||96||
60070955|NCT01853384|76186415|FG001|STARTED|Completed Follow up Visit 2||94||
60070956|NCT01853384|76186414|FG000|COMPLETED|Completed Follow up Visit 2||93||
60070957|NCT01853384|76186415|FG001|COMPLETED|Completed Follow up Visit 2||91||
60070958|NCT01853384|76186414|FG000|NOT COMPLETED|Completed Follow up Visit 2||3||
60070959|NCT01853384|76186415|FG001|NOT COMPLETED|Completed Follow up Visit 2||3||
60070960|NCT01878890|76186425|FG000|STARTED|Overall Study||5||
60070961|NCT01878890|76186426|FG001|STARTED|Overall Study||11||
60070962|NCT01878890|76186427|FG002|STARTED|Overall Study||4||
60070963|NCT01878890|76186428|FG003|STARTED|Overall Study||5||
60070964|NCT01878890|76186425|FG000|COMPLETED|Overall Study||5||
60070965|NCT01878890|76186426|FG001|COMPLETED|Overall Study||10||
60070966|NCT01878890|76186427|FG002|COMPLETED|Overall Study||4||
60070967|NCT01878890|76186428|FG003|COMPLETED|Overall Study||5||
60070968|NCT01878890|76186425|FG000|NOT COMPLETED|Overall Study||0||
60070969|NCT01878890|76186426|FG001|NOT COMPLETED|Overall Study||1||
60070970|NCT01878890|76186427|FG002|NOT COMPLETED|Overall Study||0||
60070971|NCT01878890|76186428|FG003|NOT COMPLETED|Overall Study||0||
60070972|NCT01827332|76186441|FG000|STARTED|Overall Study||8||
60070973|NCT01827332|76186442|FG001|STARTED|Overall Study||8||
60070974|NCT01827332|76186441|FG000|COMPLETED|Overall Study||6||
60070975|NCT01827332|76186442|FG001|COMPLETED|Overall Study||7||
60070976|NCT01827332|76186441|FG000|NOT COMPLETED|Overall Study||2||
60070977|NCT01827332|76186442|FG001|NOT COMPLETED|Overall Study||1||
60070978|NCT01719003|76186456|FG000|STARTED|Overall Study||170||
60070979|NCT01719003|76186457|FG001|STARTED|Overall Study||170||
60070980|NCT01719003|76186458|FG002|STARTED|Overall Study||171||
60070981|NCT01719003|76186459|FG003|STARTED|Overall Study||169||
60070982|NCT01719003|76186460|FG004|STARTED|Overall Study||167||
60070983|NCT01719003|76186461|FG005|STARTED|Overall Study||172||
60070984|NCT01719003|76186462|FG006|STARTED|Overall Study||170||
60070985|NCT01719003|76186463|FG007|STARTED|Overall Study||171||
60070986|NCT01719003|76186464|FG008|STARTED|Overall Study||53||
60070987|NCT01719003|76186456|FG000|COMPLETED|Overall Study||161||
60070988|NCT01719003|76186457|FG001|COMPLETED|Overall Study||153||
60070989|NCT01719003|76186458|FG002|COMPLETED|Overall Study||154||
60070990|NCT01719003|76186459|FG003|COMPLETED|Overall Study||156||
60070991|NCT01719003|76186460|FG004|COMPLETED|Overall Study||150||
60070992|NCT01719003|76186461|FG005|COMPLETED|Overall Study||160||
60070993|NCT01719003|76186462|FG006|COMPLETED|Overall Study||150||
60070994|NCT01719003|76186463|FG007|COMPLETED|Overall Study||151||
60070995|NCT01719003|76186464|FG008|COMPLETED|Overall Study||49||
60070996|NCT01719003|76186456|FG000|NOT COMPLETED|Overall Study||9||
60070997|NCT01719003|76186457|FG001|NOT COMPLETED|Overall Study||17||
60070998|NCT01719003|76186458|FG002|NOT COMPLETED|Overall Study||17||
60070999|NCT01719003|76186459|FG003|NOT COMPLETED|Overall Study||13||
60071000|NCT01719003|76186460|FG004|NOT COMPLETED|Overall Study||17||
60071001|NCT01719003|76186461|FG005|NOT COMPLETED|Overall Study||12||
60071002|NCT01719003|76186462|FG006|NOT COMPLETED|Overall Study||20||
60071003|NCT01719003|76186463|FG007|NOT COMPLETED|Overall Study||20||
60071004|NCT01719003|76186464|FG008|NOT COMPLETED|Overall Study||4||
60071005|NCT01853228|76186483|FG000|STARTED|Phase 1||9||
60071006|NCT01853228|76186484|FG001|STARTED|Phase 1||7||
60071007|NCT01853228|76186483|FG000|COMPLETED|Phase 1||0||
60071008|NCT01853228|76186484|FG001|COMPLETED|Phase 1|Participants who completed Phase 1 moved to Phase 2.|7||
60071009|NCT01853228|76186483|FG000|NOT COMPLETED|Phase 1||9||
60071010|NCT01853228|76186484|FG001|NOT COMPLETED|Phase 1||0||
60071011|NCT01853228|76186483|FG000|STARTED|Phase 2||0||
60071012|NCT01853228|76186484|FG001|STARTED|Phase 2|1 additional participant was enrolled, making total of 8 participants evaluable in Phase 2.|8||
60071013|NCT01853228|76186483|FG000|COMPLETED|Phase 2||0||
60071014|NCT01853228|76186484|FG001|COMPLETED|Phase 2||0||
60071015|NCT01853228|76186483|FG000|NOT COMPLETED|Phase 2||0||
60071016|NCT01853228|76186484|FG001|NOT COMPLETED|Phase 2||8||
60071017|NCT01705587|76186491|FG000|STARTED|Overall Study||7||
60071018|NCT01705587|76186492|FG001|STARTED|Overall Study||6||
60071019|NCT01705587|76186491|FG000|COMPLETED|Overall Study||7||
60071020|NCT01705587|76186492|FG001|COMPLETED|Overall Study||5||
60071021|NCT01705587|76186491|FG000|NOT COMPLETED|Overall Study||0||
60071022|NCT01705587|76186492|FG001|NOT COMPLETED|Overall Study||1||
60071023|NCT01718535|76186508|FG000|STARTED|Overall Study||131||
60071024|NCT01718535|76186509|FG001|STARTED|Overall Study||95||
60071025|NCT01718535|76186510|FG002|STARTED|Overall Study||19||
60071026|NCT01718535|76186511|FG003|STARTED|Overall Study||8||
60071027|NCT01718535|76186512|FG004|STARTED|Overall Study||1||
60071028|NCT01718535|76186513|FG005|STARTED|Overall Study||40||
60071029|NCT01718535|76186514|FG006|STARTED|Overall Study||11||
60071030|NCT01718535|76186515|FG007|STARTED|Overall Study||6||
60071031|NCT01718535|76186516|FG008|STARTED|Overall Study||15||
60071032|NCT01718535|76186517|FG009|STARTED|Overall Study||1||
60071033|NCT01718535|76186508|FG000|First Pass|Overall Study||128||
60071034|NCT01718535|76186509|FG001|First Pass|Overall Study||94||
60071035|NCT01718535|76186510|FG002|First Pass|Overall Study||19||
60071036|NCT01718535|76186511|FG003|First Pass|Overall Study||7||
60071037|NCT01718535|76186512|FG004|First Pass|Overall Study||1||
60071038|NCT01718535|76186513|FG005|First Pass|Overall Study||39||
60071039|NCT01718535|76186514|FG006|First Pass|Overall Study||11||
60071040|NCT01718535|76186515|FG007|First Pass|Overall Study||6||
60071041|NCT01718535|76186516|FG008|First Pass|Overall Study||15||
60071042|NCT01718535|76186517|FG009|First Pass|Overall Study||1||
60071043|NCT01718535|76186508|FG000|COMPLETED|Overall Study||130||
60071044|NCT01718535|76186509|FG001|COMPLETED|Overall Study||95||
60071045|NCT01718535|76186510|FG002|COMPLETED|Overall Study||19||
60071046|NCT01718535|76186511|FG003|COMPLETED|Overall Study||7||
60071047|NCT01718535|76186512|FG004|COMPLETED|Overall Study||1||
60071048|NCT01718535|76186513|FG005|COMPLETED|Overall Study||40||
60071049|NCT01718535|76186514|FG006|COMPLETED|Overall Study||11||
60071050|NCT01718535|76186515|FG007|COMPLETED|Overall Study||6||
60071051|NCT01718535|76186516|FG008|COMPLETED|Overall Study||15||
60071052|NCT01718535|76186517|FG009|COMPLETED|Overall Study||1||
60071053|NCT01718535|76186508|FG000|NOT COMPLETED|Overall Study||1||
60071054|NCT01718535|76186509|FG001|NOT COMPLETED|Overall Study||0||
60071055|NCT01718535|76186510|FG002|NOT COMPLETED|Overall Study||0||
60071056|NCT01718535|76186511|FG003|NOT COMPLETED|Overall Study||1||
60071057|NCT01718535|76186512|FG004|NOT COMPLETED|Overall Study||0||
60071058|NCT01718535|76186513|FG005|NOT COMPLETED|Overall Study||0||
60071059|NCT01718535|76186514|FG006|NOT COMPLETED|Overall Study||0||
60071060|NCT01718535|76186515|FG007|NOT COMPLETED|Overall Study||0||
60071061|NCT01718535|76186516|FG008|NOT COMPLETED|Overall Study||0||
60071062|NCT01718535|76186517|FG009|NOT COMPLETED|Overall Study||0||
60071063|NCT01717989|76186539|FG000|STARTED|Overall Study||2248||
60071064|NCT01717989|76186539|FG000|COMPLETED|Overall Study||1182||
60071065|NCT01717989|76186539|FG000|NOT COMPLETED|Overall Study||1066||
60071066|NCT01705509|76186558|FG000|STARTED|Inclusion CPET||14||
60071067|NCT01705509|76186558|FG000|COMPLETED|Inclusion CPET||7||
60071068|NCT01705509|76186558|FG000|NOT COMPLETED|Inclusion CPET||7||
60071069|NCT01705509|76186558|FG000|STARTED|CPET w/ Ranexa||7||
60071070|NCT01705509|76186558|FG000|COMPLETED|CPET w/ Ranexa||5||
60071071|NCT01705509|76186558|FG000|NOT COMPLETED|CPET w/ Ranexa||2||
60071072|NCT01853072|76186564|FG000|STARTED|Overall Study||308||
60071073|NCT01853072|76186565|FG001|STARTED|Overall Study||307||
60071074|NCT01853072|76186564|FG000|Randomized|Overall Study||308||
60071075|NCT01853072|76186565|FG001|Randomized|Overall Study||307||
60071076|NCT01853072|76186564|FG000|Treated (Safety Analysis Set)|Overall Study||301||
60071077|NCT01853072|76186565|FG001|Treated (Safety Analysis Set)|Overall Study||302||
60071078|NCT01853072|76186564|FG000|Full Analysis Set|Overall Study||298||
60071079|NCT01853072|76186565|FG001|Full Analysis Set|Overall Study||300||
60071080|NCT01853072|76186564|FG000|COMPLETED|Overall Study||296||
60071081|NCT01853072|76186565|FG001|COMPLETED|Overall Study||286||
60071082|NCT01853072|76186564|FG000|NOT COMPLETED|Overall Study||12||
60071083|NCT01853072|76186565|FG001|NOT COMPLETED|Overall Study||21||
60071084|NCT01877720|76186573|FG000|STARTED|Overall Study||8||
60071085|NCT01877720|76186574|FG001|STARTED|Overall Study||8||
60071086|NCT01877720|76186573|FG000|1st Intervention|Overall Study||7||
60071087|NCT01877720|76186574|FG001|1st Intervention|Overall Study||8||
60071088|NCT01877720|76186573|FG000|2nd Intervention|Overall Study||7||
60071089|NCT01877720|76186574|FG001|2nd Intervention|Overall Study||8||
60071090|NCT01877720|76186573|FG000|COMPLETED|Overall Study||7||
60071091|NCT01877720|76186574|FG001|COMPLETED|Overall Study||8||
60071092|NCT01877720|76186573|FG000|NOT COMPLETED|Overall Study||1||
60071093|NCT01877720|76186574|FG001|NOT COMPLETED|Overall Study||0||
60071094|NCT01870869|76186584|FG000|STARTED|Overall Study||288||
60071095|NCT01870869|76186585|FG001|STARTED|Overall Study||206||
60071096|NCT01870869|76186586|FG002|STARTED|Overall Study||1222||
60071097|NCT01870869|76186587|FG003|STARTED|Overall Study||235||
60071098|NCT01870869|76186584|FG000|COMPLETED|Overall Study||260||
60071099|NCT01870869|76186585|FG001|COMPLETED|Overall Study||192||
60071100|NCT01870869|76186586|FG002|COMPLETED|Overall Study||1092||
60071101|NCT01870869|76186587|FG003|COMPLETED|Overall Study||205||
60071102|NCT01870869|76186584|FG000|NOT COMPLETED|Overall Study||28||
60071103|NCT01870869|76186585|FG001|NOT COMPLETED|Overall Study||14||
60071104|NCT01870869|76186586|FG002|NOT COMPLETED|Overall Study||130||
60071105|NCT01870869|76186587|FG003|NOT COMPLETED|Overall Study||30||
60071106|NCT01877408|76186599|FG000|STARTED|Overall Study||50||
60071107|NCT01877408|76186600|FG001|STARTED|Overall Study||100||
60071108|NCT01877408|76186599|FG000|COMPLETED|Overall Study|Completed follow up visit 28 days after procedure|50||
60071109|NCT01877408|76186600|FG001|COMPLETED|Overall Study|Completed follow up visit 28 days after procedure|98||
60071110|NCT01877408|76186599|FG000|NOT COMPLETED|Overall Study||0||
60071111|NCT01877408|76186600|FG001|NOT COMPLETED|Overall Study||2||
60071112|NCT01717287|76186609|FG000|STARTED|Overall Study||4||
60071113|NCT01717287|76186610|FG001|STARTED|Overall Study||28||
60071114|NCT01717287|76186609|FG000|COMPLETED|Overall Study||4||
60071115|NCT01717287|76186610|FG001|COMPLETED|Overall Study||25||
60071116|NCT01717287|76186609|FG000|NOT COMPLETED|Overall Study||0||
60071117|NCT01717287|76186610|FG001|NOT COMPLETED|Overall Study||3||
60071118|NCT01827254|76186616|FG000|STARTED|Overall Study||61||
60071119|NCT01827254|76186616|FG000|Evaluable Population|Overall Study||52||
60071120|NCT01827254|76186616|FG000|COMPLETED|Overall Study||2||
60071121|NCT01827254|76186616|FG000|NOT COMPLETED|Overall Study||59||
60071122|NCT01824602|76186628|FG000|STARTED|Overall Study||11||
60071123|NCT01824602|76186629|FG001|STARTED|Overall Study||8||
60071124|NCT01824602|76186630|FG002|STARTED|Overall Study||9||
60071125|NCT01824602|76186631|FG003|STARTED|Overall Study||10||
60071126|NCT01824602|76186628|FG000|Safety Population|Overall Study||11||
60071127|NCT01824602|76186629|FG001|Safety Population|Overall Study||8||
60071128|NCT01824602|76186630|FG002|Safety Population|Overall Study||9||
60071129|NCT01824602|76186631|FG003|Safety Population|Overall Study||10||
60071130|NCT01824602|76186628|FG000|Intent-to-treat Population|Overall Study||11||
60071131|NCT01824602|76186629|FG001|Intent-to-treat Population|Overall Study||8||
60071132|NCT01824602|76186630|FG002|Intent-to-treat Population|Overall Study||9||
60071133|NCT01824602|76186631|FG003|Intent-to-treat Population|Overall Study||9||
60071134|NCT01824602|76186628|FG000|COMPLETED|Overall Study||10||
60071135|NCT01824602|76186629|FG001|COMPLETED|Overall Study||8||
60071136|NCT01824602|76186630|FG002|COMPLETED|Overall Study||5||
60071137|NCT01824602|76186631|FG003|COMPLETED|Overall Study||5||
60071138|NCT01824602|76186628|FG000|NOT COMPLETED|Overall Study||1||
60071139|NCT01824602|76186629|FG001|NOT COMPLETED|Overall Study||0||
60071140|NCT01824602|76186630|FG002|NOT COMPLETED|Overall Study||4||
60071141|NCT01824602|76186631|FG003|NOT COMPLETED|Overall Study||5||
60071142|NCT01704651|76186643|FG000|STARTED|Overall Study||71||
59519365|NCT03605914|75613283|FG001|COMPLETED|Overall Study||24||
59519366|NCT03605914|75613282|FG000|NOT COMPLETED|Overall Study||27||
59519367|NCT03605914|75613283|FG001|NOT COMPLETED|Overall Study||19||
59519368|NCT03554746|75613291|FG000|STARTED|Overall Study||24||
59519369|NCT03554746|75613292|FG001|STARTED|Overall Study||24||
60071143|NCT01704651|76186644|FG001|STARTED|Overall Study||75||
60071144|NCT01704651|76186643|FG000|COMPLETED|Overall Study||66||
60071145|NCT01704651|76186644|FG001|COMPLETED|Overall Study||68||
60071146|NCT01704651|76186643|FG000|NOT COMPLETED|Overall Study||5||
60071147|NCT01704651|76186644|FG001|NOT COMPLETED|Overall Study||7||
60071148|NCT01876706|76186650|FG000|STARTED|Overall Study||51||
60071149|NCT01876706|76186650|FG000|1 Month|Overall Study||51||
60071150|NCT01876706|76186650|FG000|3 Months|Overall Study||51||
60071151|NCT01876706|76186650|FG000|6 Months|Overall Study||46||
60071152|NCT01876706|76186650|FG000|12 Months|Overall Study||42||
60071153|NCT01876706|76186650|FG000|24 Months|Overall Study||35||
60071154|NCT01876706|76186650|FG000|36 Months|Overall Study||32||
60071155|NCT01876706|76186650|FG000|48 Months|Overall Study||31||
60071156|NCT01876706|76186650|FG000|60 Months|Overall Study||26||
60071157|NCT01876706|76186650|FG000|COMPLETED|Overall Study||26||
60071158|NCT01876706|76186650|FG000|NOT COMPLETED|Overall Study||25||
60071159|NCT01876082|76186656|FG000|STARTED|Overall Study||48||
60071160|NCT01876082|76186657|FG001|STARTED|Overall Study||24||
60071161|NCT01876082|76186656|FG000|Safety Population|Overall Study||48|subjects having received at least one administration of treatment allocated by randomization.|
60071162|NCT01876082|76186657|FG001|Safety Population|Overall Study|2 patients did not start control treatment|22|subjects having received at least one administration of treatment allocated by randomization.|
60071163|NCT01876082|76186656|FG000|COMPLETED|Overall Study||46|Subjects contributing data to the primary endpoint analysis (6-month non-progression) are considered to have completed the study.|
60071164|NCT01876082|76186657|FG001|COMPLETED|Overall Study||20|Subjects contributing data to the primary endpoint analysis (6-month non-progression) are considered to have completed the study.|
60071165|NCT01876082|76186656|FG000|NOT COMPLETED|Overall Study||2||
60071166|NCT01876082|76186657|FG001|NOT COMPLETED|Overall Study||4||
60071167|NCT01704495|76186667|FG000|STARTED|Subjects Randomized||162||
60071168|NCT01704495|76186668|FG001|STARTED|Subjects Randomized||156||
60071169|NCT01704495|76186669|FG002|STARTED|Subjects Randomized||160||
60071170|NCT01704495|76186670|FG003|STARTED|Subjects Randomized||162||
60071171|NCT01704495|76186667|FG000|COMPLETED|Subjects Randomized||140||
60071172|NCT01704495|76186668|FG001|COMPLETED|Subjects Randomized||141||
60071173|NCT01704495|76186669|FG002|COMPLETED|Subjects Randomized||144||
60071174|NCT01704495|76186670|FG003|COMPLETED|Subjects Randomized||145||
60071175|NCT01704495|76186667|FG000|NOT COMPLETED|Subjects Randomized||22||
60071176|NCT01704495|76186668|FG001|NOT COMPLETED|Subjects Randomized||15||
60071177|NCT01704495|76186669|FG002|NOT COMPLETED|Subjects Randomized||16||
60071178|NCT01704495|76186670|FG003|NOT COMPLETED|Subjects Randomized||17||
60071179|NCT01704495|76186667|FG000|STARTED|Optional Safety Extension|46 subjects did not enter safety extension|116||
60071180|NCT01704495|76186668|FG001|STARTED|Optional Safety Extension|35 subjects did not enter safety extension|121||
60071181|NCT01704495|76186669|FG002|STARTED|Optional Safety Extension|46 subjects did not enter safety extension|114||
60071182|NCT01704495|76186670|FG003|STARTED|Optional Safety Extension|46 subjects did not enter safety extension|116||
60071183|NCT01704495|76186667|FG000|COMPLETED|Optional Safety Extension||87||
60071184|NCT01704495|76186668|FG001|COMPLETED|Optional Safety Extension||88||
60071185|NCT01704495|76186669|FG002|COMPLETED|Optional Safety Extension||83||
60071186|NCT01704495|76186670|FG003|COMPLETED|Optional Safety Extension||85||
60071187|NCT01704495|76186667|FG000|NOT COMPLETED|Optional Safety Extension||29||
60071188|NCT01704495|76186668|FG001|NOT COMPLETED|Optional Safety Extension||33||
60071189|NCT01704495|76186669|FG002|NOT COMPLETED|Optional Safety Extension||31||
60071190|NCT01704495|76186670|FG003|NOT COMPLETED|Optional Safety Extension||31||
60103559|NCT03518619|76221793|FG000|COMPLETED|Overall Study||15||
59519370|NCT03554746|75613291|FG000|COMPLETED|Overall Study||24||
59519371|NCT03554746|75613292|FG001|COMPLETED|Overall Study||24||
60071191|NCT01716663|76186680|FG000|STARTED|Overall Study|Enrolled = signed informed consent and met eligibility requirements|234||
60071192|NCT01716663|76186680|FG000|Safety|Overall Study|Enrolled patients who had a study device inserted.|230||
60071193|NCT01716663|76186680|FG000|COMPLETED|Overall Study|Effectiveness population = enrolled and treated (study device inserted and RF energy applied)|228||
59519372|NCT03554746|75613291|FG000|NOT COMPLETED|Overall Study||0||
60071194|NCT01716663|76186680|FG000|NOT COMPLETED|Overall Study||6||
60071195|NCT01716585|76186686|FG000|STARTED|Double-blind Treatment||477||
60071196|NCT01716585|76186687|FG001|STARTED|Double-blind Treatment||159||
60071197|NCT01716585|76186686|FG000|Randomized But Not Treated|Double-blind Treatment||4||
60071198|NCT01716585|76186687|FG001|Randomized But Not Treated|Double-blind Treatment||1||
60071199|NCT01716585|76186686|FG000|COMPLETED|Double-blind Treatment|The number of participants who completed double-blind study drug.|464||
60071200|NCT01716585|76186687|FG001|COMPLETED|Double-blind Treatment|The number of participants who completed double-blind study drug.|157||
60071201|NCT01716585|76186686|FG000|NOT COMPLETED|Double-blind Treatment||13||
60071202|NCT01716585|76186687|FG001|NOT COMPLETED|Double-blind Treatment||2||
60071203|NCT01716585|76186686|FG000|STARTED|Open-label Treatment|not applicable to this arm|0||
60071204|NCT01716585|76186687|FG001|STARTED|Open-label Treatment||157||
60071205|NCT01716585|76186686|FG000|COMPLETED|Open-label Treatment|not applicable to this arm|0||
60071206|NCT01716585|76186687|FG001|COMPLETED|Open-label Treatment|The number of participants who completed open-label study drug.|150||
60071207|NCT01716585|76186686|FG000|NOT COMPLETED|Open-label Treatment||0||
60071208|NCT01716585|76186687|FG001|NOT COMPLETED|Open-label Treatment||7||
60071209|NCT01852292|76186696|FG000|STARTED|Overall Study||79||
60071210|NCT01852292|76186697|FG001|STARTED|Overall Study||79||
60071211|NCT01852292|76186696|FG000|COMPLETED|Overall Study|Completed = participants who were ongoing and did not discontinue study treatment per protocol|0||
60071212|NCT01852292|76186697|FG001|COMPLETED|Overall Study|Completed = participants who were ongoing and did not discontinue study treatment per protocol|0||
60071213|NCT01852292|76186696|FG000|NOT COMPLETED|Overall Study||79||
60071214|NCT01852292|76186697|FG001|NOT COMPLETED|Overall Study||79||
60071215|NCT01715805|76186703|FG000|STARTED|Placebo + ADT Lead-in Period||1022||
60071216|NCT01715805|76186704|FG001|STARTED|Placebo + ADT Lead-in Period||0||
60071217|NCT01715805|76186705|FG002|STARTED|Placebo + ADT Lead-in Period||0||
60071218|NCT01715805|76186706|FG003|STARTED|Placebo + ADT Lead-in Period||0||
60071219|NCT01715805|76186703|FG000|COMPLETED|Placebo + ADT Lead-in Period||807||
60071220|NCT01715805|76186704|FG001|COMPLETED|Placebo + ADT Lead-in Period||0||
60071221|NCT01715805|76186705|FG002|COMPLETED|Placebo + ADT Lead-in Period||0||
60071222|NCT01715805|76186706|FG003|COMPLETED|Placebo + ADT Lead-in Period||0||
60071223|NCT01715805|76186703|FG000|NOT COMPLETED|Placebo + ADT Lead-in Period||215||
60071224|NCT01715805|76186704|FG001|NOT COMPLETED|Placebo + ADT Lead-in Period||0||
60071225|NCT01715805|76186705|FG002|NOT COMPLETED|Placebo + ADT Lead-in Period||0||
60071226|NCT01715805|76186706|FG003|NOT COMPLETED|Placebo + ADT Lead-in Period||0||
60071227|NCT01715805|76186703|FG000|STARTED|Double-Blind or Continued Treatment||0||
60071228|NCT01715805|76186704|FG001|STARTED|Double-Blind or Continued Treatment||261||
60071229|NCT01715805|76186705|FG002|STARTED|Double-Blind or Continued Treatment||269||
60071230|NCT01715805|76186706|FG003|STARTED|Double-Blind or Continued Treatment||270||
60071231|NCT01715805|76186703|FG000|Double-Blind Safety Population|Double-Blind or Continued Treatment||0||
60071232|NCT01715805|76186704|FG001|Double-Blind Safety Population|Double-Blind or Continued Treatment||258||
60071233|NCT01715805|76186705|FG002|Double-Blind Safety Population|Double-Blind or Continued Treatment||269||
60071234|NCT01715805|76186706|FG003|Double-Blind Safety Population|Double-Blind or Continued Treatment||0||
60071235|NCT01715805|76186703|FG000|COMPLETED|Double-Blind or Continued Treatment||0||
60071236|NCT01715805|76186704|FG001|COMPLETED|Double-Blind or Continued Treatment||222||
60071237|NCT01715805|76186705|FG002|COMPLETED|Double-Blind or Continued Treatment||213||
60071238|NCT01715805|76186706|FG003|COMPLETED|Double-Blind or Continued Treatment||222||
60071239|NCT01715805|76186703|FG000|NOT COMPLETED|Double-Blind or Continued Treatment||0||
60071240|NCT01715805|76186704|FG001|NOT COMPLETED|Double-Blind or Continued Treatment||39||
60071241|NCT01715805|76186705|FG002|NOT COMPLETED|Double-Blind or Continued Treatment||56||
60071242|NCT01715805|76186706|FG003|NOT COMPLETED|Double-Blind or Continued Treatment||48||
60071243|NCT01852214|76186714|FG000|STARTED|Period 1||26||
60071244|NCT01852214|76186715|FG001|STARTED|Period 1||24||
60071245|NCT01852214|76186714|FG000|COMPLETED|Period 1||25||
60071246|NCT01852214|76186715|FG001|COMPLETED|Period 1||21||
60071247|NCT01852214|76186714|FG000|NOT COMPLETED|Period 1||1||
60071248|NCT01852214|76186715|FG001|NOT COMPLETED|Period 1||3||
60071249|NCT01852214|76186714|FG000|STARTED|Washout Period||25||
60071250|NCT01852214|76186715|FG001|STARTED|Washout Period||21||
60071251|NCT01852214|76186714|FG000|COMPLETED|Washout Period||25||
60071252|NCT01852214|76186715|FG001|COMPLETED|Washout Period||20||
59519373|NCT03554746|75613292|FG001|NOT COMPLETED|Overall Study||0||
59519374|NCT03608488|75613302|FG000|STARTED|Overall Study||22||
59519375|NCT03608488|75613303|FG001|STARTED|Overall Study||21||
59519376|NCT03608488|75613304|FG002|STARTED|Overall Study||22||
59519377|NCT03608488|75613305|FG003|STARTED|Overall Study||45||
59519378|NCT03608488|75613302|FG000|COMPLETED|Overall Study||21||
59519379|NCT03608488|75613303|FG001|COMPLETED|Overall Study||18||
59519380|NCT03608488|75613304|FG002|COMPLETED|Overall Study||20||
59519381|NCT03608488|75613305|FG003|COMPLETED|Overall Study||40||
60071253|NCT01852214|76186714|FG000|NOT COMPLETED|Washout Period||0||
60071254|NCT01852214|76186715|FG001|NOT COMPLETED|Washout Period||1||
60071255|NCT01852214|76186714|FG000|STARTED|Period 2||25||
60071256|NCT01852214|76186715|FG001|STARTED|Period 2||20||
60071257|NCT01852214|76186714|FG000|COMPLETED|Period 2||25||
60071258|NCT01852214|76186715|FG001|COMPLETED|Period 2||20||
60071259|NCT01852214|76186714|FG000|NOT COMPLETED|Period 2||0||
60071260|NCT01852214|76186715|FG001|NOT COMPLETED|Period 2||0||
60071261|NCT01393990|76186740|FG000|STARTED|Overall Study||4||
60071262|NCT01393990|76186741|FG001|STARTED|Overall Study||3||
60071263|NCT01393990|76186742|FG002|STARTED|Overall Study||3||
60071264|NCT01393990|76186743|FG003|STARTED|Overall Study||3||
60071265|NCT01393990|76186744|FG004|STARTED|Overall Study||5||
60071266|NCT01393990|76186745|FG005|STARTED|Overall Study||3||
60071267|NCT01393990|76186746|FG006|STARTED|Overall Study||3||
60071268|NCT01393990|76186747|FG007|STARTED|Overall Study||7||
60071269|NCT01393990|76186748|FG008|STARTED|Overall Study||6||
60071270|NCT01393990|76186749|FG009|STARTED|Overall Study||3||
60071271|NCT01393990|76186750|FG010|STARTED|Overall Study||3||
60071272|NCT01393990|76186751|FG011|STARTED|Overall Study||3||
60071273|NCT01393990|76186752|FG012|STARTED|Overall Study||3||
60071274|NCT01393990|76186753|FG013|STARTED|Overall Study||5||
60071275|NCT01393990|76186754|FG014|STARTED|Overall Study||18||
60071276|NCT01393990|76186755|FG015|STARTED|Overall Study||8||
60071277|NCT01393990|76186756|FG016|STARTED|Overall Study||3||
60071278|NCT01393990|76186757|FG017|STARTED|Overall Study||6||
60071279|NCT01393990|76186740|FG000|Received at Least 1 Dose of Study Drug|Overall Study||4||
60071280|NCT01393990|76186741|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3||
60071281|NCT01393990|76186742|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3||
60071282|NCT01393990|76186743|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3||
60071283|NCT01393990|76186744|FG004|Received at Least 1 Dose of Study Drug|Overall Study||5||
60071284|NCT01393990|76186745|FG005|Received at Least 1 Dose of Study Drug|Overall Study||3||
60071285|NCT01393990|76186746|FG006|Received at Least 1 Dose of Study Drug|Overall Study||3||
60071286|NCT01393990|76186747|FG007|Received at Least 1 Dose of Study Drug|Overall Study||7||
60071287|NCT01393990|76186748|FG008|Received at Least 1 Dose of Study Drug|Overall Study||6||
60071288|NCT01393990|76186749|FG009|Received at Least 1 Dose of Study Drug|Overall Study||3||
60071289|NCT01393990|76186750|FG010|Received at Least 1 Dose of Study Drug|Overall Study||3||
60071290|NCT01393990|76186751|FG011|Received at Least 1 Dose of Study Drug|Overall Study||3||
60071291|NCT01393990|76186752|FG012|Received at Least 1 Dose of Study Drug|Overall Study||3||
60071292|NCT01393990|76186753|FG013|Received at Least 1 Dose of Study Drug|Overall Study||5||
60071293|NCT01393990|76186754|FG014|Received at Least 1 Dose of Study Drug|Overall Study||18||
60071294|NCT01393990|76186755|FG015|Received at Least 1 Dose of Study Drug|Overall Study||8||
60071295|NCT01393990|76186756|FG016|Received at Least 1 Dose of Study Drug|Overall Study||3||
60071296|NCT01393990|76186757|FG017|Received at Least 1 Dose of Study Drug|Overall Study||6||
60071297|NCT01393990|76186740|FG000|COMPLETED|Overall Study||3||
60071298|NCT01393990|76186741|FG001|COMPLETED|Overall Study||3||
60071299|NCT01393990|76186742|FG002|COMPLETED|Overall Study||3||
60071300|NCT01393990|76186743|FG003|COMPLETED|Overall Study||2||
60071301|NCT01393990|76186744|FG004|COMPLETED|Overall Study||3||
60071302|NCT01393990|76186745|FG005|COMPLETED|Overall Study||2||
60071303|NCT01393990|76186746|FG006|COMPLETED|Overall Study||2||
60071304|NCT01393990|76186747|FG007|COMPLETED|Overall Study||6||
60071305|NCT01393990|76186748|FG008|COMPLETED|Overall Study||3||
60071306|NCT01393990|76186749|FG009|COMPLETED|Overall Study||2||
60071307|NCT01393990|76186750|FG010|COMPLETED|Overall Study||3||
60071308|NCT01393990|76186751|FG011|COMPLETED|Overall Study||3||
60071309|NCT01393990|76186752|FG012|COMPLETED|Overall Study||3||
60071310|NCT01393990|76186753|FG013|COMPLETED|Overall Study||3||
60071311|NCT01393990|76186754|FG014|COMPLETED|Overall Study||9||
60071312|NCT01393990|76186755|FG015|COMPLETED|Overall Study||5||
60071313|NCT01393990|76186756|FG016|COMPLETED|Overall Study||3||
60071314|NCT01393990|76186757|FG017|COMPLETED|Overall Study||6||
60071315|NCT01393990|76186740|FG000|NOT COMPLETED|Overall Study||1||
60071316|NCT01393990|76186741|FG001|NOT COMPLETED|Overall Study||0||
60071317|NCT01393990|76186742|FG002|NOT COMPLETED|Overall Study||0||
60071318|NCT01393990|76186743|FG003|NOT COMPLETED|Overall Study||1||
60071319|NCT01393990|76186744|FG004|NOT COMPLETED|Overall Study||2||
60071320|NCT01393990|76186745|FG005|NOT COMPLETED|Overall Study||1||
60071321|NCT01393990|76186746|FG006|NOT COMPLETED|Overall Study||1||
60071322|NCT01393990|76186747|FG007|NOT COMPLETED|Overall Study||1||
60071323|NCT01393990|76186748|FG008|NOT COMPLETED|Overall Study||3||
60071324|NCT01393990|76186749|FG009|NOT COMPLETED|Overall Study||1||
60071325|NCT01393990|76186750|FG010|NOT COMPLETED|Overall Study||0||
60071326|NCT01393990|76186751|FG011|NOT COMPLETED|Overall Study||0||
60071327|NCT01393990|76186752|FG012|NOT COMPLETED|Overall Study||0||
60071328|NCT01393990|76186753|FG013|NOT COMPLETED|Overall Study||2||
60071329|NCT01393990|76186754|FG014|NOT COMPLETED|Overall Study||9||
59519382|NCT03608488|75613302|FG000|NOT COMPLETED|Overall Study||1||
59951693|NCT02734862|76070690|FG000|NOT COMPLETED|Part A||12||
59951694|NCT02734862|76070691|FG001|NOT COMPLETED|Part A||8||
59951695|NCT02734862|76070692|FG002|NOT COMPLETED|Part A||14||
59951696|NCT02734862|76070690|FG000|STARTED|Part B||46|"The Intent-to-Treat (ITT) population analyzed consisted of all subjects randomized to treatment. Subjects were analyzed based on the treatment group to which they were randomized.~In Part B, subjects were randomized 2:1 to receive rezafungin treatment or IV caspofungin."|
59951697|NCT02734862|76070691|FG001|STARTED|Part B||21|"The Intent-to-Treat (ITT) population analyzed consisted of all subjects randomized to treatment. Subjects were analyzed based on the treatment group to which they were randomized.~In Part B, subjects were randomized 2:1 to receive rezafungin treatment or IV caspofungin."|
59951698|NCT02734862|76070692|FG002|STARTED|Part B||33|"The Intent-to-Treat (ITT) population analyzed consisted of all subjects randomized to treatment. Subjects were analyzed based on the treatment group to which they were randomized.~In Part B, subjects were randomized 2:1 to receive rezafungin treatment or IV caspofungin."|
59951699|NCT02734862|76070690|FG000|COMPLETED|Part B||33||
59951700|NCT02734862|76070691|FG001|COMPLETED|Part B||14||
59951701|NCT02734862|76070692|FG002|COMPLETED|Part B||28||
59951702|NCT02734862|76070690|FG000|NOT COMPLETED|Part B||13||
59951703|NCT02734862|76070691|FG001|NOT COMPLETED|Part B||7||
59951704|NCT02734862|76070692|FG002|NOT COMPLETED|Part B||5||
59951705|NCT00858702|76070703|FG000|STARTED|Overall Study||53||
59951706|NCT00858702|76070704|FG001|STARTED|Overall Study||52||
59951707|NCT00858702|76070703|FG000|COMPLETED|Overall Study||48||
59951708|NCT00858702|76070704|FG001|COMPLETED|Overall Study||50||
59951709|NCT00858702|76070703|FG000|NOT COMPLETED|Overall Study||5||
59951710|NCT00858702|76070704|FG001|NOT COMPLETED|Overall Study||2||
59951711|NCT02598934|76070712|FG000|STARTED|Overall Study||154||
59951712|NCT02598934|76070713|FG001|STARTED|Overall Study||154||
59951713|NCT02598934|76070712|FG000|COMPLETED|Overall Study||135||
59951714|NCT02598934|76070713|FG001|COMPLETED|Overall Study||132||
59951715|NCT02598934|76070712|FG000|NOT COMPLETED|Overall Study||19||
59951716|NCT02598934|76070713|FG001|NOT COMPLETED|Overall Study||22||
59951717|NCT02598622|76070721|FG000|STARTED|Overall Study||8||
59951718|NCT02598622|76070722|FG001|STARTED|Overall Study|Study terminated prior to randomization phase. No enrollment in this arm.|0||
59951719|NCT02598622|76070721|FG000|COMPLETED|Overall Study||2||
59951720|NCT02598622|76070722|FG001|COMPLETED|Overall Study||0||
59951721|NCT02598622|76070721|FG000|NOT COMPLETED|Overall Study||6||
59951722|NCT02598622|76070722|FG001|NOT COMPLETED|Overall Study||0||
59951723|NCT00841698|76070730|FG000|STARTED|First Intervention||25||
59951724|NCT00841698|76070731|FG001|STARTED|First Intervention||25||
59951725|NCT00841698|76070730|FG000|COMPLETED|First Intervention||24||
59951726|NCT00841698|76070731|FG001|COMPLETED|First Intervention||25||
59951727|NCT00841698|76070730|FG000|NOT COMPLETED|First Intervention||1||
59951728|NCT00841698|76070731|FG001|NOT COMPLETED|First Intervention||0||
59951729|NCT00841698|76070730|FG000|STARTED|Washout: 2 Weeks||24||
59951730|NCT00841698|76070731|FG001|STARTED|Washout: 2 Weeks||25||
59951731|NCT00841698|76070730|FG000|COMPLETED|Washout: 2 Weeks||24||
59951732|NCT00841698|76070731|FG001|COMPLETED|Washout: 2 Weeks||25||
59951733|NCT00841698|76070730|FG000|NOT COMPLETED|Washout: 2 Weeks||0||
59951734|NCT00841698|76070731|FG001|NOT COMPLETED|Washout: 2 Weeks||0||
59951735|NCT00841698|76070730|FG000|STARTED|Second Intervention||24||
59951736|NCT00841698|76070731|FG001|STARTED|Second Intervention||25||
59951737|NCT00841698|76070730|FG000|COMPLETED|Second Intervention||24||
59951738|NCT00841698|76070731|FG001|COMPLETED|Second Intervention||25||
59951739|NCT00841698|76070730|FG000|NOT COMPLETED|Second Intervention||0||
59951740|NCT00841698|76070731|FG001|NOT COMPLETED|Second Intervention||0||
59951741|NCT00841542|76070737|FG000|STARTED|Period 1||14||
59951742|NCT00841542|76070738|FG001|STARTED|Period 1||14||
59951743|NCT00841542|76070737|FG000|COMPLETED|Period 1||13||
59951744|NCT00841542|76070738|FG001|COMPLETED|Period 1||14||
59951745|NCT00841542|76070737|FG000|NOT COMPLETED|Period 1||1||
59951746|NCT00841542|76070738|FG001|NOT COMPLETED|Period 1||0||
59951747|NCT00841542|76070737|FG000|STARTED|Period 2||13||
59951748|NCT00841542|76070738|FG001|STARTED|Period 2||14||
59951749|NCT00841542|76070737|FG000|COMPLETED|Period 2||13||
59951750|NCT00841542|76070738|FG001|COMPLETED|Period 2||14||
59951751|NCT00841542|76070737|FG000|NOT COMPLETED|Period 2||0||
59951752|NCT00841542|76070738|FG001|NOT COMPLETED|Period 2||0||
59951753|NCT00840840|76070744|FG000|STARTED|Period 1||24||
59951754|NCT00840840|76070745|FG001|STARTED|Period 1||24||
59951755|NCT00840840|76070744|FG000|COMPLETED|Period 1||24||
59951756|NCT00840840|76070745|FG001|COMPLETED|Period 1||24||
59951757|NCT00840840|76070744|FG000|NOT COMPLETED|Period 1||0||
59951758|NCT00840840|76070745|FG001|NOT COMPLETED|Period 1||0||
59951759|NCT00840840|76070744|FG000|STARTED|Period 2|One subject was withdrawn due to AE after Period 1|23||
59951760|NCT00840840|76070745|FG001|STARTED|Period 2||24||
59951761|NCT00840840|76070744|FG000|COMPLETED|Period 2||23||
59951762|NCT00840840|76070745|FG001|COMPLETED|Period 2||24||
59951763|NCT00840840|76070744|FG000|NOT COMPLETED|Period 2||0||
59951764|NCT00840840|76070745|FG001|NOT COMPLETED|Period 2||0||
59951765|NCT03595982|76070751|FG000|STARTED|Overall Study||3||
59951766|NCT03595982|76070752|FG001|STARTED|Overall Study||2||
59951767|NCT03595982|76070751|FG000|COMPLETED|Overall Study||3||
59519383|NCT03608488|75613303|FG001|NOT COMPLETED|Overall Study||3||
59519384|NCT03608488|75613304|FG002|NOT COMPLETED|Overall Study||2||
59519385|NCT03608488|75613305|FG003|NOT COMPLETED|Overall Study||5||
59951768|NCT03595982|76070752|FG001|COMPLETED|Overall Study||2||
59951769|NCT03595982|76070751|FG000|NOT COMPLETED|Overall Study||0||
59951770|NCT03595982|76070752|FG001|NOT COMPLETED|Overall Study||0||
59951771|NCT00840216|76070760|FG000|STARTED|First Intervention||11||
59951772|NCT00840216|76070761|FG001|STARTED|First Intervention||11||
60071330|NCT01393990|76186755|FG015|NOT COMPLETED|Overall Study||3||
60071331|NCT01393990|76186756|FG016|NOT COMPLETED|Overall Study||0||
60071332|NCT01393990|76186757|FG017|NOT COMPLETED|Overall Study||0||
60071333|NCT00210184|76186806|FG000|STARTED|Overall Study||42||
60071334|NCT00210184|76186806|FG000|COMPLETED|Overall Study||40||
60071335|NCT00210184|76186806|FG000|NOT COMPLETED|Overall Study||2||
60071336|NCT00210106|76186810|FG000|STARTED|Overall Study||52||
60071337|NCT00210106|76186810|FG000|Safety Population|Overall Study||49|safety population is defined as patients who received IRFA treatment with our without resection.|
60071338|NCT00210106|76186810|FG000|COMPLETED|Overall Study||38|Patients eligible (without major protocol deviation) who received the treatment (IRFA +/- surgery) and for whom 2 scans (2 months and 3 months) were available.|
60071339|NCT00210106|76186810|FG000|NOT COMPLETED|Overall Study||14||
60071340|NCT01851590|76186818|FG000|STARTED|Overall Study|In addition to clinical control visits, patients were contacted by phone during weeks 6, 13, and 29.|23||
60071341|NCT01851590|76186819|FG001|STARTED|Overall Study|In addition to clinical control visits, patients were contacted by phone during weeks 6, 13, and 29.|25||
60071342|NCT01851590|76186820|FG002|STARTED|Overall Study|In addition to clinical control visits, patients were contacted by phone during weeks 6, 13, and 29.|25||
60071343|NCT01851590|76186818|FG000|At 3 Month: End of Terbinafine Treatment|Overall Study|Topical Resin Lacquer treatment continues ->|23||
60071344|NCT01851590|76186819|FG001|At 3 Month: End of Terbinafine Treatment|Overall Study|Topical Amorolfine Lacquer Treatment continues ->|24||
60071345|NCT01851590|76186820|FG002|At 3 Month: End of Terbinafine Treatment|Overall Study|End of oral Terbinafine treatment. Washout period of the Terbinafine treatment arm begins.|22||
60071346|NCT01851590|76186818|FG000|At 4 Month: Follow-up Visit and Control|Overall Study|Clinical response to treatment, toenails samples and laboratory exams were controlled.|23||
60071347|NCT01851590|76186819|FG001|At 4 Month: Follow-up Visit and Control|Overall Study|Clinical response to treatment, toenails samples and laboratory exams were controlled.|24||
60071348|NCT01851590|76186820|FG002|At 4 Month: Follow-up Visit and Control|Overall Study|Clinical response to treatment, toenails samples and laboratory exams were controlled.|22||
60071349|NCT01851590|76186818|FG000|At 9 Month: End of Topical Treatments|Overall Study|End of topical Resin Lacquer treatment. Washout period of the Resin Lacquer treatment arm begins.|23||
60071350|NCT01851590|76186819|FG001|At 9 Month: End of Topical Treatments|Overall Study|End of topical Amorolfine Lacquer treatment. Washout period of the Amorolfine treatment arm begins.|24||
60071351|NCT01851590|76186820|FG002|At 9 Month: End of Topical Treatments|Overall Study|Washout period of the Terbinafine treatment arm continues.|22||
60071352|NCT01851590|76186818|FG000|At 10 Month: Follow-up Visit and Control|Overall Study|Study completed. Clinical response to treatment, toenails samples and lab. exams were controlled.|23||
60071353|NCT01851590|76186819|FG001|At 10 Month: Follow-up Visit and Control|Overall Study|Study completed. Clinical response to treatment, toenails samples and lab. exams were controlled.|24||
60071354|NCT01851590|76186820|FG002|At 10 Month: Follow-up Visit and Control|Overall Study|Study completed. Clinical response to treatment, toenails samples and lab. exams were controlled.|22||
60071355|NCT01851590|76186818|FG000|COMPLETED|Overall Study|All patients (23) were included in the ITT population and final outcome analyses.|23||
60071356|NCT01851590|76186819|FG001|COMPLETED|Overall Study|All patients (25) were included in the ITT population and final outcome analyses.|24||
60071357|NCT01851590|76186820|FG002|COMPLETED|Overall Study|All patients (25) were included in the ITT population and final outcome analyses.|22||
60071358|NCT01851590|76186818|FG000|NOT COMPLETED|Overall Study||0||
60071359|NCT01851590|76186819|FG001|NOT COMPLETED|Overall Study||1||
60071360|NCT01851590|76186820|FG002|NOT COMPLETED|Overall Study||3||
60071361|NCT01852058|76186835|FG000|STARTED|Treatment Cycle 1, Occurred in Study 120||31||
60071362|NCT01852058|76186836|FG001|STARTED|Treatment Cycle 1, Occurred in Study 120||39||
60071363|NCT01852058|76186837|FG002|STARTED|Treatment Cycle 1, Occurred in Study 120||25||
60071364|NCT01852058|76186838|FG003|STARTED|Treatment Cycle 1, Occurred in Study 120||0||
60071365|NCT01852058|76186839|FG004|STARTED|Treatment Cycle 1, Occurred in Study 120||0||
60071366|NCT01852058|76186840|FG005|STARTED|Treatment Cycle 1, Occurred in Study 120||0||
60071367|NCT01852058|76186841|FG006|STARTED|Treatment Cycle 1, Occurred in Study 120||0||
60071368|NCT01852058|76186842|FG007|STARTED|Treatment Cycle 1, Occurred in Study 120||0||
60071369|NCT01852058|76186843|FG008|STARTED|Treatment Cycle 1, Occurred in Study 120||0||
60071370|NCT01852058|76186844|FG009|STARTED|Treatment Cycle 1, Occurred in Study 120||0||
60071371|NCT01852058|76186845|FG010|STARTED|Treatment Cycle 1, Occurred in Study 120||0||
60071372|NCT01852058|76186846|FG011|STARTED|Treatment Cycle 1, Occurred in Study 120||0||
60071373|NCT01852058|76186835|FG000|COMPLETED|Treatment Cycle 1, Occurred in Study 120||30|Completed=Completed the entire study in this Cycle|
60071374|NCT01852058|76186836|FG001|COMPLETED|Treatment Cycle 1, Occurred in Study 120||39|Completed=Completed the entire study in this Cycle|
60071375|NCT01852058|76186837|FG002|COMPLETED|Treatment Cycle 1, Occurred in Study 120||25|Completed=Completed the entire study in this Cycle|
60071376|NCT01852058|76186838|FG003|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0|Completed=Completed the entire study in this Cycle|
60071377|NCT01852058|76186839|FG004|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0|Completed=Completed the entire study in this Cycle|
60071378|NCT01852058|76186840|FG005|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0|Completed=Completed the entire study in this Cycle|
60071379|NCT01852058|76186841|FG006|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0|Completed=Completed the entire study in this Cycle|
60071380|NCT01852058|76186842|FG007|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0|Completed=Completed the entire study in this Cycle|
60071381|NCT01852058|76186843|FG008|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0|Completed=Completed the entire study in this Cycle|
60103560|NCT03518619|76221793|FG000|NOT COMPLETED|Overall Study||5||
60071382|NCT01852058|76186844|FG009|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0|Completed=Completed the entire study in this Cycle|
60071383|NCT01852058|76186845|FG010|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0|Completed=Completed the entire study in this Cycle|
60071384|NCT01852058|76186846|FG011|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0|Completed=Completed the entire study in this Cycle|
60071385|NCT01852058|76186835|FG000|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||1||
60071386|NCT01852058|76186836|FG001|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0||
60071387|NCT01852058|76186837|FG002|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0||
60071388|NCT01852058|76186838|FG003|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0||
60071389|NCT01852058|76186839|FG004|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0||
60071390|NCT01852058|76186840|FG005|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0||
60071391|NCT01852058|76186841|FG006|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0||
60071392|NCT01852058|76186842|FG007|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0||
60071393|NCT01852058|76186843|FG008|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0||
60071394|NCT01852058|76186844|FG009|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0||
60071395|NCT01852058|76186845|FG010|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0||
60071396|NCT01852058|76186846|FG011|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0||
60071397|NCT01852058|76186835|FG000|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0||
60071398|NCT01852058|76186836|FG001|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0||
60071399|NCT01852058|76186837|FG002|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0||
60071400|NCT01852058|76186838|FG003|STARTED|Treatment Cycle2:Retreatment 1,Study 121||9||
60071401|NCT01852058|76186839|FG004|STARTED|Treatment Cycle2:Retreatment 1,Study 121||45||
60071402|NCT01852058|76186840|FG005|STARTED|Treatment Cycle2:Retreatment 1,Study 121||36||
60071403|NCT01852058|76186841|FG006|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0||
60071404|NCT01852058|76186842|FG007|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0||
60071405|NCT01852058|76186843|FG008|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0||
60071406|NCT01852058|76186844|FG009|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0||
60071407|NCT01852058|76186845|FG010|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0||
60071408|NCT01852058|76186846|FG011|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0||
60071409|NCT01852058|76186835|FG000|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0|Completed=Completed the entire study in this Cycle|
60071410|NCT01852058|76186836|FG001|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0|Completed=Completed the entire study in this Cycle|
60071411|NCT01852058|76186837|FG002|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0|Completed=Completed the entire study in this Cycle|
60071412|NCT01852058|76186838|FG003|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||8|Completed=Completed the entire study in this Cycle|
60071413|NCT01852058|76186839|FG004|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||38|Completed=Completed the entire study in this Cycle|
60071414|NCT01852058|76186840|FG005|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||27|Completed=Completed the entire study in this Cycle|
60071415|NCT01852058|76186841|FG006|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0|Completed=Completed the entire study in this Cycle|
60071416|NCT01852058|76186842|FG007|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0|Completed=Completed the entire study in this Cycle|
60071417|NCT01852058|76186843|FG008|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0|Completed=Completed the entire study in this Cycle|
60071418|NCT01852058|76186844|FG009|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0|Completed=Completed the entire study in this Cycle|
60071419|NCT01852058|76186845|FG010|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0|Completed=Completed the entire study in this Cycle|
60071420|NCT01852058|76186846|FG011|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0|Completed=Completed the entire study in this Cycle|
60071421|NCT01852058|76186835|FG000|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0||
60071422|NCT01852058|76186836|FG001|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0||
60071423|NCT01852058|76186837|FG002|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0||
60071424|NCT01852058|76186838|FG003|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||1||
60071425|NCT01852058|76186839|FG004|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||7||
60071426|NCT01852058|76186840|FG005|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||9||
60071427|NCT01852058|76186841|FG006|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0||
60071428|NCT01852058|76186842|FG007|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0||
60071429|NCT01852058|76186843|FG008|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0||
60071430|NCT01852058|76186844|FG009|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0||
60071431|NCT01852058|76186845|FG010|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0||
60071432|NCT01852058|76186846|FG011|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0||
60071433|NCT01852058|76186835|FG000|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0||
60071434|NCT01852058|76186836|FG001|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0||
60071435|NCT01852058|76186837|FG002|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0||
60071436|NCT01852058|76186838|FG003|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0||
60071437|NCT01852058|76186839|FG004|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0||
60071438|NCT01852058|76186840|FG005|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0||
60071439|NCT01852058|76186841|FG006|STARTED|Treatment Cycle3:Retreatment 2,Study 121||5||
60071440|NCT01852058|76186842|FG007|STARTED|Treatment Cycle3:Retreatment 2,Study 121||16||
60071441|NCT01852058|76186843|FG008|STARTED|Treatment Cycle3:Retreatment 2,Study 121||34||
60071442|NCT01852058|76186844|FG009|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0||
60071443|NCT01852058|76186845|FG010|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0||
60071444|NCT01852058|76186846|FG011|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0||
60071445|NCT01852058|76186835|FG000|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0|Completed=Completed the entire study in this Cycle|
60071446|NCT01852058|76186836|FG001|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0|Completed=Completed the entire study in this Cycle|
60071447|NCT01852058|76186837|FG002|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0|Completed=Completed the entire study in this Cycle|
60071448|NCT01852058|76186838|FG003|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0|Completed=Completed the entire study in this Cycle|
60071449|NCT01852058|76186839|FG004|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0|Completed=Completed the entire study in this Cycle|
60071450|NCT01852058|76186840|FG005|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0|Completed=Completed the entire study in this Cycle|
60071451|NCT01852058|76186841|FG006|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||5|Completed=Completed the entire study in this Cycle|
60071452|NCT01852058|76186842|FG007|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||15|Completed=Completed the entire study in this Cycle|
60071453|NCT01852058|76186843|FG008|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||33|Completed=Completed the entire study in this Cycle|
60071454|NCT01852058|76186844|FG009|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0|Completed=Completed the entire study in this Cycle|
60071455|NCT01852058|76186845|FG010|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0|Completed=Completed the entire study in this Cycle|
59951773|NCT00840216|76070760|FG000|COMPLETED|First Intervention||11||
59951774|NCT00840216|76070761|FG001|COMPLETED|First Intervention||11||
59951775|NCT00840216|76070760|FG000|NOT COMPLETED|First Intervention||0||
59951776|NCT00840216|76070761|FG001|NOT COMPLETED|First Intervention||0||
59951777|NCT00840216|76070760|FG000|STARTED|Washout: 7 Days||11||
59951778|NCT00840216|76070761|FG001|STARTED|Washout: 7 Days||11||
59951779|NCT00840216|76070760|FG000|COMPLETED|Washout: 7 Days||10||
59951780|NCT00840216|76070761|FG001|COMPLETED|Washout: 7 Days||11||
59951781|NCT00840216|76070760|FG000|NOT COMPLETED|Washout: 7 Days||1||
59951782|NCT00840216|76070761|FG001|NOT COMPLETED|Washout: 7 Days||0||
59951783|NCT00840216|76070760|FG000|STARTED|Second Intervention||10||
59951784|NCT00840216|76070761|FG001|STARTED|Second Intervention||11||
59951785|NCT00840216|76070760|FG000|COMPLETED|Second Intervention||10||
59951786|NCT00840216|76070761|FG001|COMPLETED|Second Intervention||11||
59951787|NCT00840216|76070760|FG000|NOT COMPLETED|Second Intervention||0||
59951788|NCT00840216|76070761|FG001|NOT COMPLETED|Second Intervention||0||
59951789|NCT04266158|76070765|FG000|STARTED|Overall Study||0||
59951790|NCT04266158|76070765|FG000|COMPLETED|Overall Study||0||
59951791|NCT04266158|76070765|FG000|NOT COMPLETED|Overall Study||0||
59951792|NCT00836706|76070771|FG000|STARTED|First Intervention||11||
59951793|NCT00836706|76070772|FG001|STARTED|First Intervention||12||
59951794|NCT00836706|76070771|FG000|COMPLETED|First Intervention||11||
59951795|NCT00836706|76070772|FG001|COMPLETED|First Intervention||12||
59951796|NCT00836706|76070771|FG000|NOT COMPLETED|First Intervention||0||
59951797|NCT00836706|76070772|FG001|NOT COMPLETED|First Intervention||0||
59951798|NCT00836706|76070771|FG000|STARTED|Washout: 7 Days||11||
59951799|NCT00836706|76070772|FG001|STARTED|Washout: 7 Days||12||
59951800|NCT00836706|76070771|FG000|COMPLETED|Washout: 7 Days||11||
59951801|NCT00836706|76070772|FG001|COMPLETED|Washout: 7 Days||11||
59951802|NCT00836706|76070771|FG000|NOT COMPLETED|Washout: 7 Days||0||
59951803|NCT00836706|76070772|FG001|NOT COMPLETED|Washout: 7 Days||1||
59951804|NCT00836706|76070771|FG000|STARTED|Second Intervention||11||
59951805|NCT00836706|76070772|FG001|STARTED|Second Intervention||11||
59951806|NCT00836706|76070771|FG000|COMPLETED|Second Intervention||11||
59951807|NCT00836706|76070772|FG001|COMPLETED|Second Intervention||11||
59951808|NCT00836706|76070771|FG000|NOT COMPLETED|Second Intervention||0||
59951809|NCT00836706|76070772|FG001|NOT COMPLETED|Second Intervention||0||
59951810|NCT00836472|76070778|FG000|STARTED|First Intervention||30||
59951811|NCT00836472|76070779|FG001|STARTED|First Intervention||30||
59951812|NCT00836472|76070778|FG000|COMPLETED|First Intervention||30||
59951813|NCT00836472|76070779|FG001|COMPLETED|First Intervention||30||
59951814|NCT00836472|76070778|FG000|NOT COMPLETED|First Intervention||0||
59951815|NCT00836472|76070779|FG001|NOT COMPLETED|First Intervention||0||
59951816|NCT00836472|76070778|FG000|STARTED|Washout||30||
59951817|NCT00836472|76070779|FG001|STARTED|Washout||30||
59951818|NCT00836472|76070778|FG000|COMPLETED|Washout||28||
59951819|NCT00836472|76070779|FG001|COMPLETED|Washout||27||
60071456|NCT01852058|76186846|FG011|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0|Completed=Completed the entire study in this Cycle|
60071457|NCT01852058|76186835|FG000|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0||
60071458|NCT01852058|76186836|FG001|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0||
60103561|NCT01342666|76221799|FG000|STARTED|Overall Study||26||
59951820|NCT00836472|76070778|FG000|NOT COMPLETED|Washout||2||
59951821|NCT00836472|76070779|FG001|NOT COMPLETED|Washout||3||
59951822|NCT00836472|76070778|FG000|STARTED|Second Intervention||28||
59951823|NCT00836472|76070779|FG001|STARTED|Second Intervention||27||
59951824|NCT00836472|76070778|FG000|COMPLETED|Second Intervention||28||
59951825|NCT00836472|76070779|FG001|COMPLETED|Second Intervention||27||
59951826|NCT00836472|76070778|FG000|NOT COMPLETED|Second Intervention||0||
60071459|NCT01852058|76186837|FG002|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0||
59519386|NCT03557086|75613317|FG000|STARTED|Overall Study||26||
59519387|NCT03557086|75613318|FG001|STARTED|Overall Study||24||
59519388|NCT03557086|75613317|FG000|COMPLETED|Overall Study||26||
60071460|NCT01852058|76186838|FG003|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0||
60071461|NCT01852058|76186839|FG004|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0||
60071462|NCT01852058|76186840|FG005|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0||
60071463|NCT01852058|76186841|FG006|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0||
60071464|NCT01852058|76186842|FG007|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||1||
60071465|NCT01852058|76186843|FG008|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||1||
60071466|NCT01852058|76186844|FG009|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0||
60071467|NCT01852058|76186845|FG010|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0||
60071468|NCT01852058|76186846|FG011|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0||
60071469|NCT01852058|76186835|FG000|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0||
60071470|NCT01852058|76186836|FG001|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0||
60071471|NCT01852058|76186837|FG002|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0||
60071472|NCT01852058|76186838|FG003|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0||
60071473|NCT01852058|76186839|FG004|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0||
60071474|NCT01852058|76186840|FG005|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0||
60071475|NCT01852058|76186841|FG006|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0||
60071476|NCT01852058|76186842|FG007|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0||
60071477|NCT01852058|76186843|FG008|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0||
60071478|NCT01852058|76186844|FG009|STARTED|Treatment Cycle4:Retreatment 3,Study 121||3||
60071479|NCT01852058|76186845|FG010|STARTED|Treatment Cycle4:Retreatment 3,Study 121||4||
60071480|NCT01852058|76186846|FG011|STARTED|Treatment Cycle4:Retreatment 3,Study 121||4||
60071481|NCT01852058|76186835|FG000|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0|Completed=Completed the entire study in this Cycle|
59519389|NCT03557086|75613318|FG001|COMPLETED|Overall Study||24||
59519390|NCT03557086|75613317|FG000|NOT COMPLETED|Overall Study||0||
59519391|NCT03557086|75613318|FG001|NOT COMPLETED|Overall Study||0||
59519392|NCT03557476|75613328|FG000|STARTED|Overall Study||13||
59519393|NCT03557476|75613329|FG001|STARTED|Overall Study||13||
59519394|NCT03557476|75613328|FG000|COMPLETED|Overall Study||13||
59519395|NCT03557476|75613329|FG001|COMPLETED|Overall Study||13||
59519396|NCT03557476|75613328|FG000|NOT COMPLETED|Overall Study||0||
59519397|NCT03557476|75613329|FG001|NOT COMPLETED|Overall Study||0||
59519398|NCT03403504|75613337|FG000|STARTED|Period 1||12||
59519399|NCT03403504|75613338|FG001|STARTED|Period 1||12||
59519400|NCT03403504|75613337|FG000|COMPLETED|Period 1||12||
59519401|NCT03403504|75613338|FG001|COMPLETED|Period 1||11||
59519402|NCT03403504|75613337|FG000|NOT COMPLETED|Period 1||0||
59519403|NCT03403504|75613338|FG001|NOT COMPLETED|Period 1||1||
59519404|NCT03403504|75613337|FG000|STARTED|Period 2||12||
59519405|NCT03403504|75613338|FG001|STARTED|Period 2||11||
59519406|NCT03403504|75613337|FG000|COMPLETED|Period 2||12||
59519407|NCT03403504|75613338|FG001|COMPLETED|Period 2||11||
59519408|NCT03403504|75613337|FG000|NOT COMPLETED|Period 2||0||
59519409|NCT03403504|75613338|FG001|NOT COMPLETED|Period 2||0||
59519410|NCT03609658|75613360|FG000|STARTED|Overall Study||379||
59519411|NCT03609658|75613361|FG001|STARTED|Overall Study||380||
59519412|NCT03609658|75613360|FG000|COMPLETED|Overall Study||379||
59519413|NCT03609658|75613361|FG001|COMPLETED|Overall Study||380||
59519414|NCT03609658|75613360|FG000|NOT COMPLETED|Overall Study||0||
59519415|NCT03609658|75613361|FG001|NOT COMPLETED|Overall Study||0||
59519416|NCT02565810|75613367|FG000|STARTED|Overall Study||49||
59519417|NCT02565810|75613367|FG000|COMPLETED|Overall Study||48||
59519418|NCT02565810|75613367|FG000|NOT COMPLETED|Overall Study||1||
59519419|NCT00940901|75613378|FG000|STARTED|Weeks 1-8 (Phase 1)||6||
59519420|NCT00940901|75613379|FG001|STARTED|Weeks 1-8 (Phase 1)||7||
59519421|NCT00940901|75613378|FG000|COMPLETED|Weeks 1-8 (Phase 1)||6||
59519422|NCT00940901|75613379|FG001|COMPLETED|Weeks 1-8 (Phase 1)||7||
59519423|NCT00940901|75613378|FG000|NOT COMPLETED|Weeks 1-8 (Phase 1)||0||
59519424|NCT00940901|75613379|FG001|NOT COMPLETED|Weeks 1-8 (Phase 1)||0||
59519425|NCT00940901|75613378|FG000|STARTED|Week 9-16 (Phase 2)||6||
59519426|NCT00940901|75613379|FG001|STARTED|Week 9-16 (Phase 2)||7||
59519427|NCT00940901|75613378|FG000|COMPLETED|Week 9-16 (Phase 2)||4||
59519428|NCT00940901|75613379|FG001|COMPLETED|Week 9-16 (Phase 2)||4||
59519429|NCT00940901|75613378|FG000|NOT COMPLETED|Week 9-16 (Phase 2)||2||
59519430|NCT00940901|75613379|FG001|NOT COMPLETED|Week 9-16 (Phase 2)||3||
59519431|NCT03611062|75613389|FG000|STARTED|Overall Study||14||
59519432|NCT03611062|75613390|FG001|STARTED|Overall Study||13||
59519433|NCT03611062|75613389|FG000|COMPLETED|Overall Study||13||
59519434|NCT03611062|75613390|FG001|COMPLETED|Overall Study||12||
59519435|NCT03611062|75613389|FG000|NOT COMPLETED|Overall Study||1||
59519436|NCT03611062|75613390|FG001|NOT COMPLETED|Overall Study||1||
59519437|NCT03560128|75613398|FG000|STARTED|Overall Study||306||
59519438|NCT03560128|75613399|FG001|STARTED|Overall Study||306||
59519439|NCT03560128|75613398|FG000|COMPLETED|Overall Study||294||
59519440|NCT03560128|75613399|FG001|COMPLETED|Overall Study||298||
59519441|NCT03560128|75613398|FG000|NOT COMPLETED|Overall Study||12||
59519442|NCT03560128|75613399|FG001|NOT COMPLETED|Overall Study||8||
59519443|NCT03614416|75613405|FG000|STARTED|Overall Study||13||
59519444|NCT03614416|75613405|FG000|COMPLETED|Overall Study||13||
60071482|NCT01852058|76186836|FG001|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0|Completed=Completed the entire study in this Cycle|
60071483|NCT01852058|76186837|FG002|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0|Completed=Completed the entire study in this Cycle|
60071484|NCT01852058|76186838|FG003|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0|Completed=Completed the entire study in this Cycle|
60071485|NCT01852058|76186839|FG004|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0|Completed=Completed the entire study in this Cycle|
60071486|NCT01852058|76186840|FG005|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0|Completed=Completed the entire study in this Cycle|
60071487|NCT01852058|76186841|FG006|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0|Completed=Completed the entire study in this Cycle|
60071488|NCT01852058|76186842|FG007|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0|Completed=Completed the entire study in this Cycle|
60071489|NCT01852058|76186843|FG008|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0|Completed=Completed the entire study in this Cycle|
60071490|NCT01852058|76186844|FG009|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||3|Completed=Completed the entire study in this Cycle|
60071491|NCT01852058|76186845|FG010|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||4|Completed=Completed the entire study in this Cycle|
60071492|NCT01852058|76186846|FG011|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||4|Completed=Completed the entire study in this Cycle|
60071493|NCT01852058|76186835|FG000|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0||
60071494|NCT01852058|76186836|FG001|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0||
60071495|NCT01852058|76186837|FG002|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0||
60071496|NCT01852058|76186838|FG003|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0||
60071497|NCT01852058|76186839|FG004|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0||
60071498|NCT01852058|76186840|FG005|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0||
60071499|NCT01852058|76186841|FG006|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0||
60071500|NCT01852058|76186842|FG007|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0||
60071501|NCT01852058|76186843|FG008|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0||
60071502|NCT01852058|76186844|FG009|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0||
60071503|NCT01852058|76186845|FG010|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0||
60071504|NCT01852058|76186846|FG011|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0||
60071505|NCT00218296|76186883|FG000|STARTED|Overall Study||163|Randomized at phone screen.|
60071506|NCT00218296|76186884|FG001|STARTED|Overall Study||169|Randomized at phone screen.|
60071507|NCT00218296|76186883|FG000|Attended Visti|Overall Study||97||
60071508|NCT00218296|76186884|FG001|Attended Visti|Overall Study||102||
60071509|NCT00218296|76186883|FG000|COMPLETED|Overall Study||52||
60071510|NCT00218296|76186884|FG001|COMPLETED|Overall Study||48||
60071511|NCT00218296|76186883|FG000|NOT COMPLETED|Overall Study||111||
60071512|NCT00218296|76186884|FG001|NOT COMPLETED|Overall Study||121||
60071513|NCT00217672|76186892|FG000|STARTED|Allocation||69||
60071514|NCT00217672|76186893|FG001|STARTED|Allocation|When bevacizumab became available, study converted to a 1-arm open-label trial with just bevacizumab|7||
60071515|NCT00217672|76186892|FG000|COMPLETED|Allocation||67||
59519445|NCT03614416|75613405|FG000|NOT COMPLETED|Overall Study||0||
59519446|NCT03564886|75613413|FG000|STARTED|Overall Study||24||
59519447|NCT03564886|75613414|FG001|STARTED|Overall Study||24||
59519448|NCT03564886|75613413|FG000|COMPLETED|Overall Study||23||
59519449|NCT03564886|75613414|FG001|COMPLETED|Overall Study||23||
59519450|NCT03564886|75613413|FG000|NOT COMPLETED|Overall Study||1||
59519451|NCT03564886|75613414|FG001|NOT COMPLETED|Overall Study||1||
59519452|NCT03565666|75613420|FG000|STARTED|Overall Study||12||
59519453|NCT03565666|75613421|FG001|STARTED|Overall Study||12||
59519454|NCT03565666|75613422|FG002|STARTED|Overall Study||12||
59519455|NCT03565666|75613420|FG000|COMPLETED|Overall Study||12||
59951827|NCT00836472|76070779|FG001|NOT COMPLETED|Second Intervention||0||
59951828|NCT02598388|76070795|FG000|STARTED|Overall Study||40||
59951829|NCT02598388|76070796|FG001|STARTED|Overall Study||10||
59951830|NCT02598388|76070797|FG002|STARTED|Overall Study||20||
59951831|NCT02598388|76070798|FG003|STARTED|Overall Study||5||
59951832|NCT02598388|76070799|FG004|STARTED|Overall Study||161||
59951833|NCT02598388|76070800|FG005|STARTED|Overall Study||39||
59519456|NCT03565666|75613421|FG001|COMPLETED|Overall Study||12||
59519457|NCT03565666|75613422|FG002|COMPLETED|Overall Study||11||
59519458|NCT03565666|75613420|FG000|NOT COMPLETED|Overall Study||0||
59519459|NCT03565666|75613421|FG001|NOT COMPLETED|Overall Study||0||
59519460|NCT03565666|75613422|FG002|NOT COMPLETED|Overall Study||1||
59519461|NCT03620890|75613435|FG000|STARTED|Overall Study||57||
59519462|NCT03620890|75613436|FG001|STARTED|Overall Study||51||
60071516|NCT00217672|76186893|FG001|COMPLETED|Allocation||7||
60071517|NCT00217672|76186892|FG000|NOT COMPLETED|Allocation||2||
60071518|NCT00217672|76186893|FG001|NOT COMPLETED|Allocation||0||
60071519|NCT00217672|76186892|FG000|STARTED|Treatment||67||
60071520|NCT00217672|76186893|FG001|STARTED|Treatment|When bevacizumab became available, study converted to a 1-arm open-label trial with just bevacizumab|7||
60071521|NCT00217672|76186892|FG000|COMPLETED|Treatment||0||
60071522|NCT00217672|76186893|FG001|COMPLETED|Treatment||0||
60071523|NCT00217672|76186892|FG000|NOT COMPLETED|Treatment||67||
60071524|NCT00217672|76186893|FG001|NOT COMPLETED|Treatment||7||
60071525|NCT00217672|76186892|FG000|STARTED|Follow-up|when bevacizumab became available, converted to a 1-arm open-label trial (67+7=74)|74||
60071526|NCT00217672|76186893|FG001|STARTED|Follow-up||0||
60071527|NCT00217672|76186892|FG000|COMPLETED|Follow-up||69||
60071528|NCT00217672|76186893|FG001|COMPLETED|Follow-up||0||
60071529|NCT00217672|76186892|FG000|NOT COMPLETED|Follow-up||5||
60071530|NCT00217672|76186893|FG001|NOT COMPLETED|Follow-up||0||
60071531|NCT00216736|76186899|FG000|STARTED|Overall Study||32||
60071532|NCT00216736|76186900|FG001|STARTED|Overall Study||31||
60071533|NCT00216736|76186899|FG000|COMPLETED|Overall Study||31||
60071534|NCT00216736|76186900|FG001|COMPLETED|Overall Study||30||
60071535|NCT00216736|76186899|FG000|NOT COMPLETED|Overall Study||1||
60071536|NCT00216736|76186900|FG001|NOT COMPLETED|Overall Study||1||
60071537|NCT01850030|76186908|FG000|STARTED|Overall Study||520||
60071538|NCT01850030|76186909|FG001|STARTED|Overall Study||511||
60071539|NCT01850030|76186908|FG000|COMPLETED|Overall Study||173||
60071540|NCT01850030|76186909|FG001|COMPLETED|Overall Study||142||
60071541|NCT01850030|76186908|FG000|NOT COMPLETED|Overall Study||347||
60071542|NCT01850030|76186909|FG001|NOT COMPLETED|Overall Study||369||
60071543|NCT00215644|76186917|FG000|STARTED|Overall Study||36||
60071544|NCT00215644|76186918|FG001|STARTED|Overall Study||36||
60071545|NCT00215644|76186917|FG000|Treated|Overall Study||35||
60071546|NCT00215644|76186918|FG001|Treated|Overall Study||36||
60071547|NCT00215644|76186917|FG000|COMPLETED|Overall Study||0||
60071548|NCT00215644|76186918|FG001|COMPLETED|Overall Study||0||
60071549|NCT00215644|76186917|FG000|NOT COMPLETED|Overall Study||36||
60071550|NCT00215644|76186918|FG001|NOT COMPLETED|Overall Study||36||
60071551|NCT01870401|76186926|FG000|STARTED|Overall Study||287||
60071552|NCT01870401|76186927|FG001|STARTED|Overall Study||155||
60071553|NCT01870401|76186926|FG000|COMPLETED|Overall Study||137||
60071554|NCT01870401|76186927|FG001|COMPLETED|Overall Study||59||
60071555|NCT01870401|76186926|FG000|NOT COMPLETED|Overall Study||150||
60071556|NCT01870401|76186927|FG001|NOT COMPLETED|Overall Study||96||
60071557|NCT00213148|76186939|FG000|STARTED|Cycle 1 (1 Month)||77||
60071558|NCT00213148|76186940|FG001|STARTED|Cycle 1 (1 Month)||0||
60071559|NCT00213148|76186941|FG002|STARTED|Cycle 1 (1 Month)||79||
60071560|NCT00213148|76186942|FG003|STARTED|Cycle 1 (1 Month)||76||
60071561|NCT00213148|76186943|FG004|STARTED|Cycle 1 (1 Month)||39||
60071562|NCT00213148|76186939|FG000|COMPLETED|Cycle 1 (1 Month)||53||
60071563|NCT00213148|76186940|FG001|COMPLETED|Cycle 1 (1 Month)||0||
60071564|NCT00213148|76186941|FG002|COMPLETED|Cycle 1 (1 Month)||60||
60071565|NCT00213148|76186942|FG003|COMPLETED|Cycle 1 (1 Month)||58||
60071566|NCT00213148|76186943|FG004|COMPLETED|Cycle 1 (1 Month)||17||
60071567|NCT00213148|76186939|FG000|NOT COMPLETED|Cycle 1 (1 Month)||24||
60071568|NCT00213148|76186940|FG001|NOT COMPLETED|Cycle 1 (1 Month)||0||
60071569|NCT00213148|76186941|FG002|NOT COMPLETED|Cycle 1 (1 Month)||19||
60071570|NCT00213148|76186942|FG003|NOT COMPLETED|Cycle 1 (1 Month)||18||
60071571|NCT00213148|76186943|FG004|NOT COMPLETED|Cycle 1 (1 Month)||22||
60071572|NCT00213148|76186939|FG000|STARTED|Cycle 2 (1 Month)||43||
60071573|NCT00213148|76186940|FG001|STARTED|Cycle 2 (1 Month)||10||
60071574|NCT00213148|76186941|FG002|STARTED|Cycle 2 (1 Month)||42||
60071575|NCT00213148|76186942|FG003|STARTED|Cycle 2 (1 Month)||52||
60071576|NCT00213148|76186943|FG004|STARTED|Cycle 2 (1 Month)||41||
60071577|NCT00213148|76186939|FG000|COMPLETED|Cycle 2 (1 Month)||29||
60071578|NCT00213148|76186940|FG001|COMPLETED|Cycle 2 (1 Month)||4||
60071579|NCT00213148|76186941|FG002|COMPLETED|Cycle 2 (1 Month)||28||
60071580|NCT00213148|76186942|FG003|COMPLETED|Cycle 2 (1 Month)||33||
60071581|NCT00213148|76186943|FG004|COMPLETED|Cycle 2 (1 Month)||11||
60071582|NCT00213148|76186939|FG000|NOT COMPLETED|Cycle 2 (1 Month)||14||
60071583|NCT00213148|76186940|FG001|NOT COMPLETED|Cycle 2 (1 Month)||6||
59519463|NCT03620890|75613435|FG000|First Trimester Miscarriage|Overall Study||2||
59519464|NCT03620890|75613436|FG001|First Trimester Miscarriage|Overall Study||1||
59519465|NCT03620890|75613435|FG000|Major Fetal Anomalies (Hypoplastic Left Heart and Sacral Agenesis) With 2nd Trimester Stillbirth|Overall Study||1||
59519466|NCT03620890|75613436|FG001|Major Fetal Anomalies (Hypoplastic Left Heart and Sacral Agenesis) With 2nd Trimester Stillbirth|Overall Study||0||
59519467|NCT03620890|75613435|FG000|Major Fetal Anomaly (Holoprosencephaly) With 2nd Trimester Pregnancy Termination|Overall Study||1||
59613548|NCT01565694|75724685|FG000|COMPLETED|Dose-Titration Period||62||
60071584|NCT00213148|76186941|FG002|NOT COMPLETED|Cycle 2 (1 Month)||14||
60071585|NCT00213148|76186942|FG003|NOT COMPLETED|Cycle 2 (1 Month)||19||
60071586|NCT00213148|76186943|FG004|NOT COMPLETED|Cycle 2 (1 Month)||30||
60071587|NCT00213148|76186939|FG000|STARTED|Cycle 3 (1 Month)||23||
60071588|NCT00213148|76186940|FG001|STARTED|Cycle 3 (1 Month)||10||
60071589|NCT00213148|76186941|FG002|STARTED|Cycle 3 (1 Month)||26||
60071590|NCT00213148|76186942|FG003|STARTED|Cycle 3 (1 Month)||24||
60071591|NCT00213148|76186943|FG004|STARTED|Cycle 3 (1 Month)||22||
59519468|NCT03620890|75613436|FG001|Major Fetal Anomaly (Holoprosencephaly) With 2nd Trimester Pregnancy Termination|Overall Study||0||
59519469|NCT03620890|75613435|FG000|COMPLETED|Overall Study||53||
59519470|NCT03620890|75613436|FG001|COMPLETED|Overall Study||50||
59519471|NCT03620890|75613435|FG000|NOT COMPLETED|Overall Study||4||
60071592|NCT00213148|76186939|FG000|COMPLETED|Cycle 3 (1 Month)||23||
60071593|NCT00213148|76186940|FG001|COMPLETED|Cycle 3 (1 Month)||8||
60071594|NCT00213148|76186941|FG002|COMPLETED|Cycle 3 (1 Month)||25||
60071595|NCT00213148|76186942|FG003|COMPLETED|Cycle 3 (1 Month)||23||
60071596|NCT00213148|76186943|FG004|COMPLETED|Cycle 3 (1 Month)||21||
60071597|NCT00213148|76186939|FG000|NOT COMPLETED|Cycle 3 (1 Month)||0||
60071598|NCT00213148|76186940|FG001|NOT COMPLETED|Cycle 3 (1 Month)||2||
60071599|NCT00213148|76186941|FG002|NOT COMPLETED|Cycle 3 (1 Month)||1||
60071600|NCT00213148|76186942|FG003|NOT COMPLETED|Cycle 3 (1 Month)||1||
60071601|NCT00213148|76186943|FG004|NOT COMPLETED|Cycle 3 (1 Month)||1||
60071602|NCT01704261|76186965|FG000|STARTED|Overall Study||154||
60071603|NCT01704261|76186966|FG001|STARTED|Overall Study||153||
60071604|NCT01704261|76186965|FG000|COMPLETED|Overall Study||141||
60071605|NCT01704261|76186966|FG001|COMPLETED|Overall Study||138||
60071606|NCT01704261|76186965|FG000|NOT COMPLETED|Overall Study||13||
60071607|NCT01704261|76186966|FG001|NOT COMPLETED|Overall Study||15||
60071608|NCT01715571|76186972|FG000|STARTED|Overall Study||11||
60071609|NCT01715571|76186972|FG000|COMPLETED|Overall Study||3||
60071610|NCT01715571|76186972|FG000|NOT COMPLETED|Overall Study||8||
60071611|NCT00212758|76186976|FG000|STARTED|First Intervention (7 Days)||8||
60071612|NCT00212758|76186977|FG001|STARTED|First Intervention (7 Days)||9||
60071613|NCT00212758|76186976|FG000|COMPLETED|First Intervention (7 Days)||8||
60071614|NCT00212758|76186977|FG001|COMPLETED|First Intervention (7 Days)||9||
60071615|NCT00212758|76186976|FG000|NOT COMPLETED|First Intervention (7 Days)||0||
60071616|NCT00212758|76186977|FG001|NOT COMPLETED|First Intervention (7 Days)||0||
60071617|NCT00212758|76186976|FG000|STARTED|Wash Out Period (2 Weeks)||8||
60071618|NCT00212758|76186977|FG001|STARTED|Wash Out Period (2 Weeks)||9||
60071619|NCT00212758|76186976|FG000|COMPLETED|Wash Out Period (2 Weeks)||8||
60071620|NCT00212758|76186977|FG001|COMPLETED|Wash Out Period (2 Weeks)||9||
60071621|NCT00212758|76186976|FG000|NOT COMPLETED|Wash Out Period (2 Weeks)||0||
60071622|NCT00212758|76186977|FG001|NOT COMPLETED|Wash Out Period (2 Weeks)||0||
60071623|NCT00212758|76186976|FG000|STARTED|Second Intervention (7 Days)||8||
60071624|NCT00212758|76186977|FG001|STARTED|Second Intervention (7 Days)||9||
60071625|NCT00212758|76186976|FG000|COMPLETED|Second Intervention (7 Days)||8||
60071626|NCT00212758|76186977|FG001|COMPLETED|Second Intervention (7 Days)||9||
60071627|NCT00212758|76186976|FG000|NOT COMPLETED|Second Intervention (7 Days)||0||
60071628|NCT00212758|76186977|FG001|NOT COMPLETED|Second Intervention (7 Days)||0||
60071629|NCT00212758|76186976|FG000|STARTED|Standard Therapy of GH (12 Months)||8||
59519472|NCT03620890|75613436|FG001|NOT COMPLETED|Overall Study||1||
59519473|NCT03569020|75613444|FG000|STARTED|Period 1||22||
60071630|NCT00212758|76186977|FG001|STARTED|Standard Therapy of GH (12 Months)||9||
60071631|NCT00212758|76186976|FG000|COMPLETED|Standard Therapy of GH (12 Months)||6||
60071632|NCT00212758|76186977|FG001|COMPLETED|Standard Therapy of GH (12 Months)||8||
60071633|NCT00212758|76186976|FG000|NOT COMPLETED|Standard Therapy of GH (12 Months)||2||
60071634|NCT00212758|76186977|FG001|NOT COMPLETED|Standard Therapy of GH (12 Months)||1||
60071635|NCT01824290|76186985|FG000|STARTED|Period 1: Double Blind||18||
60071636|NCT01824290|76186986|FG001|STARTED|Period 1: Double Blind||17||
60071637|NCT01824290|76186987|FG002|STARTED|Period 1: Double Blind||0||
60071638|NCT01824290|76186988|FG003|STARTED|Period 1: Double Blind||0||
60071639|NCT01824290|76186985|FG000|Received at Least One Dose of Study Drug|Period 1: Double Blind||18||
60071640|NCT01824290|76186986|FG001|Received at Least One Dose of Study Drug|Period 1: Double Blind||17||
59519474|NCT03569020|75613445|FG001|STARTED|Period 1||21||
59519475|NCT03569020|75613444|FG000|COMPLETED|Period 1||22||
60071641|NCT01824290|76186987|FG002|Received at Least One Dose of Study Drug|Period 1: Double Blind||0||
60071642|NCT01824290|76186988|FG003|Received at Least One Dose of Study Drug|Period 1: Double Blind||0||
60071643|NCT01824290|76186985|FG000|Received 20 mg|Period 1: Double Blind||0||
60071644|NCT01824290|76186986|FG001|Received 20 mg|Period 1: Double Blind||4||
60071645|NCT01824290|76186987|FG002|Received 20 mg|Period 1: Double Blind||0||
60071646|NCT01824290|76186988|FG003|Received 20 mg|Period 1: Double Blind||0||
60071647|NCT01824290|76186985|FG000|Received 40 mg|Period 1: Double Blind||0||
59519476|NCT03569020|75613445|FG001|COMPLETED|Period 1||21||
59519477|NCT03569020|75613444|FG000|NOT COMPLETED|Period 1||0||
59519478|NCT03569020|75613445|FG001|NOT COMPLETED|Period 1||0||
60071648|NCT01824290|76186986|FG001|Received 40 mg|Period 1: Double Blind||13||
60071649|NCT01824290|76186987|FG002|Received 40 mg|Period 1: Double Blind||0||
60071650|NCT01824290|76186988|FG003|Received 40 mg|Period 1: Double Blind||0||
59762713|NCT00856557|75882565|FG000|NOT COMPLETED|Overall Study||12||
59762714|NCT00856557|75882566|FG001|NOT COMPLETED|Overall Study||16||
59762715|NCT00856323|75882572|FG000|STARTED|Overall Study||53||
59762716|NCT00856323|75882572|FG000|COMPLETED|Overall Study||51||
59762717|NCT00856323|75882572|FG000|NOT COMPLETED|Overall Study||2||
59762718|NCT01666145|75882576|FG000|STARTED|Overall Study||14||
59762719|NCT01666145|75882576|FG000|COMPLETED|Overall Study||14||
59762720|NCT01666145|75882576|FG000|NOT COMPLETED|Overall Study||0||
59762721|NCT00856245|75882580|FG000|STARTED|Overall Study||19||
59762722|NCT00856245|75882580|FG000|COMPLETED|Overall Study||14||
59762723|NCT00856245|75882580|FG000|NOT COMPLETED|Overall Study||5||
59762724|NCT00855933|75882586|FG000|STARTED|Overall Study||30||
60071651|NCT01824290|76186985|FG000|COMPLETED|Period 1: Double Blind||15||
60071652|NCT01824290|76186986|FG001|COMPLETED|Period 1: Double Blind||15||
60071653|NCT01824290|76186987|FG002|COMPLETED|Period 1: Double Blind||0||
60071654|NCT01824290|76186988|FG003|COMPLETED|Period 1: Double Blind||0||
60071655|NCT01824290|76186985|FG000|NOT COMPLETED|Period 1: Double Blind||3||
60071656|NCT01824290|76186986|FG001|NOT COMPLETED|Period 1: Double Blind||2||
60071657|NCT01824290|76186987|FG002|NOT COMPLETED|Period 1: Double Blind||0||
60071658|NCT01824290|76186988|FG003|NOT COMPLETED|Period 1: Double Blind||0||
60071659|NCT01824290|76186985|FG000|STARTED|Period 2: Open-Label Treatment||0||
60071660|NCT01824290|76186986|FG001|STARTED|Period 2: Open-Label Treatment||0||
60071661|NCT01824290|76186987|FG002|STARTED|Period 2: Open-Label Treatment|As per the protocol, period 2 eligibility were participants who completed period 1 or experienced clinical worsening (CW) in period 1. 1 participant that had CW in period 1 continued to period 2.|16||
60071662|NCT01824290|76186988|FG003|STARTED|Period 2: Open-Label Treatment|As per the protocol, period 2 eligibility were participants who completed period 1 or experienced clinical worsening (CW) in period 1. 1 participant that had CW in period 1 continued to period 2.|16||
60071663|NCT01824290|76186985|FG000|Received 20 mg|Period 2: Open-Label Treatment||0||
60071664|NCT01824290|76186986|FG001|Received 20 mg|Period 2: Open-Label Treatment||0||
60071665|NCT01824290|76186987|FG002|Received 20 mg|Period 2: Open-Label Treatment||3||
60071666|NCT01824290|76186988|FG003|Received 20 mg|Period 2: Open-Label Treatment||3||
59762725|NCT00855933|75882587|FG001|STARTED|Overall Study||30||
59519479|NCT03569020|75613444|FG000|STARTED|Period 2||22||
59519480|NCT03569020|75613445|FG001|STARTED|Period 2||21||
59519481|NCT03569020|75613444|FG000|COMPLETED|Period 2||22||
59519482|NCT03569020|75613445|FG001|COMPLETED|Period 2||21||
59519483|NCT03569020|75613444|FG000|NOT COMPLETED|Period 2||0||
59519484|NCT03569020|75613445|FG001|NOT COMPLETED|Period 2||0||
59519485|NCT00952133|75613457|FG000|STARTED|Overall Study||59||
59519486|NCT00952133|75613458|FG001|STARTED|Overall Study||59||
59519487|NCT00952133|75613457|FG000|COMPLETED|Overall Study||59||
59519488|NCT00952133|75613458|FG001|COMPLETED|Overall Study||59||
59519489|NCT00952133|75613457|FG000|NOT COMPLETED|Overall Study||0||
59519490|NCT00952133|75613458|FG001|NOT COMPLETED|Overall Study||0||
59519491|NCT03570658|75613470|FG000|STARTED|Single Ascending Dose (SAD)||6||
59519492|NCT03570658|75613471|FG001|STARTED|Single Ascending Dose (SAD)||2||
59519493|NCT03570658|75613472|FG002|STARTED|Single Ascending Dose (SAD)||10||
59519494|NCT03570658|75613473|FG003|STARTED|Single Ascending Dose (SAD)||10||
59519495|NCT03570658|75613470|FG000|COMPLETED|Single Ascending Dose (SAD)||6||
59519496|NCT03570658|75613471|FG001|COMPLETED|Single Ascending Dose (SAD)||2||
59613549|NCT01565694|75724685|FG000|NOT COMPLETED|Dose-Titration Period||14||
59613550|NCT01565694|75724685|FG000|STARTED|Fixed-Dose Assessment Period||62||
59613551|NCT01565694|75724685|FG000|COMPLETED|Fixed-Dose Assessment Period||58||
59613552|NCT01565694|75724685|FG000|NOT COMPLETED|Fixed-Dose Assessment Period||4||
59613553|NCT01543152|75724694|FG000|STARTED|Overall Study||3||
59613554|NCT01543152|75724695|FG001|STARTED|Overall Study||6||
59519497|NCT03570658|75613472|FG002|COMPLETED|Single Ascending Dose (SAD)||10||
59519498|NCT03570658|75613473|FG003|COMPLETED|Single Ascending Dose (SAD)||10||
59519499|NCT03570658|75613470|FG000|NOT COMPLETED|Single Ascending Dose (SAD)||0||
59519500|NCT03570658|75613471|FG001|NOT COMPLETED|Single Ascending Dose (SAD)||0||
59519501|NCT03570658|75613472|FG002|NOT COMPLETED|Single Ascending Dose (SAD)||0||
59519502|NCT03570658|75613473|FG003|NOT COMPLETED|Single Ascending Dose (SAD)||0||
59519503|NCT03570658|75613470|FG000|STARTED|Multiple Ascending Dose (MAD)||4||
59519504|NCT03570658|75613471|FG001|STARTED|Multiple Ascending Dose (MAD)||0||
59519505|NCT03570658|75613472|FG002|STARTED|Multiple Ascending Dose (MAD)||10||
59613555|NCT01543152|75724696|FG002|STARTED|Overall Study||11||
59613556|NCT01543152|75724697|FG003|STARTED|Overall Study||3||
59613557|NCT01543152|75724698|FG004|STARTED|Overall Study||3||
59613558|NCT01543152|75724694|FG000|COMPLETED|Overall Study||3||
59613559|NCT01543152|75724695|FG001|COMPLETED|Overall Study||4||
59613560|NCT01543152|75724696|FG002|COMPLETED|Overall Study||11||
59613561|NCT01543152|75724697|FG003|COMPLETED|Overall Study||3||
59613562|NCT01543152|75724698|FG004|COMPLETED|Overall Study||3||
60071667|NCT01824290|76186985|FG000|Received 40 mg|Period 2: Open-Label Treatment||0||
60071668|NCT01824290|76186986|FG001|Received 40 mg|Period 2: Open-Label Treatment||0||
59519506|NCT03570658|75613473|FG003|STARTED|Multiple Ascending Dose (MAD)||10||
59519507|NCT03570658|75613470|FG000|COMPLETED|Multiple Ascending Dose (MAD)||4||
59519508|NCT03570658|75613471|FG001|COMPLETED|Multiple Ascending Dose (MAD)||0||
59519509|NCT03570658|75613472|FG002|COMPLETED|Multiple Ascending Dose (MAD)||10||
59519510|NCT03570658|75613473|FG003|COMPLETED|Multiple Ascending Dose (MAD)||10||
59519511|NCT03570658|75613470|FG000|NOT COMPLETED|Multiple Ascending Dose (MAD)||0||
59519512|NCT03570658|75613471|FG001|NOT COMPLETED|Multiple Ascending Dose (MAD)||0||
59519513|NCT03570658|75613472|FG002|NOT COMPLETED|Multiple Ascending Dose (MAD)||0||
59519514|NCT03570658|75613473|FG003|NOT COMPLETED|Multiple Ascending Dose (MAD)||0||
59613563|NCT01543152|75724694|FG000|NOT COMPLETED|Overall Study||0||
59613564|NCT01543152|75724695|FG001|NOT COMPLETED|Overall Study||2||
59613565|NCT01543152|75724696|FG002|NOT COMPLETED|Overall Study||0||
59613566|NCT01543152|75724697|FG003|NOT COMPLETED|Overall Study||0||
59613567|NCT01543152|75724698|FG004|NOT COMPLETED|Overall Study||0||
59613568|NCT01590810|75724715|FG000|STARTED|Overall Study||8||
59613569|NCT01590810|75724716|FG001|STARTED|Overall Study||8||
59613570|NCT01590810|75724717|FG002|STARTED|Overall Study||8||
59613571|NCT01590810|75724718|FG003|STARTED|Overall Study||8||
59613572|NCT01590810|75724719|FG004|STARTED|Overall Study||2||
59519515|NCT00941681|75613500|FG000|STARTED|Overall Study||12||
59519516|NCT00941681|75613501|FG001|STARTED|Overall Study||11||
59519517|NCT00941681|75613502|FG002|STARTED|Overall Study||12||
59519518|NCT00941681|75613500|FG000|COMPLETED|Overall Study||12||
59519519|NCT00941681|75613501|FG001|COMPLETED|Overall Study||10||
59519520|NCT00941681|75613502|FG002|COMPLETED|Overall Study||12||
59519521|NCT00941681|75613500|FG000|NOT COMPLETED|Overall Study||0||
59613573|NCT01590810|75724715|FG000|COMPLETED|Overall Study||8||
59613574|NCT01590810|75724716|FG001|COMPLETED|Overall Study||7||
59613575|NCT01590810|75724717|FG002|COMPLETED|Overall Study||7||
59613576|NCT01590810|75724718|FG003|COMPLETED|Overall Study||8||
59613577|NCT01590810|75724719|FG004|COMPLETED|Overall Study||2||
59613578|NCT01590810|75724715|FG000|NOT COMPLETED|Overall Study||0||
59613579|NCT01590810|75724716|FG001|NOT COMPLETED|Overall Study||1||
59613580|NCT01590810|75724717|FG002|NOT COMPLETED|Overall Study||1||
59613581|NCT01590810|75724718|FG003|NOT COMPLETED|Overall Study||0||
59613582|NCT01590810|75724719|FG004|NOT COMPLETED|Overall Study||0||
59613583|NCT01542528|75724754|FG000|STARTED|Overall Study||61||
59613584|NCT01542528|75724755|FG001|STARTED|Overall Study||56||
60071669|NCT01824290|76186987|FG002|Received 40 mg|Period 2: Open-Label Treatment||13||
60071670|NCT01824290|76186988|FG003|Received 40 mg|Period 2: Open-Label Treatment||13||
60071671|NCT01824290|76186985|FG000|COMPLETED|Period 2: Open-Label Treatment||0||
60071672|NCT01824290|76186986|FG001|COMPLETED|Period 2: Open-Label Treatment||0||
60071673|NCT01824290|76186987|FG002|COMPLETED|Period 2: Open-Label Treatment||13||
60071674|NCT01824290|76186988|FG003|COMPLETED|Period 2: Open-Label Treatment||13||
60071675|NCT01824290|76186985|FG000|NOT COMPLETED|Period 2: Open-Label Treatment||0||
60071676|NCT01824290|76186986|FG001|NOT COMPLETED|Period 2: Open-Label Treatment||0||
60071677|NCT01824290|76186987|FG002|NOT COMPLETED|Period 2: Open-Label Treatment||3||
60071678|NCT01824290|76186988|FG003|NOT COMPLETED|Period 2: Open-Label Treatment||3||
60071679|NCT01715415|76187002|FG000|STARTED|Double-blind Treatment||297||
60071680|NCT01715415|76187003|FG001|STARTED|Double-blind Treatment||98||
60071681|NCT01715415|76187002|FG000|Randomized But Not Treated|Double-blind Treatment||0||
60071682|NCT01715415|76187003|FG001|Randomized But Not Treated|Double-blind Treatment||1||
60071683|NCT01715415|76187002|FG000|COMPLETED|Double-blind Treatment|The number of participants who completed double-blind study drug.|292||
60071684|NCT01715415|76187003|FG001|COMPLETED|Double-blind Treatment|The number of participants who completed double-blind study drug.|96||
59613585|NCT01542528|75724754|FG000|COMPLETED|Overall Study||49||
59613586|NCT01542528|75724755|FG001|COMPLETED|Overall Study||49||
59613587|NCT01542528|75724754|FG000|NOT COMPLETED|Overall Study||12||
59613588|NCT01542528|75724755|FG001|NOT COMPLETED|Overall Study||7||
60071685|NCT01715415|76187002|FG000|NOT COMPLETED|Double-blind Treatment||5||
60071686|NCT01715415|76187003|FG001|NOT COMPLETED|Double-blind Treatment||2||
60071687|NCT01715415|76187002|FG000|STARTED|Open-label Treatment|not applicable to this arm|0||
60071688|NCT01715415|76187003|FG001|STARTED|Open-label Treatment||96||
59613589|NCT01565148|75724765|FG000|STARTED|Overall Study||47||
59613590|NCT01565148|75724766|FG001|STARTED|Overall Study||46||
59613591|NCT01565148|75724767|FG002|STARTED|Overall Study||47||
60071689|NCT01715415|76187002|FG000|COMPLETED|Open-label Treatment|not applicable to this arm|0||
60071690|NCT01715415|76187003|FG001|COMPLETED|Open-label Treatment|The number of participants who completed open-label study drug.|94||
60071691|NCT01715415|76187002|FG000|NOT COMPLETED|Open-label Treatment||0||
60071692|NCT01715415|76187003|FG001|NOT COMPLETED|Open-label Treatment||2||
60071693|NCT00211510|76187012|FG000|STARTED|Overall Study||72||
60071694|NCT00211510|76187013|FG001|STARTED|Overall Study||74||
60071695|NCT00211510|76187012|FG000|COMPLETED|Overall Study||66||
60071696|NCT00211510|76187013|FG001|COMPLETED|Overall Study||72||
60071697|NCT00211510|76187012|FG000|NOT COMPLETED|Overall Study||6||
60071698|NCT00211510|76187013|FG001|NOT COMPLETED|Overall Study||2||
60071699|NCT01869777|76187022|FG000|STARTED|Overall Study||102||
60071700|NCT01869777|76187022|FG000|COMPLETED|Overall Study||101||
60071701|NCT01869777|76187022|FG000|NOT COMPLETED|Overall Study||1||
60071702|NCT01714947|76187026|FG000|STARTED|Part A||3||
59613592|NCT01565148|75724768|FG003|STARTED|Overall Study||45||
59613593|NCT01565148|75724765|FG000|COMPLETED|Overall Study||32||
59613594|NCT01565148|75724766|FG001|COMPLETED|Overall Study||31||
59613595|NCT01565148|75724767|FG002|COMPLETED|Overall Study||40||
59613596|NCT01565148|75724768|FG003|COMPLETED|Overall Study||32||
59613597|NCT01565148|75724765|FG000|NOT COMPLETED|Overall Study||15||
59613598|NCT01565148|75724766|FG001|NOT COMPLETED|Overall Study||15||
59613599|NCT01565148|75724767|FG002|NOT COMPLETED|Overall Study||7||
59613600|NCT01565148|75724768|FG003|NOT COMPLETED|Overall Study||13||
59613601|NCT01564758|75724782|FG000|STARTED|Overall Study||99||
59613602|NCT01564758|75724782|FG000|COMPLETED|Overall Study||85||
59613603|NCT01564758|75724782|FG000|NOT COMPLETED|Overall Study||14||
59613604|NCT01541826|75724789|FG000|STARTED|Overall Study||28||
59613605|NCT01541826|75724790|FG001|STARTED|Overall Study||28||
59613606|NCT01541826|75724791|FG002|STARTED|Overall Study||6||
59613607|NCT01541826|75724789|FG000|COMPLETED|Overall Study||24||
59613608|NCT01541826|75724790|FG001|COMPLETED|Overall Study||25||
59613609|NCT01541826|75724791|FG002|COMPLETED|Overall Study||6||
59613610|NCT01541826|75724789|FG000|NOT COMPLETED|Overall Study||4||
59613611|NCT01541826|75724790|FG001|NOT COMPLETED|Overall Study||3||
59613612|NCT01541826|75724791|FG002|NOT COMPLETED|Overall Study||0||
59613613|NCT01541748|75724799|FG000|STARTED|Overall Study|74 subjects were consented; however, 5 were screen failures and 1 did not receive the study device.|74||
59613614|NCT01541748|75724799|FG000|COMPLETED|Overall Study||43||
59613615|NCT01541748|75724799|FG000|NOT COMPLETED|Overall Study||31||
59613616|NCT01589094|75724812|FG000|STARTED|Overall Study||51||
59951834|NCT02598388|76070801|FG006|STARTED|Overall Study||161||
59951835|NCT02598388|76070802|FG007|STARTED|Overall Study||39||
59951836|NCT02598388|76070803|FG008|STARTED|Overall Study||39||
59951837|NCT02598388|76070804|FG009|STARTED|Overall Study||10||
59613617|NCT01589094|75724812|FG000|COMPLETED|Overall Study||49||
59613618|NCT01589094|75724812|FG000|NOT COMPLETED|Overall Study||2||
59613619|NCT01563978|75724818|FG000|STARTED|Overall Study|Patients who received treatment.|68||
59613620|NCT01563978|75724819|FG001|STARTED|Overall Study|Patients who received treatment.|67||
59613621|NCT01563978|75724818|FG000|Randomised But Did Not Receive Treatment|Overall Study||0||
59613622|NCT01563978|75724819|FG001|Randomised But Did Not Receive Treatment|Overall Study||0||
59613623|NCT01563978|75724818|FG000|COMPLETED|Overall Study||64||
59613624|NCT01563978|75724819|FG001|COMPLETED|Overall Study||65||
59613625|NCT01563978|75724818|FG000|NOT COMPLETED|Overall Study||4||
59613626|NCT01563978|75724819|FG001|NOT COMPLETED|Overall Study||2||
59613627|NCT01563354|75724828|FG000|STARTED|Core Phase||41||
59613628|NCT01563354|75724829|FG001|STARTED|Core Phase||42||
59613629|NCT01563354|75724830|FG002|STARTED|Core Phase||41||
59613630|NCT01563354|75724828|FG000|Entered Extension Phase|Core Phase||12||
59613631|NCT01563354|75724829|FG001|Entered Extension Phase|Core Phase||14||
59951838|NCT02598388|76070805|FG010|STARTED|Overall Study||40||
59951839|NCT02598388|76070806|FG011|STARTED|Overall Study||10||
59951840|NCT02598388|76070795|FG000|COMPLETED|Overall Study||39||
59951841|NCT02598388|76070796|FG001|COMPLETED|Overall Study||10||
59951842|NCT02598388|76070797|FG002|COMPLETED|Overall Study||18||
59951843|NCT02598388|76070798|FG003|COMPLETED|Overall Study||5||
59951844|NCT02598388|76070799|FG004|COMPLETED|Overall Study||151||
59951845|NCT02598388|76070800|FG005|COMPLETED|Overall Study||38||
59951846|NCT02598388|76070801|FG006|COMPLETED|Overall Study||156||
59951847|NCT02598388|76070802|FG007|COMPLETED|Overall Study||38||
59951848|NCT02598388|76070803|FG008|COMPLETED|Overall Study||39||
59951849|NCT02598388|76070804|FG009|COMPLETED|Overall Study||9||
59951850|NCT02598388|76070805|FG010|COMPLETED|Overall Study||39||
59951851|NCT02598388|76070806|FG011|COMPLETED|Overall Study||10||
59951852|NCT02598388|76070795|FG000|NOT COMPLETED|Overall Study||1||
59951853|NCT02598388|76070796|FG001|NOT COMPLETED|Overall Study||0||
59951854|NCT02598388|76070797|FG002|NOT COMPLETED|Overall Study||2||
59951855|NCT02598388|76070798|FG003|NOT COMPLETED|Overall Study||0||
59951856|NCT02598388|76070799|FG004|NOT COMPLETED|Overall Study||10||
59951857|NCT02598388|76070800|FG005|NOT COMPLETED|Overall Study||1||
59951858|NCT02598388|76070801|FG006|NOT COMPLETED|Overall Study||5||
59951859|NCT02598388|76070802|FG007|NOT COMPLETED|Overall Study||1||
59613632|NCT01563354|75724830|FG002|Entered Extension Phase|Core Phase||15||
59613633|NCT01563354|75724828|FG000|COMPLETED|Core Phase||12||
59613634|NCT01563354|75724829|FG001|COMPLETED|Core Phase||14||
59613635|NCT01563354|75724830|FG002|COMPLETED|Core Phase||15||
59613636|NCT01563354|75724828|FG000|NOT COMPLETED|Core Phase||29||
59613637|NCT01563354|75724829|FG001|NOT COMPLETED|Core Phase||28||
59613638|NCT01563354|75724830|FG002|NOT COMPLETED|Core Phase||26||
59613639|NCT01563354|75724828|FG000|STARTED|Extension Phase|Criteria to enter Extension: continued clinical benefit and no unacceptable toxicity|12||
59951860|NCT02598388|76070803|FG008|NOT COMPLETED|Overall Study||0||
59951861|NCT02598388|76070804|FG009|NOT COMPLETED|Overall Study||1||
59613640|NCT01563354|75724829|FG001|STARTED|Extension Phase|Criteria to enter Extension: continued clinical benefit and no unacceptable toxicity|14||
59613641|NCT01563354|75724830|FG002|STARTED|Extension Phase||15||
59613642|NCT01563354|75724828|FG000|COMPLETED|Extension Phase||0||
59613643|NCT01563354|75724829|FG001|COMPLETED|Extension Phase||0||
59613644|NCT01563354|75724830|FG002|COMPLETED|Extension Phase||0||
59613645|NCT01563354|75724828|FG000|NOT COMPLETED|Extension Phase||12||
59613646|NCT01563354|75724829|FG001|NOT COMPLETED|Extension Phase||14||
59613647|NCT01563354|75724830|FG002|NOT COMPLETED|Extension Phase||15||
59613648|NCT01588548|75724844|FG000|STARTED|Overall Study||3||
59613649|NCT01588548|75724845|FG001|STARTED|Overall Study||7||
59613650|NCT01588548|75724846|FG002|STARTED|Overall Study||6||
59613651|NCT01588548|75724847|FG003|STARTED|Overall Study||7||
59613652|NCT01588548|75724848|FG004|STARTED|Overall Study||6||
59613653|NCT01588548|75724849|FG005|STARTED|Overall Study||6||
59613654|NCT01588548|75724844|FG000|Cycle 1 Day 21|Overall Study||3||
59613655|NCT01588548|75724845|FG001|Cycle 1 Day 21|Overall Study||5||
59613656|NCT01588548|75724846|FG002|Cycle 1 Day 21|Overall Study||2||
59613657|NCT01588548|75724847|FG003|Cycle 1 Day 21|Overall Study||5||
59613658|NCT01588548|75724848|FG004|Cycle 1 Day 21|Overall Study||3||
59613659|NCT01588548|75724849|FG005|Cycle 1 Day 21|Overall Study||3||
59613660|NCT01588548|75724844|FG000|COMPLETED|Overall Study||0||
59613661|NCT01588548|75724845|FG001|COMPLETED|Overall Study||0||
59613662|NCT01588548|75724846|FG002|COMPLETED|Overall Study||0||
59613663|NCT01588548|75724847|FG003|COMPLETED|Overall Study||0||
59613664|NCT01588548|75724848|FG004|COMPLETED|Overall Study||0||
59613665|NCT01588548|75724849|FG005|COMPLETED|Overall Study||0||
59613666|NCT01588548|75724844|FG000|NOT COMPLETED|Overall Study||3||
59613667|NCT01588548|75724845|FG001|NOT COMPLETED|Overall Study||7||
59613668|NCT01588548|75724846|FG002|NOT COMPLETED|Overall Study||6||
59613669|NCT01588548|75724847|FG003|NOT COMPLETED|Overall Study||7||
59613670|NCT01588548|75724848|FG004|NOT COMPLETED|Overall Study||6||
59613671|NCT01588548|75724849|FG005|NOT COMPLETED|Overall Study||6||
59613672|NCT01587924|75724867|FG000|STARTED|Overall Study||21||
59613673|NCT01587924|75724868|FG001|STARTED|Overall Study||21||
59613674|NCT01587924|75724869|FG002|STARTED|Overall Study||21||
59613675|NCT01587924|75724870|FG003|STARTED|Overall Study||20||
59613676|NCT01587924|75724867|FG000|COMPLETED|Overall Study||17||
59613677|NCT01587924|75724868|FG001|COMPLETED|Overall Study||17||
59613678|NCT01587924|75724869|FG002|COMPLETED|Overall Study||17||
59613679|NCT01587924|75724870|FG003|COMPLETED|Overall Study||19||
59613680|NCT01587924|75724867|FG000|NOT COMPLETED|Overall Study||4||
59613681|NCT01587924|75724868|FG001|NOT COMPLETED|Overall Study||4||
59613682|NCT01587924|75724869|FG002|NOT COMPLETED|Overall Study||4||
59613683|NCT01587924|75724870|FG003|NOT COMPLETED|Overall Study||1||
59613684|NCT01539642|75724882|FG000|STARTED|Overall Study||114||
59613685|NCT01539642|75724883|FG001|STARTED|Overall Study||58||
59613686|NCT01539642|75724882|FG000|COMPLETED|Overall Study||78||
59613687|NCT01539642|75724883|FG001|COMPLETED|Overall Study||27||
59613688|NCT01539642|75724882|FG000|NOT COMPLETED|Overall Study||36||
59613689|NCT01539642|75724883|FG001|NOT COMPLETED|Overall Study||31||
59613690|NCT01586364|75724889|FG000|STARTED|Overall Study||301||
59613691|NCT01586364|75724889|FG000|COMPLETED|Overall Study||184||
59613692|NCT01586364|75724889|FG000|NOT COMPLETED|Overall Study||117||
59613693|NCT01538628|75724895|FG000|STARTED|Overall Study||149||
59613694|NCT01538628|75724896|FG001|STARTED|Overall Study||73||
59613695|NCT01538628|75724895|FG000|COMPLETED|Overall Study||148||
59951862|NCT02598388|76070805|FG010|NOT COMPLETED|Overall Study||1||
59613696|NCT01538628|75724896|FG001|COMPLETED|Overall Study||71||
59613697|NCT01538628|75724895|FG000|NOT COMPLETED|Overall Study||1||
59613698|NCT01538628|75724896|FG001|NOT COMPLETED|Overall Study||2||
59613699|NCT01538472|75724903|FG000|STARTED|Overall Study||40||
59613700|NCT01538472|75724903|FG000|COMPLETED|Overall Study||36||
59613701|NCT01538472|75724903|FG000|NOT COMPLETED|Overall Study||4||
59613702|NCT01562028|75724909|FG000|STARTED|Overall Study||37||
59613703|NCT01562028|75724910|FG001|STARTED|Overall Study||72||
59613704|NCT01562028|75724909|FG000|COMPLETED|Overall Study||34||
59613705|NCT01562028|75724910|FG001|COMPLETED|Overall Study||70||
59613706|NCT01562028|75724909|FG000|NOT COMPLETED|Overall Study||3||
59613707|NCT01562028|75724910|FG001|NOT COMPLETED|Overall Study||2||
59613708|NCT01585584|75724916|FG000|STARTED|Overall Study||10||
59613709|NCT01585584|75724916|FG000|COMPLETED|Overall Study||6||
59613710|NCT01585584|75724916|FG000|NOT COMPLETED|Overall Study||4||
59613711|NCT01561560|75724920|FG000|STARTED|First Two Weeks of Wear||60||
59613712|NCT01561560|75724921|FG001|STARTED|First Two Weeks of Wear||61||
59613713|NCT01561560|75724920|FG000|COMPLETED|First Two Weeks of Wear||60||
59613714|NCT01561560|75724921|FG001|COMPLETED|First Two Weeks of Wear||59||
59613715|NCT01561560|75724920|FG000|NOT COMPLETED|First Two Weeks of Wear||0||
59613716|NCT01561560|75724921|FG001|NOT COMPLETED|First Two Weeks of Wear||2||
59613717|NCT01561560|75724920|FG000|STARTED|Second Two Weeks of Wear||60||
59613718|NCT01561560|75724921|FG001|STARTED|Second Two Weeks of Wear||59||
59613719|NCT01561560|75724920|FG000|COMPLETED|Second Two Weeks of Wear||60||
59613720|NCT01561560|75724921|FG001|COMPLETED|Second Two Weeks of Wear||58||
59519522|NCT00941681|75613501|FG001|NOT COMPLETED|Overall Study||1||
59519523|NCT00941681|75613502|FG002|NOT COMPLETED|Overall Study||0||
59519524|NCT03571672|75613510|FG000|STARTED|Overall Study||153||
59519525|NCT03571672|75613510|FG000|COMPLETED|Overall Study||148||
59519526|NCT03571672|75613510|FG000|NOT COMPLETED|Overall Study||5||
59519527|NCT00952211|75613518|FG000|STARTED|Overall Study||3||
59519528|NCT00952211|75613519|FG001|STARTED|Overall Study||0||
59519529|NCT00952211|75613518|FG000|COMPLETED|Overall Study||3||
59519530|NCT00952211|75613519|FG001|COMPLETED|Overall Study||0||
59519531|NCT00952211|75613518|FG000|NOT COMPLETED|Overall Study||0||
59519532|NCT00952211|75613519|FG001|NOT COMPLETED|Overall Study||0||
59519533|NCT00941993|75613525|FG000|STARTED|Overall Study||109||
59519534|NCT00941993|75613525|FG000|COMPLETED|Overall Study||109||
59519535|NCT00941993|75613525|FG000|NOT COMPLETED|Overall Study||0||
59519536|NCT02561832|75613532|FG000|STARTED|Overall Study||8||
59519537|NCT02561832|75613533|FG001|STARTED|Overall Study||7||
59519538|NCT02561832|75613532|FG000|INFORMED CONSENT OBTAINED|Overall Study||8||
59519539|NCT02561832|75613533|FG001|INFORMED CONSENT OBTAINED|Overall Study||7||
59519540|NCT02561832|75613532|FG000|COMPLETED|Overall Study||1|Subjects were still receiving study treatment when the study was terminated early by the Sponsor.|
59519541|NCT02561832|75613533|FG001|COMPLETED|Overall Study||3|Subjects were still receiving study treatment when the study was terminated early by the Sponsor.|
59519542|NCT02561832|75613532|FG000|NOT COMPLETED|Overall Study||7||
59519543|NCT02561832|75613533|FG001|NOT COMPLETED|Overall Study||4||
59519544|NCT00942149|75613539|FG000|STARTED|Overall Study||20||
59519545|NCT00942149|75613539|FG000|COMPLETED|Overall Study||20||
59519546|NCT00942149|75613539|FG000|NOT COMPLETED|Overall Study||0||
59519547|NCT01037881|75613550|FG000|STARTED|Overall Study||25||
59519548|NCT01037881|75613551|FG001|STARTED|Overall Study||24||
59519549|NCT01037881|75613552|FG002|STARTED|Overall Study||25||
59519550|NCT01037881|75613553|FG003|STARTED|Overall Study||25||
59519551|NCT01037881|75613554|FG004|STARTED|Overall Study||29||
59519552|NCT01037881|75613555|FG005|STARTED|Overall Study||30||
59519553|NCT01037881|75613556|FG006|STARTED|Overall Study||25||
59519554|NCT01037881|75613550|FG000|COMPLETED|Overall Study||19||
59519555|NCT01037881|75613551|FG001|COMPLETED|Overall Study||22||
59519556|NCT01037881|75613552|FG002|COMPLETED|Overall Study||22||
59519557|NCT01037881|75613553|FG003|COMPLETED|Overall Study||24||
59519558|NCT01037881|75613554|FG004|COMPLETED|Overall Study||26||
59519559|NCT01037881|75613555|FG005|COMPLETED|Overall Study||27||
59519560|NCT01037881|75613556|FG006|COMPLETED|Overall Study||23||
59519561|NCT01037881|75613550|FG000|NOT COMPLETED|Overall Study||6||
59519562|NCT01037881|75613551|FG001|NOT COMPLETED|Overall Study||2||
59519563|NCT01037881|75613552|FG002|NOT COMPLETED|Overall Study||3||
59519564|NCT01037881|75613553|FG003|NOT COMPLETED|Overall Study||1||
59519565|NCT01037881|75613554|FG004|NOT COMPLETED|Overall Study||3||
59519566|NCT01037881|75613555|FG005|NOT COMPLETED|Overall Study||3||
59519567|NCT01037881|75613556|FG006|NOT COMPLETED|Overall Study||2||
59519568|NCT01099111|75613586|FG000|STARTED|Overall Study||50||
59519569|NCT01099111|75613587|FG001|STARTED|Overall Study||50||
59519570|NCT01099111|75613588|FG002|STARTED|Overall Study||46||
59519571|NCT01099111|75613589|FG003|STARTED|Overall Study||29||
59519572|NCT01099111|75613590|FG004|STARTED|Overall Study||50||
59519573|NCT01099111|75613586|FG000|COMPLETED|Overall Study|5 subjects were dropped out because of insufficient DNA extraction and accordingly replaced randomly|50||
59519574|NCT01099111|75613587|FG001|COMPLETED|Overall Study|3 subjects were dropped out because of insufficient DNA extraction and accordingly replaced randomly|50||
59519575|NCT01099111|75613588|FG002|COMPLETED|Overall Study|2 subjects were dropped out because of insufficient DNA extraction and accordingly replaced randomly|46||
59519576|NCT01099111|75613589|FG003|COMPLETED|Overall Study||29||
59519577|NCT01099111|75613590|FG004|COMPLETED|Overall Study|6 subjects were dropped out because of insufficient DNA extraction and accordingly replaced randomly|50||
59519578|NCT01099111|75613586|FG000|NOT COMPLETED|Overall Study||0||
59519579|NCT01099111|75613587|FG001|NOT COMPLETED|Overall Study||0||
59519580|NCT01099111|75613588|FG002|NOT COMPLETED|Overall Study||0||
59519581|NCT01099111|75613589|FG003|NOT COMPLETED|Overall Study||0||
59519582|NCT01099111|75613590|FG004|NOT COMPLETED|Overall Study||0||
59519583|NCT00947219|75613605|FG000|STARTED|Overall Study||28||
59519584|NCT00947219|75613606|FG001|STARTED|Overall Study||25||
59519585|NCT00947219|75613607|FG002|STARTED|Overall Study||26||
59519586|NCT00947219|75613605|FG000|COMPLETED|Overall Study||22||
59519587|NCT00947219|75613606|FG001|COMPLETED|Overall Study||21||
59519588|NCT00947219|75613607|FG002|COMPLETED|Overall Study||22||
59519589|NCT00947219|75613605|FG000|NOT COMPLETED|Overall Study||6||
59519590|NCT00947219|75613606|FG001|NOT COMPLETED|Overall Study||4||
59519591|NCT00947219|75613607|FG002|NOT COMPLETED|Overall Study||4||
59519592|NCT01124305|75613617|FG000|STARTED|Overall Study||34||
59519593|NCT01124305|75613618|FG001|STARTED|Overall Study||36||
59519594|NCT01124305|75613617|FG000|COMPLETED|Overall Study||26||
59519595|NCT01124305|75613618|FG001|COMPLETED|Overall Study||26||
59519596|NCT01124305|75613617|FG000|NOT COMPLETED|Overall Study||8||
59519597|NCT01124305|75613618|FG001|NOT COMPLETED|Overall Study||10||
59519598|NCT03408730|75613628|FG000|STARTED|Overall Study||712||
59519599|NCT03408730|75613629|FG001|STARTED|Overall Study||711||
59519600|NCT03408730|75613630|FG002|STARTED|Overall Study||709||
59613721|NCT01561560|75724920|FG000|NOT COMPLETED|Second Two Weeks of Wear||0||
59613722|NCT01561560|75724921|FG001|NOT COMPLETED|Second Two Weeks of Wear||1||
59613723|NCT01537068|75724929|FG000|STARTED|Overall Study||30||
59613724|NCT01537068|75724930|FG001|STARTED|Overall Study||29||
59613725|NCT01537068|75724929|FG000|COMPLETED|Overall Study||26||
59613726|NCT01537068|75724930|FG001|COMPLETED|Overall Study||26||
59613727|NCT01537068|75724929|FG000|NOT COMPLETED|Overall Study||4||
59613728|NCT01537068|75724930|FG001|NOT COMPLETED|Overall Study||3||
59613729|NCT01585428|75724938|FG000|STARTED|Overall Study||18||
59613730|NCT01585428|75724939|FG001|STARTED|Overall Study||11||
59613731|NCT01585428|75724938|FG000|COMPLETED|Overall Study||17||
59613732|NCT01585428|75724939|FG001|COMPLETED|Overall Study||11||
59613733|NCT01585428|75724938|FG000|NOT COMPLETED|Overall Study||1||
59613734|NCT01585428|75724939|FG001|NOT COMPLETED|Overall Study||0||
59613735|NCT01585272|75724946|FG000|STARTED|Overall Study||121||
59613736|NCT01585272|75724946|FG000|Safety Set|Overall Study|Subjects received 3 mg bid Exelon caps for more than 4 weeks & used at least 1 dose of Exelon patch.|102||
59613737|NCT01585272|75724946|FG000|Exelon Patch 5 cm2|Overall Study||114||
59613738|NCT01585272|75724946|FG000|Exelon Patch 10 cm2|Overall Study||96||
59613739|NCT01585272|75724946|FG000|COMPLETED|Overall Study||82||
59613740|NCT01585272|75724946|FG000|NOT COMPLETED|Overall Study||39||
59613741|NCT01560780|75724952|FG000|STARTED|Overall Study||42||
59613742|NCT01560780|75724953|FG001|STARTED|Overall Study||42||
59613743|NCT01560780|75724952|FG000|Clinical Follow-Up at 12 Months|Overall Study||42||
59613744|NCT01560780|75724953|FG001|Clinical Follow-Up at 12 Months|Overall Study||42||
59613745|NCT01560780|75724952|FG000|Completed Study Drug for 12 Months|Overall Study||27||
59613746|NCT01560780|75724953|FG001|Completed Study Drug for 12 Months|Overall Study||27||
59613747|NCT01560780|75724952|FG000|COMPLETED|Overall Study||29|Underwent Angiography at 12 months|
59613748|NCT01560780|75724953|FG001|COMPLETED|Overall Study||30|Underwent Angiography at 12 months|
59613749|NCT01560780|75724952|FG000|NOT COMPLETED|Overall Study||13||
59613750|NCT01560780|75724953|FG001|NOT COMPLETED|Overall Study||12||
59613751|NCT01585038|75724961|FG000|STARTED|Overall Study||20||
59613752|NCT01585038|75724962|FG001|STARTED|Overall Study||20||
59613753|NCT01585038|75724961|FG000|COMPLETED|Overall Study||18||
59613754|NCT01585038|75724962|FG001|COMPLETED|Overall Study||18||
59613755|NCT01585038|75724961|FG000|NOT COMPLETED|Overall Study||2||
59613756|NCT01585038|75724962|FG001|NOT COMPLETED|Overall Study||2||
59613757|NCT01560234|75724976|FG000|STARTED|Overall Study||16||
59613758|NCT01560234|75724977|FG001|STARTED|Overall Study||4||
59613759|NCT01560234|75724978|FG002|STARTED|Overall Study||4||
59613760|NCT01560234|75724979|FG003|STARTED|Overall Study||3||
59613761|NCT01560234|75724980|FG004|STARTED|Overall Study||4||
59613762|NCT01560234|75724981|FG005|STARTED|Overall Study||4||
59613763|NCT01560234|75724982|FG006|STARTED|Overall Study||4||
59613764|NCT01560234|75724983|FG007|STARTED|Overall Study||8||
59613765|NCT01560234|75724976|FG000|COMPLETED|Overall Study||13||
59613766|NCT01560234|75724977|FG001|COMPLETED|Overall Study||4||
59613767|NCT01560234|75724978|FG002|COMPLETED|Overall Study||3||
59613768|NCT01560234|75724979|FG003|COMPLETED|Overall Study||3||
59613769|NCT01560234|75724980|FG004|COMPLETED|Overall Study||4||
59613770|NCT01560234|75724981|FG005|COMPLETED|Overall Study||2||
59613771|NCT01560234|75724982|FG006|COMPLETED|Overall Study||4||
59613772|NCT01560234|75724983|FG007|COMPLETED|Overall Study||6||
59613773|NCT01560234|75724976|FG000|NOT COMPLETED|Overall Study||3||
59613774|NCT01560234|75724977|FG001|NOT COMPLETED|Overall Study||0||
59613775|NCT01560234|75724978|FG002|NOT COMPLETED|Overall Study||1||
59519601|NCT03408730|75613631|FG003|STARTED|Overall Study||706||
59519602|NCT03408730|75613628|FG000|COMPLETED|Overall Study||643||
59519603|NCT03408730|75613629|FG001|COMPLETED|Overall Study||636||
59519604|NCT03408730|75613630|FG002|COMPLETED|Overall Study||637||
59519605|NCT03408730|75613631|FG003|COMPLETED|Overall Study||625||
59519606|NCT03408730|75613628|FG000|NOT COMPLETED|Overall Study||69||
59519607|NCT03408730|75613629|FG001|NOT COMPLETED|Overall Study||75||
59519608|NCT03408730|75613630|FG002|NOT COMPLETED|Overall Study||72||
59519609|NCT03408730|75613631|FG003|NOT COMPLETED|Overall Study||81||
59519610|NCT03408808|75613647|FG000|STARTED|Overall Study||8||
59519611|NCT03408808|75613648|FG001|STARTED|Overall Study||9||
59519612|NCT03408808|75613647|FG000|COMPLETED|Overall Study||8||
59519613|NCT03408808|75613648|FG001|COMPLETED|Overall Study||8||
59519614|NCT03408808|75613647|FG000|NOT COMPLETED|Overall Study||0||
59519615|NCT03408808|75613648|FG001|NOT COMPLETED|Overall Study||1||
59519616|NCT03410914|75613654|FG000|STARTED|Overall Study||52||
59519617|NCT03410914|75613654|FG000|COMPLETED|Overall Study||52||
59519618|NCT03410914|75613654|FG000|NOT COMPLETED|Overall Study||0||
59519619|NCT01039207|75613658|FG000|STARTED|Overall Study||31||
59519620|NCT01039207|75613658|FG000|COMPLETED|Overall Study||31|Eligible and treated patients.|
59519621|NCT01039207|75613658|FG000|NOT COMPLETED|Overall Study||0||
59613776|NCT01560234|75724979|FG003|NOT COMPLETED|Overall Study||0||
59613777|NCT01560234|75724980|FG004|NOT COMPLETED|Overall Study||0||
59613778|NCT01560234|75724981|FG005|NOT COMPLETED|Overall Study||2||
59613779|NCT01560234|75724982|FG006|NOT COMPLETED|Overall Study||0||
59613780|NCT01560234|75724983|FG007|NOT COMPLETED|Overall Study||2||
59613781|NCT01559844|75725001|FG000|STARTED|Overall Study||61||
59519622|NCT03417466|75613662|FG000|STARTED|Overall Study||66||
59519623|NCT03417466|75613662|FG000|COMPLETED|Overall Study||66||
59519624|NCT03417466|75613662|FG000|NOT COMPLETED|Overall Study||0||
59519625|NCT03621202|75613666|FG000|STARTED|Overall Study||66||
59519626|NCT03621202|75613666|FG000|COMPLETED|Overall Study||60||
59519627|NCT03621202|75613666|FG000|NOT COMPLETED|Overall Study||6||
59519628|NCT01125163|75613672|FG000|STARTED|Overall Study||76||
59519629|NCT01125163|75613673|FG001|STARTED|Overall Study||74||
59519630|NCT01125163|75613672|FG000|COMPLETED|Overall Study||76||
59519631|NCT01125163|75613673|FG001|COMPLETED|Overall Study||74||
59519632|NCT01125163|75613672|FG000|NOT COMPLETED|Overall Study||0||
59519633|NCT01125163|75613673|FG001|NOT COMPLETED|Overall Study||0||
59519634|NCT01099969|75613684|FG000|STARTED|Overall Study||15||
59519635|NCT01099969|75613685|FG001|STARTED|Overall Study||15||
59519636|NCT01099969|75613686|FG002|STARTED|Overall Study||15||
59519637|NCT01099969|75613687|FG003|STARTED|Overall Study||15||
59519638|NCT01099969|75613684|FG000|COMPLETED|Overall Study||15||
59519639|NCT01099969|75613685|FG001|COMPLETED|Overall Study||15||
59519640|NCT01099969|75613686|FG002|COMPLETED|Overall Study||15||
59519641|NCT01099969|75613687|FG003|COMPLETED|Overall Study||15||
59519642|NCT01099969|75613684|FG000|NOT COMPLETED|Overall Study||0||
59519643|NCT01099969|75613685|FG001|NOT COMPLETED|Overall Study||0||
59519644|NCT01099969|75613686|FG002|NOT COMPLETED|Overall Study||0||
59519645|NCT01099969|75613687|FG003|NOT COMPLETED|Overall Study||0||
59519646|NCT03417778|75613699|FG000|STARTED|Overall Study||10||
59519647|NCT03417778|75613700|FG001|STARTED|Overall Study||10||
59519648|NCT03417778|75613699|FG000|COMPLETED|Overall Study||10||
59519649|NCT03417778|75613700|FG001|COMPLETED|Overall Study||10||
59519650|NCT03417778|75613699|FG000|NOT COMPLETED|Overall Study||0||
59519651|NCT03417778|75613700|FG001|NOT COMPLETED|Overall Study||0||
59519652|NCT03575962|75613706|FG000|STARTED|Treatment Period 1 (4 Days)||7||
59519653|NCT03575962|75613707|FG001|STARTED|Treatment Period 1 (4 Days)||7||
59519654|NCT03575962|75613706|FG000|COMPLETED|Treatment Period 1 (4 Days)||7||
59519655|NCT03575962|75613707|FG001|COMPLETED|Treatment Period 1 (4 Days)||7||
59519656|NCT03575962|75613706|FG000|NOT COMPLETED|Treatment Period 1 (4 Days)||0||
59519657|NCT03575962|75613707|FG001|NOT COMPLETED|Treatment Period 1 (4 Days)||0||
59519658|NCT03575962|75613706|FG000|STARTED|Washout Period (7 Days)||7||
59519659|NCT03575962|75613707|FG001|STARTED|Washout Period (7 Days)||7||
59519660|NCT03575962|75613706|FG000|COMPLETED|Washout Period (7 Days)||7||
59519661|NCT03575962|75613707|FG001|COMPLETED|Washout Period (7 Days)||7||
59519662|NCT03575962|75613706|FG000|NOT COMPLETED|Washout Period (7 Days)||0||
59519663|NCT03575962|75613707|FG001|NOT COMPLETED|Washout Period (7 Days)||0||
59519664|NCT03575962|75613706|FG000|STARTED|Treatment Period 2 (4 Days)||7||
59519665|NCT03575962|75613707|FG001|STARTED|Treatment Period 2 (4 Days)||7||
59519666|NCT03575962|75613706|FG000|COMPLETED|Treatment Period 2 (4 Days)||7||
59519667|NCT03575962|75613707|FG001|COMPLETED|Treatment Period 2 (4 Days)||7||
59519668|NCT03575962|75613706|FG000|NOT COMPLETED|Treatment Period 2 (4 Days)||0||
59519669|NCT03575962|75613707|FG001|NOT COMPLETED|Treatment Period 2 (4 Days)||0||
59519670|NCT00947297|75613713|FG000|STARTED|Overall Study||60||
59519671|NCT00947297|75613713|FG000|COMPLETED|Overall Study||53||
59519672|NCT00947297|75613713|FG000|NOT COMPLETED|Overall Study||7||
59519673|NCT03576118|75613720|FG000|STARTED|Overall Study||37||
59519674|NCT03576118|75613721|FG001|STARTED|Overall Study||37||
59519675|NCT03576118|75613720|FG000|COMPLETED|Overall Study||34||
59519676|NCT03576118|75613721|FG001|COMPLETED|Overall Study||33||
59519677|NCT03576118|75613720|FG000|NOT COMPLETED|Overall Study||3||
59519678|NCT03576118|75613721|FG001|NOT COMPLETED|Overall Study||4||
59519679|NCT03623698|75613727|FG000|STARTED|Overall Study||24||
59519680|NCT03623698|75613727|FG000|COMPLETED|Overall Study||24||
59519681|NCT03623698|75613727|FG000|NOT COMPLETED|Overall Study||0||
59519682|NCT03628456|75613738|FG000|STARTED|Overall Study||10||
59519683|NCT03628456|75613738|FG000|COMPLETED|Overall Study||10||
59519684|NCT03628456|75613738|FG000|NOT COMPLETED|Overall Study||0||
59519685|NCT00955877|75613749|FG000|STARTED|Overall Study|Drug manufacturer ceased producing the drug prior to completion of 10 enrolled in this arm.|6||
59519686|NCT00955877|75613750|FG001|STARTED|Overall Study|No patients were enrolled because analysis of previous arm wasn't completed.|0||
59519687|NCT00955877|75613751|FG002|STARTED|Overall Study||7||
59519688|NCT00955877|75613749|FG000|COMPLETED|Overall Study||6||
59519689|NCT00955877|75613750|FG001|COMPLETED|Overall Study||0||
59519690|NCT00955877|75613751|FG002|COMPLETED|Overall Study||7||
59519691|NCT00955877|75613749|FG000|NOT COMPLETED|Overall Study||0||
59519692|NCT00955877|75613750|FG001|NOT COMPLETED|Overall Study||0||
59519693|NCT00955877|75613751|FG002|NOT COMPLETED|Overall Study||0||
59519694|NCT03951610|75613759|FG000|STARTED|First Intervention||27||
59519695|NCT03951610|75613760|FG001|STARTED|First Intervention||25||
59519696|NCT03951610|75613759|FG000|COMPLETED|First Intervention||27||
59519697|NCT03951610|75613760|FG001|COMPLETED|First Intervention||25||
59519698|NCT03951610|75613759|FG000|NOT COMPLETED|First Intervention||0||
59519699|NCT03951610|75613760|FG001|NOT COMPLETED|First Intervention||0||
59519700|NCT03951610|75613759|FG000|STARTED|Second Intervention||27||
59519701|NCT03951610|75613760|FG001|STARTED|Second Intervention||25||
59519702|NCT03951610|75613759|FG000|COMPLETED|Second Intervention||27||
59613782|NCT01559844|75725001|FG000|COMPLETED|Overall Study||36||
59613783|NCT01559844|75725001|FG000|NOT COMPLETED|Overall Study||25||
59613784|NCT01584648|75725007|FG000|STARTED|Overall Study||211|All randomized patients included into Intent-to-Treat (ITT) population.|
59613785|NCT01584648|75725008|FG001|STARTED|Overall Study||212|All randomized patients included into Intent-to-Treat (ITT) population.|
59613786|NCT01584648|75725007|FG000|Safety Set|Overall Study||209|All patients who received at least one dose of study treatment|
59613787|NCT01584648|75725008|FG001|Safety Set|Overall Study||211|All patients who received at least one dose of study treatment|
59613788|NCT01584648|75725007|FG000|Crossover Population|Overall Study||0|All monotherapy randomized patients who crossed over to combination therapy|
59613789|NCT01584648|75725008|FG001|Crossover Population|Overall Study||28|All monotherapy randomized patients who crossed over to combination therapy|
59613790|NCT01584648|75725007|FG000|COMPLETED|Overall Study||0||
59613791|NCT01584648|75725008|FG001|COMPLETED|Overall Study||0||
59613792|NCT01584648|75725007|FG000|NOT COMPLETED|Overall Study||211||
59613793|NCT01584648|75725008|FG001|NOT COMPLETED|Overall Study||212||
59613794|NCT01559454|75725019|FG000|STARTED|Overall Study||9||
59613795|NCT01559454|75725020|FG001|STARTED|Overall Study||10||
59613796|NCT01559454|75725019|FG000|COMPLETED|Overall Study||6||
59613797|NCT01559454|75725020|FG001|COMPLETED|Overall Study||4||
59613798|NCT01559454|75725019|FG000|NOT COMPLETED|Overall Study||3||
59613799|NCT01559454|75725020|FG001|NOT COMPLETED|Overall Study||6||
59613800|NCT01584024|75725026|FG000|STARTED|Overall Study||42||84
59613801|NCT01584024|75725026|FG000|COMPLETED|Overall Study||29||58
59613802|NCT01584024|75725026|FG000|NOT COMPLETED|Overall Study||13||26
59613803|NCT01583166|75725033|FG000|STARTED|Overall Study||45||
59613804|NCT01583166|75725034|FG001|STARTED|Overall Study||45||
59613805|NCT01583166|75725033|FG000|COMPLETED|Overall Study||41||
59613806|NCT01583166|75725034|FG001|COMPLETED|Overall Study||39||
59613807|NCT01583166|75725033|FG000|NOT COMPLETED|Overall Study||4||
59613808|NCT01583166|75725034|FG001|NOT COMPLETED|Overall Study||6||
59613809|NCT01535274|75725042|FG000|STARTED|Overall Study||28||
59613810|NCT01535274|75725043|FG001|STARTED|Overall Study|"29 participants were initially randomized to receive desflurane treatment. One participant initially randomized to the desflurane arm was misallocated to the propofol arm and received propofol treatment, as shown in the reason not completed section below."|29||
59613811|NCT01535274|75725042|FG000|Received Propofol|Overall Study||28||
59613812|NCT01535274|75725043|FG001|Received Propofol|Overall Study|"Of the 29 participants initially randomized to receive desflurane treatment, one was misallocated to the propofol arm and received propofol treatment, as shown in the reason not completed section below. That participant is included in the baseline characteristics, outcome measures, and adverse events with the propofol arm."|1||
59613813|NCT01535274|75725042|FG000|Received Desflurane|Overall Study||0||
59613814|NCT01535274|75725043|FG001|Received Desflurane|Overall Study||28||
59613815|NCT01535274|75725042|FG000|COMPLETED|Overall Study||28||
59613816|NCT01535274|75725043|FG001|COMPLETED|Overall Study||27||
59613817|NCT01535274|75725042|FG000|NOT COMPLETED|Overall Study||0||
59613818|NCT01535274|75725043|FG001|NOT COMPLETED|Overall Study||2||
59613819|NCT01558752|75725053|FG000|STARTED|Overall Study||42||
59613820|NCT01558752|75725054|FG001|STARTED|Overall Study||46||
59613821|NCT01558752|75725053|FG000|COMPLETED|Overall Study||40||
59613822|NCT01558752|75725054|FG001|COMPLETED|Overall Study||46||
59613823|NCT01558752|75725053|FG000|NOT COMPLETED|Overall Study||2||
59613824|NCT01558752|75725054|FG001|NOT COMPLETED|Overall Study||0||
59613825|NCT01582854|75725062|FG000|STARTED|Overall Study||248||
59613826|NCT01582854|75725063|FG001|STARTED|Overall Study||255||
59613827|NCT01582854|75725062|FG000|COMPLETED|Overall Study||212||
59613828|NCT01582854|75725063|FG001|COMPLETED|Overall Study||221||
59613829|NCT01582854|75725062|FG000|NOT COMPLETED|Overall Study||36||
59613830|NCT01582854|75725063|FG001|NOT COMPLETED|Overall Study||34||
59613831|NCT01582308|75725069|FG000|STARTED|Period 1||2||
59613832|NCT01582308|75725070|FG001|STARTED|Period 1||2||
59613833|NCT01582308|75725071|FG002|STARTED|Period 1||2||
59613834|NCT01582308|75725072|FG003|STARTED|Period 1||2||
59613835|NCT01582308|75725073|FG004|STARTED|Period 1|Includes replacement for a participant who discontinued after period 1|3||
59613836|NCT01582308|75725074|FG005|STARTED|Period 1||2||
59613837|NCT01582308|75725075|FG006|STARTED|Period 1|Includes replacement for a participant who discontinued during period 1|3||
59613838|NCT01582308|75725076|FG007|STARTED|Period 1||2||
59613839|NCT01582308|75725077|FG008|STARTED|Period 1||2||
59613840|NCT01582308|75725078|FG009|STARTED|Period 1||2||
59613841|NCT01582308|75725069|FG000|COMPLETED|Period 1||2||
59613842|NCT01582308|75725070|FG001|COMPLETED|Period 1||2||
59613843|NCT01582308|75725071|FG002|COMPLETED|Period 1||2||
59613844|NCT01582308|75725072|FG003|COMPLETED|Period 1||2||
59613845|NCT01582308|75725073|FG004|COMPLETED|Period 1||3||
59613846|NCT01582308|75725074|FG005|COMPLETED|Period 1||2||
59613847|NCT01582308|75725075|FG006|COMPLETED|Period 1||2||
59613848|NCT01582308|75725076|FG007|COMPLETED|Period 1||2||
59613849|NCT01582308|75725077|FG008|COMPLETED|Period 1||2||
59613850|NCT01582308|75725078|FG009|COMPLETED|Period 1||2||
59613851|NCT01582308|75725069|FG000|NOT COMPLETED|Period 1||0||
59613852|NCT01582308|75725070|FG001|NOT COMPLETED|Period 1||0||
59613853|NCT01582308|75725071|FG002|NOT COMPLETED|Period 1||0||
59613854|NCT01582308|75725072|FG003|NOT COMPLETED|Period 1||0||
59613855|NCT01582308|75725073|FG004|NOT COMPLETED|Period 1||0||
59613856|NCT01582308|75725074|FG005|NOT COMPLETED|Period 1||0||
59613857|NCT01582308|75725075|FG006|NOT COMPLETED|Period 1||1||
59613858|NCT01582308|75725076|FG007|NOT COMPLETED|Period 1||0||
59613859|NCT01582308|75725077|FG008|NOT COMPLETED|Period 1||0||
59613860|NCT01582308|75725078|FG009|NOT COMPLETED|Period 1||0||
59613861|NCT01582308|75725069|FG000|STARTED|10-day Washout Following Period 1||2||
59613862|NCT01582308|75725070|FG001|STARTED|10-day Washout Following Period 1||2||
59613863|NCT01582308|75725071|FG002|STARTED|10-day Washout Following Period 1||2||
59613864|NCT01582308|75725072|FG003|STARTED|10-day Washout Following Period 1||2||
59613865|NCT01582308|75725073|FG004|STARTED|10-day Washout Following Period 1||3||
59613866|NCT01582308|75725074|FG005|STARTED|10-day Washout Following Period 1||2||
59613867|NCT01582308|75725075|FG006|STARTED|10-day Washout Following Period 1||2||
59613868|NCT01582308|75725076|FG007|STARTED|10-day Washout Following Period 1||2||
59613869|NCT01582308|75725077|FG008|STARTED|10-day Washout Following Period 1||2||
59613870|NCT01582308|75725078|FG009|STARTED|10-day Washout Following Period 1||2||
59613871|NCT01582308|75725069|FG000|COMPLETED|10-day Washout Following Period 1||2||
59613872|NCT01582308|75725070|FG001|COMPLETED|10-day Washout Following Period 1||2||
59613873|NCT01582308|75725071|FG002|COMPLETED|10-day Washout Following Period 1||2||
59613874|NCT01582308|75725072|FG003|COMPLETED|10-day Washout Following Period 1||2||
59613875|NCT01582308|75725073|FG004|COMPLETED|10-day Washout Following Period 1||2||
59613876|NCT01582308|75725074|FG005|COMPLETED|10-day Washout Following Period 1||2||
59613877|NCT01582308|75725075|FG006|COMPLETED|10-day Washout Following Period 1||2||
59613878|NCT01582308|75725076|FG007|COMPLETED|10-day Washout Following Period 1||2||
59613879|NCT01582308|75725077|FG008|COMPLETED|10-day Washout Following Period 1||2||
59613880|NCT01582308|75725078|FG009|COMPLETED|10-day Washout Following Period 1||2||
59613881|NCT01582308|75725069|FG000|NOT COMPLETED|10-day Washout Following Period 1||0||
59613882|NCT01582308|75725070|FG001|NOT COMPLETED|10-day Washout Following Period 1||0||
59613883|NCT01582308|75725071|FG002|NOT COMPLETED|10-day Washout Following Period 1||0||
59613884|NCT01582308|75725072|FG003|NOT COMPLETED|10-day Washout Following Period 1||0||
59613885|NCT01582308|75725073|FG004|NOT COMPLETED|10-day Washout Following Period 1||1||
59613886|NCT01582308|75725074|FG005|NOT COMPLETED|10-day Washout Following Period 1||0||
59613887|NCT01582308|75725075|FG006|NOT COMPLETED|10-day Washout Following Period 1||0||
59613888|NCT01582308|75725076|FG007|NOT COMPLETED|10-day Washout Following Period 1||0||
59613889|NCT01582308|75725077|FG008|NOT COMPLETED|10-day Washout Following Period 1||0||
59613890|NCT01582308|75725078|FG009|NOT COMPLETED|10-day Washout Following Period 1||0||
59613891|NCT01582308|75725069|FG000|STARTED|Period 2||2||
59613892|NCT01582308|75725070|FG001|STARTED|Period 2||2||
59613893|NCT01582308|75725071|FG002|STARTED|Period 2||2||
59613894|NCT01582308|75725072|FG003|STARTED|Period 2||2||
59613895|NCT01582308|75725073|FG004|STARTED|Period 2||2||
59613896|NCT01582308|75725074|FG005|STARTED|Period 2||2||
59613897|NCT01582308|75725075|FG006|STARTED|Period 2||2||
59613898|NCT01582308|75725076|FG007|STARTED|Period 2||2||
59613899|NCT01582308|75725077|FG008|STARTED|Period 2||2||
59613900|NCT01582308|75725078|FG009|STARTED|Period 2||2||
59613901|NCT01582308|75725069|FG000|COMPLETED|Period 2||2||
59613902|NCT01582308|75725070|FG001|COMPLETED|Period 2||2||
59613903|NCT01582308|75725071|FG002|COMPLETED|Period 2||2||
59613904|NCT01582308|75725072|FG003|COMPLETED|Period 2||2||
59613905|NCT01582308|75725073|FG004|COMPLETED|Period 2||2||
59613906|NCT01582308|75725074|FG005|COMPLETED|Period 2||2||
59613907|NCT01582308|75725075|FG006|COMPLETED|Period 2||2||
59613908|NCT01582308|75725076|FG007|COMPLETED|Period 2||2||
59613909|NCT01582308|75725077|FG008|COMPLETED|Period 2||2||
59613910|NCT01582308|75725078|FG009|COMPLETED|Period 2||2||
59613911|NCT01582308|75725069|FG000|NOT COMPLETED|Period 2||0||
59613912|NCT01582308|75725070|FG001|NOT COMPLETED|Period 2||0||
59613913|NCT01582308|75725071|FG002|NOT COMPLETED|Period 2||0||
59613914|NCT01582308|75725072|FG003|NOT COMPLETED|Period 2||0||
59613915|NCT01582308|75725073|FG004|NOT COMPLETED|Period 2||0||
59613916|NCT01582308|75725074|FG005|NOT COMPLETED|Period 2||0||
59613917|NCT01582308|75725075|FG006|NOT COMPLETED|Period 2||0||
59613918|NCT01582308|75725076|FG007|NOT COMPLETED|Period 2||0||
59613919|NCT01582308|75725077|FG008|NOT COMPLETED|Period 2||0||
59613920|NCT01582308|75725078|FG009|NOT COMPLETED|Period 2||0||
59613921|NCT01582308|75725069|FG000|STARTED|10-day Washout Following Period 2||2||
59613922|NCT01582308|75725070|FG001|STARTED|10-day Washout Following Period 2||2||
59613923|NCT01582308|75725071|FG002|STARTED|10-day Washout Following Period 2||2||
59613924|NCT01582308|75725072|FG003|STARTED|10-day Washout Following Period 2||2||
59613925|NCT01582308|75725073|FG004|STARTED|10-day Washout Following Period 2||2||
59613926|NCT01582308|75725074|FG005|STARTED|10-day Washout Following Period 2||2||
59613927|NCT01582308|75725075|FG006|STARTED|10-day Washout Following Period 2||2||
59613928|NCT01582308|75725076|FG007|STARTED|10-day Washout Following Period 2||2||
59613929|NCT01582308|75725077|FG008|STARTED|10-day Washout Following Period 2||2||
59613930|NCT01582308|75725078|FG009|STARTED|10-day Washout Following Period 2||2||
59613931|NCT01582308|75725069|FG000|COMPLETED|10-day Washout Following Period 2||2||
59613932|NCT01582308|75725070|FG001|COMPLETED|10-day Washout Following Period 2||2||
59613933|NCT01582308|75725071|FG002|COMPLETED|10-day Washout Following Period 2||2||
59613934|NCT01582308|75725072|FG003|COMPLETED|10-day Washout Following Period 2||2||
59613935|NCT01582308|75725073|FG004|COMPLETED|10-day Washout Following Period 2||2||
59519703|NCT03951610|75613760|FG001|COMPLETED|Second Intervention||25||
59519704|NCT03951610|75613759|FG000|NOT COMPLETED|Second Intervention||0||
59519705|NCT03951610|75613760|FG001|NOT COMPLETED|Second Intervention||0||
59519706|NCT03960658|75613766|FG000|STARTED|Overall Study||12||
59519707|NCT03960658|75613766|FG000|COMPLETED|Overall Study||10||
59519708|NCT03960658|75613766|FG000|NOT COMPLETED|Overall Study||2||
59519709|NCT04580290|75613772|FG000|STARTED|Overall Study||88||
59519710|NCT04580290|75613773|FG001|STARTED|Overall Study||32||
59519711|NCT04580290|75613772|FG000|COMPLETED|Overall Study||88||
59519712|NCT04580290|75613773|FG001|COMPLETED|Overall Study||32||
59519713|NCT04580290|75613772|FG000|NOT COMPLETED|Overall Study||0||
59519714|NCT04580290|75613773|FG001|NOT COMPLETED|Overall Study||0||
59519715|NCT04617574|75613781|FG000|STARTED|Overall Study||30||
59519716|NCT04617574|75613782|FG001|STARTED|Overall Study||30||
59519717|NCT04617574|75613781|FG000|COMPLETED|Overall Study||30||
59519718|NCT04617574|75613782|FG001|COMPLETED|Overall Study||30||
59519719|NCT04617574|75613781|FG000|NOT COMPLETED|Overall Study||0||
59519720|NCT04617574|75613782|FG001|NOT COMPLETED|Overall Study||0||
59519721|NCT01005407|75613790|FG000|STARTED|Overall Study||1969||
59519722|NCT01005407|75613791|FG001|STARTED|Overall Study||483||
59519723|NCT01005407|75613790|FG000|COMPLETED|Overall Study||1818||
59519724|NCT01005407|75613791|FG001|COMPLETED|Overall Study||451||
59519725|NCT01005407|75613790|FG000|NOT COMPLETED|Overall Study||151||
59519726|NCT01005407|75613791|FG001|NOT COMPLETED|Overall Study||32||
59519727|NCT03633448|75613799|FG000|STARTED|Period 1 (1 Day)||12||
59519728|NCT03633448|75613800|FG001|STARTED|Period 1 (1 Day)||12||
59519729|NCT03633448|75613799|FG000|COMPLETED|Period 1 (1 Day)||12||
59519730|NCT03633448|75613800|FG001|COMPLETED|Period 1 (1 Day)||12||
59519731|NCT03633448|75613799|FG000|NOT COMPLETED|Period 1 (1 Day)||0||
59519732|NCT03633448|75613800|FG001|NOT COMPLETED|Period 1 (1 Day)||0||
59519733|NCT03633448|75613799|FG000|STARTED|Washout (7 Days)||12||
59519734|NCT03633448|75613800|FG001|STARTED|Washout (7 Days)||12||
59519735|NCT03633448|75613799|FG000|COMPLETED|Washout (7 Days)||12||
59519736|NCT03633448|75613800|FG001|COMPLETED|Washout (7 Days)||12||
59519737|NCT03633448|75613799|FG000|NOT COMPLETED|Washout (7 Days)||0||
59519738|NCT03633448|75613800|FG001|NOT COMPLETED|Washout (7 Days)||0||
59519739|NCT03633448|75613799|FG000|STARTED|Period 2 (1 Day)||12||
59519740|NCT03633448|75613800|FG001|STARTED|Period 2 (1 Day)||12||
59519741|NCT03633448|75613799|FG000|COMPLETED|Period 2 (1 Day)||12||
59519742|NCT03633448|75613800|FG001|COMPLETED|Period 2 (1 Day)||12||
59519743|NCT03633448|75613799|FG000|NOT COMPLETED|Period 2 (1 Day)||0||
59519744|NCT03633448|75613800|FG001|NOT COMPLETED|Period 2 (1 Day)||0||
59519745|NCT01006655|75613812|FG000|STARTED|First Intervention||11||
59519746|NCT01006655|75613813|FG001|STARTED|First Intervention||10||
59519747|NCT01006655|75613812|FG000|COMPLETED|First Intervention||11||
59519748|NCT01006655|75613813|FG001|COMPLETED|First Intervention||10||
59519749|NCT01006655|75613812|FG000|NOT COMPLETED|First Intervention||0||
59519750|NCT01006655|75613813|FG001|NOT COMPLETED|First Intervention||0||
59519751|NCT01006655|75613812|FG000|STARTED|Washout Period of 2 Weeks||11||
59519752|NCT01006655|75613813|FG001|STARTED|Washout Period of 2 Weeks||10||
59519753|NCT01006655|75613812|FG000|COMPLETED|Washout Period of 2 Weeks||11||
59519754|NCT01006655|75613813|FG001|COMPLETED|Washout Period of 2 Weeks||10||
59519755|NCT01006655|75613812|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0||
59613936|NCT01582308|75725074|FG005|COMPLETED|10-day Washout Following Period 2||2||
59613937|NCT01582308|75725075|FG006|COMPLETED|10-day Washout Following Period 2||2||
59613938|NCT01582308|75725076|FG007|COMPLETED|10-day Washout Following Period 2||2||
59613939|NCT01582308|75725077|FG008|COMPLETED|10-day Washout Following Period 2||2||
59613940|NCT01582308|75725078|FG009|COMPLETED|10-day Washout Following Period 2||2||
59613941|NCT01582308|75725069|FG000|NOT COMPLETED|10-day Washout Following Period 2||0||
59613942|NCT01582308|75725070|FG001|NOT COMPLETED|10-day Washout Following Period 2||0||
59613943|NCT01582308|75725071|FG002|NOT COMPLETED|10-day Washout Following Period 2||0||
59613944|NCT01582308|75725072|FG003|NOT COMPLETED|10-day Washout Following Period 2||0||
59613945|NCT01582308|75725073|FG004|NOT COMPLETED|10-day Washout Following Period 2||0||
59613946|NCT01582308|75725074|FG005|NOT COMPLETED|10-day Washout Following Period 2||0||
59613947|NCT01582308|75725075|FG006|NOT COMPLETED|10-day Washout Following Period 2||0||
59613948|NCT01582308|75725076|FG007|NOT COMPLETED|10-day Washout Following Period 2||0||
59613949|NCT01582308|75725077|FG008|NOT COMPLETED|10-day Washout Following Period 2||0||
59613950|NCT01582308|75725078|FG009|NOT COMPLETED|10-day Washout Following Period 2||0||
59613951|NCT01582308|75725069|FG000|STARTED|Period 3||2||
59613952|NCT01582308|75725070|FG001|STARTED|Period 3||2||
59613953|NCT01582308|75725071|FG002|STARTED|Period 3||2||
59613954|NCT01582308|75725072|FG003|STARTED|Period 3||2||
59613955|NCT01582308|75725073|FG004|STARTED|Period 3||2||
59613956|NCT01582308|75725074|FG005|STARTED|Period 3||2||
59613957|NCT01582308|75725075|FG006|STARTED|Period 3||2||
59613958|NCT01582308|75725076|FG007|STARTED|Period 3||2||
59613959|NCT01582308|75725077|FG008|STARTED|Period 3||2||
59613960|NCT01582308|75725078|FG009|STARTED|Period 3||2||
59613961|NCT01582308|75725069|FG000|COMPLETED|Period 3||2||
59613962|NCT01582308|75725070|FG001|COMPLETED|Period 3||2||
59613963|NCT01582308|75725071|FG002|COMPLETED|Period 3||2||
59613964|NCT01582308|75725072|FG003|COMPLETED|Period 3||2||
59613965|NCT01582308|75725073|FG004|COMPLETED|Period 3||2||
59519756|NCT01006655|75613813|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0||
59519757|NCT01006655|75613812|FG000|STARTED|Second Intervention||11||
59519758|NCT01006655|75613813|FG001|STARTED|Second Intervention||10||
59519759|NCT01006655|75613812|FG000|COMPLETED|Second Intervention||11||
59519760|NCT01006655|75613813|FG001|COMPLETED|Second Intervention||10||
59519761|NCT01006655|75613812|FG000|NOT COMPLETED|Second Intervention||0||
59519762|NCT01006655|75613813|FG001|NOT COMPLETED|Second Intervention||0||
59519763|NCT01006967|75613821|FG000|STARTED|Overall Study||253||
59519764|NCT01006967|75613822|FG001|STARTED|Overall Study||253||
59519765|NCT01006967|75613821|FG000|Received Treatment|Overall Study||245||
59519766|NCT01006967|75613822|FG001|Received Treatment|Overall Study||245||
59519767|NCT01006967|75613821|FG000|3 Month Follow-up|Overall Study||212||
59519768|NCT01006967|75613822|FG001|3 Month Follow-up|Overall Study||210||
59519769|NCT01006967|75613821|FG000|COMPLETED|Overall Study||187||
59519770|NCT01006967|75613822|FG001|COMPLETED|Overall Study||190||
59519771|NCT01006967|75613821|FG000|NOT COMPLETED|Overall Study||66||
59519772|NCT01006967|75613822|FG001|NOT COMPLETED|Overall Study||63||
59519773|NCT03633526|75613830|FG000|STARTED|Overall Study||16||
59519774|NCT03633526|75613830|FG000|COMPLETED|Overall Study||16||
59519775|NCT03633526|75613830|FG000|NOT COMPLETED|Overall Study||0||
59519776|NCT04502056|75613836|FG000|STARTED|Overall Study||2046||
59519777|NCT04502056|75613837|FG001|STARTED|Overall Study||2044||
59519778|NCT04502056|75613838|FG002|STARTED|Overall Study||2045||
59519779|NCT04502056|75613839|FG003|STARTED|Overall Study||2046||
59519780|NCT04502056|75613840|FG004|STARTED|Overall Study||2044||
59519781|NCT04502056|75613841|FG005|STARTED|Overall Study||2052||
59519782|NCT04502056|75613842|FG006|STARTED|Overall Study||2046||
59613966|NCT01582308|75725074|FG005|COMPLETED|Period 3||2||
59613967|NCT01582308|75725075|FG006|COMPLETED|Period 3||2||
59613968|NCT01582308|75725076|FG007|COMPLETED|Period 3||2||
59519783|NCT04502056|75613843|FG007|STARTED|Overall Study||2043||
59519784|NCT04502056|75613844|FG008|STARTED|Overall Study||1026||
59519785|NCT04502056|75613845|FG009|STARTED|Overall Study||1025||
59613969|NCT01582308|75725077|FG008|COMPLETED|Period 3||2||
59613970|NCT01582308|75725078|FG009|COMPLETED|Period 3||2||
59613971|NCT01582308|75725069|FG000|NOT COMPLETED|Period 3||0||
59613972|NCT01582308|75725070|FG001|NOT COMPLETED|Period 3||0||
59613973|NCT01582308|75725071|FG002|NOT COMPLETED|Period 3||0||
59613974|NCT01582308|75725072|FG003|NOT COMPLETED|Period 3||0||
59613975|NCT01582308|75725073|FG004|NOT COMPLETED|Period 3||0||
59613976|NCT01582308|75725074|FG005|NOT COMPLETED|Period 3||0||
59613977|NCT01582308|75725075|FG006|NOT COMPLETED|Period 3||0||
59613978|NCT01582308|75725076|FG007|NOT COMPLETED|Period 3||0||
59613979|NCT01582308|75725077|FG008|NOT COMPLETED|Period 3||0||
59613980|NCT01582308|75725078|FG009|NOT COMPLETED|Period 3||0||
59613981|NCT01582308|75725069|FG000|STARTED|10-day Washout Following Period 3||2||
59613982|NCT01582308|75725070|FG001|STARTED|10-day Washout Following Period 3||2||
59613983|NCT01582308|75725071|FG002|STARTED|10-day Washout Following Period 3||2||
59613984|NCT01582308|75725072|FG003|STARTED|10-day Washout Following Period 3||2||
59519786|NCT04502056|75613846|FG010|STARTED|Overall Study||1023||
59519787|NCT04502056|75613847|FG011|STARTED|Overall Study||1020||
59519788|NCT04502056|75613836|FG000|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||1859||
59519789|NCT04502056|75613837|FG001|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||1881||
59519790|NCT04502056|75613838|FG002|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||1879||
59519791|NCT04502056|75613839|FG003|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||1886||
59519792|NCT04502056|75613840|FG004|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||1846||
59519793|NCT04502056|75613841|FG005|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||1877||
59519794|NCT04502056|75613842|FG006|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||1888||
59519795|NCT04502056|75613843|FG007|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||1883||
59519796|NCT04502056|75613844|FG008|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||947||
59519797|NCT04502056|75613845|FG009|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||942||
59519798|NCT04502056|75613846|FG010|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||946||
59519799|NCT04502056|75613847|FG011|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||928||
59519800|NCT04502056|75613836|FG000|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||1799||
59519801|NCT04502056|75613837|FG001|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||1828||
59519802|NCT04502056|75613838|FG002|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||1830||
59519803|NCT04502056|75613839|FG003|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||1835||
59519804|NCT04502056|75613840|FG004|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||1792||
59519805|NCT04502056|75613841|FG005|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||1820||
59519806|NCT04502056|75613842|FG006|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||1821||
59519807|NCT04502056|75613843|FG007|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||1844||
59519808|NCT04502056|75613844|FG008|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||914||
59519809|NCT04502056|75613845|FG009|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||912||
59519810|NCT04502056|75613846|FG010|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||928||
59519811|NCT04502056|75613847|FG011|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||900||
59519812|NCT04502056|75613836|FG000|Completed the Follow-up Survey|Overall Study||608||
59519813|NCT04502056|75613837|FG001|Completed the Follow-up Survey|Overall Study||607||
59519814|NCT04502056|75613838|FG002|Completed the Follow-up Survey|Overall Study||591||
59519815|NCT04502056|75613839|FG003|Completed the Follow-up Survey|Overall Study||601||
59519816|NCT04502056|75613840|FG004|Completed the Follow-up Survey|Overall Study||631||
59519817|NCT04502056|75613841|FG005|Completed the Follow-up Survey|Overall Study||598||
59519818|NCT04502056|75613842|FG006|Completed the Follow-up Survey|Overall Study||607||
59519819|NCT04502056|75613843|FG007|Completed the Follow-up Survey|Overall Study||607||
59519820|NCT04502056|75613844|FG008|Completed the Follow-up Survey|Overall Study||301||
59519821|NCT04502056|75613845|FG009|Completed the Follow-up Survey|Overall Study||313||
59519822|NCT04502056|75613846|FG010|Completed the Follow-up Survey|Overall Study||291||
59519823|NCT04502056|75613847|FG011|Completed the Follow-up Survey|Overall Study||316||
59519824|NCT04502056|75613836|FG000|COMPLETED|Overall Study||604|Participants who completed follow-up and have no missing on baseline observables, included for follow-up analysis|
59519825|NCT04502056|75613837|FG001|COMPLETED|Overall Study||602|Participants who completed follow-up and have no missing on baseline observables, included for follow-up analysis|
59519826|NCT04502056|75613838|FG002|COMPLETED|Overall Study||586|Participants who completed follow-up and have no missing on baseline observables, included for follow-up analysis|
59519827|NCT04502056|75613839|FG003|COMPLETED|Overall Study||597|Participants who completed follow-up and have no missing on baseline observables, included for follow-up analysis|
59519828|NCT04502056|75613840|FG004|COMPLETED|Overall Study||626|Participants who completed follow-up and have no missing on baseline observables, included for follow-up analysis|
59519829|NCT04502056|75613841|FG005|COMPLETED|Overall Study||596|Participants who completed follow-up and have no missing on baseline observables, included for follow-up analysis|
59519830|NCT04502056|75613842|FG006|COMPLETED|Overall Study||605|Participants who completed follow-up and have no missing on baseline observables, included for follow-up analysis|
59519831|NCT04502056|75613843|FG007|COMPLETED|Overall Study||603|Participants who completed follow-up and have no missing on baseline observables, included for follow-up analysis|
59519832|NCT04502056|75613844|FG008|COMPLETED|Overall Study||298|Participants who completed follow-up and have no missing on baseline observables, included for follow-up analysis|
59519833|NCT04502056|75613845|FG009|COMPLETED|Overall Study||311|Participants who completed follow-up and have no missing on baseline observables, included for follow-up analysis|
59519834|NCT04502056|75613846|FG010|COMPLETED|Overall Study||288|Participants who completed follow-up and have no missing on baseline observables, included for follow-up analysis|
59519835|NCT04502056|75613847|FG011|COMPLETED|Overall Study||614|Participants who completed follow-up and have no missing on baseline observables, included for follow-up analysis|
59519836|NCT04502056|75613836|FG000|NOT COMPLETED|Overall Study||1442||
59519837|NCT04502056|75613837|FG001|NOT COMPLETED|Overall Study||1442||
59519838|NCT04502056|75613838|FG002|NOT COMPLETED|Overall Study||1459||
59613985|NCT01582308|75725073|FG004|STARTED|10-day Washout Following Period 3||2||
59613986|NCT01582308|75725074|FG005|STARTED|10-day Washout Following Period 3||2||
59613987|NCT01582308|75725075|FG006|STARTED|10-day Washout Following Period 3||2||
59613988|NCT01582308|75725076|FG007|STARTED|10-day Washout Following Period 3||2||
59613989|NCT01582308|75725077|FG008|STARTED|10-day Washout Following Period 3||2||
59613990|NCT01582308|75725078|FG009|STARTED|10-day Washout Following Period 3||2||
59613991|NCT01582308|75725069|FG000|COMPLETED|10-day Washout Following Period 3||2||
59613992|NCT01582308|75725070|FG001|COMPLETED|10-day Washout Following Period 3||2||
59613993|NCT01582308|75725071|FG002|COMPLETED|10-day Washout Following Period 3||2||
59613994|NCT01582308|75725072|FG003|COMPLETED|10-day Washout Following Period 3||2||
59613995|NCT01582308|75725073|FG004|COMPLETED|10-day Washout Following Period 3||2||
59613996|NCT01582308|75725074|FG005|COMPLETED|10-day Washout Following Period 3||2||
59613997|NCT01582308|75725075|FG006|COMPLETED|10-day Washout Following Period 3||2||
59613998|NCT01582308|75725076|FG007|COMPLETED|10-day Washout Following Period 3||2||
59613999|NCT01582308|75725077|FG008|COMPLETED|10-day Washout Following Period 3||2||
59614000|NCT01582308|75725078|FG009|COMPLETED|10-day Washout Following Period 3||2||
59614001|NCT01582308|75725069|FG000|NOT COMPLETED|10-day Washout Following Period 3||0||
59614002|NCT01582308|75725070|FG001|NOT COMPLETED|10-day Washout Following Period 3||0||
59614003|NCT01582308|75725071|FG002|NOT COMPLETED|10-day Washout Following Period 3||0||
59614004|NCT01582308|75725072|FG003|NOT COMPLETED|10-day Washout Following Period 3||0||
59614005|NCT01582308|75725073|FG004|NOT COMPLETED|10-day Washout Following Period 3||0||
59614006|NCT01582308|75725074|FG005|NOT COMPLETED|10-day Washout Following Period 3||0||
59614007|NCT01582308|75725075|FG006|NOT COMPLETED|10-day Washout Following Period 3||0||
59614008|NCT01582308|75725076|FG007|NOT COMPLETED|10-day Washout Following Period 3||0||
59614009|NCT01582308|75725077|FG008|NOT COMPLETED|10-day Washout Following Period 3||0||
59614010|NCT01582308|75725078|FG009|NOT COMPLETED|10-day Washout Following Period 3||0||
59614011|NCT01582308|75725069|FG000|STARTED|Period 4||2||
59614012|NCT01582308|75725070|FG001|STARTED|Period 4||2||
59614013|NCT01582308|75725071|FG002|STARTED|Period 4||2||
59614014|NCT01582308|75725072|FG003|STARTED|Period 4||2||
59614015|NCT01582308|75725073|FG004|STARTED|Period 4||2||
59614016|NCT01582308|75725074|FG005|STARTED|Period 4||2||
59614017|NCT01582308|75725075|FG006|STARTED|Period 4||2||
59614018|NCT01582308|75725076|FG007|STARTED|Period 4||2||
59614019|NCT01582308|75725077|FG008|STARTED|Period 4||2||
59614020|NCT01582308|75725078|FG009|STARTED|Period 4||2||
59614021|NCT01582308|75725069|FG000|COMPLETED|Period 4||1||
59614022|NCT01582308|75725070|FG001|COMPLETED|Period 4||2||
59614023|NCT01582308|75725071|FG002|COMPLETED|Period 4||2||
59614024|NCT01582308|75725072|FG003|COMPLETED|Period 4||2||
59614025|NCT01582308|75725073|FG004|COMPLETED|Period 4||2||
59614026|NCT01582308|75725074|FG005|COMPLETED|Period 4||1||
59614027|NCT01582308|75725075|FG006|COMPLETED|Period 4||2||
59614028|NCT01582308|75725076|FG007|COMPLETED|Period 4||2||
59614029|NCT01582308|75725077|FG008|COMPLETED|Period 4||2||
59614030|NCT01582308|75725078|FG009|COMPLETED|Period 4||1||
59614031|NCT01582308|75725069|FG000|NOT COMPLETED|Period 4||1||
59614032|NCT01582308|75725070|FG001|NOT COMPLETED|Period 4||0||
59614033|NCT01582308|75725071|FG002|NOT COMPLETED|Period 4||0||
59614034|NCT01582308|75725072|FG003|NOT COMPLETED|Period 4||0||
59614035|NCT01582308|75725073|FG004|NOT COMPLETED|Period 4||0||
59614036|NCT01582308|75725074|FG005|NOT COMPLETED|Period 4||1||
59614037|NCT01582308|75725075|FG006|NOT COMPLETED|Period 4||0||
59614038|NCT01582308|75725076|FG007|NOT COMPLETED|Period 4||0||
59614039|NCT01582308|75725077|FG008|NOT COMPLETED|Period 4||0||
59614040|NCT01582308|75725078|FG009|NOT COMPLETED|Period 4||1||
59614041|NCT01582308|75725069|FG000|STARTED|10-day Washout Following Period 4||1||
59614042|NCT01582308|75725070|FG001|STARTED|10-day Washout Following Period 4||2||
59614043|NCT01582308|75725071|FG002|STARTED|10-day Washout Following Period 4||2||
59614044|NCT01582308|75725072|FG003|STARTED|10-day Washout Following Period 4||2||
59614045|NCT01582308|75725073|FG004|STARTED|10-day Washout Following Period 4||2||
59614046|NCT01582308|75725074|FG005|STARTED|10-day Washout Following Period 4||1||
59614047|NCT01582308|75725075|FG006|STARTED|10-day Washout Following Period 4||2||
59614048|NCT01582308|75725076|FG007|STARTED|10-day Washout Following Period 4||2||
59614049|NCT01582308|75725077|FG008|STARTED|10-day Washout Following Period 4||2||
59614050|NCT01582308|75725078|FG009|STARTED|10-day Washout Following Period 4||1||
59614051|NCT01582308|75725069|FG000|COMPLETED|10-day Washout Following Period 4||1||
59614052|NCT01582308|75725070|FG001|COMPLETED|10-day Washout Following Period 4||2||
59614053|NCT01582308|75725071|FG002|COMPLETED|10-day Washout Following Period 4||2||
59614054|NCT01582308|75725072|FG003|COMPLETED|10-day Washout Following Period 4||2||
59614055|NCT01582308|75725073|FG004|COMPLETED|10-day Washout Following Period 4||2||
59614056|NCT01582308|75725074|FG005|COMPLETED|10-day Washout Following Period 4||1||
59614057|NCT01582308|75725075|FG006|COMPLETED|10-day Washout Following Period 4||2||
59614058|NCT01582308|75725076|FG007|COMPLETED|10-day Washout Following Period 4||2||
59614059|NCT01582308|75725077|FG008|COMPLETED|10-day Washout Following Period 4||2||
59614060|NCT01582308|75725078|FG009|COMPLETED|10-day Washout Following Period 4||1||
59614061|NCT01582308|75725069|FG000|NOT COMPLETED|10-day Washout Following Period 4||0||
59614062|NCT01582308|75725070|FG001|NOT COMPLETED|10-day Washout Following Period 4||0||
59614063|NCT01582308|75725071|FG002|NOT COMPLETED|10-day Washout Following Period 4||0||
59614064|NCT01582308|75725072|FG003|NOT COMPLETED|10-day Washout Following Period 4||0||
59614065|NCT01582308|75725073|FG004|NOT COMPLETED|10-day Washout Following Period 4||0||
59614066|NCT01582308|75725074|FG005|NOT COMPLETED|10-day Washout Following Period 4||0||
59614067|NCT01582308|75725075|FG006|NOT COMPLETED|10-day Washout Following Period 4||0||
59614068|NCT01582308|75725076|FG007|NOT COMPLETED|10-day Washout Following Period 4||0||
59614069|NCT01582308|75725077|FG008|NOT COMPLETED|10-day Washout Following Period 4||0||
59614070|NCT01582308|75725078|FG009|NOT COMPLETED|10-day Washout Following Period 4||0||
59614071|NCT01582308|75725069|FG000|STARTED|Period 5||1||
59614072|NCT01582308|75725070|FG001|STARTED|Period 5||2||
59614073|NCT01582308|75725071|FG002|STARTED|Period 5||2||
59614074|NCT01582308|75725072|FG003|STARTED|Period 5||2||
59614075|NCT01582308|75725073|FG004|STARTED|Period 5||2||
59614076|NCT01582308|75725074|FG005|STARTED|Period 5||1||
59614077|NCT01582308|75725075|FG006|STARTED|Period 5||2||
59614078|NCT01582308|75725076|FG007|STARTED|Period 5||2||
59614079|NCT01582308|75725077|FG008|STARTED|Period 5||2||
59614080|NCT01582308|75725078|FG009|STARTED|Period 5||1||
59614081|NCT01582308|75725069|FG000|COMPLETED|Period 5||1||
59614082|NCT01582308|75725070|FG001|COMPLETED|Period 5||2||
59614083|NCT01582308|75725071|FG002|COMPLETED|Period 5||2||
59614084|NCT01582308|75725072|FG003|COMPLETED|Period 5||2||
59614085|NCT01582308|75725073|FG004|COMPLETED|Period 5||2||
59614086|NCT01582308|75725074|FG005|COMPLETED|Period 5||1||
59614087|NCT01582308|75725075|FG006|COMPLETED|Period 5||2||
59614088|NCT01582308|75725076|FG007|COMPLETED|Period 5||2||
59614089|NCT01582308|75725077|FG008|COMPLETED|Period 5||2||
59614090|NCT01582308|75725078|FG009|COMPLETED|Period 5||1||
59614091|NCT01582308|75725069|FG000|NOT COMPLETED|Period 5||0||
59614092|NCT01582308|75725070|FG001|NOT COMPLETED|Period 5||0||
59614093|NCT01582308|75725071|FG002|NOT COMPLETED|Period 5||0||
59614094|NCT01582308|75725072|FG003|NOT COMPLETED|Period 5||0||
59614095|NCT01582308|75725073|FG004|NOT COMPLETED|Period 5||0||
59614096|NCT01582308|75725074|FG005|NOT COMPLETED|Period 5||0||
59614097|NCT01582308|75725075|FG006|NOT COMPLETED|Period 5||0||
59614098|NCT01582308|75725076|FG007|NOT COMPLETED|Period 5||0||
59614099|NCT01582308|75725077|FG008|NOT COMPLETED|Period 5||0||
59519839|NCT04502056|75613839|FG003|NOT COMPLETED|Overall Study||1449||
59519840|NCT04502056|75613840|FG004|NOT COMPLETED|Overall Study||1418||
59519841|NCT04502056|75613841|FG005|NOT COMPLETED|Overall Study||1456||
59519842|NCT04502056|75613842|FG006|NOT COMPLETED|Overall Study||1441||
59519843|NCT04502056|75613843|FG007|NOT COMPLETED|Overall Study||1440||
59519844|NCT04502056|75613844|FG008|NOT COMPLETED|Overall Study||728||
59519845|NCT04502056|75613845|FG009|NOT COMPLETED|Overall Study||714||
59519846|NCT04502056|75613846|FG010|NOT COMPLETED|Overall Study||735||
59519847|NCT04502056|75613847|FG011|NOT COMPLETED|Overall Study||406||
59614100|NCT01582308|75725078|FG009|NOT COMPLETED|Period 5||0||
59614101|NCT01558674|75725093|FG000|STARTED|Part 1||11||
59614102|NCT01558674|75725094|FG001|STARTED|Part 1||0||
59614103|NCT01558674|75725093|FG000|COMPLETED|Part 1||0||
59614104|NCT01558674|75725094|FG001|COMPLETED|Part 1||0||
59519848|NCT01007591|75613871|FG000|STARTED|Overall Study||27||
59519849|NCT01007591|75613872|FG001|STARTED|Overall Study||13||
59519850|NCT01007591|75613871|FG000|COMPLETED|Overall Study||26||
59614105|NCT01558674|75725093|FG000|NOT COMPLETED|Part 1||11||
59614106|NCT01558674|75725094|FG001|NOT COMPLETED|Part 1||0||
59614107|NCT01558674|75725093|FG000|STARTED|Part 2||0||
59614108|NCT01558674|75725094|FG001|STARTED|Part 2||0||
59614109|NCT01558674|75725093|FG000|COMPLETED|Part 2||0||
59614110|NCT01558674|75725094|FG001|COMPLETED|Part 2||0||
59614111|NCT01558674|75725093|FG000|NOT COMPLETED|Part 2||0||
59614112|NCT01558674|75725094|FG001|NOT COMPLETED|Part 2||0||
59614113|NCT01558596|75725115|FG000|STARTED|Overall Study||104||
59614114|NCT01558596|75725116|FG001|STARTED|Overall Study||101||
59614115|NCT01558596|75725115|FG000|COMPLETED|Overall Study||101||
59614116|NCT01558596|75725116|FG001|COMPLETED|Overall Study||100||
59614117|NCT01558596|75725115|FG000|NOT COMPLETED|Overall Study||3||
59614118|NCT01558596|75725116|FG001|NOT COMPLETED|Overall Study||1||
59614119|NCT01535040|75725124|FG000|STARTED|Overall Study||65||
59614120|NCT01535040|75725125|FG001|STARTED|Overall Study||65||
59614121|NCT01535040|75725124|FG000|COMPLETED|Overall Study||35||
59614122|NCT01535040|75725125|FG001|COMPLETED|Overall Study||44||
59614123|NCT01535040|75725124|FG000|NOT COMPLETED|Overall Study||30||
59614124|NCT01535040|75725125|FG001|NOT COMPLETED|Overall Study||21||
59614125|NCT01534962|75725135|FG000|STARTED|Overall Study||67||
59614126|NCT01534962|75725136|FG001|STARTED|Overall Study||60||
59614127|NCT01534962|75725137|FG002|STARTED|Overall Study||58||
59614128|NCT01534962|75725138|FG003|STARTED|Overall Study||56||
59614129|NCT01534962|75725135|FG000|COMPLETED|Overall Study||30||
59614130|NCT01534962|75725136|FG001|COMPLETED|Overall Study||34||
59614131|NCT01534962|75725137|FG002|COMPLETED|Overall Study||34||
59614132|NCT01534962|75725138|FG003|COMPLETED|Overall Study||24||
59614133|NCT01534962|75725135|FG000|NOT COMPLETED|Overall Study||37||
59614134|NCT01534962|75725136|FG001|NOT COMPLETED|Overall Study||26||
59614135|NCT01534962|75725137|FG002|NOT COMPLETED|Overall Study||24||
59614136|NCT01534962|75725138|FG003|NOT COMPLETED|Overall Study||32||
59614137|NCT01582152|75725150|FG000|STARTED|Overall Study||6||
59614138|NCT01582152|75725151|FG001|STARTED|Overall Study||6||
59614139|NCT01582152|75725150|FG000|COMPLETED|Overall Study||0||
59614140|NCT01582152|75725151|FG001|COMPLETED|Overall Study||0||
59614141|NCT01582152|75725150|FG000|NOT COMPLETED|Overall Study||6||
59614142|NCT01582152|75725151|FG001|NOT COMPLETED|Overall Study||6||
59614143|NCT01581684|75725167|FG000|STARTED|Overall Study||14||
59614144|NCT01581684|75725168|FG001|STARTED|Overall Study||6||
59614145|NCT01581684|75725169|FG002|STARTED|Overall Study||6||
59614146|NCT01581684|75725170|FG003|STARTED|Overall Study||6||
59614147|NCT01581684|75725171|FG004|STARTED|Overall Study||6||
59614148|NCT01581684|75725172|FG005|STARTED|Overall Study||6||
59614149|NCT01581684|75725173|FG006|STARTED|Overall Study||6||
59614150|NCT01581684|75725174|FG007|STARTED|Overall Study||6||
59614151|NCT01581684|75725175|FG008|STARTED|Overall Study||1||
59614152|NCT01581684|75725176|FG009|STARTED|Overall Study||5||
59614153|NCT01581684|75725167|FG000|COMPLETED|Overall Study||14||
59614154|NCT01581684|75725168|FG001|COMPLETED|Overall Study||6||
59614155|NCT01581684|75725169|FG002|COMPLETED|Overall Study||6||
59614156|NCT01581684|75725170|FG003|COMPLETED|Overall Study||6||
59614157|NCT01581684|75725171|FG004|COMPLETED|Overall Study||6||
59614158|NCT01581684|75725172|FG005|COMPLETED|Overall Study||6||
59614159|NCT01581684|75725173|FG006|COMPLETED|Overall Study||6||
59614160|NCT01581684|75725174|FG007|COMPLETED|Overall Study||6||
59614161|NCT01581684|75725175|FG008|COMPLETED|Overall Study||0||
59614162|NCT01581684|75725176|FG009|COMPLETED|Overall Study||5||
59614163|NCT01581684|75725167|FG000|NOT COMPLETED|Overall Study||0||
59614164|NCT01581684|75725168|FG001|NOT COMPLETED|Overall Study||0||
59614165|NCT01581684|75725169|FG002|NOT COMPLETED|Overall Study||0||
59614166|NCT01581684|75725170|FG003|NOT COMPLETED|Overall Study||0||
59614167|NCT01581684|75725171|FG004|NOT COMPLETED|Overall Study||0||
59614168|NCT01581684|75725172|FG005|NOT COMPLETED|Overall Study||0||
59614169|NCT01581684|75725173|FG006|NOT COMPLETED|Overall Study||0||
59614170|NCT01581684|75725174|FG007|NOT COMPLETED|Overall Study||0||
59614171|NCT01581684|75725175|FG008|NOT COMPLETED|Overall Study||1||
59614172|NCT01581684|75725176|FG009|NOT COMPLETED|Overall Study||0||
59614173|NCT01557582|75725209|FG000|STARTED|Overall Study||103||
59614174|NCT01557582|75725209|FG000|COMPLETED|Overall Study||97||
59614175|NCT01557582|75725209|FG000|NOT COMPLETED|Overall Study||6||
59614176|NCT01557504|75725215|FG000|STARTED|Overall Study||13||
59614177|NCT01557504|75725216|FG001|STARTED|Overall Study||12||
59614178|NCT01557504|75725215|FG000|COMPLETED|Overall Study||12||
59614179|NCT01557504|75725216|FG001|COMPLETED|Overall Study||12||
59614180|NCT01557504|75725215|FG000|NOT COMPLETED|Overall Study||1||
59614181|NCT01557504|75725216|FG001|NOT COMPLETED|Overall Study||0||
59614182|NCT01557348|75725230|FG000|STARTED|Overall Study||604||
59614183|NCT01557348|75725231|FG001|STARTED|Overall Study||507||
59614184|NCT01557348|75725230|FG000|Safety Population|Overall Study||604||
59614185|NCT01557348|75725231|FG001|Safety Population|Overall Study||507||
59614186|NCT01557348|75725230|FG000|COMPLETED|Overall Study||524||
59614187|NCT01557348|75725231|FG001|COMPLETED|Overall Study||417||
59614188|NCT01557348|75725230|FG000|NOT COMPLETED|Overall Study||80||
59614189|NCT01557348|75725231|FG001|NOT COMPLETED|Overall Study||90||
59614190|NCT01580670|75725238|FG000|STARTED|Induction Period (Week 0 to 14)||14||
59614191|NCT01580670|75725238|FG000|COMPLETED|Induction Period (Week 0 to 14)||14||
59614192|NCT01580670|75725238|FG000|NOT COMPLETED|Induction Period (Week 0 to 14)||0||
59614193|NCT01580670|75725238|FG000|STARTED|Maintenance Period (Week 14 to 54)||14||
59614194|NCT01580670|75725238|FG000|COMPLETED|Maintenance Period (Week 14 to 54)||12||
59614195|NCT01580670|75725238|FG000|NOT COMPLETED|Maintenance Period (Week 14 to 54)||2||
59614196|NCT01534260|75725244|FG000|STARTED|Overall Study||17||
59614197|NCT01534260|75725245|FG001|STARTED|Overall Study||20||
59614198|NCT01534260|75725244|FG000|COMPLETED|Overall Study||1||
59614199|NCT01534260|75725245|FG001|COMPLETED|Overall Study||0||
59614200|NCT01534260|75725244|FG000|NOT COMPLETED|Overall Study||16||
59614201|NCT01534260|75725245|FG001|NOT COMPLETED|Overall Study||20||
59614202|NCT01534182|75725253|FG000|STARTED|Overall Study||230||
59614203|NCT01534182|75725254|FG001|STARTED|Overall Study||68||
59614204|NCT01534182|75725253|FG000|Safety Set|Overall Study||230||
59614205|NCT01534182|75725254|FG001|Safety Set|Overall Study||64||
59614206|NCT01534182|75725253|FG000|Full Analysis Set|Overall Study||229||
59614207|NCT01534182|75725254|FG001|Full Analysis Set|Overall Study||62||
59614208|NCT01534182|75725253|FG000|COMPLETED|Overall Study||218||
59614209|NCT01534182|75725254|FG001|COMPLETED|Overall Study||58||
59614210|NCT01534182|75725253|FG000|NOT COMPLETED|Overall Study||12||
59614211|NCT01534182|75725254|FG001|NOT COMPLETED|Overall Study||10||
59614212|NCT01579812|75725261|FG000|STARTED|Overall Study||90||
59614213|NCT01579812|75725261|FG000|COMPLETED|Overall Study||38||
59614214|NCT01579812|75725261|FG000|NOT COMPLETED|Overall Study||52||
59614215|NCT01533714|75725274|FG000|STARTED|Overall Study||10||
59614216|NCT01533714|75725275|FG001|STARTED|Overall Study||15||
59614217|NCT01533714|75725276|FG002|STARTED|Overall Study||11||
59614218|NCT01533714|75725277|FG003|STARTED|Overall Study||15||
59614219|NCT01533714|75725278|FG004|STARTED|Overall Study||28||
59614220|NCT01533714|75725279|FG005|STARTED|Overall Study||24||
59614221|NCT01533714|75725274|FG000|COMPLETED|Overall Study||10||
59614222|NCT01533714|75725275|FG001|COMPLETED|Overall Study||12||
59614223|NCT01533714|75725276|FG002|COMPLETED|Overall Study||7||
59614224|NCT01533714|75725277|FG003|COMPLETED|Overall Study||11||
59614225|NCT01533714|75725278|FG004|COMPLETED|Overall Study||21||
59614226|NCT01533714|75725279|FG005|COMPLETED|Overall Study||21||
59614227|NCT01533714|75725274|FG000|NOT COMPLETED|Overall Study||0||
59614228|NCT01533714|75725275|FG001|NOT COMPLETED|Overall Study||3||
59614229|NCT01533714|75725276|FG002|NOT COMPLETED|Overall Study||4||
59614230|NCT01533714|75725277|FG003|NOT COMPLETED|Overall Study||4||
59614231|NCT01533714|75725278|FG004|NOT COMPLETED|Overall Study||7||
59614232|NCT01533714|75725279|FG005|NOT COMPLETED|Overall Study||3||
59614233|NCT01533246|75725293|FG000|STARTED|Overall Study||17||
59614234|NCT01533246|75725293|FG000|COMPLETED|Overall Study||15||
59614235|NCT01533246|75725293|FG000|NOT COMPLETED|Overall Study||2||
59614236|NCT01579578|75725299|FG000|STARTED|Overall Study||13||
59614237|NCT01579578|75725300|FG001|STARTED|Overall Study||12||
59614238|NCT01579578|75725299|FG000|Ongoing|Overall Study||3||
59614239|NCT01579578|75725300|FG001|Ongoing|Overall Study||0||
59614240|NCT01579578|75725299|FG000|COMPLETED|Overall Study||0||
59614241|NCT01579578|75725300|FG001|COMPLETED|Overall Study||0||
59614242|NCT01579578|75725299|FG000|NOT COMPLETED|Overall Study||13||
59614243|NCT01579578|75725300|FG001|NOT COMPLETED|Overall Study||12||
59614244|NCT01578486|75725306|FG000|STARTED|Overall Study||13||
59614245|NCT01578486|75725306|FG000|COMPLETED|Overall Study||8||
59614246|NCT01578486|75725306|FG000|NOT COMPLETED|Overall Study||5||
59614247|NCT01532934|75725312|FG000|STARTED|Overall Study||53||
59614248|NCT01532934|75725313|FG001|STARTED|Overall Study||52||
59614249|NCT01532934|75725312|FG000|COMPLETED|Overall Study||39||
59614250|NCT01532934|75725313|FG001|COMPLETED|Overall Study||39||
59614251|NCT01532934|75725312|FG000|NOT COMPLETED|Overall Study||14||
59614252|NCT01532934|75725313|FG001|NOT COMPLETED|Overall Study||13||
59614253|NCT01555164|75725323|FG000|STARTED|Overall Study||222||
59614254|NCT01555164|75725324|FG001|STARTED|Overall Study||220||
59614255|NCT01555164|75725323|FG000|COMPLETED|Overall Study||182||
59614256|NCT01555164|75725324|FG001|COMPLETED|Overall Study||185||
59614257|NCT01555164|75725323|FG000|NOT COMPLETED|Overall Study||40||
59614258|NCT01555164|75725324|FG001|NOT COMPLETED|Overall Study||35||
59614259|NCT01578330|75725330|FG000|STARTED|Overall Study||42||
59614260|NCT01578330|75725330|FG000|Per Protocol Population|Overall Study||35||
59614261|NCT01578330|75725330|FG000|COMPLETED|Overall Study||35||
59614262|NCT01578330|75725330|FG000|NOT COMPLETED|Overall Study||7||
59614263|NCT01577160|75725334|FG000|STARTED|Overall Study||353||
59614264|NCT01577160|75725334|FG000|COMPLETED|Overall Study||255||
59614265|NCT01577160|75725334|FG000|NOT COMPLETED|Overall Study||98||
59614266|NCT01554618|75725340|FG000|STARTED|Randomized Through Start of Treatment||59||
59614267|NCT01554618|75725341|FG001|STARTED|Randomized Through Start of Treatment||24||
59614268|NCT01554618|75725340|FG000|COMPLETED|Randomized Through Start of Treatment||58||
59614269|NCT01554618|75725341|FG001|COMPLETED|Randomized Through Start of Treatment||24||
59614270|NCT01554618|75725340|FG000|NOT COMPLETED|Randomized Through Start of Treatment||1||
59614271|NCT01554618|75725341|FG001|NOT COMPLETED|Randomized Through Start of Treatment||0||
59614272|NCT01554618|75725340|FG000|STARTED|Controlled Assessment Period||58|Received treatment during controlled assessment period|
59519851|NCT01007591|75613872|FG001|COMPLETED|Overall Study||12||
59519852|NCT01007591|75613871|FG000|NOT COMPLETED|Overall Study||1||
59519853|NCT01007591|75613872|FG001|NOT COMPLETED|Overall Study||1||
59519854|NCT01008059|75613878|FG000|STARTED|Control Sequential Alfentanil||6||
59519855|NCT01008059|75613879|FG001|STARTED|Control Sequential Alfentanil||0||
59519856|NCT01008059|75613880|FG002|STARTED|Control Sequential Alfentanil||0||
59519857|NCT01008059|75613881|FG003|STARTED|Control Sequential Alfentanil||0||
59519858|NCT01008059|75613882|FG004|STARTED|Control Sequential Alfentanil||0||
59519859|NCT01008059|75613883|FG005|STARTED|Control Sequential Alfentanil||0||
59519860|NCT01008059|75613884|FG006|STARTED|Control Sequential Alfentanil||0||
59519861|NCT01008059|75613885|FG007|STARTED|Control Sequential Alfentanil||0||
59519862|NCT01008059|75613878|FG000|COMPLETED|Control Sequential Alfentanil||6||
59519863|NCT01008059|75613879|FG001|COMPLETED|Control Sequential Alfentanil||0||
59519864|NCT01008059|75613880|FG002|COMPLETED|Control Sequential Alfentanil||0||
59519865|NCT01008059|75613881|FG003|COMPLETED|Control Sequential Alfentanil||0||
59519866|NCT01008059|75613882|FG004|COMPLETED|Control Sequential Alfentanil||0||
59519867|NCT01008059|75613883|FG005|COMPLETED|Control Sequential Alfentanil||0||
59519868|NCT01008059|75613884|FG006|COMPLETED|Control Sequential Alfentanil||0||
59519869|NCT01008059|75613885|FG007|COMPLETED|Control Sequential Alfentanil||0||
59519870|NCT01008059|75613878|FG000|NOT COMPLETED|Control Sequential Alfentanil||0||
59519871|NCT01008059|75613879|FG001|NOT COMPLETED|Control Sequential Alfentanil||0||
59519872|NCT01008059|75613880|FG002|NOT COMPLETED|Control Sequential Alfentanil||0||
59519873|NCT01008059|75613881|FG003|NOT COMPLETED|Control Sequential Alfentanil||0||
59519874|NCT01008059|75613882|FG004|NOT COMPLETED|Control Sequential Alfentanil||0||
59519875|NCT01008059|75613883|FG005|NOT COMPLETED|Control Sequential Alfentanil||0||
59519876|NCT01008059|75613884|FG006|NOT COMPLETED|Control Sequential Alfentanil||0||
59519877|NCT01008059|75613885|FG007|NOT COMPLETED|Control Sequential Alfentanil||0||
59519878|NCT01008059|75613878|FG000|STARTED|Rifampin Sequential Alfentanil||0||
59519879|NCT01008059|75613879|FG001|STARTED|Rifampin Sequential Alfentanil||6||
59519880|NCT01008059|75613880|FG002|STARTED|Rifampin Sequential Alfentanil||0||
59519881|NCT01008059|75613881|FG003|STARTED|Rifampin Sequential Alfentanil||0||
59519882|NCT01008059|75613882|FG004|STARTED|Rifampin Sequential Alfentanil||0||
59519883|NCT01008059|75613883|FG005|STARTED|Rifampin Sequential Alfentanil||0||
59519884|NCT01008059|75613884|FG006|STARTED|Rifampin Sequential Alfentanil||0||
59519885|NCT01008059|75613885|FG007|STARTED|Rifampin Sequential Alfentanil||0||
59519886|NCT01008059|75613878|FG000|COMPLETED|Rifampin Sequential Alfentanil||0||
59519887|NCT01008059|75613879|FG001|COMPLETED|Rifampin Sequential Alfentanil||6||
59519888|NCT01008059|75613880|FG002|COMPLETED|Rifampin Sequential Alfentanil||0||
59519889|NCT01008059|75613881|FG003|COMPLETED|Rifampin Sequential Alfentanil||0||
59519890|NCT01008059|75613882|FG004|COMPLETED|Rifampin Sequential Alfentanil||0||
59519891|NCT01008059|75613883|FG005|COMPLETED|Rifampin Sequential Alfentanil||0||
59519892|NCT01008059|75613884|FG006|COMPLETED|Rifampin Sequential Alfentanil||0||
59519893|NCT01008059|75613885|FG007|COMPLETED|Rifampin Sequential Alfentanil||0||
59519894|NCT01008059|75613878|FG000|NOT COMPLETED|Rifampin Sequential Alfentanil||0||
59519895|NCT01008059|75613879|FG001|NOT COMPLETED|Rifampin Sequential Alfentanil||0||
59519896|NCT01008059|75613880|FG002|NOT COMPLETED|Rifampin Sequential Alfentanil||0||
59519897|NCT01008059|75613881|FG003|NOT COMPLETED|Rifampin Sequential Alfentanil||0||
59519898|NCT01008059|75613882|FG004|NOT COMPLETED|Rifampin Sequential Alfentanil||0||
59519899|NCT01008059|75613883|FG005|NOT COMPLETED|Rifampin Sequential Alfentanil||0||
59519900|NCT01008059|75613884|FG006|NOT COMPLETED|Rifampin Sequential Alfentanil||0||
59519901|NCT01008059|75613885|FG007|NOT COMPLETED|Rifampin Sequential Alfentanil||0||
59519902|NCT01008059|75613878|FG000|STARTED|Grapefruit Juice Sequential Alfentanil||0||
59519903|NCT01008059|75613879|FG001|STARTED|Grapefruit Juice Sequential Alfentanil||0||
59519904|NCT01008059|75613880|FG002|STARTED|Grapefruit Juice Sequential Alfentanil||6||
59519905|NCT01008059|75613881|FG003|STARTED|Grapefruit Juice Sequential Alfentanil||0||
59519906|NCT01008059|75613882|FG004|STARTED|Grapefruit Juice Sequential Alfentanil||0||
59519907|NCT01008059|75613883|FG005|STARTED|Grapefruit Juice Sequential Alfentanil||0||
59519908|NCT01008059|75613884|FG006|STARTED|Grapefruit Juice Sequential Alfentanil||0||
59519909|NCT01008059|75613885|FG007|STARTED|Grapefruit Juice Sequential Alfentanil||0||
59519910|NCT01008059|75613878|FG000|COMPLETED|Grapefruit Juice Sequential Alfentanil||0||
59519911|NCT01008059|75613879|FG001|COMPLETED|Grapefruit Juice Sequential Alfentanil||0||
59519912|NCT01008059|75613880|FG002|COMPLETED|Grapefruit Juice Sequential Alfentanil||6||
59519913|NCT01008059|75613881|FG003|COMPLETED|Grapefruit Juice Sequential Alfentanil||0||
59519914|NCT01008059|75613882|FG004|COMPLETED|Grapefruit Juice Sequential Alfentanil||0||
59519915|NCT01008059|75613883|FG005|COMPLETED|Grapefruit Juice Sequential Alfentanil||0||
59519916|NCT01008059|75613884|FG006|COMPLETED|Grapefruit Juice Sequential Alfentanil||0||
59519917|NCT01008059|75613885|FG007|COMPLETED|Grapefruit Juice Sequential Alfentanil||0||
59519918|NCT01008059|75613878|FG000|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0||
59519919|NCT01008059|75613879|FG001|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0||
59519920|NCT01008059|75613880|FG002|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0||
59519921|NCT01008059|75613881|FG003|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0||
59519922|NCT01008059|75613882|FG004|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0||
59614273|NCT01554618|75725341|FG001|STARTED|Controlled Assessment Period||24|Received treatment during controlled assessment period|
59614274|NCT01554618|75725340|FG000|COMPLETED|Controlled Assessment Period||50|Completed controlled assessment period|
59614275|NCT01554618|75725341|FG001|COMPLETED|Controlled Assessment Period||23|Completed controlled assessment period|
59614276|NCT01554618|75725340|FG000|NOT COMPLETED|Controlled Assessment Period||8||
59614277|NCT01554618|75725341|FG001|NOT COMPLETED|Controlled Assessment Period||1||
59614278|NCT01554618|75725340|FG000|STARTED|Open-Label Extension Period|1 patient who was noncompliant with study medication did not enter the open-label extension period|49|Received open-label exenatide treatment|
59614279|NCT01554618|75725341|FG001|STARTED|Open-Label Extension Period||23|Received open-label exenatide treatment|
59614280|NCT01554618|75725340|FG000|COMPLETED|Open-Label Extension Period||46|Completed extension period|
59614281|NCT01554618|75725341|FG001|COMPLETED|Open-Label Extension Period||18|Completed extension period|
59614282|NCT01554618|75725340|FG000|NOT COMPLETED|Open-Label Extension Period||3||
59614283|NCT01554618|75725341|FG001|NOT COMPLETED|Open-Label Extension Period||5||
59614284|NCT01531998|75725351|FG000|STARTED|Overall Study||11||
59614285|NCT01531998|75725351|FG000|COMPLETED|Overall Study||8||
59614286|NCT01531998|75725351|FG000|NOT COMPLETED|Overall Study||3||
59614287|NCT01576146|75725355|FG000|STARTED|Extension Period 1||30||
59614288|NCT01576146|75725355|FG000|COMPLETED|Extension Period 1||20||
59614289|NCT01576146|75725355|FG000|NOT COMPLETED|Extension Period 1||10||
59614290|NCT01576146|75725355|FG000|STARTED|Extension Period 2|Three participants who completed Extension Period 1 did not enroll in Period 2|17||
59614291|NCT01576146|75725355|FG000|COMPLETED|Extension Period 2||0||
59614292|NCT01576146|75725355|FG000|NOT COMPLETED|Extension Period 2||17||
59614293|NCT01553916|75725359|FG000|STARTED|Overall Study||19||
59614294|NCT01553916|75725359|FG000|COMPLETED|Overall Study||16||
59614295|NCT01553916|75725359|FG000|NOT COMPLETED|Overall Study||3||
59614296|NCT01553136|75725365|FG000|STARTED|Overall Study||64||
59614297|NCT01553136|75725366|FG001|STARTED|Overall Study||67||
59614298|NCT01553136|75725365|FG000|Completed Treatment|Overall Study||55|These data reflect those that had complete alcohol timeline data.|
59614299|NCT01553136|75725366|FG001|Completed Treatment|Overall Study||52|These data reflect those that had complete alcohol timeline data.|
59614300|NCT01553136|75725365|FG000|COMPLETED|Overall Study||48|The completed participants reflect those that continued on medication.|
59614301|NCT01553136|75725366|FG001|COMPLETED|Overall Study||45|The completed participants reflect those that continued on medication.|
59614302|NCT01553136|75725365|FG000|NOT COMPLETED|Overall Study||16||
60071703|NCT01714947|76187026|FG000|COMPLETED|Part A||3||
60071704|NCT01714947|76187026|FG000|NOT COMPLETED|Part A||0||
59614303|NCT01553136|75725366|FG001|NOT COMPLETED|Overall Study||22||
59614304|NCT01552902|75725375|FG000|STARTED|Overall Study||110||
59614305|NCT01552902|75725376|FG001|STARTED|Overall Study||218||
59614306|NCT01552902|75725377|FG002|STARTED|Overall Study||219||
59614307|NCT01552902|75725375|FG000|COMPLETED|Overall Study||97||
59614308|NCT01552902|75725376|FG001|COMPLETED|Overall Study||181||
59614309|NCT01552902|75725377|FG002|COMPLETED|Overall Study||186||
59614310|NCT01552902|75725375|FG000|NOT COMPLETED|Overall Study||13||
59614311|NCT01552902|75725376|FG001|NOT COMPLETED|Overall Study||37||
59614312|NCT01552902|75725377|FG002|NOT COMPLETED|Overall Study||33||
59614313|NCT03923790|75725387|FG000|STARTED|Overall Study||42||
59614314|NCT03923790|75725388|FG001|STARTED|Overall Study||41||
59614315|NCT03923790|75725387|FG000|COMPLETED|Overall Study||27||
59614316|NCT03923790|75725388|FG001|COMPLETED|Overall Study||17||
59614317|NCT03923790|75725387|FG000|NOT COMPLETED|Overall Study||15||
59614318|NCT03923790|75725388|FG001|NOT COMPLETED|Overall Study||24||
59614319|NCT02072928|75725394|FG000|STARTED|Overall Study||55||
59614320|NCT02072928|75725394|FG000|COMPLETED|Overall Study||55||
59614321|NCT02072928|75725394|FG000|NOT COMPLETED|Overall Study||0||
59614322|NCT01529346|75725403|FG000|STARTED|Overall Study||55||
59614323|NCT01529346|75725404|FG001|STARTED|Overall Study||54||
59614324|NCT01529346|75725405|FG002|STARTED|Overall Study||54||
59614325|NCT01529346|75725406|FG003|STARTED|Overall Study||36||
59614326|NCT01529346|75725407|FG004|STARTED|Overall Study||36||
59614327|NCT01529346|75725403|FG000|COMPLETED|Overall Study||53||
59614328|NCT01529346|75725404|FG001|COMPLETED|Overall Study||53||
59614329|NCT01529346|75725405|FG002|COMPLETED|Overall Study||52||
59614330|NCT01529346|75725406|FG003|COMPLETED|Overall Study||36||
59614331|NCT01529346|75725407|FG004|COMPLETED|Overall Study||36||
59614332|NCT01529346|75725403|FG000|NOT COMPLETED|Overall Study||2||
59614333|NCT01529346|75725404|FG001|NOT COMPLETED|Overall Study||1||
59614334|NCT01529346|75725405|FG002|NOT COMPLETED|Overall Study||2||
59614335|NCT01529346|75725406|FG003|NOT COMPLETED|Overall Study||0||
59614336|NCT01529346|75725407|FG004|NOT COMPLETED|Overall Study||0||
59614337|NCT02073162|75725422|FG000|STARTED|Overall Study||1499||
59614338|NCT02073162|75725423|FG001|STARTED|Overall Study||1501||
59614339|NCT02073162|75725422|FG000|COMPLETED|Overall Study||1493||
59614340|NCT02073162|75725423|FG001|COMPLETED|Overall Study||1490||
59614341|NCT02073162|75725422|FG000|NOT COMPLETED|Overall Study||6||
59614342|NCT02073162|75725423|FG001|NOT COMPLETED|Overall Study||11||
60071705|NCT01714947|76187026|FG000|STARTED|Part B||3||
60071706|NCT01714947|76187026|FG000|COMPLETED|Part B||0||
60071707|NCT01714947|76187026|FG000|NOT COMPLETED|Part B||3||
60071708|NCT01869699|76187032|FG000|STARTED|Overall Study||21||
59614343|NCT01529268|75725431|FG000|STARTED|Overall Study||88||
59614344|NCT01529268|75725432|FG001|STARTED|Overall Study||81||
59614345|NCT01529268|75725431|FG000|Completed 52-week Biopsy|Overall Study||71||
59614346|NCT01529268|75725432|FG001|Completed 52-week Biopsy|Overall Study||75||
59614347|NCT01529268|75725431|FG000|COMPLETED|Overall Study||76||
59614348|NCT01529268|75725432|FG001|COMPLETED|Overall Study||78||
59614349|NCT01529268|75725431|FG000|NOT COMPLETED|Overall Study||12||
59614350|NCT01529268|75725432|FG001|NOT COMPLETED|Overall Study||3||
59614351|NCT01529112|75725440|FG000|STARTED|Overall Study||89||
59614352|NCT01529112|75725441|FG001|STARTED|Overall Study||46||
59614353|NCT01529112|75725440|FG000|COMPLETED|Overall Study|On treatment=2, Discontinued treatment-continued follow-up=18 (data cut-off date 21 January 2014)|20||
59614354|NCT01529112|75725441|FG001|COMPLETED|Overall Study|Discontinued treatment-continued follow-up=5 (data cut-off date 21 January 2014)|5||
59614355|NCT01529112|75725440|FG000|NOT COMPLETED|Overall Study||69||
59614356|NCT01529112|75725441|FG001|NOT COMPLETED|Overall Study||41||
59614357|NCT01551420|75725449|FG000|STARTED|In-laboratory (Part A)||39||
59614358|NCT01551420|75725450|FG001|STARTED|In-laboratory (Part A)||13||
59614359|NCT01551420|75725449|FG000|COMPLETED|In-laboratory (Part A)||33||
59614360|NCT01551420|75725450|FG001|COMPLETED|In-laboratory (Part A)||11||
59614361|NCT01551420|75725449|FG000|NOT COMPLETED|In-laboratory (Part A)||6||
59614362|NCT01551420|75725450|FG001|NOT COMPLETED|In-laboratory (Part A)||2||
59614363|NCT01551420|75725449|FG000|STARTED|Screened for Part B Eligibility||33||
59614364|NCT01551420|75725450|FG001|STARTED|Screened for Part B Eligibility||11||
59614365|NCT01551420|75725449|FG000|COMPLETED|Screened for Part B Eligibility||24||
59614366|NCT01551420|75725450|FG001|COMPLETED|Screened for Part B Eligibility||8||
59614367|NCT01551420|75725449|FG000|NOT COMPLETED|Screened for Part B Eligibility||9||
59614368|NCT01551420|75725450|FG001|NOT COMPLETED|Screened for Part B Eligibility||3||
59614369|NCT01551420|75725449|FG000|STARTED|Home Use (Part B)||24||
59614370|NCT01551420|75725450|FG001|STARTED|Home Use (Part B)||8||
59614371|NCT01551420|75725449|FG000|COMPLETED|Home Use (Part B)||18||
59614372|NCT01551420|75725450|FG001|COMPLETED|Home Use (Part B)||7||
59614373|NCT01551420|75725449|FG000|NOT COMPLETED|Home Use (Part B)||6||
59614374|NCT01551420|75725450|FG001|NOT COMPLETED|Home Use (Part B)||1||
59614375|NCT01575054|75725458|FG000|STARTED|Overall Study||233||
59614376|NCT01575054|75725459|FG001|STARTED|Overall Study||235||
59614377|NCT01575054|75725458|FG000|COMPLETED|Overall Study||204||
59614378|NCT01575054|75725459|FG001|COMPLETED|Overall Study||209||
59614379|NCT01575054|75725458|FG000|NOT COMPLETED|Overall Study||29||
59614380|NCT01575054|75725459|FG001|NOT COMPLETED|Overall Study||26||
59614381|NCT01528254|75725467|FG000|STARTED|Overall Study||998|All randomized patients (RAN)|
59614382|NCT01528254|75725468|FG001|STARTED|Overall Study||1003|All randomized patients (RAN)|
59614383|NCT01528254|75725467|FG000|Safety Set|Overall Study||998|At least one dose of study medication|
59614384|NCT01528254|75725468|FG001|Safety Set|Overall Study||1001|At least one dose of study medication|
59614385|NCT01528254|75725467|FG000|Full Analysis Set (FAS)|Overall Study||983|At least one randomized study medication and a post-randomization efficacy parameter assessment.|
59614386|NCT01528254|75725468|FG001|Full Analysis Set (FAS)|Overall Study||989|At least one randomized study medication and a post-randomization efficacy parameter assessment.|
59614387|NCT01528254|75725467|FG000|Completed Treatment Period 1|Overall Study||458||
59614388|NCT01528254|75725468|FG001|Completed Treatment Period 1|Overall Study||273||
59614389|NCT01528254|75725467|FG000|Completed Treatment Period 2|Overall Study||244||
59614390|NCT01528254|75725468|FG001|Completed Treatment Period 2|Overall Study||399||
59614391|NCT01528254|75725467|FG000|Completed Treatment Period 3|Overall Study||109||
59614392|NCT01528254|75725468|FG001|Completed Treatment Period 3|Overall Study||115||
59614393|NCT01528254|75725467|FG000|COMPLETED|Overall Study||811||
59614394|NCT01528254|75725468|FG001|COMPLETED|Overall Study||787||
59614395|NCT01528254|75725467|FG000|NOT COMPLETED|Overall Study||187||
59614396|NCT01528254|75725468|FG001|NOT COMPLETED|Overall Study||216||
59614397|NCT01574352|75725477|FG000|STARTED|Overall Study|59 participants where randomized, but 4 dropped out prior to baseline measurements.|55||
59614398|NCT01574352|75725478|FG001|STARTED|Overall Study|56 participants where randomized, but 5 dropped out prior to baseline measurements.|51||
59614399|NCT01574352|75725477|FG000|COMPLETED|Overall Study|Participated in the last follow up measurement.|48||
59614400|NCT01574352|75725478|FG001|COMPLETED|Overall Study|Participated in the last follow up measurement.|38||
59614401|NCT01574352|75725477|FG000|NOT COMPLETED|Overall Study||7||
59614402|NCT01574352|75725478|FG001|NOT COMPLETED|Overall Study||13||
59614403|NCT01527006|75725486|FG000|STARTED|Core Study||22||
59614404|NCT01527006|75725487|FG001|STARTED|Core Study||28||
59614405|NCT01527006|75725486|FG000|COMPLETED|Core Study||20||
59614406|NCT01527006|75725487|FG001|COMPLETED|Core Study||22||
59614407|NCT01527006|75725486|FG000|NOT COMPLETED|Core Study||2||
59614408|NCT01527006|75725487|FG001|NOT COMPLETED|Core Study||6||
59614409|NCT01527006|75725486|FG000|STARTED|Extension Phase|Of the 20 subjects who completed the Core Study, 19 subjects continued into the Extension Phase.|19||
59614410|NCT01527006|75725487|FG001|STARTED|Extension Phase||22||
59614411|NCT01527006|75725486|FG000|COMPLETED|Extension Phase||13||
59614412|NCT01527006|75725487|FG001|COMPLETED|Extension Phase||14||
59614413|NCT01527006|75725486|FG000|NOT COMPLETED|Extension Phase||6||
59614414|NCT01527006|75725487|FG001|NOT COMPLETED|Extension Phase||8||
59614415|NCT01526928|75725505|FG000|STARTED|Overall Study||38|Total|
59614416|NCT01526928|75725506|FG001|STARTED|Overall Study||19|Total|
59614417|NCT01526928|75725507|FG002|STARTED|Overall Study||209|Total|
59614418|NCT01526928|75725508|FG003|STARTED|Overall Study||245|Total|
59614419|NCT01526928|75725509|FG004|STARTED|Overall Study||95|Total|
59614420|NCT01526928|75725510|FG005|STARTED|Overall Study||6|Total|
59614421|NCT01526928|75725505|FG000|Started Phase 1|Overall Study||38|Upon completion of Cycle 1, Phase 1 pts could participate in an optional Treatment-extension Period|
59614422|NCT01526928|75725506|FG001|Started Phase 1|Overall Study||19|Upon completion of Cycle 1, Phase 1 pts could participate in an optional Treatment-extension Period|
59614423|NCT01526928|75725507|FG002|Started Phase 1|Overall Study||18|Upon completion of Cycle 1, Phase 1 pts could participate in an optional Treatment-extension Period|
59614424|NCT01526928|75725508|FG003|Started Phase 1|Overall Study||17|Upon completion of Cycle 1, Phase 1 pts could participate in an optional Treatment-extension Period|
59614425|NCT01526928|75725509|FG004|Started Phase 1|Overall Study||13|Upon completion of Cycle 1, Phase 1 pts could participate in an optional Treatment-extension Period|
59614426|NCT01526928|75725510|FG005|Started Phase 1|Overall Study||6|Upon completion of Cycle 1, Phase 1 pts could participate in an optional Treatment-extension Period|
59614427|NCT01526928|75725505|FG000|Started Phase 2|Overall Study||0||
59614428|NCT01526928|75725506|FG001|Started Phase 2|Overall Study||0||
59614429|NCT01526928|75725507|FG002|Started Phase 2|Overall Study||191||
59614430|NCT01526928|75725508|FG003|Started Phase 2|Overall Study||228||
59614431|NCT01526928|75725509|FG004|Started Phase 2|Overall Study||82||
59614432|NCT01526928|75725510|FG005|Started Phase 2|Overall Study||0||
59614433|NCT01526928|75725505|FG000|COMPLETED|Overall Study||0||
59614434|NCT01526928|75725506|FG001|COMPLETED|Overall Study||0||
59614435|NCT01526928|75725507|FG002|COMPLETED|Overall Study||0||
59614436|NCT01526928|75725508|FG003|COMPLETED|Overall Study||0||
59614437|NCT01526928|75725509|FG004|COMPLETED|Overall Study||0||
59614438|NCT01526928|75725510|FG005|COMPLETED|Overall Study||0||
59614439|NCT01526928|75725505|FG000|NOT COMPLETED|Overall Study||38||
59614440|NCT01526928|75725506|FG001|NOT COMPLETED|Overall Study||19||
59614441|NCT01526928|75725507|FG002|NOT COMPLETED|Overall Study||209||
59614442|NCT01526928|75725508|FG003|NOT COMPLETED|Overall Study||245||
59614443|NCT01526928|75725509|FG004|NOT COMPLETED|Overall Study||95||
59614444|NCT01526928|75725510|FG005|NOT COMPLETED|Overall Study||6||
59614445|NCT01549860|75725568|FG000|STARTED|Overall Study||40||
59614446|NCT01549860|75725569|FG001|STARTED|Overall Study||41||
59614447|NCT01549860|75725568|FG000|COMPLETED|Overall Study||38||
59614448|NCT01549860|75725569|FG001|COMPLETED|Overall Study||40||
59614449|NCT01549860|75725568|FG000|NOT COMPLETED|Overall Study||2||
59614450|NCT01549860|75725569|FG001|NOT COMPLETED|Overall Study||1||
59614451|NCT01549392|75725577|FG000|STARTED|Overall Study||3||
59614452|NCT01549392|75725578|FG001|STARTED|Overall Study||0||
59614453|NCT01549392|75725577|FG000|COMPLETED|Overall Study||2||
59614454|NCT01549392|75725578|FG001|COMPLETED|Overall Study||0||
59614455|NCT01549392|75725577|FG000|NOT COMPLETED|Overall Study||1||
59614456|NCT01549392|75725578|FG001|NOT COMPLETED|Overall Study||0||
59614457|NCT01526148|75725586|FG000|STARTED|Overall Study||18||
59614458|NCT01526148|75725587|FG001|STARTED|Overall Study||24||
59614459|NCT01526148|75725586|FG000|COMPLETED|Overall Study||4||
59614460|NCT01526148|75725587|FG001|COMPLETED|Overall Study||11||
59614461|NCT01526148|75725586|FG000|NOT COMPLETED|Overall Study||14||
59614462|NCT01526148|75725587|FG001|NOT COMPLETED|Overall Study||13||
59614463|NCT01572948|75725595|FG000|STARTED|Overall Study||11||
59614464|NCT01572948|75725596|FG001|STARTED|Overall Study||16||
59614465|NCT01572948|75725595|FG000|COMPLETED|Overall Study||10||
59614466|NCT01572948|75725596|FG001|COMPLETED|Overall Study||15||
59614467|NCT01572948|75725595|FG000|NOT COMPLETED|Overall Study||1||
59614468|NCT01572948|75725596|FG001|NOT COMPLETED|Overall Study||1||
59614469|NCT01525602|75725614|FG000|STARTED|Overall Study||9||
59614470|NCT01525602|75725615|FG001|STARTED|Overall Study||3||
59614471|NCT01525602|75725616|FG002|STARTED|Overall Study||3||
59614472|NCT01525602|75725617|FG003|STARTED|Overall Study||6||
59614473|NCT01525602|75725618|FG004|STARTED|Overall Study||33||
59614474|NCT01525602|75725619|FG005|STARTED|Overall Study||7||
59614475|NCT01525602|75725620|FG006|STARTED|Overall Study||6||
59614476|NCT01525602|75725621|FG007|STARTED|Overall Study||7||
59614477|NCT01525602|75725614|FG000|COMPLETED|Overall Study||0||
59614478|NCT01525602|75725615|FG001|COMPLETED|Overall Study||0||
59614479|NCT01525602|75725616|FG002|COMPLETED|Overall Study||0||
59614480|NCT01525602|75725617|FG003|COMPLETED|Overall Study||0||
59614481|NCT01525602|75725618|FG004|COMPLETED|Overall Study||0||
59614482|NCT01525602|75725619|FG005|COMPLETED|Overall Study||0||
59614483|NCT01525602|75725620|FG006|COMPLETED|Overall Study||0||
59614484|NCT01525602|75725621|FG007|COMPLETED|Overall Study||0||
59614485|NCT01525602|75725614|FG000|NOT COMPLETED|Overall Study||9||
59614486|NCT01525602|75725615|FG001|NOT COMPLETED|Overall Study||3||
59614487|NCT01525602|75725616|FG002|NOT COMPLETED|Overall Study||3||
59614488|NCT01525602|75725617|FG003|NOT COMPLETED|Overall Study||6||
59614489|NCT01525602|75725618|FG004|NOT COMPLETED|Overall Study||33||
59614490|NCT01525602|75725619|FG005|NOT COMPLETED|Overall Study||7||
59614491|NCT01525602|75725620|FG006|NOT COMPLETED|Overall Study||6||
59614492|NCT01525602|75725621|FG007|NOT COMPLETED|Overall Study||7||
59614493|NCT01549002|75725648|FG000|STARTED|Overall Study||10||
59614494|NCT01549002|75725649|FG001|STARTED|Overall Study||10||
59614495|NCT01549002|75725648|FG000|COMPLETED|Overall Study||10||
59614496|NCT01549002|75725649|FG001|COMPLETED|Overall Study||6||
59614497|NCT01549002|75725648|FG000|NOT COMPLETED|Overall Study||0||
59614498|NCT01549002|75725649|FG001|NOT COMPLETED|Overall Study||4||
59614499|NCT01548768|75725659|FG000|STARTED|Overall Study||8||
59614500|NCT01548768|75725660|FG001|STARTED|Overall Study||4||
59614501|NCT01548768|75725661|FG002|STARTED|Overall Study||16||
59614502|NCT01548768|75725662|FG003|STARTED|Overall Study||121||
59614503|NCT01548768|75725659|FG000|COMPLETED|Overall Study||7||
59614504|NCT01548768|75725660|FG001|COMPLETED|Overall Study||2||
59614505|NCT01548768|75725661|FG002|COMPLETED|Overall Study||15||
59614506|NCT01548768|75725662|FG003|COMPLETED|Overall Study||117||
59614507|NCT01548768|75725659|FG000|NOT COMPLETED|Overall Study||1||
59614508|NCT01548768|75725660|FG001|NOT COMPLETED|Overall Study||2||
59614509|NCT01548768|75725661|FG002|NOT COMPLETED|Overall Study||1||
59614510|NCT01548768|75725662|FG003|NOT COMPLETED|Overall Study||4||
59614511|NCT01572792|75725679|FG000|STARTED|Lead-in Study||337||
59614512|NCT01572792|75725680|FG001|STARTED|Lead-in Study||338||
59614513|NCT01572792|75725681|FG002|STARTED|Lead-in Study||338||
59614514|NCT01572792|75725682|FG003|STARTED|Lead-in Study||340||
59614515|NCT01572792|75725683|FG004|STARTED|Lead-in Study||339||
59614516|NCT01572792|75725679|FG000|COMPLETED|Lead-in Study||236||
59614517|NCT01572792|75725680|FG001|COMPLETED|Lead-in Study||272||
59614518|NCT01572792|75725681|FG002|COMPLETED|Lead-in Study||276||
60071709|NCT01869699|76187033|FG001|STARTED|Overall Study||20||
60071710|NCT01869699|76187032|FG000|COMPLETED|Overall Study||20||
60071711|NCT01869699|76187033|FG001|COMPLETED|Overall Study||20||
60071712|NCT01869699|76187032|FG000|NOT COMPLETED|Overall Study||1||
60071713|NCT01869699|76187033|FG001|NOT COMPLETED|Overall Study||0||
60071714|NCT01714635|76187042|FG000|STARTED|Overall Study||147||
59614519|NCT01572792|75725682|FG003|COMPLETED|Lead-in Study||268||
59614520|NCT01572792|75725683|FG004|COMPLETED|Lead-in Study||270||
59614521|NCT01572792|75725679|FG000|NOT COMPLETED|Lead-in Study||101||
59614522|NCT01572792|75725680|FG001|NOT COMPLETED|Lead-in Study||66||
59614523|NCT01572792|75725681|FG002|NOT COMPLETED|Lead-in Study||62||
59614524|NCT01572792|75725682|FG003|NOT COMPLETED|Lead-in Study||72||
59614525|NCT01572792|75725683|FG004|NOT COMPLETED|Lead-in Study||69||
59614526|NCT01572792|75725679|FG000|STARTED|Extension Study||146||
59614527|NCT01572792|75725680|FG001|STARTED|Extension Study||184||
59614528|NCT01572792|75725681|FG002|STARTED|Extension Study||205||
59614529|NCT01572792|75725682|FG003|STARTED|Extension Study||194||
59614530|NCT01572792|75725683|FG004|STARTED|Extension Study||192||
59614531|NCT01572792|75725679|FG000|COMPLETED|Extension Study||121||
59614532|NCT01572792|75725680|FG001|COMPLETED|Extension Study||155||
59614533|NCT01572792|75725681|FG002|COMPLETED|Extension Study||179||
59614534|NCT01572792|75725682|FG003|COMPLETED|Extension Study||165||
59614535|NCT01572792|75725683|FG004|COMPLETED|Extension Study||160||
59614536|NCT01572792|75725679|FG000|NOT COMPLETED|Extension Study||25||
59614537|NCT01572792|75725680|FG001|NOT COMPLETED|Extension Study||29||
59614538|NCT01572792|75725681|FG002|NOT COMPLETED|Extension Study||26||
59614539|NCT01572792|75725682|FG003|NOT COMPLETED|Extension Study||29||
59614540|NCT01572792|75725683|FG004|NOT COMPLETED|Extension Study||32||
59614541|NCT01547598|75725698|FG000|STARTED|Overall Study||67||
59614542|NCT01547598|75725699|FG001|STARTED|Overall Study||68||
59614543|NCT01547598|75725698|FG000|COMPLETED|Overall Study||61||
59614544|NCT01547598|75725699|FG001|COMPLETED|Overall Study||63||
59614545|NCT01547598|75725698|FG000|NOT COMPLETED|Overall Study||6||
59614546|NCT01547598|75725699|FG001|NOT COMPLETED|Overall Study||5||
59614547|NCT01547286|75725706|FG000|STARTED|Overall Study||7||
59614548|NCT01547286|75725706|FG000|COMPLETED|Overall Study||5||
59614549|NCT01547286|75725706|FG000|NOT COMPLETED|Overall Study||2||
59614550|NCT01547130|75725713|FG000|STARTED|Overall Study||74||
59614551|NCT01547130|75725714|FG001|STARTED|Overall Study||73||
59614552|NCT01547130|75725713|FG000|COMPLETED|Overall Study||65||
59614553|NCT01547130|75725714|FG001|COMPLETED|Overall Study||68||
59614554|NCT01547130|75725713|FG000|NOT COMPLETED|Overall Study||9||
60071715|NCT01714635|76187043|FG001|STARTED|Overall Study||150||
60071716|NCT01714635|76187044|FG002|STARTED|Overall Study||148||
60071717|NCT01714635|76187042|FG000|COMPLETED|Overall Study||145||
60071718|NCT01714635|76187043|FG001|COMPLETED|Overall Study||150||
60071719|NCT01714635|76187044|FG002|COMPLETED|Overall Study||146||
59614555|NCT01547130|75725714|FG001|NOT COMPLETED|Overall Study||5||
59614556|NCT01524978|75725739|FG000|STARTED|Overall Study||62||
59614557|NCT01524978|75725740|FG001|STARTED|Overall Study||4||
59614558|NCT01524978|75725741|FG002|STARTED|Overall Study||10||
59614559|NCT01524978|75725742|FG003|STARTED|Overall Study||27||
59614560|NCT01524978|75725743|FG004|STARTED|Overall Study||9||
59614561|NCT01524978|75725744|FG005|STARTED|Overall Study||9||
59614562|NCT01524978|75725745|FG006|STARTED|Overall Study||26||
59614563|NCT01524978|75725746|FG007|STARTED|Overall Study||12||
60071720|NCT01714635|76187042|FG000|NOT COMPLETED|Overall Study||2||
60071721|NCT01714635|76187043|FG001|NOT COMPLETED|Overall Study||0||
60071722|NCT01714635|76187044|FG002|NOT COMPLETED|Overall Study||2||
60071723|NCT01713933|76187052|FG000|STARTED|Overall Study||37||
60071724|NCT01713933|76187052|FG000|COMPLETED|Overall Study||31||
60071725|NCT01713933|76187052|FG000|NOT COMPLETED|Overall Study||6||
59614564|NCT01524978|75725747|FG008|STARTED|Overall Study||12||
59614565|NCT01524978|75725748|FG009|STARTED|Overall Study||9||
59614566|NCT01524978|75725749|FG010|STARTED|Overall Study||28||
59614567|NCT01524978|75725739|FG000|COMPLETED|Overall Study||0||
59614568|NCT01524978|75725740|FG001|COMPLETED|Overall Study||0||
59614569|NCT01524978|75725741|FG002|COMPLETED|Overall Study||0||
59614570|NCT01524978|75725742|FG003|COMPLETED|Overall Study||0||
59614571|NCT01524978|75725743|FG004|COMPLETED|Overall Study||0||
59614572|NCT01524978|75725744|FG005|COMPLETED|Overall Study||0||
59614573|NCT01524978|75725745|FG006|COMPLETED|Overall Study||0||
59614574|NCT01524978|75725746|FG007|COMPLETED|Overall Study||0||
59614575|NCT01524978|75725747|FG008|COMPLETED|Overall Study||0||
59614576|NCT01524978|75725748|FG009|COMPLETED|Overall Study||0||
59614577|NCT01524978|75725749|FG010|COMPLETED|Overall Study||0||
59614578|NCT01524978|75725739|FG000|NOT COMPLETED|Overall Study||62||
59614579|NCT01524978|75725740|FG001|NOT COMPLETED|Overall Study||4||
59614580|NCT01524978|75725741|FG002|NOT COMPLETED|Overall Study||10||
59614581|NCT01524978|75725742|FG003|NOT COMPLETED|Overall Study||27||
59614582|NCT01524978|75725743|FG004|NOT COMPLETED|Overall Study||9||
59614583|NCT01524978|75725744|FG005|NOT COMPLETED|Overall Study||9||
59614584|NCT01524978|75725745|FG006|NOT COMPLETED|Overall Study||26||
59614585|NCT01524978|75725746|FG007|NOT COMPLETED|Overall Study||12||
59614586|NCT01524978|75725747|FG008|NOT COMPLETED|Overall Study||12||
59614587|NCT01524978|75725748|FG009|NOT COMPLETED|Overall Study||9||
59614588|NCT01524978|75725749|FG010|NOT COMPLETED|Overall Study||28||
59614589|NCT01524900|75725769|FG000|STARTED|Overall Study||49||
59614590|NCT01524900|75725770|FG001|STARTED|Overall Study||246||
59614591|NCT01524900|75725771|FG002|STARTED|Overall Study||30||
59614592|NCT01524900|75725772|FG003|STARTED|Overall Study||22||
59614593|NCT01524900|75725773|FG004|STARTED|Overall Study||40||
59614594|NCT01524900|75725769|FG000|COMPLETED|Overall Study||43||
59614595|NCT01524900|75725770|FG001|COMPLETED|Overall Study||232||
59614596|NCT01524900|75725771|FG002|COMPLETED|Overall Study||29||
59614597|NCT01524900|75725772|FG003|COMPLETED|Overall Study||21||
59614598|NCT01524900|75725773|FG004|COMPLETED|Overall Study||40||
59614599|NCT01524900|75725769|FG000|NOT COMPLETED|Overall Study||6||
59614600|NCT01524900|75725770|FG001|NOT COMPLETED|Overall Study||14||
59614601|NCT01524900|75725771|FG002|NOT COMPLETED|Overall Study||1||
59614602|NCT01524900|75725772|FG003|NOT COMPLETED|Overall Study||1||
59614603|NCT01524900|75725773|FG004|NOT COMPLETED|Overall Study||0||
59614604|NCT01524198|75725788|FG000|STARTED|Overall Study||471||
59614605|NCT01524198|75725789|FG001|STARTED|Overall Study||474||
59614606|NCT01524198|75725788|FG000|COMPLETED|Overall Study||448||
59614607|NCT01524198|75725789|FG001|COMPLETED|Overall Study||458||
59614608|NCT01524198|75725788|FG000|NOT COMPLETED|Overall Study||23||
59614609|NCT01524198|75725789|FG001|NOT COMPLETED|Overall Study||16||
59614610|NCT01523886|75725797|FG000|STARTED|Overall Study||25||
59614611|NCT01523886|75725798|FG001|STARTED|Overall Study||24||
59614612|NCT01523886|75725797|FG000|COMPLETED|Overall Study||25||
59614613|NCT01523886|75725798|FG001|COMPLETED|Overall Study||23||
59614614|NCT01523886|75725797|FG000|NOT COMPLETED|Overall Study||0||
59614615|NCT01523886|75725798|FG001|NOT COMPLETED|Overall Study||1||
59614616|NCT01546038|75725810|FG000|STARTED|Overall Study||17||
59614617|NCT01546038|75725811|FG001|STARTED|Overall Study||6||
59614618|NCT01546038|75725812|FG002|STARTED|Overall Study||4||
59614619|NCT01546038|75725813|FG003|STARTED|Overall Study||3||
59614620|NCT01546038|75725814|FG004|STARTED|Overall Study||16||
59614621|NCT01546038|75725815|FG005|STARTED|Overall Study||6||
59614622|NCT01546038|75725816|FG006|STARTED|Overall Study||71||
59614623|NCT01546038|75725817|FG007|STARTED|Overall Study||88||
59614624|NCT01546038|75725818|FG008|STARTED|Overall Study||44||
59614625|NCT01546038|75725810|FG000|Received Treatment|Overall Study||17||
59614626|NCT01546038|75725811|FG001|Received Treatment|Overall Study||6||
59614627|NCT01546038|75725812|FG002|Received Treatment|Overall Study||4||
59614628|NCT01546038|75725813|FG003|Received Treatment|Overall Study||3||
59614629|NCT01546038|75725814|FG004|Received Treatment|Overall Study||16||
59614630|NCT01546038|75725815|FG005|Received Treatment|Overall Study||6||
59614631|NCT01546038|75725816|FG006|Received Treatment|Overall Study||69||
59614632|NCT01546038|75725817|FG007|Received Treatment|Overall Study||84||
59614633|NCT01546038|75725818|FG008|Received Treatment|Overall Study||41||
59614634|NCT01546038|75725810|FG000|COMPLETED|Overall Study||1||
59614635|NCT01546038|75725811|FG001|COMPLETED|Overall Study||0||
59614636|NCT01546038|75725812|FG002|COMPLETED|Overall Study||0||
59614637|NCT01546038|75725813|FG003|COMPLETED|Overall Study||0||
59614638|NCT01546038|75725814|FG004|COMPLETED|Overall Study||6||
59614639|NCT01546038|75725815|FG005|COMPLETED|Overall Study||2||
59614640|NCT01546038|75725816|FG006|COMPLETED|Overall Study||18||
59614641|NCT01546038|75725817|FG007|COMPLETED|Overall Study||4||
59614642|NCT01546038|75725818|FG008|COMPLETED|Overall Study||1||
59614643|NCT01546038|75725810|FG000|NOT COMPLETED|Overall Study||16||
59614644|NCT01546038|75725811|FG001|NOT COMPLETED|Overall Study||6||
59614645|NCT01546038|75725812|FG002|NOT COMPLETED|Overall Study||4||
59614646|NCT01546038|75725813|FG003|NOT COMPLETED|Overall Study||3||
59614647|NCT01546038|75725814|FG004|NOT COMPLETED|Overall Study||10||
59614648|NCT01546038|75725815|FG005|NOT COMPLETED|Overall Study||4||
59614649|NCT01546038|75725816|FG006|NOT COMPLETED|Overall Study||53||
59614650|NCT01546038|75725817|FG007|NOT COMPLETED|Overall Study||84||
59614651|NCT01546038|75725818|FG008|NOT COMPLETED|Overall Study||43||
59614652|NCT01571232|75725870|FG000|STARTED|Overall Study||10||
59614653|NCT01571232|75725871|FG001|STARTED|Overall Study||10||
59614654|NCT01571232|75725870|FG000|COMPLETED|Overall Study||9||
59614655|NCT01571232|75725871|FG001|COMPLETED|Overall Study||9||
59614656|NCT01571232|75725870|FG000|NOT COMPLETED|Overall Study||1||
59614657|NCT01571232|75725871|FG001|NOT COMPLETED|Overall Study||1||
59614658|NCT01544478|75725878|FG000|STARTED|Overall Study||1030||
59614659|NCT01544478|75725878|FG000|Vaccination 1|Overall Study||1030||
59614660|NCT01544478|75725878|FG000|Vaccination 2|Overall Study||1026||
59614661|NCT01544478|75725878|FG000|Vaccination 3|Overall Study||1019||
59614662|NCT01544478|75725878|FG000|COMPLETED|Overall Study||912||
59614663|NCT01544478|75725878|FG000|NOT COMPLETED|Overall Study||118||
59614664|NCT01522950|75725885|FG000|STARTED|Overall Study||26||
59614665|NCT01522950|75725886|FG001|STARTED|Overall Study||23||
59614666|NCT01522950|75725887|FG002|STARTED|Overall Study||27||
59614667|NCT01522950|75725885|FG000|COMPLETED|Overall Study||20||
59614668|NCT01522950|75725886|FG001|COMPLETED|Overall Study||18||
59614669|NCT01522950|75725887|FG002|COMPLETED|Overall Study||22||
59614670|NCT01522950|75725885|FG000|NOT COMPLETED|Overall Study||6||
59614671|NCT01522950|75725886|FG001|NOT COMPLETED|Overall Study||5||
59614672|NCT01522950|75725887|FG002|NOT COMPLETED|Overall Study||5||
59614673|NCT01522404|75725897|FG000|STARTED|First Intervention (up to Week 29)||20||
59614674|NCT01522404|75725898|FG001|STARTED|First Intervention (up to Week 29)||19||
59614675|NCT01522404|75725897|FG000|COMPLETED|First Intervention (up to Week 29)||18||
59614676|NCT01522404|75725898|FG001|COMPLETED|First Intervention (up to Week 29)||19||
59614677|NCT01522404|75725897|FG000|NOT COMPLETED|First Intervention (up to Week 29)||2||
59614678|NCT01522404|75725898|FG001|NOT COMPLETED|First Intervention (up to Week 29)||0||
59614679|NCT01522404|75725897|FG000|STARTED|Second Intervention (up to Week 58)||18||
59614680|NCT01522404|75725898|FG001|STARTED|Second Intervention (up to Week 58)||19||
59614681|NCT01522404|75725897|FG000|COMPLETED|Second Intervention (up to Week 58)||17||
59614682|NCT01522404|75725898|FG001|COMPLETED|Second Intervention (up to Week 58)||19||
59614683|NCT01522404|75725897|FG000|NOT COMPLETED|Second Intervention (up to Week 58)||1||
59614684|NCT01522404|75725898|FG001|NOT COMPLETED|Second Intervention (up to Week 58)||0||
59614685|NCT01570686|75725914|FG000|STARTED|Overall Study||296||
59614686|NCT01570686|75725915|FG001|STARTED|Overall Study||294||
59614687|NCT01570686|75725914|FG000|Safety and Full Analysis Set (FAS)|Overall Study|One patient was mis-randomized and never received study drug. Hence not included in Safety or FAS.|295||
59614688|NCT01570686|75725915|FG001|Safety and Full Analysis Set (FAS)|Overall Study||294||
59614689|NCT01570686|75725914|FG000|COMPLETED|Overall Study||274||
59614690|NCT01570686|75725915|FG001|COMPLETED|Overall Study||278||
59762726|NCT00855933|75882586|FG000|COMPLETED|Overall Study||30||
59762727|NCT00855933|75882587|FG001|COMPLETED|Overall Study||29||
59762728|NCT00855933|75882586|FG000|NOT COMPLETED|Overall Study||0||
59762729|NCT00855933|75882587|FG001|NOT COMPLETED|Overall Study||1||
59762730|NCT00871572|75882597|FG000|STARTED|Overall Study||10||
59762731|NCT00871572|75882598|FG001|STARTED|Overall Study||17||
59762732|NCT00871572|75882599|FG002|STARTED|Overall Study||34||
59762733|NCT00871572|75882600|FG003|STARTED|Overall Study||26||
59762734|NCT00871572|75882597|FG000|≥1 Post Baseline Value by Assigned Group|Overall Study||9||
59519923|NCT01008059|75613883|FG005|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0||
59519924|NCT01008059|75613884|FG006|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0||
59519925|NCT01008059|75613885|FG007|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0||
59519926|NCT01008059|75613878|FG000|STARTED|Ketoconazole Sequential Alfentanil||0||
59519927|NCT01008059|75613879|FG001|STARTED|Ketoconazole Sequential Alfentanil||0||
59519928|NCT01008059|75613880|FG002|STARTED|Ketoconazole Sequential Alfentanil||0||
59762735|NCT00871572|75882598|FG001|≥1 Post Baseline Value by Assigned Group|Overall Study||17||
59762736|NCT00871572|75882599|FG002|≥1 Post Baseline Value by Assigned Group|Overall Study||34||
59762737|NCT00871572|75882600|FG003|≥1 Post Baseline Value by Assigned Group|Overall Study||25||
59519929|NCT01008059|75613881|FG003|STARTED|Ketoconazole Sequential Alfentanil||6||
59519930|NCT01008059|75613882|FG004|STARTED|Ketoconazole Sequential Alfentanil||0||
59519931|NCT01008059|75613883|FG005|STARTED|Ketoconazole Sequential Alfentanil||0||
59762738|NCT00871572|75882597|FG000|Received at Least 1 Dose of Study Drug|Overall Study||9||
59762739|NCT00871572|75882598|FG001|Received at Least 1 Dose of Study Drug|Overall Study||17||
59762740|NCT00871572|75882599|FG002|Received at Least 1 Dose of Study Drug|Overall Study||34||
59614691|NCT01570686|75725914|FG000|NOT COMPLETED|Overall Study||22||
59614692|NCT01570686|75725915|FG001|NOT COMPLETED|Overall Study||16||
59614693|NCT01522248|75725923|FG000|STARTED|Overall Study||10||
59762741|NCT00871572|75882600|FG003|Received at Least 1 Dose of Study Drug|Overall Study||25||
59762742|NCT00871572|75882597|FG000|COMPLETED|Overall Study||8||
59762743|NCT00871572|75882598|FG001|COMPLETED|Overall Study||11||
59762744|NCT00871572|75882599|FG002|COMPLETED|Overall Study||30||
59614694|NCT01522248|75725924|FG001|STARTED|Overall Study||10||
59614695|NCT01522248|75725923|FG000|COMPLETED|Overall Study||9||
59614696|NCT01522248|75725924|FG001|COMPLETED|Overall Study||10||
59614697|NCT01522248|75725923|FG000|NOT COMPLETED|Overall Study||1||
60071726|NCT01868997|76187058|FG000|STARTED|Overall Study|randomized and treated|45||
60071727|NCT01868997|76187059|FG001|STARTED|Overall Study|randomized and treated|42||
60071728|NCT01868997|76187058|FG000|COMPLETED|Overall Study||38||
59519932|NCT01008059|75613884|FG006|STARTED|Ketoconazole Sequential Alfentanil||0||
59519933|NCT01008059|75613885|FG007|STARTED|Ketoconazole Sequential Alfentanil||0||
59519934|NCT01008059|75613878|FG000|COMPLETED|Ketoconazole Sequential Alfentanil||0||
59519935|NCT01008059|75613879|FG001|COMPLETED|Ketoconazole Sequential Alfentanil||0||
59519936|NCT01008059|75613880|FG002|COMPLETED|Ketoconazole Sequential Alfentanil||0||
59519937|NCT01008059|75613881|FG003|COMPLETED|Ketoconazole Sequential Alfentanil||6||
59519938|NCT01008059|75613882|FG004|COMPLETED|Ketoconazole Sequential Alfentanil||0||
59519939|NCT01008059|75613883|FG005|COMPLETED|Ketoconazole Sequential Alfentanil||0||
59519940|NCT01008059|75613884|FG006|COMPLETED|Ketoconazole Sequential Alfentanil||0||
59519941|NCT01008059|75613885|FG007|COMPLETED|Ketoconazole Sequential Alfentanil||0||
59519942|NCT01008059|75613878|FG000|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0||
59519943|NCT01008059|75613879|FG001|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0||
59519944|NCT01008059|75613880|FG002|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0||
59519945|NCT01008059|75613881|FG003|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0||
59519946|NCT01008059|75613882|FG004|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0||
59519947|NCT01008059|75613883|FG005|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0||
59519948|NCT01008059|75613884|FG006|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0||
59519949|NCT01008059|75613885|FG007|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0||
59519950|NCT01008059|75613878|FG000|STARTED|Control Simultaneous Alfentanil||0||
59519951|NCT01008059|75613879|FG001|STARTED|Control Simultaneous Alfentanil||0||
59519952|NCT01008059|75613880|FG002|STARTED|Control Simultaneous Alfentanil||0||
59519953|NCT01008059|75613881|FG003|STARTED|Control Simultaneous Alfentanil||0||
59519954|NCT01008059|75613882|FG004|STARTED|Control Simultaneous Alfentanil||6||
59519955|NCT01008059|75613883|FG005|STARTED|Control Simultaneous Alfentanil||0||
59519956|NCT01008059|75613884|FG006|STARTED|Control Simultaneous Alfentanil||0||
59519957|NCT01008059|75613885|FG007|STARTED|Control Simultaneous Alfentanil||0||
59519958|NCT01008059|75613878|FG000|COMPLETED|Control Simultaneous Alfentanil||0||
59519959|NCT01008059|75613879|FG001|COMPLETED|Control Simultaneous Alfentanil||0||
59519960|NCT01008059|75613880|FG002|COMPLETED|Control Simultaneous Alfentanil||0||
59519961|NCT01008059|75613881|FG003|COMPLETED|Control Simultaneous Alfentanil||0||
59519962|NCT01008059|75613882|FG004|COMPLETED|Control Simultaneous Alfentanil||6||
59519963|NCT01008059|75613883|FG005|COMPLETED|Control Simultaneous Alfentanil||0||
59519964|NCT01008059|75613884|FG006|COMPLETED|Control Simultaneous Alfentanil||0||
59519965|NCT01008059|75613885|FG007|COMPLETED|Control Simultaneous Alfentanil||0||
59519966|NCT01008059|75613878|FG000|NOT COMPLETED|Control Simultaneous Alfentanil||0||
59519967|NCT01008059|75613879|FG001|NOT COMPLETED|Control Simultaneous Alfentanil||0||
59519968|NCT01008059|75613880|FG002|NOT COMPLETED|Control Simultaneous Alfentanil||0||
59519969|NCT01008059|75613881|FG003|NOT COMPLETED|Control Simultaneous Alfentanil||0||
59519970|NCT01008059|75613882|FG004|NOT COMPLETED|Control Simultaneous Alfentanil||0||
59519971|NCT01008059|75613883|FG005|NOT COMPLETED|Control Simultaneous Alfentanil||0||
59519972|NCT01008059|75613884|FG006|NOT COMPLETED|Control Simultaneous Alfentanil||0||
59519973|NCT01008059|75613885|FG007|NOT COMPLETED|Control Simultaneous Alfentanil||0||
59519974|NCT01008059|75613878|FG000|STARTED|Rifampin Simultaneous Alfentanil||0||
59519975|NCT01008059|75613879|FG001|STARTED|Rifampin Simultaneous Alfentanil||0||
59519976|NCT01008059|75613880|FG002|STARTED|Rifampin Simultaneous Alfentanil||0||
59519977|NCT01008059|75613881|FG003|STARTED|Rifampin Simultaneous Alfentanil||0||
59519978|NCT01008059|75613882|FG004|STARTED|Rifampin Simultaneous Alfentanil||0||
59519979|NCT01008059|75613883|FG005|STARTED|Rifampin Simultaneous Alfentanil||6||
59519980|NCT01008059|75613884|FG006|STARTED|Rifampin Simultaneous Alfentanil||0||
59519981|NCT01008059|75613885|FG007|STARTED|Rifampin Simultaneous Alfentanil||0||
59519982|NCT01008059|75613878|FG000|COMPLETED|Rifampin Simultaneous Alfentanil||0||
59519983|NCT01008059|75613879|FG001|COMPLETED|Rifampin Simultaneous Alfentanil||0||
59519984|NCT01008059|75613880|FG002|COMPLETED|Rifampin Simultaneous Alfentanil||0||
59519985|NCT01008059|75613881|FG003|COMPLETED|Rifampin Simultaneous Alfentanil||0||
59519986|NCT01008059|75613882|FG004|COMPLETED|Rifampin Simultaneous Alfentanil||0||
59519987|NCT01008059|75613883|FG005|COMPLETED|Rifampin Simultaneous Alfentanil||6||
59519988|NCT01008059|75613884|FG006|COMPLETED|Rifampin Simultaneous Alfentanil||0||
59519989|NCT01008059|75613885|FG007|COMPLETED|Rifampin Simultaneous Alfentanil||0||
59519990|NCT01008059|75613878|FG000|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0||
59519991|NCT01008059|75613879|FG001|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0||
59519992|NCT01008059|75613880|FG002|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0||
59519993|NCT01008059|75613881|FG003|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0||
60071729|NCT01868997|76187059|FG001|COMPLETED|Overall Study||36||
59519994|NCT01008059|75613882|FG004|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0||
59519995|NCT01008059|75613883|FG005|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0||
59519996|NCT01008059|75613884|FG006|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0||
60071730|NCT01868997|76187058|FG000|NOT COMPLETED|Overall Study||7||
60071731|NCT01868997|76187059|FG001|NOT COMPLETED|Overall Study||6||
60071732|NCT01875848|76187067|FG000|STARTED|Overall Study|3 patients were enrolled in the Buprenorphine arm of the study|3||
59762745|NCT00871572|75882600|FG003|COMPLETED|Overall Study||19||
59762746|NCT00871572|75882597|FG000|NOT COMPLETED|Overall Study||2||
59762747|NCT00871572|75882598|FG001|NOT COMPLETED|Overall Study||6||
59762748|NCT00871572|75882599|FG002|NOT COMPLETED|Overall Study||4||
59762749|NCT00871572|75882600|FG003|NOT COMPLETED|Overall Study||7||
59762750|NCT03885661|75882612|FG000|STARTED|Overall Study||12||
59951863|NCT02598388|76070806|FG011|NOT COMPLETED|Overall Study||0||
59951864|NCT00836004|76070839|FG000|STARTED|First Intervention||12||
59614698|NCT01522248|75725924|FG001|NOT COMPLETED|Overall Study||0||
59614699|NCT01543776|75725937|FG000|STARTED|Overall Study||36||
59614700|NCT01543776|75725938|FG001|STARTED|Overall Study||36||
59614701|NCT01543776|75725937|FG000|COMPLETED|Overall Study||34||
59614702|NCT01543776|75725938|FG001|COMPLETED|Overall Study||34||
59614703|NCT01543776|75725937|FG000|NOT COMPLETED|Overall Study||2||
59614704|NCT01543776|75725938|FG001|NOT COMPLETED|Overall Study||2||
59614705|NCT01518192|75725947|FG000|STARTED|Overall Study||145||
59614706|NCT01518192|75725948|FG001|STARTED|Overall Study||140||
59951865|NCT00836004|76070840|FG001|STARTED|First Intervention||12||
59614707|NCT01518192|75725949|FG002|STARTED|Overall Study||259||
59951866|NCT00836004|76070839|FG000|COMPLETED|First Intervention||12||
59951867|NCT00836004|76070840|FG001|COMPLETED|First Intervention||12||
59951868|NCT00836004|76070839|FG000|NOT COMPLETED|First Intervention||0||
59951869|NCT00836004|76070840|FG001|NOT COMPLETED|First Intervention||0||
60071733|NCT01875848|76187068|FG001|STARTED|Overall Study|4 patients were enrolled in the opioid dose escalation arm of the study|4||
60071734|NCT01875848|76187067|FG000|COMPLETED|Overall Study|1 patient completed the Buprenorphine arm of the study. 2 patients withdrew|1||
60071735|NCT01875848|76187068|FG001|COMPLETED|Overall Study|4 patients completed the opioid dose escalation arm of the study|4||
59614708|NCT01518192|75725947|FG000|COMPLETED|Overall Study||116||
59614709|NCT01518192|75725948|FG001|COMPLETED|Overall Study||114||
59614710|NCT01518192|75725949|FG002|COMPLETED|Overall Study||224||
59614711|NCT01518192|75725947|FG000|NOT COMPLETED|Overall Study||29||
59614712|NCT01518192|75725948|FG001|NOT COMPLETED|Overall Study||26||
59762751|NCT03885661|75882613|FG001|STARTED|Overall Study||8||
59762752|NCT03885661|75882612|FG000|Baseline|Overall Study||12||
59762753|NCT03885661|75882613|FG001|Baseline|Overall Study||8||
59951870|NCT00836004|76070839|FG000|STARTED|Washout: 7 Days||12||
60071736|NCT01875848|76187067|FG000|NOT COMPLETED|Overall Study||2||
60071737|NCT01875848|76187068|FG001|NOT COMPLETED|Overall Study||0||
60071738|NCT04191382|76187077|FG000|STARTED|Overall Study||34|Randomized|
60071739|NCT04191382|76187078|FG001|STARTED|Overall Study||36|Randomized|
60071740|NCT04191382|76187079|FG002|STARTED|Overall Study||35|Randomized|
59614713|NCT01518192|75725949|FG002|NOT COMPLETED|Overall Study||35||
59614714|NCT01517802|75725963|FG000|STARTED|Overall Study||31||
60071741|NCT04191382|76187077|FG000|Treated|Overall Study||33||
60071742|NCT04191382|76187078|FG001|Treated|Overall Study||36||
60071743|NCT04191382|76187079|FG002|Treated|Overall Study||35||
60071744|NCT04191382|76187077|FG000|COMPLETED|Overall Study||33||
59519997|NCT01008059|75613885|FG007|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0||
59519998|NCT01008059|75613878|FG000|STARTED|Grapefruit Juice Simultaneous Alfentanil||0||
59519999|NCT01008059|75613879|FG001|STARTED|Grapefruit Juice Simultaneous Alfentanil||0||
59520000|NCT01008059|75613880|FG002|STARTED|Grapefruit Juice Simultaneous Alfentanil||0||
59520001|NCT01008059|75613881|FG003|STARTED|Grapefruit Juice Simultaneous Alfentanil||0||
59520002|NCT01008059|75613882|FG004|STARTED|Grapefruit Juice Simultaneous Alfentanil||0||
59520003|NCT01008059|75613883|FG005|STARTED|Grapefruit Juice Simultaneous Alfentanil||0||
59520004|NCT01008059|75613884|FG006|STARTED|Grapefruit Juice Simultaneous Alfentanil||6||
59520005|NCT01008059|75613885|FG007|STARTED|Grapefruit Juice Simultaneous Alfentanil||0||
59520006|NCT01008059|75613878|FG000|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0||
59520007|NCT01008059|75613879|FG001|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0||
59520008|NCT01008059|75613880|FG002|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0||
59520009|NCT01008059|75613881|FG003|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0||
59520010|NCT01008059|75613882|FG004|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0||
59520011|NCT01008059|75613883|FG005|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0||
59520012|NCT01008059|75613884|FG006|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||6||
59520013|NCT01008059|75613885|FG007|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0||
59520014|NCT01008059|75613878|FG000|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0||
59520015|NCT01008059|75613879|FG001|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0||
59520016|NCT01008059|75613880|FG002|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0||
59520017|NCT01008059|75613881|FG003|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0||
59520018|NCT01008059|75613882|FG004|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0||
59520019|NCT01008059|75613883|FG005|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0||
59520020|NCT01008059|75613884|FG006|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0||
59520021|NCT01008059|75613885|FG007|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0||
59520022|NCT01008059|75613878|FG000|STARTED|Ketoconazole Simultaneous Alfentanil||0||
59520023|NCT01008059|75613879|FG001|STARTED|Ketoconazole Simultaneous Alfentanil||0||
59520024|NCT01008059|75613880|FG002|STARTED|Ketoconazole Simultaneous Alfentanil||0||
59520025|NCT01008059|75613881|FG003|STARTED|Ketoconazole Simultaneous Alfentanil||0||
59520026|NCT01008059|75613882|FG004|STARTED|Ketoconazole Simultaneous Alfentanil||0||
59520027|NCT01008059|75613883|FG005|STARTED|Ketoconazole Simultaneous Alfentanil||0||
59520028|NCT01008059|75613884|FG006|STARTED|Ketoconazole Simultaneous Alfentanil||0||
59520029|NCT01008059|75613885|FG007|STARTED|Ketoconazole Simultaneous Alfentanil||6||
59520030|NCT01008059|75613878|FG000|COMPLETED|Ketoconazole Simultaneous Alfentanil||0||
59520031|NCT01008059|75613879|FG001|COMPLETED|Ketoconazole Simultaneous Alfentanil||0||
59520032|NCT01008059|75613880|FG002|COMPLETED|Ketoconazole Simultaneous Alfentanil||0||
59520033|NCT01008059|75613881|FG003|COMPLETED|Ketoconazole Simultaneous Alfentanil||0||
59520034|NCT01008059|75613882|FG004|COMPLETED|Ketoconazole Simultaneous Alfentanil||0||
59520035|NCT01008059|75613883|FG005|COMPLETED|Ketoconazole Simultaneous Alfentanil||0||
59520036|NCT01008059|75613884|FG006|COMPLETED|Ketoconazole Simultaneous Alfentanil||0||
59520037|NCT01008059|75613885|FG007|COMPLETED|Ketoconazole Simultaneous Alfentanil||6||
59520038|NCT01008059|75613878|FG000|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0||
59520039|NCT01008059|75613879|FG001|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0||
59520040|NCT01008059|75613880|FG002|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0||
59520041|NCT01008059|75613881|FG003|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0||
59520042|NCT01008059|75613882|FG004|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0||
59520043|NCT01008059|75613883|FG005|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0||
59520044|NCT01008059|75613884|FG006|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0||
59520045|NCT01008059|75613885|FG007|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0||
59520046|NCT03634306|75613899|FG000|STARTED|Overall Study||15||
59520047|NCT03634306|75613900|FG001|STARTED|Overall Study||15||
59520048|NCT03634306|75613901|FG002|STARTED|Overall Study||5||
59520049|NCT03634306|75613899|FG000|COMPLETED|Overall Study||15||
59520050|NCT03634306|75613900|FG001|COMPLETED|Overall Study||15||
59520051|NCT03634306|75613901|FG002|COMPLETED|Overall Study||5||
59520052|NCT03634306|75613899|FG000|NOT COMPLETED|Overall Study||0||
59520053|NCT03634306|75613900|FG001|NOT COMPLETED|Overall Study||0||
59520054|NCT03634306|75613901|FG002|NOT COMPLETED|Overall Study||0||
59520055|NCT01008605|75613909|FG000|STARTED|Overall Study||48||
59520056|NCT01008605|75613909|FG000|COMPLETED|Overall Study||48||
60071745|NCT04191382|76187078|FG001|COMPLETED|Overall Study||36||
60071746|NCT04191382|76187079|FG002|COMPLETED|Overall Study||35||
60071747|NCT04191382|76187077|FG000|NOT COMPLETED|Overall Study||1||
59520057|NCT01008605|75613909|FG000|NOT COMPLETED|Overall Study||0||
59520058|NCT01009619|75613923|FG000|STARTED|Overall Study||40||
59520059|NCT01009619|75613924|FG001|STARTED|Overall Study||43||
60071748|NCT04191382|76187078|FG001|NOT COMPLETED|Overall Study||0||
60071749|NCT04191382|76187079|FG002|NOT COMPLETED|Overall Study||0||
60071750|NCT01703091|76187089|FG000|STARTED|Overall Study||98||
59614715|NCT01517802|75725963|FG000|COMPLETED|Overall Study||30||
59614716|NCT01517802|75725963|FG000|NOT COMPLETED|Overall Study||1||
59614717|NCT01520922|75725969|FG000|STARTED|Treatment Phase||44||
59614718|NCT01520922|75725970|FG001|STARTED|Treatment Phase||53||
59614719|NCT01520922|75725969|FG000|COMPLETED|Treatment Phase|Completed 6 Cycles of Study Treatment|39||
59614720|NCT01520922|75725970|FG001|COMPLETED|Treatment Phase|Completed 6 Cycles of Study Treatment|45||
59614721|NCT01520922|75725969|FG000|NOT COMPLETED|Treatment Phase||5||
59614722|NCT01520922|75725970|FG001|NOT COMPLETED|Treatment Phase||8||
59614723|NCT01520922|75725969|FG000|STARTED|Follow up||44||
59614724|NCT01520922|75725970|FG001|STARTED|Follow up||45||
59614725|NCT01520922|75725969|FG000|COMPLETED|Follow up||44||
59614726|NCT01520922|75725970|FG001|COMPLETED|Follow up||44||
59614727|NCT01520922|75725969|FG000|NOT COMPLETED|Follow up||0||
59614728|NCT01520922|75725970|FG001|NOT COMPLETED|Follow up||1||
59614729|NCT01520922|75725969|FG000|STARTED|Survival Follow-up||21||
59614730|NCT01520922|75725970|FG001|STARTED|Survival Follow-up||40||
59614731|NCT01520922|75725969|FG000|COMPLETED|Survival Follow-up||20||
59614732|NCT01520922|75725970|FG001|COMPLETED|Survival Follow-up||40||
59614733|NCT01520922|75725969|FG000|NOT COMPLETED|Survival Follow-up||1||
59614734|NCT01520922|75725970|FG001|NOT COMPLETED|Survival Follow-up||0||
59614735|NCT01569438|75725978|FG000|STARTED|Overall Study||52||
59614736|NCT01569438|75725979|FG001|STARTED|Overall Study||55||
59614737|NCT01569438|75725978|FG000|Treated|Overall Study||51||
59614738|NCT01569438|75725979|FG001|Treated|Overall Study||54||
59614739|NCT01569438|75725978|FG000|Titration Set|Overall Study||38||
59614740|NCT01569438|75725979|FG001|Titration Set|Overall Study||36||
59614741|NCT01569438|75725978|FG000|COMPLETED|Overall Study||45||
59614742|NCT01569438|75725979|FG001|COMPLETED|Overall Study||33||
59614743|NCT01569438|75725978|FG000|NOT COMPLETED|Overall Study||7||
59614744|NCT01569438|75725979|FG001|NOT COMPLETED|Overall Study||22||
59614745|NCT01517412|75725987|FG000|STARTED|Overall Study||225||
59614746|NCT01517412|75725988|FG001|STARTED|Overall Study||226||
59614747|NCT01517412|75725987|FG000|COMPLETED|Overall Study||189||
59614748|NCT01517412|75725988|FG001|COMPLETED|Overall Study||202||
59614749|NCT01517412|75725987|FG000|NOT COMPLETED|Overall Study||36||
59614750|NCT01517412|75725988|FG001|NOT COMPLETED|Overall Study||24||
59614751|NCT01517178|75725994|FG000|STARTED|Period 1|One subject (who discontinued due to an adverse event) actually used New ostomy base plate.|16||
59614752|NCT01517178|75725995|FG001|STARTED|Period 1||11||
59614753|NCT01517178|75725994|FG000|COMPLETED|Period 1||12||
59614754|NCT01517178|75725995|FG001|COMPLETED|Period 1||6||
59614755|NCT01517178|75725994|FG000|NOT COMPLETED|Period 1||4||
59614756|NCT01517178|75725995|FG001|NOT COMPLETED|Period 1||5||
59614757|NCT01517178|75725994|FG000|STARTED|Period 2|One subject discontinued during run-in and did not start period 2.|11||
59614758|NCT01517178|75725995|FG001|STARTED|Period 2||6||
59614759|NCT01517178|75725994|FG000|COMPLETED|Period 2||5||
59614760|NCT01517178|75725995|FG001|COMPLETED|Period 2||4||
59614761|NCT01517178|75725994|FG000|NOT COMPLETED|Period 2||6||
59614762|NCT01517178|75725995|FG001|NOT COMPLETED|Period 2||2||
59614763|NCT01489956|75726003|FG000|STARTED|Overall Study|Ten of the 13 participants were considered evaluable.|13||
59614764|NCT01489956|75726004|FG001|STARTED|Overall Study|Nine of the 10 participants receiving Immucothel alone had a response, so Montanide was not used.|0||
59614765|NCT01489956|75726005|FG002|STARTED|Overall Study|These 6 subjects had Immucothel alone since Montanide was not needed for the 10 participants dosed.|6||
59614766|NCT01489956|75726003|FG000|COMPLETED|Overall Study||12||
59614767|NCT01489956|75726004|FG001|COMPLETED|Overall Study||0||
59614768|NCT01489956|75726005|FG002|COMPLETED|Overall Study||5||
59614769|NCT01489956|75726003|FG000|NOT COMPLETED|Overall Study||1||
59614770|NCT01489956|75726004|FG001|NOT COMPLETED|Overall Study||0||
59614771|NCT01489956|75726005|FG002|NOT COMPLETED|Overall Study||1||
59614772|NCT01516008|75726016|FG000|STARTED|Overall Study||114||
59614773|NCT01516008|75726017|FG001|STARTED|Overall Study||121||
59614774|NCT01516008|75726018|FG002|STARTED|Overall Study||117||
59614775|NCT01516008|75726016|FG000|COMPLETED|Overall Study||69||
59614776|NCT01516008|75726017|FG001|COMPLETED|Overall Study||105||
59951871|NCT00836004|76070840|FG001|STARTED|Washout: 7 Days||12||
59951872|NCT00836004|76070839|FG000|COMPLETED|Washout: 7 Days||12||
59614777|NCT01516008|75726018|FG002|COMPLETED|Overall Study||99||
59614778|NCT01516008|75726016|FG000|NOT COMPLETED|Overall Study||45||
59614779|NCT01516008|75726017|FG001|NOT COMPLETED|Overall Study||16||
59614780|NCT01516008|75726018|FG002|NOT COMPLETED|Overall Study||18||
59614781|NCT01489254|75726029|FG000|STARTED|Double-blind Part||355||
59614782|NCT01489254|75726030|FG001|STARTED|Double-blind Part||357||
59614783|NCT01489254|75726031|FG002|STARTED|Double-blind Part||84||
59614784|NCT01489254|75726032|FG003|STARTED|Double-blind Part||0||
59614785|NCT01489254|75726029|FG000|COMPLETED|Double-blind Part||330||
59614786|NCT01489254|75726030|FG001|COMPLETED|Double-blind Part||324||
59614787|NCT01489254|75726031|FG002|COMPLETED|Double-blind Part||81||
59614788|NCT01489254|75726032|FG003|COMPLETED|Double-blind Part||0||
59614789|NCT01489254|75726029|FG000|NOT COMPLETED|Double-blind Part||25||
59614790|NCT01489254|75726030|FG001|NOT COMPLETED|Double-blind Part||33||
59614791|NCT01489254|75726031|FG002|NOT COMPLETED|Double-blind Part||3||
59951873|NCT00836004|76070840|FG001|COMPLETED|Washout: 7 Days||12||
59951874|NCT00836004|76070839|FG000|NOT COMPLETED|Washout: 7 Days||0||
59614792|NCT01489254|75726032|FG003|NOT COMPLETED|Double-blind Part||0||
59614793|NCT01489254|75726029|FG000|STARTED|Open-label Extension Part||0||
59614794|NCT01489254|75726030|FG001|STARTED|Open-label Extension Part||0||
59614795|NCT01489254|75726031|FG002|STARTED|Open-label Extension Part||0||
59614796|NCT01489254|75726032|FG003|STARTED|Open-label Extension Part|735 completed the DB part, 729 were eligible to continue in the OL part, 1 opted not to continue|728||
59614797|NCT01489254|75726029|FG000|COMPLETED|Open-label Extension Part||0||
59614798|NCT01489254|75726030|FG001|COMPLETED|Open-label Extension Part||0||
59614799|NCT01489254|75726031|FG002|COMPLETED|Open-label Extension Part||0||
59614800|NCT01489254|75726032|FG003|COMPLETED|Open-label Extension Part||670||
59614801|NCT01489254|75726029|FG000|NOT COMPLETED|Open-label Extension Part||0||
59614802|NCT01489254|75726030|FG001|NOT COMPLETED|Open-label Extension Part||0||
59614803|NCT01489254|75726031|FG002|NOT COMPLETED|Open-label Extension Part||0||
59614804|NCT01489254|75726032|FG003|NOT COMPLETED|Open-label Extension Part||58||
59614805|NCT01489020|75726047|FG000|STARTED|Overall Study||12||
59614806|NCT01489020|75726048|FG001|STARTED|Overall Study||4||
59614807|NCT01489020|75726049|FG002|STARTED|Overall Study||12||
59614808|NCT01489020|75726050|FG003|STARTED|Overall Study||4||
59614809|NCT01489020|75726051|FG004|STARTED|Overall Study||12||
59614810|NCT01489020|75726052|FG005|STARTED|Overall Study||4||
59614811|NCT01489020|75726047|FG000|COMPLETED|Overall Study||11||
59614812|NCT01489020|75726048|FG001|COMPLETED|Overall Study||4||
59614813|NCT01489020|75726049|FG002|COMPLETED|Overall Study||9||
59614814|NCT01489020|75726050|FG003|COMPLETED|Overall Study||4||
59614815|NCT01489020|75726051|FG004|COMPLETED|Overall Study||6||
59614816|NCT01489020|75726052|FG005|COMPLETED|Overall Study||4||
59614817|NCT01489020|75726047|FG000|NOT COMPLETED|Overall Study||1||
59614818|NCT01489020|75726048|FG001|NOT COMPLETED|Overall Study||0||
59614819|NCT01489020|75726049|FG002|NOT COMPLETED|Overall Study||3||
59614820|NCT01489020|75726050|FG003|NOT COMPLETED|Overall Study||0||
59614821|NCT01489020|75726051|FG004|NOT COMPLETED|Overall Study||6||
59614822|NCT01489020|75726052|FG005|NOT COMPLETED|Overall Study||0||
59614823|NCT01514760|75726072|FG000|STARTED|Overall Study||22||
59614824|NCT01514760|75726072|FG000|COMPLETED|Overall Study||20||
59614825|NCT01514760|75726072|FG000|NOT COMPLETED|Overall Study||2||
59614826|NCT01514682|75726078|FG000|STARTED|Overall Study||19||
59614827|NCT01514682|75726079|FG001|STARTED|Overall Study||20||
59614828|NCT01514682|75726078|FG000|COMPLETED|Overall Study||13||
59614829|NCT01514682|75726079|FG001|COMPLETED|Overall Study||14||
59614830|NCT01514682|75726078|FG000|NOT COMPLETED|Overall Study||6||
59614831|NCT01514682|75726079|FG001|NOT COMPLETED|Overall Study||6||
59614832|NCT01514448|75726087|FG000|STARTED|Overall Study||16||
59614833|NCT01514448|75726088|FG001|STARTED|Overall Study||13||
59614834|NCT01514448|75726087|FG000|Full Analysis Set (FAS)|Overall Study||12||
59614835|NCT01514448|75726088|FG001|Full Analysis Set (FAS)|Overall Study||13||
59614836|NCT01514448|75726087|FG000|COMPLETED|Overall Study||4||
59614837|NCT01514448|75726088|FG001|COMPLETED|Overall Study||5||
59614838|NCT01514448|75726087|FG000|NOT COMPLETED|Overall Study||12||
59614839|NCT01514448|75726088|FG001|NOT COMPLETED|Overall Study||8||
59614840|NCT01514370|75726097|FG000|STARTED|Overall Study||40||
59614841|NCT01514370|75726098|FG001|STARTED|Overall Study||40||
59614842|NCT01514370|75726097|FG000|Safety Population|Overall Study|The Safety population consisted all randomized subjects who received at least 1 dose of study drug.|38||
59614843|NCT01514370|75726098|FG001|Safety Population|Overall Study|The Safety population consisted all randomized subjects who received at least 1 dose of study drug.|40||
59614844|NCT01514370|75726097|FG000|COMPLETED|Overall Study||29||
59614845|NCT01514370|75726098|FG001|COMPLETED|Overall Study||24||
59614846|NCT01514370|75726097|FG000|NOT COMPLETED|Overall Study||11||
59614847|NCT01514370|75726098|FG001|NOT COMPLETED|Overall Study||16||
59614848|NCT01519674|75726108|FG000|STARTED|Overall Study||194||
59614849|NCT01519674|75726109|FG001|STARTED|Overall Study||195||
59614850|NCT01519674|75726110|FG002|STARTED|Overall Study||193||
59614851|NCT01519674|75726108|FG000|Exposed|Overall Study||192||
59614852|NCT01519674|75726109|FG001|Exposed|Overall Study||193||
59614853|NCT01519674|75726110|FG002|Exposed|Overall Study||190||
59614854|NCT01519674|75726108|FG000|COMPLETED|Overall Study||173||
59614855|NCT01519674|75726109|FG001|COMPLETED|Overall Study||182||
59614856|NCT01519674|75726110|FG002|COMPLETED|Overall Study||181||
59614857|NCT01519674|75726108|FG000|NOT COMPLETED|Overall Study||21||
59614858|NCT01519674|75726109|FG001|NOT COMPLETED|Overall Study||13||
59614859|NCT01519674|75726110|FG002|NOT COMPLETED|Overall Study||12||
59614860|NCT01519518|75726120|FG000|STARTED|Overall Study||914||
59614861|NCT01519518|75726121|FG001|STARTED|Overall Study||915||
59614862|NCT01519518|75726120|FG000|COMPLETED|Overall Study||907||
59614863|NCT01519518|75726121|FG001|COMPLETED|Overall Study||905||
59614864|NCT01519518|75726120|FG000|NOT COMPLETED|Overall Study||7||
59614865|NCT01519518|75726121|FG001|NOT COMPLETED|Overall Study||10||
59614866|NCT01519206|75726127|FG000|STARTED|Overall Study||32||
59614867|NCT01519206|75726127|FG000|COMPLETED|Overall Study||27||
59614868|NCT01519206|75726127|FG000|NOT COMPLETED|Overall Study||5||
59614869|NCT01518972|75726140|FG000|STARTED|Overall Study||15||
59614870|NCT01518972|75726141|FG001|STARTED|Overall Study||15||
59614871|NCT01518972|75726140|FG000|COMPLETED|Overall Study||9||
59614872|NCT01518972|75726141|FG001|COMPLETED|Overall Study||11||
59614873|NCT01518972|75726140|FG000|NOT COMPLETED|Overall Study||6||
59614874|NCT01518972|75726141|FG001|NOT COMPLETED|Overall Study||4||
59614875|NCT01514136|75726149|FG000|STARTED|Test Period 1; Test A|26 subjects tested Test A|25||
59614876|NCT01514136|75726150|FG001|STARTED|Test Period 1; Test A||0||
59614877|NCT01514136|75726151|FG002|STARTED|Test Period 1; Test A||0||
59614878|NCT01514136|75726152|FG003|STARTED|Test Period 1; Test A||0||
59614879|NCT01514136|75726153|FG004|STARTED|Test Period 1; Test A||0||
59614880|NCT01514136|75726154|FG005|STARTED|Test Period 1; Test A||0||
59614881|NCT01514136|75726155|FG006|STARTED|Test Period 1; Test A||0||
59614882|NCT01514136|75726156|FG007|STARTED|Test Period 1; Test A||0||
59614883|NCT01514136|75726149|FG000|COMPLETED|Test Period 1; Test A||22||
59614884|NCT01514136|75726150|FG001|COMPLETED|Test Period 1; Test A||0||
59614885|NCT01514136|75726151|FG002|COMPLETED|Test Period 1; Test A||0||
59614886|NCT01514136|75726152|FG003|COMPLETED|Test Period 1; Test A||0||
59614887|NCT01514136|75726153|FG004|COMPLETED|Test Period 1; Test A||0||
59614888|NCT01514136|75726154|FG005|COMPLETED|Test Period 1; Test A||0||
59614889|NCT01514136|75726155|FG006|COMPLETED|Test Period 1; Test A||0||
59614890|NCT01514136|75726156|FG007|COMPLETED|Test Period 1; Test A||0||
59614891|NCT01514136|75726149|FG000|NOT COMPLETED|Test Period 1; Test A||3||
59614892|NCT01514136|75726150|FG001|NOT COMPLETED|Test Period 1; Test A||0||
59614893|NCT01514136|75726151|FG002|NOT COMPLETED|Test Period 1; Test A||0||
59614894|NCT01514136|75726152|FG003|NOT COMPLETED|Test Period 1; Test A||0||
59614895|NCT01514136|75726153|FG004|NOT COMPLETED|Test Period 1; Test A||0||
59614896|NCT01514136|75726154|FG005|NOT COMPLETED|Test Period 1; Test A||0||
59614897|NCT01514136|75726155|FG006|NOT COMPLETED|Test Period 1; Test A||0||
59614898|NCT01514136|75726156|FG007|NOT COMPLETED|Test Period 1; Test A||0||
59614899|NCT01514136|75726149|FG000|STARTED|Test Period 1; Test B||0||
59614900|NCT01514136|75726150|FG001|STARTED|Test Period 1; Test B|2 new subjects were entered the investigation|24||
59614901|NCT01514136|75726151|FG002|STARTED|Test Period 1; Test B||0||
59614902|NCT01514136|75726152|FG003|STARTED|Test Period 1; Test B||0||
59614903|NCT01514136|75726153|FG004|STARTED|Test Period 1; Test B||0||
59614904|NCT01514136|75726154|FG005|STARTED|Test Period 1; Test B||0||
59614905|NCT01514136|75726155|FG006|STARTED|Test Period 1; Test B||0||
59614906|NCT01514136|75726156|FG007|STARTED|Test Period 1; Test B||0||
59614907|NCT01514136|75726149|FG000|COMPLETED|Test Period 1; Test B||0||
59614908|NCT01514136|75726150|FG001|COMPLETED|Test Period 1; Test B||23||
59614909|NCT01514136|75726151|FG002|COMPLETED|Test Period 1; Test B||0||
59614910|NCT01514136|75726152|FG003|COMPLETED|Test Period 1; Test B||0||
59614911|NCT01514136|75726153|FG004|COMPLETED|Test Period 1; Test B||0||
59614912|NCT01514136|75726154|FG005|COMPLETED|Test Period 1; Test B||0||
59614913|NCT01514136|75726155|FG006|COMPLETED|Test Period 1; Test B||0||
59614914|NCT01514136|75726156|FG007|COMPLETED|Test Period 1; Test B||0||
59614915|NCT01514136|75726149|FG000|NOT COMPLETED|Test Period 1; Test B||0||
59614916|NCT01514136|75726150|FG001|NOT COMPLETED|Test Period 1; Test B||1||
59614917|NCT01514136|75726151|FG002|NOT COMPLETED|Test Period 1; Test B||0||
59614918|NCT01514136|75726152|FG003|NOT COMPLETED|Test Period 1; Test B||0||
59614919|NCT01514136|75726153|FG004|NOT COMPLETED|Test Period 1; Test B||0||
59614920|NCT01514136|75726154|FG005|NOT COMPLETED|Test Period 1; Test B||0||
59614921|NCT01514136|75726155|FG006|NOT COMPLETED|Test Period 1; Test B||0||
59614922|NCT01514136|75726156|FG007|NOT COMPLETED|Test Period 1; Test B||0||
59614923|NCT01514136|75726149|FG000|STARTED|Test Period 1; Test C||0||
59614924|NCT01514136|75726150|FG001|STARTED|Test Period 1; Test C||0||
59614925|NCT01514136|75726151|FG002|STARTED|Test Period 1; Test C|1 new subject was included in the investigation|24||
59614926|NCT01514136|75726152|FG003|STARTED|Test Period 1; Test C||0||
59614927|NCT01514136|75726153|FG004|STARTED|Test Period 1; Test C||0||
59614928|NCT01514136|75726154|FG005|STARTED|Test Period 1; Test C||0||
59614929|NCT01514136|75726155|FG006|STARTED|Test Period 1; Test C||0||
59614930|NCT01514136|75726156|FG007|STARTED|Test Period 1; Test C||0||
59614931|NCT01514136|75726149|FG000|COMPLETED|Test Period 1; Test C||0||
59614932|NCT01514136|75726150|FG001|COMPLETED|Test Period 1; Test C||0||
59614933|NCT01514136|75726151|FG002|COMPLETED|Test Period 1; Test C||24||
59614934|NCT01514136|75726152|FG003|COMPLETED|Test Period 1; Test C||0||
59614935|NCT01514136|75726153|FG004|COMPLETED|Test Period 1; Test C||0||
59614936|NCT01514136|75726154|FG005|COMPLETED|Test Period 1; Test C||0||
59614937|NCT01514136|75726155|FG006|COMPLETED|Test Period 1; Test C||0||
59614938|NCT01514136|75726156|FG007|COMPLETED|Test Period 1; Test C||0||
59614939|NCT01514136|75726149|FG000|NOT COMPLETED|Test Period 1; Test C||0||
59614940|NCT01514136|75726150|FG001|NOT COMPLETED|Test Period 1; Test C||0||
59614941|NCT01514136|75726151|FG002|NOT COMPLETED|Test Period 1; Test C||0||
59614942|NCT01514136|75726152|FG003|NOT COMPLETED|Test Period 1; Test C||0||
59614943|NCT01514136|75726153|FG004|NOT COMPLETED|Test Period 1; Test C||0||
59614944|NCT01514136|75726154|FG005|NOT COMPLETED|Test Period 1; Test C||0||
59614945|NCT01514136|75726155|FG006|NOT COMPLETED|Test Period 1; Test C||0||
59614946|NCT01514136|75726156|FG007|NOT COMPLETED|Test Period 1; Test C||0||
59614947|NCT01514136|75726149|FG000|STARTED|Test Period 1; Test D||0||
59614948|NCT01514136|75726150|FG001|STARTED|Test Period 1; Test D||0||
59614949|NCT01514136|75726151|FG002|STARTED|Test Period 1; Test D||0||
59614950|NCT01514136|75726152|FG003|STARTED|Test Period 1; Test D|The two subject that were on holiday after test A re-entered the investigation|26||
59614951|NCT01514136|75726153|FG004|STARTED|Test Period 1; Test D||0||
59614952|NCT01514136|75726154|FG005|STARTED|Test Period 1; Test D||0||
59614953|NCT01514136|75726155|FG006|STARTED|Test Period 1; Test D||0||
59614954|NCT01514136|75726156|FG007|STARTED|Test Period 1; Test D||0||
59614955|NCT01514136|75726149|FG000|COMPLETED|Test Period 1; Test D||0||
59614956|NCT01514136|75726150|FG001|COMPLETED|Test Period 1; Test D||0||
59614957|NCT01514136|75726151|FG002|COMPLETED|Test Period 1; Test D||0||
59614958|NCT01514136|75726152|FG003|COMPLETED|Test Period 1; Test D||24||
59614959|NCT01514136|75726153|FG004|COMPLETED|Test Period 1; Test D||0||
59614960|NCT01514136|75726154|FG005|COMPLETED|Test Period 1; Test D||0||
59614961|NCT01514136|75726155|FG006|COMPLETED|Test Period 1; Test D||0||
59614962|NCT01514136|75726156|FG007|COMPLETED|Test Period 1; Test D||0||
59614963|NCT01514136|75726149|FG000|NOT COMPLETED|Test Period 1; Test D||0||
59614964|NCT01514136|75726150|FG001|NOT COMPLETED|Test Period 1; Test D||0||
59614965|NCT01514136|75726151|FG002|NOT COMPLETED|Test Period 1; Test D||0||
59614966|NCT01514136|75726152|FG003|NOT COMPLETED|Test Period 1; Test D||2||
59614967|NCT01514136|75726153|FG004|NOT COMPLETED|Test Period 1; Test D||0||
59614968|NCT01514136|75726154|FG005|NOT COMPLETED|Test Period 1; Test D||0||
59614969|NCT01514136|75726155|FG006|NOT COMPLETED|Test Period 1; Test D||0||
59614970|NCT01514136|75726156|FG007|NOT COMPLETED|Test Period 1; Test D||0||
59614971|NCT01514136|75726149|FG000|STARTED|Test Period 2; Test A*||0||
59614972|NCT01514136|75726150|FG001|STARTED|Test Period 2; Test A*||0||
59614973|NCT01514136|75726151|FG002|STARTED|Test Period 2; Test A*||0||
59614974|NCT01514136|75726152|FG003|STARTED|Test Period 2; Test A*||0||
59614975|NCT01514136|75726153|FG004|STARTED|Test Period 2; Test A*|4 new subjects were included in the investigation|28||
59614976|NCT01514136|75726154|FG005|STARTED|Test Period 2; Test A*||0||
59614977|NCT01514136|75726155|FG006|STARTED|Test Period 2; Test A*||0||
59614978|NCT01514136|75726156|FG007|STARTED|Test Period 2; Test A*||0||
59614979|NCT01514136|75726149|FG000|COMPLETED|Test Period 2; Test A*||0||
59614980|NCT01514136|75726150|FG001|COMPLETED|Test Period 2; Test A*||0||
59614981|NCT01514136|75726151|FG002|COMPLETED|Test Period 2; Test A*||0||
59614982|NCT01514136|75726152|FG003|COMPLETED|Test Period 2; Test A*||0||
59614983|NCT01514136|75726153|FG004|COMPLETED|Test Period 2; Test A*||26||
59614984|NCT01514136|75726154|FG005|COMPLETED|Test Period 2; Test A*||0||
59614985|NCT01514136|75726155|FG006|COMPLETED|Test Period 2; Test A*||0||
59614986|NCT01514136|75726156|FG007|COMPLETED|Test Period 2; Test A*||0||
59614987|NCT01514136|75726149|FG000|NOT COMPLETED|Test Period 2; Test A*||0||
59614988|NCT01514136|75726150|FG001|NOT COMPLETED|Test Period 2; Test A*||0||
59614989|NCT01514136|75726151|FG002|NOT COMPLETED|Test Period 2; Test A*||0||
59614990|NCT01514136|75726152|FG003|NOT COMPLETED|Test Period 2; Test A*||0||
59614991|NCT01514136|75726153|FG004|NOT COMPLETED|Test Period 2; Test A*||2||
59614992|NCT01514136|75726154|FG005|NOT COMPLETED|Test Period 2; Test A*||0||
59614993|NCT01514136|75726155|FG006|NOT COMPLETED|Test Period 2; Test A*||0||
59614994|NCT01514136|75726156|FG007|NOT COMPLETED|Test Period 2; Test A*||0||
59614995|NCT01514136|75726149|FG000|STARTED|Test Period 2; Test B*||0||
59614996|NCT01514136|75726150|FG001|STARTED|Test Period 2; Test B*||0||
59614997|NCT01514136|75726151|FG002|STARTED|Test Period 2; Test B*||0||
59614998|NCT01514136|75726152|FG003|STARTED|Test Period 2; Test B*||0||
59614999|NCT01514136|75726153|FG004|STARTED|Test Period 2; Test B*||0||
59615000|NCT01514136|75726154|FG005|STARTED|Test Period 2; Test B*|Two subjects did not test test A*, but had a break and continued again on Test B*|28||
59615001|NCT01514136|75726155|FG006|STARTED|Test Period 2; Test B*||0||
59615002|NCT01514136|75726156|FG007|STARTED|Test Period 2; Test B*||0||
59615003|NCT01514136|75726149|FG000|COMPLETED|Test Period 2; Test B*||0||
59615004|NCT01514136|75726150|FG001|COMPLETED|Test Period 2; Test B*||0||
59615005|NCT01514136|75726151|FG002|COMPLETED|Test Period 2; Test B*||0||
59615006|NCT01514136|75726152|FG003|COMPLETED|Test Period 2; Test B*||0||
59615007|NCT01514136|75726153|FG004|COMPLETED|Test Period 2; Test B*||0||
59615008|NCT01514136|75726154|FG005|COMPLETED|Test Period 2; Test B*||26||
59615009|NCT01514136|75726155|FG006|COMPLETED|Test Period 2; Test B*||0||
59615010|NCT01514136|75726156|FG007|COMPLETED|Test Period 2; Test B*||0||
59615011|NCT01514136|75726149|FG000|NOT COMPLETED|Test Period 2; Test B*||0||
59615012|NCT01514136|75726150|FG001|NOT COMPLETED|Test Period 2; Test B*||0||
59615013|NCT01514136|75726151|FG002|NOT COMPLETED|Test Period 2; Test B*||0||
59615014|NCT01514136|75726152|FG003|NOT COMPLETED|Test Period 2; Test B*||0||
59615015|NCT01514136|75726153|FG004|NOT COMPLETED|Test Period 2; Test B*||0||
59615016|NCT01514136|75726154|FG005|NOT COMPLETED|Test Period 2; Test B*||2||
59615017|NCT01514136|75726155|FG006|NOT COMPLETED|Test Period 2; Test B*||0||
59615018|NCT01514136|75726156|FG007|NOT COMPLETED|Test Period 2; Test B*||0||
59615019|NCT01514136|75726149|FG000|STARTED|Test Period 2; Test C*||0||
59615020|NCT01514136|75726150|FG001|STARTED|Test Period 2; Test C*||0||
59615021|NCT01514136|75726151|FG002|STARTED|Test Period 2; Test C*||0||
59615022|NCT01514136|75726152|FG003|STARTED|Test Period 2; Test C*||0||
59615023|NCT01514136|75726153|FG004|STARTED|Test Period 2; Test C*||0||
59615024|NCT01514136|75726154|FG005|STARTED|Test Period 2; Test C*||0||
59615025|NCT01514136|75726155|FG006|STARTED|Test Period 2; Test C*||26||
59615026|NCT01514136|75726156|FG007|STARTED|Test Period 2; Test C*||0||
59615027|NCT01514136|75726149|FG000|COMPLETED|Test Period 2; Test C*||0||
59615028|NCT01514136|75726150|FG001|COMPLETED|Test Period 2; Test C*||0||
59615029|NCT01514136|75726151|FG002|COMPLETED|Test Period 2; Test C*||0||
59615030|NCT01514136|75726152|FG003|COMPLETED|Test Period 2; Test C*||0||
59615031|NCT01514136|75726153|FG004|COMPLETED|Test Period 2; Test C*||0||
59615032|NCT01514136|75726154|FG005|COMPLETED|Test Period 2; Test C*||0||
59615033|NCT01514136|75726155|FG006|COMPLETED|Test Period 2; Test C*||23||
59615034|NCT01514136|75726156|FG007|COMPLETED|Test Period 2; Test C*||0||
59615035|NCT01514136|75726149|FG000|NOT COMPLETED|Test Period 2; Test C*||0||
59615036|NCT01514136|75726150|FG001|NOT COMPLETED|Test Period 2; Test C*||0||
59615037|NCT01514136|75726151|FG002|NOT COMPLETED|Test Period 2; Test C*||0||
59615038|NCT01514136|75726152|FG003|NOT COMPLETED|Test Period 2; Test C*||0||
59615039|NCT01514136|75726153|FG004|NOT COMPLETED|Test Period 2; Test C*||0||
59615040|NCT01514136|75726154|FG005|NOT COMPLETED|Test Period 2; Test C*||0||
59615041|NCT01514136|75726155|FG006|NOT COMPLETED|Test Period 2; Test C*||3||
59615042|NCT01514136|75726156|FG007|NOT COMPLETED|Test Period 2; Test C*||0||
59615043|NCT01514136|75726149|FG000|STARTED|Test Period; Test D*||0||
59615044|NCT01514136|75726150|FG001|STARTED|Test Period; Test D*||0||
59615045|NCT01514136|75726151|FG002|STARTED|Test Period; Test D*||0||
59615046|NCT01514136|75726152|FG003|STARTED|Test Period; Test D*||0||
59615047|NCT01514136|75726153|FG004|STARTED|Test Period; Test D*||0||
59615048|NCT01514136|75726154|FG005|STARTED|Test Period; Test D*||0||
59615049|NCT01514136|75726155|FG006|STARTED|Test Period; Test D*||0||
59615050|NCT01514136|75726156|FG007|STARTED|Test Period; Test D*||23||
59615051|NCT01514136|75726149|FG000|COMPLETED|Test Period; Test D*||0||
59615052|NCT01514136|75726150|FG001|COMPLETED|Test Period; Test D*||0||
59615053|NCT01514136|75726151|FG002|COMPLETED|Test Period; Test D*||0||
59615054|NCT01514136|75726152|FG003|COMPLETED|Test Period; Test D*||0||
59615055|NCT01514136|75726153|FG004|COMPLETED|Test Period; Test D*||0||
59615056|NCT01514136|75726154|FG005|COMPLETED|Test Period; Test D*||0||
59615057|NCT01514136|75726155|FG006|COMPLETED|Test Period; Test D*||0||
59615058|NCT01514136|75726156|FG007|COMPLETED|Test Period; Test D*||23||
59615059|NCT01514136|75726149|FG000|NOT COMPLETED|Test Period; Test D*||0||
59615060|NCT01514136|75726150|FG001|NOT COMPLETED|Test Period; Test D*||0||
59615061|NCT01514136|75726151|FG002|NOT COMPLETED|Test Period; Test D*||0||
59615062|NCT01514136|75726152|FG003|NOT COMPLETED|Test Period; Test D*||0||
59615063|NCT01514136|75726153|FG004|NOT COMPLETED|Test Period; Test D*||0||
59615064|NCT01514136|75726154|FG005|NOT COMPLETED|Test Period; Test D*||0||
59615065|NCT01514136|75726155|FG006|NOT COMPLETED|Test Period; Test D*||0||
59615066|NCT01514136|75726156|FG007|NOT COMPLETED|Test Period; Test D*||0||
59615067|NCT01513590|75726184|FG000|STARTED|Overall Study||197||
59615068|NCT01513590|75726185|FG001|STARTED|Overall Study||197||
59615069|NCT01513590|75726184|FG000|Exposed|Overall Study|"One (1) subject was withdrawn prior to exposure due to non fulfilment of inclusion criteria"|196||
59615070|NCT01513590|75726185|FG001|Exposed|Overall Study|"Two (2) subjects were withdrawn prior to exposure due to withdrawal of consent"|195||
59615071|NCT01513590|75726184|FG000|COMPLETED|Overall Study||187||
59615072|NCT01513590|75726185|FG001|COMPLETED|Overall Study||184||
59615073|NCT01513590|75726184|FG000|NOT COMPLETED|Overall Study||10||
59615074|NCT01513590|75726185|FG001|NOT COMPLETED|Overall Study||13||
59615075|NCT01512264|75726195|FG000|STARTED|Overall Study||7||
59615076|NCT01512264|75726196|FG001|STARTED|Overall Study||7||
59615077|NCT01512264|75726197|FG002|STARTED|Overall Study||7||
59615078|NCT01512264|75726198|FG003|STARTED|Overall Study||7||
59615079|NCT01512264|75726195|FG000|COMPLETED|Overall Study||7||
59615080|NCT01512264|75726196|FG001|COMPLETED|Overall Study||7||
59615081|NCT01512264|75726197|FG002|COMPLETED|Overall Study||7||
59615082|NCT01512264|75726198|FG003|COMPLETED|Overall Study||6||
59615083|NCT01512264|75726195|FG000|NOT COMPLETED|Overall Study||0||
59615084|NCT01512264|75726196|FG001|NOT COMPLETED|Overall Study||0||
59615085|NCT01512264|75726197|FG002|NOT COMPLETED|Overall Study||0||
59615086|NCT01512264|75726198|FG003|NOT COMPLETED|Overall Study||1||
59615087|NCT01512108|75726210|FG000|STARTED|Overall Study||243||
59615088|NCT01512108|75726211|FG001|STARTED|Overall Study||120||
59615089|NCT01512108|75726210|FG000|Exposed|Overall Study|3 subjects withdrew prior to exposure to trial drug|240||
59615090|NCT01512108|75726211|FG001|Exposed|Overall Study||120||
59615091|NCT01512108|75726210|FG000|COMPLETED|Overall Study||221||
59615092|NCT01512108|75726211|FG001|COMPLETED|Overall Study||111||
59615093|NCT01512108|75726210|FG000|NOT COMPLETED|Overall Study||22||
59520060|NCT01009619|75613923|FG000|COMPLETED|Overall Study||40||
59520061|NCT01009619|75613924|FG001|COMPLETED|Overall Study||43||
59520062|NCT01009619|75613923|FG000|NOT COMPLETED|Overall Study||0||
59520063|NCT01009619|75613924|FG001|NOT COMPLETED|Overall Study||0||
59520064|NCT01010009|75613933|FG000|STARTED|Overall Study||8||
59520065|NCT01010009|75613934|FG001|STARTED|Overall Study||8||
59520066|NCT01010009|75613935|FG002|STARTED|Overall Study||8||
59520067|NCT01010009|75613933|FG000|COMPLETED|Overall Study||8||
59520068|NCT01010009|75613934|FG001|COMPLETED|Overall Study||8||
59520069|NCT01010009|75613935|FG002|COMPLETED|Overall Study||8||
59520070|NCT01010009|75613933|FG000|NOT COMPLETED|Overall Study||0||
59520071|NCT01010009|75613934|FG001|NOT COMPLETED|Overall Study||0||
59520072|NCT01010009|75613935|FG002|NOT COMPLETED|Overall Study||0||
59520073|NCT04467424|75613945|FG000|STARTED|Overall Study||100||
59520074|NCT04467424|75613946|FG001|STARTED|Overall Study||100||
59520075|NCT04467424|75613945|FG000|COMPLETED|Overall Study||100||
59520076|NCT04467424|75613946|FG001|COMPLETED|Overall Study||100||
59520077|NCT04467424|75613945|FG000|NOT COMPLETED|Overall Study||0||
59520078|NCT04467424|75613946|FG001|NOT COMPLETED|Overall Study||0||
59520079|NCT03637348|75613952|FG000|STARTED|Overall Study||45||
59520080|NCT03637348|75613952|FG000|COMPLETED|Overall Study||45||
59520081|NCT03637348|75613952|FG000|NOT COMPLETED|Overall Study||0||
59520082|NCT03928522|75613962|FG000|STARTED|Overall Study||12||
59520083|NCT03928522|75613963|FG001|STARTED|Overall Study||12||
59520084|NCT03928522|75613964|FG002|STARTED|Overall Study||12||
59520085|NCT03928522|75613965|FG003|STARTED|Overall Study||12||
59520086|NCT03928522|75613966|FG004|STARTED|Overall Study||12||
59520087|NCT03928522|75613962|FG000|COMPLETED|Overall Study||12||
59520088|NCT03928522|75613963|FG001|COMPLETED|Overall Study||12||
59520089|NCT03928522|75613964|FG002|COMPLETED|Overall Study||12||
59520090|NCT03928522|75613965|FG003|COMPLETED|Overall Study||12||
59520091|NCT03928522|75613966|FG004|COMPLETED|Overall Study||12||
59520092|NCT03928522|75613962|FG000|NOT COMPLETED|Overall Study||0||
59520093|NCT03928522|75613963|FG001|NOT COMPLETED|Overall Study||0||
59520094|NCT03928522|75613964|FG002|NOT COMPLETED|Overall Study||0||
59520095|NCT03928522|75613965|FG003|NOT COMPLETED|Overall Study||0||
59520096|NCT03928522|75613966|FG004|NOT COMPLETED|Overall Study||0||
59520097|NCT01010399|75613978|FG000|STARTED|Overall Study||36||
59520098|NCT01010399|75613978|FG000|COMPLETED|Overall Study||31||
59520099|NCT01010399|75613978|FG000|NOT COMPLETED|Overall Study||5||
59520100|NCT03638908|75613982|FG000|STARTED|Overall Study||8||
59520101|NCT03638908|75613982|FG000|COMPLETED|Overall Study||7||
59520102|NCT03638908|75613982|FG000|NOT COMPLETED|Overall Study||1||
59520103|NCT01041781|75613992|FG000|STARTED|Overall Study||154||
59520104|NCT01041781|75613993|FG001|STARTED|Overall Study||158||
59520105|NCT01041781|75613992|FG000|COMPLETED|Overall Study||154||
59520106|NCT01041781|75613993|FG001|COMPLETED|Overall Study||158||
59520107|NCT01041781|75613992|FG000|NOT COMPLETED|Overall Study||0||
59520108|NCT01041781|75613993|FG001|NOT COMPLETED|Overall Study||0||
59520109|NCT01010477|75614009|FG000|STARTED|Overall Study||27||
59520110|NCT01010477|75614010|FG001|STARTED|Overall Study||25||
59520111|NCT01010477|75614009|FG000|COMPLETED|Overall Study||21||
59520112|NCT01010477|75614010|FG001|COMPLETED|Overall Study||22||
59520113|NCT01010477|75614009|FG000|NOT COMPLETED|Overall Study||6||
59520114|NCT01010477|75614010|FG001|NOT COMPLETED|Overall Study||3||
59520115|NCT03921190|75614018|FG000|STARTED|Overall Study||56||
59520116|NCT03921190|75614019|FG001|STARTED|Overall Study||64||
59520117|NCT03921190|75614018|FG000|COMPLETED|Overall Study||56||
59520118|NCT03921190|75614019|FG001|COMPLETED|Overall Study||64||
59520119|NCT03921190|75614018|FG000|NOT COMPLETED|Overall Study||0||
59520120|NCT03921190|75614019|FG001|NOT COMPLETED|Overall Study||0||
59520121|NCT00953849|75614031|FG000|STARTED|Overall Study||6||
59520122|NCT00953849|75614032|FG001|STARTED|Overall Study||6||
59520123|NCT00953849|75614033|FG002|STARTED|Overall Study||4||
59520124|NCT00953849|75614034|FG003|STARTED|Overall Study||5||
59520125|NCT00953849|75614031|FG000|COMPLETED|Overall Study||6||
59520126|NCT00953849|75614032|FG001|COMPLETED|Overall Study||6||
59520127|NCT00953849|75614033|FG002|COMPLETED|Overall Study||4||
59520128|NCT00953849|75614034|FG003|COMPLETED|Overall Study||5||
59520129|NCT00953849|75614031|FG000|NOT COMPLETED|Overall Study||0||
59520130|NCT00953849|75614032|FG001|NOT COMPLETED|Overall Study||0||
59520131|NCT00953849|75614033|FG002|NOT COMPLETED|Overall Study||0||
59520132|NCT00953849|75614034|FG003|NOT COMPLETED|Overall Study||0||
59520133|NCT03911752|75614051|FG000|STARTED|Overall Study||8||
59520134|NCT03911752|75614052|FG001|STARTED|Overall Study||2||
59520135|NCT03911752|75614053|FG002|STARTED|Overall Study||2||
59520136|NCT03911752|75614051|FG000|COMPLETED|Overall Study||8||
59520137|NCT03911752|75614052|FG001|COMPLETED|Overall Study||2||
59520138|NCT03911752|75614053|FG002|COMPLETED|Overall Study||2||
59520139|NCT03911752|75614051|FG000|NOT COMPLETED|Overall Study||0||
59520140|NCT03911752|75614052|FG001|NOT COMPLETED|Overall Study||0||
59520141|NCT03911752|75614053|FG002|NOT COMPLETED|Overall Study||0||
59520142|NCT01010555|75614063|FG000|STARTED|First Four Weeks of Wear||11||
59520143|NCT01010555|75614064|FG001|STARTED|First Four Weeks of Wear||10||
59520144|NCT01010555|75614063|FG000|COMPLETED|First Four Weeks of Wear|One participant who completed Period 1 did not start Period 2. Relocation.|11||
59615094|NCT01512108|75726211|FG001|NOT COMPLETED|Overall Study||9||
59615095|NCT01486758|75726219|FG000|STARTED|Overall Study||20||
59615096|NCT01486758|75726220|FG001|STARTED|Overall Study||20||
59615097|NCT01486758|75726219|FG000|COMPLETED|Overall Study||20||
59615098|NCT01486758|75726220|FG001|COMPLETED|Overall Study||19||
59615099|NCT01486758|75726219|FG000|NOT COMPLETED|Overall Study||0||
59615100|NCT01486758|75726220|FG001|NOT COMPLETED|Overall Study||1||
59615101|NCT01463982|75726231|FG000|STARTED|Overall Study||3||
59615102|NCT01463982|75726232|FG001|STARTED|Overall Study||8||
59615103|NCT01463982|75726233|FG002|STARTED|Overall Study||4||
59615104|NCT01463982|75726234|FG003|STARTED|Overall Study||6||
59615105|NCT01463982|75726231|FG000|COMPLETED|Overall Study||3||
59615106|NCT01463982|75726232|FG001|COMPLETED|Overall Study||7||
59615107|NCT01463982|75726233|FG002|COMPLETED|Overall Study||2||
59615108|NCT01463982|75726234|FG003|COMPLETED|Overall Study||6||
59615109|NCT01463982|75726231|FG000|NOT COMPLETED|Overall Study||0||
59615110|NCT01463982|75726232|FG001|NOT COMPLETED|Overall Study||1||
59615111|NCT01463982|75726233|FG002|NOT COMPLETED|Overall Study||2||
59615112|NCT01463982|75726234|FG003|NOT COMPLETED|Overall Study||0||
59615113|NCT01486446|75726246|FG000|STARTED|Overall Study||7||
59615114|NCT01486446|75726247|FG001|STARTED|Overall Study||1||
59615115|NCT01486446|75726246|FG000|COMPLETED|Overall Study||6||
59615116|NCT01486446|75726247|FG001|COMPLETED|Overall Study||1||
59615117|NCT01486446|75726246|FG000|NOT COMPLETED|Overall Study||1||
59615118|NCT01486446|75726247|FG001|NOT COMPLETED|Overall Study||0||
59615119|NCT01485354|75726253|FG000|STARTED|Overall Study||17||
59615120|NCT01485354|75726253|FG000|COMPLETED|Overall Study||12||
59615121|NCT01485354|75726253|FG000|NOT COMPLETED|Overall Study||5||
59615122|NCT01510158|75726260|FG000|STARTED|Overall Study||202||
59615123|NCT01510158|75726261|FG001|STARTED|Overall Study||203||
59615124|NCT01510158|75726262|FG002|STARTED|Overall Study||202||
59615125|NCT01510158|75726260|FG000|COMPLETED|Overall Study||151||
59615126|NCT01510158|75726261|FG001|COMPLETED|Overall Study||150||
59615127|NCT01510158|75726262|FG002|COMPLETED|Overall Study||152||
59615128|NCT01510158|75726260|FG000|NOT COMPLETED|Overall Study||51||
59615129|NCT01510158|75726261|FG001|NOT COMPLETED|Overall Study||53||
59615130|NCT01510158|75726262|FG002|NOT COMPLETED|Overall Study||50||
59615131|NCT04080882|75726272|FG000|STARTED|Overall Study||20||
59615132|NCT04080882|75726273|FG001|STARTED|Overall Study||60||
59615133|NCT04080882|75726272|FG000|COMPLETED|Overall Study||18||
59615134|NCT04080882|75726273|FG001|COMPLETED|Overall Study||58||
59615135|NCT04080882|75726272|FG000|NOT COMPLETED|Overall Study||2||
59615136|NCT04080882|75726273|FG001|NOT COMPLETED|Overall Study||2||
59615137|NCT01485120|75726279|FG000|STARTED|Overall Study||34||
59615138|NCT01485120|75726279|FG000|COMPLETED|Overall Study||32||
59615139|NCT01485120|75726279|FG000|NOT COMPLETED|Overall Study||2||
59615140|NCT01484496|75726286|FG000|STARTED|Period 1||280||
59615141|NCT01484496|75726287|FG001|STARTED|Period 1||556||
59615142|NCT01484496|75726288|FG002|STARTED|Period 1||0||
59615143|NCT01484496|75726289|FG003|STARTED|Period 1||0||
59615144|NCT01484496|75726286|FG000|COMPLETED|Period 1||214||
59615145|NCT01484496|75726287|FG001|COMPLETED|Period 1||463||
59615146|NCT01484496|75726288|FG002|COMPLETED|Period 1||0||
59615147|NCT01484496|75726289|FG003|COMPLETED|Period 1||0||
59615148|NCT01484496|75726286|FG000|NOT COMPLETED|Period 1||66||
59615149|NCT01484496|75726287|FG001|NOT COMPLETED|Period 1||93||
59615150|NCT01484496|75726288|FG002|NOT COMPLETED|Period 1||0||
59615151|NCT01484496|75726289|FG003|NOT COMPLETED|Period 1||0||
59615152|NCT01484496|75726286|FG000|STARTED|Period 2||0||
59615153|NCT01484496|75726287|FG001|STARTED|Period 2||0||
59615154|NCT01484496|75726288|FG002|STARTED|Period 2||206||
59615155|NCT01484496|75726289|FG003|STARTED|Period 2||456||
59615156|NCT01484496|75726286|FG000|COMPLETED|Period 2||0||
59615157|NCT01484496|75726287|FG001|COMPLETED|Period 2||0||
59615158|NCT01484496|75726288|FG002|COMPLETED|Period 2||191||
59615159|NCT01484496|75726289|FG003|COMPLETED|Period 2||434||
59615160|NCT01484496|75726286|FG000|NOT COMPLETED|Period 2||0||
59615161|NCT01484496|75726287|FG001|NOT COMPLETED|Period 2||0||
59615162|NCT01484496|75726288|FG002|NOT COMPLETED|Period 2||15||
59615163|NCT01484496|75726289|FG003|NOT COMPLETED|Period 2||22||
59615164|NCT01509846|75726302|FG000|STARTED|Received Vaccination 1||5||
59615165|NCT01509846|75726303|FG001|STARTED|Received Vaccination 1||20||
59615166|NCT01509846|75726304|FG002|STARTED|Received Vaccination 1||20||
59615167|NCT01509846|75726305|FG003|STARTED|Received Vaccination 1||20||
59615168|NCT01509846|75726306|FG004|STARTED|Received Vaccination 1||17||
59615169|NCT01509846|75726302|FG000|COMPLETED|Received Vaccination 1||5||
59615170|NCT01509846|75726303|FG001|COMPLETED|Received Vaccination 1||20||
59615171|NCT01509846|75726304|FG002|COMPLETED|Received Vaccination 1||20||
59615172|NCT01509846|75726305|FG003|COMPLETED|Received Vaccination 1||20||
59615173|NCT01509846|75726306|FG004|COMPLETED|Received Vaccination 1||17||
59615174|NCT01509846|75726302|FG000|NOT COMPLETED|Received Vaccination 1||0||
59615175|NCT01509846|75726303|FG001|NOT COMPLETED|Received Vaccination 1||0||
59615176|NCT01509846|75726304|FG002|NOT COMPLETED|Received Vaccination 1||0||
59615177|NCT01509846|75726305|FG003|NOT COMPLETED|Received Vaccination 1||0||
59615178|NCT01509846|75726306|FG004|NOT COMPLETED|Received Vaccination 1||0||
59615179|NCT01509846|75726302|FG000|STARTED|Received Vaccination 2||5||
59615180|NCT01509846|75726303|FG001|STARTED|Received Vaccination 2||20||
59615181|NCT01509846|75726304|FG002|STARTED|Received Vaccination 2||20||
59615182|NCT01509846|75726305|FG003|STARTED|Received Vaccination 2||20||
59615183|NCT01509846|75726306|FG004|STARTED|Received Vaccination 2||17||
59615184|NCT01509846|75726302|FG000|COMPLETED|Received Vaccination 2||0||
59615185|NCT01509846|75726303|FG001|COMPLETED|Received Vaccination 2||20||
59615186|NCT01509846|75726304|FG002|COMPLETED|Received Vaccination 2||19||
59615187|NCT01509846|75726305|FG003|COMPLETED|Received Vaccination 2||20||
59615188|NCT01509846|75726306|FG004|COMPLETED|Received Vaccination 2||14||
59615189|NCT01509846|75726302|FG000|NOT COMPLETED|Received Vaccination 2||5||
59615190|NCT01509846|75726303|FG001|NOT COMPLETED|Received Vaccination 2||0||
59615191|NCT01509846|75726304|FG002|NOT COMPLETED|Received Vaccination 2||1||
59615192|NCT01509846|75726305|FG003|NOT COMPLETED|Received Vaccination 2||0||
59615193|NCT01509846|75726306|FG004|NOT COMPLETED|Received Vaccination 2||3||
59615194|NCT01509846|75726302|FG000|STARTED|Received Vaccination 3||0||
59615195|NCT01509846|75726303|FG001|STARTED|Received Vaccination 3||20||
59615196|NCT01509846|75726304|FG002|STARTED|Received Vaccination 3||19||
59615197|NCT01509846|75726305|FG003|STARTED|Received Vaccination 3||20||
59615198|NCT01509846|75726306|FG004|STARTED|Received Vaccination 3||14||
59615199|NCT01509846|75726302|FG000|COMPLETED|Received Vaccination 3||0||
59615200|NCT01509846|75726303|FG001|COMPLETED|Received Vaccination 3||19||
59615201|NCT01509846|75726304|FG002|COMPLETED|Received Vaccination 3||18||
59615202|NCT01509846|75726305|FG003|COMPLETED|Received Vaccination 3||19||
59615203|NCT01509846|75726306|FG004|COMPLETED|Received Vaccination 3||14||
59615204|NCT01509846|75726302|FG000|NOT COMPLETED|Received Vaccination 3||0||
59615205|NCT01509846|75726303|FG001|NOT COMPLETED|Received Vaccination 3||1||
59615206|NCT01509846|75726304|FG002|NOT COMPLETED|Received Vaccination 3||1||
59615207|NCT01509846|75726305|FG003|NOT COMPLETED|Received Vaccination 3||1||
59615208|NCT01509846|75726306|FG004|NOT COMPLETED|Received Vaccination 3||0||
59615209|NCT01462344|75726327|FG000|STARTED|Overall Study||3107||
59615210|NCT01462344|75726328|FG001|STARTED|Overall Study||3101||
59615211|NCT01462344|75726327|FG000|COMPLETED|Overall Study||2724||
59615212|NCT01462344|75726328|FG001|COMPLETED|Overall Study||2751||
59615213|NCT01462344|75726327|FG000|NOT COMPLETED|Overall Study||383||
59615214|NCT01462344|75726328|FG001|NOT COMPLETED|Overall Study||350||
59615215|NCT01484028|75726334|FG000|STARTED|Period 1||66||
59615216|NCT01484028|75726335|FG001|STARTED|Period 1||70||
59615217|NCT01484028|75726336|FG002|STARTED|Period 1||64||
59615218|NCT01484028|75726337|FG003|STARTED|Period 1||67||
59615219|NCT01484028|75726334|FG000|COMPLETED|Period 1||66||
59615220|NCT01484028|75726335|FG001|COMPLETED|Period 1||67||
59615221|NCT01484028|75726336|FG002|COMPLETED|Period 1||64||
59615222|NCT01484028|75726337|FG003|COMPLETED|Period 1||66||
59615223|NCT01484028|75726334|FG000|NOT COMPLETED|Period 1||0||
59615224|NCT01484028|75726335|FG001|NOT COMPLETED|Period 1||3||
59615225|NCT01484028|75726336|FG002|NOT COMPLETED|Period 1||0||
59615226|NCT01484028|75726337|FG003|NOT COMPLETED|Period 1||1||
59615227|NCT01484028|75726334|FG000|STARTED|Period 2||66||
59615228|NCT01484028|75726335|FG001|STARTED|Period 2||67||
59615229|NCT01484028|75726336|FG002|STARTED|Period 2||64||
59615230|NCT01484028|75726337|FG003|STARTED|Period 2||66||
59615231|NCT01484028|75726334|FG000|COMPLETED|Period 2||66||
59615232|NCT01484028|75726335|FG001|COMPLETED|Period 2||67||
59615233|NCT01484028|75726336|FG002|COMPLETED|Period 2||64||
59615234|NCT01484028|75726337|FG003|COMPLETED|Period 2||66||
59615235|NCT01484028|75726334|FG000|NOT COMPLETED|Period 2||0||
59615236|NCT01484028|75726335|FG001|NOT COMPLETED|Period 2||0||
59615237|NCT01484028|75726336|FG002|NOT COMPLETED|Period 2||0||
59615238|NCT01484028|75726337|FG003|NOT COMPLETED|Period 2||0||
59615239|NCT01462266|75726347|FG000|STARTED|Overall Study||330||
59615240|NCT01462266|75726348|FG001|STARTED|Overall Study||330||
59615241|NCT01462266|75726347|FG000|Treated|Overall Study|One participant was randomized in error and did not receive study medication.|329||
59615242|NCT01462266|75726348|FG001|Treated|Overall Study|One participant was randomized in error and did not receive study medication.|329||
59615243|NCT01462266|75726347|FG000|COMPLETED|Overall Study||295||
59615244|NCT01462266|75726348|FG001|COMPLETED|Overall Study||303||
59615245|NCT01462266|75726347|FG000|NOT COMPLETED|Overall Study||35||
59615246|NCT01462266|75726348|FG001|NOT COMPLETED|Overall Study||27||
59615247|NCT01508910|75726357|FG000|STARTED|Randomization||57||
59615248|NCT01508910|75726358|FG001|STARTED|Randomization||27||
59615249|NCT01508910|75726359|FG002|STARTED|Randomization||28||
59615250|NCT01508910|75726360|FG003|STARTED|Randomization|Participants not randomized into Not Injected arm, but some were re-assigned here during treatment.|0||
59615251|NCT01508910|75726357|FG000|COMPLETED|Randomization||57||
59615252|NCT01508910|75726358|FG001|COMPLETED|Randomization||27||
59615253|NCT01508910|75726359|FG002|COMPLETED|Randomization||28||
59615254|NCT01508910|75726360|FG003|COMPLETED|Randomization||0||
59615255|NCT01508910|75726357|FG000|NOT COMPLETED|Randomization||0||
59615256|NCT01508910|75726358|FG001|NOT COMPLETED|Randomization||0||
59615257|NCT01508910|75726359|FG002|NOT COMPLETED|Randomization||0||
59615258|NCT01508910|75726360|FG003|NOT COMPLETED|Randomization||0||
59615259|NCT01508910|75726357|FG000|STARTED|Treatment||50||
59615260|NCT01508910|75726358|FG001|STARTED|Treatment||28||
59615261|NCT01508910|75726359|FG002|STARTED|Treatment||28||
59520145|NCT01010555|75614064|FG001|COMPLETED|First Four Weeks of Wear|One participant who completed Period 1 did not start Period 2. Non-compliance with visit schedule.|10||
59520146|NCT01010555|75614063|FG000|NOT COMPLETED|First Four Weeks of Wear||0||
59520147|NCT01010555|75614064|FG001|NOT COMPLETED|First Four Weeks of Wear||0||
59520148|NCT01010555|75614063|FG000|STARTED|Second Four Weeks of Wear||10||
59520149|NCT01010555|75614064|FG001|STARTED|Second Four Weeks of Wear||9||
59520150|NCT01010555|75614063|FG000|COMPLETED|Second Four Weeks of Wear||10||
59520151|NCT01010555|75614064|FG001|COMPLETED|Second Four Weeks of Wear||9||
59520152|NCT01010555|75614063|FG000|NOT COMPLETED|Second Four Weeks of Wear||0||
59520153|NCT01010555|75614064|FG001|NOT COMPLETED|Second Four Weeks of Wear||0||
59520154|NCT04425850|75614076|FG000|STARTED|Overall Study|Standard prophylactic measures and PPE + iota carrageenan (nasal and buccal) and ivermectin (buccal)|131||
59520155|NCT04425850|75614077|FG001|STARTED|Overall Study|Standard prophylactic measures and PPE only|98||
59520156|NCT04425850|75614076|FG000|COMPLETED|Overall Study||131||
59520157|NCT04425850|75614077|FG001|COMPLETED|Overall Study||98||
59520158|NCT04425850|75614076|FG000|NOT COMPLETED|Overall Study||0||
59520159|NCT04425850|75614077|FG001|NOT COMPLETED|Overall Study||0||
59520160|NCT01011179|75614087|FG000|STARTED|Overall Study||24||
59520161|NCT01011179|75614088|FG001|STARTED|Overall Study||22||
59520162|NCT01011179|75614087|FG000|COMPLETED|Overall Study||20||
59520163|NCT01011179|75614088|FG001|COMPLETED|Overall Study||20||
59520164|NCT01011179|75614087|FG000|NOT COMPLETED|Overall Study||4||
59520165|NCT01011179|75614088|FG001|NOT COMPLETED|Overall Study||2||
59520166|NCT03639766|75614096|FG000|STARTED|Overall Study||3||
59520167|NCT03639766|75614096|FG000|COMPLETED|Overall Study||3||
59520168|NCT03639766|75614096|FG000|NOT COMPLETED|Overall Study||0||
59520169|NCT03641716|75614102|FG000|STARTED|Overall Study||20||
59520170|NCT03641716|75614102|FG000|COMPLETED|Overall Study||15||
59520171|NCT03641716|75614102|FG000|NOT COMPLETED|Overall Study||5||
59520172|NCT01042795|75614106|FG000|STARTED|Dosing Period - 16 Weeks of Daily Doses||7||
59520173|NCT01042795|75614106|FG000|COMPLETED|Dosing Period - 16 Weeks of Daily Doses||2||
59520174|NCT01042795|75614106|FG000|NOT COMPLETED|Dosing Period - 16 Weeks of Daily Doses||5||
59520175|NCT01042795|75614106|FG000|STARTED|Follow up - 22 Months After Drug Start||2||
59520176|NCT01042795|75614106|FG000|COMPLETED|Follow up - 22 Months After Drug Start||0||
59520177|NCT01042795|75614106|FG000|NOT COMPLETED|Follow up - 22 Months After Drug Start||2||
59520178|NCT03644212|75614112|FG000|STARTED|Overall Study||63||
59520179|NCT03644212|75614113|FG001|STARTED|Overall Study||16||
59520180|NCT03644212|75614112|FG000|COMPLETED|Overall Study||63||
59520181|NCT03644212|75614113|FG001|COMPLETED|Overall Study||16||
59520182|NCT03644212|75614112|FG000|NOT COMPLETED|Overall Study||0||
59520183|NCT03644212|75614113|FG001|NOT COMPLETED|Overall Study||0||
59520184|NCT01043653|75614119|FG000|STARTED|Overall Study||250||
59520185|NCT01043653|75614119|FG000|COMPLETED|Overall Study||186||
59520186|NCT01043653|75614119|FG000|NOT COMPLETED|Overall Study||64||
59520187|NCT03906448|75614125|FG000|STARTED|Overall Study||1||
59520188|NCT03906448|75614126|FG001|STARTED|Overall Study||0||
59520189|NCT03906448|75614125|FG000|COMPLETED|Overall Study||1||
59520190|NCT03906448|75614126|FG001|COMPLETED|Overall Study||0||
59520191|NCT03906448|75614125|FG000|NOT COMPLETED|Overall Study||0||
59520192|NCT03906448|75614126|FG001|NOT COMPLETED|Overall Study||0||
59520193|NCT03897634|75614132|FG000|STARTED|Overall Study||22||
59520194|NCT03897634|75614132|FG000|COMPLETED|Overall Study||22||
59520195|NCT03897634|75614132|FG000|NOT COMPLETED|Overall Study||0||
59520196|NCT01011413|75614138|FG000|STARTED|Overall Study|312 randomised|312||
59520197|NCT01011413|75614139|FG001|STARTED|Overall Study|324 randomised|324||
59520198|NCT01011413|75614138|FG000|Did Not Start Study Drug|Overall Study||3||
59520199|NCT01011413|75614139|FG001|Did Not Start Study Drug|Overall Study||3||
59520200|NCT01011413|75614138|FG000|In Modified ITT|Overall Study||309||
59520201|NCT01011413|75614139|FG001|In Modified ITT|Overall Study||321||
59520202|NCT01011413|75614138|FG000|Died Before Week 48|Overall Study||3||
59520203|NCT01011413|75614139|FG001|Died Before Week 48|Overall Study||2||
59520204|NCT01011413|75614138|FG000|Lost to Follow up Before w48|Overall Study||3||
59520205|NCT01011413|75614139|FG001|Lost to Follow up Before w48|Overall Study||4||
59520206|NCT01011413|75614138|FG000|Withdrew Consent Before w48|Overall Study||3||
59520207|NCT01011413|75614139|FG001|Withdrew Consent Before w48|Overall Study||3||
59520208|NCT01011413|75614138|FG000|Attended w48 Visit|Overall Study||295||
59520209|NCT01011413|75614139|FG001|Attended w48 Visit|Overall Study||311||
59520210|NCT01011413|75614138|FG000|Died Between Week 48 and 96|Overall Study||2||
59520211|NCT01011413|75614139|FG001|Died Between Week 48 and 96|Overall Study||3||
59520212|NCT01011413|75614138|FG000|Withdrew Consent Between Week 48 and 96|Overall Study||2||
59520213|NCT01011413|75614139|FG001|Withdrew Consent Between Week 48 and 96|Overall Study||6||
59520214|NCT01011413|75614138|FG000|Lost to Follow-up Between Week 48 and 96|Overall Study||10||
59520215|NCT01011413|75614139|FG001|Lost to Follow-up Between Week 48 and 96|Overall Study||4||
59520216|NCT01011413|75614138|FG000|COMPLETED|Overall Study||286||
59520217|NCT01011413|75614139|FG001|COMPLETED|Overall Study||299||
59520218|NCT01011413|75614138|FG000|NOT COMPLETED|Overall Study||26||
59520219|NCT01011413|75614139|FG001|NOT COMPLETED|Overall Study||25||
59520220|NCT03889444|75614152|FG000|STARTED|Overall Study||141||
59520221|NCT03889444|75614152|FG000|COMPLETED|Overall Study||141||
59615262|NCT01508910|75726360|FG003|STARTED|Treatment|3 moved from Treatment (Tx) to Active Control (AC) Arm; 6 in Not injected Arm(4 from Tx ; 2 from AC)|6||
59615263|NCT01508910|75726357|FG000|COMPLETED|Treatment||48||
59615264|NCT01508910|75726358|FG001|COMPLETED|Treatment||24||
59615265|NCT01508910|75726359|FG002|COMPLETED|Treatment||18||
59615266|NCT01508910|75726360|FG003|COMPLETED|Treatment||3||
59615267|NCT01508910|75726357|FG000|NOT COMPLETED|Treatment||2||
59615268|NCT01508910|75726358|FG001|NOT COMPLETED|Treatment||4||
59615269|NCT01508910|75726359|FG002|NOT COMPLETED|Treatment||10||
59615270|NCT01508910|75726360|FG003|NOT COMPLETED|Treatment||3||
59615271|NCT01462110|75726374|FG000|STARTED|Overall Study||44||
59615272|NCT01462110|75726375|FG001|STARTED|Overall Study||43||
59615273|NCT01462110|75726374|FG000|COMPLETED|Overall Study||43||
59615274|NCT01462110|75726375|FG001|COMPLETED|Overall Study||43||
59615275|NCT01462110|75726374|FG000|NOT COMPLETED|Overall Study||1||
59615276|NCT01462110|75726375|FG001|NOT COMPLETED|Overall Study||0||
59615277|NCT01508676|75726383|FG000|STARTED|Phase I (2 Weeks)||18||
59615278|NCT01508676|75726384|FG001|STARTED|Phase I (2 Weeks)||17||
59615279|NCT01508676|75726383|FG000|COMPLETED|Phase I (2 Weeks)||16||
59615280|NCT01508676|75726384|FG001|COMPLETED|Phase I (2 Weeks)||14||
59615281|NCT01508676|75726383|FG000|NOT COMPLETED|Phase I (2 Weeks)||2||
59615282|NCT01508676|75726384|FG001|NOT COMPLETED|Phase I (2 Weeks)||3||
59615283|NCT01508676|75726383|FG000|STARTED|Washout Period (1 Week)||16||
59615284|NCT01508676|75726384|FG001|STARTED|Washout Period (1 Week)||14||
59615285|NCT01508676|75726383|FG000|COMPLETED|Washout Period (1 Week)||16||
59615286|NCT01508676|75726384|FG001|COMPLETED|Washout Period (1 Week)||14||
59615287|NCT01508676|75726383|FG000|NOT COMPLETED|Washout Period (1 Week)||0||
59615288|NCT01508676|75726384|FG001|NOT COMPLETED|Washout Period (1 Week)||0||
59615289|NCT01508676|75726383|FG000|STARTED|Phase II (2 Weeks)||16||
59615290|NCT01508676|75726384|FG001|STARTED|Phase II (2 Weeks)||14||
59615291|NCT01508676|75726383|FG000|COMPLETED|Phase II (2 Weeks)||15||
59615292|NCT01508676|75726384|FG001|COMPLETED|Phase II (2 Weeks)||13||
59615293|NCT01508676|75726383|FG000|NOT COMPLETED|Phase II (2 Weeks)||1||
59615294|NCT01508676|75726384|FG001|NOT COMPLETED|Phase II (2 Weeks)||1||
59615295|NCT01508130|75726393|FG000|STARTED|Overall Study||493||
59615296|NCT01508130|75726394|FG001|STARTED|Overall Study||142||
59615297|NCT01508130|75726393|FG000|mTRT|Overall Study||493||
59615298|NCT01508130|75726394|FG001|mTRT|Overall Study||142||
59615299|NCT01508130|75726393|FG000|COMPLETED|Overall Study||266||
59615300|NCT01508130|75726394|FG001|COMPLETED|Overall Study||73||
59615301|NCT01508130|75726393|FG000|NOT COMPLETED|Overall Study||227||
59615302|NCT01508130|75726394|FG001|NOT COMPLETED|Overall Study||69||
59615303|NCT01482312|75726402|FG000|STARTED|Period 1, 90 Minutes of Wear||10||
59615304|NCT01482312|75726403|FG001|STARTED|Period 1, 90 Minutes of Wear||9||
59615305|NCT01482312|75726404|FG002|STARTED|Period 1, 90 Minutes of Wear||10||
59615306|NCT01482312|75726402|FG000|COMPLETED|Period 1, 90 Minutes of Wear||9||
59615307|NCT01482312|75726403|FG001|COMPLETED|Period 1, 90 Minutes of Wear||9||
59615308|NCT01482312|75726404|FG002|COMPLETED|Period 1, 90 Minutes of Wear||10||
59615309|NCT01482312|75726402|FG000|NOT COMPLETED|Period 1, 90 Minutes of Wear||1||
59615310|NCT01482312|75726403|FG001|NOT COMPLETED|Period 1, 90 Minutes of Wear||0||
59615311|NCT01482312|75726404|FG002|NOT COMPLETED|Period 1, 90 Minutes of Wear||0||
59615312|NCT01482312|75726402|FG000|STARTED|Period 2, 90 Minutes of Wear||9||
59615313|NCT01482312|75726403|FG001|STARTED|Period 2, 90 Minutes of Wear||9||
59615314|NCT01482312|75726404|FG002|STARTED|Period 2, 90 Minutes of Wear|One participant discontinued between Period 1 and Period 2|9||
59615315|NCT01482312|75726402|FG000|COMPLETED|Period 2, 90 Minutes of Wear||8||
59615316|NCT01482312|75726403|FG001|COMPLETED|Period 2, 90 Minutes of Wear||9||
59615317|NCT01482312|75726404|FG002|COMPLETED|Period 2, 90 Minutes of Wear||9||
59615318|NCT01482312|75726402|FG000|NOT COMPLETED|Period 2, 90 Minutes of Wear||1||
59615319|NCT01482312|75726403|FG001|NOT COMPLETED|Period 2, 90 Minutes of Wear||0||
59615320|NCT01482312|75726404|FG002|NOT COMPLETED|Period 2, 90 Minutes of Wear||0||
59615321|NCT01482312|75726402|FG000|STARTED|Period 3, 90 Minutes of Wear||8||
59615322|NCT01482312|75726403|FG001|STARTED|Period 3, 90 Minutes of Wear||9||
59615323|NCT01482312|75726404|FG002|STARTED|Period 3, 90 Minutes of Wear||9||
59615324|NCT01482312|75726402|FG000|COMPLETED|Period 3, 90 Minutes of Wear||8||
59615325|NCT01482312|75726403|FG001|COMPLETED|Period 3, 90 Minutes of Wear||9||
59615326|NCT01482312|75726404|FG002|COMPLETED|Period 3, 90 Minutes of Wear||9||
59615327|NCT01482312|75726402|FG000|NOT COMPLETED|Period 3, 90 Minutes of Wear||0||
59615328|NCT01482312|75726403|FG001|NOT COMPLETED|Period 3, 90 Minutes of Wear||0||
59615329|NCT01482312|75726404|FG002|NOT COMPLETED|Period 3, 90 Minutes of Wear||0||
59615330|NCT01461096|75726414|FG000|STARTED|Overall Study||288||
59615331|NCT01461096|75726415|FG001|STARTED|Overall Study||287||
59615332|NCT01461096|75726414|FG000|Did Not Start Treatment|Overall Study||0||
59615333|NCT01461096|75726415|FG001|Did Not Start Treatment|Overall Study|Randomized but never started treatment and was discontinued from the study|1||
59615334|NCT01461096|75726414|FG000|COMPLETED|Overall Study||226|Unexpected closure of study. Completed study requirements up to the time of unexpected closure.|
59615335|NCT01461096|75726415|FG001|COMPLETED|Overall Study||226|Unexpected closure of study. Completed study requirements up to the time of unexpected closure.|
59615336|NCT01461096|75726414|FG000|NOT COMPLETED|Overall Study||62||
59615337|NCT01461096|75726415|FG001|NOT COMPLETED|Overall Study||61||
59615338|NCT01507896|75726422|FG000|STARTED|Overall Study|30 unique participants had 40 surgeries planned (participants could have multiple surgeries).|30||
59615339|NCT01507896|75726422|FG000|COMPLETED|Overall Study|28 unique participants had 38 surgeries (participants could have multiple surgeries).|28||
59615340|NCT01507896|75726422|FG000|NOT COMPLETED|Overall Study||2||
59615341|NCT01507662|75726437|FG000|STARTED|Overall Study||3898||
59615342|NCT01507662|75726438|FG001|STARTED|Overall Study||3851||
59615343|NCT01507662|75726437|FG000|COMPLETED|Overall Study||3082||
59615344|NCT01507662|75726438|FG001|COMPLETED|Overall Study||3020||
59615345|NCT01507662|75726437|FG000|NOT COMPLETED|Overall Study||816||
59615346|NCT01507662|75726438|FG001|NOT COMPLETED|Overall Study||831||
59615347|NCT01506960|75726444|FG000|STARTED|Overall Study||64||
59615348|NCT01506960|75726444|FG000|COMPLETED|Overall Study||17||
59615349|NCT01506960|75726444|FG000|NOT COMPLETED|Overall Study||47||
59615350|NCT01480674|75726450|FG000|STARTED|Overall Study||160||
59615351|NCT01480674|75726450|FG000|Safety Set|Overall Study||154||
59615352|NCT01480674|75726450|FG000|Analysed Set|Overall Study||128||
59615353|NCT01480674|75726450|FG000|COMPLETED|Overall Study||125||
59615354|NCT01480674|75726450|FG000|NOT COMPLETED|Overall Study||35||
59615355|NCT01506882|75726456|FG000|STARTED|Overall Study||61||
59615356|NCT01506882|75726457|FG001|STARTED|Overall Study||10||
59615357|NCT01506882|75726456|FG000|COMPLETED|Overall Study||39||
59615358|NCT01506882|75726457|FG001|COMPLETED|Overall Study||3||
59615359|NCT01506882|75726456|FG000|NOT COMPLETED|Overall Study||22||
59615360|NCT01506882|75726457|FG001|NOT COMPLETED|Overall Study||7||
59615361|NCT01506726|75726467|FG000|STARTED|Overall Study||6||
59615362|NCT01506726|75726468|FG001|STARTED|Overall Study||5||
59615363|NCT01506726|75726467|FG000|COMPLETED|Overall Study||5||
59615364|NCT01506726|75726468|FG001|COMPLETED|Overall Study||3||
59615365|NCT01506726|75726467|FG000|NOT COMPLETED|Overall Study||1||
59615366|NCT01506726|75726468|FG001|NOT COMPLETED|Overall Study||2||
59615367|NCT01505868|75726479|FG000|STARTED|Overall Study||4||
59615368|NCT01505868|75726480|FG001|STARTED|Overall Study||3||
59615369|NCT01505868|75726481|FG002|STARTED|Overall Study||3||
59615370|NCT01505868|75726482|FG003|STARTED|Overall Study||79||
59615371|NCT01505868|75726483|FG004|STARTED|Overall Study||81||
59615372|NCT01505868|75726479|FG000|COMPLETED|Overall Study||3||
59615373|NCT01505868|75726480|FG001|COMPLETED|Overall Study||3||
59615374|NCT01505868|75726481|FG002|COMPLETED|Overall Study||3||
59615375|NCT01505868|75726482|FG003|COMPLETED|Overall Study||79||
59615376|NCT01505868|75726483|FG004|COMPLETED|Overall Study||81||
59615377|NCT01505868|75726479|FG000|NOT COMPLETED|Overall Study||1||
59615378|NCT01505868|75726480|FG001|NOT COMPLETED|Overall Study||0||
59615379|NCT01505868|75726481|FG002|NOT COMPLETED|Overall Study||0||
59615380|NCT01505868|75726482|FG003|NOT COMPLETED|Overall Study||0||
59615381|NCT01505868|75726483|FG004|NOT COMPLETED|Overall Study||0||
59615382|NCT01505634|75726498|FG000|STARTED|Overall Study||101||
59615383|NCT01505634|75726499|FG001|STARTED|Overall Study||101||
59615384|NCT01505634|75726500|FG002|STARTED|Overall Study||100||
59615385|NCT01505634|75726498|FG000|Treated|Overall Study||99||
59615386|NCT01505634|75726499|FG001|Treated|Overall Study||99||
59615387|NCT01505634|75726500|FG002|Treated|Overall Study||100||
59615388|NCT01505634|75726498|FG000|COMPLETED|Overall Study||92||
59615389|NCT01505634|75726499|FG001|COMPLETED|Overall Study||91||
59615390|NCT01505634|75726500|FG002|COMPLETED|Overall Study||94||
59615391|NCT01505634|75726498|FG000|NOT COMPLETED|Overall Study||9||
59615392|NCT01505634|75726499|FG001|NOT COMPLETED|Overall Study||10||
59615393|NCT01505634|75726500|FG002|NOT COMPLETED|Overall Study||6||
59615394|NCT01460628|75726508|FG000|STARTED|Overall Study||25||
59615395|NCT01460628|75726508|FG000|COMPLETED|Overall Study||20||
59615396|NCT01460628|75726508|FG000|NOT COMPLETED|Overall Study||5||
59615397|NCT01480596|75726514|FG000|STARTED|Overall Study||22||
59615398|NCT01480596|75726515|FG001|STARTED|Overall Study||18||
59615399|NCT01480596|75726514|FG000|COMPLETED|Overall Study||17||
59615400|NCT01480596|75726515|FG001|COMPLETED|Overall Study||16||
59615401|NCT01480596|75726514|FG000|NOT COMPLETED|Overall Study||5||
59615402|NCT01480596|75726515|FG001|NOT COMPLETED|Overall Study||2||
59615403|NCT01480284|75726523|FG000|STARTED|Overall Study||110||
59615404|NCT01480284|75726524|FG001|STARTED|Overall Study||56||
59615405|NCT01480284|75726523|FG000|COMPLETED|Overall Study||102||
59615406|NCT01480284|75726524|FG001|COMPLETED|Overall Study||56||
59615407|NCT01480284|75726523|FG000|NOT COMPLETED|Overall Study||8||
59615408|NCT01480284|75726524|FG001|NOT COMPLETED|Overall Study||0||
59615409|NCT01459614|75726532|FG000|STARTED|Overall Study||29||
59615410|NCT01459614|75726533|FG001|STARTED|Overall Study||10||
59615411|NCT01459614|75726532|FG000|COMPLETED|Overall Study||28||
59615412|NCT01459614|75726533|FG001|COMPLETED|Overall Study||10||
59615413|NCT01459614|75726532|FG000|NOT COMPLETED|Overall Study||1||
59615414|NCT01459614|75726533|FG001|NOT COMPLETED|Overall Study||0||
59615415|NCT01458522|75726541|FG000|STARTED|Overall Study||37||
59615416|NCT01458522|75726542|FG001|STARTED|Overall Study||37||
59615417|NCT01458522|75726541|FG000|Received First Drug|Overall Study||35||
59615418|NCT01458522|75726542|FG001|Received First Drug|Overall Study||35||
59615419|NCT01458522|75726541|FG000|Crossover to Second Drug|Overall Study||15||
59615420|NCT01458522|75726542|FG001|Crossover to Second Drug|Overall Study||10||
59709498|NCT00907153|75828244|FG001|STARTED|Overall Study||15||
59615421|NCT01458522|75726541|FG000|COMPLETED|Overall Study||34|Completed all assigned intervention & observation. Not all subjects were assigned to crossover.|
59615422|NCT01458522|75726542|FG001|COMPLETED|Overall Study||26|Completed all assigned intervention & observation. Not all subjects were assigned to crossover.|
59615423|NCT01458522|75726541|FG000|NOT COMPLETED|Overall Study||3||
59615424|NCT01458522|75726542|FG001|NOT COMPLETED|Overall Study||11||
59615425|NCT01505010|75726556|FG000|STARTED|Overall Study||9||
59615426|NCT01505010|75726557|FG001|STARTED|Overall Study||8||
59615427|NCT01505010|75726556|FG000|COMPLETED|Overall Study||9||
59615428|NCT01505010|75726557|FG001|COMPLETED|Overall Study||6||
59615429|NCT01505010|75726556|FG000|NOT COMPLETED|Overall Study||0||
59615430|NCT01505010|75726557|FG001|NOT COMPLETED|Overall Study||2||
59615431|NCT01458210|75726563|FG000|STARTED|Lead-in (1st Course of Ortho-Cyclen)||22||
59615432|NCT01458210|75726563|FG000|Received at Least One Dose of Study Drug|Lead-in (1st Course of Ortho-Cyclen)||22||
59615433|NCT01458210|75726563|FG000|COMPLETED|Lead-in (1st Course of Ortho-Cyclen)||22||
59615434|NCT01458210|75726563|FG000|NOT COMPLETED|Lead-in (1st Course of Ortho-Cyclen)||0||
59615435|NCT01458210|75726563|FG000|STARTED|Ortho-Cyclen Alone (Period 1)||22||
59615436|NCT01458210|75726563|FG000|COMPLETED|Ortho-Cyclen Alone (Period 1)||18||
59615437|NCT01458210|75726563|FG000|NOT COMPLETED|Ortho-Cyclen Alone (Period 1)||4||
59615438|NCT01458210|75726563|FG000|STARTED|Ortho-Cyclen + Dulaglutide (Period 2)|1 participant received Ortho-Cyclen, discontinued due to Adverse Event before receiving Dulaglutide.|18||
59615439|NCT01458210|75726563|FG000|COMPLETED|Ortho-Cyclen + Dulaglutide (Period 2)||15||
59615440|NCT01458210|75726563|FG000|NOT COMPLETED|Ortho-Cyclen + Dulaglutide (Period 2)||3||
59615441|NCT01478958|75726573|FG000|STARTED|Overall Study||67||
59615442|NCT01478958|75726574|FG001|STARTED|Overall Study||66||
59615443|NCT01478958|75726575|FG002|STARTED|Overall Study||69||
59615444|NCT01478958|75726573|FG000|COMPLETED|Overall Study||65||
59615445|NCT01478958|75726574|FG001|COMPLETED|Overall Study||64||
59615446|NCT01478958|75726575|FG002|COMPLETED|Overall Study||66||
59615447|NCT01478958|75726573|FG000|NOT COMPLETED|Overall Study||2||
59615448|NCT01478958|75726574|FG001|NOT COMPLETED|Overall Study||2||
59615449|NCT01478958|75726575|FG002|NOT COMPLETED|Overall Study||3||
59615450|NCT01458132|75726585|FG000|STARTED|Overall Study||15||
59615451|NCT01458132|75726586|FG001|STARTED|Overall Study||4||
59615452|NCT01458132|75726585|FG000|COMPLETED|Overall Study||0||
59615453|NCT01458132|75726586|FG001|COMPLETED|Overall Study||1||
59615454|NCT01458132|75726585|FG000|NOT COMPLETED|Overall Study||15||
59615455|NCT01458132|75726586|FG001|NOT COMPLETED|Overall Study||3||
59615456|NCT05360901|75726592|FG000|STARTED|Overall Study||12||
59615457|NCT05360901|75726592|FG000|COMPLETED|Overall Study||12||
59615458|NCT05360901|75726592|FG000|NOT COMPLETED|Overall Study||0||
59615459|NCT05220254|75726596|FG000|STARTED|Overall Study||20||
59615460|NCT05220254|75726596|FG000|Used the MindCotine Intervention|Overall Study||9||
59615461|NCT05220254|75726596|FG000|Completed End of Treatment Survey|Overall Study||8||
59615462|NCT05220254|75726596|FG000|COMPLETED|Overall Study||8||
59615463|NCT05220254|75726596|FG000|NOT COMPLETED|Overall Study||12||
59615464|NCT05178121|75726600|FG000|STARTED|Overall Study|Although 19 participants consented to participate in the study, one participant did not continue with participation after the consent and enrollment process.|18||
59615465|NCT05178121|75726600|FG000|Completed Training|Overall Study||15||
59615466|NCT05178121|75726600|FG000|Completed Post-Training Survey|Overall Study||14||
59615467|NCT05178121|75726600|FG000|Completed Post-Training Role-Play|Overall Study||14||
59615468|NCT05178121|75726600|FG000|Completed 6-Month Role-Play|Overall Study||10||
59615469|NCT05178121|75726600|FG000|COMPLETED|Overall Study||13|Completed 6-Month Follow-up Survey|
59615470|NCT05178121|75726600|FG000|NOT COMPLETED|Overall Study||5||
59951875|NCT00836004|76070840|FG001|NOT COMPLETED|Washout: 7 Days||0||
59951876|NCT00836004|76070839|FG000|STARTED|Second Intervention||12||
59951877|NCT00836004|76070840|FG001|STARTED|Second Intervention||12||
59951878|NCT00836004|76070839|FG000|COMPLETED|Second Intervention||12||
59615471|NCT05110690|75726605|FG000|STARTED|Eligible for Consent and Enrollment||29||
59615472|NCT05110690|75726605|FG000|COMPLETED|Eligible for Consent and Enrollment||24||
59762754|NCT03885661|75882612|FG000|Treatment Visit (12 Week)|Overall Study||11||
59615473|NCT05110690|75726605|FG000|NOT COMPLETED|Eligible for Consent and Enrollment||5||
59615474|NCT05110690|75726605|FG000|STARTED|Enrolled||24||
59615475|NCT05110690|75726605|FG000|COMPLETED|Enrolled||24||
59615476|NCT05110690|75726605|FG000|NOT COMPLETED|Enrolled||0||
59615477|NCT05110690|75726605|FG000|STARTED|Started Intervention||24||
59615478|NCT05110690|75726605|FG000|COMPLETED|Started Intervention||23||
59615479|NCT05110690|75726605|FG000|NOT COMPLETED|Started Intervention||1||
59762755|NCT03885661|75882613|FG001|Treatment Visit (12 Week)|Overall Study||7||
59615480|NCT05110690|75726605|FG000|STARTED|Completion of Intervention||23||
59615481|NCT05110690|75726605|FG000|COMPLETED|Completion of Intervention||19||
59615482|NCT05110690|75726605|FG000|NOT COMPLETED|Completion of Intervention||4||
59615483|NCT05005260|75726611|FG000|STARTED|Overall Study||42||
59615484|NCT05005260|75726612|FG001|STARTED|Overall Study||46||
59615485|NCT05005260|75726611|FG000|COMPLETED|Overall Study||39||
59615486|NCT05005260|75726612|FG001|COMPLETED|Overall Study||44||
59615487|NCT05005260|75726611|FG000|NOT COMPLETED|Overall Study||3||
59762756|NCT03885661|75882612|FG000|COMPLETED|Overall Study||11||
59762757|NCT03885661|75882613|FG001|COMPLETED|Overall Study||7||
59615488|NCT05005260|75726612|FG001|NOT COMPLETED|Overall Study||2||
59615489|NCT04842604|75726620|FG000|STARTED|Overall Study||9||
59615490|NCT04842604|75726621|FG001|STARTED|Overall Study||5||
59615491|NCT04842604|75726620|FG000|Treated|Overall Study||8||
59615492|NCT04842604|75726621|FG001|Treated|Overall Study||5||
59615493|NCT04842604|75726620|FG000|COMPLETED|Overall Study||3||
59615494|NCT04842604|75726621|FG001|COMPLETED|Overall Study||1||
59615495|NCT04842604|75726620|FG000|NOT COMPLETED|Overall Study||6||
59615496|NCT04842604|75726621|FG001|NOT COMPLETED|Overall Study||4||
59615497|NCT04778475|75726629|FG000|STARTED|Overall Study||50||
59615498|NCT04778475|75726630|FG001|STARTED|Overall Study||50||
59615499|NCT04778475|75726629|FG000|COMPLETED|Overall Study||46||
59615500|NCT04778475|75726630|FG001|COMPLETED|Overall Study||50||
59615501|NCT04778475|75726629|FG000|NOT COMPLETED|Overall Study||4||
59615502|NCT04778475|75726630|FG001|NOT COMPLETED|Overall Study||0||
59615503|NCT04508621|75726638|FG000|STARTED|Overall Study||256||
59615504|NCT04508621|75726639|FG001|STARTED|Overall Study||258||
59615505|NCT04508621|75726638|FG000|COMPLETED|Overall Study||189||
59615506|NCT04508621|75726639|FG001|COMPLETED|Overall Study||210||
59615507|NCT04508621|75726638|FG000|NOT COMPLETED|Overall Study||67||
59615508|NCT04508621|75726639|FG001|NOT COMPLETED|Overall Study||48||
59615509|NCT04416204|75726647|FG000|STARTED|First Visit||6||
59615510|NCT04416204|75726648|FG001|STARTED|First Visit||8||
59615511|NCT04416204|75726649|FG002|STARTED|First Visit||7||
59615512|NCT04416204|75726650|FG003|STARTED|First Visit||8||
59615513|NCT04416204|75726647|FG000|COMPLETED|First Visit||6||
59615514|NCT04416204|75726648|FG001|COMPLETED|First Visit||8||
59615515|NCT04416204|75726649|FG002|COMPLETED|First Visit||7||
59615516|NCT04416204|75726650|FG003|COMPLETED|First Visit||8||
59615517|NCT04416204|75726647|FG000|NOT COMPLETED|First Visit||0||
59615518|NCT04416204|75726648|FG001|NOT COMPLETED|First Visit||0||
59615519|NCT04416204|75726649|FG002|NOT COMPLETED|First Visit||0||
59615520|NCT04416204|75726650|FG003|NOT COMPLETED|First Visit||0||
59615521|NCT04416204|75726647|FG000|STARTED|Washout (3-6 Weeks)||6||
59615522|NCT04416204|75726648|FG001|STARTED|Washout (3-6 Weeks)||8||
59615523|NCT04416204|75726649|FG002|STARTED|Washout (3-6 Weeks)||7||
59615524|NCT04416204|75726650|FG003|STARTED|Washout (3-6 Weeks)||8||
59615525|NCT04416204|75726647|FG000|COMPLETED|Washout (3-6 Weeks)||5||
59615526|NCT04416204|75726648|FG001|COMPLETED|Washout (3-6 Weeks)||8||
59615527|NCT04416204|75726649|FG002|COMPLETED|Washout (3-6 Weeks)||6||
59615528|NCT04416204|75726650|FG003|COMPLETED|Washout (3-6 Weeks)||7||
59615529|NCT04416204|75726647|FG000|NOT COMPLETED|Washout (3-6 Weeks)||1||
59615530|NCT04416204|75726648|FG001|NOT COMPLETED|Washout (3-6 Weeks)||0||
59615531|NCT04416204|75726649|FG002|NOT COMPLETED|Washout (3-6 Weeks)||1||
59615532|NCT04416204|75726650|FG003|NOT COMPLETED|Washout (3-6 Weeks)||1||
59615533|NCT04416204|75726647|FG000|STARTED|Second Visit||5||
59615534|NCT04416204|75726648|FG001|STARTED|Second Visit||8||
59615535|NCT04416204|75726649|FG002|STARTED|Second Visit||6||
59615536|NCT04416204|75726650|FG003|STARTED|Second Visit||7||
59615537|NCT04416204|75726647|FG000|COMPLETED|Second Visit||5||
59615538|NCT04416204|75726648|FG001|COMPLETED|Second Visit||8||
59615539|NCT04416204|75726649|FG002|COMPLETED|Second Visit||6||
59615540|NCT04416204|75726650|FG003|COMPLETED|Second Visit||7||
59615541|NCT04416204|75726647|FG000|NOT COMPLETED|Second Visit||0||
59615542|NCT04416204|75726648|FG001|NOT COMPLETED|Second Visit||0||
59615543|NCT04416204|75726649|FG002|NOT COMPLETED|Second Visit||0||
59615544|NCT04416204|75726650|FG003|NOT COMPLETED|Second Visit||0||
59615545|NCT04158648|75726660|FG000|STARTED|Overall Study|This is the number of participants who enrolled in the study.|73|All Participants Population|
59615546|NCT04158648|75726660|FG000|Received at Least One Dose of Study Drug|Overall Study|One participant withdrew from the study prior to receiving any treatment.|72|Treated Population|
59615547|NCT04158648|75726660|FG000|Completed 24 Weeks in the Study|Overall Study||71||
59615548|NCT04158648|75726660|FG000|Completed 52 Weeks in the Study|Overall Study||57||
59615549|NCT04158648|75726660|FG000|COMPLETED|Overall Study||0||
59615550|NCT04158648|75726660|FG000|NOT COMPLETED|Overall Study||73||
59615551|NCT04107935|75726669|FG000|STARTED|Overall Study||43||
59615552|NCT04107935|75726670|FG001|STARTED|Overall Study||30||
59615553|NCT04107935|75726669|FG000|COMPLETED|Overall Study||42||
59615554|NCT04107935|75726670|FG001|COMPLETED|Overall Study||30||
59615555|NCT04107935|75726669|FG000|NOT COMPLETED|Overall Study||1||
59615556|NCT04107935|75726670|FG001|NOT COMPLETED|Overall Study||0||
59615557|NCT04084561|75726682|FG000|STARTED|Overall Study||41||
59615558|NCT04084561|75726683|FG001|STARTED|Overall Study||40||
59615559|NCT04084561|75726684|FG002|STARTED|Overall Study||43||
59615560|NCT04084561|75726685|FG003|STARTED|Overall Study||42||
59615561|NCT04084561|75726682|FG000|COMPLETED|Overall Study||41||
59615562|NCT04084561|75726683|FG001|COMPLETED|Overall Study||40||
59615563|NCT04084561|75726684|FG002|COMPLETED|Overall Study||43||
59615564|NCT04084561|75726685|FG003|COMPLETED|Overall Study||42||
59615565|NCT04084561|75726682|FG000|NOT COMPLETED|Overall Study||0||
59615566|NCT04084561|75726683|FG001|NOT COMPLETED|Overall Study||0||
59615567|NCT04084561|75726684|FG002|NOT COMPLETED|Overall Study||0||
59615568|NCT04084561|75726685|FG003|NOT COMPLETED|Overall Study||0||
59615569|NCT03923491|75726697|FG000|STARTED|Overall Study||33||
59615570|NCT03923491|75726698|FG001|STARTED|Overall Study||30||
59520222|NCT03889444|75614152|FG000|NOT COMPLETED|Overall Study||0||
59520223|NCT00956657|75614158|FG000|STARTED|Overall Study||18||
59520224|NCT00956657|75614159|FG001|STARTED|Overall Study||13||
59520225|NCT00956657|75614158|FG000|COMPLETED|Overall Study||18||
59520226|NCT00956657|75614159|FG001|COMPLETED|Overall Study||13||
59520227|NCT00956657|75614158|FG000|NOT COMPLETED|Overall Study||0||
59520228|NCT00956657|75614159|FG001|NOT COMPLETED|Overall Study||0||
59520229|NCT01104025|75614165|FG000|STARTED|Treatment Period||31||
59520230|NCT01104025|75614165|FG000|COMPLETED|Treatment Period||25||
59520231|NCT01104025|75614165|FG000|NOT COMPLETED|Treatment Period||6||
59520232|NCT01104025|75614165|FG000|STARTED|Follow up Until BMT OR 6 Months||25||
59520233|NCT01104025|75614165|FG000|COMPLETED|Follow up Until BMT OR 6 Months||22||
59520234|NCT01104025|75614165|FG000|NOT COMPLETED|Follow up Until BMT OR 6 Months||3||
59520235|NCT01104025|75614165|FG000|STARTED|Follow up Until Day 100 Post BMT|only 11 participants proceeded to BMT; 14 did not|11||
59520236|NCT01104025|75614165|FG000|COMPLETED|Follow up Until Day 100 Post BMT||9||
59520237|NCT01104025|75614165|FG000|NOT COMPLETED|Follow up Until Day 100 Post BMT||2||
59520238|NCT03649750|75614169|FG000|STARTED|Period 1||12||
59520239|NCT03649750|75614170|FG001|STARTED|Period 1||24||
59520240|NCT03649750|75614169|FG000|COMPLETED|Period 1||12||
59520241|NCT03649750|75614170|FG001|COMPLETED|Period 1||24||
59520242|NCT03649750|75614169|FG000|NOT COMPLETED|Period 1||0||
59520243|NCT03649750|75614170|FG001|NOT COMPLETED|Period 1||0||
59520244|NCT03649750|75614169|FG000|STARTED|Washout: 7 Days||12||
59520245|NCT03649750|75614170|FG001|STARTED|Washout: 7 Days||24||
59520246|NCT03649750|75614169|FG000|COMPLETED|Washout: 7 Days||12||
59520247|NCT03649750|75614170|FG001|COMPLETED|Washout: 7 Days||24||
59520248|NCT03649750|75614169|FG000|NOT COMPLETED|Washout: 7 Days||0||
59520249|NCT03649750|75614170|FG001|NOT COMPLETED|Washout: 7 Days||0||
59520250|NCT03649750|75614169|FG000|STARTED|Period 2||12||
59520251|NCT03649750|75614170|FG001|STARTED|Period 2||24||
59520252|NCT03649750|75614169|FG000|COMPLETED|Period 2||12||
59520253|NCT03649750|75614170|FG001|COMPLETED|Period 2||24||
59520254|NCT03649750|75614169|FG000|NOT COMPLETED|Period 2||0||
59520255|NCT03649750|75614170|FG001|NOT COMPLETED|Period 2||0||
59520256|NCT01104103|75614179|FG000|STARTED|Overall Study||243||
59520257|NCT01104103|75614180|FG001|STARTED|Overall Study||224||
59520258|NCT01104103|75614179|FG000|COMPLETED|Overall Study||243||
59520259|NCT01104103|75614180|FG001|COMPLETED|Overall Study||224||
59520260|NCT01104103|75614179|FG000|NOT COMPLETED|Overall Study||0||
59520261|NCT01104103|75614180|FG001|NOT COMPLETED|Overall Study||0||
59520262|NCT04343092|75614186|FG000|STARTED|Overall Study||16||
59520263|NCT04343092|75614186|FG000|COMPLETED|Overall Study||16||
59520264|NCT04343092|75614186|FG000|NOT COMPLETED|Overall Study||0||
59520265|NCT01105117|75614192|FG000|STARTED|Overall Study||1||
59520266|NCT01105117|75614193|FG001|STARTED|Overall Study||1||
59615571|NCT03923491|75726697|FG000|COMPLETED|Overall Study||24||
59520267|NCT01105117|75614192|FG000|COMPLETED|Overall Study||1||
59520268|NCT01105117|75614193|FG001|COMPLETED|Overall Study||1||
59520269|NCT01105117|75614192|FG000|NOT COMPLETED|Overall Study||0||
59520270|NCT01105117|75614193|FG001|NOT COMPLETED|Overall Study||0||
59520271|NCT03888274|75614199|FG000|STARTED|Overall Study||30||
59520272|NCT03888274|75614199|FG000|COMPLETED|Overall Study||30||
59520273|NCT03888274|75614199|FG000|NOT COMPLETED|Overall Study||0||
59520274|NCT03650842|75614203|FG000|STARTED|Overall Study||25||
59520275|NCT03650842|75614203|FG000|COMPLETED|Overall Study||25||
59520276|NCT03650842|75614203|FG000|NOT COMPLETED|Overall Study||0||
59615572|NCT03923491|75726698|FG001|COMPLETED|Overall Study||16||
59615573|NCT03923491|75726697|FG000|NOT COMPLETED|Overall Study||9||
59615574|NCT03923491|75726698|FG001|NOT COMPLETED|Overall Study||14||
59615575|NCT03923426|75726704|FG000|STARTED|Overall Study||572|All enrolled|
59615576|NCT03923426|75726704|FG000|Full Analysis Set|Overall Study||569|All eligible participants among enrolled|
59615577|NCT03923426|75726704|FG000|COMPLETED|Overall Study||417|Followed through medical records up to 60 days after hospital discharge|
59615578|NCT03923426|75726704|FG000|NOT COMPLETED|Overall Study||155||
59615579|NCT03896152|75726710|FG000|STARTED|Overall Study||7||
59615580|NCT03896152|75726711|FG001|STARTED|Overall Study||6||
59615581|NCT03896152|75726710|FG000|COMPLETED|Overall Study||4||
59615582|NCT03896152|75726711|FG001|COMPLETED|Overall Study||4||
59615583|NCT03896152|75726710|FG000|NOT COMPLETED|Overall Study||3||
59615584|NCT03896152|75726711|FG001|NOT COMPLETED|Overall Study||2||
59615585|NCT03866278|75726727|FG000|STARTED|Overall Study||31||
59615586|NCT03866278|75726727|FG000|COMPLETED|Overall Study||28||
59615587|NCT03866278|75726727|FG000|NOT COMPLETED|Overall Study||3||
59615588|NCT03837353|75726737|FG000|STARTED|Overall Study||3||
59615589|NCT03837353|75726738|FG001|STARTED|Overall Study||3||
59615590|NCT03837353|75726739|FG002|STARTED|Overall Study||2||
59615591|NCT03837353|75726740|FG003|STARTED|Overall Study||4||
59615592|NCT03837353|75726741|FG004|STARTED|Overall Study||3||
59615593|NCT03837353|75726742|FG005|STARTED|Overall Study||3||
59615594|NCT03837353|75726737|FG000|COMPLETED|Overall Study||3||
59615595|NCT03837353|75726738|FG001|COMPLETED|Overall Study||3||
59615596|NCT03837353|75726739|FG002|COMPLETED|Overall Study||2||
59615597|NCT03837353|75726740|FG003|COMPLETED|Overall Study||4||
59615598|NCT03837353|75726741|FG004|COMPLETED|Overall Study||3||
59615599|NCT03837353|75726742|FG005|COMPLETED|Overall Study||3||
59615600|NCT03837353|75726737|FG000|NOT COMPLETED|Overall Study||0||
59615601|NCT03837353|75726738|FG001|NOT COMPLETED|Overall Study||0||
59615602|NCT03837353|75726739|FG002|NOT COMPLETED|Overall Study||0||
59615603|NCT03837353|75726740|FG003|NOT COMPLETED|Overall Study||0||
59615604|NCT03837353|75726741|FG004|NOT COMPLETED|Overall Study||0||
59615605|NCT03837353|75726742|FG005|NOT COMPLETED|Overall Study||0||
59615606|NCT03794583|75726756|FG000|STARTED|Overall Study||41||
59615607|NCT03794583|75726756|FG000|Received At Least 1 Dose of Study Drug|Overall Study||41||
59615608|NCT03794583|75726756|FG000|COMPLETED|Overall Study||0||
59615609|NCT03794583|75726756|FG000|NOT COMPLETED|Overall Study||41||
59615610|NCT03759379|75726763|FG000|STARTED|Treatment Period||122||
59615611|NCT03759379|75726764|FG001|STARTED|Treatment Period||42||
59615612|NCT03759379|75726763|FG000|COMPLETED|Treatment Period||0||
59615613|NCT03759379|75726764|FG001|COMPLETED|Treatment Period||0||
59615614|NCT03759379|75726763|FG000|NOT COMPLETED|Treatment Period||122||
59615615|NCT03759379|75726764|FG001|NOT COMPLETED|Treatment Period||42||
59615616|NCT03759379|75726763|FG000|STARTED|Randomized Treatment Extension Period||0||
59615617|NCT03759379|75726764|FG001|STARTED|Randomized Treatment Extension Period||0||
59615618|NCT03759379|75726763|FG000|COMPLETED|Randomized Treatment Extension Period||0||
59615619|NCT03759379|75726764|FG001|COMPLETED|Randomized Treatment Extension Period||0||
59615620|NCT03759379|75726763|FG000|NOT COMPLETED|Randomized Treatment Extension Period||0||
59615621|NCT03759379|75726764|FG001|NOT COMPLETED|Randomized Treatment Extension Period||0||
59615622|NCT03759366|75726770|FG000|STARTED|Primary Evaluation Period (26 Weeks)||11||
59615623|NCT03759366|75726770|FG000|COMPLETED|Primary Evaluation Period (26 Weeks)||10||
59615624|NCT03759366|75726770|FG000|NOT COMPLETED|Primary Evaluation Period (26 Weeks)||1||
59615625|NCT03759366|75726770|FG000|STARTED|Extension Period (Up to 208 Weeks)||10||
59615626|NCT03759366|75726770|FG000|COMPLETED|Extension Period (Up to 208 Weeks)||0||
59615627|NCT03759366|75726770|FG000|NOT COMPLETED|Extension Period (Up to 208 Weeks)||10||
59615628|NCT03738904|75726776|FG000|STARTED|Overall Study||54||
59615629|NCT03738904|75726777|FG001|STARTED|Overall Study||55||
59615630|NCT03738904|75726776|FG000|COMPLETED|Overall Study||45||
59615631|NCT03738904|75726777|FG001|COMPLETED|Overall Study||44||
59615632|NCT03738904|75726776|FG000|NOT COMPLETED|Overall Study||9||
59615633|NCT03738904|75726777|FG001|NOT COMPLETED|Overall Study||11||
59615634|NCT03695237|75726785|FG000|STARTED|Overall Study||18||
59615635|NCT03695237|75726786|FG001|STARTED|Overall Study||27||
59615636|NCT03695237|75726785|FG000|COMPLETED|Overall Study||17|Completed Part 1 (Week 48)|
59762758|NCT03885661|75882612|FG000|NOT COMPLETED|Overall Study||1||
59762759|NCT03885661|75882613|FG001|NOT COMPLETED|Overall Study||1||
59762760|NCT00868530|75882619|FG000|STARTED|Overall Study||53||
59762761|NCT00868530|75882619|FG000|COMPLETED|Overall Study||49||
59762762|NCT00868530|75882619|FG000|NOT COMPLETED|Overall Study||4||
59762763|NCT00598442|75882626|FG000|STARTED|Overall Study||167||
59615637|NCT03695237|75726786|FG001|COMPLETED|Overall Study||27|Completed Part 1 (Week 48)|
59615638|NCT03695237|75726785|FG000|NOT COMPLETED|Overall Study||1||
59615639|NCT03695237|75726786|FG001|NOT COMPLETED|Overall Study||0||
59615640|NCT03584373|75726795|FG000|STARTED|Overall Study||51||
59615641|NCT03584373|75726796|FG001|STARTED|Overall Study||54||
59615642|NCT03584373|75726795|FG000|COMPLETED|Overall Study||44||
59615643|NCT03584373|75726796|FG001|COMPLETED|Overall Study||46||
59615644|NCT03584373|75726795|FG000|NOT COMPLETED|Overall Study||7||
59615645|NCT03584373|75726796|FG001|NOT COMPLETED|Overall Study||8||
59615646|NCT03527589|75726802|FG000|STARTED|Overall Study||499||
59615647|NCT03527589|75726802|FG000|COMPLETED|Overall Study||487||
59615648|NCT03527589|75726802|FG000|NOT COMPLETED|Overall Study||12||
59615649|NCT03386929|75726809|FG000|STARTED|Overall Study||6||
59615650|NCT03386929|75726810|FG001|STARTED|Overall Study||6||
59615651|NCT03386929|75726811|FG002|STARTED|Overall Study||3||
59615652|NCT03386929|75726809|FG000|COMPLETED|Overall Study||0||
59615653|NCT03386929|75726810|FG001|COMPLETED|Overall Study||0||
59615654|NCT03386929|75726811|FG002|COMPLETED|Overall Study||0||
59615655|NCT03386929|75726809|FG000|NOT COMPLETED|Overall Study||6||
59615656|NCT03386929|75726810|FG001|NOT COMPLETED|Overall Study||6||
59615657|NCT03386929|75726811|FG002|NOT COMPLETED|Overall Study||3||
59615658|NCT03194256|75726819|FG000|STARTED|Overall Study||41||
59615659|NCT03194256|75726820|FG001|STARTED|Overall Study||39||
59615660|NCT03194256|75726819|FG000|Laboratory Session 2|Overall Study||41||
59615661|NCT03194256|75726820|FG001|Laboratory Session 2|Overall Study||36||
59615662|NCT03194256|75726819|FG000|Laboratory Session 3|Overall Study||40||
59615663|NCT03194256|75726820|FG001|Laboratory Session 3|Overall Study||33||
59615664|NCT03194256|75726819|FG000|Laboratory Session 4|Overall Study||39||
59615665|NCT03194256|75726820|FG001|Laboratory Session 4|Overall Study||33||
59615666|NCT03194256|75726819|FG000|COMPLETED|Overall Study||38||
59615667|NCT03194256|75726820|FG001|COMPLETED|Overall Study||32||
59615668|NCT03194256|75726819|FG000|NOT COMPLETED|Overall Study||3||
59615669|NCT03194256|75726820|FG001|NOT COMPLETED|Overall Study||7||
59615670|NCT03023930|75726828|FG000|STARTED|Overall Study||394||
59615671|NCT03023930|75726829|FG001|STARTED|Overall Study||362||
59615672|NCT03023930|75726830|FG002|STARTED|Overall Study||706||
59615673|NCT03023930|75726831|FG003|STARTED|Overall Study||92||
59615674|NCT03023930|75726832|FG004|STARTED|Overall Study||177||
59615675|NCT03023930|75726828|FG000|COMPLETED|Overall Study||394||
59615676|NCT03023930|75726829|FG001|COMPLETED|Overall Study||362||
59615677|NCT03023930|75726830|FG002|COMPLETED|Overall Study||706||
59615678|NCT03023930|75726831|FG003|COMPLETED|Overall Study||92||
59615679|NCT03023930|75726832|FG004|COMPLETED|Overall Study||177||
59615680|NCT03023930|75726828|FG000|NOT COMPLETED|Overall Study||0||
59615681|NCT03023930|75726829|FG001|NOT COMPLETED|Overall Study||0||
59615682|NCT03023930|75726830|FG002|NOT COMPLETED|Overall Study||0||
59615683|NCT03023930|75726831|FG003|NOT COMPLETED|Overall Study||0||
59615684|NCT03023930|75726832|FG004|NOT COMPLETED|Overall Study||0||
59615685|NCT02943590|75726840|FG000|STARTED|Overall Study||150||
59615686|NCT02943590|75726841|FG001|STARTED|Overall Study||150||
59615687|NCT02943590|75726840|FG000|COMPLETED|Overall Study||144||
59615688|NCT02943590|75726841|FG001|COMPLETED|Overall Study||142||
59615689|NCT02943590|75726840|FG000|NOT COMPLETED|Overall Study||6||
59615690|NCT02943590|75726841|FG001|NOT COMPLETED|Overall Study||8||
59615691|NCT02914561|75726853|FG000|STARTED|Induction Study (Day 1 to Week 10)||223||
59615692|NCT02914561|75726854|FG001|STARTED|Induction Study (Day 1 to Week 10)||245||
59615693|NCT02914561|75726855|FG002|STARTED|Induction Study (Day 1 to Week 10)||239||
59615694|NCT02914561|75726856|FG003|STARTED|Induction Study (Day 1 to Week 10)||204||
59615695|NCT02914561|75726857|FG004|STARTED|Induction Study (Day 1 to Week 10)||230||
59615696|NCT02914561|75726858|FG005|STARTED|Induction Study (Day 1 to Week 10)||231||
59615697|NCT02914561|75726859|FG006|STARTED|Induction Study (Day 1 to Week 10)||0||
59615698|NCT02914561|75726860|FG007|STARTED|Induction Study (Day 1 to Week 10)||0||
59615699|NCT02914561|75726861|FG008|STARTED|Induction Study (Day 1 to Week 10)||0||
59615700|NCT02914561|75726862|FG009|STARTED|Induction Study (Day 1 to Week 10)||0||
59615701|NCT02914561|75726863|FG010|STARTED|Induction Study (Day 1 to Week 10)||0||
59615702|NCT02914561|75726853|FG000|Treated|Induction Study (Day 1 to Week 10)||222||
59615703|NCT02914561|75726854|FG001|Treated|Induction Study (Day 1 to Week 10)||245||
59615704|NCT02914561|75726855|FG002|Treated|Induction Study (Day 1 to Week 10)||237||
59615705|NCT02914561|75726856|FG003|Treated|Induction Study (Day 1 to Week 10)||202||
59615706|NCT02914561|75726857|FG004|Treated|Induction Study (Day 1 to Week 10)||228||
59615707|NCT02914561|75726858|FG005|Treated|Induction Study (Day 1 to Week 10)||229||
59615708|NCT02914561|75726859|FG006|Treated|Induction Study (Day 1 to Week 10)||0||
59615709|NCT02914561|75726860|FG007|Treated|Induction Study (Day 1 to Week 10)||0||
59615710|NCT02914561|75726861|FG008|Treated|Induction Study (Day 1 to Week 10)||0||
59615711|NCT02914561|75726862|FG009|Treated|Induction Study (Day 1 to Week 10)||0||
59951879|NCT00836004|76070840|FG001|COMPLETED|Second Intervention||12||
59951880|NCT00836004|76070839|FG000|NOT COMPLETED|Second Intervention||0||
59615712|NCT02914561|75726863|FG010|Treated|Induction Study (Day 1 to Week 10)||0||
59615713|NCT02914561|75726853|FG000|COMPLETED|Induction Study (Day 1 to Week 10)||204||
59615714|NCT02914561|75726854|FG001|COMPLETED|Induction Study (Day 1 to Week 10)||213||
59615715|NCT02914561|75726855|FG002|COMPLETED|Induction Study (Day 1 to Week 10)||212||
59615716|NCT02914561|75726856|FG003|COMPLETED|Induction Study (Day 1 to Week 10)||177||
59615717|NCT02914561|75726857|FG004|COMPLETED|Induction Study (Day 1 to Week 10)||183||
59615718|NCT02914561|75726858|FG005|COMPLETED|Induction Study (Day 1 to Week 10)||192||
59615719|NCT02914561|75726859|FG006|COMPLETED|Induction Study (Day 1 to Week 10)||0||
59615720|NCT02914561|75726860|FG007|COMPLETED|Induction Study (Day 1 to Week 10)||0||
59951881|NCT00836004|76070840|FG001|NOT COMPLETED|Second Intervention||0||
59615721|NCT02914561|75726861|FG008|COMPLETED|Induction Study (Day 1 to Week 10)||0||
59951882|NCT00835692|76070846|FG000|STARTED|First Intervention||28||
59951883|NCT00835692|76070847|FG001|STARTED|First Intervention||28||
59951884|NCT00835692|76070846|FG000|COMPLETED|First Intervention||27||
59615722|NCT02914561|75726862|FG009|COMPLETED|Induction Study (Day 1 to Week 10)||0||
59615723|NCT02914561|75726863|FG010|COMPLETED|Induction Study (Day 1 to Week 10)||0||
59615724|NCT02914561|75726853|FG000|NOT COMPLETED|Induction Study (Day 1 to Week 10)||19||
59615725|NCT02914561|75726854|FG001|NOT COMPLETED|Induction Study (Day 1 to Week 10)||32||
59615726|NCT02914561|75726855|FG002|NOT COMPLETED|Induction Study (Day 1 to Week 10)||27||
59615727|NCT02914561|75726856|FG003|NOT COMPLETED|Induction Study (Day 1 to Week 10)||27||
59615728|NCT02914561|75726857|FG004|NOT COMPLETED|Induction Study (Day 1 to Week 10)||47||
59615729|NCT02914561|75726858|FG005|NOT COMPLETED|Induction Study (Day 1 to Week 10)||39||
59615730|NCT02914561|75726859|FG006|NOT COMPLETED|Induction Study (Day 1 to Week 10)||0||
59615731|NCT02914561|75726860|FG007|NOT COMPLETED|Induction Study (Day 1 to Week 10)||0||
59615732|NCT02914561|75726861|FG008|NOT COMPLETED|Induction Study (Day 1 to Week 10)||0||
59615733|NCT02914561|75726862|FG009|NOT COMPLETED|Induction Study (Day 1 to Week 10)||0||
59615734|NCT02914561|75726863|FG010|NOT COMPLETED|Induction Study (Day 1 to Week 10)||0||
59615735|NCT02914561|75726853|FG000|STARTED|Maintenance Study (Weeks 11 to 58)||0||
59615736|NCT02914561|75726854|FG001|STARTED|Maintenance Study (Weeks 11 to 58)||0||
59615737|NCT02914561|75726855|FG002|STARTED|Maintenance Study (Weeks 11 to 58)||0||
59615738|NCT02914561|75726856|FG003|STARTED|Maintenance Study (Weeks 11 to 58)||0||
59615739|NCT02914561|75726857|FG004|STARTED|Maintenance Study (Weeks 11 to 58)||0||
59615740|NCT02914561|75726858|FG005|STARTED|Maintenance Study (Weeks 11 to 58)||0||
59615741|NCT02914561|75726859|FG006|STARTED|Maintenance Study (Weeks 11 to 58)|Not all participants who completed the induction study entered the maintenance study.|118||
59615742|NCT02914561|75726860|FG007|STARTED|Maintenance Study (Weeks 11 to 58)|Not all participants who completed the induction study entered the maintenance study.|56||
59615743|NCT02914561|75726861|FG008|STARTED|Maintenance Study (Weeks 11 to 58)|Not all participants who completed the induction study entered the maintenance study.|105||
59615744|NCT02914561|75726862|FG009|STARTED|Maintenance Study (Weeks 11 to 58)|Not all participants who completed the induction study entered the maintenance study.|56||
59615745|NCT02914561|75726863|FG010|STARTED|Maintenance Study (Weeks 11 to 58)|Not all participants who completed the induction study entered the maintenance study.|146||
59615746|NCT02914561|75726853|FG000|Treated|Maintenance Study (Weeks 11 to 58)||0||
59615747|NCT02914561|75726854|FG001|Treated|Maintenance Study (Weeks 11 to 58)||0||
59615748|NCT02914561|75726855|FG002|Treated|Maintenance Study (Weeks 11 to 58)||0||
59615749|NCT02914561|75726856|FG003|Treated|Maintenance Study (Weeks 11 to 58)||0||
59615750|NCT02914561|75726857|FG004|Treated|Maintenance Study (Weeks 11 to 58)||0||
59615751|NCT02914561|75726858|FG005|Treated|Maintenance Study (Weeks 11 to 58)||0||
59615752|NCT02914561|75726859|FG006|Treated|Maintenance Study (Weeks 11 to 58)||118||
59615753|NCT02914561|75726860|FG007|Treated|Maintenance Study (Weeks 11 to 58)||56||
59615754|NCT02914561|75726861|FG008|Treated|Maintenance Study (Weeks 11 to 58)||104||
59615755|NCT02914561|75726862|FG009|Treated|Maintenance Study (Weeks 11 to 58)||55||
59615756|NCT02914561|75726863|FG010|Treated|Maintenance Study (Weeks 11 to 58)||145||
59615757|NCT02914561|75726853|FG000|COMPLETED|Maintenance Study (Weeks 11 to 58)||0||
59615758|NCT02914561|75726854|FG001|COMPLETED|Maintenance Study (Weeks 11 to 58)||0||
59615759|NCT02914561|75726855|FG002|COMPLETED|Maintenance Study (Weeks 11 to 58)||0||
59615760|NCT02914561|75726856|FG003|COMPLETED|Maintenance Study (Weeks 11 to 58)||0||
59615761|NCT02914561|75726857|FG004|COMPLETED|Maintenance Study (Weeks 11 to 58)||0||
59615762|NCT02914561|75726858|FG005|COMPLETED|Maintenance Study (Weeks 11 to 58)||0||
59615763|NCT02914561|75726859|FG006|COMPLETED|Maintenance Study (Weeks 11 to 58)||64||
59615764|NCT02914561|75726860|FG007|COMPLETED|Maintenance Study (Weeks 11 to 58)||21||
59615765|NCT02914561|75726861|FG008|COMPLETED|Maintenance Study (Weeks 11 to 58)||45||
59615766|NCT02914561|75726862|FG009|COMPLETED|Maintenance Study (Weeks 11 to 58)||26||
59615767|NCT02914561|75726863|FG010|COMPLETED|Maintenance Study (Weeks 11 to 58)||74||
59615768|NCT02914561|75726853|FG000|NOT COMPLETED|Maintenance Study (Weeks 11 to 58)||0||
59615769|NCT02914561|75726854|FG001|NOT COMPLETED|Maintenance Study (Weeks 11 to 58)||0||
59615770|NCT02914561|75726855|FG002|NOT COMPLETED|Maintenance Study (Weeks 11 to 58)||0||
59615771|NCT02914561|75726856|FG003|NOT COMPLETED|Maintenance Study (Weeks 11 to 58)||0||
59615772|NCT02914561|75726857|FG004|NOT COMPLETED|Maintenance Study (Weeks 11 to 58)||0||
59615773|NCT02914561|75726858|FG005|NOT COMPLETED|Maintenance Study (Weeks 11 to 58)||0||
59615774|NCT02914561|75726859|FG006|NOT COMPLETED|Maintenance Study (Weeks 11 to 58)||54||
59615775|NCT02914561|75726860|FG007|NOT COMPLETED|Maintenance Study (Weeks 11 to 58)||35||
59615776|NCT02914561|75726861|FG008|NOT COMPLETED|Maintenance Study (Weeks 11 to 58)||60||
59615777|NCT02914561|75726862|FG009|NOT COMPLETED|Maintenance Study (Weeks 11 to 58)||30||
59615778|NCT02914561|75726863|FG010|NOT COMPLETED|Maintenance Study (Weeks 11 to 58)||72||
59615779|NCT02840799|75726893|FG000|STARTED|Phase 1||41||
59615780|NCT02840799|75726894|FG001|STARTED|Phase 1||43||
59615781|NCT02840799|75726893|FG000|COMPLETED|Phase 1||36||
59615782|NCT02840799|75726894|FG001|COMPLETED|Phase 1||40||
59615783|NCT02840799|75726893|FG000|NOT COMPLETED|Phase 1||5||
59951885|NCT00835692|76070847|FG001|COMPLETED|First Intervention||28||
59951886|NCT00835692|76070846|FG000|NOT COMPLETED|First Intervention||1||
59615784|NCT02840799|75726894|FG001|NOT COMPLETED|Phase 1||3||
59709499|NCT00907153|75828243|FG000|COMPLETED|Overall Study||11||
59951887|NCT00835692|76070847|FG001|NOT COMPLETED|First Intervention||0||
59951888|NCT00835692|76070846|FG000|STARTED|Washout||27||
59615785|NCT02840799|75726893|FG000|STARTED|Phase 2 (Crossover)||41|Nine participants did not cross over due to dispensing error. The subjects received the same treatment that was originally dispensed during Period 1/Phase 1.|
59615786|NCT02840799|75726894|FG001|STARTED|Phase 2 (Crossover)||35|Nine participants did not cross over due to dispensing error. The subjects received the same treatment that was originally dispensed during Period 1/Phase 1.|
59615787|NCT02840799|75726893|FG000|COMPLETED|Phase 2 (Crossover)||41||
59615788|NCT02840799|75726894|FG001|COMPLETED|Phase 2 (Crossover)||33||
59615789|NCT02840799|75726893|FG000|NOT COMPLETED|Phase 2 (Crossover)||0||
59615790|NCT02840799|75726894|FG001|NOT COMPLETED|Phase 2 (Crossover)||2||
59615791|NCT02481414|75726909|FG000|STARTED|Overall Study||39||
59615792|NCT02481414|75726910|FG001|STARTED|Overall Study||42||
59615793|NCT02481414|75726909|FG000|COMPLETED|Overall Study||35||
59615794|NCT02481414|75726910|FG001|COMPLETED|Overall Study||41||
59615795|NCT02481414|75726909|FG000|NOT COMPLETED|Overall Study||4||
59615796|NCT02481414|75726910|FG001|NOT COMPLETED|Overall Study||1||
59615797|NCT02400255|75726920|FG000|STARTED|Overall Study||22||
59615798|NCT02400255|75726921|FG001|STARTED|Overall Study||5||
59615799|NCT02400255|75726922|FG002|STARTED|Overall Study||1||
59615800|NCT02400255|75726923|FG003|STARTED|Overall Study||2||
59615801|NCT02400255|75726920|FG000|COMPLETED|Overall Study||5||
59615802|NCT02400255|75726921|FG001|COMPLETED|Overall Study||1||
59615803|NCT02400255|75726922|FG002|COMPLETED|Overall Study||0||
59615804|NCT02400255|75726923|FG003|COMPLETED|Overall Study||0||
59615805|NCT02400255|75726920|FG000|NOT COMPLETED|Overall Study||17||
59615806|NCT02400255|75726921|FG001|NOT COMPLETED|Overall Study||4||
59615807|NCT02400255|75726922|FG002|NOT COMPLETED|Overall Study||1||
59615808|NCT02400255|75726923|FG003|NOT COMPLETED|Overall Study||2||
59615809|NCT01868438|75726931|FG000|STARTED|First Intervention||30||
59615810|NCT01868438|75726932|FG001|STARTED|First Intervention||30||
59615811|NCT01868438|75726931|FG000|COMPLETED|First Intervention||23||
59615812|NCT01868438|75726932|FG001|COMPLETED|First Intervention||25||
59615813|NCT01868438|75726931|FG000|NOT COMPLETED|First Intervention||7||
59615814|NCT01868438|75726932|FG001|NOT COMPLETED|First Intervention||5||
59615815|NCT01868438|75726931|FG000|STARTED|Second Intervention||23||
59615816|NCT01868438|75726932|FG001|STARTED|Second Intervention||25||
59615817|NCT01868438|75726931|FG000|COMPLETED|Second Intervention||20||
59615818|NCT01868438|75726932|FG001|COMPLETED|Second Intervention||22||
59615819|NCT01868438|75726931|FG000|NOT COMPLETED|Second Intervention||3||
59615820|NCT01868438|75726932|FG001|NOT COMPLETED|Second Intervention||3||
59615821|NCT01208662|75726941|FG000|STARTED|Induction and Consolidation||357||
59615822|NCT01208662|75726942|FG001|STARTED|Induction and Consolidation||365||
59615823|NCT01208662|75726943|FG002|STARTED|Induction and Consolidation||7||
59615824|NCT01208662|75726941|FG000|Randomized|Induction and Consolidation||357|Participants were randomized after 1 cycle of therapy only if cycle 1 therapy was completed and/or participant did not withdraw.|
59615825|NCT01208662|75726942|FG001|Randomized|Induction and Consolidation||365|Participants were randomized after 1 cycle of therapy only if cycle 1 therapy was completed and/or participant did not withdraw.|
59615826|NCT01208662|75726943|FG002|Randomized|Induction and Consolidation||0|Participants were randomized after 1 cycle of therapy only if cycle 1 therapy was completed and/or participant did not withdraw.|
59615827|NCT01208662|75726941|FG000|Underwent Stem Cell Mobilization|Induction and Consolidation||324||
59615828|NCT01208662|75726942|FG001|Underwent Stem Cell Mobilization|Induction and Consolidation||330||
59615829|NCT01208662|75726943|FG002|Underwent Stem Cell Mobilization|Induction and Consolidation||0||
59615830|NCT01208662|75726941|FG000|COMPLETED|Induction and Consolidation||291||
59615831|NCT01208662|75726942|FG001|COMPLETED|Induction and Consolidation||289||
59615832|NCT01208662|75726943|FG002|COMPLETED|Induction and Consolidation||0||
59615833|NCT01208662|75726941|FG000|NOT COMPLETED|Induction and Consolidation||66||
59615834|NCT01208662|75726942|FG001|NOT COMPLETED|Induction and Consolidation||76||
59615835|NCT01208662|75726943|FG002|NOT COMPLETED|Induction and Consolidation||7||
59615836|NCT01208662|75726941|FG000|STARTED|Maintenance||291||
59615837|NCT01208662|75726942|FG001|STARTED|Maintenance||289||
59615838|NCT01208662|75726943|FG002|STARTED|Maintenance||0||
59615839|NCT01208662|75726941|FG000|Minimal Residual Disease (MRD) Evaluable at Maintenance Start|Maintenance||108|MRD evaluable subset represents participants with clonal sequence identified at baseline plus MRD assessment at start of maintenance.|
59615840|NCT01208662|75726942|FG001|Minimal Residual Disease (MRD) Evaluable at Maintenance Start|Maintenance||90|MRD evaluable subset represents participants with clonal sequence identified at baseline plus MRD assessment at start of maintenance.|
59615841|NCT01208662|75726943|FG002|Minimal Residual Disease (MRD) Evaluable at Maintenance Start|Maintenance||0|MRD evaluable subset represents participants with clonal sequence identified at baseline plus MRD assessment at start of maintenance.|
59615842|NCT01208662|75726941|FG000|COMPLETED|Maintenance||0|Given maintenance treatment duration is not fixed, all participants are considered as 'Not Completed'.|
59615843|NCT01208662|75726942|FG001|COMPLETED|Maintenance||0|Given maintenance treatment duration is not fixed, all participants are considered as 'Not Completed'.|
59615844|NCT01208662|75726943|FG002|COMPLETED|Maintenance||0|Given maintenance treatment duration is not fixed, all participants are considered as 'Not Completed'.|
59615845|NCT01208662|75726941|FG000|NOT COMPLETED|Maintenance||291||
59615846|NCT01208662|75726942|FG001|NOT COMPLETED|Maintenance||289||
59615847|NCT01208662|75726943|FG002|NOT COMPLETED|Maintenance||0||
59615848|NCT01457352|75726952|FG000|STARTED|Period 1||392|16 subjects were discontinued during Part 1 of the study.|
59709500|NCT00907153|75828244|FG001|COMPLETED|Overall Study||11||
59615849|NCT01457352|75726953|FG001|STARTED|Period 1||0|16 subjects were discontinued during Part 1 of the study.|
59615850|NCT01457352|75726952|FG000|COMPLETED|Period 1||376|6 subjects were discontinued during Part 3 of the study.|
59615851|NCT01457352|75726953|FG001|COMPLETED|Period 1||0|6 subjects were discontinued during Part 3 of the study.|
60071751|NCT01703091|76187090|FG001|STARTED|Overall Study||99||
60071752|NCT01703091|76187089|FG000|Received at Least One Dose of Study Drug|Overall Study||94||
60071753|NCT01703091|76187090|FG001|Received at Least One Dose of Study Drug|Overall Study||98||
60071754|NCT01703091|76187089|FG000|COMPLETED|Overall Study||89||
60071755|NCT01703091|76187090|FG001|COMPLETED|Overall Study||95||
60071756|NCT01703091|76187089|FG000|NOT COMPLETED|Overall Study||9||
59615852|NCT01457352|75726952|FG000|NOT COMPLETED|Period 1||16||
59615853|NCT01457352|75726953|FG001|NOT COMPLETED|Period 1||0||
59615854|NCT01457352|75726952|FG000|STARTED|Period 2||376|80 subjects were discontinued in Part 2 of the study.|
59615855|NCT01457352|75726953|FG001|STARTED|Period 2||0|80 subjects were discontinued in Part 2 of the study.|
59615856|NCT01457352|75726952|FG000|COMPLETED|Period 2||296||
60071757|NCT01703091|76187090|FG001|NOT COMPLETED|Overall Study||4||
59615857|NCT01457352|75726953|FG001|COMPLETED|Period 2||0||
59615858|NCT01457352|75726952|FG000|NOT COMPLETED|Period 2||80||
59615859|NCT01457352|75726953|FG001|NOT COMPLETED|Period 2||0||
59615860|NCT01457352|75726952|FG000|STARTED|Period 3||147||
59615861|NCT01457352|75726953|FG001|STARTED|Period 3||149||
59615862|NCT01457352|75726952|FG000|Randomization|Period 3||147||
59615863|NCT01457352|75726953|FG001|Randomization|Period 3||149||
59615864|NCT01457352|75726952|FG000|COMPLETED|Period 3||146||
59615865|NCT01457352|75726953|FG001|COMPLETED|Period 3||144||
59615866|NCT01457352|75726952|FG000|NOT COMPLETED|Period 3||1||
59615867|NCT01457352|75726953|FG001|NOT COMPLETED|Period 3||5||
59615868|NCT01457118|75726967|FG000|STARTED|Overall Study||20||
59615869|NCT01457118|75726968|FG001|STARTED|Overall Study||4||
59615870|NCT01457118|75726969|FG002|STARTED|Overall Study||1||
59615871|NCT01457118|75726970|FG003|STARTED|Overall Study||2||
59615872|NCT01457118|75726967|FG000|COMPLETED|Overall Study||0||
59615873|NCT01457118|75726968|FG001|COMPLETED|Overall Study||0||
59615874|NCT01457118|75726969|FG002|COMPLETED|Overall Study||0||
59615875|NCT01457118|75726970|FG003|COMPLETED|Overall Study||0||
59615876|NCT01457118|75726967|FG000|NOT COMPLETED|Overall Study||20||
59615877|NCT01457118|75726968|FG001|NOT COMPLETED|Overall Study||4||
59615878|NCT01457118|75726969|FG002|NOT COMPLETED|Overall Study||1||
59615879|NCT01457118|75726970|FG003|NOT COMPLETED|Overall Study||2||
59615880|NCT01456962|75726982|FG000|STARTED|Overall Study||16||
59615881|NCT01456962|75726983|FG001|STARTED|Overall Study||20||
59615882|NCT01456962|75726982|FG000|COMPLETED|Overall Study||14||
59615883|NCT01456962|75726983|FG001|COMPLETED|Overall Study||19||
59615884|NCT01456962|75726982|FG000|NOT COMPLETED|Overall Study||2||
59615885|NCT01456962|75726983|FG001|NOT COMPLETED|Overall Study||1||
59615886|NCT01501110|75726991|FG000|STARTED|Overall Study||34||
59615887|NCT01501110|75726992|FG001|STARTED|Overall Study||34||
59615888|NCT01501110|75726991|FG000|COMPLETED|Overall Study||34||
59615889|NCT01501110|75726992|FG001|COMPLETED|Overall Study||33||
59615890|NCT01501110|75726991|FG000|NOT COMPLETED|Overall Study||0||
59615891|NCT01501110|75726992|FG001|NOT COMPLETED|Overall Study||1||
59615892|NCT01500720|75727000|FG000|STARTED|Overall Study|Randomized|90||
59615893|NCT01500720|75727001|FG001|STARTED|Overall Study|Randomized|89||
59615894|NCT01500720|75727000|FG000|Treated|Overall Study||89||
59615895|NCT01500720|75727001|FG001|Treated|Overall Study||88||
59615896|NCT01500720|75727000|FG000|COMPLETED|Overall Study|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|85||
59615897|NCT01500720|75727001|FG001|COMPLETED|Overall Study|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|80||
59615898|NCT01500720|75727000|FG000|NOT COMPLETED|Overall Study||5||
59615899|NCT01500720|75727001|FG001|NOT COMPLETED|Overall Study||9||
59615900|NCT01500252|75727009|FG000|STARTED|Overall Study||21||
59615901|NCT01500252|75727010|FG001|STARTED|Overall Study||17||
59615902|NCT01500252|75727009|FG000|One Years|Overall Study||20||
59615903|NCT01500252|75727010|FG001|One Years|Overall Study||16||
59615904|NCT01500252|75727009|FG000|Five Years|Overall Study||17||
59615905|NCT01500252|75727010|FG001|Five Years|Overall Study||13||
60071758|NCT01712685|76187096|FG000|STARTED|Overall Study||12||
60071759|NCT01712685|76187096|FG000|COMPLETED|Overall Study||11||
60071760|NCT01712685|76187096|FG000|NOT COMPLETED|Overall Study||1||
60071761|NCT01867671|76187102|FG000|STARTED|Overall Study||96||
59615906|NCT01500252|75727009|FG000|Ten Years|Overall Study||12||
59615907|NCT01500252|75727010|FG001|Ten Years|Overall Study||11||
59615908|NCT01500252|75727009|FG000|COMPLETED|Overall Study|2 participants died within 5 years; 2 participants died between 5 & 10 years for a total of 4 deaths|12||
60071762|NCT01867671|76187103|FG001|STARTED|Overall Study||50||
59615909|NCT01500252|75727010|FG001|COMPLETED|Overall Study|2 participant deceased by 5 years; no further deaths between 5 & 10 years for a total of 2 deaths|11||
59615910|NCT01500252|75727009|FG000|NOT COMPLETED|Overall Study||9||
59615911|NCT01500252|75727010|FG001|NOT COMPLETED|Overall Study||6||
59615912|NCT01476696|75727017|FG000|STARTED|Overall Study||15||
60071763|NCT01867671|76187102|FG000|COMPLETED|Overall Study||67||
60071764|NCT01867671|76187103|FG001|COMPLETED|Overall Study||22||
59615913|NCT01476696|75727018|FG001|STARTED|Overall Study||9||
59615914|NCT01476696|75727019|FG002|STARTED|Overall Study||9||
59615915|NCT01476696|75727017|FG000|Received at Least 1 Dose of Study Drug|Overall Study||15||
59615916|NCT01476696|75727018|FG001|Received at Least 1 Dose of Study Drug|Overall Study||9||
59615917|NCT01476696|75727019|FG002|Received at Least 1 Dose of Study Drug|Overall Study||9||
59615918|NCT01476696|75727017|FG000|COMPLETED|Overall Study||12||
59615919|NCT01476696|75727018|FG001|COMPLETED|Overall Study||8||
59615920|NCT01476696|75727019|FG002|COMPLETED|Overall Study||9||
59615921|NCT01476696|75727017|FG000|NOT COMPLETED|Overall Study||3||
59615922|NCT01476696|75727018|FG001|NOT COMPLETED|Overall Study||1||
59615923|NCT01476696|75727019|FG002|NOT COMPLETED|Overall Study||0||
59615924|NCT01500096|75727036|FG000|STARTED|Overall Study||32||
59615925|NCT01500096|75727037|FG001|STARTED|Overall Study||17||
59615926|NCT01500096|75727038|FG002|STARTED|Overall Study||31||
59615927|NCT01500096|75727039|FG003|STARTED|Overall Study||16||
59615928|NCT01500096|75727036|FG000|COMPLETED|Overall Study||31||
59615929|NCT01500096|75727037|FG001|COMPLETED|Overall Study||17||
59615930|NCT01500096|75727038|FG002|COMPLETED|Overall Study||31||
59615931|NCT01500096|75727039|FG003|COMPLETED|Overall Study||14||
59615932|NCT01500096|75727036|FG000|NOT COMPLETED|Overall Study||1||
59615933|NCT01500096|75727037|FG001|NOT COMPLETED|Overall Study||0||
59615934|NCT01500096|75727038|FG002|NOT COMPLETED|Overall Study||0||
59615935|NCT01500096|75727039|FG003|NOT COMPLETED|Overall Study||2||
59615936|NCT01455012|75727051|FG000|STARTED|Overall Study||41||
59615937|NCT01455012|75727052|FG001|STARTED|Overall Study||40||
59615938|NCT01455012|75727051|FG000|COMPLETED|Overall Study||30||
59615939|NCT01455012|75727052|FG001|COMPLETED|Overall Study||36||
59615940|NCT01455012|75727051|FG000|NOT COMPLETED|Overall Study||11||
59615941|NCT01455012|75727052|FG001|NOT COMPLETED|Overall Study||4||
59615942|NCT01454778|75727058|FG000|STARTED|Overall Study||50||
59615943|NCT01454778|75727058|FG000|COMPLETED|Overall Study||47||
59615944|NCT01454778|75727058|FG000|NOT COMPLETED|Overall Study||3||
59615945|NCT01454076|75727067|FG000|STARTED|Overall Study||29||
59615946|NCT01454076|75727068|FG001|STARTED|Overall Study||20||
59615947|NCT01454076|75727069|FG002|STARTED|Overall Study||24||
59615948|NCT01454076|75727070|FG003|STARTED|Overall Study||18||
59615949|NCT01454076|75727071|FG004|STARTED|Overall Study||21||
59615950|NCT01454076|75727067|FG000|COMPLETED|Overall Study||16||
59615951|NCT01454076|75727068|FG001|COMPLETED|Overall Study||14||
59615952|NCT01454076|75727069|FG002|COMPLETED|Overall Study||15||
59615953|NCT01454076|75727070|FG003|COMPLETED|Overall Study||16||
59615954|NCT01454076|75727071|FG004|COMPLETED|Overall Study||15||
59615955|NCT01454076|75727067|FG000|NOT COMPLETED|Overall Study||13||
59615956|NCT01454076|75727068|FG001|NOT COMPLETED|Overall Study||6||
59615957|NCT01454076|75727069|FG002|NOT COMPLETED|Overall Study||9||
59615958|NCT01454076|75727070|FG003|NOT COMPLETED|Overall Study||2||
59615959|NCT01454076|75727071|FG004|NOT COMPLETED|Overall Study||6||
59615960|NCT01453998|75727095|FG000|STARTED|Before Protocol Amendment 2||85||
59615961|NCT01453998|75727096|FG001|STARTED|Before Protocol Amendment 2||88||
59615962|NCT01453998|75727097|FG002|STARTED|Before Protocol Amendment 2||99||
59615963|NCT01453998|75727095|FG000|COMPLETED|Before Protocol Amendment 2||85||
59615964|NCT01453998|75727096|FG001|COMPLETED|Before Protocol Amendment 2||88||
59615965|NCT01453998|75727097|FG002|COMPLETED|Before Protocol Amendment 2||99||
59615966|NCT01453998|75727095|FG000|NOT COMPLETED|Before Protocol Amendment 2||0||
59615967|NCT01453998|75727096|FG001|NOT COMPLETED|Before Protocol Amendment 2||0||
59615968|NCT01453998|75727097|FG002|NOT COMPLETED|Before Protocol Amendment 2||0||
59615969|NCT01453998|75727095|FG000|STARTED|After Protocol Amendment 2.||131||
59615970|NCT01453998|75727096|FG001|STARTED|After Protocol Amendment 2.||130||
59615971|NCT01453998|75727097|FG002|STARTED|After Protocol Amendment 2.||124||
59615972|NCT01453998|75727095|FG000|COMPLETED|After Protocol Amendment 2.||130||
59615973|NCT01453998|75727096|FG001|COMPLETED|After Protocol Amendment 2.||130||
59615974|NCT01453998|75727097|FG002|COMPLETED|After Protocol Amendment 2.||124||
59615975|NCT01453998|75727095|FG000|NOT COMPLETED|After Protocol Amendment 2.||1||
59615976|NCT01453998|75727096|FG001|NOT COMPLETED|After Protocol Amendment 2.||0||
59615977|NCT01453998|75727097|FG002|NOT COMPLETED|After Protocol Amendment 2.||0||
59615978|NCT01453374|75727108|FG000|STARTED|Overall Study||27||
59615979|NCT01453374|75727108|FG000|COMPLETED|Overall Study|Defined as receiving 7 injections and 2 follow-up visits.|9||
59615980|NCT01453374|75727108|FG000|NOT COMPLETED|Overall Study||18||
59615981|NCT01453296|75727114|FG000|STARTED|Treatment Period 1||14||
59615982|NCT01453296|75727115|FG001|STARTED|Treatment Period 1||14||
59615983|NCT01453296|75727114|FG000|COMPLETED|Treatment Period 1||13||
59615984|NCT01453296|75727115|FG001|COMPLETED|Treatment Period 1||13||
59615985|NCT01453296|75727114|FG000|NOT COMPLETED|Treatment Period 1||1||
59615986|NCT01453296|75727115|FG001|NOT COMPLETED|Treatment Period 1||1||
59615987|NCT01453296|75727114|FG000|STARTED|Washout Period||13||
59615988|NCT01453296|75727115|FG001|STARTED|Washout Period||13||
59615989|NCT01453296|75727114|FG000|COMPLETED|Washout Period||13||
59615990|NCT01453296|75727115|FG001|COMPLETED|Washout Period||13||
59615991|NCT01453296|75727114|FG000|NOT COMPLETED|Washout Period||0||
59615992|NCT01453296|75727115|FG001|NOT COMPLETED|Washout Period||0||
59615993|NCT01453296|75727114|FG000|STARTED|Treatment Period 2||13||
59615994|NCT01453296|75727115|FG001|STARTED|Treatment Period 2||13||
59615995|NCT01453296|75727114|FG000|COMPLETED|Treatment Period 2||11||
59615996|NCT01453296|75727115|FG001|COMPLETED|Treatment Period 2||13||
59615997|NCT01453296|75727114|FG000|NOT COMPLETED|Treatment Period 2||2||
59615998|NCT01453296|75727115|FG001|NOT COMPLETED|Treatment Period 2||0||
59615999|NCT01453140|75727121|FG000|STARTED|Overall Study|3 patients were enrolled|3||
59616000|NCT01453140|75727121|FG000|COMPLETED|Overall Study|All three patients experienced grade 4 limiting toxicities (possible treatment related)|0||
59616001|NCT01453140|75727121|FG000|NOT COMPLETED|Overall Study||3||
59616002|NCT01499940|75727129|FG000|STARTED|Overall Study||9||
59616003|NCT01499940|75727129|FG000|COMPLETED|Overall Study||0||
59616004|NCT01499940|75727129|FG000|NOT COMPLETED|Overall Study||9||
59616005|NCT01499160|75727133|FG000|STARTED|Overall Study||7||
59616006|NCT01499160|75727133|FG000|COMPLETED|Overall Study|"1 pt-withdrew consent~1pt-had cardiac toxicity"|5|number of who completed all study treatments|
59616007|NCT01499160|75727133|FG000|NOT COMPLETED|Overall Study||2||
59616008|NCT01498692|75727138|FG000|STARTED|Overall Study||94||
59616009|NCT01498692|75727138|FG000|COMPLETED|Overall Study||86||
59616010|NCT01498692|75727138|FG000|NOT COMPLETED|Overall Study||8||
59616011|NCT01498068|75727144|FG000|STARTED|Overall Study||16||
59616012|NCT01498068|75727145|FG001|STARTED|Overall Study||20||
59616013|NCT01498068|75727144|FG000|COMPLETED|Overall Study||15||
59616014|NCT01498068|75727145|FG001|COMPLETED|Overall Study||19||
59616015|NCT01498068|75727144|FG000|NOT COMPLETED|Overall Study||1||
59616016|NCT01498068|75727145|FG001|NOT COMPLETED|Overall Study||1||
59616017|NCT01497366|75727153|FG000|STARTED|Overall Study||263||
59616018|NCT01497366|75727154|FG001|STARTED|Overall Study||264||
59616019|NCT01497366|75727153|FG000|Randomized But Not Treated|Overall Study||7||
59616020|NCT01497366|75727154|FG001|Randomized But Not Treated|Overall Study||21||
59616021|NCT01497366|75727153|FG000|COMPLETED|Overall Study||224||
59616022|NCT01497366|75727154|FG001|COMPLETED|Overall Study||176||
59616023|NCT01497366|75727153|FG000|NOT COMPLETED|Overall Study||39||
59616024|NCT01497366|75727154|FG001|NOT COMPLETED|Overall Study||88||
59616025|NCT01475838|75727163|FG000|STARTED|Randomized Phase||293||
59616026|NCT01475838|75727164|FG001|STARTED|Randomized Phase||145||
59616027|NCT01475838|75727163|FG000|COMPLETED|Randomized Phase||263||
59616028|NCT01475838|75727164|FG001|COMPLETED|Randomized Phase||109||
59616029|NCT01475838|75727163|FG000|NOT COMPLETED|Randomized Phase||30||
59616030|NCT01475838|75727164|FG001|NOT COMPLETED|Randomized Phase||36||
59616031|NCT01475838|75727163|FG000|STARTED|Extension Phase||42||
59616032|NCT01475838|75727164|FG001|STARTED|Extension Phase||20||
59616033|NCT01475838|75727163|FG000|COMPLETED|Extension Phase||41||
59616034|NCT01475838|75727164|FG001|COMPLETED|Extension Phase||20||
59616035|NCT01475838|75727163|FG000|NOT COMPLETED|Extension Phase||1||
59616036|NCT01475838|75727164|FG001|NOT COMPLETED|Extension Phase||0||
59616037|NCT01451814|75727173|FG000|STARTED|Overall Study||35||
59616038|NCT01451814|75727174|FG001|STARTED|Overall Study||31||
59616039|NCT01451814|75727173|FG000|Attended a Session|Overall Study||35||
59616040|NCT01451814|75727174|FG001|Attended a Session|Overall Study||31||
59616041|NCT01451814|75727173|FG000|COMPLETED|Overall Study||29||
59616042|NCT01451814|75727174|FG001|COMPLETED|Overall Study||26||
59616043|NCT01451814|75727173|FG000|NOT COMPLETED|Overall Study||6||
59616044|NCT01451814|75727174|FG001|NOT COMPLETED|Overall Study||5||
59616045|NCT01475370|75727183|FG000|STARTED|Overall Study||3||
59616046|NCT01475370|75727184|FG001|STARTED|Overall Study||3||
59616047|NCT01475370|75727185|FG002|STARTED|Overall Study||3||
59616048|NCT01475370|75727183|FG000|COMPLETED|Overall Study||0||
59616049|NCT01475370|75727184|FG001|COMPLETED|Overall Study||0||
59616050|NCT01475370|75727185|FG002|COMPLETED|Overall Study||0||
59616051|NCT01475370|75727183|FG000|NOT COMPLETED|Overall Study||3||
59616052|NCT01475370|75727184|FG001|NOT COMPLETED|Overall Study||3||
59616053|NCT01475370|75727185|FG002|NOT COMPLETED|Overall Study||3||
59616054|NCT01496430|75727196|FG000|STARTED|Overall Study||35||
59616055|NCT01496430|75727197|FG001|STARTED|Overall Study||35||
59616056|NCT01496430|75727198|FG002|STARTED|Overall Study||35||
59616057|NCT01496430|75727196|FG000|COMPLETED|Overall Study||29||
59616058|NCT01496430|75727197|FG001|COMPLETED|Overall Study||30||
59616059|NCT01496430|75727198|FG002|COMPLETED|Overall Study||25||
59616060|NCT01496430|75727196|FG000|NOT COMPLETED|Overall Study||6||
59616061|NCT01496430|75727197|FG001|NOT COMPLETED|Overall Study||5||
59616062|NCT01496430|75727198|FG002|NOT COMPLETED|Overall Study||10||
59616063|NCT01451424|75727210|FG000|STARTED|Overall Study||9||
59616064|NCT01451424|75727211|FG001|STARTED|Overall Study||9||
59616065|NCT01451424|75727212|FG002|STARTED|Overall Study||12||
59616066|NCT01451424|75727213|FG003|STARTED|Overall Study||10||
59616067|NCT01451424|75727210|FG000|COMPLETED|Overall Study||8||
59616068|NCT01451424|75727211|FG001|COMPLETED|Overall Study||7||
59616069|NCT01451424|75727212|FG002|COMPLETED|Overall Study||11||
59616070|NCT01451424|75727213|FG003|COMPLETED|Overall Study||5||
59616071|NCT01451424|75727210|FG000|NOT COMPLETED|Overall Study||1||
59616072|NCT01451424|75727211|FG001|NOT COMPLETED|Overall Study||2||
59616073|NCT01451424|75727212|FG002|NOT COMPLETED|Overall Study||1||
59616074|NCT01451424|75727213|FG003|NOT COMPLETED|Overall Study||5||
59616075|NCT01475214|75727231|FG000|STARTED|Overall Study||84||
59616076|NCT01475214|75727232|FG001|STARTED|Overall Study||79||
59616077|NCT01475214|75727233|FG002|STARTED|Overall Study||81||
59616078|NCT01475214|75727231|FG000|COMPLETED|Overall Study||79||
59616079|NCT01475214|75727232|FG001|COMPLETED|Overall Study||75||
59616080|NCT01475214|75727233|FG002|COMPLETED|Overall Study||79||
59616081|NCT01475214|75727231|FG000|NOT COMPLETED|Overall Study||5||
59616082|NCT01475214|75727232|FG001|NOT COMPLETED|Overall Study||4||
59616083|NCT01475214|75727233|FG002|NOT COMPLETED|Overall Study||2||
59616084|NCT01496274|75727244|FG000|STARTED|Overall Study||40||
59616085|NCT01496274|75727245|FG001|STARTED|Overall Study||23||
59616086|NCT01496274|75727244|FG000|COMPLETED|Overall Study||37||
59616087|NCT01496274|75727245|FG001|COMPLETED|Overall Study||18||
59616088|NCT01496274|75727244|FG000|NOT COMPLETED|Overall Study||3||
59616089|NCT01496274|75727245|FG001|NOT COMPLETED|Overall Study||5||
59616090|NCT01475136|75727270|FG000|STARTED|Overall Study||7||
59616091|NCT01475136|75727271|FG001|STARTED|Overall Study||9||
59616092|NCT01475136|75727272|FG002|STARTED|Overall Study||9||
59616093|NCT01475136|75727273|FG003|STARTED|Overall Study||12||
59616094|NCT01475136|75727270|FG000|Received 1 Dose of Study Drug|Overall Study||7||
59616095|NCT01475136|75727271|FG001|Received 1 Dose of Study Drug|Overall Study||6||
59616096|NCT01475136|75727272|FG002|Received 1 Dose of Study Drug|Overall Study||6||
59616097|NCT01475136|75727273|FG003|Received 1 Dose of Study Drug|Overall Study||7||
59616098|NCT01475136|75727270|FG000|COMPLETED|Overall Study||6||
59616099|NCT01475136|75727271|FG001|COMPLETED|Overall Study||6||
59616100|NCT01475136|75727272|FG002|COMPLETED|Overall Study||6||
60071765|NCT01867671|76187102|FG000|NOT COMPLETED|Overall Study||29||
60071766|NCT01867671|76187103|FG001|NOT COMPLETED|Overall Study||28||
60071767|NCT01702311|76187111|FG000|STARTED|Overall Study||122||
60071768|NCT01702311|76187112|FG001|STARTED|Overall Study||113||
60071769|NCT01702311|76187111|FG000|COMPLETED|Overall Study||106||
60071770|NCT01702311|76187112|FG001|COMPLETED|Overall Study||100||
60071771|NCT01702311|76187111|FG000|NOT COMPLETED|Overall Study||16||
60071772|NCT01702311|76187112|FG001|NOT COMPLETED|Overall Study||13||
60071773|NCT04552743|76187121|FG000|STARTED|Overall Study||25||
60071774|NCT04552743|76187121|FG000|COMPLETED|Overall Study||25||
60071775|NCT04552743|76187121|FG000|NOT COMPLETED|Overall Study||0||
60071776|NCT01712061|76187128|FG000|STARTED|Overall Study||30||
60071777|NCT01712061|76187129|FG001|STARTED|Overall Study||140||
60071778|NCT01712061|76187130|FG002|STARTED|Overall Study||56||
60071779|NCT01712061|76187128|FG000|COMPLETED|Overall Study||20||
60071780|NCT01712061|76187129|FG001|COMPLETED|Overall Study||114||
60071781|NCT01712061|76187130|FG002|COMPLETED|Overall Study||45||
60071782|NCT01712061|76187128|FG000|NOT COMPLETED|Overall Study||10||
60071783|NCT01712061|76187129|FG001|NOT COMPLETED|Overall Study||26||
60071784|NCT01712061|76187130|FG002|NOT COMPLETED|Overall Study||11||
60071785|NCT03592186|76187141|FG000|STARTED|Overall Study||60||30
60071786|NCT03592186|76187142|FG001|STARTED|Overall Study||62||31
60071787|NCT03592186|76187141|FG000|6-week Follow-up|Overall Study||49|At 6-week follow-up, 25 PW+ dyads (25 parents, 24 teens) and 29 TAU dyads (29 parents, 27 teens)|25
60071788|NCT03592186|76187142|FG001|6-week Follow-up|Overall Study||56|At 6-week follow-up, 25 PW+ dyads (25 parents, 24 teens) and 29 TAU dyads (29 parents, 27 teens)|29
60071789|NCT03592186|76187141|FG000|12-week Follow-up|Overall Study||47|At 12-week follow-up, 27 PW+ dyads (25 parents, 22 teens) and 27 TAU dyads (26 parents, 25 teens)|27
60071790|NCT03592186|76187142|FG001|12-week Follow-up|Overall Study||51|At 12-week follow-up, 27 PW+ dyads (25 parents, 22 teens) and 27 TAU dyads (26 parents, 25 teens)|27
60071791|NCT03592186|76187141|FG000|COMPLETED|Overall Study||43|At 24-week (final), 24 PW+ dyads (23 parents, 20 teens) and 27 TAU dyads (25 parents, 26 teens).|24
60071792|NCT03592186|76187142|FG001|COMPLETED|Overall Study||51|At 24-week (final), 24 PW+ dyads (23 parents, 20 teens) and 27 TAU dyads (25 parents, 26 teens).|27
60071793|NCT03592186|76187141|FG000|NOT COMPLETED|Overall Study||17||6
59616101|NCT01475136|75727273|FG003|COMPLETED|Overall Study||7||
59616102|NCT01475136|75727270|FG000|NOT COMPLETED|Overall Study||1||
59616103|NCT01475136|75727271|FG001|NOT COMPLETED|Overall Study||3||
59616104|NCT01475136|75727272|FG002|NOT COMPLETED|Overall Study||3||
59616105|NCT01475136|75727273|FG003|NOT COMPLETED|Overall Study||5||
59616106|NCT01474746|75727285|FG000|STARTED|Overall Study||30||
59616107|NCT01474746|75727286|FG001|STARTED|Overall Study||27||
59616108|NCT01474746|75727285|FG000|COMPLETED|Overall Study||27||
59616109|NCT01474746|75727286|FG001|COMPLETED|Overall Study||25||
59616110|NCT01474746|75727285|FG000|NOT COMPLETED|Overall Study||3||
59616111|NCT01474746|75727286|FG001|NOT COMPLETED|Overall Study||2||
59616112|NCT01450800|75727294|FG000|STARTED|Overall Study|82 participants were randomized to nitrofurantoin|82||
59616113|NCT01450800|75727295|FG001|STARTED|Overall Study|81 participants were randomized to placebo|81||
60071794|NCT03592186|76187142|FG001|NOT COMPLETED|Overall Study||11||4
60071795|NCT03598114|76187150|FG000|STARTED|Overall Study||127||11
59616114|NCT01450800|75727294|FG000|COMPLETED|Overall Study||81||
59616115|NCT01450800|75727295|FG001|COMPLETED|Overall Study||78||
59616116|NCT01450800|75727294|FG000|NOT COMPLETED|Overall Study||1||
59616117|NCT01450800|75727295|FG001|NOT COMPLETED|Overall Study||3||
59616118|NCT01474512|75727306|FG000|STARTED|Induction Period||431||
59616119|NCT01474512|75727307|FG001|STARTED|Induction Period||432||
59616120|NCT01474512|75727308|FG002|STARTED|Induction Period||433||
59616121|NCT01474512|75727309|FG003|STARTED|Induction Period||0||
59616122|NCT01474512|75727310|FG004|STARTED|Induction Period||0||
59616123|NCT01474512|75727311|FG005|STARTED|Induction Period||0||
59616124|NCT01474512|75727312|FG006|STARTED|Induction Period||0||
59616125|NCT01474512|75727313|FG007|STARTED|Induction Period||0||
59616126|NCT01474512|75727314|FG008|STARTED|Induction Period||0||
59616127|NCT01474512|75727315|FG009|STARTED|Induction Period||0||
59616128|NCT01474512|75727316|FG010|STARTED|Induction Period||0||
59616129|NCT01474512|75727317|FG011|STARTED|Induction Period||0||
59616130|NCT01474512|75727318|FG012|STARTED|Induction Period||0||
59616131|NCT01474512|75727319|FG013|STARTED|Induction Period||0||
59616132|NCT01474512|75727320|FG014|STARTED|Induction Period||0||
59616133|NCT01474512|75727321|FG015|STARTED|Induction Period||0||
59616134|NCT01474512|75727322|FG016|STARTED|Induction Period||0||
59616135|NCT01474512|75727323|FG017|STARTED|Induction Period||0||
59616136|NCT01474512|75727306|FG000|Received Study Drug|Induction Period||431||
59616137|NCT01474512|75727307|FG001|Received Study Drug|Induction Period||432||
59616138|NCT01474512|75727308|FG002|Received Study Drug|Induction Period||433||
59616139|NCT01474512|75727309|FG003|Received Study Drug|Induction Period||0||
59616140|NCT01474512|75727310|FG004|Received Study Drug|Induction Period||0||
59616141|NCT01474512|75727311|FG005|Received Study Drug|Induction Period||0||
59616142|NCT01474512|75727312|FG006|Received Study Drug|Induction Period||0||
59616143|NCT01474512|75727313|FG007|Received Study Drug|Induction Period||0||
59616144|NCT01474512|75727314|FG008|Received Study Drug|Induction Period||0||
59616145|NCT01474512|75727315|FG009|Received Study Drug|Induction Period||0||
59616146|NCT01474512|75727316|FG010|Received Study Drug|Induction Period||0||
59616147|NCT01474512|75727317|FG011|Received Study Drug|Induction Period||0||
59616148|NCT01474512|75727318|FG012|Received Study Drug|Induction Period||0||
59616149|NCT01474512|75727319|FG013|Received Study Drug|Induction Period||0||
59616150|NCT01474512|75727320|FG014|Received Study Drug|Induction Period||0||
59616151|NCT01474512|75727321|FG015|Received Study Drug|Induction Period||0||
59616152|NCT01474512|75727322|FG016|Received Study Drug|Induction Period||0||
59616153|NCT01474512|75727323|FG017|Received Study Drug|Induction Period||0||
59616154|NCT01474512|75727306|FG000|COMPLETED|Induction Period||407||
59616155|NCT01474512|75727307|FG001|COMPLETED|Induction Period||408||
59616156|NCT01474512|75727308|FG002|COMPLETED|Induction Period||415||
59616157|NCT01474512|75727309|FG003|COMPLETED|Induction Period||0||
59616158|NCT01474512|75727310|FG004|COMPLETED|Induction Period||0||
59616159|NCT01474512|75727311|FG005|COMPLETED|Induction Period||0||
59616160|NCT01474512|75727312|FG006|COMPLETED|Induction Period||0||
59616161|NCT01474512|75727313|FG007|COMPLETED|Induction Period||0||
59616162|NCT01474512|75727314|FG008|COMPLETED|Induction Period||0||
59616163|NCT01474512|75727315|FG009|COMPLETED|Induction Period||0||
59616164|NCT01474512|75727316|FG010|COMPLETED|Induction Period||0||
59616165|NCT01474512|75727317|FG011|COMPLETED|Induction Period||0||
59616166|NCT01474512|75727318|FG012|COMPLETED|Induction Period||0||
59616167|NCT01474512|75727319|FG013|COMPLETED|Induction Period||0||
59616168|NCT01474512|75727320|FG014|COMPLETED|Induction Period||0||
59616169|NCT01474512|75727321|FG015|COMPLETED|Induction Period||0||
59616170|NCT01474512|75727322|FG016|COMPLETED|Induction Period||0||
59616171|NCT01474512|75727323|FG017|COMPLETED|Induction Period||0||
59616172|NCT01474512|75727306|FG000|NOT COMPLETED|Induction Period||24||
59616173|NCT01474512|75727307|FG001|NOT COMPLETED|Induction Period||24||
59616174|NCT01474512|75727308|FG002|NOT COMPLETED|Induction Period||18||
59616175|NCT01474512|75727309|FG003|NOT COMPLETED|Induction Period||0||
59616176|NCT01474512|75727310|FG004|NOT COMPLETED|Induction Period||0||
59616177|NCT01474512|75727311|FG005|NOT COMPLETED|Induction Period||0||
59616178|NCT01474512|75727312|FG006|NOT COMPLETED|Induction Period||0||
59616179|NCT01474512|75727313|FG007|NOT COMPLETED|Induction Period||0||
59616180|NCT01474512|75727314|FG008|NOT COMPLETED|Induction Period||0||
59616181|NCT01474512|75727315|FG009|NOT COMPLETED|Induction Period||0||
59616182|NCT01474512|75727316|FG010|NOT COMPLETED|Induction Period||0||
59616183|NCT01474512|75727317|FG011|NOT COMPLETED|Induction Period||0||
59616184|NCT01474512|75727318|FG012|NOT COMPLETED|Induction Period||0||
59616185|NCT01474512|75727319|FG013|NOT COMPLETED|Induction Period||0||
59616186|NCT01474512|75727320|FG014|NOT COMPLETED|Induction Period||0||
59616187|NCT01474512|75727321|FG015|NOT COMPLETED|Induction Period||0||
59616188|NCT01474512|75727322|FG016|NOT COMPLETED|Induction Period||0||
59616189|NCT01474512|75727323|FG017|NOT COMPLETED|Induction Period||0||
59616190|NCT01474512|75727306|FG000|STARTED|Maintenance Period||0||
59616191|NCT01474512|75727307|FG001|STARTED|Maintenance Period||0||
59616192|NCT01474512|75727308|FG002|STARTED|Maintenance Period||0||
59616193|NCT01474512|75727309|FG003|STARTED|Maintenance Period||226||
59616194|NCT01474512|75727310|FG004|STARTED|Maintenance Period|One participant withdrew end of Induction but re-randomized and treated with maintenance dose ixe.|227||
59616195|NCT01474512|75727311|FG005|STARTED|Maintenance Period||229||
59616196|NCT01474512|75727312|FG006|STARTED|Maintenance Period||16||
59616197|NCT01474512|75727313|FG007|STARTED|Maintenance Period||391||
59616198|NCT01474512|75727314|FG008|STARTED|Maintenance Period||78||
59616199|NCT01474512|75727315|FG009|STARTED|Maintenance Period||62||
59616200|NCT01474512|75727316|FG010|STARTED|Maintenance Period||0||
59616201|NCT01474512|75727317|FG011|STARTED|Maintenance Period||0||
59616202|NCT01474512|75727318|FG012|STARTED|Maintenance Period||0||
59616203|NCT01474512|75727319|FG013|STARTED|Maintenance Period||0||
59616204|NCT01474512|75727320|FG014|STARTED|Maintenance Period||0||
59616205|NCT01474512|75727321|FG015|STARTED|Maintenance Period||0||
59616206|NCT01474512|75727322|FG016|STARTED|Maintenance Period||0||
59616207|NCT01474512|75727323|FG017|STARTED|Maintenance Period||0||
59616208|NCT01474512|75727306|FG000|Received Study Drug|Maintenance Period||0||
59616209|NCT01474512|75727307|FG001|Received Study Drug|Maintenance Period||0||
59616210|NCT01474512|75727308|FG002|Received Study Drug|Maintenance Period||0||
59616211|NCT01474512|75727309|FG003|Received Study Drug|Maintenance Period||226||
59616212|NCT01474512|75727310|FG004|Received Study Drug|Maintenance Period||227||
59616213|NCT01474512|75727311|FG005|Received Study Drug|Maintenance Period||229||
59616214|NCT01474512|75727312|FG006|Received Study Drug|Maintenance Period||16||
59616215|NCT01474512|75727313|FG007|Received Study Drug|Maintenance Period||391||
59616216|NCT01474512|75727314|FG008|Received Study Drug|Maintenance Period||78||
59616217|NCT01474512|75727315|FG009|Received Study Drug|Maintenance Period||62||
59616218|NCT01474512|75727316|FG010|Received Study Drug|Maintenance Period||0||
59616219|NCT01474512|75727317|FG011|Received Study Drug|Maintenance Period||0||
59616220|NCT01474512|75727318|FG012|Received Study Drug|Maintenance Period||0||
59616221|NCT01474512|75727319|FG013|Received Study Drug|Maintenance Period||0||
59616222|NCT01474512|75727320|FG014|Received Study Drug|Maintenance Period||0||
59616223|NCT01474512|75727321|FG015|Received Study Drug|Maintenance Period||0||
59616224|NCT01474512|75727322|FG016|Received Study Drug|Maintenance Period||0||
59616225|NCT01474512|75727323|FG017|Received Study Drug|Maintenance Period||0||
59616226|NCT01474512|75727306|FG000|Relapsed Population Received Drug|Maintenance Period||0||
59616227|NCT01474512|75727307|FG001|Relapsed Population Received Drug|Maintenance Period||0||
59616228|NCT01474512|75727308|FG002|Relapsed Population Received Drug|Maintenance Period||0||
59616229|NCT01474512|75727309|FG003|Relapsed Population Received Drug|Maintenance Period||0||
59616230|NCT01474512|75727310|FG004|Relapsed Population Received Drug|Maintenance Period||0||
59616231|NCT01474512|75727311|FG005|Relapsed Population Received Drug|Maintenance Period||0||
59616232|NCT01474512|75727312|FG006|Relapsed Population Received Drug|Maintenance Period||0||
59616233|NCT01474512|75727313|FG007|Relapsed Population Received Drug|Maintenance Period||0||
59616234|NCT01474512|75727314|FG008|Relapsed Population Received Drug|Maintenance Period||0||
59616235|NCT01474512|75727315|FG009|Relapsed Population Received Drug|Maintenance Period||0||
59616236|NCT01474512|75727316|FG010|Relapsed Population Received Drug|Maintenance Period||348||
59616237|NCT01474512|75727317|FG011|Relapsed Population Received Drug|Maintenance Period||0||
59616238|NCT01474512|75727318|FG012|Relapsed Population Received Drug|Maintenance Period||0||
59616239|NCT01474512|75727319|FG013|Relapsed Population Received Drug|Maintenance Period||0||
59616240|NCT01474512|75727320|FG014|Relapsed Population Received Drug|Maintenance Period||0||
59616241|NCT01474512|75727321|FG015|Relapsed Population Received Drug|Maintenance Period||0||
59616242|NCT01474512|75727322|FG016|Relapsed Population Received Drug|Maintenance Period||0||
59616243|NCT01474512|75727323|FG017|Relapsed Population Received Drug|Maintenance Period||0||
59616244|NCT01474512|75727306|FG000|Relapsed Population Completers|Maintenance Period||0||
59616245|NCT01474512|75727307|FG001|Relapsed Population Completers|Maintenance Period||0||
59616246|NCT01474512|75727308|FG002|Relapsed Population Completers|Maintenance Period||0||
59616247|NCT01474512|75727309|FG003|Relapsed Population Completers|Maintenance Period||0||
59616248|NCT01474512|75727310|FG004|Relapsed Population Completers|Maintenance Period||0||
59616249|NCT01474512|75727311|FG005|Relapsed Population Completers|Maintenance Period||0||
59616250|NCT01474512|75727312|FG006|Relapsed Population Completers|Maintenance Period||0||
59616251|NCT01474512|75727313|FG007|Relapsed Population Completers|Maintenance Period||0||
59616252|NCT01474512|75727314|FG008|Relapsed Population Completers|Maintenance Period||0||
59616253|NCT01474512|75727315|FG009|Relapsed Population Completers|Maintenance Period||0||
59616254|NCT01474512|75727316|FG010|Relapsed Population Completers|Maintenance Period||321||
59616255|NCT01474512|75727317|FG011|Relapsed Population Completers|Maintenance Period||0||
59616256|NCT01474512|75727318|FG012|Relapsed Population Completers|Maintenance Period||0||
59616257|NCT01474512|75727319|FG013|Relapsed Population Completers|Maintenance Period||0||
59616258|NCT01474512|75727320|FG014|Relapsed Population Completers|Maintenance Period||0||
59616259|NCT01474512|75727321|FG015|Relapsed Population Completers|Maintenance Period||0||
59616260|NCT01474512|75727322|FG016|Relapsed Population Completers|Maintenance Period||0||
59616261|NCT01474512|75727323|FG017|Relapsed Population Completers|Maintenance Period||0||
59616262|NCT01474512|75727306|FG000|COMPLETED|Maintenance Period||0||
59616263|NCT01474512|75727307|FG001|COMPLETED|Maintenance Period||0||
59616264|NCT01474512|75727308|FG002|COMPLETED|Maintenance Period||0||
59616265|NCT01474512|75727309|FG003|COMPLETED|Maintenance Period||24||
59616266|NCT01474512|75727310|FG004|COMPLETED|Maintenance Period||108||
59616267|NCT01474512|75727311|FG005|COMPLETED|Maintenance Period||177||
59616268|NCT01474512|75727312|FG006|COMPLETED|Maintenance Period||6||
59616269|NCT01474512|75727313|FG007|COMPLETED|Maintenance Period||350||
59616270|NCT01474512|75727314|FG008|COMPLETED|Maintenance Period||62||
59616271|NCT01474512|75727315|FG009|COMPLETED|Maintenance Period||44||
59616272|NCT01474512|75727316|FG010|COMPLETED|Maintenance Period||0||
59616273|NCT01474512|75727317|FG011|COMPLETED|Maintenance Period||0||
59616274|NCT01474512|75727318|FG012|COMPLETED|Maintenance Period||0||
59616275|NCT01474512|75727319|FG013|COMPLETED|Maintenance Period||0||
59616276|NCT01474512|75727320|FG014|COMPLETED|Maintenance Period||0||
59616277|NCT01474512|75727321|FG015|COMPLETED|Maintenance Period||0||
59616278|NCT01474512|75727322|FG016|COMPLETED|Maintenance Period||0||
59616279|NCT01474512|75727323|FG017|COMPLETED|Maintenance Period||0||
59616280|NCT01474512|75727306|FG000|NOT COMPLETED|Maintenance Period||0||
59616281|NCT01474512|75727307|FG001|NOT COMPLETED|Maintenance Period||0||
59616282|NCT01474512|75727308|FG002|NOT COMPLETED|Maintenance Period||0||
59616283|NCT01474512|75727309|FG003|NOT COMPLETED|Maintenance Period||202||
59616284|NCT01474512|75727310|FG004|NOT COMPLETED|Maintenance Period||119||
59616285|NCT01474512|75727311|FG005|NOT COMPLETED|Maintenance Period||52||
59616286|NCT01474512|75727312|FG006|NOT COMPLETED|Maintenance Period||10||
59616287|NCT01474512|75727313|FG007|NOT COMPLETED|Maintenance Period||41||
59616288|NCT01474512|75727314|FG008|NOT COMPLETED|Maintenance Period||16||
59616289|NCT01474512|75727315|FG009|NOT COMPLETED|Maintenance Period||18||
59616290|NCT01474512|75727316|FG010|NOT COMPLETED|Maintenance Period||0||
59616291|NCT01474512|75727317|FG011|NOT COMPLETED|Maintenance Period||0||
59616292|NCT01474512|75727318|FG012|NOT COMPLETED|Maintenance Period||0||
59616293|NCT01474512|75727319|FG013|NOT COMPLETED|Maintenance Period||0||
59616294|NCT01474512|75727320|FG014|NOT COMPLETED|Maintenance Period||0||
59616295|NCT01474512|75727321|FG015|NOT COMPLETED|Maintenance Period||0||
59616296|NCT01474512|75727322|FG016|NOT COMPLETED|Maintenance Period||0||
59616297|NCT01474512|75727323|FG017|NOT COMPLETED|Maintenance Period||0||
59616298|NCT01474512|75727306|FG000|STARTED|Long-Term Extension Period||0||
59616299|NCT01474512|75727307|FG001|STARTED|Long-Term Extension Period||0||
59616300|NCT01474512|75727308|FG002|STARTED|Long-Term Extension Period||0||
59616301|NCT01474512|75727309|FG003|STARTED|Long-Term Extension Period||0||
59616302|NCT01474512|75727310|FG004|STARTED|Long-Term Extension Period||0||
59616303|NCT01474512|75727311|FG005|STARTED|Long-Term Extension Period||0||
59616304|NCT01474512|75727312|FG006|STARTED|Long-Term Extension Period||0||
59616305|NCT01474512|75727313|FG007|STARTED|Long-Term Extension Period||0||
59616306|NCT01474512|75727314|FG008|STARTED|Long-Term Extension Period||0||
59616307|NCT01474512|75727315|FG009|STARTED|Long-Term Extension Period||0||
59616308|NCT01474512|75727316|FG010|STARTED|Long-Term Extension Period||0||
59616309|NCT01474512|75727317|FG011|STARTED|Long-Term Extension Period|9 participants did not start the long-term extension period.|26||
59616310|NCT01474512|75727318|FG012|STARTED|Long-Term Extension Period|Participants received Ixe alone at the start of long-term extension.|1054||
59616311|NCT01474512|75727319|FG013|STARTED|Long-Term Extension Period|Participants received Ixe in all dosing regimens, including participants who switched PBO to Ixe.|1075||
59616312|NCT01474512|75727320|FG014|STARTED|Long-Term Extension Period||0||
59616313|NCT01474512|75727321|FG015|STARTED|Long-Term Extension Period||0||
59616314|NCT01474512|75727322|FG016|STARTED|Long-Term Extension Period||0||
59616315|NCT01474512|75727323|FG017|STARTED|Long-Term Extension Period||0||
59616316|NCT01474512|75727306|FG000|COMPLETED|Long-Term Extension Period||0||
59616317|NCT01474512|75727307|FG001|COMPLETED|Long-Term Extension Period||0||
59616318|NCT01474512|75727308|FG002|COMPLETED|Long-Term Extension Period||0||
59616319|NCT01474512|75727309|FG003|COMPLETED|Long-Term Extension Period||0||
59616320|NCT01474512|75727310|FG004|COMPLETED|Long-Term Extension Period||0||
59616321|NCT01474512|75727311|FG005|COMPLETED|Long-Term Extension Period||0||
59616322|NCT01474512|75727312|FG006|COMPLETED|Long-Term Extension Period||0||
59616323|NCT01474512|75727313|FG007|COMPLETED|Long-Term Extension Period||0||
59616324|NCT01474512|75727314|FG008|COMPLETED|Long-Term Extension Period||0||
59616325|NCT01474512|75727315|FG009|COMPLETED|Long-Term Extension Period||0||
59616326|NCT01474512|75727316|FG010|COMPLETED|Long-Term Extension Period||0||
59616327|NCT01474512|75727317|FG011|COMPLETED|Long-Term Extension Period||0||
59616328|NCT01474512|75727318|FG012|COMPLETED|Long-Term Extension Period||836||
59616329|NCT01474512|75727319|FG013|COMPLETED|Long-Term Extension Period||855||
59616330|NCT01474512|75727320|FG014|COMPLETED|Long-Term Extension Period||0||
59616331|NCT01474512|75727321|FG015|COMPLETED|Long-Term Extension Period||0||
59616332|NCT01474512|75727322|FG016|COMPLETED|Long-Term Extension Period||0||
59616333|NCT01474512|75727323|FG017|COMPLETED|Long-Term Extension Period||0||
59616334|NCT01474512|75727306|FG000|NOT COMPLETED|Long-Term Extension Period||0||
59616335|NCT01474512|75727307|FG001|NOT COMPLETED|Long-Term Extension Period||0||
59616336|NCT01474512|75727308|FG002|NOT COMPLETED|Long-Term Extension Period||0||
59616337|NCT01474512|75727309|FG003|NOT COMPLETED|Long-Term Extension Period||0||
59616338|NCT01474512|75727310|FG004|NOT COMPLETED|Long-Term Extension Period||0||
59616339|NCT01474512|75727311|FG005|NOT COMPLETED|Long-Term Extension Period||0||
59616340|NCT01474512|75727312|FG006|NOT COMPLETED|Long-Term Extension Period||0||
59616341|NCT01474512|75727313|FG007|NOT COMPLETED|Long-Term Extension Period||0||
59616342|NCT01474512|75727314|FG008|NOT COMPLETED|Long-Term Extension Period||0||
59616343|NCT01474512|75727315|FG009|NOT COMPLETED|Long-Term Extension Period||0||
59616344|NCT01474512|75727316|FG010|NOT COMPLETED|Long-Term Extension Period||0||
59616345|NCT01474512|75727317|FG011|NOT COMPLETED|Long-Term Extension Period||26||
59616346|NCT01474512|75727318|FG012|NOT COMPLETED|Long-Term Extension Period||218||
59616347|NCT01474512|75727319|FG013|NOT COMPLETED|Long-Term Extension Period||220||
59616348|NCT01474512|75727320|FG014|NOT COMPLETED|Long-Term Extension Period||0||
59616349|NCT01474512|75727321|FG015|NOT COMPLETED|Long-Term Extension Period||0||
59616350|NCT01474512|75727322|FG016|NOT COMPLETED|Long-Term Extension Period||0||
59616351|NCT01474512|75727323|FG017|NOT COMPLETED|Long-Term Extension Period||0||
59616352|NCT01474512|75727306|FG000|STARTED|Post-Treatment Follow-Up||0||
59616353|NCT01474512|75727307|FG001|STARTED|Post-Treatment Follow-Up||0||
59616354|NCT01474512|75727308|FG002|STARTED|Post-Treatment Follow-Up||0||
59616355|NCT01474512|75727309|FG003|STARTED|Post-Treatment Follow-Up||0||
59616356|NCT01474512|75727310|FG004|STARTED|Post-Treatment Follow-Up||0||
59616357|NCT01474512|75727311|FG005|STARTED|Post-Treatment Follow-Up||0||
59616358|NCT01474512|75727312|FG006|STARTED|Post-Treatment Follow-Up||0||
59616359|NCT01474512|75727313|FG007|STARTED|Post-Treatment Follow-Up||0||
59616360|NCT01474512|75727314|FG008|STARTED|Post-Treatment Follow-Up||0||
59616361|NCT01474512|75727315|FG009|STARTED|Post-Treatment Follow-Up||0||
59616362|NCT01474512|75727316|FG010|STARTED|Post-Treatment Follow-Up||0||
59616363|NCT01474512|75727317|FG011|STARTED|Post-Treatment Follow-Up||0||
59616364|NCT01474512|75727318|FG012|STARTED|Post-Treatment Follow-Up||0||
59616365|NCT01474512|75727319|FG013|STARTED|Post-Treatment Follow-Up||0||
59616366|NCT01474512|75727320|FG014|STARTED|Post-Treatment Follow-Up|Includes participants who started the post treatment follow-up period.|18||
59616367|NCT01474512|75727321|FG015|STARTED|Post-Treatment Follow-Up|Includes participants who started the post treatment follow-up period.|25||
59616368|NCT01474512|75727322|FG016|STARTED|Post-Treatment Follow-Up|Includes participants who started the post treatment follow-up period.|700||
59616369|NCT01474512|75727323|FG017|STARTED|Post-Treatment Follow-Up|Includes participants who started the post treatment follow-up period.|285||
59616370|NCT01474512|75727306|FG000|COMPLETED|Post-Treatment Follow-Up||0||
59616371|NCT01474512|75727307|FG001|COMPLETED|Post-Treatment Follow-Up||0||
59616372|NCT01474512|75727308|FG002|COMPLETED|Post-Treatment Follow-Up||0||
59616373|NCT01474512|75727309|FG003|COMPLETED|Post-Treatment Follow-Up||0||
59616374|NCT01474512|75727310|FG004|COMPLETED|Post-Treatment Follow-Up||0||
59616375|NCT01474512|75727311|FG005|COMPLETED|Post-Treatment Follow-Up||0||
59616376|NCT01474512|75727312|FG006|COMPLETED|Post-Treatment Follow-Up||0||
59616377|NCT01474512|75727313|FG007|COMPLETED|Post-Treatment Follow-Up||0||
59616378|NCT01474512|75727314|FG008|COMPLETED|Post-Treatment Follow-Up||0||
59616379|NCT01474512|75727315|FG009|COMPLETED|Post-Treatment Follow-Up||0||
59616380|NCT01474512|75727316|FG010|COMPLETED|Post-Treatment Follow-Up||0||
59616381|NCT01474512|75727317|FG011|COMPLETED|Post-Treatment Follow-Up||0||
59616382|NCT01474512|75727318|FG012|COMPLETED|Post-Treatment Follow-Up||0||
59616383|NCT01474512|75727319|FG013|COMPLETED|Post-Treatment Follow-Up||0||
59616384|NCT01474512|75727320|FG014|COMPLETED|Post-Treatment Follow-Up||0||
59616385|NCT01474512|75727321|FG015|COMPLETED|Post-Treatment Follow-Up||17||
59616386|NCT01474512|75727322|FG016|COMPLETED|Post-Treatment Follow-Up||544||
59616387|NCT01474512|75727323|FG017|COMPLETED|Post-Treatment Follow-Up||239||
59616388|NCT01474512|75727306|FG000|NOT COMPLETED|Post-Treatment Follow-Up||0||
59616389|NCT01474512|75727307|FG001|NOT COMPLETED|Post-Treatment Follow-Up||0||
59616390|NCT01474512|75727308|FG002|NOT COMPLETED|Post-Treatment Follow-Up||0||
59616391|NCT01474512|75727309|FG003|NOT COMPLETED|Post-Treatment Follow-Up||0||
59616392|NCT01474512|75727310|FG004|NOT COMPLETED|Post-Treatment Follow-Up||0||
59616393|NCT01474512|75727311|FG005|NOT COMPLETED|Post-Treatment Follow-Up||0||
59616394|NCT01474512|75727312|FG006|NOT COMPLETED|Post-Treatment Follow-Up||0||
59616395|NCT01474512|75727313|FG007|NOT COMPLETED|Post-Treatment Follow-Up||0||
59616396|NCT01474512|75727314|FG008|NOT COMPLETED|Post-Treatment Follow-Up||0||
59616397|NCT01474512|75727315|FG009|NOT COMPLETED|Post-Treatment Follow-Up||0||
59616398|NCT01474512|75727316|FG010|NOT COMPLETED|Post-Treatment Follow-Up||0||
59616399|NCT01474512|75727317|FG011|NOT COMPLETED|Post-Treatment Follow-Up||0||
59616400|NCT01474512|75727318|FG012|NOT COMPLETED|Post-Treatment Follow-Up||0||
59616401|NCT01474512|75727319|FG013|NOT COMPLETED|Post-Treatment Follow-Up||0||
59616402|NCT01474512|75727320|FG014|NOT COMPLETED|Post-Treatment Follow-Up||18||
59616403|NCT01474512|75727321|FG015|NOT COMPLETED|Post-Treatment Follow-Up||8||
59616404|NCT01474512|75727322|FG016|NOT COMPLETED|Post-Treatment Follow-Up||156||
59616405|NCT01474512|75727323|FG017|NOT COMPLETED|Post-Treatment Follow-Up||46||
59616406|NCT01474434|75727357|FG000|STARTED|Treatment Period 1 (5 Days [Day 1 - 5])||8||
59616407|NCT01474434|75727358|FG001|STARTED|Treatment Period 1 (5 Days [Day 1 - 5])||9||
59616408|NCT01474434|75727359|FG002|STARTED|Treatment Period 1 (5 Days [Day 1 - 5])||11||
59616409|NCT01474434|75727360|FG003|STARTED|Treatment Period 1 (5 Days [Day 1 - 5])||13||
59616410|NCT01474434|75727357|FG000|COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||7||
59616411|NCT01474434|75727358|FG001|COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||9||
59616412|NCT01474434|75727359|FG002|COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||10||
59616413|NCT01474434|75727360|FG003|COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||11||
59616414|NCT01474434|75727357|FG000|NOT COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||1||
59616415|NCT01474434|75727358|FG001|NOT COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||0||
59616416|NCT01474434|75727359|FG002|NOT COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||1||
59616417|NCT01474434|75727360|FG003|NOT COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||2||
59616418|NCT01474434|75727357|FG000|STARTED|Treatment Period 2(5 Days[Day 36 - 40])||7||
59616419|NCT01474434|75727358|FG001|STARTED|Treatment Period 2(5 Days[Day 36 - 40])||9||
59616420|NCT01474434|75727359|FG002|STARTED|Treatment Period 2(5 Days[Day 36 - 40])||10||
59616421|NCT01474434|75727360|FG003|STARTED|Treatment Period 2(5 Days[Day 36 - 40])||11||
59616422|NCT01474434|75727357|FG000|COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||7||
59616423|NCT01474434|75727358|FG001|COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||9||
59616424|NCT01474434|75727359|FG002|COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||10||
59616425|NCT01474434|75727360|FG003|COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||11||
59616426|NCT01474434|75727357|FG000|NOT COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||0||
59616427|NCT01474434|75727358|FG001|NOT COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||0||
59616428|NCT01474434|75727359|FG002|NOT COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||0||
59616429|NCT01474434|75727360|FG003|NOT COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||0||
59616430|NCT01473732|75727376|FG000|STARTED|Overall Study||2||
59616431|NCT01473732|75727377|FG001|STARTED|Overall Study||0||
59616432|NCT01473732|75727376|FG000|COMPLETED|Overall Study||0||
59616433|NCT01473732|75727377|FG001|COMPLETED|Overall Study||0||
59616434|NCT01473732|75727376|FG000|NOT COMPLETED|Overall Study||2||
59616435|NCT01473732|75727377|FG001|NOT COMPLETED|Overall Study||0||
59616436|NCT01450098|75727385|FG000|STARTED|Period 1||8||
59616437|NCT01450098|75727386|FG001|STARTED|Period 1||31||
59616438|NCT01450098|75727385|FG000|Received at Least 1 Dose of Study Drug|Period 1||8||
59616439|NCT01450098|75727386|FG001|Received at Least 1 Dose of Study Drug|Period 1||31||
59616440|NCT01450098|75727385|FG000|COMPLETED|Period 1||8||
59616441|NCT01450098|75727386|FG001|COMPLETED|Period 1||31||
59616442|NCT01450098|75727385|FG000|NOT COMPLETED|Period 1||0||
59616443|NCT01450098|75727386|FG001|NOT COMPLETED|Period 1||0||
59616444|NCT01450098|75727385|FG000|STARTED|Washout Period of at Least 14 Days||8||
59616445|NCT01450098|75727386|FG001|STARTED|Washout Period of at Least 14 Days||31||
59616446|NCT01450098|75727385|FG000|COMPLETED|Washout Period of at Least 14 Days||8||
59616447|NCT01450098|75727386|FG001|COMPLETED|Washout Period of at Least 14 Days||31||
59616448|NCT01450098|75727385|FG000|NOT COMPLETED|Washout Period of at Least 14 Days||0||
59616449|NCT01450098|75727386|FG001|NOT COMPLETED|Washout Period of at Least 14 Days||0||
59616450|NCT01450098|75727385|FG000|STARTED|Period 2||8||
59616451|NCT01450098|75727386|FG001|STARTED|Period 2||31||
59616452|NCT01450098|75727385|FG000|Received at Least 1 Dose of Study Drug|Period 2||8||
59616453|NCT01450098|75727386|FG001|Received at Least 1 Dose of Study Drug|Period 2||31||
59616454|NCT01450098|75727385|FG000|COMPLETED|Period 2||8||
59616455|NCT01450098|75727386|FG001|COMPLETED|Period 2||31||
59616456|NCT01450098|75727385|FG000|NOT COMPLETED|Period 2||0||
59616457|NCT01450098|75727386|FG001|NOT COMPLETED|Period 2||0||
59616458|NCT01450098|75727385|FG000|STARTED|Washout of at Least 14 Days||8||
59616459|NCT01450098|75727386|FG001|STARTED|Washout of at Least 14 Days||31||
59616460|NCT01450098|75727385|FG000|COMPLETED|Washout of at Least 14 Days||8||
59616461|NCT01450098|75727386|FG001|COMPLETED|Washout of at Least 14 Days||31||
59616462|NCT01450098|75727385|FG000|NOT COMPLETED|Washout of at Least 14 Days||0||
59616463|NCT01450098|75727386|FG001|NOT COMPLETED|Washout of at Least 14 Days||0||
59616464|NCT01450098|75727385|FG000|STARTED|Period 3||8||
59616465|NCT01450098|75727386|FG001|STARTED|Period 3||31||
59616466|NCT01450098|75727385|FG000|Received at Least 1 Dose of Study Drug|Period 3||8||
59616467|NCT01450098|75727386|FG001|Received at Least 1 Dose of Study Drug|Period 3||30||
59616468|NCT01450098|75727385|FG000|COMPLETED|Period 3||8||
59616469|NCT01450098|75727386|FG001|COMPLETED|Period 3||28||
59616470|NCT01450098|75727385|FG000|NOT COMPLETED|Period 3||0||
59616471|NCT01450098|75727386|FG001|NOT COMPLETED|Period 3||3||
59616472|NCT01449708|75727401|FG000|STARTED|Overall Study||61||
59616473|NCT01449708|75727402|FG001|STARTED|Overall Study||63||
59616474|NCT01449708|75727401|FG000|COMPLETED|Overall Study||59||
59616475|NCT01449708|75727402|FG001|COMPLETED|Overall Study||60||
59616476|NCT01449708|75727401|FG000|NOT COMPLETED|Overall Study||2||
59616477|NCT01449708|75727402|FG001|NOT COMPLETED|Overall Study||3||
59616478|NCT01449630|75727420|FG000|STARTED|Period 1||2||
59616479|NCT01449630|75727421|FG001|STARTED|Period 1||6||
59616480|NCT01449630|75727422|FG002|STARTED|Period 1||2||
59616481|NCT01449630|75727423|FG003|STARTED|Period 1||2||
59616482|NCT01449630|75727424|FG004|STARTED|Period 1||5||
59616483|NCT01449630|75727425|FG005|STARTED|Period 1||2||
59616484|NCT01449630|75727426|FG006|STARTED|Period 1||2||
59616485|NCT01449630|75727427|FG007|STARTED|Period 1||6||
59616486|NCT01449630|75727428|FG008|STARTED|Period 1||2||
59616487|NCT01449630|75727420|FG000|Received at Least 1 Dose|Period 1||2||
59616488|NCT01449630|75727421|FG001|Received at Least 1 Dose|Period 1||6||
59616489|NCT01449630|75727422|FG002|Received at Least 1 Dose|Period 1||2||
59616490|NCT01449630|75727423|FG003|Received at Least 1 Dose|Period 1||2||
59616491|NCT01449630|75727424|FG004|Received at Least 1 Dose|Period 1||5||
59616492|NCT01449630|75727425|FG005|Received at Least 1 Dose|Period 1||1||
59616493|NCT01449630|75727426|FG006|Received at Least 1 Dose|Period 1||2||
59616494|NCT01449630|75727427|FG007|Received at Least 1 Dose|Period 1||6||
59616495|NCT01449630|75727428|FG008|Received at Least 1 Dose|Period 1||2||
59616496|NCT01449630|75727420|FG000|COMPLETED|Period 1||1||
59616497|NCT01449630|75727421|FG001|COMPLETED|Period 1||6||
59616498|NCT01449630|75727422|FG002|COMPLETED|Period 1||2||
59616499|NCT01449630|75727423|FG003|COMPLETED|Period 1||1||
59616500|NCT01449630|75727424|FG004|COMPLETED|Period 1||5||
59616501|NCT01449630|75727425|FG005|COMPLETED|Period 1||1||
59616502|NCT01449630|75727426|FG006|COMPLETED|Period 1||2||
59616503|NCT01449630|75727427|FG007|COMPLETED|Period 1||6||
59616504|NCT01449630|75727428|FG008|COMPLETED|Period 1||2||
59616505|NCT01449630|75727420|FG000|NOT COMPLETED|Period 1||1||
59616506|NCT01449630|75727421|FG001|NOT COMPLETED|Period 1||0||
59616507|NCT01449630|75727422|FG002|NOT COMPLETED|Period 1||0||
59616508|NCT01449630|75727423|FG003|NOT COMPLETED|Period 1||1||
59616509|NCT01449630|75727424|FG004|NOT COMPLETED|Period 1||0||
59616510|NCT01449630|75727425|FG005|NOT COMPLETED|Period 1||1||
59616511|NCT01449630|75727426|FG006|NOT COMPLETED|Period 1||0||
59616512|NCT01449630|75727427|FG007|NOT COMPLETED|Period 1||0||
59616513|NCT01449630|75727428|FG008|NOT COMPLETED|Period 1||0||
59616514|NCT01449630|75727420|FG000|STARTED|Period 2||1||
59616515|NCT01449630|75727421|FG001|STARTED|Period 2||6||
59616516|NCT01449630|75727422|FG002|STARTED|Period 2||2||
59616517|NCT01449630|75727423|FG003|STARTED|Period 2||1||
59616518|NCT01449630|75727424|FG004|STARTED|Period 2||5||
59616519|NCT01449630|75727425|FG005|STARTED|Period 2||1||
59616520|NCT01449630|75727426|FG006|STARTED|Period 2||2||
59616521|NCT01449630|75727427|FG007|STARTED|Period 2||6||
59616522|NCT01449630|75727428|FG008|STARTED|Period 2||2||
59616523|NCT01449630|75727420|FG000|COMPLETED|Period 2||1||
59616524|NCT01449630|75727421|FG001|COMPLETED|Period 2||6||
59616525|NCT01449630|75727422|FG002|COMPLETED|Period 2||2||
59616526|NCT01449630|75727423|FG003|COMPLETED|Period 2||1||
59616527|NCT01449630|75727424|FG004|COMPLETED|Period 2||5||
59616528|NCT01449630|75727425|FG005|COMPLETED|Period 2||1||
59616529|NCT01449630|75727426|FG006|COMPLETED|Period 2||1||
59616530|NCT01449630|75727427|FG007|COMPLETED|Period 2||6||
59616531|NCT01449630|75727428|FG008|COMPLETED|Period 2||2||
59616532|NCT01449630|75727420|FG000|NOT COMPLETED|Period 2||0||
59616533|NCT01449630|75727421|FG001|NOT COMPLETED|Period 2||0||
59616534|NCT01449630|75727422|FG002|NOT COMPLETED|Period 2||0||
59616535|NCT01449630|75727423|FG003|NOT COMPLETED|Period 2||0||
59616536|NCT01449630|75727424|FG004|NOT COMPLETED|Period 2||0||
59616537|NCT01449630|75727425|FG005|NOT COMPLETED|Period 2||0||
59616538|NCT01449630|75727426|FG006|NOT COMPLETED|Period 2||1||
59616539|NCT01449630|75727427|FG007|NOT COMPLETED|Period 2||0||
59616540|NCT01449630|75727428|FG008|NOT COMPLETED|Period 2||0||
59616541|NCT01449630|75727420|FG000|STARTED|Period 3||1||
59616542|NCT01449630|75727421|FG001|STARTED|Period 3||6||
59616543|NCT01449630|75727422|FG002|STARTED|Period 3||2||
59616544|NCT01449630|75727423|FG003|STARTED|Period 3||1||
59616545|NCT01449630|75727424|FG004|STARTED|Period 3||5||
59616546|NCT01449630|75727425|FG005|STARTED|Period 3||1||
59616547|NCT01449630|75727426|FG006|STARTED|Period 3||1||
59616548|NCT01449630|75727427|FG007|STARTED|Period 3||6||
59616549|NCT01449630|75727428|FG008|STARTED|Period 3||2||
59616550|NCT01449630|75727420|FG000|COMPLETED|Period 3||1||
59616551|NCT01449630|75727421|FG001|COMPLETED|Period 3||6||
59616552|NCT01449630|75727422|FG002|COMPLETED|Period 3||2||
59616553|NCT01449630|75727423|FG003|COMPLETED|Period 3||1||
59616554|NCT01449630|75727424|FG004|COMPLETED|Period 3||5||
59616555|NCT01449630|75727425|FG005|COMPLETED|Period 3||1||
59616556|NCT01449630|75727426|FG006|COMPLETED|Period 3||1||
59616557|NCT01449630|75727427|FG007|COMPLETED|Period 3||6||
59616558|NCT01449630|75727428|FG008|COMPLETED|Period 3||2||
59616559|NCT01449630|75727420|FG000|NOT COMPLETED|Period 3||0||
59616560|NCT01449630|75727421|FG001|NOT COMPLETED|Period 3||0||
59762764|NCT00598442|75882627|FG001|STARTED|Overall Study||163||
59616561|NCT01449630|75727422|FG002|NOT COMPLETED|Period 3||0||
59616562|NCT01449630|75727423|FG003|NOT COMPLETED|Period 3||0||
59616563|NCT01449630|75727424|FG004|NOT COMPLETED|Period 3||0||
59616564|NCT01449630|75727425|FG005|NOT COMPLETED|Period 3||0||
59616565|NCT01449630|75727426|FG006|NOT COMPLETED|Period 3||0||
59616566|NCT01449630|75727427|FG007|NOT COMPLETED|Period 3||0||
59616567|NCT01449630|75727428|FG008|NOT COMPLETED|Period 3||0||
59616568|NCT01493778|75727450|FG000|STARTED|Overall Study||60||
59616569|NCT01493778|75727450|FG000|COMPLETED|Overall Study||52||
59616570|NCT01493778|75727450|FG000|NOT COMPLETED|Overall Study||8||
59616571|NCT01473420|75727465|FG000|STARTED|Titration Period (18 Weeks)||160||
59616572|NCT01473420|75727466|FG001|STARTED|Titration Period (18 Weeks)||160||
59616573|NCT01473420|75727465|FG000|Treated|Titration Period (18 Weeks)||80||
59616574|NCT01473420|75727466|FG001|Treated|Titration Period (18 Weeks)||86||
59616575|NCT01473420|75727465|FG000|COMPLETED|Titration Period (18 Weeks)||124||
59616576|NCT01473420|75727466|FG001|COMPLETED|Titration Period (18 Weeks)||122||
59616577|NCT01473420|75727465|FG000|NOT COMPLETED|Titration Period (18 Weeks)||36||
59616578|NCT01473420|75727466|FG001|NOT COMPLETED|Titration Period (18 Weeks)||38||
59616579|NCT01473420|75727465|FG000|STARTED|Maintenance Period (16 Weeks)||124||
59616580|NCT01473420|75727466|FG001|STARTED|Maintenance Period (16 Weeks)||122||
59616581|NCT01473420|75727465|FG000|COMPLETED|Maintenance Period (16 Weeks)||106||
59616582|NCT01473420|75727466|FG001|COMPLETED|Maintenance Period (16 Weeks)||105||
59616583|NCT01473420|75727465|FG000|NOT COMPLETED|Maintenance Period (16 Weeks)||18||
59616584|NCT01473420|75727466|FG001|NOT COMPLETED|Maintenance Period (16 Weeks)||17||
59616585|NCT01492686|75727480|FG000|STARTED|Double-blind Phase||69||
59616586|NCT01492686|75727481|FG001|STARTED|Double-blind Phase||68||
59616587|NCT01492686|75727480|FG000|COMPLETED|Double-blind Phase||67||
59616588|NCT01492686|75727481|FG001|COMPLETED|Double-blind Phase||60||
59616589|NCT01492686|75727480|FG000|NOT COMPLETED|Double-blind Phase||2||
59616590|NCT01492686|75727481|FG001|NOT COMPLETED|Double-blind Phase||8||
59616591|NCT01492686|75727480|FG000|STARTED|Open-label Phase||65||
59616592|NCT01492686|75727481|FG001|STARTED|Open-label Phase||58||
59616593|NCT01492686|75727480|FG000|COMPLETED|Open-label Phase||53||
59616594|NCT01492686|75727481|FG001|COMPLETED|Open-label Phase||40||
59616595|NCT01492686|75727480|FG000|NOT COMPLETED|Open-label Phase||12||
59616596|NCT01492686|75727481|FG001|NOT COMPLETED|Open-label Phase||18||
59616597|NCT01449006|75727491|FG000|STARTED|Overall Study||8||
59616598|NCT01449006|75727492|FG001|STARTED|Overall Study||9||
59616599|NCT01449006|75727491|FG000|COMPLETED|Overall Study||5||
59616600|NCT01449006|75727492|FG001|COMPLETED|Overall Study||9||
59616601|NCT01449006|75727491|FG000|NOT COMPLETED|Overall Study||3||
59616602|NCT01449006|75727492|FG001|NOT COMPLETED|Overall Study||0||
59616603|NCT01448850|75727500|FG000|STARTED|Overall Study||164||
59616604|NCT01448850|75727501|FG001|STARTED|Overall Study||160||
59520277|NCT01044589|75614209|FG000|STARTED|Overall Study||6||
59520278|NCT01044589|75614210|FG001|STARTED|Overall Study||7||
59616605|NCT01448850|75727500|FG000|COMPLETED|Overall Study||130||
59616606|NCT01448850|75727501|FG001|COMPLETED|Overall Study||120||
59616607|NCT01448850|75727500|FG000|NOT COMPLETED|Overall Study||34||
59616608|NCT01448850|75727501|FG001|NOT COMPLETED|Overall Study||40||
59616609|NCT01491672|75727511|FG000|STARTED|Overall Study||58||
59616610|NCT01491672|75727512|FG001|STARTED|Overall Study|1 participant died prior to treatment initiation.|62||
59616611|NCT01491672|75727513|FG002|STARTED|Overall Study||14||
59616612|NCT01491672|75727511|FG000|Safety Set|Overall Study||58||
59616613|NCT01491672|75727512|FG001|Safety Set|Overall Study||61||
59616614|NCT01491672|75727513|FG002|Safety Set|Overall Study||14||
59616615|NCT01491672|75727511|FG000|COMPLETED|Overall Study||2||
59616616|NCT01491672|75727512|FG001|COMPLETED|Overall Study||2||
59616617|NCT01491672|75727513|FG002|COMPLETED|Overall Study||3||
59616618|NCT01491672|75727511|FG000|NOT COMPLETED|Overall Study||56||
59616619|NCT01491672|75727512|FG001|NOT COMPLETED|Overall Study||60||
59616620|NCT01491672|75727513|FG002|NOT COMPLETED|Overall Study||11||
59616621|NCT01447446|75727529|FG000|STARTED|Overall Study|Started means participants who started treatment and included in core population.|2312||
59616622|NCT01447446|75727530|FG001|STARTED|Overall Study||496||
59616623|NCT01447446|75727531|FG002|STARTED|Overall Study||292||
59616624|NCT01447446|75727532|FG003|STARTED|Overall Study||93||
59616625|NCT01447446|75727533|FG004|STARTED|Overall Study||821||
59616626|NCT01447446|75727534|FG005|STARTED|Overall Study||86||
59616627|NCT01447446|75727529|FG000|COMPLETED|Overall Study|Completed means the participants who completed the 24- weeks of follow-up period.|1590||
59616628|NCT01447446|75727530|FG001|COMPLETED|Overall Study|Insuff.=Insufficient VR= Virological response TRT.=Treatment SVR= Sustained Virological Response|331||
59616629|NCT01447446|75727531|FG002|COMPLETED|Overall Study||192||
59616630|NCT01447446|75727532|FG003|COMPLETED|Overall Study||60||
59616631|NCT01447446|75727533|FG004|COMPLETED|Overall Study||610||
59616632|NCT01447446|75727534|FG005|COMPLETED|Overall Study||54||
59616633|NCT01447446|75727529|FG000|NOT COMPLETED|Overall Study||722||
59616634|NCT01447446|75727530|FG001|NOT COMPLETED|Overall Study||165||
59616635|NCT01447446|75727531|FG002|NOT COMPLETED|Overall Study||100||
59616636|NCT01447446|75727532|FG003|NOT COMPLETED|Overall Study||33||
59616637|NCT01447446|75727533|FG004|NOT COMPLETED|Overall Study||211||
59616638|NCT01447446|75727534|FG005|NOT COMPLETED|Overall Study||32||
59616639|NCT01490814|75727556|FG000|STARTED|Overall Study|378 subjects randomized to Cryoballoon arm|378||
59616640|NCT01490814|75727557|FG001|STARTED|Overall Study|384 subjects randomized to radiofrequency arm|384||
59616641|NCT01490814|75727556|FG000|COMPLETED|Overall Study|374 received ablation|374||
59616642|NCT01490814|75727557|FG001|COMPLETED|Overall Study|376 received ablation|376||
59616643|NCT01490814|75727556|FG000|NOT COMPLETED|Overall Study||4||
59616644|NCT01490814|75727557|FG001|NOT COMPLETED|Overall Study||8||
59616645|NCT01471782|75727569|FG000|STARTED|Overall Study||5||
59616646|NCT01471782|75727570|FG001|STARTED|Overall Study||7||
59616647|NCT01471782|75727571|FG002|STARTED|Overall Study||5||
59616648|NCT01471782|75727572|FG003|STARTED|Overall Study||6||
59616649|NCT01471782|75727573|FG004|STARTED|Overall Study||26||
59616650|NCT01471782|75727574|FG005|STARTED|Overall Study||44||
59616651|NCT01471782|75727569|FG000|COMPLETED|Overall Study|Completed 5 cycles|0||
59616652|NCT01471782|75727570|FG001|COMPLETED|Overall Study|Completed 5 cycles|1||
59616653|NCT01471782|75727571|FG002|COMPLETED|Overall Study|Completed 5 cycles|0||
59616654|NCT01471782|75727572|FG003|COMPLETED|Overall Study|Completed 5 cycles|1||
59616655|NCT01471782|75727573|FG004|COMPLETED|Overall Study|Completed 5 cycles|0||
59616656|NCT01471782|75727574|FG005|COMPLETED|Overall Study|Completed 5 cycles|3||
59616657|NCT01471782|75727569|FG000|NOT COMPLETED|Overall Study||5||
59616658|NCT01471782|75727570|FG001|NOT COMPLETED|Overall Study||6||
59616659|NCT01471782|75727571|FG002|NOT COMPLETED|Overall Study||5||
59616660|NCT01471782|75727572|FG003|NOT COMPLETED|Overall Study||5||
59616661|NCT01471782|75727573|FG004|NOT COMPLETED|Overall Study||26||
59616662|NCT01471782|75727574|FG005|NOT COMPLETED|Overall Study||41||
59616663|NCT01490580|75727601|FG000|STARTED|Overall Study||82||
59616664|NCT01490580|75727602|FG001|STARTED|Overall Study||91||
59616665|NCT01490580|75727601|FG000|COMPLETED|Overall Study||82||
59616666|NCT01490580|75727602|FG001|COMPLETED|Overall Study||89||
59616667|NCT01490580|75727601|FG000|NOT COMPLETED|Overall Study||0||
59616668|NCT01490580|75727602|FG001|NOT COMPLETED|Overall Study||2||
59616669|NCT01490190|75727612|FG000|STARTED|Overall Study||252||
59616670|NCT01490190|75727612|FG000|COMPLETED|Overall Study||204||
59616671|NCT01490190|75727612|FG000|NOT COMPLETED|Overall Study||48||
59616672|NCT01446042|75727619|FG000|STARTED|Overall Study||142||
59616673|NCT01446042|75727620|FG001|STARTED|Overall Study||86||
59616674|NCT01446042|75727621|FG002|STARTED|Overall Study||78||
59616675|NCT01446042|75727619|FG000|COMPLETED|Overall Study||122||
59616676|NCT01446042|75727620|FG001|COMPLETED|Overall Study||83||
59616677|NCT01446042|75727621|FG002|COMPLETED|Overall Study||69||
59616678|NCT01446042|75727619|FG000|NOT COMPLETED|Overall Study||20||
59616679|NCT01446042|75727620|FG001|NOT COMPLETED|Overall Study||3||
59616680|NCT01446042|75727621|FG002|NOT COMPLETED|Overall Study||9||
59616681|NCT01445886|75727629|FG000|STARTED|Overall Study||33||
59616682|NCT01445886|75727629|FG000|COMPLETED|Overall Study||28||
59616683|NCT01445886|75727629|FG000|NOT COMPLETED|Overall Study||5||
59616684|NCT01470612|75727637|FG000|STARTED|Overall Study||175||
59520279|NCT01044589|75614209|FG000|COMPLETED|Overall Study||3||
59520280|NCT01044589|75614210|FG001|COMPLETED|Overall Study||2||
59520281|NCT01044589|75614209|FG000|NOT COMPLETED|Overall Study||3||
59520282|NCT01044589|75614210|FG001|NOT COMPLETED|Overall Study||5||
59520283|NCT03885154|75614220|FG000|STARTED|Overall Study||12||
59520284|NCT03885154|75614221|FG001|STARTED|Overall Study||10||
59520285|NCT03885154|75614222|FG002|STARTED|Overall Study||0||
59616685|NCT01470612|75727638|FG001|STARTED|Overall Study||769||
59616686|NCT01470612|75727637|FG000|COMPLETED|Overall Study||91||
59520286|NCT03885154|75614223|FG003|STARTED|Overall Study||2||
59520287|NCT03885154|75614220|FG000|COMPLETED|Overall Study||12||
59520288|NCT03885154|75614221|FG001|COMPLETED|Overall Study||10||
59520289|NCT03885154|75614222|FG002|COMPLETED|Overall Study||0||
59520290|NCT03885154|75614223|FG003|COMPLETED|Overall Study||2||
59520291|NCT03885154|75614220|FG000|NOT COMPLETED|Overall Study||0||
59520292|NCT03885154|75614221|FG001|NOT COMPLETED|Overall Study||0||
59520293|NCT03885154|75614222|FG002|NOT COMPLETED|Overall Study||0||
59520294|NCT03885154|75614223|FG003|NOT COMPLETED|Overall Study||0||
59520295|NCT01106833|75614233|FG000|STARTED|Overall Study||74||
59520296|NCT01106833|75614234|FG001|STARTED|Overall Study||77||
59520297|NCT01106833|75614233|FG000|COMPLETED|Overall Study||74||
59520298|NCT01106833|75614234|FG001|COMPLETED|Overall Study||77||
59520299|NCT01106833|75614233|FG000|NOT COMPLETED|Overall Study||0||
59520300|NCT01106833|75614234|FG001|NOT COMPLETED|Overall Study||0||
59520301|NCT00957047|75614244|FG000|STARTED|PART I||100||
59520302|NCT00957047|75614245|FG001|STARTED|PART I||96||
59520303|NCT00957047|75614246|FG002|STARTED|PART I||101||
59520304|NCT00957047|75614247|FG003|STARTED|PART I||98||
59520305|NCT00957047|75614248|FG004|STARTED|PART I||0||
59520306|NCT00957047|75614244|FG000|Randomized/Safety Population|PART I||100||
59520307|NCT00957047|75614245|FG001|Randomized/Safety Population|PART I||96||
59520308|NCT00957047|75614246|FG002|Randomized/Safety Population|PART I||101||
59520309|NCT00957047|75614247|FG003|Randomized/Safety Population|PART I||98||
59520310|NCT00957047|75614248|FG004|Randomized/Safety Population|PART I||0||
59520311|NCT00957047|75614244|FG000|Intention-to-treat (ITT) Population|PART I||100||
59520312|NCT00957047|75614245|FG001|Intention-to-treat (ITT) Population|PART I||96||
59520313|NCT00957047|75614246|FG002|Intention-to-treat (ITT) Population|PART I||100||
59520314|NCT00957047|75614247|FG003|Intention-to-treat (ITT) Population|PART I||97||
59520315|NCT00957047|75614248|FG004|Intention-to-treat (ITT) Population|PART I||0||
59520316|NCT00957047|75614244|FG000|Per-Protocol Population|PART I||81||
59520317|NCT00957047|75614245|FG001|Per-Protocol Population|PART I||70||
59520318|NCT00957047|75614246|FG002|Per-Protocol Population|PART I||75||
59520319|NCT00957047|75614247|FG003|Per-Protocol Population|PART I||54||
59520320|NCT00957047|75614248|FG004|Per-Protocol Population|PART I||0||
59520321|NCT00957047|75614244|FG000|COMPLETED|PART I||94||
59520322|NCT00957047|75614245|FG001|COMPLETED|PART I||83||
59520323|NCT00957047|75614246|FG002|COMPLETED|PART I||80||
59520324|NCT00957047|75614247|FG003|COMPLETED|PART I||68||
59520325|NCT00957047|75614248|FG004|COMPLETED|PART I||0||
59520326|NCT00957047|75614244|FG000|NOT COMPLETED|PART I||6||
59520327|NCT00957047|75614245|FG001|NOT COMPLETED|PART I||13||
59520328|NCT00957047|75614246|FG002|NOT COMPLETED|PART I||21||
59520329|NCT00957047|75614247|FG003|NOT COMPLETED|PART I||30||
59520330|NCT00957047|75614248|FG004|NOT COMPLETED|PART I||0||
59520331|NCT00957047|75614244|FG000|STARTED|PART II||0||
59520332|NCT00957047|75614245|FG001|STARTED|PART II||0||
59616687|NCT01470612|75727638|FG001|COMPLETED|Overall Study||104||
59520333|NCT00957047|75614246|FG002|STARTED|PART II||0||
59520334|NCT00957047|75614247|FG003|STARTED|PART II||0||
59520335|NCT00957047|75614248|FG004|STARTED|PART II|325 patients who completed Part I were enrolled in Part II.|325||
59520336|NCT00957047|75614244|FG000|Terminated Prematurely|PART II||0||
59520337|NCT00957047|75614245|FG001|Terminated Prematurely|PART II||0||
59520338|NCT00957047|75614246|FG002|Terminated Prematurely|PART II||0||
59520339|NCT00957047|75614247|FG003|Terminated Prematurely|PART II||0||
59520340|NCT00957047|75614248|FG004|Terminated Prematurely|PART II|Terminated Prematurely during 1-year Open-Label Period|102||
59520341|NCT00957047|75614244|FG000|COMPLETED|PART II||0||
59520342|NCT00957047|75614245|FG001|COMPLETED|PART II||0||
59520343|NCT00957047|75614246|FG002|COMPLETED|PART II||0||
59616688|NCT01470612|75727637|FG000|NOT COMPLETED|Overall Study||84||
59616689|NCT01470612|75727638|FG001|NOT COMPLETED|Overall Study||665||
59616690|NCT01445730|75727644|FG000|STARTED|Overall Study||82||
59616691|NCT01445730|75727644|FG000|COMPLETED|Overall Study||71||
59616692|NCT01445730|75727644|FG000|NOT COMPLETED|Overall Study||11||
59616693|NCT01445652|75727650|FG000|STARTED|Overall Study||57||
59616694|NCT01445652|75727651|FG001|STARTED|Overall Study||53||
59616695|NCT01445652|75727650|FG000|COMPLETED|Overall Study||47||
59616696|NCT01445652|75727651|FG001|COMPLETED|Overall Study||50||
59616697|NCT01445652|75727650|FG000|NOT COMPLETED|Overall Study||10||
59616698|NCT01445652|75727651|FG001|NOT COMPLETED|Overall Study||3||
59616699|NCT01470144|75727657|FG000|STARTED|Overall Study||41||
59616700|NCT01470144|75727657|FG000|COMPLETED|Overall Study|"Completed corresponds to subjects switching to commercial EFI upon market approval/reimbursement"|31||
59616701|NCT01470144|75727657|FG000|NOT COMPLETED|Overall Study||10||
59616702|NCT01443858|75727664|FG000|STARTED|Overall Study||25||
59616703|NCT01443858|75727665|FG001|STARTED|Overall Study||25||
59616704|NCT01443858|75727666|FG002|STARTED|Overall Study||25||
59616705|NCT01443858|75727664|FG000|COMPLETED|Overall Study||10||
59616706|NCT01443858|75727665|FG001|COMPLETED|Overall Study||12||
59616707|NCT01443858|75727666|FG002|COMPLETED|Overall Study||18||
59616708|NCT01443858|75727664|FG000|NOT COMPLETED|Overall Study||15||
59616709|NCT01443858|75727665|FG001|NOT COMPLETED|Overall Study||13||
59616710|NCT01443858|75727666|FG002|NOT COMPLETED|Overall Study||7||
59616711|NCT01443078|75727674|FG000|STARTED|Overall Study||42||
59616712|NCT01443078|75727674|FG000|COMPLETED|Overall Study||13||
59616713|NCT01443078|75727674|FG000|NOT COMPLETED|Overall Study||29||
59616714|NCT01439880|75727680|FG000|STARTED|SOC-controlled Period (Year 1)||442||
59616715|NCT01439880|75727681|FG001|STARTED|SOC-controlled Period (Year 1)||882||
59616716|NCT01439880|75727680|FG000|Received Evolocumab|SOC-controlled Period (Year 1)||0||
59616717|NCT01439880|75727681|FG001|Received Evolocumab|SOC-controlled Period (Year 1)||881||
59616718|NCT01439880|75727680|FG000|COMPLETED|SOC-controlled Period (Year 1)||398||
59616719|NCT01439880|75727681|FG001|COMPLETED|SOC-controlled Period (Year 1)||822||
59616720|NCT01439880|75727680|FG000|NOT COMPLETED|SOC-controlled Period (Year 1)||44||
59616721|NCT01439880|75727681|FG001|NOT COMPLETED|SOC-controlled Period (Year 1)||60||
59616722|NCT01439880|75727680|FG000|STARTED|All-IP Period (Years 2 to 5)||398||
59616723|NCT01439880|75727681|FG001|STARTED|All-IP Period (Years 2 to 5)||822||
59616724|NCT01439880|75727680|FG000|Received Evolocumab|All-IP Period (Years 2 to 5)||374||
59616725|NCT01439880|75727681|FG001|Received Evolocumab|All-IP Period (Years 2 to 5)||777||
59616726|NCT01439880|75727680|FG000|COMPLETED|All-IP Period (Years 2 to 5)||328||
59616727|NCT01439880|75727681|FG001|COMPLETED|All-IP Period (Years 2 to 5)||682||
59616728|NCT01439880|75727680|FG000|NOT COMPLETED|All-IP Period (Years 2 to 5)||70||
59616729|NCT01439880|75727681|FG001|NOT COMPLETED|All-IP Period (Years 2 to 5)||140||
59616730|NCT01469364|75727698|FG000|STARTED|Overall Study||30||
59616731|NCT01469364|75727698|FG000|COMPLETED|Overall Study||28||
59616732|NCT01469364|75727698|FG000|NOT COMPLETED|Overall Study||2||
59616733|NCT01439724|75727704|FG000|STARTED|Overall Study||47||
60071796|NCT03598114|76187151|FG001|STARTED|Overall Study||128||12
60071797|NCT03598114|76187150|FG000|COMPLETED|Overall Study||124||11
60071798|NCT03598114|76187151|FG001|COMPLETED|Overall Study||89||12
59616734|NCT01439724|75727705|FG001|STARTED|Overall Study||47||
59616735|NCT01439724|75727704|FG000|COMPLETED|Overall Study||38||
59616736|NCT01439724|75727705|FG001|COMPLETED|Overall Study||39||
59616737|NCT01439724|75727704|FG000|NOT COMPLETED|Overall Study||9||
59616738|NCT01439724|75727705|FG001|NOT COMPLETED|Overall Study||8||
59616739|NCT01439568|75727713|FG000|STARTED|Overall Study||47||
59616740|NCT01439568|75727714|FG001|STARTED|Overall Study||43||
59616741|NCT01439568|75727713|FG000|Received at Least One Dose of Study Drug|Overall Study||47||
59616742|NCT01439568|75727714|FG001|Received at Least One Dose of Study Drug|Overall Study||43||
59616743|NCT01439568|75727713|FG000|COMPLETED|Overall Study||44||
59616744|NCT01439568|75727714|FG001|COMPLETED|Overall Study||41||
59616745|NCT01439568|75727713|FG000|NOT COMPLETED|Overall Study||3||
59616746|NCT01439568|75727714|FG001|NOT COMPLETED|Overall Study||2||
60071799|NCT03598114|76187150|FG000|NOT COMPLETED|Overall Study||3||0
60071800|NCT03598114|76187151|FG001|NOT COMPLETED|Overall Study||39||0
60071801|NCT01711983|76187178|FG000|STARTED|6-Month Clinical Success Evaluation||400||
60071802|NCT01711983|76187178|FG000|COMPLETED|6-Month Clinical Success Evaluation||368||
60071803|NCT01711983|76187178|FG000|NOT COMPLETED|6-Month Clinical Success Evaluation||32||
60071804|NCT01711983|76187178|FG000|STARTED|6-Month Closure Evaluation||368||
60071805|NCT01711983|76187178|FG000|COMPLETED|6-Month Closure Evaluation||342||
59616747|NCT01469052|75727726|FG000|STARTED|Overall Study||6||
60071806|NCT01711983|76187178|FG000|NOT COMPLETED|6-Month Closure Evaluation||26||
60071807|NCT01711983|76187178|FG000|STARTED|36-Month Closure Evaluation||342||
59616748|NCT01469052|75727727|FG001|STARTED|Overall Study||4||
59616749|NCT01469052|75727728|FG002|STARTED|Overall Study||6||
59616750|NCT01469052|75727729|FG003|STARTED|Overall Study||6||
59616751|NCT01469052|75727730|FG004|STARTED|Overall Study||8||
59616752|NCT01469052|75727731|FG005|STARTED|Overall Study||6||
59616753|NCT01469052|75727726|FG000|COMPLETED|Overall Study||0||
59616754|NCT01469052|75727727|FG001|COMPLETED|Overall Study||0||
59616755|NCT01469052|75727728|FG002|COMPLETED|Overall Study||0||
59616756|NCT01469052|75727729|FG003|COMPLETED|Overall Study||1||
59616757|NCT01469052|75727730|FG004|COMPLETED|Overall Study||0||
59616758|NCT01469052|75727731|FG005|COMPLETED|Overall Study||0||
59616759|NCT01469052|75727726|FG000|NOT COMPLETED|Overall Study||6||
59616760|NCT01469052|75727727|FG001|NOT COMPLETED|Overall Study||4||
59616761|NCT01469052|75727728|FG002|NOT COMPLETED|Overall Study||6||
59616762|NCT01469052|75727729|FG003|NOT COMPLETED|Overall Study||5||
59616763|NCT01469052|75727730|FG004|NOT COMPLETED|Overall Study||8||
59616764|NCT01469052|75727731|FG005|NOT COMPLETED|Overall Study||6||
59616765|NCT01468818|75727743|FG000|STARTED|Overall Study||18||
59616766|NCT01468818|75727743|FG000|COMPLETED|Overall Study||16||
59616767|NCT01468818|75727743|FG000|NOT COMPLETED|Overall Study||2||
59616768|NCT01442376|75727750|FG000|STARTED|Overall Study|Randomized patients|169||
59616769|NCT01442376|75727751|FG001|STARTED|Overall Study|Randomized patients|169||
59616770|NCT01442376|75727752|FG002|STARTED|Overall Study|Randomized patients|164||
59616771|NCT01442376|75727750|FG000|COMPLETED|Overall Study||166||
59616772|NCT01442376|75727751|FG001|COMPLETED|Overall Study||160||
59616773|NCT01442376|75727752|FG002|COMPLETED|Overall Study||159||
59616774|NCT01442376|75727750|FG000|NOT COMPLETED|Overall Study||3||
59616775|NCT01442376|75727751|FG001|NOT COMPLETED|Overall Study||9||
59616776|NCT01442376|75727752|FG002|NOT COMPLETED|Overall Study||5||
59616777|NCT01442064|75727766|FG000|STARTED|Overall Study||97||
59616778|NCT01442064|75727767|FG001|STARTED|Overall Study||103||
59616779|NCT01442064|75727768|FG002|STARTED|Overall Study||104||
59616780|NCT01442064|75727769|FG003|STARTED|Overall Study||98||
59616781|NCT01442064|75727770|FG004|STARTED|Overall Study||107||
59616782|NCT01442064|75727771|FG005|STARTED|Overall Study||99||
59616783|NCT01442064|75727766|FG000|Ranibizumab-Treated Subjects|Overall Study|Includes participants who received Ranibizumab in either the initial studies or the extension study.|93||
59616784|NCT01442064|75727767|FG001|Ranibizumab-Treated Subjects|Overall Study||103||
59616785|NCT01442064|75727768|FG002|Ranibizumab-Treated Subjects|Overall Study||104||
59616786|NCT01442064|75727769|FG003|Ranibizumab-Treated Subjects|Overall Study||96||
59616787|NCT01442064|75727770|FG004|Ranibizumab-Treated Subjects|Overall Study||107||
59616788|NCT01442064|75727771|FG005|Ranibizumab-Treated Subjects|Overall Study||99||
59616789|NCT01442064|75727766|FG000|Received Study Drug in Extension Study|Overall Study||61||
59616790|NCT01442064|75727767|FG001|Received Study Drug in Extension Study|Overall Study||70||
59616791|NCT01442064|75727768|FG002|Received Study Drug in Extension Study|Overall Study||60||
59616792|NCT01442064|75727769|FG003|Received Study Drug in Extension Study|Overall Study||70||
59616793|NCT01442064|75727770|FG004|Received Study Drug in Extension Study|Overall Study||89||
59616794|NCT01442064|75727771|FG005|Received Study Drug in Extension Study|Overall Study||81||
59616795|NCT01442064|75727766|FG000|COMPLETED|Overall Study||0||
59616796|NCT01442064|75727767|FG001|COMPLETED|Overall Study||2||
59616797|NCT01442064|75727768|FG002|COMPLETED|Overall Study||0||
59616798|NCT01442064|75727769|FG003|COMPLETED|Overall Study||0||
59616799|NCT01442064|75727770|FG004|COMPLETED|Overall Study||1||
59616800|NCT01442064|75727771|FG005|COMPLETED|Overall Study||0||
59616801|NCT01442064|75727766|FG000|NOT COMPLETED|Overall Study||97||
59616802|NCT01442064|75727767|FG001|NOT COMPLETED|Overall Study||101||
59616803|NCT01442064|75727768|FG002|NOT COMPLETED|Overall Study||104||
59616804|NCT01442064|75727769|FG003|NOT COMPLETED|Overall Study||98||
59616805|NCT01442064|75727770|FG004|NOT COMPLETED|Overall Study||106||
59616806|NCT01442064|75727771|FG005|NOT COMPLETED|Overall Study||99||
59616807|NCT01467960|75727794|FG000|STARTED|Overall Study||30||
59616808|NCT01467960|75727795|FG001|STARTED|Overall Study||30||
59616809|NCT01467960|75727796|FG002|STARTED|Overall Study||30||
59616810|NCT01467960|75727797|FG003|STARTED|Overall Study||30||
59616811|NCT01467960|75727798|FG004|STARTED|Overall Study||30||
59616812|NCT01467960|75727799|FG005|STARTED|Overall Study||30||
59616813|NCT01467960|75727794|FG000|COMPLETED|Overall Study||30||
59616814|NCT01467960|75727795|FG001|COMPLETED|Overall Study||30||
59616815|NCT01467960|75727796|FG002|COMPLETED|Overall Study||30||
59616816|NCT01467960|75727797|FG003|COMPLETED|Overall Study||0||
59616817|NCT01467960|75727798|FG004|COMPLETED|Overall Study||0||
59616818|NCT01467960|75727799|FG005|COMPLETED|Overall Study||0||
59616819|NCT01467960|75727794|FG000|NOT COMPLETED|Overall Study||0||
59616820|NCT01467960|75727795|FG001|NOT COMPLETED|Overall Study||0||
59616821|NCT01467960|75727796|FG002|NOT COMPLETED|Overall Study||0||
59616822|NCT01467960|75727797|FG003|NOT COMPLETED|Overall Study||30||
59616823|NCT01467960|75727798|FG004|NOT COMPLETED|Overall Study||30||
59616824|NCT01467960|75727799|FG005|NOT COMPLETED|Overall Study||30||
59616825|NCT01441596|75727816|FG000|STARTED|Overall Study||40||
59616826|NCT01441596|75727817|FG001|STARTED|Overall Study||38||
59616827|NCT01441596|75727818|FG002|STARTED|Overall Study||43||
59616828|NCT01441596|75727816|FG000|COMPLETED|Overall Study||36||
59616829|NCT01441596|75727817|FG001|COMPLETED|Overall Study||35||
59616830|NCT01441596|75727818|FG002|COMPLETED|Overall Study||39||
59616831|NCT01441596|75727816|FG000|NOT COMPLETED|Overall Study||4||
59616832|NCT01441596|75727817|FG001|NOT COMPLETED|Overall Study||3||
59616833|NCT01441596|75727818|FG002|NOT COMPLETED|Overall Study||4||
59616834|NCT01441440|75727829|FG000|STARTED|Overall Study|Safety analysis set|183||
59616835|NCT01441440|75727830|FG001|STARTED|Overall Study|Safety analysis set|174||
59616836|NCT01441440|75727831|FG002|STARTED|Overall Study|Safety analysis set|180||
59616837|NCT01441440|75727829|FG000|COMPLETED|Overall Study||166||
59616838|NCT01441440|75727830|FG001|COMPLETED|Overall Study||151||
59616839|NCT01441440|75727831|FG002|COMPLETED|Overall Study||158||
59616840|NCT01441440|75727829|FG000|NOT COMPLETED|Overall Study||17||
59616841|NCT01441440|75727830|FG001|NOT COMPLETED|Overall Study||23||
59616842|NCT01441440|75727831|FG002|NOT COMPLETED|Overall Study||22||
59616843|NCT01438476|75727841|FG000|STARTED|Overall Study||116||
59616844|NCT01438476|75727842|FG001|STARTED|Overall Study||45||
59616845|NCT01438476|75727841|FG000|COMPLETED|Overall Study||106||
59616846|NCT01438476|75727842|FG001|COMPLETED|Overall Study||34||
59616847|NCT01438476|75727841|FG000|NOT COMPLETED|Overall Study||10||
59616848|NCT01438476|75727842|FG001|NOT COMPLETED|Overall Study||11||
59616849|NCT01467570|75727850|FG000|STARTED|Overall Study||75||
59616850|NCT01467570|75727851|FG001|STARTED|Overall Study||72||
59616851|NCT01467570|75727850|FG000|COMPLETED|Overall Study||67||
59616852|NCT01467570|75727851|FG001|COMPLETED|Overall Study||63||
59616853|NCT01467570|75727850|FG000|NOT COMPLETED|Overall Study||8||
59616854|NCT01467570|75727851|FG001|NOT COMPLETED|Overall Study||9||
59616855|NCT01437540|75727861|FG000|STARTED|Overall Study||392||
59616856|NCT01437540|75727862|FG001|STARTED|Overall Study||198||
59616857|NCT01437540|75727861|FG000|COMPLETED|Overall Study||265||
59616858|NCT01437540|75727862|FG001|COMPLETED|Overall Study||133||
59616859|NCT01437540|75727861|FG000|NOT COMPLETED|Overall Study||127||
59616860|NCT01437540|75727862|FG001|NOT COMPLETED|Overall Study||65||
59616861|NCT01440972|75727870|FG000|STARTED|Overall Study||24||
59616862|NCT01440972|75727871|FG001|STARTED|Overall Study||21||
59616863|NCT01440972|75727870|FG000|COMPLETED|Overall Study||21||
59616864|NCT01440972|75727871|FG001|COMPLETED|Overall Study||19||
59616865|NCT01440972|75727870|FG000|NOT COMPLETED|Overall Study||3||
59616866|NCT01440972|75727871|FG001|NOT COMPLETED|Overall Study||2||
59616867|NCT01420536|75727879|FG000|STARTED|Period 1 (30 Days)||22||
59616868|NCT01420536|75727880|FG001|STARTED|Period 1 (30 Days)||22||
59616869|NCT01420536|75727879|FG000|COMPLETED|Period 1 (30 Days)|Participants declined to participate further before changing interventions.|19||
59616870|NCT01420536|75727880|FG001|COMPLETED|Period 1 (30 Days)||22||
59616871|NCT01420536|75727879|FG000|NOT COMPLETED|Period 1 (30 Days)||3||
59616872|NCT01420536|75727880|FG001|NOT COMPLETED|Period 1 (30 Days)||0||
59616873|NCT01420536|75727879|FG000|STARTED|Period 2 (30 Days)||19||
59616874|NCT01420536|75727880|FG001|STARTED|Period 2 (30 Days)||22||
59616875|NCT01420536|75727879|FG000|COMPLETED|Period 2 (30 Days)||19||
59616876|NCT01420536|75727880|FG001|COMPLETED|Period 2 (30 Days)||22||
59616877|NCT01420536|75727879|FG000|NOT COMPLETED|Period 2 (30 Days)||0||
59616878|NCT01420536|75727880|FG001|NOT COMPLETED|Period 2 (30 Days)||0||
59616879|NCT01420068|75727890|FG000|STARTED|Overall Study||51||
59616880|NCT01420068|75727891|FG001|STARTED|Overall Study||55||
59616881|NCT01420068|75727890|FG000|COMPLETED|Overall Study||49||
59616882|NCT01420068|75727891|FG001|COMPLETED|Overall Study||50||
59616883|NCT01420068|75727890|FG000|NOT COMPLETED|Overall Study||2||
59616884|NCT01420068|75727891|FG001|NOT COMPLETED|Overall Study||5||
59616885|NCT01467492|75727899|FG000|STARTED|Overall Study||83||
59616886|NCT01467492|75727900|FG001|STARTED|Overall Study||38||
59616887|NCT01467492|75727899|FG000|COMPLETED|Overall Study||61||
59616888|NCT01467492|75727900|FG001|COMPLETED|Overall Study||25||
59616889|NCT01467492|75727899|FG000|NOT COMPLETED|Overall Study||22||
59616890|NCT01467492|75727900|FG001|NOT COMPLETED|Overall Study||13||
59616891|NCT01466790|75727915|FG000|STARTED|Overall Study|Not including 1 participant who was randomized to this group, but never received treatment.|24||
59616892|NCT01466790|75727916|FG001|STARTED|Overall Study||15||
59616893|NCT01466790|75727917|FG002|STARTED|Overall Study||27||
59616894|NCT01466790|75727918|FG003|STARTED|Overall Study||14||
59616895|NCT01466790|75727919|FG004|STARTED|Overall Study||30||
59616896|NCT01466790|75727920|FG005|STARTED|Overall Study||16||
59616897|NCT01466790|75727921|FG006|STARTED|Overall Study||27||
59616898|NCT01466790|75727922|FG007|STARTED|Overall Study||14||
59616899|NCT01466790|75727915|FG000|COMPLETED|Overall Study||20||
59616900|NCT01466790|75727916|FG001|COMPLETED|Overall Study||14||
59616901|NCT01466790|75727917|FG002|COMPLETED|Overall Study||27||
59616902|NCT01466790|75727918|FG003|COMPLETED|Overall Study||14||
59616903|NCT01466790|75727919|FG004|COMPLETED|Overall Study||27||
59616904|NCT01466790|75727920|FG005|COMPLETED|Overall Study||16||
59616905|NCT01466790|75727921|FG006|COMPLETED|Overall Study||26||
59616906|NCT01466790|75727922|FG007|COMPLETED|Overall Study||13||
59616907|NCT01466790|75727915|FG000|NOT COMPLETED|Overall Study||4||
59616908|NCT01466790|75727916|FG001|NOT COMPLETED|Overall Study||1||
59616909|NCT01466790|75727917|FG002|NOT COMPLETED|Overall Study||0||
59616910|NCT01466790|75727918|FG003|NOT COMPLETED|Overall Study||0||
59616911|NCT01466790|75727919|FG004|NOT COMPLETED|Overall Study||3||
59616912|NCT01466790|75727920|FG005|NOT COMPLETED|Overall Study||0||
59616913|NCT01466790|75727921|FG006|NOT COMPLETED|Overall Study||1||
59616914|NCT01466790|75727922|FG007|NOT COMPLETED|Overall Study||1||
59616915|NCT01418352|75727940|FG000|STARTED|Overall Study||20||
59616916|NCT01418352|75727941|FG001|STARTED|Overall Study||21||
59616917|NCT01418352|75727942|FG002|STARTED|Overall Study||21||
59616918|NCT01418352|75727943|FG003|STARTED|Overall Study||21||
59616919|NCT01418352|75727940|FG000|COMPLETED|Overall Study||17||
59616920|NCT01418352|75727941|FG001|COMPLETED|Overall Study||17||
59616921|NCT01418352|75727942|FG002|COMPLETED|Overall Study||16||
59616922|NCT01418352|75727943|FG003|COMPLETED|Overall Study||18||
59616923|NCT01418352|75727940|FG000|NOT COMPLETED|Overall Study||3||
59616924|NCT01418352|75727941|FG001|NOT COMPLETED|Overall Study||4||
59616925|NCT01418352|75727942|FG002|NOT COMPLETED|Overall Study||5||
59616926|NCT01418352|75727943|FG003|NOT COMPLETED|Overall Study||3||
59616927|NCT01436370|75727961|FG000|STARTED|Overall Study||6||
59616928|NCT01436370|75727962|FG001|STARTED|Overall Study||6||
59616929|NCT01436370|75727963|FG002|STARTED|Overall Study||10||
59616930|NCT01436370|75727964|FG003|STARTED|Overall Study||10||
59616931|NCT01436370|75727965|FG004|STARTED|Overall Study||19||
59616932|NCT01436370|75727966|FG005|STARTED|Overall Study||19||
59616933|NCT01436370|75727967|FG006|STARTED|Overall Study||16||
59616934|NCT01436370|75727968|FG007|STARTED|Overall Study||16||
59616935|NCT01436370|75727961|FG000|COMPLETED|Overall Study||6||
59616936|NCT01436370|75727962|FG001|COMPLETED|Overall Study||6||
59616937|NCT01436370|75727963|FG002|COMPLETED|Overall Study||10||
59616938|NCT01436370|75727964|FG003|COMPLETED|Overall Study||10||
59616939|NCT01436370|75727965|FG004|COMPLETED|Overall Study||18||
59616940|NCT01436370|75727966|FG005|COMPLETED|Overall Study||19||
59616941|NCT01436370|75727967|FG006|COMPLETED|Overall Study||16||
59616942|NCT01436370|75727968|FG007|COMPLETED|Overall Study||16||
59616943|NCT01436370|75727961|FG000|NOT COMPLETED|Overall Study||0||
59616944|NCT01436370|75727962|FG001|NOT COMPLETED|Overall Study||0||
59616945|NCT01436370|75727963|FG002|NOT COMPLETED|Overall Study||0||
59616946|NCT01436370|75727964|FG003|NOT COMPLETED|Overall Study||0||
59616947|NCT01436370|75727965|FG004|NOT COMPLETED|Overall Study||1||
59616948|NCT01436370|75727966|FG005|NOT COMPLETED|Overall Study||0||
59616949|NCT01436370|75727967|FG006|NOT COMPLETED|Overall Study||0||
59616950|NCT01436370|75727968|FG007|NOT COMPLETED|Overall Study||0||
59616951|NCT01465464|75727996|FG000|STARTED|Overall Study||444||
59616952|NCT01465464|75727997|FG001|STARTED|Overall Study||444||
59616953|NCT01465464|75727996|FG000|COMPLETED|Overall Study||0||
59616954|NCT01465464|75727997|FG001|COMPLETED|Overall Study||0||
59616955|NCT01465464|75727996|FG000|NOT COMPLETED|Overall Study||444||
59616956|NCT01465464|75727997|FG001|NOT COMPLETED|Overall Study||444||
59616957|NCT01417104|75728005|FG000|STARTED|Overall Study||34||
59616958|NCT01417104|75728006|FG001|STARTED|Overall Study||37||
59616959|NCT01417104|75728005|FG000|COMPLETED|Overall Study||28||
59616960|NCT01417104|75728006|FG001|COMPLETED|Overall Study||35||
59616961|NCT01417104|75728005|FG000|NOT COMPLETED|Overall Study||6||
59616962|NCT01417104|75728006|FG001|NOT COMPLETED|Overall Study||2||
59616963|NCT01465386|75728012|FG000|STARTED|Overall Study||6||
59616964|NCT01465386|75728012|FG000|COMPLETED|Overall Study||2||
59616965|NCT01465386|75728012|FG000|NOT COMPLETED|Overall Study||4||
59616966|NCT01465230|75728016|FG000|STARTED|Overall Study||2||
59616967|NCT01465230|75728016|FG000|COMPLETED|Overall Study||0||
59616968|NCT01465230|75728016|FG000|NOT COMPLETED|Overall Study||2||
59616969|NCT01435356|75728022|FG000|STARTED|Overall Study||48||
59616970|NCT01435356|75728023|FG001|STARTED|Overall Study||29||
59616971|NCT01435356|75728022|FG000|COMPLETED|Overall Study||16||
59616972|NCT01435356|75728023|FG001|COMPLETED|Overall Study||5||
59616973|NCT01435356|75728022|FG000|NOT COMPLETED|Overall Study||32||
59616974|NCT01435356|75728023|FG001|NOT COMPLETED|Overall Study||24||
59616975|NCT01435122|75728029|FG000|STARTED|Overall Study||30||
59616976|NCT01435122|75728029|FG000|COMPLETED|Overall Study||22||
59616977|NCT01435122|75728029|FG000|NOT COMPLETED|Overall Study||8||
59616978|NCT04048122|75728035|FG000|STARTED|Overall Study||28||
59616979|NCT04048122|75728036|FG001|STARTED|Overall Study||29||
59616980|NCT04048122|75728035|FG000|COMPLETED|Overall Study||25||
59616981|NCT04048122|75728036|FG001|COMPLETED|Overall Study||26||
59616982|NCT04048122|75728035|FG000|NOT COMPLETED|Overall Study||3||
59616983|NCT04048122|75728036|FG001|NOT COMPLETED|Overall Study||3||
59616984|NCT01434810|75728044|FG000|STARTED|Overall Study||224||
59616985|NCT01434810|75728045|FG001|STARTED|Overall Study||223||
59616986|NCT01434810|75728044|FG000|COMPLETED|Overall Study||201||
59616987|NCT01434810|75728045|FG001|COMPLETED|Overall Study||213||
59616988|NCT01434810|75728044|FG000|NOT COMPLETED|Overall Study||23||
59616989|NCT01434810|75728045|FG001|NOT COMPLETED|Overall Study||10||
59616990|NCT01393626|75728055|FG000|STARTED|Overall Study||91||
59616991|NCT01393626|75728056|FG001|STARTED|Overall Study||86||
59616992|NCT01393626|75728057|FG002|STARTED|Overall Study||86||
59616993|NCT01393626|75728058|FG003|STARTED|Overall Study||16||
59616994|NCT01393626|75728055|FG000|COMPLETED|Overall Study||73||
59616995|NCT01393626|75728056|FG001|COMPLETED|Overall Study||74||
59616996|NCT01393626|75728057|FG002|COMPLETED|Overall Study||74||
59616997|NCT01393626|75728058|FG003|COMPLETED|Overall Study||15||
59616998|NCT01393626|75728055|FG000|NOT COMPLETED|Overall Study||18||
59616999|NCT01393626|75728056|FG001|NOT COMPLETED|Overall Study||12||
59617000|NCT01393626|75728057|FG002|NOT COMPLETED|Overall Study||12||
59617001|NCT01393626|75728058|FG003|NOT COMPLETED|Overall Study||1||
59617002|NCT01434654|75728077|FG000|STARTED|Overall Study||7||
59617003|NCT01434654|75728078|FG001|STARTED|Overall Study||12||
59617004|NCT01434654|75728077|FG000|COMPLETED|Overall Study||5||
59762765|NCT00598442|75882628|FG002|STARTED|Overall Study||163||
59762766|NCT00598442|75882626|FG000|COMPLETED|Overall Study||124||
59762767|NCT00598442|75882627|FG001|COMPLETED|Overall Study||124||
59762768|NCT00598442|75882628|FG002|COMPLETED|Overall Study||139||
59762769|NCT00598442|75882626|FG000|NOT COMPLETED|Overall Study||43||
59762770|NCT00598442|75882627|FG001|NOT COMPLETED|Overall Study||39||
59762771|NCT00598442|75882628|FG002|NOT COMPLETED|Overall Study||24||
59762772|NCT00593814|75882638|FG000|STARTED|Overall Study||139||
59762773|NCT00593814|75882639|FG001|STARTED|Overall Study||120||
59762774|NCT00593814|75882638|FG000|COMPLETED|Overall Study||115||
59762775|NCT00593814|75882639|FG001|COMPLETED|Overall Study||120||
59762776|NCT00593814|75882638|FG000|NOT COMPLETED|Overall Study||24||
59762777|NCT00593814|75882639|FG001|NOT COMPLETED|Overall Study||0||
59762778|NCT00855309|75882647|FG000|STARTED|Overall Study||57||
60071808|NCT01711983|76187178|FG000|COMPLETED|36-Month Closure Evaluation||278||
60071809|NCT01711983|76187178|FG000|NOT COMPLETED|36-Month Closure Evaluation||64||
60071810|NCT02080312|76187182|FG000|STARTED|Overall Study||6||
60071811|NCT02080312|76187182|FG000|COMPLETED|Overall Study||6||
60071812|NCT02080312|76187182|FG000|NOT COMPLETED|Overall Study||0||
60071813|NCT01874288|76187192|FG000|STARTED|Overall Study||3||
59520344|NCT00957047|75614247|FG003|COMPLETED|PART II||0||
59520345|NCT00957047|75614248|FG004|COMPLETED|PART II||223||
59520346|NCT00957047|75614244|FG000|NOT COMPLETED|PART II||0||
59520347|NCT00957047|75614245|FG001|NOT COMPLETED|PART II||0||
59520348|NCT00957047|75614246|FG002|NOT COMPLETED|PART II||0||
59520349|NCT00957047|75614247|FG003|NOT COMPLETED|PART II||0||
59520350|NCT00957047|75614248|FG004|NOT COMPLETED|PART II||102||
59520351|NCT00957359|75614268|FG000|STARTED|Overall Study||14||
59520352|NCT00957359|75614269|FG001|STARTED|Overall Study||15||
59520353|NCT00957359|75614268|FG000|COMPLETED|Overall Study||14||
59520354|NCT00957359|75614269|FG001|COMPLETED|Overall Study||15||
59520355|NCT00957359|75614268|FG000|NOT COMPLETED|Overall Study||0||
59520356|NCT00957359|75614269|FG001|NOT COMPLETED|Overall Study||0||
59520357|NCT03880474|75614277|FG000|STARTED|Overall Study||1077||
59520358|NCT03880474|75614278|FG001|STARTED|Overall Study||1075||
59520359|NCT03880474|75614277|FG000|COMPLETED|Overall Study||1054||
59520360|NCT03880474|75614278|FG001|COMPLETED|Overall Study||1055||
59617005|NCT01434654|75728078|FG001|COMPLETED|Overall Study||12||
59617006|NCT01434654|75728077|FG000|NOT COMPLETED|Overall Study||2||
59617007|NCT01434654|75728078|FG001|NOT COMPLETED|Overall Study||0||
59617008|NCT01393158|75728088|FG000|STARTED|Overall Study||6||
59617009|NCT01393158|75728089|FG001|STARTED|Overall Study||10||
59617010|NCT01393158|75728088|FG000|COMPLETED|Overall Study||5||
59762779|NCT00855309|75882648|FG001|STARTED|Overall Study||55||
59762780|NCT00855309|75882647|FG000|COMPLETED|Overall Study||56||
59762781|NCT00855309|75882648|FG001|COMPLETED|Overall Study||55||
59762782|NCT00855309|75882647|FG000|NOT COMPLETED|Overall Study||1||
59762783|NCT00855309|75882648|FG001|NOT COMPLETED|Overall Study||0||
59762784|NCT00532129|75882654|FG000|STARTED|Treatment Period||100||
59762785|NCT00532129|75882654|FG000|COMPLETED|Treatment Period||51||
59762786|NCT00532129|75882654|FG000|NOT COMPLETED|Treatment Period||49||
59762787|NCT00532129|75882654|FG000|STARTED|Follow-up Period||98||
60071814|NCT01874288|76187193|FG001|STARTED|Overall Study||3||
60071815|NCT01874288|76187194|FG002|STARTED|Overall Study||9||
60071816|NCT01874288|76187195|FG003|STARTED|Overall Study||7||
59762788|NCT00532129|75882654|FG000|COMPLETED|Follow-up Period||33||
59762789|NCT00532129|75882654|FG000|NOT COMPLETED|Follow-up Period||65||
59762790|NCT00854607|75882658|FG000|STARTED|Enrollment||116||
59762791|NCT00854607|75882658|FG000|COMPLETED|Enrollment||116||
59762792|NCT00854607|75882658|FG000|NOT COMPLETED|Enrollment||0||
60071817|NCT01874288|76187196|FG004|STARTED|Overall Study||2||
59520361|NCT03880474|75614277|FG000|NOT COMPLETED|Overall Study||23||
59520362|NCT03880474|75614278|FG001|NOT COMPLETED|Overall Study||20||
59520363|NCT01045057|75614284|FG000|STARTED|Overall Study||27||
59520364|NCT01045057|75614284|FG000|COMPLETED|Overall Study||27||
59520365|NCT01045057|75614284|FG000|NOT COMPLETED|Overall Study||0||
59520366|NCT00957593|75614292|FG000|STARTED|Overall Study||127||
59520367|NCT00957593|75614293|FG001|STARTED|Overall Study||125||
59520368|NCT00957593|75614292|FG000|COMPLETED|Overall Study||127||
59520369|NCT00957593|75614293|FG001|COMPLETED|Overall Study||125||
59762793|NCT00854607|75882658|FG000|STARTED|2 Weeks After Start Anti-fungal Therapy||116||
59617011|NCT01393158|75728089|FG001|COMPLETED|Overall Study||10||
59617012|NCT01393158|75728088|FG000|NOT COMPLETED|Overall Study||1||
59617013|NCT01393158|75728089|FG001|NOT COMPLETED|Overall Study||0||
59617014|NCT01413360|75728101|FG000|STARTED|Overall Study||10||
59617015|NCT01413360|75728101|FG000|COMPLETED|Overall Study||7||
59617016|NCT01413360|75728101|FG000|NOT COMPLETED|Overall Study||3||
59617017|NCT01413204|75728108|FG000|STARTED|Overall Study||90||
59617018|NCT01413204|75728109|FG001|STARTED|Overall Study||89||
59617019|NCT01413204|75728110|FG002|STARTED|Overall Study||93||
59617020|NCT01413204|75728108|FG000|COMPLETED|Overall Study||84||
59617021|NCT01413204|75728109|FG001|COMPLETED|Overall Study||83||
59617022|NCT01413204|75728110|FG002|COMPLETED|Overall Study||74||
59617023|NCT01413204|75728108|FG000|NOT COMPLETED|Overall Study||6||
59617024|NCT01413204|75728109|FG001|NOT COMPLETED|Overall Study||6||
59617025|NCT01413204|75728110|FG002|NOT COMPLETED|Overall Study||19||
59617026|NCT01392378|75728123|FG000|STARTED|Infant Series||173||
59617027|NCT01392378|75728124|FG001|STARTED|Infant Series||176||
59617028|NCT01392378|75728125|FG002|STARTED|Infant Series||172||
59617029|NCT01392378|75728126|FG003|STARTED|Infant Series||177||
59617030|NCT01392378|75728127|FG004|STARTED|Infant Series||210||
59617031|NCT01392378|75728123|FG000|Vaccinated Dose 1|Infant Series||173||
59617032|NCT01392378|75728124|FG001|Vaccinated Dose 1|Infant Series||176||
59617033|NCT01392378|75728125|FG002|Vaccinated Dose 1|Infant Series||172||
59617034|NCT01392378|75728126|FG003|Vaccinated Dose 1|Infant Series||177||
59617035|NCT01392378|75728127|FG004|Vaccinated Dose 1|Infant Series||210||
59617036|NCT01392378|75728123|FG000|Vaccinated Dose 2|Infant Series||171||
59617037|NCT01392378|75728124|FG001|Vaccinated Dose 2|Infant Series||174||
59617038|NCT01392378|75728125|FG002|Vaccinated Dose 2|Infant Series||172||
59617039|NCT01392378|75728126|FG003|Vaccinated Dose 2|Infant Series||177||
59617040|NCT01392378|75728127|FG004|Vaccinated Dose 2|Infant Series||210||
59617041|NCT01392378|75728123|FG000|Vaccinated Dose 3|Infant Series||170||
59617042|NCT01392378|75728124|FG001|Vaccinated Dose 3|Infant Series||174||
59617043|NCT01392378|75728125|FG002|Vaccinated Dose 3|Infant Series||172||
59617044|NCT01392378|75728126|FG003|Vaccinated Dose 3|Infant Series||176||
59617045|NCT01392378|75728127|FG004|Vaccinated Dose 3|Infant Series||210||
59617046|NCT01392378|75728123|FG000|COMPLETED|Infant Series||169||
59617047|NCT01392378|75728124|FG001|COMPLETED|Infant Series||174||
59617048|NCT01392378|75728125|FG002|COMPLETED|Infant Series||172||
59617049|NCT01392378|75728126|FG003|COMPLETED|Infant Series||175||
59617050|NCT01392378|75728127|FG004|COMPLETED|Infant Series||210||
59617051|NCT01392378|75728123|FG000|NOT COMPLETED|Infant Series||4||
59617052|NCT01392378|75728124|FG001|NOT COMPLETED|Infant Series||2||
59617053|NCT01392378|75728125|FG002|NOT COMPLETED|Infant Series||0||
59617054|NCT01392378|75728126|FG003|NOT COMPLETED|Infant Series||2||
59617055|NCT01392378|75728127|FG004|NOT COMPLETED|Infant Series||0||
59617056|NCT01392378|75728123|FG000|STARTED|After Infant Series||169||
59617057|NCT01392378|75728124|FG001|STARTED|After Infant Series||174||
59617058|NCT01392378|75728125|FG002|STARTED|After Infant Series||172||
59617059|NCT01392378|75728126|FG003|STARTED|After Infant Series||175||
59617060|NCT01392378|75728127|FG004|STARTED|After Infant Series||210||
59617061|NCT01392378|75728123|FG000|COMPLETED|After Infant Series||169||
59617062|NCT01392378|75728124|FG001|COMPLETED|After Infant Series||173||
59617063|NCT01392378|75728125|FG002|COMPLETED|After Infant Series||170||
59617064|NCT01392378|75728126|FG003|COMPLETED|After Infant Series||175||
59617065|NCT01392378|75728127|FG004|COMPLETED|After Infant Series||209||
59617066|NCT01392378|75728123|FG000|NOT COMPLETED|After Infant Series||0||
59617067|NCT01392378|75728124|FG001|NOT COMPLETED|After Infant Series||1||
59617068|NCT01392378|75728125|FG002|NOT COMPLETED|After Infant Series||2||
59617069|NCT01392378|75728126|FG003|NOT COMPLETED|After Infant Series||0||
59617070|NCT01392378|75728127|FG004|NOT COMPLETED|After Infant Series||1||
59617071|NCT01392378|75728123|FG000|STARTED|Toddler Dose||169||
59617072|NCT01392378|75728124|FG001|STARTED|Toddler Dose||173||
59617073|NCT01392378|75728125|FG002|STARTED|Toddler Dose||170||
59617074|NCT01392378|75728126|FG003|STARTED|Toddler Dose||175||
59617075|NCT01392378|75728127|FG004|STARTED|Toddler Dose||209||
59617076|NCT01392378|75728123|FG000|COMPLETED|Toddler Dose||169||
59617077|NCT01392378|75728124|FG001|COMPLETED|Toddler Dose||172||
59617078|NCT01392378|75728125|FG002|COMPLETED|Toddler Dose||170||
59617079|NCT01392378|75728126|FG003|COMPLETED|Toddler Dose||173||
59617080|NCT01392378|75728127|FG004|COMPLETED|Toddler Dose||208||
59617081|NCT01392378|75728123|FG000|NOT COMPLETED|Toddler Dose||0||
59617082|NCT01392378|75728124|FG001|NOT COMPLETED|Toddler Dose||1||
59617083|NCT01392378|75728125|FG002|NOT COMPLETED|Toddler Dose||0||
59617084|NCT01392378|75728126|FG003|NOT COMPLETED|Toddler Dose||2||
59617085|NCT01392378|75728127|FG004|NOT COMPLETED|Toddler Dose||1||
59617086|NCT01412424|75728149|FG000|STARTED|Core Treatment Period||155||
59617087|NCT01412424|75728149|FG000|COMPLETED|Core Treatment Period||102||
59617088|NCT01412424|75728149|FG000|NOT COMPLETED|Core Treatment Period||53||
59617089|NCT01412424|75728149|FG000|STARTED|Extension Treatment Period|86% of participants who completed the core period voluntarily entered the optional extension period.|88||
59617090|NCT01412424|75728149|FG000|COMPLETED|Extension Treatment Period||82||
59617091|NCT01412424|75728149|FG000|NOT COMPLETED|Extension Treatment Period||6||
59617092|NCT01433250|75728161|FG000|STARTED|Overall Study||22||
59617093|NCT01433250|75728162|FG001|STARTED|Overall Study||17||
59617094|NCT01433250|75728161|FG000|COMPLETED|Overall Study||19||
59617095|NCT01433250|75728162|FG001|COMPLETED|Overall Study||14||
59617096|NCT01433250|75728161|FG000|NOT COMPLETED|Overall Study||3||
59617097|NCT01433250|75728162|FG001|NOT COMPLETED|Overall Study||3||
59617098|NCT01433172|75728171|FG000|STARTED|Overall Study||3||
59617099|NCT01433172|75728172|FG001|STARTED|Overall Study||37||
59617100|NCT01433172|75728173|FG002|STARTED|Overall Study||33||
59617101|NCT01433172|75728171|FG000|COMPLETED|Overall Study||3||
59617102|NCT01433172|75728172|FG001|COMPLETED|Overall Study||34||
59617103|NCT01433172|75728173|FG002|COMPLETED|Overall Study||32||
59617104|NCT01433172|75728171|FG000|NOT COMPLETED|Overall Study||0||
59617105|NCT01433172|75728172|FG001|NOT COMPLETED|Overall Study||3||
59617106|NCT01433172|75728173|FG002|NOT COMPLETED|Overall Study||1||
59617107|NCT01432938|75728181|FG000|STARTED|First Intervention||14||
59617108|NCT01432938|75728182|FG001|STARTED|First Intervention||14||
59617109|NCT01432938|75728181|FG000|Received at Least 1 Dose of Study Drug|First Intervention||14||
59617110|NCT01432938|75728182|FG001|Received at Least 1 Dose of Study Drug|First Intervention||14||
59617111|NCT01432938|75728181|FG000|COMPLETED|First Intervention||12||
59617112|NCT01432938|75728182|FG001|COMPLETED|First Intervention||14||
59617113|NCT01432938|75728181|FG000|NOT COMPLETED|First Intervention||2||
59617114|NCT01432938|75728182|FG001|NOT COMPLETED|First Intervention||0||
59617115|NCT01432938|75728181|FG000|STARTED|Washout Period of at Least 24 Days||12||
59617116|NCT01432938|75728182|FG001|STARTED|Washout Period of at Least 24 Days||14||
59617117|NCT01432938|75728181|FG000|COMPLETED|Washout Period of at Least 24 Days||12||
59617118|NCT01432938|75728182|FG001|COMPLETED|Washout Period of at Least 24 Days||14||
59617119|NCT01432938|75728181|FG000|NOT COMPLETED|Washout Period of at Least 24 Days||0||
59617120|NCT01432938|75728182|FG001|NOT COMPLETED|Washout Period of at Least 24 Days||0||
59617121|NCT01432938|75728181|FG000|STARTED|Second Intervention||12||
59617122|NCT01432938|75728182|FG001|STARTED|Second Intervention||14||
59617123|NCT01432938|75728181|FG000|COMPLETED|Second Intervention||11||
59617124|NCT01432938|75728182|FG001|COMPLETED|Second Intervention||14||
59617125|NCT01432938|75728181|FG000|NOT COMPLETED|Second Intervention||1||
59617126|NCT01432938|75728182|FG001|NOT COMPLETED|Second Intervention||0||
59617127|NCT01392300|75728191|FG000|STARTED|Main Period (MP)||210||
59617128|NCT01392300|75728192|FG001|STARTED|Main Period (MP)||107||
59617129|NCT01392300|75728193|FG002|STARTED|Main Period (MP)||0||
59617130|NCT01392300|75728191|FG000|COMPLETED|Main Period (MP)||199||
59617131|NCT01392300|75728192|FG001|COMPLETED|Main Period (MP)||100||
59617132|NCT01392300|75728193|FG002|COMPLETED|Main Period (MP)||0||
59617133|NCT01392300|75728191|FG000|NOT COMPLETED|Main Period (MP)||11||
59617134|NCT01392300|75728192|FG001|NOT COMPLETED|Main Period (MP)||7||
59617135|NCT01392300|75728193|FG002|NOT COMPLETED|Main Period (MP)||0||
59617136|NCT01392300|75728191|FG000|STARTED|Open Label Extension (OLEX) Period|Subjects from double-blind arms were switched to arm OLEX IncobotulinumtoxinA (Xeomin) (...)|0||
59951889|NCT00835692|76070847|FG001|STARTED|Washout||28||
59951890|NCT00835692|76070846|FG000|COMPLETED|Washout||27||
59762794|NCT00854607|75882658|FG000|COMPLETED|2 Weeks After Start Anti-fungal Therapy||51||
59951891|NCT00835692|76070847|FG001|COMPLETED|Washout||28||
59951892|NCT00835692|76070846|FG000|NOT COMPLETED|Washout||0||
59951893|NCT00835692|76070847|FG001|NOT COMPLETED|Washout||0||
59617137|NCT01392300|75728192|FG001|STARTED|Open Label Extension (OLEX) Period|Subjects from double-blind arms were switched to arm OLEX IncobotulinumtoxinA (Xeomin) (...)|0||
59617138|NCT01392300|75728193|FG002|STARTED|Open Label Extension (OLEX) Period|Subjects from double-blind arms were switched to arm OLEX IncobotulinumtoxinA (Xeomin) (...)|299||
59617139|NCT01392300|75728191|FG000|COMPLETED|Open Label Extension (OLEX) Period||0||
59617140|NCT01392300|75728192|FG001|COMPLETED|Open Label Extension (OLEX) Period||0||
59617141|NCT01392300|75728193|FG002|COMPLETED|Open Label Extension (OLEX) Period||248||
59617142|NCT01392300|75728191|FG000|NOT COMPLETED|Open Label Extension (OLEX) Period||0||
59617143|NCT01392300|75728192|FG001|NOT COMPLETED|Open Label Extension (OLEX) Period||0||
59617144|NCT01392300|75728193|FG002|NOT COMPLETED|Open Label Extension (OLEX) Period||51||
59617145|NCT01432626|75728200|FG000|STARTED|Overall Study||10||
59617146|NCT01432626|75728200|FG000|COMPLETED|Overall Study|Completed both images|3||
59617147|NCT01432626|75728200|FG000|NOT COMPLETED|Overall Study||7||
59617148|NCT01410474|75728206|FG000|STARTED|Overall Study||173||
59617149|NCT01410474|75728207|FG001|STARTED|Overall Study||168||
59951894|NCT00835692|76070846|FG000|STARTED|Second Intervention||27||
59951895|NCT00835692|76070847|FG001|STARTED|Second Intervention||28||
59951896|NCT00835692|76070846|FG000|COMPLETED|Second Intervention||27||
59617150|NCT01410474|75728206|FG000|COMPLETED|Overall Study||173||
59617151|NCT01410474|75728207|FG001|COMPLETED|Overall Study||167||
59617152|NCT01410474|75728206|FG000|NOT COMPLETED|Overall Study||0||
59617153|NCT01410474|75728207|FG001|NOT COMPLETED|Overall Study||1||
59617154|NCT01391130|75728222|FG000|STARTED|Overall Study||73||
59617155|NCT01391130|75728223|FG001|STARTED|Overall Study||37||
59617156|NCT01391130|75728222|FG000|Received At Least One Dose of Study Drug|Overall Study||72||
59617157|NCT01391130|75728223|FG001|Received At Least One Dose of Study Drug|Overall Study||36||
59617158|NCT01391130|75728222|FG000|COMPLETED|Overall Study||67||
59617159|NCT01391130|75728223|FG001|COMPLETED|Overall Study||31||
59617160|NCT01391130|75728222|FG000|NOT COMPLETED|Overall Study||6||
59617161|NCT01391130|75728223|FG001|NOT COMPLETED|Overall Study||6||
59617162|NCT01410240|75728232|FG000|STARTED|Overall Study||53||
59617163|NCT01410240|75728233|FG001|STARTED|Overall Study||53||
59617164|NCT01410240|75728234|FG002|STARTED|Overall Study||12||
59617165|NCT01410240|75728232|FG000|COMPLETED|Overall Study||52||
59617166|NCT01410240|75728233|FG001|COMPLETED|Overall Study||52||
59617167|NCT01410240|75728234|FG002|COMPLETED|Overall Study||10||
59617168|NCT01410240|75728232|FG000|NOT COMPLETED|Overall Study||1||
59617169|NCT01410240|75728233|FG001|NOT COMPLETED|Overall Study||1||
59617170|NCT01410240|75728234|FG002|NOT COMPLETED|Overall Study||2||
59617171|NCT01409928|75728243|FG000|STARTED|Overall Study||16||
59617172|NCT01409928|75728243|FG000|COMPLETED|Overall Study||4||
59617173|NCT01409928|75728243|FG000|NOT COMPLETED|Overall Study||12||
59617174|NCT01431534|75728250|FG000|STARTED|Treatment Phase||4||
59617175|NCT01431534|75728251|FG001|STARTED|Treatment Phase||3||
59617176|NCT01431534|75728252|FG002|STARTED|Treatment Phase||13||
59617177|NCT01431534|75728250|FG000|COMPLETED|Treatment Phase||0||
59617178|NCT01431534|75728251|FG001|COMPLETED|Treatment Phase||0||
59617179|NCT01431534|75728252|FG002|COMPLETED|Treatment Phase|Participants completing Treatment Phase could continue in Extension Phase.|2||
59617180|NCT01431534|75728250|FG000|NOT COMPLETED|Treatment Phase||4||
59617181|NCT01431534|75728251|FG001|NOT COMPLETED|Treatment Phase||3||
59617182|NCT01431534|75728252|FG002|NOT COMPLETED|Treatment Phase||11||
59617183|NCT01431534|75728250|FG000|STARTED|Extension Phase|No participants continued in Extension Phase.|0||
59617184|NCT01431534|75728251|FG001|STARTED|Extension Phase|No participants continued in Extension Phase.|0||
59617185|NCT01431534|75728252|FG002|STARTED|Extension Phase|Participants from Treatment Phase who continued in Extension Phase.|2||
59617186|NCT01431534|75728250|FG000|COMPLETED|Extension Phase||0||
59617187|NCT01431534|75728251|FG001|COMPLETED|Extension Phase||0||
59617188|NCT01431534|75728252|FG002|COMPLETED|Extension Phase||2||
59617189|NCT01431534|75728250|FG000|NOT COMPLETED|Extension Phase||0||
59617190|NCT01431534|75728251|FG001|NOT COMPLETED|Extension Phase||0||
59617191|NCT01431534|75728252|FG002|NOT COMPLETED|Extension Phase||0||
59617192|NCT01409382|75728262|FG000|STARTED|Overall Study||240||
59617193|NCT01409382|75728263|FG001|STARTED|Overall Study||240||
59617194|NCT01409382|75728262|FG000|COMPLETED|Overall Study||159||
59617195|NCT01409382|75728263|FG001|COMPLETED|Overall Study||160||
59617196|NCT01409382|75728262|FG000|NOT COMPLETED|Overall Study||81||
59617197|NCT01409382|75728263|FG001|NOT COMPLETED|Overall Study||80||
59617198|NCT01408914|75728276|FG000|STARTED|Overall Study||60||
59617199|NCT01408914|75728277|FG001|STARTED|Overall Study||60||
59617200|NCT01408914|75728278|FG002|STARTED|Overall Study||60||
59617201|NCT01408914|75728276|FG000|COMPLETED|Overall Study||48||
59617202|NCT01408914|75728277|FG001|COMPLETED|Overall Study||48||
59617203|NCT01408914|75728278|FG002|COMPLETED|Overall Study||47||
59617204|NCT01408914|75728276|FG000|NOT COMPLETED|Overall Study||12||
59617205|NCT01408914|75728277|FG001|NOT COMPLETED|Overall Study||12||
59617206|NCT01408914|75728278|FG002|NOT COMPLETED|Overall Study||13||
59617207|NCT01431144|75728288|FG000|STARTED|Overall Study||13||
59617208|NCT01431144|75728289|FG001|STARTED|Overall Study||14||
59617209|NCT01431144|75728288|FG000|COMPLETED|Overall Study||11||
59617210|NCT01431144|75728289|FG001|COMPLETED|Overall Study||14||
59617211|NCT01431144|75728288|FG000|NOT COMPLETED|Overall Study||2||
59617212|NCT01431144|75728289|FG001|NOT COMPLETED|Overall Study||0||
59617213|NCT01430754|75728298|FG000|STARTED|Run-In Phase||57||
59617214|NCT01430754|75728299|FG001|STARTED|Run-In Phase|During the run-in phase, participants were treated with tasimelteon only.|0||
59617215|NCT01430754|75728298|FG000|Entrained - After Run-In Phase|Run-In Phase||24||
59617216|NCT01430754|75728299|FG001|Entrained - After Run-In Phase|Run-In Phase||0||
59617217|NCT01430754|75728298|FG000|COMPLETED|Run-In Phase|Defined as the number of patients who entered the randomized-withdrawal phase|20||
59617218|NCT01430754|75728299|FG001|COMPLETED|Run-In Phase||0||
59617219|NCT01430754|75728298|FG000|NOT COMPLETED|Run-In Phase||37||
59617220|NCT01430754|75728299|FG001|NOT COMPLETED|Run-In Phase||0||
59617221|NCT01430754|75728298|FG000|STARTED|Randomized Phase||10||
59617222|NCT01430754|75728299|FG001|STARTED|Randomized Phase||10||
59617223|NCT01430754|75728298|FG000|COMPLETED|Randomized Phase||10||
59617224|NCT01430754|75728299|FG001|COMPLETED|Randomized Phase||10||
59617225|NCT01430754|75728298|FG000|NOT COMPLETED|Randomized Phase||0||
59617226|NCT01430754|75728299|FG001|NOT COMPLETED|Randomized Phase||0||
59617227|NCT01390428|75728313|FG000|STARTED|Overall Study||8||
59617228|NCT01390428|75728314|FG001|STARTED|Overall Study||8||
59617229|NCT01390428|75728315|FG002|STARTED|Overall Study||9||
59617230|NCT01390428|75728316|FG003|STARTED|Overall Study||9||
59617231|NCT01390428|75728317|FG004|STARTED|Overall Study||8||
59617232|NCT01390428|75728318|FG005|STARTED|Overall Study||8||
59617233|NCT01390428|75728313|FG000|COMPLETED|Overall Study||8||
59617234|NCT01390428|75728314|FG001|COMPLETED|Overall Study||8||
59617235|NCT01390428|75728315|FG002|COMPLETED|Overall Study||8||
59617236|NCT01390428|75728316|FG003|COMPLETED|Overall Study||9||
59617237|NCT01390428|75728317|FG004|COMPLETED|Overall Study||7||
59617238|NCT01390428|75728318|FG005|COMPLETED|Overall Study||8||
59617239|NCT01390428|75728313|FG000|NOT COMPLETED|Overall Study||0||
59617240|NCT01390428|75728314|FG001|NOT COMPLETED|Overall Study||0||
59617241|NCT01390428|75728315|FG002|NOT COMPLETED|Overall Study||1||
59617242|NCT01390428|75728316|FG003|NOT COMPLETED|Overall Study||0||
59617243|NCT01390428|75728317|FG004|NOT COMPLETED|Overall Study||1||
59617244|NCT01390428|75728318|FG005|NOT COMPLETED|Overall Study||0||
59617245|NCT01430130|75728332|FG000|STARTED|Overall Study||12||
59617246|NCT01430130|75728332|FG000|COMPLETED|Overall Study||10||
59617247|NCT01430130|75728332|FG000|NOT COMPLETED|Overall Study||2||
59617248|NCT01407354|75728338|FG000|STARTED|First Intervention||20||
59617249|NCT01407354|75728339|FG001|STARTED|First Intervention||17||
59617250|NCT01407354|75728338|FG000|COMPLETED|First Intervention||18||
59617251|NCT01407354|75728339|FG001|COMPLETED|First Intervention||15||
59617252|NCT01407354|75728338|FG000|NOT COMPLETED|First Intervention||2||
59617253|NCT01407354|75728339|FG001|NOT COMPLETED|First Intervention||2||
59617254|NCT01407354|75728338|FG000|STARTED|Second Intervention||18||
59617255|NCT01407354|75728339|FG001|STARTED|Second Intervention||15||
59617256|NCT01407354|75728338|FG000|COMPLETED|Second Intervention||18||
59617257|NCT01407354|75728339|FG001|COMPLETED|Second Intervention||13||
59617258|NCT01407354|75728338|FG000|NOT COMPLETED|Second Intervention||0||
59617259|NCT01407354|75728339|FG001|NOT COMPLETED|Second Intervention||2||
59617260|NCT01407276|75728354|FG000|STARTED|Overall Study||6||
59617261|NCT01407276|75728355|FG001|STARTED|Overall Study||6||
59617262|NCT01407276|75728356|FG002|STARTED|Overall Study||6||
59617263|NCT01407276|75728357|FG003|STARTED|Overall Study||6||
59617264|NCT01407276|75728358|FG004|STARTED|Overall Study||6||
59617265|NCT01407276|75728359|FG005|STARTED|Overall Study||6||
59617266|NCT01407276|75728360|FG006|STARTED|Overall Study||6||
59617267|NCT01407276|75728361|FG007|STARTED|Overall Study||7||
59617268|NCT01407276|75728354|FG000|COMPLETED|Overall Study||6||
59617269|NCT01407276|75728355|FG001|COMPLETED|Overall Study||6||
59617270|NCT01407276|75728356|FG002|COMPLETED|Overall Study||6||
59617271|NCT01407276|75728357|FG003|COMPLETED|Overall Study||6||
59617272|NCT01407276|75728358|FG004|COMPLETED|Overall Study||6||
59617273|NCT01407276|75728359|FG005|COMPLETED|Overall Study||6||
59762795|NCT00854607|75882658|FG000|NOT COMPLETED|2 Weeks After Start Anti-fungal Therapy||65||
59762796|NCT00854373|75882671|FG000|STARTED|Overall Study||95||
59617274|NCT01407276|75728360|FG006|COMPLETED|Overall Study||6||
59617275|NCT01407276|75728361|FG007|COMPLETED|Overall Study||6||
59617276|NCT01407276|75728354|FG000|NOT COMPLETED|Overall Study||0||
59617277|NCT01407276|75728355|FG001|NOT COMPLETED|Overall Study||0||
59617278|NCT01407276|75728356|FG002|NOT COMPLETED|Overall Study||0||
59617279|NCT01407276|75728357|FG003|NOT COMPLETED|Overall Study||0||
59617280|NCT01407276|75728358|FG004|NOT COMPLETED|Overall Study||0||
59617281|NCT01407276|75728359|FG005|NOT COMPLETED|Overall Study||0||
59617282|NCT01407276|75728360|FG006|NOT COMPLETED|Overall Study||0||
59617283|NCT01407276|75728361|FG007|NOT COMPLETED|Overall Study||1||
59617284|NCT01390272|75728388|FG000|STARTED|Overall Study||192||
59617285|NCT01390272|75728389|FG001|STARTED|Overall Study||193||
59617286|NCT01390272|75728388|FG000|6 Month Follow up|Overall Study|30 of 192 participants in the Titration Intervention group had missing blood pressure measurement|162||
59617287|NCT01390272|75728389|FG001|6 Month Follow up|Overall Study|22 of 193 in the LPN control group had missing blood pressure measurement|171||
59617288|NCT01390272|75728388|FG000|12 Month Follow up|Overall Study|53 of 192 participants in the Titration Intervention group had missing measurement|139||
59617289|NCT01390272|75728389|FG001|12 Month Follow up|Overall Study|34 of 193 in the LPN control group had missing blood pressure measurement|159||
59617290|NCT01390272|75728388|FG000|18 Month Follow up|Overall Study|37 of 192 participants in the Titration Intervention group had missing blood pressure measurement|155||
59617291|NCT01390272|75728389|FG001|18 Month Follow up|Overall Study|33 of 193 in the LPN control group had missing blood pressure measurement|160||
59617292|NCT01390272|75728388|FG000|COMPLETED|Overall Study||175||
59617293|NCT01390272|75728389|FG001|COMPLETED|Overall Study||178||
59617294|NCT01390272|75728388|FG000|NOT COMPLETED|Overall Study||17||
59617295|NCT01390272|75728389|FG001|NOT COMPLETED|Overall Study||15||
59617296|NCT01429584|75728397|FG000|STARTED|Overall Study||15||
59617297|NCT01429584|75728398|FG001|STARTED|Overall Study||15||
59617298|NCT01429584|75728397|FG000|COMPLETED|Overall Study||14||
59617299|NCT01429584|75728398|FG001|COMPLETED|Overall Study||14||
59617300|NCT01429584|75728397|FG000|NOT COMPLETED|Overall Study||1||
59617301|NCT01429584|75728398|FG001|NOT COMPLETED|Overall Study||1||
59617302|NCT01406652|75728406|FG000|STARTED|Overall Study||109||
59617303|NCT01406652|75728407|FG001|STARTED|Overall Study||115||
59617304|NCT01406652|75728406|FG000|COMPLETED|Overall Study||89||
59617305|NCT01406652|75728407|FG001|COMPLETED|Overall Study||95||
59617306|NCT01406652|75728406|FG000|NOT COMPLETED|Overall Study||20||
59617307|NCT01406652|75728407|FG001|NOT COMPLETED|Overall Study||20||
59617308|NCT01406574|75728415|FG000|STARTED|Overall Study||7||
59617309|NCT01406574|75728416|FG001|STARTED|Overall Study||4||
59617310|NCT01406574|75728417|FG002|STARTED|Overall Study||7||
59617311|NCT01406574|75728418|FG003|STARTED|Overall Study||5||
59617312|NCT01406574|75728415|FG000|COMPLETED|Overall Study||6||
59617313|NCT01406574|75728416|FG001|COMPLETED|Overall Study||3||
59617314|NCT01406574|75728417|FG002|COMPLETED|Overall Study||6||
59617315|NCT01406574|75728418|FG003|COMPLETED|Overall Study||1||
59617316|NCT01406574|75728415|FG000|NOT COMPLETED|Overall Study||1||
59617317|NCT01406574|75728416|FG001|NOT COMPLETED|Overall Study||1||
59617318|NCT01406574|75728417|FG002|NOT COMPLETED|Overall Study||1||
59617319|NCT01406574|75728418|FG003|NOT COMPLETED|Overall Study||4||
59617320|NCT01405950|75728431|FG000|STARTED|Overall Study||8||
59617321|NCT01405950|75728432|FG001|STARTED|Overall Study||2||
59617322|NCT01405950|75728433|FG002|STARTED|Overall Study||0||
59617323|NCT01405950|75728434|FG003|STARTED|Overall Study||0||
59617324|NCT01405950|75728431|FG000|COMPLETED|Overall Study||7||
59617325|NCT01405950|75728432|FG001|COMPLETED|Overall Study||2||
59617326|NCT01405950|75728433|FG002|COMPLETED|Overall Study||0||
59617327|NCT01405950|75728434|FG003|COMPLETED|Overall Study||0||
59617328|NCT01405950|75728431|FG000|NOT COMPLETED|Overall Study||1||
59617329|NCT01405950|75728432|FG001|NOT COMPLETED|Overall Study||0||
59617330|NCT01405950|75728433|FG002|NOT COMPLETED|Overall Study||0||
59617331|NCT01405950|75728434|FG003|NOT COMPLETED|Overall Study||0||
59617332|NCT01405560|75728442|FG000|STARTED|Overall Study||42||
59617333|NCT01405560|75728442|FG000|COMPLETED|Overall Study||41||
59617334|NCT01405560|75728442|FG000|NOT COMPLETED|Overall Study||1||
59617335|NCT01428882|75728448|FG000|STARTED|Overall Study||67||
59617336|NCT01428882|75728449|FG001|STARTED|Overall Study||68||
59617337|NCT01428882|75728448|FG000|COMPLETED|Overall Study||61||
59617338|NCT01428882|75728449|FG001|COMPLETED|Overall Study||58||
59617339|NCT01428882|75728448|FG000|NOT COMPLETED|Overall Study||6||
59617340|NCT01428882|75728449|FG001|NOT COMPLETED|Overall Study||10||
59617341|NCT01428258|75728457|FG000|STARTED|Intervention 1||17||
59617342|NCT01428258|75728458|FG001|STARTED|Intervention 1||15||
59617343|NCT01428258|75728457|FG000|COMPLETED|Intervention 1||15||
59617344|NCT01428258|75728458|FG001|COMPLETED|Intervention 1||15||
59617345|NCT01428258|75728457|FG000|NOT COMPLETED|Intervention 1||2||
59617346|NCT01428258|75728458|FG001|NOT COMPLETED|Intervention 1||0||
59617347|NCT01428258|75728457|FG000|STARTED|Intervention 2||15||
59617348|NCT01428258|75728458|FG001|STARTED|Intervention 2||15||
59617349|NCT01428258|75728457|FG000|COMPLETED|Intervention 2||15||
59617350|NCT01428258|75728458|FG001|COMPLETED|Intervention 2||15||
59617351|NCT01428258|75728457|FG000|NOT COMPLETED|Intervention 2||0||
59617352|NCT01428258|75728458|FG001|NOT COMPLETED|Intervention 2||0||
59617353|NCT01389882|75728474|FG000|STARTED|Overall Study||13||
59617354|NCT01389882|75728475|FG001|STARTED|Overall Study||11||
59617355|NCT01389882|75728474|FG000|COMPLETED|Overall Study||12||
59617356|NCT01389882|75728475|FG001|COMPLETED|Overall Study||7||
59617357|NCT01389882|75728474|FG000|NOT COMPLETED|Overall Study||1||
59617358|NCT01389882|75728475|FG001|NOT COMPLETED|Overall Study||4||
59617359|NCT01442688|75728483|FG000|STARTED|First Intervention||31||
59617360|NCT01442688|75728484|FG001|STARTED|First Intervention||31||
59617361|NCT01442688|75728483|FG000|COMPLETED|First Intervention||29||
59617362|NCT01442688|75728484|FG001|COMPLETED|First Intervention||31||
59617363|NCT01442688|75728483|FG000|NOT COMPLETED|First Intervention||2||
59617364|NCT01442688|75728484|FG001|NOT COMPLETED|First Intervention||0||
59617365|NCT01442688|75728483|FG000|STARTED|Second Intervention||29||
59617366|NCT01442688|75728484|FG001|STARTED|Second Intervention||31||
59617367|NCT01442688|75728483|FG000|COMPLETED|Second Intervention||28||
59617368|NCT01442688|75728484|FG001|COMPLETED|Second Intervention||31||
59617369|NCT01442688|75728483|FG000|NOT COMPLETED|Second Intervention||1||
59617370|NCT01442688|75728484|FG001|NOT COMPLETED|Second Intervention||0||
59617371|NCT01466166|75728490|FG000|STARTED|Overall Study||188||
59617372|NCT01466166|75728490|FG000|Received Treatment|Overall Study||188||
59617373|NCT01466166|75728490|FG000|Completed 24 Weeks of Treatment|Overall Study||55||
59617374|NCT01466166|75728490|FG000|COMPLETED|Overall Study||25|Patients completed the treatment phase of the study (on study for 52 weeks)|
59617375|NCT01466166|75728490|FG000|NOT COMPLETED|Overall Study||163||
59617376|NCT01426854|75728496|FG000|STARTED|Overall Study||131||
59617377|NCT01426854|75728497|FG001|STARTED|Overall Study||129||
59617378|NCT01426854|75728496|FG000|COMPLETED|Overall Study||119||
59617379|NCT01426854|75728497|FG001|COMPLETED|Overall Study||98||
59617380|NCT01426854|75728496|FG000|NOT COMPLETED|Overall Study||12||
59617381|NCT01426854|75728497|FG001|NOT COMPLETED|Overall Study||31||
59617382|NCT01426386|75728509|FG000|STARTED|Overall Study||42||
59617383|NCT01426386|75728510|FG001|STARTED|Overall Study||45||
59617384|NCT01426386|75728511|FG002|STARTED|Overall Study||44||
59617385|NCT01426386|75728512|FG003|STARTED|Overall Study||44||
59617386|NCT01426386|75728513|FG004|STARTED|Overall Study||47||
59617387|NCT01426386|75728514|FG005|STARTED|Overall Study||43||
59617388|NCT01426386|75728509|FG000|COMPLETED|Overall Study||39||
59617389|NCT01426386|75728510|FG001|COMPLETED|Overall Study||39||
59617390|NCT01426386|75728511|FG002|COMPLETED|Overall Study||42||
59617391|NCT01426386|75728512|FG003|COMPLETED|Overall Study||44||
59617392|NCT01426386|75728513|FG004|COMPLETED|Overall Study||43||
59617393|NCT01426386|75728514|FG005|COMPLETED|Overall Study||42||
59617394|NCT01426386|75728509|FG000|NOT COMPLETED|Overall Study||3||
59617395|NCT01426386|75728510|FG001|NOT COMPLETED|Overall Study||6||
59617396|NCT01426386|75728511|FG002|NOT COMPLETED|Overall Study||2||
59617397|NCT01426386|75728512|FG003|NOT COMPLETED|Overall Study||0||
59617398|NCT01426386|75728513|FG004|NOT COMPLETED|Overall Study||4||
59617399|NCT01426386|75728514|FG005|NOT COMPLETED|Overall Study||1||
59617400|NCT01404234|75728528|FG000|STARTED|Overall Study||61||
59617401|NCT01404234|75728528|FG000|COMPLETED|Overall Study||59||
59617402|NCT01404234|75728528|FG000|NOT COMPLETED|Overall Study||2||
59617403|NCT01403610|75728536|FG000|STARTED|Overall Study||5||
59617404|NCT01403610|75728537|FG001|STARTED|Overall Study||6||
59617405|NCT01403610|75728538|FG002|STARTED|Overall Study||4||
59617406|NCT01403610|75728539|FG003|STARTED|Overall Study||13||
59617407|NCT01403610|75728536|FG000|COMPLETED|Overall Study||3||
59617408|NCT01403610|75728537|FG001|COMPLETED|Overall Study||3||
59762797|NCT00854373|75882672|FG001|STARTED|Overall Study||93||
59617409|NCT01403610|75728538|FG002|COMPLETED|Overall Study||4||
59617410|NCT01403610|75728539|FG003|COMPLETED|Overall Study||13||
59617411|NCT01403610|75728536|FG000|NOT COMPLETED|Overall Study||2||
59617412|NCT01403610|75728537|FG001|NOT COMPLETED|Overall Study||3||
59617413|NCT01403610|75728538|FG002|NOT COMPLETED|Overall Study||0||
59617414|NCT01403610|75728539|FG003|NOT COMPLETED|Overall Study||0||
59617415|NCT01403064|75728553|FG000|STARTED|Overall Study||24||
59617416|NCT01403064|75728554|FG001|STARTED|Overall Study||7||
59617417|NCT01403064|75728555|FG002|STARTED|Overall Study||23||
59617418|NCT01403064|75728556|FG003|STARTED|Overall Study||22||
59617419|NCT01403064|75728553|FG000|COMPLETED|Overall Study||23||
59617420|NCT01403064|75728554|FG001|COMPLETED|Overall Study||7||
59617421|NCT01403064|75728555|FG002|COMPLETED|Overall Study||19||
59617422|NCT01403064|75728556|FG003|COMPLETED|Overall Study||19||
59617423|NCT01403064|75728553|FG000|NOT COMPLETED|Overall Study||1||
59617424|NCT01403064|75728554|FG001|NOT COMPLETED|Overall Study||0||
59617425|NCT01403064|75728555|FG002|NOT COMPLETED|Overall Study||4||
59617426|NCT01403064|75728556|FG003|NOT COMPLETED|Overall Study||3||
59617427|NCT01402986|75728575|FG000|STARTED|Overall Study||76||
59617428|NCT01402986|75728576|FG001|STARTED|Overall Study||150||
59617429|NCT01402986|75728577|FG002|STARTED|Overall Study||75||
59617430|NCT01402986|75728578|FG003|STARTED|Overall Study||151||
59617431|NCT01402986|75728575|FG000|COMPLETED|Overall Study||67||
59617432|NCT01402986|75728576|FG001|COMPLETED|Overall Study||135||
59617433|NCT01402986|75728577|FG002|COMPLETED|Overall Study||67||
59617434|NCT01402986|75728578|FG003|COMPLETED|Overall Study||129||
59617435|NCT01402986|75728575|FG000|NOT COMPLETED|Overall Study||9||
59617436|NCT01402986|75728576|FG001|NOT COMPLETED|Overall Study||15||
59617437|NCT01402986|75728577|FG002|NOT COMPLETED|Overall Study||8||
59617438|NCT01402986|75728578|FG003|NOT COMPLETED|Overall Study||22||
59617439|NCT01402908|75728590|FG000|STARTED|Overall Study||258||
59617440|NCT01402908|75728591|FG001|STARTED|Overall Study||261||
59617441|NCT01402908|75728590|FG000|COMPLETED|Overall Study||224||
59617442|NCT01402908|75728591|FG001|COMPLETED|Overall Study||243||
59617443|NCT01402908|75728590|FG000|NOT COMPLETED|Overall Study||34||
59617444|NCT01402908|75728591|FG001|NOT COMPLETED|Overall Study||18||
59617445|NCT01389258|75728597|FG000|STARTED|Overall Study||45||47
59617446|NCT01389258|75728597|FG000|COMPLETED|Overall Study||40||42
59617447|NCT01389258|75728597|FG000|NOT COMPLETED|Overall Study||5||5
59617448|NCT01389102|75728607|FG000|STARTED|Overall Study||75||
59617449|NCT01389102|75728608|FG001|STARTED|Overall Study||76||
59617450|NCT01389102|75728609|FG002|STARTED|Overall Study||77||
59617451|NCT01389102|75728610|FG003|STARTED|Overall Study||76||
59617452|NCT01389102|75728611|FG004|STARTED|Overall Study||74||
59617453|NCT01389102|75728612|FG005|STARTED|Overall Study||76||
59617454|NCT01389102|75728607|FG000|COMPLETED|Overall Study||57||
59617455|NCT01389102|75728608|FG001|COMPLETED|Overall Study||64||
59617456|NCT01389102|75728609|FG002|COMPLETED|Overall Study||58||
59617457|NCT01389102|75728610|FG003|COMPLETED|Overall Study||69||
59617458|NCT01389102|75728611|FG004|COMPLETED|Overall Study||61||
59617459|NCT01389102|75728612|FG005|COMPLETED|Overall Study||68||
59617460|NCT01389102|75728607|FG000|NOT COMPLETED|Overall Study||18||
59617461|NCT01389102|75728608|FG001|NOT COMPLETED|Overall Study||12||
59617462|NCT01389102|75728609|FG002|NOT COMPLETED|Overall Study||19||
59617463|NCT01389102|75728610|FG003|NOT COMPLETED|Overall Study||7||
59617464|NCT01389102|75728611|FG004|NOT COMPLETED|Overall Study||13||
59617465|NCT01389102|75728612|FG005|NOT COMPLETED|Overall Study||8||
59617466|NCT01402284|75728632|FG000|STARTED|Overall Study||45||
59617467|NCT01402284|75728632|FG000|COMPLETED|Overall Study||31||
59617468|NCT01402284|75728632|FG000|NOT COMPLETED|Overall Study||14||
59617469|NCT01388790|75728636|FG000|STARTED|Overall Study||40||
59617470|NCT01388790|75728636|FG000|COMPLETED|Overall Study||32||
59617471|NCT01388790|75728636|FG000|NOT COMPLETED|Overall Study||8||
59617472|NCT01388478|75728640|FG000|STARTED|Overall Study||20||
59617473|NCT01388478|75728640|FG000|COMPLETED|Overall Study||15||
59617474|NCT01388478|75728640|FG000|NOT COMPLETED|Overall Study||5||
59617475|NCT01424670|75728646|FG000|STARTED|6-Month Intensive Period (182 Days)||341||
59617476|NCT01424670|75728647|FG001|STARTED|6-Month Intensive Period (182 Days)||170||
59617477|NCT01424670|75728646|FG000|Received at Least 1 Dose of Study Drug|6-Month Intensive Period (182 Days)||341||
59617478|NCT01424670|75728647|FG001|Received at Least 1 Dose of Study Drug|6-Month Intensive Period (182 Days)||170||
59617479|NCT01424670|75728646|FG000|COMPLETED|6-Month Intensive Period (182 Days)||322|The duration of the 6-month Intensive Period was over 182 days from the date of the first dose.|
59617480|NCT01424670|75728647|FG001|COMPLETED|6-Month Intensive Period (182 Days)||156|The duration of the 6-month Intensive Period was over 182 days from the date of the first dose.|
59617481|NCT01424670|75728646|FG000|NOT COMPLETED|6-Month Intensive Period (182 Days)||19||
59617482|NCT01424670|75728647|FG001|NOT COMPLETED|6-Month Intensive Period (182 Days)||14||
59762798|NCT00854373|75882671|FG000|COMPLETED|Overall Study||93||
59762799|NCT00854373|75882672|FG001|COMPLETED|Overall Study||89||
59762800|NCT00854373|75882671|FG000|NOT COMPLETED|Overall Study||2||
59762801|NCT00854373|75882672|FG001|NOT COMPLETED|Overall Study||4||
59762802|NCT00853905|75882680|FG000|STARTED|Overall Study||37||
59762803|NCT00853905|75882681|FG001|STARTED|Overall Study||40||
59762804|NCT00853905|75882680|FG000|COMPLETED|Overall Study||35||
59762805|NCT00853905|75882681|FG001|COMPLETED|Overall Study||36||
59762806|NCT00853905|75882680|FG000|NOT COMPLETED|Overall Study||2||
59762807|NCT00853905|75882681|FG001|NOT COMPLETED|Overall Study||4||
59762808|NCT00868296|75882692|FG000|STARTED|Overall Study||12||
59762809|NCT00868296|75882693|FG001|STARTED|Overall Study||46||
59762810|NCT00868296|75882692|FG000|COMPLETED|Overall Study||12||
59762811|NCT00868296|75882693|FG001|COMPLETED|Overall Study||43||
59762812|NCT00868296|75882692|FG000|NOT COMPLETED|Overall Study||0||
59762813|NCT00868296|75882693|FG001|NOT COMPLETED|Overall Study||3||
59762814|NCT00867360|75882701|FG000|STARTED|Overall Study||4||
59762815|NCT00867360|75882702|FG001|STARTED|Overall Study||6||
59762816|NCT00867360|75882701|FG000|COMPLETED|Overall Study||3||
59762817|NCT00867360|75882702|FG001|COMPLETED|Overall Study||5||
59762818|NCT00867360|75882701|FG000|NOT COMPLETED|Overall Study||1||
59762819|NCT00867360|75882702|FG001|NOT COMPLETED|Overall Study||1||
59762820|NCT00593736|75882713|FG000|STARTED|Screening Period and Placebo Run-in||0||
59762821|NCT00593736|75882714|FG001|STARTED|Screening Period and Placebo Run-in||0||
59762822|NCT00593736|75882715|FG002|STARTED|Screening Period and Placebo Run-in||0||
59762823|NCT00593736|75882716|FG003|STARTED|Screening Period and Placebo Run-in||549||
59762824|NCT00593736|75882713|FG000|COMPLETED|Screening Period and Placebo Run-in||0||
59762825|NCT00593736|75882714|FG001|COMPLETED|Screening Period and Placebo Run-in||0||
59762826|NCT00593736|75882715|FG002|COMPLETED|Screening Period and Placebo Run-in||0||
59762827|NCT00593736|75882716|FG003|COMPLETED|Screening Period and Placebo Run-in||132||
59762828|NCT00593736|75882713|FG000|NOT COMPLETED|Screening Period and Placebo Run-in||0||
59762829|NCT00593736|75882714|FG001|NOT COMPLETED|Screening Period and Placebo Run-in||0||
59762830|NCT00593736|75882715|FG002|NOT COMPLETED|Screening Period and Placebo Run-in||0||
59762831|NCT00593736|75882716|FG003|NOT COMPLETED|Screening Period and Placebo Run-in||417||
59762832|NCT00593736|75882713|FG000|STARTED|Treatment Period and Placebo Run-out||32||
59762833|NCT00593736|75882714|FG001|STARTED|Treatment Period and Placebo Run-out||33||
59762834|NCT00593736|75882715|FG002|STARTED|Treatment Period and Placebo Run-out||35||
59762835|NCT00593736|75882716|FG003|STARTED|Treatment Period and Placebo Run-out||32||
59762836|NCT00593736|75882713|FG000|COMPLETED|Treatment Period and Placebo Run-out||29||
59762837|NCT00593736|75882714|FG001|COMPLETED|Treatment Period and Placebo Run-out||31||
59762838|NCT00593736|75882715|FG002|COMPLETED|Treatment Period and Placebo Run-out||30||
59762839|NCT00593736|75882716|FG003|COMPLETED|Treatment Period and Placebo Run-out||28||
59762840|NCT00593736|75882713|FG000|NOT COMPLETED|Treatment Period and Placebo Run-out||3||
59762841|NCT00593736|75882714|FG001|NOT COMPLETED|Treatment Period and Placebo Run-out||2||
59762842|NCT00593736|75882715|FG002|NOT COMPLETED|Treatment Period and Placebo Run-out||5||
59762843|NCT00593736|75882716|FG003|NOT COMPLETED|Treatment Period and Placebo Run-out||4||
59762844|NCT00883688|75882726|FG000|STARTED|Overall Study||24||
59762845|NCT00883688|75882726|FG000|COMPLETED|Overall Study||22||
59762846|NCT00883688|75882726|FG000|NOT COMPLETED|Overall Study||2||
59762847|NCT03883477|75882732|FG000|STARTED|Overall Study||13||
59762848|NCT03883477|75882733|FG001|STARTED|Overall Study||13||
59762849|NCT03883477|75882732|FG000|COMPLETED|Overall Study||12||
59762850|NCT03883477|75882733|FG001|COMPLETED|Overall Study||12||
59762851|NCT03883477|75882732|FG000|NOT COMPLETED|Overall Study||1||
59762852|NCT03883477|75882733|FG001|NOT COMPLETED|Overall Study||1||
59762853|NCT00853827|75882741|FG000|STARTED|Single Blind Period (1 Week)|Enrolled patients in single blind|652||
59762854|NCT00853827|75882742|FG001|STARTED|Single Blind Period (1 Week)|This arm was only used in double blind period|0||
59762855|NCT00853827|75882741|FG000|COMPLETED|Single Blind Period (1 Week)|Completed patients in single blind period|613||
59762856|NCT00853827|75882742|FG001|COMPLETED|Single Blind Period (1 Week)||0||
59762857|NCT00853827|75882741|FG000|NOT COMPLETED|Single Blind Period (1 Week)||39||
59951897|NCT00835692|76070847|FG001|COMPLETED|Second Intervention||28||
59951898|NCT00835692|76070846|FG000|NOT COMPLETED|Second Intervention||0||
60071818|NCT01874288|76187192|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3||
59762858|NCT00853827|75882742|FG001|NOT COMPLETED|Single Blind Period (1 Week)||0||
59762859|NCT00853827|75882741|FG000|STARTED|Double Blind Period (103 Weeks)|"Started indicates number of patients in randomized set, full analysis set (FAS) and safety set."|305||
59762860|NCT00853827|75882742|FG001|STARTED|Double Blind Period (103 Weeks)||308||
59762861|NCT00853827|75882741|FG000|Modified Full Analysis Set (mFAS)|Double Blind Period (103 Weeks)||225||
59762862|NCT00853827|75882742|FG001|Modified Full Analysis Set (mFAS)|Double Blind Period (103 Weeks)||233||
59762863|NCT00853827|75882741|FG000|COMPLETED|Double Blind Period (103 Weeks)||201||
59762864|NCT00853827|75882742|FG001|COMPLETED|Double Blind Period (103 Weeks)||199||
59951899|NCT00835692|76070847|FG001|NOT COMPLETED|Second Intervention||0||
59951900|NCT00835614|76070853|FG000|STARTED|First Intervention||13||
59951901|NCT00835614|76070854|FG001|STARTED|First Intervention||13||
59951902|NCT00835614|76070853|FG000|COMPLETED|First Intervention||13||
59951903|NCT00835614|76070854|FG001|COMPLETED|First Intervention||13||
60071819|NCT01874288|76187193|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3||
60071820|NCT01874288|76187194|FG002|Received at Least 1 Dose of Study Drug|Overall Study||9||
60071821|NCT01874288|76187195|FG003|Received at Least 1 Dose of Study Drug|Overall Study||7||
60071822|NCT01874288|76187196|FG004|Received at Least 1 Dose of Study Drug|Overall Study||2||
60071823|NCT01874288|76187192|FG000|COMPLETED|Overall Study||0||
60071824|NCT01874288|76187193|FG001|COMPLETED|Overall Study||3||
60071825|NCT01874288|76187194|FG002|COMPLETED|Overall Study||4||
60071826|NCT01874288|76187195|FG003|COMPLETED|Overall Study||0||
60071827|NCT01874288|76187196|FG004|COMPLETED|Overall Study||0||
60071828|NCT01874288|76187192|FG000|NOT COMPLETED|Overall Study||3||
60071829|NCT01874288|76187193|FG001|NOT COMPLETED|Overall Study||0||
60071830|NCT01874288|76187194|FG002|NOT COMPLETED|Overall Study||5||
60071831|NCT01874288|76187195|FG003|NOT COMPLETED|Overall Study||7||
60071832|NCT01874288|76187196|FG004|NOT COMPLETED|Overall Study||2||
60071833|NCT02080468|76187211|FG000|STARTED|Overall Study||16||
60071834|NCT02080468|76187212|FG001|STARTED|Overall Study||16||
60071835|NCT02080468|76187211|FG000|COMPLETED|Overall Study||14||
60071836|NCT02080468|76187212|FG001|COMPLETED|Overall Study||14||
60071837|NCT02080468|76187211|FG000|NOT COMPLETED|Overall Study||2||
60071838|NCT02080468|76187212|FG001|NOT COMPLETED|Overall Study||2||
60071839|NCT01874054|76187225|FG000|STARTED|Overall Study||55||
60071840|NCT01874054|76187225|FG000|Completed ≥2 Cycles of Combo Treatment|Overall Study||53||
60071841|NCT01874054|76187225|FG000|Completed 16 Cycles of BV Treatment|Overall Study||17||
60071842|NCT01874054|76187225|FG000|COMPLETED|Overall Study||0|No patients completed per protocol as there was no pre-defined follow-up period|
60071843|NCT01874054|76187225|FG000|NOT COMPLETED|Overall Study||55||
60071844|NCT01873742|76187231|FG000|STARTED|Overall Study||165||
60071845|NCT01873742|76187232|FG001|STARTED|Overall Study||163||
59762865|NCT00853827|75882741|FG000|NOT COMPLETED|Double Blind Period (103 Weeks)||104||
59762866|NCT00853827|75882742|FG001|NOT COMPLETED|Double Blind Period (103 Weeks)||109||
59762867|NCT00853749|75882750|FG000|STARTED|Overall Study||50||
59762868|NCT00853749|75882751|FG001|STARTED|Overall Study||39||
59762869|NCT00853749|75882750|FG000|Vaccinated|Overall Study||50||
59762870|NCT00853749|75882751|FG001|Vaccinated|Overall Study||39||
59762871|NCT00853749|75882750|FG000|COMPLETED|Overall Study||50||
59762872|NCT00853749|75882751|FG001|COMPLETED|Overall Study||38||
59762873|NCT00853749|75882750|FG000|NOT COMPLETED|Overall Study||0||
59762874|NCT00853749|75882751|FG001|NOT COMPLETED|Overall Study||1||
59762875|NCT00592839|75882760|FG000|STARTED|Overall Study||53||
59762876|NCT00592839|75882761|FG001|STARTED|Overall Study||52||
59762877|NCT00592839|75882762|FG002|STARTED|Overall Study||52||
59762878|NCT00592839|75882760|FG000|COMPLETED|Overall Study||51||
59762879|NCT00592839|75882761|FG001|COMPLETED|Overall Study||48||
59762880|NCT00592839|75882762|FG002|COMPLETED|Overall Study||46||
59762881|NCT00592839|75882760|FG000|NOT COMPLETED|Overall Study||2||
59762882|NCT00592839|75882761|FG001|NOT COMPLETED|Overall Study||4||
59762883|NCT00592839|75882762|FG002|NOT COMPLETED|Overall Study||6||
59762884|NCT00598832|75882772|FG000|STARTED|Overall Study||533||
59762885|NCT00598832|75882773|FG001|STARTED|Overall Study||542||
59762886|NCT00598832|75882772|FG000|COMPLETED|Overall Study||471||
59762887|NCT00598832|75882773|FG001|COMPLETED|Overall Study||460||
59762888|NCT00598832|75882772|FG000|NOT COMPLETED|Overall Study||62||
59762889|NCT00598832|75882773|FG001|NOT COMPLETED|Overall Study||82||
59762890|NCT00853593|75882779|FG000|STARTED|Overall Study||197||
59762891|NCT00853593|75882779|FG000|Implant Attempted|Overall Study||193||
59762892|NCT00853593|75882779|FG000|Model 4396 Lead Attempted|Overall Study||164||
59762893|NCT00853593|75882779|FG000|COMPLETED|Overall Study||152||
59762894|NCT00853593|75882779|FG000|NOT COMPLETED|Overall Study||45||
59762895|NCT00853125|75882800|FG000|STARTED|Overall Study||10||
59762896|NCT00853125|75882800|FG000|COMPLETED|Overall Study||9||
59762897|NCT00853125|75882800|FG000|NOT COMPLETED|Overall Study||1||
59762898|NCT00530023|75882807|FG000|STARTED|Overall Study||14||
59762899|NCT00530023|75882808|FG001|STARTED|Overall Study||15||
59762900|NCT00530023|75882807|FG000|COMPLETED|Overall Study||14||
59762901|NCT00530023|75882808|FG001|COMPLETED|Overall Study||14||
59762902|NCT00530023|75882807|FG000|NOT COMPLETED|Overall Study||0||
59762903|NCT00530023|75882808|FG001|NOT COMPLETED|Overall Study||1||
59762904|NCT00529087|75882817|FG000|STARTED|Overall Study||150||
59762905|NCT00529087|75882818|FG001|STARTED|Overall Study||148||
59762906|NCT00529087|75882819|FG002|STARTED|Overall Study||162||
59762907|NCT00529087|75882817|FG000|COMPLETED|Overall Study||122||
59762908|NCT00529087|75882818|FG001|COMPLETED|Overall Study||120||
59762909|NCT00529087|75882819|FG002|COMPLETED|Overall Study||146||
60071846|NCT01873742|76187231|FG000|COMPLETED|Overall Study||97||
60071847|NCT01873742|76187232|FG001|COMPLETED|Overall Study||87||
60071848|NCT01873742|76187231|FG000|NOT COMPLETED|Overall Study||68||
60071849|NCT01873742|76187232|FG001|NOT COMPLETED|Overall Study||76||
60071850|NCT01873586|76187238|FG000|STARTED|Overall Study||29||54
60071851|NCT01873586|76187238|FG000|COMPLETED|Overall Study||26||47
59762910|NCT00529087|75882817|FG000|NOT COMPLETED|Overall Study||28||
59762911|NCT00529087|75882818|FG001|NOT COMPLETED|Overall Study||28||
59762912|NCT00529087|75882819|FG002|NOT COMPLETED|Overall Study||16||
59762913|NCT04318210|75882837|FG000|STARTED|Overall Study||229||
59762914|NCT04318210|75882837|FG000|COMPLETED|Overall Study||153||
59762915|NCT04318210|75882837|FG000|NOT COMPLETED|Overall Study||76||
59762916|NCT03809117|75882843|FG000|STARTED|Overall Study||38||
59762917|NCT03809117|75882844|FG001|STARTED|Overall Study||36||
59762918|NCT03809117|75882843|FG000|COMPLETED|Overall Study||38||
59762919|NCT03809117|75882844|FG001|COMPLETED|Overall Study||36||
59617483|NCT01424670|75728646|FG000|STARTED|Continuation Period||322||
59617484|NCT01424670|75728647|FG001|STARTED|Continuation Period||156||
59617485|NCT01424670|75728646|FG000|COMPLETED|Continuation Period||288||
59762920|NCT03809117|75882843|FG000|NOT COMPLETED|Overall Study||0||
59762921|NCT03809117|75882844|FG001|NOT COMPLETED|Overall Study||0||
59762922|NCT00870870|75882854|FG000|STARTED|Overall Study||4||
59762923|NCT00870870|75882855|FG001|STARTED|Overall Study||6||
59762924|NCT00870870|75882856|FG002|STARTED|Overall Study||29||
59762925|NCT00870870|75882857|FG003|STARTED|Overall Study||25||
59762926|NCT00870870|75882854|FG000|COMPLETED|Overall Study||4||
59762927|NCT00870870|75882855|FG001|COMPLETED|Overall Study||5||
59762928|NCT00870870|75882856|FG002|COMPLETED|Overall Study||26||
59762929|NCT00870870|75882857|FG003|COMPLETED|Overall Study||20||
59762930|NCT00870870|75882854|FG000|NOT COMPLETED|Overall Study||0||
59762931|NCT00870870|75882855|FG001|NOT COMPLETED|Overall Study||1||
59762932|NCT00870870|75882856|FG002|NOT COMPLETED|Overall Study||3||
59762933|NCT00870870|75882857|FG003|NOT COMPLETED|Overall Study||5||
59762934|NCT03877237|75882874|FG000|STARTED|Overall Study||156||
59762935|NCT03877237|75882875|FG001|STARTED|Overall Study||157||
59762936|NCT03877237|75882874|FG000|Treated|Overall Study||156||
59762937|NCT03877237|75882875|FG001|Treated|Overall Study||157||
59762938|NCT03877237|75882874|FG000|COMPLETED|Overall Study||151||
59762939|NCT03877237|75882875|FG001|COMPLETED|Overall Study||151||
59762940|NCT03877237|75882874|FG000|NOT COMPLETED|Overall Study||5||
59762941|NCT03877237|75882875|FG001|NOT COMPLETED|Overall Study||6||
59762942|NCT00528931|75882881|FG000|STARTED|Overall Study||16||
59762943|NCT00528931|75882881|FG000|COMPLETED|Overall Study||15||
59762944|NCT00528931|75882881|FG000|NOT COMPLETED|Overall Study||1||
59762945|NCT00866814|75882886|FG000|STARTED|Overall Study||119||
59762946|NCT00866814|75882886|FG000|COMPLETED|Overall Study||99||
59762947|NCT00866814|75882886|FG000|NOT COMPLETED|Overall Study||20||
59762948|NCT00871494|75882890|FG000|STARTED|Overall Study||76||
59762949|NCT00871494|75882890|FG000|COMPLETED|Overall Study||62||
59762950|NCT00871494|75882890|FG000|NOT COMPLETED|Overall Study||14||
59762951|NCT00529789|75882894|FG000|STARTED|Study Period II/III||72||
59762952|NCT00529789|75882894|FG000|COMPLETED|Study Period II/III||48||
59762953|NCT00529789|75882894|FG000|NOT COMPLETED|Study Period II/III||24||
59762954|NCT00529789|75882894|FG000|STARTED|Study Period IV||48||
59762955|NCT00529789|75882894|FG000|COMPLETED|Study Period IV|Includes 1 patient who withdrew at last visit; didn't enter Taper; however received 30 weeks of drug|42||
59762956|NCT00529789|75882894|FG000|NOT COMPLETED|Study Period IV||6||
59762957|NCT00577642|75882904|FG000|STARTED|Overall Study||29||
59762958|NCT00577642|75882904|FG000|COMPLETED|Overall Study||28||
59762959|NCT00577642|75882904|FG000|NOT COMPLETED|Overall Study||1||
59762960|NCT00866658|75882910|FG000|STARTED|Overall Study|Randomized.|157||
59762961|NCT00866658|75882911|FG001|STARTED|Overall Study||154||
59762962|NCT00866658|75882910|FG000|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|157||
59762963|NCT00866658|75882911|FG001|Safety Population|Overall Study||154||
59762964|NCT00866658|75882910|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|157||
59762965|NCT00866658|75882911|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||154||
59762966|NCT00866658|75882910|FG000|COMPLETED|Overall Study||144||
59762967|NCT00866658|75882911|FG001|COMPLETED|Overall Study||133||
59762968|NCT00866658|75882910|FG000|NOT COMPLETED|Overall Study||13||
59762969|NCT00866658|75882911|FG001|NOT COMPLETED|Overall Study||21||
59762970|NCT00597584|75882919|FG000|STARTED|Overall Study|Randomization was 2:1 peginesatide to epoetin|549||
59762971|NCT00597584|75882920|FG001|STARTED|Overall Study||274||
59762972|NCT00597584|75882919|FG000|COMPLETED|Overall Study||421||
59762973|NCT00597584|75882920|FG001|COMPLETED|Overall Study||211||
59762974|NCT00597584|75882919|FG000|NOT COMPLETED|Overall Study||128||
59762975|NCT00597584|75882920|FG001|NOT COMPLETED|Overall Study||63||
59762976|NCT00529633|75882928|FG000|STARTED|Overall Study||2||
59762977|NCT00529633|75882929|FG001|STARTED|Overall Study||2||
59762978|NCT00529633|75882928|FG000|COMPLETED|Overall Study||1||
59762979|NCT00529633|75882929|FG001|COMPLETED|Overall Study||1||
59762980|NCT00529633|75882928|FG000|NOT COMPLETED|Overall Study||1||
59762981|NCT00529633|75882929|FG001|NOT COMPLETED|Overall Study||1||
59762982|NCT00530335|75882935|FG000|STARTED|Overall Study||45||
59762983|NCT00530335|75882935|FG000|COMPLETED|Overall Study||39||
59762984|NCT00530335|75882935|FG000|NOT COMPLETED|Overall Study||6||
59762985|NCT00712270|75882942|FG000|STARTED|Overall Study||21|Unknown - study was terminated back in 2009 with limited data available. Randomization is not known|
59762986|NCT00712270|75882942|FG000|COMPLETED|Overall Study||7|Unknown - study was terminated back in 2009 with limited data available. Randomization is not known|
59762987|NCT00712270|75882942|FG000|NOT COMPLETED|Overall Study||14||
59762988|NCT03860597|75882955|FG000|STARTED|Overall Study||11||
59617486|NCT01424670|75728647|FG001|COMPLETED|Continuation Period||142||
59762989|NCT03860597|75882956|FG001|STARTED|Overall Study||11||
59762990|NCT03860597|75882957|FG002|STARTED|Overall Study||10||
59762991|NCT03860597|75882958|FG003|STARTED|Overall Study||10||
59762992|NCT03860597|75882955|FG000|COMPLETED|Overall Study||11||
59762993|NCT03860597|75882956|FG001|COMPLETED|Overall Study||11||
59762994|NCT03860597|75882957|FG002|COMPLETED|Overall Study||10||
59762995|NCT03860597|75882958|FG003|COMPLETED|Overall Study||10||
59762996|NCT03860597|75882955|FG000|NOT COMPLETED|Overall Study||0||
59762997|NCT03860597|75882956|FG001|NOT COMPLETED|Overall Study||0||
59762998|NCT03860597|75882957|FG002|NOT COMPLETED|Overall Study||0||
59762999|NCT03860597|75882958|FG003|NOT COMPLETED|Overall Study||0||
59763000|NCT00530257|75882968|FG000|STARTED|Overall Study||31||
59763001|NCT00530257|75882968|FG000|COMPLETED|Overall Study||30||
59763002|NCT00530257|75882968|FG000|NOT COMPLETED|Overall Study||1||
59763003|NCT00869778|75882978|FG000|STARTED|Overall Study||120||
59763004|NCT00869778|75882979|FG001|STARTED|Overall Study||120||
59763005|NCT00869778|75882980|FG002|STARTED|Overall Study||120||
59763006|NCT00869778|75882978|FG000|COMPLETED|Overall Study||108||
59763007|NCT00869778|75882979|FG001|COMPLETED|Overall Study||113||
59763008|NCT00869778|75882980|FG002|COMPLETED|Overall Study||110||
59763009|NCT00869778|75882978|FG000|NOT COMPLETED|Overall Study||12||
59763010|NCT00869778|75882979|FG001|NOT COMPLETED|Overall Study||7||
59763011|NCT00869778|75882980|FG002|NOT COMPLETED|Overall Study||10||
59763012|NCT00549172|75882993|FG000|STARTED|Overall Study||70||
59763013|NCT00549172|75882994|FG001|STARTED|Overall Study||76||
59763014|NCT00549172|75882993|FG000|COMPLETED|Overall Study||70||
59763015|NCT00549172|75882994|FG001|COMPLETED|Overall Study||76||
59763016|NCT00549172|75882993|FG000|NOT COMPLETED|Overall Study||0||
59763017|NCT00549172|75882994|FG001|NOT COMPLETED|Overall Study||0||
59763018|NCT04246541|75883002|FG000|STARTED|Overall Study||25||
59763019|NCT04246541|75883003|FG001|STARTED|Overall Study||23||
59763020|NCT04246541|75883002|FG000|COMPLETED|Overall Study||22||
59763021|NCT04246541|75883003|FG001|COMPLETED|Overall Study||20||
59763022|NCT04246541|75883002|FG000|NOT COMPLETED|Overall Study||3||
59763023|NCT04246541|75883003|FG001|NOT COMPLETED|Overall Study||3||
59763024|NCT00711958|75883011|FG000|STARTED|Overall Study||74||
59763025|NCT00711958|75883012|FG001|STARTED|Overall Study||40||
59763026|NCT00711958|75883011|FG000|COMPLETED|Overall Study||41||
59763027|NCT00711958|75883012|FG001|COMPLETED|Overall Study||17||
59763028|NCT00711958|75883011|FG000|NOT COMPLETED|Overall Study||33||
59763029|NCT00711958|75883012|FG001|NOT COMPLETED|Overall Study||23||
59763030|NCT00711880|75883020|FG000|STARTED|Overall Study||63||
59763031|NCT00711880|75883021|FG001|STARTED|Overall Study||62||
59763032|NCT00711880|75883020|FG000|COMPLETED|Overall Study||50||
59763033|NCT00711880|75883021|FG001|COMPLETED|Overall Study||55||
59763034|NCT00711880|75883020|FG000|NOT COMPLETED|Overall Study||13||
59763035|NCT00711880|75883021|FG001|NOT COMPLETED|Overall Study||7||
59763036|NCT00528775|75883027|FG000|STARTED|Overall Study||6||
59763037|NCT00528775|75883027|FG000|COMPLETED|Overall Study||5||
59763038|NCT00528775|75883027|FG000|NOT COMPLETED|Overall Study||1||
59763039|NCT00529399|75883034|FG000|STARTED|Overall Study||48||
59763040|NCT00529399|75883035|FG001|STARTED|Overall Study||49||
59763041|NCT00529399|75883036|FG002|STARTED|Overall Study||48||
59763042|NCT00529399|75883034|FG000|COMPLETED|Overall Study||46||
59763043|NCT00529399|75883035|FG001|COMPLETED|Overall Study||48||
59763044|NCT00529399|75883036|FG002|COMPLETED|Overall Study||46||
59763045|NCT00529399|75883034|FG000|NOT COMPLETED|Overall Study||2||
59763046|NCT00529399|75883035|FG001|NOT COMPLETED|Overall Study||1||
59763047|NCT00529399|75883036|FG002|NOT COMPLETED|Overall Study||2||
59763048|NCT00852969|75883046|FG000|STARTED|Overall Study||15||
59763049|NCT00852969|75883047|FG001|STARTED|Overall Study||15||
59763050|NCT00852969|75883046|FG000|COMPLETED|Overall Study||15||
59763051|NCT00852969|75883047|FG001|COMPLETED|Overall Study||13||
59763052|NCT00852969|75883046|FG000|NOT COMPLETED|Overall Study||0||
59763053|NCT00852969|75883047|FG001|NOT COMPLETED|Overall Study||2||
59763054|NCT03870997|75883059|FG000|STARTED|Overall Study||15702||
59763055|NCT03870997|75883060|FG001|STARTED|Overall Study||15702||
59763056|NCT03870997|75883061|FG002|STARTED|Overall Study||15756||
59763057|NCT03870997|75883062|FG003|STARTED|Overall Study||15757||
59763058|NCT03870997|75883063|FG004|STARTED|Overall Study||15702||
59763059|NCT03870997|75883064|FG005|STARTED|Overall Study||15702||
59763060|NCT03870997|75883059|FG000|COMPLETED|Overall Study||5158||
59763061|NCT03870997|75883060|FG001|COMPLETED|Overall Study||5271||
59763062|NCT03870997|75883061|FG002|COMPLETED|Overall Study||4778||
59763063|NCT03870997|75883062|FG003|COMPLETED|Overall Study||4810||
59763064|NCT03870997|75883063|FG004|COMPLETED|Overall Study||5114||
59763065|NCT03870997|75883064|FG005|COMPLETED|Overall Study||5171||
59763066|NCT03870997|75883059|FG000|NOT COMPLETED|Overall Study||10544||
59763067|NCT03870997|75883060|FG001|NOT COMPLETED|Overall Study||10431||
59763068|NCT03870997|75883061|FG002|NOT COMPLETED|Overall Study||10978||
59763069|NCT03870997|75883062|FG003|NOT COMPLETED|Overall Study||10947||
59763070|NCT03870997|75883063|FG004|NOT COMPLETED|Overall Study||10588||
59763071|NCT03870997|75883064|FG005|NOT COMPLETED|Overall Study||10531||
59763072|NCT00521365|75883073|FG000|STARTED|Overall Study|98 participants were screened and obtain 88 patients who receive study treatment|88||
59817840|NCT04488770|75940331|FG005|STARTED|Part 1-Cohort 1: Period 4 (Up to 5 Days)||0||
59763073|NCT00521365|75883073|FG000|Modified Intention to Treat (mITT)|Overall Study|Participants who have an YMRS assessment at inclusion, and at least one assessment after inclusion|88||
59763074|NCT00521365|75883073|FG000|Per Protocol (PP) Population|Overall Study|All participants without protocol deviations|68||
59763075|NCT00521365|75883073|FG000|Safety Analysis Set|Overall Study|All participants who received study treatment|88||
59763076|NCT00521365|75883073|FG000|COMPLETED|Overall Study|68 participants completed the study and 68 completed without protocol deviations|68||
59763077|NCT00521365|75883073|FG000|NOT COMPLETED|Overall Study||20||
59763078|NCT00711802|75883085|FG000|STARTED|Overall Study||75||
59763079|NCT00711802|75883086|FG001|STARTED|Overall Study||38||
59763080|NCT00711802|75883087|FG002|STARTED|Overall Study||75||
59763081|NCT00711802|75883088|FG003|STARTED|Overall Study||38||
59763082|NCT00711802|75883089|FG004|STARTED|Overall Study||83||
59763083|NCT00711802|75883090|FG005|STARTED|Overall Study||42||
59763084|NCT00711802|75883091|FG006|STARTED|Overall Study||30||
59763085|NCT00711802|75883092|FG007|STARTED|Overall Study||15||
59763086|NCT00711802|75883085|FG000|Received at Least 1 Dose of Study Drug|Overall Study||73||
59763087|NCT00711802|75883086|FG001|Received at Least 1 Dose of Study Drug|Overall Study||37||
59763088|NCT00711802|75883087|FG002|Received at Least 1 Dose of Study Drug|Overall Study||73||
59763089|NCT00711802|75883088|FG003|Received at Least 1 Dose of Study Drug|Overall Study||38||
59763090|NCT00711802|75883089|FG004|Received at Least 1 Dose of Study Drug|Overall Study||81||
59763091|NCT00711802|75883090|FG005|Received at Least 1 Dose of Study Drug|Overall Study||42||
59763092|NCT00711802|75883091|FG006|Received at Least 1 Dose of Study Drug|Overall Study||30||
59763093|NCT00711802|75883092|FG007|Received at Least 1 Dose of Study Drug|Overall Study||15||
59763094|NCT00711802|75883085|FG000|COMPLETED|Overall Study||73||
59763095|NCT00711802|75883086|FG001|COMPLETED|Overall Study||32||
59763096|NCT00711802|75883087|FG002|COMPLETED|Overall Study||69||
59763097|NCT00711802|75883088|FG003|COMPLETED|Overall Study||35||
59763098|NCT00711802|75883089|FG004|COMPLETED|Overall Study||69||
59763099|NCT00711802|75883090|FG005|COMPLETED|Overall Study||34||
59763100|NCT00711802|75883091|FG006|COMPLETED|Overall Study||25||
59763101|NCT00711802|75883092|FG007|COMPLETED|Overall Study||13||
59763102|NCT00711802|75883085|FG000|NOT COMPLETED|Overall Study||2||
59763103|NCT00711802|75883086|FG001|NOT COMPLETED|Overall Study||6||
59763104|NCT00711802|75883087|FG002|NOT COMPLETED|Overall Study||6||
59763105|NCT00711802|75883088|FG003|NOT COMPLETED|Overall Study||3||
59763106|NCT00711802|75883089|FG004|NOT COMPLETED|Overall Study||14||
59763107|NCT00711802|75883090|FG005|NOT COMPLETED|Overall Study||8||
59763108|NCT00711802|75883091|FG006|NOT COMPLETED|Overall Study||5||
59763109|NCT00711802|75883092|FG007|NOT COMPLETED|Overall Study||2||
59763110|NCT00851877|75883113|FG000|STARTED|Phase I-1||7||
59763111|NCT00851877|75883114|FG001|STARTED|Phase I-1||0||
59763112|NCT00851877|75883115|FG002|STARTED|Phase I-1||0||
59763113|NCT00851877|75883113|FG000|COMPLETED|Phase I-1||6||
59763114|NCT00851877|75883114|FG001|COMPLETED|Phase I-1||0||
59763115|NCT00851877|75883115|FG002|COMPLETED|Phase I-1||0||
59763116|NCT00851877|75883113|FG000|NOT COMPLETED|Phase I-1||1||
59763117|NCT00851877|75883114|FG001|NOT COMPLETED|Phase I-1||0||
59763118|NCT00851877|75883115|FG002|NOT COMPLETED|Phase I-1||0||
59763119|NCT00851877|75883113|FG000|STARTED|Phase I-2||0||
59763120|NCT00851877|75883114|FG001|STARTED|Phase I-2||5||
59763121|NCT00851877|75883115|FG002|STARTED|Phase I-2||0||
59763122|NCT00851877|75883113|FG000|COMPLETED|Phase I-2||0||
59763123|NCT00851877|75883114|FG001|COMPLETED|Phase I-2||5||
59763124|NCT00851877|75883115|FG002|COMPLETED|Phase I-2||0||
59763125|NCT00851877|75883113|FG000|NOT COMPLETED|Phase I-2||0||
59763126|NCT00851877|75883114|FG001|NOT COMPLETED|Phase I-2||0||
59763127|NCT00851877|75883115|FG002|NOT COMPLETED|Phase I-2||0||
59763128|NCT00851877|75883113|FG000|STARTED|Phase II||0||
59763129|NCT00851877|75883114|FG001|STARTED|Phase II||0||
59763130|NCT00851877|75883115|FG002|STARTED|Phase II||25||
59763131|NCT00851877|75883113|FG000|COMPLETED|Phase II||0||
59763132|NCT00851877|75883114|FG001|COMPLETED|Phase II||0||
59763133|NCT00851877|75883115|FG002|COMPLETED|Phase II||22||
59763134|NCT00851877|75883113|FG000|NOT COMPLETED|Phase II||0||
59763135|NCT00851877|75883114|FG001|NOT COMPLETED|Phase II||0||
59763136|NCT00851877|75883115|FG002|NOT COMPLETED|Phase II||3||
59763137|NCT00882908|75883126|FG000|STARTED|Overall Study||78||
59763138|NCT00882908|75883127|FG001|STARTED|Overall Study||75||
59763139|NCT00882908|75883128|FG002|STARTED|Overall Study||77||
59763140|NCT00882908|75883129|FG003|STARTED|Overall Study||79||
59763141|NCT00882908|75883130|FG004|STARTED|Overall Study||77||
59763142|NCT00882908|75883126|FG000|COMPLETED|Overall Study||75||
59763143|NCT00882908|75883127|FG001|COMPLETED|Overall Study||69||
59763144|NCT00882908|75883128|FG002|COMPLETED|Overall Study||70||
59763145|NCT00882908|75883129|FG003|COMPLETED|Overall Study||72||
59763146|NCT00882908|75883130|FG004|COMPLETED|Overall Study||71||
59763147|NCT00882908|75883126|FG000|NOT COMPLETED|Overall Study||3||
59763148|NCT00882908|75883127|FG001|NOT COMPLETED|Overall Study||6||
59763149|NCT00882908|75883128|FG002|NOT COMPLETED|Overall Study||7||
59763150|NCT00882908|75883129|FG003|NOT COMPLETED|Overall Study||7||
59763151|NCT00882908|75883130|FG004|NOT COMPLETED|Overall Study||6||
59763152|NCT00851799|75883146|FG000|STARTED|Overall Study||109||
59763153|NCT00851799|75883147|FG001|STARTED|Overall Study||106||
59763154|NCT00851799|75883148|FG002|STARTED|Overall Study||113||
59763155|NCT00851799|75883146|FG000|COMPLETED|Overall Study||93||
59763156|NCT00851799|75883147|FG001|COMPLETED|Overall Study||93||
59763157|NCT00851799|75883148|FG002|COMPLETED|Overall Study||89||
59763158|NCT00851799|75883146|FG000|NOT COMPLETED|Overall Study||16||
59763159|NCT00851799|75883147|FG001|NOT COMPLETED|Overall Study||13||
59763160|NCT00851799|75883148|FG002|NOT COMPLETED|Overall Study||24||
59763161|NCT00521053|75883156|FG000|STARTED|Treatment Phase||80||
59763162|NCT00521053|75883156|FG000|Received 1 Cycle of PV-10|Treatment Phase||35||
59763163|NCT00521053|75883156|FG000|Received 2 Cycles of PV-10|Treatment Phase||26||
59763164|NCT00521053|75883156|FG000|Received 3 Cycles of PV-10|Treatment Phase||16||
59763165|NCT00521053|75883156|FG000|Received 4 Cycles of PV-10|Treatment Phase||3||
59763166|NCT00521053|75883156|FG000|COMPLETED|Treatment Phase||80||
59763167|NCT00521053|75883156|FG000|NOT COMPLETED|Treatment Phase||0||
59763168|NCT00521053|75883156|FG000|STARTED|Observation Phase||80||
59763169|NCT00521053|75883156|FG000|COMPLETED|Observation Phase||12||
59763170|NCT00521053|75883156|FG000|NOT COMPLETED|Observation Phase||68||
59763171|NCT00853047|75883168|FG000|STARTED|Core Phase||5||
59763172|NCT00853047|75883169|FG001|STARTED|Core Phase||3||
59763173|NCT00853047|75883170|FG002|STARTED|Core Phase||3||
59763174|NCT00853047|75883171|FG003|STARTED|Core Phase||3||
59763175|NCT00853047|75883172|FG004|STARTED|Core Phase||9||
59763176|NCT00853047|75883173|FG005|STARTED|Core Phase||0||
59763177|NCT00853047|75883168|FG000|COMPLETED|Core Phase||5||
59763178|NCT00853047|75883169|FG001|COMPLETED|Core Phase||3||
59763179|NCT00853047|75883170|FG002|COMPLETED|Core Phase||3||
59763180|NCT00853047|75883171|FG003|COMPLETED|Core Phase||2||
59763181|NCT00853047|75883172|FG004|COMPLETED|Core Phase||9||
59763182|NCT00853047|75883173|FG005|COMPLETED|Core Phase||0||
59763183|NCT00853047|75883168|FG000|NOT COMPLETED|Core Phase||0||
59763184|NCT00853047|75883169|FG001|NOT COMPLETED|Core Phase||0||
59763185|NCT00853047|75883170|FG002|NOT COMPLETED|Core Phase||0||
59763186|NCT00853047|75883171|FG003|NOT COMPLETED|Core Phase||1||
59763187|NCT00853047|75883172|FG004|NOT COMPLETED|Core Phase||0||
59763188|NCT00853047|75883173|FG005|NOT COMPLETED|Core Phase||0||
59763189|NCT00853047|75883168|FG000|STARTED|Open-Label Extension Phase||0||
59763190|NCT00853047|75883169|FG001|STARTED|Open-Label Extension Phase||0||
59763191|NCT00853047|75883170|FG002|STARTED|Open-Label Extension Phase||0||
59763192|NCT00853047|75883171|FG003|STARTED|Open-Label Extension Phase||0||
59763193|NCT00853047|75883172|FG004|STARTED|Open-Label Extension Phase||0||
59763194|NCT00853047|75883173|FG005|STARTED|Open-Label Extension Phase|19 of the 22 participants who completed the Core Phase entered the optional Open-Label Extension.|19||
59763195|NCT00853047|75883168|FG000|Completed 8-week Extension Period|Open-Label Extension Phase||0||
59763196|NCT00853047|75883169|FG001|Completed 8-week Extension Period|Open-Label Extension Phase||0||
59520370|NCT00957593|75614292|FG000|NOT COMPLETED|Overall Study||0||
59520371|NCT00957593|75614293|FG001|NOT COMPLETED|Overall Study||0||
59763197|NCT00853047|75883170|FG002|Completed 8-week Extension Period|Open-Label Extension Phase||0||
59520372|NCT00957671|75614301|FG000|STARTED|Overall Study|15 subjects began the treatment phase.|15||
59520373|NCT00957671|75614301|FG000|COMPLETED|Overall Study|15 subjects completed the treatment phase of the study.|15||
59520374|NCT00957671|75614301|FG000|NOT COMPLETED|Overall Study||0||
59520375|NCT04322968|75614310|FG000|STARTED|Overall Study||11||
59520376|NCT04322968|75614311|FG001|STARTED|Overall Study||10||
59520377|NCT04322968|75614312|FG002|STARTED|Overall Study||10||
59520378|NCT04322968|75614313|FG003|STARTED|Overall Study||10||
59520379|NCT04322968|75614310|FG000|COMPLETED|Overall Study||10||
59520380|NCT04322968|75614311|FG001|COMPLETED|Overall Study||9||
59763198|NCT00853047|75883171|FG003|Completed 8-week Extension Period|Open-Label Extension Phase||0||
59763199|NCT00853047|75883172|FG004|Completed 8-week Extension Period|Open-Label Extension Phase||0||
59763200|NCT00853047|75883173|FG005|Completed 8-week Extension Period|Open-Label Extension Phase||16||
59763201|NCT00853047|75883168|FG000|COMPLETED|Open-Label Extension Phase||0||
59763202|NCT00853047|75883169|FG001|COMPLETED|Open-Label Extension Phase||0||
59763203|NCT00853047|75883170|FG002|COMPLETED|Open-Label Extension Phase||0||
59763204|NCT00853047|75883171|FG003|COMPLETED|Open-Label Extension Phase||0||
59763205|NCT00853047|75883172|FG004|COMPLETED|Open-Label Extension Phase||0||
59763206|NCT00853047|75883173|FG005|COMPLETED|Open-Label Extension Phase||2||
59763207|NCT00853047|75883168|FG000|NOT COMPLETED|Open-Label Extension Phase||0||
59763208|NCT00853047|75883169|FG001|NOT COMPLETED|Open-Label Extension Phase||0||
59520381|NCT04322968|75614312|FG002|COMPLETED|Overall Study||10||
59520382|NCT04322968|75614313|FG003|COMPLETED|Overall Study||10||
59763209|NCT00853047|75883170|FG002|NOT COMPLETED|Open-Label Extension Phase||0||
59763210|NCT00853047|75883171|FG003|NOT COMPLETED|Open-Label Extension Phase||0||
59763211|NCT00853047|75883172|FG004|NOT COMPLETED|Open-Label Extension Phase||0||
59763212|NCT00853047|75883173|FG005|NOT COMPLETED|Open-Label Extension Phase||17||
59763213|NCT00520975|75883190|FG000|STARTED|Overall Study||48||
59763214|NCT00520975|75883191|FG001|STARTED|Overall Study||48||
59763215|NCT00520975|75883190|FG000|Treated and Reported Adverse Events Data|Overall Study||47||
59763216|NCT00520975|75883191|FG001|Treated and Reported Adverse Events Data|Overall Study||45||
59763217|NCT00520975|75883190|FG000|COMPLETED|Overall Study|Treatment continued until progression or intolerable toxicity.|0||
59763218|NCT00520975|75883191|FG001|COMPLETED|Overall Study|Treatment continued until progression or intolerable toxicity.|0||
59763219|NCT00520975|75883190|FG000|NOT COMPLETED|Overall Study||48||
59763220|NCT00520975|75883191|FG001|NOT COMPLETED|Overall Study||48||
59763221|NCT00851721|75883199|FG000|STARTED|Overall Study||19||
59763222|NCT00851721|75883200|FG001|STARTED|Overall Study||17||
59763223|NCT00851721|75883199|FG000|COMPLETED|Overall Study||17||
59763224|NCT00851721|75883200|FG001|COMPLETED|Overall Study||16||
59763225|NCT00851721|75883199|FG000|NOT COMPLETED|Overall Study||2||
59763226|NCT00851721|75883200|FG001|NOT COMPLETED|Overall Study||1||
59763227|NCT00520741|75883214|FG000|STARTED|Overall Study||106||
59763228|NCT00520741|75883215|FG001|STARTED|Overall Study|One subject was randomized at 2 sites and excluded from the Safety Set.|319||
59763229|NCT00520741|75883214|FG000|COMPLETED|Overall Study||69||
59763230|NCT00520741|75883215|FG001|COMPLETED|Overall Study||194||
59763231|NCT00520741|75883214|FG000|NOT COMPLETED|Overall Study||37||
59763232|NCT00520741|75883215|FG001|NOT COMPLETED|Overall Study||125||
59763233|NCT00882518|75883225|FG000|STARTED|Overall Study||196||
59763234|NCT00882518|75883226|FG001|STARTED|Overall Study||192||
59763235|NCT00882518|75883225|FG000|COMPLETED|Overall Study||158||
59763236|NCT00882518|75883226|FG001|COMPLETED|Overall Study||148||
59763237|NCT00882518|75883225|FG000|NOT COMPLETED|Overall Study||38||
59763238|NCT00882518|75883226|FG001|NOT COMPLETED|Overall Study||44||
59763239|NCT03847337|75883234|FG000|STARTED|Overall Study||73||
59763240|NCT03847337|75883235|FG001|STARTED|Overall Study||71||
59763241|NCT03847337|75883234|FG000|COMPLETED|Overall Study||73||
59763242|NCT03847337|75883235|FG001|COMPLETED|Overall Study||71||
59763243|NCT03847337|75883234|FG000|NOT COMPLETED|Overall Study||0||
59763244|NCT03847337|75883235|FG001|NOT COMPLETED|Overall Study||0||
59763245|NCT00882362|75883243|FG000|STARTED|Overall Study||122||
59763246|NCT00882362|75883244|FG001|STARTED|Overall Study||33||
59763247|NCT00882362|75883243|FG000|COMPLETED|Overall Study||73||
59763248|NCT00882362|75883244|FG001|COMPLETED|Overall Study||10||
59763249|NCT00882362|75883243|FG000|NOT COMPLETED|Overall Study||49||
59763250|NCT00882362|75883244|FG001|NOT COMPLETED|Overall Study||23||
59763251|NCT00851643|75883256|FG000|STARTED|Base Study (Up to 12 Months)||15||
59763252|NCT00851643|75883257|FG001|STARTED|Base Study (Up to 12 Months)||30||
59763253|NCT00851643|75883258|FG002|STARTED|Base Study (Up to 12 Months)||30||
59763254|NCT00851643|75883259|FG003|STARTED|Base Study (Up to 12 Months)||15||
59763255|NCT00851643|75883260|FG004|STARTED|Base Study (Up to 12 Months)||30||
59763256|NCT00851643|75883261|FG005|STARTED|Base Study (Up to 12 Months)||30||
59763257|NCT00851643|75883256|FG000|COMPLETED|Base Study (Up to 12 Months)||14||
59763258|NCT00851643|75883257|FG001|COMPLETED|Base Study (Up to 12 Months)||30||
59763259|NCT00851643|75883258|FG002|COMPLETED|Base Study (Up to 12 Months)||30||
59763260|NCT00851643|75883259|FG003|COMPLETED|Base Study (Up to 12 Months)||15||
59763261|NCT00851643|75883260|FG004|COMPLETED|Base Study (Up to 12 Months)||30||
59763262|NCT00851643|75883261|FG005|COMPLETED|Base Study (Up to 12 Months)||29||
59763263|NCT00851643|75883256|FG000|NOT COMPLETED|Base Study (Up to 12 Months)||1||
59763264|NCT00851643|75883257|FG001|NOT COMPLETED|Base Study (Up to 12 Months)||0||
59763265|NCT00851643|75883258|FG002|NOT COMPLETED|Base Study (Up to 12 Months)||0||
59763266|NCT00851643|75883259|FG003|NOT COMPLETED|Base Study (Up to 12 Months)||0||
59763267|NCT00851643|75883260|FG004|NOT COMPLETED|Base Study (Up to 12 Months)||0||
59763268|NCT00851643|75883261|FG005|NOT COMPLETED|Base Study (Up to 12 Months)||1||
59763269|NCT00851643|75883256|FG000|STARTED|Extension Study (Up to 36 Months)||10||
59763270|NCT00851643|75883257|FG001|STARTED|Extension Study (Up to 36 Months)||19||
59763271|NCT00851643|75883258|FG002|STARTED|Extension Study (Up to 36 Months)||19||
59763272|NCT00851643|75883259|FG003|STARTED|Extension Study (Up to 36 Months)||7||
59763273|NCT00851643|75883260|FG004|STARTED|Extension Study (Up to 36 Months)||21||
59763274|NCT00851643|75883261|FG005|STARTED|Extension Study (Up to 36 Months)||15||
59763275|NCT00851643|75883256|FG000|COMPLETED|Extension Study (Up to 36 Months)||6||
59763276|NCT00851643|75883257|FG001|COMPLETED|Extension Study (Up to 36 Months)||15||
59763277|NCT00851643|75883258|FG002|COMPLETED|Extension Study (Up to 36 Months)||14||
59763278|NCT00851643|75883259|FG003|COMPLETED|Extension Study (Up to 36 Months)||5||
59763279|NCT00851643|75883260|FG004|COMPLETED|Extension Study (Up to 36 Months)||19||
59763280|NCT00851643|75883261|FG005|COMPLETED|Extension Study (Up to 36 Months)||14||
59763281|NCT00851643|75883256|FG000|NOT COMPLETED|Extension Study (Up to 36 Months)||4||
59763282|NCT00851643|75883257|FG001|NOT COMPLETED|Extension Study (Up to 36 Months)||4||
59763283|NCT00851643|75883258|FG002|NOT COMPLETED|Extension Study (Up to 36 Months)||5||
59763284|NCT00851643|75883259|FG003|NOT COMPLETED|Extension Study (Up to 36 Months)||2||
59763285|NCT00851643|75883260|FG004|NOT COMPLETED|Extension Study (Up to 36 Months)||2||
59763286|NCT00851643|75883261|FG005|NOT COMPLETED|Extension Study (Up to 36 Months)||1||
59763287|NCT00529243|75883274|FG000|STARTED|Overall Study||52||
59763288|NCT00529243|75883274|FG000|COMPLETED|Overall Study||49||
59763289|NCT00529243|75883274|FG000|NOT COMPLETED|Overall Study||3||
59763290|NCT03728309|75883280|FG000|STARTED|Overall Study||73||
59763291|NCT03728309|75883281|FG001|STARTED|Overall Study||136||
59763292|NCT03728309|75883280|FG000|mITT Population|Overall Study||71|mITT Population included all randomized participants who have baseline assessment on the Allergan Cheek Smoothness Scale (ACSS) for both cheeks, and are not in the Fitzpatrick V/VI safety cohort.|
59763293|NCT03728309|75883281|FG001|mITT Population|Overall Study||131|mITT Population included all randomized participants who have baseline assessment on the Allergan Cheek Smoothness Scale (ACSS) for both cheeks, and are not in the Fitzpatrick V/VI safety cohort.|
59763294|NCT03728309|75883280|FG000|Volite Treated (VT) Population|Overall Study||64|VT Population included participants randomized and received VOLITE treatment at the beginning of the Control Period.|
59763295|NCT03728309|75883281|FG001|Volite Treated (VT) Population|Overall Study||135|VT Population included participants randomized and received VOLITE treatment at the beginning of the Control Period.|
59763296|NCT03728309|75883280|FG000|VOLITE Repeat Treatment (VRT) Population|Overall Study||0|VRT Population included participants in the VT who received VOLITE repeat treatment.|
59763297|NCT03728309|75883281|FG001|VOLITE Repeat Treatment (VRT) Population|Overall Study||79|VRT Population included participants in the VT who received VOLITE repeat treatment.|
59763298|NCT03728309|75883280|FG000|COMPLETED|Overall Study||61||
59763299|NCT03728309|75883281|FG001|COMPLETED|Overall Study||112||
59763300|NCT03728309|75883280|FG000|NOT COMPLETED|Overall Study||12||
59763301|NCT03728309|75883281|FG001|NOT COMPLETED|Overall Study||24||
59763302|NCT03683719|75883298|FG000|STARTED|Overall Study||52||
59763303|NCT03683719|75883299|FG001|STARTED|Overall Study||51||
59763304|NCT03683719|75883300|FG002|STARTED|Overall Study||52||
59763305|NCT03683719|75883301|FG003|STARTED|Overall Study||53||
59763306|NCT03683719|75883302|FG004|STARTED|Overall Study||50||
59763307|NCT03683719|75883298|FG000|COMPLETED|Overall Study||40||
59763308|NCT03683719|75883299|FG001|COMPLETED|Overall Study||38||
59763309|NCT03683719|75883300|FG002|COMPLETED|Overall Study||44||
59763310|NCT03683719|75883301|FG003|COMPLETED|Overall Study||46||
59763311|NCT03683719|75883302|FG004|COMPLETED|Overall Study||36||
59763312|NCT03683719|75883298|FG000|NOT COMPLETED|Overall Study||12||
59763313|NCT03683719|75883299|FG001|NOT COMPLETED|Overall Study||13||
59763314|NCT03683719|75883300|FG002|NOT COMPLETED|Overall Study||8||
59763315|NCT03683719|75883301|FG003|NOT COMPLETED|Overall Study||7||
59763316|NCT03683719|75883302|FG004|NOT COMPLETED|Overall Study||14||
59763317|NCT00851253|75883316|FG000|STARTED|Overall Study||2||
59763318|NCT00851253|75883317|FG001|STARTED|Overall Study||10||
59763319|NCT00851253|75883316|FG000|COMPLETED|Overall Study||1||
59763320|NCT00851253|75883317|FG001|COMPLETED|Overall Study||10||
59763321|NCT00851253|75883316|FG000|NOT COMPLETED|Overall Study||1||
59763322|NCT00851253|75883317|FG001|NOT COMPLETED|Overall Study||0||
59763323|NCT00520351|75883325|FG000|STARTED|First Intervention|Start date is Sep.06, 2007|15||
59763324|NCT00520351|75883326|FG001|STARTED|First Intervention|Start date is Sep.06, 2007|15||
59763325|NCT00520351|75883325|FG000|COMPLETED|First Intervention|End date is Feb.25, 2008|14||
59763326|NCT00520351|75883326|FG001|COMPLETED|First Intervention|End date is Feb.25, 2008|14||
59763327|NCT00520351|75883325|FG000|NOT COMPLETED|First Intervention||1||
59763328|NCT00520351|75883326|FG001|NOT COMPLETED|First Intervention||1||
59763329|NCT00520351|75883325|FG000|STARTED|Second Intervention||14||
59763330|NCT00520351|75883326|FG001|STARTED|Second Intervention||14||
59763331|NCT00520351|75883325|FG000|COMPLETED|Second Intervention||14||
59763332|NCT00520351|75883326|FG001|COMPLETED|Second Intervention||14||
59763333|NCT00520351|75883325|FG000|NOT COMPLETED|Second Intervention||0||
59763334|NCT00520351|75883326|FG001|NOT COMPLETED|Second Intervention||0||
59763335|NCT03722459|75883332|FG000|STARTED|Overall Study||22||
59763336|NCT03722459|75883332|FG000|COMPLETED|Overall Study||22||
59763337|NCT03722459|75883332|FG000|NOT COMPLETED|Overall Study||0||
59763338|NCT00850395|75883336|FG000|STARTED|Overall Study||79||
59763339|NCT00850395|75883336|FG000|COMPLETED|Overall Study||69||
59763340|NCT00850395|75883336|FG000|NOT COMPLETED|Overall Study||10||
59763341|NCT00520039|75883342|FG000|STARTED|Overall Study||28||
59763342|NCT00520039|75883343|FG001|STARTED|Overall Study||24||
59763343|NCT00520039|75883342|FG000|COMPLETED|Overall Study||21||
59763344|NCT00520039|75883343|FG001|COMPLETED|Overall Study||19||
59763345|NCT00520039|75883342|FG000|NOT COMPLETED|Overall Study||7||
59763346|NCT00520039|75883343|FG001|NOT COMPLETED|Overall Study||5||
59763347|NCT00577720|75883355|FG000|STARTED|Overall Study||37||
59763348|NCT00577720|75883356|FG001|STARTED|Overall Study||36||
59763349|NCT00577720|75883357|FG002|STARTED|Overall Study||36||
59951904|NCT00835614|76070853|FG000|NOT COMPLETED|First Intervention||0||
59951905|NCT00835614|76070854|FG001|NOT COMPLETED|First Intervention||0||
59763350|NCT00577720|75883358|FG003|STARTED|Overall Study||72||
59763351|NCT00577720|75883355|FG000|ITT (Intent to Treat) Population|Overall Study||34||
59763352|NCT00577720|75883356|FG001|ITT (Intent to Treat) Population|Overall Study||35||
59763353|NCT00577720|75883357|FG002|ITT (Intent to Treat) Population|Overall Study||35||
59951906|NCT00835614|76070853|FG000|STARTED|Washout of 7 Days||13||
59951907|NCT00835614|76070854|FG001|STARTED|Washout of 7 Days||13||
59763354|NCT00577720|75883358|FG003|ITT (Intent to Treat) Population|Overall Study||65||
59763355|NCT00577720|75883355|FG000|COMPLETED|Overall Study||33||
59763356|NCT00577720|75883356|FG001|COMPLETED|Overall Study||35||
59763357|NCT00577720|75883357|FG002|COMPLETED|Overall Study||35||
59763358|NCT00577720|75883358|FG003|COMPLETED|Overall Study||65||
59763359|NCT00577720|75883355|FG000|NOT COMPLETED|Overall Study||4||
59763360|NCT00577720|75883356|FG001|NOT COMPLETED|Overall Study||1||
59763361|NCT00577720|75883357|FG002|NOT COMPLETED|Overall Study||1||
59763362|NCT00577720|75883358|FG003|NOT COMPLETED|Overall Study||7||
59763363|NCT00519649|75883368|FG000|STARTED|Overall Study||300||
59763364|NCT00519649|75883368|FG000|COMPLETED|Overall Study||299||
59763365|NCT00519649|75883368|FG000|NOT COMPLETED|Overall Study||1||
59763366|NCT03384173|75883374|FG000|STARTED|Overall Study||35||
59763367|NCT03384173|75883374|FG000|COMPLETED|Overall Study||35||
59763368|NCT03384173|75883374|FG000|NOT COMPLETED|Overall Study||0||
59763369|NCT00512707|75883386|FG000|STARTED|Overall Study||70||
59763370|NCT00512707|75883387|FG001|STARTED|Overall Study||70||
59763371|NCT00512707|75883386|FG000|COMPLETED|Overall Study||60||
59763372|NCT00512707|75883387|FG001|COMPLETED|Overall Study||58||
59763373|NCT00512707|75883386|FG000|NOT COMPLETED|Overall Study||10||
59763374|NCT00512707|75883387|FG001|NOT COMPLETED|Overall Study||12||
59763375|NCT03471767|75883395|FG000|STARTED|Overall Study||31||
59763376|NCT03471767|75883396|FG001|STARTED|Overall Study||27||
59763377|NCT03471767|75883395|FG000|COMPLETED|Overall Study||25||
59763378|NCT03471767|75883396|FG001|COMPLETED|Overall Study||23||
59763379|NCT03471767|75883395|FG000|NOT COMPLETED|Overall Study||6||
59763380|NCT03471767|75883396|FG001|NOT COMPLETED|Overall Study||4||
59763381|NCT00849693|75883406|FG000|STARTED|Acute Treatment Phase||108||
59763382|NCT00849693|75883407|FG001|STARTED|Acute Treatment Phase||116||
59763383|NCT00849693|75883408|FG002|STARTED|Acute Treatment Phase||117||
59763384|NCT00849693|75883409|FG003|STARTED|Acute Treatment Phase||122||
59763385|NCT00849693|75883406|FG000|COMPLETED|Acute Treatment Phase|2 didn't enter extension phase.|75||
59763386|NCT00849693|75883407|FG001|COMPLETED|Acute Treatment Phase|1 didn't enter extension phase|81||
59763387|NCT00849693|75883408|FG002|COMPLETED|Acute Treatment Phase||84||
59763388|NCT00849693|75883409|FG003|COMPLETED|Acute Treatment Phase|3 didn't enter extension phase|85||
59763389|NCT00849693|75883406|FG000|NOT COMPLETED|Acute Treatment Phase||33||
59763390|NCT00849693|75883407|FG001|NOT COMPLETED|Acute Treatment Phase||35||
59763391|NCT00849693|75883408|FG002|NOT COMPLETED|Acute Treatment Phase||33||
59763392|NCT00849693|75883409|FG003|NOT COMPLETED|Acute Treatment Phase||37||
59763393|NCT00849693|75883406|FG000|STARTED|Extension Phase||73||
59763394|NCT00849693|75883407|FG001|STARTED|Extension Phase||80||
59763395|NCT00849693|75883408|FG002|STARTED|Extension Phase||84||
59763396|NCT00849693|75883409|FG003|STARTED|Extension Phase||82||
59763397|NCT00849693|75883406|FG000|COMPLETED|Extension Phase||43||
59763398|NCT00849693|75883407|FG001|COMPLETED|Extension Phase||50||
59763399|NCT00849693|75883408|FG002|COMPLETED|Extension Phase||49||
59763400|NCT00849693|75883409|FG003|COMPLETED|Extension Phase||44||
59763401|NCT00849693|75883406|FG000|NOT COMPLETED|Extension Phase||30||
59763402|NCT00849693|75883407|FG001|NOT COMPLETED|Extension Phase||30||
59763403|NCT00849693|75883408|FG002|NOT COMPLETED|Extension Phase||35||
59763404|NCT00849693|75883409|FG003|NOT COMPLETED|Extension Phase||38||
59520383|NCT04322968|75614310|FG000|NOT COMPLETED|Overall Study||1||
59520384|NCT04322968|75614311|FG001|NOT COMPLETED|Overall Study||1||
59763405|NCT00527605|75883433|FG000|STARTED|Overall Study||126||
59763406|NCT00527605|75883434|FG001|STARTED|Overall Study||127||
59520385|NCT04322968|75614312|FG002|NOT COMPLETED|Overall Study||0||
59763407|NCT00527605|75883433|FG000|COMPLETED|Overall Study||113||
59763408|NCT00527605|75883434|FG001|COMPLETED|Overall Study||116||
59763409|NCT00527605|75883433|FG000|NOT COMPLETED|Overall Study||13||
59763410|NCT00527605|75883434|FG001|NOT COMPLETED|Overall Study||11||
59763411|NCT00849381|75883440|FG000|STARTED|Overall Study|Out of the subjects who started, 243 were enrolled at the center having compliance issues.|1237||
59763412|NCT00849381|75883440|FG000|COMPLETED|Overall Study|Out of the subjects who completed, 167 were enrolled at the center having compliance issues.|1092||
59763413|NCT00849381|75883440|FG000|NOT COMPLETED|Overall Study||145||
59763414|NCT00711412|75883444|FG000|STARTED|Induction Treatment||44||
59763415|NCT00711412|75883444|FG000|Registered to Study|Induction Treatment||44||
59763416|NCT00711412|75883444|FG000|Started Induction Treatment|Induction Treatment||43||
59763417|NCT00711412|75883444|FG000|COMPLETED|Induction Treatment||40||
59763418|NCT00711412|75883444|FG000|NOT COMPLETED|Induction Treatment||4||
59763419|NCT00711412|75883444|FG000|STARTED|Evaluated for Combination Treatment||40||
59763420|NCT00711412|75883444|FG000|COMPLETED|Evaluated for Combination Treatment||34||
59763421|NCT00711412|75883444|FG000|NOT COMPLETED|Evaluated for Combination Treatment||6||
59763422|NCT00711412|75883444|FG000|STARTED|Combination Treatment||34||
59520386|NCT04322968|75614313|FG003|NOT COMPLETED|Overall Study||0||
59520387|NCT01108003|75614325|FG000|STARTED|Overall Study||4||
59763423|NCT00711412|75883444|FG000|COMPLETED|Combination Treatment||33||
59763424|NCT00711412|75883444|FG000|NOT COMPLETED|Combination Treatment||1||
59763425|NCT00711412|75883444|FG000|STARTED|Evaluation for Response and Surgery|1 patient only completed 2 cycles of therapy was evaluated and eligible for surgical resection.|34||
59520388|NCT01108003|75614326|FG001|STARTED|Overall Study||3||
59763426|NCT00711412|75883444|FG000|COMPLETED|Evaluation for Response and Surgery||28||
59763427|NCT00711412|75883444|FG000|NOT COMPLETED|Evaluation for Response and Surgery||6||
59763428|NCT00711412|75883444|FG000|STARTED|Survival Follow up Until Death|All patients that received treatment went into follow up period.|38||
59763429|NCT00711412|75883444|FG000|COMPLETED|Survival Follow up Until Death||26||
59763430|NCT00711412|75883444|FG000|NOT COMPLETED|Survival Follow up Until Death||12||
59763431|NCT03746951|75883451|FG000|STARTED|Overall Study||8||
59763432|NCT03746951|75883452|FG001|STARTED|Overall Study||7||
59763433|NCT03746951|75883451|FG000|COMPLETED|Overall Study||8||
59763434|NCT03746951|75883452|FG001|COMPLETED|Overall Study||7||
59763435|NCT03746951|75883451|FG000|NOT COMPLETED|Overall Study||0||
59763436|NCT03746951|75883452|FG001|NOT COMPLETED|Overall Study||0||
59763437|NCT00577408|75883460|FG000|STARTED|Overall Study||28||
59763438|NCT00577408|75883461|FG001|STARTED|Overall Study||32||
59763439|NCT00577408|75883460|FG000|COMPLETED|Overall Study||16||
59763440|NCT00577408|75883461|FG001|COMPLETED|Overall Study||9||
59763441|NCT00577408|75883460|FG000|NOT COMPLETED|Overall Study||12||
59763442|NCT00577408|75883461|FG001|NOT COMPLETED|Overall Study||23||
59763443|NCT00713596|75883470|FG000|STARTED|Overall Study||9||
59763444|NCT00713596|75883471|FG001|STARTED|Overall Study||8||
59763445|NCT00713596|75883472|FG002|STARTED|Overall Study||8||
59763446|NCT00713596|75883470|FG000|COMPLETED|Overall Study||7||
59763447|NCT00713596|75883471|FG001|COMPLETED|Overall Study||5||
59763448|NCT00713596|75883472|FG002|COMPLETED|Overall Study||6||
59763449|NCT00713596|75883470|FG000|NOT COMPLETED|Overall Study||2||
59763450|NCT00713596|75883471|FG001|NOT COMPLETED|Overall Study||3||
59763451|NCT00713596|75883472|FG002|NOT COMPLETED|Overall Study||2||
59763452|NCT00880568|75883489|FG000|STARTED|Overall Study||3||
59763453|NCT00880568|75883490|FG001|STARTED|Overall Study||3||
59763454|NCT00880568|75883491|FG002|STARTED|Overall Study||3||
59763455|NCT00880568|75883492|FG003|STARTED|Overall Study||1||
59763456|NCT00880568|75883493|FG004|STARTED|Overall Study||3||
59763457|NCT00880568|75883494|FG005|STARTED|Overall Study||3||
59763458|NCT00880568|75883495|FG006|STARTED|Overall Study||6||
59763459|NCT00880568|75883496|FG007|STARTED|Overall Study||2||
59763460|NCT00880568|75883497|FG008|STARTED|Overall Study||3||
59763461|NCT00880568|75883489|FG000|COMPLETED|Overall Study||0||
59763462|NCT00880568|75883490|FG001|COMPLETED|Overall Study||0||
59763463|NCT00880568|75883491|FG002|COMPLETED|Overall Study||0||
59763464|NCT00880568|75883492|FG003|COMPLETED|Overall Study||0||
59763465|NCT00880568|75883493|FG004|COMPLETED|Overall Study||0||
59763466|NCT00880568|75883494|FG005|COMPLETED|Overall Study||0||
59763467|NCT00880568|75883495|FG006|COMPLETED|Overall Study||0||
59763468|NCT00880568|75883496|FG007|COMPLETED|Overall Study||0||
59763469|NCT00880568|75883497|FG008|COMPLETED|Overall Study||0||
59763470|NCT00880568|75883489|FG000|NOT COMPLETED|Overall Study||3||
59763471|NCT00880568|75883490|FG001|NOT COMPLETED|Overall Study||3||
59763472|NCT00880568|75883491|FG002|NOT COMPLETED|Overall Study||3||
59763473|NCT00880568|75883492|FG003|NOT COMPLETED|Overall Study||1||
59763474|NCT00880568|75883493|FG004|NOT COMPLETED|Overall Study||3||
59763475|NCT00880568|75883494|FG005|NOT COMPLETED|Overall Study||3||
59763476|NCT00880568|75883495|FG006|NOT COMPLETED|Overall Study||6||
59763477|NCT00880568|75883496|FG007|NOT COMPLETED|Overall Study||2||
59763478|NCT00880568|75883497|FG008|NOT COMPLETED|Overall Study||3||
59763479|NCT00881894|75883524|FG000|STARTED|Overall Study||26||
59763480|NCT00881894|75883525|FG001|STARTED|Overall Study||26||
59763481|NCT00881894|75883524|FG000|Pharmacokinetic Set (PKS)|Overall Study|Patients with an insufficient patch adhesiveness were excluded from the PKS.|23||
59763482|NCT00881894|75883525|FG001|Pharmacokinetic Set (PKS)|Overall Study|Patients with an insufficient patch adhesiveness were excluded from the PKS.|21||
59763483|NCT00881894|75883524|FG000|COMPLETED|Overall Study||25||
59763484|NCT00881894|75883525|FG001|COMPLETED|Overall Study||23||
59763485|NCT00881894|75883524|FG000|NOT COMPLETED|Overall Study||1||
59763486|NCT00881894|75883525|FG001|NOT COMPLETED|Overall Study||3||
59763487|NCT00711100|75883531|FG000|STARTED|Overall Study||104||
59763488|NCT00711100|75883531|FG000|COMPLETED|Overall Study||91||
59763489|NCT00711100|75883531|FG000|NOT COMPLETED|Overall Study||13||
59763490|NCT00827931|75883549|FG000|STARTED|Overall Study||49||
59763491|NCT00827931|75883550|FG001|STARTED|Overall Study||45||
59763492|NCT00827931|75883549|FG000|COMPLETED|Overall Study||43||
59763493|NCT00827931|75883550|FG001|COMPLETED|Overall Study||39||
59763494|NCT00827931|75883549|FG000|NOT COMPLETED|Overall Study||6||
59763495|NCT00827931|75883550|FG001|NOT COMPLETED|Overall Study||6||
59763496|NCT00526669|75883556|FG000|STARTED|7-Day Run-in Monotherapy Treatment Phase||67||
59763497|NCT00526669|75883557|FG001|STARTED|7-Day Run-in Monotherapy Treatment Phase||0||
59763498|NCT00526669|75883556|FG000|COMPLETED|7-Day Run-in Monotherapy Treatment Phase||67||
59763499|NCT00526669|75883557|FG001|COMPLETED|7-Day Run-in Monotherapy Treatment Phase||0||
59951908|NCT00835614|76070853|FG000|COMPLETED|Washout of 7 Days||13||
59763500|NCT00526669|75883556|FG000|NOT COMPLETED|7-Day Run-in Monotherapy Treatment Phase||0||
59763501|NCT00526669|75883557|FG001|NOT COMPLETED|7-Day Run-in Monotherapy Treatment Phase||0||
59763502|NCT00526669|75883556|FG000|STARTED|Combined Treatment Phase||0||
59763503|NCT00526669|75883557|FG001|STARTED|Combined Treatment Phase||67||
59763504|NCT00526669|75883556|FG000|COMPLETED|Combined Treatment Phase||0||
59763505|NCT00526669|75883557|FG001|COMPLETED|Combined Treatment Phase||59||
59763506|NCT00526669|75883556|FG000|NOT COMPLETED|Combined Treatment Phase||0||
59763507|NCT00526669|75883557|FG001|NOT COMPLETED|Combined Treatment Phase||8||
59763508|NCT02474927|75883563|FG000|STARTED|Overall Study||22||
59763509|NCT02474927|75883563|FG000|COMPLETED|Overall Study||22||
59763510|NCT02474927|75883563|FG000|NOT COMPLETED|Overall Study||0||
59763511|NCT00710866|75883569|FG000|STARTED|Overall Study||133||
59763512|NCT00710866|75883570|FG001|STARTED|Overall Study||134||
59763513|NCT00710866|75883569|FG000|COMPLETED|Overall Study||124||
59763514|NCT00710866|75883570|FG001|COMPLETED|Overall Study||128||
59763515|NCT00710866|75883569|FG000|NOT COMPLETED|Overall Study||9||
59763516|NCT00710866|75883570|FG001|NOT COMPLETED|Overall Study||6||
59763517|NCT03640949|75883578|FG000|STARTED|Overall Study||237||
59763518|NCT03640949|75883579|FG001|STARTED|Overall Study||264||
59763519|NCT03640949|75883578|FG000|COMPLETED|Overall Study||237||
59763520|NCT03640949|75883579|FG001|COMPLETED|Overall Study||264||
59763521|NCT03640949|75883578|FG000|NOT COMPLETED|Overall Study||0||
59763522|NCT03640949|75883579|FG001|NOT COMPLETED|Overall Study||0||
59763523|NCT00827775|75883587|FG000|STARTED|Overall Study||25||
59763524|NCT00827775|75883588|FG001|STARTED|Overall Study||30||
59763525|NCT00827775|75883587|FG000|COMPLETED|Overall Study||25||
59763526|NCT00827775|75883588|FG001|COMPLETED|Overall Study||25||
59763527|NCT00827775|75883587|FG000|NOT COMPLETED|Overall Study||0||
59763528|NCT00827775|75883588|FG001|NOT COMPLETED|Overall Study||5||
59763529|NCT00827541|75883596|FG000|STARTED|Overall Study||19||
59763530|NCT00827541|75883597|FG001|STARTED|Overall Study||96||
59763531|NCT00827541|75883596|FG000|COMPLETED|Overall Study||15||
59763532|NCT00827541|75883597|FG001|COMPLETED|Overall Study||85||
59763533|NCT00827541|75883596|FG000|NOT COMPLETED|Overall Study||4||
59763534|NCT00827541|75883597|FG001|NOT COMPLETED|Overall Study||11||
59763535|NCT00518323|75883607|FG000|STARTED|Overall Study||54||
59763536|NCT00518323|75883608|FG001|STARTED|Overall Study||48||
59763537|NCT00518323|75883609|FG002|STARTED|Overall Study||48||
59763538|NCT00518323|75883610|FG003|STARTED|Overall Study||51||
59763539|NCT00518323|75883607|FG000|COMPLETED|Overall Study||35||
59763540|NCT00518323|75883608|FG001|COMPLETED|Overall Study||40||
59763541|NCT00518323|75883609|FG002|COMPLETED|Overall Study||37||
59763542|NCT00518323|75883610|FG003|COMPLETED|Overall Study||26||
59763543|NCT00518323|75883607|FG000|NOT COMPLETED|Overall Study||19||
59763544|NCT00518323|75883608|FG001|NOT COMPLETED|Overall Study||8||
59763545|NCT00518323|75883609|FG002|NOT COMPLETED|Overall Study||11||
59763546|NCT00518323|75883610|FG003|NOT COMPLETED|Overall Study||25||
59763547|NCT00826449|75883622|FG000|STARTED|Overall Study||47||
59763548|NCT00826449|75883622|FG000|Phase I|Overall Study||12||
59763549|NCT00826449|75883622|FG000|Phase II|Overall Study||35||
59763550|NCT00826449|75883622|FG000|COMPLETED|Overall Study||42||
59763551|NCT00826449|75883622|FG000|NOT COMPLETED|Overall Study||5||
59763552|NCT00825825|75883627|FG000|STARTED|First Medication Period (14 Days)||6||
59763553|NCT00825825|75883628|FG001|STARTED|First Medication Period (14 Days)||4||
59763554|NCT00825825|75883629|FG002|STARTED|First Medication Period (14 Days)||3||
59763555|NCT00825825|75883630|FG003|STARTED|First Medication Period (14 Days)||5||
59763556|NCT00825825|75883631|FG004|STARTED|First Medication Period (14 Days)||4||
59763557|NCT00825825|75883632|FG005|STARTED|First Medication Period (14 Days)||5||
59763558|NCT00825825|75883627|FG000|COMPLETED|First Medication Period (14 Days)||3||
59763559|NCT00825825|75883628|FG001|COMPLETED|First Medication Period (14 Days)||4||
59763560|NCT00825825|75883629|FG002|COMPLETED|First Medication Period (14 Days)||2||
59763561|NCT00825825|75883630|FG003|COMPLETED|First Medication Period (14 Days)||5||
59763562|NCT00825825|75883631|FG004|COMPLETED|First Medication Period (14 Days)||4||
59763563|NCT00825825|75883632|FG005|COMPLETED|First Medication Period (14 Days)||3||
59763564|NCT00825825|75883627|FG000|NOT COMPLETED|First Medication Period (14 Days)||3||
59763565|NCT00825825|75883628|FG001|NOT COMPLETED|First Medication Period (14 Days)||0||
59763566|NCT00825825|75883629|FG002|NOT COMPLETED|First Medication Period (14 Days)||1||
59763567|NCT00825825|75883630|FG003|NOT COMPLETED|First Medication Period (14 Days)||0||
59763568|NCT00825825|75883631|FG004|NOT COMPLETED|First Medication Period (14 Days)||0||
59763569|NCT00825825|75883632|FG005|NOT COMPLETED|First Medication Period (14 Days)||2||
59763570|NCT00825825|75883627|FG000|STARTED|First Washout Period (14 Days)||3||
59763571|NCT00825825|75883628|FG001|STARTED|First Washout Period (14 Days)||4||
59763572|NCT00825825|75883629|FG002|STARTED|First Washout Period (14 Days)||2||
59763573|NCT00825825|75883630|FG003|STARTED|First Washout Period (14 Days)||5||
59763574|NCT00825825|75883631|FG004|STARTED|First Washout Period (14 Days)||4||
59763575|NCT00825825|75883632|FG005|STARTED|First Washout Period (14 Days)||3||
59763576|NCT00825825|75883627|FG000|COMPLETED|First Washout Period (14 Days)||3||
59763577|NCT00825825|75883628|FG001|COMPLETED|First Washout Period (14 Days)||4||
59763578|NCT00825825|75883629|FG002|COMPLETED|First Washout Period (14 Days)||2||
59763579|NCT00825825|75883630|FG003|COMPLETED|First Washout Period (14 Days)||5||
59763580|NCT00825825|75883631|FG004|COMPLETED|First Washout Period (14 Days)||4||
59763581|NCT00825825|75883632|FG005|COMPLETED|First Washout Period (14 Days)||3||
59763582|NCT00825825|75883627|FG000|NOT COMPLETED|First Washout Period (14 Days)||0||
59763583|NCT00825825|75883628|FG001|NOT COMPLETED|First Washout Period (14 Days)||0||
59763584|NCT00825825|75883629|FG002|NOT COMPLETED|First Washout Period (14 Days)||0||
59763585|NCT00825825|75883630|FG003|NOT COMPLETED|First Washout Period (14 Days)||0||
59763586|NCT00825825|75883631|FG004|NOT COMPLETED|First Washout Period (14 Days)||0||
59763587|NCT00825825|75883632|FG005|NOT COMPLETED|First Washout Period (14 Days)||0||
59763588|NCT00825825|75883627|FG000|STARTED|Second Medication Period (14 Days)||3||
59763589|NCT00825825|75883628|FG001|STARTED|Second Medication Period (14 Days)||4||
59763590|NCT00825825|75883629|FG002|STARTED|Second Medication Period (14 Days)||2||
59763591|NCT00825825|75883630|FG003|STARTED|Second Medication Period (14 Days)||5||
59763592|NCT00825825|75883631|FG004|STARTED|Second Medication Period (14 Days)||4||
59763593|NCT00825825|75883632|FG005|STARTED|Second Medication Period (14 Days)||3||
59763594|NCT00825825|75883627|FG000|COMPLETED|Second Medication Period (14 Days)||1||
59763595|NCT00825825|75883628|FG001|COMPLETED|Second Medication Period (14 Days)||4||
59763596|NCT00825825|75883629|FG002|COMPLETED|Second Medication Period (14 Days)||2||
59763597|NCT00825825|75883630|FG003|COMPLETED|Second Medication Period (14 Days)||3||
59763598|NCT00825825|75883631|FG004|COMPLETED|Second Medication Period (14 Days)||3||
59763599|NCT00825825|75883632|FG005|COMPLETED|Second Medication Period (14 Days)||3||
59763600|NCT00825825|75883627|FG000|NOT COMPLETED|Second Medication Period (14 Days)||2||
59763601|NCT00825825|75883628|FG001|NOT COMPLETED|Second Medication Period (14 Days)||0||
59763602|NCT00825825|75883629|FG002|NOT COMPLETED|Second Medication Period (14 Days)||0||
59763603|NCT00825825|75883630|FG003|NOT COMPLETED|Second Medication Period (14 Days)||2||
59763604|NCT00825825|75883631|FG004|NOT COMPLETED|Second Medication Period (14 Days)||1||
59763605|NCT00825825|75883632|FG005|NOT COMPLETED|Second Medication Period (14 Days)||0||
59763606|NCT00825825|75883627|FG000|STARTED|Second Washout Period (14 Days)||1||
59763607|NCT00825825|75883628|FG001|STARTED|Second Washout Period (14 Days)||4||
59763608|NCT00825825|75883629|FG002|STARTED|Second Washout Period (14 Days)||2||
59763609|NCT00825825|75883630|FG003|STARTED|Second Washout Period (14 Days)||3||
59763610|NCT00825825|75883631|FG004|STARTED|Second Washout Period (14 Days)||3||
59763611|NCT00825825|75883632|FG005|STARTED|Second Washout Period (14 Days)||3||
59763612|NCT00825825|75883627|FG000|COMPLETED|Second Washout Period (14 Days)||1||
59763613|NCT00825825|75883628|FG001|COMPLETED|Second Washout Period (14 Days)||4||
59763614|NCT00825825|75883629|FG002|COMPLETED|Second Washout Period (14 Days)||2||
59763615|NCT00825825|75883630|FG003|COMPLETED|Second Washout Period (14 Days)||3||
59763616|NCT00825825|75883631|FG004|COMPLETED|Second Washout Period (14 Days)||3||
59763617|NCT00825825|75883632|FG005|COMPLETED|Second Washout Period (14 Days)||3||
59763618|NCT00825825|75883627|FG000|NOT COMPLETED|Second Washout Period (14 Days)||0||
59763619|NCT00825825|75883628|FG001|NOT COMPLETED|Second Washout Period (14 Days)||0||
59763620|NCT00825825|75883629|FG002|NOT COMPLETED|Second Washout Period (14 Days)||0||
59763621|NCT00825825|75883630|FG003|NOT COMPLETED|Second Washout Period (14 Days)||0||
59763622|NCT00825825|75883631|FG004|NOT COMPLETED|Second Washout Period (14 Days)||0||
59763623|NCT00825825|75883632|FG005|NOT COMPLETED|Second Washout Period (14 Days)||0||
59763624|NCT00825825|75883627|FG000|STARTED|Third Medication Period (14 Days)||1||
59763625|NCT00825825|75883628|FG001|STARTED|Third Medication Period (14 Days)||4||
59763626|NCT00825825|75883629|FG002|STARTED|Third Medication Period (14 Days)||2||
59763627|NCT00825825|75883630|FG003|STARTED|Third Medication Period (14 Days)||3||
59763628|NCT00825825|75883631|FG004|STARTED|Third Medication Period (14 Days)||3||
59763629|NCT00825825|75883632|FG005|STARTED|Third Medication Period (14 Days)||3||
59763630|NCT00825825|75883627|FG000|COMPLETED|Third Medication Period (14 Days)||1||
59763631|NCT00825825|75883628|FG001|COMPLETED|Third Medication Period (14 Days)||2||
59763632|NCT00825825|75883629|FG002|COMPLETED|Third Medication Period (14 Days)||2||
59763633|NCT00825825|75883630|FG003|COMPLETED|Third Medication Period (14 Days)||3||
59763634|NCT00825825|75883631|FG004|COMPLETED|Third Medication Period (14 Days)||3||
59763635|NCT00825825|75883632|FG005|COMPLETED|Third Medication Period (14 Days)||1||
59763636|NCT00825825|75883627|FG000|NOT COMPLETED|Third Medication Period (14 Days)||0||
59763637|NCT00825825|75883628|FG001|NOT COMPLETED|Third Medication Period (14 Days)||2||
59763638|NCT00825825|75883629|FG002|NOT COMPLETED|Third Medication Period (14 Days)||0||
59763639|NCT00825825|75883630|FG003|NOT COMPLETED|Third Medication Period (14 Days)||0||
59763640|NCT00825825|75883631|FG004|NOT COMPLETED|Third Medication Period (14 Days)||0||
59763641|NCT00825825|75883632|FG005|NOT COMPLETED|Third Medication Period (14 Days)||2||
59763642|NCT00710710|75883641|FG000|STARTED|Overall Study||45||
59763643|NCT00710710|75883642|FG001|STARTED|Overall Study||44||
59763644|NCT00710710|75883641|FG000|Treated|Overall Study||43||
59763645|NCT00710710|75883642|FG001|Treated|Overall Study||43||
59763646|NCT00710710|75883641|FG000|COMPLETED|Overall Study||0||
59763647|NCT00710710|75883642|FG001|COMPLETED|Overall Study||0||
59763648|NCT00710710|75883641|FG000|NOT COMPLETED|Overall Study||45||
59763649|NCT00710710|75883642|FG001|NOT COMPLETED|Overall Study||44||
59763650|NCT00880334|75883650|FG000|STARTED|Randomized Phase||74||
59763651|NCT00880334|75883651|FG001|STARTED|Randomized Phase||75||
59763652|NCT00880334|75883650|FG000|Eligible & Treated|Randomized Phase||70||
59763653|NCT00880334|75883651|FG001|Eligible & Treated|Randomized Phase||72||
59763654|NCT00880334|75883650|FG000|COMPLETED|Randomized Phase||70||
59763655|NCT00880334|75883651|FG001|COMPLETED|Randomized Phase||35||
59763656|NCT00880334|75883650|FG000|NOT COMPLETED|Randomized Phase||4||
59763657|NCT00880334|75883651|FG001|NOT COMPLETED|Randomized Phase||40||
59763658|NCT00880334|75883650|FG000|STARTED|Crossover Phase||0||
59763659|NCT00880334|75883651|FG001|STARTED|Crossover Phase|Only participants randomized to placebo and docetaxel potentially received crossover treatment.|37||
59763660|NCT00880334|75883650|FG000|COMPLETED|Crossover Phase||0||
59763661|NCT00880334|75883651|FG001|COMPLETED|Crossover Phase||37||
59763662|NCT00880334|75883650|FG000|NOT COMPLETED|Crossover Phase||0||
59763663|NCT00880334|75883651|FG001|NOT COMPLETED|Crossover Phase||0||
59763664|NCT00865566|75883663|FG000|STARTED|Overall Study||1253|Enrollment is defined as receiving the first vaccination.|
59763665|NCT00865566|75883664|FG001|STARTED|Overall Study||1251|Enrollment is defined as receiving the first vaccination.|
59763666|NCT00865566|75883663|FG000|Modified Intent-to-Treat Population|Overall Study||1251|Participants excluded from MITT if HIV-1 positive at first vaccination (retrospective testing)|
59763667|NCT00865566|75883664|FG001|Modified Intent-to-Treat Population|Overall Study||1245|Participants excluded from MITT if HIV-1 positive at first vaccination (retrospective testing)|
59763668|NCT00865566|75883663|FG000|COMPLETED|Overall Study||629|Completed if attended all visits. Note dropout endpoint does NOT include all visits.|
59763669|NCT00865566|75883664|FG001|COMPLETED|Overall Study||564|Completed if attended all visits. Note dropout endpoint does NOT include all visits.|
60071852|NCT01873586|76187238|FG000|NOT COMPLETED|Overall Study||3||7
60071853|NCT04020718|76187247|FG000|STARTED|Pre-assessment and Adaptation||16||
59763670|NCT00865566|75883663|FG000|NOT COMPLETED|Overall Study||624||
59763671|NCT00865566|75883664|FG001|NOT COMPLETED|Overall Study||687||
59763672|NCT03866473|75883672|FG000|STARTED|Phase 1||69||69
59763673|NCT03866473|75883673|FG001|STARTED|Phase 1||66||66
59763674|NCT03866473|75883672|FG000|COMPLETED|Phase 1||68||68
59763675|NCT03866473|75883673|FG001|COMPLETED|Phase 1||66||66
59763676|NCT03866473|75883672|FG000|NOT COMPLETED|Phase 1||1||1
59763677|NCT03866473|75883673|FG001|NOT COMPLETED|Phase 1||0||0
59763678|NCT03866473|75883672|FG000|STARTED|Phase 2|Three participants completed the study by receiving alternate treatment for diabetic macular edema in phase 1 and 3 were dropped.|62||62
59763679|NCT03866473|75883673|FG001|STARTED|Phase 2||61||61
59763680|NCT03866473|75883672|FG000|COMPLETED|Phase 2||60||60
59763681|NCT03866473|75883673|FG001|COMPLETED|Phase 2|One participant completed the study by receiving alternate treatment for diabetic macular edema in Phase 1 and 4 participants were dropped.|58||58
59763682|NCT03866473|75883672|FG000|NOT COMPLETED|Phase 2||2||2
59763683|NCT03866473|75883673|FG001|NOT COMPLETED|Phase 2||3||3
59763684|NCT00525499|75883687|FG000|STARTED|Overall Study||47||
59763685|NCT00525499|75883688|FG001|STARTED|Overall Study||46||
59763686|NCT00525499|75883689|FG002|STARTED|Overall Study||47||
59763687|NCT00525499|75883690|FG003|STARTED|Overall Study||46||
59763688|NCT00525499|75883687|FG000|COMPLETED|Overall Study||40||
59763689|NCT00525499|75883688|FG001|COMPLETED|Overall Study||39||
59763690|NCT00525499|75883689|FG002|COMPLETED|Overall Study||40||
59763691|NCT00525499|75883690|FG003|COMPLETED|Overall Study||39||
59763692|NCT00525499|75883687|FG000|NOT COMPLETED|Overall Study||7||
59763693|NCT00525499|75883688|FG001|NOT COMPLETED|Overall Study||7||
59763694|NCT00525499|75883689|FG002|NOT COMPLETED|Overall Study||7||
59763695|NCT00525499|75883690|FG003|NOT COMPLETED|Overall Study||7||
59763696|NCT00824655|75883702|FG000|STARTED|Infant Series (5 Months of Age)||118||
59763697|NCT00824655|75883703|FG001|STARTED|Infant Series (5 Months of Age)||0||
59763698|NCT00824655|75883702|FG000|COMPLETED|Infant Series (5 Months of Age)||118||
59763699|NCT00824655|75883703|FG001|COMPLETED|Infant Series (5 Months of Age)||0||
59763700|NCT00824655|75883702|FG000|NOT COMPLETED|Infant Series (5 Months of Age)||0||
59763701|NCT00824655|75883703|FG001|NOT COMPLETED|Infant Series (5 Months of Age)||0||
60071854|NCT04020718|76187248|FG001|STARTED|Pre-assessment and Adaptation||19||
60071855|NCT04020718|76187249|FG002|STARTED|Pre-assessment and Adaptation||0||
59763702|NCT00824655|75883702|FG000|STARTED|After Infant Dose (6 Months of Age)||118||
60071856|NCT04020718|76187250|FG003|STARTED|Pre-assessment and Adaptation||0||
59763703|NCT00824655|75883703|FG001|STARTED|After Infant Dose (6 Months of Age)||0||
59763704|NCT00824655|75883702|FG000|COMPLETED|After Infant Dose (6 Months of Age)||118||
59763705|NCT00824655|75883703|FG001|COMPLETED|After Infant Dose (6 Months of Age)||0||
59763706|NCT00824655|75883702|FG000|NOT COMPLETED|After Infant Dose (6 Months of Age)||0||
59763707|NCT00824655|75883703|FG001|NOT COMPLETED|After Infant Dose (6 Months of Age)||0||
59763708|NCT00824655|75883702|FG000|STARTED|Toddler Dose (12 Months of Age)||118||
59763709|NCT00824655|75883703|FG001|STARTED|Toddler Dose (12 Months of Age)||116||
59763710|NCT00824655|75883702|FG000|COMPLETED|Toddler Dose (12 Months of Age)||116||
59763711|NCT00824655|75883703|FG001|COMPLETED|Toddler Dose (12 Months of Age)||116||
59763712|NCT00824655|75883702|FG000|NOT COMPLETED|Toddler Dose (12 Months of Age)||2||
60071857|NCT04020718|76187251|FG004|STARTED|Pre-assessment and Adaptation||0||
60071858|NCT04020718|76187252|FG005|STARTED|Pre-assessment and Adaptation||0||
60071859|NCT04020718|76187253|FG006|STARTED|Pre-assessment and Adaptation||0||
60071860|NCT04020718|76187254|FG007|STARTED|Pre-assessment and Adaptation||0||
60071861|NCT04020718|76187247|FG000|COMPLETED|Pre-assessment and Adaptation||16||
60071862|NCT04020718|76187248|FG001|COMPLETED|Pre-assessment and Adaptation||15||
60071863|NCT04020718|76187249|FG002|COMPLETED|Pre-assessment and Adaptation||0||
59520389|NCT01108003|75614325|FG000|COMPLETED|Overall Study||4||
60071864|NCT04020718|76187250|FG003|COMPLETED|Pre-assessment and Adaptation||0||
60071865|NCT04020718|76187251|FG004|COMPLETED|Pre-assessment and Adaptation||0||
59520390|NCT01108003|75614326|FG001|COMPLETED|Overall Study||3||
59520391|NCT01108003|75614325|FG000|NOT COMPLETED|Overall Study||0||
59520392|NCT01108003|75614326|FG001|NOT COMPLETED|Overall Study||0||
59520393|NCT01108081|75614336|FG000|STARTED|Overall Study||46||
59520394|NCT01108081|75614337|FG001|STARTED|Overall Study||42||
59520395|NCT01108081|75614338|FG002|STARTED|Overall Study||38||
59520396|NCT01108081|75614339|FG003|STARTED|Overall Study||43||
59520397|NCT01108081|75614336|FG000|COMPLETED|Overall Study||44||
59520398|NCT01108081|75614337|FG001|COMPLETED|Overall Study||40||
59520399|NCT01108081|75614338|FG002|COMPLETED|Overall Study||38||
59520400|NCT01108081|75614339|FG003|COMPLETED|Overall Study||39||
59520401|NCT01108081|75614336|FG000|NOT COMPLETED|Overall Study||2||
59520402|NCT01108081|75614337|FG001|NOT COMPLETED|Overall Study||2||
59520403|NCT01108081|75614338|FG002|NOT COMPLETED|Overall Study||0||
59520404|NCT01108081|75614339|FG003|NOT COMPLETED|Overall Study||4||
59520405|NCT00958919|75614349|FG000|STARTED|First Intervention||7||
59520406|NCT00958919|75614350|FG001|STARTED|First Intervention||7||
59520407|NCT00958919|75614349|FG000|COMPLETED|First Intervention||7||
59520408|NCT00958919|75614350|FG001|COMPLETED|First Intervention||7||
59520409|NCT00958919|75614349|FG000|NOT COMPLETED|First Intervention||0||
59520410|NCT00958919|75614350|FG001|NOT COMPLETED|First Intervention||0||
59520411|NCT00958919|75614349|FG000|STARTED|Second Intervention||7||
59520412|NCT00958919|75614350|FG001|STARTED|Second Intervention||7||
59520413|NCT00958919|75614349|FG000|COMPLETED|Second Intervention||7||
59520414|NCT00958919|75614350|FG001|COMPLETED|Second Intervention||7||
59520415|NCT00958919|75614349|FG000|NOT COMPLETED|Second Intervention||0||
59520416|NCT00958919|75614350|FG001|NOT COMPLETED|Second Intervention||0||
59520417|NCT01045135|75614363|FG000|STARTED|Overall Study||300||
59520418|NCT01045135|75614363|FG000|COMPLETED|Overall Study||274||
59520419|NCT01045135|75614363|FG000|NOT COMPLETED|Overall Study||26||
59520420|NCT04323592|75614371|FG000|STARTED|Overall Study||83||
60071866|NCT04020718|76187252|FG005|COMPLETED|Pre-assessment and Adaptation||0||
60071867|NCT04020718|76187253|FG006|COMPLETED|Pre-assessment and Adaptation||0||
60071868|NCT04020718|76187254|FG007|COMPLETED|Pre-assessment and Adaptation||0||
60071869|NCT04020718|76187247|FG000|NOT COMPLETED|Pre-assessment and Adaptation||0||
60071870|NCT04020718|76187248|FG001|NOT COMPLETED|Pre-assessment and Adaptation||4||
60071871|NCT04020718|76187249|FG002|NOT COMPLETED|Pre-assessment and Adaptation||0||
60071872|NCT04020718|76187250|FG003|NOT COMPLETED|Pre-assessment and Adaptation||0||
60071873|NCT04020718|76187251|FG004|NOT COMPLETED|Pre-assessment and Adaptation||0||
60071874|NCT04020718|76187252|FG005|NOT COMPLETED|Pre-assessment and Adaptation||0||
60071875|NCT04020718|76187253|FG006|NOT COMPLETED|Pre-assessment and Adaptation||0||
60071876|NCT04020718|76187254|FG007|NOT COMPLETED|Pre-assessment and Adaptation||0||
60071877|NCT04020718|76187247|FG000|STARTED|Post-assessment and Adaptation||0||
60071878|NCT04020718|76187248|FG001|STARTED|Post-assessment and Adaptation||0||
59520421|NCT04323592|75614372|FG001|STARTED|Overall Study||90||
59520422|NCT04323592|75614371|FG000|COMPLETED|Overall Study||83||
59520423|NCT04323592|75614372|FG001|COMPLETED|Overall Study||90||
59520424|NCT04323592|75614371|FG000|NOT COMPLETED|Overall Study||0||
59520425|NCT04323592|75614372|FG001|NOT COMPLETED|Overall Study||0||
59520426|NCT01047241|75614378|FG000|STARTED|Overall Study||50||
59520427|NCT01047241|75614378|FG000|COMPLETED|Overall Study||50||
59520428|NCT01047241|75614378|FG000|NOT COMPLETED|Overall Study||0||
59520429|NCT03651856|75614385|FG000|STARTED|Overall Study||10||
59520430|NCT03651856|75614385|FG000|COMPLETED|Overall Study||10||
59520431|NCT03651856|75614385|FG000|NOT COMPLETED|Overall Study||0||
59520432|NCT01012661|75614389|FG000|STARTED|Overall Study||50||
59520433|NCT01012661|75614389|FG000|COMPLETED|Overall Study||50||
59520434|NCT01012661|75614389|FG000|NOT COMPLETED|Overall Study||0||
59520435|NCT04325542|75614395|FG000|STARTED|Overall Study|one participant withdraw consent during the study|743||
59520436|NCT04325542|75614395|FG000|COMPLETED|Overall Study||742||
59520437|NCT04325542|75614395|FG000|NOT COMPLETED|Overall Study||1||
59617487|NCT01424670|75728646|FG000|NOT COMPLETED|Continuation Period||34||
59617488|NCT01424670|75728647|FG001|NOT COMPLETED|Continuation Period||14||
59617489|NCT01424514|75728655|FG000|STARTED|Period 1:Intervention Period 1 (14 Days)||20||
59617490|NCT01424514|75728656|FG001|STARTED|Period 1:Intervention Period 1 (14 Days)||20||
59617491|NCT01424514|75728655|FG000|COMPLETED|Period 1:Intervention Period 1 (14 Days)||19||
59617492|NCT01424514|75728656|FG001|COMPLETED|Period 1:Intervention Period 1 (14 Days)||19||
59617493|NCT01424514|75728655|FG000|NOT COMPLETED|Period 1:Intervention Period 1 (14 Days)||1||
60071879|NCT04020718|76187249|FG002|STARTED|Post-assessment and Adaptation||8||
59763713|NCT00824655|75883703|FG001|NOT COMPLETED|Toddler Dose (12 Months of Age)||0||
59763714|NCT00525265|75883713|FG000|STARTED|Overall Study||10||
59763715|NCT00525265|75883714|FG001|STARTED|Overall Study||10||
59763716|NCT00525265|75883713|FG000|COMPLETED|Overall Study||9||
59763717|NCT00525265|75883714|FG001|COMPLETED|Overall Study||10||
59763718|NCT00525265|75883713|FG000|NOT COMPLETED|Overall Study||1||
59763719|NCT00525265|75883714|FG001|NOT COMPLETED|Overall Study||0||
59763720|NCT00880256|75883720|FG000|STARTED|Overall Study||93||
59763721|NCT00880256|75883720|FG000|COMPLETED|Overall Study||65||
59763722|NCT00880256|75883720|FG000|NOT COMPLETED|Overall Study||28||
59763723|NCT03767881|75883724|FG000|STARTED|Overall Study||30||
59763724|NCT03767881|75883724|FG000|COMPLETED|Overall Study||25||
59763725|NCT03767881|75883724|FG000|NOT COMPLETED|Overall Study||5||
59763726|NCT03865381|75883729|FG000|STARTED|Overall Study||60||
59763727|NCT03865381|75883729|FG000|COMPLETED|Overall Study||55||
59763728|NCT03865381|75883729|FG000|NOT COMPLETED|Overall Study||5||
59763729|NCT00865098|75883733|FG000|STARTED|Overall Study||22||
59763730|NCT00865098|75883733|FG000|COMPLETED|Overall Study|Discontinued from the study due to progressive disease, after completing planned treatment schedule|21||
59763731|NCT00865098|75883733|FG000|NOT COMPLETED|Overall Study||1||
59763732|NCT00880100|75883737|FG000|STARTED|Baseline Phase-Usual Pancreatic Enzymes||49||
59763733|NCT00880100|75883737|FG000|COMPLETED|Baseline Phase-Usual Pancreatic Enzymes||48||
59763734|NCT00880100|75883737|FG000|NOT COMPLETED|Baseline Phase-Usual Pancreatic Enzymes||1||
59763735|NCT00880100|75883737|FG000|STARTED|Treatment Phase With Ultrase® MT12||48||
59763736|NCT00880100|75883737|FG000|COMPLETED|Treatment Phase With Ultrase® MT12||45||
59763737|NCT00880100|75883737|FG000|NOT COMPLETED|Treatment Phase With Ultrase® MT12||3||
59763738|NCT00518011|75883743|FG000|STARTED|Overall Study||9||
59763739|NCT00518011|75883744|FG001|STARTED|Overall Study||8||
59763740|NCT00518011|75883743|FG000|COMPLETED|Overall Study||0||
59763741|NCT00518011|75883744|FG001|COMPLETED|Overall Study||0||
59763742|NCT00518011|75883743|FG000|NOT COMPLETED|Overall Study||9||
59763743|NCT00518011|75883744|FG001|NOT COMPLETED|Overall Study||8||
59763744|NCT00865020|75883753|FG000|STARTED|Overall Study||414||
59763745|NCT00865020|75883754|FG001|STARTED|Overall Study||408||
59763746|NCT00865020|75883753|FG000|COMPLETED|Overall Study||365||
59763747|NCT00865020|75883754|FG001|COMPLETED|Overall Study||357||
59763748|NCT00865020|75883753|FG000|NOT COMPLETED|Overall Study||49||
59763749|NCT00865020|75883754|FG001|NOT COMPLETED|Overall Study||51||
59763750|NCT00517933|75883762|FG000|STARTED|Period 1|Patients decreased due to death, adverse event, lost to follow up and other (see below)|89||
59763751|NCT00517933|75883763|FG001|STARTED|Period 1|Patients decreased due to death, adverse event and other (see below)|91||
59763752|NCT00517933|75883762|FG000|COMPLETED|Period 1||81||
59763753|NCT00517933|75883763|FG001|COMPLETED|Period 1||85||
59763754|NCT00517933|75883762|FG000|NOT COMPLETED|Period 1||8||
59763755|NCT00517933|75883763|FG001|NOT COMPLETED|Period 1||6||
59763756|NCT00517933|75883762|FG000|STARTED|Period 2|2 patients terminated after completion of period one, but before starting period 2|79||
59763757|NCT00517933|75883763|FG001|STARTED|Period 2|2 patients terminated after completion of period one, but before starting period 2|83||
59763758|NCT00517933|75883762|FG000|COMPLETED|Period 2||73||
59763759|NCT00517933|75883763|FG001|COMPLETED|Period 2||70||
59763760|NCT00517933|75883762|FG000|NOT COMPLETED|Period 2||6||
59763761|NCT00517933|75883763|FG001|NOT COMPLETED|Period 2||13||
59763762|NCT00701038|75883774|FG000|STARTED|Overall Study||27||
59951909|NCT00835614|76070854|FG001|COMPLETED|Washout of 7 Days||13||
59951910|NCT00835614|76070853|FG000|NOT COMPLETED|Washout of 7 Days||0||
59951911|NCT00835614|76070854|FG001|NOT COMPLETED|Washout of 7 Days||0||
59951912|NCT00835614|76070853|FG000|STARTED|Second Intervention||13||
59951913|NCT00835614|76070854|FG001|STARTED|Second Intervention||13||
59951914|NCT00835614|76070853|FG000|COMPLETED|Second Intervention||13||
59951915|NCT00835614|76070854|FG001|COMPLETED|Second Intervention||13||
59951916|NCT00835614|76070853|FG000|NOT COMPLETED|Second Intervention||0||
59951917|NCT00835614|76070854|FG001|NOT COMPLETED|Second Intervention||0||
59951918|NCT00835536|76070860|FG000|STARTED|First Intervention||13||
59951919|NCT00835536|76070861|FG001|STARTED|First Intervention||14||
59763763|NCT00701038|75883775|FG001|STARTED|Overall Study||27||
59763764|NCT00701038|75883774|FG000|COMPLETED|Overall Study||23||
59763765|NCT00701038|75883775|FG001|COMPLETED|Overall Study||23||
59763766|NCT00701038|75883774|FG000|NOT COMPLETED|Overall Study||4||
59763767|NCT00701038|75883775|FG001|NOT COMPLETED|Overall Study||4||
59763768|NCT00857766|75883783|FG000|STARTED|Overall Study||123||
59763769|NCT00857766|75883784|FG001|STARTED|Overall Study||126||
59763770|NCT00857766|75883783|FG000|COMPLETED|Overall Study||92||
59763771|NCT00857766|75883784|FG001|COMPLETED|Overall Study||96||
59763772|NCT00857766|75883783|FG000|NOT COMPLETED|Overall Study||31||
59763773|NCT00857766|75883784|FG001|NOT COMPLETED|Overall Study||30||
59763774|NCT00517699|75883790|FG000|STARTED|Overall Study||5||
59763775|NCT00517699|75883790|FG000|COMPLETED|Overall Study||0||
59763776|NCT00517699|75883790|FG000|NOT COMPLETED|Overall Study||5||
59763777|NCT00857454|75883794|FG000|STARTED|Overall Study||71||
59763778|NCT00857454|75883794|FG000|COMPLETED|Overall Study||51||
59951920|NCT00835536|76070860|FG000|COMPLETED|First Intervention||13||
59951921|NCT00835536|76070861|FG001|COMPLETED|First Intervention||14||
59763779|NCT00857454|75883794|FG000|NOT COMPLETED|Overall Study||20||
59763780|NCT00525031|75883800|FG000|STARTED|Overall Study||27||
59763781|NCT00525031|75883801|FG001|STARTED|Overall Study||25||
59763782|NCT00525031|75883800|FG000|COMPLETED|Overall Study||26||
59763783|NCT00525031|75883801|FG001|COMPLETED|Overall Study||24||
59763784|NCT00525031|75883800|FG000|NOT COMPLETED|Overall Study||1||
59763785|NCT00525031|75883801|FG001|NOT COMPLETED|Overall Study||1||
59763786|NCT00524485|75883808|FG000|STARTED|Overall Study||12||
59763787|NCT00524485|75883808|FG000|COMPLETED|Overall Study||7||
59763788|NCT00524485|75883808|FG000|NOT COMPLETED|Overall Study||5||
59763789|NCT00857220|75883812|FG000|STARTED|Overall Study||304||
59763790|NCT00857220|75883812|FG000|COMPLETED|Overall Study||121||
59763791|NCT00857220|75883812|FG000|NOT COMPLETED|Overall Study||183||
59763792|NCT00524173|75883818|FG000|STARTED|Overall Study||17||
59763793|NCT00524173|75883819|FG001|STARTED|Overall Study||15||
59763794|NCT00524173|75883818|FG000|COMPLETED|Overall Study||12||
59763795|NCT00524173|75883819|FG001|COMPLETED|Overall Study||13||
59763796|NCT00524173|75883818|FG000|NOT COMPLETED|Overall Study||5||
59763797|NCT00524173|75883819|FG001|NOT COMPLETED|Overall Study||2||
59763798|NCT00879710|75883827|FG000|STARTED|Phase 1 - 6 Weeks|Started with simvastatin 40 mg as the starting drug|12||
59763799|NCT00879710|75883828|FG001|STARTED|Phase 1 - 6 Weeks|Started with simvastatin 40 mg as the starting drug|17||
59763800|NCT00879710|75883829|FG002|STARTED|Phase 1 - 6 Weeks|Started with ezetimibe 10 mg as the starting drug|11||
59763801|NCT00879710|75883830|FG003|STARTED|Phase 1 - 6 Weeks|Started with ezetimibe 10 mg as the starting drug|17||
59763802|NCT00879710|75883827|FG000|COMPLETED|Phase 1 - 6 Weeks||10||
59763803|NCT00879710|75883828|FG001|COMPLETED|Phase 1 - 6 Weeks||14||
59763804|NCT00879710|75883829|FG002|COMPLETED|Phase 1 - 6 Weeks||9||
59763805|NCT00879710|75883830|FG003|COMPLETED|Phase 1 - 6 Weeks||13||
59763806|NCT00879710|75883827|FG000|NOT COMPLETED|Phase 1 - 6 Weeks||2||
59763807|NCT00879710|75883828|FG001|NOT COMPLETED|Phase 1 - 6 Weeks||3||
59763808|NCT00879710|75883829|FG002|NOT COMPLETED|Phase 1 - 6 Weeks||2||
59763809|NCT00879710|75883830|FG003|NOT COMPLETED|Phase 1 - 6 Weeks||4||
59763810|NCT00879710|75883827|FG000|STARTED|Wash Out Period of 4 Weeks||10||
59763811|NCT00879710|75883828|FG001|STARTED|Wash Out Period of 4 Weeks||14||
59763812|NCT00879710|75883829|FG002|STARTED|Wash Out Period of 4 Weeks|The person who did not complete ezetimibe arm came back to complete simvastatin arm.|10||
59763813|NCT00879710|75883830|FG003|STARTED|Wash Out Period of 4 Weeks||13||
59763814|NCT00879710|75883827|FG000|COMPLETED|Wash Out Period of 4 Weeks||10||
59763815|NCT00879710|75883828|FG001|COMPLETED|Wash Out Period of 4 Weeks||14||
59763816|NCT00879710|75883829|FG002|COMPLETED|Wash Out Period of 4 Weeks||10||
59520438|NCT03655444|75614401|FG000|STARTED|Overall Study||3||
59520439|NCT03655444|75614402|FG001|STARTED|Overall Study||3||
59520440|NCT03655444|75614401|FG000|COMPLETED|Overall Study||3||
59520441|NCT03655444|75614402|FG001|COMPLETED|Overall Study||3||
59520442|NCT03655444|75614401|FG000|NOT COMPLETED|Overall Study||0||
59520443|NCT03655444|75614402|FG001|NOT COMPLETED|Overall Study||0||
59520444|NCT04322500|75614410|FG000|STARTED|Overall Study||13||
59520445|NCT04322500|75614411|FG001|STARTED|Overall Study||13||
59520446|NCT04322500|75614410|FG000|COMPLETED|Overall Study||13||
59520447|NCT04322500|75614411|FG001|COMPLETED|Overall Study||13||
59520448|NCT04322500|75614410|FG000|NOT COMPLETED|Overall Study||0||
59520449|NCT04322500|75614411|FG001|NOT COMPLETED|Overall Study||0||
59520450|NCT01014455|75614419|FG000|STARTED|Overall Study||82||
59520451|NCT01014455|75614420|FG001|STARTED|Overall Study||87||
59520452|NCT01014455|75614419|FG000|COMPLETED|Overall Study||82||
59763817|NCT00879710|75883830|FG003|COMPLETED|Wash Out Period of 4 Weeks||13||
59763818|NCT00879710|75883827|FG000|NOT COMPLETED|Wash Out Period of 4 Weeks||0||
59763819|NCT00879710|75883828|FG001|NOT COMPLETED|Wash Out Period of 4 Weeks||0||
59763820|NCT00879710|75883829|FG002|NOT COMPLETED|Wash Out Period of 4 Weeks||0||
59763821|NCT00879710|75883830|FG003|NOT COMPLETED|Wash Out Period of 4 Weeks||0||
59763822|NCT00879710|75883827|FG000|STARTED|Phase 2 6 Weeks||10||
59520453|NCT01014455|75614420|FG001|COMPLETED|Overall Study||87||
59520454|NCT01014455|75614419|FG000|NOT COMPLETED|Overall Study||0||
59763823|NCT00879710|75883828|FG001|STARTED|Phase 2 6 Weeks||14||
59763824|NCT00879710|75883829|FG002|STARTED|Phase 2 6 Weeks||10||
59763825|NCT00879710|75883830|FG003|STARTED|Phase 2 6 Weeks||13||
59763826|NCT00879710|75883827|FG000|COMPLETED|Phase 2 6 Weeks||10||
59763827|NCT00879710|75883828|FG001|COMPLETED|Phase 2 6 Weeks||14||
59763828|NCT00879710|75883829|FG002|COMPLETED|Phase 2 6 Weeks||10||
59763829|NCT00879710|75883830|FG003|COMPLETED|Phase 2 6 Weeks||13||
59763830|NCT00879710|75883827|FG000|NOT COMPLETED|Phase 2 6 Weeks||0||
59520455|NCT01014455|75614420|FG001|NOT COMPLETED|Overall Study||0||
59520456|NCT01047475|75614428|FG000|STARTED|Overall Study||34||
59520457|NCT01047475|75614429|FG001|STARTED|Overall Study||38||
59520458|NCT01047475|75614428|FG000|COMPLETED|Overall Study||29||
59520459|NCT01047475|75614429|FG001|COMPLETED|Overall Study||31||
59520460|NCT01047475|75614428|FG000|NOT COMPLETED|Overall Study||5||
59520461|NCT01047475|75614429|FG001|NOT COMPLETED|Overall Study||7||
59520462|NCT03877432|75614435|FG000|STARTED|Overall Study||10||
59763831|NCT00879710|75883828|FG001|NOT COMPLETED|Phase 2 6 Weeks||0||
59763832|NCT00879710|75883829|FG002|NOT COMPLETED|Phase 2 6 Weeks||0||
59763833|NCT00879710|75883830|FG003|NOT COMPLETED|Phase 2 6 Weeks||0||
59763834|NCT00597506|75883838|FG000|STARTED|Overall Study||50||
59763835|NCT00597506|75883838|FG000|COMPLETED|Overall Study||49||
59763836|NCT00597506|75883838|FG000|NOT COMPLETED|Overall Study||1||
59763837|NCT02373683|75883844|FG000|STARTED|Overall Study||6||
59763838|NCT02373683|75883845|FG001|STARTED|Overall Study||4||
59763839|NCT02373683|75883844|FG000|COMPLETED|Overall Study||6||
59763840|NCT02373683|75883845|FG001|COMPLETED|Overall Study||4||
59763841|NCT02373683|75883844|FG000|NOT COMPLETED|Overall Study||0||
59763842|NCT02373683|75883845|FG001|NOT COMPLETED|Overall Study||0||
59763843|NCT00708682|75883851|FG000|STARTED|Infant Series||225||
59763844|NCT00708682|75883851|FG000|Vaccinated Dose 1|Infant Series||223||
59763845|NCT00708682|75883851|FG000|Vaccinated Dose 2|Infant Series||214||
59763846|NCT00708682|75883851|FG000|Vaccinated Dose 3|Infant Series||194||
59763847|NCT00708682|75883851|FG000|COMPLETED|Infant Series||192||
59763848|NCT00708682|75883851|FG000|NOT COMPLETED|Infant Series||33||
59763849|NCT00708682|75883851|FG000|STARTED|After Infant Series||192||
59763850|NCT00708682|75883851|FG000|COMPLETED|After Infant Series||191||
59763851|NCT00708682|75883851|FG000|NOT COMPLETED|After Infant Series||1||
59763852|NCT00708682|75883851|FG000|STARTED|Toddler Dose||191||
59763853|NCT00708682|75883851|FG000|COMPLETED|Toddler Dose||183||
59763854|NCT00708682|75883851|FG000|NOT COMPLETED|Toddler Dose||8||
59763855|NCT00712348|75883857|FG000|STARTED|Overall Study||31||
59763856|NCT00712348|75883857|FG000|COMPLETED|Overall Study||30||
59763857|NCT00712348|75883857|FG000|NOT COMPLETED|Overall Study||1||
59763858|NCT00881504|75883861|FG000|STARTED|Overall Study||9||
59763859|NCT00881504|75883861|FG000|COMPLETED|Overall Study||8||
59763860|NCT00881504|75883861|FG000|NOT COMPLETED|Overall Study||1||
59763861|NCT01936831|75883874|FG000|STARTED|Step 1: Group Identification||110||
59763862|NCT01936831|75883875|FG001|STARTED|Step 1: Group Identification||85||
59763863|NCT01936831|75883876|FG002|STARTED|Step 1: Group Identification||87||
59763864|NCT01936831|75883877|FG003|STARTED|Step 1: Group Identification||0||
59763865|NCT01936831|75883878|FG004|STARTED|Step 1: Group Identification||0||
59763866|NCT01936831|75883879|FG005|STARTED|Step 1: Group Identification||0||
59763867|NCT01936831|75883880|FG006|STARTED|Step 1: Group Identification||0||
59763868|NCT01936831|75883881|FG007|STARTED|Step 1: Group Identification||0||
59763869|NCT01936831|75883882|FG008|STARTED|Step 1: Group Identification||0||
59763870|NCT01936831|75883874|FG000|COMPLETED|Step 1: Group Identification||110||
59763871|NCT01936831|75883875|FG001|COMPLETED|Step 1: Group Identification||85||
59763872|NCT01936831|75883876|FG002|COMPLETED|Step 1: Group Identification||87||
59763873|NCT01936831|75883877|FG003|COMPLETED|Step 1: Group Identification||0||
59763874|NCT01936831|75883878|FG004|COMPLETED|Step 1: Group Identification||0||
59763875|NCT01936831|75883879|FG005|COMPLETED|Step 1: Group Identification||0||
59763876|NCT01936831|75883880|FG006|COMPLETED|Step 1: Group Identification||0||
59763877|NCT01936831|75883881|FG007|COMPLETED|Step 1: Group Identification||0||
59763878|NCT01936831|75883882|FG008|COMPLETED|Step 1: Group Identification||0||
59763879|NCT01936831|75883874|FG000|NOT COMPLETED|Step 1: Group Identification||0||
59763880|NCT01936831|75883875|FG001|NOT COMPLETED|Step 1: Group Identification||0||
59763881|NCT01936831|75883876|FG002|NOT COMPLETED|Step 1: Group Identification||0||
59763882|NCT01936831|75883877|FG003|NOT COMPLETED|Step 1: Group Identification||0||
59763883|NCT01936831|75883878|FG004|NOT COMPLETED|Step 1: Group Identification||0||
59763884|NCT01936831|75883879|FG005|NOT COMPLETED|Step 1: Group Identification||0||
59763885|NCT01936831|75883880|FG006|NOT COMPLETED|Step 1: Group Identification||0||
59763886|NCT01936831|75883881|FG007|NOT COMPLETED|Step 1: Group Identification||0||
59763887|NCT01936831|75883882|FG008|NOT COMPLETED|Step 1: Group Identification||0||
59763888|NCT01936831|75883874|FG000|STARTED|Step 2: Arm Randomization||0||
60071880|NCT04020718|76187250|FG003|STARTED|Post-assessment and Adaptation||6||
60071881|NCT04020718|76187251|FG004|STARTED|Post-assessment and Adaptation||8||
60071882|NCT04020718|76187252|FG005|STARTED|Post-assessment and Adaptation||7||
59520463|NCT03877432|75614435|FG000|COMPLETED|Overall Study||10||
59763889|NCT01936831|75883875|FG001|STARTED|Step 2: Arm Randomization||0||
59763890|NCT01936831|75883876|FG002|STARTED|Step 2: Arm Randomization||0||
59763891|NCT01936831|75883877|FG003|STARTED|Step 2: Arm Randomization||13||
59763892|NCT01936831|75883878|FG004|STARTED|Step 2: Arm Randomization||14||
59763893|NCT01936831|75883879|FG005|STARTED|Step 2: Arm Randomization||16||
59763894|NCT01936831|75883880|FG006|STARTED|Step 2: Arm Randomization||16||
59763895|NCT01936831|75883881|FG007|STARTED|Step 2: Arm Randomization||11||
59763896|NCT01936831|75883882|FG008|STARTED|Step 2: Arm Randomization||10||
59763897|NCT01936831|75883874|FG000|COMPLETED|Step 2: Arm Randomization||0||
59763898|NCT01936831|75883875|FG001|COMPLETED|Step 2: Arm Randomization||0||
59763899|NCT01936831|75883876|FG002|COMPLETED|Step 2: Arm Randomization||0||
59763900|NCT01936831|75883877|FG003|COMPLETED|Step 2: Arm Randomization||13||
59763901|NCT01936831|75883878|FG004|COMPLETED|Step 2: Arm Randomization||14||
59763902|NCT01936831|75883879|FG005|COMPLETED|Step 2: Arm Randomization||15||
59763903|NCT01936831|75883880|FG006|COMPLETED|Step 2: Arm Randomization||16||
59763904|NCT01936831|75883881|FG007|COMPLETED|Step 2: Arm Randomization||11||
59763905|NCT01936831|75883882|FG008|COMPLETED|Step 2: Arm Randomization||10||
59763906|NCT01936831|75883874|FG000|NOT COMPLETED|Step 2: Arm Randomization||0||
59763907|NCT01936831|75883875|FG001|NOT COMPLETED|Step 2: Arm Randomization||0||
59763908|NCT01936831|75883876|FG002|NOT COMPLETED|Step 2: Arm Randomization||0||
59763909|NCT01936831|75883877|FG003|NOT COMPLETED|Step 2: Arm Randomization||0||
59763910|NCT01936831|75883878|FG004|NOT COMPLETED|Step 2: Arm Randomization||0||
59763911|NCT01936831|75883879|FG005|NOT COMPLETED|Step 2: Arm Randomization||1||
59763912|NCT01936831|75883880|FG006|NOT COMPLETED|Step 2: Arm Randomization||0||
59763913|NCT01936831|75883881|FG007|NOT COMPLETED|Step 2: Arm Randomization||0||
59763914|NCT01936831|75883882|FG008|NOT COMPLETED|Step 2: Arm Randomization||0||
59763915|NCT03863353|75883899|FG000|STARTED|Overall Study||282||
59763916|NCT03863353|75883900|FG001|STARTED|Overall Study||221||
59763917|NCT03863353|75883899|FG000|COMPLETED|Overall Study||258||
59763918|NCT03863353|75883900|FG001|COMPLETED|Overall Study||201||
59763919|NCT03863353|75883899|FG000|NOT COMPLETED|Overall Study||24||
59763920|NCT03863353|75883900|FG001|NOT COMPLETED|Overall Study||20||
59763921|NCT00523705|75883908|FG000|STARTED|Overall Study||7||
59763922|NCT00523705|75883909|FG001|STARTED|Overall Study||4||
59763923|NCT00523705|75883908|FG000|COMPLETED|Overall Study||7||
59763924|NCT00523705|75883909|FG001|COMPLETED|Overall Study|1 withdrew due to no time|3||
59763925|NCT00523705|75883908|FG000|NOT COMPLETED|Overall Study||0||
59763926|NCT00523705|75883909|FG001|NOT COMPLETED|Overall Study||1||
59763927|NCT00193427|75883915|FG000|STARTED|Overall Study||75||
59763928|NCT00193427|75883915|FG000|COMPLETED|Overall Study||26||
59763929|NCT00193427|75883915|FG000|NOT COMPLETED|Overall Study||49||
59520464|NCT03877432|75614435|FG000|NOT COMPLETED|Overall Study||0||
59520465|NCT01047709|75614443|FG000|STARTED|Positional Therapy (1 Night)||9||
59520466|NCT01047709|75614444|FG001|STARTED|Positional Therapy (1 Night)||9||
59520467|NCT01047709|75614443|FG000|COMPLETED|Positional Therapy (1 Night)||9||
59520468|NCT01047709|75614444|FG001|COMPLETED|Positional Therapy (1 Night)||9||
59520469|NCT01047709|75614443|FG000|NOT COMPLETED|Positional Therapy (1 Night)||0||
59520470|NCT01047709|75614444|FG001|NOT COMPLETED|Positional Therapy (1 Night)||0||
59520471|NCT01047709|75614443|FG000|STARTED|Control/Positioning ad Lib (1 Night)||9||
59520472|NCT01047709|75614444|FG001|STARTED|Control/Positioning ad Lib (1 Night)||9||
59520473|NCT01047709|75614443|FG000|COMPLETED|Control/Positioning ad Lib (1 Night)||9||
59520474|NCT01047709|75614444|FG001|COMPLETED|Control/Positioning ad Lib (1 Night)||9||
59520475|NCT01047709|75614443|FG000|NOT COMPLETED|Control/Positioning ad Lib (1 Night)||0||
59763930|NCT00523549|75883922|FG000|STARTED|Overall Study||114||
59763931|NCT00523549|75883923|FG001|STARTED|Overall Study||115||
59763932|NCT00523549|75883922|FG000|COMPLETED|Overall Study||95||
59763933|NCT00523549|75883923|FG001|COMPLETED|Overall Study||99||
59763934|NCT00523549|75883922|FG000|NOT COMPLETED|Overall Study||19||
59763935|NCT00523549|75883923|FG001|NOT COMPLETED|Overall Study||16||
59763936|NCT03504085|75883931|FG000|STARTED|End of Intervention - 12 Weeks||24||
59763937|NCT03504085|75883932|FG001|STARTED|End of Intervention - 12 Weeks||25||
59763938|NCT03504085|75883931|FG000|COMPLETED|End of Intervention - 12 Weeks||21||
59763939|NCT03504085|75883932|FG001|COMPLETED|End of Intervention - 12 Weeks||21||
59763940|NCT03504085|75883931|FG000|NOT COMPLETED|End of Intervention - 12 Weeks||3||
59763941|NCT03504085|75883932|FG001|NOT COMPLETED|End of Intervention - 12 Weeks||4||
59763942|NCT03504085|75883931|FG000|STARTED|Final Assessment - 6 Months||24||
59763943|NCT03504085|75883932|FG001|STARTED|Final Assessment - 6 Months||25||
59763944|NCT03504085|75883931|FG000|COMPLETED|Final Assessment - 6 Months||19||
59763945|NCT03504085|75883932|FG001|COMPLETED|Final Assessment - 6 Months||20||
59763946|NCT03504085|75883931|FG000|NOT COMPLETED|Final Assessment - 6 Months||5||
59763947|NCT03504085|75883932|FG001|NOT COMPLETED|Final Assessment - 6 Months||5||
59763948|NCT00700102|75883940|FG000|STARTED|Overall Study||411||
59763949|NCT00700102|75883941|FG001|STARTED|Overall Study||409||
59763950|NCT00700102|75883940|FG000|Intention to Treat|Overall Study||410||
59763951|NCT00700102|75883941|FG001|Intention to Treat|Overall Study||409||
59763952|NCT00700102|75883940|FG000|Received at Least One Dose|Overall Study||407||
59763953|NCT00700102|75883941|FG001|Received at Least One Dose|Overall Study||403||
59763954|NCT00700102|75883940|FG000|COMPLETED|Overall Study||9||
59520476|NCT01047709|75614444|FG001|NOT COMPLETED|Control/Positioning ad Lib (1 Night)||0||
59520477|NCT03866434|75614450|FG000|STARTED|Overall Study||20||
59520478|NCT03866434|75614450|FG000|COMPLETED|Overall Study||20||
59520479|NCT03866434|75614450|FG000|NOT COMPLETED|Overall Study||0||
59520480|NCT00962039|75614458|FG000|STARTED|Overall Study||40||
59763955|NCT00700102|75883941|FG001|COMPLETED|Overall Study||14||
59763956|NCT00700102|75883940|FG000|NOT COMPLETED|Overall Study||402||
59763957|NCT00700102|75883941|FG001|NOT COMPLETED|Overall Study||395||
59763958|NCT00595478|75883949|FG000|STARTED|Treatment||37||
59763959|NCT00595478|75883950|FG001|STARTED|Treatment||38||
59763960|NCT00595478|75883949|FG000|COMPLETED|Treatment||37||
59763961|NCT00595478|75883950|FG001|COMPLETED|Treatment||38||
59763962|NCT00595478|75883949|FG000|NOT COMPLETED|Treatment||0||
59763963|NCT00595478|75883950|FG001|NOT COMPLETED|Treatment||0||
59520481|NCT00962039|75614459|FG001|STARTED|Overall Study||41||
59520482|NCT00962039|75614458|FG000|COMPLETED|Overall Study||35||
59763964|NCT00595478|75883949|FG000|STARTED|36-week Follow-up Period||37||
59763965|NCT00595478|75883950|FG001|STARTED|36-week Follow-up Period||38||
59763966|NCT00595478|75883949|FG000|COMPLETED|36-week Follow-up Period||28||
59763967|NCT00595478|75883950|FG001|COMPLETED|36-week Follow-up Period||30||
59763968|NCT00595478|75883949|FG000|NOT COMPLETED|36-week Follow-up Period||9||
59763969|NCT00595478|75883950|FG001|NOT COMPLETED|36-week Follow-up Period||8||
59617494|NCT01424514|75728656|FG001|NOT COMPLETED|Period 1:Intervention Period 1 (14 Days)||1||
59617495|NCT01424514|75728655|FG000|STARTED|Period 2:Washout Period (4 Weeks)||19||
59617496|NCT01424514|75728656|FG001|STARTED|Period 2:Washout Period (4 Weeks)||19||
59617497|NCT01424514|75728655|FG000|COMPLETED|Period 2:Washout Period (4 Weeks)||19||
59617498|NCT01424514|75728656|FG001|COMPLETED|Period 2:Washout Period (4 Weeks)||19||
59617499|NCT01424514|75728655|FG000|NOT COMPLETED|Period 2:Washout Period (4 Weeks)||0||
59617500|NCT01424514|75728656|FG001|NOT COMPLETED|Period 2:Washout Period (4 Weeks)||0||
59617501|NCT01424514|75728655|FG000|STARTED|Period 3:Intervention Period 2 (14 Days)||19||
59617502|NCT01424514|75728656|FG001|STARTED|Period 3:Intervention Period 2 (14 Days)||19||
59617503|NCT01424514|75728655|FG000|COMPLETED|Period 3:Intervention Period 2 (14 Days)||18||
59617504|NCT01424514|75728656|FG001|COMPLETED|Period 3:Intervention Period 2 (14 Days)||19||
59617505|NCT01424514|75728655|FG000|NOT COMPLETED|Period 3:Intervention Period 2 (14 Days)||1||
59617506|NCT01424514|75728656|FG001|NOT COMPLETED|Period 3:Intervention Period 2 (14 Days)||0||
59617507|NCT01400958|75728669|FG000|STARTED|Overall Study||3||
59617508|NCT01400958|75728670|FG001|STARTED|Overall Study||3||
59617509|NCT01400958|75728669|FG000|COMPLETED|Overall Study||2||
59617510|NCT01400958|75728670|FG001|COMPLETED|Overall Study||1||
59617511|NCT01400958|75728669|FG000|NOT COMPLETED|Overall Study||1||
59617512|NCT01400958|75728670|FG001|NOT COMPLETED|Overall Study||2||
59617513|NCT01388166|75728676|FG000|STARTED|Overall Study||1253||
59617514|NCT01388166|75728676|FG000|COMPLETED|Overall Study||1194||
59617515|NCT01388166|75728676|FG000|NOT COMPLETED|Overall Study||59||
59617516|NCT01400412|75728682|FG000|STARTED|Overall Study||130||
59617517|NCT01400412|75728683|FG001|STARTED|Overall Study||132||
59617518|NCT01400412|75728682|FG000|COMPLETED|Overall Study||120||
59617519|NCT01400412|75728683|FG001|COMPLETED|Overall Study||115||
59617520|NCT01400412|75728682|FG000|NOT COMPLETED|Overall Study||10||
59617521|NCT01400412|75728683|FG001|NOT COMPLETED|Overall Study||17||
59617522|NCT01422876|75728701|FG000|STARTED|Week 24||137||
59617523|NCT01422876|75728702|FG001|STARTED|Week 24||136||
59617524|NCT01422876|75728703|FG002|STARTED|Week 24||141||
59617525|NCT01422876|75728704|FG003|STARTED|Week 24||140||
59617526|NCT01422876|75728705|FG004|STARTED|Week 24||132||
59617527|NCT01422876|75728706|FG005|STARTED|Week 24||137||
59617528|NCT01422876|75728707|FG006|STARTED|Week 24||136||
59617529|NCT01422876|75728708|FG007|STARTED|Week 24||135||
59617530|NCT01422876|75728709|FG008|STARTED|Week 24||134||
59617531|NCT01422876|75728710|FG009|STARTED|Week 24||135||
59617532|NCT01422876|75728701|FG000|COMPLETED|Week 24||131||
59617533|NCT01422876|75728702|FG001|COMPLETED|Week 24||133||
59617534|NCT01422876|75728703|FG002|COMPLETED|Week 24||136||
59617535|NCT01422876|75728704|FG003|COMPLETED|Week 24||132||
59617536|NCT01422876|75728705|FG004|COMPLETED|Week 24||125||
59617537|NCT01422876|75728706|FG005|COMPLETED|Week 24||131||
59617538|NCT01422876|75728707|FG006|COMPLETED|Week 24||130||
59617539|NCT01422876|75728708|FG007|COMPLETED|Week 24||128||
59617540|NCT01422876|75728709|FG008|COMPLETED|Week 24||128||
59617541|NCT01422876|75728710|FG009|COMPLETED|Week 24||125||
59617542|NCT01422876|75728701|FG000|NOT COMPLETED|Week 24||6||
59617543|NCT01422876|75728702|FG001|NOT COMPLETED|Week 24||3||
59617544|NCT01422876|75728703|FG002|NOT COMPLETED|Week 24||5||
59617545|NCT01422876|75728704|FG003|NOT COMPLETED|Week 24||8||
59617546|NCT01422876|75728705|FG004|NOT COMPLETED|Week 24||7||
59617547|NCT01422876|75728706|FG005|NOT COMPLETED|Week 24||6||
59617548|NCT01422876|75728707|FG006|NOT COMPLETED|Week 24||6||
59617549|NCT01422876|75728708|FG007|NOT COMPLETED|Week 24||7||
59617550|NCT01422876|75728709|FG008|NOT COMPLETED|Week 24||6||
59617551|NCT01422876|75728710|FG009|NOT COMPLETED|Week 24||10||
59617552|NCT01422876|75728701|FG000|STARTED|Week 52||137||
59617553|NCT01422876|75728702|FG001|STARTED|Week 52||136||
59617554|NCT01422876|75728703|FG002|STARTED|Week 52||141||
59617555|NCT01422876|75728704|FG003|STARTED|Week 52||140||
59617556|NCT01422876|75728705|FG004|STARTED|Week 52||132||
59617557|NCT01422876|75728706|FG005|STARTED|Week 52||137||
59617558|NCT01422876|75728707|FG006|STARTED|Week 52||136||
59617559|NCT01422876|75728708|FG007|STARTED|Week 52||135||
59617560|NCT01422876|75728709|FG008|STARTED|Week 52||134||
59617561|NCT01422876|75728710|FG009|STARTED|Week 52||135||
59617562|NCT01422876|75728701|FG000|COMPLETED|Week 52||125||
59617563|NCT01422876|75728702|FG001|COMPLETED|Week 52||126||
59617564|NCT01422876|75728703|FG002|COMPLETED|Week 52||128||
59617565|NCT01422876|75728704|FG003|COMPLETED|Week 52||122||
59617566|NCT01422876|75728705|FG004|COMPLETED|Week 52||117||
59617567|NCT01422876|75728706|FG005|COMPLETED|Week 52||120||
59617568|NCT01422876|75728707|FG006|COMPLETED|Week 52||120||
59617569|NCT01422876|75728708|FG007|COMPLETED|Week 52||112||
59617570|NCT01422876|75728709|FG008|COMPLETED|Week 52||113||
59617571|NCT01422876|75728710|FG009|COMPLETED|Week 52||118||
59617572|NCT01422876|75728701|FG000|NOT COMPLETED|Week 52||12||
59617573|NCT01422876|75728702|FG001|NOT COMPLETED|Week 52||10||
59617574|NCT01422876|75728703|FG002|NOT COMPLETED|Week 52||13||
59617575|NCT01422876|75728704|FG003|NOT COMPLETED|Week 52||18||
59617576|NCT01422876|75728705|FG004|NOT COMPLETED|Week 52||15||
59617577|NCT01422876|75728706|FG005|NOT COMPLETED|Week 52||17||
59617578|NCT01422876|75728707|FG006|NOT COMPLETED|Week 52||16||
59617579|NCT01422876|75728708|FG007|NOT COMPLETED|Week 52||23||
59617580|NCT01422876|75728709|FG008|NOT COMPLETED|Week 52||21||
59617581|NCT01422876|75728710|FG009|NOT COMPLETED|Week 52||17||
59763970|NCT00516295|75883959|FG000|STARTED|Overall Study||7||
59763971|NCT00516295|75883960|FG001|STARTED|Overall Study||0||
59763972|NCT00516295|75883961|FG002|STARTED|Overall Study||0||
59763973|NCT00516295|75883959|FG000|COMPLETED|Overall Study||4||
59763974|NCT00516295|75883960|FG001|COMPLETED|Overall Study||0||
59763975|NCT00516295|75883961|FG002|COMPLETED|Overall Study||0||
59763976|NCT00516295|75883959|FG000|NOT COMPLETED|Overall Study||3||
59763977|NCT00516295|75883960|FG001|NOT COMPLETED|Overall Study||0||
59763978|NCT00516295|75883961|FG002|NOT COMPLETED|Overall Study||0||
59763979|NCT03861559|75883971|FG000|STARTED|Overall Study||101||
59763980|NCT03861559|75883972|FG001|STARTED|Overall Study||100||
59763981|NCT03861559|75883971|FG000|COMPLETED|Overall Study||99||
59763982|NCT03861559|75883972|FG001|COMPLETED|Overall Study||95||
59763983|NCT03861559|75883971|FG000|NOT COMPLETED|Overall Study||2||
59763984|NCT03861559|75883972|FG001|NOT COMPLETED|Overall Study||5||
59763985|NCT00516139|75883978|FG000|STARTED|Overall Study||122||
59763986|NCT00516139|75883978|FG000|COMPLETED|Overall Study|Study completers completed Escalation, AM, and either AO or both Conversion and Monotherapy Phases.|84||
59763987|NCT00516139|75883978|FG000|NOT COMPLETED|Overall Study||38||
59763988|NCT00515827|75883988|FG000|STARTED|First Intervention (12 Weeks)||27||
59763989|NCT00515827|75883989|FG001|STARTED|First Intervention (12 Weeks)||26||
59763990|NCT00515827|75883988|FG000|COMPLETED|First Intervention (12 Weeks)||26||
59763991|NCT00515827|75883989|FG001|COMPLETED|First Intervention (12 Weeks)||25||
59763992|NCT00515827|75883988|FG000|NOT COMPLETED|First Intervention (12 Weeks)||1||
59763993|NCT00515827|75883989|FG001|NOT COMPLETED|First Intervention (12 Weeks)||1||
59763994|NCT00515827|75883988|FG000|STARTED|Second Intervention (12 Weeks)||26||
59763995|NCT00515827|75883989|FG001|STARTED|Second Intervention (12 Weeks)||25||
59763996|NCT00515827|75883988|FG000|COMPLETED|Second Intervention (12 Weeks)||25||
59763997|NCT00515827|75883989|FG001|COMPLETED|Second Intervention (12 Weeks)||25||
59763998|NCT00515827|75883988|FG000|NOT COMPLETED|Second Intervention (12 Weeks)||1||
59763999|NCT00515827|75883989|FG001|NOT COMPLETED|Second Intervention (12 Weeks)||0||
59764000|NCT00522457|75883997|FG000|STARTED|Overall Study||19||
59764001|NCT00522457|75883997|FG000|COMPLETED|Overall Study||1||
59764002|NCT00522457|75883997|FG000|NOT COMPLETED|Overall Study||18||
59764003|NCT00856986|75884006|FG000|STARTED|Run-in Period, Weeks -12-0||161||
59764004|NCT00856986|75884007|FG001|STARTED|Run-in Period, Weeks -12-0||162||
59764005|NCT00856986|75884008|FG002|STARTED|Run-in Period, Weeks -12-0||498||
59764006|NCT00856986|75884009|FG003|STARTED|Run-in Period, Weeks -12-0||167||
59764007|NCT00856986|75884010|FG004|STARTED|Run-in Period, Weeks -12-0||0||
59764008|NCT00856986|75884006|FG000|COMPLETED|Run-in Period, Weeks -12-0||161||
59764009|NCT00856986|75884007|FG001|COMPLETED|Run-in Period, Weeks -12-0||162||
59764010|NCT00856986|75884008|FG002|COMPLETED|Run-in Period, Weeks -12-0||498||
59764011|NCT00856986|75884009|FG003|COMPLETED|Run-in Period, Weeks -12-0|Subjects who withdrew during run-in and before randomisation were Early Withdrawals|0||
59764012|NCT00856986|75884010|FG004|COMPLETED|Run-in Period, Weeks -12-0||0||
59764013|NCT00856986|75884006|FG000|NOT COMPLETED|Run-in Period, Weeks -12-0||0||
59764014|NCT00856986|75884007|FG001|NOT COMPLETED|Run-in Period, Weeks -12-0||0||
59764015|NCT00856986|75884008|FG002|NOT COMPLETED|Run-in Period, Weeks -12-0||0||
59764016|NCT00856986|75884009|FG003|NOT COMPLETED|Run-in Period, Weeks -12-0||167||
59764017|NCT00856986|75884010|FG004|NOT COMPLETED|Run-in Period, Weeks -12-0||0||
59764018|NCT00856986|75884006|FG000|STARTED|Main Period, Weeks 0-26||161||
59764019|NCT00856986|75884007|FG001|STARTED|Main Period, Weeks 0-26||162||
59764020|NCT00856986|75884008|FG002|STARTED|Main Period, Weeks 0-26||498||
59764021|NCT00856986|75884009|FG003|STARTED|Main Period, Weeks 0-26||0||
59764022|NCT00856986|75884010|FG004|STARTED|Main Period, Weeks 0-26||0||
59764023|NCT00856986|75884006|FG000|COMPLETED|Main Period, Weeks 0-26||127||
59764024|NCT00856986|75884007|FG001|COMPLETED|Main Period, Weeks 0-26||144||
59764025|NCT00856986|75884008|FG002|COMPLETED|Main Period, Weeks 0-26||470||
59764026|NCT00856986|75884009|FG003|COMPLETED|Main Period, Weeks 0-26||0||
59764027|NCT00856986|75884010|FG004|COMPLETED|Main Period, Weeks 0-26||0||
59764028|NCT00856986|75884006|FG000|NOT COMPLETED|Main Period, Weeks 0-26||34||
59764029|NCT00856986|75884007|FG001|NOT COMPLETED|Main Period, Weeks 0-26||18||
59764030|NCT00856986|75884008|FG002|NOT COMPLETED|Main Period, Weeks 0-26||28||
59764031|NCT00856986|75884009|FG003|NOT COMPLETED|Main Period, Weeks 0-26||0||
60071883|NCT04020718|76187253|FG006|STARTED|Post-assessment and Adaptation||2||
60071884|NCT04020718|76187254|FG007|STARTED|Post-assessment and Adaptation||0||
59764032|NCT00856986|75884010|FG004|NOT COMPLETED|Main Period, Weeks 0-26||0||
59764033|NCT00856986|75884006|FG000|STARTED|Extension Period, Weeks 26-52|Subjects with HbA1c ≥8.0% who accepted intensification with detemir = 17 (Intensified Group)|127||
59764034|NCT00856986|75884007|FG001|STARTED|Extension Period, Weeks 26-52||144||
59764035|NCT00856986|75884008|FG002|STARTED|Extension Period, Weeks 26-52|Subjects with HbA1c ≥8.0% who accepted intensification with detemir = 7 (Intensified Group)|470||
59764036|NCT00856986|75884009|FG003|STARTED|Extension Period, Weeks 26-52||0||
59764037|NCT00856986|75884010|FG004|STARTED|Extension Period, Weeks 26-52||0||
59764038|NCT00856986|75884006|FG000|Enrolled in Extension|Extension Period, Weeks 26-52||122||
59764039|NCT00856986|75884007|FG001|Enrolled in Extension|Extension Period, Weeks 26-52||140||
59764040|NCT00856986|75884008|FG002|Enrolled in Extension|Extension Period, Weeks 26-52||461||
59764041|NCT00856986|75884009|FG003|Enrolled in Extension|Extension Period, Weeks 26-52||0||
59764042|NCT00856986|75884010|FG004|Enrolled in Extension|Extension Period, Weeks 26-52||0||
59764043|NCT00856986|75884006|FG000|COMPLETED|Extension Period, Weeks 26-52||108||
59764044|NCT00856986|75884007|FG001|COMPLETED|Extension Period, Weeks 26-52||130||
59764045|NCT00856986|75884008|FG002|COMPLETED|Extension Period, Weeks 26-52||432||
59764046|NCT00856986|75884009|FG003|COMPLETED|Extension Period, Weeks 26-52||0||
59764047|NCT00856986|75884010|FG004|COMPLETED|Extension Period, Weeks 26-52||0||
59764048|NCT00856986|75884006|FG000|NOT COMPLETED|Extension Period, Weeks 26-52||19||
59764049|NCT00856986|75884007|FG001|NOT COMPLETED|Extension Period, Weeks 26-52||14||
59764050|NCT00856986|75884008|FG002|NOT COMPLETED|Extension Period, Weeks 26-52||38||
59764051|NCT00856986|75884009|FG003|NOT COMPLETED|Extension Period, Weeks 26-52||0||
59764052|NCT00856986|75884010|FG004|NOT COMPLETED|Extension Period, Weeks 26-52||0||
59764053|NCT00707746|75884024|FG000|STARTED|Treatment Period||12||
59764054|NCT00707746|75884025|FG001|STARTED|Treatment Period||22||
59764055|NCT00707746|75884024|FG000|Full Analysis Set (FAS) and Safety Set|Treatment Period|FAS: Treated patients with a valid baseline & post-baseline LDL-C measurement|12||
59764056|NCT00707746|75884025|FG001|Full Analysis Set (FAS) and Safety Set|Treatment Period|FAS: Treated patients with a valid baseline & post-baseline LDL-C measurement|21||
59764057|NCT00707746|75884024|FG000|COMPLETED|Treatment Period||10||
59764058|NCT00707746|75884025|FG001|COMPLETED|Treatment Period||17||
59764059|NCT00707746|75884024|FG000|NOT COMPLETED|Treatment Period||2||
59764060|NCT00707746|75884025|FG001|NOT COMPLETED|Treatment Period||5||
59520483|NCT00962039|75614459|FG001|COMPLETED|Overall Study||37||
59520484|NCT00962039|75614458|FG000|NOT COMPLETED|Overall Study||5||
59520485|NCT00962039|75614459|FG001|NOT COMPLETED|Overall Study||4||
59520486|NCT03867838|75614465|FG000|STARTED|Overall Study||6||
59520487|NCT03867838|75614465|FG000|COMPLETED|Overall Study||6||
59520488|NCT03867838|75614465|FG000|NOT COMPLETED|Overall Study||0||
59520489|NCT01015781|75614471|FG000|STARTED|Overall Study||150||
59520490|NCT01015781|75614472|FG001|STARTED|Overall Study||150||
59520491|NCT01015781|75614471|FG000|COMPLETED|Overall Study||113||
59520492|NCT01015781|75614472|FG001|COMPLETED|Overall Study||121||
59520493|NCT01015781|75614471|FG000|NOT COMPLETED|Overall Study||37||
59520494|NCT01015781|75614472|FG001|NOT COMPLETED|Overall Study||29||
59520495|NCT03661762|75614478|FG000|STARTED|Overall Study||18||
59520496|NCT03661762|75614478|FG000|COMPLETED|Overall Study||10||
59520497|NCT03661762|75614478|FG000|NOT COMPLETED|Overall Study||8||
59520498|NCT04316260|75614485|FG000|STARTED|Overall Study||34||
59520499|NCT04316260|75614486|FG001|STARTED|Overall Study||17||
59520500|NCT04316260|75614485|FG000|COMPLETED|Overall Study||34||
59520501|NCT04316260|75614486|FG001|COMPLETED|Overall Study||17||
59520502|NCT04316260|75614485|FG000|NOT COMPLETED|Overall Study||0||
59520503|NCT04316260|75614486|FG001|NOT COMPLETED|Overall Study||0||
59520504|NCT01048879|75614496|FG000|STARTED|Overall Study||1||
59520505|NCT01048879|75614497|FG001|STARTED|Overall Study||9||
59520506|NCT01048879|75614498|FG002|STARTED|Overall Study||5||
59520507|NCT01048879|75614496|FG000|COMPLETED|Overall Study||1||
59520508|NCT01048879|75614497|FG001|COMPLETED|Overall Study||9||
59520509|NCT01048879|75614498|FG002|COMPLETED|Overall Study||5||
59520510|NCT01048879|75614496|FG000|NOT COMPLETED|Overall Study||0||
59520511|NCT01048879|75614497|FG001|NOT COMPLETED|Overall Study||0||
59520512|NCT01048879|75614498|FG002|NOT COMPLETED|Overall Study||0||
59520513|NCT04296448|75614508|FG000|STARTED|Overall Study||98||
59617582|NCT01422720|75728728|FG000|STARTED|Overall Study||72||
59617583|NCT01422720|75728728|FG000|Safety Set|Overall Study||72||
59617584|NCT01422720|75728728|FG000|Full Analysis Set (FAS)|Overall Study||71||
59617585|NCT01422720|75728728|FG000|Per-Protocol Set (PPS)|Overall Study||55||
59617586|NCT01422720|75728728|FG000|COMPLETED|Overall Study||50||
59617587|NCT01422720|75728728|FG000|NOT COMPLETED|Overall Study||22||
59617588|NCT01387932|75728738|FG000|STARTED|Randomized and Treated||118||
59617589|NCT01387932|75728739|FG001|STARTED|Randomized and Treated||117||
59617590|NCT01387932|75728738|FG000|COMPLETED|Randomized and Treated||111||
59520514|NCT04296448|75614509|FG001|STARTED|Overall Study||99||
59520515|NCT04296448|75614508|FG000|COMPLETED|Overall Study||98||
59520516|NCT04296448|75614509|FG001|COMPLETED|Overall Study||99||
59520517|NCT04296448|75614508|FG000|NOT COMPLETED|Overall Study||0||
59520518|NCT04296448|75614509|FG001|NOT COMPLETED|Overall Study||0||
59520519|NCT04290676|75614515|FG000|STARTED|Overall Study||527||641
59520520|NCT04290676|75614515|FG000|COMPLETED|Overall Study||527||641
59520521|NCT04290676|75614515|FG000|NOT COMPLETED|Overall Study||0||0
59520522|NCT03112993|75614521|FG000|STARTED|Overall Study||19||
59764061|NCT00707746|75884024|FG000|STARTED|Follow-up Period||12||
59764062|NCT00707746|75884025|FG001|STARTED|Follow-up Period||21||
59764063|NCT00707746|75884024|FG000|COMPLETED|Follow-up Period||12||
59764064|NCT00707746|75884025|FG001|COMPLETED|Follow-up Period||21||
59764065|NCT00707746|75884024|FG000|NOT COMPLETED|Follow-up Period||0||
59764066|NCT00707746|75884025|FG001|NOT COMPLETED|Follow-up Period||0||
59764067|NCT00856908|75884033|FG000|STARTED|Overall Study||15||
59764068|NCT00856908|75884034|FG001|STARTED|Overall Study||5||
59764069|NCT00856908|75884033|FG000|COMPLETED|Overall Study||14||
59764070|NCT00856908|75884034|FG001|COMPLETED|Overall Study||5||
59764071|NCT00856908|75884033|FG000|NOT COMPLETED|Overall Study||1||
59764072|NCT00856908|75884034|FG001|NOT COMPLETED|Overall Study||0||
59764073|NCT00522379|75884045|FG000|STARTED|Overall Study||101||
59764074|NCT00522379|75884046|FG001|STARTED|Overall Study||107||
59764075|NCT00522379|75884047|FG002|STARTED|Overall Study||104||
59764076|NCT00522379|75884048|FG003|STARTED|Overall Study||94||
59764077|NCT00522379|75884049|FG004|STARTED|Overall Study||108||
59764078|NCT00522379|75884045|FG000|COMPLETED|Overall Study||79||
59764079|NCT00522379|75884046|FG001|COMPLETED|Overall Study||84||
59764080|NCT00522379|75884047|FG002|COMPLETED|Overall Study||82||
59764081|NCT00522379|75884048|FG003|COMPLETED|Overall Study||80||
59764082|NCT00522379|75884049|FG004|COMPLETED|Overall Study||81||
59764083|NCT00522379|75884045|FG000|NOT COMPLETED|Overall Study||22||
59764084|NCT00522379|75884046|FG001|NOT COMPLETED|Overall Study||23||
59764085|NCT00522379|75884047|FG002|NOT COMPLETED|Overall Study||22||
59764086|NCT00522379|75884048|FG003|NOT COMPLETED|Overall Study||14||
59764087|NCT00522379|75884049|FG004|NOT COMPLETED|Overall Study||27||
59764088|NCT00856830|75884065|FG000|STARTED|Irinotecan & Bendamustine||3||
59764089|NCT00856830|75884066|FG001|STARTED|Irinotecan & Bendamustine||6||
59764090|NCT00856830|75884067|FG002|STARTED|Irinotecan & Bendamustine||6||
59764091|NCT00856830|75884068|FG003|STARTED|Irinotecan & Bendamustine||15||
59764092|NCT00856830|75884065|FG000|Maximum Tolerated Dose|Irinotecan & Bendamustine||3||
59764093|NCT00856830|75884066|FG001|Maximum Tolerated Dose|Irinotecan & Bendamustine||6||
59764094|NCT00856830|75884067|FG002|Maximum Tolerated Dose|Irinotecan & Bendamustine||6||
59764095|NCT00856830|75884068|FG003|Maximum Tolerated Dose|Irinotecan & Bendamustine||12||
59764096|NCT00856830|75884065|FG000|COMPLETED|Irinotecan & Bendamustine||3||
59764097|NCT00856830|75884066|FG001|COMPLETED|Irinotecan & Bendamustine||6||
59764098|NCT00856830|75884067|FG002|COMPLETED|Irinotecan & Bendamustine||6||
59764099|NCT00856830|75884068|FG003|COMPLETED|Irinotecan & Bendamustine||12||
60071885|NCT04020718|76187247|FG000|COMPLETED|Post-assessment and Adaptation||0||
60071886|NCT04020718|76187248|FG001|COMPLETED|Post-assessment and Adaptation||0||
59764100|NCT00856830|75884065|FG000|NOT COMPLETED|Irinotecan & Bendamustine||0||
59764101|NCT00856830|75884066|FG001|NOT COMPLETED|Irinotecan & Bendamustine||0||
59764102|NCT00856830|75884067|FG002|NOT COMPLETED|Irinotecan & Bendamustine||0||
59764103|NCT00856830|75884068|FG003|NOT COMPLETED|Irinotecan & Bendamustine||3||
59764104|NCT00856830|75884065|FG000|STARTED|Regimen - B (Carboplatin & Etoposide)||3||
59764105|NCT00856830|75884066|FG001|STARTED|Regimen - B (Carboplatin & Etoposide)||6||
59764106|NCT00856830|75884067|FG002|STARTED|Regimen - B (Carboplatin & Etoposide)||6||
59764107|NCT00856830|75884068|FG003|STARTED|Regimen - B (Carboplatin & Etoposide)||12||
59764108|NCT00856830|75884065|FG000|COMPLETED|Regimen - B (Carboplatin & Etoposide)||3||
59764109|NCT00856830|75884066|FG001|COMPLETED|Regimen - B (Carboplatin & Etoposide)||6||
59764110|NCT00856830|75884067|FG002|COMPLETED|Regimen - B (Carboplatin & Etoposide)||6||
59764111|NCT00856830|75884068|FG003|COMPLETED|Regimen - B (Carboplatin & Etoposide)||12||
59764112|NCT00856830|75884065|FG000|NOT COMPLETED|Regimen - B (Carboplatin & Etoposide)||0||
59764113|NCT00856830|75884066|FG001|NOT COMPLETED|Regimen - B (Carboplatin & Etoposide)||0||
59764114|NCT00856830|75884067|FG002|NOT COMPLETED|Regimen - B (Carboplatin & Etoposide)||0||
59764115|NCT00856830|75884068|FG003|NOT COMPLETED|Regimen - B (Carboplatin & Etoposide)||0||
59764116|NCT00522301|75884073|FG000|STARTED|Overall Study||6||
59764117|NCT00522301|75884073|FG000|COMPLETED|Overall Study||0||
59764118|NCT00522301|75884073|FG000|NOT COMPLETED|Overall Study||6||
59764119|NCT00863928|75884079|FG000|STARTED|Overall Study||94||
59764120|NCT00863928|75884080|FG001|STARTED|Overall Study||41||
59764121|NCT00863928|75884079|FG000|COMPLETED|Overall Study||58||
59764122|NCT00863928|75884080|FG001|COMPLETED|Overall Study||41||
60071887|NCT04020718|76187249|FG002|COMPLETED|Post-assessment and Adaptation||8||
59764123|NCT00863928|75884079|FG000|NOT COMPLETED|Overall Study||36||
59764124|NCT00863928|75884080|FG001|NOT COMPLETED|Overall Study||0||
59764125|NCT00856518|75884088|FG000|STARTED|Overall Study||24||
59764126|NCT00856518|75884089|FG001|STARTED|Overall Study||18||
59764127|NCT00856518|75884088|FG000|COMPLETED|Overall Study||20||
59764128|NCT00856518|75884089|FG001|COMPLETED|Overall Study||16||
59764129|NCT00856518|75884088|FG000|NOT COMPLETED|Overall Study||4||
59764130|NCT00856518|75884089|FG001|NOT COMPLETED|Overall Study||2||
59764131|NCT00506389|75884100|FG000|STARTED|In-treatment Period||143||
59764132|NCT00506389|75884101|FG001|STARTED|In-treatment Period||139||
59764133|NCT00506389|75884102|FG002|STARTED|In-treatment Period||137||
59764134|NCT00506389|75884100|FG000|All Participants Treated|In-treatment Period||139||
59764135|NCT00506389|75884101|FG001|All Participants Treated|In-treatment Period||138||
60071888|NCT04020718|76187250|FG003|COMPLETED|Post-assessment and Adaptation||5||
59764136|NCT00506389|75884102|FG002|All Participants Treated|In-treatment Period||136||
59764137|NCT00506389|75884100|FG000|COMPLETED|In-treatment Period||117||
59764138|NCT00506389|75884101|FG001|COMPLETED|In-treatment Period||124||
59764139|NCT00506389|75884102|FG002|COMPLETED|In-treatment Period||125||
59764140|NCT00506389|75884100|FG000|NOT COMPLETED|In-treatment Period||26||
59764141|NCT00506389|75884101|FG001|NOT COMPLETED|In-treatment Period||15||
59764142|NCT00506389|75884102|FG002|NOT COMPLETED|In-treatment Period||12||
59764143|NCT00506389|75884100|FG000|STARTED|Follow-up Period|22 participants who discontinued treatment entered the Follow-up Period.|139||
59764144|NCT00506389|75884101|FG001|STARTED|Follow-up Period|14 participants who discontinued treatment entered the Follow-up Period.|138||
59764145|NCT00506389|75884102|FG002|STARTED|Follow-up Period|11 participants who discontinued treatment entered the Follow-up Period.|136||
59764146|NCT00506389|75884100|FG000|COMPLETED|Follow-up Period||139||
59764147|NCT00506389|75884101|FG001|COMPLETED|Follow-up Period||138||
59764148|NCT00506389|75884102|FG002|COMPLETED|Follow-up Period||136||
59764149|NCT00506389|75884100|FG000|NOT COMPLETED|Follow-up Period||0||
59764150|NCT00506389|75884101|FG001|NOT COMPLETED|Follow-up Period||0||
59764151|NCT00506389|75884102|FG002|NOT COMPLETED|Follow-up Period||0||
59764152|NCT00871338|75884115|FG000|STARTED|Prior to Booster||142||
59764153|NCT00871338|75884116|FG001|STARTED|Prior to Booster||142||
59764154|NCT00871338|75884115|FG000|COMPLETED|Prior to Booster||140||
59764155|NCT00871338|75884116|FG001|COMPLETED|Prior to Booster||139||
59764156|NCT00871338|75884115|FG000|NOT COMPLETED|Prior to Booster||2||
59764157|NCT00871338|75884116|FG001|NOT COMPLETED|Prior to Booster||3||
59764158|NCT00871338|75884115|FG000|STARTED|After Booster||139||
59764159|NCT00871338|75884116|FG001|STARTED|After Booster||135||
59764160|NCT00871338|75884115|FG000|COMPLETED|After Booster||139||
60071889|NCT04020718|76187251|FG004|COMPLETED|Post-assessment and Adaptation||8||
60071890|NCT04020718|76187252|FG005|COMPLETED|Post-assessment and Adaptation||7||
60071891|NCT04020718|76187253|FG006|COMPLETED|Post-assessment and Adaptation||2||
60071892|NCT04020718|76187254|FG007|COMPLETED|Post-assessment and Adaptation||0||
60071893|NCT04020718|76187247|FG000|NOT COMPLETED|Post-assessment and Adaptation||0||
60071894|NCT04020718|76187248|FG001|NOT COMPLETED|Post-assessment and Adaptation||0||
60071895|NCT04020718|76187249|FG002|NOT COMPLETED|Post-assessment and Adaptation||0||
60071896|NCT04020718|76187250|FG003|NOT COMPLETED|Post-assessment and Adaptation||1||
60071897|NCT04020718|76187251|FG004|NOT COMPLETED|Post-assessment and Adaptation||0||
60071898|NCT04020718|76187252|FG005|NOT COMPLETED|Post-assessment and Adaptation||0||
60071899|NCT04020718|76187253|FG006|NOT COMPLETED|Post-assessment and Adaptation||0||
60071900|NCT04020718|76187254|FG007|NOT COMPLETED|Post-assessment and Adaptation||0||
60071901|NCT04027348|76187272|FG000|STARTED|Overall Study||15||
60071902|NCT04027348|76187272|FG000|COMPLETED|Overall Study||13||
60071903|NCT04027348|76187272|FG000|NOT COMPLETED|Overall Study||2||
60071904|NCT02080546|76187278|FG000|STARTED|Overall Study||57||
60071905|NCT02080546|76187279|FG001|STARTED|Overall Study||63||
60071906|NCT02080546|76187278|FG000|COMPLETED|Overall Study||49||
60071907|NCT02080546|76187279|FG001|COMPLETED|Overall Study||52||
60071908|NCT02080546|76187278|FG000|NOT COMPLETED|Overall Study||8||
60071909|NCT02080546|76187279|FG001|NOT COMPLETED|Overall Study||11||
60071910|NCT04196686|76187285|FG000|STARTED|First Treatment (4 Minutes)||78||
60071911|NCT04196686|76187286|FG001|STARTED|First Treatment (4 Minutes)||78||
60071912|NCT04196686|76187285|FG000|COMPLETED|First Treatment (4 Minutes)||78||
60071913|NCT04196686|76187286|FG001|COMPLETED|First Treatment (4 Minutes)||75||
60071914|NCT04196686|76187285|FG000|NOT COMPLETED|First Treatment (4 Minutes)||0||
60071915|NCT04196686|76187286|FG001|NOT COMPLETED|First Treatment (4 Minutes)||3||
60071916|NCT04196686|76187285|FG000|STARTED|Second Treatment (4 Minutes)||78||
60071917|NCT04196686|76187286|FG001|STARTED|Second Treatment (4 Minutes)||75||
60071918|NCT04196686|76187285|FG000|COMPLETED|Second Treatment (4 Minutes)||78||
60071919|NCT04196686|76187286|FG001|COMPLETED|Second Treatment (4 Minutes)||75||
60071920|NCT04196686|76187285|FG000|NOT COMPLETED|Second Treatment (4 Minutes)||0||
60071921|NCT04196686|76187286|FG001|NOT COMPLETED|Second Treatment (4 Minutes)||0||
60071922|NCT02708680|76187295|FG000|STARTED|Overall Study||8||
60071923|NCT02708680|76187296|FG001|STARTED|Overall Study||40||
60071924|NCT02708680|76187297|FG002|STARTED|Overall Study||41||
60071925|NCT02708680|76187295|FG000|Received At Least 1 Dose Of Study Drug|Overall Study||8|Safety Population|
60071926|NCT02708680|76187296|FG001|Received At Least 1 Dose Of Study Drug|Overall Study||40|Safety Population|
59764161|NCT00871338|75884116|FG001|COMPLETED|After Booster||135||
59764162|NCT00871338|75884115|FG000|NOT COMPLETED|After Booster||0||
59764163|NCT00871338|75884116|FG001|NOT COMPLETED|After Booster||0||
59764164|NCT00824421|75884125|FG000|STARTED|Overall Study||66||
59764165|NCT00824421|75884126|FG001|STARTED|Overall Study||66||
59764166|NCT00824421|75884127|FG002|STARTED|Overall Study||63||
59764167|NCT00824421|75884125|FG000|Treated|Overall Study||65||
59764168|NCT00824421|75884126|FG001|Treated|Overall Study||65||
59764169|NCT00824421|75884127|FG002|Treated|Overall Study||63||
59764170|NCT00824421|75884125|FG000|COMPLETED|Overall Study||49||
59764171|NCT00824421|75884126|FG001|COMPLETED|Overall Study||44||
59764172|NCT00824421|75884127|FG002|COMPLETED|Overall Study||49||
59764173|NCT00824421|75884125|FG000|NOT COMPLETED|Overall Study||17||
60071927|NCT02708680|76187297|FG002|Received At Least 1 Dose Of Study Drug|Overall Study||39|Safety Population|
60071928|NCT02708680|76187295|FG000|Dose-limiting Toxicity (DLT) Evaluable|Overall Study||6|A participant that experienced an adverse event (AE) meeting DLT criteria during Cycle 1 or who received the full dose of atezolizumab and all doses of entinostat during Cycle 1 without experiencing a DLT was considered DLT evaluable.|
60071929|NCT02708680|76187296|FG001|Dose-limiting Toxicity (DLT) Evaluable|Overall Study|DLTs were not evaluated in Phase 2.|0|A participant that experienced an adverse event (AE) meeting DLT criteria during Cycle 1 or who received the full dose of atezolizumab and all doses of entinostat during Cycle 1 without experiencing a DLT was considered DLT evaluable.|
60071930|NCT02708680|76187297|FG002|Dose-limiting Toxicity (DLT) Evaluable|Overall Study|DLTs were not evaluated in Phase 2.|0|A participant that experienced an adverse event (AE) meeting DLT criteria during Cycle 1 or who received the full dose of atezolizumab and all doses of entinostat during Cycle 1 without experiencing a DLT was considered DLT evaluable.|
60071931|NCT02708680|76187295|FG000|COMPLETED|Overall Study||0||
60071932|NCT02708680|76187296|FG001|COMPLETED|Overall Study||0||
60071933|NCT02708680|76187297|FG002|COMPLETED|Overall Study||0||
60071934|NCT02708680|76187295|FG000|NOT COMPLETED|Overall Study||8||
60071935|NCT02708680|76187296|FG001|NOT COMPLETED|Overall Study||40||
60071936|NCT02708680|76187297|FG002|NOT COMPLETED|Overall Study||41||
60071937|NCT01611974|76187311|FG000|STARTED|Overall Study||40||
60071938|NCT01611974|76187312|FG001|STARTED|Overall Study||40||
60071939|NCT01611974|76187313|FG002|STARTED|Overall Study||40||
60071940|NCT01611974|76187311|FG000|COMPLETED|Overall Study||25||
60071941|NCT01611974|76187312|FG001|COMPLETED|Overall Study||25||
60071942|NCT01611974|76187313|FG002|COMPLETED|Overall Study||24||
60071943|NCT01611974|76187311|FG000|NOT COMPLETED|Overall Study||15||
60071944|NCT01611974|76187312|FG001|NOT COMPLETED|Overall Study||15||
60071945|NCT01611974|76187313|FG002|NOT COMPLETED|Overall Study||16||
60071946|NCT01848938|76187323|FG000|STARTED|Overall Study||62||
59520523|NCT03112993|75614522|FG001|STARTED|Overall Study||21||
59520524|NCT03112993|75614521|FG000|COMPLETED|Overall Study||19||
59520525|NCT03112993|75614522|FG001|COMPLETED|Overall Study||21||
59520526|NCT03112993|75614521|FG000|NOT COMPLETED|Overall Study||0||
59520527|NCT03112993|75614522|FG001|NOT COMPLETED|Overall Study||0||
59520528|NCT03670030|75614530|FG000|STARTED|Overall Study||5||
59520529|NCT03670030|75614530|FG000|COMPLETED|Overall Study||5||
60071947|NCT01848938|76187324|FG001|STARTED|Overall Study||61||
60071948|NCT01848938|76187323|FG000|COMPLETED|Overall Study||61||
59520530|NCT03670030|75614530|FG000|NOT COMPLETED|Overall Study||0||
59520531|NCT04271020|75614534|FG000|STARTED|Overall Study||12||
59520532|NCT04271020|75614534|FG000|COMPLETED|Overall Study||12||
59520533|NCT04271020|75614534|FG000|NOT COMPLETED|Overall Study||0||
59520534|NCT03859960|75614540|FG000|STARTED|Overall Study||14||
59520535|NCT03859960|75614541|FG001|STARTED|Overall Study||19||
59520536|NCT03859960|75614540|FG000|COMPLETED|Overall Study||14||
59520537|NCT03859960|75614541|FG001|COMPLETED|Overall Study||19||
59520538|NCT03859960|75614540|FG000|NOT COMPLETED|Overall Study||0||
59520539|NCT03859960|75614541|FG001|NOT COMPLETED|Overall Study||0||
59520540|NCT01163461|75614549|FG000|STARTED|Overall Study||14||
59520541|NCT01163461|75614550|FG001|STARTED|Overall Study||14||
59520542|NCT01163461|75614549|FG000|COMPLETED|Overall Study||14||
59520543|NCT01163461|75614550|FG001|COMPLETED|Overall Study||14||
59520544|NCT01163461|75614549|FG000|NOT COMPLETED|Overall Study||0||
59520545|NCT01163461|75614550|FG001|NOT COMPLETED|Overall Study||0||
59520546|NCT03857230|75614556|FG000|STARTED|Period 1 (Primapur-Gonal-F)||12||
59520547|NCT03857230|75614557|FG001|STARTED|Period 1 (Primapur-Gonal-F)||12||
59520548|NCT03857230|75614556|FG000|COMPLETED|Period 1 (Primapur-Gonal-F)||12||
59520549|NCT03857230|75614557|FG001|COMPLETED|Period 1 (Primapur-Gonal-F)||12||
59520550|NCT03857230|75614556|FG000|NOT COMPLETED|Period 1 (Primapur-Gonal-F)||0||
59520551|NCT03857230|75614557|FG001|NOT COMPLETED|Period 1 (Primapur-Gonal-F)||0||
59520552|NCT03857230|75614556|FG000|STARTED|Period 2 (Gonal-F-Primapur)||12||
59520553|NCT03857230|75614557|FG001|STARTED|Period 2 (Gonal-F-Primapur)||12||
59520554|NCT03857230|75614556|FG000|COMPLETED|Period 2 (Gonal-F-Primapur)||12||
59520555|NCT03857230|75614557|FG001|COMPLETED|Period 2 (Gonal-F-Primapur)||12||
59520556|NCT03857230|75614556|FG000|NOT COMPLETED|Period 2 (Gonal-F-Primapur)||0||
59520557|NCT03857230|75614557|FG001|NOT COMPLETED|Period 2 (Gonal-F-Primapur)||0||
59520558|NCT02181127|75614563|FG000|STARTED|Overall Study||22||
59520559|NCT02181127|75614563|FG000|COMPLETED|Overall Study||22||
59520560|NCT02181127|75614563|FG000|NOT COMPLETED|Overall Study||0||
59520561|NCT03670264|75614573|FG000|STARTED|Overall Study||5||
59520562|NCT03670264|75614574|FG001|STARTED|Overall Study||5||
59520563|NCT03670264|75614575|FG002|STARTED|Overall Study||5||
59520564|NCT03670264|75614573|FG000|COMPLETED|Overall Study||5||
59520565|NCT03670264|75614574|FG001|COMPLETED|Overall Study||5||
59520566|NCT03670264|75614575|FG002|COMPLETED|Overall Study||5||
59520567|NCT03670264|75614573|FG000|NOT COMPLETED|Overall Study||0||
59520568|NCT03670264|75614574|FG001|NOT COMPLETED|Overall Study||0||
59520569|NCT03670264|75614575|FG002|NOT COMPLETED|Overall Study||0||
59520570|NCT04241146|75614585|FG000|STARTED|Overall Study||24||
59520571|NCT04241146|75614586|FG001|STARTED|Overall Study||28||
59520572|NCT04241146|75614585|FG000|COMPLETED|Overall Study||24||
59520573|NCT04241146|75614586|FG001|COMPLETED|Overall Study||28||
59520574|NCT04241146|75614585|FG000|NOT COMPLETED|Overall Study||0||
60071949|NCT01848938|76187324|FG001|COMPLETED|Overall Study||60||
60071950|NCT01848938|76187323|FG000|NOT COMPLETED|Overall Study||1||
60071951|NCT01848938|76187324|FG001|NOT COMPLETED|Overall Study||1||
60071952|NCT01871870|76187330|FG000|STARTED|Overall Study||20||
60071953|NCT01871870|76187330|FG000|COMPLETED|Overall Study||11||
60071954|NCT01871870|76187330|FG000|NOT COMPLETED|Overall Study||9||
60071955|NCT02080780|76187334|FG000|STARTED|Overall Study||24||
60071956|NCT02080780|76187334|FG000|COMPLETED|Overall Study||24||
60071957|NCT02080780|76187334|FG000|NOT COMPLETED|Overall Study||0||
60071958|NCT01871558|76187343|FG000|STARTED|Overall Study||21||
60071959|NCT01871558|76187344|FG001|STARTED|Overall Study||21||
60071960|NCT01871558|76187343|FG000|COMPLETED|Overall Study||18||
60071961|NCT01871558|76187344|FG001|COMPLETED|Overall Study||19||
60071962|NCT01871558|76187343|FG000|NOT COMPLETED|Overall Study||3||
60071963|NCT01871558|76187344|FG001|NOT COMPLETED|Overall Study||2||
60071964|NCT01711359|76187353|FG000|STARTED|Treatment Period||213||
60071965|NCT01711359|76187354|FG001|STARTED|Treatment Period||160||
60071966|NCT01711359|76187355|FG002|STARTED|Treatment Period||215||
60071967|NCT01711359|76187353|FG000|Received at Least One Dose of Study Drug|Treatment Period||210||
60071968|NCT01711359|76187354|FG001|Received at Least One Dose of Study Drug|Treatment Period||159||
60071969|NCT01711359|76187355|FG002|Received at Least One Dose of Study Drug|Treatment Period||215||
60071970|NCT01711359|76187353|FG000|Rescued|Treatment Period||26||
59764174|NCT00824421|75884126|FG001|NOT COMPLETED|Overall Study||22||
59764175|NCT00824421|75884127|FG002|NOT COMPLETED|Overall Study||14||
59764176|NCT00514813|75884141|FG000|STARTED|Overall Study||15||
59764177|NCT00514813|75884142|FG001|STARTED|Overall Study||86||
59764178|NCT00514813|75884143|FG002|STARTED|Overall Study||47||
59764179|NCT00514813|75884144|FG003|STARTED|Overall Study||4||
59764180|NCT00514813|75884141|FG000|COMPLETED|Overall Study||0||
59764181|NCT00514813|75884142|FG001|COMPLETED|Overall Study||0||
59764182|NCT00514813|75884143|FG002|COMPLETED|Overall Study||0||
59764183|NCT00514813|75884144|FG003|COMPLETED|Overall Study||0||
59764184|NCT00514813|75884141|FG000|NOT COMPLETED|Overall Study||15||
59764185|NCT00514813|75884142|FG001|NOT COMPLETED|Overall Study||86||
59764186|NCT00514813|75884143|FG002|NOT COMPLETED|Overall Study||47||
59764187|NCT00514813|75884144|FG003|NOT COMPLETED|Overall Study||4||
59764188|NCT00597116|75884156|FG000|STARTED|Overall Study||14||
59764189|NCT00597116|75884157|FG001|STARTED|Overall Study||11||
59764190|NCT00597116|75884156|FG000|COMPLETED|Overall Study|Randomised patients ongoing study treatment at data cut-off|0||
59764191|NCT00597116|75884157|FG001|COMPLETED|Overall Study|Randomised patients ongoing study treatment at data cut-off|0||
59764192|NCT00597116|75884156|FG000|NOT COMPLETED|Overall Study||14||
59764193|NCT00597116|75884157|FG001|NOT COMPLETED|Overall Study||11||
59764194|NCT00514735|75884165|FG000|STARTED|Overall Study||138||
59764195|NCT00514735|75884166|FG001|STARTED|Overall Study||72||
59764196|NCT00514735|75884165|FG000|COMPLETED|Overall Study||124||
59764197|NCT00514735|75884166|FG001|COMPLETED|Overall Study||66||
59764198|NCT00514735|75884165|FG000|NOT COMPLETED|Overall Study||14||
59764199|NCT00514735|75884166|FG001|NOT COMPLETED|Overall Study||6||
59764200|NCT03252587|75884178|FG000|STARTED|Overall Study||90|Started = Randomized and treated|
59764201|NCT03252587|75884179|FG001|STARTED|Overall Study||91|Started = Randomized and treated|
59764202|NCT03252587|75884180|FG002|STARTED|Overall Study||93|Started = Randomized and treated|
59764203|NCT03252587|75884181|FG003|STARTED|Overall Study||89|Started = Randomized and treated|
59764204|NCT03252587|75884178|FG000|COMPLETED|Overall Study||66|Completed = Completed treatment|
59764205|NCT03252587|75884179|FG001|COMPLETED|Overall Study||71|Completed = Completed treatment|
59764206|NCT03252587|75884180|FG002|COMPLETED|Overall Study||76|Completed = Completed treatment|
59764207|NCT03252587|75884181|FG003|COMPLETED|Overall Study||62|Completed = Completed treatment|
59764208|NCT03252587|75884178|FG000|NOT COMPLETED|Overall Study||24||
59764209|NCT03252587|75884179|FG001|NOT COMPLETED|Overall Study||20||
60071971|NCT01711359|76187354|FG001|Rescued|Treatment Period||7||
60071972|NCT01711359|76187355|FG002|Rescued|Treatment Period||6||
60071973|NCT01711359|76187353|FG000|COMPLETED|Treatment Period||161||
60071974|NCT01711359|76187354|FG001|COMPLETED|Treatment Period||136||
60071975|NCT01711359|76187355|FG002|COMPLETED|Treatment Period||173||
60071976|NCT01711359|76187353|FG000|NOT COMPLETED|Treatment Period||52||
60071977|NCT01711359|76187354|FG001|NOT COMPLETED|Treatment Period||24||
60071978|NCT01711359|76187355|FG002|NOT COMPLETED|Treatment Period||42||
60071979|NCT01711359|76187353|FG000|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|25||
60071980|NCT01711359|76187354|FG001|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|15||
60071981|NCT01711359|76187355|FG002|STARTED|Follow Up|Participants from treatment and rescue who entered the post-treatment follow-up period.|28||
60071982|NCT01711359|76187353|FG000|COMPLETED|Follow Up||0||
60071983|NCT01711359|76187354|FG001|COMPLETED|Follow Up||0||
60071984|NCT01711359|76187355|FG002|COMPLETED|Follow Up||0||
60071985|NCT01711359|76187353|FG000|NOT COMPLETED|Follow Up||25||
60071986|NCT01711359|76187354|FG001|NOT COMPLETED|Follow Up||15||
60071987|NCT01711359|76187355|FG002|NOT COMPLETED|Follow Up||28||
60071988|NCT03929224|76187370|FG000|STARTED|Overall Study||8||
60071989|NCT03929224|76187371|FG001|STARTED|Overall Study||9||
60071990|NCT03929224|76187370|FG000|COMPLETED|Overall Study||8||
60071991|NCT03929224|76187371|FG001|COMPLETED|Overall Study||9||
60071992|NCT03929224|76187370|FG000|NOT COMPLETED|Overall Study||0||
60071993|NCT03929224|76187371|FG001|NOT COMPLETED|Overall Study||0||
60071994|NCT01710657|76187382|FG000|STARTED|Overall Study||184||
59520575|NCT04241146|75614586|FG001|NOT COMPLETED|Overall Study||0||
59520576|NCT03672370|75614592|FG000|STARTED|Overall Study|11 hips did not receive the study devices acc. to the protocol and therefore had to be excluded.|89||
59520577|NCT03672370|75614592|FG000|COMPLETED|Overall Study||42||
59520578|NCT03672370|75614592|FG000|NOT COMPLETED|Overall Study||47||
59520579|NCT01166347|75614598|FG000|STARTED|Overall Study||297||
59520580|NCT01166347|75614599|FG001|STARTED|Overall Study||149||
59520581|NCT01166347|75614598|FG000|COMPLETED|Overall Study||295||
59520582|NCT01166347|75614599|FG001|COMPLETED|Overall Study||148||
59520583|NCT01166347|75614598|FG000|NOT COMPLETED|Overall Study||2||
59520584|NCT01166347|75614599|FG001|NOT COMPLETED|Overall Study||1||
59520585|NCT04240678|75614607|FG000|STARTED|Overall Study||4141||
59520586|NCT04240678|75614608|FG001|STARTED|Overall Study||4158||
59764210|NCT03252587|75884180|FG002|NOT COMPLETED|Overall Study||17||
60071995|NCT01710657|76187383|FG001|STARTED|Overall Study||183||
59520587|NCT04240678|75614607|FG000|COMPLETED|Overall Study||4141||
59520588|NCT04240678|75614608|FG001|COMPLETED|Overall Study||4158||
59520589|NCT04240678|75614607|FG000|NOT COMPLETED|Overall Study||0||
59520590|NCT04240678|75614608|FG001|NOT COMPLETED|Overall Study||0||
59520591|NCT04234672|75614614|FG000|STARTED|Treatment Period 1 (Day 1)||6||
59520592|NCT04234672|75614614|FG000|COMPLETED|Treatment Period 1 (Day 1)||6||
59520593|NCT04234672|75614614|FG000|NOT COMPLETED|Treatment Period 1 (Day 1)||0||
59520594|NCT04234672|75614614|FG000|STARTED|Washout Period (Day 2 to 8)||6||
59520595|NCT04234672|75614614|FG000|COMPLETED|Washout Period (Day 2 to 8)||6||
59520596|NCT04234672|75614614|FG000|NOT COMPLETED|Washout Period (Day 2 to 8)||0||
59520597|NCT04234672|75614614|FG000|STARTED|Treatment Period 2(Day9[Day1of Period2])||6||
59520598|NCT04234672|75614614|FG000|COMPLETED|Treatment Period 2(Day9[Day1of Period2])||6||
59520599|NCT04234672|75614614|FG000|NOT COMPLETED|Treatment Period 2(Day9[Day1of Period2])||0||
59520600|NCT03676270|75614625|FG000|STARTED|Overall Study||6915||224
59520601|NCT03676270|75614625|FG000|COMPLETED|Overall Study||6915||224
59520602|NCT03676270|75614625|FG000|NOT COMPLETED|Overall Study||0||0
59520603|NCT03676972|75614629|FG000|STARTED|Overall Study||60||
59520604|NCT03676972|75614629|FG000|COMPLETED|Overall Study||58||
59520605|NCT03676972|75614629|FG000|NOT COMPLETED|Overall Study||2||
59520606|NCT03681808|75614635|FG000|STARTED|Overall Study||123||
59520607|NCT03681808|75614636|FG001|STARTED|Overall Study||119||
59520608|NCT03681808|75614635|FG000|COMPLETED|Overall Study||109||
59520609|NCT03681808|75614636|FG001|COMPLETED|Overall Study||102||
59520610|NCT03681808|75614635|FG000|NOT COMPLETED|Overall Study||14||
59520611|NCT03681808|75614636|FG001|NOT COMPLETED|Overall Study||17||
60071996|NCT01710657|76187384|FG002|STARTED|Overall Study||180||
60071997|NCT01710657|76187382|FG000|Titration Period (4 Weeks)|Overall Study||184||
60071998|NCT01710657|76187383|FG001|Titration Period (4 Weeks)|Overall Study||183||
60071999|NCT01710657|76187384|FG002|Titration Period (4 Weeks)|Overall Study||180||
60072000|NCT01710657|76187382|FG000|Maintenance Period (12 Weeks)|Overall Study||176||
60072001|NCT01710657|76187383|FG001|Maintenance Period (12 Weeks)|Overall Study||175||
59520612|NCT01166971|75614644|FG000|STARTED|Overall Study||33||
59520613|NCT01166971|75614645|FG001|STARTED|Overall Study||31||
59520614|NCT01166971|75614644|FG000|COMPLETED|Overall Study||32||
59520615|NCT01166971|75614645|FG001|COMPLETED|Overall Study||30||
59520616|NCT01166971|75614644|FG000|NOT COMPLETED|Overall Study||1||
59520617|NCT01166971|75614645|FG001|NOT COMPLETED|Overall Study||1||
59520618|NCT04208698|75614656|FG000|STARTED|Overall Study||2||
59520619|NCT04208698|75614657|FG001|STARTED|Overall Study||0||
59520620|NCT04208698|75614658|FG002|STARTED|Overall Study||0||
59520621|NCT04208698|75614659|FG003|STARTED|Overall Study||0||
59520622|NCT04208698|75614660|FG004|STARTED|Overall Study||0||
59520623|NCT04208698|75614656|FG000|COMPLETED|Overall Study||0||
59520624|NCT04208698|75614657|FG001|COMPLETED|Overall Study||0||
59520625|NCT04208698|75614658|FG002|COMPLETED|Overall Study||0||
59520626|NCT04208698|75614659|FG003|COMPLETED|Overall Study||0||
59520627|NCT04208698|75614660|FG004|COMPLETED|Overall Study||0||
60072002|NCT01710657|76187384|FG002|Maintenance Period (12 Weeks)|Overall Study||168||
60072003|NCT01710657|76187382|FG000|COMPLETED|Overall Study||166||
60072004|NCT01710657|76187383|FG001|COMPLETED|Overall Study||171||
59520628|NCT04208698|75614656|FG000|NOT COMPLETED|Overall Study||2||
59520629|NCT04208698|75614657|FG001|NOT COMPLETED|Overall Study||0||
59520630|NCT04208698|75614658|FG002|NOT COMPLETED|Overall Study||0||
59520631|NCT04208698|75614659|FG003|NOT COMPLETED|Overall Study||0||
59520632|NCT04208698|75614660|FG004|NOT COMPLETED|Overall Study||0||
59520633|NCT01167595|75614672|FG000|STARTED|Overall Study||522||9
60072005|NCT01710657|76187384|FG002|COMPLETED|Overall Study||148||
60072006|NCT01710657|76187382|FG000|NOT COMPLETED|Overall Study||18||
60072007|NCT01710657|76187383|FG001|NOT COMPLETED|Overall Study||12||
60072008|NCT01710657|76187384|FG002|NOT COMPLETED|Overall Study||32||
60072009|NCT01701063|76187395|FG000|STARTED|Overall Study||13||
60072010|NCT01701063|76187396|FG001|STARTED|Overall Study||19||
60072011|NCT01701063|76187397|FG002|STARTED|Overall Study||10||
60072012|NCT01701063|76187395|FG000|COMPLETED|Overall Study||13||
60072013|NCT01701063|76187396|FG001|COMPLETED|Overall Study||18||
60072014|NCT01701063|76187397|FG002|COMPLETED|Overall Study||8||
60072015|NCT01701063|76187395|FG000|NOT COMPLETED|Overall Study||0||
60072016|NCT01701063|76187396|FG001|NOT COMPLETED|Overall Study||1||
60072017|NCT01701063|76187397|FG002|NOT COMPLETED|Overall Study||2||
60072018|NCT01700985|76187408|FG000|STARTED|Overall Study||23||
60072019|NCT01700985|76187409|FG001|STARTED|Overall Study||21||
60072020|NCT01700985|76187408|FG000|COMPLETED|Overall Study||23||
60072021|NCT01700985|76187409|FG001|COMPLETED|Overall Study||20||
60072022|NCT01700985|76187408|FG000|NOT COMPLETED|Overall Study||0||
60072023|NCT01700985|76187409|FG001|NOT COMPLETED|Overall Study||1||
60072024|NCT01710501|76187418|FG000|STARTED|Overall Study||29||
60072025|NCT01710501|76187419|FG001|STARTED|Overall Study||28||
60072026|NCT01710501|76187420|FG002|STARTED|Overall Study||30||
60072027|NCT01710501|76187418|FG000|COMPLETED|Overall Study||27||
60072028|NCT01710501|76187419|FG001|COMPLETED|Overall Study||28||
60072029|NCT01710501|76187420|FG002|COMPLETED|Overall Study||30||
60072030|NCT01710501|76187418|FG000|NOT COMPLETED|Overall Study||2||
60072031|NCT01710501|76187419|FG001|NOT COMPLETED|Overall Study||0||
60072032|NCT01710501|76187420|FG002|NOT COMPLETED|Overall Study||0||
60072033|NCT01700829|76187430|FG000|STARTED|Overall Study||41||
60072034|NCT01700829|76187431|FG001|STARTED|Overall Study||41||
60072035|NCT01700829|76187430|FG000|COMPLETED|Overall Study||40||
60072036|NCT01700829|76187431|FG001|COMPLETED|Overall Study||40||
60072037|NCT01700829|76187430|FG000|NOT COMPLETED|Overall Study||1||
60072038|NCT01700829|76187431|FG001|NOT COMPLETED|Overall Study||1||
60072039|NCT01710345|76187440|FG000|STARTED|Overall Study|41 patients were randomized to sufentanil 20 mcg, one patient not dosed due to damaged medication.|40||
60072040|NCT01710345|76187441|FG001|STARTED|Overall Study||40||
60072041|NCT01710345|76187442|FG002|STARTED|Overall Study||20||
60072042|NCT01710345|76187440|FG000|COMPLETED|Overall Study||37||
60072043|NCT01710345|76187441|FG001|COMPLETED|Overall Study||35||
60072044|NCT01710345|76187442|FG002|COMPLETED|Overall Study||19||
59764211|NCT03252587|75884181|FG003|NOT COMPLETED|Overall Study||27||
59764212|NCT00511147|75884194|FG000|STARTED|Overall Study||64||
59764213|NCT00511147|75884194|FG000|COMPLETED|Overall Study||57||
59764214|NCT00511147|75884194|FG000|NOT COMPLETED|Overall Study||7||
59764215|NCT00510835|75884201|FG000|STARTED|Overall Study||445||
59764216|NCT00510835|75884202|FG001|STARTED|Overall Study||448||
59764217|NCT00510835|75884203|FG002|STARTED|Overall Study||458||
59764218|NCT00510835|75884201|FG000|COMPLETED|Overall Study||439||
60072045|NCT01710345|76187440|FG000|NOT COMPLETED|Overall Study||3||
59764219|NCT00510835|75884202|FG001|COMPLETED|Overall Study||446||
59764220|NCT00510835|75884203|FG002|COMPLETED|Overall Study||456||
59764221|NCT00510835|75884201|FG000|NOT COMPLETED|Overall Study||6||
59764222|NCT00510835|75884202|FG001|NOT COMPLETED|Overall Study||2||
59764223|NCT00510835|75884203|FG002|NOT COMPLETED|Overall Study||2||
59764224|NCT00506077|75884213|FG000|STARTED|Treatment Period 1||28||
59764225|NCT00506077|75884214|FG001|STARTED|Treatment Period 1||27||
60072046|NCT01710345|76187441|FG001|NOT COMPLETED|Overall Study||5||
60072047|NCT01710345|76187442|FG002|NOT COMPLETED|Overall Study||1||
60072048|NCT02335216|76187450|FG000|STARTED|Overall Study||22||
60072049|NCT02335216|76187450|FG000|Received Trial System|Overall Study||16||
60072050|NCT02335216|76187450|FG000|Received Permanent System|Overall Study||13||
60072051|NCT02335216|76187450|FG000|COMPLETED|Overall Study||9||
60072052|NCT02335216|76187450|FG000|NOT COMPLETED|Overall Study||13||
60072053|NCT01710033|76187458|FG000|STARTED|Stage 1||6||
59764226|NCT00506077|75884213|FG000|COMPLETED|Treatment Period 1||24||
59764227|NCT00506077|75884214|FG001|COMPLETED|Treatment Period 1||24||
60072054|NCT01710033|76187459|FG001|STARTED|Stage 1||6||
60072055|NCT01710033|76187460|FG002|STARTED|Stage 1||6||
60072056|NCT01710033|76187461|FG003|STARTED|Stage 1||6||
60072057|NCT01710033|76187462|FG004|STARTED|Stage 1||0||
60072058|NCT01710033|76187458|FG000|COMPLETED|Stage 1||6||
59764228|NCT00506077|75884213|FG000|NOT COMPLETED|Treatment Period 1||4||
59764229|NCT00506077|75884214|FG001|NOT COMPLETED|Treatment Period 1||3||
60072059|NCT01710033|76187459|FG001|COMPLETED|Stage 1||6||
59764230|NCT00506077|75884213|FG000|STARTED|Washout||24||
60072060|NCT01710033|76187460|FG002|COMPLETED|Stage 1||6||
60072061|NCT01710033|76187461|FG003|COMPLETED|Stage 1||6||
60072062|NCT01710033|76187462|FG004|COMPLETED|Stage 1||0||
59764231|NCT00506077|75884214|FG001|STARTED|Washout||24||
59764232|NCT00506077|75884213|FG000|COMPLETED|Washout||24||
59764233|NCT00506077|75884214|FG001|COMPLETED|Washout||24||
59764234|NCT00506077|75884213|FG000|NOT COMPLETED|Washout||0||
60072063|NCT01710033|76187458|FG000|NOT COMPLETED|Stage 1||0||
60072064|NCT01710033|76187459|FG001|NOT COMPLETED|Stage 1||0||
60072065|NCT01710033|76187460|FG002|NOT COMPLETED|Stage 1||0||
60072066|NCT01710033|76187461|FG003|NOT COMPLETED|Stage 1||0||
60072067|NCT01710033|76187462|FG004|NOT COMPLETED|Stage 1||0||
60072068|NCT01710033|76187458|FG000|STARTED|Stage 2||0||
60072069|NCT01710033|76187459|FG001|STARTED|Stage 2||0||
60072070|NCT01710033|76187460|FG002|STARTED|Stage 2||0||
60072071|NCT01710033|76187461|FG003|STARTED|Stage 2||0||
60072072|NCT01710033|76187462|FG004|STARTED|Stage 2||4||
60072073|NCT01710033|76187458|FG000|COMPLETED|Stage 2||0||
60072074|NCT01710033|76187459|FG001|COMPLETED|Stage 2||0||
60072075|NCT01710033|76187460|FG002|COMPLETED|Stage 2||0||
59764235|NCT00506077|75884214|FG001|NOT COMPLETED|Washout||0||
59764236|NCT00506077|75884213|FG000|STARTED|Treatment Period 2||24||
59764237|NCT00506077|75884214|FG001|STARTED|Treatment Period 2||24||
59764238|NCT00506077|75884213|FG000|COMPLETED|Treatment Period 2||23||
59764239|NCT00506077|75884214|FG001|COMPLETED|Treatment Period 2||23||
59764240|NCT00506077|75884213|FG000|NOT COMPLETED|Treatment Period 2||1||
59764241|NCT00506077|75884214|FG001|NOT COMPLETED|Treatment Period 2||1||
59764242|NCT00505921|75884220|FG000|STARTED|Overall Study||27||
59764243|NCT00505921|75884220|FG000|COMPLETED|Overall Study||18||
60072076|NCT01710033|76187461|FG003|COMPLETED|Stage 2||0||
60072077|NCT01710033|76187462|FG004|COMPLETED|Stage 2||3||
60072078|NCT01710033|76187458|FG000|NOT COMPLETED|Stage 2||0||
60072079|NCT01710033|76187459|FG001|NOT COMPLETED|Stage 2||0||
60072080|NCT01710033|76187460|FG002|NOT COMPLETED|Stage 2||0||
60072081|NCT01710033|76187461|FG003|NOT COMPLETED|Stage 2||0||
60072082|NCT01710033|76187462|FG004|NOT COMPLETED|Stage 2||1||
60072083|NCT01822496|76187479|FG000|STARTED|Overall Study||16||
60072084|NCT01822496|76187480|FG001|STARTED|Overall Study||23||
60072085|NCT01822496|76187481|FG002|STARTED|Overall Study||9||
60072086|NCT01822496|76187482|FG003|STARTED|Overall Study||11||
60072087|NCT01822496|76187479|FG000|Eligible|Overall Study||14||
60072088|NCT01822496|76187480|FG001|Eligible|Overall Study||21||
60072089|NCT01822496|76187481|FG002|Eligible|Overall Study||9||
60072090|NCT01822496|76187482|FG003|Eligible|Overall Study||7||
60072091|NCT01822496|76187479|FG000|Eligible With Disease Assessment|Overall Study||10||
60072092|NCT01822496|76187480|FG001|Eligible With Disease Assessment|Overall Study||15||
60072093|NCT01822496|76187481|FG002|Eligible With Disease Assessment|Overall Study||6||
60072094|NCT01822496|76187482|FG003|Eligible With Disease Assessment|Overall Study||4||
60072095|NCT01822496|76187479|FG000|Eligible and Started Study Treatment|Overall Study||14||
60072096|NCT01822496|76187480|FG001|Eligible and Started Study Treatment|Overall Study||20||
60072097|NCT01822496|76187481|FG002|Eligible and Started Study Treatment|Overall Study||9||
60072098|NCT01822496|76187482|FG003|Eligible and Started Study Treatment|Overall Study||7||
60072099|NCT01822496|76187479|FG000|COMPLETED|Overall Study||14|Subjects contributing any data to results are considered to have completed the study|
60072100|NCT01822496|76187480|FG001|COMPLETED|Overall Study||21|Subjects contributing any data to results are considered to have completed the study|
60072101|NCT01822496|76187481|FG002|COMPLETED|Overall Study||9|Subjects contributing any data to results are considered to have completed the study|
60072102|NCT01822496|76187482|FG003|COMPLETED|Overall Study||7|Subjects contributing any data to results are considered to have completed the study|
60072103|NCT01822496|76187479|FG000|NOT COMPLETED|Overall Study||2||
60072104|NCT01822496|76187480|FG001|NOT COMPLETED|Overall Study||2||
60072105|NCT01822496|76187481|FG002|NOT COMPLETED|Overall Study||0||
60072106|NCT01822496|76187482|FG003|NOT COMPLETED|Overall Study||4||
60072107|NCT01867047|76187494|FG000|STARTED|Overall Study||31||
60072108|NCT01867047|76187495|FG001|STARTED|Overall Study||28||
60072109|NCT01867047|76187494|FG000|COMPLETED|Overall Study||23||
60072110|NCT01867047|76187495|FG001|COMPLETED|Overall Study||23||
59764244|NCT00505921|75884220|FG000|NOT COMPLETED|Overall Study||9||
59764245|NCT00596960|75884226|FG000|STARTED|Overall Study||70||
59764246|NCT00596960|75884227|FG001|STARTED|Overall Study|One subject did not have any alcohol use data and thus was excluded from the statistical analysis|69||
59764247|NCT00596960|75884226|FG000|COMPLETED|Overall Study||59||
59764248|NCT00596960|75884227|FG001|COMPLETED|Overall Study||60||
59951922|NCT00835536|76070860|FG000|NOT COMPLETED|First Intervention||0||
59951923|NCT00835536|76070861|FG001|NOT COMPLETED|First Intervention||0||
59951924|NCT00835536|76070860|FG000|STARTED|Washout of 5 Weeks||13||
59951925|NCT00835536|76070861|FG001|STARTED|Washout of 5 Weeks||14||
59951926|NCT00835536|76070860|FG000|COMPLETED|Washout of 5 Weeks||12||
59951927|NCT00835536|76070861|FG001|COMPLETED|Washout of 5 Weeks||14||
59951928|NCT00835536|76070860|FG000|NOT COMPLETED|Washout of 5 Weeks||1||
59951929|NCT00835536|76070861|FG001|NOT COMPLETED|Washout of 5 Weeks||0||
59951930|NCT00835536|76070860|FG000|STARTED|Second Intervention||12||
59951931|NCT00835536|76070861|FG001|STARTED|Second Intervention||14||
59951932|NCT00835536|76070860|FG000|COMPLETED|Second Intervention||12||
59951933|NCT00835536|76070861|FG001|COMPLETED|Second Intervention||14||
59951934|NCT00835536|76070860|FG000|NOT COMPLETED|Second Intervention||0||
60072111|NCT01867047|76187494|FG000|NOT COMPLETED|Overall Study||8||
60072112|NCT01867047|76187495|FG001|NOT COMPLETED|Overall Study||5||
60072113|NCT01821560|76187507|FG000|STARTED|Overall Study||22||
60072114|NCT01821560|76187508|FG001|STARTED|Overall Study||22||
60072115|NCT01821560|76187507|FG000|COMPLETED|Overall Study||16||
60072116|NCT01821560|76187508|FG001|COMPLETED|Overall Study||15||
60072117|NCT01821560|76187507|FG000|NOT COMPLETED|Overall Study||6||
60072118|NCT01821560|76187508|FG001|NOT COMPLETED|Overall Study||7||
59764249|NCT00596960|75884226|FG000|NOT COMPLETED|Overall Study||11||
59764250|NCT00596960|75884227|FG001|NOT COMPLETED|Overall Study||9||
59764251|NCT00505765|75884236|FG000|STARTED|Overall Study||21||
59764252|NCT00505765|75884237|FG001|STARTED|Overall Study||20||
59764253|NCT00505765|75884238|FG002|STARTED|Overall Study||22||
60072119|NCT01871402|76187516|FG000|STARTED|Overall Study||110||
60072120|NCT01871402|76187517|FG001|STARTED|Overall Study||111||
60072121|NCT01871402|76187516|FG000|COMPLETED|Overall Study||109||
60072122|NCT01871402|76187517|FG001|COMPLETED|Overall Study||108||
60072123|NCT01871402|76187516|FG000|NOT COMPLETED|Overall Study||1||
60072124|NCT01871402|76187517|FG001|NOT COMPLETED|Overall Study||3||
60072125|NCT03901300|76187525|FG000|STARTED|Overall Study|Children were enrolled study participants. Parents were not study participants.|35||
60072126|NCT03901300|76187526|FG001|STARTED|Overall Study||37||
60072127|NCT03901300|76187525|FG000|COMPLETED|Overall Study||32||
60072128|NCT03901300|76187526|FG001|COMPLETED|Overall Study||37||
60072129|NCT03901300|76187525|FG000|NOT COMPLETED|Overall Study||3||
60072130|NCT03901300|76187526|FG001|NOT COMPLETED|Overall Study||0||
60072131|NCT01846442|76187536|FG000|STARTED|Overall Study||54||
60072132|NCT01846442|76187537|FG001|STARTED|Overall Study||54||
60072133|NCT01846442|76187538|FG002|STARTED|Overall Study||56||
60072134|NCT01846442|76187539|FG003|STARTED|Overall Study||54||
60072135|NCT01846442|76187536|FG000|Safety Population|Overall Study||54||
60072136|NCT01846442|76187537|FG001|Safety Population|Overall Study||53||
60072137|NCT01846442|76187538|FG002|Safety Population|Overall Study||56||
60072138|NCT01846442|76187539|FG003|Safety Population|Overall Study||54||
60072139|NCT01846442|76187536|FG000|ITT Population|Overall Study||53||
60072140|NCT01846442|76187537|FG001|ITT Population|Overall Study||53||
60072141|NCT01846442|76187538|FG002|ITT Population|Overall Study||56||
60072142|NCT01846442|76187539|FG003|ITT Population|Overall Study||54||
60072143|NCT01846442|76187536|FG000|COMPLETED|Overall Study||48||
60072144|NCT01846442|76187537|FG001|COMPLETED|Overall Study||48||
60072145|NCT01846442|76187538|FG002|COMPLETED|Overall Study||52||
60072146|NCT01846442|76187539|FG003|COMPLETED|Overall Study||51||
60072147|NCT01846442|76187536|FG000|NOT COMPLETED|Overall Study||6||
60072148|NCT01846442|76187537|FG001|NOT COMPLETED|Overall Study||6||
60072149|NCT01846442|76187538|FG002|NOT COMPLETED|Overall Study||4||
60072150|NCT01846442|76187539|FG003|NOT COMPLETED|Overall Study||3||
60072151|NCT01709721|76187552|FG000|STARTED|Open Label Phase||41|The purpose of the 12-week Open Label Phase of the trial is to titrate subjects to an optimal dose of hydromorphone hydrochloride and demonstrate the ability to maintain adequate pain relief in subjects requiring intrathecal opioid therapy.|
60072152|NCT01709721|76187553|FG001|STARTED|Open Label Phase||40|The purpose of the 12-week Open Label Phase of the trial is to titrate subjects to an optimal dose of hydromorphone hydrochloride and demonstrate the ability to maintain adequate pain relief in subjects requiring intrathecal opioid therapy.|
60072153|NCT01709721|76187554|FG002|STARTED|Open Label Phase||72|The purpose of the 12-week Open Label Phase of the trial is to titrate subjects to an optimal dose of hydromorphone hydrochloride and demonstrate the ability to maintain adequate pain relief in subjects requiring intrathecal opioid therapy.|
60072154|NCT01709721|76187552|FG000|COMPLETED|Open Label Phase||41||
60072155|NCT01709721|76187553|FG001|COMPLETED|Open Label Phase||40||
60072156|NCT01709721|76187554|FG002|COMPLETED|Open Label Phase||0||
60072157|NCT01709721|76187552|FG000|NOT COMPLETED|Open Label Phase||0||
59764254|NCT00505765|75884236|FG000|Mid-Point Assessment|Overall Study||20||
59764255|NCT00505765|75884237|FG001|Mid-Point Assessment|Overall Study||19||
59764256|NCT00505765|75884238|FG002|Mid-Point Assessment|Overall Study||21||
59764257|NCT00505765|75884236|FG000|COMPLETED|Overall Study||19||
59764258|NCT00505765|75884237|FG001|COMPLETED|Overall Study||17||
59764259|NCT00505765|75884238|FG002|COMPLETED|Overall Study||19||
59764260|NCT00505765|75884236|FG000|NOT COMPLETED|Overall Study||2||
59764261|NCT00505765|75884237|FG001|NOT COMPLETED|Overall Study||3||
59764262|NCT00505765|75884238|FG002|NOT COMPLETED|Overall Study||3||
59764263|NCT00505687|75884246|FG000|STARTED|Overall Study||186||
59764264|NCT00505687|75884246|FG000|COMPLETED|Overall Study||91||
59764265|NCT00505687|75884246|FG000|NOT COMPLETED|Overall Study||95||
59764266|NCT00505375|75884252|FG000|STARTED|Overall Study||77||
59764267|NCT00505375|75884253|FG001|STARTED|Overall Study||35||
59764268|NCT00505375|75884252|FG000|COMPLETED|Overall Study||73||
59764269|NCT00505375|75884253|FG001|COMPLETED|Overall Study||30||
59764270|NCT00505375|75884252|FG000|NOT COMPLETED|Overall Study||4||
59764271|NCT00505375|75884253|FG001|NOT COMPLETED|Overall Study||5||
59764272|NCT00594932|75884261|FG000|STARTED|First 3 Months||13||
59764273|NCT00594932|75884262|FG001|STARTED|First 3 Months||14||
60072158|NCT01709721|76187553|FG001|NOT COMPLETED|Open Label Phase||0||
60072159|NCT01709721|76187554|FG002|NOT COMPLETED|Open Label Phase||72||
59764274|NCT00594932|75884261|FG000|COMPLETED|First 3 Months||12||
59764275|NCT00594932|75884262|FG001|COMPLETED|First 3 Months||11||
59764276|NCT00594932|75884261|FG000|NOT COMPLETED|First 3 Months||1||
60072160|NCT01709721|76187552|FG000|STARTED|Randomized Phase||41|At the end of the Open Label Phase (ie, the 12 week chronic dosing period), subjects who meet criteria for randomization will be assigned to either remain at their current dose of hydromorphone hydrochloride or to have their dose titrated downward (control group) in a blinded fashion.|
59764277|NCT00594932|75884262|FG001|NOT COMPLETED|First 3 Months||3||
59764278|NCT00594932|75884261|FG000|STARTED|Final 3 Months||12||
60072161|NCT01709721|76187553|FG001|STARTED|Randomized Phase||40|At the end of the Open Label Phase (ie, the 12 week chronic dosing period), subjects who meet criteria for randomization will be assigned to either remain at their current dose of hydromorphone hydrochloride or to have their dose titrated downward (control group) in a blinded fashion.|
60072162|NCT01709721|76187554|FG002|STARTED|Randomized Phase||0|At the end of the Open Label Phase (ie, the 12 week chronic dosing period), subjects who meet criteria for randomization will be assigned to either remain at their current dose of hydromorphone hydrochloride or to have their dose titrated downward (control group) in a blinded fashion.|
60072163|NCT01709721|76187552|FG000|COMPLETED|Randomized Phase||38||
60072164|NCT01709721|76187553|FG001|COMPLETED|Randomized Phase||34||
59764279|NCT00594932|75884262|FG001|STARTED|Final 3 Months||11||
59764280|NCT00594932|75884261|FG000|COMPLETED|Final 3 Months||8||
59764281|NCT00594932|75884262|FG001|COMPLETED|Final 3 Months||8||
59764282|NCT00594932|75884261|FG000|NOT COMPLETED|Final 3 Months||4||
59764283|NCT00594932|75884262|FG001|NOT COMPLETED|Final 3 Months||3||
59764284|NCT00504829|75884271|FG000|STARTED|Overall Study||73||
60072165|NCT01709721|76187554|FG002|COMPLETED|Randomized Phase||0||
60072166|NCT01709721|76187552|FG000|NOT COMPLETED|Randomized Phase||3||
60072167|NCT01709721|76187553|FG001|NOT COMPLETED|Randomized Phase||6||
60072168|NCT01709721|76187554|FG002|NOT COMPLETED|Randomized Phase||0||
60072169|NCT01866657|76187564|FG000|STARTED|Overall Study||38||
60072170|NCT01866657|76187565|FG001|STARTED|Overall Study||36||
60072171|NCT01866657|76187564|FG000|COMPLETED|Overall Study||36||
60072172|NCT01866657|76187565|FG001|COMPLETED|Overall Study||36||
60072173|NCT01866657|76187564|FG000|NOT COMPLETED|Overall Study||2||
60072174|NCT01866657|76187565|FG001|NOT COMPLETED|Overall Study||0||
60072175|NCT01700205|76187573|FG000|STARTED|Overall Study|Mother-Infant Dyads|59||
60072176|NCT01700205|76187574|FG001|STARTED|Overall Study|Mother-Infant Dyads|54||
60072177|NCT01700205|76187573|FG000|COMPLETED|Overall Study|Mother-Infant Dyads|44||
60072178|NCT01700205|76187574|FG001|COMPLETED|Overall Study|Mother-Infant Dyads|39||
60072179|NCT01700205|76187573|FG000|NOT COMPLETED|Overall Study||15||
60072180|NCT01700205|76187574|FG001|NOT COMPLETED|Overall Study||15||
60072181|NCT01700049|76187580|FG000|STARTED|Overall Study||28||
60072182|NCT01700049|76187580|FG000|COMPLETED|Overall Study||27||
60072183|NCT01700049|76187580|FG000|NOT COMPLETED|Overall Study||1||
60072184|NCT01699815|76187587|FG000|STARTED|Overall Study||62||
60072185|NCT01699815|76187588|FG001|STARTED|Overall Study||64||
60072186|NCT01699815|76187587|FG000|COMPLETED|Overall Study||57||
60072187|NCT01699815|76187588|FG001|COMPLETED|Overall Study||56||
60072188|NCT01699815|76187587|FG000|NOT COMPLETED|Overall Study||5||
59764285|NCT00504829|75884272|FG001|STARTED|Overall Study||74||
60072189|NCT01699815|76187588|FG001|NOT COMPLETED|Overall Study||8||
60072190|NCT01866423|76187594|FG000|STARTED|Overall Study||4||
60072191|NCT01866423|76187594|FG000|COMPLETED|Overall Study||0||
59520634|NCT01167595|75614673|FG001|STARTED|Overall Study||537||9
59520635|NCT01167595|75614672|FG000|COMPLETED|Overall Study||522||9
59520636|NCT01167595|75614673|FG001|COMPLETED|Overall Study||537||9
59520637|NCT01167595|75614672|FG000|NOT COMPLETED|Overall Study||0||0
59520638|NCT01167595|75614673|FG001|NOT COMPLETED|Overall Study||0||0
60072192|NCT01866423|76187594|FG000|NOT COMPLETED|Overall Study||4||
60072193|NCT01846208|76187601|FG000|STARTED|Overall Study||28||
60072194|NCT01846208|76187602|FG001|STARTED|Overall Study||24||
60072195|NCT01846208|76187603|FG002|STARTED|Overall Study||40||
59520639|NCT03835078|75614679|FG000|STARTED|Overall Study||39||
59520640|NCT03835078|75614679|FG000|COMPLETED|Overall Study||39||
59520641|NCT03835078|75614679|FG000|NOT COMPLETED|Overall Study||0||
59520642|NCT02184169|75614687|FG000|STARTED|Overall Study||21||
59520643|NCT02184169|75614688|FG001|STARTED|Overall Study||6||
59520644|NCT02184169|75614687|FG000|COMPLETED|Overall Study||21||
59520645|NCT02184169|75614688|FG001|COMPLETED|Overall Study||6||
59520646|NCT02184169|75614687|FG000|NOT COMPLETED|Overall Study||0||
59520647|NCT02184169|75614688|FG001|NOT COMPLETED|Overall Study||0||
59520648|NCT03681886|75614696|FG000|STARTED|Overall Study||78||100
60072196|NCT01846208|76187601|FG000|Initiatiated Treatment|Overall Study||27||
60072197|NCT01846208|76187602|FG001|Initiatiated Treatment|Overall Study||23||
59520649|NCT03681886|75614696|FG000|Successful Implantation|Overall Study||76||98
59520650|NCT03681886|75614696|FG000|Failed Implantation|Overall Study||2||2
59520651|NCT03681886|75614696|FG000|Underwent Optic Exchange|Overall Study||4||4
59520652|NCT03681886|75614696|FG000|COMPLETED|Overall Study||76||98
59520653|NCT03681886|75614696|FG000|NOT COMPLETED|Overall Study||2||2
59520654|NCT01167829|75614717|FG000|STARTED|Overall Study||12||
59520655|NCT01167829|75614717|FG000|COMPLETED|Overall Study||12||
59520656|NCT01167829|75614717|FG000|NOT COMPLETED|Overall Study||0||
59520657|NCT03820258|75614723|FG000|STARTED|Overall Study||21||
59520658|NCT03820258|75614723|FG000|COMPLETED|Overall Study||21||
59520659|NCT03820258|75614723|FG000|NOT COMPLETED|Overall Study||0||
59520660|NCT04195594|75614727|FG000|STARTED|Overall Study||14||
59520661|NCT04195594|75614727|FG000|COMPLETED|Overall Study||11||
59520662|NCT04195594|75614727|FG000|NOT COMPLETED|Overall Study||3||
59764286|NCT00504829|75884273|FG002|STARTED|Overall Study||73||
59764287|NCT00504829|75884271|FG000|COMPLETED|Overall Study||67||
59764288|NCT00504829|75884272|FG001|COMPLETED|Overall Study||70||
59764289|NCT00504829|75884273|FG002|COMPLETED|Overall Study||63||
59520663|NCT01168687|75614733|FG000|STARTED|Overall Study||23||
59520664|NCT01168687|75614734|FG001|STARTED|Overall Study||23||
59520665|NCT01168687|75614733|FG000|COMPLETED|Overall Study||23||
59520666|NCT01168687|75614734|FG001|COMPLETED|Overall Study||23||
59520667|NCT01168687|75614733|FG000|NOT COMPLETED|Overall Study||0||
59520668|NCT01168687|75614734|FG001|NOT COMPLETED|Overall Study||0||
60072198|NCT01846208|76187603|FG002|Initiatiated Treatment|Overall Study||39||
60072199|NCT01846208|76187601|FG000|Year 1 Desensitization OFC|Overall Study||23|OFC = oral food challenge|
60072200|NCT01846208|76187602|FG001|Year 1 Desensitization OFC|Overall Study||20|OFC = oral food challenge|
60072201|NCT01846208|76187603|FG002|Year 1 Desensitization OFC|Overall Study||34|OFC = oral food challenge|
60072202|NCT01846208|76187601|FG000|Year 2 Desensitization OFC|Overall Study||19|Completed Year 2 desensitization oral food challenge|
60072203|NCT01846208|76187602|FG001|Year 2 Desensitization OFC|Overall Study||20|Completed Year 2 desensitization oral food challenge|
60072204|NCT01846208|76187603|FG002|Year 2 Desensitization OFC|Overall Study||33|Completed Year 2 desensitization oral food challenge|
60072205|NCT01846208|76187601|FG000|Year 2 Sustained Unresponsiveness OFC|Overall Study||4|Completed Year 2 sustained unresponsiveness oral food challenge (SU OFC)|
60072206|NCT01846208|76187602|FG001|Year 2 Sustained Unresponsiveness OFC|Overall Study||18|Completed Year 2 sustained unresponsiveness oral food challenge (SU OFC)|
60072207|NCT01846208|76187603|FG002|Year 2 Sustained Unresponsiveness OFC|Overall Study||21|Completed Year 2 sustained unresponsiveness oral food challenge (SU OFC)|
60072208|NCT01846208|76187601|FG000|COMPLETED|Overall Study||19||
59520669|NCT03685396|75614742|FG000|STARTED|Overall Study||21||
60072209|NCT01846208|76187602|FG001|COMPLETED|Overall Study||20||
60072210|NCT01846208|76187603|FG002|COMPLETED|Overall Study||32||
59520670|NCT03685396|75614743|FG001|STARTED|Overall Study||21||
59520671|NCT03685396|75614742|FG000|COMPLETED|Overall Study||21||
59520672|NCT03685396|75614743|FG001|COMPLETED|Overall Study||21||
59520673|NCT03685396|75614742|FG000|NOT COMPLETED|Overall Study||0||
59520674|NCT03685396|75614743|FG001|NOT COMPLETED|Overall Study||0||
59520675|NCT04214080|75614751|FG000|STARTED|Overall Study||20||
59520676|NCT04214080|75614752|FG001|STARTED|Overall Study||20||
59520677|NCT04214080|75614751|FG000|COMPLETED|Overall Study||20||
59520678|NCT04214080|75614752|FG001|COMPLETED|Overall Study||20||
59520679|NCT04214080|75614751|FG000|NOT COMPLETED|Overall Study||0||
59520680|NCT04214080|75614752|FG001|NOT COMPLETED|Overall Study||0||
59520681|NCT01169311|75614760|FG000|STARTED|Overall Study||27||
60072211|NCT01846208|76187601|FG000|NOT COMPLETED|Overall Study||9||
60072212|NCT01846208|76187602|FG001|NOT COMPLETED|Overall Study||4||
60072213|NCT01846208|76187603|FG002|NOT COMPLETED|Overall Study||8||
60072214|NCT01845974|76187613|FG000|STARTED|Overall Study||4||
60072215|NCT01845974|76187614|FG001|STARTED|Overall Study||9||
60072216|NCT01845974|76187613|FG000|COMPLETED|Overall Study||3||
59520682|NCT01169311|75614760|FG000|COMPLETED|Overall Study||27||
59520683|NCT01169311|75614760|FG000|NOT COMPLETED|Overall Study||0||
59520684|NCT03688282|75614765|FG000|STARTED|Sham Treatment for 30 Minutes||18||
59617591|NCT01387932|75728739|FG001|COMPLETED|Randomized and Treated||113||
59617592|NCT01387932|75728738|FG000|NOT COMPLETED|Randomized and Treated||7||
59617593|NCT01387932|75728739|FG001|NOT COMPLETED|Randomized and Treated||4||
59617594|NCT01387932|75728738|FG000|STARTED|Completion of TACE Cycle||111||
59617595|NCT01387932|75728739|FG001|STARTED|Completion of TACE Cycle||113||
59617596|NCT01387932|75728738|FG000|COMPLETED|Completion of TACE Cycle||111|One hundred percent of the hqTACE arm and 100% of the cTACE arm received their first TACE Cycle.|
59617597|NCT01387932|75728739|FG001|COMPLETED|Completion of TACE Cycle||113|One hundred percent of the hqTACE arm and 100% of the cTACE arm received their first TACE Cycle.|
59617598|NCT01387932|75728738|FG000|NOT COMPLETED|Completion of TACE Cycle||0||
59617599|NCT01387932|75728739|FG001|NOT COMPLETED|Completion of TACE Cycle||0||
59617600|NCT01387932|75728738|FG000|STARTED|Survival Follow-up||111|All subjects that completed at least one TACE cycle were eligible for long-term survival follow-up.|
59617601|NCT01387932|75728739|FG001|STARTED|Survival Follow-up||113|All subjects that completed at least one TACE cycle were eligible for long-term survival follow-up.|
59617602|NCT01387932|75728738|FG000|COMPLETED|Survival Follow-up||27||
59617603|NCT01387932|75728739|FG001|COMPLETED|Survival Follow-up||23||
59617604|NCT01387932|75728738|FG000|NOT COMPLETED|Survival Follow-up||84||
59617605|NCT01387932|75728739|FG001|NOT COMPLETED|Survival Follow-up||90||
59617606|NCT01422408|75728747|FG000|STARTED|Overall Study||34||
59617607|NCT01422408|75728747|FG000|COMPLETED|Overall Study||30||
59617608|NCT01422408|75728747|FG000|NOT COMPLETED|Overall Study||4||
59617609|NCT01399788|75728751|FG000|STARTED|First Intervention Period||18||
59617610|NCT01399788|75728752|FG001|STARTED|First Intervention Period||18||
59617611|NCT01399788|75728751|FG000|COMPLETED|First Intervention Period||17||
59617612|NCT01399788|75728752|FG001|COMPLETED|First Intervention Period||18||
59709501|NCT00907153|75828243|FG000|NOT COMPLETED|Overall Study||2||
59764290|NCT00504829|75884271|FG000|NOT COMPLETED|Overall Study||6||
59764291|NCT00504829|75884272|FG001|NOT COMPLETED|Overall Study||4||
59764292|NCT00504829|75884273|FG002|NOT COMPLETED|Overall Study||10||
59764293|NCT00504595|75884285|FG000|STARTED|Overall Study||50||
59764294|NCT00504595|75884286|FG001|STARTED|Overall Study||10||
59764295|NCT00504595|75884287|FG002|STARTED|Overall Study||10||
59764296|NCT00504595|75884288|FG003|STARTED|Overall Study||10||
59764297|NCT00504595|75884285|FG000|COMPLETED|Overall Study||49||
59764298|NCT00504595|75884286|FG001|COMPLETED|Overall Study||10||
59764299|NCT00504595|75884287|FG002|COMPLETED|Overall Study||8||
59764300|NCT00504595|75884288|FG003|COMPLETED|Overall Study||10||
59764301|NCT00504595|75884285|FG000|NOT COMPLETED|Overall Study||1||
59764302|NCT00504595|75884286|FG001|NOT COMPLETED|Overall Study||0||
59764303|NCT00504595|75884287|FG002|NOT COMPLETED|Overall Study||2||
59951935|NCT00835536|76070861|FG001|NOT COMPLETED|Second Intervention||0||
59951936|NCT03865316|76070865|FG000|STARTED|Overall Study||108||
59951937|NCT03865316|76070865|FG000|COMPLETED|Overall Study||100||
59951938|NCT03865316|76070865|FG000|NOT COMPLETED|Overall Study||8||
59951939|NCT02598076|76070871|FG000|STARTED|Overall Study||31||
59951940|NCT02598076|76070872|FG001|STARTED|Overall Study||29||
59951941|NCT02598076|76070871|FG000|COMPLETED|Overall Study||29||
59951942|NCT02598076|76070872|FG001|COMPLETED|Overall Study||26||
59951943|NCT02598076|76070871|FG000|NOT COMPLETED|Overall Study||2||
59951944|NCT02598076|76070872|FG001|NOT COMPLETED|Overall Study||3||
59951945|NCT02602288|76070880|FG000|STARTED|End of Treatment/3 Month Follow-up||199||
59951946|NCT02602288|76070881|FG001|STARTED|End of Treatment/3 Month Follow-up||197||
59951947|NCT02602288|76070880|FG000|COMPLETED|End of Treatment/3 Month Follow-up||174||
59951948|NCT02602288|76070881|FG001|COMPLETED|End of Treatment/3 Month Follow-up||179||
59951949|NCT02602288|76070880|FG000|NOT COMPLETED|End of Treatment/3 Month Follow-up||25||
59951950|NCT02602288|76070881|FG001|NOT COMPLETED|End of Treatment/3 Month Follow-up||18||
59951951|NCT02602288|76070880|FG000|STARTED|12 Month Follow-up||174||
59951952|NCT02602288|76070881|FG001|STARTED|12 Month Follow-up||179||
59951953|NCT02602288|76070880|FG000|COMPLETED|12 Month Follow-up||172||
59951954|NCT02602288|76070881|FG001|COMPLETED|12 Month Follow-up||175||
59951955|NCT02602288|76070880|FG000|NOT COMPLETED|12 Month Follow-up||2||
59951956|NCT02602288|76070881|FG001|NOT COMPLETED|12 Month Follow-up||4||
59994865|NCT02732119|76110684|FG001|STARTED|Phase II||0||
59994866|NCT02732119|76110685|FG002|STARTED|Phase II||0||
59994867|NCT02732119|76110686|FG003|STARTED|Phase II||46||
59994868|NCT02732119|76110687|FG004|STARTED|Phase II||33||
59994869|NCT02732119|76110683|FG000|Protocol Analysis Set|Phase II||0|One patient had a major protocol deviation in Group II|
59994870|NCT02732119|76110684|FG001|Protocol Analysis Set|Phase II||0|One patient had a major protocol deviation in Group II|
59994871|NCT02732119|76110685|FG002|Protocol Analysis Set|Phase II||0|One patient had a major protocol deviation in Group II|
59994872|NCT02732119|76110686|FG003|Protocol Analysis Set|Phase II||46|One patient had a major protocol deviation in Group II|
59994873|NCT02732119|76110687|FG004|Protocol Analysis Set|Phase II||32|One patient had a major protocol deviation in Group II|
59994874|NCT02732119|76110683|FG000|COMPLETED|Phase II||0||
59994875|NCT02732119|76110684|FG001|COMPLETED|Phase II||0||
59994876|NCT02732119|76110685|FG002|COMPLETED|Phase II||0||
59994877|NCT02732119|76110686|FG003|COMPLETED|Phase II||0||
59994878|NCT02732119|76110687|FG004|COMPLETED|Phase II||0||
59994879|NCT02732119|76110683|FG000|NOT COMPLETED|Phase II||0||
59994880|NCT02732119|76110684|FG001|NOT COMPLETED|Phase II||0||
59994881|NCT02732119|76110685|FG002|NOT COMPLETED|Phase II||0||
59994882|NCT02732119|76110686|FG003|NOT COMPLETED|Phase II||46||
59994883|NCT02732119|76110687|FG004|NOT COMPLETED|Phase II||33||
59994884|NCT03660865|76110701|FG000|STARTED|Overall Study||105||105
59994885|NCT03660865|76110702|FG001|STARTED|Overall Study||105||105
59994886|NCT03660865|76110701|FG000|COMPLETED|Overall Study||105||105
59994887|NCT03660865|76110702|FG001|COMPLETED|Overall Study||105||105
59994888|NCT03660865|76110701|FG000|NOT COMPLETED|Overall Study||0||0
59994889|NCT03660865|76110702|FG001|NOT COMPLETED|Overall Study||0||0
59994890|NCT03252925|76110710|FG000|STARTED|Overall Study||80||
59994891|NCT03252925|76110711|FG001|STARTED|Overall Study||80||
59994892|NCT03252925|76110710|FG000|COMPLETED|Overall Study||66||
59994893|NCT03252925|76110711|FG001|COMPLETED|Overall Study||74||
59994894|NCT03252925|76110710|FG000|NOT COMPLETED|Overall Study||14||
59994895|NCT03252925|76110711|FG001|NOT COMPLETED|Overall Study||6||
59994896|NCT01327885|76110719|FG000|STARTED|Overall Study||228||
59994897|NCT01327885|76110720|FG001|STARTED|Overall Study||224||
59994898|NCT01327885|76110719|FG000|COMPLETED|Overall Study||0||
59994899|NCT01327885|76110720|FG001|COMPLETED|Overall Study||0||
59994900|NCT01327885|76110719|FG000|NOT COMPLETED|Overall Study||228||
59994901|NCT01327885|76110720|FG001|NOT COMPLETED|Overall Study||224||
59994902|NCT03099863|76110729|FG000|STARTED|Overall Study||121||
59994903|NCT03099863|76110730|FG001|STARTED|Overall Study||121||
59994904|NCT03099863|76110729|FG000|COMPLETED|Overall Study||111||
59994905|NCT03099863|76110730|FG001|COMPLETED|Overall Study||105||
59994906|NCT03099863|76110729|FG000|NOT COMPLETED|Overall Study||10||
59951957|NCT02601820|76070887|FG000|STARTED|Pre-Treatment (T1)|1601 patients were enrolled and completed Baseline PROs (T1).|1601||
59951958|NCT02601820|76070887|FG000|COMPLETED|Pre-Treatment (T1)||1601||
59951959|NCT02601820|76070887|FG000|NOT COMPLETED|Pre-Treatment (T1)||0||
59951960|NCT02601820|76070887|FG000|STARTED|Early On-Treatment (T2)|Of 1601, 17 were excluded at T2 due to death, withdrawal, other reason. 1584 remained in the study.|1584||
59951961|NCT02601820|76070887|FG000|COMPLETED|Early On-Treatment (T2)|Of 1584, 51 were excluded for a missing T2 record. 1533 provided data at T2. Some outcomes missing.|1533||
59951962|NCT02601820|76070887|FG000|NOT COMPLETED|Early On-Treatment (T2)||51||
59951963|NCT02601820|76070887|FG000|STARTED|Late On-Treatment (T3)|Of 1601, 28 were excluded at T3 due to death, withdrawal, other reason. 1573 remained in the study.|1573||
59951964|NCT02601820|76070887|FG000|COMPLETED|Late On-Treatment (T3)|Of 1573, 49 were excluded for a missing T3 record. 1524 provided data at T3. Some outcomes missing.|1524||
59951965|NCT02601820|76070887|FG000|NOT COMPLETED|Late On-Treatment (T3)||49||
59951966|NCT02601820|76070887|FG000|STARTED|12 Weeks Post-Treatment (T4)|Of 1601, 37 were excluded at T4 due to death, withdrawal, other reason. 1564 remained in the study.|1564||
59951967|NCT02601820|76070887|FG000|COMPLETED|12 Weeks Post-Treatment (T4)|Of 1564, 3 were excluded for a missing T4 record. 1561 provided data at T4. Some outcomes missing.|1561||
59951968|NCT02601820|76070887|FG000|NOT COMPLETED|12 Weeks Post-Treatment (T4)||3||
59951969|NCT02601820|76070887|FG000|STARTED|1-Yr Post-Treatment (T5)|Of 1601, 73 were excluded at T5 due to death, withdrawal, other reason. 1528 remained in the study.|1528||
59951970|NCT02601820|76070887|FG000|COMPLETED|1-Yr Post-Treatment (T5)|Of 1528, 88 were excluded for a missing T5 record. 1440 provided data at T5. Some outcomes missing.|1440||
59951971|NCT02601820|76070887|FG000|NOT COMPLETED|1-Yr Post-Treatment (T5)||88||
59951972|NCT02807454|76070906|FG000|STARTED|Overall Study||32||
59951973|NCT02807454|76070907|FG001|STARTED|Overall Study||5||
59951974|NCT02807454|76070906|FG000|Participants in the D2 Arm Who Also Received Pomalidomide + Dexamethasone|Overall Study||7||
59951975|NCT02807454|76070907|FG001|Participants in the D2 Arm Who Also Received Pomalidomide + Dexamethasone|Overall Study||0||
59951976|NCT02807454|76070906|FG000|COMPLETED|Overall Study||0||
59951977|NCT02807454|76070907|FG001|COMPLETED|Overall Study||0||
59951978|NCT02807454|76070906|FG000|NOT COMPLETED|Overall Study||32||
59951979|NCT02807454|76070907|FG001|NOT COMPLETED|Overall Study||5||
59951980|NCT02597920|76070922|FG000|STARTED|Overall Study|Information about study termination is not available for 1 subject.|585||
59951981|NCT02597920|76070923|FG001|STARTED|Overall Study||1159||
59951982|NCT02597920|76070924|FG002|STARTED|Overall Study||78||
59951983|NCT02597920|76070922|FG000|COMPLETED|Overall Study||544||
59951984|NCT02597920|76070923|FG001|COMPLETED|Overall Study||1075||
59951985|NCT02597920|76070924|FG002|COMPLETED|Overall Study||72||
59951986|NCT02597920|76070922|FG000|NOT COMPLETED|Overall Study||41||
59951987|NCT02597920|76070923|FG001|NOT COMPLETED|Overall Study||84||
59951988|NCT02597920|76070924|FG002|NOT COMPLETED|Overall Study||6||
59951989|NCT00835146|76070936|FG000|STARTED|First Intervention||14||
59951990|NCT00835146|76070937|FG001|STARTED|First Intervention||14||
59951991|NCT00835146|76070936|FG000|COMPLETED|First Intervention||14||
59951992|NCT00835146|76070937|FG001|COMPLETED|First Intervention||14||
59951993|NCT00835146|76070936|FG000|NOT COMPLETED|First Intervention||0||
59951994|NCT00835146|76070937|FG001|NOT COMPLETED|First Intervention||0||
59951995|NCT00835146|76070936|FG000|STARTED|Washout of 5 Weeks||14||
59951996|NCT00835146|76070937|FG001|STARTED|Washout of 5 Weeks||14||
59951997|NCT00835146|76070936|FG000|COMPLETED|Washout of 5 Weeks||14||
59951998|NCT00835146|76070937|FG001|COMPLETED|Washout of 5 Weeks||14||
59951999|NCT00835146|76070936|FG000|NOT COMPLETED|Washout of 5 Weeks||0||
59952000|NCT00835146|76070937|FG001|NOT COMPLETED|Washout of 5 Weeks||0||
59952001|NCT00835146|76070936|FG000|STARTED|Second Intervention||14||
59952002|NCT00835146|76070937|FG001|STARTED|Second Intervention||14||
59952003|NCT00835146|76070936|FG000|COMPLETED|Second Intervention||14||
59952004|NCT00835146|76070937|FG001|COMPLETED|Second Intervention||14||
59952005|NCT00835146|76070936|FG000|NOT COMPLETED|Second Intervention||0||
59952006|NCT00835146|76070937|FG001|NOT COMPLETED|Second Intervention||0||
59952007|NCT01235234|76070944|FG000|STARTED|Overall Study||77||
59952008|NCT01235234|76070945|FG001|STARTED|Overall Study||78||
59952009|NCT01235234|76070946|FG002|STARTED|Overall Study||81||
59952010|NCT01235234|76070944|FG000|COMPLETED|Overall Study||75||
59952011|NCT01235234|76070945|FG001|COMPLETED|Overall Study||76||
59952012|NCT01235234|76070946|FG002|COMPLETED|Overall Study||80||
59952013|NCT01235234|76070944|FG000|NOT COMPLETED|Overall Study||2||
59952014|NCT01235234|76070945|FG001|NOT COMPLETED|Overall Study||2||
59952015|NCT01235234|76070946|FG002|NOT COMPLETED|Overall Study||1||
59952016|NCT00834990|76070956|FG000|STARTED|First Intervention||12||
59952017|NCT00834990|76070957|FG001|STARTED|First Intervention||11||
59952018|NCT00834990|76070956|FG000|COMPLETED|First Intervention||12||
59952019|NCT00834990|76070957|FG001|COMPLETED|First Intervention||11||
59952020|NCT00834990|76070956|FG000|NOT COMPLETED|First Intervention||0||
59952021|NCT00834990|76070957|FG001|NOT COMPLETED|First Intervention||0||
59952022|NCT00834990|76070956|FG000|STARTED|Washout of 7 Days||12||
59952023|NCT00834990|76070957|FG001|STARTED|Washout of 7 Days||11||
59952024|NCT00834990|76070956|FG000|COMPLETED|Washout of 7 Days||12||
59952025|NCT00834990|76070957|FG001|COMPLETED|Washout of 7 Days||11||
59952026|NCT00834990|76070956|FG000|NOT COMPLETED|Washout of 7 Days||0||
59952027|NCT00834990|76070957|FG001|NOT COMPLETED|Washout of 7 Days||0||
59952028|NCT00834990|76070956|FG000|STARTED|Second Intervention||12||
60072217|NCT01845974|76187614|FG001|COMPLETED|Overall Study||9||
60072218|NCT01845974|76187613|FG000|NOT COMPLETED|Overall Study||1||
60072219|NCT01845974|76187614|FG001|NOT COMPLETED|Overall Study||0||
59764304|NCT00504595|75884288|FG003|NOT COMPLETED|Overall Study||0||
59764305|NCT00513409|75884300|FG000|STARTED|Overall Study||84||
59764306|NCT00513409|75884301|FG001|STARTED|Overall Study||79||
59764307|NCT00513409|75884300|FG000|COMPLETED|Overall Study||82||
59764308|NCT00513409|75884301|FG001|COMPLETED|Overall Study||73||
59764309|NCT00513409|75884300|FG000|NOT COMPLETED|Overall Study||2||
60072220|NCT01865487|76187626|FG000|STARTED|Overall Study||15||
60072221|NCT01865487|76187627|FG001|STARTED|Overall Study||15||
59764310|NCT00513409|75884301|FG001|NOT COMPLETED|Overall Study||6||
59764311|NCT03150095|75884309|FG000|STARTED|Overall Study||30||
59764312|NCT03150095|75884310|FG001|STARTED|Overall Study||30||
59764313|NCT03150095|75884309|FG000|COMPLETED|Overall Study||21||
59764314|NCT03150095|75884310|FG001|COMPLETED|Overall Study||28||
59764315|NCT03150095|75884309|FG000|NOT COMPLETED|Overall Study||9||
60072222|NCT01865487|76187628|FG002|STARTED|Overall Study||15||
60072223|NCT01865487|76187629|FG003|STARTED|Overall Study||5||
60072224|NCT01865487|76187630|FG004|STARTED|Overall Study||12||
60072225|NCT01865487|76187631|FG005|STARTED|Overall Study||4||
60072226|NCT01865487|76187632|FG006|STARTED|Overall Study||12||
60072227|NCT01865487|76187633|FG007|STARTED|Overall Study||4||
60072228|NCT01865487|76187634|FG008|STARTED|Overall Study||12||
60072229|NCT01865487|76187635|FG009|STARTED|Overall Study||4||
60072230|NCT01865487|76187626|FG000|COMPLETED|Overall Study||15||
60072231|NCT01865487|76187627|FG001|COMPLETED|Overall Study||15||
60072232|NCT01865487|76187628|FG002|COMPLETED|Overall Study||15||
60072233|NCT01865487|76187629|FG003|COMPLETED|Overall Study||4||
60072234|NCT01865487|76187630|FG004|COMPLETED|Overall Study||11||
60072235|NCT01865487|76187631|FG005|COMPLETED|Overall Study||4||
60072236|NCT01865487|76187632|FG006|COMPLETED|Overall Study||11||
60072237|NCT01865487|76187633|FG007|COMPLETED|Overall Study||4||
60072238|NCT01865487|76187634|FG008|COMPLETED|Overall Study||12||
60072239|NCT01865487|76187635|FG009|COMPLETED|Overall Study||4||
60072240|NCT01865487|76187626|FG000|NOT COMPLETED|Overall Study||0||
60072241|NCT01865487|76187627|FG001|NOT COMPLETED|Overall Study||0||
59764316|NCT03150095|75884310|FG001|NOT COMPLETED|Overall Study||2||
59764317|NCT00705016|75884319|FG000|STARTED|Overall Study||62||
59764318|NCT00705016|75884320|FG001|STARTED|Overall Study||60||
60072242|NCT01865487|76187628|FG002|NOT COMPLETED|Overall Study||0||
60072243|NCT01865487|76187629|FG003|NOT COMPLETED|Overall Study||1||
59764319|NCT00705016|75884321|FG002|STARTED|Overall Study||62||
60072244|NCT01865487|76187630|FG004|NOT COMPLETED|Overall Study||1||
60072245|NCT01865487|76187631|FG005|NOT COMPLETED|Overall Study||0||
60072246|NCT01865487|76187632|FG006|NOT COMPLETED|Overall Study||1||
60072247|NCT01865487|76187633|FG007|NOT COMPLETED|Overall Study||0||
60072248|NCT01865487|76187634|FG008|NOT COMPLETED|Overall Study||0||
60072249|NCT01865487|76187635|FG009|NOT COMPLETED|Overall Study||0||
60072250|NCT01699503|76187665|FG000|STARTED|Overall Study||2008||
60072251|NCT01699503|76187666|FG001|STARTED|Overall Study||1997||
60072252|NCT01699503|76187665|FG000|Baseline|Overall Study||1723||
60072253|NCT01699503|76187666|FG001|Baseline|Overall Study||1693||
60072254|NCT01699503|76187665|FG000|1 Month Follow-up|Overall Study||998||
60072255|NCT01699503|76187666|FG001|1 Month Follow-up|Overall Study||1022||
60072256|NCT01699503|76187665|FG000|6 Month Follow-up|Overall Study||903||
60072257|NCT01699503|76187666|FG001|6 Month Follow-up|Overall Study||893||
59764320|NCT00705016|75884319|FG000|COMPLETED|Overall Study||2||
59764321|NCT00705016|75884320|FG001|COMPLETED|Overall Study||2||
60072258|NCT01699503|76187665|FG000|COMPLETED|Overall Study||1008||
60072259|NCT01699503|76187666|FG001|COMPLETED|Overall Study||992||
60072260|NCT01699503|76187665|FG000|NOT COMPLETED|Overall Study||1000||
60072261|NCT01699503|76187666|FG001|NOT COMPLETED|Overall Study||1005||
60072262|NCT01709409|76187674|FG000|STARTED|Overall Study||43||
60072263|NCT01709409|76187675|FG001|STARTED|Overall Study||45||
60072264|NCT01709409|76187674|FG000|COMPLETED|Overall Study||42||
60072265|NCT01709409|76187675|FG001|COMPLETED|Overall Study||45||
60072266|NCT01709409|76187674|FG000|NOT COMPLETED|Overall Study||1||
60072267|NCT01709409|76187675|FG001|NOT COMPLETED|Overall Study||0||
60072268|NCT01698879|76187684|FG000|STARTED|Overall Study||6||
60072269|NCT01698879|76187685|FG001|STARTED|Overall Study||20||
60072270|NCT01698879|76187686|FG002|STARTED|Overall Study||20||
59764322|NCT00705016|75884321|FG002|COMPLETED|Overall Study||4||
59764323|NCT00705016|75884319|FG000|NOT COMPLETED|Overall Study||60||
59764324|NCT00705016|75884320|FG001|NOT COMPLETED|Overall Study||58||
60072271|NCT01698879|76187684|FG000|COMPLETED|Overall Study||5||
60072272|NCT01698879|76187685|FG001|COMPLETED|Overall Study||20||
60072273|NCT01698879|76187686|FG002|COMPLETED|Overall Study||20||
59764325|NCT00705016|75884321|FG002|NOT COMPLETED|Overall Study||58||
60072274|NCT01698879|76187684|FG000|NOT COMPLETED|Overall Study||1||
60072275|NCT01698879|76187685|FG001|NOT COMPLETED|Overall Study||0||
60072276|NCT01698879|76187686|FG002|NOT COMPLETED|Overall Study||0||
60072277|NCT02335294|76187706|FG000|STARTED|Overall Study||39||
60072278|NCT02335294|76187707|FG001|STARTED|Overall Study||42||
60072279|NCT02335294|76187708|FG002|STARTED|Overall Study||19||
60072280|NCT02335294|76187709|FG003|STARTED|Overall Study||39||
60072281|NCT02335294|76187710|FG004|STARTED|Overall Study||41||
60072282|NCT02335294|76187711|FG005|STARTED|Overall Study||20||
60072283|NCT02335294|76187706|FG000|COMPLETED|Overall Study||36||
60072284|NCT02335294|76187707|FG001|COMPLETED|Overall Study||38||
60072285|NCT02335294|76187708|FG002|COMPLETED|Overall Study||18||
60072286|NCT02335294|76187709|FG003|COMPLETED|Overall Study||36||
59764326|NCT00595868|75884331|FG000|STARTED|Overall Study||107||
59764327|NCT00595868|75884332|FG001|STARTED|Overall Study||111||
59764328|NCT00595868|75884331|FG000|COMPLETED|Overall Study||62||
59764329|NCT00595868|75884332|FG001|COMPLETED|Overall Study||61||
59764330|NCT00595868|75884331|FG000|NOT COMPLETED|Overall Study||45||
59764331|NCT00595868|75884332|FG001|NOT COMPLETED|Overall Study||50||
59764332|NCT02727907|75884341|FG000|STARTED|Overall Study||53||
59764333|NCT02727907|75884342|FG001|STARTED|Overall Study||56||
59764334|NCT02727907|75884343|FG002|STARTED|Overall Study||54||
59764335|NCT02727907|75884341|FG000|Recived One Injection of Drug|Overall Study||53||
59764336|NCT02727907|75884342|FG001|Recived One Injection of Drug|Overall Study||55||
59764337|NCT02727907|75884343|FG002|Recived One Injection of Drug|Overall Study||54||
59520685|NCT03688282|75614765|FG000|COMPLETED|Sham Treatment for 30 Minutes||17||
59520686|NCT03688282|75614765|FG000|NOT COMPLETED|Sham Treatment for 30 Minutes||1||
59520687|NCT03688282|75614765|FG000|STARTED|Washout (7 Days)||17||
59520688|NCT03688282|75614765|FG000|COMPLETED|Washout (7 Days)||17||
59520689|NCT03688282|75614765|FG000|NOT COMPLETED|Washout (7 Days)||0||
59520690|NCT03688282|75614765|FG000|STARTED|Active Treatment for 30 Minutes||17||
59520691|NCT03688282|75614765|FG000|COMPLETED|Active Treatment for 30 Minutes||17||
59520692|NCT03688282|75614765|FG000|NOT COMPLETED|Active Treatment for 30 Minutes||0||
59520693|NCT04198948|75614773|FG000|STARTED|First Period||7||
59520694|NCT04198948|75614774|FG001|STARTED|First Period||8||
59617613|NCT01399788|75728751|FG000|NOT COMPLETED|First Intervention Period||1||
59617614|NCT01399788|75728752|FG001|NOT COMPLETED|First Intervention Period||0||
59617615|NCT01399788|75728751|FG000|STARTED|Washout Period (at Least 1 Week)||17||
59617616|NCT01399788|75728752|FG001|STARTED|Washout Period (at Least 1 Week)||18||
59617617|NCT01399788|75728751|FG000|COMPLETED|Washout Period (at Least 1 Week)||17||
59617618|NCT01399788|75728752|FG001|COMPLETED|Washout Period (at Least 1 Week)||18||
59617619|NCT01399788|75728751|FG000|NOT COMPLETED|Washout Period (at Least 1 Week)||0||
59764338|NCT02727907|75884341|FG000|COMPLETED|Overall Study||40||
59764339|NCT02727907|75884342|FG001|COMPLETED|Overall Study||43||
59764340|NCT02727907|75884343|FG002|COMPLETED|Overall Study||43||
59764341|NCT02727907|75884341|FG000|NOT COMPLETED|Overall Study||13||
59764342|NCT02727907|75884342|FG001|NOT COMPLETED|Overall Study||13||
59617620|NCT01399788|75728752|FG001|NOT COMPLETED|Washout Period (at Least 1 Week)||0||
59617621|NCT01399788|75728751|FG000|STARTED|Second Intervention Period||17||
59617622|NCT01399788|75728752|FG001|STARTED|Second Intervention Period||18||
59764343|NCT02727907|75884343|FG002|NOT COMPLETED|Overall Study||11||
59764344|NCT00856284|75884362|FG000|STARTED|Overall Study||880||
59764345|NCT00856284|75884363|FG001|STARTED|Overall Study||885||
59764346|NCT00856284|75884364|FG002|STARTED|Overall Study||874||
59764347|NCT00856284|75884362|FG000|Received Study Drug|Overall Study||873||
59764348|NCT00856284|75884363|FG001|Received Study Drug|Overall Study||878||
59764349|NCT00856284|75884364|FG002|Received Study Drug|Overall Study||869||
59764350|NCT00856284|75884362|FG000|COMPLETED|Overall Study||472||
59764351|NCT00856284|75884363|FG001|COMPLETED|Overall Study||493||
59764352|NCT00856284|75884364|FG002|COMPLETED|Overall Study||427||
59764353|NCT00856284|75884362|FG000|NOT COMPLETED|Overall Study||408||
59764354|NCT00856284|75884363|FG001|NOT COMPLETED|Overall Study||392||
59764355|NCT00856284|75884364|FG002|NOT COMPLETED|Overall Study||447||
59764356|NCT00510289|75884372|FG000|STARTED|Overall Study|All patients who consented|19||
60072287|NCT02335294|76187710|FG004|COMPLETED|Overall Study||39||
60072288|NCT02335294|76187711|FG005|COMPLETED|Overall Study||19||
60072289|NCT02335294|76187706|FG000|NOT COMPLETED|Overall Study||3||
60072290|NCT02335294|76187707|FG001|NOT COMPLETED|Overall Study||4||
60072291|NCT02335294|76187708|FG002|NOT COMPLETED|Overall Study||1||
60072292|NCT02335294|76187709|FG003|NOT COMPLETED|Overall Study||3||
60072293|NCT02335294|76187710|FG004|NOT COMPLETED|Overall Study||2||
60072294|NCT02335294|76187711|FG005|NOT COMPLETED|Overall Study||1||
60072295|NCT01698801|76187725|FG000|STARTED|Treatment Phase||26||
60072296|NCT01698801|76187725|FG000|COMPLETED|Treatment Phase|Completed includes participants who continued to receive study medication and treatment is ongoing.|15||
60072297|NCT01698801|76187725|FG000|NOT COMPLETED|Treatment Phase||11||
60072298|NCT01698801|76187725|FG000|STARTED|Follow Up Phase|11 participants did not complete the study and moved into the follow up phase lasting up to 5 years.|11||
60072299|NCT01698801|76187725|FG000|COMPLETED|Follow Up Phase|Completed includes participants who remain in follow-up for up to 5 years from start of treatment|6||
59764357|NCT00510289|75884372|FG000|Started Study Drug|Overall Study|3 patients progressed prior to starting study drug|16||
59764358|NCT00510289|75884372|FG000|COMPLETED|Overall Study|Completed at least one cycle of study drug and had disease assessments|7||
59764359|NCT00510289|75884372|FG000|NOT COMPLETED|Overall Study||12||
59764360|NCT00492115|75884379|FG000|STARTED|Overall Study||19||
59764361|NCT00492115|75884380|FG001|STARTED|Overall Study||19||
59764362|NCT00492115|75884379|FG000|COMPLETED|Overall Study|3 dropped due to anxiety or not being able to tolerate CPAP|16||
59764363|NCT00492115|75884380|FG001|COMPLETED|Overall Study|4 dropped due to not being able to tolerate CPAP|15||
59764364|NCT00492115|75884379|FG000|NOT COMPLETED|Overall Study||3||
59764365|NCT00492115|75884380|FG001|NOT COMPLETED|Overall Study||4||
59764366|NCT00856206|75884388|FG000|STARTED|Overall Study||330||
59764367|NCT00856206|75884389|FG001|STARTED|Overall Study||985||
59764368|NCT00856206|75884388|FG000|COMPLETED|Overall Study||276||
59764369|NCT00856206|75884389|FG001|COMPLETED|Overall Study||824||
59764370|NCT00856206|75884388|FG000|NOT COMPLETED|Overall Study||54||
59764371|NCT00856206|75884389|FG001|NOT COMPLETED|Overall Study||161||
59764372|NCT00593112|75884397|FG000|STARTED|Overall Study||27||
59764373|NCT00593112|75884398|FG001|STARTED|Overall Study||12||
59764374|NCT00593112|75884397|FG000|COMPLETED|Overall Study||17||
59764375|NCT00593112|75884398|FG001|COMPLETED|Overall Study||12||
59764376|NCT00593112|75884397|FG000|NOT COMPLETED|Overall Study||10||
59764377|NCT00593112|75884398|FG001|NOT COMPLETED|Overall Study||0||
59764378|NCT00491179|75884406|FG000|STARTED|Overall Study||25||
59764379|NCT00491179|75884407|FG001|STARTED|Overall Study||10||
59764380|NCT00491179|75884406|FG000|COMPLETED|Overall Study||18||
59764381|NCT00491179|75884407|FG001|COMPLETED|Overall Study||8||
59764382|NCT00491179|75884406|FG000|NOT COMPLETED|Overall Study||7||
59764383|NCT00491179|75884407|FG001|NOT COMPLETED|Overall Study||2||
59764384|NCT00503581|75884416|FG000|STARTED|Overall Study||3||
59764385|NCT00503581|75884417|FG001|STARTED|Overall Study||4||
59764386|NCT00503581|75884418|FG002|STARTED|Overall Study||2||
59764387|NCT00503581|75884416|FG000|COMPLETED|Overall Study||0||
59764388|NCT00503581|75884417|FG001|COMPLETED|Overall Study||0||
59764389|NCT00503581|75884418|FG002|COMPLETED|Overall Study||0||
59764390|NCT00503581|75884416|FG000|NOT COMPLETED|Overall Study||3||
59764391|NCT00503581|75884417|FG001|NOT COMPLETED|Overall Study||4||
59764392|NCT00503581|75884418|FG002|NOT COMPLETED|Overall Study||2||
59764393|NCT00703534|75884428|FG000|STARTED|Overall Study||235||
59764394|NCT00703534|75884429|FG001|STARTED|Overall Study||243||
59764395|NCT00703534|75884428|FG000|COMPLETED|Overall Study||205||
59764396|NCT00703534|75884429|FG001|COMPLETED|Overall Study||218||
59764397|NCT00703534|75884428|FG000|NOT COMPLETED|Overall Study||30||
59764398|NCT00703534|75884429|FG001|NOT COMPLETED|Overall Study||25||
59764399|NCT00503425|75884435|FG000|STARTED|Overall Study||215||
59764400|NCT00503425|75884435|FG000|COMPLETED|Overall Study||161||
59764401|NCT00503425|75884435|FG000|NOT COMPLETED|Overall Study||54||
59764402|NCT00863772|75884443|FG000|STARTED|Overall Study||74||
59764403|NCT00863772|75884444|FG001|STARTED|Overall Study||74||
59764404|NCT00863772|75884445|FG002|STARTED|Overall Study||72||
59764405|NCT00863772|75884443|FG000|Treated|Overall Study||73||
59764406|NCT00863772|75884444|FG001|Treated|Overall Study||74||
59764407|NCT00863772|75884445|FG002|Treated|Overall Study||72||
59764408|NCT00863772|75884443|FG000|COMPLETED|Overall Study||6||
59764409|NCT00863772|75884444|FG001|COMPLETED|Overall Study||9||
59764410|NCT00863772|75884445|FG002|COMPLETED|Overall Study||11||
59764411|NCT00863772|75884443|FG000|NOT COMPLETED|Overall Study||68||
59764412|NCT00863772|75884444|FG001|NOT COMPLETED|Overall Study||65||
59764413|NCT00863772|75884445|FG002|NOT COMPLETED|Overall Study||61||
59764414|NCT00502801|75884453|FG000|STARTED|Treatment Period||183||
59764415|NCT00502801|75884453|FG000|COMPLETED|Treatment Period||129||
59764416|NCT00502801|75884453|FG000|NOT COMPLETED|Treatment Period||54||
59764417|NCT00502801|75884453|FG000|STARTED|End of Therapy to Test of Cure||129||
59764418|NCT00502801|75884453|FG000|COMPLETED|End of Therapy to Test of Cure||121||
59764419|NCT00502801|75884453|FG000|NOT COMPLETED|End of Therapy to Test of Cure||8||
59764420|NCT00824265|75884459|FG000|STARTED|Treatment Phase||183||
59764421|NCT00824265|75884460|FG001|STARTED|Treatment Phase||182||
59764422|NCT00824265|75884459|FG000|COMPLETED|Treatment Phase||119||
59764423|NCT00824265|75884460|FG001|COMPLETED|Treatment Phase||102||
59764424|NCT00824265|75884459|FG000|NOT COMPLETED|Treatment Phase||64||
59764425|NCT00824265|75884460|FG001|NOT COMPLETED|Treatment Phase||80||
59764426|NCT00824265|75884459|FG000|STARTED|Follow-up Phase||172||
59764427|NCT00824265|75884460|FG001|STARTED|Follow-up Phase||160||
59764428|NCT00824265|75884459|FG000|COMPLETED|Follow-up Phase||154||
59764429|NCT00824265|75884460|FG001|COMPLETED|Follow-up Phase||129||
59764430|NCT00824265|75884459|FG000|NOT COMPLETED|Follow-up Phase||18||
59764431|NCT00824265|75884460|FG001|NOT COMPLETED|Follow-up Phase||31||
59764432|NCT00824265|75884459|FG000|STARTED|Survival Follow-up Phase||96||
59764433|NCT00824265|75884460|FG001|STARTED|Survival Follow-up Phase||89||
59764434|NCT00824265|75884459|FG000|COMPLETED|Survival Follow-up Phase||87||
59764435|NCT00824265|75884460|FG001|COMPLETED|Survival Follow-up Phase||73||
59764436|NCT00824265|75884459|FG000|NOT COMPLETED|Survival Follow-up Phase||9||
59764437|NCT00824265|75884460|FG001|NOT COMPLETED|Survival Follow-up Phase||16||
59764438|NCT00855894|75884470|FG000|STARTED|Overall Study||41||
59764439|NCT00855894|75884470|FG000|COMPLETED|Overall Study||8||
59764440|NCT00855894|75884470|FG000|NOT COMPLETED|Overall Study||33||
59764441|NCT00855816|75884476|FG000|STARTED|Overall Study||47||
59764442|NCT00855816|75884477|FG001|STARTED|Overall Study||33||
59764443|NCT00855816|75884476|FG000|COMPLETED|Overall Study||21||
59764444|NCT00855816|75884477|FG001|COMPLETED|Overall Study||12||
59764445|NCT00855816|75884476|FG000|NOT COMPLETED|Overall Study||26||
59764446|NCT00855816|75884477|FG001|NOT COMPLETED|Overall Study||21||
59764447|NCT00855738|75884483|FG000|STARTED|Overall Study||111||
59764448|NCT00855738|75884483|FG000|At Least 1 Dose and 1 Endpoint|Overall Study|Received at least 1 dose of study drug and had data for at least 1 efficacy endpoint.|108||
59764449|NCT00855738|75884483|FG000|COMPLETED|Overall Study||106||
59764450|NCT00855738|75884483|FG000|NOT COMPLETED|Overall Study||5||
59764451|NCT06033079|75884491|FG000|STARTED|Overall Study||269||
59764452|NCT06033079|75884492|FG001|STARTED|Overall Study||267||
59764453|NCT06033079|75884491|FG000|COMPLETED|Overall Study||269||
59764454|NCT06033079|75884492|FG001|COMPLETED|Overall Study||267||
59764455|NCT06033079|75884491|FG000|NOT COMPLETED|Overall Study||0||
59764456|NCT06033079|75884492|FG001|NOT COMPLETED|Overall Study||0||
59764457|NCT05810714|75884501|FG000|STARTED|Overall Study||20||
59764458|NCT05810714|75884502|FG001|STARTED|Overall Study||42||
59764459|NCT05810714|75884503|FG002|STARTED|Overall Study||32||
59764460|NCT05810714|75884501|FG000|COMPLETED|Overall Study||20||
59764461|NCT05810714|75884502|FG001|COMPLETED|Overall Study||42||
59520695|NCT04198948|75614773|FG000|COMPLETED|First Period||7||
59520696|NCT04198948|75614774|FG001|COMPLETED|First Period||8||
59520697|NCT04198948|75614773|FG000|NOT COMPLETED|First Period||0||
59520698|NCT04198948|75614774|FG001|NOT COMPLETED|First Period||0||
59520699|NCT04198948|75614773|FG000|STARTED|Wash-out (10 Days)||7||
59617623|NCT01399788|75728751|FG000|COMPLETED|Second Intervention Period||17||
59617624|NCT01399788|75728752|FG001|COMPLETED|Second Intervention Period||18||
59617625|NCT01399788|75728751|FG000|NOT COMPLETED|Second Intervention Period||0||
59617626|NCT01399788|75728752|FG001|NOT COMPLETED|Second Intervention Period||0||
59617627|NCT01387542|75728758|FG000|STARTED|Overall Study||40||
59617628|NCT01387542|75728758|FG000|Treated|Overall Study||38||
59617629|NCT01387542|75728758|FG000|COMPLETED|Overall Study||32||
59617630|NCT01387542|75728758|FG000|NOT COMPLETED|Overall Study||8||
59617631|NCT01387230|75728765|FG000|STARTED|Overall Study||68||
59617632|NCT01387230|75728766|FG001|STARTED|Overall Study||69||
59617633|NCT01387230|75728767|FG002|STARTED|Overall Study||69||
59617634|NCT01387230|75728765|FG000|COMPLETED|Overall Study||50||
59617635|NCT01387230|75728766|FG001|COMPLETED|Overall Study||62||
59617636|NCT01387230|75728767|FG002|COMPLETED|Overall Study||56||
59617637|NCT01387230|75728765|FG000|NOT COMPLETED|Overall Study||18||
59617638|NCT01387230|75728766|FG001|NOT COMPLETED|Overall Study||7||
59520700|NCT04198948|75614774|FG001|STARTED|Wash-out (10 Days)||8||
59520701|NCT04198948|75614773|FG000|COMPLETED|Wash-out (10 Days)||7||
59520702|NCT04198948|75614774|FG001|COMPLETED|Wash-out (10 Days)||8||
59520703|NCT04198948|75614773|FG000|NOT COMPLETED|Wash-out (10 Days)||0||
59520704|NCT04198948|75614774|FG001|NOT COMPLETED|Wash-out (10 Days)||0||
59520705|NCT04198948|75614773|FG000|STARTED|Second Period||7||
59520706|NCT04198948|75614774|FG001|STARTED|Second Period||8||
59617639|NCT01387230|75728767|FG002|NOT COMPLETED|Overall Study||13||
59617640|NCT01387074|75728775|FG000|STARTED|Overall Study||108||
59764462|NCT05810714|75884503|FG002|COMPLETED|Overall Study||32||
59764463|NCT05810714|75884501|FG000|NOT COMPLETED|Overall Study||0||
59764464|NCT05810714|75884502|FG001|NOT COMPLETED|Overall Study||0||
59764465|NCT05810714|75884503|FG002|NOT COMPLETED|Overall Study||0||
59764466|NCT05513625|75884511|FG000|STARTED|Overall Study||16||
59764467|NCT05513625|75884511|FG000|COMPLETED|Overall Study||15||
59764468|NCT05513625|75884511|FG000|NOT COMPLETED|Overall Study||1||
59764469|NCT05093790|75884521|FG000|STARTED|Overall Study||16||
59764470|NCT05093790|75884522|FG001|STARTED|Overall Study||15||
59764471|NCT05093790|75884523|FG002|STARTED|Overall Study||16||
59764472|NCT05093790|75884524|FG003|STARTED|Overall Study||11||
59764473|NCT05093790|75884521|FG000|COMPLETED|Overall Study||15||
59764474|NCT05093790|75884522|FG001|COMPLETED|Overall Study||15||
59764475|NCT05093790|75884523|FG002|COMPLETED|Overall Study||15||
59764476|NCT05093790|75884524|FG003|COMPLETED|Overall Study||11||
59764477|NCT05093790|75884521|FG000|NOT COMPLETED|Overall Study||1||
59764478|NCT05093790|75884522|FG001|NOT COMPLETED|Overall Study||0||
59764479|NCT05093790|75884523|FG002|NOT COMPLETED|Overall Study||1||
59764480|NCT05093790|75884524|FG003|NOT COMPLETED|Overall Study||0||
59764481|NCT04894994|75884535|FG000|STARTED|Overall Study||6||
59520707|NCT04198948|75614773|FG000|COMPLETED|Second Period||7||
59764482|NCT04894994|75884535|FG000|COMPLETED|Overall Study||6||
59764483|NCT04894994|75884535|FG000|NOT COMPLETED|Overall Study||0||
59764484|NCT04800510|75884545|FG000|STARTED|Overall Study||0||
59764485|NCT04800510|75884546|FG001|STARTED|Overall Study||4||
59520708|NCT04198948|75614774|FG001|COMPLETED|Second Period||7||
59520709|NCT04198948|75614773|FG000|NOT COMPLETED|Second Period||0||
59520710|NCT04198948|75614774|FG001|NOT COMPLETED|Second Period||1||
59617641|NCT01387074|75728775|FG000|COMPLETED|Overall Study||100||
59617642|NCT01387074|75728775|FG000|NOT COMPLETED|Overall Study||8||
59617643|NCT01386606|75728783|FG000|STARTED|Overall Study||16||
59764486|NCT04800510|75884547|FG002|STARTED|Overall Study||1||
59764487|NCT04800510|75884548|FG003|STARTED|Overall Study||1||
59764488|NCT04800510|75884549|FG004|STARTED|Overall Study||2||
59764489|NCT04800510|75884550|FG005|STARTED|Overall Study||1||
59764490|NCT04800510|75884545|FG000|COMPLETED|Overall Study||0||
59764491|NCT04800510|75884546|FG001|COMPLETED|Overall Study||4||
59764492|NCT04800510|75884547|FG002|COMPLETED|Overall Study||1||
59764493|NCT04800510|75884548|FG003|COMPLETED|Overall Study||1||
59764494|NCT04800510|75884549|FG004|COMPLETED|Overall Study||2||
59764495|NCT04800510|75884550|FG005|COMPLETED|Overall Study||1||
59520711|NCT01169467|75614782|FG000|STARTED|Overall Study||44||
59520712|NCT01169467|75614783|FG001|STARTED|Overall Study||40||
59520713|NCT01169467|75614782|FG000|COMPLETED|Overall Study||37||
59520714|NCT01169467|75614783|FG001|COMPLETED|Overall Study||36||
59520715|NCT01169467|75614782|FG000|NOT COMPLETED|Overall Study||7||
59520716|NCT01169467|75614783|FG001|NOT COMPLETED|Overall Study||4||
59520717|NCT04186780|75614791|FG000|STARTED|Overall Study||36||
59520718|NCT04186780|75614792|FG001|STARTED|Overall Study||32||
59520719|NCT04186780|75614791|FG000|COMPLETED|Overall Study||22||
59520720|NCT04186780|75614792|FG001|COMPLETED|Overall Study||25||
59520721|NCT04186780|75614791|FG000|NOT COMPLETED|Overall Study||14||
59520722|NCT04186780|75614792|FG001|NOT COMPLETED|Overall Study||7||
59520723|NCT01170247|75614802|FG000|STARTED|Overall Study||2||
59520724|NCT01170247|75614803|FG001|STARTED|Overall Study||1||
59520725|NCT01170247|75614802|FG000|COMPLETED|Overall Study||2||
59520726|NCT01170247|75614803|FG001|COMPLETED|Overall Study||1||
59520727|NCT01170247|75614802|FG000|NOT COMPLETED|Overall Study||0||
59520728|NCT01170247|75614803|FG001|NOT COMPLETED|Overall Study||0||
59520729|NCT03700372|75614809|FG000|STARTED|Overall Study||7||
59520730|NCT03700372|75614809|FG000|COMPLETED|Overall Study||7||
59520731|NCT03700372|75614809|FG000|NOT COMPLETED|Overall Study||0||
59520732|NCT04182958|75614813|FG000|STARTED|Overall Study||8||
59520733|NCT04182958|75614813|FG000|COMPLETED|Overall Study||8||
59520734|NCT04182958|75614813|FG000|NOT COMPLETED|Overall Study||0||
59520735|NCT01126099|75614819|FG000|STARTED|Double Blind Phase||11||
59520736|NCT01126099|75614820|FG001|STARTED|Double Blind Phase||9||
59520737|NCT01126099|75614819|FG000|COMPLETED|Double Blind Phase||7||
59520738|NCT01126099|75614820|FG001|COMPLETED|Double Blind Phase||7||
59520739|NCT01126099|75614819|FG000|NOT COMPLETED|Double Blind Phase||4||
59520740|NCT01126099|75614820|FG001|NOT COMPLETED|Double Blind Phase||2||
59764496|NCT04800510|75884545|FG000|NOT COMPLETED|Overall Study||0||
59764497|NCT04800510|75884546|FG001|NOT COMPLETED|Overall Study||0||
59764498|NCT04800510|75884547|FG002|NOT COMPLETED|Overall Study||0||
59764499|NCT04800510|75884548|FG003|NOT COMPLETED|Overall Study||0||
59764500|NCT04800510|75884549|FG004|NOT COMPLETED|Overall Study||0||
59764501|NCT04800510|75884550|FG005|NOT COMPLETED|Overall Study||0||
59764502|NCT04739306|75884565|FG000|STARTED|Main Study Period||173||
59764503|NCT04739306|75884566|FG001|STARTED|Main Study Period||175||
59764504|NCT04739306|75884565|FG000|COMPLETED|Main Study Period||153||
59764505|NCT04739306|75884566|FG001|COMPLETED|Main Study Period||153||
59764506|NCT04739306|75884565|FG000|NOT COMPLETED|Main Study Period||20||
59520741|NCT01126099|75614819|FG000|STARTED|Open-label Extension|2 in the Prazosin arm of the Double Blind Phase elected not to enter the Open-Label extension|5||
59520742|NCT01126099|75614820|FG001|STARTED|Open-label Extension||7||
59520743|NCT01126099|75614819|FG000|COMPLETED|Open-label Extension||4||
59520744|NCT01126099|75614820|FG001|COMPLETED|Open-label Extension||6||
59520745|NCT01126099|75614819|FG000|NOT COMPLETED|Open-label Extension||1||
59520746|NCT01126099|75614820|FG001|NOT COMPLETED|Open-label Extension||1||
59520747|NCT04176406|75614826|FG000|STARTED|Overall Study||0|None of the participants were randomized to any of the Arms/Groups|
59520748|NCT04176406|75614827|FG001|STARTED|Overall Study||0|None of the participants were randomized to any of the Arms/Groups|
59520749|NCT04176406|75614828|FG002|STARTED|Overall Study||0|None of the participants were randomized to any of the Arms/Groups|
59520750|NCT04176406|75614829|FG003|STARTED|Overall Study||0|None of the participants were randomized to any of the Arms/Groups|
59520751|NCT04176406|75614826|FG000|COMPLETED|Overall Study||0||
59520752|NCT04176406|75614827|FG001|COMPLETED|Overall Study||0||
59520753|NCT04176406|75614828|FG002|COMPLETED|Overall Study||0||
59520754|NCT04176406|75614829|FG003|COMPLETED|Overall Study||0||
59520755|NCT04176406|75614826|FG000|NOT COMPLETED|Overall Study||0||
59520756|NCT04176406|75614827|FG001|NOT COMPLETED|Overall Study||0||
59520757|NCT04176406|75614828|FG002|NOT COMPLETED|Overall Study||0||
59520758|NCT04176406|75614829|FG003|NOT COMPLETED|Overall Study||0||
59520759|NCT04171102|75614843|FG000|STARTED|Overall Study||4||
59520760|NCT04171102|75614844|FG001|STARTED|Overall Study||5||
59520761|NCT04171102|75614845|FG002|STARTED|Overall Study||6||
59520762|NCT04171102|75614843|FG000|COMPLETED|Overall Study||4||
59764507|NCT04739306|75884566|FG001|NOT COMPLETED|Main Study Period||22||
59764508|NCT04739306|75884565|FG000|STARTED|CT-P42 PFS (Extension Study Period)||15||
59764509|NCT04739306|75884566|FG001|STARTED|CT-P42 PFS (Extension Study Period)||16||
59520763|NCT04171102|75614844|FG001|COMPLETED|Overall Study||5||
59520764|NCT04171102|75614845|FG002|COMPLETED|Overall Study||6||
59520765|NCT04171102|75614843|FG000|NOT COMPLETED|Overall Study||0||
59520766|NCT04171102|75614844|FG001|NOT COMPLETED|Overall Study||0||
59520767|NCT04171102|75614845|FG002|NOT COMPLETED|Overall Study||0||
59764510|NCT04739306|75884565|FG000|COMPLETED|CT-P42 PFS (Extension Study Period)||15||
59764511|NCT04739306|75884566|FG001|COMPLETED|CT-P42 PFS (Extension Study Period)||16||
59764512|NCT04739306|75884565|FG000|NOT COMPLETED|CT-P42 PFS (Extension Study Period)||0||
59764513|NCT04739306|75884566|FG001|NOT COMPLETED|CT-P42 PFS (Extension Study Period)||0||
59764514|NCT04463615|75884573|FG000|STARTED|Overall Study||1||
59764515|NCT04463615|75884573|FG000|COMPLETED|Overall Study||1||
59764516|NCT04463615|75884573|FG000|NOT COMPLETED|Overall Study||0||
59764517|NCT04442490|75884579|FG000|STARTED|Overall Study||272||
59764518|NCT04442490|75884580|FG001|STARTED|Overall Study||271||
59764519|NCT04442490|75884579|FG000|Safety Set|Overall Study||269|Safety Set included all participants who were administered investigational product (IP).|
59764520|NCT04442490|75884580|FG001|Safety Set|Overall Study||268|Safety Set included all participants who were administered investigational product (IP).|
59764521|NCT04442490|75884579|FG000|COMPLETED|Overall Study||235||
59764522|NCT04442490|75884580|FG001|COMPLETED|Overall Study||242||
59764523|NCT04442490|75884579|FG000|NOT COMPLETED|Overall Study||37||
59764524|NCT04442490|75884580|FG001|NOT COMPLETED|Overall Study||29||
59764525|NCT04375761|75884588|FG000|STARTED|Overall Study|Index participants who were enrolled and contributed at least 1 nasal swab|1387||
59764526|NCT04375761|75884589|FG001|STARTED|Overall Study|All participants who were enrolled and contributed at least 1 nasal swab|2755||
59764527|NCT04375761|75884588|FG000|COMPLETED|Overall Study|Index participants who at least started the exit survey|1012||
59764528|NCT04375761|75884589|FG001|COMPLETED|Overall Study|Participants who at least started the exit survey|2011||
59764529|NCT04375761|75884588|FG000|NOT COMPLETED|Overall Study||375||
59764530|NCT04375761|75884589|FG001|NOT COMPLETED|Overall Study||744||
59764531|NCT04219189|75884598|FG000|STARTED|Overall Study||19||
59764532|NCT04219189|75884599|FG001|STARTED|Overall Study||21||
59764533|NCT04219189|75884598|FG000|COMPLETED|Overall Study||18||
59764534|NCT04219189|75884599|FG001|COMPLETED|Overall Study||16||
59764535|NCT04219189|75884598|FG000|NOT COMPLETED|Overall Study||1||
59764536|NCT04219189|75884599|FG001|NOT COMPLETED|Overall Study||5||
59764537|NCT04209725|75884607|FG000|STARTED|Overall Study||1||
59764538|NCT04209725|75884607|FG000|COMPLETED|Overall Study||0||
59764539|NCT04209725|75884607|FG000|NOT COMPLETED|Overall Study||1||
59764540|NCT04164901|75884613|FG000|STARTED|Overall Study|One subject in the vorasidenib arm withdrew consent prior to treatment. They are counted in the total number started.|168|The participant flow data is based on the Full Analysis Set (FAS) which includes all subjects randomized, classified according to the randomized treatment arm.|
59764541|NCT04164901|75884614|FG001|STARTED|Overall Study||163|The participant flow data is based on the Full Analysis Set (FAS) which includes all subjects randomized, classified according to the randomized treatment arm.|
59764542|NCT04164901|75884613|FG000|COMPLETED|Overall Study||164|"As the study is still ongoing, the number of participants Completed reflects the number of participants who were still on study at the time of data collection for the purposes of this results submission."|
59764543|NCT04164901|75884614|FG001|COMPLETED|Overall Study||159|"As the study is still ongoing, the number of participants Completed reflects the number of participants who were still on study at the time of data collection for the purposes of this results submission."|
59764544|NCT04164901|75884613|FG000|NOT COMPLETED|Overall Study||4||
59764545|NCT04164901|75884614|FG001|NOT COMPLETED|Overall Study||4||
59764546|NCT03778931|75884623|FG000|STARTED|Overall Study||239||
59764547|NCT03778931|75884624|FG001|STARTED|Overall Study||239||
59764548|NCT03778931|75884623|FG000|Intent-to-Treat Population|Overall Study||239||
59764549|NCT03778931|75884624|FG001|Intent-to-Treat Population|Overall Study||239||
59764550|NCT03778931|75884623|FG000|Safety Population|Overall Study||237||
59764551|NCT03778931|75884624|FG001|Safety Population|Overall Study||230||
59764552|NCT03778931|75884623|FG000|COMPLETED|Overall Study|"Overall study includes survival follow-up; subjects designated as Not Completed were still in survival follow-up."|95||
59764553|NCT03778931|75884624|FG001|COMPLETED|Overall Study|"Overall study includes survival follow-up; subjects designated as Not Completed were still in survival follow-up."|114||
59764554|NCT03778931|75884623|FG000|NOT COMPLETED|Overall Study||144||
59764555|NCT03778931|75884624|FG001|NOT COMPLETED|Overall Study||125||
59764556|NCT03739762|75884632|FG000|STARTED|Overall Study||140||
59764557|NCT03739762|75884633|FG001|STARTED|Overall Study||143||
59764558|NCT03739762|75884632|FG000|COMPLETED|Overall Study||137||
59764559|NCT03739762|75884633|FG001|COMPLETED|Overall Study||136||
59764560|NCT03739762|75884632|FG000|NOT COMPLETED|Overall Study||3||
59764561|NCT03739762|75884633|FG001|NOT COMPLETED|Overall Study||7||
59764562|NCT03725605|75884639|FG000|STARTED|Overall Study||6||
59764563|NCT03725605|75884639|FG000|COMPLETED|Overall Study||4||
59764564|NCT03725605|75884639|FG000|NOT COMPLETED|Overall Study||2||
59764565|NCT03650387|75884643|FG000|STARTED|Overall Study||207||
59764566|NCT03650387|75884643|FG000|COMPLETED|Overall Study||173||
59764567|NCT03650387|75884643|FG000|NOT COMPLETED|Overall Study||34||
59764568|NCT03584490|75884658|FG000|STARTED|Overall Study||362||
59764569|NCT03584490|75884659|FG001|STARTED|Overall Study||367||
59764570|NCT03584490|75884658|FG000|COMPLETED|Overall Study||235||
59764571|NCT03584490|75884659|FG001|COMPLETED|Overall Study||230||
59764572|NCT03584490|75884658|FG000|NOT COMPLETED|Overall Study||127||
59764573|NCT03584490|75884659|FG001|NOT COMPLETED|Overall Study||137||
59764574|NCT03536754|75884669|FG000|STARTED|Double Blind Period 1||12||
59764575|NCT03536754|75884670|FG001|STARTED|Double Blind Period 1||11||
59764576|NCT03536754|75884671|FG002|STARTED|Double Blind Period 1||12||
59764577|NCT03536754|75884672|FG003|STARTED|Double Blind Period 1||11||
59764578|NCT03536754|75884673|FG004|STARTED|Double Blind Period 1||0||
59764579|NCT03536754|75884669|FG000|COMPLETED|Double Blind Period 1||12||
59764580|NCT03536754|75884670|FG001|COMPLETED|Double Blind Period 1||11||
59764581|NCT03536754|75884671|FG002|COMPLETED|Double Blind Period 1||11||
59764582|NCT03536754|75884672|FG003|COMPLETED|Double Blind Period 1||11||
59764583|NCT03536754|75884673|FG004|COMPLETED|Double Blind Period 1||0||
59764584|NCT03536754|75884669|FG000|NOT COMPLETED|Double Blind Period 1||0||
59764585|NCT03536754|75884670|FG001|NOT COMPLETED|Double Blind Period 1||0||
59764586|NCT03536754|75884671|FG002|NOT COMPLETED|Double Blind Period 1||1||
59764587|NCT03536754|75884672|FG003|NOT COMPLETED|Double Blind Period 1||0||
59764588|NCT03536754|75884673|FG004|NOT COMPLETED|Double Blind Period 1||0||
59764589|NCT03536754|75884669|FG000|STARTED|Open Label Extension|46 subjects were randomised in Period A. Only 43 subjects entered the Open-Label Extension.|0||
59764590|NCT03536754|75884670|FG001|STARTED|Open Label Extension|46 subjects were randomised in Period A. Only 43 subjects entered the Open-Label Extension.|0||
59764591|NCT03536754|75884671|FG002|STARTED|Open Label Extension|46 subjects were randomised in Period A. Only 43 subjects entered the Open-Label Extension.|0||
59764592|NCT03536754|75884672|FG003|STARTED|Open Label Extension|46 subjects were randomised in Period A. Only 43 subjects entered the Open-Label Extension.|0||
59764593|NCT03536754|75884673|FG004|STARTED|Open Label Extension||43||
59764594|NCT03536754|75884669|FG000|COMPLETED|Open Label Extension||0||
59764595|NCT03536754|75884670|FG001|COMPLETED|Open Label Extension||0||
59764596|NCT03536754|75884671|FG002|COMPLETED|Open Label Extension||0||
59764597|NCT03536754|75884672|FG003|COMPLETED|Open Label Extension||0||
59764598|NCT03536754|75884673|FG004|COMPLETED|Open Label Extension||42||
59764599|NCT03536754|75884669|FG000|NOT COMPLETED|Open Label Extension||0||
59764600|NCT03536754|75884670|FG001|NOT COMPLETED|Open Label Extension||0||
59764601|NCT03536754|75884671|FG002|NOT COMPLETED|Open Label Extension||0||
59764602|NCT03536754|75884672|FG003|NOT COMPLETED|Open Label Extension||0||
59764603|NCT03536754|75884673|FG004|NOT COMPLETED|Open Label Extension||1||
59764604|NCT03436862|75884689|FG000|STARTED|Overall Study||37||
59764605|NCT03436862|75884689|FG000|COMPLETED|Overall Study||31||
59764606|NCT03436862|75884689|FG000|NOT COMPLETED|Overall Study||6||
59764607|NCT03280836|75884695|FG000|STARTED|Overall Study||10||
59764608|NCT03280836|75884696|FG001|STARTED|Overall Study||9||
59764609|NCT03280836|75884695|FG000|COMPLETED|Overall Study||9||
59764610|NCT03280836|75884696|FG001|COMPLETED|Overall Study||8||
59764611|NCT03280836|75884695|FG000|NOT COMPLETED|Overall Study||1||
59764612|NCT03280836|75884696|FG001|NOT COMPLETED|Overall Study||1||
59764613|NCT03173248|75884705|FG000|STARTED|Overall Study||72||
59764614|NCT03173248|75884706|FG001|STARTED|Overall Study||74||
59764615|NCT03173248|75884705|FG000|Safety Analysis Set|Overall Study||71|Safety Analysis Set (SAS) included all participants who received at least 1 dose of the study treatment.|
59764616|NCT03173248|75884706|FG001|Safety Analysis Set|Overall Study||73|Safety Analysis Set (SAS) included all participants who received at least 1 dose of the study treatment.|
59764617|NCT03173248|75884705|FG000|COMPLETED|Overall Study||0||
59764618|NCT03173248|75884706|FG001|COMPLETED|Overall Study||0||
59764619|NCT03173248|75884705|FG000|NOT COMPLETED|Overall Study||72||
59764620|NCT03173248|75884706|FG001|NOT COMPLETED|Overall Study||74||
59764621|NCT03164616|75884715|FG000|STARTED|Overall Study||338|Randomized and included in global cohort analysis|
59764622|NCT03164616|75884716|FG001|STARTED|Overall Study||338|Randomized and included in global cohort analysis|
59764623|NCT03164616|75884717|FG002|STARTED|Overall Study||337|Randomized and included in global cohort analysis|
59764624|NCT03164616|75884715|FG000|Received Treatment|Overall Study||331||
59764625|NCT03164616|75884716|FG001|Received Treatment|Overall Study||335||
59764626|NCT03164616|75884717|FG002|Received Treatment|Overall Study||331||
59764627|NCT03164616|75884715|FG000|COMPLETED|Overall Study||80|Completed study or ongoing in study at primary completion date (global cohort final analysis DCO of 12 March 2021)|
59764628|NCT03164616|75884716|FG001|COMPLETED|Overall Study||65|Completed study or ongoing in study at primary completion date (global cohort final analysis DCO of 12 March 2021)|
59764629|NCT03164616|75884717|FG002|COMPLETED|Overall Study||40|Completed study or ongoing in study at primary completion date (global cohort final analysis DCO of 12 March 2021)|
59764630|NCT03164616|75884715|FG000|NOT COMPLETED|Overall Study||258||
59764631|NCT03164616|75884716|FG001|NOT COMPLETED|Overall Study||273||
59764632|NCT03164616|75884717|FG002|NOT COMPLETED|Overall Study||297||
59764633|NCT03100747|75884730|FG000|STARTED|Overall Study||1631||2299
59764634|NCT03100747|75884731|FG001|STARTED|Overall Study||1648||2337
59764635|NCT03100747|75884732|FG002|STARTED|Overall Study||1635||2304
59764636|NCT03100747|75884730|FG000|Completed Week 6|Overall Study||1514||2132
59764637|NCT03100747|75884731|FG001|Completed Week 6|Overall Study||1498||2136
59764638|NCT03100747|75884732|FG002|Completed Week 6|Overall Study||1518||2148
59764639|NCT03100747|75884730|FG000|Completed Month 12|Overall Study||1467||2052
59764640|NCT03100747|75884731|FG001|Completed Month 12|Overall Study||1478||2097
59764641|NCT03100747|75884732|FG002|Completed Month 12|Overall Study||1468||2081
59764642|NCT03100747|75884730|FG000|Completed Week 6 and/or Month 12|Overall Study||1600|End of data collection for the primary outcome.|2257
59764643|NCT03100747|75884731|FG001|Completed Week 6 and/or Month 12|Overall Study||1609|End of data collection for the primary outcome.|2290
59764644|NCT03100747|75884732|FG002|Completed Week 6 and/or Month 12|Overall Study||1610|End of data collection for the primary outcome.|2268
59764645|NCT03100747|75884730|FG000|Completed Year 3|Overall Study||1253||1760
59764646|NCT03100747|75884731|FG001|Completed Year 3|Overall Study||1238||1757
59764647|NCT03100747|75884732|FG002|Completed Year 3|Overall Study||1261||1781
59764648|NCT03100747|75884730|FG000|COMPLETED|Overall Study||1253||1760
59764649|NCT03100747|75884731|FG001|COMPLETED|Overall Study||1238||1757
59764650|NCT03100747|75884732|FG002|COMPLETED|Overall Study||1261||1781
59764651|NCT03100747|75884730|FG000|NOT COMPLETED|Overall Study||378||539
59764652|NCT03100747|75884731|FG001|NOT COMPLETED|Overall Study||410||580
59764653|NCT03100747|75884732|FG002|NOT COMPLETED|Overall Study||374||523
59764654|NCT02918565|75884745|FG000|STARTED|Overall Study||220||
59764655|NCT02918565|75884746|FG001|STARTED|Overall Study||213||
59764656|NCT02918565|75884747|FG002|STARTED|Overall Study||232||
59764657|NCT02918565|75884748|FG003|STARTED|Overall Study||224||
59764658|NCT02918565|75884749|FG004|STARTED|Overall Study||242||
59764659|NCT02918565|75884745|FG000|COMPLETED|Overall Study||213||
59764660|NCT02918565|75884746|FG001|COMPLETED|Overall Study||202||
59764661|NCT02918565|75884747|FG002|COMPLETED|Overall Study||221||
59764662|NCT02918565|75884748|FG003|COMPLETED|Overall Study||216||
59764663|NCT02918565|75884749|FG004|COMPLETED|Overall Study||231||
59764664|NCT02918565|75884745|FG000|NOT COMPLETED|Overall Study||7||
59764665|NCT02918565|75884746|FG001|NOT COMPLETED|Overall Study||11||
59764666|NCT02918565|75884747|FG002|NOT COMPLETED|Overall Study||11||
59764667|NCT02918565|75884748|FG003|NOT COMPLETED|Overall Study||8||
60072300|NCT01698801|76187725|FG000|NOT COMPLETED|Follow Up Phase||5||
60072301|NCT01682811|76187737|FG000|STARTED|Part 1 Levulan Injection||1||9
59520768|NCT03807544|75614853|FG000|STARTED|Overall Study||17||
59520769|NCT03807544|75614853|FG000|COMPLETED|Overall Study||17||
59520770|NCT03807544|75614853|FG000|NOT COMPLETED|Overall Study||0||
59520771|NCT01170715|75614858|FG000|STARTED|Overall Study||21||
59520772|NCT01170715|75614858|FG000|COMPLETED|Overall Study||14||
59520773|NCT01170715|75614858|FG000|NOT COMPLETED|Overall Study||7||
59520774|NCT03809182|75614864|FG000|STARTED|Overall Study||20||
59520775|NCT03809182|75614865|FG001|STARTED|Overall Study||20||
59520776|NCT03809182|75614864|FG000|COMPLETED|Overall Study||20||
59520777|NCT03809182|75614865|FG001|COMPLETED|Overall Study||20||
59520778|NCT03809182|75614864|FG000|NOT COMPLETED|Overall Study||0||
59520779|NCT03809182|75614865|FG001|NOT COMPLETED|Overall Study||0||
59520780|NCT01170949|75614875|FG000|STARTED|Overall Study||50||
59520781|NCT01170949|75614876|FG001|STARTED|Overall Study||26||
59520782|NCT01170949|75614875|FG000|COMPLETED|Overall Study||43||
59520783|NCT01170949|75614876|FG001|COMPLETED|Overall Study||22||
59520784|NCT01170949|75614875|FG000|NOT COMPLETED|Overall Study||7||
59520785|NCT01170949|75614876|FG001|NOT COMPLETED|Overall Study||4||
59520786|NCT03805672|75614884|FG000|STARTED|Overall Study||2||
59520787|NCT03805672|75614885|FG001|STARTED|Overall Study||2||
59520788|NCT03805672|75614884|FG000|COMPLETED|Overall Study||2||
59520789|NCT03805672|75614885|FG001|COMPLETED|Overall Study||2||
59520790|NCT03805672|75614884|FG000|NOT COMPLETED|Overall Study||0||
59520791|NCT03805672|75614885|FG001|NOT COMPLETED|Overall Study||0||
59520792|NCT04158466|75614893|FG000|STARTED|Overall Study||124||
59520793|NCT04158466|75614894|FG001|STARTED|Overall Study||127||
59520794|NCT04158466|75614893|FG000|COMPLETED|Overall Study||121||
59520795|NCT04158466|75614894|FG001|COMPLETED|Overall Study||126||
59520796|NCT04158466|75614893|FG000|NOT COMPLETED|Overall Study||3||
59520797|NCT04158466|75614894|FG001|NOT COMPLETED|Overall Study||1||
59520798|NCT03802864|75614902|FG000|STARTED|Overall Study||25||
59520799|NCT03802864|75614903|FG001|STARTED|Overall Study||25||
59520800|NCT03802864|75614902|FG000|COMPLETED|Overall Study||25||
59520801|NCT03802864|75614903|FG001|COMPLETED|Overall Study||25||
59520802|NCT03802864|75614902|FG000|NOT COMPLETED|Overall Study||0||
59520803|NCT03802864|75614903|FG001|NOT COMPLETED|Overall Study||0||
59520804|NCT03797872|75614911|FG000|STARTED|Overall Study||1||
59520805|NCT03797872|75614912|FG001|STARTED|Overall Study||0||
59520806|NCT03797872|75614911|FG000|COMPLETED|Overall Study||0||
59520807|NCT03797872|75614912|FG001|COMPLETED|Overall Study||0||
59520808|NCT03797872|75614911|FG000|NOT COMPLETED|Overall Study||1||
59520809|NCT03797872|75614912|FG001|NOT COMPLETED|Overall Study||0||
59520810|NCT03782272|75614920|FG000|STARTED|Overall Study||6||
59520811|NCT03782272|75614921|FG001|STARTED|Overall Study||6||
59520812|NCT03782272|75614920|FG000|COMPLETED|Overall Study||6||
59520813|NCT03782272|75614921|FG001|COMPLETED|Overall Study||6||
59520814|NCT03782272|75614920|FG000|NOT COMPLETED|Overall Study||0||
59764668|NCT02918565|75884749|FG004|NOT COMPLETED|Overall Study||11||
59764669|NCT02887248|75884761|FG000|STARTED|Overall Study||3||
59764670|NCT02887248|75884761|FG000|COMPLETED|Overall Study||0||
60072302|NCT01682811|76187738|FG001|STARTED|Part 1 Levulan Injection||0||0
59520815|NCT03782272|75614921|FG001|NOT COMPLETED|Overall Study||0||
59520816|NCT01127581|75614930|FG000|STARTED|Overall Study||678||
59520817|NCT01127581|75614931|FG001|STARTED|Overall Study||680||
59520818|NCT01127581|75614930|FG000|COMPLETED|Overall Study||678||
59520819|NCT01127581|75614931|FG001|COMPLETED|Overall Study||680||
59520820|NCT01127581|75614930|FG000|NOT COMPLETED|Overall Study||0||
59520821|NCT01127581|75614931|FG001|NOT COMPLETED|Overall Study||0||
59520822|NCT03794752|75614937|FG000|STARTED|Overall Study||8||
59520823|NCT03794752|75614937|FG000|COMPLETED|Overall Study||8||
59520824|NCT03794752|75614937|FG000|NOT COMPLETED|Overall Study||0||
59520825|NCT04124536|75614950|FG000|STARTED|Overall Study||58||
59520826|NCT04124536|75614951|FG001|STARTED|Overall Study||58||
59520827|NCT04124536|75614952|FG002|STARTED|Overall Study||105||
59520828|NCT04124536|75614953|FG003|STARTED|Overall Study||105||
59520829|NCT04124536|75614954|FG004|STARTED|Overall Study||15||
59520830|NCT04124536|75614950|FG000|COMPLETED|Overall Study||47||
59520831|NCT04124536|75614951|FG001|COMPLETED|Overall Study||53||
59520832|NCT04124536|75614952|FG002|COMPLETED|Overall Study||102||
59520833|NCT04124536|75614953|FG003|COMPLETED|Overall Study||98||
59520834|NCT04124536|75614954|FG004|COMPLETED|Overall Study||15||
59520835|NCT04124536|75614950|FG000|NOT COMPLETED|Overall Study||11||
59520836|NCT04124536|75614951|FG001|NOT COMPLETED|Overall Study||5||
59520837|NCT04124536|75614952|FG002|NOT COMPLETED|Overall Study||3||
59520838|NCT04124536|75614953|FG003|NOT COMPLETED|Overall Study||7||
59520839|NCT04124536|75614954|FG004|NOT COMPLETED|Overall Study||0||
59520840|NCT01127737|75614967|FG000|STARTED|Overall Study||37||
59520841|NCT01127737|75614968|FG001|STARTED|Overall Study||38||
59520842|NCT01127737|75614967|FG000|COMPLETED|Overall Study||37||
59520843|NCT01127737|75614968|FG001|COMPLETED|Overall Study||38||
59520844|NCT01127737|75614967|FG000|NOT COMPLETED|Overall Study||0||
59520845|NCT01127737|75614968|FG001|NOT COMPLETED|Overall Study||0||
59520846|NCT03709810|75614974|FG000|STARTED|Treatment Period 1 (Visit 2)||24||
59520847|NCT03709810|75614975|FG001|STARTED|Treatment Period 1 (Visit 2)||24||
59520848|NCT03709810|75614974|FG000|COMPLETED|Treatment Period 1 (Visit 2)||24||
59520849|NCT03709810|75614975|FG001|COMPLETED|Treatment Period 1 (Visit 2)||24||
59764671|NCT02887248|75884761|FG000|NOT COMPLETED|Overall Study||3||
59764672|NCT02879448|75884767|FG000|STARTED|Overall Study||934||
59764673|NCT02879448|75884768|FG001|STARTED|Overall Study||944||
59764674|NCT02879448|75884767|FG000|COMPLETED|Overall Study||796||
59764675|NCT02879448|75884768|FG001|COMPLETED|Overall Study||742||
59764676|NCT02879448|75884767|FG000|NOT COMPLETED|Overall Study||138||
59764677|NCT02879448|75884768|FG001|NOT COMPLETED|Overall Study||202||
59764678|NCT02859064|75884774|FG000|STARTED|Overall Study||6||
59764679|NCT02859064|75884774|FG000|COMPLETED|Overall Study||0||
59764680|NCT02859064|75884774|FG000|NOT COMPLETED|Overall Study||6||
59764681|NCT02843074|75884778|FG000|STARTED|Overall Study||52||
59764682|NCT02843074|75884778|FG000|COMPLETED|Overall Study||35||
60072303|NCT01682811|76187739|FG002|STARTED|Part 1 Levulan Injection||0||0
60072304|NCT01682811|76187740|FG003|STARTED|Part 1 Levulan Injection||0||0
59520850|NCT03709810|75614974|FG000|NOT COMPLETED|Treatment Period 1 (Visit 2)||0||
59520851|NCT03709810|75614975|FG001|NOT COMPLETED|Treatment Period 1 (Visit 2)||0||
59764683|NCT02843074|75884778|FG000|NOT COMPLETED|Overall Study||17||
59764684|NCT02795156|75884786|FG000|STARTED|Overall Study||39||
59764685|NCT02795156|75884787|FG001|STARTED|Overall Study||10||
59764686|NCT02795156|75884788|FG002|STARTED|Overall Study||42||
59764687|NCT02795156|75884789|FG003|STARTED|Overall Study||9||
59764688|NCT02795156|75884786|FG000|COMPLETED|Overall Study||0||
59764689|NCT02795156|75884787|FG001|COMPLETED|Overall Study||0||
59764690|NCT02795156|75884788|FG002|COMPLETED|Overall Study||0||
59764691|NCT02795156|75884789|FG003|COMPLETED|Overall Study||0||
59764692|NCT02795156|75884786|FG000|NOT COMPLETED|Overall Study||39||
59764693|NCT02795156|75884787|FG001|NOT COMPLETED|Overall Study||10||
59764694|NCT02795156|75884788|FG002|NOT COMPLETED|Overall Study||42||
59764695|NCT02795156|75884789|FG003|NOT COMPLETED|Overall Study||9||
59764696|NCT02642094|75884805|FG000|STARTED|Overall Study||40||
59764697|NCT02642094|75884806|FG001|STARTED|Overall Study||18||
59817841|NCT04488770|75940332|FG006|STARTED|Part 1-Cohort 1: Period 4 (Up to 5 Days)||0||
59817842|NCT04488770|75940333|FG007|STARTED|Part 1-Cohort 1: Period 4 (Up to 5 Days)||0||
60072305|NCT01682811|76187741|FG004|STARTED|Part 1 Levulan Injection||0||0
60072306|NCT01682811|76187742|FG005|STARTED|Part 1 Levulan Injection||0||0
60072307|NCT01682811|76187743|FG006|STARTED|Part 1 Levulan Injection||0||0
60072308|NCT01682811|76187737|FG000|Control|Part 1 Levulan Injection||1||3
60072309|NCT01682811|76187738|FG001|Control|Part 1 Levulan Injection||0||0
59520852|NCT03709810|75614974|FG000|STARTED|Treatment Period 2 (Visit 3)||24||
59520853|NCT03709810|75614975|FG001|STARTED|Treatment Period 2 (Visit 3)||24||
59520854|NCT03709810|75614974|FG000|COMPLETED|Treatment Period 2 (Visit 3)||24||
59520855|NCT03709810|75614975|FG001|COMPLETED|Treatment Period 2 (Visit 3)||24||
59520856|NCT03709810|75614974|FG000|NOT COMPLETED|Treatment Period 2 (Visit 3)||0||
59520857|NCT03709810|75614975|FG001|NOT COMPLETED|Treatment Period 2 (Visit 3)||0||
59520858|NCT01128049|75614984|FG000|STARTED|Overall Study||5||
59520859|NCT01128049|75614985|FG001|STARTED|Overall Study||5||
59520860|NCT01128049|75614986|FG002|STARTED|Overall Study||5||
59764698|NCT02642094|75884805|FG000|COMPLETED|Overall Study|We enrolled 40 patients as of Feb. 2022, which is 67% of planned enrollment. Since COVID-19 started, it had been very difficult to enroll patients and to keep them on schedule for surgery, which was considered non-essential surgery and was often postponed.|38||
59764699|NCT02642094|75884806|FG001|COMPLETED|Overall Study||18||
59764700|NCT02642094|75884805|FG000|NOT COMPLETED|Overall Study||2||
59764701|NCT02642094|75884806|FG001|NOT COMPLETED|Overall Study||0||
59764702|NCT02636582|75884818|FG000|STARTED|Overall Study||4||
59764703|NCT02636582|75884819|FG001|STARTED|Overall Study||9||
59520861|NCT01128049|75614984|FG000|COMPLETED|Overall Study||5||
59520862|NCT01128049|75614985|FG001|COMPLETED|Overall Study||5||
59520863|NCT01128049|75614986|FG002|COMPLETED|Overall Study||5||
59520864|NCT01128049|75614984|FG000|NOT COMPLETED|Overall Study||0||
59520865|NCT01128049|75614985|FG001|NOT COMPLETED|Overall Study||0||
59520866|NCT01128049|75614986|FG002|NOT COMPLETED|Overall Study||0||
59520867|NCT03784300|75615000|FG000|STARTED|Overall Study||6||
59520868|NCT03784300|75615001|FG001|STARTED|Overall Study||2||
59520869|NCT03784300|75615002|FG002|STARTED|Overall Study||6||
59520870|NCT03784300|75615003|FG003|STARTED|Overall Study||2||
59520871|NCT03784300|75615004|FG004|STARTED|Overall Study||6||
59520872|NCT03784300|75615005|FG005|STARTED|Overall Study||2||
59520873|NCT03784300|75615000|FG000|COMPLETED|Overall Study||6||
59520874|NCT03784300|75615001|FG001|COMPLETED|Overall Study||2||
59520875|NCT03784300|75615002|FG002|COMPLETED|Overall Study||6||
59520876|NCT03784300|75615003|FG003|COMPLETED|Overall Study||2||
59520877|NCT03784300|75615004|FG004|COMPLETED|Overall Study||6||
59520878|NCT03784300|75615005|FG005|COMPLETED|Overall Study||2||
59520879|NCT03784300|75615000|FG000|NOT COMPLETED|Overall Study||0||
59520880|NCT03784300|75615001|FG001|NOT COMPLETED|Overall Study||0||
59520881|NCT03784300|75615002|FG002|NOT COMPLETED|Overall Study||0||
59520882|NCT03784300|75615003|FG003|NOT COMPLETED|Overall Study||0||
59520883|NCT03784300|75615004|FG004|NOT COMPLETED|Overall Study||0||
59520884|NCT03784300|75615005|FG005|NOT COMPLETED|Overall Study||0||
59520885|NCT02186665|75615021|FG000|STARTED|Overall Study||8||
59520886|NCT02186665|75615022|FG001|STARTED|Overall Study||11||
59520887|NCT02186665|75615021|FG000|COMPLETED|Overall Study||8||
59520888|NCT02186665|75615022|FG001|COMPLETED|Overall Study||10||
59520889|NCT02186665|75615021|FG000|NOT COMPLETED|Overall Study||0||
59520890|NCT02186665|75615022|FG001|NOT COMPLETED|Overall Study||1||
59520891|NCT03713398|75615030|FG000|STARTED|Overall Study||50||
59520892|NCT03713398|75615031|FG001|STARTED|Overall Study||50||
59520893|NCT03713398|75615030|FG000|COMPLETED|Overall Study||24||
59520894|NCT03713398|75615031|FG001|COMPLETED|Overall Study||23||
59520895|NCT03713398|75615030|FG000|NOT COMPLETED|Overall Study||26||
59520896|NCT03713398|75615031|FG001|NOT COMPLETED|Overall Study||27||
59520897|NCT01172197|75615039|FG000|STARTED|Overall Study||7||
59520898|NCT01172197|75615040|FG001|STARTED|Overall Study||7||
59520899|NCT01172197|75615039|FG000|COMPLETED|Overall Study||7||
59520900|NCT01172197|75615040|FG001|COMPLETED|Overall Study||7||
59520901|NCT01172197|75615039|FG000|NOT COMPLETED|Overall Study||0||
59520902|NCT01172197|75615040|FG001|NOT COMPLETED|Overall Study||0||
59520903|NCT03771274|75615046|FG000|STARTED|Overall Study||39||
59520904|NCT03771274|75615046|FG000|COMPLETED|Overall Study||39||
59520905|NCT03771274|75615046|FG000|NOT COMPLETED|Overall Study||0||
59764704|NCT02636582|75884818|FG000|At Surgery|Overall Study||4||
59764705|NCT02636582|75884819|FG001|At Surgery|Overall Study||9||
59764706|NCT02636582|75884818|FG000|1- Month Post-Op|Overall Study||4||
59764707|NCT02636582|75884819|FG001|1- Month Post-Op|Overall Study||9||
59764708|NCT02636582|75884818|FG000|3-6 Months Post-Op|Overall Study||3||
59764709|NCT02636582|75884819|FG001|3-6 Months Post-Op|Overall Study||9||
59764710|NCT02636582|75884818|FG000|COMPLETED|Overall Study||3||
59764711|NCT02636582|75884819|FG001|COMPLETED|Overall Study||9||
59764712|NCT02636582|75884818|FG000|NOT COMPLETED|Overall Study||1||
59764713|NCT02636582|75884819|FG001|NOT COMPLETED|Overall Study||0||
59764714|NCT02578914|75884827|FG000|STARTED|Overall Study||50||
59520906|NCT04141930|75615050|FG000|STARTED|Overall Study||302||
59520907|NCT04141930|75615051|FG001|STARTED|Overall Study|The 179 individuals that were not eligible to receive the study drug, participated in an observation portion of the study where all study procedures were the same excluding telehealth visit and an antiviral delivery.|179||
59520908|NCT04141930|75615050|FG000|COMPLETED|Overall Study||302||
59520909|NCT04141930|75615051|FG001|COMPLETED|Overall Study||179||
59520910|NCT04141930|75615050|FG000|NOT COMPLETED|Overall Study||0||
59520911|NCT04141930|75615051|FG001|NOT COMPLETED|Overall Study||0||
59520912|NCT04374565|75615055|FG000|STARTED|Overall Study||29||
59520913|NCT04374565|75615055|FG000|COMPLETED|Overall Study||29||
59520914|NCT04374565|75615055|FG000|NOT COMPLETED|Overall Study||0||
59520915|NCT01128829|75615059|FG000|STARTED|Overall Study||6||
59520916|NCT01128829|75615060|FG001|STARTED|Overall Study||11||
59520917|NCT01128829|75615059|FG000|COMPLETED|Overall Study||6||
59520918|NCT01128829|75615060|FG001|COMPLETED|Overall Study||11||
59520919|NCT01128829|75615059|FG000|NOT COMPLETED|Overall Study||0||
59520920|NCT01128829|75615060|FG001|NOT COMPLETED|Overall Study||0||
59520921|NCT01129141|75615066|FG000|STARTED|Overall Study||101||
59520922|NCT01129141|75615067|FG001|STARTED|Overall Study||104||
59520923|NCT01129141|75615066|FG000|COMPLETED|Overall Study||86||
59764715|NCT02578914|75884828|FG001|STARTED|Overall Study||50||
59764716|NCT02578914|75884827|FG000|COMPLETED|Overall Study||48||
59764717|NCT02578914|75884828|FG001|COMPLETED|Overall Study||50||
59764718|NCT02578914|75884827|FG000|NOT COMPLETED|Overall Study||2||
59764719|NCT02578914|75884828|FG001|NOT COMPLETED|Overall Study||0||
59764720|NCT02544035|75884842|FG000|STARTED|Overall Study||60||
59764721|NCT02544035|75884843|FG001|STARTED|Overall Study||61||
59764722|NCT02544035|75884844|FG002|STARTED|Overall Study||62||
59764723|NCT02544035|75884845|FG003|STARTED|Overall Study||60||
59764724|NCT02544035|75884846|FG004|STARTED|Overall Study||60||
59764725|NCT02544035|75884847|FG005|STARTED|Overall Study||61||
59764726|NCT02544035|75884848|FG006|STARTED|Overall Study||62||
59764727|NCT02544035|75884849|FG007|STARTED|Overall Study||60||
59764728|NCT02544035|75884842|FG000|COMPLETED|Overall Study||60||
59764729|NCT02544035|75884843|FG001|COMPLETED|Overall Study||61||
59764730|NCT02544035|75884844|FG002|COMPLETED|Overall Study||62||
59764731|NCT02544035|75884845|FG003|COMPLETED|Overall Study||60||
59764732|NCT02544035|75884846|FG004|COMPLETED|Overall Study||60||
59764733|NCT02544035|75884847|FG005|COMPLETED|Overall Study||61||
59764734|NCT02544035|75884848|FG006|COMPLETED|Overall Study||62||
59764735|NCT02544035|75884849|FG007|COMPLETED|Overall Study||60||
59764736|NCT02544035|75884842|FG000|NOT COMPLETED|Overall Study||0||
59764737|NCT02544035|75884843|FG001|NOT COMPLETED|Overall Study||0||
59764738|NCT02544035|75884844|FG002|NOT COMPLETED|Overall Study||0||
59764739|NCT02544035|75884845|FG003|NOT COMPLETED|Overall Study||0||
59764740|NCT02544035|75884846|FG004|NOT COMPLETED|Overall Study||0||
59764741|NCT02544035|75884847|FG005|NOT COMPLETED|Overall Study||0||
59764742|NCT02544035|75884848|FG006|NOT COMPLETED|Overall Study||0||
59764743|NCT02544035|75884849|FG007|NOT COMPLETED|Overall Study||0||
59764744|NCT02509546|75884873|FG000|STARTED|Overall Study||3||
59764745|NCT02509546|75884874|FG001|STARTED|Overall Study||3||
59764746|NCT02509546|75884875|FG002|STARTED|Overall Study||4||
59764747|NCT02509546|75884876|FG003|STARTED|Overall Study||2||
59764748|NCT02509546|75884877|FG004|STARTED|Overall Study||2||
59764749|NCT02509546|75884878|FG005|STARTED|Overall Study||6||
59764750|NCT02509546|75884873|FG000|COMPLETED|Overall Study||3||
59764751|NCT02509546|75884874|FG001|COMPLETED|Overall Study||3||
59764752|NCT02509546|75884875|FG002|COMPLETED|Overall Study||4||
59764753|NCT02509546|75884876|FG003|COMPLETED|Overall Study||2||
59764754|NCT02509546|75884877|FG004|COMPLETED|Overall Study||2||
59764755|NCT02509546|75884878|FG005|COMPLETED|Overall Study||6||
59764756|NCT02509546|75884873|FG000|NOT COMPLETED|Overall Study||0||
59764757|NCT02509546|75884874|FG001|NOT COMPLETED|Overall Study||0||
59764758|NCT02509546|75884875|FG002|NOT COMPLETED|Overall Study||0||
59764759|NCT02509546|75884876|FG003|NOT COMPLETED|Overall Study||0||
59764760|NCT02509546|75884877|FG004|NOT COMPLETED|Overall Study||0||
59764761|NCT02509546|75884878|FG005|NOT COMPLETED|Overall Study||0||
59764762|NCT02435849|75884895|FG000|STARTED|Overall Study||79|Started = Enrolled in All cohorts|
59764763|NCT02435849|75884896|FG001|STARTED|Overall Study||1|Started = Enrolled in All cohorts|
59764764|NCT02435849|75884895|FG000|Enrolled and Infused|Overall Study||79||
59520924|NCT01129141|75615067|FG001|COMPLETED|Overall Study||91||
59764765|NCT02435849|75884896|FG001|Enrolled and Infused|Overall Study||1||
59764766|NCT02435849|75884895|FG000|Discontinued Study Follow-up|Overall Study||48||
59764767|NCT02435849|75884896|FG001|Discontinued Study Follow-up|Overall Study||1||
59764768|NCT02435849|75884895|FG000|COMPLETED|Overall Study||31|Completed = study follow-up completed|
59764769|NCT02435849|75884896|FG001|COMPLETED|Overall Study||0|Completed = study follow-up completed|
59764770|NCT02435849|75884895|FG000|NOT COMPLETED|Overall Study||48||
59764771|NCT02435849|75884896|FG001|NOT COMPLETED|Overall Study||1||
59764772|NCT02318784|75884902|FG000|STARTED|Overall Study||62||
59764773|NCT02318784|75884902|FG000|COMPLETED|Overall Study||0||
59764774|NCT02318784|75884902|FG000|NOT COMPLETED|Overall Study||62||
59764775|NCT02195011|75884908|FG000|STARTED|Overall Study||25||
59764776|NCT02195011|75884909|FG001|STARTED|Overall Study||1||
59764777|NCT02195011|75884908|FG000|COMPLETED|Overall Study||0||
59764778|NCT02195011|75884909|FG001|COMPLETED|Overall Study||0||
59764779|NCT02195011|75884908|FG000|NOT COMPLETED|Overall Study||25||
59764780|NCT02195011|75884909|FG001|NOT COMPLETED|Overall Study||1||
59764781|NCT02087501|75884915|FG000|STARTED|Overall Study||30||
59764782|NCT02087501|75884915|FG000|COMPLETED|Overall Study||20||
59764783|NCT02087501|75884915|FG000|NOT COMPLETED|Overall Study||10||
59764784|NCT01897454|75884921|FG000|STARTED|Overall Study||23||
59764785|NCT01897454|75884921|FG000|COMPLETED|Overall Study||22||
59764786|NCT01897454|75884921|FG000|NOT COMPLETED|Overall Study||1||
59764787|NCT01856023|75884927|FG000|STARTED|Overall Study||13|I pt withdrew consent prior to receiving study drug- should have been listed as screen failure|
59764788|NCT01856023|75884928|FG001|STARTED|Overall Study||16|I pt withdrew consent prior to receiving study drug- should have been listed as screen failure|
59764789|NCT01856023|75884927|FG000|Intent to Treat: Received One Dose of Study Drug|Overall Study||12||
59764790|NCT01856023|75884928|FG001|Intent to Treat: Received One Dose of Study Drug|Overall Study||16||
59764791|NCT01856023|75884927|FG000|Evaluable: Received 50% of Each Study Drug|Overall Study||8||
59764792|NCT01856023|75884928|FG001|Evaluable: Received 50% of Each Study Drug|Overall Study||10||
59764793|NCT01856023|75884927|FG000|COMPLETED|Overall Study||3|completed all study requirements|
59520925|NCT01129141|75615066|FG000|NOT COMPLETED|Overall Study||15||
59520926|NCT01129141|75615067|FG001|NOT COMPLETED|Overall Study||13||
59520927|NCT04138498|75615077|FG000|STARTED|Overall Study||11||
59520928|NCT04138498|75615078|FG001|STARTED|Overall Study||10||
59520929|NCT04138498|75615079|FG002|STARTED|Overall Study||12||
59520930|NCT04138498|75615080|FG003|STARTED|Overall Study||12||
59520931|NCT04138498|75615077|FG000|COMPLETED|Overall Study||10||
59520932|NCT04138498|75615078|FG001|COMPLETED|Overall Study||10||
59520933|NCT04138498|75615079|FG002|COMPLETED|Overall Study||10||
59520934|NCT04138498|75615080|FG003|COMPLETED|Overall Study||9||
59520935|NCT04138498|75615077|FG000|NOT COMPLETED|Overall Study||1||
59520936|NCT04138498|75615078|FG001|NOT COMPLETED|Overall Study||0||
59520937|NCT04138498|75615079|FG002|NOT COMPLETED|Overall Study||2||
59520938|NCT04138498|75615080|FG003|NOT COMPLETED|Overall Study||3||
59520939|NCT03714256|75615096|FG000|STARTED|Overall Study||14||
59520940|NCT03714256|75615097|FG001|STARTED|Overall Study||19||
59520941|NCT03714256|75615096|FG000|COMPLETED|Overall Study||14||
59520942|NCT03714256|75615097|FG001|COMPLETED|Overall Study||19||
59520943|NCT03714256|75615096|FG000|NOT COMPLETED|Overall Study||0||
59520944|NCT03714256|75615097|FG001|NOT COMPLETED|Overall Study||0||
59520945|NCT03715426|75615105|FG000|STARTED|Overall Study||133||
59520946|NCT03715426|75615106|FG001|STARTED|Overall Study||117||
59520947|NCT03715426|75615105|FG000|1-Month Follow-Up Survey|Overall Study||113||
59520948|NCT03715426|75615106|FG001|1-Month Follow-Up Survey|Overall Study||97||
59617644|NCT01386606|75728784|FG001|STARTED|Overall Study||14||
59617645|NCT01386606|75728785|FG002|STARTED|Overall Study||16||
59617646|NCT01386606|75728786|FG003|STARTED|Overall Study||14||
59617647|NCT01386606|75728783|FG000|COMPLETED|Overall Study||12||
59617648|NCT01386606|75728784|FG001|COMPLETED|Overall Study||10||
59617649|NCT01386606|75728785|FG002|COMPLETED|Overall Study||13||
59617650|NCT01386606|75728786|FG003|COMPLETED|Overall Study||13||
59617651|NCT01386606|75728783|FG000|NOT COMPLETED|Overall Study||4||
59617652|NCT01386606|75728784|FG001|NOT COMPLETED|Overall Study||4||
59617653|NCT01386606|75728785|FG002|NOT COMPLETED|Overall Study||3||
59617654|NCT01386606|75728786|FG003|NOT COMPLETED|Overall Study||1||
59617655|NCT01385748|75728803|FG000|STARTED|Overall Study||56||
59617656|NCT01385748|75728804|FG001|STARTED|Overall Study||65||
59617657|NCT01385748|75728805|FG002|STARTED|Overall Study||62||
59617658|NCT01385748|75728803|FG000|COMPLETED|Overall Study||41||
59617659|NCT01385748|75728804|FG001|COMPLETED|Overall Study||51||
59617660|NCT01385748|75728805|FG002|COMPLETED|Overall Study||49||
59617661|NCT01385748|75728803|FG000|NOT COMPLETED|Overall Study||15||
59617662|NCT01385748|75728804|FG001|NOT COMPLETED|Overall Study||14||
59617663|NCT01385748|75728805|FG002|NOT COMPLETED|Overall Study||13||
59617664|NCT01397448|75728820|FG000|STARTED|Overall Study||156||
59617665|NCT01397448|75728821|FG001|STARTED|Overall Study|158 participants were randomized but 1 participant was not treated with drug.|157||
59617666|NCT01397448|75728822|FG002|STARTED|Overall Study||158||
59617667|NCT01397448|75728820|FG000|COMPLETED|Overall Study||138||
59617668|NCT01397448|75728821|FG001|COMPLETED|Overall Study||142||
59617669|NCT01397448|75728822|FG002|COMPLETED|Overall Study||140||
59617670|NCT01397448|75728820|FG000|NOT COMPLETED|Overall Study||18||
59617671|NCT01397448|75728821|FG001|NOT COMPLETED|Overall Study||15||
59617672|NCT01397448|75728822|FG002|NOT COMPLETED|Overall Study||18||
59617673|NCT01385202|75728830|FG000|STARTED|Overall Study|Per protocol, enrolled subjects were defined as those who signed inform consent form.|172||
59617674|NCT01385202|75728830|FG000|Study Catheter Inserted|Overall Study||161||
59617675|NCT01385202|75728830|FG000|Undergoing Ablation|Overall Study||160||
59617676|NCT01385202|75728830|FG000|COMPLETED|Overall Study||154||
59617677|NCT01385202|75728830|FG000|NOT COMPLETED|Overall Study||18||
59617678|NCT01384734|75728841|FG000|STARTED|Overall Study||50||
59617679|NCT01384734|75728842|FG001|STARTED|Overall Study||49||
59617680|NCT01384734|75728843|FG002|STARTED|Overall Study||51||
59617681|NCT01384734|75728844|FG003|STARTED|Overall Study||50||
59617682|NCT01384734|75728845|FG004|STARTED|Overall Study||51||
59617683|NCT01384734|75728841|FG000|COMPLETED|Overall Study||33||
59617684|NCT01384734|75728842|FG001|COMPLETED|Overall Study||25||
59617685|NCT01384734|75728843|FG002|COMPLETED|Overall Study||28||
59764794|NCT01856023|75884928|FG001|COMPLETED|Overall Study||4|completed all study requirements|
59520949|NCT03715426|75615105|FG000|4-Month Follow-Up Survey|Overall Study||112||
59520950|NCT03715426|75615106|FG001|4-Month Follow-Up Survey|Overall Study||92||
59617686|NCT01384734|75728844|FG003|COMPLETED|Overall Study||22||
59520951|NCT03715426|75615105|FG000|COMPLETED|Overall Study||112||
59520952|NCT03715426|75615106|FG001|COMPLETED|Overall Study||92||
59520953|NCT03715426|75615105|FG000|NOT COMPLETED|Overall Study||21||
59520954|NCT03715426|75615106|FG001|NOT COMPLETED|Overall Study||25||
59520955|NCT01129531|75615115|FG000|STARTED|Treatment Cycle 1||84||
59520956|NCT01129531|75615116|FG001|STARTED|Treatment Cycle 1||84||
59520957|NCT01129531|75615117|FG002|STARTED|Treatment Cycle 1||126||
59520958|NCT01129531|75615115|FG000|COMPLETED|Treatment Cycle 1||80||
59520959|NCT01129531|75615116|FG001|COMPLETED|Treatment Cycle 1||78||
59520960|NCT01129531|75615117|FG002|COMPLETED|Treatment Cycle 1||110||
59617687|NCT01384734|75728845|FG004|COMPLETED|Overall Study||22||
59617688|NCT01384734|75728841|FG000|NOT COMPLETED|Overall Study||17||
59617689|NCT01384734|75728842|FG001|NOT COMPLETED|Overall Study||24||
59764795|NCT01856023|75884927|FG000|NOT COMPLETED|Overall Study||10||
59764796|NCT01856023|75884928|FG001|NOT COMPLETED|Overall Study||12||
59764797|NCT01364597|75884940|FG000|STARTED|Overall Study||36||
59764798|NCT01364597|75884941|FG001|STARTED|Overall Study||15||
59764799|NCT01364597|75884942|FG002|STARTED|Overall Study||141||
59764800|NCT01364597|75884943|FG003|STARTED|Overall Study||65||
59764801|NCT01364597|75884940|FG000|Directly Enrolled (DE) Participants|Overall Study||0||
59764802|NCT01364597|75884941|FG001|Directly Enrolled (DE) Participants|Overall Study||0||
59764803|NCT01364597|75884942|FG002|Directly Enrolled (DE) Participants|Overall Study||85||
59764804|NCT01364597|75884943|FG003|Directly Enrolled (DE) Participants|Overall Study||35||
59764805|NCT01364597|75884940|FG000|Long-term Follow-up (LTFU) Participants|Overall Study||36||
59764806|NCT01364597|75884941|FG001|Long-term Follow-up (LTFU) Participants|Overall Study||15||
59764807|NCT01364597|75884942|FG002|Long-term Follow-up (LTFU) Participants|Overall Study||56||
59764808|NCT01364597|75884943|FG003|Long-term Follow-up (LTFU) Participants|Overall Study||30||
59764809|NCT01364597|75884940|FG000|COMPLETED|Overall Study||18||
59764810|NCT01364597|75884941|FG001|COMPLETED|Overall Study||4||
59764811|NCT01364597|75884942|FG002|COMPLETED|Overall Study||65||
59764812|NCT01364597|75884943|FG003|COMPLETED|Overall Study||37||
59764813|NCT01364597|75884940|FG000|NOT COMPLETED|Overall Study||18||
59764814|NCT01364597|75884941|FG001|NOT COMPLETED|Overall Study||11||
59764815|NCT01364597|75884942|FG002|NOT COMPLETED|Overall Study||76||
59764816|NCT01364597|75884943|FG003|NOT COMPLETED|Overall Study||28||
59764817|NCT01311648|75884959|FG000|STARTED|Main Study||51||
59764818|NCT01311648|75884960|FG001|STARTED|Main Study||43||
59764819|NCT01311648|75884959|FG000|Started 0-<6 Years|Main Study||25||
59764820|NCT01311648|75884960|FG001|Started 0-<6 Years|Main Study||43||
59764821|NCT01311648|75884959|FG000|Started 6-12 Years|Main Study||26||
59764822|NCT01311648|75884960|FG001|Started 6-12 Years|Main Study||0||
59764823|NCT01311648|75884959|FG000|COMPLETED|Main Study||51||
59764824|NCT01311648|75884960|FG001|COMPLETED|Main Study||22||
59764825|NCT01311648|75884959|FG000|NOT COMPLETED|Main Study||0||
59764826|NCT01311648|75884960|FG001|NOT COMPLETED|Main Study||21||
59764827|NCT01311648|75884959|FG000|STARTED|Extension Study||46||
59764828|NCT01311648|75884960|FG001|STARTED|Extension Study||36||
59764829|NCT01311648|75884959|FG000|COMPLETED|Extension Study||45||
59764830|NCT01311648|75884960|FG001|COMPLETED|Extension Study||25||
59764831|NCT01311648|75884959|FG000|NOT COMPLETED|Extension Study||1||
59764832|NCT01311648|75884960|FG001|NOT COMPLETED|Extension Study||11||
59764833|NCT00759096|75884973|FG000|STARTED|Overall Study||30||
59764834|NCT00759096|75884973|FG000|COMPLETED|Overall Study||30||
59764835|NCT00759096|75884973|FG000|NOT COMPLETED|Overall Study||0||
59764836|NCT00758342|75884979|FG000|STARTED|Overall Study||19||
59764837|NCT00758342|75884980|FG001|STARTED|Overall Study||18||
59764838|NCT00758342|75884979|FG000|COMPLETED|Overall Study||15||
59764839|NCT00758342|75884980|FG001|COMPLETED|Overall Study||17||
59764840|NCT00758342|75884979|FG000|NOT COMPLETED|Overall Study||4||
59952029|NCT00834990|76070957|FG001|STARTED|Second Intervention||11||
59952030|NCT00834990|76070956|FG000|COMPLETED|Second Intervention||12||
59952031|NCT00834990|76070957|FG001|COMPLETED|Second Intervention||11||
59952032|NCT00834990|76070956|FG000|NOT COMPLETED|Second Intervention||0||
59952033|NCT00834990|76070957|FG001|NOT COMPLETED|Second Intervention||0||
59952034|NCT02597452|76070961|FG000|STARTED|Overall Study||516||
59952035|NCT02597452|76070961|FG000|COMPLETED|Overall Study||486||
59764841|NCT00758342|75884980|FG001|NOT COMPLETED|Overall Study||1||
59764842|NCT00470704|75884988|FG000|STARTED|Overall Study||41||
59764843|NCT00470704|75884989|FG001|STARTED|Overall Study||46||
59764844|NCT00470704|75884988|FG000|Safety Population|Overall Study||41||
59764845|NCT00470704|75884989|FG001|Safety Population|Overall Study||45||
59764846|NCT00470704|75884988|FG000|Treated|Overall Study||40||
59952036|NCT02597452|76070961|FG000|NOT COMPLETED|Overall Study||30||
59952037|NCT00834756|76070967|FG000|STARTED|First Intervention||18||
59952038|NCT00834756|76070968|FG001|STARTED|First Intervention||18||
59764847|NCT00470704|75884989|FG001|Treated|Overall Study||45||
59764848|NCT00470704|75884988|FG000|COMPLETED|Overall Study||0||
59764849|NCT00470704|75884989|FG001|COMPLETED|Overall Study||0||
59952039|NCT00834756|76070967|FG000|COMPLETED|First Intervention||17||
59952040|NCT00834756|76070968|FG001|COMPLETED|First Intervention||18||
59952041|NCT00834756|76070967|FG000|NOT COMPLETED|First Intervention||1||
59952042|NCT00834756|76070968|FG001|NOT COMPLETED|First Intervention||0||
59764850|NCT00470704|75884988|FG000|NOT COMPLETED|Overall Study||41||
59764851|NCT00470704|75884989|FG001|NOT COMPLETED|Overall Study||46||
59764852|NCT00385697|75885000|FG000|STARTED|Open-label Segment 1||38||
59764853|NCT00385697|75885001|FG001|STARTED|Open-label Segment 1||0||
59764854|NCT00385697|75885002|FG002|STARTED|Open-label Segment 1||0||
59764855|NCT00385697|75885003|FG003|STARTED|Open-label Segment 1||0||
59764856|NCT00385697|75885004|FG004|STARTED|Open-label Segment 1||0||
59764857|NCT00385697|75885000|FG000|COMPLETED|Open-label Segment 1||35||
59764858|NCT00385697|75885001|FG001|COMPLETED|Open-label Segment 1||0||
59764859|NCT00385697|75885002|FG002|COMPLETED|Open-label Segment 1||0||
59764860|NCT00385697|75885003|FG003|COMPLETED|Open-label Segment 1||0||
59764861|NCT00385697|75885004|FG004|COMPLETED|Open-label Segment 1||0||
59764862|NCT00385697|75885000|FG000|NOT COMPLETED|Open-label Segment 1||3||
59764863|NCT00385697|75885001|FG001|NOT COMPLETED|Open-label Segment 1||0||
59764864|NCT00385697|75885002|FG002|NOT COMPLETED|Open-label Segment 1||0||
59764865|NCT00385697|75885003|FG003|NOT COMPLETED|Open-label Segment 1||0||
59764866|NCT00385697|75885004|FG004|NOT COMPLETED|Open-label Segment 1||0||
59764867|NCT00385697|75885000|FG000|STARTED|Double-blind Segment 2||0||
59764868|NCT00385697|75885001|FG001|STARTED|Double-blind Segment 2|2 patients were randomized but not dosed, so are not included in baseline demographics or region of enrollment.|209||
59764869|NCT00385697|75885002|FG002|STARTED|Double-blind Segment 2||102||
59764870|NCT00385697|75885003|FG003|STARTED|Double-blind Segment 2||106||
59764871|NCT00385697|75885004|FG004|STARTED|Double-blind Segment 2|1 patient was randomized and not dosed, so not included in baseline demographics or region of enrollment..|99||
59764872|NCT00385697|75885000|FG000|Full Analysis Set (FAS) Population|Double-blind Segment 2||0|Randomized subjects that received any amount of study treatment, analyzed according to randomization.|
59764873|NCT00385697|75885001|FG001|Full Analysis Set (FAS) Population|Double-blind Segment 2||207|Randomized subjects that received any amount of study treatment, analyzed according to randomization.|
59764874|NCT00385697|75885002|FG002|Full Analysis Set (FAS) Population|Double-blind Segment 2||102|Randomized subjects that received any amount of study treatment, analyzed according to randomization.|
59764875|NCT00385697|75885003|FG003|Full Analysis Set (FAS) Population|Double-blind Segment 2||106|Randomized subjects that received any amount of study treatment, analyzed according to randomization.|
59764876|NCT00385697|75885004|FG004|Full Analysis Set (FAS) Population|Double-blind Segment 2||98|Randomized subjects that received any amount of study treatment, analyzed according to randomization.|
59764877|NCT00385697|75885000|FG000|Safety Population|Double-blind Segment 2||0|Randomized subjects that received any amount of study treatment, analyzed according to actual treatment received.|
59764878|NCT00385697|75885001|FG001|Safety Population|Double-blind Segment 2||207|Randomized subjects that received any amount of study treatment, analyzed according to actual treatment received.|
59764879|NCT00385697|75885002|FG002|Safety Population|Double-blind Segment 2||102|Randomized subjects that received any amount of study treatment, analyzed according to actual treatment received.|
59764880|NCT00385697|75885003|FG003|Safety Population|Double-blind Segment 2||106|Randomized subjects that received any amount of study treatment, analyzed according to actual treatment received.|
59764881|NCT00385697|75885004|FG004|Safety Population|Double-blind Segment 2||98|Randomized subjects that received any amount of study treatment, analyzed according to actual treatment received.|
59764882|NCT00385697|75885000|FG000|COMPLETED|Double-blind Segment 2||0||
59617690|NCT01384734|75728843|FG002|NOT COMPLETED|Overall Study||23||
59617691|NCT01384734|75728844|FG003|NOT COMPLETED|Overall Study||28||
59617692|NCT01384734|75728845|FG004|NOT COMPLETED|Overall Study||29||
59617693|NCT01396512|75728856|FG000|STARTED|Overall Study||137||
59617694|NCT01396512|75728857|FG001|STARTED|Overall Study||137||
59617695|NCT01396512|75728856|FG000|COMPLETED|Overall Study||137||
59764883|NCT00385697|75885001|FG001|COMPLETED|Double-blind Segment 2||183||
59764884|NCT00385697|75885002|FG002|COMPLETED|Double-blind Segment 2||90||
59764885|NCT00385697|75885003|FG003|COMPLETED|Double-blind Segment 2||97||
59764886|NCT00385697|75885004|FG004|COMPLETED|Double-blind Segment 2||92||
59764887|NCT00385697|75885000|FG000|NOT COMPLETED|Double-blind Segment 2||0||
59764888|NCT00385697|75885001|FG001|NOT COMPLETED|Double-blind Segment 2||26||
59764889|NCT00385697|75885002|FG002|NOT COMPLETED|Double-blind Segment 2||12||
59764890|NCT00385697|75885003|FG003|NOT COMPLETED|Double-blind Segment 2||9||
59764891|NCT00385697|75885004|FG004|NOT COMPLETED|Double-blind Segment 2||7||
59764892|NCT00385697|75885000|FG000|STARTED|Long-term Follow up Segment 3||35||
59764893|NCT00385697|75885001|FG001|STARTED|Long-term Follow up Segment 3||183||
59764894|NCT00385697|75885002|FG002|STARTED|Long-term Follow up Segment 3||90||
59764895|NCT00385697|75885003|FG003|STARTED|Long-term Follow up Segment 3||97||
59764896|NCT00385697|75885004|FG004|STARTED|Long-term Follow up Segment 3||92||
59764897|NCT00385697|75885000|FG000|COMPLETED|Long-term Follow up Segment 3||35||
59764898|NCT00385697|75885001|FG001|COMPLETED|Long-term Follow up Segment 3||183||
59764899|NCT00385697|75885002|FG002|COMPLETED|Long-term Follow up Segment 3||90||
59764900|NCT00385697|75885003|FG003|COMPLETED|Long-term Follow up Segment 3||97||
59952043|NCT00834756|76070967|FG000|STARTED|Washout: 21 Days||17||
59952044|NCT00834756|76070968|FG001|STARTED|Washout: 21 Days||18||
59764901|NCT00385697|75885004|FG004|COMPLETED|Long-term Follow up Segment 3||92||
59764902|NCT00385697|75885000|FG000|NOT COMPLETED|Long-term Follow up Segment 3||0||
59952045|NCT00834756|76070967|FG000|COMPLETED|Washout: 21 Days||16||
59617696|NCT01396512|75728857|FG001|COMPLETED|Overall Study||136||
59617697|NCT01396512|75728856|FG000|NOT COMPLETED|Overall Study||0||
59764903|NCT00385697|75885001|FG001|NOT COMPLETED|Long-term Follow up Segment 3||0||
59764904|NCT00385697|75885002|FG002|NOT COMPLETED|Long-term Follow up Segment 3||0||
59764905|NCT00385697|75885003|FG003|NOT COMPLETED|Long-term Follow up Segment 3||0||
59764906|NCT00385697|75885004|FG004|NOT COMPLETED|Long-term Follow up Segment 3||0||
59764907|NCT00490945|75885022|FG000|STARTED|Overall Study||8||
59764908|NCT00490945|75885023|FG001|STARTED|Overall Study||9||
59764909|NCT00490945|75885024|FG002|STARTED|Overall Study||8||
59764910|NCT00490945|75885025|FG003|STARTED|Overall Study||7||
59764911|NCT00490945|75885026|FG004|STARTED|Overall Study||7||
59764912|NCT00490945|75885022|FG000|COMPLETED|Overall Study||8||
59764913|NCT00490945|75885023|FG001|COMPLETED|Overall Study||8||
59764914|NCT00490945|75885024|FG002|COMPLETED|Overall Study||8||
59764915|NCT00490945|75885025|FG003|COMPLETED|Overall Study||7||
59764916|NCT00490945|75885026|FG004|COMPLETED|Overall Study||7||
59764917|NCT00490945|75885022|FG000|NOT COMPLETED|Overall Study||0||
59764918|NCT00490945|75885023|FG001|NOT COMPLETED|Overall Study||1||
59764919|NCT00490945|75885024|FG002|NOT COMPLETED|Overall Study||0||
59764920|NCT00490945|75885025|FG003|NOT COMPLETED|Overall Study||0||
59764921|NCT00490945|75885026|FG004|NOT COMPLETED|Overall Study||0||
59764922|NCT00879398|75885044|FG000|STARTED|Overall Study||3109||
59764923|NCT00879398|75885044|FG000|COMPLETED|Overall Study||2434||
59764924|NCT00879398|75885044|FG000|NOT COMPLETED|Overall Study||675||
59764925|NCT00696436|75885053|FG000|STARTED|Overall Study|Randomized participants only.|280||
59764926|NCT00696436|75885054|FG001|STARTED|Overall Study|Randomized participants only. One participant treated but not randomized and is not included.|285||
59764927|NCT00696436|75885055|FG002|STARTED|Overall Study|Randomized participants only.|282||
59764928|NCT00696436|75885056|FG003|STARTED|Overall Study|Randomized participants only.|290||
59764929|NCT00696436|75885057|FG004|STARTED|Overall Study|Randomized participants only.|154||
59764930|NCT00696436|75885053|FG000|COMPLETED|Overall Study||257||
59764931|NCT00696436|75885054|FG001|COMPLETED|Overall Study||255||
59764932|NCT00696436|75885055|FG002|COMPLETED|Overall Study||254||
59764933|NCT00696436|75885056|FG003|COMPLETED|Overall Study||268||
59764934|NCT00696436|75885057|FG004|COMPLETED|Overall Study||141||
59764935|NCT00696436|75885053|FG000|NOT COMPLETED|Overall Study||23||
59764936|NCT00696436|75885054|FG001|NOT COMPLETED|Overall Study||30||
59764937|NCT00696436|75885055|FG002|NOT COMPLETED|Overall Study||28||
59764938|NCT00696436|75885056|FG003|NOT COMPLETED|Overall Study||22||
59764939|NCT00696436|75885057|FG004|NOT COMPLETED|Overall Study||13||
59764940|NCT00878072|75885069|FG000|STARTED|Overall Study||53||
59764941|NCT00878072|75885069|FG000|COMPLETED|Overall Study||51||
59764942|NCT00878072|75885069|FG000|NOT COMPLETED|Overall Study||2||
59764943|NCT03045341|75885082|FG000|STARTED|Overall Study||34||
59764944|NCT03045341|75885083|FG001|STARTED|Overall Study||32||
59764945|NCT03045341|75885084|FG002|STARTED|Overall Study||35||
59764946|NCT03045341|75885085|FG003|STARTED|Overall Study||35||
59764947|NCT03045341|75885082|FG000|COMPLETED|Overall Study||29||
59764948|NCT03045341|75885083|FG001|COMPLETED|Overall Study||27||
59764949|NCT03045341|75885084|FG002|COMPLETED|Overall Study||27||
59764950|NCT03045341|75885085|FG003|COMPLETED|Overall Study||29||
59764951|NCT03045341|75885082|FG000|NOT COMPLETED|Overall Study||5||
59764952|NCT03045341|75885083|FG001|NOT COMPLETED|Overall Study||5||
59764953|NCT03045341|75885084|FG002|NOT COMPLETED|Overall Study||8||
59764954|NCT03045341|75885085|FG003|NOT COMPLETED|Overall Study||6||
59764955|NCT00594854|75885097|FG000|STARTED|Overall Study||9||
59764956|NCT00594854|75885098|FG001|STARTED|Overall Study||11||
59764957|NCT00594854|75885097|FG000|COMPLETED|Overall Study|POZEN reached an agreement with the FDA to terminate the study due to low and inadequate enrollment.|2||
59764958|NCT00594854|75885098|FG001|COMPLETED|Overall Study|POZEN reached an agreement with the FDA to terminate the study due to low and inadequate enrollment.|1||
59764959|NCT00594854|75885097|FG000|NOT COMPLETED|Overall Study||7||
59764960|NCT00594854|75885098|FG001|NOT COMPLETED|Overall Study||10||
59764961|NCT00855582|75885107|FG000|STARTED|Overall Study||198||
59764962|NCT00855582|75885108|FG001|STARTED|Overall Study||208||
59764963|NCT00855582|75885109|FG002|STARTED|Overall Study||200||
59764964|NCT00855582|75885107|FG000|COMPLETED|Overall Study||172||
59764965|NCT00855582|75885108|FG001|COMPLETED|Overall Study||184||
59764966|NCT00855582|75885109|FG002|COMPLETED|Overall Study||170||
59617698|NCT01396512|75728857|FG001|NOT COMPLETED|Overall Study||1||
59617699|NCT01396434|75728866|FG000|STARTED|Overall Study||2817||
59617700|NCT01396434|75728867|FG001|STARTED|Overall Study||175||
59617701|NCT01396434|75728868|FG002|STARTED|Overall Study||14||
59617702|NCT01396434|75728866|FG000|COMPLETED|Overall Study||2806||
59764967|NCT00855582|75885107|FG000|NOT COMPLETED|Overall Study||26||
59764968|NCT00855582|75885108|FG001|NOT COMPLETED|Overall Study||24||
59764969|NCT00855582|75885109|FG002|NOT COMPLETED|Overall Study||30||
59764970|NCT00854724|75885122|FG000|STARTED|First Intervention||8||
59764971|NCT00854724|75885123|FG001|STARTED|First Intervention||8||
59764972|NCT00854724|75885122|FG000|COMPLETED|First Intervention||7||
59764973|NCT00854724|75885123|FG001|COMPLETED|First Intervention||7||
59764974|NCT00854724|75885122|FG000|NOT COMPLETED|First Intervention||1||
59764975|NCT00854724|75885123|FG001|NOT COMPLETED|First Intervention||1||
59617703|NCT01396434|75728867|FG001|COMPLETED|Overall Study||175||
59617704|NCT01396434|75728868|FG002|COMPLETED|Overall Study||14||
59764976|NCT00854724|75885122|FG000|STARTED|Washout||7||
59764977|NCT00854724|75885123|FG001|STARTED|Washout||7||
59764978|NCT00854724|75885122|FG000|COMPLETED|Washout||6||
59764979|NCT00854724|75885123|FG001|COMPLETED|Washout||6||
59764980|NCT00854724|75885122|FG000|NOT COMPLETED|Washout||1||
59764981|NCT00854724|75885123|FG001|NOT COMPLETED|Washout||1||
59764982|NCT00854724|75885122|FG000|STARTED|Second Intervention||6||
59617705|NCT01396434|75728866|FG000|NOT COMPLETED|Overall Study||11||
59617706|NCT01396434|75728867|FG001|NOT COMPLETED|Overall Study||0||
59617707|NCT01396434|75728868|FG002|NOT COMPLETED|Overall Study||0||
59617708|NCT01383954|75728876|FG000|STARTED|Overall Study||52||
59617709|NCT01383954|75728876|FG000|Safety Population: Received Treatment|Overall Study||48||
59617710|NCT01383954|75728876|FG000|COMPLETED|Overall Study||38|Completed = completed at least 2 weeks of being on study medication|
59617711|NCT01383954|75728876|FG000|NOT COMPLETED|Overall Study||14||
59617712|NCT01383486|75728880|FG000|STARTED|Overall Study|Number of participants who were provided with investigational products|253||
59617713|NCT01383486|75728880|FG000|Treated|Overall Study|Number of participants who took any study medication (Safety Population)|237||
59617714|NCT01383486|75728880|FG000|COMPLETED|Overall Study|Took any study medication and gave estimated duration of pain (Selection Evaluation Population)|235||
59617715|NCT01383486|75728880|FG000|NOT COMPLETED|Overall Study||18||
59764983|NCT00854724|75885123|FG001|STARTED|Second Intervention||6||
59764984|NCT00854724|75885122|FG000|COMPLETED|Second Intervention||5||
59764985|NCT00854724|75885123|FG001|COMPLETED|Second Intervention||5||
59764986|NCT00854724|75885122|FG000|NOT COMPLETED|Second Intervention||1||
59764987|NCT00854724|75885123|FG001|NOT COMPLETED|Second Intervention||1||
59764988|NCT04653766|75885134|FG000|STARTED|Overall Study||6||
59764989|NCT04653766|75885135|FG001|STARTED|Overall Study||6||
59764990|NCT04653766|75885136|FG002|STARTED|Overall Study||6||
59764991|NCT04653766|75885137|FG003|STARTED|Overall Study||6||
59764992|NCT04653766|75885138|FG004|STARTED|Overall Study||8||
59764993|NCT04653766|75885134|FG000|COMPLETED|Overall Study||6||
59764994|NCT04653766|75885135|FG001|COMPLETED|Overall Study||6||
59764995|NCT04653766|75885136|FG002|COMPLETED|Overall Study||6||
59764996|NCT04653766|75885137|FG003|COMPLETED|Overall Study||6||
59764997|NCT04653766|75885138|FG004|COMPLETED|Overall Study||8||
59764998|NCT04653766|75885134|FG000|NOT COMPLETED|Overall Study||0||
59764999|NCT04653766|75885135|FG001|NOT COMPLETED|Overall Study||0||
59765000|NCT04653766|75885136|FG002|NOT COMPLETED|Overall Study||0||
59765001|NCT04653766|75885137|FG003|NOT COMPLETED|Overall Study||0||
59765002|NCT04653766|75885138|FG004|NOT COMPLETED|Overall Study||0||
59765003|NCT00698932|75885161|FG000|STARTED|Overall Study|Randomized and treated|284||
59765004|NCT00698932|75885162|FG001|STARTED|Overall Study|Randomized and treated|284||
59765005|NCT00698932|75885161|FG000|COMPLETED|Overall Study|Completed 24 Weeks of treatment|262||
59765006|NCT00698932|75885162|FG001|COMPLETED|Overall Study|Completed 24 Weeks of treatment|248||
59765007|NCT00698932|75885161|FG000|NOT COMPLETED|Overall Study||22||
59765008|NCT00698932|75885162|FG001|NOT COMPLETED|Overall Study||36||
59765009|NCT00823719|75885170|FG000|STARTED|Overall Study||26||
59765010|NCT00823719|75885171|FG001|STARTED|Overall Study||35||
59765011|NCT00823719|75885170|FG000|COMPLETED|Overall Study||20||
59765012|NCT00823719|75885171|FG001|COMPLETED|Overall Study||24||
59765013|NCT00823719|75885170|FG000|NOT COMPLETED|Overall Study||6||
59765014|NCT00823719|75885171|FG001|NOT COMPLETED|Overall Study||11||
59765015|NCT00875420|75885184|FG000|STARTED|Overall Study||22||
59765016|NCT00875420|75885185|FG001|STARTED|Overall Study||20||
59765017|NCT00875420|75885186|FG002|STARTED|Overall Study||21||
59765018|NCT00875420|75885187|FG003|STARTED|Overall Study||18||
59765019|NCT00875420|75885188|FG004|STARTED|Overall Study||19||
59765020|NCT00875420|75885184|FG000|COMPLETED|Overall Study||20||
59765021|NCT00875420|75885185|FG001|COMPLETED|Overall Study||18||
59765022|NCT00875420|75885186|FG002|COMPLETED|Overall Study||18||
59765023|NCT00875420|75885187|FG003|COMPLETED|Overall Study||16||
59765024|NCT00875420|75885188|FG004|COMPLETED|Overall Study||17||
59765025|NCT00875420|75885184|FG000|NOT COMPLETED|Overall Study||2||
59765026|NCT00875420|75885185|FG001|NOT COMPLETED|Overall Study||2||
59765027|NCT00875420|75885186|FG002|NOT COMPLETED|Overall Study||3||
59765028|NCT00875420|75885187|FG003|NOT COMPLETED|Overall Study||2||
59765029|NCT00875420|75885188|FG004|NOT COMPLETED|Overall Study||2||
59765030|NCT00822237|75885202|FG000|STARTED|Dose 1 Vaccination|Number randomized|299||
59765031|NCT00822237|75885203|FG001|STARTED|Dose 1 Vaccination|Number randomized|299||
59765032|NCT00822237|75885202|FG000|COMPLETED|Dose 1 Vaccination||274||
59765033|NCT00822237|75885203|FG001|COMPLETED|Dose 1 Vaccination||273||
59765034|NCT00822237|75885202|FG000|NOT COMPLETED|Dose 1 Vaccination||25||
59765035|NCT00822237|75885203|FG001|NOT COMPLETED|Dose 1 Vaccination||26||
59765036|NCT00822237|75885202|FG000|STARTED|Dose 2 Vaccination|Number who received second dose|274||
59765037|NCT00822237|75885203|FG001|STARTED|Dose 2 Vaccination|Number who received second dose|273||
59765038|NCT00822237|75885202|FG000|COMPLETED|Dose 2 Vaccination||270||
59765039|NCT00822237|75885203|FG001|COMPLETED|Dose 2 Vaccination||262||
59765040|NCT00822237|75885202|FG000|NOT COMPLETED|Dose 2 Vaccination||4||
59765041|NCT00822237|75885203|FG001|NOT COMPLETED|Dose 2 Vaccination||11||
59765042|NCT00577096|75885210|FG000|STARTED|Short Term Participation||69||
59765043|NCT00577096|75885211|FG001|STARTED|Short Term Participation||66||
59765044|NCT00577096|75885210|FG000|COMPLETED|Short Term Participation||62||
59617716|NCT01383174|75728887|FG000|STARTED|Baseline Assessment||76||
59617717|NCT01383174|75728888|FG001|STARTED|Baseline Assessment||75||
59617718|NCT01383174|75728887|FG000|COMPLETED|Baseline Assessment|These 76 completed the baseline assessment and continued in the study.|76||
59617719|NCT01383174|75728888|FG001|COMPLETED|Baseline Assessment|These 75 completed the baseline assessment and continued in the study.|75||
59617720|NCT01383174|75728887|FG000|NOT COMPLETED|Baseline Assessment||0||
59617721|NCT01383174|75728888|FG001|NOT COMPLETED|Baseline Assessment||0||
59617722|NCT01383174|75728887|FG000|STARTED|3 Month Assessment||76||
59617723|NCT01383174|75728888|FG001|STARTED|3 Month Assessment||75||
59617724|NCT01383174|75728887|FG000|COMPLETED|3 Month Assessment|These 70 completed the 3 month assessment and continued in the study.|70||
59617725|NCT01383174|75728888|FG001|COMPLETED|3 Month Assessment|These 74 completed the 3 month assessment and continued in the study.|74||
59617726|NCT01383174|75728887|FG000|NOT COMPLETED|3 Month Assessment||6||
59617727|NCT01383174|75728888|FG001|NOT COMPLETED|3 Month Assessment||1||
59617728|NCT01383174|75728887|FG000|STARTED|6 Month Assessment|All 76 people were contacted at 6 months;1 person returned and 5 did not return to study at 6 months|76||
59617729|NCT01383174|75728888|FG001|STARTED|6 Month Assessment||74||
59617730|NCT01383174|75728887|FG000|COMPLETED|6 Month Assessment|These 71 completed the 6 month assessment and completed the study.|71||
59617731|NCT01383174|75728888|FG001|COMPLETED|6 Month Assessment|These 73 completed the 6 month assessment and completed the study.|73||
59617732|NCT01383174|75728887|FG000|NOT COMPLETED|6 Month Assessment||5||
59617733|NCT01383174|75728888|FG001|NOT COMPLETED|6 Month Assessment||1||
59617734|NCT01396278|75728899|FG000|STARTED|Overall Study||2||
59617735|NCT01396278|75728900|FG001|STARTED|Overall Study||2||
59765045|NCT00577096|75885211|FG001|COMPLETED|Short Term Participation||58||
59765046|NCT00577096|75885210|FG000|NOT COMPLETED|Short Term Participation||7||
59765047|NCT00577096|75885211|FG001|NOT COMPLETED|Short Term Participation||8||
59765048|NCT00577096|75885210|FG000|STARTED|Long Term Participation|Only the first 34 patients who met long-term eligibility (response to EPO) were enrolled.|34||
59765049|NCT00577096|75885211|FG001|STARTED|Long Term Participation|Only 35 patients who met long-term eligibility (response to EPO) were enrolled.|35||
59765050|NCT00577096|75885210|FG000|COMPLETED|Long Term Participation||34||
59765051|NCT00577096|75885211|FG001|COMPLETED|Long Term Participation|Sub-set of patients (n=69) who completed short term (n=120) continued in long term participation.|35||
59765052|NCT00577096|75885210|FG000|NOT COMPLETED|Long Term Participation||0||
59765053|NCT00577096|75885211|FG001|NOT COMPLETED|Long Term Participation||0||
59765054|NCT00863304|75885221|FG000|STARTED|Overall Study||212||
59765055|NCT00863304|75885222|FG001|STARTED|Overall Study||212||
59765056|NCT00863304|75885223|FG002|STARTED|Overall Study||213||
59765057|NCT00863304|75885224|FG003|STARTED|Overall Study||212||
59765058|NCT00863304|75885221|FG000|Treated|Overall Study||209||
59765059|NCT00863304|75885222|FG001|Treated|Overall Study||211||
59765060|NCT00863304|75885223|FG002|Treated|Overall Study||209||
59765061|NCT00863304|75885224|FG003|Treated|Overall Study||211||
59765062|NCT00863304|75885221|FG000|COMPLETED|Overall Study||18||
59765063|NCT00863304|75885222|FG001|COMPLETED|Overall Study||27||
59765064|NCT00863304|75885223|FG002|COMPLETED|Overall Study||26||
59765065|NCT00863304|75885224|FG003|COMPLETED|Overall Study||21||
59765066|NCT00863304|75885221|FG000|NOT COMPLETED|Overall Study||194||
59765067|NCT00863304|75885222|FG001|NOT COMPLETED|Overall Study||185||
59765068|NCT00863304|75885223|FG002|NOT COMPLETED|Overall Study||187||
59765069|NCT00863304|75885224|FG003|NOT COMPLETED|Overall Study||191||
59765070|NCT00695110|75885236|FG000|STARTED|Treatment Period 1||29||
59765071|NCT00695110|75885236|FG000|COMPLETED|Treatment Period 1||26||
59765072|NCT00695110|75885236|FG000|NOT COMPLETED|Treatment Period 1||3||
59765073|NCT00695110|75885236|FG000|STARTED|Treatment Period 2||26||
59765074|NCT00695110|75885236|FG000|COMPLETED|Treatment Period 2||26||
59765075|NCT00695110|75885236|FG000|NOT COMPLETED|Treatment Period 2||0||
59765076|NCT00695110|75885236|FG000|STARTED|Treatment Period 3||26||
59765077|NCT00695110|75885236|FG000|COMPLETED|Treatment Period 3||25||
59765078|NCT00695110|75885236|FG000|NOT COMPLETED|Treatment Period 3||1||
59765079|NCT00695110|75885236|FG000|STARTED|Treatment Period 4||25||
59520961|NCT01129531|75615115|FG000|NOT COMPLETED|Treatment Cycle 1||4||
59520962|NCT01129531|75615116|FG001|NOT COMPLETED|Treatment Cycle 1||6||
59520963|NCT01129531|75615117|FG002|NOT COMPLETED|Treatment Cycle 1||16||
59520964|NCT01129531|75615115|FG000|STARTED|Treatment Cycle 2|Participants who completed Treatment Cycle 1 were re-randomized.|94||
59520965|NCT01129531|75615116|FG001|STARTED|Treatment Cycle 2|Participants who completed Treatment Cycle 1 were re-randomized.|95||
59520966|NCT01129531|75615117|FG002|STARTED|Treatment Cycle 2|Participants who completed Treatment Cycle 1 were re-randomized.|79||
59520967|NCT01129531|75615115|FG000|COMPLETED|Treatment Cycle 2||88||
59520968|NCT01129531|75615116|FG001|COMPLETED|Treatment Cycle 2||92||
59520969|NCT01129531|75615117|FG002|COMPLETED|Treatment Cycle 2||74||
59520970|NCT01129531|75615115|FG000|NOT COMPLETED|Treatment Cycle 2||6||
59617736|NCT01396278|75728901|FG002|STARTED|Overall Study||1||
59617737|NCT01396278|75728902|FG003|STARTED|Overall Study||2||
59617738|NCT01396278|75728903|FG004|STARTED|Overall Study||2||
59617739|NCT01396278|75728899|FG000|COMPLETED|Overall Study||0||
59617740|NCT01396278|75728900|FG001|COMPLETED|Overall Study||1||
59617741|NCT01396278|75728901|FG002|COMPLETED|Overall Study||0||
59520971|NCT01129531|75615116|FG001|NOT COMPLETED|Treatment Cycle 2||3||
59520972|NCT01129531|75615117|FG002|NOT COMPLETED|Treatment Cycle 2||5||
59520973|NCT03746002|75615131|FG000|STARTED|Overall Study||1||
59617742|NCT01396278|75728902|FG003|COMPLETED|Overall Study||0||
59617743|NCT01396278|75728903|FG004|COMPLETED|Overall Study||0||
59617744|NCT01396278|75728899|FG000|NOT COMPLETED|Overall Study||2||
59617745|NCT01396278|75728900|FG001|NOT COMPLETED|Overall Study||1||
59617746|NCT01396278|75728901|FG002|NOT COMPLETED|Overall Study||1||
59617747|NCT01396278|75728902|FG003|NOT COMPLETED|Overall Study||2||
59617748|NCT01396278|75728903|FG004|NOT COMPLETED|Overall Study||2||
59617749|NCT01383096|75728918|FG000|STARTED|First Intervention (8 Days)||19||
59617750|NCT01383096|75728919|FG001|STARTED|First Intervention (8 Days)||17||
59617751|NCT01383096|75728920|FG002|STARTED|First Intervention (8 Days)||16||
59617752|NCT01383096|75728918|FG000|COMPLETED|First Intervention (8 Days)||19||
59617753|NCT01383096|75728919|FG001|COMPLETED|First Intervention (8 Days)||17||
59617754|NCT01383096|75728920|FG002|COMPLETED|First Intervention (8 Days)||16||
59617755|NCT01383096|75728918|FG000|NOT COMPLETED|First Intervention (8 Days)||0||
59617756|NCT01383096|75728919|FG001|NOT COMPLETED|First Intervention (8 Days)||0||
59617757|NCT01383096|75728920|FG002|NOT COMPLETED|First Intervention (8 Days)||0||
59617758|NCT01383096|75728918|FG000|STARTED|Second Intervention (8 Days)||19||
59617759|NCT01383096|75728919|FG001|STARTED|Second Intervention (8 Days)||17||
59617760|NCT01383096|75728920|FG002|STARTED|Second Intervention (8 Days)||16||
59617761|NCT01383096|75728918|FG000|COMPLETED|Second Intervention (8 Days)||19||
59617762|NCT01383096|75728919|FG001|COMPLETED|Second Intervention (8 Days)||16||
59617763|NCT01383096|75728920|FG002|COMPLETED|Second Intervention (8 Days)||14||
59617764|NCT01383096|75728918|FG000|NOT COMPLETED|Second Intervention (8 Days)||0||
59617765|NCT01383096|75728919|FG001|NOT COMPLETED|Second Intervention (8 Days)||1||
59617766|NCT01383096|75728920|FG002|NOT COMPLETED|Second Intervention (8 Days)||2||
59617767|NCT01383096|75728918|FG000|STARTED|Third Intervention (8 Days)||19||
59617768|NCT01383096|75728919|FG001|STARTED|Third Intervention (8 Days)||16||
59617769|NCT01383096|75728920|FG002|STARTED|Third Intervention (8 Days)|Only 2 interventions in Cohort 3.|0||
59617770|NCT01383096|75728918|FG000|COMPLETED|Third Intervention (8 Days)||15||
59617771|NCT01383096|75728919|FG001|COMPLETED|Third Intervention (8 Days)||12||
59617772|NCT01383096|75728920|FG002|COMPLETED|Third Intervention (8 Days)|Only 2 interventions in Cohort 3.|0||
59617773|NCT01383096|75728918|FG000|NOT COMPLETED|Third Intervention (8 Days)||4||
59617774|NCT01383096|75728919|FG001|NOT COMPLETED|Third Intervention (8 Days)||4||
59617775|NCT01383096|75728920|FG002|NOT COMPLETED|Third Intervention (8 Days)||0||
59617776|NCT01383096|75728918|FG000|STARTED|Fourth Intervention (8 Days)||15||
59617777|NCT01383096|75728919|FG001|STARTED|Fourth Intervention (8 Days)||12||
59617778|NCT01383096|75728920|FG002|STARTED|Fourth Intervention (8 Days)|Only 2 interventions in Cohort 3.|0||
59520974|NCT03746002|75615132|FG001|STARTED|Overall Study||2||
59520975|NCT03746002|75615131|FG000|COMPLETED|Overall Study||1||
59520976|NCT03746002|75615132|FG001|COMPLETED|Overall Study||2||
59617779|NCT01383096|75728918|FG000|COMPLETED|Fourth Intervention (8 Days)||13||
59617780|NCT01383096|75728919|FG001|COMPLETED|Fourth Intervention (8 Days)||12||
59617781|NCT01383096|75728920|FG002|COMPLETED|Fourth Intervention (8 Days)|Only 2 interventions in Cohort 3.|0||
59617782|NCT01383096|75728918|FG000|NOT COMPLETED|Fourth Intervention (8 Days)||2||
59520977|NCT03746002|75615131|FG000|NOT COMPLETED|Overall Study||0||
59520978|NCT03746002|75615132|FG001|NOT COMPLETED|Overall Study||0||
59520979|NCT01172353|75615140|FG000|STARTED|Overall Study||150||
59520980|NCT01172353|75615141|FG001|STARTED|Overall Study||151||
59520981|NCT01172353|75615140|FG000|COMPLETED|Overall Study||150||
59520982|NCT01172353|75615141|FG001|COMPLETED|Overall Study||151||
59520983|NCT01172353|75615140|FG000|NOT COMPLETED|Overall Study||0||
59520984|NCT01172353|75615141|FG001|NOT COMPLETED|Overall Study||0||
59520985|NCT01129609|75615147|FG000|STARTED|Overall Study||20||
59520986|NCT01129609|75615147|FG000|COMPLETED|Overall Study||18||
59617783|NCT01383096|75728919|FG001|NOT COMPLETED|Fourth Intervention (8 Days)||0||
59617784|NCT01383096|75728920|FG002|NOT COMPLETED|Fourth Intervention (8 Days)||0||
59520987|NCT01129609|75615147|FG000|NOT COMPLETED|Overall Study||2||
59520988|NCT04089982|75615153|FG000|STARTED|Overall Study||6||
59520989|NCT04089982|75615154|FG001|STARTED|Overall Study||5||
59520990|NCT04089982|75615153|FG000|COMPLETED|Overall Study||6||
59520991|NCT04089982|75615154|FG001|COMPLETED|Overall Study||5||
59520992|NCT04089982|75615153|FG000|NOT COMPLETED|Overall Study||0||
59520993|NCT04089982|75615154|FG001|NOT COMPLETED|Overall Study||0||
59617785|NCT01383096|75728918|FG000|STARTED|Fifth Intervention (8 Days)||13||
59617786|NCT01383096|75728919|FG001|STARTED|Fifth Intervention (8 Days)|Only 4 interventions in Cohort 2.|0||
59709502|NCT00907153|75828244|FG001|NOT COMPLETED|Overall Study||4||
59709503|NCT00904033|75828254|FG000|STARTED|Overall Study||10||
59520994|NCT00985088|75615168|FG000|STARTED|Overall Study||222||
59520995|NCT00985088|75615169|FG001|STARTED|Overall Study||114||
59520996|NCT00985088|75615170|FG002|STARTED|Overall Study||112||
59709504|NCT00904033|75828255|FG001|STARTED|Overall Study||10||
59709505|NCT00904033|75828256|FG002|STARTED|Overall Study||10||
59709506|NCT00904033|75828257|FG003|STARTED|Overall Study||11||
59709507|NCT00904033|75828254|FG000|COMPLETED|Overall Study||9||
59709508|NCT00904033|75828255|FG001|COMPLETED|Overall Study||9||
59617787|NCT01383096|75728920|FG002|STARTED|Fifth Intervention (8 Days)|Only 2 interventions in Cohort 3.|0||
59617788|NCT01383096|75728918|FG000|COMPLETED|Fifth Intervention (8 Days)||11||
59617789|NCT01383096|75728919|FG001|COMPLETED|Fifth Intervention (8 Days)|Only 4 interventions in Cohort 2.|0||
59520997|NCT00985088|75615171|FG003|STARTED|Overall Study||221||
59520998|NCT00985088|75615172|FG004|STARTED|Overall Study||223||
59520999|NCT00985088|75615173|FG005|STARTED|Overall Study||115||
59521000|NCT00985088|75615174|FG006|STARTED|Overall Study||111||
59521001|NCT00985088|75615175|FG007|STARTED|Overall Study||222||
59521002|NCT00985088|75615168|FG000|COMPLETED|Overall Study||211||
59521003|NCT00985088|75615169|FG001|COMPLETED|Overall Study||112||
59521004|NCT00985088|75615170|FG002|COMPLETED|Overall Study||108||
59521005|NCT00985088|75615171|FG003|COMPLETED|Overall Study||214||
59521006|NCT00985088|75615172|FG004|COMPLETED|Overall Study||214||
59521007|NCT00985088|75615173|FG005|COMPLETED|Overall Study||108||
59521008|NCT00985088|75615174|FG006|COMPLETED|Overall Study||107||
59521009|NCT00985088|75615175|FG007|COMPLETED|Overall Study||216||
59521010|NCT00985088|75615168|FG000|NOT COMPLETED|Overall Study||11||
59521011|NCT00985088|75615169|FG001|NOT COMPLETED|Overall Study||2||
59521012|NCT00985088|75615170|FG002|NOT COMPLETED|Overall Study||4||
59521013|NCT00985088|75615171|FG003|NOT COMPLETED|Overall Study||7||
59521014|NCT00985088|75615172|FG004|NOT COMPLETED|Overall Study||9||
59521015|NCT00985088|75615173|FG005|NOT COMPLETED|Overall Study||7||
59521016|NCT00985088|75615174|FG006|NOT COMPLETED|Overall Study||4||
59521017|NCT00985088|75615175|FG007|NOT COMPLETED|Overall Study||6||
59521018|NCT03783130|75615207|FG000|STARTED|Overall Study||3||
59521019|NCT03783130|75615208|FG001|STARTED|Overall Study||3||
59521020|NCT03783130|75615209|FG002|STARTED|Overall Study||5||
59521021|NCT03783130|75615210|FG003|STARTED|Overall Study||5||
59617790|NCT01383096|75728920|FG002|COMPLETED|Fifth Intervention (8 Days)|Only 2 interventions in Cohort 3.|0||
59617791|NCT01383096|75728918|FG000|NOT COMPLETED|Fifth Intervention (8 Days)||2||
59617792|NCT01383096|75728919|FG001|NOT COMPLETED|Fifth Intervention (8 Days)||0||
59521022|NCT03783130|75615207|FG000|Received All Product Administrations|Overall Study||3||
59521023|NCT03783130|75615208|FG001|Received All Product Administrations|Overall Study||3||
59521024|NCT03783130|75615209|FG002|Received All Product Administrations|Overall Study||5||
59617793|NCT01383096|75728920|FG002|NOT COMPLETED|Fifth Intervention (8 Days)||0||
59521025|NCT03783130|75615210|FG003|Received All Product Administrations|Overall Study||5||
59521026|NCT03783130|75615207|FG000|COMPLETED|Overall Study||3||
59521027|NCT03783130|75615208|FG001|COMPLETED|Overall Study||3||
59521028|NCT03783130|75615209|FG002|COMPLETED|Overall Study||5||
59521029|NCT03783130|75615210|FG003|COMPLETED|Overall Study||5||
59521030|NCT03783130|75615207|FG000|NOT COMPLETED|Overall Study||0||
59521031|NCT03783130|75615208|FG001|NOT COMPLETED|Overall Study||0||
59521032|NCT03783130|75615209|FG002|NOT COMPLETED|Overall Study||0||
59521033|NCT03783130|75615210|FG003|NOT COMPLETED|Overall Study||0||
59617794|NCT04040244|75728957|FG000|STARTED|Overall Study||16||
59617795|NCT04040244|75728957|FG000|COMPLETED|Overall Study||16||
59617796|NCT04040244|75728957|FG000|NOT COMPLETED|Overall Study||0||
59617797|NCT01383018|75728961|FG000|STARTED|Overall Study||1457||
59617798|NCT01383018|75728961|FG000|COMPLETED|Overall Study||1082||
59617799|NCT01383018|75728961|FG000|NOT COMPLETED|Overall Study||375||
59617800|NCT01382940|75728975|FG000|STARTED|Overall Study||351||
59617801|NCT01382940|75728975|FG000|Received Day 1 Infusion|Overall Study||351||
59617802|NCT01382940|75728975|FG000|Received Day 15 Infusions|Overall Study||341||
59617803|NCT01382940|75728975|FG000|Received Day 168 Infusion|Overall Study||290||
59617804|NCT01382940|75728975|FG000|Received Day 182 Infusion|Overall Study||278||
59617805|NCT01382940|75728975|FG000|COMPLETED|Overall Study||278||
59617806|NCT01382940|75728975|FG000|NOT COMPLETED|Overall Study||73||
59617807|NCT01381926|75728981|FG000|STARTED|Low/High Dose of 1st Treatment (2months)||5|The number of participants started is for each segment. Crossover study. Total is not applicable.|
59617808|NCT01381926|75728982|FG001|STARTED|Low/High Dose of 1st Treatment (2months)||5|The number of participants started is for each segment. Crossover study. Total is not applicable.|
59617809|NCT01381926|75728981|FG000|COMPLETED|Low/High Dose of 1st Treatment (2months)||3||
59617810|NCT01381926|75728982|FG001|COMPLETED|Low/High Dose of 1st Treatment (2months)||4||
59617811|NCT01381926|75728981|FG000|NOT COMPLETED|Low/High Dose of 1st Treatment (2months)||2||
59617812|NCT01381926|75728982|FG001|NOT COMPLETED|Low/High Dose of 1st Treatment (2months)||1||
59617813|NCT01381926|75728981|FG000|STARTED|Low/High Dose of 2nd Treatment (2months)||3||
59617814|NCT01381926|75728982|FG001|STARTED|Low/High Dose of 2nd Treatment (2months)||4||
59617815|NCT01381926|75728981|FG000|COMPLETED|Low/High Dose of 2nd Treatment (2months)||3||
59617816|NCT01381926|75728982|FG001|COMPLETED|Low/High Dose of 2nd Treatment (2months)||4||
59617817|NCT01381926|75728981|FG000|NOT COMPLETED|Low/High Dose of 2nd Treatment (2months)||0||
59617818|NCT01381926|75728982|FG001|NOT COMPLETED|Low/High Dose of 2nd Treatment (2months)||0||
59617819|NCT01395888|75728992|FG000|STARTED|2-week Run-in Period||279||
59617820|NCT01395888|75728993|FG001|STARTED|2-week Run-in Period||0||
59617821|NCT01395888|75728994|FG002|STARTED|2-week Run-in Period||0||
59617822|NCT01395888|75728992|FG000|COMPLETED|2-week Run-in Period||257||
59617823|NCT01395888|75728993|FG001|COMPLETED|2-week Run-in Period||0||
59617824|NCT01395888|75728994|FG002|COMPLETED|2-week Run-in Period||0||
59617825|NCT01395888|75728992|FG000|NOT COMPLETED|2-week Run-in Period||22||
59617826|NCT01395888|75728993|FG001|NOT COMPLETED|2-week Run-in Period||0||
59617827|NCT01395888|75728994|FG002|NOT COMPLETED|2-week Run-in Period||0||
59617828|NCT01395888|75728992|FG000|STARTED|Treatment Period (TP)||0||
59617829|NCT01395888|75728993|FG001|STARTED|Treatment Period (TP)||127||
59617830|NCT01395888|75728994|FG002|STARTED|Treatment Period (TP)||130||
59617831|NCT01395888|75728992|FG000|Completed the Treatment Period|Treatment Period (TP)||0||
59617832|NCT01395888|75728993|FG001|Completed the Treatment Period|Treatment Period (TP)|Participants were considered to have completed the TP if they attended Visit 5 (Week 12).|112||
59617833|NCT01395888|75728994|FG002|Completed the Treatment Period|Treatment Period (TP)|Participants were considered to have completed the TP if they attended Visit 5 (Week 12).|113||
59617834|NCT01395888|75728992|FG000|COMPLETED|Treatment Period (TP)||0||
59617835|NCT01395888|75728993|FG001|COMPLETED|Treatment Period (TP)|Par. completed the study if they completed the TP and a safety follow-up phone contact 1 week later.|112||
59617836|NCT01395888|75728994|FG002|COMPLETED|Treatment Period (TP)|Par. completed the study if they completed the TP and a safety follow-up phone contact 1 week later.|113||
59617837|NCT01395888|75728992|FG000|NOT COMPLETED|Treatment Period (TP)||0||
59617838|NCT01395888|75728993|FG001|NOT COMPLETED|Treatment Period (TP)||15||
59617839|NCT01395888|75728994|FG002|NOT COMPLETED|Treatment Period (TP)||17||
59617840|NCT01395810|75729004|FG000|STARTED|Overall Study||18||
59617841|NCT01395810|75729005|FG001|STARTED|Overall Study||48||
59617842|NCT01395810|75729006|FG002|STARTED|Overall Study||0||
59617843|NCT01395810|75729007|FG003|STARTED|Overall Study||5||
59617844|NCT01395810|75729004|FG000|After Switching the Arms|Overall Study|18 subjects started in this arm and additional 3 subjects from 40 IU/kg switched to this arm|21|Patients were free to switch between treatment arms if agreed between investigator and patient|
59617845|NCT01395810|75729005|FG001|After Switching the Arms|Overall Study|48 subjects started in this arm, 3 subjects in 10 IU/kg+1 subject in on-demand switched to this arm|52|Patients were free to switch between treatment arms if agreed between investigator and patient|
59617846|NCT01395810|75729006|FG002|After Switching the Arms|Overall Study|No subjects started in this arm initially, 2 patients in 40 IU/kg arm switched to this arm.|2|Patients were free to switch between treatment arms if agreed between investigator and patient|
59617847|NCT01395810|75729007|FG003|After Switching the Arms|Overall Study||5|Patients were free to switch between treatment arms if agreed between investigator and patient|
59617848|NCT01395810|75729004|FG000|COMPLETED|Overall Study||16||
59617849|NCT01395810|75729005|FG001|COMPLETED|Overall Study||44||
59765080|NCT00695110|75885236|FG000|COMPLETED|Treatment Period 4||24||
59765081|NCT00695110|75885236|FG000|NOT COMPLETED|Treatment Period 4||1||
59765082|NCT00594386|75885243|FG000|STARTED|Overall Study||258||
59765083|NCT00594386|75885243|FG000|COMPLETED|Overall Study|Study fully recruited. Completed upon market authorization and commercial availability of Neupro.|0||
59765084|NCT00594386|75885243|FG000|NOT COMPLETED|Overall Study||258||
59765085|NCT00862992|75885250|FG000|STARTED|Overall Study||12||
59765086|NCT00862992|75885251|FG001|STARTED|Overall Study||10||
59765087|NCT00862992|75885252|FG002|STARTED|Overall Study||12||
59765088|NCT00862992|75885250|FG000|COMPLETED|Overall Study||9||
59765089|NCT00862992|75885251|FG001|COMPLETED|Overall Study||9||
59765090|NCT00862992|75885252|FG002|COMPLETED|Overall Study||9||
59765091|NCT00862992|75885250|FG000|NOT COMPLETED|Overall Study||3||
59765092|NCT00862992|75885251|FG001|NOT COMPLETED|Overall Study||1||
59765093|NCT00862992|75885252|FG002|NOT COMPLETED|Overall Study||3||
59765094|NCT00694096|75885260|FG000|STARTED|Overall Study||25||
59765095|NCT00694096|75885260|FG000|COMPLETED|Overall Study||20||
59765096|NCT00694096|75885260|FG000|NOT COMPLETED|Overall Study||5||
59765097|NCT00854100|75885267|FG000|STARTED|Overall Study||81||
59765098|NCT00854100|75885268|FG001|STARTED|Overall Study||76||
59765099|NCT00854100|75885269|FG002|STARTED|Overall Study||74||
59765100|NCT00854100|75885267|FG000|COMPLETED|Overall Study||72||
59765101|NCT00854100|75885268|FG001|COMPLETED|Overall Study||70||
59765102|NCT00854100|75885269|FG002|COMPLETED|Overall Study||63||
59765103|NCT00854100|75885267|FG000|NOT COMPLETED|Overall Study||9||
59765104|NCT00854100|75885268|FG001|NOT COMPLETED|Overall Study||6||
59765105|NCT00854100|75885269|FG002|NOT COMPLETED|Overall Study||11||
59765106|NCT00509899|75885286|FG000|STARTED|Overall Study||30||
59765107|NCT00509899|75885287|FG001|STARTED|Overall Study||35||
59765108|NCT00509899|75885288|FG002|STARTED|Overall Study||47||
59765109|NCT00509899|75885289|FG003|STARTED|Overall Study||5||
59765110|NCT00509899|75885290|FG004|STARTED|Overall Study||6||
59765111|NCT00509899|75885291|FG005|STARTED|Overall Study||22||
59765112|NCT00509899|75885292|FG006|STARTED|Overall Study||6||
59765113|NCT00509899|75885293|FG007|STARTED|Overall Study||3||
59765114|NCT00509899|75885286|FG000|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|14||
59765115|NCT00509899|75885287|FG001|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|26||
59765116|NCT00509899|75885288|FG002|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|27||
59765117|NCT00509899|75885289|FG003|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|1||
59765118|NCT00509899|75885290|FG004|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|1||
59765119|NCT00509899|75885291|FG005|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|12||
60072310|NCT01682811|76187739|FG002|Control|Part 1 Levulan Injection||0||0
60072311|NCT01682811|76187740|FG003|Control|Part 1 Levulan Injection||0||0
60072312|NCT01682811|76187741|FG004|Control|Part 1 Levulan Injection||0||0
60072313|NCT01682811|76187742|FG005|Control|Part 1 Levulan Injection||0||0
60072314|NCT01682811|76187743|FG006|Control|Part 1 Levulan Injection||0||0
60072315|NCT01682811|76187737|FG000|Treated 3 Hours|Part 1 Levulan Injection||1||3
60072316|NCT01682811|76187738|FG001|Treated 3 Hours|Part 1 Levulan Injection||0||0
60072317|NCT01682811|76187739|FG002|Treated 3 Hours|Part 1 Levulan Injection||0||0
60072318|NCT01682811|76187740|FG003|Treated 3 Hours|Part 1 Levulan Injection||0||0
60072319|NCT01682811|76187741|FG004|Treated 3 Hours|Part 1 Levulan Injection||0||0
60072320|NCT01682811|76187742|FG005|Treated 3 Hours|Part 1 Levulan Injection||0||0
60072321|NCT01682811|76187743|FG006|Treated 3 Hours|Part 1 Levulan Injection||0||0
60072322|NCT01682811|76187737|FG000|Treated 24 Hours|Part 1 Levulan Injection||1||3
60072323|NCT01682811|76187738|FG001|Treated 24 Hours|Part 1 Levulan Injection||0||0
60072324|NCT01682811|76187739|FG002|Treated 24 Hours|Part 1 Levulan Injection||0||0
60072325|NCT01682811|76187740|FG003|Treated 24 Hours|Part 1 Levulan Injection||0||0
60072326|NCT01682811|76187741|FG004|Treated 24 Hours|Part 1 Levulan Injection||0||0
60072327|NCT01682811|76187742|FG005|Treated 24 Hours|Part 1 Levulan Injection||0||0
60072328|NCT01682811|76187743|FG006|Treated 24 Hours|Part 1 Levulan Injection||0||0
60072329|NCT01682811|76187737|FG000|COMPLETED|Part 1 Levulan Injection||1||9
60072330|NCT01682811|76187738|FG001|COMPLETED|Part 1 Levulan Injection||0||0
60072331|NCT01682811|76187739|FG002|COMPLETED|Part 1 Levulan Injection||0||0
60072332|NCT01682811|76187740|FG003|COMPLETED|Part 1 Levulan Injection||0||0
60072333|NCT01682811|76187741|FG004|COMPLETED|Part 1 Levulan Injection||0||0
60072334|NCT01682811|76187742|FG005|COMPLETED|Part 1 Levulan Injection||0||0
59765120|NCT00509899|75885292|FG006|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|5||
59765121|NCT00509899|75885293|FG007|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|2||
59765122|NCT00509899|75885286|FG000|NOT COMPLETED|Overall Study||16||
59765123|NCT00509899|75885287|FG001|NOT COMPLETED|Overall Study||9||
59765124|NCT00509899|75885288|FG002|NOT COMPLETED|Overall Study||20||
59765125|NCT00509899|75885289|FG003|NOT COMPLETED|Overall Study||4||
59765126|NCT00509899|75885290|FG004|NOT COMPLETED|Overall Study||5||
59765127|NCT00509899|75885291|FG005|NOT COMPLETED|Overall Study||10||
59765128|NCT00509899|75885292|FG006|NOT COMPLETED|Overall Study||1||
59617850|NCT01395810|75729006|FG002|COMPLETED|Overall Study||0||
59617851|NCT01395810|75729007|FG003|COMPLETED|Overall Study||5||
59617852|NCT01395810|75729004|FG000|NOT COMPLETED|Overall Study||2||
59617853|NCT01395810|75729005|FG001|NOT COMPLETED|Overall Study||4||
59765129|NCT00509899|75885293|FG007|NOT COMPLETED|Overall Study||1||
59765130|NCT00862836|75885307|FG000|STARTED|Overall Study||15||
59765131|NCT00862836|75885307|FG000|Evaluable for Safety/Toxicity|Overall Study|1 patient withdrew consent before first cycle|14||
59765132|NCT00862836|75885307|FG000|Evaluable for Activity (Tumour Response)|Overall Study||10||
59765133|NCT00862836|75885307|FG000|COMPLETED|Overall Study||14||
59765134|NCT00862836|75885307|FG000|NOT COMPLETED|Overall Study||1||
59765135|NCT00820755|75885311|FG000|STARTED|Period 1: Combination Therapy Phase||583||
59765136|NCT00820755|75885312|FG001|STARTED|Period 1: Combination Therapy Phase||0||
59765137|NCT00820755|75885313|FG002|STARTED|Period 1: Combination Therapy Phase||0||
59765138|NCT00820755|75885311|FG000|COMPLETED|Period 1: Combination Therapy Phase|2 of 313 participants excluded from maintenance phase analysis (reason: not eligible)|313||
59765139|NCT00820755|75885312|FG001|COMPLETED|Period 1: Combination Therapy Phase||0||
59765140|NCT00820755|75885313|FG002|COMPLETED|Period 1: Combination Therapy Phase||0||
59765141|NCT00820755|75885311|FG000|NOT COMPLETED|Period 1: Combination Therapy Phase||270||
59765142|NCT00820755|75885312|FG001|NOT COMPLETED|Period 1: Combination Therapy Phase||0||
59765143|NCT00820755|75885313|FG002|NOT COMPLETED|Period 1: Combination Therapy Phase||0||
59765144|NCT00820755|75885311|FG000|STARTED|Period 2: Maintenance Therapy Phase||0||
59765145|NCT00820755|75885312|FG001|STARTED|Period 2: Maintenance Therapy Phase||157||
59765146|NCT00820755|75885313|FG002|STARTED|Period 2: Maintenance Therapy Phase||154||
59765147|NCT00820755|75885311|FG000|COMPLETED|Period 2: Maintenance Therapy Phase||0||
59765148|NCT00820755|75885312|FG001|COMPLETED|Period 2: Maintenance Therapy Phase||112||
59765149|NCT00820755|75885313|FG002|COMPLETED|Period 2: Maintenance Therapy Phase||109||
59765150|NCT00820755|75885311|FG000|NOT COMPLETED|Period 2: Maintenance Therapy Phase||0||
59765151|NCT00820755|75885312|FG001|NOT COMPLETED|Period 2: Maintenance Therapy Phase||45||
59765152|NCT00820755|75885313|FG002|NOT COMPLETED|Period 2: Maintenance Therapy Phase||45||
59765153|NCT00820599|75885321|FG000|STARTED|Overall Study||211||
59765154|NCT00820599|75885321|FG000|COMPLETED|Overall Study||80||
59765155|NCT00820599|75885321|FG000|NOT COMPLETED|Overall Study||131||
59765156|NCT00819741|75885327|FG000|STARTED|Overall Study||218||
59765157|NCT00819741|75885328|FG001|STARTED|Overall Study||215||
59765158|NCT00819741|75885327|FG000|Exposed to Drug|Overall Study||218||
59765159|NCT00819741|75885328|FG001|Exposed to Drug|Overall Study|One subject after randomisation was not exposed to the treatment due to non-compliance|214||
59765160|NCT00819741|75885327|FG000|COMPLETED|Overall Study||196||
59765161|NCT00819741|75885328|FG001|COMPLETED|Overall Study||201||
59765162|NCT00819741|75885327|FG000|NOT COMPLETED|Overall Study||22||
59765163|NCT00819741|75885328|FG001|NOT COMPLETED|Overall Study||14||
59765164|NCT00862134|75885336|FG000|STARTED|Overall Study||19||
59765165|NCT00862134|75885337|FG001|STARTED|Overall Study||23||
59765166|NCT00862134|75885336|FG000|COMPLETED|Overall Study||8||
59765167|NCT00862134|75885337|FG001|COMPLETED|Overall Study||11||
59765168|NCT00862134|75885336|FG000|NOT COMPLETED|Overall Study||11||
59765169|NCT00862134|75885337|FG001|NOT COMPLETED|Overall Study||12||
59765170|NCT00848484|75885345|FG000|STARTED|First Intervention (Treatment Period 1)||27||
59765171|NCT00848484|75885346|FG001|STARTED|First Intervention (Treatment Period 1)||27||
59765172|NCT00848484|75885345|FG000|With Reduced Dose at Treatment Period 1|First Intervention (Treatment Period 1)||2||
59952046|NCT00834756|76070968|FG001|COMPLETED|Washout: 21 Days||18||
59952047|NCT00834756|76070967|FG000|NOT COMPLETED|Washout: 21 Days||1||
59952048|NCT00834756|76070968|FG001|NOT COMPLETED|Washout: 21 Days||0||
59952049|NCT00834756|76070967|FG000|STARTED|Second Intervention||16||
59952050|NCT00834756|76070968|FG001|STARTED|Second Intervention||18||
59765173|NCT00848484|75885346|FG001|With Reduced Dose at Treatment Period 1|First Intervention (Treatment Period 1)||1||
59952051|NCT00834756|76070967|FG000|COMPLETED|Second Intervention||16||
59952052|NCT00834756|76070968|FG001|COMPLETED|Second Intervention||18||
59952053|NCT00834756|76070967|FG000|NOT COMPLETED|Second Intervention||0||
59952054|NCT00834756|76070968|FG001|NOT COMPLETED|Second Intervention||0||
59952055|NCT00828854|76070972|FG000|STARTED|Overall Study||27||
59994907|NCT03099863|76110730|FG001|NOT COMPLETED|Overall Study||16||
59994908|NCT03420781|76110738|FG000|STARTED|Treatment Period (40 Weeks)||236||
59994909|NCT03420781|76110739|FG001|STARTED|Treatment Period (40 Weeks)||231||
59617854|NCT01395810|75729006|FG002|NOT COMPLETED|Overall Study||0||
59617855|NCT01395810|75729007|FG003|NOT COMPLETED|Overall Study||0||
59765174|NCT00848484|75885345|FG000|COMPLETED|First Intervention (Treatment Period 1)||25||
59765175|NCT00848484|75885346|FG001|COMPLETED|First Intervention (Treatment Period 1)||24||
59765176|NCT00848484|75885345|FG000|NOT COMPLETED|First Intervention (Treatment Period 1)||2||
59765177|NCT00848484|75885346|FG001|NOT COMPLETED|First Intervention (Treatment Period 1)||3||
59765178|NCT00848484|75885345|FG000|STARTED|Washout Period of Two Weeks||25||
59765179|NCT00848484|75885346|FG001|STARTED|Washout Period of Two Weeks||24||
59765180|NCT00848484|75885345|FG000|COMPLETED|Washout Period of Two Weeks||25||
59765181|NCT00848484|75885346|FG001|COMPLETED|Washout Period of Two Weeks||21||
59765182|NCT00848484|75885345|FG000|NOT COMPLETED|Washout Period of Two Weeks||0||
59765183|NCT00848484|75885346|FG001|NOT COMPLETED|Washout Period of Two Weeks||3||
59765184|NCT00848484|75885345|FG000|STARTED|Second Intervention (Treatment Period 2)||25||
59765185|NCT00848484|75885346|FG001|STARTED|Second Intervention (Treatment Period 2)||21||
59765186|NCT00848484|75885345|FG000|With Reduced Dose at Treatment Period 2|Second Intervention (Treatment Period 2)||0||
59765187|NCT00848484|75885346|FG001|With Reduced Dose at Treatment Period 2|Second Intervention (Treatment Period 2)||0||
59765188|NCT00848484|75885345|FG000|COMPLETED|Second Intervention (Treatment Period 2)||25||
59765189|NCT00848484|75885346|FG001|COMPLETED|Second Intervention (Treatment Period 2)||20||
59765190|NCT00848484|75885345|FG000|NOT COMPLETED|Second Intervention (Treatment Period 2)||0||
59765191|NCT00848484|75885346|FG001|NOT COMPLETED|Second Intervention (Treatment Period 2)||1||
59765192|NCT00509821|75885354|FG000|STARTED|Study Period 1 (Induction)||3||
59765193|NCT00509821|75885355|FG001|STARTED|Study Period 1 (Induction)||57||
59765194|NCT00509821|75885354|FG000|Received at Least 1 Dose of Study Drug|Study Period 1 (Induction)||3||
59765195|NCT00509821|75885355|FG001|Received at Least 1 Dose of Study Drug|Study Period 1 (Induction)||57||
59765196|NCT00509821|75885354|FG000|COMPLETED|Study Period 1 (Induction)||3||
59765197|NCT00509821|75885355|FG001|COMPLETED|Study Period 1 (Induction)||53||
59765198|NCT00509821|75885354|FG000|NOT COMPLETED|Study Period 1 (Induction)||0||
59765199|NCT00509821|75885355|FG001|NOT COMPLETED|Study Period 1 (Induction)||4||
59765200|NCT00509821|75885354|FG000|STARTED|Study Period 2 (Radiation)|Participants moved to Radiation Phase.|3||
59765201|NCT00509821|75885355|FG001|STARTED|Study Period 2 (Radiation)|Participants moved to Radiation Phase.|53||
59765202|NCT00509821|75885354|FG000|COMPLETED|Study Period 2 (Radiation)||3||
59765203|NCT00509821|75885355|FG001|COMPLETED|Study Period 2 (Radiation)||0||
59765204|NCT00509821|75885354|FG000|NOT COMPLETED|Study Period 2 (Radiation)||0||
59765205|NCT00509821|75885355|FG001|NOT COMPLETED|Study Period 2 (Radiation)||53||
59765206|NCT00509821|75885354|FG000|STARTED|Study Period 3 (Maintenance)||3||
59765207|NCT00509821|75885355|FG001|STARTED|Study Period 3 (Maintenance)|4 participants completed Radiation Phase but did not enter Maintenance Phase.|49||
59765208|NCT00509821|75885354|FG000|COMPLETED|Study Period 3 (Maintenance)||3||
59765209|NCT00509821|75885355|FG001|COMPLETED|Study Period 3 (Maintenance)||0||
59765210|NCT00509821|75885354|FG000|NOT COMPLETED|Study Period 3 (Maintenance)||0||
59765211|NCT00509821|75885355|FG001|NOT COMPLETED|Study Period 3 (Maintenance)||49||
59765212|NCT00509821|75885354|FG000|STARTED|Study Period 4 (Follow Up)|1 Participant completed Maintenance Phase but did not enter Follow-Up.|2||
59765213|NCT00509821|75885355|FG001|STARTED|Study Period 4 (Follow Up)|1 Participant completed Radiation Phase, did not enter Maintenance Phase but entered Follow Up.|50||
59765214|NCT00509821|75885354|FG000|COMPLETED|Study Period 4 (Follow Up)||2||
59765215|NCT00509821|75885355|FG001|COMPLETED|Study Period 4 (Follow Up)||50||
59765216|NCT00509821|75885354|FG000|NOT COMPLETED|Study Period 4 (Follow Up)||0||
59765217|NCT00509821|75885355|FG001|NOT COMPLETED|Study Period 4 (Follow Up)||0||
59765218|NCT00508651|75885368|FG000|STARTED|Overall Study||20||
59765219|NCT00508651|75885369|FG001|STARTED|Overall Study||10||
59765220|NCT00508651|75885368|FG000|COMPLETED|Overall Study||16||
60072335|NCT01682811|76187743|FG006|COMPLETED|Part 1 Levulan Injection||0||0
59765221|NCT00508651|75885369|FG001|COMPLETED|Overall Study||8||
59765222|NCT00508651|75885368|FG000|NOT COMPLETED|Overall Study||4||
59765223|NCT00508651|75885369|FG001|NOT COMPLETED|Overall Study||2||
59765224|NCT00490555|75885379|FG000|STARTED|Overall Study||8||
59765225|NCT00490555|75885380|FG001|STARTED|Overall Study||8||
59765226|NCT00490555|75885381|FG002|STARTED|Overall Study||9||
59765227|NCT00490555|75885382|FG003|STARTED|Overall Study||7||
59765228|NCT00490555|75885379|FG000|COMPLETED|Overall Study||8||
59765229|NCT00490555|75885380|FG001|COMPLETED|Overall Study||8||
59765230|NCT00490555|75885381|FG002|COMPLETED|Overall Study||7||
59765231|NCT00490555|75885382|FG003|COMPLETED|Overall Study||7||
59765232|NCT00490555|75885379|FG000|NOT COMPLETED|Overall Study||0||
59765233|NCT00490555|75885380|FG001|NOT COMPLETED|Overall Study||0||
59765234|NCT00490555|75885381|FG002|NOT COMPLETED|Overall Study||2||
59765235|NCT00490555|75885382|FG003|NOT COMPLETED|Overall Study||0||
59765236|NCT00501085|75885392|FG000|STARTED|Overall Study|Number of participants who were treated with the LAP-BAND System.|515||
60072336|NCT01682811|76187737|FG000|NOT COMPLETED|Part 1 Levulan Injection||0||0
59521034|NCT00984542|75615221|FG000|STARTED|Overall Study||50||
59765237|NCT00501085|75885392|FG000|COMPLETED|Overall Study|Number of participants completing 5 year follow-up visit.|83||
59765238|NCT00501085|75885392|FG000|NOT COMPLETED|Overall Study||432||
59765239|NCT00501007|75885396|FG000|STARTED|Overall Study||100||
60072337|NCT01682811|76187738|FG001|NOT COMPLETED|Part 1 Levulan Injection||0||0
60072338|NCT01682811|76187739|FG002|NOT COMPLETED|Part 1 Levulan Injection||0||0
59765240|NCT00501007|75885397|FG001|STARTED|Overall Study||103||
59765241|NCT00501007|75885396|FG000|COMPLETED|Overall Study||71||
59765242|NCT00501007|75885397|FG001|COMPLETED|Overall Study||78||
59765243|NCT00501007|75885396|FG000|NOT COMPLETED|Overall Study||29||
59765244|NCT00501007|75885397|FG001|NOT COMPLETED|Overall Study||25||
59765245|NCT00873860|75885407|FG000|STARTED|Overall Study||48||
59765246|NCT00873860|75885408|FG001|STARTED|Overall Study||47||
59765247|NCT00873860|75885409|FG002|STARTED|Overall Study||51||
59765248|NCT00873860|75885410|FG003|STARTED|Overall Study||48||
59765249|NCT00873860|75885407|FG000|Treated|Overall Study||47||
59765250|NCT00873860|75885408|FG001|Treated|Overall Study||47||
59765251|NCT00873860|75885409|FG002|Treated|Overall Study||51||
59765252|NCT00873860|75885410|FG003|Treated|Overall Study||48||
59765253|NCT00873860|75885407|FG000|COMPLETED|Overall Study||44||
59765254|NCT00873860|75885408|FG001|COMPLETED|Overall Study||47||
59765255|NCT00873860|75885409|FG002|COMPLETED|Overall Study||48||
59765256|NCT00873860|75885410|FG003|COMPLETED|Overall Study||47||
59765257|NCT00873860|75885407|FG000|NOT COMPLETED|Overall Study||4||
59765258|NCT00873860|75885408|FG001|NOT COMPLETED|Overall Study||0||
59765259|NCT00873860|75885409|FG002|NOT COMPLETED|Overall Study||3||
59765260|NCT00873860|75885410|FG003|NOT COMPLETED|Overall Study||1||
59765261|NCT04350905|75885423|FG000|STARTED|Overall Study||42||
59765262|NCT04350905|75885423|FG000|COMPLETED|Overall Study||41||
59765263|NCT04350905|75885423|FG000|NOT COMPLETED|Overall Study||1||
59765264|NCT03853291|75885433|FG000|STARTED|Overall Study||18||
59765265|NCT03853291|75885434|FG001|STARTED|Overall Study||16||
59765266|NCT03853291|75885435|FG002|STARTED|Overall Study||18||
59765267|NCT03853291|75885436|FG003|STARTED|Overall Study||16||
59765268|NCT03853291|75885437|FG004|STARTED|Overall Study||6||
59765269|NCT03853291|75885438|FG005|STARTED|Overall Study||11||
59765270|NCT03853291|75885433|FG000|COMPLETED|Overall Study||16||
59765271|NCT03853291|75885434|FG001|COMPLETED|Overall Study||13||
59765272|NCT03853291|75885435|FG002|COMPLETED|Overall Study||18||
59765273|NCT03853291|75885436|FG003|COMPLETED|Overall Study||16||
59765274|NCT03853291|75885437|FG004|COMPLETED|Overall Study||6||
59765275|NCT03853291|75885438|FG005|COMPLETED|Overall Study||11||
59765276|NCT03853291|75885433|FG000|NOT COMPLETED|Overall Study||2||
59765277|NCT03853291|75885434|FG001|NOT COMPLETED|Overall Study||3||
59765278|NCT03853291|75885435|FG002|NOT COMPLETED|Overall Study||0||
59765279|NCT03853291|75885436|FG003|NOT COMPLETED|Overall Study||0||
59765280|NCT03853291|75885437|FG004|NOT COMPLETED|Overall Study||0||
59765281|NCT03853291|75885438|FG005|NOT COMPLETED|Overall Study||0||
59765282|NCT03853213|75885451|FG000|STARTED|Overall Study||11||
59765283|NCT03853213|75885452|FG001|STARTED|Overall Study||9||
59765284|NCT03853213|75885451|FG000|COMPLETED|Overall Study||10||
59765285|NCT03853213|75885452|FG001|COMPLETED|Overall Study||7||
59765286|NCT03853213|75885451|FG000|NOT COMPLETED|Overall Study||1||
59765287|NCT03853213|75885452|FG001|NOT COMPLETED|Overall Study||2||
59765288|NCT04236635|75885458|FG000|STARTED|Overall Study||2||
59765289|NCT04236635|75885459|FG001|STARTED|Overall Study||1||
59765290|NCT04236635|75885460|FG002|STARTED|Overall Study||1||
59765291|NCT04236635|75885461|FG003|STARTED|Overall Study||4||
59765292|NCT04236635|75885462|FG004|STARTED|Overall Study||1||
59765293|NCT04236635|75885463|FG005|STARTED|Overall Study||1||
59765294|NCT04236635|75885458|FG000|Safety Population|Overall Study||2|All participants who received at least 1 injection of study drug irrespective of the timing window of abdominoplasty.|
59765295|NCT04236635|75885459|FG001|Safety Population|Overall Study||1|All participants who received at least 1 injection of study drug irrespective of the timing window of abdominoplasty.|
59765296|NCT04236635|75885460|FG002|Safety Population|Overall Study||1|All participants who received at least 1 injection of study drug irrespective of the timing window of abdominoplasty.|
59765297|NCT04236635|75885461|FG003|Safety Population|Overall Study||4|All participants who received at least 1 injection of study drug irrespective of the timing window of abdominoplasty.|
59765298|NCT04236635|75885462|FG004|Safety Population|Overall Study||1|All participants who received at least 1 injection of study drug irrespective of the timing window of abdominoplasty.|
59765299|NCT04236635|75885463|FG005|Safety Population|Overall Study||1|All participants who received at least 1 injection of study drug irrespective of the timing window of abdominoplasty.|
59765300|NCT04236635|75885458|FG000|Evaluable Population|Overall Study||2|All participants who received at least 1 injection of study drug, underwent abdominoplasty within the protocol specified timelines, and had a histopathology and immunohistochemistry report.|
59765301|NCT04236635|75885459|FG001|Evaluable Population|Overall Study||1|All participants who received at least 1 injection of study drug, underwent abdominoplasty within the protocol specified timelines, and had a histopathology and immunohistochemistry report.|
59765302|NCT04236635|75885460|FG002|Evaluable Population|Overall Study||1|All participants who received at least 1 injection of study drug, underwent abdominoplasty within the protocol specified timelines, and had a histopathology and immunohistochemistry report.|
59765303|NCT04236635|75885461|FG003|Evaluable Population|Overall Study||2|All participants who received at least 1 injection of study drug, underwent abdominoplasty within the protocol specified timelines, and had a histopathology and immunohistochemistry report.|
59765304|NCT04236635|75885462|FG004|Evaluable Population|Overall Study||1|All participants who received at least 1 injection of study drug, underwent abdominoplasty within the protocol specified timelines, and had a histopathology and immunohistochemistry report.|
59817843|NCT04488770|75940334|FG008|STARTED|Part 1-Cohort 1: Period 4 (Up to 5 Days)||0||
59817844|NCT04488770|75940335|FG009|STARTED|Part 1-Cohort 1: Period 4 (Up to 5 Days)||0||
59765305|NCT04236635|75885463|FG005|Evaluable Population|Overall Study||1|All participants who received at least 1 injection of study drug, underwent abdominoplasty within the protocol specified timelines, and had a histopathology and immunohistochemistry report.|
59765306|NCT04236635|75885458|FG000|COMPLETED|Overall Study||2||
59765307|NCT04236635|75885459|FG001|COMPLETED|Overall Study||1||
59765308|NCT04236635|75885460|FG002|COMPLETED|Overall Study||1||
59765309|NCT04236635|75885461|FG003|COMPLETED|Overall Study||4||
59765310|NCT04236635|75885462|FG004|COMPLETED|Overall Study||1||
59765311|NCT04236635|75885463|FG005|COMPLETED|Overall Study||1||
59765312|NCT04236635|75885458|FG000|NOT COMPLETED|Overall Study||0||
59765313|NCT04236635|75885459|FG001|NOT COMPLETED|Overall Study||0||
59765314|NCT04236635|75885460|FG002|NOT COMPLETED|Overall Study||0||
59765315|NCT04236635|75885461|FG003|NOT COMPLETED|Overall Study||0||
59765316|NCT04236635|75885462|FG004|NOT COMPLETED|Overall Study||0||
59765317|NCT04236635|75885463|FG005|NOT COMPLETED|Overall Study||0||
59765318|NCT02666105|75885478|FG000|STARTED|Overall Study||6||
59765319|NCT02666105|75885478|FG000|COMPLETED|Overall Study||5||
59765320|NCT02666105|75885478|FG000|NOT COMPLETED|Overall Study||1||
59765321|NCT00819585|75885497|FG000|STARTED|Core Study|Participants who started the core study are included in the randomized and full analysis sets.|55||
59765322|NCT00819585|75885498|FG001|STARTED|Core Study||54||
59765323|NCT00819585|75885499|FG002|STARTED|Core Study||54||
59765324|NCT00819585|75885500|FG003|STARTED|Core Study||54||
59765325|NCT00819585|75885501|FG004|STARTED|Core Study||53||
59765326|NCT00819585|75885502|FG005|STARTED|Core Study||54||
59765327|NCT00819585|75885503|FG006|STARTED|Core Study||108||
59765328|NCT00819585|75885504|FG007|STARTED|Core Study|There were no participants in this arm during the core study.|0||
59765329|NCT00819585|75885505|FG008|STARTED|Core Study|There were no participants in this arm during the core study.|0||
59765330|NCT00819585|75885506|FG009|STARTED|Core Study|There were no participants in this arm during the core study.|0||
59765331|NCT00819585|75885507|FG010|STARTED|Core Study|There were no participants in this arm during the core study.|0||
59765332|NCT00819585|75885497|FG000|Received Study Medication|Core Study|Participants who received study medication are included in the safety population.|55||
59765333|NCT00819585|75885498|FG001|Received Study Medication|Core Study||54||
59765334|NCT00819585|75885499|FG002|Received Study Medication|Core Study||54||
59765335|NCT00819585|75885500|FG003|Received Study Medication|Core Study||54||
59765336|NCT00819585|75885501|FG004|Received Study Medication|Core Study||53||
59765337|NCT00819585|75885502|FG005|Received Study Medication|Core Study|One participant in this treatment arm was HIV+ve and did not receive any study medication.|53||
59765338|NCT00819585|75885503|FG006|Received Study Medication|Core Study||108||
59765339|NCT00819585|75885504|FG007|Received Study Medication|Core Study||0||
59765340|NCT00819585|75885505|FG008|Received Study Medication|Core Study||0||
59765341|NCT00819585|75885506|FG009|Received Study Medication|Core Study||0||
59765342|NCT00819585|75885507|FG010|Received Study Medication|Core Study||0||
59765343|NCT00819585|75885497|FG000|COMPLETED|Core Study||49||
59765344|NCT00819585|75885498|FG001|COMPLETED|Core Study||48||
59765345|NCT00819585|75885499|FG002|COMPLETED|Core Study||48||
59765346|NCT00819585|75885500|FG003|COMPLETED|Core Study||49||
59765347|NCT00819585|75885501|FG004|COMPLETED|Core Study||50||
59765348|NCT00819585|75885502|FG005|COMPLETED|Core Study||52||
59765349|NCT00819585|75885503|FG006|COMPLETED|Core Study||95||
59765350|NCT00819585|75885504|FG007|COMPLETED|Core Study||0||
59765351|NCT00819585|75885505|FG008|COMPLETED|Core Study||0||
59765352|NCT00819585|75885506|FG009|COMPLETED|Core Study||0||
59765353|NCT00819585|75885507|FG010|COMPLETED|Core Study||0||
59765354|NCT00819585|75885497|FG000|NOT COMPLETED|Core Study||6||
59765355|NCT00819585|75885498|FG001|NOT COMPLETED|Core Study||6||
59765356|NCT00819585|75885499|FG002|NOT COMPLETED|Core Study||6||
59765357|NCT00819585|75885500|FG003|NOT COMPLETED|Core Study||5||
59765358|NCT00819585|75885501|FG004|NOT COMPLETED|Core Study||3||
59765359|NCT00819585|75885502|FG005|NOT COMPLETED|Core Study||2||
59765360|NCT00819585|75885503|FG006|NOT COMPLETED|Core Study||13||
59765361|NCT00819585|75885504|FG007|NOT COMPLETED|Core Study||0||
59765362|NCT00819585|75885505|FG008|NOT COMPLETED|Core Study||0||
59765363|NCT00819585|75885506|FG009|NOT COMPLETED|Core Study||0||
59765364|NCT00819585|75885507|FG010|NOT COMPLETED|Core Study||0||
59765365|NCT00819585|75885497|FG000|STARTED|Extension Study|There were no participants in this arm during the extension study.|0||
59765366|NCT00819585|75885498|FG001|STARTED|Extension Study|There were no participants in this arm during the extension study.|0||
59765367|NCT00819585|75885499|FG002|STARTED|Extension Study|There were no participants in this arm during the extension study.|0||
59765368|NCT00819585|75885500|FG003|STARTED|Extension Study|There were no participants in this arm during the extension study.|0||
59765369|NCT00819585|75885501|FG004|STARTED|Extension Study|There were no participants in this arm during the extension study.|0||
59765370|NCT00819585|75885502|FG005|STARTED|Extension Study|There were no participants in this arm during the extension study.|0||
59765371|NCT00819585|75885503|FG006|STARTED|Extension Study|There were no participants in this arm during the extension study.|0||
59765372|NCT00819585|75885504|FG007|STARTED|Extension Study||75||
59765373|NCT00819585|75885505|FG008|STARTED|Extension Study||181||
59765374|NCT00819585|75885506|FG009|STARTED|Extension Study||25||
59765375|NCT00819585|75885507|FG010|STARTED|Extension Study||60||
59765376|NCT00819585|75885497|FG000|COMPLETED|Extension Study||0||
59765377|NCT00819585|75885498|FG001|COMPLETED|Extension Study||0||
59765378|NCT00819585|75885499|FG002|COMPLETED|Extension Study||0||
59765379|NCT00819585|75885500|FG003|COMPLETED|Extension Study||0||
59765380|NCT00819585|75885501|FG004|COMPLETED|Extension Study||0||
59765381|NCT00819585|75885502|FG005|COMPLETED|Extension Study||0||
59765382|NCT00819585|75885503|FG006|COMPLETED|Extension Study||0||
59765383|NCT00819585|75885504|FG007|COMPLETED|Extension Study||75||
59765384|NCT00819585|75885505|FG008|COMPLETED|Extension Study||173||
59765385|NCT00819585|75885506|FG009|COMPLETED|Extension Study||24||
59765386|NCT00819585|75885507|FG010|COMPLETED|Extension Study||58||
59765387|NCT00819585|75885497|FG000|NOT COMPLETED|Extension Study||0||
59765388|NCT00819585|75885498|FG001|NOT COMPLETED|Extension Study||0||
59765389|NCT00819585|75885499|FG002|NOT COMPLETED|Extension Study||0||
59765390|NCT00819585|75885500|FG003|NOT COMPLETED|Extension Study||0||
59765391|NCT00819585|75885501|FG004|NOT COMPLETED|Extension Study||0||
59765392|NCT00819585|75885502|FG005|NOT COMPLETED|Extension Study||0||
59765393|NCT00819585|75885503|FG006|NOT COMPLETED|Extension Study||0||
59765394|NCT00819585|75885504|FG007|NOT COMPLETED|Extension Study||0||
59765395|NCT00819585|75885505|FG008|NOT COMPLETED|Extension Study||8||
59765396|NCT00819585|75885506|FG009|NOT COMPLETED|Extension Study||1||
59765397|NCT00819585|75885507|FG010|NOT COMPLETED|Extension Study||2||
59765398|NCT00508261|75885539|FG000|STARTED|Overall Study||222||
59765399|NCT00508261|75885540|FG001|STARTED|Overall Study||220||
59765400|NCT00508261|75885541|FG002|STARTED|Overall Study||224||
59765401|NCT00508261|75885542|FG003|STARTED|Overall Study||127||
59765402|NCT00508261|75885539|FG000|COMPLETED|Overall Study||219||
59765403|NCT00508261|75885540|FG001|COMPLETED|Overall Study||212||
59765404|NCT00508261|75885541|FG002|COMPLETED|Overall Study||218||
59765405|NCT00508261|75885542|FG003|COMPLETED|Overall Study||126||
59765406|NCT00508261|75885539|FG000|NOT COMPLETED|Overall Study||3||
59765407|NCT00508261|75885540|FG001|NOT COMPLETED|Overall Study||8||
59765408|NCT00508261|75885541|FG002|NOT COMPLETED|Overall Study||6||
59765409|NCT00508261|75885542|FG003|NOT COMPLETED|Overall Study||1||
59765410|NCT03928847|75885561|FG000|STARTED|Overall Study||5||
59765411|NCT03928847|75885562|FG001|STARTED|Overall Study||5||
59765412|NCT03928847|75885563|FG002|STARTED|Overall Study||5||
59765413|NCT03928847|75885564|FG003|STARTED|Overall Study||10||
59765414|NCT03928847|75885565|FG004|STARTED|Overall Study||10||
59765415|NCT03928847|75885561|FG000|COMPLETED|Overall Study||5||
59765416|NCT03928847|75885562|FG001|COMPLETED|Overall Study||5||
59765417|NCT03928847|75885563|FG002|COMPLETED|Overall Study||5||
59765418|NCT03928847|75885564|FG003|COMPLETED|Overall Study||10||
59765419|NCT03928847|75885565|FG004|COMPLETED|Overall Study||10||
59765420|NCT03928847|75885561|FG000|NOT COMPLETED|Overall Study||0||
59765421|NCT03928847|75885562|FG001|NOT COMPLETED|Overall Study||0||
59765422|NCT03928847|75885563|FG002|NOT COMPLETED|Overall Study||0||
59765423|NCT03928847|75885564|FG003|NOT COMPLETED|Overall Study||0||
59765424|NCT03928847|75885565|FG004|NOT COMPLETED|Overall Study||0||
59765425|NCT00819039|75885581|FG000|STARTED|Overall Study||46||
59765426|NCT00819039|75885582|FG001|STARTED|Overall Study||27||
59765427|NCT00819039|75885583|FG002|STARTED|Overall Study||25||
59765428|NCT00819039|75885581|FG000|COMPLETED|Overall Study||44||
59765429|NCT00819039|75885582|FG001|COMPLETED|Overall Study||27||
59765430|NCT00819039|75885583|FG002|COMPLETED|Overall Study||24||
59765431|NCT00819039|75885581|FG000|NOT COMPLETED|Overall Study||2||
59765432|NCT00819039|75885582|FG001|NOT COMPLETED|Overall Study||0||
59765433|NCT00819039|75885583|FG002|NOT COMPLETED|Overall Study||1||
59765434|NCT00500539|75885593|FG000|STARTED|Treatment Period (24 Weeks)||155||
59765435|NCT00500539|75885593|FG000|COMPLETED|Treatment Period (24 Weeks)||140||
59765436|NCT00500539|75885593|FG000|NOT COMPLETED|Treatment Period (24 Weeks)||15||
59765437|NCT00500539|75885593|FG000|STARTED|Follow-up Period (16 Weeks)|Participants could discontinue study drug and still enter the follow-up period.|148||
59765438|NCT00500539|75885593|FG000|COMPLETED|Follow-up Period (16 Weeks)||136||
59765439|NCT00500539|75885593|FG000|NOT COMPLETED|Follow-up Period (16 Weeks)||12||
59765440|NCT00818883|75885602|FG000|STARTED|Overall Study||303||
59765441|NCT00818883|75885603|FG001|STARTED|Overall Study||306||
59765442|NCT00818883|75885602|FG000|COMPLETED|Overall Study||252||
59765443|NCT00818883|75885603|FG001|COMPLETED|Overall Study||260||
59765444|NCT00818883|75885602|FG000|NOT COMPLETED|Overall Study||51||
59765445|NCT00818883|75885603|FG001|NOT COMPLETED|Overall Study||46||
59765446|NCT00508027|75885609|FG000|STARTED|Dose Level 1|The participants starting each dose period is a new cohort of subjects. 20 subjects started dose 1|20||
59765447|NCT00508027|75885609|FG000|COMPLETED|Dose Level 1||12||
59765448|NCT00508027|75885609|FG000|NOT COMPLETED|Dose Level 1||8||
59765449|NCT00508027|75885609|FG000|STARTED|Dose Level 2|The participants starting each dose period is a new cohort of subjects. 20 new subjects in dose 2|20||
59765450|NCT00508027|75885609|FG000|COMPLETED|Dose Level 2||16||
59765451|NCT00508027|75885609|FG000|NOT COMPLETED|Dose Level 2||4||
59765452|NCT00508027|75885609|FG000|STARTED|Dose Level 3|enrollment discontinued due to FDA recommendations regarding high dose (80mg/day) simvastatin|2||
59765453|NCT00508027|75885609|FG000|COMPLETED|Dose Level 3||2||
59765454|NCT00508027|75885609|FG000|NOT COMPLETED|Dose Level 3||0||
59765455|NCT01986101|75885625|FG000|STARTED|Overall Study||172||
59765456|NCT01986101|75885626|FG001|STARTED|Overall Study||184||
59765457|NCT01986101|75885627|FG002|STARTED|Overall Study||169||
59765458|NCT01986101|75885625|FG000|Intent-to-Treat Population|Overall Study||171||
59765459|NCT01986101|75885626|FG001|Intent-to-Treat Population|Overall Study||182||
59765460|NCT01986101|75885627|FG002|Intent-to-Treat Population|Overall Study||169||
59765461|NCT01986101|75885625|FG000|Safety Population|Overall Study||172||
59765462|NCT01986101|75885626|FG001|Safety Population|Overall Study||184||
59765463|NCT01986101|75885627|FG002|Safety Population|Overall Study||169||
59765464|NCT01986101|75885625|FG000|COMPLETED|Overall Study||139||
59765465|NCT01986101|75885626|FG001|COMPLETED|Overall Study||157||
59765466|NCT01986101|75885627|FG002|COMPLETED|Overall Study||137||
59765467|NCT01986101|75885625|FG000|NOT COMPLETED|Overall Study||33||
59765468|NCT01986101|75885626|FG001|NOT COMPLETED|Overall Study||27||
59765469|NCT01986101|75885627|FG002|NOT COMPLETED|Overall Study||32||
59765470|NCT00500149|75885638|FG000|STARTED|Enrolled (Dose-optimization Phase)||129||
59765471|NCT00500149|75885639|FG001|STARTED|Enrolled (Dose-optimization Phase)||0||
59765472|NCT00500149|75885638|FG000|COMPLETED|Enrolled (Dose-optimization Phase)||117||
59765473|NCT00500149|75885639|FG001|COMPLETED|Enrolled (Dose-optimization Phase)||0||
59765474|NCT00500149|75885638|FG000|NOT COMPLETED|Enrolled (Dose-optimization Phase)||12||
59765475|NCT00500149|75885639|FG001|NOT COMPLETED|Enrolled (Dose-optimization Phase)||0||
59765476|NCT00500149|75885638|FG000|STARTED|First Intervention (Cross-over Phase)||58||
59765477|NCT00500149|75885639|FG001|STARTED|First Intervention (Cross-over Phase)||59||
59765478|NCT00500149|75885638|FG000|COMPLETED|First Intervention (Cross-over Phase)||56||
59765479|NCT00500149|75885639|FG001|COMPLETED|First Intervention (Cross-over Phase)||57||
59765480|NCT00500149|75885638|FG000|NOT COMPLETED|First Intervention (Cross-over Phase)||2||
59765481|NCT00500149|75885639|FG001|NOT COMPLETED|First Intervention (Cross-over Phase)||2||
59765482|NCT00500149|75885638|FG000|STARTED|Second Intervention (Cross-over Phase)||56||
59765483|NCT00500149|75885639|FG001|STARTED|Second Intervention (Cross-over Phase)||57||
59765484|NCT00500149|75885638|FG000|COMPLETED|Second Intervention (Cross-over Phase)||54||
59765485|NCT00500149|75885639|FG001|COMPLETED|Second Intervention (Cross-over Phase)||57||
59765486|NCT00500149|75885638|FG000|NOT COMPLETED|Second Intervention (Cross-over Phase)||2||
59765487|NCT00500149|75885639|FG001|NOT COMPLETED|Second Intervention (Cross-over Phase)||0||
59765488|NCT00489853|75885645|FG000|STARTED|Treatment Period 1||36||
59765489|NCT00489853|75885646|FG001|STARTED|Treatment Period 1||37||
59765490|NCT00489853|75885647|FG002|STARTED|Treatment Period 1||38||
59765491|NCT00489853|75885645|FG000|COMPLETED|Treatment Period 1||36||
59765492|NCT00489853|75885646|FG001|COMPLETED|Treatment Period 1||37||
59765493|NCT00489853|75885647|FG002|COMPLETED|Treatment Period 1||38||
59765494|NCT00489853|75885645|FG000|NOT COMPLETED|Treatment Period 1||0||
59765495|NCT00489853|75885646|FG001|NOT COMPLETED|Treatment Period 1||0||
59765496|NCT00489853|75885647|FG002|NOT COMPLETED|Treatment Period 1||0||
59765497|NCT00489853|75885645|FG000|STARTED|Wash-out Period 1||36||
59765498|NCT00489853|75885646|FG001|STARTED|Wash-out Period 1||37||
59765499|NCT00489853|75885647|FG002|STARTED|Wash-out Period 1||38||
59765500|NCT00489853|75885645|FG000|COMPLETED|Wash-out Period 1||35||
59765501|NCT00489853|75885646|FG001|COMPLETED|Wash-out Period 1||34||
59765502|NCT00489853|75885647|FG002|COMPLETED|Wash-out Period 1||32||
59765503|NCT00489853|75885645|FG000|NOT COMPLETED|Wash-out Period 1||1||
59765504|NCT00489853|75885646|FG001|NOT COMPLETED|Wash-out Period 1||3||
59765505|NCT00489853|75885647|FG002|NOT COMPLETED|Wash-out Period 1||6||
59765506|NCT00489853|75885645|FG000|STARTED|Treatment Period 2||33||
59765507|NCT00489853|75885646|FG001|STARTED|Treatment Period 2||35||
59765508|NCT00489853|75885647|FG002|STARTED|Treatment Period 2||33||
59765509|NCT00489853|75885645|FG000|COMPLETED|Treatment Period 2||33||
59765510|NCT00489853|75885646|FG001|COMPLETED|Treatment Period 2||35||
59765511|NCT00489853|75885647|FG002|COMPLETED|Treatment Period 2||33||
59765512|NCT00489853|75885645|FG000|NOT COMPLETED|Treatment Period 2||0||
59765513|NCT00489853|75885646|FG001|NOT COMPLETED|Treatment Period 2||0||
59765514|NCT00489853|75885647|FG002|NOT COMPLETED|Treatment Period 2||0||
59765515|NCT00489853|75885645|FG000|STARTED|Wash-out Period 2||33||
59765516|NCT00489853|75885646|FG001|STARTED|Wash-out Period 2||35||
59765517|NCT00489853|75885647|FG002|STARTED|Wash-out Period 2||33||
59765518|NCT00489853|75885645|FG000|COMPLETED|Wash-out Period 2||29||
59765519|NCT00489853|75885646|FG001|COMPLETED|Wash-out Period 2||32||
59765520|NCT00489853|75885647|FG002|COMPLETED|Wash-out Period 2||31||
59765521|NCT00489853|75885645|FG000|NOT COMPLETED|Wash-out Period 2||4||
59765522|NCT00489853|75885646|FG001|NOT COMPLETED|Wash-out Period 2||3||
59765523|NCT00489853|75885647|FG002|NOT COMPLETED|Wash-out Period 2||2||
59765524|NCT00489853|75885645|FG000|STARTED|Treatment Period 3||29||
59765525|NCT00489853|75885646|FG001|STARTED|Treatment Period 3||30||
59765526|NCT00489853|75885647|FG002|STARTED|Treatment Period 3||33||
59765527|NCT00489853|75885645|FG000|COMPLETED|Treatment Period 3||29||
59765528|NCT00489853|75885646|FG001|COMPLETED|Treatment Period 3||29||
59765529|NCT00489853|75885647|FG002|COMPLETED|Treatment Period 3||33||
60072339|NCT01682811|76187740|FG003|NOT COMPLETED|Part 1 Levulan Injection||0||0
60072340|NCT01682811|76187741|FG004|NOT COMPLETED|Part 1 Levulan Injection||0||0
59765530|NCT00489853|75885645|FG000|NOT COMPLETED|Treatment Period 3||0||
59765531|NCT00489853|75885646|FG001|NOT COMPLETED|Treatment Period 3||1||
60072341|NCT01682811|76187742|FG005|NOT COMPLETED|Part 1 Levulan Injection||0||0
59765532|NCT00489853|75885647|FG002|NOT COMPLETED|Treatment Period 3||0||
59765533|NCT00489853|75885645|FG000|STARTED|Follow-up Period||29||
59765534|NCT00489853|75885646|FG001|STARTED|Follow-up Period||29||
59765535|NCT00489853|75885647|FG002|STARTED|Follow-up Period||33||
59765536|NCT00489853|75885645|FG000|COMPLETED|Follow-up Period||29||
59765537|NCT00489853|75885646|FG001|COMPLETED|Follow-up Period||29||
59765538|NCT00489853|75885647|FG002|COMPLETED|Follow-up Period||33||
59765539|NCT00489853|75885645|FG000|NOT COMPLETED|Follow-up Period||0||
59765540|NCT00489853|75885646|FG001|NOT COMPLETED|Follow-up Period||0||
59765541|NCT00489853|75885647|FG002|NOT COMPLETED|Follow-up Period||0||
59765542|NCT03686423|75885655|FG000|STARTED|Overall Study||44||
59765543|NCT03686423|75885655|FG000|COMPLETED|Overall Study||29||
59765544|NCT03686423|75885655|FG000|NOT COMPLETED|Overall Study||15||
59765545|NCT00499681|75885661|FG000|STARTED|Overall Study||4||
59765546|NCT00499681|75885662|FG001|STARTED|Overall Study||2||
59765547|NCT00499681|75885661|FG000|COMPLETED|Overall Study||4||
59765548|NCT00499681|75885662|FG001|COMPLETED|Overall Study||0||
59765549|NCT00499681|75885661|FG000|NOT COMPLETED|Overall Study||0||
59765550|NCT00499681|75885662|FG001|NOT COMPLETED|Overall Study||2||
59765551|NCT03673943|75885668|FG000|STARTED|Overall Study||63||
59765552|NCT03673943|75885668|FG000|COMPLETED|Overall Study||63||
59765553|NCT03673943|75885668|FG000|NOT COMPLETED|Overall Study||0||
59765554|NCT00875810|75885673|FG000|STARTED|Overall Study||194||
59765555|NCT00875810|75885673|FG000|Implanted|Overall Study||190||
59765556|NCT00875810|75885673|FG000|Discharged|Overall Study||177||
59765557|NCT00875810|75885673|FG000|3 Months Follow up|Overall Study||175||
59765558|NCT00875810|75885673|FG000|6 Months Follow up|Overall Study||80||
59765559|NCT00875810|75885673|FG000|12 Months Follow up|Overall Study||112||
59765560|NCT00875810|75885673|FG000|24 Months Follow up|Overall Study||148||
59765561|NCT00875810|75885673|FG000|COMPLETED|Overall Study||148||
59765562|NCT00875810|75885673|FG000|NOT COMPLETED|Overall Study||46||
59765563|NCT00499603|75885679|FG000|STARTED|Overall Study||27||
59765564|NCT00499603|75885680|FG001|STARTED|Overall Study||23||
59765565|NCT00499603|75885679|FG000|COMPLETED|Overall Study||27||
59765566|NCT00499603|75885680|FG001|COMPLETED|Overall Study||22||
59765567|NCT00499603|75885679|FG000|NOT COMPLETED|Overall Study||0||
59765568|NCT00499603|75885680|FG001|NOT COMPLETED|Overall Study||1||
59765569|NCT01946711|75885690|FG000|STARTED|Overall Study||8||
59765570|NCT01946711|75885691|FG001|STARTED|Overall Study||6||
59765571|NCT01946711|75885690|FG000|COMPLETED|Overall Study||8||
59765572|NCT01946711|75885691|FG001|COMPLETED|Overall Study||6||
59765573|NCT01946711|75885690|FG000|NOT COMPLETED|Overall Study||0||
59765574|NCT01946711|75885691|FG001|NOT COMPLETED|Overall Study||0||
59765575|NCT00810069|75885699|FG000|STARTED|Lead-in Period I||840||
59765576|NCT00810069|75885700|FG001|STARTED|Lead-in Period I||0||
59765577|NCT00810069|75885701|FG002|STARTED|Lead-in Period I||0||
59765578|NCT00810069|75885699|FG000|COMPLETED|Lead-in Period I||566||
59765579|NCT00810069|75885700|FG001|COMPLETED|Lead-in Period I||0||
59765580|NCT00810069|75885701|FG002|COMPLETED|Lead-in Period I||0||
59617856|NCT01381692|75729020|FG000|STARTED|Overall Study||7||
59617857|NCT01381692|75729021|FG001|STARTED|Overall Study||2||
59617858|NCT01381692|75729022|FG002|STARTED|Overall Study||0||
59617859|NCT01381692|75729023|FG003|STARTED|Overall Study||0||
59617860|NCT01381692|75729024|FG004|STARTED|Overall Study||0||
59617861|NCT01381692|75729025|FG005|STARTED|Overall Study||0||
59617862|NCT01381692|75729020|FG000|COMPLETED|Overall Study||6||
59617863|NCT01381692|75729021|FG001|COMPLETED|Overall Study||2||
59617864|NCT01381692|75729022|FG002|COMPLETED|Overall Study||0||
59617865|NCT01381692|75729023|FG003|COMPLETED|Overall Study||0||
59617866|NCT01381692|75729024|FG004|COMPLETED|Overall Study||0||
59617867|NCT01381692|75729025|FG005|COMPLETED|Overall Study||0||
59617868|NCT01381692|75729020|FG000|NOT COMPLETED|Overall Study||1||
59617869|NCT01381692|75729021|FG001|NOT COMPLETED|Overall Study||0||
59617870|NCT01381692|75729022|FG002|NOT COMPLETED|Overall Study||0||
59617871|NCT01381692|75729023|FG003|NOT COMPLETED|Overall Study||0||
59617872|NCT01381692|75729024|FG004|NOT COMPLETED|Overall Study||0||
59617873|NCT01381692|75729025|FG005|NOT COMPLETED|Overall Study||0||
59617874|NCT01395030|75729033|FG000|STARTED|Overall Study||64||
59617875|NCT01395030|75729033|FG000|Complete FCH PET/CT|Overall Study||57||
59617876|NCT01395030|75729033|FG000|Adequate Tissue for Analysis|Overall Study||50||
59617877|NCT01395030|75729033|FG000|COMPLETED|Overall Study||57||
59617878|NCT01395030|75729033|FG000|NOT COMPLETED|Overall Study||7||
59617879|NCT01381068|75729041|FG000|STARTED|Overall Study||25|one infant had an unassigned randomization and was not included|
59617880|NCT01381068|75729042|FG001|STARTED|Overall Study||24|one infant had an unassigned randomization and was not included|
59617881|NCT01381068|75729041|FG000|COMPLETED|Overall Study||24||
59617882|NCT01381068|75729042|FG001|COMPLETED|Overall Study||24||
59765581|NCT00810069|75885699|FG000|NOT COMPLETED|Lead-in Period I||274||
59765582|NCT00810069|75885700|FG001|NOT COMPLETED|Lead-in Period I||0||
59765583|NCT00810069|75885701|FG002|NOT COMPLETED|Lead-in Period I||0||
59617883|NCT01381068|75729041|FG000|NOT COMPLETED|Overall Study||1||
59617884|NCT01381068|75729042|FG001|NOT COMPLETED|Overall Study||0||
59617885|NCT01394952|75729050|FG000|STARTED|Overall Study||4952||
59765584|NCT00810069|75885699|FG000|STARTED|Double-Blind Period II||0||
59765585|NCT00810069|75885700|FG001|STARTED|Double-Blind Period II||282||
59765586|NCT00810069|75885701|FG002|STARTED|Double-Blind Period II|At Week 8 - delayed intervention divided by response to treatment (nonresponders or responders).|284||
59765587|NCT00810069|75885699|FG000|COMPLETED|Double-Blind Period II||0||
59765588|NCT00810069|75885700|FG001|COMPLETED|Double-Blind Period II||226||
59765589|NCT00810069|75885701|FG002|COMPLETED|Double-Blind Period II||212||
59765590|NCT00810069|75885699|FG000|NOT COMPLETED|Double-Blind Period II||0||
59765591|NCT00810069|75885700|FG001|NOT COMPLETED|Double-Blind Period II||56||
59765592|NCT00810069|75885701|FG002|NOT COMPLETED|Double-Blind Period II||72||
59765593|NCT00489541|75885712|FG000|STARTED|12-Month Clinical Follow-up||224||
59765594|NCT00489541|75885713|FG001|STARTED|12-Month Clinical Follow-up||125||
59765595|NCT00489541|75885712|FG000|COMPLETED|12-Month Clinical Follow-up||215||
59765596|NCT00489541|75885713|FG001|COMPLETED|12-Month Clinical Follow-up||120||
59765597|NCT00489541|75885712|FG000|NOT COMPLETED|12-Month Clinical Follow-up||9||
59765598|NCT00489541|75885713|FG001|NOT COMPLETED|12-Month Clinical Follow-up||5||
59765599|NCT00489541|75885712|FG000|STARTED|9-Month Angiographic Follow-up||224||
59765600|NCT00489541|75885713|FG001|STARTED|9-Month Angiographic Follow-up||125||
59765601|NCT00489541|75885712|FG000|COMPLETED|9-Month Angiographic Follow-up||197||
59765602|NCT00489541|75885713|FG001|COMPLETED|9-Month Angiographic Follow-up||108||
59765603|NCT00489541|75885712|FG000|NOT COMPLETED|9-Month Angiographic Follow-up||27||
59765604|NCT00489541|75885713|FG001|NOT COMPLETED|9-Month Angiographic Follow-up||17||
59765605|NCT00809835|75885723|FG000|STARTED|Overall Study||28||
59765606|NCT00809835|75885724|FG001|STARTED|Overall Study||27||
59765607|NCT00809835|75885725|FG002|STARTED|Overall Study||38||
59765608|NCT00809835|75885726|FG003|STARTED|Overall Study||27||
59765609|NCT00809835|75885723|FG000|COMPLETED|Overall Study||20||
59765610|NCT00809835|75885724|FG001|COMPLETED|Overall Study||20||
59765611|NCT00809835|75885725|FG002|COMPLETED|Overall Study||27||
59765612|NCT00809835|75885726|FG003|COMPLETED|Overall Study||25||
59765613|NCT00809835|75885723|FG000|NOT COMPLETED|Overall Study||8||
59765614|NCT00809835|75885724|FG001|NOT COMPLETED|Overall Study||7||
59765615|NCT00809835|75885725|FG002|NOT COMPLETED|Overall Study||11||
59765616|NCT00809835|75885726|FG003|NOT COMPLETED|Overall Study||2||
59765617|NCT00853242|75885743|FG000|STARTED|Overall Study||50||
59765618|NCT00853242|75885744|FG001|STARTED|Overall Study||50||
59765619|NCT00853242|75885745|FG002|STARTED|Overall Study||49||
59765620|NCT00853242|75885746|FG003|STARTED|Overall Study||50||
59765621|NCT00853242|75885747|FG004|STARTED|Overall Study||50||
59765622|NCT00853242|75885748|FG005|STARTED|Overall Study||51||
59765623|NCT00853242|75885749|FG006|STARTED|Overall Study||49||
59765624|NCT00853242|75885743|FG000|Treated|Overall Study||50||
59765625|NCT00853242|75885744|FG001|Treated|Overall Study||49||
59765626|NCT00853242|75885745|FG002|Treated|Overall Study||48||
59765627|NCT00853242|75885746|FG003|Treated|Overall Study||50||
59765628|NCT00853242|75885747|FG004|Treated|Overall Study||50||
59765629|NCT00853242|75885748|FG005|Treated|Overall Study||51||
59765630|NCT00853242|75885749|FG006|Treated|Overall Study||48||
59765631|NCT00853242|75885743|FG000|COMPLETED|Overall Study||47||
59765632|NCT00853242|75885744|FG001|COMPLETED|Overall Study||47||
59765633|NCT00853242|75885745|FG002|COMPLETED|Overall Study||46||
59765634|NCT00853242|75885746|FG003|COMPLETED|Overall Study||46||
59765635|NCT00853242|75885747|FG004|COMPLETED|Overall Study||46||
59765636|NCT00853242|75885748|FG005|COMPLETED|Overall Study||49||
59765637|NCT00853242|75885749|FG006|COMPLETED|Overall Study||44||
59765638|NCT00853242|75885743|FG000|NOT COMPLETED|Overall Study||3||
59765639|NCT00853242|75885744|FG001|NOT COMPLETED|Overall Study||3||
59765640|NCT00853242|75885745|FG002|NOT COMPLETED|Overall Study||3||
59765641|NCT00853242|75885746|FG003|NOT COMPLETED|Overall Study||4||
60072342|NCT01682811|76187743|FG006|NOT COMPLETED|Part 1 Levulan Injection||0||0
60072343|NCT01682811|76187737|FG000|STARTED|Part 1 Levulan Painting||0||0
59521035|NCT00984542|75615221|FG000|COMPLETED|Overall Study||9||
59521036|NCT00984542|75615221|FG000|NOT COMPLETED|Overall Study||41||
59521037|NCT00983918|75615230|FG000|STARTED|Overall Study||20||
59765642|NCT00853242|75885747|FG004|NOT COMPLETED|Overall Study||4||
59765643|NCT00853242|75885748|FG005|NOT COMPLETED|Overall Study||2||
59765644|NCT00853242|75885749|FG006|NOT COMPLETED|Overall Study||5||
59765645|NCT00848250|75885773|FG000|STARTED|Overall Study||11||
59765646|NCT00848250|75885774|FG001|STARTED|Overall Study||10||
59521038|NCT00983918|75615231|FG001|STARTED|Overall Study||20||
59521039|NCT00983918|75615232|FG002|STARTED|Overall Study||20||
59521040|NCT00983918|75615233|FG003|STARTED|Overall Study||20||
59521041|NCT00983918|75615230|FG000|COMPLETED|Overall Study||20||
59765647|NCT00848250|75885773|FG000|COMPLETED|Overall Study||11||
59765648|NCT00848250|75885774|FG001|COMPLETED|Overall Study||9||
59765649|NCT00848250|75885773|FG000|NOT COMPLETED|Overall Study||0||
59765650|NCT00848250|75885774|FG001|NOT COMPLETED|Overall Study||1||
59765651|NCT00809757|75885784|FG000|STARTED|Overall Study||68||
59765652|NCT00809757|75885785|FG001|STARTED|Overall Study||65||
59765653|NCT00809757|75885786|FG002|STARTED|Overall Study||64||
59765654|NCT00809757|75885784|FG000|COMPLETED|Overall Study||62||
60072344|NCT01682811|76187738|FG001|STARTED|Part 1 Levulan Painting||1||9
60072345|NCT01682811|76187739|FG002|STARTED|Part 1 Levulan Painting||0||0
59521042|NCT00983918|75615231|FG001|COMPLETED|Overall Study||18||
59765655|NCT00809757|75885785|FG001|COMPLETED|Overall Study||60||
59765656|NCT00809757|75885786|FG002|COMPLETED|Overall Study||53||
59765657|NCT00809757|75885784|FG000|NOT COMPLETED|Overall Study||6||
59765658|NCT00809757|75885785|FG001|NOT COMPLETED|Overall Study||5||
59765659|NCT00809757|75885786|FG002|NOT COMPLETED|Overall Study||11||
59765660|NCT00594464|75885800|FG000|STARTED|Overall Study||14||
59765661|NCT00594464|75885800|FG000|COMPLETED|Overall Study||11||
59765662|NCT00594464|75885800|FG000|NOT COMPLETED|Overall Study||3||
59765663|NCT00809445|75885813|FG000|STARTED|1 Month Follow-up||429||
59765664|NCT00809445|75885814|FG001|STARTED|1 Month Follow-up||433||
59765665|NCT00809445|75885815|FG002|STARTED|1 Month Follow-up||419||
59765666|NCT00809445|75885813|FG000|COMPLETED|1 Month Follow-up||427||
59765667|NCT00809445|75885814|FG001|COMPLETED|1 Month Follow-up||429||
59765668|NCT00809445|75885815|FG002|COMPLETED|1 Month Follow-up||415||
59765669|NCT00809445|75885813|FG000|NOT COMPLETED|1 Month Follow-up||2||
59765670|NCT00809445|75885814|FG001|NOT COMPLETED|1 Month Follow-up||4||
59765671|NCT00809445|75885815|FG002|NOT COMPLETED|1 Month Follow-up||4||
59765672|NCT00809445|75885813|FG000|STARTED|6 Month Follow-up||429||
59765673|NCT00809445|75885814|FG001|STARTED|6 Month Follow-up||433||
59765674|NCT00809445|75885815|FG002|STARTED|6 Month Follow-up||419||
59765675|NCT00809445|75885813|FG000|COMPLETED|6 Month Follow-up||405||
59765676|NCT00809445|75885814|FG001|COMPLETED|6 Month Follow-up||410||
59765677|NCT00809445|75885815|FG002|COMPLETED|6 Month Follow-up||395||
59765678|NCT00809445|75885813|FG000|NOT COMPLETED|6 Month Follow-up||24||
59765679|NCT00809445|75885814|FG001|NOT COMPLETED|6 Month Follow-up||23||
59765680|NCT00809445|75885815|FG002|NOT COMPLETED|6 Month Follow-up||24||
59765681|NCT01614899|75885826|FG000|STARTED|Overall Study||150||
59765682|NCT01614899|75885827|FG001|STARTED|Overall Study||155||
59765683|NCT01614899|75885828|FG002|STARTED|Overall Study||152||
59765684|NCT01614899|75885826|FG000|COMPLETED|Overall Study||106||
59765685|NCT01614899|75885827|FG001|COMPLETED|Overall Study||116||
59765686|NCT01614899|75885828|FG002|COMPLETED|Overall Study||110||
59765687|NCT01614899|75885826|FG000|NOT COMPLETED|Overall Study||44||
59765688|NCT01614899|75885827|FG001|NOT COMPLETED|Overall Study||39||
59765689|NCT01614899|75885828|FG002|NOT COMPLETED|Overall Study||42||
59765690|NCT00593918|75885838|FG000|STARTED|Overall Study|Number of children with Toll-like Receptor 4 (TLR4) -2026/GG Genotype|17||
59765691|NCT00593918|75885839|FG001|STARTED|Overall Study|Number of children with Toll-like Receptor 4 (TLR4) -2026/AG and AA genotypes|74||
59765692|NCT00593918|75885838|FG000|COMPLETED|Overall Study|Some children did not come in for the blood draw at visit 2|12||
59765693|NCT00593918|75885839|FG001|COMPLETED|Overall Study|Some children did not come in for the blood draw at visit 2|50||
59765694|NCT00593918|75885838|FG000|NOT COMPLETED|Overall Study||5||
59765695|NCT00593918|75885839|FG001|NOT COMPLETED|Overall Study||24||
59765696|NCT04135196|75885850|FG000|STARTED|Overall Study||21||
59765697|NCT04135196|75885851|FG001|STARTED|Overall Study||24||
59765698|NCT04135196|75885852|FG002|STARTED|Overall Study||21||
59765699|NCT04135196|75885853|FG003|STARTED|Overall Study||20||
59765700|NCT04135196|75885854|FG004|STARTED|Overall Study||16||
59765701|NCT04135196|75885850|FG000|COMPLETED|Overall Study|13 participants analyzed at 12 months 15 participants analyzed at interim timepoints|13||
59765702|NCT04135196|75885851|FG001|COMPLETED|Overall Study|17 participants analyzed at 12 months 21 participants analyzed at interim timepoints|17||
59765703|NCT04135196|75885852|FG002|COMPLETED|Overall Study|12 participants analyzed at 12 months 15 participants analyzed at interim timepoints|12||
59765704|NCT04135196|75885853|FG003|COMPLETED|Overall Study|11 participants analyzed at 12 months 11 participants analyzed at interim time points|11||
59765705|NCT04135196|75885854|FG004|COMPLETED|Overall Study|13 participants analyzed at 12 months (data not available for n=1) 15 participants analyzed at interim timepoints|14||
59765706|NCT04135196|75885850|FG000|NOT COMPLETED|Overall Study||8||
59765707|NCT04135196|75885851|FG001|NOT COMPLETED|Overall Study||7||
59765708|NCT04135196|75885852|FG002|NOT COMPLETED|Overall Study||9||
59765709|NCT04135196|75885853|FG003|NOT COMPLETED|Overall Study||9||
59765710|NCT04135196|75885854|FG004|NOT COMPLETED|Overall Study||2||
59765711|NCT00499369|75885871|FG000|STARTED|Overall Study||16||
59765712|NCT00499369|75885872|FG001|STARTED|Overall Study||18||
59765713|NCT00499369|75885873|FG002|STARTED|Overall Study||17||
59765714|NCT00499369|75885874|FG003|STARTED|Overall Study||9||
59765715|NCT00499369|75885875|FG004|STARTED|Overall Study||12||
59765716|NCT00499369|75885871|FG000|Eligible|Overall Study||14||
59765717|NCT00499369|75885872|FG001|Eligible|Overall Study||16||
59765718|NCT00499369|75885873|FG002|Eligible|Overall Study||16||
59765719|NCT00499369|75885874|FG003|Eligible|Overall Study||8||
59765720|NCT00499369|75885875|FG004|Eligible|Overall Study||12||
59765721|NCT00499369|75885871|FG000|COMPLETED|Overall Study||0||
59765722|NCT00499369|75885872|FG001|COMPLETED|Overall Study||0||
59765723|NCT00499369|75885873|FG002|COMPLETED|Overall Study||0||
59765724|NCT00499369|75885874|FG003|COMPLETED|Overall Study||0||
59765725|NCT00499369|75885875|FG004|COMPLETED|Overall Study||0||
59765726|NCT00499369|75885871|FG000|NOT COMPLETED|Overall Study||16||
59765727|NCT00499369|75885872|FG001|NOT COMPLETED|Overall Study||18||
59765728|NCT00499369|75885873|FG002|NOT COMPLETED|Overall Study||17||
59765729|NCT00499369|75885874|FG003|NOT COMPLETED|Overall Study||9||
59765730|NCT00499369|75885875|FG004|NOT COMPLETED|Overall Study||12||
59765731|NCT00869258|75885887|FG000|STARTED|Overall Study||32||
59765732|NCT00869258|75885887|FG000|COMPLETED|Overall Study||31||
59765733|NCT00869258|75885887|FG000|NOT COMPLETED|Overall Study||1||
59765734|NCT00693784|75885891|FG000|STARTED|Overall Study||15||
59765735|NCT00693784|75885891|FG000|26-Week Primary Endpoint|Overall Study||15||
59765736|NCT00693784|75885891|FG000|52-week Extended Follow-up|Overall Study||13||
59765737|NCT00693784|75885891|FG000|104-week Extended Follow-up|Overall Study||11||
59765738|NCT00693784|75885891|FG000|COMPLETED|Overall Study||11||
59765739|NCT00693784|75885891|FG000|NOT COMPLETED|Overall Study||4||
59765740|NCT00693706|75885897|FG000|STARTED|Overall Study||101||
59765741|NCT00693706|75885898|FG001|STARTED|Overall Study||99||
59765742|NCT00693706|75885897|FG000|COMPLETED|Overall Study||101||
59765743|NCT00693706|75885898|FG001|COMPLETED|Overall Study||98||
59765744|NCT00693706|75885897|FG000|NOT COMPLETED|Overall Study||0||
59765745|NCT00693706|75885898|FG001|NOT COMPLETED|Overall Study||1||
59765746|NCT00488683|75885907|FG000|STARTED|Overall Study||108||
59765747|NCT00488683|75885908|FG001|STARTED|Overall Study||54||
59765748|NCT00488683|75885909|FG002|STARTED|Overall Study||54||
59765749|NCT00488683|75885907|FG000|COMPLETED|Overall Study||96||
59765750|NCT00488683|75885908|FG001|COMPLETED|Overall Study||48||
59765751|NCT00488683|75885909|FG002|COMPLETED|Overall Study||52||
59765752|NCT00488683|75885907|FG000|NOT COMPLETED|Overall Study||12||
59765753|NCT00488683|75885908|FG001|NOT COMPLETED|Overall Study||6||
59765754|NCT00488683|75885909|FG002|NOT COMPLETED|Overall Study||2||
59765755|NCT00711269|75885925|FG000|STARTED|Overall Study||131||
59765756|NCT00711269|75885926|FG001|STARTED|Overall Study||131||
59765757|NCT00711269|75885927|FG002|STARTED|Overall Study||133||
59765758|NCT00711269|75885928|FG003|STARTED|Overall Study||65||
59765759|NCT00711269|75885925|FG000|COMPLETED|Overall Study||87||
59765760|NCT00711269|75885926|FG001|COMPLETED|Overall Study||83||
59765761|NCT00711269|75885927|FG002|COMPLETED|Overall Study||83||
59765762|NCT00711269|75885928|FG003|COMPLETED|Overall Study||51||
59765763|NCT00711269|75885925|FG000|NOT COMPLETED|Overall Study||44||
59765764|NCT00711269|75885926|FG001|NOT COMPLETED|Overall Study||48||
59765765|NCT00711269|75885927|FG002|NOT COMPLETED|Overall Study||50||
59765766|NCT00711269|75885928|FG003|NOT COMPLETED|Overall Study||14||
59765767|NCT00693472|75885943|FG000|STARTED|Part 1||19||
59765768|NCT00693472|75885944|FG001|STARTED|Part 1||13||
59765769|NCT00693472|75885945|FG002|STARTED|Part 1||0||
59765770|NCT00693472|75885946|FG003|STARTED|Part 1||0||
59765771|NCT00693472|75885943|FG000|COMPLETED|Part 1||13||
59765772|NCT00693472|75885944|FG001|COMPLETED|Part 1||9||
59765773|NCT00693472|75885945|FG002|COMPLETED|Part 1||0||
59765774|NCT00693472|75885946|FG003|COMPLETED|Part 1||0||
59765775|NCT00693472|75885943|FG000|NOT COMPLETED|Part 1||6||
59765776|NCT00693472|75885944|FG001|NOT COMPLETED|Part 1||4||
59765777|NCT00693472|75885945|FG002|NOT COMPLETED|Part 1||0||
59765778|NCT00693472|75885946|FG003|NOT COMPLETED|Part 1||0||
59765779|NCT00693472|75885943|FG000|STARTED|Part 2||0||
59765780|NCT00693472|75885944|FG001|STARTED|Part 2||0||
59765781|NCT00693472|75885945|FG002|STARTED|Part 2||8||
59765782|NCT00693472|75885946|FG003|STARTED|Part 2||6||
59765783|NCT00693472|75885943|FG000|COMPLETED|Part 2||0||
59765784|NCT00693472|75885944|FG001|COMPLETED|Part 2||0||
59765785|NCT00693472|75885945|FG002|COMPLETED|Part 2||6||
59765786|NCT00693472|75885946|FG003|COMPLETED|Part 2||4||
59765787|NCT00693472|75885943|FG000|NOT COMPLETED|Part 2||0||
59765788|NCT00693472|75885944|FG001|NOT COMPLETED|Part 2||0||
59765789|NCT00693472|75885945|FG002|NOT COMPLETED|Part 2||2||
59765790|NCT00693472|75885946|FG003|NOT COMPLETED|Part 2||2||
59765791|NCT00498433|75885959|FG000|STARTED|Part 1, Period 1:Placebo Run-in(2 Weeks)||10||
59765792|NCT00498433|75885960|FG001|STARTED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0||
59765793|NCT00498433|75885961|FG002|STARTED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0||
59765794|NCT00498433|75885959|FG000|COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||10||
59765795|NCT00498433|75885960|FG001|COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0||
59765796|NCT00498433|75885961|FG002|COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0||
59765797|NCT00498433|75885959|FG000|NOT COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0||
59765798|NCT00498433|75885960|FG001|NOT COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0||
59765799|NCT00498433|75885961|FG002|NOT COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0||
59765800|NCT00498433|75885959|FG000|STARTED|Part 1, Period 2: Aliskiren (4 Weeks)||0||
59765801|NCT00498433|75885960|FG001|STARTED|Part 1, Period 2: Aliskiren (4 Weeks)||10||
59765802|NCT00498433|75885961|FG002|STARTED|Part 1, Period 2: Aliskiren (4 Weeks)||0||
59765803|NCT00498433|75885959|FG000|COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0||
59765804|NCT00498433|75885960|FG001|COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||10||
59765805|NCT00498433|75885961|FG002|COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0||
59765806|NCT00498433|75885959|FG000|NOT COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0||
59765807|NCT00498433|75885960|FG001|NOT COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0||
59765808|NCT00498433|75885961|FG002|NOT COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0||
59765809|NCT00498433|75885959|FG000|STARTED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0||
59765810|NCT00498433|75885960|FG001|STARTED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0||
59765811|NCT00498433|75885961|FG002|STARTED|Part 1, Period 3: Amlodipine (4-8 Weeks)||10||
59765812|NCT00498433|75885959|FG000|COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0||
59765813|NCT00498433|75885960|FG001|COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0||
59765814|NCT00498433|75885961|FG002|COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||10||
59765815|NCT00498433|75885959|FG000|NOT COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0||
59765816|NCT00498433|75885960|FG001|NOT COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0||
59765817|NCT00498433|75885961|FG002|NOT COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0||
59765818|NCT00498433|75885959|FG000|STARTED|Part 2: Placebo Run-in (2 Weeks)||36||
59765819|NCT00498433|75885960|FG001|STARTED|Part 2: Placebo Run-in (2 Weeks)|For part 2, this arm belongs to randomized, double blind period.|0||
59765820|NCT00498433|75885961|FG002|STARTED|Part 2: Placebo Run-in (2 Weeks)|For part 2, this arm belongs to randomized, double blind period.|0||
59765821|NCT00498433|75885959|FG000|COMPLETED|Part 2: Placebo Run-in (2 Weeks)||16||
59765822|NCT00498433|75885960|FG001|COMPLETED|Part 2: Placebo Run-in (2 Weeks)||0||
59765823|NCT00498433|75885961|FG002|COMPLETED|Part 2: Placebo Run-in (2 Weeks)||0||
59765824|NCT00498433|75885959|FG000|NOT COMPLETED|Part 2: Placebo Run-in (2 Weeks)||20||
59765825|NCT00498433|75885960|FG001|NOT COMPLETED|Part 2: Placebo Run-in (2 Weeks)||0||
59765826|NCT00498433|75885961|FG002|NOT COMPLETED|Part 2: Placebo Run-in (2 Weeks)||0||
59765827|NCT00498433|75885959|FG000|STARTED|Part 2: Double Blind (12 Weeks)||0||
59765828|NCT00498433|75885960|FG001|STARTED|Part 2: Double Blind (12 Weeks)||8||
59765829|NCT00498433|75885961|FG002|STARTED|Part 2: Double Blind (12 Weeks)||8||
59765830|NCT00498433|75885959|FG000|COMPLETED|Part 2: Double Blind (12 Weeks)||0||
59765831|NCT00498433|75885960|FG001|COMPLETED|Part 2: Double Blind (12 Weeks)||8||
59765832|NCT00498433|75885961|FG002|COMPLETED|Part 2: Double Blind (12 Weeks)||8||
59765833|NCT00498433|75885959|FG000|NOT COMPLETED|Part 2: Double Blind (12 Weeks)||0||
59765834|NCT00498433|75885960|FG001|NOT COMPLETED|Part 2: Double Blind (12 Weeks)||0||
59765835|NCT00498433|75885961|FG002|NOT COMPLETED|Part 2: Double Blind (12 Weeks)||0||
59765836|NCT00498355|75885978|FG000|STARTED|Overall Study||7||
59765837|NCT00498355|75885978|FG000|COMPLETED|Overall Study||6||
59765838|NCT00498355|75885978|FG000|NOT COMPLETED|Overall Study||1||
59765839|NCT04327271|75885985|FG000|STARTED|Overall Study||553||
59765840|NCT04327271|75885986|FG001|STARTED|Overall Study||540||
59765841|NCT04327271|75885985|FG000|COMPLETED|Overall Study||547||
59765842|NCT04327271|75885986|FG001|COMPLETED|Overall Study||537||
59765843|NCT04327271|75885985|FG000|NOT COMPLETED|Overall Study||6||
59765844|NCT04327271|75885986|FG001|NOT COMPLETED|Overall Study||3||
59765845|NCT03382769|75885994|FG000|STARTED|Overall Study||0||
59765846|NCT03382769|75885995|FG001|STARTED|Overall Study||1||
59765847|NCT03382769|75885994|FG000|COMPLETED|Overall Study||0||
59765848|NCT03382769|75885995|FG001|COMPLETED|Overall Study||0||
59765849|NCT03382769|75885994|FG000|NOT COMPLETED|Overall Study||0||
59765850|NCT03382769|75885995|FG001|NOT COMPLETED|Overall Study||1||
59765851|NCT00688636|75886003|FG000|STARTED|Overall Study||11||
59765852|NCT00688636|75886004|FG001|STARTED|Overall Study||13||
59765853|NCT00688636|75886003|FG000|COMPLETED|Overall Study||9||
59765854|NCT00688636|75886004|FG001|COMPLETED|Overall Study||12||
59765855|NCT00688636|75886003|FG000|NOT COMPLETED|Overall Study||2||
59765856|NCT00688636|75886004|FG001|NOT COMPLETED|Overall Study||1||
59765857|NCT00870740|75886016|FG000|STARTED|Overall Study|number randomized and dosed|86||
59765858|NCT00870740|75886017|FG001|STARTED|Overall Study|number randomized and dosed|84||
59765859|NCT00870740|75886018|FG002|STARTED|Overall Study|number randomized and dosed|86||
59765860|NCT00870740|75886019|FG003|STARTED|Overall Study|number randomized and dosed|86||
59765861|NCT00870740|75886020|FG004|STARTED|Overall Study|number randomized and dosed|88||
59765862|NCT00870740|75886021|FG005|STARTED|Overall Study|number randomized and dosed|87||
59765863|NCT00870740|75886016|FG000|COMPLETED|Overall Study||74||
59765864|NCT00870740|75886017|FG001|COMPLETED|Overall Study||75||
59765865|NCT00870740|75886018|FG002|COMPLETED|Overall Study||76||
59765866|NCT00870740|75886019|FG003|COMPLETED|Overall Study||74||
59765867|NCT00870740|75886020|FG004|COMPLETED|Overall Study||77||
59765868|NCT00870740|75886021|FG005|COMPLETED|Overall Study||70||
59765869|NCT00870740|75886016|FG000|NOT COMPLETED|Overall Study||12||
59765870|NCT00870740|75886017|FG001|NOT COMPLETED|Overall Study||9||
59765871|NCT00870740|75886018|FG002|NOT COMPLETED|Overall Study||10||
59765872|NCT00870740|75886019|FG003|NOT COMPLETED|Overall Study||12||
59765873|NCT00870740|75886020|FG004|NOT COMPLETED|Overall Study||11||
59765874|NCT00870740|75886021|FG005|NOT COMPLETED|Overall Study||17||
59765875|NCT00869024|75886048|FG000|STARTED|Overall Study||16||
59765876|NCT00869024|75886049|FG001|STARTED|Overall Study|One patient intent to treat, did not receive study product|9||
59765877|NCT00869024|75886048|FG000|COMPLETED|Overall Study||14||
59765878|NCT00869024|75886049|FG001|COMPLETED|Overall Study||4||
59765879|NCT00869024|75886048|FG000|NOT COMPLETED|Overall Study||2||
59765880|NCT00869024|75886049|FG001|NOT COMPLETED|Overall Study||5||
59765881|NCT00506779|75886057|FG000|STARTED|Overall Study||4||
59765882|NCT00506779|75886058|FG001|STARTED|Overall Study||6||
59765883|NCT00506779|75886059|FG002|STARTED|Overall Study||2||
59765884|NCT00506779|75886060|FG003|STARTED|Overall Study||5||
59765885|NCT00506779|75886057|FG000|COMPLETED|Overall Study||3||
59765886|NCT00506779|75886058|FG001|COMPLETED|Overall Study||5||
59765887|NCT00506779|75886059|FG002|COMPLETED|Overall Study||0||
59765888|NCT00506779|75886060|FG003|COMPLETED|Overall Study||4||
59765889|NCT00506779|75886057|FG000|NOT COMPLETED|Overall Study||1||
59765890|NCT00506779|75886058|FG001|NOT COMPLETED|Overall Study||1||
59765891|NCT00506779|75886059|FG002|NOT COMPLETED|Overall Study||2||
59765892|NCT00506779|75886060|FG003|NOT COMPLETED|Overall Study||1||
59765893|NCT00488293|75886073|FG000|STARTED|Overall Study||196||
59765894|NCT00488293|75886074|FG001|STARTED|Overall Study||196||
59765895|NCT00488293|75886073|FG000|COMPLETED|Overall Study||160||
59765896|NCT00488293|75886074|FG001|COMPLETED|Overall Study||166||
59765897|NCT00488293|75886073|FG000|NOT COMPLETED|Overall Study||36||
59765898|NCT00488293|75886074|FG001|NOT COMPLETED|Overall Study||30||
59765899|NCT00868790|75886080|FG000|STARTED|Period 1||11||
59765900|NCT00868790|75886081|FG001|STARTED|Period 1||8||
59765901|NCT00868790|75886082|FG002|STARTED|Period 1||4||
59765902|NCT00868790|75886083|FG003|STARTED|Period 1||4||
59765903|NCT00868790|75886084|FG004|STARTED|Period 1||19||
59765904|NCT00868790|75886085|FG005|STARTED|Period 1||3||
59765905|NCT00868790|75886086|FG006|STARTED|Period 1||4||
59765906|NCT00868790|75886087|FG007|STARTED|Period 1||20||
59765907|NCT00868790|75886088|FG008|STARTED|Period 1||11||
59765908|NCT00868790|75886089|FG009|STARTED|Period 1||3||
59765909|NCT00868790|75886090|FG010|STARTED|Period 1||9||
59765910|NCT00868790|75886091|FG011|STARTED|Period 1||4||
59765911|NCT00868790|75886092|FG012|STARTED|Period 1||7||
59765912|NCT00868790|75886093|FG013|STARTED|Period 1||11||
59765913|NCT00868790|75886080|FG000|COMPLETED|Period 1||9||
59765914|NCT00868790|75886081|FG001|COMPLETED|Period 1||7||
59765915|NCT00868790|75886082|FG002|COMPLETED|Period 1||4||
59765916|NCT00868790|75886083|FG003|COMPLETED|Period 1||4||
59765917|NCT00868790|75886084|FG004|COMPLETED|Period 1||18||
59765918|NCT00868790|75886085|FG005|COMPLETED|Period 1||2||
59765919|NCT00868790|75886086|FG006|COMPLETED|Period 1||4||
59765920|NCT00868790|75886087|FG007|COMPLETED|Period 1||17||
59765921|NCT00868790|75886088|FG008|COMPLETED|Period 1||10||
59765922|NCT00868790|75886089|FG009|COMPLETED|Period 1||3||
59765923|NCT00868790|75886090|FG010|COMPLETED|Period 1||9||
59765924|NCT00868790|75886091|FG011|COMPLETED|Period 1||4||
59765925|NCT00868790|75886092|FG012|COMPLETED|Period 1||7||
59765926|NCT00868790|75886093|FG013|COMPLETED|Period 1||9||
59765927|NCT00868790|75886080|FG000|NOT COMPLETED|Period 1||2||
59765928|NCT00868790|75886081|FG001|NOT COMPLETED|Period 1||1||
59765929|NCT00868790|75886082|FG002|NOT COMPLETED|Period 1||0||
59765930|NCT00868790|75886083|FG003|NOT COMPLETED|Period 1||0||
59765931|NCT00868790|75886084|FG004|NOT COMPLETED|Period 1||1||
59765932|NCT00868790|75886085|FG005|NOT COMPLETED|Period 1||1||
59765933|NCT00868790|75886086|FG006|NOT COMPLETED|Period 1||0||
59765934|NCT00868790|75886087|FG007|NOT COMPLETED|Period 1||3||
59765935|NCT00868790|75886088|FG008|NOT COMPLETED|Period 1||1||
59765936|NCT00868790|75886089|FG009|NOT COMPLETED|Period 1||0||
59765937|NCT00868790|75886090|FG010|NOT COMPLETED|Period 1||0||
59765938|NCT00868790|75886091|FG011|NOT COMPLETED|Period 1||0||
59765939|NCT00868790|75886092|FG012|NOT COMPLETED|Period 1||0||
59765940|NCT00868790|75886093|FG013|NOT COMPLETED|Period 1||2||
59765941|NCT00868790|75886080|FG000|STARTED|Period 2||9||
59765942|NCT00868790|75886081|FG001|STARTED|Period 2||7||
59765943|NCT00868790|75886082|FG002|STARTED|Period 2||4||
59765944|NCT00868790|75886083|FG003|STARTED|Period 2||4||
59765945|NCT00868790|75886084|FG004|STARTED|Period 2||18||
59765946|NCT00868790|75886085|FG005|STARTED|Period 2||2||
59765947|NCT00868790|75886086|FG006|STARTED|Period 2||4||
59765948|NCT00868790|75886087|FG007|STARTED|Period 2||17||
59765949|NCT00868790|75886088|FG008|STARTED|Period 2||10||
59765950|NCT00868790|75886089|FG009|STARTED|Period 2||3||
59765951|NCT00868790|75886090|FG010|STARTED|Period 2||9||
59765952|NCT00868790|75886091|FG011|STARTED|Period 2||4||
59765953|NCT00868790|75886092|FG012|STARTED|Period 2||7||
59765954|NCT00868790|75886093|FG013|STARTED|Period 2||9||
59765955|NCT00868790|75886080|FG000|COMPLETED|Period 2||9||
59765956|NCT00868790|75886081|FG001|COMPLETED|Period 2||6||
59765957|NCT00868790|75886082|FG002|COMPLETED|Period 2||4||
59765958|NCT00868790|75886083|FG003|COMPLETED|Period 2||4||
59765959|NCT00868790|75886084|FG004|COMPLETED|Period 2||18||
59765960|NCT00868790|75886085|FG005|COMPLETED|Period 2||1||
59765961|NCT00868790|75886086|FG006|COMPLETED|Period 2||4||
59765962|NCT00868790|75886087|FG007|COMPLETED|Period 2||17||
59765963|NCT00868790|75886088|FG008|COMPLETED|Period 2||8||
59765964|NCT00868790|75886089|FG009|COMPLETED|Period 2||3||
59765965|NCT00868790|75886090|FG010|COMPLETED|Period 2||9||
59765966|NCT00868790|75886091|FG011|COMPLETED|Period 2||4||
59765967|NCT00868790|75886092|FG012|COMPLETED|Period 2||7||
59765968|NCT00868790|75886093|FG013|COMPLETED|Period 2||8||
59765969|NCT00868790|75886080|FG000|NOT COMPLETED|Period 2||0||
59765970|NCT00868790|75886081|FG001|NOT COMPLETED|Period 2||1||
59765971|NCT00868790|75886082|FG002|NOT COMPLETED|Period 2||0||
59765972|NCT00868790|75886083|FG003|NOT COMPLETED|Period 2||0||
59765973|NCT00868790|75886084|FG004|NOT COMPLETED|Period 2||0||
59765974|NCT00868790|75886085|FG005|NOT COMPLETED|Period 2||1||
59765975|NCT00868790|75886086|FG006|NOT COMPLETED|Period 2||0||
59765976|NCT00868790|75886087|FG007|NOT COMPLETED|Period 2||0||
59765977|NCT00868790|75886088|FG008|NOT COMPLETED|Period 2||2||
59765978|NCT00868790|75886089|FG009|NOT COMPLETED|Period 2||0||
59765979|NCT00868790|75886090|FG010|NOT COMPLETED|Period 2||0||
59765980|NCT00868790|75886091|FG011|NOT COMPLETED|Period 2||0||
59765981|NCT00868790|75886092|FG012|NOT COMPLETED|Period 2||0||
59765982|NCT00868790|75886093|FG013|NOT COMPLETED|Period 2||1||
59765983|NCT00868790|75886080|FG000|STARTED|Period 3||9||
59765984|NCT00868790|75886081|FG001|STARTED|Period 3||6||
59765985|NCT00868790|75886082|FG002|STARTED|Period 3||4||
59765986|NCT00868790|75886083|FG003|STARTED|Period 3||4||
59765987|NCT00868790|75886084|FG004|STARTED|Period 3||18||
59765988|NCT00868790|75886085|FG005|STARTED|Period 3||1||
59765989|NCT00868790|75886086|FG006|STARTED|Period 3||4||
59765990|NCT00868790|75886087|FG007|STARTED|Period 3||17||
59765991|NCT00868790|75886088|FG008|STARTED|Period 3||8||
59765992|NCT00868790|75886089|FG009|STARTED|Period 3||3||
59765993|NCT00868790|75886090|FG010|STARTED|Period 3||9||
59765994|NCT00868790|75886091|FG011|STARTED|Period 3||4||
59765995|NCT00868790|75886092|FG012|STARTED|Period 3||7||
59765996|NCT00868790|75886093|FG013|STARTED|Period 3||8||
59765997|NCT00868790|75886080|FG000|COMPLETED|Period 3||9||
59765998|NCT00868790|75886081|FG001|COMPLETED|Period 3||6||
59765999|NCT00868790|75886082|FG002|COMPLETED|Period 3||4||
59766000|NCT00868790|75886083|FG003|COMPLETED|Period 3||3||
59766001|NCT00868790|75886084|FG004|COMPLETED|Period 3||18||
59766002|NCT00868790|75886085|FG005|COMPLETED|Period 3||1||
59766003|NCT00868790|75886086|FG006|COMPLETED|Period 3||4||
59766004|NCT00868790|75886087|FG007|COMPLETED|Period 3||17||
59766005|NCT00868790|75886088|FG008|COMPLETED|Period 3||8||
59766006|NCT00868790|75886089|FG009|COMPLETED|Period 3||2||
59766007|NCT00868790|75886090|FG010|COMPLETED|Period 3||8||
59766008|NCT00868790|75886091|FG011|COMPLETED|Period 3||4||
59766009|NCT00868790|75886092|FG012|COMPLETED|Period 3||7||
59766010|NCT00868790|75886093|FG013|COMPLETED|Period 3||8||
59766011|NCT00868790|75886080|FG000|NOT COMPLETED|Period 3||0||
59766012|NCT00868790|75886081|FG001|NOT COMPLETED|Period 3||0||
59766013|NCT00868790|75886082|FG002|NOT COMPLETED|Period 3||0||
59766014|NCT00868790|75886083|FG003|NOT COMPLETED|Period 3||1||
59766015|NCT00868790|75886084|FG004|NOT COMPLETED|Period 3||0||
59766016|NCT00868790|75886085|FG005|NOT COMPLETED|Period 3||0||
59766017|NCT00868790|75886086|FG006|NOT COMPLETED|Period 3||0||
59766018|NCT00868790|75886087|FG007|NOT COMPLETED|Period 3||0||
59766019|NCT00868790|75886088|FG008|NOT COMPLETED|Period 3||0||
59766020|NCT00868790|75886089|FG009|NOT COMPLETED|Period 3||1||
59766021|NCT00868790|75886090|FG010|NOT COMPLETED|Period 3||1||
59766022|NCT00868790|75886091|FG011|NOT COMPLETED|Period 3||0||
59766023|NCT00868790|75886092|FG012|NOT COMPLETED|Period 3||0||
59766024|NCT00868790|75886093|FG013|NOT COMPLETED|Period 3||0||
59766025|NCT00868790|75886080|FG000|STARTED|Period 4||9||
59766026|NCT00868790|75886081|FG001|STARTED|Period 4||6||
59766027|NCT00868790|75886082|FG002|STARTED|Period 4||4||
59766028|NCT00868790|75886083|FG003|STARTED|Period 4||3||
59766029|NCT00868790|75886084|FG004|STARTED|Period 4||18||
59766030|NCT00868790|75886085|FG005|STARTED|Period 4||1||
59766031|NCT00868790|75886086|FG006|STARTED|Period 4||4||
59766032|NCT00868790|75886087|FG007|STARTED|Period 4||17||
59766033|NCT00868790|75886088|FG008|STARTED|Period 4||8||
59766034|NCT00868790|75886089|FG009|STARTED|Period 4||2||
59766035|NCT00868790|75886090|FG010|STARTED|Period 4||8||
59766036|NCT00868790|75886091|FG011|STARTED|Period 4||4||
59766037|NCT00868790|75886092|FG012|STARTED|Period 4||7||
59766038|NCT00868790|75886093|FG013|STARTED|Period 4||8||
59766039|NCT00868790|75886080|FG000|COMPLETED|Period 4||7||
59766040|NCT00868790|75886081|FG001|COMPLETED|Period 4||6||
59766041|NCT00868790|75886082|FG002|COMPLETED|Period 4|One non-completion due to abnormal alanine aminotransferase/aspartate aminotransferase (ALT/AST)|3||
59766042|NCT00868790|75886083|FG003|COMPLETED|Period 4||3||
59766043|NCT00868790|75886084|FG004|COMPLETED|Period 4||18||
59766044|NCT00868790|75886085|FG005|COMPLETED|Period 4||1||
59766045|NCT00868790|75886086|FG006|COMPLETED|Period 4||4||
59766046|NCT00868790|75886087|FG007|COMPLETED|Period 4||14||
59766047|NCT00868790|75886088|FG008|COMPLETED|Period 4||6||
59766048|NCT00868790|75886089|FG009|COMPLETED|Period 4||2||
59766049|NCT00868790|75886090|FG010|COMPLETED|Period 4||5||
59766050|NCT00868790|75886091|FG011|COMPLETED|Period 4||3||
59766051|NCT00868790|75886092|FG012|COMPLETED|Period 4||6||
59766052|NCT00868790|75886093|FG013|COMPLETED|Period 4||7||
59766053|NCT00868790|75886080|FG000|NOT COMPLETED|Period 4||2||
59766054|NCT00868790|75886081|FG001|NOT COMPLETED|Period 4||0||
59766055|NCT00868790|75886082|FG002|NOT COMPLETED|Period 4||1||
59766056|NCT00868790|75886083|FG003|NOT COMPLETED|Period 4||0||
59766057|NCT00868790|75886084|FG004|NOT COMPLETED|Period 4||0||
59766058|NCT00868790|75886085|FG005|NOT COMPLETED|Period 4||0||
59766059|NCT00868790|75886086|FG006|NOT COMPLETED|Period 4||0||
59766060|NCT00868790|75886087|FG007|NOT COMPLETED|Period 4||3||
59766061|NCT00868790|75886088|FG008|NOT COMPLETED|Period 4||2||
59766062|NCT00868790|75886089|FG009|NOT COMPLETED|Period 4||0||
59766063|NCT00868790|75886090|FG010|NOT COMPLETED|Period 4||3||
59766064|NCT00868790|75886091|FG011|NOT COMPLETED|Period 4||1||
59766065|NCT00868790|75886092|FG012|NOT COMPLETED|Period 4||1||
59766066|NCT00868790|75886093|FG013|NOT COMPLETED|Period 4||1||
59766067|NCT00868790|75886080|FG000|STARTED|Post-study||7||
59766068|NCT00868790|75886081|FG001|STARTED|Post-study||6||
59766069|NCT00868790|75886082|FG002|STARTED|Post-study||3||
59766070|NCT00868790|75886083|FG003|STARTED|Post-study||3||
59766071|NCT00868790|75886084|FG004|STARTED|Post-study||18||
59766072|NCT00868790|75886085|FG005|STARTED|Post-study||1||
59766073|NCT00868790|75886086|FG006|STARTED|Post-study||4||
59766074|NCT00868790|75886087|FG007|STARTED|Post-study||14||
59766075|NCT00868790|75886088|FG008|STARTED|Post-study||6||
59766076|NCT00868790|75886089|FG009|STARTED|Post-study||2||
59766077|NCT00868790|75886090|FG010|STARTED|Post-study||5||
59766078|NCT00868790|75886091|FG011|STARTED|Post-study||3||
59766079|NCT00868790|75886092|FG012|STARTED|Post-study||6||
59766080|NCT00868790|75886093|FG013|STARTED|Post-study||7||
59766081|NCT00868790|75886080|FG000|COMPLETED|Post-study||7||
59766082|NCT00868790|75886081|FG001|COMPLETED|Post-study||6||
59766083|NCT00868790|75886082|FG002|COMPLETED|Post-study||3||
59766084|NCT00868790|75886083|FG003|COMPLETED|Post-study||3||
59766085|NCT00868790|75886084|FG004|COMPLETED|Post-study||17||
59766086|NCT00868790|75886085|FG005|COMPLETED|Post-study||1||
59766087|NCT00868790|75886086|FG006|COMPLETED|Post-study||4||
59766088|NCT00868790|75886087|FG007|COMPLETED|Post-study||12||
59766089|NCT00868790|75886088|FG008|COMPLETED|Post-study||6||
59766090|NCT00868790|75886089|FG009|COMPLETED|Post-study||1||
59766091|NCT00868790|75886090|FG010|COMPLETED|Post-study||5||
59766092|NCT00868790|75886091|FG011|COMPLETED|Post-study||3||
59521043|NCT00983918|75615232|FG002|COMPLETED|Overall Study||18||
59521044|NCT00983918|75615233|FG003|COMPLETED|Overall Study||18||
59521045|NCT00983918|75615230|FG000|NOT COMPLETED|Overall Study||0||
59521046|NCT00983918|75615231|FG001|NOT COMPLETED|Overall Study||2||
59521047|NCT00983918|75615232|FG002|NOT COMPLETED|Overall Study||2||
59521048|NCT00983918|75615233|FG003|NOT COMPLETED|Overall Study||2||
59521049|NCT00983528|75615243|FG000|STARTED|Overall Study||6||
59521050|NCT00983528|75615243|FG000|COMPLETED|Overall Study||0||
59521051|NCT00983528|75615243|FG000|NOT COMPLETED|Overall Study||6||
59521052|NCT00983372|75615247|FG000|STARTED|Colchicine Alone||24||
59521053|NCT00983372|75615247|FG000|COMPLETED|Colchicine Alone||24||
59521054|NCT00983372|75615247|FG000|NOT COMPLETED|Colchicine Alone||0||
59521055|NCT00983372|75615247|FG000|STARTED|14 Day Washout Period||24||
59521056|NCT00983372|75615247|FG000|COMPLETED|14 Day Washout Period|subject withdrew consent due to schedule conflict - during washout period or diltiazem alone|23||
59521057|NCT00983372|75615247|FG000|NOT COMPLETED|14 Day Washout Period||1||
59521058|NCT00983372|75615247|FG000|STARTED|Diltiazem ER Alone||23||
59521059|NCT00983372|75615247|FG000|COMPLETED|Diltiazem ER Alone|two subjects dropped due to missed diltiazem ER dose; one subject dropped due to vomitting|20||
59521060|NCT00983372|75615247|FG000|NOT COMPLETED|Diltiazem ER Alone||3||
59521061|NCT00983372|75615247|FG000|STARTED|Colchicine With Diltiazem ER||20||
59521062|NCT00983372|75615247|FG000|COMPLETED|Colchicine With Diltiazem ER||20||
59521063|NCT00983372|75615247|FG000|NOT COMPLETED|Colchicine With Diltiazem ER||0||
59521064|NCT01173211|75615260|FG000|STARTED|Overall Study||48||
59521065|NCT01173211|75615261|FG001|STARTED|Overall Study||45||
59521066|NCT01173211|75615262|FG002|STARTED|Overall Study||46||
59521067|NCT01173211|75615263|FG003|STARTED|Overall Study||15||
59521068|NCT01173211|75615264|FG004|STARTED|Overall Study||16||
59521069|NCT01173211|75615265|FG005|STARTED|Overall Study||13||
59521070|NCT01173211|75615260|FG000|COMPLETED|Overall Study||46||
59521071|NCT01173211|75615261|FG001|COMPLETED|Overall Study||44||
59521072|NCT01173211|75615262|FG002|COMPLETED|Overall Study||44||
59521073|NCT01173211|75615263|FG003|COMPLETED|Overall Study||15||
59521074|NCT01173211|75615264|FG004|COMPLETED|Overall Study||16||
59521075|NCT01173211|75615265|FG005|COMPLETED|Overall Study||13||
59521076|NCT01173211|75615260|FG000|NOT COMPLETED|Overall Study||2||
59521077|NCT01173211|75615261|FG001|NOT COMPLETED|Overall Study||1||
59521078|NCT01173211|75615262|FG002|NOT COMPLETED|Overall Study||2||
59521079|NCT01173211|75615263|FG003|NOT COMPLETED|Overall Study||0||
59521080|NCT01173211|75615264|FG004|NOT COMPLETED|Overall Study||0||
59521081|NCT01173211|75615265|FG005|NOT COMPLETED|Overall Study||0||
59521082|NCT00983294|75615279|FG000|STARTED|Colchicine Alone||24||
59521083|NCT00983294|75615279|FG000|COMPLETED|Colchicine Alone||24||
59521084|NCT00983294|75615279|FG000|NOT COMPLETED|Colchicine Alone||0||
59521085|NCT00983294|75615279|FG000|STARTED|14 Day Washout Period||24||
59521086|NCT00983294|75615279|FG000|COMPLETED|14 Day Washout Period|two subjects withdrew consent due to personal reasons|22||
59617886|NCT01394952|75729051|FG001|STARTED|Overall Study||4949||
59617887|NCT01394952|75729050|FG000|Received at Least One Dose of Study Drug|Overall Study||4949||
59617888|NCT01394952|75729051|FG001|Received at Least One Dose of Study Drug|Overall Study||4943||
59617889|NCT01394952|75729050|FG000|COMPLETED|Overall Study||4935||
59617890|NCT01394952|75729051|FG001|COMPLETED|Overall Study||4932||
59617891|NCT01394952|75729050|FG000|NOT COMPLETED|Overall Study||17||
59617892|NCT01394952|75729051|FG001|NOT COMPLETED|Overall Study||17||
59617893|NCT01394718|75729059|FG000|STARTED|Overall Study||30||
59766093|NCT00868790|75886092|FG012|COMPLETED|Post-study||6||
59766094|NCT00868790|75886093|FG013|COMPLETED|Post-study||7||
59766095|NCT00868790|75886080|FG000|NOT COMPLETED|Post-study||0||
59766096|NCT00868790|75886081|FG001|NOT COMPLETED|Post-study||0||
59766097|NCT00868790|75886082|FG002|NOT COMPLETED|Post-study||0||
59521087|NCT00983294|75615279|FG000|NOT COMPLETED|14 Day Washout Period||2||
59521088|NCT00983294|75615279|FG000|STARTED|Azithromycin Alone||22||
59521089|NCT00983294|75615279|FG000|COMPLETED|Azithromycin Alone||22||
59521090|NCT00983294|75615279|FG000|NOT COMPLETED|Azithromycin Alone||0||
59521091|NCT00983294|75615279|FG000|STARTED|Colchicine With Azithromycin||22||
59521092|NCT00983294|75615279|FG000|COMPLETED|Colchicine With Azithromycin|withdrawn by sponsor on Day 21 due to vomiting on Day 15, prior to azithromycin dosing(1)|21||
59521093|NCT00983294|75615279|FG000|NOT COMPLETED|Colchicine With Azithromycin||1||
59521094|NCT01129765|75615286|FG000|STARTED|Overall Study||30||
59521095|NCT01129765|75615286|FG000|COMPLETED|Overall Study||30||
59521096|NCT01129765|75615286|FG000|NOT COMPLETED|Overall Study||0||
59521097|NCT01175005|75615290|FG000|STARTED|Overall Study||62||
59521098|NCT01175005|75615290|FG000|COMPLETED|Overall Study||62||
59521099|NCT01175005|75615290|FG000|NOT COMPLETED|Overall Study||0||
59521100|NCT00982280|75615295|FG000|STARTED|Observation Period||82||
59521101|NCT00982280|75615295|FG000|COMPLETED|Observation Period||63||
59521102|NCT00982280|75615295|FG000|NOT COMPLETED|Observation Period||19||
59521103|NCT00982280|75615295|FG000|STARTED|Titration and Optimal Dose Period||63||
59521104|NCT00982280|75615295|FG000|COMPLETED|Titration and Optimal Dose Period||55||
59521105|NCT00982280|75615295|FG000|NOT COMPLETED|Titration and Optimal Dose Period||8||
59521106|NCT00982280|75615295|FG000|STARTED|Maintenance Period||55||
59521107|NCT00982280|75615295|FG000|COMPLETED|Maintenance Period||54||
59521108|NCT00982280|75615295|FG000|NOT COMPLETED|Maintenance Period||1||
59521109|NCT01175317|75615302|FG000|STARTED|Overall Study||27||
59521110|NCT01175317|75615303|FG001|STARTED|Overall Study||31||
59521111|NCT01175317|75615302|FG000|COMPLETED|Overall Study||27||
59521112|NCT01175317|75615303|FG001|COMPLETED|Overall Study||31||
59521113|NCT01175317|75615302|FG000|NOT COMPLETED|Overall Study||0||
59521114|NCT01175317|75615303|FG001|NOT COMPLETED|Overall Study||0||
59521115|NCT01175395|75615309|FG000|STARTED|Overall Study||10||
59521116|NCT01175395|75615309|FG000|COMPLETED|Overall Study||10||
59521117|NCT01175395|75615309|FG000|NOT COMPLETED|Overall Study||0||
59521118|NCT00981578|75615313|FG000|STARTED|Overall Study||17||
59521119|NCT00981578|75615313|FG000|COMPLETED|Overall Study||14||
59521120|NCT00981578|75615313|FG000|NOT COMPLETED|Overall Study||3||
59521121|NCT01176877|75615317|FG000|STARTED|Overall Study||40||
59521122|NCT01176877|75615317|FG000|COMPLETED|Overall Study||31||
59521123|NCT01176877|75615317|FG000|NOT COMPLETED|Overall Study||9||
59521124|NCT01176955|75615324|FG000|STARTED|Overall Study||10||
59521125|NCT01176955|75615325|FG001|STARTED|Overall Study||10||
59521126|NCT01176955|75615324|FG000|COMPLETED|Overall Study||7||
59521127|NCT01176955|75615325|FG001|COMPLETED|Overall Study||8||
59521128|NCT01176955|75615324|FG000|NOT COMPLETED|Overall Study||3||
59521129|NCT01176955|75615325|FG001|NOT COMPLETED|Overall Study||2||
59521130|NCT00980798|75615336|FG000|STARTED|Overall Study||149||
59521131|NCT00980798|75615337|FG001|STARTED|Overall Study||139||
59521132|NCT00980798|75615336|FG000|COMPLETED|Overall Study||116||
59521133|NCT00980798|75615337|FG001|COMPLETED|Overall Study||84||
59521134|NCT00980798|75615336|FG000|NOT COMPLETED|Overall Study||33||
59521135|NCT00980798|75615337|FG001|NOT COMPLETED|Overall Study||55||
59521136|NCT01177189|75615345|FG000|STARTED|Overall Study||42||
59521137|NCT01177189|75615346|FG001|STARTED|Overall Study||45||
59521138|NCT01177189|75615345|FG000|COMPLETED|Overall Study||42||
59521139|NCT01177189|75615346|FG001|COMPLETED|Overall Study||45||
59521140|NCT01177189|75615345|FG000|NOT COMPLETED|Overall Study||0||
59521141|NCT01177189|75615346|FG001|NOT COMPLETED|Overall Study||0||
59521142|NCT01177735|75615352|FG000|STARTED|Overall Study||71||
59521143|NCT01177735|75615352|FG000|COMPLETED|Overall Study||0||
59521144|NCT01177735|75615352|FG000|NOT COMPLETED|Overall Study||71||
59521145|NCT01135069|75615359|FG000|STARTED|Overall Study||205||
59521146|NCT01135069|75615360|FG001|STARTED|Overall Study||209||
59521147|NCT01135069|75615361|FG002|STARTED|Overall Study||66||
59521148|NCT01135069|75615359|FG000|COMPLETED|Overall Study||169||
59521149|NCT01135069|75615360|FG001|COMPLETED|Overall Study||177||
59521150|NCT01135069|75615361|FG002|COMPLETED|Overall Study||56||
59521151|NCT01135069|75615359|FG000|NOT COMPLETED|Overall Study||36||
59521152|NCT01135069|75615360|FG001|NOT COMPLETED|Overall Study||32||
59521153|NCT01135069|75615361|FG002|NOT COMPLETED|Overall Study||10||
59521154|NCT01178281|75615372|FG000|STARTED|Overall Study||168||
59521155|NCT01178281|75615373|FG001|STARTED|Overall Study||84||
59521156|NCT01178281|75615374|FG002|STARTED|Overall Study||15||
59521157|NCT01178281|75615372|FG000|Received Study Drug|Overall Study||167||
59521158|NCT01178281|75615373|FG001|Received Study Drug|Overall Study||83||
59521159|NCT01178281|75615374|FG002|Received Study Drug|Overall Study||15||
59521160|NCT01178281|75615372|FG000|COMPLETED|Overall Study||168|Completed study, no longer in follow-up|
59521161|NCT01178281|75615373|FG001|COMPLETED|Overall Study||84|Completed study, no longer in follow-up|
59521162|NCT01178281|75615374|FG002|COMPLETED|Overall Study||15|Completed study, no longer in follow-up|
59521163|NCT01178281|75615372|FG000|NOT COMPLETED|Overall Study||0||
59521164|NCT01178281|75615373|FG001|NOT COMPLETED|Overall Study||0||
59521165|NCT01178281|75615374|FG002|NOT COMPLETED|Overall Study||0||
59521166|NCT01135381|75615388|FG000|STARTED|Overall Study||189||
59521167|NCT01135381|75615389|FG001|STARTED|Overall Study||185||
59521168|NCT01135381|75615390|FG002|STARTED|Overall Study||69||
59521169|NCT01135381|75615391|FG003|STARTED|Overall Study||68||
59521170|NCT01135381|75615388|FG000|COMPLETED|Overall Study||168||
59521171|NCT01135381|75615389|FG001|COMPLETED|Overall Study||178||
59521172|NCT01135381|75615390|FG002|COMPLETED|Overall Study||65||
59521173|NCT01135381|75615391|FG003|COMPLETED|Overall Study||67||
59521174|NCT01135381|75615388|FG000|NOT COMPLETED|Overall Study||21||
59521175|NCT01135381|75615389|FG001|NOT COMPLETED|Overall Study||7||
59521176|NCT01135381|75615390|FG002|NOT COMPLETED|Overall Study||4||
59521177|NCT01135381|75615391|FG003|NOT COMPLETED|Overall Study||1||
59521178|NCT01178827|75615404|FG000|STARTED|Overall Study||6||
59521179|NCT01178827|75615405|FG001|STARTED|Overall Study||10||
59521180|NCT01178827|75615406|FG002|STARTED|Overall Study||4||
59521181|NCT01178827|75615404|FG000|COMPLETED|Overall Study||6||
59521182|NCT01178827|75615405|FG001|COMPLETED|Overall Study||10||
59521183|NCT01178827|75615406|FG002|COMPLETED|Overall Study||4||
59521184|NCT01178827|75615404|FG000|NOT COMPLETED|Overall Study||0||
59521185|NCT01178827|75615405|FG001|NOT COMPLETED|Overall Study||0||
59521186|NCT01178827|75615406|FG002|NOT COMPLETED|Overall Study||0||
59521187|NCT01135537|75615414|FG000|STARTED|Overall Study||30||
59521188|NCT01135537|75615414|FG000|COMPLETED|Overall Study||17||
59521189|NCT01135537|75615414|FG000|NOT COMPLETED|Overall Study||13||
59521190|NCT02181517|75615421|FG000|STARTED|Overall Study||10||
59521191|NCT02181517|75615422|FG001|STARTED|Overall Study||10||
59521192|NCT02181517|75615423|FG002|STARTED|Overall Study||5||
59521193|NCT02181517|75615421|FG000|COMPLETED|Overall Study||10||
59521194|NCT02181517|75615422|FG001|COMPLETED|Overall Study||10||
59521195|NCT02181517|75615423|FG002|COMPLETED|Overall Study||5||
59521196|NCT02181517|75615421|FG000|NOT COMPLETED|Overall Study||0||
59521197|NCT02181517|75615422|FG001|NOT COMPLETED|Overall Study||0||
59521198|NCT02181517|75615423|FG002|NOT COMPLETED|Overall Study||0||
59521199|NCT01179217|75615433|FG000|STARTED|Overall Study||152||
59521200|NCT01179217|75615434|FG001|STARTED|Overall Study||78||
59521201|NCT01179217|75615433|FG000|COMPLETED|Overall Study||97||
59521202|NCT01179217|75615434|FG001|COMPLETED|Overall Study||59||
59521203|NCT01179217|75615433|FG000|NOT COMPLETED|Overall Study||55||
59521204|NCT01179217|75615434|FG001|NOT COMPLETED|Overall Study||19||
59521205|NCT02181829|75615442|FG000|STARTED|Overall Study||10||
59521206|NCT02181829|75615442|FG000|COMPLETED|Overall Study||10||
59521207|NCT02181829|75615442|FG000|NOT COMPLETED|Overall Study||0||
59521208|NCT01181323|75615450|FG000|STARTED|Overall Study||124||
59521209|NCT01181323|75615451|FG001|STARTED|Overall Study||124||
59521210|NCT01181323|75615452|FG002|STARTED|Overall Study||124||
59521211|NCT01181323|75615453|FG003|STARTED|Overall Study||125||
59521212|NCT01181323|75615450|FG000|COMPLETED|Overall Study||123||
59521213|NCT01181323|75615451|FG001|COMPLETED|Overall Study||121||
59521214|NCT01181323|75615452|FG002|COMPLETED|Overall Study||123||
59521215|NCT01181323|75615453|FG003|COMPLETED|Overall Study||122||
59521216|NCT01181323|75615450|FG000|NOT COMPLETED|Overall Study||1||
59521217|NCT01181323|75615451|FG001|NOT COMPLETED|Overall Study||3||
59521218|NCT01181323|75615452|FG002|NOT COMPLETED|Overall Study||1||
59521219|NCT01181323|75615453|FG003|NOT COMPLETED|Overall Study||3||
59521220|NCT00980330|75615482|FG000|STARTED|Overall Study||66||
59521221|NCT00980330|75615483|FG001|STARTED|Overall Study||65||
59521222|NCT00980330|75615484|FG002|STARTED|Overall Study||66||
59521223|NCT00980330|75615485|FG003|STARTED|Overall Study||66||
59521224|NCT00980330|75615486|FG004|STARTED|Overall Study||68||
59521225|NCT00980330|75615487|FG005|STARTED|Overall Study||65||
59521226|NCT00980330|75615488|FG006|STARTED|Overall Study||66||
59521227|NCT00980330|75615482|FG000|COMPLETED|Overall Study||61||
59521228|NCT00980330|75615483|FG001|COMPLETED|Overall Study||60||
59521229|NCT00980330|75615484|FG002|COMPLETED|Overall Study||58||
59521230|NCT00980330|75615485|FG003|COMPLETED|Overall Study||61||
59521231|NCT00980330|75615486|FG004|COMPLETED|Overall Study||63||
59521232|NCT00980330|75615487|FG005|COMPLETED|Overall Study||61||
59521233|NCT00980330|75615488|FG006|COMPLETED|Overall Study||59||
59521234|NCT00980330|75615482|FG000|NOT COMPLETED|Overall Study||5||
59521235|NCT00980330|75615483|FG001|NOT COMPLETED|Overall Study||5||
59521236|NCT00980330|75615484|FG002|NOT COMPLETED|Overall Study||8||
59521237|NCT00980330|75615485|FG003|NOT COMPLETED|Overall Study||5||
59521238|NCT00980330|75615486|FG004|NOT COMPLETED|Overall Study||5||
59521239|NCT00980330|75615487|FG005|NOT COMPLETED|Overall Study||4||
59521240|NCT00980330|75615488|FG006|NOT COMPLETED|Overall Study||7||
59521241|NCT01138735|75615507|FG000|STARTED|Overall Study||142||
59521242|NCT01138735|75615508|FG001|STARTED|Overall Study||143||
59521243|NCT01138735|75615507|FG000|COMPLETED|Overall Study||134||
59521244|NCT01138735|75615508|FG001|COMPLETED|Overall Study||126||
59521245|NCT01138735|75615507|FG000|NOT COMPLETED|Overall Study||8||
59521246|NCT01138735|75615508|FG001|NOT COMPLETED|Overall Study||17||
59521247|NCT01181479|75615516|FG000|STARTED|Subjects Receive AG200-15 or Lessina||1129|Includes all subjects that were randomized.|
59521248|NCT01181479|75615517|FG001|STARTED|Subjects Receive AG200-15 or Lessina||375|Includes all subjects that were randomized.|
59521249|NCT01181479|75615518|FG002|STARTED|Subjects Receive AG200-15 or Lessina|"This column is a subset of the Lessina completers in the Lessina (Cycles 1-6) column."|0|Includes all subjects that were randomized.|
59521250|NCT01181479|75615516|FG000|COMPLETED|Subjects Receive AG200-15 or Lessina||485||
59521251|NCT01181479|75615517|FG001|COMPLETED|Subjects Receive AG200-15 or Lessina||249||
59521252|NCT01181479|75615518|FG002|COMPLETED|Subjects Receive AG200-15 or Lessina||0||
59521253|NCT01181479|75615516|FG000|NOT COMPLETED|Subjects Receive AG200-15 or Lessina||644||
59617894|NCT01394718|75729060|FG001|STARTED|Overall Study||30||
59766098|NCT00868790|75886083|FG003|NOT COMPLETED|Post-study||0||
59766099|NCT00868790|75886084|FG004|NOT COMPLETED|Post-study||1||
59766100|NCT00868790|75886085|FG005|NOT COMPLETED|Post-study||0||
59766101|NCT00868790|75886086|FG006|NOT COMPLETED|Post-study||0||
59766102|NCT00868790|75886087|FG007|NOT COMPLETED|Post-study||2||
59766103|NCT00868790|75886088|FG008|NOT COMPLETED|Post-study||0||
59766104|NCT00868790|75886089|FG009|NOT COMPLETED|Post-study||1||
59766105|NCT00868790|75886090|FG010|NOT COMPLETED|Post-study||0||
59766106|NCT00868790|75886091|FG011|NOT COMPLETED|Post-study||0||
59766107|NCT00868790|75886092|FG012|NOT COMPLETED|Post-study||0||
59766108|NCT00868790|75886093|FG013|NOT COMPLETED|Post-study||0||
59766109|NCT00496483|75886109|FG000|STARTED|Overall Study||60||
59766110|NCT00496483|75886109|FG000|Dosed|Overall Study||51||
59766111|NCT00496483|75886109|FG000|COMPLETED|Overall Study||48||
59766112|NCT00496483|75886109|FG000|NOT COMPLETED|Overall Study||12||
59766113|NCT03528551|75886119|FG000|STARTED|Overall Study||25||
59766114|NCT03528551|75886120|FG001|STARTED|Overall Study||133||
59766115|NCT03528551|75886121|FG002|STARTED|Overall Study||2||
59766116|NCT03528551|75886119|FG000|COMPLETED|Overall Study||23||
59766117|NCT03528551|75886120|FG001|COMPLETED|Overall Study||114||
59766118|NCT03528551|75886121|FG002|COMPLETED|Overall Study||2||
59766119|NCT03528551|75886119|FG000|NOT COMPLETED|Overall Study||2||
59766120|NCT03528551|75886120|FG001|NOT COMPLETED|Overall Study||19||
59766121|NCT03528551|75886121|FG002|NOT COMPLETED|Overall Study||0||
59766122|NCT00487981|75886130|FG000|STARTED|Overall Study||1||
59952056|NCT00828854|76070972|FG000|COMPLETED|Overall Study||0|Completed=Completed Treatment|
59952057|NCT00828854|76070972|FG000|NOT COMPLETED|Overall Study||27||
59952058|NCT00834522|76070978|FG000|STARTED|First Intervention||40||
59952059|NCT00834522|76070979|FG001|STARTED|First Intervention||40||
59952060|NCT00834522|76070978|FG000|COMPLETED|First Intervention||40||
59952061|NCT00834522|76070979|FG001|COMPLETED|First Intervention||40||
59952062|NCT00834522|76070978|FG000|NOT COMPLETED|First Intervention||0||
59952063|NCT00834522|76070979|FG001|NOT COMPLETED|First Intervention||0||
59952064|NCT00834522|76070978|FG000|STARTED|Washout||40||
59952065|NCT00834522|76070979|FG001|STARTED|Washout||40||
59952066|NCT00834522|76070978|FG000|COMPLETED|Washout||37||
59952067|NCT00834522|76070979|FG001|COMPLETED|Washout||39||
59952068|NCT00834522|76070978|FG000|NOT COMPLETED|Washout||3||
59952069|NCT00834522|76070979|FG001|NOT COMPLETED|Washout||1||
59952070|NCT00834522|76070978|FG000|STARTED|Second Intervention||37||
59952071|NCT00834522|76070979|FG001|STARTED|Second Intervention||39||
59952072|NCT00834522|76070978|FG000|COMPLETED|Second Intervention||37||
59952073|NCT00834522|76070979|FG001|COMPLETED|Second Intervention||39||
59952074|NCT00834522|76070978|FG000|NOT COMPLETED|Second Intervention||0||
59952075|NCT00834522|76070979|FG001|NOT COMPLETED|Second Intervention||0||
59952076|NCT00834444|76070985|FG000|STARTED|First Intervention||18||
59952077|NCT00834444|76070986|FG001|STARTED|First Intervention||18||
59952078|NCT00834444|76070985|FG000|COMPLETED|First Intervention||17||
59952079|NCT00834444|76070986|FG001|COMPLETED|First Intervention||17||
59952080|NCT00834444|76070985|FG000|NOT COMPLETED|First Intervention||1||
60072346|NCT01682811|76187740|FG003|STARTED|Part 1 Levulan Painting||0||0
60072347|NCT01682811|76187741|FG004|STARTED|Part 1 Levulan Painting||0||0
60072348|NCT01682811|76187742|FG005|STARTED|Part 1 Levulan Painting||0||0
60072349|NCT01682811|76187743|FG006|STARTED|Part 1 Levulan Painting||0||0
60072350|NCT01682811|76187737|FG000|Control|Part 1 Levulan Painting||0||0
60072351|NCT01682811|76187738|FG001|Control|Part 1 Levulan Painting||1||3
59766123|NCT00487981|75886130|FG000|COMPLETED|Overall Study||0||
60072352|NCT01682811|76187739|FG002|Control|Part 1 Levulan Painting||0||0
60072353|NCT01682811|76187740|FG003|Control|Part 1 Levulan Painting||0||0
60072354|NCT01682811|76187741|FG004|Control|Part 1 Levulan Painting||0||0
60072355|NCT01682811|76187742|FG005|Control|Part 1 Levulan Painting||0||0
59766124|NCT00487981|75886130|FG000|NOT COMPLETED|Overall Study||1||
59766125|NCT00861744|75886138|FG000|STARTED|Overall Study||304||
59766126|NCT00861744|75886139|FG001|STARTED|Overall Study||304||
59952081|NCT00834444|76070986|FG001|NOT COMPLETED|First Intervention||1||
60072356|NCT01682811|76187743|FG006|Control|Part 1 Levulan Painting||0||0
60072357|NCT01682811|76187737|FG000|Treated 3 Hours|Part 1 Levulan Painting||0||0
60072358|NCT01682811|76187738|FG001|Treated 3 Hours|Part 1 Levulan Painting||1||3
60072359|NCT01682811|76187739|FG002|Treated 3 Hours|Part 1 Levulan Painting||0||0
59766127|NCT00861744|75886140|FG002|STARTED|Overall Study||304||
59766128|NCT00861744|75886141|FG003|STARTED|Overall Study||308||
59766129|NCT00861744|75886138|FG000|COMPLETED|Overall Study||287||
59952082|NCT00834444|76070985|FG000|STARTED|Washout of 7 Days||17||
59952083|NCT00834444|76070986|FG001|STARTED|Washout of 7 Days||17||
59952084|NCT00834444|76070985|FG000|COMPLETED|Washout of 7 Days||17||
59766130|NCT00861744|75886139|FG001|COMPLETED|Overall Study||275||
59766131|NCT00861744|75886140|FG002|COMPLETED|Overall Study||280||
59766132|NCT00861744|75886141|FG003|COMPLETED|Overall Study||275||
59766133|NCT00861744|75886138|FG000|NOT COMPLETED|Overall Study||17||
59766134|NCT00861744|75886139|FG001|NOT COMPLETED|Overall Study||29||
59521254|NCT01181479|75615517|FG001|NOT COMPLETED|Subjects Receive AG200-15 or Lessina||126||
59766135|NCT00861744|75886140|FG002|NOT COMPLETED|Overall Study||24||
59766136|NCT00861744|75886141|FG003|NOT COMPLETED|Overall Study||33||
59766137|NCT00603239|75886153|FG000|STARTED|Overall Study||111||
59766138|NCT00603239|75886154|FG001|STARTED|Overall Study||54||
59766139|NCT00603239|75886153|FG000|COMPLETED|Overall Study||96||
59766140|NCT00603239|75886154|FG001|COMPLETED|Overall Study||50||
59766141|NCT00603239|75886153|FG000|NOT COMPLETED|Overall Study||15||
59766142|NCT00603239|75886154|FG001|NOT COMPLETED|Overall Study||4||
59766143|NCT00852930|75886163|FG000|STARTED|Overall Study||16||
59766144|NCT00852930|75886164|FG001|STARTED|Overall Study||17||
59766145|NCT00852930|75886165|FG002|STARTED|Overall Study||17||
59766146|NCT00852930|75886163|FG000|COMPLETED|Overall Study||15||
59766147|NCT00852930|75886164|FG001|COMPLETED|Overall Study||16||
59766148|NCT00852930|75886165|FG002|COMPLETED|Overall Study||15||
59766149|NCT00852930|75886163|FG000|NOT COMPLETED|Overall Study||1||
59766150|NCT00852930|75886164|FG001|NOT COMPLETED|Overall Study||1||
59766151|NCT00852930|75886165|FG002|NOT COMPLETED|Overall Study||2||
59766152|NCT00852540|75886176|FG000|STARTED|Overall Study||270||
59766153|NCT00852540|75886177|FG001|STARTED|Overall Study||140||
59766154|NCT00852540|75886176|FG000|COMPLETED|Overall Study||234||
59766155|NCT00852540|75886177|FG001|COMPLETED|Overall Study||122||
59766156|NCT00852540|75886176|FG000|NOT COMPLETED|Overall Study||36||
59766157|NCT00852540|75886177|FG001|NOT COMPLETED|Overall Study||18||
59766158|NCT00861198|75886184|FG000|STARTED|Overall Study||75||
60072360|NCT01682811|76187740|FG003|Treated 3 Hours|Part 1 Levulan Painting||0||0
60072361|NCT01682811|76187741|FG004|Treated 3 Hours|Part 1 Levulan Painting||0||0
60072362|NCT01682811|76187742|FG005|Treated 3 Hours|Part 1 Levulan Painting||0||0
60072363|NCT01682811|76187743|FG006|Treated 3 Hours|Part 1 Levulan Painting||0||0
60072364|NCT01682811|76187737|FG000|Treated 24 Hours|Part 1 Levulan Painting||0||0
60072365|NCT01682811|76187738|FG001|Treated 24 Hours|Part 1 Levulan Painting||1||3
60072366|NCT01682811|76187739|FG002|Treated 24 Hours|Part 1 Levulan Painting||0||0
60072367|NCT01682811|76187740|FG003|Treated 24 Hours|Part 1 Levulan Painting||0||0
60072368|NCT01682811|76187741|FG004|Treated 24 Hours|Part 1 Levulan Painting||0||0
60072369|NCT01682811|76187742|FG005|Treated 24 Hours|Part 1 Levulan Painting||0||0
60072370|NCT01682811|76187743|FG006|Treated 24 Hours|Part 1 Levulan Painting||0||0
60072371|NCT01682811|76187737|FG000|COMPLETED|Part 1 Levulan Painting||0||0
60072372|NCT01682811|76187738|FG001|COMPLETED|Part 1 Levulan Painting||1||9
60072373|NCT01682811|76187739|FG002|COMPLETED|Part 1 Levulan Painting||0||0
60072374|NCT01682811|76187740|FG003|COMPLETED|Part 1 Levulan Painting||0||0
60072375|NCT01682811|76187741|FG004|COMPLETED|Part 1 Levulan Painting||0||0
60072376|NCT01682811|76187742|FG005|COMPLETED|Part 1 Levulan Painting||0||0
60072377|NCT01682811|76187743|FG006|COMPLETED|Part 1 Levulan Painting||0||0
60072378|NCT01682811|76187737|FG000|NOT COMPLETED|Part 1 Levulan Painting||0||0
60072379|NCT01682811|76187738|FG001|NOT COMPLETED|Part 1 Levulan Painting||0||0
60072380|NCT01682811|76187739|FG002|NOT COMPLETED|Part 1 Levulan Painting||0||0
60072381|NCT01682811|76187740|FG003|NOT COMPLETED|Part 1 Levulan Painting||0||0
60072382|NCT01682811|76187741|FG004|NOT COMPLETED|Part 1 Levulan Painting||0||0
60072383|NCT01682811|76187742|FG005|NOT COMPLETED|Part 1 Levulan Painting||0||0
60072384|NCT01682811|76187743|FG006|NOT COMPLETED|Part 1 Levulan Painting||0||0
60072385|NCT01682811|76187737|FG000|STARTED|Part 1 Levulan Painted Twice||0||0
60072386|NCT01682811|76187738|FG001|STARTED|Part 1 Levulan Painted Twice||0||0
60072387|NCT01682811|76187739|FG002|STARTED|Part 1 Levulan Painted Twice||2||12
60072388|NCT01682811|76187740|FG003|STARTED|Part 1 Levulan Painted Twice||0||0
60072389|NCT01682811|76187741|FG004|STARTED|Part 1 Levulan Painted Twice||0||0
60072390|NCT01682811|76187742|FG005|STARTED|Part 1 Levulan Painted Twice||0||0
60072391|NCT01682811|76187743|FG006|STARTED|Part 1 Levulan Painted Twice||0||0
60072392|NCT01682811|76187737|FG000|Control|Part 1 Levulan Painted Twice||0||0
60072393|NCT01682811|76187738|FG001|Control|Part 1 Levulan Painted Twice||0||0
59766159|NCT00861198|75886184|FG000|COMPLETED|Overall Study||70||
59766160|NCT00861198|75886184|FG000|NOT COMPLETED|Overall Study||5||
60072394|NCT01682811|76187739|FG002|Control|Part 1 Levulan Painted Twice||2||6
60072395|NCT01682811|76187740|FG003|Control|Part 1 Levulan Painted Twice||0||0
60072396|NCT01682811|76187741|FG004|Control|Part 1 Levulan Painted Twice||0||0
60072397|NCT01682811|76187742|FG005|Control|Part 1 Levulan Painted Twice||0||0
60072398|NCT01682811|76187743|FG006|Control|Part 1 Levulan Painted Twice||0||0
59521255|NCT01181479|75615518|FG002|NOT COMPLETED|Subjects Receive AG200-15 or Lessina||0||
59521256|NCT01181479|75615516|FG000|STARTED|Crossover Subjects Recieve AG200-15||0||
59766161|NCT00847704|75886188|FG000|STARTED|Overall Study||3||
59766162|NCT00847704|75886188|FG000|COMPLETED|Overall Study||2||
59766163|NCT00847704|75886188|FG000|NOT COMPLETED|Overall Study||1||
59766164|NCT00860574|75886192|FG000|STARTED|Overall Study||96||
60072399|NCT01682811|76187737|FG000|Treated 24 Hours|Part 1 Levulan Painted Twice||0||0
59766165|NCT00860574|75886192|FG000|COMPLETED|Overall Study||93||
59766166|NCT00860574|75886192|FG000|NOT COMPLETED|Overall Study||3||
59766167|NCT00496015|75886201|FG000|STARTED|Overall Study||178||
59766168|NCT00496015|75886202|FG001|STARTED|Overall Study||27||
59766169|NCT00496015|75886203|FG002|STARTED|Overall Study||172||
59766170|NCT00496015|75886204|FG003|STARTED|Overall Study||37||
59766171|NCT00496015|75886205|FG004|STARTED|Overall Study||336||
59766172|NCT00496015|75886201|FG000|COMPLETED|Overall Study||177||
59766173|NCT00496015|75886202|FG001|COMPLETED|Overall Study||27||
59766174|NCT00496015|75886203|FG002|COMPLETED|Overall Study||172||
59766175|NCT00496015|75886204|FG003|COMPLETED|Overall Study||36||
59766176|NCT00496015|75886205|FG004|COMPLETED|Overall Study||336||
59766177|NCT00496015|75886201|FG000|NOT COMPLETED|Overall Study||1||
59766178|NCT00496015|75886202|FG001|NOT COMPLETED|Overall Study||0||
59766179|NCT00496015|75886203|FG002|NOT COMPLETED|Overall Study||0||
59766180|NCT00496015|75886204|FG003|NOT COMPLETED|Overall Study||1||
59766181|NCT00496015|75886205|FG004|NOT COMPLETED|Overall Study||0||
59766182|NCT00487825|75886227|FG000|STARTED|Overall Study|"Started indicates Intent-to-treat population (ITT)"|52||
59766183|NCT00487825|75886228|FG001|STARTED|Overall Study||26||
59766184|NCT00487825|75886227|FG000|COMPLETED|Overall Study||46||
59766185|NCT00487825|75886228|FG001|COMPLETED|Overall Study||21||
59766186|NCT00487825|75886227|FG000|NOT COMPLETED|Overall Study||6||
59766187|NCT00487825|75886228|FG001|NOT COMPLETED|Overall Study||5||
59766188|NCT00487747|75886234|FG000|STARTED|Overall Study||18||
59766189|NCT00487747|75886234|FG000|COMPLETED|Overall Study||7||
59766190|NCT00487747|75886234|FG000|NOT COMPLETED|Overall Study||11||
59766191|NCT00487435|75886238|FG000|STARTED|Overall Study|Patients who received at least one dose of Tapentadol (CG5503) Extended Release (ER)|1154||
59766192|NCT00487435|75886238|FG000|COMPLETED|Overall Study||669||
59766193|NCT00487435|75886238|FG000|NOT COMPLETED|Overall Study||485||
59766194|NCT00487279|75886244|FG000|STARTED|Overall Study||44||
59766195|NCT00487279|75886245|FG001|STARTED|Overall Study||37||
59766196|NCT00487279|75886244|FG000|COMPLETED|Overall Study||43||
59766197|NCT00487279|75886245|FG001|COMPLETED|Overall Study||35||
59766198|NCT00487279|75886244|FG000|NOT COMPLETED|Overall Study||1||
59766199|NCT00487279|75886245|FG001|NOT COMPLETED|Overall Study||2||
59766200|NCT00495625|75886251|FG000|STARTED|Overall Study||33||
59766201|NCT00495625|75886251|FG000|COMPLETED|Overall Study||23||
59766202|NCT00495625|75886251|FG000|NOT COMPLETED|Overall Study||10||
59766203|NCT00847626|75886266|FG000|STARTED|Overall Study||156||
59766204|NCT00847626|75886267|FG001|STARTED|Overall Study||154||
59766205|NCT00847626|75886268|FG002|STARTED|Overall Study|Includes participant who was randomized but did not receive study medication.|147||
59766206|NCT00847626|75886269|FG003|STARTED|Overall Study||156||
59766207|NCT00847626|75886270|FG004|STARTED|Overall Study||153||
59766208|NCT00847626|75886271|FG005|STARTED|Overall Study|Includes participant who was randomized but did not receive study medication.|162||
59766209|NCT00847626|75886272|FG006|STARTED|Overall Study|Includes participant who was randomized but did not receive study medication.|157||
59766210|NCT00847626|75886273|FG007|STARTED|Overall Study|Includes participant who was treated with double-blind study medication but not randomized.|160||
59766211|NCT00847626|75886274|FG008|STARTED|Overall Study||155||
59766212|NCT00847626|75886275|FG009|STARTED|Overall Study||153||
59766213|NCT00847626|75886276|FG010|STARTED|Overall Study||162||
59766214|NCT00847626|75886266|FG000|COMPLETED|Overall Study||135||
59766215|NCT00847626|75886267|FG001|COMPLETED|Overall Study||131||
59766216|NCT00847626|75886268|FG002|COMPLETED|Overall Study||131||
59766217|NCT00847626|75886269|FG003|COMPLETED|Overall Study||125||
59766218|NCT00847626|75886270|FG004|COMPLETED|Overall Study||125||
59766219|NCT00847626|75886271|FG005|COMPLETED|Overall Study||125||
59766220|NCT00847626|75886272|FG006|COMPLETED|Overall Study||135||
59766221|NCT00847626|75886273|FG007|COMPLETED|Overall Study||141||
60072400|NCT01682811|76187738|FG001|Treated 24 Hours|Part 1 Levulan Painted Twice||0||0
59766222|NCT00847626|75886274|FG008|COMPLETED|Overall Study||141||
59766223|NCT00847626|75886275|FG009|COMPLETED|Overall Study||139||
59766224|NCT00847626|75886276|FG010|COMPLETED|Overall Study||142||
59766225|NCT00847626|75886266|FG000|NOT COMPLETED|Overall Study||21||
59766226|NCT00847626|75886267|FG001|NOT COMPLETED|Overall Study||23||
59766227|NCT00847626|75886268|FG002|NOT COMPLETED|Overall Study||16||
59766228|NCT00847626|75886269|FG003|NOT COMPLETED|Overall Study||31||
59766229|NCT00847626|75886270|FG004|NOT COMPLETED|Overall Study||28||
59766230|NCT00847626|75886271|FG005|NOT COMPLETED|Overall Study||37||
59766231|NCT00847626|75886272|FG006|NOT COMPLETED|Overall Study||22||
59766232|NCT00847626|75886273|FG007|NOT COMPLETED|Overall Study||19||
59766233|NCT00847626|75886274|FG008|NOT COMPLETED|Overall Study||14||
59766234|NCT00847626|75886275|FG009|NOT COMPLETED|Overall Study||14||
59766235|NCT00847626|75886276|FG010|NOT COMPLETED|Overall Study||20||
59766236|NCT00851682|75886305|FG000|STARTED|Overall Study||60||
59766237|NCT00851682|75886306|FG001|STARTED|Overall Study||5||
59766238|NCT00851682|75886305|FG000|COMPLETED|Overall Study||55||
59766239|NCT00851682|75886306|FG001|COMPLETED|Overall Study||5||
59766240|NCT00851682|75886305|FG000|NOT COMPLETED|Overall Study||5||
59766241|NCT00851682|75886306|FG001|NOT COMPLETED|Overall Study||0||
59766242|NCT00860262|75886315|FG000|STARTED|Overall Study||421||
59766243|NCT00860262|75886316|FG001|STARTED|Overall Study||217||
60103562|NCT01342666|76221800|FG001|STARTED|Overall Study||24||
59766244|NCT00860262|75886317|FG002|STARTED|Overall Study||220||
59766245|NCT00860262|75886315|FG000|COMPLETED|Overall Study||401||
59766246|NCT00860262|75886316|FG001|COMPLETED|Overall Study||195||
59766247|NCT00860262|75886317|FG002|COMPLETED|Overall Study||202||
59766248|NCT00860262|75886315|FG000|NOT COMPLETED|Overall Study||20||
59766249|NCT00860262|75886316|FG001|NOT COMPLETED|Overall Study||22||
59766250|NCT00860262|75886317|FG002|NOT COMPLETED|Overall Study||18||
59766251|NCT00860028|75886329|FG000|STARTED|Placebo Controlled Pretreatment Period||15||
59766252|NCT00860028|75886330|FG001|STARTED|Placebo Controlled Pretreatment Period||15||
59766253|NCT00860028|75886329|FG000|COMPLETED|Placebo Controlled Pretreatment Period||13||
59766254|NCT00860028|75886330|FG001|COMPLETED|Placebo Controlled Pretreatment Period||14||
59766255|NCT00860028|75886329|FG000|NOT COMPLETED|Placebo Controlled Pretreatment Period||2||
59766256|NCT00860028|75886330|FG001|NOT COMPLETED|Placebo Controlled Pretreatment Period||1||
59766257|NCT00860028|75886329|FG000|STARTED|Smoking Cessation Phase||13||
59766258|NCT00860028|75886330|FG001|STARTED|Smoking Cessation Phase||14||
59766259|NCT00860028|75886329|FG000|COMPLETED|Smoking Cessation Phase||13||
59766260|NCT00860028|75886330|FG001|COMPLETED|Smoking Cessation Phase||12||
59766261|NCT00860028|75886329|FG000|NOT COMPLETED|Smoking Cessation Phase||0||
59766262|NCT00860028|75886330|FG001|NOT COMPLETED|Smoking Cessation Phase||2||
59766263|NCT00859638|75886340|FG000|STARTED|Overall Study||65||
59766264|NCT00859638|75886341|FG001|STARTED|Overall Study||59||
59766265|NCT00859638|75886340|FG000|COMPLETED|Overall Study||55||
59766266|NCT00859638|75886341|FG001|COMPLETED|Overall Study||55||
59766267|NCT00859638|75886340|FG000|NOT COMPLETED|Overall Study||10||
59766268|NCT00859638|75886341|FG001|NOT COMPLETED|Overall Study||4||
59766269|NCT00846846|75886347|FG000|STARTED|Overall Study||1018||
59766270|NCT00846846|75886347|FG000|COMPLETED|Overall Study|Study ongoing but not recruiting participants.|943||
59766271|NCT00846846|75886347|FG000|NOT COMPLETED|Overall Study||75||
59766272|NCT00846768|75886351|FG000|STARTED|Overall Study||11||
59766273|NCT00846768|75886352|FG001|STARTED|Overall Study||12||
59766274|NCT00846768|75886353|FG002|STARTED|Overall Study||12||
59766275|NCT00846768|75886354|FG003|STARTED|Overall Study||12||
59766276|NCT00846768|75886351|FG000|COMPLETED|Overall Study||11||
59766277|NCT00846768|75886352|FG001|COMPLETED|Overall Study||11||
59766278|NCT00846768|75886353|FG002|COMPLETED|Overall Study||12||
59766279|NCT00846768|75886354|FG003|COMPLETED|Overall Study||12||
59766280|NCT00846768|75886351|FG000|NOT COMPLETED|Overall Study||0||
59766281|NCT00846768|75886352|FG001|NOT COMPLETED|Overall Study||1||
59766282|NCT00846768|75886353|FG002|NOT COMPLETED|Overall Study||0||
59766283|NCT00846768|75886354|FG003|NOT COMPLETED|Overall Study||0||
59766284|NCT00863798|75886367|FG000|STARTED|Overall Study||227||
59766285|NCT00863798|75886368|FG001|STARTED|Overall Study||228||
59766286|NCT00863798|75886369|FG002|STARTED|Overall Study||227||
59766287|NCT00863798|75886367|FG000|Treated|Overall Study||223||
59766288|NCT00863798|75886368|FG001|Treated|Overall Study||226||
59766289|NCT00863798|75886369|FG002|Treated|Overall Study||224||
59766290|NCT00863798|75886367|FG000|COMPLETED|Overall Study||195||
59766291|NCT00863798|75886368|FG001|COMPLETED|Overall Study||198||
59766292|NCT00863798|75886369|FG002|COMPLETED|Overall Study||202||
59766293|NCT00863798|75886367|FG000|NOT COMPLETED|Overall Study||32||
59766294|NCT00863798|75886368|FG001|NOT COMPLETED|Overall Study||30||
59766295|NCT00863798|75886369|FG002|NOT COMPLETED|Overall Study||25||
59521257|NCT01181479|75615517|FG001|STARTED|Crossover Subjects Recieve AG200-15||0||
59521258|NCT01181479|75615518|FG002|STARTED|Crossover Subjects Recieve AG200-15|"This column is a subset of the Lessina completers in the Lessina (Cycles 1-6) column."|249||
59521259|NCT01181479|75615516|FG000|COMPLETED|Crossover Subjects Recieve AG200-15||0||
59521260|NCT01181479|75615517|FG001|COMPLETED|Crossover Subjects Recieve AG200-15||0||
59521261|NCT01181479|75615518|FG002|COMPLETED|Crossover Subjects Recieve AG200-15||150||
59521262|NCT01181479|75615516|FG000|NOT COMPLETED|Crossover Subjects Recieve AG200-15||0||
59766296|NCT00859014|75886377|FG000|STARTED|Overall Study||25||
59766297|NCT00859014|75886377|FG000|COMPLETED|Overall Study||20||
60072401|NCT01682811|76187739|FG002|Treated 24 Hours|Part 1 Levulan Painted Twice||2||6
59766298|NCT00859014|75886377|FG000|NOT COMPLETED|Overall Study||5||
59766299|NCT00593606|75886381|FG000|STARTED|Overall Study||124||
59766300|NCT00593606|75886381|FG000|Start of Treatment - Safety Set|Overall Study||116||
59766301|NCT00593606|75886381|FG000|Full Analysis Set|Overall Study||114||
59766302|NCT00593606|75886381|FG000|Treatment Period Completed|Overall Study||99||
59766303|NCT00593606|75886381|FG000|COMPLETED|Overall Study||97||
59766304|NCT00593606|75886381|FG000|NOT COMPLETED|Overall Study||27||
59766305|NCT00870584|75886387|FG000|STARTED|Overall Study||136||
59766306|NCT00870584|75886388|FG001|STARTED|Overall Study||135||
59521263|NCT01181479|75615517|FG001|NOT COMPLETED|Crossover Subjects Recieve AG200-15||0||
59521264|NCT01181479|75615518|FG002|NOT COMPLETED|Crossover Subjects Recieve AG200-15||99||
59521265|NCT00980174|75615532|FG000|STARTED|Overall Study||121||
59766307|NCT00870584|75886387|FG000|COMPLETED|Overall Study||120||
59766308|NCT00870584|75886388|FG001|COMPLETED|Overall Study||122||
59766309|NCT00870584|75886387|FG000|NOT COMPLETED|Overall Study||16||
59766310|NCT00870584|75886388|FG001|NOT COMPLETED|Overall Study||13||
59766311|NCT00870194|75886396|FG000|STARTED|Overall Study||127||
59521266|NCT00980174|75615533|FG001|STARTED|Overall Study||121||
59766312|NCT00870194|75886397|FG001|STARTED|Overall Study||128||
59766313|NCT00870194|75886396|FG000|Per Protocol Set|Overall Study||97||
59766314|NCT00870194|75886397|FG001|Per Protocol Set|Overall Study||111||
59766315|NCT00870194|75886396|FG000|COMPLETED|Overall Study||101||
59766316|NCT00870194|75886397|FG001|COMPLETED|Overall Study||114||
59766317|NCT00870194|75886396|FG000|NOT COMPLETED|Overall Study||26||
59766318|NCT00870194|75886397|FG001|NOT COMPLETED|Overall Study||14||
59766319|NCT00690430|75886405|FG000|STARTED|Core Phase|"Started indicates Full Analysis Set (FAS) and Safety Set."|53||
59766320|NCT00690430|75886406|FG001|STARTED|Core Phase||57||
59766321|NCT00690430|75886407|FG002|STARTED|Core Phase|This arm belongs to Extension Phase.|0||
59766322|NCT00690430|75886405|FG000|COMPLETED|Core Phase||35||
59766323|NCT00690430|75886406|FG001|COMPLETED|Core Phase||34||
59766324|NCT00690430|75886407|FG002|COMPLETED|Core Phase||0||
59766325|NCT00690430|75886405|FG000|NOT COMPLETED|Core Phase||18||
59766326|NCT00690430|75886406|FG001|NOT COMPLETED|Core Phase||23||
59766327|NCT00690430|75886407|FG002|NOT COMPLETED|Core Phase||0||
59766328|NCT00690430|75886405|FG000|STARTED|Extension Phase|Only those patients (except from UK) who received clinical benefit could extend therapy in extension|20||
59766329|NCT00690430|75886406|FG001|STARTED|Extension Phase|Only those patients (except from UK) who received clinical benefit could extend therapy in extension|6||
59766330|NCT00690430|75886407|FG002|STARTED|Extension Phase|Only those patients (except from UK) who received clinical benefit could extend therapy in extension|15||
59766331|NCT00690430|75886405|FG000|COMPLETED|Extension Phase||2||
59766332|NCT00690430|75886406|FG001|COMPLETED|Extension Phase||1||
59766333|NCT00690430|75886407|FG002|COMPLETED|Extension Phase||2||
59766334|NCT00690430|75886405|FG000|NOT COMPLETED|Extension Phase||18||
59766335|NCT00690430|75886406|FG001|NOT COMPLETED|Extension Phase||5||
59766336|NCT00690430|75886407|FG002|NOT COMPLETED|Extension Phase||13||
59766337|NCT00863330|75886416|FG000|STARTED|Overall Study||6||
59766338|NCT00863330|75886416|FG000|COMPLETED|Overall Study||0||
59766339|NCT00863330|75886416|FG000|NOT COMPLETED|Overall Study||6||
59766340|NCT00688324|75886420|FG000|STARTED|Overall Study||36||
59766341|NCT00688324|75886420|FG000|COMPLETED|Overall Study||28||
59766342|NCT00688324|75886420|FG000|NOT COMPLETED|Overall Study||8||
59766343|NCT00862940|75886427|FG000|STARTED|Overall Study||133||
59766344|NCT00862940|75886428|FG001|STARTED|Overall Study||144||
59766345|NCT00862940|75886427|FG000|COMPLETED|Overall Study||103||
59766346|NCT00862940|75886428|FG001|COMPLETED|Overall Study||114||
59766347|NCT00862940|75886427|FG000|NOT COMPLETED|Overall Study||30||
59766348|NCT00862940|75886428|FG001|NOT COMPLETED|Overall Study||30||
59766349|NCT00868166|75886436|FG000|STARTED|Overall Study||259||
59766350|NCT00868166|75886437|FG001|STARTED|Overall Study||253||
59766351|NCT00868166|75886436|FG000|COMPLETED|Overall Study||147||
59766352|NCT00868166|75886437|FG001|COMPLETED|Overall Study||139||
59766353|NCT00868166|75886436|FG000|NOT COMPLETED|Overall Study||112||
59766354|NCT00868166|75886437|FG001|NOT COMPLETED|Overall Study||114||
59766355|NCT00858780|75886443|FG000|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||91||
59766356|NCT00858780|75886444|FG001|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||0||
59766357|NCT00858780|75886445|FG002|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||0||
59766358|NCT00858780|75886446|FG003|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||0||
59766359|NCT00858780|75886447|FG004|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||0||
59766360|NCT00858780|75886443|FG000|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||73||
59766361|NCT00858780|75886444|FG001|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0||
59766362|NCT00858780|75886445|FG002|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0||
59766363|NCT00858780|75886446|FG003|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0||
59766364|NCT00858780|75886447|FG004|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0||
59766365|NCT00858780|75886443|FG000|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||18||
59766366|NCT00858780|75886444|FG001|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0||
59766367|NCT00858780|75886445|FG002|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0||
59766368|NCT00858780|75886446|FG003|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0||
59766369|NCT00858780|75886447|FG004|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0||
59766370|NCT00858780|75886443|FG000|STARTED|Double-Blind (Week 0 to Failure/Week 48)||0||
59766371|NCT00858780|75886444|FG001|STARTED|Double-Blind (Week 0 to Failure/Week 48)||23||
59766372|NCT00858780|75886445|FG002|STARTED|Double-Blind (Week 0 to Failure/Week 48)||27||
59766373|NCT00858780|75886446|FG003|STARTED|Double-Blind (Week 0 to Failure/Week 48)||23||
59766374|NCT00858780|75886447|FG004|STARTED|Double-Blind (Week 0 to Failure/Week 48)||0||
59766375|NCT00858780|75886443|FG000|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||0||
59766376|NCT00858780|75886444|FG001|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||21||
59766377|NCT00858780|75886445|FG002|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||25||
59766378|NCT00858780|75886446|FG003|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||22||
59766379|NCT00858780|75886447|FG004|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||0||
59766380|NCT00858780|75886443|FG000|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||0||
59766381|NCT00858780|75886444|FG001|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||2||
59766382|NCT00858780|75886445|FG002|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||2||
59766383|NCT00858780|75886446|FG003|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||1||
59766384|NCT00858780|75886447|FG004|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||0||
59766385|NCT00858780|75886443|FG000|STARTED|OL Re-Treatment (Failure to Week 48)||0||
59617895|NCT01394718|75729059|FG000|COMPLETED|Overall Study||28||
59617896|NCT01394718|75729060|FG001|COMPLETED|Overall Study||29||
59617897|NCT01394718|75729059|FG000|NOT COMPLETED|Overall Study||2||
59617898|NCT01394718|75729060|FG001|NOT COMPLETED|Overall Study||1||
59617899|NCT01394250|75729068|FG000|STARTED|Randomization and IV Placement Attempt||134||
59617900|NCT01394250|75729069|FG001|STARTED|Randomization and IV Placement Attempt||134||
59617901|NCT01394250|75729068|FG000|COMPLETED|Randomization and IV Placement Attempt||120||
59617902|NCT01394250|75729069|FG001|COMPLETED|Randomization and IV Placement Attempt||121||
59617903|NCT01394250|75729068|FG000|NOT COMPLETED|Randomization and IV Placement Attempt||14||
59617904|NCT01394250|75729069|FG001|NOT COMPLETED|Randomization and IV Placement Attempt||13||
59617905|NCT01394250|75729068|FG000|STARTED|Successful IV Placement & Follow-Up||120||
59617906|NCT01394250|75729069|FG001|STARTED|Successful IV Placement & Follow-Up||121||
59617907|NCT01394250|75729068|FG000|COMPLETED|Successful IV Placement & Follow-Up||114||
59617908|NCT01394250|75729069|FG001|COMPLETED|Successful IV Placement & Follow-Up||110||
59617909|NCT01394250|75729068|FG000|NOT COMPLETED|Successful IV Placement & Follow-Up||6||
59617910|NCT01394250|75729069|FG001|NOT COMPLETED|Successful IV Placement & Follow-Up||11||
59617911|NCT01380990|75729077|FG000|STARTED|Overall Study||20||
59617912|NCT01380990|75729078|FG001|STARTED|Overall Study||16||
59617913|NCT01380990|75729077|FG000|COMPLETED|Overall Study||19||
59617914|NCT01380990|75729078|FG001|COMPLETED|Overall Study||15||
59617915|NCT01380990|75729077|FG000|NOT COMPLETED|Overall Study||1||
59617916|NCT01380990|75729078|FG001|NOT COMPLETED|Overall Study||1||
59617917|NCT01380834|75729090|FG000|STARTED|Overall Study||42||
59617918|NCT01380834|75729091|FG001|STARTED|Overall Study||42||
59617919|NCT01380834|75729090|FG000|COMPLETED|Overall Study||41||
59617920|NCT01380834|75729091|FG001|COMPLETED|Overall Study||42||
59617921|NCT01380834|75729090|FG000|NOT COMPLETED|Overall Study||1||
59617922|NCT01380834|75729091|FG001|NOT COMPLETED|Overall Study||0||
59617923|NCT00214422|75729100|FG000|STARTED|Overall Study||12||
59617924|NCT00214422|75729101|FG001|STARTED|Overall Study||3||
59617925|NCT00214422|75729102|FG002|STARTED|Overall Study||4||
59617926|NCT00214422|75729100|FG000|COMPLETED|Overall Study||7||
59617927|NCT00214422|75729101|FG001|COMPLETED|Overall Study||2||
59617928|NCT00214422|75729102|FG002|COMPLETED|Overall Study||3||
59617929|NCT00214422|75729100|FG000|NOT COMPLETED|Overall Study||5||
59617930|NCT00214422|75729101|FG001|NOT COMPLETED|Overall Study||1||
59617931|NCT00214422|75729102|FG002|NOT COMPLETED|Overall Study||1||
59617932|NCT00218634|75729116|FG000|STARTED|Overall Study||44||
59617933|NCT00218634|75729117|FG001|STARTED|Overall Study||45||
59617934|NCT00218634|75729116|FG000|COMPLETED|Overall Study||36||
59617935|NCT00218634|75729117|FG001|COMPLETED|Overall Study||30||
59617936|NCT00218634|75729116|FG000|NOT COMPLETED|Overall Study||8||
59617937|NCT00218634|75729117|FG001|NOT COMPLETED|Overall Study||15||
59617938|NCT00217620|75729126|FG000|STARTED|Overall Study||51||
59617939|NCT00217620|75729126|FG000|Eligible|Overall Study||38||
59617940|NCT00217620|75729126|FG000|Eligible and Began Protocol Therapy|Overall Study||37||
59617941|NCT00217620|75729126|FG000|COMPLETED|Overall Study||0||
59617942|NCT00217620|75729126|FG000|NOT COMPLETED|Overall Study||51||
59617943|NCT00217464|75729134|FG000|STARTED|Overall Study||17||
59617944|NCT00217464|75729134|FG000|COMPLETED|Overall Study||0||
59617945|NCT00217464|75729134|FG000|NOT COMPLETED|Overall Study||17||
59617946|NCT00214500|75729138|FG000|STARTED|Treatment Period|All eligible-enrolled participants who received at least 1 dose of study drug|9|6 additional participants were dosed screen failures and are not included|
59617947|NCT00214500|75729138|FG000|Safety Population|Treatment Period||9|All eligible-enrolled participants who received at least 1 dose of study drug|
59617948|NCT00214500|75729138|FG000|Pharmacokinetic (PK) Population|Treatment Period||9|Received study drug and had at least 1 postbaseline PK parameter recorded|
59617949|NCT00214500|75729138|FG000|Pharmacodynamic (PD) Population|Treatment Period||9|Received study drug on Day 1 and had a non-missing baseline and postbaseline PD parameter recorded|
59617950|NCT00214500|75729138|FG000|COMPLETED|Treatment Period||8||
59617951|NCT00214500|75729138|FG000|NOT COMPLETED|Treatment Period||1||
59617952|NCT00214500|75729138|FG000|STARTED|Extension Period||8||
59617953|NCT00214500|75729138|FG000|COMPLETED|Extension Period||6||
59617954|NCT00214500|75729138|FG000|NOT COMPLETED|Extension Period||2||
59617955|NCT00211536|75729147|FG000|STARTED|Overall Study||53||
59617956|NCT00211536|75729148|FG001|STARTED|Overall Study||54||
59617957|NCT00211536|75729147|FG000|As Treated Data Analysis Set|Overall Study|This set includes all subjects followed to Visit 5 (90 days, first insulin refill for MIP group).|52||
59617958|NCT00211536|75729148|FG001|As Treated Data Analysis Set|Overall Study||48||
59617959|NCT00211536|75729147|FG000|COMPLETED|Overall Study||49||
59617960|NCT00211536|75729148|FG001|COMPLETED|Overall Study|This set includes all subjects followed to Visit 5 (90 days, first insulin refill for MIP group).|47||
59617961|NCT00211536|75729147|FG000|NOT COMPLETED|Overall Study||4||
59617962|NCT00211536|75729148|FG001|NOT COMPLETED|Overall Study||7||
59617963|NCT04147650|75729158|FG000|STARTED|Overall Study||127||
59617964|NCT04147650|75729159|FG001|STARTED|Overall Study||126||
59617965|NCT04147650|75729160|FG002|STARTED|Overall Study||128||
59617966|NCT04147650|75729161|FG003|STARTED|Overall Study||127||
59617967|NCT04147650|75729158|FG000|Modified Intent to Treat (mITT)|Overall Study||120||
59617968|NCT04147650|75729159|FG001|Modified Intent to Treat (mITT)|Overall Study||119||
59709509|NCT00904033|75828256|FG002|COMPLETED|Overall Study||9||
59766386|NCT00858780|75886444|FG001|STARTED|OL Re-Treatment (Failure to Week 48)||0||
59766387|NCT00858780|75886445|FG002|STARTED|OL Re-Treatment (Failure to Week 48)||0||
59766388|NCT00858780|75886446|FG003|STARTED|OL Re-Treatment (Failure to Week 48)||0||
59766389|NCT00858780|75886447|FG004|STARTED|OL Re-Treatment (Failure to Week 48)|43 participants showed treatment failure in Period 2 and entered in Period 3.|43||
59766390|NCT00858780|75886443|FG000|COMPLETED|OL Re-Treatment (Failure to Week 48)||0||
59766391|NCT00858780|75886444|FG001|COMPLETED|OL Re-Treatment (Failure to Week 48)||0||
59766392|NCT00858780|75886445|FG002|COMPLETED|OL Re-Treatment (Failure to Week 48)||0||
59766393|NCT00858780|75886446|FG003|COMPLETED|OL Re-Treatment (Failure to Week 48)||0||
59766394|NCT00858780|75886447|FG004|COMPLETED|OL Re-Treatment (Failure to Week 48)||41||
59766395|NCT00858780|75886443|FG000|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||0||
59766396|NCT00858780|75886444|FG001|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||0||
59766397|NCT00858780|75886445|FG002|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||0||
59766398|NCT00858780|75886446|FG003|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||0||
59766399|NCT00858780|75886447|FG004|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||2||
59766400|NCT00850200|75886457|FG000|STARTED|Overall Study||20||
59766401|NCT00850200|75886457|FG000|COMPLETED|Overall Study||15||
59766402|NCT00850200|75886457|FG000|NOT COMPLETED|Overall Study||5||
59521267|NCT00980174|75615532|FG000|COMPLETED|Overall Study||117||
59521268|NCT00980174|75615533|FG001|COMPLETED|Overall Study||111||
59521269|NCT00980174|75615532|FG000|NOT COMPLETED|Overall Study||4||
59766403|NCT00858234|75886464|FG000|STARTED|Overall Study||9||
59766404|NCT00858234|75886464|FG000|COMPLETED|Overall Study||0||
59766405|NCT00858234|75886464|FG000|NOT COMPLETED|Overall Study||9||
59766406|NCT00862082|75886470|FG000|STARTED|Overall Study||8||
59766407|NCT00862082|75886471|FG001|STARTED|Overall Study||6||
59766408|NCT00862082|75886470|FG000|COMPLETED|Overall Study||3||
59766409|NCT00862082|75886471|FG001|COMPLETED|Overall Study||5||
59766410|NCT00862082|75886470|FG000|NOT COMPLETED|Overall Study||5||
59766411|NCT00862082|75886471|FG001|NOT COMPLETED|Overall Study||1||
59766412|NCT00692770|75886486|FG000|STARTED|Overall Study||556||
59766413|NCT00692770|75886487|FG001|STARTED|Overall Study||558||
59766414|NCT00692770|75886486|FG000|Participants Received Treatment|Overall Study||553||
59766415|NCT00692770|75886487|FG001|Participants Received Treatment|Overall Study||554||
59766416|NCT00692770|75886486|FG000|COMPLETED|Overall Study||0||
59766417|NCT00692770|75886487|FG001|COMPLETED|Overall Study||0||
59766418|NCT00692770|75886486|FG000|NOT COMPLETED|Overall Study||556||
59766419|NCT00692770|75886487|FG001|NOT COMPLETED|Overall Study||558||
59766420|NCT00849108|75886502|FG000|STARTED|Cohort 1 Dose Ranging and Dose Interval||33||
59766421|NCT00849108|75886503|FG001|STARTED|Cohort 1 Dose Ranging and Dose Interval|Cohort 2(Pharm Stress) subjects did not participate in dose range, dose frequency|0||
59766422|NCT00849108|75886502|FG000|COMPLETED|Cohort 1 Dose Ranging and Dose Interval||32||
59766423|NCT00849108|75886503|FG001|COMPLETED|Cohort 1 Dose Ranging and Dose Interval||0||
59766424|NCT00849108|75886502|FG000|NOT COMPLETED|Cohort 1 Dose Ranging and Dose Interval||1||
59766425|NCT00849108|75886503|FG001|NOT COMPLETED|Cohort 1 Dose Ranging and Dose Interval||0||
59766426|NCT00849108|75886502|FG000|STARTED|Cohort 2 Efficacy|Cohort 1 subjects did not participate in period 2: efficacy|0||
59766427|NCT00849108|75886503|FG001|STARTED|Cohort 2 Efficacy||143||
59766428|NCT00849108|75886502|FG000|COMPLETED|Cohort 2 Efficacy||0||
59766429|NCT00849108|75886503|FG001|COMPLETED|Cohort 2 Efficacy||133||
59766430|NCT00849108|75886502|FG000|NOT COMPLETED|Cohort 2 Efficacy||0||
59766431|NCT00849108|75886503|FG001|NOT COMPLETED|Cohort 2 Efficacy||10||
59766432|NCT00867308|75886513|FG000|STARTED|Overall Study||9||
59766433|NCT00867308|75886514|FG001|STARTED|Overall Study||18||
59766434|NCT00867308|75886513|FG000|COMPLETED|Overall Study||0||
59766435|NCT00867308|75886514|FG001|COMPLETED|Overall Study||0||
59766436|NCT00867308|75886513|FG000|NOT COMPLETED|Overall Study||9||
59766437|NCT00867308|75886514|FG001|NOT COMPLETED|Overall Study||18||
59766438|NCT00849186|75886520|FG000|STARTED|Overall Study||26||
59766439|NCT00849186|75886520|FG000|COMPLETED|Overall Study||16||
59766440|NCT00849186|75886520|FG000|NOT COMPLETED|Overall Study||10||
59766441|NCT00866918|75886527|FG000|STARTED|Overall Study||69||
59766442|NCT00866918|75886528|FG001|STARTED|Overall Study||39||
59766443|NCT00866918|75886527|FG000|COMPLETED|Overall Study||53||
59766444|NCT00866918|75886528|FG001|COMPLETED|Overall Study||27||
59766445|NCT00866918|75886527|FG000|NOT COMPLETED|Overall Study||16||
59766446|NCT00866918|75886528|FG001|NOT COMPLETED|Overall Study||12||
59766447|NCT03158285|75886537|FG000|STARTED|Placebo-controlled Period: Week 0 - 24||246||
59766448|NCT03158285|75886538|FG001|STARTED|Placebo-controlled Period: Week 0 - 24||248||
59766449|NCT03158285|75886539|FG002|STARTED|Placebo-controlled Period: Week 0 - 24||245||
59766450|NCT03158285|75886537|FG000|Pooled Population: Enthesitis Assessment|Placebo-controlled Period: Week 0 - 24|Pooled population (255) = 77 (CNTO1959PSA3001[NCT03162796]) + 178 (CNTO1959PSA3002)|255||
59766451|NCT03158285|75886538|FG001|Pooled Population: Enthesitis Assessment|Placebo-controlled Period: Week 0 - 24|Pooled population (230)= 72 (CNTO1959PSA3001) + 158 (CNTO1959PSA3002)|230||
59817845|NCT04488770|75940336|FG010|STARTED|Part 1-Cohort 1: Period 4 (Up to 5 Days)||0||
59521270|NCT00980174|75615533|FG001|NOT COMPLETED|Overall Study||10||
59521271|NCT01138969|75615541|FG000|STARTED|Overall Study||83||
59521272|NCT01138969|75615542|FG001|STARTED|Overall Study||82||
59521273|NCT01138969|75615541|FG000|COMPLETED|Overall Study||83||
59766452|NCT03158285|75886539|FG002|Pooled Population: Enthesitis Assessment|Placebo-controlled Period: Week 0 - 24|Pooled population (243)= 73 (CNTO1959PSA3001) + 170 (CNTO1959PSA3002)|243||
59766453|NCT03158285|75886537|FG000|Pooled Population: Dactylitis Assessment|Placebo-controlled Period: Week 0 - 24|Pooled population (154) = 55 (CNTO1959PSA3001) + 99 (CNTO1959PSA3002)|154||
59766454|NCT03158285|75886538|FG001|Pooled Population: Dactylitis Assessment|Placebo-controlled Period: Week 0 - 24|Pooled population (160) = 49 (CNTO1959PSA3001) + 111 (CNTO1959PSA3002)|160||
59766455|NCT03158285|75886539|FG002|Pooled Population: Dactylitis Assessment|Placebo-controlled Period: Week 0 - 24|Pooled population (159) = 38 (CNTO1959PSA3001) + 121 (CNTO1959PSA3002)|159||
59766456|NCT03158285|75886537|FG000|COMPLETED|Placebo-controlled Period: Week 0 - 24||240||
59766457|NCT03158285|75886538|FG001|COMPLETED|Placebo-controlled Period: Week 0 - 24||240||
59766458|NCT03158285|75886539|FG002|COMPLETED|Placebo-controlled Period: Week 0 - 24||236||
59766459|NCT03158285|75886537|FG000|NOT COMPLETED|Placebo-controlled Period: Week 0 - 24||6||
59766460|NCT03158285|75886538|FG001|NOT COMPLETED|Placebo-controlled Period: Week 0 - 24||8||
59766461|NCT03158285|75886539|FG002|NOT COMPLETED|Placebo-controlled Period: Week 0 - 24||9||
59766462|NCT03158285|75886537|FG000|STARTED|Active Treatment Period: Week 24 - 52|2 participants did not enter the active treatment.|238||
59766463|NCT03158285|75886538|FG001|STARTED|Active Treatment Period: Week 24 - 52||240||
59766464|NCT03158285|75886539|FG002|STARTED|Active Treatment Period: Week 24 - 52|2 participants did not enter the active treatment.|234||
59766465|NCT03158285|75886537|FG000|COMPLETED|Active Treatment Period: Week 24 - 52||228||
59766466|NCT03158285|75886538|FG001|COMPLETED|Active Treatment Period: Week 24 - 52||234||
59766467|NCT03158285|75886539|FG002|COMPLETED|Active Treatment Period: Week 24 - 52||227||
59766468|NCT03158285|75886537|FG000|NOT COMPLETED|Active Treatment Period: Week 24 - 52||10||
59766469|NCT03158285|75886538|FG001|NOT COMPLETED|Active Treatment Period: Week 24 - 52||6||
59766470|NCT03158285|75886539|FG002|NOT COMPLETED|Active Treatment Period: Week 24 - 52||7||
59617969|NCT04147650|75729160|FG002|Modified Intent to Treat (mITT)|Overall Study||122||
59617970|NCT04147650|75729161|FG003|Modified Intent to Treat (mITT)|Overall Study||121||
59617971|NCT04147650|75729158|FG000|COMPLETED|Overall Study||116||
59617972|NCT04147650|75729159|FG001|COMPLETED|Overall Study||107||
59617973|NCT04147650|75729160|FG002|COMPLETED|Overall Study||121||
59617974|NCT04147650|75729161|FG003|COMPLETED|Overall Study||120||
59766471|NCT03158285|75886537|FG000|STARTED|Active Treatment Period: Week 52-100||228||
59766472|NCT03158285|75886538|FG001|STARTED|Active Treatment Period: Week 52-100|2 participants did not enter the active treatment.|232||
59766473|NCT03158285|75886539|FG002|STARTED|Active Treatment Period: Week 52-100||227||
59766474|NCT03158285|75886537|FG000|COMPLETED|Active Treatment Period: Week 52-100||210||
59766475|NCT03158285|75886538|FG001|COMPLETED|Active Treatment Period: Week 52-100||223||
59766476|NCT03158285|75886539|FG002|COMPLETED|Active Treatment Period: Week 52-100||219||
59766477|NCT03158285|75886537|FG000|NOT COMPLETED|Active Treatment Period: Week 52-100||18||
59766478|NCT03158285|75886538|FG001|NOT COMPLETED|Active Treatment Period: Week 52-100||9||
59766479|NCT03158285|75886539|FG002|NOT COMPLETED|Active Treatment Period: Week 52-100||8||
59766480|NCT00861692|75886552|FG000|STARTED|Overall Study||20||
59766481|NCT00861692|75886552|FG000|COMPLETED|Overall Study||14||
59766482|NCT00861692|75886552|FG000|NOT COMPLETED|Overall Study||6||
59766483|NCT00602927|75886558|FG000|STARTED|Period 1: 13 Days||19||
59766484|NCT00602927|75886559|FG001|STARTED|Period 1: 13 Days||19||
59766485|NCT00602927|75886558|FG000|COMPLETED|Period 1: 13 Days||15||
59766486|NCT00602927|75886559|FG001|COMPLETED|Period 1: 13 Days||14||
59766487|NCT00602927|75886558|FG000|NOT COMPLETED|Period 1: 13 Days||4||
59766488|NCT00602927|75886559|FG001|NOT COMPLETED|Period 1: 13 Days||5||
59766489|NCT00602927|75886558|FG000|STARTED|Period 2: 14 Days||15||
59766490|NCT00602927|75886559|FG001|STARTED|Period 2: 14 Days||14||
59617975|NCT04147650|75729158|FG000|NOT COMPLETED|Overall Study||11||
59617976|NCT04147650|75729159|FG001|NOT COMPLETED|Overall Study||19||
59617977|NCT04147650|75729160|FG002|NOT COMPLETED|Overall Study||7||
59617978|NCT04147650|75729161|FG003|NOT COMPLETED|Overall Study||7||
59617979|NCT04026126|75729171|FG000|STARTED|Overall Study||15||
59617980|NCT04026126|75729171|FG000|COMPLETED|Overall Study||15||
59617981|NCT04026126|75729171|FG000|NOT COMPLETED|Overall Study||0||
59617982|NCT02703714|75729175|FG000|STARTED|Overall Study||42||
59617983|NCT02703714|75729175|FG000|COMPLETED|Overall Study||42||
59617984|NCT02703714|75729175|FG000|NOT COMPLETED|Overall Study||0||
59617985|NCT03904446|75729181|FG000|STARTED|Overall Study||80||
59617986|NCT03904446|75729182|FG001|STARTED|Overall Study||80||
59617987|NCT03904446|75729181|FG000|COMPLETED|Overall Study||80||
59617988|NCT03904446|75729182|FG001|COMPLETED|Overall Study||80||
59617989|NCT03904446|75729181|FG000|NOT COMPLETED|Overall Study||0||
59617990|NCT03904446|75729182|FG001|NOT COMPLETED|Overall Study||0||
59617991|NCT03645408|75729190|FG000|STARTED|Overall Study||1||
59617992|NCT03645408|75729191|FG001|STARTED|Overall Study||2||
59617993|NCT03645408|75729190|FG000|COMPLETED|Overall Study||1||
59617994|NCT03645408|75729191|FG001|COMPLETED|Overall Study||2||
59617995|NCT03645408|75729190|FG000|NOT COMPLETED|Overall Study||0||
59617996|NCT03645408|75729191|FG001|NOT COMPLETED|Overall Study||0||
59617997|NCT03900624|75729199|FG000|STARTED|Overall Study||61||
59617998|NCT03900624|75729200|FG001|STARTED|Overall Study||31||
59617999|NCT03900624|75729199|FG000|COMPLETED|Overall Study||61||
59618000|NCT03900624|75729200|FG001|COMPLETED|Overall Study||31||
59618001|NCT03900624|75729199|FG000|NOT COMPLETED|Overall Study||0||
59766491|NCT00602927|75886558|FG000|COMPLETED|Period 2: 14 Days||15||
59766492|NCT00602927|75886559|FG001|COMPLETED|Period 2: 14 Days||12||
59766493|NCT00602927|75886558|FG000|NOT COMPLETED|Period 2: 14 Days||0||
59766494|NCT00602927|75886559|FG001|NOT COMPLETED|Period 2: 14 Days||2||
59766495|NCT00602927|75886558|FG000|STARTED|Period 3: 13 Days||15||
59766496|NCT00602927|75886559|FG001|STARTED|Period 3: 13 Days||12||
59766497|NCT00602927|75886558|FG000|COMPLETED|Period 3: 13 Days||13||
59766498|NCT00602927|75886559|FG001|COMPLETED|Period 3: 13 Days||9||
59766499|NCT00602927|75886558|FG000|NOT COMPLETED|Period 3: 13 Days||2||
59766500|NCT00602927|75886559|FG001|NOT COMPLETED|Period 3: 13 Days||3||
59766501|NCT00602537|75886567|FG000|STARTED|12 Week Double Blind Comparison||65||
59766502|NCT00602537|75886568|FG001|STARTED|12 Week Double Blind Comparison||64||
60072402|NCT01682811|76187740|FG003|Treated 24 Hours|Part 1 Levulan Painted Twice||0||0
59766503|NCT00602537|75886567|FG000|Responded|12 Week Double Blind Comparison||44||
59766504|NCT00602537|75886568|FG001|Responded|12 Week Double Blind Comparison||22||
59766505|NCT00602537|75886567|FG000|COMPLETED|12 Week Double Blind Comparison||42||
59766506|NCT00602537|75886568|FG001|COMPLETED|12 Week Double Blind Comparison||17||
59766507|NCT00602537|75886567|FG000|NOT COMPLETED|12 Week Double Blind Comparison||23||
59766508|NCT00602537|75886568|FG001|NOT COMPLETED|12 Week Double Blind Comparison||47||
59766509|NCT00602537|75886567|FG000|STARTED|Follow Up Study Comparison||42||
59766510|NCT00602537|75886568|FG001|STARTED|Follow Up Study Comparison||17||
59766511|NCT00602537|75886567|FG000|COMPLETED|Follow Up Study Comparison||31||
59766512|NCT00602537|75886568|FG001|COMPLETED|Follow Up Study Comparison||14||
59766513|NCT00602537|75886567|FG000|NOT COMPLETED|Follow Up Study Comparison||11||
59766514|NCT00602537|75886568|FG001|NOT COMPLETED|Follow Up Study Comparison||3||
59766515|NCT00861614|75886576|FG000|STARTED|Overall Study||393||
59766516|NCT00861614|75886577|FG001|STARTED|Overall Study||396||
59766517|NCT00861614|75886576|FG000|COMPLETED|Overall Study||22||
59766518|NCT00861614|75886577|FG001|COMPLETED|Overall Study||28||
59766519|NCT00861614|75886576|FG000|NOT COMPLETED|Overall Study||371||
59766520|NCT00861614|75886577|FG001|NOT COMPLETED|Overall Study||368||
59766521|NCT00485173|75886585|FG000|STARTED|Overall Study||224||
59766522|NCT00485173|75886586|FG001|STARTED|Overall Study||486||
59766523|NCT00485173|75886585|FG000|COMPLETED|Overall Study|The number of completed participants is reported the number of subjects who had any 24-month data.|188||
59766524|NCT00485173|75886586|FG001|COMPLETED|Overall Study|The number of completed participants is reported the number of subjects who had any 24-month data.|422||
59766525|NCT00485173|75886585|FG000|NOT COMPLETED|Overall Study||36||
59766526|NCT00485173|75886586|FG001|NOT COMPLETED|Overall Study||64||
59766527|NCT00495469|75886599|FG000|STARTED|Overall Study||36||
59766528|NCT00495469|75886600|FG001|STARTED|Overall Study||37||
59766529|NCT00495469|75886601|FG002|STARTED|Overall Study||34||
59766530|NCT00495469|75886602|FG003|STARTED|Overall Study||36||
59766531|NCT00495469|75886603|FG004|STARTED|Overall Study||36||
59766532|NCT00495469|75886604|FG005|STARTED|Overall Study||36||
59766533|NCT00495469|75886605|FG006|STARTED|Overall Study||35||
59766534|NCT00495469|75886599|FG000|COMPLETED|Overall Study||30||
59766535|NCT00495469|75886600|FG001|COMPLETED|Overall Study||30||
59766536|NCT00495469|75886601|FG002|COMPLETED|Overall Study||27||
59766537|NCT00495469|75886602|FG003|COMPLETED|Overall Study||32||
59766538|NCT00495469|75886603|FG004|COMPLETED|Overall Study||31||
59766539|NCT00495469|75886604|FG005|COMPLETED|Overall Study||31||
59766540|NCT00495469|75886605|FG006|COMPLETED|Overall Study||30||
59766541|NCT00495469|75886599|FG000|NOT COMPLETED|Overall Study||6||
59766542|NCT00495469|75886600|FG001|NOT COMPLETED|Overall Study||7||
59766543|NCT00495469|75886601|FG002|NOT COMPLETED|Overall Study||7||
59766544|NCT00495469|75886602|FG003|NOT COMPLETED|Overall Study||4||
59766545|NCT00495469|75886603|FG004|NOT COMPLETED|Overall Study||5||
59766546|NCT00495469|75886604|FG005|NOT COMPLETED|Overall Study||5||
60072403|NCT01682811|76187741|FG004|Treated 24 Hours|Part 1 Levulan Painted Twice||0||0
60072404|NCT01682811|76187742|FG005|Treated 24 Hours|Part 1 Levulan Painted Twice||0||0
59766547|NCT00495469|75886605|FG006|NOT COMPLETED|Overall Study||5||
59766548|NCT00861380|75886635|FG000|STARTED|Overall Study||8427||
59766549|NCT00861380|75886636|FG001|STARTED|Overall Study||9112||
59766550|NCT00861380|75886637|FG002|STARTED|Overall Study||8872||
59766551|NCT00861380|75886638|FG003|STARTED|Overall Study||3689||
60072405|NCT01682811|76187743|FG006|Treated 24 Hours|Part 1 Levulan Painted Twice||0||0
60072406|NCT01682811|76187737|FG000|COMPLETED|Part 1 Levulan Painted Twice||0||0
59766552|NCT00861380|75886639|FG004|STARTED|Overall Study||1812||
59766553|NCT00861380|75886640|FG005|STARTED|Overall Study||6249||
59766554|NCT00861380|75886641|FG006|STARTED|Overall Study||3020||
59766555|NCT00861380|75886635|FG000|COMPLETED|Overall Study||0||
59766556|NCT00861380|75886636|FG001|COMPLETED|Overall Study||0||
59766557|NCT00861380|75886637|FG002|COMPLETED|Overall Study||0||
59766558|NCT00861380|75886638|FG003|COMPLETED|Overall Study||0||
60072407|NCT01682811|76187738|FG001|COMPLETED|Part 1 Levulan Painted Twice||0||0
60072408|NCT01682811|76187739|FG002|COMPLETED|Part 1 Levulan Painted Twice||2||12
60072409|NCT01682811|76187740|FG003|COMPLETED|Part 1 Levulan Painted Twice||0||0
59766559|NCT00861380|75886639|FG004|COMPLETED|Overall Study||0||
59766560|NCT00861380|75886640|FG005|COMPLETED|Overall Study||0||
59766561|NCT00861380|75886641|FG006|COMPLETED|Overall Study||0||
59766562|NCT00861380|75886635|FG000|NOT COMPLETED|Overall Study||8427||
59766563|NCT00861380|75886636|FG001|NOT COMPLETED|Overall Study||9112||
59766564|NCT00861380|75886637|FG002|NOT COMPLETED|Overall Study||8872||
59766565|NCT00861380|75886638|FG003|NOT COMPLETED|Overall Study||3689||
59766566|NCT00861380|75886639|FG004|NOT COMPLETED|Overall Study||1812||
59766567|NCT00861380|75886640|FG005|NOT COMPLETED|Overall Study||6249||
59766568|NCT00861380|75886641|FG006|NOT COMPLETED|Overall Study||3020||
59766569|NCT00495391|75886676|FG000|STARTED|Overall Study||42||
59766570|NCT00495391|75886677|FG001|STARTED|Overall Study||22||
59766571|NCT00495391|75886676|FG000|From Baseline to Week 8|Overall Study||31||
59766572|NCT00495391|75886677|FG001|From Baseline to Week 8|Overall Study||20||
59766573|NCT00495391|75886676|FG000|From Baseline to Week 16|Overall Study||24||
59766574|NCT00495391|75886677|FG001|From Baseline to Week 16|Overall Study||11||
59766575|NCT00495391|75886676|FG000|From Baseline to End of Treatment|Overall Study||6||
59766576|NCT00495391|75886677|FG001|From Baseline to End of Treatment|Overall Study||1||
59766577|NCT00495391|75886676|FG000|From Baseline to End of Follow up|Overall Study||6||
59766578|NCT00495391|75886677|FG001|From Baseline to End of Follow up|Overall Study||1||
59766579|NCT00495391|75886676|FG000|COMPLETED|Overall Study||6||
59766580|NCT00495391|75886677|FG001|COMPLETED|Overall Study||1||
59766581|NCT00495391|75886676|FG000|NOT COMPLETED|Overall Study||36||
59766582|NCT00495391|75886677|FG001|NOT COMPLETED|Overall Study||21||
59766583|NCT00869960|75886683|FG000|STARTED|Overall Study||24||
59766584|NCT00869960|75886683|FG000|COMPLETED|Overall Study||22||
59766585|NCT00869960|75886683|FG000|NOT COMPLETED|Overall Study||2||
59766586|NCT00494299|75886689|FG000|STARTED|Overall Study||229||
59766587|NCT00494299|75886690|FG001|STARTED|Overall Study||229||
59766588|NCT00494299|75886689|FG000|Received Treatment|Overall Study||229||
59766589|NCT00494299|75886690|FG001|Received Treatment|Overall Study||227||
59766590|NCT00494299|75886689|FG000|COMPLETED|Overall Study||0||
59766591|NCT00494299|75886690|FG001|COMPLETED|Overall Study||0||
59766592|NCT00494299|75886689|FG000|NOT COMPLETED|Overall Study||229||
59766593|NCT00494299|75886690|FG001|NOT COMPLETED|Overall Study||229||
59766594|NCT00593684|75886698|FG000|STARTED|Overall Study||25||
59766595|NCT00593684|75886699|FG001|STARTED|Overall Study||25||
59766596|NCT00593684|75886698|FG000|COMPLETED|Overall Study||23||
59766597|NCT00593684|75886699|FG001|COMPLETED|Overall Study||24||
59766598|NCT00593684|75886698|FG000|NOT COMPLETED|Overall Study||2||
59766599|NCT00593684|75886699|FG001|NOT COMPLETED|Overall Study||1||
59766600|NCT02963831|75886709|FG000|STARTED|Overall Study||4|Started includes all subjects who received at least one dose of study therapy.|
59766601|NCT02963831|75886710|FG001|STARTED|Overall Study||5|Started includes all subjects who received at least one dose of study therapy.|
59766602|NCT02963831|75886711|FG002|STARTED|Overall Study||19|Started includes all subjects who received at least one dose of study therapy.|
59766603|NCT02963831|75886712|FG003|STARTED|Overall Study||36|Started includes all subjects who received at least one dose of study therapy.|
59766604|NCT02963831|75886709|FG000|COMPLETED|Overall Study||0|Completed includes all subjects who completed 12 cycles of treatment.|
59766605|NCT02963831|75886710|FG001|COMPLETED|Overall Study||1|Completed includes all subjects who completed 12 cycles of treatment.|
59766606|NCT02963831|75886711|FG002|COMPLETED|Overall Study||0|Completed includes all subjects who completed 12 cycles of treatment.|
59766607|NCT02963831|75886712|FG003|COMPLETED|Overall Study||1|Completed includes all subjects who completed 12 cycles of treatment.|
59766608|NCT02963831|75886709|FG000|NOT COMPLETED|Overall Study||4||
59766609|NCT02963831|75886710|FG001|NOT COMPLETED|Overall Study||4||
59766610|NCT02963831|75886711|FG002|NOT COMPLETED|Overall Study||19||
59766611|NCT02963831|75886712|FG003|NOT COMPLETED|Overall Study||35||
59766612|NCT00859898|75886727|FG000|STARTED|Overall Study||211||
59766613|NCT00859898|75886728|FG001|STARTED|Overall Study||219||
59766614|NCT00859898|75886729|FG002|STARTED|Overall Study||208||
59766615|NCT00859898|75886727|FG000|COMPLETED|Overall Study||183||
59766616|NCT00859898|75886728|FG001|COMPLETED|Overall Study||188||
59766617|NCT00859898|75886729|FG002|COMPLETED|Overall Study||181||
59766618|NCT00859898|75886727|FG000|NOT COMPLETED|Overall Study||28||
59766619|NCT00859898|75886728|FG001|NOT COMPLETED|Overall Study||31||
59766620|NCT00859898|75886729|FG002|NOT COMPLETED|Overall Study||27||
59766621|NCT00859586|75886738|FG000|STARTED|Overall Study||8||
59766622|NCT00859586|75886738|FG000|COMPLETED|Overall Study||4||
59766623|NCT00859586|75886738|FG000|NOT COMPLETED|Overall Study||4||
59766624|NCT00494221|75886745|FG000|STARTED|Overall Study||58||
59766625|NCT00494221|75886746|FG001|STARTED|Overall Study||56||
59766626|NCT00494221|75886747|FG002|STARTED|Overall Study||58||
59766627|NCT00494221|75886745|FG000|COMPLETED|Overall Study||42||
59766628|NCT00494221|75886746|FG001|COMPLETED|Overall Study||45||
59766629|NCT00494221|75886747|FG002|COMPLETED|Overall Study||44||
59766630|NCT00494221|75886745|FG000|NOT COMPLETED|Overall Study||16||
59766631|NCT00494221|75886746|FG001|NOT COMPLETED|Overall Study||11||
59766632|NCT00494221|75886747|FG002|NOT COMPLETED|Overall Study||14||
59766633|NCT00857948|75886759|FG000|STARTED|Overall Study||18||
59766634|NCT00857948|75886760|FG001|STARTED|Overall Study||18||
59766635|NCT00857948|75886761|FG002|STARTED|Overall Study||19||
59766636|NCT00857948|75886762|FG003|STARTED|Overall Study||23||
59766637|NCT00857948|75886759|FG000|COMPLETED|Overall Study||15||
59766638|NCT00857948|75886760|FG001|COMPLETED|Overall Study||18||
59766639|NCT00857948|75886761|FG002|COMPLETED|Overall Study||18||
59766640|NCT00857948|75886762|FG003|COMPLETED|Overall Study||23||
59766641|NCT00857948|75886759|FG000|NOT COMPLETED|Overall Study||3||
59766642|NCT00857948|75886760|FG001|NOT COMPLETED|Overall Study||0||
59766643|NCT00857948|75886761|FG002|NOT COMPLETED|Overall Study||1||
59766644|NCT00857948|75886762|FG003|NOT COMPLETED|Overall Study||0||
59766645|NCT00866606|75886772|FG000|STARTED|Overall Study||35||
59766646|NCT00866606|75886772|FG000|COMPLETED|Overall Study||31||
59766647|NCT00866606|75886772|FG000|NOT COMPLETED|Overall Study||4||
59766648|NCT00857792|75886776|FG000|STARTED|Overall Study||120||
59766649|NCT00857792|75886776|FG000|COMPLETED|Overall Study||108||
59766650|NCT00857792|75886776|FG000|NOT COMPLETED|Overall Study||12||
59766651|NCT00601835|75886782|FG000|STARTED|Overall Study||2950||
59766652|NCT00601835|75886783|FG001|STARTED|Overall Study||700||
59766653|NCT00601835|75886782|FG000|COMPLETED|Overall Study||2890||
59766654|NCT00601835|75886783|FG001|COMPLETED|Overall Study||686||
59766655|NCT00601835|75886782|FG000|NOT COMPLETED|Overall Study||60||
59766656|NCT00601835|75886783|FG001|NOT COMPLETED|Overall Study||14||
59766657|NCT00857246|75886789|FG000|STARTED|Induction Regimen||30||
59766658|NCT00857246|75886789|FG000|COMPLETED|Induction Regimen||27||
59766659|NCT00857246|75886789|FG000|NOT COMPLETED|Induction Regimen||3||
59766660|NCT00857246|75886789|FG000|STARTED|Surgery (Curative)||27||
59766661|NCT00857246|75886789|FG000|COMPLETED|Surgery (Curative)||21||
59766662|NCT00857246|75886789|FG000|NOT COMPLETED|Surgery (Curative)||6||
59766663|NCT00857246|75886789|FG000|STARTED|ChemoRT|6 did not start adjuvant therapy due to disease-related complications or patient withdrawal.|15||
59766664|NCT00857246|75886789|FG000|COMPLETED|ChemoRT||12||
59766665|NCT00857246|75886789|FG000|NOT COMPLETED|ChemoRT||3||
59766666|NCT00856856|75886796|FG000|STARTED|Baseline||101||
59766667|NCT00856856|75886796|FG000|COMPLETED|Baseline||101||
59766668|NCT00856856|75886796|FG000|NOT COMPLETED|Baseline||0||
59766669|NCT00856856|75886796|FG000|STARTED|30-day Clinical Follow-up||101||
59766670|NCT00856856|75886796|FG000|COMPLETED|30-day Clinical Follow-up||101||
59766671|NCT00856856|75886796|FG000|NOT COMPLETED|30-day Clinical Follow-up||0||
59766672|NCT00856856|75886796|FG000|STARTED|180-day Clinical Follow-up||101||
59766673|NCT00856856|75886796|FG000|COMPLETED|180-day Clinical Follow-up||101||
59766674|NCT00856856|75886796|FG000|NOT COMPLETED|180-day Clinical Follow-up||0||
59766675|NCT00856856|75886796|FG000|STARTED|270-day Clinical Follow-up||101||
59766676|NCT00856856|75886796|FG000|COMPLETED|270-day Clinical Follow-up||101||
59766677|NCT00856856|75886796|FG000|NOT COMPLETED|270-day Clinical Follow-up||0||
59766678|NCT00856856|75886796|FG000|STARTED|1-year Clinical Follow-up||101||
59766679|NCT00856856|75886796|FG000|COMPLETED|1-year Clinical Follow-up||101||
59521274|NCT01138969|75615542|FG001|COMPLETED|Overall Study||82||
59521275|NCT01138969|75615541|FG000|NOT COMPLETED|Overall Study||0||
59521276|NCT01138969|75615542|FG001|NOT COMPLETED|Overall Study||0||
59766680|NCT00856856|75886796|FG000|NOT COMPLETED|1-year Clinical Follow-up||0||
59766681|NCT00856856|75886796|FG000|STARTED|2-year Clinical Follow-up||101||
59766682|NCT00856856|75886796|FG000|COMPLETED|2-year Clinical Follow-up||100||
59766683|NCT00856856|75886796|FG000|NOT COMPLETED|2-year Clinical Follow-up||1||
59766684|NCT00856856|75886796|FG000|STARTED|3-year Clinical Follow-up||100||
59766685|NCT00856856|75886796|FG000|COMPLETED|3-year Clinical Follow-up||100||
59766686|NCT00856856|75886796|FG000|NOT COMPLETED|3-year Clinical Follow-up||0||
59766687|NCT00856856|75886796|FG000|STARTED|4-year Clinical Follow-up||100||
59766688|NCT00856856|75886796|FG000|COMPLETED|4-year Clinical Follow-up||99||
59766689|NCT00856856|75886796|FG000|NOT COMPLETED|4-year Clinical Follow-up||1||
59766690|NCT00856856|75886796|FG000|STARTED|5-year Clinical Follow-up||100||
59766691|NCT00856856|75886796|FG000|COMPLETED|5-year Clinical Follow-up|One patient missed the 4-year clinical follow-up but returned at 5 year.|100||
59766692|NCT00856856|75886796|FG000|NOT COMPLETED|5-year Clinical Follow-up||0||
59766693|NCT00493285|75886811|FG000|STARTED|Overall Study||13||
59766694|NCT00493285|75886812|FG001|STARTED|Overall Study||6||
59766695|NCT00493285|75886813|FG002|STARTED|Overall Study||9||
59766696|NCT00493285|75886814|FG003|STARTED|Overall Study||6||
59766697|NCT00493285|75886815|FG004|STARTED|Overall Study||10||
59766698|NCT00493285|75886816|FG005|STARTED|Overall Study||5||
59766699|NCT00493285|75886811|FG000|COMPLETED|Overall Study||13||
59766700|NCT00493285|75886812|FG001|COMPLETED|Overall Study||6||
59766701|NCT00493285|75886813|FG002|COMPLETED|Overall Study||9||
59766702|NCT00493285|75886814|FG003|COMPLETED|Overall Study||6||
59766703|NCT00493285|75886815|FG004|COMPLETED|Overall Study||9||
59766704|NCT00493285|75886816|FG005|COMPLETED|Overall Study||5||
59766705|NCT00493285|75886811|FG000|NOT COMPLETED|Overall Study||0||
59521277|NCT01139515|75615548|FG000|STARTED|First Intervention Period||4||
59521278|NCT01139515|75615549|FG001|STARTED|First Intervention Period||4||
59521279|NCT01139515|75615550|FG002|STARTED|First Intervention Period||4||
59521280|NCT01139515|75615551|FG003|STARTED|First Intervention Period||4||
59766706|NCT00493285|75886812|FG001|NOT COMPLETED|Overall Study||0||
59766707|NCT00493285|75886813|FG002|NOT COMPLETED|Overall Study||0||
59766708|NCT00493285|75886814|FG003|NOT COMPLETED|Overall Study||0||
59766709|NCT00493285|75886815|FG004|NOT COMPLETED|Overall Study||1||
59766710|NCT00493285|75886816|FG005|NOT COMPLETED|Overall Study||0||
59766711|NCT00856778|75886830|FG000|STARTED|Overall Study||98||
59766712|NCT00856778|75886830|FG000|COMPLETED|Overall Study||74||
59766713|NCT00856778|75886830|FG000|NOT COMPLETED|Overall Study||24||
59766714|NCT00603473|75886834|FG000|STARTED|Overall Study||89||
59766715|NCT00603473|75886834|FG000|COMPLETED|Overall Study||80||
59766716|NCT00603473|75886834|FG000|NOT COMPLETED|Overall Study||9||
59766717|NCT00486889|75886838|FG000|STARTED|Overall Study||12||
59766718|NCT00486889|75886838|FG000|COMPLETED|Overall Study||1||
59766719|NCT00486889|75886838|FG000|NOT COMPLETED|Overall Study||11||
59766720|NCT00486811|75886845|FG000|STARTED|Overall Study||337||
59766721|NCT00486811|75886846|FG001|STARTED|Overall Study|One participant was not eligible to be dosed.|320||
59766722|NCT00486811|75886847|FG002|STARTED|Overall Study|Two participants were not eligible to be dosed.|333||
59766723|NCT00486811|75886845|FG000|COMPLETED|Overall Study||215||
59766724|NCT00486811|75886846|FG001|COMPLETED|Overall Study||179||
59766725|NCT00486811|75886847|FG002|COMPLETED|Overall Study||119||
59766726|NCT00486811|75886845|FG000|NOT COMPLETED|Overall Study||122||
59766727|NCT00486811|75886846|FG001|NOT COMPLETED|Overall Study||141||
59766728|NCT00486811|75886847|FG002|NOT COMPLETED|Overall Study||214||
59766729|NCT00486265|75886855|FG000|STARTED|Overall Study|Partipants dosed on day 1.|9||
59766730|NCT00486265|75886855|FG000|COMPLETED|Overall Study|Treatment is not for a fixed period and continues until a discontinuation criterion is met|0||
59766731|NCT00486265|75886855|FG000|NOT COMPLETED|Overall Study||9||
59766732|NCT02151604|75886859|FG000|STARTED|Overall Study||22||
59766733|NCT02151604|75886859|FG000|COMPLETED|Overall Study||13||
59766734|NCT02151604|75886859|FG000|NOT COMPLETED|Overall Study||9||
59766735|NCT00466921|75886864|FG000|STARTED|First 3 Cycles of Treatment|One patient completed only a few days of treatment|33||
59766736|NCT00466921|75886864|FG000|Completed 1 Cycle|First 3 Cycles of Treatment||32||
59766737|NCT00466921|75886864|FG000|Started Cycle 2|First 3 Cycles of Treatment||31||
59766738|NCT00466921|75886864|FG000|Completed 3 Cycles|First 3 Cycles of Treatment||26||
59766739|NCT00466921|75886864|FG000|COMPLETED|First 3 Cycles of Treatment||26||
59766740|NCT00466921|75886864|FG000|NOT COMPLETED|First 3 Cycles of Treatment||7||
59766741|NCT00466921|75886864|FG000|STARTED|Completed 4 Cycles/Reached 1st Response||26||
59766742|NCT00466921|75886864|FG000|Completed 4 Cycles/1st Response|Completed 4 Cycles/Reached 1st Response||21||
59766743|NCT00466921|75886864|FG000|COMPLETED|Completed 4 Cycles/Reached 1st Response||21||
60072410|NCT01682811|76187741|FG004|COMPLETED|Part 1 Levulan Painted Twice||0||0
60072411|NCT01682811|76187742|FG005|COMPLETED|Part 1 Levulan Painted Twice||0||0
60072412|NCT01682811|76187743|FG006|COMPLETED|Part 1 Levulan Painted Twice||0||0
60072413|NCT01682811|76187737|FG000|NOT COMPLETED|Part 1 Levulan Painted Twice||0||0
60072414|NCT01682811|76187738|FG001|NOT COMPLETED|Part 1 Levulan Painted Twice||0||0
60072415|NCT01682811|76187739|FG002|NOT COMPLETED|Part 1 Levulan Painted Twice||0||0
60072416|NCT01682811|76187740|FG003|NOT COMPLETED|Part 1 Levulan Painted Twice||0||0
60072417|NCT01682811|76187741|FG004|NOT COMPLETED|Part 1 Levulan Painted Twice||0||0
60072418|NCT01682811|76187742|FG005|NOT COMPLETED|Part 1 Levulan Painted Twice||0||0
59766744|NCT00466921|75886864|FG000|NOT COMPLETED|Completed 4 Cycles/Reached 1st Response||5||
59766745|NCT00466921|75886864|FG000|STARTED|Continued Treatment||21|Patients with partial response/stable disease continued for up to 2 years of treatment. Patients with complete response were treated with up to 2 more cycles.|
59766746|NCT00466921|75886864|FG000|COMPLETED|Continued Treatment||21||
59766747|NCT00466921|75886864|FG000|NOT COMPLETED|Continued Treatment||0||
59766748|NCT00466921|75886864|FG000|STARTED|Follow up for a Minimum of 1 Year||33|All patients who have at least one dose of study treatment go into follow up for survival endpoints.|
59766749|NCT00466921|75886864|FG000|COMPLETED|Follow up for a Minimum of 1 Year||27||
59766750|NCT00466921|75886864|FG000|NOT COMPLETED|Follow up for a Minimum of 1 Year||6||
60072419|NCT01682811|76187743|FG006|NOT COMPLETED|Part 1 Levulan Painted Twice||0||0
60072420|NCT01682811|76187737|FG000|STARTED|Part 1 Levulan Paint Twice Microneedling||0||0
60072421|NCT01682811|76187738|FG001|STARTED|Part 1 Levulan Paint Twice Microneedling||0||0
59766751|NCT00601523|75886870|FG000|STARTED|Overall Study||368||
59766752|NCT00601523|75886871|FG001|STARTED|Overall Study||143||
59766753|NCT00601523|75886870|FG000|COMPLETED|Overall Study||291||
59766754|NCT00601523|75886871|FG001|COMPLETED|Overall Study||117||
59766755|NCT00601523|75886870|FG000|NOT COMPLETED|Overall Study||77||
59766756|NCT00601523|75886871|FG001|NOT COMPLETED|Overall Study||26||
60072422|NCT01682811|76187739|FG002|STARTED|Part 1 Levulan Paint Twice Microneedling||0||0
60072423|NCT01682811|76187740|FG003|STARTED|Part 1 Levulan Paint Twice Microneedling||2||12
60072424|NCT01682811|76187741|FG004|STARTED|Part 1 Levulan Paint Twice Microneedling||0||0
59766757|NCT00466687|75886877|FG000|STARTED|Overall Study||34||
59766758|NCT00466687|75886877|FG000|COMPLETED|Overall Study||0||
59766759|NCT00466687|75886877|FG000|NOT COMPLETED|Overall Study||34||
60072425|NCT01682811|76187742|FG005|STARTED|Part 1 Levulan Paint Twice Microneedling||0||0
60072426|NCT01682811|76187743|FG006|STARTED|Part 1 Levulan Paint Twice Microneedling||0||0
60072427|NCT01682811|76187737|FG000|Control|Part 1 Levulan Paint Twice Microneedling||0||0
60072428|NCT01682811|76187738|FG001|Control|Part 1 Levulan Paint Twice Microneedling||0||0
60072429|NCT01682811|76187739|FG002|Control|Part 1 Levulan Paint Twice Microneedling||0||0
60072430|NCT01682811|76187740|FG003|Control|Part 1 Levulan Paint Twice Microneedling||2||6
59766760|NCT01759459|75886886|FG000|STARTED|Overall Study||50||
59766761|NCT01759459|75886887|FG001|STARTED|Overall Study||50||
59766762|NCT01759459|75886888|FG002|STARTED|Overall Study||50||
60072431|NCT01682811|76187741|FG004|Control|Part 1 Levulan Paint Twice Microneedling||0||0
60072432|NCT01682811|76187742|FG005|Control|Part 1 Levulan Paint Twice Microneedling||0||0
59766763|NCT01759459|75886886|FG000|COMPLETED|Overall Study||50||
59766764|NCT01759459|75886887|FG001|COMPLETED|Overall Study||50||
59766765|NCT01759459|75886888|FG002|COMPLETED|Overall Study||50||
59766766|NCT01759459|75886886|FG000|NOT COMPLETED|Overall Study||0||
59766767|NCT01759459|75886887|FG001|NOT COMPLETED|Overall Study||0||
59766768|NCT01759459|75886888|FG002|NOT COMPLETED|Overall Study||0||
59766769|NCT00465985|75886899|FG000|STARTED|Part I - Open-label Treatment Period|All patients received treatment with ACZ885 in Part I of the study.|35||
59766770|NCT00465985|75886900|FG001|STARTED|Part I - Open-label Treatment Period||0||
59766771|NCT00465985|75886899|FG000|COMPLETED|Part I - Open-label Treatment Period|Only patients with a complete response completed Part I and entered Part II of the study.|31||
59766772|NCT00465985|75886900|FG001|COMPLETED|Part I - Open-label Treatment Period||0||
59766773|NCT00465985|75886899|FG000|NOT COMPLETED|Part I - Open-label Treatment Period||4||
59766774|NCT00465985|75886900|FG001|NOT COMPLETED|Part I - Open-label Treatment Period||0||
59766775|NCT00465985|75886899|FG000|STARTED|Part II - 1:1 ACZ885:Placebo|Patients with complete response to treatment entered Part II and were randomized to ACZ885 ,placebo.|15||
59766776|NCT00465985|75886900|FG001|STARTED|Part II - 1:1 ACZ885:Placebo||16||
59766777|NCT00465985|75886899|FG000|COMPLETED|Part II - 1:1 ACZ885:Placebo||15||
59766778|NCT00465985|75886900|FG001|COMPLETED|Part II - 1:1 ACZ885:Placebo||4||
59766779|NCT00465985|75886899|FG000|NOT COMPLETED|Part II - 1:1 ACZ885:Placebo||0||
59766780|NCT00465985|75886900|FG001|NOT COMPLETED|Part II - 1:1 ACZ885:Placebo||12||
59766781|NCT00465985|75886899|FG000|STARTED|Part III - Open-label Treatment Period|All patients received treatment with ACZ885 in Part III of the study.|31||
59766782|NCT00465985|75886900|FG001|STARTED|Part III - Open-label Treatment Period||0||
59766783|NCT00465985|75886899|FG000|COMPLETED|Part III - Open-label Treatment Period||29||
59766784|NCT00465985|75886900|FG001|COMPLETED|Part III - Open-label Treatment Period||0||
59766785|NCT00465985|75886899|FG000|NOT COMPLETED|Part III - Open-label Treatment Period||2||
59766786|NCT00465985|75886900|FG001|NOT COMPLETED|Part III - Open-label Treatment Period||0||
59766787|NCT00454051|75886911|FG000|STARTED|Overall Study||20||
59766788|NCT00454051|75886912|FG001|STARTED|Overall Study||11||
59766789|NCT00454051|75886911|FG000|COMPLETED|Overall Study||17||
59766790|NCT00454051|75886912|FG001|COMPLETED|Overall Study||8||
59766791|NCT00454051|75886911|FG000|NOT COMPLETED|Overall Study||3||
59766792|NCT00454051|75886912|FG001|NOT COMPLETED|Overall Study||3||
59766793|NCT00484939|75886920|FG000|STARTED|Overall Study||140||
59766794|NCT00484939|75886921|FG001|STARTED|Overall Study||140||
59766795|NCT00484939|75886920|FG000|COMPLETED|Overall Study||0||
59766796|NCT00484939|75886921|FG001|COMPLETED|Overall Study||0||
60072433|NCT01682811|76187743|FG006|Control|Part 1 Levulan Paint Twice Microneedling||0||0
59766797|NCT00484939|75886920|FG000|NOT COMPLETED|Overall Study||140||
59766798|NCT00484939|75886921|FG001|NOT COMPLETED|Overall Study||140||
59766799|NCT00453973|75886929|FG000|STARTED|Overall Study||51||
59766800|NCT00453973|75886930|FG001|STARTED|Overall Study||63||
59766801|NCT00453973|75886929|FG000|COMPLETED|Overall Study||0||
59766802|NCT00453973|75886930|FG001|COMPLETED|Overall Study||15||
59766803|NCT00453973|75886929|FG000|NOT COMPLETED|Overall Study||51||
59766804|NCT00453973|75886930|FG001|NOT COMPLETED|Overall Study||48||
59766805|NCT00465361|75886936|FG000|STARTED|Baseline Assessment||7||
59766806|NCT00465361|75886936|FG000|COMPLETED|Baseline Assessment||3||
59766807|NCT00465361|75886936|FG000|NOT COMPLETED|Baseline Assessment||4||
59766808|NCT00465361|75886936|FG000|STARTED|Post-Intervention Assessment||3||
59766809|NCT00465361|75886936|FG000|COMPLETED|Post-Intervention Assessment||3||
59766810|NCT00465361|75886936|FG000|NOT COMPLETED|Post-Intervention Assessment||0||
59766811|NCT00464815|75886942|FG000|STARTED|Overall Study||768||
59766812|NCT00464815|75886943|FG001|STARTED|Overall Study||257||
59766813|NCT00464815|75886942|FG000|COMPLETED|Overall Study||762||
59766814|NCT00464815|75886943|FG001|COMPLETED|Overall Study||254||
59766815|NCT00464815|75886942|FG000|NOT COMPLETED|Overall Study||6||
59766816|NCT00464815|75886943|FG001|NOT COMPLETED|Overall Study||3||
59766817|NCT00464737|75886952|FG000|STARTED|Overall Study||82||
59766818|NCT00464737|75886953|FG001|STARTED|Overall Study||74||
59766819|NCT00464737|75886954|FG002|STARTED|Overall Study||74||
59766820|NCT00464737|75886952|FG000|COMPLETED|Overall Study||50||
59766821|NCT00464737|75886953|FG001|COMPLETED|Overall Study||42||
59766822|NCT00464737|75886954|FG002|COMPLETED|Overall Study||19||
59766823|NCT00464737|75886952|FG000|NOT COMPLETED|Overall Study||32||
59766824|NCT00464737|75886953|FG001|NOT COMPLETED|Overall Study||32||
59766825|NCT00464737|75886954|FG002|NOT COMPLETED|Overall Study||55||
60072434|NCT01682811|76187737|FG000|Treated 24 Hours|Part 1 Levulan Paint Twice Microneedling||0||0
60072435|NCT01682811|76187738|FG001|Treated 24 Hours|Part 1 Levulan Paint Twice Microneedling||0||0
60072436|NCT01682811|76187739|FG002|Treated 24 Hours|Part 1 Levulan Paint Twice Microneedling||0||0
60072437|NCT01682811|76187740|FG003|Treated 24 Hours|Part 1 Levulan Paint Twice Microneedling||2||6
59766826|NCT00453349|75886964|FG000|STARTED|Randomized||228||
60103563|NCT01342666|76221799|FG000|COMPLETED|Overall Study||26||
59766827|NCT00453349|75886965|FG001|STARTED|Randomized||232||
59766828|NCT00453349|75886964|FG000|COMPLETED|Randomized||203||
59766829|NCT00453349|75886965|FG001|COMPLETED|Randomized||209||
59766830|NCT00453349|75886964|FG000|NOT COMPLETED|Randomized||25||
59766831|NCT00453349|75886965|FG001|NOT COMPLETED|Randomized||23||
59817846|NCT04488770|75940337|FG011|STARTED|Part 1-Cohort 1: Period 4 (Up to 5 Days)||0||
59766832|NCT00453349|75886964|FG000|STARTED|Reaching of Primary Endpoint (TOC)|Subjects who attended the TOC visit or at least had a clinical evaluation at TOC|225||
59766833|NCT00453349|75886965|FG001|STARTED|Reaching of Primary Endpoint (TOC)|i.e. the ITT population|230||
59766834|NCT00453349|75886964|FG000|Valid for Primary Efficacy Analysis|Reaching of Primary Endpoint (TOC)||194||
59766835|NCT00453349|75886965|FG001|Valid for Primary Efficacy Analysis|Reaching of Primary Endpoint (TOC)||190||
59766836|NCT00453349|75886964|FG000|COMPLETED|Reaching of Primary Endpoint (TOC)|All PP patients and ITT patients with a clinical response with no missing information|215||
59766837|NCT00453349|75886965|FG001|COMPLETED|Reaching of Primary Endpoint (TOC)||219||
59766838|NCT00453349|75886964|FG000|NOT COMPLETED|Reaching of Primary Endpoint (TOC)||10||
59766839|NCT00453349|75886965|FG001|NOT COMPLETED|Reaching of Primary Endpoint (TOC)||11||
59766840|NCT00453349|75886964|FG000|STARTED|Completed Study||228||
59766841|NCT00453349|75886965|FG001|STARTED|Completed Study||232||
59521281|NCT01139515|75615548|FG000|COMPLETED|First Intervention Period||4||
59521282|NCT01139515|75615549|FG001|COMPLETED|First Intervention Period||4||
59521283|NCT01139515|75615550|FG002|COMPLETED|First Intervention Period||4||
59521284|NCT01139515|75615551|FG003|COMPLETED|First Intervention Period||4||
59766842|NCT00453349|75886964|FG000|Completed Study Treatment|Completed Study|25 terminated prematurely|203||
59766843|NCT00453349|75886965|FG001|Completed Study Treatment|Completed Study|23 terminated prematurely|209||
59766844|NCT00453349|75886964|FG000|COMPLETED|Completed Study|had follow-up assessment or alternative antibiotic assessment|201||
59766845|NCT00453349|75886965|FG001|COMPLETED|Completed Study|had follow-up assessment or alternative antibiotic assessment|198||
59766846|NCT00453349|75886964|FG000|NOT COMPLETED|Completed Study||27||
59766847|NCT00453349|75886965|FG001|NOT COMPLETED|Completed Study||34||
59766848|NCT00464269|75886975|FG000|STARTED|Overall Study||99||
59766849|NCT00464269|75886976|FG001|STARTED|Overall Study||99||
59766850|NCT00464269|75886977|FG002|STARTED|Overall Study||100||
59766851|NCT00464269|75886978|FG003|STARTED|Overall Study||102||
59766852|NCT00464269|75886975|FG000|COMPLETED|Overall Study||93||
59766853|NCT00464269|75886976|FG001|COMPLETED|Overall Study||82||
59766854|NCT00464269|75886977|FG002|COMPLETED|Overall Study||93||
59952085|NCT00834444|76070986|FG001|COMPLETED|Washout of 7 Days||16||
59952086|NCT00834444|76070985|FG000|NOT COMPLETED|Washout of 7 Days||0||
59952087|NCT00834444|76070986|FG001|NOT COMPLETED|Washout of 7 Days||1||
59952088|NCT00834444|76070985|FG000|STARTED|Second Intervention||17||
59952089|NCT00834444|76070986|FG001|STARTED|Second Intervention||16||
59952090|NCT00834444|76070985|FG000|COMPLETED|Second Intervention||16||
59952091|NCT00834444|76070986|FG001|COMPLETED|Second Intervention||16||
59952092|NCT00834444|76070985|FG000|NOT COMPLETED|Second Intervention||1||
59952093|NCT00834444|76070986|FG001|NOT COMPLETED|Second Intervention||0||
59521285|NCT01139515|75615548|FG000|NOT COMPLETED|First Intervention Period||0||
59521286|NCT01139515|75615549|FG001|NOT COMPLETED|First Intervention Period||0||
59766855|NCT00464269|75886978|FG003|COMPLETED|Overall Study||93||
59766856|NCT00464269|75886975|FG000|NOT COMPLETED|Overall Study||6||
59766857|NCT00464269|75886976|FG001|NOT COMPLETED|Overall Study||17||
59766858|NCT00464269|75886977|FG002|NOT COMPLETED|Overall Study||7||
59766859|NCT00464269|75886978|FG003|NOT COMPLETED|Overall Study||9||
59766860|NCT00484315|75886992|FG000|STARTED|12-Month Clinical Follow-up||942||
59952094|NCT00834132|76070992|FG000|STARTED|First Intervention||12||
59952095|NCT00834132|76070993|FG001|STARTED|First Intervention||12||
59952096|NCT00834132|76070992|FG000|COMPLETED|First Intervention||12||
59952097|NCT00834132|76070993|FG001|COMPLETED|First Intervention||12||
59952098|NCT00834132|76070992|FG000|NOT COMPLETED|First Intervention||0||
59952099|NCT00834132|76070993|FG001|NOT COMPLETED|First Intervention||0||
59952100|NCT00834132|76070992|FG000|STARTED|Washout: 21 Days||12||
59952101|NCT00834132|76070993|FG001|STARTED|Washout: 21 Days||12||
59952102|NCT00834132|76070992|FG000|COMPLETED|Washout: 21 Days||12||
59952103|NCT00834132|76070993|FG001|COMPLETED|Washout: 21 Days||12||
59521287|NCT01139515|75615550|FG002|NOT COMPLETED|First Intervention Period||0||
59766861|NCT00484315|75886993|FG001|STARTED|12-Month Clinical Follow-up||320||
59766862|NCT00484315|75886992|FG000|COMPLETED|12-Month Clinical Follow-up||914||
59766863|NCT00484315|75886993|FG001|COMPLETED|12-Month Clinical Follow-up||311||
59766864|NCT00484315|75886992|FG000|NOT COMPLETED|12-Month Clinical Follow-up||28||
59766865|NCT00484315|75886993|FG001|NOT COMPLETED|12-Month Clinical Follow-up||9||
59766866|NCT00484315|75886992|FG000|STARTED|9-Month Angiographic Follow-up||256||
59766867|NCT00484315|75886993|FG001|STARTED|9-Month Angiographic Follow-up||74||
59766868|NCT00484315|75886992|FG000|COMPLETED|9-Month Angiographic Follow-up||228||
59766869|NCT00484315|75886993|FG001|COMPLETED|9-Month Angiographic Follow-up||61||
59766870|NCT00484315|75886992|FG000|NOT COMPLETED|9-Month Angiographic Follow-up||28||
59766871|NCT00484315|75886993|FG001|NOT COMPLETED|9-Month Angiographic Follow-up||13||
59766872|NCT00463801|75886999|FG000|STARTED|Overall Study||52||
59766873|NCT00463801|75886999|FG000|COMPLETED|Overall Study||39||
59766874|NCT00463801|75886999|FG000|NOT COMPLETED|Overall Study||13||
59952104|NCT00834132|76070992|FG000|NOT COMPLETED|Washout: 21 Days||0||
59952105|NCT00834132|76070993|FG001|NOT COMPLETED|Washout: 21 Days||0||
59952106|NCT00834132|76070992|FG000|STARTED|Second Intervention||12||
59952107|NCT00834132|76070993|FG001|STARTED|Second Intervention||12||
59952108|NCT00834132|76070992|FG000|COMPLETED|Second Intervention||12||
59521288|NCT01139515|75615551|FG003|NOT COMPLETED|First Intervention Period||0||
59766875|NCT00463567|75887010|FG000|STARTED|Overall Study|Randomized Participants|420||
59766876|NCT00463567|75887011|FG001|STARTED|Overall Study||418||
59766877|NCT00463567|75887012|FG002|STARTED|Overall Study||420||
59766878|NCT00463567|75887013|FG003|STARTED|Overall Study||425||
59766879|NCT00463567|75887014|FG004|STARTED|Overall Study||130||
59766880|NCT00463567|75887015|FG005|STARTED|Overall Study||123||
59766881|NCT00463567|75887016|FG006|STARTED|Overall Study||123||
59766882|NCT00463567|75887010|FG000|Safety Population: Received Study Drug|Overall Study||416||
59766883|NCT00463567|75887011|FG001|Safety Population: Received Study Drug|Overall Study||416||
59766884|NCT00463567|75887012|FG002|Safety Population: Received Study Drug|Overall Study||415||
59766885|NCT00463567|75887013|FG003|Safety Population: Received Study Drug|Overall Study||418||
59766886|NCT00463567|75887014|FG004|Safety Population: Received Study Drug|Overall Study|'Completed' indicates the number of patients in the interim analysis.|127||
59766887|NCT00463567|75887015|FG005|Safety Population: Received Study Drug|Overall Study|'Completed' indicates the number of patients in the interim analysis.|122||
59766888|NCT00463567|75887016|FG006|Safety Population: Received Study Drug|Overall Study|'Completed' indicates the number of patients in the interim analysis.|122||
59766889|NCT00463567|75887010|FG000|COMPLETED|Overall Study||325||
59766890|NCT00463567|75887011|FG001|COMPLETED|Overall Study||341||
59766891|NCT00463567|75887012|FG002|COMPLETED|Overall Study||331||
59766892|NCT00463567|75887013|FG003|COMPLETED|Overall Study||294||
59766893|NCT00463567|75887014|FG004|COMPLETED|Overall Study||107||
59766894|NCT00463567|75887015|FG005|COMPLETED|Overall Study||102||
60072438|NCT01682811|76187741|FG004|Treated 24 Hours|Part 1 Levulan Paint Twice Microneedling||0||0
60072439|NCT01682811|76187742|FG005|Treated 24 Hours|Part 1 Levulan Paint Twice Microneedling||0||0
60072440|NCT01682811|76187743|FG006|Treated 24 Hours|Part 1 Levulan Paint Twice Microneedling||0||0
60072441|NCT01682811|76187737|FG000|COMPLETED|Part 1 Levulan Paint Twice Microneedling||0||0
60072442|NCT01682811|76187738|FG001|COMPLETED|Part 1 Levulan Paint Twice Microneedling||0||0
60072443|NCT01682811|76187739|FG002|COMPLETED|Part 1 Levulan Paint Twice Microneedling||0||0
60072444|NCT01682811|76187740|FG003|COMPLETED|Part 1 Levulan Paint Twice Microneedling||2||12
59521289|NCT01139515|75615548|FG000|STARTED|Washout Period I (46hrs)||4||
59521290|NCT01139515|75615549|FG001|STARTED|Washout Period I (46hrs)||4||
59521291|NCT01139515|75615550|FG002|STARTED|Washout Period I (46hrs)||4||
59521292|NCT01139515|75615551|FG003|STARTED|Washout Period I (46hrs)||4||
59521293|NCT01139515|75615548|FG000|COMPLETED|Washout Period I (46hrs)||4||
59521294|NCT01139515|75615549|FG001|COMPLETED|Washout Period I (46hrs)||4||
59521295|NCT01139515|75615550|FG002|COMPLETED|Washout Period I (46hrs)||4||
59521296|NCT01139515|75615551|FG003|COMPLETED|Washout Period I (46hrs)||4||
59521297|NCT01139515|75615548|FG000|NOT COMPLETED|Washout Period I (46hrs)||0||
59766895|NCT00463567|75887016|FG006|COMPLETED|Overall Study||112||
59766896|NCT00463567|75887010|FG000|NOT COMPLETED|Overall Study||95||
59766897|NCT00463567|75887011|FG001|NOT COMPLETED|Overall Study||77||
59766898|NCT00463567|75887012|FG002|NOT COMPLETED|Overall Study||89||
59766899|NCT00463567|75887013|FG003|NOT COMPLETED|Overall Study||131||
59766900|NCT00463567|75887014|FG004|NOT COMPLETED|Overall Study||23||
59766901|NCT00463567|75887015|FG005|NOT COMPLETED|Overall Study||21||
59766902|NCT00463567|75887016|FG006|NOT COMPLETED|Overall Study||11||
59766903|NCT00484159|75887041|FG000|STARTED|Overall Study||50||
59766904|NCT00484159|75887042|FG001|STARTED|Overall Study||50||
59766905|NCT00484159|75887043|FG002|STARTED|Overall Study||51||
59766906|NCT00484159|75887041|FG000|COMPLETED|Overall Study||49||
59766907|NCT00484159|75887042|FG001|COMPLETED|Overall Study||49||
59766908|NCT00484159|75887043|FG002|COMPLETED|Overall Study||51||
60072445|NCT01682811|76187741|FG004|COMPLETED|Part 1 Levulan Paint Twice Microneedling||0||0
60072446|NCT01682811|76187742|FG005|COMPLETED|Part 1 Levulan Paint Twice Microneedling||0||0
60072447|NCT01682811|76187743|FG006|COMPLETED|Part 1 Levulan Paint Twice Microneedling||0||0
60072448|NCT01682811|76187737|FG000|NOT COMPLETED|Part 1 Levulan Paint Twice Microneedling||0||0
60072449|NCT01682811|76187738|FG001|NOT COMPLETED|Part 1 Levulan Paint Twice Microneedling||0||0
60072450|NCT01682811|76187739|FG002|NOT COMPLETED|Part 1 Levulan Paint Twice Microneedling||0||0
60072451|NCT01682811|76187740|FG003|NOT COMPLETED|Part 1 Levulan Paint Twice Microneedling||0||0
60072452|NCT01682811|76187741|FG004|NOT COMPLETED|Part 1 Levulan Paint Twice Microneedling||0||0
60072453|NCT01682811|76187742|FG005|NOT COMPLETED|Part 1 Levulan Paint Twice Microneedling||0||0
60072454|NCT01682811|76187743|FG006|NOT COMPLETED|Part 1 Levulan Paint Twice Microneedling||0||0
60072455|NCT01682811|76187737|FG000|STARTED|Part 2 Dose Level 1||0||0
60072456|NCT01682811|76187738|FG001|STARTED|Part 2 Dose Level 1||0||0
59521298|NCT01139515|75615549|FG001|NOT COMPLETED|Washout Period I (46hrs)||0||
59521299|NCT01139515|75615550|FG002|NOT COMPLETED|Washout Period I (46hrs)||0||
59521300|NCT01139515|75615551|FG003|NOT COMPLETED|Washout Period I (46hrs)||0||
59521301|NCT01139515|75615548|FG000|STARTED|Second Intervention Period||4||
59521302|NCT01139515|75615549|FG001|STARTED|Second Intervention Period||4||
59521303|NCT01139515|75615550|FG002|STARTED|Second Intervention Period||4||
59521304|NCT01139515|75615551|FG003|STARTED|Second Intervention Period||4||
59521305|NCT01139515|75615548|FG000|COMPLETED|Second Intervention Period||4||
59521306|NCT01139515|75615549|FG001|COMPLETED|Second Intervention Period||4||
59521307|NCT01139515|75615550|FG002|COMPLETED|Second Intervention Period||4||
59766909|NCT00484159|75887041|FG000|NOT COMPLETED|Overall Study||1||
59766910|NCT00484159|75887042|FG001|NOT COMPLETED|Overall Study||1||
59766911|NCT00484159|75887043|FG002|NOT COMPLETED|Overall Study||0||
59766912|NCT00462865|75887051|FG000|STARTED|Overall Study|18 pts enrolled,1 pt experienced a SAE infection normal ANC (gr 3) and did not begin study,see SAE|18||
59766913|NCT00462865|75887051|FG000|COMPLETED|Overall Study||17||
59766914|NCT00462865|75887051|FG000|NOT COMPLETED|Overall Study||1||
59766915|NCT03839641|75887057|FG000|STARTED|Overall Study||5||
59766916|NCT03839641|75887058|FG001|STARTED|Overall Study||5||
59766917|NCT03839641|75887057|FG000|COMPLETED|Overall Study||4||
59766918|NCT03839641|75887058|FG001|COMPLETED|Overall Study||4||
59766919|NCT03839641|75887057|FG000|NOT COMPLETED|Overall Study||1||
59766920|NCT03839641|75887058|FG001|NOT COMPLETED|Overall Study||1||
59766921|NCT00462709|75887066|FG000|STARTED|Overall Study||146||
59766922|NCT00462709|75887066|FG000|COMPLETED|Overall Study||79||
59766923|NCT00462709|75887066|FG000|NOT COMPLETED|Overall Study||67||
59766924|NCT00461305|75887072|FG000|STARTED|Treatment|Enrolled|355||
59766925|NCT00461305|75887073|FG001|STARTED|Treatment|Enrolled|65||
59766926|NCT00461305|75887072|FG000|Subjects Dispensed Drugs|Treatment||350||
59766927|NCT00461305|75887073|FG001|Subjects Dispensed Drugs|Treatment||65||
59766928|NCT00461305|75887072|FG000|Subjects Received Treatment|Treatment|FAS, safety population|349||
59766929|NCT00461305|75887073|FG001|Subjects Received Treatment|Treatment|FAS, safety population|65||
59766930|NCT00461305|75887072|FG000|COMPLETED|Treatment||254||
59766931|NCT00461305|75887073|FG001|COMPLETED|Treatment||56||
59766932|NCT00461305|75887072|FG000|NOT COMPLETED|Treatment||101||
59766933|NCT00461305|75887073|FG001|NOT COMPLETED|Treatment||9||
59766934|NCT00461305|75887072|FG000|STARTED|Continued Treatment|FAS, participants from previous treatment who were available to continue treatment|349||
59766935|NCT00461305|75887073|FG001|STARTED|Continued Treatment|no participants were treated with the DRSP 3 mg/EE 30 μg combination beyond 6 cycles|0||
59766936|NCT00461305|75887072|FG000|COMPLETED|Continued Treatment||254||
59766937|NCT00461305|75887073|FG001|COMPLETED|Continued Treatment||0||
59766938|NCT00461305|75887072|FG000|NOT COMPLETED|Continued Treatment||95||
59766939|NCT00461305|75887073|FG001|NOT COMPLETED|Continued Treatment||0||
59766940|NCT00856544|75887084|FG000|STARTED|Overall Study||318||
59766941|NCT00856544|75887085|FG001|STARTED|Overall Study||318||
59766942|NCT00856544|75887086|FG002|STARTED|Overall Study||79||
59766943|NCT00856544|75887087|FG003|STARTED|Overall Study||80||
59766944|NCT00856544|75887084|FG000|Treated|Overall Study||315||
59766945|NCT00856544|75887085|FG001|Treated|Overall Study||318||
59766946|NCT00856544|75887086|FG002|Treated|Overall Study||79||
59766947|NCT00856544|75887087|FG003|Treated|Overall Study||80||
59766948|NCT00856544|75887084|FG000|COMPLETED|Overall Study||261||
59766949|NCT00856544|75887085|FG001|COMPLETED|Overall Study||252||
59766950|NCT00856544|75887086|FG002|COMPLETED|Overall Study||71||
59766951|NCT00856544|75887087|FG003|COMPLETED|Overall Study||67||
59766952|NCT00856544|75887084|FG000|NOT COMPLETED|Overall Study||57||
60072457|NCT01682811|76187739|FG002|STARTED|Part 2 Dose Level 1||0||0
60072458|NCT01682811|76187740|FG003|STARTED|Part 2 Dose Level 1||0||0
60072459|NCT01682811|76187741|FG004|STARTED|Part 2 Dose Level 1||11||60
59766953|NCT00856544|75887085|FG001|NOT COMPLETED|Overall Study||66||
59766954|NCT00856544|75887086|FG002|NOT COMPLETED|Overall Study||8||
59766955|NCT00856544|75887087|FG003|NOT COMPLETED|Overall Study||13||
59766956|NCT00856388|75887109|FG000|STARTED|Overall Study||62||
59766957|NCT00856388|75887109|FG000|COMPLETED|Overall Study||61||
59766958|NCT00856388|75887109|FG000|NOT COMPLETED|Overall Study||1||
59766959|NCT00848354|75887116|FG000|STARTED|Phase 1|One participant was randomized to the Etanercept + Methotrexate group but received SSZ in error.|281||
59766960|NCT00848354|75887117|FG001|STARTED|Phase 1||143||
59766961|NCT00848354|75887116|FG000|COMPLETED|Phase 1||269||
59766962|NCT00848354|75887117|FG001|COMPLETED|Phase 1||129||
59766963|NCT00848354|75887116|FG000|NOT COMPLETED|Phase 1||12||
59766964|NCT00848354|75887117|FG001|NOT COMPLETED|Phase 1||14||
59766965|NCT00848354|75887116|FG000|STARTED|Phase 2 Year 1|Randomized Phase 1 treatment assignment. 9 participants discontinued between Phase 1 and Phase 2.|260||
59766966|NCT00848354|75887117|FG001|STARTED|Phase 2 Year 1|Randomized Phase 1 treatment assignment. 3 participants discontinued between Phase 1 and Phase 2.|126||
59766967|NCT00848354|75887116|FG000|COMPLETED|Phase 2 Year 1||242||
59766968|NCT00848354|75887117|FG001|COMPLETED|Phase 2 Year 1||120||
59766969|NCT00848354|75887116|FG000|NOT COMPLETED|Phase 2 Year 1||18||
59766970|NCT00848354|75887117|FG001|NOT COMPLETED|Phase 2 Year 1||6||
59766971|NCT00848354|75887116|FG000|STARTED|Phase 2 Year 2|"Randomized Phase 1 treatment assignment.~1 participant discontinued between Year 1 and Year 2."|241||
59766972|NCT00848354|75887117|FG001|STARTED|Phase 2 Year 2|Randomized Phase 1 treatment assignment.|120||
59766973|NCT00848354|75887116|FG000|COMPLETED|Phase 2 Year 2||218||
59766974|NCT00848354|75887117|FG001|COMPLETED|Phase 2 Year 2||113||
60072460|NCT01682811|76187742|FG005|STARTED|Part 2 Dose Level 1||0||0
60072461|NCT01682811|76187743|FG006|STARTED|Part 2 Dose Level 1||0||0
60072462|NCT01682811|76187737|FG000|Control|Part 2 Dose Level 1||0||0
59766975|NCT00848354|75887116|FG000|NOT COMPLETED|Phase 2 Year 2||23||
59766976|NCT00848354|75887117|FG001|NOT COMPLETED|Phase 2 Year 2||7||
60072463|NCT01682811|76187738|FG001|Control|Part 2 Dose Level 1||0||0
59766977|NCT00848198|75887127|FG000|STARTED|Overall Study||314||
60072464|NCT01682811|76187739|FG002|Control|Part 2 Dose Level 1||0||0
60072465|NCT01682811|76187740|FG003|Control|Part 2 Dose Level 1||0||0
60072466|NCT01682811|76187741|FG004|Control|Part 2 Dose Level 1||10||30
59618002|NCT03900624|75729200|FG001|NOT COMPLETED|Overall Study||0||
59618003|NCT03192462|75729211|FG000|STARTED|Overall Study||13||
59618004|NCT03192462|75729212|FG001|STARTED|Overall Study||12||
59618005|NCT03192462|75729213|FG002|STARTED|Overall Study||12||
59618006|NCT03192462|75729211|FG000|COMPLETED|Overall Study||0||
59618007|NCT03192462|75729212|FG001|COMPLETED|Overall Study||0||
60072467|NCT01682811|76187742|FG005|Control|Part 2 Dose Level 1||0||0
60072468|NCT01682811|76187743|FG006|Control|Part 2 Dose Level 1||0||0
60072469|NCT01682811|76187737|FG000|Treated|Part 2 Dose Level 1||0||0
60072470|NCT01682811|76187738|FG001|Treated|Part 2 Dose Level 1||0||0
60072471|NCT01682811|76187739|FG002|Treated|Part 2 Dose Level 1||0||0
60072472|NCT01682811|76187740|FG003|Treated|Part 2 Dose Level 1||0||0
60072473|NCT01682811|76187741|FG004|Treated|Part 2 Dose Level 1||10||30
60072474|NCT01682811|76187742|FG005|Treated|Part 2 Dose Level 1||0||0
60072475|NCT01682811|76187743|FG006|Treated|Part 2 Dose Level 1||0||0
60072476|NCT01682811|76187737|FG000|COMPLETED|Part 2 Dose Level 1||0||0
60072477|NCT01682811|76187738|FG001|COMPLETED|Part 2 Dose Level 1||0||0
60072478|NCT01682811|76187739|FG002|COMPLETED|Part 2 Dose Level 1||0||0
60072479|NCT01682811|76187740|FG003|COMPLETED|Part 2 Dose Level 1||0||0
60072480|NCT01682811|76187741|FG004|COMPLETED|Part 2 Dose Level 1||0||0
60072481|NCT01682811|76187742|FG005|COMPLETED|Part 2 Dose Level 1||0||0
60072482|NCT01682811|76187743|FG006|COMPLETED|Part 2 Dose Level 1||0||0
60072483|NCT01682811|76187737|FG000|NOT COMPLETED|Part 2 Dose Level 1||0||0
60072484|NCT01682811|76187738|FG001|NOT COMPLETED|Part 2 Dose Level 1||0||0
60072485|NCT01682811|76187739|FG002|NOT COMPLETED|Part 2 Dose Level 1||0||0
60072486|NCT01682811|76187740|FG003|NOT COMPLETED|Part 2 Dose Level 1||0||0
60072487|NCT01682811|76187741|FG004|NOT COMPLETED|Part 2 Dose Level 1||11||60
60072488|NCT01682811|76187742|FG005|NOT COMPLETED|Part 2 Dose Level 1||0||0
60072489|NCT01682811|76187743|FG006|NOT COMPLETED|Part 2 Dose Level 1||0||0
60072490|NCT01682811|76187737|FG000|STARTED|Part 2 Dose Level 2||0||0
60072491|NCT01682811|76187738|FG001|STARTED|Part 2 Dose Level 2||0||0
60072492|NCT01682811|76187739|FG002|STARTED|Part 2 Dose Level 2||0||0
60072493|NCT01682811|76187740|FG003|STARTED|Part 2 Dose Level 2||0||0
60072494|NCT01682811|76187741|FG004|STARTED|Part 2 Dose Level 2||0||0
60072495|NCT01682811|76187742|FG005|STARTED|Part 2 Dose Level 2||3||18
60072496|NCT01682811|76187743|FG006|STARTED|Part 2 Dose Level 2||0||0
60072497|NCT01682811|76187737|FG000|Control|Part 2 Dose Level 2||0||0
60072498|NCT01682811|76187738|FG001|Control|Part 2 Dose Level 2||0||0
60072499|NCT01682811|76187739|FG002|Control|Part 2 Dose Level 2||0||0
60072500|NCT01682811|76187740|FG003|Control|Part 2 Dose Level 2||0||0
60072501|NCT01682811|76187741|FG004|Control|Part 2 Dose Level 2||0||0
60072502|NCT01682811|76187742|FG005|Control|Part 2 Dose Level 2||3||9
60072503|NCT01682811|76187743|FG006|Control|Part 2 Dose Level 2||0||0
60072504|NCT01682811|76187737|FG000|Treated|Part 2 Dose Level 2||0||0
60072505|NCT01682811|76187738|FG001|Treated|Part 2 Dose Level 2||0||0
60072506|NCT01682811|76187739|FG002|Treated|Part 2 Dose Level 2||0||0
60072507|NCT01682811|76187740|FG003|Treated|Part 2 Dose Level 2||0||0
60072508|NCT01682811|76187741|FG004|Treated|Part 2 Dose Level 2||0||0
60072509|NCT01682811|76187742|FG005|Treated|Part 2 Dose Level 2||3||9
60072510|NCT01682811|76187743|FG006|Treated|Part 2 Dose Level 2||0||0
60072511|NCT01682811|76187737|FG000|COMPLETED|Part 2 Dose Level 2||0||0
60072512|NCT01682811|76187738|FG001|COMPLETED|Part 2 Dose Level 2||0||0
60072513|NCT01682811|76187739|FG002|COMPLETED|Part 2 Dose Level 2||0||0
60072514|NCT01682811|76187740|FG003|COMPLETED|Part 2 Dose Level 2||0||0
60072515|NCT01682811|76187741|FG004|COMPLETED|Part 2 Dose Level 2||0||0
60072516|NCT01682811|76187742|FG005|COMPLETED|Part 2 Dose Level 2||0||0
60072517|NCT01682811|76187743|FG006|COMPLETED|Part 2 Dose Level 2||0||0
60072518|NCT01682811|76187737|FG000|NOT COMPLETED|Part 2 Dose Level 2||0||0
60072519|NCT01682811|76187738|FG001|NOT COMPLETED|Part 2 Dose Level 2||0||0
60072520|NCT01682811|76187739|FG002|NOT COMPLETED|Part 2 Dose Level 2||0||0
60072521|NCT01682811|76187740|FG003|NOT COMPLETED|Part 2 Dose Level 2||0||0
60072522|NCT01682811|76187741|FG004|NOT COMPLETED|Part 2 Dose Level 2||0||0
60072523|NCT01682811|76187742|FG005|NOT COMPLETED|Part 2 Dose Level 2||3||18
60072524|NCT01682811|76187743|FG006|NOT COMPLETED|Part 2 Dose Level 2||0||0
60072525|NCT01682811|76187737|FG000|STARTED|Part 2 Dose Level 3||0||0
60072526|NCT01682811|76187738|FG001|STARTED|Part 2 Dose Level 3||0||0
60072527|NCT01682811|76187739|FG002|STARTED|Part 2 Dose Level 3||0||0
60072528|NCT01682811|76187740|FG003|STARTED|Part 2 Dose Level 3||0||0
60072529|NCT01682811|76187741|FG004|STARTED|Part 2 Dose Level 3||0||0
60072530|NCT01682811|76187742|FG005|STARTED|Part 2 Dose Level 3||0||0
60072531|NCT01682811|76187743|FG006|STARTED|Part 2 Dose Level 3||0||0
60072532|NCT01682811|76187737|FG000|Control|Part 2 Dose Level 3||0||0
60072533|NCT01682811|76187738|FG001|Control|Part 2 Dose Level 3||0||0
60072534|NCT01682811|76187739|FG002|Control|Part 2 Dose Level 3||0||0
60072535|NCT01682811|76187740|FG003|Control|Part 2 Dose Level 3||0||0
59618008|NCT03192462|75729213|FG002|COMPLETED|Overall Study||0||
59618009|NCT03192462|75729211|FG000|NOT COMPLETED|Overall Study||13||
59618010|NCT03192462|75729212|FG001|NOT COMPLETED|Overall Study||12||
60072536|NCT01682811|76187741|FG004|Control|Part 2 Dose Level 3||0||0
59766978|NCT00848198|75887127|FG000|COMPLETED|Overall Study||299||
59766979|NCT00848198|75887127|FG000|NOT COMPLETED|Overall Study||15||
59766980|NCT00848120|75887135|FG000|STARTED|Overall Study||29||
59766981|NCT00848120|75887135|FG000|COMPLETED|Overall Study||28||
59766982|NCT00848120|75887135|FG000|NOT COMPLETED|Overall Study||1||
59766983|NCT00600821|75887141|FG000|STARTED|Overall Study||58||
59766984|NCT00600821|75887142|FG001|STARTED|Overall Study||60||
59766985|NCT00600821|75887141|FG000|Treated|Overall Study||58||
59766986|NCT00600821|75887142|FG001|Treated|Overall Study||59||
59766987|NCT00600821|75887141|FG000|COMPLETED|Overall Study||0||
59766988|NCT00600821|75887142|FG001|COMPLETED|Overall Study||0||
59766989|NCT00600821|75887141|FG000|NOT COMPLETED|Overall Study||58||
59766990|NCT00600821|75887142|FG001|NOT COMPLETED|Overall Study||60||
59766991|NCT00592904|75887154|FG000|STARTED|Overall Study||57||
59766992|NCT00592904|75887155|FG001|STARTED|Overall Study||148||
59766993|NCT00592904|75887156|FG002|STARTED|Overall Study||27||
59766994|NCT00592904|75887157|FG003|STARTED|Overall Study||30||
59766995|NCT00592904|75887154|FG000|COMPLETED|Overall Study||32||
59766996|NCT00592904|75887155|FG001|COMPLETED|Overall Study||93||
59766997|NCT00592904|75887156|FG002|COMPLETED|Overall Study||10||
59766998|NCT00592904|75887157|FG003|COMPLETED|Overall Study||19||
59766999|NCT00592904|75887154|FG000|NOT COMPLETED|Overall Study||25||
59767000|NCT00592904|75887155|FG001|NOT COMPLETED|Overall Study||55||
59767001|NCT00592904|75887156|FG002|NOT COMPLETED|Overall Study||17||
59767002|NCT00592904|75887157|FG003|NOT COMPLETED|Overall Study||11||
59767003|NCT00855920|75887170|FG000|STARTED|Overall Study||76||
59767004|NCT00855920|75887171|FG001|STARTED|Overall Study||74||
59767005|NCT00855920|75887172|FG002|STARTED|Overall Study||75||
59767006|NCT00855920|75887170|FG000|Safety Population|Overall Study|1 participant from Rilonacept+Indomethacin arm received Placebo (for Rilonacept)+Indomethacin|77||
59767007|NCT00855920|75887171|FG001|Safety Population|Overall Study|1 participant from Rilonacept+Indomethacin arm received Placebo (for Rilonacept)+Indomethacin|73||
59767008|NCT00855920|75887172|FG002|Safety Population|Overall Study||75||
59767009|NCT00855920|75887170|FG000|COMPLETED|Overall Study||68||
59767010|NCT00855920|75887171|FG001|COMPLETED|Overall Study||65||
59767011|NCT00855920|75887172|FG002|COMPLETED|Overall Study||64||
59767012|NCT00855920|75887170|FG000|NOT COMPLETED|Overall Study||8||
59767013|NCT00855920|75887171|FG001|NOT COMPLETED|Overall Study||9||
59767014|NCT00855920|75887172|FG002|NOT COMPLETED|Overall Study||11||
59767015|NCT00848042|75887183|FG000|STARTED|Overall Study||5||
59767016|NCT00848042|75887184|FG001|STARTED|Overall Study||5||
59767017|NCT00848042|75887185|FG002|STARTED|Overall Study||1||
59767018|NCT00848042|75887183|FG000|Day 1|Overall Study||5||
59767019|NCT00848042|75887184|FG001|Day 1|Overall Study||5||
59767020|NCT00848042|75887185|FG002|Day 1|Overall Study||1||
59767021|NCT00848042|75887183|FG000|Day 2|Overall Study||5||
59767022|NCT00848042|75887184|FG001|Day 2|Overall Study||5||
59767023|NCT00848042|75887185|FG002|Day 2|Overall Study||1||
59767024|NCT00848042|75887183|FG000|Day 3|Overall Study||5||
59767025|NCT00848042|75887184|FG001|Day 3|Overall Study||5||
59767026|NCT00848042|75887185|FG002|Day 3|Overall Study||1||
59767027|NCT00848042|75887183|FG000|Day 8|Overall Study||5||
59767028|NCT00848042|75887184|FG001|Day 8|Overall Study||5||
59767029|NCT00848042|75887185|FG002|Day 8|Overall Study||1||
59767030|NCT00848042|75887183|FG000|Day 15|Overall Study||4||
59767031|NCT00848042|75887184|FG001|Day 15|Overall Study||5||
59767032|NCT00848042|75887185|FG002|Day 15|Overall Study||1||
59767033|NCT00848042|75887183|FG000|Month 1|Overall Study||4||
59767034|NCT00848042|75887184|FG001|Month 1|Overall Study||5||
59767035|NCT00848042|75887185|FG002|Month 1|Overall Study||1||
59767036|NCT00848042|75887183|FG000|Month 2|Overall Study||1||
59767037|NCT00848042|75887184|FG001|Month 2|Overall Study||5||
59767038|NCT00848042|75887185|FG002|Month 2|Overall Study||1||
59952109|NCT00834132|76070993|FG001|COMPLETED|Second Intervention||12||
59952110|NCT00834132|76070992|FG000|NOT COMPLETED|Second Intervention||0||
60072537|NCT01682811|76187742|FG005|Control|Part 2 Dose Level 3||0||0
59767039|NCT00848042|75887183|FG000|Month 3|Overall Study||1||
59767040|NCT00848042|75887184|FG001|Month 3|Overall Study||4||
59767041|NCT00848042|75887185|FG002|Month 3|Overall Study||1||
59767042|NCT00848042|75887183|FG000|Month 4|Overall Study||1||
59952111|NCT00834132|76070993|FG001|NOT COMPLETED|Second Intervention||0||
59952112|NCT00833586|76070999|FG000|STARTED|First Intervention||14||
59767043|NCT00848042|75887184|FG001|Month 4|Overall Study||4||
59767044|NCT00848042|75887185|FG002|Month 4|Overall Study||1||
59767045|NCT00848042|75887183|FG000|Month 5|Overall Study||1||
59767046|NCT00848042|75887184|FG001|Month 5|Overall Study||3||
59767047|NCT00848042|75887185|FG002|Month 5|Overall Study||1||
59767048|NCT00848042|75887183|FG000|Month 6|Overall Study||1||
59767049|NCT00848042|75887184|FG001|Month 6|Overall Study||3||
59767050|NCT00848042|75887185|FG002|Month 6|Overall Study||1||
59767051|NCT00848042|75887183|FG000|COMPLETED|Overall Study||1||
59767052|NCT00848042|75887184|FG001|COMPLETED|Overall Study||3||
59767053|NCT00848042|75887185|FG002|COMPLETED|Overall Study||1||
59767054|NCT00848042|75887183|FG000|NOT COMPLETED|Overall Study||4||
59767055|NCT00848042|75887184|FG001|NOT COMPLETED|Overall Study||2||
59767056|NCT00848042|75887185|FG002|NOT COMPLETED|Overall Study||0||
59767057|NCT00847886|75887195|FG000|STARTED|Overall Study||12||
59767058|NCT00847886|75887196|FG001|STARTED|Overall Study||4||
59767059|NCT00847886|75887195|FG000|COMPLETED|Overall Study||12||
59767060|NCT00847886|75887196|FG001|COMPLETED|Overall Study||3||
59767061|NCT00847886|75887195|FG000|NOT COMPLETED|Overall Study||0||
59767062|NCT00847886|75887196|FG001|NOT COMPLETED|Overall Study||1||
59767063|NCT00847808|75887202|FG000|STARTED|Overall Study||178||
59767064|NCT00847808|75887202|FG000|COMPLETED|Overall Study||163||
59767065|NCT00847808|75887202|FG000|NOT COMPLETED|Overall Study||15||
59767066|NCT00600353|75887208|FG000|STARTED|Overall Study||10||
59767067|NCT00600353|75887209|FG001|STARTED|Overall Study||10||
59767068|NCT00600353|75887208|FG000|COMPLETED|Overall Study||9||
59767069|NCT00600353|75887209|FG001|COMPLETED|Overall Study||9||
59767070|NCT00600353|75887208|FG000|NOT COMPLETED|Overall Study||1||
59767071|NCT00600353|75887209|FG001|NOT COMPLETED|Overall Study||1||
59767072|NCT00691210|75887223|FG000|STARTED|Overall Study||3||
59767073|NCT00691210|75887224|FG001|STARTED|Overall Study||5||
59767074|NCT00691210|75887225|FG002|STARTED|Overall Study||3||
59767075|NCT00691210|75887226|FG003|STARTED|Overall Study||9||
59767076|NCT00691210|75887227|FG004|STARTED|Overall Study||5||
59767077|NCT00691210|75887228|FG005|STARTED|Overall Study||7||
59767078|NCT00691210|75887229|FG006|STARTED|Overall Study||6||
59767079|NCT00691210|75887230|FG007|STARTED|Overall Study||0||
59767080|NCT00691210|75887223|FG000|COMPLETED|Overall Study||3||
59767081|NCT00691210|75887224|FG001|COMPLETED|Overall Study||5||
59767082|NCT00691210|75887225|FG002|COMPLETED|Overall Study||3||
59767083|NCT00691210|75887226|FG003|COMPLETED|Overall Study||6||
59767084|NCT00691210|75887227|FG004|COMPLETED|Overall Study||5||
59767085|NCT00691210|75887228|FG005|COMPLETED|Overall Study||6||
59767086|NCT00691210|75887229|FG006|COMPLETED|Overall Study||6||
59767087|NCT00691210|75887230|FG007|COMPLETED|Overall Study||0||
59767088|NCT00691210|75887223|FG000|NOT COMPLETED|Overall Study||0||
59767089|NCT00691210|75887224|FG001|NOT COMPLETED|Overall Study||0||
59767090|NCT00691210|75887225|FG002|NOT COMPLETED|Overall Study||0||
59767091|NCT00691210|75887226|FG003|NOT COMPLETED|Overall Study||3||
59767092|NCT00691210|75887227|FG004|NOT COMPLETED|Overall Study||0||
59767093|NCT00691210|75887228|FG005|NOT COMPLETED|Overall Study||1||
59767094|NCT00691210|75887229|FG006|NOT COMPLETED|Overall Study||0||
59767095|NCT00691210|75887230|FG007|NOT COMPLETED|Overall Study||0||
59767096|NCT00691132|75887250|FG000|STARTED|Overall Study||53||
59767097|NCT00691132|75887251|FG001|STARTED|Overall Study|107 total randomized. Approximately 1/2 per arm.|54||
59767098|NCT00691132|75887250|FG000|COMPLETED|Overall Study||41||
59767099|NCT00691132|75887251|FG001|COMPLETED|Overall Study|45 completed, but 4 excluded b/c urinary measures indicated they did not smoke study cigarettes.|41||
59767100|NCT00691132|75887250|FG000|NOT COMPLETED|Overall Study||12||
59767101|NCT00691132|75887251|FG001|NOT COMPLETED|Overall Study||13||
59767102|NCT04262219|75887267|FG000|STARTED|Overall Study||32||
59767103|NCT04262219|75887267|FG000|COMPLETED|Overall Study||30||
59767104|NCT04262219|75887267|FG000|NOT COMPLETED|Overall Study||2||
59767105|NCT00855218|75887273|FG000|STARTED|Overall Study||154||
59767106|NCT00855218|75887274|FG001|STARTED|Overall Study||153||
59767107|NCT00855218|75887273|FG000|Participants Received Treatment|Overall Study||153||
59767108|NCT00855218|75887274|FG001|Participants Received Treatment|Overall Study||151||
59767109|NCT00855218|75887273|FG000|COMPLETED|Overall Study||0||
59767110|NCT00855218|75887274|FG001|COMPLETED|Overall Study||0||
59767111|NCT00855218|75887273|FG000|NOT COMPLETED|Overall Study||154||
59767112|NCT00855218|75887274|FG001|NOT COMPLETED|Overall Study||153||
59767113|NCT01063348|75887282|FG000|STARTED|Overall Study||35||
59767114|NCT01063348|75887283|FG001|STARTED|Overall Study||31||
59767115|NCT01063348|75887282|FG000|COMPLETED|Overall Study||32||
59767116|NCT01063348|75887283|FG001|COMPLETED|Overall Study||21||
59767117|NCT01063348|75887282|FG000|NOT COMPLETED|Overall Study||3||
59767118|NCT01063348|75887283|FG001|NOT COMPLETED|Overall Study||10||
59767119|NCT00855062|75887291|FG000|STARTED|Step1||36||
59767120|NCT00855062|75887292|FG001|STARTED|Step1||37||
59952113|NCT00833586|76071000|FG001|STARTED|First Intervention||14||
59952114|NCT00833586|76070999|FG000|COMPLETED|First Intervention||14||
59767121|NCT00855062|75887291|FG000|COMPLETED|Step1||26||
59767122|NCT00855062|75887292|FG001|COMPLETED|Step1||26||
59767123|NCT00855062|75887291|FG000|NOT COMPLETED|Step1||10||
59767124|NCT00855062|75887292|FG001|NOT COMPLETED|Step1||11||
59767125|NCT00855062|75887291|FG000|STARTED|Step2|26 participants completed STEP1; however, only 19 out of the 26 decided to enroll in STEP2.|19||
59767126|NCT00855062|75887292|FG001|STARTED|Step2|26 participants completed STEP1; however, only 21 out of the 26 decided to enroll in STEP2.|21||
59767127|NCT00855062|75887291|FG000|COMPLETED|Step2||13||
59767128|NCT00855062|75887292|FG001|COMPLETED|Step2||15||
59767129|NCT00855062|75887291|FG000|NOT COMPLETED|Step2||6||
59767130|NCT00855062|75887292|FG001|NOT COMPLETED|Step2||6||
59817847|NCT04488770|75940338|FG012|STARTED|Part 1-Cohort 1: Period 4 (Up to 5 Days)||0||
59767131|NCT00854906|75887298|FG000|STARTED|Overall Study|There were 26 participants whose eyes were measured in the KTBUT group.|26||
59767132|NCT00854906|75887298|FG000|COMPLETED|Overall Study|There were 26 participants in this group. One person was excluded be causes of no ocular history.|25||
59767133|NCT00854906|75887298|FG000|NOT COMPLETED|Overall Study||1||
59767134|NCT00854828|75887309|FG000|STARTED|Overall Study|6 patients crossed over to non-operative intervention.|30|Baseline enrollment data collected and completed intervention.|
59767135|NCT00854828|75887310|FG001|STARTED|Overall Study||33|Baseline enrollment data collected and completed intervention.|
59767136|NCT00854828|75887311|FG002|STARTED|Overall Study||112|Baseline enrollment data collected and completed intervention.|
59767137|NCT00854828|75887312|FG003|STARTED|Overall Study||111|Baseline enrollment data collected and completed intervention.|
59767138|NCT00854828|75887309|FG000|3 Months Post Intervention|Overall Study|6 missed visits|24||
59767139|NCT00854828|75887310|FG001|3 Months Post Intervention|Overall Study|1 missed visit|32||
59767140|NCT00854828|75887311|FG002|3 Months Post Intervention|Overall Study|112 (100%) of patients underwent operative treatment.|112||
59767141|NCT00854828|75887312|FG003|3 Months Post Intervention|Overall Study|2 missed visits. 3 withdrew.|106||
59767142|NCT00854828|75887309|FG000|12 Months Post Intervention|Overall Study|"2 missed visits.~1 withdrew.~1 deceased."|26||
59767143|NCT00854828|75887310|FG001|12 Months Post Intervention|Overall Study|1 withdrew. 15 (45%) crossed over to operative treatment.|32||
59767144|NCT00854828|75887311|FG002|12 Months Post Intervention|Overall Study||112||
59767145|NCT00854828|75887312|FG003|12 Months Post Intervention|Overall Study|4 missed visits. 6 withdrew. 6 (5%) crossed over to operative treatment.|101||
59767146|NCT00854828|75887309|FG000|24 Months Post Intervention|Overall Study|"1 missed visit.~1 withdrew.~1 deceased. 24 patients (80%) underwent surgery."|27||
59767147|NCT00854828|75887310|FG001|24 Months Post Intervention|Overall Study|"1 missed visit.~1 withdrew. 21 (64%) crossed over to operative treatment."|31||
59767148|NCT00854828|75887311|FG002|24 Months Post Intervention|Overall Study|8 missed visits.|104||
59767149|NCT00854828|75887312|FG003|24 Months Post Intervention|Overall Study|8 missed visits. 9 withdrew. 14 (13%) crossed over to operative treatment.|94||
59767150|NCT00854828|75887309|FG000|COMPLETED|Overall Study||27||
59767151|NCT00854828|75887310|FG001|COMPLETED|Overall Study||31||
59767152|NCT00854828|75887311|FG002|COMPLETED|Overall Study||104||
59767153|NCT00854828|75887312|FG003|COMPLETED|Overall Study||94||
59767154|NCT00854828|75887309|FG000|NOT COMPLETED|Overall Study||3||
59767155|NCT00854828|75887310|FG001|NOT COMPLETED|Overall Study||2||
59767156|NCT00854828|75887311|FG002|NOT COMPLETED|Overall Study||8||
59767157|NCT00854828|75887312|FG003|NOT COMPLETED|Overall Study||17||
59767158|NCT00847730|75887322|FG000|STARTED|Overall Study||33||
59767159|NCT00847730|75887322|FG000|COMPLETED|Overall Study||25||
59767160|NCT00847730|75887322|FG000|NOT COMPLETED|Overall Study||8||
59767161|NCT00600119|75887332|FG000|STARTED|Single-blind Placebo run-in Period||36||
59767162|NCT00600119|75887333|FG001|STARTED|Single-blind Placebo run-in Period||35||
59767163|NCT00600119|75887334|FG002|STARTED|Single-blind Placebo run-in Period||29||
59767164|NCT00600119|75887335|FG003|STARTED|Single-blind Placebo run-in Period||31||
59767165|NCT00600119|75887336|FG004|STARTED|Single-blind Placebo run-in Period||39||
59767166|NCT00600119|75887337|FG005|STARTED|Single-blind Placebo run-in Period||37||
59767167|NCT00600119|75887332|FG000|COMPLETED|Single-blind Placebo run-in Period||32||
59767168|NCT00600119|75887333|FG001|COMPLETED|Single-blind Placebo run-in Period||33||
59767169|NCT00600119|75887334|FG002|COMPLETED|Single-blind Placebo run-in Period||27||
59767170|NCT00600119|75887335|FG003|COMPLETED|Single-blind Placebo run-in Period||30||
59767171|NCT00600119|75887336|FG004|COMPLETED|Single-blind Placebo run-in Period||37||
59767172|NCT00600119|75887337|FG005|COMPLETED|Single-blind Placebo run-in Period||35||
59767173|NCT00600119|75887332|FG000|NOT COMPLETED|Single-blind Placebo run-in Period||4||
59767174|NCT00600119|75887333|FG001|NOT COMPLETED|Single-blind Placebo run-in Period||2||
59767175|NCT00600119|75887334|FG002|NOT COMPLETED|Single-blind Placebo run-in Period||2||
59767176|NCT00600119|75887335|FG003|NOT COMPLETED|Single-blind Placebo run-in Period||1||
59767177|NCT00600119|75887336|FG004|NOT COMPLETED|Single-blind Placebo run-in Period||2||
59767178|NCT00600119|75887337|FG005|NOT COMPLETED|Single-blind Placebo run-in Period||2||
59767179|NCT00600119|75887332|FG000|STARTED|Double-blind Treatment Period||32||
59767180|NCT00600119|75887333|FG001|STARTED|Double-blind Treatment Period||33||
59767181|NCT00600119|75887334|FG002|STARTED|Double-blind Treatment Period||27||
59767182|NCT00600119|75887335|FG003|STARTED|Double-blind Treatment Period||30||
59767183|NCT00600119|75887336|FG004|STARTED|Double-blind Treatment Period||37||
59767184|NCT00600119|75887337|FG005|STARTED|Double-blind Treatment Period||35||
59952115|NCT00833586|76071000|FG001|COMPLETED|First Intervention||14||
59767185|NCT00600119|75887332|FG000|COMPLETED|Double-blind Treatment Period||27||
59767186|NCT00600119|75887333|FG001|COMPLETED|Double-blind Treatment Period||28||
59767187|NCT00600119|75887334|FG002|COMPLETED|Double-blind Treatment Period||27||
59767188|NCT00600119|75887335|FG003|COMPLETED|Double-blind Treatment Period||28||
59767189|NCT00600119|75887336|FG004|COMPLETED|Double-blind Treatment Period||31||
59767190|NCT00600119|75887337|FG005|COMPLETED|Double-blind Treatment Period||21||
59767191|NCT00600119|75887332|FG000|NOT COMPLETED|Double-blind Treatment Period||5||
59767192|NCT00600119|75887333|FG001|NOT COMPLETED|Double-blind Treatment Period||5||
59767193|NCT00600119|75887334|FG002|NOT COMPLETED|Double-blind Treatment Period||0||
59767194|NCT00600119|75887335|FG003|NOT COMPLETED|Double-blind Treatment Period||2||
59767195|NCT00600119|75887336|FG004|NOT COMPLETED|Double-blind Treatment Period||6||
59767196|NCT00600119|75887337|FG005|NOT COMPLETED|Double-blind Treatment Period||14||
59767197|NCT00600119|75887332|FG000|STARTED|Follow-up Period||27||
59767198|NCT00600119|75887333|FG001|STARTED|Follow-up Period||28||
59767199|NCT00600119|75887334|FG002|STARTED|Follow-up Period||27||
59767200|NCT00600119|75887335|FG003|STARTED|Follow-up Period||28||
59767201|NCT00600119|75887336|FG004|STARTED|Follow-up Period||31||
59767202|NCT00600119|75887337|FG005|STARTED|Follow-up Period||21||
59767203|NCT00600119|75887332|FG000|COMPLETED|Follow-up Period||26||
59767204|NCT00600119|75887333|FG001|COMPLETED|Follow-up Period||28||
59767205|NCT00600119|75887334|FG002|COMPLETED|Follow-up Period||27||
59767206|NCT00600119|75887335|FG003|COMPLETED|Follow-up Period||28||
59767207|NCT00600119|75887336|FG004|COMPLETED|Follow-up Period||31||
59767208|NCT00600119|75887337|FG005|COMPLETED|Follow-up Period||20||
59767209|NCT00600119|75887332|FG000|NOT COMPLETED|Follow-up Period||1||
59767210|NCT00600119|75887333|FG001|NOT COMPLETED|Follow-up Period||0||
59767211|NCT00600119|75887334|FG002|NOT COMPLETED|Follow-up Period||0||
59767212|NCT00600119|75887335|FG003|NOT COMPLETED|Follow-up Period||0||
59767213|NCT00600119|75887336|FG004|NOT COMPLETED|Follow-up Period||0||
59767214|NCT00600119|75887337|FG005|NOT COMPLETED|Follow-up Period||1||
59767215|NCT00866294|75887354|FG000|STARTED|Overall Study||172||
59767216|NCT00866294|75887355|FG001|STARTED|Overall Study||161||
59767217|NCT00866294|75887356|FG002|STARTED|Overall Study||83||
59767218|NCT00866294|75887354|FG000|COMPLETED|Overall Study||139||
59767219|NCT00866294|75887355|FG001|COMPLETED|Overall Study||141||
59767220|NCT00866294|75887356|FG002|COMPLETED|Overall Study||72||
59767221|NCT00866294|75887354|FG000|NOT COMPLETED|Overall Study||33||
59767222|NCT00866294|75887355|FG001|NOT COMPLETED|Overall Study||20||
59767223|NCT00866294|75887356|FG002|NOT COMPLETED|Overall Study||11||
59767224|NCT00854360|75887376|FG000|STARTED|Overall Study||118||
59767225|NCT00854360|75887377|FG001|STARTED|Overall Study||123||
59767226|NCT00854360|75887378|FG002|STARTED|Overall Study||122||
59767227|NCT00854360|75887379|FG003|STARTED|Overall Study||124||
59767228|NCT00854360|75887376|FG000|Intent to Treat / Safety Population|Overall Study||118||
59767229|NCT00854360|75887377|FG001|Intent to Treat / Safety Population|Overall Study||123||
59767230|NCT00854360|75887378|FG002|Intent to Treat / Safety Population|Overall Study||122||
59767231|NCT00854360|75887379|FG003|Intent to Treat / Safety Population|Overall Study|One patient did not receive any double-blind study medication.|123||
59767232|NCT00854360|75887376|FG000|COMPLETED|Overall Study||116||
59767233|NCT00854360|75887377|FG001|COMPLETED|Overall Study|One patient discontinued due to both an AE and study medication discontinuation.|120||
59767234|NCT00854360|75887378|FG002|COMPLETED|Overall Study||120||
59767235|NCT00854360|75887379|FG003|COMPLETED|Overall Study||114||
59767236|NCT00854360|75887376|FG000|NOT COMPLETED|Overall Study||2||
59767237|NCT00854360|75887377|FG001|NOT COMPLETED|Overall Study||3||
59767238|NCT00854360|75887378|FG002|NOT COMPLETED|Overall Study||2||
59767239|NCT00854360|75887379|FG003|NOT COMPLETED|Overall Study||10||
59767240|NCT00853970|75887391|FG000|STARTED|Overall Study||152||
59767241|NCT00853970|75887392|FG001|STARTED|Overall Study||147||
59767242|NCT00853970|75887391|FG000|COMPLETED|Overall Study||146||
59767243|NCT00853970|75887392|FG001|COMPLETED|Overall Study||144||
59767244|NCT00853970|75887391|FG000|NOT COMPLETED|Overall Study||6||
59767245|NCT00853970|75887392|FG001|NOT COMPLETED|Overall Study||3||
59767246|NCT03785327|75887402|FG000|STARTED|Overall Study||0||
59767247|NCT03785327|75887403|FG001|STARTED|Overall Study||0||
59767248|NCT03785327|75887404|FG002|STARTED|Overall Study||38||
59767249|NCT03785327|75887405|FG003|STARTED|Overall Study||40||
59767250|NCT03785327|75887402|FG000|COMPLETED|Overall Study||0||
59767251|NCT03785327|75887403|FG001|COMPLETED|Overall Study||0||
59767252|NCT03785327|75887404|FG002|COMPLETED|Overall Study||38||
59767253|NCT03785327|75887405|FG003|COMPLETED|Overall Study||40||
59767254|NCT03785327|75887402|FG000|NOT COMPLETED|Overall Study||0||
59767255|NCT03785327|75887403|FG001|NOT COMPLETED|Overall Study||0||
59767256|NCT03785327|75887404|FG002|NOT COMPLETED|Overall Study||0||
59767257|NCT03785327|75887405|FG003|NOT COMPLETED|Overall Study||0||
59767258|NCT00865904|75887420|FG000|STARTED|Overall Study|Randomized.|19||
59767259|NCT00865904|75887421|FG001|STARTED|Overall Study|Randomized.|18||
59767260|NCT00865904|75887422|FG002|STARTED|Overall Study|Randomized.|18||
59767261|NCT00865904|75887423|FG003|STARTED|Overall Study|Randomized.|18||
59767262|NCT00865904|75887424|FG004|STARTED|Overall Study|Randomized.|20||
59767263|NCT00865904|75887420|FG000|COMPLETED|Overall Study|Completed 14-day follow-up.|17||
59767264|NCT00865904|75887421|FG001|COMPLETED|Overall Study|Completed 14-day follow-up.|18||
59767265|NCT00865904|75887422|FG002|COMPLETED|Overall Study|Completed 14-day follow-up.|18||
59767266|NCT00865904|75887423|FG003|COMPLETED|Overall Study|Completed 14-day follow-up.|17||
59767267|NCT00865904|75887424|FG004|COMPLETED|Overall Study|Completed 14-day follow-up.|19||
59767268|NCT00865904|75887420|FG000|NOT COMPLETED|Overall Study||2||
59767269|NCT00865904|75887421|FG001|NOT COMPLETED|Overall Study||0||
59767270|NCT00865904|75887422|FG002|NOT COMPLETED|Overall Study||0||
59767271|NCT00865904|75887423|FG003|NOT COMPLETED|Overall Study||1||
59767272|NCT00865904|75887424|FG004|NOT COMPLETED|Overall Study||1||
59767273|NCT00599339|75887440|FG000|STARTED|Overall Study||2195||
59767274|NCT00599339|75887440|FG000|Safety Set|Overall Study||2179||
59767275|NCT00599339|75887440|FG000|COMPLETED|Overall Study||1531||
59767276|NCT00599339|75887440|FG000|NOT COMPLETED|Overall Study||664||
59767277|NCT00599027|75887464|FG000|STARTED|Overall Study||26||
59767278|NCT00599027|75887465|FG001|STARTED|Overall Study||25||
59767279|NCT00599027|75887464|FG000|COMPLETED|Overall Study||25||
59767280|NCT00599027|75887465|FG001|COMPLETED|Overall Study||22||
59767281|NCT00599027|75887464|FG000|NOT COMPLETED|Overall Study||1||
59767282|NCT00599027|75887465|FG001|NOT COMPLETED|Overall Study||3||
59767283|NCT03272633|75887473|FG000|STARTED|Overall Study||0||
59767284|NCT03272633|75887474|FG001|STARTED|Overall Study||2||
59767285|NCT03272633|75887473|FG000|COMPLETED|Overall Study||0||
59767286|NCT03272633|75887474|FG001|COMPLETED|Overall Study||2||
59767287|NCT03272633|75887473|FG000|NOT COMPLETED|Overall Study||0||
59767288|NCT03272633|75887474|FG001|NOT COMPLETED|Overall Study||0||
59767289|NCT02881151|75887480|FG000|STARTED|Hospital Admission and Surgery (3 Days)||6||
59767290|NCT02881151|75887480|FG000|COMPLETED|Hospital Admission and Surgery (3 Days)||6||
59767291|NCT02881151|75887480|FG000|NOT COMPLETED|Hospital Admission and Surgery (3 Days)||0||
59767292|NCT02881151|75887480|FG000|STARTED|Post-surgical Washout (65 to 93 Days)||6||
59767293|NCT02881151|75887480|FG000|COMPLETED|Post-surgical Washout (65 to 93 Days)||5||
59767294|NCT02881151|75887480|FG000|NOT COMPLETED|Post-surgical Washout (65 to 93 Days)||1||
59767295|NCT02881151|75887480|FG000|STARTED|DBS Titration-Optimization (14 Days)||5||
59767296|NCT02881151|75887480|FG000|COMPLETED|DBS Titration-Optimization (14 Days)||5||
59767297|NCT02881151|75887480|FG000|NOT COMPLETED|DBS Titration-Optimization (14 Days)||0||
59767298|NCT02881151|75887480|FG000|STARTED|Unblinded Treatment Phase (90 Days)||5||
59767299|NCT02881151|75887480|FG000|COMPLETED|Unblinded Treatment Phase (90 Days)||5||
59767300|NCT02881151|75887480|FG000|NOT COMPLETED|Unblinded Treatment Phase (90 Days)||0||
59767301|NCT02881151|75887480|FG000|STARTED|Withdrawal Phase (21 Days)|2 participants did not participate in the Withdrawal Phase (declined stimulator deactivation) but did proceed to the Continuation Phase.|3||
59767302|NCT02881151|75887480|FG000|COMPLETED|Withdrawal Phase (21 Days)||3||
59767303|NCT02881151|75887480|FG000|NOT COMPLETED|Withdrawal Phase (21 Days)||0||
59767304|NCT02881151|75887480|FG000|STARTED|Continuation Phase (6 Months)||5||
59767305|NCT02881151|75887480|FG000|COMPLETED|Continuation Phase (6 Months)||5||
59767306|NCT02881151|75887480|FG000|NOT COMPLETED|Continuation Phase (6 Months)||0||
59767307|NCT00689728|75887488|FG000|STARTED|Double-Blind Treatment||35||
59767308|NCT00689728|75887489|FG001|STARTED|Double-Blind Treatment||30||
59767309|NCT00689728|75887490|FG002|STARTED|Double-Blind Treatment||35||
59767310|NCT00689728|75887488|FG000|COMPLETED|Double-Blind Treatment||31||
59767311|NCT00689728|75887489|FG001|COMPLETED|Double-Blind Treatment||26||
59767312|NCT00689728|75887490|FG002|COMPLETED|Double-Blind Treatment||30||
59767313|NCT00689728|75887488|FG000|NOT COMPLETED|Double-Blind Treatment||4||
59767314|NCT00689728|75887489|FG001|NOT COMPLETED|Double-Blind Treatment||4||
59767315|NCT00689728|75887490|FG002|NOT COMPLETED|Double-Blind Treatment||5||
59767316|NCT00689728|75887488|FG000|STARTED|Rescue||31||
59767317|NCT00689728|75887489|FG001|STARTED|Rescue||26||
59767318|NCT00689728|75887490|FG002|STARTED|Rescue||30||
59767319|NCT00689728|75887488|FG000|COMPLETED|Rescue||30||
59767320|NCT00689728|75887489|FG001|COMPLETED|Rescue||24||
59767321|NCT00689728|75887490|FG002|COMPLETED|Rescue||29||
59767322|NCT00689728|75887488|FG000|NOT COMPLETED|Rescue||1||
59767323|NCT00689728|75887489|FG001|NOT COMPLETED|Rescue||2||
59767324|NCT00689728|75887490|FG002|NOT COMPLETED|Rescue||1||
59767325|NCT00689728|75887488|FG000|STARTED|Optional Follow-Up|21 participants who completed the rescue period did not enter the optional follow-up period.|9||
59767326|NCT00689728|75887489|FG001|STARTED|Optional Follow-Up|13 participants who completed the rescue period did not enter the optional follow-up period.|11||
59767327|NCT00689728|75887490|FG002|STARTED|Optional Follow-Up|19 participants who completed the rescue period did not enter the optional follow-up period.|10||
59767328|NCT00689728|75887488|FG000|COMPLETED|Optional Follow-Up||6||
59767329|NCT00689728|75887489|FG001|COMPLETED|Optional Follow-Up||5||
59767330|NCT00689728|75887490|FG002|COMPLETED|Optional Follow-Up||4||
59767331|NCT00689728|75887488|FG000|NOT COMPLETED|Optional Follow-Up||3||
59767332|NCT00689728|75887489|FG001|NOT COMPLETED|Optional Follow-Up||6||
59767333|NCT00689728|75887490|FG002|NOT COMPLETED|Optional Follow-Up||6||
59767334|NCT00691054|75887519|FG000|STARTED|Overall Study||20||
59767335|NCT00691054|75887519|FG000|COMPLETED|Overall Study||19||
59767336|NCT00691054|75887519|FG000|NOT COMPLETED|Overall Study||1||
59767337|NCT00598871|75887527|FG000|STARTED|Overall Study||3||
59767338|NCT00598871|75887528|FG001|STARTED|Overall Study||9||
59767339|NCT00598871|75887527|FG000|COMPLETED|Overall Study||3||
59767340|NCT00598871|75887528|FG001|COMPLETED|Overall Study||8||
59767341|NCT00598871|75887527|FG000|NOT COMPLETED|Overall Study||0||
59767342|NCT00598871|75887528|FG001|NOT COMPLETED|Overall Study||1||
59767343|NCT00690820|75887536|FG000|STARTED|Period 1||8||
59767344|NCT00690820|75887537|FG001|STARTED|Period 1||9||
59767345|NCT00690820|75887536|FG000|COMPLETED|Period 1||8||
59767346|NCT00690820|75887537|FG001|COMPLETED|Period 1||8||
59767347|NCT00690820|75887536|FG000|NOT COMPLETED|Period 1||0||
59767348|NCT00690820|75887537|FG001|NOT COMPLETED|Period 1||1||
59767349|NCT00690820|75887536|FG000|STARTED|Period 2||8||
59767350|NCT00690820|75887537|FG001|STARTED|Period 2||8||
59767351|NCT00690820|75887536|FG000|COMPLETED|Period 2||8||
59767352|NCT00690820|75887537|FG001|COMPLETED|Period 2||8||
59767353|NCT00690820|75887536|FG000|NOT COMPLETED|Period 2||0||
59767354|NCT00690820|75887537|FG001|NOT COMPLETED|Period 2||0||
59767355|NCT00689338|75887543|FG000|STARTED|Overall Study||216||
59767356|NCT00689338|75887543|FG000|COMPLETED|Overall Study||73||
59767357|NCT00689338|75887543|FG000|NOT COMPLETED|Overall Study||143||
59767358|NCT00686998|75887550|FG000|STARTED|Overall Study|Randomized & received study medication|43||
59767359|NCT00686998|75887551|FG001|STARTED|Overall Study|Randomized & received study medication|41||
59767360|NCT00686998|75887552|FG002|STARTED|Overall Study|Randomized & received study medication|22||
59767361|NCT00686998|75887550|FG000|Randomized|Overall Study||43||
59767362|NCT00686998|75887551|FG001|Randomized|Overall Study||41||
59767363|NCT00686998|75887552|FG002|Randomized|Overall Study||22||
59767364|NCT00686998|75887550|FG000|Received Treatment|Overall Study||43||
59767365|NCT00686998|75887551|FG001|Received Treatment|Overall Study||41||
59767366|NCT00686998|75887552|FG002|Received Treatment|Overall Study||22||
59767367|NCT00686998|75887550|FG000|Eligible for Efficacy Analysis|Overall Study||42||
59767368|NCT00686998|75887551|FG001|Eligible for Efficacy Analysis|Overall Study||39||
59767369|NCT00686998|75887552|FG002|Eligible for Efficacy Analysis|Overall Study||21||
59767370|NCT00686998|75887550|FG000|Completed Scheduled Treatment|Overall Study||30||
59767371|NCT00686998|75887551|FG001|Completed Scheduled Treatment|Overall Study||33||
59767372|NCT00686998|75887552|FG002|Completed Scheduled Treatment|Overall Study||18||
59767373|NCT00686998|75887550|FG000|COMPLETED|Overall Study||30||
59767374|NCT00686998|75887551|FG001|COMPLETED|Overall Study||33||
59767375|NCT00686998|75887552|FG002|COMPLETED|Overall Study||18||
59767376|NCT00686998|75887550|FG000|NOT COMPLETED|Overall Study||13||
59767377|NCT00686998|75887551|FG001|NOT COMPLETED|Overall Study||8||
59767378|NCT00686998|75887552|FG002|NOT COMPLETED|Overall Study||4||
59767379|NCT00848718|75887573|FG000|STARTED|Overall Study||7||
59767380|NCT00848718|75887574|FG001|STARTED|Overall Study||9||
59767381|NCT00848718|75887575|FG002|STARTED|Overall Study||6||
59767382|NCT00848718|75887576|FG003|STARTED|Overall Study||5||
59767383|NCT00848718|75887577|FG004|STARTED|Overall Study||6||
59767384|NCT00848718|75887578|FG005|STARTED|Overall Study||5||
59767385|NCT00848718|75887579|FG006|STARTED|Overall Study||3||
59767386|NCT00848718|75887580|FG007|STARTED|Overall Study||5||
59767387|NCT00848718|75887581|FG008|STARTED|Overall Study||4||
59767388|NCT00848718|75887582|FG009|STARTED|Overall Study||9||
59767389|NCT00848718|75887583|FG010|STARTED|Overall Study||4||
59767390|NCT00848718|75887584|FG011|STARTED|Overall Study||6||
59767391|NCT00848718|75887585|FG012|STARTED|Overall Study||8||
59767392|NCT00848718|75887573|FG000|Treated|Overall Study|1 participant was allocated but did not receive treatment due to progression of disease|6||
59767393|NCT00848718|75887574|FG001|Treated|Overall Study||9||
59767394|NCT00848718|75887575|FG002|Treated|Overall Study|1 participant was allocated but did not receive treatment due to progression of disease|5||
59767395|NCT00848718|75887576|FG003|Treated|Overall Study||5||
59767396|NCT00848718|75887577|FG004|Treated|Overall Study||6||
59767397|NCT00848718|75887578|FG005|Treated|Overall Study||5||
59767398|NCT00848718|75887579|FG006|Treated|Overall Study||3||
59767399|NCT00848718|75887580|FG007|Treated|Overall Study|1 participant was allocated but did not receive treatment due to progression of disease|4||
59767400|NCT00848718|75887581|FG008|Treated|Overall Study||4||
59767401|NCT00848718|75887582|FG009|Treated|Overall Study||9||
59767402|NCT00848718|75887583|FG010|Treated|Overall Study||4||
59767403|NCT00848718|75887584|FG011|Treated|Overall Study||6||
59767404|NCT00848718|75887585|FG012|Treated|Overall Study|2 participants were allocated but did not receive treatment due to progression of disease|6||
59767405|NCT00848718|75887573|FG000|COMPLETED|Overall Study||0||
59767406|NCT00848718|75887574|FG001|COMPLETED|Overall Study||0||
59767407|NCT00848718|75887575|FG002|COMPLETED|Overall Study||0||
59767408|NCT00848718|75887576|FG003|COMPLETED|Overall Study||0||
59767409|NCT00848718|75887577|FG004|COMPLETED|Overall Study||0||
59767410|NCT00848718|75887578|FG005|COMPLETED|Overall Study||0||
59767411|NCT00848718|75887579|FG006|COMPLETED|Overall Study||0||
59767412|NCT00848718|75887580|FG007|COMPLETED|Overall Study||0||
59767413|NCT00848718|75887581|FG008|COMPLETED|Overall Study||0||
59767414|NCT00848718|75887582|FG009|COMPLETED|Overall Study||0||
59767415|NCT00848718|75887583|FG010|COMPLETED|Overall Study||0||
59767416|NCT00848718|75887584|FG011|COMPLETED|Overall Study||0||
59767417|NCT00848718|75887585|FG012|COMPLETED|Overall Study||0||
59767418|NCT00848718|75887573|FG000|NOT COMPLETED|Overall Study||7||
59767419|NCT00848718|75887574|FG001|NOT COMPLETED|Overall Study||9||
59767420|NCT00848718|75887575|FG002|NOT COMPLETED|Overall Study||6||
59767421|NCT00848718|75887576|FG003|NOT COMPLETED|Overall Study||5||
59767422|NCT00848718|75887577|FG004|NOT COMPLETED|Overall Study||6||
59767423|NCT00848718|75887578|FG005|NOT COMPLETED|Overall Study||5||
59767424|NCT00848718|75887579|FG006|NOT COMPLETED|Overall Study||3||
59767425|NCT00848718|75887580|FG007|NOT COMPLETED|Overall Study||5||
59767426|NCT00848718|75887581|FG008|NOT COMPLETED|Overall Study||4||
59767427|NCT00848718|75887582|FG009|NOT COMPLETED|Overall Study||9||
59767428|NCT00848718|75887583|FG010|NOT COMPLETED|Overall Study||4||
59767429|NCT00848718|75887584|FG011|NOT COMPLETED|Overall Study||6||
59767430|NCT00848718|75887585|FG012|NOT COMPLETED|Overall Study||8||
59767431|NCT00883337|75887622|FG000|STARTED|Core Treatment Period||109||
59767432|NCT00883337|75887623|FG001|STARTED|Core Treatment Period||111||
59767433|NCT00883337|75887624|FG002|STARTED|Core Treatment Period||104||
59767434|NCT00883337|75887622|FG000|Treated|Core Treatment Period||109||
59767435|NCT00883337|75887623|FG001|Treated|Core Treatment Period|One participant received teriflunomide 7 mg instead of teriflunomide 14 mg|111||
59767436|NCT00883337|75887624|FG002|Treated|Core Treatment Period|3 participants refused treatment with Rebif®|101||
59767437|NCT00883337|75887622|FG000|COMPLETED|Core Treatment Period||89||
59767438|NCT00883337|75887623|FG001|COMPLETED|Core Treatment Period||89||
59767439|NCT00883337|75887624|FG002|COMPLETED|Core Treatment Period||71||
59767440|NCT00883337|75887622|FG000|NOT COMPLETED|Core Treatment Period||20||
59767441|NCT00883337|75887623|FG001|NOT COMPLETED|Core Treatment Period||22||
59767442|NCT00883337|75887624|FG002|NOT COMPLETED|Core Treatment Period||33||
59767443|NCT00883337|75887622|FG000|STARTED|Extension Treatment Period||89||
59767444|NCT00883337|75887623|FG001|STARTED|Extension Treatment Period||89||
59767445|NCT00883337|75887624|FG002|STARTED|Extension Treatment Period|12 participants completed the core period but didn't enter the extension period.|59||
59767446|NCT00883337|75887622|FG000|COMPLETED|Extension Treatment Period||61||
59767447|NCT00883337|75887623|FG001|COMPLETED|Extension Treatment Period||66||
59767448|NCT00883337|75887624|FG002|COMPLETED|Extension Treatment Period||40||
59767449|NCT00883337|75887622|FG000|NOT COMPLETED|Extension Treatment Period||28||
59767450|NCT00883337|75887623|FG001|NOT COMPLETED|Extension Treatment Period||23||
59767451|NCT00883337|75887624|FG002|NOT COMPLETED|Extension Treatment Period||19||
59767452|NCT00838110|75887640|FG000|STARTED|Overall Study||127||
59767453|NCT00838110|75887641|FG001|STARTED|Overall Study||128||
59952116|NCT00833586|76070999|FG000|NOT COMPLETED|First Intervention||0||
59952117|NCT00833586|76071000|FG001|NOT COMPLETED|First Intervention||0||
59952118|NCT00833586|76070999|FG000|STARTED|Washout: 14 Days||14||
59952119|NCT00833586|76071000|FG001|STARTED|Washout: 14 Days||14||
59952120|NCT00833586|76070999|FG000|COMPLETED|Washout: 14 Days||14||
59767454|NCT00838110|75887642|FG002|STARTED|Overall Study||243||
59767455|NCT00838110|75887643|FG003|STARTED|Overall Study||244||
59767456|NCT00838110|75887640|FG000|Treated|Overall Study||127||
59767457|NCT00838110|75887641|FG001|Treated|Overall Study||127||
59767458|NCT00838110|75887642|FG002|Treated|Overall Study||243||
59767459|NCT00838110|75887643|FG003|Treated|Overall Study||244||
59767460|NCT00838110|75887640|FG000|COMPLETED|Overall Study||105||
59767461|NCT00838110|75887641|FG001|COMPLETED|Overall Study||106||
59767462|NCT00838110|75887642|FG002|COMPLETED|Overall Study||226||
59767463|NCT00838110|75887643|FG003|COMPLETED|Overall Study||226||
59767464|NCT00838110|75887640|FG000|NOT COMPLETED|Overall Study||22||
59767465|NCT00838110|75887641|FG001|NOT COMPLETED|Overall Study||22||
59767466|NCT00838110|75887642|FG002|NOT COMPLETED|Overall Study||17||
59767467|NCT00838110|75887643|FG003|NOT COMPLETED|Overall Study||18||
59767468|NCT00837876|75887653|FG000|STARTED|Overall Study||37||
59767469|NCT00837876|75887653|FG000|COMPLETED|Overall Study||0||
59767470|NCT00837876|75887653|FG000|NOT COMPLETED|Overall Study||37||
59767471|NCT00686920|75887659|FG000|STARTED|Overall Study||252||
59767472|NCT00686920|75887660|FG001|STARTED|Overall Study||70||
59767473|NCT00686920|75887659|FG000|Received At Least 1 Dose Of Study Drug|Overall Study||252||
59767474|NCT00686920|75887660|FG001|Received At Least 1 Dose Of Study Drug|Overall Study||70||
59767475|NCT00686920|75887659|FG000|COMPLETED|Overall Study||120||
59767476|NCT00686920|75887660|FG001|COMPLETED|Overall Study||34||
59767477|NCT00686920|75887659|FG000|NOT COMPLETED|Overall Study||132||
59767478|NCT00686920|75887660|FG001|NOT COMPLETED|Overall Study||36||
59767479|NCT00845832|75887669|FG000|STARTED|Treatment Period||4||
59767480|NCT00845832|75887670|FG001|STARTED|Treatment Period||10||
59767481|NCT00845832|75887671|FG002|STARTED|Treatment Period||10||
59767482|NCT00845832|75887669|FG000|COMPLETED|Treatment Period||3||
59767483|NCT00845832|75887670|FG001|COMPLETED|Treatment Period||7||
59767484|NCT00845832|75887671|FG002|COMPLETED|Treatment Period||10||
59767485|NCT00845832|75887669|FG000|NOT COMPLETED|Treatment Period||1||
59767486|NCT00845832|75887670|FG001|NOT COMPLETED|Treatment Period||3||
59767487|NCT00845832|75887671|FG002|NOT COMPLETED|Treatment Period||0||
59767488|NCT00845832|75887669|FG000|STARTED|Safety Follow-Up|One participant from this group was re-assigned to TCZ (4 mg/kg) group.|3||
59767489|NCT00845832|75887670|FG001|STARTED|Safety Follow-Up|All participants who withdrew from study were asked to return for safety follow-up.|9||
59767490|NCT00845832|75887671|FG002|STARTED|Safety Follow-Up|One participant each from the placebo and TCZ (2 mg/kg) groups were re-assigned to this group.|12||
59767491|NCT00845832|75887669|FG000|COMPLETED|Safety Follow-Up||2||
59767492|NCT00845832|75887670|FG001|COMPLETED|Safety Follow-Up|One participant from this group was re-assigned to TCZ (4 mg/kg) group.|9||
59952121|NCT00833586|76071000|FG001|COMPLETED|Washout: 14 Days||14||
59767493|NCT00845832|75887671|FG002|COMPLETED|Safety Follow-Up||12||
59767494|NCT00845832|75887669|FG000|NOT COMPLETED|Safety Follow-Up||1||
59767495|NCT00845832|75887670|FG001|NOT COMPLETED|Safety Follow-Up||0||
59767496|NCT00845832|75887671|FG002|NOT COMPLETED|Safety Follow-Up||0||
59767497|NCT00845832|75887669|FG000|STARTED|Extended Safety Follow-Up||2||
59767498|NCT00845832|75887670|FG001|STARTED|Extended Safety Follow-Up|Only participants who remained B cell depleted required extended safety follow-up.|5||
59767499|NCT00845832|75887671|FG002|STARTED|Extended Safety Follow-Up|Only participants who remained B cell depleted required extended safety follow-up.|7||
59767500|NCT00845832|75887669|FG000|COMPLETED|Extended Safety Follow-Up||2||
59767501|NCT00845832|75887670|FG001|COMPLETED|Extended Safety Follow-Up||5||
59767502|NCT00845832|75887671|FG002|COMPLETED|Extended Safety Follow-Up||0||
59767503|NCT00845832|75887669|FG000|NOT COMPLETED|Extended Safety Follow-Up||0||
59767504|NCT00845832|75887670|FG001|NOT COMPLETED|Extended Safety Follow-Up||0||
59767505|NCT00845832|75887671|FG002|NOT COMPLETED|Extended Safety Follow-Up||7||
59767506|NCT00591864|75887679|FG000|STARTED|Overall Study||89||
59767507|NCT00591864|75887679|FG000|COMPLETED|Overall Study||84||
59767508|NCT00591864|75887679|FG000|NOT COMPLETED|Overall Study||5||
59767509|NCT00885755|75887687|FG000|STARTED|Part I: Trastuzumab+Taxane||31||
59767510|NCT00885755|75887688|FG001|STARTED|Part I: Trastuzumab+Taxane||1||
59767511|NCT00885755|75887689|FG002|STARTED|Part I: Trastuzumab+Taxane||1||
59767512|NCT00885755|75887687|FG000|COMPLETED|Part I: Trastuzumab+Taxane||13||
59767513|NCT00885755|75887688|FG001|COMPLETED|Part I: Trastuzumab+Taxane||1||
59767514|NCT00885755|75887689|FG002|COMPLETED|Part I: Trastuzumab+Taxane||0||
59767515|NCT00885755|75887687|FG000|NOT COMPLETED|Part I: Trastuzumab+Taxane||18||
59767516|NCT00885755|75887688|FG001|NOT COMPLETED|Part I: Trastuzumab+Taxane||0||
59767517|NCT00885755|75887689|FG002|NOT COMPLETED|Part I: Trastuzumab+Taxane||1||
59767518|NCT00885755|75887687|FG000|STARTED|Part II: Trastuzumab + Capecitabine.||13||
59767519|NCT00885755|75887688|FG001|STARTED|Part II: Trastuzumab + Capecitabine.||1||
59767520|NCT00885755|75887689|FG002|STARTED|Part II: Trastuzumab + Capecitabine.||0||
59767521|NCT00885755|75887687|FG000|COMPLETED|Part II: Trastuzumab + Capecitabine.||8||
59767522|NCT00885755|75887688|FG001|COMPLETED|Part II: Trastuzumab + Capecitabine.||1||
59618011|NCT03192462|75729213|FG002|NOT COMPLETED|Overall Study||12||
59618012|NCT03589326|75729223|FG000|STARTED|IP (Cycles 1-3) (Cycle Length=28 Days)||164||
59618013|NCT03589326|75729224|FG001|STARTED|IP (Cycles 1-3) (Cycle Length=28 Days)||81||
59767523|NCT00885755|75887689|FG002|COMPLETED|Part II: Trastuzumab + Capecitabine.||0||
59767524|NCT00885755|75887687|FG000|NOT COMPLETED|Part II: Trastuzumab + Capecitabine.||5||
59767525|NCT00885755|75887688|FG001|NOT COMPLETED|Part II: Trastuzumab + Capecitabine.||0||
59767526|NCT00885755|75887689|FG002|NOT COMPLETED|Part II: Trastuzumab + Capecitabine.||0||
59767527|NCT00837486|75887699|FG000|STARTED|Blinded-treatment Phase||16||
59767528|NCT00837486|75887700|FG001|STARTED|Blinded-treatment Phase||14||
60072538|NCT01682811|76187743|FG006|Control|Part 2 Dose Level 3||0||0
60072539|NCT01682811|76187737|FG000|Treated|Part 2 Dose Level 3||0||0
60072540|NCT01682811|76187738|FG001|Treated|Part 2 Dose Level 3||0||0
59952122|NCT00833586|76070999|FG000|NOT COMPLETED|Washout: 14 Days||0||
59952123|NCT00833586|76071000|FG001|NOT COMPLETED|Washout: 14 Days||0||
60072541|NCT01682811|76187739|FG002|Treated|Part 2 Dose Level 3||0||0
60072542|NCT01682811|76187740|FG003|Treated|Part 2 Dose Level 3||0||0
60072543|NCT01682811|76187741|FG004|Treated|Part 2 Dose Level 3||0||0
59952124|NCT00833586|76070999|FG000|STARTED|Second Intervention||14||
59952125|NCT00833586|76071000|FG001|STARTED|Second Intervention||14||
60072544|NCT01682811|76187742|FG005|Treated|Part 2 Dose Level 3||0||0
60072545|NCT01682811|76187743|FG006|Treated|Part 2 Dose Level 3||0||0
59952126|NCT00833586|76070999|FG000|COMPLETED|Second Intervention||14||
59952127|NCT00833586|76071000|FG001|COMPLETED|Second Intervention||14||
59952128|NCT00833586|76070999|FG000|NOT COMPLETED|Second Intervention||0||
59767529|NCT00837486|75887699|FG000|COMPLETED|Blinded-treatment Phase|One subject did not receive the allocated intervention.|15||
59767530|NCT00837486|75887700|FG001|COMPLETED|Blinded-treatment Phase||14||
59767531|NCT00837486|75887699|FG000|NOT COMPLETED|Blinded-treatment Phase||1||
59767532|NCT00837486|75887700|FG001|NOT COMPLETED|Blinded-treatment Phase||0||
59767533|NCT00837486|75887699|FG000|STARTED|Long-term Follow-up Phase - Open Label|All subjects received open-label stimulation during this phase.|29||
59767534|NCT00837486|75887700|FG001|STARTED|Long-term Follow-up Phase - Open Label||0||
59767535|NCT00837486|75887699|FG000|COMPLETED|Long-term Follow-up Phase - Open Label||24||
59767536|NCT00837486|75887700|FG001|COMPLETED|Long-term Follow-up Phase - Open Label||0||
59767537|NCT00837486|75887699|FG000|NOT COMPLETED|Long-term Follow-up Phase - Open Label||5||
59767538|NCT00837486|75887700|FG001|NOT COMPLETED|Long-term Follow-up Phase - Open Label||0||
59767539|NCT00845676|75887708|FG000|STARTED|Overall Study||21||
59767540|NCT00845676|75887708|FG000|COMPLETED|Overall Study||19||
59767541|NCT00845676|75887708|FG000|NOT COMPLETED|Overall Study||2||
59767542|NCT00883181|75887713|FG000|STARTED|Overall Study|Full analysis set|1347||
59767543|NCT00883181|75887713|FG000|COMPLETED|Overall Study|Completed planned chemotherapy|1069||
59767544|NCT00883181|75887713|FG000|NOT COMPLETED|Overall Study||278||
59767545|NCT00845520|75887733|FG000|STARTED|Overall Study||25||25
59767546|NCT00845520|75887734|FG001|STARTED|Overall Study||25||25
59767547|NCT00845520|75887735|FG002|STARTED|Overall Study||24||24
59767548|NCT00845520|75887733|FG000|COMPLETED|Overall Study||23||23
59767549|NCT00845520|75887734|FG001|COMPLETED|Overall Study||23||23
59767550|NCT00845520|75887735|FG002|COMPLETED|Overall Study||23||23
59767551|NCT00845520|75887733|FG000|NOT COMPLETED|Overall Study||2||2
59767552|NCT00845520|75887734|FG001|NOT COMPLETED|Overall Study||2||2
59767553|NCT00845520|75887735|FG002|NOT COMPLETED|Overall Study||1||1
59767554|NCT00844896|75887751|FG000|STARTED|Overall Study||29||
59767555|NCT00844896|75887752|FG001|STARTED|Overall Study||28||
59767556|NCT00844896|75887751|FG000|COMPLETED|Overall Study||17||
59767557|NCT00844896|75887752|FG001|COMPLETED|Overall Study||11||
59767558|NCT00844896|75887751|FG000|NOT COMPLETED|Overall Study||12||
59767559|NCT00844896|75887752|FG001|NOT COMPLETED|Overall Study||17||
59767560|NCT00827502|75887759|FG000|STARTED|Overall Study||421||
59767561|NCT00827502|75887759|FG000|Received Treatment (Number Treated)|Overall Study||410||
59767562|NCT00827502|75887759|FG000|COMPLETED|Overall Study||400||
59767563|NCT00827502|75887759|FG000|NOT COMPLETED|Overall Study||21||
59767564|NCT00837330|75887765|FG000|STARTED|Overall Study||10||
59767565|NCT00837330|75887766|FG001|STARTED|Overall Study||10||
59767566|NCT00837330|75887765|FG000|COMPLETED|Overall Study||9||
59767567|NCT00837330|75887766|FG001|COMPLETED|Overall Study||7||
59767568|NCT00837330|75887765|FG000|NOT COMPLETED|Overall Study||1||
59767569|NCT00837330|75887766|FG001|NOT COMPLETED|Overall Study||3||
59767570|NCT00837096|75887774|FG000|STARTED|Overall Study||10||
59767571|NCT00837096|75887775|FG001|STARTED|Overall Study||9||
59767572|NCT00837096|75887774|FG000|COMPLETED|Overall Study||0||
59767573|NCT00837096|75887775|FG001|COMPLETED|Overall Study||0||
59767574|NCT00837096|75887774|FG000|NOT COMPLETED|Overall Study||10||
59767575|NCT00837096|75887775|FG001|NOT COMPLETED|Overall Study||9||
59767576|NCT00885677|75887783|FG000|STARTED|Overall Study||462||
59767577|NCT00885677|75887784|FG001|STARTED|Overall Study||455||
59767578|NCT00885677|75887783|FG000|Intention To Treat|Overall Study||437||
59767579|NCT00885677|75887784|FG001|Intention To Treat|Overall Study||428||
59767580|NCT00885677|75887783|FG000|COMPLETED|Overall Study||279||
59767581|NCT00885677|75887784|FG001|COMPLETED|Overall Study||277||
59767582|NCT00885677|75887783|FG000|NOT COMPLETED|Overall Study||183||
59767583|NCT00885677|75887784|FG001|NOT COMPLETED|Overall Study||178||
59767584|NCT00885365|75887792|FG000|STARTED|4 Weeks ON Treatment||159||
59767585|NCT00885365|75887793|FG001|STARTED|4 Weeks ON Treatment||165||
59767586|NCT00885365|75887792|FG000|Intent-to-Treat Population|4 Weeks ON Treatment|Participants who took 1 dose of study medication and had baseline and at least 1 post-treatment FEV1|158||
59767587|NCT00885365|75887793|FG001|Intent-to-Treat Population|4 Weeks ON Treatment||163||
59767588|NCT00885365|75887792|FG000|Safety Population|4 Weeks ON Treatment|Nine participants randomized to Bramitob were administered TOBI.|156||
60072546|NCT01682811|76187737|FG000|COMPLETED|Part 2 Dose Level 3||0||0
59767589|NCT00885365|75887793|FG001|Safety Population|4 Weeks ON Treatment|Six participants randomized to TOBI were administered Bramitob|168||
59767590|NCT00885365|75887792|FG000|COMPLETED|4 Weeks ON Treatment||155||
59767591|NCT00885365|75887793|FG001|COMPLETED|4 Weeks ON Treatment||159||
59767592|NCT00885365|75887792|FG000|NOT COMPLETED|4 Weeks ON Treatment||4||
59767593|NCT00885365|75887793|FG001|NOT COMPLETED|4 Weeks ON Treatment||6||
59767594|NCT00885365|75887792|FG000|STARTED|4 Weeks OFF Treatment||155||
59952129|NCT00833586|76071000|FG001|NOT COMPLETED|Second Intervention||0||
59767595|NCT00885365|75887793|FG001|STARTED|4 Weeks OFF Treatment||159||
59767596|NCT00885365|75887792|FG000|COMPLETED|4 Weeks OFF Treatment||155||
59767597|NCT00885365|75887793|FG001|COMPLETED|4 Weeks OFF Treatment||159||
59767598|NCT00885365|75887792|FG000|NOT COMPLETED|4 Weeks OFF Treatment||0||
59767599|NCT00885365|75887793|FG001|NOT COMPLETED|4 Weeks OFF Treatment||0||
59952130|NCT02605954|76071006|FG000|STARTED|Overall Study||183||
59952131|NCT02605954|76071007|FG001|STARTED|Overall Study||92||
59952132|NCT02605954|76071006|FG000|COMPLETED|Overall Study||171||
59952133|NCT02605954|76071007|FG001|COMPLETED|Overall Study||88||
59767600|NCT00827112|75887801|FG000|STARTED|Overall Study||65||
59767601|NCT00827112|75887802|FG001|STARTED|Overall Study||64||
59767602|NCT00827112|75887801|FG000|Treated|Overall Study||60||
59767603|NCT00827112|75887802|FG001|Treated|Overall Study||61||
59767604|NCT00827112|75887801|FG000|COMPLETED|Overall Study||50||
59767605|NCT00827112|75887802|FG001|COMPLETED|Overall Study||52||
59767606|NCT00827112|75887801|FG000|NOT COMPLETED|Overall Study||15||
59767607|NCT00827112|75887802|FG001|NOT COMPLETED|Overall Study||12||
59767608|NCT00689104|75887812|FG000|STARTED|Overall Study||497||
59767609|NCT00689104|75887813|FG001|STARTED|Overall Study||497||
59767610|NCT00689104|75887814|FG002|STARTED|Overall Study||498||
59767611|NCT00689104|75887815|FG003|STARTED|Overall Study||495||
59767612|NCT00689104|75887812|FG000|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|494||
59767613|NCT00689104|75887813|FG001|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|493||
59767614|NCT00689104|75887814|FG002|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|496||
59767615|NCT00689104|75887815|FG003|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|495||
59767616|NCT00689104|75887812|FG000|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|480||
59767617|NCT00689104|75887813|FG001|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|473||
59767618|NCT00689104|75887814|FG002|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|478||
59767619|NCT00689104|75887815|FG003|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|475||
59767620|NCT00689104|75887812|FG000|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|291||
59767621|NCT00689104|75887813|FG001|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|293||
59767622|NCT00689104|75887814|FG002|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|281||
59767623|NCT00689104|75887815|FG003|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|300||
59767624|NCT00689104|75887812|FG000|COMPLETED|Overall Study||453||
59767625|NCT00689104|75887813|FG001|COMPLETED|Overall Study||440||
59767626|NCT00689104|75887814|FG002|COMPLETED|Overall Study||453||
59767627|NCT00689104|75887815|FG003|COMPLETED|Overall Study||445||
59767628|NCT00689104|75887812|FG000|NOT COMPLETED|Overall Study||44||
59767629|NCT00689104|75887813|FG001|NOT COMPLETED|Overall Study||57||
59767630|NCT00689104|75887814|FG002|NOT COMPLETED|Overall Study||45||
59767631|NCT00689104|75887815|FG003|NOT COMPLETED|Overall Study||50||
59767632|NCT00689026|75887827|FG000|STARTED|Overall Study||30||
59767633|NCT00689026|75887828|FG001|STARTED|Overall Study||30||
59767634|NCT00689026|75887827|FG000|COMPLETED|Overall Study||17||
59767635|NCT00689026|75887828|FG001|COMPLETED|Overall Study||24||
59767636|NCT00689026|75887827|FG000|NOT COMPLETED|Overall Study||13||
59767637|NCT00689026|75887828|FG001|NOT COMPLETED|Overall Study||6||
59767638|NCT00598559|75887837|FG000|STARTED|Overall Study||92||
59767639|NCT00598559|75887838|FG001|STARTED|Overall Study||91||
59767640|NCT00598559|75887839|FG002|STARTED|Overall Study||30||
59767641|NCT00598559|75887837|FG000|COMPLETED|Overall Study|Subjects completed 5 days of treatment|65||
59767642|NCT00598559|75887838|FG001|COMPLETED|Overall Study|Subjects completed 5 days of treatment|63||
59767643|NCT00598559|75887839|FG002|COMPLETED|Overall Study|Subjects completed 5 days of treatment|27||
59767644|NCT00598559|75887837|FG000|NOT COMPLETED|Overall Study||27||
59952134|NCT02605954|76071006|FG000|NOT COMPLETED|Overall Study||12||
59952135|NCT02605954|76071007|FG001|NOT COMPLETED|Overall Study||4||
59952136|NCT00724698|76071016|FG000|STARTED|Overall Study||3011||
59952137|NCT00724698|76071016|FG000|COMPLETED|Overall Study||2921||
59952138|NCT00724698|76071016|FG000|NOT COMPLETED|Overall Study||90||
59952139|NCT00829998|76071021|FG000|STARTED|First Intervention||21||
59952140|NCT00829998|76071022|FG001|STARTED|First Intervention||20||
59952141|NCT00829998|76071021|FG000|COMPLETED|First Intervention||21||
59952142|NCT00829998|76071022|FG001|COMPLETED|First Intervention||20||
59952143|NCT00829998|76071021|FG000|NOT COMPLETED|First Intervention||0||
59952144|NCT00829998|76071022|FG001|NOT COMPLETED|First Intervention||0||
59952145|NCT00829998|76071021|FG000|STARTED|Washout||21||
59952146|NCT00829998|76071022|FG001|STARTED|Washout||20||
59767645|NCT00598559|75887838|FG001|NOT COMPLETED|Overall Study||28||
59767646|NCT00598559|75887839|FG002|NOT COMPLETED|Overall Study||3||
59767647|NCT00686686|75887847|FG000|STARTED|Overall Study||23||
59767648|NCT00686686|75887847|FG000|COMPLETED|Overall Study||17||
59767649|NCT00686686|75887847|FG000|NOT COMPLETED|Overall Study||6||
59767650|NCT04160195|75887853|FG000|STARTED|Overall Study||2||
59767651|NCT04160195|75887854|FG001|STARTED|Overall Study||0||
59767652|NCT04160195|75887853|FG000|COMPLETED|Overall Study||1||
59767653|NCT04160195|75887854|FG001|COMPLETED|Overall Study||0||
59767654|NCT04160195|75887853|FG000|NOT COMPLETED|Overall Study||1||
59767655|NCT04160195|75887854|FG001|NOT COMPLETED|Overall Study||0||
59952147|NCT00829998|76071021|FG000|COMPLETED|Washout||21||
59952148|NCT00829998|76071022|FG001|COMPLETED|Washout||19||
59952149|NCT00829998|76071021|FG000|NOT COMPLETED|Washout||0||
59767656|NCT00686374|75887862|FG000|STARTED|Overall Study||100||
59767657|NCT00686374|75887862|FG000|COMPLETED|Overall Study||39||
59767658|NCT00686374|75887862|FG000|NOT COMPLETED|Overall Study||61||
59767659|NCT00571948|75887868|FG000|STARTED|Overall Study||66||
59767660|NCT00571948|75887869|FG001|STARTED|Overall Study||66||
59767661|NCT00571948|75887868|FG000|COMPLETED|Overall Study|Excluded from analysis (n = 2) Reason: diet record for less than 75 % of days (n = 2)|55||
59767662|NCT00571948|75887869|FG001|COMPLETED|Overall Study|Excluded n = 3) Reasons: diet record < 75 % of days (n = 2); blood analysis failed (n= 1)|52||
59767663|NCT00571948|75887868|FG000|NOT COMPLETED|Overall Study||11||
59767664|NCT00571948|75887869|FG001|NOT COMPLETED|Overall Study||14||
59767665|NCT00684424|75887875|FG000|STARTED|Overall Study||199||
59767666|NCT00684424|75887875|FG000|COMPLETED|Overall Study||194||
59767667|NCT00684424|75887875|FG000|NOT COMPLETED|Overall Study||5||
59767668|NCT00685750|75887887|FG000|STARTED|Overall Study||17||
59767669|NCT00685750|75887888|FG001|STARTED|Overall Study||3||
59767670|NCT00685750|75887889|FG002|STARTED|Overall Study||21||
59767671|NCT00685750|75887890|FG003|STARTED|Overall Study||2||
59767672|NCT00685750|75887891|FG004|STARTED|Overall Study||15||
59767673|NCT00685750|75887892|FG005|STARTED|Overall Study||20||
59767674|NCT00685750|75887893|FG006|STARTED|Overall Study||10||
59767675|NCT00685750|75887887|FG000|COMPLETED|Overall Study||17||
59767676|NCT00685750|75887888|FG001|COMPLETED|Overall Study||3||
59767677|NCT00685750|75887889|FG002|COMPLETED|Overall Study||19||
59767678|NCT00685750|75887890|FG003|COMPLETED|Overall Study||2||
59767679|NCT00685750|75887891|FG004|COMPLETED|Overall Study||15||
59767680|NCT00685750|75887892|FG005|COMPLETED|Overall Study||20||
59767681|NCT00685750|75887893|FG006|COMPLETED|Overall Study||9||
59767682|NCT00685750|75887887|FG000|NOT COMPLETED|Overall Study||0||
59767683|NCT00685750|75887888|FG001|NOT COMPLETED|Overall Study||0||
59767684|NCT00685750|75887889|FG002|NOT COMPLETED|Overall Study||2||
59767685|NCT00685750|75887890|FG003|NOT COMPLETED|Overall Study||0||
59767686|NCT00685750|75887891|FG004|NOT COMPLETED|Overall Study||0||
59767687|NCT00685750|75887892|FG005|NOT COMPLETED|Overall Study||0||
59767688|NCT00685750|75887893|FG006|NOT COMPLETED|Overall Study||1||
59767689|NCT00576628|75887913|FG000|STARTED|Overall Study||125||
59767690|NCT00576628|75887913|FG000|COMPLETED|Overall Study||82||
59767691|NCT00576628|75887913|FG000|NOT COMPLETED|Overall Study||43||
59767692|NCT00683878|75887921|FG000|STARTED|Overall Study||139||
59767693|NCT00683878|75887922|FG001|STARTED|Overall Study||141||
59767694|NCT00683878|75887923|FG002|STARTED|Overall Study||140||
59767695|NCT00683878|75887921|FG000|COMPLETED|Overall Study||116||
59767696|NCT00683878|75887922|FG001|COMPLETED|Overall Study||125||
59767697|NCT00683878|75887923|FG002|COMPLETED|Overall Study||126||
59767698|NCT00683878|75887921|FG000|NOT COMPLETED|Overall Study||23||
59767699|NCT00683878|75887922|FG001|NOT COMPLETED|Overall Study||16||
59767700|NCT00683878|75887923|FG002|NOT COMPLETED|Overall Study||14||
59767701|NCT00884741|75887934|FG000|STARTED|Step 1 Registration: Tissue Screening||978||
59767702|NCT00884741|75887935|FG001|STARTED|Step 1 Registration: Tissue Screening||0||
59767703|NCT00884741|75887936|FG002|STARTED|Step 1 Registration: Tissue Screening||0||
59767704|NCT00884741|75887937|FG003|STARTED|Step 1 Registration: Tissue Screening||0||
59767705|NCT00884741|75887934|FG000|COMPLETED|Step 1 Registration: Tissue Screening||666||
59767706|NCT00884741|75887935|FG001|COMPLETED|Step 1 Registration: Tissue Screening||0||
59767707|NCT00884741|75887936|FG002|COMPLETED|Step 1 Registration: Tissue Screening||0||
59767708|NCT00884741|75887937|FG003|COMPLETED|Step 1 Registration: Tissue Screening||0||
59767709|NCT00884741|75887934|FG000|NOT COMPLETED|Step 1 Registration: Tissue Screening||312||
59767710|NCT00884741|75887935|FG001|NOT COMPLETED|Step 1 Registration: Tissue Screening||0||
59767711|NCT00884741|75887936|FG002|NOT COMPLETED|Step 1 Registration: Tissue Screening||0||
59767712|NCT00884741|75887937|FG003|NOT COMPLETED|Step 1 Registration: Tissue Screening||0||
59767713|NCT00884741|75887934|FG000|STARTED|Step 2 Registration: Tissue Analysis|Step 1 Registration Arm goes to Step 2 Registration Arm|0||
59767714|NCT00884741|75887935|FG001|STARTED|Step 2 Registration: Tissue Analysis|These patients completed the previous period on the Step 1 Registration arm.|666||
59767715|NCT00884741|75887936|FG002|STARTED|Step 2 Registration: Tissue Analysis||0||
59767716|NCT00884741|75887937|FG003|STARTED|Step 2 Registration: Tissue Analysis||0||
59767717|NCT00884741|75887934|FG000|COMPLETED|Step 2 Registration: Tissue Analysis||0||
59767718|NCT00884741|75887935|FG001|COMPLETED|Step 2 Registration: Tissue Analysis||637||
59767719|NCT00884741|75887936|FG002|COMPLETED|Step 2 Registration: Tissue Analysis||0||
59767720|NCT00884741|75887937|FG003|COMPLETED|Step 2 Registration: Tissue Analysis||0||
59767721|NCT00884741|75887934|FG000|NOT COMPLETED|Step 2 Registration: Tissue Analysis||0||
59767722|NCT00884741|75887935|FG001|NOT COMPLETED|Step 2 Registration: Tissue Analysis||29||
59767723|NCT00884741|75887936|FG002|NOT COMPLETED|Step 2 Registration: Tissue Analysis||0||
59767724|NCT00884741|75887937|FG003|NOT COMPLETED|Step 2 Registration: Tissue Analysis||0||
59767725|NCT00884741|75887934|FG000|STARTED|Randomization||0||
59767726|NCT00884741|75887935|FG001|STARTED|Randomization|Step 2 Registration Arm goes to a randomized arm.|0||
59767727|NCT00884741|75887936|FG002|STARTED|Randomization|These patients completed the previous period on the Step 2 Registration arm.|317||
59767728|NCT00884741|75887937|FG003|STARTED|Randomization|These patients completed the previous period on the Step 2 Registration arm.|320||
59767729|NCT00884741|75887934|FG000|COMPLETED|Randomization||0||
59767730|NCT00884741|75887935|FG001|COMPLETED|Randomization||0||
59767731|NCT00884741|75887936|FG002|COMPLETED|Randomization|Patients with data available for the primary analysis are considered to have completed the study.|309||
59767732|NCT00884741|75887937|FG003|COMPLETED|Randomization|Patients with data available for the primary analysis are considered to have completed the study.|312||
59767733|NCT00884741|75887934|FG000|NOT COMPLETED|Randomization||0||
59767734|NCT00884741|75887935|FG001|NOT COMPLETED|Randomization||0||
59767735|NCT00884741|75887936|FG002|NOT COMPLETED|Randomization||8||
59767736|NCT00884741|75887937|FG003|NOT COMPLETED|Randomization||8||
59767737|NCT00880763|75887948|FG000|STARTED|Initial Treatment Period (Part 1)||23||
59767738|NCT00880763|75887949|FG001|STARTED|Initial Treatment Period (Part 1)||22||
59767739|NCT00880763|75887950|FG002|STARTED|Initial Treatment Period (Part 1)||23||
59767740|NCT00880763|75887951|FG003|STARTED|Initial Treatment Period (Part 1)||22||
59767741|NCT00880763|75887948|FG000|COMPLETED|Initial Treatment Period (Part 1)||23||
59767742|NCT00880763|75887949|FG001|COMPLETED|Initial Treatment Period (Part 1)||22||
59767743|NCT00880763|75887950|FG002|COMPLETED|Initial Treatment Period (Part 1)||23||
59767744|NCT00880763|75887951|FG003|COMPLETED|Initial Treatment Period (Part 1)||22||
59767745|NCT00880763|75887948|FG000|NOT COMPLETED|Initial Treatment Period (Part 1)||0||
59767746|NCT00880763|75887949|FG001|NOT COMPLETED|Initial Treatment Period (Part 1)||0||
59767747|NCT00880763|75887950|FG002|NOT COMPLETED|Initial Treatment Period (Part 1)||0||
59767748|NCT00880763|75887951|FG003|NOT COMPLETED|Initial Treatment Period (Part 1)||0||
59767749|NCT00880763|75887948|FG000|STARTED|Extension Period (Part 2)||23||
59767750|NCT00880763|75887949|FG001|STARTED|Extension Period (Part 2)||22||
59767751|NCT00880763|75887950|FG002|STARTED|Extension Period (Part 2)||23||
59767752|NCT00880763|75887951|FG003|STARTED|Extension Period (Part 2)||22||
59767753|NCT00880763|75887948|FG000|COMPLETED|Extension Period (Part 2)||23||
59767754|NCT00880763|75887949|FG001|COMPLETED|Extension Period (Part 2)||19||
59767755|NCT00880763|75887950|FG002|COMPLETED|Extension Period (Part 2)||20||
59767756|NCT00880763|75887951|FG003|COMPLETED|Extension Period (Part 2)||19||
59767757|NCT00880763|75887948|FG000|NOT COMPLETED|Extension Period (Part 2)||0||
59952150|NCT00829998|76071022|FG001|NOT COMPLETED|Washout||1||
59952151|NCT00829998|76071021|FG000|STARTED|Second Intervention||21||
59952152|NCT00829998|76071022|FG001|STARTED|Second Intervention||19||
59952153|NCT00829998|76071021|FG000|COMPLETED|Second Intervention||21||
59952154|NCT00829998|76071022|FG001|COMPLETED|Second Intervention||19||
59952155|NCT00829998|76071021|FG000|NOT COMPLETED|Second Intervention||0||
59767758|NCT00880763|75887949|FG001|NOT COMPLETED|Extension Period (Part 2)||3||
59767759|NCT00880763|75887950|FG002|NOT COMPLETED|Extension Period (Part 2)||3||
59767760|NCT00880763|75887951|FG003|NOT COMPLETED|Extension Period (Part 2)||3||
59952156|NCT00829998|76071022|FG001|NOT COMPLETED|Second Intervention||0||
59952157|NCT02551718|76071026|FG000|STARTED|Overall Study||34||
59952158|NCT02551718|76071026|FG000|COMPLETED|Overall Study||34||
59952159|NCT02551718|76071026|FG000|NOT COMPLETED|Overall Study||0||
59952160|NCT00829764|76071033|FG000|STARTED|First Intervention||15||
59952161|NCT00829764|76071034|FG001|STARTED|First Intervention||15||
59767761|NCT00884273|75887963|FG000|STARTED|Overall Study|Intention-to-treat (ITT) population.|84||
59767762|NCT00884273|75887964|FG001|STARTED|Overall Study|ITT population.|98||
59767763|NCT00884273|75887963|FG000|Full Analysis Set (FAS)|Overall Study|Two participants did not have any post-dose efficacy assessment and were excluded from the FAS.|82||
59817848|NCT04488770|75940326|FG000|COMPLETED|Part 1-Cohort 1: Period 4 (Up to 5 Days)||2||
59952162|NCT00829764|76071033|FG000|COMPLETED|First Intervention||13||
59952163|NCT00829764|76071034|FG001|COMPLETED|First Intervention||14||
59618014|NCT03589326|75729223|FG000|Efficacy Evaluable Population|IP (Cycles 1-3) (Cycle Length=28 Days)||154|Efficacy evaluable population was defined as all participants in the ITT population with BCR:ABL1 dominant variant of p190 or p210 confirmed by central lab.|
59618015|NCT03589326|75729224|FG001|Efficacy Evaluable Population|IP (Cycles 1-3) (Cycle Length=28 Days)||78|Efficacy evaluable population was defined as all participants in the ITT population with BCR:ABL1 dominant variant of p190 or p210 confirmed by central lab.|
59709510|NCT00904033|75828257|FG003|COMPLETED|Overall Study||9||
59709511|NCT00904033|75828254|FG000|NOT COMPLETED|Overall Study||1||
59709512|NCT00904033|75828255|FG001|NOT COMPLETED|Overall Study||1||
59709513|NCT00904033|75828256|FG002|NOT COMPLETED|Overall Study||1||
59709514|NCT00904033|75828257|FG003|NOT COMPLETED|Overall Study||2||
59709515|NCT00903877|75828268|FG000|STARTED|Overall Study||51||
59952164|NCT00829764|76071033|FG000|NOT COMPLETED|First Intervention||2||
59952165|NCT00829764|76071034|FG001|NOT COMPLETED|First Intervention||1||
59952166|NCT00829764|76071033|FG000|STARTED|Washout of 14 Days||13||
59709516|NCT00903877|75828268|FG000|COMPLETED|Overall Study||8||
59709517|NCT00903877|75828268|FG000|NOT COMPLETED|Overall Study||43||
59709518|NCT01241591|75828276|FG000|STARTED|Overall Study||329||
59709519|NCT01241591|75828277|FG001|STARTED|Overall Study||330||
59709520|NCT01241591|75828278|FG002|STARTED|Overall Study||335||
59709521|NCT01241591|75828279|FG003|STARTED|Overall Study||107||
59709522|NCT01241591|75828276|FG000|COMPLETED|Overall Study||306||
59709523|NCT01241591|75828277|FG001|COMPLETED|Overall Study||306||
59709524|NCT01241591|75828278|FG002|COMPLETED|Overall Study||313||
59709525|NCT01241591|75828279|FG003|COMPLETED|Overall Study||95||
59709526|NCT01241591|75828276|FG000|NOT COMPLETED|Overall Study||23||
59709527|NCT01241591|75828277|FG001|NOT COMPLETED|Overall Study||24||
59521308|NCT01139515|75615551|FG003|COMPLETED|Second Intervention Period||4||
59521309|NCT01139515|75615548|FG000|NOT COMPLETED|Second Intervention Period||0||
59521310|NCT01139515|75615549|FG001|NOT COMPLETED|Second Intervention Period||0||
59521311|NCT01139515|75615550|FG002|NOT COMPLETED|Second Intervention Period||0||
59521312|NCT01139515|75615551|FG003|NOT COMPLETED|Second Intervention Period||0||
59521313|NCT01139515|75615548|FG000|STARTED|Washout Period 2 (46 Hrs)||4||
59521314|NCT01139515|75615549|FG001|STARTED|Washout Period 2 (46 Hrs)||4||
59521315|NCT01139515|75615550|FG002|STARTED|Washout Period 2 (46 Hrs)||4||
59521316|NCT01139515|75615551|FG003|STARTED|Washout Period 2 (46 Hrs)||4||
59521317|NCT01139515|75615548|FG000|COMPLETED|Washout Period 2 (46 Hrs)||4||
59521318|NCT01139515|75615549|FG001|COMPLETED|Washout Period 2 (46 Hrs)||4||
59521319|NCT01139515|75615550|FG002|COMPLETED|Washout Period 2 (46 Hrs)||4||
59521320|NCT01139515|75615551|FG003|COMPLETED|Washout Period 2 (46 Hrs)||4||
59521321|NCT01139515|75615548|FG000|NOT COMPLETED|Washout Period 2 (46 Hrs)||0||
59521322|NCT01139515|75615549|FG001|NOT COMPLETED|Washout Period 2 (46 Hrs)||0||
59521323|NCT01139515|75615550|FG002|NOT COMPLETED|Washout Period 2 (46 Hrs)||0||
59521324|NCT01139515|75615551|FG003|NOT COMPLETED|Washout Period 2 (46 Hrs)||0||
59521325|NCT01139515|75615548|FG000|STARTED|Third Intervention Period||4||
59521326|NCT01139515|75615549|FG001|STARTED|Third Intervention Period||4||
59521327|NCT01139515|75615550|FG002|STARTED|Third Intervention Period||4||
59521328|NCT01139515|75615551|FG003|STARTED|Third Intervention Period||4||
59521329|NCT01139515|75615548|FG000|COMPLETED|Third Intervention Period||4||
59521330|NCT01139515|75615549|FG001|COMPLETED|Third Intervention Period||4||
59521331|NCT01139515|75615550|FG002|COMPLETED|Third Intervention Period||4||
59521332|NCT01139515|75615551|FG003|COMPLETED|Third Intervention Period||4||
59521333|NCT01139515|75615548|FG000|NOT COMPLETED|Third Intervention Period||0||
59521334|NCT01139515|75615549|FG001|NOT COMPLETED|Third Intervention Period||0||
59521335|NCT01139515|75615550|FG002|NOT COMPLETED|Third Intervention Period||0||
59521336|NCT01139515|75615551|FG003|NOT COMPLETED|Third Intervention Period||0||
59521337|NCT01139515|75615548|FG000|STARTED|Washout Period 3 (46 Hrs)||4||
59521338|NCT01139515|75615549|FG001|STARTED|Washout Period 3 (46 Hrs)||4||
59521339|NCT01139515|75615550|FG002|STARTED|Washout Period 3 (46 Hrs)||4||
59521340|NCT01139515|75615551|FG003|STARTED|Washout Period 3 (46 Hrs)||4||
59521341|NCT01139515|75615548|FG000|COMPLETED|Washout Period 3 (46 Hrs)||4||
59521342|NCT01139515|75615549|FG001|COMPLETED|Washout Period 3 (46 Hrs)||4||
59521343|NCT01139515|75615550|FG002|COMPLETED|Washout Period 3 (46 Hrs)||4||
59521344|NCT01139515|75615551|FG003|COMPLETED|Washout Period 3 (46 Hrs)||4||
59521345|NCT01139515|75615548|FG000|NOT COMPLETED|Washout Period 3 (46 Hrs)||0||
59521346|NCT01139515|75615549|FG001|NOT COMPLETED|Washout Period 3 (46 Hrs)||0||
59521347|NCT01139515|75615550|FG002|NOT COMPLETED|Washout Period 3 (46 Hrs)||0||
59521348|NCT01139515|75615551|FG003|NOT COMPLETED|Washout Period 3 (46 Hrs)||0||
59521349|NCT01139515|75615548|FG000|STARTED|Fourth Intervention Period||4||
59521350|NCT01139515|75615549|FG001|STARTED|Fourth Intervention Period||4||
59521351|NCT01139515|75615550|FG002|STARTED|Fourth Intervention Period||4||
59521352|NCT01139515|75615551|FG003|STARTED|Fourth Intervention Period||4||
59521353|NCT01139515|75615548|FG000|COMPLETED|Fourth Intervention Period||4||
59521354|NCT01139515|75615549|FG001|COMPLETED|Fourth Intervention Period||4||
59521355|NCT01139515|75615550|FG002|COMPLETED|Fourth Intervention Period||4||
59521356|NCT01139515|75615551|FG003|COMPLETED|Fourth Intervention Period||4||
59521357|NCT01139515|75615548|FG000|NOT COMPLETED|Fourth Intervention Period||0||
59521358|NCT01139515|75615549|FG001|NOT COMPLETED|Fourth Intervention Period||0||
59521359|NCT01139515|75615550|FG002|NOT COMPLETED|Fourth Intervention Period||0||
59521360|NCT01139515|75615551|FG003|NOT COMPLETED|Fourth Intervention Period||0||
59521361|NCT00980018|75615561|FG000|STARTED|Overall Study||52||
59521362|NCT00980018|75615561|FG000|COMPLETED|Overall Study||40||
59521363|NCT00980018|75615561|FG000|NOT COMPLETED|Overall Study||12||
59521364|NCT01182103|75615567|FG000|STARTED|Overall Study||48||
59521365|NCT01182103|75615568|FG001|STARTED|Overall Study||62||
59521366|NCT01182103|75615567|FG000|COMPLETED|Overall Study||48||
59521367|NCT01182103|75615568|FG001|COMPLETED|Overall Study||62||
59521368|NCT01182103|75615567|FG000|NOT COMPLETED|Overall Study||0||
59521369|NCT01182103|75615568|FG001|NOT COMPLETED|Overall Study||0||
59521370|NCT00988052|75615579|FG000|STARTED|Overall Study||423||
59521371|NCT00988052|75615580|FG001|STARTED|Overall Study||416||
59521372|NCT00988052|75615579|FG000|COMPLETED|Overall Study||0||
59521373|NCT00988052|75615580|FG001|COMPLETED|Overall Study||0||
59521374|NCT00988052|75615579|FG000|NOT COMPLETED|Overall Study||423||
59521375|NCT00988052|75615580|FG001|NOT COMPLETED|Overall Study||416||
59521376|NCT01182493|75615588|FG000|STARTED|Overall Study||168||
59521377|NCT01182493|75615589|FG001|STARTED|Overall Study||163||
59521378|NCT01182493|75615588|FG000|COMPLETED|Overall Study||152||
59521379|NCT01182493|75615589|FG001|COMPLETED|Overall Study||156||
59521380|NCT01182493|75615588|FG000|NOT COMPLETED|Overall Study||16||
59521381|NCT01182493|75615589|FG001|NOT COMPLETED|Overall Study||7||
59521382|NCT01140295|75615597|FG000|STARTED|Overall Study||17||
59521383|NCT01140295|75615598|FG001|STARTED|Overall Study||16||
59521384|NCT01140295|75615597|FG000|COMPLETED|Overall Study||16||
59521385|NCT01140295|75615598|FG001|COMPLETED|Overall Study||14||
59521386|NCT01140295|75615597|FG000|NOT COMPLETED|Overall Study||1||
59521387|NCT01140295|75615598|FG001|NOT COMPLETED|Overall Study||2||
59521388|NCT01182805|75615606|FG000|STARTED|Overall Study||50||
59521389|NCT01182805|75615606|FG000|COMPLETED|Overall Study||50||
59521390|NCT01182805|75615606|FG000|NOT COMPLETED|Overall Study||0||
59521391|NCT01184755|75615615|FG000|STARTED|Overall Study||126||
59521392|NCT01184755|75615616|FG001|STARTED|Overall Study||65||
59521393|NCT01184755|75615617|FG002|STARTED|Overall Study||62||
59521394|NCT01184755|75615615|FG000|COMPLETED|Overall Study||101||
59521395|NCT01184755|75615616|FG001|COMPLETED|Overall Study||54||
59767764|NCT00884273|75887964|FG001|Full Analysis Set (FAS)|Overall Study|One participant did not have any post-dose efficacy assessment and was excluded from the FAS.|97||
59767765|NCT00884273|75887963|FG000|Per Protocol (PP) Analysis Set|Overall Study||81||
59767766|NCT00884273|75887964|FG001|Per Protocol (PP) Analysis Set|Overall Study||92||
59767767|NCT00884273|75887963|FG000|Safety Analysis Set|Overall Study||84||
59767768|NCT00884273|75887964|FG001|Safety Analysis Set|Overall Study||98||
59767769|NCT00884273|75887963|FG000|COMPLETED|Overall Study||82||
59767770|NCT00884273|75887964|FG001|COMPLETED|Overall Study||93||
59767771|NCT00884273|75887963|FG000|NOT COMPLETED|Overall Study||2||
59767772|NCT00884273|75887964|FG001|NOT COMPLETED|Overall Study||5||
59767773|NCT00884117|75887970|FG000|STARTED|Overall Study||4561||
59767774|NCT00884117|75887970|FG000|COMPLETED|Overall Study|Defined as Day 6 visit for those enrolled before Amendment D; thereafter defined as Day 10 visit.|4312||
59767775|NCT00884117|75887970|FG000|NOT COMPLETED|Overall Study||249||
59767776|NCT00884039|75887989|FG000|STARTED|Overall Study||5||
59767777|NCT00884039|75887990|FG001|STARTED|Overall Study||2||
59767778|NCT00884039|75887989|FG000|COMPLETED|Overall Study||3||
59767779|NCT00884039|75887990|FG001|COMPLETED|Overall Study||1||
60072547|NCT01682811|76187738|FG001|COMPLETED|Part 2 Dose Level 3||0||0
60072548|NCT01682811|76187739|FG002|COMPLETED|Part 2 Dose Level 3||0||0
60072549|NCT01682811|76187740|FG003|COMPLETED|Part 2 Dose Level 3||0||0
60072550|NCT01682811|76187741|FG004|COMPLETED|Part 2 Dose Level 3||0||0
60072551|NCT01682811|76187742|FG005|COMPLETED|Part 2 Dose Level 3||0||0
59521396|NCT01184755|75615617|FG002|COMPLETED|Overall Study||56||
59521397|NCT01184755|75615615|FG000|NOT COMPLETED|Overall Study||25||
59521398|NCT01184755|75615616|FG001|NOT COMPLETED|Overall Study||11||
59521399|NCT01184755|75615617|FG002|NOT COMPLETED|Overall Study||6||
59521400|NCT01141075|75615625|FG000|STARTED|Cycle 1||11||
59521401|NCT01141075|75615625|FG000|Received at Least 1 Dose of Study Drug|Cycle 1||11||
59767780|NCT00884039|75887989|FG000|NOT COMPLETED|Overall Study||2||
59767781|NCT00884039|75887990|FG001|NOT COMPLETED|Overall Study||1||
59767782|NCT00835770|75887998|FG000|STARTED|Overall Study||868||
59767783|NCT00835770|75887999|FG001|STARTED|Overall Study||868||
59767784|NCT00835770|75887998|FG000|COMPLETED|Overall Study||384||
59767785|NCT00835770|75887999|FG001|COMPLETED|Overall Study||375||
59767786|NCT00835770|75887998|FG000|NOT COMPLETED|Overall Study||484||
59767787|NCT00835770|75887999|FG001|NOT COMPLETED|Overall Study||493||
59767788|NCT00880685|75888011|FG000|STARTED|Memantine 10mg||12||
59767789|NCT00880685|75888011|FG000|COMPLETED|Memantine 10mg||10||
59767790|NCT00880685|75888011|FG000|NOT COMPLETED|Memantine 10mg||2||
59767791|NCT00880685|75888011|FG000|STARTED|Memantine 20mg||10||
59767792|NCT00880685|75888011|FG000|COMPLETED|Memantine 20mg||9||
59767793|NCT00880685|75888011|FG000|NOT COMPLETED|Memantine 20mg||1||
59767794|NCT00880685|75888011|FG000|STARTED|Memantine 30mg||9||
59952167|NCT00829764|76071034|FG001|STARTED|Washout of 14 Days||14||
59952168|NCT00829764|76071033|FG000|COMPLETED|Washout of 14 Days||13||
59952169|NCT00829764|76071034|FG001|COMPLETED|Washout of 14 Days||14||
59952170|NCT00829764|76071033|FG000|NOT COMPLETED|Washout of 14 Days||0||
59521402|NCT01141075|75615625|FG000|COMPLETED|Cycle 1||11||
59521403|NCT01141075|75615625|FG000|NOT COMPLETED|Cycle 1||0||
59521404|NCT01141075|75615625|FG000|STARTED|Cycle 2||11||
59521405|NCT01141075|75615625|FG000|Received at Least 1 Dose of Study Drug|Cycle 2||11||
59521406|NCT01141075|75615625|FG000|COMPLETED|Cycle 2||11||
59521407|NCT01141075|75615625|FG000|NOT COMPLETED|Cycle 2||0||
59952171|NCT00829764|76071034|FG001|NOT COMPLETED|Washout of 14 Days||0||
59952172|NCT00829764|76071033|FG000|STARTED|Second Intervention||13||
59952173|NCT00829764|76071034|FG001|STARTED|Second Intervention||14||
59952174|NCT00829764|76071033|FG000|COMPLETED|Second Intervention||13||
59952175|NCT00829764|76071034|FG001|COMPLETED|Second Intervention||14||
59952176|NCT00829764|76071033|FG000|NOT COMPLETED|Second Intervention||0||
59952177|NCT00829764|76071034|FG001|NOT COMPLETED|Second Intervention||0||
59952178|NCT03388008|76071040|FG000|STARTED|Overall Study||14||
59952179|NCT03388008|76071041|FG001|STARTED|Overall Study||13||
59952180|NCT03388008|76071040|FG000|COMPLETED|Overall Study||14||
59952181|NCT03388008|76071041|FG001|COMPLETED|Overall Study||13||
59952182|NCT03388008|76071040|FG000|NOT COMPLETED|Overall Study||0||
59952183|NCT03388008|76071041|FG001|NOT COMPLETED|Overall Study||0||
59952184|NCT00829686|76071049|FG000|STARTED|Overall Study||13||
59952185|NCT00829686|76071050|FG001|STARTED|Overall Study||18||
59952186|NCT00829686|76071049|FG000|COMPLETED|Overall Study||13||
59952187|NCT00829686|76071050|FG001|COMPLETED|Overall Study||18||
59952188|NCT00829686|76071049|FG000|NOT COMPLETED|Overall Study||0||
59952189|NCT00829686|76071050|FG001|NOT COMPLETED|Overall Study||0||
59952190|NCT00829530|76071056|FG000|STARTED|First Intervention||20||
59618016|NCT03589326|75729223|FG000|Safety Population|IP (Cycles 1-3) (Cycle Length=28 Days)||163|The safety population was defined as all participants who were randomized to the ponatinib or imatinib arm and received at least 1 dose of any study drug.|
59767795|NCT00880685|75888011|FG000|COMPLETED|Memantine 30mg||9||
59952191|NCT00829530|76071057|FG001|STARTED|First Intervention||20||
59952192|NCT00829530|76071056|FG000|COMPLETED|First Intervention||20||
59952193|NCT00829530|76071057|FG001|COMPLETED|First Intervention||18||
59952194|NCT00829530|76071056|FG000|NOT COMPLETED|First Intervention||0||
59952195|NCT00829530|76071057|FG001|NOT COMPLETED|First Intervention||2||
59952196|NCT00829530|76071056|FG000|STARTED|Washout of 42 Days||20||
59952197|NCT00829530|76071057|FG001|STARTED|Washout of 42 Days||18||
59952198|NCT00829530|76071056|FG000|COMPLETED|Washout of 42 Days||20||
59952199|NCT00829530|76071057|FG001|COMPLETED|Washout of 42 Days||18||
59952200|NCT00829530|76071056|FG000|NOT COMPLETED|Washout of 42 Days||0||
59952201|NCT00829530|76071057|FG001|NOT COMPLETED|Washout of 42 Days||0||
59952202|NCT00829530|76071056|FG000|STARTED|Second Intervention||20||
59952203|NCT00829530|76071057|FG001|STARTED|Second Intervention||18||
59952204|NCT00829530|76071056|FG000|COMPLETED|Second Intervention||19||
59952205|NCT00829530|76071057|FG001|COMPLETED|Second Intervention||18||
59952206|NCT00829530|76071056|FG000|NOT COMPLETED|Second Intervention||1||
59952207|NCT00829530|76071057|FG001|NOT COMPLETED|Second Intervention||0||
59952208|NCT01377194|76071064|FG000|STARTED|Overall Study||186||
59952209|NCT01377194|76071065|FG001|STARTED|Overall Study||188||
59952210|NCT01377194|76071066|FG002|STARTED|Overall Study||188||
59952211|NCT01377194|76071064|FG000|COMPLETED|Overall Study||154||
59767796|NCT00880685|75888011|FG000|NOT COMPLETED|Memantine 30mg||0||
59767797|NCT00835380|75888018|FG000|STARTED|Overall Study||80||
59767798|NCT00835380|75888018|FG000|COMPLETED|Overall Study||78||
59767799|NCT00835380|75888018|FG000|NOT COMPLETED|Overall Study||2||
59767800|NCT00880607|75888024|FG000|STARTED|Overall Study||44||
59767801|NCT00880607|75888025|FG001|STARTED|Overall Study||37||
59767802|NCT00880607|75888024|FG000|Observation After Receiving Medication|Overall Study||42||
59767803|NCT00880607|75888025|FG001|Observation After Receiving Medication|Overall Study||35||
59767804|NCT00880607|75888024|FG000|COMPLETED|Overall Study||37||
59767805|NCT00880607|75888025|FG001|COMPLETED|Overall Study||34||
59767806|NCT00880607|75888024|FG000|NOT COMPLETED|Overall Study||7||
59767807|NCT00880607|75888025|FG001|NOT COMPLETED|Overall Study||3||
59767808|NCT00835068|75888035|FG000|STARTED|Overall Study||57||
59767809|NCT00835068|75888036|FG001|STARTED|Overall Study||1||
59767810|NCT00835068|75888035|FG000|COMPLETED|Overall Study||47||
59767811|NCT00835068|75888036|FG001|COMPLETED|Overall Study||0||
59767812|NCT00835068|75888035|FG000|NOT COMPLETED|Overall Study||10||
59767813|NCT00835068|75888036|FG001|NOT COMPLETED|Overall Study||1||
59767814|NCT00834912|75888048|FG000|STARTED|Treatment Period 1||6||
59767815|NCT00834912|75888049|FG001|STARTED|Treatment Period 1||6||
59767816|NCT00834912|75888050|FG002|STARTED|Treatment Period 1||6||
59767817|NCT00834912|75888051|FG003|STARTED|Treatment Period 1||6||
59767818|NCT00834912|75888052|FG004|STARTED|Treatment Period 1||6||
59767819|NCT00834912|75888053|FG005|STARTED|Treatment Period 1||6||
59952212|NCT01377194|76071065|FG001|COMPLETED|Overall Study||145||
59952213|NCT01377194|76071066|FG002|COMPLETED|Overall Study||142||
59952214|NCT01377194|76071064|FG000|NOT COMPLETED|Overall Study||32||
59767820|NCT00834912|75888048|FG000|COMPLETED|Treatment Period 1||6||
59767821|NCT00834912|75888049|FG001|COMPLETED|Treatment Period 1|One subject completed all of treatment period 1 assessments but did not enter treatment period 2|5||
59767822|NCT00834912|75888050|FG002|COMPLETED|Treatment Period 1||6||
59767823|NCT00834912|75888051|FG003|COMPLETED|Treatment Period 1|One subject completed all of treatment period 1 assessments but did not enter treatment period 2|5||
59767824|NCT00834912|75888052|FG004|COMPLETED|Treatment Period 1||6||
59952215|NCT01377194|76071065|FG001|NOT COMPLETED|Overall Study||43||
59952216|NCT01377194|76071066|FG002|NOT COMPLETED|Overall Study||46||
59618017|NCT03589326|75729224|FG001|Safety Population|IP (Cycles 1-3) (Cycle Length=28 Days)||81|The safety population was defined as all participants who were randomized to the ponatinib or imatinib arm and received at least 1 dose of any study drug.|
59618018|NCT03589326|75729223|FG000|COMPLETED|IP (Cycles 1-3) (Cycle Length=28 Days)||0||
59618019|NCT03589326|75729224|FG001|COMPLETED|IP (Cycles 1-3) (Cycle Length=28 Days)||0||
59618020|NCT03589326|75729223|FG000|NOT COMPLETED|IP (Cycles 1-3) (Cycle Length=28 Days)||164||
59618021|NCT03589326|75729224|FG001|NOT COMPLETED|IP (Cycles 1-3) (Cycle Length=28 Days)||81||
59767825|NCT00834912|75888053|FG005|COMPLETED|Treatment Period 1||6||
59952217|NCT00829452|76071079|FG000|STARTED|First Intervention||20||
59618022|NCT03589326|75729223|FG000|STARTED|CP (Cycles 4-9) (Cycle Length=28 Days)||0|Participants are still ongoing in Induction Phase.|
59618023|NCT03589326|75729224|FG001|STARTED|CP (Cycles 4-9) (Cycle Length=28 Days)||0|Participants are still ongoing in Induction Phase.|
59618024|NCT03589326|75729223|FG000|COMPLETED|CP (Cycles 4-9) (Cycle Length=28 Days)||0||
59618025|NCT03589326|75729224|FG001|COMPLETED|CP (Cycles 4-9) (Cycle Length=28 Days)||0||
59952218|NCT00829452|76071080|FG001|STARTED|First Intervention||20||
59952219|NCT00829452|76071079|FG000|COMPLETED|First Intervention||20||
59952220|NCT00829452|76071080|FG001|COMPLETED|First Intervention||19||
59767826|NCT00834912|75888048|FG000|NOT COMPLETED|Treatment Period 1||0||
59767827|NCT00834912|75888049|FG001|NOT COMPLETED|Treatment Period 1||1||
59767828|NCT00834912|75888050|FG002|NOT COMPLETED|Treatment Period 1||0||
59767829|NCT00834912|75888051|FG003|NOT COMPLETED|Treatment Period 1||1||
59767830|NCT00834912|75888052|FG004|NOT COMPLETED|Treatment Period 1||0||
59767831|NCT00834912|75888053|FG005|NOT COMPLETED|Treatment Period 1||0||
59767832|NCT00834912|75888048|FG000|STARTED|Treatment Period 2||6||
59767833|NCT00834912|75888049|FG001|STARTED|Treatment Period 2||5||
59767834|NCT00834912|75888050|FG002|STARTED|Treatment Period 2||6||
59767835|NCT00834912|75888051|FG003|STARTED|Treatment Period 2||5||
59767836|NCT00834912|75888052|FG004|STARTED|Treatment Period 2||6||
59767837|NCT00834912|75888053|FG005|STARTED|Treatment Period 2||6||
59952221|NCT00829452|76071079|FG000|NOT COMPLETED|First Intervention||0||
59952222|NCT00829452|76071080|FG001|NOT COMPLETED|First Intervention||1||
59952223|NCT00829452|76071079|FG000|STARTED|Washout of 42 Days||20||
59952224|NCT00829452|76071080|FG001|STARTED|Washout of 42 Days||19||
59952225|NCT00829452|76071079|FG000|COMPLETED|Washout of 42 Days||20||
59952226|NCT00829452|76071080|FG001|COMPLETED|Washout of 42 Days||18||
59767838|NCT00834912|75888048|FG000|COMPLETED|Treatment Period 2||6||
59767839|NCT00834912|75888049|FG001|COMPLETED|Treatment Period 2||5||
59767840|NCT00834912|75888050|FG002|COMPLETED|Treatment Period 2|One subject completed treatment period 2 but did not enter treatment period 3|5||
59952227|NCT00829452|76071079|FG000|NOT COMPLETED|Washout of 42 Days||0||
59952228|NCT00829452|76071080|FG001|NOT COMPLETED|Washout of 42 Days||1||
59952229|NCT00829452|76071079|FG000|STARTED|Second Intervention||20||
59952230|NCT00829452|76071080|FG001|STARTED|Second Intervention||18||
59952231|NCT00829452|76071079|FG000|COMPLETED|Second Intervention||20||
59952232|NCT00829452|76071080|FG001|COMPLETED|Second Intervention||17||
59952233|NCT00829452|76071079|FG000|NOT COMPLETED|Second Intervention||0||
59952234|NCT00829452|76071080|FG001|NOT COMPLETED|Second Intervention||1||
59952235|NCT04600076|76071084|FG000|STARTED|Overall Study||22||
59952236|NCT04600076|76071084|FG000|COMPLETED|Overall Study||19||
59952237|NCT04600076|76071084|FG000|NOT COMPLETED|Overall Study||3||
59952238|NCT02064387|76071100|FG000|STARTED|Part 1 Max 23.5 Months Followup Duration||1||
59952239|NCT02064387|76071101|FG001|STARTED|Part 1 Max 23.5 Months Followup Duration||1||
59952240|NCT02064387|76071102|FG002|STARTED|Part 1 Max 23.5 Months Followup Duration||4||
59952241|NCT02064387|76071103|FG003|STARTED|Part 1 Max 23.5 Months Followup Duration||4||
59952242|NCT02064387|76071104|FG004|STARTED|Part 1 Max 23.5 Months Followup Duration||4||
59952243|NCT02064387|76071105|FG005|STARTED|Part 1 Max 23.5 Months Followup Duration||3||
59618026|NCT03589326|75729223|FG000|NOT COMPLETED|CP (Cycles 4-9) (Cycle Length=28 Days)||0||
59618027|NCT03589326|75729224|FG001|NOT COMPLETED|CP (Cycles 4-9) (Cycle Length=28 Days)||0||
59618028|NCT03589326|75729223|FG000|STARTED|MP (Cycles 10-20) (Cycle Length=28 Days)||0|Participants are still ongoing in Induction Phase.|
59618029|NCT03589326|75729224|FG001|STARTED|MP (Cycles 10-20) (Cycle Length=28 Days)||0|Participants are still ongoing in Induction Phase.|
59618030|NCT03589326|75729223|FG000|COMPLETED|MP (Cycles 10-20) (Cycle Length=28 Days)||0||
59618031|NCT03589326|75729224|FG001|COMPLETED|MP (Cycles 10-20) (Cycle Length=28 Days)||0||
59618032|NCT03589326|75729223|FG000|NOT COMPLETED|MP (Cycles 10-20) (Cycle Length=28 Days)||0||
59618033|NCT03589326|75729224|FG001|NOT COMPLETED|MP (Cycles 10-20) (Cycle Length=28 Days)||0||
59618034|NCT03027414|75729233|FG000|STARTED|Overall Study||28||
59618035|NCT03027414|75729234|FG001|STARTED|Overall Study||0||
59618036|NCT03027414|75729235|FG002|STARTED|Overall Study||26||
59618037|NCT03027414|75729233|FG000|COMPLETED|Overall Study||19||
59618038|NCT03027414|75729234|FG001|COMPLETED|Overall Study||0||
59618039|NCT03027414|75729235|FG002|COMPLETED|Overall Study||20||
59952244|NCT02064387|76071106|FG006|STARTED|Part 1 Max 23.5 Months Followup Duration||4||
59995228|NCT04185909|76111057|FG000|STARTED|Overall Study||55||
59618040|NCT03027414|75729233|FG000|NOT COMPLETED|Overall Study||9||
59618041|NCT03027414|75729234|FG001|NOT COMPLETED|Overall Study||0||
59618042|NCT03027414|75729235|FG002|NOT COMPLETED|Overall Study||6||
59618043|NCT03028740|75729245|FG000|STARTED|Overall Study||593||
59618044|NCT03028740|75729246|FG001|STARTED|Overall Study||1185||
59618045|NCT03028740|75729245|FG000|Full Study Cohort: Received Study Drug|Overall Study||589||
59618046|NCT03028740|75729246|FG001|Full Study Cohort: Received Study Drug|Overall Study||1180||
59618047|NCT03028740|75729245|FG000|Participated in Part 1|Overall Study||432||
59618048|NCT03028740|75729246|FG001|Participated in Part 1|Overall Study||861||
59618049|NCT03028740|75729245|FG000|Part 1: Received Study Drug|Overall Study||429||
59767841|NCT00834912|75888051|FG003|COMPLETED|Treatment Period 2||5||
59521408|NCT02185105|75615629|FG000|STARTED|Overall Study||30||
59521409|NCT02185105|75615629|FG000|COMPLETED|Overall Study||30||
59521410|NCT02185105|75615629|FG000|NOT COMPLETED|Overall Study||0||
59521411|NCT02185183|75615640|FG000|STARTED|Overall Study||14||
59521412|NCT02185183|75615640|FG000|COMPLETED|Overall Study||14||
59521413|NCT02185183|75615640|FG000|NOT COMPLETED|Overall Study||0||
59521414|NCT02185339|75615646|FG000|STARTED|Overall Study||30||
59521415|NCT02185339|75615647|FG001|STARTED|Overall Study||31||
59521416|NCT02185339|75615646|FG000|COMPLETED|Overall Study||30||
59521417|NCT02185339|75615647|FG001|COMPLETED|Overall Study||30||
59521418|NCT02185339|75615646|FG000|NOT COMPLETED|Overall Study||0||
59521419|NCT02185339|75615647|FG001|NOT COMPLETED|Overall Study||1||
59521420|NCT01186705|75615653|FG000|STARTED|Overall Study||1||
59521421|NCT01186705|75615653|FG000|COMPLETED|Overall Study||1||
59521422|NCT01186705|75615653|FG000|NOT COMPLETED|Overall Study||0||
59521423|NCT01218997|75615659|FG000|STARTED|Overall Study||371||
59521424|NCT01218997|75615660|FG001|STARTED|Overall Study||65||
59521425|NCT01218997|75615659|FG000|COMPLETED|Overall Study||126||
59521426|NCT01218997|75615660|FG001|COMPLETED|Overall Study||24||
59521427|NCT01218997|75615659|FG000|NOT COMPLETED|Overall Study||245||
59521428|NCT01218997|75615660|FG001|NOT COMPLETED|Overall Study||41||
59521429|NCT01219777|75615666|FG000|STARTED|Overall Study||9||
59521430|NCT01219777|75615666|FG000|COMPLETED|Overall Study||9||
59521431|NCT01219777|75615666|FG000|NOT COMPLETED|Overall Study||0||
59521432|NCT02569710|75615681|FG000|STARTED|Overall Study||20||
59521433|NCT02569710|75615682|FG001|STARTED|Overall Study||25||
59521434|NCT02569710|75615683|FG002|STARTED|Overall Study||20||
59521435|NCT02569710|75615684|FG003|STARTED|Overall Study||20||
59521436|NCT02569710|75615685|FG004|STARTED|Overall Study||8||
59521437|NCT02569710|75615686|FG005|STARTED|Overall Study||5||
59521438|NCT02569710|75615687|FG006|STARTED|Overall Study||14||
59521439|NCT02569710|75615688|FG007|STARTED|Overall Study||30||
59521440|NCT02569710|75615689|FG008|STARTED|Overall Study||15||
59521441|NCT02569710|75615690|FG009|STARTED|Overall Study||4||
59521442|NCT02569710|75615681|FG000|COMPLETED|Overall Study||19||
59521443|NCT02569710|75615682|FG001|COMPLETED|Overall Study||25||
59521444|NCT02569710|75615683|FG002|COMPLETED|Overall Study||20||
59952245|NCT02064387|76071107|FG007|STARTED|Part 1 Max 23.5 Months Followup Duration||8||
59521445|NCT02569710|75615684|FG003|COMPLETED|Overall Study||20||
59521446|NCT02569710|75615685|FG004|COMPLETED|Overall Study||7||
59521447|NCT02569710|75615686|FG005|COMPLETED|Overall Study||4||
59521448|NCT02569710|75615687|FG006|COMPLETED|Overall Study||12||
59521449|NCT02569710|75615688|FG007|COMPLETED|Overall Study||30||
59521450|NCT02569710|75615689|FG008|COMPLETED|Overall Study||14||
59521451|NCT02569710|75615690|FG009|COMPLETED|Overall Study||4||
59521452|NCT02569710|75615681|FG000|NOT COMPLETED|Overall Study||1||
59521453|NCT02569710|75615682|FG001|NOT COMPLETED|Overall Study||0||
59521454|NCT02569710|75615683|FG002|NOT COMPLETED|Overall Study||0||
59521455|NCT02569710|75615684|FG003|NOT COMPLETED|Overall Study||0||
59521456|NCT02569710|75615685|FG004|NOT COMPLETED|Overall Study||1||
59521457|NCT02569710|75615686|FG005|NOT COMPLETED|Overall Study||1||
59521458|NCT02569710|75615687|FG006|NOT COMPLETED|Overall Study||2||
59521459|NCT02569710|75615688|FG007|NOT COMPLETED|Overall Study||0||
59521460|NCT02569710|75615689|FG008|NOT COMPLETED|Overall Study||1||
59521461|NCT02569710|75615690|FG009|NOT COMPLETED|Overall Study||0||
59521462|NCT01219855|75615728|FG000|STARTED|Overall Study||17||
59521463|NCT01219855|75615729|FG001|STARTED|Overall Study||17||
59521464|NCT01219855|75615730|FG002|STARTED|Overall Study||17||
59521465|NCT01219855|75615731|FG003|STARTED|Overall Study||13||
59521466|NCT01219855|75615732|FG004|STARTED|Overall Study||14||
59521467|NCT01219855|75615728|FG000|COMPLETED|Overall Study||16||
59521468|NCT01219855|75615729|FG001|COMPLETED|Overall Study||12||
59521469|NCT01219855|75615730|FG002|COMPLETED|Overall Study||16||
59521470|NCT01219855|75615731|FG003|COMPLETED|Overall Study||12||
59521471|NCT01219855|75615732|FG004|COMPLETED|Overall Study||13||
59521472|NCT01219855|75615728|FG000|NOT COMPLETED|Overall Study||1||
59521473|NCT01219855|75615729|FG001|NOT COMPLETED|Overall Study||5||
59521474|NCT01219855|75615730|FG002|NOT COMPLETED|Overall Study||1||
59521475|NCT01219855|75615731|FG003|NOT COMPLETED|Overall Study||1||
59952246|NCT02064387|76071108|FG008|STARTED|Part 1 Max 23.5 Months Followup Duration||3||
59952247|NCT02064387|76071109|FG009|STARTED|Part 1 Max 23.5 Months Followup Duration||6||
59952248|NCT02064387|76071110|FG010|STARTED|Part 1 Max 23.5 Months Followup Duration||0||
59521476|NCT01219855|75615732|FG004|NOT COMPLETED|Overall Study||1||
59521477|NCT01220869|75615743|FG000|STARTED|Overall Study||110||
59521478|NCT01220869|75615743|FG000|COMPLETED|Overall Study||104||
59521479|NCT01220869|75615743|FG000|NOT COMPLETED|Overall Study||6||
59521480|NCT01016483|75615751|FG000|STARTED|Safety Run-in Part||27||
59521481|NCT01016483|75615752|FG001|STARTED|Safety Run-in Part||26||
59521482|NCT01016483|75615753|FG002|STARTED|Safety Run-in Part||0||
59521483|NCT01016483|75615754|FG003|STARTED|Safety Run-in Part||0||
59521484|NCT01016483|75615751|FG000|COMPLETED|Safety Run-in Part||27||
59521485|NCT01016483|75615752|FG001|COMPLETED|Safety Run-in Part||26||
59521486|NCT01016483|75615753|FG002|COMPLETED|Safety Run-in Part||0||
59521487|NCT01016483|75615754|FG003|COMPLETED|Safety Run-in Part||0||
59952249|NCT02064387|76071111|FG011|STARTED|Part 1 Max 23.5 Months Followup Duration||0||
59952250|NCT02064387|76071100|FG000|COMPLETED|Part 1 Max 23.5 Months Followup Duration||1||
59952251|NCT02064387|76071101|FG001|COMPLETED|Part 1 Max 23.5 Months Followup Duration||1||
59952252|NCT02064387|76071102|FG002|COMPLETED|Part 1 Max 23.5 Months Followup Duration||4||
59952253|NCT02064387|76071103|FG003|COMPLETED|Part 1 Max 23.5 Months Followup Duration||4||
59952254|NCT02064387|76071104|FG004|COMPLETED|Part 1 Max 23.5 Months Followup Duration||4||
59952255|NCT02064387|76071105|FG005|COMPLETED|Part 1 Max 23.5 Months Followup Duration||3||
59952256|NCT02064387|76071106|FG006|COMPLETED|Part 1 Max 23.5 Months Followup Duration||4||
59952257|NCT02064387|76071107|FG007|COMPLETED|Part 1 Max 23.5 Months Followup Duration||6||
59952258|NCT02064387|76071108|FG008|COMPLETED|Part 1 Max 23.5 Months Followup Duration||2||
59767842|NCT00834912|75888052|FG004|COMPLETED|Treatment Period 2|One subject completed treatment period 2 but did not enter treatment period 3|5||
59767843|NCT00834912|75888053|FG005|COMPLETED|Treatment Period 2||6||
59767844|NCT00834912|75888048|FG000|NOT COMPLETED|Treatment Period 2||0||
59767845|NCT00834912|75888049|FG001|NOT COMPLETED|Treatment Period 2||0||
59767846|NCT00834912|75888050|FG002|NOT COMPLETED|Treatment Period 2||1||
59767847|NCT00834912|75888051|FG003|NOT COMPLETED|Treatment Period 2||0||
59952259|NCT02064387|76071109|FG009|COMPLETED|Part 1 Max 23.5 Months Followup Duration||5||
59952260|NCT02064387|76071110|FG010|COMPLETED|Part 1 Max 23.5 Months Followup Duration||0||
59952261|NCT02064387|76071111|FG011|COMPLETED|Part 1 Max 23.5 Months Followup Duration||0||
59952262|NCT02064387|76071100|FG000|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0||
59952263|NCT02064387|76071101|FG001|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0||
59952264|NCT02064387|76071102|FG002|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0||
59952265|NCT02064387|76071103|FG003|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0||
59952266|NCT02064387|76071104|FG004|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0||
59952267|NCT02064387|76071105|FG005|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0||
59952268|NCT02064387|76071106|FG006|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0||
59952269|NCT02064387|76071107|FG007|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||2||
59952270|NCT02064387|76071108|FG008|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||1||
59952271|NCT02064387|76071109|FG009|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||1||
59952272|NCT02064387|76071110|FG010|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0||
59952273|NCT02064387|76071111|FG011|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0||
59952274|NCT02064387|76071100|FG000|STARTED|Part 2 Max 35 Months Followup Duration||0||
59952275|NCT02064387|76071101|FG001|STARTED|Part 2 Max 35 Months Followup Duration||0||
59952276|NCT02064387|76071102|FG002|STARTED|Part 2 Max 35 Months Followup Duration||0||
59952277|NCT02064387|76071103|FG003|STARTED|Part 2 Max 35 Months Followup Duration||0||
59952278|NCT02064387|76071104|FG004|STARTED|Part 2 Max 35 Months Followup Duration||0||
59952279|NCT02064387|76071105|FG005|STARTED|Part 2 Max 35 Months Followup Duration||0||
59952280|NCT02064387|76071106|FG006|STARTED|Part 2 Max 35 Months Followup Duration||0||
59952281|NCT02064387|76071107|FG007|STARTED|Part 2 Max 35 Months Followup Duration||0||
59952282|NCT02064387|76071108|FG008|STARTED|Part 2 Max 35 Months Followup Duration||0||
59952283|NCT02064387|76071109|FG009|STARTED|Part 2 Max 35 Months Followup Duration||0||
59952284|NCT02064387|76071110|FG010|STARTED|Part 2 Max 35 Months Followup Duration||35||
59952285|NCT02064387|76071111|FG011|STARTED|Part 2 Max 35 Months Followup Duration||6||
59767848|NCT00834912|75888052|FG004|NOT COMPLETED|Treatment Period 2||1||
59767849|NCT00834912|75888053|FG005|NOT COMPLETED|Treatment Period 2||0||
59767850|NCT00834912|75888048|FG000|STARTED|Treatment Period 3||6||
59767851|NCT00834912|75888049|FG001|STARTED|Treatment Period 3||5||
59767852|NCT00834912|75888050|FG002|STARTED|Treatment Period 3||5||
59767853|NCT00834912|75888051|FG003|STARTED|Treatment Period 3||5||
59952286|NCT02064387|76071100|FG000|COMPLETED|Part 2 Max 35 Months Followup Duration||0||
59952287|NCT02064387|76071101|FG001|COMPLETED|Part 2 Max 35 Months Followup Duration||0||
59952288|NCT02064387|76071102|FG002|COMPLETED|Part 2 Max 35 Months Followup Duration||0||
59952289|NCT02064387|76071103|FG003|COMPLETED|Part 2 Max 35 Months Followup Duration||0||
59952290|NCT02064387|76071104|FG004|COMPLETED|Part 2 Max 35 Months Followup Duration||0||
59952291|NCT02064387|76071105|FG005|COMPLETED|Part 2 Max 35 Months Followup Duration||0||
59952292|NCT02064387|76071106|FG006|COMPLETED|Part 2 Max 35 Months Followup Duration||0||
59952293|NCT02064387|76071107|FG007|COMPLETED|Part 2 Max 35 Months Followup Duration||0||
59952294|NCT02064387|76071108|FG008|COMPLETED|Part 2 Max 35 Months Followup Duration||0||
59952295|NCT02064387|76071109|FG009|COMPLETED|Part 2 Max 35 Months Followup Duration||0||
59952296|NCT02064387|76071110|FG010|COMPLETED|Part 2 Max 35 Months Followup Duration||29||
59952297|NCT02064387|76071111|FG011|COMPLETED|Part 2 Max 35 Months Followup Duration||3||
59952298|NCT02064387|76071100|FG000|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0||
59952299|NCT02064387|76071101|FG001|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0||
59767854|NCT00834912|75888052|FG004|STARTED|Treatment Period 3||5||
59767855|NCT00834912|75888053|FG005|STARTED|Treatment Period 3||6||
59952300|NCT02064387|76071102|FG002|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0||
59952301|NCT02064387|76071103|FG003|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0||
59952302|NCT02064387|76071104|FG004|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0||
59952303|NCT02064387|76071105|FG005|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0||
59952304|NCT02064387|76071106|FG006|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0||
59952305|NCT02064387|76071107|FG007|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0||
59952306|NCT02064387|76071108|FG008|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0||
60072552|NCT01682811|76187743|FG006|COMPLETED|Part 2 Dose Level 3||0||0
59618050|NCT03028740|75729246|FG001|Part 1: Received Study Drug|Overall Study||859||
59618051|NCT03028740|75729245|FG000|COMPLETED|Overall Study||0||
59618052|NCT03028740|75729246|FG001|COMPLETED|Overall Study||0||
59618053|NCT03028740|75729245|FG000|NOT COMPLETED|Overall Study||593||
59618054|NCT03028740|75729246|FG001|NOT COMPLETED|Overall Study||1185||
59618055|NCT03028896|75729257|FG000|STARTED|Overall Study||66||
59618056|NCT03028896|75729258|FG001|STARTED|Overall Study||66||
59618057|NCT03028896|75729257|FG000|COMPLETED|Overall Study||63||
59618058|NCT03028896|75729258|FG001|COMPLETED|Overall Study||66||
59618059|NCT03028896|75729257|FG000|NOT COMPLETED|Overall Study||3||
59618060|NCT03028896|75729258|FG001|NOT COMPLETED|Overall Study||0||
59618061|NCT02980692|75729269|FG000|STARTED|Double Blind Placebo Controlled Period||78||
59618062|NCT02980692|75729270|FG001|STARTED|Double Blind Placebo Controlled Period||79||
59618063|NCT02980692|75729271|FG002|STARTED|Double Blind Placebo Controlled Period||77||
59618064|NCT02980692|75729272|FG003|STARTED|Double Blind Placebo Controlled Period||78||
59618065|NCT02980692|75729273|FG004|STARTED|Double Blind Placebo Controlled Period||79||
59618066|NCT02980692|75729269|FG000|COMPLETED|Double Blind Placebo Controlled Period||62||
59618067|NCT02980692|75729270|FG001|COMPLETED|Double Blind Placebo Controlled Period||64||
59618068|NCT02980692|75729271|FG002|COMPLETED|Double Blind Placebo Controlled Period||60||
59618069|NCT02980692|75729272|FG003|COMPLETED|Double Blind Placebo Controlled Period||71||
59618070|NCT02980692|75729273|FG004|COMPLETED|Double Blind Placebo Controlled Period||74||
59618071|NCT02980692|75729269|FG000|NOT COMPLETED|Double Blind Placebo Controlled Period||16||
59618072|NCT02980692|75729270|FG001|NOT COMPLETED|Double Blind Placebo Controlled Period||15||
59618073|NCT02980692|75729271|FG002|NOT COMPLETED|Double Blind Placebo Controlled Period||17||
59618074|NCT02980692|75729272|FG003|NOT COMPLETED|Double Blind Placebo Controlled Period||7||
59618075|NCT02980692|75729273|FG004|NOT COMPLETED|Double Blind Placebo Controlled Period||5||
59618076|NCT02980692|75729269|FG000|STARTED|Double-blind Follow-up Period||62||
59618077|NCT02980692|75729270|FG001|STARTED|Double-blind Follow-up Period||64||
59618078|NCT02980692|75729271|FG002|STARTED|Double-blind Follow-up Period||60||
59618079|NCT02980692|75729272|FG003|STARTED|Double-blind Follow-up Period||71||
59618080|NCT02980692|75729273|FG004|STARTED|Double-blind Follow-up Period||74||
59618081|NCT02980692|75729269|FG000|COMPLETED|Double-blind Follow-up Period||62||
59618082|NCT02980692|75729270|FG001|COMPLETED|Double-blind Follow-up Period||61||
59618083|NCT02980692|75729271|FG002|COMPLETED|Double-blind Follow-up Period||56||
59618084|NCT02980692|75729272|FG003|COMPLETED|Double-blind Follow-up Period||67||
59618085|NCT02980692|75729273|FG004|COMPLETED|Double-blind Follow-up Period||69||
59618086|NCT02980692|75729269|FG000|NOT COMPLETED|Double-blind Follow-up Period||0||
59618087|NCT02980692|75729270|FG001|NOT COMPLETED|Double-blind Follow-up Period||3||
59618088|NCT02980692|75729271|FG002|NOT COMPLETED|Double-blind Follow-up Period||4||
59618089|NCT02980692|75729272|FG003|NOT COMPLETED|Double-blind Follow-up Period||4||
59618090|NCT02980692|75729273|FG004|NOT COMPLETED|Double-blind Follow-up Period||5||
59618091|NCT02335710|75729302|FG000|STARTED|Overall Study||40||
59618092|NCT02335710|75729303|FG001|STARTED|Overall Study||10||
59618093|NCT02335710|75729302|FG000|COMPLETED|Overall Study||40||
59618094|NCT02335710|75729303|FG001|COMPLETED|Overall Study||10||
59618095|NCT02335710|75729302|FG000|NOT COMPLETED|Overall Study||0||
59618096|NCT02335710|75729303|FG001|NOT COMPLETED|Overall Study||0||
59618097|NCT03875664|75729311|FG000|STARTED|Overall Study||37||
59618098|NCT03875664|75729312|FG001|STARTED|Overall Study||35||
59618099|NCT03875664|75729311|FG000|COMPLETED|Overall Study|vaginal surgery n=18; vaginal + abdominal surgery n=19|37||
59618100|NCT03875664|75729312|FG001|COMPLETED|Overall Study|Vaginal surgery n=18; vaginal + abdominal surgery n=17|35||
59618101|NCT03875664|75729311|FG000|NOT COMPLETED|Overall Study||0||
59618102|NCT03875664|75729312|FG001|NOT COMPLETED|Overall Study||0||
59618103|NCT03870048|75729318|FG000|STARTED|SHAM Effects on Pain and Fatigue||6||
59618104|NCT03870048|75729318|FG000|COMPLETED|SHAM Effects on Pain and Fatigue||6||
59618105|NCT03870048|75729318|FG000|NOT COMPLETED|SHAM Effects on Pain and Fatigue||0||
59618106|NCT03870048|75729318|FG000|STARTED|tDCS Effects on Pain and Fatigue||6||
59618107|NCT03870048|75729318|FG000|COMPLETED|tDCS Effects on Pain and Fatigue||6||
59618108|NCT03870048|75729318|FG000|NOT COMPLETED|tDCS Effects on Pain and Fatigue||0||
59618109|NCT03866538|75729326|FG000|STARTED|Overall Study||0||
59618110|NCT03866538|75729327|FG001|STARTED|Overall Study||1||
59618111|NCT03866538|75729326|FG000|COMPLETED|Overall Study||0||
59952307|NCT02064387|76071109|FG009|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0||
59952308|NCT02064387|76071110|FG010|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||6||
59952309|NCT02064387|76071111|FG011|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||3||
59952310|NCT01328366|76071150|FG000|STARTED|Overall Study||153||
59952311|NCT01328366|76071150|FG000|COMPLETED|Overall Study||143||
59952312|NCT01328366|76071150|FG000|NOT COMPLETED|Overall Study||10||
59618112|NCT03866538|75729327|FG001|COMPLETED|Overall Study||1||
59618113|NCT03866538|75729326|FG000|NOT COMPLETED|Overall Study||0||
59952313|NCT03256344|76071156|FG000|STARTED|Overall Study||11||
59952314|NCT03256344|76071157|FG001|STARTED|Overall Study||25||
59952315|NCT03256344|76071156|FG000|Received Talimogene Laherparepvec|Overall Study||8||
59952316|NCT03256344|76071157|FG001|Received Talimogene Laherparepvec|Overall Study||23||
59952317|NCT03256344|76071156|FG000|Received Atezolizumab|Overall Study||10||
59952318|NCT03256344|76071157|FG001|Received Atezolizumab|Overall Study||24||
59952319|NCT03256344|76071156|FG000|Safety Analysis Set|Overall Study||10|All participants who received at least 1 dose of talimogene laherparepvec or atezolizumab.|
60072553|NCT01682811|76187737|FG000|NOT COMPLETED|Part 2 Dose Level 3||0||0
59952320|NCT03256344|76071157|FG001|Safety Analysis Set|Overall Study||24|All participants who received at least 1 dose of talimogene laherparepvec or atezolizumab.|
59767856|NCT00834912|75888048|FG000|COMPLETED|Treatment Period 3||6||
59767857|NCT00834912|75888049|FG001|COMPLETED|Treatment Period 3||5||
59767858|NCT00834912|75888050|FG002|COMPLETED|Treatment Period 3||5||
59767859|NCT00834912|75888051|FG003|COMPLETED|Treatment Period 3||5||
59767860|NCT00834912|75888052|FG004|COMPLETED|Treatment Period 3||5||
59767861|NCT00834912|75888053|FG005|COMPLETED|Treatment Period 3||6||
59952321|NCT03256344|76071156|FG000|COMPLETED|Overall Study||1||
59952322|NCT03256344|76071157|FG001|COMPLETED|Overall Study||0||
59952323|NCT03256344|76071156|FG000|NOT COMPLETED|Overall Study||10||
59952324|NCT03256344|76071157|FG001|NOT COMPLETED|Overall Study||25||
59952325|NCT01370499|76071165|FG000|STARTED|Overall Study||195||
59952326|NCT01370499|76071166|FG001|STARTED|Overall Study||93||
59952327|NCT01370499|76071165|FG000|Entered Abrupt Discontinuation Phase|Overall Study||188||
59952328|NCT01370499|76071166|FG001|Entered Abrupt Discontinuation Phase|Overall Study|One participant who entered the abrupt discontinuation phase did not receive study drug.|85||
59952329|NCT01370499|76071165|FG000|Received at Least 1 Dose of Study Drug|Overall Study||195||
59952330|NCT01370499|76071166|FG001|Received at Least 1 Dose of Study Drug|Overall Study||92||
59952331|NCT01370499|76071165|FG000|COMPLETED|Overall Study||84||
59952332|NCT01370499|76071166|FG001|COMPLETED|Overall Study||49||
59952333|NCT01370499|76071165|FG000|NOT COMPLETED|Overall Study||111||
59952334|NCT01370499|76071166|FG001|NOT COMPLETED|Overall Study||44||
59952335|NCT01370265|76071174|FG000|STARTED|Resting Myocardial Blood Flow (MBF)||6||
59767862|NCT00834912|75888048|FG000|NOT COMPLETED|Treatment Period 3||0||
59767863|NCT00834912|75888049|FG001|NOT COMPLETED|Treatment Period 3||0||
59767864|NCT00834912|75888050|FG002|NOT COMPLETED|Treatment Period 3||0||
59767865|NCT00834912|75888051|FG003|NOT COMPLETED|Treatment Period 3||0||
59767866|NCT00834912|75888052|FG004|NOT COMPLETED|Treatment Period 3||0||
59767867|NCT00834912|75888053|FG005|NOT COMPLETED|Treatment Period 3||0||
59767868|NCT00883493|75888063|FG000|STARTED|Overall Study||212||
59767869|NCT00883493|75888064|FG001|STARTED|Overall Study||209||
59767870|NCT00883493|75888063|FG000|Intention To Treat Analysis Population|Overall Study||204||
59767871|NCT00883493|75888064|FG001|Intention To Treat Analysis Population|Overall Study||195||
59767872|NCT00883493|75888063|FG000|Per Protocol Analysis Population|Overall Study||162||
59767873|NCT00883493|75888064|FG001|Per Protocol Analysis Population|Overall Study||155||
59767874|NCT00883493|75888063|FG000|COMPLETED|Overall Study||166||
59767875|NCT00883493|75888064|FG001|COMPLETED|Overall Study||159||
59767876|NCT00883493|75888063|FG000|NOT COMPLETED|Overall Study||46||
59952336|NCT01370265|76071175|FG001|STARTED|Resting Myocardial Blood Flow (MBF)||6||
59952337|NCT01370265|76071174|FG000|COMPLETED|Resting Myocardial Blood Flow (MBF)||6||
59952338|NCT01370265|76071175|FG001|COMPLETED|Resting Myocardial Blood Flow (MBF)||6||
59952339|NCT01370265|76071174|FG000|NOT COMPLETED|Resting Myocardial Blood Flow (MBF)||0||
59952340|NCT01370265|76071175|FG001|NOT COMPLETED|Resting Myocardial Blood Flow (MBF)||0||
59952341|NCT01370265|76071174|FG000|STARTED|Washout Period (50-minute Period Decay)||6||
59952342|NCT01370265|76071175|FG001|STARTED|Washout Period (50-minute Period Decay)||6||
59767877|NCT00883493|75888064|FG001|NOT COMPLETED|Overall Study||50||
59767878|NCT04995666|75888070|FG000|STARTED|Overall Study||19||
59767879|NCT04995666|75888070|FG000|COMPLETED|Overall Study||19||
59767880|NCT04995666|75888070|FG000|NOT COMPLETED|Overall Study||0||
59767881|NCT04887922|75888079|FG000|STARTED|1st Randomization||1||
59767882|NCT04887922|75888080|FG001|STARTED|1st Randomization||1||
59767883|NCT04887922|75888081|FG002|STARTED|1st Randomization||0||
59767884|NCT04887922|75888082|FG003|STARTED|1st Randomization||0||
59952343|NCT01370265|76071174|FG000|COMPLETED|Washout Period (50-minute Period Decay)||6||
59952344|NCT01370265|76071175|FG001|COMPLETED|Washout Period (50-minute Period Decay)||6||
59952345|NCT01370265|76071174|FG000|NOT COMPLETED|Washout Period (50-minute Period Decay)||0||
59952346|NCT01370265|76071175|FG001|NOT COMPLETED|Washout Period (50-minute Period Decay)||0||
59952347|NCT01370265|76071174|FG000|STARTED|First Intervention||6||
59952348|NCT01370265|76071175|FG001|STARTED|First Intervention||6||
60072554|NCT01682811|76187738|FG001|NOT COMPLETED|Part 2 Dose Level 3||0||0
59767885|NCT04887922|75888083|FG004|STARTED|1st Randomization||0||
59767886|NCT04887922|75888079|FG000|COMPLETED|1st Randomization||1||
59767887|NCT04887922|75888080|FG001|COMPLETED|1st Randomization||0||
59767888|NCT04887922|75888081|FG002|COMPLETED|1st Randomization||0||
59767889|NCT04887922|75888082|FG003|COMPLETED|1st Randomization||0||
59952349|NCT01370265|76071174|FG000|COMPLETED|First Intervention||5||
60072555|NCT01682811|76187739|FG002|NOT COMPLETED|Part 2 Dose Level 3||0||0
59767890|NCT04887922|75888083|FG004|COMPLETED|1st Randomization||0||
60072556|NCT01682811|76187740|FG003|NOT COMPLETED|Part 2 Dose Level 3||0||0
59767891|NCT04887922|75888079|FG000|NOT COMPLETED|1st Randomization||0||
59767892|NCT04887922|75888080|FG001|NOT COMPLETED|1st Randomization||1||
59767893|NCT04887922|75888081|FG002|NOT COMPLETED|1st Randomization||0||
59767894|NCT04887922|75888082|FG003|NOT COMPLETED|1st Randomization||0||
59767895|NCT04887922|75888083|FG004|NOT COMPLETED|1st Randomization||0||
59767896|NCT04887922|75888079|FG000|STARTED|2nd Randomization||0||
59767897|NCT04887922|75888080|FG001|STARTED|2nd Randomization||0||
59767898|NCT04887922|75888081|FG002|STARTED|2nd Randomization||0||
59767899|NCT04887922|75888082|FG003|STARTED|2nd Randomization||0||
59767900|NCT04887922|75888083|FG004|STARTED|2nd Randomization||1||
59767901|NCT04887922|75888079|FG000|COMPLETED|2nd Randomization||0||
59767902|NCT04887922|75888080|FG001|COMPLETED|2nd Randomization||0||
59767903|NCT04887922|75888081|FG002|COMPLETED|2nd Randomization||0||
59767904|NCT04887922|75888082|FG003|COMPLETED|2nd Randomization||0||
59767905|NCT04887922|75888083|FG004|COMPLETED|2nd Randomization||1||
59767906|NCT04887922|75888079|FG000|NOT COMPLETED|2nd Randomization||0||
59767907|NCT04887922|75888080|FG001|NOT COMPLETED|2nd Randomization||0||
59767908|NCT04887922|75888081|FG002|NOT COMPLETED|2nd Randomization||0||
59767909|NCT04887922|75888082|FG003|NOT COMPLETED|2nd Randomization||0||
59767910|NCT04887922|75888083|FG004|NOT COMPLETED|2nd Randomization||0||
59767911|NCT04877730|75888091|FG000|STARTED|Overall Study||5||
59767912|NCT04877730|75888092|FG001|STARTED|Overall Study||7||
59767913|NCT04877730|75888093|FG002|STARTED|Overall Study||7||
59767914|NCT04877730|75888094|FG003|STARTED|Overall Study||8||
59767915|NCT04877730|75888095|FG004|STARTED|Overall Study||4||
59767916|NCT04877730|75888096|FG005|STARTED|Overall Study||5||
59767917|NCT04877730|75888091|FG000|COMPLETED|Overall Study||5||
59767918|NCT04877730|75888092|FG001|COMPLETED|Overall Study||6||
59767919|NCT04877730|75888093|FG002|COMPLETED|Overall Study||7||
59767920|NCT04877730|75888094|FG003|COMPLETED|Overall Study||8||
59767921|NCT04877730|75888095|FG004|COMPLETED|Overall Study||4||
59767922|NCT04877730|75888096|FG005|COMPLETED|Overall Study||5||
59767923|NCT04877730|75888091|FG000|NOT COMPLETED|Overall Study||0||
59767924|NCT04877730|75888092|FG001|NOT COMPLETED|Overall Study||1||
59767925|NCT04877730|75888093|FG002|NOT COMPLETED|Overall Study||0||
59767926|NCT04877730|75888094|FG003|NOT COMPLETED|Overall Study||0||
59767927|NCT04877730|75888095|FG004|NOT COMPLETED|Overall Study||0||
59767928|NCT04877730|75888096|FG005|NOT COMPLETED|Overall Study||0||
59767929|NCT04771403|75888106|FG000|STARTED|Dexcom Training Visit (1 Week)||13||
59767930|NCT04771403|75888107|FG001|STARTED|Dexcom Training Visit (1 Week)||12||
59767931|NCT04771403|75888106|FG000|COMPLETED|Dexcom Training Visit (1 Week)||13||
59767932|NCT04771403|75888107|FG001|COMPLETED|Dexcom Training Visit (1 Week)||12||
59767933|NCT04771403|75888106|FG000|NOT COMPLETED|Dexcom Training Visit (1 Week)||0||
59767934|NCT04771403|75888107|FG001|NOT COMPLETED|Dexcom Training Visit (1 Week)||0||
59767935|NCT04771403|75888106|FG000|STARTED|First Rest Period (1-12 Weeks)||13||
59767936|NCT04771403|75888107|FG001|STARTED|First Rest Period (1-12 Weeks)||12||
59767937|NCT04771403|75888106|FG000|COMPLETED|First Rest Period (1-12 Weeks)||13||
59767938|NCT04771403|75888107|FG001|COMPLETED|First Rest Period (1-12 Weeks)||12||
59767939|NCT04771403|75888106|FG000|NOT COMPLETED|First Rest Period (1-12 Weeks)||0||
59767940|NCT04771403|75888107|FG001|NOT COMPLETED|First Rest Period (1-12 Weeks)||0||
59767941|NCT04771403|75888106|FG000|STARTED|First Intervention (~76 Hours)||13||
59767942|NCT04771403|75888107|FG001|STARTED|First Intervention (~76 Hours)||12||
59767943|NCT04771403|75888106|FG000|COMPLETED|First Intervention (~76 Hours)||9||
59767944|NCT04771403|75888107|FG001|COMPLETED|First Intervention (~76 Hours)||10||
59767945|NCT04771403|75888106|FG000|NOT COMPLETED|First Intervention (~76 Hours)||4||
59767946|NCT04771403|75888107|FG001|NOT COMPLETED|First Intervention (~76 Hours)||2||
59767947|NCT04771403|75888106|FG000|STARTED|Second Rest Period (1-10 Weeks)||13||
59767948|NCT04771403|75888107|FG001|STARTED|Second Rest Period (1-10 Weeks)||12||
59767949|NCT04771403|75888106|FG000|COMPLETED|Second Rest Period (1-10 Weeks)||12||
59767950|NCT04771403|75888107|FG001|COMPLETED|Second Rest Period (1-10 Weeks)||12||
59767951|NCT04771403|75888106|FG000|NOT COMPLETED|Second Rest Period (1-10 Weeks)||1||
59952350|NCT01370265|76071175|FG001|COMPLETED|First Intervention||5||
59952351|NCT01370265|76071174|FG000|NOT COMPLETED|First Intervention||1||
59952352|NCT01370265|76071175|FG001|NOT COMPLETED|First Intervention||1||
59952353|NCT01370265|76071174|FG000|STARTED|Washout Period (50-minute Period Decay)||5||
59767952|NCT04771403|75888107|FG001|NOT COMPLETED|Second Rest Period (1-10 Weeks)||0||
59767953|NCT04771403|75888106|FG000|STARTED|Second Intervention Visit (~76 Hours)||12||
59767954|NCT04771403|75888107|FG001|STARTED|Second Intervention Visit (~76 Hours)||12||
59767955|NCT04771403|75888106|FG000|COMPLETED|Second Intervention Visit (~76 Hours)||11||
59767956|NCT04771403|75888107|FG001|COMPLETED|Second Intervention Visit (~76 Hours)||12||
59767957|NCT04771403|75888106|FG000|NOT COMPLETED|Second Intervention Visit (~76 Hours)||1||
59767958|NCT04771403|75888107|FG001|NOT COMPLETED|Second Intervention Visit (~76 Hours)||0||
59767959|NCT04698525|75888116|FG000|STARTED|Overall Study||17||
59767960|NCT04698525|75888117|FG001|STARTED|Overall Study||16||
59767961|NCT04698525|75888116|FG000|COMPLETED|Overall Study||14||
59767962|NCT04698525|75888117|FG001|COMPLETED|Overall Study||13||
59767963|NCT04698525|75888116|FG000|NOT COMPLETED|Overall Study||3||
59767964|NCT04698525|75888117|FG001|NOT COMPLETED|Overall Study||3||
59767965|NCT04510675|75888131|FG000|STARTED|Overall Study||58||
59952354|NCT01370265|76071175|FG001|STARTED|Washout Period (50-minute Period Decay)||5||
59952355|NCT01370265|76071174|FG000|COMPLETED|Washout Period (50-minute Period Decay)||5||
59952356|NCT01370265|76071175|FG001|COMPLETED|Washout Period (50-minute Period Decay)||5||
59952357|NCT01370265|76071174|FG000|NOT COMPLETED|Washout Period (50-minute Period Decay)||0||
59767966|NCT04510675|75888131|FG000|COMPLETED|Overall Study||53||
59767967|NCT04510675|75888131|FG000|NOT COMPLETED|Overall Study||5||
59767968|NCT04452292|75888140|FG000|STARTED|Overall Study||2||
59767969|NCT04452292|75888141|FG001|STARTED|Overall Study||0||
59767970|NCT04452292|75888140|FG000|COMPLETED|Overall Study||2||
59767971|NCT04452292|75888141|FG001|COMPLETED|Overall Study||0||
59767972|NCT04452292|75888140|FG000|NOT COMPLETED|Overall Study||0||
59767973|NCT04452292|75888141|FG001|NOT COMPLETED|Overall Study||0||
59767974|NCT04228783|75888153|FG000|STARTED|Overall Study||287||
59767975|NCT04228783|75888154|FG001|STARTED|Overall Study||288||
59767976|NCT04228783|75888155|FG002|STARTED|Overall Study||287||
59767977|NCT04228783|75888156|FG003|STARTED|Overall Study||48||
59767978|NCT04228783|75888157|FG004|STARTED|Overall Study||50||
59767979|NCT04228783|75888158|FG005|STARTED|Overall Study||10||
59767980|NCT04228783|75888153|FG000|COMPLETED|Overall Study||239||
59767981|NCT04228783|75888154|FG001|COMPLETED|Overall Study||237||
59767982|NCT04228783|75888155|FG002|COMPLETED|Overall Study||236||
59767983|NCT04228783|75888156|FG003|COMPLETED|Overall Study||39||
59767984|NCT04228783|75888157|FG004|COMPLETED|Overall Study||33||
59767985|NCT04228783|75888158|FG005|COMPLETED|Overall Study||6||
59767986|NCT04228783|75888153|FG000|NOT COMPLETED|Overall Study||48||
59767987|NCT04228783|75888154|FG001|NOT COMPLETED|Overall Study||51||
60072557|NCT01682811|76187741|FG004|NOT COMPLETED|Part 2 Dose Level 3||0||0
60072558|NCT01682811|76187742|FG005|NOT COMPLETED|Part 2 Dose Level 3||0||0
60072559|NCT01682811|76187743|FG006|NOT COMPLETED|Part 2 Dose Level 3||0||0
59767988|NCT04228783|75888155|FG002|NOT COMPLETED|Overall Study||51||
59767989|NCT04228783|75888156|FG003|NOT COMPLETED|Overall Study||9||
59767990|NCT04228783|75888157|FG004|NOT COMPLETED|Overall Study||17||
59767991|NCT04228783|75888158|FG005|NOT COMPLETED|Overall Study||4||
59767992|NCT03950674|75888174|FG000|STARTED|Overall Study||25||
59767993|NCT03950674|75888175|FG001|STARTED|Overall Study||15||
59767994|NCT03950674|75888174|FG000|Treated|Overall Study||25||
59767995|NCT03950674|75888175|FG001|Treated|Overall Study||15||
59767996|NCT03950674|75888174|FG000|Switched to Pembrolizumab|Overall Study||0||
60072560|NCT01682031|76187764|FG000|STARTED|Overall Study||8||
60072561|NCT01682031|76187765|FG001|STARTED|Overall Study||10||
59767997|NCT03950674|75888175|FG001|Switched to Pembrolizumab|Overall Study||4||
59767998|NCT03950674|75888174|FG000|COMPLETED|Overall Study||0||
59767999|NCT03950674|75888175|FG001|COMPLETED|Overall Study||0||
59768000|NCT03950674|75888174|FG000|NOT COMPLETED|Overall Study||25||
59768001|NCT03950674|75888175|FG001|NOT COMPLETED|Overall Study||15||
59768002|NCT03702621|75888184|FG000|STARTED|Overall Study||44||
59768003|NCT03702621|75888185|FG001|STARTED|Overall Study||46||
59768004|NCT03702621|75888184|FG000|COMPLETED|Overall Study||38||
59768005|NCT03702621|75888185|FG001|COMPLETED|Overall Study||40||
59768006|NCT03702621|75888184|FG000|NOT COMPLETED|Overall Study||6||
59768007|NCT03702621|75888185|FG001|NOT COMPLETED|Overall Study||6||
59768008|NCT03577990|75888193|FG000|STARTED|Overall Study||45||
59768009|NCT03577990|75888194|FG001|STARTED|Overall Study||45||
59768010|NCT03577990|75888193|FG000|Month 1-3|Overall Study||42||
59768011|NCT03577990|75888194|FG001|Month 1-3|Overall Study||41||
59768012|NCT03577990|75888193|FG000|Month 4-6|Overall Study||41||
59952358|NCT01370265|76071175|FG001|NOT COMPLETED|Washout Period (50-minute Period Decay)||0||
59952359|NCT01370265|76071174|FG000|STARTED|Second Intervention||5||
59952360|NCT01370265|76071175|FG001|STARTED|Second Intervention||5||
59952361|NCT01370265|76071174|FG000|COMPLETED|Second Intervention||5||
59952362|NCT01370265|76071175|FG001|COMPLETED|Second Intervention||5||
59952363|NCT01370265|76071174|FG000|NOT COMPLETED|Second Intervention||0||
59952364|NCT01370265|76071175|FG001|NOT COMPLETED|Second Intervention||0||
60072562|NCT01682031|76187764|FG000|COMPLETED|Overall Study||7||
59768013|NCT03577990|75888194|FG001|Month 4-6|Overall Study||39||
59768014|NCT03577990|75888193|FG000|Month 7-9|Overall Study||38||
59768015|NCT03577990|75888194|FG001|Month 7-9|Overall Study||34||
59952365|NCT01973166|76071182|FG000|STARTED|Overall Study||42||84
60072563|NCT01682031|76187765|FG001|COMPLETED|Overall Study||5||
60072564|NCT01682031|76187764|FG000|NOT COMPLETED|Overall Study||1||
60072565|NCT01682031|76187765|FG001|NOT COMPLETED|Overall Study||5||
60072566|NCT03020524|76187774|FG000|STARTED|Overall Study||3||
59768016|NCT03577990|75888193|FG000|COMPLETED|Overall Study||37||
59768017|NCT03577990|75888194|FG001|COMPLETED|Overall Study||32||
59768018|NCT03577990|75888193|FG000|NOT COMPLETED|Overall Study||8||
59768019|NCT03577990|75888194|FG001|NOT COMPLETED|Overall Study||13||
59768020|NCT03565497|75888204|FG000|STARTED|Overall Study||8|Participants that were enrolled and randomized to study groups.|
59768021|NCT03565497|75888205|FG001|STARTED|Overall Study||8|Participants that were enrolled and randomized to study groups.|
59952366|NCT01973166|76071182|FG000|Treatment With Cutera Investigational Picosecond Q-Switched Nd:YAG Laser|Overall Study||42||42
60072567|NCT03020524|76187775|FG001|STARTED|Overall Study||3||
60072568|NCT03020524|76187776|FG002|STARTED|Overall Study||3||
59768022|NCT03565497|75888206|FG002|STARTED|Overall Study||8|Participants that were enrolled and randomized to study groups.|
59768023|NCT03565497|75888204|FG000|V1|Overall Study||8|Intervention visit 1 completed.|
59768024|NCT03565497|75888205|FG001|V1|Overall Study||7|Intervention visit 1 completed.|
59768025|NCT03565497|75888206|FG002|V1|Overall Study||7|Intervention visit 1 completed.|
59768026|NCT03565497|75888204|FG000|V2|Overall Study||8|Intervention visit 2 completed|
59768027|NCT03565497|75888205|FG001|V2|Overall Study||7|Intervention visit 2 completed|
59768028|NCT03565497|75888206|FG002|V2|Overall Study||5|Intervention visit 2 completed|
59768029|NCT03565497|75888204|FG000|V3|Overall Study||6|Intervention visit 3 completed|
59768030|NCT03565497|75888205|FG001|V3|Overall Study||6|Intervention visit 3 completed|
59768031|NCT03565497|75888206|FG002|V3|Overall Study||5|Intervention visit 3 completed|
59768032|NCT03565497|75888204|FG000|V4|Overall Study||6|Intervention visit 4 completed|
59768033|NCT03565497|75888205|FG001|V4|Overall Study||6|Intervention visit 4 completed|
59768034|NCT03565497|75888206|FG002|V4|Overall Study||5|Intervention visit 4 completed|
59768035|NCT03565497|75888204|FG000|V5|Overall Study||6|Intervention visit 5 completed|
59768036|NCT03565497|75888205|FG001|V5|Overall Study||6|Intervention visit 5 completed|
59768037|NCT03565497|75888206|FG002|V5|Overall Study||5|Intervention visit 5 completed|
59768038|NCT03565497|75888204|FG000|V6|Overall Study||6|Intervention visit 6 completed|
59768039|NCT03565497|75888205|FG001|V6|Overall Study||6|Intervention visit 6 completed|
59768040|NCT03565497|75888206|FG002|V6|Overall Study||5|Intervention visit 6 completed|
59768041|NCT03565497|75888204|FG000|SSA|Overall Study||6|1-week Post-Intervention Smoking Context- Standard smoking assessment (SSA) completed|
59768042|NCT03565497|75888205|FG001|SSA|Overall Study||6|1-week Post-Intervention Smoking Context- Standard smoking assessment (SSA) completed|
59768043|NCT03565497|75888206|FG002|SSA|Overall Study||5|1-week Post-Intervention Smoking Context- Standard smoking assessment (SSA) completed|
59952367|NCT01973166|76071182|FG000|Treatment With Comparator Nanosecond Q-switched Nd:YAG Laser|Overall Study||42||42
59952368|NCT01973166|76071182|FG000|COMPLETED|Overall Study||41||82
59952369|NCT01973166|76071182|FG000|NOT COMPLETED|Overall Study||1||2
59952370|NCT03440840|76071191|FG000|STARTED|Overall Study||16||
59952371|NCT03440840|76071192|FG001|STARTED|Overall Study||15||
59952372|NCT03440840|76071193|FG002|STARTED|Overall Study||15||
59952373|NCT03440840|76071191|FG000|COMPLETED|Overall Study||15||
59952374|NCT03440840|76071192|FG001|COMPLETED|Overall Study||14||
59952375|NCT03440840|76071193|FG002|COMPLETED|Overall Study||15||
59952376|NCT03440840|76071191|FG000|NOT COMPLETED|Overall Study||1||
59952377|NCT03440840|76071192|FG001|NOT COMPLETED|Overall Study||1||
59952378|NCT03440840|76071193|FG002|NOT COMPLETED|Overall Study||0||
59952379|NCT03433430|76071201|FG000|STARTED|Overall Study||9||
59952380|NCT03433430|76071201|FG000|COMPLETED|Overall Study||8||
59952381|NCT03433430|76071201|FG000|NOT COMPLETED|Overall Study||1||
59952382|NCT02792829|76071213|FG000|STARTED|Treatment Period 1||10||
59952383|NCT02792829|76071214|FG001|STARTED|Treatment Period 1||10||
59952384|NCT02792829|76071215|FG002|STARTED|Treatment Period 1||5||
59952385|NCT02792829|76071216|FG003|STARTED|Treatment Period 1||5||
59952386|NCT02792829|76071217|FG004|STARTED|Treatment Period 1||5||
59952387|NCT02792829|76071218|FG005|STARTED|Treatment Period 1||5||
59952388|NCT02792829|76071219|FG006|STARTED|Treatment Period 1||10||
59952389|NCT02792829|76071220|FG007|STARTED|Treatment Period 1||10||
59952390|NCT02792829|76071213|FG000|COMPLETED|Treatment Period 1||10||
59952391|NCT02792829|76071214|FG001|COMPLETED|Treatment Period 1||10||
59952392|NCT02792829|76071215|FG002|COMPLETED|Treatment Period 1||5||
59952393|NCT02792829|76071216|FG003|COMPLETED|Treatment Period 1||5||
59952394|NCT02792829|76071217|FG004|COMPLETED|Treatment Period 1||5||
59952395|NCT02792829|76071218|FG005|COMPLETED|Treatment Period 1||5||
59952396|NCT02792829|76071219|FG006|COMPLETED|Treatment Period 1||10||
59952397|NCT02792829|76071220|FG007|COMPLETED|Treatment Period 1||10||
59952398|NCT02792829|76071213|FG000|NOT COMPLETED|Treatment Period 1||0||
59952399|NCT02792829|76071214|FG001|NOT COMPLETED|Treatment Period 1||0||
59952400|NCT02792829|76071215|FG002|NOT COMPLETED|Treatment Period 1||0||
59952401|NCT02792829|76071216|FG003|NOT COMPLETED|Treatment Period 1||0||
59952402|NCT02792829|76071217|FG004|NOT COMPLETED|Treatment Period 1||0||
59952403|NCT02792829|76071218|FG005|NOT COMPLETED|Treatment Period 1||0||
59952404|NCT02792829|76071219|FG006|NOT COMPLETED|Treatment Period 1||0||
59952405|NCT02792829|76071220|FG007|NOT COMPLETED|Treatment Period 1||0||
59952406|NCT02792829|76071213|FG000|STARTED|Wash Out Period||10||
59952407|NCT02792829|76071214|FG001|STARTED|Wash Out Period||10||
59952408|NCT02792829|76071215|FG002|STARTED|Wash Out Period||5||
59952409|NCT02792829|76071216|FG003|STARTED|Wash Out Period||5||
59952410|NCT02792829|76071217|FG004|STARTED|Wash Out Period||5||
59952411|NCT02792829|76071218|FG005|STARTED|Wash Out Period||5||
59952412|NCT02792829|76071219|FG006|STARTED|Wash Out Period||10||
59952413|NCT02792829|76071220|FG007|STARTED|Wash Out Period||10||
59952414|NCT02792829|76071213|FG000|COMPLETED|Wash Out Period||10||
59952415|NCT02792829|76071214|FG001|COMPLETED|Wash Out Period||10||
59952416|NCT02792829|76071215|FG002|COMPLETED|Wash Out Period||5||
59952417|NCT02792829|76071216|FG003|COMPLETED|Wash Out Period||5||
59952418|NCT02792829|76071217|FG004|COMPLETED|Wash Out Period||5||
59952419|NCT02792829|76071218|FG005|COMPLETED|Wash Out Period||5||
59952420|NCT02792829|76071219|FG006|COMPLETED|Wash Out Period||10||
59952421|NCT02792829|76071220|FG007|COMPLETED|Wash Out Period||10||
59952422|NCT02792829|76071213|FG000|NOT COMPLETED|Wash Out Period||0||
59952423|NCT02792829|76071214|FG001|NOT COMPLETED|Wash Out Period||0||
59952424|NCT02792829|76071215|FG002|NOT COMPLETED|Wash Out Period||0||
59952425|NCT02792829|76071216|FG003|NOT COMPLETED|Wash Out Period||0||
59952426|NCT02792829|76071217|FG004|NOT COMPLETED|Wash Out Period||0||
59952427|NCT02792829|76071218|FG005|NOT COMPLETED|Wash Out Period||0||
59952428|NCT02792829|76071219|FG006|NOT COMPLETED|Wash Out Period||0||
59952429|NCT02792829|76071220|FG007|NOT COMPLETED|Wash Out Period||0||
59952430|NCT02792829|76071213|FG000|STARTED|Treatment Period 2||10||
59952431|NCT02792829|76071214|FG001|STARTED|Treatment Period 2||10||
59952432|NCT02792829|76071215|FG002|STARTED|Treatment Period 2||5||
59952433|NCT02792829|76071216|FG003|STARTED|Treatment Period 2||5||
59952434|NCT02792829|76071217|FG004|STARTED|Treatment Period 2||5||
59952435|NCT02792829|76071218|FG005|STARTED|Treatment Period 2||5||
59952436|NCT02792829|76071219|FG006|STARTED|Treatment Period 2||10||
59952437|NCT02792829|76071220|FG007|STARTED|Treatment Period 2||10||
59952438|NCT02792829|76071213|FG000|COMPLETED|Treatment Period 2||10||
59952439|NCT02792829|76071214|FG001|COMPLETED|Treatment Period 2||9||
59952440|NCT02792829|76071215|FG002|COMPLETED|Treatment Period 2||5||
59952441|NCT02792829|76071216|FG003|COMPLETED|Treatment Period 2||5||
59952442|NCT02792829|76071217|FG004|COMPLETED|Treatment Period 2||4||
59952443|NCT02792829|76071218|FG005|COMPLETED|Treatment Period 2||5||
59952444|NCT02792829|76071219|FG006|COMPLETED|Treatment Period 2||9||
59952445|NCT02792829|76071220|FG007|COMPLETED|Treatment Period 2||8||
59952446|NCT02792829|76071213|FG000|NOT COMPLETED|Treatment Period 2||0||
59952447|NCT02792829|76071214|FG001|NOT COMPLETED|Treatment Period 2||1||
59952448|NCT02792829|76071215|FG002|NOT COMPLETED|Treatment Period 2||0||
59952449|NCT02792829|76071216|FG003|NOT COMPLETED|Treatment Period 2||0||
59952450|NCT02792829|76071217|FG004|NOT COMPLETED|Treatment Period 2||1||
59952451|NCT02792829|76071218|FG005|NOT COMPLETED|Treatment Period 2||0||
59952452|NCT02792829|76071219|FG006|NOT COMPLETED|Treatment Period 2||1||
59952453|NCT02792829|76071220|FG007|NOT COMPLETED|Treatment Period 2||2||
59768044|NCT03565497|75888204|FG000|DWA|Overall Study||6|1week+2days Post-Intervention Deprivation Context- Deprivation window assessment (DWA) completed|
59768045|NCT03565497|75888205|FG001|DWA|Overall Study|One participant from MT group refused the McKee protocol and dropped out of the study during the DWA visit. Data was collected for some outcome variables during this visit, but not all. This participant's data was not included in the calculation of primary outcome measures.|5|1week+2days Post-Intervention Deprivation Context- Deprivation window assessment (DWA) completed|
59768046|NCT03565497|75888206|FG002|DWA|Overall Study||4|1week+2days Post-Intervention Deprivation Context- Deprivation window assessment (DWA) completed|
59768047|NCT03565497|75888204|FG000|PFU|Overall Study||6|6 week Post-Intervention- Phone follow-up (PFU) completed|
59768048|NCT03565497|75888205|FG001|PFU|Overall Study||5|6 week Post-Intervention- Phone follow-up (PFU) completed|
59768049|NCT03565497|75888206|FG002|PFU|Overall Study||4|6 week Post-Intervention- Phone follow-up (PFU) completed|
59768050|NCT03565497|75888204|FG000|COMPLETED|Overall Study||6||
59768051|NCT03565497|75888205|FG001|COMPLETED|Overall Study||5||
59952454|NCT02867592|76071252|FG000|STARTED|Overall Study||15||
59952455|NCT02867592|76071253|FG001|STARTED|Overall Study||14||
59952456|NCT02867592|76071254|FG002|STARTED|Overall Study||13||
59952457|NCT02867592|76071255|FG003|STARTED|Overall Study||13||
59952458|NCT02867592|76071256|FG004|STARTED|Overall Study||25||
59952459|NCT02867592|76071257|FG005|STARTED|Overall Study||29||
59952460|NCT02867592|76071252|FG000|COMPLETED|Overall Study||0||
59952461|NCT02867592|76071253|FG001|COMPLETED|Overall Study||0||
59952462|NCT02867592|76071254|FG002|COMPLETED|Overall Study||0||
59952463|NCT02867592|76071255|FG003|COMPLETED|Overall Study||0||
59952464|NCT02867592|76071256|FG004|COMPLETED|Overall Study||0||
59952465|NCT02867592|76071257|FG005|COMPLETED|Overall Study||0||
59952466|NCT02867592|76071252|FG000|NOT COMPLETED|Overall Study||15||
59952467|NCT02867592|76071253|FG001|NOT COMPLETED|Overall Study||14||
59952468|NCT02867592|76071254|FG002|NOT COMPLETED|Overall Study||13||
59952469|NCT02867592|76071255|FG003|NOT COMPLETED|Overall Study||13||
59952470|NCT02867592|76071256|FG004|NOT COMPLETED|Overall Study||25||
59952471|NCT02867592|76071257|FG005|NOT COMPLETED|Overall Study||29||
59952472|NCT00676494|76071273|FG000|STARTED|Overall Study||172||
59952473|NCT00676494|76071273|FG000|COMPLETED|Overall Study||158||
59952474|NCT00676494|76071273|FG000|NOT COMPLETED|Overall Study||14||
59952475|NCT02605642|76071278|FG000|STARTED|Overall Study||227||
59952476|NCT02605642|76071279|FG001|STARTED|Overall Study||107||
59952477|NCT02605642|76071278|FG000|Safety Set|Overall Study||221|Included all participants who received at least 1 dose of CT- P13 during study observation period|
59952478|NCT02605642|76071279|FG001|Safety Set|Overall Study||107|Included all participants who received at least 1 dose of CT- P13 during study observation period|
59952479|NCT02605642|76071278|FG000|COMPLETED|Overall Study||131||
59952480|NCT02605642|76071279|FG001|COMPLETED|Overall Study||86||
59952481|NCT02605642|76071278|FG000|NOT COMPLETED|Overall Study||96||
59952482|NCT02605642|76071279|FG001|NOT COMPLETED|Overall Study||21||
59952483|NCT02253810|76071287|FG000|STARTED|Overall Study||45||
59952484|NCT02253810|76071288|FG001|STARTED|Overall Study||44||
59952485|NCT02253810|76071287|FG000|COMPLETED|Overall Study||40||
59952486|NCT02253810|76071288|FG001|COMPLETED|Overall Study||41||
59952487|NCT02253810|76071287|FG000|NOT COMPLETED|Overall Study||5||
59952488|NCT02253810|76071288|FG001|NOT COMPLETED|Overall Study||3||
59952489|NCT02071953|76071294|FG000|STARTED|Overall Study|Number of participants is being calculated more than once per row. Note that most participants had subject teeth in both arms of the study.|35||53
59952490|NCT02071953|76071295|FG001|STARTED|Overall Study|Number of participants is being calculated more than once per row. Note that most participants had subject teeth in both arms of the study.|35||54
59952491|NCT02071953|76071294|FG000|COMPLETED|Overall Study|Number of participants is being calculated more than once per row. Note that most participants had subject teeth in both arms of the study.|18||30
59952492|NCT02071953|76071295|FG001|COMPLETED|Overall Study|Number of participants is being calculated more than once per row. Note that most participants had subject teeth in both arms of the study.|21||34
59952493|NCT02071953|76071294|FG000|NOT COMPLETED|Overall Study||17||23
59952494|NCT02071953|76071295|FG001|NOT COMPLETED|Overall Study||14||20
59952495|NCT00495222|76071307|FG000|STARTED|Overall Study||9||
59952496|NCT00495222|76071307|FG000|COMPLETED|Overall Study||9||
59952497|NCT00495222|76071307|FG000|NOT COMPLETED|Overall Study||0||
59952498|NCT02732912|76071312|FG000|STARTED|Overall Study||97||
59952499|NCT02732912|76071313|FG001|STARTED|Overall Study||109||
59952500|NCT02732912|76071312|FG000|COMPLETED|Overall Study||87||
59952501|NCT02732912|76071313|FG001|COMPLETED|Overall Study||91||
59952502|NCT02732912|76071312|FG000|NOT COMPLETED|Overall Study||10||
59952503|NCT02732912|76071313|FG001|NOT COMPLETED|Overall Study||18||
59952504|NCT02792517|76071319|FG000|STARTED|Overall Study||41||
59952505|NCT02792517|76071319|FG000|Received Erenumab|Overall Study||24||
59952506|NCT02792517|76071319|FG000|COMPLETED|Overall Study||21||
59952507|NCT02792517|76071319|FG000|NOT COMPLETED|Overall Study||20||
59952508|NCT03795116|76071326|FG000|STARTED|Overall Study||10||10
59952509|NCT03795116|76071327|FG001|STARTED|Overall Study||10||10
59952510|NCT03795116|76071328|FG002|STARTED|Overall Study||10||10
59952511|NCT03795116|76071329|FG003|STARTED|Overall Study||10||10
59952512|NCT03795116|76071330|FG004|STARTED|Overall Study||10||10
59768052|NCT03565497|75888206|FG002|COMPLETED|Overall Study||4||
59768053|NCT03565497|75888204|FG000|NOT COMPLETED|Overall Study||2||
59768054|NCT03565497|75888205|FG001|NOT COMPLETED|Overall Study||3||
59768055|NCT03565497|75888206|FG002|NOT COMPLETED|Overall Study||4||
59768056|NCT03362931|75888214|FG000|STARTED|Overall Study||62||
59768057|NCT03362931|75888214|FG000|COMPLETED|Overall Study||59||
59768058|NCT03362931|75888214|FG000|NOT COMPLETED|Overall Study||3||
59768059|NCT03360019|75888221|FG000|STARTED|Overall Study||10||
59768060|NCT03360019|75888222|FG001|STARTED|Overall Study||0||
59768061|NCT03360019|75888223|FG002|STARTED|Overall Study||3||
59768062|NCT03360019|75888221|FG000|COMPLETED|Overall Study||2||
59768063|NCT03360019|75888222|FG001|COMPLETED|Overall Study||0||
59952513|NCT03795116|76071331|FG005|STARTED|Overall Study||10||10
59952514|NCT03795116|76071326|FG000|COMPLETED|Overall Study||6||6
59952515|NCT03795116|76071327|FG001|COMPLETED|Overall Study||6||6
59952516|NCT03795116|76071328|FG002|COMPLETED|Overall Study||9||9
59952517|NCT03795116|76071329|FG003|COMPLETED|Overall Study||9||9
59952518|NCT03795116|76071330|FG004|COMPLETED|Overall Study||9||9
59952519|NCT03795116|76071331|FG005|COMPLETED|Overall Study||9||9
59952520|NCT03795116|76071326|FG000|NOT COMPLETED|Overall Study||4||4
59952521|NCT03795116|76071327|FG001|NOT COMPLETED|Overall Study||4||4
59952522|NCT03795116|76071328|FG002|NOT COMPLETED|Overall Study||1||1
59952523|NCT03795116|76071329|FG003|NOT COMPLETED|Overall Study||1||1
59952524|NCT03795116|76071330|FG004|NOT COMPLETED|Overall Study||1||1
59952525|NCT03795116|76071331|FG005|NOT COMPLETED|Overall Study||1||1
59952526|NCT01369485|76071354|FG000|STARTED|Randomized Phase (Day 0 to Week 12)||80||
59952527|NCT01369485|76071355|FG001|STARTED|Randomized Phase (Day 0 to Week 12)||83||
59952528|NCT01369485|76071354|FG000|COMPLETED|Randomized Phase (Day 0 to Week 12)||57||
59952529|NCT01369485|76071355|FG001|COMPLETED|Randomized Phase (Day 0 to Week 12)||66||
59952530|NCT01369485|76071354|FG000|NOT COMPLETED|Randomized Phase (Day 0 to Week 12)||23||
59952531|NCT01369485|76071355|FG001|NOT COMPLETED|Randomized Phase (Day 0 to Week 12)||17||
59952532|NCT01369485|76071354|FG000|STARTED|Open Label Phase (Week 12 to Month 12)||57||
59952533|NCT01369485|76071355|FG001|STARTED|Open Label Phase (Week 12 to Month 12)||66||
59952534|NCT01369485|76071354|FG000|COMPLETED|Open Label Phase (Week 12 to Month 12)||24||
59952535|NCT01369485|76071355|FG001|COMPLETED|Open Label Phase (Week 12 to Month 12)||26||
60072569|NCT03020524|76187774|FG000|COMPLETED|Overall Study||3||
60072570|NCT03020524|76187775|FG001|COMPLETED|Overall Study||3||
59952536|NCT01369485|76071354|FG000|NOT COMPLETED|Open Label Phase (Week 12 to Month 12)||33||
59952537|NCT01369485|76071355|FG001|NOT COMPLETED|Open Label Phase (Week 12 to Month 12)||40||
59952538|NCT03749252|76071372|FG000|STARTED|Overall Study||26||
59768064|NCT03360019|75888223|FG002|COMPLETED|Overall Study||3||
59768065|NCT03360019|75888221|FG000|NOT COMPLETED|Overall Study||8||
59768066|NCT03360019|75888222|FG001|NOT COMPLETED|Overall Study||0||
59768067|NCT03360019|75888223|FG002|NOT COMPLETED|Overall Study||0||
59768068|NCT03245008|75888240|FG000|STARTED|Overall Study||204||
59768069|NCT03245008|75888241|FG001|STARTED|Overall Study||203||
59768070|NCT03245008|75888242|FG002|STARTED|Overall Study||162||
59768071|NCT03245008|75888243|FG003|STARTED|Overall Study||28||
59952539|NCT03749252|76071373|FG001|STARTED|Overall Study||23||
59952540|NCT03749252|76071374|FG002|STARTED|Overall Study||31||
59952541|NCT03749252|76071372|FG000|COMPLETED|Overall Study||26||
59952542|NCT03749252|76071373|FG001|COMPLETED|Overall Study||23||
59952543|NCT03749252|76071374|FG002|COMPLETED|Overall Study||31||
59952544|NCT03749252|76071372|FG000|NOT COMPLETED|Overall Study||0||
59952545|NCT03749252|76071373|FG001|NOT COMPLETED|Overall Study||0||
59768072|NCT03245008|75888244|FG004|STARTED|Overall Study||29||
59768073|NCT03245008|75888240|FG000|COMPLETED|Overall Study||164||
59768074|NCT03245008|75888241|FG001|COMPLETED|Overall Study||159||
59768075|NCT03245008|75888242|FG002|COMPLETED|Overall Study||132||
59768076|NCT03245008|75888243|FG003|COMPLETED|Overall Study||0||
59768077|NCT03245008|75888244|FG004|COMPLETED|Overall Study||0||
59768078|NCT03245008|75888240|FG000|NOT COMPLETED|Overall Study||40||
59768079|NCT03245008|75888241|FG001|NOT COMPLETED|Overall Study||44||
59768080|NCT03245008|75888242|FG002|NOT COMPLETED|Overall Study||30||
59768081|NCT03245008|75888243|FG003|NOT COMPLETED|Overall Study||28||
59768082|NCT03245008|75888244|FG004|NOT COMPLETED|Overall Study||29||
59768083|NCT03203473|75888266|FG000|STARTED|Induction Phase||85||
59768084|NCT03203473|75888267|FG001|STARTED|Induction Phase||0||
59768085|NCT03203473|75888268|FG002|STARTED|Induction Phase||0||
59768086|NCT03203473|75888266|FG000|COMPLETED|Induction Phase||69||
59768087|NCT03203473|75888267|FG001|COMPLETED|Induction Phase||0||
59768088|NCT03203473|75888268|FG002|COMPLETED|Induction Phase||0||
59768089|NCT03203473|75888266|FG000|NOT COMPLETED|Induction Phase||16||
59768090|NCT03203473|75888267|FG001|NOT COMPLETED|Induction Phase||0||
59768091|NCT03203473|75888268|FG002|NOT COMPLETED|Induction Phase||0||
59768092|NCT03203473|75888266|FG000|STARTED|Arm Allocation Phase||0|All 85 patients were off primary treatment (induction phase), of whom, 69 patients entered the 2nd period (12 were allocated to Arm A and 57 were allocated to Arm B).|
59768093|NCT03203473|75888267|FG001|STARTED|Arm Allocation Phase||12|All 85 patients were off primary treatment (induction phase), of whom, 69 patients entered the 2nd period (12 were allocated to Arm A and 57 were allocated to Arm B).|
59768094|NCT03203473|75888268|FG002|STARTED|Arm Allocation Phase||57|All 85 patients were off primary treatment (induction phase), of whom, 69 patients entered the 2nd period (12 were allocated to Arm A and 57 were allocated to Arm B).|
59768095|NCT03203473|75888266|FG000|COMPLETED|Arm Allocation Phase||0||
59768096|NCT03203473|75888267|FG001|COMPLETED|Arm Allocation Phase||0||
59768097|NCT03203473|75888268|FG002|COMPLETED|Arm Allocation Phase||0||
59768098|NCT03203473|75888266|FG000|NOT COMPLETED|Arm Allocation Phase||0||
59768099|NCT03203473|75888267|FG001|NOT COMPLETED|Arm Allocation Phase||12||
59768100|NCT03203473|75888268|FG002|NOT COMPLETED|Arm Allocation Phase||57||
59768101|NCT03158051|75888281|FG000|STARTED|Overall Study||157||
59768102|NCT03158051|75888282|FG001|STARTED|Overall Study||159||
59768103|NCT03158051|75888281|FG000|Visit 3|Overall Study||100||
59768104|NCT03158051|75888282|FG001|Visit 3|Overall Study||104||
59768105|NCT03158051|75888281|FG000|Visit 4|Overall Study||100||
59768106|NCT03158051|75888282|FG001|Visit 4|Overall Study||104||
59768107|NCT03158051|75888281|FG000|Visit 5|Overall Study||86||
59768108|NCT03158051|75888282|FG001|Visit 5|Overall Study||90||
59768109|NCT03158051|75888281|FG000|Visit 6|Overall Study||86||
59768110|NCT03158051|75888282|FG001|Visit 6|Overall Study||89||
59768111|NCT03158051|75888281|FG000|COMPLETED|Overall Study||86||
59768112|NCT03158051|75888282|FG001|COMPLETED|Overall Study||89||
59768113|NCT03158051|75888281|FG000|NOT COMPLETED|Overall Study||71||
59768114|NCT03158051|75888282|FG001|NOT COMPLETED|Overall Study||70||
59768115|NCT03115567|75888290|FG000|STARTED|Overall Study||7||
59768116|NCT03115567|75888291|FG001|STARTED|Overall Study||7||
59768117|NCT03115567|75888290|FG000|COMPLETED|Overall Study||7||
59768118|NCT03115567|75888291|FG001|COMPLETED|Overall Study||7||
59768119|NCT03115567|75888290|FG000|NOT COMPLETED|Overall Study||0||
59768120|NCT03115567|75888291|FG001|NOT COMPLETED|Overall Study||0||
59768121|NCT02971761|75888297|FG000|STARTED|Overall Study||18||
59768122|NCT02971761|75888297|FG000|COMPLETED|Overall Study||16||
59768123|NCT02971761|75888297|FG000|NOT COMPLETED|Overall Study||2||
59768124|NCT02600507|75888304|FG000|STARTED|Overall Study||176||
59768125|NCT02600507|75888305|FG001|STARTED|Overall Study||177||
59768126|NCT02600507|75888306|FG002|STARTED|Overall Study|176 patients were randomized to the placebo treatment group but only 175 patients took study drug. The number completed and discontinued is based on the 175 patients that took study drug.|175||
59768127|NCT02600507|75888304|FG000|COMPLETED|Overall Study||147||
59768128|NCT02600507|75888305|FG001|COMPLETED|Overall Study||133||
59768129|NCT02600507|75888306|FG002|COMPLETED|Overall Study||150||
59768130|NCT02600507|75888304|FG000|NOT COMPLETED|Overall Study||29||
59768131|NCT02600507|75888305|FG001|NOT COMPLETED|Overall Study||44||
59768132|NCT02600507|75888306|FG002|NOT COMPLETED|Overall Study||25||
59768133|NCT02578680|75888316|FG000|STARTED|Overall Study||410||
59768134|NCT02578680|75888317|FG001|STARTED|Overall Study||206||
59952546|NCT03749252|76071374|FG002|NOT COMPLETED|Overall Study||0||
59952547|NCT02886572|76071382|FG000|STARTED|Overall Study||40||
59952548|NCT02886572|76071382|FG000|Survival Analysis Population|Overall Study||40|All subjects were included in the survival analysis including 8 subjects who died prior to the first MRI.|
59768135|NCT02578680|75888316|FG000|Treated|Overall Study||405||
59768136|NCT02578680|75888317|FG001|Treated|Overall Study||202||
59768137|NCT02578680|75888316|FG000|Switched to Pembrolizumab|Overall Study||0||
59768138|NCT02578680|75888317|FG001|Switched to Pembrolizumab|Overall Study||67||
59768139|NCT02578680|75888316|FG000|COMPLETED|Overall Study||0||
59952549|NCT02886572|76071382|FG000|Distant Brain Recurrence|Overall Study||32||
59768140|NCT02578680|75888317|FG001|COMPLETED|Overall Study||0||
59768141|NCT02578680|75888316|FG000|NOT COMPLETED|Overall Study||410||
59768142|NCT02578680|75888317|FG001|NOT COMPLETED|Overall Study||206||
59768143|NCT02385266|75888325|FG000|STARTED|Overall Study||12||
59768144|NCT02385266|75888326|FG001|STARTED|Overall Study||12||
59768145|NCT02385266|75888325|FG000|COMPLETED|Overall Study||11||
59768146|NCT02385266|75888326|FG001|COMPLETED|Overall Study||9||
59768147|NCT02385266|75888325|FG000|NOT COMPLETED|Overall Study||1||
59768148|NCT02385266|75888326|FG001|NOT COMPLETED|Overall Study||3||
59768149|NCT02379988|75888332|FG000|STARTED|Overall Study||15||
59768150|NCT02379988|75888332|FG000|COMPLETED|Overall Study||14||
59768151|NCT02379988|75888332|FG000|NOT COMPLETED|Overall Study||1||
59768152|NCT02251431|75888338|FG000|STARTED|Overall Study||29||
59768153|NCT02251431|75888339|FG001|STARTED|Overall Study||28||
59768154|NCT02251431|75888338|FG000|COMPLETED|Overall Study||29||
59768155|NCT02251431|75888339|FG001|COMPLETED|Overall Study||28||
59768156|NCT02251431|75888338|FG000|NOT COMPLETED|Overall Study||0||
59768157|NCT02251431|75888339|FG001|NOT COMPLETED|Overall Study||0||
59768158|NCT02006069|75888347|FG000|STARTED|Overall Study||510||
59768159|NCT02006069|75888348|FG001|STARTED|Overall Study||558||
59768160|NCT02006069|75888347|FG000|COMPLETED|Overall Study||271||
59768161|NCT02006069|75888348|FG001|COMPLETED|Overall Study||555||
59768162|NCT02006069|75888347|FG000|NOT COMPLETED|Overall Study||239||
59768163|NCT02006069|75888348|FG001|NOT COMPLETED|Overall Study||3||
59768164|NCT01985867|75888356|FG000|STARTED|Overall Study||48||
59768165|NCT01985867|75888357|FG001|STARTED|Overall Study||46||
59768166|NCT01985867|75888356|FG000|COMPLETED|Overall Study||41||
59768167|NCT01985867|75888357|FG001|COMPLETED|Overall Study||40||
59768168|NCT01985867|75888356|FG000|NOT COMPLETED|Overall Study||7||
59768169|NCT01985867|75888357|FG001|NOT COMPLETED|Overall Study||6||
59768170|NCT01367002|75888365|FG000|STARTED|Overall Study||29||
59768171|NCT01367002|75888366|FG001|STARTED|Overall Study||32||
59768172|NCT01367002|75888365|FG000|Participants Receive Drug|Overall Study||28||
59768173|NCT01367002|75888366|FG001|Participants Receive Drug|Overall Study||32||
59768174|NCT01367002|75888365|FG000|Participants Evaluable for PFS|Overall Study||28|PFS= Progression Free Survival|
59768175|NCT01367002|75888366|FG001|Participants Evaluable for PFS|Overall Study||30|PFS= Progression Free Survival|
59768176|NCT01367002|75888365|FG000|COMPLETED|Overall Study||28||
59768177|NCT01367002|75888366|FG001|COMPLETED|Overall Study||30||
59768178|NCT01367002|75888365|FG000|NOT COMPLETED|Overall Study||1||
59768179|NCT01367002|75888366|FG001|NOT COMPLETED|Overall Study||2||
59768180|NCT00858273|75888374|FG000|STARTED|Overall Study||20||
59768181|NCT00858273|75888375|FG001|STARTED|Overall Study||20||
59768182|NCT00858273|75888374|FG000|COMPLETED|Overall Study||17||
59768183|NCT00858273|75888375|FG001|COMPLETED|Overall Study||15||
59768184|NCT00858273|75888374|FG000|NOT COMPLETED|Overall Study||3||
59768185|NCT00858273|75888375|FG001|NOT COMPLETED|Overall Study||5||
59768186|NCT00624234|75888387|FG000|STARTED|Overall Study||8||
59768187|NCT00624234|75888388|FG001|STARTED|Overall Study||9||
59768188|NCT00624234|75888389|FG002|STARTED|Overall Study||26||
59768189|NCT00624234|75888390|FG003|STARTED|Overall Study||14||
59768190|NCT00624234|75888391|FG004|STARTED|Overall Study||18||
59768191|NCT00624234|75888392|FG005|STARTED|Overall Study||14||
59768192|NCT00624234|75888387|FG000|COMPLETED|Overall Study||8||
59768193|NCT00624234|75888388|FG001|COMPLETED|Overall Study||9||
59768194|NCT00624234|75888389|FG002|COMPLETED|Overall Study||26||
59768195|NCT00624234|75888390|FG003|COMPLETED|Overall Study||14||
59768196|NCT00624234|75888391|FG004|COMPLETED|Overall Study||18||
59768197|NCT00624234|75888392|FG005|COMPLETED|Overall Study||14||
59768198|NCT00624234|75888387|FG000|NOT COMPLETED|Overall Study||0||
59768199|NCT00624234|75888388|FG001|NOT COMPLETED|Overall Study||0||
59768200|NCT00624234|75888389|FG002|NOT COMPLETED|Overall Study||0||
59768201|NCT00624234|75888390|FG003|NOT COMPLETED|Overall Study||0||
59768202|NCT00624234|75888391|FG004|NOT COMPLETED|Overall Study||0||
59768203|NCT00624234|75888392|FG005|NOT COMPLETED|Overall Study||0||
59768204|NCT00844428|75888406|FG000|STARTED|Screening Period||23||
59768205|NCT00844428|75888406|FG000|COMPLETED|Screening Period||20||
59768206|NCT00844428|75888406|FG000|NOT COMPLETED|Screening Period||3||
59768207|NCT00844428|75888406|FG000|STARTED|Observation Period (8 Weeks)||20||
59768208|NCT00844428|75888406|FG000|COMPLETED|Observation Period (8 Weeks)||20||
59768209|NCT00844428|75888406|FG000|NOT COMPLETED|Observation Period (8 Weeks)||0||
59768210|NCT00844428|75888406|FG000|STARTED|Treatment Period (26 Weeks)||20||
59768211|NCT00844428|75888406|FG000|COMPLETED|Treatment Period (26 Weeks)||20||
59768212|NCT00844428|75888406|FG000|NOT COMPLETED|Treatment Period (26 Weeks)||0||
59768213|NCT00844428|75888406|FG000|STARTED|Extension Treatment Period||19||
59768214|NCT00844428|75888406|FG000|COMPLETED|Extension Treatment Period||18||
59768215|NCT00844428|75888406|FG000|NOT COMPLETED|Extension Treatment Period||1||
59768216|NCT00844428|75888406|FG000|STARTED|Post Treatment Period (Patients Who Disc||5||
59768217|NCT00844428|75888406|FG000|COMPLETED|Post Treatment Period (Patients Who Disc||4||
59768218|NCT00844428|75888406|FG000|NOT COMPLETED|Post Treatment Period (Patients Who Disc||1||
59768219|NCT00834834|75888412|FG000|STARTED|Overall Study||42||
59768220|NCT00834834|75888413|FG001|STARTED|Overall Study||42||
59768221|NCT00834834|75888412|FG000|COMPLETED|Overall Study||38||
59768222|NCT00834834|75888413|FG001|COMPLETED|Overall Study||39||
59768223|NCT00834834|75888412|FG000|NOT COMPLETED|Overall Study||4||
59768224|NCT00834834|75888413|FG001|NOT COMPLETED|Overall Study||3||
59768225|NCT00834366|75888421|FG000|STARTED|Treatment Period 1||13||
59768226|NCT00834366|75888422|FG001|STARTED|Treatment Period 1||13||
59768227|NCT00834366|75888421|FG000|COMPLETED|Treatment Period 1||12||
59768228|NCT00834366|75888422|FG001|COMPLETED|Treatment Period 1||12||
59768229|NCT00834366|75888421|FG000|NOT COMPLETED|Treatment Period 1||1||
59768230|NCT00834366|75888422|FG001|NOT COMPLETED|Treatment Period 1||1||
59768231|NCT00834366|75888421|FG000|STARTED|Treatment Period 2||12||
59768232|NCT00834366|75888422|FG001|STARTED|Treatment Period 2||12||
59768233|NCT00834366|75888421|FG000|COMPLETED|Treatment Period 2||12||
59768234|NCT00834366|75888422|FG001|COMPLETED|Treatment Period 2||12||
59768235|NCT00834366|75888421|FG000|NOT COMPLETED|Treatment Period 2||0||
59768236|NCT00834366|75888422|FG001|NOT COMPLETED|Treatment Period 2||0||
59768237|NCT00844194|75888430|FG000|STARTED|Overall Study||78||
59768238|NCT00844194|75888431|FG001|STARTED|Overall Study||30||
59768239|NCT00844194|75888430|FG000|COMPLETED|Overall Study||53||
59768240|NCT00844194|75888431|FG001|COMPLETED|Overall Study||22||
59768241|NCT00844194|75888430|FG000|NOT COMPLETED|Overall Study||25||
59768242|NCT00844194|75888431|FG001|NOT COMPLETED|Overall Study||8||
59768243|NCT00826176|75888443|FG000|STARTED|Overall Study|enrolled|128||
59768244|NCT00826176|75888444|FG001|STARTED|Overall Study|enrolled|36||
59768245|NCT00826176|75888443|FG000|COMPLETED|Overall Study|treated and completed|115||
59768246|NCT00826176|75888444|FG001|COMPLETED|Overall Study|treated and completed|36||
59768247|NCT00826176|75888443|FG000|NOT COMPLETED|Overall Study||13||
59768248|NCT00826176|75888444|FG001|NOT COMPLETED|Overall Study||0||
59768249|NCT00878969|75888453|FG000|STARTED|Overall Study||25||
59768250|NCT00878969|75888454|FG001|STARTED|Overall Study||27||
59768251|NCT00878969|75888455|FG002|STARTED|Overall Study||26||
59768252|NCT00878969|75888453|FG000|COMPLETED|Overall Study||10||
59768253|NCT00878969|75888454|FG001|COMPLETED|Overall Study||12||
59768254|NCT00878969|75888455|FG002|COMPLETED|Overall Study||15||
59768255|NCT00878969|75888453|FG000|NOT COMPLETED|Overall Study||15||
59768256|NCT00878969|75888454|FG001|NOT COMPLETED|Overall Study||15||
59768257|NCT00878969|75888455|FG002|NOT COMPLETED|Overall Study||11||
59768258|NCT04057235|75888463|FG000|STARTED|Overall Study||129||
59768259|NCT04057235|75888463|FG000|Had Radiographic Data|Overall Study||58||
59768260|NCT04057235|75888463|FG000|Had ODI Data|Overall Study||43||
59768261|NCT04057235|75888463|FG000|Had VAS Back Data|Overall Study||45||
59768262|NCT04057235|75888463|FG000|Had VAS Leg Data|Overall Study||45||
59768263|NCT04057235|75888463|FG000|COMPLETED|Overall Study|All 129 participants had data for at least one of the primary/secondary outcomes or adverse events|129||
59768264|NCT04057235|75888463|FG000|NOT COMPLETED|Overall Study||0||
59768265|NCT00843726|75888469|FG000|STARTED|Overall Study||49||
59768266|NCT00843726|75888470|FG001|STARTED|Overall Study||49||
59768267|NCT00843726|75888469|FG000|COMPLETED|Overall Study||48||
59768268|NCT00843726|75888470|FG001|COMPLETED|Overall Study||48||
59768269|NCT00843726|75888469|FG000|NOT COMPLETED|Overall Study||1||
59768270|NCT00843726|75888470|FG001|NOT COMPLETED|Overall Study||1||
59768271|NCT00843492|75888479|FG000|STARTED|Overall Study||622||
59768272|NCT00843492|75888480|FG001|STARTED|Overall Study||621||
59768273|NCT00843492|75888479|FG000|COMPLETED|Overall Study||614||
59768274|NCT00843492|75888480|FG001|COMPLETED|Overall Study||607||
59768275|NCT00843492|75888479|FG000|NOT COMPLETED|Overall Study||8||
59768276|NCT00843492|75888480|FG001|NOT COMPLETED|Overall Study||14||
59768277|NCT00833976|75888486|FG000|STARTED|Overall Study||65||
59768278|NCT00833976|75888486|FG000|COMPLETED|Overall Study||14||
59768279|NCT00833976|75888486|FG000|NOT COMPLETED|Overall Study||51||
59768280|NCT00833898|75888492|FG000|STARTED|Overall Study||74||
59768281|NCT00833898|75888493|FG001|STARTED|Overall Study||74||
59768282|NCT00833898|75888492|FG000|Month 1 (Post Transplantation)|Overall Study||72||
59768283|NCT00833898|75888493|FG001|Month 1 (Post Transplantation)|Overall Study||74||
59768284|NCT00833898|75888492|FG000|Month 3 (Post Transplantation)|Overall Study||66||
59768285|NCT00833898|75888493|FG001|Month 3 (Post Transplantation)|Overall Study||64||
59768286|NCT00833898|75888492|FG000|Month 6 (Post Transplantation)|Overall Study||59||
59768287|NCT00833898|75888493|FG001|Month 6 (Post Transplantation)|Overall Study||54||
59768288|NCT00833898|75888492|FG000|Month 12 (Post Transplantation)|Overall Study||50||
59768289|NCT00833898|75888493|FG001|Month 12 (Post Transplantation)|Overall Study||50||
59768290|NCT00833898|75888492|FG000|COMPLETED|Overall Study||34||
59768291|NCT00833898|75888493|FG001|COMPLETED|Overall Study||38||
59768292|NCT00833898|75888492|FG000|NOT COMPLETED|Overall Study||40||
59768293|NCT00833898|75888493|FG001|NOT COMPLETED|Overall Study||36||
59768294|NCT00825162|75888502|FG000|STARTED|Overall Study||710||
59768295|NCT00825162|75888503|FG001|STARTED|Overall Study||880||
59768296|NCT00825162|75888504|FG002|STARTED|Overall Study||402||
59768297|NCT00825162|75888502|FG000|COMPLETED|Overall Study||682||
59768298|NCT00825162|75888503|FG001|COMPLETED|Overall Study||859||
59768299|NCT00825162|75888504|FG002|COMPLETED|Overall Study||396||
59768300|NCT00825162|75888502|FG000|NOT COMPLETED|Overall Study||28||
59768301|NCT00825162|75888503|FG001|NOT COMPLETED|Overall Study||21||
59768302|NCT00825162|75888504|FG002|NOT COMPLETED|Overall Study||6||
59768303|NCT00824850|75888519|FG000|STARTED|Overall Study||38||
59768304|NCT00824850|75888520|FG001|STARTED|Overall Study||37||
59768305|NCT00824850|75888519|FG000|Received Vaccination 13vPnC|Overall Study||38||
59768306|NCT00824850|75888520|FG001|Received Vaccination 13vPnC|Overall Study||36||
59768307|NCT00824850|75888519|FG000|COMPLETED|Overall Study||38||
59768308|NCT00824850|75888520|FG001|COMPLETED|Overall Study||36||
59768309|NCT00824850|75888519|FG000|NOT COMPLETED|Overall Study||0||
59768310|NCT00824850|75888520|FG001|NOT COMPLETED|Overall Study||1||
59768311|NCT00596687|75888534|FG000|STARTED|Overall Study||118||
59768312|NCT00596687|75888535|FG001|STARTED|Overall Study||116||
59768313|NCT00596687|75888534|FG000|COMPLETED|Overall Study||104||
59768314|NCT00596687|75888535|FG001|COMPLETED|Overall Study||107||
59768315|NCT00596687|75888534|FG000|NOT COMPLETED|Overall Study||14||
59768316|NCT00596687|75888535|FG001|NOT COMPLETED|Overall Study||9||
59768317|NCT00824772|75888541|FG000|STARTED|Overall Study||204||
59768318|NCT00824772|75888541|FG000|COMPLETED|Overall Study||196||
59768319|NCT00824772|75888541|FG000|NOT COMPLETED|Overall Study||8||
59768320|NCT00824616|75888547|FG000|STARTED|Overall Study||34||
59768321|NCT00824616|75888548|FG001|STARTED|Overall Study||34||
59768322|NCT00824616|75888547|FG000|COMPLETED|Overall Study||28||
59768323|NCT00824616|75888548|FG001|COMPLETED|Overall Study||27||
59768324|NCT00824616|75888547|FG000|NOT COMPLETED|Overall Study||6||
59768325|NCT00824616|75888548|FG001|NOT COMPLETED|Overall Study||7||
59768326|NCT00824382|75888558|FG000|STARTED|Overall Study||79||
59768327|NCT00824382|75888559|FG001|STARTED|Overall Study||84||
59768328|NCT00824382|75888560|FG002|STARTED|Overall Study||79||
59768329|NCT00824382|75888561|FG003|STARTED|Overall Study||86||
59768330|NCT00824382|75888558|FG000|COMPLETED|Overall Study||74||
59768331|NCT00824382|75888559|FG001|COMPLETED|Overall Study||82||
59768332|NCT00824382|75888560|FG002|COMPLETED|Overall Study||76||
59768333|NCT00824382|75888561|FG003|COMPLETED|Overall Study||81||
59768334|NCT00824382|75888558|FG000|NOT COMPLETED|Overall Study||5||
59768335|NCT00824382|75888559|FG001|NOT COMPLETED|Overall Study||2||
59768336|NCT00824382|75888560|FG002|NOT COMPLETED|Overall Study||3||
59768337|NCT00824382|75888561|FG003|NOT COMPLETED|Overall Study||5||
59768338|NCT00833040|75888573|FG000|STARTED|Overall Study||6||
59768339|NCT00833040|75888574|FG001|STARTED|Overall Study||6||
59768340|NCT00833040|75888575|FG002|STARTED|Overall Study||6||
59768341|NCT00833040|75888576|FG003|STARTED|Overall Study||6||
59768342|NCT00833040|75888577|FG004|STARTED|Overall Study||5||
59768343|NCT00833040|75888578|FG005|STARTED|Overall Study||5||
59768344|NCT00833040|75888573|FG000|COMPLETED|Overall Study||6||
59768345|NCT00833040|75888574|FG001|COMPLETED|Overall Study||6||
59768346|NCT00833040|75888575|FG002|COMPLETED|Overall Study||6||
59768347|NCT00833040|75888576|FG003|COMPLETED|Overall Study||6||
59768348|NCT00833040|75888577|FG004|COMPLETED|Overall Study||5||
59768349|NCT00833040|75888578|FG005|COMPLETED|Overall Study||4||
59768350|NCT00833040|75888573|FG000|NOT COMPLETED|Overall Study||0||
59768351|NCT00833040|75888574|FG001|NOT COMPLETED|Overall Study||0||
59768352|NCT00833040|75888575|FG002|NOT COMPLETED|Overall Study||0||
59768353|NCT00833040|75888576|FG003|NOT COMPLETED|Overall Study||0||
59768354|NCT00833040|75888577|FG004|NOT COMPLETED|Overall Study||0||
59768355|NCT00833040|75888578|FG005|NOT COMPLETED|Overall Study||1||
59768356|NCT00843024|75888587|FG000|STARTED|Single-blind Placebo Run-In Phase||408||
59768357|NCT00843024|75888588|FG001|STARTED|Single-blind Placebo Run-In Phase||457||
59768358|NCT00843024|75888589|FG002|STARTED|Single-blind Placebo Run-In Phase||0||
59768359|NCT00843024|75888590|FG003|STARTED|Single-blind Placebo Run-In Phase||0||
59768360|NCT00843024|75888591|FG004|STARTED|Single-blind Placebo Run-In Phase||0||
59768361|NCT00843024|75888592|FG005|STARTED|Single-blind Placebo Run-In Phase||0||
59768362|NCT00843024|75888587|FG000|COMPLETED|Single-blind Placebo Run-In Phase||268||
59768363|NCT00843024|75888588|FG001|COMPLETED|Single-blind Placebo Run-In Phase||321||
59768364|NCT00843024|75888589|FG002|COMPLETED|Single-blind Placebo Run-In Phase||0||
59768365|NCT00843024|75888590|FG003|COMPLETED|Single-blind Placebo Run-In Phase||0||
59768366|NCT00843024|75888591|FG004|COMPLETED|Single-blind Placebo Run-In Phase||0||
59768367|NCT00843024|75888592|FG005|COMPLETED|Single-blind Placebo Run-In Phase||0||
59768368|NCT00843024|75888587|FG000|NOT COMPLETED|Single-blind Placebo Run-In Phase||140||
59768369|NCT00843024|75888588|FG001|NOT COMPLETED|Single-blind Placebo Run-In Phase||136||
59768370|NCT00843024|75888589|FG002|NOT COMPLETED|Single-blind Placebo Run-In Phase||0||
59768371|NCT00843024|75888590|FG003|NOT COMPLETED|Single-blind Placebo Run-In Phase||0||
59768372|NCT00843024|75888591|FG004|NOT COMPLETED|Single-blind Placebo Run-In Phase||0||
59768373|NCT00843024|75888592|FG005|NOT COMPLETED|Single-blind Placebo Run-In Phase||0||
59768374|NCT00843024|75888587|FG000|STARTED|Double-blind Treatment Phase||0||
59768375|NCT00843024|75888588|FG001|STARTED|Double-blind Treatment Phase||0||
59768376|NCT00843024|75888589|FG002|STARTED|Double-blind Treatment Phase||176||
59768377|NCT00843024|75888590|FG003|STARTED|Double-blind Treatment Phase||119||
59768378|NCT00843024|75888591|FG004|STARTED|Double-blind Treatment Phase||117||
59768379|NCT00843024|75888592|FG005|STARTED|Double-blind Treatment Phase||177||
59768380|NCT00843024|75888587|FG000|COMPLETED|Double-blind Treatment Phase||0||
59768381|NCT00843024|75888588|FG001|COMPLETED|Double-blind Treatment Phase||0||
59768382|NCT00843024|75888589|FG002|COMPLETED|Double-blind Treatment Phase||145||
59768383|NCT00843024|75888590|FG003|COMPLETED|Double-blind Treatment Phase||96||
59768384|NCT00843024|75888591|FG004|COMPLETED|Double-blind Treatment Phase||97||
59768385|NCT00843024|75888592|FG005|COMPLETED|Double-blind Treatment Phase||152||
59768386|NCT00843024|75888587|FG000|NOT COMPLETED|Double-blind Treatment Phase||0||
59768387|NCT00843024|75888588|FG001|NOT COMPLETED|Double-blind Treatment Phase||0||
59768388|NCT00843024|75888589|FG002|NOT COMPLETED|Double-blind Treatment Phase||31||
59768389|NCT00843024|75888590|FG003|NOT COMPLETED|Double-blind Treatment Phase||23||
59768390|NCT00843024|75888591|FG004|NOT COMPLETED|Double-blind Treatment Phase||20||
59768391|NCT00843024|75888592|FG005|NOT COMPLETED|Double-blind Treatment Phase||25||
59768392|NCT00832650|75888608|FG000|STARTED|Overall Study||25||
59768393|NCT00832650|75888609|FG001|STARTED|Overall Study||12||
59768394|NCT00832650|75888610|FG002|STARTED|Overall Study||23||
59768395|NCT00832650|75888608|FG000|Treated|Overall Study||25||
59768396|NCT00832650|75888609|FG001|Treated|Overall Study||12||
59768397|NCT00832650|75888610|FG002|Treated|Overall Study||22||
59768398|NCT00832650|75888608|FG000|COMPLETED|Overall Study||25||
59768399|NCT00832650|75888609|FG001|COMPLETED|Overall Study||12||
59768400|NCT00832650|75888610|FG002|COMPLETED|Overall Study||22||
59768401|NCT00832650|75888608|FG000|NOT COMPLETED|Overall Study||0||
59768402|NCT00832650|75888609|FG001|NOT COMPLETED|Overall Study||0||
59768403|NCT00832650|75888610|FG002|NOT COMPLETED|Overall Study||1||
59768404|NCT00595517|75888618|FG000|STARTED|Overall Study||130||
59768405|NCT00595517|75888618|FG000|COMPLETED|Overall Study||111||
59768406|NCT00595517|75888618|FG000|NOT COMPLETED|Overall Study||19||
59768407|NCT00823836|75888624|FG000|STARTED|NV and PR/XR Switching Phases||156||
59768408|NCT00823836|75888625|FG001|STARTED|NV and PR/XR Switching Phases||146||
59768409|NCT00823836|75888624|FG000|COMPLETED|NV and PR/XR Switching Phases||124||
59768410|NCT00823836|75888625|FG001|COMPLETED|NV and PR/XR Switching Phases||117||
59768411|NCT00823836|75888624|FG000|NOT COMPLETED|NV and PR/XR Switching Phases||32||
59768412|NCT00823836|75888625|FG001|NOT COMPLETED|NV and PR/XR Switching Phases||29||
59768413|NCT00823836|75888624|FG000|STARTED|Long-term Phase||73||
59768414|NCT00823836|75888625|FG001|STARTED|Long-term Phase||84||
59768415|NCT00823836|75888624|FG000|COMPLETED|Long-term Phase||68||
59768416|NCT00823836|75888625|FG001|COMPLETED|Long-term Phase||79||
59768417|NCT00823836|75888624|FG000|NOT COMPLETED|Long-term Phase||5||
59768418|NCT00823836|75888625|FG001|NOT COMPLETED|Long-term Phase||5||
59768419|NCT00879437|75888634|FG000|STARTED|Overall Study||20||
59768420|NCT00879437|75888635|FG001|STARTED|Overall Study||18||
59768421|NCT00879437|75888634|FG000|COMPLETED|Overall Study||19||
59768422|NCT00879437|75888635|FG001|COMPLETED|Overall Study||17||
59768423|NCT00879437|75888634|FG000|NOT COMPLETED|Overall Study||1||
59768424|NCT00879437|75888635|FG001|NOT COMPLETED|Overall Study||1||
59768425|NCT00877799|75888648|FG000|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||25||
59768426|NCT00877799|75888649|FG001|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||22||
59768427|NCT00877799|75888650|FG002|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||21||
59768428|NCT00877799|75888651|FG003|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||0||
59768429|NCT00877799|75888652|FG004|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||0||
59768430|NCT00877799|75888648|FG000|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||22||
59768431|NCT00877799|75888649|FG001|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||17||
59768432|NCT00877799|75888650|FG002|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||18||
59768433|NCT00877799|75888651|FG003|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||0||
59768434|NCT00877799|75888652|FG004|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||0||
59768435|NCT00877799|75888648|FG000|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||3||
59768436|NCT00877799|75888649|FG001|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||5||
59768437|NCT00877799|75888650|FG002|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||3||
59768438|NCT00877799|75888651|FG003|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||0||
59768439|NCT00877799|75888652|FG004|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||0||
59768440|NCT00877799|75888648|FG000|STARTED|Cohort 2: Immediately Post-op (Day 0)||0||
59768441|NCT00877799|75888649|FG001|STARTED|Cohort 2: Immediately Post-op (Day 0)||0||
59768442|NCT00877799|75888650|FG002|STARTED|Cohort 2: Immediately Post-op (Day 0)||0||
59768443|NCT00877799|75888651|FG003|STARTED|Cohort 2: Immediately Post-op (Day 0)||26||
59768444|NCT00877799|75888652|FG004|STARTED|Cohort 2: Immediately Post-op (Day 0)||20||
59768445|NCT00877799|75888648|FG000|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0||
59768446|NCT00877799|75888649|FG001|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0||
59768447|NCT00877799|75888650|FG002|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0||
59768448|NCT00877799|75888651|FG003|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||24||
59768449|NCT00877799|75888652|FG004|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||19||
59768450|NCT00877799|75888648|FG000|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0||
59768451|NCT00877799|75888649|FG001|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0||
59768452|NCT00877799|75888650|FG002|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0||
59768453|NCT00877799|75888651|FG003|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||2||
59768454|NCT00877799|75888652|FG004|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||1||
59768455|NCT00595127|75888663|FG000|STARTED|Overall Study||21||
59768456|NCT00595127|75888663|FG000|COMPLETED|Overall Study||11||
59768457|NCT00595127|75888663|FG000|NOT COMPLETED|Overall Study||10||
59768458|NCT00877487|75888667|FG000|STARTED|Open-label Treatment Phase||123||
59768459|NCT00877487|75888668|FG001|STARTED|Open-label Treatment Phase||0||
59768460|NCT00877487|75888667|FG000|COMPLETED|Open-label Treatment Phase||116||
59768461|NCT00877487|75888668|FG001|COMPLETED|Open-label Treatment Phase||0||
59768462|NCT00877487|75888667|FG000|NOT COMPLETED|Open-label Treatment Phase||7||
59768463|NCT00877487|75888668|FG001|NOT COMPLETED|Open-label Treatment Phase||0||
59768464|NCT00877487|75888667|FG000|STARTED|Double-blind Randomized Withdrawal Phase||56||
59768465|NCT00877487|75888668|FG001|STARTED|Double-blind Randomized Withdrawal Phase||60||
59768466|NCT00877487|75888667|FG000|COMPLETED|Double-blind Randomized Withdrawal Phase||50||
59768467|NCT00877487|75888668|FG001|COMPLETED|Double-blind Randomized Withdrawal Phase||13||
59768468|NCT00877487|75888667|FG000|NOT COMPLETED|Double-blind Randomized Withdrawal Phase||6||
59768469|NCT00877487|75888668|FG001|NOT COMPLETED|Double-blind Randomized Withdrawal Phase||47||
59768470|NCT00878501|75888677|FG000|STARTED|Overall Study|One of these patients did not receive study drug since incorrectly enrolled (mis-randomisation)|104||
59768471|NCT00878501|75888678|FG001|STARTED|Overall Study||44||
59768472|NCT00878501|75888679|FG002|STARTED|Overall Study||93||
59768473|NCT00878501|75888677|FG000|Interim Analysis|Overall Study||83||
59768474|NCT00878501|75888678|FG001|Interim Analysis|Overall Study||37||
59768475|NCT00878501|75888679|FG002|Interim Analysis|Overall Study||81||
59768476|NCT00878501|75888677|FG000|COMPLETED|Overall Study||87||
59768477|NCT00878501|75888678|FG001|COMPLETED|Overall Study||37||
59768478|NCT00878501|75888679|FG002|COMPLETED|Overall Study||85||
59768479|NCT00878501|75888677|FG000|NOT COMPLETED|Overall Study||17||
59768480|NCT00878501|75888678|FG001|NOT COMPLETED|Overall Study||7||
59768481|NCT00878501|75888679|FG002|NOT COMPLETED|Overall Study||8||
59768482|NCT00882713|75888687|FG000|STARTED|Overall Study||194||
59768483|NCT00882713|75888687|FG000|COMPLETED|Overall Study||172||
59768484|NCT00882713|75888687|FG000|NOT COMPLETED|Overall Study||22||
59768485|NCT00809133|75888706|FG000|STARTED|Overall Study||3||
59768486|NCT00809133|75888707|FG001|STARTED|Overall Study||7||
59768487|NCT00809133|75888708|FG002|STARTED|Overall Study||6||
59768488|NCT00809133|75888709|FG003|STARTED|Overall Study||3||
59768489|NCT00809133|75888710|FG004|STARTED|Overall Study||5||
59768490|NCT00809133|75888711|FG005|STARTED|Overall Study||7||
59768491|NCT00809133|75888712|FG006|STARTED|Overall Study||6||
59768492|NCT00809133|75888713|FG007|STARTED|Overall Study||8||
59768493|NCT00809133|75888714|FG008|STARTED|Overall Study||3||
59768494|NCT00809133|75888715|FG009|STARTED|Overall Study||9||
59768495|NCT00809133|75888716|FG010|STARTED|Overall Study||6||
59768496|NCT00809133|75888717|FG011|STARTED|Overall Study||8||
59768497|NCT00809133|75888718|FG012|STARTED|Overall Study||5||
59768498|NCT00809133|75888719|FG013|STARTED|Overall Study||7||
59768499|NCT00809133|75888706|FG000|COMPLETED|Overall Study||0||
59768500|NCT00809133|75888707|FG001|COMPLETED|Overall Study||0||
59768501|NCT00809133|75888708|FG002|COMPLETED|Overall Study||0||
59768502|NCT00809133|75888709|FG003|COMPLETED|Overall Study||0||
59768503|NCT00809133|75888710|FG004|COMPLETED|Overall Study||0||
59768504|NCT00809133|75888711|FG005|COMPLETED|Overall Study||0||
59768505|NCT00809133|75888712|FG006|COMPLETED|Overall Study||0||
59768506|NCT00809133|75888713|FG007|COMPLETED|Overall Study||0||
59768507|NCT00809133|75888714|FG008|COMPLETED|Overall Study||0||
59768508|NCT00809133|75888715|FG009|COMPLETED|Overall Study||0||
59768509|NCT00809133|75888716|FG010|COMPLETED|Overall Study||0||
59768510|NCT00809133|75888717|FG011|COMPLETED|Overall Study||0||
59768511|NCT00809133|75888718|FG012|COMPLETED|Overall Study||0||
59768512|NCT00809133|75888719|FG013|COMPLETED|Overall Study||0||
59768513|NCT00809133|75888706|FG000|NOT COMPLETED|Overall Study||3||
59768514|NCT00809133|75888707|FG001|NOT COMPLETED|Overall Study||7||
59768515|NCT00809133|75888708|FG002|NOT COMPLETED|Overall Study||6||
59768516|NCT00809133|75888709|FG003|NOT COMPLETED|Overall Study||3||
59768517|NCT00809133|75888710|FG004|NOT COMPLETED|Overall Study||5||
59768518|NCT00809133|75888711|FG005|NOT COMPLETED|Overall Study||7||
59768519|NCT00809133|75888712|FG006|NOT COMPLETED|Overall Study||6||
59768520|NCT00809133|75888713|FG007|NOT COMPLETED|Overall Study||8||
59768521|NCT00809133|75888714|FG008|NOT COMPLETED|Overall Study||3||
59768522|NCT00809133|75888715|FG009|NOT COMPLETED|Overall Study||9||
59768523|NCT00809133|75888716|FG010|NOT COMPLETED|Overall Study||6||
59768524|NCT00809133|75888717|FG011|NOT COMPLETED|Overall Study||8||
59768525|NCT00809133|75888718|FG012|NOT COMPLETED|Overall Study||5||
59768526|NCT00809133|75888719|FG013|NOT COMPLETED|Overall Study||7||
59768527|NCT00882557|75888764|FG000|STARTED|Overall Study||8||
59768528|NCT00882557|75888765|FG001|STARTED|Overall Study||8||
59768529|NCT00882557|75888764|FG000|Completed Dose 1|Overall Study||8||
59768530|NCT00882557|75888765|FG001|Completed Dose 1|Overall Study||7||
59768531|NCT00882557|75888764|FG000|Completed Dose 2|Overall Study||6||
59768532|NCT00882557|75888765|FG001|Completed Dose 2|Overall Study||7||
59768533|NCT00882557|75888764|FG000|COMPLETED|Overall Study||6||
59768534|NCT00882557|75888765|FG001|COMPLETED|Overall Study||7||
59768535|NCT00882557|75888764|FG000|NOT COMPLETED|Overall Study||2||
59768536|NCT00882557|75888765|FG001|NOT COMPLETED|Overall Study||1||
59768537|NCT00808899|75888771|FG000|STARTED|Overall Study||4||
59768538|NCT00808899|75888771|FG000|COMPLETED|Overall Study||0||
59768539|NCT00808899|75888771|FG000|NOT COMPLETED|Overall Study||4||
59768540|NCT00808665|75888777|FG000|STARTED|Overall Study||31||
59768541|NCT00808665|75888778|FG001|STARTED|Overall Study||32||
59768542|NCT00808665|75888777|FG000|Medication Started|Overall Study||30||
59768543|NCT00808665|75888778|FG001|Medication Started|Overall Study||32||
59768544|NCT00808665|75888777|FG000|Completed Intra-operative Dose|Overall Study||26||
59768545|NCT00808665|75888778|FG001|Completed Intra-operative Dose|Overall Study||32||
59768546|NCT00808665|75888777|FG000|Completed Post Operative Doses|Overall Study||25||
59768547|NCT00808665|75888778|FG001|Completed Post Operative Doses|Overall Study||29||
59768548|NCT00808665|75888777|FG000|COMPLETED|Overall Study||25||
59768549|NCT00808665|75888778|FG001|COMPLETED|Overall Study||29||
59768550|NCT00808665|75888777|FG000|NOT COMPLETED|Overall Study||6||
59768551|NCT00808665|75888778|FG001|NOT COMPLETED|Overall Study||3||
59768552|NCT00808509|75888786|FG000|STARTED|Randomized Phase||17||
59768553|NCT00808509|75888787|FG001|STARTED|Randomized Phase||16||
59768554|NCT00808509|75888786|FG000|Received Rescue Therapy|Randomized Phase||0||
59768555|NCT00808509|75888787|FG001|Received Rescue Therapy|Randomized Phase||9||
59768556|NCT00808509|75888786|FG000|COMPLETED|Randomized Phase||15||
59768557|NCT00808509|75888787|FG001|COMPLETED|Randomized Phase|Includes participants who received rescue therapy & follow-up for 12 weeks|11||
59768558|NCT00808509|75888786|FG000|NOT COMPLETED|Randomized Phase||2||
59768559|NCT00808509|75888787|FG001|NOT COMPLETED|Randomized Phase||5||
59768560|NCT00808509|75888786|FG000|STARTED|Observation Phase|The observation phase was open to all participants|16||
59768561|NCT00808509|75888787|FG001|STARTED|Observation Phase|The observation phase was open to all participants|15||
59768562|NCT00808509|75888786|FG000|COMPLETED|Observation Phase||16||
59768563|NCT00808509|75888787|FG001|COMPLETED|Observation Phase||15||
59768564|NCT00808509|75888786|FG000|NOT COMPLETED|Observation Phase||0||
59768565|NCT00808509|75888787|FG001|NOT COMPLETED|Observation Phase||0||
59768566|NCT00807885|75888804|FG000|STARTED|Overall Study||10||
59768567|NCT00807885|75888805|FG001|STARTED|Overall Study||11||
59768568|NCT00807885|75888806|FG002|STARTED|Overall Study||11||
59768569|NCT00807885|75888807|FG003|STARTED|Overall Study||10||
59768570|NCT00807885|75888808|FG004|STARTED|Overall Study||12||
59768571|NCT00807885|75888809|FG005|STARTED|Overall Study||12||
59768572|NCT00807885|75888810|FG006|STARTED|Overall Study||12||
59768573|NCT00807885|75888811|FG007|STARTED|Overall Study||11||
59768574|NCT00807885|75888812|FG008|STARTED|Overall Study||11||
59768575|NCT00807885|75888804|FG000|COMPLETED|Overall Study||10||
59768576|NCT00807885|75888805|FG001|COMPLETED|Overall Study||11||
59768577|NCT00807885|75888806|FG002|COMPLETED|Overall Study||11||
59768578|NCT00807885|75888807|FG003|COMPLETED|Overall Study||10||
59768579|NCT00807885|75888808|FG004|COMPLETED|Overall Study||12||
59768580|NCT00807885|75888809|FG005|COMPLETED|Overall Study|Subject completed treatment, but lost to follow-up|11||
59768581|NCT00807885|75888810|FG006|COMPLETED|Overall Study||12||
59768582|NCT00807885|75888811|FG007|COMPLETED|Overall Study||11||
59768583|NCT00807885|75888812|FG008|COMPLETED|Overall Study||11||
59768584|NCT00807885|75888804|FG000|NOT COMPLETED|Overall Study||0||
59768585|NCT00807885|75888805|FG001|NOT COMPLETED|Overall Study||0||
59768586|NCT00807885|75888806|FG002|NOT COMPLETED|Overall Study||0||
59768587|NCT00807885|75888807|FG003|NOT COMPLETED|Overall Study||0||
59768588|NCT00807885|75888808|FG004|NOT COMPLETED|Overall Study||0||
59768589|NCT00807885|75888809|FG005|NOT COMPLETED|Overall Study||1||
59768590|NCT00807885|75888810|FG006|NOT COMPLETED|Overall Study||0||
59768591|NCT00807885|75888811|FG007|NOT COMPLETED|Overall Study||0||
59768592|NCT00807885|75888812|FG008|NOT COMPLETED|Overall Study||0||
59768593|NCT00807573|75888832|FG000|STARTED|Overall Study||44||
59768594|NCT00807573|75888832|FG000|COMPLETED|Overall Study||42||
59768595|NCT00807573|75888832|FG000|NOT COMPLETED|Overall Study||2||
59768596|NCT00842712|75888843|FG000|STARTED|Safety Run-in Part||3||
59768597|NCT00842712|75888844|FG001|STARTED|Safety Run-in Part||3||
59768598|NCT00842712|75888845|FG002|STARTED|Safety Run-in Part||3||
59768599|NCT00842712|75888846|FG003|STARTED|Safety Run-in Part||3||
59768600|NCT00842712|75888847|FG004|STARTED|Safety Run-in Part||0||
59768601|NCT00842712|75888848|FG005|STARTED|Safety Run-in Part||0||
59768602|NCT00842712|75888849|FG006|STARTED|Safety Run-in Part||0||
59768603|NCT00842712|75888843|FG000|COMPLETED|Safety Run-in Part||0||
59768604|NCT00842712|75888844|FG001|COMPLETED|Safety Run-in Part||1||
59768605|NCT00842712|75888845|FG002|COMPLETED|Safety Run-in Part||3||
59768606|NCT00842712|75888846|FG003|COMPLETED|Safety Run-in Part||2||
59768607|NCT00842712|75888847|FG004|COMPLETED|Safety Run-in Part||0||
59768608|NCT00842712|75888848|FG005|COMPLETED|Safety Run-in Part||0||
59768609|NCT00842712|75888849|FG006|COMPLETED|Safety Run-in Part||0||
59768610|NCT00842712|75888843|FG000|NOT COMPLETED|Safety Run-in Part||3||
59768611|NCT00842712|75888844|FG001|NOT COMPLETED|Safety Run-in Part||2||
59768612|NCT00842712|75888845|FG002|NOT COMPLETED|Safety Run-in Part||0||
59768613|NCT00842712|75888846|FG003|NOT COMPLETED|Safety Run-in Part||1||
59768614|NCT00842712|75888847|FG004|NOT COMPLETED|Safety Run-in Part||0||
59768615|NCT00842712|75888848|FG005|NOT COMPLETED|Safety Run-in Part||0||
59768616|NCT00842712|75888849|FG006|NOT COMPLETED|Safety Run-in Part||0||
59768617|NCT00842712|75888843|FG000|STARTED|Randomized Part||0||
59768618|NCT00842712|75888844|FG001|STARTED|Randomized Part||0||
59768619|NCT00842712|75888845|FG002|STARTED|Randomized Part||0||
59768620|NCT00842712|75888846|FG003|STARTED|Randomized Part||0||
59768621|NCT00842712|75888847|FG004|STARTED|Randomized Part||85||
59768622|NCT00842712|75888848|FG005|STARTED|Randomized Part||51||
59768623|NCT00842712|75888849|FG006|STARTED|Randomized Part||84||
59768624|NCT00842712|75888843|FG000|Treated|Randomized Part||0||
59768625|NCT00842712|75888844|FG001|Treated|Randomized Part||0||
59768626|NCT00842712|75888845|FG002|Treated|Randomized Part||0||
59768627|NCT00842712|75888846|FG003|Treated|Randomized Part||0||
59768628|NCT00842712|75888847|FG004|Treated|Randomized Part||85||
59768629|NCT00842712|75888848|FG005|Treated|Randomized Part||50||
59768630|NCT00842712|75888849|FG006|Treated|Randomized Part||80||
59768631|NCT00842712|75888843|FG000|COMPLETED|Randomized Part||0||
59768632|NCT00842712|75888844|FG001|COMPLETED|Randomized Part||0||
59768633|NCT00842712|75888845|FG002|COMPLETED|Randomized Part||0||
59768634|NCT00842712|75888846|FG003|COMPLETED|Randomized Part||0||
59768635|NCT00842712|75888847|FG004|COMPLETED|Randomized Part||85||
59768636|NCT00842712|75888848|FG005|COMPLETED|Randomized Part||50||
59768637|NCT00842712|75888849|FG006|COMPLETED|Randomized Part||78||
59768638|NCT00842712|75888843|FG000|NOT COMPLETED|Randomized Part||0||
59768639|NCT00842712|75888844|FG001|NOT COMPLETED|Randomized Part||0||
59768640|NCT00842712|75888845|FG002|NOT COMPLETED|Randomized Part||0||
59768641|NCT00842712|75888846|FG003|NOT COMPLETED|Randomized Part||0||
59768642|NCT00842712|75888847|FG004|NOT COMPLETED|Randomized Part||0||
59768643|NCT00842712|75888848|FG005|NOT COMPLETED|Randomized Part||1||
59768644|NCT00842712|75888849|FG006|NOT COMPLETED|Randomized Part||6||
59768645|NCT00842244|75888865|FG000|STARTED|Overall Study||22||
59768646|NCT00842244|75888865|FG000|COMPLETED|Overall Study||1||
59768647|NCT00842244|75888865|FG000|NOT COMPLETED|Overall Study||21||
59768648|NCT00832416|75888876|FG000|STARTED|Overall Study||110||
59768649|NCT00832416|75888877|FG001|STARTED|Overall Study||113||
59768650|NCT00832416|75888878|FG002|STARTED|Overall Study||115||
59768651|NCT00832416|75888879|FG003|STARTED|Overall Study||227||
59768652|NCT00832416|75888876|FG000|COMPLETED|Overall Study||64||
59768653|NCT00832416|75888877|FG001|COMPLETED|Overall Study||60||
59768654|NCT00832416|75888878|FG002|COMPLETED|Overall Study||54||
59768655|NCT00832416|75888879|FG003|COMPLETED|Overall Study||144||
59768656|NCT00832416|75888876|FG000|NOT COMPLETED|Overall Study||46||
59768657|NCT00832416|75888877|FG001|NOT COMPLETED|Overall Study||53||
59768658|NCT00832416|75888878|FG002|NOT COMPLETED|Overall Study||61||
59768659|NCT00832416|75888879|FG003|NOT COMPLETED|Overall Study||83||
59768660|NCT00841776|75888891|FG000|STARTED|Overall Study||27||
59768661|NCT00841776|75888892|FG001|STARTED|Overall Study||27||
59768662|NCT00841776|75888891|FG000|COMPLETED|Overall Study||25||
59768663|NCT00841776|75888892|FG001|COMPLETED|Overall Study||24||
59768664|NCT00841776|75888891|FG000|NOT COMPLETED|Overall Study||2||
59768665|NCT00841776|75888892|FG001|NOT COMPLETED|Overall Study||3||
59768666|NCT00683800|75888900|FG000|STARTED|Overall Study||1101||
59768667|NCT00683800|75888901|FG001|STARTED|Overall Study||1085||
59768668|NCT00683800|75888900|FG000|Treated|Overall Study||1066||
59768669|NCT00683800|75888901|FG001|Treated|Overall Study||1052||
59768670|NCT00683800|75888900|FG000|COMPLETED|Overall Study||669||
59768671|NCT00683800|75888901|FG001|COMPLETED|Overall Study||719||
59768672|NCT00683800|75888900|FG000|NOT COMPLETED|Overall Study||432||
59768673|NCT00683800|75888901|FG001|NOT COMPLETED|Overall Study||366||
59768674|NCT00683644|75888909|FG000|STARTED|Overall Study||58||
59768675|NCT00683644|75888910|FG001|STARTED|Overall Study||58||
59768676|NCT00683644|75888909|FG000|COMPLETED|Overall Study||45||
59768677|NCT00683644|75888910|FG001|COMPLETED|Overall Study||44||
59768678|NCT00683644|75888909|FG000|NOT COMPLETED|Overall Study||13||
59768679|NCT00683644|75888910|FG001|NOT COMPLETED|Overall Study||14||
59768680|NCT00685360|75888923|FG000|STARTED|Overall Study||161||
59768681|NCT00685360|75888924|FG001|STARTED|Overall Study||160||
59768682|NCT00685360|75888925|FG002|STARTED|Overall Study||160||
59768683|NCT00685360|75888923|FG000|Modified Intent-to-Treat (MITT)|Overall Study||141|MITT Population included all participants who had sputum cultures positive for multidrug resistant tuberculosis (MDR TB) at baseline (Day -1 and/or Day 1) using the mycobacteria growth indicator tube (MGIT) system.|
59768684|NCT00685360|75888924|FG001|Modified Intent-to-Treat (MITT)|Overall Study||136|MITT Population included all participants who had sputum cultures positive for multidrug resistant tuberculosis (MDR TB) at baseline (Day -1 and/or Day 1) using the mycobacteria growth indicator tube (MGIT) system.|
59768685|NCT00685360|75888925|FG002|Modified Intent-to-Treat (MITT)|Overall Study||125|MITT Population included all participants who had sputum cultures positive for multidrug resistant tuberculosis (MDR TB) at baseline (Day -1 and/or Day 1) using the mycobacteria growth indicator tube (MGIT) system.|
59768686|NCT00685360|75888923|FG000|MITT (Solid Culture)|Overall Study||119|MITT (Solid Culture) Population included all participants who had sputum cultures positive for MDR TB at baseline (Day -1 and/or Day 1) using solid culture medium.|
59768687|NCT00685360|75888924|FG001|MITT (Solid Culture)|Overall Study||115|MITT (Solid Culture) Population included all participants who had sputum cultures positive for MDR TB at baseline (Day -1 and/or Day 1) using solid culture medium.|
59768688|NCT00685360|75888925|FG002|MITT (Solid Culture)|Overall Study||113|MITT (Solid Culture) Population included all participants who had sputum cultures positive for MDR TB at baseline (Day -1 and/or Day 1) using solid culture medium.|
59768689|NCT00685360|75888923|FG000|COMPLETED|Overall Study||143||
59768690|NCT00685360|75888924|FG001|COMPLETED|Overall Study||146||
59768691|NCT00685360|75888925|FG002|COMPLETED|Overall Study||145||
59768692|NCT00685360|75888923|FG000|NOT COMPLETED|Overall Study||18||
59768693|NCT00685360|75888924|FG001|NOT COMPLETED|Overall Study||14||
59768694|NCT00685360|75888925|FG002|NOT COMPLETED|Overall Study||15||
59768695|NCT00684814|75888933|FG000|STARTED|First Intervention||19||
59768696|NCT00684814|75888934|FG001|STARTED|First Intervention||19||
59768697|NCT00684814|75888933|FG000|COMPLETED|First Intervention||19||
59768698|NCT00684814|75888934|FG001|COMPLETED|First Intervention||19||
59768699|NCT00684814|75888933|FG000|NOT COMPLETED|First Intervention||0||
60072571|NCT03020524|76187776|FG002|COMPLETED|Overall Study||3||
60072572|NCT03020524|76187774|FG000|NOT COMPLETED|Overall Study||0||
60072573|NCT03020524|76187775|FG001|NOT COMPLETED|Overall Study||0||
59768700|NCT00684814|75888934|FG001|NOT COMPLETED|First Intervention||0||
59768701|NCT00684814|75888933|FG000|STARTED|Washout Period of 7 Days||19||
59768702|NCT00684814|75888934|FG001|STARTED|Washout Period of 7 Days||19||
59768703|NCT00684814|75888933|FG000|COMPLETED|Washout Period of 7 Days||17||
59768704|NCT00684814|75888934|FG001|COMPLETED|Washout Period of 7 Days||15||
59768705|NCT00684814|75888933|FG000|NOT COMPLETED|Washout Period of 7 Days||2||
59768706|NCT00684814|75888934|FG001|NOT COMPLETED|Washout Period of 7 Days||4||
59768707|NCT00684814|75888933|FG000|STARTED|Second Intervention||17||
59768708|NCT00684814|75888934|FG001|STARTED|Second Intervention||15||
59768709|NCT00684814|75888933|FG000|COMPLETED|Second Intervention||16||
60072574|NCT03020524|76187776|FG002|NOT COMPLETED|Overall Study||0||
60072575|NCT01567527|76187786|FG000|STARTED|Conversion Phase.||466||
60072576|NCT01567527|76187787|FG001|STARTED|Conversion Phase.|There were no subjects in this reporting group in this phase of the study.|0||
59768710|NCT00684814|75888934|FG001|COMPLETED|Second Intervention||15||
59768711|NCT00684814|75888933|FG000|NOT COMPLETED|Second Intervention||1||
59768712|NCT00684814|75888934|FG001|NOT COMPLETED|Second Intervention||0||
59768713|NCT00576472|75888955|FG000|STARTED|Initial Screening||230||
59768714|NCT00576472|75888956|FG001|STARTED|Initial Screening||40||
59768715|NCT00576472|75888957|FG002|STARTED|Initial Screening||199||
59768716|NCT00576472|75888958|FG003|STARTED|Initial Screening||0||
59768717|NCT00576472|75888959|FG004|STARTED|Initial Screening||0||
59768718|NCT00576472|75888960|FG005|STARTED|Initial Screening||0||
59768719|NCT00576472|75888961|FG006|STARTED|Initial Screening||0||
59768720|NCT00576472|75888962|FG007|STARTED|Initial Screening||0||
59768721|NCT00576472|75888963|FG008|STARTED|Initial Screening||0||
59768722|NCT00576472|75888964|FG009|STARTED|Initial Screening||0||
59768723|NCT00576472|75888965|FG010|STARTED|Initial Screening||0||
59768724|NCT00576472|75888966|FG011|STARTED|Initial Screening||0||
59768725|NCT00576472|75888967|FG012|STARTED|Initial Screening||0||
59768726|NCT00576472|75888968|FG013|STARTED|Initial Screening||0||
59768727|NCT00576472|75888969|FG014|STARTED|Initial Screening||0||
59768728|NCT00576472|75888955|FG000|COMPLETED|Initial Screening||230||
59768729|NCT00576472|75888956|FG001|COMPLETED|Initial Screening||40||
59768730|NCT00576472|75888957|FG002|COMPLETED|Initial Screening||199||
59768731|NCT00576472|75888958|FG003|COMPLETED|Initial Screening||0||
59768732|NCT00576472|75888959|FG004|COMPLETED|Initial Screening||0||
59768733|NCT00576472|75888960|FG005|COMPLETED|Initial Screening||0||
59768734|NCT00576472|75888961|FG006|COMPLETED|Initial Screening||0||
59768735|NCT00576472|75888962|FG007|COMPLETED|Initial Screening||0||
59768736|NCT00576472|75888963|FG008|COMPLETED|Initial Screening||0||
59768737|NCT00576472|75888964|FG009|COMPLETED|Initial Screening||0||
59768738|NCT00576472|75888965|FG010|COMPLETED|Initial Screening||0||
59768739|NCT00576472|75888966|FG011|COMPLETED|Initial Screening||0||
59768740|NCT00576472|75888967|FG012|COMPLETED|Initial Screening||0||
59768741|NCT00576472|75888968|FG013|COMPLETED|Initial Screening||0||
59768742|NCT00576472|75888969|FG014|COMPLETED|Initial Screening||0||
59768743|NCT00576472|75888955|FG000|NOT COMPLETED|Initial Screening||0||
59768744|NCT00576472|75888956|FG001|NOT COMPLETED|Initial Screening||0||
59768745|NCT00576472|75888957|FG002|NOT COMPLETED|Initial Screening||0||
59768746|NCT00576472|75888958|FG003|NOT COMPLETED|Initial Screening||0||
59768747|NCT00576472|75888959|FG004|NOT COMPLETED|Initial Screening||0||
59768748|NCT00576472|75888960|FG005|NOT COMPLETED|Initial Screening||0||
59768749|NCT00576472|75888961|FG006|NOT COMPLETED|Initial Screening||0||
59768750|NCT00576472|75888962|FG007|NOT COMPLETED|Initial Screening||0||
59768751|NCT00576472|75888963|FG008|NOT COMPLETED|Initial Screening||0||
59768752|NCT00576472|75888964|FG009|NOT COMPLETED|Initial Screening||0||
59768753|NCT00576472|75888965|FG010|NOT COMPLETED|Initial Screening||0||
59768754|NCT00576472|75888966|FG011|NOT COMPLETED|Initial Screening||0||
59768755|NCT00576472|75888967|FG012|NOT COMPLETED|Initial Screening||0||
59768756|NCT00576472|75888968|FG013|NOT COMPLETED|Initial Screening||0||
59768757|NCT00576472|75888969|FG014|NOT COMPLETED|Initial Screening||0||
59768758|NCT00576472|75888955|FG000|STARTED|MPH In-Lab Phase|Group only associated with Screening phase.|0||
59768759|NCT00576472|75888956|FG001|STARTED|MPH In-Lab Phase|Group only associated with Screening phase.|0||
59768760|NCT00576472|75888957|FG002|STARTED|MPH In-Lab Phase|Group only associated with Screening phase.|0||
59768761|NCT00576472|75888958|FG003|STARTED|MPH In-Lab Phase||335||
59768762|NCT00576472|75888959|FG004|STARTED|MPH In-Lab Phase||67||
59768763|NCT00576472|75888960|FG005|STARTED|MPH In-Lab Phase||67||
59768764|NCT00576472|75888961|FG006|STARTED|MPH In-Lab Phase||0||
59768765|NCT00576472|75888962|FG007|STARTED|MPH In-Lab Phase||0||
59768766|NCT00576472|75888963|FG008|STARTED|MPH In-Lab Phase||0||
59768767|NCT00576472|75888964|FG009|STARTED|MPH In-Lab Phase||0||
59768768|NCT00576472|75888965|FG010|STARTED|MPH In-Lab Phase||0||
59768769|NCT00576472|75888966|FG011|STARTED|MPH In-Lab Phase||0||
59768770|NCT00576472|75888967|FG012|STARTED|MPH In-Lab Phase||0||
59768771|NCT00576472|75888968|FG013|STARTED|MPH In-Lab Phase||0||
59768772|NCT00576472|75888969|FG014|STARTED|MPH In-Lab Phase||0||
59768773|NCT00576472|75888955|FG000|COMPLETED|MPH In-Lab Phase||0||
59768774|NCT00576472|75888956|FG001|COMPLETED|MPH In-Lab Phase||0||
59768775|NCT00576472|75888957|FG002|COMPLETED|MPH In-Lab Phase||0||
59768776|NCT00576472|75888958|FG003|COMPLETED|MPH In-Lab Phase||0||
59768777|NCT00576472|75888959|FG004|COMPLETED|MPH In-Lab Phase||67||
59768778|NCT00576472|75888960|FG005|COMPLETED|MPH In-Lab Phase||67||
59768779|NCT00576472|75888961|FG006|COMPLETED|MPH In-Lab Phase||0||
59768780|NCT00576472|75888962|FG007|COMPLETED|MPH In-Lab Phase||0||
59768781|NCT00576472|75888963|FG008|COMPLETED|MPH In-Lab Phase||0||
59768782|NCT00576472|75888964|FG009|COMPLETED|MPH In-Lab Phase||0||
59768783|NCT00576472|75888965|FG010|COMPLETED|MPH In-Lab Phase||0||
59768784|NCT00576472|75888966|FG011|COMPLETED|MPH In-Lab Phase||0||
59768785|NCT00576472|75888967|FG012|COMPLETED|MPH In-Lab Phase||0||
59768786|NCT00576472|75888968|FG013|COMPLETED|MPH In-Lab Phase||0||
59768787|NCT00576472|75888969|FG014|COMPLETED|MPH In-Lab Phase||0||
59768788|NCT00576472|75888955|FG000|NOT COMPLETED|MPH In-Lab Phase||0||
59768789|NCT00576472|75888956|FG001|NOT COMPLETED|MPH In-Lab Phase||0||
59768790|NCT00576472|75888957|FG002|NOT COMPLETED|MPH In-Lab Phase||0||
59768791|NCT00576472|75888958|FG003|NOT COMPLETED|MPH In-Lab Phase||335||
59768792|NCT00576472|75888959|FG004|NOT COMPLETED|MPH In-Lab Phase||0||
59768793|NCT00576472|75888960|FG005|NOT COMPLETED|MPH In-Lab Phase||0||
59768794|NCT00576472|75888961|FG006|NOT COMPLETED|MPH In-Lab Phase||0||
59768795|NCT00576472|75888962|FG007|NOT COMPLETED|MPH In-Lab Phase||0||
59768796|NCT00576472|75888963|FG008|NOT COMPLETED|MPH In-Lab Phase||0||
59768797|NCT00576472|75888964|FG009|NOT COMPLETED|MPH In-Lab Phase||0||
59768798|NCT00576472|75888965|FG010|NOT COMPLETED|MPH In-Lab Phase||0||
59768799|NCT00576472|75888966|FG011|NOT COMPLETED|MPH In-Lab Phase||0||
59768800|NCT00576472|75888967|FG012|NOT COMPLETED|MPH In-Lab Phase||0||
59768801|NCT00576472|75888968|FG013|NOT COMPLETED|MPH In-Lab Phase||0||
59768802|NCT00576472|75888969|FG014|NOT COMPLETED|MPH In-Lab Phase||0||
59768803|NCT00576472|75888955|FG000|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0||
59768804|NCT00576472|75888956|FG001|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0||
59768805|NCT00576472|75888957|FG002|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0||
59768806|NCT00576472|75888958|FG003|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0||
59768807|NCT00576472|75888959|FG004|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0||
59768808|NCT00576472|75888960|FG005|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0||
59768809|NCT00576472|75888961|FG006|STARTED|MPH Cross Over Phase||12||
59768810|NCT00576472|75888962|FG007|STARTED|MPH Cross Over Phase||20||
59768811|NCT00576472|75888963|FG008|STARTED|MPH Cross Over Phase||18||
59768812|NCT00576472|75888964|FG009|STARTED|MPH Cross Over Phase||22||
59768813|NCT00576472|75888965|FG010|STARTED|MPH Cross Over Phase||23||
59768814|NCT00576472|75888966|FG011|STARTED|MPH Cross Over Phase||18||
59768815|NCT00576472|75888967|FG012|STARTED|MPH Cross Over Phase||21||
59768816|NCT00576472|75888968|FG013|STARTED|MPH Cross Over Phase||0||
59768817|NCT00576472|75888969|FG014|STARTED|MPH Cross Over Phase||0||
59768818|NCT00576472|75888955|FG000|COMPLETED|MPH Cross Over Phase||0||
59768819|NCT00576472|75888956|FG001|COMPLETED|MPH Cross Over Phase||0||
59768820|NCT00576472|75888957|FG002|COMPLETED|MPH Cross Over Phase||0||
59768821|NCT00576472|75888958|FG003|COMPLETED|MPH Cross Over Phase||0||
59768822|NCT00576472|75888959|FG004|COMPLETED|MPH Cross Over Phase||0||
59768823|NCT00576472|75888960|FG005|COMPLETED|MPH Cross Over Phase||0||
59768824|NCT00576472|75888961|FG006|COMPLETED|MPH Cross Over Phase||0||
59768825|NCT00576472|75888962|FG007|COMPLETED|MPH Cross Over Phase||20||
59768826|NCT00576472|75888963|FG008|COMPLETED|MPH Cross Over Phase||16||
59768827|NCT00576472|75888964|FG009|COMPLETED|MPH Cross Over Phase||22||
59768828|NCT00576472|75888965|FG010|COMPLETED|MPH Cross Over Phase||22||
59768829|NCT00576472|75888966|FG011|COMPLETED|MPH Cross Over Phase||17||
59768830|NCT00576472|75888967|FG012|COMPLETED|MPH Cross Over Phase||21||
59768831|NCT00576472|75888968|FG013|COMPLETED|MPH Cross Over Phase||0||
59952550|NCT02886572|76071382|FG000|Local Recurrence|Overall Study||32||
59952551|NCT02886572|76071382|FG000|Time to Neurologic Death|Overall Study||32||
59952552|NCT02886572|76071382|FG000|SRS Related Adverse Events|Overall Study||32||
59952553|NCT02886572|76071382|FG000|COMPLETED|Overall Study||32||
60103564|NCT01342666|76221800|FG001|COMPLETED|Overall Study||24||
59768832|NCT00576472|75888969|FG014|COMPLETED|MPH Cross Over Phase||0||
59768833|NCT00576472|75888955|FG000|NOT COMPLETED|MPH Cross Over Phase||0||
59768834|NCT00576472|75888956|FG001|NOT COMPLETED|MPH Cross Over Phase||0||
59768835|NCT00576472|75888957|FG002|NOT COMPLETED|MPH Cross Over Phase||0||
59768836|NCT00576472|75888958|FG003|NOT COMPLETED|MPH Cross Over Phase||0||
59768837|NCT00576472|75888959|FG004|NOT COMPLETED|MPH Cross Over Phase||0||
59768838|NCT00576472|75888960|FG005|NOT COMPLETED|MPH Cross Over Phase||0||
59768839|NCT00576472|75888961|FG006|NOT COMPLETED|MPH Cross Over Phase||12||
59768840|NCT00576472|75888962|FG007|NOT COMPLETED|MPH Cross Over Phase||0||
59768841|NCT00576472|75888963|FG008|NOT COMPLETED|MPH Cross Over Phase||2||
59768842|NCT00576472|75888964|FG009|NOT COMPLETED|MPH Cross Over Phase||0||
59768843|NCT00576472|75888965|FG010|NOT COMPLETED|MPH Cross Over Phase||1||
59768844|NCT00576472|75888966|FG011|NOT COMPLETED|MPH Cross Over Phase||1||
59768845|NCT00576472|75888967|FG012|NOT COMPLETED|MPH Cross Over Phase||0||
59768846|NCT00576472|75888968|FG013|NOT COMPLETED|MPH Cross Over Phase||0||
59768847|NCT00576472|75888969|FG014|NOT COMPLETED|MPH Cross Over Phase||0||
59768848|NCT00576472|75888955|FG000|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0||
59768849|NCT00576472|75888956|FG001|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0||
59768850|NCT00576472|75888957|FG002|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0||
59768851|NCT00576472|75888958|FG003|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0||
59768852|NCT00576472|75888959|FG004|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0||
59768853|NCT00576472|75888960|FG005|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0||
59952554|NCT02886572|76071382|FG000|NOT COMPLETED|Overall Study||8||
59952555|NCT00434226|76071388|FG000|STARTED|Overall Study||30||
59952556|NCT00434226|76071389|FG001|STARTED|Overall Study||26||
59952557|NCT00434226|76071388|FG000|COMPLETED|Overall Study||0||
59952558|NCT00434226|76071389|FG001|COMPLETED|Overall Study||0||
59952559|NCT00434226|76071388|FG000|NOT COMPLETED|Overall Study||30||
59768854|NCT00576472|75888961|FG006|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0||
59768855|NCT00576472|75888962|FG007|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0||
59768856|NCT00576472|75888963|FG008|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0||
59768857|NCT00576472|75888964|FG009|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0||
59768858|NCT00576472|75888965|FG010|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0||
59768859|NCT00576472|75888966|FG011|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0||
59768860|NCT00576472|75888967|FG012|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0||
59768861|NCT00576472|75888968|FG013|STARTED|MPH Home Maintenance Phase||27||
59768862|NCT00576472|75888969|FG014|STARTED|MPH Home Maintenance Phase||91||
59768863|NCT00576472|75888955|FG000|COMPLETED|MPH Home Maintenance Phase||0||
59768864|NCT00576472|75888956|FG001|COMPLETED|MPH Home Maintenance Phase||0||
59768865|NCT00576472|75888957|FG002|COMPLETED|MPH Home Maintenance Phase||0||
59768866|NCT00576472|75888958|FG003|COMPLETED|MPH Home Maintenance Phase||0||
59768867|NCT00576472|75888959|FG004|COMPLETED|MPH Home Maintenance Phase||0||
59768868|NCT00576472|75888960|FG005|COMPLETED|MPH Home Maintenance Phase||0||
59768869|NCT00576472|75888961|FG006|COMPLETED|MPH Home Maintenance Phase||0||
59768870|NCT00576472|75888962|FG007|COMPLETED|MPH Home Maintenance Phase||0||
59768871|NCT00576472|75888963|FG008|COMPLETED|MPH Home Maintenance Phase||0||
59768872|NCT00576472|75888964|FG009|COMPLETED|MPH Home Maintenance Phase||0||
59768873|NCT00576472|75888965|FG010|COMPLETED|MPH Home Maintenance Phase||0||
59768874|NCT00576472|75888966|FG011|COMPLETED|MPH Home Maintenance Phase||0||
59768875|NCT00576472|75888967|FG012|COMPLETED|MPH Home Maintenance Phase||0||
59768876|NCT00576472|75888968|FG013|COMPLETED|MPH Home Maintenance Phase||0||
59768877|NCT00576472|75888969|FG014|COMPLETED|MPH Home Maintenance Phase||68||
59768878|NCT00576472|75888955|FG000|NOT COMPLETED|MPH Home Maintenance Phase||0||
59768879|NCT00576472|75888956|FG001|NOT COMPLETED|MPH Home Maintenance Phase||0||
59768880|NCT00576472|75888957|FG002|NOT COMPLETED|MPH Home Maintenance Phase||0||
59768881|NCT00576472|75888958|FG003|NOT COMPLETED|MPH Home Maintenance Phase||0||
59768882|NCT00576472|75888959|FG004|NOT COMPLETED|MPH Home Maintenance Phase||0||
59768883|NCT00576472|75888960|FG005|NOT COMPLETED|MPH Home Maintenance Phase||0||
59768884|NCT00576472|75888961|FG006|NOT COMPLETED|MPH Home Maintenance Phase||0||
59768885|NCT00576472|75888962|FG007|NOT COMPLETED|MPH Home Maintenance Phase||0||
59768886|NCT00576472|75888963|FG008|NOT COMPLETED|MPH Home Maintenance Phase||0||
59768887|NCT00576472|75888964|FG009|NOT COMPLETED|MPH Home Maintenance Phase||0||
59768888|NCT00576472|75888965|FG010|NOT COMPLETED|MPH Home Maintenance Phase||0||
59768889|NCT00576472|75888966|FG011|NOT COMPLETED|MPH Home Maintenance Phase||0||
59768890|NCT00576472|75888967|FG012|NOT COMPLETED|MPH Home Maintenance Phase||0||
59768891|NCT00576472|75888968|FG013|NOT COMPLETED|MPH Home Maintenance Phase||27||
59768892|NCT00576472|75888969|FG014|NOT COMPLETED|MPH Home Maintenance Phase||23||
59768893|NCT00823212|75889002|FG000|STARTED|Overall Study||762||
59768894|NCT00823212|75889003|FG001|STARTED|Overall Study||768||
59768895|NCT00823212|75889002|FG000|COMPLETED|Overall Study|12-month follow-up|727||
59768896|NCT00823212|75889003|FG001|COMPLETED|Overall Study|12-month follow-up|735||
59768897|NCT00823212|75889002|FG000|NOT COMPLETED|Overall Study||35||
59768898|NCT00823212|75889003|FG001|NOT COMPLETED|Overall Study||33||
59768899|NCT00807495|75889016|FG000|STARTED|Overall Study||22||
59768900|NCT00807495|75889017|FG001|STARTED|Overall Study||13||
59768901|NCT00807495|75889018|FG002|STARTED|Overall Study||5||
59768902|NCT00807495|75889019|FG003|STARTED|Overall Study||1||
59768903|NCT00807495|75889020|FG004|STARTED|Overall Study|An ATL participant had late on-study biopsy and was in DLBL, reducing ATL participants from 8 to 7.|7||
59768904|NCT00807495|75889016|FG000|COMPLETED|Overall Study|Completed = participants who completed the study treatment to PD or symptomatic deterioration.|14||
59768905|NCT00807495|75889017|FG001|COMPLETED|Overall Study||7||
59768906|NCT00807495|75889018|FG002|COMPLETED|Overall Study||1||
59768907|NCT00807495|75889019|FG003|COMPLETED|Overall Study||0||
59768908|NCT00807495|75889020|FG004|COMPLETED|Overall Study||2||
59768909|NCT00807495|75889016|FG000|NOT COMPLETED|Overall Study||8||
59768910|NCT00807495|75889017|FG001|NOT COMPLETED|Overall Study||6||
59768911|NCT00807495|75889018|FG002|NOT COMPLETED|Overall Study||4||
59768912|NCT00807495|75889019|FG003|NOT COMPLETED|Overall Study||1||
59768913|NCT00807495|75889020|FG004|NOT COMPLETED|Overall Study||5||
60072577|NCT01567527|76187788|FG002|STARTED|Conversion Phase.|There were no subjects in this reporting group in this phase of the study.|0||
60072578|NCT01567527|76187789|FG003|STARTED|Conversion Phase.|There were no subjects in this reporting group in this phase of the study.|0||
59768914|NCT05074433|75889036|FG000|STARTED|Overall Study||16||
59768915|NCT05074433|75889037|FG001|STARTED|Overall Study||17||
59768916|NCT05074433|75889038|FG002|STARTED|Overall Study||16||
59768917|NCT05074433|75889039|FG003|STARTED|Overall Study||17||
59768918|NCT05074433|75889036|FG000|COMPLETED|Overall Study||7||
59768919|NCT05074433|75889037|FG001|COMPLETED|Overall Study||8||
60072579|NCT01567527|76187790|FG004|STARTED|Conversion Phase.|There were no subjects in this reporting group in this phase of the study.|0||
60072580|NCT01567527|76187786|FG000|COMPLETED|Conversion Phase.||367||
59768920|NCT05074433|75889038|FG002|COMPLETED|Overall Study||9||
59768921|NCT05074433|75889039|FG003|COMPLETED|Overall Study||11||
59768922|NCT05074433|75889036|FG000|NOT COMPLETED|Overall Study||9||
59768923|NCT05074433|75889037|FG001|NOT COMPLETED|Overall Study||9||
59768924|NCT05074433|75889038|FG002|NOT COMPLETED|Overall Study||7||
59768925|NCT05074433|75889039|FG003|NOT COMPLETED|Overall Study||6||
59768926|NCT04940390|75889054|FG000|STARTED|Overall Study||796||
59768927|NCT04940390|75889055|FG001|STARTED|Overall Study||795||
59768928|NCT04940390|75889054|FG000|Modified Intent-to Treat Population|Overall Study||716||
59768929|NCT04940390|75889055|FG001|Modified Intent-to Treat Population|Overall Study||708||
59768930|NCT04940390|75889054|FG000|Safety Population|Overall Study||731||
59768931|NCT04940390|75889055|FG001|Safety Population|Overall Study||729||
59768932|NCT04940390|75889054|FG000|COMPLETED|Overall Study||771||
59768933|NCT04940390|75889055|FG001|COMPLETED|Overall Study||770||
59768934|NCT04940390|75889054|FG000|NOT COMPLETED|Overall Study||25||
59768935|NCT04940390|75889055|FG001|NOT COMPLETED|Overall Study||25||
59768936|NCT04922021|75889063|FG000|STARTED|Overall Study||29||
59768937|NCT04922021|75889064|FG001|STARTED|Overall Study||29||
59768938|NCT04922021|75889063|FG000|COMPLETED|Overall Study||22||
59768939|NCT04922021|75889064|FG001|COMPLETED|Overall Study||16||
59768940|NCT04922021|75889063|FG000|NOT COMPLETED|Overall Study||7||
59768941|NCT04922021|75889064|FG001|NOT COMPLETED|Overall Study||13||
59768942|NCT04901507|75889070|FG000|STARTED|Overall Study||16||
59768943|NCT04901507|75889070|FG000|COMPLETED|Overall Study||13||
60072581|NCT01567527|76187787|FG001|COMPLETED|Conversion Phase.||0||
60072582|NCT01567527|76187788|FG002|COMPLETED|Conversion Phase.||0||
59618114|NCT03866538|75729327|FG001|NOT COMPLETED|Overall Study||0||
59618115|NCT02082288|75729333|FG000|STARTED|Overall Study||243||
59618116|NCT02082288|75729333|FG000|COMPLETED|Overall Study||243||
59618117|NCT02082288|75729333|FG000|NOT COMPLETED|Overall Study||0||
59618118|NCT03646188|75729342|FG000|STARTED|Overall Study||3||
59618119|NCT03646188|75729343|FG001|STARTED|Overall Study||3||
59618120|NCT03646188|75729344|FG002|STARTED|Overall Study||3||
59618121|NCT03646188|75729345|FG003|STARTED|Overall Study||3||
59618122|NCT03646188|75729346|FG004|STARTED|Overall Study||1||
59618123|NCT03646188|75729342|FG000|COMPLETED|Overall Study||3||
59618124|NCT03646188|75729343|FG001|COMPLETED|Overall Study||3||
59618125|NCT03646188|75729344|FG002|COMPLETED|Overall Study||3||
59618126|NCT03646188|75729345|FG003|COMPLETED|Overall Study||3||
59618127|NCT03646188|75729346|FG004|COMPLETED|Overall Study||1||
59768944|NCT04901507|75889070|FG000|NOT COMPLETED|Overall Study||3||
59768945|NCT04543786|75889074|FG000|STARTED|Overall Study||3||
59768946|NCT04543786|75889074|FG000|COMPLETED|Overall Study||3||
59768947|NCT04543786|75889074|FG000|NOT COMPLETED|Overall Study||0||
59618128|NCT03646188|75729342|FG000|NOT COMPLETED|Overall Study||0||
59618129|NCT03646188|75729343|FG001|NOT COMPLETED|Overall Study||0||
59618130|NCT03646188|75729344|FG002|NOT COMPLETED|Overall Study||0||
59618131|NCT03646188|75729345|FG003|NOT COMPLETED|Overall Study||0||
59618132|NCT03646188|75729346|FG004|NOT COMPLETED|Overall Study||0||
59618133|NCT03844386|75729362|FG000|STARTED|Overall Study||7||
59618134|NCT03844386|75729363|FG001|STARTED|Overall Study||7||
59618135|NCT03844386|75729364|FG002|STARTED|Overall Study||8||
59618136|NCT03844386|75729365|FG003|STARTED|Overall Study||4||
59618137|NCT03844386|75729362|FG000|Completed Day 28|Overall Study||7||
59618138|NCT03844386|75729363|FG001|Completed Day 28|Overall Study||7||
59618139|NCT03844386|75729364|FG002|Completed Day 28|Overall Study||8||
59618140|NCT03844386|75729365|FG003|Completed Day 28|Overall Study||3||
59618141|NCT03844386|75729362|FG000|COMPLETED|Overall Study||7||
59618142|NCT03844386|75729363|FG001|COMPLETED|Overall Study||7||
59618143|NCT03844386|75729364|FG002|COMPLETED|Overall Study||7||
59618144|NCT03844386|75729365|FG003|COMPLETED|Overall Study||3||
59618145|NCT03844386|75729362|FG000|NOT COMPLETED|Overall Study||0||
59618146|NCT03844386|75729363|FG001|NOT COMPLETED|Overall Study||0||
59618147|NCT03844386|75729364|FG002|NOT COMPLETED|Overall Study||1||
59618148|NCT03844386|75729365|FG003|NOT COMPLETED|Overall Study||1||
59618149|NCT02082678|75729377|FG000|STARTED|Overall Study||35||
59768948|NCT04519658|75889082|FG000|STARTED|Overall Study||69||
59768949|NCT04519658|75889083|FG001|STARTED|Overall Study||70||
60072583|NCT01567527|76187789|FG003|COMPLETED|Conversion Phase.||0||
60072584|NCT01567527|76187790|FG004|COMPLETED|Conversion Phase.||0||
59618150|NCT02082678|75729378|FG001|STARTED|Overall Study||35||
59618151|NCT02082678|75729377|FG000|COMPLETED|Overall Study||23||
59618152|NCT02082678|75729378|FG001|COMPLETED|Overall Study||21||
59618153|NCT02082678|75729377|FG000|NOT COMPLETED|Overall Study||12||
59768950|NCT04519658|75889084|FG002|STARTED|Overall Study||67||
59768951|NCT04519658|75889085|FG003|STARTED|Overall Study||69||
59618154|NCT02082678|75729378|FG001|NOT COMPLETED|Overall Study||14||
59618155|NCT00003816|75729389|FG000|STARTED|Overall Study||55||
59618156|NCT00003816|75729390|FG001|STARTED|Overall Study||69||
59618157|NCT00003816|75729391|FG002|STARTED|Overall Study||199||
59768952|NCT04519658|75889082|FG000|COMPLETED|Overall Study||65||
59768953|NCT04519658|75889083|FG001|COMPLETED|Overall Study||60||
59618158|NCT00003816|75729392|FG003|STARTED|Overall Study||23||
59618159|NCT00003816|75729393|FG004|STARTED|Overall Study||15||
59618160|NCT00003816|75729389|FG000|COMPLETED|Overall Study||55||
59618161|NCT00003816|75729390|FG001|COMPLETED|Overall Study||69||
59618162|NCT00003816|75729391|FG002|COMPLETED|Overall Study||199||
59768954|NCT04519658|75889084|FG002|COMPLETED|Overall Study||56||
59768955|NCT04519658|75889085|FG003|COMPLETED|Overall Study||67||
59768956|NCT04519658|75889082|FG000|NOT COMPLETED|Overall Study||4||
59768957|NCT04519658|75889083|FG001|NOT COMPLETED|Overall Study||10||
59768958|NCT04519658|75889084|FG002|NOT COMPLETED|Overall Study||11||
59768959|NCT04519658|75889085|FG003|NOT COMPLETED|Overall Study||2||
59768960|NCT04405765|75889097|FG000|STARTED|Overall Study||22||
59768961|NCT04405765|75889098|FG001|STARTED|Overall Study||20||
59768962|NCT04405765|75889097|FG000|COMPLETED|Overall Study||21||
59768963|NCT04405765|75889098|FG001|COMPLETED|Overall Study||19||
59768964|NCT04405765|75889097|FG000|NOT COMPLETED|Overall Study||1||
59768965|NCT04405765|75889098|FG001|NOT COMPLETED|Overall Study||1||
59768966|NCT04392375|75889106|FG000|STARTED|Overall Study||55||
59768967|NCT04392375|75889107|FG001|STARTED|Overall Study||55||
59768968|NCT04392375|75889106|FG000|COMPLETED|Overall Study||53||
59768969|NCT04392375|75889107|FG001|COMPLETED|Overall Study||49||
59768970|NCT04392375|75889106|FG000|NOT COMPLETED|Overall Study||2||
59768971|NCT04392375|75889107|FG001|NOT COMPLETED|Overall Study||6||
59768972|NCT04233580|75889115|FG000|STARTED|Overall Study||20||
59768973|NCT04233580|75889116|FG001|STARTED|Overall Study||20||
59768974|NCT04233580|75889115|FG000|COMPLETED|Overall Study||15||
59768975|NCT04233580|75889116|FG001|COMPLETED|Overall Study||16||
59768976|NCT04233580|75889115|FG000|NOT COMPLETED|Overall Study||5||
59768977|NCT04233580|75889116|FG001|NOT COMPLETED|Overall Study||4||
59768978|NCT04201197|75889122|FG000|STARTED|Overall Study||22||
59768979|NCT04201197|75889122|FG000|Placebo, THC, THC+CBD|Overall Study||3||
59768980|NCT04201197|75889122|FG000|Placebo, THC+CBD, THC|Overall Study||3||
59768981|NCT04201197|75889122|FG000|THC, Placebo, THC+CBD|Overall Study||3||
59768982|NCT04201197|75889122|FG000|THC, THC+CBD, Placebo|Overall Study||3||
59768983|NCT04201197|75889122|FG000|THC+CBD, THC, Placebo|Overall Study||3||
59768984|NCT04201197|75889122|FG000|THC+CBD, THC, Placebo|Overall Study||3||
59768985|NCT04201197|75889122|FG000|COMPLETED|Overall Study||18||
59768986|NCT04201197|75889122|FG000|NOT COMPLETED|Overall Study||4||
59768987|NCT04016805|75889136|FG000|STARTED|Overall Study||30||
59768988|NCT04016805|75889137|FG001|STARTED|Overall Study||6||
59768989|NCT04016805|75889138|FG002|STARTED|Overall Study||5||
59768990|NCT04016805|75889136|FG000|COMPLETED|Overall Study||0||
59768991|NCT04016805|75889137|FG001|COMPLETED|Overall Study||0||
59768992|NCT04016805|75889138|FG002|COMPLETED|Overall Study||0||
59768993|NCT04016805|75889136|FG000|NOT COMPLETED|Overall Study||30||
59768994|NCT04016805|75889137|FG001|NOT COMPLETED|Overall Study||6||
59768995|NCT04016805|75889138|FG002|NOT COMPLETED|Overall Study||5||
59768996|NCT03982199|75889148|FG000|STARTED|Overall Study||2909||
59768997|NCT03982199|75889149|FG001|STARTED|Overall Study||2906||
59768998|NCT03982199|75889148|FG000|Vaccinated (Full Analysis Set [FAS])|Overall Study||2891||
59768999|NCT03982199|75889149|FG001|Vaccinated (Full Analysis Set [FAS])|Overall Study||2891||
59769000|NCT03982199|75889148|FG000|COMPLETED|Overall Study||1308||
59769001|NCT03982199|75889149|FG001|COMPLETED|Overall Study||1260||
59769002|NCT03982199|75889148|FG000|NOT COMPLETED|Overall Study||1601||
59769003|NCT03982199|75889149|FG001|NOT COMPLETED|Overall Study||1646||
59769004|NCT03828448|75889155|FG000|STARTED|Overall Study||34||
59769005|NCT03828448|75889155|FG000|COMPLETED|Overall Study||0||
59769006|NCT03828448|75889155|FG000|NOT COMPLETED|Overall Study||34||
59769007|NCT03742440|75889159|FG000|STARTED|Overall Study||40||
59769008|NCT03742440|75889159|FG000|COMPLETED|Overall Study||40||
59769009|NCT03742440|75889159|FG000|NOT COMPLETED|Overall Study||0||
59769010|NCT03580369|75889167|FG000|STARTED|Overall Study||307||
59769011|NCT03580369|75889168|FG001|STARTED|Overall Study||10||
59769012|NCT03580369|75889169|FG002|STARTED|Overall Study||312||
59769013|NCT03580369|75889170|FG003|STARTED|Overall Study||12||
59769014|NCT03580369|75889171|FG004|STARTED|Overall Study||309||
59769015|NCT03580369|75889172|FG005|STARTED|Overall Study||13||
59769016|NCT03580369|75889173|FG006|STARTED|Overall Study||106||
59769017|NCT03580369|75889174|FG007|STARTED|Overall Study||3||
60072585|NCT01567527|76187786|FG000|NOT COMPLETED|Conversion Phase.||99||
59769018|NCT03580369|75889167|FG000|COMPLETED|Overall Study||263||
59769019|NCT03580369|75889168|FG001|COMPLETED|Overall Study||10||
59769020|NCT03580369|75889169|FG002|COMPLETED|Overall Study||258||
59769021|NCT03580369|75889170|FG003|COMPLETED|Overall Study||9||
59769022|NCT03580369|75889171|FG004|COMPLETED|Overall Study||267||
59769023|NCT03580369|75889172|FG005|COMPLETED|Overall Study||10||
59769024|NCT03580369|75889173|FG006|COMPLETED|Overall Study||91||
59769025|NCT03580369|75889174|FG007|COMPLETED|Overall Study||3||
59769026|NCT03580369|75889167|FG000|NOT COMPLETED|Overall Study||44||
59769027|NCT03580369|75889168|FG001|NOT COMPLETED|Overall Study||0||
59769028|NCT03580369|75889169|FG002|NOT COMPLETED|Overall Study||54||
59769029|NCT03580369|75889170|FG003|NOT COMPLETED|Overall Study||3||
59769030|NCT03580369|75889171|FG004|NOT COMPLETED|Overall Study||42||
59769031|NCT03580369|75889172|FG005|NOT COMPLETED|Overall Study||3||
59769032|NCT03580369|75889173|FG006|NOT COMPLETED|Overall Study||15||
59769033|NCT03580369|75889174|FG007|NOT COMPLETED|Overall Study||0||
59769034|NCT03338920|75889187|FG000|STARTED|Overall Study||79||
59769035|NCT03338920|75889188|FG001|STARTED|Overall Study||80||
59769036|NCT03338920|75889187|FG000|COMPLETED|Overall Study||75||
59769037|NCT03338920|75889188|FG001|COMPLETED|Overall Study||74||
59769038|NCT03338920|75889187|FG000|NOT COMPLETED|Overall Study||4||
59769039|NCT03338920|75889188|FG001|NOT COMPLETED|Overall Study||6||
59769040|NCT03331289|75889198|FG000|STARTED|Overall Study||30||
59769041|NCT03331289|75889199|FG001|STARTED|Overall Study||23||
59769042|NCT03331289|75889200|FG002|STARTED|Overall Study||28||
59769043|NCT03331289|75889201|FG003|STARTED|Overall Study||26||
59769044|NCT03331289|75889198|FG000|COMPLETED|Overall Study||25||
59769045|NCT03331289|75889199|FG001|COMPLETED|Overall Study||15||
59769046|NCT03331289|75889200|FG002|COMPLETED|Overall Study||25||
59769047|NCT03331289|75889201|FG003|COMPLETED|Overall Study||25||
59769048|NCT03331289|75889198|FG000|NOT COMPLETED|Overall Study||5||
59769049|NCT03331289|75889199|FG001|NOT COMPLETED|Overall Study||8||
59769050|NCT03331289|75889200|FG002|NOT COMPLETED|Overall Study||3||
59769051|NCT03331289|75889201|FG003|NOT COMPLETED|Overall Study||1||
59769052|NCT03215810|75889211|FG000|STARTED|Overall Study||20||
59769053|NCT03215810|75889211|FG000|COMPLETED|Overall Study||16||
59769054|NCT03215810|75889211|FG000|NOT COMPLETED|Overall Study||4||
59769055|NCT02999269|75889218|FG000|STARTED|Overall Study||20||
59769056|NCT02999269|75889219|FG001|STARTED|Overall Study||20||
59769057|NCT02999269|75889220|FG002|STARTED|Overall Study||20||
59769058|NCT02999269|75889218|FG000|COMPLETED|Overall Study||16||
59769059|NCT02999269|75889219|FG001|COMPLETED|Overall Study||15||
59769060|NCT02999269|75889220|FG002|COMPLETED|Overall Study||16||
59769061|NCT02999269|75889218|FG000|NOT COMPLETED|Overall Study||4||
59769062|NCT02999269|75889219|FG001|NOT COMPLETED|Overall Study||5||
59769063|NCT02999269|75889220|FG002|NOT COMPLETED|Overall Study||4||
59769064|NCT02672332|75889230|FG000|STARTED|Overall Study||653||
59769065|NCT02672332|75889231|FG001|STARTED|Overall Study||654||
59769066|NCT02672332|75889230|FG000|COMPLETED|Overall Study||571||
59769067|NCT02672332|75889231|FG001|COMPLETED|Overall Study||577||
59769068|NCT02672332|75889230|FG000|NOT COMPLETED|Overall Study||82||
59769069|NCT02672332|75889231|FG001|NOT COMPLETED|Overall Study||77||
59769070|NCT02667444|75889239|FG000|STARTED|Overall Study||664||
59769071|NCT02667444|75889240|FG001|STARTED|Overall Study||666||
59769072|NCT02667444|75889239|FG000|COMPLETED|Overall Study||576||
59769073|NCT02667444|75889240|FG001|COMPLETED|Overall Study||574||
59769074|NCT02667444|75889239|FG000|NOT COMPLETED|Overall Study||88||
59769075|NCT02667444|75889240|FG001|NOT COMPLETED|Overall Study||92||
59769076|NCT02634710|75889246|FG000|STARTED|Overall Study||35||
59769077|NCT02634710|75889246|FG000|COMPLETED|Overall Study||31||
59769078|NCT02634710|75889246|FG000|NOT COMPLETED|Overall Study||4||
59769079|NCT02565628|75889252|FG000|STARTED|Overall Study||10||
59769080|NCT02565628|75889253|FG001|STARTED|Overall Study||9||
59769081|NCT02565628|75889252|FG000|Received Treatment|Overall Study||10||
59769082|NCT02565628|75889253|FG001|Received Treatment|Overall Study||9||
59769083|NCT02565628|75889252|FG000|COMPLETED|Overall Study||10||
59769084|NCT02565628|75889253|FG001|COMPLETED|Overall Study||9||
59769085|NCT02565628|75889252|FG000|NOT COMPLETED|Overall Study||0||
59769086|NCT02565628|75889253|FG001|NOT COMPLETED|Overall Study||0||
59769087|NCT02540993|75889261|FG000|STARTED|Overall Study||2866|Randomized|
59769088|NCT02540993|75889262|FG001|STARTED|Overall Study||2868|Randomized|
59769089|NCT02540993|75889261|FG000|Included in FAS|Overall Study||2833|60 participants were prospectively excluded from the analyses because of critical GCP violations|
59769090|NCT02540993|75889262|FG001|Included in FAS|Overall Study||2841|60 participants were prospectively excluded from the analyses because of critical GCP violations|
59769091|NCT02540993|75889261|FG000|Treated|Overall Study||2827||
59769092|NCT02540993|75889262|FG001|Treated|Overall Study||2831||
59769093|NCT02540993|75889261|FG000|COMPLETED|Overall Study||2824|Participants (except those with critical GCP violations) were followed up regardless of having started treatment or not, and study completion is independent of administration of study treatment. A participant included in the FAS was considered as having completed the study if there was a contact with the subject after the end-of-study (EOS) notification or if the subject died.|
59769094|NCT02540993|75889262|FG001|COMPLETED|Overall Study||2832|Participants (except those with critical GCP violations) were followed up regardless of having started treatment or not, and study completion is independent of administration of study treatment. A participant included in the FAS was considered as having completed the study if there was a contact with the subject after the end-of-study (EOS) notification or if the subject died.|
59769095|NCT02540993|75889261|FG000|NOT COMPLETED|Overall Study||42||
59769096|NCT02540993|75889262|FG001|NOT COMPLETED|Overall Study||36||
59769097|NCT02519621|75889271|FG000|STARTED|Overall Study||30||
59769098|NCT02519621|75889272|FG001|STARTED|Overall Study||30||
59769099|NCT02519621|75889273|FG002|STARTED|Overall Study||30||
59769100|NCT02519621|75889271|FG000|COMPLETED|Overall Study||30||
59769101|NCT02519621|75889272|FG001|COMPLETED|Overall Study||30||
59769102|NCT02519621|75889273|FG002|COMPLETED|Overall Study||30||
59769103|NCT02519621|75889271|FG000|NOT COMPLETED|Overall Study||0||
59769104|NCT02519621|75889272|FG001|NOT COMPLETED|Overall Study||0||
59769105|NCT02519621|75889273|FG002|NOT COMPLETED|Overall Study||0||
59769106|NCT02501538|75889281|FG000|STARTED|Overall Study||23||
59769107|NCT02501538|75889281|FG000|COMPLETED|Overall Study||20||
59769108|NCT02501538|75889281|FG000|NOT COMPLETED|Overall Study||3||
59769109|NCT02463487|75889290|FG000|STARTED|Overall Study||75||
59769110|NCT02463487|75889291|FG001|STARTED|Overall Study||75||
59769111|NCT02463487|75889290|FG000|COMPLETED|Overall Study||65||
59769112|NCT02463487|75889291|FG001|COMPLETED|Overall Study||65||
59769113|NCT02463487|75889290|FG000|NOT COMPLETED|Overall Study||10||
59769114|NCT02463487|75889291|FG001|NOT COMPLETED|Overall Study||10||
59769115|NCT02449239|75889297|FG000|STARTED|Induction Phase||133||
59769116|NCT02449239|75889297|FG000|COMPLETED|Induction Phase||63||
59769117|NCT02449239|75889297|FG000|NOT COMPLETED|Induction Phase||70||
59769118|NCT02449239|75889297|FG000|STARTED|Maintenance Month 3||63||
59769119|NCT02449239|75889297|FG000|COMPLETED|Maintenance Month 3||49||
59769120|NCT02449239|75889297|FG000|NOT COMPLETED|Maintenance Month 3||14||
59769121|NCT02449239|75889297|FG000|STARTED|Maintenance Month 6||49||
59769122|NCT02449239|75889297|FG000|COMPLETED|Maintenance Month 6||36||
59769123|NCT02449239|75889297|FG000|NOT COMPLETED|Maintenance Month 6||13||
59769124|NCT02449239|75889297|FG000|STARTED|Maintenance Month 9||36||
59769125|NCT02449239|75889297|FG000|COMPLETED|Maintenance Month 9||33||
59769126|NCT02449239|75889297|FG000|NOT COMPLETED|Maintenance Month 9||3||
59769127|NCT02449239|75889297|FG000|STARTED|Maintenance Month 12||33||
59769128|NCT02449239|75889297|FG000|COMPLETED|Maintenance Month 12||26||
59769129|NCT02449239|75889297|FG000|NOT COMPLETED|Maintenance Month 12||7||
59769130|NCT02449239|75889297|FG000|STARTED|Maintenance Month 15||26||
59769131|NCT02449239|75889297|FG000|COMPLETED|Maintenance Month 15||25||
59769132|NCT02449239|75889297|FG000|NOT COMPLETED|Maintenance Month 15||1||
59769133|NCT02449239|75889297|FG000|STARTED|Maintenance Month 18||25||
59769134|NCT02449239|75889297|FG000|COMPLETED|Maintenance Month 18||25||
59769135|NCT02449239|75889297|FG000|NOT COMPLETED|Maintenance Month 18||0||
59769136|NCT02449239|75889297|FG000|STARTED|Maintenance Month 21||25||
59769137|NCT02449239|75889297|FG000|COMPLETED|Maintenance Month 21||23||
59769138|NCT02449239|75889297|FG000|NOT COMPLETED|Maintenance Month 21||2||
59769139|NCT01292928|75889301|FG000|STARTED|Overall Study||299||
59769140|NCT01292928|75889301|FG000|Completed 12-Month Clinical Follow-up|Overall Study||266||
59769141|NCT01292928|75889301|FG000|COMPLETED|Overall Study||275||
59769142|NCT01292928|75889301|FG000|NOT COMPLETED|Overall Study||24||
59769143|NCT01290445|75889310|FG000|STARTED|Overall Study||335||
59769144|NCT01290445|75889311|FG001|STARTED|Overall Study||78412||
59769145|NCT01290445|75889312|FG002|STARTED|Overall Study||806438||
59769146|NCT01290445|75889310|FG000|COMPLETED|Overall Study||335||
59769147|NCT01290445|75889311|FG001|COMPLETED|Overall Study||78412||
59769148|NCT01290445|75889312|FG002|COMPLETED|Overall Study||806438||
59769149|NCT01290445|75889310|FG000|NOT COMPLETED|Overall Study||0||
59769150|NCT01290445|75889311|FG001|NOT COMPLETED|Overall Study||0||
59769151|NCT01290445|75889312|FG002|NOT COMPLETED|Overall Study||0||
59769152|NCT00581828|75889320|FG000|STARTED|Overall Study||19||
59769153|NCT00581828|75889320|FG000|COMPLETED|Overall Study||18||
59769154|NCT00581828|75889320|FG000|NOT COMPLETED|Overall Study||1||
59769155|NCT00380861|75889326|FG000|STARTED|Overall Study||93||93
59769156|NCT00380861|75889327|FG001|STARTED|Overall Study|Two subjects received the PFC Sigma RP-F device but not the RP and their results are not included.|91||91
59769157|NCT00380861|75889326|FG000|COMPLETED|Overall Study||75||75
59769158|NCT00380861|75889327|FG001|COMPLETED|Overall Study||74||74
60072586|NCT01567527|76187787|FG001|NOT COMPLETED|Conversion Phase.||0||
60072587|NCT01567527|76187788|FG002|NOT COMPLETED|Conversion Phase.||0||
60072588|NCT01567527|76187789|FG003|NOT COMPLETED|Conversion Phase.||0||
60072589|NCT01567527|76187790|FG004|NOT COMPLETED|Conversion Phase.||0||
60072590|NCT01567527|76187786|FG000|STARTED|Oral Aripiprazole Stabilization Phase.|There were no subjects in this reporting group in this phase of the study.|0||
60072591|NCT01567527|76187787|FG001|STARTED|Oral Aripiprazole Stabilization Phase.|265 of the 632 subjects who started this phase entered the Oral Stabilization Phase directly.|632||
60072592|NCT01567527|76187788|FG002|STARTED|Oral Aripiprazole Stabilization Phase.|There were no subjects in this reporting group in this phase of the study.|0||
60072593|NCT01567527|76187789|FG003|STARTED|Oral Aripiprazole Stabilization Phase.|There were no subjects in this reporting group in this phase of the study.|0||
60072594|NCT01567527|76187790|FG004|STARTED|Oral Aripiprazole Stabilization Phase.|There were no subjects in this reporting group in this phase of the study.|0||
59769159|NCT00380861|75889326|FG000|NOT COMPLETED|Overall Study||18||18
59769160|NCT00380861|75889327|FG001|NOT COMPLETED|Overall Study||17||17
59769161|NCT00220337|75889369|FG000|STARTED|Overall Study||371||
59769162|NCT00220337|75889369|FG000|COMPLETED|Overall Study||192||
59769163|NCT00220337|75889369|FG000|NOT COMPLETED|Overall Study||179||
59769164|NCT00576316|75889373|FG000|STARTED|Overall Study|Number of patients recruited|201||
60072595|NCT01567527|76187786|FG000|COMPLETED|Oral Aripiprazole Stabilization Phase.||0||
60072596|NCT01567527|76187787|FG001|COMPLETED|Oral Aripiprazole Stabilization Phase.||425||
60072597|NCT01567527|76187788|FG002|COMPLETED|Oral Aripiprazole Stabilization Phase.||0||
60072598|NCT01567527|76187789|FG003|COMPLETED|Oral Aripiprazole Stabilization Phase.||0||
59769165|NCT00576316|75889373|FG000|COMPLETED|Overall Study|Number of patients who completed study|181||
59769166|NCT00576316|75889373|FG000|NOT COMPLETED|Overall Study||20||
59769167|NCT00823134|75889377|FG000|STARTED|Overall Study||23||
59769168|NCT00823134|75889377|FG000|COMPLETED|Overall Study||22||
59769169|NCT00823134|75889377|FG000|NOT COMPLETED|Overall Study||1||
59769170|NCT00831792|75889382|FG000|STARTED|Overall Study||46||
59769171|NCT00831792|75889382|FG000|COMPLETED|Overall Study||40||
59769172|NCT00831792|75889382|FG000|NOT COMPLETED|Overall Study||6||
59769173|NCT00575380|75889388|FG000|STARTED|Overall Study||58||
60072599|NCT01567527|76187790|FG004|COMPLETED|Oral Aripiprazole Stabilization Phase.||0||
60072600|NCT01567527|76187786|FG000|NOT COMPLETED|Oral Aripiprazole Stabilization Phase.||0||
60072601|NCT01567527|76187787|FG001|NOT COMPLETED|Oral Aripiprazole Stabilization Phase.||207||
59521488|NCT01016483|75615751|FG000|NOT COMPLETED|Safety Run-in Part||0||
59521489|NCT01016483|75615752|FG001|NOT COMPLETED|Safety Run-in Part||0||
59521490|NCT01016483|75615753|FG002|NOT COMPLETED|Safety Run-in Part||0||
59952560|NCT00434226|76071389|FG001|NOT COMPLETED|Overall Study||26||
59521491|NCT01016483|75615754|FG003|NOT COMPLETED|Safety Run-in Part||0||
59521492|NCT01016483|75615751|FG000|STARTED|Phase II||0||
59521493|NCT01016483|75615752|FG001|STARTED|Phase II||0||
59521494|NCT01016483|75615753|FG002|STARTED|Phase II|Subjects presented as randomized (Intention-to-Treat [ITT] Analysis Set).|44||
59521495|NCT01016483|75615754|FG003|STARTED|Phase II|Subjects presented as randomized (ITT Analysis Set).|44||
59521496|NCT01016483|75615751|FG000|Treated (Safety Analysis Set [SAF])|Phase II||0||
59521497|NCT01016483|75615752|FG001|Treated (Safety Analysis Set [SAF])|Phase II||0||
59521498|NCT01016483|75615753|FG002|Treated (Safety Analysis Set [SAF])|Phase II|Subjects presented as treated (SAF).|42||
59521499|NCT01016483|75615754|FG003|Treated (Safety Analysis Set [SAF])|Phase II|Subjects presented as treated (SAF).|45||
59521500|NCT01016483|75615751|FG000|COMPLETED|Phase II||0||
59521501|NCT01016483|75615752|FG001|COMPLETED|Phase II||0||
59521502|NCT01016483|75615753|FG002|COMPLETED|Phase II||44||
59521503|NCT01016483|75615754|FG003|COMPLETED|Phase II||44||
59521504|NCT01016483|75615751|FG000|NOT COMPLETED|Phase II||0||
59521505|NCT01016483|75615752|FG001|NOT COMPLETED|Phase II||0||
59521506|NCT01016483|75615753|FG002|NOT COMPLETED|Phase II||0||
59521507|NCT01016483|75615754|FG003|NOT COMPLETED|Phase II||0||
59521508|NCT02569476|75615792|FG000|STARTED|Overall Study||119||
59521509|NCT02569476|75615792|FG000|COMPLETED|Overall Study||0||
59521510|NCT02569476|75615792|FG000|NOT COMPLETED|Overall Study||119||
59521511|NCT00963677|75615804|FG000|STARTED|Overall Study|Patients without predicted difficult intubation|35||
59521512|NCT00963677|75615805|FG001|STARTED|Overall Study|Patients with predicted difficult intubation but not ventilation|20||
59521513|NCT00963677|75615804|FG000|COMPLETED|Overall Study||35||
59521514|NCT00963677|75615805|FG001|COMPLETED|Overall Study|Two patients were excluded from the study due to the difficult ventilation with facemask ventilation|18||
59521515|NCT00963677|75615804|FG000|NOT COMPLETED|Overall Study||0||
59521516|NCT00963677|75615805|FG001|NOT COMPLETED|Overall Study||2||
59521517|NCT00955253|75615811|FG000|STARTED|First Intervention (Day 2)||7||
59521518|NCT00955253|75615812|FG001|STARTED|First Intervention (Day 2)||6||
59521519|NCT00955253|75615811|FG000|COMPLETED|First Intervention (Day 2)||7||
59521520|NCT00955253|75615812|FG001|COMPLETED|First Intervention (Day 2)||6||
59521521|NCT00955253|75615811|FG000|NOT COMPLETED|First Intervention (Day 2)||0||
59521522|NCT00955253|75615812|FG001|NOT COMPLETED|First Intervention (Day 2)||0||
59521523|NCT00955253|75615811|FG000|STARTED|Second Intervention (Day 4)||7||
59521524|NCT00955253|75615812|FG001|STARTED|Second Intervention (Day 4)||6||
59521525|NCT00955253|75615811|FG000|COMPLETED|Second Intervention (Day 4)||7||
59521526|NCT00955253|75615812|FG001|COMPLETED|Second Intervention (Day 4)||6||
59521527|NCT00955253|75615811|FG000|NOT COMPLETED|Second Intervention (Day 4)||0||
59521528|NCT00955253|75615812|FG001|NOT COMPLETED|Second Intervention (Day 4)||0||
59952561|NCT02741700|76071395|FG000|STARTED|Overall Study||152||
59952562|NCT02741700|76071396|FG001|STARTED|Overall Study||154||
59952563|NCT02741700|76071395|FG000|COMPLETED|Overall Study||126||
59952564|NCT02741700|76071396|FG001|COMPLETED|Overall Study||135||
59952565|NCT02741700|76071395|FG000|NOT COMPLETED|Overall Study||26||
59952566|NCT02741700|76071396|FG001|NOT COMPLETED|Overall Study||19||
59952567|NCT00430950|76071404|FG000|STARTED|Overall Study||502||
59952568|NCT00430950|76071405|FG001|STARTED|Overall Study||508||
59952569|NCT00430950|76071404|FG000|COMPLETED|Overall Study||489||
59952570|NCT00430950|76071405|FG001|COMPLETED|Overall Study||495||
59952571|NCT00430950|76071404|FG000|NOT COMPLETED|Overall Study||13||
59952572|NCT00430950|76071405|FG001|NOT COMPLETED|Overall Study||13||
59952573|NCT02081391|76071413|FG000|STARTED|12-hour Treatment||108||
60072602|NCT01567527|76187788|FG002|NOT COMPLETED|Oral Aripiprazole Stabilization Phase.||0||
60072603|NCT01567527|76187789|FG003|NOT COMPLETED|Oral Aripiprazole Stabilization Phase.||0||
59521529|NCT00963911|75615817|FG000|STARTED|Overall Study||1674||
59521530|NCT00963911|75615817|FG000|COMPLETED|Overall Study||1674||
59521531|NCT00963911|75615817|FG000|NOT COMPLETED|Overall Study||0||
59521532|NCT00963989|75615821|FG000|STARTED|Overall Study||146||
59521533|NCT00963989|75615821|FG000|COMPLETED|Overall Study||127||
59952574|NCT02081391|76071414|FG001|STARTED|12-hour Treatment||52||
59952575|NCT02081391|76071415|FG002|STARTED|12-hour Treatment||11||
59521534|NCT00963989|75615821|FG000|NOT COMPLETED|Overall Study||19||
59521535|NCT01016873|75615828|FG000|STARTED|12 Months||75||
59521536|NCT01016873|75615829|FG001|STARTED|12 Months||75||
59521537|NCT01016873|75615830|FG002|STARTED|12 Months||80||
59521538|NCT01016873|75615828|FG000|COMPLETED|12 Months||74||
59521539|NCT01016873|75615829|FG001|COMPLETED|12 Months||72||
59521540|NCT01016873|75615830|FG002|COMPLETED|12 Months||79||
59521541|NCT01016873|75615828|FG000|NOT COMPLETED|12 Months||1||
59521542|NCT01016873|75615829|FG001|NOT COMPLETED|12 Months||3||
59521543|NCT01016873|75615830|FG002|NOT COMPLETED|12 Months||1||
59521544|NCT01016873|75615828|FG000|STARTED|24 Months||74||
60072604|NCT01567527|76187790|FG004|NOT COMPLETED|Oral Aripiprazole Stabilization Phase.||0||
60072605|NCT01567527|76187786|FG000|STARTED|IM Depot Stabilization.|There were no subjects in this reporting group in this phase of the study.|0||
60072606|NCT01567527|76187787|FG001|STARTED|IM Depot Stabilization.|There were no subjects in this reporting group in this phase of the study.|0||
60072607|NCT01567527|76187788|FG002|STARTED|IM Depot Stabilization.||425||
60072608|NCT01567527|76187789|FG003|STARTED|IM Depot Stabilization.|There were no subjects in this reporting group in this phase of the study.|0||
60072609|NCT01567527|76187790|FG004|STARTED|IM Depot Stabilization.|There were no subjects in this reporting group in this phase of the study.|0||
60072610|NCT01567527|76187786|FG000|COMPLETED|IM Depot Stabilization.||0||
60072611|NCT01567527|76187787|FG001|COMPLETED|IM Depot Stabilization.||0||
60072612|NCT01567527|76187788|FG002|COMPLETED|IM Depot Stabilization.||266||
60072613|NCT01567527|76187789|FG003|COMPLETED|IM Depot Stabilization.||0||
60072614|NCT01567527|76187790|FG004|COMPLETED|IM Depot Stabilization.||0||
60072615|NCT01567527|76187786|FG000|NOT COMPLETED|IM Depot Stabilization.||0||
60072616|NCT01567527|76187787|FG001|NOT COMPLETED|IM Depot Stabilization.||0||
60072617|NCT01567527|76187788|FG002|NOT COMPLETED|IM Depot Stabilization.||159||
60072618|NCT01567527|76187789|FG003|NOT COMPLETED|IM Depot Stabilization.||0||
60072619|NCT01567527|76187790|FG004|NOT COMPLETED|IM Depot Stabilization.||0||
60072620|NCT01567527|76187786|FG000|STARTED|Double-blind, Placebo-controlled Phase||0||
60072621|NCT01567527|76187787|FG001|STARTED|Double-blind, Placebo-controlled Phase||0||
60072622|NCT01567527|76187788|FG002|STARTED|Double-blind, Placebo-controlled Phase|Subjects were randomized to Aripiprazole IM Depot and placebo groups in this phase of the study|0||
60072623|NCT01567527|76187789|FG003|STARTED|Double-blind, Placebo-controlled Phase||133||
60072624|NCT01567527|76187790|FG004|STARTED|Double-blind, Placebo-controlled Phase||133||
60072625|NCT01567527|76187786|FG000|COMPLETED|Double-blind, Placebo-controlled Phase||0||
60072626|NCT01567527|76187787|FG001|COMPLETED|Double-blind, Placebo-controlled Phase||0||
60072627|NCT01567527|76187788|FG002|COMPLETED|Double-blind, Placebo-controlled Phase||0||
60072628|NCT01567527|76187789|FG003|COMPLETED|Double-blind, Placebo-controlled Phase||64||
60072629|NCT01567527|76187790|FG004|COMPLETED|Double-blind, Placebo-controlled Phase||38||
59769174|NCT00575380|75889389|FG001|STARTED|Overall Study||58||
59769175|NCT00575380|75889388|FG000|COMPLETED|Overall Study||57||
59769176|NCT00575380|75889389|FG001|COMPLETED|Overall Study||55||
59769177|NCT00575380|75889388|FG000|NOT COMPLETED|Overall Study||1||
59769178|NCT00575380|75889389|FG001|NOT COMPLETED|Overall Study||3||
59769179|NCT00840996|75889397|FG000|STARTED|Overall Study||58||
59769180|NCT00840996|75889398|FG001|STARTED|Overall Study||58||
59769181|NCT00840996|75889397|FG000|COMPLETED|Overall Study||57||
59769182|NCT00840996|75889398|FG001|COMPLETED|Overall Study||58||
59769183|NCT00840996|75889397|FG000|NOT COMPLETED|Overall Study||1||
59769184|NCT00840996|75889398|FG001|NOT COMPLETED|Overall Study||0||
59769185|NCT00680914|75889406|FG000|STARTED|Overall Study||374||
59769186|NCT00680914|75889407|FG001|STARTED|Overall Study||129||
59769187|NCT00680914|75889406|FG000|COMPLETED|Overall Study||364||
59769188|NCT00680914|75889407|FG001|COMPLETED|Overall Study||125||
59769189|NCT00680914|75889406|FG000|NOT COMPLETED|Overall Study||10||
59769190|NCT00680914|75889407|FG001|NOT COMPLETED|Overall Study||4||
59769191|NCT00680836|75889415|FG000|STARTED|Overall Study||27||
59769192|NCT00680836|75889416|FG001|STARTED|Overall Study||27||
59769193|NCT00680836|75889415|FG000|COMPLETED|Overall Study||19||
59769194|NCT00680836|75889416|FG001|COMPLETED|Overall Study||25||
59769195|NCT00680836|75889415|FG000|NOT COMPLETED|Overall Study||8||
59769196|NCT00680836|75889416|FG001|NOT COMPLETED|Overall Study||2||
59769197|NCT00679432|75889427|FG000|STARTED|Overall Study||126||
59769198|NCT00679432|75889428|FG001|STARTED|Overall Study||127||
59769199|NCT00679432|75889429|FG002|STARTED|Overall Study||129||
59769200|NCT00679432|75889430|FG003|STARTED|Overall Study||127||
59769201|NCT00679432|75889427|FG000|COMPLETED|Overall Study||89||
59769202|NCT00679432|75889428|FG001|COMPLETED|Overall Study||89||
59769203|NCT00679432|75889429|FG002|COMPLETED|Overall Study||76||
59769204|NCT00679432|75889430|FG003|COMPLETED|Overall Study||95||
59769205|NCT00679432|75889427|FG000|NOT COMPLETED|Overall Study||37||
59769206|NCT00679432|75889428|FG001|NOT COMPLETED|Overall Study||38||
59769207|NCT00679432|75889429|FG002|NOT COMPLETED|Overall Study||53||
59769208|NCT00679432|75889430|FG003|NOT COMPLETED|Overall Study||32||
59769209|NCT00679354|75889440|FG000|STARTED|Overall Study||30||
59769210|NCT00679354|75889440|FG000|COMPLETED|Overall Study||0||
59769211|NCT00679354|75889440|FG000|NOT COMPLETED|Overall Study||30||
59769212|NCT00822900|75889447|FG000|STARTED|Overall Study||442||
59769213|NCT00822900|75889448|FG001|STARTED|Overall Study||440||
59769214|NCT00822900|75889447|FG000|COMPLETED|Overall Study||334||
59769215|NCT00822900|75889448|FG001|COMPLETED|Overall Study||347||
60072630|NCT01567527|76187786|FG000|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0||
60072631|NCT01567527|76187787|FG001|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0||
59769216|NCT00822900|75889447|FG000|NOT COMPLETED|Overall Study||108||
59769217|NCT00822900|75889448|FG001|NOT COMPLETED|Overall Study||93||
59769218|NCT00682786|75889456|FG000|STARTED|Overall Study||98||
59769219|NCT00682786|75889457|FG001|STARTED|Overall Study||37||
59769220|NCT00682786|75889456|FG000|COMPLETED|Overall Study||96||
59769221|NCT00682786|75889457|FG001|COMPLETED|Overall Study||34||
59769222|NCT00682786|75889456|FG000|NOT COMPLETED|Overall Study||2||
59769223|NCT00682786|75889457|FG001|NOT COMPLETED|Overall Study||3||
59769224|NCT00840450|75889469|FG000|STARTED|Overall Study||12||
59769225|NCT00840450|75889469|FG000|COMPLETED|Overall Study||9||
59769226|NCT00840450|75889469|FG000|NOT COMPLETED|Overall Study||3||
59769227|NCT00840294|75889475|FG000|STARTED|Overall Study||42||
59769228|NCT00840294|75889476|FG001|STARTED|Overall Study||43||
59769229|NCT00840294|75889475|FG000|COMPLETED|Overall Study|These are the subjects included in the baseline, outcomes, and adverse events tables|39||
59769230|NCT00840294|75889476|FG001|COMPLETED|Overall Study|These are the subjects included in the baseline, outcomes, and adverse events tables|38||
59769231|NCT00840294|75889475|FG000|NOT COMPLETED|Overall Study||3||
59769232|NCT00840294|75889476|FG001|NOT COMPLETED|Overall Study||5||
59769233|NCT00680368|75889482|FG000|STARTED|Overall Study||112||
59769234|NCT00680368|75889482|FG000|COMPLETED|Overall Study|15 residents excluded because their attending physician was not participating in the study|97||
59769235|NCT00680368|75889482|FG000|NOT COMPLETED|Overall Study||15||
59769236|NCT00680056|75889490|FG000|STARTED|First Intervention||16||
59769237|NCT00680056|75889491|FG001|STARTED|First Intervention||17||
59769238|NCT00680056|75889490|FG000|COMPLETED|First Intervention||15||
59769239|NCT00680056|75889491|FG001|COMPLETED|First Intervention||15||
59769240|NCT00680056|75889490|FG000|NOT COMPLETED|First Intervention||1||
59769241|NCT00680056|75889491|FG001|NOT COMPLETED|First Intervention||2||
59769242|NCT00680056|75889490|FG000|STARTED|Washout Period of One Week||15||
59769243|NCT00680056|75889491|FG001|STARTED|Washout Period of One Week||15||
59769244|NCT00680056|75889490|FG000|COMPLETED|Washout Period of One Week||15||
59769245|NCT00680056|75889491|FG001|COMPLETED|Washout Period of One Week||15||
59769246|NCT00680056|75889490|FG000|NOT COMPLETED|Washout Period of One Week||0||
59769247|NCT00680056|75889491|FG001|NOT COMPLETED|Washout Period of One Week||0||
59769248|NCT00680056|75889490|FG000|STARTED|Second Intervention||15||
59769249|NCT00680056|75889491|FG001|STARTED|Second Intervention||15||
59769250|NCT00680056|75889490|FG000|COMPLETED|Second Intervention||12||
59769251|NCT00680056|75889491|FG001|COMPLETED|Second Intervention||14||
59769252|NCT00680056|75889490|FG000|NOT COMPLETED|Second Intervention||3||
59769253|NCT00680056|75889491|FG001|NOT COMPLETED|Second Intervention||1||
59769254|NCT00680992|75889501|FG000|STARTED|Overall Study||268||
59769255|NCT00680992|75889502|FG001|STARTED|Overall Study||252||
59769256|NCT00680992|75889503|FG002|STARTED|Overall Study||12||
59769257|NCT00680992|75889501|FG000|Safety Analysis Set|Overall Study||265|Received ≥1 dose of denosumab|
59769258|NCT00680992|75889502|FG001|Safety Analysis Set|Overall Study||249|Received ≥1 dose of denosumab|
59769259|NCT00680992|75889503|FG002|Safety Analysis Set|Overall Study||12|Received ≥1 dose of denosumab|
59769260|NCT00680992|75889501|FG000|Efficacy Analysis Set|Overall Study||260|Eligible for study and received ≥1 dose of denosumab|
59769261|NCT00680992|75889502|FG001|Efficacy Analysis Set|Overall Study||242|Eligible for study and received ≥1 dose of denosumab|
59769262|NCT00680992|75889503|FG002|Efficacy Analysis Set|Overall Study||11|Eligible for study and received ≥1 dose of denosumab|
59769263|NCT00680992|75889501|FG000|COMPLETED|Overall Study||0|Completed the initial treatment phase|
59769264|NCT00680992|75889502|FG001|COMPLETED|Overall Study||0|Completed the initial treatment phase|
59769265|NCT00680992|75889503|FG002|COMPLETED|Overall Study||0|Completed the initial treatment phase|
59769266|NCT00680992|75889501|FG000|NOT COMPLETED|Overall Study||268||
59769267|NCT00680992|75889502|FG001|NOT COMPLETED|Overall Study||252||
59769268|NCT00680992|75889503|FG002|NOT COMPLETED|Overall Study||12||
59769269|NCT00805389|75889517|FG000|STARTED|Overall Study||143||
59769270|NCT00805389|75889518|FG001|STARTED|Overall Study||142||
59952576|NCT02081391|76071416|FG003|STARTED|12-hour Treatment||4||
59952577|NCT02081391|76071413|FG000|COMPLETED|12-hour Treatment||90||
59952578|NCT02081391|76071414|FG001|COMPLETED|12-hour Treatment||46||
59952579|NCT02081391|76071415|FG002|COMPLETED|12-hour Treatment||10||
59952580|NCT02081391|76071416|FG003|COMPLETED|12-hour Treatment||4||
59769271|NCT00805389|75889519|FG002|STARTED|Overall Study||141||
59769272|NCT00805389|75889520|FG003|STARTED|Overall Study||145||
59769273|NCT00805389|75889521|FG004|STARTED|Overall Study||142||
59769274|NCT00805389|75889517|FG000|COMPLETED|Overall Study||136||
59769275|NCT00805389|75889518|FG001|COMPLETED|Overall Study||137||
59769276|NCT00805389|75889519|FG002|COMPLETED|Overall Study||129||
59769277|NCT00805389|75889520|FG003|COMPLETED|Overall Study||128||
59769278|NCT00805389|75889521|FG004|COMPLETED|Overall Study||129||
59769279|NCT00805389|75889517|FG000|NOT COMPLETED|Overall Study||7||
59769280|NCT00805389|75889518|FG001|NOT COMPLETED|Overall Study||5||
59769281|NCT00805389|75889519|FG002|NOT COMPLETED|Overall Study||12||
59769282|NCT00805389|75889520|FG003|NOT COMPLETED|Overall Study||17||
59769283|NCT00805389|75889521|FG004|NOT COMPLETED|Overall Study||13||
59952581|NCT02081391|76071413|FG000|NOT COMPLETED|12-hour Treatment||18||
59952582|NCT02081391|76071414|FG001|NOT COMPLETED|12-hour Treatment||6||
59952583|NCT02081391|76071415|FG002|NOT COMPLETED|12-hour Treatment||1||
59952584|NCT02081391|76071416|FG003|NOT COMPLETED|12-hour Treatment||0||
59952585|NCT02081391|76071413|FG000|STARTED|24-hour Treatment and Trial Completion||90||
59952586|NCT02081391|76071414|FG001|STARTED|24-hour Treatment and Trial Completion||46||
59952587|NCT02081391|76071415|FG002|STARTED|24-hour Treatment and Trial Completion||10||
59769284|NCT00678886|75889545|FG000|STARTED|Overall Study||10||
59769285|NCT00678886|75889546|FG001|STARTED|Overall Study||19||
59769286|NCT00678886|75889547|FG002|STARTED|Overall Study||81||
59769287|NCT00678886|75889548|FG003|STARTED|Overall Study||162||
59769288|NCT00678886|75889545|FG000|COMPLETED|Overall Study||10||
59769289|NCT00678886|75889546|FG001|COMPLETED|Overall Study||19||
59769290|NCT00678886|75889547|FG002|COMPLETED|Overall Study||72||
59769291|NCT00678886|75889548|FG003|COMPLETED|Overall Study||153||
59769292|NCT00678886|75889545|FG000|NOT COMPLETED|Overall Study||0||
59769293|NCT00678886|75889546|FG001|NOT COMPLETED|Overall Study||0||
59769294|NCT00678886|75889547|FG002|NOT COMPLETED|Overall Study||9||
59769295|NCT00678886|75889548|FG003|NOT COMPLETED|Overall Study||9||
59769296|NCT00804843|75889559|FG000|STARTED|Overall Study||50||
59769297|NCT00804843|75889560|FG001|STARTED|Overall Study||50||
59769298|NCT00804843|75889559|FG000|COMPLETED|Overall Study||40||
59769299|NCT00804843|75889560|FG001|COMPLETED|Overall Study||43||
59769300|NCT00804843|75889559|FG000|NOT COMPLETED|Overall Study||10||
59769301|NCT00804843|75889560|FG001|NOT COMPLETED|Overall Study||7||
59769302|NCT00822120|75889569|FG000|STARTED|Initial Registration||358||
59769303|NCT00822120|75889570|FG001|STARTED|Initial Registration||13||
59769304|NCT00822120|75889571|FG002|STARTED|Initial Registration||0||
59769305|NCT00822120|75889572|FG003|STARTED|Initial Registration||0||
59769306|NCT00822120|75889573|FG004|STARTED|Initial Registration||0||
59769307|NCT00822120|75889574|FG005|STARTED|Initial Registration||0||
59769308|NCT00822120|75889569|FG000|Eligible and Evaluable Patients|Initial Registration||336||
59769309|NCT00822120|75889570|FG001|Eligible and Evaluable Patients|Initial Registration||12||
59769310|NCT00822120|75889571|FG002|Eligible and Evaluable Patients|Initial Registration||0||
59769311|NCT00822120|75889572|FG003|Eligible and Evaluable Patients|Initial Registration||0||
59769312|NCT00822120|75889573|FG004|Eligible and Evaluable Patients|Initial Registration||0||
59769313|NCT00822120|75889574|FG005|Eligible and Evaluable Patients|Initial Registration||0||
59769314|NCT00822120|75889569|FG000|COMPLETED|Initial Registration||332||
59769315|NCT00822120|75889570|FG001|COMPLETED|Initial Registration||12||
59769316|NCT00822120|75889571|FG002|COMPLETED|Initial Registration||0||
59952588|NCT02081391|76071416|FG003|STARTED|24-hour Treatment and Trial Completion||4||
59952589|NCT02081391|76071413|FG000|COMPLETED|24-hour Treatment and Trial Completion||63||
59952590|NCT02081391|76071414|FG001|COMPLETED|24-hour Treatment and Trial Completion||28||
59769317|NCT00822120|75889572|FG003|COMPLETED|Initial Registration||0||
59769318|NCT00822120|75889573|FG004|COMPLETED|Initial Registration||0||
59769319|NCT00822120|75889574|FG005|COMPLETED|Initial Registration||0||
59769320|NCT00822120|75889569|FG000|NOT COMPLETED|Initial Registration||26||
59769321|NCT00822120|75889570|FG001|NOT COMPLETED|Initial Registration||1||
59769322|NCT00822120|75889571|FG002|NOT COMPLETED|Initial Registration||0||
59769323|NCT00822120|75889572|FG003|NOT COMPLETED|Initial Registration||0||
59769324|NCT00822120|75889573|FG004|NOT COMPLETED|Initial Registration||0||
59769325|NCT00822120|75889574|FG005|NOT COMPLETED|Initial Registration||0||
59769326|NCT00822120|75889569|FG000|STARTED|PET-directed Therapy||0||
59769327|NCT00822120|75889570|FG001|STARTED|PET-directed Therapy||0||
59769328|NCT00822120|75889571|FG002|STARTED|PET-directed Therapy||270||
59769329|NCT00822120|75889572|FG003|STARTED|PET-directed Therapy||55||
59769330|NCT00822120|75889573|FG004|STARTED|PET-directed Therapy||10||
59769331|NCT00822120|75889574|FG005|STARTED|PET-directed Therapy||1||
59769332|NCT00822120|75889569|FG000|Eligibile and Evaluable Patients|PET-directed Therapy||0||
59769333|NCT00822120|75889570|FG001|Eligibile and Evaluable Patients|PET-directed Therapy||0||
59769334|NCT00822120|75889571|FG002|Eligibile and Evaluable Patients|PET-directed Therapy||270||
59769335|NCT00822120|75889572|FG003|Eligibile and Evaluable Patients|PET-directed Therapy||55||
59769336|NCT00822120|75889573|FG004|Eligibile and Evaluable Patients|PET-directed Therapy||10||
59769337|NCT00822120|75889574|FG005|Eligibile and Evaluable Patients|PET-directed Therapy||1||
59769338|NCT00822120|75889569|FG000|COMPLETED|PET-directed Therapy||0||
59769339|NCT00822120|75889570|FG001|COMPLETED|PET-directed Therapy||0||
59769340|NCT00822120|75889571|FG002|COMPLETED|PET-directed Therapy||270||
59769341|NCT00822120|75889572|FG003|COMPLETED|PET-directed Therapy||45||
59769342|NCT00822120|75889573|FG004|COMPLETED|PET-directed Therapy||10||
59769343|NCT00822120|75889574|FG005|COMPLETED|PET-directed Therapy||1||
59769344|NCT00822120|75889569|FG000|NOT COMPLETED|PET-directed Therapy||0||
59769345|NCT00822120|75889570|FG001|NOT COMPLETED|PET-directed Therapy||0||
59769346|NCT00822120|75889571|FG002|NOT COMPLETED|PET-directed Therapy||0||
59769347|NCT00822120|75889572|FG003|NOT COMPLETED|PET-directed Therapy||10||
59769348|NCT00822120|75889573|FG004|NOT COMPLETED|PET-directed Therapy||0||
59769349|NCT00822120|75889574|FG005|NOT COMPLETED|PET-directed Therapy||0||
59769350|NCT00804687|75889595|FG000|STARTED|Period 1: Treatment Period||9||
59769351|NCT00804687|75889596|FG001|STARTED|Period 1: Treatment Period||9||
59769352|NCT00804687|75889597|FG002|STARTED|Period 1: Treatment Period||9||
59769353|NCT00804687|75889598|FG003|STARTED|Period 1: Treatment Period||9||
59769354|NCT00804687|75889599|FG004|STARTED|Period 1: Treatment Period||9||
59769355|NCT00804687|75889600|FG005|STARTED|Period 1: Treatment Period||8||
59769356|NCT00804687|75889595|FG000|COMPLETED|Period 1: Treatment Period||9||
59769357|NCT00804687|75889596|FG001|COMPLETED|Period 1: Treatment Period||9||
59769358|NCT00804687|75889597|FG002|COMPLETED|Period 1: Treatment Period||9||
59952591|NCT02081391|76071415|FG002|COMPLETED|24-hour Treatment and Trial Completion||9||
59952592|NCT02081391|76071416|FG003|COMPLETED|24-hour Treatment and Trial Completion||4||
59769359|NCT00804687|75889598|FG003|COMPLETED|Period 1: Treatment Period||9||
59769360|NCT00804687|75889599|FG004|COMPLETED|Period 1: Treatment Period||9||
59769361|NCT00804687|75889600|FG005|COMPLETED|Period 1: Treatment Period||8||
59769362|NCT00804687|75889595|FG000|NOT COMPLETED|Period 1: Treatment Period||0||
59769363|NCT00804687|75889596|FG001|NOT COMPLETED|Period 1: Treatment Period||0||
59769364|NCT00804687|75889597|FG002|NOT COMPLETED|Period 1: Treatment Period||0||
59769365|NCT00804687|75889598|FG003|NOT COMPLETED|Period 1: Treatment Period||0||
59769366|NCT00804687|75889599|FG004|NOT COMPLETED|Period 1: Treatment Period||0||
59769367|NCT00804687|75889600|FG005|NOT COMPLETED|Period 1: Treatment Period||0||
59769368|NCT00804687|75889595|FG000|STARTED|Period 2: Washout Period||9||
59769369|NCT00804687|75889596|FG001|STARTED|Period 2: Washout Period||9||
59769370|NCT00804687|75889597|FG002|STARTED|Period 2: Washout Period||9||
59769371|NCT00804687|75889598|FG003|STARTED|Period 2: Washout Period||9||
59769372|NCT00804687|75889599|FG004|STARTED|Period 2: Washout Period||9||
59769373|NCT00804687|75889600|FG005|STARTED|Period 2: Washout Period||8||
59769374|NCT00804687|75889595|FG000|COMPLETED|Period 2: Washout Period||9||
59769375|NCT00804687|75889596|FG001|COMPLETED|Period 2: Washout Period||9||
59769376|NCT00804687|75889597|FG002|COMPLETED|Period 2: Washout Period||9||
59769377|NCT00804687|75889598|FG003|COMPLETED|Period 2: Washout Period||9||
59769378|NCT00804687|75889599|FG004|COMPLETED|Period 2: Washout Period||9||
59769379|NCT00804687|75889600|FG005|COMPLETED|Period 2: Washout Period||8||
59769380|NCT00804687|75889595|FG000|NOT COMPLETED|Period 2: Washout Period||0||
59769381|NCT00804687|75889596|FG001|NOT COMPLETED|Period 2: Washout Period||0||
59769382|NCT00804687|75889597|FG002|NOT COMPLETED|Period 2: Washout Period||0||
59769383|NCT00804687|75889598|FG003|NOT COMPLETED|Period 2: Washout Period||0||
59769384|NCT00804687|75889599|FG004|NOT COMPLETED|Period 2: Washout Period||0||
59769385|NCT00804687|75889600|FG005|NOT COMPLETED|Period 2: Washout Period||0||
59769386|NCT00804687|75889595|FG000|STARTED|Period 3: Treatment Period||9||
59769387|NCT00804687|75889596|FG001|STARTED|Period 3: Treatment Period||9||
59769388|NCT00804687|75889597|FG002|STARTED|Period 3: Treatment Period||9||
59769389|NCT00804687|75889598|FG003|STARTED|Period 3: Treatment Period||9||
59769390|NCT00804687|75889599|FG004|STARTED|Period 3: Treatment Period||9||
59769391|NCT00804687|75889600|FG005|STARTED|Period 3: Treatment Period||8||
59769392|NCT00804687|75889595|FG000|COMPLETED|Period 3: Treatment Period||9||
59769393|NCT00804687|75889596|FG001|COMPLETED|Period 3: Treatment Period||9||
59618163|NCT00003816|75729392|FG003|COMPLETED|Overall Study||23||
59618164|NCT00003816|75729393|FG004|COMPLETED|Overall Study||15||
59618165|NCT00003816|75729389|FG000|NOT COMPLETED|Overall Study||0||
59618166|NCT00003816|75729390|FG001|NOT COMPLETED|Overall Study||0||
59618167|NCT00003816|75729391|FG002|NOT COMPLETED|Overall Study||0||
59769394|NCT00804687|75889597|FG002|COMPLETED|Period 3: Treatment Period||9||
59769395|NCT00804687|75889598|FG003|COMPLETED|Period 3: Treatment Period||8||
59769396|NCT00804687|75889599|FG004|COMPLETED|Period 3: Treatment Period||9||
59769397|NCT00804687|75889600|FG005|COMPLETED|Period 3: Treatment Period||8||
59769398|NCT00804687|75889595|FG000|NOT COMPLETED|Period 3: Treatment Period||0||
59769399|NCT00804687|75889596|FG001|NOT COMPLETED|Period 3: Treatment Period||0||
59769400|NCT00804687|75889597|FG002|NOT COMPLETED|Period 3: Treatment Period||0||
59769401|NCT00804687|75889598|FG003|NOT COMPLETED|Period 3: Treatment Period||1||
59769402|NCT00804687|75889599|FG004|NOT COMPLETED|Period 3: Treatment Period||0||
59769403|NCT00804687|75889600|FG005|NOT COMPLETED|Period 3: Treatment Period||0||
59769404|NCT00804687|75889595|FG000|STARTED|Period 4: Washout Period||9||
59769405|NCT00804687|75889596|FG001|STARTED|Period 4: Washout Period||9||
59769406|NCT00804687|75889597|FG002|STARTED|Period 4: Washout Period||9||
59769407|NCT00804687|75889598|FG003|STARTED|Period 4: Washout Period||8||
59769408|NCT00804687|75889599|FG004|STARTED|Period 4: Washout Period||9||
59769409|NCT00804687|75889600|FG005|STARTED|Period 4: Washout Period||8||
59769410|NCT00804687|75889595|FG000|COMPLETED|Period 4: Washout Period||9||
59769411|NCT00804687|75889596|FG001|COMPLETED|Period 4: Washout Period||9||
59769412|NCT00804687|75889597|FG002|COMPLETED|Period 4: Washout Period||9||
59769413|NCT00804687|75889598|FG003|COMPLETED|Period 4: Washout Period||8||
59769414|NCT00804687|75889599|FG004|COMPLETED|Period 4: Washout Period||9||
59769415|NCT00804687|75889600|FG005|COMPLETED|Period 4: Washout Period||8||
59769416|NCT00804687|75889595|FG000|NOT COMPLETED|Period 4: Washout Period||0||
59769417|NCT00804687|75889596|FG001|NOT COMPLETED|Period 4: Washout Period||0||
59769418|NCT00804687|75889597|FG002|NOT COMPLETED|Period 4: Washout Period||0||
59769419|NCT00804687|75889598|FG003|NOT COMPLETED|Period 4: Washout Period||0||
59769420|NCT00804687|75889599|FG004|NOT COMPLETED|Period 4: Washout Period||0||
59769421|NCT00804687|75889600|FG005|NOT COMPLETED|Period 4: Washout Period||0||
59769422|NCT00804687|75889595|FG000|STARTED|Period 5: Treatment Period||9||
59769423|NCT00804687|75889596|FG001|STARTED|Period 5: Treatment Period||9||
59769424|NCT00804687|75889597|FG002|STARTED|Period 5: Treatment Period||9||
59769425|NCT00804687|75889598|FG003|STARTED|Period 5: Treatment Period||8||
59769426|NCT00804687|75889599|FG004|STARTED|Period 5: Treatment Period||9||
59769427|NCT00804687|75889600|FG005|STARTED|Period 5: Treatment Period||8||
59769428|NCT00804687|75889595|FG000|COMPLETED|Period 5: Treatment Period||8||
59618168|NCT00003816|75729392|FG003|NOT COMPLETED|Overall Study||0||
59769429|NCT00804687|75889596|FG001|COMPLETED|Period 5: Treatment Period||9||
59769430|NCT00804687|75889597|FG002|COMPLETED|Period 5: Treatment Period||8||
59769431|NCT00804687|75889598|FG003|COMPLETED|Period 5: Treatment Period||8||
59769432|NCT00804687|75889599|FG004|COMPLETED|Period 5: Treatment Period||8||
59769433|NCT00804687|75889600|FG005|COMPLETED|Period 5: Treatment Period||8||
59769434|NCT00804687|75889595|FG000|NOT COMPLETED|Period 5: Treatment Period||1||
59769435|NCT00804687|75889596|FG001|NOT COMPLETED|Period 5: Treatment Period||0||
59769436|NCT00804687|75889597|FG002|NOT COMPLETED|Period 5: Treatment Period||1||
59769437|NCT00804687|75889598|FG003|NOT COMPLETED|Period 5: Treatment Period||0||
59769438|NCT00804687|75889599|FG004|NOT COMPLETED|Period 5: Treatment Period||1||
59769439|NCT00804687|75889600|FG005|NOT COMPLETED|Period 5: Treatment Period||0||
59769440|NCT00678652|75889612|FG000|STARTED|Overall Study||9||
59769441|NCT00678652|75889613|FG001|STARTED|Overall Study||9||
59769442|NCT00678652|75889614|FG002|STARTED|Overall Study||9||
59769443|NCT00678652|75889615|FG003|STARTED|Overall Study||9||
59769444|NCT00678652|75889612|FG000|COMPLETED|Overall Study||6||
59769445|NCT00678652|75889613|FG001|COMPLETED|Overall Study||9||
59769446|NCT00678652|75889614|FG002|COMPLETED|Overall Study||8||
59769447|NCT00678652|75889615|FG003|COMPLETED|Overall Study||9||
59769448|NCT00678652|75889612|FG000|NOT COMPLETED|Overall Study||3||
59769449|NCT00678652|75889613|FG001|NOT COMPLETED|Overall Study||0||
59769450|NCT00678652|75889614|FG002|NOT COMPLETED|Overall Study||1||
59769451|NCT00678652|75889615|FG003|NOT COMPLETED|Overall Study||0||
59769452|NCT03658642|75889627|FG000|STARTED|Patients||2787||
59769453|NCT03658642|75889628|FG001|STARTED|Patients||2260||
59769454|NCT03658642|75889627|FG000|COMPLETED|Patients||2787||
59769455|NCT03658642|75889628|FG001|COMPLETED|Patients||2260||
59769456|NCT03658642|75889627|FG000|NOT COMPLETED|Patients||0||
59769457|NCT03658642|75889628|FG001|NOT COMPLETED|Patients||0||
59769458|NCT03658642|75889627|FG000|STARTED|Physicians|A total of 599 physicians were also included in the study.|340||
59769459|NCT03658642|75889628|FG001|STARTED|Physicians|A total of 599 physicians were also included in the study.|259||
59769460|NCT03658642|75889627|FG000|COMPLETED|Physicians||340||
59769461|NCT03658642|75889628|FG001|COMPLETED|Physicians||259||
59769462|NCT03658642|75889627|FG000|NOT COMPLETED|Physicians||0||
59769463|NCT03658642|75889628|FG001|NOT COMPLETED|Physicians||0||
59769464|NCT00840060|75889636|FG000|STARTED|Overall Study||20||
59769465|NCT00840060|75889637|FG001|STARTED|Overall Study||20||
59769466|NCT00840060|75889636|FG000|COMPLETED|Overall Study||19||
59769467|NCT00840060|75889637|FG001|COMPLETED|Overall Study||19||
59769468|NCT00840060|75889636|FG000|NOT COMPLETED|Overall Study||1||
59952593|NCT02081391|76071413|FG000|NOT COMPLETED|24-hour Treatment and Trial Completion||27||
59952594|NCT02081391|76071414|FG001|NOT COMPLETED|24-hour Treatment and Trial Completion||18||
59952595|NCT02081391|76071415|FG002|NOT COMPLETED|24-hour Treatment and Trial Completion||1||
59952596|NCT02081391|76071416|FG003|NOT COMPLETED|24-hour Treatment and Trial Completion||0||
59521545|NCT01016873|75615829|FG001|STARTED|24 Months||72||
59521546|NCT01016873|75615830|FG002|STARTED|24 Months||79||
59769469|NCT00840060|75889637|FG001|NOT COMPLETED|Overall Study||1||
59769470|NCT00574912|75889643|FG000|STARTED|Overall Study||20||
59769471|NCT00574912|75889643|FG000|Completed Placebo|Overall Study|12 original participants started the trial.|12||
59952597|NCT00430092|76071439|FG000|STARTED|Overall Study||54||
59952598|NCT00430092|76071440|FG001|STARTED|Overall Study||52||
59952599|NCT00430092|76071441|FG002|STARTED|Overall Study||113||
59952600|NCT00430092|76071439|FG000|COMPLETED|Overall Study||48||
59952601|NCT00430092|76071440|FG001|COMPLETED|Overall Study||48||
59952602|NCT00430092|76071441|FG002|COMPLETED|Overall Study||56||
59952603|NCT00430092|76071439|FG000|NOT COMPLETED|Overall Study||6||
59952604|NCT00430092|76071440|FG001|NOT COMPLETED|Overall Study||4||
59952605|NCT00430092|76071441|FG002|NOT COMPLETED|Overall Study||57||
59952606|NCT00425100|76071446|FG000|STARTED|Overall Study||516||
59952607|NCT00425100|76071446|FG000|COMPLETED|Overall Study||463||
59952608|NCT00425100|76071446|FG000|NOT COMPLETED|Overall Study||53||
59952609|NCT00412932|76071451|FG000|STARTED|Olmesartan (Olm) 20 mg||178||
59521547|NCT01016873|75615828|FG000|COMPLETED|24 Months||69||
59521548|NCT01016873|75615829|FG001|COMPLETED|24 Months||68||
59521549|NCT01016873|75615830|FG002|COMPLETED|24 Months||73||
59521550|NCT01016873|75615828|FG000|NOT COMPLETED|24 Months||5||
59521551|NCT01016873|75615829|FG001|NOT COMPLETED|24 Months||4||
59769472|NCT00574912|75889643|FG000|Completed 0.5|Overall Study||12||
59952610|NCT00412932|76071451|FG000|COMPLETED|Olmesartan (Olm) 20 mg||171||
59952611|NCT00412932|76071451|FG000|NOT COMPLETED|Olmesartan (Olm) 20 mg||7||
59952612|NCT00412932|76071451|FG000|STARTED|Olmesartan 40 mg|171 -1 met blood pressure goal (stayed on olmesartan 20) -1 who erroneously skipped this step = 169.|169||
59952613|NCT00412932|76071451|FG000|COMPLETED|Olmesartan 40 mg||161||
59769473|NCT00574912|75889643|FG000|Completed 1.0|Overall Study||12||
59769474|NCT00574912|75889643|FG000|Completed 1.5|Overall Study||12||
59769475|NCT00574912|75889643|FG000|Completed 2.0|Overall Study||12||
59769476|NCT00574912|75889643|FG000|COMPLETED|Overall Study||12||
59952614|NCT00412932|76071451|FG000|NOT COMPLETED|Olmesartan 40 mg||8||
59521552|NCT01016873|75615830|FG002|NOT COMPLETED|24 Months||6||
59521553|NCT01016873|75615828|FG000|STARTED|36 Months||69||
59521554|NCT01016873|75615829|FG001|STARTED|36 Months||68||
59769477|NCT00574912|75889643|FG000|NOT COMPLETED|Overall Study||8||
59769478|NCT00674128|75889657|FG000|STARTED|Overall Study||50||
59769479|NCT00674128|75889658|FG001|STARTED|Overall Study||44||
59769480|NCT00674128|75889657|FG000|COMPLETED|Overall Study||25||
59769481|NCT00674128|75889658|FG001|COMPLETED|Overall Study||21||
59769482|NCT00674128|75889657|FG000|NOT COMPLETED|Overall Study||25||
59769483|NCT00674128|75889658|FG001|NOT COMPLETED|Overall Study||23||
59769484|NCT00804141|75889664|FG000|STARTED|Overall Study||1040||
59769485|NCT00804141|75889664|FG000|Received at Least 1 Dose of Study Drug|Overall Study||1034||
59769486|NCT00804141|75889664|FG000|COMPLETED|Overall Study||477||
59769487|NCT00804141|75889664|FG000|NOT COMPLETED|Overall Study||563||
59769488|NCT00677092|75889668|FG000|STARTED|Overall Study||12||
59769489|NCT00677092|75889668|FG000|Received Study Treatment|Overall Study||11||
59769490|NCT00677092|75889668|FG000|COMPLETED|Overall Study||6||
59769491|NCT00677092|75889668|FG000|NOT COMPLETED|Overall Study||6||
59769492|NCT00677014|75889676|FG000|STARTED|Overall Study||325||
59769493|NCT00677014|75889677|FG001|STARTED|Overall Study||323||
59769494|NCT00677014|75889678|FG002|STARTED|Overall Study||332||
59769495|NCT00677014|75889676|FG000|COMPLETED|Overall Study||281||
59769496|NCT00677014|75889677|FG001|COMPLETED|Overall Study||282||
59769497|NCT00677014|75889678|FG002|COMPLETED|Overall Study||283||
59769498|NCT00677014|75889676|FG000|NOT COMPLETED|Overall Study||44||
59769499|NCT00677014|75889677|FG001|NOT COMPLETED|Overall Study||41||
59769500|NCT00677014|75889678|FG002|NOT COMPLETED|Overall Study||49||
59769501|NCT00839436|75889689|FG000|STARTED|Overall Study||3||
59769502|NCT00839436|75889690|FG001|STARTED|Overall Study||5||
59769503|NCT00839436|75889691|FG002|STARTED|Overall Study||1||
59769504|NCT00839436|75889689|FG000|COMPLETED|Overall Study||2||
59769505|NCT00839436|75889690|FG001|COMPLETED|Overall Study||4||
59769506|NCT00839436|75889691|FG002|COMPLETED|Overall Study||0||
59769507|NCT00839436|75889689|FG000|NOT COMPLETED|Overall Study||1||
59769508|NCT00839436|75889690|FG001|NOT COMPLETED|Overall Study||1||
59618169|NCT00003816|75729393|FG004|NOT COMPLETED|Overall Study||0||
59618170|NCT00004092|75729407|FG000|STARTED|Overall Study||21||
59618171|NCT00004092|75729408|FG001|STARTED|Overall Study||51||
59618172|NCT00004092|75729407|FG000|COMPLETED|Overall Study||21||
59618173|NCT00004092|75729408|FG001|COMPLETED|Overall Study||51||
59618174|NCT00004092|75729407|FG000|NOT COMPLETED|Overall Study||0||
59618175|NCT00004092|75729408|FG001|NOT COMPLETED|Overall Study||0||
59618176|NCT00004146|75729414|FG000|STARTED|Overall Study||55||
59618177|NCT00004146|75729414|FG000|COMPLETED|Overall Study||55||
59618178|NCT00004146|75729414|FG000|NOT COMPLETED|Overall Study||0||
59618179|NCT00004500|75729422|FG000|STARTED|Overall Study||38||
59618180|NCT00004500|75729423|FG001|STARTED|Overall Study||31||
59618181|NCT00004500|75729422|FG000|1 Year Follow-Up|Overall Study||24||
59618182|NCT00004500|75729423|FG001|1 Year Follow-Up|Overall Study||24||
59618183|NCT00004500|75729422|FG000|COMPLETED|Overall Study||38||
59618184|NCT00004500|75729423|FG001|COMPLETED|Overall Study||31||
59618185|NCT00004500|75729422|FG000|NOT COMPLETED|Overall Study||0||
59618186|NCT00004500|75729423|FG001|NOT COMPLETED|Overall Study||0||
59769509|NCT00839436|75889691|FG002|NOT COMPLETED|Overall Study||1||
59769510|NCT00675766|75889703|FG000|STARTED|Overall Study||106||
59769511|NCT00675766|75889704|FG001|STARTED|Overall Study||30||
59618187|NCT03684408|75729432|FG000|STARTED|Overall Study||10||
59618188|NCT03684408|75729433|FG001|STARTED|Overall Study||16||
59618189|NCT03684408|75729434|FG002|STARTED|Overall Study||12||
59618190|NCT03684408|75729432|FG000|COMPLETED|Overall Study||9||
59618191|NCT03684408|75729433|FG001|COMPLETED|Overall Study||15||
59618192|NCT03684408|75729434|FG002|COMPLETED|Overall Study||12||
59618193|NCT03684408|75729432|FG000|NOT COMPLETED|Overall Study||1||
59618194|NCT03684408|75729433|FG001|NOT COMPLETED|Overall Study||1||
59618195|NCT03684408|75729434|FG002|NOT COMPLETED|Overall Study||0||
59618196|NCT03591354|75729445|FG000|STARTED|Overall Study||54||
59618197|NCT03591354|75729446|FG001|STARTED|Overall Study||55||
59618198|NCT03591354|75729447|FG002|STARTED|Overall Study||55||
59618199|NCT03591354|75729445|FG000|COMPLETED|Overall Study||54||
59618200|NCT03591354|75729446|FG001|COMPLETED|Overall Study||55||
59618201|NCT03591354|75729447|FG002|COMPLETED|Overall Study||55||
59618202|NCT03591354|75729445|FG000|NOT COMPLETED|Overall Study||0||
59769512|NCT00675766|75889705|FG002|STARTED|Overall Study||50||
59769513|NCT00675766|75889706|FG003|STARTED|Overall Study||37||
59769514|NCT00675766|75889703|FG000|Year 2|Overall Study||105||
59769515|NCT00675766|75889704|FG001|Year 2|Overall Study||28||
59769516|NCT00675766|75889705|FG002|Year 2|Overall Study||34||
59769517|NCT00675766|75889706|FG003|Year 2|Overall Study||20||
59769518|NCT00675766|75889703|FG000|Year 3|Overall Study||100||
59769519|NCT00675766|75889704|FG001|Year 3|Overall Study||25||
59769520|NCT00675766|75889705|FG002|Year 3|Overall Study||29||
59769521|NCT00675766|75889706|FG003|Year 3|Overall Study||11||
59769522|NCT00675766|75889703|FG000|COMPLETED|Overall Study||100||
59618203|NCT03591354|75729446|FG001|NOT COMPLETED|Overall Study||0||
59618204|NCT03591354|75729447|FG002|NOT COMPLETED|Overall Study||0||
59618205|NCT00006156|75729464|FG000|STARTED|Overall Study||42||
59618206|NCT00006156|75729465|FG001|STARTED|Overall Study||7||
59618207|NCT00006156|75729464|FG000|COMPLETED|Overall Study||42||
59618208|NCT00006156|75729465|FG001|COMPLETED|Overall Study||7||
59618209|NCT00006156|75729464|FG000|NOT COMPLETED|Overall Study||0||
59769523|NCT00675766|75889704|FG001|COMPLETED|Overall Study||25||
59769524|NCT00675766|75889705|FG002|COMPLETED|Overall Study||29||
59769525|NCT00675766|75889706|FG003|COMPLETED|Overall Study||11||
59769526|NCT00675766|75889703|FG000|NOT COMPLETED|Overall Study||6||
59769527|NCT00675766|75889704|FG001|NOT COMPLETED|Overall Study||5||
59769528|NCT00675766|75889705|FG002|NOT COMPLETED|Overall Study||21||
59769529|NCT00675766|75889706|FG003|NOT COMPLETED|Overall Study||26||
59769530|NCT00673894|75889718|FG000|STARTED|First Intervention 4 Weeks||8|First Intervention Duration 4 weeks|
59769531|NCT00673894|75889719|FG001|STARTED|First Intervention 4 Weeks||7|First Intervention Duration 4 weeks|
59769532|NCT00673894|75889718|FG000|COMPLETED|First Intervention 4 Weeks||6||
59769533|NCT00673894|75889719|FG001|COMPLETED|First Intervention 4 Weeks||7||
59769534|NCT00673894|75889718|FG000|NOT COMPLETED|First Intervention 4 Weeks||2||
59769535|NCT00673894|75889719|FG001|NOT COMPLETED|First Intervention 4 Weeks||0||
59769536|NCT00673894|75889718|FG000|STARTED|Washout 4-6 Weeks||6||
59769537|NCT00673894|75889719|FG001|STARTED|Washout 4-6 Weeks||7||
59769538|NCT00673894|75889718|FG000|COMPLETED|Washout 4-6 Weeks||6||
59769539|NCT00673894|75889719|FG001|COMPLETED|Washout 4-6 Weeks||7||
59769540|NCT00673894|75889718|FG000|NOT COMPLETED|Washout 4-6 Weeks||0||
59769541|NCT00673894|75889719|FG001|NOT COMPLETED|Washout 4-6 Weeks||0||
59769542|NCT00673894|75889718|FG000|STARTED|Second Intervention 4 Weeks||6||
59769543|NCT00673894|75889719|FG001|STARTED|Second Intervention 4 Weeks||7||
59769544|NCT00673894|75889718|FG000|COMPLETED|Second Intervention 4 Weeks||6||
59769545|NCT00673894|75889719|FG001|COMPLETED|Second Intervention 4 Weeks||7||
59769546|NCT00673894|75889718|FG000|NOT COMPLETED|Second Intervention 4 Weeks||0||
59769547|NCT00673894|75889719|FG001|NOT COMPLETED|Second Intervention 4 Weeks||0||
59769548|NCT00674986|75889727|FG000|STARTED|Overall Study||230||
59769549|NCT00674986|75889728|FG001|STARTED|Overall Study||269||
59769550|NCT00674986|75889727|FG000|Intent to Treat Population|Overall Study||227||
59769551|NCT00674986|75889728|FG001|Intent to Treat Population|Overall Study||256||
59769552|NCT00674986|75889727|FG000|COMPLETED|Overall Study||187||
59769553|NCT00674986|75889728|FG001|COMPLETED|Overall Study||188||
59769554|NCT00674986|75889727|FG000|NOT COMPLETED|Overall Study||43||
59769555|NCT00674986|75889728|FG001|NOT COMPLETED|Overall Study||81||
59769556|NCT00673660|75889735|FG000|STARTED|Overall Study||375||
59769557|NCT00673660|75889735|FG000|COMPLETED|Overall Study||268||
59769558|NCT00673660|75889735|FG000|NOT COMPLETED|Overall Study||107||
59769559|NCT00672958|75889746|FG000|STARTED|Overall Study||300||
59769560|NCT00672958|75889747|FG001|STARTED|Overall Study||300||
59769561|NCT00672958|75889746|FG000|Safety Set|Overall Study|All randomized patients who received at least 1 dose of double-blind study drug.|298||
59769562|NCT00672958|75889747|FG001|Safety Set|Overall Study|All randomized patients who received at least 1 dose of double-blind study drug.|299||
59769563|NCT00672958|75889746|FG000|Full Analysis Set|Overall Study|All safety set patients who had at least 1 valid postbaseline primary efficacy assessment.|286||
59769564|NCT00672958|75889747|FG001|Full Analysis Set|Overall Study|All safety set patients who had at least 1 valid postbaseline primary efficacy assessment.|292||
59769565|NCT00672958|75889746|FG000|COMPLETED|Overall Study||236||
59769566|NCT00672958|75889747|FG001|COMPLETED|Overall Study||244||
59769567|NCT00672958|75889746|FG000|NOT COMPLETED|Overall Study||64||
59769568|NCT00672958|75889747|FG001|NOT COMPLETED|Overall Study||56||
59769569|NCT00672646|75889756|FG000|STARTED|Overall Study||40||
59769570|NCT00672646|75889757|FG001|STARTED|Overall Study||23||
59769571|NCT00672646|75889758|FG002|STARTED|Overall Study||40||
59769572|NCT00672646|75889756|FG000|COMPLETED|Overall Study||40||
59769573|NCT00672646|75889757|FG001|COMPLETED|Overall Study||22||
59769574|NCT00672646|75889758|FG002|COMPLETED|Overall Study||37||
59769575|NCT00672646|75889756|FG000|NOT COMPLETED|Overall Study||0||
59769576|NCT00672646|75889757|FG001|NOT COMPLETED|Overall Study||1||
59769577|NCT00672646|75889758|FG002|NOT COMPLETED|Overall Study||3||
59769578|NCT00672490|75889768|FG000|STARTED|Overall Study||187||
59769579|NCT00672490|75889769|FG001|STARTED|Overall Study||189||
59769580|NCT00672490|75889768|FG000|COMPLETED|Overall Study||163||
59769581|NCT00672490|75889769|FG001|COMPLETED|Overall Study||157||
59769582|NCT00672490|75889768|FG000|NOT COMPLETED|Overall Study||24||
59769583|NCT00672490|75889769|FG001|NOT COMPLETED|Overall Study||32||
59769584|NCT00670930|75889777|FG000|STARTED|Overall Study|"Started indicates Randomized and Safety populaiton"|23||
59769585|NCT00670930|75889778|FG001|STARTED|Overall Study||13||
59769586|NCT00670930|75889777|FG000|Intent to Treat (ITT) Population|Overall Study||23||
59769587|NCT00670930|75889778|FG001|Intent to Treat (ITT) Population|Overall Study||12||
59769588|NCT00670930|75889777|FG000|COMPLETED|Overall Study||22||
59769589|NCT00670930|75889778|FG001|COMPLETED|Overall Study||12||
59769590|NCT00670930|75889777|FG000|NOT COMPLETED|Overall Study||1||
59769591|NCT00670930|75889778|FG001|NOT COMPLETED|Overall Study||1||
59769592|NCT00670540|75889784|FG000|STARTED|Overall Study||8256||
59769593|NCT00670540|75889784|FG000|COMPLETED|Overall Study|total recruited for the follow up|4931||
59769594|NCT00670540|75889784|FG000|NOT COMPLETED|Overall Study||3325||
59769595|NCT00591786|75889798|FG000|STARTED|Overall Study||9||
59769596|NCT00591786|75889799|FG001|STARTED|Overall Study||9||
59769597|NCT00591786|75889800|FG002|STARTED|Overall Study||11||
59769598|NCT00591786|75889801|FG003|STARTED|Overall Study||11||
59769599|NCT00591786|75889802|FG004|STARTED|Overall Study||10||
59769600|NCT00591786|75889803|FG005|STARTED|Overall Study||10||
59769601|NCT00591786|75889804|FG006|STARTED|Overall Study||10||
59769602|NCT00591786|75889805|FG007|STARTED|Overall Study||10||
59769603|NCT00591786|75889806|FG008|STARTED|Overall Study||10||
59769604|NCT00591786|75889807|FG009|STARTED|Overall Study||10||
59769605|NCT00591786|75889798|FG000|Treated Participants|Overall Study||9||
59769606|NCT00591786|75889799|FG001|Treated Participants|Overall Study||9||
59769607|NCT00591786|75889800|FG002|Treated Participants|Overall Study||10||
59769608|NCT00591786|75889801|FG003|Treated Participants|Overall Study||11||
59769609|NCT00591786|75889802|FG004|Treated Participants|Overall Study||10||
59769610|NCT00591786|75889803|FG005|Treated Participants|Overall Study||10||
59769611|NCT00591786|75889804|FG006|Treated Participants|Overall Study||10||
59769612|NCT00591786|75889805|FG007|Treated Participants|Overall Study||10||
59769613|NCT00591786|75889806|FG008|Treated Participants|Overall Study||10||
59769614|NCT00591786|75889807|FG009|Treated Participants|Overall Study||10||
59769615|NCT00591786|75889798|FG000|COMPLETED|Overall Study||9||
59769616|NCT00591786|75889799|FG001|COMPLETED|Overall Study||9||
59769617|NCT00591786|75889800|FG002|COMPLETED|Overall Study||10||
59769618|NCT00591786|75889801|FG003|COMPLETED|Overall Study||11||
59769619|NCT00591786|75889802|FG004|COMPLETED|Overall Study||10||
59769620|NCT00591786|75889803|FG005|COMPLETED|Overall Study||10||
59769621|NCT00591786|75889804|FG006|COMPLETED|Overall Study||10||
59769622|NCT00591786|75889805|FG007|COMPLETED|Overall Study||10||
59769623|NCT00591786|75889806|FG008|COMPLETED|Overall Study||10||
59769624|NCT00591786|75889807|FG009|COMPLETED|Overall Study||10||
59769625|NCT00591786|75889798|FG000|NOT COMPLETED|Overall Study||0||
59769626|NCT00591786|75889799|FG001|NOT COMPLETED|Overall Study||0||
59769627|NCT00591786|75889800|FG002|NOT COMPLETED|Overall Study||1||
59769628|NCT00591786|75889801|FG003|NOT COMPLETED|Overall Study||0||
59769629|NCT00591786|75889802|FG004|NOT COMPLETED|Overall Study||0||
59769630|NCT00591786|75889803|FG005|NOT COMPLETED|Overall Study||0||
59769631|NCT00591786|75889804|FG006|NOT COMPLETED|Overall Study||0||
59769632|NCT00591786|75889805|FG007|NOT COMPLETED|Overall Study||0||
59769633|NCT00591786|75889806|FG008|NOT COMPLETED|Overall Study||0||
59769634|NCT00591786|75889807|FG009|NOT COMPLETED|Overall Study||0||
59769635|NCT00674362|75889831|FG000|STARTED|Double Blind||96||
59769636|NCT00674362|75889832|FG001|STARTED|Double Blind||98||
59769637|NCT00674362|75889831|FG000|COMPLETED|Double Blind||84||
59769638|NCT00674362|75889832|FG001|COMPLETED|Double Blind||80||
59769639|NCT00674362|75889831|FG000|NOT COMPLETED|Double Blind||12||
59769640|NCT00674362|75889832|FG001|NOT COMPLETED|Double Blind||18||
59769641|NCT00674362|75889831|FG000|STARTED|Open Label||20||
59769642|NCT00674362|75889832|FG001|STARTED|Open Label||7||
59769643|NCT00674362|75889831|FG000|COMPLETED|Open Label||18||
59769644|NCT00674362|75889832|FG001|COMPLETED|Open Label||7||
59769645|NCT00674362|75889831|FG000|NOT COMPLETED|Open Label||2||
59769646|NCT00674362|75889832|FG001|NOT COMPLETED|Open Label||0||
59769647|NCT00820950|75889844|FG000|STARTED|Overall Study||6||6
59769648|NCT00820950|75889845|FG001|STARTED|Overall Study||6||6
59769649|NCT00820950|75889846|FG002|STARTED|Overall Study||6||6
59769650|NCT00820950|75889847|FG003|STARTED|Overall Study||6||6
59769651|NCT00820950|75889848|FG004|STARTED|Overall Study||6||6
59769652|NCT00820950|75889849|FG005|STARTED|Overall Study||6||6
59769653|NCT00820950|75889850|FG006|STARTED|Overall Study||6||6
59769654|NCT00820950|75889851|FG007|STARTED|Overall Study||6||6
59769655|NCT00820950|75889852|FG008|STARTED|Overall Study||5||5
59769656|NCT00820950|75889853|FG009|STARTED|Overall Study||5||5
59769657|NCT00820950|75889844|FG000|COMPLETED|Overall Study||5||5
59769658|NCT00820950|75889845|FG001|COMPLETED|Overall Study||5||5
59769659|NCT00820950|75889846|FG002|COMPLETED|Overall Study||6||6
59769660|NCT00820950|75889847|FG003|COMPLETED|Overall Study||6||6
59769661|NCT00820950|75889848|FG004|COMPLETED|Overall Study||6||6
59769662|NCT00820950|75889849|FG005|COMPLETED|Overall Study||6||6
59769663|NCT00820950|75889850|FG006|COMPLETED|Overall Study||5||5
59769664|NCT00820950|75889851|FG007|COMPLETED|Overall Study||5||5
59769665|NCT00820950|75889852|FG008|COMPLETED|Overall Study||5||5
59769666|NCT00820950|75889853|FG009|COMPLETED|Overall Study||5||5
59769667|NCT00820950|75889844|FG000|NOT COMPLETED|Overall Study||1||1
59769668|NCT00820950|75889845|FG001|NOT COMPLETED|Overall Study||1||1
59769669|NCT00820950|75889846|FG002|NOT COMPLETED|Overall Study||0||0
59769670|NCT00820950|75889847|FG003|NOT COMPLETED|Overall Study||0||0
59769671|NCT00820950|75889848|FG004|NOT COMPLETED|Overall Study||0||0
59769672|NCT00820950|75889849|FG005|NOT COMPLETED|Overall Study||0||0
59769673|NCT00820950|75889850|FG006|NOT COMPLETED|Overall Study||1||1
59769674|NCT00820950|75889851|FG007|NOT COMPLETED|Overall Study||1||1
59769675|NCT00820950|75889852|FG008|NOT COMPLETED|Overall Study||0||0
59769676|NCT00820950|75889853|FG009|NOT COMPLETED|Overall Study||0||0
59769677|NCT00670306|75889893|FG000|STARTED|Overall Study||528||
59769678|NCT00670306|75889893|FG000|COMPLETED|Overall Study||473||
59769679|NCT00670306|75889893|FG000|NOT COMPLETED|Overall Study||55||
59769680|NCT00672256|75889897|FG000|STARTED|Overall Study|January 2007|62||
59769681|NCT00672256|75889897|FG000|COMPLETED|Overall Study||18||
59769682|NCT00672256|75889897|FG000|NOT COMPLETED|Overall Study||44||
59769683|NCT00591630|75889905|FG000|STARTED|Overall Study||6||
59769684|NCT00591630|75889906|FG001|STARTED|Overall Study||8||
59769685|NCT00591630|75889907|FG002|STARTED|Overall Study||10||
59769686|NCT00591630|75889908|FG003|STARTED|Overall Study||6||
59769687|NCT00591630|75889905|FG000|COMPLETED|Overall Study||6||
59769688|NCT00591630|75889906|FG001|COMPLETED|Overall Study||8||
59769689|NCT00591630|75889907|FG002|COMPLETED|Overall Study||9||
59769690|NCT00591630|75889908|FG003|COMPLETED|Overall Study||6||
59769691|NCT00591630|75889905|FG000|NOT COMPLETED|Overall Study||0||
59769692|NCT00591630|75889906|FG001|NOT COMPLETED|Overall Study||0||
59769693|NCT00591630|75889907|FG002|NOT COMPLETED|Overall Study||1||
59769694|NCT00591630|75889908|FG003|NOT COMPLETED|Overall Study||0||
59769695|NCT00670228|75889920|FG000|STARTED|Overall Study||18||
59769696|NCT00670228|75889921|FG001|STARTED|Overall Study||15||
59769697|NCT00670228|75889920|FG000|COMPLETED|Overall Study||13||
59769698|NCT00670228|75889921|FG001|COMPLETED|Overall Study||12||
59769699|NCT00670228|75889920|FG000|NOT COMPLETED|Overall Study||5||
59769700|NCT00670228|75889921|FG001|NOT COMPLETED|Overall Study||3||
59769701|NCT00570778|75889927|FG000|STARTED|Overall Study||41||
59769702|NCT00570778|75889928|FG001|STARTED|Overall Study||38||
59769703|NCT00570778|75889929|FG002|STARTED|Overall Study||37||
59769704|NCT00570778|75889930|FG003|STARTED|Overall Study||38||
59769705|NCT00570778|75889927|FG000|Safety Population: Received Study Drug|Overall Study|Safety Population included all participants who received at least 1 dose of any study drug.|41||
59769706|NCT00570778|75889928|FG001|Safety Population: Received Study Drug|Overall Study||38||
59769707|NCT00570778|75889929|FG002|Safety Population: Received Study Drug|Overall Study||36||
59769708|NCT00570778|75889930|FG003|Safety Population: Received Study Drug|Overall Study||38||
59769709|NCT00570778|75889927|FG000|Modified Intent-to-treat Population|Overall Study||40||
59769710|NCT00570778|75889928|FG001|Modified Intent-to-treat Population|Overall Study||37||
59769711|NCT00570778|75889929|FG002|Modified Intent-to-treat Population|Overall Study||35||
59769712|NCT00570778|75889930|FG003|Modified Intent-to-treat Population|Overall Study||37||
59769713|NCT00570778|75889927|FG000|COMPLETED|Overall Study||37||
59769714|NCT00570778|75889928|FG001|COMPLETED|Overall Study||34||
59769715|NCT00570778|75889929|FG002|COMPLETED|Overall Study||30||
59769716|NCT00570778|75889930|FG003|COMPLETED|Overall Study||34||
59769717|NCT00570778|75889927|FG000|NOT COMPLETED|Overall Study||4||
59769718|NCT00570778|75889928|FG001|NOT COMPLETED|Overall Study||4||
59769719|NCT00570778|75889929|FG002|NOT COMPLETED|Overall Study||7||
59769720|NCT00570778|75889930|FG003|NOT COMPLETED|Overall Study||4||
59769721|NCT00668746|75889942|FG000|STARTED|Overall Study||23||
59769722|NCT00668746|75889943|FG001|STARTED|Overall Study||12||
59769723|NCT00668746|75889942|FG000|COMPLETED|Overall Study||21||
59769724|NCT00668746|75889943|FG001|COMPLETED|Overall Study||11||
59769725|NCT00668746|75889942|FG000|NOT COMPLETED|Overall Study||2||
59769726|NCT00668746|75889943|FG001|NOT COMPLETED|Overall Study||1||
59769727|NCT00878189|75889961|FG000|STARTED|Overall Study||3||
59769728|NCT00878189|75889962|FG001|STARTED|Overall Study||3||
59769729|NCT00878189|75889963|FG002|STARTED|Overall Study||4||
59769730|NCT00878189|75889964|FG003|STARTED|Overall Study||8||
59769731|NCT00878189|75889965|FG004|STARTED|Overall Study||4||
59769732|NCT00878189|75889966|FG005|STARTED|Overall Study||23||
59769733|NCT00878189|75889967|FG006|STARTED|Overall Study||16||
59769734|NCT00878189|75889968|FG007|STARTED|Overall Study||3||
59769735|NCT00878189|75889969|FG008|STARTED|Overall Study||8||
59769736|NCT00878189|75889961|FG000|COMPLETED|Overall Study||0||
59769737|NCT00878189|75889962|FG001|COMPLETED|Overall Study||0||
59769738|NCT00878189|75889963|FG002|COMPLETED|Overall Study||0||
59769739|NCT00878189|75889964|FG003|COMPLETED|Overall Study||0||
59769740|NCT00878189|75889965|FG004|COMPLETED|Overall Study||0||
59769741|NCT00878189|75889966|FG005|COMPLETED|Overall Study||0||
59769742|NCT00878189|75889967|FG006|COMPLETED|Overall Study||0||
59769743|NCT00878189|75889968|FG007|COMPLETED|Overall Study||0||
59769744|NCT00878189|75889969|FG008|COMPLETED|Overall Study||0||
59769745|NCT00878189|75889961|FG000|NOT COMPLETED|Overall Study||3||
59769746|NCT00878189|75889962|FG001|NOT COMPLETED|Overall Study||3||
59769747|NCT00878189|75889963|FG002|NOT COMPLETED|Overall Study||4||
59769748|NCT00878189|75889964|FG003|NOT COMPLETED|Overall Study||8||
59769749|NCT00878189|75889965|FG004|NOT COMPLETED|Overall Study||4||
59769750|NCT00878189|75889966|FG005|NOT COMPLETED|Overall Study||23||
59769751|NCT00878189|75889967|FG006|NOT COMPLETED|Overall Study||16||
59769752|NCT00878189|75889968|FG007|NOT COMPLETED|Overall Study||3||
59769753|NCT00878189|75889969|FG008|NOT COMPLETED|Overall Study||8||
59769754|NCT00668200|75890003|FG000|STARTED|Overall Study||80||
59769755|NCT00668200|75890003|FG000|Safety Population|Overall Study|1 patient was not included in the ITT patient was enrolled in error|81||
59769756|NCT00668200|75890003|FG000|Intent to Treat (ITT)|Overall Study||80||
59769757|NCT00668200|75890003|FG000|COMPLETED|Overall Study||77||
59769758|NCT00668200|75890003|FG000|NOT COMPLETED|Overall Study||3||
59769759|NCT00838578|75890007|FG000|STARTED|Overall Study|In this Ph 1/2 study, 65 subjects were enrolled; 2 were protocol violators, so only 63 treated.|65||
59769760|NCT00838578|75890007|FG000|COMPLETED|Overall Study||63||
59769761|NCT00838578|75890007|FG000|NOT COMPLETED|Overall Study||2||
59769762|NCT00829296|75890017|FG000|STARTED|Overall Study||34||
59769763|NCT00829296|75890018|FG001|STARTED|Overall Study||36||
59769764|NCT00829296|75890017|FG000|COMPLETED|Overall Study||29||
59769765|NCT00829296|75890018|FG001|COMPLETED|Overall Study||32||
59769766|NCT00829296|75890017|FG000|NOT COMPLETED|Overall Study||5||
59769767|NCT00829296|75890018|FG001|NOT COMPLETED|Overall Study||4||
59769768|NCT00881621|75890024|FG000|STARTED|Overall Study||51||
59769769|NCT00881621|75890024|FG000|COMPLETED|Overall Study||17||
59769770|NCT00881621|75890024|FG000|NOT COMPLETED|Overall Study||34||
59769771|NCT00818766|75890030|FG000|STARTED|Overall Study||125||
59769772|NCT00818766|75890031|FG001|STARTED|Overall Study||126||
59769773|NCT00818766|75890030|FG000|Received Allocated Intervention|Overall Study|1 withdrew consent, 1 had active infection and 1 was given open-label antibiotic after surgery.|122||
59769774|NCT00818766|75890031|FG001|Received Allocated Intervention|Overall Study||126||
59769775|NCT00818766|75890030|FG000|Intent-to-Treat Population|Overall Study|1 participant was randomized twice but only counted once (per first randomization).|121||
59769776|NCT00818766|75890031|FG001|Intent-to-Treat Population|Overall Study|2 participants were randomized twice but only counted once (per first randomization).|124||
59769777|NCT00818766|75890030|FG000|COMPLETED|Overall Study||110|Completed = completed through 28-day follow-up phone call|
59769778|NCT00818766|75890031|FG001|COMPLETED|Overall Study||116|Completed = completed through 28-day follow-up phone call|
59769779|NCT00818766|75890030|FG000|NOT COMPLETED|Overall Study||15||
59769780|NCT00818766|75890031|FG001|NOT COMPLETED|Overall Study||10||
59769781|NCT00667888|75890039|FG000|STARTED|Overall Study||111||
59769782|NCT00667888|75890040|FG001|STARTED|Overall Study||111||
59769783|NCT00667888|75890039|FG000|COMPLETED|Overall Study||101||
59769784|NCT00667888|75890040|FG001|COMPLETED|Overall Study||102||
59769785|NCT00667888|75890039|FG000|NOT COMPLETED|Overall Study||10||
59769786|NCT00667888|75890040|FG001|NOT COMPLETED|Overall Study||9||
59769787|NCT00594815|75890046|FG000|STARTED|Overall Study||52||
59769788|NCT00594815|75890046|FG000|COMPLETED|Overall Study||43||
59769789|NCT00594815|75890046|FG000|NOT COMPLETED|Overall Study||9||
59769790|NCT00820170|75890055|FG000|STARTED|Overall Study||3||
59769791|NCT00820170|75890056|FG001|STARTED|Overall Study||5||
59769792|NCT00820170|75890057|FG002|STARTED|Overall Study||3||
59769793|NCT00820170|75890058|FG003|STARTED|Overall Study||40||
59769794|NCT00820170|75890059|FG004|STARTED|Overall Study||4||
59769795|NCT00820170|75890055|FG000|COMPLETED|Overall Study||3||
59769796|NCT00820170|75890056|FG001|COMPLETED|Overall Study||5||
59769797|NCT00820170|75890057|FG002|COMPLETED|Overall Study||3||
59769798|NCT00820170|75890058|FG003|COMPLETED|Overall Study||40||
59769799|NCT00820170|75890059|FG004|COMPLETED|Overall Study||0||
59769800|NCT00820170|75890055|FG000|NOT COMPLETED|Overall Study||0||
59769801|NCT00820170|75890056|FG001|NOT COMPLETED|Overall Study||0||
59769802|NCT00820170|75890057|FG002|NOT COMPLETED|Overall Study||0||
59769803|NCT00820170|75890058|FG003|NOT COMPLETED|Overall Study||0||
59769804|NCT00820170|75890059|FG004|NOT COMPLETED|Overall Study||4||
59769805|NCT00818454|75890076|FG000|STARTED|Treatment Period 1||115||
59769806|NCT00818454|75890077|FG001|STARTED|Treatment Period 1||111||
59769807|NCT00818454|75890078|FG002|STARTED|Treatment Period 1||0||
59769808|NCT00818454|75890079|FG003|STARTED|Treatment Period 1||0||
59769809|NCT00818454|75890076|FG000|COMPLETED|Treatment Period 1||112||
59769810|NCT00818454|75890077|FG001|COMPLETED|Treatment Period 1||110||
59769811|NCT00818454|75890078|FG002|COMPLETED|Treatment Period 1||0||
59769812|NCT00818454|75890079|FG003|COMPLETED|Treatment Period 1||0||
59769813|NCT00818454|75890076|FG000|NOT COMPLETED|Treatment Period 1||3||
59769814|NCT00818454|75890077|FG001|NOT COMPLETED|Treatment Period 1||1||
59769815|NCT00818454|75890078|FG002|NOT COMPLETED|Treatment Period 1||0||
59769816|NCT00818454|75890079|FG003|NOT COMPLETED|Treatment Period 1||0||
59769817|NCT00818454|75890076|FG000|STARTED|Washout Period of 1 Week||112||
59769818|NCT00818454|75890077|FG001|STARTED|Washout Period of 1 Week||110||
59769819|NCT00818454|75890078|FG002|STARTED|Washout Period of 1 Week||0||
59769820|NCT00818454|75890079|FG003|STARTED|Washout Period of 1 Week||0||
59769821|NCT00818454|75890076|FG000|COMPLETED|Washout Period of 1 Week||108||
59769822|NCT00818454|75890077|FG001|COMPLETED|Washout Period of 1 Week||107||
59769823|NCT00818454|75890078|FG002|COMPLETED|Washout Period of 1 Week||0||
59769824|NCT00818454|75890079|FG003|COMPLETED|Washout Period of 1 Week||0||
59769825|NCT00818454|75890076|FG000|NOT COMPLETED|Washout Period of 1 Week||4||
59769826|NCT00818454|75890077|FG001|NOT COMPLETED|Washout Period of 1 Week||3||
59769827|NCT00818454|75890078|FG002|NOT COMPLETED|Washout Period of 1 Week||0||
59769828|NCT00818454|75890079|FG003|NOT COMPLETED|Washout Period of 1 Week||0||
59769829|NCT00818454|75890076|FG000|STARTED|Treatment Period 2||108||
59769830|NCT00818454|75890077|FG001|STARTED|Treatment Period 2||107||
59769831|NCT00818454|75890078|FG002|STARTED|Treatment Period 2||0||
59952615|NCT00412932|76071451|FG000|STARTED|Olm+Hydrochlorothiazide 12.5 mg|161 -2 met blood pressure goal (stayed on olmesartan 40) = 159|159||
59521555|NCT01016873|75615830|FG002|STARTED|36 Months||73||
59521556|NCT01016873|75615828|FG000|COMPLETED|36 Months||58||
59521557|NCT01016873|75615829|FG001|COMPLETED|36 Months||64||
59952616|NCT00412932|76071451|FG000|COMPLETED|Olm+Hydrochlorothiazide 12.5 mg||153||
59521558|NCT01016873|75615830|FG002|COMPLETED|36 Months||67||
59521559|NCT01016873|75615828|FG000|NOT COMPLETED|36 Months||11||
59521560|NCT01016873|75615829|FG001|NOT COMPLETED|36 Months||4||
59521561|NCT01016873|75615830|FG002|NOT COMPLETED|36 Months||6||
59521562|NCT01017497|75615838|FG000|STARTED|Overall Study||49||
59521563|NCT01017497|75615838|FG000|COMPLETED|Overall Study||49||
59521564|NCT01017497|75615838|FG000|NOT COMPLETED|Overall Study||0||
59521565|NCT01017653|75615844|FG000|STARTED|Overall Study||16||
59521566|NCT01017653|75615844|FG000|COMPLETED|Overall Study||16||
59521567|NCT01017653|75615844|FG000|NOT COMPLETED|Overall Study||0||
59521568|NCT00965237|75615848|FG000|STARTED|Period 1, One Week of Wear||8||
59521569|NCT00965237|75615849|FG001|STARTED|Period 1, One Week of Wear||8||
59521570|NCT00965237|75615848|FG000|COMPLETED|Period 1, One Week of Wear||8||
59521571|NCT00965237|75615849|FG001|COMPLETED|Period 1, One Week of Wear||8||
59521572|NCT00965237|75615848|FG000|NOT COMPLETED|Period 1, One Week of Wear||0||
59521573|NCT00965237|75615849|FG001|NOT COMPLETED|Period 1, One Week of Wear||0||
59521574|NCT00965237|75615848|FG000|STARTED|Period 2, One Week of Wear||8||
59521575|NCT00965237|75615849|FG001|STARTED|Period 2, One Week of Wear||8||
59521576|NCT00965237|75615848|FG000|COMPLETED|Period 2, One Week of Wear||8||
59521577|NCT00965237|75615849|FG001|COMPLETED|Period 2, One Week of Wear||8||
59521578|NCT00965237|75615848|FG000|NOT COMPLETED|Period 2, One Week of Wear||0||
59521579|NCT00965237|75615849|FG001|NOT COMPLETED|Period 2, One Week of Wear||0||
59521580|NCT00966641|75615855|FG000|STARTED|First Intervention||17||
59521581|NCT00966641|75615856|FG001|STARTED|First Intervention||17||
59521582|NCT00966641|75615855|FG000|COMPLETED|First Intervention||17||
59521583|NCT00966641|75615856|FG001|COMPLETED|First Intervention||17||
59521584|NCT00966641|75615855|FG000|NOT COMPLETED|First Intervention||0||
59521585|NCT00966641|75615856|FG001|NOT COMPLETED|First Intervention||0||
59521586|NCT00966641|75615855|FG000|STARTED|Second Intervention||17||
59521587|NCT00966641|75615856|FG001|STARTED|Second Intervention||17||
59521588|NCT00966641|75615855|FG000|COMPLETED|Second Intervention||17||
59521589|NCT00966641|75615856|FG001|COMPLETED|Second Intervention||17||
59521590|NCT00966641|75615855|FG000|NOT COMPLETED|Second Intervention||0||
59521591|NCT00966641|75615856|FG001|NOT COMPLETED|Second Intervention||0||
59521592|NCT02565576|75615864|FG000|STARTED|Overall Study||22||
59521593|NCT02565576|75615865|FG001|STARTED|Overall Study||22||
59521594|NCT02565576|75615864|FG000|COMPLETED|Overall Study||17||
59521595|NCT02565576|75615865|FG001|COMPLETED|Overall Study||17||
59521596|NCT02565576|75615864|FG000|NOT COMPLETED|Overall Study||5||
59521597|NCT02565576|75615865|FG001|NOT COMPLETED|Overall Study||5||
59521598|NCT00970073|75615874|FG000|STARTED|Overall Study||10||
59521599|NCT00970073|75615875|FG001|STARTED|Overall Study||10||
59521600|NCT00970073|75615876|FG002|STARTED|Overall Study||10||
59521601|NCT00970073|75615874|FG000|COMPLETED|Overall Study||10||
59521602|NCT00970073|75615875|FG001|COMPLETED|Overall Study||10||
59521603|NCT00970073|75615876|FG002|COMPLETED|Overall Study||10||
59521604|NCT00970073|75615874|FG000|NOT COMPLETED|Overall Study||0||
59521605|NCT00970073|75615875|FG001|NOT COMPLETED|Overall Study||0||
59521606|NCT00970073|75615876|FG002|NOT COMPLETED|Overall Study||0||
59521607|NCT00970853|75615886|FG000|STARTED|Overall Study||89||
59521608|NCT00970853|75615887|FG001|STARTED|Overall Study||98||
59521609|NCT00970853|75615886|FG000|COMPLETED|Overall Study||89||
59521610|NCT00970853|75615887|FG001|COMPLETED|Overall Study||98||
59521611|NCT00970853|75615886|FG000|NOT COMPLETED|Overall Study||0||
59521612|NCT00970853|75615887|FG001|NOT COMPLETED|Overall Study||0||
59521613|NCT02569398|75615896|FG000|STARTED|Overall Study||185||
59521614|NCT02569398|75615897|FG001|STARTED|Overall Study||189||
59521615|NCT02569398|75615898|FG002|STARTED|Overall Study||183||
59521616|NCT02569398|75615896|FG000|COMPLETED|Overall Study||0||
59521617|NCT02569398|75615897|FG001|COMPLETED|Overall Study||0||
59521618|NCT02569398|75615898|FG002|COMPLETED|Overall Study||0||
59521619|NCT02569398|75615896|FG000|NOT COMPLETED|Overall Study||185||
59521620|NCT02569398|75615897|FG001|NOT COMPLETED|Overall Study||189||
59521621|NCT02569398|75615898|FG002|NOT COMPLETED|Overall Study||183||
59521622|NCT00971633|75615906|FG000|STARTED|Period 1||2||
59521623|NCT00971633|75615907|FG001|STARTED|Period 1||2||
59521624|NCT00971633|75615908|FG002|STARTED|Period 1||2||
59521625|NCT00971633|75615909|FG003|STARTED|Period 1||2||
59521626|NCT00971633|75615910|FG004|STARTED|Period 1||2||
59521627|NCT00971633|75615911|FG005|STARTED|Period 1||2||
59521628|NCT00971633|75615906|FG000|COMPLETED|Period 1||2||
59521629|NCT00971633|75615907|FG001|COMPLETED|Period 1||2||
59521630|NCT00971633|75615908|FG002|COMPLETED|Period 1||2||
59521631|NCT00971633|75615909|FG003|COMPLETED|Period 1||2||
59521632|NCT00971633|75615910|FG004|COMPLETED|Period 1||2||
59521633|NCT00971633|75615911|FG005|COMPLETED|Period 1||2||
59995229|NCT04185909|76111057|FG000|COMPLETED|Overall Study||54||
59995230|NCT04185909|76111057|FG000|NOT COMPLETED|Overall Study||1||
59618210|NCT00006156|75729465|FG001|NOT COMPLETED|Overall Study||0||
59618211|NCT03810534|75729474|FG000|STARTED|Standard of Care (5-10 Months)||40||
59618212|NCT03810534|75729475|FG001|STARTED|Standard of Care (5-10 Months)||46||
59618213|NCT03810534|75729476|FG002|STARTED|Standard of Care (5-10 Months)||54||
59618214|NCT03810534|75729477|FG003|STARTED|Standard of Care (5-10 Months)||62||
59618215|NCT03810534|75729478|FG004|STARTED|Standard of Care (5-10 Months)||34||
59618216|NCT03810534|75729479|FG005|STARTED|Standard of Care (5-10 Months)||88||
59618217|NCT03810534|75729474|FG000|Patients Started|Standard of Care (5-10 Months)||20||
59618218|NCT03810534|75729475|FG001|Patients Started|Standard of Care (5-10 Months)||23||
59618219|NCT03810534|75729476|FG002|Patients Started|Standard of Care (5-10 Months)||27||
59618220|NCT03810534|75729477|FG003|Patients Started|Standard of Care (5-10 Months)||31||
59618221|NCT03810534|75729478|FG004|Patients Started|Standard of Care (5-10 Months)||17||
59618222|NCT03810534|75729479|FG005|Patients Started|Standard of Care (5-10 Months)||44||
59618223|NCT03810534|75729474|FG000|Caregivers Started|Standard of Care (5-10 Months)||20||
59618224|NCT03810534|75729475|FG001|Caregivers Started|Standard of Care (5-10 Months)||23||
59618225|NCT03810534|75729476|FG002|Caregivers Started|Standard of Care (5-10 Months)||27||
59618226|NCT03810534|75729477|FG003|Caregivers Started|Standard of Care (5-10 Months)||31||
59618227|NCT03810534|75729478|FG004|Caregivers Started|Standard of Care (5-10 Months)||17||
59618228|NCT03810534|75729479|FG005|Caregivers Started|Standard of Care (5-10 Months)||44||
59618229|NCT03810534|75729474|FG000|Completed 7-day (Patients)|Standard of Care (5-10 Months)||16||
59618230|NCT03810534|75729475|FG001|Completed 7-day (Patients)|Standard of Care (5-10 Months)||20||
59618231|NCT03810534|75729476|FG002|Completed 7-day (Patients)|Standard of Care (5-10 Months)||23||
59618232|NCT03810534|75729477|FG003|Completed 7-day (Patients)|Standard of Care (5-10 Months)||29||
59618233|NCT03810534|75729478|FG004|Completed 7-day (Patients)|Standard of Care (5-10 Months)||13||
59618234|NCT03810534|75729479|FG005|Completed 7-day (Patients)|Standard of Care (5-10 Months)||40||
59618235|NCT03810534|75729474|FG000|Completed 7-Day (Caregivers)|Standard of Care (5-10 Months)||18||
59618236|NCT03810534|75729475|FG001|Completed 7-Day (Caregivers)|Standard of Care (5-10 Months)||21||
59618237|NCT03810534|75729476|FG002|Completed 7-Day (Caregivers)|Standard of Care (5-10 Months)||23||
59618238|NCT03810534|75729477|FG003|Completed 7-Day (Caregivers)|Standard of Care (5-10 Months)||29||
59618239|NCT03810534|75729478|FG004|Completed 7-Day (Caregivers)|Standard of Care (5-10 Months)||13||
59618240|NCT03810534|75729479|FG005|Completed 7-Day (Caregivers)|Standard of Care (5-10 Months)||38||
59618241|NCT03810534|75729474|FG000|Completed 30-day (Patients)|Standard of Care (5-10 Months)||14||
59618242|NCT03810534|75729475|FG001|Completed 30-day (Patients)|Standard of Care (5-10 Months)||16||
59618243|NCT03810534|75729476|FG002|Completed 30-day (Patients)|Standard of Care (5-10 Months)||21||
59618244|NCT03810534|75729477|FG003|Completed 30-day (Patients)|Standard of Care (5-10 Months)||23||
59618245|NCT03810534|75729478|FG004|Completed 30-day (Patients)|Standard of Care (5-10 Months)||12||
59618246|NCT03810534|75729479|FG005|Completed 30-day (Patients)|Standard of Care (5-10 Months)||38||
59618247|NCT03810534|75729474|FG000|Completed 30-Day (Caregivers)|Standard of Care (5-10 Months)||14||
59618248|NCT03810534|75729475|FG001|Completed 30-Day (Caregivers)|Standard of Care (5-10 Months)||16||
59618249|NCT03810534|75729476|FG002|Completed 30-Day (Caregivers)|Standard of Care (5-10 Months)||21||
59618250|NCT03810534|75729477|FG003|Completed 30-Day (Caregivers)|Standard of Care (5-10 Months)||23||
59618251|NCT03810534|75729478|FG004|Completed 30-Day (Caregivers)|Standard of Care (5-10 Months)||10||
59618252|NCT03810534|75729479|FG005|Completed 30-Day (Caregivers)|Standard of Care (5-10 Months)||32||
59618253|NCT03810534|75729474|FG000|Completed 60-Day (Patients)|Standard of Care (5-10 Months)||10||
59618254|NCT03810534|75729475|FG001|Completed 60-Day (Patients)|Standard of Care (5-10 Months)||16||
59618255|NCT03810534|75729476|FG002|Completed 60-Day (Patients)|Standard of Care (5-10 Months)||17||
59618256|NCT03810534|75729477|FG003|Completed 60-Day (Patients)|Standard of Care (5-10 Months)||20||
59618257|NCT03810534|75729478|FG004|Completed 60-Day (Patients)|Standard of Care (5-10 Months)||10||
59618258|NCT03810534|75729479|FG005|Completed 60-Day (Patients)|Standard of Care (5-10 Months)||32||
59618259|NCT03810534|75729474|FG000|Completed 60-Day (Caregivers)|Standard of Care (5-10 Months)||10||
59618260|NCT03810534|75729475|FG001|Completed 60-Day (Caregivers)|Standard of Care (5-10 Months)||16||
59618261|NCT03810534|75729476|FG002|Completed 60-Day (Caregivers)|Standard of Care (5-10 Months)||15||
59618262|NCT03810534|75729477|FG003|Completed 60-Day (Caregivers)|Standard of Care (5-10 Months)||20||
59618263|NCT03810534|75729478|FG004|Completed 60-Day (Caregivers)|Standard of Care (5-10 Months)||9||
59618264|NCT03810534|75729479|FG005|Completed 60-Day (Caregivers)|Standard of Care (5-10 Months)||31||
59769832|NCT00818454|75890079|FG003|STARTED|Treatment Period 2||0||
59769833|NCT00818454|75890076|FG000|COMPLETED|Treatment Period 2||106||
59769834|NCT00818454|75890077|FG001|COMPLETED|Treatment Period 2||106||
59769835|NCT00818454|75890078|FG002|COMPLETED|Treatment Period 2||0||
59769836|NCT00818454|75890079|FG003|COMPLETED|Treatment Period 2||0||
59769837|NCT00818454|75890076|FG000|NOT COMPLETED|Treatment Period 2||2||
59769838|NCT00818454|75890077|FG001|NOT COMPLETED|Treatment Period 2||1||
59769839|NCT00818454|75890078|FG002|NOT COMPLETED|Treatment Period 2||0||
59769840|NCT00818454|75890079|FG003|NOT COMPLETED|Treatment Period 2||0||
59769841|NCT00818454|75890076|FG000|STARTED|Treatment Period 3||0||
59769842|NCT00818454|75890077|FG001|STARTED|Treatment Period 3||0||
59769843|NCT00818454|75890078|FG002|STARTED|Treatment Period 3||26||
59769844|NCT00818454|75890079|FG003|STARTED|Treatment Period 3||139||
59769845|NCT00818454|75890076|FG000|COMPLETED|Treatment Period 3||0||
59769846|NCT00818454|75890077|FG001|COMPLETED|Treatment Period 3||0||
59769847|NCT00818454|75890078|FG002|COMPLETED|Treatment Period 3||26||
59769848|NCT00818454|75890079|FG003|COMPLETED|Treatment Period 3||138||
59769849|NCT00818454|75890076|FG000|NOT COMPLETED|Treatment Period 3||0||
59769850|NCT00818454|75890077|FG001|NOT COMPLETED|Treatment Period 3||0||
59769851|NCT00818454|75890078|FG002|NOT COMPLETED|Treatment Period 3||0||
59769852|NCT00818454|75890079|FG003|NOT COMPLETED|Treatment Period 3||1||
59769853|NCT00828984|75890092|FG000|STARTED|Overall Study||28||
59769854|NCT00828984|75890093|FG001|STARTED|Overall Study||31||
59769855|NCT00828984|75890094|FG002|STARTED|Overall Study||28||
59769856|NCT00828984|75890092|FG000|Randomization|Overall Study||28||
59769857|NCT00828984|75890093|FG001|Randomization|Overall Study||31||
59769858|NCT00828984|75890094|FG002|Randomization|Overall Study||28||
59769859|NCT00828984|75890092|FG000|Treatment|Overall Study||24||
59769860|NCT00828984|75890093|FG001|Treatment|Overall Study||26||
59769861|NCT00828984|75890094|FG002|Treatment|Overall Study||24||
59769862|NCT00828984|75890092|FG000|Flexible Sigmoidoscopy|Overall Study||20||
59769863|NCT00828984|75890093|FG001|Flexible Sigmoidoscopy|Overall Study||19||
59769864|NCT00828984|75890094|FG002|Flexible Sigmoidoscopy|Overall Study||19||
59769865|NCT00828984|75890092|FG000|Post Intervention Follow-Up|Overall Study||15||
59769866|NCT00828984|75890093|FG001|Post Intervention Follow-Up|Overall Study||16||
59769867|NCT00828984|75890094|FG002|Post Intervention Follow-Up|Overall Study||19||
59769868|NCT00828984|75890092|FG000|COMPLETED|Overall Study||14||
59769869|NCT00828984|75890093|FG001|COMPLETED|Overall Study||15||
59769870|NCT00828984|75890094|FG002|COMPLETED|Overall Study||19||
59769871|NCT00828984|75890092|FG000|NOT COMPLETED|Overall Study||14||
59769872|NCT00828984|75890093|FG001|NOT COMPLETED|Overall Study||16||
59769873|NCT00828984|75890094|FG002|NOT COMPLETED|Overall Study||9||
59769874|NCT00828750|75890102|FG000|STARTED|Overall Study||19||
59769875|NCT00828750|75890102|FG000|COMPLETED|Overall Study||15||
59769876|NCT00828750|75890102|FG000|NOT COMPLETED|Overall Study||4||
59769877|NCT00667810|75890111|FG000|STARTED|Overall Study||269||
59769878|NCT00667810|75890112|FG001|STARTED|Overall Study||264||
59769879|NCT00667810|75890113|FG002|STARTED|Overall Study||346||
59769880|NCT00667810|75890114|FG003|STARTED|Overall Study||11||
59769881|NCT00667810|75890111|FG000|Treated|Overall Study||267||
59769882|NCT00667810|75890112|FG001|Treated|Overall Study||263||
59769883|NCT00667810|75890113|FG002|Treated|Overall Study||344||
59769884|NCT00667810|75890114|FG003|Treated|Overall Study||11||
59769885|NCT00667810|75890111|FG000|COMPLETED|Overall Study||102||
59769886|NCT00667810|75890112|FG001|COMPLETED|Overall Study||94||
59769887|NCT00667810|75890113|FG002|COMPLETED|Overall Study||124||
59769888|NCT00667810|75890114|FG003|COMPLETED|Overall Study||9||
59769889|NCT00667810|75890111|FG000|NOT COMPLETED|Overall Study||167||
59769890|NCT00667810|75890112|FG001|NOT COMPLETED|Overall Study||170||
59769891|NCT00667810|75890113|FG002|NOT COMPLETED|Overall Study||222||
59769892|NCT00667810|75890114|FG003|NOT COMPLETED|Overall Study||2||
59769893|NCT00819390|75890133|FG000|STARTED|Overall Study||16||
59769894|NCT00819390|75890134|FG001|STARTED|Overall Study||17||
59769895|NCT00819390|75890135|FG002|STARTED|Overall Study||18||
59769896|NCT00819390|75890136|FG003|STARTED|Overall Study||19||
59769897|NCT00819390|75890133|FG000|COMPLETED|Overall Study||13||
59769898|NCT00819390|75890134|FG001|COMPLETED|Overall Study||16||
59769899|NCT00819390|75890135|FG002|COMPLETED|Overall Study||17||
59769900|NCT00819390|75890136|FG003|COMPLETED|Overall Study||19||
59769901|NCT00819390|75890133|FG000|NOT COMPLETED|Overall Study||3||
59769902|NCT00819390|75890134|FG001|NOT COMPLETED|Overall Study||1||
59769903|NCT00819390|75890135|FG002|NOT COMPLETED|Overall Study||1||
59769904|NCT00819390|75890136|FG003|NOT COMPLETED|Overall Study||0||
59769905|NCT00876395|75890151|FG000|STARTED|Overall Study||480||
59769906|NCT00876395|75890152|FG001|STARTED|Overall Study||239||
59769907|NCT00876395|75890151|FG000|Untreated|Overall Study||8||
59769908|NCT00876395|75890152|FG001|Untreated|Overall Study||1||
59769909|NCT00876395|75890151|FG000|COMPLETED|Overall Study||0||
59769910|NCT00876395|75890152|FG001|COMPLETED|Overall Study||0||
59769911|NCT00876395|75890151|FG000|NOT COMPLETED|Overall Study||480||
59769912|NCT00876395|75890152|FG001|NOT COMPLETED|Overall Study||239||
59769913|NCT00594659|75890166|FG000|STARTED|Overall Study||29||
59769914|NCT00594659|75890167|FG001|STARTED|Overall Study||30||
59769915|NCT00594659|75890168|FG002|STARTED|Overall Study||16||
59769916|NCT00594659|75890166|FG000|COMPLETED|Overall Study||16||
59769917|NCT00594659|75890167|FG001|COMPLETED|Overall Study||21||
59769918|NCT00594659|75890168|FG002|COMPLETED|Overall Study||9||
59769919|NCT00594659|75890166|FG000|NOT COMPLETED|Overall Study||13||
59769920|NCT00594659|75890167|FG001|NOT COMPLETED|Overall Study||9||
59769921|NCT00594659|75890168|FG002|NOT COMPLETED|Overall Study||7||
59769922|NCT00667732|75890178|FG000|STARTED|Run -In (8 Weeks)||41||
59769923|NCT00667732|75890179|FG001|STARTED|Run -In (8 Weeks)||0||
59769924|NCT00667732|75890180|FG002|STARTED|Run -In (8 Weeks)||0||
59769925|NCT00667732|75890178|FG000|Participants Enrolled in Substudy|Run -In (8 Weeks)||20||
59769926|NCT00667732|75890179|FG001|Participants Enrolled in Substudy|Run -In (8 Weeks)||0||
59769927|NCT00667732|75890180|FG002|Participants Enrolled in Substudy|Run -In (8 Weeks)||0||
59769928|NCT00667732|75890178|FG000|COMPLETED|Run -In (8 Weeks)||34||
59769929|NCT00667732|75890179|FG001|COMPLETED|Run -In (8 Weeks)||0||
59769930|NCT00667732|75890180|FG002|COMPLETED|Run -In (8 Weeks)||0||
59769931|NCT00667732|75890178|FG000|NOT COMPLETED|Run -In (8 Weeks)||7||
59769932|NCT00667732|75890179|FG001|NOT COMPLETED|Run -In (8 Weeks)||0||
59769933|NCT00667732|75890180|FG002|NOT COMPLETED|Run -In (8 Weeks)||0||
59769934|NCT00667732|75890178|FG000|STARTED|Randomization (24 Weeks)||0||
59769935|NCT00667732|75890179|FG001|STARTED|Randomization (24 Weeks)||17||
59769936|NCT00667732|75890180|FG002|STARTED|Randomization (24 Weeks)||17||
59769937|NCT00667732|75890178|FG000|Participants Enrolled in Substudy|Randomization (24 Weeks)||0||
59769938|NCT00667732|75890179|FG001|Participants Enrolled in Substudy|Randomization (24 Weeks)||11||
59769939|NCT00667732|75890180|FG002|Participants Enrolled in Substudy|Randomization (24 Weeks)||9||
59769940|NCT00667732|75890178|FG000|COMPLETED|Randomization (24 Weeks)||0||
59769941|NCT00667732|75890179|FG001|COMPLETED|Randomization (24 Weeks)||16||
59769942|NCT00667732|75890180|FG002|COMPLETED|Randomization (24 Weeks)||17||
59769943|NCT00667732|75890178|FG000|NOT COMPLETED|Randomization (24 Weeks)||0||
59769944|NCT00667732|75890179|FG001|NOT COMPLETED|Randomization (24 Weeks)||1||
59769945|NCT00667732|75890180|FG002|NOT COMPLETED|Randomization (24 Weeks)||0||
59769946|NCT00667732|75890178|FG000|STARTED|Extension (26 Weeks)||0||
59769947|NCT00667732|75890179|FG001|STARTED|Extension (26 Weeks)||14||
59769948|NCT00667732|75890180|FG002|STARTED|Extension (26 Weeks)||17||
59769949|NCT00667732|75890178|FG000|COMPLETED|Extension (26 Weeks)||0||
59769950|NCT00667732|75890179|FG001|COMPLETED|Extension (26 Weeks)||14||
59769951|NCT00667732|75890180|FG002|COMPLETED|Extension (26 Weeks)||17||
59769952|NCT00667732|75890178|FG000|NOT COMPLETED|Extension (26 Weeks)||0||
59769953|NCT00667732|75890179|FG001|NOT COMPLETED|Extension (26 Weeks)||0||
59769954|NCT00667732|75890180|FG002|NOT COMPLETED|Extension (26 Weeks)||0||
59769955|NCT00671788|75890190|FG000|STARTED|Overall Study||35||
59769956|NCT00671788|75890190|FG000|COMPLETED|Overall Study|Patients treated until disease progression; completed defined as off treatment due to progression.|21||
59769957|NCT00671788|75890190|FG000|NOT COMPLETED|Overall Study||14||
59769958|NCT00875615|75890194|FG000|STARTED|Overall Study||11||
59769959|NCT00875615|75890194|FG000|COMPLETED|Overall Study||10||
59769960|NCT00875615|75890194|FG000|NOT COMPLETED|Overall Study||1||
59769961|NCT00597701|75890200|FG000|STARTED|Overall Study||25||
59769962|NCT00597701|75890201|FG001|STARTED|Overall Study||21||
59769963|NCT00597701|75890200|FG000|COMPLETED|Overall Study||18||
59769964|NCT00597701|75890201|FG001|COMPLETED|Overall Study||13||
59769965|NCT00597701|75890200|FG000|NOT COMPLETED|Overall Study||7||
59769966|NCT00597701|75890201|FG001|NOT COMPLETED|Overall Study||8||
59769967|NCT00671554|75890207|FG000|STARTED|Overall Study||3||
59769968|NCT00671554|75890207|FG000|COMPLETED|Overall Study||0||
59769969|NCT00671554|75890207|FG000|NOT COMPLETED|Overall Study||3||
59769970|NCT00667576|75890217|FG000|STARTED|Overall Study||30||
59769971|NCT00667576|75890218|FG001|STARTED|Overall Study||31||
59769972|NCT00667576|75890219|FG002|STARTED|Overall Study||31||
59769973|NCT00667576|75890220|FG003|STARTED|Overall Study||31||
59769974|NCT00667576|75890221|FG004|STARTED|Overall Study||30||
59769975|NCT00667576|75890217|FG000|COMPLETED|Overall Study||28||
59769976|NCT00667576|75890218|FG001|COMPLETED|Overall Study||30||
59769977|NCT00667576|75890219|FG002|COMPLETED|Overall Study||29||
59769978|NCT00667576|75890220|FG003|COMPLETED|Overall Study||27||
59769979|NCT00667576|75890221|FG004|COMPLETED|Overall Study||29||
59769980|NCT00667576|75890217|FG000|NOT COMPLETED|Overall Study||2||
59521634|NCT00971633|75615906|FG000|NOT COMPLETED|Period 1||0||
59521635|NCT00971633|75615907|FG001|NOT COMPLETED|Period 1||0||
59521636|NCT00971633|75615908|FG002|NOT COMPLETED|Period 1||0||
59521637|NCT00971633|75615909|FG003|NOT COMPLETED|Period 1||0||
59521638|NCT00971633|75615910|FG004|NOT COMPLETED|Period 1||0||
59521639|NCT00971633|75615911|FG005|NOT COMPLETED|Period 1||0||
59521640|NCT00971633|75615906|FG000|STARTED|Period 2||2||
59521641|NCT00971633|75615907|FG001|STARTED|Period 2||2||
59521642|NCT00971633|75615908|FG002|STARTED|Period 2||2||
59521643|NCT00971633|75615909|FG003|STARTED|Period 2||2||
59521644|NCT00971633|75615910|FG004|STARTED|Period 2||2||
59521645|NCT00971633|75615911|FG005|STARTED|Period 2||2||
59521646|NCT00971633|75615906|FG000|COMPLETED|Period 2||2||
59521647|NCT00971633|75615907|FG001|COMPLETED|Period 2||2||
59521648|NCT00971633|75615908|FG002|COMPLETED|Period 2||2||
59521649|NCT00971633|75615909|FG003|COMPLETED|Period 2||2||
59521650|NCT00971633|75615910|FG004|COMPLETED|Period 2||2||
59521651|NCT00971633|75615911|FG005|COMPLETED|Period 2||2||
59521652|NCT00971633|75615906|FG000|NOT COMPLETED|Period 2||0||
59521653|NCT00971633|75615907|FG001|NOT COMPLETED|Period 2||0||
59521654|NCT00971633|75615908|FG002|NOT COMPLETED|Period 2||0||
59521655|NCT00971633|75615909|FG003|NOT COMPLETED|Period 2||0||
59521656|NCT00971633|75615910|FG004|NOT COMPLETED|Period 2||0||
59521657|NCT00971633|75615911|FG005|NOT COMPLETED|Period 2||0||
59521658|NCT00971633|75615906|FG000|STARTED|Period 3||2||
59521659|NCT00971633|75615907|FG001|STARTED|Period 3||2||
59521660|NCT00971633|75615908|FG002|STARTED|Period 3||2||
59521661|NCT00971633|75615909|FG003|STARTED|Period 3||2||
59521662|NCT00971633|75615910|FG004|STARTED|Period 3||2||
59521663|NCT00971633|75615911|FG005|STARTED|Period 3||2||
59521664|NCT00971633|75615906|FG000|COMPLETED|Period 3||2||
59521665|NCT00971633|75615907|FG001|COMPLETED|Period 3||2||
59521666|NCT00971633|75615908|FG002|COMPLETED|Period 3||2||
59521667|NCT00971633|75615909|FG003|COMPLETED|Period 3||2||
59521668|NCT00971633|75615910|FG004|COMPLETED|Period 3||2||
59521669|NCT00971633|75615911|FG005|COMPLETED|Period 3||2||
59521670|NCT00971633|75615906|FG000|NOT COMPLETED|Period 3||0||
59521671|NCT00971633|75615907|FG001|NOT COMPLETED|Period 3||0||
59521672|NCT00971633|75615908|FG002|NOT COMPLETED|Period 3||0||
59521673|NCT00971633|75615909|FG003|NOT COMPLETED|Period 3||0||
59521674|NCT00971633|75615910|FG004|NOT COMPLETED|Period 3||0||
59521675|NCT00971633|75615911|FG005|NOT COMPLETED|Period 3||0||
59521676|NCT00971789|75615919|FG000|STARTED|Overall Study||18||
59521677|NCT00971789|75615919|FG000|COMPLETED|Overall Study||18||
59521678|NCT00971789|75615919|FG000|NOT COMPLETED|Overall Study||0||
59521679|NCT00972335|75615923|FG000|STARTED|Overall Study|One patient was enrolled but showed no evidence of disease at study entry and was not treated|17||
59618265|NCT03810534|75729474|FG000|COMPLETED|Standard of Care (5-10 Months)||20||
59521680|NCT00972335|75615923|FG000|COMPLETED|Overall Study|Patients were on study until an event or condition occured which required them to come off study|0||
59521681|NCT00972335|75615923|FG000|NOT COMPLETED|Overall Study||17||
59521682|NCT02337530|75615930|FG000|STARTED|Overall Study||20||
59521683|NCT02337530|75615931|FG001|STARTED|Overall Study||21||
59521684|NCT02337530|75615932|FG002|STARTED|Overall Study||21||
59521685|NCT02337530|75615930|FG000|COMPLETED|Overall Study||20||
59521686|NCT02337530|75615931|FG001|COMPLETED|Overall Study||21||
59521687|NCT02337530|75615932|FG002|COMPLETED|Overall Study||21||
59521688|NCT02337530|75615930|FG000|NOT COMPLETED|Overall Study||0||
59521689|NCT02337530|75615931|FG001|NOT COMPLETED|Overall Study||0||
59521690|NCT02337530|75615932|FG002|NOT COMPLETED|Overall Study||0||
59521691|NCT02569242|75615942|FG000|STARTED|Overall Study|Included in intention-to-treat analysis for overall survival and progression-free survival|210|Enrolled and randomly assigned|
59521692|NCT02569242|75615943|FG001|STARTED|Overall Study|Included in intention-to-treat analysis for overall survival and progression-free survival|209|Enrolled and randomly assigned|
59521693|NCT02569242|75615942|FG000|COMPLETED|Overall Study|Analysed for safety|209|Received assigned treatment of IMP|
59521694|NCT02569242|75615943|FG001|COMPLETED|Overall Study|Analysed for safety|208|Received assigned treatment of IMP|
59521695|NCT02569242|75615942|FG000|NOT COMPLETED|Overall Study||1||
59521696|NCT02569242|75615943|FG001|NOT COMPLETED|Overall Study||1||
59521697|NCT00972725|75615951|FG000|STARTED|Overall Study||13||
59521698|NCT00972725|75615952|FG001|STARTED|Overall Study||15||
59521699|NCT00972725|75615951|FG000|COMPLETED|Overall Study||13||
59521700|NCT00972725|75615952|FG001|COMPLETED|Overall Study||15||
59521701|NCT00972725|75615951|FG000|NOT COMPLETED|Overall Study||0||
59521702|NCT00972725|75615952|FG001|NOT COMPLETED|Overall Study||0||
59521703|NCT00972959|75615958|FG000|STARTED|Overall Study||17||
59521704|NCT00972959|75615958|FG000|COMPLETED|Overall Study||17||
59521705|NCT00972959|75615958|FG000|NOT COMPLETED|Overall Study||0||
59521706|NCT00973739|75615962|FG000|STARTED|Overall Study||21||
59521707|NCT00973739|75615962|FG000|COMPLETED|Overall Study||17||
59521708|NCT00973739|75615962|FG000|NOT COMPLETED|Overall Study||4||
59521709|NCT00974051|75615966|FG000|STARTED|Overall Study||6||
59521710|NCT00974051|75615967|FG001|STARTED|Overall Study||4||
59521711|NCT00974051|75615968|FG002|STARTED|Overall Study||6||
59521712|NCT00974051|75615966|FG000|COMPLETED|Overall Study||6||
59521713|NCT00974051|75615967|FG001|COMPLETED|Overall Study||4||
59618266|NCT03810534|75729475|FG001|COMPLETED|Standard of Care (5-10 Months)||32||
59769981|NCT00667576|75890218|FG001|NOT COMPLETED|Overall Study||1||
59769982|NCT00667576|75890219|FG002|NOT COMPLETED|Overall Study||2||
59769983|NCT00667576|75890220|FG003|NOT COMPLETED|Overall Study||4||
59769984|NCT00667576|75890221|FG004|NOT COMPLETED|Overall Study||1||
59769985|NCT00666718|75890235|FG000|STARTED|Overall Study||187||
59769986|NCT00666718|75890236|FG001|STARTED|Overall Study||187||
59769987|NCT00666718|75890235|FG000|COMPLETED|Overall Study||175||
59769988|NCT00666718|75890236|FG001|COMPLETED|Overall Study||169||
59769989|NCT00666718|75890235|FG000|NOT COMPLETED|Overall Study||12||
59769990|NCT00666718|75890236|FG001|NOT COMPLETED|Overall Study||18||
59769991|NCT00667420|75890242|FG000|STARTED|Overall Study||17||
59769992|NCT00667420|75890242|FG000|Completion of Pre-operative EOX-P|Overall Study||15||
59769993|NCT00667420|75890242|FG000|Completion of Surgery/Re-staging|Overall Study||11||
59769994|NCT00667420|75890242|FG000|COMPLETED|Overall Study||7||
59769995|NCT00667420|75890242|FG000|NOT COMPLETED|Overall Study||10||
59769996|NCT00853658|75890250|FG000|STARTED|Overall Study||2354||
59769997|NCT00853658|75890251|FG001|STARTED|Overall Study||2356||
59769998|NCT00853658|75890252|FG002|STARTED|Overall Study||2354||
59769999|NCT00853658|75890250|FG000|Full Analysis Set (FAS)|Overall Study||2340||
59770000|NCT00853658|75890251|FG001|Full Analysis Set (FAS)|Overall Study||2340||
59770001|NCT00853658|75890252|FG002|Full Analysis Set (FAS)|Overall Study||2336||
59770002|NCT00853658|75890250|FG000|Safety Set|Overall Study||2347||
59770003|NCT00853658|75890251|FG001|Safety Set|Overall Study||2348||
59770004|NCT00853658|75890252|FG002|Safety Set|Overall Study||2345||
59770005|NCT00853658|75890250|FG000|COMPLETED|Overall Study||1567||
59770006|NCT00853658|75890251|FG001|COMPLETED|Overall Study||1524||
59770007|NCT00853658|75890252|FG002|COMPLETED|Overall Study||1539||
59770008|NCT00853658|75890250|FG000|NOT COMPLETED|Overall Study||787||
59770009|NCT00853658|75890251|FG001|NOT COMPLETED|Overall Study||832||
59770010|NCT00853658|75890252|FG002|NOT COMPLETED|Overall Study||815||
59770011|NCT00666562|75890263|FG000|STARTED|Overall Study||11||
59770012|NCT00666562|75890264|FG001|STARTED|Overall Study||10||
59770013|NCT00666562|75890265|FG002|STARTED|Overall Study||10||
59770014|NCT00666562|75890263|FG000|COMPLETED|Overall Study||11||
59770015|NCT00666562|75890264|FG001|COMPLETED|Overall Study||8||
59770016|NCT00666562|75890265|FG002|COMPLETED|Overall Study||10||
59770017|NCT00666562|75890263|FG000|NOT COMPLETED|Overall Study||0||
59770018|NCT00666562|75890264|FG001|NOT COMPLETED|Overall Study||2||
59770019|NCT00666562|75890265|FG002|NOT COMPLETED|Overall Study||0||
59770020|NCT00666328|75890280|FG000|STARTED|Overall Study|Safety population: participants dosed with study drug (primary population for Safety analyses)|35||
59770021|NCT00666328|75890280|FG000|Modified Intent To Treat (mITT)|Overall Study|mITT population: participants dosed and in whom all inclusion and no exclusion criteria were met|33||
59521714|NCT00974051|75615968|FG002|COMPLETED|Overall Study||6||
59770022|NCT00666328|75890280|FG000|COMPLETED|Overall Study|30/35 completed the study within the Safety population; 28/33 completed within the mITT population.|30||
59770023|NCT00666328|75890280|FG000|NOT COMPLETED|Overall Study||5||
59770024|NCT00853580|75890288|FG000|STARTED|Overall Study||74||
59770025|NCT00853580|75890289|FG001|STARTED|Overall Study||72||
59770026|NCT00853580|75890288|FG000|COMPLETED|Overall Study||67||
59770027|NCT00853580|75890289|FG001|COMPLETED|Overall Study||56||
59770028|NCT00853580|75890288|FG000|NOT COMPLETED|Overall Study||7||
59770029|NCT00853580|75890289|FG001|NOT COMPLETED|Overall Study||16||
59770030|NCT00865514|75890295|FG000|STARTED|Overall Study||2||
59770031|NCT00865514|75890295|FG000|COMPLETED|Overall Study||0||
59770032|NCT00865514|75890295|FG000|NOT COMPLETED|Overall Study||2||
59770033|NCT00865280|75890302|FG000|STARTED|Overall Study||70||
59770034|NCT00865280|75890303|FG001|STARTED|Overall Study||73||
59770035|NCT00865280|75890302|FG000|COMPLETED|Overall Study||64||
59770036|NCT00865280|75890303|FG001|COMPLETED|Overall Study||70||
59770037|NCT00865280|75890302|FG000|NOT COMPLETED|Overall Study||6||
59770038|NCT00865280|75890303|FG001|NOT COMPLETED|Overall Study||3||
59770039|NCT00865124|75890312|FG000|STARTED|Overall Study||27||
59770040|NCT00865124|75890313|FG001|STARTED|Overall Study||25||
59770041|NCT00865124|75890314|FG002|STARTED|Overall Study||17||
59770042|NCT00865124|75890312|FG000|COMPLETED|Overall Study||23||
59770043|NCT00865124|75890313|FG001|COMPLETED|Overall Study||24||
59770044|NCT00865124|75890314|FG002|COMPLETED|Overall Study||17||
59770045|NCT00865124|75890312|FG000|NOT COMPLETED|Overall Study||4||
59770046|NCT00865124|75890313|FG001|NOT COMPLETED|Overall Study||1||
59770047|NCT00865124|75890314|FG002|NOT COMPLETED|Overall Study||0||
59521715|NCT00974051|75615966|FG000|NOT COMPLETED|Overall Study||0||
59770048|NCT00871715|75890325|FG000|STARTED|Overall Study||119||
59952617|NCT00412932|76071451|FG000|NOT COMPLETED|Olm+Hydrochlorothiazide 12.5 mg||6||
59521716|NCT00974051|75615967|FG001|NOT COMPLETED|Overall Study||0||
59521717|NCT00974051|75615968|FG002|NOT COMPLETED|Overall Study||0||
59770049|NCT00871715|75890326|FG001|STARTED|Overall Study||120||
59770050|NCT00871715|75890327|FG002|STARTED|Overall Study||122||
59770051|NCT00871715|75890325|FG000|Post-Intervention|Overall Study||112||
59770052|NCT00871715|75890326|FG001|Post-Intervention|Overall Study||115||
59770053|NCT00871715|75890327|FG002|Post-Intervention|Overall Study||115||
59770054|NCT00871715|75890325|FG000|6-mo Follow-up|Overall Study||110||
59770055|NCT00871715|75890326|FG001|6-mo Follow-up|Overall Study||113||
59770056|NCT00871715|75890327|FG002|6-mo Follow-up|Overall Study||112||
59770057|NCT00871715|75890325|FG000|COMPLETED|Overall Study|"Completed refers to participants who completed the primary outcome, Wolf Motor Function Test."|104||
59770058|NCT00871715|75890326|FG001|COMPLETED|Overall Study|"Completed refers to participants who completed the primary outcome, Wolf Motor Function Test."|104||
59770059|NCT00871715|75890327|FG002|COMPLETED|Overall Study|"Completed refers to participants who completed the primary outcome, Wolf Motor Function Test."|96||
59770060|NCT00871715|75890325|FG000|NOT COMPLETED|Overall Study||15||
59770061|NCT00871715|75890326|FG001|NOT COMPLETED|Overall Study||16||
59770062|NCT00871715|75890327|FG002|NOT COMPLETED|Overall Study||26||
59770063|NCT00819234|75890336|FG000|STARTED|Overall Study||31||
59770064|NCT00819234|75890337|FG001|STARTED|Overall Study||35||
59770065|NCT00819234|75890338|FG002|STARTED|Overall Study||36||
59770066|NCT00819234|75890339|FG003|STARTED|Overall Study||28||
59770067|NCT00819234|75890340|FG004|STARTED|Overall Study||13||
59770068|NCT00819234|75890341|FG005|STARTED|Overall Study||14||
59770069|NCT00819234|75890342|FG006|STARTED|Overall Study||13||
59770070|NCT00819234|75890343|FG007|STARTED|Overall Study||29||
59770071|NCT00819234|75890344|FG008|STARTED|Overall Study||37||
59770072|NCT00819234|75890345|FG009|STARTED|Overall Study||37||
59770073|NCT00819234|75890336|FG000|COMPLETED|Overall Study||21||
59770074|NCT00819234|75890337|FG001|COMPLETED|Overall Study||20||
59770075|NCT00819234|75890338|FG002|COMPLETED|Overall Study||28||
59770076|NCT00819234|75890339|FG003|COMPLETED|Overall Study||22||
59770077|NCT00819234|75890340|FG004|COMPLETED|Overall Study||12||
59770078|NCT00819234|75890341|FG005|COMPLETED|Overall Study||7||
59770079|NCT00819234|75890342|FG006|COMPLETED|Overall Study||8||
59770080|NCT00819234|75890343|FG007|COMPLETED|Overall Study||20||
59770081|NCT00819234|75890344|FG008|COMPLETED|Overall Study||31||
59770082|NCT00819234|75890345|FG009|COMPLETED|Overall Study||30||
59770083|NCT00819234|75890336|FG000|NOT COMPLETED|Overall Study||10||
59770084|NCT00819234|75890337|FG001|NOT COMPLETED|Overall Study||15||
59770085|NCT00819234|75890338|FG002|NOT COMPLETED|Overall Study||8||
59770086|NCT00819234|75890339|FG003|NOT COMPLETED|Overall Study||6||
59770087|NCT00819234|75890340|FG004|NOT COMPLETED|Overall Study||1||
59770088|NCT00819234|75890341|FG005|NOT COMPLETED|Overall Study||7||
59770089|NCT00819234|75890342|FG006|NOT COMPLETED|Overall Study||5||
59770090|NCT00819234|75890343|FG007|NOT COMPLETED|Overall Study||9||
59770091|NCT00819234|75890344|FG008|NOT COMPLETED|Overall Study||6||
59770092|NCT00819234|75890345|FG009|NOT COMPLETED|Overall Study||7||
59770093|NCT00871403|75890403|FG000|STARTED|Combination Treatment Phase||9||
59770094|NCT00871403|75890404|FG001|STARTED|Combination Treatment Phase||62||
59770095|NCT00871403|75890405|FG002|STARTED|Combination Treatment Phase||35||
59770096|NCT00871403|75890403|FG000|COMPLETED|Combination Treatment Phase|No particiapants completed Combination Treatement.|0||
59770097|NCT00871403|75890404|FG001|COMPLETED|Combination Treatment Phase|These participants completed combination treatment|13||
59770098|NCT00871403|75890405|FG002|COMPLETED|Combination Treatment Phase|These participants completed combination treatment|23||
59770099|NCT00871403|75890403|FG000|NOT COMPLETED|Combination Treatment Phase||9||
59770100|NCT00871403|75890404|FG001|NOT COMPLETED|Combination Treatment Phase||49||
59770101|NCT00871403|75890405|FG002|NOT COMPLETED|Combination Treatment Phase||12||
59770102|NCT00871403|75890403|FG000|STARTED|Monotherapy Treatment Phase||0||
59770103|NCT00871403|75890404|FG001|STARTED|Monotherapy Treatment Phase||13||
59770104|NCT00871403|75890405|FG002|STARTED|Monotherapy Treatment Phase||1||
59770105|NCT00871403|75890403|FG000|COMPLETED|Monotherapy Treatment Phase||0||
59770106|NCT00871403|75890404|FG001|COMPLETED|Monotherapy Treatment Phase||0||
59770107|NCT00871403|75890405|FG002|COMPLETED|Monotherapy Treatment Phase||0||
59770108|NCT00871403|75890403|FG000|NOT COMPLETED|Monotherapy Treatment Phase||0||
59770109|NCT00871403|75890404|FG001|NOT COMPLETED|Monotherapy Treatment Phase||13||
59770110|NCT00871403|75890405|FG002|NOT COMPLETED|Monotherapy Treatment Phase||1||
59770111|NCT00853112|75890419|FG000|STARTED|Overall Study||6||
59770112|NCT00853112|75890420|FG001|STARTED|Overall Study||7||
59770113|NCT00853112|75890421|FG002|STARTED|Overall Study||7||
59770114|NCT00853112|75890422|FG003|STARTED|Overall Study||8||
59770115|NCT00853112|75890423|FG004|STARTED|Overall Study||6||
59770116|NCT00853112|75890424|FG005|STARTED|Overall Study||7||
59770117|NCT00853112|75890425|FG006|STARTED|Overall Study||7||
59770118|NCT00853112|75890419|FG000|Treated|Overall Study||6||
59770119|NCT00853112|75890420|FG001|Treated|Overall Study||6||
59770120|NCT00853112|75890421|FG002|Treated|Overall Study||7||
59770121|NCT00853112|75890422|FG003|Treated|Overall Study||6||
59770122|NCT00853112|75890423|FG004|Treated|Overall Study||6||
59770123|NCT00853112|75890424|FG005|Treated|Overall Study||7||
59770124|NCT00853112|75890425|FG006|Treated|Overall Study||6||
59770125|NCT00853112|75890419|FG000|COMPLETED|Overall Study||6||
59770126|NCT00853112|75890420|FG001|COMPLETED|Overall Study||6||
59770127|NCT00853112|75890421|FG002|COMPLETED|Overall Study||7||
59770128|NCT00853112|75890422|FG003|COMPLETED|Overall Study||6||
59770129|NCT00853112|75890423|FG004|COMPLETED|Overall Study||6||
59770130|NCT00853112|75890424|FG005|COMPLETED|Overall Study||7||
59770131|NCT00853112|75890425|FG006|COMPLETED|Overall Study||6||
59770132|NCT00853112|75890419|FG000|NOT COMPLETED|Overall Study||0||
59770133|NCT00853112|75890420|FG001|NOT COMPLETED|Overall Study||1||
59770134|NCT00853112|75890421|FG002|NOT COMPLETED|Overall Study||0||
59770135|NCT00853112|75890422|FG003|NOT COMPLETED|Overall Study||2||
59770136|NCT00853112|75890423|FG004|NOT COMPLETED|Overall Study||0||
59770137|NCT00853112|75890424|FG005|NOT COMPLETED|Overall Study||0||
59770138|NCT00853112|75890425|FG006|NOT COMPLETED|Overall Study||1||
59770139|NCT00460603|75890453|FG000|STARTED|Phase 1||6||
59770140|NCT00460603|75890454|FG001|STARTED|Phase 1||6||
59770141|NCT00460603|75890455|FG002|STARTED|Phase 1||4||
59770142|NCT00460603|75890456|FG003|STARTED|Phase 1||8||
59770143|NCT00460603|75890457|FG004|STARTED|Phase 1||6||
59770144|NCT00460603|75890458|FG005|STARTED|Phase 1||4||
59770145|NCT00460603|75890459|FG006|STARTED|Phase 1||6||
59770146|NCT00460603|75890460|FG007|STARTED|Phase 1||3||
59770147|NCT00460603|75890461|FG008|STARTED|Phase 1||18||
59770148|NCT00460603|75890462|FG009|STARTED|Phase 1||0||
59770149|NCT00460603|75890463|FG010|STARTED|Phase 1||0||
59770150|NCT00460603|75890464|FG011|STARTED|Phase 1||0||
59770151|NCT00460603|75890453|FG000|COMPLETED|Phase 1||0||
59770152|NCT00460603|75890454|FG001|COMPLETED|Phase 1||0||
59770153|NCT00460603|75890455|FG002|COMPLETED|Phase 1||0||
59770154|NCT00460603|75890456|FG003|COMPLETED|Phase 1||0||
59770155|NCT00460603|75890457|FG004|COMPLETED|Phase 1||0||
59770156|NCT00460603|75890458|FG005|COMPLETED|Phase 1||0||
59770157|NCT00460603|75890459|FG006|COMPLETED|Phase 1||0||
59770158|NCT00460603|75890460|FG007|COMPLETED|Phase 1||0||
59770159|NCT00460603|75890461|FG008|COMPLETED|Phase 1||0||
59770160|NCT00460603|75890462|FG009|COMPLETED|Phase 1||0||
59770161|NCT00460603|75890463|FG010|COMPLETED|Phase 1||0||
59770162|NCT00460603|75890464|FG011|COMPLETED|Phase 1||0||
59770163|NCT00460603|75890453|FG000|NOT COMPLETED|Phase 1||6||
59770164|NCT00460603|75890454|FG001|NOT COMPLETED|Phase 1||6||
59770165|NCT00460603|75890455|FG002|NOT COMPLETED|Phase 1||4||
59770166|NCT00460603|75890456|FG003|NOT COMPLETED|Phase 1||8||
59770167|NCT00460603|75890457|FG004|NOT COMPLETED|Phase 1||6||
59770168|NCT00460603|75890458|FG005|NOT COMPLETED|Phase 1||4||
59770169|NCT00460603|75890459|FG006|NOT COMPLETED|Phase 1||6||
59770170|NCT00460603|75890460|FG007|NOT COMPLETED|Phase 1||3||
59770171|NCT00460603|75890461|FG008|NOT COMPLETED|Phase 1||18||
59770172|NCT00460603|75890462|FG009|NOT COMPLETED|Phase 1||0||
59770173|NCT00460603|75890463|FG010|NOT COMPLETED|Phase 1||0||
59770174|NCT00460603|75890464|FG011|NOT COMPLETED|Phase 1||0||
59770175|NCT00460603|75890453|FG000|STARTED|Phase 2||0||
59770176|NCT00460603|75890454|FG001|STARTED|Phase 2||0||
59770177|NCT00460603|75890455|FG002|STARTED|Phase 2||0||
59770178|NCT00460603|75890456|FG003|STARTED|Phase 2||0||
59770179|NCT00460603|75890457|FG004|STARTED|Phase 2||0||
59770180|NCT00460603|75890458|FG005|STARTED|Phase 2||0||
59770181|NCT00460603|75890459|FG006|STARTED|Phase 2||0||
59770182|NCT00460603|75890460|FG007|STARTED|Phase 2||0||
59770183|NCT00460603|75890461|FG008|STARTED|Phase 2||0||
59770184|NCT00460603|75890462|FG009|STARTED|Phase 2||42||
59770185|NCT00460603|75890463|FG010|STARTED|Phase 2||43||
59770186|NCT00460603|75890464|FG011|STARTED|Phase 2||41||
59770187|NCT00460603|75890453|FG000|Treated|Phase 2||0||
59770188|NCT00460603|75890454|FG001|Treated|Phase 2||0||
59770189|NCT00460603|75890455|FG002|Treated|Phase 2||0||
59770190|NCT00460603|75890456|FG003|Treated|Phase 2||0||
59770191|NCT00460603|75890457|FG004|Treated|Phase 2||0||
59770192|NCT00460603|75890458|FG005|Treated|Phase 2||0||
59770193|NCT00460603|75890459|FG006|Treated|Phase 2||0||
59770194|NCT00460603|75890460|FG007|Treated|Phase 2||0||
59952618|NCT00412932|76071451|FG000|STARTED|Olm+ Hydrochlorothiazide 25 mg|153 -28 met their blood pressure goal (stayed on olmesartan 40/hydrochlorothiazide 12.5) = 125|125||
59952619|NCT00412932|76071451|FG000|COMPLETED|Olm+ Hydrochlorothiazide 25 mg||123||
59952620|NCT00412932|76071451|FG000|NOT COMPLETED|Olm+ Hydrochlorothiazide 25 mg||2||
59952621|NCT02696031|76071457|FG000|STARTED|Up to Week 24||185||
59770195|NCT00460603|75890461|FG008|Treated|Phase 2||0||
59770196|NCT00460603|75890462|FG009|Treated|Phase 2||39||
59770197|NCT00460603|75890463|FG010|Treated|Phase 2||43||
59770198|NCT00460603|75890464|FG011|Treated|Phase 2||41||
59770199|NCT00460603|75890453|FG000|COMPLETED|Phase 2||0||
59770200|NCT00460603|75890454|FG001|COMPLETED|Phase 2||0||
59770201|NCT00460603|75890455|FG002|COMPLETED|Phase 2||0||
59770202|NCT00460603|75890456|FG003|COMPLETED|Phase 2||0||
59770203|NCT00460603|75890457|FG004|COMPLETED|Phase 2||0||
59770204|NCT00460603|75890458|FG005|COMPLETED|Phase 2||0||
59770205|NCT00460603|75890459|FG006|COMPLETED|Phase 2||0||
59770206|NCT00460603|75890460|FG007|COMPLETED|Phase 2||0||
59770207|NCT00460603|75890461|FG008|COMPLETED|Phase 2||0||
59770208|NCT00460603|75890462|FG009|COMPLETED|Phase 2||0||
59770209|NCT00460603|75890463|FG010|COMPLETED|Phase 2||0||
59770210|NCT00460603|75890464|FG011|COMPLETED|Phase 2||0||
59770211|NCT00460603|75890453|FG000|NOT COMPLETED|Phase 2||0||
59770212|NCT00460603|75890454|FG001|NOT COMPLETED|Phase 2||0||
59770213|NCT00460603|75890455|FG002|NOT COMPLETED|Phase 2||0||
59770214|NCT00460603|75890456|FG003|NOT COMPLETED|Phase 2||0||
59952622|NCT02696031|76071458|FG001|STARTED|Up to Week 24||184||
59770215|NCT00460603|75890457|FG004|NOT COMPLETED|Phase 2||0||
59770216|NCT00460603|75890458|FG005|NOT COMPLETED|Phase 2||0||
59770217|NCT00460603|75890459|FG006|NOT COMPLETED|Phase 2||0||
59770218|NCT00460603|75890460|FG007|NOT COMPLETED|Phase 2||0||
59770219|NCT00460603|75890461|FG008|NOT COMPLETED|Phase 2||0||
59770220|NCT00460603|75890462|FG009|NOT COMPLETED|Phase 2||42||
59770221|NCT00460603|75890463|FG010|NOT COMPLETED|Phase 2||43||
59770222|NCT00460603|75890464|FG011|NOT COMPLETED|Phase 2||41||
59618267|NCT03810534|75729476|FG002|COMPLETED|Standard of Care (5-10 Months)||32||
59618268|NCT03810534|75729477|FG003|COMPLETED|Standard of Care (5-10 Months)||40||
59618269|NCT03810534|75729478|FG004|COMPLETED|Standard of Care (5-10 Months)||19||
59618270|NCT03810534|75729479|FG005|COMPLETED|Standard of Care (5-10 Months)||63||
59618271|NCT03810534|75729474|FG000|NOT COMPLETED|Standard of Care (5-10 Months)||20||
59618272|NCT03810534|75729475|FG001|NOT COMPLETED|Standard of Care (5-10 Months)||14||
59618273|NCT03810534|75729476|FG002|NOT COMPLETED|Standard of Care (5-10 Months)||22||
59618274|NCT03810534|75729477|FG003|NOT COMPLETED|Standard of Care (5-10 Months)||22||
59618275|NCT03810534|75729478|FG004|NOT COMPLETED|Standard of Care (5-10 Months)||15||
59618276|NCT03810534|75729479|FG005|NOT COMPLETED|Standard of Care (5-10 Months)||25||
59618277|NCT03810534|75729474|FG000|STARTED|Pre-Implementation Phase (2 Months)||0||
59618278|NCT03810534|75729475|FG001|STARTED|Pre-Implementation Phase (2 Months)||0||
59618279|NCT03810534|75729476|FG002|STARTED|Pre-Implementation Phase (2 Months)||0||
59618280|NCT03810534|75729477|FG003|STARTED|Pre-Implementation Phase (2 Months)||0||
59618281|NCT03810534|75729478|FG004|STARTED|Pre-Implementation Phase (2 Months)||0||
59618282|NCT03810534|75729479|FG005|STARTED|Pre-Implementation Phase (2 Months)||0||
59618283|NCT03810534|75729474|FG000|Patients Started|Pre-Implementation Phase (2 Months)||0||
59618284|NCT03810534|75729475|FG001|Patients Started|Pre-Implementation Phase (2 Months)||0||
59618285|NCT03810534|75729476|FG002|Patients Started|Pre-Implementation Phase (2 Months)||0||
59618286|NCT03810534|75729477|FG003|Patients Started|Pre-Implementation Phase (2 Months)||0||
59618287|NCT03810534|75729478|FG004|Patients Started|Pre-Implementation Phase (2 Months)||0||
59618288|NCT03810534|75729479|FG005|Patients Started|Pre-Implementation Phase (2 Months)||0||
59618289|NCT03810534|75729474|FG000|Caregivers Started|Pre-Implementation Phase (2 Months)||0||
59618290|NCT03810534|75729475|FG001|Caregivers Started|Pre-Implementation Phase (2 Months)||0||
59618291|NCT03810534|75729476|FG002|Caregivers Started|Pre-Implementation Phase (2 Months)||0||
59618292|NCT03810534|75729477|FG003|Caregivers Started|Pre-Implementation Phase (2 Months)||0||
59618293|NCT03810534|75729478|FG004|Caregivers Started|Pre-Implementation Phase (2 Months)||0||
59618294|NCT03810534|75729479|FG005|Caregivers Started|Pre-Implementation Phase (2 Months)||0||
59618295|NCT03810534|75729474|FG000|Completed 7-Day (Patients)|Pre-Implementation Phase (2 Months)||0||
59618296|NCT03810534|75729475|FG001|Completed 7-Day (Patients)|Pre-Implementation Phase (2 Months)||0||
59618297|NCT03810534|75729476|FG002|Completed 7-Day (Patients)|Pre-Implementation Phase (2 Months)||0||
59618298|NCT03810534|75729477|FG003|Completed 7-Day (Patients)|Pre-Implementation Phase (2 Months)||0||
59618299|NCT03810534|75729478|FG004|Completed 7-Day (Patients)|Pre-Implementation Phase (2 Months)||0||
59618300|NCT03810534|75729479|FG005|Completed 7-Day (Patients)|Pre-Implementation Phase (2 Months)||0||
59618301|NCT03810534|75729474|FG000|Completed 7-Day (Caregivers)|Pre-Implementation Phase (2 Months)||0||
59618302|NCT03810534|75729475|FG001|Completed 7-Day (Caregivers)|Pre-Implementation Phase (2 Months)||0||
59618303|NCT03810534|75729476|FG002|Completed 7-Day (Caregivers)|Pre-Implementation Phase (2 Months)||0||
59618304|NCT03810534|75729477|FG003|Completed 7-Day (Caregivers)|Pre-Implementation Phase (2 Months)||0||
59618305|NCT03810534|75729478|FG004|Completed 7-Day (Caregivers)|Pre-Implementation Phase (2 Months)||0||
59618306|NCT03810534|75729479|FG005|Completed 7-Day (Caregivers)|Pre-Implementation Phase (2 Months)||0||
59618307|NCT03810534|75729474|FG000|Completed 30-Day (Patients)|Pre-Implementation Phase (2 Months)||0||
59618308|NCT03810534|75729475|FG001|Completed 30-Day (Patients)|Pre-Implementation Phase (2 Months)||0||
59618309|NCT03810534|75729476|FG002|Completed 30-Day (Patients)|Pre-Implementation Phase (2 Months)||0||
59618310|NCT03810534|75729477|FG003|Completed 30-Day (Patients)|Pre-Implementation Phase (2 Months)||0||
59618311|NCT03810534|75729478|FG004|Completed 30-Day (Patients)|Pre-Implementation Phase (2 Months)||0||
59618312|NCT03810534|75729479|FG005|Completed 30-Day (Patients)|Pre-Implementation Phase (2 Months)||0||
59618313|NCT03810534|75729474|FG000|Completed 30-Day (Caregivers)|Pre-Implementation Phase (2 Months)||0||
59618314|NCT03810534|75729475|FG001|Completed 30-Day (Caregivers)|Pre-Implementation Phase (2 Months)||0||
59618315|NCT03810534|75729476|FG002|Completed 30-Day (Caregivers)|Pre-Implementation Phase (2 Months)||0||
59618316|NCT03810534|75729477|FG003|Completed 30-Day (Caregivers)|Pre-Implementation Phase (2 Months)||0||
59618317|NCT03810534|75729478|FG004|Completed 30-Day (Caregivers)|Pre-Implementation Phase (2 Months)||0||
59618318|NCT03810534|75729479|FG005|Completed 30-Day (Caregivers)|Pre-Implementation Phase (2 Months)||0||
59618319|NCT03810534|75729474|FG000|Completed 60-Day (Patients)|Pre-Implementation Phase (2 Months)||0||
59618320|NCT03810534|75729475|FG001|Completed 60-Day (Patients)|Pre-Implementation Phase (2 Months)||0||
59618321|NCT03810534|75729476|FG002|Completed 60-Day (Patients)|Pre-Implementation Phase (2 Months)||0||
59618322|NCT03810534|75729477|FG003|Completed 60-Day (Patients)|Pre-Implementation Phase (2 Months)||0||
59618323|NCT03810534|75729478|FG004|Completed 60-Day (Patients)|Pre-Implementation Phase (2 Months)||0||
59618324|NCT03810534|75729479|FG005|Completed 60-Day (Patients)|Pre-Implementation Phase (2 Months)||0||
59618325|NCT03810534|75729474|FG000|Completed 60-Day (Caregivers)|Pre-Implementation Phase (2 Months)||0||
59618326|NCT03810534|75729475|FG001|Completed 60-Day (Caregivers)|Pre-Implementation Phase (2 Months)||0||
59618327|NCT03810534|75729476|FG002|Completed 60-Day (Caregivers)|Pre-Implementation Phase (2 Months)||0||
59618328|NCT03810534|75729477|FG003|Completed 60-Day (Caregivers)|Pre-Implementation Phase (2 Months)||0||
59618329|NCT03810534|75729478|FG004|Completed 60-Day (Caregivers)|Pre-Implementation Phase (2 Months)||0||
59618330|NCT03810534|75729479|FG005|Completed 60-Day (Caregivers)|Pre-Implementation Phase (2 Months)||0||
59709528|NCT01241591|75828278|FG002|NOT COMPLETED|Overall Study||22||
59770223|NCT00662038|75890490|FG000|STARTED|Overall Study||1058||
59770224|NCT00662038|75890490|FG000|COMPLETED|Overall Study||427||
59770225|NCT00662038|75890490|FG000|NOT COMPLETED|Overall Study||631||
59770226|NCT00459979|75890494|FG000|STARTED|Overall Study||30||
59770227|NCT00459979|75890494|FG000|COMPLETED|Overall Study||28||
59770228|NCT00459979|75890494|FG000|NOT COMPLETED|Overall Study||2||
59770229|NCT00851786|75890500|FG000|STARTED|Overall Study|One subject cannot adhere to protocol requirement and was off study with no vaccine.|296||
59770230|NCT00851786|75890501|FG001|STARTED|Overall Study|Two subjects (one found ineligible and one withdrew consent) were off study with no vaccine.|99||
59770231|NCT00851786|75890500|FG000|COMPLETED|Overall Study||291||
59770232|NCT00851786|75890501|FG001|COMPLETED|Overall Study||97||
59770233|NCT00851786|75890500|FG000|NOT COMPLETED|Overall Study||5||
59770234|NCT00851786|75890501|FG001|NOT COMPLETED|Overall Study||2||
59770235|NCT00665626|75890509|FG000|STARTED|Overall Study|Participants randomized|73||
59770236|NCT00665626|75890510|FG001|STARTED|Overall Study|Participants randomized|146||
59770237|NCT00665626|75890509|FG000|COMPLETED|Overall Study|Participants completed the study|63||
59770238|NCT00665626|75890510|FG001|COMPLETED|Overall Study|Participants completed the study|124||
59770239|NCT00665626|75890509|FG000|NOT COMPLETED|Overall Study||10||
59770240|NCT00665626|75890510|FG001|NOT COMPLETED|Overall Study||22||
59770241|NCT00828672|75890518|FG000|STARTED|Pre-treatment (Baseline)||43||
59770242|NCT00828672|75890519|FG001|STARTED|Pre-treatment (Baseline)||41||
59770243|NCT00828672|75890518|FG000|COMPLETED|Pre-treatment (Baseline)||43||
59770244|NCT00828672|75890519|FG001|COMPLETED|Pre-treatment (Baseline)||41||
59770245|NCT00828672|75890518|FG000|NOT COMPLETED|Pre-treatment (Baseline)||0||
59770246|NCT00828672|75890519|FG001|NOT COMPLETED|Pre-treatment (Baseline)||0||
59770247|NCT00828672|75890518|FG000|STARTED|Study Treatment||43||
59770248|NCT00828672|75890519|FG001|STARTED|Study Treatment||41||
59770249|NCT00828672|75890518|FG000|COMPLETED|Study Treatment||41||
59770250|NCT00828672|75890519|FG001|COMPLETED|Study Treatment||39||
59770251|NCT00828672|75890518|FG000|NOT COMPLETED|Study Treatment||2||
59770252|NCT00828672|75890519|FG001|NOT COMPLETED|Study Treatment||2||
59770253|NCT00828672|75890518|FG000|STARTED|Post-surgery (<30 Days)||41||
59770254|NCT00828672|75890519|FG001|STARTED|Post-surgery (<30 Days)||39||
59770255|NCT00828672|75890518|FG000|COMPLETED|Post-surgery (<30 Days)||41||
59770256|NCT00828672|75890519|FG001|COMPLETED|Post-surgery (<30 Days)||38||
59770257|NCT00828672|75890518|FG000|NOT COMPLETED|Post-surgery (<30 Days)||0||
59770258|NCT00828672|75890519|FG001|NOT COMPLETED|Post-surgery (<30 Days)||1||
59770259|NCT00828672|75890518|FG000|STARTED|Follow-up|Patient in Arm 1 with clinical complete response and no surgery is in follow up (joined this period)|42|Pt with compl response&no surgery and pts with no central review material and with AEs joined in FU|
59770260|NCT00828672|75890519|FG001|STARTED|Follow-up|Patients with no central review material and with adverse event are in followup (joined this period)|41|Pt with compl response&no surgery and pts with no central review material and with AEs joined in FU|
59770261|NCT00828672|75890518|FG000|COMPLETED|Follow-up||42||
59770262|NCT00828672|75890519|FG001|COMPLETED|Follow-up||41||
59770263|NCT00828672|75890518|FG000|NOT COMPLETED|Follow-up||0||
59770264|NCT00828672|75890519|FG001|NOT COMPLETED|Follow-up||0||
59770265|NCT00873119|75890527|FG000|STARTED|Overall Study||44||
59770266|NCT00873119|75890528|FG001|STARTED|Overall Study||45||
59770267|NCT00873119|75890527|FG000|COMPLETED|Overall Study|Of 42 patients treated with belinostat, 23 patients received 6 or more treatment cycles.|0||
59770268|NCT00873119|75890528|FG001|COMPLETED|Overall Study||19||
59770269|NCT00873119|75890527|FG000|NOT COMPLETED|Overall Study||44||
59521718|NCT00974363|75615979|FG000|STARTED|Overall Study||521||
59521719|NCT00974363|75615980|FG001|STARTED|Overall Study||168||
59521720|NCT00974363|75615979|FG000|COMPLETED|Overall Study||521||
59770270|NCT00873119|75890528|FG001|NOT COMPLETED|Overall Study||26||
59770271|NCT00661726|75890534|FG000|STARTED|Overall Study||6||
59770272|NCT00661726|75890534|FG000|COMPLETED|Overall Study||5||
59770273|NCT00661726|75890534|FG000|NOT COMPLETED|Overall Study||1||
59770274|NCT00865046|75890541|FG000|STARTED|Overall Study||63||
59770275|NCT00865046|75890542|FG001|STARTED|Overall Study||64||
59770276|NCT00865046|75890543|FG002|STARTED|Overall Study||63||
59770277|NCT00865046|75890541|FG000|COMPLETED|Overall Study||57||
59770278|NCT00865046|75890542|FG001|COMPLETED|Overall Study||59||
59770279|NCT00865046|75890543|FG002|COMPLETED|Overall Study||62||
59770280|NCT00865046|75890541|FG000|NOT COMPLETED|Overall Study||6||
59521721|NCT00974363|75615980|FG001|COMPLETED|Overall Study||168||
59770281|NCT00865046|75890542|FG001|NOT COMPLETED|Overall Study||5||
59770282|NCT00865046|75890543|FG002|NOT COMPLETED|Overall Study||1||
59770283|NCT00828516|75890551|FG000|STARTED|Clinical Phase: Series 1||35||
59770284|NCT00828516|75890551|FG000|COMPLETED|Clinical Phase: Series 1||33||
59521722|NCT00974363|75615979|FG000|NOT COMPLETED|Overall Study||0||
59521723|NCT00974363|75615980|FG001|NOT COMPLETED|Overall Study||0||
59770285|NCT00828516|75890551|FG000|NOT COMPLETED|Clinical Phase: Series 1||2||
59770286|NCT00828516|75890551|FG000|STARTED|Clinical Phase: Series 2||30||
59770287|NCT00828516|75890551|FG000|COMPLETED|Clinical Phase: Series 2||30||
59770288|NCT00828516|75890551|FG000|NOT COMPLETED|Clinical Phase: Series 2||0||
59770289|NCT00665392|75890555|FG000|STARTED|Overall Study||42||
59770290|NCT00665392|75890555|FG000|COMPLETED|Overall Study||41||
59521724|NCT00977171|75615986|FG000|STARTED|Overall Study||3||
59521725|NCT00977171|75615986|FG000|COMPLETED|Overall Study||3||
59770291|NCT00665392|75890555|FG000|NOT COMPLETED|Overall Study||1||
59770292|NCT00851630|75890562|FG000|STARTED|Overall Study||35||
59770293|NCT00851630|75890563|FG001|STARTED|Overall Study||35||
59770294|NCT00851630|75890562|FG000|COMPLETED|Overall Study||33||
59770295|NCT00851630|75890563|FG001|COMPLETED|Overall Study||33||
59770296|NCT00851630|75890562|FG000|NOT COMPLETED|Overall Study||2||
59770297|NCT00851630|75890563|FG001|NOT COMPLETED|Overall Study||2||
59770298|NCT00459667|75890572|FG000|STARTED|Overall Study||592||
59770299|NCT00459667|75890573|FG001|STARTED|Overall Study||647||
59770300|NCT00459667|75890574|FG002|STARTED|Overall Study||181||
59770301|NCT00459667|75890572|FG000|Study Medication Dispensed|Overall Study||586||
59770302|NCT00459667|75890573|FG001|Study Medication Dispensed|Overall Study||645||
59770303|NCT00459667|75890574|FG002|Study Medication Dispensed|Overall Study||180||
59770304|NCT00459667|75890572|FG000|Started Treatment|Overall Study||586||
59770305|NCT00459667|75890573|FG001|Started Treatment|Overall Study||644||
59770306|NCT00459667|75890574|FG002|Started Treatment|Overall Study||180||
59770307|NCT00459667|75890572|FG000|COMPLETED|Overall Study||554||
59770308|NCT00459667|75890573|FG001|COMPLETED|Overall Study||600||
59770309|NCT00459667|75890574|FG002|COMPLETED|Overall Study||161||
59770310|NCT00459667|75890572|FG000|NOT COMPLETED|Overall Study||38||
59770311|NCT00459667|75890573|FG001|NOT COMPLETED|Overall Study||47||
59770312|NCT00459667|75890574|FG002|NOT COMPLETED|Overall Study||20||
59770313|NCT00828204|75890584|FG000|STARTED|Main Study: Prior to Study Suspension||21||
59770314|NCT00828204|75890585|FG001|STARTED|Main Study: Prior to Study Suspension|Main Subset was not enrolled until after study suspension (period 2, below).|0||
59770315|NCT00828204|75890584|FG000|Completed Manual Injection|Main Study: Prior to Study Suspension||21||
59770316|NCT00828204|75890585|FG001|Completed Manual Injection|Main Study: Prior to Study Suspension||0||
59770317|NCT00828204|75890584|FG000|Continued With Autoinjector Injections|Main Study: Prior to Study Suspension||19||
59770318|NCT00828204|75890585|FG001|Continued With Autoinjector Injections|Main Study: Prior to Study Suspension||0||
59770319|NCT00828204|75890584|FG000|COMPLETED|Main Study: Prior to Study Suspension||7||
59770320|NCT00828204|75890585|FG001|COMPLETED|Main Study: Prior to Study Suspension||0||
59770321|NCT00828204|75890584|FG000|NOT COMPLETED|Main Study: Prior to Study Suspension||14||
59770322|NCT00828204|75890585|FG001|NOT COMPLETED|Main Study: Prior to Study Suspension||0||
59770323|NCT00828204|75890584|FG000|STARTED|Main Study: After Study Restart|Initial Subset participants did not continue after the study was suspended.|0||
59770324|NCT00828204|75890585|FG001|STARTED|Main Study: After Study Restart|After a protocol amendment, the Main Subset participants were enrolled.|74||
59770325|NCT00828204|75890584|FG000|Completed Manual Injection|Main Study: After Study Restart||0||
59770326|NCT00828204|75890585|FG001|Completed Manual Injection|Main Study: After Study Restart||74||
59770327|NCT00828204|75890584|FG000|Continued With Autoinjector Injections|Main Study: After Study Restart||0||
59770328|NCT00828204|75890585|FG001|Continued With Autoinjector Injections|Main Study: After Study Restart||72||
59770329|NCT00828204|75890584|FG000|COMPLETED|Main Study: After Study Restart||0||
59770330|NCT00828204|75890585|FG001|COMPLETED|Main Study: After Study Restart||71||
59770331|NCT00828204|75890584|FG000|NOT COMPLETED|Main Study: After Study Restart||0||
59770332|NCT00828204|75890585|FG001|NOT COMPLETED|Main Study: After Study Restart||3||
59770333|NCT00828204|75890584|FG000|STARTED|Extension Study|Participation in the Extension Study was not offered to Initial Subset after completing Main Study.|0||
59770334|NCT00828204|75890585|FG001|STARTED|Extension Study|Participation in Extension Study was optional for Main Subset participants completing Main Study.|64||
59770335|NCT00828204|75890584|FG000|COMPLETED|Extension Study||0||
59770336|NCT00828204|75890585|FG001|COMPLETED|Extension Study||61||
59770337|NCT00828204|75890584|FG000|NOT COMPLETED|Extension Study||0||
59770338|NCT00828204|75890585|FG001|NOT COMPLETED|Extension Study||3||
59770339|NCT00851552|75890592|FG000|STARTED|Overall Study||9||
59770340|NCT00851552|75890592|FG000|COMPLETED|Overall Study||2||
59770341|NCT00851552|75890592|FG000|NOT COMPLETED|Overall Study||7||
59770342|NCT00459355|75890598|FG000|STARTED|Overall Study|Includes 70 dyads, caregiver/care-recipient|140||
59770343|NCT00459355|75890599|FG001|STARTED|Overall Study|Includes 57 dyads, caregiver + care-recipient|114||
59770344|NCT00459355|75890598|FG000|COMPLETED|Overall Study|Includes 60 dyads, caregiver + care-recipient|120||
59770345|NCT00459355|75890599|FG001|COMPLETED|Overall Study|Includes 48 dyads, caregiver + care-recipient|96||
59770346|NCT00459355|75890598|FG000|NOT COMPLETED|Overall Study||20||
59770347|NCT00459355|75890599|FG001|NOT COMPLETED|Overall Study||18||
59770348|NCT00459043|75890611|FG000|STARTED|Overall Study||15||
59770349|NCT00459043|75890612|FG001|STARTED|Overall Study||15||
59770350|NCT00459043|75890611|FG000|COMPLETED|Overall Study||14||
59770351|NCT00459043|75890612|FG001|COMPLETED|Overall Study||15||
59770352|NCT00459043|75890611|FG000|NOT COMPLETED|Overall Study||1||
59770353|NCT00459043|75890612|FG001|NOT COMPLETED|Overall Study||0||
59770354|NCT00817206|75890620|FG000|STARTED|Overall Study||163||
59770355|NCT00817206|75890621|FG001|STARTED|Overall Study||163||
59770356|NCT00817206|75890620|FG000|COMPLETED|Overall Study||142||
59770357|NCT00817206|75890621|FG001|COMPLETED|Overall Study||154||
59770358|NCT00817206|75890620|FG000|NOT COMPLETED|Overall Study||21||
59770359|NCT00817206|75890621|FG001|NOT COMPLETED|Overall Study||9||
59770360|NCT00665002|75890627|FG000|STARTED|Overall Study||16||
59770361|NCT00665002|75890627|FG000|COMPLETED|Overall Study||4||
59770362|NCT00665002|75890627|FG000|NOT COMPLETED|Overall Study||12||
59770363|NCT03847987|75890633|FG000|STARTED|Overall Study||16||
59770364|NCT03847987|75890634|FG001|STARTED|Overall Study||8||
59770365|NCT03847987|75890633|FG000|COMPLETED|Overall Study||13||
59770366|NCT03847987|75890634|FG001|COMPLETED|Overall Study||8||
59770367|NCT03847987|75890633|FG000|NOT COMPLETED|Overall Study||3||
59770368|NCT03847987|75890634|FG001|NOT COMPLETED|Overall Study||0||
59770369|NCT00660010|75890651|FG000|STARTED|Overall Study||55||
59770370|NCT00660010|75890651|FG000|COMPLETED|Overall Study||46||
59770371|NCT00660010|75890651|FG000|NOT COMPLETED|Overall Study||9||
59770372|NCT00873041|75890658|FG000|STARTED|Core Study||55||
59770373|NCT00873041|75890659|FG001|STARTED|Core Study||55||
59770374|NCT00873041|75890660|FG002|STARTED|Core Study||56||
59770375|NCT00873041|75890658|FG000|COMPLETED|Core Study||48||
59770376|NCT00873041|75890659|FG001|COMPLETED|Core Study||49||
59770377|NCT00873041|75890660|FG002|COMPLETED|Core Study||51||
59770378|NCT00873041|75890658|FG000|NOT COMPLETED|Core Study||7||
59770379|NCT00873041|75890659|FG001|NOT COMPLETED|Core Study||6||
59770380|NCT00873041|75890660|FG002|NOT COMPLETED|Core Study||5||
59770381|NCT00873041|75890658|FG000|STARTED|Extension Study||41||
59770382|NCT00873041|75890659|FG001|STARTED|Extension Study||44||
59770383|NCT00873041|75890660|FG002|STARTED|Extension Study||48||
59770384|NCT00873041|75890658|FG000|COMPLETED|Extension Study||40||
59770385|NCT00873041|75890659|FG001|COMPLETED|Extension Study||44||
59952623|NCT02696031|76071459|FG002|STARTED|Up to Week 24||186||
59770386|NCT00873041|75890660|FG002|COMPLETED|Extension Study||46||
59770387|NCT00873041|75890658|FG000|NOT COMPLETED|Extension Study||1||
59770388|NCT00873041|75890659|FG001|NOT COMPLETED|Extension Study||0||
59770389|NCT00873041|75890660|FG002|NOT COMPLETED|Extension Study||2||
59770390|NCT00458341|75890677|FG000|STARTED|Cycle 1||15|Cycle 1: from first dose of PTC124 through day before first dosing date in Cycle 2.|
59770391|NCT00458341|75890678|FG001|STARTED|Cycle 1||15|Cycle 1: from first dose of PTC124 through day before first dosing date in Cycle 2.|
59770392|NCT00458341|75890677|FG000|Received at Least 1 Dose of Study Drug|Cycle 1||15||
59770393|NCT00458341|75890678|FG001|Received at Least 1 Dose of Study Drug|Cycle 1||15||
59770394|NCT00458341|75890677|FG000|COMPLETED|Cycle 1|1 participant did not complete Cycle 1 since all procedures were not performed due to adverse event.|14||
59770395|NCT00458341|75890678|FG001|COMPLETED|Cycle 1||15||
59770396|NCT00458341|75890677|FG000|NOT COMPLETED|Cycle 1||1||
59770397|NCT00458341|75890678|FG001|NOT COMPLETED|Cycle 1||0||
59770398|NCT00458341|75890677|FG000|STARTED|Cycle 2|The participant who did not complete Cycle 1 was eligible for Cycle 2 and completed Cycle 2.|15|Cycle 2: first dosing date after 2-week rest period in Cycle 1 through end-of-study follow-up.|
59770399|NCT00458341|75890678|FG001|STARTED|Cycle 2||15|Cycle 2: first dosing date after 2-week rest period in Cycle 1 through end-of-study follow-up.|
59770400|NCT00458341|75890677|FG000|Received at Least 1 Dose of Study Drug|Cycle 2||15||
59770401|NCT00458341|75890678|FG001|Received at Least 1 Dose of Study Drug|Cycle 2||15||
59770402|NCT00458341|75890677|FG000|COMPLETED|Cycle 2||15||
59770403|NCT00458341|75890678|FG001|COMPLETED|Cycle 2||15||
59770404|NCT00458341|75890677|FG000|NOT COMPLETED|Cycle 2||0||
59770405|NCT00458341|75890678|FG001|NOT COMPLETED|Cycle 2||0||
59770406|NCT00816036|75890686|FG000|STARTED|Overall Study||503||
59770407|NCT00816036|75890687|FG001|STARTED|Overall Study||395||
59770408|NCT00816036|75890686|FG000|COMPLETED|Overall Study||327||
59770409|NCT00816036|75890687|FG001|COMPLETED|Overall Study||287||
59770410|NCT00816036|75890686|FG000|NOT COMPLETED|Overall Study||176||
59770411|NCT00816036|75890687|FG001|NOT COMPLETED|Overall Study||108||
59770412|NCT00664534|75890695|FG000|STARTED|Overall Study||173||
59770413|NCT00664534|75890696|FG001|STARTED|Overall Study||171||
59770414|NCT00664534|75890695|FG000|COMPLETED|Overall Study||132||
59770415|NCT00664534|75890696|FG001|COMPLETED|Overall Study||138||
59770416|NCT00664534|75890695|FG000|NOT COMPLETED|Overall Study||41||
59770417|NCT00664534|75890696|FG001|NOT COMPLETED|Overall Study||33||
59770418|NCT00594035|75890704|FG000|STARTED|Overall Study|102 subjects were randomized to Spinal Sealant|102||
59770419|NCT00594035|75890705|FG001|STARTED|Overall Study|56 subjects were randomized to the control group (standard of care)|56||
59770420|NCT00594035|75890704|FG000|COMPLETED|Overall Study|100 Spinal Sealant subjects were evaluable at the 90-day visit|100||
59770421|NCT00594035|75890705|FG001|COMPLETED|Overall Study|53 control group subjects were evaluable at the 90-day visit|53||
59770422|NCT00594035|75890704|FG000|NOT COMPLETED|Overall Study||2||
59770423|NCT00594035|75890705|FG001|NOT COMPLETED|Overall Study||3||
59770424|NCT00570310|75890713|FG000|STARTED|Overall Study||53||
59770425|NCT00570310|75890714|FG001|STARTED|Overall Study||51||
59770426|NCT00570310|75890713|FG000|COMPLETED|Overall Study||51||
59770427|NCT00570310|75890714|FG001|COMPLETED|Overall Study||45||
59770428|NCT00570310|75890713|FG000|NOT COMPLETED|Overall Study||2||
59952624|NCT02696031|76071460|FG003|STARTED|Up to Week 24||0||
59952625|NCT02696031|76071461|FG004|STARTED|Up to Week 24||0||
59770429|NCT00570310|75890714|FG001|NOT COMPLETED|Overall Study||6||
59952626|NCT02696031|76071462|FG005|STARTED|Up to Week 24||0||
59952627|NCT02696031|76071457|FG000|COMPLETED|Up to Week 24||175|Completed week 24|
59770430|NCT00664066|75890720|FG000|STARTED|Overall Study||3||
59770431|NCT00664066|75890720|FG000|COMPLETED|Overall Study||0||
59770432|NCT00664066|75890720|FG000|NOT COMPLETED|Overall Study||3||
59770433|NCT00814710|75890726|FG000|STARTED|Overall Study||240||
59770434|NCT00814710|75890727|FG001|STARTED|Overall Study||120||
59995231|NCT04076943|76111061|FG000|STARTED|Overall Study||92||
59770435|NCT00814710|75890726|FG000|COMPLETED|Overall Study||232||
59770436|NCT00814710|75890727|FG001|COMPLETED|Overall Study||117||
59770437|NCT00814710|75890726|FG000|NOT COMPLETED|Overall Study||8||
59770438|NCT00814710|75890727|FG001|NOT COMPLETED|Overall Study||3||
59770439|NCT00871169|75890733|FG000|STARTED|Overall Study||61||
59770440|NCT00871169|75890733|FG000|COMPLETED|Overall Study||58||
59770441|NCT00871169|75890733|FG000|NOT COMPLETED|Overall Study||3||
59770442|NCT00814632|75890737|FG000|STARTED|Overall Study|Ten were allocated to treatment intervention however one was not treated due to lactose allergy.|9||
59770443|NCT00814632|75890737|FG000|COMPLETED|Overall Study|Two subjects withdrew early due to lack of efficacy.|7||
59770444|NCT00814632|75890737|FG000|NOT COMPLETED|Overall Study||2||
59770445|NCT00851318|75890745|FG000|STARTED|Overall Study||81||
59770446|NCT00851318|75890746|FG001|STARTED|Overall Study||19||
59770447|NCT00851318|75890747|FG002|STARTED|Overall Study||93||
59770448|NCT00851318|75890748|FG003|STARTED|Overall Study||92||
59770449|NCT00851318|75890745|FG000|Completed Week 24|Overall Study||69||
59770450|NCT00851318|75890746|FG001|Completed Week 24|Overall Study||17||
59770451|NCT00851318|75890747|FG002|Completed Week 24|Overall Study||90||
59770452|NCT00851318|75890748|FG003|Completed Week 24|Overall Study||87||
59770453|NCT00851318|75890745|FG000|Completed Week 52|Overall Study||64||
59770454|NCT00851318|75890746|FG001|Completed Week 52|Overall Study||16||
59770455|NCT00851318|75890747|FG002|Completed Week 52|Overall Study||87||
59770456|NCT00851318|75890748|FG003|Completed Week 52|Overall Study||85||
59770457|NCT00851318|75890745|FG000|COMPLETED|Overall Study||51||
59770458|NCT00851318|75890746|FG001|COMPLETED|Overall Study||14||
59770459|NCT00851318|75890747|FG002|COMPLETED|Overall Study||72||
59770460|NCT00851318|75890748|FG003|COMPLETED|Overall Study||73||
59770461|NCT00851318|75890745|FG000|NOT COMPLETED|Overall Study||30||
59770462|NCT00851318|75890746|FG001|NOT COMPLETED|Overall Study||5||
59770463|NCT00851318|75890747|FG002|NOT COMPLETED|Overall Study||21||
59770464|NCT00851318|75890748|FG003|NOT COMPLETED|Overall Study||19||
59770465|NCT00593957|75890761|FG000|STARTED|Overall Study||13||
59770466|NCT00593957|75890762|FG001|STARTED|Overall Study||13||
59770467|NCT00593957|75890763|FG002|STARTED|Overall Study||12||
59770468|NCT00593957|75890761|FG000|COMPLETED|Overall Study||13||
59770469|NCT00593957|75890762|FG001|COMPLETED|Overall Study||12||
59770470|NCT00593957|75890763|FG002|COMPLETED|Overall Study||10||
59770471|NCT00593957|75890761|FG000|NOT COMPLETED|Overall Study||0||
59770472|NCT00593957|75890762|FG001|NOT COMPLETED|Overall Study||1||
59770473|NCT00593957|75890763|FG002|NOT COMPLETED|Overall Study||2||
59770474|NCT00870233|75890785|FG000|STARTED|Overall Study||120||
59770475|NCT00870233|75890785|FG000|COMPLETED|Overall Study||96||
59770476|NCT00870233|75890785|FG000|NOT COMPLETED|Overall Study||24||
59770477|NCT00851084|75890792|FG000|STARTED|Overall Study||117||
59770478|NCT00851084|75890793|FG001|STARTED|Overall Study||119||
59770479|NCT00851084|75890792|FG000|COMPLETED|Overall Study|Participants continued treatment until they met treatment discontinuation criteria.|0||
59770480|NCT00851084|75890793|FG001|COMPLETED|Overall Study|Participants continued treatment until they met treatment discontinuation criteria.|0||
59770481|NCT00851084|75890792|FG000|NOT COMPLETED|Overall Study||117||
59770482|NCT00851084|75890793|FG001|NOT COMPLETED|Overall Study||119||
59770483|NCT00845858|75890804|FG000|STARTED|Overall Study|"95 subjects received allocated intervention.~1 subject withdrew consent and was not dosed."|96||
59770484|NCT00845858|75890805|FG001|STARTED|Overall Study|"95 subjects received allocated intervention.~1 subject was not eligible and was not dosed."|96||
59770485|NCT00845858|75890806|FG002|STARTED|Overall Study||95||
59770486|NCT00845858|75890804|FG000|COMPLETED|Overall Study||88||
59770487|NCT00845858|75890805|FG001|COMPLETED|Overall Study||84||
59770488|NCT00845858|75890806|FG002|COMPLETED|Overall Study||87||
59770489|NCT00845858|75890804|FG000|NOT COMPLETED|Overall Study||8||
59770490|NCT00845858|75890805|FG001|NOT COMPLETED|Overall Study||12||
59770491|NCT00845858|75890806|FG002|NOT COMPLETED|Overall Study||8||
59770492|NCT00850538|75890817|FG000|STARTED|Overall Study||101||
59770493|NCT00850538|75890817|FG000|COMPLETED|Overall Study||60||
59770494|NCT00850538|75890817|FG000|NOT COMPLETED|Overall Study||41||
59770495|NCT00850460|75890823|FG000|STARTED|Overall Study||7||
59770496|NCT00850460|75890824|FG001|STARTED|Overall Study||7||
59770497|NCT00850460|75890823|FG000|Started - Week 0|Overall Study||7||
59770498|NCT00850460|75890824|FG001|Started - Week 0|Overall Study||7||
59770499|NCT00850460|75890823|FG000|Completion - Week 8|Overall Study||3||
59770500|NCT00850460|75890824|FG001|Completion - Week 8|Overall Study||3||
59770501|NCT00850460|75890823|FG000|COMPLETED|Overall Study||3||
59770502|NCT00850460|75890824|FG001|COMPLETED|Overall Study||3||
59770503|NCT00850460|75890823|FG000|NOT COMPLETED|Overall Study||4||
59770504|NCT00850460|75890824|FG001|NOT COMPLETED|Overall Study||4||
59770505|NCT00661492|75890832|FG000|STARTED|Overall Study||75||
59770506|NCT00661492|75890833|FG001|STARTED|Overall Study||40||
59770507|NCT00661492|75890832|FG000|COMPLETED|Overall Study||7||
59770508|NCT00661492|75890833|FG001|COMPLETED|Overall Study||11||
59770509|NCT00661492|75890832|FG000|NOT COMPLETED|Overall Study||68||
59770510|NCT00661492|75890833|FG001|NOT COMPLETED|Overall Study||29||
59770511|NCT00850070|75890841|FG000|STARTED|Overall Study||23||
59770512|NCT00850070|75890842|FG001|STARTED|Overall Study||23||
59770513|NCT00850070|75890841|FG000|COMPLETED|Overall Study||20||
59770514|NCT00850070|75890842|FG001|COMPLETED|Overall Study||22||
59770515|NCT00850070|75890841|FG000|NOT COMPLETED|Overall Study||3||
59770516|NCT00850070|75890842|FG001|NOT COMPLETED|Overall Study||1||
59770517|NCT00592358|75890853|FG000|STARTED|Overall Study||17||
59770518|NCT00592358|75890853|FG000|COMPLETED|Overall Study||11||
59770519|NCT00592358|75890853|FG000|NOT COMPLETED|Overall Study||6||
59770520|NCT00814320|75890859|FG000|STARTED|Epoch 1 (IV Treatment)||14||
59770521|NCT00814320|75890860|FG001|STARTED|Epoch 1 (IV Treatment)||73||
59770522|NCT00814320|75890859|FG000|COMPLETED|Epoch 1 (IV Treatment)||13||
59770523|NCT00814320|75890860|FG001|COMPLETED|Epoch 1 (IV Treatment)||71||
59770524|NCT00814320|75890859|FG000|NOT COMPLETED|Epoch 1 (IV Treatment)||1||
59770525|NCT00814320|75890860|FG001|NOT COMPLETED|Epoch 1 (IV Treatment)||2||
59770526|NCT00814320|75890859|FG000|STARTED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||13||
59770527|NCT00814320|75890860|FG001|STARTED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||71||
59770528|NCT00814320|75890859|FG000|COMPLETED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||13||
59770529|NCT00814320|75890860|FG001|COMPLETED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||70||
59770530|NCT00814320|75890859|FG000|NOT COMPLETED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||0||
59770531|NCT00814320|75890860|FG001|NOT COMPLETED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||1||
59770532|NCT00814320|75890859|FG000|STARTED|"Epoch 2 Ramp-up (Ramp-up)"||13||
59770533|NCT00814320|75890860|FG001|STARTED|"Epoch 2 Ramp-up (Ramp-up)"||70||
60072632|NCT01567527|76187788|FG002|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0||
60072633|NCT01567527|76187789|FG003|NOT COMPLETED|Double-blind, Placebo-controlled Phase||69||
60072634|NCT01567527|76187790|FG004|NOT COMPLETED|Double-blind, Placebo-controlled Phase||95||
59770534|NCT00814320|75890859|FG000|COMPLETED|"Epoch 2 Ramp-up (Ramp-up)"||11||
59770535|NCT00814320|75890860|FG001|COMPLETED|"Epoch 2 Ramp-up (Ramp-up)"||70||
59770536|NCT00814320|75890859|FG000|NOT COMPLETED|"Epoch 2 Ramp-up (Ramp-up)"||2||
59952628|NCT02696031|76071458|FG001|COMPLETED|Up to Week 24||177|Completed week 24|
59770537|NCT00814320|75890860|FG001|NOT COMPLETED|"Epoch 2 Ramp-up (Ramp-up)"||0||
59770538|NCT00814320|75890859|FG000|STARTED|Epoch 2 After Ramp-up (SC/rHuPH20)||11||
59770539|NCT00814320|75890860|FG001|STARTED|Epoch 2 After Ramp-up (SC/rHuPH20)||70||
59770540|NCT00814320|75890859|FG000|COMPLETED|Epoch 2 After Ramp-up (SC/rHuPH20)||8||
59770541|NCT00814320|75890860|FG001|COMPLETED|Epoch 2 After Ramp-up (SC/rHuPH20)|Three participants who switched to safety follow-up remained in the study.|60||
59770542|NCT00814320|75890859|FG000|NOT COMPLETED|Epoch 2 After Ramp-up (SC/rHuPH20)||3||
59770543|NCT00814320|75890860|FG001|NOT COMPLETED|Epoch 2 After Ramp-up (SC/rHuPH20)||10||
59770544|NCT00869999|75890883|FG000|STARTED|Overall Study||26||
59770545|NCT00869999|75890883|FG000|COMPLETED|Overall Study||24||
59770546|NCT00869999|75890883|FG000|NOT COMPLETED|Overall Study||2||
59770547|NCT00570232|75890887|FG000|STARTED|Overall Study||31||
59770548|NCT00570232|75890887|FG000|COMPLETED|Overall Study||8||
59770549|NCT00570232|75890887|FG000|NOT COMPLETED|Overall Study||23||
59952629|NCT02696031|76071459|FG002|COMPLETED|Up to Week 24||175|Completed week 24|
59952630|NCT02696031|76071460|FG003|COMPLETED|Up to Week 24||0|Completed week 24|
59952631|NCT02696031|76071461|FG004|COMPLETED|Up to Week 24||0|Completed week 24|
59952632|NCT02696031|76071462|FG005|COMPLETED|Up to Week 24||0|Completed week 24|
59952633|NCT02696031|76071457|FG000|NOT COMPLETED|Up to Week 24||10||
59952634|NCT02696031|76071458|FG001|NOT COMPLETED|Up to Week 24||7||
60072635|NCT01818752|76187801|FG000|STARTED|Overall Study||477||
60072636|NCT01818752|76187802|FG001|STARTED|Overall Study||478||
60072637|NCT01818752|76187801|FG000|Received Treatment|Overall Study||470||
60072638|NCT01818752|76187802|FG001|Received Treatment|Overall Study||474||
60072639|NCT01818752|76187801|FG000|COMPLETED|Overall Study|Completed treatment|290||
60072640|NCT01818752|76187802|FG001|COMPLETED|Overall Study|Completed treatment|280||
60072641|NCT01818752|76187801|FG000|NOT COMPLETED|Overall Study||187||
60072642|NCT01818752|76187802|FG001|NOT COMPLETED|Overall Study||198||
59770550|NCT00809328|75890891|FG000|STARTED|Overall Study||102||
59770551|NCT00809328|75890891|FG000|COMPLETED|Overall Study||73||
59770552|NCT00809328|75890891|FG000|NOT COMPLETED|Overall Study||29||
59770553|NCT00868517|75890898|FG000|STARTED|Overall Study||12||
59770554|NCT00868517|75890899|FG001|STARTED|Overall Study||12||
59770555|NCT00868517|75890900|FG002|STARTED|Overall Study||11||
59770556|NCT00868517|75890898|FG000|COMPLETED|Overall Study||8||
59770557|NCT00868517|75890899|FG001|COMPLETED|Overall Study||8||
59770558|NCT00868517|75890900|FG002|COMPLETED|Overall Study||9||
59952635|NCT02696031|76071459|FG002|NOT COMPLETED|Up to Week 24||11||
59952636|NCT02696031|76071460|FG003|NOT COMPLETED|Up to Week 24||0||
59952637|NCT02696031|76071461|FG004|NOT COMPLETED|Up to Week 24||0||
60072643|NCT01845818|76187810|FG000|STARTED|Overall Study||126||
60072644|NCT01845818|76187811|FG001|STARTED|Overall Study||57||
60072645|NCT01845818|76187810|FG000|COMPLETED|Overall Study||81||
60072646|NCT01845818|76187811|FG001|COMPLETED|Overall Study||40||
59770559|NCT00868517|75890898|FG000|NOT COMPLETED|Overall Study||4||
59770560|NCT00868517|75890899|FG001|NOT COMPLETED|Overall Study||4||
59952638|NCT02696031|76071462|FG005|NOT COMPLETED|Up to Week 24||0||
59952639|NCT02696031|76071457|FG000|STARTED|Up to Week 52||185||
59952640|NCT02696031|76071458|FG001|STARTED|Up to Week 52||184||
60072647|NCT01845818|76187810|FG000|NOT COMPLETED|Overall Study||45||
59770561|NCT00868517|75890900|FG002|NOT COMPLETED|Overall Study||2||
59770562|NCT00868439|75890910|FG000|STARTED|Overall Study||56||
59952641|NCT02696031|76071459|FG002|STARTED|Up to Week 52||186||
59770563|NCT00868439|75890911|FG001|STARTED|Overall Study||49||
59770564|NCT00868439|75890910|FG000|COMPLETED|Overall Study||48||
59770565|NCT00868439|75890911|FG001|COMPLETED|Overall Study||40||
59770566|NCT00868439|75890910|FG000|NOT COMPLETED|Overall Study||8||
59770567|NCT00868439|75890911|FG001|NOT COMPLETED|Overall Study||9||
59770568|NCT00814164|75890917|FG000|STARTED|Overall Study||21||
59770569|NCT00814164|75890917|FG000|COMPLETED|Overall Study||2||
59770570|NCT00814164|75890917|FG000|NOT COMPLETED|Overall Study||19||
59770571|NCT00659230|75890923|FG000|STARTED|Overall Study|2 did not return post-randomization, 5 lost source documents, thus 7 excluded from results analysis|51||
59770572|NCT00659230|75890924|FG001|STARTED|Overall Study|3 did not return post-randomization, 4 lost source documents, thus 7 excluded from results analysis|49||
59770573|NCT00659230|75890923|FG000|COMPLETED|Overall Study||42||
59770574|NCT00659230|75890924|FG001|COMPLETED|Overall Study||37||
59770575|NCT00659230|75890923|FG000|NOT COMPLETED|Overall Study||9||
59770576|NCT00659230|75890924|FG001|NOT COMPLETED|Overall Study||12||
59770577|NCT00809094|75890932|FG000|STARTED|Overall Study||36||
59770578|NCT00809094|75890933|FG001|STARTED|Overall Study||34||
59770579|NCT00809094|75890932|FG000|COMPLETED|Overall Study||36||
59770580|NCT00809094|75890933|FG001|COMPLETED|Overall Study||33||
59770581|NCT00809094|75890932|FG000|NOT COMPLETED|Overall Study||0||
59770582|NCT00809094|75890933|FG001|NOT COMPLETED|Overall Study||1||
59770583|NCT00658996|75890939|FG000|STARTED|First Intervention||109||
59770584|NCT00658996|75890940|FG001|STARTED|First Intervention||107||
59770585|NCT00658996|75890939|FG000|COMPLETED|First Intervention||108||
59770586|NCT00658996|75890940|FG001|COMPLETED|First Intervention||106||
59770587|NCT00658996|75890939|FG000|NOT COMPLETED|First Intervention||1||
59770588|NCT00658996|75890940|FG001|NOT COMPLETED|First Intervention||1||
59770589|NCT00658996|75890939|FG000|STARTED|Crossover Period||108||
59770590|NCT00658996|75890940|FG001|STARTED|Crossover Period||106||
59770591|NCT00658996|75890939|FG000|COMPLETED|Crossover Period||106||
59770592|NCT00658996|75890940|FG001|COMPLETED|Crossover Period||105||
59770593|NCT00658996|75890939|FG000|NOT COMPLETED|Crossover Period||2||
59770594|NCT00658996|75890940|FG001|NOT COMPLETED|Crossover Period||1||
59770595|NCT00658996|75890939|FG000|STARTED|Second Intervention||106||
59770596|NCT00658996|75890940|FG001|STARTED|Second Intervention||105||
59770597|NCT00658996|75890939|FG000|COMPLETED|Second Intervention||105||
59770598|NCT00658996|75890940|FG001|COMPLETED|Second Intervention||104||
59770599|NCT00658996|75890939|FG000|NOT COMPLETED|Second Intervention||1||
59770600|NCT00658996|75890940|FG001|NOT COMPLETED|Second Intervention||1||
59770601|NCT00867815|75890946|FG000|STARTED|Overall Study||10|Safety Analysis Set|
59770602|NCT00867815|75890946|FG000|COMPLETED|Overall Study||9||
59770603|NCT00867815|75890946|FG000|NOT COMPLETED|Overall Study||1||
59770604|NCT00452413|75890953|FG000|STARTED|Overall Study||4||
59770605|NCT00452413|75890954|FG001|STARTED|Overall Study||12||
59770606|NCT00452413|75890955|FG002|STARTED|Overall Study||49||
59770607|NCT00452413|75890953|FG000|Received at Least 1 Dose of Study Drug|Overall Study||4||
59770608|NCT00452413|75890954|FG001|Received at Least 1 Dose of Study Drug|Overall Study||12||
59770609|NCT00452413|75890955|FG002|Received at Least 1 Dose of Study Drug|Overall Study||49||
59770610|NCT00452413|75890953|FG000|COMPLETED|Overall Study||0||
59770611|NCT00452413|75890954|FG001|COMPLETED|Overall Study||0||
59770612|NCT00452413|75890955|FG002|COMPLETED|Overall Study||0||
59770613|NCT00452413|75890953|FG000|NOT COMPLETED|Overall Study||4||
59770614|NCT00452413|75890954|FG001|NOT COMPLETED|Overall Study||12||
59770615|NCT00452413|75890955|FG002|NOT COMPLETED|Overall Study||49||
59770616|NCT00867503|75890964|FG000|STARTED|Overall Study||10||
59770617|NCT00867503|75890964|FG000|COMPLETED|Overall Study||9||
59770618|NCT00867503|75890964|FG000|NOT COMPLETED|Overall Study||1||
59770619|NCT00867113|75890970|FG000|STARTED|Treatment Period||91||
59770620|NCT00867113|75890970|FG000|Safety Set|Treatment Period||91||
59770621|NCT00867113|75890970|FG000|Full Analysis Set (FAS)|Treatment Period||91||
59770622|NCT00867113|75890970|FG000|COMPLETED|Treatment Period||46||
59770623|NCT00867113|75890970|FG000|NOT COMPLETED|Treatment Period||45||
59770624|NCT00867113|75890970|FG000|STARTED|Post Treatment After Survival Follow-up||68||
59770625|NCT00867113|75890970|FG000|COMPLETED|Post Treatment After Survival Follow-up||57||
59770626|NCT00867113|75890970|FG000|NOT COMPLETED|Post Treatment After Survival Follow-up||11||
59770627|NCT00451555|75890977|FG000|STARTED|Overall Study||96||
59770628|NCT00451555|75890978|FG001|STARTED|Overall Study||60||
59770629|NCT00451555|75890977|FG000|Received at Least One Dose of Study Drug|Overall Study||94||
59770630|NCT00451555|75890978|FG001|Received at Least One Dose of Study Drug|Overall Study||58||
59770631|NCT00451555|75890977|FG000|Enzastaurin Twice Daily Dosing (BID)|Overall Study||39||
59770632|NCT00451555|75890978|FG001|Enzastaurin Twice Daily Dosing (BID)|Overall Study||0||
59770633|NCT00451555|75890977|FG000|Enzastaurin Once Daily Dosing (QD)|Overall Study||55||
59770634|NCT00451555|75890978|FG001|Enzastaurin Once Daily Dosing (QD)|Overall Study||0||
59770635|NCT00451555|75890977|FG000|Progressive Disease|Overall Study||75||
59770636|NCT00451555|75890978|FG001|Progressive Disease|Overall Study||54||
59770637|NCT00451555|75890977|FG000|Death|Overall Study||2||
59770638|NCT00451555|75890978|FG001|Death|Overall Study||0||
59770639|NCT00451555|75890977|FG000|COMPLETED|Overall Study||83||
59770640|NCT00451555|75890978|FG001|COMPLETED|Overall Study||56||
59770641|NCT00451555|75890977|FG000|NOT COMPLETED|Overall Study||13||
59618331|NCT03810534|75729474|FG000|COMPLETED|Pre-Implementation Phase (2 Months)||0||
59618332|NCT03810534|75729475|FG001|COMPLETED|Pre-Implementation Phase (2 Months)||0||
59618333|NCT03810534|75729476|FG002|COMPLETED|Pre-Implementation Phase (2 Months)||0||
59618334|NCT03810534|75729477|FG003|COMPLETED|Pre-Implementation Phase (2 Months)||0||
59618335|NCT03810534|75729478|FG004|COMPLETED|Pre-Implementation Phase (2 Months)||0||
59618336|NCT03810534|75729479|FG005|COMPLETED|Pre-Implementation Phase (2 Months)||0||
59618337|NCT03810534|75729474|FG000|NOT COMPLETED|Pre-Implementation Phase (2 Months)||0||
59618338|NCT03810534|75729475|FG001|NOT COMPLETED|Pre-Implementation Phase (2 Months)||0||
59618339|NCT03810534|75729476|FG002|NOT COMPLETED|Pre-Implementation Phase (2 Months)||0||
59618340|NCT03810534|75729477|FG003|NOT COMPLETED|Pre-Implementation Phase (2 Months)||0||
59770642|NCT00451555|75890978|FG001|NOT COMPLETED|Overall Study||4||
59770643|NCT00808236|75890995|FG000|STARTED|Overall Study||96||
59770644|NCT00808236|75890996|FG001|STARTED|Overall Study||104||
59770645|NCT00808236|75890995|FG000|Met Eligibility Criteria|Overall Study|Pre-defined exclusions: DNAR(4); had pulse(2); CVA(2); Drug OD(2); On home oxygen(1); Unwitnessed(1)|84||
59770646|NCT00808236|75890996|FG001|Met Eligibility Criteria|Overall Study|Pre-defined exclusions: Terminal(1); Asphyxia(1), In-hospital(1)|101||
59770647|NCT00808236|75890995|FG000|Included in Analysis|Overall Study|Lost to Follow-Up: taken to non-participating hospital (1)|83||
59770648|NCT00808236|75890996|FG001|Included in Analysis|Overall Study|Crossed over & withdrawn (1); Lost to Follow-Up: taken to non-participating hospital (1)|99||
59770649|NCT00808236|75890995|FG000|Achieved ROSC|Overall Study||33||
59770650|NCT00808236|75890996|FG001|Achieved ROSC|Overall Study||43||
59952642|NCT02696031|76071460|FG003|STARTED|Up to Week 52||0||
59952643|NCT02696031|76071461|FG004|STARTED|Up to Week 52||0||
59952644|NCT02696031|76071462|FG005|STARTED|Up to Week 52||0||
59952645|NCT02696031|76071457|FG000|COMPLETED|Up to Week 52||156||
59952646|NCT02696031|76071458|FG001|COMPLETED|Up to Week 52||165||
59952647|NCT02696031|76071459|FG002|COMPLETED|Up to Week 52||160||
59952648|NCT02696031|76071460|FG003|COMPLETED|Up to Week 52||0||
59952649|NCT02696031|76071461|FG004|COMPLETED|Up to Week 52||0||
59952650|NCT02696031|76071462|FG005|COMPLETED|Up to Week 52||0||
59952651|NCT02696031|76071457|FG000|NOT COMPLETED|Up to Week 52||29||
59521726|NCT00977171|75615986|FG000|NOT COMPLETED|Overall Study||0||
59521727|NCT00955487|75615992|FG000|STARTED|Overall Study||10||
59521728|NCT00955487|75615993|FG001|STARTED|Overall Study||9||
59521729|NCT00955487|75615994|FG002|STARTED|Overall Study||17||
59521730|NCT00955487|75615995|FG003|STARTED|Overall Study||21||
59521731|NCT00955487|75615996|FG004|STARTED|Overall Study||32||
59521732|NCT00955487|75615997|FG005|STARTED|Overall Study||35||
59618341|NCT03810534|75729478|FG004|NOT COMPLETED|Pre-Implementation Phase (2 Months)||0||
59618342|NCT03810534|75729479|FG005|NOT COMPLETED|Pre-Implementation Phase (2 Months)||0||
59618343|NCT03810534|75729474|FG000|STARTED|Connect-Home (5-10 Months)||82||
59618344|NCT03810534|75729475|FG001|STARTED|Connect-Home (5-10 Months)||80||
59618345|NCT03810534|75729476|FG002|STARTED|Connect-Home (5-10 Months)||66||
59618346|NCT03810534|75729477|FG003|STARTED|Connect-Home (5-10 Months)||54||
59618347|NCT03810534|75729478|FG004|STARTED|Connect-Home (5-10 Months)||10||
59618348|NCT03810534|75729479|FG005|STARTED|Connect-Home (5-10 Months)||38||
59618349|NCT03810534|75729474|FG000|Patients Started|Connect-Home (5-10 Months)||41||
59618350|NCT03810534|75729475|FG001|Patients Started|Connect-Home (5-10 Months)||40||
59618351|NCT03810534|75729476|FG002|Patients Started|Connect-Home (5-10 Months)||33||
59618352|NCT03810534|75729477|FG003|Patients Started|Connect-Home (5-10 Months)||27||
59618353|NCT03810534|75729478|FG004|Patients Started|Connect-Home (5-10 Months)||5||
59618354|NCT03810534|75729479|FG005|Patients Started|Connect-Home (5-10 Months)||19||
59618355|NCT03810534|75729474|FG000|Caregivers Started|Connect-Home (5-10 Months)||41||
59618356|NCT03810534|75729475|FG001|Caregivers Started|Connect-Home (5-10 Months)||40||
59618357|NCT03810534|75729476|FG002|Caregivers Started|Connect-Home (5-10 Months)||33||
59618358|NCT03810534|75729477|FG003|Caregivers Started|Connect-Home (5-10 Months)||27||
59618359|NCT03810534|75729478|FG004|Caregivers Started|Connect-Home (5-10 Months)||5||
59618360|NCT03810534|75729479|FG005|Caregivers Started|Connect-Home (5-10 Months)||19||
59709529|NCT01241591|75828279|FG003|NOT COMPLETED|Overall Study||12||
59709530|NCT00906373|75828291|FG000|STARTED|Overall Study||6||
59709531|NCT00906373|75828292|FG001|STARTED|Overall Study||41||
59709532|NCT00906373|75828291|FG000|Received Any Amount of Study Drug|Overall Study||6||
59521733|NCT00955487|75615992|FG000|COMPLETED|Overall Study||10||
59521734|NCT00955487|75615993|FG001|COMPLETED|Overall Study||9||
59521735|NCT00955487|75615994|FG002|COMPLETED|Overall Study||17||
59709533|NCT00906373|75828292|FG001|Received Any Amount of Study Drug|Overall Study||41||
59709534|NCT00906373|75828291|FG000|COMPLETED|Overall Study||6||
59709535|NCT00906373|75828292|FG001|COMPLETED|Overall Study||33||
59709536|NCT00906373|75828291|FG000|NOT COMPLETED|Overall Study||0||
59709537|NCT00906373|75828292|FG001|NOT COMPLETED|Overall Study||8||
59709538|NCT04202419|75828299|FG000|STARTED|Overall Study||30||
59709539|NCT04202419|75828299|FG000|COMPLETED|Overall Study||20||
59709540|NCT04202419|75828299|FG000|NOT COMPLETED|Overall Study||10||
59709541|NCT00905437|75828305|FG000|STARTED|Overall Study||35||
59709542|NCT00905437|75828306|FG001|STARTED|Overall Study||37||
59709543|NCT00905437|75828305|FG000|COMPLETED|Overall Study||27||
59709544|NCT00905437|75828306|FG001|COMPLETED|Overall Study||27||
59521736|NCT00955487|75615995|FG003|COMPLETED|Overall Study||21||
59521737|NCT00955487|75615996|FG004|COMPLETED|Overall Study||32||
59521738|NCT00955487|75615997|FG005|COMPLETED|Overall Study||35||
59521739|NCT00955487|75615992|FG000|NOT COMPLETED|Overall Study||0||
59521740|NCT00955487|75615993|FG001|NOT COMPLETED|Overall Study||0||
59521741|NCT00955487|75615994|FG002|NOT COMPLETED|Overall Study||0||
59521742|NCT00955487|75615995|FG003|NOT COMPLETED|Overall Study||0||
59521743|NCT00955487|75615996|FG004|NOT COMPLETED|Overall Study||0||
59521744|NCT00955487|75615997|FG005|NOT COMPLETED|Overall Study||0||
59521745|NCT01663740|75616011|FG000|STARTED|Overall Study|Safety Population|38||
59521746|NCT01663740|75616012|FG001|STARTED|Overall Study|Safety Population|21||
59521747|NCT01663740|75616011|FG000|COMPLETED|Overall Study||22||
59521748|NCT01663740|75616012|FG001|COMPLETED|Overall Study||13||
59521749|NCT01663740|75616011|FG000|NOT COMPLETED|Overall Study||16||
59521750|NCT01663740|75616012|FG001|NOT COMPLETED|Overall Study||8||
59521751|NCT02984228|75616020|FG000|STARTED|Overall Study||34||
59521752|NCT02984228|75616021|FG001|STARTED|Overall Study||36||
59521753|NCT02984228|75616020|FG000|COMPLETED|Overall Study||34||
59770651|NCT00808236|75890995|FG000|Admitted to Hospital|Overall Study|Died during transport to hospital(2); DNAR determination was made at hospital(1)|30||
59770652|NCT00808236|75890996|FG001|Admitted to Hospital|Overall Study|Died during transport to hospital(1)|42||
59770653|NCT00808236|75890995|FG000|COMPLETED|Overall Study||14||
59770654|NCT00808236|75890996|FG001|COMPLETED|Overall Study||13||
59770655|NCT00808236|75890995|FG000|NOT COMPLETED|Overall Study||82||
59770656|NCT00808236|75890996|FG001|NOT COMPLETED|Overall Study||91||
59770657|NCT00867035|75891004|FG000|STARTED|Baseline to 1 Hour||13||
59770658|NCT00867035|75891005|FG001|STARTED|Baseline to 1 Hour||9||
59770659|NCT00867035|75891004|FG000|COMPLETED|Baseline to 1 Hour||12||
59770660|NCT00867035|75891005|FG001|COMPLETED|Baseline to 1 Hour||8||
59770661|NCT00867035|75891004|FG000|NOT COMPLETED|Baseline to 1 Hour||1||
59770662|NCT00867035|75891005|FG001|NOT COMPLETED|Baseline to 1 Hour||1||
59770663|NCT00867035|75891004|FG000|STARTED|Baseline to 2 Hours||12||
59770664|NCT00867035|75891005|FG001|STARTED|Baseline to 2 Hours||8||
59770665|NCT00867035|75891004|FG000|COMPLETED|Baseline to 2 Hours||12||
59770666|NCT00867035|75891005|FG001|COMPLETED|Baseline to 2 Hours||8||
59770667|NCT00867035|75891004|FG000|NOT COMPLETED|Baseline to 2 Hours||0||
59770668|NCT00867035|75891005|FG001|NOT COMPLETED|Baseline to 2 Hours||0||
59770669|NCT00867035|75891004|FG000|STARTED|Baseline to 4 Hours||12||
59770670|NCT00867035|75891005|FG001|STARTED|Baseline to 4 Hours||8||
59770671|NCT00867035|75891004|FG000|COMPLETED|Baseline to 4 Hours||12||
59770672|NCT00867035|75891005|FG001|COMPLETED|Baseline to 4 Hours||8||
59770673|NCT00867035|75891004|FG000|NOT COMPLETED|Baseline to 4 Hours||0||
59770674|NCT00867035|75891005|FG001|NOT COMPLETED|Baseline to 4 Hours||0||
59770675|NCT00867035|75891004|FG000|STARTED|Baseline to 1 Week||12||
59770676|NCT00867035|75891005|FG001|STARTED|Baseline to 1 Week||8||
59770677|NCT00867035|75891004|FG000|COMPLETED|Baseline to 1 Week||11||
59770678|NCT00867035|75891005|FG001|COMPLETED|Baseline to 1 Week||8||
59770679|NCT00867035|75891004|FG000|NOT COMPLETED|Baseline to 1 Week||1||
59770680|NCT00867035|75891005|FG001|NOT COMPLETED|Baseline to 1 Week||0||
59770681|NCT00663208|75891018|FG000|STARTED|Treatment Period||4||
59770682|NCT00663208|75891019|FG001|STARTED|Treatment Period||4||
59952652|NCT02696031|76071458|FG001|NOT COMPLETED|Up to Week 52||19||
59952653|NCT02696031|76071459|FG002|NOT COMPLETED|Up to Week 52||26||
59521754|NCT02984228|75616021|FG001|COMPLETED|Overall Study||35||
59521755|NCT02984228|75616020|FG000|NOT COMPLETED|Overall Study||0||
59770683|NCT00663208|75891020|FG002|STARTED|Treatment Period||4||
59770684|NCT00663208|75891021|FG003|STARTED|Treatment Period||4||
59770685|NCT00663208|75891022|FG004|STARTED|Treatment Period||4||
59770686|NCT00663208|75891023|FG005|STARTED|Treatment Period||4||
59770687|NCT00663208|75891024|FG006|STARTED|Treatment Period||6||
59770688|NCT00663208|75891018|FG000|COMPLETED|Treatment Period||4||
59770689|NCT00663208|75891019|FG001|COMPLETED|Treatment Period||3||
59770690|NCT00663208|75891020|FG002|COMPLETED|Treatment Period||4||
59770691|NCT00663208|75891021|FG003|COMPLETED|Treatment Period||4||
59770692|NCT00663208|75891022|FG004|COMPLETED|Treatment Period||4||
59770693|NCT00663208|75891023|FG005|COMPLETED|Treatment Period||4||
59952654|NCT02696031|76071460|FG003|NOT COMPLETED|Up to Week 52||0||
59952655|NCT02696031|76071461|FG004|NOT COMPLETED|Up to Week 52||0||
59770694|NCT00663208|75891024|FG006|COMPLETED|Treatment Period||6||
59770695|NCT00663208|75891018|FG000|NOT COMPLETED|Treatment Period||0||
59770696|NCT00663208|75891019|FG001|NOT COMPLETED|Treatment Period||1||
59770697|NCT00663208|75891020|FG002|NOT COMPLETED|Treatment Period||0||
59770698|NCT00663208|75891021|FG003|NOT COMPLETED|Treatment Period||0||
59770699|NCT00663208|75891022|FG004|NOT COMPLETED|Treatment Period||0||
59770700|NCT00663208|75891023|FG005|NOT COMPLETED|Treatment Period||0||
59952656|NCT02696031|76071462|FG005|NOT COMPLETED|Up to Week 52||0||
59521756|NCT02984228|75616021|FG001|NOT COMPLETED|Overall Study||1||
59521757|NCT00979121|75616029|FG000|STARTED|Overall Study||379||
59521758|NCT00979121|75616030|FG001|STARTED|Overall Study||366||
59521759|NCT00979121|75616029|FG000|COMPLETED|Overall Study||379||
59521760|NCT00979121|75616030|FG001|COMPLETED|Overall Study||366||
59770701|NCT00663208|75891024|FG006|NOT COMPLETED|Treatment Period||0||
59952657|NCT02696031|76071457|FG000|STARTED|Up to Week 104||185||
59770702|NCT00663208|75891018|FG000|STARTED|Follow-up Period||4||
59770703|NCT00663208|75891019|FG001|STARTED|Follow-up Period||3||
59770704|NCT00663208|75891020|FG002|STARTED|Follow-up Period||4||
59770705|NCT00663208|75891021|FG003|STARTED|Follow-up Period||4||
59770706|NCT00663208|75891022|FG004|STARTED|Follow-up Period||4||
59952658|NCT02696031|76071458|FG001|STARTED|Up to Week 104||184||
59770707|NCT00663208|75891023|FG005|STARTED|Follow-up Period||4||
59770708|NCT00663208|75891024|FG006|STARTED|Follow-up Period||6||
59770709|NCT00663208|75891018|FG000|COMPLETED|Follow-up Period||1||
59770710|NCT00663208|75891019|FG001|COMPLETED|Follow-up Period||3||
59770711|NCT00663208|75891020|FG002|COMPLETED|Follow-up Period||1||
59770712|NCT00663208|75891021|FG003|COMPLETED|Follow-up Period||2||
59770713|NCT00663208|75891022|FG004|COMPLETED|Follow-up Period||4||
59770714|NCT00663208|75891023|FG005|COMPLETED|Follow-up Period||4||
59770715|NCT00663208|75891024|FG006|COMPLETED|Follow-up Period||5||
59770716|NCT00663208|75891018|FG000|NOT COMPLETED|Follow-up Period||3||
59770717|NCT00663208|75891019|FG001|NOT COMPLETED|Follow-up Period||0||
59770718|NCT00663208|75891020|FG002|NOT COMPLETED|Follow-up Period||3||
59770719|NCT00663208|75891021|FG003|NOT COMPLETED|Follow-up Period||2||
59770720|NCT00663208|75891022|FG004|NOT COMPLETED|Follow-up Period||0||
59770721|NCT00663208|75891023|FG005|NOT COMPLETED|Follow-up Period||0||
59770722|NCT00663208|75891024|FG006|NOT COMPLETED|Follow-up Period||1||
59770723|NCT00810810|75891046|FG000|STARTED|Overall Study||124||
59770724|NCT00810810|75891047|FG001|STARTED|Overall Study||49||
59770725|NCT00810810|75891048|FG002|STARTED|Overall Study||56||
59770726|NCT00810810|75891049|FG003|STARTED|Overall Study||51||
59770727|NCT00810810|75891046|FG000|COMPLETED|Overall Study||124||
59770728|NCT00810810|75891047|FG001|COMPLETED|Overall Study||38||
59770729|NCT00810810|75891048|FG002|COMPLETED|Overall Study||45||
59770730|NCT00810810|75891049|FG003|COMPLETED|Overall Study||38||
59770731|NCT00810810|75891046|FG000|NOT COMPLETED|Overall Study||0||
59770732|NCT00810810|75891047|FG001|NOT COMPLETED|Overall Study||11||
59770733|NCT00810810|75891048|FG002|NOT COMPLETED|Overall Study||11||
59770734|NCT00810810|75891049|FG003|NOT COMPLETED|Overall Study||13||
59770735|NCT00661258|75891061|FG000|STARTED|Overall Study||34||
59770736|NCT00661258|75891062|FG001|STARTED|Overall Study||34||
59770737|NCT00661258|75891061|FG000|COMPLETED|Overall Study||31||
59770738|NCT00661258|75891062|FG001|COMPLETED|Overall Study||33||
59770739|NCT00661258|75891061|FG000|NOT COMPLETED|Overall Study||3||
59770740|NCT00661258|75891062|FG001|NOT COMPLETED|Overall Study||1||
59770741|NCT00871871|75891070|FG000|STARTED|Part I||18||
59770742|NCT00871871|75891071|FG001|STARTED|Part I||18||
59770743|NCT00871871|75891072|FG002|STARTED|Part I||0||
59770744|NCT00871871|75891073|FG003|STARTED|Part I||0||
59770745|NCT00871871|75891070|FG000|COMPLETED|Part I||15||
59770746|NCT00871871|75891071|FG001|COMPLETED|Part I||15||
59770747|NCT00871871|75891072|FG002|COMPLETED|Part I||0||
59770748|NCT00871871|75891073|FG003|COMPLETED|Part I||0||
59770749|NCT00871871|75891070|FG000|NOT COMPLETED|Part I||3||
59770750|NCT00871871|75891071|FG001|NOT COMPLETED|Part I||3||
59770751|NCT00871871|75891072|FG002|NOT COMPLETED|Part I||0||
59770752|NCT00871871|75891073|FG003|NOT COMPLETED|Part I||0||
59770753|NCT00871871|75891070|FG000|STARTED|Part II||0||
59770754|NCT00871871|75891071|FG001|STARTED|Part II||0||
59770755|NCT00871871|75891072|FG002|STARTED|Part II||13||
59770756|NCT00871871|75891073|FG003|STARTED|Part II||15||
59770757|NCT00871871|75891070|FG000|COMPLETED|Part II||0||
59770758|NCT00871871|75891071|FG001|COMPLETED|Part II||0||
59770759|NCT00871871|75891072|FG002|COMPLETED|Part II||9||
59770760|NCT00871871|75891073|FG003|COMPLETED|Part II||11||
59952659|NCT02696031|76071459|FG002|STARTED|Up to Week 104||186||
59952660|NCT02696031|76071460|FG003|STARTED|Up to Week 104||0||
59952661|NCT02696031|76071461|FG004|STARTED|Up to Week 104||0||
59952662|NCT02696031|76071462|FG005|STARTED|Up to Week 104||0||
60072648|NCT01845818|76187811|FG001|NOT COMPLETED|Overall Study||17||
59770761|NCT00871871|75891070|FG000|NOT COMPLETED|Part II||0||
59770762|NCT00871871|75891071|FG001|NOT COMPLETED|Part II||0||
59770763|NCT00871871|75891072|FG002|NOT COMPLETED|Part II||4||
59770764|NCT00871871|75891073|FG003|NOT COMPLETED|Part II||4||
59770765|NCT00849680|75891091|FG000|STARTED|Overall Study||27||
59770766|NCT00849680|75891092|FG001|STARTED|Overall Study||13||
59770767|NCT00849680|75891093|FG002|STARTED|Overall Study||42||
59770768|NCT00849680|75891094|FG003|STARTED|Overall Study||42||
59770769|NCT00849680|75891095|FG004|STARTED|Overall Study||42||
59770770|NCT00849680|75891096|FG005|STARTED|Overall Study||42||
59770771|NCT00849680|75891097|FG006|STARTED|Overall Study||78||
59770772|NCT00849680|75891098|FG007|STARTED|Overall Study||31||
59770773|NCT00849680|75891091|FG000|COMPLETED|Overall Study||16||
59770774|NCT00849680|75891092|FG001|COMPLETED|Overall Study||10||
59770775|NCT00849680|75891093|FG002|COMPLETED|Overall Study||27||
59770776|NCT00849680|75891094|FG003|COMPLETED|Overall Study||28||
59770777|NCT00849680|75891095|FG004|COMPLETED|Overall Study||32||
59952663|NCT02696031|76071457|FG000|COMPLETED|Up to Week 104||146||
59952664|NCT02696031|76071458|FG001|COMPLETED|Up to Week 104||143||
59770778|NCT00849680|75891096|FG005|COMPLETED|Overall Study||27||
59770779|NCT00849680|75891097|FG006|COMPLETED|Overall Study||61||
59770780|NCT00849680|75891098|FG007|COMPLETED|Overall Study||23||
59770781|NCT00849680|75891091|FG000|NOT COMPLETED|Overall Study||11||
59952665|NCT02696031|76071459|FG002|COMPLETED|Up to Week 104||149||
59952666|NCT02696031|76071460|FG003|COMPLETED|Up to Week 104||0||
59952667|NCT02696031|76071461|FG004|COMPLETED|Up to Week 104||0||
59952668|NCT02696031|76071462|FG005|COMPLETED|Up to Week 104||0||
59770782|NCT00849680|75891092|FG001|NOT COMPLETED|Overall Study||3||
59770783|NCT00849680|75891093|FG002|NOT COMPLETED|Overall Study||15||
59770784|NCT00849680|75891094|FG003|NOT COMPLETED|Overall Study||14||
59770785|NCT00849680|75891095|FG004|NOT COMPLETED|Overall Study||10||
59770786|NCT00849680|75891096|FG005|NOT COMPLETED|Overall Study||15||
59770787|NCT00849680|75891097|FG006|NOT COMPLETED|Overall Study||17||
59770788|NCT00849680|75891098|FG007|NOT COMPLETED|Overall Study||8||
59770789|NCT00810342|75891118|FG000|STARTED|Month 1 Follow-up||154||
59770790|NCT00810342|75891119|FG001|STARTED|Month 1 Follow-up||157||
59770791|NCT00810342|75891118|FG000|COMPLETED|Month 1 Follow-up||149||
59770792|NCT00810342|75891119|FG001|COMPLETED|Month 1 Follow-up||155||
59770793|NCT00810342|75891118|FG000|NOT COMPLETED|Month 1 Follow-up||5||
59770794|NCT00810342|75891119|FG001|NOT COMPLETED|Month 1 Follow-up||2||
59770795|NCT00810342|75891118|FG000|STARTED|6-month Follow-up||149||
59770796|NCT00810342|75891119|FG001|STARTED|6-month Follow-up||155||
59770797|NCT00810342|75891118|FG000|COMPLETED|6-month Follow-up||125||
59770798|NCT00810342|75891119|FG001|COMPLETED|6-month Follow-up||147||
59770799|NCT00810342|75891118|FG000|NOT COMPLETED|6-month Follow-up||24||
59770800|NCT00810342|75891119|FG001|NOT COMPLETED|6-month Follow-up||8||
59770801|NCT00810342|75891118|FG000|STARTED|12-month Followup||125||
59770802|NCT00810342|75891119|FG001|STARTED|12-month Followup||147||
59770803|NCT00810342|75891118|FG000|COMPLETED|12-month Followup||113||
59770804|NCT00810342|75891119|FG001|COMPLETED|12-month Followup||136||
59770805|NCT00810342|75891118|FG000|NOT COMPLETED|12-month Followup||12||
59770806|NCT00810342|75891119|FG001|NOT COMPLETED|12-month Followup||11||
59770807|NCT00849524|75891127|FG000|STARTED|Overall Study||6||
59770808|NCT00849524|75891127|FG000|COMPLETED|Overall Study||3||
59770809|NCT00849524|75891127|FG000|NOT COMPLETED|Overall Study||3||
59770810|NCT00808080|75891131|FG000|STARTED|Overall Study||6||
59770811|NCT00808080|75891131|FG000|COMPLETED|Overall Study||0||
59770812|NCT00808080|75891131|FG000|NOT COMPLETED|Overall Study||6||
59770813|NCT00866723|75891136|FG000|STARTED|Overall Study||5||
59770814|NCT00866723|75891136|FG000|COMPLETED|Overall Study||0||
59770815|NCT00866723|75891136|FG000|NOT COMPLETED|Overall Study||5||
59770816|NCT00849212|75891140|FG000|STARTED|Overall Study||30||
59770817|NCT00849212|75891140|FG000|COMPLETED|Overall Study||23||
59770818|NCT00849212|75891140|FG000|NOT COMPLETED|Overall Study||7||
59770819|NCT00810264|75891144|FG000|STARTED|Overall Study||2499||
59770820|NCT00810264|75891144|FG000|COMPLETED|Overall Study||946||
59770821|NCT00810264|75891144|FG000|NOT COMPLETED|Overall Study||1553||
59770822|NCT00849056|75891154|FG000|STARTED|Treatment Period (TP) (156 Weeks)||151||
59770823|NCT00849056|75891155|FG001|STARTED|Treatment Period (TP) (156 Weeks)||150||
59770824|NCT00849056|75891154|FG000|COMPLETED|Treatment Period (TP) (156 Weeks)||88||
59770825|NCT00849056|75891155|FG001|COMPLETED|Treatment Period (TP) (156 Weeks)||100||
59770826|NCT00849056|75891154|FG000|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||63||
59770827|NCT00849056|75891155|FG001|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||50||
59770828|NCT00849056|75891154|FG000|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. Two par. did not participate in the FUP.|149||
59770829|NCT00849056|75891155|FG001|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. One par. did not participate in the FUP.|149||
59770830|NCT00849056|75891154|FG000|COMPLETED|Follow-up Period (FUP) (8 Weeks)||122||
59770831|NCT00849056|75891155|FG001|COMPLETED|Follow-up Period (FUP) (8 Weeks)||124||
59770832|NCT00849056|75891154|FG000|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||27||
59770833|NCT00849056|75891155|FG001|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||25||
59770834|NCT00837434|75891163|FG000|STARTED|Overall Study||43||
59770835|NCT00837434|75891164|FG001|STARTED|Overall Study||20||
59770836|NCT00837434|75891163|FG000|COMPLETED|Overall Study||34||
59770837|NCT00837434|75891164|FG001|COMPLETED|Overall Study||19||
59770838|NCT00837434|75891163|FG000|NOT COMPLETED|Overall Study||9||
59770839|NCT00837434|75891164|FG001|NOT COMPLETED|Overall Study||1||
59770840|NCT00827918|75891173|FG000|STARTED|Overall Study||86||
59770841|NCT00827918|75891174|FG001|STARTED|Overall Study||47||
59770842|NCT00827918|75891175|FG002|STARTED|Overall Study||83||
59770843|NCT00827918|75891173|FG000|COMPLETED|Overall Study||58||
59770844|NCT00827918|75891174|FG001|COMPLETED|Overall Study||38||
59770845|NCT00827918|75891175|FG002|COMPLETED|Overall Study||62||
59770846|NCT00827918|75891173|FG000|NOT COMPLETED|Overall Study||28||
59770847|NCT00827918|75891174|FG001|NOT COMPLETED|Overall Study||9||
59770848|NCT00827918|75891175|FG002|NOT COMPLETED|Overall Study||21||
59770849|NCT00813150|75891185|FG000|STARTED|Treatment Period|Number of randomized and treated participants|46||
59770850|NCT00813150|75891186|FG001|STARTED|Treatment Period|Number of randomized and treated participants|47||
59770851|NCT00813150|75891185|FG000|Intent-to-treat Participants|Treatment Period||43||
59770852|NCT00813150|75891186|FG001|Intent-to-treat Participants|Treatment Period||47||
59770853|NCT00813150|75891185|FG000|COMPLETED|Treatment Period|Participants who completed 8 cycles of treatment|14||
59770854|NCT00813150|75891186|FG001|COMPLETED|Treatment Period|Participants who completed 8 cycles of treatment|15||
59770855|NCT00813150|75891185|FG000|NOT COMPLETED|Treatment Period||32||
59770856|NCT00813150|75891186|FG001|NOT COMPLETED|Treatment Period||32||
59770857|NCT00813150|75891185|FG000|STARTED|Long Term Follow-up|Number of participants who entered follow-up phase|26||
59770858|NCT00813150|75891186|FG001|STARTED|Long Term Follow-up|Number of participants who entered follow-up phase|31||
59770859|NCT00813150|75891185|FG000|COMPLETED|Long Term Follow-up|Number of participants who completed follow-up phase|2||
59770860|NCT00813150|75891186|FG001|COMPLETED|Long Term Follow-up|Number of participants who completed follow-up phase|0||
59770861|NCT00813150|75891185|FG000|NOT COMPLETED|Long Term Follow-up||24||
59770862|NCT00813150|75891186|FG001|NOT COMPLETED|Long Term Follow-up||31||
59770863|NCT00807846|75891194|FG000|STARTED|Overall Study||100||
59770864|NCT00807846|75891195|FG001|STARTED|Overall Study||98||
59770865|NCT00807846|75891194|FG000|COMPLETED|Overall Study||88||
59770866|NCT00807846|75891195|FG001|COMPLETED|Overall Study||94||
59770867|NCT00807846|75891194|FG000|NOT COMPLETED|Overall Study||12||
59770868|NCT00807846|75891195|FG001|NOT COMPLETED|Overall Study||4||
59770869|NCT00810108|75891203|FG000|STARTED|Overall Study||6||
59770870|NCT00810108|75891204|FG001|STARTED|Overall Study||7||
59770871|NCT00810108|75891203|FG000|COMPLETED|Overall Study||5||
59770872|NCT00810108|75891204|FG001|COMPLETED|Overall Study||7||
59770873|NCT00810108|75891203|FG000|NOT COMPLETED|Overall Study||1||
59770874|NCT00810108|75891204|FG001|NOT COMPLETED|Overall Study||0||
59770875|NCT00827606|75891211|FG000|STARTED|Overall Study||139||
59770876|NCT00827606|75891212|FG001|STARTED|Overall Study||132||
59770877|NCT00827606|75891211|FG000|COMPLETED|Overall Study||112||
59770878|NCT00827606|75891212|FG001|COMPLETED|Overall Study||94||
59770879|NCT00827606|75891211|FG000|NOT COMPLETED|Overall Study||27||
59770880|NCT00827606|75891212|FG001|NOT COMPLETED|Overall Study||38||
59770881|NCT00663052|75891226|FG000|STARTED|Overall Study||136||
59770882|NCT00663052|75891227|FG001|STARTED|Overall Study||137||
59770883|NCT00663052|75891226|FG000|COMPLETED|Overall Study||124||
59770884|NCT00663052|75891227|FG001|COMPLETED|Overall Study||127||
59770885|NCT00663052|75891226|FG000|NOT COMPLETED|Overall Study||12||
59770886|NCT00663052|75891227|FG001|NOT COMPLETED|Overall Study||10||
59770887|NCT00826748|75891236|FG000|STARTED|Overall Study||6||
59770888|NCT00826748|75891237|FG001|STARTED|Overall Study||4||
59770889|NCT00826748|75891238|FG002|STARTED|Overall Study||12||
59770890|NCT00826748|75891236|FG000|COMPLETED|Overall Study||6||
59770891|NCT00826748|75891237|FG001|COMPLETED|Overall Study||4||
59952669|NCT02696031|76071457|FG000|NOT COMPLETED|Up to Week 104||39||
59952670|NCT02696031|76071458|FG001|NOT COMPLETED|Up to Week 104||41||
59952671|NCT02696031|76071459|FG002|NOT COMPLETED|Up to Week 104||37||
59952672|NCT02696031|76071460|FG003|NOT COMPLETED|Up to Week 104||0||
59952673|NCT02696031|76071461|FG004|NOT COMPLETED|Up to Week 104||0||
59952674|NCT02696031|76071462|FG005|NOT COMPLETED|Up to Week 104||0||
59952675|NCT02696031|76071457|FG000|STARTED|Extension Phase From wk 104 to wk 208||0||
59952676|NCT02696031|76071458|FG001|STARTED|Extension Phase From wk 104 to wk 208||0||
59952677|NCT02696031|76071459|FG002|STARTED|Extension Phase From wk 104 to wk 208||0||
60072649|NCT01362608|76187821|FG000|STARTED|Overall Study||67||
60072650|NCT01362608|76187822|FG001|STARTED|Overall Study||69||
60072651|NCT01362608|76187821|FG000|COMPLETED|Overall Study||63||
60072652|NCT01362608|76187822|FG001|COMPLETED|Overall Study||61||
60072653|NCT01362608|76187821|FG000|NOT COMPLETED|Overall Study||4||
60072654|NCT01362608|76187822|FG001|NOT COMPLETED|Overall Study||8||
60072655|NCT01871090|76187830|FG000|STARTED|Overall Study||35||
60072656|NCT01871090|76187831|FG001|STARTED|Overall Study||48||
60072657|NCT01871090|76187830|FG000|COMPLETED|Overall Study||33||
60072658|NCT01871090|76187831|FG001|COMPLETED|Overall Study||25||
59770892|NCT00826748|75891238|FG002|COMPLETED|Overall Study||8||
59770893|NCT00826748|75891236|FG000|NOT COMPLETED|Overall Study||0||
59770894|NCT00826748|75891237|FG001|NOT COMPLETED|Overall Study||0||
59770895|NCT00826748|75891238|FG002|NOT COMPLETED|Overall Study||4||
59770896|NCT00806988|75891248|FG000|STARTED|Overall Study||150||
59770897|NCT00806988|75891249|FG001|STARTED|Overall Study||151||
59770898|NCT00806988|75891248|FG000|COMPLETED|Overall Study||123||
59770899|NCT00806988|75891249|FG001|COMPLETED|Overall Study||108||
59770900|NCT00806988|75891248|FG000|NOT COMPLETED|Overall Study||27||
59770901|NCT00806988|75891249|FG001|NOT COMPLETED|Overall Study||43||
59770902|NCT00807144|75891257|FG000|STARTED|Overall Study||52||
59770903|NCT00807144|75891258|FG001|STARTED|Overall Study||50||
59770904|NCT00807144|75891257|FG000|COMPLETED|Overall Study||52||
59770905|NCT00807144|75891258|FG001|COMPLETED|Overall Study||49||
59770906|NCT00807144|75891257|FG000|NOT COMPLETED|Overall Study||0||
59770907|NCT00807144|75891258|FG001|NOT COMPLETED|Overall Study||1||
59770908|NCT00591006|75891264|FG000|STARTED|Overall Study||1||
59770909|NCT00591006|75891265|FG001|STARTED|Overall Study||0||
59770910|NCT00591006|75891266|FG002|STARTED|Overall Study||1||
59770911|NCT00591006|75891267|FG003|STARTED|Overall Study||1||
59952678|NCT02696031|76071460|FG003|STARTED|Extension Phase From wk 104 to wk 208||147||
60072659|NCT01871090|76187830|FG000|NOT COMPLETED|Overall Study||2||
60072660|NCT01871090|76187831|FG001|NOT COMPLETED|Overall Study||23||
60072661|NCT01818596|76187839|FG000|STARTED|Overall Study||246||
60072662|NCT01818596|76187840|FG001|STARTED|Overall Study||6||
60072663|NCT01818596|76187839|FG000|COMPLETED|Overall Study||215||
60072664|NCT01818596|76187840|FG001|COMPLETED|Overall Study||6||
60072665|NCT01818596|76187839|FG000|NOT COMPLETED|Overall Study||31||
59770912|NCT00591006|75891268|FG004|STARTED|Overall Study||1||
59770913|NCT00591006|75891269|FG005|STARTED|Overall Study||0||
59770914|NCT00591006|75891270|FG006|STARTED|Overall Study||1||
59770915|NCT00591006|75891271|FG007|STARTED|Overall Study||0||
59770916|NCT00591006|75891272|FG008|STARTED|Overall Study||1||
59770917|NCT00591006|75891273|FG009|STARTED|Overall Study||1||
59770918|NCT00591006|75891274|FG010|STARTED|Overall Study||0||
59770919|NCT00591006|75891275|FG011|STARTED|Overall Study||1||
59770920|NCT00591006|75891276|FG012|STARTED|Overall Study||1||
59770921|NCT00591006|75891277|FG013|STARTED|Overall Study||2||
59770922|NCT00591006|75891278|FG014|STARTED|Overall Study||0||
59770923|NCT00591006|75891279|FG015|STARTED|Overall Study||1||
59770924|NCT00591006|75891280|FG016|STARTED|Overall Study||0||
59770925|NCT00591006|75891281|FG017|STARTED|Overall Study||1||
59770926|NCT00591006|75891282|FG018|STARTED|Overall Study||0||
59770927|NCT00591006|75891283|FG019|STARTED|Overall Study||1||
59770928|NCT00591006|75891284|FG020|STARTED|Overall Study||0||
59770929|NCT00591006|75891285|FG021|STARTED|Overall Study||1||
59770930|NCT00591006|75891286|FG022|STARTED|Overall Study||1||
59770931|NCT00591006|75891287|FG023|STARTED|Overall Study||1||
59770932|NCT00591006|75891264|FG000|Treatment #2|Overall Study||1||
59770933|NCT00591006|75891265|FG001|Treatment #2|Overall Study||0||
59770934|NCT00591006|75891266|FG002|Treatment #2|Overall Study||1||
59770935|NCT00591006|75891267|FG003|Treatment #2|Overall Study||1||
59770936|NCT00591006|75891268|FG004|Treatment #2|Overall Study||1||
59770937|NCT00591006|75891269|FG005|Treatment #2|Overall Study||0||
59770938|NCT00591006|75891270|FG006|Treatment #2|Overall Study||1||
59770939|NCT00591006|75891271|FG007|Treatment #2|Overall Study||0||
59770940|NCT00591006|75891272|FG008|Treatment #2|Overall Study||1||
59770941|NCT00591006|75891273|FG009|Treatment #2|Overall Study||1||
59770942|NCT00591006|75891274|FG010|Treatment #2|Overall Study||0||
59770943|NCT00591006|75891275|FG011|Treatment #2|Overall Study||1||
59770944|NCT00591006|75891276|FG012|Treatment #2|Overall Study||1||
59770945|NCT00591006|75891277|FG013|Treatment #2|Overall Study||2||
59770946|NCT00591006|75891278|FG014|Treatment #2|Overall Study||0||
59770947|NCT00591006|75891279|FG015|Treatment #2|Overall Study||0||
59770948|NCT00591006|75891280|FG016|Treatment #2|Overall Study||0||
59770949|NCT00591006|75891281|FG017|Treatment #2|Overall Study||1||
59770950|NCT00591006|75891282|FG018|Treatment #2|Overall Study||0||
59770951|NCT00591006|75891283|FG019|Treatment #2|Overall Study||1||
59770952|NCT00591006|75891284|FG020|Treatment #2|Overall Study||0||
59770953|NCT00591006|75891285|FG021|Treatment #2|Overall Study||1||
59770954|NCT00591006|75891286|FG022|Treatment #2|Overall Study||1||
59770955|NCT00591006|75891287|FG023|Treatment #2|Overall Study||1||
59770956|NCT00591006|75891264|FG000|Treatment #3|Overall Study||1||
59770957|NCT00591006|75891265|FG001|Treatment #3|Overall Study||0||
59770958|NCT00591006|75891266|FG002|Treatment #3|Overall Study||1||
59770959|NCT00591006|75891267|FG003|Treatment #3|Overall Study||1||
59770960|NCT00591006|75891268|FG004|Treatment #3|Overall Study||1||
59952679|NCT02696031|76071461|FG004|STARTED|Extension Phase From wk 104 to wk 208||147||
59952680|NCT02696031|76071462|FG005|STARTED|Extension Phase From wk 104 to wk 208||78||
59952681|NCT02696031|76071457|FG000|COMPLETED|Extension Phase From wk 104 to wk 208||0||
59770961|NCT00591006|75891269|FG005|Treatment #3|Overall Study||0||
59770962|NCT00591006|75891270|FG006|Treatment #3|Overall Study||1||
59770963|NCT00591006|75891271|FG007|Treatment #3|Overall Study||0||
59770964|NCT00591006|75891272|FG008|Treatment #3|Overall Study||1||
59770965|NCT00591006|75891273|FG009|Treatment #3|Overall Study||1||
59770966|NCT00591006|75891274|FG010|Treatment #3|Overall Study||0||
59770967|NCT00591006|75891275|FG011|Treatment #3|Overall Study||1||
59770968|NCT00591006|75891276|FG012|Treatment #3|Overall Study||1||
59770969|NCT00591006|75891277|FG013|Treatment #3|Overall Study||2||
59770970|NCT00591006|75891278|FG014|Treatment #3|Overall Study||0||
59770971|NCT00591006|75891279|FG015|Treatment #3|Overall Study||0||
59770972|NCT00591006|75891280|FG016|Treatment #3|Overall Study||0||
59770973|NCT00591006|75891281|FG017|Treatment #3|Overall Study||1||
59770974|NCT00591006|75891282|FG018|Treatment #3|Overall Study||0||
59770975|NCT00591006|75891283|FG019|Treatment #3|Overall Study||1||
59770976|NCT00591006|75891284|FG020|Treatment #3|Overall Study||0||
59770977|NCT00591006|75891285|FG021|Treatment #3|Overall Study||1||
59770978|NCT00591006|75891286|FG022|Treatment #3|Overall Study||1||
59770979|NCT00591006|75891287|FG023|Treatment #3|Overall Study||1||
59770980|NCT00591006|75891264|FG000|Treatment #4|Overall Study||1||
59770981|NCT00591006|75891265|FG001|Treatment #4|Overall Study||0||
59770982|NCT00591006|75891266|FG002|Treatment #4|Overall Study||1||
59770983|NCT00591006|75891267|FG003|Treatment #4|Overall Study||1||
59770984|NCT00591006|75891268|FG004|Treatment #4|Overall Study||1||
59770985|NCT00591006|75891269|FG005|Treatment #4|Overall Study||0||
59770986|NCT00591006|75891270|FG006|Treatment #4|Overall Study||1||
59770987|NCT00591006|75891271|FG007|Treatment #4|Overall Study||0||
59770988|NCT00591006|75891272|FG008|Treatment #4|Overall Study||1||
59770989|NCT00591006|75891273|FG009|Treatment #4|Overall Study||1||
59770990|NCT00591006|75891274|FG010|Treatment #4|Overall Study||0||
59952682|NCT02696031|76071458|FG001|COMPLETED|Extension Phase From wk 104 to wk 208||0||
59770991|NCT00591006|75891275|FG011|Treatment #4|Overall Study||1||
59770992|NCT00591006|75891276|FG012|Treatment #4|Overall Study||1||
59770993|NCT00591006|75891277|FG013|Treatment #4|Overall Study||2||
59770994|NCT00591006|75891278|FG014|Treatment #4|Overall Study||0||
59770995|NCT00591006|75891279|FG015|Treatment #4|Overall Study||0||
59770996|NCT00591006|75891280|FG016|Treatment #4|Overall Study||0||
59770997|NCT00591006|75891281|FG017|Treatment #4|Overall Study||1||
59770998|NCT00591006|75891282|FG018|Treatment #4|Overall Study||0||
59770999|NCT00591006|75891283|FG019|Treatment #4|Overall Study||1||
59771000|NCT00591006|75891284|FG020|Treatment #4|Overall Study||0||
59771001|NCT00591006|75891285|FG021|Treatment #4|Overall Study||1||
59771002|NCT00591006|75891286|FG022|Treatment #4|Overall Study||0||
59771003|NCT00591006|75891287|FG023|Treatment #4|Overall Study||0||
59771004|NCT00591006|75891264|FG000|COMPLETED|Overall Study||1||
59771005|NCT00591006|75891265|FG001|COMPLETED|Overall Study||0||
59771006|NCT00591006|75891266|FG002|COMPLETED|Overall Study||1||
59771007|NCT00591006|75891267|FG003|COMPLETED|Overall Study||1||
59771008|NCT00591006|75891268|FG004|COMPLETED|Overall Study||1||
59771009|NCT00591006|75891269|FG005|COMPLETED|Overall Study||0||
59771010|NCT00591006|75891270|FG006|COMPLETED|Overall Study||1||
59771011|NCT00591006|75891271|FG007|COMPLETED|Overall Study||0||
59771012|NCT00591006|75891272|FG008|COMPLETED|Overall Study||1||
59771013|NCT00591006|75891273|FG009|COMPLETED|Overall Study||1||
59771014|NCT00591006|75891274|FG010|COMPLETED|Overall Study||0||
59771015|NCT00591006|75891275|FG011|COMPLETED|Overall Study||1||
59771016|NCT00591006|75891276|FG012|COMPLETED|Overall Study||1||
59771017|NCT00591006|75891277|FG013|COMPLETED|Overall Study||2||
59771018|NCT00591006|75891278|FG014|COMPLETED|Overall Study||0||
59771019|NCT00591006|75891279|FG015|COMPLETED|Overall Study||0||
59771020|NCT00591006|75891280|FG016|COMPLETED|Overall Study||0||
59771021|NCT00591006|75891281|FG017|COMPLETED|Overall Study||1||
59771022|NCT00591006|75891282|FG018|COMPLETED|Overall Study||0||
59771023|NCT00591006|75891283|FG019|COMPLETED|Overall Study||1||
59771024|NCT00591006|75891284|FG020|COMPLETED|Overall Study||0||
59771025|NCT00591006|75891285|FG021|COMPLETED|Overall Study||1||
59771026|NCT00591006|75891286|FG022|COMPLETED|Overall Study||0||
59771027|NCT00591006|75891287|FG023|COMPLETED|Overall Study||0||
59771028|NCT00591006|75891264|FG000|NOT COMPLETED|Overall Study||0||
59771029|NCT00591006|75891265|FG001|NOT COMPLETED|Overall Study||0||
59771030|NCT00591006|75891266|FG002|NOT COMPLETED|Overall Study||0||
59771031|NCT00591006|75891267|FG003|NOT COMPLETED|Overall Study||0||
59771032|NCT00591006|75891268|FG004|NOT COMPLETED|Overall Study||0||
59771033|NCT00591006|75891269|FG005|NOT COMPLETED|Overall Study||0||
59771034|NCT00591006|75891270|FG006|NOT COMPLETED|Overall Study||0||
59771035|NCT00591006|75891271|FG007|NOT COMPLETED|Overall Study||0||
59771036|NCT00591006|75891272|FG008|NOT COMPLETED|Overall Study||0||
59771037|NCT00591006|75891273|FG009|NOT COMPLETED|Overall Study||0||
59771038|NCT00591006|75891274|FG010|NOT COMPLETED|Overall Study||0||
59771039|NCT00591006|75891275|FG011|NOT COMPLETED|Overall Study||0||
59771040|NCT00591006|75891276|FG012|NOT COMPLETED|Overall Study||0||
59771041|NCT00591006|75891277|FG013|NOT COMPLETED|Overall Study||0||
59771042|NCT00591006|75891278|FG014|NOT COMPLETED|Overall Study||0||
59771043|NCT00591006|75891279|FG015|NOT COMPLETED|Overall Study||1||
59771044|NCT00591006|75891280|FG016|NOT COMPLETED|Overall Study||0||
59771045|NCT00591006|75891281|FG017|NOT COMPLETED|Overall Study||0||
59952683|NCT02696031|76071459|FG002|COMPLETED|Extension Phase From wk 104 to wk 208||0||
59952684|NCT02696031|76071460|FG003|COMPLETED|Extension Phase From wk 104 to wk 208||137||
59771046|NCT00591006|75891282|FG018|NOT COMPLETED|Overall Study||0||
59771047|NCT00591006|75891283|FG019|NOT COMPLETED|Overall Study||0||
59771048|NCT00591006|75891284|FG020|NOT COMPLETED|Overall Study||0||
59771049|NCT00591006|75891285|FG021|NOT COMPLETED|Overall Study||0||
59771050|NCT00591006|75891286|FG022|NOT COMPLETED|Overall Study||1||
59771051|NCT00591006|75891287|FG023|NOT COMPLETED|Overall Study||1||
59771052|NCT00844844|75891304|FG000|STARTED|Screening Period||17||
59771053|NCT00844844|75891304|FG000|COMPLETED|Screening Period||17||
59771054|NCT00844844|75891304|FG000|NOT COMPLETED|Screening Period||0||
59771055|NCT00844844|75891304|FG000|STARTED|Treatment Period (26 Weeks)||17||
59771056|NCT00844844|75891304|FG000|COMPLETED|Treatment Period (26 Weeks)||15||
59771057|NCT00844844|75891304|FG000|NOT COMPLETED|Treatment Period (26 Weeks)||2||
59771058|NCT00844844|75891304|FG000|STARTED|Extension Treatment Period||13||
59771059|NCT00844844|75891304|FG000|COMPLETED|Extension Treatment Period||11||
59771060|NCT00844844|75891304|FG000|NOT COMPLETED|Extension Treatment Period||2||
59771061|NCT00844844|75891304|FG000|STARTED|Post Treatment Period||6||
59771062|NCT00844844|75891304|FG000|COMPLETED|Post Treatment Period||5||
59771063|NCT00844844|75891304|FG000|NOT COMPLETED|Post Treatment Period||1||
59771064|NCT00660790|75891308|FG000|STARTED|Baseline to 3 Months||97||
59771065|NCT00660790|75891308|FG000|COMPLETED|Baseline to 3 Months||94||
59771066|NCT00660790|75891308|FG000|NOT COMPLETED|Baseline to 3 Months||3||
59771067|NCT00660790|75891308|FG000|STARTED|3 Months to 2 Years||94||
59771068|NCT00660790|75891308|FG000|COMPLETED|3 Months to 2 Years||77||
59771069|NCT00660790|75891308|FG000|NOT COMPLETED|3 Months to 2 Years||17||
59771070|NCT00836810|75891314|FG000|STARTED|Overall Study||5||
59771071|NCT00836810|75891315|FG001|STARTED|Overall Study||6||
59771072|NCT00836810|75891314|FG000|COMPLETED|Overall Study|1 patient was subsequently diagnosed with SLE and, per protocol, was not included.|4||
59771073|NCT00836810|75891315|FG001|COMPLETED|Overall Study||6||
59771074|NCT00836810|75891314|FG000|NOT COMPLETED|Overall Study||1||
59771075|NCT00836810|75891315|FG001|NOT COMPLETED|Overall Study||0||
59771076|NCT00658684|75891324|FG000|STARTED|Overall Study||152||
59771077|NCT00658684|75891325|FG001|STARTED|Overall Study||99||
59771078|NCT00658684|75891326|FG002|STARTED|Overall Study||25||
59771079|NCT00658684|75891327|FG003|STARTED|Overall Study||28||
59771080|NCT00658684|75891324|FG000|COMPLETED|Overall Study||133||
59771081|NCT00658684|75891325|FG001|COMPLETED|Overall Study||84||
59771082|NCT00658684|75891326|FG002|COMPLETED|Overall Study||22||
59771083|NCT00658684|75891327|FG003|COMPLETED|Overall Study||27||
59771084|NCT00658684|75891324|FG000|NOT COMPLETED|Overall Study||19||
59771085|NCT00658684|75891325|FG001|NOT COMPLETED|Overall Study||15||
59771086|NCT00658684|75891326|FG002|NOT COMPLETED|Overall Study||3||
59771087|NCT00658684|75891327|FG003|NOT COMPLETED|Overall Study||1||
59771088|NCT00660400|75891337|FG000|STARTED|Overall Study||25||
59771089|NCT00660400|75891337|FG000|COMPLETED|Overall Study||21||
59771090|NCT00660400|75891337|FG000|NOT COMPLETED|Overall Study||4||
59771091|NCT00826514|75891343|FG000|STARTED|Overall Study||30||
59771092|NCT00826514|75891344|FG001|STARTED|Overall Study||32||
59771093|NCT00826514|75891343|FG000|COMPLETED|Overall Study||27||
59771094|NCT00826514|75891344|FG001|COMPLETED|Overall Study||27||
59771095|NCT00826514|75891343|FG000|NOT COMPLETED|Overall Study||3||
59771096|NCT00826514|75891344|FG001|NOT COMPLETED|Overall Study||5||
59771097|NCT00826280|75891353|FG000|STARTED|Overall Study||114||
59771098|NCT00826280|75891354|FG001|STARTED|Overall Study||116||
59771099|NCT00826280|75891355|FG002|STARTED|Overall Study||117||
59771100|NCT00826280|75891353|FG000|Safety Analysis Set|Overall Study|Safety Analysis Set (SAF) was all randomized subjects who received at least one dose of regadenoson|113||
59771101|NCT00826280|75891354|FG001|Safety Analysis Set|Overall Study|SAF was all randomized subjects who received at least one dose of regadenoson|116||
59771102|NCT00826280|75891355|FG002|Safety Analysis Set|Overall Study|SAF was all randomized subjects who received at least one dose of regadenoson|116||
59771103|NCT00826280|75891353|FG000|Completed Treatment|Overall Study|Subjects who completed treatment but had ≥ 1 non-interpretable scan were not included in FAS|66||
59771104|NCT00826280|75891354|FG001|Completed Treatment|Overall Study|Subjects who completed treatment but had ≥ 1 non-interpretable scan were not included in FAS|71||
59771105|NCT00826280|75891355|FG002|Completed Treatment|Overall Study|Subjects who completed treatment but had ≥ 1 non-interpretable scan were not included in FAS|72||
59771106|NCT00826280|75891353|FG000|COMPLETED|Overall Study|Ending Population equals FAS, all randomized subjects with interpretable MPI scans|66||
59771107|NCT00826280|75891354|FG001|COMPLETED|Overall Study|Ending Population equals FAS, all randomized subjects with interpretable MPI scans|70||
59771108|NCT00826280|75891355|FG002|COMPLETED|Overall Study|Ending Population equals FAS, all randomized subjects with interpretable MPI scans|71||
59771109|NCT00826280|75891353|FG000|NOT COMPLETED|Overall Study||48||
59771110|NCT00826280|75891354|FG001|NOT COMPLETED|Overall Study||46||
59771111|NCT00826280|75891355|FG002|NOT COMPLETED|Overall Study||46||
59771112|NCT00864851|75891366|FG000|STARTED|Overall Study||20||
59771113|NCT00864851|75891367|FG001|STARTED|Overall Study||19||
59771114|NCT00864851|75891368|FG002|STARTED|Overall Study||5||
59771115|NCT00864851|75891366|FG000|COMPLETED|Overall Study||17||
59771116|NCT00864851|75891367|FG001|COMPLETED|Overall Study||18||
59771117|NCT00864851|75891368|FG002|COMPLETED|Overall Study||5||
59771118|NCT00864851|75891366|FG000|NOT COMPLETED|Overall Study||3||
59771119|NCT00864851|75891367|FG001|NOT COMPLETED|Overall Study||1||
59771120|NCT00864851|75891368|FG002|NOT COMPLETED|Overall Study||0||
59771121|NCT00857207|75891380|FG000|STARTED|Overall Study||48||
59771122|NCT00857207|75891381|FG001|STARTED|Overall Study||3||
59771123|NCT00857207|75891380|FG000|COMPLETED|Overall Study||14||
59771124|NCT00857207|75891381|FG001|COMPLETED|Overall Study||3||
59771125|NCT00857207|75891380|FG000|NOT COMPLETED|Overall Study||34||
59771126|NCT00857207|75891381|FG001|NOT COMPLETED|Overall Study||0||
59771127|NCT00836498|75891390|FG000|STARTED|Overall Study||44||
59771128|NCT00836498|75891391|FG001|STARTED|Overall Study||22||
59771129|NCT00836498|75891390|FG000|COMPLETED|Overall Study|Participant who discontinued the study vaccination due to AE completed the 180-day safety follow-up.|40||
59771130|NCT00836498|75891391|FG001|COMPLETED|Overall Study||21||
59771131|NCT00836498|75891390|FG000|NOT COMPLETED|Overall Study||4||
59771132|NCT00836498|75891391|FG001|NOT COMPLETED|Overall Study||1||
59771133|NCT00856973|75891401|FG000|STARTED|Overall Study||162||
59771134|NCT00856973|75891402|FG001|STARTED|Overall Study||163||
59771135|NCT00856973|75891403|FG002|STARTED|Overall Study||161||
59771136|NCT00856973|75891401|FG000|COMPLETED|Overall Study||126||
59771137|NCT00856973|75891402|FG001|COMPLETED|Overall Study||122||
59771138|NCT00856973|75891403|FG002|COMPLETED|Overall Study||123||
59771139|NCT00856973|75891401|FG000|NOT COMPLETED|Overall Study||36||
59771140|NCT00856973|75891402|FG001|NOT COMPLETED|Overall Study||41||
59771141|NCT00856973|75891403|FG002|NOT COMPLETED|Overall Study||38||
59771142|NCT00844532|75891415|FG000|STARTED|Overall Study||151||
59771143|NCT00844532|75891415|FG000|COMPLETED|Overall Study||112||
59771144|NCT00844532|75891415|FG000|NOT COMPLETED|Overall Study||39||
59771145|NCT00805194|75891421|FG000|STARTED|Overall Study|randomised patients|655||
59771146|NCT00805194|75891422|FG001|STARTED|Overall Study|randomised patients|659||
59771147|NCT00805194|75891421|FG000|COMPLETED|Overall Study||6||
59771148|NCT00805194|75891422|FG001|COMPLETED|Overall Study||5||
59771149|NCT00805194|75891421|FG000|NOT COMPLETED|Overall Study||649||
59771150|NCT00805194|75891422|FG001|NOT COMPLETED|Overall Study||654||
59771151|NCT00836186|75891433|FG000|STARTED|Overall Study||82||
59771152|NCT00836186|75891433|FG000|COMPLETED|Overall Study||81||
59771153|NCT00836186|75891433|FG000|NOT COMPLETED|Overall Study||1||
59771154|NCT00657046|75891441|FG000|STARTED|Overall Study||30||
59771155|NCT00657046|75891442|FG001|STARTED|Overall Study||32||
59771156|NCT00657046|75891443|FG002|STARTED|Overall Study||23||
59771157|NCT00657046|75891441|FG000|Had at Least 1 Post Baseline Visit|Overall Study||30||
59771158|NCT00657046|75891442|FG001|Had at Least 1 Post Baseline Visit|Overall Study||31||
59771159|NCT00657046|75891443|FG002|Had at Least 1 Post Baseline Visit|Overall Study||23||
59771160|NCT00657046|75891441|FG000|Had Visits up to Visit 18|Overall Study||28||
59771161|NCT00657046|75891442|FG001|Had Visits up to Visit 18|Overall Study||30||
59771162|NCT00657046|75891443|FG002|Had Visits up to Visit 18|Overall Study||23||
59771163|NCT00657046|75891441|FG000|COMPLETED|Overall Study||26||
59771164|NCT00657046|75891442|FG001|COMPLETED|Overall Study||29||
59771165|NCT00657046|75891443|FG002|COMPLETED|Overall Study||21||
59771166|NCT00657046|75891441|FG000|NOT COMPLETED|Overall Study||4||
59771167|NCT00657046|75891442|FG001|NOT COMPLETED|Overall Study||3||
59771168|NCT00657046|75891443|FG002|NOT COMPLETED|Overall Study||2||
59771169|NCT00856661|75891453|FG000|STARTED|Overall Study|Randomised|135||
59771170|NCT00856661|75891454|FG001|STARTED|Overall Study|Randomised|135||
59771171|NCT00856661|75891453|FG000|Treated|Overall Study||126||
59771172|NCT00856661|75891454|FG001|Treated|Overall Study||131||
59771173|NCT00856661|75891453|FG000|Randomized Not Treated|Overall Study||9||
59771174|NCT00856661|75891454|FG001|Randomized Not Treated|Overall Study||4||
59771175|NCT00856661|75891453|FG000|COMPLETED|Overall Study||108||
59771176|NCT00856661|75891454|FG001|COMPLETED|Overall Study||106||
59771177|NCT00856661|75891453|FG000|NOT COMPLETED|Overall Study||27||
59771178|NCT00856661|75891454|FG001|NOT COMPLETED|Overall Study||29||
59771179|NCT00844376|75891460|FG000|STARTED|Period 1: First Intervention||6||
59771180|NCT00844376|75891461|FG001|STARTED|Period 1: First Intervention||6||
59771181|NCT00844376|75891460|FG000|COMPLETED|Period 1: First Intervention||5||
59771182|NCT00844376|75891461|FG001|COMPLETED|Period 1: First Intervention||6||
59771183|NCT00844376|75891460|FG000|NOT COMPLETED|Period 1: First Intervention||1||
59771184|NCT00844376|75891461|FG001|NOT COMPLETED|Period 1: First Intervention||0||
59771185|NCT00844376|75891460|FG000|STARTED|Period 2: Second Intervention||5||
59771186|NCT00844376|75891461|FG001|STARTED|Period 2: Second Intervention||6||
59771187|NCT00844376|75891460|FG000|COMPLETED|Period 2: Second Intervention|Total subjects administered Test drug = 12; total subjects administered Reference drug = 11.|5||
59771188|NCT00844376|75891461|FG001|COMPLETED|Period 2: Second Intervention||6||
59771189|NCT00844376|75891460|FG000|NOT COMPLETED|Period 2: Second Intervention||0||
59771190|NCT00844376|75891461|FG001|NOT COMPLETED|Period 2: Second Intervention||0||
59771191|NCT00658606|75891469|FG000|STARTED|Overall Study||49||
59771192|NCT00658606|75891470|FG001|STARTED|Overall Study||49||
59771193|NCT00658606|75891469|FG000|Completed Treatment|Overall Study||42||
59771194|NCT00658606|75891470|FG001|Completed Treatment|Overall Study||44||
59771195|NCT00658606|75891469|FG000|COMPLETED|Overall Study|Represents patients who completed follow-up|33||
59771196|NCT00658606|75891470|FG001|COMPLETED|Overall Study|Represents patients who completed follow-up|26||
59771197|NCT00658606|75891469|FG000|NOT COMPLETED|Overall Study||16||
59771198|NCT00658606|75891470|FG001|NOT COMPLETED|Overall Study||23||
59771199|NCT00589290|75891476|FG000|STARTED|Overall Study||41||
59771200|NCT00589290|75891476|FG000|COMPLETED|Overall Study||40||
59771201|NCT00589290|75891476|FG000|NOT COMPLETED|Overall Study||1||
59771202|NCT00843518|75891484|FG000|STARTED|Period 2 (Double-blind Treatment)||63||
59771203|NCT00843518|75891485|FG001|STARTED|Period 2 (Double-blind Treatment)||69||
59771204|NCT00843518|75891484|FG000|COMPLETED|Period 2 (Double-blind Treatment)||43||
59771205|NCT00843518|75891485|FG001|COMPLETED|Period 2 (Double-blind Treatment)||49||
59771206|NCT00843518|75891484|FG000|NOT COMPLETED|Period 2 (Double-blind Treatment)||20||
59771207|NCT00843518|75891485|FG001|NOT COMPLETED|Period 2 (Double-blind Treatment)||20||
59771208|NCT00843518|75891484|FG000|STARTED|Period 3 (Single-blind Washout)|1 LY451395 participant completed double-blind treatment, but did not enter washout period.|42||
59771209|NCT00843518|75891485|FG001|STARTED|Period 3 (Single-blind Washout)||49||
59771210|NCT00843518|75891484|FG000|COMPLETED|Period 3 (Single-blind Washout)||42||
59771211|NCT00843518|75891485|FG001|COMPLETED|Period 3 (Single-blind Washout)||49||
59771212|NCT00843518|75891484|FG000|NOT COMPLETED|Period 3 (Single-blind Washout)||0||
59771213|NCT00843518|75891485|FG001|NOT COMPLETED|Period 3 (Single-blind Washout)||0||
59771214|NCT00843284|75891495|FG000|STARTED|Overall Study||691||
59771215|NCT00843284|75891495|FG000|COMPLETED|Overall Study||619||
59771216|NCT00843284|75891495|FG000|NOT COMPLETED|Overall Study||72||
59771217|NCT02972892|75891501|FG000|STARTED|Overall Study||110||
59771218|NCT02972892|75891502|FG001|STARTED|Overall Study||118||
59771219|NCT02972892|75891501|FG000|COMPLETED|Overall Study||101||
59771220|NCT02972892|75891502|FG001|COMPLETED|Overall Study||116||
59771221|NCT02972892|75891501|FG000|NOT COMPLETED|Overall Study||9||
59771222|NCT02972892|75891502|FG001|NOT COMPLETED|Overall Study||2||
59771223|NCT00652834|75891512|FG000|STARTED|Overall Study||23||
59771224|NCT00652834|75891512|FG000|COMPLETED|Overall Study|3 subjects withdrew after completing baseline questionnaire. 2 did not complete 30-day visit.|18||
59771225|NCT00652834|75891512|FG000|NOT COMPLETED|Overall Study||5||
59771226|NCT00825812|75891520|FG000|STARTED|Overall Study||29||
59771227|NCT00825812|75891521|FG001|STARTED|Overall Study||32||
59771228|NCT00825812|75891522|FG002|STARTED|Overall Study||126||
59771229|NCT00825812|75891523|FG003|STARTED|Overall Study||121||
59771230|NCT00825812|75891520|FG000|TREATED|Overall Study||29||
59771231|NCT00825812|75891521|FG001|TREATED|Overall Study||31||
59771232|NCT00825812|75891522|FG002|TREATED|Overall Study||120||
59771233|NCT00825812|75891523|FG003|TREATED|Overall Study||111||
59771234|NCT00825812|75891520|FG000|COMPLETED|Overall Study||29||
59771235|NCT00825812|75891521|FG001|COMPLETED|Overall Study||31||
59771236|NCT00825812|75891522|FG002|COMPLETED|Overall Study||120||
59771237|NCT00825812|75891523|FG003|COMPLETED|Overall Study||111||
59771238|NCT00825812|75891520|FG000|NOT COMPLETED|Overall Study||0||
59771239|NCT00825812|75891521|FG001|NOT COMPLETED|Overall Study||1||
59771240|NCT00825812|75891522|FG002|NOT COMPLETED|Overall Study||6||
59771241|NCT00825812|75891523|FG003|NOT COMPLETED|Overall Study||10||
59771242|NCT00824720|75891536|FG000|STARTED|Overall Study|3 subjects in the high dose group did not receive device - unable to insert.|19||
59771243|NCT00824720|75891537|FG001|STARTED|Overall Study|1 subject in the low dose group did not receive device - unable to insert.|16||
59771244|NCT00824720|75891538|FG002|STARTED|Overall Study||20||
59771245|NCT00824720|75891536|FG000|COMPLETED|Overall Study||16||
59771246|NCT00824720|75891537|FG001|COMPLETED|Overall Study||15||
59771247|NCT00824720|75891538|FG002|COMPLETED|Overall Study||19||
59771248|NCT00824720|75891536|FG000|NOT COMPLETED|Overall Study||3||
59771249|NCT00824720|75891537|FG001|NOT COMPLETED|Overall Study||1||
59771250|NCT00824720|75891538|FG002|NOT COMPLETED|Overall Study||1||
59771251|NCT03704064|75891548|FG000|STARTED|Overall Study||52||
59771252|NCT03704064|75891549|FG001|STARTED|Overall Study||53||
59771253|NCT03704064|75891548|FG000|Week 20|Overall Study||44||
59771254|NCT03704064|75891549|FG001|Week 20|Overall Study||46||
59771255|NCT03704064|75891548|FG000|Week 46|Overall Study||44||
59771256|NCT03704064|75891549|FG001|Week 46|Overall Study||46||
59771257|NCT03704064|75891548|FG000|Week 72|Overall Study||42||
59771258|NCT03704064|75891549|FG001|Week 72|Overall Study||47||
59771259|NCT03704064|75891548|FG000|COMPLETED|Overall Study||42||
59771260|NCT03704064|75891549|FG001|COMPLETED|Overall Study||47||
59771261|NCT03704064|75891548|FG000|NOT COMPLETED|Overall Study||10||
59771262|NCT03704064|75891549|FG001|NOT COMPLETED|Overall Study||6||
59771263|NCT00824564|75891557|FG000|STARTED|Overall Study||42||
59771264|NCT00824564|75891558|FG001|STARTED|Overall Study||40||
59771265|NCT00824564|75891557|FG000|Treated|Overall Study||41||
59771266|NCT00824564|75891558|FG001|Treated|Overall Study||40||
59771267|NCT00824564|75891557|FG000|COMPLETED|Overall Study||34||
59771268|NCT00824564|75891558|FG001|COMPLETED|Overall Study||30||
59771269|NCT00824564|75891557|FG000|NOT COMPLETED|Overall Study||8||
59771270|NCT00824564|75891558|FG001|NOT COMPLETED|Overall Study||10||
59771271|NCT00658528|75891566|FG000|STARTED|Overall Study|Treated|531||
59771272|NCT00658528|75891567|FG001|STARTED|Overall Study|Treated|524||
59771273|NCT00658528|75891566|FG000|COMPLETED|Overall Study||491||
59771274|NCT00658528|75891567|FG001|COMPLETED|Overall Study||479||
59771275|NCT00658528|75891566|FG000|NOT COMPLETED|Overall Study||40||
59771276|NCT00658528|75891567|FG001|NOT COMPLETED|Overall Study||45||
59771277|NCT00856583|75891575|FG000|STARTED|Overall Study|Patients treated|4905||
59771278|NCT00856583|75891576|FG001|STARTED|Overall Study|Patients treated|4904||
59771279|NCT00856583|75891575|FG000|COMPLETED|Overall Study|Patients who were still on study drug at the time of study closure|1768||
59771280|NCT00856583|75891576|FG001|COMPLETED|Overall Study|Patients who were still on study drug at the time of study closure|2307||
59771281|NCT00856583|75891575|FG000|NOT COMPLETED|Overall Study||3137||
59771282|NCT00856583|75891576|FG001|NOT COMPLETED|Overall Study||2597||
59771283|NCT00856349|75891582|FG000|STARTED|Overall Study||4132||
59771284|NCT00856349|75891582|FG000|12 Month Follow-up|Overall Study||3228||
59771285|NCT00856349|75891582|FG000|18 Month Follow-up|Overall Study||2467||
59771286|NCT00856349|75891582|FG000|24 Month Follow-up|Overall Study||1698||
59771287|NCT00856349|75891582|FG000|COMPLETED|Overall Study||3111||
59771288|NCT00856349|75891582|FG000|NOT COMPLETED|Overall Study||1021||
59771289|NCT00803244|75891590|FG000|STARTED|Overall Study||188||
59771290|NCT00803244|75891591|FG001|STARTED|Overall Study||193||
59771291|NCT00803244|75891590|FG000|COMPLETED|Overall Study||181||
59771292|NCT00803244|75891591|FG001|COMPLETED|Overall Study||178||
59771293|NCT00803244|75891590|FG000|NOT COMPLETED|Overall Study||7||
59771294|NCT00803244|75891591|FG001|NOT COMPLETED|Overall Study||15||
59771295|NCT00804570|75891599|FG000|STARTED|Overall Study||187||
59771296|NCT00804570|75891600|FG001|STARTED|Overall Study||188||
59771297|NCT00804570|75891599|FG000|COMPLETED|Overall Study||115||
59771298|NCT00804570|75891600|FG001|COMPLETED|Overall Study||94||
59771299|NCT00804570|75891599|FG000|NOT COMPLETED|Overall Study||72||
59771300|NCT00804570|75891600|FG001|NOT COMPLETED|Overall Study||94||
59771301|NCT00824408|75891612|FG000|STARTED|Run-in Phase||6||
59771302|NCT00824408|75891613|FG001|STARTED|Run-in Phase||6||
59771303|NCT00824408|75891614|FG002|STARTED|Run-in Phase||0||
59771304|NCT00824408|75891615|FG003|STARTED|Run-in Phase||0||
59771305|NCT00824408|75891616|FG004|STARTED|Run-in Phase||0||
59771306|NCT00824408|75891612|FG000|COMPLETED|Run-in Phase||0||
59771307|NCT00824408|75891613|FG001|COMPLETED|Run-in Phase||0||
59771308|NCT00824408|75891614|FG002|COMPLETED|Run-in Phase||0||
59771309|NCT00824408|75891615|FG003|COMPLETED|Run-in Phase||0||
59771310|NCT00824408|75891616|FG004|COMPLETED|Run-in Phase||0||
59771311|NCT00824408|75891612|FG000|NOT COMPLETED|Run-in Phase||6||
59771312|NCT00824408|75891613|FG001|NOT COMPLETED|Run-in Phase||6||
59771313|NCT00824408|75891614|FG002|NOT COMPLETED|Run-in Phase||0||
59771314|NCT00824408|75891615|FG003|NOT COMPLETED|Run-in Phase||0||
59771315|NCT00824408|75891616|FG004|NOT COMPLETED|Run-in Phase||0||
59771316|NCT00824408|75891612|FG000|STARTED|Randomized Phase||0||
59771317|NCT00824408|75891613|FG001|STARTED|Randomized Phase||0||
59771318|NCT00824408|75891614|FG002|STARTED|Randomized Phase||37||
59771319|NCT00824408|75891615|FG003|STARTED|Randomized Phase||47||
59771320|NCT00824408|75891616|FG004|STARTED|Randomized Phase||47||
59771321|NCT00824408|75891612|FG000|COMPLETED|Randomized Phase||0||
59771322|NCT00824408|75891613|FG001|COMPLETED|Randomized Phase||0||
59771323|NCT00824408|75891614|FG002|COMPLETED|Randomized Phase|On-treatment at data cutoff (21Dec2012)|1||
59771324|NCT00824408|75891615|FG003|COMPLETED|Randomized Phase|On-treatment at data cutoff (21Dec2012)|1||
59771325|NCT00824408|75891616|FG004|COMPLETED|Randomized Phase|On-treatment at data cutoff (21Dec2012)|1||
59771326|NCT00824408|75891612|FG000|NOT COMPLETED|Randomized Phase||0||
59771327|NCT00824408|75891613|FG001|NOT COMPLETED|Randomized Phase||0||
59771328|NCT00824408|75891614|FG002|NOT COMPLETED|Randomized Phase||36||
59771329|NCT00824408|75891615|FG003|NOT COMPLETED|Randomized Phase||46||
59771330|NCT00824408|75891616|FG004|NOT COMPLETED|Randomized Phase||46||
59771331|NCT00866333|75891637|FG000|STARTED|Overall Study||16||
59771332|NCT00866333|75891638|FG001|STARTED|Overall Study||17||
59771333|NCT00866333|75891639|FG002|STARTED|Overall Study||16||
59771334|NCT00866333|75891637|FG000|COMPLETED|Overall Study||11||
59771335|NCT00866333|75891638|FG001|COMPLETED|Overall Study||10||
59771336|NCT00866333|75891639|FG002|COMPLETED|Overall Study||4||
59771337|NCT00866333|75891637|FG000|NOT COMPLETED|Overall Study||5||
59771338|NCT00866333|75891638|FG001|NOT COMPLETED|Overall Study||7||
59771339|NCT00866333|75891639|FG002|NOT COMPLETED|Overall Study||12||
59771340|NCT00834080|75891647|FG000|STARTED|Overall Study||38||
59771341|NCT00834080|75891647|FG000|COMPLETED|Overall Study||15||
59771342|NCT00834080|75891647|FG000|NOT COMPLETED|Overall Study||23||
59771343|NCT00823472|75891653|FG000|STARTED|Overall Study||80||
59771344|NCT00823472|75891654|FG001|STARTED|Overall Study||67||
59771345|NCT00823472|75891653|FG000|COMPLETED|Overall Study||56||
59771346|NCT00823472|75891654|FG001|COMPLETED|Overall Study||39||
59771347|NCT00823472|75891653|FG000|NOT COMPLETED|Overall Study||24||
59771348|NCT00823472|75891654|FG001|NOT COMPLETED|Overall Study||28||
59771349|NCT00856193|75891660|FG000|STARTED|Period 1||16||
59771350|NCT00856193|75891661|FG001|STARTED|Period 1||17||
59771351|NCT00856193|75891660|FG000|COMPLETED|Period 1||16||
59771352|NCT00856193|75891661|FG001|COMPLETED|Period 1||17||
59771353|NCT00856193|75891660|FG000|NOT COMPLETED|Period 1||0||
59771354|NCT00856193|75891661|FG001|NOT COMPLETED|Period 1||0||
59771355|NCT00856193|75891660|FG000|STARTED|Period 2||16||
59771356|NCT00856193|75891661|FG001|STARTED|Period 2||17||
59771357|NCT00856193|75891660|FG000|COMPLETED|Period 2||16||
59771358|NCT00856193|75891661|FG001|COMPLETED|Period 2||15||
59771359|NCT00856193|75891660|FG000|NOT COMPLETED|Period 2||0||
59771360|NCT00856193|75891661|FG001|NOT COMPLETED|Period 2||2||
59771361|NCT00652366|75891672|FG000|STARTED|Overall Study||106||
59771362|NCT00652366|75891673|FG001|STARTED|Overall Study||75||
59771363|NCT00652366|75891674|FG002|STARTED|Overall Study||71||
59771364|NCT00652366|75891675|FG003|STARTED|Overall Study||179||
59771365|NCT00652366|75891676|FG004|STARTED|Overall Study||36||
59771366|NCT00652366|75891672|FG000|COMPLETED|Overall Study||0||
59771367|NCT00652366|75891673|FG001|COMPLETED|Overall Study||0||
59771368|NCT00652366|75891674|FG002|COMPLETED|Overall Study||0||
59952685|NCT02696031|76071461|FG004|COMPLETED|Extension Phase From wk 104 to wk 208||132||
59771369|NCT00652366|75891675|FG003|COMPLETED|Overall Study||0||
59771370|NCT00652366|75891676|FG004|COMPLETED|Overall Study||0||
59771371|NCT00652366|75891672|FG000|NOT COMPLETED|Overall Study||106||
59771372|NCT00652366|75891673|FG001|NOT COMPLETED|Overall Study||75||
59771373|NCT00652366|75891674|FG002|NOT COMPLETED|Overall Study||71||
59771374|NCT00652366|75891675|FG003|NOT COMPLETED|Overall Study||179||
59771375|NCT00652366|75891676|FG004|NOT COMPLETED|Overall Study||36||
59771376|NCT00841568|75891690|FG000|STARTED|Overall Study||17||
59771377|NCT00841568|75891690|FG000|COMPLETED|Overall Study||12||
59771378|NCT00841568|75891690|FG000|NOT COMPLETED|Overall Study||5||
59771379|NCT00855959|75891698|FG000|STARTED|Overall Study||108||
59771380|NCT00855959|75891698|FG000|Patients Who Received Pulmicort Respules|Overall Study||105||
59771381|NCT00855959|75891698|FG000|COMPLETED|Overall Study||99||
59771382|NCT00855959|75891698|FG000|NOT COMPLETED|Overall Study||9||
59771383|NCT00841100|75891702|FG000|STARTED|Acute Component (24 Hours)||21||
59771384|NCT00841100|75891702|FG000|COMPLETED|Acute Component (24 Hours)||21||
59771385|NCT00841100|75891702|FG000|NOT COMPLETED|Acute Component (24 Hours)||0||
59952686|NCT02696031|76071462|FG005|COMPLETED|Extension Phase From wk 104 to wk 208||72||
59771386|NCT00841100|75891702|FG000|STARTED|Phase 1 (28 Days)|3 participants from the acute phase elected not to continue to the Phase 1 component of the study.|18||
59771387|NCT00841100|75891702|FG000|COMPLETED|Phase 1 (28 Days)||15||
59771388|NCT00841100|75891702|FG000|NOT COMPLETED|Phase 1 (28 Days)||3||
59771389|NCT00841100|75891702|FG000|STARTED|Phase 2 (2 Weeks)|Participants who were non-responsive on the Phase 1 component of the study continued on to Phase 2.|5||
59771390|NCT00841100|75891702|FG000|COMPLETED|Phase 2 (2 Weeks)||5||
59771391|NCT00841100|75891702|FG000|NOT COMPLETED|Phase 2 (2 Weeks)||0||
59771392|NCT00841100|75891702|FG000|STARTED|Phase 3 (28 Days)|Participants who achieved a fasting blood phenylalanine of <600 umol/l can continue to Phase 3.|4||
59771393|NCT00841100|75891702|FG000|COMPLETED|Phase 3 (28 Days)||4||
59771394|NCT00841100|75891702|FG000|NOT COMPLETED|Phase 3 (28 Days)||0||
59771395|NCT00651820|75891706|FG000|STARTED|Overall Study||28||
59771396|NCT00651820|75891706|FG000|COMPLETED|Overall Study||26||
59771397|NCT00651820|75891706|FG000|NOT COMPLETED|Overall Study||2||
59771398|NCT00866177|75891712|FG000|STARTED|Overall Study||167||
59771399|NCT00866177|75891712|FG000|COMPLETED|Overall Study||15||
59771400|NCT00866177|75891712|FG000|NOT COMPLETED|Overall Study||152||
59771401|NCT00833924|75891716|FG000|STARTED|Overall Study||120||
59771402|NCT00833924|75891716|FG000|30-day|Overall Study||120||
59771403|NCT00833924|75891716|FG000|12-month|Overall Study||113||
59771404|NCT00833924|75891716|FG000|COMPLETED|Overall Study||11||
59771405|NCT00833924|75891716|FG000|NOT COMPLETED|Overall Study||109||
59771406|NCT00840086|75891720|FG000|STARTED|Overall Study||150||
59771407|NCT00840086|75891720|FG000|COMPLETED|Overall Study||146||
59771408|NCT00840086|75891720|FG000|NOT COMPLETED|Overall Study||4||
59771409|NCT00822926|75891729|FG000|STARTED|First Injection Visit||2||
59771410|NCT00822926|75891730|FG001|STARTED|First Injection Visit||3||
59771411|NCT00822926|75891729|FG000|COMPLETED|First Injection Visit||2||
59771412|NCT00822926|75891730|FG001|COMPLETED|First Injection Visit||3||
59771413|NCT00822926|75891729|FG000|NOT COMPLETED|First Injection Visit||0||
59771414|NCT00822926|75891730|FG001|NOT COMPLETED|First Injection Visit||0||
59771415|NCT00822926|75891729|FG000|STARTED|Washout (Varies Based on Scheduling)||2||
59771416|NCT00822926|75891730|FG001|STARTED|Washout (Varies Based on Scheduling)||3||
59771417|NCT00822926|75891729|FG000|COMPLETED|Washout (Varies Based on Scheduling)||2||
59771418|NCT00822926|75891730|FG001|COMPLETED|Washout (Varies Based on Scheduling)||3||
59771419|NCT00822926|75891729|FG000|NOT COMPLETED|Washout (Varies Based on Scheduling)||0||
59771420|NCT00822926|75891730|FG001|NOT COMPLETED|Washout (Varies Based on Scheduling)||0||
59771421|NCT00822926|75891729|FG000|STARTED|Second Injection Visit||2||
59771422|NCT00822926|75891730|FG001|STARTED|Second Injection Visit||3||
59771423|NCT00822926|75891729|FG000|COMPLETED|Second Injection Visit||1||
59771424|NCT00822926|75891730|FG001|COMPLETED|Second Injection Visit||2||
59771425|NCT00822926|75891729|FG000|NOT COMPLETED|Second Injection Visit||1||
59771426|NCT00822926|75891730|FG001|NOT COMPLETED|Second Injection Visit||1||
59771427|NCT00822770|75891741|FG000|STARTED|Overall Study||18||
59771428|NCT00822770|75891742|FG001|STARTED|Overall Study||29||
59771429|NCT00822770|75891741|FG000|COMPLETED|Overall Study||15||
59771430|NCT00822770|75891742|FG001|COMPLETED|Overall Study||28||
59771431|NCT00822770|75891741|FG000|NOT COMPLETED|Overall Study||3||
59771432|NCT00822770|75891742|FG001|NOT COMPLETED|Overall Study||1||
59771433|NCT00822692|75891750|FG000|STARTED|Overall Study|July 1, 2008|63||
59771434|NCT00822692|75891751|FG001|STARTED|Overall Study|July 1, 2008|76||
59771435|NCT00822692|75891750|FG000|COMPLETED|Overall Study|June 1, 2009|46||
59771436|NCT00822692|75891751|FG001|COMPLETED|Overall Study|June 1 , 2009|51||
59952687|NCT02696031|76071457|FG000|NOT COMPLETED|Extension Phase From wk 104 to wk 208||0||
59952688|NCT02696031|76071458|FG001|NOT COMPLETED|Extension Phase From wk 104 to wk 208||0||
59952689|NCT02696031|76071459|FG002|NOT COMPLETED|Extension Phase From wk 104 to wk 208||0||
59952690|NCT02696031|76071460|FG003|NOT COMPLETED|Extension Phase From wk 104 to wk 208||10||
59952691|NCT02696031|76071461|FG004|NOT COMPLETED|Extension Phase From wk 104 to wk 208||15||
59952692|NCT02696031|76071462|FG005|NOT COMPLETED|Extension Phase From wk 104 to wk 208||6||
59771437|NCT00822692|75891750|FG000|NOT COMPLETED|Overall Study||17||
59771438|NCT00822692|75891751|FG001|NOT COMPLETED|Overall Study||25||
59771439|NCT00806442|75891757|FG000|STARTED|Overall Study||18||
59771440|NCT00806442|75891758|FG001|STARTED|Overall Study||21||
59771441|NCT00806442|75891757|FG000|First Intervention (3 Wks)|Overall Study||18||
59771442|NCT00806442|75891758|FG001|First Intervention (3 Wks)|Overall Study||21||
59771443|NCT00806442|75891757|FG000|Washout (3 Wks)|Overall Study||15||
59771444|NCT00806442|75891758|FG001|Washout (3 Wks)|Overall Study||14||
59771445|NCT00806442|75891757|FG000|Second Intervention (3 Wks)|Overall Study||15||
59771446|NCT00806442|75891758|FG001|Second Intervention (3 Wks)|Overall Study||14||
59771447|NCT00806442|75891757|FG000|COMPLETED|Overall Study||14||
59771448|NCT00806442|75891758|FG001|COMPLETED|Overall Study||14||
59771449|NCT00806442|75891757|FG000|NOT COMPLETED|Overall Study||4||
59771450|NCT00806442|75891758|FG001|NOT COMPLETED|Overall Study||7||
59771451|NCT00821678|75891768|FG000|STARTED|Overall Study||133||
59771452|NCT00821678|75891769|FG001|STARTED|Overall Study||132||
59771453|NCT00821678|75891768|FG000|COMPLETED|Overall Study||112||
59771454|NCT00821678|75891769|FG001|COMPLETED|Overall Study||118||
59771455|NCT00821678|75891768|FG000|NOT COMPLETED|Overall Study||21||
59771456|NCT00821678|75891769|FG001|NOT COMPLETED|Overall Study||14||
59771457|NCT00839852|75891777|FG000|STARTED|Overall Study||93||
59771458|NCT00839852|75891777|FG000|COMPLETED|Overall Study||46||
59771459|NCT00839852|75891777|FG000|NOT COMPLETED|Overall Study||47||
59771460|NCT00833690|75891784|FG000|STARTED|Overall Study||25||
59771461|NCT00833690|75891785|FG001|STARTED|Overall Study||24||
59771462|NCT00833690|75891786|FG002|STARTED|Overall Study||26||
59771463|NCT00833690|75891784|FG000|COMPLETED|Overall Study||21||
59771464|NCT00833690|75891785|FG001|COMPLETED|Overall Study||22||
59771465|NCT00833690|75891786|FG002|COMPLETED|Overall Study||26||
59771466|NCT00833690|75891784|FG000|NOT COMPLETED|Overall Study||4||
59771467|NCT00833690|75891785|FG001|NOT COMPLETED|Overall Study||2||
59771468|NCT00833690|75891786|FG002|NOT COMPLETED|Overall Study||0||
59771469|NCT00820898|75891794|FG000|STARTED|Overall Study||24||
59771470|NCT00820898|75891794|FG000|COMPLETED|Overall Study||23|Eligible and treated patients|
59771471|NCT00820898|75891794|FG000|NOT COMPLETED|Overall Study||1||
59771472|NCT00865709|75891806|FG000|STARTED|Treatment||97||
59771473|NCT00865709|75891807|FG001|STARTED|Treatment||101||
59771474|NCT00865709|75891806|FG000|Received Treatment|Treatment|Safety population|97||
59771475|NCT00865709|75891807|FG001|Received Treatment|Treatment|Safety population|101||
59771476|NCT00865709|75891806|FG000|COMPLETED|Treatment|Patients who continued treatment at data cut-off or discontinued treatment due to PD or death|67||
59771477|NCT00865709|75891807|FG001|COMPLETED|Treatment|Patients who continued treatment at data cut-off or discontinued treatment due to PD or death|83||
59771478|NCT00865709|75891806|FG000|NOT COMPLETED|Treatment||30||
59771479|NCT00865709|75891807|FG001|NOT COMPLETED|Treatment||18||
59771480|NCT00865709|75891806|FG000|STARTED|Active Follow-up||25||
59771481|NCT00865709|75891807|FG001|STARTED|Active Follow-up||16||
59771482|NCT00865709|75891806|FG000|COMPLETED|Active Follow-up||17||
59771483|NCT00865709|75891807|FG001|COMPLETED|Active Follow-up||15||
59771484|NCT00865709|75891806|FG000|NOT COMPLETED|Active Follow-up||8||
59771485|NCT00865709|75891807|FG001|NOT COMPLETED|Active Follow-up||1||
59771486|NCT00865709|75891806|FG000|STARTED|Long Term Follow-up||70||
59771487|NCT00865709|75891807|FG001|STARTED|Long Term Follow-up||82||
59771488|NCT00865709|75891806|FG000|COMPLETED|Long Term Follow-up||24||
59771489|NCT00865709|75891807|FG001|COMPLETED|Long Term Follow-up||33||
59771490|NCT00865709|75891806|FG000|NOT COMPLETED|Long Term Follow-up||46||
59771491|NCT00865709|75891807|FG001|NOT COMPLETED|Long Term Follow-up||49||
59771492|NCT00839306|75891817|FG000|STARTED|Overall Study|Treated|60||
59771493|NCT00839306|75891818|FG001|STARTED|Overall Study|Treated|177||
59771494|NCT00839306|75891817|FG000|COMPLETED|Overall Study||35||
59771495|NCT00839306|75891818|FG001|COMPLETED|Overall Study||134||
59771496|NCT00839306|75891817|FG000|NOT COMPLETED|Overall Study||25||
59771497|NCT00839306|75891818|FG001|NOT COMPLETED|Overall Study||43||
59771498|NCT00839072|75891825|FG000|STARTED|First Intervention Period||12||
59771499|NCT00839072|75891826|FG001|STARTED|First Intervention Period||12||
59771500|NCT00839072|75891825|FG000|COMPLETED|First Intervention Period||10||
59771501|NCT00839072|75891826|FG001|COMPLETED|First Intervention Period||11||
59771502|NCT00839072|75891825|FG000|NOT COMPLETED|First Intervention Period||2||
59771503|NCT00839072|75891826|FG001|NOT COMPLETED|First Intervention Period||1||
59771504|NCT00839072|75891825|FG000|STARTED|Washout Period of 7 Days||10||
59771505|NCT00839072|75891826|FG001|STARTED|Washout Period of 7 Days||11||
59771506|NCT00839072|75891825|FG000|COMPLETED|Washout Period of 7 Days||10||
59771507|NCT00839072|75891826|FG001|COMPLETED|Washout Period of 7 Days||11||
59771508|NCT00839072|75891825|FG000|NOT COMPLETED|Washout Period of 7 Days||0||
59771509|NCT00839072|75891826|FG001|NOT COMPLETED|Washout Period of 7 Days||0||
59771510|NCT00839072|75891825|FG000|STARTED|Second Intervention Period||10||
59771511|NCT00839072|75891826|FG001|STARTED|Second Intervention Period||11||
59771512|NCT00839072|75891825|FG000|COMPLETED|Second Intervention Period||9||
59771513|NCT00839072|75891826|FG001|COMPLETED|Second Intervention Period||11||
59771514|NCT00839072|75891825|FG000|NOT COMPLETED|Second Intervention Period||1||
59771515|NCT00839072|75891826|FG001|NOT COMPLETED|Second Intervention Period||0||
59771516|NCT00855803|75891832|FG000|STARTED|Overall Study||35||
59771517|NCT00855803|75891832|FG000|COMPLETED|Overall Study||21||
59771518|NCT00855803|75891832|FG000|NOT COMPLETED|Overall Study||14||
59771519|NCT00838916|75891838|FG000|STARTED|Treatment Period (156 Weeks)||504||
59952693|NCT00397254|76071471|FG000|STARTED|Overall Study||79||
59952694|NCT00397254|76071472|FG001|STARTED|Overall Study||76||
59952695|NCT00397254|76071471|FG000|COMPLETED|Overall Study||77||
59771520|NCT00838916|75891839|FG001|STARTED|Treatment Period (156 Weeks)||241||
59771521|NCT00838916|75891838|FG000|COMPLETED|Treatment Period (156 Weeks)||308||
59771522|NCT00838916|75891839|FG001|COMPLETED|Treatment Period (156 Weeks)||164||
59771523|NCT00838916|75891838|FG000|NOT COMPLETED|Treatment Period (156 Weeks)||196||
59771524|NCT00838916|75891839|FG001|NOT COMPLETED|Treatment Period (156 Weeks)||77||
59771525|NCT00838916|75891838|FG000|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|504||
59771526|NCT00838916|75891839|FG001|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|241||
59952696|NCT00397254|76071472|FG001|COMPLETED|Overall Study||74||
59952697|NCT00397254|76071471|FG000|NOT COMPLETED|Overall Study||2||
59952698|NCT00397254|76071472|FG001|NOT COMPLETED|Overall Study||2||
59952699|NCT01369641|76071476|FG000|STARTED|Overall Study||1||
59952700|NCT01369641|76071476|FG000|COMPLETED|Overall Study||0||
59771527|NCT00838916|75891838|FG000|COMPLETED|Follow-up Period (8 Weeks)||408||
59771528|NCT00838916|75891839|FG001|COMPLETED|Follow-up Period (8 Weeks)||190||
59771529|NCT00838916|75891838|FG000|NOT COMPLETED|Follow-up Period (8 Weeks)||96||
59771530|NCT00838916|75891839|FG001|NOT COMPLETED|Follow-up Period (8 Weeks)||51||
59771531|NCT00838682|75891847|FG000|STARTED|Overall Study||54||
59771532|NCT00838682|75891848|FG001|STARTED|Overall Study||52||
59771533|NCT00838682|75891847|FG000|COMPLETED|Overall Study||29||
59771534|NCT00838682|75891848|FG001|COMPLETED|Overall Study||33||
59771535|NCT00838682|75891847|FG000|NOT COMPLETED|Overall Study||25||
59771536|NCT00838682|75891848|FG001|NOT COMPLETED|Overall Study||19||
59771537|NCT00820040|75891854|FG000|STARTED|Overall Study||10||
59771538|NCT00820040|75891854|FG000|Safety Evaluable Population|Overall Study||8||
59771539|NCT00820040|75891854|FG000|Full Analysis Set|Overall Study||8||
59771540|NCT00820040|75891854|FG000|COMPLETED|Overall Study||7||
59771541|NCT00820040|75891854|FG000|NOT COMPLETED|Overall Study||3||
59771542|NCT00803712|75891860|FG000|STARTED|Overall Study|154 participants were randomized to the cinacalcet group|154||
59771543|NCT00803712|75891861|FG001|STARTED|Overall Study|155 participants were randomized to the control group|155||
59771544|NCT00803712|75891860|FG000|Full Analysis Set|Overall Study|153 participants randomized and had at least one PTH concentration available after study day 1.|153||
59771545|NCT00803712|75891861|FG001|Full Analysis Set|Overall Study|151 participants randomized and had at least one PTH concentration available after study day 1.|151||
59771546|NCT00803712|75891860|FG000|Safety Analysis Set|Overall Study|Rz'ed to cinacalcet and received at least 1 dose, or to control but received cinacalcet throughout|155||
59771547|NCT00803712|75891861|FG001|Safety Analysis Set|Overall Study|Randomized to the control group|154||
59771548|NCT00803712|75891860|FG000|COMPLETED|Overall Study|118 participants randomized to the cinacalcet group completed the study|118||
59771549|NCT00803712|75891861|FG001|COMPLETED|Overall Study|128 participants randomized to the control group completed the study|128||
59771550|NCT00803712|75891860|FG000|NOT COMPLETED|Overall Study||36||
59771551|NCT00803712|75891861|FG001|NOT COMPLETED|Overall Study||27||
59771552|NCT00591344|75891869|FG000|STARTED|Overall Study|25 randomized, 1 withdrew before the 6 month test and was replaced; 24 completed the 6 month test|25||
59771553|NCT00591344|75891870|FG001|STARTED|Overall Study|26 randomized, 2 withdrew before the 6 month test and were replaced, 24 completed 6 month test|26||
59771554|NCT00591344|75891869|FG000|Completed the 6 Month Test|Overall Study|Number of subjects who completed the 6 month test|24||
59771555|NCT00591344|75891870|FG001|Completed the 6 Month Test|Overall Study|Number of subjects who completed the 6 month test|24||
59771556|NCT00591344|75891869|FG000|COMPLETED|Overall Study|Number of subjects who completed the final 24 month test|20||
59771557|NCT00591344|75891870|FG001|COMPLETED|Overall Study|Number of subjects who completed the final 24 month test|18||
59771558|NCT00591344|75891869|FG000|NOT COMPLETED|Overall Study||5||
59771559|NCT00591344|75891870|FG001|NOT COMPLETED|Overall Study||8||
59771560|NCT00803634|75891882|FG000|STARTED|Overall Study|All patients dosed with clevidipine [Safety population]|51||
59771561|NCT00803634|75891883|FG001|STARTED|Overall Study|All patients dosed with SOC antihypertensive therapy [Safety population]|53||
59771562|NCT00803634|75891882|FG000|mITT (Dosed & Have Confirmed AHF)|Overall Study|All patients dosed with clevidipine and confirmed to have AHF [mITT population]|44||
59771563|NCT00803634|75891883|FG001|mITT (Dosed & Have Confirmed AHF)|Overall Study|All patients dosed with SOC antihypertensive therapy and confirmed to have AHF [mITT population]|41||
59771564|NCT00803634|75891882|FG000|COMPLETED|Overall Study|All patients dosed with clevidipine [Safety population]|45||
59771565|NCT00803634|75891883|FG001|COMPLETED|Overall Study|All patients dosed with SOC antihypertensive therapy [Safety population]|48||
59771566|NCT00803634|75891882|FG000|NOT COMPLETED|Overall Study||6||
59771567|NCT00803634|75891883|FG001|NOT COMPLETED|Overall Study||5||
59771568|NCT00838526|75891892|FG000|STARTED|Overall Study|Treated|59||
59771569|NCT00838526|75891893|FG001|STARTED|Overall Study|Treated|176||
59771570|NCT00838526|75891892|FG000|COMPLETED|Overall Study||35||
59771571|NCT00838526|75891893|FG001|COMPLETED|Overall Study||137||
59771572|NCT00838526|75891892|FG000|NOT COMPLETED|Overall Study||24||
59771573|NCT00838526|75891893|FG001|NOT COMPLETED|Overall Study||39||
59771574|NCT02688270|75891903|FG000|STARTED|Overall Study||16||
59771575|NCT02688270|75891904|FG001|STARTED|Overall Study||16||
59771576|NCT02688270|75891905|FG002|STARTED|Overall Study||17||
59771577|NCT02688270|75891906|FG003|STARTED|Overall Study||16||
59771578|NCT02688270|75891903|FG000|COMPLETED|Overall Study||16||
59771579|NCT02688270|75891904|FG001|COMPLETED|Overall Study||16||
59771580|NCT02688270|75891905|FG002|COMPLETED|Overall Study||17||
59771581|NCT02688270|75891906|FG003|COMPLETED|Overall Study||16||
59771582|NCT02688270|75891903|FG000|NOT COMPLETED|Overall Study||0||
59771583|NCT02688270|75891904|FG001|NOT COMPLETED|Overall Study||0||
59771584|NCT02688270|75891905|FG002|NOT COMPLETED|Overall Study||0||
59771585|NCT02688270|75891906|FG003|NOT COMPLETED|Overall Study||0||
59771586|NCT00818246|75891912|FG000|STARTED|Overall Study||40||
59771587|NCT00818246|75891912|FG000|COMPLETED|Overall Study|split-face study|35||
59771588|NCT00818246|75891912|FG000|NOT COMPLETED|Overall Study||5||
59771589|NCT00818168|75891916|FG000|STARTED|Overall Study||320||
59771590|NCT00818168|75891916|FG000|COMPLETED|Overall Study|Includes 78 participants whose completer/non-completer status was not reported (missing)|250||
59771591|NCT00818168|75891916|FG000|NOT COMPLETED|Overall Study||70||
59771592|NCT00817778|75891922|FG000|STARTED|Overall Study||19||
59771593|NCT00817778|75891923|FG001|STARTED|Overall Study||8||
59771594|NCT00817778|75891922|FG000|COMPLETED|Overall Study||16||
59771595|NCT00817778|75891923|FG001|COMPLETED|Overall Study||5||
59771596|NCT00817778|75891922|FG000|NOT COMPLETED|Overall Study||3||
59771597|NCT00817778|75891923|FG001|NOT COMPLETED|Overall Study||3||
59771598|NCT00813098|75891932|FG000|STARTED|Overall Study||49||
59771599|NCT00813098|75891933|FG001|STARTED|Overall Study||54||
59771600|NCT00813098|75891934|FG002|STARTED|Overall Study||52||
59771601|NCT00813098|75891932|FG000|COMPLETED|Overall Study||46||
59771602|NCT00813098|75891933|FG001|COMPLETED|Overall Study||46||
59771603|NCT00813098|75891934|FG002|COMPLETED|Overall Study||50||
59952701|NCT01369641|76071476|FG000|NOT COMPLETED|Overall Study||1||
59952702|NCT00529152|76071480|FG000|STARTED|Overall Study||100||
59521761|NCT00979121|75616029|FG000|NOT COMPLETED|Overall Study||0||
59521762|NCT00979121|75616030|FG001|NOT COMPLETED|Overall Study||0||
59521763|NCT00979199|75616041|FG000|STARTED|Overall Study||697||
59521764|NCT00979199|75616041|FG000|COMPLETED|Overall Study||475||
59521765|NCT00979199|75616041|FG000|NOT COMPLETED|Overall Study||222||
59521766|NCT00979745|75616047|FG000|STARTED|Overall Study||38||
59521767|NCT00979745|75616048|FG001|STARTED|Overall Study||36||
59521768|NCT00979745|75616047|FG000|COMPLETED|Overall Study||34||
59521769|NCT00979745|75616048|FG001|COMPLETED|Overall Study||34||
59521770|NCT00979745|75616047|FG000|NOT COMPLETED|Overall Study||4||
59521771|NCT00979745|75616048|FG001|NOT COMPLETED|Overall Study||2||
59521772|NCT00980681|75616054|FG000|STARTED|TOF MRA|Out of the 13 enrolled patients, three did not receive treatment|10||
59521773|NCT00980681|75616054|FG000|COMPLETED|TOF MRA||10||
59521774|NCT00980681|75616054|FG000|NOT COMPLETED|TOF MRA||0||
59521775|NCT00980681|75616054|FG000|STARTED|Dotarem MRA|Out of the 13 enrolled patients, three did not receive treatment|10||
59521776|NCT00980681|75616054|FG000|COMPLETED|Dotarem MRA||10||
59521777|NCT00980681|75616054|FG000|NOT COMPLETED|Dotarem MRA||0||
59521778|NCT00981227|75616066|FG000|STARTED|Overall Study||102||
59521779|NCT00981227|75616067|FG001|STARTED|Overall Study||94||
59521780|NCT00981227|75616068|FG002|STARTED|Overall Study||94||
59521781|NCT00981227|75616069|FG003|STARTED|Overall Study||94||
59521782|NCT00981227|75616070|FG004|STARTED|Overall Study||90||
59521783|NCT00981227|75616071|FG005|STARTED|Overall Study||93||
59521784|NCT00981227|75616066|FG000|Randomized|Overall Study||102||
59521785|NCT00981227|75616067|FG001|Randomized|Overall Study||94||
59521786|NCT00981227|75616068|FG002|Randomized|Overall Study||94||
59521787|NCT00981227|75616069|FG003|Randomized|Overall Study||94||
59521788|NCT00981227|75616070|FG004|Randomized|Overall Study||90||
59521789|NCT00981227|75616071|FG005|Randomized|Overall Study||93||
59521790|NCT00981227|75616066|FG000|Safety Population|Overall Study||102||
59521791|NCT00981227|75616067|FG001|Safety Population|Overall Study||94||
59521792|NCT00981227|75616068|FG002|Safety Population|Overall Study||94||
59521793|NCT00981227|75616069|FG003|Safety Population|Overall Study||94||
59521794|NCT00981227|75616070|FG004|Safety Population|Overall Study||90||
59521795|NCT00981227|75616071|FG005|Safety Population|Overall Study||93||
59521796|NCT00981227|75616066|FG000|Per-Protocol|Overall Study||69||
59521797|NCT00981227|75616067|FG001|Per-Protocol|Overall Study||72||
59521798|NCT00981227|75616068|FG002|Per-Protocol|Overall Study||67||
59521799|NCT00981227|75616069|FG003|Per-Protocol|Overall Study||68||
59521800|NCT00981227|75616070|FG004|Per-Protocol|Overall Study||50||
59521801|NCT00981227|75616071|FG005|Per-Protocol|Overall Study||70||
59521802|NCT00981227|75616066|FG000|COMPLETED|Overall Study||80||
59521803|NCT00981227|75616067|FG001|COMPLETED|Overall Study||75||
59521804|NCT00981227|75616068|FG002|COMPLETED|Overall Study||73||
59521805|NCT00981227|75616069|FG003|COMPLETED|Overall Study||73||
59952703|NCT00529152|76071480|FG000|COMPLETED|Overall Study||95||
59952704|NCT00529152|76071480|FG000|NOT COMPLETED|Overall Study||5||
59521806|NCT00981227|75616070|FG004|COMPLETED|Overall Study||60||
59521807|NCT00981227|75616071|FG005|COMPLETED|Overall Study||75||
59521808|NCT00981227|75616066|FG000|NOT COMPLETED|Overall Study||22||
59521809|NCT00981227|75616067|FG001|NOT COMPLETED|Overall Study||19||
59521810|NCT00981227|75616068|FG002|NOT COMPLETED|Overall Study||21||
59521811|NCT00981227|75616069|FG003|NOT COMPLETED|Overall Study||21||
59521812|NCT00981227|75616070|FG004|NOT COMPLETED|Overall Study||30||
59771604|NCT00813098|75891932|FG000|NOT COMPLETED|Overall Study||3||
59771605|NCT00813098|75891933|FG001|NOT COMPLETED|Overall Study||8||
59771606|NCT00813098|75891934|FG002|NOT COMPLETED|Overall Study||2||
59771607|NCT00796653|75891946|FG000|STARTED|Overall Study||235||
59771608|NCT00796653|75891947|FG001|STARTED|Overall Study||232||
59952705|NCT02605174|76071487|FG000|STARTED|Overall Study||501||
59521813|NCT00981227|75616071|FG005|NOT COMPLETED|Overall Study||18||
59952706|NCT02605174|76071488|FG001|STARTED|Overall Study||249||
59521814|NCT00981305|75616091|FG000|STARTED|Overall Study||69||
59521815|NCT00981305|75616092|FG001|STARTED|Overall Study||67||
59771609|NCT00796653|75891948|FG002|STARTED|Overall Study||234||
59771610|NCT00796653|75891949|FG003|STARTED|Overall Study||233||
59771611|NCT00796653|75891946|FG000|COMPLETED|Overall Study||184||
59771612|NCT00796653|75891947|FG001|COMPLETED|Overall Study||195||
59771613|NCT00796653|75891948|FG002|COMPLETED|Overall Study||198||
59771614|NCT00796653|75891949|FG003|COMPLETED|Overall Study||193||
59771615|NCT00796653|75891946|FG000|NOT COMPLETED|Overall Study||51||
59771616|NCT00796653|75891947|FG001|NOT COMPLETED|Overall Study||37||
59771617|NCT00796653|75891948|FG002|NOT COMPLETED|Overall Study||36||
59771618|NCT00796653|75891949|FG003|NOT COMPLETED|Overall Study||40||
59771619|NCT00806286|75891970|FG000|STARTED|Overall Study||54||
59771620|NCT00806286|75891971|FG001|STARTED|Overall Study||54||
59771621|NCT00806286|75891972|FG002|STARTED|Overall Study||3||
59771622|NCT00806286|75891970|FG000|COMPLETED|Overall Study||0||
59771623|NCT00806286|75891971|FG001|COMPLETED|Overall Study||0||
59771624|NCT00806286|75891972|FG002|COMPLETED|Overall Study||0||
59771625|NCT00806286|75891970|FG000|NOT COMPLETED|Overall Study||54||
59771626|NCT00806286|75891971|FG001|NOT COMPLETED|Overall Study||54||
59771627|NCT00806286|75891972|FG002|NOT COMPLETED|Overall Study||3||
59771628|NCT00590538|75891980|FG000|STARTED|Overall Study|STUDY NOT UNBLINDED AT TIME OF TERMINATION; THEREFORE NUMBER ASSIGNED TO EACH GROUP IS NOT KNOWN.|9||
59771629|NCT00590538|75891980|FG000|COMPLETED|Overall Study||7||
59771630|NCT00590538|75891980|FG000|NOT COMPLETED|Overall Study||2||
59771631|NCT00796419|75891986|FG000|STARTED|Overall Study||13||
59771632|NCT00796419|75891987|FG001|STARTED|Overall Study||14||
59771633|NCT00796419|75891986|FG000|COMPLETED|Overall Study||13||
59771634|NCT00796419|75891987|FG001|COMPLETED|Overall Study||13||
59771635|NCT00796419|75891986|FG000|NOT COMPLETED|Overall Study||0||
59771636|NCT00796419|75891987|FG001|NOT COMPLETED|Overall Study||1||
59771637|NCT00796107|75891993|FG000|STARTED|Overall Study||6||
59771638|NCT00796107|75891993|FG000|COMPLETED|Overall Study||0||
59771639|NCT00796107|75891993|FG000|NOT COMPLETED|Overall Study||6||
59771640|NCT00795951|75891997|FG000|STARTED|Overall Study||102||
59771641|NCT00795951|75891997|FG000|COMPLETED|Overall Study||100||
59771642|NCT00795951|75891997|FG000|NOT COMPLETED|Overall Study||2||
59771643|NCT00795717|75892004|FG000|STARTED|Phase I Followed by Wash Out x 4 Weeks|Randomized to treatment first|20||
59771644|NCT00795717|75892005|FG001|STARTED|Phase I Followed by Wash Out x 4 Weeks|Randomized to placebo first|21||
59771645|NCT00795717|75892004|FG000|COMPLETED|Phase I Followed by Wash Out x 4 Weeks||18||
59771646|NCT00795717|75892005|FG001|COMPLETED|Phase I Followed by Wash Out x 4 Weeks||19||
59771647|NCT00795717|75892004|FG000|NOT COMPLETED|Phase I Followed by Wash Out x 4 Weeks||2||
59771648|NCT00795717|75892005|FG001|NOT COMPLETED|Phase I Followed by Wash Out x 4 Weeks||2||
59771649|NCT00795717|75892004|FG000|STARTED|Phase II||18||
59771650|NCT00795717|75892005|FG001|STARTED|Phase II||19||
59771651|NCT00795717|75892004|FG000|COMPLETED|Phase II||18||
59771652|NCT00795717|75892005|FG001|COMPLETED|Phase II||18||
59771653|NCT00795717|75892004|FG000|NOT COMPLETED|Phase II||0||
59771654|NCT00795717|75892005|FG001|NOT COMPLETED|Phase II||1||
59771655|NCT00805740|75892014|FG000|STARTED|Overall Study||28||
59771656|NCT00805740|75892015|FG001|STARTED|Overall Study||13||
59771657|NCT00805740|75892014|FG000|Treated|Overall Study||26||
59771658|NCT00805740|75892015|FG001|Treated|Overall Study||13||
59771659|NCT00805740|75892014|FG000|COMPLETED|Overall Study||17||
59771660|NCT00805740|75892015|FG001|COMPLETED|Overall Study||9||
59771661|NCT00805740|75892014|FG000|NOT COMPLETED|Overall Study||11||
59771662|NCT00805740|75892015|FG001|NOT COMPLETED|Overall Study||4||
59771663|NCT00795639|75892023|FG000|STARTED|Overall Study||91||
59771664|NCT00795639|75892024|FG001|STARTED|Overall Study||92||
59771665|NCT00795639|75892023|FG000|Randomized and Not Treated|Overall Study||0||
59771666|NCT00795639|75892024|FG001|Randomized and Not Treated|Overall Study||1||
59771667|NCT00795639|75892023|FG000|COMPLETED|Overall Study||70||
59771668|NCT00795639|75892024|FG001|COMPLETED|Overall Study||66||
59771669|NCT00795639|75892023|FG000|NOT COMPLETED|Overall Study||21||
59771670|NCT00795639|75892024|FG001|NOT COMPLETED|Overall Study||26||
59771671|NCT00589602|75892030|FG000|STARTED|Overall Study||13||
59771672|NCT00589602|75892030|FG000|COMPLETED|Overall Study||12||
59771673|NCT00589602|75892030|FG000|NOT COMPLETED|Overall Study||1||
59771674|NCT00794157|75892039|FG000|STARTED|Overall Study||114||
59771675|NCT00794157|75892040|FG001|STARTED|Overall Study||116||
59771676|NCT00794157|75892041|FG002|STARTED|Overall Study||117||
59771677|NCT00794157|75892039|FG000|COMPLETED|Overall Study||104||
59771678|NCT00794157|75892040|FG001|COMPLETED|Overall Study||106||
59771679|NCT00794157|75892041|FG002|COMPLETED|Overall Study||98||
59771680|NCT00794157|75892039|FG000|NOT COMPLETED|Overall Study||10||
59771681|NCT00794157|75892040|FG001|NOT COMPLETED|Overall Study||10||
59771682|NCT00794157|75892041|FG002|NOT COMPLETED|Overall Study||19||
59771683|NCT00588237|75892049|FG000|STARTED|Overall Study||42||
59771684|NCT00588237|75892049|FG000|COMPLETED|Overall Study||38||
59771685|NCT00588237|75892049|FG000|NOT COMPLETED|Overall Study||4||
59771686|NCT00790023|75892056|FG000|STARTED|Overall Study||237||
59771687|NCT00790023|75892057|FG001|STARTED|Overall Study||235||
59771688|NCT00790023|75892058|FG002|STARTED|Overall Study||235||
59771689|NCT00790023|75892056|FG000|COMPLETED|Overall Study||226||
59771690|NCT00790023|75892057|FG001|COMPLETED|Overall Study||225||
59771691|NCT00790023|75892058|FG002|COMPLETED|Overall Study||214||
59771692|NCT00790023|75892056|FG000|NOT COMPLETED|Overall Study||11||
59771693|NCT00790023|75892057|FG001|NOT COMPLETED|Overall Study||10||
59771694|NCT00790023|75892058|FG002|NOT COMPLETED|Overall Study||21||
59771695|NCT00588822|75892067|FG000|STARTED|Overall Study||21||
59771696|NCT00588822|75892067|FG000|COMPLETED|Overall Study||13||
59771697|NCT00588822|75892067|FG000|NOT COMPLETED|Overall Study||8||
59771698|NCT00589914|75892073|FG000|STARTED|Overall Study||606||
59771699|NCT00589914|75892074|FG001|STARTED|Overall Study||608||
59771700|NCT00589914|75892073|FG000|COMPLETED|Overall Study||456||
59771701|NCT00589914|75892074|FG001|COMPLETED|Overall Study||471||
59771702|NCT00589914|75892073|FG000|NOT COMPLETED|Overall Study||150||
59771703|NCT00589914|75892074|FG001|NOT COMPLETED|Overall Study||137||
59771704|NCT00789555|75892083|FG000|STARTED|Overall Study||421||
59771705|NCT00789555|75892084|FG001|STARTED|Overall Study||417||
59771706|NCT00789555|75892085|FG002|STARTED|Overall Study||422||
59771707|NCT00789555|75892083|FG000|COMPLETED|Overall Study||262||
59771708|NCT00789555|75892084|FG001|COMPLETED|Overall Study||278||
59771709|NCT00789555|75892085|FG002|COMPLETED|Overall Study||263||
59771710|NCT00789555|75892083|FG000|NOT COMPLETED|Overall Study||159||
59771711|NCT00789555|75892084|FG001|NOT COMPLETED|Overall Study||139||
59771712|NCT00789555|75892085|FG002|NOT COMPLETED|Overall Study||159||
59771713|NCT00451321|75892101|FG000|STARTED|Overall Study||8||
59771714|NCT00451321|75892102|FG001|STARTED|Overall Study||15||
59771715|NCT00451321|75892103|FG002|STARTED|Overall Study||18||
59771716|NCT00451321|75892104|FG003|STARTED|Overall Study||19||
59771717|NCT00451321|75892105|FG004|STARTED|Overall Study||7||
59771718|NCT00451321|75892106|FG005|STARTED|Overall Study||9||
59618361|NCT03810534|75729474|FG000|Completed 7-Day (Patients)|Connect-Home (5-10 Months)||38||
59618362|NCT03810534|75729475|FG001|Completed 7-Day (Patients)|Connect-Home (5-10 Months)||35||
59618363|NCT03810534|75729476|FG002|Completed 7-Day (Patients)|Connect-Home (5-10 Months)||27||
60072666|NCT01818596|76187840|FG001|NOT COMPLETED|Overall Study||0||
59771719|NCT00451321|75892107|FG006|STARTED|Overall Study||6||
59771720|NCT00451321|75892108|FG007|STARTED|Overall Study||6||
59771721|NCT00451321|75892101|FG000|COMPLETED|Overall Study||1||
59771722|NCT00451321|75892102|FG001|COMPLETED|Overall Study||10||
59771723|NCT00451321|75892103|FG002|COMPLETED|Overall Study||0||
59771724|NCT00451321|75892104|FG003|COMPLETED|Overall Study||7||
59771725|NCT00451321|75892105|FG004|COMPLETED|Overall Study||0||
59771726|NCT00451321|75892106|FG005|COMPLETED|Overall Study||0||
59771727|NCT00451321|75892107|FG006|COMPLETED|Overall Study||0||
59771728|NCT00451321|75892108|FG007|COMPLETED|Overall Study||0||
59771729|NCT00451321|75892101|FG000|NOT COMPLETED|Overall Study||7||
59771730|NCT00451321|75892102|FG001|NOT COMPLETED|Overall Study||5||
59771731|NCT00451321|75892103|FG002|NOT COMPLETED|Overall Study||18||
59771732|NCT00451321|75892104|FG003|NOT COMPLETED|Overall Study||12||
59771733|NCT00451321|75892105|FG004|NOT COMPLETED|Overall Study||7||
59771734|NCT00451321|75892106|FG005|NOT COMPLETED|Overall Study||9||
59771735|NCT00451321|75892107|FG006|NOT COMPLETED|Overall Study||6||
59771736|NCT00451321|75892108|FG007|NOT COMPLETED|Overall Study||6||
60072667|NCT02899078|76187847|FG000|STARTED|Overall Study||31||
60072668|NCT02899078|76187847|FG000|COMPLETED|Overall Study||28||
60072669|NCT02899078|76187847|FG000|NOT COMPLETED|Overall Study||3||
60072670|NCT04577794|76187853|FG000|STARTED|Overall Study||21||
59618364|NCT03810534|75729477|FG003|Completed 7-Day (Patients)|Connect-Home (5-10 Months)||23||
59618365|NCT03810534|75729478|FG004|Completed 7-Day (Patients)|Connect-Home (5-10 Months)||4||
59618366|NCT03810534|75729479|FG005|Completed 7-Day (Patients)|Connect-Home (5-10 Months)||14||
59618367|NCT03810534|75729474|FG000|Completed 7-Day (Caregivers)|Connect-Home (5-10 Months)||35||
59618368|NCT03810534|75729475|FG001|Completed 7-Day (Caregivers)|Connect-Home (5-10 Months)||34||
59771737|NCT03770455|75892126|FG000|STARTED|Overall Study||5||
59771738|NCT03770455|75892126|FG000|COMPLETED|Overall Study||5||
59771739|NCT03770455|75892126|FG000|NOT COMPLETED|Overall Study||0||
59771740|NCT00802464|75892134|FG000|STARTED|Month 0 - Month 8||38||
59771741|NCT00802464|75892135|FG001|STARTED|Month 0 - Month 8||73||
59771742|NCT00802464|75892136|FG002|STARTED|Month 0 - Month 8||149||
59771743|NCT00802464|75892137|FG003|STARTED|Month 0 - Month 8||150||
59771744|NCT00802464|75892134|FG000|COMPLETED|Month 0 - Month 8||38||
59771745|NCT00802464|75892135|FG001|COMPLETED|Month 0 - Month 8||70||
60072671|NCT04577794|76187854|FG001|STARTED|Overall Study||10||
60072672|NCT04577794|76187853|FG000|COMPLETED|Overall Study||20||
60072673|NCT04577794|76187854|FG001|COMPLETED|Overall Study||9||
59618369|NCT03810534|75729476|FG002|Completed 7-Day (Caregivers)|Connect-Home (5-10 Months)||29||
59771746|NCT00802464|75892136|FG002|COMPLETED|Month 0 - Month 8||142||
59771747|NCT00802464|75892137|FG003|COMPLETED|Month 0 - Month 8||141||
59771748|NCT00802464|75892134|FG000|NOT COMPLETED|Month 0 - Month 8||0||
59771749|NCT00802464|75892135|FG001|NOT COMPLETED|Month 0 - Month 8||3||
59771750|NCT00802464|75892136|FG002|NOT COMPLETED|Month 0 - Month 8||7||
59771751|NCT00802464|75892137|FG003|NOT COMPLETED|Month 0 - Month 8||9||
59771752|NCT00802464|75892134|FG000|STARTED|Month 8 - Month 14||34||
59771753|NCT00802464|75892135|FG001|STARTED|Month 8 - Month 14||65||
59771754|NCT00802464|75892136|FG002|STARTED|Month 8 - Month 14||130||
59771755|NCT00802464|75892137|FG003|STARTED|Month 8 - Month 14||126||
60072674|NCT04577794|76187853|FG000|NOT COMPLETED|Overall Study||1||
59771756|NCT00802464|75892134|FG000|COMPLETED|Month 8 - Month 14||33||
59771757|NCT00802464|75892135|FG001|COMPLETED|Month 8 - Month 14||63||
59771758|NCT00802464|75892136|FG002|COMPLETED|Month 8 - Month 14||129||
59771759|NCT00802464|75892137|FG003|COMPLETED|Month 8 - Month 14||126||
59771760|NCT00802464|75892134|FG000|NOT COMPLETED|Month 8 - Month 14||1||
59771761|NCT00802464|75892135|FG001|NOT COMPLETED|Month 8 - Month 14||2||
59771762|NCT00802464|75892136|FG002|NOT COMPLETED|Month 8 - Month 14||1||
59771763|NCT00802464|75892137|FG003|NOT COMPLETED|Month 8 - Month 14||0||
59771764|NCT00450619|75892151|FG000|STARTED|Overall Study||22||
59771765|NCT00450619|75892152|FG001|STARTED|Overall Study||22||
59771766|NCT00450619|75892151|FG000|COMPLETED|Overall Study||18||
59771767|NCT00450619|75892152|FG001|COMPLETED|Overall Study||21||
59771768|NCT00450619|75892151|FG000|NOT COMPLETED|Overall Study||4||
59771769|NCT00450619|75892152|FG001|NOT COMPLETED|Overall Study||1||
59771770|NCT00802074|75892165|FG000|STARTED|Overall Study||9||
59771771|NCT00802074|75892166|FG001|STARTED|Overall Study||8||
59771772|NCT00802074|75892167|FG002|STARTED|Overall Study||7||
59771773|NCT00802074|75892168|FG003|STARTED|Overall Study||7||
59771774|NCT00802074|75892169|FG004|STARTED|Overall Study||7||
59771775|NCT00802074|75892170|FG005|STARTED|Overall Study||7||
59771776|NCT00802074|75892165|FG000|COMPLETED|Overall Study||7||
59771777|NCT00802074|75892166|FG001|COMPLETED|Overall Study||7||
59771778|NCT00802074|75892167|FG002|COMPLETED|Overall Study||6||
59771779|NCT00802074|75892168|FG003|COMPLETED|Overall Study||7||
59771780|NCT00802074|75892169|FG004|COMPLETED|Overall Study||7||
59771781|NCT00802074|75892170|FG005|COMPLETED|Overall Study||7||
59771782|NCT00802074|75892165|FG000|NOT COMPLETED|Overall Study||2||
59771783|NCT00802074|75892166|FG001|NOT COMPLETED|Overall Study||1||
59771784|NCT00802074|75892167|FG002|NOT COMPLETED|Overall Study||1||
59771785|NCT00802074|75892168|FG003|NOT COMPLETED|Overall Study||0||
59771786|NCT00802074|75892169|FG004|NOT COMPLETED|Overall Study||0||
59771787|NCT00802074|75892170|FG005|NOT COMPLETED|Overall Study||0||
59771788|NCT00450385|75892187|FG000|STARTED|Overall Study||57||
59771789|NCT00450385|75892187|FG000|COMPLETED|Overall Study||44||
59771790|NCT00450385|75892187|FG000|NOT COMPLETED|Overall Study||13||
59771791|NCT00588354|75892194|FG000|STARTED|Baseline to 2 Weeks||11||
59771792|NCT00588354|75892195|FG001|STARTED|Baseline to 2 Weeks||15||
59771793|NCT00588354|75892194|FG000|COMPLETED|Baseline to 2 Weeks||9||
59771794|NCT00588354|75892195|FG001|COMPLETED|Baseline to 2 Weeks||15||
59771795|NCT00588354|75892194|FG000|NOT COMPLETED|Baseline to 2 Weeks||2||
59771796|NCT00588354|75892195|FG001|NOT COMPLETED|Baseline to 2 Weeks||0||
60072675|NCT04577794|76187854|FG001|NOT COMPLETED|Overall Study||1||
59521816|NCT00981305|75616091|FG000|COMPLETED|Overall Study||50||
59521817|NCT00981305|75616092|FG001|COMPLETED|Overall Study||57||
59521818|NCT00981305|75616091|FG000|NOT COMPLETED|Overall Study||19||
59521819|NCT00981305|75616092|FG001|NOT COMPLETED|Overall Study||10||
59521820|NCT01022567|75616100|FG000|STARTED|Overall Study||273||
59521821|NCT01022567|75616101|FG001|STARTED|Overall Study||257||
59521822|NCT01022567|75616100|FG000|COMPLETED|Overall Study||272||
59521823|NCT01022567|75616101|FG001|COMPLETED|Overall Study||242||
59521824|NCT01022567|75616100|FG000|NOT COMPLETED|Overall Study||1||
59521825|NCT01022567|75616101|FG001|NOT COMPLETED|Overall Study||15||
59771797|NCT00588354|75892194|FG000|STARTED|Baseline to 4 Weeks||9||
60072676|NCT01923298|76187860|FG000|STARTED|Overall Study||14||
59771798|NCT00588354|75892195|FG001|STARTED|Baseline to 4 Weeks||15||
59771799|NCT00588354|75892194|FG000|COMPLETED|Baseline to 4 Weeks||9||
59771800|NCT00588354|75892195|FG001|COMPLETED|Baseline to 4 Weeks||14||
59771801|NCT00588354|75892194|FG000|NOT COMPLETED|Baseline to 4 Weeks||0||
59771802|NCT00588354|75892195|FG001|NOT COMPLETED|Baseline to 4 Weeks||1||
59771803|NCT00449761|75892202|FG000|STARTED|Overall Study||27||
59771804|NCT00449761|75892202|FG000|COMPLETED|Overall Study||9||
59771805|NCT00449761|75892202|FG000|NOT COMPLETED|Overall Study||18||
59771806|NCT00800982|75892209|FG000|STARTED|Overall Study||15||
59771807|NCT00800982|75892210|FG001|STARTED|Overall Study||15||
59771808|NCT00800982|75892209|FG000|COMPLETED|Overall Study||13||
60072677|NCT01923298|76187860|FG000|COMPLETED|Overall Study||14||
59521826|NCT00982007|75616111|FG000|STARTED|Overall Study||250||
59521827|NCT00982007|75616112|FG001|STARTED|Overall Study||257||
59521828|NCT00982007|75616113|FG002|STARTED|Overall Study||253||
59771809|NCT00800982|75892210|FG001|COMPLETED|Overall Study||12||
59771810|NCT00800982|75892209|FG000|NOT COMPLETED|Overall Study||2||
59771811|NCT00800982|75892210|FG001|NOT COMPLETED|Overall Study||3||
59771812|NCT00830960|75892222|FG000|STARTED|Overall Study|"Number of participants STARTED equals the number of participants randomized."|124||
59771813|NCT00830960|75892223|FG001|STARTED|Overall Study||124||
59521829|NCT00982007|75616114|FG003|STARTED|Overall Study||251||
59521830|NCT00982007|75616111|FG000|COMPLETED|Overall Study||246||
59771814|NCT00830960|75892224|FG002|STARTED|Overall Study||137||
59771815|NCT00830960|75892225|FG003|STARTED|Overall Study||138||
59771816|NCT00830960|75892226|FG004|STARTED|Overall Study||96||
59771817|NCT00830960|75892227|FG005|STARTED|Overall Study|Total 720 participants were randomized; 1 was not included in a cohort as baseline weight missing.|100||
59771818|NCT00830960|75892222|FG000|Received at Least 1 Dose of Study Drug|Overall Study|Baseline Characteristics (below) include those who received ≥1 dose study drug, not all who STARTED.|117||
60072678|NCT01923298|76187860|FG000|NOT COMPLETED|Overall Study||0||
59771819|NCT00830960|75892223|FG001|Received at Least 1 Dose of Study Drug|Overall Study||122||
59771820|NCT00830960|75892224|FG002|Received at Least 1 Dose of Study Drug|Overall Study||133||
59771821|NCT00830960|75892225|FG003|Received at Least 1 Dose of Study Drug|Overall Study||135||
59771822|NCT00830960|75892226|FG004|Received at Least 1 Dose of Study Drug|Overall Study||91||
59771823|NCT00830960|75892227|FG005|Received at Least 1 Dose of Study Drug|Overall Study||93||
59771824|NCT00830960|75892222|FG000|COMPLETED|Overall Study||91||
59771825|NCT00830960|75892223|FG001|COMPLETED|Overall Study||96||
59771826|NCT00830960|75892224|FG002|COMPLETED|Overall Study||108||
59771827|NCT00830960|75892225|FG003|COMPLETED|Overall Study||106||
59771828|NCT00830960|75892226|FG004|COMPLETED|Overall Study|6 participants not completed due to death; 1 additional death occurred after study discontinuation.|64||
59771829|NCT00830960|75892227|FG005|COMPLETED|Overall Study||63||
59771830|NCT00830960|75892222|FG000|NOT COMPLETED|Overall Study||33||
59771831|NCT00830960|75892223|FG001|NOT COMPLETED|Overall Study||28||
59771832|NCT00830960|75892224|FG002|NOT COMPLETED|Overall Study||29||
59771833|NCT00830960|75892225|FG003|NOT COMPLETED|Overall Study||32||
59771834|NCT00830960|75892226|FG004|NOT COMPLETED|Overall Study||32||
59771835|NCT00830960|75892227|FG005|NOT COMPLETED|Overall Study||37||
59771836|NCT00830804|75892264|FG000|STARTED|Overall Study|113 subjects enrolled. One subject never started study treatment and was excluded in all analysis.|112||
59771837|NCT00830804|75892264|FG000|COMPLETED|Overall Study||97||
59771838|NCT00830804|75892264|FG000|NOT COMPLETED|Overall Study||15||
59771839|NCT00789477|75892274|FG000|STARTED|Overall Study|randomized|44||
59771840|NCT00789477|75892275|FG001|STARTED|Overall Study|randomized|44||
59771841|NCT00789477|75892276|FG002|STARTED|Overall Study|randomized|44||
59771842|NCT00789477|75892277|FG003|STARTED|Overall Study|randomized|44||
59771843|NCT00789477|75892278|FG004|STARTED|Overall Study|randomized|45||
59771844|NCT00789477|75892274|FG000|Participants Received Treatment|Overall Study|safety analysis set (SAF)|44||
59771845|NCT00789477|75892275|FG001|Participants Received Treatment|Overall Study|SAF|44||
59771846|NCT00789477|75892276|FG002|Participants Received Treatment|Overall Study|SAF|44||
59771847|NCT00789477|75892277|FG003|Participants Received Treatment|Overall Study|SAF|42||
59771848|NCT00789477|75892278|FG004|Participants Received Treatment|Overall Study|SAF|45||
59771849|NCT00789477|75892274|FG000|COMPLETED|Overall Study||33||
59771850|NCT00789477|75892275|FG001|COMPLETED|Overall Study||38||
59771851|NCT00789477|75892276|FG002|COMPLETED|Overall Study||33||
59771852|NCT00789477|75892277|FG003|COMPLETED|Overall Study||34||
59771853|NCT00789477|75892278|FG004|COMPLETED|Overall Study||38||
59771854|NCT00789477|75892274|FG000|NOT COMPLETED|Overall Study||11||
59771855|NCT00789477|75892275|FG001|NOT COMPLETED|Overall Study||6||
59771856|NCT00789477|75892276|FG002|NOT COMPLETED|Overall Study||11||
59771857|NCT00789477|75892277|FG003|NOT COMPLETED|Overall Study||10||
59771858|NCT00789477|75892278|FG004|NOT COMPLETED|Overall Study||7||
59771859|NCT00796614|75892296|FG000|STARTED|Overall Study||41||
59771860|NCT00796614|75892297|FG001|STARTED|Overall Study||40||
59771861|NCT00796614|75892298|FG002|STARTED|Overall Study||39||
59771862|NCT00796614|75892299|FG003|STARTED|Overall Study||41||
59771863|NCT00796614|75892296|FG000|Not Treated|Overall Study||0||
59771864|NCT00796614|75892297|FG001|Not Treated|Overall Study||0||
59771865|NCT00796614|75892298|FG002|Not Treated|Overall Study||1||
59771866|NCT00796614|75892299|FG003|Not Treated|Overall Study||0||
59771867|NCT00796614|75892296|FG000|COMPLETED|Overall Study||36||
59771868|NCT00796614|75892297|FG001|COMPLETED|Overall Study||36||
59771869|NCT00796614|75892298|FG002|COMPLETED|Overall Study||36||
59771870|NCT00796614|75892299|FG003|COMPLETED|Overall Study||40||
59771871|NCT00796614|75892296|FG000|NOT COMPLETED|Overall Study||5||
59771872|NCT00796614|75892297|FG001|NOT COMPLETED|Overall Study||4||
59771873|NCT00796614|75892298|FG002|NOT COMPLETED|Overall Study||3||
59771874|NCT00796614|75892299|FG003|NOT COMPLETED|Overall Study||1||
59771875|NCT00448747|75892311|FG000|STARTED|Overall Study||53|Safety Analysis Set: all subjects enrolled; one subject included who had not received AEZS-130.|
59771876|NCT00448747|75892312|FG001|STARTED|Overall Study||48|Safety Analysis Set: all subjects enrolled; one subject included who had not received AEZS-130.|
59771877|NCT00448747|75892311|FG000|Received First Drug Administration|Overall Study||53||
59771878|NCT00448747|75892312|FG001|Received First Drug Administration|Overall Study||48||
59771879|NCT00448747|75892311|FG000|Received Second Drug Administration|Overall Study||42||
59771880|NCT00448747|75892312|FG001|Received Second Drug Administration|Overall Study||10||
59771881|NCT00448747|75892311|FG000|Received AEZS-130|Overall Study||52||
59771882|NCT00448747|75892312|FG001|Received AEZS-130|Overall Study||48||
59771883|NCT00448747|75892311|FG000|Received L-ARG-GHRH|Overall Study||43||
59771884|NCT00448747|75892312|FG001|Received L-ARG-GHRH|Overall Study||10||
59771885|NCT00448747|75892311|FG000|Received L-ARG-GHRH and AEZS-130|Overall Study||42||
59771886|NCT00448747|75892312|FG001|Received L-ARG-GHRH and AEZS-130|Overall Study||10||
59771887|NCT00448747|75892311|FG000|Per Protocol Population (PPS)|Overall Study||50||
59771888|NCT00448747|75892312|FG001|Per Protocol Population (PPS)|Overall Study||48||
59771889|NCT00448747|75892311|FG000|COMPLETED|Overall Study||52|modified Intention-to-treat (mITT) population|
59771890|NCT00448747|75892312|FG001|COMPLETED|Overall Study||48|modified Intention-to-treat (mITT) population|
59771891|NCT00448747|75892311|FG000|NOT COMPLETED|Overall Study||1||
59771892|NCT00448747|75892312|FG001|NOT COMPLETED|Overall Study||0||
59771893|NCT00830180|75892328|FG000|STARTED|Overall Study||41||
59771894|NCT00830180|75892328|FG000|Received Tanezumab in Parent Study A4091003|Overall Study||19||
59771895|NCT00830180|75892328|FG000|Received Placebo in Parent Study A4091003|Overall Study||22||
59771896|NCT00830180|75892328|FG000|COMPLETED|Overall Study||15||
59771897|NCT00830180|75892328|FG000|NOT COMPLETED|Overall Study||26||
59771898|NCT00789321|75892336|FG000|STARTED|Overall Study||24||
59771899|NCT00789321|75892337|FG001|STARTED|Overall Study||23||
59771900|NCT00789321|75892336|FG000|COMPLETED|Overall Study||24||
59771901|NCT00789321|75892337|FG001|COMPLETED|Overall Study||22||
59771902|NCT00789321|75892336|FG000|NOT COMPLETED|Overall Study||0||
59771903|NCT00789321|75892337|FG001|NOT COMPLETED|Overall Study||1||
59771904|NCT00811928|75892345|FG000|STARTED|Overall Study||129||
59771905|NCT00811928|75892346|FG001|STARTED|Overall Study||123||
59771906|NCT00811928|75892345|FG000|COMPLETED|Overall Study||90||
59771907|NCT00811928|75892346|FG001|COMPLETED|Overall Study||90||
59771908|NCT00811928|75892345|FG000|NOT COMPLETED|Overall Study||39||
59771909|NCT00811928|75892346|FG001|NOT COMPLETED|Overall Study||33||
59771910|NCT00788775|75892354|FG000|STARTED|Overall Study||11||
59771911|NCT00788775|75892355|FG001|STARTED|Overall Study||9||
59771912|NCT00788775|75892354|FG000|Treated|Overall Study||11||
59771913|NCT00788775|75892355|FG001|Treated|Overall Study||8||
59771914|NCT00788775|75892354|FG000|COMPLETED|Overall Study||1||
59771915|NCT00788775|75892355|FG001|COMPLETED|Overall Study||1||
59771916|NCT00788775|75892354|FG000|NOT COMPLETED|Overall Study||10||
59771917|NCT00788775|75892355|FG001|NOT COMPLETED|Overall Study||8||
59771918|NCT00448669|75892363|FG000|STARTED|Overall Study||611||
59771919|NCT00448669|75892364|FG001|STARTED|Overall Study||608||
59771920|NCT00448669|75892363|FG000|COMPLETED|Overall Study||393||
59771921|NCT00448669|75892364|FG001|COMPLETED|Overall Study||410||
59771922|NCT00448669|75892363|FG000|NOT COMPLETED|Overall Study||218||
59771923|NCT00448669|75892364|FG001|NOT COMPLETED|Overall Study||198||
59771924|NCT00591734|75892372|FG000|STARTED|Overall Study||57||
59771925|NCT00591734|75892372|FG000|COMPLETED|Overall Study||4||
59771926|NCT00591734|75892372|FG000|NOT COMPLETED|Overall Study||53||
59771927|NCT00788697|75892376|FG000|STARTED|Overall Study||349||
59771928|NCT00788697|75892376|FG000|COMPLETED|Overall Study||240||
59771929|NCT00788697|75892376|FG000|NOT COMPLETED|Overall Study||109||
59771930|NCT00848549|75892390|FG000|STARTED|E2090-E044-310 (Base Study) Disposition||282||
59771931|NCT00848549|75892391|FG001|STARTED|E2090-E044-310 (Base Study) Disposition||301||
59771932|NCT00848549|75892390|FG000|COMPLETED|E2090-E044-310 (Base Study) Disposition||161||
59771933|NCT00848549|75892391|FG001|COMPLETED|E2090-E044-310 (Base Study) Disposition||192||
59771934|NCT00848549|75892390|FG000|NOT COMPLETED|E2090-E044-310 (Base Study) Disposition||121||
59771935|NCT00848549|75892391|FG001|NOT COMPLETED|E2090-E044-310 (Base Study) Disposition||109||
59771936|NCT00848549|75892390|FG000|STARTED|E2090-E044-310 (Base Study) Transition||161||
59771937|NCT00848549|75892391|FG001|STARTED|E2090-E044-310 (Base Study) Transition||192||
59771938|NCT00848549|75892390|FG000|COMPLETED|E2090-E044-310 (Base Study) Transition||137||
59771939|NCT00848549|75892391|FG001|COMPLETED|E2090-E044-310 (Base Study) Transition||158||
59771940|NCT00848549|75892390|FG000|NOT COMPLETED|E2090-E044-310 (Base Study) Transition||24||
59771941|NCT00848549|75892391|FG001|NOT COMPLETED|E2090-E044-310 (Base Study) Transition||34||
59771942|NCT00848549|75892390|FG000|STARTED|E2090-E044-314 (Extension Study)||137||
59771943|NCT00848549|75892391|FG001|STARTED|E2090-E044-314 (Extension Study)||158||
59771944|NCT00848549|75892390|FG000|COMPLETED|E2090-E044-314 (Extension Study)||120||
59771945|NCT00848549|75892391|FG001|COMPLETED|E2090-E044-314 (Extension Study)||134||
59771946|NCT00848549|75892390|FG000|NOT COMPLETED|E2090-E044-314 (Extension Study)||17||
59771947|NCT00848549|75892391|FG001|NOT COMPLETED|E2090-E044-314 (Extension Study)||24||
59771948|NCT00788151|75892401|FG000|STARTED|Overall Study||200||
59771949|NCT00788151|75892402|FG001|STARTED|Overall Study||100||
59771950|NCT00788151|75892401|FG000|Received Vaccination 1|Overall Study||199||
59771951|NCT00788151|75892402|FG001|Received Vaccination 1|Overall Study||99||
59771952|NCT00788151|75892401|FG000|Received Vaccination 2|Overall Study||188||
59771953|NCT00788151|75892402|FG001|Received Vaccination 2|Overall Study||92||
59771954|NCT00788151|75892401|FG000|Received Vaccination 3|Overall Study||186||
59771955|NCT00788151|75892402|FG001|Received Vaccination 3|Overall Study||90||
59771956|NCT00788151|75892401|FG000|COMPLETED|Overall Study||186||
59771957|NCT00788151|75892402|FG001|COMPLETED|Overall Study||90||
59771958|NCT00788151|75892401|FG000|NOT COMPLETED|Overall Study||14||
59771959|NCT00788151|75892402|FG001|NOT COMPLETED|Overall Study||10||
59771960|NCT00788073|75892410|FG000|STARTED|STX209 Then Placebo||30||
59771961|NCT00788073|75892411|FG001|STARTED|STX209 Then Placebo||33||
59771962|NCT00788073|75892410|FG000|COMPLETED|STX209 Then Placebo||29||
59771963|NCT00788073|75892411|FG001|COMPLETED|STX209 Then Placebo||30||
59771964|NCT00788073|75892410|FG000|NOT COMPLETED|STX209 Then Placebo||1||
59952707|NCT02605174|76071489|FG002|STARTED|Overall Study||502||
59771965|NCT00788073|75892411|FG001|NOT COMPLETED|STX209 Then Placebo||3||
59771966|NCT00788073|75892410|FG000|STARTED|Placebo Then STX209||29||
59771967|NCT00788073|75892411|FG001|STARTED|Placebo Then STX209||30||
59771968|NCT00788073|75892410|FG000|COMPLETED|Placebo Then STX209||27||
59771969|NCT00788073|75892411|FG001|COMPLETED|Placebo Then STX209||29||
59771970|NCT00788073|75892410|FG000|NOT COMPLETED|Placebo Then STX209||2||
59771971|NCT00788073|75892411|FG001|NOT COMPLETED|Placebo Then STX209||1||
59952708|NCT02605174|76071490|FG003|STARTED|Overall Study||252||
59771972|NCT00848393|75892420|FG000|STARTED|Overall Study||17||
59771973|NCT00848393|75892421|FG001|STARTED|Overall Study||16||
59771974|NCT00848393|75892422|FG002|STARTED|Overall Study||18||
59771975|NCT00848393|75892420|FG000|COMPLETED|Overall Study||17||
59771976|NCT00848393|75892421|FG001|COMPLETED|Overall Study||16||
59771977|NCT00848393|75892422|FG002|COMPLETED|Overall Study||15||
59771978|NCT00848393|75892420|FG000|NOT COMPLETED|Overall Study||0||
59771979|NCT00848393|75892421|FG001|NOT COMPLETED|Overall Study||0||
59771980|NCT00848393|75892422|FG002|NOT COMPLETED|Overall Study||3||
59771981|NCT00815516|75892436|FG000|STARTED|Overall Study||20||
59771982|NCT00815516|75892437|FG001|STARTED|Overall Study||10||
59771983|NCT00815516|75892436|FG000|COMPLETED|Overall Study||16||
59771984|NCT00815516|75892437|FG001|COMPLETED|Overall Study||9||
59771985|NCT00815516|75892436|FG000|NOT COMPLETED|Overall Study||4||
59771986|NCT00815516|75892437|FG001|NOT COMPLETED|Overall Study||1||
59771987|NCT00787917|75892445|FG000|STARTED|Blinded Treatment||9||
59771988|NCT00787917|75892446|FG001|STARTED|Blinded Treatment||5||
59771989|NCT00787917|75892445|FG000|COMPLETED|Blinded Treatment||4||
59771990|NCT00787917|75892446|FG001|COMPLETED|Blinded Treatment||3||
59771991|NCT00787917|75892445|FG000|NOT COMPLETED|Blinded Treatment||5||
59771992|NCT00787917|75892446|FG001|NOT COMPLETED|Blinded Treatment||2||
59771993|NCT00787917|75892445|FG000|STARTED|Open Label||7||
59771994|NCT00787917|75892446|FG001|STARTED|Open Label|"Placebo was not an arm in open label treatment."|0||
59771995|NCT00787917|75892445|FG000|COMPLETED|Open Label||3||
59771996|NCT00787917|75892446|FG001|COMPLETED|Open Label||0||
59771997|NCT00787917|75892445|FG000|NOT COMPLETED|Open Label||4||
59771998|NCT00787917|75892446|FG001|NOT COMPLETED|Open Label||0||
59771999|NCT00814892|75892454|FG000|STARTED|Overall Study||2||
59772000|NCT00814892|75892454|FG000|COMPLETED|Overall Study||0||
59772001|NCT00814892|75892454|FG000|NOT COMPLETED|Overall Study||2||
59772002|NCT00787839|75892458|FG000|STARTED|Overall Study||1939||
59772003|NCT00787839|75892458|FG000|Consented|Overall Study|consented|1939||
59772004|NCT00787839|75892458|FG000|Completed GCT Screening|Overall Study||1876||
59772005|NCT00787839|75892458|FG000|Complete GCT, OGTT, A1c, Demographics|Overall Study||1535||
59772006|NCT00787839|75892458|FG000|COMPLETED|Overall Study||1535||
59772007|NCT00787839|75892458|FG000|NOT COMPLETED|Overall Study||404||
59772008|NCT00829244|75892481|FG000|STARTED|Overall Study||96||
59772009|NCT00829244|75892482|FG001|STARTED|Overall Study||104||
59772010|NCT00829244|75892481|FG000|COMPLETED|Overall Study||82||
59772011|NCT00829244|75892482|FG001|COMPLETED|Overall Study||83||
59772012|NCT00829244|75892481|FG000|NOT COMPLETED|Overall Study||14||
59772013|NCT00829244|75892482|FG001|NOT COMPLETED|Overall Study||21||
59772014|NCT00787605|75892490|FG000|STARTED|Overall Study||428||
59772015|NCT00787605|75892491|FG001|STARTED|Overall Study||432||
59772016|NCT00787605|75892490|FG000|COMPLETED|Overall Study||382||
59772017|NCT00787605|75892491|FG001|COMPLETED|Overall Study||376||
59772018|NCT00787605|75892490|FG000|NOT COMPLETED|Overall Study||46||
59772019|NCT00787605|75892491|FG001|NOT COMPLETED|Overall Study||56||
59772020|NCT00448591|75892497|FG000|STARTED|Overall Study||2296||
59772021|NCT00448591|75892497|FG000|COMPLETED|Overall Study||0||
59772022|NCT00448591|75892497|FG000|NOT COMPLETED|Overall Study||2296||
59772023|NCT00651664|75892513|FG000|STARTED|Overall Study||3||
59772024|NCT00651664|75892514|FG001|STARTED|Overall Study||3||
59772025|NCT00651664|75892515|FG002|STARTED|Overall Study||3||
59772026|NCT00651664|75892516|FG003|STARTED|Overall Study||14||
59772027|NCT00651664|75892517|FG004|STARTED|Overall Study||6||
59772028|NCT00651664|75892518|FG005|STARTED|Overall Study||3||
59772029|NCT00651664|75892519|FG006|STARTED|Overall Study||6||
59772030|NCT00651664|75892520|FG007|STARTED|Overall Study||7||
59772031|NCT00651664|75892521|FG008|STARTED|Overall Study||7||
59772032|NCT00651664|75892522|FG009|STARTED|Overall Study||7||
59772033|NCT00651664|75892513|FG000|COMPLETED|Overall Study||0||
59772034|NCT00651664|75892514|FG001|COMPLETED|Overall Study||0||
59772035|NCT00651664|75892515|FG002|COMPLETED|Overall Study||0||
59772036|NCT00651664|75892516|FG003|COMPLETED|Overall Study||0||
59772037|NCT00651664|75892517|FG004|COMPLETED|Overall Study||0||
59772038|NCT00651664|75892518|FG005|COMPLETED|Overall Study||0||
59772039|NCT00651664|75892519|FG006|COMPLETED|Overall Study||0||
59772040|NCT00651664|75892520|FG007|COMPLETED|Overall Study||0||
59952709|NCT02605174|76071491|FG004|STARTED|Overall Study||501||
59772041|NCT00651664|75892521|FG008|COMPLETED|Overall Study||0||
59772042|NCT00651664|75892522|FG009|COMPLETED|Overall Study||0||
59772043|NCT00651664|75892513|FG000|NOT COMPLETED|Overall Study||3||
59772044|NCT00651664|75892514|FG001|NOT COMPLETED|Overall Study||3||
59772045|NCT00651664|75892515|FG002|NOT COMPLETED|Overall Study||3||
59772046|NCT00651664|75892516|FG003|NOT COMPLETED|Overall Study||14||
59772047|NCT00651664|75892517|FG004|NOT COMPLETED|Overall Study||6||
59772048|NCT00651664|75892518|FG005|NOT COMPLETED|Overall Study||3||
59772049|NCT00651664|75892519|FG006|NOT COMPLETED|Overall Study||6||
59772050|NCT00651664|75892520|FG007|NOT COMPLETED|Overall Study||7||
59772051|NCT00651664|75892521|FG008|NOT COMPLETED|Overall Study||7||
59772052|NCT00651664|75892522|FG009|NOT COMPLETED|Overall Study||7||
59772053|NCT00787527|75892548|FG000|STARTED|Overall Study||14||
59772054|NCT00787527|75892548|FG000|COMPLETED|Overall Study||11||
59952710|NCT02605174|76071492|FG005|STARTED|Overall Study||249||
59772055|NCT00787527|75892548|FG000|NOT COMPLETED|Overall Study||3||
59772056|NCT00787137|75892559|FG000|STARTED|Overall Study||6||
59772057|NCT00787137|75892560|FG001|STARTED|Overall Study||6||
59772058|NCT00787137|75892561|FG002|STARTED|Overall Study||5||
59772059|NCT00787137|75892559|FG000|COMPLETED|Overall Study||6||
59772060|NCT00787137|75892560|FG001|COMPLETED|Overall Study||6||
59772061|NCT00787137|75892561|FG002|COMPLETED|Overall Study||4||
59772062|NCT00787137|75892559|FG000|NOT COMPLETED|Overall Study||0||
59772063|NCT00787137|75892560|FG001|NOT COMPLETED|Overall Study||0||
59772064|NCT00787137|75892561|FG002|NOT COMPLETED|Overall Study||1||
59772065|NCT00448435|75892569|FG000|STARTED|Treatment Period I - 4 Weeks||26||
59772066|NCT00448435|75892570|FG001|STARTED|Treatment Period I - 4 Weeks||25||
59772067|NCT00448435|75892569|FG000|COMPLETED|Treatment Period I - 4 Weeks||26||
59772068|NCT00448435|75892570|FG001|COMPLETED|Treatment Period I - 4 Weeks||25||
59772069|NCT00448435|75892569|FG000|NOT COMPLETED|Treatment Period I - 4 Weeks||0||
59772070|NCT00448435|75892570|FG001|NOT COMPLETED|Treatment Period I - 4 Weeks||0||
59772071|NCT00448435|75892569|FG000|STARTED|Washout Period - 2 Weeks||26||
59772072|NCT00448435|75892570|FG001|STARTED|Washout Period - 2 Weeks||25||
59772073|NCT00448435|75892569|FG000|COMPLETED|Washout Period - 2 Weeks||25||
59772074|NCT00448435|75892570|FG001|COMPLETED|Washout Period - 2 Weeks||25||
59772075|NCT00448435|75892569|FG000|NOT COMPLETED|Washout Period - 2 Weeks||1||
59772076|NCT00448435|75892570|FG001|NOT COMPLETED|Washout Period - 2 Weeks||0||
59772077|NCT00448435|75892569|FG000|STARTED|Treatment Period II - 4 Weeks||25||
59772078|NCT00448435|75892570|FG001|STARTED|Treatment Period II - 4 Weeks||25||
59772079|NCT00448435|75892569|FG000|COMPLETED|Treatment Period II - 4 Weeks||25||
59772080|NCT00448435|75892570|FG001|COMPLETED|Treatment Period II - 4 Weeks||25||
59772081|NCT00448435|75892569|FG000|NOT COMPLETED|Treatment Period II - 4 Weeks||0||
59772082|NCT00448435|75892570|FG001|NOT COMPLETED|Treatment Period II - 4 Weeks||0||
59772083|NCT00448435|75892569|FG000|STARTED|Extension Period - 20 Weeks||50||
59772084|NCT00448435|75892570|FG001|STARTED|Extension Period - 20 Weeks||0||
59772085|NCT00448435|75892569|FG000|COMPLETED|Extension Period - 20 Weeks||50||
59772086|NCT00448435|75892570|FG001|COMPLETED|Extension Period - 20 Weeks||0||
59772087|NCT00448435|75892569|FG000|NOT COMPLETED|Extension Period - 20 Weeks||0||
59772088|NCT00448435|75892570|FG001|NOT COMPLETED|Extension Period - 20 Weeks||0||
59772089|NCT00448279|75892581|FG000|STARTED|Overall Study||29||
59772090|NCT00448279|75892582|FG001|STARTED|Overall Study||29||
59772091|NCT00448279|75892581|FG000|COMPLETED|Overall Study||0||
59772092|NCT00448279|75892582|FG001|COMPLETED|Overall Study||0||
59772093|NCT00448279|75892581|FG000|NOT COMPLETED|Overall Study||29||
59772094|NCT00448279|75892582|FG001|NOT COMPLETED|Overall Study||29||
59772095|NCT00448123|75892590|FG000|STARTED|Overall Study||62||
59772096|NCT00448123|75892591|FG001|STARTED|Overall Study||65||
59772097|NCT00448123|75892590|FG000|COMPLETED|Overall Study||47||
59772098|NCT00448123|75892591|FG001|COMPLETED|Overall Study||53||
59772099|NCT00448123|75892590|FG000|NOT COMPLETED|Overall Study||15||
59772100|NCT00448123|75892591|FG001|NOT COMPLETED|Overall Study||12||
59772101|NCT00447499|75892600|FG000|STARTED|Overall Study||59||
59772102|NCT00447499|75892600|FG000|COMPLETED|Overall Study||52||
59772103|NCT00447499|75892600|FG000|NOT COMPLETED|Overall Study||7||
59772104|NCT00800436|75892613|FG000|STARTED|Overall Study||6||
59772105|NCT00800436|75892614|FG001|STARTED|Overall Study||6||
59772106|NCT00800436|75892615|FG002|STARTED|Overall Study||6||
59772107|NCT00800436|75892616|FG003|STARTED|Overall Study||6||
59772108|NCT00800436|75892617|FG004|STARTED|Overall Study||6||
59772109|NCT00800436|75892618|FG005|STARTED|Overall Study||20||
59772110|NCT00800436|75892619|FG006|STARTED|Overall Study||20||
59772111|NCT00800436|75892613|FG000|COMPLETED|Overall Study||6||
59772112|NCT00800436|75892614|FG001|COMPLETED|Overall Study||6||
59772113|NCT00800436|75892615|FG002|COMPLETED|Overall Study||5||
59772114|NCT00800436|75892616|FG003|COMPLETED|Overall Study||5||
59772115|NCT00800436|75892617|FG004|COMPLETED|Overall Study||6||
59772116|NCT00800436|75892618|FG005|COMPLETED|Overall Study||20||
59772117|NCT00800436|75892619|FG006|COMPLETED|Overall Study||20||
59772118|NCT00800436|75892613|FG000|NOT COMPLETED|Overall Study||0||
59772119|NCT00800436|75892614|FG001|NOT COMPLETED|Overall Study||0||
59772120|NCT00800436|75892615|FG002|NOT COMPLETED|Overall Study||1||
59772121|NCT00800436|75892616|FG003|NOT COMPLETED|Overall Study||1||
59772122|NCT00800436|75892617|FG004|NOT COMPLETED|Overall Study||0||
59772123|NCT00800436|75892618|FG005|NOT COMPLETED|Overall Study||0||
59772124|NCT00800436|75892619|FG006|NOT COMPLETED|Overall Study||0||
59772125|NCT00655564|75892635|FG000|STARTED|Overall Study||15||
59772126|NCT00655564|75892635|FG000|COMPLETED|Overall Study||12||
59772127|NCT00655564|75892635|FG000|NOT COMPLETED|Overall Study||3||
59772128|NCT00447421|75892640|FG000|STARTED|Overall Study||9||
59772129|NCT00447421|75892640|FG000|COMPLETED|Overall Study||3||
59772130|NCT00447421|75892640|FG000|NOT COMPLETED|Overall Study||6||
59772131|NCT00651118|75892648|FG000|STARTED|Overall Study||207||
59772132|NCT00651118|75892649|FG001|STARTED|Overall Study||207||
59772133|NCT00651118|75892650|FG002|STARTED|Overall Study||208||
59772134|NCT00651118|75892651|FG003|STARTED|Overall Study||210||
59772135|NCT00651118|75892648|FG000|COMPLETED|Overall Study||198||
59772136|NCT00651118|75892649|FG001|COMPLETED|Overall Study||200||
59772137|NCT00651118|75892650|FG002|COMPLETED|Overall Study||197||
59772138|NCT00651118|75892651|FG003|COMPLETED|Overall Study||203||
59772139|NCT00651118|75892648|FG000|NOT COMPLETED|Overall Study||9||
59772140|NCT00651118|75892649|FG001|NOT COMPLETED|Overall Study||7||
59772141|NCT00651118|75892650|FG002|NOT COMPLETED|Overall Study||11||
59772142|NCT00651118|75892651|FG003|NOT COMPLETED|Overall Study||7||
59772143|NCT00447265|75892664|FG000|STARTED|Overall Study||1||
59772144|NCT00447265|75892665|FG001|STARTED|Overall Study||0||
59772145|NCT00447265|75892664|FG000|COMPLETED|Overall Study|The participant completed treatment and discontinued follow-up at week 39 after randomization|0||
59772146|NCT00447265|75892665|FG001|COMPLETED|Overall Study||0||
59772147|NCT00447265|75892664|FG000|NOT COMPLETED|Overall Study||1||
59772148|NCT00447265|75892665|FG001|NOT COMPLETED|Overall Study||0||
59772149|NCT00657358|75892669|FG000|STARTED|Overall Study||22||
59772150|NCT00657358|75892669|FG000|COMPLETED|Overall Study||16||
59772151|NCT00657358|75892669|FG000|NOT COMPLETED|Overall Study||6||
59772152|NCT00457639|75892674|FG000|STARTED|Intervention 1 (6 Months)|6 months on Cholic Acid and crossover to Placebo for 6 months|9||
59772153|NCT00457639|75892675|FG001|STARTED|Intervention 1 (6 Months)|6 months on Placebo and crossover to cholic acid for 6 months|9||
59772154|NCT00457639|75892674|FG000|COMPLETED|Intervention 1 (6 Months)|Number of Patients completing Cholic Acid Phase|6||
59772155|NCT00457639|75892675|FG001|COMPLETED|Intervention 1 (6 Months)|Number of patients completing Placebo Phase|7||
59772156|NCT00457639|75892674|FG000|NOT COMPLETED|Intervention 1 (6 Months)||3||
59772157|NCT00457639|75892675|FG001|NOT COMPLETED|Intervention 1 (6 Months)||2||
59772158|NCT00457639|75892674|FG000|STARTED|Intervention 2 (6 Months)||6||
59772159|NCT00457639|75892675|FG001|STARTED|Intervention 2 (6 Months)||7||
59772160|NCT00457639|75892674|FG000|COMPLETED|Intervention 2 (6 Months)||6||
59772161|NCT00457639|75892675|FG001|COMPLETED|Intervention 2 (6 Months)||6||
59772162|NCT00457639|75892674|FG000|NOT COMPLETED|Intervention 2 (6 Months)||0||
59772163|NCT00457639|75892675|FG001|NOT COMPLETED|Intervention 2 (6 Months)||1||
59772164|NCT00800202|75892683|FG000|STARTED|Overall Study||67||
59772165|NCT00800202|75892684|FG001|STARTED|Overall Study||24||
59772166|NCT00800202|75892683|FG000|COMPLETED|Overall Study||0||
59772167|NCT00800202|75892684|FG001|COMPLETED|Overall Study||0||
59772168|NCT00800202|75892683|FG000|NOT COMPLETED|Overall Study||67||
59772169|NCT00800202|75892684|FG001|NOT COMPLETED|Overall Study||24||
59772170|NCT00655486|75892690|FG000|STARTED|Overall Study||97||
59772171|NCT00655486|75892690|FG000|COMPLETED|Overall Study||69||
59772172|NCT00655486|75892690|FG000|NOT COMPLETED|Overall Study||28||
59772173|NCT00457249|75892696|FG000|STARTED|Overall Study||1170||
59772174|NCT00457249|75892697|FG001|STARTED|Overall Study||391||
59772175|NCT00457249|75892696|FG000|COMPLETED|Overall Study||1158||
59772176|NCT00457249|75892697|FG001|COMPLETED|Overall Study||389||
59772177|NCT00457249|75892696|FG000|NOT COMPLETED|Overall Study||12||
59772178|NCT00457249|75892697|FG001|NOT COMPLETED|Overall Study||2||
59772179|NCT00457015|75892707|FG000|STARTED|Overall Study||48||
59772180|NCT00457015|75892708|FG001|STARTED|Overall Study||48||
59772181|NCT00457015|75892707|FG000|COMPLETED|Overall Study||48||
59772182|NCT00457015|75892708|FG001|COMPLETED|Overall Study||47||
59772183|NCT00457015|75892707|FG000|NOT COMPLETED|Overall Study||0||
59772184|NCT00457015|75892708|FG001|NOT COMPLETED|Overall Study||1||
59772185|NCT00654940|75892716|FG000|STARTED|Period 1|Assigned to study treatment.|13||
59772186|NCT00654940|75892717|FG001|STARTED|Period 1|Assigned to study treatment.|12||
59772187|NCT00654940|75892716|FG000|Received Study Treatment|Period 1||12||
59772188|NCT00654940|75892717|FG001|Received Study Treatment|Period 1||12||
59521831|NCT00982007|75616112|FG001|COMPLETED|Overall Study||253||
59772189|NCT00654940|75892716|FG000|COMPLETED|Period 1||12||
59772190|NCT00654940|75892717|FG001|COMPLETED|Period 1||11||
59772191|NCT00654940|75892716|FG000|NOT COMPLETED|Period 1||1||
59772192|NCT00654940|75892717|FG001|NOT COMPLETED|Period 1||1||
59772193|NCT00654940|75892716|FG000|STARTED|Washout Period of 2 Weeks||12||
59772194|NCT00654940|75892717|FG001|STARTED|Washout Period of 2 Weeks||11||
59772195|NCT00654940|75892716|FG000|COMPLETED|Washout Period of 2 Weeks||12||
59772196|NCT00654940|75892717|FG001|COMPLETED|Washout Period of 2 Weeks||11||
59772197|NCT00654940|75892716|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0||
59772198|NCT00654940|75892717|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0||
59772199|NCT00654940|75892716|FG000|STARTED|Period 2||12||
59772200|NCT00654940|75892717|FG001|STARTED|Period 2||11||
59772201|NCT00654940|75892716|FG000|COMPLETED|Period 2||12||
59772202|NCT00654940|75892717|FG001|COMPLETED|Period 2||11||
59772203|NCT00654940|75892716|FG000|NOT COMPLETED|Period 2||0||
59772204|NCT00654940|75892717|FG001|NOT COMPLETED|Period 2||0||
59772205|NCT00588666|75892729|FG000|STARTED|Overall Study||51||
59772206|NCT00588666|75892729|FG000|COMPLETED|Overall Study||47||
59772207|NCT00588666|75892729|FG000|NOT COMPLETED|Overall Study||4||
59772208|NCT03835351|75892735|FG000|STARTED|Overall Study||241||
59772209|NCT03835351|75892736|FG001|STARTED|Overall Study||250||
59772210|NCT03835351|75892735|FG000|COMPLETED|Overall Study||241||
59772211|NCT03835351|75892736|FG001|COMPLETED|Overall Study||250||
59772212|NCT03835351|75892735|FG000|NOT COMPLETED|Overall Study||0||
59772213|NCT03835351|75892736|FG001|NOT COMPLETED|Overall Study||0||
59772214|NCT00793182|75892744|FG000|STARTED|Overall Study||2||
59772215|NCT00793182|75892745|FG001|STARTED|Overall Study||4||
59772216|NCT00793182|75892744|FG000|COMPLETED|Overall Study||2||
59772217|NCT00793182|75892745|FG001|COMPLETED|Overall Study||3||
59772218|NCT00793182|75892744|FG000|NOT COMPLETED|Overall Study||0||
59772219|NCT00793182|75892745|FG001|NOT COMPLETED|Overall Study||1||
59772220|NCT00793104|75892751|FG000|STARTED|Overall Study||10||
59772221|NCT00793104|75892751|FG000|COMPLETED|Overall Study||9||
59772222|NCT00793104|75892751|FG000|NOT COMPLETED|Overall Study||1||
59772223|NCT00446797|75892757|FG000|STARTED|Overall Study||141||
59772224|NCT00446797|75892758|FG001|STARTED|Overall Study||137||
59772225|NCT00446797|75892757|FG000|COMPLETED|Overall Study||133||
59772226|NCT00446797|75892758|FG001|COMPLETED|Overall Study||125||
59772227|NCT00446797|75892757|FG000|NOT COMPLETED|Overall Study||8||
59772228|NCT00446797|75892758|FG001|NOT COMPLETED|Overall Study||12||
59772229|NCT00855335|75892769|FG000|STARTED|Overall Study||18||
59772230|NCT00855335|75892770|FG001|STARTED|Overall Study||18||
59772231|NCT00855335|75892771|FG002|STARTED|Overall Study||15||
59772232|NCT00855335|75892772|FG003|STARTED|Overall Study||19||
59772233|NCT00855335|75892773|FG004|STARTED|Overall Study||7||
59772234|NCT00855335|75892769|FG000|COMPLETED|Overall Study||13||
59772235|NCT00855335|75892770|FG001|COMPLETED|Overall Study||16||
59772236|NCT00855335|75892771|FG002|COMPLETED|Overall Study||10||
59772237|NCT00855335|75892772|FG003|COMPLETED|Overall Study||12||
59772238|NCT00855335|75892773|FG004|COMPLETED|Overall Study||6||
59772239|NCT00855335|75892769|FG000|NOT COMPLETED|Overall Study||5||
59772240|NCT00855335|75892770|FG001|NOT COMPLETED|Overall Study||2||
59772241|NCT00855335|75892771|FG002|NOT COMPLETED|Overall Study||5||
59772242|NCT00855335|75892772|FG003|NOT COMPLETED|Overall Study||7||
59772243|NCT00855335|75892773|FG004|NOT COMPLETED|Overall Study||1||
59772244|NCT00799422|75892798|FG000|STARTED|First Week of Wear||4||
59772245|NCT00799422|75892799|FG001|STARTED|First Week of Wear||4||
59772246|NCT00799422|75892800|FG002|STARTED|First Week of Wear||4||
59772247|NCT00799422|75892801|FG003|STARTED|First Week of Wear||5||
59772248|NCT00799422|75892802|FG004|STARTED|First Week of Wear||4||
59772249|NCT00799422|75892803|FG005|STARTED|First Week of Wear||5||
59772250|NCT00799422|75892798|FG000|COMPLETED|First Week of Wear||4||
59772251|NCT00799422|75892799|FG001|COMPLETED|First Week of Wear||4||
59772252|NCT00799422|75892800|FG002|COMPLETED|First Week of Wear||3||
59772253|NCT00799422|75892801|FG003|COMPLETED|First Week of Wear||4||
59772254|NCT00799422|75892802|FG004|COMPLETED|First Week of Wear||4||
59772255|NCT00799422|75892803|FG005|COMPLETED|First Week of Wear||5||
59772256|NCT00799422|75892798|FG000|NOT COMPLETED|First Week of Wear||0||
59772257|NCT00799422|75892799|FG001|NOT COMPLETED|First Week of Wear||0||
59772258|NCT00799422|75892800|FG002|NOT COMPLETED|First Week of Wear||1||
59772259|NCT00799422|75892801|FG003|NOT COMPLETED|First Week of Wear||1||
59772260|NCT00799422|75892802|FG004|NOT COMPLETED|First Week of Wear||0||
59772261|NCT00799422|75892803|FG005|NOT COMPLETED|First Week of Wear||0||
59772262|NCT00799422|75892798|FG000|STARTED|Second Week of Wear||4||
59772263|NCT00799422|75892799|FG001|STARTED|Second Week of Wear||4||
59772264|NCT00799422|75892800|FG002|STARTED|Second Week of Wear||3||
59772265|NCT00799422|75892801|FG003|STARTED|Second Week of Wear|One subject discontinued between First and Second 3 weeks (adverse event)|3||
59772266|NCT00799422|75892802|FG004|STARTED|Second Week of Wear||4||
59772267|NCT00799422|75892803|FG005|STARTED|Second Week of Wear|One subject discontinued between First and Second 3 weeks (adverse event)|4||
59772268|NCT00799422|75892798|FG000|COMPLETED|Second Week of Wear||4||
59772269|NCT00799422|75892799|FG001|COMPLETED|Second Week of Wear||4||
59772270|NCT00799422|75892800|FG002|COMPLETED|Second Week of Wear||3||
59772271|NCT00799422|75892801|FG003|COMPLETED|Second Week of Wear||3||
59772272|NCT00799422|75892802|FG004|COMPLETED|Second Week of Wear||4||
59772273|NCT00799422|75892803|FG005|COMPLETED|Second Week of Wear||4||
59772274|NCT00799422|75892798|FG000|NOT COMPLETED|Second Week of Wear||0||
59772275|NCT00799422|75892799|FG001|NOT COMPLETED|Second Week of Wear||0||
59772276|NCT00799422|75892800|FG002|NOT COMPLETED|Second Week of Wear||0||
59772277|NCT00799422|75892801|FG003|NOT COMPLETED|Second Week of Wear||0||
59772278|NCT00799422|75892802|FG004|NOT COMPLETED|Second Week of Wear||0||
59772279|NCT00799422|75892803|FG005|NOT COMPLETED|Second Week of Wear||0||
59772280|NCT00799422|75892798|FG000|STARTED|Third Week of Wear||4||
59772281|NCT00799422|75892799|FG001|STARTED|Third Week of Wear||4||
59772282|NCT00799422|75892800|FG002|STARTED|Third Week of Wear||3||
59772283|NCT00799422|75892801|FG003|STARTED|Third Week of Wear||3||
59772284|NCT00799422|75892802|FG004|STARTED|Third Week of Wear||4||
59772285|NCT00799422|75892803|FG005|STARTED|Third Week of Wear||4||
59772286|NCT00799422|75892798|FG000|COMPLETED|Third Week of Wear||4||
59772287|NCT00799422|75892799|FG001|COMPLETED|Third Week of Wear||4||
59772288|NCT00799422|75892800|FG002|COMPLETED|Third Week of Wear||3||
59772289|NCT00799422|75892801|FG003|COMPLETED|Third Week of Wear||3||
59772290|NCT00799422|75892802|FG004|COMPLETED|Third Week of Wear||4||
59772291|NCT00799422|75892803|FG005|COMPLETED|Third Week of Wear||4||
59772292|NCT00799422|75892798|FG000|NOT COMPLETED|Third Week of Wear||0||
59772293|NCT00799422|75892799|FG001|NOT COMPLETED|Third Week of Wear||0||
59772294|NCT00799422|75892800|FG002|NOT COMPLETED|Third Week of Wear||0||
59772295|NCT00799422|75892801|FG003|NOT COMPLETED|Third Week of Wear||0||
59772296|NCT00799422|75892802|FG004|NOT COMPLETED|Third Week of Wear||0||
59772297|NCT00799422|75892803|FG005|NOT COMPLETED|Third Week of Wear||0||
59772298|NCT00593489|75892813|FG000|STARTED|Allocation|allocated to intervention group to receive the intervention|75||
59772299|NCT00593489|75892814|FG001|STARTED|Allocation|allocated to usual care group|79||
59772300|NCT00593489|75892813|FG000|COMPLETED|Allocation||73||
59772301|NCT00593489|75892814|FG001|COMPLETED|Allocation||78||
59772302|NCT00593489|75892813|FG000|NOT COMPLETED|Allocation||2||
59772303|NCT00593489|75892814|FG001|NOT COMPLETED|Allocation||1||
59772304|NCT00593489|75892813|FG000|STARTED|Analysis|physician withdrawal (N=3) primary outcome set to 0|73||
59772305|NCT00593489|75892814|FG001|STARTED|Analysis|physician withdrawal (N=3) primary outcome set to 0|78||
59772306|NCT00593489|75892813|FG000|COMPLETED|Analysis||73||
59772307|NCT00593489|75892814|FG001|COMPLETED|Analysis||78||
59772308|NCT00593489|75892813|FG000|NOT COMPLETED|Analysis||0||
59772309|NCT00593489|75892814|FG001|NOT COMPLETED|Analysis||0||
59772310|NCT00446641|75892824|FG000|STARTED|Overall Study||125||
59772311|NCT00446641|75892825|FG001|STARTED|Overall Study||119||
59772312|NCT00446641|75892824|FG000|COMPLETED|Overall Study||108||
59772313|NCT00446641|75892825|FG001|COMPLETED|Overall Study||109||
59772314|NCT00446641|75892824|FG000|NOT COMPLETED|Overall Study||17||
59772315|NCT00446641|75892825|FG001|NOT COMPLETED|Overall Study||10||
59772316|NCT00646282|75892833|FG000|STARTED|Overall Study||4||
59772317|NCT00646282|75892834|FG001|STARTED|Overall Study||4||
59772318|NCT00646282|75892833|FG000|COMPLETED|Overall Study||0||
59772319|NCT00646282|75892834|FG001|COMPLETED|Overall Study||0||
59772320|NCT00646282|75892833|FG000|NOT COMPLETED|Overall Study||4||
59772321|NCT00646282|75892834|FG001|NOT COMPLETED|Overall Study||4||
59772322|NCT00792636|75892843|FG000|STARTED|Overall Study||135||
59772323|NCT00792636|75892844|FG001|STARTED|Overall Study||136||
59772324|NCT00792636|75892845|FG002|STARTED|Overall Study||136||
59772325|NCT00792636|75892843|FG000|COMPLETED|Overall Study||67||
59772326|NCT00792636|75892844|FG001|COMPLETED|Overall Study||55||
59772327|NCT00792636|75892845|FG002|COMPLETED|Overall Study||55||
59772328|NCT00792636|75892843|FG000|NOT COMPLETED|Overall Study||68||
59772329|NCT00792636|75892844|FG001|NOT COMPLETED|Overall Study||81||
59772330|NCT00792636|75892845|FG002|NOT COMPLETED|Overall Study||81||
59772331|NCT00446563|75892857|FG000|STARTED|Overall Study||43||
59772332|NCT00446563|75892858|FG001|STARTED|Overall Study||47||
59772333|NCT00446563|75892857|FG000|COMPLETED|Overall Study||36||
59772334|NCT00446563|75892858|FG001|COMPLETED|Overall Study||38||
59772335|NCT00446563|75892857|FG000|NOT COMPLETED|Overall Study||7||
59772336|NCT00446563|75892858|FG001|NOT COMPLETED|Overall Study||9||
59772337|NCT00650806|75892868|FG000|STARTED|Overall Study||89||
59772338|NCT00650806|75892869|FG001|STARTED|Overall Study||98||
59772339|NCT00650806|75892870|FG002|STARTED|Overall Study||93||
59772340|NCT00650806|75892871|FG003|STARTED|Overall Study||96||
59772341|NCT00650806|75892868|FG000|COMPLETED|Overall Study||71||
59772342|NCT00650806|75892869|FG001|COMPLETED|Overall Study||77||
59772343|NCT00650806|75892870|FG002|COMPLETED|Overall Study||64||
59772344|NCT00650806|75892871|FG003|COMPLETED|Overall Study||70||
59772345|NCT00650806|75892868|FG000|NOT COMPLETED|Overall Study||18||
59772346|NCT00650806|75892869|FG001|NOT COMPLETED|Overall Study||21||
59772347|NCT00650806|75892870|FG002|NOT COMPLETED|Overall Study||29||
59952711|NCT02605174|76071493|FG006|STARTED|Overall Study||751||
59772348|NCT00650806|75892871|FG003|NOT COMPLETED|Overall Study||26||
59772349|NCT00863057|75892887|FG000|STARTED|Milestones Period 1 (Weeks 0-5)||4||
59772350|NCT00863057|75892888|FG001|STARTED|Milestones Period 1 (Weeks 0-5)||4||
59772351|NCT00863057|75892889|FG002|STARTED|Milestones Period 1 (Weeks 0-5)||3||
59772352|NCT00863057|75892890|FG003|STARTED|Milestones Period 1 (Weeks 0-5)||4||
59772353|NCT00863057|75892887|FG000|COMPLETED|Milestones Period 1 (Weeks 0-5)||3||
59772354|NCT00863057|75892888|FG001|COMPLETED|Milestones Period 1 (Weeks 0-5)||2||
59772355|NCT00863057|75892889|FG002|COMPLETED|Milestones Period 1 (Weeks 0-5)||3||
59772356|NCT00863057|75892890|FG003|COMPLETED|Milestones Period 1 (Weeks 0-5)||3||
59772357|NCT00863057|75892887|FG000|NOT COMPLETED|Milestones Period 1 (Weeks 0-5)||1||
59772358|NCT00863057|75892888|FG001|NOT COMPLETED|Milestones Period 1 (Weeks 0-5)||2||
59772359|NCT00863057|75892889|FG002|NOT COMPLETED|Milestones Period 1 (Weeks 0-5)||0||
59772360|NCT00863057|75892890|FG003|NOT COMPLETED|Milestones Period 1 (Weeks 0-5)||1||
59772361|NCT00863057|75892887|FG000|STARTED|Period 2 (Weeks 6-10)||3||
59772362|NCT00863057|75892888|FG001|STARTED|Period 2 (Weeks 6-10)||2||
59772363|NCT00863057|75892889|FG002|STARTED|Period 2 (Weeks 6-10)||3||
59772364|NCT00863057|75892890|FG003|STARTED|Period 2 (Weeks 6-10)||3||
59772365|NCT00863057|75892887|FG000|COMPLETED|Period 2 (Weeks 6-10)||3||
59772366|NCT00863057|75892888|FG001|COMPLETED|Period 2 (Weeks 6-10)||1||
59772367|NCT00863057|75892889|FG002|COMPLETED|Period 2 (Weeks 6-10)||2||
59772368|NCT00863057|75892890|FG003|COMPLETED|Period 2 (Weeks 6-10)||2||
59772369|NCT00863057|75892887|FG000|NOT COMPLETED|Period 2 (Weeks 6-10)||0||
59772370|NCT00863057|75892888|FG001|NOT COMPLETED|Period 2 (Weeks 6-10)||1||
59772371|NCT00863057|75892889|FG002|NOT COMPLETED|Period 2 (Weeks 6-10)||1||
59772372|NCT00863057|75892890|FG003|NOT COMPLETED|Period 2 (Weeks 6-10)||1||
59952712|NCT02605174|76071487|FG000|Received at Least 1 Dose of Study Drug|Overall Study||429||
59952713|NCT02605174|76071488|FG001|Received at Least 1 Dose of Study Drug|Overall Study||225||
59618370|NCT03810534|75729477|FG003|Completed 7-Day (Caregivers)|Connect-Home (5-10 Months)||24||
59618371|NCT03810534|75729478|FG004|Completed 7-Day (Caregivers)|Connect-Home (5-10 Months)||4||
59618372|NCT03810534|75729479|FG005|Completed 7-Day (Caregivers)|Connect-Home (5-10 Months)||13||
59618373|NCT03810534|75729474|FG000|Completed 30-Day (Patients)|Connect-Home (5-10 Months)||35||
59618374|NCT03810534|75729475|FG001|Completed 30-Day (Patients)|Connect-Home (5-10 Months)||31||
59618375|NCT03810534|75729476|FG002|Completed 30-Day (Patients)|Connect-Home (5-10 Months)||25||
59618376|NCT03810534|75729477|FG003|Completed 30-Day (Patients)|Connect-Home (5-10 Months)||19||
59618377|NCT03810534|75729478|FG004|Completed 30-Day (Patients)|Connect-Home (5-10 Months)||3||
59618378|NCT03810534|75729479|FG005|Completed 30-Day (Patients)|Connect-Home (5-10 Months)||12||
59618379|NCT03810534|75729474|FG000|Completed 30-Day (Caregivers)|Connect-Home (5-10 Months)||34||
59618380|NCT03810534|75729475|FG001|Completed 30-Day (Caregivers)|Connect-Home (5-10 Months)||30||
59618381|NCT03810534|75729476|FG002|Completed 30-Day (Caregivers)|Connect-Home (5-10 Months)||25||
59618382|NCT03810534|75729477|FG003|Completed 30-Day (Caregivers)|Connect-Home (5-10 Months)||21||
59618383|NCT03810534|75729478|FG004|Completed 30-Day (Caregivers)|Connect-Home (5-10 Months)||2||
59618384|NCT03810534|75729479|FG005|Completed 30-Day (Caregivers)|Connect-Home (5-10 Months)||10||
59618385|NCT03810534|75729474|FG000|Completed 60-Day (Patients)|Connect-Home (5-10 Months)||30||
59618386|NCT03810534|75729475|FG001|Completed 60-Day (Patients)|Connect-Home (5-10 Months)||25||
59618387|NCT03810534|75729476|FG002|Completed 60-Day (Patients)|Connect-Home (5-10 Months)||23||
59618388|NCT03810534|75729477|FG003|Completed 60-Day (Patients)|Connect-Home (5-10 Months)||19||
59618389|NCT03810534|75729478|FG004|Completed 60-Day (Patients)|Connect-Home (5-10 Months)||2||
59618390|NCT03810534|75729479|FG005|Completed 60-Day (Patients)|Connect-Home (5-10 Months)||10||
59618391|NCT03810534|75729474|FG000|Completed 60-Day (Caregivers)|Connect-Home (5-10 Months)||32||
59618392|NCT03810534|75729475|FG001|Completed 60-Day (Caregivers)|Connect-Home (5-10 Months)||27||
59618393|NCT03810534|75729476|FG002|Completed 60-Day (Caregivers)|Connect-Home (5-10 Months)||21||
59618394|NCT03810534|75729477|FG003|Completed 60-Day (Caregivers)|Connect-Home (5-10 Months)||19||
59618395|NCT03810534|75729478|FG004|Completed 60-Day (Caregivers)|Connect-Home (5-10 Months)||2||
59618396|NCT03810534|75729479|FG005|Completed 60-Day (Caregivers)|Connect-Home (5-10 Months)||9||
59618397|NCT03810534|75729474|FG000|COMPLETED|Connect-Home (5-10 Months)||62||
59618398|NCT03810534|75729475|FG001|COMPLETED|Connect-Home (5-10 Months)||52||
59618399|NCT03810534|75729476|FG002|COMPLETED|Connect-Home (5-10 Months)||44||
59618400|NCT03810534|75729477|FG003|COMPLETED|Connect-Home (5-10 Months)||38||
59618401|NCT03810534|75729478|FG004|COMPLETED|Connect-Home (5-10 Months)||4||
59618402|NCT03810534|75729479|FG005|COMPLETED|Connect-Home (5-10 Months)||19||
59618403|NCT03810534|75729474|FG000|NOT COMPLETED|Connect-Home (5-10 Months)||20||
59618404|NCT03810534|75729475|FG001|NOT COMPLETED|Connect-Home (5-10 Months)||28||
59618405|NCT03810534|75729476|FG002|NOT COMPLETED|Connect-Home (5-10 Months)||22||
59618406|NCT03810534|75729477|FG003|NOT COMPLETED|Connect-Home (5-10 Months)||16||
59618407|NCT03810534|75729478|FG004|NOT COMPLETED|Connect-Home (5-10 Months)||6||
59618408|NCT03810534|75729479|FG005|NOT COMPLETED|Connect-Home (5-10 Months)||19||
59618409|NCT06002347|75729488|FG000|STARTED|Overall Study||23||
59618410|NCT06002347|75729488|FG000|COMPLETED|Overall Study||20||
59618411|NCT06002347|75729488|FG000|NOT COMPLETED|Overall Study||3||
59618412|NCT05194722|75729492|FG000|STARTED|Overall Study||30||
59618413|NCT05194722|75729492|FG000|COMPLETED|Overall Study||30||
59618414|NCT05194722|75729492|FG000|NOT COMPLETED|Overall Study||0||
59618415|NCT05139615|75729500|FG000|STARTED|Overall Study||4||
59618416|NCT05139615|75729501|FG001|STARTED|Overall Study||3||
59618417|NCT05139615|75729502|FG002|STARTED|Overall Study||11||
59618418|NCT05139615|75729503|FG003|STARTED|Overall Study||4||
59618419|NCT05139615|75729500|FG000|COMPLETED|Overall Study||4||
59618420|NCT05139615|75729501|FG001|COMPLETED|Overall Study||3||
59618421|NCT05139615|75729502|FG002|COMPLETED|Overall Study||11||
59618422|NCT05139615|75729503|FG003|COMPLETED|Overall Study||4||
59618423|NCT05139615|75729500|FG000|NOT COMPLETED|Overall Study||0||
59772373|NCT00863057|75892887|FG000|STARTED|Period 3 (Weeks 11-15)||3||
59772374|NCT00863057|75892888|FG001|STARTED|Period 3 (Weeks 11-15)||1||
59772375|NCT00863057|75892889|FG002|STARTED|Period 3 (Weeks 11-15)||2||
59772376|NCT00863057|75892890|FG003|STARTED|Period 3 (Weeks 11-15)||2||
59952714|NCT02605174|76071489|FG002|Received at Least 1 Dose of Study Drug|Overall Study||423||
59772377|NCT00863057|75892887|FG000|COMPLETED|Period 3 (Weeks 11-15)||3||
59772378|NCT00863057|75892888|FG001|COMPLETED|Period 3 (Weeks 11-15)||1||
59772379|NCT00863057|75892889|FG002|COMPLETED|Period 3 (Weeks 11-15)||2||
59772380|NCT00863057|75892890|FG003|COMPLETED|Period 3 (Weeks 11-15)||2||
59772381|NCT00863057|75892887|FG000|NOT COMPLETED|Period 3 (Weeks 11-15)||0||
59772382|NCT00863057|75892888|FG001|NOT COMPLETED|Period 3 (Weeks 11-15)||0||
59772383|NCT00863057|75892889|FG002|NOT COMPLETED|Period 3 (Weeks 11-15)||0||
59772384|NCT00863057|75892890|FG003|NOT COMPLETED|Period 3 (Weeks 11-15)||0||
59772385|NCT00863057|75892887|FG000|STARTED|Period 4 (Weeks 16-20)||3||
59772386|NCT00863057|75892888|FG001|STARTED|Period 4 (Weeks 16-20)||1||
59772387|NCT00863057|75892889|FG002|STARTED|Period 4 (Weeks 16-20)||2||
59772388|NCT00863057|75892890|FG003|STARTED|Period 4 (Weeks 16-20)||2||
59772389|NCT00863057|75892887|FG000|COMPLETED|Period 4 (Weeks 16-20)||3||
59772390|NCT00863057|75892888|FG001|COMPLETED|Period 4 (Weeks 16-20)||1||
59772391|NCT00863057|75892889|FG002|COMPLETED|Period 4 (Weeks 16-20)||2||
59772392|NCT00863057|75892890|FG003|COMPLETED|Period 4 (Weeks 16-20)||2||
59772393|NCT00863057|75892887|FG000|NOT COMPLETED|Period 4 (Weeks 16-20)||0||
59772394|NCT00863057|75892888|FG001|NOT COMPLETED|Period 4 (Weeks 16-20)||0||
59772395|NCT00863057|75892889|FG002|NOT COMPLETED|Period 4 (Weeks 16-20)||0||
59772396|NCT00863057|75892890|FG003|NOT COMPLETED|Period 4 (Weeks 16-20)||0||
59772397|NCT00829166|75892908|FG000|STARTED|Overall Study||495||
59772398|NCT00829166|75892909|FG001|STARTED|Overall Study||496||
59772399|NCT00829166|75892908|FG000|Treated|Overall Study||490||
59772400|NCT00829166|75892909|FG001|Treated|Overall Study||488||
59772401|NCT00829166|75892908|FG000|COMPLETED|Overall Study||0||
60072679|NCT01854268|76187864|FG000|STARTED|Overall Study||25||
60072680|NCT01854268|76187864|FG000|COMPLETED|Overall Study||25||
60072681|NCT01854268|76187864|FG000|NOT COMPLETED|Overall Study||0||
59618424|NCT05139615|75729501|FG001|NOT COMPLETED|Overall Study||0||
59618425|NCT05139615|75729502|FG002|NOT COMPLETED|Overall Study||0||
59618426|NCT05139615|75729503|FG003|NOT COMPLETED|Overall Study||0||
59618427|NCT04946552|75729514|FG000|STARTED|Overall Study||3||
59618428|NCT04946552|75729515|FG001|STARTED|Overall Study||2||
59618429|NCT04946552|75729514|FG000|COMPLETED|Overall Study||3||
59618430|NCT04946552|75729515|FG001|COMPLETED|Overall Study||2||
59618431|NCT04946552|75729514|FG000|NOT COMPLETED|Overall Study||0||
59618432|NCT04946552|75729515|FG001|NOT COMPLETED|Overall Study||0||
59618433|NCT04739865|75729521|FG000|STARTED|Overall Study||19||
59618434|NCT04739865|75729521|FG000|COMPLETED|Overall Study||19||
59618435|NCT04739865|75729521|FG000|NOT COMPLETED|Overall Study||0||
59618436|NCT04623996|75729527|FG000|STARTED|Overall Study||2||
59618437|NCT04623996|75729528|FG001|STARTED|Overall Study||0||
59618438|NCT04623996|75729527|FG000|COMPLETED|Overall Study||2||
59618439|NCT04623996|75729528|FG001|COMPLETED|Overall Study||0||
59618440|NCT04623996|75729527|FG000|NOT COMPLETED|Overall Study||0||
59618441|NCT04623996|75729528|FG001|NOT COMPLETED|Overall Study||0||
59618442|NCT04442893|75729536|FG000|STARTED|Overall Study||44||
59618443|NCT04442893|75729537|FG001|STARTED|Overall Study||41||
59618444|NCT04442893|75729536|FG000|COMPLETED|Overall Study||34||
59618445|NCT04442893|75729537|FG001|COMPLETED|Overall Study||36||
59618446|NCT04442893|75729536|FG000|NOT COMPLETED|Overall Study||10||
59618447|NCT04442893|75729537|FG001|NOT COMPLETED|Overall Study||5||
59618448|NCT04439279|75729543|FG000|STARTED|Overall Study||35||
59618449|NCT04439279|75729543|FG000|Started Protocol Therapy|Overall Study||35||
59618450|NCT04439279|75729543|FG000|Eligible|Overall Study||33||
59618451|NCT04439279|75729543|FG000|Reported Adverse Events Data|Overall Study|Adverse event was not assessed on one patient before discontinuing therapy due to withdraw/refusal|34||
59618452|NCT04439279|75729543|FG000|COMPLETED|Overall Study|Treatment continued until disease progression or intolerability.|0||
59618453|NCT04439279|75729543|FG000|NOT COMPLETED|Overall Study||35||
59618454|NCT04308941|75729550|FG000|STARTED|Overall Study||10||
59618455|NCT04308941|75729551|FG001|STARTED|Overall Study||10||
59618456|NCT04308941|75729552|FG002|STARTED|Overall Study||10||
59772402|NCT00829166|75892909|FG001|COMPLETED|Overall Study||0||
59772403|NCT00829166|75892908|FG000|NOT COMPLETED|Overall Study||495||
59772404|NCT00829166|75892909|FG001|NOT COMPLETED|Overall Study||496||
59772405|NCT00799266|75892918|FG000|STARTED|Overall Study||18|All randomized patients (ITT)|
59772406|NCT00799266|75892919|FG001|STARTED|Overall Study||16|All randomized patients (ITT)|
59772407|NCT00799266|75892918|FG000|Modified Intention-to-treat (MITT)|Overall Study||17|All patients with baseline and at least one post-baseline lumbar spine BMD Z-score|
60103565|NCT01342666|76221799|FG000|NOT COMPLETED|Overall Study||0||
59618457|NCT04308941|75729550|FG000|COMPLETED|Overall Study||10||
59618458|NCT04308941|75729551|FG001|COMPLETED|Overall Study||10||
59618459|NCT04308941|75729552|FG002|COMPLETED|Overall Study||10||
59618460|NCT04308941|75729550|FG000|NOT COMPLETED|Overall Study||0||
59618461|NCT04308941|75729551|FG001|NOT COMPLETED|Overall Study||0||
59618462|NCT04308941|75729552|FG002|NOT COMPLETED|Overall Study||0||
59618463|NCT04294966|75729563|FG000|STARTED|Overall Study||8||
59618464|NCT04294966|75729564|FG001|STARTED|Overall Study||8||
59772408|NCT00799266|75892919|FG001|Modified Intention-to-treat (MITT)|Overall Study||16|All patients with baseline and at least one post-baseline lumbar spine BMD Z-score|
59772409|NCT00799266|75892918|FG000|Safety Set|Overall Study||18|All patients with at least one infusion of study drug|
59772410|NCT00799266|75892919|FG001|Safety Set|Overall Study||16|All patients with at least one infusion of study drug|
59772411|NCT00799266|75892918|FG000|COMPLETED|Overall Study||15||
59772412|NCT00799266|75892919|FG001|COMPLETED|Overall Study||15||
59772413|NCT00799266|75892918|FG000|NOT COMPLETED|Overall Study||3||
59772414|NCT00799266|75892919|FG001|NOT COMPLETED|Overall Study||1||
59772415|NCT00650104|75892925|FG000|STARTED|Overall Study||83||
59772416|NCT00650104|75892925|FG000|COMPLETED|Overall Study||42||
59772417|NCT00650104|75892925|FG000|NOT COMPLETED|Overall Study||41||
59772418|NCT00654238|75892929|FG000|STARTED|Overall Study||59||
59772419|NCT00654238|75892929|FG000|COMPLETED|Overall Study||55||
59772420|NCT00654238|75892929|FG000|NOT COMPLETED|Overall Study||4||
59772421|NCT00862979|75892936|FG000|STARTED|Overall Study||84||
59772422|NCT00862979|75892937|FG001|STARTED|Overall Study||78||
59772423|NCT00862979|75892936|FG000|Full Analysis Set (FAS)|Overall Study||74||
59772424|NCT00862979|75892937|FG001|Full Analysis Set (FAS)|Overall Study||71||
59772425|NCT00862979|75892936|FG000|COMPLETED|Overall Study||76||
59772426|NCT00862979|75892937|FG001|COMPLETED|Overall Study||71||
59772427|NCT00862979|75892936|FG000|NOT COMPLETED|Overall Study||8||
59772428|NCT00862979|75892937|FG001|NOT COMPLETED|Overall Study||7||
59772429|NCT00483379|75892945|FG000|STARTED|Treatment Period||6||
59772430|NCT00483379|75892946|FG001|STARTED|Treatment Period||7||
59772431|NCT00483379|75892945|FG000|COMPLETED|Treatment Period||4||
59772432|NCT00483379|75892946|FG001|COMPLETED|Treatment Period||7||
59772433|NCT00483379|75892945|FG000|NOT COMPLETED|Treatment Period||2||
59772434|NCT00483379|75892946|FG001|NOT COMPLETED|Treatment Period||0||
59772435|NCT00483379|75892945|FG000|STARTED|Extension Period|Extension allowed late-onset participants access to treatment until commercially available.|1||
59772436|NCT00483379|75892946|FG001|STARTED|Extension Period|Extension allowed late-onset participants access to treatment until commercially available.|2||
59772437|NCT00483379|75892945|FG000|COMPLETED|Extension Period||1||
59772438|NCT00483379|75892946|FG001|COMPLETED|Extension Period||2||
59772439|NCT00483379|75892945|FG000|NOT COMPLETED|Extension Period||0||
59772440|NCT00483379|75892946|FG001|NOT COMPLETED|Extension Period||0||
59772441|NCT00446251|75892954|FG000|STARTED|Overall Study|14 subjects were enrolled in this Rituximab-mycophenolic mofetil group.|14||
59772442|NCT00446251|75892954|FG000|COMPLETED|Overall Study||9||
59772443|NCT00446251|75892954|FG000|NOT COMPLETED|Overall Study||5||
59772444|NCT00796224|75892960|FG000|STARTED|Overall Study||19||
59772445|NCT00796224|75892961|FG001|STARTED|Overall Study||19||
59772446|NCT00796224|75892960|FG000|COMPLETED|Overall Study||18||
59772447|NCT00796224|75892961|FG001|COMPLETED|Overall Study||18||
59772448|NCT00796224|75892960|FG000|NOT COMPLETED|Overall Study||1||
59772449|NCT00796224|75892961|FG001|NOT COMPLETED|Overall Study||1||
59772450|NCT00791934|75892969|FG000|STARTED|Overall Study||63||
59772451|NCT00791934|75892969|FG000|COMPLETED|Overall Study|Follow-up extended to 1 yr. 13 subjects chose not to participate in the extension.|48||
59772452|NCT00791934|75892969|FG000|NOT COMPLETED|Overall Study||15||
59772453|NCT00848081|75892975|FG000|STARTED|Overall Study||160||
59772454|NCT00848081|75892976|FG001|STARTED|Overall Study||158||
59772455|NCT00848081|75892975|FG000|COMPLETED|Overall Study||140||
59772456|NCT00848081|75892976|FG001|COMPLETED|Overall Study||140||
59772457|NCT00848081|75892975|FG000|NOT COMPLETED|Overall Study||20||
59772458|NCT00848081|75892976|FG001|NOT COMPLETED|Overall Study||18||
59772459|NCT00654004|75892984|FG000|STARTED|Overall Study||14||
59772460|NCT00654004|75892985|FG001|STARTED|Overall Study||12||
59772461|NCT00654004|75892984|FG000|COMPLETED|Overall Study||13||
59772462|NCT00654004|75892985|FG001|COMPLETED|Overall Study||12||
59772463|NCT00654004|75892984|FG000|NOT COMPLETED|Overall Study||1||
59772464|NCT00654004|75892985|FG001|NOT COMPLETED|Overall Study||0||
59772465|NCT00791778|75892993|FG000|STARTED|Double-blind Treatment||123||
59772466|NCT00791778|75892994|FG001|STARTED|Double-blind Treatment||123||
59772467|NCT00791778|75892993|FG000|COMPLETED|Double-blind Treatment|includes: 42 subjects with progression, 4 subjects transferred to a continuation study|46||
59772468|NCT00791778|75892994|FG001|COMPLETED|Double-blind Treatment|includes: 75 subjects with progression|75||
59772469|NCT00791778|75892993|FG000|NOT COMPLETED|Double-blind Treatment||77||
59772470|NCT00791778|75892994|FG001|NOT COMPLETED|Double-blind Treatment||48||
59772471|NCT00791778|75892993|FG000|STARTED|Follow-up||100||
59772472|NCT00791778|75892994|FG001|STARTED|Follow-up||91||
59772473|NCT00791778|75892993|FG000|COMPLETED|Follow-up|Includes 79 participants with study follow-up terminated by sponsor and 16 deaths|95||
59772474|NCT00791778|75892994|FG001|COMPLETED|Follow-up|Includes 78 participants with study follow-up terminated by sponsor and 12 deaths|90||
59772475|NCT00791778|75892993|FG000|NOT COMPLETED|Follow-up||5||
59772476|NCT00791778|75892994|FG001|NOT COMPLETED|Follow-up||1||
59772477|NCT00798174|75893000|FG000|STARTED|Overall Study||16||
59772478|NCT00798174|75893001|FG001|STARTED|Overall Study||16||
59772479|NCT00798174|75893000|FG000|COMPLETED|Overall Study||12||
59772480|NCT00798174|75893001|FG001|COMPLETED|Overall Study||13||
59772481|NCT00798174|75893000|FG000|NOT COMPLETED|Overall Study||4||
59772482|NCT00798174|75893001|FG001|NOT COMPLETED|Overall Study||3||
59772483|NCT00798096|75893005|FG000|STARTED|Overall Study|Treatment with 200 mg bid, oral Fostamatanib until disease progression, toxicity or withdrawal|18||
59772484|NCT00798096|75893005|FG000|COMPLETED|Overall Study|Completion of Study is defined as a minimum of 8 weeks of treatment or early disease progression|16||
59772485|NCT00798096|75893005|FG000|NOT COMPLETED|Overall Study||2||
59772486|NCT00795600|75893011|FG000|STARTED|Overall Study||25||
59772487|NCT00795600|75893012|FG001|STARTED|Overall Study||35||
59772488|NCT00795600|75893011|FG000|Exposed to Drug|Overall Study|1 patient did not take study medication because the patient withdrew consent|24||
59772489|NCT00795600|75893012|FG001|Exposed to Drug|Overall Study||35||
59772490|NCT00795600|75893011|FG000|COMPLETED|Overall Study||21||
59772491|NCT00795600|75893012|FG001|COMPLETED|Overall Study||31||
59772492|NCT00795600|75893011|FG000|NOT COMPLETED|Overall Study||4||
59772493|NCT00795600|75893012|FG001|NOT COMPLETED|Overall Study||4||
59772494|NCT00795132|75893018|FG000|STARTED|Overall Study||47||
59772495|NCT00795132|75893018|FG000|COMPLETED|Overall Study||44||
59772496|NCT00795132|75893018|FG000|NOT COMPLETED|Overall Study||3||
59772497|NCT00647296|75893034|FG000|STARTED|Part 1: 12-week Double-Blind Treatment||27||
59772498|NCT00647296|75893035|FG001|STARTED|Part 1: 12-week Double-Blind Treatment||23||
59772499|NCT00647296|75893036|FG002|STARTED|Part 1: 12-week Double-Blind Treatment||26||
59772500|NCT00647296|75893037|FG003|STARTED|Part 1: 12-week Double-Blind Treatment||26||
59772501|NCT00647296|75893034|FG000|COMPLETED|Part 1: 12-week Double-Blind Treatment||26||
59772502|NCT00647296|75893035|FG001|COMPLETED|Part 1: 12-week Double-Blind Treatment||22||
59772503|NCT00647296|75893036|FG002|COMPLETED|Part 1: 12-week Double-Blind Treatment||26||
59772504|NCT00647296|75893037|FG003|COMPLETED|Part 1: 12-week Double-Blind Treatment||24||
59772505|NCT00647296|75893034|FG000|NOT COMPLETED|Part 1: 12-week Double-Blind Treatment||1||
59772506|NCT00647296|75893035|FG001|NOT COMPLETED|Part 1: 12-week Double-Blind Treatment||1||
59772507|NCT00647296|75893036|FG002|NOT COMPLETED|Part 1: 12-week Double-Blind Treatment||0||
59772508|NCT00647296|75893037|FG003|NOT COMPLETED|Part 1: 12-week Double-Blind Treatment||2||
59772509|NCT00647296|75893034|FG000|STARTED|Part 2: 4-week Placebo Washout||97||
59772510|NCT00647296|75893035|FG001|STARTED|Part 2: 4-week Placebo Washout||0||
59772511|NCT00647296|75893036|FG002|STARTED|Part 2: 4-week Placebo Washout||0||
59772512|NCT00647296|75893037|FG003|STARTED|Part 2: 4-week Placebo Washout||0||
59772513|NCT00647296|75893034|FG000|COMPLETED|Part 2: 4-week Placebo Washout||92||
59772514|NCT00647296|75893035|FG001|COMPLETED|Part 2: 4-week Placebo Washout||0||
59772515|NCT00647296|75893036|FG002|COMPLETED|Part 2: 4-week Placebo Washout||0||
59772516|NCT00647296|75893037|FG003|COMPLETED|Part 2: 4-week Placebo Washout||0||
59772517|NCT00647296|75893034|FG000|NOT COMPLETED|Part 2: 4-week Placebo Washout||5||
59772518|NCT00647296|75893035|FG001|NOT COMPLETED|Part 2: 4-week Placebo Washout||0||
59772519|NCT00647296|75893036|FG002|NOT COMPLETED|Part 2: 4-week Placebo Washout||0||
59772520|NCT00647296|75893037|FG003|NOT COMPLETED|Part 2: 4-week Placebo Washout||0||
59772521|NCT00647296|75893034|FG000|STARTED|Part 2: 76-week Double-Blind Treatment||0||
59772522|NCT00647296|75893035|FG001|STARTED|Part 2: 76-week Double-Blind Treatment||48||
59772523|NCT00647296|75893036|FG002|STARTED|Part 2: 76-week Double-Blind Treatment||0||
59772524|NCT00647296|75893037|FG003|STARTED|Part 2: 76-week Double-Blind Treatment||44||
59772525|NCT00647296|75893034|FG000|COMPLETED|Part 2: 76-week Double-Blind Treatment||0||
59772526|NCT00647296|75893035|FG001|COMPLETED|Part 2: 76-week Double-Blind Treatment||33||
59772527|NCT00647296|75893036|FG002|COMPLETED|Part 2: 76-week Double-Blind Treatment||0||
59772528|NCT00647296|75893037|FG003|COMPLETED|Part 2: 76-week Double-Blind Treatment||30||
59772529|NCT00647296|75893034|FG000|NOT COMPLETED|Part 2: 76-week Double-Blind Treatment||0||
59772530|NCT00647296|75893035|FG001|NOT COMPLETED|Part 2: 76-week Double-Blind Treatment||15||
59772531|NCT00647296|75893036|FG002|NOT COMPLETED|Part 2: 76-week Double-Blind Treatment||0||
59772532|NCT00647296|75893037|FG003|NOT COMPLETED|Part 2: 76-week Double-Blind Treatment||14||
59772533|NCT00644878|75893059|FG000|STARTED|Overall Study||18||
59772534|NCT00644878|75893059|FG000|COMPLETED|Overall Study||0||
59772535|NCT00644878|75893059|FG000|NOT COMPLETED|Overall Study||18||
60072682|NCT01594281|76187871|FG000|STARTED|Interventional Core Phase||36|All randomized patients, including one patient who withdrew prior to the baseline visit|
60072683|NCT01594281|76187872|FG001|STARTED|Interventional Core Phase||36|All randomized patients, including one patient who withdrew prior to the baseline visit|
60072684|NCT01594281|76187873|FG002|STARTED|Interventional Core Phase||36|All randomized patients, including one patient who withdrew prior to the baseline visit|
60072685|NCT01594281|76187871|FG000|Full Analysis Set (FAS)|Interventional Core Phase||35|All randomized patients with at least one study treatment and one post-baseline assessment|
60072686|NCT01594281|76187872|FG001|Full Analysis Set (FAS)|Interventional Core Phase||35|All randomized patients with at least one study treatment and one post-baseline assessment|
60072687|NCT01594281|76187873|FG002|Full Analysis Set (FAS)|Interventional Core Phase||36|All randomized patients with at least one study treatment and one post-baseline assessment|
60072688|NCT01594281|76187871|FG000|COMPLETED|Interventional Core Phase||29|End of Core Study (EOCS), defined as the last visit under therapy, up to Month 12|
60072689|NCT01594281|76187872|FG001|COMPLETED|Interventional Core Phase||26|End of Core Study (EOCS), defined as the last visit under therapy, up to Month 12|
60072690|NCT01594281|76187873|FG002|COMPLETED|Interventional Core Phase||28|End of Core Study (EOCS), defined as the last visit under therapy, up to Month 12|
59772536|NCT00646906|75893067|FG000|STARTED|Crossover Period 1||9||
59772537|NCT00646906|75893068|FG001|STARTED|Crossover Period 1||9||
59772538|NCT00646906|75893069|FG002|STARTED|Crossover Period 1||10||
59772539|NCT00646906|75893070|FG003|STARTED|Crossover Period 1||9||
59772540|NCT00646906|75893071|FG004|STARTED|Crossover Period 1||8||
59772541|NCT00646906|75893072|FG005|STARTED|Crossover Period 1||5||
59772542|NCT00646906|75893073|FG006|STARTED|Crossover Period 1||5||
59772543|NCT00646906|75893067|FG000|COMPLETED|Crossover Period 1||8||
59772544|NCT00646906|75893068|FG001|COMPLETED|Crossover Period 1||9||
59772545|NCT00646906|75893069|FG002|COMPLETED|Crossover Period 1||10||
59772546|NCT00646906|75893070|FG003|COMPLETED|Crossover Period 1||9||
59772547|NCT00646906|75893071|FG004|COMPLETED|Crossover Period 1|Phase 1b had only one treatment period and no crossover. Phase 1b ended here.|8||
59772548|NCT00646906|75893072|FG005|COMPLETED|Crossover Period 1||4||
59772549|NCT00646906|75893073|FG006|COMPLETED|Crossover Period 1||5||
59772550|NCT00646906|75893067|FG000|NOT COMPLETED|Crossover Period 1||1||
59772551|NCT00646906|75893068|FG001|NOT COMPLETED|Crossover Period 1||0||
59772552|NCT00646906|75893069|FG002|NOT COMPLETED|Crossover Period 1||0||
59772553|NCT00646906|75893070|FG003|NOT COMPLETED|Crossover Period 1||0||
59772554|NCT00646906|75893071|FG004|NOT COMPLETED|Crossover Period 1||0||
59772555|NCT00646906|75893072|FG005|NOT COMPLETED|Crossover Period 1||1||
59772556|NCT00646906|75893073|FG006|NOT COMPLETED|Crossover Period 1||0||
59772557|NCT00646906|75893067|FG000|STARTED|Washout (>/= 14 Days)||8||
59772558|NCT00646906|75893068|FG001|STARTED|Washout (>/= 14 Days)||9||
59772559|NCT00646906|75893069|FG002|STARTED|Washout (>/= 14 Days)||10||
59772560|NCT00646906|75893070|FG003|STARTED|Washout (>/= 14 Days)||9||
59772561|NCT00646906|75893071|FG004|STARTED|Washout (>/= 14 Days)|Phase 1b had only one treatment period and no crossover.|0||
59772562|NCT00646906|75893072|FG005|STARTED|Washout (>/= 14 Days)||4||
59772563|NCT00646906|75893073|FG006|STARTED|Washout (>/= 14 Days)||5||
59772564|NCT00646906|75893067|FG000|COMPLETED|Washout (>/= 14 Days)||8||
59772565|NCT00646906|75893068|FG001|COMPLETED|Washout (>/= 14 Days)||9||
59772566|NCT00646906|75893069|FG002|COMPLETED|Washout (>/= 14 Days)||10||
59772567|NCT00646906|75893070|FG003|COMPLETED|Washout (>/= 14 Days)||9||
59772568|NCT00646906|75893071|FG004|COMPLETED|Washout (>/= 14 Days)|Phase 1b had only one treatment period and no crossover.|0||
59772569|NCT00646906|75893072|FG005|COMPLETED|Washout (>/= 14 Days)||4||
59772570|NCT00646906|75893073|FG006|COMPLETED|Washout (>/= 14 Days)||5||
59772571|NCT00646906|75893067|FG000|NOT COMPLETED|Washout (>/= 14 Days)||0||
59772572|NCT00646906|75893068|FG001|NOT COMPLETED|Washout (>/= 14 Days)||0||
59772573|NCT00646906|75893069|FG002|NOT COMPLETED|Washout (>/= 14 Days)||0||
59772574|NCT00646906|75893070|FG003|NOT COMPLETED|Washout (>/= 14 Days)||0||
59772575|NCT00646906|75893071|FG004|NOT COMPLETED|Washout (>/= 14 Days)||0||
59772576|NCT00646906|75893072|FG005|NOT COMPLETED|Washout (>/= 14 Days)||0||
59772577|NCT00646906|75893073|FG006|NOT COMPLETED|Washout (>/= 14 Days)||0||
59772578|NCT00646906|75893067|FG000|STARTED|Crossover Period 2||8||
59772579|NCT00646906|75893068|FG001|STARTED|Crossover Period 2||9||
59772580|NCT00646906|75893069|FG002|STARTED|Crossover Period 2||10||
59772581|NCT00646906|75893070|FG003|STARTED|Crossover Period 2||9||
59772582|NCT00646906|75893071|FG004|STARTED|Crossover Period 2|Phase 1b had only one treatment period and no crossover.|0||
59772583|NCT00646906|75893072|FG005|STARTED|Crossover Period 2||4||
59772584|NCT00646906|75893073|FG006|STARTED|Crossover Period 2||5||
59772585|NCT00646906|75893067|FG000|COMPLETED|Crossover Period 2||8||
59772586|NCT00646906|75893068|FG001|COMPLETED|Crossover Period 2||8||
59772587|NCT00646906|75893069|FG002|COMPLETED|Crossover Period 2||8||
59772588|NCT00646906|75893070|FG003|COMPLETED|Crossover Period 2||8||
59772589|NCT00646906|75893071|FG004|COMPLETED|Crossover Period 2|Phase 1b had only one treatment period and no crossover.|0||
59952715|NCT02605174|76071490|FG003|Received at Least 1 Dose of Study Drug|Overall Study||212||
59952716|NCT02605174|76071491|FG004|Received at Least 1 Dose of Study Drug|Overall Study||434||
59952717|NCT02605174|76071492|FG005|Received at Least 1 Dose of Study Drug|Overall Study||215||
59952718|NCT02605174|76071493|FG006|Received at Least 1 Dose of Study Drug|Overall Study||645||
59952719|NCT02605174|76071487|FG000|Received Optional 2nd Dose|Overall Study||206||
59952720|NCT02605174|76071488|FG001|Received Optional 2nd Dose|Overall Study||96||
59952721|NCT02605174|76071489|FG002|Received Optional 2nd Dose|Overall Study||177||
59952722|NCT02605174|76071490|FG003|Received Optional 2nd Dose|Overall Study||83||
59952723|NCT02605174|76071491|FG004|Received Optional 2nd Dose|Overall Study||144||
59952724|NCT02605174|76071492|FG005|Received Optional 2nd Dose|Overall Study||74||
59952725|NCT02605174|76071493|FG006|Received Optional 2nd Dose|Overall Study||361||
59952726|NCT02605174|76071487|FG000|COMPLETED|Overall Study||437|One site was burned down and several participants have incomplete data.|
59952727|NCT02605174|76071488|FG001|COMPLETED|Overall Study||226|One site was burned down and several participants have incomplete data.|
59952728|NCT02605174|76071489|FG002|COMPLETED|Overall Study||426|One site was burned down and several participants have incomplete data.|
59952729|NCT02605174|76071490|FG003|COMPLETED|Overall Study||216|One site was burned down and several participants have incomplete data.|
59994910|NCT03420781|76110740|FG002|STARTED|Treatment Period (40 Weeks)||0||
59994911|NCT03420781|76110741|FG003|STARTED|Treatment Period (40 Weeks)||0||
59772590|NCT00646906|75893072|FG005|COMPLETED|Crossover Period 2||4||
59772591|NCT00646906|75893073|FG006|COMPLETED|Crossover Period 2||4||
59772592|NCT00646906|75893067|FG000|NOT COMPLETED|Crossover Period 2||0||
59772593|NCT00646906|75893068|FG001|NOT COMPLETED|Crossover Period 2||1||
59772594|NCT00646906|75893069|FG002|NOT COMPLETED|Crossover Period 2||2||
59772595|NCT00646906|75893070|FG003|NOT COMPLETED|Crossover Period 2||1||
59772596|NCT00646906|75893071|FG004|NOT COMPLETED|Crossover Period 2||0||
59772597|NCT00646906|75893072|FG005|NOT COMPLETED|Crossover Period 2||0||
59772598|NCT00646906|75893073|FG006|NOT COMPLETED|Crossover Period 2||1||
59772599|NCT00642772|75893086|FG000|STARTED|Overall Study||24||
59772600|NCT00642772|75893086|FG000|COMPLETED|Overall Study||14||
59772601|NCT00642772|75893086|FG000|NOT COMPLETED|Overall Study||10||
59772602|NCT00446095|75893095|FG000|STARTED|Phase II (8 Weeks)||23||
59772603|NCT00446095|75893096|FG001|STARTED|Phase II (8 Weeks)||21||
59772604|NCT00446095|75893097|FG002|STARTED|Phase II (8 Weeks)||24||
59772605|NCT00446095|75893098|FG003|STARTED|Phase II (8 Weeks)||0||
59772606|NCT00446095|75893099|FG004|STARTED|Phase II (8 Weeks)||0||
59772607|NCT00446095|75893095|FG000|COMPLETED|Phase II (8 Weeks)||11||
59772608|NCT00446095|75893096|FG001|COMPLETED|Phase II (8 Weeks)||18||
59772609|NCT00446095|75893097|FG002|COMPLETED|Phase II (8 Weeks)||21||
59772610|NCT00446095|75893098|FG003|COMPLETED|Phase II (8 Weeks)||0||
59772611|NCT00446095|75893099|FG004|COMPLETED|Phase II (8 Weeks)||0||
59772612|NCT00446095|75893095|FG000|NOT COMPLETED|Phase II (8 Weeks)||12||
59772613|NCT00446095|75893096|FG001|NOT COMPLETED|Phase II (8 Weeks)||3||
59772614|NCT00446095|75893097|FG002|NOT COMPLETED|Phase II (8 Weeks)||3||
59772615|NCT00446095|75893098|FG003|NOT COMPLETED|Phase II (8 Weeks)||0||
59772616|NCT00446095|75893099|FG004|NOT COMPLETED|Phase II (8 Weeks)||0||
59772617|NCT00446095|75893095|FG000|STARTED|Phase I (28 Days)||0||
59772618|NCT00446095|75893096|FG001|STARTED|Phase I (28 Days)||0||
59772619|NCT00446095|75893097|FG002|STARTED|Phase I (28 Days)||0||
59772620|NCT00446095|75893098|FG003|STARTED|Phase I (28 Days)||6||
59772621|NCT00446095|75893099|FG004|STARTED|Phase I (28 Days)||7||
59772622|NCT00446095|75893095|FG000|COMPLETED|Phase I (28 Days)||0||
59772623|NCT00446095|75893096|FG001|COMPLETED|Phase I (28 Days)||0||
59772624|NCT00446095|75893097|FG002|COMPLETED|Phase I (28 Days)||0||
59772625|NCT00446095|75893098|FG003|COMPLETED|Phase I (28 Days)||5||
59772626|NCT00446095|75893099|FG004|COMPLETED|Phase I (28 Days)||4||
59772627|NCT00446095|75893095|FG000|NOT COMPLETED|Phase I (28 Days)||0||
59772628|NCT00446095|75893096|FG001|NOT COMPLETED|Phase I (28 Days)||0||
59772629|NCT00446095|75893097|FG002|NOT COMPLETED|Phase I (28 Days)||0||
59772630|NCT00446095|75893098|FG003|NOT COMPLETED|Phase I (28 Days)||1||
59772631|NCT00446095|75893099|FG004|NOT COMPLETED|Phase I (28 Days)||3||
59772632|NCT00829010|75893115|FG000|STARTED|Overall Study||83||
59772633|NCT00829010|75893116|FG001|STARTED|Overall Study||101||
59772634|NCT00829010|75893117|FG002|STARTED|Overall Study||100||
59772635|NCT00829010|75893118|FG003|STARTED|Overall Study||100||
59772636|NCT00829010|75893119|FG004|STARTED|Overall Study||100||
59772637|NCT00829010|75893115|FG000|COMPLETED|Overall Study||73||
59772638|NCT00829010|75893116|FG001|COMPLETED|Overall Study||92||
59772639|NCT00829010|75893117|FG002|COMPLETED|Overall Study||97||
59772640|NCT00829010|75893118|FG003|COMPLETED|Overall Study||92||
59772641|NCT00829010|75893119|FG004|COMPLETED|Overall Study||98||
59772642|NCT00829010|75893115|FG000|NOT COMPLETED|Overall Study||10||
59772643|NCT00829010|75893116|FG001|NOT COMPLETED|Overall Study||9||
59772644|NCT00829010|75893117|FG002|NOT COMPLETED|Overall Study||3||
60072691|NCT01594281|76187871|FG000|NOT COMPLETED|Interventional Core Phase||7||
60072692|NCT01594281|76187872|FG001|NOT COMPLETED|Interventional Core Phase||10||
60072693|NCT01594281|76187873|FG002|NOT COMPLETED|Interventional Core Phase||8||
60072694|NCT01594281|76187871|FG000|STARTED|Non-Interventional Follow Up Phase|1 patient exited after completing Core Phase and did not start the Follow-Up Phase|28|All patients signing an Informed Consent, including one patient who withdrew without documented data|
59618465|NCT04294966|75729565|FG002|STARTED|Overall Study||8||
59618466|NCT04294966|75729563|FG000|COMPLETED|Overall Study||8||
59618467|NCT04294966|75729564|FG001|COMPLETED|Overall Study||8||
59618468|NCT04294966|75729565|FG002|COMPLETED|Overall Study||8||
59618469|NCT04294966|75729563|FG000|NOT COMPLETED|Overall Study||0||
59618470|NCT04294966|75729564|FG001|NOT COMPLETED|Overall Study||0||
59618471|NCT04294966|75729565|FG002|NOT COMPLETED|Overall Study||0||
59618472|NCT04123548|75729573|FG000|STARTED|Overall Study||52||
59618473|NCT04123548|75729573|FG000|COMPLETED|Overall Study||38||
59618474|NCT04123548|75729573|FG000|NOT COMPLETED|Overall Study||14||
59618475|NCT04022733|75729579|FG000|STARTED|Overall Study||67||
59618476|NCT04022733|75729580|FG001|STARTED|Overall Study||67||
59618477|NCT04022733|75729579|FG000|COMPLETED|Overall Study||64||
59618478|NCT04022733|75729580|FG001|COMPLETED|Overall Study||64||
59618479|NCT04022733|75729579|FG000|NOT COMPLETED|Overall Study||3||
59618480|NCT04022733|75729580|FG001|NOT COMPLETED|Overall Study||3||
59772645|NCT00829010|75893118|FG003|NOT COMPLETED|Overall Study||8||
59618481|NCT03969420|75729590|FG000|STARTED|Overall Study|Any patient who received at least 1 dose of study drug|3||
59772646|NCT00829010|75893119|FG004|NOT COMPLETED|Overall Study||2||
59772647|NCT00644332|75893131|FG000|STARTED|Overall Study|172 patients were enrolled; one withdrew consent prior to starting treatment|171||
59772648|NCT00644332|75893131|FG000|COMPLETED|Overall Study||150||
59772649|NCT00644332|75893131|FG000|NOT COMPLETED|Overall Study||21||
59772650|NCT00445939|75893138|FG000|STARTED|Period A - Week 0 - Week 4||33||
59772651|NCT00445939|75893139|FG001|STARTED|Period A - Week 0 - Week 4||34||
59772652|NCT00445939|75893140|FG002|STARTED|Period A - Week 0 - Week 4||23||
59772653|NCT00445939|75893141|FG003|STARTED|Period A - Week 0 - Week 4||0||
59772654|NCT00445939|75893138|FG000|COMPLETED|Period A - Week 0 - Week 4|23 rated as responders and 9 rated as non-responders in evaluation on Week 4.|32||
59772655|NCT00445939|75893139|FG001|COMPLETED|Period A - Week 0 - Week 4|20 rated as responders and 12 rated as non-responders in evaluation on Week 4.|32||
59772656|NCT00445939|75893140|FG002|COMPLETED|Period A - Week 0 - Week 4|7 rated as responders and 16 rated as non-responders in evaluation on Week 4.|23||
59772657|NCT00445939|75893141|FG003|COMPLETED|Period A - Week 0 - Week 4||0||
59772658|NCT00445939|75893138|FG000|NOT COMPLETED|Period A - Week 0 - Week 4||1||
59772659|NCT00445939|75893139|FG001|NOT COMPLETED|Period A - Week 0 - Week 4||2||
59772660|NCT00445939|75893140|FG002|NOT COMPLETED|Period A - Week 0 - Week 4||0||
59772661|NCT00445939|75893141|FG003|NOT COMPLETED|Period A - Week 0 - Week 4||0||
59772662|NCT00445939|75893138|FG000|STARTED|Period B - Week 4 - Week 8|Non-responders continued after 4 weeks, previous 16 placebo subjects allocated to 160/80 mg group.|16||
59772663|NCT00445939|75893139|FG001|STARTED|Period B - Week 4 - Week 8|Non-responders continued after 4 weeks, previous 80/40 mg subjects allocated to 40/40 mg group.|0||
59772664|NCT00445939|75893140|FG002|STARTED|Period B - Week 4 - Week 8|Non-responders continued after 4 weeks, previous placebo subjects allocated to 160/80 mg group.|0||
59772665|NCT00445939|75893141|FG003|STARTED|Period B - Week 4 - Week 8|Non-responders continued after 4 weeks, previous 160/80 and 80/40 subjects allocated to 40/40 group.|21||
59772666|NCT00445939|75893138|FG000|COMPLETED|Period B - Week 4 - Week 8||14||
59772667|NCT00445939|75893139|FG001|COMPLETED|Period B - Week 4 - Week 8||0||
59772668|NCT00445939|75893140|FG002|COMPLETED|Period B - Week 4 - Week 8||0||
59772669|NCT00445939|75893141|FG003|COMPLETED|Period B - Week 4 - Week 8||20||
59772670|NCT00445939|75893138|FG000|NOT COMPLETED|Period B - Week 4 - Week 8||2||
59772671|NCT00445939|75893139|FG001|NOT COMPLETED|Period B - Week 4 - Week 8||0||
59772672|NCT00445939|75893140|FG002|NOT COMPLETED|Period B - Week 4 - Week 8||0||
59772673|NCT00445939|75893141|FG003|NOT COMPLETED|Period B - Week 4 - Week 8||1||
59772674|NCT00482053|75893161|FG000|STARTED|Autologous Peripheral Stem Cells||3||
59772675|NCT00482053|75893161|FG000|COMPLETED|Autologous Peripheral Stem Cells||3||
59772676|NCT00482053|75893161|FG000|NOT COMPLETED|Autologous Peripheral Stem Cells||0||
59772677|NCT00482053|75893161|FG000|STARTED|Inter-treatment Period||3||
59772678|NCT00482053|75893161|FG000|COMPLETED|Inter-treatment Period||2||
59772679|NCT00482053|75893161|FG000|NOT COMPLETED|Inter-treatment Period||1||
59772680|NCT00482053|75893161|FG000|STARTED|Allogeneic Peripheral Stem Cells||2||
59772681|NCT00482053|75893161|FG000|COMPLETED|Allogeneic Peripheral Stem Cells||2||
59772682|NCT00482053|75893161|FG000|NOT COMPLETED|Allogeneic Peripheral Stem Cells||0||
59772683|NCT00455923|75893167|FG000|STARTED|Overall Study||50||
59772684|NCT00455923|75893168|FG001|STARTED|Overall Study||50||
59772685|NCT00455923|75893167|FG000|COMPLETED|Overall Study||47||
59772686|NCT00455923|75893168|FG001|COMPLETED|Overall Study||47||
59772687|NCT00455923|75893167|FG000|NOT COMPLETED|Overall Study||3||
59772688|NCT00455923|75893168|FG001|NOT COMPLETED|Overall Study||3||
59772689|NCT00642616|75893178|FG000|STARTED|Overall Study||9||
59772690|NCT00642616|75893179|FG001|STARTED|Overall Study||8||
59772691|NCT00642616|75893180|FG002|STARTED|Overall Study||9||
59772692|NCT00642616|75893181|FG003|STARTED|Overall Study||8||
59772693|NCT00642616|75893178|FG000|COMPLETED|Overall Study||0||
59772694|NCT00642616|75893179|FG001|COMPLETED|Overall Study||1||
59772695|NCT00642616|75893180|FG002|COMPLETED|Overall Study||0||
59772696|NCT00642616|75893181|FG003|COMPLETED|Overall Study||1||
59772697|NCT00642616|75893178|FG000|NOT COMPLETED|Overall Study||9||
59772698|NCT00642616|75893179|FG001|NOT COMPLETED|Overall Study||7||
59772699|NCT00642616|75893180|FG002|NOT COMPLETED|Overall Study||9||
59772700|NCT00642616|75893181|FG003|NOT COMPLETED|Overall Study||7||
59772701|NCT03844945|75893197|FG000|STARTED|Overall Study||55||
59772702|NCT03844945|75893198|FG001|STARTED|Overall Study||54||
59772703|NCT03844945|75893199|FG002|STARTED|Overall Study||51||
59772704|NCT03844945|75893200|FG003|STARTED|Overall Study||55||
59772705|NCT03844945|75893197|FG000|COMPLETED|Overall Study||54||
59772706|NCT03844945|75893198|FG001|COMPLETED|Overall Study||53||
59772707|NCT03844945|75893199|FG002|COMPLETED|Overall Study||46||
59772708|NCT03844945|75893200|FG003|COMPLETED|Overall Study||54||
59772709|NCT03844945|75893197|FG000|NOT COMPLETED|Overall Study||1||
59772710|NCT03844945|75893198|FG001|NOT COMPLETED|Overall Study||1||
59772711|NCT03844945|75893199|FG002|NOT COMPLETED|Overall Study||5||
59772712|NCT03844945|75893200|FG003|NOT COMPLETED|Overall Study||1||
59772713|NCT00445549|75893210|FG000|STARTED|Overall Study||12||
59772714|NCT00445549|75893210|FG000|COMPLETED|Overall Study||0||
59772715|NCT00445549|75893210|FG000|NOT COMPLETED|Overall Study||12||
59772716|NCT00445003|75893217|FG000|STARTED|Overall Study||123||
59772717|NCT00445003|75893218|FG001|STARTED|Overall Study||113||
59772718|NCT00445003|75893219|FG002|STARTED|Overall Study||109||
59772719|NCT00445003|75893217|FG000|COMPLETED|Overall Study||118||
59772720|NCT00445003|75893218|FG001|COMPLETED|Overall Study||103||
59994912|NCT03420781|76110742|FG004|STARTED|Treatment Period (40 Weeks)||0||
59772721|NCT00445003|75893219|FG002|COMPLETED|Overall Study||105||
59772722|NCT00445003|75893217|FG000|NOT COMPLETED|Overall Study||5||
59772723|NCT00445003|75893218|FG001|NOT COMPLETED|Overall Study||10||
59772724|NCT00445003|75893219|FG002|NOT COMPLETED|Overall Study||4||
59772725|NCT00811070|75893233|FG000|STARTED|Overall Study||7||
59772726|NCT00811070|75893234|FG001|STARTED|Overall Study||7||
59772727|NCT00811070|75893235|FG002|STARTED|Overall Study||3||
59772728|NCT00811070|75893236|FG003|STARTED|Overall Study||28||
59772729|NCT00811070|75893237|FG004|STARTED|Overall Study||7||
59772730|NCT00811070|75893238|FG005|STARTED|Overall Study||11||
59772731|NCT00811070|75893233|FG000|COMPLETED|Overall Study||6||
59772732|NCT00811070|75893234|FG001|COMPLETED|Overall Study||6||
59772733|NCT00811070|75893235|FG002|COMPLETED|Overall Study||3||
59772734|NCT00811070|75893236|FG003|COMPLETED|Overall Study||26||
59772735|NCT00811070|75893237|FG004|COMPLETED|Overall Study||2||
59772736|NCT00811070|75893238|FG005|COMPLETED|Overall Study||10||
59772737|NCT00811070|75893233|FG000|NOT COMPLETED|Overall Study||1||
59772738|NCT00811070|75893234|FG001|NOT COMPLETED|Overall Study||1||
59772739|NCT00811070|75893235|FG002|NOT COMPLETED|Overall Study||0||
59772740|NCT00811070|75893236|FG003|NOT COMPLETED|Overall Study||2||
59772741|NCT00811070|75893237|FG004|NOT COMPLETED|Overall Study||5||
59772742|NCT00811070|75893238|FG005|NOT COMPLETED|Overall Study||1||
59772743|NCT00642460|75893256|FG000|STARTED|Part I: 12 Week Double-Blind||37||
59772744|NCT00642460|75893257|FG001|STARTED|Part I: 12 Week Double-Blind||38||
59772745|NCT00642460|75893258|FG002|STARTED|Part I: 12 Week Double-Blind||37||
59772746|NCT00642460|75893259|FG003|STARTED|Part I: 12 Week Double-Blind||0||
59772747|NCT00642460|75893260|FG004|STARTED|Part I: 12 Week Double-Blind||0||
59772748|NCT00642460|75893261|FG005|STARTED|Part I: 12 Week Double-Blind||0||
59772749|NCT00642460|75893256|FG000|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||37||
59772750|NCT00642460|75893257|FG001|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||38||
59772751|NCT00642460|75893258|FG002|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||37||
59772752|NCT00642460|75893259|FG003|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||0||
59772753|NCT00642460|75893260|FG004|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||0||
59772754|NCT00642460|75893261|FG005|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||0||
59772755|NCT00642460|75893256|FG000|COMPLETED|Part I: 12 Week Double-Blind||36||
59772756|NCT00642460|75893257|FG001|COMPLETED|Part I: 12 Week Double-Blind||37||
59772757|NCT00642460|75893258|FG002|COMPLETED|Part I: 12 Week Double-Blind||36||
59772758|NCT00642460|75893259|FG003|COMPLETED|Part I: 12 Week Double-Blind||0||
59772759|NCT00642460|75893260|FG004|COMPLETED|Part I: 12 Week Double-Blind||0||
59772760|NCT00642460|75893261|FG005|COMPLETED|Part I: 12 Week Double-Blind||0||
59772761|NCT00642460|75893256|FG000|NOT COMPLETED|Part I: 12 Week Double-Blind||1||
59772762|NCT00642460|75893257|FG001|NOT COMPLETED|Part I: 12 Week Double-Blind||1||
59772763|NCT00642460|75893258|FG002|NOT COMPLETED|Part I: 12 Week Double-Blind||1||
59772764|NCT00642460|75893259|FG003|NOT COMPLETED|Part I: 12 Week Double-Blind||0||
59772765|NCT00642460|75893260|FG004|NOT COMPLETED|Part I: 12 Week Double-Blind||0||
59772766|NCT00642460|75893261|FG005|NOT COMPLETED|Part I: 12 Week Double-Blind||0||
59772767|NCT00642460|75893256|FG000|STARTED|Part II: Open-Label Up to Week 92|Includes Participants who received Open-Label in Part II or Open-Label escape therapy in Part I.|52||
59772768|NCT00642460|75893257|FG001|STARTED|Part II: Open-Label Up to Week 92||40||
59772769|NCT00642460|75893258|FG002|STARTED|Part II: Open-Label Up to Week 92|Placebo group received open-label Tocilizumab 8 mg/kg or 12 mg/kg based on body weight in Part II.|0||
59772770|NCT00642460|75893259|FG003|STARTED|Part II: Open-Label Up to Week 92|19 Participants switched from 12 mg/kg to 8 mg/kg and 1 Participant switched from 8mg/kg to 12 mg/kg|20||
59772771|NCT00642460|75893260|FG004|STARTED|Part II: Open-Label Up to Week 92||0||
59772772|NCT00642460|75893261|FG005|STARTED|Part II: Open-Label Up to Week 92||0||
59772773|NCT00642460|75893256|FG000|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||52||
59772774|NCT00642460|75893257|FG001|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||40||
59772775|NCT00642460|75893258|FG002|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||0||
59772776|NCT00642460|75893259|FG003|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||20||
59772777|NCT00642460|75893260|FG004|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||0||
59772778|NCT00642460|75893261|FG005|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||0||
59772779|NCT00642460|75893256|FG000|COMPLETED|Part II: Open-Label Up to Week 92||43||
59772780|NCT00642460|75893257|FG001|COMPLETED|Part II: Open-Label Up to Week 92||32||
59772781|NCT00642460|75893258|FG002|COMPLETED|Part II: Open-Label Up to Week 92||0||
59772782|NCT00642460|75893259|FG003|COMPLETED|Part II: Open-Label Up to Week 92||17||
59772783|NCT00642460|75893260|FG004|COMPLETED|Part II: Open-Label Up to Week 92||0||
59772784|NCT00642460|75893261|FG005|COMPLETED|Part II: Open-Label Up to Week 92||0||
59772785|NCT00642460|75893256|FG000|NOT COMPLETED|Part II: Open-Label Up to Week 92||9||
59772786|NCT00642460|75893257|FG001|NOT COMPLETED|Part II: Open-Label Up to Week 92||8||
59772787|NCT00642460|75893258|FG002|NOT COMPLETED|Part II: Open-Label Up to Week 92||0||
59772788|NCT00642460|75893259|FG003|NOT COMPLETED|Part II: Open-Label Up to Week 92||3||
59772789|NCT00642460|75893260|FG004|NOT COMPLETED|Part II: Open-Label Up to Week 92||0||
59772790|NCT00642460|75893261|FG005|NOT COMPLETED|Part II: Open-Label Up to Week 92||0||
59772791|NCT00642460|75893256|FG000|STARTED|Part III: Open-Label Up to Week 260||0||
59772792|NCT00642460|75893257|FG001|STARTED|Part III: Open-Label Up to Week 260||0||
59772793|NCT00642460|75893258|FG002|STARTED|Part III: Open-Label Up to Week 260||0||
59772794|NCT00642460|75893259|FG003|STARTED|Part III: Open-Label Up to Week 260||0||
59772795|NCT00642460|75893260|FG004|STARTED|Part III: Open-Label Up to Week 260||53||
59772796|NCT00642460|75893261|FG005|STARTED|Part III: Open-Label Up to Week 260||59||
59772797|NCT00642460|75893256|FG000|COMPLETED|Part III: Open-Label Up to Week 260||0||
59772798|NCT00642460|75893257|FG001|COMPLETED|Part III: Open-Label Up to Week 260||0||
59772799|NCT00642460|75893258|FG002|COMPLETED|Part III: Open-Label Up to Week 260||0||
59772800|NCT00642460|75893259|FG003|COMPLETED|Part III: Open-Label Up to Week 260||0||
59772801|NCT00642460|75893260|FG004|COMPLETED|Part III: Open-Label Up to Week 260||28||
59772802|NCT00642460|75893261|FG005|COMPLETED|Part III: Open-Label Up to Week 260||38||
59772803|NCT00642460|75893256|FG000|NOT COMPLETED|Part III: Open-Label Up to Week 260||0||
59772804|NCT00642460|75893257|FG001|NOT COMPLETED|Part III: Open-Label Up to Week 260||0||
59772805|NCT00642460|75893258|FG002|NOT COMPLETED|Part III: Open-Label Up to Week 260||0||
59772806|NCT00642460|75893259|FG003|NOT COMPLETED|Part III: Open-Label Up to Week 260||0||
59772807|NCT00642460|75893260|FG004|NOT COMPLETED|Part III: Open-Label Up to Week 260||25||
59772808|NCT00642460|75893261|FG005|NOT COMPLETED|Part III: Open-Label Up to Week 260||21||
59772809|NCT00814658|75893273|FG000|STARTED|Overall Study||9||
59772810|NCT00814658|75893274|FG001|STARTED|Overall Study||12||
59772811|NCT00814658|75893273|FG000|COMPLETED|Overall Study||5||
59772812|NCT00814658|75893274|FG001|COMPLETED|Overall Study||8||
59772813|NCT00814658|75893273|FG000|NOT COMPLETED|Overall Study||4||
59772814|NCT00814658|75893274|FG001|NOT COMPLETED|Overall Study||4||
59772815|NCT00642304|75893290|FG000|STARTED|Overall Study||20||
59772816|NCT00642304|75893290|FG000|COMPLETED|Overall Study||14||
59772817|NCT00642304|75893290|FG000|NOT COMPLETED|Overall Study||6||
59772818|NCT00814580|75893296|FG000|STARTED|Overall Study||194||
59772819|NCT00814580|75893297|FG001|STARTED|Overall Study||188||
59772820|NCT00814580|75893296|FG000|COMPLETED|Overall Study||163||
59772821|NCT00814580|75893297|FG001|COMPLETED|Overall Study||141||
59772822|NCT00814580|75893296|FG000|NOT COMPLETED|Overall Study||31||
59772823|NCT00814580|75893297|FG001|NOT COMPLETED|Overall Study||47||
59772824|NCT00643162|75893317|FG000|STARTED|Overall Study||7||
59772825|NCT00643162|75893318|FG001|STARTED|Overall Study||5||
59772826|NCT00643162|75893317|FG000|COMPLETED|Overall Study||6||
59772827|NCT00643162|75893318|FG001|COMPLETED|Overall Study||4||
59772828|NCT00643162|75893317|FG000|NOT COMPLETED|Overall Study||1||
59772829|NCT00643162|75893318|FG001|NOT COMPLETED|Overall Study||1||
59772830|NCT00643006|75893326|FG000|STARTED|Overall Study||34||
59772831|NCT00643006|75893327|FG001|STARTED|Overall Study||33||
59772832|NCT00643006|75893326|FG000|COMPLETED|Overall Study||29||
59772833|NCT00643006|75893327|FG001|COMPLETED|Overall Study||29||
59772834|NCT00643006|75893326|FG000|NOT COMPLETED|Overall Study||5||
59772835|NCT00643006|75893327|FG001|NOT COMPLETED|Overall Study||4||
59772836|NCT00814502|75893337|FG000|STARTED|Overall Study||8||
59772837|NCT00814502|75893338|FG001|STARTED|Overall Study||9||
59772838|NCT00814502|75893337|FG000|COMPLETED|Overall Study||7||
59772839|NCT00814502|75893338|FG001|COMPLETED|Overall Study||7||
59772840|NCT00814502|75893337|FG000|NOT COMPLETED|Overall Study||1||
59772841|NCT00814502|75893338|FG001|NOT COMPLETED|Overall Study||2||
59772842|NCT00653224|75893348|FG000|STARTED|Overall Study||293||
59772843|NCT00653224|75893349|FG001|STARTED|Overall Study||287||
59772844|NCT00653224|75893348|FG000|COMPLETED|Overall Study||286||
59772845|NCT00653224|75893349|FG001|COMPLETED|Overall Study||280||
59772846|NCT00653224|75893348|FG000|NOT COMPLETED|Overall Study||7||
59772847|NCT00653224|75893349|FG001|NOT COMPLETED|Overall Study||7||
59772848|NCT00444925|75893358|FG000|STARTED|Single-blind Placebo Run-In Period||2446||
59772849|NCT00444925|75893359|FG001|STARTED|Single-blind Placebo Run-In Period||0||
59772850|NCT00444925|75893360|FG002|STARTED|Single-blind Placebo Run-In Period||0||
59772851|NCT00444925|75893358|FG000|COMPLETED|Single-blind Placebo Run-In Period|progressed to randomization in double-blind treatment period|1712||
59772852|NCT00444925|75893359|FG001|COMPLETED|Single-blind Placebo Run-In Period||0||
59772853|NCT00444925|75893360|FG002|COMPLETED|Single-blind Placebo Run-In Period||0||
59772854|NCT00444925|75893358|FG000|NOT COMPLETED|Single-blind Placebo Run-In Period||734||
59772855|NCT00444925|75893359|FG001|NOT COMPLETED|Single-blind Placebo Run-In Period||0||
59772856|NCT00444925|75893360|FG002|NOT COMPLETED|Single-blind Placebo Run-In Period||0||
59772857|NCT00444925|75893358|FG000|STARTED|Randomized to Double-blind Treatment||337||
59772858|NCT00444925|75893359|FG001|STARTED|Randomized to Double-blind Treatment||690||
59772859|NCT00444925|75893360|FG002|STARTED|Randomized to Double-blind Treatment||685||
59772860|NCT00444925|75893358|FG000|COMPLETED|Randomized to Double-blind Treatment||334||
59772861|NCT00444925|75893359|FG001|COMPLETED|Randomized to Double-blind Treatment||684||
59772862|NCT00444925|75893360|FG002|COMPLETED|Randomized to Double-blind Treatment||679||
59772863|NCT00444925|75893358|FG000|NOT COMPLETED|Randomized to Double-blind Treatment||3||
59772864|NCT00444925|75893359|FG001|NOT COMPLETED|Randomized to Double-blind Treatment||6||
59952730|NCT02605174|76071491|FG004|COMPLETED|Overall Study||448|One site was burned down and several participants have incomplete data.|
59952731|NCT02605174|76071492|FG005|COMPLETED|Overall Study||217|One site was burned down and several participants have incomplete data.|
59772865|NCT00444925|75893360|FG002|NOT COMPLETED|Randomized to Double-blind Treatment||6||
59772866|NCT00444925|75893358|FG000|STARTED|Double-blind Treatment Period||334||
59772867|NCT00444925|75893359|FG001|STARTED|Double-blind Treatment Period||684||
59772868|NCT00444925|75893360|FG002|STARTED|Double-blind Treatment Period||679||
59772869|NCT00444925|75893358|FG000|COMPLETED|Double-blind Treatment Period||304||
59772870|NCT00444925|75893359|FG001|COMPLETED|Double-blind Treatment Period||628||
59772871|NCT00444925|75893360|FG002|COMPLETED|Double-blind Treatment Period||598||
59772872|NCT00444925|75893358|FG000|NOT COMPLETED|Double-blind Treatment Period||30||
59772873|NCT00444925|75893359|FG001|NOT COMPLETED|Double-blind Treatment Period||56||
59772874|NCT00444925|75893360|FG002|NOT COMPLETED|Double-blind Treatment Period||81||
59772875|NCT00641056|75893370|FG000|STARTED|Overall Study||233||
59772876|NCT00641056|75893371|FG001|STARTED|Overall Study||234||
59772877|NCT00641056|75893370|FG000|Intent to Treat (ITT)|Overall Study||233||
59772878|NCT00641056|75893371|FG001|Intent to Treat (ITT)|Overall Study||223||
59772879|NCT00641056|75893370|FG000|COMPLETED|Overall Study||204||
59772880|NCT00641056|75893371|FG001|COMPLETED|Overall Study||209||
59772881|NCT00641056|75893370|FG000|NOT COMPLETED|Overall Study||29||
59772882|NCT00641056|75893371|FG001|NOT COMPLETED|Overall Study||25||
59772883|NCT00814346|75893383|FG000|STARTED|Double-blind Phase (4 Weeks)||23||
59772884|NCT00814346|75893384|FG001|STARTED|Double-blind Phase (4 Weeks)||26||
59772885|NCT00814346|75893383|FG000|CNE|Double-blind Phase (4 Weeks)||10||
59772886|NCT00814346|75893384|FG001|CNE|Double-blind Phase (4 Weeks)||13||
59772887|NCT00814346|75893383|FG000|MC|Double-blind Phase (4 Weeks)||10||
59772888|NCT00814346|75893384|FG001|MC|Double-blind Phase (4 Weeks)||11||
59772889|NCT00814346|75893383|FG000|AD|Double-blind Phase (4 Weeks)||3||
59772890|NCT00814346|75893384|FG001|AD|Double-blind Phase (4 Weeks)||2||
59772891|NCT00814346|75893383|FG000|COMPLETED|Double-blind Phase (4 Weeks)||23||
59772892|NCT00814346|75893384|FG001|COMPLETED|Double-blind Phase (4 Weeks)||23||
59772893|NCT00814346|75893383|FG000|NOT COMPLETED|Double-blind Phase (4 Weeks)||0||
59772894|NCT00814346|75893384|FG001|NOT COMPLETED|Double-blind Phase (4 Weeks)||3||
59772895|NCT00814346|75893383|FG000|STARTED|Open Phase (17 Months)|Open period was treated with EGB761®. 41 subjects accepted follow-up open period(21 in CNE,20 in MC)|41||
59772896|NCT00814346|75893384|FG001|STARTED|Open Phase (17 Months)|This was an open period, without placebo arm, the number of subject on placebo is 0.|0||
59772897|NCT00814346|75893383|FG000|CNE|Open Phase (17 Months)||21||
59772898|NCT00814346|75893384|FG001|CNE|Open Phase (17 Months)||0||
59772899|NCT00814346|75893383|FG000|MC|Open Phase (17 Months)||20||
59772900|NCT00814346|75893384|FG001|MC|Open Phase (17 Months)||0||
59772901|NCT00814346|75893383|FG000|AD|Open Phase (17 Months)|Open period was not proposed to AD subjects.|0||
59772902|NCT00814346|75893384|FG001|AD|Open Phase (17 Months)||0||
59772903|NCT00814346|75893383|FG000|COMPLETED|Open Phase (17 Months)||31||
59772904|NCT00814346|75893384|FG001|COMPLETED|Open Phase (17 Months)||0||
59772905|NCT00814346|75893383|FG000|NOT COMPLETED|Open Phase (17 Months)||10||
59772906|NCT00814346|75893384|FG001|NOT COMPLETED|Open Phase (17 Months)||0||
59772907|NCT00569374|75893403|FG000|STARTED|Overall Study||8||
59772908|NCT00569374|75893403|FG000|COMPLETED|Overall Study||4||
59772909|NCT00569374|75893403|FG000|NOT COMPLETED|Overall Study||4||
59521832|NCT00982007|75616113|FG002|COMPLETED|Overall Study||253||
59521833|NCT00982007|75616114|FG003|COMPLETED|Overall Study||245||
59521834|NCT00982007|75616111|FG000|NOT COMPLETED|Overall Study||4||
59521835|NCT00982007|75616112|FG001|NOT COMPLETED|Overall Study||4||
59521836|NCT00982007|75616113|FG002|NOT COMPLETED|Overall Study||0||
59521837|NCT00982007|75616114|FG003|NOT COMPLETED|Overall Study||6||
59521838|NCT03018392|75616124|FG000|STARTED|Overall Study||20||
59521839|NCT03018392|75616124|FG000|COMPLETED|Overall Study||20||
59521840|NCT03018392|75616124|FG000|NOT COMPLETED|Overall Study||0||
59521841|NCT01663506|75616128|FG000|STARTED|Overall Study||23||
59521842|NCT01663506|75616128|FG000|COMPLETED|Overall Study||15||
59521843|NCT01663506|75616128|FG000|NOT COMPLETED|Overall Study||8||
59521844|NCT02568384|75616132|FG000|STARTED|Overall Study||45||
59521845|NCT02568384|75616132|FG000|COMPLETED|Overall Study||43||
59709545|NCT00905437|75828305|FG000|NOT COMPLETED|Overall Study||8||
59772910|NCT00828464|75893407|FG000|STARTED|Overall Study||30||
59772911|NCT00828464|75893407|FG000|COMPLETED|Overall Study||29||
59772912|NCT00828464|75893407|FG000|NOT COMPLETED|Overall Study||1||
59772913|NCT00810602|75893411|FG000|STARTED|Overall Study||27||
59772914|NCT00810602|75893412|FG001|STARTED|Overall Study||34||
59772915|NCT00810602|75893411|FG000|COMPLETED|Overall Study||19||
59772916|NCT00810602|75893412|FG001|COMPLETED|Overall Study||31||
59772917|NCT00810602|75893411|FG000|NOT COMPLETED|Overall Study||8||
59772918|NCT00810602|75893412|FG001|NOT COMPLETED|Overall Study||3||
59772919|NCT00791700|75893420|FG000|STARTED|Overall Study||16||
59772920|NCT00791700|75893421|FG001|STARTED|Overall Study||31||
59772921|NCT00791700|75893422|FG002|STARTED|Overall Study||13||
59772922|NCT00791700|75893423|FG003|STARTED|Overall Study||43||
59772923|NCT00791700|75893420|FG000|COMPLETED|Overall Study||10||
59772924|NCT00791700|75893421|FG001|COMPLETED|Overall Study||20||
59521846|NCT02568384|75616132|FG000|NOT COMPLETED|Overall Study||2||
59521847|NCT03826472|75616138|FG000|STARTED|First Intervention (1-week)||5||
59521848|NCT03826472|75616139|FG001|STARTED|First Intervention (1-week)||5||
59521849|NCT03826472|75616138|FG000|COMPLETED|First Intervention (1-week)||5||
59521850|NCT03826472|75616139|FG001|COMPLETED|First Intervention (1-week)||5||
59709546|NCT00905437|75828306|FG001|NOT COMPLETED|Overall Study||10||
59709547|NCT01238861|75828318|FG000|STARTED|Overall Study||80||
59709548|NCT01238861|75828319|FG001|STARTED|Overall Study||81||
59709549|NCT01238861|75828320|FG002|STARTED|Overall Study||81||
59709550|NCT01238861|75828321|FG003|STARTED|Overall Study||82||
59709551|NCT01238861|75828322|FG004|STARTED|Overall Study||142||
59709552|NCT01238861|75828323|FG005|STARTED|Overall Study||140||
59709553|NCT01238861|75828318|FG000|COMPLETED|Overall Study||69||
59709554|NCT01238861|75828319|FG001|COMPLETED|Overall Study||73||
59772925|NCT00791700|75893422|FG002|COMPLETED|Overall Study||7||
59772926|NCT00791700|75893423|FG003|COMPLETED|Overall Study||13||
59772927|NCT00791700|75893420|FG000|NOT COMPLETED|Overall Study||6||
59772928|NCT00791700|75893421|FG001|NOT COMPLETED|Overall Study||11||
59772929|NCT00791700|75893422|FG002|NOT COMPLETED|Overall Study||6||
59772930|NCT00791700|75893423|FG003|NOT COMPLETED|Overall Study||30||
59772931|NCT00810368|75893446|FG000|STARTED|Overall Study||18||
59772932|NCT00810368|75893447|FG001|STARTED|Overall Study||15||
59772933|NCT00810368|75893446|FG000|COMPLETED|Overall Study||12||
59772934|NCT00810368|75893447|FG001|COMPLETED|Overall Study||13||
59772935|NCT00810368|75893446|FG000|NOT COMPLETED|Overall Study||6||
59772936|NCT00810368|75893447|FG001|NOT COMPLETED|Overall Study||2||
59772937|NCT00628108|75893457|FG000|STARTED|Overall Study||23||
59772938|NCT00628108|75893458|FG001|STARTED|Overall Study|One subject was randomized to levocetirizine but received placebo.|46||
59772939|NCT00628108|75893457|FG000|Safety Population|Overall Study||24||
59772940|NCT00628108|75893458|FG001|Safety Population|Overall Study|Subjects in the Safety Population were analyzed as treated.|45||
59772941|NCT00628108|75893457|FG000|COMPLETED|Overall Study||22||
59772942|NCT00628108|75893458|FG001|COMPLETED|Overall Study||43||
59772943|NCT00628108|75893457|FG000|NOT COMPLETED|Overall Study||1||
59772944|NCT00628108|75893458|FG001|NOT COMPLETED|Overall Study||3||
59772945|NCT00628030|75893466|FG000|STARTED|Baseline to Post-Assessment||92||
59772946|NCT00628030|75893467|FG001|STARTED|Baseline to Post-Assessment||92||
59772947|NCT00628030|75893466|FG000|COMPLETED|Baseline to Post-Assessment||59||
59772948|NCT00628030|75893467|FG001|COMPLETED|Baseline to Post-Assessment||63||
59772949|NCT00628030|75893466|FG000|NOT COMPLETED|Baseline to Post-Assessment||33||
59772950|NCT00628030|75893467|FG001|NOT COMPLETED|Baseline to Post-Assessment||29||
59772951|NCT00628030|75893466|FG000|STARTED|Post to 6 Month Follow-up||59||
59772952|NCT00628030|75893467|FG001|STARTED|Post to 6 Month Follow-up||63||
59772953|NCT00628030|75893466|FG000|COMPLETED|Post to 6 Month Follow-up||27||
59772954|NCT00628030|75893467|FG001|COMPLETED|Post to 6 Month Follow-up||33||
59772955|NCT00628030|75893466|FG000|NOT COMPLETED|Post to 6 Month Follow-up||32||
59772956|NCT00628030|75893467|FG001|NOT COMPLETED|Post to 6 Month Follow-up||30||
59772957|NCT00591578|75893476|FG000|STARTED|Double-Blind Treatment Phase||327||
59772958|NCT00591578|75893477|FG001|STARTED|Double-Blind Treatment Phase||329||
59772959|NCT00591578|75893478|FG002|STARTED|Double-Blind Treatment Phase|Two participants randomized but not treated.|328||
59772960|NCT00591578|75893476|FG000|COMPLETED|Double-Blind Treatment Phase||249||
59772961|NCT00591578|75893477|FG001|COMPLETED|Double-Blind Treatment Phase||249||
59772962|NCT00591578|75893478|FG002|COMPLETED|Double-Blind Treatment Phase||244||
59772963|NCT00591578|75893476|FG000|NOT COMPLETED|Double-Blind Treatment Phase||78||
59772964|NCT00591578|75893477|FG001|NOT COMPLETED|Double-Blind Treatment Phase||80||
59772965|NCT00591578|75893478|FG002|NOT COMPLETED|Double-Blind Treatment Phase||84||
59772966|NCT00591578|75893476|FG000|STARTED|Open-Label Extension Phase||55||
59772967|NCT00591578|75893477|FG001|STARTED|Open-Label Extension Phase||115||
59772968|NCT00591578|75893478|FG002|STARTED|Open-Label Extension Phase||0||
59772969|NCT00591578|75893476|FG000|COMPLETED|Open-Label Extension Phase||49||
59772970|NCT00591578|75893477|FG001|COMPLETED|Open-Label Extension Phase||105||
59772971|NCT00591578|75893478|FG002|COMPLETED|Open-Label Extension Phase||0||
59772972|NCT00591578|75893476|FG000|NOT COMPLETED|Open-Label Extension Phase||6||
59772973|NCT00591578|75893477|FG001|NOT COMPLETED|Open-Label Extension Phase||10||
59772974|NCT00591578|75893478|FG002|NOT COMPLETED|Open-Label Extension Phase||0||
59772975|NCT00797862|75893490|FG000|STARTED|Overall Study|3 participants were mis-randomized and discontinued. Only 617 participants received study drug.|620||
59772976|NCT00797862|75893491|FG001|STARTED|Overall Study|3 participants were mis-randomized and discontinued. Only 315 participants received study drug.|318||
59772977|NCT00797862|75893492|FG002|STARTED|Overall Study|1 participant was mis-randomized and discontinued. Only 315 participants received study drug.|316||
59772978|NCT00797862|75893490|FG000|Entered Double-Blind Treatment (FAS)|Overall Study||617||
59772979|NCT00797862|75893491|FG001|Entered Double-Blind Treatment (FAS)|Overall Study||315||
59772980|NCT00797862|75893492|FG002|Entered Double-Blind Treatment (FAS)|Overall Study||315||
59772981|NCT00797862|75893490|FG000|COMPLETED|Overall Study||496||
59772982|NCT00797862|75893491|FG001|COMPLETED|Overall Study||250||
59772983|NCT00797862|75893492|FG002|COMPLETED|Overall Study||230||
59772984|NCT00797862|75893490|FG000|NOT COMPLETED|Overall Study||124||
59772985|NCT00797862|75893491|FG001|NOT COMPLETED|Overall Study||68||
59772986|NCT00797862|75893492|FG002|NOT COMPLETED|Overall Study||86||
59772987|NCT00794820|75893500|FG000|STARTED|Overall Study||66||
59772988|NCT00794820|75893500|FG000|COMPLETED|Overall Study||50||
59772989|NCT00794820|75893500|FG000|NOT COMPLETED|Overall Study||16||
59772990|NCT00455533|75893506|FG000|STARTED|Period One: Initial Chemotherapy||313||
59772991|NCT00455533|75893507|FG001|STARTED|Period One: Initial Chemotherapy||0||
59772992|NCT00455533|75893508|FG002|STARTED|Period One: Initial Chemotherapy||0||
59772993|NCT00455533|75893506|FG000|COMPLETED|Period One: Initial Chemotherapy||295||
59772994|NCT00455533|75893507|FG001|COMPLETED|Period One: Initial Chemotherapy||0||
59772995|NCT00455533|75893508|FG002|COMPLETED|Period One: Initial Chemotherapy||0||
59772996|NCT00455533|75893506|FG000|NOT COMPLETED|Period One: Initial Chemotherapy||18||
59772997|NCT00455533|75893507|FG001|NOT COMPLETED|Period One: Initial Chemotherapy||0||
59772998|NCT00455533|75893508|FG002|NOT COMPLETED|Period One: Initial Chemotherapy||0||
59772999|NCT00455533|75893506|FG000|STARTED|Period Two: Randomized Period||0||
59773000|NCT00455533|75893507|FG001|STARTED|Period Two: Randomized Period|148 randomized, 145 randomized and treated with ixabepilone|145||
59773001|NCT00455533|75893508|FG002|STARTED|Period Two: Randomized Period|147 randomized, 144 randomized and treated with paclitaxel|144||
59773002|NCT00455533|75893506|FG000|COMPLETED|Period Two: Randomized Period||0||
59773003|NCT00455533|75893507|FG001|COMPLETED|Period Two: Randomized Period||139||
59773004|NCT00455533|75893508|FG002|COMPLETED|Period Two: Randomized Period||138||
59773005|NCT00455533|75893506|FG000|NOT COMPLETED|Period Two: Randomized Period||0||
59773006|NCT00455533|75893507|FG001|NOT COMPLETED|Period Two: Randomized Period||6||
59773007|NCT00455533|75893508|FG002|NOT COMPLETED|Period Two: Randomized Period||6||
59773008|NCT00627094|75893518|FG000|STARTED|Overall Study||60||
59773009|NCT00627094|75893519|FG001|STARTED|Overall Study||60||
59773010|NCT00627094|75893518|FG000|COMPLETED|Overall Study||48||
59773011|NCT00627094|75893519|FG001|COMPLETED|Overall Study||45||
59773012|NCT00627094|75893518|FG000|NOT COMPLETED|Overall Study||12||
59773013|NCT00627094|75893519|FG001|NOT COMPLETED|Overall Study||15||
59773014|NCT00642850|75893527|FG000|STARTED|Overall Study||188||
59773015|NCT00642850|75893527|FG000|COMPLETED|Overall Study||155||
59773016|NCT00642850|75893527|FG000|NOT COMPLETED|Overall Study||33||
59773017|NCT00455455|75893531|FG000|STARTED|Washout||25||
59773018|NCT00455455|75893532|FG001|STARTED|Washout||25||
59773019|NCT00455455|75893531|FG000|COMPLETED|Washout||25||
59773020|NCT00455455|75893532|FG001|COMPLETED|Washout||24||
59773021|NCT00455455|75893531|FG000|NOT COMPLETED|Washout||0||
59773022|NCT00455455|75893532|FG001|NOT COMPLETED|Washout||1||
59773023|NCT00455455|75893531|FG000|STARTED|First Intervention||25||
59773024|NCT00455455|75893532|FG001|STARTED|First Intervention||24||
59773025|NCT00455455|75893531|FG000|COMPLETED|First Intervention||25||
59773026|NCT00455455|75893532|FG001|COMPLETED|First Intervention||24||
59773027|NCT00455455|75893531|FG000|NOT COMPLETED|First Intervention||0||
59773028|NCT00455455|75893532|FG001|NOT COMPLETED|First Intervention||0||
59773029|NCT00455455|75893531|FG000|STARTED|Washout||25||
59773030|NCT00455455|75893532|FG001|STARTED|Washout||24||
59773031|NCT00455455|75893531|FG000|COMPLETED|Washout||24||
59773032|NCT00455455|75893532|FG001|COMPLETED|Washout||24||
59773033|NCT00455455|75893531|FG000|NOT COMPLETED|Washout||1||
59773034|NCT00455455|75893532|FG001|NOT COMPLETED|Washout||0||
59773035|NCT00455455|75893531|FG000|STARTED|Second Intervention||24||
59773036|NCT00455455|75893532|FG001|STARTED|Second Intervention||24||
59773037|NCT00455455|75893531|FG000|COMPLETED|Second Intervention||24||
59773038|NCT00455455|75893532|FG001|COMPLETED|Second Intervention||24||
59773039|NCT00455455|75893531|FG000|NOT COMPLETED|Second Intervention||0||
59773040|NCT00455455|75893532|FG001|NOT COMPLETED|Second Intervention||0||
59773041|NCT03840811|75893544|FG000|STARTED|Overall Study||9||
59773042|NCT03840811|75893545|FG001|STARTED|Overall Study||6||
59773043|NCT03840811|75893546|FG002|STARTED|Overall Study||12||
59773044|NCT03840811|75893544|FG000|COMPLETED|Overall Study||9||
59773045|NCT03840811|75893545|FG001|COMPLETED|Overall Study||6||
59773046|NCT03840811|75893546|FG002|COMPLETED|Overall Study||11||
59773047|NCT03840811|75893544|FG000|NOT COMPLETED|Overall Study||0||
59773048|NCT03840811|75893545|FG001|NOT COMPLETED|Overall Study||0||
59773049|NCT03840811|75893546|FG002|NOT COMPLETED|Overall Study||1||
59773050|NCT00640510|75893556|FG000|STARTED|Overall Study||17||
59773051|NCT00640510|75893557|FG001|STARTED|Overall Study|One patient randomized to placebo discontinued prior to receiving study drug.|17||
59773052|NCT00640510|75893556|FG000|COMPLETED|Overall Study||16||
59773053|NCT00640510|75893557|FG001|COMPLETED|Overall Study||15||
59773054|NCT00640510|75893556|FG000|NOT COMPLETED|Overall Study||1||
59773055|NCT00640510|75893557|FG001|NOT COMPLETED|Overall Study||2||
59773056|NCT00813800|75893563|FG000|STARTED|Overall Study||11||
59773057|NCT00813800|75893563|FG000|COMPLETED|Overall Study||5||
59773058|NCT00813800|75893563|FG000|NOT COMPLETED|Overall Study||6||
59773059|NCT00627016|75893569|FG000|STARTED|Overall Study||153||
59773060|NCT00627016|75893570|FG001|STARTED|Overall Study||152||
59773061|NCT00627016|75893569|FG000|COMPLETED|Overall Study||147||
59773062|NCT00627016|75893570|FG001|COMPLETED|Overall Study||146||
59773063|NCT00627016|75893569|FG000|NOT COMPLETED|Overall Study||6||
59773064|NCT00627016|75893570|FG001|NOT COMPLETED|Overall Study||6||
59773065|NCT00794664|75893578|FG000|STARTED|Treatment Period||19||
59773066|NCT00794664|75893579|FG001|STARTED|Treatment Period||39||
59773067|NCT00794664|75893578|FG000|COMPLETED|Treatment Period|3 participants enrolled in open-label extension study NCT00694109|18||
59773068|NCT00794664|75893579|FG001|COMPLETED|Treatment Period|6 participants enrolled in open-label extension study NCT00694109|27||
59773069|NCT00794664|75893578|FG000|NOT COMPLETED|Treatment Period||1||
59773070|NCT00794664|75893579|FG001|NOT COMPLETED|Treatment Period||12||
59773071|NCT00794664|75893578|FG000|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|16||
59773072|NCT00794664|75893579|FG001|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|33||
59773073|NCT00794664|75893578|FG000|COMPLETED|Follow-up Period||15||
59773074|NCT00794664|75893579|FG001|COMPLETED|Follow-up Period||28||
59773075|NCT00794664|75893578|FG000|NOT COMPLETED|Follow-up Period||1||
59773076|NCT00794664|75893579|FG001|NOT COMPLETED|Follow-up Period||5||
59773077|NCT00444535|75893585|FG000|STARTED|Overall Study||52||
59773078|NCT00444535|75893585|FG000|COMPLETED|Overall Study||39||
59773079|NCT00444535|75893585|FG000|NOT COMPLETED|Overall Study||13||
59773080|NCT00847613|75893593|FG000|STARTED|Overall Study||321||
59773081|NCT00847613|75893594|FG001|STARTED|Overall Study||319||
59773082|NCT00847613|75893595|FG002|STARTED|Overall Study||81||
59773083|NCT00847613|75893596|FG003|STARTED|Overall Study||79||
59773084|NCT00847613|75893593|FG000|Treated|Overall Study||321||
59773085|NCT00847613|75893594|FG001|Treated|Overall Study||316||
59773086|NCT00847613|75893595|FG002|Treated|Overall Study||81||
59773087|NCT00847613|75893596|FG003|Treated|Overall Study||79||
59773088|NCT00847613|75893593|FG000|COMPLETED|Overall Study||0||
59773089|NCT00847613|75893594|FG001|COMPLETED|Overall Study||0||
59773090|NCT00847613|75893595|FG002|COMPLETED|Overall Study||0||
59773091|NCT00847613|75893596|FG003|COMPLETED|Overall Study||0||
59773092|NCT00847613|75893593|FG000|NOT COMPLETED|Overall Study||321||
59773093|NCT00847613|75893594|FG001|NOT COMPLETED|Overall Study||319||
59773094|NCT00847613|75893595|FG002|NOT COMPLETED|Overall Study||81||
59773095|NCT00847613|75893596|FG003|NOT COMPLETED|Overall Study||79||
59773096|NCT00794196|75893615|FG000|STARTED|Overall Study||92||
59773097|NCT00794196|75893616|FG001|STARTED|Overall Study||87||
59773098|NCT00794196|75893615|FG000|COMPLETED|Overall Study||87||
59773099|NCT00794196|75893616|FG001|COMPLETED|Overall Study||64||
59773100|NCT00794196|75893615|FG000|NOT COMPLETED|Overall Study||5||
59773101|NCT00794196|75893616|FG001|NOT COMPLETED|Overall Study||23||
59773102|NCT00807092|75893624|FG000|STARTED|Overall Study||72||
59773103|NCT00807092|75893625|FG001|STARTED|Overall Study||73||
59773104|NCT00807092|75893624|FG000|Exposed to Drug|Overall Study|Subject was randomised, but not exposed to any trial drug|71||
59773105|NCT00807092|75893625|FG001|Exposed to Drug|Overall Study||73||
59773106|NCT00807092|75893624|FG000|COMPLETED|Overall Study||71||
59773107|NCT00807092|75893625|FG001|COMPLETED|Overall Study||69||
59773108|NCT00807092|75893624|FG000|NOT COMPLETED|Overall Study||1||
59773109|NCT00807092|75893625|FG001|NOT COMPLETED|Overall Study||4||
59773110|NCT00794118|75893631|FG000|STARTED|Overall Study||299||
59773111|NCT00794118|75893631|FG000|COMPLETED|Overall Study||272||
59773112|NCT00794118|75893631|FG000|NOT COMPLETED|Overall Study||27||
59773113|NCT00640042|75893635|FG000|STARTED|Enrollment|Number of patients with evidence of prescription card receipt|1570||
59773114|NCT00640042|75893635|FG000|COMPLETED|Enrollment|Number of patients with evidence of study drug receipt|1487||
59773115|NCT00640042|75893635|FG000|NOT COMPLETED|Enrollment||83||
59773116|NCT00640042|75893635|FG000|STARTED|Treatment||1487||
59773117|NCT00640042|75893635|FG000|COMPLETED|Treatment||561||
59773118|NCT00640042|75893635|FG000|NOT COMPLETED|Treatment||926||
59773119|NCT00807014|75893641|FG000|STARTED|Overall Study||83||
59773120|NCT00807014|75893642|FG001|STARTED|Overall Study||85||
59773121|NCT00807014|75893641|FG000|COMPLETED|Overall Study||56||
59773122|NCT00807014|75893642|FG001|COMPLETED|Overall Study||58||
59773123|NCT00807014|75893641|FG000|NOT COMPLETED|Overall Study||27||
59773124|NCT00807014|75893642|FG001|NOT COMPLETED|Overall Study||27||
59773125|NCT00592631|75893650|FG000|STARTED|Overall Study||16||
59773126|NCT00592631|75893651|FG001|STARTED|Overall Study||11||
59773127|NCT00592631|75893650|FG000|COMPLETED|Overall Study||16||
59773128|NCT00592631|75893651|FG001|COMPLETED|Overall Study||9||
59773129|NCT00592631|75893650|FG000|NOT COMPLETED|Overall Study||0||
59773130|NCT00592631|75893651|FG001|NOT COMPLETED|Overall Study||2||
59773131|NCT00791388|75893662|FG000|STARTED|Period 1 - 50 mg Dose Group||3||
59773132|NCT00791388|75893663|FG001|STARTED|Period 1 - 50 mg Dose Group||8||
59773133|NCT00791388|75893664|FG002|STARTED|Period 1 - 50 mg Dose Group||0||
59773134|NCT00791388|75893665|FG003|STARTED|Period 1 - 50 mg Dose Group||0||
59773135|NCT00791388|75893666|FG004|STARTED|Period 1 - 50 mg Dose Group||0||
59773136|NCT00791388|75893662|FG000|COMPLETED|Period 1 - 50 mg Dose Group||3||
59773137|NCT00791388|75893663|FG001|COMPLETED|Period 1 - 50 mg Dose Group||7||
59773138|NCT00791388|75893664|FG002|COMPLETED|Period 1 - 50 mg Dose Group||0||
59773139|NCT00791388|75893665|FG003|COMPLETED|Period 1 - 50 mg Dose Group||0||
59773140|NCT00791388|75893666|FG004|COMPLETED|Period 1 - 50 mg Dose Group||0||
59773141|NCT00791388|75893662|FG000|NOT COMPLETED|Period 1 - 50 mg Dose Group||0||
59773142|NCT00791388|75893663|FG001|NOT COMPLETED|Period 1 - 50 mg Dose Group||1||
59773143|NCT00791388|75893664|FG002|NOT COMPLETED|Period 1 - 50 mg Dose Group||0||
59773144|NCT00791388|75893665|FG003|NOT COMPLETED|Period 1 - 50 mg Dose Group||0||
59773145|NCT00791388|75893666|FG004|NOT COMPLETED|Period 1 - 50 mg Dose Group||0||
59773146|NCT00791388|75893662|FG000|STARTED|Period 2 - 100 mg Dose Group||3||
59773147|NCT00791388|75893663|FG001|STARTED|Period 2 - 100 mg Dose Group||0||
59773148|NCT00791388|75893664|FG002|STARTED|Period 2 - 100 mg Dose Group||8||
59773149|NCT00791388|75893665|FG003|STARTED|Period 2 - 100 mg Dose Group||0||
59773150|NCT00791388|75893666|FG004|STARTED|Period 2 - 100 mg Dose Group||0||
59773151|NCT00791388|75893662|FG000|COMPLETED|Period 2 - 100 mg Dose Group||2||
59773152|NCT00791388|75893663|FG001|COMPLETED|Period 2 - 100 mg Dose Group||0||
59773153|NCT00791388|75893664|FG002|COMPLETED|Period 2 - 100 mg Dose Group||8||
59773154|NCT00791388|75893665|FG003|COMPLETED|Period 2 - 100 mg Dose Group||0||
59773155|NCT00791388|75893666|FG004|COMPLETED|Period 2 - 100 mg Dose Group||0||
59773156|NCT00791388|75893662|FG000|NOT COMPLETED|Period 2 - 100 mg Dose Group||1||
59952732|NCT02605174|76071493|FG006|COMPLETED|Overall Study||662|One site was burned down and several participants have incomplete data.|
59773157|NCT00791388|75893663|FG001|NOT COMPLETED|Period 2 - 100 mg Dose Group||0||
59773158|NCT00791388|75893664|FG002|NOT COMPLETED|Period 2 - 100 mg Dose Group||0||
59773159|NCT00791388|75893665|FG003|NOT COMPLETED|Period 2 - 100 mg Dose Group||0||
59773160|NCT00791388|75893666|FG004|NOT COMPLETED|Period 2 - 100 mg Dose Group||0||
59773161|NCT00791388|75893662|FG000|STARTED|Period 3 - 200 mg Dose Group||3||
59709555|NCT01238861|75828320|FG002|COMPLETED|Overall Study||70||
59773162|NCT00791388|75893663|FG001|STARTED|Period 3 - 200 mg Dose Group||0||
59773163|NCT00791388|75893664|FG002|STARTED|Period 3 - 200 mg Dose Group||0||
59773164|NCT00791388|75893665|FG003|STARTED|Period 3 - 200 mg Dose Group||8||
59773165|NCT00791388|75893666|FG004|STARTED|Period 3 - 200 mg Dose Group||0||
59773166|NCT00791388|75893662|FG000|COMPLETED|Period 3 - 200 mg Dose Group||3||
59773167|NCT00791388|75893663|FG001|COMPLETED|Period 3 - 200 mg Dose Group||0||
59773168|NCT00791388|75893664|FG002|COMPLETED|Period 3 - 200 mg Dose Group||0||
59952733|NCT02605174|76071487|FG000|NOT COMPLETED|Overall Study||64||
59952734|NCT02605174|76071488|FG001|NOT COMPLETED|Overall Study||23||
59952735|NCT02605174|76071489|FG002|NOT COMPLETED|Overall Study||76||
59952736|NCT02605174|76071490|FG003|NOT COMPLETED|Overall Study||36||
59952737|NCT02605174|76071491|FG004|NOT COMPLETED|Overall Study||53||
59952738|NCT02605174|76071492|FG005|NOT COMPLETED|Overall Study||32||
59952739|NCT02605174|76071493|FG006|NOT COMPLETED|Overall Study||89||
59952740|NCT02604550|76071521|FG000|STARTED|Overall Study||56||
59952741|NCT02604550|76071522|FG001|STARTED|Overall Study||59||
59952742|NCT02604550|76071521|FG000|COMPLETED|Overall Study||31||
59952743|NCT02604550|76071522|FG001|COMPLETED|Overall Study||33||
59952744|NCT02604550|76071521|FG000|NOT COMPLETED|Overall Study||25||
59952745|NCT02604550|76071522|FG001|NOT COMPLETED|Overall Study||26||
59952746|NCT02591290|76071528|FG000|STARTED|Overall Study||60||
59952747|NCT02591290|76071528|FG000|Vaccinated Dose 1|Overall Study||60||
59952748|NCT02591290|76071528|FG000|Vaccinated Dose 2|Overall Study||58||
59952749|NCT02591290|76071528|FG000|COMPLETED|Overall Study||58||
59952750|NCT02591290|76071528|FG000|NOT COMPLETED|Overall Study||2||
59952751|NCT02791893|76071534|FG000|STARTED|Blinded Phase||13||
59952752|NCT02791893|76071535|FG001|STARTED|Blinded Phase||14||
59952753|NCT02791893|76071534|FG000|COMPLETED|Blinded Phase||10||
59952754|NCT02791893|76071535|FG001|COMPLETED|Blinded Phase||10||
59952755|NCT02791893|76071534|FG000|NOT COMPLETED|Blinded Phase||3||
59952756|NCT02791893|76071535|FG001|NOT COMPLETED|Blinded Phase||4||
59952757|NCT02791893|76071534|FG000|STARTED|Open Label Phase||10||
59952758|NCT02791893|76071535|FG001|STARTED|Open Label Phase||10||
59952759|NCT02791893|76071534|FG000|COMPLETED|Open Label Phase||7||
59952760|NCT02791893|76071535|FG001|COMPLETED|Open Label Phase||8||
59952761|NCT02791893|76071534|FG000|NOT COMPLETED|Open Label Phase||3||
59952762|NCT02791893|76071535|FG001|NOT COMPLETED|Open Label Phase||2||
59952763|NCT00120042|76071544|FG000|STARTED|Overall Study||85||
59952764|NCT00120042|76071545|FG001|STARTED|Overall Study||83||
59952765|NCT00120042|76071546|FG002|STARTED|Overall Study||83||
59952766|NCT00120042|76071544|FG000|COMPLETED|Overall Study||85||
59952767|NCT00120042|76071545|FG001|COMPLETED|Overall Study||83||
59952768|NCT00120042|76071546|FG002|COMPLETED|Overall Study||83||
59952769|NCT00120042|76071544|FG000|NOT COMPLETED|Overall Study||0||
59952770|NCT00120042|76071545|FG001|NOT COMPLETED|Overall Study||0||
59709556|NCT01238861|75828321|FG003|COMPLETED|Overall Study||69||
59709557|NCT01238861|75828322|FG004|COMPLETED|Overall Study||129||
59709558|NCT01238861|75828323|FG005|COMPLETED|Overall Study||125||
59709559|NCT01238861|75828318|FG000|NOT COMPLETED|Overall Study||11||
59709560|NCT01238861|75828319|FG001|NOT COMPLETED|Overall Study||8||
59709561|NCT01238861|75828320|FG002|NOT COMPLETED|Overall Study||11||
59709562|NCT01238861|75828321|FG003|NOT COMPLETED|Overall Study||13||
59709563|NCT01238861|75828322|FG004|NOT COMPLETED|Overall Study||13||
59709564|NCT01238861|75828323|FG005|NOT COMPLETED|Overall Study||15||
59709565|NCT00903409|75828346|FG000|STARTED|Overall Study||88||
59709566|NCT00903409|75828347|FG001|STARTED|Overall Study||100||
59709567|NCT00903409|75828346|FG000|COMPLETED|Overall Study||62||
59709568|NCT00903409|75828347|FG001|COMPLETED|Overall Study||73||
59709569|NCT00903409|75828346|FG000|NOT COMPLETED|Overall Study||26||
59709570|NCT00903409|75828347|FG001|NOT COMPLETED|Overall Study||27||
59709571|NCT01237223|75828361|FG000|STARTED|Single Blind(Run-in Period, 4 Weeks)|All the patients enrolled to single blind period received only placebo treatment.|1342||
59709572|NCT01237223|75828362|FG001|STARTED|Single Blind(Run-in Period, 4 Weeks)||0||
59709573|NCT01237223|75828363|FG002|STARTED|Single Blind(Run-in Period, 4 Weeks)||0||
59709574|NCT01237223|75828364|FG003|STARTED|Single Blind(Run-in Period, 4 Weeks)||0||
59709575|NCT01237223|75828365|FG004|STARTED|Single Blind(Run-in Period, 4 Weeks)||0||
59709576|NCT01237223|75828366|FG005|STARTED|Single Blind(Run-in Period, 4 Weeks)||0||
59709577|NCT01237223|75828361|FG000|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||944||
59709578|NCT01237223|75828362|FG001|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0||
59709579|NCT01237223|75828363|FG002|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0||
59709580|NCT01237223|75828364|FG003|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0||
59709581|NCT01237223|75828365|FG004|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0||
59773169|NCT00791388|75893665|FG003|COMPLETED|Period 3 - 200 mg Dose Group||8||
59773170|NCT00791388|75893666|FG004|COMPLETED|Period 3 - 200 mg Dose Group||0||
59773171|NCT00791388|75893662|FG000|NOT COMPLETED|Period 3 - 200 mg Dose Group||0||
59773172|NCT00791388|75893663|FG001|NOT COMPLETED|Period 3 - 200 mg Dose Group||0||
59773173|NCT00791388|75893664|FG002|NOT COMPLETED|Period 3 - 200 mg Dose Group||0||
59773174|NCT00791388|75893665|FG003|NOT COMPLETED|Period 3 - 200 mg Dose Group||0||
59773175|NCT00791388|75893666|FG004|NOT COMPLETED|Period 3 - 200 mg Dose Group||0||
59773176|NCT00791388|75893662|FG000|STARTED|Period 4 - 400 mg Dose Group||4||
59773177|NCT00791388|75893663|FG001|STARTED|Period 4 - 400 mg Dose Group||0||
59773178|NCT00791388|75893664|FG002|STARTED|Period 4 - 400 mg Dose Group||0||
59773179|NCT00791388|75893665|FG003|STARTED|Period 4 - 400 mg Dose Group||0||
59773180|NCT00791388|75893666|FG004|STARTED|Period 4 - 400 mg Dose Group||8||
59773181|NCT00791388|75893662|FG000|COMPLETED|Period 4 - 400 mg Dose Group||4||
59773182|NCT00791388|75893663|FG001|COMPLETED|Period 4 - 400 mg Dose Group||0||
59773183|NCT00791388|75893664|FG002|COMPLETED|Period 4 - 400 mg Dose Group||0||
59773184|NCT00791388|75893665|FG003|COMPLETED|Period 4 - 400 mg Dose Group||0||
59773185|NCT00791388|75893666|FG004|COMPLETED|Period 4 - 400 mg Dose Group||4||
59773186|NCT00791388|75893662|FG000|NOT COMPLETED|Period 4 - 400 mg Dose Group||0||
59773187|NCT00791388|75893663|FG001|NOT COMPLETED|Period 4 - 400 mg Dose Group||0||
59773188|NCT00791388|75893664|FG002|NOT COMPLETED|Period 4 - 400 mg Dose Group||0||
59773189|NCT00791388|75893665|FG003|NOT COMPLETED|Period 4 - 400 mg Dose Group||0||
59773190|NCT00791388|75893666|FG004|NOT COMPLETED|Period 4 - 400 mg Dose Group||4||
59773191|NCT00794040|75893680|FG000|STARTED|Overall Study||25||
59773192|NCT00794040|75893681|FG001|STARTED|Overall Study||28||
59773193|NCT00794040|75893680|FG000|COMPLETED|Overall Study||22||
59773194|NCT00794040|75893681|FG001|COMPLETED|Overall Study||23||
59773195|NCT00794040|75893680|FG000|NOT COMPLETED|Overall Study||3||
59773196|NCT00794040|75893681|FG001|NOT COMPLETED|Overall Study||5||
59773197|NCT00813488|75893687|FG000|STARTED|Titration Period 1||107||
59773198|NCT00813488|75893688|FG001|STARTED|Titration Period 1||106||
59773199|NCT00813488|75893687|FG000|COMPLETED|Titration Period 1||80||
59773200|NCT00813488|75893688|FG001|COMPLETED|Titration Period 1||89||
59773201|NCT00813488|75893687|FG000|NOT COMPLETED|Titration Period 1||27||
59773202|NCT00813488|75893688|FG001|NOT COMPLETED|Titration Period 1||17||
59773203|NCT00813488|75893687|FG000|STARTED|Titration Period 2||80||
59773204|NCT00813488|75893688|FG001|STARTED|Titration Period 2||89||
59773205|NCT00813488|75893687|FG000|COMPLETED|Titration Period 2||64||
59773206|NCT00813488|75893688|FG001|COMPLETED|Titration Period 2||79||
59773207|NCT00813488|75893687|FG000|NOT COMPLETED|Titration Period 2||16||
59773208|NCT00813488|75893688|FG001|NOT COMPLETED|Titration Period 2||10||
59773209|NCT00813488|75893687|FG000|STARTED|Double-blind Treatment Period 1|After titration subjects were re-randomized to these two treatment arms|72||
59773210|NCT00813488|75893688|FG001|STARTED|Double-blind Treatment Period 1|After titration subjects were re-randomized to these two treatment arms|71||
59773211|NCT00813488|75893687|FG000|COMPLETED|Double-blind Treatment Period 1||71||
59773212|NCT00813488|75893688|FG001|COMPLETED|Double-blind Treatment Period 1||66||
59773213|NCT00813488|75893687|FG000|NOT COMPLETED|Double-blind Treatment Period 1||1||
59773214|NCT00813488|75893688|FG001|NOT COMPLETED|Double-blind Treatment Period 1||5||
59773215|NCT00813488|75893687|FG000|STARTED|Double-blind Treatment Period 2||71||
59773216|NCT00813488|75893688|FG001|STARTED|Double-blind Treatment Period 2||66||
59773217|NCT00813488|75893687|FG000|COMPLETED|Double-blind Treatment Period 2||66||
59773218|NCT00813488|75893688|FG001|COMPLETED|Double-blind Treatment Period 2||65||
59773219|NCT00813488|75893687|FG000|NOT COMPLETED|Double-blind Treatment Period 2||5||
59773220|NCT00813488|75893688|FG001|NOT COMPLETED|Double-blind Treatment Period 2||1||
59773221|NCT00813488|75893687|FG000|STARTED|Open-label Extension|Patients completing double-blind periods were randomized to FBT or standard of care for open-label|65||
59773222|NCT00813488|75893688|FG001|STARTED|Open-label Extension|Patients completing double-blind periods were randomized to FBT or standard of care for open-label|66||
59773223|NCT00813488|75893687|FG000|COMPLETED|Open-label Extension|This group received FBT open--label|53||
59773224|NCT00813488|75893688|FG001|COMPLETED|Open-label Extension|This group received standard of care (including immediate-release oxycodone)|59||
59773225|NCT00813488|75893687|FG000|NOT COMPLETED|Open-label Extension||12||
59773226|NCT00813488|75893688|FG001|NOT COMPLETED|Open-label Extension||7||
59773227|NCT00797316|75893700|FG000|STARTED|Overall Study||267||
59773228|NCT00797316|75893701|FG001|STARTED|Overall Study||265||
59773229|NCT00797316|75893700|FG000|COMPLETED|Overall Study||244||
59773230|NCT00797316|75893701|FG001|COMPLETED|Overall Study||233||
59773231|NCT00797316|75893700|FG000|NOT COMPLETED|Overall Study||23||
59773232|NCT00797316|75893701|FG001|NOT COMPLETED|Overall Study||32||
59773233|NCT00587964|75893707|FG000|STARTED|Overall Study||51||
59773234|NCT00587964|75893707|FG000|COMPLETED|Overall Study||39||
59773235|NCT00587964|75893707|FG000|NOT COMPLETED|Overall Study||12||
59773236|NCT00590954|75893711|FG000|STARTED|Overall Study||32||
59773237|NCT00590954|75893711|FG000|COMPLETED|Overall Study||30||
59773238|NCT00590954|75893711|FG000|NOT COMPLETED|Overall Study||2||
59773239|NCT00791076|75893717|FG000|STARTED|Overall Study||8||
59773240|NCT00791076|75893717|FG000|COMPLETED|Overall Study||0||
59773241|NCT00791076|75893717|FG000|NOT COMPLETED|Overall Study||8||
59773242|NCT00590720|75893725|FG000|STARTED|Overall Study||4||
59773243|NCT00590720|75893726|FG001|STARTED|Overall Study||7||
59773244|NCT00590720|75893725|FG000|COMPLETED|Overall Study||3||
59773245|NCT00590720|75893726|FG001|COMPLETED|Overall Study||6||
59773246|NCT00590720|75893725|FG000|NOT COMPLETED|Overall Study||1||
59773247|NCT00590720|75893726|FG001|NOT COMPLETED|Overall Study||1||
59773248|NCT00625378|75893734|FG000|STARTED|Overall Study||205||
59773249|NCT00625378|75893735|FG001|STARTED|Overall Study||1||
59773250|NCT00625378|75893734|FG000|Treated in STEP|Overall Study||203||
59773251|NCT00625378|75893735|FG001|Treated in STEP|Overall Study||1||
59773252|NCT00625378|75893734|FG000|COMPLETED|Overall Study||0||
59773253|NCT00625378|75893735|FG001|COMPLETED|Overall Study||0||
59773254|NCT00625378|75893734|FG000|NOT COMPLETED|Overall Study||205||
59773255|NCT00625378|75893735|FG001|NOT COMPLETED|Overall Study||1||
59773256|NCT00806624|75893744|FG000|STARTED|Overall Study||79||
59773257|NCT00806624|75893745|FG001|STARTED|Overall Study||80||
59773258|NCT00806624|75893746|FG002|STARTED|Overall Study||75||
59773259|NCT00806624|75893744|FG000|COMPLETED|Overall Study||70||
59773260|NCT00806624|75893745|FG001|COMPLETED|Overall Study||68||
59773261|NCT00806624|75893746|FG002|COMPLETED|Overall Study||69||
59773262|NCT00806624|75893744|FG000|NOT COMPLETED|Overall Study||9||
59773263|NCT00806624|75893745|FG001|NOT COMPLETED|Overall Study||12||
59773264|NCT00806624|75893746|FG002|NOT COMPLETED|Overall Study||6||
59773265|NCT00806546|75893754|FG000|STARTED|Overall Study|35 subjects were enrolled but did not treat for a total of 479 subjects in the safety population|514||
59773266|NCT00806546|75893754|FG000|COMPLETED|Overall Study||207||
59773267|NCT00806546|75893754|FG000|NOT COMPLETED|Overall Study||307||
59773268|NCT00624832|75893762|FG000|STARTED|Overall Study||18||
59773269|NCT00624832|75893763|FG001|STARTED|Overall Study||16||
59773270|NCT00624832|75893764|FG002|STARTED|Overall Study||10||
59773271|NCT00624832|75893765|FG003|STARTED|Overall Study||16||
59773272|NCT00624832|75893762|FG000|COMPLETED|Overall Study||16||
59773273|NCT00624832|75893763|FG001|COMPLETED|Overall Study||15||
59773274|NCT00624832|75893764|FG002|COMPLETED|Overall Study||10||
59773275|NCT00624832|75893765|FG003|COMPLETED|Overall Study||15||
59773276|NCT00624832|75893762|FG000|NOT COMPLETED|Overall Study||2||
59773277|NCT00624832|75893763|FG001|NOT COMPLETED|Overall Study||1||
59773278|NCT00624832|75893764|FG002|NOT COMPLETED|Overall Study||0||
59773279|NCT00624832|75893765|FG003|NOT COMPLETED|Overall Study||1||
59773280|NCT00633880|75893777|FG000|STARTED|Open Label Titration||181||
59773281|NCT00633880|75893778|FG001|STARTED|Open Label Titration||0||
59773282|NCT00633880|75893779|FG002|STARTED|Open Label Titration||0||
59773283|NCT00633880|75893777|FG000|COMPLETED|Open Label Titration||101||
59773284|NCT00633880|75893778|FG001|COMPLETED|Open Label Titration||0||
59773285|NCT00633880|75893779|FG002|COMPLETED|Open Label Titration||0||
59773286|NCT00633880|75893777|FG000|NOT COMPLETED|Open Label Titration||80||
59773287|NCT00633880|75893778|FG001|NOT COMPLETED|Open Label Titration||0||
59773288|NCT00633880|75893779|FG002|NOT COMPLETED|Open Label Titration||0||
59773289|NCT00633880|75893777|FG000|STARTED|Randomized Double Blind||0||
59773290|NCT00633880|75893778|FG001|STARTED|Randomized Double Blind||50||
59773291|NCT00633880|75893779|FG002|STARTED|Randomized Double Blind||51||
59773292|NCT00633880|75893777|FG000|COMPLETED|Randomized Double Blind||0||
59773293|NCT00633880|75893778|FG001|COMPLETED|Randomized Double Blind||50||
59773294|NCT00633880|75893779|FG002|COMPLETED|Randomized Double Blind||51||
59773295|NCT00633880|75893777|FG000|NOT COMPLETED|Randomized Double Blind||0||
59773296|NCT00633880|75893778|FG001|NOT COMPLETED|Randomized Double Blind||0||
59521851|NCT03826472|75616138|FG000|NOT COMPLETED|First Intervention (1-week)||0||
59773297|NCT00633880|75893779|FG002|NOT COMPLETED|Randomized Double Blind||0||
59773298|NCT00590564|75893786|FG000|STARTED|Overall Study||42||
59521852|NCT03826472|75616139|FG001|NOT COMPLETED|First Intervention (1-week)||0||
59521853|NCT03826472|75616138|FG000|STARTED|Second Intervention (1-week)||5||
59521854|NCT03826472|75616139|FG001|STARTED|Second Intervention (1-week)||5||
59773299|NCT00590564|75893786|FG000|COMPLETED|Overall Study||24||
59773300|NCT00590564|75893786|FG000|NOT COMPLETED|Overall Study||18||
59773301|NCT00631696|75893792|FG000|STARTED|Overall Study||112||
59773302|NCT00631696|75893793|FG001|STARTED|Overall Study||110||
59773303|NCT00631696|75893792|FG000|Received Study Treatment (Tx)|Overall Study||111||
59773304|NCT00631696|75893793|FG001|Received Study Treatment (Tx)|Overall Study||109||
59773305|NCT00631696|75893792|FG000|Ongoing at Database Release 18Oct2011|Overall Study|Completed Tx at time of database release 18Oct2011; included in all analyses.|2||
59773306|NCT00631696|75893793|FG001|Ongoing at Database Release 18Oct2011|Overall Study||0||
59521855|NCT03826472|75616138|FG000|COMPLETED|Second Intervention (1-week)||5||
59952771|NCT00120042|76071546|FG002|NOT COMPLETED|Overall Study||0||
59773307|NCT00631696|75893792|FG000|COMPLETED|Overall Study|Completed study at time of database release 18Oct2011.|75||
59773308|NCT00631696|75893793|FG001|COMPLETED|Overall Study|Completed study at time of database release 18Oct2011.|70||
59773309|NCT00631696|75893792|FG000|NOT COMPLETED|Overall Study||37||
59773310|NCT00631696|75893793|FG001|NOT COMPLETED|Overall Study||40||
59773311|NCT00631540|75893799|FG000|STARTED|Overall Study||100||
59773312|NCT00631540|75893799|FG000|COMPLETED|Overall Study||86||
59773313|NCT00631540|75893799|FG000|NOT COMPLETED|Overall Study||14||
59773314|NCT00630916|75893803|FG000|STARTED|Overall Study|Total patients enrolled (i.e. consented) to participate in the study.|756||
59773315|NCT00630916|75893803|FG000|Study Cohort|Overall Study|Enrolled but did not receive device via physician decision, protocol violation, or lack of efficacy.|699||
59773316|NCT00630916|75893803|FG000|COMPLETED|Overall Study|The number of patients that were active (i.e. not drop out) at the end of the study.|546||
59773317|NCT00630916|75893803|FG000|NOT COMPLETED|Overall Study||210||
59773318|NCT00630292|75893807|FG000|STARTED|Overall Study||6||
59773319|NCT00630292|75893807|FG000|COMPLETED|Overall Study||5||
59773320|NCT00630292|75893807|FG000|NOT COMPLETED|Overall Study||1||
59773321|NCT00626548|75893813|FG000|STARTED|Overall Study||705||
59773322|NCT00626548|75893814|FG001|STARTED|Overall Study||716||
59773323|NCT00626548|75893813|FG000|Patients Received Treatment|Overall Study||703||
59773324|NCT00626548|75893814|FG001|Patients Received Treatment|Overall Study||712||
59773325|NCT00626548|75893813|FG000|COMPLETED|Overall Study||0||
59773326|NCT00626548|75893814|FG001|COMPLETED|Overall Study||0||
59773327|NCT00626548|75893813|FG000|NOT COMPLETED|Overall Study||705||
59773328|NCT00626548|75893814|FG001|NOT COMPLETED|Overall Study||716||
59773329|NCT00847379|75893823|FG000|STARTED|Overall Study||59||
59773330|NCT00847379|75893824|FG001|STARTED|Overall Study||57||
59773331|NCT00847379|75893825|FG002|STARTED|Overall Study||57||
59773332|NCT00847379|75893823|FG000|As-treated Population|Overall Study||59|All participants who completed Study 007 and received ≥1 dose of ataluren in Study 007e.|
59773333|NCT00847379|75893824|FG001|As-treated Population|Overall Study||57|All participants who completed Study 007 and received ≥1 dose of ataluren in Study 007e.|
59773334|NCT00847379|75893825|FG002|As-treated Population|Overall Study||57|All participants who completed Study 007 and received ≥1 dose of ataluren in Study 007e.|
59773335|NCT00847379|75893823|FG000|COMPLETED|Overall Study||0||
59773336|NCT00847379|75893824|FG001|COMPLETED|Overall Study||0||
59773337|NCT00847379|75893825|FG002|COMPLETED|Overall Study||0||
59773338|NCT00847379|75893823|FG000|NOT COMPLETED|Overall Study||59||
59773339|NCT00847379|75893824|FG001|NOT COMPLETED|Overall Study||57||
59773340|NCT00847379|75893825|FG002|NOT COMPLETED|Overall Study||57||
59773341|NCT00847301|75893835|FG000|STARTED|Overall Study||428||
59773342|NCT00847301|75893835|FG000|COMPLETED|Overall Study||374||
59773343|NCT00847301|75893835|FG000|NOT COMPLETED|Overall Study||54||
59773344|NCT00624520|75893841|FG000|STARTED|Overall Study||56||
59773345|NCT00624520|75893842|FG001|STARTED|Overall Study||47||
59773346|NCT00624520|75893841|FG000|COMPLETED|Overall Study||44||
59773347|NCT00624520|75893842|FG001|COMPLETED|Overall Study||39||
59773348|NCT00624520|75893841|FG000|NOT COMPLETED|Overall Study||12||
59773349|NCT00624520|75893842|FG001|NOT COMPLETED|Overall Study||8||
59773350|NCT00847145|75893856|FG000|STARTED|Overall Study||629||
59773351|NCT00847145|75893857|FG001|STARTED|Overall Study||633||
59773352|NCT00847145|75893858|FG002|STARTED|Overall Study||285||
59773353|NCT00847145|75893859|FG003|STARTED|Overall Study||117||
59773354|NCT00847145|75893860|FG004|STARTED|Overall Study||137||
59773355|NCT00847145|75893861|FG005|STARTED|Overall Study||156||
59773356|NCT00847145|75893862|FG006|STARTED|Overall Study||152||
59773357|NCT00847145|75893863|FG007|STARTED|Overall Study||140||
59773358|NCT00847145|75893856|FG000|COMPLETED|Overall Study||623||
59773359|NCT00847145|75893857|FG001|COMPLETED|Overall Study||627||
59773360|NCT00847145|75893858|FG002|COMPLETED|Overall Study||274||
59773361|NCT00847145|75893859|FG003|COMPLETED|Overall Study||116||
59773362|NCT00847145|75893860|FG004|COMPLETED|Overall Study||131||
59773363|NCT00847145|75893861|FG005|COMPLETED|Overall Study||152||
59773364|NCT00847145|75893862|FG006|COMPLETED|Overall Study||143||
59773365|NCT00847145|75893863|FG007|COMPLETED|Overall Study||136||
59773366|NCT00847145|75893856|FG000|NOT COMPLETED|Overall Study||6||
59773367|NCT00847145|75893857|FG001|NOT COMPLETED|Overall Study||6||
59773368|NCT00847145|75893858|FG002|NOT COMPLETED|Overall Study||11||
59773369|NCT00847145|75893859|FG003|NOT COMPLETED|Overall Study||1||
59773370|NCT00847145|75893860|FG004|NOT COMPLETED|Overall Study||6||
59773371|NCT00847145|75893861|FG005|NOT COMPLETED|Overall Study||4||
59773372|NCT00847145|75893862|FG006|NOT COMPLETED|Overall Study||9||
59773373|NCT00847145|75893863|FG007|NOT COMPLETED|Overall Study||4||
59773374|NCT00846521|75893890|FG000|STARTED|Overall Study||23||
59773375|NCT00846521|75893890|FG000|COMPLETED|Overall Study||12||
59773376|NCT00846521|75893890|FG000|NOT COMPLETED|Overall Study||11||
59773377|NCT00862823|75893894|FG000|STARTED|First Intervention||6||
59773378|NCT00862823|75893895|FG001|STARTED|First Intervention||10||
59773379|NCT00862823|75893894|FG000|COMPLETED|First Intervention||5||
59773380|NCT00862823|75893895|FG001|COMPLETED|First Intervention||9||
59773381|NCT00862823|75893894|FG000|NOT COMPLETED|First Intervention||1||
59773382|NCT00862823|75893895|FG001|NOT COMPLETED|First Intervention||1||
59773383|NCT00862823|75893894|FG000|STARTED|Washout Period of 2 Weeks||5||
59773384|NCT00862823|75893895|FG001|STARTED|Washout Period of 2 Weeks||9||
59773385|NCT00862823|75893894|FG000|COMPLETED|Washout Period of 2 Weeks||5||
59773386|NCT00862823|75893895|FG001|COMPLETED|Washout Period of 2 Weeks||9||
59773387|NCT00862823|75893894|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0||
59773388|NCT00862823|75893895|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0||
59773389|NCT00862823|75893894|FG000|STARTED|Second Intervention||5||
59773390|NCT00862823|75893895|FG001|STARTED|Second Intervention||9||
59773391|NCT00862823|75893894|FG000|COMPLETED|Second Intervention||5||
59773392|NCT00862823|75893895|FG001|COMPLETED|Second Intervention||9||
59773393|NCT00862823|75893894|FG000|NOT COMPLETED|Second Intervention||0||
59773394|NCT00862823|75893895|FG001|NOT COMPLETED|Second Intervention||0||
59773395|NCT00790842|75893903|FG000|STARTED|Dose Level 1||6||
59773396|NCT00790842|75893904|FG001|STARTED|Dose Level 1||0||
59773397|NCT00790842|75893905|FG002|STARTED|Dose Level 1||0||
59773398|NCT00790842|75893906|FG003|STARTED|Dose Level 1||3||
59773399|NCT00790842|75893907|FG004|STARTED|Dose Level 1||0||
59773400|NCT00790842|75893908|FG005|STARTED|Dose Level 1||0||
59773401|NCT00790842|75893909|FG006|STARTED|Dose Level 1||0||
59773402|NCT00790842|75893910|FG007|STARTED|Dose Level 1||3||
59773403|NCT00790842|75893911|FG008|STARTED|Dose Level 1||0||
59773404|NCT00790842|75893912|FG009|STARTED|Dose Level 1||0||
59773405|NCT00790842|75893913|FG010|STARTED|Dose Level 1||0||
59773406|NCT00790842|75893903|FG000|Began Treatment|Dose Level 1||6||
59773407|NCT00790842|75893904|FG001|Began Treatment|Dose Level 1||0||
59773408|NCT00790842|75893905|FG002|Began Treatment|Dose Level 1||0||
59773409|NCT00790842|75893906|FG003|Began Treatment|Dose Level 1||3||
59773410|NCT00790842|75893907|FG004|Began Treatment|Dose Level 1||0||
59773411|NCT00790842|75893908|FG005|Began Treatment|Dose Level 1||0||
59773412|NCT00790842|75893909|FG006|Began Treatment|Dose Level 1||0||
59773413|NCT00790842|75893910|FG007|Began Treatment|Dose Level 1||3||
59773414|NCT00790842|75893911|FG008|Began Treatment|Dose Level 1||0||
59773415|NCT00790842|75893912|FG009|Began Treatment|Dose Level 1||0||
59773416|NCT00790842|75893913|FG010|Began Treatment|Dose Level 1||0||
59773417|NCT00790842|75893903|FG000|COMPLETED|Dose Level 1||3|Treated until disease progression|
59773418|NCT00790842|75893904|FG001|COMPLETED|Dose Level 1||0|Treated until disease progression|
59773419|NCT00790842|75893905|FG002|COMPLETED|Dose Level 1||0|Treated until disease progression|
59773420|NCT00790842|75893906|FG003|COMPLETED|Dose Level 1||1|Treated until disease progression|
59773421|NCT00790842|75893907|FG004|COMPLETED|Dose Level 1||0|Treated until disease progression|
59773422|NCT00790842|75893908|FG005|COMPLETED|Dose Level 1||0|Treated until disease progression|
59773423|NCT00790842|75893909|FG006|COMPLETED|Dose Level 1||0|Treated until disease progression|
59773424|NCT00790842|75893910|FG007|COMPLETED|Dose Level 1||1|Treated until disease progression|
59773425|NCT00790842|75893911|FG008|COMPLETED|Dose Level 1||0|Treated until disease progression|
59773426|NCT00790842|75893912|FG009|COMPLETED|Dose Level 1||0|Treated until disease progression|
59773427|NCT00790842|75893913|FG010|COMPLETED|Dose Level 1||0|Treated until disease progression|
59773428|NCT00790842|75893903|FG000|NOT COMPLETED|Dose Level 1||3||
59773429|NCT00790842|75893904|FG001|NOT COMPLETED|Dose Level 1||0||
59773430|NCT00790842|75893905|FG002|NOT COMPLETED|Dose Level 1||0||
59773431|NCT00790842|75893906|FG003|NOT COMPLETED|Dose Level 1||2||
59773432|NCT00790842|75893907|FG004|NOT COMPLETED|Dose Level 1||0||
59773433|NCT00790842|75893908|FG005|NOT COMPLETED|Dose Level 1||0||
59773434|NCT00790842|75893909|FG006|NOT COMPLETED|Dose Level 1||0||
59773435|NCT00790842|75893910|FG007|NOT COMPLETED|Dose Level 1||2||
59773436|NCT00790842|75893911|FG008|NOT COMPLETED|Dose Level 1||0||
59773437|NCT00790842|75893912|FG009|NOT COMPLETED|Dose Level 1||0||
59773438|NCT00790842|75893913|FG010|NOT COMPLETED|Dose Level 1||0||
59773439|NCT00790842|75893903|FG000|STARTED|Dose Level 2||0||
59773440|NCT00790842|75893904|FG001|STARTED|Dose Level 2||3||
59773441|NCT00790842|75893905|FG002|STARTED|Dose Level 2||0||
59773442|NCT00790842|75893906|FG003|STARTED|Dose Level 2||0||
59773443|NCT00790842|75893907|FG004|STARTED|Dose Level 2||3||
59773444|NCT00790842|75893908|FG005|STARTED|Dose Level 2||0||
59773445|NCT00790842|75893909|FG006|STARTED|Dose Level 2||0||
59773446|NCT00790842|75893910|FG007|STARTED|Dose Level 2||0||
59773447|NCT00790842|75893911|FG008|STARTED|Dose Level 2||3||
59773448|NCT00790842|75893912|FG009|STARTED|Dose Level 2||0||
59773449|NCT00790842|75893913|FG010|STARTED|Dose Level 2||0||
59773450|NCT00790842|75893903|FG000|Began Treatment|Dose Level 2||0||
59773451|NCT00790842|75893904|FG001|Began Treatment|Dose Level 2||3||
59773452|NCT00790842|75893905|FG002|Began Treatment|Dose Level 2||0||
59773453|NCT00790842|75893906|FG003|Began Treatment|Dose Level 2||0||
59773454|NCT00790842|75893907|FG004|Began Treatment|Dose Level 2||3||
59773455|NCT00790842|75893908|FG005|Began Treatment|Dose Level 2||0||
59773456|NCT00790842|75893909|FG006|Began Treatment|Dose Level 2||0||
59773457|NCT00790842|75893910|FG007|Began Treatment|Dose Level 2||0||
59773458|NCT00790842|75893911|FG008|Began Treatment|Dose Level 2||3||
59773459|NCT00790842|75893912|FG009|Began Treatment|Dose Level 2||0||
59773460|NCT00790842|75893913|FG010|Began Treatment|Dose Level 2||0||
59773461|NCT00790842|75893903|FG000|COMPLETED|Dose Level 2||0||
59773462|NCT00790842|75893904|FG001|COMPLETED|Dose Level 2||0||
59773463|NCT00790842|75893905|FG002|COMPLETED|Dose Level 2||0||
59773464|NCT00790842|75893906|FG003|COMPLETED|Dose Level 2||0||
59773465|NCT00790842|75893907|FG004|COMPLETED|Dose Level 2||2||
59773466|NCT00790842|75893908|FG005|COMPLETED|Dose Level 2||0||
59773467|NCT00790842|75893909|FG006|COMPLETED|Dose Level 2||0||
59773468|NCT00790842|75893910|FG007|COMPLETED|Dose Level 2||0||
59773469|NCT00790842|75893911|FG008|COMPLETED|Dose Level 2||1||
59773470|NCT00790842|75893912|FG009|COMPLETED|Dose Level 2||0||
59773471|NCT00790842|75893913|FG010|COMPLETED|Dose Level 2||0||
59773472|NCT00790842|75893903|FG000|NOT COMPLETED|Dose Level 2||0||
59773473|NCT00790842|75893904|FG001|NOT COMPLETED|Dose Level 2||3||
59773474|NCT00790842|75893905|FG002|NOT COMPLETED|Dose Level 2||0||
59773475|NCT00790842|75893906|FG003|NOT COMPLETED|Dose Level 2||0||
59773476|NCT00790842|75893907|FG004|NOT COMPLETED|Dose Level 2||1||
59773477|NCT00790842|75893908|FG005|NOT COMPLETED|Dose Level 2||0||
59521856|NCT03826472|75616139|FG001|COMPLETED|Second Intervention (1-week)||5||
59521857|NCT03826472|75616138|FG000|NOT COMPLETED|Second Intervention (1-week)||0||
59521858|NCT03826472|75616139|FG001|NOT COMPLETED|Second Intervention (1-week)||0||
59773478|NCT00790842|75893909|FG006|NOT COMPLETED|Dose Level 2||0||
59773479|NCT00790842|75893910|FG007|NOT COMPLETED|Dose Level 2||0||
59773480|NCT00790842|75893911|FG008|NOT COMPLETED|Dose Level 2||2||
59773481|NCT00790842|75893912|FG009|NOT COMPLETED|Dose Level 2||0||
59773482|NCT00790842|75893913|FG010|NOT COMPLETED|Dose Level 2||0||
59773483|NCT00790842|75893903|FG000|STARTED|Dose Level 3||0||
59773484|NCT00790842|75893904|FG001|STARTED|Dose Level 3||0||
59773485|NCT00790842|75893905|FG002|STARTED|Dose Level 3||7||
59773486|NCT00790842|75893906|FG003|STARTED|Dose Level 3||0||
59773487|NCT00790842|75893907|FG004|STARTED|Dose Level 3||0||
59773488|NCT00790842|75893908|FG005|STARTED|Dose Level 3||3||
59773489|NCT00790842|75893909|FG006|STARTED|Dose Level 3||0||
59773490|NCT00790842|75893910|FG007|STARTED|Dose Level 3||0||
59773491|NCT00790842|75893911|FG008|STARTED|Dose Level 3||0||
59773492|NCT00790842|75893912|FG009|STARTED|Dose Level 3||3||
59773493|NCT00790842|75893913|FG010|STARTED|Dose Level 3||0||
59773494|NCT00790842|75893903|FG000|Began Treatment|Dose Level 3||0||
59773495|NCT00790842|75893904|FG001|Began Treatment|Dose Level 3||0||
59773496|NCT00790842|75893905|FG002|Began Treatment|Dose Level 3||6||
59773497|NCT00790842|75893906|FG003|Began Treatment|Dose Level 3||0||
59773498|NCT00790842|75893907|FG004|Began Treatment|Dose Level 3||0||
59773499|NCT00790842|75893908|FG005|Began Treatment|Dose Level 3||3||
59773500|NCT00790842|75893909|FG006|Began Treatment|Dose Level 3||0||
59773501|NCT00790842|75893910|FG007|Began Treatment|Dose Level 3||0||
59773502|NCT00790842|75893911|FG008|Began Treatment|Dose Level 3||0||
59773503|NCT00790842|75893912|FG009|Began Treatment|Dose Level 3||3||
59773504|NCT00790842|75893913|FG010|Began Treatment|Dose Level 3||0||
59773505|NCT00790842|75893903|FG000|COMPLETED|Dose Level 3||0||
59773506|NCT00790842|75893904|FG001|COMPLETED|Dose Level 3||0||
59773507|NCT00790842|75893905|FG002|COMPLETED|Dose Level 3||2||
59773508|NCT00790842|75893906|FG003|COMPLETED|Dose Level 3||0||
59773509|NCT00790842|75893907|FG004|COMPLETED|Dose Level 3||0||
59773510|NCT00790842|75893908|FG005|COMPLETED|Dose Level 3||2||
59773511|NCT00790842|75893909|FG006|COMPLETED|Dose Level 3||0||
59773512|NCT00790842|75893910|FG007|COMPLETED|Dose Level 3||0||
59773513|NCT00790842|75893911|FG008|COMPLETED|Dose Level 3||0||
59773514|NCT00790842|75893912|FG009|COMPLETED|Dose Level 3||1||
59773515|NCT00790842|75893913|FG010|COMPLETED|Dose Level 3||0||
59773516|NCT00790842|75893903|FG000|NOT COMPLETED|Dose Level 3||0||
59773517|NCT00790842|75893904|FG001|NOT COMPLETED|Dose Level 3||0||
59773518|NCT00790842|75893905|FG002|NOT COMPLETED|Dose Level 3||5||
59773519|NCT00790842|75893906|FG003|NOT COMPLETED|Dose Level 3||0||
59773520|NCT00790842|75893907|FG004|NOT COMPLETED|Dose Level 3||0||
59773521|NCT00790842|75893908|FG005|NOT COMPLETED|Dose Level 3||1||
59773522|NCT00790842|75893909|FG006|NOT COMPLETED|Dose Level 3||0||
59773523|NCT00790842|75893910|FG007|NOT COMPLETED|Dose Level 3||0||
60072695|NCT01594281|76187872|FG001|STARTED|Non-Interventional Follow Up Phase|5 patients exited after completing Core Phase and did not start the Follow-Up Phase|21|All patients signing an Informed Consent, including one patient who withdrew without documented data|
60072696|NCT01594281|76187873|FG002|STARTED|Non-Interventional Follow Up Phase|3 patients exited after completing Core Phase and did not start the Follow-Up Phase|25|All patients signing an Informed Consent, including one patient who withdrew without documented data|
59773524|NCT00790842|75893911|FG008|NOT COMPLETED|Dose Level 3||0||
60103566|NCT01342666|76221800|FG001|NOT COMPLETED|Overall Study||0||
59773525|NCT00790842|75893912|FG009|NOT COMPLETED|Dose Level 3||2||
59773526|NCT00790842|75893913|FG010|NOT COMPLETED|Dose Level 3||0||
59773527|NCT00790842|75893903|FG000|STARTED|Dose Level 4||0||
59773528|NCT00790842|75893904|FG001|STARTED|Dose Level 4||0||
59773529|NCT00790842|75893905|FG002|STARTED|Dose Level 4||0||
59773530|NCT00790842|75893906|FG003|STARTED|Dose Level 4||0||
59773531|NCT00790842|75893907|FG004|STARTED|Dose Level 4||0||
59773532|NCT00790842|75893908|FG005|STARTED|Dose Level 4||0||
59773533|NCT00790842|75893909|FG006|STARTED|Dose Level 4||8||
59773534|NCT00790842|75893910|FG007|STARTED|Dose Level 4||0||
59773535|NCT00790842|75893911|FG008|STARTED|Dose Level 4||0||
59773536|NCT00790842|75893912|FG009|STARTED|Dose Level 4||0||
59773537|NCT00790842|75893913|FG010|STARTED|Dose Level 4||5||
59773538|NCT00790842|75893903|FG000|Began Treatment|Dose Level 4||0||
59773539|NCT00790842|75893904|FG001|Began Treatment|Dose Level 4||0||
59773540|NCT00790842|75893905|FG002|Began Treatment|Dose Level 4||0||
59773541|NCT00790842|75893906|FG003|Began Treatment|Dose Level 4||0||
59773542|NCT00790842|75893907|FG004|Began Treatment|Dose Level 4||0||
59773543|NCT00790842|75893908|FG005|Began Treatment|Dose Level 4||0||
59773544|NCT00790842|75893909|FG006|Began Treatment|Dose Level 4||8||
59773545|NCT00790842|75893910|FG007|Began Treatment|Dose Level 4||0||
59773546|NCT00790842|75893911|FG008|Began Treatment|Dose Level 4||0||
59773547|NCT00790842|75893912|FG009|Began Treatment|Dose Level 4||0||
59773548|NCT00790842|75893913|FG010|Began Treatment|Dose Level 4||5||
59773549|NCT00790842|75893903|FG000|COMPLETED|Dose Level 4||0||
59773550|NCT00790842|75893904|FG001|COMPLETED|Dose Level 4||0||
59773551|NCT00790842|75893905|FG002|COMPLETED|Dose Level 4||0||
59773552|NCT00790842|75893906|FG003|COMPLETED|Dose Level 4||0||
59773553|NCT00790842|75893907|FG004|COMPLETED|Dose Level 4||0||
59773554|NCT00790842|75893908|FG005|COMPLETED|Dose Level 4||0||
59773555|NCT00790842|75893909|FG006|COMPLETED|Dose Level 4||6||
59773556|NCT00790842|75893910|FG007|COMPLETED|Dose Level 4||0||
59773557|NCT00790842|75893911|FG008|COMPLETED|Dose Level 4||0||
59773558|NCT00790842|75893912|FG009|COMPLETED|Dose Level 4||0||
59773559|NCT00790842|75893913|FG010|COMPLETED|Dose Level 4||3||
59773560|NCT00790842|75893903|FG000|NOT COMPLETED|Dose Level 4||0||
59773561|NCT00790842|75893904|FG001|NOT COMPLETED|Dose Level 4||0||
59773562|NCT00790842|75893905|FG002|NOT COMPLETED|Dose Level 4||0||
59773563|NCT00790842|75893906|FG003|NOT COMPLETED|Dose Level 4||0||
59773564|NCT00790842|75893907|FG004|NOT COMPLETED|Dose Level 4||0||
59773565|NCT00790842|75893908|FG005|NOT COMPLETED|Dose Level 4||0||
59773566|NCT00790842|75893909|FG006|NOT COMPLETED|Dose Level 4||2||
59773567|NCT00790842|75893910|FG007|NOT COMPLETED|Dose Level 4||0||
59773568|NCT00790842|75893911|FG008|NOT COMPLETED|Dose Level 4||0||
59773569|NCT00790842|75893912|FG009|NOT COMPLETED|Dose Level 4||0||
59773570|NCT00790842|75893913|FG010|NOT COMPLETED|Dose Level 4||2||
59773571|NCT00790842|75893903|FG000|STARTED|Expansion Cohort||0||
59773572|NCT00790842|75893904|FG001|STARTED|Expansion Cohort||0||
59773573|NCT00790842|75893905|FG002|STARTED|Expansion Cohort||14||
59773574|NCT00790842|75893906|FG003|STARTED|Expansion Cohort||0||
59773575|NCT00790842|75893907|FG004|STARTED|Expansion Cohort||0||
59773576|NCT00790842|75893908|FG005|STARTED|Expansion Cohort||0||
59773577|NCT00790842|75893909|FG006|STARTED|Expansion Cohort||2||
59773578|NCT00790842|75893910|FG007|STARTED|Expansion Cohort||0||
59773579|NCT00790842|75893911|FG008|STARTED|Expansion Cohort||0||
59773580|NCT00790842|75893912|FG009|STARTED|Expansion Cohort||0||
59773581|NCT00790842|75893913|FG010|STARTED|Expansion Cohort||0||
59773582|NCT00790842|75893903|FG000|Began Treatment|Expansion Cohort||0||
59773583|NCT00790842|75893904|FG001|Began Treatment|Expansion Cohort||0||
59773584|NCT00790842|75893905|FG002|Began Treatment|Expansion Cohort||14||
59773585|NCT00790842|75893906|FG003|Began Treatment|Expansion Cohort||0||
59773586|NCT00790842|75893907|FG004|Began Treatment|Expansion Cohort||0||
59773587|NCT00790842|75893908|FG005|Began Treatment|Expansion Cohort||0||
59773588|NCT00790842|75893909|FG006|Began Treatment|Expansion Cohort||2||
59773589|NCT00790842|75893910|FG007|Began Treatment|Expansion Cohort||0||
59773590|NCT00790842|75893911|FG008|Began Treatment|Expansion Cohort||0||
59773591|NCT00790842|75893912|FG009|Began Treatment|Expansion Cohort||0||
59773592|NCT00790842|75893913|FG010|Began Treatment|Expansion Cohort||0||
59773593|NCT00790842|75893903|FG000|COMPLETED|Expansion Cohort||0||
59773594|NCT00790842|75893904|FG001|COMPLETED|Expansion Cohort||0||
59773595|NCT00790842|75893905|FG002|COMPLETED|Expansion Cohort||7||
59773596|NCT00790842|75893906|FG003|COMPLETED|Expansion Cohort||0||
59773597|NCT00790842|75893907|FG004|COMPLETED|Expansion Cohort||0||
59773598|NCT00790842|75893908|FG005|COMPLETED|Expansion Cohort||0||
59773599|NCT00790842|75893909|FG006|COMPLETED|Expansion Cohort||1||
59773600|NCT00790842|75893910|FG007|COMPLETED|Expansion Cohort||0||
59773601|NCT00790842|75893911|FG008|COMPLETED|Expansion Cohort||0||
59773602|NCT00790842|75893912|FG009|COMPLETED|Expansion Cohort||0||
59773603|NCT00790842|75893913|FG010|COMPLETED|Expansion Cohort||0||
59773604|NCT00790842|75893903|FG000|NOT COMPLETED|Expansion Cohort||0||
59773605|NCT00790842|75893904|FG001|NOT COMPLETED|Expansion Cohort||0||
59773606|NCT00790842|75893905|FG002|NOT COMPLETED|Expansion Cohort||7||
59773607|NCT00790842|75893906|FG003|NOT COMPLETED|Expansion Cohort||0||
59773608|NCT00790842|75893907|FG004|NOT COMPLETED|Expansion Cohort||0||
59773609|NCT00790842|75893908|FG005|NOT COMPLETED|Expansion Cohort||0||
59773610|NCT00790842|75893909|FG006|NOT COMPLETED|Expansion Cohort||1||
59773611|NCT00790842|75893910|FG007|NOT COMPLETED|Expansion Cohort||0||
59773612|NCT00790842|75893911|FG008|NOT COMPLETED|Expansion Cohort||0||
59773613|NCT00790842|75893912|FG009|NOT COMPLETED|Expansion Cohort||0||
59773614|NCT00790842|75893913|FG010|NOT COMPLETED|Expansion Cohort||0||
59773615|NCT00574288|75893968|FG000|STARTED|Overall Study||20||
59773616|NCT00574288|75893969|FG001|STARTED|Overall Study||3||
59773617|NCT00574288|75893970|FG002|STARTED|Overall Study||3||
59773618|NCT00574288|75893971|FG003|STARTED|Overall Study||3||
59773619|NCT00574288|75893972|FG004|STARTED|Overall Study||3||
59773620|NCT00574288|75893973|FG005|STARTED|Overall Study||30||
59773621|NCT00574288|75893974|FG006|STARTED|Overall Study||42||
59773622|NCT00574288|75893968|FG000|COMPLETED|Overall Study||0||
59773623|NCT00574288|75893969|FG001|COMPLETED|Overall Study||0||
59773624|NCT00574288|75893970|FG002|COMPLETED|Overall Study||0||
59773625|NCT00574288|75893971|FG003|COMPLETED|Overall Study||1||
59773626|NCT00574288|75893972|FG004|COMPLETED|Overall Study||1||
59773627|NCT00574288|75893973|FG005|COMPLETED|Overall Study||4||
59773628|NCT00574288|75893974|FG006|COMPLETED|Overall Study||14||
59773629|NCT00574288|75893968|FG000|NOT COMPLETED|Overall Study||20||
59773630|NCT00574288|75893969|FG001|NOT COMPLETED|Overall Study||3||
59773631|NCT00574288|75893970|FG002|NOT COMPLETED|Overall Study||3||
59773632|NCT00574288|75893971|FG003|NOT COMPLETED|Overall Study||2||
59773633|NCT00574288|75893972|FG004|NOT COMPLETED|Overall Study||2||
59773634|NCT00574288|75893973|FG005|NOT COMPLETED|Overall Study||26||
59773635|NCT00574288|75893974|FG006|NOT COMPLETED|Overall Study||28||
59773636|NCT00790452|75894002|FG000|STARTED|Overall Study||1||
59773637|NCT00790452|75894003|FG001|STARTED|Overall Study||0||
59773638|NCT00790452|75894002|FG000|COMPLETED|Overall Study||0||
59773639|NCT00790452|75894003|FG001|COMPLETED|Overall Study||0||
59773640|NCT00790452|75894002|FG000|NOT COMPLETED|Overall Study||1||
59773641|NCT00790452|75894003|FG001|NOT COMPLETED|Overall Study||0||
59773642|NCT00626392|75894015|FG000|STARTED|Run-in Period||45||
59773643|NCT00626392|75894016|FG001|STARTED|Run-in Period||44||
59773644|NCT00626392|75894017|FG002|STARTED|Run-in Period||44||
59773645|NCT00626392|75894018|FG003|STARTED|Run-in Period||44||
59773646|NCT00626392|75894019|FG004|STARTED|Run-in Period||45||
59773647|NCT00626392|75894020|FG005|STARTED|Run-in Period||45||
59773648|NCT00626392|75894015|FG000|COMPLETED|Run-in Period||44||
59773649|NCT00626392|75894016|FG001|COMPLETED|Run-in Period||43||
59773650|NCT00626392|75894017|FG002|COMPLETED|Run-in Period||41||
59773651|NCT00626392|75894018|FG003|COMPLETED|Run-in Period||43||
59773652|NCT00626392|75894019|FG004|COMPLETED|Run-in Period||41||
59773653|NCT00626392|75894020|FG005|COMPLETED|Run-in Period||44||
59773654|NCT00626392|75894015|FG000|NOT COMPLETED|Run-in Period||1||
59773655|NCT00626392|75894016|FG001|NOT COMPLETED|Run-in Period||1||
59773656|NCT00626392|75894017|FG002|NOT COMPLETED|Run-in Period||3||
59773657|NCT00626392|75894018|FG003|NOT COMPLETED|Run-in Period||1||
59773658|NCT00626392|75894019|FG004|NOT COMPLETED|Run-in Period||4||
59773659|NCT00626392|75894020|FG005|NOT COMPLETED|Run-in Period||1||
59773660|NCT00626392|75894015|FG000|STARTED|Coadministration Period||44||
59773661|NCT00626392|75894016|FG001|STARTED|Coadministration Period||43||
59773662|NCT00626392|75894017|FG002|STARTED|Coadministration Period||41||
59773663|NCT00626392|75894018|FG003|STARTED|Coadministration Period||43||
59773664|NCT00626392|75894019|FG004|STARTED|Coadministration Period||41||
59773665|NCT00626392|75894020|FG005|STARTED|Coadministration Period||44||
59773666|NCT00626392|75894015|FG000|COMPLETED|Coadministration Period||40||
59773667|NCT00626392|75894016|FG001|COMPLETED|Coadministration Period||38||
59773668|NCT00626392|75894017|FG002|COMPLETED|Coadministration Period||31||
59773669|NCT00626392|75894018|FG003|COMPLETED|Coadministration Period||36||
59773670|NCT00626392|75894019|FG004|COMPLETED|Coadministration Period||36||
59773671|NCT00626392|75894020|FG005|COMPLETED|Coadministration Period||38||
59773672|NCT00626392|75894015|FG000|NOT COMPLETED|Coadministration Period||4||
59773673|NCT00626392|75894016|FG001|NOT COMPLETED|Coadministration Period||5||
59773674|NCT00626392|75894017|FG002|NOT COMPLETED|Coadministration Period||10||
59773675|NCT00626392|75894018|FG003|NOT COMPLETED|Coadministration Period||7||
59773676|NCT00626392|75894019|FG004|NOT COMPLETED|Coadministration Period||5||
59773677|NCT00626392|75894020|FG005|NOT COMPLETED|Coadministration Period||6||
59773678|NCT00624286|75894028|FG000|STARTED|Overall Study||211||
59773679|NCT00624286|75894029|FG001|STARTED|Overall Study||205||
59773680|NCT00624286|75894028|FG000|COMPLETED|Overall Study||186||
59773681|NCT00624286|75894029|FG001|COMPLETED|Overall Study||178||
59773682|NCT00624286|75894028|FG000|NOT COMPLETED|Overall Study||25||
59773683|NCT00624286|75894029|FG001|NOT COMPLETED|Overall Study||27||
59773684|NCT00624052|75894039|FG000|STARTED|Overall Study||219||
59773685|NCT00624052|75894040|FG001|STARTED|Overall Study||436||
59773686|NCT00624052|75894041|FG002|STARTED|Overall Study||91||
59773687|NCT00624052|75894042|FG003|STARTED|Overall Study||92||
59773688|NCT00624052|75894039|FG000|COMPLETED|Overall Study||204||
59773689|NCT00624052|75894040|FG001|COMPLETED|Overall Study||422||
59773690|NCT00624052|75894041|FG002|COMPLETED|Overall Study||88||
59773691|NCT00624052|75894042|FG003|COMPLETED|Overall Study||88||
59773692|NCT00624052|75894039|FG000|NOT COMPLETED|Overall Study||15||
59773693|NCT00624052|75894040|FG001|NOT COMPLETED|Overall Study||14||
59773694|NCT00624052|75894041|FG002|NOT COMPLETED|Overall Study||3||
59773695|NCT00624052|75894042|FG003|NOT COMPLETED|Overall Study||4||
59773696|NCT00785577|75894061|FG000|STARTED|Study Period 2: Therapy Phase||89||
59773697|NCT00785577|75894062|FG001|STARTED|Study Period 2: Therapy Phase||45||
59773698|NCT00785577|75894063|FG002|STARTED|Study Period 2: Therapy Phase||43||
59773699|NCT00785577|75894064|FG003|STARTED|Study Period 2: Therapy Phase||49||
59773700|NCT00785577|75894065|FG004|STARTED|Study Period 2: Therapy Phase||47||
59773701|NCT00785577|75894061|FG000|COMPLETED|Study Period 2: Therapy Phase||78||
59773702|NCT00785577|75894062|FG001|COMPLETED|Study Period 2: Therapy Phase||36||
59773703|NCT00785577|75894063|FG002|COMPLETED|Study Period 2: Therapy Phase||25||
59773704|NCT00785577|75894064|FG003|COMPLETED|Study Period 2: Therapy Phase||36||
59773705|NCT00785577|75894065|FG004|COMPLETED|Study Period 2: Therapy Phase||27||
59773706|NCT00785577|75894061|FG000|NOT COMPLETED|Study Period 2: Therapy Phase||11||
59773707|NCT00785577|75894062|FG001|NOT COMPLETED|Study Period 2: Therapy Phase||9||
59773708|NCT00785577|75894063|FG002|NOT COMPLETED|Study Period 2: Therapy Phase||18||
59773709|NCT00785577|75894064|FG003|NOT COMPLETED|Study Period 2: Therapy Phase||13||
59773710|NCT00785577|75894065|FG004|NOT COMPLETED|Study Period 2: Therapy Phase||20||
59773711|NCT00785577|75894061|FG000|STARTED|Study Period 3: 1-Week Washout Phase||78||
59773712|NCT00785577|75894062|FG001|STARTED|Study Period 3: 1-Week Washout Phase||36||
59773713|NCT00785577|75894063|FG002|STARTED|Study Period 3: 1-Week Washout Phase||25||
59773714|NCT00785577|75894064|FG003|STARTED|Study Period 3: 1-Week Washout Phase||36||
59773715|NCT00785577|75894065|FG004|STARTED|Study Period 3: 1-Week Washout Phase||27||
59773716|NCT00785577|75894061|FG000|COMPLETED|Study Period 3: 1-Week Washout Phase||78||
59773717|NCT00785577|75894062|FG001|COMPLETED|Study Period 3: 1-Week Washout Phase||36||
59773718|NCT00785577|75894063|FG002|COMPLETED|Study Period 3: 1-Week Washout Phase||25||
59773719|NCT00785577|75894064|FG003|COMPLETED|Study Period 3: 1-Week Washout Phase||35||
59773720|NCT00785577|75894065|FG004|COMPLETED|Study Period 3: 1-Week Washout Phase||26||
59773721|NCT00785577|75894061|FG000|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||0||
59773722|NCT00785577|75894062|FG001|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||0||
59773723|NCT00785577|75894063|FG002|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||0||
59773724|NCT00785577|75894064|FG003|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||1||
59773725|NCT00785577|75894065|FG004|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||1||
59773726|NCT00789828|75894089|FG000|STARTED|Core Period (48 Weeks)||78||
59773727|NCT00789828|75894090|FG001|STARTED|Core Period (48 Weeks)||39||
59773728|NCT00789828|75894089|FG000|COMPLETED|Core Period (48 Weeks)||78||
59773729|NCT00789828|75894090|FG001|COMPLETED|Core Period (48 Weeks)||33||
59773730|NCT00789828|75894089|FG000|NOT COMPLETED|Core Period (48 Weeks)||0||
59773731|NCT00789828|75894090|FG001|NOT COMPLETED|Core Period (48 Weeks)||6||
59773732|NCT00789828|75894089|FG000|STARTED|Open-label Extension Period (4 Years)|Of 117 participants only 111 completed the core period and continued in the extension period|111||
59773733|NCT00789828|75894090|FG001|STARTED|Open-label Extension Period (4 Years)|No participant received placebo.|0||
59773734|NCT00789828|75894089|FG000|COMPLETED|Open-label Extension Period (4 Years)||82||
59773735|NCT00789828|75894090|FG001|COMPLETED|Open-label Extension Period (4 Years)||0||
59773736|NCT00789828|75894089|FG000|NOT COMPLETED|Open-label Extension Period (4 Years)||29||
59773737|NCT00789828|75894090|FG001|NOT COMPLETED|Open-label Extension Period (4 Years)||0||
59773738|NCT00790296|75894101|FG000|STARTED|Overall Study||5||
59773739|NCT00790296|75894102|FG001|STARTED|Overall Study||6||
59773740|NCT00790296|75894101|FG000|COMPLETED|Overall Study||4||
59773741|NCT00790296|75894102|FG001|COMPLETED|Overall Study||4||
59773742|NCT00790296|75894101|FG000|NOT COMPLETED|Overall Study||1||
59773743|NCT00790296|75894102|FG001|NOT COMPLETED|Overall Study||2||
59773744|NCT00623194|75894108|FG000|STARTED|Overall Study||146||
59773745|NCT00623194|75894108|FG000|COMPLETED|Overall Study||141||
59773746|NCT00623194|75894108|FG000|NOT COMPLETED|Overall Study||5||
59773747|NCT00784368|75894115|FG000|STARTED|Overall Study||16||
59773748|NCT00784368|75894116|FG001|STARTED|Overall Study||16||
59773749|NCT00784368|75894117|FG002|STARTED|Overall Study||23||
59773750|NCT00784368|75894115|FG000|COMPLETED|Overall Study||8||
59773751|NCT00784368|75894116|FG001|COMPLETED|Overall Study||5||
59773752|NCT00784368|75894117|FG002|COMPLETED|Overall Study||12||
59773753|NCT00784368|75894115|FG000|NOT COMPLETED|Overall Study||8||
59773754|NCT00784368|75894116|FG001|NOT COMPLETED|Overall Study||11||
59773755|NCT00784368|75894117|FG002|NOT COMPLETED|Overall Study||11||
59773756|NCT00622726|75894130|FG000|STARTED|March, 2008 to August, 2010||75||
59773757|NCT00622726|75894131|FG001|STARTED|March, 2008 to August, 2010||75||
59773758|NCT00622726|75894130|FG000|COMPLETED|March, 2008 to August, 2010|All infants were extremely immature with multiple neonatal intensive care unit complications.|70||
59773759|NCT00622726|75894131|FG001|COMPLETED|March, 2008 to August, 2010|All infants were extremely immature with multiple neonatal intensive care unit complications.|73||
59773760|NCT00622726|75894130|FG000|NOT COMPLETED|March, 2008 to August, 2010||5||
59773761|NCT00622726|75894131|FG001|NOT COMPLETED|March, 2008 to August, 2010||2||
59773762|NCT00622726|75894130|FG000|STARTED|August, 2010 to April, 2013||70||
59773763|NCT00622726|75894131|FG001|STARTED|August, 2010 to April, 2013||73||
59773764|NCT00622726|75894130|FG000|COMPLETED|August, 2010 to April, 2013||69||
59773765|NCT00622726|75894131|FG001|COMPLETED|August, 2010 to April, 2013||68||
59773766|NCT00622726|75894130|FG000|NOT COMPLETED|August, 2010 to April, 2013||1||
59773767|NCT00622726|75894131|FG001|NOT COMPLETED|August, 2010 to April, 2013||5||
59773768|NCT00623428|75894143|FG000|STARTED|Treatment Period||95||
59773769|NCT00623428|75894144|FG001|STARTED|Treatment Period||93||
59773770|NCT00623428|75894143|FG000|COMPLETED|Treatment Period|Patients who completed 24 weeks of treatment|95||
59773771|NCT00623428|75894144|FG001|COMPLETED|Treatment Period|Patients who completed 48 weeks of treatment|66||
59952772|NCT02476851|76071553|FG000|STARTED|Overall Study||31||
59773772|NCT00623428|75894143|FG000|NOT COMPLETED|Treatment Period||0||
59773773|NCT00623428|75894144|FG001|NOT COMPLETED|Treatment Period||27||
59952773|NCT02476851|76071554|FG001|STARTED|Overall Study||31||
59952774|NCT02476851|76071553|FG000|COMPLETED|Overall Study||30||
59952775|NCT02476851|76071554|FG001|COMPLETED|Overall Study||30||
59773774|NCT00623428|75894143|FG000|STARTED|Follow-up Period||95||
59773775|NCT00623428|75894144|FG001|STARTED|Follow-up Period||93||
59773776|NCT00623428|75894143|FG000|COMPLETED|Follow-up Period|Patients who had an HCV RNA sample at 48 weeks of follow-up|66||
59773777|NCT00623428|75894144|FG001|COMPLETED|Follow-up Period|Patients who had an HCV RNA sample at 24 weeks of follow-up|78||
59773778|NCT00623428|75894143|FG000|NOT COMPLETED|Follow-up Period||29||
59773779|NCT00623428|75894144|FG001|NOT COMPLETED|Follow-up Period||15||
59773780|NCT00784134|75894152|FG000|STARTED|Overall Study||249||
59773781|NCT00784134|75894153|FG001|STARTED|Overall Study||251||
59773782|NCT00784134|75894152|FG000|COMPLETED|Overall Study||246||
59773783|NCT00784134|75894153|FG001|COMPLETED|Overall Study||245||
59773784|NCT00784134|75894152|FG000|NOT COMPLETED|Overall Study||3||
59773785|NCT00784134|75894153|FG001|NOT COMPLETED|Overall Study||6||
59773786|NCT00776100|75894161|FG000|STARTED|Overall Study||1||
59773787|NCT00776100|75894162|FG001|STARTED|Overall Study||1||
59773788|NCT00776100|75894161|FG000|COMPLETED|Overall Study||0||
59773789|NCT00776100|75894162|FG001|COMPLETED|Overall Study||1||
59773790|NCT00776100|75894161|FG000|NOT COMPLETED|Overall Study||1||
59773791|NCT00776100|75894162|FG001|NOT COMPLETED|Overall Study||0||
59773792|NCT00783432|75894170|FG000|STARTED|Overall Study|This includes 2 subjects that received a randomization number but did not receive study drug|430||
59773793|NCT00783432|75894171|FG001|STARTED|Overall Study|This includes 2 subjects that received a randomization number but did not receive study drug|432||
59773794|NCT00783432|75894170|FG000|COMPLETED|Overall Study||345||
59773795|NCT00783432|75894171|FG001|COMPLETED|Overall Study||354||
59773796|NCT00783432|75894170|FG000|NOT COMPLETED|Overall Study||85||
59773797|NCT00783432|75894171|FG001|NOT COMPLETED|Overall Study||78||
59773798|NCT00783198|75894180|FG000|STARTED|Overall Study||190||
59773799|NCT00783198|75894181|FG001|STARTED|Overall Study||187||
59773800|NCT00783198|75894182|FG002|STARTED|Overall Study||188||
59773801|NCT00783198|75894180|FG000|COMPLETED|Overall Study||133||
59773802|NCT00783198|75894181|FG001|COMPLETED|Overall Study||144||
59773803|NCT00783198|75894182|FG002|COMPLETED|Overall Study||146||
59773804|NCT00783198|75894180|FG000|NOT COMPLETED|Overall Study||57||
59773805|NCT00783198|75894181|FG001|NOT COMPLETED|Overall Study||43||
59773806|NCT00783198|75894182|FG002|NOT COMPLETED|Overall Study||42||
59773807|NCT00789360|75894192|FG000|STARTED|Overall Study||15||
59773808|NCT00789360|75894193|FG001|STARTED|Overall Study||15||
59773809|NCT00789360|75894192|FG000|COMPLETED|Overall Study||12||
59773810|NCT00789360|75894193|FG001|COMPLETED|Overall Study||14||
59773811|NCT00789360|75894192|FG000|NOT COMPLETED|Overall Study||3||
59773812|NCT00789360|75894193|FG001|NOT COMPLETED|Overall Study||1||
59773813|NCT00782496|75894202|FG000|STARTED|Overall Study||106||
59521859|NCT02338076|75616147|FG000|STARTED|Overall Study||20||
59521860|NCT02338076|75616147|FG000|COMPLETED|Overall Study||20||
59521861|NCT02338076|75616147|FG000|NOT COMPLETED|Overall Study||0||
59521862|NCT01222117|75616164|FG000|STARTED|Overall Study||20||
59521863|NCT01222117|75616165|FG001|STARTED|Overall Study||20||
59521864|NCT01222117|75616166|FG002|STARTED|Overall Study||22||
59521865|NCT01222117|75616167|FG003|STARTED|Overall Study||20||
59521866|NCT01222117|75616168|FG004|STARTED|Overall Study||9||
59521867|NCT01222117|75616169|FG005|STARTED|Overall Study||10||
59521868|NCT01222117|75616170|FG006|STARTED|Overall Study||13||
59521869|NCT01222117|75616171|FG007|STARTED|Overall Study||12||
59773814|NCT00782496|75894203|FG001|STARTED|Overall Study||105||
59773815|NCT00782496|75894202|FG000|COMPLETED|Overall Study||92||
59773816|NCT00782496|75894203|FG001|COMPLETED|Overall Study||90||
59773817|NCT00782496|75894202|FG000|NOT COMPLETED|Overall Study||14||
59773818|NCT00782496|75894203|FG001|NOT COMPLETED|Overall Study||15||
59773819|NCT00782418|75894210|FG000|STARTED|Period 1 Procedure/Treatment Groups||3||
59773820|NCT00782418|75894211|FG001|STARTED|Period 1 Procedure/Treatment Groups||4||
59773821|NCT00782418|75894212|FG002|STARTED|Period 1 Procedure/Treatment Groups||4||
59773822|NCT00782418|75894213|FG003|STARTED|Period 1 Procedure/Treatment Groups||2||
59773823|NCT00782418|75894214|FG004|STARTED|Period 1 Procedure/Treatment Groups||5||
59773824|NCT00782418|75894215|FG005|STARTED|Period 1 Procedure/Treatment Groups||5||
59773825|NCT00782418|75894216|FG006|STARTED|Period 1 Procedure/Treatment Groups||4||
59773826|NCT00782418|75894210|FG000|COMPLETED|Period 1 Procedure/Treatment Groups||1||
59521870|NCT01222117|75616172|FG008|STARTED|Overall Study||23||
59521871|NCT01222117|75616173|FG009|STARTED|Overall Study||19||
59521872|NCT01222117|75616174|FG010|STARTED|Overall Study||6||
59521873|NCT01222117|75616164|FG000|COMPLETED|Overall Study||17||
59521874|NCT01222117|75616165|FG001|COMPLETED|Overall Study||19||
59773827|NCT00782418|75894211|FG001|COMPLETED|Period 1 Procedure/Treatment Groups||4||
59521875|NCT01222117|75616166|FG002|COMPLETED|Overall Study||22||
59521876|NCT01222117|75616167|FG003|COMPLETED|Overall Study||19||
59521877|NCT01222117|75616168|FG004|COMPLETED|Overall Study||8||
59521878|NCT01222117|75616169|FG005|COMPLETED|Overall Study||9||
59773828|NCT00782418|75894212|FG002|COMPLETED|Period 1 Procedure/Treatment Groups||4||
59773829|NCT00782418|75894213|FG003|COMPLETED|Period 1 Procedure/Treatment Groups||2||
59773830|NCT00782418|75894214|FG004|COMPLETED|Period 1 Procedure/Treatment Groups||4||
59773831|NCT00782418|75894215|FG005|COMPLETED|Period 1 Procedure/Treatment Groups||4||
59521879|NCT01222117|75616170|FG006|COMPLETED|Overall Study||13||
59521880|NCT01222117|75616171|FG007|COMPLETED|Overall Study||12||
59773832|NCT00782418|75894216|FG006|COMPLETED|Period 1 Procedure/Treatment Groups||4||
59773833|NCT00782418|75894210|FG000|NOT COMPLETED|Period 1 Procedure/Treatment Groups||2||
59773834|NCT00782418|75894211|FG001|NOT COMPLETED|Period 1 Procedure/Treatment Groups||0||
59773835|NCT00782418|75894212|FG002|NOT COMPLETED|Period 1 Procedure/Treatment Groups||0||
59773836|NCT00782418|75894213|FG003|NOT COMPLETED|Period 1 Procedure/Treatment Groups||0||
59773837|NCT00782418|75894214|FG004|NOT COMPLETED|Period 1 Procedure/Treatment Groups||1||
59773838|NCT00782418|75894215|FG005|NOT COMPLETED|Period 1 Procedure/Treatment Groups||1||
59773839|NCT00782418|75894216|FG006|NOT COMPLETED|Period 1 Procedure/Treatment Groups||0||
59773840|NCT00782418|75894210|FG000|STARTED|Period 2 Procedure/Treatment Groups||3||
59773841|NCT00782418|75894211|FG001|STARTED|Period 2 Procedure/Treatment Groups||4||
59773842|NCT00782418|75894212|FG002|STARTED|Period 2 Procedure/Treatment Groups||4||
59773843|NCT00782418|75894213|FG003|STARTED|Period 2 Procedure/Treatment Groups||1||
59773844|NCT00782418|75894214|FG004|STARTED|Period 2 Procedure/Treatment Groups||3||
59773845|NCT00782418|75894215|FG005|STARTED|Period 2 Procedure/Treatment Groups||4||
59773846|NCT00782418|75894216|FG006|STARTED|Period 2 Procedure/Treatment Groups||4||
59773847|NCT00782418|75894210|FG000|COMPLETED|Period 2 Procedure/Treatment Groups||3||
59773848|NCT00782418|75894211|FG001|COMPLETED|Period 2 Procedure/Treatment Groups||4||
59773849|NCT00782418|75894212|FG002|COMPLETED|Period 2 Procedure/Treatment Groups||4||
59773850|NCT00782418|75894213|FG003|COMPLETED|Period 2 Procedure/Treatment Groups||1||
59773851|NCT00782418|75894214|FG004|COMPLETED|Period 2 Procedure/Treatment Groups||3||
59773852|NCT00782418|75894215|FG005|COMPLETED|Period 2 Procedure/Treatment Groups||4||
59773853|NCT00782418|75894216|FG006|COMPLETED|Period 2 Procedure/Treatment Groups||4||
59773854|NCT00782418|75894210|FG000|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0||
59773855|NCT00782418|75894211|FG001|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0||
59773856|NCT00782418|75894212|FG002|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0||
59773857|NCT00782418|75894213|FG003|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0||
59773858|NCT00782418|75894214|FG004|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0||
59773859|NCT00782418|75894215|FG005|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0||
59773860|NCT00782418|75894216|FG006|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0||
59773861|NCT00782340|75894233|FG000|STARTED|Open Label Titration||263||
59773862|NCT00782340|75894234|FG001|STARTED|Open Label Titration||0||
59773863|NCT00782340|75894235|FG002|STARTED|Open Label Titration||0||
59773864|NCT00782340|75894233|FG000|COMPLETED|Open Label Titration||162||
59773865|NCT00782340|75894234|FG001|COMPLETED|Open Label Titration||0||
59773866|NCT00782340|75894235|FG002|COMPLETED|Open Label Titration||0||
59773867|NCT00782340|75894233|FG000|NOT COMPLETED|Open Label Titration||101||
59773868|NCT00782340|75894234|FG001|NOT COMPLETED|Open Label Titration||0||
59773869|NCT00782340|75894235|FG002|NOT COMPLETED|Open Label Titration||0||
59773870|NCT00782340|75894233|FG000|STARTED|Randomized Double Blind||0||
59773871|NCT00782340|75894234|FG001|STARTED|Randomized Double Blind||82||
59773872|NCT00782340|75894235|FG002|STARTED|Randomized Double Blind||80||
59773873|NCT00782340|75894233|FG000|COMPLETED|Randomized Double Blind||0||
59773874|NCT00782340|75894234|FG001|COMPLETED|Randomized Double Blind||82||
59773875|NCT00782340|75894235|FG002|COMPLETED|Randomized Double Blind||80||
59773876|NCT00782340|75894233|FG000|NOT COMPLETED|Randomized Double Blind||0||
59773877|NCT00782340|75894234|FG001|NOT COMPLETED|Randomized Double Blind||0||
59773878|NCT00782340|75894235|FG002|NOT COMPLETED|Randomized Double Blind||0||
59773879|NCT00774852|75894244|FG000|STARTED|Overall Study||69||
59773880|NCT00774852|75894245|FG001|STARTED|Overall Study||68||
59773881|NCT00774852|75894244|FG000|COMPLETED|Overall Study||24||
59773882|NCT00774852|75894245|FG001|COMPLETED|Overall Study||27||
59773883|NCT00774852|75894244|FG000|NOT COMPLETED|Overall Study||45||
59773884|NCT00774852|75894245|FG001|NOT COMPLETED|Overall Study||41||
59773885|NCT00774306|75894265|FG000|STARTED|Overall Study||24||
59773886|NCT00774306|75894266|FG001|STARTED|Overall Study||5||
59773887|NCT00774306|75894267|FG002|STARTED|Overall Study||16||
59773888|NCT00774306|75894268|FG003|STARTED|Overall Study||7||
59773889|NCT00774306|75894265|FG000|COMPLETED|Overall Study||6||
59773890|NCT00774306|75894266|FG001|COMPLETED|Overall Study||3||
59773891|NCT00774306|75894267|FG002|COMPLETED|Overall Study||8||
59773892|NCT00774306|75894268|FG003|COMPLETED|Overall Study||2||
59773893|NCT00774306|75894265|FG000|NOT COMPLETED|Overall Study||18||
59773894|NCT00774306|75894266|FG001|NOT COMPLETED|Overall Study||2||
59773895|NCT00774306|75894267|FG002|NOT COMPLETED|Overall Study||8||
59773896|NCT00774306|75894268|FG003|NOT COMPLETED|Overall Study||5||
59773897|NCT00781326|75894278|FG000|STARTED|Phase I|Nine subjects consented; 3 did not meet eligibility criteria. 6 started antidepressant treatment.|6||
59773898|NCT00781326|75894278|FG000|COMPLETED|Phase I||2||
59773899|NCT00781326|75894278|FG000|NOT COMPLETED|Phase I||4||
59773900|NCT00781326|75894278|FG000|STARTED|Phase 2|Study terminated prior to enrollment into Phase II|0||
59773901|NCT00781326|75894278|FG000|COMPLETED|Phase 2||0||
59773902|NCT00781326|75894278|FG000|NOT COMPLETED|Phase 2||0||
59773903|NCT00787800|75894284|FG000|STARTED|Overall Study||50||
59773904|NCT00787800|75894285|FG001|STARTED|Overall Study||50||
59773905|NCT00787800|75894284|FG000|COMPLETED|Overall Study||47||
59773906|NCT00787800|75894285|FG001|COMPLETED|Overall Study||43||
59773907|NCT00787800|75894284|FG000|NOT COMPLETED|Overall Study||3||
59773908|NCT00787800|75894285|FG001|NOT COMPLETED|Overall Study||7||
59773909|NCT00773838|75894292|FG000|STARTED|Overall Study||143||
59773910|NCT00773838|75894292|FG000|COMPLETED|Overall Study||0||
59773911|NCT00773838|75894292|FG000|NOT COMPLETED|Overall Study||143||
59773912|NCT00787644|75894298|FG000|STARTED|Overall Study||12||
59773913|NCT00787644|75894299|FG001|STARTED|Overall Study||11||
59773914|NCT00787644|75894298|FG000|COMPLETED|Overall Study||10||
59773915|NCT00787644|75894299|FG001|COMPLETED|Overall Study||9||
59773916|NCT00787644|75894298|FG000|NOT COMPLETED|Overall Study||2||
59773917|NCT00787644|75894299|FG001|NOT COMPLETED|Overall Study||2||
59773918|NCT00787566|75894308|FG000|STARTED|Overall Study||21||
60072697|NCT01594281|76187871|FG000|Follow Up Set (FUS)|Non-Interventional Follow Up Phase||28|All patients with documented data in the follow up phase|
60072698|NCT01594281|76187872|FG001|Follow Up Set (FUS)|Non-Interventional Follow Up Phase||20|All patients with documented data in the follow up phase|
60072699|NCT01594281|76187873|FG002|Follow Up Set (FUS)|Non-Interventional Follow Up Phase||25|All patients with documented data in the follow up phase|
60072700|NCT01594281|76187871|FG000|COMPLETED|Non-Interventional Follow Up Phase||25||
60072701|NCT01594281|76187872|FG001|COMPLETED|Non-Interventional Follow Up Phase||19||
60072702|NCT01594281|76187873|FG002|COMPLETED|Non-Interventional Follow Up Phase||23||
60072703|NCT01594281|76187871|FG000|NOT COMPLETED|Non-Interventional Follow Up Phase||3||
60072704|NCT01594281|76187872|FG001|NOT COMPLETED|Non-Interventional Follow Up Phase||2||
60072705|NCT01594281|76187873|FG002|NOT COMPLETED|Non-Interventional Follow Up Phase||2||
60072706|NCT01566981|76187886|FG000|STARTED|Overall Study||58||
60072707|NCT01566981|76187887|FG001|STARTED|Overall Study||62||
60072708|NCT01566981|76187886|FG000|COMPLETED|Overall Study||53||
60072709|NCT01566981|76187887|FG001|COMPLETED|Overall Study||54||
60072710|NCT01566981|76187886|FG000|NOT COMPLETED|Overall Study||5||
60072711|NCT01566981|76187887|FG001|NOT COMPLETED|Overall Study||8||
59773919|NCT00787566|75894309|FG001|STARTED|Overall Study||25||
59773920|NCT00787566|75894310|FG002|STARTED|Overall Study||22||
60072712|NCT01870778|76187897|FG000|STARTED|Overall Study||3274||
60072713|NCT01870778|76187898|FG001|STARTED|Overall Study||3271||
60072714|NCT01870778|76187897|FG000|Safety Set|Overall Study||3257||
60072715|NCT01870778|76187898|FG001|Safety Set|Overall Study||3248||
60072716|NCT01870778|76187897|FG000|Full Analysis Set|Overall Study||3274||
60072717|NCT01870778|76187898|FG001|Full Analysis Set|Overall Study||3271||
60072718|NCT01870778|76187897|FG000|Biomarker Analysis Set|Overall Study||521||
60072719|NCT01870778|76187898|FG001|Biomarker Analysis Set|Overall Study||510||
60072720|NCT01870778|76187897|FG000|COMPLETED|Overall Study||3266||
60072721|NCT01870778|76187898|FG001|COMPLETED|Overall Study||3262||
60072722|NCT01870778|76187897|FG000|NOT COMPLETED|Overall Study||8||
60072723|NCT01870778|76187898|FG001|NOT COMPLETED|Overall Study||9||
60072724|NCT03420742|76187904|FG000|STARTED|Part A (Cycle 1)||24||
60072725|NCT03420742|76187904|FG000|COMPLETED|Part A (Cycle 1)||24||
60072726|NCT03420742|76187904|FG000|NOT COMPLETED|Part A (Cycle 1)||0||
60072727|NCT03420742|76187904|FG000|STARTED|Part B (Cycle 2 to Cycle 20)|These were the eligible participants from Part A who had the option to continue their treatment in Part B.|22||
60072728|NCT03420742|76187904|FG000|COMPLETED|Part B (Cycle 2 to Cycle 20)||22||
60072729|NCT03420742|76187904|FG000|NOT COMPLETED|Part B (Cycle 2 to Cycle 20)||0||
60072730|NCT01818284|76187911|FG000|STARTED|Overall Study||11||
60072731|NCT01818284|76187912|FG001|STARTED|Overall Study||11||
60072732|NCT01818284|76187911|FG000|COMPLETED|Overall Study||7||
60072733|NCT01818284|76187912|FG001|COMPLETED|Overall Study||5||
60072734|NCT01818284|76187911|FG000|NOT COMPLETED|Overall Study||4||
60072735|NCT01818284|76187912|FG001|NOT COMPLETED|Overall Study||6||
60072736|NCT02081014|76187917|FG000|STARTED|Overall Study||2||
60072737|NCT02081014|76187918|FG001|STARTED|Overall Study||2||
60072738|NCT02081014|76187919|FG002|STARTED|Overall Study||2||
60072739|NCT02081014|76187920|FG003|STARTED|Overall Study||2||
59773921|NCT00787566|75894308|FG000|COMPLETED|Overall Study||21||
59773922|NCT00787566|75894309|FG001|COMPLETED|Overall Study|1 patient withdrew from the study due to an AE related to chemotherapy agent administration.|24||
59773923|NCT00787566|75894310|FG002|COMPLETED|Overall Study||22||
59773924|NCT00787566|75894308|FG000|NOT COMPLETED|Overall Study||0||
59773925|NCT00787566|75894309|FG001|NOT COMPLETED|Overall Study||1||
59773926|NCT00787566|75894310|FG002|NOT COMPLETED|Overall Study||0||
59773927|NCT00787254|75894320|FG000|STARTED|Overall Study||185||
59773928|NCT00787254|75894321|FG001|STARTED|Overall Study||181||
59773929|NCT00787254|75894320|FG000|COMPLETED|Overall Study||109||
59773930|NCT00787254|75894321|FG001|COMPLETED|Overall Study||99||
59773931|NCT00787254|75894320|FG000|NOT COMPLETED|Overall Study||76||
59773932|NCT00787254|75894321|FG001|NOT COMPLETED|Overall Study||82||
59773933|NCT00625846|75894331|FG000|STARTED|Overall Study||39||
59773934|NCT00625846|75894332|FG001|STARTED|Overall Study||35||
60072740|NCT02081014|76187921|FG004|STARTED|Overall Study||2||
60072741|NCT02081014|76187922|FG005|STARTED|Overall Study||2||
60072742|NCT02081014|76187917|FG000|COMPLETED|Overall Study||2||
60072743|NCT02081014|76187918|FG001|COMPLETED|Overall Study||2||
60072744|NCT02081014|76187919|FG002|COMPLETED|Overall Study||2||
60072745|NCT02081014|76187920|FG003|COMPLETED|Overall Study||2||
60072746|NCT02081014|76187921|FG004|COMPLETED|Overall Study||2||
60072747|NCT02081014|76187922|FG005|COMPLETED|Overall Study||2||
60072748|NCT02081014|76187917|FG000|NOT COMPLETED|Overall Study||0||
60072749|NCT02081014|76187918|FG001|NOT COMPLETED|Overall Study||0||
60072750|NCT02081014|76187919|FG002|NOT COMPLETED|Overall Study||0||
60072751|NCT02081014|76187920|FG003|NOT COMPLETED|Overall Study||0||
60072752|NCT02081014|76187921|FG004|NOT COMPLETED|Overall Study||0||
60072753|NCT02081014|76187922|FG005|NOT COMPLETED|Overall Study||0||
60072754|NCT02634268|76187941|FG000|STARTED|Overall Study||346||
60072755|NCT02634268|76187942|FG001|STARTED|Overall Study||338||
60072756|NCT02634268|76187941|FG000|COMPLETED|Overall Study|In-person visit completion = 267 for both groups. Some participants completed only surveys because of Covid-19 restrictions.|287||
60072757|NCT02634268|76187942|FG001|COMPLETED|Overall Study|In-person visit completion = 267 for both groups. Some participants completed only surveys because of Covid-19 restrictions.|291||
60072758|NCT02634268|76187941|FG000|NOT COMPLETED|Overall Study||59||
59773935|NCT00625846|75894333|FG002|STARTED|Overall Study||16||
59773936|NCT00625846|75894334|FG003|STARTED|Overall Study||62||
59773937|NCT00625846|75894331|FG000|COMPLETED|Overall Study||37||
59773938|NCT00625846|75894332|FG001|COMPLETED|Overall Study||35||
59773939|NCT00625846|75894333|FG002|COMPLETED|Overall Study||15||
59773940|NCT00625846|75894334|FG003|COMPLETED|Overall Study||60||
59773941|NCT00625846|75894331|FG000|NOT COMPLETED|Overall Study||2||
59773942|NCT00625846|75894332|FG001|NOT COMPLETED|Overall Study||0||
59773943|NCT00625846|75894333|FG002|NOT COMPLETED|Overall Study||1||
59773944|NCT00625846|75894334|FG003|NOT COMPLETED|Overall Study||2||
59773945|NCT00773292|75894348|FG000|STARTED|Pre-treatment 4 Weeks||7||
59773946|NCT00773292|75894348|FG000|COMPLETED|Pre-treatment 4 Weeks||7||
59773947|NCT00773292|75894348|FG000|NOT COMPLETED|Pre-treatment 4 Weeks||0||
59773948|NCT00773292|75894348|FG000|STARTED|Treatment 48 Weeks||7||
59773949|NCT00773292|75894348|FG000|COMPLETED|Treatment 48 Weeks|Two patients discontinued the treatment but remained on the study|5||
59773950|NCT00773292|75894348|FG000|NOT COMPLETED|Treatment 48 Weeks||2||
59773951|NCT00773292|75894348|FG000|STARTED|Post Treatment 24 Weeks||7|Two patients discontinued the intervention but remained under follow up within the study|
59773952|NCT00773292|75894348|FG000|COMPLETED|Post Treatment 24 Weeks||7||
59773953|NCT00773292|75894348|FG000|NOT COMPLETED|Post Treatment 24 Weeks||0||
59773954|NCT00786864|75894354|FG000|STARTED|Overall Study||39||
60072759|NCT02634268|76187942|FG001|NOT COMPLETED|Overall Study||47||
60072760|NCT01610492|76187948|FG000|STARTED|Overall Study||14||
60072761|NCT01610492|76187948|FG000|COMPLETED|Overall Study||8||
60072762|NCT01610492|76187948|FG000|NOT COMPLETED|Overall Study||6||
60072763|NCT01817582|76187955|FG000|STARTED|Overall Study||33||
60072764|NCT01817582|76187956|FG001|STARTED|Overall Study||36||
60072765|NCT01817582|76187957|FG002|STARTED|Overall Study||33||
60072766|NCT01817582|76187955|FG000|Received at Least 1 Dose of Study Drug|Overall Study||33||
60072767|NCT01817582|76187956|FG001|Received at Least 1 Dose of Study Drug|Overall Study||36||
60072768|NCT01817582|76187957|FG002|Received at Least 1 Dose of Study Drug|Overall Study||33||
60072769|NCT01817582|76187955|FG000|COMPLETED|Overall Study||31||
60072770|NCT01817582|76187956|FG001|COMPLETED|Overall Study||35||
60072771|NCT01817582|76187957|FG002|COMPLETED|Overall Study||33||
60072772|NCT01817582|76187955|FG000|NOT COMPLETED|Overall Study||2||
60072773|NCT01817582|76187956|FG001|NOT COMPLETED|Overall Study||1||
60072774|NCT01817582|76187957|FG002|NOT COMPLETED|Overall Study||0||
60072775|NCT01594125|76187970|FG000|STARTED|Overall Study||4||
60072776|NCT01594125|76187971|FG001|STARTED|Overall Study||12||
59773955|NCT00786864|75894355|FG001|STARTED|Overall Study||33||
59773956|NCT00786864|75894354|FG000|COMPLETED|Overall Study|1 child excluded at the 3 month follow-up, as he sustained a serious back injury|38||
59773957|NCT00786864|75894355|FG001|COMPLETED|Overall Study|1 child lost to study immediately post-intervention as she left the school|32||
59773958|NCT00786864|75894354|FG000|NOT COMPLETED|Overall Study||1||
59773959|NCT00786864|75894355|FG001|NOT COMPLETED|Overall Study||1||
59773960|NCT00621322|75894367|FG000|STARTED|Overall Study||10||
59773961|NCT00621322|75894368|FG001|STARTED|Overall Study||10||
59773962|NCT00621322|75894369|FG002|STARTED|Overall Study||40||
59773963|NCT00621322|75894370|FG003|STARTED|Overall Study||40||
59773964|NCT00621322|75894371|FG004|STARTED|Overall Study||40||
59773965|NCT00621322|75894372|FG005|STARTED|Overall Study||40||
59773966|NCT00621322|75894367|FG000|COMPLETED|Overall Study||9||
59773967|NCT00621322|75894368|FG001|COMPLETED|Overall Study||10||
59773968|NCT00621322|75894369|FG002|COMPLETED|Overall Study||38||
59773969|NCT00621322|75894370|FG003|COMPLETED|Overall Study||37||
59773970|NCT00621322|75894371|FG004|COMPLETED|Overall Study||39||
59773971|NCT00621322|75894372|FG005|COMPLETED|Overall Study||36||
59773972|NCT00621322|75894367|FG000|NOT COMPLETED|Overall Study||1||
59773973|NCT00621322|75894368|FG001|NOT COMPLETED|Overall Study||0||
60072777|NCT01594125|76187972|FG002|STARTED|Overall Study||3||
60072778|NCT01594125|76187973|FG003|STARTED|Overall Study||4||
59773974|NCT00621322|75894369|FG002|NOT COMPLETED|Overall Study||2||
59773975|NCT00621322|75894370|FG003|NOT COMPLETED|Overall Study||3||
59773976|NCT00621322|75894371|FG004|NOT COMPLETED|Overall Study||1||
59773977|NCT00621322|75894372|FG005|NOT COMPLETED|Overall Study||4||
59773978|NCT00853385|75894391|FG000|STARTED|Overall Study||204||
59773979|NCT00853385|75894392|FG001|STARTED|Overall Study||201||
59773980|NCT00853385|75894393|FG002|STARTED|Overall Study||56||
59773981|NCT00853385|75894394|FG003|STARTED|Overall Study||52||
59773982|NCT00853385|75894395|FG004|STARTED|Overall Study||204||
59773983|NCT00853385|75894391|FG000|COMPLETED|Overall Study||150||
59773984|NCT00853385|75894392|FG001|COMPLETED|Overall Study||158||
59773985|NCT00853385|75894393|FG002|COMPLETED|Overall Study||47||
59773986|NCT00853385|75894394|FG003|COMPLETED|Overall Study||39||
59773987|NCT00853385|75894395|FG004|COMPLETED|Overall Study||162||
59773988|NCT00853385|75894391|FG000|NOT COMPLETED|Overall Study||54||
59773989|NCT00853385|75894392|FG001|NOT COMPLETED|Overall Study||43||
59773990|NCT00853385|75894393|FG002|NOT COMPLETED|Overall Study||9||
59773991|NCT00853385|75894394|FG003|NOT COMPLETED|Overall Study||13||
59773992|NCT00853385|75894395|FG004|NOT COMPLETED|Overall Study||42||
59773993|NCT00622336|75894417|FG000|STARTED|Treatment Phase||330||
59773994|NCT00622336|75894417|FG000|Safety Population|Treatment Phase||330||
59773995|NCT00622336|75894417|FG000|COMPLETED|Treatment Phase|Completed = those who completed the treatment phase and were ongoing in the extension study|21||
59773996|NCT00622336|75894417|FG000|NOT COMPLETED|Treatment Phase||309||
59773997|NCT00622336|75894417|FG000|STARTED|Extension Phase||21||
59773998|NCT00622336|75894417|FG000|COMPLETED|Extension Phase||0||
59773999|NCT00622336|75894417|FG000|NOT COMPLETED|Extension Phase||21||
59774000|NCT00779766|75894425|FG000|STARTED|Month 24||3026||
59774001|NCT00779766|75894426|FG001|STARTED|Month 24||3025||
59774002|NCT00779766|75894425|FG000|COMPLETED|Month 24||2694||
59774003|NCT00779766|75894426|FG001|COMPLETED|Month 24||2693||
59774004|NCT00779766|75894425|FG000|NOT COMPLETED|Month 24||332||
59774005|NCT00779766|75894426|FG001|NOT COMPLETED|Month 24||332||
59774006|NCT00779766|75894425|FG000|STARTED|Month 48||2703||
59774007|NCT00779766|75894426|FG001|STARTED|Month 48||2727||
59774008|NCT00779766|75894425|FG000|COMPLETED|Month 48||2529||
59774009|NCT00779766|75894426|FG001|COMPLETED|Month 48||2559||
59774010|NCT00779766|75894425|FG000|NOT COMPLETED|Month 48||174||
59774011|NCT00779766|75894426|FG001|NOT COMPLETED|Month 48||168||
59774012|NCT00779766|75894425|FG000|STARTED|Month 72||2319||
59774013|NCT00779766|75894426|FG001|STARTED|Month 72||2347||
59774014|NCT00779766|75894425|FG000|COMPLETED|Month 72||2134||
59774015|NCT00779766|75894426|FG001|COMPLETED|Month 72||2158||
59774016|NCT00779766|75894425|FG000|NOT COMPLETED|Month 72||185||
59774017|NCT00779766|75894426|FG001|NOT COMPLETED|Month 72||189||
59774018|NCT00846365|75894436|FG000|STARTED|Overall Study||372||
59774019|NCT00846365|75894437|FG001|STARTED|Overall Study||357||
59774020|NCT00846365|75894438|FG002|STARTED|Overall Study||356||
59774021|NCT00846365|75894436|FG000|COMPLETED|Overall Study||317||
59774022|NCT00846365|75894437|FG001|COMPLETED|Overall Study||308||
59774023|NCT00846365|75894438|FG002|COMPLETED|Overall Study||323||
59774024|NCT00846365|75894436|FG000|NOT COMPLETED|Overall Study||55||
59774025|NCT00846365|75894437|FG001|NOT COMPLETED|Overall Study||49||
59774026|NCT00846365|75894438|FG002|NOT COMPLETED|Overall Study||33||
59774027|NCT00779142|75894446|FG000|STARTED|Overall Study|5 patients signed consent and were screened.|5||
59774028|NCT00779142|75894446|FG000|COMPLETED|Overall Study|Only 2 patients were actually enrolled.|2||
59774029|NCT00779142|75894446|FG000|NOT COMPLETED|Overall Study||3||
59774030|NCT00622180|75894451|FG000|STARTED|Overall Study||6||
59774031|NCT00622180|75894452|FG001|STARTED|Overall Study||7||
59774032|NCT00622180|75894451|FG000|COMPLETED|Overall Study||5||
59774033|NCT00622180|75894452|FG001|COMPLETED|Overall Study||5||
59618482|NCT03969420|75729591|FG001|STARTED|Overall Study|Any patient who received at least 1 dose of study drug|4||
59618483|NCT03969420|75729592|FG002|STARTED|Overall Study|Any patient who received at least 1 dose of study drug|2||
59618484|NCT03969420|75729593|FG003|STARTED|Overall Study|Any patient who received at least 1 dose of study drug|2||
59618485|NCT03969420|75729590|FG000|COMPLETED|Overall Study|Any patient who received at least 1 dose of study drug|3||
59618486|NCT03969420|75729591|FG001|COMPLETED|Overall Study|Any patient who received at least 1 dose of study drug|4||
59618487|NCT03969420|75729592|FG002|COMPLETED|Overall Study|Any patient who received at least 1 dose of study drug|2||
59618488|NCT03969420|75729593|FG003|COMPLETED|Overall Study|Any patient who received at least 1 dose of study drug|2||
59618489|NCT03969420|75729590|FG000|NOT COMPLETED|Overall Study||0||
59618490|NCT03969420|75729591|FG001|NOT COMPLETED|Overall Study||0||
59774034|NCT00622180|75894451|FG000|NOT COMPLETED|Overall Study||1||
59774035|NCT00622180|75894452|FG001|NOT COMPLETED|Overall Study||2||
59774036|NCT00773136|75894458|FG000|STARTED|Overall Study||21||
59774037|NCT00773136|75894458|FG000|COMPLETED|Overall Study||19||
59774038|NCT00773136|75894458|FG000|NOT COMPLETED|Overall Study||2||
59774039|NCT00853307|75894465|FG000|STARTED|Overall Study||6||
59774040|NCT00853307|75894466|FG001|STARTED|Overall Study||25||
59774041|NCT00853307|75894465|FG000|COMPLETED|Overall Study|Completed = participants who completed the study treatment.|4||
59774042|NCT00853307|75894466|FG001|COMPLETED|Overall Study||20||
59774043|NCT00853307|75894465|FG000|NOT COMPLETED|Overall Study||2||
59774044|NCT00853307|75894466|FG001|NOT COMPLETED|Overall Study||5||
59774045|NCT00778830|75894474|FG000|STARTED|Overall Study||101||
59774046|NCT00778830|75894475|FG001|STARTED|Overall Study||188||
59774047|NCT00778830|75894474|FG000|COMPLETED|Overall Study||101||
59774048|NCT00778830|75894475|FG001|COMPLETED|Overall Study||187||
59774049|NCT00778830|75894474|FG000|NOT COMPLETED|Overall Study||0||
59774050|NCT00778830|75894475|FG001|NOT COMPLETED|Overall Study||1||
59618491|NCT03969420|75729592|FG002|NOT COMPLETED|Overall Study||0||
59618492|NCT03969420|75729593|FG003|NOT COMPLETED|Overall Study||0||
59618493|NCT03593915|75729609|FG000|STARTED|Overall Study||3|Any patient who received at least 1 dose of study drug.|
59618494|NCT03593915|75729610|FG001|STARTED|Overall Study||3|Any patient who received at least 1 dose of study drug.|
59618495|NCT03593915|75729611|FG002|STARTED|Overall Study||3|Any patient who received at least 1 dose of study drug.|
59618496|NCT03593915|75729612|FG003|STARTED|Overall Study||4|Any patient who received at least 1 dose of study drug.|
59774051|NCT00772668|75894481|FG000|STARTED|Overall Study||3||
59774052|NCT00772668|75894481|FG000|COMPLETED|Overall Study||0||
59774053|NCT00772668|75894481|FG000|NOT COMPLETED|Overall Study||3||
59774054|NCT00786474|75894488|FG000|STARTED|Overall Study||950||
59774055|NCT00786474|75894489|FG001|STARTED|Overall Study||934||
59774056|NCT00786474|75894488|FG000|COMPLETED|Overall Study||913||
59774057|NCT00786474|75894489|FG001|COMPLETED|Overall Study||891||
59774058|NCT00786474|75894488|FG000|NOT COMPLETED|Overall Study||37||
59774059|NCT00786474|75894489|FG001|NOT COMPLETED|Overall Study||43||
59774060|NCT00784875|75894499|FG000|STARTED|Period A - Baseline||0||
59774061|NCT00784875|75894500|FG001|STARTED|Period A - Baseline||0||
59774062|NCT00784875|75894501|FG002|STARTED|Period A - Baseline||0||
59774063|NCT00784875|75894502|FG003|STARTED|Period A - Baseline||643||
59774064|NCT00784875|75894499|FG000|COMPLETED|Period A - Baseline||0||
59774065|NCT00784875|75894500|FG001|COMPLETED|Period A - Baseline||0||
59774066|NCT00784875|75894501|FG002|COMPLETED|Period A - Baseline||0||
59774067|NCT00784875|75894502|FG003|COMPLETED|Period A - Baseline||461||
59774068|NCT00784875|75894499|FG000|NOT COMPLETED|Period A - Baseline||0||
59774069|NCT00784875|75894500|FG001|NOT COMPLETED|Period A - Baseline||0||
59774070|NCT00784875|75894501|FG002|NOT COMPLETED|Period A - Baseline||0||
59774071|NCT00784875|75894502|FG003|NOT COMPLETED|Period A - Baseline||182||
59618497|NCT03593915|75729613|FG004|STARTED|Overall Study||3|Any patient who received at least 1 dose of study drug.|
59618498|NCT03593915|75729614|FG005|STARTED|Overall Study||4|Any patient who received at least 1 dose of study drug.|
59618499|NCT03593915|75729609|FG000|COMPLETED|Overall Study||3|Completed Cycle 1|
59618500|NCT03593915|75729610|FG001|COMPLETED|Overall Study||3|Completed Cycle 1|
59618501|NCT03593915|75729611|FG002|COMPLETED|Overall Study||3|Completed Cycle 1|
59618502|NCT03593915|75729612|FG003|COMPLETED|Overall Study||3|Completed Cycle 1|
59618503|NCT03593915|75729613|FG004|COMPLETED|Overall Study||3|Completed Cycle 1|
59618504|NCT03593915|75729614|FG005|COMPLETED|Overall Study||3|Completed Cycle 1|
59618505|NCT03593915|75729609|FG000|NOT COMPLETED|Overall Study||0||
59618506|NCT03593915|75729610|FG001|NOT COMPLETED|Overall Study||0||
59618507|NCT03593915|75729611|FG002|NOT COMPLETED|Overall Study||0||
59618508|NCT03593915|75729612|FG003|NOT COMPLETED|Overall Study||1||
59618509|NCT03593915|75729613|FG004|NOT COMPLETED|Overall Study||0||
59618510|NCT03593915|75729614|FG005|NOT COMPLETED|Overall Study||1||
59618511|NCT03572634|75729630|FG000|STARTED|Overall Study||1||
59618512|NCT03572634|75729631|FG001|STARTED|Overall Study||2||
59618513|NCT03572634|75729630|FG000|COMPLETED|Overall Study||1||
59618514|NCT03572634|75729631|FG001|COMPLETED|Overall Study||2||
59618515|NCT03572634|75729630|FG000|NOT COMPLETED|Overall Study||0||
59618516|NCT03572634|75729631|FG001|NOT COMPLETED|Overall Study||0||
59618517|NCT03563716|75729640|FG000|STARTED|Overall Study||68||
59618518|NCT03563716|75729641|FG001|STARTED|Overall Study||67||
59618519|NCT03563716|75729640|FG000|COMPLETED|Overall Study||0|Study still on-going|
59618520|NCT03563716|75729641|FG001|COMPLETED|Overall Study|"One participant who died had as reason for discontinuation Withdrawal by Subject"|0|Study still on-going|
59618521|NCT03563716|75729640|FG000|NOT COMPLETED|Overall Study||68||
59618522|NCT03563716|75729641|FG001|NOT COMPLETED|Overall Study||67||
59618523|NCT03462030|75729649|FG000|STARTED|Overall Study||15||
59618524|NCT03462030|75729650|FG001|STARTED|Overall Study||15||
59618525|NCT03462030|75729649|FG000|End of Build-up|Overall Study||14||
59618526|NCT03462030|75729650|FG001|End of Build-up|Overall Study||14||
59618527|NCT03462030|75729649|FG000|Month 12 Food Challenge|Overall Study||14||
59618528|NCT03462030|75729650|FG001|Month 12 Food Challenge|Overall Study||14||
59618529|NCT03462030|75729649|FG000|COMPLETED|Overall Study||14||
59618530|NCT03462030|75729650|FG001|COMPLETED|Overall Study||14||
59774072|NCT00784875|75894499|FG000|STARTED|Period B - Efficacy Endpoint||114||
59774073|NCT00784875|75894500|FG001|STARTED|Period B - Efficacy Endpoint||113||
59774074|NCT00784875|75894501|FG002|STARTED|Period B - Efficacy Endpoint||117||
59774075|NCT00784875|75894502|FG003|STARTED|Period B - Efficacy Endpoint||117||
59774076|NCT00784875|75894499|FG000|Cohort 2|Period B - Efficacy Endpoint||102||
59774077|NCT00784875|75894500|FG001|Cohort 2|Period B - Efficacy Endpoint||102||
59774078|NCT00784875|75894501|FG002|Cohort 2|Period B - Efficacy Endpoint||102||
59774079|NCT00784875|75894502|FG003|Cohort 2|Period B - Efficacy Endpoint||101||
59774080|NCT00784875|75894499|FG000|COMPLETED|Period B - Efficacy Endpoint||100||
59774081|NCT00784875|75894500|FG001|COMPLETED|Period B - Efficacy Endpoint||101||
59774082|NCT00784875|75894501|FG002|COMPLETED|Period B - Efficacy Endpoint||96||
59774083|NCT00784875|75894502|FG003|COMPLETED|Period B - Efficacy Endpoint||98||
59774084|NCT00784875|75894499|FG000|NOT COMPLETED|Period B - Efficacy Endpoint||14||
59774085|NCT00784875|75894500|FG001|NOT COMPLETED|Period B - Efficacy Endpoint||12||
59774086|NCT00784875|75894501|FG002|NOT COMPLETED|Period B - Efficacy Endpoint||21||
59618531|NCT03462030|75729649|FG000|NOT COMPLETED|Overall Study||1||
59618532|NCT03462030|75729650|FG001|NOT COMPLETED|Overall Study||1||
59618533|NCT03336333|75729659|FG000|STARTED|Overall Study||238||
59618534|NCT03336333|75729660|FG001|STARTED|Overall Study||241||
59618535|NCT03336333|75729661|FG002|STARTED|Overall Study||111||
59618536|NCT03336333|75729659|FG000|Treated|Overall Study||227||
59618537|NCT03336333|75729660|FG001|Treated|Overall Study||240||
59618538|NCT03336333|75729661|FG002|Treated|Overall Study||111||
59618539|NCT03336333|75729659|FG000|COMPLETED|Overall Study||0||
59618540|NCT03336333|75729660|FG001|COMPLETED|Overall Study||0||
59618541|NCT03336333|75729661|FG002|COMPLETED|Overall Study||0||
59618542|NCT03336333|75729659|FG000|NOT COMPLETED|Overall Study||238||
59618543|NCT03336333|75729660|FG001|NOT COMPLETED|Overall Study||241||
59618544|NCT03336333|75729661|FG002|NOT COMPLETED|Overall Study||111||
59618545|NCT03275285|75729670|FG000|STARTED|Overall Study||123||
59618546|NCT03275285|75729671|FG001|STARTED|Overall Study||179||
59618547|NCT03275285|75729670|FG000|Treated|Overall Study||122||
59618548|NCT03275285|75729671|FG001|Treated|Overall Study||177||
59618549|NCT03275285|75729670|FG000|COMPLETED|Overall Study||62||
59618550|NCT03275285|75729671|FG001|COMPLETED|Overall Study||74||
59618551|NCT03275285|75729670|FG000|NOT COMPLETED|Overall Study||61||
59618552|NCT03275285|75729671|FG001|NOT COMPLETED|Overall Study||105||
59618553|NCT03240874|75729685|FG000|STARTED|Overall Study||16||
59618554|NCT03240874|75729686|FG001|STARTED|Overall Study||24||
59618555|NCT03240874|75729687|FG002|STARTED|Overall Study||30||
59618556|NCT03240874|75729688|FG003|STARTED|Overall Study||10||
59618557|NCT03240874|75729685|FG000|COMPLETED|Overall Study||16||
59618558|NCT03240874|75729686|FG001|COMPLETED|Overall Study||22||
59618559|NCT03240874|75729687|FG002|COMPLETED|Overall Study||26||
59618560|NCT03240874|75729688|FG003|COMPLETED|Overall Study||9||
59618561|NCT03240874|75729685|FG000|NOT COMPLETED|Overall Study||0||
59618562|NCT03240874|75729686|FG001|NOT COMPLETED|Overall Study||2||
59618563|NCT03240874|75729687|FG002|NOT COMPLETED|Overall Study||4||
59618564|NCT03240874|75729688|FG003|NOT COMPLETED|Overall Study||1||
59618565|NCT03083665|75729699|FG000|STARTED|Double-Blind Period||149||
59618566|NCT03083665|75729700|FG001|STARTED|Double-Blind Period||152||
59618567|NCT03083665|75729701|FG002|STARTED|Double-Blind Period||148||
59618568|NCT03083665|75729702|FG003|STARTED|Double-Blind Period||0||
59618569|NCT03083665|75729703|FG004|STARTED|Double-Blind Period||0||
59618570|NCT03083665|75729704|FG005|STARTED|Double-Blind Period||0||
59618571|NCT03083665|75729699|FG000|Started Treatment Period (12 Weeks)|Double-Blind Period||149||
59618572|NCT03083665|75729700|FG001|Started Treatment Period (12 Weeks)|Double-Blind Period||152||
59618573|NCT03083665|75729701|FG002|Started Treatment Period (12 Weeks)|Double-Blind Period||148||
59618574|NCT03083665|75729702|FG003|Started Treatment Period (12 Weeks)|Double-Blind Period||0||
59618575|NCT03083665|75729703|FG004|Started Treatment Period (12 Weeks)|Double-Blind Period||0||
59618576|NCT03083665|75729704|FG005|Started Treatment Period (12 Weeks)|Double-Blind Period||0||
59618577|NCT03083665|75729699|FG000|Started Down-Titration Period (4 Weeks)|Double-Blind Period||7||
59618578|NCT03083665|75729700|FG001|Started Down-Titration Period (4 Weeks)|Double-Blind Period||9||
59618579|NCT03083665|75729701|FG002|Started Down-Titration Period (4 Weeks)|Double-Blind Period||7||
59618580|NCT03083665|75729702|FG003|Started Down-Titration Period (4 Weeks)|Double-Blind Period||0||
59618581|NCT03083665|75729703|FG004|Started Down-Titration Period (4 Weeks)|Double-Blind Period||0||
59618582|NCT03083665|75729704|FG005|Started Down-Titration Period (4 Weeks)|Double-Blind Period||0||
59618583|NCT03083665|75729699|FG000|Started Study Drug-Free Period (2 Weeks)|Double-Blind Period||7||
59618584|NCT03083665|75729700|FG001|Started Study Drug-Free Period (2 Weeks)|Double-Blind Period||9||
59618585|NCT03083665|75729701|FG002|Started Study Drug-Free Period (2 Weeks)|Double-Blind Period||7||
59618586|NCT03083665|75729702|FG003|Started Study Drug-Free Period (2 Weeks)|Double-Blind Period||0||
59618587|NCT03083665|75729703|FG004|Started Study Drug-Free Period (2 Weeks)|Double-Blind Period||0||
59618588|NCT03083665|75729704|FG005|Started Study Drug-Free Period (2 Weeks)|Double-Blind Period||0||
59618589|NCT03083665|75729699|FG000|Started Transition Period (2 Weeks)|Double-Blind Period||133||
59618590|NCT03083665|75729700|FG001|Started Transition Period (2 Weeks)|Double-Blind Period||139||
59618591|NCT03083665|75729701|FG002|Started Transition Period (2 Weeks)|Double-Blind Period||137||
59618592|NCT03083665|75729702|FG003|Started Transition Period (2 Weeks)|Double-Blind Period||0||
59618593|NCT03083665|75729703|FG004|Started Transition Period (2 Weeks)|Double-Blind Period||0||
59618594|NCT03083665|75729704|FG005|Started Transition Period (2 Weeks)|Double-Blind Period||0||
59618595|NCT03083665|75729699|FG000|COMPLETED|Double-Blind Period||138||
59618596|NCT03083665|75729700|FG001|COMPLETED|Double-Blind Period||147||
59618597|NCT03083665|75729701|FG002|COMPLETED|Double-Blind Period||140||
59618598|NCT03083665|75729702|FG003|COMPLETED|Double-Blind Period||0||
59618599|NCT03083665|75729703|FG004|COMPLETED|Double-Blind Period||0||
59618600|NCT03083665|75729704|FG005|COMPLETED|Double-Blind Period||0||
59618601|NCT03083665|75729699|FG000|NOT COMPLETED|Double-Blind Period||11||
59618602|NCT03083665|75729700|FG001|NOT COMPLETED|Double-Blind Period||5||
59618603|NCT03083665|75729701|FG002|NOT COMPLETED|Double-Blind Period||8||
59618604|NCT03083665|75729702|FG003|NOT COMPLETED|Double-Blind Period||0||
59618605|NCT03083665|75729703|FG004|NOT COMPLETED|Double-Blind Period||0||
59774087|NCT00784875|75894502|FG003|NOT COMPLETED|Period B - Efficacy Endpoint||19||
59774088|NCT00784875|75894499|FG000|STARTED|Period C||103||
59774089|NCT00784875|75894500|FG001|STARTED|Period C||97||
59774090|NCT00784875|75894501|FG002|STARTED|Period C||97||
59774091|NCT00784875|75894502|FG003|STARTED|Period C||98||
59774092|NCT00784875|75894499|FG000|COMPLETED|Period C||96||
59774093|NCT00784875|75894500|FG001|COMPLETED|Period C||91||
59774094|NCT00784875|75894501|FG002|COMPLETED|Period C||84||
59774095|NCT00784875|75894502|FG003|COMPLETED|Period C||91||
59774096|NCT00784875|75894499|FG000|NOT COMPLETED|Period C||7||
59774097|NCT00784875|75894500|FG001|NOT COMPLETED|Period C||6||
59774098|NCT00784875|75894501|FG002|NOT COMPLETED|Period C||13||
59774099|NCT00784875|75894502|FG003|NOT COMPLETED|Period C||7||
59774100|NCT00784875|75894499|FG000|STARTED|Period D||91||
59774101|NCT00784875|75894500|FG001|STARTED|Period D||89||
59774102|NCT00784875|75894501|FG002|STARTED|Period D||94||
59774103|NCT00784875|75894502|FG003|STARTED|Period D||88||
59774104|NCT00784875|75894499|FG000|COMPLETED|Period D||86||
59774105|NCT00784875|75894500|FG001|COMPLETED|Period D||85||
59774106|NCT00784875|75894501|FG002|COMPLETED|Period D||88||
59774107|NCT00784875|75894502|FG003|COMPLETED|Period D||87||
59774108|NCT00784875|75894499|FG000|NOT COMPLETED|Period D||5||
59774109|NCT00784875|75894500|FG001|NOT COMPLETED|Period D||4||
59774110|NCT00784875|75894501|FG002|NOT COMPLETED|Period D||6||
59774111|NCT00784875|75894502|FG003|NOT COMPLETED|Period D||1||
59774112|NCT00592553|75894528|FG000|STARTED|Overall Study||60||
59774113|NCT00592553|75894529|FG001|STARTED|Overall Study||57||
59774114|NCT00592553|75894530|FG002|STARTED|Overall Study||57||
59774115|NCT00592553|75894528|FG000|As-treated Population|Overall Study||60|All Randomized participants who received any study treatment.|
59774116|NCT00592553|75894529|FG001|As-treated Population|Overall Study||57|All Randomized participants who received any study treatment.|
59774117|NCT00592553|75894530|FG002|As-treated Population|Overall Study||57|All Randomized participants who received any study treatment.|
59774118|NCT00592553|75894528|FG000|ITT Population|Overall Study||60|Received any study treatment; had a valid baseline, and at least 1 valid post-baseline 6MWD value.|
59774119|NCT00592553|75894529|FG001|ITT Population|Overall Study||57|Received any study treatment; had a valid baseline, and at least 1 valid post-baseline 6MWD value.|
59774120|NCT00592553|75894530|FG002|ITT Population|Overall Study||57|Received any study treatment; had a valid baseline, and at least 1 valid post-baseline 6MWD value.|
59774121|NCT00592553|75894528|FG000|COMPLETED|Overall Study||59||
59774122|NCT00592553|75894529|FG001|COMPLETED|Overall Study||57||
59774123|NCT00592553|75894530|FG002|COMPLETED|Overall Study||57||
59774124|NCT00592553|75894528|FG000|NOT COMPLETED|Overall Study||1||
59774125|NCT00592553|75894529|FG001|NOT COMPLETED|Overall Study||0||
59774126|NCT00592553|75894530|FG002|NOT COMPLETED|Overall Study||0||
59774127|NCT00853229|75894540|FG000|STARTED|Phase 1: Initial Intervention||8||
59774128|NCT00853229|75894541|FG001|STARTED|Phase 1: Initial Intervention||8||
59774129|NCT00853229|75894540|FG000|COMPLETED|Phase 1: Initial Intervention||0||
59774130|NCT00853229|75894541|FG001|COMPLETED|Phase 1: Initial Intervention||0||
59774131|NCT00853229|75894540|FG000|NOT COMPLETED|Phase 1: Initial Intervention||8||
59774132|NCT00853229|75894541|FG001|NOT COMPLETED|Phase 1: Initial Intervention||8||
59774133|NCT00853229|75894540|FG000|STARTED|Phase 2: Cross Over||0||
59774134|NCT00853229|75894541|FG001|STARTED|Phase 2: Cross Over||0||
59774135|NCT00853229|75894540|FG000|COMPLETED|Phase 2: Cross Over||0||
59774136|NCT00853229|75894541|FG001|COMPLETED|Phase 2: Cross Over||0||
59774137|NCT00853229|75894540|FG000|NOT COMPLETED|Phase 2: Cross Over||0||
59774138|NCT00853229|75894541|FG001|NOT COMPLETED|Phase 2: Cross Over||0||
59774139|NCT00853151|75894553|FG000|STARTED|Overall Study||38||
59774140|NCT00853151|75894554|FG001|STARTED|Overall Study||37||
59774141|NCT00853151|75894555|FG002|STARTED|Overall Study||38||
59774142|NCT00853151|75894556|FG003|STARTED|Overall Study||18||
59774143|NCT00853151|75894553|FG000|COMPLETED|Overall Study||28||
59774144|NCT00853151|75894554|FG001|COMPLETED|Overall Study||24||
59774145|NCT00853151|75894555|FG002|COMPLETED|Overall Study||30||
59774146|NCT00853151|75894556|FG003|COMPLETED|Overall Study||15||
59774147|NCT00853151|75894553|FG000|NOT COMPLETED|Overall Study||10||
59774148|NCT00853151|75894554|FG001|NOT COMPLETED|Overall Study||13||
59774149|NCT00853151|75894555|FG002|NOT COMPLETED|Overall Study||8||
59774150|NCT00853151|75894556|FG003|NOT COMPLETED|Overall Study||3||
59774151|NCT00853073|75894571|FG000|STARTED|Overall Study||32||
59774152|NCT00853073|75894572|FG001|STARTED|Overall Study||31||
59774153|NCT00853073|75894571|FG000|COMPLETED|Overall Study||29||
59774154|NCT00853073|75894572|FG001|COMPLETED|Overall Study||29||
59774155|NCT00853073|75894571|FG000|NOT COMPLETED|Overall Study||3||
59774156|NCT00853073|75894572|FG001|NOT COMPLETED|Overall Study||2||
59774157|NCT00846053|75894580|FG000|STARTED|Overall Study|No milestones. Enrollment continued until end of study.|13||
59774158|NCT00846053|75894581|FG001|STARTED|Overall Study||8||
59774159|NCT00846053|75894580|FG000|COMPLETED|Overall Study|No milestones. Enrollment continued until end of study. 21 subjects enrolled.|10||
59774160|NCT00846053|75894581|FG001|COMPLETED|Overall Study||8||
59774161|NCT00846053|75894580|FG000|NOT COMPLETED|Overall Study||3||
59774162|NCT00846053|75894581|FG001|NOT COMPLETED|Overall Study||0||
59774163|NCT00845897|75894592|FG000|STARTED|Overall Study||5||
59774164|NCT00845897|75894593|FG001|STARTED|Overall Study||7||
59774165|NCT00845897|75894594|FG002|STARTED|Overall Study||5||
59774166|NCT00845897|75894592|FG000|COMPLETED|Overall Study||3||
59774167|NCT00845897|75894593|FG001|COMPLETED|Overall Study||2||
59774168|NCT00845897|75894594|FG002|COMPLETED|Overall Study||2||
59774169|NCT00845897|75894592|FG000|NOT COMPLETED|Overall Study||2||
59774170|NCT00845897|75894593|FG001|NOT COMPLETED|Overall Study||5||
59774171|NCT00845897|75894594|FG002|NOT COMPLETED|Overall Study||3||
59774172|NCT00862277|75894605|FG000|STARTED|Overall Study||561||
59774173|NCT00862277|75894606|FG001|STARTED|Overall Study||96||
59774174|NCT00862277|75894607|FG002|STARTED|Overall Study||105||
59774175|NCT00862277|75894605|FG000|COMPLETED|Overall Study||560||
59774176|NCT00862277|75894606|FG001|COMPLETED|Overall Study||94||
59774177|NCT00862277|75894607|FG002|COMPLETED|Overall Study||100||
59774178|NCT00862277|75894605|FG000|NOT COMPLETED|Overall Study||1||
59774179|NCT00862277|75894606|FG001|NOT COMPLETED|Overall Study||2||
59774180|NCT00862277|75894607|FG002|NOT COMPLETED|Overall Study||5||
59774181|NCT00852995|75894620|FG000|STARTED|Overall Study||46||
59774182|NCT00852995|75894621|FG001|STARTED|Overall Study||43||
59774183|NCT00852995|75894622|FG002|STARTED|Overall Study||44||
59774184|NCT00852995|75894623|FG003|STARTED|Overall Study||45||
59774185|NCT00852995|75894624|FG004|STARTED|Overall Study||50||
59774186|NCT00852995|75894620|FG000|COMPLETED|Overall Study||38||
59774187|NCT00852995|75894621|FG001|COMPLETED|Overall Study||42||
59774188|NCT00852995|75894622|FG002|COMPLETED|Overall Study||39||
59774189|NCT00852995|75894623|FG003|COMPLETED|Overall Study||40||
59774190|NCT00852995|75894624|FG004|COMPLETED|Overall Study||46||
59774191|NCT00852995|75894620|FG000|NOT COMPLETED|Overall Study||8||
59774192|NCT00852995|75894621|FG001|NOT COMPLETED|Overall Study||1||
59774193|NCT00852995|75894622|FG002|NOT COMPLETED|Overall Study||5||
59774194|NCT00852995|75894623|FG003|NOT COMPLETED|Overall Study||5||
59774195|NCT00852995|75894624|FG004|NOT COMPLETED|Overall Study||4||
59774196|NCT00592319|75894643|FG000|STARTED|Overall Study||2||
59774197|NCT00592319|75894644|FG001|STARTED|Overall Study||8||
59774198|NCT00592319|75894643|FG000|COMPLETED|Overall Study||2||
59774199|NCT00592319|75894644|FG001|COMPLETED|Overall Study||5||
59774200|NCT00592319|75894643|FG000|NOT COMPLETED|Overall Study||0||
59774201|NCT00592319|75894644|FG001|NOT COMPLETED|Overall Study||3||
59774202|NCT00862121|75894654|FG000|STARTED|Overall Study||8||
59774203|NCT00862121|75894655|FG001|STARTED|Overall Study|Randomised, intent-to-treat (ITT)|12||
59774204|NCT00862121|75894654|FG000|Full Analysis Set (FAS)|Overall Study|One participant had no evaluable post-baseline CDAI score.|7||
59774205|NCT00862121|75894655|FG001|Full Analysis Set (FAS)|Overall Study|One participant randomised in error (no IMP taken).|11||
59774206|NCT00862121|75894654|FG000|Safety Analysis Set|Overall Study|The participant with no evaluable post-baseline CDAI score was included in the Safety Analysis Set.|8||
59774207|NCT00862121|75894655|FG001|Safety Analysis Set|Overall Study||11||
59774208|NCT00862121|75894654|FG000|COMPLETED|Overall Study||7||
59774209|NCT00862121|75894655|FG001|COMPLETED|Overall Study||4||
59774210|NCT00862121|75894654|FG000|NOT COMPLETED|Overall Study||1||
59774211|NCT00862121|75894655|FG001|NOT COMPLETED|Overall Study||8||
59774212|NCT00784719|75894668|FG000|STARTED|Overall Study||47||
59521881|NCT01222117|75616172|FG008|COMPLETED|Overall Study||20||
59774213|NCT00784719|75894669|FG001|STARTED|Overall Study||46||
59774214|NCT00784719|75894670|FG002|STARTED|Overall Study||47||
59774215|NCT00784719|75894671|FG003|STARTED|Overall Study||48||
59774216|NCT00784719|75894672|FG004|STARTED|Overall Study||48||
59774217|NCT00784719|75894673|FG005|STARTED|Overall Study||44||
59774218|NCT00784719|75894674|FG006|STARTED|Overall Study||47||
59774219|NCT00784719|75894668|FG000|COMPLETED|Overall Study||44||
59774220|NCT00784719|75894669|FG001|COMPLETED|Overall Study||43||
59774221|NCT00784719|75894670|FG002|COMPLETED|Overall Study||46||
59774222|NCT00784719|75894671|FG003|COMPLETED|Overall Study||48||
59774223|NCT00784719|75894672|FG004|COMPLETED|Overall Study||42||
59774224|NCT00784719|75894673|FG005|COMPLETED|Overall Study||41||
59774225|NCT00784719|75894674|FG006|COMPLETED|Overall Study||42||
59774226|NCT00784719|75894668|FG000|NOT COMPLETED|Overall Study||3||
59952776|NCT02476851|76071553|FG000|NOT COMPLETED|Overall Study||1||
59521882|NCT01222117|75616173|FG009|COMPLETED|Overall Study||17||
59774227|NCT00784719|75894669|FG001|NOT COMPLETED|Overall Study||3||
59774228|NCT00784719|75894670|FG002|NOT COMPLETED|Overall Study||1||
59774229|NCT00784719|75894671|FG003|NOT COMPLETED|Overall Study||0||
59774230|NCT00784719|75894672|FG004|NOT COMPLETED|Overall Study||6||
59774231|NCT00784719|75894673|FG005|NOT COMPLETED|Overall Study||3||
59774232|NCT00784719|75894674|FG006|NOT COMPLETED|Overall Study||5||
59774233|NCT00852917|75894694|FG000|STARTED|Overall Study||106||
59774234|NCT00852917|75894695|FG001|STARTED|Overall Study||111||
59774235|NCT00852917|75894696|FG002|STARTED|Overall Study||108||
59774236|NCT00852917|75894697|FG003|STARTED|Overall Study||227||
59774237|NCT00852917|75894694|FG000|COMPLETED|Overall Study||62||
59774238|NCT00852917|75894695|FG001|COMPLETED|Overall Study||65||
59774239|NCT00852917|75894696|FG002|COMPLETED|Overall Study||50||
59774240|NCT00852917|75894697|FG003|COMPLETED|Overall Study||134||
59774241|NCT00852917|75894694|FG000|NOT COMPLETED|Overall Study||44||
59774242|NCT00852917|75894695|FG001|NOT COMPLETED|Overall Study||46||
59774243|NCT00852917|75894696|FG002|NOT COMPLETED|Overall Study||58||
59774244|NCT00852917|75894697|FG003|NOT COMPLETED|Overall Study||93||
59774245|NCT00845429|75894710|FG000|STARTED|Overall Study||244||
59774246|NCT00845429|75894711|FG001|STARTED|Overall Study||241||
59774247|NCT00845429|75894712|FG002|STARTED|Overall Study||244||
59774248|NCT00845429|75894710|FG000|COMPLETED|Overall Study||230||
59774249|NCT00845429|75894711|FG001|COMPLETED|Overall Study||226||
59774250|NCT00845429|75894712|FG002|COMPLETED|Overall Study||224||
59774251|NCT00845429|75894710|FG000|NOT COMPLETED|Overall Study||14||
59774252|NCT00845429|75894711|FG001|NOT COMPLETED|Overall Study||15||
59774253|NCT00845429|75894712|FG002|NOT COMPLETED|Overall Study||20||
59774254|NCT00593333|75894722|FG000|STARTED|Overall Study||54||
59774255|NCT00593333|75894723|FG001|STARTED|Overall Study||56||
59774256|NCT00593333|75894722|FG000|COMPLETED|Overall Study||44||
59774257|NCT00593333|75894723|FG001|COMPLETED|Overall Study||45||
59774258|NCT00593333|75894722|FG000|NOT COMPLETED|Overall Study||10||
59774259|NCT00593333|75894723|FG001|NOT COMPLETED|Overall Study||11||
59774260|NCT00844883|75894729|FG000|STARTED|Overall Study||50|Patients evaluable for survival and safety analysis, and started on sorafenib|
59774261|NCT00844883|75894729|FG000|Patients Who Received TACE|Overall Study|2 patients withdrawn at Week 1 prior to TACE for intolerance to sorafenib|48||
59774262|NCT00844883|75894729|FG000|COMPLETED|Overall Study||46|Patients evaluable for time to progression analysis|
59774263|NCT00844883|75894729|FG000|NOT COMPLETED|Overall Study||4||
59774264|NCT00851903|75894733|FG000|STARTED|Overall Study||112||
59774265|NCT00851903|75894733|FG000|Safety Population|Overall Study|patients treated with at least one dose of insulin glargine OR one dose of sitagliptin|112||
59774266|NCT00851903|75894733|FG000|Treated by Combination|Overall Study|patients treated with at least one dose of insulin glargine AND one dose of sitagliptin|111||
59774267|NCT00851903|75894733|FG000|Modified Intent-To-Treat Population|Overall Study|mITT population: patients treated by combination with at least 1 on-treatment efficacy measure|111||
59774268|NCT00851903|75894733|FG000|COMPLETED|Overall Study||110||
59774269|NCT00851903|75894733|FG000|NOT COMPLETED|Overall Study||2||
59774270|NCT00587457|75894740|FG000|STARTED|Overall Study||3||
59774271|NCT00587457|75894741|FG001|STARTED|Overall Study||3||
59774272|NCT00587457|75894742|FG002|STARTED|Overall Study||5||
59774273|NCT00587457|75894740|FG000|COMPLETED|Overall Study||0||
59774274|NCT00587457|75894741|FG001|COMPLETED|Overall Study||0||
59774275|NCT00587457|75894742|FG002|COMPLETED|Overall Study||0||
59774276|NCT00587457|75894740|FG000|NOT COMPLETED|Overall Study||3||
59774277|NCT00587457|75894741|FG001|NOT COMPLETED|Overall Study||3||
59774278|NCT00587457|75894742|FG002|NOT COMPLETED|Overall Study||5||
59774279|NCT00851747|75894753|FG000|STARTED|Overall Study||6||
59774280|NCT00851747|75894754|FG001|STARTED|Overall Study||6||
59774281|NCT00851747|75894755|FG002|STARTED|Overall Study||6||
59774282|NCT00851747|75894753|FG000|COMPLETED|Overall Study||0||
59774283|NCT00851747|75894754|FG001|COMPLETED|Overall Study||0||
59774284|NCT00851747|75894755|FG002|COMPLETED|Overall Study||0||
59774285|NCT00851747|75894753|FG000|NOT COMPLETED|Overall Study||6||
59774286|NCT00851747|75894754|FG001|NOT COMPLETED|Overall Study||6||
59774287|NCT00851747|75894755|FG002|NOT COMPLETED|Overall Study||6||
59774288|NCT00767325|75894762|FG000|STARTED|Overall Study||104||
59774289|NCT00767325|75894762|FG000|COMPLETED|Overall Study||89||
59774290|NCT00767325|75894762|FG000|NOT COMPLETED|Overall Study||15||
59774291|NCT00851591|75894768|FG000|STARTED|Overall Study|These 2 participants did not receive treatment.|2||
59774292|NCT00851591|75894769|FG001|STARTED|Overall Study|One received treatment.|1||
59774293|NCT00851591|75894768|FG000|COMPLETED|Overall Study||0||
59774294|NCT00851591|75894769|FG001|COMPLETED|Overall Study||1||
59774295|NCT00851591|75894768|FG000|NOT COMPLETED|Overall Study||2||
59774296|NCT00851591|75894769|FG001|NOT COMPLETED|Overall Study||0||
59774297|NCT00861341|75894775|FG000|STARTED|Overall Study||40||
59774298|NCT00861341|75894775|FG000|COMPLETED|Overall Study||38||
59774299|NCT00861341|75894775|FG000|NOT COMPLETED|Overall Study||2||
59774300|NCT00766467|75894781|FG000|STARTED|Overall Study||42||
59774301|NCT00766467|75894782|FG001|STARTED|Overall Study||39||
59774302|NCT00766467|75894781|FG000|Initiated Treatment|Overall Study||39||
59774303|NCT00766467|75894782|FG001|Initiated Treatment|Overall Study||38||
59774304|NCT00766467|75894781|FG000|COMPLETED|Overall Study||31||
59774305|NCT00766467|75894782|FG001|COMPLETED|Overall Study||31||
59774306|NCT00766467|75894781|FG000|NOT COMPLETED|Overall Study||11||
59774307|NCT00766467|75894782|FG001|NOT COMPLETED|Overall Study||8||
59774308|NCT00850499|75894790|FG000|STARTED|Overall Study||4||
59774309|NCT00850499|75894791|FG001|STARTED|Overall Study||8||
59774310|NCT00850499|75894790|FG000|COMPLETED|Overall Study||1||
59774311|NCT00850499|75894791|FG001|COMPLETED|Overall Study||6||
59774312|NCT00850499|75894790|FG000|NOT COMPLETED|Overall Study||3||
59774313|NCT00850499|75894791|FG001|NOT COMPLETED|Overall Study||2||
59774314|NCT00860951|75894797|FG000|STARTED|Overall Study||29||
59774315|NCT00860951|75894797|FG000|COMPLETED|Overall Study||22||
59774316|NCT00860951|75894797|FG000|NOT COMPLETED|Overall Study||7||
59774317|NCT03123549|75894805|FG000|STARTED|Overall Study||182||
59774318|NCT03123549|75894806|FG001|STARTED|Overall Study||170||
59774319|NCT03123549|75894805|FG000|COMPLETED|Overall Study|"For subject accounting purposes, completed is defined as having either a 24-month change in NDI score or an available motor neurological assessment at 24-months."|168||
59774320|NCT03123549|75894806|FG001|COMPLETED|Overall Study|"For subject accounting purposes, completed is defined as having either a 24-month change in NDI score or an available motor neurological assessment at 24-months."|127||
59774321|NCT03123549|75894805|FG000|NOT COMPLETED|Overall Study||14||
59774322|NCT03123549|75894806|FG001|NOT COMPLETED|Overall Study||43||
59774323|NCT00844805|75894815|FG000|STARTED|Treatment Phase||106||
59774324|NCT00844805|75894816|FG001|STARTED|Treatment Phase||52||
59774325|NCT00844805|75894817|FG002|STARTED|Treatment Phase||0||
59774326|NCT00844805|75894818|FG003|STARTED|Treatment Phase||0||
59774327|NCT00844805|75894815|FG000|COMPLETED|Treatment Phase||96||
59774328|NCT00844805|75894816|FG001|COMPLETED|Treatment Phase||45||
59774329|NCT00844805|75894817|FG002|COMPLETED|Treatment Phase||0||
59774330|NCT00844805|75894818|FG003|COMPLETED|Treatment Phase||0||
59774331|NCT00844805|75894815|FG000|NOT COMPLETED|Treatment Phase||10||
59774332|NCT00844805|75894816|FG001|NOT COMPLETED|Treatment Phase||7||
59774333|NCT00844805|75894817|FG002|NOT COMPLETED|Treatment Phase||0||
59774334|NCT00844805|75894818|FG003|NOT COMPLETED|Treatment Phase||0||
59774335|NCT00844805|75894815|FG000|STARTED|Follow-Up Phase||0||
59774336|NCT00844805|75894816|FG001|STARTED|Follow-Up Phase||0||
59774337|NCT00844805|75894817|FG002|STARTED|Follow-Up Phase|Participants who met partial remission criteria at the end of treatment entered the Follow-Up Phase.|41||
59774338|NCT00844805|75894818|FG003|STARTED|Follow-Up Phase|Participants who met partial remission criteria at the end of treatment entered the Follow-Up Phase.|41||
59774339|NCT00844805|75894815|FG000|COMPLETED|Follow-Up Phase||0||
59774340|NCT00844805|75894816|FG001|COMPLETED|Follow-Up Phase||0||
59774341|NCT00844805|75894817|FG002|COMPLETED|Follow-Up Phase||32||
59774342|NCT00844805|75894818|FG003|COMPLETED|Follow-Up Phase||32||
59774343|NCT00844805|75894815|FG000|NOT COMPLETED|Follow-Up Phase||0||
59774344|NCT00844805|75894816|FG001|NOT COMPLETED|Follow-Up Phase||0||
59774345|NCT00844805|75894817|FG002|NOT COMPLETED|Follow-Up Phase||9||
59774346|NCT00844805|75894818|FG003|NOT COMPLETED|Follow-Up Phase||9||
59774347|NCT00765999|75894829|FG000|STARTED|Overall Study||1554||
59774348|NCT00765999|75894829|FG000|COMPLETED|Overall Study||770||
59774349|NCT00765999|75894829|FG000|NOT COMPLETED|Overall Study||784||
59774350|NCT00765843|75894838|FG000|STARTED|Overall Study||26||
59774351|NCT00765843|75894839|FG001|STARTED|Overall Study||25||
59774352|NCT00765843|75894840|FG002|STARTED|Overall Study||26||
59774353|NCT00765843|75894838|FG000|COMPLETED|Overall Study||25||
59774354|NCT00765843|75894839|FG001|COMPLETED|Overall Study||21||
59774355|NCT00765843|75894840|FG002|COMPLETED|Overall Study||23||
59774356|NCT00765843|75894838|FG000|NOT COMPLETED|Overall Study||1||
59774357|NCT00765843|75894839|FG001|NOT COMPLETED|Overall Study||4||
59774358|NCT00765843|75894840|FG002|NOT COMPLETED|Overall Study||3||
59774359|NCT00765063|75894848|FG000|STARTED|Overall Study||62||
59521883|NCT01222117|75616174|FG010|COMPLETED|Overall Study||6||
59774360|NCT00765063|75894848|FG000|COMPLETED|Overall Study||30||
59774361|NCT00765063|75894848|FG000|NOT COMPLETED|Overall Study||32||
59774362|NCT00764751|75894854|FG000|STARTED|Overall Study||39||
59774363|NCT00764751|75894855|FG001|STARTED|Overall Study||12||
59774364|NCT00764751|75894854|FG000|COMPLETED|Overall Study||37||
59774365|NCT00764751|75894855|FG001|COMPLETED|Overall Study||11||
59774366|NCT00764751|75894854|FG000|NOT COMPLETED|Overall Study||2||
59774367|NCT00764751|75894855|FG001|NOT COMPLETED|Overall Study||1||
59774368|NCT00764673|75894866|FG000|STARTED|Overall Study||71||
59774369|NCT00764673|75894866|FG000|COMPLETED|Overall Study||59||
59774370|NCT00764673|75894866|FG000|NOT COMPLETED|Overall Study||12||
59774371|NCT00764517|75894872|FG000|STARTED|Overall Study||39||
59774372|NCT00764517|75894873|FG001|STARTED|Overall Study||18||
59774373|NCT00764517|75894872|FG000|COMPLETED|Overall Study||24||
59774374|NCT00764517|75894873|FG001|COMPLETED|Overall Study||4||
59774375|NCT00764517|75894872|FG000|NOT COMPLETED|Overall Study||15||
59774376|NCT00764517|75894873|FG001|NOT COMPLETED|Overall Study||14||
59774377|NCT00764361|75894881|FG000|STARTED|Overall Study||8||
59774378|NCT00764361|75894882|FG001|STARTED|Overall Study||7||
59774379|NCT00764361|75894881|FG000|COMPLETED|Overall Study||6||
59774380|NCT00764361|75894882|FG001|COMPLETED|Overall Study||3||
59774381|NCT00764361|75894881|FG000|NOT COMPLETED|Overall Study||2||
59774382|NCT00764361|75894882|FG001|NOT COMPLETED|Overall Study||4||
59774383|NCT00763971|75894891|FG000|STARTED|Overall Study||113||
59774384|NCT00763971|75894892|FG001|STARTED|Overall Study||112||
59774385|NCT00763971|75894893|FG002|STARTED|Overall Study||111||
59774386|NCT00763971|75894891|FG000|COMPLETED|Overall Study||80||
59774387|NCT00763971|75894892|FG001|COMPLETED|Overall Study||74||
59774388|NCT00763971|75894893|FG002|COMPLETED|Overall Study||42||
59774389|NCT00763971|75894891|FG000|NOT COMPLETED|Overall Study||33||
59774390|NCT00763971|75894892|FG001|NOT COMPLETED|Overall Study||38||
59774391|NCT00763971|75894893|FG002|NOT COMPLETED|Overall Study||69||
59774392|NCT00763815|75894903|FG000|STARTED|Overall Study|Randomized.|161||
59774393|NCT00763815|75894904|FG001|STARTED|Overall Study||323||
59774394|NCT00763815|75894903|FG000|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|161||
59774395|NCT00763815|75894904|FG001|Treated/Safety Population|Overall Study||323||
59774396|NCT00763815|75894903|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|159||
59774397|NCT00763815|75894904|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||320||
59774398|NCT00763815|75894903|FG000|COMPLETED|Overall Study||109||
59774399|NCT00763815|75894904|FG001|COMPLETED|Overall Study||239||
59774400|NCT00763815|75894903|FG000|NOT COMPLETED|Overall Study||52||
59774401|NCT00763815|75894904|FG001|NOT COMPLETED|Overall Study||84||
59774402|NCT00763269|75894912|FG000|STARTED|Overall Study||314||
59774403|NCT00763269|75894913|FG001|STARTED|Overall Study||312||
59774404|NCT00763269|75894912|FG000|COMPLETED|Overall Study||302||
59774405|NCT00763269|75894913|FG001|COMPLETED|Overall Study||299||
59774406|NCT00763269|75894912|FG000|NOT COMPLETED|Overall Study||12||
59774407|NCT00763269|75894913|FG001|NOT COMPLETED|Overall Study||13||
59774408|NCT00763035|75894919|FG000|STARTED|First Intervention||10||
59774409|NCT00763035|75894920|FG001|STARTED|First Intervention||4||
59774410|NCT00763035|75894919|FG000|COMPLETED|First Intervention||9||
59774411|NCT00763035|75894920|FG001|COMPLETED|First Intervention||3||
59774412|NCT00763035|75894919|FG000|NOT COMPLETED|First Intervention||1||
59774413|NCT00763035|75894920|FG001|NOT COMPLETED|First Intervention||1||
59774414|NCT00763035|75894919|FG000|STARTED|Second Intervention||9||
59774415|NCT00763035|75894920|FG001|STARTED|Second Intervention||3||
59774416|NCT00763035|75894919|FG000|COMPLETED|Second Intervention||6||
59774417|NCT00763035|75894920|FG001|COMPLETED|Second Intervention||3||
59774418|NCT00763035|75894919|FG000|NOT COMPLETED|Second Intervention||3||
59774419|NCT00763035|75894920|FG001|NOT COMPLETED|Second Intervention||0||
59774420|NCT00844649|75894928|FG000|STARTED|Overall Study|Started = Intent to Treat Population and includes all randomized participants|431||
59774421|NCT00844649|75894929|FG001|STARTED|Overall Study|Started = Intent to Treat Population and includes all randomized participants|430||
59774422|NCT00844649|75894928|FG000|Treated Population|Overall Study|Treated population = all randomized patients who received at least one dose of study drug|421||
59774423|NCT00844649|75894929|FG001|Treated Population|Overall Study|Treated population = all randomized patients who received at least one dose of study drug|402||
59774424|NCT00844649|75894928|FG000|COMPLETED|Overall Study|Completed = participants remaining on treatment at the time of the data cut off 17 Sept 2012|26||
59774425|NCT00844649|75894929|FG001|COMPLETED|Overall Study|Completed = participants remaining on treatment at the time of the data cut off 17 Sept 2012|12||
59774426|NCT00844649|75894928|FG000|NOT COMPLETED|Overall Study||405||
59774427|NCT00844649|75894929|FG001|NOT COMPLETED|Overall Study||418||
59774428|NCT00762723|75894940|FG000|STARTED|Overall Study||5||
59774429|NCT00762723|75894941|FG001|STARTED|Overall Study||11||
59774430|NCT00762723|75894942|FG002|STARTED|Overall Study||3||
59774431|NCT00762723|75894940|FG000|COMPLETED|Overall Study||0||
59774432|NCT00762723|75894941|FG001|COMPLETED|Overall Study||6||
59774433|NCT00762723|75894942|FG002|COMPLETED|Overall Study||0||
59774434|NCT00762723|75894940|FG000|NOT COMPLETED|Overall Study||5||
59774435|NCT00762723|75894941|FG001|NOT COMPLETED|Overall Study||5||
59774436|NCT00762723|75894942|FG002|NOT COMPLETED|Overall Study||3||
59774437|NCT00850343|75894954|FG000|STARTED|Overall Study||110||
59774438|NCT00850343|75894955|FG001|STARTED|Overall Study||12||
59774439|NCT00850343|75894956|FG002|STARTED|Overall Study||43||
59774440|NCT00850343|75894957|FG003|STARTED|Overall Study||43||
59774441|NCT00850343|75894954|FG000|Completed Week 24|Overall Study||94||
59774442|NCT00850343|75894955|FG001|Completed Week 24|Overall Study||12||
59774443|NCT00850343|75894956|FG002|Completed Week 24|Overall Study||39||
59774444|NCT00850343|75894957|FG003|Completed Week 24|Overall Study||39||
59774445|NCT00850343|75894954|FG000|Completed Week 52|Overall Study||88||
59774446|NCT00850343|75894955|FG001|Completed Week 52|Overall Study||11||
59774447|NCT00850343|75894956|FG002|Completed Week 52|Overall Study||37||
59774448|NCT00850343|75894957|FG003|Completed Week 52|Overall Study||37||
59774449|NCT00850343|75894954|FG000|COMPLETED|Overall Study||64||
59774450|NCT00850343|75894955|FG001|COMPLETED|Overall Study||9||
59774451|NCT00850343|75894956|FG002|COMPLETED|Overall Study||29||
59774452|NCT00850343|75894957|FG003|COMPLETED|Overall Study||30||
59774453|NCT00850343|75894954|FG000|NOT COMPLETED|Overall Study||46||
59774454|NCT00850343|75894955|FG001|NOT COMPLETED|Overall Study||3||
59774455|NCT00850343|75894956|FG002|NOT COMPLETED|Overall Study||14||
59774456|NCT00850343|75894957|FG003|NOT COMPLETED|Overall Study||13||
59774457|NCT00849875|75894970|FG000|STARTED|Overall Study||48||
59774458|NCT00849875|75894970|FG000|COMPLETED|Overall Study||1||
59774459|NCT00849875|75894970|FG000|NOT COMPLETED|Overall Study||47||
59774460|NCT00844415|75894981|FG000|STARTED|Overall Study|Entered and treated.|9||
59774461|NCT00844415|75894981|FG000|Pat. Received 75mg Followed by 100mg|Overall Study||3||
59774462|NCT00844415|75894981|FG000|Pat. Received 100mg Followed by 125mg|Overall Study||3||
59774463|NCT00844415|75894981|FG000|Pat. Received 125mg Followed by 150mg|Overall Study||2||
59774464|NCT00844415|75894981|FG000|Pat. Received Single Dose 75mg|Overall Study||1||
59774465|NCT00844415|75894981|FG000|COMPLETED|Overall Study|Completed.|8||
59774466|NCT00844415|75894981|FG000|NOT COMPLETED|Overall Study||1||
59774467|NCT00843635|75894989|FG000|STARTED|Overall Study||15||
59774468|NCT00843635|75894990|FG001|STARTED|Overall Study||15||
59774469|NCT00843635|75894991|FG002|STARTED|Overall Study||5||
59774470|NCT00843635|75894989|FG000|COMPLETED|Overall Study||13||
59774471|NCT00843635|75894990|FG001|COMPLETED|Overall Study||13||
59774472|NCT00843635|75894991|FG002|COMPLETED|Overall Study||5||
59774473|NCT00843635|75894989|FG000|NOT COMPLETED|Overall Study||2||
59774474|NCT00843635|75894990|FG001|NOT COMPLETED|Overall Study||2||
59774475|NCT00843635|75894991|FG002|NOT COMPLETED|Overall Study||0||
59774476|NCT00843167|75895005|FG000|STARTED|Treatment Period||27||
59774477|NCT00843167|75895006|FG001|STARTED|Treatment Period||27||
59774478|NCT00843167|75895005|FG000|COMPLETED|Treatment Period||24||
59774479|NCT00843167|75895006|FG001|COMPLETED|Treatment Period||19||
59774480|NCT00843167|75895005|FG000|NOT COMPLETED|Treatment Period||3||
59774481|NCT00843167|75895006|FG001|NOT COMPLETED|Treatment Period||8||
59774482|NCT00843167|75895005|FG000|STARTED|Follow-up||24||
59774483|NCT00843167|75895006|FG001|STARTED|Follow-up||24||
59774484|NCT00843167|75895005|FG000|Completed Final Visit|Follow-up||24||
59774485|NCT00843167|75895006|FG001|Completed Final Visit|Follow-up||24||
59774486|NCT00843167|75895005|FG000|COMPLETED|Follow-up||24||
59774487|NCT00843167|75895006|FG001|COMPLETED|Follow-up||24||
59774488|NCT00843167|75895005|FG000|NOT COMPLETED|Follow-up||0||
59774489|NCT00843167|75895006|FG001|NOT COMPLETED|Follow-up||0||
59774490|NCT00849017|75895019|FG000|STARTED|Treatment Period (156 Weeks)||101||
59774491|NCT00849017|75895020|FG001|STARTED|Treatment Period (156 Weeks)||101||
59774492|NCT00849017|75895021|FG002|STARTED|Treatment Period (156 Weeks)||99||
59774493|NCT00849017|75895019|FG000|COMPLETED|Treatment Period (156 Weeks)||58||
59774494|NCT00849017|75895020|FG001|COMPLETED|Treatment Period (156 Weeks)||68||
59774495|NCT00849017|75895021|FG002|COMPLETED|Treatment Period (156 Weeks)||57||
59774496|NCT00849017|75895019|FG000|NOT COMPLETED|Treatment Period (156 Weeks)||43||
59774497|NCT00849017|75895020|FG001|NOT COMPLETED|Treatment Period (156 Weeks)||33||
59774498|NCT00849017|75895021|FG002|NOT COMPLETED|Treatment Period (156 Weeks)||42||
59774499|NCT00849017|75895019|FG000|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|101||
59774500|NCT00849017|75895020|FG001|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|101||
59774501|NCT00849017|75895021|FG002|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|99||
59774502|NCT00849017|75895019|FG000|COMPLETED|Follow-up Period (8 Weeks)||76||
59774503|NCT00849017|75895020|FG001|COMPLETED|Follow-up Period (8 Weeks)||83||
59774504|NCT00849017|75895021|FG002|COMPLETED|Follow-up Period (8 Weeks)||74||
59774505|NCT00849017|75895019|FG000|NOT COMPLETED|Follow-up Period (8 Weeks)||25||
59774506|NCT00849017|75895020|FG001|NOT COMPLETED|Follow-up Period (8 Weeks)||18||
59774507|NCT00849017|75895021|FG002|NOT COMPLETED|Follow-up Period (8 Weeks)||25||
59774508|NCT00842543|75895037|FG000|STARTED|Overall Study||13||
59774509|NCT00842543|75895038|FG001|STARTED|Overall Study||5||
59774510|NCT00842543|75895039|FG002|STARTED|Overall Study||13||
59774511|NCT00842543|75895040|FG003|STARTED|Overall Study||8||
59774512|NCT00842543|75895037|FG000|COMPLETED|Overall Study||11||
59774513|NCT00842543|75895038|FG001|COMPLETED|Overall Study||5||
59774514|NCT00842543|75895039|FG002|COMPLETED|Overall Study||10||
59774515|NCT00842543|75895040|FG003|COMPLETED|Overall Study||4||
59774516|NCT00842543|75895037|FG000|NOT COMPLETED|Overall Study||2||
59774517|NCT00842543|75895038|FG001|NOT COMPLETED|Overall Study||0||
59774518|NCT00842543|75895039|FG002|NOT COMPLETED|Overall Study||3||
59774519|NCT00842543|75895040|FG003|NOT COMPLETED|Overall Study||4||
59774520|NCT00785928|75895059|FG000|STARTED|Treatment Phase||36||
59774521|NCT00785928|75895060|FG001|STARTED|Treatment Phase||30||
59774522|NCT00785928|75895061|FG002|STARTED|Treatment Phase||20||
59774523|NCT00785928|75895062|FG003|STARTED|Treatment Phase||15||
59774524|NCT00785928|75895063|FG004|STARTED|Treatment Phase||18||
59774525|NCT00785928|75895064|FG005|STARTED|Treatment Phase||13||
59774526|NCT00785928|75895065|FG006|STARTED|Treatment Phase||26||
59774527|NCT00785928|75895059|FG000|COMPLETED|Treatment Phase||33||
59774528|NCT00785928|75895060|FG001|COMPLETED|Treatment Phase||25||
59774529|NCT00785928|75895061|FG002|COMPLETED|Treatment Phase||17||
59774530|NCT00785928|75895062|FG003|COMPLETED|Treatment Phase||15||
59774531|NCT00785928|75895063|FG004|COMPLETED|Treatment Phase||16||
59774532|NCT00785928|75895064|FG005|COMPLETED|Treatment Phase||13||
59774533|NCT00785928|75895065|FG006|COMPLETED|Treatment Phase||23||
59774534|NCT00785928|75895059|FG000|NOT COMPLETED|Treatment Phase||3||
59774535|NCT00785928|75895060|FG001|NOT COMPLETED|Treatment Phase||5||
59774536|NCT00785928|75895061|FG002|NOT COMPLETED|Treatment Phase||3||
59774537|NCT00785928|75895062|FG003|NOT COMPLETED|Treatment Phase||0||
59774538|NCT00785928|75895063|FG004|NOT COMPLETED|Treatment Phase||2||
59774539|NCT00785928|75895064|FG005|NOT COMPLETED|Treatment Phase||0||
59774540|NCT00785928|75895065|FG006|NOT COMPLETED|Treatment Phase||3||
59774541|NCT00785928|75895059|FG000|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|8||
59774542|NCT00785928|75895060|FG001|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|8||
59774543|NCT00785928|75895061|FG002|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|6||
59774544|NCT00785928|75895062|FG003|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|4||
59774545|NCT00785928|75895063|FG004|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|6||
59774546|NCT00785928|75895064|FG005|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|0||
59774547|NCT00785928|75895065|FG006|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|14||
59774548|NCT00785928|75895059|FG000|COMPLETED|Follow-up Phases (Weeks 24-72)||7||
59774549|NCT00785928|75895060|FG001|COMPLETED|Follow-up Phases (Weeks 24-72)||5||
59774550|NCT00785928|75895061|FG002|COMPLETED|Follow-up Phases (Weeks 24-72)||4||
59774551|NCT00785928|75895062|FG003|COMPLETED|Follow-up Phases (Weeks 24-72)||4||
59774552|NCT00785928|75895063|FG004|COMPLETED|Follow-up Phases (Weeks 24-72)||4||
59774553|NCT00785928|75895064|FG005|COMPLETED|Follow-up Phases (Weeks 24-72)||0||
59774554|NCT00785928|75895065|FG006|COMPLETED|Follow-up Phases (Weeks 24-72)||9||
59774555|NCT00785928|75895059|FG000|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||1||
59774556|NCT00785928|75895060|FG001|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||3||
59774557|NCT00785928|75895061|FG002|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||2||
59774558|NCT00785928|75895062|FG003|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||0||
59774559|NCT00785928|75895063|FG004|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||2||
59774560|NCT00785928|75895064|FG005|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||0||
59774561|NCT00785928|75895065|FG006|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||5||
59774562|NCT00842309|75895105|FG000|STARTED|Overall Study|14 randomized. 2 withdrew prior to initiating DCS-not included in modified intent-to-treat analyses.|14||
59774563|NCT00842309|75895106|FG001|STARTED|Overall Study||14||
59774564|NCT00842309|75895105|FG000|COMPLETED|Overall Study||11||
59774565|NCT00842309|75895106|FG001|COMPLETED|Overall Study||13||
59774566|NCT00842309|75895105|FG000|NOT COMPLETED|Overall Study||3||
59774567|NCT00842309|75895106|FG001|NOT COMPLETED|Overall Study||1||
59774568|NCT00842153|75895114|FG000|STARTED|Overall Study||28||
59774569|NCT00842153|75895115|FG001|STARTED|Overall Study||30||
59774570|NCT00842153|75895114|FG000|COMPLETED|Overall Study||27||
59774571|NCT00842153|75895115|FG001|COMPLETED|Overall Study||27||
59774572|NCT00842153|75895114|FG000|NOT COMPLETED|Overall Study||1||
59774573|NCT00842153|75895115|FG001|NOT COMPLETED|Overall Study||3||
59774574|NCT00762411|75895123|FG000|STARTED|Initial Treatment||556||
59774575|NCT00762411|75895124|FG001|STARTED|Initial Treatment||555||
59774576|NCT00762411|75895123|FG000|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants(pts) who received at least 1 dose of study drug.|555||
59774577|NCT00762411|75895124|FG001|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants who received at least 1 dose of study drug.|553||
59774578|NCT00762411|75895123|FG000|COMPLETED|Initial Treatment||22||
59774579|NCT00762411|75895124|FG001|COMPLETED|Initial Treatment||34||
59774580|NCT00762411|75895123|FG000|NOT COMPLETED|Initial Treatment||534||
59774581|NCT00762411|75895124|FG001|NOT COMPLETED|Initial Treatment||521||
59774582|NCT00762411|75895123|FG000|STARTED|Delayed Start||22||
59774583|NCT00762411|75895124|FG001|STARTED|Delayed Start||34||
59774584|NCT00762411|75895123|FG000|COMPLETED|Delayed Start||5||
59774585|NCT00762411|75895124|FG001|COMPLETED|Delayed Start||8||
59774586|NCT00762411|75895123|FG000|NOT COMPLETED|Delayed Start||17||
59774587|NCT00762411|75895124|FG001|NOT COMPLETED|Delayed Start||26||
59774588|NCT00762411|75895123|FG000|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional; pts entered from initial treatment and delayed start or did not enter SFU.|312||
59774589|NCT00762411|75895124|FG001|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional; pts entered from initial treatment and delayed start or did not enter SFU.|430||
59774590|NCT00762411|75895123|FG000|COMPLETED|Safety Follow Up (SFU)-Optional||228||
59774591|NCT00762411|75895124|FG001|COMPLETED|Safety Follow Up (SFU)-Optional||312||
59774592|NCT00762411|75895123|FG000|NOT COMPLETED|Safety Follow Up (SFU)-Optional||84||
59774593|NCT00762411|75895124|FG001|NOT COMPLETED|Safety Follow Up (SFU)-Optional||118||
59774594|NCT00761865|75895136|FG000|STARTED|Overall Study||16||
59774595|NCT00761865|75895137|FG001|STARTED|Overall Study||18||
59774596|NCT00761865|75895136|FG000|COMPLETED|Overall Study||8||
59774597|NCT00761865|75895137|FG001|COMPLETED|Overall Study||11||
59774598|NCT00761865|75895136|FG000|NOT COMPLETED|Overall Study||8||
59774599|NCT00761865|75895137|FG001|NOT COMPLETED|Overall Study||7||
59774600|NCT00841763|75895145|FG000|STARTED|Overall Study||2691||
60072779|NCT01594125|76187974|FG004|STARTED|Overall Study||7||
60072780|NCT01594125|76187970|FG000|COMPLETED|Overall Study||0||
60072781|NCT01594125|76187971|FG001|COMPLETED|Overall Study||0||
60072782|NCT01594125|76187972|FG002|COMPLETED|Overall Study||0||
60072783|NCT01594125|76187973|FG003|COMPLETED|Overall Study||0||
60072784|NCT01594125|76187974|FG004|COMPLETED|Overall Study||0||
60072785|NCT01594125|76187970|FG000|NOT COMPLETED|Overall Study||4||
59774601|NCT00841763|75895146|FG001|STARTED|Overall Study||681||
59774602|NCT00841763|75895147|FG002|STARTED|Overall Study||219||
59774603|NCT00841763|75895148|FG003|STARTED|Overall Study||56||
59774604|NCT00841763|75895145|FG000|COMPLETED|Overall Study||2529||
59774605|NCT00841763|75895146|FG001|COMPLETED|Overall Study||624||
59774606|NCT00841763|75895147|FG002|COMPLETED|Overall Study||211||
59774607|NCT00841763|75895148|FG003|COMPLETED|Overall Study||53||
59774608|NCT00841763|75895145|FG000|NOT COMPLETED|Overall Study||162||
59774609|NCT00841763|75895146|FG001|NOT COMPLETED|Overall Study||57||
59774610|NCT00841763|75895147|FG002|NOT COMPLETED|Overall Study||8||
59774611|NCT00841763|75895148|FG003|NOT COMPLETED|Overall Study||3||
59774612|NCT00838331|75895193|FG000|STARTED|Fresh Blood Transfusion||17||
59774613|NCT00838331|75895193|FG000|COMPLETED|Fresh Blood Transfusion||17||
59774614|NCT00838331|75895193|FG000|NOT COMPLETED|Fresh Blood Transfusion||0||
59774615|NCT00838331|75895193|FG000|STARTED|Aged Blood Transfusion||17||
59774616|NCT00838331|75895193|FG000|COMPLETED|Aged Blood Transfusion||8||
59774617|NCT00838331|75895193|FG000|NOT COMPLETED|Aged Blood Transfusion||9||
59774618|NCT00785538|75895201|FG000|STARTED|PK Period||7||
59774619|NCT00785538|75895202|FG001|STARTED|PK Period||1||
59774620|NCT00785538|75895203|FG002|STARTED|PK Period||1||
59774621|NCT00785538|75895204|FG003|STARTED|PK Period||0||
59774622|NCT00785538|75895201|FG000|COMPLETED|PK Period||7||
59774623|NCT00785538|75895202|FG001|COMPLETED|PK Period||1||
59774624|NCT00785538|75895203|FG002|COMPLETED|PK Period||1||
59774625|NCT00785538|75895204|FG003|COMPLETED|PK Period||0||
59774626|NCT00785538|75895201|FG000|NOT COMPLETED|PK Period||0||
59774627|NCT00785538|75895202|FG001|NOT COMPLETED|PK Period||0||
59774628|NCT00785538|75895203|FG002|NOT COMPLETED|PK Period||0||
59774629|NCT00785538|75895204|FG003|NOT COMPLETED|PK Period||0||
59774630|NCT00785538|75895201|FG000|STARTED|Treatment Period||7||
59774631|NCT00785538|75895202|FG001|STARTED|Treatment Period||9||
59774632|NCT00785538|75895203|FG002|STARTED|Treatment Period||6||
59774633|NCT00785538|75895204|FG003|STARTED|Treatment Period||2||
59774634|NCT00785538|75895201|FG000|Received at Least 1 Dose of Study Drug|Treatment Period||7||
59774635|NCT00785538|75895202|FG001|Received at Least 1 Dose of Study Drug|Treatment Period||9||
59774636|NCT00785538|75895203|FG002|Received at Least 1 Dose of Study Drug|Treatment Period||6||
59774637|NCT00785538|75895204|FG003|Received at Least 1 Dose of Study Drug|Treatment Period||2||
59774638|NCT00785538|75895201|FG000|COMPLETED|Treatment Period||6||
59774639|NCT00785538|75895202|FG001|COMPLETED|Treatment Period||7||
59774640|NCT00785538|75895203|FG002|COMPLETED|Treatment Period||4||
59774641|NCT00785538|75895204|FG003|COMPLETED|Treatment Period||1||
59774642|NCT00785538|75895201|FG000|NOT COMPLETED|Treatment Period||1||
59774643|NCT00785538|75895202|FG001|NOT COMPLETED|Treatment Period||2||
59774644|NCT00785538|75895203|FG002|NOT COMPLETED|Treatment Period||2||
59774645|NCT00785538|75895204|FG003|NOT COMPLETED|Treatment Period||1||
59774646|NCT00860405|75895217|FG000|STARTED|Overall Study||31||
59774647|NCT00860405|75895218|FG001|STARTED|Overall Study||30||
59774648|NCT00860405|75895217|FG000|Completed Treatment|Overall Study||31||
59774649|NCT00860405|75895218|FG001|Completed Treatment|Overall Study||29||
59774650|NCT00860405|75895217|FG000|Day 28 Follow-up Performed|Overall Study||31||
59774651|NCT00860405|75895218|FG001|Day 28 Follow-up Performed|Overall Study||29||
59774652|NCT00860405|75895217|FG000|COMPLETED|Overall Study|completed overall study|26||
59774653|NCT00860405|75895218|FG001|COMPLETED|Overall Study||26||
59774654|NCT00860405|75895217|FG000|NOT COMPLETED|Overall Study||5||
59774655|NCT00860405|75895218|FG001|NOT COMPLETED|Overall Study||4||
59774656|NCT00838097|75895224|FG000|STARTED|Overall Study||321||
59774657|NCT00838097|75895224|FG000|Received Darbepoetin Alfa|Overall Study||319||
59774658|NCT00838097|75895224|FG000|COMPLETED|Overall Study||145||
59774659|NCT00838097|75895224|FG000|NOT COMPLETED|Overall Study||176||
59774660|NCT00840827|75895228|FG000|STARTED|Overall Study||6||
59774661|NCT00840827|75895228|FG000|COMPLETED|Overall Study||0||
59774662|NCT00840827|75895228|FG000|NOT COMPLETED|Overall Study||6||
59774663|NCT00860249|75895235|FG000|STARTED|Overall Study||21||
59774664|NCT00860249|75895236|FG001|STARTED|Overall Study||18||
59774665|NCT00860249|75895237|FG002|STARTED|Overall Study||21||
59774666|NCT00860249|75895235|FG000|COMPLETED|Overall Study||0||
59774667|NCT00860249|75895236|FG001|COMPLETED|Overall Study||0||
59774668|NCT00860249|75895237|FG002|COMPLETED|Overall Study||0||
59774669|NCT00860249|75895235|FG000|NOT COMPLETED|Overall Study||21||
59774670|NCT00860249|75895236|FG001|NOT COMPLETED|Overall Study||18||
59774671|NCT00860249|75895237|FG002|NOT COMPLETED|Overall Study||21||
59774672|NCT00840749|75895247|FG000|STARTED|Overall Study|includes patients who were screened but did not end up treated on protocol|31||
59774673|NCT00840749|75895248|FG001|STARTED|Overall Study|includes patients who were screened but did not end up treated on protocol|27||
59774674|NCT00840749|75895247|FG000|Treatment|Overall Study||20||
59774675|NCT00840749|75895248|FG001|Treatment|Overall Study||16||
59774676|NCT00840749|75895247|FG000|1 Month Post tx|Overall Study||19||
59774677|NCT00840749|75895248|FG001|1 Month Post tx|Overall Study||15||
59774678|NCT00840749|75895247|FG000|6 Months Post tx|Overall Study||16||
59774679|NCT00840749|75895248|FG001|6 Months Post tx|Overall Study||10||
59774680|NCT00840749|75895247|FG000|12 Months Post tx|Overall Study||14||
59774681|NCT00840749|75895248|FG001|12 Months Post tx|Overall Study||7||
59774682|NCT00840749|75895247|FG000|18 Months Post tx|Overall Study||12||
59774683|NCT00840749|75895248|FG001|18 Months Post tx|Overall Study||6||
59774684|NCT00840749|75895247|FG000|24 Months Post tx|Overall Study||9||
59774685|NCT00840749|75895248|FG001|24 Months Post tx|Overall Study||3||
59774686|NCT00840749|75895247|FG000|36 Months Post tx|Overall Study||1||
59774687|NCT00840749|75895248|FG001|36 Months Post tx|Overall Study||0||
59774688|NCT00840749|75895247|FG000|COMPLETED|Overall Study||0||
59774689|NCT00840749|75895248|FG001|COMPLETED|Overall Study||0||
59774690|NCT00840749|75895247|FG000|NOT COMPLETED|Overall Study||31||
59774691|NCT00840749|75895248|FG001|NOT COMPLETED|Overall Study||27||
59774692|NCT00859937|75895256|FG000|STARTED|Overall Study||41||
59774693|NCT00859937|75895257|FG001|STARTED|Overall Study||14||
59774694|NCT00859937|75895256|FG000|COMPLETED|Overall Study||40||
59774695|NCT00859937|75895257|FG001|COMPLETED|Overall Study||14||
59774696|NCT00859937|75895256|FG000|NOT COMPLETED|Overall Study||1||
59774697|NCT00859937|75895257|FG001|NOT COMPLETED|Overall Study||0||
59774698|NCT00592007|75895263|FG000|STARTED|Overall Study||7||
59774699|NCT00592007|75895263|FG000|COMPLETED|Overall Study||5||
59774700|NCT00592007|75895263|FG000|NOT COMPLETED|Overall Study||2||
59774701|NCT00837473|75895267|FG000|STARTED|Overall Study||15||
59774702|NCT00837473|75895267|FG000|COMPLETED|Overall Study||12||
59774703|NCT00837473|75895267|FG000|NOT COMPLETED|Overall Study||3||
59774704|NCT00839423|75895275|FG000|STARTED|Overall Study||105||
59774705|NCT00839423|75895276|FG001|STARTED|Overall Study||108||
59774706|NCT00839423|75895277|FG002|STARTED|Overall Study||100||
59774707|NCT00839423|75895278|FG003|STARTED|Overall Study||113||
59774708|NCT00839423|75895275|FG000|COMPLETED|Overall Study||87||
59774709|NCT00839423|75895276|FG001|COMPLETED|Overall Study||98||
59774710|NCT00839423|75895277|FG002|COMPLETED|Overall Study||82||
59774711|NCT00839423|75895278|FG003|COMPLETED|Overall Study||93||
59774712|NCT00839423|75895275|FG000|NOT COMPLETED|Overall Study||18||
59774713|NCT00839423|75895276|FG001|NOT COMPLETED|Overall Study||10||
59774714|NCT00839423|75895277|FG002|NOT COMPLETED|Overall Study||18||
59774715|NCT00839423|75895278|FG003|NOT COMPLETED|Overall Study||20||
59774716|NCT00837161|75895288|FG000|STARTED|Overall Study||11||
59774717|NCT00837161|75895288|FG000|COMPLETED|Overall Study||9||
59774718|NCT00837161|75895288|FG000|NOT COMPLETED|Overall Study||2||
59774719|NCT00859547|75895292|FG000|STARTED|Overall Study||30||
59774720|NCT00859547|75895292|FG000|COMPLETED|Overall Study||28||
59774721|NCT00859547|75895292|FG000|NOT COMPLETED|Overall Study||2||
59774722|NCT00859469|75895296|FG000|STARTED|Overall Study||29||
59774723|NCT00859469|75895296|FG000|6 Cycles|Overall Study||16||
59774724|NCT00859469|75895296|FG000|COMPLETED|Overall Study||1||
59774725|NCT00859469|75895296|FG000|NOT COMPLETED|Overall Study||28||
59774726|NCT00859313|75895300|FG000|STARTED|Overall Study||30||
59774727|NCT00859313|75895300|FG000|COMPLETED|Overall Study||26||
59774728|NCT00859313|75895300|FG000|NOT COMPLETED|Overall Study||4||
59774729|NCT00771810|75895307|FG000|STARTED|Overall Study||10||
59774730|NCT00771810|75895308|FG001|STARTED|Overall Study||11||
59774731|NCT00771810|75895309|FG002|STARTED|Overall Study||13||
59774732|NCT00771810|75895307|FG000|COMPLETED|Overall Study||5||
59774733|NCT00771810|75895308|FG001|COMPLETED|Overall Study||6||
59774734|NCT00771810|75895309|FG002|COMPLETED|Overall Study||6||
59774735|NCT00771810|75895307|FG000|NOT COMPLETED|Overall Study||5||
59774736|NCT00771810|75895308|FG001|NOT COMPLETED|Overall Study||5||
59774737|NCT00771810|75895309|FG002|NOT COMPLETED|Overall Study||7||
59774738|NCT00836927|75895323|FG000|STARTED|Overall Study||3||
59774739|NCT00836927|75895324|FG001|STARTED|Overall Study||1||
59774740|NCT00836927|75895325|FG002|STARTED|Overall Study|One participant received ridaforolimus 3 mg IV infusion before being switched to the oral tablet.|1||
59774741|NCT00836927|75895326|FG003|STARTED|Overall Study||1||
59774742|NCT00836927|75895327|FG004|STARTED|Overall Study||1||
59774743|NCT00836927|75895323|FG000|Completed Dosing Through 03 Apr 2017|Overall Study||0||
59774744|NCT00836927|75895324|FG001|Completed Dosing Through 03 Apr 2017|Overall Study|Participant continued to receive study drug past the data cut-off date of 03 Apr 2017|1||
59774745|NCT00836927|75895325|FG002|Completed Dosing Through 03 Apr 2017|Overall Study|Participant continued to receive study drug past the data cut-off date of 03 Apr 2017|1||
59774746|NCT00836927|75895326|FG003|Completed Dosing Through 03 Apr 2017|Overall Study||0||
59774747|NCT00836927|75895327|FG004|Completed Dosing Through 03 Apr 2017|Overall Study||0||
59774748|NCT00836927|75895323|FG000|COMPLETED|Overall Study||0||
59774749|NCT00836927|75895324|FG001|COMPLETED|Overall Study|Participant completed treatment by 04 Feb 2018|1||
59774750|NCT00836927|75895325|FG002|COMPLETED|Overall Study|Participant completed treatment by 04 Feb 2018|1||
59774751|NCT00836927|75895326|FG003|COMPLETED|Overall Study||0||
59774752|NCT00836927|75895327|FG004|COMPLETED|Overall Study||0||
59774753|NCT00836927|75895323|FG000|NOT COMPLETED|Overall Study||3||
59774754|NCT00836927|75895324|FG001|NOT COMPLETED|Overall Study||0||
59774755|NCT00836927|75895325|FG002|NOT COMPLETED|Overall Study||0||
59774756|NCT00836927|75895326|FG003|NOT COMPLETED|Overall Study||1||
59774757|NCT00836927|75895327|FG004|NOT COMPLETED|Overall Study||1||
59774758|NCT00771030|75895348|FG000|STARTED|Overall Study||6||
59774759|NCT00771030|75895349|FG001|STARTED|Overall Study||4||
59774760|NCT00771030|75895350|FG002|STARTED|Overall Study||6||
59774761|NCT00771030|75895351|FG003|STARTED|Overall Study||6||
59774762|NCT00771030|75895352|FG004|STARTED|Overall Study||6||
59774763|NCT00771030|75895353|FG005|STARTED|Overall Study||6||
59774764|NCT00771030|75895354|FG006|STARTED|Overall Study||6||
59774765|NCT00771030|75895348|FG000|Received Study Drug|Overall Study||6|Study drug refers to placebo or brodalumab|
59774766|NCT00771030|75895349|FG001|Received Study Drug|Overall Study||4|Study drug refers to placebo or brodalumab|
59774767|NCT00771030|75895350|FG002|Received Study Drug|Overall Study||6|Study drug refers to placebo or brodalumab|
59774768|NCT00771030|75895351|FG003|Received Study Drug|Overall Study||6|Study drug refers to placebo or brodalumab|
59774769|NCT00771030|75895352|FG004|Received Study Drug|Overall Study||6|Study drug refers to placebo or brodalumab|
59774770|NCT00771030|75895353|FG005|Received Study Drug|Overall Study||6|Study drug refers to placebo or brodalumab|
59774771|NCT00771030|75895354|FG006|Received Study Drug|Overall Study||6|Study drug refers to placebo or brodalumab|
59774772|NCT00771030|75895348|FG000|COMPLETED|Overall Study||6||
59774773|NCT00771030|75895349|FG001|COMPLETED|Overall Study||3||
59774774|NCT00771030|75895350|FG002|COMPLETED|Overall Study||6||
59774775|NCT00771030|75895351|FG003|COMPLETED|Overall Study||6||
59774776|NCT00771030|75895352|FG004|COMPLETED|Overall Study||6||
59774777|NCT00771030|75895353|FG005|COMPLETED|Overall Study||6||
59774778|NCT00771030|75895354|FG006|COMPLETED|Overall Study||6||
59521884|NCT01222117|75616164|FG000|NOT COMPLETED|Overall Study||3||
59774779|NCT00771030|75895348|FG000|NOT COMPLETED|Overall Study||0||
59774780|NCT00771030|75895349|FG001|NOT COMPLETED|Overall Study||1||
59774781|NCT00771030|75895350|FG002|NOT COMPLETED|Overall Study||0||
59774782|NCT00771030|75895351|FG003|NOT COMPLETED|Overall Study||0||
59774783|NCT00771030|75895352|FG004|NOT COMPLETED|Overall Study||0||
59774784|NCT00771030|75895353|FG005|NOT COMPLETED|Overall Study||0||
59774785|NCT00771030|75895354|FG006|NOT COMPLETED|Overall Study||0||
59774786|NCT00768300|75895377|FG000|STARTED|Overall Study||330||
59774787|NCT00768300|75895378|FG001|STARTED|Overall Study||164||
59774788|NCT00768300|75895377|FG000|Randomized and Treated|Overall Study||329||
59774789|NCT00768300|75895378|FG001|Randomized and Treated|Overall Study||163||
59774790|NCT00768300|75895377|FG000|COMPLETED|Overall Study||1||
59774791|NCT00768300|75895378|FG001|COMPLETED|Overall Study||1||
59774792|NCT00768300|75895377|FG000|NOT COMPLETED|Overall Study||329||
59774793|NCT00768300|75895378|FG001|NOT COMPLETED|Overall Study||163||
59774794|NCT00768222|75895386|FG000|STARTED|Overall Study||50||
59774795|NCT00768222|75895387|FG001|STARTED|Overall Study||51||
59774796|NCT00768222|75895386|FG000|COMPLETED|Overall Study||46||
59774797|NCT00768222|75895387|FG001|COMPLETED|Overall Study||47||
59774798|NCT00768222|75895386|FG000|NOT COMPLETED|Overall Study||4||
59774799|NCT00768222|75895387|FG001|NOT COMPLETED|Overall Study||4||
59774800|NCT00768144|75895393|FG000|STARTED|Overall Study||36||
59774801|NCT00768144|75895393|FG000|COMPLETED|Overall Study||0||
59774802|NCT00768144|75895393|FG000|NOT COMPLETED|Overall Study||36||
59774803|NCT00784836|75895397|FG000|STARTED|Overall Study||3||
59774804|NCT00784836|75895397|FG000|COMPLETED|Overall Study|The study was terminated early by the Sponsor for business reason not related to safety.|0||
59774805|NCT00784836|75895397|FG000|NOT COMPLETED|Overall Study||3||
59774806|NCT00784758|75895403|FG000|STARTED|Overall Study||42||
59774807|NCT00784758|75895404|FG001|STARTED|Overall Study||39||
59774808|NCT00784758|75895403|FG000|Began Treatment|Overall Study||41||
59774809|NCT00784758|75895404|FG001|Began Treatment|Overall Study||39||
59774810|NCT00784758|75895403|FG000|Completed Treatment|Overall Study||40||
59774811|NCT00784758|75895404|FG001|Completed Treatment|Overall Study||39||
59774812|NCT00784758|75895403|FG000|COMPLETED|Overall Study||38||
59774813|NCT00784758|75895404|FG001|COMPLETED|Overall Study||39||
59774814|NCT00784758|75895403|FG000|NOT COMPLETED|Overall Study||4||
59774815|NCT00784758|75895404|FG001|NOT COMPLETED|Overall Study||0||
59521885|NCT01222117|75616165|FG001|NOT COMPLETED|Overall Study||1||
59521886|NCT01222117|75616166|FG002|NOT COMPLETED|Overall Study||0||
59521887|NCT01222117|75616167|FG003|NOT COMPLETED|Overall Study||1||
59521888|NCT01222117|75616168|FG004|NOT COMPLETED|Overall Study||1||
59521889|NCT01222117|75616169|FG005|NOT COMPLETED|Overall Study||1||
59521890|NCT01222117|75616170|FG006|NOT COMPLETED|Overall Study||0||
59521891|NCT01222117|75616171|FG007|NOT COMPLETED|Overall Study||0||
59521892|NCT01222117|75616172|FG008|NOT COMPLETED|Overall Study||3||
59521893|NCT01222117|75616173|FG009|NOT COMPLETED|Overall Study||2||
59521894|NCT01222117|75616174|FG010|NOT COMPLETED|Overall Study||0||
59618606|NCT03083665|75729704|FG005|NOT COMPLETED|Double-Blind Period||0||
59618607|NCT03083665|75729699|FG000|STARTED|Open-Label Temporary Period (OLTP)||0||
59618608|NCT03083665|75729700|FG001|STARTED|Open-Label Temporary Period (OLTP)||0||
59618609|NCT03083665|75729701|FG002|STARTED|Open-Label Temporary Period (OLTP)||0||
59618610|NCT03083665|75729702|FG003|STARTED|Open-Label Temporary Period (OLTP)||64||
59618611|NCT03083665|75729703|FG004|STARTED|Open-Label Temporary Period (OLTP)||68||
59618612|NCT03083665|75729704|FG005|STARTED|Open-Label Temporary Period (OLTP)||74||
59774816|NCT00768066|75895415|FG000|STARTED|Overall Study||22||
59521895|NCT01222195|75616198|FG000|STARTED|Overall Study||1||
59521896|NCT01222195|75616198|FG000|COMPLETED|Overall Study||1||
59521897|NCT01222195|75616198|FG000|NOT COMPLETED|Overall Study||0||
59521898|NCT01222273|75616202|FG000|STARTED|Overall Study||7||
59774817|NCT00768066|75895416|FG001|STARTED|Overall Study||22||
59774818|NCT00768066|75895417|FG002|STARTED|Overall Study||21||
59774819|NCT00768066|75895415|FG000|COMPLETED|Overall Study||19||
59774820|NCT00768066|75895416|FG001|COMPLETED|Overall Study||19||
59774821|NCT00768066|75895417|FG002|COMPLETED|Overall Study||21||
59774822|NCT00768066|75895415|FG000|NOT COMPLETED|Overall Study||3||
59774823|NCT00768066|75895416|FG001|NOT COMPLETED|Overall Study||3||
59774824|NCT00768066|75895417|FG002|NOT COMPLETED|Overall Study||0||
59774825|NCT00767676|75895425|FG000|STARTED|Overall Study||259||
59774826|NCT00767676|75895425|FG000|COMPLETED|Overall Study||205||
59774827|NCT00767676|75895425|FG000|NOT COMPLETED|Overall Study||54||
59774828|NCT00767520|75895431|FG000|STARTED|Overall Study||79||
59774829|NCT00767520|75895432|FG001|STARTED|Overall Study||78||
59774830|NCT00767520|75895431|FG000|COMPLETED|Overall Study|Completed=Off-treatment; Major reasons: disease progression-50, study drug toxicity-10,AE-3,Death-2|68||
59774831|NCT00767520|75895432|FG001|COMPLETED|Overall Study|Completed=Off-treatment; Major reasons: disease progression-56, study drug toxicity-2,AE-1,Death-1|61||
59774832|NCT00767520|75895431|FG000|NOT COMPLETED|Overall Study||11||
59774833|NCT00767520|75895432|FG001|NOT COMPLETED|Overall Study||17||
59774834|NCT00838565|75895444|FG000|STARTED|Overall Study||9||
59774835|NCT00838565|75895445|FG001|STARTED|Overall Study||7||
59774836|NCT00838565|75895446|FG002|STARTED|Overall Study||6||
59774837|NCT00838565|75895447|FG003|STARTED|Overall Study||6||
59774838|NCT00838565|75895448|FG004|STARTED|Overall Study||6||
59774839|NCT00838565|75895449|FG005|STARTED|Overall Study||7||
59774840|NCT00838565|75895444|FG000|Treated|Overall Study||9||
59774841|NCT00838565|75895445|FG001|Treated|Overall Study||6||
59774842|NCT00838565|75895446|FG002|Treated|Overall Study||6||
59774843|NCT00838565|75895447|FG003|Treated|Overall Study||6||
59774844|NCT00838565|75895448|FG004|Treated|Overall Study||6||
59774845|NCT00838565|75895449|FG005|Treated|Overall Study||7||
59774846|NCT00838565|75895444|FG000|COMPLETED|Overall Study||9||
59774847|NCT00838565|75895445|FG001|COMPLETED|Overall Study||4||
59774848|NCT00838565|75895446|FG002|COMPLETED|Overall Study||5||
59774849|NCT00838565|75895447|FG003|COMPLETED|Overall Study||6||
59774850|NCT00838565|75895448|FG004|COMPLETED|Overall Study||6||
59774851|NCT00838565|75895449|FG005|COMPLETED|Overall Study||5||
59774852|NCT00838565|75895444|FG000|NOT COMPLETED|Overall Study||0||
59774853|NCT00838565|75895445|FG001|NOT COMPLETED|Overall Study||3||
59774854|NCT00838565|75895446|FG002|NOT COMPLETED|Overall Study||1||
59774855|NCT00838565|75895447|FG003|NOT COMPLETED|Overall Study||0||
59774856|NCT00838565|75895448|FG004|NOT COMPLETED|Overall Study||0||
59774857|NCT00838565|75895449|FG005|NOT COMPLETED|Overall Study||2||
59774858|NCT00858845|75895470|FG000|STARTED|Overall Study||5||
59521899|NCT01222273|75616202|FG000|COMPLETED|Overall Study||7||
59521900|NCT01222273|75616202|FG000|NOT COMPLETED|Overall Study||0||
59521901|NCT01222585|75616206|FG000|STARTED|Overall Study||24||
59521902|NCT01222585|75616206|FG000|COMPLETED|Overall Study||24||
59774859|NCT00858845|75895471|FG001|STARTED|Overall Study||6||
59774860|NCT00858845|75895470|FG000|COMPLETED|Overall Study||5||
59774861|NCT00858845|75895471|FG001|COMPLETED|Overall Study||5||
59774862|NCT00858845|75895470|FG000|NOT COMPLETED|Overall Study||0||
59774863|NCT00858845|75895471|FG001|NOT COMPLETED|Overall Study||1||
59774864|NCT00770562|75895479|FG000|STARTED|Overall Study||53||
59774865|NCT00770562|75895480|FG001|STARTED|Overall Study||50||
59774866|NCT00770562|75895479|FG000|COMPLETED|Overall Study||52||
59774867|NCT00770562|75895480|FG001|COMPLETED|Overall Study||49||
59774868|NCT00770562|75895479|FG000|NOT COMPLETED|Overall Study||1||
59774869|NCT00770562|75895480|FG001|NOT COMPLETED|Overall Study||1||
59774870|NCT00836693|75895489|FG000|STARTED|Overall Study||147||
59774871|NCT00836693|75895490|FG001|STARTED|Overall Study||70||
59774872|NCT00836693|75895489|FG000|COMPLETED|Overall Study||130||
59774873|NCT00836693|75895490|FG001|COMPLETED|Overall Study||64||
59521903|NCT01222585|75616206|FG000|NOT COMPLETED|Overall Study||0||
59521904|NCT01142323|75616210|FG000|STARTED|Overall Study||8||
59521905|NCT01142323|75616210|FG000|COMPLETED|Overall Study||8||
59521906|NCT01142323|75616210|FG000|NOT COMPLETED|Overall Study||0||
59521907|NCT01142947|75616216|FG000|STARTED|Overall Study||362||
59774874|NCT00836693|75895489|FG000|NOT COMPLETED|Overall Study||17||
59521908|NCT01142947|75616216|FG000|COMPLETED|Overall Study||244||
59774875|NCT00836693|75895490|FG001|NOT COMPLETED|Overall Study||6||
59774876|NCT00770484|75895498|FG000|STARTED|Overall Study||8||
59774877|NCT00770484|75895499|FG001|STARTED|Overall Study||4||
59774878|NCT00770484|75895498|FG000|COMPLETED|Overall Study||7||
59774879|NCT00770484|75895499|FG001|COMPLETED|Overall Study||4||
59774880|NCT00770484|75895498|FG000|NOT COMPLETED|Overall Study||1||
59774881|NCT00770484|75895499|FG001|NOT COMPLETED|Overall Study||0||
59774882|NCT00835679|75895509|FG000|STARTED|Overall Study||9||
59774883|NCT00835679|75895510|FG001|STARTED|Overall Study|This study closed prematurely, thus no patients went on Cohort B, C or D.|0||
59774884|NCT00835679|75895511|FG002|STARTED|Overall Study||0||
59774885|NCT00835679|75895512|FG003|STARTED|Overall Study||0||
59774886|NCT00835679|75895509|FG000|COMPLETED|Overall Study||8||
59774887|NCT00835679|75895510|FG001|COMPLETED|Overall Study||0||
59774888|NCT00835679|75895511|FG002|COMPLETED|Overall Study||0||
59774889|NCT00835679|75895512|FG003|COMPLETED|Overall Study||0||
59774890|NCT00835679|75895509|FG000|NOT COMPLETED|Overall Study||1||
59774891|NCT00835679|75895510|FG001|NOT COMPLETED|Overall Study||0||
59774892|NCT00835679|75895511|FG002|NOT COMPLETED|Overall Study||0||
59774893|NCT00835679|75895512|FG003|NOT COMPLETED|Overall Study||0||
59774894|NCT00766506|75895528|FG000|STARTED|Overall Study||58||
59774895|NCT00766506|75895529|FG001|STARTED|Overall Study||50||
59774896|NCT00766506|75895528|FG000|COMPLETED|Overall Study||53||
59774897|NCT00766506|75895529|FG001|COMPLETED|Overall Study||48||
59774898|NCT00766506|75895528|FG000|NOT COMPLETED|Overall Study||5||
59774899|NCT00766506|75895529|FG001|NOT COMPLETED|Overall Study||2||
59774900|NCT00770328|75895537|FG000|STARTED|Overall Study||22||
59774901|NCT00770328|75895538|FG001|STARTED|Overall Study||15||
59774902|NCT00770328|75895537|FG000|COMPLETED|Overall Study||9||
59774903|NCT00770328|75895538|FG001|COMPLETED|Overall Study||11||
59774904|NCT00770328|75895537|FG000|NOT COMPLETED|Overall Study||13||
59774905|NCT00770328|75895538|FG001|NOT COMPLETED|Overall Study||4||
59774906|NCT00766038|75895546|FG000|STARTED|Overall Study||31||
59774907|NCT00766038|75895547|FG001|STARTED|Overall Study||32||
59774908|NCT00766038|75895546|FG000|COMPLETED|Overall Study||16||
59774909|NCT00766038|75895547|FG001|COMPLETED|Overall Study||18||
59774910|NCT00766038|75895546|FG000|NOT COMPLETED|Overall Study||15||
59774911|NCT00766038|75895547|FG001|NOT COMPLETED|Overall Study||14||
59774912|NCT00765882|75895558|FG000|STARTED|Overall Study||215||
59774913|NCT00765882|75895559|FG001|STARTED|Overall Study||213||
59774914|NCT00765882|75895560|FG002|STARTED|Overall Study||205||
59774915|NCT00765882|75895558|FG000|COMPLETED|Overall Study||191||
59774916|NCT00765882|75895559|FG001|COMPLETED|Overall Study||173||
59774917|NCT00765882|75895560|FG002|COMPLETED|Overall Study||169||
59774918|NCT00765882|75895558|FG000|NOT COMPLETED|Overall Study||24||
59774919|NCT00765882|75895559|FG001|NOT COMPLETED|Overall Study||40||
59774920|NCT00765882|75895560|FG002|NOT COMPLETED|Overall Study||36||
59774921|NCT00769860|75895570|FG000|STARTED|Overall Study||16||
59774922|NCT00769860|75895571|FG001|STARTED|Overall Study||8||
59774923|NCT00769860|75895570|FG000|Month 4|Overall Study||16||
59774924|NCT00769860|75895571|FG001|Month 4|Overall Study||8||
59774925|NCT00769860|75895570|FG000|Month 8|Overall Study||14||
59774926|NCT00769860|75895571|FG001|Month 8|Overall Study||8||
59774927|NCT00769860|75895570|FG000|COMPLETED|Overall Study||14||
59774928|NCT00769860|75895571|FG001|COMPLETED|Overall Study||8||
59774929|NCT00769860|75895570|FG000|NOT COMPLETED|Overall Study||2||
59774930|NCT00769860|75895571|FG001|NOT COMPLETED|Overall Study||0||
59774931|NCT00858143|75895577|FG000|STARTED|Overall Study|Baseline|311||
59774932|NCT00858143|75895577|FG000|COMPLETED|Overall Study||261||
59774933|NCT00858143|75895577|FG000|NOT COMPLETED|Overall Study||50||
59774934|NCT00828113|75895583|FG000|STARTED|Overall Study||50||
59774935|NCT00828113|75895584|FG001|STARTED|Overall Study||51||
59774936|NCT00828113|75895583|FG000|COMPLETED|Overall Study||20||
59774937|NCT00828113|75895584|FG001|COMPLETED|Overall Study||20||
59774938|NCT00828113|75895583|FG000|NOT COMPLETED|Overall Study||30||
59774939|NCT00828113|75895584|FG001|NOT COMPLETED|Overall Study||31||
59774940|NCT00769704|75895592|FG000|STARTED|Overall Study||141||
59774941|NCT00769704|75895593|FG001|STARTED|Overall Study||296||
59774942|NCT00769704|75895592|FG000|Intent-to-treat Population|Overall Study|All participants who were randomized once to study treatment|141||
59774943|NCT00769704|75895593|FG001|Intent-to-treat Population|Overall Study|Participants who were randomized once to study treatment; excludes 1 participant randomized 3 times|295||
59774944|NCT00769704|75895592|FG000|Received Treatment|Overall Study||127||
59774945|NCT00769704|75895593|FG001|Received Treatment|Overall Study||292||
59774946|NCT00769704|75895592|FG000|COMPLETED|Overall Study||30||
59774947|NCT00769704|75895593|FG001|COMPLETED|Overall Study||97||
59774948|NCT00769704|75895592|FG000|NOT COMPLETED|Overall Study||111||
59774949|NCT00769704|75895593|FG001|NOT COMPLETED|Overall Study||199||
59774950|NCT00818753|75895603|FG000|STARTED|Overall Study|There were 53 participants randomised, but only 51 were treated.|22||
59774951|NCT00818753|75895604|FG001|STARTED|Overall Study|There were 53 participants randomised, but only 51 were treated.|21||
59774952|NCT00818753|75895605|FG002|STARTED|Overall Study|There were 53 participants randomised, but only 51 were treated.|10||
59774953|NCT00818753|75895603|FG000|COMPLETED|Overall Study||19||
59774954|NCT00818753|75895604|FG001|COMPLETED|Overall Study||21||
59774955|NCT00818753|75895605|FG002|COMPLETED|Overall Study||9||
59774956|NCT00818753|75895603|FG000|NOT COMPLETED|Overall Study||3||
59774957|NCT00818753|75895604|FG001|NOT COMPLETED|Overall Study||0||
59774958|NCT00818753|75895605|FG002|NOT COMPLETED|Overall Study||1||
59774959|NCT00765726|75895613|FG000|STARTED|Overall Study||12||
59774960|NCT00765726|75895613|FG000|COMPLETED|Overall Study||3||
59774961|NCT00765726|75895613|FG000|NOT COMPLETED|Overall Study||9||
59774962|NCT00765336|75895619|FG000|STARTED|Overall Study||91||
59774963|NCT00765336|75895620|FG001|STARTED|Overall Study||89||
59774964|NCT00765336|75895619|FG000|COMPLETED|Overall Study||72||
59774965|NCT00765336|75895620|FG001|COMPLETED|Overall Study||73||
59774966|NCT00765336|75895619|FG000|NOT COMPLETED|Overall Study||19||
59774967|NCT00765336|75895620|FG001|NOT COMPLETED|Overall Study||16||
59774968|NCT00818519|75895628|FG000|STARTED|Overall Study|2 excluded from FAS because study drug intake unknown or never administered|89||
59774969|NCT00818519|75895629|FG001|STARTED|Overall Study|4 excluded from FAS because study drug intake unknown or never administered|90||
59774970|NCT00818519|75895628|FG000|Participants Received Treatment|Overall Study|= Baseline|87||
59774971|NCT00818519|75895629|FG001|Participants Received Treatment|Overall Study|= Baseline|86||
59774972|NCT00818519|75895628|FG000|COMPLETED|Overall Study||75||
59774973|NCT00818519|75895629|FG001|COMPLETED|Overall Study||71||
59774974|NCT00818519|75895628|FG000|NOT COMPLETED|Overall Study||14||
59774975|NCT00818519|75895629|FG001|NOT COMPLETED|Overall Study||19||
59774976|NCT00827567|75895635|FG000|STARTED|Overall Study||4||
59774977|NCT00827567|75895635|FG000|COMPLETED|Overall Study|2 screen failures, 4 withdrew from study to go on to other therapies|0||
59774978|NCT00827567|75895635|FG000|NOT COMPLETED|Overall Study||4||
59774979|NCT00765102|75895639|FG000|STARTED|Overall Study||32||
59774980|NCT00765102|75895639|FG000|COMPLETED|Overall Study|Completed 8 cycles of treatment|1||
59774981|NCT00765102|75895639|FG000|NOT COMPLETED|Overall Study||31||
59774982|NCT00809354|75895655|FG000|STARTED|Overall Study||288||
59774983|NCT00809354|75895656|FG001|STARTED|Overall Study||289||
59774984|NCT00809354|75895657|FG002|STARTED|Overall Study||286||
59774985|NCT00809354|75895658|FG003|STARTED|Overall Study||288||
59774986|NCT00809354|75895659|FG004|STARTED|Overall Study||288||
59774987|NCT00809354|75895660|FG005|STARTED|Overall Study||256||
59774988|NCT00809354|75895661|FG006|STARTED|Overall Study||255||
59774989|NCT00809354|75895662|FG007|STARTED|Overall Study||257||
59774990|NCT00809354|75895663|FG008|STARTED|Overall Study||256||
59774991|NCT00809354|75895664|FG009|STARTED|Overall Study||257||
59774992|NCT00809354|75895655|FG000|Treated|Overall Study||285||
59774993|NCT00809354|75895656|FG001|Treated|Overall Study||288||
59774994|NCT00809354|75895657|FG002|Treated|Overall Study||280||
59774995|NCT00809354|75895658|FG003|Treated|Overall Study||288||
59774996|NCT00809354|75895659|FG004|Treated|Overall Study||283||
59774997|NCT00809354|75895660|FG005|Treated|Overall Study||256||
59774998|NCT00809354|75895661|FG006|Treated|Overall Study||254||
59774999|NCT00809354|75895662|FG007|Treated|Overall Study||256||
59775000|NCT00809354|75895663|FG008|Treated|Overall Study||254||
59521909|NCT01142947|75616216|FG000|NOT COMPLETED|Overall Study||118||
59521910|NCT02085356|75616224|FG000|STARTED|Overall Study||577||
59775001|NCT00809354|75895664|FG009|Treated|Overall Study||256||
59775002|NCT00809354|75895655|FG000|COMPLETED|Overall Study||33||
59775003|NCT00809354|75895656|FG001|COMPLETED|Overall Study||31||
59775004|NCT00809354|75895657|FG002|COMPLETED|Overall Study||32||
59775005|NCT00809354|75895658|FG003|COMPLETED|Overall Study||32||
59775006|NCT00809354|75895659|FG004|COMPLETED|Overall Study||32||
59775007|NCT00809354|75895660|FG005|COMPLETED|Overall Study||31||
59775008|NCT00809354|75895661|FG006|COMPLETED|Overall Study||32||
59775009|NCT00809354|75895662|FG007|COMPLETED|Overall Study||19||
59775010|NCT00809354|75895663|FG008|COMPLETED|Overall Study||28||
59775011|NCT00809354|75895664|FG009|COMPLETED|Overall Study||31||
59775012|NCT00809354|75895655|FG000|NOT COMPLETED|Overall Study||255||
59775013|NCT00809354|75895656|FG001|NOT COMPLETED|Overall Study||258||
59775014|NCT00809354|75895657|FG002|NOT COMPLETED|Overall Study||254||
59775015|NCT00809354|75895658|FG003|NOT COMPLETED|Overall Study||256||
59775016|NCT00809354|75895659|FG004|NOT COMPLETED|Overall Study||256||
59775017|NCT00809354|75895660|FG005|NOT COMPLETED|Overall Study||225||
59775018|NCT00809354|75895661|FG006|NOT COMPLETED|Overall Study||223||
59775019|NCT00809354|75895662|FG007|NOT COMPLETED|Overall Study||238||
59775020|NCT00809354|75895663|FG008|NOT COMPLETED|Overall Study||228||
59775021|NCT00809354|75895664|FG009|NOT COMPLETED|Overall Study||226||
59775022|NCT00834899|75895693|FG000|STARTED|Overall Study||9||
59775023|NCT00834899|75895694|FG001|STARTED|Overall Study||4||
59775024|NCT00834899|75895693|FG000|COMPLETED|Overall Study|One patient withdrew consent following completion of the study drug infusion.|8||
59775025|NCT00834899|75895694|FG001|COMPLETED|Overall Study|One patient was withdrawn early because she did not meet eligibility criteria.|3||
59775026|NCT00834899|75895693|FG000|NOT COMPLETED|Overall Study||1||
59775027|NCT00834899|75895694|FG001|NOT COMPLETED|Overall Study||1||
59521911|NCT02085356|75616225|FG001|STARTED|Overall Study||348||
59521912|NCT02085356|75616226|FG002|STARTED|Overall Study||681||
59775028|NCT00764946|75895703|FG000|STARTED|Overall Study||98||
59775029|NCT00764946|75895704|FG001|STARTED|Overall Study||89||
59775030|NCT00764946|75895705|FG002|STARTED|Overall Study||22||
59775031|NCT00764946|75895703|FG000|TREATED|Overall Study||97||
59775032|NCT00764946|75895704|FG001|TREATED|Overall Study||88||
59775033|NCT00764946|75895705|FG002|TREATED|Overall Study||21||
59775034|NCT00764946|75895703|FG000|COMPLETED|Overall Study||85||
59775035|NCT00764946|75895704|FG001|COMPLETED|Overall Study||72||
59775036|NCT00764946|75895705|FG002|COMPLETED|Overall Study||18||
59775037|NCT00764946|75895703|FG000|NOT COMPLETED|Overall Study||13||
59775038|NCT00764946|75895704|FG001|NOT COMPLETED|Overall Study||17||
59775039|NCT00764946|75895705|FG002|NOT COMPLETED|Overall Study||4||
59775040|NCT00764868|75895719|FG000|STARTED|Overall Study||269||
59775041|NCT00764868|75895719|FG000|COMPLETED|Overall Study||156||
59775042|NCT00764868|75895719|FG000|NOT COMPLETED|Overall Study||113||
59775043|NCT00764790|75895726|FG000|STARTED|Overall Study||1107||
59775044|NCT00764790|75895727|FG001|STARTED|Overall Study||1106||
59775045|NCT00764790|75895728|FG002|STARTED|Overall Study||1104||
59775046|NCT00764790|75895726|FG000|COMPLETED|Overall Study||1069||
59775047|NCT00764790|75895727|FG001|COMPLETED|Overall Study||1065||
59775048|NCT00764790|75895728|FG002|COMPLETED|Overall Study||1074||
59775049|NCT00764790|75895726|FG000|NOT COMPLETED|Overall Study||38||
59775050|NCT00764790|75895727|FG001|NOT COMPLETED|Overall Study||41||
59775051|NCT00764790|75895728|FG002|NOT COMPLETED|Overall Study||30||
59775052|NCT00756444|75895738|FG000|STARTED|Overall Study||33||
59775053|NCT00756444|75895739|FG001|STARTED|Overall Study||34||
59775054|NCT00756444|75895738|FG000|COMPLETED|Overall Study||18||
59775055|NCT00756444|75895739|FG001|COMPLETED|Overall Study||13||
59775056|NCT00756444|75895738|FG000|NOT COMPLETED|Overall Study||15||
59775057|NCT00756444|75895739|FG001|NOT COMPLETED|Overall Study||21||
59775058|NCT00769002|75895750|FG000|STARTED|Overall Study||9||
59775059|NCT00769002|75895751|FG001|STARTED|Overall Study||9||
59775060|NCT00769002|75895750|FG000|COMPLETED|Overall Study||0||
59775061|NCT00769002|75895751|FG001|COMPLETED|Overall Study||0||
59775062|NCT00769002|75895750|FG000|NOT COMPLETED|Overall Study||9||
59775063|NCT00769002|75895751|FG001|NOT COMPLETED|Overall Study||9||
59775064|NCT00753012|75895758|FG000|STARTED|Overall Study||15||
59775065|NCT00753012|75895759|FG001|STARTED|Overall Study||9||
59775066|NCT00753012|75895758|FG000|COMPLETED|Overall Study||7||
59775067|NCT00753012|75895759|FG001|COMPLETED|Overall Study||8||
59775068|NCT00753012|75895758|FG000|NOT COMPLETED|Overall Study||8||
59775069|NCT00753012|75895759|FG001|NOT COMPLETED|Overall Study||1||
59775070|NCT00806156|75895768|FG000|STARTED|Overall Study||39||
59775071|NCT00806156|75895769|FG001|STARTED|Overall Study||139||
59775072|NCT00806156|75895768|FG000|COMPLETED|Overall Study||0||
59618613|NCT03083665|75729699|FG000|COMPLETED|Open-Label Temporary Period (OLTP)||0||
59618614|NCT03083665|75729700|FG001|COMPLETED|Open-Label Temporary Period (OLTP)||0||
59618615|NCT03083665|75729701|FG002|COMPLETED|Open-Label Temporary Period (OLTP)||0||
59618616|NCT03083665|75729702|FG003|COMPLETED|Open-Label Temporary Period (OLTP)||60||
59618617|NCT03083665|75729703|FG004|COMPLETED|Open-Label Temporary Period (OLTP)||67||
59618618|NCT03083665|75729704|FG005|COMPLETED|Open-Label Temporary Period (OLTP)||68||
59618619|NCT03083665|75729699|FG000|NOT COMPLETED|Open-Label Temporary Period (OLTP)||0||
59618620|NCT03083665|75729700|FG001|NOT COMPLETED|Open-Label Temporary Period (OLTP)||0||
59618621|NCT03083665|75729701|FG002|NOT COMPLETED|Open-Label Temporary Period (OLTP)||0||
59618622|NCT03083665|75729702|FG003|NOT COMPLETED|Open-Label Temporary Period (OLTP)||4||
59618623|NCT03083665|75729703|FG004|NOT COMPLETED|Open-Label Temporary Period (OLTP)||1||
59618624|NCT03083665|75729704|FG005|NOT COMPLETED|Open-Label Temporary Period (OLTP)||6||
59775073|NCT00806156|75895769|FG001|COMPLETED|Overall Study||0||
59618625|NCT03045276|75729725|FG000|STARTED|Intervention Phase||77||
59618626|NCT03045276|75729726|FG001|STARTED|Intervention Phase||78||
59618627|NCT03045276|75729727|FG002|STARTED|Intervention Phase||52||
59618628|NCT03045276|75729728|FG003|STARTED|Intervention Phase||51||
59618629|NCT03045276|75729725|FG000|COMPLETED|Intervention Phase||67||
59618630|NCT03045276|75729726|FG001|COMPLETED|Intervention Phase||73||
59618631|NCT03045276|75729727|FG002|COMPLETED|Intervention Phase||49||
59618632|NCT03045276|75729728|FG003|COMPLETED|Intervention Phase||44||
59618633|NCT03045276|75729725|FG000|NOT COMPLETED|Intervention Phase||10||
59618634|NCT03045276|75729726|FG001|NOT COMPLETED|Intervention Phase||5||
59618635|NCT03045276|75729727|FG002|NOT COMPLETED|Intervention Phase||3||
59618636|NCT03045276|75729728|FG003|NOT COMPLETED|Intervention Phase||7||
59618637|NCT03045276|75729725|FG000|STARTED|Follow-Up Phase||67||
59618638|NCT03045276|75729726|FG001|STARTED|Follow-Up Phase||73||
59618639|NCT03045276|75729727|FG002|STARTED|Follow-Up Phase||49||
59618640|NCT03045276|75729728|FG003|STARTED|Follow-Up Phase||44||
59618641|NCT03045276|75729725|FG000|COMPLETED|Follow-Up Phase||66||
59618642|NCT03045276|75729726|FG001|COMPLETED|Follow-Up Phase||68||
59618643|NCT03045276|75729727|FG002|COMPLETED|Follow-Up Phase||45||
59618644|NCT03045276|75729728|FG003|COMPLETED|Follow-Up Phase||39||
59618645|NCT03045276|75729725|FG000|NOT COMPLETED|Follow-Up Phase||1||
59618646|NCT03045276|75729726|FG001|NOT COMPLETED|Follow-Up Phase||5||
59618647|NCT03045276|75729727|FG002|NOT COMPLETED|Follow-Up Phase||4||
59618648|NCT03045276|75729728|FG003|NOT COMPLETED|Follow-Up Phase||5||
59618649|NCT02957968|75729743|FG000|STARTED|Overall Study||21||
59775074|NCT00806156|75895768|FG000|NOT COMPLETED|Overall Study||39||
59775075|NCT00806156|75895769|FG001|NOT COMPLETED|Overall Study||139||
59775076|NCT00764478|75895790|FG000|STARTED|Overall Study||122||
59775077|NCT00764478|75895791|FG001|STARTED|Overall Study||119||
59775078|NCT00764478|75895792|FG002|STARTED|Overall Study||126||
59775079|NCT00764478|75895790|FG000|COMPLETED|Overall Study||107||
59775080|NCT00764478|75895791|FG001|COMPLETED|Overall Study||97||
59775081|NCT00764478|75895792|FG002|COMPLETED|Overall Study||118||
59775082|NCT00764478|75895790|FG000|NOT COMPLETED|Overall Study||15||
59775083|NCT00764478|75895791|FG001|NOT COMPLETED|Overall Study||22||
59775084|NCT00764478|75895792|FG002|NOT COMPLETED|Overall Study||8||
59775085|NCT00805766|75895800|FG000|STARTED|Screening Period||45||
59775086|NCT00805766|75895800|FG000|COMPLETED|Screening Period||39||
59775087|NCT00805766|75895800|FG000|NOT COMPLETED|Screening Period||6||
59775088|NCT00805766|75895800|FG000|STARTED|Increased Dose Period||39||
59775089|NCT00805766|75895800|FG000|COMPLETED|Increased Dose Period||26||
59775090|NCT00805766|75895800|FG000|NOT COMPLETED|Increased Dose Period||13||
59775091|NCT00805532|75895810|FG000|STARTED|Overall Study||42||
59775092|NCT00805532|75895811|FG001|STARTED|Overall Study||39||
59775093|NCT00805532|75895810|FG000|COMPLETED|Overall Study|We did intent-to-treat analyses so 42 participants' data were analyzed.|42||
59775094|NCT00805532|75895811|FG001|COMPLETED|Overall Study||38||
59775095|NCT00805532|75895810|FG000|NOT COMPLETED|Overall Study||0||
59521913|NCT02085356|75616227|FG003|STARTED|Overall Study||361||
59775096|NCT00805532|75895811|FG001|NOT COMPLETED|Overall Study||1||
59775097|NCT00764322|75895821|FG000|STARTED|Overall Study||500||
59775098|NCT00764322|75895821|FG000|COMPLETED|Overall Study||480||
59775099|NCT00764322|75895821|FG000|NOT COMPLETED|Overall Study||20||
59775100|NCT00752856|75895840|FG000|STARTED|Overall Study||26||
59775101|NCT00752856|75895841|FG001|STARTED|Overall Study||25||
59775102|NCT00752856|75895840|FG000|COMPLETED|Overall Study||26||
59775103|NCT00752856|75895841|FG001|COMPLETED|Overall Study||24||
59775104|NCT00752856|75895840|FG000|NOT COMPLETED|Overall Study||0||
59775105|NCT00752856|75895841|FG001|NOT COMPLETED|Overall Study||1||
59775106|NCT00755196|75895847|FG000|STARTED|Overall Study||30||
59775107|NCT00755196|75895847|FG000|COMPLETED|Overall Study||28||
59775108|NCT00755196|75895847|FG000|NOT COMPLETED|Overall Study||2||
59775109|NCT00805142|75895854|FG000|STARTED|Titration Period||36||
59775110|NCT00805142|75895855|FG001|STARTED|Titration Period||42||
59775111|NCT00805142|75895854|FG000|COMPLETED|Titration Period||30||
59775112|NCT00805142|75895855|FG001|COMPLETED|Titration Period||32||
59775113|NCT00805142|75895854|FG000|NOT COMPLETED|Titration Period||6||
59775114|NCT00805142|75895855|FG001|NOT COMPLETED|Titration Period||10||
59775115|NCT00805142|75895854|FG000|STARTED|Maintenance Period||30||
59775116|NCT00805142|75895855|FG001|STARTED|Maintenance Period||32||
59775117|NCT00805142|75895854|FG000|COMPLETED|Maintenance Period||30||
59775118|NCT00805142|75895855|FG001|COMPLETED|Maintenance Period||30||
59775119|NCT00805142|75895854|FG000|NOT COMPLETED|Maintenance Period||0||
59775120|NCT00805142|75895855|FG001|NOT COMPLETED|Maintenance Period||2||
59775121|NCT00761631|75895872|FG000|STARTED|Overall Study||126||
59775122|NCT00761631|75895873|FG001|STARTED|Overall Study||181||
59775123|NCT00761631|75895874|FG002|STARTED|Overall Study||176||
59775124|NCT00761631|75895875|FG003|STARTED|Overall Study||119||
59775125|NCT00761631|75895876|FG004|STARTED|Overall Study||299||
59775126|NCT00761631|75895877|FG005|STARTED|Overall Study||299||
59775127|NCT00761631|75895872|FG000|Vaccinated Dose 1|Overall Study||124||
59775128|NCT00761631|75895873|FG001|Vaccinated Dose 1|Overall Study||179||
59775129|NCT00761631|75895874|FG002|Vaccinated Dose 1|Overall Study||175||
59775130|NCT00761631|75895875|FG003|Vaccinated Dose 1|Overall Study||118||
59775131|NCT00761631|75895876|FG004|Vaccinated Dose 1|Overall Study||294||
59775132|NCT00761631|75895877|FG005|Vaccinated Dose 1|Overall Study||298||
59775133|NCT00761631|75895872|FG000|Vaccinated Dose 2|Overall Study||112||
59775134|NCT00761631|75895873|FG001|Vaccinated Dose 2|Overall Study||0||
59775135|NCT00761631|75895874|FG002|Vaccinated Dose 2|Overall Study||165||
59775136|NCT00761631|75895875|FG003|Vaccinated Dose 2|Overall Study||0||
59775137|NCT00761631|75895876|FG004|Vaccinated Dose 2|Overall Study||0||
59775138|NCT00761631|75895877|FG005|Vaccinated Dose 2|Overall Study||0||
59775139|NCT00761631|75895872|FG000|COMPLETED|Overall Study||111||
59775140|NCT00761631|75895873|FG001|COMPLETED|Overall Study||174||
59775141|NCT00761631|75895874|FG002|COMPLETED|Overall Study||160||
59775142|NCT00761631|75895875|FG003|COMPLETED|Overall Study||116||
59775143|NCT00761631|75895876|FG004|COMPLETED|Overall Study||277||
59775144|NCT00761631|75895877|FG005|COMPLETED|Overall Study||294||
59775145|NCT00761631|75895872|FG000|NOT COMPLETED|Overall Study||15||
59775146|NCT00761631|75895873|FG001|NOT COMPLETED|Overall Study||7||
59775147|NCT00761631|75895874|FG002|NOT COMPLETED|Overall Study||16||
59775148|NCT00761631|75895875|FG003|NOT COMPLETED|Overall Study||3||
59775149|NCT00761631|75895876|FG004|NOT COMPLETED|Overall Study||22||
59775150|NCT00761631|75895877|FG005|NOT COMPLETED|Overall Study||5||
59775151|NCT00763698|75895900|FG000|STARTED|Overall Study||86||
59775152|NCT00763698|75895900|FG000|COMPLETED|Overall Study||76||
59775153|NCT00763698|75895900|FG000|NOT COMPLETED|Overall Study||10||
59775154|NCT00763386|75895907|FG000|STARTED|Overall Study||164||
59775155|NCT00763386|75895908|FG001|STARTED|Overall Study||167||
59775156|NCT00763386|75895907|FG000|COMPLETED|Overall Study||116||
59775157|NCT00763386|75895908|FG001|COMPLETED|Overall Study||127||
59775158|NCT00763386|75895907|FG000|NOT COMPLETED|Overall Study||48||
59775159|NCT00763386|75895908|FG001|NOT COMPLETED|Overall Study||40||
59775160|NCT00761319|75895916|FG000|STARTED|Overall Study||353||
59775161|NCT00761319|75895917|FG001|STARTED|Overall Study||352||
59775162|NCT00761319|75895916|FG000|COMPLETED|Overall Study||305||
59775163|NCT00761319|75895917|FG001|COMPLETED|Overall Study||318||
59775164|NCT00761319|75895916|FG000|NOT COMPLETED|Overall Study||48||
60072786|NCT01594125|76187971|FG001|NOT COMPLETED|Overall Study||12||
60072787|NCT01594125|76187972|FG002|NOT COMPLETED|Overall Study||3||
60072788|NCT01594125|76187973|FG003|NOT COMPLETED|Overall Study||4||
60072789|NCT01594125|76187974|FG004|NOT COMPLETED|Overall Study||7||
60072790|NCT01870076|76187990|FG000|STARTED|Overall Study||10||
60072791|NCT01870076|76187991|FG001|STARTED|Overall Study||12||
59952777|NCT02476851|76071554|FG001|NOT COMPLETED|Overall Study||1||
59952778|NCT02595970|76071560|FG000|STARTED|Overall Study||120||
59952779|NCT02595970|76071560|FG000|COMPLETED|Overall Study|Out of 100 patients who completed treatment period 2, 20 patients completed the extension period.|100||
59952780|NCT02595970|76071560|FG000|NOT COMPLETED|Overall Study||20||
59952781|NCT01866111|76071568|FG000|STARTED|Double-blind Period of Study YKP3089C017||108||
59952782|NCT01866111|76071569|FG001|STARTED|Double-blind Period of Study YKP3089C017||108||
59952783|NCT01866111|76071570|FG002|STARTED|Double-blind Period of Study YKP3089C017||110||
59952784|NCT01866111|76071571|FG003|STARTED|Double-blind Period of Study YKP3089C017||111||
59952785|NCT01866111|76071568|FG000|COMPLETED|Double-blind Period of Study YKP3089C017||94||
59952786|NCT01866111|76071569|FG001|COMPLETED|Double-blind Period of Study YKP3089C017||95||
59952787|NCT01866111|76071570|FG002|COMPLETED|Double-blind Period of Study YKP3089C017||90||
59952788|NCT01866111|76071571|FG003|COMPLETED|Double-blind Period of Study YKP3089C017||81||
59952789|NCT01866111|76071568|FG000|NOT COMPLETED|Double-blind Period of Study YKP3089C017||14||
59775165|NCT00761319|75895917|FG001|NOT COMPLETED|Overall Study||34||
59775166|NCT00762996|75895923|FG000|STARTED|Period One||15||
59775167|NCT00762996|75895924|FG001|STARTED|Period One||16||
59775168|NCT00762996|75895925|FG002|STARTED|Period One||17||
59775169|NCT00762996|75895926|FG003|STARTED|Period One||17||
59775170|NCT00762996|75895923|FG000|COMPLETED|Period One||15||
59952790|NCT01866111|76071569|FG001|NOT COMPLETED|Double-blind Period of Study YKP3089C017||13||
60072792|NCT01870076|76187992|FG002|STARTED|Overall Study||8||
60072793|NCT01870076|76187993|FG003|STARTED|Overall Study||11||
60072794|NCT01870076|76187990|FG000|COMPLETED|Overall Study||9||
60072795|NCT01870076|76187991|FG001|COMPLETED|Overall Study||12||
60072796|NCT01870076|76187992|FG002|COMPLETED|Overall Study||7||
60072797|NCT01870076|76187993|FG003|COMPLETED|Overall Study||11||
60072798|NCT01870076|76187990|FG000|NOT COMPLETED|Overall Study||1||
60072799|NCT01870076|76187991|FG001|NOT COMPLETED|Overall Study||0||
60072800|NCT01870076|76187992|FG002|NOT COMPLETED|Overall Study||1||
60072801|NCT01870076|76187993|FG003|NOT COMPLETED|Overall Study||0||
60072802|NCT01592721|76188003|FG000|STARTED|Treatment Period||6||
60072803|NCT01592721|76188003|FG000|COMPLETED|Treatment Period||6||
60072804|NCT01592721|76188003|FG000|NOT COMPLETED|Treatment Period||0||
60072805|NCT01592721|76188003|FG000|STARTED|Long-term Follow-up||6||
60072806|NCT01592721|76188003|FG000|COMPLETED|Long-term Follow-up||5||
60072807|NCT01592721|76188003|FG000|NOT COMPLETED|Long-term Follow-up||1||
60072808|NCT01613378|76188007|FG000|STARTED|Overall Study||200||
59775171|NCT00762996|75895924|FG001|COMPLETED|Period One||16||
59775172|NCT00762996|75895925|FG002|COMPLETED|Period One||13||
59952791|NCT01866111|76071570|FG002|NOT COMPLETED|Double-blind Period of Study YKP3089C017||20||
59952792|NCT01866111|76071571|FG003|NOT COMPLETED|Double-blind Period of Study YKP3089C017||30||
59952793|NCT01866111|76071568|FG000|STARTED|Open-label Extension Study YKP3089C017|Not all patients from double-blind rolled over to open-label|91|Study is ongoing|
60072809|NCT01613378|76188007|FG000|COMPLETED|Overall Study||161||
60072810|NCT01613378|76188007|FG000|NOT COMPLETED|Overall Study||39||
59775173|NCT00762996|75895926|FG003|COMPLETED|Period One||16||
59775174|NCT00762996|75895923|FG000|NOT COMPLETED|Period One||0||
59775175|NCT00762996|75895924|FG001|NOT COMPLETED|Period One||0||
59775176|NCT00762996|75895925|FG002|NOT COMPLETED|Period One||4||
59775177|NCT00762996|75895926|FG003|NOT COMPLETED|Period One||1||
59775178|NCT00762996|75895923|FG000|STARTED|Period Two||15||
59775179|NCT00762996|75895924|FG001|STARTED|Period Two||16||
59775180|NCT00762996|75895925|FG002|STARTED|Period Two||13||
59952794|NCT01866111|76071569|FG001|STARTED|Open-label Extension Study YKP3089C017||95|Study is ongoing|
59952795|NCT01866111|76071570|FG002|STARTED|Open-label Extension Study YKP3089C017||90|Study is ongoing|
60072811|NCT01592409|76188013|FG000|STARTED|Overall Study||67||
60072812|NCT01592409|76188014|FG001|STARTED|Overall Study||32||
60072813|NCT01592409|76188013|FG000|COMPLETED|Overall Study||67||
60072814|NCT01592409|76188014|FG001|COMPLETED|Overall Study||31||
60072815|NCT01592409|76188013|FG000|NOT COMPLETED|Overall Study||0||
60072816|NCT01592409|76188014|FG001|NOT COMPLETED|Overall Study||1||
60072817|NCT02081638|76188022|FG000|STARTED|Overall Study||26||
60072818|NCT02081638|76188023|FG001|STARTED|Overall Study||27||
60072819|NCT02081638|76188022|FG000|COMPLETED|Overall Study||24||
60072820|NCT02081638|76188023|FG001|COMPLETED|Overall Study||20||
60072821|NCT02081638|76188022|FG000|NOT COMPLETED|Overall Study||2||
60072822|NCT02081638|76188023|FG001|NOT COMPLETED|Overall Study||7||
60072823|NCT01697319|76188033|FG000|STARTED|Primary Phase|One subject enrolled but did not receive a single dose of study drug|16||
60072824|NCT01697319|76188033|FG000|COMPLETED|Primary Phase||15||
60072825|NCT01697319|76188033|FG000|NOT COMPLETED|Primary Phase||1||
60072826|NCT01697319|76188033|FG000|STARTED|Extension Phase||15||
60072827|NCT01697319|76188033|FG000|COMPLETED|Extension Phase||0||
60072828|NCT01697319|76188033|FG000|NOT COMPLETED|Extension Phase||15||
60072829|NCT02081950|76188037|FG000|STARTED|Treatment Period 1||14||
60072830|NCT02081950|76188037|FG000|COMPLETED|Treatment Period 1||14|The same 14 subjects received two doses of s.c. Clexane over 2 Treatment Periods (1 dose/period).|
60072831|NCT02081950|76188037|FG000|NOT COMPLETED|Treatment Period 1||0||
60072832|NCT02081950|76188037|FG000|STARTED|Treatment Period 2||14||
60072833|NCT02081950|76188037|FG000|COMPLETED|Treatment Period 2||14||
60072834|NCT02081950|76188037|FG000|NOT COMPLETED|Treatment Period 2||0||
60072835|NCT03155932|76188043|FG000|STARTED|Overall Study||2||
60072836|NCT03155932|76188043|FG000|Participants Escalated to 2 mg Dose of APD334 at Week 12 to Week 24|Overall Study||2||
60072837|NCT03155932|76188043|FG000|COMPLETED|Overall Study||2||
60072838|NCT03155932|76188043|FG000|NOT COMPLETED|Overall Study||0||
60072839|NCT01566435|76188048|FG000|STARTED|ACF Induction Therapy||30||
60072840|NCT01566435|76188048|FG000|COMPLETED|ACF Induction Therapy||30||
60072841|NCT01566435|76188048|FG000|NOT COMPLETED|ACF Induction Therapy||0||
59952796|NCT01866111|76071571|FG003|STARTED|Open-label Extension Study YKP3089C017|Not all patients from double-blind rolled over to open-label|80|Study is ongoing|
59952797|NCT01866111|76071568|FG000|COMPLETED|Open-label Extension Study YKP3089C017||26|OLE terminated in US|
59952798|NCT01866111|76071569|FG001|COMPLETED|Open-label Extension Study YKP3089C017||28|OLE terminated in US|
59952799|NCT01866111|76071570|FG002|COMPLETED|Open-label Extension Study YKP3089C017||27|OLE terminated in US|
59952800|NCT01866111|76071571|FG003|COMPLETED|Open-label Extension Study YKP3089C017||28|OLE terminated in US|
59952801|NCT01866111|76071568|FG000|NOT COMPLETED|Open-label Extension Study YKP3089C017||65||
59952802|NCT01866111|76071569|FG001|NOT COMPLETED|Open-label Extension Study YKP3089C017||67||
59952803|NCT01866111|76071570|FG002|NOT COMPLETED|Open-label Extension Study YKP3089C017||63||
59952804|NCT01866111|76071571|FG003|NOT COMPLETED|Open-label Extension Study YKP3089C017||52||
59952805|NCT02595502|76071581|FG000|STARTED|Period 1||143||
59952806|NCT02595502|76071582|FG001|STARTED|Period 1||142||
59952807|NCT02595502|76071581|FG000|COMPLETED|Period 1||142||
59952808|NCT02595502|76071582|FG001|COMPLETED|Period 1||140||
59952809|NCT02595502|76071581|FG000|NOT COMPLETED|Period 1||1||
59952810|NCT02595502|76071582|FG001|NOT COMPLETED|Period 1||2||
59952811|NCT02595502|76071581|FG000|STARTED|Period 2||142||
59952812|NCT02595502|76071582|FG001|STARTED|Period 2||140||
59952813|NCT02595502|76071581|FG000|COMPLETED|Period 2||141||
59952814|NCT02595502|76071582|FG001|COMPLETED|Period 2||138||
59952815|NCT02595502|76071581|FG000|NOT COMPLETED|Period 2||1||
59952816|NCT02595502|76071582|FG001|NOT COMPLETED|Period 2||2||
59952817|NCT02595502|76071581|FG000|STARTED|Period 3||141||
59952818|NCT02595502|76071582|FG001|STARTED|Period 3||138||
59952819|NCT02595502|76071581|FG000|COMPLETED|Period 3||140||
59952820|NCT02595502|76071582|FG001|COMPLETED|Period 3||136||
59952821|NCT02595502|76071581|FG000|NOT COMPLETED|Period 3||1||
59952822|NCT02595502|76071582|FG001|NOT COMPLETED|Period 3||2||
59952823|NCT01369329|76071591|FG000|STARTED|Overall Study||256||
59952824|NCT01369329|76071592|FG001|STARTED|Overall Study||254||
59952825|NCT01369329|76071593|FG002|STARTED|Overall Study||259||
60072842|NCT01566435|76188048|FG000|STARTED|ACF Definitive Chemoradiation-cisplatin||28||
60103567|NCT01290640|76221808|FG000|STARTED|Overall Study||12||
59775181|NCT00762996|75895926|FG003|STARTED|Period Two||16||
59775182|NCT00762996|75895923|FG000|COMPLETED|Period Two||15||
59952826|NCT01369329|76071591|FG000|COMPLETED|Overall Study||244||
59952827|NCT01369329|76071592|FG001|COMPLETED|Overall Study||243||
59952828|NCT01369329|76071593|FG002|COMPLETED|Overall Study||245||
59952829|NCT01369329|76071591|FG000|NOT COMPLETED|Overall Study||12||
59952830|NCT01369329|76071592|FG001|NOT COMPLETED|Overall Study||11||
59952831|NCT01369329|76071593|FG002|NOT COMPLETED|Overall Study||14||
59952832|NCT02791659|76071603|FG000|STARTED|Overall Study||27||
59775183|NCT00762996|75895924|FG001|COMPLETED|Period Two||16||
59775184|NCT00762996|75895925|FG002|COMPLETED|Period Two||13||
59775185|NCT00762996|75895926|FG003|COMPLETED|Period Two||16||
59775186|NCT00762996|75895923|FG000|NOT COMPLETED|Period Two||0||
59775187|NCT00762996|75895924|FG001|NOT COMPLETED|Period Two||0||
59775188|NCT00762996|75895925|FG002|NOT COMPLETED|Period Two||0||
59775189|NCT00762996|75895926|FG003|NOT COMPLETED|Period Two||0||
59775190|NCT00762606|75895936|FG000|STARTED|Overall Study||55||
59775191|NCT00762606|75895937|FG001|STARTED|Overall Study||51||
59775192|NCT00762606|75895936|FG000|COMPLETED|Overall Study||37||
59775193|NCT00762606|75895937|FG001|COMPLETED|Overall Study||38||
59775194|NCT00762606|75895936|FG000|NOT COMPLETED|Overall Study||18||
59775195|NCT00762606|75895937|FG001|NOT COMPLETED|Overall Study||13||
59775196|NCT00818441|75895945|FG000|STARTED|Overall Study||89||
59775197|NCT00818441|75895946|FG001|STARTED|Overall Study||30||
59775198|NCT00818441|75895945|FG000|COMPLETED|Overall Study||0||
59775199|NCT00818441|75895946|FG001|COMPLETED|Overall Study||0||
59775200|NCT00818441|75895945|FG000|NOT COMPLETED|Overall Study||89||
59775201|NCT00818441|75895946|FG001|NOT COMPLETED|Overall Study||30||
59775202|NCT00826943|75895953|FG000|STARTED|Overall Study||6||
59775203|NCT00826943|75895954|FG001|STARTED|Overall Study||6||
59775204|NCT00826943|75895955|FG002|STARTED|Overall Study||4||
59775205|NCT00826943|75895956|FG003|STARTED|Overall Study||5||
59775206|NCT00826943|75895957|FG004|STARTED|Overall Study||7||
59775207|NCT00826943|75895958|FG005|STARTED|Overall Study||2||
59775208|NCT00826943|75895953|FG000|COMPLETED|Overall Study||6||
59775209|NCT00826943|75895954|FG001|COMPLETED|Overall Study||6||
59775210|NCT00826943|75895955|FG002|COMPLETED|Overall Study||4||
59775211|NCT00826943|75895956|FG003|COMPLETED|Overall Study||5||
59775212|NCT00826943|75895957|FG004|COMPLETED|Overall Study||6||
59775213|NCT00826943|75895958|FG005|COMPLETED|Overall Study||2||
59775214|NCT00826943|75895953|FG000|NOT COMPLETED|Overall Study||0||
59775215|NCT00826943|75895954|FG001|NOT COMPLETED|Overall Study||0||
59775216|NCT00826943|75895955|FG002|NOT COMPLETED|Overall Study||0||
59775217|NCT00826943|75895956|FG003|NOT COMPLETED|Overall Study||0||
59775218|NCT00826943|75895957|FG004|NOT COMPLETED|Overall Study||1||
59775219|NCT00826943|75895958|FG005|NOT COMPLETED|Overall Study||0||
59775220|NCT00834041|75895968|FG000|STARTED|Overall Study||19||
59775221|NCT00834041|75895969|FG001|STARTED|Overall Study||20||
59775222|NCT00834041|75895968|FG000|COMPLETED|Overall Study||18||
59775223|NCT00834041|75895969|FG001|COMPLETED|Overall Study||19||
59775224|NCT00834041|75895968|FG000|NOT COMPLETED|Overall Study||1||
59775225|NCT00834041|75895969|FG001|NOT COMPLETED|Overall Study||1||
59775226|NCT00760929|75895979|FG000|STARTED|Overall Study||26||
59775227|NCT00760929|75895980|FG001|STARTED|Overall Study||29||
59775228|NCT00760929|75895981|FG002|STARTED|Overall Study||59||
59775229|NCT00760929|75895982|FG003|STARTED|Overall Study||57||
59775230|NCT00760929|75895979|FG000|COMPLETED|Overall Study||0||
59775231|NCT00760929|75895980|FG001|COMPLETED|Overall Study||1||
59775232|NCT00760929|75895981|FG002|COMPLETED|Overall Study||1||
59775233|NCT00760929|75895982|FG003|COMPLETED|Overall Study||2||
59775234|NCT00760929|75895979|FG000|NOT COMPLETED|Overall Study||26||
59775235|NCT00760929|75895980|FG001|NOT COMPLETED|Overall Study||28||
59775236|NCT00760929|75895981|FG002|NOT COMPLETED|Overall Study||58||
59775237|NCT00760929|75895982|FG003|NOT COMPLETED|Overall Study||55||
59775238|NCT00818207|75895993|FG000|STARTED|Overall Study||696||
59775239|NCT00818207|75895994|FG001|STARTED|Overall Study||684||
59618650|NCT02957968|75729744|FG001|STARTED|Overall Study||18||
59775240|NCT00818207|75895993|FG000|COMPLETED|Overall Study||474||
59775241|NCT00818207|75895994|FG001|COMPLETED|Overall Study||417||
59775242|NCT00818207|75895993|FG000|NOT COMPLETED|Overall Study||222||
59775243|NCT00818207|75895994|FG001|NOT COMPLETED|Overall Study||267||
59775244|NCT00760617|75896003|FG000|STARTED|Overall Study||266||
59775245|NCT00760617|75896004|FG001|STARTED|Overall Study||144||
59775246|NCT00760617|75896005|FG002|STARTED|Overall Study||116||
59775247|NCT00760617|75896003|FG000|COMPLETED|Overall Study||261||
59775248|NCT00760617|75896004|FG001|COMPLETED|Overall Study||142||
59775249|NCT00760617|75896005|FG002|COMPLETED|Overall Study||111||
59775250|NCT00760617|75896003|FG000|NOT COMPLETED|Overall Study||5||
59775251|NCT00760617|75896004|FG001|NOT COMPLETED|Overall Study||2||
59775252|NCT00760617|75896005|FG002|NOT COMPLETED|Overall Study||5||
59775253|NCT00760383|75896015|FG000|STARTED|Overall Study||21||
59775254|NCT00760383|75896016|FG001|STARTED|Overall Study||19||
59775255|NCT00760383|75896015|FG000|COMPLETED|Overall Study||16||
59775256|NCT00760383|75896016|FG001|COMPLETED|Overall Study||12||
59775257|NCT00760383|75896015|FG000|NOT COMPLETED|Overall Study||5||
59775258|NCT00760383|75896016|FG001|NOT COMPLETED|Overall Study||7||
59775259|NCT00759915|75896024|FG000|STARTED|Overall Study||18||
59775260|NCT00759915|75896025|FG001|STARTED|Overall Study||18||
59775261|NCT00759915|75896024|FG000|COMPLETED|Overall Study||17||
59775262|NCT00759915|75896025|FG001|COMPLETED|Overall Study||17||
59775263|NCT00759915|75896024|FG000|NOT COMPLETED|Overall Study||1||
59775264|NCT00759915|75896025|FG001|NOT COMPLETED|Overall Study||1||
59775265|NCT00759759|75896033|FG000|STARTED|Overall Study||18||
59775266|NCT00759759|75896034|FG001|STARTED|Overall Study||18||
59775267|NCT00759759|75896033|FG000|COMPLETED|Overall Study||14||
59775268|NCT00759759|75896034|FG001|COMPLETED|Overall Study||17||
59775269|NCT00759759|75896033|FG000|NOT COMPLETED|Overall Study||4||
59775270|NCT00759759|75896034|FG001|NOT COMPLETED|Overall Study||1||
59775271|NCT00759681|75896042|FG000|STARTED|Overall Study||107||
59775272|NCT00759681|75896043|FG001|STARTED|Overall Study||110||
59775273|NCT00759681|75896042|FG000|COMPLETED|Overall Study||97||
59775274|NCT00759681|75896043|FG001|COMPLETED|Overall Study||100||
59775275|NCT00759681|75896042|FG000|NOT COMPLETED|Overall Study||10||
59775276|NCT00759681|75896043|FG001|NOT COMPLETED|Overall Study||10||
59775277|NCT00826241|75896050|FG000|STARTED|Overall Study||58||
59775278|NCT00826241|75896050|FG000|COMPLETED|Overall Study||31||
59775279|NCT00826241|75896050|FG000|NOT COMPLETED|Overall Study||27||
59775280|NCT00758589|75896058|FG000|STARTED|Overall Study||95||
59775281|NCT00758589|75896059|FG001|STARTED|Overall Study||90||
59775282|NCT00758589|75896060|FG002|STARTED|Overall Study||92||
59775283|NCT00758589|75896061|FG003|STARTED|Overall Study||91||
59775284|NCT00758589|75896058|FG000|COMPLETED|Overall Study||92||
59775285|NCT00758589|75896059|FG001|COMPLETED|Overall Study||87||
59775286|NCT00758589|75896060|FG002|COMPLETED|Overall Study||86||
59775287|NCT00758589|75896061|FG003|COMPLETED|Overall Study||85||
59775288|NCT00758589|75896058|FG000|NOT COMPLETED|Overall Study||3||
59775289|NCT00758589|75896059|FG001|NOT COMPLETED|Overall Study||3||
59775290|NCT00758589|75896060|FG002|NOT COMPLETED|Overall Study||6||
59775291|NCT00758589|75896061|FG003|NOT COMPLETED|Overall Study||6||
59775292|NCT00833417|75896073|FG000|STARTED|Overall Study||33||
59775293|NCT00833417|75896074|FG001|STARTED|Overall Study||71||
59775294|NCT00833417|75896073|FG000|COMPLETED|Overall Study||0||
59775295|NCT00833417|75896074|FG001|COMPLETED|Overall Study||0||
59775296|NCT00833417|75896073|FG000|NOT COMPLETED|Overall Study||33||
59775297|NCT00833417|75896074|FG001|NOT COMPLETED|Overall Study||71||
59775298|NCT00762372|75896084|FG000|STARTED|Overall Study|N=114 enrolled but 3 participant's discontinued before start of study drug administration.|111||
59775299|NCT00762372|75896085|FG001|STARTED|Overall Study|N=57 enrolled but 2 participant's discontinued before start of study drug administration.|55||
59775300|NCT00762372|75896086|FG002|STARTED|Overall Study|N=53 enrolled but 3 participant's discontinued before start of study drug administration.|50||
59775301|NCT00762372|75896084|FG000|COMPLETED|Overall Study||110||
59775302|NCT00762372|75896085|FG001|COMPLETED|Overall Study||55||
59775303|NCT00762372|75896086|FG002|COMPLETED|Overall Study||50||
59775304|NCT00762372|75896084|FG000|NOT COMPLETED|Overall Study||1||
59775305|NCT00762372|75896085|FG001|NOT COMPLETED|Overall Study||0||
59775306|NCT00762372|75896086|FG002|NOT COMPLETED|Overall Study||0||
59775307|NCT00833261|75896100|FG000|STARTED|Overall Study||37||
59775308|NCT00833261|75896100|FG000|COMPLETED|Overall Study|3 patients withdrew from the study prior to treatment & 1 receiving it did not complete the course.|33||
59775309|NCT00833261|75896100|FG000|NOT COMPLETED|Overall Study||4||
59775310|NCT00833105|75896104|FG000|STARTED|Overall Study||13||
59775311|NCT00833105|75896104|FG000|COMPLETED|Overall Study||10||
59775312|NCT00833105|75896104|FG000|NOT COMPLETED|Overall Study||3||
59775313|NCT00833027|75896110|FG000|STARTED|Overall Study||608||
59775314|NCT00833027|75896110|FG000|COMPLETED|Overall Study||397||
59775315|NCT00833027|75896110|FG000|NOT COMPLETED|Overall Study||211||
59775316|NCT00752622|75896114|FG000|STARTED|Induction Phase|The ELIG population comprised of 98 participants|100||
59775317|NCT00752622|75896114|FG000|COMPLETED|Induction Phase||65||
59775318|NCT00752622|75896114|FG000|NOT COMPLETED|Induction Phase||35||
59775319|NCT00752622|75896114|FG000|STARTED|Observational Phase||65||
59775320|NCT00752622|75896114|FG000|COMPLETED|Observational Phase|14 completed without loss of response 8 had loss of response & randomized into interventional phase|22||
59775321|NCT00752622|75896114|FG000|NOT COMPLETED|Observational Phase||43||
59775322|NCT00752622|75896114|FG000|STARTED|Interventional Phase|5 participants randomized into increased dose group and 3 randomized into shortened interval group|8||
59775323|NCT00752622|75896114|FG000|COMPLETED|Interventional Phase|8 participants received at least 1 infusion of interventional treatment, but none completed trial|0||
59775324|NCT00752622|75896114|FG000|NOT COMPLETED|Interventional Phase||8||
59775325|NCT00754650|75896119|FG000|STARTED|Overall Study||2||
59775326|NCT00754650|75896119|FG000|COMPLETED|Overall Study||0||
59775327|NCT00754650|75896119|FG000|NOT COMPLETED|Overall Study||2||
59775328|NCT00761748|75896123|FG000|STARTED|First Intervention (21 +/- 3 Days)||20||
59775329|NCT00761748|75896124|FG001|STARTED|First Intervention (21 +/- 3 Days)||10||
59775330|NCT00761748|75896123|FG000|COMPLETED|First Intervention (21 +/- 3 Days)||17||
59775331|NCT00761748|75896124|FG001|COMPLETED|First Intervention (21 +/- 3 Days)||7||
59775332|NCT00761748|75896123|FG000|NOT COMPLETED|First Intervention (21 +/- 3 Days)||3||
59775333|NCT00761748|75896124|FG001|NOT COMPLETED|First Intervention (21 +/- 3 Days)||3||
59775334|NCT00761748|75896123|FG000|STARTED|Second Intervention (21 +/- 3 Days)||17||
59775335|NCT00761748|75896124|FG001|STARTED|Second Intervention (21 +/- 3 Days)||7||
59775336|NCT00761748|75896123|FG000|COMPLETED|Second Intervention (21 +/- 3 Days)||17||
59775337|NCT00761748|75896124|FG001|COMPLETED|Second Intervention (21 +/- 3 Days)||7||
59775338|NCT00761748|75896123|FG000|NOT COMPLETED|Second Intervention (21 +/- 3 Days)||0||
59775339|NCT00761748|75896124|FG001|NOT COMPLETED|Second Intervention (21 +/- 3 Days)||0||
59775340|NCT00825305|75896132|FG000|STARTED|Overall Study||550||
59775341|NCT00825305|75896133|FG001|STARTED|Overall Study||275||
59775342|NCT00825305|75896132|FG000|COMPLETED|Overall Study||533||
59775343|NCT00825305|75896133|FG001|COMPLETED|Overall Study||252||
59775344|NCT00825305|75896132|FG000|NOT COMPLETED|Overall Study||17||
59775345|NCT00825305|75896133|FG001|NOT COMPLETED|Overall Study||23||
59775346|NCT00754572|75896139|FG000|STARTED|Overall Study||418||
59775347|NCT00754572|75896139|FG000|COMPLETED|Overall Study||347||
59775348|NCT00754572|75896139|FG000|NOT COMPLETED|Overall Study||71||
59775349|NCT00824993|75896145|FG000|STARTED|Overall Study||39||
59775350|NCT00824993|75896146|FG001|STARTED|Overall Study||39||
59775351|NCT00824993|75896145|FG000|6 Month Follow up|Overall Study||33||
59775352|NCT00824993|75896146|FG001|6 Month Follow up|Overall Study||27||
59775353|NCT00824993|75896145|FG000|COMPLETED|Overall Study||25||
59775354|NCT00824993|75896146|FG001|COMPLETED|Overall Study||22||
59775355|NCT00824993|75896145|FG000|NOT COMPLETED|Overall Study||14||
59775356|NCT00824993|75896146|FG001|NOT COMPLETED|Overall Study||17||
59775357|NCT00832091|75896154|FG000|STARTED|Overall Study||17||
59775358|NCT00832091|75896155|FG001|STARTED|Overall Study||55||
59775359|NCT00832091|75896154|FG000|COMPLETED|Overall Study||12||
59775360|NCT00832091|75896155|FG001|COMPLETED|Overall Study||53||
59775361|NCT00832091|75896154|FG000|NOT COMPLETED|Overall Study||5||
59775362|NCT00832091|75896155|FG001|NOT COMPLETED|Overall Study||2||
59775363|NCT00761514|75896161|FG000|STARTED|Overall Study||14||
59775364|NCT00761514|75896161|FG000|COMPLETED|Overall Study||7||
59775365|NCT00761514|75896161|FG000|NOT COMPLETED|Overall Study||7||
59775366|NCT00831779|75896167|FG000|STARTED|Overall Study||21||
59775367|NCT00831779|75896168|FG001|STARTED|Overall Study||23||
59775368|NCT00831779|75896167|FG000|COMPLETED|Overall Study||20||
59775369|NCT00831779|75896168|FG001|COMPLETED|Overall Study||22||
59775370|NCT00831779|75896167|FG000|NOT COMPLETED|Overall Study||1||
59775371|NCT00831779|75896168|FG001|NOT COMPLETED|Overall Study||1||
59775372|NCT00758043|75896178|FG000|STARTED|Overall Study||162||
59775373|NCT00758043|75896179|FG001|STARTED|Overall Study||160||
59775374|NCT00758043|75896180|FG002|STARTED|Overall Study||118||
59775375|NCT00758043|75896181|FG003|STARTED|Overall Study||100||
59775376|NCT00758043|75896178|FG000|COMPLETED|Overall Study||161||
59775377|NCT00758043|75896179|FG001|COMPLETED|Overall Study||119||
59775378|NCT00758043|75896180|FG002|COMPLETED|Overall Study||79||
59775379|NCT00758043|75896181|FG003|COMPLETED|Overall Study||0||
59775380|NCT00758043|75896178|FG000|NOT COMPLETED|Overall Study||1||
59775381|NCT00758043|75896179|FG001|NOT COMPLETED|Overall Study||41||
59775382|NCT00758043|75896180|FG002|NOT COMPLETED|Overall Study||39||
59775383|NCT00758043|75896181|FG003|NOT COMPLETED|Overall Study||100||
59775384|NCT00831701|75896199|FG000|STARTED|Overall Study||50||
59775385|NCT00831701|75896200|FG001|STARTED|Overall Study||50||
59775386|NCT00831701|75896199|FG000|COMPLETED|Overall Study||45||
59775387|NCT00831701|75896200|FG001|COMPLETED|Overall Study||45||
59775388|NCT00831701|75896199|FG000|NOT COMPLETED|Overall Study||5||
59775389|NCT00831701|75896200|FG001|NOT COMPLETED|Overall Study||5||
59775390|NCT00752895|75896208|FG000|STARTED|Overall Study||147||
59775391|NCT00752895|75896209|FG001|STARTED|Overall Study||146||
59775392|NCT00752895|75896208|FG000|COMPLETED|Overall Study||139||
59775393|NCT00752895|75896209|FG001|COMPLETED|Overall Study||143||
59775394|NCT00752895|75896208|FG000|NOT COMPLETED|Overall Study||8||
59775395|NCT00752895|75896209|FG001|NOT COMPLETED|Overall Study||3||
59775396|NCT00831389|75896217|FG000|STARTED|Overall Study||6||
59775397|NCT00831389|75896218|FG001|STARTED|Overall Study||7||
59775398|NCT00831389|75896217|FG000|COMPLETED|Overall Study||6||
59775399|NCT00831389|75896218|FG001|COMPLETED|Overall Study||6||
59775400|NCT00831389|75896217|FG000|NOT COMPLETED|Overall Study||0||
59775401|NCT00831389|75896218|FG001|NOT COMPLETED|Overall Study||1||
59775402|NCT00831311|75896226|FG000|STARTED|Overall Study||312||
59775403|NCT00831311|75896227|FG001|STARTED|Overall Study||312||
59775404|NCT00831311|75896226|FG000|COMPLETED|Overall Study||300||
59775405|NCT00831311|75896227|FG001|COMPLETED|Overall Study||304||
59775406|NCT00831311|75896226|FG000|NOT COMPLETED|Overall Study||12||
59775407|NCT00831311|75896227|FG001|NOT COMPLETED|Overall Study||8||
59775408|NCT00831233|75896236|FG000|STARTED|Overall Study|Intention-to-treat (ITT) population.|29||
59775409|NCT00831233|75896237|FG001|STARTED|Overall Study|ITT population.|13||
59775410|NCT00831233|75896236|FG000|Full Analysis Set (FAS)|Overall Study|2 participants were randomised but never treated.|27||
59775411|NCT00831233|75896237|FG001|Full Analysis Set (FAS)|Overall Study||13||
59775412|NCT00831233|75896236|FG000|Per Protocol (PP) Analysis Set|Overall Study||26||
59775413|NCT00831233|75896237|FG001|Per Protocol (PP) Analysis Set|Overall Study||11||
59775414|NCT00831233|75896236|FG000|COMPLETED|Overall Study||26||
59775415|NCT00831233|75896237|FG001|COMPLETED|Overall Study||12||
59775416|NCT00831233|75896236|FG000|NOT COMPLETED|Overall Study||3||
59775417|NCT00831233|75896237|FG001|NOT COMPLETED|Overall Study||1||
59775418|NCT05438277|75896245|FG000|STARTED|Overall Study|4 patients received bilateral shoulder injections|205||209
59775419|NCT05438277|75896246|FG001|STARTED|Overall Study|11 patients received bilateral shoulder injections|216||227
59775420|NCT05438277|75896245|FG000|COMPLETED|Overall Study||205||209
59775421|NCT05438277|75896246|FG001|COMPLETED|Overall Study||216||227
59775422|NCT05438277|75896245|FG000|NOT COMPLETED|Overall Study||0||0
59775423|NCT05438277|75896246|FG001|NOT COMPLETED|Overall Study||0||0
59775424|NCT00761280|75896254|FG000|STARTED|Randomization to First Dose||14||
59775425|NCT00761280|75896255|FG001|STARTED|Randomization to First Dose||13||
59775426|NCT00761280|75896254|FG000|Catheter Surgery|Randomization to First Dose|Safety population|13||
59775427|NCT00761280|75896255|FG001|Catheter Surgery|Randomization to First Dose|Not applicable to control group|0||
59775428|NCT00761280|75896254|FG000|First Dose of Study Drug / Chemotherapy|Randomization to First Dose||12||
59775429|NCT00761280|75896255|FG001|First Dose of Study Drug / Chemotherapy|Randomization to First Dose|Safety population|11||
59775430|NCT00761280|75896254|FG000|COMPLETED|Randomization to First Dose||12||
59775431|NCT00761280|75896255|FG001|COMPLETED|Randomization to First Dose||11||
59775432|NCT00761280|75896254|FG000|NOT COMPLETED|Randomization to First Dose||2||
59775433|NCT00761280|75896255|FG001|NOT COMPLETED|Randomization to First Dose||2||
59775434|NCT00761280|75896254|FG000|STARTED|First Dose to End of Study||12||
59775435|NCT00761280|75896255|FG001|STARTED|First Dose to End of Study||11||
59775436|NCT00761280|75896254|FG000|COMPLETED|First Dose to End of Study|Study was discontinued early due to the inability to recruit a sufficient number of participants.|0||
59775437|NCT00761280|75896255|FG001|COMPLETED|First Dose to End of Study|Study was discontinued early due to the inability to recruit a sufficient number of participants.|0||
59775438|NCT00761280|75896254|FG000|NOT COMPLETED|First Dose to End of Study||12||
59775439|NCT00761280|75896255|FG001|NOT COMPLETED|First Dose to End of Study||11||
59775440|NCT00824369|75896267|FG000|STARTED|Overall Study||5||
59775441|NCT00824369|75896268|FG001|STARTED|Overall Study||4||
59775442|NCT00824369|75896269|FG002|STARTED|Overall Study||3||
59775443|NCT00824369|75896270|FG003|STARTED|Overall Study||11||
59775444|NCT00824369|75896271|FG004|STARTED|Overall Study||12||
59775445|NCT00824369|75896272|FG005|STARTED|Overall Study||17||
59775446|NCT00824369|75896267|FG000|COMPLETED|Overall Study||4||
59775447|NCT00824369|75896268|FG001|COMPLETED|Overall Study||4||
59775448|NCT00824369|75896269|FG002|COMPLETED|Overall Study||2||
59775449|NCT00824369|75896270|FG003|COMPLETED|Overall Study||9||
59775450|NCT00824369|75896271|FG004|COMPLETED|Overall Study||11||
59775451|NCT00824369|75896272|FG005|COMPLETED|Overall Study||16||
59775452|NCT00824369|75896267|FG000|NOT COMPLETED|Overall Study||1||
59775453|NCT00824369|75896268|FG001|NOT COMPLETED|Overall Study||0||
59775454|NCT00824369|75896269|FG002|NOT COMPLETED|Overall Study||1||
59775455|NCT00824369|75896270|FG003|NOT COMPLETED|Overall Study||2||
59775456|NCT00824369|75896271|FG004|NOT COMPLETED|Overall Study||1||
59775457|NCT00824369|75896272|FG005|NOT COMPLETED|Overall Study||1||
59775458|NCT00824291|75896288|FG000|STARTED|Overall Study||285||
59775459|NCT00824291|75896289|FG001|STARTED|Overall Study||142||
59775460|NCT00824291|75896288|FG000|COMPLETED|Overall Study||231||
59775461|NCT00824291|75896289|FG001|COMPLETED|Overall Study||107||
59775462|NCT00824291|75896288|FG000|NOT COMPLETED|Overall Study||54||
59775463|NCT00824291|75896289|FG001|NOT COMPLETED|Overall Study||35||
59775464|NCT00804986|75896301|FG000|STARTED|Overall Study||36||
59775465|NCT00804986|75896302|FG001|STARTED|Overall Study||43||
59775466|NCT00804986|75896303|FG002|STARTED|Overall Study||42||
59775467|NCT00804986|75896304|FG003|STARTED|Overall Study||42||
59775468|NCT00804986|75896305|FG004|STARTED|Overall Study||43||
59775469|NCT00804986|75896306|FG005|STARTED|Overall Study||41||
59775470|NCT00804986|75896301|FG000|COMPLETED|Overall Study||35||
59775471|NCT00804986|75896302|FG001|COMPLETED|Overall Study||35||
59775472|NCT00804986|75896303|FG002|COMPLETED|Overall Study||40||
59775473|NCT00804986|75896304|FG003|COMPLETED|Overall Study||34||
59775474|NCT00804986|75896305|FG004|COMPLETED|Overall Study||34||
59775475|NCT00804986|75896306|FG005|COMPLETED|Overall Study||31||
59775476|NCT00804986|75896301|FG000|NOT COMPLETED|Overall Study||1||
59775477|NCT00804986|75896302|FG001|NOT COMPLETED|Overall Study||8||
59775478|NCT00804986|75896303|FG002|NOT COMPLETED|Overall Study||2||
59775479|NCT00804986|75896304|FG003|NOT COMPLETED|Overall Study||8||
59775480|NCT00804986|75896305|FG004|NOT COMPLETED|Overall Study||9||
59775481|NCT00804986|75896306|FG005|NOT COMPLETED|Overall Study||10||
59775482|NCT00752232|75896327|FG000|STARTED|Overall Study||6||
59775483|NCT00752232|75896328|FG001|STARTED|Overall Study||6||
59775484|NCT00752232|75896329|FG002|STARTED|Overall Study||6||
59775485|NCT00752232|75896330|FG003|STARTED|Overall Study||6||
59775486|NCT00752232|75896331|FG004|STARTED|Overall Study||6||
59775487|NCT00752232|75896332|FG005|STARTED|Overall Study||6||
59775488|NCT00752232|75896333|FG006|STARTED|Overall Study||4||
59775489|NCT00752232|75896327|FG000|COMPLETED|Overall Study||4||
59775490|NCT00752232|75896328|FG001|COMPLETED|Overall Study||6||
59775491|NCT00752232|75896329|FG002|COMPLETED|Overall Study||5||
59775492|NCT00752232|75896330|FG003|COMPLETED|Overall Study||5||
59775493|NCT00752232|75896331|FG004|COMPLETED|Overall Study||3||
59775494|NCT00752232|75896332|FG005|COMPLETED|Overall Study||5||
59775495|NCT00752232|75896333|FG006|COMPLETED|Overall Study||4||
59775496|NCT00752232|75896327|FG000|NOT COMPLETED|Overall Study||2||
59775497|NCT00752232|75896328|FG001|NOT COMPLETED|Overall Study||0||
59775498|NCT00752232|75896329|FG002|NOT COMPLETED|Overall Study||1||
59775499|NCT00752232|75896330|FG003|NOT COMPLETED|Overall Study||1||
59775500|NCT00752232|75896331|FG004|NOT COMPLETED|Overall Study||3||
59775501|NCT00752232|75896332|FG005|NOT COMPLETED|Overall Study||1||
59775502|NCT00752232|75896333|FG006|NOT COMPLETED|Overall Study||0||
59775503|NCT00760266|75896352|FG000|STARTED|Overall Study||228||
59775504|NCT00760266|75896353|FG001|STARTED|Overall Study||223||
59775505|NCT00760266|75896352|FG000|COMPLETED|Overall Study||204||
59775506|NCT00760266|75896353|FG001|COMPLETED|Overall Study||205||
59775507|NCT00760266|75896352|FG000|NOT COMPLETED|Overall Study||24||
59775508|NCT00760266|75896353|FG001|NOT COMPLETED|Overall Study||18||
59775509|NCT00753714|75896361|FG000|STARTED|Overall Study||61||
59775510|NCT00753714|75896362|FG001|STARTED|Overall Study||63||
59775511|NCT00753714|75896361|FG000|COMPLETED|Overall Study||1||
59775512|NCT00753714|75896362|FG001|COMPLETED|Overall Study||1||
59775513|NCT00753714|75896361|FG000|NOT COMPLETED|Overall Study||60||
59775514|NCT00753714|75896362|FG001|NOT COMPLETED|Overall Study||62||
59775515|NCT00759954|75896373|FG000|STARTED|Overall Study|All assigned participants entered trial|18||
59775516|NCT00759954|75896374|FG001|STARTED|Overall Study|All assigned participants entered trial|18||
59775517|NCT00759954|75896373|FG000|COMPLETED|Overall Study|One participant(#225) did not enter Period 2 and one participant (#203)dropped out during Period 2|16||
59775518|NCT00759954|75896374|FG001|COMPLETED|Overall Study|Two participants (#202 and #228) did not enter Period 2.|16||
59775519|NCT00759954|75896373|FG000|NOT COMPLETED|Overall Study||2||
59775520|NCT00759954|75896374|FG001|NOT COMPLETED|Overall Study||2||
59775521|NCT00804908|75896383|FG000|STARTED|Overall Study||115|Intent-to-treat (ITT) population defined as all randomized subjects.|
59775522|NCT00804908|75896384|FG001|STARTED|Overall Study||116|Intent-to-treat (ITT) population defined as all randomized subjects.|
59775523|NCT00804908|75896385|FG002|STARTED|Overall Study||115|Intent-to-treat (ITT) population defined as all randomized subjects.|
59775524|NCT00804908|75896383|FG000|COMPLETED|Overall Study||0||
59775525|NCT00804908|75896384|FG001|COMPLETED|Overall Study||0||
59775526|NCT00804908|75896385|FG002|COMPLETED|Overall Study||1||
59775527|NCT00804908|75896383|FG000|NOT COMPLETED|Overall Study||115||
59775528|NCT00804908|75896384|FG001|NOT COMPLETED|Overall Study||116||
59775529|NCT00804908|75896385|FG002|NOT COMPLETED|Overall Study||114||
59775530|NCT00808808|75896396|FG000|STARTED|Overall Study|Started includes all employees at participating sites.|4078||
59775531|NCT00808808|75896397|FG001|STARTED|Overall Study|Started includes all employees at participating sites|3757||
59775532|NCT00808808|75896398|FG002|STARTED|Overall Study|Started includes all employees at participating sites.|4387||
59775533|NCT00808808|75896396|FG000|Vaccinated|Overall Study|Vaccinated includes all employees who were vaccinated at the employee vaccination clinics.|1392||
59775534|NCT00808808|75896397|FG001|Vaccinated|Overall Study|Vaccinated includes all employees who were vaccinated at the employee vaccination clinics.|1489||
59775535|NCT00808808|75896398|FG002|Vaccinated|Overall Study|Vaccinated includes all employees who were vaccinated at the employee vaccination clinics.|2132||
59775536|NCT00808808|75896396|FG000|COMPLETED|Overall Study|Completed includes vaccinated employees who completed surveys.|1261||
59775537|NCT00808808|75896397|FG001|COMPLETED|Overall Study|Completed includes vaccinated employees who completed surveys.|1320||
59775538|NCT00808808|75896398|FG002|COMPLETED|Overall Study|Completed includes vaccinated employees who completed surveys.|1830||
59775539|NCT00808808|75896396|FG000|NOT COMPLETED|Overall Study||2817||
59775540|NCT00808808|75896397|FG001|NOT COMPLETED|Overall Study||2437||
59775541|NCT00808808|75896398|FG002|NOT COMPLETED|Overall Study||2557||
59775542|NCT00589784|75896414|FG000|STARTED|Overall Study||36||
59775543|NCT00589784|75896415|FG001|STARTED|Overall Study||14||
59775544|NCT00589784|75896414|FG000|COMPLETED|Overall Study||35||
59775545|NCT00589784|75896415|FG001|COMPLETED|Overall Study||4||
59775546|NCT00589784|75896414|FG000|NOT COMPLETED|Overall Study||1||
59775547|NCT00589784|75896415|FG001|NOT COMPLETED|Overall Study||10||
59775548|NCT00759876|75896420|FG000|STARTED|Overall Study||36||
59775549|NCT00759876|75896420|FG000|As-Treated Population|Overall Study||36|All participants who received at least 1 dose of study drug in this study.|
59775550|NCT00759876|75896420|FG000|Evaluable Population|Overall Study||35|Participants in the As-Treated Population with Baseline and on-treatment data in this study.|
59775551|NCT00759876|75896420|FG000|Ambulatory Evaluable Population|Overall Study||24|Participants with the ability to walk ≥75 meters unassisted at screening.|
59775552|NCT00759876|75896420|FG000|COMPLETED|Overall Study||0||
59775553|NCT00759876|75896420|FG000|NOT COMPLETED|Overall Study||36||
59775554|NCT00823979|75896427|FG000|STARTED|Overall Study||35||
59775555|NCT00823979|75896428|FG001|STARTED|Overall Study||35||
59775556|NCT00823979|75896429|FG002|STARTED|Overall Study||35||
59775557|NCT00823979|75896427|FG000|Treated|Overall Study||31||
59952833|NCT02791659|76071604|FG001|STARTED|Overall Study||28||
59952834|NCT02791659|76071603|FG000|COMPLETED|Overall Study||27||
59952835|NCT02791659|76071604|FG001|COMPLETED|Overall Study||27||
59952836|NCT02791659|76071603|FG000|NOT COMPLETED|Overall Study||0||
59952837|NCT02791659|76071604|FG001|NOT COMPLETED|Overall Study||1||
59775558|NCT00823979|75896428|FG001|Treated|Overall Study||32||
59952838|NCT02594098|76071612|FG000|STARTED|Overall Study||27||
59952839|NCT02594098|76071613|FG001|STARTED|Overall Study||14||
59952840|NCT02594098|76071612|FG000|COMPLETED|Overall Study||1||
59952841|NCT02594098|76071613|FG001|COMPLETED|Overall Study||1||
59775559|NCT00823979|75896429|FG002|Treated|Overall Study||34||
59775560|NCT00823979|75896427|FG000|COMPLETED|Overall Study||6||
59775561|NCT00823979|75896428|FG001|COMPLETED|Overall Study||3||
59775562|NCT00823979|75896429|FG002|COMPLETED|Overall Study||11||
59775563|NCT00823979|75896427|FG000|NOT COMPLETED|Overall Study||29||
59775564|NCT00823979|75896428|FG001|NOT COMPLETED|Overall Study||32||
59775565|NCT00823979|75896429|FG002|NOT COMPLETED|Overall Study||24||
59775566|NCT00823901|75896439|FG000|STARTED|Overall Study|Randomized to clindamycin/tretinoin gel|43||
59775567|NCT00823901|75896440|FG001|STARTED|Overall Study|Randomized to placebo gel|40||
59775568|NCT00823901|75896439|FG000|COMPLETED|Overall Study|Discontinued intervention (n=2) Only baseline completed (n=2)|39||
59775569|NCT00823901|75896440|FG001|COMPLETED|Overall Study|Discontinued intervention (n=1) Only baseline completed (n=1)|38||
59775570|NCT00823901|75896439|FG000|NOT COMPLETED|Overall Study||4||
59775571|NCT00823901|75896440|FG001|NOT COMPLETED|Overall Study||2||
59775572|NCT00823823|75896448|FG000|STARTED|Overall Study||109||
59775573|NCT00823823|75896449|FG001|STARTED|Overall Study||107||
59775574|NCT00823823|75896448|FG000|COMPLETED|Overall Study||101||
59775575|NCT00823823|75896449|FG001|COMPLETED|Overall Study||101||
59775576|NCT00823823|75896448|FG000|NOT COMPLETED|Overall Study||8||
59775577|NCT00823823|75896449|FG001|NOT COMPLETED|Overall Study||6||
59775578|NCT02926898|75896457|FG000|STARTED|Overall Study||43||
59775579|NCT02926898|75896458|FG001|STARTED|Overall Study||44||
59775580|NCT02926898|75896457|FG000|COMPLETED|Overall Study||36||
59775581|NCT02926898|75896458|FG001|COMPLETED|Overall Study||41||
59775582|NCT02926898|75896457|FG000|NOT COMPLETED|Overall Study||7||
59775583|NCT02926898|75896458|FG001|NOT COMPLETED|Overall Study||3||
59775584|NCT00759564|75896469|FG000|STARTED|First Intervention Period (4 Days)||8||
59775585|NCT00759564|75896470|FG001|STARTED|First Intervention Period (4 Days)||8||
59775586|NCT00759564|75896471|FG002|STARTED|First Intervention Period (4 Days)||8||
59775587|NCT00759564|75896472|FG003|STARTED|First Intervention Period (4 Days)||1||
59775588|NCT00759564|75896473|FG004|STARTED|First Intervention Period (4 Days)||4||
59775589|NCT00759564|75896469|FG000|COMPLETED|First Intervention Period (4 Days)||8||
59775590|NCT00759564|75896470|FG001|COMPLETED|First Intervention Period (4 Days)||8||
59775591|NCT00759564|75896471|FG002|COMPLETED|First Intervention Period (4 Days)||8||
59775592|NCT00759564|75896472|FG003|COMPLETED|First Intervention Period (4 Days)||1||
59775593|NCT00759564|75896473|FG004|COMPLETED|First Intervention Period (4 Days)||4||
59775594|NCT00759564|75896469|FG000|NOT COMPLETED|First Intervention Period (4 Days)||0||
59775595|NCT00759564|75896470|FG001|NOT COMPLETED|First Intervention Period (4 Days)||0||
59775596|NCT00759564|75896471|FG002|NOT COMPLETED|First Intervention Period (4 Days)||0||
59775597|NCT00759564|75896472|FG003|NOT COMPLETED|First Intervention Period (4 Days)||0||
59775598|NCT00759564|75896473|FG004|NOT COMPLETED|First Intervention Period (4 Days)||0||
59775599|NCT00759564|75896469|FG000|STARTED|Washout Period (at Least 14 Days)||8||
59775600|NCT00759564|75896470|FG001|STARTED|Washout Period (at Least 14 Days)||8||
59775601|NCT00759564|75896471|FG002|STARTED|Washout Period (at Least 14 Days)||8||
59775602|NCT00759564|75896472|FG003|STARTED|Washout Period (at Least 14 Days)||1||
59775603|NCT00759564|75896473|FG004|STARTED|Washout Period (at Least 14 Days)||4||
59775604|NCT00759564|75896469|FG000|COMPLETED|Washout Period (at Least 14 Days)||8||
59775605|NCT00759564|75896470|FG001|COMPLETED|Washout Period (at Least 14 Days)||8||
59775606|NCT00759564|75896471|FG002|COMPLETED|Washout Period (at Least 14 Days)||8||
59775607|NCT00759564|75896472|FG003|COMPLETED|Washout Period (at Least 14 Days)||1||
59775608|NCT00759564|75896473|FG004|COMPLETED|Washout Period (at Least 14 Days)||3||
59775609|NCT00759564|75896469|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0||
59775610|NCT00759564|75896470|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0||
59775611|NCT00759564|75896471|FG002|NOT COMPLETED|Washout Period (at Least 14 Days)||0||
59775612|NCT00759564|75896472|FG003|NOT COMPLETED|Washout Period (at Least 14 Days)||0||
59775613|NCT00759564|75896473|FG004|NOT COMPLETED|Washout Period (at Least 14 Days)||1||
59775614|NCT00759564|75896469|FG000|STARTED|Second Intervention Period (4 Days)||8||
59775615|NCT00759564|75896470|FG001|STARTED|Second Intervention Period (4 Days)||8||
59775616|NCT00759564|75896471|FG002|STARTED|Second Intervention Period (4 Days)||8||
59775617|NCT00759564|75896472|FG003|STARTED|Second Intervention Period (4 Days)||1||
59775618|NCT00759564|75896473|FG004|STARTED|Second Intervention Period (4 Days)||3||
59775619|NCT00759564|75896469|FG000|COMPLETED|Second Intervention Period (4 Days)||8||
59775620|NCT00759564|75896470|FG001|COMPLETED|Second Intervention Period (4 Days)||8||
59775621|NCT00759564|75896471|FG002|COMPLETED|Second Intervention Period (4 Days)||8||
59775622|NCT00759564|75896472|FG003|COMPLETED|Second Intervention Period (4 Days)||1||
59775623|NCT00759564|75896473|FG004|COMPLETED|Second Intervention Period (4 Days)||3||
59775624|NCT00759564|75896469|FG000|NOT COMPLETED|Second Intervention Period (4 Days)||0||
59775625|NCT00759564|75896470|FG001|NOT COMPLETED|Second Intervention Period (4 Days)||0||
59775626|NCT00759564|75896471|FG002|NOT COMPLETED|Second Intervention Period (4 Days)||0||
59775627|NCT00759564|75896472|FG003|NOT COMPLETED|Second Intervention Period (4 Days)||0||
59775628|NCT00759564|75896473|FG004|NOT COMPLETED|Second Intervention Period (4 Days)||0||
59775629|NCT00816023|75896509|FG000|STARTED|Overall Study||71||
59775630|NCT00816023|75896510|FG001|STARTED|Overall Study||62||
59775631|NCT00816023|75896511|FG002|STARTED|Overall Study||69||
59775632|NCT00816023|75896512|FG003|STARTED|Overall Study||74||
59775633|NCT00816023|75896509|FG000|Completed Therapy|Overall Study||65||
59775634|NCT00816023|75896510|FG001|Completed Therapy|Overall Study||59||
59775635|NCT00816023|75896511|FG002|Completed Therapy|Overall Study||61||
59775636|NCT00816023|75896512|FG003|Completed Therapy|Overall Study||63||
59775637|NCT00816023|75896509|FG000|COMPLETED|Overall Study||62||
59775638|NCT00816023|75896510|FG001|COMPLETED|Overall Study||56||
59775639|NCT00816023|75896511|FG002|COMPLETED|Overall Study||60||
59775640|NCT00816023|75896512|FG003|COMPLETED|Overall Study||62||
59775641|NCT00816023|75896509|FG000|NOT COMPLETED|Overall Study||9||
59775642|NCT00816023|75896510|FG001|NOT COMPLETED|Overall Study||6||
59775643|NCT00816023|75896511|FG002|NOT COMPLETED|Overall Study||9||
59775644|NCT00816023|75896512|FG003|NOT COMPLETED|Overall Study||12||
59775645|NCT00759174|75896524|FG000|STARTED|Overall Study||76||
59775646|NCT00759174|75896525|FG001|STARTED|Overall Study||597||
59775647|NCT00759174|75896524|FG000|COMPLETED|Overall Study||76||
59775648|NCT00759174|75896525|FG001|COMPLETED|Overall Study||595||
59775649|NCT00759174|75896524|FG000|NOT COMPLETED|Overall Study||0||
59775650|NCT00759174|75896525|FG001|NOT COMPLETED|Overall Study||2||
59775651|NCT00815633|75896532|FG000|STARTED|Overall Study||1||
59775652|NCT00815633|75896532|FG000|COMPLETED|Overall Study||0||
59775653|NCT00815633|75896532|FG000|NOT COMPLETED|Overall Study||1||
59775654|NCT00830765|75896538|FG000|STARTED|Overall Study||73||
59775655|NCT00830765|75896539|FG001|STARTED|Overall Study||71||
59775656|NCT00830765|75896538|FG000|COMPLETED|Overall Study||70||
59775657|NCT00830765|75896539|FG001|COMPLETED|Overall Study||69||
59775658|NCT00830765|75896538|FG000|NOT COMPLETED|Overall Study||3||
59775659|NCT00830765|75896539|FG001|NOT COMPLETED|Overall Study||2||
59775660|NCT00830375|75896545|FG000|STARTED|Overall Study||10||
59775661|NCT00830375|75896545|FG000|COMPLETED|Overall Study||9||
59775662|NCT00830375|75896545|FG000|NOT COMPLETED|Overall Study||1||
59775663|NCT00803270|75896551|FG000|STARTED|Overall Study||13||
59775664|NCT00803270|75896552|FG001|STARTED|Overall Study||14||
59775665|NCT00803270|75896551|FG000|COMPLETED|Overall Study||12||
59775666|NCT00803270|75896552|FG001|COMPLETED|Overall Study||12||
59775667|NCT00803270|75896551|FG000|NOT COMPLETED|Overall Study||1||
59775668|NCT00803270|75896552|FG001|NOT COMPLETED|Overall Study||2||
59775669|NCT00751998|75896558|FG000|STARTED|Overall Study||297||
59775670|NCT00751998|75896558|FG000|COMPLETED|Overall Study||277||
59775671|NCT00751998|75896558|FG000|NOT COMPLETED|Overall Study||20||
59775672|NCT00803738|75896564|FG000|STARTED|Overall Study||286||
59775673|NCT00803738|75896565|FG001|STARTED|Overall Study||286||
59775674|NCT00803738|75896564|FG000|COMPLETED|Overall Study||192||
59775675|NCT00803738|75896565|FG001|COMPLETED|Overall Study||176||
59775676|NCT00803738|75896564|FG000|NOT COMPLETED|Overall Study||94||
59775677|NCT00803738|75896565|FG001|NOT COMPLETED|Overall Study||110||
59775678|NCT00758706|75896573|FG000|STARTED|Overall Study||26||
59775679|NCT00758706|75896574|FG001|STARTED|Overall Study||29||
59775680|NCT00758706|75896573|FG000|COMPLETED|Overall Study||22||
59775681|NCT00758706|75896574|FG001|COMPLETED|Overall Study||25||
59775682|NCT00758706|75896573|FG000|NOT COMPLETED|Overall Study||4||
59775683|NCT00758706|75896574|FG001|NOT COMPLETED|Overall Study||4||
59775684|NCT00591266|75896583|FG000|STARTED|Overall Study|Randomized only|189||
59775685|NCT00591266|75896584|FG001|STARTED|Overall Study|Randomized only|188||
59775686|NCT00591266|75896585|FG002|STARTED|Overall Study|Randomized only|189||
59775687|NCT00591266|75896583|FG000|COMPLETED|Overall Study||180||
59775688|NCT00591266|75896584|FG001|COMPLETED|Overall Study||177||
59775689|NCT00591266|75896585|FG002|COMPLETED|Overall Study||175||
59775690|NCT00591266|75896583|FG000|NOT COMPLETED|Overall Study||9||
59775691|NCT00591266|75896584|FG001|NOT COMPLETED|Overall Study||11||
59775692|NCT00591266|75896585|FG002|NOT COMPLETED|Overall Study||14||
59775693|NCT00758394|75896597|FG000|STARTED|1st Intervention||8||
59775694|NCT00758394|75896598|FG001|STARTED|1st Intervention||7||
59775695|NCT00758394|75896599|FG002|STARTED|1st Intervention||6||
59775696|NCT00758394|75896600|FG003|STARTED|1st Intervention||8||
59775697|NCT00758394|75896597|FG000|COMPLETED|1st Intervention||8||
59775698|NCT00758394|75896598|FG001|COMPLETED|1st Intervention||7||
59775699|NCT00758394|75896599|FG002|COMPLETED|1st Intervention||6||
59775700|NCT00758394|75896600|FG003|COMPLETED|1st Intervention||8||
59775701|NCT00758394|75896597|FG000|NOT COMPLETED|1st Intervention||0||
59775702|NCT00758394|75896598|FG001|NOT COMPLETED|1st Intervention||0||
59775703|NCT00758394|75896599|FG002|NOT COMPLETED|1st Intervention||0||
59775704|NCT00758394|75896600|FG003|NOT COMPLETED|1st Intervention||0||
59775705|NCT00758394|75896597|FG000|STARTED|Washout After 1st Intervention||8||
59775706|NCT00758394|75896598|FG001|STARTED|Washout After 1st Intervention||7||
59775707|NCT00758394|75896599|FG002|STARTED|Washout After 1st Intervention||6||
59775708|NCT00758394|75896600|FG003|STARTED|Washout After 1st Intervention||8||
59775709|NCT00758394|75896597|FG000|COMPLETED|Washout After 1st Intervention||8||
59775710|NCT00758394|75896598|FG001|COMPLETED|Washout After 1st Intervention||7||
59775711|NCT00758394|75896599|FG002|COMPLETED|Washout After 1st Intervention||6||
59775712|NCT00758394|75896600|FG003|COMPLETED|Washout After 1st Intervention||8||
59775713|NCT00758394|75896597|FG000|NOT COMPLETED|Washout After 1st Intervention||0||
59775714|NCT00758394|75896598|FG001|NOT COMPLETED|Washout After 1st Intervention||0||
59775715|NCT00758394|75896599|FG002|NOT COMPLETED|Washout After 1st Intervention||0||
59775716|NCT00758394|75896600|FG003|NOT COMPLETED|Washout After 1st Intervention||0||
59775717|NCT00758394|75896597|FG000|STARTED|2nd Intervention Order||8||
59775718|NCT00758394|75896598|FG001|STARTED|2nd Intervention Order||7||
59775719|NCT00758394|75896599|FG002|STARTED|2nd Intervention Order||6||
59775720|NCT00758394|75896600|FG003|STARTED|2nd Intervention Order||8||
59775721|NCT00758394|75896597|FG000|COMPLETED|2nd Intervention Order||8||
59775722|NCT00758394|75896598|FG001|COMPLETED|2nd Intervention Order||6||
59775723|NCT00758394|75896599|FG002|COMPLETED|2nd Intervention Order||6||
59775724|NCT00758394|75896600|FG003|COMPLETED|2nd Intervention Order||8||
59775725|NCT00758394|75896597|FG000|NOT COMPLETED|2nd Intervention Order||0||
59775726|NCT00758394|75896598|FG001|NOT COMPLETED|2nd Intervention Order||1||
59775727|NCT00758394|75896599|FG002|NOT COMPLETED|2nd Intervention Order||0||
59775728|NCT00758394|75896600|FG003|NOT COMPLETED|2nd Intervention Order||0||
59775729|NCT00758394|75896597|FG000|STARTED|Washout After 2nd Intervention||8||
59775730|NCT00758394|75896598|FG001|STARTED|Washout After 2nd Intervention||6||
59775731|NCT00758394|75896599|FG002|STARTED|Washout After 2nd Intervention||6||
59775732|NCT00758394|75896600|FG003|STARTED|Washout After 2nd Intervention||8||
59775733|NCT00758394|75896597|FG000|COMPLETED|Washout After 2nd Intervention||8||
59775734|NCT00758394|75896598|FG001|COMPLETED|Washout After 2nd Intervention||6||
59775735|NCT00758394|75896599|FG002|COMPLETED|Washout After 2nd Intervention||6||
59775736|NCT00758394|75896600|FG003|COMPLETED|Washout After 2nd Intervention||8||
59775737|NCT00758394|75896597|FG000|NOT COMPLETED|Washout After 2nd Intervention||0||
59775738|NCT00758394|75896598|FG001|NOT COMPLETED|Washout After 2nd Intervention||0||
59775739|NCT00758394|75896599|FG002|NOT COMPLETED|Washout After 2nd Intervention||0||
59775740|NCT00758394|75896600|FG003|NOT COMPLETED|Washout After 2nd Intervention||0||
59775741|NCT00758394|75896597|FG000|STARTED|3rd Intervention||8||
59775742|NCT00758394|75896598|FG001|STARTED|3rd Intervention||6||
59775743|NCT00758394|75896599|FG002|STARTED|3rd Intervention||6||
59775744|NCT00758394|75896600|FG003|STARTED|3rd Intervention||8||
59775745|NCT00758394|75896597|FG000|COMPLETED|3rd Intervention||7||
59775746|NCT00758394|75896598|FG001|COMPLETED|3rd Intervention||6||
59775747|NCT00758394|75896599|FG002|COMPLETED|3rd Intervention||6||
59775748|NCT00758394|75896600|FG003|COMPLETED|3rd Intervention||7||
59775749|NCT00758394|75896597|FG000|NOT COMPLETED|3rd Intervention||1||
59775750|NCT00758394|75896598|FG001|NOT COMPLETED|3rd Intervention||0||
59775751|NCT00758394|75896599|FG002|NOT COMPLETED|3rd Intervention||0||
59775752|NCT00758394|75896600|FG003|NOT COMPLETED|3rd Intervention||1||
59775753|NCT00758394|75896597|FG000|STARTED|Washout After 3rd Intervention||7||
59775754|NCT00758394|75896598|FG001|STARTED|Washout After 3rd Intervention||6||
59775755|NCT00758394|75896599|FG002|STARTED|Washout After 3rd Intervention||6||
59775756|NCT00758394|75896600|FG003|STARTED|Washout After 3rd Intervention||7||
59775757|NCT00758394|75896597|FG000|COMPLETED|Washout After 3rd Intervention||7||
59775758|NCT00758394|75896598|FG001|COMPLETED|Washout After 3rd Intervention||6||
59775759|NCT00758394|75896599|FG002|COMPLETED|Washout After 3rd Intervention||6||
59775760|NCT00758394|75896600|FG003|COMPLETED|Washout After 3rd Intervention||7||
59775761|NCT00758394|75896597|FG000|NOT COMPLETED|Washout After 3rd Intervention||0||
59775762|NCT00758394|75896598|FG001|NOT COMPLETED|Washout After 3rd Intervention||0||
59775763|NCT00758394|75896599|FG002|NOT COMPLETED|Washout After 3rd Intervention||0||
59775764|NCT00758394|75896600|FG003|NOT COMPLETED|Washout After 3rd Intervention||0||
59775765|NCT00758394|75896597|FG000|STARTED|4th Intervention||7||
59775766|NCT00758394|75896598|FG001|STARTED|4th Intervention||6||
59775767|NCT00758394|75896599|FG002|STARTED|4th Intervention||6||
59775768|NCT00758394|75896600|FG003|STARTED|4th Intervention||7||
59952842|NCT02594098|76071612|FG000|NOT COMPLETED|Overall Study||26||
59952843|NCT02594098|76071613|FG001|NOT COMPLETED|Overall Study||13||
59952844|NCT02593864|76071621|FG000|STARTED|Overall Study||25||
59952845|NCT02593864|76071621|FG000|COMPLETED|Overall Study||19||
59775769|NCT00758394|75896597|FG000|COMPLETED|4th Intervention||7||
59775770|NCT00758394|75896598|FG001|COMPLETED|4th Intervention||6||
59775771|NCT00758394|75896599|FG002|COMPLETED|4th Intervention||6||
59775772|NCT00758394|75896600|FG003|COMPLETED|4th Intervention||7||
59775773|NCT00758394|75896597|FG000|NOT COMPLETED|4th Intervention||0||
59775774|NCT00758394|75896598|FG001|NOT COMPLETED|4th Intervention||0||
59775775|NCT00758394|75896599|FG002|NOT COMPLETED|4th Intervention||0||
59775776|NCT00758394|75896600|FG003|NOT COMPLETED|4th Intervention||0||
59775777|NCT04450394|75896613|FG000|STARTED|Overall Study||129||
59775778|NCT04450394|75896614|FG001|STARTED|Overall Study||135||
59775779|NCT04450394|75896615|FG002|STARTED|Overall Study||14||
59775780|NCT04450394|75896613|FG000|Received at Least One Dose of Study Drug|Overall Study||129||
59775781|NCT04450394|75896614|FG001|Received at Least One Dose of Study Drug|Overall Study||135||
59775782|NCT04450394|75896615|FG002|Received at Least One Dose of Study Drug|Overall Study||14||
59952846|NCT02593864|76071621|FG000|NOT COMPLETED|Overall Study||6||
59775783|NCT04450394|75896613|FG000|COMPLETED|Overall Study||119||
59775784|NCT04450394|75896614|FG001|COMPLETED|Overall Study||121||
59775785|NCT04450394|75896615|FG002|COMPLETED|Overall Study||14||
59775786|NCT04450394|75896613|FG000|NOT COMPLETED|Overall Study||10||
59775787|NCT04450394|75896614|FG001|NOT COMPLETED|Overall Study||14||
59775788|NCT04450394|75896615|FG002|NOT COMPLETED|Overall Study||0||
59775789|NCT00758160|75896622|FG000|STARTED|Overall Study||296||
59775790|NCT00758160|75896622|FG000|COMPLETED|Overall Study||230||
59775791|NCT00758160|75896622|FG000|NOT COMPLETED|Overall Study||66||
59775792|NCT00757848|75896632|FG000|STARTED|Overall Study||27||
59775793|NCT00757848|75896633|FG001|STARTED|Overall Study||29||
59775794|NCT00757848|75896632|FG000|COMPLETED|Overall Study||24||
59775795|NCT00757848|75896633|FG001|COMPLETED|Overall Study||27||
59775796|NCT00757848|75896632|FG000|NOT COMPLETED|Overall Study||3||
59775797|NCT00757848|75896633|FG001|NOT COMPLETED|Overall Study||2||
59775798|NCT00751296|75896639|FG000|STARTED|Overall Study|The start date of the study was 25 August 2006.|27||
59775799|NCT00751296|75896639|FG000|COMPLETED|Overall Study||25||
59775800|NCT00751296|75896639|FG000|NOT COMPLETED|Overall Study||2||
59775801|NCT00751140|75896643|FG000|STARTED|Overall Study||20||
59775802|NCT00751140|75896643|FG000|COMPLETED|Overall Study||19||
59775803|NCT00751140|75896643|FG000|NOT COMPLETED|Overall Study||1||
59775804|NCT00751881|75896654|FG000|STARTED|Core Treatment Period|Randomized|389||
59775805|NCT00751881|75896655|FG001|STARTED|Core Treatment Period|Randomized|408||
59775806|NCT00751881|75896656|FG002|STARTED|Core Treatment Period|Randomized|372||
59775807|NCT00751881|75896654|FG000|Treated|Core Treatment Period|1 participant received teriflunomide 7 mg and 2 participants teriflunomide 14 mg (at least 1 dose)|388||
59775808|NCT00751881|75896655|FG001|Treated|Core Treatment Period|1 participant received placebo (at least 1 dose)|407||
59775809|NCT00751881|75896656|FG002|Treated|Core Treatment Period|1 participant received teriflunomide 7 mg and 1 participant placebo (at least 1 dose)|370||
59775810|NCT00751881|75896654|FG000|COMPLETED|Core Treatment Period||263||
59775811|NCT00751881|75896655|FG001|COMPLETED|Core Treatment Period||273||
59775812|NCT00751881|75896656|FG002|COMPLETED|Core Treatment Period||244||
59775813|NCT00751881|75896654|FG000|NOT COMPLETED|Core Treatment Period||126||
59775814|NCT00751881|75896655|FG001|NOT COMPLETED|Core Treatment Period||135||
59775815|NCT00751881|75896656|FG002|NOT COMPLETED|Core Treatment Period||128||
59775816|NCT00751881|75896654|FG000|STARTED|Extension Study Period|10 participants completed core treatment period but did not enter in extension treatment period.|253||
59775817|NCT00751881|75896655|FG001|STARTED|Extension Study Period|8 participants completed core treatment period but did not enter in extension treatment period.|265||
59775818|NCT00751881|75896656|FG002|STARTED|Extension Study Period|11 participants completed core treatment period but did not enter in extension treatment period.|233||
59775819|NCT00751881|75896654|FG000|COMPLETED|Extension Study Period||188||
59775820|NCT00751881|75896655|FG001|COMPLETED|Extension Study Period||194||
59775821|NCT00751881|75896656|FG002|COMPLETED|Extension Study Period||167||
59775822|NCT00751881|75896654|FG000|NOT COMPLETED|Extension Study Period||65||
59775823|NCT00751881|75896655|FG001|NOT COMPLETED|Extension Study Period||71||
59775824|NCT00751881|75896656|FG002|NOT COMPLETED|Extension Study Period||66||
59775825|NCT00747474|75896670|FG000|STARTED|Cohort 1 (1.5 mg/m^2) Period||3||
59775826|NCT00747474|75896671|FG001|STARTED|Cohort 1 (1.5 mg/m^2) Period||0||
59775827|NCT00747474|75896672|FG002|STARTED|Cohort 1 (1.5 mg/m^2) Period||0||
59775828|NCT00747474|75896673|FG003|STARTED|Cohort 1 (1.5 mg/m^2) Period||0||
59775829|NCT00747474|75896674|FG004|STARTED|Cohort 1 (1.5 mg/m^2) Period||0||
59775830|NCT00747474|75896675|FG005|STARTED|Cohort 1 (1.5 mg/m^2) Period||0||
59775831|NCT00747474|75896676|FG006|STARTED|Cohort 1 (1.5 mg/m^2) Period||0||
59775832|NCT00747474|75896677|FG007|STARTED|Cohort 1 (1.5 mg/m^2) Period||0||
59775833|NCT00747474|75896678|FG008|STARTED|Cohort 1 (1.5 mg/m^2) Period||0||
59775834|NCT00747474|75896679|FG009|STARTED|Cohort 1 (1.5 mg/m^2) Period||0||
59775835|NCT00747474|75896680|FG010|STARTED|Cohort 1 (1.5 mg/m^2) Period||0||
59775836|NCT00747474|75896681|FG011|STARTED|Cohort 1 (1.5 mg/m^2) Period||0||
59775837|NCT00747474|75896670|FG000|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||3||
59775838|NCT00747474|75896671|FG001|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0||
59775839|NCT00747474|75896672|FG002|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0||
59775840|NCT00747474|75896673|FG003|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0||
59775841|NCT00747474|75896674|FG004|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0||
59775842|NCT00747474|75896675|FG005|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0||
59775843|NCT00747474|75896676|FG006|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0||
59775844|NCT00747474|75896677|FG007|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0||
59775845|NCT00747474|75896678|FG008|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0||
59775846|NCT00747474|75896679|FG009|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0||
59775847|NCT00747474|75896680|FG010|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0||
59775848|NCT00747474|75896681|FG011|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0||
59775849|NCT00747474|75896670|FG000|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0||
59775850|NCT00747474|75896671|FG001|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0||
59775851|NCT00747474|75896672|FG002|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0||
59775852|NCT00747474|75896673|FG003|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0||
59775853|NCT00747474|75896674|FG004|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0||
59775854|NCT00747474|75896675|FG005|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0||
59775855|NCT00747474|75896676|FG006|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0||
59775856|NCT00747474|75896677|FG007|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0||
59775857|NCT00747474|75896678|FG008|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0||
59775858|NCT00747474|75896679|FG009|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0||
59775859|NCT00747474|75896680|FG010|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0||
59775860|NCT00747474|75896681|FG011|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0||
59775861|NCT00747474|75896670|FG000|STARTED|Cohort 2 (3 mg/m^2) Period||0||
59775862|NCT00747474|75896671|FG001|STARTED|Cohort 2 (3 mg/m^2) Period||4||
59775863|NCT00747474|75896672|FG002|STARTED|Cohort 2 (3 mg/m^2) Period||0||
59775864|NCT00747474|75896673|FG003|STARTED|Cohort 2 (3 mg/m^2) Period||0||
59775865|NCT00747474|75896674|FG004|STARTED|Cohort 2 (3 mg/m^2) Period||0||
59775866|NCT00747474|75896675|FG005|STARTED|Cohort 2 (3 mg/m^2) Period||0||
59775867|NCT00747474|75896676|FG006|STARTED|Cohort 2 (3 mg/m^2) Period||0||
59775868|NCT00747474|75896677|FG007|STARTED|Cohort 2 (3 mg/m^2) Period||0||
59775869|NCT00747474|75896678|FG008|STARTED|Cohort 2 (3 mg/m^2) Period||0||
59775870|NCT00747474|75896679|FG009|STARTED|Cohort 2 (3 mg/m^2) Period||0||
59775871|NCT00747474|75896680|FG010|STARTED|Cohort 2 (3 mg/m^2) Period||0||
59775872|NCT00747474|75896681|FG011|STARTED|Cohort 2 (3 mg/m^2) Period||0||
59775873|NCT00747474|75896670|FG000|COMPLETED|Cohort 2 (3 mg/m^2) Period||0||
59775874|NCT00747474|75896671|FG001|COMPLETED|Cohort 2 (3 mg/m^2) Period||4||
59775875|NCT00747474|75896672|FG002|COMPLETED|Cohort 2 (3 mg/m^2) Period||0||
59775876|NCT00747474|75896673|FG003|COMPLETED|Cohort 2 (3 mg/m^2) Period||0||
59775877|NCT00747474|75896674|FG004|COMPLETED|Cohort 2 (3 mg/m^2) Period||0||
59775878|NCT00747474|75896675|FG005|COMPLETED|Cohort 2 (3 mg/m^2) Period||0||
59775879|NCT00747474|75896676|FG006|COMPLETED|Cohort 2 (3 mg/m^2) Period||0||
59775880|NCT00747474|75896677|FG007|COMPLETED|Cohort 2 (3 mg/m^2) Period||0||
59775881|NCT00747474|75896678|FG008|COMPLETED|Cohort 2 (3 mg/m^2) Period||0||
59775882|NCT00747474|75896679|FG009|COMPLETED|Cohort 2 (3 mg/m^2) Period||0||
59775883|NCT00747474|75896680|FG010|COMPLETED|Cohort 2 (3 mg/m^2) Period||0||
59775884|NCT00747474|75896681|FG011|COMPLETED|Cohort 2 (3 mg/m^2) Period||0||
59775885|NCT00747474|75896670|FG000|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0||
59775886|NCT00747474|75896671|FG001|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0||
59775887|NCT00747474|75896672|FG002|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0||
59775888|NCT00747474|75896673|FG003|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0||
59775889|NCT00747474|75896674|FG004|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0||
59775890|NCT00747474|75896675|FG005|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0||
59775891|NCT00747474|75896676|FG006|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0||
59775892|NCT00747474|75896677|FG007|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0||
59775893|NCT00747474|75896678|FG008|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0||
59775894|NCT00747474|75896679|FG009|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0||
59775895|NCT00747474|75896680|FG010|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0||
59775896|NCT00747474|75896681|FG011|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0||
59775897|NCT00747474|75896670|FG000|STARTED|Cohort 3 (6 mg/m^2) Period||0||
59775898|NCT00747474|75896671|FG001|STARTED|Cohort 3 (6 mg/m^2) Period||0||
59775899|NCT00747474|75896672|FG002|STARTED|Cohort 3 (6 mg/m^2) Period||3||
59775900|NCT00747474|75896673|FG003|STARTED|Cohort 3 (6 mg/m^2) Period||0||
59775901|NCT00747474|75896674|FG004|STARTED|Cohort 3 (6 mg/m^2) Period||0||
59952847|NCT02590588|76071625|FG000|STARTED|Overall Study||1||
59952848|NCT02590588|76071625|FG000|COMPLETED|Overall Study||0||
60072843|NCT01566435|76188048|FG000|COMPLETED|ACF Definitive Chemoradiation-cisplatin||27||
60072844|NCT01566435|76188048|FG000|NOT COMPLETED|ACF Definitive Chemoradiation-cisplatin||1||
60072845|NCT01566435|76188048|FG000|STARTED|ACF Definitive Chemoradiation-cetuximab||2||
60072846|NCT01566435|76188048|FG000|COMPLETED|ACF Definitive Chemoradiation-cetuximab||2||
59775902|NCT00747474|75896675|FG005|STARTED|Cohort 3 (6 mg/m^2) Period||0||
59775903|NCT00747474|75896676|FG006|STARTED|Cohort 3 (6 mg/m^2) Period||0||
59775904|NCT00747474|75896677|FG007|STARTED|Cohort 3 (6 mg/m^2) Period||0||
59775905|NCT00747474|75896678|FG008|STARTED|Cohort 3 (6 mg/m^2) Period||0||
59775906|NCT00747474|75896679|FG009|STARTED|Cohort 3 (6 mg/m^2) Period||0||
59775907|NCT00747474|75896680|FG010|STARTED|Cohort 3 (6 mg/m^2) Period||0||
59775908|NCT00747474|75896681|FG011|STARTED|Cohort 3 (6 mg/m^2) Period||0||
59775909|NCT00747474|75896670|FG000|COMPLETED|Cohort 3 (6 mg/m^2) Period||0||
59952849|NCT02590588|76071625|FG000|NOT COMPLETED|Overall Study||1||
59952850|NCT01434602|76071634|FG000|STARTED|Phase I Dose Escalation||6||
59952851|NCT01434602|76071635|FG001|STARTED|Phase I Dose Escalation||7||
59952852|NCT01434602|76071636|FG002|STARTED|Phase I Dose Escalation||0||
59952853|NCT01434602|76071637|FG003|STARTED|Phase I Dose Escalation||0||
59952854|NCT01434602|76071638|FG004|STARTED|Phase I Dose Escalation||0||
59952855|NCT01434602|76071634|FG000|COMPLETED|Phase I Dose Escalation||6||
60072847|NCT01566435|76188048|FG000|NOT COMPLETED|ACF Definitive Chemoradiation-cetuximab||0||
60072848|NCT01696929|76188056|FG000|STARTED|Overall Study||6||
60072849|NCT01696929|76188056|FG000|COMPLETED|Overall Study||5||
60072850|NCT01696929|76188056|FG000|NOT COMPLETED|Overall Study||1||
59775910|NCT00747474|75896671|FG001|COMPLETED|Cohort 3 (6 mg/m^2) Period||0||
59775911|NCT00747474|75896672|FG002|COMPLETED|Cohort 3 (6 mg/m^2) Period||3||
59775912|NCT00747474|75896673|FG003|COMPLETED|Cohort 3 (6 mg/m^2) Period||0||
59775913|NCT00747474|75896674|FG004|COMPLETED|Cohort 3 (6 mg/m^2) Period||0||
59775914|NCT00747474|75896675|FG005|COMPLETED|Cohort 3 (6 mg/m^2) Period||0||
59775915|NCT00747474|75896676|FG006|COMPLETED|Cohort 3 (6 mg/m^2) Period||0||
59775916|NCT00747474|75896677|FG007|COMPLETED|Cohort 3 (6 mg/m^2) Period||0||
59775917|NCT00747474|75896678|FG008|COMPLETED|Cohort 3 (6 mg/m^2) Period||0||
59775918|NCT00747474|75896679|FG009|COMPLETED|Cohort 3 (6 mg/m^2) Period||0||
59952856|NCT01434602|76071635|FG001|COMPLETED|Phase I Dose Escalation||6||
59952857|NCT01434602|76071636|FG002|COMPLETED|Phase I Dose Escalation||0||
59775919|NCT00747474|75896680|FG010|COMPLETED|Cohort 3 (6 mg/m^2) Period||0||
59775920|NCT00747474|75896681|FG011|COMPLETED|Cohort 3 (6 mg/m^2) Period||0||
59775921|NCT00747474|75896670|FG000|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0||
59775922|NCT00747474|75896671|FG001|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0||
59775923|NCT00747474|75896672|FG002|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0||
59775924|NCT00747474|75896673|FG003|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0||
59775925|NCT00747474|75896674|FG004|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0||
59775926|NCT00747474|75896675|FG005|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0||
59775927|NCT00747474|75896676|FG006|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0||
59775928|NCT00747474|75896677|FG007|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0||
59775929|NCT00747474|75896678|FG008|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0||
59775930|NCT00747474|75896679|FG009|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0||
59775931|NCT00747474|75896680|FG010|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0||
59775932|NCT00747474|75896681|FG011|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0||
59775933|NCT00747474|75896670|FG000|STARTED|Cohort 4 (9 mg/m^2) Period||0||
59775934|NCT00747474|75896671|FG001|STARTED|Cohort 4 (9 mg/m^2) Period||0||
59775935|NCT00747474|75896672|FG002|STARTED|Cohort 4 (9 mg/m^2) Period||0||
59775936|NCT00747474|75896673|FG003|STARTED|Cohort 4 (9 mg/m^2) Period||4||
59775937|NCT00747474|75896674|FG004|STARTED|Cohort 4 (9 mg/m^2) Period||0||
59775938|NCT00747474|75896675|FG005|STARTED|Cohort 4 (9 mg/m^2) Period||0||
59775939|NCT00747474|75896676|FG006|STARTED|Cohort 4 (9 mg/m^2) Period||0||
59775940|NCT00747474|75896677|FG007|STARTED|Cohort 4 (9 mg/m^2) Period||0||
59775941|NCT00747474|75896678|FG008|STARTED|Cohort 4 (9 mg/m^2) Period||0||
59775942|NCT00747474|75896679|FG009|STARTED|Cohort 4 (9 mg/m^2) Period||0||
59775943|NCT00747474|75896680|FG010|STARTED|Cohort 4 (9 mg/m^2) Period||0||
59775944|NCT00747474|75896681|FG011|STARTED|Cohort 4 (9 mg/m^2) Period||0||
59775945|NCT00747474|75896670|FG000|COMPLETED|Cohort 4 (9 mg/m^2) Period||0||
59775946|NCT00747474|75896671|FG001|COMPLETED|Cohort 4 (9 mg/m^2) Period||0||
59775947|NCT00747474|75896672|FG002|COMPLETED|Cohort 4 (9 mg/m^2) Period||0||
59775948|NCT00747474|75896673|FG003|COMPLETED|Cohort 4 (9 mg/m^2) Period||4||
59775949|NCT00747474|75896674|FG004|COMPLETED|Cohort 4 (9 mg/m^2) Period||0||
59775950|NCT00747474|75896675|FG005|COMPLETED|Cohort 4 (9 mg/m^2) Period||0||
59775951|NCT00747474|75896676|FG006|COMPLETED|Cohort 4 (9 mg/m^2) Period||0||
59775952|NCT00747474|75896677|FG007|COMPLETED|Cohort 4 (9 mg/m^2) Period||0||
59775953|NCT00747474|75896678|FG008|COMPLETED|Cohort 4 (9 mg/m^2) Period||0||
59775954|NCT00747474|75896679|FG009|COMPLETED|Cohort 4 (9 mg/m^2) Period||0||
59775955|NCT00747474|75896680|FG010|COMPLETED|Cohort 4 (9 mg/m^2) Period||0||
59775956|NCT00747474|75896681|FG011|COMPLETED|Cohort 4 (9 mg/m^2) Period||0||
59775957|NCT00747474|75896670|FG000|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0||
59775958|NCT00747474|75896671|FG001|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0||
59775959|NCT00747474|75896672|FG002|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0||
59775960|NCT00747474|75896673|FG003|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0||
59775961|NCT00747474|75896674|FG004|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0||
59775962|NCT00747474|75896675|FG005|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0||
59775963|NCT00747474|75896676|FG006|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0||
59775964|NCT00747474|75896677|FG007|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0||
59775965|NCT00747474|75896678|FG008|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0||
59775966|NCT00747474|75896679|FG009|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0||
59775967|NCT00747474|75896680|FG010|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0||
59775968|NCT00747474|75896681|FG011|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0||
59775969|NCT00747474|75896670|FG000|STARTED|Cohort 5 (13.5 mg/m^2) Period||0||
59775970|NCT00747474|75896671|FG001|STARTED|Cohort 5 (13.5 mg/m^2) Period||0||
59775971|NCT00747474|75896672|FG002|STARTED|Cohort 5 (13.5 mg/m^2) Period||0||
59775972|NCT00747474|75896673|FG003|STARTED|Cohort 5 (13.5 mg/m^2) Period||0||
59775973|NCT00747474|75896674|FG004|STARTED|Cohort 5 (13.5 mg/m^2) Period||4||
59775974|NCT00747474|75896675|FG005|STARTED|Cohort 5 (13.5 mg/m^2) Period||0||
59775975|NCT00747474|75896676|FG006|STARTED|Cohort 5 (13.5 mg/m^2) Period||0||
59775976|NCT00747474|75896677|FG007|STARTED|Cohort 5 (13.5 mg/m^2) Period||0||
59775977|NCT00747474|75896678|FG008|STARTED|Cohort 5 (13.5 mg/m^2) Period||0||
59775978|NCT00747474|75896679|FG009|STARTED|Cohort 5 (13.5 mg/m^2) Period||0||
59775979|NCT00747474|75896680|FG010|STARTED|Cohort 5 (13.5 mg/m^2) Period||0||
59775980|NCT00747474|75896681|FG011|STARTED|Cohort 5 (13.5 mg/m^2) Period||0||
59775981|NCT00747474|75896670|FG000|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0||
59775982|NCT00747474|75896671|FG001|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0||
59775983|NCT00747474|75896672|FG002|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0||
59775984|NCT00747474|75896673|FG003|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0||
59775985|NCT00747474|75896674|FG004|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||4||
59775986|NCT00747474|75896675|FG005|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0||
59775987|NCT00747474|75896676|FG006|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0||
59775988|NCT00747474|75896677|FG007|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0||
59775989|NCT00747474|75896678|FG008|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0||
59775990|NCT00747474|75896679|FG009|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0||
59775991|NCT00747474|75896680|FG010|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0||
59775992|NCT00747474|75896681|FG011|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0||
59775993|NCT00747474|75896670|FG000|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0||
59775994|NCT00747474|75896671|FG001|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0||
59775995|NCT00747474|75896672|FG002|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0||
59775996|NCT00747474|75896673|FG003|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0||
59775997|NCT00747474|75896674|FG004|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0||
59775998|NCT00747474|75896675|FG005|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0||
59775999|NCT00747474|75896676|FG006|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0||
59776000|NCT00747474|75896677|FG007|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0||
59776001|NCT00747474|75896678|FG008|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0||
59776002|NCT00747474|75896679|FG009|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0||
59776003|NCT00747474|75896680|FG010|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0||
59776004|NCT00747474|75896681|FG011|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0||
59776005|NCT00747474|75896670|FG000|STARTED|Cohort 6 (20 mg/m^2) Period||0||
59776006|NCT00747474|75896671|FG001|STARTED|Cohort 6 (20 mg/m^2) Period||0||
59776007|NCT00747474|75896672|FG002|STARTED|Cohort 6 (20 mg/m^2) Period||0||
59776008|NCT00747474|75896673|FG003|STARTED|Cohort 6 (20 mg/m^2) Period||0||
59776009|NCT00747474|75896674|FG004|STARTED|Cohort 6 (20 mg/m^2) Period||0||
59776010|NCT00747474|75896675|FG005|STARTED|Cohort 6 (20 mg/m^2) Period||4||
59776011|NCT00747474|75896676|FG006|STARTED|Cohort 6 (20 mg/m^2) Period||0||
59776012|NCT00747474|75896677|FG007|STARTED|Cohort 6 (20 mg/m^2) Period||0||
59776013|NCT00747474|75896678|FG008|STARTED|Cohort 6 (20 mg/m^2) Period||0||
59776014|NCT00747474|75896679|FG009|STARTED|Cohort 6 (20 mg/m^2) Period||0||
59776015|NCT00747474|75896680|FG010|STARTED|Cohort 6 (20 mg/m^2) Period||0||
59776016|NCT00747474|75896681|FG011|STARTED|Cohort 6 (20 mg/m^2) Period||0||
59776017|NCT00747474|75896670|FG000|COMPLETED|Cohort 6 (20 mg/m^2) Period||0||
59776018|NCT00747474|75896671|FG001|COMPLETED|Cohort 6 (20 mg/m^2) Period||0||
59776019|NCT00747474|75896672|FG002|COMPLETED|Cohort 6 (20 mg/m^2) Period||0||
59776020|NCT00747474|75896673|FG003|COMPLETED|Cohort 6 (20 mg/m^2) Period||0||
59776021|NCT00747474|75896674|FG004|COMPLETED|Cohort 6 (20 mg/m^2) Period||0||
59776022|NCT00747474|75896675|FG005|COMPLETED|Cohort 6 (20 mg/m^2) Period||4||
59776023|NCT00747474|75896676|FG006|COMPLETED|Cohort 6 (20 mg/m^2) Period||0||
59776024|NCT00747474|75896677|FG007|COMPLETED|Cohort 6 (20 mg/m^2) Period||0||
59776025|NCT00747474|75896678|FG008|COMPLETED|Cohort 6 (20 mg/m^2) Period||0||
59776026|NCT00747474|75896679|FG009|COMPLETED|Cohort 6 (20 mg/m^2) Period||0||
59776027|NCT00747474|75896680|FG010|COMPLETED|Cohort 6 (20 mg/m^2) Period||0||
59776028|NCT00747474|75896681|FG011|COMPLETED|Cohort 6 (20 mg/m^2) Period||0||
59776029|NCT00747474|75896670|FG000|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0||
59776030|NCT00747474|75896671|FG001|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0||
59776031|NCT00747474|75896672|FG002|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0||
59776032|NCT00747474|75896673|FG003|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0||
59776033|NCT00747474|75896674|FG004|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0||
59776034|NCT00747474|75896675|FG005|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0||
59776035|NCT00747474|75896676|FG006|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0||
59776036|NCT00747474|75896677|FG007|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0||
59776037|NCT00747474|75896678|FG008|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0||
59776038|NCT00747474|75896679|FG009|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0||
59776039|NCT00747474|75896680|FG010|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0||
59776040|NCT00747474|75896681|FG011|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0||
59776041|NCT00747474|75896670|FG000|STARTED|Cohort 7 (30 mg/m^2) Period||0||
59776042|NCT00747474|75896671|FG001|STARTED|Cohort 7 (30 mg/m^2) Period||0||
59776043|NCT00747474|75896672|FG002|STARTED|Cohort 7 (30 mg/m^2) Period||0||
59776044|NCT00747474|75896673|FG003|STARTED|Cohort 7 (30 mg/m^2) Period||0||
59776045|NCT00747474|75896674|FG004|STARTED|Cohort 7 (30 mg/m^2) Period||0||
59776046|NCT00747474|75896675|FG005|STARTED|Cohort 7 (30 mg/m^2) Period||0||
59776047|NCT00747474|75896676|FG006|STARTED|Cohort 7 (30 mg/m^2) Period||4||
59776048|NCT00747474|75896677|FG007|STARTED|Cohort 7 (30 mg/m^2) Period||0||
59776049|NCT00747474|75896678|FG008|STARTED|Cohort 7 (30 mg/m^2) Period||0||
59776050|NCT00747474|75896679|FG009|STARTED|Cohort 7 (30 mg/m^2) Period||0||
59776051|NCT00747474|75896680|FG010|STARTED|Cohort 7 (30 mg/m^2) Period||0||
59776052|NCT00747474|75896681|FG011|STARTED|Cohort 7 (30 mg/m^2) Period||0||
59776053|NCT00747474|75896670|FG000|COMPLETED|Cohort 7 (30 mg/m^2) Period||0||
59776054|NCT00747474|75896671|FG001|COMPLETED|Cohort 7 (30 mg/m^2) Period||0||
59776055|NCT00747474|75896672|FG002|COMPLETED|Cohort 7 (30 mg/m^2) Period||0||
59776056|NCT00747474|75896673|FG003|COMPLETED|Cohort 7 (30 mg/m^2) Period||0||
59776057|NCT00747474|75896674|FG004|COMPLETED|Cohort 7 (30 mg/m^2) Period||0||
59776058|NCT00747474|75896675|FG005|COMPLETED|Cohort 7 (30 mg/m^2) Period||0||
59776059|NCT00747474|75896676|FG006|COMPLETED|Cohort 7 (30 mg/m^2) Period||4||
59776060|NCT00747474|75896677|FG007|COMPLETED|Cohort 7 (30 mg/m^2) Period||0||
59776061|NCT00747474|75896678|FG008|COMPLETED|Cohort 7 (30 mg/m^2) Period||0||
59776062|NCT00747474|75896679|FG009|COMPLETED|Cohort 7 (30 mg/m^2) Period||0||
59776063|NCT00747474|75896680|FG010|COMPLETED|Cohort 7 (30 mg/m^2) Period||0||
59776064|NCT00747474|75896681|FG011|COMPLETED|Cohort 7 (30 mg/m^2) Period||0||
59776065|NCT00747474|75896670|FG000|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0||
59776066|NCT00747474|75896671|FG001|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0||
59776067|NCT00747474|75896672|FG002|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0||
59776068|NCT00747474|75896673|FG003|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0||
59776069|NCT00747474|75896674|FG004|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0||
59776070|NCT00747474|75896675|FG005|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0||
59776071|NCT00747474|75896676|FG006|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0||
59776072|NCT00747474|75896677|FG007|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0||
59776073|NCT00747474|75896678|FG008|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0||
59776074|NCT00747474|75896679|FG009|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0||
59776075|NCT00747474|75896680|FG010|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0||
59776076|NCT00747474|75896681|FG011|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0||
59776077|NCT00747474|75896670|FG000|STARTED|Cohort 8 (40 mg/m^2) Period||0||
59776078|NCT00747474|75896671|FG001|STARTED|Cohort 8 (40 mg/m^2) Period||0||
59776079|NCT00747474|75896672|FG002|STARTED|Cohort 8 (40 mg/m^2) Period||0||
59776080|NCT00747474|75896673|FG003|STARTED|Cohort 8 (40 mg/m^2) Period||0||
59776081|NCT00747474|75896674|FG004|STARTED|Cohort 8 (40 mg/m^2) Period||0||
59776082|NCT00747474|75896675|FG005|STARTED|Cohort 8 (40 mg/m^2) Period||0||
59776083|NCT00747474|75896676|FG006|STARTED|Cohort 8 (40 mg/m^2) Period||0||
59776084|NCT00747474|75896677|FG007|STARTED|Cohort 8 (40 mg/m^2) Period||6||
59776085|NCT00747474|75896678|FG008|STARTED|Cohort 8 (40 mg/m^2) Period||0||
59776086|NCT00747474|75896679|FG009|STARTED|Cohort 8 (40 mg/m^2) Period||0||
59776087|NCT00747474|75896680|FG010|STARTED|Cohort 8 (40 mg/m^2) Period||0||
59776088|NCT00747474|75896681|FG011|STARTED|Cohort 8 (40 mg/m^2) Period||0||
59776089|NCT00747474|75896670|FG000|COMPLETED|Cohort 8 (40 mg/m^2) Period||0||
59776090|NCT00747474|75896671|FG001|COMPLETED|Cohort 8 (40 mg/m^2) Period||0||
59776091|NCT00747474|75896672|FG002|COMPLETED|Cohort 8 (40 mg/m^2) Period||0||
59776092|NCT00747474|75896673|FG003|COMPLETED|Cohort 8 (40 mg/m^2) Period||0||
59776093|NCT00747474|75896674|FG004|COMPLETED|Cohort 8 (40 mg/m^2) Period||0||
59776094|NCT00747474|75896675|FG005|COMPLETED|Cohort 8 (40 mg/m^2) Period||0||
59776095|NCT00747474|75896676|FG006|COMPLETED|Cohort 8 (40 mg/m^2) Period||0||
59776096|NCT00747474|75896677|FG007|COMPLETED|Cohort 8 (40 mg/m^2) Period||5||
59776097|NCT00747474|75896678|FG008|COMPLETED|Cohort 8 (40 mg/m^2) Period||0||
59776098|NCT00747474|75896679|FG009|COMPLETED|Cohort 8 (40 mg/m^2) Period||0||
59776099|NCT00747474|75896680|FG010|COMPLETED|Cohort 8 (40 mg/m^2) Period||0||
59776100|NCT00747474|75896681|FG011|COMPLETED|Cohort 8 (40 mg/m^2) Period||0||
59776101|NCT00747474|75896670|FG000|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0||
59776102|NCT00747474|75896671|FG001|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0||
59776103|NCT00747474|75896672|FG002|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0||
59776104|NCT00747474|75896673|FG003|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0||
59776105|NCT00747474|75896674|FG004|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0||
59776106|NCT00747474|75896675|FG005|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0||
59776107|NCT00747474|75896676|FG006|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0||
59776108|NCT00747474|75896677|FG007|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||1||
59776109|NCT00747474|75896678|FG008|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0||
59776110|NCT00747474|75896679|FG009|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0||
59776111|NCT00747474|75896680|FG010|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0||
59776112|NCT00747474|75896681|FG011|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0||
59776113|NCT00747474|75896670|FG000|STARTED|Cohort 9 (35 mg/m^2) Period||0||
59776114|NCT00747474|75896671|FG001|STARTED|Cohort 9 (35 mg/m^2) Period||0||
59776115|NCT00747474|75896672|FG002|STARTED|Cohort 9 (35 mg/m^2) Period||0||
59776116|NCT00747474|75896673|FG003|STARTED|Cohort 9 (35 mg/m^2) Period||0||
59776117|NCT00747474|75896674|FG004|STARTED|Cohort 9 (35 mg/m^2) Period||0||
59776118|NCT00747474|75896675|FG005|STARTED|Cohort 9 (35 mg/m^2) Period||0||
59776119|NCT00747474|75896676|FG006|STARTED|Cohort 9 (35 mg/m^2) Period||0||
59776120|NCT00747474|75896677|FG007|STARTED|Cohort 9 (35 mg/m^2) Period||0||
59776121|NCT00747474|75896678|FG008|STARTED|Cohort 9 (35 mg/m^2) Period||4||
59776122|NCT00747474|75896679|FG009|STARTED|Cohort 9 (35 mg/m^2) Period||0||
59776123|NCT00747474|75896680|FG010|STARTED|Cohort 9 (35 mg/m^2) Period||0||
59776124|NCT00747474|75896681|FG011|STARTED|Cohort 9 (35 mg/m^2) Period||0||
59776125|NCT00747474|75896670|FG000|COMPLETED|Cohort 9 (35 mg/m^2) Period||0||
59776126|NCT00747474|75896671|FG001|COMPLETED|Cohort 9 (35 mg/m^2) Period||0||
59776127|NCT00747474|75896672|FG002|COMPLETED|Cohort 9 (35 mg/m^2) Period||0||
59776128|NCT00747474|75896673|FG003|COMPLETED|Cohort 9 (35 mg/m^2) Period||0||
59776129|NCT00747474|75896674|FG004|COMPLETED|Cohort 9 (35 mg/m^2) Period||0||
59776130|NCT00747474|75896675|FG005|COMPLETED|Cohort 9 (35 mg/m^2) Period||0||
59776131|NCT00747474|75896676|FG006|COMPLETED|Cohort 9 (35 mg/m^2) Period||0||
59776132|NCT00747474|75896677|FG007|COMPLETED|Cohort 9 (35 mg/m^2) Period||0||
59776133|NCT00747474|75896678|FG008|COMPLETED|Cohort 9 (35 mg/m^2) Period||4||
59776134|NCT00747474|75896679|FG009|COMPLETED|Cohort 9 (35 mg/m^2) Period||0||
59776135|NCT00747474|75896680|FG010|COMPLETED|Cohort 9 (35 mg/m^2) Period||0||
59776136|NCT00747474|75896681|FG011|COMPLETED|Cohort 9 (35 mg/m^2) Period||0||
59776137|NCT00747474|75896670|FG000|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0||
59776138|NCT00747474|75896671|FG001|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0||
59776139|NCT00747474|75896672|FG002|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0||
59776140|NCT00747474|75896673|FG003|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0||
59776141|NCT00747474|75896674|FG004|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0||
59776142|NCT00747474|75896675|FG005|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0||
59776143|NCT00747474|75896676|FG006|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0||
59776144|NCT00747474|75896677|FG007|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0||
59776145|NCT00747474|75896678|FG008|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0||
59776146|NCT00747474|75896679|FG009|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0||
59776147|NCT00747474|75896680|FG010|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0||
59776148|NCT00747474|75896681|FG011|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0||
59776149|NCT00747474|75896670|FG000|STARTED|Cohort 10 (40 mg/m^2) Period||0||
59776150|NCT00747474|75896671|FG001|STARTED|Cohort 10 (40 mg/m^2) Period||0||
59776151|NCT00747474|75896672|FG002|STARTED|Cohort 10 (40 mg/m^2) Period||0||
59776152|NCT00747474|75896673|FG003|STARTED|Cohort 10 (40 mg/m^2) Period||0||
59952858|NCT01434602|76071637|FG003|COMPLETED|Phase I Dose Escalation||0||
59952859|NCT01434602|76071638|FG004|COMPLETED|Phase I Dose Escalation||0||
59776153|NCT00747474|75896674|FG004|STARTED|Cohort 10 (40 mg/m^2) Period||0||
59776154|NCT00747474|75896675|FG005|STARTED|Cohort 10 (40 mg/m^2) Period||0||
59776155|NCT00747474|75896676|FG006|STARTED|Cohort 10 (40 mg/m^2) Period||0||
59776156|NCT00747474|75896677|FG007|STARTED|Cohort 10 (40 mg/m^2) Period||0||
59776157|NCT00747474|75896678|FG008|STARTED|Cohort 10 (40 mg/m^2) Period||0||
59776158|NCT00747474|75896679|FG009|STARTED|Cohort 10 (40 mg/m^2) Period||7||
59776159|NCT00747474|75896680|FG010|STARTED|Cohort 10 (40 mg/m^2) Period||0||
59776160|NCT00747474|75896681|FG011|STARTED|Cohort 10 (40 mg/m^2) Period||0||
59776161|NCT00747474|75896670|FG000|COMPLETED|Cohort 10 (40 mg/m^2) Period||0||
59776162|NCT00747474|75896671|FG001|COMPLETED|Cohort 10 (40 mg/m^2) Period||0||
59776163|NCT00747474|75896672|FG002|COMPLETED|Cohort 10 (40 mg/m^2) Period||0||
59776164|NCT00747474|75896673|FG003|COMPLETED|Cohort 10 (40 mg/m^2) Period||0||
59776165|NCT00747474|75896674|FG004|COMPLETED|Cohort 10 (40 mg/m^2) Period||0||
59776166|NCT00747474|75896675|FG005|COMPLETED|Cohort 10 (40 mg/m^2) Period||0||
59776167|NCT00747474|75896676|FG006|COMPLETED|Cohort 10 (40 mg/m^2) Period||0||
59776168|NCT00747474|75896677|FG007|COMPLETED|Cohort 10 (40 mg/m^2) Period||0||
59776169|NCT00747474|75896678|FG008|COMPLETED|Cohort 10 (40 mg/m^2) Period||0||
59776170|NCT00747474|75896679|FG009|COMPLETED|Cohort 10 (40 mg/m^2) Period||7||
59776171|NCT00747474|75896680|FG010|COMPLETED|Cohort 10 (40 mg/m^2) Period||0||
59776172|NCT00747474|75896681|FG011|COMPLETED|Cohort 10 (40 mg/m^2) Period||0||
59776173|NCT00747474|75896670|FG000|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0||
59776174|NCT00747474|75896671|FG001|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0||
59776175|NCT00747474|75896672|FG002|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0||
59776176|NCT00747474|75896673|FG003|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0||
59776177|NCT00747474|75896674|FG004|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0||
59776178|NCT00747474|75896675|FG005|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0||
59776179|NCT00747474|75896676|FG006|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0||
59776180|NCT00747474|75896677|FG007|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0||
59776181|NCT00747474|75896678|FG008|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0||
59776182|NCT00747474|75896679|FG009|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0||
59776183|NCT00747474|75896680|FG010|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0||
59776184|NCT00747474|75896681|FG011|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0||
59776185|NCT00747474|75896670|FG000|STARTED|Cohort 11 (50 mg/m^2) Period||0||
59776186|NCT00747474|75896671|FG001|STARTED|Cohort 11 (50 mg/m^2) Period||0||
59776187|NCT00747474|75896672|FG002|STARTED|Cohort 11 (50 mg/m^2) Period||0||
59776188|NCT00747474|75896673|FG003|STARTED|Cohort 11 (50 mg/m^2) Period||0||
59776189|NCT00747474|75896674|FG004|STARTED|Cohort 11 (50 mg/m^2) Period||0||
59776190|NCT00747474|75896675|FG005|STARTED|Cohort 11 (50 mg/m^2) Period||0||
59776191|NCT00747474|75896676|FG006|STARTED|Cohort 11 (50 mg/m^2) Period||0||
59776192|NCT00747474|75896677|FG007|STARTED|Cohort 11 (50 mg/m^2) Period||0||
59776193|NCT00747474|75896678|FG008|STARTED|Cohort 11 (50 mg/m^2) Period||0||
59776194|NCT00747474|75896679|FG009|STARTED|Cohort 11 (50 mg/m^2) Period||0||
59776195|NCT00747474|75896680|FG010|STARTED|Cohort 11 (50 mg/m^2) Period||5||
59776196|NCT00747474|75896681|FG011|STARTED|Cohort 11 (50 mg/m^2) Period||0||
59776197|NCT00747474|75896670|FG000|COMPLETED|Cohort 11 (50 mg/m^2) Period||0||
59776198|NCT00747474|75896671|FG001|COMPLETED|Cohort 11 (50 mg/m^2) Period||0||
59776199|NCT00747474|75896672|FG002|COMPLETED|Cohort 11 (50 mg/m^2) Period||0||
59776200|NCT00747474|75896673|FG003|COMPLETED|Cohort 11 (50 mg/m^2) Period||0||
59776201|NCT00747474|75896674|FG004|COMPLETED|Cohort 11 (50 mg/m^2) Period||0||
59776202|NCT00747474|75896675|FG005|COMPLETED|Cohort 11 (50 mg/m^2) Period||0||
59776203|NCT00747474|75896676|FG006|COMPLETED|Cohort 11 (50 mg/m^2) Period||0||
59776204|NCT00747474|75896677|FG007|COMPLETED|Cohort 11 (50 mg/m^2) Period||0||
59776205|NCT00747474|75896678|FG008|COMPLETED|Cohort 11 (50 mg/m^2) Period||0||
59776206|NCT00747474|75896679|FG009|COMPLETED|Cohort 11 (50 mg/m^2) Period||0||
59776207|NCT00747474|75896680|FG010|COMPLETED|Cohort 11 (50 mg/m^2) Period||5||
59776208|NCT00747474|75896681|FG011|COMPLETED|Cohort 11 (50 mg/m^2) Period||0||
59776209|NCT00747474|75896670|FG000|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0||
59776210|NCT00747474|75896671|FG001|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0||
59776211|NCT00747474|75896672|FG002|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0||
59776212|NCT00747474|75896673|FG003|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0||
59776213|NCT00747474|75896674|FG004|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0||
59776214|NCT00747474|75896675|FG005|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0||
59776215|NCT00747474|75896676|FG006|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0||
59776216|NCT00747474|75896677|FG007|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0||
59776217|NCT00747474|75896678|FG008|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0||
59776218|NCT00747474|75896679|FG009|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0||
59776219|NCT00747474|75896680|FG010|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0||
59776220|NCT00747474|75896681|FG011|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0||
59776221|NCT00747474|75896670|FG000|STARTED|Cohort 12 (60 mg/m^2) Period||0||
59776222|NCT00747474|75896671|FG001|STARTED|Cohort 12 (60 mg/m^2) Period||0||
59776223|NCT00747474|75896672|FG002|STARTED|Cohort 12 (60 mg/m^2) Period||0||
59776224|NCT00747474|75896673|FG003|STARTED|Cohort 12 (60 mg/m^2) Period||0||
59776225|NCT00747474|75896674|FG004|STARTED|Cohort 12 (60 mg/m^2) Period||0||
59776226|NCT00747474|75896675|FG005|STARTED|Cohort 12 (60 mg/m^2) Period||0||
59776227|NCT00747474|75896676|FG006|STARTED|Cohort 12 (60 mg/m^2) Period||0||
59776228|NCT00747474|75896677|FG007|STARTED|Cohort 12 (60 mg/m^2) Period||0||
59776229|NCT00747474|75896678|FG008|STARTED|Cohort 12 (60 mg/m^2) Period||0||
59776230|NCT00747474|75896679|FG009|STARTED|Cohort 12 (60 mg/m^2) Period||0||
59776231|NCT00747474|75896680|FG010|STARTED|Cohort 12 (60 mg/m^2) Period||0||
59776232|NCT00747474|75896681|FG011|STARTED|Cohort 12 (60 mg/m^2) Period||6||
59776233|NCT00747474|75896670|FG000|COMPLETED|Cohort 12 (60 mg/m^2) Period||0||
59776234|NCT00747474|75896671|FG001|COMPLETED|Cohort 12 (60 mg/m^2) Period||0||
59776235|NCT00747474|75896672|FG002|COMPLETED|Cohort 12 (60 mg/m^2) Period||0||
59776236|NCT00747474|75896673|FG003|COMPLETED|Cohort 12 (60 mg/m^2) Period||0||
59521914|NCT02085356|75616224|FG000|COMPLETED|Overall Study||577||
59521915|NCT02085356|75616225|FG001|COMPLETED|Overall Study||348||
59521916|NCT02085356|75616226|FG002|COMPLETED|Overall Study||681||
59521917|NCT02085356|75616227|FG003|COMPLETED|Overall Study||361||
59521918|NCT02085356|75616224|FG000|NOT COMPLETED|Overall Study||0||
59521919|NCT02085356|75616225|FG001|NOT COMPLETED|Overall Study||0||
59521920|NCT02085356|75616226|FG002|NOT COMPLETED|Overall Study||0||
59521921|NCT02085356|75616227|FG003|NOT COMPLETED|Overall Study||0||
59521922|NCT02965976|75616239|FG000|STARTED|Overall Study||15||
59521923|NCT02965976|75616240|FG001|STARTED|Overall Study||17||
59521924|NCT02965976|75616239|FG000|COMPLETED|Overall Study||13||
59521925|NCT02965976|75616240|FG001|COMPLETED|Overall Study||17||
59521926|NCT02965976|75616239|FG000|NOT COMPLETED|Overall Study||2||
59521927|NCT02965976|75616240|FG001|NOT COMPLETED|Overall Study||0||
59521928|NCT00982397|75616248|FG000|STARTED|Phase I||236||
59521929|NCT00982397|75616249|FG001|STARTED|Phase I||0||
59521930|NCT00982397|75616248|FG000|COMPLETED|Phase I||236||
59521931|NCT00982397|75616249|FG001|COMPLETED|Phase I||0||
59521932|NCT00982397|75616248|FG000|NOT COMPLETED|Phase I||0||
59521933|NCT00982397|75616249|FG001|NOT COMPLETED|Phase I||0||
59521934|NCT00982397|75616248|FG000|STARTED|Phase II/Overall Study||2019|Note additional subjects were enrolled for Phase II|
59521935|NCT00982397|75616249|FG001|STARTED|Phase II/Overall Study||751|Note additional subjects were enrolled for Phase II|
59521936|NCT00982397|75616248|FG000|Secondary Prevention Randomized 18/24NID|Phase II/Overall Study||231|NID=number of intervals to detect prior to therapy delivery|
59521937|NCT00982397|75616249|FG001|Secondary Prevention Randomized 18/24NID|Phase II/Overall Study||122|NID=number of intervals to detect prior to therapy delivery|
59521938|NCT00982397|75616248|FG000|Secondary Prevention Randomized 30/40NID|Phase II/Overall Study||221|NID=number of intervals to detect prior to therapy delivery|
59521939|NCT00982397|75616249|FG001|Secondary Prevention Randomized 30/40NID|Phase II/Overall Study||131|NID=number of intervals to detect prior to therapy delivery|
59521940|NCT00982397|75616248|FG000|COMPLETED|Phase II/Overall Study||2019||
59521941|NCT00982397|75616249|FG001|COMPLETED|Phase II/Overall Study||751||
59521942|NCT00982397|75616248|FG000|NOT COMPLETED|Phase II/Overall Study||0||
59521943|NCT00982397|75616249|FG001|NOT COMPLETED|Phase II/Overall Study||0||
59521944|NCT04125680|75616258|FG000|STARTED|Overall Study||17||
59521945|NCT04125680|75616258|FG000|COMPLETED|Overall Study||2||
59521946|NCT04125680|75616258|FG000|NOT COMPLETED|Overall Study||15||
59521947|NCT01025453|75616263|FG000|STARTED|Overall Study||37||
59521948|NCT01025453|75616263|FG000|COMPLETED|Overall Study||37||
59521949|NCT01025453|75616263|FG000|NOT COMPLETED|Overall Study||0||
59521950|NCT00982553|75616267|FG000|STARTED|Phase1||14||
59521951|NCT00982553|75616267|FG000|COMPLETED|Phase1||14||
59521952|NCT00982553|75616267|FG000|NOT COMPLETED|Phase1||0||
59521953|NCT00982553|75616267|FG000|STARTED|Phase2||14||
59521954|NCT00982553|75616267|FG000|COMPLETED|Phase2||14||
59521955|NCT00982553|75616267|FG000|NOT COMPLETED|Phase2||0||
59521956|NCT00982553|75616267|FG000|STARTED|Phase3||14||
59521957|NCT00982553|75616267|FG000|COMPLETED|Phase3||14||
59521958|NCT00982553|75616267|FG000|NOT COMPLETED|Phase3||0||
59521959|NCT02939300|75616276|FG000|STARTED|Overall Study||18||
59521960|NCT02939300|75616276|FG000|COMPLETED|Overall Study||18||
59521961|NCT02939300|75616276|FG000|NOT COMPLETED|Overall Study||0||
59521962|NCT02565186|75616282|FG000|STARTED|Overall Study||1046||
59521963|NCT02565186|75616283|FG001|STARTED|Overall Study||1125||
59521964|NCT02565186|75616282|FG000|Received at Least One Dose of Study Drug|Overall Study||991||
59776237|NCT00747474|75896674|FG004|COMPLETED|Cohort 12 (60 mg/m^2) Period||0||
59776238|NCT00747474|75896675|FG005|COMPLETED|Cohort 12 (60 mg/m^2) Period||0||
59776239|NCT00747474|75896676|FG006|COMPLETED|Cohort 12 (60 mg/m^2) Period||0||
59776240|NCT00747474|75896677|FG007|COMPLETED|Cohort 12 (60 mg/m^2) Period||0||
59776241|NCT00747474|75896678|FG008|COMPLETED|Cohort 12 (60 mg/m^2) Period||0||
59776242|NCT00747474|75896679|FG009|COMPLETED|Cohort 12 (60 mg/m^2) Period||0||
59776243|NCT00747474|75896680|FG010|COMPLETED|Cohort 12 (60 mg/m^2) Period||0||
59521965|NCT02565186|75616283|FG001|Received at Least One Dose of Study Drug|Overall Study||1039||
59521966|NCT02565186|75616282|FG000|COMPLETED|Overall Study||466||
59521967|NCT02565186|75616283|FG001|COMPLETED|Overall Study||504||
59776244|NCT00747474|75896681|FG011|COMPLETED|Cohort 12 (60 mg/m^2) Period||6||
59995476|NCT02152995|76111309|FG000|COMPLETED|Overall Study||24||
59521968|NCT02565186|75616282|FG000|NOT COMPLETED|Overall Study||580||
59521969|NCT02565186|75616283|FG001|NOT COMPLETED|Overall Study||621||
59521970|NCT02568072|75616289|FG000|STARTED|Overall Study||120||
59521971|NCT02568072|75616289|FG000|COMPLETED|Overall Study||68||
59776245|NCT00747474|75896670|FG000|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0||
59776246|NCT00747474|75896671|FG001|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0||
59776247|NCT00747474|75896672|FG002|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0||
59776248|NCT00747474|75896673|FG003|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0||
59776249|NCT00747474|75896674|FG004|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0||
59776250|NCT00747474|75896675|FG005|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0||
59776251|NCT00747474|75896676|FG006|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0||
59776252|NCT00747474|75896677|FG007|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0||
59776253|NCT00747474|75896678|FG008|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0||
59776254|NCT00747474|75896679|FG009|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0||
59776255|NCT00747474|75896680|FG010|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0||
59776256|NCT00747474|75896681|FG011|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0||
59776257|NCT00830063|75896690|FG000|STARTED|Overall Study||208||
59776258|NCT00830063|75896691|FG001|STARTED|Overall Study||208||
59776259|NCT00830063|75896692|FG002|STARTED|Overall Study||208||
59776260|NCT00830063|75896693|FG003|STARTED|Overall Study||208||
59776261|NCT00830063|75896690|FG000|Treated|Overall Study||208||
59776262|NCT00830063|75896691|FG001|Treated|Overall Study||206||
59776263|NCT00830063|75896692|FG002|Treated|Overall Study||208||
59776264|NCT00830063|75896693|FG003|Treated|Overall Study||206||
59776265|NCT00830063|75896690|FG000|COMPLETED|Overall Study||8||
59776266|NCT00830063|75896691|FG001|COMPLETED|Overall Study||16||
59776267|NCT00830063|75896692|FG002|COMPLETED|Overall Study||10||
59776268|NCT00830063|75896693|FG003|COMPLETED|Overall Study||13||
59776269|NCT00830063|75896690|FG000|NOT COMPLETED|Overall Study||200||
59776270|NCT00830063|75896691|FG001|NOT COMPLETED|Overall Study||192||
59776271|NCT00830063|75896692|FG002|NOT COMPLETED|Overall Study||198||
59776272|NCT00830063|75896693|FG003|NOT COMPLETED|Overall Study||195||
59776273|NCT00750438|75896707|FG000|STARTED|Overall Study||31||
60072851|NCT03865654|76188060|FG000|STARTED|Overall Study||45||
60072852|NCT03865654|76188060|FG000|COMPLETED|Overall Study||40||
60072853|NCT03865654|76188060|FG000|NOT COMPLETED|Overall Study||5||
60072854|NCT01696773|76188066|FG000|STARTED|Days 1-13, Washout||6||
60072855|NCT01696773|76188067|FG001|STARTED|Days 1-13, Washout||6||
60072856|NCT01696773|76188066|FG000|COMPLETED|Days 1-13, Washout||6||
60072857|NCT01696773|76188067|FG001|COMPLETED|Days 1-13, Washout||6||
60072858|NCT01696773|76188066|FG000|NOT COMPLETED|Days 1-13, Washout||0||
59776274|NCT00750438|75896708|FG001|STARTED|Overall Study||29||
59776275|NCT00750438|75896707|FG000|COMPLETED|Overall Study||24||
59776276|NCT00750438|75896708|FG001|COMPLETED|Overall Study||25||
59776277|NCT00750438|75896707|FG000|NOT COMPLETED|Overall Study||7||
59776278|NCT00750438|75896708|FG001|NOT COMPLETED|Overall Study||4||
59776279|NCT00586326|75896714|FG000|STARTED|Enrollment to Device Placement-Enrolled||133||
59776280|NCT00586326|75896714|FG000|COMPLETED|Enrollment to Device Placement-Enrolled||118||
59776281|NCT00586326|75896714|FG000|NOT COMPLETED|Enrollment to Device Placement-Enrolled||15||
59776282|NCT00586326|75896714|FG000|STARTED|Device Placed toTreatment-ITT||118||
59776283|NCT00586326|75896714|FG000|COMPLETED|Device Placed toTreatment-ITT||100||
59776284|NCT00586326|75896714|FG000|NOT COMPLETED|Device Placed toTreatment-ITT||18||
59776285|NCT00586326|75896714|FG000|STARTED|Treated Through 5-yr Follow Up-Treated||100||
59776286|NCT00586326|75896714|FG000|COMPLETED|Treated Through 5-yr Follow Up-Treated||74||
59776287|NCT00586326|75896714|FG000|NOT COMPLETED|Treated Through 5-yr Follow Up-Treated||26||
59776288|NCT00751101|75896724|FG000|STARTED|Overall Study||12||
59776289|NCT00751101|75896725|FG001|STARTED|Overall Study||12||
59776290|NCT00751101|75896724|FG000|Started Capecitabine|Overall Study||11||
59776291|NCT00751101|75896725|FG001|Started Capecitabine|Overall Study||11||
59776292|NCT00751101|75896724|FG000|COMPLETED|Overall Study||10||
59952860|NCT01434602|76071634|FG000|NOT COMPLETED|Phase I Dose Escalation||0||
59952861|NCT01434602|76071635|FG001|NOT COMPLETED|Phase I Dose Escalation||1||
59952862|NCT01434602|76071636|FG002|NOT COMPLETED|Phase I Dose Escalation||0||
59952863|NCT01434602|76071637|FG003|NOT COMPLETED|Phase I Dose Escalation||0||
59952864|NCT01434602|76071638|FG004|NOT COMPLETED|Phase I Dose Escalation||0||
59952865|NCT01434602|76071634|FG000|STARTED|Phase II Recommended Phase 2 Dose||0||
59952866|NCT01434602|76071635|FG001|STARTED|Phase II Recommended Phase 2 Dose||0||
59952867|NCT01434602|76071636|FG002|STARTED|Phase II Recommended Phase 2 Dose||12||
59952868|NCT01434602|76071637|FG003|STARTED|Phase II Recommended Phase 2 Dose||40||
59952869|NCT01434602|76071638|FG004|STARTED|Phase II Recommended Phase 2 Dose||21||
59952870|NCT01434602|76071634|FG000|COMPLETED|Phase II Recommended Phase 2 Dose||0||
59952871|NCT01434602|76071635|FG001|COMPLETED|Phase II Recommended Phase 2 Dose||0||
59952872|NCT01434602|76071636|FG002|COMPLETED|Phase II Recommended Phase 2 Dose||12||
59952873|NCT01434602|76071637|FG003|COMPLETED|Phase II Recommended Phase 2 Dose||31||
59952874|NCT01434602|76071638|FG004|COMPLETED|Phase II Recommended Phase 2 Dose||19||
59952875|NCT01434602|76071634|FG000|NOT COMPLETED|Phase II Recommended Phase 2 Dose||0||
59952876|NCT01434602|76071635|FG001|NOT COMPLETED|Phase II Recommended Phase 2 Dose||0||
59952877|NCT01434602|76071636|FG002|NOT COMPLETED|Phase II Recommended Phase 2 Dose||0||
59952878|NCT01434602|76071637|FG003|NOT COMPLETED|Phase II Recommended Phase 2 Dose||9||
59952879|NCT01434602|76071638|FG004|NOT COMPLETED|Phase II Recommended Phase 2 Dose||2||
60072859|NCT01696773|76188067|FG001|NOT COMPLETED|Days 1-13, Washout||0||
59776293|NCT00751101|75896725|FG001|COMPLETED|Overall Study||7||
59776294|NCT00751101|75896724|FG000|NOT COMPLETED|Overall Study||2||
59776295|NCT00751101|75896725|FG001|NOT COMPLETED|Overall Study||5||
59776296|NCT00750204|75896737|FG000|STARTED|Overall Study||1||
59776297|NCT00750204|75896738|FG001|STARTED|Overall Study||1||
59776298|NCT00750204|75896737|FG000|COMPLETED|Overall Study||0||
59776299|NCT00750204|75896738|FG001|COMPLETED|Overall Study||0||
59776300|NCT00750204|75896737|FG000|NOT COMPLETED|Overall Study||1||
59776301|NCT00750204|75896738|FG001|NOT COMPLETED|Overall Study||1||
59776302|NCT00751023|75896746|FG000|STARTED|Overall Study||20||
59776303|NCT00751023|75896747|FG001|STARTED|Overall Study||20||
59776304|NCT00751023|75896746|FG000|COMPLETED|Overall Study||9||
59776305|NCT00751023|75896747|FG001|COMPLETED|Overall Study||13||
59776306|NCT00751023|75896746|FG000|NOT COMPLETED|Overall Study||11||
59776307|NCT00751023|75896747|FG001|NOT COMPLETED|Overall Study||7||
59776308|NCT00591773|75896756|FG000|STARTED|Overall Study||185||
59776309|NCT00591773|75896757|FG001|STARTED|Overall Study||182||
59776310|NCT00591773|75896758|FG002|STARTED|Overall Study||184||
59776311|NCT00591773|75896756|FG000|COMPLETED|Overall Study||169||
59776312|NCT00591773|75896757|FG001|COMPLETED|Overall Study||158||
59776313|NCT00591773|75896758|FG002|COMPLETED|Overall Study||168||
59776314|NCT00591773|75896756|FG000|NOT COMPLETED|Overall Study||16||
59776315|NCT00591773|75896757|FG001|NOT COMPLETED|Overall Study||24||
59776316|NCT00591773|75896758|FG002|NOT COMPLETED|Overall Study||16||
59776317|NCT00750867|75896766|FG000|STARTED|Overall Study||9||
59776318|NCT00750867|75896766|FG000|COMPLETED|Overall Study||7||
59776319|NCT00750867|75896766|FG000|NOT COMPLETED|Overall Study||2||
59776320|NCT00744042|75896770|FG000|STARTED|Overall Study||11||
59776321|NCT00744042|75896770|FG000|COMPLETED|Overall Study||10||
59776322|NCT00744042|75896770|FG000|NOT COMPLETED|Overall Study||1||
59776323|NCT00829829|75896783|FG000|STARTED|Overall Study||80||
59776324|NCT00829829|75896784|FG001|STARTED|Overall Study||80||
59776325|NCT00829829|75896785|FG002|STARTED|Overall Study||81||
59776326|NCT00829829|75896783|FG000|Treated|Overall Study||79|Participants treated were included in safety population.|
59776327|NCT00829829|75896784|FG001|Treated|Overall Study||80|Participants treated were included in safety population.|
59776328|NCT00829829|75896785|FG002|Treated|Overall Study||81|Participants treated were included in safety population.|
59776329|NCT00829829|75896783|FG000|COMPLETED|Overall Study||58||
59776330|NCT00829829|75896784|FG001|COMPLETED|Overall Study||64||
59776331|NCT00829829|75896785|FG002|COMPLETED|Overall Study||70||
59776332|NCT00829829|75896783|FG000|NOT COMPLETED|Overall Study||22||
59776333|NCT00829829|75896784|FG001|NOT COMPLETED|Overall Study||16||
59776334|NCT00829829|75896785|FG002|NOT COMPLETED|Overall Study||11||
59776335|NCT00823199|75896794|FG000|STARTED|Overall Study||10||
59776336|NCT00823199|75896794|FG000|COMPLETED|Overall Study||8||
59776337|NCT00823199|75896794|FG000|NOT COMPLETED|Overall Study||2||
59776338|NCT00829439|75896799|FG000|STARTED|Overall Study||3||
59776339|NCT00829439|75896800|FG001|STARTED|Overall Study||3||
59776340|NCT00829439|75896801|FG002|STARTED|Overall Study||6||
59776341|NCT00829439|75896802|FG003|STARTED|Overall Study||4||
59776342|NCT00829439|75896799|FG000|COMPLETED|Overall Study||3||
59776343|NCT00829439|75896800|FG001|COMPLETED|Overall Study||3||
59776344|NCT00829439|75896801|FG002|COMPLETED|Overall Study||5||
59776345|NCT00829439|75896802|FG003|COMPLETED|Overall Study||4||
59776346|NCT00829439|75896799|FG000|NOT COMPLETED|Overall Study||0||
59776347|NCT00829439|75896800|FG001|NOT COMPLETED|Overall Study||0||
59776348|NCT00829439|75896801|FG002|NOT COMPLETED|Overall Study||1||
59776349|NCT00829439|75896802|FG003|NOT COMPLETED|Overall Study||0||
59776350|NCT00749775|75896806|FG000|STARTED|Overall Study||3317||
59776351|NCT00749775|75896806|FG000|COMPLETED|Overall Study||3210||
59776352|NCT00749775|75896806|FG000|NOT COMPLETED|Overall Study||107||
59776353|NCT00829283|75896822|FG000|STARTED|Overall Study||39||
59776354|NCT00829283|75896823|FG001|STARTED|Overall Study||152||
59776355|NCT00829283|75896822|FG000|COMPLETED|Overall Study||32||
59776356|NCT00829283|75896823|FG001|COMPLETED|Overall Study||127||
59776357|NCT00829283|75896822|FG000|NOT COMPLETED|Overall Study||7||
59776358|NCT00829283|75896823|FG001|NOT COMPLETED|Overall Study||25||
59776359|NCT00821873|75896829|FG000|STARTED|Overall Study||9||
59776360|NCT00821873|75896829|FG000|COMPLETED|Overall Study||5||
59776361|NCT00821873|75896829|FG000|NOT COMPLETED|Overall Study||4||
59776362|NCT00749463|75896836|FG000|STARTED|Overall Study||86||
59776363|NCT00749463|75896837|FG001|STARTED|Overall Study||64||
59776364|NCT00749463|75896838|FG002|STARTED|Overall Study||150||
59776365|NCT00749463|75896836|FG000|COMPLETED|Overall Study||85||
59776366|NCT00749463|75896837|FG001|COMPLETED|Overall Study||60||
59776367|NCT00749463|75896838|FG002|COMPLETED|Overall Study||149||
59776368|NCT00749463|75896836|FG000|NOT COMPLETED|Overall Study||1||
59776369|NCT00749463|75896837|FG001|NOT COMPLETED|Overall Study||4||
59776370|NCT00749463|75896838|FG002|NOT COMPLETED|Overall Study||1||
59776371|NCT00821327|75896846|FG000|STARTED|Overall Study||36||
59776372|NCT00821327|75896846|FG000|COMPLETED|Overall Study||1||
59776373|NCT00821327|75896846|FG000|NOT COMPLETED|Overall Study||35||
59776374|NCT00821093|75896852|FG000|STARTED|Overall Study||560||
59776375|NCT00821093|75896853|FG001|STARTED|Overall Study||563||
59776376|NCT00821093|75896852|FG000|Exposed to Drug|Overall Study||559||
59776377|NCT00821093|75896853|FG001|Exposed to Drug|Overall Study||562||
59776378|NCT00821093|75896852|FG000|COMPLETED|Overall Study||511||
59776379|NCT00821093|75896853|FG001|COMPLETED|Overall Study||523||
59776380|NCT00821093|75896852|FG000|NOT COMPLETED|Overall Study||49||
59776381|NCT00821093|75896853|FG001|NOT COMPLETED|Overall Study||40||
59776382|NCT00821015|75896859|FG000|STARTED|Overall Study||27||
59776383|NCT00821015|75896859|FG000|COMPLETED|Overall Study||15||
59776384|NCT00821015|75896859|FG000|NOT COMPLETED|Overall Study||12||
59776385|NCT00814463|75896863|FG000|STARTED|Overall Study||1||
59776386|NCT00814463|75896863|FG000|COMPLETED|Overall Study||0||
59776387|NCT00814463|75896863|FG000|NOT COMPLETED|Overall Study||1||
59776388|NCT00743652|75896873|FG000|STARTED|Overall Study||151||
59776389|NCT00743652|75896874|FG001|STARTED|Overall Study||51||
59776390|NCT00743652|75896875|FG002|STARTED|Overall Study||25||
59776391|NCT00743652|75896876|FG003|STARTED|Overall Study||67||
59776392|NCT00743652|75896877|FG004|STARTED|Overall Study||79||
59776393|NCT00743652|75896873|FG000|Vaccinated Dose 1|Overall Study||151||
59776394|NCT00743652|75896874|FG001|Vaccinated Dose 1|Overall Study||51||
59776395|NCT00743652|75896875|FG002|Vaccinated Dose 1|Overall Study||25||
59776396|NCT00743652|75896876|FG003|Vaccinated Dose 1|Overall Study||66||
59776397|NCT00743652|75896877|FG004|Vaccinated Dose 1|Overall Study||79||
59776398|NCT00743652|75896873|FG000|Vaccinated Dose 2|Overall Study||112||
59776399|NCT00743652|75896874|FG001|Vaccinated Dose 2|Overall Study||41||
59776400|NCT00743652|75896875|FG002|Vaccinated Dose 2|Overall Study||0||
59776401|NCT00743652|75896876|FG003|Vaccinated Dose 2|Overall Study||49||
59776402|NCT00743652|75896877|FG004|Vaccinated Dose 2|Overall Study||0||
59776403|NCT00743652|75896873|FG000|Vaccinated Dose 3|Overall Study||74||
59776404|NCT00743652|75896874|FG001|Vaccinated Dose 3|Overall Study||0||
59776405|NCT00743652|75896875|FG002|Vaccinated Dose 3|Overall Study||0||
59776406|NCT00743652|75896876|FG003|Vaccinated Dose 3|Overall Study||0||
59776407|NCT00743652|75896877|FG004|Vaccinated Dose 3|Overall Study||0||
59776408|NCT00743652|75896873|FG000|Toddler Dose|Overall Study||15||
59776409|NCT00743652|75896874|FG001|Toddler Dose|Overall Study||23||
59776410|NCT00743652|75896875|FG002|Toddler Dose|Overall Study||16||
59776411|NCT00743652|75896876|FG003|Toddler Dose|Overall Study||0||
59776412|NCT00743652|75896877|FG004|Toddler Dose|Overall Study||0||
59776413|NCT00743652|75896873|FG000|COMPLETED|Overall Study||141||
59776414|NCT00743652|75896874|FG001|COMPLETED|Overall Study||48||
59776415|NCT00743652|75896875|FG002|COMPLETED|Overall Study||23||
59776416|NCT00743652|75896876|FG003|COMPLETED|Overall Study||63||
59776417|NCT00743652|75896877|FG004|COMPLETED|Overall Study||79||
59776418|NCT00743652|75896873|FG000|NOT COMPLETED|Overall Study||10||
59776419|NCT00743652|75896874|FG001|NOT COMPLETED|Overall Study||3||
59776420|NCT00743652|75896875|FG002|NOT COMPLETED|Overall Study||2||
59776421|NCT00743652|75896876|FG003|NOT COMPLETED|Overall Study||4||
59776422|NCT00743652|75896877|FG004|NOT COMPLETED|Overall Study||0||
59776423|NCT00748215|75896895|FG000|STARTED|Overall Study||50||
59776424|NCT00748215|75896896|FG001|STARTED|Overall Study||50||
59776425|NCT00748215|75896895|FG000|Open Label CASAD After Initial 6 Weeks Intervention|Overall Study||22||
59776426|NCT00748215|75896896|FG001|Open Label CASAD After Initial 6 Weeks Intervention|Overall Study||17||
59776427|NCT00748215|75896895|FG000|COMPLETED|Overall Study||41||
59776428|NCT00748215|75896896|FG001|COMPLETED|Overall Study||32||
59776429|NCT00748215|75896895|FG000|NOT COMPLETED|Overall Study||9||
59776430|NCT00748215|75896896|FG001|NOT COMPLETED|Overall Study||18||
59952880|NCT01767129|76071660|FG000|STARTED|Treatment Period 1 (14 Days)||7||
59952881|NCT01767129|76071661|FG001|STARTED|Treatment Period 1 (14 Days)||7||
59952882|NCT01767129|76071660|FG000|COMPLETED|Treatment Period 1 (14 Days)||6||
59776431|NCT00749892|75896902|FG000|STARTED|Overall Study||34||
59776432|NCT00749892|75896902|FG000|COMPLETED|Overall Study||31||
59776433|NCT00749892|75896902|FG000|NOT COMPLETED|Overall Study||3||
59776434|NCT00749580|75896908|FG000|STARTED|Overall Study|September 2008|21||
59776435|NCT00749580|75896909|FG001|STARTED|Overall Study||25||
59776436|NCT00749580|75896908|FG000|COMPLETED|Overall Study|December 2010|17||
59776437|NCT00749580|75896909|FG001|COMPLETED|Overall Study||16||
59776438|NCT00749580|75896908|FG000|NOT COMPLETED|Overall Study||4||
59776439|NCT00749580|75896909|FG001|NOT COMPLETED|Overall Study||9||
59776440|NCT00747006|75896918|FG000|STARTED|Overall Study||7||
59776441|NCT00747006|75896919|FG001|STARTED|Overall Study||8||
59776442|NCT00747006|75896920|FG002|STARTED|Overall Study||3||
59776443|NCT00747006|75896918|FG000|COMPLETED|Overall Study||4||
59776444|NCT00747006|75896919|FG001|COMPLETED|Overall Study||7||
59776445|NCT00747006|75896920|FG002|COMPLETED|Overall Study||2||
59776446|NCT00747006|75896918|FG000|NOT COMPLETED|Overall Study||3||
59776447|NCT00747006|75896919|FG001|NOT COMPLETED|Overall Study||1||
59776448|NCT00747006|75896920|FG002|NOT COMPLETED|Overall Study||1||
59776449|NCT00743340|75896931|FG000|STARTED|Overall Study||50||
59776450|NCT00743340|75896931|FG000|COMPLETED|Overall Study||9||
59776451|NCT00743340|75896931|FG000|NOT COMPLETED|Overall Study||41||
59776452|NCT00749190|75896942|FG000|STARTED|Overall Study||71||
59776453|NCT00749190|75896943|FG001|STARTED|Overall Study||71||
59776454|NCT00749190|75896944|FG002|STARTED|Overall Study||71||
59776455|NCT00749190|75896945|FG003|STARTED|Overall Study||71||
59776456|NCT00749190|75896946|FG004|STARTED|Overall Study||70||
59776457|NCT00749190|75896947|FG005|STARTED|Overall Study||70||
59776458|NCT00749190|75896948|FG006|STARTED|Overall Study||71||
59776459|NCT00749190|75896942|FG000|COMPLETED|Overall Study||66||
59776460|NCT00749190|75896943|FG001|COMPLETED|Overall Study||66||
59776461|NCT00749190|75896944|FG002|COMPLETED|Overall Study||70||
59776462|NCT00749190|75896945|FG003|COMPLETED|Overall Study||66||
59776463|NCT00749190|75896946|FG004|COMPLETED|Overall Study||70||
59776464|NCT00749190|75896947|FG005|COMPLETED|Overall Study||65||
59776465|NCT00749190|75896948|FG006|COMPLETED|Overall Study||70||
59776466|NCT00749190|75896942|FG000|NOT COMPLETED|Overall Study||5||
59776467|NCT00749190|75896943|FG001|NOT COMPLETED|Overall Study||5||
59776468|NCT00749190|75896944|FG002|NOT COMPLETED|Overall Study||1||
59776469|NCT00749190|75896945|FG003|NOT COMPLETED|Overall Study||5||
59776470|NCT00749190|75896946|FG004|NOT COMPLETED|Overall Study||0||
59776471|NCT00749190|75896947|FG005|NOT COMPLETED|Overall Study||5||
59776472|NCT00749190|75896948|FG006|NOT COMPLETED|Overall Study||1||
59776473|NCT00748566|75896969|FG000|STARTED|Overall Study||172||
59776474|NCT00748566|75896969|FG000|COMPLETED|Overall Study||60||
59776475|NCT00748566|75896969|FG000|NOT COMPLETED|Overall Study||112||
59776476|NCT00743106|75896975|FG000|STARTED|Overall Study||42||
59776477|NCT00743106|75896976|FG001|STARTED|Overall Study||48||
59776478|NCT00743106|75896975|FG000|COMPLETED|Overall Study||34||
59776479|NCT00743106|75896976|FG001|COMPLETED|Overall Study||43||
59776480|NCT00743106|75896975|FG000|NOT COMPLETED|Overall Study||8||
59776481|NCT00743106|75896976|FG001|NOT COMPLETED|Overall Study||5||
59776482|NCT00738699|75896984|FG000|STARTED|Overall Study||275||
59776483|NCT00738699|75896985|FG001|STARTED|Overall Study||140||
59776484|NCT00738699|75896984|FG000|Participants Not Treated|Overall Study||2||
59776485|NCT00738699|75896985|FG001|Participants Not Treated|Overall Study||1||
59776486|NCT00738699|75896984|FG000|Participants Treated|Overall Study||273||
59776487|NCT00738699|75896985|FG001|Participants Treated|Overall Study||139||
59776488|NCT00738699|75896984|FG000|COMPLETED|Overall Study||0||
59776489|NCT00738699|75896985|FG001|COMPLETED|Overall Study||0||
59776490|NCT00738699|75896984|FG000|NOT COMPLETED|Overall Study||275||
59776491|NCT00738699|75896985|FG001|NOT COMPLETED|Overall Study||140||
59776492|NCT00814307|75896995|FG000|STARTED|Overall Study||244||
59776493|NCT00814307|75896996|FG001|STARTED|Overall Study||245||
59776494|NCT00814307|75896997|FG002|STARTED|Overall Study||61||
59776495|NCT00814307|75896998|FG003|STARTED|Overall Study||61||
59776496|NCT00814307|75896995|FG000|Treated|Overall Study||243||
59776497|NCT00814307|75896996|FG001|Treated|Overall Study||245||
59776498|NCT00814307|75896997|FG002|Treated|Overall Study||61||
59776499|NCT00814307|75896998|FG003|Treated|Overall Study||61||
59776500|NCT00814307|75896995|FG000|COMPLETED|Overall Study||232||
59776501|NCT00814307|75896996|FG001|COMPLETED|Overall Study||218||
59776502|NCT00814307|75896997|FG002|COMPLETED|Overall Study||54||
59776503|NCT00814307|75896998|FG003|COMPLETED|Overall Study||51||
59776504|NCT00814307|75896995|FG000|NOT COMPLETED|Overall Study||12||
59776505|NCT00814307|75896996|FG001|NOT COMPLETED|Overall Study||27||
59776506|NCT00814307|75896997|FG002|NOT COMPLETED|Overall Study||7||
60072860|NCT01696773|76188066|FG000|STARTED|Day 14, First Intervention||6||
59776507|NCT00814307|75896998|FG003|NOT COMPLETED|Overall Study||10||
59776508|NCT00748098|75897010|FG000|STARTED|First Treatment Intervention Period||69||
59776509|NCT00748098|75897011|FG001|STARTED|First Treatment Intervention Period||67||
59776510|NCT00748098|75897010|FG000|COMPLETED|First Treatment Intervention Period||64||
59776511|NCT00748098|75897011|FG001|COMPLETED|First Treatment Intervention Period||66||
59776512|NCT00748098|75897010|FG000|NOT COMPLETED|First Treatment Intervention Period||5||
59776513|NCT00748098|75897011|FG001|NOT COMPLETED|First Treatment Intervention Period||1||
59776514|NCT00748098|75897010|FG000|STARTED|First Taper Period||64||
59776515|NCT00748098|75897011|FG001|STARTED|First Taper Period||66||
59776516|NCT00748098|75897010|FG000|COMPLETED|First Taper Period||61||
59776517|NCT00748098|75897011|FG001|COMPLETED|First Taper Period||65||
59776518|NCT00748098|75897010|FG000|NOT COMPLETED|First Taper Period||3||
59776519|NCT00748098|75897011|FG001|NOT COMPLETED|First Taper Period||1||
59776520|NCT00748098|75897010|FG000|STARTED|1-Week Washout Period||61||
59776521|NCT00748098|75897011|FG001|STARTED|1-Week Washout Period||65||
59776522|NCT00748098|75897010|FG000|COMPLETED|1-Week Washout Period||59||
59776523|NCT00748098|75897011|FG001|COMPLETED|1-Week Washout Period||64||
59776524|NCT00748098|75897010|FG000|NOT COMPLETED|1-Week Washout Period||2||
59776525|NCT00748098|75897011|FG001|NOT COMPLETED|1-Week Washout Period||1||
59776526|NCT00748098|75897010|FG000|STARTED|Second Treatment Intervention Period||59||
59776527|NCT00748098|75897011|FG001|STARTED|Second Treatment Intervention Period||64||
59776528|NCT00748098|75897010|FG000|COMPLETED|Second Treatment Intervention Period||53||
59776529|NCT00748098|75897011|FG001|COMPLETED|Second Treatment Intervention Period||61||
59776530|NCT00748098|75897010|FG000|NOT COMPLETED|Second Treatment Intervention Period||6||
59776531|NCT00748098|75897011|FG001|NOT COMPLETED|Second Treatment Intervention Period||3||
59776532|NCT00748098|75897010|FG000|STARTED|Second Taper Period||53||
59776533|NCT00748098|75897011|FG001|STARTED|Second Taper Period||61||
59776534|NCT00748098|75897010|FG000|COMPLETED|Second Taper Period||53||
59776535|NCT00748098|75897011|FG001|COMPLETED|Second Taper Period||61||
59776536|NCT00748098|75897010|FG000|NOT COMPLETED|Second Taper Period||0||
59776537|NCT00748098|75897011|FG001|NOT COMPLETED|Second Taper Period||0||
59776538|NCT00813995|75897020|FG000|STARTED|Overall Study||197||
59776539|NCT00813995|75897021|FG001|STARTED|Overall Study||198||
59776540|NCT00813995|75897020|FG000|COMPLETED|Overall Study||174||
59776541|NCT00813995|75897021|FG001|COMPLETED|Overall Study||182||
59776542|NCT00813995|75897020|FG000|NOT COMPLETED|Overall Study||23||
59776543|NCT00813995|75897021|FG001|NOT COMPLETED|Overall Study||16||
59776544|NCT00737529|75897031|FG000|STARTED|Overall Study||134||
59776545|NCT00737529|75897031|FG000|COMPLETED|Overall Study|Completed equals participants ongoing on treatment at the time of the data cut-off of 30 March 2017|1||
59776546|NCT00737529|75897031|FG000|NOT COMPLETED|Overall Study||133||
59776547|NCT00813917|75897037|FG000|STARTED|Overall Study||38||
59776548|NCT00813917|75897038|FG001|STARTED|Overall Study||38||
59776549|NCT00813917|75897037|FG000|COMPLETED|Overall Study||32||
59776550|NCT00813917|75897038|FG001|COMPLETED|Overall Study||32||
59776551|NCT00813917|75897037|FG000|NOT COMPLETED|Overall Study||6||
59776552|NCT00813917|75897038|FG001|NOT COMPLETED|Overall Study||6||
59776553|NCT00737061|75897044|FG000|STARTED|Waiting Period||645||
59776554|NCT00737061|75897044|FG000|COMPLETED|Waiting Period||570||
59776555|NCT00737061|75897044|FG000|NOT COMPLETED|Waiting Period||75||
59776556|NCT00737061|75897044|FG000|STARTED|1 Year Wearing Period||570||
59776557|NCT00737061|75897044|FG000|COMPLETED|1 Year Wearing Period||553||
59776558|NCT00737061|75897044|FG000|NOT COMPLETED|1 Year Wearing Period||17||
59776559|NCT00585975|75897050|FG000|STARTED|Overall Study||277||
59776560|NCT00585975|75897051|FG001|STARTED|Overall Study||291||
59776561|NCT00585975|75897050|FG000|COMPLETED|Overall Study||262||
59776562|NCT00585975|75897051|FG001|COMPLETED|Overall Study||278||
59776563|NCT00585975|75897050|FG000|NOT COMPLETED|Overall Study||15||
59776564|NCT00585975|75897051|FG001|NOT COMPLETED|Overall Study||13||
59952883|NCT01767129|76071661|FG001|COMPLETED|Treatment Period 1 (14 Days)||7||
59776565|NCT00585585|75897057|FG000|STARTED|Overall Study||1||
59776566|NCT00585585|75897057|FG000|Patients Receiving Drug|Overall Study||1||
59952884|NCT01767129|76071660|FG000|NOT COMPLETED|Treatment Period 1 (14 Days)||1||
59952885|NCT01767129|76071661|FG001|NOT COMPLETED|Treatment Period 1 (14 Days)||0||
59952886|NCT01767129|76071660|FG000|STARTED|Treatment Period 2 (14 Days)||6||
59952887|NCT01767129|76071661|FG001|STARTED|Treatment Period 2 (14 Days)||7||
59952888|NCT01767129|76071660|FG000|COMPLETED|Treatment Period 2 (14 Days)||6||
59952889|NCT01767129|76071661|FG001|COMPLETED|Treatment Period 2 (14 Days)||7||
59952890|NCT01767129|76071660|FG000|NOT COMPLETED|Treatment Period 2 (14 Days)||0||
59952891|NCT01767129|76071661|FG001|NOT COMPLETED|Treatment Period 2 (14 Days)||0||
59952892|NCT02791269|76071670|FG000|STARTED|Overall Study||4||
59952893|NCT02791269|76071671|FG001|STARTED|Overall Study||20||
59952894|NCT02791269|76071670|FG000|COMPLETED|Overall Study||4||
59952895|NCT02791269|76071671|FG001|COMPLETED|Overall Study||19||
59952896|NCT02791269|76071670|FG000|NOT COMPLETED|Overall Study||0||
59952897|NCT02791269|76071671|FG001|NOT COMPLETED|Overall Study||1||
59952898|NCT02696564|76071681|FG000|STARTED|Overall Study||108||
59952899|NCT02696564|76071682|FG001|STARTED|Overall Study||112||
59952900|NCT02696564|76071681|FG000|COMPLETED|Overall Study||94||
59952901|NCT02696564|76071682|FG001|COMPLETED|Overall Study||99||
59952902|NCT02696564|76071681|FG000|NOT COMPLETED|Overall Study||14||
59952903|NCT02696564|76071682|FG001|NOT COMPLETED|Overall Study||13||
59952904|NCT02640950|76071688|FG000|STARTED|Overall Study||31||
60072861|NCT01696773|76188067|FG001|STARTED|Day 14, First Intervention||6||
60072862|NCT01696773|76188066|FG000|COMPLETED|Day 14, First Intervention||6||
60072863|NCT01696773|76188067|FG001|COMPLETED|Day 14, First Intervention||6||
60072864|NCT01696773|76188066|FG000|NOT COMPLETED|Day 14, First Intervention||0||
60072865|NCT01696773|76188067|FG001|NOT COMPLETED|Day 14, First Intervention||0||
59776567|NCT00585585|75897057|FG000|COMPLETED|Overall Study||0||
59776568|NCT00585585|75897057|FG000|NOT COMPLETED|Overall Study||1||
59776569|NCT00734097|75897061|FG000|STARTED|Screening||337||
59776570|NCT00734097|75897061|FG000|COMPLETED|Screening|20 participants were screening failure.|317||
59776571|NCT00734097|75897061|FG000|NOT COMPLETED|Screening||20||
59776572|NCT00734097|75897061|FG000|STARTED|Open Label|Full analysis performed in 311|317||
59776573|NCT00734097|75897061|FG000|Safety Analysis|Open Label||317||
59776574|NCT00734097|75897061|FG000|Full Analysis|Open Label||311||
59776575|NCT00734097|75897061|FG000|Per Protocol|Open Label||301||
59952905|NCT02640950|76071688|FG000|COMPLETED|Overall Study||29||
59952906|NCT02640950|76071688|FG000|NOT COMPLETED|Overall Study||2||
59952907|NCT02593786|76071696|FG000|STARTED|Overall Study||15||
59952908|NCT02593786|76071697|FG001|STARTED|Overall Study||20||
59952909|NCT02593786|76071698|FG002|STARTED|Overall Study||11||
59952910|NCT02593786|76071699|FG003|STARTED|Overall Study||12||
59952911|NCT02593786|76071696|FG000|COMPLETED|Overall Study||0||
59952912|NCT02593786|76071697|FG001|COMPLETED|Overall Study||0||
59952913|NCT02593786|76071698|FG002|COMPLETED|Overall Study||0||
59952914|NCT02593786|76071699|FG003|COMPLETED|Overall Study||0||
59952915|NCT02593786|76071696|FG000|NOT COMPLETED|Overall Study||15||
59952916|NCT02593786|76071697|FG001|NOT COMPLETED|Overall Study||20||
59952917|NCT02593786|76071698|FG002|NOT COMPLETED|Overall Study||11||
59952918|NCT02593786|76071699|FG003|NOT COMPLETED|Overall Study||12||
59952919|NCT01878500|76071711|FG000|STARTED|Overall Study||47||
59776576|NCT00734097|75897061|FG000|COMPLETED|Open Label|16 patients discontinued after randomization|301||
59776577|NCT00734097|75897061|FG000|NOT COMPLETED|Open Label||16||
59776578|NCT00819767|75897067|FG000|STARTED|Overall Study||33||
59776579|NCT00819767|75897068|FG001|STARTED|Overall Study||35||
59776580|NCT00819767|75897067|FG000|COMPLETED|Overall Study||32||
59776581|NCT00819767|75897068|FG001|COMPLETED|Overall Study||33||
59776582|NCT00819767|75897067|FG000|NOT COMPLETED|Overall Study||1||
59776583|NCT00819767|75897068|FG001|NOT COMPLETED|Overall Study||2||
59776584|NCT00733005|75897076|FG000|STARTED|Overall Study||162||
59776585|NCT00733005|75897077|FG001|STARTED|Overall Study||162||
59776586|NCT00733005|75897076|FG000|COMPLETED|Overall Study||160||
59776587|NCT00733005|75897077|FG001|COMPLETED|Overall Study||159||
59776588|NCT00733005|75897076|FG000|NOT COMPLETED|Overall Study||2||
59776589|NCT00733005|75897077|FG001|NOT COMPLETED|Overall Study||3||
59776590|NCT00812981|75897085|FG000|STARTED|Overall Study||160||
59776591|NCT00812981|75897086|FG001|STARTED|Overall Study||160||
59776592|NCT00812981|75897085|FG000|COMPLETED|Overall Study||160||
59776593|NCT00812981|75897086|FG001|COMPLETED|Overall Study||159||
59776594|NCT00812981|75897085|FG000|NOT COMPLETED|Overall Study||0||
59776595|NCT00812981|75897086|FG001|NOT COMPLETED|Overall Study||1||
59776596|NCT00732615|75897094|FG000|STARTED|Overall Study||40||
59776597|NCT00732615|75897095|FG001|STARTED|Overall Study||84||
59776598|NCT00732615|75897094|FG000|COMPLETED|Overall Study||33||
59776599|NCT00732615|75897095|FG001|COMPLETED|Overall Study||79||
59776600|NCT00732615|75897094|FG000|NOT COMPLETED|Overall Study||7||
59776601|NCT00732615|75897095|FG001|NOT COMPLETED|Overall Study||5||
59776602|NCT00732381|75897104|FG000|STARTED|Overall Study||176||
59776603|NCT00732381|75897105|FG001|STARTED|Overall Study||175||
59776604|NCT00732381|75897104|FG000|COMPLETED|Overall Study||174||
59776605|NCT00732381|75897105|FG001|COMPLETED|Overall Study||174||
59776606|NCT00732381|75897104|FG000|NOT COMPLETED|Overall Study||2||
59776607|NCT00732381|75897105|FG001|NOT COMPLETED|Overall Study||1||
59776608|NCT00732303|75897111|FG000|STARTED|Overall Study||8||
59776609|NCT00732303|75897111|FG000|COMPLETED|Overall Study||6||
59776610|NCT00732303|75897111|FG000|NOT COMPLETED|Overall Study||2||
59776611|NCT00813761|75897117|FG000|STARTED|Phase 1 (Baseline to 4 Weeks)||121||
59776612|NCT00813761|75897118|FG001|STARTED|Phase 1 (Baseline to 4 Weeks)||103||
59776613|NCT00813761|75897119|FG002|STARTED|Phase 1 (Baseline to 4 Weeks)||115||
59776614|NCT00813761|75897120|FG003|STARTED|Phase 1 (Baseline to 4 Weeks)||107||
59776615|NCT00813761|75897117|FG000|COMPLETED|Phase 1 (Baseline to 4 Weeks)||117||
59776616|NCT00813761|75897118|FG001|COMPLETED|Phase 1 (Baseline to 4 Weeks)||100||
59776617|NCT00813761|75897119|FG002|COMPLETED|Phase 1 (Baseline to 4 Weeks)||103||
59776618|NCT00813761|75897120|FG003|COMPLETED|Phase 1 (Baseline to 4 Weeks)||105||
59776619|NCT00813761|75897117|FG000|NOT COMPLETED|Phase 1 (Baseline to 4 Weeks)||4||
59776620|NCT00813761|75897118|FG001|NOT COMPLETED|Phase 1 (Baseline to 4 Weeks)||3||
59618651|NCT02957968|75729745|FG002|STARTED|Overall Study||7||
59618652|NCT02957968|75729743|FG000|COMPLETED|Overall Study||17||
59618653|NCT02957968|75729744|FG001|COMPLETED|Overall Study||14||
59618654|NCT02957968|75729745|FG002|COMPLETED|Overall Study||6||
59776621|NCT00813761|75897119|FG002|NOT COMPLETED|Phase 1 (Baseline to 4 Weeks)||12||
59776622|NCT00813761|75897120|FG003|NOT COMPLETED|Phase 1 (Baseline to 4 Weeks)||2||
59776623|NCT00813761|75897117|FG000|STARTED|Phase 2 (4 Weeks to 24 Weeks)||117||
59618655|NCT02957968|75729743|FG000|NOT COMPLETED|Overall Study||4||
59618656|NCT02957968|75729744|FG001|NOT COMPLETED|Overall Study||4||
59618657|NCT02957968|75729745|FG002|NOT COMPLETED|Overall Study||1||
59618658|NCT02819518|75729760|FG000|STARTED|Overall Study||11||
59618659|NCT02819518|75729761|FG001|STARTED|Overall Study||14||
59618660|NCT02819518|75729762|FG002|STARTED|Overall Study||10||
59618661|NCT02819518|75729763|FG003|STARTED|Overall Study||566||
59618662|NCT02819518|75729764|FG004|STARTED|Overall Study||281||
59618663|NCT02819518|75729760|FG000|COMPLETED|Overall Study||0||
59776624|NCT00813761|75897118|FG001|STARTED|Phase 2 (4 Weeks to 24 Weeks)||100||
59776625|NCT00813761|75897119|FG002|STARTED|Phase 2 (4 Weeks to 24 Weeks)||103||
59776626|NCT00813761|75897120|FG003|STARTED|Phase 2 (4 Weeks to 24 Weeks)||105||
59776627|NCT00813761|75897117|FG000|COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||101||
59776628|NCT00813761|75897118|FG001|COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||91||
59776629|NCT00813761|75897119|FG002|COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||94||
59776630|NCT00813761|75897120|FG003|COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||100||
59776631|NCT00813761|75897117|FG000|NOT COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||16||
59618664|NCT02819518|75729761|FG001|COMPLETED|Overall Study||0||
59776632|NCT00813761|75897118|FG001|NOT COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||9||
59776633|NCT00813761|75897119|FG002|NOT COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||9||
59776634|NCT00813761|75897120|FG003|NOT COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||5||
59776635|NCT00732069|75897136|FG000|STARTED|First Study Drug||3||
59776636|NCT00732069|75897137|FG001|STARTED|First Study Drug||3||
59776637|NCT00732069|75897138|FG002|STARTED|First Study Drug||3||
59776638|NCT00732069|75897139|FG003|STARTED|First Study Drug||2||
59776639|NCT00732069|75897140|FG004|STARTED|First Study Drug||3||
59776640|NCT00732069|75897141|FG005|STARTED|First Study Drug||2||
59776641|NCT00732069|75897136|FG000|COMPLETED|First Study Drug||3||
59776642|NCT00732069|75897137|FG001|COMPLETED|First Study Drug||3||
59776643|NCT00732069|75897138|FG002|COMPLETED|First Study Drug||3||
59776644|NCT00732069|75897139|FG003|COMPLETED|First Study Drug||2||
59776645|NCT00732069|75897140|FG004|COMPLETED|First Study Drug||3||
59776646|NCT00732069|75897141|FG005|COMPLETED|First Study Drug||2||
59776647|NCT00732069|75897136|FG000|NOT COMPLETED|First Study Drug||0||
59776648|NCT00732069|75897137|FG001|NOT COMPLETED|First Study Drug||0||
59776649|NCT00732069|75897138|FG002|NOT COMPLETED|First Study Drug||0||
59776650|NCT00732069|75897139|FG003|NOT COMPLETED|First Study Drug||0||
59776651|NCT00732069|75897140|FG004|NOT COMPLETED|First Study Drug||0||
59776652|NCT00732069|75897141|FG005|NOT COMPLETED|First Study Drug||0||
59776653|NCT00732069|75897136|FG000|STARTED|Washout After First Study Drug||3||
59776654|NCT00732069|75897137|FG001|STARTED|Washout After First Study Drug||3||
59776655|NCT00732069|75897138|FG002|STARTED|Washout After First Study Drug||3||
59776656|NCT00732069|75897139|FG003|STARTED|Washout After First Study Drug||2||
59776657|NCT00732069|75897140|FG004|STARTED|Washout After First Study Drug||3||
59776658|NCT00732069|75897141|FG005|STARTED|Washout After First Study Drug||2||
59776659|NCT00732069|75897136|FG000|COMPLETED|Washout After First Study Drug||2||
59776660|NCT00732069|75897137|FG001|COMPLETED|Washout After First Study Drug||3||
59776661|NCT00732069|75897138|FG002|COMPLETED|Washout After First Study Drug||3||
59776662|NCT00732069|75897139|FG003|COMPLETED|Washout After First Study Drug||2||
59776663|NCT00732069|75897140|FG004|COMPLETED|Washout After First Study Drug||3||
59776664|NCT00732069|75897141|FG005|COMPLETED|Washout After First Study Drug||2||
59776665|NCT00732069|75897136|FG000|NOT COMPLETED|Washout After First Study Drug||1||
59776666|NCT00732069|75897137|FG001|NOT COMPLETED|Washout After First Study Drug||0||
59776667|NCT00732069|75897138|FG002|NOT COMPLETED|Washout After First Study Drug||0||
59776668|NCT00732069|75897139|FG003|NOT COMPLETED|Washout After First Study Drug||0||
59776669|NCT00732069|75897140|FG004|NOT COMPLETED|Washout After First Study Drug||0||
59776670|NCT00732069|75897141|FG005|NOT COMPLETED|Washout After First Study Drug||0||
59776671|NCT00732069|75897136|FG000|STARTED|Second Study Drug||2||
59776672|NCT00732069|75897137|FG001|STARTED|Second Study Drug||3||
59776673|NCT00732069|75897138|FG002|STARTED|Second Study Drug||3||
59776674|NCT00732069|75897139|FG003|STARTED|Second Study Drug||2||
59776675|NCT00732069|75897140|FG004|STARTED|Second Study Drug||3||
59776676|NCT00732069|75897141|FG005|STARTED|Second Study Drug||2||
59776677|NCT00732069|75897136|FG000|COMPLETED|Second Study Drug||2||
59776678|NCT00732069|75897137|FG001|COMPLETED|Second Study Drug||3||
59776679|NCT00732069|75897138|FG002|COMPLETED|Second Study Drug||3||
59776680|NCT00732069|75897139|FG003|COMPLETED|Second Study Drug||2||
59776681|NCT00732069|75897140|FG004|COMPLETED|Second Study Drug||3||
59776682|NCT00732069|75897141|FG005|COMPLETED|Second Study Drug||2||
59776683|NCT00732069|75897136|FG000|NOT COMPLETED|Second Study Drug||0||
59776684|NCT00732069|75897137|FG001|NOT COMPLETED|Second Study Drug||0||
59776685|NCT00732069|75897138|FG002|NOT COMPLETED|Second Study Drug||0||
59776686|NCT00732069|75897139|FG003|NOT COMPLETED|Second Study Drug||0||
59776687|NCT00732069|75897140|FG004|NOT COMPLETED|Second Study Drug||0||
59776688|NCT00732069|75897141|FG005|NOT COMPLETED|Second Study Drug||0||
59776689|NCT00732069|75897136|FG000|STARTED|Washout After Second Study Drug||2||
59776690|NCT00732069|75897137|FG001|STARTED|Washout After Second Study Drug||3||
59776691|NCT00732069|75897138|FG002|STARTED|Washout After Second Study Drug||3||
59776692|NCT00732069|75897139|FG003|STARTED|Washout After Second Study Drug||2||
59776693|NCT00732069|75897140|FG004|STARTED|Washout After Second Study Drug||3||
59776694|NCT00732069|75897141|FG005|STARTED|Washout After Second Study Drug||2||
59776695|NCT00732069|75897136|FG000|COMPLETED|Washout After Second Study Drug||2||
59776696|NCT00732069|75897137|FG001|COMPLETED|Washout After Second Study Drug||3||
59776697|NCT00732069|75897138|FG002|COMPLETED|Washout After Second Study Drug||3||
59776698|NCT00732069|75897139|FG003|COMPLETED|Washout After Second Study Drug||2||
59776699|NCT00732069|75897140|FG004|COMPLETED|Washout After Second Study Drug||3||
59776700|NCT00732069|75897141|FG005|COMPLETED|Washout After Second Study Drug||2||
59776701|NCT00732069|75897136|FG000|NOT COMPLETED|Washout After Second Study Drug||0||
59776702|NCT00732069|75897137|FG001|NOT COMPLETED|Washout After Second Study Drug||0||
59776703|NCT00732069|75897138|FG002|NOT COMPLETED|Washout After Second Study Drug||0||
59776704|NCT00732069|75897139|FG003|NOT COMPLETED|Washout After Second Study Drug||0||
59776705|NCT00732069|75897140|FG004|NOT COMPLETED|Washout After Second Study Drug||0||
59776706|NCT00732069|75897141|FG005|NOT COMPLETED|Washout After Second Study Drug||0||
59776707|NCT00732069|75897136|FG000|STARTED|Third Study Drug||2||
59776708|NCT00732069|75897137|FG001|STARTED|Third Study Drug||3||
59776709|NCT00732069|75897138|FG002|STARTED|Third Study Drug||3||
59776710|NCT00732069|75897139|FG003|STARTED|Third Study Drug||2||
59776711|NCT00732069|75897140|FG004|STARTED|Third Study Drug||3||
59776712|NCT00732069|75897141|FG005|STARTED|Third Study Drug||2||
59776713|NCT00732069|75897136|FG000|COMPLETED|Third Study Drug||2||
59776714|NCT00732069|75897137|FG001|COMPLETED|Third Study Drug||3||
59776715|NCT00732069|75897138|FG002|COMPLETED|Third Study Drug||3||
59776716|NCT00732069|75897139|FG003|COMPLETED|Third Study Drug||2||
59776717|NCT00732069|75897140|FG004|COMPLETED|Third Study Drug||3||
59776718|NCT00732069|75897141|FG005|COMPLETED|Third Study Drug||2||
59776719|NCT00732069|75897136|FG000|NOT COMPLETED|Third Study Drug||0||
59776720|NCT00732069|75897137|FG001|NOT COMPLETED|Third Study Drug||0||
59776721|NCT00732069|75897138|FG002|NOT COMPLETED|Third Study Drug||0||
59776722|NCT00732069|75897139|FG003|NOT COMPLETED|Third Study Drug||0||
59776723|NCT00732069|75897140|FG004|NOT COMPLETED|Third Study Drug||0||
59776724|NCT00732069|75897141|FG005|NOT COMPLETED|Third Study Drug||0||
59776725|NCT00731679|75897151|FG000|STARTED|Overall Study||314||
59776726|NCT00731679|75897152|FG001|STARTED|Overall Study||309||
59776727|NCT00731679|75897151|FG000|COMPLETED|Overall Study||292||
59776728|NCT00731679|75897152|FG001|COMPLETED|Overall Study||283||
59776729|NCT00731679|75897151|FG000|NOT COMPLETED|Overall Study||22||
59776730|NCT00731679|75897152|FG001|NOT COMPLETED|Overall Study||26||
59776731|NCT00731133|75897158|FG000|STARTED|Overall Study||15||
59776732|NCT00731133|75897158|FG000|COMPLETED|Overall Study||5||
59776733|NCT00731133|75897158|FG000|NOT COMPLETED|Overall Study||10||
59776734|NCT00730275|75897166|FG000|STARTED|Overall Study||9||
59776735|NCT00730275|75897167|FG001|STARTED|Overall Study||9||
59776736|NCT00730275|75897168|FG002|STARTED|Overall Study||8||
59776737|NCT00730275|75897169|FG003|STARTED|Overall Study||9||
59776738|NCT00730275|75897166|FG000|COMPLETED|Overall Study||9||
59776739|NCT00730275|75897167|FG001|COMPLETED|Overall Study||9||
59776740|NCT00730275|75897168|FG002|COMPLETED|Overall Study||8||
59776741|NCT00730275|75897169|FG003|COMPLETED|Overall Study||8||
59776742|NCT00730275|75897166|FG000|NOT COMPLETED|Overall Study||0||
59776743|NCT00730275|75897167|FG001|NOT COMPLETED|Overall Study||0||
59776744|NCT00730275|75897168|FG002|NOT COMPLETED|Overall Study||0||
59776745|NCT00730275|75897169|FG003|NOT COMPLETED|Overall Study||1||
59776746|NCT04793711|75897180|FG000|STARTED|Overall Study||1||
59776747|NCT04793711|75897180|FG000|COMPLETED|Overall Study||1||
59776748|NCT04793711|75897180|FG000|NOT COMPLETED|Overall Study||0||
59776749|NCT00730041|75897187|FG000|STARTED|Overall Study|4/26 (15.4%) female, 22/26 (84.6%) male|26||
59776750|NCT00730041|75897188|FG001|STARTED|Overall Study|4/25 (16.0%) female, 21/25 (84.0%) male|25||
59776751|NCT00730041|75897187|FG000|COMPLETED|Overall Study||26||
59776752|NCT00730041|75897188|FG001|COMPLETED|Overall Study|One subject did not return for the final PSG or final visit, and one missed only the final visit.|23||
59776753|NCT00730041|75897187|FG000|NOT COMPLETED|Overall Study||0||
59776754|NCT00730041|75897188|FG001|NOT COMPLETED|Overall Study||2||
59776755|NCT00729651|75897196|FG000|STARTED|Overall Study||173||
59776756|NCT00729651|75897197|FG001|STARTED|Overall Study||170||
59776757|NCT00729651|75897196|FG000|COMPLETED|Overall Study||154||
59776758|NCT00729651|75897197|FG001|COMPLETED|Overall Study||152||
59776759|NCT00729651|75897196|FG000|NOT COMPLETED|Overall Study||19||
59776760|NCT00729651|75897197|FG001|NOT COMPLETED|Overall Study||18||
59776761|NCT00729183|75897205|FG000|STARTED|Overall Study||109||
59776762|NCT00729183|75897206|FG001|STARTED|Overall Study||105||
59776763|NCT00729183|75897205|FG000|COMPLETED|Overall Study|Completed 24 month visit|84||
59776764|NCT00729183|75897206|FG001|COMPLETED|Overall Study|Completed 24 month visit|90||
59776765|NCT00729183|75897205|FG000|NOT COMPLETED|Overall Study||25||
59776766|NCT00729183|75897206|FG001|NOT COMPLETED|Overall Study||15||
59776767|NCT00811733|75897214|FG000|STARTED|Overall Study||15||
59776768|NCT00811733|75897215|FG001|STARTED|Overall Study||22||
59776769|NCT00811733|75897214|FG000|COMPLETED|Overall Study||4||
59776770|NCT00811733|75897215|FG001|COMPLETED|Overall Study||12||
59776771|NCT00811733|75897214|FG000|NOT COMPLETED|Overall Study||11||
59776772|NCT00811733|75897215|FG001|NOT COMPLETED|Overall Study||10||
59776773|NCT00728949|75897223|FG000|STARTED|Overall Study||62||
59776774|NCT00728949|75897224|FG001|STARTED|Overall Study||31||
59776775|NCT00728949|75897223|FG000|COMPLETED|Overall Study||51||
59776776|NCT00728949|75897224|FG001|COMPLETED|Overall Study||27||
59776777|NCT00728949|75897223|FG000|NOT COMPLETED|Overall Study||11||
59776778|NCT00728949|75897224|FG001|NOT COMPLETED|Overall Study||4||
59776779|NCT00728481|75897232|FG000|STARTED|Overall Study||19||
59776780|NCT00728481|75897233|FG001|STARTED|Overall Study||32||
59776781|NCT00728481|75897232|FG000|COMPLETED|Overall Study||18||
59521972|NCT02568072|75616289|FG000|NOT COMPLETED|Overall Study||52||
59521973|NCT02565108|75616296|FG000|STARTED|Overall Study||16|Randomized|
59521974|NCT02565108|75616297|FG001|STARTED|Overall Study||4|Randomized|
59521975|NCT02565108|75616296|FG000|Safety Set|Overall Study||16|Received at least 1 IMP dose; analyzed as treatment received.|
59521976|NCT02565108|75616297|FG001|Safety Set|Overall Study||4|Received at least 1 IMP dose; analyzed as treatment received.|
59521977|NCT02565108|75616296|FG000|Pharmacokinetic (PK) Set|Overall Study||10|Received at least 1 IMP dose, had not reduced CLB dose between Days 1 and 33, and provided PK data.|
59521978|NCT02565108|75616297|FG001|Pharmacokinetic (PK) Set|Overall Study||3|Received at least 1 IMP dose, had not reduced CLB dose between Days 1 and 33, and provided PK data.|
59521979|NCT02565108|75616296|FG000|COMPLETED|Overall Study||14||
59521980|NCT02565108|75616297|FG001|COMPLETED|Overall Study||4||
59521981|NCT02565108|75616296|FG000|NOT COMPLETED|Overall Study||2||
59521982|NCT02565108|75616297|FG001|NOT COMPLETED|Overall Study||0||
59521983|NCT02564952|75616303|FG000|STARTED|Overall Study||18||
59521984|NCT02564952|75616303|FG000|Received at Least 1 Dose of Study Drug|Overall Study||18||
59521985|NCT02564952|75616303|FG000|Completed OLE Titration Period|Overall Study||16|OLE population: enrolled participants with ≥1 dose of study drug from Day 2 of Visit 4 onwards.|
59521986|NCT02564952|75616303|FG000|COMPLETED|Overall Study||7||
59521987|NCT02564952|75616303|FG000|NOT COMPLETED|Overall Study||11||
59521988|NCT02566902|75616309|FG000|STARTED|Overall Study||60||
59521989|NCT02566902|75616310|FG001|STARTED|Overall Study||58||
59521990|NCT02566902|75616309|FG000|COMPLETED|Overall Study||58||
59521991|NCT02566902|75616310|FG001|COMPLETED|Overall Study||57||
59521992|NCT02566902|75616309|FG000|NOT COMPLETED|Overall Study||2||
59521993|NCT02566902|75616310|FG001|NOT COMPLETED|Overall Study||1||
59521994|NCT02564796|75616318|FG000|STARTED|Overall Study||2||
59521995|NCT02564796|75616319|FG001|STARTED|Overall Study||2||
59521996|NCT02564796|75616318|FG000|COMPLETED|Overall Study||0||
59521997|NCT02564796|75616319|FG001|COMPLETED|Overall Study||0||
59521998|NCT02564796|75616318|FG000|NOT COMPLETED|Overall Study||2||
59521999|NCT02564796|75616319|FG001|NOT COMPLETED|Overall Study||2||
59522000|NCT02564718|75616327|FG000|STARTED|Overall Study||5||
59522001|NCT02564718|75616328|FG001|STARTED|Overall Study||5||
59522002|NCT02564718|75616327|FG000|COMPLETED|Overall Study||5||
59522003|NCT02564718|75616328|FG001|COMPLETED|Overall Study||4||
59522004|NCT02564718|75616327|FG000|NOT COMPLETED|Overall Study||0||
59522005|NCT02564718|75616328|FG001|NOT COMPLETED|Overall Study||1||
59522006|NCT01453946|75616334|FG000|STARTED|Overall Study||50||
59522007|NCT01453946|75616334|FG000|COMPLETED|Overall Study||41||
59522008|NCT01453946|75616334|FG000|NOT COMPLETED|Overall Study||9||
59522009|NCT02579174|75616342|FG000|STARTED|Overall Study||29||
59522010|NCT02579174|75616343|FG001|STARTED|Overall Study||30||
59522011|NCT02579174|75616344|FG002|STARTED|Overall Study||28||
59522012|NCT02579174|75616345|FG003|STARTED|Overall Study||25||
59522013|NCT02579174|75616342|FG000|COMPLETED|Overall Study||18||
59522014|NCT02579174|75616343|FG001|COMPLETED|Overall Study||16||
59522015|NCT02579174|75616344|FG002|COMPLETED|Overall Study||16||
59522016|NCT02579174|75616345|FG003|COMPLETED|Overall Study||16||
59522017|NCT02579174|75616342|FG000|NOT COMPLETED|Overall Study||11||
59522018|NCT02579174|75616343|FG001|NOT COMPLETED|Overall Study||14||
59522019|NCT02579174|75616344|FG002|NOT COMPLETED|Overall Study||12||
59522020|NCT02579174|75616345|FG003|NOT COMPLETED|Overall Study||9||
59522021|NCT03780010|75616359|FG000|STARTED|Overall Study||3||
59522022|NCT03780010|75616360|FG001|STARTED|Overall Study||12||
59522023|NCT03780010|75616359|FG000|COMPLETED|Overall Study||3||
59522024|NCT03780010|75616360|FG001|COMPLETED|Overall Study||12||
59522025|NCT03780010|75616359|FG000|NOT COMPLETED|Overall Study||0||
59522026|NCT03780010|75616360|FG001|NOT COMPLETED|Overall Study||0||
59522027|NCT03768856|75616377|FG000|STARTED|Overall Study||5||
59522028|NCT03768856|75616377|FG000|COMPLETED|Overall Study||5||
59522029|NCT03768856|75616377|FG000|NOT COMPLETED|Overall Study||0||
59522030|NCT03767062|75616383|FG000|STARTED|Overall Study||45||
59522031|NCT03767062|75616384|FG001|STARTED|Overall Study||45||
59522032|NCT03767062|75616383|FG000|COMPLETED|Overall Study||37||
59522033|NCT03767062|75616384|FG001|COMPLETED|Overall Study||41||
59522034|NCT03767062|75616383|FG000|NOT COMPLETED|Overall Study||8||
59522035|NCT03767062|75616384|FG001|NOT COMPLETED|Overall Study||4||
59522036|NCT03765502|75616393|FG000|STARTED|Simulation 1||20||
59522037|NCT03765502|75616394|FG001|STARTED|Simulation 1||13||
59522038|NCT03765502|75616395|FG002|STARTED|Simulation 1||33||
59522039|NCT03765502|75616396|FG003|STARTED|Simulation 1||16||
59522040|NCT03765502|75616397|FG004|STARTED|Simulation 1||17||
59522041|NCT03765502|75616393|FG000|COMPLETED|Simulation 1||20||
59522042|NCT03765502|75616394|FG001|COMPLETED|Simulation 1||13||
59522043|NCT03765502|75616395|FG002|COMPLETED|Simulation 1||33||
59522044|NCT03765502|75616396|FG003|COMPLETED|Simulation 1||16||
59522045|NCT03765502|75616397|FG004|COMPLETED|Simulation 1||17||
59522046|NCT03765502|75616393|FG000|NOT COMPLETED|Simulation 1||0||
59522047|NCT03765502|75616394|FG001|NOT COMPLETED|Simulation 1||0||
59522048|NCT03765502|75616395|FG002|NOT COMPLETED|Simulation 1||0||
59522049|NCT03765502|75616396|FG003|NOT COMPLETED|Simulation 1||0||
59522050|NCT03765502|75616397|FG004|NOT COMPLETED|Simulation 1||0||
59522051|NCT03765502|75616393|FG000|STARTED|Simulation 2||20||
59776782|NCT00728481|75897233|FG001|COMPLETED|Overall Study||28||
59776783|NCT00728481|75897232|FG000|NOT COMPLETED|Overall Study||1||
59776784|NCT00728481|75897233|FG001|NOT COMPLETED|Overall Study||4||
59776785|NCT00811655|75897239|FG000|STARTED|Overall Study||6||
59522052|NCT03765502|75616394|FG001|STARTED|Simulation 2|Participant completed Period 1 GEK simulation but did not return for the Period 2 NG simulation.|12||
59522053|NCT03765502|75616395|FG002|STARTED|Simulation 2|PWD completed Period 1 GEK simulation but did not return for the Period 2 NG simulation.|32||
59522054|NCT03765502|75616396|FG003|STARTED|Simulation 2||16||
59522055|NCT03765502|75616397|FG004|STARTED|Simulation 2||17||
59522056|NCT03765502|75616393|FG000|COMPLETED|Simulation 2||20||
59776786|NCT00811655|75897239|FG000|COMPLETED|Overall Study||5||
59776787|NCT00811655|75897239|FG000|NOT COMPLETED|Overall Study||1||
59776788|NCT00727311|75897243|FG000|STARTED|Overall Study||2302||
59776789|NCT00727311|75897243|FG000|COMPLETED|Overall Study||1195||
59776790|NCT00727311|75897243|FG000|NOT COMPLETED|Overall Study||1107||
59776791|NCT00726999|75897249|FG000|STARTED|Overall Study||32||
59776792|NCT00726999|75897250|FG001|STARTED|Overall Study||31||
59776793|NCT00726999|75897249|FG000|COMPLETED|Overall Study||29||
59776794|NCT00726999|75897250|FG001|COMPLETED|Overall Study||30||
59776795|NCT00726999|75897249|FG000|NOT COMPLETED|Overall Study||3||
59776796|NCT00726999|75897250|FG001|NOT COMPLETED|Overall Study||1||
59776797|NCT00585351|75897264|FG000|STARTED|Notification Period (Informed Consent)||50||
59776798|NCT00585351|75897265|FG001|STARTED|Notification Period (Informed Consent)||50||
59776799|NCT00585351|75897266|FG002|STARTED|Notification Period (Informed Consent)||0||
59776800|NCT00585351|75897267|FG003|STARTED|Notification Period (Informed Consent)||0||
59776801|NCT00585351|75897268|FG004|STARTED|Notification Period (Informed Consent)||0||
59776802|NCT00585351|75897269|FG005|STARTED|Notification Period (Informed Consent)||0||
59776803|NCT00585351|75897270|FG006|STARTED|Notification Period (Informed Consent)||0||
59776804|NCT00585351|75897271|FG007|STARTED|Notification Period (Informed Consent)||0||
59776805|NCT00585351|75897264|FG000|COMPLETED|Notification Period (Informed Consent)||27||
59776806|NCT00585351|75897265|FG001|COMPLETED|Notification Period (Informed Consent)||25||
59776807|NCT00585351|75897266|FG002|COMPLETED|Notification Period (Informed Consent)||0||
59776808|NCT00585351|75897267|FG003|COMPLETED|Notification Period (Informed Consent)||0||
59776809|NCT00585351|75897268|FG004|COMPLETED|Notification Period (Informed Consent)||0||
59776810|NCT00585351|75897269|FG005|COMPLETED|Notification Period (Informed Consent)||0||
59776811|NCT00585351|75897270|FG006|COMPLETED|Notification Period (Informed Consent)||0||
59776812|NCT00585351|75897271|FG007|COMPLETED|Notification Period (Informed Consent)||0||
59522057|NCT03765502|75616394|FG001|COMPLETED|Simulation 2||12||
59522058|NCT03765502|75616395|FG002|COMPLETED|Simulation 2||32||
59522059|NCT03765502|75616396|FG003|COMPLETED|Simulation 2||16||
59522060|NCT03765502|75616397|FG004|COMPLETED|Simulation 2||17||
59522061|NCT03765502|75616393|FG000|NOT COMPLETED|Simulation 2||0||
59522062|NCT03765502|75616394|FG001|NOT COMPLETED|Simulation 2||0||
59522063|NCT03765502|75616395|FG002|NOT COMPLETED|Simulation 2||0||
59522064|NCT03765502|75616396|FG003|NOT COMPLETED|Simulation 2||0||
59522065|NCT03765502|75616397|FG004|NOT COMPLETED|Simulation 2||0||
59522066|NCT03761368|75616419|FG000|STARTED|Overall Study||50||
59522067|NCT03761368|75616420|FG001|STARTED|Overall Study||51||
59522068|NCT03761368|75616419|FG000|COMPLETED|Overall Study||50||
59522069|NCT03761368|75616420|FG001|COMPLETED|Overall Study||51||
59522070|NCT03761368|75616419|FG000|NOT COMPLETED|Overall Study||0||
59522071|NCT03761368|75616420|FG001|NOT COMPLETED|Overall Study||0||
59522072|NCT03758716|75616426|FG000|STARTED|Overall Study||12||
59522073|NCT03758716|75616426|FG000|COMPLETED|Overall Study||12||
59522074|NCT03758716|75616426|FG000|NOT COMPLETED|Overall Study||0||
59522075|NCT03757312|75616432|FG000|STARTED|Overall Study||5||
59522076|NCT03757312|75616433|FG001|STARTED|Overall Study||9||
59522077|NCT03757312|75616432|FG000|COMPLETED|Overall Study||5||
59522078|NCT03757312|75616433|FG001|COMPLETED|Overall Study||9||
59522079|NCT03757312|75616432|FG000|NOT COMPLETED|Overall Study||0||
59522080|NCT03757312|75616433|FG001|NOT COMPLETED|Overall Study||0||
59776813|NCT00585351|75897264|FG000|NOT COMPLETED|Notification Period (Informed Consent)||23||
59776814|NCT00585351|75897265|FG001|NOT COMPLETED|Notification Period (Informed Consent)||25||
59776815|NCT00585351|75897266|FG002|NOT COMPLETED|Notification Period (Informed Consent)||0||
59776816|NCT00585351|75897267|FG003|NOT COMPLETED|Notification Period (Informed Consent)||0||
59776817|NCT00585351|75897268|FG004|NOT COMPLETED|Notification Period (Informed Consent)||0||
59776818|NCT00585351|75897269|FG005|NOT COMPLETED|Notification Period (Informed Consent)||0||
59776819|NCT00585351|75897270|FG006|NOT COMPLETED|Notification Period (Informed Consent)||0||
59776820|NCT00585351|75897271|FG007|NOT COMPLETED|Notification Period (Informed Consent)||0||
59776821|NCT00585351|75897264|FG000|STARTED|Enrollment Period (Intervention)|"Please refer to additional columns for subjects in Advanced Notification group for this period."|0||
59776822|NCT00585351|75897265|FG001|STARTED|Enrollment Period (Intervention)|"Please refer to additional columns for subjects in No Advanced Notification group for this period."|0||
59776823|NCT00585351|75897266|FG002|STARTED|Enrollment Period (Intervention)||15||
59776824|NCT00585351|75897267|FG003|STARTED|Enrollment Period (Intervention)||15||
59776825|NCT00585351|75897268|FG004|STARTED|Enrollment Period (Intervention)||5||
59776826|NCT00585351|75897269|FG005|STARTED|Enrollment Period (Intervention)||7||
59952920|NCT01878500|76071711|FG000|COMPLETED|Overall Study||47||
59776827|NCT00585351|75897270|FG006|STARTED|Enrollment Period (Intervention)||7||
59776828|NCT00585351|75897271|FG007|STARTED|Enrollment Period (Intervention)||3||
59776829|NCT00585351|75897264|FG000|COMPLETED|Enrollment Period (Intervention)||0||
59776830|NCT00585351|75897265|FG001|COMPLETED|Enrollment Period (Intervention)||0||
59776831|NCT00585351|75897266|FG002|COMPLETED|Enrollment Period (Intervention)||15||
59776832|NCT00585351|75897267|FG003|COMPLETED|Enrollment Period (Intervention)||15||
59776833|NCT00585351|75897268|FG004|COMPLETED|Enrollment Period (Intervention)||3||
59776834|NCT00585351|75897269|FG005|COMPLETED|Enrollment Period (Intervention)||5||
59776835|NCT00585351|75897270|FG006|COMPLETED|Enrollment Period (Intervention)||5||
59776836|NCT00585351|75897271|FG007|COMPLETED|Enrollment Period (Intervention)||2||
59776837|NCT00585351|75897264|FG000|NOT COMPLETED|Enrollment Period (Intervention)||0||
59776838|NCT00585351|75897265|FG001|NOT COMPLETED|Enrollment Period (Intervention)||0||
59776839|NCT00585351|75897266|FG002|NOT COMPLETED|Enrollment Period (Intervention)||0||
59776840|NCT00585351|75897267|FG003|NOT COMPLETED|Enrollment Period (Intervention)||0||
59776841|NCT00585351|75897268|FG004|NOT COMPLETED|Enrollment Period (Intervention)||2||
59776842|NCT00585351|75897269|FG005|NOT COMPLETED|Enrollment Period (Intervention)||2||
59776843|NCT00585351|75897270|FG006|NOT COMPLETED|Enrollment Period (Intervention)||2||
59776844|NCT00585351|75897271|FG007|NOT COMPLETED|Enrollment Period (Intervention)||1||
59776845|NCT00726609|75897285|FG000|STARTED|Overall Study||214||
59776846|NCT00726609|75897285|FG000|COMPLETED|Overall Study|For 26 participants in the Missing category, it is unknown if they completed the study.|116||
59776847|NCT00726609|75897285|FG000|NOT COMPLETED|Overall Study||98||
59776848|NCT00726453|75897291|FG000|STARTED|Primary Enrollment Group||1402||
59776849|NCT00726453|75897292|FG001|STARTED|Primary Enrollment Group||0||
59776850|NCT00726453|75897291|FG000|COMPLETED|Primary Enrollment Group||1371||
59776851|NCT00726453|75897292|FG001|COMPLETED|Primary Enrollment Group||0||
59776852|NCT00726453|75897291|FG000|NOT COMPLETED|Primary Enrollment Group||31||
59776853|NCT00726453|75897292|FG001|NOT COMPLETED|Primary Enrollment Group||0||
59776854|NCT00726453|75897291|FG000|STARTED|38 mm Length Group||0||
59522081|NCT03748264|75616444|FG000|STARTED|Overall Study||21||
59522082|NCT03748264|75616445|FG001|STARTED|Overall Study||21||
59522083|NCT03748264|75616446|FG002|STARTED|Overall Study||20||
59522084|NCT03748264|75616444|FG000|COMPLETED|Overall Study||21||
59522085|NCT03748264|75616445|FG001|COMPLETED|Overall Study||21||
59522086|NCT03748264|75616446|FG002|COMPLETED|Overall Study||20||
59522087|NCT03748264|75616444|FG000|NOT COMPLETED|Overall Study||0||
59776855|NCT00726453|75897292|FG001|STARTED|38 mm Length Group||114||
59776856|NCT00726453|75897291|FG000|COMPLETED|38 mm Length Group||0||
59776857|NCT00726453|75897292|FG001|COMPLETED|38 mm Length Group|This sub-study completed the primary endpoint in March 2012 results not yet available.|111||
59776858|NCT00726453|75897291|FG000|NOT COMPLETED|38 mm Length Group||0||
59776859|NCT00726453|75897292|FG001|NOT COMPLETED|38 mm Length Group||3||
59776860|NCT00726063|75897299|FG000|STARTED|Overall Study|Number of implants= 239|122||
59776861|NCT00726063|75897300|FG001|STARTED|Overall Study|Number of implants= 246|119||
59522088|NCT03748264|75616445|FG001|NOT COMPLETED|Overall Study||0||
59522089|NCT03748264|75616446|FG002|NOT COMPLETED|Overall Study||0||
59522090|NCT02563548|75616456|FG000|STARTED|Dose Escalation (Up to 46 Weeks)||3||
59522091|NCT02563548|75616457|FG001|STARTED|Dose Escalation (Up to 46 Weeks)||2||
59522092|NCT02563548|75616458|FG002|STARTED|Dose Escalation (Up to 46 Weeks)||7||
59522093|NCT02563548|75616459|FG003|STARTED|Dose Escalation (Up to 46 Weeks)||2||
59522094|NCT02563548|75616460|FG004|STARTED|Dose Escalation (Up to 46 Weeks)||0||
59522095|NCT02563548|75616461|FG005|STARTED|Dose Escalation (Up to 46 Weeks)||0||
59522096|NCT02563548|75616456|FG000|Received at Least 1 Dose of Study Drug|Dose Escalation (Up to 46 Weeks)||3||
59522097|NCT02563548|75616457|FG001|Received at Least 1 Dose of Study Drug|Dose Escalation (Up to 46 Weeks)||2||
59522098|NCT02563548|75616458|FG002|Received at Least 1 Dose of Study Drug|Dose Escalation (Up to 46 Weeks)||7||
59522099|NCT02563548|75616459|FG003|Received at Least 1 Dose of Study Drug|Dose Escalation (Up to 46 Weeks)||2||
59522100|NCT02563548|75616460|FG004|Received at Least 1 Dose of Study Drug|Dose Escalation (Up to 46 Weeks)||0||
59522101|NCT02563548|75616461|FG005|Received at Least 1 Dose of Study Drug|Dose Escalation (Up to 46 Weeks)||0||
59522102|NCT02563548|75616456|FG000|COMPLETED|Dose Escalation (Up to 46 Weeks)||0||
59522103|NCT02563548|75616457|FG001|COMPLETED|Dose Escalation (Up to 46 Weeks)||0||
59522104|NCT02563548|75616458|FG002|COMPLETED|Dose Escalation (Up to 46 Weeks)||0||
59522105|NCT02563548|75616459|FG003|COMPLETED|Dose Escalation (Up to 46 Weeks)||0||
59522106|NCT02563548|75616460|FG004|COMPLETED|Dose Escalation (Up to 46 Weeks)||0||
59522107|NCT02563548|75616461|FG005|COMPLETED|Dose Escalation (Up to 46 Weeks)||0||
59522108|NCT02563548|75616456|FG000|NOT COMPLETED|Dose Escalation (Up to 46 Weeks)||3||
59522109|NCT02563548|75616457|FG001|NOT COMPLETED|Dose Escalation (Up to 46 Weeks)||2||
59522110|NCT02563548|75616458|FG002|NOT COMPLETED|Dose Escalation (Up to 46 Weeks)||7||
59522111|NCT02563548|75616459|FG003|NOT COMPLETED|Dose Escalation (Up to 46 Weeks)||2||
59522112|NCT02563548|75616460|FG004|NOT COMPLETED|Dose Escalation (Up to 46 Weeks)||0||
59522113|NCT02563548|75616461|FG005|NOT COMPLETED|Dose Escalation (Up to 46 Weeks)||0||
59522114|NCT02563548|75616456|FG000|STARTED|Dose Expansion (Up to 60 Weeks)||0||
59522115|NCT02563548|75616457|FG001|STARTED|Dose Expansion (Up to 60 Weeks)||0||
59522116|NCT02563548|75616458|FG002|STARTED|Dose Expansion (Up to 60 Weeks)||0||
59522117|NCT02563548|75616459|FG003|STARTED|Dose Expansion (Up to 60 Weeks)||0||
59776862|NCT00726063|75897299|FG000|COMPLETED|Overall Study|Number of implants =230|113||
59776863|NCT00726063|75897300|FG001|COMPLETED|Overall Study|Number of implants = 239|112||
59776864|NCT00726063|75897299|FG000|NOT COMPLETED|Overall Study||9||
59776865|NCT00726063|75897300|FG001|NOT COMPLETED|Overall Study||7||
59776866|NCT00808028|75897310|FG000|STARTED|Stage 1 (6 Months)||121||
59776867|NCT00808028|75897311|FG001|STARTED|Stage 1 (6 Months)|Participants in rLP2086 60 mcg group participated only in Stage 1 and were not eligible for Stage 2|22||
59776868|NCT00808028|75897312|FG002|STARTED|Stage 1 (6 Months)||198||
59776869|NCT00808028|75897313|FG003|STARTED|Stage 1 (6 Months)||198||
59776870|NCT00808028|75897310|FG000|COMPLETED|Stage 1 (6 Months)||116||
59776871|NCT00808028|75897311|FG001|COMPLETED|Stage 1 (6 Months)|Participants in rLP2086 60 mcg group participated only in Stage 1 and were not eligible for Stage 2|21||
59776872|NCT00808028|75897312|FG002|COMPLETED|Stage 1 (6 Months)||191||
59776873|NCT00808028|75897313|FG003|COMPLETED|Stage 1 (6 Months)||183||
59776874|NCT00808028|75897310|FG000|NOT COMPLETED|Stage 1 (6 Months)||5||
59776875|NCT00808028|75897311|FG001|NOT COMPLETED|Stage 1 (6 Months)||1||
59776876|NCT00808028|75897312|FG002|NOT COMPLETED|Stage 1 (6 Months)||7||
59776877|NCT00808028|75897313|FG003|NOT COMPLETED|Stage 1 (6 Months)||15||
59776878|NCT00808028|75897310|FG000|STARTED|Stage 2 (Followed up to 48 Months )|Out of 511 completed participants in Stage 1, 89 did not enter Stage 2|80||
59776879|NCT00808028|75897311|FG001|STARTED|Stage 2 (Followed up to 48 Months )||0||
59776880|NCT00808028|75897312|FG002|STARTED|Stage 2 (Followed up to 48 Months )||170||
59776881|NCT00808028|75897313|FG003|STARTED|Stage 2 (Followed up to 48 Months )||151||
59776882|NCT00808028|75897310|FG000|COMPLETED|Stage 2 (Followed up to 48 Months )|Out of 511 completed participants in Stage 1, 89 did not enter Stage 2|69||
59776883|NCT00808028|75897311|FG001|COMPLETED|Stage 2 (Followed up to 48 Months )||0||
59776884|NCT00808028|75897312|FG002|COMPLETED|Stage 2 (Followed up to 48 Months )||141||
59776885|NCT00808028|75897313|FG003|COMPLETED|Stage 2 (Followed up to 48 Months )||128||
59776886|NCT00808028|75897310|FG000|NOT COMPLETED|Stage 2 (Followed up to 48 Months )||11||
59776887|NCT00808028|75897311|FG001|NOT COMPLETED|Stage 2 (Followed up to 48 Months )||0||
59776888|NCT00808028|75897312|FG002|NOT COMPLETED|Stage 2 (Followed up to 48 Months )||29||
59776889|NCT00808028|75897313|FG003|NOT COMPLETED|Stage 2 (Followed up to 48 Months )||23||
59776890|NCT00809783|75897336|FG000|STARTED|Overall Study||525||
59776891|NCT00809783|75897337|FG001|STARTED|Overall Study||832||
59776892|NCT00809783|75897338|FG002|STARTED|Overall Study||790||
59776893|NCT00809783|75897336|FG000|Treated|Overall Study||522||
59776894|NCT00809783|75897337|FG001|Treated|Overall Study||832||
59776895|NCT00809783|75897338|FG002|Treated|Overall Study||788||
59776896|NCT00809783|75897336|FG000|COMPLETED|Overall Study||0||
59776897|NCT00809783|75897337|FG001|COMPLETED|Overall Study||0||
59522118|NCT02563548|75616460|FG004|STARTED|Dose Expansion (Up to 60 Weeks)||25||
59522119|NCT02563548|75616461|FG005|STARTED|Dose Expansion (Up to 60 Weeks)||17||
59522120|NCT02563548|75616456|FG000|Received at Least 1 Dose of Study Drug|Dose Expansion (Up to 60 Weeks)||0||
59522121|NCT02563548|75616457|FG001|Received at Least 1 Dose of Study Drug|Dose Expansion (Up to 60 Weeks)||0||
59522122|NCT02563548|75616458|FG002|Received at Least 1 Dose of Study Drug|Dose Expansion (Up to 60 Weeks)||0||
59522123|NCT02563548|75616459|FG003|Received at Least 1 Dose of Study Drug|Dose Expansion (Up to 60 Weeks)||0||
59776898|NCT00809783|75897338|FG002|COMPLETED|Overall Study||0||
59776899|NCT00809783|75897336|FG000|NOT COMPLETED|Overall Study||525||
59776900|NCT00809783|75897337|FG001|NOT COMPLETED|Overall Study||832||
59776901|NCT00809783|75897338|FG002|NOT COMPLETED|Overall Study||790||
59776902|NCT00809471|75897349|FG000|STARTED|Overall Study||130||
59776903|NCT00809471|75897350|FG001|STARTED|Overall Study||129||
59776904|NCT00809471|75897351|FG002|STARTED|Overall Study||131||
59776905|NCT00809471|75897349|FG000|COMPLETED|Overall Study||110||
59776906|NCT00809471|75897350|FG001|COMPLETED|Overall Study||109||
59776907|NCT00809471|75897351|FG002|COMPLETED|Overall Study||114||
59776908|NCT00809471|75897349|FG000|NOT COMPLETED|Overall Study||20||
59776909|NCT00809471|75897350|FG001|NOT COMPLETED|Overall Study||20||
59776910|NCT00809471|75897351|FG002|NOT COMPLETED|Overall Study||17||
59776911|NCT00807248|75897363|FG000|STARTED|Overall Study||71||
59776912|NCT00807248|75897364|FG001|STARTED|Overall Study||140||
59776913|NCT00807248|75897365|FG002|STARTED|Overall Study||139||
59776914|NCT00807248|75897366|FG003|STARTED|Overall Study||140||
59776915|NCT00807248|75897363|FG000|COMPLETED|Overall Study||50||
59776916|NCT00807248|75897364|FG001|COMPLETED|Overall Study||128||
59776917|NCT00807248|75897365|FG002|COMPLETED|Overall Study||121||
59776918|NCT00807248|75897366|FG003|COMPLETED|Overall Study||126||
59776919|NCT00807248|75897363|FG000|NOT COMPLETED|Overall Study||21||
59776920|NCT00807248|75897364|FG001|NOT COMPLETED|Overall Study||12||
59522124|NCT02563548|75616460|FG004|Received at Least 1 Dose of Study Drug|Dose Expansion (Up to 60 Weeks)||24||
59522125|NCT02563548|75616461|FG005|Received at Least 1 Dose of Study Drug|Dose Expansion (Up to 60 Weeks)||17||
59776921|NCT00807248|75897365|FG002|NOT COMPLETED|Overall Study||18||
59776922|NCT00807248|75897366|FG003|NOT COMPLETED|Overall Study||14||
59776923|NCT00589628|75897378|FG000|STARTED|Overall Study||7||
59776924|NCT00589628|75897379|FG001|STARTED|Overall Study||6||
59776925|NCT00589628|75897378|FG000|COMPLETED|Overall Study||7||
59776926|NCT00589628|75897379|FG001|COMPLETED|Overall Study||5||
59522126|NCT02563548|75616456|FG000|COMPLETED|Dose Expansion (Up to 60 Weeks)||0||
59522127|NCT02563548|75616457|FG001|COMPLETED|Dose Expansion (Up to 60 Weeks)||0||
59776927|NCT00589628|75897378|FG000|NOT COMPLETED|Overall Study||0||
59776928|NCT00589628|75897379|FG001|NOT COMPLETED|Overall Study||1||
59776929|NCT00588848|75897387|FG000|STARTED|Overall Study||3||
59776930|NCT00588848|75897388|FG001|STARTED|Overall Study||8||
59776931|NCT00588848|75897387|FG000|COMPLETED|Overall Study||3||
59776932|NCT00588848|75897388|FG001|COMPLETED|Overall Study||5||
59776933|NCT00588848|75897387|FG000|NOT COMPLETED|Overall Study||0||
59776934|NCT00588848|75897388|FG001|NOT COMPLETED|Overall Study||3||
59776935|NCT00797108|75897399|FG000|STARTED|Overall Study||12||
59776936|NCT00797108|75897400|FG001|STARTED|Overall Study||11||
59776937|NCT00797108|75897401|FG002|STARTED|Overall Study||12||
59776938|NCT00797108|75897399|FG000|Treated|Overall Study||10||
59776939|NCT00797108|75897400|FG001|Treated|Overall Study||11||
59776940|NCT00797108|75897401|FG002|Treated|Overall Study||12||
59776941|NCT00797108|75897399|FG000|COMPLETED|Overall Study||8||
59776942|NCT00797108|75897400|FG001|COMPLETED|Overall Study||9||
59776943|NCT00797108|75897401|FG002|COMPLETED|Overall Study||6||
59776944|NCT00797108|75897399|FG000|NOT COMPLETED|Overall Study||4||
59776945|NCT00797108|75897400|FG001|NOT COMPLETED|Overall Study||2||
59776946|NCT00797108|75897401|FG002|NOT COMPLETED|Overall Study||6||
59776947|NCT00742560|75897414|FG000|STARTED|Overall Study||3|Safety population: all randomized participants who received at least 1 dose of study drug|
59776948|NCT00742560|75897415|FG001|STARTED|Overall Study||3|Safety population: all randomized participants who received at least 1 dose of study drug|
59776949|NCT00742560|75897416|FG002|STARTED|Overall Study||22|Safety population: all randomized participants who received at least 1 dose of study drug|
59776950|NCT00742560|75897417|FG003|STARTED|Overall Study||36|Safety population: all randomized participants who received at least 1 dose of study drug|
59776951|NCT00742560|75897418|FG004|STARTED|Overall Study||37|Safety population: all randomized participants who received at least 1 dose of study drug|
59776952|NCT00742560|75897414|FG000|COMPLETED|Overall Study||0||
59776953|NCT00742560|75897415|FG001|COMPLETED|Overall Study||0||
59776954|NCT00742560|75897416|FG002|COMPLETED|Overall Study||0||
59776955|NCT00742560|75897417|FG003|COMPLETED|Overall Study||0||
59776956|NCT00742560|75897418|FG004|COMPLETED|Overall Study||0||
59776957|NCT00742560|75897414|FG000|NOT COMPLETED|Overall Study||3||
59776958|NCT00742560|75897415|FG001|NOT COMPLETED|Overall Study||3||
59776959|NCT00742560|75897416|FG002|NOT COMPLETED|Overall Study||22||
59776960|NCT00742560|75897417|FG003|NOT COMPLETED|Overall Study||36||
59776961|NCT00742560|75897418|FG004|NOT COMPLETED|Overall Study||37||
59776962|NCT00740220|75897449|FG000|STARTED|Overall Study||97||
59776963|NCT00740220|75897449|FG000|COMPLETED|Overall Study||88||
59776964|NCT00740220|75897449|FG000|NOT COMPLETED|Overall Study||9||
59776965|NCT00796718|75897453|FG000|STARTED|Overall Study||62||
59776966|NCT00796718|75897453|FG000|COMPLETED|Overall Study||53||
59776967|NCT00796718|75897453|FG000|NOT COMPLETED|Overall Study||9||
59776968|NCT00809159|75897461|FG000|STARTED|Part 1||24||
59776969|NCT00809159|75897462|FG001|STARTED|Part 1||6||
59776970|NCT00809159|75897463|FG002|STARTED|Part 1||0||
59776971|NCT00809159|75897464|FG003|STARTED|Part 1||0||
59776972|NCT00809159|75897465|FG004|STARTED|Part 1||0||
59776973|NCT00809159|75897466|FG005|STARTED|Part 1||0||
59776974|NCT00809159|75897461|FG000|PK Analysis Set|Part 1||24||
59776975|NCT00809159|75897462|FG001|PK Analysis Set|Part 1||6||
59776976|NCT00809159|75897463|FG002|PK Analysis Set|Part 1||0||
59776977|NCT00809159|75897464|FG003|PK Analysis Set|Part 1||0||
59776978|NCT00809159|75897465|FG004|PK Analysis Set|Part 1||0||
59776979|NCT00809159|75897466|FG005|PK Analysis Set|Part 1||0||
59776980|NCT00809159|75897461|FG000|PD Analysis Set|Part 1||23||
59776981|NCT00809159|75897462|FG001|PD Analysis Set|Part 1||6||
59522128|NCT02563548|75616458|FG002|COMPLETED|Dose Expansion (Up to 60 Weeks)||0||
59522129|NCT02563548|75616459|FG003|COMPLETED|Dose Expansion (Up to 60 Weeks)||0||
59522130|NCT02563548|75616460|FG004|COMPLETED|Dose Expansion (Up to 60 Weeks)||0||
59522131|NCT02563548|75616461|FG005|COMPLETED|Dose Expansion (Up to 60 Weeks)||0||
59522132|NCT02563548|75616456|FG000|NOT COMPLETED|Dose Expansion (Up to 60 Weeks)||0||
59522133|NCT02563548|75616457|FG001|NOT COMPLETED|Dose Expansion (Up to 60 Weeks)||0||
59776982|NCT00809159|75897463|FG002|PD Analysis Set|Part 1||0||
59776983|NCT00809159|75897464|FG003|PD Analysis Set|Part 1||0||
59776984|NCT00809159|75897465|FG004|PD Analysis Set|Part 1||0||
59776985|NCT00809159|75897466|FG005|PD Analysis Set|Part 1||0||
59776986|NCT00809159|75897461|FG000|COMPLETED|Part 1||16||
59776987|NCT00809159|75897462|FG001|COMPLETED|Part 1||3||
59776988|NCT00809159|75897463|FG002|COMPLETED|Part 1||0||
59776989|NCT00809159|75897464|FG003|COMPLETED|Part 1||0||
59522134|NCT02563548|75616458|FG002|NOT COMPLETED|Dose Expansion (Up to 60 Weeks)||0||
59776990|NCT00809159|75897465|FG004|COMPLETED|Part 1||0||
59776991|NCT00809159|75897466|FG005|COMPLETED|Part 1||0||
59776992|NCT00809159|75897461|FG000|NOT COMPLETED|Part 1||8||
59776993|NCT00809159|75897462|FG001|NOT COMPLETED|Part 1||3||
59776994|NCT00809159|75897463|FG002|NOT COMPLETED|Part 1||0||
59776995|NCT00809159|75897464|FG003|NOT COMPLETED|Part 1||0||
59776996|NCT00809159|75897465|FG004|NOT COMPLETED|Part 1||0||
59776997|NCT00809159|75897466|FG005|NOT COMPLETED|Part 1||0||
59776998|NCT00809159|75897461|FG000|STARTED|Part 1 and 2||0||
59776999|NCT00809159|75897462|FG001|STARTED|Part 1 and 2||0||
59777000|NCT00809159|75897463|FG002|STARTED|Part 1 and 2||30||
59522135|NCT02563548|75616459|FG003|NOT COMPLETED|Dose Expansion (Up to 60 Weeks)||0||
59777001|NCT00809159|75897464|FG003|STARTED|Part 1 and 2||12||
59777002|NCT00809159|75897465|FG004|STARTED|Part 1 and 2||12||
59777003|NCT00809159|75897466|FG005|STARTED|Part 1 and 2||6||
59777004|NCT00809159|75897461|FG000|PK Analysis Set|Part 1 and 2||0||
59777005|NCT00809159|75897462|FG001|PK Analysis Set|Part 1 and 2||0||
59777006|NCT00809159|75897463|FG002|PK Analysis Set|Part 1 and 2||30||
59777007|NCT00809159|75897464|FG003|PK Analysis Set|Part 1 and 2||12||
59777008|NCT00809159|75897465|FG004|PK Analysis Set|Part 1 and 2||12||
59777009|NCT00809159|75897466|FG005|PK Analysis Set|Part 1 and 2||6||
59777010|NCT00809159|75897461|FG000|PD Analysis Set|Part 1 and 2||0||
59777011|NCT00809159|75897462|FG001|PD Analysis Set|Part 1 and 2||0||
59777012|NCT00809159|75897463|FG002|PD Analysis Set|Part 1 and 2||28||
59777013|NCT00809159|75897464|FG003|PD Analysis Set|Part 1 and 2||12||
59777014|NCT00809159|75897465|FG004|PD Analysis Set|Part 1 and 2||12||
59777015|NCT00809159|75897466|FG005|PD Analysis Set|Part 1 and 2||6||
59777016|NCT00809159|75897461|FG000|COMPLETED|Part 1 and 2||0||
59777017|NCT00809159|75897462|FG001|COMPLETED|Part 1 and 2||0||
59777018|NCT00809159|75897463|FG002|COMPLETED|Part 1 and 2||20||
59777019|NCT00809159|75897464|FG003|COMPLETED|Part 1 and 2||7||
59777020|NCT00809159|75897465|FG004|COMPLETED|Part 1 and 2||6||
59777021|NCT00809159|75897466|FG005|COMPLETED|Part 1 and 2||3||
59777022|NCT00809159|75897461|FG000|NOT COMPLETED|Part 1 and 2||0||
59777023|NCT00809159|75897462|FG001|NOT COMPLETED|Part 1 and 2||0||
59777024|NCT00809159|75897463|FG002|NOT COMPLETED|Part 1 and 2||10||
59777025|NCT00809159|75897464|FG003|NOT COMPLETED|Part 1 and 2||5||
59777026|NCT00809159|75897465|FG004|NOT COMPLETED|Part 1 and 2||6||
59777027|NCT00809159|75897466|FG005|NOT COMPLETED|Part 1 and 2||3||
59777028|NCT00745368|75897480|FG000|STARTED|Overall Study|Of the 28 subjects who enrolled, 19 participated in a study visit|19||
59777029|NCT00745368|75897480|FG000|COMPLETED|Overall Study|3 male subjects were unable to provide a sample and are not included in the results|16||
59777030|NCT00745368|75897480|FG000|NOT COMPLETED|Overall Study||3||
59777031|NCT00589472|75897484|FG000|STARTED|Overall Study||19||
59777032|NCT00589472|75897484|FG000|COMPLETED|Overall Study||18||
59777033|NCT00589472|75897484|FG000|NOT COMPLETED|Overall Study||1||
59777034|NCT00811577|75897490|FG000|STARTED|Overall Study||126||
59777035|NCT00811577|75897491|FG001|STARTED|Overall Study||24||
59777036|NCT00811577|75897490|FG000|COMPLETED|Overall Study||116||
59777037|NCT00811577|75897491|FG001|COMPLETED|Overall Study||23||
59777038|NCT00811577|75897490|FG000|NOT COMPLETED|Overall Study||10||
59777039|NCT00811577|75897491|FG001|NOT COMPLETED|Overall Study||1||
59777040|NCT00802178|75897540|FG000|STARTED|Overall Study||2448||
59777041|NCT00802178|75897540|FG000|COMPLETED|Overall Study||2335||
59777042|NCT00802178|75897540|FG000|NOT COMPLETED|Overall Study||113||
59777043|NCT00744978|75897546|FG000|STARTED|Period 1||32||
59777044|NCT00744978|75897547|FG001|STARTED|Period 1||34||
59777045|NCT00744978|75897546|FG000|Treated|Period 1||31||
59777046|NCT00744978|75897547|FG001|Treated|Period 1||33||
59777047|NCT00744978|75897546|FG000|COMPLETED|Period 1||26||
59777048|NCT00744978|75897547|FG001|COMPLETED|Period 1||29||
59777049|NCT00744978|75897546|FG000|NOT COMPLETED|Period 1||6||
59777050|NCT00744978|75897547|FG001|NOT COMPLETED|Period 1||5||
59777051|NCT00744978|75897546|FG000|STARTED|Placebo Washout||26||
59777052|NCT00744978|75897547|FG001|STARTED|Placebo Washout||29||
59777053|NCT00744978|75897546|FG000|COMPLETED|Placebo Washout||26||
59777054|NCT00744978|75897547|FG001|COMPLETED|Placebo Washout||29||
59777055|NCT00744978|75897546|FG000|NOT COMPLETED|Placebo Washout||0||
59777056|NCT00744978|75897547|FG001|NOT COMPLETED|Placebo Washout||0||
59777057|NCT00744978|75897546|FG000|STARTED|Period 2||26||
59777058|NCT00744978|75897547|FG001|STARTED|Period 2||29||
59777059|NCT00744978|75897546|FG000|COMPLETED|Period 2||26||
59777060|NCT00744978|75897547|FG001|COMPLETED|Period 2||28||
59777061|NCT00744978|75897546|FG000|NOT COMPLETED|Period 2||0||
59777062|NCT00744978|75897547|FG001|NOT COMPLETED|Period 2||1||
59777063|NCT00739908|75897555|FG000|STARTED|Overall Study||142||
59777064|NCT00739908|75897556|FG001|STARTED|Overall Study||143||
59777065|NCT00739908|75897555|FG000|COMPLETED|Overall Study||117||
59777066|NCT00739908|75897556|FG001|COMPLETED|Overall Study||118||
59777067|NCT00739908|75897555|FG000|NOT COMPLETED|Overall Study||25||
59777068|NCT00739908|75897556|FG001|NOT COMPLETED|Overall Study||25||
59777069|NCT00739596|75897566|FG000|STARTED|Overall Study||166||
59777070|NCT00739596|75897567|FG001|STARTED|Overall Study||166||
59777071|NCT00739596|75897566|FG000|COMPLETED|Overall Study||141||
59777072|NCT00739596|75897567|FG001|COMPLETED|Overall Study||149||
59777073|NCT00739596|75897566|FG000|NOT COMPLETED|Overall Study||25||
59777074|NCT00739596|75897567|FG001|NOT COMPLETED|Overall Study||17||
59777075|NCT00742326|75897575|FG000|STARTED|Overall Study||6||
59777076|NCT00742326|75897576|FG001|STARTED|Overall Study||7||
59777077|NCT00742326|75897575|FG000|COMPLETED|Overall Study||6||
59777078|NCT00742326|75897576|FG001|COMPLETED|Overall Study||6||
59777079|NCT00742326|75897575|FG000|NOT COMPLETED|Overall Study||0||
59777080|NCT00742326|75897576|FG001|NOT COMPLETED|Overall Study||1||
59777081|NCT00741936|75897584|FG000|STARTED|Overall Study||60||
59777082|NCT00741936|75897585|FG001|STARTED|Overall Study||60||
59777083|NCT00741936|75897584|FG000|COMPLETED|Overall Study||51||
59777084|NCT00741936|75897585|FG001|COMPLETED|Overall Study||52||
59777085|NCT00741936|75897584|FG000|NOT COMPLETED|Overall Study||9||
59777086|NCT00741936|75897585|FG001|NOT COMPLETED|Overall Study||8||
59777087|NCT00811187|75897593|FG000|STARTED|Overall Study||40||
59777088|NCT00811187|75897594|FG001|STARTED|Overall Study||40||
59777089|NCT00811187|75897593|FG000|COMPLETED|Overall Study||37||
59777090|NCT00811187|75897594|FG001|COMPLETED|Overall Study||37||
59777091|NCT00811187|75897593|FG000|NOT COMPLETED|Overall Study||3||
59777092|NCT00811187|75897594|FG001|NOT COMPLETED|Overall Study||3||
59777093|NCT00591149|75897600|FG000|STARTED|Overall Study||16||
59777094|NCT00591149|75897600|FG000|COMPLETED|Overall Study||11||
59777095|NCT00591149|75897600|FG000|NOT COMPLETED|Overall Study||5||
59777096|NCT00735072|75897606|FG000|STARTED|Overall Study||23||
59777097|NCT00735072|75897607|FG001|STARTED|Overall Study||22||
59777098|NCT00735072|75897606|FG000|COMPLETED|Overall Study||22||
59777099|NCT00735072|75897607|FG001|COMPLETED|Overall Study||21||
59777100|NCT00735072|75897606|FG000|NOT COMPLETED|Overall Study||1||
59777101|NCT00735072|75897607|FG001|NOT COMPLETED|Overall Study||1||
59777102|NCT00810641|75897618|FG000|STARTED|Overall Study||52||
59777103|NCT00810641|75897619|FG001|STARTED|Overall Study||54||
59777104|NCT00810641|75897620|FG002|STARTED|Overall Study||51||
59777105|NCT00810641|75897618|FG000|COMPLETED|Overall Study||52||
59777106|NCT00810641|75897619|FG001|COMPLETED|Overall Study||53||
59777107|NCT00810641|75897620|FG002|COMPLETED|Overall Study||49||
59777108|NCT00810641|75897618|FG000|NOT COMPLETED|Overall Study||0||
59777109|NCT00810641|75897619|FG001|NOT COMPLETED|Overall Study||1||
59777110|NCT00810641|75897620|FG002|NOT COMPLETED|Overall Study||2||
59777111|NCT00793598|75897633|FG000|STARTED|Overall Study||1||
59777112|NCT00793598|75897634|FG001|STARTED|Overall Study||1||
59777113|NCT00793598|75897635|FG002|STARTED|Overall Study||1||
59777114|NCT00793598|75897636|FG003|STARTED|Overall Study||2||
59777115|NCT00793598|75897637|FG004|STARTED|Overall Study||8||
59777116|NCT00793598|75897638|FG005|STARTED|Overall Study||8||
59777117|NCT00793598|75897639|FG006|STARTED|Overall Study||4||
59777118|NCT00793598|75897640|FG007|STARTED|Overall Study||4||
59777119|NCT00793598|75897633|FG000|COMPLETED|Overall Study||1||
59777120|NCT00793598|75897634|FG001|COMPLETED|Overall Study||0||
59777121|NCT00793598|75897635|FG002|COMPLETED|Overall Study||1||
59777122|NCT00793598|75897636|FG003|COMPLETED|Overall Study||2||
59777123|NCT00793598|75897637|FG004|COMPLETED|Overall Study||8||
59777124|NCT00793598|75897638|FG005|COMPLETED|Overall Study||7||
59777125|NCT00793598|75897639|FG006|COMPLETED|Overall Study||4||
59777126|NCT00793598|75897640|FG007|COMPLETED|Overall Study||3||
59777127|NCT00793598|75897633|FG000|NOT COMPLETED|Overall Study||0||
59777128|NCT00793598|75897634|FG001|NOT COMPLETED|Overall Study||1||
59777129|NCT00793598|75897635|FG002|NOT COMPLETED|Overall Study||0||
59777130|NCT00793598|75897636|FG003|NOT COMPLETED|Overall Study||0||
59777131|NCT00793598|75897637|FG004|NOT COMPLETED|Overall Study||0||
59777132|NCT00793598|75897638|FG005|NOT COMPLETED|Overall Study||1||
59777133|NCT00793598|75897639|FG006|NOT COMPLETED|Overall Study||0||
59777134|NCT00793598|75897640|FG007|NOT COMPLETED|Overall Study||1||
59777135|NCT00796562|75897662|FG000|STARTED|Overall Study||96||
59777136|NCT00796562|75897662|FG000|COMPLETED|Overall Study||47||
59777137|NCT00796562|75897662|FG000|NOT COMPLETED|Overall Study||49||
59777138|NCT00801632|75897666|FG000|STARTED|Overall Study||5||
59777139|NCT00801632|75897666|FG000|COMPLETED|Overall Study||4||
59777140|NCT00801632|75897666|FG000|NOT COMPLETED|Overall Study||1||
59777141|NCT00806819|75897672|FG000|STARTED|Overall Study|randomised patients|353||
59777142|NCT00806819|75897673|FG001|STARTED|Overall Study|randomised patients|360||
59777143|NCT00806819|75897672|FG000|COMPLETED|Overall Study|On-treatment at analysis DBL date (15 February 2013)|7||
59777144|NCT00806819|75897673|FG001|COMPLETED|Overall Study|On-treatment at analysis DBL date (15 February 2013)|2||
59952921|NCT01878500|76071711|FG000|NOT COMPLETED|Overall Study||0||
59952922|NCT05030454|76071715|FG000|STARTED|Overall Study||10||
59777145|NCT00806819|75897672|FG000|NOT COMPLETED|Overall Study||346||
59777146|NCT00806819|75897673|FG001|NOT COMPLETED|Overall Study||358||
59777147|NCT00801242|75897680|FG000|STARTED|Overall Study|Randomized participants.|220||
59777148|NCT00801242|75897680|FG000|Safety Analysis Set|Overall Study|Randomized participants who received ≥1 dose of degarelix.|216||
59777149|NCT00801242|75897680|FG000|Full Analysis Set (FAS), Cycle 1|Overall Study|Randomized participants who received ≥1 dose and had ≥1 efficacy assessment.|213||
59777150|NCT00801242|75897680|FG000|FAS, Off-treatment Cycle 1|Overall Study|Completed 7 months induction period and were enrolled in the off-treatment period of cycle 1.|191||
59777151|NCT00801242|75897680|FG000|Started Cycle 2|Overall Study||35||
59777152|NCT00801242|75897680|FG000|Started Cycle 3|Overall Study||2||
59952923|NCT05030454|76071715|FG000|COMPLETED|Overall Study||10||
59952924|NCT05030454|76071715|FG000|NOT COMPLETED|Overall Study||0||
59777153|NCT00801242|75897680|FG000|COMPLETED|Overall Study|42, 10, and 0 participants withdrew during Cycles 1, 2, and 3 (i.e. 168 completed the trial).|168||
59777154|NCT00801242|75897680|FG000|NOT COMPLETED|Overall Study||52||
59777155|NCT04377659|75897686|FG000|STARTED|Overall Study||3||
59952925|NCT04829331|76071721|FG000|STARTED|Overall Study||3||
59952926|NCT04829331|76071722|FG001|STARTED|Overall Study||2||
59952927|NCT04829331|76071721|FG000|COMPLETED|Overall Study||2||
59952928|NCT04829331|76071722|FG001|COMPLETED|Overall Study||2||
59952929|NCT04829331|76071721|FG000|NOT COMPLETED|Overall Study||1||
59777156|NCT04377659|75897687|FG001|STARTED|Overall Study||6||
59777157|NCT04377659|75897686|FG000|COMPLETED|Overall Study||3||
59777158|NCT04377659|75897687|FG001|COMPLETED|Overall Study||6||
59777159|NCT04377659|75897686|FG000|NOT COMPLETED|Overall Study||0||
59777160|NCT04377659|75897687|FG001|NOT COMPLETED|Overall Study||0||
59777161|NCT00800540|75897693|FG000|STARTED|Period One: 6 Weeks||17||
59777162|NCT00800540|75897694|FG001|STARTED|Period One: 6 Weeks||18||
59777163|NCT00800540|75897693|FG000|COMPLETED|Period One: 6 Weeks||16||
59777164|NCT00800540|75897694|FG001|COMPLETED|Period One: 6 Weeks||17||
59777165|NCT00800540|75897693|FG000|NOT COMPLETED|Period One: 6 Weeks||1||
59777166|NCT00800540|75897694|FG001|NOT COMPLETED|Period One: 6 Weeks||1||
59777167|NCT00800540|75897693|FG000|STARTED|Washout: 4 Weeks||16||
59777168|NCT00800540|75897694|FG001|STARTED|Washout: 4 Weeks||17||
59777169|NCT00800540|75897693|FG000|COMPLETED|Washout: 4 Weeks||16||
59777170|NCT00800540|75897694|FG001|COMPLETED|Washout: 4 Weeks||17||
59777171|NCT00800540|75897693|FG000|NOT COMPLETED|Washout: 4 Weeks||0||
59777172|NCT00800540|75897694|FG001|NOT COMPLETED|Washout: 4 Weeks||0||
59777173|NCT00800540|75897693|FG000|STARTED|Period 2: 6 Weeks||16||
59777174|NCT00800540|75897694|FG001|STARTED|Period 2: 6 Weeks||17||
59777175|NCT00800540|75897693|FG000|COMPLETED|Period 2: 6 Weeks||16||
59777176|NCT00800540|75897694|FG001|COMPLETED|Period 2: 6 Weeks||16||
59777177|NCT00800540|75897693|FG000|NOT COMPLETED|Period 2: 6 Weeks||0||
59777178|NCT00800540|75897694|FG001|NOT COMPLETED|Period 2: 6 Weeks||1||
59777179|NCT00800384|75897702|FG000|STARTED|Overall Study||1247||
59777180|NCT00800384|75897703|FG001|STARTED|Overall Study||1253||
59777181|NCT00800384|75897702|FG000|COMPLETED|Overall Study||1206||
59777182|NCT00800384|75897703|FG001|COMPLETED|Overall Study||1210||
59777183|NCT00800384|75897702|FG000|NOT COMPLETED|Overall Study||41||
59777184|NCT00800384|75897703|FG001|NOT COMPLETED|Overall Study||43||
59777185|NCT00796328|75897710|FG000|STARTED|Overall Study||46||
59777186|NCT00796328|75897710|FG000|COMPLETED|Overall Study||40||
59777187|NCT00796328|75897710|FG000|NOT COMPLETED|Overall Study||6||
59777188|NCT00588692|75897716|FG000|STARTED|Overall Study||30||
59777189|NCT00588692|75897717|FG001|STARTED|Overall Study||30||
59777190|NCT00588692|75897716|FG000|COMPLETED|Overall Study||23||
59777191|NCT00588692|75897717|FG001|COMPLETED|Overall Study||27||
59777192|NCT00588692|75897716|FG000|NOT COMPLETED|Overall Study||7||
59777193|NCT00588692|75897717|FG001|NOT COMPLETED|Overall Study||3||
59777194|NCT00588146|75897725|FG000|STARTED|First Intervention (Baseline to 6 mo)||5||
59777195|NCT00588146|75897726|FG001|STARTED|First Intervention (Baseline to 6 mo)||5||
59777196|NCT00588146|75897725|FG000|COMPLETED|First Intervention (Baseline to 6 mo)||1||
59777197|NCT00588146|75897726|FG001|COMPLETED|First Intervention (Baseline to 6 mo)||2||
59777198|NCT00588146|75897725|FG000|NOT COMPLETED|First Intervention (Baseline to 6 mo)||4||
59777199|NCT00588146|75897726|FG001|NOT COMPLETED|First Intervention (Baseline to 6 mo)||3||
59777200|NCT00588146|75897725|FG000|STARTED|Second Intervention (6 Months to 1 Year)||1||
59777201|NCT00588146|75897726|FG001|STARTED|Second Intervention (6 Months to 1 Year)||2||
59777202|NCT00588146|75897725|FG000|COMPLETED|Second Intervention (6 Months to 1 Year)||1||
59777203|NCT00588146|75897726|FG001|COMPLETED|Second Intervention (6 Months to 1 Year)||2||
59777204|NCT00588146|75897725|FG000|NOT COMPLETED|Second Intervention (6 Months to 1 Year)||0||
59777205|NCT00588146|75897726|FG001|NOT COMPLETED|Second Intervention (6 Months to 1 Year)||0||
59777206|NCT00795704|75897734|FG000|STARTED|Overall Study||12||
59777207|NCT00795704|75897735|FG001|STARTED|Overall Study||12||
59777208|NCT00795704|75897734|FG000|COMPLETED|Overall Study||8||
59777209|NCT00795704|75897735|FG001|COMPLETED|Overall Study||9||
59777210|NCT00795704|75897734|FG000|NOT COMPLETED|Overall Study||4||
59777211|NCT00795704|75897735|FG001|NOT COMPLETED|Overall Study||3||
59777212|NCT00444457|75897745|FG000|STARTED|Infant Series||489||
59777213|NCT00444457|75897746|FG001|STARTED|Infant Series||488||
59777214|NCT00444457|75897747|FG002|STARTED|Infant Series||489||
59777215|NCT00444457|75897748|FG003|STARTED|Infant Series||246||
59522136|NCT02563548|75616460|FG004|NOT COMPLETED|Dose Expansion (Up to 60 Weeks)||25||
59777216|NCT00444457|75897745|FG000|Vaccinated Dose 1|Infant Series||486||
59777217|NCT00444457|75897746|FG001|Vaccinated Dose 1|Infant Series||484||
59777218|NCT00444457|75897747|FG002|Vaccinated Dose 1|Infant Series||485||
59952930|NCT04829331|76071722|FG001|NOT COMPLETED|Overall Study||0||
59777219|NCT00444457|75897748|FG003|Vaccinated Dose 1|Infant Series||244||
59777220|NCT00444457|75897745|FG000|Vaccinated Dose 2|Infant Series||455||
59777221|NCT00444457|75897746|FG001|Vaccinated Dose 2|Infant Series||447||
59777222|NCT00444457|75897747|FG002|Vaccinated Dose 2|Infant Series||455||
59777223|NCT00444457|75897748|FG003|Vaccinated Dose 2|Infant Series||228||
59777224|NCT00444457|75897745|FG000|Vaccinated Dose 3|Infant Series||442||
59777225|NCT00444457|75897746|FG001|Vaccinated Dose 3|Infant Series||435||
59777226|NCT00444457|75897747|FG002|Vaccinated Dose 3|Infant Series||438||
59777227|NCT00444457|75897748|FG003|Vaccinated Dose 3|Infant Series||225||
59777228|NCT00444457|75897745|FG000|COMPLETED|Infant Series||435||
59777229|NCT00444457|75897746|FG001|COMPLETED|Infant Series||427||
59777230|NCT00444457|75897747|FG002|COMPLETED|Infant Series||428||
59777231|NCT00444457|75897748|FG003|COMPLETED|Infant Series||218||
59777232|NCT00444457|75897745|FG000|NOT COMPLETED|Infant Series||54||
59777233|NCT00444457|75897746|FG001|NOT COMPLETED|Infant Series||61||
59777234|NCT00444457|75897747|FG002|NOT COMPLETED|Infant Series||61||
59777235|NCT00444457|75897748|FG003|NOT COMPLETED|Infant Series||28||
59777236|NCT00444457|75897745|FG000|STARTED|After Infant Series||435||
59777237|NCT00444457|75897746|FG001|STARTED|After Infant Series||427||
59777238|NCT00444457|75897747|FG002|STARTED|After Infant Series||427||
59777239|NCT00444457|75897748|FG003|STARTED|After Infant Series||218||
59618665|NCT02819518|75729762|FG002|COMPLETED|Overall Study||0||
59618666|NCT02819518|75729763|FG003|COMPLETED|Overall Study||0||
59618667|NCT02819518|75729764|FG004|COMPLETED|Overall Study||0||
59618668|NCT02819518|75729760|FG000|NOT COMPLETED|Overall Study||11||
59618669|NCT02819518|75729761|FG001|NOT COMPLETED|Overall Study||14||
59618670|NCT02819518|75729762|FG002|NOT COMPLETED|Overall Study||10||
59618671|NCT02819518|75729763|FG003|NOT COMPLETED|Overall Study||566||
59618672|NCT02819518|75729764|FG004|NOT COMPLETED|Overall Study||281||
59618673|NCT02661022|75729780|FG000|STARTED|Overall Study||7||
59618674|NCT02661022|75729781|FG001|STARTED|Overall Study||2||
59618675|NCT02661022|75729780|FG000|COMPLETED|Overall Study||0||
59618676|NCT02661022|75729781|FG001|COMPLETED|Overall Study||0||
59618677|NCT02661022|75729780|FG000|NOT COMPLETED|Overall Study||7||
59618678|NCT02661022|75729781|FG001|NOT COMPLETED|Overall Study||2||
59618679|NCT02475681|75729792|FG000|STARTED|Overall Study||177|Randomized|
59618680|NCT02475681|75729793|FG001|STARTED|Overall Study||179|Randomized|
59618681|NCT02475681|75729794|FG002|STARTED|Overall Study||179|Randomized|
59618682|NCT02475681|75729792|FG000|Crossed Over From Arm A to Arm C|Overall Study||45||
59618683|NCT02475681|75729793|FG001|Crossed Over From Arm A to Arm C|Overall Study||0||
59618684|NCT02475681|75729794|FG002|Crossed Over From Arm A to Arm C|Overall Study||0||
59618685|NCT02475681|75729792|FG000|COMPLETED|Overall Study||145||
59618686|NCT02475681|75729793|FG001|COMPLETED|Overall Study||0||
59618687|NCT02475681|75729794|FG002|COMPLETED|Overall Study||0||
59618688|NCT02475681|75729792|FG000|NOT COMPLETED|Overall Study||32||
59618689|NCT02475681|75729793|FG001|NOT COMPLETED|Overall Study||179||
59618690|NCT02475681|75729794|FG002|NOT COMPLETED|Overall Study||179||
59618691|NCT02232126|75729806|FG000|STARTED|Overall Study||91||
59618692|NCT02232126|75729807|FG001|STARTED|Overall Study||90||
59618693|NCT02232126|75729806|FG000|COMPLETED|Overall Study||91||
59618694|NCT02232126|75729807|FG001|COMPLETED|Overall Study||90||
59618695|NCT02232126|75729806|FG000|NOT COMPLETED|Overall Study||0||
59618696|NCT02232126|75729807|FG001|NOT COMPLETED|Overall Study||0||
59618697|NCT02127073|75729815|FG000|STARTED|Overall Study||8||
59618698|NCT02127073|75729815|FG000|COMPLETED|Overall Study||8||
59618699|NCT02127073|75729815|FG000|NOT COMPLETED|Overall Study||0||
59618700|NCT01901562|75729819|FG000|STARTED|Overall Study||9||
59618701|NCT01901562|75729819|FG000|COMPLETED|Overall Study||0||
59618702|NCT01901562|75729819|FG000|NOT COMPLETED|Overall Study||9||
59618703|NCT00819247|75729826|FG000|STARTED|Overall Study||43||
59618704|NCT00819247|75729827|FG001|STARTED|Overall Study||46||
59618705|NCT00819247|75729828|FG002|STARTED|Overall Study||40||
59618706|NCT00819247|75729826|FG000|Randomized|Overall Study||43||
59618707|NCT00819247|75729827|FG001|Randomized|Overall Study||46||
59618708|NCT00819247|75729828|FG002|Randomized|Overall Study||40||
59618709|NCT00819247|75729826|FG000|Intent-to-treat Population|Overall Study|One randomised participant withdrew at Day 1.|42||
59618710|NCT00819247|75729827|FG001|Intent-to-treat Population|Overall Study||46||
59777240|NCT00444457|75897745|FG000|COMPLETED|After Infant Series|Not completed=Withdrawn after infant series|415||
59952931|NCT04678284|76071728|FG000|STARTED|Overall Study||10||
59952932|NCT04678284|76071728|FG000|COMPLETED|Overall Study||10||
59618711|NCT00819247|75729828|FG002|Intent-to-treat Population|Overall Study|One randomised participant withdrew at Day 1.|39||
59618712|NCT00819247|75729826|FG000|Per Protocol Population|Overall Study|One participant- baseline testosterone outside normal range. Three participants- prohibited drugs.|38||
59618713|NCT00819247|75729827|FG001|Per Protocol Population|Overall Study|Two participants - prohibited drugs|44||
59618714|NCT00819247|75729828|FG002|Per Protocol Population|Overall Study|One participant - baseline testosterone outside normal range.|38||
59618715|NCT00819247|75729826|FG000|COMPLETED|Overall Study||32||
59618716|NCT00819247|75729827|FG001|COMPLETED|Overall Study||30||
59618717|NCT00819247|75729828|FG002|COMPLETED|Overall Study||26||
59618718|NCT00819247|75729826|FG000|NOT COMPLETED|Overall Study||11||
59618719|NCT00819247|75729827|FG001|NOT COMPLETED|Overall Study||16||
59618720|NCT00819247|75729828|FG002|NOT COMPLETED|Overall Study||14||
59618721|NCT00716976|75729838|FG000|STARTED|Overall Study||65||
59618722|NCT00716976|75729839|FG001|STARTED|Overall Study||66||
59618723|NCT00716976|75729838|FG000|COMPLETED|Overall Study||45||
59618724|NCT00716976|75729839|FG001|COMPLETED|Overall Study||57||
59618725|NCT00716976|75729838|FG000|NOT COMPLETED|Overall Study||20||
59618726|NCT00716976|75729839|FG001|NOT COMPLETED|Overall Study||9||
59618727|NCT00670709|75729849|FG000|STARTED|Overall Study||27||
59618728|NCT00670709|75729850|FG001|STARTED|Overall Study||15||
59618729|NCT00670709|75729849|FG000|COMPLETED|Overall Study||27||
59618730|NCT00670709|75729850|FG001|COMPLETED|Overall Study||15||
59618731|NCT00670709|75729849|FG000|NOT COMPLETED|Overall Study||0||
59618732|NCT00670709|75729850|FG001|NOT COMPLETED|Overall Study||0||
59618733|NCT00634634|75729860|FG000|STARTED|Overall Study||1||
59618734|NCT00634634|75729861|FG001|STARTED|Overall Study||3||
59777241|NCT00444457|75897746|FG001|COMPLETED|After Infant Series|Not completed=Withdrawn after infant series|397||
59777242|NCT00444457|75897747|FG002|COMPLETED|After Infant Series|Not completed=Withdrawn after infant series|408||
59777243|NCT00444457|75897748|FG003|COMPLETED|After Infant Series|Not completed=Withdrawn after infant series|208||
59777244|NCT00444457|75897745|FG000|NOT COMPLETED|After Infant Series||20||
59777245|NCT00444457|75897746|FG001|NOT COMPLETED|After Infant Series||30||
59777246|NCT00444457|75897747|FG002|NOT COMPLETED|After Infant Series||19||
59777247|NCT00444457|75897748|FG003|NOT COMPLETED|After Infant Series||10||
59777248|NCT00444457|75897745|FG000|STARTED|Toddler Dose|Vaccinated toddler dose|415||
59777249|NCT00444457|75897746|FG001|STARTED|Toddler Dose|Vaccinated toddler dose|397||
59777250|NCT00444457|75897747|FG002|STARTED|Toddler Dose|Vaccinated toddler dose|408||
59777251|NCT00444457|75897748|FG003|STARTED|Toddler Dose|Vaccinated toddler dose|208||
59777252|NCT00444457|75897745|FG000|COMPLETED|Toddler Dose||408||
59777253|NCT00444457|75897746|FG001|COMPLETED|Toddler Dose||391||
59777254|NCT00444457|75897747|FG002|COMPLETED|Toddler Dose||404||
59777255|NCT00444457|75897748|FG003|COMPLETED|Toddler Dose||200||
59777256|NCT00444457|75897745|FG000|NOT COMPLETED|Toddler Dose||7||
59777257|NCT00444457|75897746|FG001|NOT COMPLETED|Toddler Dose||6||
59777258|NCT00444457|75897747|FG002|NOT COMPLETED|Toddler Dose||4||
59777259|NCT00444457|75897748|FG003|NOT COMPLETED|Toddler Dose||8||
59777260|NCT00799058|75897772|FG000|STARTED|Overall Study||43||
59777261|NCT00799058|75897773|FG001|STARTED|Overall Study||43||
59777262|NCT00799058|75897774|FG002|STARTED|Overall Study||42||
59777263|NCT00799058|75897772|FG000|COMPLETED|Overall Study||33||
59777264|NCT00799058|75897773|FG001|COMPLETED|Overall Study||34||
59777265|NCT00799058|75897774|FG002|COMPLETED|Overall Study||36||
59777266|NCT00799058|75897772|FG000|NOT COMPLETED|Overall Study||10||
59777267|NCT00799058|75897773|FG001|NOT COMPLETED|Overall Study||9||
59777268|NCT00799058|75897774|FG002|NOT COMPLETED|Overall Study||6||
59777269|NCT00725985|75897787|FG000|STARTED|ITP- Treatment Disposition||205||
59777270|NCT00725985|75897788|FG001|STARTED|ITP- Treatment Disposition||206||
59777271|NCT00725985|75897789|FG002|STARTED|ITP- Treatment Disposition||206||
59777272|NCT00725985|75897790|FG003|STARTED|ITP- Treatment Disposition||0||
59777273|NCT00725985|75897791|FG004|STARTED|ITP- Treatment Disposition||0||
59777274|NCT00725985|75897792|FG005|STARTED|ITP- Treatment Disposition||0||
59777275|NCT00725985|75897793|FG006|STARTED|ITP- Treatment Disposition||0||
59777276|NCT00725985|75897794|FG007|STARTED|ITP- Treatment Disposition||0||
59777277|NCT00725985|75897795|FG008|STARTED|ITP- Treatment Disposition||0||
59777278|NCT00725985|75897796|FG009|STARTED|ITP- Treatment Disposition||0||
59777279|NCT00725985|75897797|FG010|STARTED|ITP- Treatment Disposition||0||
59777280|NCT00725985|75897798|FG011|STARTED|ITP- Treatment Disposition||0||
59777281|NCT00725985|75897787|FG000|Treated|ITP- Treatment Disposition||204||
59777282|NCT00725985|75897788|FG001|Treated|ITP- Treatment Disposition||206||
59777283|NCT00725985|75897789|FG002|Treated|ITP- Treatment Disposition||206||
59777284|NCT00725985|75897790|FG003|Treated|ITP- Treatment Disposition||0||
59777285|NCT00725985|75897791|FG004|Treated|ITP- Treatment Disposition||0||
59777286|NCT00725985|75897792|FG005|Treated|ITP- Treatment Disposition||0||
59777287|NCT00725985|75897793|FG006|Treated|ITP- Treatment Disposition||0||
59777288|NCT00725985|75897794|FG007|Treated|ITP- Treatment Disposition||0||
59777289|NCT00725985|75897795|FG008|Treated|ITP- Treatment Disposition||0||
59777290|NCT00725985|75897796|FG009|Treated|ITP- Treatment Disposition||0||
59777291|NCT00725985|75897797|FG010|Treated|ITP- Treatment Disposition||0||
59777292|NCT00725985|75897798|FG011|Treated|ITP- Treatment Disposition||0||
59777293|NCT00725985|75897787|FG000|COMPLETED|ITP- Treatment Disposition||104||
59777294|NCT00725985|75897788|FG001|COMPLETED|ITP- Treatment Disposition||131||
60072866|NCT01696773|76188066|FG000|STARTED|Days 15-27, Washout||6||
60072867|NCT01696773|76188067|FG001|STARTED|Days 15-27, Washout||6||
60072868|NCT01696773|76188066|FG000|COMPLETED|Days 15-27, Washout||5||
60072869|NCT01696773|76188067|FG001|COMPLETED|Days 15-27, Washout||6||
60072870|NCT01696773|76188066|FG000|NOT COMPLETED|Days 15-27, Washout||1||
60072871|NCT01696773|76188067|FG001|NOT COMPLETED|Days 15-27, Washout||0||
59777295|NCT00725985|75897789|FG002|COMPLETED|ITP- Treatment Disposition||104||
59777296|NCT00725985|75897790|FG003|COMPLETED|ITP- Treatment Disposition||0||
59777297|NCT00725985|75897791|FG004|COMPLETED|ITP- Treatment Disposition||0||
59777298|NCT00725985|75897792|FG005|COMPLETED|ITP- Treatment Disposition||0||
59777299|NCT00725985|75897793|FG006|COMPLETED|ITP- Treatment Disposition||0||
59777300|NCT00725985|75897794|FG007|COMPLETED|ITP- Treatment Disposition||0||
59777301|NCT00725985|75897795|FG008|COMPLETED|ITP- Treatment Disposition||0||
59777302|NCT00725985|75897796|FG009|COMPLETED|ITP- Treatment Disposition||0||
59777303|NCT00725985|75897797|FG010|COMPLETED|ITP- Treatment Disposition||0||
59777304|NCT00725985|75897798|FG011|COMPLETED|ITP- Treatment Disposition||0||
59777305|NCT00725985|75897787|FG000|NOT COMPLETED|ITP- Treatment Disposition||101||
60072872|NCT01696773|76188066|FG000|STARTED|Day 28, Second Intervention||5||
60072873|NCT01696773|76188067|FG001|STARTED|Day 28, Second Intervention||6||
60072874|NCT01696773|76188066|FG000|COMPLETED|Day 28, Second Intervention||5||
59777306|NCT00725985|75897788|FG001|NOT COMPLETED|ITP- Treatment Disposition||75||
59777307|NCT00725985|75897789|FG002|NOT COMPLETED|ITP- Treatment Disposition||102||
59777308|NCT00725985|75897790|FG003|NOT COMPLETED|ITP- Treatment Disposition||0||
59777309|NCT00725985|75897791|FG004|NOT COMPLETED|ITP- Treatment Disposition||0||
59777310|NCT00725985|75897792|FG005|NOT COMPLETED|ITP- Treatment Disposition||0||
59777311|NCT00725985|75897793|FG006|NOT COMPLETED|ITP- Treatment Disposition||0||
59777312|NCT00725985|75897794|FG007|NOT COMPLETED|ITP- Treatment Disposition||0||
59777313|NCT00725985|75897795|FG008|NOT COMPLETED|ITP- Treatment Disposition||0||
59777314|NCT00725985|75897796|FG009|NOT COMPLETED|ITP- Treatment Disposition||0||
59777315|NCT00725985|75897797|FG010|NOT COMPLETED|ITP- Treatment Disposition||0||
59777316|NCT00725985|75897798|FG011|NOT COMPLETED|ITP- Treatment Disposition||0||
59777317|NCT00725985|75897787|FG000|STARTED|OLMP (Up to 96 Weeks)||0||
59777318|NCT00725985|75897788|FG001|STARTED|OLMP (Up to 96 Weeks)||0||
59777319|NCT00725985|75897789|FG002|STARTED|OLMP (Up to 96 Weeks)||0||
59777320|NCT00725985|75897790|FG003|STARTED|OLMP (Up to 96 Weeks)||24||
59777321|NCT00725985|75897791|FG004|STARTED|OLMP (Up to 96 Weeks)||25||
59777322|NCT00725985|75897792|FG005|STARTED|OLMP (Up to 96 Weeks)||60||
59777323|NCT00725985|75897793|FG006|STARTED|OLMP (Up to 96 Weeks)||0||
59777324|NCT00725985|75897794|FG007|STARTED|OLMP (Up to 96 Weeks)||0||
59777325|NCT00725985|75897795|FG008|STARTED|OLMP (Up to 96 Weeks)||0||
59777326|NCT00725985|75897796|FG009|STARTED|OLMP (Up to 96 Weeks)||0||
59777327|NCT00725985|75897797|FG010|STARTED|OLMP (Up to 96 Weeks)||0||
59777328|NCT00725985|75897798|FG011|STARTED|OLMP (Up to 96 Weeks)||0||
59777329|NCT00725985|75897787|FG000|COMPLETED|OLMP (Up to 96 Weeks)||0||
59777330|NCT00725985|75897788|FG001|COMPLETED|OLMP (Up to 96 Weeks)||0||
59777331|NCT00725985|75897789|FG002|COMPLETED|OLMP (Up to 96 Weeks)||0||
59777332|NCT00725985|75897790|FG003|COMPLETED|OLMP (Up to 96 Weeks)||6||
59777333|NCT00725985|75897791|FG004|COMPLETED|OLMP (Up to 96 Weeks)||2||
59777334|NCT00725985|75897792|FG005|COMPLETED|OLMP (Up to 96 Weeks)||7||
59777335|NCT00725985|75897793|FG006|COMPLETED|OLMP (Up to 96 Weeks)||0||
59777336|NCT00725985|75897794|FG007|COMPLETED|OLMP (Up to 96 Weeks)||0||
59777337|NCT00725985|75897795|FG008|COMPLETED|OLMP (Up to 96 Weeks)||0||
59777338|NCT00725985|75897796|FG009|COMPLETED|OLMP (Up to 96 Weeks)||0||
59777339|NCT00725985|75897797|FG010|COMPLETED|OLMP (Up to 96 Weeks)||0||
59777340|NCT00725985|75897798|FG011|COMPLETED|OLMP (Up to 96 Weeks)||0||
59777341|NCT00725985|75897787|FG000|NOT COMPLETED|OLMP (Up to 96 Weeks)||0||
59777342|NCT00725985|75897788|FG001|NOT COMPLETED|OLMP (Up to 96 Weeks)||0||
59777343|NCT00725985|75897789|FG002|NOT COMPLETED|OLMP (Up to 96 Weeks)||0||
59777344|NCT00725985|75897790|FG003|NOT COMPLETED|OLMP (Up to 96 Weeks)||18||
59777345|NCT00725985|75897791|FG004|NOT COMPLETED|OLMP (Up to 96 Weeks)||23||
59777346|NCT00725985|75897792|FG005|NOT COMPLETED|OLMP (Up to 96 Weeks)||53||
59777347|NCT00725985|75897793|FG006|NOT COMPLETED|OLMP (Up to 96 Weeks)||0||
59777348|NCT00725985|75897794|FG007|NOT COMPLETED|OLMP (Up to 96 Weeks)||0||
59777349|NCT00725985|75897795|FG008|NOT COMPLETED|OLMP (Up to 96 Weeks)||0||
59777350|NCT00725985|75897796|FG009|NOT COMPLETED|OLMP (Up to 96 Weeks)||0||
59777351|NCT00725985|75897797|FG010|NOT COMPLETED|OLMP (Up to 96 Weeks)||0||
59777352|NCT00725985|75897798|FG011|NOT COMPLETED|OLMP (Up to 96 Weeks)||0||
59777353|NCT00725985|75897787|FG000|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||0||
59777354|NCT00725985|75897788|FG001|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||0||
59777355|NCT00725985|75897789|FG002|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||0||
59777356|NCT00725985|75897790|FG003|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||0||
59777357|NCT00725985|75897791|FG004|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||0||
59777358|NCT00725985|75897792|FG005|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||0||
59777359|NCT00725985|75897793|FG006|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||9||
59777360|NCT00725985|75897794|FG007|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||9||
59777361|NCT00725985|75897795|FG008|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||17||
59777362|NCT00725985|75897796|FG009|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||0||
59777363|NCT00725985|75897797|FG010|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||0||
59777364|NCT00725985|75897798|FG011|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||0||
59777365|NCT00725985|75897787|FG000|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0||
59777366|NCT00725985|75897788|FG001|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0||
59777367|NCT00725985|75897789|FG002|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0||
59777368|NCT00725985|75897790|FG003|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0||
59777369|NCT00725985|75897791|FG004|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0||
59777370|NCT00725985|75897792|FG005|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0||
59777371|NCT00725985|75897793|FG006|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0||
59777372|NCT00725985|75897794|FG007|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0||
59777373|NCT00725985|75897795|FG008|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0||
59777374|NCT00725985|75897796|FG009|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0||
59777375|NCT00725985|75897797|FG010|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0||
59777376|NCT00725985|75897798|FG011|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0||
59777377|NCT00725985|75897787|FG000|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0||
59777378|NCT00725985|75897788|FG001|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0||
59777379|NCT00725985|75897789|FG002|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0||
59777380|NCT00725985|75897790|FG003|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0||
59777381|NCT00725985|75897791|FG004|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0||
59777382|NCT00725985|75897792|FG005|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0||
59777383|NCT00725985|75897793|FG006|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||9||
59777384|NCT00725985|75897794|FG007|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||9||
59777385|NCT00725985|75897795|FG008|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||17||
59777386|NCT00725985|75897796|FG009|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0||
59777387|NCT00725985|75897797|FG010|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0||
59777388|NCT00725985|75897798|FG011|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0||
59777389|NCT00725985|75897787|FG000|STARTED|LTFU (No Cladribine) (48 Weeks)||0||
59777390|NCT00725985|75897788|FG001|STARTED|LTFU (No Cladribine) (48 Weeks)||0||
59777391|NCT00725985|75897789|FG002|STARTED|LTFU (No Cladribine) (48 Weeks)||0||
59777392|NCT00725985|75897790|FG003|STARTED|LTFU (No Cladribine) (48 Weeks)||0||
59777393|NCT00725985|75897791|FG004|STARTED|LTFU (No Cladribine) (48 Weeks)||0||
59777394|NCT00725985|75897792|FG005|STARTED|LTFU (No Cladribine) (48 Weeks)||0||
59777395|NCT00725985|75897793|FG006|STARTED|LTFU (No Cladribine) (48 Weeks)||0||
59777396|NCT00725985|75897794|FG007|STARTED|LTFU (No Cladribine) (48 Weeks)||0||
59777397|NCT00725985|75897795|FG008|STARTED|LTFU (No Cladribine) (48 Weeks)||0||
59777398|NCT00725985|75897796|FG009|STARTED|LTFU (No Cladribine) (48 Weeks)||34||
59777399|NCT00725985|75897797|FG010|STARTED|LTFU (No Cladribine) (48 Weeks)||36||
59777400|NCT00725985|75897798|FG011|STARTED|LTFU (No Cladribine) (48 Weeks)||14||
59777401|NCT00725985|75897787|FG000|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0||
59777402|NCT00725985|75897788|FG001|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0||
59777403|NCT00725985|75897789|FG002|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0||
59777404|NCT00725985|75897790|FG003|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0||
59777405|NCT00725985|75897791|FG004|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0||
59777406|NCT00725985|75897792|FG005|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0||
59777407|NCT00725985|75897793|FG006|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0||
59777408|NCT00725985|75897794|FG007|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0||
59777409|NCT00725985|75897795|FG008|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0||
59777410|NCT00725985|75897796|FG009|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0||
59777411|NCT00725985|75897797|FG010|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0||
59777412|NCT00725985|75897798|FG011|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0||
59777413|NCT00725985|75897787|FG000|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||0||
59777414|NCT00725985|75897788|FG001|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||0||
59777415|NCT00725985|75897789|FG002|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||0||
59777416|NCT00725985|75897790|FG003|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||0||
59777417|NCT00725985|75897791|FG004|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||0||
59777418|NCT00725985|75897792|FG005|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||0||
59777419|NCT00725985|75897793|FG006|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||0||
59777420|NCT00725985|75897794|FG007|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||0||
59777421|NCT00725985|75897795|FG008|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||0||
59777422|NCT00725985|75897796|FG009|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||34||
59777423|NCT00725985|75897797|FG010|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||36||
59777424|NCT00725985|75897798|FG011|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||14||
59777425|NCT00793910|75897826|FG000|STARTED|Overall Study||53||
59777426|NCT00793910|75897827|FG001|STARTED|Overall Study||53||
59777427|NCT00793910|75897826|FG000|COMPLETED|Overall Study||48||
59777428|NCT00793910|75897827|FG001|COMPLETED|Overall Study||46||
59777429|NCT00793910|75897826|FG000|NOT COMPLETED|Overall Study||5||
60072875|NCT01696773|76188067|FG001|COMPLETED|Day 28, Second Intervention||6||
60072876|NCT01696773|76188066|FG000|NOT COMPLETED|Day 28, Second Intervention||0||
59777430|NCT00793910|75897827|FG001|NOT COMPLETED|Overall Study||7||
59777431|NCT00444145|75897833|FG000|STARTED|Overall Study||38||
59777432|NCT00444145|75897833|FG000|COMPLETED|Overall Study||19||
59777433|NCT00444145|75897833|FG000|NOT COMPLETED|Overall Study||19||
59777434|NCT00725283|75897837|FG000|STARTED|Overall Study||34||
59777435|NCT00725283|75897837|FG000|COMPLETED|Overall Study||10||
59777436|NCT00725283|75897837|FG000|NOT COMPLETED|Overall Study||24||
59777437|NCT00444067|75897843|FG000|STARTED|Overall Study||74||
59777438|NCT00444067|75897844|FG001|STARTED|Overall Study||24||
59777439|NCT00444067|75897843|FG000|COMPLETED|Overall Study||74||
59777440|NCT00444067|75897844|FG001|COMPLETED|Overall Study||23||
59777441|NCT00444067|75897843|FG000|NOT COMPLETED|Overall Study||0||
59777442|NCT00444067|75897844|FG001|NOT COMPLETED|Overall Study||1||
59777443|NCT00789854|75897853|FG000|STARTED|Overall Study||228||
59777444|NCT00789854|75897854|FG001|STARTED|Overall Study||231||
60072877|NCT01696773|76188067|FG001|NOT COMPLETED|Day 28, Second Intervention||0||
59777445|NCT00789854|75897855|FG002|STARTED|Overall Study||229||
59777446|NCT00789854|75897853|FG000|COMPLETED|Overall Study||179||
59777447|NCT00789854|75897854|FG001|COMPLETED|Overall Study||196||
59777448|NCT00789854|75897855|FG002|COMPLETED|Overall Study||182||
59777449|NCT00789854|75897853|FG000|NOT COMPLETED|Overall Study||49||
59777450|NCT00789854|75897854|FG001|NOT COMPLETED|Overall Study||35||
59777451|NCT00789854|75897855|FG002|NOT COMPLETED|Overall Study||47||
59777452|NCT00725205|75897863|FG000|STARTED|Overall Study||294||
60072878|NCT03158740|76188075|FG000|STARTED|Overall Study||15||
60072879|NCT03158740|76188076|FG001|STARTED|Overall Study||8||
59777453|NCT00725205|75897863|FG000|COMPLETED|Overall Study||207||
59777454|NCT00725205|75897863|FG000|NOT COMPLETED|Overall Study||87||
59777455|NCT00443755|75897869|FG000|STARTED|Overall Study||14||
59777456|NCT00443755|75897870|FG001|STARTED|Overall Study||14||
59777457|NCT00443755|75897869|FG000|COMPLETED|Overall Study||12||
59777458|NCT00443755|75897870|FG001|COMPLETED|Overall Study||13||
59777459|NCT00443755|75897869|FG000|NOT COMPLETED|Overall Study||2||
59777460|NCT00443755|75897870|FG001|NOT COMPLETED|Overall Study||1||
59777461|NCT00724971|75897876|FG000|STARTED|Overall Study||10||
59777462|NCT00724971|75897876|FG000|COMPLETED|Overall Study||4||
59777463|NCT00724971|75897876|FG000|NOT COMPLETED|Overall Study||6||
59777464|NCT00443599|75897882|FG000|STARTED|Overall Study|Randomly Assigned to Tight Glycemic Control|496||
59777465|NCT00443599|75897883|FG001|STARTED|Overall Study|Randomly Assigned to Standard Care|493||
59777466|NCT00443599|75897882|FG000|COMPLETED|Overall Study|Included in per-protocol analysis|490||
59777467|NCT00443599|75897883|FG001|COMPLETED|Overall Study|Included in per-protocol analysis|490||
59777468|NCT00443599|75897882|FG000|NOT COMPLETED|Overall Study||6||
59777469|NCT00443599|75897883|FG001|NOT COMPLETED|Overall Study||3||
59777470|NCT00455143|75897889|FG000|STARTED|Overall Study||27||
59777471|NCT00455143|75897889|FG000|COMPLETED|Overall Study||21||
59777472|NCT00455143|75897889|FG000|NOT COMPLETED|Overall Study||6||
59777473|NCT00454987|75897897|FG000|STARTED|Booster Period (NCT00258700)||359||
59777474|NCT00454987|75897898|FG001|STARTED|Booster Period (NCT00258700)||117||
59777475|NCT00454987|75897899|FG002|STARTED|Booster Period (NCT00258700)||0||
59777476|NCT00454987|75897897|FG000|COMPLETED|Booster Period (NCT00258700)||357||
59777477|NCT00454987|75897898|FG001|COMPLETED|Booster Period (NCT00258700)||116||
59777478|NCT00454987|75897899|FG002|COMPLETED|Booster Period (NCT00258700)||0||
59777479|NCT00454987|75897897|FG000|NOT COMPLETED|Booster Period (NCT00258700)||2||
59777480|NCT00454987|75897898|FG001|NOT COMPLETED|Booster Period (NCT00258700)||1||
59777481|NCT00454987|75897899|FG002|NOT COMPLETED|Booster Period (NCT00258700)||0||
59777482|NCT00454987|75897897|FG000|STARTED|Year 1 (NCT00454987)||221||
59777483|NCT00454987|75897898|FG001|STARTED|Year 1 (NCT00454987)||67||
59777484|NCT00454987|75897899|FG002|STARTED|Year 1 (NCT00454987)||0||
59777485|NCT00454987|75897897|FG000|COMPLETED|Year 1 (NCT00454987)||221||
59777486|NCT00454987|75897898|FG001|COMPLETED|Year 1 (NCT00454987)||67||
59777487|NCT00454987|75897899|FG002|COMPLETED|Year 1 (NCT00454987)||0||
59777488|NCT00454987|75897897|FG000|NOT COMPLETED|Year 1 (NCT00454987)||0||
59777489|NCT00454987|75897898|FG001|NOT COMPLETED|Year 1 (NCT00454987)||0||
59777490|NCT00454987|75897899|FG002|NOT COMPLETED|Year 1 (NCT00454987)||0||
59777491|NCT00454987|75897897|FG000|STARTED|Year 2 (NCT00454987)||235||
59777492|NCT00454987|75897898|FG001|STARTED|Year 2 (NCT00454987)||77||
59777493|NCT00454987|75897899|FG002|STARTED|Year 2 (NCT00454987)||74||
59777494|NCT00454987|75897897|FG000|COMPLETED|Year 2 (NCT00454987)||235||
59777495|NCT00454987|75897898|FG001|COMPLETED|Year 2 (NCT00454987)||77||
59777496|NCT00454987|75897899|FG002|COMPLETED|Year 2 (NCT00454987)||74||
59777497|NCT00454987|75897897|FG000|NOT COMPLETED|Year 2 (NCT00454987)||0||
59777498|NCT00454987|75897898|FG001|NOT COMPLETED|Year 2 (NCT00454987)||0||
59777499|NCT00454987|75897899|FG002|NOT COMPLETED|Year 2 (NCT00454987)||0||
59777500|NCT00454987|75897897|FG000|STARTED|Year 4 (NCT00454987)||206||
59777501|NCT00454987|75897898|FG001|STARTED|Year 4 (NCT00454987)||62||
59777502|NCT00454987|75897899|FG002|STARTED|Year 4 (NCT00454987)||0||
59777503|NCT00454987|75897897|FG000|COMPLETED|Year 4 (NCT00454987)||206||
59777504|NCT00454987|75897898|FG001|COMPLETED|Year 4 (NCT00454987)||62||
59777505|NCT00454987|75897899|FG002|COMPLETED|Year 4 (NCT00454987)||0||
59777506|NCT00454987|75897897|FG000|NOT COMPLETED|Year 4 (NCT00454987)||0||
59777507|NCT00454987|75897898|FG001|NOT COMPLETED|Year 4 (NCT00454987)||0||
59777508|NCT00454987|75897899|FG002|NOT COMPLETED|Year 4 (NCT00454987)||0||
59777509|NCT00724893|75897910|FG000|STARTED|Overall Study||1302||
59952933|NCT04678284|76071728|FG000|NOT COMPLETED|Overall Study||0||
59952934|NCT04602546|76071737|FG000|STARTED|Overall Study||33||
59777510|NCT00724893|75897911|FG001|STARTED|Overall Study||1128||
59777511|NCT00724893|75897910|FG000|COMPLETED|Overall Study||938||
59777512|NCT00724893|75897911|FG001|COMPLETED|Overall Study||670||
59777513|NCT00724893|75897910|FG000|NOT COMPLETED|Overall Study||364||
59777514|NCT00724893|75897911|FG001|NOT COMPLETED|Overall Study||458||
59952935|NCT04602546|76071738|FG001|STARTED|Overall Study||29||
59777515|NCT00789698|75897936|FG000|STARTED|Overall Study||72||
59777516|NCT00789698|75897937|FG001|STARTED|Overall Study||79||
59777517|NCT00789698|75897938|FG002|STARTED|Overall Study||56||
59777518|NCT00789698|75897939|FG003|STARTED|Overall Study||85||
59777519|NCT00789698|75897936|FG000|COMPLETED|Overall Study||32||
59777520|NCT00789698|75897937|FG001|COMPLETED|Overall Study||46||
59777521|NCT00789698|75897938|FG002|COMPLETED|Overall Study||29||
59777522|NCT00789698|75897939|FG003|COMPLETED|Overall Study||33||
59777523|NCT00789698|75897936|FG000|NOT COMPLETED|Overall Study||40||
59777524|NCT00789698|75897937|FG001|NOT COMPLETED|Overall Study||33||
59777525|NCT00789698|75897938|FG002|NOT COMPLETED|Overall Study||27||
59952936|NCT04602546|76071739|FG002|STARTED|Overall Study||32||
59952937|NCT04602546|76071740|FG003|STARTED|Overall Study||35||
59952938|NCT04602546|76071741|FG004|STARTED|Overall Study||33||
59952939|NCT04602546|76071737|FG000|COMPLETED|Overall Study||29||
59952940|NCT04602546|76071738|FG001|COMPLETED|Overall Study||27||
59777526|NCT00789698|75897939|FG003|NOT COMPLETED|Overall Study||52||
59777527|NCT00724815|75897950|FG000|STARTED|Overall Study|subjects randomized|265||
59777528|NCT00724815|75897951|FG001|STARTED|Overall Study|subjects randomized|265||
59777529|NCT00724815|75897950|FG000|COMPLETED|Overall Study||222||
59777530|NCT00724815|75897951|FG001|COMPLETED|Overall Study||226||
59777531|NCT00724815|75897950|FG000|NOT COMPLETED|Overall Study||43||
59777532|NCT00724815|75897951|FG001|NOT COMPLETED|Overall Study||39||
59777533|NCT00454909|75897960|FG000|STARTED|Overall Study||587||
59777534|NCT00454909|75897961|FG001|STARTED|Overall Study||197||
59777535|NCT00454909|75897962|FG002|STARTED|Overall Study||88||
59777536|NCT00454909|75897960|FG000|COMPLETED|Overall Study||580||
59777537|NCT00454909|75897961|FG001|COMPLETED|Overall Study||194||
59777538|NCT00454909|75897962|FG002|COMPLETED|Overall Study||86||
59777539|NCT00454909|75897960|FG000|NOT COMPLETED|Overall Study||7||
59777540|NCT00454909|75897961|FG001|NOT COMPLETED|Overall Study||3||
59777541|NCT00454909|75897962|FG002|NOT COMPLETED|Overall Study||2||
59777542|NCT00798590|75897973|FG000|STARTED|Overall Study||11||
59777543|NCT00798590|75897974|FG001|STARTED|Overall Study||8||
59777544|NCT00798590|75897973|FG000|COMPLETED|Overall Study||0||
59777545|NCT00798590|75897974|FG001|COMPLETED|Overall Study||0||
59777546|NCT00798590|75897973|FG000|NOT COMPLETED|Overall Study||11||
59777547|NCT00798590|75897974|FG001|NOT COMPLETED|Overall Study||8||
59777548|NCT00481195|75897982|FG000|STARTED|Overall Study|Two of these subjects were randomized but never received study medication.|128||
59777549|NCT00481195|75897983|FG001|STARTED|Overall Study|Four of these subjects were randomized but never received study medication.|129||
59777550|NCT00481195|75897982|FG000|COMPLETED|Overall Study||89||
59777551|NCT00481195|75897983|FG001|COMPLETED|Overall Study||90||
59777552|NCT00481195|75897982|FG000|NOT COMPLETED|Overall Study||39||
59777553|NCT00481195|75897983|FG001|NOT COMPLETED|Overall Study||39||
59777554|NCT03604549|75897991|FG000|STARTED|Overall Study||29||
59777555|NCT03604549|75897992|FG001|STARTED|Overall Study||29||
59777556|NCT03604549|75897991|FG000|COMPLETED|Overall Study||24||
59777557|NCT03604549|75897992|FG001|COMPLETED|Overall Study||24||
59777558|NCT03604549|75897991|FG000|NOT COMPLETED|Overall Study||5||
59777559|NCT03604549|75897992|FG001|NOT COMPLETED|Overall Study||5||
59777560|NCT00454363|75898000|FG000|STARTED|Overall Study||20||
59777561|NCT00454363|75898001|FG001|STARTED|Overall Study||31||
59777562|NCT00454363|75898000|FG000|COMPLETED|Overall Study||15||
59777563|NCT00454363|75898001|FG001|COMPLETED|Overall Study||29||
59777564|NCT00454363|75898000|FG000|NOT COMPLETED|Overall Study||5||
59777565|NCT00454363|75898001|FG001|NOT COMPLETED|Overall Study||2||
59777566|NCT00454207|75898008|FG000|STARTED|Overall Study||21||
59777567|NCT00454207|75898009|FG001|STARTED|Overall Study||23||
59777568|NCT00454207|75898008|FG000|COMPLETED|Overall Study|19 participants completed Part I period. 17 of 19 participants continued from part I into Part II.|17||
59777569|NCT00454207|75898009|FG001|COMPLETED|Overall Study||21||
59777570|NCT00454207|75898008|FG000|NOT COMPLETED|Overall Study||4||
59777571|NCT00454207|75898009|FG001|NOT COMPLETED|Overall Study||2||
59777572|NCT00738894|75898029|FG000|STARTED|Overall Study||441||
59777573|NCT00738894|75898030|FG001|STARTED|Overall Study||223||
59777574|NCT00738894|75898029|FG000|COMPLETED|Overall Study||402||
59777575|NCT00738894|75898030|FG001|COMPLETED|Overall Study||190||
59777576|NCT00738894|75898029|FG000|NOT COMPLETED|Overall Study||39||
59777577|NCT00738894|75898030|FG001|NOT COMPLETED|Overall Study||33||
59777578|NCT00480493|75898038|FG000|STARTED|Overall Study||32||
59777579|NCT00480493|75898039|FG001|STARTED|Overall Study||28||
59777580|NCT00480493|75898038|FG000|Randomized|Overall Study||32||
59777581|NCT00480493|75898039|FG001|Randomized|Overall Study||28||
59777582|NCT00480493|75898038|FG000|COMPLETED|Overall Study||30||
59777583|NCT00480493|75898039|FG001|COMPLETED|Overall Study||21||
59777584|NCT00480493|75898038|FG000|NOT COMPLETED|Overall Study||2||
59777585|NCT00480493|75898039|FG001|NOT COMPLETED|Overall Study||7||
59777586|NCT00734994|75898047|FG000|STARTED|Overall Study||15||
59777587|NCT00734994|75898047|FG000|COMPLETED|Overall Study||14||
59777588|NCT00734994|75898047|FG000|NOT COMPLETED|Overall Study||1||
59777589|NCT00798434|75898054|FG000|STARTED|Double-Blind||396||
59777590|NCT00798434|75898055|FG001|STARTED|Double-Blind||398||
59777591|NCT00798434|75898054|FG000|Received Treatment|Double-Blind||393||
59777592|NCT00798434|75898055|FG001|Received Treatment|Double-Blind||392||
59777593|NCT00798434|75898054|FG000|COMPLETED|Double-Blind||341||
59777594|NCT00798434|75898055|FG001|COMPLETED|Double-Blind||314||
59777595|NCT00798434|75898054|FG000|NOT COMPLETED|Double-Blind||55||
59777596|NCT00798434|75898055|FG001|NOT COMPLETED|Double-Blind||84||
59777597|NCT00798434|75898054|FG000|STARTED|Open-Label||341||
59777598|NCT00798434|75898055|FG001|STARTED|Open-Label||314||
59777599|NCT00798434|75898054|FG000|Received Treatment|Open-Label||341||
59777600|NCT00798434|75898055|FG001|Received Treatment|Open-Label||313||
59777601|NCT00798434|75898054|FG000|COMPLETED|Open-Label||299||
59777602|NCT00798434|75898055|FG001|COMPLETED|Open-Label||282||
59777603|NCT00798434|75898054|FG000|NOT COMPLETED|Open-Label||42||
59777604|NCT00798434|75898055|FG001|NOT COMPLETED|Open-Label||32||
59777605|NCT00724503|75898068|FG000|STARTED|Overall Study||267||
59777606|NCT00724503|75898069|FG001|STARTED|Overall Study||263||
59777607|NCT00724503|75898068|FG000|COMPLETED|Overall Study||57||
59777608|NCT00724503|75898069|FG001|COMPLETED|Overall Study||43||
59777609|NCT00724503|75898068|FG000|NOT COMPLETED|Overall Study||210||
59777610|NCT00724503|75898069|FG001|NOT COMPLETED|Overall Study||220||
59777611|NCT00791648|75898079|FG000|STARTED|Overall Study||308||
59777612|NCT00791648|75898080|FG001|STARTED|Overall Study||309||
59777613|NCT00791648|75898079|FG000|COMPLETED|Overall Study||308||
59777614|NCT00791648|75898080|FG001|COMPLETED|Overall Study||307||
59777615|NCT00791648|75898079|FG000|NOT COMPLETED|Overall Study||0||
59777616|NCT00791648|75898080|FG001|NOT COMPLETED|Overall Study||2||
59777617|NCT00791492|75898088|FG000|STARTED|Overall Study||45||
59777618|NCT00791492|75898089|FG001|STARTED|Overall Study||41||
59777619|NCT00791492|75898088|FG000|TREATED|Overall Study||44||
59777620|NCT00791492|75898089|FG001|TREATED|Overall Study||41||
59777621|NCT00791492|75898088|FG000|COMPLETED|Overall Study||39||
59777622|NCT00791492|75898089|FG001|COMPLETED|Overall Study||38||
59777623|NCT00791492|75898088|FG000|NOT COMPLETED|Overall Study||6||
59777624|NCT00791492|75898089|FG001|NOT COMPLETED|Overall Study||3||
59777625|NCT00723957|75898097|FG000|STARTED|Overall Study|Randomized|98||
59777626|NCT00723957|75898098|FG001|STARTED|Overall Study|Randomized|99||
59777627|NCT00723957|75898097|FG000|COMPLETED|Overall Study|Completed 6 cycles of study drug (maximum per protocol)|47||
59777628|NCT00723957|75898098|FG001|COMPLETED|Overall Study|Completed 6 cycles of study drug (maximum per protocol)|46||
59777629|NCT00723957|75898097|FG000|NOT COMPLETED|Overall Study||51||
59777630|NCT00723957|75898098|FG001|NOT COMPLETED|Overall Study||53||
59777631|NCT00723801|75898106|FG000|STARTED|Overall Study||20||
59777632|NCT00723801|75898107|FG001|STARTED|Overall Study||20||
59777633|NCT00723801|75898106|FG000|COMPLETED|Overall Study||17||
59777634|NCT00723801|75898107|FG001|COMPLETED|Overall Study||17||
59777635|NCT00723801|75898106|FG000|NOT COMPLETED|Overall Study||3||
59777636|NCT00723801|75898107|FG001|NOT COMPLETED|Overall Study||3||
59777637|NCT00797966|75898117|FG000|STARTED|Phase A||0||
59777638|NCT00797966|75898118|FG001|STARTED|Phase A||0||
59777639|NCT00797966|75898119|FG002|STARTED|Phase A||0||
59777640|NCT00797966|75898120|FG003|STARTED|Phase A||0||
59777641|NCT00797966|75898121|FG004|STARTED|Phase A|850 participants entered Phase A; 849 participants were treated.|849||
59777642|NCT00797966|75898122|FG005|STARTED|Phase A||0||
59777643|NCT00797966|75898117|FG000|COMPLETED|Phase A||0||
59777644|NCT00797966|75898118|FG001|COMPLETED|Phase A||0||
59777645|NCT00797966|75898119|FG002|COMPLETED|Phase A||0||
59777646|NCT00797966|75898120|FG003|COMPLETED|Phase A||0||
59777647|NCT00797966|75898121|FG004|COMPLETED|Phase A||664||
59777648|NCT00797966|75898122|FG005|COMPLETED|Phase A||0||
59777649|NCT00797966|75898117|FG000|NOT COMPLETED|Phase A||0||
59777650|NCT00797966|75898118|FG001|NOT COMPLETED|Phase A||0||
59777651|NCT00797966|75898119|FG002|NOT COMPLETED|Phase A||0||
59777652|NCT00797966|75898120|FG003|NOT COMPLETED|Phase A||0||
59777653|NCT00797966|75898121|FG004|NOT COMPLETED|Phase A||185||
59777654|NCT00797966|75898122|FG005|NOT COMPLETED|Phase A||0||
59777655|NCT00797966|75898117|FG000|STARTED|Phase B|Randomized participants.|62||
59777656|NCT00797966|75898118|FG001|STARTED|Phase B|Randomized participants.|120||
59777657|NCT00797966|75898119|FG002|STARTED|Phase B|Randomized participants.|121||
59777658|NCT00797966|75898120|FG003|STARTED|Phase B|Randomized participants.|126||
59777659|NCT00797966|75898121|FG004|STARTED|Phase B||0||
59777660|NCT00797966|75898122|FG005|STARTED|Phase B||0||
59777661|NCT00797966|75898117|FG000|COMPLETED|Phase B||51||
60072880|NCT03158740|76188075|FG000|COMPLETED|Overall Study||11||
60072881|NCT03158740|76188076|FG001|COMPLETED|Overall Study||7||
60072882|NCT03158740|76188075|FG000|NOT COMPLETED|Overall Study||4||
60072883|NCT03158740|76188076|FG001|NOT COMPLETED|Overall Study||1||
59777662|NCT00797966|75898118|FG001|COMPLETED|Phase B||102||
59777663|NCT00797966|75898119|FG002|COMPLETED|Phase B||100||
59777664|NCT00797966|75898120|FG003|COMPLETED|Phase B||110||
59777665|NCT00797966|75898121|FG004|COMPLETED|Phase B||0||
59777666|NCT00797966|75898122|FG005|COMPLETED|Phase B||0||
59777667|NCT00797966|75898117|FG000|NOT COMPLETED|Phase B||11||
59777668|NCT00797966|75898118|FG001|NOT COMPLETED|Phase B||18||
59777669|NCT00797966|75898119|FG002|NOT COMPLETED|Phase B||21||
59777670|NCT00797966|75898120|FG003|NOT COMPLETED|Phase B||16||
59777671|NCT00797966|75898121|FG004|NOT COMPLETED|Phase B||0||
59777672|NCT00797966|75898122|FG005|NOT COMPLETED|Phase B||0||
59777673|NCT00797966|75898117|FG000|STARTED|Phase A+||0||
59777674|NCT00797966|75898118|FG001|STARTED|Phase A+||0||
59777675|NCT00797966|75898119|FG002|STARTED|Phase A+||0||
59777676|NCT00797966|75898120|FG003|STARTED|Phase A+||0||
59777677|NCT00797966|75898121|FG004|STARTED|Phase A+||0||
59777678|NCT00797966|75898122|FG005|STARTED|Phase A+||235||
59777679|NCT00797966|75898117|FG000|COMPLETED|Phase A+||0||
59777680|NCT00797966|75898118|FG001|COMPLETED|Phase A+||0||
59777681|NCT00797966|75898119|FG002|COMPLETED|Phase A+||0||
59777682|NCT00797966|75898120|FG003|COMPLETED|Phase A+||0||
59777683|NCT00797966|75898121|FG004|COMPLETED|Phase A+||0||
59777684|NCT00797966|75898122|FG005|COMPLETED|Phase A+||207||
59777685|NCT00797966|75898117|FG000|NOT COMPLETED|Phase A+||0||
59777686|NCT00797966|75898118|FG001|NOT COMPLETED|Phase A+||0||
59777687|NCT00797966|75898119|FG002|NOT COMPLETED|Phase A+||0||
60072884|NCT01696695|76188082|FG000|STARTED|Overall Study||882||
60072885|NCT01696695|76188082|FG000|COMPLETED|Overall Study||0||
60072886|NCT01696695|76188082|FG000|NOT COMPLETED|Overall Study||882||
60072887|NCT03861988|76188089|FG000|STARTED|Overall Study||5||
59777688|NCT00797966|75898120|FG003|NOT COMPLETED|Phase A+||0||
59777689|NCT00797966|75898121|FG004|NOT COMPLETED|Phase A+||0||
59777690|NCT00797966|75898122|FG005|NOT COMPLETED|Phase A+||28||
59777691|NCT00723489|75898138|FG000|STARTED|Overall Study||21||
59777692|NCT00723489|75898139|FG001|STARTED|Overall Study||19||
59777693|NCT00723489|75898140|FG002|STARTED|Overall Study||19||
59777694|NCT00723489|75898141|FG003|STARTED|Overall Study||23||
59777695|NCT00723489|75898138|FG000|COMPLETED|Overall Study|Includes seroconverters and non-seroconverters|20||
59777696|NCT00723489|75898139|FG001|COMPLETED|Overall Study|Includes seroconverters and non-seroconverters|15||
59777697|NCT00723489|75898140|FG002|COMPLETED|Overall Study|Includes seroconverters and non-seroconverters|19||
59777698|NCT00723489|75898141|FG003|COMPLETED|Overall Study|Includes seroconverters and non-seroconverters|20||
59777699|NCT00723489|75898138|FG000|NOT COMPLETED|Overall Study||1||
59777700|NCT00723489|75898139|FG001|NOT COMPLETED|Overall Study||4||
59777701|NCT00723489|75898140|FG002|NOT COMPLETED|Overall Study||0||
59777702|NCT00723489|75898141|FG003|NOT COMPLETED|Overall Study||3||
59777703|NCT00587990|75898154|FG000|STARTED|Overall Study||2||
59777704|NCT00587990|75898155|FG001|STARTED|Overall Study||4||
59777705|NCT00587990|75898156|FG002|STARTED|Overall Study||3||
59777706|NCT00587990|75898154|FG000|COMPLETED|Overall Study||2||
59777707|NCT00587990|75898155|FG001|COMPLETED|Overall Study||4||
59777708|NCT00587990|75898156|FG002|COMPLETED|Overall Study||2||
59777709|NCT00587990|75898154|FG000|NOT COMPLETED|Overall Study||0||
59777710|NCT00587990|75898155|FG001|NOT COMPLETED|Overall Study||0||
59777711|NCT00587990|75898156|FG002|NOT COMPLETED|Overall Study||1||
59777712|NCT00723255|75898164|FG000|STARTED|Overall Study||53||
59777713|NCT00723255|75898164|FG000|COMPLETED|Overall Study|Eligible and treated patients|49||
59777714|NCT00723255|75898164|FG000|NOT COMPLETED|Overall Study||4||
59777715|NCT00791258|75898180|FG000|STARTED|Overall Study||999||
59777716|NCT00791258|75898180|FG000|COMPLETED|Overall Study||736||
59952941|NCT04602546|76071739|FG002|COMPLETED|Overall Study||29||
59952942|NCT04602546|76071740|FG003|COMPLETED|Overall Study||28||
60072888|NCT03861988|76188090|FG001|STARTED|Overall Study||20||
60072889|NCT03861988|76188091|FG002|STARTED|Overall Study||20||
59522137|NCT02563548|75616461|FG005|NOT COMPLETED|Dose Expansion (Up to 60 Weeks)||17||
59522138|NCT04081324|75616485|FG000|STARTED|Overall Study||6||
59522139|NCT04081324|75616486|FG001|STARTED|Overall Study||10||
59522140|NCT04081324|75616487|FG002|STARTED|Overall Study||10||
59522141|NCT04081324|75616488|FG003|STARTED|Overall Study||10||
59522142|NCT04081324|75616485|FG000|Received At Least One Dose of Study Drug|Overall Study||6||
59522143|NCT04081324|75616486|FG001|Received At Least One Dose of Study Drug|Overall Study||10||
59522144|NCT04081324|75616487|FG002|Received At Least One Dose of Study Drug|Overall Study||10||
59522145|NCT04081324|75616488|FG003|Received At Least One Dose of Study Drug|Overall Study||10||
59522146|NCT04081324|75616485|FG000|COMPLETED|Overall Study||6||
59522147|NCT04081324|75616486|FG001|COMPLETED|Overall Study||10||
59522148|NCT04081324|75616487|FG002|COMPLETED|Overall Study||10||
59522149|NCT04081324|75616488|FG003|COMPLETED|Overall Study||10||
59522150|NCT04081324|75616485|FG000|NOT COMPLETED|Overall Study||0||
59522151|NCT04081324|75616486|FG001|NOT COMPLETED|Overall Study||0||
59522152|NCT04081324|75616487|FG002|NOT COMPLETED|Overall Study||0||
59522153|NCT04081324|75616488|FG003|NOT COMPLETED|Overall Study||0||
59522154|NCT04042324|75616497|FG000|STARTED|UFH and Triferic Admixture (Day 1)||12||
59522155|NCT04042324|75616498|FG001|STARTED|UFH and Triferic Admixture (Day 1)||0||
59777717|NCT00791258|75898180|FG000|NOT COMPLETED|Overall Study||263||
59777718|NCT00808067|75898186|FG000|STARTED|Overall Study|Number of patients which are treated.|2927||
59952943|NCT04602546|76071741|FG004|COMPLETED|Overall Study||30||
59777719|NCT00808067|75898187|FG001|STARTED|Overall Study|Number of patients which are treated.|2956||
59777720|NCT00808067|75898186|FG000|COMPLETED|Overall Study||2446||
59777721|NCT00808067|75898187|FG001|COMPLETED|Overall Study||2438||
59952944|NCT04602546|76071737|FG000|NOT COMPLETED|Overall Study||4||
59952945|NCT04602546|76071738|FG001|NOT COMPLETED|Overall Study||2||
59952946|NCT04602546|76071739|FG002|NOT COMPLETED|Overall Study||3||
59952947|NCT04602546|76071740|FG003|NOT COMPLETED|Overall Study||7||
59952948|NCT04602546|76071741|FG004|NOT COMPLETED|Overall Study||3||
59952949|NCT04495868|76071755|FG000|STARTED|Overall Study||19||
59952950|NCT04495868|76071756|FG001|STARTED|Overall Study||21||
59952951|NCT04495868|76071755|FG000|COMPLETED|Overall Study||19||
60072890|NCT03861988|76188089|FG000|COMPLETED|Overall Study||5||
60072891|NCT03861988|76188090|FG001|COMPLETED|Overall Study||19||
60072892|NCT03861988|76188091|FG002|COMPLETED|Overall Study||19||
59522156|NCT04042324|75616499|FG002|STARTED|UFH and Triferic Admixture (Day 1)||0||
59522157|NCT04042324|75616497|FG000|COMPLETED|UFH and Triferic Admixture (Day 1)||12||
59522158|NCT04042324|75616498|FG001|COMPLETED|UFH and Triferic Admixture (Day 1)||0||
59952952|NCT04495868|76071756|FG001|COMPLETED|Overall Study||21||
59952953|NCT04495868|76071755|FG000|NOT COMPLETED|Overall Study||0||
59952954|NCT04495868|76071756|FG001|NOT COMPLETED|Overall Study||0||
60072893|NCT03861988|76188089|FG000|NOT COMPLETED|Overall Study||0||
59522159|NCT04042324|75616499|FG002|COMPLETED|UFH and Triferic Admixture (Day 1)||0||
60072894|NCT03861988|76188090|FG001|NOT COMPLETED|Overall Study||1||
60072895|NCT03861988|76188091|FG002|NOT COMPLETED|Overall Study||1||
60072896|NCT03860974|76188101|FG000|STARTED|Overall Study||49||
59618735|NCT00634634|75729862|FG002|STARTED|Overall Study||9||
59618736|NCT00634634|75729863|FG003|STARTED|Overall Study||39||
59618737|NCT00634634|75729860|FG000|COMPLETED|Overall Study||1||
59618738|NCT00634634|75729861|FG001|COMPLETED|Overall Study||3||
59618739|NCT00634634|75729862|FG002|COMPLETED|Overall Study||9||
59618740|NCT00634634|75729863|FG003|COMPLETED|Overall Study||39||
59618741|NCT00634634|75729860|FG000|NOT COMPLETED|Overall Study||0||
59618742|NCT00634634|75729861|FG001|NOT COMPLETED|Overall Study||0||
59618743|NCT00634634|75729862|FG002|NOT COMPLETED|Overall Study||0||
59618744|NCT00634634|75729863|FG003|NOT COMPLETED|Overall Study||0||
59618745|NCT03570918|75729882|FG000|STARTED|Period 1||1||
59618746|NCT03570918|75729883|FG001|STARTED|Period 1||1||
59777722|NCT00808067|75898186|FG000|NOT COMPLETED|Overall Study||481||
59777723|NCT00808067|75898187|FG001|NOT COMPLETED|Overall Study||518||
59777724|NCT00723021|75898193|FG000|STARTED|Intervention Period 1||3||
59777725|NCT00723021|75898194|FG001|STARTED|Intervention Period 1||3||
59777726|NCT00723021|75898195|FG002|STARTED|Intervention Period 1||3||
59777727|NCT00723021|75898196|FG003|STARTED|Intervention Period 1||3||
59777728|NCT00723021|75898197|FG004|STARTED|Intervention Period 1||3||
59777729|NCT00723021|75898193|FG000|COMPLETED|Intervention Period 1||3||
59777730|NCT00723021|75898194|FG001|COMPLETED|Intervention Period 1||3||
59777731|NCT00723021|75898195|FG002|COMPLETED|Intervention Period 1||3||
59777732|NCT00723021|75898196|FG003|COMPLETED|Intervention Period 1||3||
59777733|NCT00723021|75898197|FG004|COMPLETED|Intervention Period 1||3||
59777734|NCT00723021|75898193|FG000|NOT COMPLETED|Intervention Period 1||0||
59777735|NCT00723021|75898194|FG001|NOT COMPLETED|Intervention Period 1||0||
59777736|NCT00723021|75898195|FG002|NOT COMPLETED|Intervention Period 1||0||
59777737|NCT00723021|75898196|FG003|NOT COMPLETED|Intervention Period 1||0||
59777738|NCT00723021|75898197|FG004|NOT COMPLETED|Intervention Period 1||0||
59777739|NCT00723021|75898193|FG000|STARTED|Intervention Period 2||3||
59777740|NCT00723021|75898194|FG001|STARTED|Intervention Period 2||3||
59777741|NCT00723021|75898195|FG002|STARTED|Intervention Period 2||3||
59777742|NCT00723021|75898196|FG003|STARTED|Intervention Period 2||3||
59777743|NCT00723021|75898197|FG004|STARTED|Intervention Period 2||3||
59777744|NCT00723021|75898193|FG000|COMPLETED|Intervention Period 2||3||
59777745|NCT00723021|75898194|FG001|COMPLETED|Intervention Period 2||3||
59777746|NCT00723021|75898195|FG002|COMPLETED|Intervention Period 2||3||
59777747|NCT00723021|75898196|FG003|COMPLETED|Intervention Period 2||3||
60072897|NCT03860974|76188102|FG001|STARTED|Overall Study||51||
60072898|NCT03860974|76188101|FG000|COMPLETED|Overall Study||49||
60072899|NCT03860974|76188102|FG001|COMPLETED|Overall Study||51||
60072900|NCT03860974|76188101|FG000|NOT COMPLETED|Overall Study||0||
60072901|NCT03860974|76188102|FG001|NOT COMPLETED|Overall Study||0||
60072902|NCT01565889|76188114|FG000|STARTED|Part A||12||
60072903|NCT01565889|76188115|FG001|STARTED|Part A||4||
60072904|NCT01565889|76188116|FG002|STARTED|Part A||8||
60072905|NCT01565889|76188117|FG003|STARTED|Part A||7||
60072906|NCT01565889|76188118|FG004|STARTED|Part A||7||
60072907|NCT01565889|76188119|FG005|STARTED|Part A||0||
60072908|NCT01565889|76188114|FG000|COMPLETED|Part A|3 participants from this group continued in the Part B: SOF+PEG+RBV group.|11||
60072909|NCT01565889|76188115|FG001|COMPLETED|Part A|No participants from this group continued in the Part B: SOF+PEG+RBV group.|4||
60072910|NCT01565889|76188116|FG002|COMPLETED|Part A|3 participants from this group continued in the Part B: SOF+PEG+RBV group.|8||
60072911|NCT01565889|76188117|FG003|COMPLETED|Part A|2 participants from this group continued in the Part B: SOF+PEG+RBV group.|7||
60072912|NCT01565889|76188118|FG004|COMPLETED|Part A|1 participant from this group continued in the Part B: SOF+PEG+RBV group.|7||
60072913|NCT01565889|76188119|FG005|COMPLETED|Part A||0||
60072914|NCT01565889|76188114|FG000|NOT COMPLETED|Part A||1||
60072915|NCT01565889|76188115|FG001|NOT COMPLETED|Part A||0||
60072916|NCT01565889|76188116|FG002|NOT COMPLETED|Part A||0||
60072917|NCT01565889|76188117|FG003|NOT COMPLETED|Part A||0||
60072918|NCT01565889|76188118|FG004|NOT COMPLETED|Part A||0||
60072919|NCT01565889|76188119|FG005|NOT COMPLETED|Part A||0||
60072920|NCT01565889|76188114|FG000|STARTED|Part B||0||
60072921|NCT01565889|76188115|FG001|STARTED|Part B||0||
60072922|NCT01565889|76188116|FG002|STARTED|Part B||0||
59777748|NCT00723021|75898197|FG004|COMPLETED|Intervention Period 2||3||
59777749|NCT00723021|75898193|FG000|NOT COMPLETED|Intervention Period 2||0||
59777750|NCT00723021|75898194|FG001|NOT COMPLETED|Intervention Period 2||0||
60072923|NCT01565889|76188117|FG003|STARTED|Part B||0||
60072924|NCT01565889|76188118|FG004|STARTED|Part B||0||
59777751|NCT00723021|75898195|FG002|NOT COMPLETED|Intervention Period 2||0||
59777752|NCT00723021|75898196|FG003|NOT COMPLETED|Intervention Period 2||0||
59777753|NCT00723021|75898197|FG004|NOT COMPLETED|Intervention Period 2||0||
59777754|NCT00723021|75898193|FG000|STARTED|Intervention Period 3||3||
59777755|NCT00723021|75898194|FG001|STARTED|Intervention Period 3||3||
59777756|NCT00723021|75898195|FG002|STARTED|Intervention Period 3||3||
60072925|NCT01565889|76188119|FG005|STARTED|Part B|9 participants in this group transferred from a Part A cohort, and 14 participants joined the study.|23||
60072926|NCT01565889|76188114|FG000|COMPLETED|Part B||0||
60072927|NCT01565889|76188115|FG001|COMPLETED|Part B||0||
60072928|NCT01565889|76188116|FG002|COMPLETED|Part B||0||
59777757|NCT00723021|75898196|FG003|STARTED|Intervention Period 3||3||
59777758|NCT00723021|75898197|FG004|STARTED|Intervention Period 3||3||
59777759|NCT00723021|75898193|FG000|COMPLETED|Intervention Period 3||3||
59777760|NCT00723021|75898194|FG001|COMPLETED|Intervention Period 3||3||
59777761|NCT00723021|75898195|FG002|COMPLETED|Intervention Period 3||3||
59777762|NCT00723021|75898196|FG003|COMPLETED|Intervention Period 3||3||
59777763|NCT00723021|75898197|FG004|COMPLETED|Intervention Period 3||3||
59777764|NCT00723021|75898193|FG000|NOT COMPLETED|Intervention Period 3||0||
59777765|NCT00723021|75898194|FG001|NOT COMPLETED|Intervention Period 3||0||
59777766|NCT00723021|75898195|FG002|NOT COMPLETED|Intervention Period 3||0||
59777767|NCT00723021|75898196|FG003|NOT COMPLETED|Intervention Period 3||0||
59777768|NCT00723021|75898197|FG004|NOT COMPLETED|Intervention Period 3||0||
59777769|NCT00723021|75898193|FG000|STARTED|Intervention Period 4||3||
59777770|NCT00723021|75898194|FG001|STARTED|Intervention Period 4||3||
59777771|NCT00723021|75898195|FG002|STARTED|Intervention Period 4||3||
59777772|NCT00723021|75898196|FG003|STARTED|Intervention Period 4||3||
59777773|NCT00723021|75898197|FG004|STARTED|Intervention Period 4||3||
59777774|NCT00723021|75898193|FG000|COMPLETED|Intervention Period 4||3||
59777775|NCT00723021|75898194|FG001|COMPLETED|Intervention Period 4||3||
59777776|NCT00723021|75898195|FG002|COMPLETED|Intervention Period 4||3||
59777777|NCT00723021|75898196|FG003|COMPLETED|Intervention Period 4||3||
59777778|NCT00723021|75898197|FG004|COMPLETED|Intervention Period 4||2||
59777779|NCT00723021|75898193|FG000|NOT COMPLETED|Intervention Period 4||0||
59777780|NCT00723021|75898194|FG001|NOT COMPLETED|Intervention Period 4||0||
59777781|NCT00723021|75898195|FG002|NOT COMPLETED|Intervention Period 4||0||
59777782|NCT00723021|75898196|FG003|NOT COMPLETED|Intervention Period 4||0||
59777783|NCT00723021|75898197|FG004|NOT COMPLETED|Intervention Period 4||1||
59777784|NCT00723021|75898193|FG000|STARTED|Intervention Period 5||3||
59777785|NCT00723021|75898194|FG001|STARTED|Intervention Period 5||3||
59777786|NCT00723021|75898195|FG002|STARTED|Intervention Period 5||3||
59777787|NCT00723021|75898196|FG003|STARTED|Intervention Period 5||3||
59777788|NCT00723021|75898197|FG004|STARTED|Intervention Period 5||2||
59777789|NCT00723021|75898193|FG000|COMPLETED|Intervention Period 5||3||
59777790|NCT00723021|75898194|FG001|COMPLETED|Intervention Period 5||3||
59777791|NCT00723021|75898195|FG002|COMPLETED|Intervention Period 5||3||
59777792|NCT00723021|75898196|FG003|COMPLETED|Intervention Period 5||3||
59777793|NCT00723021|75898197|FG004|COMPLETED|Intervention Period 5||2||
59777794|NCT00723021|75898193|FG000|NOT COMPLETED|Intervention Period 5||0||
59777795|NCT00723021|75898194|FG001|NOT COMPLETED|Intervention Period 5||0||
59777796|NCT00723021|75898195|FG002|NOT COMPLETED|Intervention Period 5||0||
59777797|NCT00723021|75898196|FG003|NOT COMPLETED|Intervention Period 5||0||
59777798|NCT00723021|75898197|FG004|NOT COMPLETED|Intervention Period 5||0||
59777799|NCT00721227|75898218|FG000|STARTED|Overall Study||9||
59777800|NCT00721227|75898219|FG001|STARTED|Overall Study||6||
59777801|NCT00721227|75898218|FG000|COMPLETED|Overall Study|3 subjects lost to follow up; 1 subject did not complete due to noncompliance of scheduled visits.|5||
59777802|NCT00721227|75898219|FG001|COMPLETED|Overall Study||6||
59777803|NCT00721227|75898218|FG000|NOT COMPLETED|Overall Study||4||
59777804|NCT00721227|75898219|FG001|NOT COMPLETED|Overall Study||0||
59777805|NCT00807599|75898227|FG000|STARTED|Overall Study||26||
59777806|NCT00807599|75898228|FG001|STARTED|Overall Study||24||
59777807|NCT00807599|75898229|FG002|STARTED|Overall Study||17||
59777808|NCT00807599|75898227|FG000|COMPLETED|Overall Study||26||
59777809|NCT00807599|75898228|FG001|COMPLETED|Overall Study||24||
59777810|NCT00807599|75898229|FG002|COMPLETED|Overall Study||0||
59777811|NCT00807599|75898227|FG000|NOT COMPLETED|Overall Study||0||
59777812|NCT00807599|75898228|FG001|NOT COMPLETED|Overall Study||0||
59777813|NCT00807599|75898229|FG002|NOT COMPLETED|Overall Study||17||
59777814|NCT00721149|75898235|FG000|STARTED|Overall Study|Enrollment was stopped after 10 subjects entered the trial.|10||
59777815|NCT00721149|75898235|FG000|COMPLETED|Overall Study||9||
59777816|NCT00721149|75898235|FG000|NOT COMPLETED|Overall Study||1||
59777817|NCT00788372|75898239|FG000|STARTED|Period 1 (up to 4 Weeks)||142||
59777818|NCT00788372|75898239|FG000|COMPLETED|Period 1 (up to 4 Weeks)||111||
59777819|NCT00788372|75898239|FG000|NOT COMPLETED|Period 1 (up to 4 Weeks)||31||
59952955|NCT04207333|76071762|FG000|STARTED|First Intervention (Single 1-Day Visit)||3||
59777820|NCT00788372|75898239|FG000|STARTED|Period 2 (Week 4 to Week 52)||111||
59777821|NCT00788372|75898239|FG000|COMPLETED|Period 2 (Week 4 to Week 52)||79||
59777822|NCT00788372|75898239|FG000|NOT COMPLETED|Period 2 (Week 4 to Week 52)||32||
59777823|NCT00738582|75898243|FG000|STARTED|Combination Therapy||89||
59777824|NCT00738582|75898244|FG001|STARTED|Combination Therapy||0||
59777825|NCT00738582|75898243|FG000|COMPLETED|Combination Therapy||56||
59777826|NCT00738582|75898244|FG001|COMPLETED|Combination Therapy||0||
59777827|NCT00738582|75898243|FG000|NOT COMPLETED|Combination Therapy||33||
59777828|NCT00738582|75898244|FG001|NOT COMPLETED|Combination Therapy||0||
59777829|NCT00738582|75898243|FG000|STARTED|Maintenance Therapy|This arm ended once all participants entered into the Maintenance Therapy phase of the study.|0||
59777830|NCT00738582|75898244|FG001|STARTED|Maintenance Therapy|Only eligible participants entered into this phase of the study.|56||
59777831|NCT00738582|75898243|FG000|COMPLETED|Maintenance Therapy||0||
59777832|NCT00738582|75898244|FG001|COMPLETED|Maintenance Therapy||0||
59777833|NCT00738582|75898243|FG000|NOT COMPLETED|Maintenance Therapy||0||
59777834|NCT00738582|75898244|FG001|NOT COMPLETED|Maintenance Therapy||56||
59777835|NCT00720759|75898255|FG000|STARTED|Overall Study||6||
59777836|NCT00720759|75898256|FG001|STARTED|Overall Study||6||
59777837|NCT00720759|75898257|FG002|STARTED|Overall Study||6||
59777838|NCT00720759|75898258|FG003|STARTED|Overall Study||6||
59777839|NCT00720759|75898255|FG000|COMPLETED|Overall Study||6||
59777840|NCT00720759|75898256|FG001|COMPLETED|Overall Study||5||
59777841|NCT00720759|75898257|FG002|COMPLETED|Overall Study||5||
59777842|NCT00720759|75898258|FG003|COMPLETED|Overall Study||6||
59777843|NCT00720759|75898255|FG000|NOT COMPLETED|Overall Study||0||
59777844|NCT00720759|75898256|FG001|NOT COMPLETED|Overall Study||1||
59777845|NCT00720759|75898257|FG002|NOT COMPLETED|Overall Study||1||
59777846|NCT00720759|75898258|FG003|NOT COMPLETED|Overall Study||0||
59777847|NCT00720213|75898268|FG000|STARTED|Screening Phase With Diagnostic PSG||44||
59777848|NCT00720213|75898269|FG001|STARTED|Screening Phase With Diagnostic PSG||0||
59777849|NCT00720213|75898270|FG002|STARTED|Screening Phase With Diagnostic PSG||0||
59777850|NCT00720213|75898268|FG000|COMPLETED|Screening Phase With Diagnostic PSG||37||
59777851|NCT00720213|75898269|FG001|COMPLETED|Screening Phase With Diagnostic PSG||0||
59777852|NCT00720213|75898270|FG002|COMPLETED|Screening Phase With Diagnostic PSG||0||
59777853|NCT00720213|75898268|FG000|NOT COMPLETED|Screening Phase With Diagnostic PSG||7||
59777854|NCT00720213|75898269|FG001|NOT COMPLETED|Screening Phase With Diagnostic PSG||0||
59777855|NCT00720213|75898270|FG002|NOT COMPLETED|Screening Phase With Diagnostic PSG||0||
59777856|NCT00720213|75898268|FG000|STARTED|Treatment Period||0||
59777857|NCT00720213|75898269|FG001|STARTED|Treatment Period||20||
59777858|NCT00720213|75898270|FG002|STARTED|Treatment Period||17||
59777859|NCT00720213|75898268|FG000|COMPLETED|Treatment Period||0||
59777860|NCT00720213|75898269|FG001|COMPLETED|Treatment Period||20||
59777861|NCT00720213|75898270|FG002|COMPLETED|Treatment Period||17||
59777862|NCT00720213|75898268|FG000|NOT COMPLETED|Treatment Period||0||
59777863|NCT00720213|75898269|FG001|NOT COMPLETED|Treatment Period||0||
59777864|NCT00720213|75898270|FG002|NOT COMPLETED|Treatment Period||0||
59777865|NCT00810407|75898278|FG000|STARTED|Overall Study||594||
59777866|NCT00810407|75898278|FG000|COMPLETED|Overall Study||588||
59777867|NCT00810407|75898278|FG000|NOT COMPLETED|Overall Study||6||
59777868|NCT00720057|75898284|FG000|STARTED|Overall Study||153||
59777869|NCT00720057|75898285|FG001|STARTED|Overall Study||159||
59777870|NCT00720057|75898284|FG000|COMPLETED|Overall Study||152||
59777871|NCT00720057|75898285|FG001|COMPLETED|Overall Study||156||
59777872|NCT00720057|75898284|FG000|NOT COMPLETED|Overall Study||1||
59777873|NCT00720057|75898285|FG001|NOT COMPLETED|Overall Study||3||
59777874|NCT00790868|75898293|FG000|STARTED|Overall Study||88|98 participants were deemed ineligible at baseline and 15 others were not randomized.|
59777875|NCT00790868|75898294|FG001|STARTED|Overall Study||92|98 participants were deemed ineligible at baseline and 15 others were not randomized.|
59777876|NCT00790868|75898293|FG000|COMPLETED|Overall Study||82|All randomized participants (n = 180) were included in data analysis.|
59777877|NCT00790868|75898294|FG001|COMPLETED|Overall Study||75|All randomized participants (n = 180) were included in data analysis.|
59777878|NCT00790868|75898293|FG000|NOT COMPLETED|Overall Study||6||
59777879|NCT00790868|75898294|FG001|NOT COMPLETED|Overall Study||17||
59777880|NCT00719901|75898302|FG000|STARTED|Overall Study||11||
59777881|NCT00719901|75898302|FG000|COMPLETED|Overall Study||0||
59777882|NCT00719901|75898302|FG000|NOT COMPLETED|Overall Study||11||
59777883|NCT00807365|75898306|FG000|STARTED|Overall Study||5||
59777884|NCT00807365|75898306|FG000|COMPLETED|Overall Study||0||
59777885|NCT00807365|75898306|FG000|NOT COMPLETED|Overall Study||5||
59777886|NCT00719355|75898312|FG000|STARTED|Overall Study||51||
59777887|NCT00719355|75898313|FG001|STARTED|Overall Study||52||
59777888|NCT00719355|75898312|FG000|Completed 6 Weeks|Overall Study||49||
59777889|NCT00719355|75898313|FG001|Completed 6 Weeks|Overall Study||48||
59777890|NCT00719355|75898312|FG000|Completed 12 Weeks|Overall Study||43||
59777891|NCT00719355|75898313|FG001|Completed 12 Weeks|Overall Study||46||
59777892|NCT00719355|75898312|FG000|Completed 24 Weeks|Overall Study||34||
59777893|NCT00719355|75898313|FG001|Completed 24 Weeks|Overall Study||43||
59777894|NCT00719355|75898312|FG000|Completed 32 Weeks|Overall Study||33||
59777895|NCT00719355|75898313|FG001|Completed 32 Weeks|Overall Study||39||
59777896|NCT00719355|75898312|FG000|COMPLETED|Overall Study||33||
60072929|NCT01565889|76188117|FG003|COMPLETED|Part B||0||
60072930|NCT01565889|76188118|FG004|COMPLETED|Part B||0||
60072931|NCT01565889|76188119|FG005|COMPLETED|Part B||19||
60072932|NCT01565889|76188114|FG000|NOT COMPLETED|Part B||0||
60072933|NCT01565889|76188115|FG001|NOT COMPLETED|Part B||0||
60072934|NCT01565889|76188116|FG002|NOT COMPLETED|Part B||0||
60072935|NCT01565889|76188117|FG003|NOT COMPLETED|Part B||0||
60072936|NCT01565889|76188118|FG004|NOT COMPLETED|Part B||0||
59777897|NCT00719355|75898313|FG001|COMPLETED|Overall Study||39||
59777898|NCT00719355|75898312|FG000|NOT COMPLETED|Overall Study||18||
59777899|NCT00719355|75898313|FG001|NOT COMPLETED|Overall Study||13||
59777900|NCT00590759|75898319|FG000|STARTED|Overall Study||150||
59777901|NCT00590759|75898319|FG000|COMPLETED|Overall Study||70||
59777902|NCT00590759|75898319|FG000|NOT COMPLETED|Overall Study||80||
60072937|NCT01565889|76188119|FG005|NOT COMPLETED|Part B||4||
60072938|NCT01696071|76188134|FG000|STARTED|Treatment Period 1: 4 Weeks||51||
60072939|NCT01696071|76188135|FG001|STARTED|Treatment Period 1: 4 Weeks||47||
60072940|NCT01696071|76188134|FG000|COMPLETED|Treatment Period 1: 4 Weeks||51||
59777903|NCT00734604|75898329|FG000|STARTED|Overall Study||62||
59777904|NCT00734604|75898330|FG001|STARTED|Overall Study||63||
59777905|NCT00734604|75898331|FG002|STARTED|Overall Study||63||
59777906|NCT00734604|75898332|FG003|STARTED|Overall Study||63||
59777907|NCT00734604|75898333|FG004|STARTED|Overall Study||63||
59777908|NCT00734604|75898334|FG005|STARTED|Overall Study||64||
59777909|NCT00734604|75898329|FG000|COMPLETED|Overall Study||59||
59777910|NCT00734604|75898330|FG001|COMPLETED|Overall Study||51||
59777911|NCT00734604|75898331|FG002|COMPLETED|Overall Study||57||
59777912|NCT00734604|75898332|FG003|COMPLETED|Overall Study||54||
59777913|NCT00734604|75898333|FG004|COMPLETED|Overall Study||55||
59777914|NCT00734604|75898334|FG005|COMPLETED|Overall Study||58||
59777915|NCT00734604|75898329|FG000|NOT COMPLETED|Overall Study||3||
59777916|NCT00734604|75898330|FG001|NOT COMPLETED|Overall Study||12||
59777917|NCT00734604|75898331|FG002|NOT COMPLETED|Overall Study||6||
59777918|NCT00734604|75898332|FG003|NOT COMPLETED|Overall Study||9||
59777919|NCT00734604|75898333|FG004|NOT COMPLETED|Overall Study||8||
59777920|NCT00734604|75898334|FG005|NOT COMPLETED|Overall Study||6||
59777921|NCT00590681|75898345|FG000|STARTED|Overall Study||62||
59777922|NCT00590681|75898345|FG000|COMPLETED|Overall Study|The forty-two participants who did proceed to the post-RT phase|42||
59777923|NCT00590681|75898345|FG000|NOT COMPLETED|Overall Study||20||
59777924|NCT00727272|75898349|FG000|STARTED|Period I||9||
59777925|NCT00727272|75898350|FG001|STARTED|Period I||9||
59777926|NCT00727272|75898351|FG002|STARTED|Period I||9||
59777927|NCT00727272|75898349|FG000|COMPLETED|Period I||9||
59777928|NCT00727272|75898350|FG001|COMPLETED|Period I||9||
59777929|NCT00727272|75898351|FG002|COMPLETED|Period I||9||
59777930|NCT00727272|75898349|FG000|NOT COMPLETED|Period I||0||
59777931|NCT00727272|75898350|FG001|NOT COMPLETED|Period I||0||
59777932|NCT00727272|75898351|FG002|NOT COMPLETED|Period I||0||
59777933|NCT00727272|75898349|FG000|STARTED|Washout Period A||9||
59777934|NCT00727272|75898350|FG001|STARTED|Washout Period A||9||
59777935|NCT00727272|75898351|FG002|STARTED|Washout Period A||9||
59777936|NCT00727272|75898349|FG000|COMPLETED|Washout Period A||9||
59777937|NCT00727272|75898350|FG001|COMPLETED|Washout Period A||9||
59777938|NCT00727272|75898351|FG002|COMPLETED|Washout Period A|positive pregnancy test - recorded as an adverse event|8||
59777939|NCT00727272|75898349|FG000|NOT COMPLETED|Washout Period A||0||
59777940|NCT00727272|75898350|FG001|NOT COMPLETED|Washout Period A||0||
59777941|NCT00727272|75898351|FG002|NOT COMPLETED|Washout Period A||1||
59777942|NCT00727272|75898349|FG000|STARTED|Period II||9||
59777943|NCT00727272|75898350|FG001|STARTED|Period II||9||
59777944|NCT00727272|75898351|FG002|STARTED|Period II||8||
59777945|NCT00727272|75898349|FG000|COMPLETED|Period II||9||
59777946|NCT00727272|75898350|FG001|COMPLETED|Period II||9||
59777947|NCT00727272|75898351|FG002|COMPLETED|Period II||8||
59777948|NCT00727272|75898349|FG000|NOT COMPLETED|Period II||0||
59777949|NCT00727272|75898350|FG001|NOT COMPLETED|Period II||0||
59777950|NCT00727272|75898351|FG002|NOT COMPLETED|Period II||0||
59777951|NCT00727272|75898349|FG000|STARTED|Washout Period B||9||
59777952|NCT00727272|75898350|FG001|STARTED|Washout Period B||9||
59777953|NCT00727272|75898351|FG002|STARTED|Washout Period B||8||
59777954|NCT00727272|75898349|FG000|COMPLETED|Washout Period B||9||
59777955|NCT00727272|75898350|FG001|COMPLETED|Washout Period B||9||
59777956|NCT00727272|75898351|FG002|COMPLETED|Washout Period B|personal reasons|7||
59777957|NCT00727272|75898349|FG000|NOT COMPLETED|Washout Period B||0||
59777958|NCT00727272|75898350|FG001|NOT COMPLETED|Washout Period B||0||
59777959|NCT00727272|75898351|FG002|NOT COMPLETED|Washout Period B||1||
59777960|NCT00727272|75898349|FG000|STARTED|Period III||9||
59777961|NCT00727272|75898350|FG001|STARTED|Period III||9||
59777962|NCT00727272|75898351|FG002|STARTED|Period III||7||
59777963|NCT00727272|75898349|FG000|COMPLETED|Period III||9||
59777964|NCT00727272|75898350|FG001|COMPLETED|Period III||9||
59777965|NCT00727272|75898351|FG002|COMPLETED|Period III||7||
59777966|NCT00727272|75898349|FG000|NOT COMPLETED|Period III||0||
59777967|NCT00727272|75898350|FG001|NOT COMPLETED|Period III||0||
59777968|NCT00727272|75898351|FG002|NOT COMPLETED|Period III||0||
59777969|NCT00805025|75898361|FG000|STARTED|Overall Study||131||
59777970|NCT00805025|75898361|FG000|Enrolled and Treated|Overall Study||89||
59777971|NCT00805025|75898361|FG000|COMPLETED|Overall Study||82||
59777972|NCT00805025|75898361|FG000|NOT COMPLETED|Overall Study||49||
59777973|NCT00734214|75898367|FG000|STARTED|Overall Study||128||
59777974|NCT00734214|75898368|FG001|STARTED|Overall Study||130||
60072941|NCT01696071|76188135|FG001|COMPLETED|Treatment Period 1: 4 Weeks||47||
59777975|NCT00734214|75898367|FG000|COMPLETED|Overall Study||124||
59777976|NCT00734214|75898368|FG001|COMPLETED|Overall Study||126||
59777977|NCT00734214|75898367|FG000|NOT COMPLETED|Overall Study||4||
59777978|NCT00734214|75898368|FG001|NOT COMPLETED|Overall Study||4||
59777979|NCT00787202|75898379|FG000|STARTED|Overall Study||49||
59777980|NCT00787202|75898380|FG001|STARTED|Overall Study||31||
59777981|NCT00787202|75898381|FG002|STARTED|Overall Study||33||
59777982|NCT00787202|75898382|FG003|STARTED|Overall Study||33||
59777983|NCT00787202|75898383|FG004|STARTED|Overall Study||49||
59777984|NCT00787202|75898379|FG000|Treated|Overall Study||48||
59777985|NCT00787202|75898380|FG001|Treated|Overall Study||31||
59777986|NCT00787202|75898381|FG002|Treated|Overall Study||33||
59777987|NCT00787202|75898382|FG003|Treated|Overall Study||33||
59777988|NCT00787202|75898383|FG004|Treated|Overall Study||49||
59777989|NCT00787202|75898379|FG000|COMPLETED|Overall Study||35||
59777990|NCT00787202|75898380|FG001|COMPLETED|Overall Study||20||
59777991|NCT00787202|75898381|FG002|COMPLETED|Overall Study||26||
59777992|NCT00787202|75898382|FG003|COMPLETED|Overall Study||31||
59777993|NCT00787202|75898383|FG004|COMPLETED|Overall Study||45||
59777994|NCT00787202|75898379|FG000|NOT COMPLETED|Overall Study||14||
59777995|NCT00787202|75898380|FG001|NOT COMPLETED|Overall Study||11||
59777996|NCT00787202|75898381|FG002|NOT COMPLETED|Overall Study||7||
59777997|NCT00787202|75898382|FG003|NOT COMPLETED|Overall Study||2||
59777998|NCT00787202|75898383|FG004|NOT COMPLETED|Overall Study||4||
59777999|NCT04033367|75898401|FG000|STARTED|DB Period (Up to Week 12)||127||
59778000|NCT04033367|75898402|FG001|STARTED|DB Period (Up to Week 12)||61||
59778001|NCT04033367|75898401|FG000|COMPLETED|DB Period (Up to Week 12)||122||
59778002|NCT04033367|75898402|FG001|COMPLETED|DB Period (Up to Week 12)||60||
59778003|NCT04033367|75898401|FG000|NOT COMPLETED|DB Period (Up to Week 12)||5||
59778004|NCT04033367|75898402|FG001|NOT COMPLETED|DB Period (Up to Week 12)||1||
59778005|NCT04033367|75898401|FG000|STARTED|OLE Period (Week 12 to Week 24)||122||
59778006|NCT04033367|75898402|FG001|STARTED|OLE Period (Week 12 to Week 24)||60||
59778007|NCT04033367|75898401|FG000|COMPLETED|OLE Period (Week 12 to Week 24)||117||
59778008|NCT04033367|75898402|FG001|COMPLETED|OLE Period (Week 12 to Week 24)||59||
59778009|NCT04033367|75898401|FG000|NOT COMPLETED|OLE Period (Week 12 to Week 24)||5||
59778010|NCT04033367|75898402|FG001|NOT COMPLETED|OLE Period (Week 12 to Week 24)||1||
59778011|NCT00733980|75898414|FG000|STARTED|Overall Study||74||
59778012|NCT00733980|75898415|FG001|STARTED|Overall Study||76||
59778013|NCT00733980|75898414|FG000|COMPLETED|Overall Study||52||
59778014|NCT00733980|75898415|FG001|COMPLETED|Overall Study||55||
59778015|NCT00733980|75898414|FG000|NOT COMPLETED|Overall Study||22||
59778016|NCT00733980|75898415|FG001|NOT COMPLETED|Overall Study||21||
59778017|NCT00806585|75898427|FG000|STARTED|Overall Study||137||
59778018|NCT00806585|75898428|FG001|STARTED|Overall Study||134||
59778019|NCT00806585|75898429|FG002|STARTED|Overall Study||141||
59778020|NCT00806585|75898430|FG003|STARTED|Overall Study||71||
59778021|NCT00806585|75898431|FG004|STARTED|Overall Study||137||
59778022|NCT00806585|75898427|FG000|COMPLETED|Overall Study||105||
59778023|NCT00806585|75898428|FG001|COMPLETED|Overall Study||103||
59778024|NCT00806585|75898429|FG002|COMPLETED|Overall Study||109||
59778025|NCT00806585|75898430|FG003|COMPLETED|Overall Study||56||
59778026|NCT00806585|75898431|FG004|COMPLETED|Overall Study||106||
59778027|NCT00806585|75898427|FG000|NOT COMPLETED|Overall Study||32||
59778028|NCT00806585|75898428|FG001|NOT COMPLETED|Overall Study||31||
59778029|NCT00806585|75898429|FG002|NOT COMPLETED|Overall Study||32||
59778030|NCT00806585|75898430|FG003|NOT COMPLETED|Overall Study||15||
59778031|NCT00806585|75898431|FG004|NOT COMPLETED|Overall Study||31||
59778032|NCT00480025|75898445|FG000|STARTED|Overall Study||1515||
59778033|NCT00480025|75898446|FG001|STARTED|Overall Study||757||
59778034|NCT00480025|75898445|FG000|COMPLETED|Overall Study||763||
59778035|NCT00480025|75898446|FG001|COMPLETED|Overall Study||388||
59778036|NCT00480025|75898445|FG000|NOT COMPLETED|Overall Study||752||
59778037|NCT00480025|75898446|FG001|NOT COMPLETED|Overall Study||369||
59778038|NCT00806351|75898460|FG000|STARTED|Overall Study||15||
59778039|NCT00806351|75898461|FG001|STARTED|Overall Study||6||
59778040|NCT00806351|75898460|FG000|COMPLETED|Overall Study||10||
59778041|NCT00806351|75898461|FG001|COMPLETED|Overall Study||2||
59778042|NCT00806351|75898460|FG000|NOT COMPLETED|Overall Study||5||
59778043|NCT00806351|75898461|FG001|NOT COMPLETED|Overall Study||4||
59778044|NCT00733902|75898471|FG000|STARTED|Overall Study||174||
59778045|NCT00733902|75898472|FG001|STARTED|Overall Study||174||
59778046|NCT00733902|75898473|FG002|STARTED|Overall Study||174||
59778047|NCT00733902|75898474|FG003|STARTED|Overall Study||175||
59778048|NCT00733902|75898471|FG000|Treated|Overall Study||172||
59778049|NCT00733902|75898472|FG001|Treated|Overall Study||172||
59778050|NCT00733902|75898473|FG002|Treated|Overall Study||172||
59778051|NCT00733902|75898474|FG003|Treated|Overall Study||174||
59778052|NCT00733902|75898471|FG000|COMPLETED|Overall Study||10||
59778053|NCT00733902|75898472|FG001|COMPLETED|Overall Study||12||
59778054|NCT00733902|75898473|FG002|COMPLETED|Overall Study||13||
59778055|NCT00733902|75898474|FG003|COMPLETED|Overall Study||11||
59778056|NCT00733902|75898471|FG000|NOT COMPLETED|Overall Study||164||
59778057|NCT00733902|75898472|FG001|NOT COMPLETED|Overall Study||162||
59778058|NCT00733902|75898473|FG002|NOT COMPLETED|Overall Study||161||
59778059|NCT00733902|75898474|FG003|NOT COMPLETED|Overall Study||164||
59778060|NCT00790790|75898487|FG000|STARTED|Study Period 2: Therapy Phase||49||
59778061|NCT00790790|75898488|FG001|STARTED|Study Period 2: Therapy Phase||50||
59778062|NCT00790790|75898489|FG002|STARTED|Study Period 2: Therapy Phase||48||
59778063|NCT00790790|75898487|FG000|COMPLETED|Study Period 2: Therapy Phase||37||
59778064|NCT00790790|75898488|FG001|COMPLETED|Study Period 2: Therapy Phase||32||
59778065|NCT00790790|75898489|FG002|COMPLETED|Study Period 2: Therapy Phase||27||
59778066|NCT00790790|75898487|FG000|NOT COMPLETED|Study Period 2: Therapy Phase||12||
59778067|NCT00790790|75898488|FG001|NOT COMPLETED|Study Period 2: Therapy Phase||18||
59778068|NCT00790790|75898489|FG002|NOT COMPLETED|Study Period 2: Therapy Phase||21||
59778069|NCT00790790|75898487|FG000|STARTED|Study Period 3: 1-Week Washout Phase||37||
59778070|NCT00790790|75898488|FG001|STARTED|Study Period 3: 1-Week Washout Phase||32||
59778071|NCT00790790|75898489|FG002|STARTED|Study Period 3: 1-Week Washout Phase||27||
59778072|NCT00790790|75898487|FG000|COMPLETED|Study Period 3: 1-Week Washout Phase||37||
59778073|NCT00790790|75898488|FG001|COMPLETED|Study Period 3: 1-Week Washout Phase||31||
59778074|NCT00790790|75898489|FG002|COMPLETED|Study Period 3: 1-Week Washout Phase||26||
59778075|NCT00790790|75898487|FG000|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||0||
59778076|NCT00790790|75898488|FG001|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||1||
59778077|NCT00790790|75898489|FG002|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||1||
59778078|NCT00719043|75898509|FG000|STARTED|Overall Study||120||
59778079|NCT00719043|75898510|FG001|STARTED|Overall Study||121||
59778080|NCT00719043|75898511|FG002|STARTED|Overall Study||119||
59778081|NCT00719043|75898512|FG003|STARTED|Overall Study||119||
59778082|NCT00719043|75898513|FG004|STARTED|Overall Study||122||
59778083|NCT00719043|75898514|FG005|STARTED|Overall Study||120||
59778084|NCT00719043|75898515|FG006|STARTED|Overall Study||120||
59778085|NCT00719043|75898509|FG000|COMPLETED|Overall Study|Up to Day 909|88||
59778086|NCT00719043|75898510|FG001|COMPLETED|Overall Study|Up to Day 909|96||
59778087|NCT00719043|75898511|FG002|COMPLETED|Overall Study|Up to Day 909|99||
59778088|NCT00719043|75898512|FG003|COMPLETED|Overall Study|Up to Day 909|96||
59778089|NCT00719043|75898513|FG004|COMPLETED|Overall Study|Up to Day 909|95||
59778090|NCT00719043|75898514|FG005|COMPLETED|Overall Study|Up to Day 909|86||
59778091|NCT00719043|75898515|FG006|COMPLETED|Overall Study|Up to Day 909|92||
59778092|NCT00719043|75898509|FG000|NOT COMPLETED|Overall Study||32||
59778093|NCT00719043|75898510|FG001|NOT COMPLETED|Overall Study||25||
59778094|NCT00719043|75898511|FG002|NOT COMPLETED|Overall Study||20||
59778095|NCT00719043|75898512|FG003|NOT COMPLETED|Overall Study||23||
59778096|NCT00719043|75898513|FG004|NOT COMPLETED|Overall Study||27||
59778097|NCT00719043|75898514|FG005|NOT COMPLETED|Overall Study||34||
59778098|NCT00719043|75898515|FG006|NOT COMPLETED|Overall Study||28||
59778099|NCT00786422|75898543|FG000|STARTED|Rivaroxaban Treatment||25||
59778100|NCT00786422|75898543|FG000|COMPLETED|Rivaroxaban Treatment||14||
59778101|NCT00786422|75898543|FG000|NOT COMPLETED|Rivaroxaban Treatment||11||
59778102|NCT00786422|75898543|FG000|STARTED|Follow-up Period|Participants entered follow-up period. No reason documents for those not entering this period|20||
59778103|NCT00786422|75898543|FG000|COMPLETED|Follow-up Period||17||
59778104|NCT00786422|75898543|FG000|NOT COMPLETED|Follow-up Period||3||
59778105|NCT00718887|75898551|FG000|STARTED|Overall Study|Participants who received treatment.|89||
59778106|NCT00718887|75898552|FG001|STARTED|Overall Study|Participants who received treatment.|77||
59778107|NCT00718887|75898551|FG000|COMPLETED|Overall Study|Continued in study after 48 weeks|84||
59778108|NCT00718887|75898552|FG001|COMPLETED|Overall Study||68||
59778109|NCT00718887|75898551|FG000|NOT COMPLETED|Overall Study||5||
59778110|NCT00718887|75898552|FG001|NOT COMPLETED|Overall Study||9||
59778111|NCT00786188|75898566|FG000|STARTED|Overall Study||50||
59778112|NCT00786188|75898567|FG001|STARTED|Overall Study||52||
59778113|NCT00786188|75898566|FG000|COMPLETED|Overall Study||45||
59778114|NCT00786188|75898567|FG001|COMPLETED|Overall Study||51||
59778115|NCT00786188|75898566|FG000|NOT COMPLETED|Overall Study||5||
59778116|NCT00786188|75898567|FG001|NOT COMPLETED|Overall Study||1||
59778117|NCT00790556|75898575|FG000|STARTED|Treatment Period 1||8||
59778118|NCT00790556|75898576|FG001|STARTED|Treatment Period 1||6||
59778119|NCT00790556|75898575|FG000|COMPLETED|Treatment Period 1||6||
59778120|NCT00790556|75898576|FG001|COMPLETED|Treatment Period 1||6||
59778121|NCT00790556|75898575|FG000|NOT COMPLETED|Treatment Period 1||2||
59522160|NCT04042324|75616497|FG000|NOT COMPLETED|UFH and Triferic Admixture (Day 1)||0||
59778122|NCT00790556|75898576|FG001|NOT COMPLETED|Treatment Period 1||0||
59778123|NCT00790556|75898575|FG000|STARTED|Washout After Period 1||6||
59778124|NCT00790556|75898576|FG001|STARTED|Washout After Period 1||6||
59778125|NCT00790556|75898575|FG000|COMPLETED|Washout After Period 1||6||
59778126|NCT00790556|75898576|FG001|COMPLETED|Washout After Period 1||6||
59778127|NCT00790556|75898575|FG000|NOT COMPLETED|Washout After Period 1||0||
59778128|NCT00790556|75898576|FG001|NOT COMPLETED|Washout After Period 1||0||
59778129|NCT00790556|75898575|FG000|STARTED|Treatment Period 2||6||
59778130|NCT00790556|75898576|FG001|STARTED|Treatment Period 2||6||
59778131|NCT00790556|75898575|FG000|COMPLETED|Treatment Period 2||6||
59778132|NCT00790556|75898576|FG001|COMPLETED|Treatment Period 2||6||
59778133|NCT00790556|75898575|FG000|NOT COMPLETED|Treatment Period 2||0||
59778134|NCT00790556|75898576|FG001|NOT COMPLETED|Treatment Period 2||0||
59778135|NCT00733824|75898587|FG000|STARTED|Phase I||10||
59778136|NCT00733824|75898588|FG001|STARTED|Phase I||3||
59778137|NCT00733824|75898589|FG002|STARTED|Phase I||6||
59778138|NCT00733824|75898590|FG003|STARTED|Phase I||6||
59778139|NCT00733824|75898591|FG004|STARTED|Phase I||0||
59778140|NCT00733824|75898587|FG000|COMPLETED|Phase I||9||
59778141|NCT00733824|75898588|FG001|COMPLETED|Phase I||3||
59778142|NCT00733824|75898589|FG002|COMPLETED|Phase I||6||
59778143|NCT00733824|75898590|FG003|COMPLETED|Phase I||6||
59778144|NCT00733824|75898591|FG004|COMPLETED|Phase I||0||
59778145|NCT00733824|75898587|FG000|NOT COMPLETED|Phase I||1||
59778146|NCT00733824|75898588|FG001|NOT COMPLETED|Phase I||0||
59778147|NCT00733824|75898589|FG002|NOT COMPLETED|Phase I||0||
59778148|NCT00733824|75898590|FG003|NOT COMPLETED|Phase I||0||
59778149|NCT00733824|75898591|FG004|NOT COMPLETED|Phase I||0||
59778150|NCT00733824|75898587|FG000|STARTED|Phase II||0||
59778151|NCT00733824|75898588|FG001|STARTED|Phase II||0||
59778152|NCT00733824|75898589|FG002|STARTED|Phase II||0||
59778153|NCT00733824|75898590|FG003|STARTED|Phase II||0||
59778154|NCT00733824|75898591|FG004|STARTED|Phase II||36||
59778155|NCT00733824|75898587|FG000|COMPLETED|Phase II||0||
59778156|NCT00733824|75898588|FG001|COMPLETED|Phase II||0||
59778157|NCT00733824|75898589|FG002|COMPLETED|Phase II||0||
59778158|NCT00733824|75898590|FG003|COMPLETED|Phase II||0||
59778159|NCT00733824|75898591|FG004|COMPLETED|Phase II||36||
59778160|NCT00733824|75898587|FG000|NOT COMPLETED|Phase II||0||
59778161|NCT00733824|75898588|FG001|NOT COMPLETED|Phase II||0||
59778162|NCT00733824|75898589|FG002|NOT COMPLETED|Phase II||0||
59778163|NCT00733824|75898590|FG003|NOT COMPLETED|Phase II||0||
59778164|NCT00733824|75898591|FG004|NOT COMPLETED|Phase II||0||
59778165|NCT00718809|75898607|FG000|STARTED|Overall Study||12||
59778166|NCT00718809|75898608|FG001|STARTED|Overall Study||9||
59778167|NCT00718809|75898607|FG000|COMPLETED|Overall Study||0||
59778168|NCT00718809|75898608|FG001|COMPLETED|Overall Study||0||
59778169|NCT00718809|75898607|FG000|NOT COMPLETED|Overall Study||12||
59778170|NCT00718809|75898608|FG001|NOT COMPLETED|Overall Study||9||
59778171|NCT00585039|75898616|FG000|STARTED|Overall Study||57||
59778172|NCT00585039|75898617|FG001|STARTED|Overall Study||44||
59778173|NCT00585039|75898616|FG000|COMPLETED|Overall Study||55||
59778174|NCT00585039|75898617|FG001|COMPLETED|Overall Study||44||
59778175|NCT00585039|75898616|FG000|NOT COMPLETED|Overall Study||2||
59778176|NCT00585039|75898617|FG001|NOT COMPLETED|Overall Study||0||
59778177|NCT00806195|75898629|FG000|STARTED|Overall Study||4363||
59778178|NCT00806195|75898630|FG001|STARTED|Overall Study||1483||
59778179|NCT00806195|75898631|FG002|STARTED|Overall Study||1409||
59778180|NCT00806195|75898632|FG003|STARTED|Overall Study||489||
59778181|NCT00806195|75898629|FG000|COMPLETED|Overall Study||3849||
59778182|NCT00806195|75898630|FG001|COMPLETED|Overall Study||1321||
59778183|NCT00806195|75898631|FG002|COMPLETED|Overall Study||1139||
59778184|NCT00806195|75898632|FG003|COMPLETED|Overall Study||383||
59778185|NCT00806195|75898629|FG000|NOT COMPLETED|Overall Study||514||
59778186|NCT00806195|75898630|FG001|NOT COMPLETED|Overall Study||162||
59778187|NCT00806195|75898631|FG002|NOT COMPLETED|Overall Study||270||
59778188|NCT00806195|75898632|FG003|NOT COMPLETED|Overall Study||106||
59778189|NCT00733746|75898644|FG000|STARTED|Overall Study||119||
59778190|NCT00733746|75898644|FG000|COMPLETED|Overall Study||114||
59778191|NCT00733746|75898644|FG000|NOT COMPLETED|Overall Study||5||
59778192|NCT00718419|75898650|FG000|STARTED|Overall Study||14||
59778193|NCT00718419|75898651|FG001|STARTED|Overall Study||42||
59778194|NCT00718419|75898650|FG000|Received at Least One Dose of Study Drug|Overall Study||14||
59778195|NCT00718419|75898651|FG001|Received at Least One Dose of Study Drug|Overall Study||42||
59778196|NCT00718419|75898650|FG000|COMPLETED|Overall Study|Participants who completed 8 cycles of treatment.|1||
59778197|NCT00718419|75898651|FG001|COMPLETED|Overall Study|Participants who completed 8 cycles of treatment.|3||
59778198|NCT00718419|75898650|FG000|NOT COMPLETED|Overall Study||13||
59778199|NCT00718419|75898651|FG001|NOT COMPLETED|Overall Study||39||
59778200|NCT00717249|75898659|FG000|STARTED|Overall Study||326||
59778201|NCT00717249|75898660|FG001|STARTED|Overall Study||165||
59778202|NCT00717249|75898659|FG000|COMPLETED|Overall Study||304||
59778203|NCT00717249|75898660|FG001|COMPLETED|Overall Study||150||
59778204|NCT00717249|75898659|FG000|NOT COMPLETED|Overall Study||22||
59778205|NCT00717249|75898660|FG001|NOT COMPLETED|Overall Study||15||
59778206|NCT00727194|75898666|FG000|STARTED|Screening Period||7||
59778207|NCT00727194|75898667|FG001|STARTED|Screening Period||7||
59778208|NCT00727194|75898668|FG002|STARTED|Screening Period||16||
59778209|NCT00727194|75898666|FG000|COMPLETED|Screening Period||7||
59778210|NCT00727194|75898667|FG001|COMPLETED|Screening Period||7||
59778211|NCT00727194|75898668|FG002|COMPLETED|Screening Period||0||
59778212|NCT00727194|75898666|FG000|NOT COMPLETED|Screening Period||0||
59778213|NCT00727194|75898667|FG001|NOT COMPLETED|Screening Period||0||
59778214|NCT00727194|75898668|FG002|NOT COMPLETED|Screening Period||16||
59778215|NCT00727194|75898666|FG000|STARTED|Treatment Period 1||7||
59778216|NCT00727194|75898667|FG001|STARTED|Treatment Period 1||7||
59778217|NCT00727194|75898668|FG002|STARTED|Treatment Period 1||0||
59778218|NCT00727194|75898666|FG000|COMPLETED|Treatment Period 1||7||
59778219|NCT00727194|75898667|FG001|COMPLETED|Treatment Period 1||7||
59778220|NCT00727194|75898668|FG002|COMPLETED|Treatment Period 1||0||
59778221|NCT00727194|75898666|FG000|NOT COMPLETED|Treatment Period 1||0||
59778222|NCT00727194|75898667|FG001|NOT COMPLETED|Treatment Period 1||0||
59778223|NCT00727194|75898668|FG002|NOT COMPLETED|Treatment Period 1||0||
59778224|NCT00727194|75898666|FG000|STARTED|Washout Period||7||
59778225|NCT00727194|75898667|FG001|STARTED|Washout Period||7||
59778226|NCT00727194|75898668|FG002|STARTED|Washout Period||0||
59778227|NCT00727194|75898666|FG000|COMPLETED|Washout Period||7||
59778228|NCT00727194|75898667|FG001|COMPLETED|Washout Period||7||
59778229|NCT00727194|75898668|FG002|COMPLETED|Washout Period||0||
59778230|NCT00727194|75898666|FG000|NOT COMPLETED|Washout Period||0||
59778231|NCT00727194|75898667|FG001|NOT COMPLETED|Washout Period||0||
59778232|NCT00727194|75898668|FG002|NOT COMPLETED|Washout Period||0||
59778233|NCT00727194|75898666|FG000|STARTED|Treatment Period 2|Sponsor terminated study early; 2 patients (total) exited study without starting Treatment Period 2.|6||
59778234|NCT00727194|75898667|FG001|STARTED|Treatment Period 2|Sponsor terminated study early; 2 patients (total) exited study without starting Treatment Period 2.|6||
59778235|NCT00727194|75898668|FG002|STARTED|Treatment Period 2||0||
59778236|NCT00727194|75898666|FG000|COMPLETED|Treatment Period 2||6||
59778237|NCT00727194|75898667|FG001|COMPLETED|Treatment Period 2||5||
59778238|NCT00727194|75898668|FG002|COMPLETED|Treatment Period 2||0||
59778239|NCT00727194|75898666|FG000|NOT COMPLETED|Treatment Period 2||0||
59778240|NCT00727194|75898667|FG001|NOT COMPLETED|Treatment Period 2||1||
59778241|NCT00727194|75898668|FG002|NOT COMPLETED|Treatment Period 2||0||
59778242|NCT00717093|75898684|FG000|STARTED|Overall Study||214||
59778243|NCT00717093|75898685|FG001|STARTED|Overall Study||218||
59778244|NCT00717093|75898684|FG000|Received Treatment|Overall Study||213||
59778245|NCT00717093|75898685|FG001|Received Treatment|Overall Study||218||
59778246|NCT00717093|75898684|FG000|COMPLETED|Overall Study||170||
59778247|NCT00717093|75898685|FG001|COMPLETED|Overall Study||170||
59778248|NCT00717093|75898684|FG000|NOT COMPLETED|Overall Study||44||
59778249|NCT00717093|75898685|FG001|NOT COMPLETED|Overall Study||48||
59778250|NCT00716859|75898693|FG000|STARTED|Overall Study||70||
59778251|NCT00716859|75898694|FG001|STARTED|Overall Study||69||
59778252|NCT00716859|75898693|FG000|Received Treatment|Overall Study||69||
59778253|NCT00716859|75898694|FG001|Received Treatment|Overall Study||68||
59778254|NCT00716859|75898693|FG000|COMPLETED|Overall Study||61||
59778255|NCT00716859|75898694|FG001|COMPLETED|Overall Study||64||
59778256|NCT00716859|75898693|FG000|NOT COMPLETED|Overall Study||9||
59778257|NCT00716859|75898694|FG001|NOT COMPLETED|Overall Study||5||
59778258|NCT00589121|75898702|FG000|STARTED|Overall Study||12||
59778259|NCT00589121|75898703|FG001|STARTED|Overall Study||86||
59778260|NCT00589121|75898702|FG000|COMPLETED|Overall Study|Subjects with data available for the analysis are considered to have completed the study.|10||
59778261|NCT00589121|75898703|FG001|COMPLETED|Overall Study|Subjects with data available for the analysis are considered to have completed the study.|79||
59778262|NCT00589121|75898702|FG000|NOT COMPLETED|Overall Study||2||
59778263|NCT00589121|75898703|FG001|NOT COMPLETED|Overall Study||7||
59778264|NCT00590135|75898712|FG000|STARTED|Overall Study||59||
59778265|NCT00590135|75898712|FG000|COMPLETED|Overall Study||0||
59778266|NCT00590135|75898712|FG000|NOT COMPLETED|Overall Study||59||
59778267|NCT00589667|75898717|FG000|STARTED|Overall Study||26||
59778268|NCT00589667|75898717|FG000|COMPLETED|Overall Study||23||
59778269|NCT00589667|75898717|FG000|NOT COMPLETED|Overall Study||3||
59778270|NCT00737568|75898723|FG000|STARTED|Treatment Period Through Week 240||141||
59778271|NCT00737568|75898724|FG001|STARTED|Treatment Period Through Week 240||139||
59778272|NCT00737568|75898723|FG000|COMPLETED|Treatment Period Through Week 240||121||
59778273|NCT00737568|75898724|FG001|COMPLETED|Treatment Period Through Week 240||118||
59778274|NCT00737568|75898723|FG000|NOT COMPLETED|Treatment Period Through Week 240||20||
59778275|NCT00737568|75898724|FG001|NOT COMPLETED|Treatment Period Through Week 240||21||
59778276|NCT00737568|75898723|FG000|STARTED|Treatment-Free Follow-up (TFFU) Period|1 participant not completing the 240 week treatment period enrolled in the TFFU period.|38||
59778277|NCT00737568|75898724|FG001|STARTED|Treatment-Free Follow-up (TFFU) Period|4 participants not completing the 240 week treatment period enrolled in the TFFU period.|37||
59778278|NCT00737568|75898723|FG000|COMPLETED|Treatment-Free Follow-up (TFFU) Period||12||
59778279|NCT00737568|75898724|FG001|COMPLETED|Treatment-Free Follow-up (TFFU) Period||19||
59952956|NCT04207333|76071763|FG001|STARTED|First Intervention (Single 1-Day Visit)||3||
59952957|NCT04207333|76071762|FG000|COMPLETED|First Intervention (Single 1-Day Visit)||3||
59952958|NCT04207333|76071763|FG001|COMPLETED|First Intervention (Single 1-Day Visit)||3||
60072942|NCT01696071|76188134|FG000|NOT COMPLETED|Treatment Period 1: 4 Weeks||0||
59522161|NCT04042324|75616498|FG001|NOT COMPLETED|UFH and Triferic Admixture (Day 1)||0||
59522162|NCT04042324|75616499|FG002|NOT COMPLETED|UFH and Triferic Admixture (Day 1)||0||
59522163|NCT04042324|75616497|FG000|STARTED|Triferic Post-dialyzer (Day 3)||0||
59522164|NCT04042324|75616498|FG001|STARTED|Triferic Post-dialyzer (Day 3)||12||
59522165|NCT04042324|75616499|FG002|STARTED|Triferic Post-dialyzer (Day 3)||0||
59522166|NCT04042324|75616497|FG000|COMPLETED|Triferic Post-dialyzer (Day 3)||0||
59522167|NCT04042324|75616498|FG001|COMPLETED|Triferic Post-dialyzer (Day 3)||12||
59618747|NCT03570918|75729884|FG002|STARTED|Period 1||4||
59618748|NCT03570918|75729885|FG003|STARTED|Period 1||3||
59618749|NCT03570918|75729886|FG004|STARTED|Period 1||3||
59618750|NCT03570918|75729887|FG005|STARTED|Period 1||3||
59618751|NCT03570918|75729888|FG006|STARTED|Period 1||3||
60072943|NCT01696071|76188135|FG001|NOT COMPLETED|Treatment Period 1: 4 Weeks||0||
59522168|NCT04042324|75616499|FG002|COMPLETED|Triferic Post-dialyzer (Day 3)||0||
59522169|NCT04042324|75616497|FG000|NOT COMPLETED|Triferic Post-dialyzer (Day 3)||0||
59522170|NCT04042324|75616498|FG001|NOT COMPLETED|Triferic Post-dialyzer (Day 3)||0||
59522171|NCT04042324|75616499|FG002|NOT COMPLETED|Triferic Post-dialyzer (Day 3)||0||
59522172|NCT04042324|75616497|FG000|STARTED|Triferic Pre-dialyzer (Day 5)||0||
59522173|NCT04042324|75616498|FG001|STARTED|Triferic Pre-dialyzer (Day 5)||0||
59618752|NCT03570918|75729889|FG007|STARTED|Period 1||3||
59618753|NCT03570918|75729890|FG008|STARTED|Period 1||0||
59618754|NCT03570918|75729882|FG000|COMPLETED|Period 1||1||
59618755|NCT03570918|75729883|FG001|COMPLETED|Period 1||1||
59618756|NCT03570918|75729884|FG002|COMPLETED|Period 1||4||
59618757|NCT03570918|75729885|FG003|COMPLETED|Period 1||3||
59618758|NCT03570918|75729886|FG004|COMPLETED|Period 1||3||
59618759|NCT03570918|75729887|FG005|COMPLETED|Period 1||3||
59618760|NCT03570918|75729888|FG006|COMPLETED|Period 1||3||
59618761|NCT03570918|75729889|FG007|COMPLETED|Period 1||3||
59618762|NCT03570918|75729890|FG008|COMPLETED|Period 1||0||
59618763|NCT03570918|75729882|FG000|NOT COMPLETED|Period 1||0||
59618764|NCT03570918|75729883|FG001|NOT COMPLETED|Period 1||0||
59618765|NCT03570918|75729884|FG002|NOT COMPLETED|Period 1||0||
59618766|NCT03570918|75729885|FG003|NOT COMPLETED|Period 1||0||
59618767|NCT03570918|75729886|FG004|NOT COMPLETED|Period 1||0||
59618768|NCT03570918|75729887|FG005|NOT COMPLETED|Period 1||0||
59618769|NCT03570918|75729888|FG006|NOT COMPLETED|Period 1||0||
59618770|NCT03570918|75729889|FG007|NOT COMPLETED|Period 1||0||
59618771|NCT03570918|75729890|FG008|NOT COMPLETED|Period 1||0||
59618772|NCT03570918|75729882|FG000|STARTED|Period 2||0||
59618773|NCT03570918|75729883|FG001|STARTED|Period 2||0||
59618774|NCT03570918|75729884|FG002|STARTED|Period 2||0||
59618775|NCT03570918|75729885|FG003|STARTED|Period 2||0||
59618776|NCT03570918|75729886|FG004|STARTED|Period 2||0||
59618777|NCT03570918|75729887|FG005|STARTED|Period 2||0||
59618778|NCT03570918|75729888|FG006|STARTED|Period 2||0||
59618779|NCT03570918|75729889|FG007|STARTED|Period 2||0||
59618780|NCT03570918|75729890|FG008|STARTED|Period 2||3||
59618781|NCT03570918|75729882|FG000|COMPLETED|Period 2||0||
59618782|NCT03570918|75729883|FG001|COMPLETED|Period 2||0||
59618783|NCT03570918|75729884|FG002|COMPLETED|Period 2||0||
59618784|NCT03570918|75729885|FG003|COMPLETED|Period 2||0||
59618785|NCT03570918|75729886|FG004|COMPLETED|Period 2||0||
59618786|NCT03570918|75729887|FG005|COMPLETED|Period 2||0||
59618787|NCT03570918|75729888|FG006|COMPLETED|Period 2||0||
59618788|NCT03570918|75729889|FG007|COMPLETED|Period 2||0||
59618789|NCT03570918|75729890|FG008|COMPLETED|Period 2||3||
59618790|NCT03570918|75729882|FG000|NOT COMPLETED|Period 2||0||
59618791|NCT03570918|75729883|FG001|NOT COMPLETED|Period 2||0||
59618792|NCT03570918|75729884|FG002|NOT COMPLETED|Period 2||0||
59618793|NCT03570918|75729885|FG003|NOT COMPLETED|Period 2||0||
59618794|NCT03570918|75729886|FG004|NOT COMPLETED|Period 2||0||
59618795|NCT03570918|75729887|FG005|NOT COMPLETED|Period 2||0||
59618796|NCT03570918|75729888|FG006|NOT COMPLETED|Period 2||0||
59618797|NCT03570918|75729889|FG007|NOT COMPLETED|Period 2||0||
59618798|NCT03570918|75729890|FG008|NOT COMPLETED|Period 2||0||
59618799|NCT03552822|75729921|FG000|STARTED|Overall Study||112||
59618800|NCT03552822|75729922|FG001|STARTED|Overall Study||429||
59618801|NCT03552822|75729921|FG000|COMPLETED|Overall Study||112||
59618802|NCT03552822|75729922|FG001|COMPLETED|Overall Study||429||
59618803|NCT03552822|75729921|FG000|NOT COMPLETED|Overall Study||0||
59618804|NCT03552822|75729922|FG001|NOT COMPLETED|Overall Study||0||
59618805|NCT03462966|75729928|FG000|STARTED|Overall Study||4||
59618806|NCT03462966|75729928|FG000|COMPLETED|Overall Study||4||
59618807|NCT03462966|75729928|FG000|NOT COMPLETED|Overall Study||0||
59618808|NCT03794700|75729935|FG000|STARTED|Overall Study||43||
59618809|NCT03794700|75729936|FG001|STARTED|Overall Study||88||
59618810|NCT03794700|75729935|FG000|COMPLETED|Overall Study||43||
59618811|NCT03794700|75729936|FG001|COMPLETED|Overall Study||88||
59618812|NCT03794700|75729935|FG000|NOT COMPLETED|Overall Study||0||
59778280|NCT00737568|75898723|FG000|NOT COMPLETED|Treatment-Free Follow-up (TFFU) Period||26||
59778281|NCT00737568|75898724|FG001|NOT COMPLETED|Treatment-Free Follow-up (TFFU) Period||18||
59778282|NCT00737100|75898733|FG000|STARTED|Overall Study||168||
59778283|NCT00737100|75898734|FG001|STARTED|Overall Study||166||
59778284|NCT00737100|75898735|FG002|STARTED|Overall Study||176||
59778285|NCT00737100|75898733|FG000|COMPLETED|Overall Study||161||
59778286|NCT00737100|75898734|FG001|COMPLETED|Overall Study||159||
59778287|NCT00737100|75898735|FG002|COMPLETED|Overall Study||169||
59778288|NCT00737100|75898733|FG000|NOT COMPLETED|Overall Study||7||
59778289|NCT00737100|75898734|FG001|NOT COMPLETED|Overall Study||7||
59778290|NCT00737100|75898735|FG002|NOT COMPLETED|Overall Study||7||
59778291|NCT00732498|75898745|FG000|STARTED|Overall Study||28||
59778292|NCT00732498|75898745|FG000|COMPLETED|Overall Study||22||
59778293|NCT00732498|75898745|FG000|NOT COMPLETED|Overall Study||6||
59778294|NCT00726882|75898749|FG000|STARTED|Overall Study||35||
59778295|NCT00726882|75898749|FG000|Received ABT-333 in Study M10-380|Overall Study|Participants who received ABT-333 (and not placebo) in previous study (NCT00851890/M10-380).|22||
59778296|NCT00726882|75898749|FG000|Received ABT-333 in Study M10-351|Overall Study|Participants who received ABT-333 (and not placebo) in previous study (NCT00696904/M10-351).|6||
59778297|NCT00726882|75898749|FG000|COMPLETED|Overall Study||13||
59778298|NCT00726882|75898749|FG000|NOT COMPLETED|Overall Study||22||
59778299|NCT00790400|75898757|FG000|STARTED|Double-blind Period (Core Phase)||79||
59778300|NCT00790400|75898758|FG001|STARTED|Double-blind Period (Core Phase)||39||
59778301|NCT00790400|75898757|FG000|COMPLETED|Double-blind Period (Core Phase)|Completed = Completed the Core phase & moved to Extension phase|72||
59778302|NCT00790400|75898758|FG001|COMPLETED|Double-blind Period (Core Phase)|Completed = 1st received Placebo in the Core phase, switched to Everolimus in Extension phase|26||
59778303|NCT00790400|75898757|FG000|NOT COMPLETED|Double-blind Period (Core Phase)||7||
59778304|NCT00790400|75898758|FG001|NOT COMPLETED|Double-blind Period (Core Phase)||13||
59778305|NCT00790400|75898757|FG000|STARTED|Everolimus Period (Core or Extension)|112 pts had Everolimus during core and/or extension (6 from placebo did not switch to Eve. in ext.)|112||
59778306|NCT00790400|75898758|FG001|STARTED|Everolimus Period (Core or Extension)|"Placebo randomized patients who switched to Everolimus are reported in Everolimus arm."|0||
59778307|NCT00790400|75898757|FG000|COMPLETED|Everolimus Period (Core or Extension)|Treatment duration completed as per protocol|83||
59778308|NCT00790400|75898758|FG001|COMPLETED|Everolimus Period (Core or Extension)||0||
59778309|NCT00790400|75898757|FG000|NOT COMPLETED|Everolimus Period (Core or Extension)||29||
59778310|NCT00790400|75898758|FG001|NOT COMPLETED|Everolimus Period (Core or Extension)||0||
59778311|NCT00786032|75898767|FG000|STARTED|Overall Study||27||
59778312|NCT00786032|75898767|FG000|Independent Users|Overall Study|All data analyses were based on the 14 independent users.|14||
59778313|NCT00786032|75898767|FG000|COMPLETED|Overall Study||3||
59778314|NCT00786032|75898767|FG000|NOT COMPLETED|Overall Study||24||
59778315|NCT00785486|75898773|FG000|STARTED|Midazolam Alone||24||
59778316|NCT00785486|75898773|FG000|COMPLETED|Midazolam Alone|one participant withdrew for personal reasons after first midazolam dose|23||
59778317|NCT00785486|75898773|FG000|NOT COMPLETED|Midazolam Alone||1||
59778318|NCT00785486|75898773|FG000|STARTED|3 Day Washout||23||
59778319|NCT00785486|75898773|FG000|COMPLETED|3 Day Washout||23||
59778320|NCT00785486|75898773|FG000|NOT COMPLETED|3 Day Washout||0||
59778321|NCT00785486|75898773|FG000|STARTED|Qualaquin Alone at Steady State||23||
59778322|NCT00785486|75898773|FG000|COMPLETED|Qualaquin Alone at Steady State||23||
59778323|NCT00785486|75898773|FG000|NOT COMPLETED|Qualaquin Alone at Steady State||0||
59778324|NCT00785486|75898773|FG000|STARTED|Midazolam With Qualaquin at Steady State||23||
59778325|NCT00785486|75898773|FG000|COMPLETED|Midazolam With Qualaquin at Steady State||23||
59778326|NCT00785486|75898773|FG000|NOT COMPLETED|Midazolam With Qualaquin at Steady State||0||
59778327|NCT00589979|75898796|FG000|STARTED|Run-In Period||169||
59778328|NCT00589979|75898797|FG001|STARTED|Run-In Period||0||
59778329|NCT00589979|75898798|FG002|STARTED|Run-In Period||0||
59778330|NCT00589979|75898796|FG000|COMPLETED|Run-In Period||93||
59778331|NCT00589979|75898797|FG001|COMPLETED|Run-In Period||0||
59778332|NCT00589979|75898798|FG002|COMPLETED|Run-In Period||0||
59778333|NCT00589979|75898796|FG000|NOT COMPLETED|Run-In Period||76||
59778334|NCT00589979|75898797|FG001|NOT COMPLETED|Run-In Period||0||
59778335|NCT00589979|75898798|FG002|NOT COMPLETED|Run-In Period||0||
59778336|NCT00589979|75898796|FG000|STARTED|Double-Blind Treatment Period 1|Participants completing the Run-in Period were then randomized to two different treatment sequences.|0||
59778337|NCT00589979|75898797|FG001|STARTED|Double-Blind Treatment Period 1|N=21 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|50||
59778338|NCT00589979|75898798|FG002|STARTED|Double-Blind Treatment Period 1|N=21 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|43||
59778339|NCT00589979|75898796|FG000|COMPLETED|Double-Blind Treatment Period 1||0||
59778340|NCT00589979|75898797|FG001|COMPLETED|Double-Blind Treatment Period 1||48||
59778341|NCT00589979|75898798|FG002|COMPLETED|Double-Blind Treatment Period 1||41||
59778342|NCT00589979|75898796|FG000|NOT COMPLETED|Double-Blind Treatment Period 1||0||
59778343|NCT00589979|75898797|FG001|NOT COMPLETED|Double-Blind Treatment Period 1||2||
59778344|NCT00589979|75898798|FG002|NOT COMPLETED|Double-Blind Treatment Period 1||2||
59778345|NCT00589979|75898796|FG000|STARTED|Double-Blind Treatment Period 2||0||
59778346|NCT00589979|75898797|FG001|STARTED|Double-Blind Treatment Period 2|N=19 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|48||
59778347|NCT00589979|75898798|FG002|STARTED|Double-Blind Treatment Period 2|N=20 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|41||
59778348|NCT00589979|75898796|FG000|COMPLETED|Double-Blind Treatment Period 2||0||
59778349|NCT00589979|75898797|FG001|COMPLETED|Double-Blind Treatment Period 2||47||
59778350|NCT00589979|75898798|FG002|COMPLETED|Double-Blind Treatment Period 2||39||
59778351|NCT00589979|75898796|FG000|NOT COMPLETED|Double-Blind Treatment Period 2||0||
59778352|NCT00589979|75898797|FG001|NOT COMPLETED|Double-Blind Treatment Period 2||1||
59778353|NCT00589979|75898798|FG002|NOT COMPLETED|Double-Blind Treatment Period 2||2||
59778354|NCT00589979|75898796|FG000|STARTED|Double-Blind Treatment Period 3||0||
59778355|NCT00589979|75898797|FG001|STARTED|Double-Blind Treatment Period 3|N=19 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|47||
59778356|NCT00589979|75898798|FG002|STARTED|Double-Blind Treatment Period 3|N=19 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|39||
59778357|NCT00589979|75898796|FG000|COMPLETED|Double-Blind Treatment Period 3||0||
59778358|NCT00589979|75898797|FG001|COMPLETED|Double-Blind Treatment Period 3||46||
59778359|NCT00589979|75898798|FG002|COMPLETED|Double-Blind Treatment Period 3||38||
59778360|NCT00589979|75898796|FG000|NOT COMPLETED|Double-Blind Treatment Period 3||0||
59778361|NCT00589979|75898797|FG001|NOT COMPLETED|Double-Blind Treatment Period 3||1||
59778362|NCT00589979|75898798|FG002|NOT COMPLETED|Double-Blind Treatment Period 3||1||
59778363|NCT00797732|75898812|FG000|STARTED|Overall Study||21||
59778364|NCT00797732|75898813|FG001|STARTED|Overall Study||21||
59778365|NCT00797732|75898814|FG002|STARTED|Overall Study||154||
59778366|NCT00797732|75898812|FG000|Evaluable at Baseline|Overall Study||18|Evaluable for quality of life assessment.|
59778367|NCT00797732|75898813|FG001|Evaluable at Baseline|Overall Study||18|Evaluable for quality of life assessment.|
59778368|NCT00797732|75898814|FG002|Evaluable at Baseline|Overall Study||0|Evaluable for quality of life assessment.|
59778369|NCT00797732|75898812|FG000|Evaluable at 20 Weeks|Overall Study||17|Evaluable for quality of life assessment.|
59778370|NCT00797732|75898813|FG001|Evaluable at 20 Weeks|Overall Study||18|Evaluable for quality of life assessment.|
59778371|NCT00797732|75898814|FG002|Evaluable at 20 Weeks|Overall Study||0|Evaluable for quality of life assessment.|
59778372|NCT00797732|75898812|FG000|Evaluable at 12 Months|Overall Study||17|Evaluable for quality of life assessment.|
59778373|NCT00797732|75898813|FG001|Evaluable at 12 Months|Overall Study||18|Evaluable for quality of life assessment.|
59778374|NCT00797732|75898814|FG002|Evaluable at 12 Months|Overall Study||0|Evaluable for quality of life assessment.|
59778375|NCT00797732|75898812|FG000|COMPLETED|Overall Study||16||
59778376|NCT00797732|75898813|FG001|COMPLETED|Overall Study||18||
59778377|NCT00797732|75898814|FG002|COMPLETED|Overall Study||0||
59778378|NCT00797732|75898812|FG000|NOT COMPLETED|Overall Study||5||
59778379|NCT00797732|75898813|FG001|NOT COMPLETED|Overall Study||3||
59778380|NCT00797732|75898814|FG002|NOT COMPLETED|Overall Study||154||
59778381|NCT00790088|75898820|FG000|STARTED|Overall Study||274||
59778382|NCT00790088|75898820|FG000|Eligible for Data Analysis|Overall Study|Number of participants minus 11 protocol violation|263||
59778383|NCT00790088|75898820|FG000|COMPLETED|Overall Study||235||
59778384|NCT00790088|75898820|FG000|NOT COMPLETED|Overall Study||39||
59778385|NCT00736944|75898826|FG000|STARTED|Induction||30||
59778386|NCT00736944|75898826|FG000|COMPLETED|Induction||29||
59778387|NCT00736944|75898826|FG000|NOT COMPLETED|Induction||1||
59778388|NCT00736944|75898826|FG000|STARTED|Definitive Treatment||29||
59778389|NCT00736944|75898826|FG000|COMPLETED|Definitive Treatment||28||
59778390|NCT00736944|75898826|FG000|NOT COMPLETED|Definitive Treatment||1||
59778391|NCT00736476|75898835|FG000|STARTED|Overall Study||36||
59778392|NCT00736476|75898836|FG001|STARTED|Overall Study||27||
59778393|NCT00736476|75898835|FG000|COMPLETED|Overall Study||35||
59778394|NCT00736476|75898836|FG001|COMPLETED|Overall Study||27||
59778395|NCT00736476|75898835|FG000|NOT COMPLETED|Overall Study||1||
59778396|NCT00736476|75898836|FG001|NOT COMPLETED|Overall Study||0||
59778397|NCT00715299|75898848|FG000|STARTED|Overall Study|A total of 38 participants were consented to the study, but only 36 made it to day one of testing.|36||
59778398|NCT00715299|75898848|FG000|COMPLETED|Overall Study||30||
59778399|NCT00715299|75898848|FG000|NOT COMPLETED|Overall Study||6||
59778400|NCT00730236|75898852|FG000|STARTED|Overall Study||29||
59778401|NCT00730236|75898852|FG000|COMPLETED|Overall Study||23||
59778402|NCT00730236|75898852|FG000|NOT COMPLETED|Overall Study||6||
59778403|NCT00714285|75898860|FG000|STARTED|Overall Study||105||
59778404|NCT00714285|75898861|FG001|STARTED|Overall Study||105||
59778405|NCT00714285|75898862|FG002|STARTED|Overall Study||105||
59778406|NCT00714285|75898863|FG003|STARTED|Overall Study||105||
59778407|NCT00714285|75898860|FG000|COMPLETED|Overall Study|Completed upto Day 180|105||
59778408|NCT00714285|75898861|FG001|COMPLETED|Overall Study|Completed upto Day 180|102||
59778409|NCT00714285|75898862|FG002|COMPLETED|Overall Study|Completed upto Day 180|105||
59778410|NCT00714285|75898863|FG003|COMPLETED|Overall Study|Completed upto Day 180|104||
59778411|NCT00714285|75898860|FG000|NOT COMPLETED|Overall Study||0||
59778412|NCT00714285|75898861|FG001|NOT COMPLETED|Overall Study||3||
59778413|NCT00714285|75898862|FG002|NOT COMPLETED|Overall Study||0||
59778414|NCT00714285|75898863|FG003|NOT COMPLETED|Overall Study||1||
59522174|NCT04042324|75616499|FG002|STARTED|Triferic Pre-dialyzer (Day 5)||12||
59778415|NCT00776984|75898877|FG000|STARTED|Overall Study||234||
59778416|NCT00776984|75898878|FG001|STARTED|Overall Study||219||
59778417|NCT00776984|75898877|FG000|COMPLETED|Overall Study||203||
60072944|NCT01696071|76188134|FG000|STARTED|Treatment Period 2: 4 Weeks||51||
60072945|NCT01696071|76188135|FG001|STARTED|Treatment Period 2: 4 Weeks||47||
60072946|NCT01696071|76188134|FG000|COMPLETED|Treatment Period 2: 4 Weeks||50||
60072947|NCT01696071|76188135|FG001|COMPLETED|Treatment Period 2: 4 Weeks||47||
59778418|NCT00776984|75898878|FG001|COMPLETED|Overall Study||198||
59778419|NCT00776984|75898877|FG000|NOT COMPLETED|Overall Study||31||
59778420|NCT00776984|75898878|FG001|NOT COMPLETED|Overall Study||21||
59778421|NCT00714051|75898886|FG000|STARTED|Overall Study||27||
59778422|NCT00714051|75898887|FG001|STARTED|Overall Study||28||
59778423|NCT00714051|75898886|FG000|COMPLETED|Overall Study||26||
59778424|NCT00714051|75898887|FG001|COMPLETED|Overall Study||27||
59778425|NCT00714051|75898886|FG000|NOT COMPLETED|Overall Study||1||
59778426|NCT00714051|75898887|FG001|NOT COMPLETED|Overall Study||1||
59778427|NCT00784784|75898895|FG000|STARTED|Overall Study||22||
59778428|NCT00784784|75898896|FG001|STARTED|Overall Study||42||
59778429|NCT00784784|75898895|FG000|COMPLETED|Overall Study||20||
59778430|NCT00784784|75898896|FG001|COMPLETED|Overall Study||40||
59778431|NCT00784784|75898895|FG000|NOT COMPLETED|Overall Study||2||
59778432|NCT00784784|75898896|FG001|NOT COMPLETED|Overall Study||2||
59778433|NCT00801983|75898904|FG000|STARTED|Period 1||44||
59778434|NCT00801983|75898905|FG001|STARTED|Period 1||41||
59778435|NCT00801983|75898904|FG000|COMPLETED|Period 1||40||
59778436|NCT00801983|75898905|FG001|COMPLETED|Period 1||33||
59778437|NCT00801983|75898904|FG000|NOT COMPLETED|Period 1||4||
59778438|NCT00801983|75898905|FG001|NOT COMPLETED|Period 1||8||
59778439|NCT00801983|75898904|FG000|STARTED|Period 2||40||
59778440|NCT00801983|75898905|FG001|STARTED|Period 2||33||
59778441|NCT00801983|75898904|FG000|COMPLETED|Period 2||38||
59778442|NCT00801983|75898905|FG001|COMPLETED|Period 2||32||
59778443|NCT00801983|75898904|FG000|NOT COMPLETED|Period 2||2||
59778444|NCT00801983|75898905|FG001|NOT COMPLETED|Period 2||1||
59778445|NCT00587288|75898913|FG000|STARTED|Overall Study||53||
59778446|NCT00587288|75898914|FG001|STARTED|Overall Study||53||
59778447|NCT00587288|75898913|FG000|COMPLETED|Overall Study||50||
59778448|NCT00587288|75898914|FG001|COMPLETED|Overall Study||44||
59778449|NCT00587288|75898913|FG000|NOT COMPLETED|Overall Study||3||
59778450|NCT00587288|75898914|FG001|NOT COMPLETED|Overall Study||9||
59778451|NCT00800735|75898922|FG000|STARTED|Overall Study||30||
59778452|NCT00800735|75898922|FG000|COMPLETED|Overall Study||16||
59778453|NCT00800735|75898922|FG000|NOT COMPLETED|Overall Study||14||
59778454|NCT00730158|75898928|FG000|STARTED|Overall Study||17||
59778455|NCT00730158|75898929|FG001|STARTED|Overall Study||16||
59778456|NCT00730158|75898928|FG000|COMPLETED|Overall Study||16||
59778457|NCT00730158|75898929|FG001|COMPLETED|Overall Study||15||
59778458|NCT00730158|75898928|FG000|NOT COMPLETED|Overall Study||1||
59778459|NCT00730158|75898929|FG001|NOT COMPLETED|Overall Study||1||
59778460|NCT00784550|75898941|FG000|STARTED|Overall Study||173||
59778461|NCT00784550|75898942|FG001|STARTED|Overall Study||169||
59778462|NCT00784550|75898941|FG000|COMPLETED|Overall Study||137||
59778463|NCT00784550|75898942|FG001|COMPLETED|Overall Study||127||
59778464|NCT00784550|75898941|FG000|NOT COMPLETED|Overall Study||36||
59778465|NCT00784550|75898942|FG001|NOT COMPLETED|Overall Study||42||
59778466|NCT00729690|75898951|FG000|STARTED|Overall Study||16||
59778467|NCT00729690|75898952|FG001|STARTED|Overall Study||16||
59778468|NCT00729690|75898953|FG002|STARTED|Overall Study||16||
59778469|NCT00729690|75898951|FG000|COMPLETED|Overall Study||16||
59778470|NCT00729690|75898952|FG001|COMPLETED|Overall Study||14||
59778471|NCT00729690|75898953|FG002|COMPLETED|Overall Study||14||
59778472|NCT00729690|75898951|FG000|NOT COMPLETED|Overall Study||0||
59778473|NCT00729690|75898952|FG001|NOT COMPLETED|Overall Study||2||
59778474|NCT00729690|75898953|FG002|NOT COMPLETED|Overall Study||2||
59778475|NCT00784238|75898961|FG000|STARTED|Overall Study||289||
59778476|NCT00784238|75898961|FG000|COMPLETED|Overall Study||170||
59778477|NCT00784238|75898961|FG000|NOT COMPLETED|Overall Study||119||
59778478|NCT00729612|75898968|FG000|STARTED|Overall Study||63||
59778479|NCT00729612|75898968|FG000|Died Before Cycle 1|Overall Study||1||
60072948|NCT01696071|76188134|FG000|NOT COMPLETED|Treatment Period 2: 4 Weeks||1||
60072949|NCT01696071|76188135|FG001|NOT COMPLETED|Treatment Period 2: 4 Weeks||0||
60072950|NCT03744598|76188142|FG000|STARTED|Overall Study||20||
60072951|NCT03744598|76188142|FG000|COMPLETED|Overall Study||19||
60072952|NCT03744598|76188142|FG000|NOT COMPLETED|Overall Study||1||
59778480|NCT00729612|75898968|FG000|Received Cycle 1|Overall Study||62||
59778481|NCT00729612|75898968|FG000|Did Not Receive Cycle 2|Overall Study||7||
59778482|NCT00729612|75898968|FG000|Received Cycle 2|Overall Study||54||
59778483|NCT00729612|75898968|FG000|Died After Cycle 2 Before Response Eval|Overall Study||1||
59778484|NCT00729612|75898968|FG000|COMPLETED|Overall Study||53||
59778485|NCT00729612|75898968|FG000|NOT COMPLETED|Overall Study||10||
59778486|NCT00585546|75898972|FG000|STARTED|LVAD Implantation Required for 4 Months||18||
59778487|NCT00585546|75898972|FG000|COMPLETED|LVAD Implantation Required for 4 Months||13||
59778488|NCT00585546|75898972|FG000|NOT COMPLETED|LVAD Implantation Required for 4 Months||5||
59778489|NCT00585546|75898972|FG000|STARTED|Clenbuterol Treatment - up to 12 Months||13||
59778490|NCT00585546|75898972|FG000|COMPLETED|Clenbuterol Treatment - up to 12 Months||9||
59778491|NCT00585546|75898972|FG000|NOT COMPLETED|Clenbuterol Treatment - up to 12 Months||4||
59778492|NCT00768248|75898978|FG000|STARTED|Overall Study||1||
59778493|NCT00768248|75898979|FG001|STARTED|Overall Study||1||
59778494|NCT00768248|75898978|FG000|COMPLETED|Overall Study||0||
59778495|NCT00768248|75898979|FG001|COMPLETED|Overall Study||0||
59778496|NCT00768248|75898978|FG000|NOT COMPLETED|Overall Study||1||
59778497|NCT00768248|75898979|FG001|NOT COMPLETED|Overall Study||1||
59778498|NCT00775268|75898987|FG000|STARTED|Baseline||9||
59778499|NCT00775268|75898988|FG001|STARTED|Baseline||22||
59778500|NCT00775268|75898987|FG000|COMPLETED|Baseline||8||
59778501|NCT00775268|75898988|FG001|COMPLETED|Baseline||21||
59522175|NCT04042324|75616497|FG000|COMPLETED|Triferic Pre-dialyzer (Day 5)||0||
59522176|NCT04042324|75616498|FG001|COMPLETED|Triferic Pre-dialyzer (Day 5)||0||
59522177|NCT04042324|75616499|FG002|COMPLETED|Triferic Pre-dialyzer (Day 5)||12||
59522178|NCT04042324|75616497|FG000|NOT COMPLETED|Triferic Pre-dialyzer (Day 5)||0||
59522179|NCT04042324|75616498|FG001|NOT COMPLETED|Triferic Pre-dialyzer (Day 5)||0||
59522180|NCT04042324|75616499|FG002|NOT COMPLETED|Triferic Pre-dialyzer (Day 5)||0||
59522181|NCT04066426|75616513|FG000|STARTED|Overall Study||50||
59522182|NCT04066426|75616514|FG001|STARTED|Overall Study||50||
59522183|NCT04066426|75616515|FG002|STARTED|Overall Study||50||
59522184|NCT04066426|75616516|FG003|STARTED|Overall Study||50||
59522185|NCT04066426|75616513|FG000|COMPLETED|Overall Study||40||
59522186|NCT04066426|75616514|FG001|COMPLETED|Overall Study||40||
59522187|NCT04066426|75616515|FG002|COMPLETED|Overall Study||42||
59522188|NCT04066426|75616516|FG003|COMPLETED|Overall Study||47||
59522189|NCT04066426|75616513|FG000|NOT COMPLETED|Overall Study||10||
59522190|NCT04066426|75616514|FG001|NOT COMPLETED|Overall Study||10||
59522191|NCT04066426|75616515|FG002|NOT COMPLETED|Overall Study||8||
59522192|NCT04066426|75616516|FG003|NOT COMPLETED|Overall Study||3||
59522193|NCT04059250|75616526|FG000|STARTED|Overall Study||25||25
59522194|NCT04059250|75616527|FG001|STARTED|Overall Study||25||25
59522195|NCT04059250|75616526|FG000|COMPLETED|Overall Study||25||25
59522196|NCT04059250|75616527|FG001|COMPLETED|Overall Study||25||25
59522197|NCT04059250|75616526|FG000|NOT COMPLETED|Overall Study||0||0
59522198|NCT04059250|75616527|FG001|NOT COMPLETED|Overall Study||0||0
59522199|NCT03808948|75616533|FG000|STARTED|Overall Study||50||
59522200|NCT03808948|75616533|FG000|COMPLETED|Overall Study||50||
59522201|NCT03808948|75616533|FG000|NOT COMPLETED|Overall Study||0||
59522202|NCT02559570|75616542|FG000|STARTED|Overall Study||41||
59522203|NCT02559570|75616543|FG001|STARTED|Overall Study||36||
59522204|NCT02559570|75616544|FG002|STARTED|Overall Study||41||
59522205|NCT02559570|75616545|FG003|STARTED|Overall Study||39||
59522206|NCT02559570|75616546|FG004|STARTED|Overall Study||16||
59522207|NCT02559570|75616542|FG000|COMPLETED|Overall Study||39|Completed = Participants who completed the Treatment period.|
59778502|NCT00775268|75898987|FG000|NOT COMPLETED|Baseline||1||
59778503|NCT00775268|75898988|FG001|NOT COMPLETED|Baseline||1||
59522208|NCT02559570|75616543|FG001|COMPLETED|Overall Study||34|Completed = Participants who completed the Treatment period.|
59522209|NCT02559570|75616544|FG002|COMPLETED|Overall Study||39|Completed = Participants who completed the Treatment period.|
59522210|NCT02559570|75616545|FG003|COMPLETED|Overall Study||36|Completed = Participants who completed the Treatment period.|
59522211|NCT02559570|75616546|FG004|COMPLETED|Overall Study||14|Completed = Participants who completed the Treatment period.|
59522212|NCT02559570|75616542|FG000|NOT COMPLETED|Overall Study||2||
59522213|NCT02559570|75616543|FG001|NOT COMPLETED|Overall Study||2||
59522214|NCT02559570|75616544|FG002|NOT COMPLETED|Overall Study||2||
59522215|NCT02559570|75616545|FG003|NOT COMPLETED|Overall Study||3||
59522216|NCT02559570|75616546|FG004|NOT COMPLETED|Overall Study||2||
59522217|NCT04051684|75616559|FG000|STARTED|Overall Study||12||
59522218|NCT04051684|75616560|FG001|STARTED|Overall Study||11||
59522219|NCT04051684|75616559|FG000|COMPLETED|Overall Study||12||
59522220|NCT04051684|75616560|FG001|COMPLETED|Overall Study||11||
59522221|NCT04051684|75616559|FG000|NOT COMPLETED|Overall Study||0||
59522222|NCT04051684|75616560|FG001|NOT COMPLETED|Overall Study||0||
59778504|NCT00775268|75898987|FG000|STARTED|After 2 Cycles||8||
59778505|NCT00775268|75898988|FG001|STARTED|After 2 Cycles|These 21 patients were not scanned after 2-cycles in this Arm. They were only scanned at baseline.|0||
59778506|NCT00775268|75898987|FG000|COMPLETED|After 2 Cycles||7||
59778507|NCT00775268|75898988|FG001|COMPLETED|After 2 Cycles||0||
59778508|NCT00775268|75898987|FG000|NOT COMPLETED|After 2 Cycles||1||
59778509|NCT00775268|75898988|FG001|NOT COMPLETED|After 2 Cycles||0||
59778510|NCT00775268|75898987|FG000|STARTED|After Completion||7||
59778511|NCT00775268|75898988|FG001|STARTED|After Completion||0||
59778512|NCT00775268|75898987|FG000|COMPLETED|After Completion||6||
59778513|NCT00775268|75898988|FG001|COMPLETED|After Completion||0||
59778514|NCT00775268|75898987|FG000|NOT COMPLETED|After Completion||1||
59778515|NCT00775268|75898988|FG001|NOT COMPLETED|After Completion||0||
59778516|NCT00775190|75899007|FG000|STARTED|Overall Study||7||
59952959|NCT04207333|76071762|FG000|NOT COMPLETED|First Intervention (Single 1-Day Visit)||0||
59952960|NCT04207333|76071763|FG001|NOT COMPLETED|First Intervention (Single 1-Day Visit)||0||
59952961|NCT04207333|76071762|FG000|STARTED|Washout (2-7 Days)||3||
59952962|NCT04207333|76071763|FG001|STARTED|Washout (2-7 Days)||3||
59952963|NCT04207333|76071762|FG000|COMPLETED|Washout (2-7 Days)||3||
59522223|NCT04057768|75616566|FG000|STARTED|Overall Study||10||
59522224|NCT04057768|75616566|FG000|COMPLETED|Overall Study||10||
59522225|NCT04057768|75616566|FG000|NOT COMPLETED|Overall Study||0||
59952964|NCT04207333|76071763|FG001|COMPLETED|Washout (2-7 Days)||3||
59952965|NCT04207333|76071762|FG000|NOT COMPLETED|Washout (2-7 Days)||0||
59952966|NCT04207333|76071763|FG001|NOT COMPLETED|Washout (2-7 Days)||0||
59522226|NCT04052542|75616582|FG000|STARTED|Overall Study||116||
59522227|NCT04052542|75616583|FG001|STARTED|Overall Study||28||
59522228|NCT04052542|75616584|FG002|STARTED|Overall Study||146||
59522229|NCT04052542|75616585|FG003|STARTED|Overall Study||188||
59522230|NCT04052542|75616586|FG004|STARTED|Overall Study||24||
59522231|NCT04052542|75616587|FG005|STARTED|Overall Study||183||
59522232|NCT04052542|75616588|FG006|STARTED|Overall Study||275||
59522233|NCT04052542|75616589|FG007|STARTED|Overall Study||27||
59522234|NCT04052542|75616590|FG008|STARTED|Overall Study||276||
59522235|NCT04052542|75616591|FG009|STARTED|Overall Study||22||
59778517|NCT00775190|75899008|FG001|STARTED|Overall Study||5||
59778518|NCT00775190|75899007|FG000|COMPLETED|Overall Study||3||
59952967|NCT04207333|76071762|FG000|STARTED|Second Intervention (Single 1-Day Visit)||3||
59522236|NCT04052542|75616592|FG010|STARTED|Overall Study||31||
59522237|NCT04052542|75616593|FG011|STARTED|Overall Study||12||
59522238|NCT04052542|75616582|FG000|COMPLETED|Overall Study||116||
59522239|NCT04052542|75616583|FG001|COMPLETED|Overall Study||28||
59522240|NCT04052542|75616584|FG002|COMPLETED|Overall Study||146||
59522241|NCT04052542|75616585|FG003|COMPLETED|Overall Study||188||
59522242|NCT04052542|75616586|FG004|COMPLETED|Overall Study||24||
59522243|NCT04052542|75616587|FG005|COMPLETED|Overall Study||183||
59522244|NCT04052542|75616588|FG006|COMPLETED|Overall Study||275||
59778519|NCT00775190|75899008|FG001|COMPLETED|Overall Study||0||
59778520|NCT00775190|75899007|FG000|NOT COMPLETED|Overall Study||4||
59778521|NCT00775190|75899008|FG001|NOT COMPLETED|Overall Study||5||
59778522|NCT00479557|75899021|FG000|STARTED|Overall Study||36||
59778523|NCT00479557|75899022|FG001|STARTED|Overall Study||61||
59778524|NCT00479557|75899023|FG002|STARTED|Overall Study||40||
59778525|NCT00479557|75899024|FG003|STARTED|Overall Study||35||
59778526|NCT00479557|75899025|FG004|STARTED|Overall Study||12||
59778527|NCT00479557|75899026|FG005|STARTED|Overall Study||44||
59778528|NCT00479557|75899027|FG006|STARTED|Overall Study||17||
59778529|NCT00479557|75899021|FG000|Treated|Overall Study||36||
59778530|NCT00479557|75899022|FG001|Treated|Overall Study|One participant discontinued due to an AE, with an outcome of death.|60||
59778531|NCT00479557|75899023|FG002|Treated|Overall Study||40||
59778532|NCT00479557|75899024|FG003|Treated|Overall Study||35||
59778533|NCT00479557|75899025|FG004|Treated|Overall Study||12||
59778534|NCT00479557|75899026|FG005|Treated|Overall Study||44||
59778535|NCT00479557|75899027|FG006|Treated|Overall Study||17||
59778536|NCT00479557|75899021|FG000|COMPLETED|Overall Study||26||
59778537|NCT00479557|75899022|FG001|COMPLETED|Overall Study||51||
59778538|NCT00479557|75899023|FG002|COMPLETED|Overall Study||32||
59778539|NCT00479557|75899024|FG003|COMPLETED|Overall Study||30||
59778540|NCT00479557|75899025|FG004|COMPLETED|Overall Study||8||
59778541|NCT00479557|75899026|FG005|COMPLETED|Overall Study||31||
59778542|NCT00479557|75899027|FG006|COMPLETED|Overall Study||15||
59778543|NCT00479557|75899021|FG000|NOT COMPLETED|Overall Study||10||
59778544|NCT00479557|75899022|FG001|NOT COMPLETED|Overall Study||10||
59778545|NCT00479557|75899023|FG002|NOT COMPLETED|Overall Study||8||
59778546|NCT00479557|75899024|FG003|NOT COMPLETED|Overall Study||5||
59778547|NCT00479557|75899025|FG004|NOT COMPLETED|Overall Study||4||
59778548|NCT00479557|75899026|FG005|NOT COMPLETED|Overall Study||13||
59778549|NCT00479557|75899027|FG006|NOT COMPLETED|Overall Study||2||
59778550|NCT00774800|75899049|FG000|STARTED|Intervention 1||22||
59778551|NCT00774800|75899049|FG000|Received at Least One Dose of Study Drug|Intervention 1||22||
59778552|NCT00774800|75899049|FG000|COMPLETED|Intervention 1||22||
59778553|NCT00774800|75899049|FG000|NOT COMPLETED|Intervention 1||0||
59778554|NCT00774800|75899049|FG000|STARTED|Washout (3 to 10 Days)||22||
59778555|NCT00774800|75899049|FG000|COMPLETED|Washout (3 to 10 Days)||22||
59778556|NCT00774800|75899049|FG000|NOT COMPLETED|Washout (3 to 10 Days)||0||
59778557|NCT00774800|75899049|FG000|STARTED|Intervention 2||22||
59778558|NCT00774800|75899049|FG000|Received at Least One Dose of Study Drug|Intervention 2||22||
59778559|NCT00774800|75899049|FG000|COMPLETED|Intervention 2||22||
59778560|NCT00774800|75899049|FG000|NOT COMPLETED|Intervention 2||0||
59778561|NCT00774800|75899049|FG000|STARTED|Washout (3 to 10 Days)||22||
59778562|NCT00774800|75899049|FG000|COMPLETED|Washout (3 to 10 Days)||22||
59778563|NCT00774800|75899049|FG000|NOT COMPLETED|Washout (3 to 10 Days)||0||
59778564|NCT00774800|75899049|FG000|STARTED|Intervention 3||22||
59618813|NCT03794700|75729936|FG001|NOT COMPLETED|Overall Study||0||
59618814|NCT01672242|75729942|FG000|STARTED|Period 1||4||
59618815|NCT01672242|75729943|FG001|STARTED|Period 1||2||
59618816|NCT01672242|75729942|FG000|COMPLETED|Period 1||4||
59618817|NCT01672242|75729943|FG001|COMPLETED|Period 1||2||
59618818|NCT01672242|75729942|FG000|NOT COMPLETED|Period 1||0||
59618819|NCT01672242|75729943|FG001|NOT COMPLETED|Period 1||0||
59618820|NCT01672242|75729942|FG000|STARTED|Period 2||4||
59618821|NCT01672242|75729943|FG001|STARTED|Period 2||2||
59618822|NCT01672242|75729942|FG000|COMPLETED|Period 2||4||
59618823|NCT01672242|75729943|FG001|COMPLETED|Period 2||2||
59618824|NCT01672242|75729942|FG000|NOT COMPLETED|Period 2||0||
59778565|NCT00774800|75899049|FG000|Received at Least One Dose of Study Drug|Intervention 3||22||
59778566|NCT00774800|75899049|FG000|COMPLETED|Intervention 3||22||
59778567|NCT00774800|75899049|FG000|NOT COMPLETED|Intervention 3||0||
59778568|NCT00774800|75899049|FG000|STARTED|Washout (3 to 10 Days)||22||
59778569|NCT00774800|75899049|FG000|COMPLETED|Washout (3 to 10 Days)||22||
59778570|NCT00774800|75899049|FG000|NOT COMPLETED|Washout (3 to 10 Days)||0||
59618825|NCT01672242|75729943|FG001|NOT COMPLETED|Period 2||0||
59618826|NCT03457818|75729951|FG000|STARTED|Overall Study||4||
59618827|NCT03457818|75729952|FG001|STARTED|Overall Study||4||
59618828|NCT03457818|75729951|FG000|COMPLETED|Overall Study|Study terminated|0||
59618829|NCT03457818|75729952|FG001|COMPLETED|Overall Study|study terminated|0||
59618830|NCT03457818|75729951|FG000|NOT COMPLETED|Overall Study||4||
59618831|NCT03457818|75729952|FG001|NOT COMPLETED|Overall Study||4||
59618832|NCT00089778|75729961|FG000|STARTED|Overall Study||2||
59618833|NCT00089778|75729962|FG001|STARTED|Overall Study||1||
59618834|NCT00089778|75729963|FG002|STARTED|Overall Study||8||
59618835|NCT00089778|75729961|FG000|COMPLETED|Overall Study||2||
59618836|NCT00089778|75729962|FG001|COMPLETED|Overall Study||1||
59618837|NCT00089778|75729963|FG002|COMPLETED|Overall Study||7||
59618838|NCT00089778|75729961|FG000|NOT COMPLETED|Overall Study||0||
59618839|NCT00089778|75729962|FG001|NOT COMPLETED|Overall Study||0||
59618840|NCT00089778|75729963|FG002|NOT COMPLETED|Overall Study||1||
59618841|NCT00089544|75729975|FG000|STARTED|Overall Study||16||
59618842|NCT00089544|75729976|FG001|STARTED|Overall Study||7||
59778571|NCT00774800|75899049|FG000|STARTED|Intervention 4||22||
59778572|NCT00774800|75899049|FG000|Received at Least One Dose of Study Drug|Intervention 4||21||
59778573|NCT00774800|75899049|FG000|COMPLETED|Intervention 4||21||
59778574|NCT00774800|75899049|FG000|NOT COMPLETED|Intervention 4||1||
59778575|NCT00439309|75899061|FG000|STARTED|Treatment||54||
59778576|NCT00439309|75899062|FG001|STARTED|Treatment||15||
59778577|NCT00439309|75899061|FG000|COMPLETED|Treatment||54||
59778578|NCT00439309|75899062|FG001|COMPLETED|Treatment||15||
59778579|NCT00439309|75899061|FG000|NOT COMPLETED|Treatment||0||
59778580|NCT00439309|75899062|FG001|NOT COMPLETED|Treatment||0||
59778581|NCT00439309|75899061|FG000|STARTED|Follow-Up||54||
59778582|NCT00439309|75899062|FG001|STARTED|Follow-Up||15||
59778583|NCT00439309|75899061|FG000|COMPLETED|Follow-Up||51||
59778584|NCT00439309|75899062|FG001|COMPLETED|Follow-Up||13||
59778585|NCT00439309|75899061|FG000|NOT COMPLETED|Follow-Up||3||
59778586|NCT00439309|75899062|FG001|NOT COMPLETED|Follow-Up||2||
59778587|NCT00479167|75899068|FG000|STARTED|Overall Study||1||
59778588|NCT00479167|75899068|FG000|COMPLETED|Overall Study||0||
59778589|NCT00479167|75899068|FG000|NOT COMPLETED|Overall Study||1||
59778590|NCT00725712|75899075|FG000|STARTED|Overall Study||48||
59778591|NCT00725712|75899076|FG001|STARTED|Overall Study||26||
59778592|NCT00725712|75899075|FG000|COMPLETED|Overall Study||0||
59778593|NCT00725712|75899076|FG001|COMPLETED|Overall Study||0||
59778594|NCT00725712|75899075|FG000|NOT COMPLETED|Overall Study||48||
59778595|NCT00725712|75899076|FG001|NOT COMPLETED|Overall Study||26||
59778596|NCT00729378|75899088|FG000|STARTED|Baseline||430||
59778597|NCT00729378|75899089|FG001|STARTED|Baseline||309||
59778598|NCT00729378|75899088|FG000|COMPLETED|Baseline||292||
59778599|NCT00729378|75899089|FG001|COMPLETED|Baseline||217||
59778600|NCT00729378|75899088|FG000|NOT COMPLETED|Baseline||138||
59778601|NCT00729378|75899089|FG001|NOT COMPLETED|Baseline||92||
59778602|NCT00729378|75899088|FG000|STARTED|12-months||292||
59778603|NCT00729378|75899089|FG001|STARTED|12-months||217||
59778604|NCT00729378|75899088|FG000|COMPLETED|12-months||192||
59778605|NCT00729378|75899089|FG001|COMPLETED|12-months||152||
59778606|NCT00729378|75899088|FG000|NOT COMPLETED|12-months||100||
59778607|NCT00729378|75899089|FG001|NOT COMPLETED|12-months||65||
59778608|NCT00729378|75899088|FG000|STARTED|24-months||192||
59778609|NCT00729378|75899089|FG001|STARTED|24-months||152||
59778610|NCT00729378|75899088|FG000|COMPLETED|24-months||120||
59778611|NCT00729378|75899089|FG001|COMPLETED|24-months||101||
59778612|NCT00729378|75899088|FG000|NOT COMPLETED|24-months||72||
59778613|NCT00729378|75899089|FG001|NOT COMPLETED|24-months||51||
59778614|NCT00729378|75899088|FG000|STARTED|36-months||120||
59778615|NCT00729378|75899089|FG001|STARTED|36-months||101||
59778616|NCT00729378|75899088|FG000|COMPLETED|36-months||105||
59778617|NCT00729378|75899089|FG001|COMPLETED|36-months||95||
59778618|NCT00729378|75899088|FG000|NOT COMPLETED|36-months||15||
59778619|NCT00729378|75899089|FG001|NOT COMPLETED|36-months||6||
59778620|NCT00478933|75899098|FG000|STARTED|Overall Study||1223||
59778621|NCT00478933|75899098|FG000|COMPLETED|Overall Study||1145||
59778622|NCT00478933|75899098|FG000|NOT COMPLETED|Overall Study||78||
59778623|NCT00725322|75899124|FG000|STARTED|First Injection Visit||15||
59778624|NCT00725322|75899125|FG001|STARTED|First Injection Visit||15||
59778625|NCT00725322|75899124|FG000|COMPLETED|First Injection Visit||15||
59778626|NCT00725322|75899125|FG001|COMPLETED|First Injection Visit||15||
59778627|NCT00725322|75899124|FG000|NOT COMPLETED|First Injection Visit||0||
59778628|NCT00725322|75899125|FG001|NOT COMPLETED|First Injection Visit||0||
59778629|NCT00725322|75899124|FG000|STARTED|Washout (28 Days)||15||
59778630|NCT00725322|75899125|FG001|STARTED|Washout (28 Days)||15||
59778631|NCT00725322|75899124|FG000|COMPLETED|Washout (28 Days)||13||
59778632|NCT00725322|75899125|FG001|COMPLETED|Washout (28 Days)||14||
59778633|NCT00725322|75899124|FG000|NOT COMPLETED|Washout (28 Days)||2||
59778634|NCT00725322|75899125|FG001|NOT COMPLETED|Washout (28 Days)||1||
59778635|NCT00725322|75899124|FG000|STARTED|Second Injection Visit||13||
59778636|NCT00725322|75899125|FG001|STARTED|Second Injection Visit||14||
59778637|NCT00725322|75899124|FG000|COMPLETED|Second Injection Visit||13||
59778638|NCT00725322|75899125|FG001|COMPLETED|Second Injection Visit||14||
59778639|NCT00725322|75899124|FG000|NOT COMPLETED|Second Injection Visit||0||
59778640|NCT00725322|75899125|FG001|NOT COMPLETED|Second Injection Visit||0||
59778641|NCT00725010|75899131|FG000|STARTED|Overall Study|Only in 50 of 64 participants the documentation of therapy and follow-up was received and evaluated.|50||
59778642|NCT00725010|75899131|FG000|COMPLETED|Overall Study||25||
59778643|NCT00725010|75899131|FG000|NOT COMPLETED|Overall Study||25||
59778644|NCT00767000|75899142|FG000|STARTED|54-week Study||119||
59778645|NCT00767000|75899143|FG001|STARTED|54-week Study||117||
59778646|NCT00767000|75899144|FG002|STARTED|54-week Study||117||
59778647|NCT00767000|75899145|FG003|STARTED|54-week Study|Includes additional participants enrolled to enhance evaluation of the safety profile of MK-0941|229||
59778648|NCT00767000|75899146|FG004|STARTED|54-week Study|Includes additional participants enrolled to enhance evaluation of the safety profile of MK-0941|231||
59778649|NCT00767000|75899142|FG000|COMPLETED|54-week Study||11||
59778650|NCT00767000|75899143|FG001|COMPLETED|54-week Study||4||
59778651|NCT00767000|75899144|FG002|COMPLETED|54-week Study||8||
59778652|NCT00767000|75899145|FG003|COMPLETED|54-week Study||4||
59778653|NCT00767000|75899146|FG004|COMPLETED|54-week Study||7||
59778654|NCT00767000|75899142|FG000|NOT COMPLETED|54-week Study||108||
59778655|NCT00767000|75899143|FG001|NOT COMPLETED|54-week Study||113||
59778656|NCT00767000|75899144|FG002|NOT COMPLETED|54-week Study||109||
59778657|NCT00767000|75899145|FG003|NOT COMPLETED|54-week Study||225||
59778658|NCT00767000|75899146|FG004|NOT COMPLETED|54-week Study||224||
59778659|NCT00767000|75899142|FG000|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|7||
59778660|NCT00767000|75899143|FG001|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|3||
59778661|NCT00767000|75899144|FG002|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|7||
59778662|NCT00767000|75899145|FG003|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|2||
59778663|NCT00767000|75899146|FG004|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|4||
59778664|NCT00767000|75899142|FG000|COMPLETED|Optional 104-week Extension||0||
59778665|NCT00767000|75899143|FG001|COMPLETED|Optional 104-week Extension||0||
59778666|NCT00767000|75899144|FG002|COMPLETED|Optional 104-week Extension||0||
59778667|NCT00767000|75899145|FG003|COMPLETED|Optional 104-week Extension||0||
59778668|NCT00767000|75899146|FG004|COMPLETED|Optional 104-week Extension||0||
59778669|NCT00767000|75899142|FG000|NOT COMPLETED|Optional 104-week Extension||7||
59778670|NCT00767000|75899143|FG001|NOT COMPLETED|Optional 104-week Extension||3||
59778671|NCT00767000|75899144|FG002|NOT COMPLETED|Optional 104-week Extension||7||
59778672|NCT00767000|75899145|FG003|NOT COMPLETED|Optional 104-week Extension||2||
59778673|NCT00767000|75899146|FG004|NOT COMPLETED|Optional 104-week Extension||4||
59778674|NCT00724932|75899160|FG000|STARTED|Overall Study||70||
59778675|NCT00724932|75899161|FG001|STARTED|Overall Study||70||
59778676|NCT00724932|75899160|FG000|COMPLETED|Overall Study||65||
59778677|NCT00724932|75899161|FG001|COMPLETED|Overall Study||67||
59778678|NCT00724932|75899160|FG000|NOT COMPLETED|Overall Study||5||
59778679|NCT00724932|75899161|FG001|NOT COMPLETED|Overall Study||3||
59778680|NCT00766532|75899169|FG000|STARTED|Overall Study||12||
59778681|NCT00766532|75899169|FG000|COMPLETED|Overall Study||10||
59778682|NCT00766532|75899169|FG000|NOT COMPLETED|Overall Study||2||
59778683|NCT00774566|75899175|FG000|STARTED|Overall Study||159||
59778684|NCT00774566|75899176|FG001|STARTED|Overall Study||156||
59778685|NCT00774566|75899175|FG000|6 Month Follow up|Overall Study||154||
59778686|NCT00774566|75899176|FG001|6 Month Follow up|Overall Study||150||
59778687|NCT00774566|75899175|FG000|12 Month Follow up|Overall Study||141||
59778688|NCT00774566|75899176|FG001|12 Month Follow up|Overall Study||141||
59778689|NCT00774566|75899175|FG000|COMPLETED|Overall Study||141||
59778690|NCT00774566|75899176|FG001|COMPLETED|Overall Study||141||
59778691|NCT00774566|75899175|FG000|NOT COMPLETED|Overall Study||18||
59778692|NCT00774566|75899176|FG001|NOT COMPLETED|Overall Study||15||
59778693|NCT00766376|75899182|FG000|STARTED|Overall Study||151||
59778694|NCT00766376|75899182|FG000|COMPLETED|Overall Study||124||
59778695|NCT00766376|75899182|FG000|NOT COMPLETED|Overall Study||27||
59778696|NCT00587054|75899186|FG000|STARTED|Overall Study||129||
59778697|NCT00587054|75899186|FG000|COMPLETED|Overall Study||120||
59778698|NCT00587054|75899186|FG000|NOT COMPLETED|Overall Study||9||
59778699|NCT00766142|75899190|FG000|STARTED|Overall Study||18||
59778700|NCT00766142|75899190|FG000|COMPLETED|Overall Study||14||
59778701|NCT00766142|75899190|FG000|NOT COMPLETED|Overall Study||4||
59778702|NCT00724854|75899196|FG000|STARTED|Overall Study|Number enrolled was 1146. 64 participants were screen failures.|1010||
59778703|NCT00724854|75899197|FG001|STARTED|Overall Study|Number enrolled was 1146. 64 participants were screen failures.|72||
59778704|NCT00724854|75899196|FG000|COMPLETED|Overall Study||607||
59778705|NCT00724854|75899197|FG001|COMPLETED|Overall Study||41||
59778706|NCT00724854|75899196|FG000|NOT COMPLETED|Overall Study||403||
59778707|NCT00724854|75899197|FG001|NOT COMPLETED|Overall Study||31||
59778708|NCT00728988|75899206|FG000|STARTED|Overall Study||247||
59778709|NCT00728988|75899207|FG001|STARTED|Overall Study||252||
59778710|NCT00728988|75899206|FG000|Treated|Overall Study||245||
59778711|NCT00728988|75899207|FG001|Treated|Overall Study||250||
59778712|NCT00728988|75899206|FG000|Full Analysis Set|Overall Study||163||
59778713|NCT00728988|75899207|FG001|Full Analysis Set|Overall Study||172||
60072953|NCT01591863|76188146|FG000|STARTED|Overall Study||38||
60072954|NCT01591863|76188146|FG000|COMPLETED|Overall Study||24||
60072955|NCT01591863|76188146|FG000|NOT COMPLETED|Overall Study||14||
60072956|NCT01591785|76188152|FG000|STARTED|Overall Study||30||
60072957|NCT01591785|76188153|FG001|STARTED|Overall Study||30||
60072958|NCT01591785|76188152|FG000|COMPLETED|Overall Study||26||
59522245|NCT04052542|75616589|FG007|COMPLETED|Overall Study||27||
59778714|NCT00728988|75899206|FG000|COMPLETED|Overall Study||154||
59778715|NCT00728988|75899207|FG001|COMPLETED|Overall Study||164||
59778716|NCT00728988|75899206|FG000|NOT COMPLETED|Overall Study||93||
59778717|NCT00728988|75899207|FG001|NOT COMPLETED|Overall Study||88||
59778718|NCT00728754|75899216|FG000|STARTED|Implant Placement Surgery|Individual test implant units is 75|29||
59778719|NCT00728754|75899217|FG001|STARTED|Implant Placement Surgery|Individual control implant units is 78|32||
59778720|NCT00728754|75899216|FG000|COMPLETED|Implant Placement Surgery|Individual test implant units completed = 75|29||
59778721|NCT00728754|75899217|FG001|COMPLETED|Implant Placement Surgery|Individual control implant units completed = 78|32||
59778722|NCT00728754|75899216|FG000|NOT COMPLETED|Implant Placement Surgery||0||
59778723|NCT00728754|75899217|FG001|NOT COMPLETED|Implant Placement Surgery||0||
59778724|NCT00728754|75899216|FG000|STARTED|Permanent Prosthesis Placement|Individual test implant units is 75|29||
59778725|NCT00728754|75899217|FG001|STARTED|Permanent Prosthesis Placement|Individual control implant units is 78|32||
59778726|NCT00728754|75899216|FG000|COMPLETED|Permanent Prosthesis Placement|Individual test implant units completed = 66|25||
59778727|NCT00728754|75899217|FG001|COMPLETED|Permanent Prosthesis Placement|Individual control implant units completed = 68|28||
59778728|NCT00728754|75899216|FG000|NOT COMPLETED|Permanent Prosthesis Placement||4||
59522246|NCT04052542|75616590|FG008|COMPLETED|Overall Study||276||
59778729|NCT00728754|75899217|FG001|NOT COMPLETED|Permanent Prosthesis Placement||4||
59778730|NCT00728754|75899216|FG000|STARTED|One Year Post Placement Follow-up|individual test implant units is 66|25||
59778731|NCT00728754|75899217|FG001|STARTED|One Year Post Placement Follow-up|individual control implant units is 68|28||
59778732|NCT00728754|75899216|FG000|COMPLETED|One Year Post Placement Follow-up|individual test implant units completing is 65|24||
59778733|NCT00728754|75899217|FG001|COMPLETED|One Year Post Placement Follow-up|individual control implant units completed= 68|28||
59778734|NCT00728754|75899216|FG000|NOT COMPLETED|One Year Post Placement Follow-up||1||
59778735|NCT00728754|75899217|FG001|NOT COMPLETED|One Year Post Placement Follow-up||0||
59778736|NCT00728754|75899216|FG000|STARTED|Two Year Post Placement Follow-up|individual test implant units is 65|24||
59778737|NCT00728754|75899217|FG001|STARTED|Two Year Post Placement Follow-up|individual control implant units is 68|28||
59778738|NCT00728754|75899216|FG000|COMPLETED|Two Year Post Placement Follow-up|individual test implant units completed= 65|24||
59778739|NCT00728754|75899217|FG001|COMPLETED|Two Year Post Placement Follow-up|individual test implant units completed= 68|28||
59778740|NCT00728754|75899216|FG000|NOT COMPLETED|Two Year Post Placement Follow-up||0||
59778741|NCT00728754|75899217|FG001|NOT COMPLETED|Two Year Post Placement Follow-up||0||
59778742|NCT00728130|75899223|FG000|STARTED|Overall Study||22||
59778743|NCT00728130|75899223|FG000|COMPLETED|Overall Study||19||
59778744|NCT00728130|75899223|FG000|NOT COMPLETED|Overall Study||3||
59778745|NCT00735696|75899227|FG000|STARTED|Overall Study||41||
59778746|NCT00735696|75899227|FG000|Received Any Quantity of Study Drug|Overall Study||40||
59778747|NCT00735696|75899227|FG000|COMPLETED|Overall Study||39||
59778748|NCT00735696|75899227|FG000|NOT COMPLETED|Overall Study||2||
59778749|NCT02591862|75899231|FG000|STARTED|Overall Study||1||
59778750|NCT02591862|75899231|FG000|COMPLETED|Overall Study||1||
59778751|NCT02591862|75899231|FG000|NOT COMPLETED|Overall Study||0||
59778752|NCT00478231|75899236|FG000|STARTED|Overall Study||209||
59778753|NCT00478231|75899236|FG000|Treated|Overall Study||206||
59778754|NCT00478231|75899236|FG000|COMPLETED|Overall Study||125||
59778755|NCT00478231|75899236|FG000|NOT COMPLETED|Overall Study||84||
59778756|NCT00474175|75899243|FG000|STARTED|Overall Study||115||
59778757|NCT00474175|75899244|FG001|STARTED|Overall Study||233||
59778758|NCT00474175|75899245|FG002|STARTED|Overall Study||229||
59778759|NCT00474175|75899243|FG000|Treated|Overall Study||115||
59778760|NCT00474175|75899244|FG001|Treated|Overall Study||233||
59778761|NCT00474175|75899245|FG002|Treated|Overall Study||228||
59778762|NCT00474175|75899243|FG000|COMPLETED|Overall Study||114||
59778763|NCT00474175|75899244|FG001|COMPLETED|Overall Study||226||
59778764|NCT00474175|75899245|FG002|COMPLETED|Overall Study||225||
59778765|NCT00474175|75899243|FG000|NOT COMPLETED|Overall Study||1||
59778766|NCT00474175|75899244|FG001|NOT COMPLETED|Overall Study||7||
59778767|NCT00474175|75899245|FG002|NOT COMPLETED|Overall Study||4||
59778768|NCT03574129|75899255|FG000|STARTED|Overall Study||578||
59778769|NCT03574129|75899256|FG001|STARTED|Overall Study||488||
59778770|NCT03574129|75899255|FG000|COMPLETED|Overall Study||506||
59778771|NCT03574129|75899256|FG001|COMPLETED|Overall Study||440||
59778772|NCT03574129|75899255|FG000|NOT COMPLETED|Overall Study||72||
59778773|NCT03574129|75899256|FG001|NOT COMPLETED|Overall Study||48||
59778774|NCT00443209|75899276|FG000|STARTED|Months 1 to 12 Treatment Period||712||
59778775|NCT00443209|75899277|FG001|STARTED|Months 1 to 12 Treatment Period||356||
59778776|NCT00443209|75899276|FG000|Treated|Months 1 to 12 Treatment Period||641||
59778777|NCT00443209|75899277|FG001|Treated|Months 1 to 12 Treatment Period||313||
59778778|NCT00443209|75899276|FG000|COMPLETED|Months 1 to 12 Treatment Period|Trial terminated used for participants not completing 12 months of treatment due to trial completion|367||
59778779|NCT00443209|75899277|FG001|COMPLETED|Months 1 to 12 Treatment Period|Trial terminated used for participants not completing 12 months of treatment due to trial completion|202||
59778780|NCT00443209|75899276|FG000|NOT COMPLETED|Months 1 to 12 Treatment Period||345||
59778781|NCT00443209|75899277|FG001|NOT COMPLETED|Months 1 to 12 Treatment Period||154||
59778782|NCT00443209|75899276|FG000|STARTED|Months 13 to 18 Treatment Period|The Months 13 to 18 Treatment Period.was optional. 181 participants chose not to continue.|186||
59778783|NCT00443209|75899277|FG001|STARTED|Months 13 to 18 Treatment Period|The Months 13 to 18 Treatment Period was optional. 116 participants chose not to continue.|86||
59778784|NCT00443209|75899276|FG000|COMPLETED|Months 13 to 18 Treatment Period|Trial terminated used for participants not completing 18 months of treatment due to trial completion|87||
59778785|NCT00443209|75899277|FG001|COMPLETED|Months 13 to 18 Treatment Period|Trial terminated used for participants not completing 18 months of treatment due to trial completion|39||
59778786|NCT00443209|75899276|FG000|NOT COMPLETED|Months 13 to 18 Treatment Period||99||
59778787|NCT00443209|75899277|FG001|NOT COMPLETED|Months 13 to 18 Treatment Period||47||
59778788|NCT00439231|75899283|FG000|STARTED|Overall Study||33||
59778789|NCT00439231|75899283|FG000|COMPLETED|Overall Study|5 subjects had a partial response, 0 complete response, 28 completed off study,|5||
59778790|NCT00439231|75899283|FG000|NOT COMPLETED|Overall Study||28||
59778791|NCT00437983|75899289|FG000|STARTED|Overall Study||79||
59778792|NCT00437983|75899290|FG001|STARTED|Overall Study||78||
59778793|NCT00437983|75899289|FG000|COMPLETED|Overall Study||66||
59778794|NCT00437983|75899290|FG001|COMPLETED|Overall Study||65||
59778795|NCT00437983|75899289|FG000|NOT COMPLETED|Overall Study||13||
59778796|NCT00437983|75899290|FG001|NOT COMPLETED|Overall Study||13||
59778797|NCT00783692|75899299|FG000|STARTED|Induction Phase||148||
59778798|NCT00783692|75899300|FG001|STARTED|Induction Phase||220||
59618843|NCT00089544|75729975|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|15||
59618844|NCT00089544|75729976|FG001|COMPLETED|Overall Study||7||
59618845|NCT00089544|75729975|FG000|NOT COMPLETED|Overall Study||1||
59618846|NCT00089544|75729976|FG001|NOT COMPLETED|Overall Study||0||
59618847|NCT00089076|75729982|FG000|STARTED|Overall Study||18||
59618848|NCT00089076|75729982|FG000|COMPLETED|Overall Study||8||
59618849|NCT00089076|75729982|FG000|NOT COMPLETED|Overall Study||10||
59618850|NCT00088374|75729986|FG000|STARTED|Overall Study||9||
59618851|NCT00088374|75729986|FG000|COMPLETED|Overall Study||7||
59618852|NCT00088374|75729986|FG000|NOT COMPLETED|Overall Study||2||
59618853|NCT00087594|75729992|FG000|STARTED|Overall Study||24||
59618854|NCT00087594|75729993|FG001|STARTED|Overall Study||24||
59618855|NCT00087594|75729992|FG000|COMPLETED|Overall Study||16||
59618856|NCT00087594|75729993|FG001|COMPLETED|Overall Study||12||
59618857|NCT00087594|75729992|FG000|NOT COMPLETED|Overall Study||8||
59618858|NCT00087594|75729993|FG001|NOT COMPLETED|Overall Study||12||
59618859|NCT00087516|75730002|FG000|STARTED|Overall Study||238||
59618860|NCT00087516|75730003|FG001|STARTED|Overall Study||250||
59618861|NCT00087516|75730004|FG002|STARTED|Overall Study||130||
59618862|NCT00087516|75730005|FG003|STARTED|Overall Study||123||
59618863|NCT00087516|75730002|FG000|COMPLETED|Overall Study||77||
59618864|NCT00087516|75730003|FG001|COMPLETED|Overall Study||81||
59618865|NCT00087516|75730004|FG002|COMPLETED|Overall Study||33||
59618866|NCT00087516|75730005|FG003|COMPLETED|Overall Study||38||
59618867|NCT00087516|75730002|FG000|NOT COMPLETED|Overall Study||161||
59618868|NCT00087516|75730003|FG001|NOT COMPLETED|Overall Study||169||
59618869|NCT00087516|75730004|FG002|NOT COMPLETED|Overall Study||97||
59618870|NCT00087516|75730005|FG003|NOT COMPLETED|Overall Study||85||
59618871|NCT00087126|75730019|FG000|STARTED|Overall Study||27||
59618872|NCT00087126|75730019|FG000|COMPLETED|Overall Study||25|Eligible and treated patients|
59618873|NCT00087126|75730019|FG000|NOT COMPLETED|Overall Study||2||
59618874|NCT03490734|75730032|FG000|STARTED|Pre-intervention Baseline Visit||47||
59618875|NCT03490734|75730033|FG001|STARTED|Pre-intervention Baseline Visit||38||
59618876|NCT03490734|75730034|FG002|STARTED|Pre-intervention Baseline Visit||34||
59618877|NCT03490734|75730035|FG003|STARTED|Pre-intervention Baseline Visit||41||
59618878|NCT03490734|75730032|FG000|COMPLETED|Pre-intervention Baseline Visit||47||
59618879|NCT03490734|75730033|FG001|COMPLETED|Pre-intervention Baseline Visit||38||
59618880|NCT03490734|75730034|FG002|COMPLETED|Pre-intervention Baseline Visit||34||
59618881|NCT03490734|75730035|FG003|COMPLETED|Pre-intervention Baseline Visit||41||
59618882|NCT03490734|75730032|FG000|NOT COMPLETED|Pre-intervention Baseline Visit||0||
59618883|NCT03490734|75730033|FG001|NOT COMPLETED|Pre-intervention Baseline Visit||0||
59618884|NCT03490734|75730034|FG002|NOT COMPLETED|Pre-intervention Baseline Visit||0||
59618885|NCT03490734|75730035|FG003|NOT COMPLETED|Pre-intervention Baseline Visit||0||
59618886|NCT03490734|75730032|FG000|STARTED|Pre-intervention Scan Visit||47||
59618887|NCT03490734|75730033|FG001|STARTED|Pre-intervention Scan Visit||38||
59618888|NCT03490734|75730034|FG002|STARTED|Pre-intervention Scan Visit||34||
59618889|NCT03490734|75730035|FG003|STARTED|Pre-intervention Scan Visit||41||
59618890|NCT03490734|75730032|FG000|COMPLETED|Pre-intervention Scan Visit||45||
59618891|NCT03490734|75730033|FG001|COMPLETED|Pre-intervention Scan Visit||37||
59618892|NCT03490734|75730034|FG002|COMPLETED|Pre-intervention Scan Visit||34||
59618893|NCT03490734|75730035|FG003|COMPLETED|Pre-intervention Scan Visit||37||
59618894|NCT03490734|75730032|FG000|NOT COMPLETED|Pre-intervention Scan Visit||2||
59618895|NCT03490734|75730033|FG001|NOT COMPLETED|Pre-intervention Scan Visit||1||
59618896|NCT03490734|75730034|FG002|NOT COMPLETED|Pre-intervention Scan Visit||0||
59618897|NCT03490734|75730035|FG003|NOT COMPLETED|Pre-intervention Scan Visit||4||
59618898|NCT03490734|75730032|FG000|STARTED|Post-intervention Scan Visit||45||
59618899|NCT03490734|75730033|FG001|STARTED|Post-intervention Scan Visit||37||
59618900|NCT03490734|75730034|FG002|STARTED|Post-intervention Scan Visit||34||
59618901|NCT03490734|75730035|FG003|STARTED|Post-intervention Scan Visit||37||
59618902|NCT03490734|75730032|FG000|COMPLETED|Post-intervention Scan Visit||43||
59618903|NCT03490734|75730033|FG001|COMPLETED|Post-intervention Scan Visit||34||
59618904|NCT03490734|75730034|FG002|COMPLETED|Post-intervention Scan Visit||34||
59618905|NCT03490734|75730035|FG003|COMPLETED|Post-intervention Scan Visit||34||
59618906|NCT03490734|75730032|FG000|NOT COMPLETED|Post-intervention Scan Visit||2||
59618907|NCT03490734|75730033|FG001|NOT COMPLETED|Post-intervention Scan Visit||3||
59618908|NCT03490734|75730034|FG002|NOT COMPLETED|Post-intervention Scan Visit||0||
59618909|NCT03490734|75730035|FG003|NOT COMPLETED|Post-intervention Scan Visit||3||
59618910|NCT03490734|75730032|FG000|STARTED|Post-intervention Behavioral Visit||43||
59618911|NCT03490734|75730033|FG001|STARTED|Post-intervention Behavioral Visit||34||
59618912|NCT03490734|75730034|FG002|STARTED|Post-intervention Behavioral Visit||34||
59618913|NCT03490734|75730035|FG003|STARTED|Post-intervention Behavioral Visit||34||
59618914|NCT03490734|75730032|FG000|COMPLETED|Post-intervention Behavioral Visit||43||
59618915|NCT03490734|75730033|FG001|COMPLETED|Post-intervention Behavioral Visit||34||
59618916|NCT03490734|75730034|FG002|COMPLETED|Post-intervention Behavioral Visit||34||
59618917|NCT03490734|75730035|FG003|COMPLETED|Post-intervention Behavioral Visit||34||
59618918|NCT03490734|75730032|FG000|NOT COMPLETED|Post-intervention Behavioral Visit||0||
59778799|NCT00783692|75899301|FG002|STARTED|Induction Phase||748||
59778800|NCT00783692|75899302|FG003|STARTED|Induction Phase||0||
59778801|NCT00783692|75899303|FG004|STARTED|Induction Phase||0||
59778802|NCT00783692|75899304|FG005|STARTED|Induction Phase||0||
59778803|NCT00783692|75899305|FG006|STARTED|Induction Phase||0||
59778804|NCT00783692|75899299|FG000|Treated|Induction Phase||148||
59778805|NCT00783692|75899300|FG001|Treated|Induction Phase||220||
59778806|NCT00783692|75899301|FG002|Treated|Induction Phase||747||
59778807|NCT00783692|75899302|FG003|Treated|Induction Phase||0||
59778808|NCT00783692|75899303|FG004|Treated|Induction Phase||0||
59778809|NCT00783692|75899304|FG005|Treated|Induction Phase||0||
59778810|NCT00783692|75899305|FG006|Treated|Induction Phase||0||
59778811|NCT00783692|75899299|FG000|COMPLETED|Induction Phase||137||
59778812|NCT00783692|75899300|FG001|COMPLETED|Induction Phase||199||
59778813|NCT00783692|75899301|FG002|COMPLETED|Induction Phase||674||
59778814|NCT00783692|75899302|FG003|COMPLETED|Induction Phase||0||
59778815|NCT00783692|75899303|FG004|COMPLETED|Induction Phase||0||
59778816|NCT00783692|75899304|FG005|COMPLETED|Induction Phase||0||
59778817|NCT00783692|75899305|FG006|COMPLETED|Induction Phase||0||
59778818|NCT00783692|75899299|FG000|NOT COMPLETED|Induction Phase||11||
59778819|NCT00783692|75899300|FG001|NOT COMPLETED|Induction Phase||21||
59778820|NCT00783692|75899301|FG002|NOT COMPLETED|Induction Phase||74||
59778821|NCT00783692|75899302|FG003|NOT COMPLETED|Induction Phase||0||
59778822|NCT00783692|75899303|FG004|NOT COMPLETED|Induction Phase||0||
59778823|NCT00783692|75899304|FG005|NOT COMPLETED|Induction Phase||0||
59778824|NCT00783692|75899305|FG006|NOT COMPLETED|Induction Phase||0||
59778825|NCT00783692|75899299|FG000|STARTED|Maintenance Phase||137||
59778826|NCT00783692|75899300|FG001|STARTED|Maintenance Phase||0||
59778827|NCT00783692|75899301|FG002|STARTED|Maintenance Phase||0||
59778828|NCT00783692|75899302|FG003|STARTED|Maintenance Phase||153||
59778829|NCT00783692|75899303|FG004|STARTED|Maintenance Phase||154||
59778830|NCT00783692|75899304|FG005|STARTED|Maintenance Phase||154||
59778831|NCT00783692|75899305|FG006|STARTED|Maintenance Phase||412||
59778832|NCT00783692|75899299|FG000|COMPLETED|Maintenance Phase||42||
59778833|NCT00783692|75899300|FG001|COMPLETED|Maintenance Phase||0||
59778834|NCT00783692|75899301|FG002|COMPLETED|Maintenance Phase||0||
59778835|NCT00783692|75899302|FG003|COMPLETED|Maintenance Phase||64||
59778836|NCT00783692|75899303|FG004|COMPLETED|Maintenance Phase||73||
59778837|NCT00783692|75899304|FG005|COMPLETED|Maintenance Phase||82||
59778838|NCT00783692|75899305|FG006|COMPLETED|Maintenance Phase||163||
59778839|NCT00783692|75899299|FG000|NOT COMPLETED|Maintenance Phase||95||
59778840|NCT00783692|75899300|FG001|NOT COMPLETED|Maintenance Phase||0||
59778841|NCT00783692|75899301|FG002|NOT COMPLETED|Maintenance Phase||0||
59778842|NCT00783692|75899302|FG003|NOT COMPLETED|Maintenance Phase||89||
59778843|NCT00783692|75899303|FG004|NOT COMPLETED|Maintenance Phase||81||
59778844|NCT00783692|75899304|FG005|NOT COMPLETED|Maintenance Phase||72||
59778845|NCT00783692|75899305|FG006|NOT COMPLETED|Maintenance Phase||249||
59778846|NCT04992273|75899320|FG000|STARTED|Overall Study||2||
59778847|NCT04992273|75899321|FG001|STARTED|Overall Study||5||
59778848|NCT04992273|75899320|FG000|COMPLETED|Overall Study||2||
59778849|NCT04992273|75899321|FG001|COMPLETED|Overall Study||4||
59778850|NCT04992273|75899320|FG000|NOT COMPLETED|Overall Study||0||
59778851|NCT04992273|75899321|FG001|NOT COMPLETED|Overall Study||1||
59778852|NCT00783302|75899328|FG000|STARTED|Overall Study||885||
59778853|NCT00783302|75899328|FG000|COMPLETED|Overall Study||850||
59778854|NCT00783302|75899328|FG000|NOT COMPLETED|Overall Study||35||
59778855|NCT00783224|75899350|FG000|STARTED|Overall Study||32||
59778856|NCT00783224|75899351|FG001|STARTED|Overall Study||34||
59778857|NCT00783224|75899352|FG002|STARTED|Overall Study||143||
59778858|NCT00783224|75899353|FG003|STARTED|Overall Study||142||
59778859|NCT00783224|75899350|FG000|COMPLETED|Overall Study||32||
59778860|NCT00783224|75899351|FG001|COMPLETED|Overall Study||34||
59778861|NCT00783224|75899352|FG002|COMPLETED|Overall Study||142||
59778862|NCT00783224|75899353|FG003|COMPLETED|Overall Study||140||
59778863|NCT00783224|75899350|FG000|NOT COMPLETED|Overall Study||0||
59778864|NCT00783224|75899351|FG001|NOT COMPLETED|Overall Study||0||
59778865|NCT00783224|75899352|FG002|NOT COMPLETED|Overall Study||1||
59778866|NCT00783224|75899353|FG003|NOT COMPLETED|Overall Study||2||
59778867|NCT00782834|75899362|FG000|STARTED|Screened Patients||15||
59778868|NCT00782834|75899362|FG000|COMPLETED|Screened Patients|1 pt ineligible d/t arrhythmia|14||
59778869|NCT00782834|75899362|FG000|NOT COMPLETED|Screened Patients||1||
59778870|NCT00782834|75899362|FG000|STARTED|Treatment Phase||14||
59778871|NCT00782834|75899362|FG000|COMPLETED|Treatment Phase||13||
59778872|NCT00782834|75899362|FG000|NOT COMPLETED|Treatment Phase||1||
59778873|NCT00584805|75899366|FG000|STARTED|Overall Study||138||
59778874|NCT00584805|75899366|FG000|COMPLETED|Overall Study||39||
59778875|NCT00584805|75899366|FG000|NOT COMPLETED|Overall Study||99||
59778876|NCT00765674|75899376|FG000|STARTED|Overall Study||287||
59778877|NCT00765674|75899377|FG001|STARTED|Overall Study|1 patient was randomized in error and discontinued without taking any double-blind study medication.|298||
59778878|NCT00765674|75899378|FG002|STARTED|Overall Study||296||
59778879|NCT00765674|75899379|FG003|STARTED|Overall Study|1 patient was randomized in error and discontinued without taking any double-blind study medication.|310||
59778880|NCT00765674|75899376|FG000|COMPLETED|Overall Study||266||
59778881|NCT00765674|75899377|FG001|COMPLETED|Overall Study||276||
59778882|NCT00765674|75899378|FG002|COMPLETED|Overall Study||279||
59778883|NCT00765674|75899379|FG003|COMPLETED|Overall Study||285||
59778884|NCT00765674|75899376|FG000|NOT COMPLETED|Overall Study||21||
59778885|NCT00765674|75899377|FG001|NOT COMPLETED|Overall Study||22||
59778886|NCT00765674|75899378|FG002|NOT COMPLETED|Overall Study||17||
59778887|NCT00765674|75899379|FG003|NOT COMPLETED|Overall Study||25||
59778888|NCT00765362|75899389|FG000|STARTED|Overall Study||419||
59778889|NCT00765362|75899389|FG000|COMPLETED|Overall Study||282||
59778890|NCT00765362|75899389|FG000|NOT COMPLETED|Overall Study||137||
59778891|NCT00586898|75899393|FG000|STARTED|Overall Study||36||
59778892|NCT00586898|75899393|FG000|COMPLETED|Overall Study||29||
59778893|NCT00586898|75899393|FG000|NOT COMPLETED|Overall Study||7||
59778894|NCT04912245|75899397|FG000|STARTED|Overall Study||107||
59778895|NCT04912245|75899398|FG001|STARTED|Overall Study||45||
59778896|NCT04912245|75899397|FG000|COMPLETED|Overall Study||81|Caregivers Completed|
59778897|NCT04912245|75899398|FG001|COMPLETED|Overall Study||30|Caregivers Completed|
59778898|NCT04912245|75899397|FG000|NOT COMPLETED|Overall Study||26||
59778899|NCT04912245|75899398|FG001|NOT COMPLETED|Overall Study||15||
59778900|NCT00796991|75899405|FG000|STARTED|Overall Study||20||
59778901|NCT00796991|75899406|FG001|STARTED|Overall Study||19||
59778902|NCT00796991|75899407|FG002|STARTED|Overall Study||20||
59778903|NCT00796991|75899405|FG000|COMPLETED|Overall Study|Participants continued treatment into maintenance phase.|5||
59778904|NCT00796991|75899406|FG001|COMPLETED|Overall Study|Participants continued treatment into maintenance phase.|7||
59778905|NCT00796991|75899407|FG002|COMPLETED|Overall Study|Participants continued treatment into maintenance phase.|6||
59778906|NCT00796991|75899405|FG000|NOT COMPLETED|Overall Study||15||
59778907|NCT00796991|75899406|FG001|NOT COMPLETED|Overall Study||12||
59778908|NCT00796991|75899407|FG002|NOT COMPLETED|Overall Study||14||
59778909|NCT00799487|75899418|FG000|STARTED|Dose Adjustment Period||21||
59778910|NCT00799487|75899419|FG001|STARTED|Dose Adjustment Period||34||
59778911|NCT00799487|75899420|FG002|STARTED|Dose Adjustment Period||34||
59778912|NCT00799487|75899418|FG000|COMPLETED|Dose Adjustment Period||0||
59778913|NCT00799487|75899419|FG001|COMPLETED|Dose Adjustment Period||34||
59778914|NCT00799487|75899420|FG002|COMPLETED|Dose Adjustment Period||34||
59778915|NCT00799487|75899418|FG000|NOT COMPLETED|Dose Adjustment Period||21||
59778916|NCT00799487|75899419|FG001|NOT COMPLETED|Dose Adjustment Period||0||
59778917|NCT00799487|75899420|FG002|NOT COMPLETED|Dose Adjustment Period||0||
59778918|NCT00799487|75899418|FG000|STARTED|Double-Blind Assessment Period||0||
59778919|NCT00799487|75899419|FG001|STARTED|Double-Blind Assessment Period||34||
59778920|NCT00799487|75899420|FG002|STARTED|Double-Blind Assessment Period||34||
59778921|NCT00799487|75899418|FG000|COMPLETED|Double-Blind Assessment Period||0||
59778922|NCT00799487|75899419|FG001|COMPLETED|Double-Blind Assessment Period||33||
59778923|NCT00799487|75899420|FG002|COMPLETED|Double-Blind Assessment Period||32||
59778924|NCT00799487|75899418|FG000|NOT COMPLETED|Double-Blind Assessment Period||0||
59778925|NCT00799487|75899419|FG001|NOT COMPLETED|Double-Blind Assessment Period||1||
59778926|NCT00799487|75899420|FG002|NOT COMPLETED|Double-Blind Assessment Period||2||
59778927|NCT00584727|75899431|FG000|STARTED|First Intervention||17||
59778928|NCT00584727|75899432|FG001|STARTED|First Intervention||17||
59778929|NCT00584727|75899433|FG002|STARTED|First Intervention||16||
59778930|NCT00584727|75899434|FG003|STARTED|First Intervention||14||
59778931|NCT00584727|75899435|FG004|STARTED|First Intervention||16||
59778932|NCT00584727|75899436|FG005|STARTED|First Intervention||16||
59778933|NCT00584727|75899431|FG000|COMPLETED|First Intervention||17||
59778934|NCT00584727|75899432|FG001|COMPLETED|First Intervention||17||
59778935|NCT00584727|75899433|FG002|COMPLETED|First Intervention||15||
59778936|NCT00584727|75899434|FG003|COMPLETED|First Intervention||14||
59778937|NCT00584727|75899435|FG004|COMPLETED|First Intervention||16||
59778938|NCT00584727|75899436|FG005|COMPLETED|First Intervention||16||
59778939|NCT00584727|75899431|FG000|NOT COMPLETED|First Intervention||0||
59778940|NCT00584727|75899432|FG001|NOT COMPLETED|First Intervention||0||
59778941|NCT00584727|75899433|FG002|NOT COMPLETED|First Intervention||1||
59778942|NCT00584727|75899434|FG003|NOT COMPLETED|First Intervention||0||
59778943|NCT00584727|75899435|FG004|NOT COMPLETED|First Intervention||0||
59778944|NCT00584727|75899436|FG005|NOT COMPLETED|First Intervention||0||
59778945|NCT00584727|75899431|FG000|STARTED|Second Intervention||17||
59778946|NCT00584727|75899432|FG001|STARTED|Second Intervention||17||
59778947|NCT00584727|75899433|FG002|STARTED|Second Intervention||15||
59778948|NCT00584727|75899434|FG003|STARTED|Second Intervention||14||
59778949|NCT00584727|75899435|FG004|STARTED|Second Intervention||16||
59778950|NCT00584727|75899436|FG005|STARTED|Second Intervention||16||
59778951|NCT00584727|75899431|FG000|COMPLETED|Second Intervention||17||
59778952|NCT00584727|75899432|FG001|COMPLETED|Second Intervention||17||
59778953|NCT00584727|75899433|FG002|COMPLETED|Second Intervention||15||
59778954|NCT00584727|75899434|FG003|COMPLETED|Second Intervention||14||
59778955|NCT00584727|75899435|FG004|COMPLETED|Second Intervention||16||
59778956|NCT00584727|75899436|FG005|COMPLETED|Second Intervention||16||
59778957|NCT00584727|75899431|FG000|NOT COMPLETED|Second Intervention||0||
59778958|NCT00584727|75899432|FG001|NOT COMPLETED|Second Intervention||0||
59778959|NCT00584727|75899433|FG002|NOT COMPLETED|Second Intervention||0||
59778960|NCT00584727|75899434|FG003|NOT COMPLETED|Second Intervention||0||
59778961|NCT00584727|75899435|FG004|NOT COMPLETED|Second Intervention||0||
59778962|NCT00584727|75899436|FG005|NOT COMPLETED|Second Intervention||0||
59778963|NCT00584727|75899431|FG000|STARTED|Third Intervention||17||
59778964|NCT00584727|75899432|FG001|STARTED|Third Intervention||17||
59778965|NCT00584727|75899433|FG002|STARTED|Third Intervention||15||
59778966|NCT00584727|75899434|FG003|STARTED|Third Intervention||14||
59778967|NCT00584727|75899435|FG004|STARTED|Third Intervention||16||
59778968|NCT00584727|75899436|FG005|STARTED|Third Intervention||16||
59778969|NCT00584727|75899431|FG000|COMPLETED|Third Intervention||17||
59778970|NCT00584727|75899432|FG001|COMPLETED|Third Intervention||17||
59778971|NCT00584727|75899433|FG002|COMPLETED|Third Intervention||14||
59778972|NCT00584727|75899434|FG003|COMPLETED|Third Intervention||14||
59778973|NCT00584727|75899435|FG004|COMPLETED|Third Intervention||12||
59778974|NCT00584727|75899436|FG005|COMPLETED|Third Intervention||14||
59778975|NCT00584727|75899431|FG000|NOT COMPLETED|Third Intervention||0||
59778976|NCT00584727|75899432|FG001|NOT COMPLETED|Third Intervention||0||
59778977|NCT00584727|75899433|FG002|NOT COMPLETED|Third Intervention||1||
59778978|NCT00584727|75899434|FG003|NOT COMPLETED|Third Intervention||0||
59778979|NCT00584727|75899435|FG004|NOT COMPLETED|Third Intervention||4||
59778980|NCT00584727|75899436|FG005|NOT COMPLETED|Third Intervention||2||
59778981|NCT00799409|75899450|FG000|STARTED|Overall Study||7||
59778982|NCT00799409|75899451|FG001|STARTED|Overall Study||36||
59778983|NCT00799409|75899452|FG002|STARTED|Overall Study||35||
59778984|NCT00799409|75899450|FG000|COMPLETED|Overall Study||0||
59778985|NCT00799409|75899451|FG001|COMPLETED|Overall Study||36||
59778986|NCT00799409|75899452|FG002|COMPLETED|Overall Study||35||
59778987|NCT00799409|75899450|FG000|NOT COMPLETED|Overall Study||7||
59778988|NCT00799409|75899451|FG001|NOT COMPLETED|Overall Study||0||
59778989|NCT00799409|75899452|FG002|NOT COMPLETED|Overall Study||0||
59778990|NCT00782210|75899463|FG000|STARTED|Overall Study||209||
59778991|NCT00782210|75899464|FG001|STARTED|Overall Study||208||
59778992|NCT00782210|75899465|FG002|STARTED|Overall Study||207||
59778993|NCT00782210|75899463|FG000|COMPLETED|Overall Study||159||
59778994|NCT00782210|75899464|FG001|COMPLETED|Overall Study||173||
59778995|NCT00782210|75899465|FG002|COMPLETED|Overall Study||172||
59778996|NCT00782210|75899463|FG000|NOT COMPLETED|Overall Study||50||
59778997|NCT00782210|75899464|FG001|NOT COMPLETED|Overall Study||35||
59778998|NCT00782210|75899465|FG002|NOT COMPLETED|Overall Study||35||
59778999|NCT01558115|75899482|FG000|STARTED|Overall Study||8||
59779000|NCT01558115|75899482|FG000|COMPLETED|Overall Study||1||
59779001|NCT01558115|75899482|FG000|NOT COMPLETED|Overall Study||7||
59779002|NCT01294007|75899490|FG000|STARTED|Overall Study||1||
59779003|NCT01294007|75899490|FG000|COMPLETED|Overall Study||1||
59779004|NCT01294007|75899490|FG000|NOT COMPLETED|Overall Study||0||
59779005|NCT00764660|75899496|FG000|STARTED|Overall Study||75||
59779006|NCT00764660|75899497|FG001|STARTED|Overall Study||66||
59779007|NCT00764660|75899496|FG000|COMPLETED|Overall Study||53||
59779008|NCT00764660|75899497|FG001|COMPLETED|Overall Study||55||
59779009|NCT00764660|75899496|FG000|NOT COMPLETED|Overall Study||22||
59779010|NCT00764660|75899497|FG001|NOT COMPLETED|Overall Study||11||
59779011|NCT00584415|75899503|FG000|STARTED|Overall Study|A total of 119 enrolled and 112 underwent the ablation procedure;|119||
59779012|NCT00584415|75899503|FG000|COMPLETED|Overall Study||112||
59779013|NCT00584415|75899503|FG000|NOT COMPLETED|Overall Study||7||
59779014|NCT00764504|75899511|FG000|STARTED|Overall Study||141||
59779015|NCT00764504|75899512|FG001|STARTED|Overall Study||141||
59779016|NCT00764504|75899513|FG002|STARTED|Overall Study||234||
59779017|NCT00764504|75899511|FG000|COMPLETED|Overall Study||75||
59779018|NCT00764504|75899512|FG001|COMPLETED|Overall Study||71||
59779019|NCT00764504|75899513|FG002|COMPLETED|Overall Study||131||
59779020|NCT00764504|75899511|FG000|NOT COMPLETED|Overall Study||66||
59779021|NCT00764504|75899512|FG001|NOT COMPLETED|Overall Study||70||
59952968|NCT04207333|76071763|FG001|STARTED|Second Intervention (Single 1-Day Visit)||3||
59952969|NCT04207333|76071762|FG000|COMPLETED|Second Intervention (Single 1-Day Visit)||3||
59952970|NCT04207333|76071763|FG001|COMPLETED|Second Intervention (Single 1-Day Visit)||3||
59952971|NCT04207333|76071762|FG000|NOT COMPLETED|Second Intervention (Single 1-Day Visit)||0||
59952972|NCT04207333|76071763|FG001|NOT COMPLETED|Second Intervention (Single 1-Day Visit)||0||
59952973|NCT04074109|76071771|FG000|STARTED|Overall Study||18||
59779022|NCT00764504|75899513|FG002|NOT COMPLETED|Overall Study||103||
59779023|NCT00763958|75899523|FG000|STARTED|Overall Study||28||
59779024|NCT00763958|75899524|FG001|STARTED|Overall Study||16||
59779025|NCT00763958|75899523|FG000|COMPLETED|Overall Study||14||
59779026|NCT00763958|75899524|FG001|COMPLETED|Overall Study||5||
59779027|NCT00763958|75899523|FG000|NOT COMPLETED|Overall Study||14||
59779028|NCT00763958|75899524|FG001|NOT COMPLETED|Overall Study||11||
59779029|NCT00763256|75899533|FG000|STARTED|Overall Study||15||
59779030|NCT00763256|75899534|FG001|STARTED|Overall Study||18||
59952974|NCT04074109|76071772|FG001|STARTED|Overall Study||16||
59952975|NCT04074109|76071771|FG000|COMPLETED|Overall Study||13||
59779031|NCT00763256|75899533|FG000|COMPLETED|Overall Study||8||
59779032|NCT00763256|75899534|FG001|COMPLETED|Overall Study||8||
59779033|NCT00763256|75899533|FG000|NOT COMPLETED|Overall Study||7||
59779034|NCT00763256|75899534|FG001|NOT COMPLETED|Overall Study||10||
59779035|NCT00762788|75899546|FG000|STARTED|Overall Study||55||
59779036|NCT00762788|75899547|FG001|STARTED|Overall Study||58||
59779037|NCT00762788|75899548|FG002|STARTED|Overall Study||42||
59779038|NCT00762788|75899549|FG003|STARTED|Overall Study||64||
59779039|NCT00762788|75899550|FG004|STARTED|Overall Study||43||
59779040|NCT00762788|75899551|FG005|STARTED|Overall Study||52||
59779041|NCT00762788|75899546|FG000|COMPLETED|Overall Study||29||
59779042|NCT00762788|75899547|FG001|COMPLETED|Overall Study||21||
59779043|NCT00762788|75899548|FG002|COMPLETED|Overall Study||21||
59779044|NCT00762788|75899549|FG003|COMPLETED|Overall Study||38||
59779045|NCT00762788|75899550|FG004|COMPLETED|Overall Study||30||
59779046|NCT00762788|75899551|FG005|COMPLETED|Overall Study||31||
59779047|NCT00762788|75899546|FG000|NOT COMPLETED|Overall Study||26||
59779048|NCT00762788|75899547|FG001|NOT COMPLETED|Overall Study||37||
59779049|NCT00762788|75899548|FG002|NOT COMPLETED|Overall Study||21||
59779050|NCT00762788|75899549|FG003|NOT COMPLETED|Overall Study||26||
59779051|NCT00762788|75899550|FG004|NOT COMPLETED|Overall Study||13||
59779052|NCT00762788|75899551|FG005|NOT COMPLETED|Overall Study||21||
59779053|NCT00583947|75899567|FG000|STARTED|Cross-over Period|Participants were stratified by age group at randomization: ages 2-5 yrs and 6-11 years|27||
59779054|NCT00583947|75899568|FG001|STARTED|Cross-over Period|Participants were stratified by age group at randomization: ages 2-5 yrs and 6-11 years|26||
59779055|NCT00583947|75899567|FG000|COMPLETED|Cross-over Period||22||
59779056|NCT00583947|75899568|FG001|COMPLETED|Cross-over Period||24||
59779057|NCT00583947|75899567|FG000|NOT COMPLETED|Cross-over Period||5||
59779058|NCT00583947|75899568|FG001|NOT COMPLETED|Cross-over Period||2||
59779059|NCT00583947|75899567|FG000|STARTED|Washout||22||
59779060|NCT00583947|75899568|FG001|STARTED|Washout||24||
59779061|NCT00583947|75899567|FG000|COMPLETED|Washout||22||
59779062|NCT00583947|75899568|FG001|COMPLETED|Washout||24||
59779063|NCT00583947|75899567|FG000|NOT COMPLETED|Washout||0||
59779064|NCT00583947|75899568|FG001|NOT COMPLETED|Washout||0||
59779065|NCT00583947|75899567|FG000|STARTED|Open Label Period|3 subjects were dosed with arformoterol 7.5 microgram in error|22||
59779066|NCT00583947|75899568|FG001|STARTED|Open Label Period|3 subjects were dosed with arformoterol 7.5 microgram in error|24||
59779067|NCT00583947|75899567|FG000|COMPLETED|Open Label Period||22||
59779068|NCT00583947|75899568|FG001|COMPLETED|Open Label Period||24||
59779069|NCT00583947|75899567|FG000|NOT COMPLETED|Open Label Period||0||
59779070|NCT00583947|75899568|FG001|NOT COMPLETED|Open Label Period||0||
59779071|NCT00772928|75899578|FG000|STARTED|Overall Study||587||
59779072|NCT00772928|75899579|FG001|STARTED|Overall Study||579||
59779073|NCT00772928|75899578|FG000|COMPLETED|Overall Study||543||
59779074|NCT00772928|75899579|FG001|COMPLETED|Overall Study||538||
59779075|NCT00772928|75899578|FG000|NOT COMPLETED|Overall Study||44||
59779076|NCT00772928|75899579|FG001|NOT COMPLETED|Overall Study||41||
59779077|NCT00762476|75899587|FG000|STARTED|Overall Study||206||
59779078|NCT00762476|75899588|FG001|STARTED|Overall Study||205||
59779079|NCT00762476|75899587|FG000|COMPLETED|Overall Study||183||
59779080|NCT00762476|75899588|FG001|COMPLETED|Overall Study||169||
59779081|NCT00762476|75899587|FG000|NOT COMPLETED|Overall Study||23||
59779082|NCT00762476|75899588|FG001|NOT COMPLETED|Overall Study||36||
59779083|NCT00762164|75899597|FG000|STARTED|Overall Study||17||
59779084|NCT00762164|75899598|FG001|STARTED|Overall Study||17||
59779085|NCT00762164|75899597|FG000|COMPLETED|Overall Study||14||
59779086|NCT00762164|75899598|FG001|COMPLETED|Overall Study||15||
59779087|NCT00762164|75899597|FG000|NOT COMPLETED|Overall Study||3||
59779088|NCT00762164|75899598|FG001|NOT COMPLETED|Overall Study||2||
59779089|NCT00762086|75899606|FG000|STARTED|Overall Study||39||
59779090|NCT00762086|75899607|FG001|STARTED|Overall Study||28||
59779091|NCT00762086|75899606|FG000|COMPLETED|Overall Study||33||
59779092|NCT00762086|75899607|FG001|COMPLETED|Overall Study||24||
59779093|NCT00762086|75899606|FG000|NOT COMPLETED|Overall Study||6||
59779094|NCT00762086|75899607|FG001|NOT COMPLETED|Overall Study||4||
59779095|NCT00761774|75899613|FG000|STARTED|Overall Study||108||
59779096|NCT00761774|75899613|FG000|COMPLETED|Overall Study||29||
59779097|NCT00761774|75899613|FG000|NOT COMPLETED|Overall Study||79||
59952976|NCT04074109|76071772|FG001|COMPLETED|Overall Study||8||
59779098|NCT00583791|75899619|FG000|STARTED|Overall Study||91||
59779099|NCT00583791|75899619|FG000|COMPLETED|Overall Study||18||
59779100|NCT00583791|75899619|FG000|NOT COMPLETED|Overall Study||73||
59779101|NCT00781274|75899623|FG000|STARTED|Overall Study||32||
59779102|NCT00781274|75899623|FG000|COMPLETED|Overall Study||30||
59779103|NCT00781274|75899623|FG000|NOT COMPLETED|Overall Study||2||
59779104|NCT00780416|75899629|FG000|STARTED|Overall Study||126||
59779105|NCT00780416|75899630|FG001|STARTED|Overall Study||63||
59779106|NCT00780416|75899629|FG000|COMPLETED|Overall Study||114||
59779107|NCT00780416|75899630|FG001|COMPLETED|Overall Study||54||
59779108|NCT00780416|75899629|FG000|NOT COMPLETED|Overall Study||12||
59779109|NCT00780416|75899630|FG001|NOT COMPLETED|Overall Study||9||
59779110|NCT00761462|75899638|FG000|STARTED|Treatment|Patients enrolled in study group|510||
59779111|NCT00761462|75899639|FG001|STARTED|Treatment|Patients enrolled in study group|519||
59779112|NCT00761462|75899638|FG000|COMPLETED|Treatment|Patients with confirmed intake of study drug|487||
59779113|NCT00761462|75899639|FG001|COMPLETED|Treatment|Patients with confirmed intake of study drug|507||
59779114|NCT00761462|75899638|FG000|NOT COMPLETED|Treatment||23||
59779115|NCT00761462|75899639|FG001|NOT COMPLETED|Treatment||12||
59779116|NCT00761462|75899638|FG000|STARTED|2 or 5 Years Long-term Safety Follow-up|Patients with confirmed intake of study drug entering long-term safety evaluation|487||
59779117|NCT00761462|75899639|FG001|STARTED|2 or 5 Years Long-term Safety Follow-up|Patients with confirmed intake of study drug entering long-term safety evaluation|507||
59779118|NCT00761462|75899638|FG000|4-6 Weeks Post Treatment|2 or 5 Years Long-term Safety Follow-up||487||
59779119|NCT00761462|75899639|FG001|4-6 Weeks Post Treatment|2 or 5 Years Long-term Safety Follow-up||507||
59779120|NCT00761462|75899638|FG000|1 Year Follow-up|2 or 5 Years Long-term Safety Follow-up||485||
59779121|NCT00761462|75899639|FG001|1 Year Follow-up|2 or 5 Years Long-term Safety Follow-up||507||
59779122|NCT00761462|75899638|FG000|COMPLETED|2 or 5 Years Long-term Safety Follow-up|Patients under safety evaluation at end of 5 year safety Follow-up.|333||
59779123|NCT00761462|75899639|FG001|COMPLETED|2 or 5 Years Long-term Safety Follow-up|Patients under safety evaluation at end of 2 year safety Follow-up.|456||
59779124|NCT00761462|75899638|FG000|NOT COMPLETED|2 or 5 Years Long-term Safety Follow-up||154||
59779125|NCT00761462|75899639|FG001|NOT COMPLETED|2 or 5 Years Long-term Safety Follow-up||51||
59779126|NCT00761306|75899645|FG000|STARTED|Overall Study||74||
59779127|NCT00761306|75899645|FG000|COMPLETED|Overall Study||54||
59779128|NCT00761306|75899645|FG000|NOT COMPLETED|Overall Study||20||
59779129|NCT00772538|75899651|FG000|STARTED|Overall Study||222||
59779130|NCT00772538|75899652|FG001|STARTED|Overall Study||237||
59779131|NCT00772538|75899651|FG000|COMPLETED|Overall Study||202||
59779132|NCT00772538|75899652|FG001|COMPLETED|Overall Study||211||
59779133|NCT00772538|75899651|FG000|NOT COMPLETED|Overall Study||20||
59779134|NCT00772538|75899652|FG001|NOT COMPLETED|Overall Study||26||
59779135|NCT00761150|75899661|FG000|STARTED|Open-label Period||308||
59779136|NCT00761150|75899662|FG001|STARTED|Open-label Period||0||
59779137|NCT00761150|75899663|FG002|STARTED|Open-label Period||0||
59779138|NCT00761150|75899661|FG000|COMPLETED|Open-label Period||238||
59779139|NCT00761150|75899662|FG001|COMPLETED|Open-label Period||0||
59779140|NCT00761150|75899663|FG002|COMPLETED|Open-label Period||0||
59952977|NCT04074109|76071771|FG000|NOT COMPLETED|Overall Study||5||
59952978|NCT04074109|76071772|FG001|NOT COMPLETED|Overall Study||8||
59952979|NCT04057820|76071780|FG000|STARTED|Period 1||27||4
59952980|NCT04057820|76071781|FG001|STARTED|Period 1||0||0
59952981|NCT04057820|76071782|FG002|STARTED|Period 1||8||2
59952982|NCT04057820|76071783|FG003|STARTED|Period 1||0||0
59952983|NCT04057820|76071784|FG004|STARTED|Period 1||23||3
59952984|NCT04057820|76071785|FG005|STARTED|Period 1||0||0
59952985|NCT04057820|76071786|FG006|STARTED|Period 1||23||3
59952986|NCT04057820|76071787|FG007|STARTED|Period 1||0||0
59952987|NCT04057820|76071788|FG008|STARTED|Period 1||41||4
59952988|NCT04057820|76071789|FG009|STARTED|Period 1||0||0
59952989|NCT04057820|76071790|FG010|STARTED|Period 1||27||4
59952990|NCT04057820|76071791|FG011|STARTED|Period 1||0||0
59952991|NCT04057820|76071792|FG012|STARTED|Period 1||16||3
59952992|NCT04057820|76071793|FG013|STARTED|Period 1||0||0
59618919|NCT03490734|75730033|FG001|NOT COMPLETED|Post-intervention Behavioral Visit||0||
59618920|NCT03490734|75730034|FG002|NOT COMPLETED|Post-intervention Behavioral Visit||0||
59618921|NCT03490734|75730035|FG003|NOT COMPLETED|Post-intervention Behavioral Visit||0||
59618922|NCT00086346|75730046|FG000|STARTED|Randomization||393||
59618923|NCT00086346|75730047|FG001|STARTED|Randomization||214||
59618924|NCT00086346|75730046|FG000|COMPLETED|Randomization||389||
59618925|NCT00086346|75730047|FG001|COMPLETED|Randomization||210||
59618926|NCT00086346|75730046|FG000|NOT COMPLETED|Randomization||4||
59618927|NCT00086346|75730047|FG001|NOT COMPLETED|Randomization||4||
59618928|NCT00086346|75730046|FG000|STARTED|Patients Dosed With Test Article||389||
59618929|NCT00086346|75730047|FG001|STARTED|Patients Dosed With Test Article||210||
59779141|NCT00761150|75899661|FG000|NOT COMPLETED|Open-label Period||70||
59779142|NCT00761150|75899662|FG001|NOT COMPLETED|Open-label Period||0||
59779143|NCT00761150|75899663|FG002|NOT COMPLETED|Open-label Period||0||
59779144|NCT00761150|75899661|FG000|STARTED|Double-blind Period||0||
59779145|NCT00761150|75899662|FG001|STARTED|Double-blind Period||120||
59779146|NCT00761150|75899663|FG002|STARTED|Double-blind Period||118||
59952993|NCT04057820|76071794|FG014|STARTED|Period 1||20||3
59952994|NCT04057820|76071795|FG015|STARTED|Period 1||0||0
59952995|NCT04057820|76071780|FG000|COMPLETED|Period 1||27||4
59952996|NCT04057820|76071781|FG001|COMPLETED|Period 1||0||0
59952997|NCT04057820|76071782|FG002|COMPLETED|Period 1||8||2
59618930|NCT00086346|75730046|FG000|COMPLETED|Patients Dosed With Test Article||249||
59618931|NCT00086346|75730047|FG001|COMPLETED|Patients Dosed With Test Article||187||
59618932|NCT00086346|75730046|FG000|NOT COMPLETED|Patients Dosed With Test Article||140||
59618933|NCT00086346|75730047|FG001|NOT COMPLETED|Patients Dosed With Test Article||23||
59618934|NCT00085566|75730056|FG000|STARTED|Overall Study||3||
59618935|NCT00085566|75730057|FG001|STARTED|Overall Study||3||
59618936|NCT00085566|75730058|FG002|STARTED|Overall Study||57||
59618937|NCT00085566|75730056|FG000|COMPLETED|Overall Study||3||
59618938|NCT00085566|75730057|FG001|COMPLETED|Overall Study||3||
59779147|NCT00761150|75899661|FG000|COMPLETED|Double-blind Period||0||
59779148|NCT00761150|75899662|FG001|COMPLETED|Double-blind Period||106||
59779149|NCT00761150|75899663|FG002|COMPLETED|Double-blind Period||89||
59779150|NCT00761150|75899661|FG000|NOT COMPLETED|Double-blind Period||0||
59779151|NCT00761150|75899662|FG001|NOT COMPLETED|Double-blind Period||14||
59779152|NCT00761150|75899663|FG002|NOT COMPLETED|Double-blind Period||29||
59779153|NCT00760994|75899673|FG000|STARTED|Overall Study||29||
59779154|NCT00760994|75899674|FG001|STARTED|Overall Study||31||
59779155|NCT00760994|75899675|FG002|STARTED|Overall Study||20||
59779156|NCT00760994|75899673|FG000|COMPLETED|Overall Study||25||
59779157|NCT00760994|75899674|FG001|COMPLETED|Overall Study||27||
59779158|NCT00760994|75899675|FG002|COMPLETED|Overall Study||17||
59779159|NCT00760994|75899673|FG000|NOT COMPLETED|Overall Study||4||
59779160|NCT00760994|75899674|FG001|NOT COMPLETED|Overall Study||4||
59779161|NCT00760994|75899675|FG002|NOT COMPLETED|Overall Study||3||
59779162|NCT00583557|75899685|FG000|STARTED|Overall Study||155||
59779163|NCT00583557|75899685|FG000|Received at Least 1 Dose Belimumab|Overall Study||153||
59779164|NCT00583557|75899685|FG000|COMPLETED|Overall Study|Completer defined as subjects whose reason for discontinuation was sponsor discontinuation of study|85||
59779165|NCT00583557|75899685|FG000|NOT COMPLETED|Overall Study||70||
59779166|NCT00586820|75899691|FG000|STARTED|Overall Study||12||
59779167|NCT00586820|75899692|FG001|STARTED|Overall Study||11||
59779168|NCT00586820|75899691|FG000|COMPLETED|Overall Study||11||
59779169|NCT00586820|75899692|FG001|COMPLETED|Overall Study||11||
59779170|NCT00586820|75899691|FG000|NOT COMPLETED|Overall Study||1||
59779171|NCT00586820|75899692|FG001|NOT COMPLETED|Overall Study||0||
59779172|NCT00760838|75899700|FG000|STARTED|Overall Study||54||
59779173|NCT00760838|75899701|FG001|STARTED|Overall Study||55||
59779174|NCT00760838|75899700|FG000|COMPLETED|Overall Study||49||
59779175|NCT00760838|75899701|FG001|COMPLETED|Overall Study||53||
59779176|NCT00760838|75899700|FG000|NOT COMPLETED|Overall Study||5||
59779177|NCT00760838|75899701|FG001|NOT COMPLETED|Overall Study||2||
59779178|NCT00586664|75899710|FG000|STARTED|Overall Study||43||
59779179|NCT00586664|75899711|FG001|STARTED|Overall Study||43||
59779180|NCT00586664|75899712|FG002|STARTED|Overall Study||44||
59779181|NCT00586664|75899710|FG000|COMPLETED|Overall Study||38||
59779182|NCT00586664|75899711|FG001|COMPLETED|Overall Study||36||
59779183|NCT00586664|75899712|FG002|COMPLETED|Overall Study||43||
59779184|NCT00586664|75899710|FG000|NOT COMPLETED|Overall Study||5||
59779185|NCT00586664|75899711|FG001|NOT COMPLETED|Overall Study||7||
59779186|NCT00586664|75899712|FG002|NOT COMPLETED|Overall Study||1||
59779187|NCT00437281|75899740|FG000|STARTED|Overall Study||3||
59779188|NCT00437281|75899741|FG001|STARTED|Overall Study||3||
59779189|NCT00437281|75899742|FG002|STARTED|Overall Study||3||
59779190|NCT00437281|75899743|FG003|STARTED|Overall Study||3||
59779191|NCT00437281|75899744|FG004|STARTED|Overall Study||4||
59779192|NCT00437281|75899745|FG005|STARTED|Overall Study||4||
59779193|NCT00437281|75899746|FG006|STARTED|Overall Study||3||
59779194|NCT00437281|75899747|FG007|STARTED|Overall Study||3||
59779195|NCT00437281|75899748|FG008|STARTED|Overall Study||3||
59779196|NCT00437281|75899749|FG009|STARTED|Overall Study||5||
59779197|NCT00437281|75899750|FG010|STARTED|Overall Study||3||
59779198|NCT00437281|75899751|FG011|STARTED|Overall Study||3||
59779199|NCT00437281|75899752|FG012|STARTED|Overall Study||2||
59779200|NCT00437281|75899753|FG013|STARTED|Overall Study||3||
59779201|NCT00437281|75899754|FG014|STARTED|Overall Study||5||
59779202|NCT00437281|75899755|FG015|STARTED|Overall Study||3||
59779203|NCT00437281|75899756|FG016|STARTED|Overall Study||3||
59779204|NCT00437281|75899757|FG017|STARTED|Overall Study||4||
59779205|NCT00437281|75899758|FG018|STARTED|Overall Study||2||
59779206|NCT00437281|75899759|FG019|STARTED|Overall Study||3||
59779207|NCT00437281|75899740|FG000|COMPLETED|Overall Study||3||
59779208|NCT00437281|75899741|FG001|COMPLETED|Overall Study||3||
59779209|NCT00437281|75899742|FG002|COMPLETED|Overall Study||3||
59779210|NCT00437281|75899743|FG003|COMPLETED|Overall Study||2||
59779211|NCT00437281|75899744|FG004|COMPLETED|Overall Study||4||
59779212|NCT00437281|75899745|FG005|COMPLETED|Overall Study||3||
59779213|NCT00437281|75899746|FG006|COMPLETED|Overall Study||3||
59779214|NCT00437281|75899747|FG007|COMPLETED|Overall Study||3||
59779215|NCT00437281|75899748|FG008|COMPLETED|Overall Study||3||
59779216|NCT00437281|75899749|FG009|COMPLETED|Overall Study||4||
59779217|NCT00437281|75899750|FG010|COMPLETED|Overall Study||3||
59779218|NCT00437281|75899751|FG011|COMPLETED|Overall Study||3||
59779219|NCT00437281|75899752|FG012|COMPLETED|Overall Study||2||
59779220|NCT00437281|75899753|FG013|COMPLETED|Overall Study||2||
59779221|NCT00437281|75899754|FG014|COMPLETED|Overall Study||4||
59779222|NCT00437281|75899755|FG015|COMPLETED|Overall Study||3||
59779223|NCT00437281|75899756|FG016|COMPLETED|Overall Study||3||
59779224|NCT00437281|75899757|FG017|COMPLETED|Overall Study||4||
59779225|NCT00437281|75899758|FG018|COMPLETED|Overall Study||1||
59779226|NCT00437281|75899759|FG019|COMPLETED|Overall Study||2||
59779227|NCT00437281|75899740|FG000|NOT COMPLETED|Overall Study||0||
59779228|NCT00437281|75899741|FG001|NOT COMPLETED|Overall Study||0||
59779229|NCT00437281|75899742|FG002|NOT COMPLETED|Overall Study||0||
59779230|NCT00437281|75899743|FG003|NOT COMPLETED|Overall Study||1||
59779231|NCT00437281|75899744|FG004|NOT COMPLETED|Overall Study||0||
59779232|NCT00437281|75899745|FG005|NOT COMPLETED|Overall Study||1||
59779233|NCT00437281|75899746|FG006|NOT COMPLETED|Overall Study||0||
59779234|NCT00437281|75899747|FG007|NOT COMPLETED|Overall Study||0||
59779235|NCT00437281|75899748|FG008|NOT COMPLETED|Overall Study||0||
59779236|NCT00437281|75899749|FG009|NOT COMPLETED|Overall Study||1||
59779237|NCT00437281|75899750|FG010|NOT COMPLETED|Overall Study||0||
59779238|NCT00437281|75899751|FG011|NOT COMPLETED|Overall Study||0||
59779239|NCT00437281|75899752|FG012|NOT COMPLETED|Overall Study||0||
59779240|NCT00437281|75899753|FG013|NOT COMPLETED|Overall Study||1||
59779241|NCT00437281|75899754|FG014|NOT COMPLETED|Overall Study||1||
59779242|NCT00437281|75899755|FG015|NOT COMPLETED|Overall Study||0||
59779243|NCT00437281|75899756|FG016|NOT COMPLETED|Overall Study||0||
59779244|NCT00437281|75899757|FG017|NOT COMPLETED|Overall Study||0||
59779245|NCT00437281|75899758|FG018|NOT COMPLETED|Overall Study||1||
59779246|NCT00437281|75899759|FG019|NOT COMPLETED|Overall Study||1||
59779247|NCT00741039|75899833|FG000|STARTED|Overall Study||102||
59779248|NCT00741039|75899834|FG001|STARTED|Overall Study||25||
59779249|NCT00741039|75899833|FG000|COMPLETED|Overall Study||100||
59779250|NCT00741039|75899834|FG001|COMPLETED|Overall Study||25||
59779251|NCT00741039|75899833|FG000|NOT COMPLETED|Overall Study||2||
59779252|NCT00741039|75899834|FG001|NOT COMPLETED|Overall Study||0||
59779253|NCT00772382|75899840|FG000|STARTED|Overall Study||116||
59779254|NCT00772382|75899840|FG000|COMPLETED|Overall Study||61||
59779255|NCT00772382|75899840|FG000|NOT COMPLETED|Overall Study||55||
59779256|NCT00798707|75899847|FG000|STARTED|Overall Study||235||
59779257|NCT00798707|75899848|FG001|STARTED|Overall Study||237||
59779258|NCT00798707|75899849|FG002|STARTED|Overall Study||237||
59779259|NCT00798707|75899847|FG000|Treated|Overall Study||231||
59779260|NCT00798707|75899848|FG001|Treated|Overall Study||232||
59779261|NCT00798707|75899849|FG002|Treated|Overall Study||236||
59779262|NCT00798707|75899847|FG000|COMPLETED|Overall Study||209||
59779263|NCT00798707|75899848|FG001|COMPLETED|Overall Study||204||
59779264|NCT00798707|75899849|FG002|COMPLETED|Overall Study||215||
59779265|NCT00798707|75899847|FG000|NOT COMPLETED|Overall Study||26||
59779266|NCT00798707|75899848|FG001|NOT COMPLETED|Overall Study||33||
59779267|NCT00798707|75899849|FG002|NOT COMPLETED|Overall Study||22||
59779268|NCT00760214|75899860|FG000|STARTED|Overall Study||295||
59779269|NCT00760214|75899861|FG001|STARTED|Overall Study||294||
59779270|NCT00760214|75899862|FG002|STARTED|Overall Study||296||
59779271|NCT00760214|75899860|FG000|COMPLETED|Overall Study||265||
59779272|NCT00760214|75899861|FG001|COMPLETED|Overall Study||264||
59779273|NCT00760214|75899862|FG002|COMPLETED|Overall Study||255||
59779274|NCT00760214|75899860|FG000|NOT COMPLETED|Overall Study||30||
59779275|NCT00760214|75899861|FG001|NOT COMPLETED|Overall Study||30||
59779276|NCT00760214|75899862|FG002|NOT COMPLETED|Overall Study||41||
59779277|NCT00802841|75899872|FG000|STARTED|Overall Study||96||
59779278|NCT00802841|75899873|FG001|STARTED|Overall Study||95||
59779279|NCT00802841|75899872|FG000|Full Analysis Set|Overall Study||96||
59779280|NCT00802841|75899873|FG001|Full Analysis Set|Overall Study||95||
59779281|NCT00802841|75899872|FG000|Safety Set|Overall Study||96||
59779282|NCT00802841|75899873|FG001|Safety Set|Overall Study||93||
59779283|NCT00802841|75899872|FG000|Cross-over Set|Overall Study||13||
59779284|NCT00802841|75899873|FG001|Cross-over Set|Overall Study||56||
60072959|NCT01591785|76188153|FG001|COMPLETED|Overall Study||28||
59779285|NCT00802841|75899872|FG000|COMPLETED|Overall Study||0||
59779286|NCT00802841|75899873|FG001|COMPLETED|Overall Study||0||
59779287|NCT00802841|75899872|FG000|NOT COMPLETED|Overall Study||96||
59779288|NCT00802841|75899873|FG001|NOT COMPLETED|Overall Study||95||
59779289|NCT00772148|75899883|FG000|STARTED|Pharmacokinetic Phase (14 Days)||29||
59779290|NCT00772148|75899884|FG001|STARTED|Pharmacokinetic Phase (14 Days)||29||
59779291|NCT00772148|75899883|FG000|COMPLETED|Pharmacokinetic Phase (14 Days)||21||
59779292|NCT00772148|75899884|FG001|COMPLETED|Pharmacokinetic Phase (14 Days)||23||
59779293|NCT00772148|75899883|FG000|NOT COMPLETED|Pharmacokinetic Phase (14 Days)||8||
59779294|NCT00772148|75899884|FG001|NOT COMPLETED|Pharmacokinetic Phase (14 Days)||6||
59779295|NCT00772148|75899883|FG000|STARTED|Maintenance Phase (Week 52)||21||
59779296|NCT00772148|75899884|FG001|STARTED|Maintenance Phase (Week 52)||23||
60072960|NCT01591785|76188152|FG000|NOT COMPLETED|Overall Study||4||
60072961|NCT01591785|76188153|FG001|NOT COMPLETED|Overall Study||2||
59779297|NCT00772148|75899883|FG000|COMPLETED|Maintenance Phase (Week 52)||17||
59779298|NCT00772148|75899884|FG001|COMPLETED|Maintenance Phase (Week 52)||18||
59779299|NCT00772148|75899883|FG000|NOT COMPLETED|Maintenance Phase (Week 52)||4||
59779300|NCT00772148|75899884|FG001|NOT COMPLETED|Maintenance Phase (Week 52)||5||
59779301|NCT00759902|75899892|FG000|STARTED|Overall Study||18||
59779302|NCT00759902|75899893|FG001|STARTED|Overall Study||18||
59779303|NCT00759902|75899892|FG000|COMPLETED|Overall Study||18||
60072962|NCT01695993|76188162|FG000|STARTED|Overall Study||81||
59779304|NCT00759902|75899893|FG001|COMPLETED|Overall Study||17||
59779305|NCT00759902|75899892|FG000|NOT COMPLETED|Overall Study||0||
59779306|NCT00759902|75899893|FG001|NOT COMPLETED|Overall Study||1||
59779307|NCT00772070|75899901|FG000|STARTED|Overall Study||102||
59779308|NCT00772070|75899902|FG001|STARTED|Overall Study||71||
59779309|NCT00772070|75899901|FG000|COMPLETED|Overall Study|Two participants had vaccination errors, they were removed from analysis.|100||
59779310|NCT00772070|75899902|FG001|COMPLETED|Overall Study||61||
59779311|NCT00772070|75899901|FG000|NOT COMPLETED|Overall Study||2||
59779312|NCT00772070|75899902|FG001|NOT COMPLETED|Overall Study||10||
59779313|NCT00796757|75899908|FG000|STARTED|Overall Study||146||
59779314|NCT00796757|75899908|FG000|COMPLETED|Overall Study||60||
59779315|NCT00796757|75899908|FG000|NOT COMPLETED|Overall Study||86||
59779316|NCT00759356|75899914|FG000|STARTED|Overall Study||18||
59779317|NCT00759356|75899915|FG001|STARTED|Overall Study||18||
59779318|NCT00759356|75899914|FG000|COMPLETED|Overall Study||17||
59779319|NCT00759356|75899915|FG001|COMPLETED|Overall Study||15||
59779320|NCT00759356|75899914|FG000|NOT COMPLETED|Overall Study||1||
59779321|NCT00759356|75899915|FG001|NOT COMPLETED|Overall Study||3||
59779322|NCT00721734|75899926|FG000|STARTED|Overall Study||12||
59779323|NCT00721734|75899927|FG001|STARTED|Overall Study||12||
59779324|NCT00721734|75899928|FG002|STARTED|Overall Study||10||
59779325|NCT00721734|75899929|FG003|STARTED|Overall Study||8||
59779326|NCT00721734|75899930|FG004|STARTED|Overall Study||8||
59779327|NCT00721734|75899926|FG000|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|4||
59779328|NCT00721734|75899927|FG001|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|0||
59779329|NCT00721734|75899928|FG002|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|2||
59952998|NCT04057820|76071783|FG003|COMPLETED|Period 1||0||0
59618939|NCT00085566|75730058|FG002|COMPLETED|Overall Study||43||
59618940|NCT00085566|75730056|FG000|NOT COMPLETED|Overall Study||0||
59618941|NCT00085566|75730057|FG001|NOT COMPLETED|Overall Study||0||
59618942|NCT00085566|75730058|FG002|NOT COMPLETED|Overall Study||14||
59618943|NCT00085098|75730068|FG000|STARTED|Overall Study||11||
59618944|NCT00085098|75730069|FG001|STARTED|Overall Study||13||
59618945|NCT00085098|75730068|FG000|COMPLETED|Overall Study||10||
59618946|NCT00085098|75730069|FG001|COMPLETED|Overall Study||11||
59618947|NCT00085098|75730068|FG000|NOT COMPLETED|Overall Study||1||
59618948|NCT00085098|75730069|FG001|NOT COMPLETED|Overall Study||2||
59618949|NCT00084864|75730082|FG000|STARTED|Overall Study||10||
59618950|NCT00084864|75730083|FG001|STARTED|Overall Study||7||
59618951|NCT00084864|75730084|FG002|STARTED|Overall Study||4||
59618952|NCT00084864|75730085|FG003|STARTED|Overall Study||4||
59618953|NCT00084864|75730082|FG000|COMPLETED|Overall Study||9||
59618954|NCT00084864|75730083|FG001|COMPLETED|Overall Study||7||
59618955|NCT00084864|75730084|FG002|COMPLETED|Overall Study||4||
59618956|NCT00084864|75730085|FG003|COMPLETED|Overall Study||4||
59618957|NCT00084864|75730082|FG000|NOT COMPLETED|Overall Study||1||
59618958|NCT00084864|75730083|FG001|NOT COMPLETED|Overall Study||0||
59618959|NCT00084864|75730084|FG002|NOT COMPLETED|Overall Study||0||
59618960|NCT00084864|75730085|FG003|NOT COMPLETED|Overall Study||0||
59618961|NCT00084318|75730097|FG000|STARTED|Overall Study||119||
59618962|NCT00084318|75730098|FG001|STARTED|Overall Study||119||
59618963|NCT00084318|75730097|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|97||
59618964|NCT00084318|75730098|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|106||
59618965|NCT00084318|75730097|FG000|NOT COMPLETED|Overall Study||22||
59618966|NCT00084318|75730098|FG001|NOT COMPLETED|Overall Study||13||
59618967|NCT00084084|75730106|FG000|STARTED|Phase 1 (Treatment With Replagal RB)||17||
59618968|NCT00084084|75730106|FG000|COMPLETED|Phase 1 (Treatment With Replagal RB)||16||
59618969|NCT00084084|75730106|FG000|NOT COMPLETED|Phase 1 (Treatment With Replagal RB)||1||
59618970|NCT00084084|75730106|FG000|STARTED|Phase 2 (Transition to Replagal AF)|The 11 patients remaining in TKT029 at the time Replagal AF was made available continued to Phase 2.|11||
59618971|NCT00084084|75730106|FG000|COMPLETED|Phase 2 (Transition to Replagal AF)||10||
59618972|NCT00084084|75730106|FG000|NOT COMPLETED|Phase 2 (Transition to Replagal AF)||1||
59618973|NCT00083616|75730111|FG000|STARTED|Overall Study||185||
59618974|NCT00083616|75730111|FG000|Received Study Medication|Overall Study||182||
59618975|NCT00083616|75730111|FG000|COMPLETED|Overall Study|Completed safety followup or died on study as of the data cut-off date of 22 December 2006|154||
59618976|NCT00083616|75730111|FG000|NOT COMPLETED|Overall Study||31||
59618977|NCT00083226|75730115|FG000|STARTED|Overall Study||42||
59618978|NCT00083226|75730115|FG000|COMPLETED|Overall Study||0||
59618979|NCT00083226|75730115|FG000|NOT COMPLETED|Overall Study||42||
59618980|NCT00082758|75730122|FG000|STARTED|Overall Study||15||
59618981|NCT00082758|75730123|FG001|STARTED|Overall Study||24||
59618982|NCT00082758|75730124|FG002|STARTED|Overall Study||0||
59618983|NCT00082758|75730122|FG000|COMPLETED|Overall Study||0||
59618984|NCT00082758|75730123|FG001|COMPLETED|Overall Study||7||
59618985|NCT00082758|75730124|FG002|COMPLETED|Overall Study||0||
59618986|NCT00082758|75730122|FG000|NOT COMPLETED|Overall Study||15||
59618987|NCT00082758|75730123|FG001|NOT COMPLETED|Overall Study||17||
59779330|NCT00721734|75899929|FG003|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|2||
59952999|NCT04057820|76071784|FG004|COMPLETED|Period 1||23||3
59779331|NCT00721734|75899930|FG004|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|2||
59779332|NCT00721734|75899926|FG000|NOT COMPLETED|Overall Study||8||
59779333|NCT00721734|75899927|FG001|NOT COMPLETED|Overall Study||12||
59779334|NCT00721734|75899928|FG002|NOT COMPLETED|Overall Study||8||
59779335|NCT00721734|75899929|FG003|NOT COMPLETED|Overall Study||6||
59779336|NCT00721734|75899930|FG004|NOT COMPLETED|Overall Study||6||
59779337|NCT00798317|75899944|FG000|STARTED|Overall Study||245||
59779338|NCT00798317|75899945|FG001|STARTED|Overall Study||81||
59779339|NCT00798317|75899944|FG000|COMPLETED|Overall Study||235||
59779340|NCT00798317|75899945|FG001|COMPLETED|Overall Study||74||
59779341|NCT00798317|75899944|FG000|NOT COMPLETED|Overall Study||10||
59779342|NCT00798317|75899945|FG001|NOT COMPLETED|Overall Study||7||
59779343|NCT00779402|75899953|FG000|STARTED|Treatment Phase 1||117||
59779344|NCT00779402|75899954|FG001|STARTED|Treatment Phase 1||59||
59779345|NCT00779402|75899953|FG000|Received ≥1 Leukapherisis (Safety Set)|Treatment Phase 1||116||
59779346|NCT00779402|75899954|FG001|Received ≥1 Leukapherisis (Safety Set)|Treatment Phase 1||59||
59779347|NCT00779402|75899953|FG000|Received ≥1 Study Product (Exposure Set)|Treatment Phase 1||113||
59779348|NCT00779402|75899954|FG001|Received ≥1 Study Product (Exposure Set)|Treatment Phase 1||59||
59779349|NCT00779402|75899953|FG000|Received Booster Infusion|Treatment Phase 1||50||
59779350|NCT00779402|75899954|FG001|Received Booster Infusion|Treatment Phase 1||30||
59779351|NCT00779402|75899953|FG000|COMPLETED|Treatment Phase 1||84|Completed 3 scheduled infusion treatments and had confirmed Biochemical Failure (BF).|
59779352|NCT00779402|75899954|FG001|COMPLETED|Treatment Phase 1||44|Completed 3 scheduled infusion treatments and had confirmed Biochemical Failure (BF).|
59779353|NCT00779402|75899953|FG000|NOT COMPLETED|Treatment Phase 1||33||
59779354|NCT00779402|75899954|FG001|NOT COMPLETED|Treatment Phase 1||15||
59779355|NCT00779402|75899953|FG000|STARTED|Surveillance Phase||84||
59779356|NCT00779402|75899954|FG001|STARTED|Surveillance Phase||44||
59779357|NCT00779402|75899953|FG000|COMPLETED|Surveillance Phase||41|Reached Distant Failure (DF) following Treatment Phase.|
59779358|NCT00779402|75899954|FG001|COMPLETED|Surveillance Phase||13|Reached Distant Failure (DF) following Treatment Phase.|
59779359|NCT00779402|75899953|FG000|NOT COMPLETED|Surveillance Phase||43||
59779360|NCT00779402|75899954|FG001|NOT COMPLETED|Surveillance Phase||31||
59779361|NCT00779402|75899953|FG000|STARTED|Long-term Follow-up||41||
59779362|NCT00779402|75899954|FG001|STARTED|Long-term Follow-up||13||
59779363|NCT00779402|75899953|FG000|COMPLETED|Long-term Follow-up||20|Subject survival status was assessed by phone Q6 months until death of subject. Death=Completion.|
59779364|NCT00779402|75899954|FG001|COMPLETED|Long-term Follow-up||7|Subject survival status was assessed by phone Q6 months until death of subject. Death=Completion.|
59779365|NCT00779402|75899953|FG000|NOT COMPLETED|Long-term Follow-up||21||
59779366|NCT00779402|75899954|FG001|NOT COMPLETED|Long-term Follow-up||6||
59779367|NCT00771914|75899964|FG000|STARTED|Overall Study||7||
59779368|NCT00771914|75899965|FG001|STARTED|Overall Study||6||
59779369|NCT00771914|75899966|FG002|STARTED|Overall Study||6||
59779370|NCT00771914|75899967|FG003|STARTED|Overall Study||8||
59779371|NCT00771914|75899964|FG000|COMPLETED|Overall Study||7||
59779372|NCT00771914|75899965|FG001|COMPLETED|Overall Study||6||
59779373|NCT00771914|75899966|FG002|COMPLETED|Overall Study||6||
59779374|NCT00771914|75899967|FG003|COMPLETED|Overall Study||6||
59779375|NCT00771914|75899964|FG000|NOT COMPLETED|Overall Study||0||
59779376|NCT00771914|75899965|FG001|NOT COMPLETED|Overall Study||0||
59779377|NCT00771914|75899966|FG002|NOT COMPLETED|Overall Study||0||
59779378|NCT00771914|75899967|FG003|NOT COMPLETED|Overall Study||2||
59779379|NCT00779324|75899979|FG000|STARTED|Overall Study||82||
59779380|NCT00779324|75899980|FG001|STARTED|Overall Study||86||
59779381|NCT00779324|75899979|FG000|Completed 28-day Mid-point|Overall Study||80||
59779382|NCT00779324|75899980|FG001|Completed 28-day Mid-point|Overall Study||81||
59779383|NCT00779324|75899979|FG000|COMPLETED|Overall Study||75||
59779384|NCT00779324|75899980|FG001|COMPLETED|Overall Study||82||
59779385|NCT00779324|75899979|FG000|NOT COMPLETED|Overall Study||7||
59779386|NCT00779324|75899980|FG001|NOT COMPLETED|Overall Study||4||
59779387|NCT00779246|75899988|FG000|STARTED|Overall Study||750||
59779388|NCT00779246|75899989|FG001|STARTED|Overall Study||768||
59779389|NCT00779246|75899988|FG000|COMPLETED|Overall Study||717||
59779390|NCT00779246|75899989|FG001|COMPLETED|Overall Study||715||
59779391|NCT00779246|75899988|FG000|NOT COMPLETED|Overall Study||33||
59779392|NCT00779246|75899989|FG001|NOT COMPLETED|Overall Study||53||
59779393|NCT00771758|75899998|FG000|STARTED|Overall Study||44||
59779394|NCT00771758|75899999|FG001|STARTED|Overall Study||43||
59779395|NCT00771758|75900000|FG002|STARTED|Overall Study||21||
59779396|NCT00771758|75899998|FG000|COMPLETED|Overall Study||36||
59779397|NCT00771758|75899999|FG001|COMPLETED|Overall Study||31||
59779398|NCT00771758|75900000|FG002|COMPLETED|Overall Study||19||
59779399|NCT00771758|75899998|FG000|NOT COMPLETED|Overall Study||8||
59779400|NCT00771758|75899999|FG001|NOT COMPLETED|Overall Study||12||
59779401|NCT00771758|75900000|FG002|NOT COMPLETED|Overall Study||2||
59779402|NCT00758498|75900028|FG000|STARTED|Overall Study||142||
59779403|NCT00758498|75900029|FG001|STARTED|Overall Study||143||
59779404|NCT00758498|75900030|FG002|STARTED|Overall Study||142||
59779405|NCT00758498|75900028|FG000|COMPLETED|Overall Study||139||
59779406|NCT00758498|75900029|FG001|COMPLETED|Overall Study||141||
59779407|NCT00758498|75900030|FG002|COMPLETED|Overall Study||137||
59779408|NCT00758498|75900028|FG000|NOT COMPLETED|Overall Study||3||
59779409|NCT00758498|75900029|FG001|NOT COMPLETED|Overall Study||2||
59779410|NCT00758498|75900030|FG002|NOT COMPLETED|Overall Study||5||
59779411|NCT00798161|75900045|FG000|STARTED|Overall Study||72||
59779412|NCT00798161|75900046|FG001|STARTED|Overall Study||144||
59779413|NCT00798161|75900047|FG002|STARTED|Overall Study||147||
59779414|NCT00798161|75900048|FG003|STARTED|Overall Study||142||
59779415|NCT00798161|75900049|FG004|STARTED|Overall Study||143||
59779416|NCT00798161|75900050|FG005|STARTED|Overall Study||143||
59779417|NCT00798161|75900051|FG006|STARTED|Overall Study||66||
59779418|NCT00798161|75900045|FG000|COMPLETED|Overall Study||54||
59779419|NCT00798161|75900046|FG001|COMPLETED|Overall Study||127||
59779420|NCT00798161|75900047|FG002|COMPLETED|Overall Study||126||
59779421|NCT00798161|75900048|FG003|COMPLETED|Overall Study||121||
59779422|NCT00798161|75900049|FG004|COMPLETED|Overall Study||127||
59779423|NCT00798161|75900050|FG005|COMPLETED|Overall Study||132||
59779424|NCT00798161|75900051|FG006|COMPLETED|Overall Study||56||
59779425|NCT00798161|75900045|FG000|NOT COMPLETED|Overall Study||18||
59779426|NCT00798161|75900046|FG001|NOT COMPLETED|Overall Study||17||
59779427|NCT00798161|75900047|FG002|NOT COMPLETED|Overall Study||21||
59779428|NCT00798161|75900048|FG003|NOT COMPLETED|Overall Study||21||
59779429|NCT00798161|75900049|FG004|NOT COMPLETED|Overall Study||16||
59779430|NCT00798161|75900050|FG005|NOT COMPLETED|Overall Study||11||
59779431|NCT00798161|75900051|FG006|NOT COMPLETED|Overall Study||10||
59779432|NCT00588341|75900067|FG000|STARTED|Overall Study||24||
59779433|NCT00588341|75900067|FG000|COMPLETED|Overall Study||19||
59779434|NCT00588341|75900067|FG000|NOT COMPLETED|Overall Study||5||
59779435|NCT00802529|75900073|FG000|STARTED|Overall Study||30||
59779436|NCT00802529|75900074|FG001|STARTED|Overall Study||30||
59779437|NCT00802529|75900073|FG000|COMPLETED|Overall Study|2 patients crossed-over to gentamicin after steroids failed to control vertigo (as per protocol).|30||
59779438|NCT00802529|75900074|FG001|COMPLETED|Overall Study||29||
59779439|NCT00802529|75900073|FG000|NOT COMPLETED|Overall Study||0||
59779440|NCT00802529|75900074|FG001|NOT COMPLETED|Overall Study||1||
59779441|NCT00758264|75900083|FG000|STARTED|Active Phase||182||
59779442|NCT00758264|75900084|FG001|STARTED|Active Phase||91||
59779443|NCT00758264|75900085|FG002|STARTED|Active Phase||90||
59779444|NCT00758264|75900083|FG000|COMPLETED|Active Phase||181||
59779445|NCT00758264|75900084|FG001|COMPLETED|Active Phase||91||
59779446|NCT00758264|75900085|FG002|COMPLETED|Active Phase||85||
59779447|NCT00758264|75900083|FG000|NOT COMPLETED|Active Phase||1||
59779448|NCT00758264|75900084|FG001|NOT COMPLETED|Active Phase||0||
59779449|NCT00758264|75900085|FG002|NOT COMPLETED|Active Phase||5||
59779450|NCT00758264|75900083|FG000|STARTED|Extended Safety Follow Up (ESFU) Phase||181||
59779451|NCT00758264|75900084|FG001|STARTED|Extended Safety Follow Up (ESFU) Phase||90||
59779452|NCT00758264|75900085|FG002|STARTED|Extended Safety Follow Up (ESFU) Phase||89||
59779453|NCT00758264|75900083|FG000|COMPLETED|Extended Safety Follow Up (ESFU) Phase||181||
59779454|NCT00758264|75900084|FG001|COMPLETED|Extended Safety Follow Up (ESFU) Phase||90||
59779455|NCT00758264|75900085|FG002|COMPLETED|Extended Safety Follow Up (ESFU) Phase||89||
59779456|NCT00758264|75900083|FG000|NOT COMPLETED|Extended Safety Follow Up (ESFU) Phase||0||
59779457|NCT00758264|75900084|FG001|NOT COMPLETED|Extended Safety Follow Up (ESFU) Phase||0||
59779458|NCT00758264|75900085|FG002|NOT COMPLETED|Extended Safety Follow Up (ESFU) Phase||0||
59779459|NCT00588731|75900095|FG000|STARTED|Overall Study||21||
59779460|NCT00588731|75900096|FG001|STARTED|Overall Study||20||
59779461|NCT00588731|75900095|FG000|COMPLETED|Overall Study||18||
59779462|NCT00588731|75900096|FG001|COMPLETED|Overall Study||18||
59779463|NCT00588731|75900095|FG000|NOT COMPLETED|Overall Study||3||
59779464|NCT00588731|75900096|FG001|NOT COMPLETED|Overall Study||2||
59779465|NCT00757172|75900102|FG000|STARTED|Overall Study||65||
59779466|NCT00757172|75900102|FG000|COMPLETED|Overall Study|Participants underwent surgery.|54||
59779467|NCT00757172|75900102|FG000|NOT COMPLETED|Overall Study||11||
59779468|NCT00797225|75900110|FG000|STARTED|Weeks 1 to 12||43||
59779469|NCT00797225|75900111|FG001|STARTED|Weeks 1 to 12||43||
59779470|NCT00797225|75900112|FG002|STARTED|Weeks 1 to 12||44||
59779471|NCT00797225|75900113|FG003|STARTED|Weeks 1 to 12||44||
59779472|NCT00797225|75900114|FG004|STARTED|Weeks 1 to 12||0||
59779473|NCT00797225|75900115|FG005|STARTED|Weeks 1 to 12||0||
59779474|NCT00797225|75900116|FG006|STARTED|Weeks 1 to 12||0||
59779475|NCT00797225|75900117|FG007|STARTED|Weeks 1 to 12||0||
59779476|NCT00797225|75900110|FG000|Received Study Drug|Weeks 1 to 12||43||
59779477|NCT00797225|75900111|FG001|Received Study Drug|Weeks 1 to 12||43||
59779478|NCT00797225|75900112|FG002|Received Study Drug|Weeks 1 to 12||44||
59779479|NCT00797225|75900113|FG003|Received Study Drug|Weeks 1 to 12||44||
59779480|NCT00797225|75900114|FG004|Received Study Drug|Weeks 1 to 12||0||
59779481|NCT00797225|75900115|FG005|Received Study Drug|Weeks 1 to 12||0||
59779482|NCT00797225|75900116|FG006|Received Study Drug|Weeks 1 to 12||0||
59779483|NCT00797225|75900117|FG007|Received Study Drug|Weeks 1 to 12||0||
59779484|NCT00797225|75900110|FG000|COMPLETED|Weeks 1 to 12||41||
59779485|NCT00797225|75900111|FG001|COMPLETED|Weeks 1 to 12||42||
59779486|NCT00797225|75900112|FG002|COMPLETED|Weeks 1 to 12||43||
59779487|NCT00797225|75900113|FG003|COMPLETED|Weeks 1 to 12||44||
59779488|NCT00797225|75900114|FG004|COMPLETED|Weeks 1 to 12||0||
59779489|NCT00797225|75900115|FG005|COMPLETED|Weeks 1 to 12||0||
59779490|NCT00797225|75900116|FG006|COMPLETED|Weeks 1 to 12||0||
59779491|NCT00797225|75900117|FG007|COMPLETED|Weeks 1 to 12||0||
59779492|NCT00797225|75900110|FG000|NOT COMPLETED|Weeks 1 to 12||2||
59779493|NCT00797225|75900111|FG001|NOT COMPLETED|Weeks 1 to 12||1||
59779494|NCT00797225|75900112|FG002|NOT COMPLETED|Weeks 1 to 12||1||
59779495|NCT00797225|75900113|FG003|NOT COMPLETED|Weeks 1 to 12||0||
59779496|NCT00797225|75900114|FG004|NOT COMPLETED|Weeks 1 to 12||0||
59779497|NCT00797225|75900115|FG005|NOT COMPLETED|Weeks 1 to 12||0||
59779498|NCT00797225|75900116|FG006|NOT COMPLETED|Weeks 1 to 12||0||
59779499|NCT00797225|75900117|FG007|NOT COMPLETED|Weeks 1 to 12||0||
59779500|NCT00797225|75900110|FG000|STARTED|Weeks 13 to 24||0||
59779501|NCT00797225|75900111|FG001|STARTED|Weeks 13 to 24||42||
59779502|NCT00797225|75900112|FG002|STARTED|Weeks 13 to 24||43||
59779503|NCT00797225|75900113|FG003|STARTED|Weeks 13 to 24||0||
59779504|NCT00797225|75900114|FG004|STARTED|Weeks 13 to 24||20||
59779505|NCT00797225|75900115|FG005|STARTED|Weeks 13 to 24||21||
59779506|NCT00797225|75900116|FG006|STARTED|Weeks 13 to 24||22||
59779507|NCT00797225|75900117|FG007|STARTED|Weeks 13 to 24||22||
59779508|NCT00797225|75900110|FG000|COMPLETED|Weeks 13 to 24||0||
59779509|NCT00797225|75900111|FG001|COMPLETED|Weeks 13 to 24||38||
59779510|NCT00797225|75900112|FG002|COMPLETED|Weeks 13 to 24||41||
59779511|NCT00797225|75900113|FG003|COMPLETED|Weeks 13 to 24||0||
59779512|NCT00797225|75900114|FG004|COMPLETED|Weeks 13 to 24||19||
59779513|NCT00797225|75900115|FG005|COMPLETED|Weeks 13 to 24||21||
59779514|NCT00797225|75900116|FG006|COMPLETED|Weeks 13 to 24||20||
59779515|NCT00797225|75900117|FG007|COMPLETED|Weeks 13 to 24||22||
59779516|NCT00797225|75900110|FG000|NOT COMPLETED|Weeks 13 to 24||0||
59779517|NCT00797225|75900111|FG001|NOT COMPLETED|Weeks 13 to 24||4||
59779518|NCT00797225|75900112|FG002|NOT COMPLETED|Weeks 13 to 24||2||
59779519|NCT00797225|75900113|FG003|NOT COMPLETED|Weeks 13 to 24||0||
59779520|NCT00797225|75900114|FG004|NOT COMPLETED|Weeks 13 to 24||1||
59779521|NCT00797225|75900115|FG005|NOT COMPLETED|Weeks 13 to 24||0||
59779522|NCT00797225|75900116|FG006|NOT COMPLETED|Weeks 13 to 24||2||
59779523|NCT00797225|75900117|FG007|NOT COMPLETED|Weeks 13 to 24||0||
59779524|NCT00778700|75900137|FG000|STARTED|Overall Study||50||
59779525|NCT00778700|75900138|FG001|STARTED|Overall Study||51||
59779526|NCT00778700|75900139|FG002|STARTED|Overall Study||49||
59779527|NCT00778700|75900140|FG003|STARTED|Overall Study||49||
59779528|NCT00778700|75900137|FG000|COMPLETED|Overall Study||32||
59779529|NCT00778700|75900138|FG001|COMPLETED|Overall Study||44||
59779530|NCT00778700|75900139|FG002|COMPLETED|Overall Study||43||
59779531|NCT00778700|75900140|FG003|COMPLETED|Overall Study||36||
59779532|NCT00778700|75900137|FG000|NOT COMPLETED|Overall Study||18||
59779533|NCT00778700|75900138|FG001|NOT COMPLETED|Overall Study||7||
59779534|NCT00778700|75900139|FG002|NOT COMPLETED|Overall Study||6||
59779535|NCT00778700|75900140|FG003|NOT COMPLETED|Overall Study||13||
59779536|NCT00793403|75900154|FG000|STARTED|Overall Study||293||
59779537|NCT00793403|75900154|FG000|COMPLETED|Overall Study||220||
59779538|NCT00793403|75900154|FG000|NOT COMPLETED|Overall Study||73||
59779539|NCT00793325|75900158|FG000|STARTED|Overall Study||909||
59779540|NCT00793325|75900158|FG000|COMPLETED|Overall Study||890||
59779541|NCT00793325|75900158|FG000|NOT COMPLETED|Overall Study||19||
59779542|NCT00778622|75900184|FG000|STARTED|Overall Study||125||
59779543|NCT00778622|75900185|FG001|STARTED|Overall Study||122||
59779544|NCT00778622|75900186|FG002|STARTED|Overall Study||124||
59779545|NCT00778622|75900184|FG000|COMPLETED|Overall Study||109||
59779546|NCT00778622|75900185|FG001|COMPLETED|Overall Study||107||
59779547|NCT00778622|75900186|FG002|COMPLETED|Overall Study||109||
59779548|NCT00778622|75900184|FG000|NOT COMPLETED|Overall Study||16||
59779549|NCT00778622|75900185|FG001|NOT COMPLETED|Overall Study||15||
59779550|NCT00778622|75900186|FG002|NOT COMPLETED|Overall Study||15||
59779551|NCT00777920|75900198|FG000|STARTED|Overall Study||140||
59779552|NCT00777920|75900198|FG000|COMPLETED|Overall Study||90||
59779553|NCT00777920|75900198|FG000|NOT COMPLETED|Overall Study||50||
59779554|NCT04236141|75900204|FG000|STARTED|Overall Study||28||
59779555|NCT04236141|75900205|FG001|STARTED|Overall Study||14||
59779556|NCT04236141|75900204|FG000|Safety Population|Overall Study||27|Safety population included all randomized participants who received at least one dose of the study drug.|
59779557|NCT04236141|75900205|FG001|Safety Population|Overall Study||14|Safety population included all randomized participants who received at least one dose of the study drug.|
59779558|NCT04236141|75900204|FG000|Pharmacokinetic-Evaluable Population|Overall Study||27|Pharmacokinetic (PK)-evaluable population included all participants who had at least one evaluable PK sample post dose for at least one analyte.|
59779559|NCT04236141|75900205|FG001|Pharmacokinetic-Evaluable Population|Overall Study||0|Pharmacokinetic (PK)-evaluable population included all participants who had at least one evaluable PK sample post dose for at least one analyte.|
59779560|NCT04236141|75900204|FG000|Immunogenicity-Evaluable Population (Baseline Evaluable)|Overall Study||27|Immunogenicity-evaluable population included all participants with anti-drug antibody (ADA) assay results from baseline sample.|
59953000|NCT04057820|76071785|FG005|COMPLETED|Period 1||0||0
59779561|NCT04236141|75900205|FG001|Immunogenicity-Evaluable Population (Baseline Evaluable)|Overall Study||14|Immunogenicity-evaluable population included all participants with anti-drug antibody (ADA) assay results from baseline sample.|
59779562|NCT04236141|75900204|FG000|Immunogenicity-Evaluable Population (Post-Baseline Evaluable)|Overall Study||24|Immunogenicity-evaluable population included all participants with at least one evaluable post-baseline ADA sample|
59779563|NCT04236141|75900205|FG001|Immunogenicity-Evaluable Population (Post-Baseline Evaluable)|Overall Study||0|Immunogenicity-evaluable population included all participants with at least one evaluable post-baseline ADA sample|
59779564|NCT04236141|75900204|FG000|Intent-to-treat Population|Overall Study||28|Intention-to-treat (ITT) population included all participants randomized, whether or not the participants received the assigned treatment.|
59779565|NCT04236141|75900205|FG001|Intent-to-treat Population|Overall Study||14|Intention-to-treat (ITT) population included all participants randomized, whether or not the participants received the assigned treatment.|
59779566|NCT04236141|75900204|FG000|COMPLETED|Overall Study||0||
59779567|NCT04236141|75900205|FG001|COMPLETED|Overall Study||0||
59779568|NCT04236141|75900204|FG000|NOT COMPLETED|Overall Study||28||
59779569|NCT04236141|75900205|FG001|NOT COMPLETED|Overall Study||14||
59779570|NCT00796445|75900213|FG000|STARTED|Overall Study||895||
59779571|NCT00796445|75900214|FG001|STARTED|Overall Study||450||
59779572|NCT00796445|75900213|FG000|COMPLETED|Overall Study||310||
59779573|NCT00796445|75900214|FG001|COMPLETED|Overall Study||158||
59779574|NCT00796445|75900213|FG000|NOT COMPLETED|Overall Study||585||
59779575|NCT00796445|75900214|FG001|NOT COMPLETED|Overall Study||292||
59779576|NCT03939819|75900230|FG000|STARTED|Overall Study||50||
59779577|NCT03939819|75900231|FG001|STARTED|Overall Study||56||
59779578|NCT03939819|75900230|FG000|COMPLETED|Overall Study||48||
59779579|NCT03939819|75900231|FG001|COMPLETED|Overall Study||56||
59779580|NCT03939819|75900230|FG000|NOT COMPLETED|Overall Study||2||
59779581|NCT03939819|75900231|FG001|NOT COMPLETED|Overall Study||0||
59779582|NCT00756938|75900240|FG000|STARTED|12-week Base Study||33||
59779583|NCT00756938|75900241|FG001|STARTED|12-week Base Study||34||
59779584|NCT00756938|75900242|FG002|STARTED|12-week Base Study||34||
59779585|NCT00756938|75900243|FG003|STARTED|12-week Base Study||0||
59779586|NCT00756938|75900240|FG000|COMPLETED|12-week Base Study||31||
59779587|NCT00756938|75900241|FG001|COMPLETED|12-week Base Study||34||
59779588|NCT00756938|75900242|FG002|COMPLETED|12-week Base Study||32||
59779589|NCT00756938|75900243|FG003|COMPLETED|12-week Base Study||0||
59779590|NCT00756938|75900240|FG000|NOT COMPLETED|12-week Base Study||2||
59779591|NCT00756938|75900241|FG001|NOT COMPLETED|12-week Base Study||0||
59779592|NCT00756938|75900242|FG002|NOT COMPLETED|12-week Base Study||2||
59779593|NCT00756938|75900243|FG003|NOT COMPLETED|12-week Base Study||0||
59779594|NCT00756938|75900240|FG000|STARTED|Optional Extension||0||
59779595|NCT00756938|75900241|FG001|STARTED|Optional Extension||0||
59779596|NCT00756938|75900242|FG002|STARTED|Optional Extension||0||
59779597|NCT00756938|75900243|FG003|STARTED|Optional Extension|7 participants who completed base study opted not to enter extension|90||
59779598|NCT00756938|75900240|FG000|COMPLETED|Optional Extension||0||
59779599|NCT00756938|75900241|FG001|COMPLETED|Optional Extension||0||
59779600|NCT00756938|75900242|FG002|COMPLETED|Optional Extension||0||
59779601|NCT00756938|75900243|FG003|COMPLETED|Optional Extension||53||
59779602|NCT00756938|75900240|FG000|NOT COMPLETED|Optional Extension||0||
59779603|NCT00756938|75900241|FG001|NOT COMPLETED|Optional Extension||0||
59779604|NCT00756938|75900242|FG002|NOT COMPLETED|Optional Extension||0||
59779605|NCT00756938|75900243|FG003|NOT COMPLETED|Optional Extension||37||
59779606|NCT00796367|75900264|FG000|STARTED|Overall Study||227||
59779607|NCT00796367|75900265|FG001|STARTED|Overall Study|one participant signed ICF but withdrew from study prior to first dosing in OB-305|154||
59779608|NCT00796367|75900266|FG002|STARTED|Overall Study||295||
59779609|NCT00796367|75900264|FG000|COMPLETED|Overall Study||197||
59779610|NCT00796367|75900265|FG001|COMPLETED|Overall Study||129||
59779611|NCT00796367|75900266|FG002|COMPLETED|Overall Study||248||
59779612|NCT00796367|75900264|FG000|NOT COMPLETED|Overall Study||30||
59779613|NCT00796367|75900265|FG001|NOT COMPLETED|Overall Study||25||
59779614|NCT00796367|75900266|FG002|NOT COMPLETED|Overall Study||47||
59779615|NCT00770588|75900276|FG000|STARTED|Overall Study||148||
59779616|NCT00770588|75900277|FG001|STARTED|Overall Study||148||
59779617|NCT00770588|75900276|FG000|COMPLETED|Overall Study||67||
59779618|NCT00770588|75900277|FG001|COMPLETED|Overall Study||53||
59779619|NCT00770588|75900276|FG000|NOT COMPLETED|Overall Study||81||
59779620|NCT00770588|75900277|FG001|NOT COMPLETED|Overall Study||95||
59779621|NCT00777608|75900286|FG000|STARTED|Overall Study||53||
59779622|NCT00777608|75900287|FG001|STARTED|Overall Study||53||
59779623|NCT00777608|75900286|FG000|COMPLETED|Overall Study||49||
59779624|NCT00777608|75900287|FG001|COMPLETED|Overall Study||47||
59779625|NCT00777608|75900286|FG000|NOT COMPLETED|Overall Study||4||
59779626|NCT00777608|75900287|FG001|NOT COMPLETED|Overall Study||6||
59779627|NCT00792935|75900295|FG000|STARTED|Overall Study||72||
59779628|NCT00792935|75900296|FG001|STARTED|Overall Study||71||
59779629|NCT00792935|75900295|FG000|COMPLETED|Overall Study||68||
59779630|NCT00792935|75900296|FG001|COMPLETED|Overall Study||68||
59779631|NCT00792935|75900295|FG000|NOT COMPLETED|Overall Study||4||
59779632|NCT00792935|75900296|FG001|NOT COMPLETED|Overall Study||3||
59779633|NCT00770510|75900302|FG000|STARTED|Overall Study||72||
59779634|NCT00770510|75900302|FG000|COMPLETED|Overall Study||67||
59779635|NCT00770510|75900302|FG000|NOT COMPLETED|Overall Study||5||
59779636|NCT00770432|75900316|FG000|STARTED|Overall Study||102||
59779637|NCT00770432|75900317|FG001|STARTED|Overall Study||101||
59779638|NCT00770432|75900316|FG000|COMPLETED|Overall Study||98||
59779639|NCT00770432|75900317|FG001|COMPLETED|Overall Study||94||
59779640|NCT00770432|75900316|FG000|NOT COMPLETED|Overall Study||4||
59779641|NCT00770432|75900317|FG001|NOT COMPLETED|Overall Study||7||
59779642|NCT00792701|75900325|FG000|STARTED|Overall Study||19||
59779643|NCT00792701|75900326|FG001|STARTED|Overall Study||66||
59779644|NCT00792701|75900325|FG000|Eligible|Overall Study||18||
59779645|NCT00792701|75900326|FG001|Eligible|Overall Study||63||
59779646|NCT00792701|75900325|FG000|Eligible and Analyzable|Overall Study||17||
59779647|NCT00792701|75900326|FG001|Eligible and Analyzable|Overall Study||44||
59779648|NCT00792701|75900325|FG000|COMPLETED|Overall Study||0||
59779649|NCT00792701|75900326|FG001|COMPLETED|Overall Study||22||
59779650|NCT00792701|75900325|FG000|NOT COMPLETED|Overall Study||19||
59779651|NCT00792701|75900326|FG001|NOT COMPLETED|Overall Study||44||
59779652|NCT00777296|75900338|FG000|STARTED|Overall Study||21||
59779653|NCT00777296|75900339|FG001|STARTED|Overall Study||11||
59779654|NCT00777296|75900340|FG002|STARTED|Overall Study||23||
59779655|NCT00777296|75900341|FG003|STARTED|Overall Study||11||
59779656|NCT00777296|75900338|FG000|COMPLETED|Overall Study||20||
59779657|NCT00777296|75900339|FG001|COMPLETED|Overall Study||10||
59779658|NCT00777296|75900340|FG002|COMPLETED|Overall Study||21||
59779659|NCT00777296|75900341|FG003|COMPLETED|Overall Study||10||
59779660|NCT00777296|75900338|FG000|NOT COMPLETED|Overall Study||1||
59779661|NCT00777296|75900339|FG001|NOT COMPLETED|Overall Study||1||
59779662|NCT00777296|75900340|FG002|NOT COMPLETED|Overall Study||2||
59779663|NCT00777296|75900341|FG003|NOT COMPLETED|Overall Study||1||
59779664|NCT00756470|75900363|FG000|STARTED|Overall Study||15||
59779665|NCT00756470|75900363|FG000|COMPLETED|Overall Study||10||
59779666|NCT00756470|75900363|FG000|NOT COMPLETED|Overall Study||5||
59779667|NCT00792623|75900367|FG000|STARTED|Overall Study||29||
59779668|NCT00792623|75900367|FG000|COMPLETED|Overall Study||22||
59779669|NCT00792623|75900367|FG000|NOT COMPLETED|Overall Study||7||
59779670|NCT00756314|75900374|FG000|STARTED|Overall Study||123||
59779671|NCT00756314|75900375|FG001|STARTED|Overall Study||123||
59779672|NCT00756314|75900374|FG000|COMPLETED|Overall Study|"2 participants discontinued the intervention and were analyzed by intention to treat analysis."|121||
59779673|NCT00756314|75900375|FG001|COMPLETED|Overall Study|"4 participants did not do the follow up, 55 discontinued and were analyzed by intention to treat"|64||
59779674|NCT00756314|75900374|FG000|NOT COMPLETED|Overall Study||2||
59779675|NCT00756314|75900375|FG001|NOT COMPLETED|Overall Study||59||
59779676|NCT00727506|75900387|FG000|STARTED|Overall Study|Entered|6||
59779677|NCT00727506|75900388|FG001|STARTED|Overall Study|Entered|8||
59779678|NCT00727506|75900389|FG002|STARTED|Overall Study|Entered|18||
59779679|NCT00727506|75900390|FG003|STARTED|Overall Study|Randomized|39||
59779680|NCT00727506|75900391|FG004|STARTED|Overall Study|Randomized|41||
59779681|NCT00727506|75900392|FG005|STARTED|Overall Study|Randomized|39||
59779682|NCT00727506|75900387|FG000|COMPLETED|Overall Study||0||
59779683|NCT00727506|75900388|FG001|COMPLETED|Overall Study||0||
59779684|NCT00727506|75900389|FG002|COMPLETED|Overall Study||0||
59779685|NCT00727506|75900390|FG003|COMPLETED|Overall Study||0||
59779686|NCT00727506|75900391|FG004|COMPLETED|Overall Study||0||
59779687|NCT00727506|75900392|FG005|COMPLETED|Overall Study||0||
59779688|NCT00727506|75900387|FG000|NOT COMPLETED|Overall Study||6||
59779689|NCT00727506|75900388|FG001|NOT COMPLETED|Overall Study||8||
59779690|NCT00727506|75900389|FG002|NOT COMPLETED|Overall Study||18||
59779691|NCT00727506|75900390|FG003|NOT COMPLETED|Overall Study||39||
59779692|NCT00727506|75900391|FG004|NOT COMPLETED|Overall Study||41||
59779693|NCT00727506|75900392|FG005|NOT COMPLETED|Overall Study||39||
59779694|NCT00789815|75900414|FG000|STARTED|Overall Study||250||
59779695|NCT00789815|75900415|FG001|STARTED|Overall Study||250||
59779696|NCT00789815|75900414|FG000|COMPLETED|Overall Study||243||
59779697|NCT00789815|75900415|FG001|COMPLETED|Overall Study||249||
59779698|NCT00789815|75900414|FG000|NOT COMPLETED|Overall Study||7||
59779699|NCT00789815|75900415|FG001|NOT COMPLETED|Overall Study||1||
59779700|NCT00721578|75900421|FG000|STARTED|Overall Study||12||
59779701|NCT00721578|75900422|FG001|STARTED|Overall Study||11||
59779702|NCT00721578|75900421|FG000|COMPLETED|Overall Study||10||
59779703|NCT00721578|75900422|FG001|COMPLETED|Overall Study||9||
59779704|NCT00721578|75900421|FG000|NOT COMPLETED|Overall Study||2||
59779705|NCT00721578|75900422|FG001|NOT COMPLETED|Overall Study||2||
59779706|NCT00789737|75900430|FG000|STARTED|Overall Study||176||
59779707|NCT00789737|75900431|FG001|STARTED|Overall Study||181||
59779708|NCT00789737|75900430|FG000|COMPLETED|Overall Study||128||
59779709|NCT00789737|75900431|FG001|COMPLETED|Overall Study||126||
59779710|NCT00789737|75900430|FG000|NOT COMPLETED|Overall Study||48||
59779711|NCT00789737|75900431|FG001|NOT COMPLETED|Overall Study||55||
59779712|NCT00792467|75900437|FG000|STARTED|Overall Study||24||
59779713|NCT00792467|75900437|FG000|COMPLETED|Overall Study||2||
59779714|NCT00792467|75900437|FG000|NOT COMPLETED|Overall Study||22||
59779715|NCT00585468|75900442|FG000|STARTED|First Intervention||10||
59779716|NCT00585468|75900443|FG001|STARTED|First Intervention||11||
59779717|NCT00585468|75900442|FG000|COMPLETED|First Intervention||9||
59779718|NCT00585468|75900443|FG001|COMPLETED|First Intervention||10||
59779719|NCT00585468|75900442|FG000|NOT COMPLETED|First Intervention||1||
59779720|NCT00585468|75900443|FG001|NOT COMPLETED|First Intervention||1||
59779721|NCT00585468|75900442|FG000|STARTED|Second Intervention||9||
59779722|NCT00585468|75900443|FG001|STARTED|Second Intervention||10||
59779723|NCT00585468|75900442|FG000|COMPLETED|Second Intervention||9||
59779724|NCT00585468|75900443|FG001|COMPLETED|Second Intervention||10||
59779725|NCT00585468|75900442|FG000|NOT COMPLETED|Second Intervention||0||
59779726|NCT00585468|75900443|FG001|NOT COMPLETED|Second Intervention||0||
59779727|NCT00724152|75900456|FG000|STARTED|Two-arm Study Period||14||
59779728|NCT00724152|75900457|FG001|STARTED|Two-arm Study Period||11||
59779729|NCT00724152|75900458|FG002|STARTED|Two-arm Study Period|Standard Care arm was added later (Period 2)|0||
59779730|NCT00724152|75900456|FG000|COMPLETED|Two-arm Study Period||11||
59779731|NCT00724152|75900457|FG001|COMPLETED|Two-arm Study Period||9||
59779732|NCT00724152|75900458|FG002|COMPLETED|Two-arm Study Period||0||
59779733|NCT00724152|75900456|FG000|NOT COMPLETED|Two-arm Study Period||3||
59779734|NCT00724152|75900457|FG001|NOT COMPLETED|Two-arm Study Period||2||
59779735|NCT00724152|75900458|FG002|NOT COMPLETED|Two-arm Study Period||0||
59779736|NCT00724152|75900456|FG000|STARTED|Three-arm Study Period (+Standard Care)||4||
60072963|NCT01695993|76188163|FG001|STARTED|Overall Study||80||
60072964|NCT01695993|76188164|FG002|STARTED|Overall Study||81||
60072965|NCT01695993|76188162|FG000|COMPLETED|Overall Study||76||
59779737|NCT00724152|75900457|FG001|STARTED|Three-arm Study Period (+Standard Care)||2||
59779738|NCT00724152|75900458|FG002|STARTED|Three-arm Study Period (+Standard Care)|3-group randomization began|2||
59779739|NCT00724152|75900456|FG000|COMPLETED|Three-arm Study Period (+Standard Care)||3||
59779740|NCT00724152|75900457|FG001|COMPLETED|Three-arm Study Period (+Standard Care)||0||
59779741|NCT00724152|75900458|FG002|COMPLETED|Three-arm Study Period (+Standard Care)||1||
59779742|NCT00724152|75900456|FG000|NOT COMPLETED|Three-arm Study Period (+Standard Care)||1||
59779743|NCT00724152|75900457|FG001|NOT COMPLETED|Three-arm Study Period (+Standard Care)||2||
59779744|NCT00724152|75900458|FG002|NOT COMPLETED|Three-arm Study Period (+Standard Care)||1||
59779745|NCT00721110|75900472|FG000|STARTED|Overall Study||16||
59779746|NCT00721110|75900473|FG001|STARTED|Overall Study||16||
59779747|NCT00721110|75900474|FG002|STARTED|Overall Study||16||
59779748|NCT00721110|75900475|FG003|STARTED|Overall Study||16||
59779749|NCT00721110|75900472|FG000|COMPLETED|Overall Study||15||
59779750|NCT00721110|75900473|FG001|COMPLETED|Overall Study||16||
59779751|NCT00721110|75900474|FG002|COMPLETED|Overall Study||15||
59779752|NCT00721110|75900475|FG003|COMPLETED|Overall Study||16||
59779753|NCT00721110|75900472|FG000|NOT COMPLETED|Overall Study||1||
59779754|NCT00721110|75900473|FG001|NOT COMPLETED|Overall Study||0||
59779755|NCT00721110|75900474|FG002|NOT COMPLETED|Overall Study||1||
59779756|NCT00721110|75900475|FG003|NOT COMPLETED|Overall Study||0||
59779757|NCT00791999|75900489|FG000|STARTED|Overall Study||72||
59779758|NCT00791999|75900490|FG001|STARTED|Overall Study||82||
59779759|NCT00791999|75900491|FG002|STARTED|Overall Study||85||
59779760|NCT00791999|75900492|FG003|STARTED|Overall Study||77||
59779761|NCT00791999|75900489|FG000|COMPLETED|Overall Study||51||
59779762|NCT00791999|75900490|FG001|COMPLETED|Overall Study||66||
59779763|NCT00791999|75900491|FG002|COMPLETED|Overall Study||65||
59779764|NCT00791999|75900492|FG003|COMPLETED|Overall Study||25||
59779765|NCT00791999|75900489|FG000|NOT COMPLETED|Overall Study||21||
59779766|NCT00791999|75900490|FG001|NOT COMPLETED|Overall Study||16||
59779767|NCT00791999|75900491|FG002|NOT COMPLETED|Overall Study||20||
59779768|NCT00791999|75900492|FG003|NOT COMPLETED|Overall Study||52||
59779769|NCT03499821|75900502|FG000|STARTED|Overall Study||35||70
59779770|NCT03499821|75900502|FG000|COMPLETED|Overall Study||34||68
59779771|NCT03499821|75900502|FG000|NOT COMPLETED|Overall Study||1||2
59779772|NCT00585078|75900506|FG000|STARTED|Overall Study||40||
59779773|NCT00585078|75900506|FG000|Treated|Overall Study||37||
60072966|NCT01695993|76188163|FG001|COMPLETED|Overall Study||75||
60072967|NCT01695993|76188164|FG002|COMPLETED|Overall Study||75||
60072968|NCT01695993|76188162|FG000|NOT COMPLETED|Overall Study||5||
59779774|NCT00585078|75900506|FG000|Toxicity Evaluable|Overall Study||36|Participants who received treatment and with toxicity data reported were evaluable for toxicity.|
59779775|NCT00585078|75900506|FG000|Response Evaluable|Overall Study||24|Per protocol, participants must have completed 2 cycles of treatment to be evaluable for response.|
59779776|NCT00585078|75900506|FG000|COMPLETED|Overall Study||0|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|
60072969|NCT01695993|76188163|FG001|NOT COMPLETED|Overall Study||5||
60072970|NCT01695993|76188164|FG002|NOT COMPLETED|Overall Study||6||
60072971|NCT01565343|76188175|FG000|STARTED|Overall Study||11||
59779777|NCT00585078|75900506|FG000|NOT COMPLETED|Overall Study||40||
59779778|NCT00720876|75900510|FG000|STARTED|Overall Study||30||
59779779|NCT00720876|75900510|FG000|COMPLETED|Overall Study||28||
59779780|NCT00720876|75900510|FG000|NOT COMPLETED|Overall Study||2||
59779781|NCT00723840|75900514|FG000|STARTED|Overall Study||245||
59779782|NCT00723840|75900514|FG000|COMPLETED|Overall Study||163||
59779783|NCT00723840|75900514|FG000|NOT COMPLETED|Overall Study||82||
59779784|NCT00789581|75900527|FG000|STARTED|AC Therapy||306|All randomized patients.|
59779785|NCT00789581|75900528|FG001|STARTED|AC Therapy||308|All randomized patients.|
59779786|NCT00789581|75900527|FG000|COMPLETED|AC Therapy||295|5 patients were randomized but never treated.|
59779787|NCT00789581|75900528|FG001|COMPLETED|AC Therapy||291|5 patients were randomized but never treated.|
59779788|NCT00789581|75900527|FG000|NOT COMPLETED|AC Therapy||11||
59779789|NCT00789581|75900528|FG001|NOT COMPLETED|AC Therapy||17||
59779790|NCT00789581|75900527|FG000|STARTED|Adjuvant Therapy||295||
59779791|NCT00789581|75900528|FG001|STARTED|Adjuvant Therapy||291||
59779792|NCT00789581|75900527|FG000|COMPLETED|Adjuvant Therapy||255|4 patients completed AC therapy but did not initiate adjuvant treatment.|
59779793|NCT00789581|75900528|FG001|COMPLETED|Adjuvant Therapy||234|4 patients completed AC therapy but did not initiate adjuvant treatment.|
59779794|NCT00789581|75900527|FG000|NOT COMPLETED|Adjuvant Therapy||40||
59779795|NCT00789581|75900528|FG001|NOT COMPLETED|Adjuvant Therapy||57||
59779796|NCT00717756|75900535|FG000|STARTED|Overall Study||41||
59779797|NCT00717756|75900535|FG000|COMPLETED|Overall Study||40||
59779798|NCT00717756|75900535|FG000|NOT COMPLETED|Overall Study||1||
59779799|NCT00717522|75900539|FG000|STARTED|Overall Study||7||
59779800|NCT00717522|75900539|FG000|COMPLETED|Overall Study||0||
59779801|NCT00717522|75900539|FG000|NOT COMPLETED|Overall Study||7||
59779802|NCT00791921|75900545|FG000|STARTED|Overall Study||116||
59779803|NCT00791921|75900546|FG001|STARTED|Overall Study||114||
59779804|NCT00791921|75900545|FG000|COMPLETED|Overall Study||82||
59779805|NCT00791921|75900546|FG001|COMPLETED|Overall Study||18||
59779806|NCT00791921|75900545|FG000|NOT COMPLETED|Overall Study||34||
59779807|NCT00791921|75900546|FG001|NOT COMPLETED|Overall Study||96||
59779808|NCT00582933|75900552|FG000|STARTED|Overall Study||95||
59779809|NCT00582933|75900552|FG000|COMPLETED|Overall Study||92||
59779810|NCT00582933|75900552|FG000|NOT COMPLETED|Overall Study||3||
59779811|NCT00791765|75900558|FG000|STARTED|Weeks 1 to 12||62||
59779812|NCT00791765|75900559|FG001|STARTED|Weeks 1 to 12||62||
59779813|NCT00791765|75900558|FG000|Treated|Weeks 1 to 12||62||
59779814|NCT00791765|75900559|FG001|Treated|Weeks 1 to 12||59||
59779815|NCT00791765|75900558|FG000|COMPLETED|Weeks 1 to 12||54||
59779816|NCT00791765|75900559|FG001|COMPLETED|Weeks 1 to 12||58||
59779817|NCT00791765|75900558|FG000|NOT COMPLETED|Weeks 1 to 12||8||
59779818|NCT00791765|75900559|FG001|NOT COMPLETED|Weeks 1 to 12||4||
59522247|NCT04052542|75616591|FG009|COMPLETED|Overall Study||22||
59779819|NCT00791765|75900558|FG000|STARTED|Weeks 13 to 24||54||
59779820|NCT00791765|75900559|FG001|STARTED|Weeks 13 to 24|1 participant discontinued due to an adverse event after completing 12 weeks.|57||
59779821|NCT00791765|75900558|FG000|COMPLETED|Weeks 13 to 24||49||
59779822|NCT00791765|75900559|FG001|COMPLETED|Weeks 13 to 24||49||
59779823|NCT00791765|75900558|FG000|NOT COMPLETED|Weeks 13 to 24||5||
59779824|NCT00791765|75900559|FG001|NOT COMPLETED|Weeks 13 to 24||8||
59779825|NCT00789191|75900567|FG000|STARTED|Overall Study||111||
59779826|NCT00789191|75900568|FG001|STARTED|Overall Study||111||
59779827|NCT00789191|75900567|FG000|Exposed|Overall Study|2 withdrew informed consent. 1 randomised by mistake. 1 non-compliance|107||
59779828|NCT00789191|75900568|FG001|Exposed|Overall Study|1 non-compliance|110||
59779829|NCT00789191|75900567|FG000|COMPLETED|Overall Study||97||
59779830|NCT00789191|75900568|FG001|COMPLETED|Overall Study||92||
59779831|NCT00789191|75900567|FG000|NOT COMPLETED|Overall Study||14||
59522248|NCT04052542|75616592|FG010|COMPLETED|Overall Study||31||
59779832|NCT00789191|75900568|FG001|NOT COMPLETED|Overall Study||19||
59779833|NCT00789035|75900579|FG000|STARTED|Overall Study||82||
59779834|NCT00789035|75900580|FG001|STARTED|Overall Study||81||
59779835|NCT00789035|75900581|FG002|STARTED|Overall Study||81||
59779836|NCT00789035|75900582|FG003|STARTED|Overall Study||82||
59779837|NCT00789035|75900583|FG004|STARTED|Overall Study||80||
59779838|NCT00789035|75900579|FG000|COMPLETED|Overall Study||76||
59779839|NCT00789035|75900580|FG001|COMPLETED|Overall Study||74||
59779840|NCT00789035|75900581|FG002|COMPLETED|Overall Study||80||
59779841|NCT00789035|75900582|FG003|COMPLETED|Overall Study||81||
59779842|NCT00789035|75900583|FG004|COMPLETED|Overall Study||74||
59779843|NCT00789035|75900579|FG000|NOT COMPLETED|Overall Study||6||
59522249|NCT04052542|75616593|FG011|COMPLETED|Overall Study||12||
59522250|NCT04052542|75616582|FG000|NOT COMPLETED|Overall Study||0||
59522251|NCT04052542|75616583|FG001|NOT COMPLETED|Overall Study||0||
59522252|NCT04052542|75616584|FG002|NOT COMPLETED|Overall Study||0||
59779844|NCT00789035|75900580|FG001|NOT COMPLETED|Overall Study||7||
59522253|NCT04052542|75616585|FG003|NOT COMPLETED|Overall Study||0||
59522254|NCT04052542|75616586|FG004|NOT COMPLETED|Overall Study||0||
59779845|NCT00789035|75900581|FG002|NOT COMPLETED|Overall Study||1||
59779846|NCT00789035|75900582|FG003|NOT COMPLETED|Overall Study||1||
59779847|NCT00789035|75900583|FG004|NOT COMPLETED|Overall Study||6||
59779848|NCT03386253|75900600|FG000|STARTED|Overall Study||8||
59779849|NCT03386253|75900601|FG001|STARTED|Overall Study||8||
59779850|NCT03386253|75900600|FG000|Completed tDCS / Sham Sessions|Overall Study||7||
59779851|NCT03386253|75900601|FG001|Completed tDCS / Sham Sessions|Overall Study||8||
59779852|NCT03386253|75900600|FG000|COMPLETED|Overall Study||7|Completed 4 week follow-up session|
59779853|NCT03386253|75900601|FG001|COMPLETED|Overall Study||7|Completed 4 week follow-up session|
59779854|NCT03386253|75900600|FG000|NOT COMPLETED|Overall Study||1||
59779855|NCT03386253|75900601|FG001|NOT COMPLETED|Overall Study||1||
59779856|NCT03326193|75900607|FG000|STARTED|Overall Study||105||
59779857|NCT03326193|75900607|FG000|COMPLETED|Overall Study||52||
59779858|NCT03326193|75900607|FG000|NOT COMPLETED|Overall Study||53||
59779859|NCT02517099|75900613|FG000|STARTED|Overall Study||30||
59779860|NCT02517099|75900614|FG001|STARTED|Overall Study||30||
59779861|NCT02517099|75900613|FG000|COMPLETED|Overall Study||25||
59779862|NCT02517099|75900614|FG001|COMPLETED|Overall Study||27||
59779863|NCT02517099|75900613|FG000|NOT COMPLETED|Overall Study||5||
59779864|NCT02517099|75900614|FG001|NOT COMPLETED|Overall Study||3||
59779865|NCT00437203|75900630|FG000|STARTED|Overall Study||6||
59779866|NCT00437203|75900631|FG001|STARTED|Overall Study||8||
59779867|NCT00437203|75900632|FG002|STARTED|Overall Study||3||
59779868|NCT00437203|75900633|FG003|STARTED|Overall Study||3||
59779869|NCT00437203|75900634|FG004|STARTED|Overall Study||3||
59779870|NCT00437203|75900635|FG005|STARTED|Overall Study||3||
59779871|NCT00437203|75900636|FG006|STARTED|Overall Study||7||
59779872|NCT00437203|75900637|FG007|STARTED|Overall Study||3||
59779873|NCT00437203|75900638|FG008|STARTED|Overall Study||3||
59779874|NCT00437203|75900639|FG009|STARTED|Overall Study||4||
59779875|NCT00437203|75900630|FG000|COMPLETED|Overall Study||0||
59779876|NCT00437203|75900631|FG001|COMPLETED|Overall Study||0||
59779877|NCT00437203|75900632|FG002|COMPLETED|Overall Study||0||
59779878|NCT00437203|75900633|FG003|COMPLETED|Overall Study||0||
59779879|NCT00437203|75900634|FG004|COMPLETED|Overall Study||0||
59779880|NCT00437203|75900635|FG005|COMPLETED|Overall Study||0||
59779881|NCT00437203|75900636|FG006|COMPLETED|Overall Study||0||
59779882|NCT00437203|75900637|FG007|COMPLETED|Overall Study||0||
59779883|NCT00437203|75900638|FG008|COMPLETED|Overall Study||0||
59779884|NCT00437203|75900639|FG009|COMPLETED|Overall Study||0||
59779885|NCT00437203|75900630|FG000|NOT COMPLETED|Overall Study||6||
59779886|NCT00437203|75900631|FG001|NOT COMPLETED|Overall Study||8||
59779887|NCT00437203|75900632|FG002|NOT COMPLETED|Overall Study||3||
59779888|NCT00437203|75900633|FG003|NOT COMPLETED|Overall Study||3||
59779889|NCT00437203|75900634|FG004|NOT COMPLETED|Overall Study||3||
59779890|NCT00437203|75900635|FG005|NOT COMPLETED|Overall Study||3||
59779891|NCT00437203|75900636|FG006|NOT COMPLETED|Overall Study||7||
59779892|NCT00437203|75900637|FG007|NOT COMPLETED|Overall Study||3||
59779893|NCT00437203|75900638|FG008|NOT COMPLETED|Overall Study||3||
59779894|NCT00437203|75900639|FG009|NOT COMPLETED|Overall Study||4||
59779895|NCT00753272|75900672|FG000|STARTED|Overall Study||21893||
59779896|NCT00753272|75900673|FG001|STARTED|Overall Study||21802||
59779897|NCT00753272|75900672|FG000|COMPLETED|Overall Study||16911||
59779898|NCT00753272|75900673|FG001|COMPLETED|Overall Study||16895||
59779899|NCT00753272|75900672|FG000|NOT COMPLETED|Overall Study||4982||
59779900|NCT00753272|75900673|FG001|NOT COMPLETED|Overall Study||4907||
59779901|NCT00437125|75900682|FG000|STARTED|Overall Study||151||
59779902|NCT00437125|75900682|FG000|COMPLETED|Overall Study||119||
59779903|NCT00437125|75900682|FG000|NOT COMPLETED|Overall Study||32||
59779904|NCT03116997|75900688|FG000|STARTED|Overall Study||100||
59779905|NCT03116997|75900689|FG001|STARTED|Overall Study||101||
59779906|NCT03116997|75900688|FG000|COMPLETED|Overall Study||100||
59779907|NCT03116997|75900689|FG001|COMPLETED|Overall Study||101||
59779908|NCT03116997|75900688|FG000|NOT COMPLETED|Overall Study||0||
59779909|NCT03116997|75900689|FG001|NOT COMPLETED|Overall Study||0||
59779910|NCT00582309|75900698|FG000|STARTED|Overall Study||56||
59779911|NCT00582309|75900699|FG001|STARTED|Overall Study||49||
59779912|NCT00582309|75900700|FG002|STARTED|Overall Study||46||
59779913|NCT00582309|75900698|FG000|COMPLETED|Overall Study||56||
59779914|NCT00582309|75900699|FG001|COMPLETED|Overall Study||49||
59779915|NCT00582309|75900700|FG002|COMPLETED|Overall Study|2 did not have enough data collected to be used|44||
59779916|NCT00582309|75900698|FG000|NOT COMPLETED|Overall Study||0||
59779917|NCT00582309|75900699|FG001|NOT COMPLETED|Overall Study||0||
59779918|NCT00582309|75900700|FG002|NOT COMPLETED|Overall Study||2||
59779919|NCT00443053|75900710|FG000|STARTED|Overall Study||1502||
59779920|NCT00443053|75900711|FG001|STARTED|Overall Study||1500||
59779921|NCT00443053|75900710|FG000|COMPLETED|Overall Study||1481||
59779922|NCT00443053|75900711|FG001|COMPLETED|Overall Study||1467||
59779923|NCT00443053|75900710|FG000|NOT COMPLETED|Overall Study||21||
59779924|NCT00443053|75900711|FG001|NOT COMPLETED|Overall Study||33||
59779925|NCT00720798|75900717|FG000|STARTED|Overall Study||2067||
59779926|NCT00720798|75900717|FG000|COMPLETED|Overall Study||1311||
59779927|NCT00720798|75900717|FG000|NOT COMPLETED|Overall Study||756||
59779928|NCT01816971|75900721|FG000|STARTED|Overall Study||76||
59779929|NCT01816971|75900721|FG000|COMPLETED|Overall Study||64||
59779930|NCT01816971|75900721|FG000|NOT COMPLETED|Overall Study||12||
59779931|NCT00756002|75900727|FG000|STARTED|Placebo Run-in||488||
59779932|NCT00756002|75900728|FG001|STARTED|Placebo Run-in||0||
59779933|NCT00756002|75900727|FG000|COMPLETED|Placebo Run-in||259||
59779934|NCT00756002|75900728|FG001|COMPLETED|Placebo Run-in||0||
59779935|NCT00756002|75900727|FG000|NOT COMPLETED|Placebo Run-in||229||
59779936|NCT00756002|75900728|FG001|NOT COMPLETED|Placebo Run-in||0||
59779937|NCT00756002|75900727|FG000|STARTED|Double-Blind Treatment Period||129||
59779938|NCT00756002|75900728|FG001|STARTED|Double-Blind Treatment Period||130||
59779939|NCT00756002|75900727|FG000|COMPLETED|Double-Blind Treatment Period||114||
59779940|NCT00756002|75900728|FG001|COMPLETED|Double-Blind Treatment Period||115||
59779941|NCT00756002|75900727|FG000|NOT COMPLETED|Double-Blind Treatment Period||15||
59779942|NCT00756002|75900728|FG001|NOT COMPLETED|Double-Blind Treatment Period||15||
59779943|NCT00756002|75900727|FG000|STARTED|Placebo Run-out||114||
59779944|NCT00756002|75900728|FG001|STARTED|Placebo Run-out||0||
59779945|NCT00756002|75900727|FG000|COMPLETED|Placebo Run-out||114||
59779946|NCT00756002|75900728|FG001|COMPLETED|Placebo Run-out||0||
59779947|NCT00756002|75900727|FG000|NOT COMPLETED|Placebo Run-out||0||
59779948|NCT00756002|75900728|FG001|NOT COMPLETED|Placebo Run-out||0||
59779949|NCT00717366|75900736|FG000|STARTED|Core Study Period (20 Weeks)||16||
59779950|NCT00717366|75900737|FG001|STARTED|Core Study Period (20 Weeks)||48||
59779951|NCT00717366|75900736|FG000|COMPLETED|Core Study Period (20 Weeks)||12||
59779952|NCT00717366|75900737|FG001|COMPLETED|Core Study Period (20 Weeks)||35||
59779953|NCT00717366|75900736|FG000|NOT COMPLETED|Core Study Period (20 Weeks)||4||
59779954|NCT00717366|75900737|FG001|NOT COMPLETED|Core Study Period (20 Weeks)||13||
59779955|NCT00717366|75900736|FG000|STARTED|Extension Period (52 Weeks)||9||
59779956|NCT00717366|75900737|FG001|STARTED|Extension Period (52 Weeks)||28||
59779957|NCT00717366|75900736|FG000|Received Visit/Week 21 Dose|Extension Period (52 Weeks)||8||
59779958|NCT00717366|75900737|FG001|Received Visit/Week 21 Dose|Extension Period (52 Weeks)||28||
59779959|NCT00717366|75900736|FG000|COMPLETED|Extension Period (52 Weeks)||5||
59779960|NCT00717366|75900737|FG001|COMPLETED|Extension Period (52 Weeks)||12||
59779961|NCT00717366|75900736|FG000|NOT COMPLETED|Extension Period (52 Weeks)||4||
59779962|NCT00717366|75900737|FG001|NOT COMPLETED|Extension Period (52 Weeks)||16||
59779963|NCT02939989|75900745|FG000|STARTED|Overall Study||5||
59779964|NCT02939989|75900746|FG001|STARTED|Overall Study||28||
59779965|NCT02939989|75900745|FG000|COMPLETED|Overall Study||5||
59779966|NCT02939989|75900746|FG001|COMPLETED|Overall Study||28||
59779967|NCT02939989|75900745|FG000|NOT COMPLETED|Overall Study||0||
59779968|NCT02939989|75900746|FG001|NOT COMPLETED|Overall Study||0||
59779969|NCT00723606|75900756|FG000|STARTED|Overall Study||189||
59779970|NCT00723606|75900757|FG001|STARTED|Overall Study||187||
59779971|NCT00723606|75900756|FG000|COMPLETED|Overall Study||185||
59779972|NCT00723606|75900757|FG001|COMPLETED|Overall Study||180||
59779973|NCT00723606|75900756|FG000|NOT COMPLETED|Overall Study||4||
59779974|NCT00723606|75900757|FG001|NOT COMPLETED|Overall Study||7||
59779975|NCT00442351|75900765|FG000|STARTED|Overall Study|Due to poor enrollment and a high screening failure rate, this study was terminated early.|17||
59779976|NCT00442351|75900766|FG001|STARTED|Overall Study||9||
59779977|NCT00442351|75900765|FG000|COMPLETED|Overall Study||10||
59779978|NCT00442351|75900766|FG001|COMPLETED|Overall Study||3||
59779979|NCT00442351|75900765|FG000|NOT COMPLETED|Overall Study||7||
59779980|NCT00442351|75900766|FG001|NOT COMPLETED|Overall Study||6||
59779981|NCT00436501|75900774|FG000|STARTED|Complete Study Participation|Phase 1 opened on January 17, 2007 and closed to new patient entry on March 7, 2008.|9||
59779982|NCT00436501|75900775|FG001|STARTED|Complete Study Participation|After toxicity observations, Phase 2 opened June 4, 2008 and closed September 27, 2010.|49||
59779983|NCT00436501|75900774|FG000|COMPLETED|Complete Study Participation||9||
59779984|NCT00436501|75900775|FG001|COMPLETED|Complete Study Participation||49||
59779985|NCT00436501|75900774|FG000|NOT COMPLETED|Complete Study Participation||0||
59779986|NCT00436501|75900775|FG001|NOT COMPLETED|Complete Study Participation||0||
59779987|NCT00436501|75900774|FG000|STARTED|Phase 1: VEGF Trap Escalating Dose|Phase 1 opened on January 17, 2007 and closed to new patient entry on March 7, 2008.|9||
59779988|NCT00436501|75900775|FG001|STARTED|Phase 1: VEGF Trap Escalating Dose|Participants registered in next period.|0||
59779989|NCT00436501|75900774|FG000|COMPLETED|Phase 1: VEGF Trap Escalating Dose||9||
59779990|NCT00436501|75900775|FG001|COMPLETED|Phase 1: VEGF Trap Escalating Dose||0||
59779991|NCT00436501|75900774|FG000|NOT COMPLETED|Phase 1: VEGF Trap Escalating Dose||0||
59779992|NCT00436501|75900775|FG001|NOT COMPLETED|Phase 1: VEGF Trap Escalating Dose||0||
59779993|NCT00436501|75900774|FG000|STARTED|Phase 2: MTD VEGF Trap + Docetaxel||0||
59779994|NCT00436501|75900775|FG001|STARTED|Phase 2: MTD VEGF Trap + Docetaxel|After toxicity observations Phase 2 opened June 4, 2008 and closed to entry September 27, 2010.|49||
59779995|NCT00436501|75900774|FG000|COMPLETED|Phase 2: MTD VEGF Trap + Docetaxel||0||
59779996|NCT00436501|75900775|FG001|COMPLETED|Phase 2: MTD VEGF Trap + Docetaxel||46||
59779997|NCT00436501|75900774|FG000|NOT COMPLETED|Phase 2: MTD VEGF Trap + Docetaxel||0||
59779998|NCT00436501|75900775|FG001|NOT COMPLETED|Phase 2: MTD VEGF Trap + Docetaxel||3||
59779999|NCT00755846|75900788|FG000|STARTED|Overall Study||43||
59780000|NCT00755846|75900789|FG001|STARTED|Overall Study||44||
59780001|NCT00755846|75900790|FG002|STARTED|Overall Study||44||
59780002|NCT00755846|75900791|FG003|STARTED|Overall Study||45||
59780003|NCT00755846|75900792|FG004|STARTED|Overall Study||44||
59780004|NCT00755846|75900793|FG005|STARTED|Overall Study||45||
59780005|NCT00755846|75900788|FG000|COMPLETED|Overall Study||18||
59780006|NCT00755846|75900789|FG001|COMPLETED|Overall Study||27||
59780007|NCT00755846|75900790|FG002|COMPLETED|Overall Study||32||
59780008|NCT00755846|75900791|FG003|COMPLETED|Overall Study||32||
59780009|NCT00755846|75900792|FG004|COMPLETED|Overall Study||27||
59780010|NCT00755846|75900793|FG005|COMPLETED|Overall Study||31||
59780011|NCT00755846|75900788|FG000|NOT COMPLETED|Overall Study||25||
59780012|NCT00755846|75900789|FG001|NOT COMPLETED|Overall Study||17||
59780013|NCT00755846|75900790|FG002|NOT COMPLETED|Overall Study||12||
59780014|NCT00755846|75900791|FG003|NOT COMPLETED|Overall Study||13||
59780015|NCT00755846|75900792|FG004|NOT COMPLETED|Overall Study||17||
59780016|NCT00755846|75900793|FG005|NOT COMPLETED|Overall Study||14||
59780017|NCT03850093|75900810|FG000|STARTED|Overall Study||22||
59780018|NCT03850093|75900811|FG001|STARTED|Overall Study||22||
59780019|NCT03850093|75900812|FG002|STARTED|Overall Study||19||
59780020|NCT03850093|75900810|FG000|COMPLETED|Overall Study||21||
59618988|NCT00082758|75730124|FG002|NOT COMPLETED|Overall Study||0||
59618989|NCT00088452|75730135|FG000|STARTED|Overall Study||156||
59618990|NCT00088452|75730136|FG001|STARTED|Overall Study||149||
59618991|NCT00088452|75730137|FG002|STARTED|Overall Study||148||
59618992|NCT00088452|75730135|FG000|COMPLETED|Overall Study||155||
59618993|NCT00088452|75730136|FG001|COMPLETED|Overall Study||149||
59618994|NCT00088452|75730137|FG002|COMPLETED|Overall Study||147||
59618995|NCT00088452|75730135|FG000|NOT COMPLETED|Overall Study||1||
59618996|NCT00088452|75730136|FG001|NOT COMPLETED|Overall Study||0||
59618997|NCT00088452|75730137|FG002|NOT COMPLETED|Overall Study||1||
59618998|NCT03417570|75730147|FG000|STARTED|Overall Study||50||
59618999|NCT03417570|75730148|FG001|STARTED|Overall Study||50||
59619000|NCT03417570|75730147|FG000|COMPLETED|Overall Study||50||
59619001|NCT03417570|75730148|FG001|COMPLETED|Overall Study||50||
59619002|NCT03417570|75730147|FG000|NOT COMPLETED|Overall Study||0||
59619003|NCT03417570|75730148|FG001|NOT COMPLETED|Overall Study||0||
59619004|NCT02336958|75730158|FG000|STARTED|Overall Study||20||
59619005|NCT02336958|75730159|FG001|STARTED|Overall Study||20||
59619006|NCT02336958|75730158|FG000|COMPLETED|Overall Study||20||
59619007|NCT02336958|75730159|FG001|COMPLETED|Overall Study||20||
59619008|NCT02336958|75730158|FG000|NOT COMPLETED|Overall Study||0||
59619009|NCT02336958|75730159|FG001|NOT COMPLETED|Overall Study||0||
59619010|NCT03406104|75730165|FG000|STARTED|Overall Study||62||
59619011|NCT03406104|75730165|FG000|COMPLETED|Overall Study||55||
59619012|NCT03406104|75730165|FG000|NOT COMPLETED|Overall Study||7||
59619013|NCT03338244|75730174|FG000|STARTED|Overall Study||33173||295
59619014|NCT03338244|75730175|FG001|STARTED|Overall Study||33055||297
59619015|NCT03338244|75730174|FG000|COMPLETED|Overall Study||25995||295
59619016|NCT03338244|75730175|FG001|COMPLETED|Overall Study||25568||297
59619017|NCT03338244|75730174|FG000|NOT COMPLETED|Overall Study||7178||0
59619018|NCT03338244|75730175|FG001|NOT COMPLETED|Overall Study||7487||0
59619019|NCT03334344|75730183|FG000|STARTED|Overall Study||44||
59619020|NCT03334344|75730184|FG001|STARTED|Overall Study||48||
59619021|NCT03334344|75730183|FG000|COMPLETED|Overall Study||44||
59619022|NCT03334344|75730184|FG001|COMPLETED|Overall Study||48||
59619023|NCT03334344|75730183|FG000|NOT COMPLETED|Overall Study||0||
59619024|NCT03334344|75730184|FG001|NOT COMPLETED|Overall Study||0||
59619025|NCT03293238|75730194|FG000|STARTED|Overall Study||19||
59619026|NCT03293238|75730195|FG001|STARTED|Overall Study||16||
59619027|NCT03293238|75730196|FG002|STARTED|Overall Study||14||
59619028|NCT03293238|75730197|FG003|STARTED|Overall Study||14||
59619029|NCT03293238|75730194|FG000|COMPLETED|Overall Study||19||
59619030|NCT03293238|75730195|FG001|COMPLETED|Overall Study||16||
59619031|NCT03293238|75730196|FG002|COMPLETED|Overall Study||14||
59619032|NCT03293238|75730197|FG003|COMPLETED|Overall Study||14||
59619033|NCT03293238|75730194|FG000|NOT COMPLETED|Overall Study||0||
59619034|NCT03293238|75730195|FG001|NOT COMPLETED|Overall Study||0||
59619035|NCT03293238|75730196|FG002|NOT COMPLETED|Overall Study||0||
59619036|NCT03293238|75730197|FG003|NOT COMPLETED|Overall Study||0||
59619037|NCT03693144|75730210|FG000|STARTED|Overall Study||7||
59619038|NCT03693144|75730211|FG001|STARTED|Overall Study||7||
59619039|NCT03693144|75730212|FG002|STARTED|Overall Study||5||
59619040|NCT03693144|75730210|FG000|COMPLETED|Overall Study||7|Completion = maintaining the app on their phone, or participating in an end-of-study interview, but as COVID shut down Fast Food Restaurants approximately four months after the first enrollment, no six-month data could be gathered from the app.|
59619041|NCT03693144|75730211|FG001|COMPLETED|Overall Study||5|Completion = maintaining the app on their phone, or participating in an end-of-study interview, but as COVID shut down Fast Food Restaurants approximately four months after the first enrollment, no six-month data could be gathered from the app.|
59619042|NCT03693144|75730212|FG002|COMPLETED|Overall Study||4|Completion = maintaining the app on their phone, or participating in an end-of-study interview, but as COVID shut down Fast Food Restaurants approximately four months after the first enrollment, no six-month data could be gathered from the app.|
59619043|NCT03693144|75730210|FG000|NOT COMPLETED|Overall Study||0||
59780021|NCT03850093|75900811|FG001|COMPLETED|Overall Study||22||
59619044|NCT03693144|75730211|FG001|NOT COMPLETED|Overall Study||2||
59619045|NCT03693144|75730212|FG002|NOT COMPLETED|Overall Study||1||
59619046|NCT02084628|75730221|FG000|STARTED|Overall Study||1||
59619047|NCT02084628|75730221|FG000|COMPLETED|Overall Study||1||
59780022|NCT03850093|75900812|FG002|COMPLETED|Overall Study||17||
59780023|NCT03850093|75900810|FG000|NOT COMPLETED|Overall Study||1||
59780024|NCT03850093|75900811|FG001|NOT COMPLETED|Overall Study||0||
59780025|NCT03850093|75900812|FG002|NOT COMPLETED|Overall Study||2||
59780026|NCT00442117|75900822|FG000|STARTED|Overall Study||85||
59780027|NCT00442117|75900823|FG001|STARTED|Overall Study||87||
59780028|NCT00442117|75900822|FG000|COMPLETED|Overall Study||47||
59780029|NCT00442117|75900823|FG001|COMPLETED|Overall Study||49||
59780030|NCT00442117|75900822|FG000|NOT COMPLETED|Overall Study||38||
59780031|NCT00442117|75900823|FG001|NOT COMPLETED|Overall Study||38||
59780032|NCT00752726|75900831|FG000|STARTED|Overall Study||65||
59780033|NCT00752726|75900832|FG001|STARTED|Overall Study||66||
59780034|NCT00752726|75900831|FG000|Safety Population|Overall Study|2 participants were never dosed with the study medication.|63||
59780035|NCT00752726|75900832|FG001|Safety Population|Overall Study|2 participants were never dosed with the study medication.|64||
59780036|NCT00752726|75900831|FG000|Intention to Treat (ITT) Population|Overall Study|ITT population had atleast 1 post treatment efficacy measurement.|62||
59780037|NCT00752726|75900832|FG001|Intention to Treat (ITT) Population|Overall Study|ITT population had atleast 1 post treatment efficacy measurement.|61||
59780038|NCT00752726|75900831|FG000|COMPLETED|Overall Study||54||
59780039|NCT00752726|75900832|FG001|COMPLETED|Overall Study||53||
59780040|NCT00752726|75900831|FG000|NOT COMPLETED|Overall Study||11||
59780041|NCT00752726|75900832|FG001|NOT COMPLETED|Overall Study||13||
59780042|NCT00755222|75900840|FG000|STARTED|Overall Study||111||
59780043|NCT00755222|75900841|FG001|STARTED|Overall Study||36||
59780044|NCT00755222|75900840|FG000|COMPLETED|Overall Study||103||
59780045|NCT00755222|75900841|FG001|COMPLETED|Overall Study||34||
59780046|NCT00755222|75900840|FG000|NOT COMPLETED|Overall Study||8||
59780047|NCT00755222|75900841|FG001|NOT COMPLETED|Overall Study||2||
59780048|NCT00441727|75900850|FG000|STARTED|Overall Study|ITT/randomised|817||
59780049|NCT00441727|75900851|FG001|STARTED|Overall Study|ITT/randomised|804||
59780050|NCT00441727|75900852|FG002|STARTED|Overall Study|ITT/randomised|805||
59780051|NCT00441727|75900850|FG000|COMPLETED|Overall Study|ITT/randomised|711||
59780052|NCT00441727|75900851|FG001|COMPLETED|Overall Study|ITT/randomised|686||
59780053|NCT00441727|75900852|FG002|COMPLETED|Overall Study|ITT/randomised|637||
59780054|NCT00441727|75900850|FG000|NOT COMPLETED|Overall Study||106||
59780055|NCT00441727|75900851|FG001|NOT COMPLETED|Overall Study||118||
59780056|NCT00441727|75900852|FG002|NOT COMPLETED|Overall Study||168||
59780057|NCT02955225|75900867|FG000|STARTED|Overall Study||26||
59780058|NCT02955225|75900868|FG001|STARTED|Overall Study||12||
59780059|NCT02955225|75900867|FG000|COMPLETED|Overall Study||21||
59780060|NCT02955225|75900868|FG001|COMPLETED|Overall Study||12||
59780061|NCT02955225|75900867|FG000|NOT COMPLETED|Overall Study||5||
59780062|NCT02955225|75900868|FG001|NOT COMPLETED|Overall Study||0||
59780063|NCT00770120|75900874|FG000|STARTED|Overall Study||61||
59780064|NCT00770120|75900874|FG000|Eligible|Overall Study||60||
59780065|NCT00770120|75900874|FG000|Not Analyzable|Overall Study||1||
59780066|NCT00770120|75900874|FG000|COMPLETED|Overall Study||0||
59780067|NCT00770120|75900874|FG000|NOT COMPLETED|Overall Study||61||
59780068|NCT00436345|75900881|FG000|STARTED|Overall Study||21||
59780069|NCT00436345|75900882|FG001|STARTED|Overall Study||18||
59780070|NCT00436345|75900881|FG000|COMPLETED|Overall Study||18||
59780071|NCT00436345|75900882|FG001|COMPLETED|Overall Study||18||
59780072|NCT00436345|75900881|FG000|NOT COMPLETED|Overall Study||3||
59780073|NCT00436345|75900882|FG001|NOT COMPLETED|Overall Study||0||
59780074|NCT00769184|75900889|FG000|STARTED|Corticosteroid + LCD/ +Placebo (2 Weeks)||7||
59780075|NCT00769184|75900890|FG001|STARTED|Corticosteroid + LCD/ +Placebo (2 Weeks)||8||
59780076|NCT00769184|75900889|FG000|COMPLETED|Corticosteroid + LCD/ +Placebo (2 Weeks)||6||
59780077|NCT00769184|75900890|FG001|COMPLETED|Corticosteroid + LCD/ +Placebo (2 Weeks)||7||
59780078|NCT00769184|75900889|FG000|NOT COMPLETED|Corticosteroid + LCD/ +Placebo (2 Weeks)||1||
59780079|NCT00769184|75900890|FG001|NOT COMPLETED|Corticosteroid + LCD/ +Placebo (2 Weeks)||1||
59780080|NCT00769184|75900889|FG000|STARTED|+LCD / +Placebo Only (4 Weeks)||6||
59780081|NCT00769184|75900890|FG001|STARTED|+LCD / +Placebo Only (4 Weeks)||7||
59780082|NCT00769184|75900889|FG000|COMPLETED|+LCD / +Placebo Only (4 Weeks)||6||
60072972|NCT01565343|76188176|FG001|STARTED|Overall Study||4||
59780083|NCT00769184|75900890|FG001|COMPLETED|+LCD / +Placebo Only (4 Weeks)||7||
59780084|NCT00769184|75900889|FG000|NOT COMPLETED|+LCD / +Placebo Only (4 Weeks)||0||
59780085|NCT00769184|75900890|FG001|NOT COMPLETED|+LCD / +Placebo Only (4 Weeks)||0||
59780086|NCT00769184|75900889|FG000|STARTED|No Treatment (6 Weeks)||6||
59780087|NCT00769184|75900890|FG001|STARTED|No Treatment (6 Weeks)||7||
59780088|NCT00769184|75900889|FG000|COMPLETED|No Treatment (6 Weeks)||5||
59780089|NCT00769184|75900890|FG001|COMPLETED|No Treatment (6 Weeks)||6||
59780090|NCT00769184|75900889|FG000|NOT COMPLETED|No Treatment (6 Weeks)||1||
59780091|NCT00769184|75900890|FG001|NOT COMPLETED|No Treatment (6 Weeks)||1||
59780092|NCT00768560|75900904|FG000|STARTED|Intervention Set 1|3-period/treatment crossover|5||
59780093|NCT00768560|75900905|FG001|STARTED|Intervention Set 1|3-period/treatment crossover|6||
59780094|NCT00768560|75900906|FG002|STARTED|Intervention Set 1|3-period/treatment crossover|6||
59780095|NCT00768560|75900907|FG003|STARTED|Intervention Set 1|3-period/treatment crossover|6||
59780096|NCT00768560|75900908|FG004|STARTED|Intervention Set 1|3-period/treatment crossover|6||
59780097|NCT00768560|75900909|FG005|STARTED|Intervention Set 1|3-period/treatment crossover|6||
59780098|NCT00768560|75900904|FG000|Subjects Received Treatment|Intervention Set 1|40 mg OD for 2 weeks|5||
60072973|NCT01565343|76188177|FG002|STARTED|Overall Study||10||
60072974|NCT01565343|76188175|FG000|COMPLETED|Overall Study||10||
59780099|NCT00768560|75900905|FG001|Subjects Received Treatment|Intervention Set 1|40 mg OD for 2 weeks|6||
59780100|NCT00768560|75900906|FG002|Subjects Received Treatment|Intervention Set 1|40 mg twice daily (BID) for 2 weeks|6||
59780101|NCT00768560|75900907|FG003|Subjects Received Treatment|Intervention Set 1|40 mg BID for 2 weeks|6||
59780102|NCT00768560|75900908|FG004|Subjects Received Treatment|Intervention Set 1|80 mg OD for 2 weeks|6||
59780103|NCT00768560|75900909|FG005|Subjects Received Treatment|Intervention Set 1|80 mg OD for 2 weeks|6||
59780104|NCT00768560|75900904|FG000|COMPLETED|Intervention Set 1||5||
59780105|NCT00768560|75900905|FG001|COMPLETED|Intervention Set 1||5||
59780106|NCT00768560|75900906|FG002|COMPLETED|Intervention Set 1||6||
59780107|NCT00768560|75900907|FG003|COMPLETED|Intervention Set 1||6||
59780108|NCT00768560|75900908|FG004|COMPLETED|Intervention Set 1||6||
59780109|NCT00768560|75900909|FG005|COMPLETED|Intervention Set 1||6||
59780110|NCT00768560|75900904|FG000|NOT COMPLETED|Intervention Set 1||0||
59780111|NCT00768560|75900905|FG001|NOT COMPLETED|Intervention Set 1||1||
59780112|NCT00768560|75900906|FG002|NOT COMPLETED|Intervention Set 1||0||
59780113|NCT00768560|75900907|FG003|NOT COMPLETED|Intervention Set 1||0||
59780114|NCT00768560|75900908|FG004|NOT COMPLETED|Intervention Set 1||0||
59780115|NCT00768560|75900909|FG005|NOT COMPLETED|Intervention Set 1||0||
59780116|NCT00768560|75900904|FG000|STARTED|Intervention Set 2|40 mg BID for 2 weeks|5||
59780117|NCT00768560|75900905|FG001|STARTED|Intervention Set 2|80 mg OD for 2 weeks|5||
59780118|NCT00768560|75900906|FG002|STARTED|Intervention Set 2|80 mg OD for 2 weeks|6||
59780119|NCT00768560|75900907|FG003|STARTED|Intervention Set 2|40 mg OD for 2 weeks|6||
59780120|NCT00768560|75900908|FG004|STARTED|Intervention Set 2|40 mg OD for 2 weeks|6||
59780121|NCT00768560|75900909|FG005|STARTED|Intervention Set 2|40 mg BID for 2 weeks|6||
59780122|NCT00768560|75900904|FG000|COMPLETED|Intervention Set 2||5||
59780123|NCT00768560|75900905|FG001|COMPLETED|Intervention Set 2||5||
59780124|NCT00768560|75900906|FG002|COMPLETED|Intervention Set 2||6||
59780125|NCT00768560|75900907|FG003|COMPLETED|Intervention Set 2||6||
59780126|NCT00768560|75900908|FG004|COMPLETED|Intervention Set 2||6||
59780127|NCT00768560|75900909|FG005|COMPLETED|Intervention Set 2||6||
59780128|NCT00768560|75900904|FG000|NOT COMPLETED|Intervention Set 2||0||
59780129|NCT00768560|75900905|FG001|NOT COMPLETED|Intervention Set 2||0||
60072975|NCT01565343|76188176|FG001|COMPLETED|Overall Study||4||
60072976|NCT01565343|76188177|FG002|COMPLETED|Overall Study||10||
60072977|NCT01565343|76188175|FG000|NOT COMPLETED|Overall Study||1||
60072978|NCT01565343|76188176|FG001|NOT COMPLETED|Overall Study||0||
60072979|NCT01565343|76188177|FG002|NOT COMPLETED|Overall Study||0||
60072980|NCT00003460|76188184|FG000|STARTED|Overall Study||13||
60072981|NCT00003460|76188184|FG000|COMPLETED|Overall Study|One patient was not evaluable.|12||
59780130|NCT00768560|75900906|FG002|NOT COMPLETED|Intervention Set 2||0||
59780131|NCT00768560|75900907|FG003|NOT COMPLETED|Intervention Set 2||0||
59780132|NCT00768560|75900908|FG004|NOT COMPLETED|Intervention Set 2||0||
59780133|NCT00768560|75900909|FG005|NOT COMPLETED|Intervention Set 2||0||
59780134|NCT00768560|75900904|FG000|STARTED|Intervention Set 3|80 mg OD for 2 weeks|5||
59780135|NCT00768560|75900905|FG001|STARTED|Intervention Set 3|40 mg BID for 2 weeks|5||
59780136|NCT00768560|75900906|FG002|STARTED|Intervention Set 3|40 mg OD for 2 weeks|6||
59780137|NCT00768560|75900907|FG003|STARTED|Intervention Set 3|80 mg OD for 2 weeks|6||
59780138|NCT00768560|75900908|FG004|STARTED|Intervention Set 3|40 mg BID for 2 weeks|6||
59780139|NCT00768560|75900909|FG005|STARTED|Intervention Set 3|40 mg OD for 2 weeks|6||
59780140|NCT00768560|75900904|FG000|COMPLETED|Intervention Set 3||5||
59780141|NCT00768560|75900905|FG001|COMPLETED|Intervention Set 3||5||
59780142|NCT00768560|75900906|FG002|COMPLETED|Intervention Set 3||6||
59780143|NCT00768560|75900907|FG003|COMPLETED|Intervention Set 3||6||
59780144|NCT00768560|75900908|FG004|COMPLETED|Intervention Set 3||6||
59780145|NCT00768560|75900909|FG005|COMPLETED|Intervention Set 3||6||
59780146|NCT00768560|75900904|FG000|NOT COMPLETED|Intervention Set 3||0||
59780147|NCT00768560|75900905|FG001|NOT COMPLETED|Intervention Set 3||0||
59780148|NCT00768560|75900906|FG002|NOT COMPLETED|Intervention Set 3||0||
59780149|NCT00768560|75900907|FG003|NOT COMPLETED|Intervention Set 3||0||
59780150|NCT00768560|75900908|FG004|NOT COMPLETED|Intervention Set 3||0||
59780151|NCT00768560|75900909|FG005|NOT COMPLETED|Intervention Set 3||0||
59780152|NCT00468559|75900919|FG000|STARTED|Open-label Treatment Phase|All participants received open-label esomeprazole during this phase of the study|98||
59780153|NCT00468559|75900920|FG001|STARTED|Open-label Treatment Phase||0||
59780154|NCT00468559|75900921|FG002|STARTED|Open-label Treatment Phase||0||
59780155|NCT00468559|75900919|FG000|COMPLETED|Open-label Treatment Phase|18 patients discontinued (were not randomized into the double-blind treatment withdrawal phase)|80||
59780156|NCT00468559|75900920|FG001|COMPLETED|Open-label Treatment Phase||0||
59780157|NCT00468559|75900921|FG002|COMPLETED|Open-label Treatment Phase||0||
59780158|NCT00468559|75900919|FG000|NOT COMPLETED|Open-label Treatment Phase||18||
59780159|NCT00468559|75900920|FG001|NOT COMPLETED|Open-label Treatment Phase||0||
59780160|NCT00468559|75900921|FG002|NOT COMPLETED|Open-label Treatment Phase||0||
59780161|NCT00468559|75900919|FG000|STARTED|Double-blind, Treatment-withdrawal Phase||0||
59780162|NCT00468559|75900920|FG001|STARTED|Double-blind, Treatment-withdrawal Phase||39||
59780163|NCT00468559|75900921|FG002|STARTED|Double-blind, Treatment-withdrawal Phase||41||
60072982|NCT00003460|76188184|FG000|NOT COMPLETED|Overall Study||1||
60072983|NCT03834142|76188190|FG000|STARTED|Overall Study||10||
59780164|NCT00468559|75900919|FG000|COMPLETED|Double-blind, Treatment-withdrawal Phase||0||
59780165|NCT00468559|75900920|FG001|COMPLETED|Double-blind, Treatment-withdrawal Phase||29||
59780166|NCT00468559|75900921|FG002|COMPLETED|Double-blind, Treatment-withdrawal Phase||24||
59780167|NCT00468559|75900919|FG000|NOT COMPLETED|Double-blind, Treatment-withdrawal Phase||0||
59780168|NCT00468559|75900920|FG001|NOT COMPLETED|Double-blind, Treatment-withdrawal Phase||10||
59780169|NCT00468559|75900921|FG002|NOT COMPLETED|Double-blind, Treatment-withdrawal Phase||17||
59780170|NCT00754442|75900931|FG000|STARTED|Overall Study|controls 11|11||
59780171|NCT00754442|75900932|FG001|STARTED|Overall Study|patients 9|9||
59780172|NCT00754442|75900931|FG000|COMPLETED|Overall Study||6||
59780173|NCT00754442|75900932|FG001|COMPLETED|Overall Study||6||
59780174|NCT00754442|75900931|FG000|NOT COMPLETED|Overall Study||5||
59780175|NCT00754442|75900932|FG001|NOT COMPLETED|Overall Study||3||
59780176|NCT00754052|75900941|FG000|STARTED|Overall Study||5||
59780177|NCT00754052|75900942|FG001|STARTED|Overall Study||3||
59780178|NCT00754052|75900941|FG000|COMPLETED|Overall Study||0||
59780179|NCT00754052|75900942|FG001|COMPLETED|Overall Study||0||
59780180|NCT00754052|75900941|FG000|NOT COMPLETED|Overall Study||5||
59780181|NCT00754052|75900942|FG001|NOT COMPLETED|Overall Study||3||
59780182|NCT00747812|75900950|FG000|STARTED|Overall Study||5||
59780183|NCT00747812|75900951|FG001|STARTED|Overall Study|4 subjects were randomized to the Control Group; 1 was not implanted due to early enrollment closure|3||
59780184|NCT00747812|75900950|FG000|COMPLETED|Overall Study||0||
59780185|NCT00747812|75900951|FG001|COMPLETED|Overall Study||0||
59780186|NCT00747812|75900950|FG000|NOT COMPLETED|Overall Study||5||
59780187|NCT00747812|75900951|FG001|NOT COMPLETED|Overall Study||3||
59780188|NCT02927067|75900959|FG000|STARTED|Overall Study||277||
59780189|NCT02927067|75900960|FG001|STARTED|Overall Study||276||
59780190|NCT02927067|75900959|FG000|Treated Participants|Overall Study||274|Treated participants (full analysis set) included the participants from the randomized set who took at least one dose of assigned study drug and were analyzed for efficacy and safety evaluations.|
59780191|NCT02927067|75900960|FG001|Treated Participants|Overall Study||273|Treated participants (full analysis set) included the participants from the randomized set who took at least one dose of assigned study drug and were analyzed for efficacy and safety evaluations.|
59780192|NCT02927067|75900959|FG000|Participants Received 8 Weeks Treatment|Overall Study||140|Participants who received 8 weeks of treatment include the participants who completed study drug treatment.|
59780193|NCT02927067|75900960|FG001|Participants Received 8 Weeks Treatment|Overall Study||179|Participants who received 8 weeks of treatment include the participants who completed study drug treatment.|
59780194|NCT02927067|75900959|FG000|COMPLETED|Overall Study||217||
59780195|NCT02927067|75900960|FG001|COMPLETED|Overall Study||215||
59780196|NCT02927067|75900959|FG000|NOT COMPLETED|Overall Study||60||
59780197|NCT02927067|75900960|FG001|NOT COMPLETED|Overall Study||61||
59780198|NCT01751685|75900970|FG000|STARTED|6-mo Followup||51||
59780199|NCT01751685|75900971|FG001|STARTED|6-mo Followup||48||
59780200|NCT01751685|75900970|FG000|COMPLETED|6-mo Followup||48||
59780201|NCT01751685|75900971|FG001|COMPLETED|6-mo Followup||45||
59780202|NCT01751685|75900970|FG000|NOT COMPLETED|6-mo Followup||3||
59780203|NCT01751685|75900971|FG001|NOT COMPLETED|6-mo Followup||3||
59780204|NCT01751685|75900970|FG000|STARTED|12-mo Followup||48||
59953001|NCT04057820|76071786|FG006|COMPLETED|Period 1||23||3
59780205|NCT01751685|75900971|FG001|STARTED|12-mo Followup||45||
59780206|NCT01751685|75900970|FG000|COMPLETED|12-mo Followup||43||
59780207|NCT01751685|75900971|FG001|COMPLETED|12-mo Followup||45||
59780208|NCT01751685|75900970|FG000|NOT COMPLETED|12-mo Followup||5||
59780209|NCT01751685|75900971|FG001|NOT COMPLETED|12-mo Followup||0||
59780210|NCT00586508|75900979|FG000|STARTED|Overall Study||68||
59780211|NCT00586508|75900980|FG001|STARTED|Overall Study||13||
59780212|NCT00586508|75900979|FG000|Received at Least 1 Dose of Study Drug|Overall Study||68||
59780213|NCT00586508|75900980|FG001|Received at Least 1 Dose of Study Drug|Overall Study||13||
59780214|NCT00586508|75900979|FG000|COMPLETED|Overall Study||0||
59780215|NCT00586508|75900980|FG001|COMPLETED|Overall Study||0||
59780216|NCT00586508|75900979|FG000|NOT COMPLETED|Overall Study||68||
59780217|NCT00586508|75900980|FG001|NOT COMPLETED|Overall Study||13||
59780218|NCT00581919|75900986|FG000|STARTED|Overall Study||32||
59780219|NCT00581919|75900986|FG000|COMPLETED|Overall Study||8||
59780220|NCT00581919|75900986|FG000|NOT COMPLETED|Overall Study||24||
59780221|NCT00723528|75900994|FG000|STARTED|Period 1: Controlled Period (CP)||32||
59780222|NCT00723528|75900995|FG001|STARTED|Period 1: Controlled Period (CP)||64||
59780223|NCT00723528|75900996|FG002|STARTED|Period 1: Controlled Period (CP)||62||
59780224|NCT00723528|75900997|FG003|STARTED|Period 1: Controlled Period (CP)||0||
59780225|NCT00723528|75900998|FG004|STARTED|Period 1: Controlled Period (CP)||0||
59780226|NCT00723528|75900999|FG005|STARTED|Period 1: Controlled Period (CP)||0||
59780227|NCT00723528|75901000|FG006|STARTED|Period 1: Controlled Period (CP)||0||
59780228|NCT00723528|75900994|FG000|COMPLETED|Period 1: Controlled Period (CP)||28||
59780229|NCT00723528|75900995|FG001|COMPLETED|Period 1: Controlled Period (CP)||64||
59780230|NCT00723528|75900996|FG002|COMPLETED|Period 1: Controlled Period (CP)||58||
59780231|NCT00723528|75900997|FG003|COMPLETED|Period 1: Controlled Period (CP)||0||
59780232|NCT00723528|75900998|FG004|COMPLETED|Period 1: Controlled Period (CP)||0||
59780233|NCT00723528|75900999|FG005|COMPLETED|Period 1: Controlled Period (CP)||0||
59953002|NCT04057820|76071787|FG007|COMPLETED|Period 1||0||0
59780234|NCT00723528|75901000|FG006|COMPLETED|Period 1: Controlled Period (CP)||0||
59780235|NCT00723528|75900994|FG000|NOT COMPLETED|Period 1: Controlled Period (CP)||4||
59780236|NCT00723528|75900995|FG001|NOT COMPLETED|Period 1: Controlled Period (CP)||0||
59780237|NCT00723528|75900996|FG002|NOT COMPLETED|Period 1: Controlled Period (CP)||4||
59780238|NCT00723528|75900997|FG003|NOT COMPLETED|Period 1: Controlled Period (CP)||0||
59780239|NCT00723528|75900998|FG004|NOT COMPLETED|Period 1: Controlled Period (CP)||0||
59780240|NCT00723528|75900999|FG005|NOT COMPLETED|Period 1: Controlled Period (CP)||0||
59780241|NCT00723528|75901000|FG006|NOT COMPLETED|Period 1: Controlled Period (CP)||0||
59780242|NCT00723528|75900994|FG000|STARTED|Period 2: After Controlled Period||0||
59780243|NCT00723528|75900995|FG001|STARTED|Period 2: After Controlled Period||0||
59780244|NCT00723528|75900996|FG002|STARTED|Period 2: After Controlled Period||0||
59780245|NCT00723528|75900997|FG003|STARTED|Period 2: After Controlled Period||15||
59780246|NCT00723528|75900998|FG004|STARTED|Period 2: After Controlled Period||13||
59780247|NCT00723528|75900999|FG005|STARTED|Period 2: After Controlled Period||64||
59780248|NCT00723528|75901000|FG006|STARTED|Period 2: After Controlled Period||58||
59780249|NCT00723528|75900994|FG000|COMPLETED|Period 2: After Controlled Period||0||
59780250|NCT00723528|75900995|FG001|COMPLETED|Period 2: After Controlled Period||0||
59780251|NCT00723528|75900996|FG002|COMPLETED|Period 2: After Controlled Period||0||
59780252|NCT00723528|75900997|FG003|COMPLETED|Period 2: After Controlled Period||14||
59780253|NCT00723528|75900998|FG004|COMPLETED|Period 2: After Controlled Period||11||
59780254|NCT00723528|75900999|FG005|COMPLETED|Period 2: After Controlled Period||58||
59780255|NCT00723528|75901000|FG006|COMPLETED|Period 2: After Controlled Period||54||
59780256|NCT00723528|75900994|FG000|NOT COMPLETED|Period 2: After Controlled Period||0||
59780257|NCT00723528|75900995|FG001|NOT COMPLETED|Period 2: After Controlled Period||0||
59780258|NCT00723528|75900996|FG002|NOT COMPLETED|Period 2: After Controlled Period||0||
59953003|NCT04057820|76071788|FG008|COMPLETED|Period 1||41||4
59953004|NCT04057820|76071789|FG009|COMPLETED|Period 1||0||0
59780259|NCT00723528|75900997|FG003|NOT COMPLETED|Period 2: After Controlled Period||1||
59780260|NCT00723528|75900998|FG004|NOT COMPLETED|Period 2: After Controlled Period||2||
59780261|NCT00723528|75900999|FG005|NOT COMPLETED|Period 2: After Controlled Period||6||
59780262|NCT00723528|75901000|FG006|NOT COMPLETED|Period 2: After Controlled Period||4||
59780263|NCT00751790|75901016|FG000|STARTED|Overall Study||120||
59780264|NCT00751790|75901016|FG000|COMPLETED|Overall Study||115||
59780265|NCT00751790|75901016|FG000|NOT COMPLETED|Overall Study||5||
59780266|NCT00723450|75901022|FG000|STARTED|Open-Label Phase||298||
59780267|NCT00723450|75901023|FG001|STARTED|Open-Label Phase||0||
59780268|NCT00723450|75901024|FG002|STARTED|Open-Label Phase||0||
59780269|NCT00723450|75901022|FG000|COMPLETED|Open-Label Phase||173||
59780270|NCT00723450|75901023|FG001|COMPLETED|Open-Label Phase||0||
59780271|NCT00723450|75901024|FG002|COMPLETED|Open-Label Phase||0||
59780272|NCT00723450|75901022|FG000|NOT COMPLETED|Open-Label Phase||125||
59780273|NCT00723450|75901023|FG001|NOT COMPLETED|Open-Label Phase||0||
59780274|NCT00723450|75901024|FG002|NOT COMPLETED|Open-Label Phase||0||
59780275|NCT00723450|75901022|FG000|STARTED|Randomized Phase||0||
59780276|NCT00723450|75901023|FG001|STARTED|Randomized Phase||86||
59780277|NCT00723450|75901024|FG002|STARTED|Randomized Phase||87||
59953005|NCT04057820|76071790|FG010|COMPLETED|Period 1||27||4
59953006|NCT04057820|76071791|FG011|COMPLETED|Period 1||0||0
59953007|NCT04057820|76071792|FG012|COMPLETED|Period 1||16||3
59953008|NCT04057820|76071793|FG013|COMPLETED|Period 1||0||0
59953009|NCT04057820|76071794|FG014|COMPLETED|Period 1||20||3
59953010|NCT04057820|76071795|FG015|COMPLETED|Period 1||0||0
59780278|NCT00723450|75901022|FG000|COMPLETED|Randomized Phase||0||
59780279|NCT00723450|75901023|FG001|COMPLETED|Randomized Phase||21||
59780280|NCT00723450|75901024|FG002|COMPLETED|Randomized Phase||20||
59780281|NCT00723450|75901022|FG000|NOT COMPLETED|Randomized Phase||0||
59780282|NCT00723450|75901023|FG001|NOT COMPLETED|Randomized Phase||65||
59780283|NCT00723450|75901024|FG002|NOT COMPLETED|Randomized Phase||67||
59780284|NCT00751400|75901033|FG000|STARTED|Overall Study||497||
59780285|NCT00751400|75901033|FG000|Subjects Provided Drug|Overall Study||497||
59780286|NCT00751400|75901033|FG000|Subjects Consumed Drug|Overall Study||485||
59780287|NCT00751400|75901033|FG000|Subjects Provided Detailed Use Data|Overall Study||467||
59780288|NCT00751400|75901033|FG000|COMPLETED|Overall Study||487||
59780289|NCT00751400|75901033|FG000|NOT COMPLETED|Overall Study||10||
59780290|NCT00585312|75901039|FG000|STARTED|Overall Study|STARTED=Randomized|55||
59780291|NCT00585312|75901040|FG001|STARTED|Overall Study|STARTED=Randomized|51||
59780292|NCT00585312|75901039|FG000|Treated|Overall Study||53||
59780293|NCT00585312|75901040|FG001|Treated|Overall Study||48||
59780294|NCT00585312|75901039|FG000|COMPLETED|Overall Study||4||
59780295|NCT00585312|75901040|FG001|COMPLETED|Overall Study||7||
59780296|NCT00585312|75901039|FG000|NOT COMPLETED|Overall Study||51||
59780297|NCT00585312|75901040|FG001|NOT COMPLETED|Overall Study||44||
59780298|NCT00753506|75901048|FG000|STARTED|Overall Study||33||
59780299|NCT00753506|75901049|FG001|STARTED|Overall Study||33||
59780300|NCT00753506|75901048|FG000|COMPLETED|Overall Study||26||
59780301|NCT00753506|75901049|FG001|COMPLETED|Overall Study||31||
59780302|NCT00753506|75901048|FG000|NOT COMPLETED|Overall Study||7||
59780303|NCT00753506|75901049|FG001|NOT COMPLETED|Overall Study||2||
59780304|NCT00720096|75901057|FG000|STARTED|Overall Study||2||
59780305|NCT00720096|75901058|FG001|STARTED|Overall Study||2||
59780306|NCT00720096|75901057|FG000|COMPLETED|Overall Study||2||
59780307|NCT00720096|75901058|FG001|COMPLETED|Overall Study||0||
59780308|NCT00720096|75901057|FG000|NOT COMPLETED|Overall Study||0||
59780309|NCT00720096|75901058|FG001|NOT COMPLETED|Overall Study||2||
59780310|NCT00723294|75901064|FG000|STARTED|Overall Study||99||
59780311|NCT00723294|75901064|FG000|COMPLETED|Overall Study||86||
59780312|NCT00723294|75901064|FG000|NOT COMPLETED|Overall Study||13||
59780313|NCT00747344|75901070|FG000|STARTED|Controlled Period||60||
59780314|NCT00747344|75901071|FG001|STARTED|Controlled Period||61||
59780315|NCT00747344|75901072|FG002|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0||
59780316|NCT00747344|75901073|FG003|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0||
59780317|NCT00747344|75901070|FG000|COMPLETED|Controlled Period||55||
59780318|NCT00747344|75901071|FG001|COMPLETED|Controlled Period||57||
59780319|NCT00747344|75901072|FG002|COMPLETED|Controlled Period||0||
59780320|NCT00747344|75901073|FG003|COMPLETED|Controlled Period||0||
59780321|NCT00747344|75901070|FG000|NOT COMPLETED|Controlled Period||5||
59780322|NCT00747344|75901071|FG001|NOT COMPLETED|Controlled Period||4||
59780323|NCT00747344|75901072|FG002|NOT COMPLETED|Controlled Period||0||
59780324|NCT00747344|75901073|FG003|NOT COMPLETED|Controlled Period||0||
59780325|NCT00747344|75901070|FG000|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0||
59780326|NCT00747344|75901071|FG001|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0||
59780327|NCT00747344|75901072|FG002|STARTED|After Controlled Period||55||
59780328|NCT00747344|75901073|FG003|STARTED|After Controlled Period|2 participants discontinued in CP, had follow-up, and are among frequent and serious adverse events.|57||
59780329|NCT00747344|75901070|FG000|COMPLETED|After Controlled Period||0||
59780330|NCT00747344|75901071|FG001|COMPLETED|After Controlled Period||0||
59780331|NCT00747344|75901072|FG002|COMPLETED|After Controlled Period||55||
59780332|NCT00747344|75901073|FG003|COMPLETED|After Controlled Period||56||
59780333|NCT00747344|75901070|FG000|NOT COMPLETED|After Controlled Period||0||
59780334|NCT00747344|75901071|FG001|NOT COMPLETED|After Controlled Period||0||
59780335|NCT00747344|75901072|FG002|NOT COMPLETED|After Controlled Period||0||
59780336|NCT00747344|75901073|FG003|NOT COMPLETED|After Controlled Period||1||
59780337|NCT00580983|75901081|FG000|STARTED|Overall Study||80||
59780338|NCT00580983|75901081|FG000|COMPLETED|Overall Study||73||
59780339|NCT00580983|75901081|FG000|NOT COMPLETED|Overall Study||7||
59780340|NCT00753896|75901085|FG000|STARTED|Overall Study||134||
59780341|NCT00753896|75901085|FG000|COMPLETED|Overall Study||118||
59780342|NCT00753896|75901085|FG000|NOT COMPLETED|Overall Study||16||
59780343|NCT00743444|75901089|FG000|STARTED|First Intervention||14||
59780344|NCT00743444|75901090|FG001|STARTED|First Intervention||13||
59780345|NCT00743444|75901089|FG000|COMPLETED|First Intervention||14||
59780346|NCT00743444|75901090|FG001|COMPLETED|First Intervention||12||
59780347|NCT00743444|75901089|FG000|NOT COMPLETED|First Intervention||0||
59780348|NCT00743444|75901090|FG001|NOT COMPLETED|First Intervention||1||
59780349|NCT00743444|75901089|FG000|STARTED|Washout Period||14||
59780350|NCT00743444|75901090|FG001|STARTED|Washout Period||12||
59780351|NCT00743444|75901089|FG000|COMPLETED|Washout Period||14||
59780352|NCT00743444|75901090|FG001|COMPLETED|Washout Period||11||
59780353|NCT00743444|75901089|FG000|NOT COMPLETED|Washout Period||0||
59780354|NCT00743444|75901090|FG001|NOT COMPLETED|Washout Period||1||
59780355|NCT00743444|75901089|FG000|STARTED|Second Intervention||14||
59780356|NCT00743444|75901090|FG001|STARTED|Second Intervention||11||
59780357|NCT00743444|75901089|FG000|COMPLETED|Second Intervention||14||
59780358|NCT00743444|75901090|FG001|COMPLETED|Second Intervention||11||
59780359|NCT00743444|75901089|FG000|NOT COMPLETED|Second Intervention||0||
59780360|NCT00743444|75901090|FG001|NOT COMPLETED|Second Intervention||0||
59780361|NCT00743366|75901096|FG000|STARTED|Intervention 1 (8 Days)||10||
59780362|NCT00743366|75901097|FG001|STARTED|Intervention 1 (8 Days)||10||
59780363|NCT00743366|75901096|FG000|COMPLETED|Intervention 1 (8 Days)|A total of 6 participants withdrew before completion of the final inpatient phase|7||
59780364|NCT00743366|75901097|FG001|COMPLETED|Intervention 1 (8 Days)|A total of 6 participants withdrew before completion of the final inpatient phase|7||
59780365|NCT00743366|75901096|FG000|NOT COMPLETED|Intervention 1 (8 Days)||3||
59780366|NCT00743366|75901097|FG001|NOT COMPLETED|Intervention 1 (8 Days)||3||
59780367|NCT00743366|75901096|FG000|STARTED|Intervention 2 (8 Days)||7||
59780368|NCT00743366|75901097|FG001|STARTED|Intervention 2 (8 Days)||7||
59780369|NCT00743366|75901096|FG000|COMPLETED|Intervention 2 (8 Days)||7||
59780370|NCT00743366|75901097|FG001|COMPLETED|Intervention 2 (8 Days)||7||
59780371|NCT00743366|75901096|FG000|NOT COMPLETED|Intervention 2 (8 Days)||0||
59780372|NCT00743366|75901097|FG001|NOT COMPLETED|Intervention 2 (8 Days)||0||
59780373|NCT00721968|75901105|FG000|STARTED|Overall Study||27||
59780374|NCT00721968|75901106|FG001|STARTED|Overall Study||17||
59780375|NCT00721968|75901105|FG000|COMPLETED|Overall Study||25||
59780376|NCT00721968|75901106|FG001|COMPLETED|Overall Study||17||
59780377|NCT00721968|75901105|FG000|NOT COMPLETED|Overall Study||2||
59780378|NCT00721968|75901106|FG001|NOT COMPLETED|Overall Study||0||
59780379|NCT00743288|75901112|FG000|STARTED|Overall Study||3||
59780380|NCT00743288|75901113|FG001|STARTED|Overall Study||3||
59780381|NCT00743288|75901114|FG002|STARTED|Overall Study||6||
59780382|NCT00743288|75901115|FG003|STARTED|Overall Study||7||
59780383|NCT00743288|75901116|FG004|STARTED|Overall Study||6||
59780384|NCT00743288|75901117|FG005|STARTED|Overall Study||6||
59780385|NCT00743288|75901118|FG006|STARTED|Overall Study|6 subjects were enrolled in phase 1 and 3 subjects were enrolled as part of the phase 2 expansion.|9||
59780386|NCT00743288|75901112|FG000|COMPLETED|Overall Study||0||
59780387|NCT00743288|75901113|FG001|COMPLETED|Overall Study||0||
59780388|NCT00743288|75901114|FG002|COMPLETED|Overall Study||1||
59780389|NCT00743288|75901115|FG003|COMPLETED|Overall Study||0||
59780390|NCT00743288|75901116|FG004|COMPLETED|Overall Study||0||
59780391|NCT00743288|75901117|FG005|COMPLETED|Overall Study||1||
59780392|NCT00743288|75901118|FG006|COMPLETED|Overall Study||0||
59780393|NCT00743288|75901112|FG000|NOT COMPLETED|Overall Study||3||
59780394|NCT00743288|75901113|FG001|NOT COMPLETED|Overall Study||3||
59619048|NCT02084628|75730221|FG000|NOT COMPLETED|Overall Study||0||
59780395|NCT00743288|75901114|FG002|NOT COMPLETED|Overall Study||5||
59780396|NCT00743288|75901115|FG003|NOT COMPLETED|Overall Study||7||
59780397|NCT00743288|75901116|FG004|NOT COMPLETED|Overall Study||6||
59780398|NCT00743288|75901117|FG005|NOT COMPLETED|Overall Study||5||
59780399|NCT00743288|75901118|FG006|NOT COMPLETED|Overall Study||9||
59780400|NCT00750308|75901129|FG000|STARTED|First Treatment|One female withdrew due to muscle pain|2||
59780401|NCT00750308|75901130|FG001|STARTED|First Treatment||3||
59780402|NCT00750308|75901131|FG002|STARTED|First Treatment||2||
59780403|NCT00750308|75901132|FG003|STARTED|First Treatment||2||
59780404|NCT00750308|75901133|FG004|STARTED|First Treatment||2||
59780405|NCT00750308|75901134|FG005|STARTED|First Treatment||3||
59780406|NCT00750308|75901135|FG006|STARTED|First Treatment||2||
59780407|NCT00750308|75901136|FG007|STARTED|First Treatment||3||
59780408|NCT00750308|75901137|FG008|STARTED|First Treatment||2||
59780409|NCT00750308|75901138|FG009|STARTED|First Treatment||2||
59780410|NCT00750308|75901139|FG010|STARTED|First Treatment||2||
59780411|NCT00750308|75901140|FG011|STARTED|First Treatment||2||
59780412|NCT00750308|75901129|FG000|COMPLETED|First Treatment||2||
59780413|NCT00750308|75901130|FG001|COMPLETED|First Treatment||2||
59780414|NCT00750308|75901131|FG002|COMPLETED|First Treatment||2||
59780415|NCT00750308|75901132|FG003|COMPLETED|First Treatment||1||
59780416|NCT00750308|75901133|FG004|COMPLETED|First Treatment||2||
59780417|NCT00750308|75901134|FG005|COMPLETED|First Treatment||3||
59780418|NCT00750308|75901135|FG006|COMPLETED|First Treatment||2||
59780419|NCT00750308|75901136|FG007|COMPLETED|First Treatment||2||
59780420|NCT00750308|75901137|FG008|COMPLETED|First Treatment||2||
59780421|NCT00750308|75901138|FG009|COMPLETED|First Treatment||2||
59780422|NCT00750308|75901139|FG010|COMPLETED|First Treatment||1||
59780423|NCT00750308|75901140|FG011|COMPLETED|First Treatment||1||
59780424|NCT00750308|75901129|FG000|NOT COMPLETED|First Treatment||0||
59780425|NCT00750308|75901130|FG001|NOT COMPLETED|First Treatment||1||
59780426|NCT00750308|75901131|FG002|NOT COMPLETED|First Treatment||0||
59780427|NCT00750308|75901132|FG003|NOT COMPLETED|First Treatment||1||
59780428|NCT00750308|75901133|FG004|NOT COMPLETED|First Treatment||0||
59780429|NCT00750308|75901134|FG005|NOT COMPLETED|First Treatment||0||
59780430|NCT00750308|75901135|FG006|NOT COMPLETED|First Treatment||0||
59780431|NCT00750308|75901136|FG007|NOT COMPLETED|First Treatment||1||
59780432|NCT00750308|75901137|FG008|NOT COMPLETED|First Treatment||0||
59780433|NCT00750308|75901138|FG009|NOT COMPLETED|First Treatment||0||
59780434|NCT00750308|75901139|FG010|NOT COMPLETED|First Treatment||1||
59780435|NCT00750308|75901140|FG011|NOT COMPLETED|First Treatment||1||
59780436|NCT00750308|75901129|FG000|STARTED|Washout||2||
59619049|NCT02084706|75730227|FG000|STARTED|Overall Study||29||
59619050|NCT02084706|75730228|FG001|STARTED|Overall Study||31||
59619051|NCT02084706|75730227|FG000|COMPLETED|Overall Study||29||
59619052|NCT02084706|75730228|FG001|COMPLETED|Overall Study||31||
59619053|NCT02084706|75730227|FG000|NOT COMPLETED|Overall Study||0||
59619054|NCT02084706|75730228|FG001|NOT COMPLETED|Overall Study||0||
59619055|NCT04686084|75730234|FG000|STARTED|Overall Study||26||
59619056|NCT04686084|75730234|FG000|COMPLETED|Overall Study||25||
59619057|NCT04686084|75730234|FG000|NOT COMPLETED|Overall Study||1||
59619058|NCT04685538|75730241|FG000|STARTED|Overall Study||167||
59619059|NCT04685538|75730242|FG001|STARTED|Overall Study||171||
59619060|NCT04685538|75730241|FG000|COMPLETED|Overall Study||167||
59619061|NCT04685538|75730242|FG001|COMPLETED|Overall Study||168||
59619062|NCT04685538|75730241|FG000|NOT COMPLETED|Overall Study||0||
59619063|NCT04685538|75730242|FG001|NOT COMPLETED|Overall Study||3||
59619064|NCT03174132|75730248|FG000|STARTED|Overall Study||70||
59619065|NCT03174132|75730248|FG000|COMPLETED|Overall Study||70||
59619066|NCT03174132|75730248|FG000|NOT COMPLETED|Overall Study||0||
59619067|NCT04213326|75730254|FG000|STARTED|Overall Study||937||
59780437|NCT00750308|75901130|FG001|STARTED|Washout||2||
59780438|NCT00750308|75901131|FG002|STARTED|Washout||2||
59780439|NCT00750308|75901132|FG003|STARTED|Washout||1||
59780440|NCT00750308|75901133|FG004|STARTED|Washout||2||
59780441|NCT00750308|75901134|FG005|STARTED|Washout||3||
59780442|NCT00750308|75901135|FG006|STARTED|Washout||2||
59780443|NCT00750308|75901136|FG007|STARTED|Washout||2||
59780444|NCT00750308|75901137|FG008|STARTED|Washout||2||
59780445|NCT00750308|75901138|FG009|STARTED|Washout||2||
59780446|NCT00750308|75901139|FG010|STARTED|Washout||1||
59780447|NCT00750308|75901140|FG011|STARTED|Washout||1||
59780448|NCT00750308|75901129|FG000|COMPLETED|Washout||2||
59780449|NCT00750308|75901130|FG001|COMPLETED|Washout||2||
59780450|NCT00750308|75901131|FG002|COMPLETED|Washout||2||
59780451|NCT00750308|75901132|FG003|COMPLETED|Washout||1||
59780452|NCT00750308|75901133|FG004|COMPLETED|Washout||2||
59780453|NCT00750308|75901134|FG005|COMPLETED|Washout||3||
59780454|NCT00750308|75901135|FG006|COMPLETED|Washout||2||
59780455|NCT00750308|75901136|FG007|COMPLETED|Washout||2||
59780456|NCT00750308|75901137|FG008|COMPLETED|Washout||2||
59780457|NCT00750308|75901138|FG009|COMPLETED|Washout||2||
59780458|NCT00750308|75901139|FG010|COMPLETED|Washout||1||
59780459|NCT00750308|75901140|FG011|COMPLETED|Washout||1||
59780460|NCT00750308|75901129|FG000|NOT COMPLETED|Washout||0||
59780461|NCT00750308|75901130|FG001|NOT COMPLETED|Washout||0||
59780462|NCT00750308|75901131|FG002|NOT COMPLETED|Washout||0||
59780463|NCT00750308|75901132|FG003|NOT COMPLETED|Washout||0||
59780464|NCT00750308|75901133|FG004|NOT COMPLETED|Washout||0||
59780465|NCT00750308|75901134|FG005|NOT COMPLETED|Washout||0||
59780466|NCT00750308|75901135|FG006|NOT COMPLETED|Washout||0||
59780467|NCT00750308|75901136|FG007|NOT COMPLETED|Washout||0||
59780468|NCT00750308|75901137|FG008|NOT COMPLETED|Washout||0||
59780469|NCT00750308|75901138|FG009|NOT COMPLETED|Washout||0||
59780470|NCT00750308|75901139|FG010|NOT COMPLETED|Washout||0||
59780471|NCT00750308|75901140|FG011|NOT COMPLETED|Washout||0||
59780472|NCT00750308|75901129|FG000|STARTED|Second Treatment||2||
59780473|NCT00750308|75901130|FG001|STARTED|Second Treatment||2||
59780474|NCT00750308|75901131|FG002|STARTED|Second Treatment||2||
59780475|NCT00750308|75901132|FG003|STARTED|Second Treatment||1||
59780476|NCT00750308|75901133|FG004|STARTED|Second Treatment||2||
59780477|NCT00750308|75901134|FG005|STARTED|Second Treatment||3||
59780478|NCT00750308|75901135|FG006|STARTED|Second Treatment||2||
59780479|NCT00750308|75901136|FG007|STARTED|Second Treatment||2||
59780480|NCT00750308|75901137|FG008|STARTED|Second Treatment||2||
59780481|NCT00750308|75901138|FG009|STARTED|Second Treatment||2||
59780482|NCT00750308|75901139|FG010|STARTED|Second Treatment||1||
59780483|NCT00750308|75901140|FG011|STARTED|Second Treatment||1||
59780484|NCT00750308|75901129|FG000|COMPLETED|Second Treatment||2||
59780485|NCT00750308|75901130|FG001|COMPLETED|Second Treatment||2||
59780486|NCT00750308|75901131|FG002|COMPLETED|Second Treatment||2||
59780487|NCT00750308|75901132|FG003|COMPLETED|Second Treatment||1||
59780488|NCT00750308|75901133|FG004|COMPLETED|Second Treatment||1||
59780489|NCT00750308|75901134|FG005|COMPLETED|Second Treatment||2||
59780490|NCT00750308|75901135|FG006|COMPLETED|Second Treatment||2||
59780491|NCT00750308|75901136|FG007|COMPLETED|Second Treatment||2||
59780492|NCT00750308|75901137|FG008|COMPLETED|Second Treatment||1||
59780493|NCT00750308|75901138|FG009|COMPLETED|Second Treatment||2||
59780494|NCT00750308|75901139|FG010|COMPLETED|Second Treatment||1||
59780495|NCT00750308|75901140|FG011|COMPLETED|Second Treatment||1||
59780496|NCT00750308|75901129|FG000|NOT COMPLETED|Second Treatment||0||
59780497|NCT00750308|75901130|FG001|NOT COMPLETED|Second Treatment||0||
59780498|NCT00750308|75901131|FG002|NOT COMPLETED|Second Treatment||0||
59780499|NCT00750308|75901132|FG003|NOT COMPLETED|Second Treatment||0||
59780500|NCT00750308|75901133|FG004|NOT COMPLETED|Second Treatment||1||
59780501|NCT00750308|75901134|FG005|NOT COMPLETED|Second Treatment||1||
59780502|NCT00750308|75901135|FG006|NOT COMPLETED|Second Treatment||0||
59780503|NCT00750308|75901136|FG007|NOT COMPLETED|Second Treatment||0||
59780504|NCT00750308|75901137|FG008|NOT COMPLETED|Second Treatment||1||
59780505|NCT00750308|75901138|FG009|NOT COMPLETED|Second Treatment||0||
59780506|NCT00750308|75901139|FG010|NOT COMPLETED|Second Treatment||0||
59953011|NCT04057820|76071780|FG000|NOT COMPLETED|Period 1||0||0
59953012|NCT04057820|76071781|FG001|NOT COMPLETED|Period 1||0||0
59953013|NCT04057820|76071782|FG002|NOT COMPLETED|Period 1||0||0
59522255|NCT04052542|75616587|FG005|NOT COMPLETED|Overall Study||0||
59522256|NCT04052542|75616588|FG006|NOT COMPLETED|Overall Study||0||
59522257|NCT04052542|75616589|FG007|NOT COMPLETED|Overall Study||0||
59522258|NCT04052542|75616590|FG008|NOT COMPLETED|Overall Study||0||
59522259|NCT04052542|75616591|FG009|NOT COMPLETED|Overall Study||0||
59522260|NCT04052542|75616592|FG010|NOT COMPLETED|Overall Study||0||
59780507|NCT00750308|75901140|FG011|NOT COMPLETED|Second Treatment||0||
59780508|NCT00750308|75901129|FG000|STARTED|Washout||2||
59780509|NCT00750308|75901130|FG001|STARTED|Washout||2||
59780510|NCT00750308|75901131|FG002|STARTED|Washout||2||
59953014|NCT04057820|76071783|FG003|NOT COMPLETED|Period 1||0||0
59953015|NCT04057820|76071784|FG004|NOT COMPLETED|Period 1||0||0
59780511|NCT00750308|75901132|FG003|STARTED|Washout||1||
59780512|NCT00750308|75901133|FG004|STARTED|Washout||1||
59780513|NCT00750308|75901134|FG005|STARTED|Washout||2||
59780514|NCT00750308|75901135|FG006|STARTED|Washout||2||
59780515|NCT00750308|75901136|FG007|STARTED|Washout||2||
59780516|NCT00750308|75901137|FG008|STARTED|Washout||1||
59780517|NCT00750308|75901138|FG009|STARTED|Washout||2||
59780518|NCT00750308|75901139|FG010|STARTED|Washout||1||
59780519|NCT00750308|75901140|FG011|STARTED|Washout||1||
59780520|NCT00750308|75901129|FG000|COMPLETED|Washout||2||
59780521|NCT00750308|75901130|FG001|COMPLETED|Washout||2||
59780522|NCT00750308|75901131|FG002|COMPLETED|Washout||2||
59953016|NCT04057820|76071785|FG005|NOT COMPLETED|Period 1||0||0
59780523|NCT00750308|75901132|FG003|COMPLETED|Washout||1||
59780524|NCT00750308|75901133|FG004|COMPLETED|Washout||1||
59780525|NCT00750308|75901134|FG005|COMPLETED|Washout||2||
59780526|NCT00750308|75901135|FG006|COMPLETED|Washout||2||
59522261|NCT04052542|75616593|FG011|NOT COMPLETED|Overall Study||0||
59522262|NCT03829618|75616622|FG000|STARTED|Overall Study||15||
59522263|NCT03829618|75616623|FG001|STARTED|Overall Study||7||
59522264|NCT03829618|75616624|FG002|STARTED|Overall Study||7||
59522265|NCT03829618|75616622|FG000|COMPLETED|Overall Study||15||
59522266|NCT03829618|75616623|FG001|COMPLETED|Overall Study||7||
59522267|NCT03829618|75616624|FG002|COMPLETED|Overall Study||7||
59522268|NCT03829618|75616622|FG000|NOT COMPLETED|Overall Study||0||
59522269|NCT03829618|75616623|FG001|NOT COMPLETED|Overall Study||0||
59522270|NCT03829618|75616624|FG002|NOT COMPLETED|Overall Study||0||
59522271|NCT03741088|75616632|FG000|STARTED|Overall Study||8||11
59522272|NCT03741088|75616632|FG000|COMPLETED|Overall Study||5||6
59522273|NCT03741088|75616632|FG000|NOT COMPLETED|Overall Study||3||5
59522274|NCT01143181|75616640|FG000|STARTED|Overall Study||30||
59780527|NCT00750308|75901136|FG007|COMPLETED|Washout||2||
59780528|NCT00750308|75901137|FG008|COMPLETED|Washout||1||
59780529|NCT00750308|75901138|FG009|COMPLETED|Washout||2||
59780530|NCT00750308|75901139|FG010|COMPLETED|Washout||1||
59522275|NCT01143181|75616641|FG001|STARTED|Overall Study||38||
59522276|NCT01143181|75616642|FG002|STARTED|Overall Study||102||
59522277|NCT01143181|75616643|FG003|STARTED|Overall Study||40||
59522278|NCT01143181|75616640|FG000|COMPLETED|Overall Study||14||
59522279|NCT01143181|75616641|FG001|COMPLETED|Overall Study||22||
59522280|NCT01143181|75616642|FG002|COMPLETED|Overall Study||58||
59522281|NCT01143181|75616643|FG003|COMPLETED|Overall Study||17||
59522282|NCT01143181|75616640|FG000|NOT COMPLETED|Overall Study||16||
59522283|NCT01143181|75616641|FG001|NOT COMPLETED|Overall Study||16||
59522284|NCT01143181|75616642|FG002|NOT COMPLETED|Overall Study||44||
59522285|NCT01143181|75616643|FG003|NOT COMPLETED|Overall Study||23||
59522286|NCT03740152|75616653|FG000|STARTED|Overall Study||10||
59522287|NCT03740152|75616653|FG000|COMPLETED|Overall Study||10||
59522288|NCT03740152|75616653|FG000|NOT COMPLETED|Overall Study||0||
59522289|NCT03739684|75616657|FG000|STARTED|Overall Study||208||
59522290|NCT03739684|75616657|FG000|COMPLETED|Overall Study||195||
59522291|NCT03739684|75616657|FG000|NOT COMPLETED|Overall Study||13||
59522292|NCT01143649|75616666|FG000|STARTED|Overall Study||7||
59522293|NCT01143649|75616667|FG001|STARTED|Overall Study||7||
59522294|NCT01143649|75616668|FG002|STARTED|Overall Study||10||
59522295|NCT01143649|75616669|FG003|STARTED|Overall Study||10||
59522296|NCT01143649|75616670|FG004|STARTED|Overall Study||5||
59522297|NCT01143649|75616671|FG005|STARTED|Overall Study||5||
59522298|NCT01143649|75616666|FG000|COMPLETED|Overall Study||7||
59522299|NCT01143649|75616667|FG001|COMPLETED|Overall Study||7||
59522300|NCT01143649|75616668|FG002|COMPLETED|Overall Study||10||
59522301|NCT01143649|75616669|FG003|COMPLETED|Overall Study||10||
59522302|NCT01143649|75616670|FG004|COMPLETED|Overall Study||4||
59522303|NCT01143649|75616671|FG005|COMPLETED|Overall Study||3||
59522304|NCT01143649|75616666|FG000|NOT COMPLETED|Overall Study||0||
59522305|NCT01143649|75616667|FG001|NOT COMPLETED|Overall Study||0||
59522306|NCT01143649|75616668|FG002|NOT COMPLETED|Overall Study||0||
59522307|NCT01143649|75616669|FG003|NOT COMPLETED|Overall Study||0||
59522308|NCT01143649|75616670|FG004|NOT COMPLETED|Overall Study||1||
59522309|NCT01143649|75616671|FG005|NOT COMPLETED|Overall Study||2||
59522310|NCT03937570|75616687|FG000|STARTED|Overall Study||13||
59522311|NCT03937570|75616688|FG001|STARTED|Overall Study||14||
59780531|NCT00750308|75901140|FG011|COMPLETED|Washout||1||
59780532|NCT00750308|75901129|FG000|NOT COMPLETED|Washout||0||
59780533|NCT00750308|75901130|FG001|NOT COMPLETED|Washout||0||
59780534|NCT00750308|75901131|FG002|NOT COMPLETED|Washout||0||
59780535|NCT00750308|75901132|FG003|NOT COMPLETED|Washout||0||
59522312|NCT03937570|75616687|FG000|COMPLETED|Overall Study||13||
59522313|NCT03937570|75616688|FG001|COMPLETED|Overall Study||14||
59522314|NCT03937570|75616687|FG000|NOT COMPLETED|Overall Study||0||
59522315|NCT03937570|75616688|FG001|NOT COMPLETED|Overall Study||0||
59522316|NCT01143727|75616696|FG000|STARTED|Overall Study||9||
59522317|NCT01143727|75616697|FG001|STARTED|Overall Study||8||
59522318|NCT01143727|75616696|FG000|COMPLETED|Overall Study||9||
59522319|NCT01143727|75616697|FG001|COMPLETED|Overall Study||8||
59522320|NCT01143727|75616696|FG000|NOT COMPLETED|Overall Study||0||
59522321|NCT01143727|75616697|FG001|NOT COMPLETED|Overall Study||0||
59522322|NCT03738826|75616705|FG000|STARTED|Overall Study||130||
59522323|NCT03738826|75616706|FG001|STARTED|Overall Study||5||
59522324|NCT03738826|75616705|FG000|COMPLETED|Overall Study||130||
59522325|NCT03738826|75616706|FG001|COMPLETED|Overall Study||5||
59522326|NCT03738826|75616705|FG000|NOT COMPLETED|Overall Study||0||
59522327|NCT03738826|75616706|FG001|NOT COMPLETED|Overall Study||0||
59522328|NCT03735862|75616712|FG000|STARTED|Overall Study||73||
59522329|NCT03735862|75616712|FG000|COMPLETED|Overall Study||73||
59780536|NCT00750308|75901133|FG004|NOT COMPLETED|Washout||0||
59780537|NCT00750308|75901134|FG005|NOT COMPLETED|Washout||0||
59522330|NCT03735862|75616712|FG000|NOT COMPLETED|Overall Study||0||
59780538|NCT00750308|75901135|FG006|NOT COMPLETED|Washout||0||
59780539|NCT00750308|75901136|FG007|NOT COMPLETED|Washout||0||
59780540|NCT00750308|75901137|FG008|NOT COMPLETED|Washout||0||
59780541|NCT00750308|75901138|FG009|NOT COMPLETED|Washout||0||
59780542|NCT00750308|75901139|FG010|NOT COMPLETED|Washout||0||
59780543|NCT00750308|75901140|FG011|NOT COMPLETED|Washout||0||
59780544|NCT00750308|75901129|FG000|STARTED|Third Treatment||2||
59780545|NCT00750308|75901130|FG001|STARTED|Third Treatment||2||
59780546|NCT00750308|75901131|FG002|STARTED|Third Treatment||2||
59780547|NCT00750308|75901132|FG003|STARTED|Third Treatment||1||
59780548|NCT00750308|75901133|FG004|STARTED|Third Treatment||1||
59780549|NCT00750308|75901134|FG005|STARTED|Third Treatment||2||
59780550|NCT00750308|75901135|FG006|STARTED|Third Treatment||2||
59780551|NCT00750308|75901136|FG007|STARTED|Third Treatment||2||
59780552|NCT00750308|75901137|FG008|STARTED|Third Treatment||1||
59780553|NCT00750308|75901138|FG009|STARTED|Third Treatment||2||
59780554|NCT00750308|75901139|FG010|STARTED|Third Treatment||1||
59780555|NCT00750308|75901140|FG011|STARTED|Third Treatment||1||
59780556|NCT00750308|75901129|FG000|COMPLETED|Third Treatment||2||
59780557|NCT00750308|75901130|FG001|COMPLETED|Third Treatment||1||
59780558|NCT00750308|75901131|FG002|COMPLETED|Third Treatment||2||
59780559|NCT00750308|75901132|FG003|COMPLETED|Third Treatment||1||
59780560|NCT00750308|75901133|FG004|COMPLETED|Third Treatment||1||
59780561|NCT00750308|75901134|FG005|COMPLETED|Third Treatment||2||
59780562|NCT00750308|75901135|FG006|COMPLETED|Third Treatment||2||
59780563|NCT00750308|75901136|FG007|COMPLETED|Third Treatment||2||
59780564|NCT00750308|75901137|FG008|COMPLETED|Third Treatment||1||
59780565|NCT00750308|75901138|FG009|COMPLETED|Third Treatment||2||
59780566|NCT00750308|75901139|FG010|COMPLETED|Third Treatment||1||
59780567|NCT00750308|75901140|FG011|COMPLETED|Third Treatment||1||
59780568|NCT00750308|75901129|FG000|NOT COMPLETED|Third Treatment||0||
59780569|NCT00750308|75901130|FG001|NOT COMPLETED|Third Treatment||1||
59780570|NCT00750308|75901131|FG002|NOT COMPLETED|Third Treatment||0||
59780571|NCT00750308|75901132|FG003|NOT COMPLETED|Third Treatment||0||
59780572|NCT00750308|75901133|FG004|NOT COMPLETED|Third Treatment||0||
59780573|NCT00750308|75901134|FG005|NOT COMPLETED|Third Treatment||0||
59780574|NCT00750308|75901135|FG006|NOT COMPLETED|Third Treatment||0||
59780575|NCT00750308|75901136|FG007|NOT COMPLETED|Third Treatment||0||
59780576|NCT00750308|75901137|FG008|NOT COMPLETED|Third Treatment||0||
59780577|NCT00750308|75901138|FG009|NOT COMPLETED|Third Treatment||0||
59780578|NCT00750308|75901139|FG010|NOT COMPLETED|Third Treatment||0||
59780579|NCT00750308|75901140|FG011|NOT COMPLETED|Third Treatment||0||
59780580|NCT00750308|75901129|FG000|STARTED|Washout||2||
59780581|NCT00750308|75901130|FG001|STARTED|Washout||1||
59780582|NCT00750308|75901131|FG002|STARTED|Washout||2||
59780583|NCT00750308|75901132|FG003|STARTED|Washout||1||
59780584|NCT00750308|75901133|FG004|STARTED|Washout||1||
59780585|NCT00750308|75901134|FG005|STARTED|Washout||2||
59780586|NCT00750308|75901135|FG006|STARTED|Washout||2||
59780587|NCT00750308|75901136|FG007|STARTED|Washout||2||
59780588|NCT00750308|75901137|FG008|STARTED|Washout||1||
59780589|NCT00750308|75901138|FG009|STARTED|Washout||2||
59780590|NCT00750308|75901139|FG010|STARTED|Washout||1||
59780591|NCT00750308|75901140|FG011|STARTED|Washout||1||
59780592|NCT00750308|75901129|FG000|COMPLETED|Washout||2||
59780593|NCT00750308|75901130|FG001|COMPLETED|Washout||1||
59780594|NCT00750308|75901131|FG002|COMPLETED|Washout||2||
59780595|NCT00750308|75901132|FG003|COMPLETED|Washout||1||
59780596|NCT00750308|75901133|FG004|COMPLETED|Washout||1||
59780597|NCT00750308|75901134|FG005|COMPLETED|Washout||2||
59780598|NCT00750308|75901135|FG006|COMPLETED|Washout||2||
59780599|NCT00750308|75901136|FG007|COMPLETED|Washout||2||
59780600|NCT00750308|75901137|FG008|COMPLETED|Washout||1||
59780601|NCT00750308|75901138|FG009|COMPLETED|Washout||2||
59780602|NCT00750308|75901139|FG010|COMPLETED|Washout||1||
59780603|NCT00750308|75901140|FG011|COMPLETED|Washout||1||
59780604|NCT00750308|75901129|FG000|NOT COMPLETED|Washout||0||
59780605|NCT00750308|75901130|FG001|NOT COMPLETED|Washout||0||
59780606|NCT00750308|75901131|FG002|NOT COMPLETED|Washout||0||
59780607|NCT00750308|75901132|FG003|NOT COMPLETED|Washout||0||
59780608|NCT00750308|75901133|FG004|NOT COMPLETED|Washout||0||
59780609|NCT00750308|75901134|FG005|NOT COMPLETED|Washout||0||
59780610|NCT00750308|75901135|FG006|NOT COMPLETED|Washout||0||
59780611|NCT00750308|75901136|FG007|NOT COMPLETED|Washout||0||
59780612|NCT00750308|75901137|FG008|NOT COMPLETED|Washout||0||
59780613|NCT00750308|75901138|FG009|NOT COMPLETED|Washout||0||
59780614|NCT00750308|75901139|FG010|NOT COMPLETED|Washout||0||
59780615|NCT00750308|75901140|FG011|NOT COMPLETED|Washout||0||
59780616|NCT00750308|75901129|FG000|STARTED|Fourth Treatment||2||
59780617|NCT00750308|75901130|FG001|STARTED|Fourth Treatment||1||
59780618|NCT00750308|75901131|FG002|STARTED|Fourth Treatment||2||
59780619|NCT00750308|75901132|FG003|STARTED|Fourth Treatment||1||
59780620|NCT00750308|75901133|FG004|STARTED|Fourth Treatment||1||
59780621|NCT00750308|75901134|FG005|STARTED|Fourth Treatment||2||
59780622|NCT00750308|75901135|FG006|STARTED|Fourth Treatment||2||
59780623|NCT00750308|75901136|FG007|STARTED|Fourth Treatment||2||
59780624|NCT00750308|75901137|FG008|STARTED|Fourth Treatment||1||
59780625|NCT00750308|75901138|FG009|STARTED|Fourth Treatment||2||
59780626|NCT00750308|75901139|FG010|STARTED|Fourth Treatment||1||
59780627|NCT00750308|75901140|FG011|STARTED|Fourth Treatment||1||
59780628|NCT00750308|75901129|FG000|COMPLETED|Fourth Treatment||2||
59780629|NCT00750308|75901130|FG001|COMPLETED|Fourth Treatment||1||
59780630|NCT00750308|75901131|FG002|COMPLETED|Fourth Treatment||2||
59780631|NCT00750308|75901132|FG003|COMPLETED|Fourth Treatment||1||
59780632|NCT00750308|75901133|FG004|COMPLETED|Fourth Treatment||1||
59780633|NCT00750308|75901134|FG005|COMPLETED|Fourth Treatment||2||
59780634|NCT00750308|75901135|FG006|COMPLETED|Fourth Treatment||2||
59780635|NCT00750308|75901136|FG007|COMPLETED|Fourth Treatment||2||
59780636|NCT00750308|75901137|FG008|COMPLETED|Fourth Treatment||1||
59780637|NCT00750308|75901138|FG009|COMPLETED|Fourth Treatment||2||
59780638|NCT00750308|75901139|FG010|COMPLETED|Fourth Treatment||1||
59780639|NCT00750308|75901140|FG011|COMPLETED|Fourth Treatment||1||
59780640|NCT00750308|75901129|FG000|NOT COMPLETED|Fourth Treatment||0||
59780641|NCT00750308|75901130|FG001|NOT COMPLETED|Fourth Treatment||0||
59780642|NCT00750308|75901131|FG002|NOT COMPLETED|Fourth Treatment||0||
59780643|NCT00750308|75901132|FG003|NOT COMPLETED|Fourth Treatment||0||
59780644|NCT00750308|75901133|FG004|NOT COMPLETED|Fourth Treatment||0||
59780645|NCT00750308|75901134|FG005|NOT COMPLETED|Fourth Treatment||0||
59780646|NCT00750308|75901135|FG006|NOT COMPLETED|Fourth Treatment||0||
59780647|NCT00750308|75901136|FG007|NOT COMPLETED|Fourth Treatment||0||
59780648|NCT00750308|75901137|FG008|NOT COMPLETED|Fourth Treatment||0||
59780649|NCT00750308|75901138|FG009|NOT COMPLETED|Fourth Treatment||0||
59780650|NCT00750308|75901139|FG010|NOT COMPLETED|Fourth Treatment||0||
59780651|NCT00750308|75901140|FG011|NOT COMPLETED|Fourth Treatment||0||
59780652|NCT00750152|75901156|FG000|STARTED|Overall Study||166||
59780653|NCT00750152|75901157|FG001|STARTED|Overall Study||168||
59780654|NCT00750152|75901156|FG000|COMPLETED|Overall Study||144||
59780655|NCT00750152|75901157|FG001|COMPLETED|Overall Study||141||
59780656|NCT00750152|75901156|FG000|NOT COMPLETED|Overall Study||22||
59780657|NCT00750152|75901157|FG001|NOT COMPLETED|Overall Study||27||
59780658|NCT00749996|75901165|FG000|STARTED|Overall Study|4 pts were removed due to compliance issue. 2 pts were randomized but not treated (non-eligible)|75||
59780659|NCT00749996|75901166|FG001|STARTED|Overall Study|5 pts were removed due to compliance issue. 1 pt was randomized but not treated (Non-eligible)|71||
59780660|NCT00749996|75901165|FG000|6 Weeks Follow-up|Overall Study|Withdrawn (n=1). Visit not done (n=2)|72||
59780661|NCT00749996|75901166|FG001|6 Weeks Follow-up|Overall Study|Withdrawn (n=2). Visit not done (n=2)|67||
59780662|NCT00749996|75901165|FG000|3 Months Follow-up|Overall Study|Visit not done (n=2)|72||
59780663|NCT00749996|75901166|FG001|3 Months Follow-up|Overall Study|Visit not done (n=1)|68||
59780664|NCT00749996|75901165|FG000|6 Months Follow-up|Overall Study|Visit not done (n=3)|71||
59780665|NCT00749996|75901166|FG001|6 Months Follow-up|Overall Study|Withdrawn (n=3). Visit not done (n=3)|63||
59780666|NCT00749996|75901165|FG000|12 Months Follow-up|Overall Study|Withdrawn(n=4). Visit not done (n=2)|68||
59780667|NCT00749996|75901166|FG001|12 Months Follow-up|Overall Study|Withdrawn (n=1). Visit not done (n=4). Lost to follow-up (n=1)|60||
59780668|NCT00749996|75901165|FG000|24 Months Follow up|Overall Study|Withdrawn (n=5) Accidental death (n=1) Lost to follow up (n=7)|57||
59780669|NCT00749996|75901166|FG001|24 Months Follow up|Overall Study|Withdrawn (n=3). Lost to follow-up (n=3)|58||
59780670|NCT00749996|75901165|FG000|COMPLETED|Overall Study||57||
59780671|NCT00749996|75901166|FG001|COMPLETED|Overall Study||58||
59780672|NCT00749996|75901165|FG000|NOT COMPLETED|Overall Study||18||
59780673|NCT00749996|75901166|FG001|NOT COMPLETED|Overall Study||13||
59780674|NCT00749684|75901172|FG000|STARTED|Overall Study||138||
59780675|NCT00749684|75901172|FG000|COMPLETED|Overall Study||56||
59780676|NCT00749684|75901172|FG000|NOT COMPLETED|Overall Study||82||
59780677|NCT00746798|75901180|FG000|STARTED|Overall Study||122||
59780678|NCT00746798|75901181|FG001|STARTED|Overall Study||124||
59780679|NCT00746798|75901182|FG002|STARTED|Overall Study||113||
59780680|NCT00746798|75901183|FG003|STARTED|Overall Study||120||
59953017|NCT04057820|76071786|FG006|NOT COMPLETED|Period 1||0||0
59780681|NCT00746798|75901180|FG000|COMPLETED|Overall Study||121||
59780682|NCT00746798|75901181|FG001|COMPLETED|Overall Study||122||
59780683|NCT00746798|75901182|FG002|COMPLETED|Overall Study||110||
59780684|NCT00746798|75901183|FG003|COMPLETED|Overall Study||120||
59780685|NCT00746798|75901180|FG000|NOT COMPLETED|Overall Study||1||
59780686|NCT00746798|75901181|FG001|NOT COMPLETED|Overall Study||2||
59780687|NCT00746798|75901182|FG002|NOT COMPLETED|Overall Study||3||
59780688|NCT00746798|75901183|FG003|NOT COMPLETED|Overall Study||0||
59780689|NCT00716274|75901196|FG000|STARTED|Study Period II (16-Weeks)||45||
59780690|NCT00716274|75901197|FG001|STARTED|Study Period II (16-Weeks)||44||
59780691|NCT00716274|75901198|FG002|STARTED|Study Period II (16-Weeks)||0||
59780692|NCT00716274|75901199|FG003|STARTED|Study Period II (16-Weeks)||0||
59780693|NCT00716274|75901200|FG004|STARTED|Study Period II (16-Weeks)||0||
59780694|NCT00716274|75901201|FG005|STARTED|Study Period II (16-Weeks)||21||
59780695|NCT00716274|75901196|FG000|COMPLETED|Study Period II (16-Weeks)||36||
59780696|NCT00716274|75901197|FG001|COMPLETED|Study Period II (16-Weeks)||35||
59780697|NCT00716274|75901198|FG002|COMPLETED|Study Period II (16-Weeks)||0||
59780698|NCT00716274|75901199|FG003|COMPLETED|Study Period II (16-Weeks)||0||
59780699|NCT00716274|75901200|FG004|COMPLETED|Study Period II (16-Weeks)||0||
59780700|NCT00716274|75901201|FG005|COMPLETED|Study Period II (16-Weeks)||19||
59780701|NCT00716274|75901196|FG000|NOT COMPLETED|Study Period II (16-Weeks)||9||
59780702|NCT00716274|75901197|FG001|NOT COMPLETED|Study Period II (16-Weeks)||9||
59780703|NCT00716274|75901198|FG002|NOT COMPLETED|Study Period II (16-Weeks)||0||
59780704|NCT00716274|75901199|FG003|NOT COMPLETED|Study Period II (16-Weeks)||0||
59780705|NCT00716274|75901200|FG004|NOT COMPLETED|Study Period II (16-Weeks)||0||
59780706|NCT00716274|75901201|FG005|NOT COMPLETED|Study Period II (16-Weeks)||2||
59780707|NCT00716274|75901196|FG000|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|0||
59780708|NCT00716274|75901197|FG001|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|0||
59780709|NCT00716274|75901198|FG002|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|18||
59780710|NCT00716274|75901199|FG003|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|18||
59780711|NCT00716274|75901200|FG004|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|35||
59780712|NCT00716274|75901201|FG005|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|19||
59780713|NCT00716274|75901196|FG000|COMPLETED|Study Period III (16-Weeks)||0||
59780714|NCT00716274|75901197|FG001|COMPLETED|Study Period III (16-Weeks)||0||
59780715|NCT00716274|75901198|FG002|COMPLETED|Study Period III (16-Weeks)||16||
59780716|NCT00716274|75901199|FG003|COMPLETED|Study Period III (16-Weeks)||17||
59780717|NCT00716274|75901200|FG004|COMPLETED|Study Period III (16-Weeks)||32||
59780718|NCT00716274|75901201|FG005|COMPLETED|Study Period III (16-Weeks)||19||
59780719|NCT00716274|75901196|FG000|NOT COMPLETED|Study Period III (16-Weeks)||0||
59780720|NCT00716274|75901197|FG001|NOT COMPLETED|Study Period III (16-Weeks)||0||
59780721|NCT00716274|75901198|FG002|NOT COMPLETED|Study Period III (16-Weeks)||2||
59780722|NCT00716274|75901199|FG003|NOT COMPLETED|Study Period III (16-Weeks)||1||
59780723|NCT00716274|75901200|FG004|NOT COMPLETED|Study Period III (16-Weeks)||3||
59780724|NCT00716274|75901201|FG005|NOT COMPLETED|Study Period III (16-Weeks)||0||
59780725|NCT00746564|75901218|FG000|STARTED|Overall Study||75||
59780726|NCT00746564|75901218|FG000|COMPLETED|Overall Study||73||
59780727|NCT00746564|75901218|FG000|NOT COMPLETED|Overall Study||2||
59780728|NCT01298193|75901224|FG000|STARTED|Observational Phase (First Cycle)||212||
59780729|NCT01298193|75901224|FG000|COMPLETED|Observational Phase (First Cycle)|From these 185 completed patients, only 24 experiment emesis on Cycle 1 (NCR) (efficacy phase).|185||
59780730|NCT01298193|75901224|FG000|NOT COMPLETED|Observational Phase (First Cycle)||27||
59780731|NCT01298193|75901224|FG000|STARTED|Efficacy Phase (Second Cycle)||24||
59780732|NCT01298193|75901224|FG000|COMPLETED|Efficacy Phase (Second Cycle)||23||
59780733|NCT01298193|75901224|FG000|NOT COMPLETED|Efficacy Phase (Second Cycle)||1||
59780734|NCT00719862|75901233|FG000|STARTED|Overall Study||242||
59780735|NCT00719862|75901234|FG001|STARTED|Overall Study|1 subject was randomized in error|239||
59780736|NCT00719862|75901233|FG000|COMPLETED|Overall Study||234||
59780737|NCT00719862|75901234|FG001|COMPLETED|Overall Study||233||
59780738|NCT00719862|75901233|FG000|NOT COMPLETED|Overall Study||8||
59780739|NCT00719862|75901234|FG001|NOT COMPLETED|Overall Study||6||
59780740|NCT00742508|75901242|FG000|STARTED|8-Week Primary Evaluation Period||22||
59780741|NCT00742508|75901243|FG001|STARTED|8-Week Primary Evaluation Period||19||
59780742|NCT00742508|75901242|FG000|COMPLETED|8-Week Primary Evaluation Period||11||
59780743|NCT00742508|75901243|FG001|COMPLETED|8-Week Primary Evaluation Period||8||
59780744|NCT00742508|75901242|FG000|NOT COMPLETED|8-Week Primary Evaluation Period||11||
59780745|NCT00742508|75901243|FG001|NOT COMPLETED|8-Week Primary Evaluation Period||11||
59780746|NCT00742508|75901242|FG000|STARTED|4-Week Exploratory Evaluation Period||0||
59780747|NCT00742508|75901243|FG001|STARTED|4-Week Exploratory Evaluation Period||8||
59780748|NCT00742508|75901242|FG000|COMPLETED|4-Week Exploratory Evaluation Period||0||
59780749|NCT00742508|75901243|FG001|COMPLETED|4-Week Exploratory Evaluation Period||7||
59780750|NCT00742508|75901242|FG000|NOT COMPLETED|4-Week Exploratory Evaluation Period||0||
59780751|NCT00742508|75901243|FG001|NOT COMPLETED|4-Week Exploratory Evaluation Period||1||
59780752|NCT00719706|75901251|FG000|STARTED|Overall Study||20||
59780753|NCT00719706|75901252|FG001|STARTED|Overall Study||20||
59780754|NCT00719706|75901251|FG000|COMPLETED|Overall Study||11||
59780755|NCT00719706|75901252|FG001|COMPLETED|Overall Study||14||
59780756|NCT00719706|75901251|FG000|NOT COMPLETED|Overall Study||9||
59780757|NCT00719706|75901252|FG001|NOT COMPLETED|Overall Study||6||
59780758|NCT00742274|75901260|FG000|STARTED|Overall Study||30||
59780759|NCT00742274|75901261|FG001|STARTED|Overall Study||31||
59780760|NCT00742274|75901260|FG000|COMPLETED|Overall Study||27||
59780761|NCT00742274|75901261|FG001|COMPLETED|Overall Study||28||
59780762|NCT00742274|75901260|FG000|NOT COMPLETED|Overall Study||3||
59780763|NCT00742274|75901261|FG001|NOT COMPLETED|Overall Study||3||
59953018|NCT04057820|76071787|FG007|NOT COMPLETED|Period 1||0||0
59953019|NCT04057820|76071788|FG008|NOT COMPLETED|Period 1||0||0
59953020|NCT04057820|76071789|FG009|NOT COMPLETED|Period 1||0||0
59780764|NCT00719472|75901267|FG000|STARTED|Enrolled in Study||451||
59780765|NCT00719472|75901267|FG000|COMPLETED|Enrolled in Study||425||
59780766|NCT00719472|75901267|FG000|NOT COMPLETED|Enrolled in Study||26||
59780767|NCT00719472|75901267|FG000|STARTED|Received Cycle 1 Treatment||425||
59780768|NCT00719472|75901267|FG000|COMPLETED|Received Cycle 1 Treatment||372||
59780769|NCT00719472|75901267|FG000|NOT COMPLETED|Received Cycle 1 Treatment||53||
59780770|NCT00719472|75901267|FG000|STARTED|Received Cycle 2 Treatment||372||
59780771|NCT00719472|75901267|FG000|COMPLETED|Received Cycle 2 Treatment||304||
59780772|NCT00719472|75901267|FG000|NOT COMPLETED|Received Cycle 2 Treatment||68||
59780773|NCT00579501|75901271|FG000|STARTED|Overall Study||29||
59780774|NCT00579501|75901271|FG000|COMPLETED|Overall Study||0||
59780775|NCT00579501|75901271|FG000|NOT COMPLETED|Overall Study||29||
59780776|NCT00741338|75901277|FG000|STARTED|Overall Study||3||
59780777|NCT00741338|75901278|FG001|STARTED|Overall Study||3||
59780778|NCT00741338|75901277|FG000|COMPLETED|Overall Study||3||
59780779|NCT00741338|75901278|FG001|COMPLETED|Overall Study||2||
59780780|NCT00741338|75901277|FG000|NOT COMPLETED|Overall Study||0||
59780781|NCT00741338|75901278|FG001|NOT COMPLETED|Overall Study||1||
59780782|NCT00746330|75901288|FG000|STARTED|Period 1||7||
59780783|NCT00746330|75901289|FG001|STARTED|Period 1||9||
59780784|NCT00746330|75901290|FG002|STARTED|Period 1||9||
59780785|NCT00746330|75901291|FG003|STARTED|Period 1||7||
59780786|NCT00746330|75901288|FG000|COMPLETED|Period 1||7||
59780787|NCT00746330|75901289|FG001|COMPLETED|Period 1||9||
59780788|NCT00746330|75901290|FG002|COMPLETED|Period 1||8||
59780789|NCT00746330|75901291|FG003|COMPLETED|Period 1||7||
59780790|NCT00746330|75901288|FG000|NOT COMPLETED|Period 1||0||
59780791|NCT00746330|75901289|FG001|NOT COMPLETED|Period 1||0||
59780792|NCT00746330|75901290|FG002|NOT COMPLETED|Period 1||1||
59619068|NCT04213326|75730255|FG001|STARTED|Overall Study||5463||
59619069|NCT04213326|75730254|FG000|COMPLETED|Overall Study||727||
59619070|NCT04213326|75730255|FG001|COMPLETED|Overall Study||3893||
59619071|NCT04213326|75730254|FG000|NOT COMPLETED|Overall Study||210||
59619072|NCT04213326|75730255|FG001|NOT COMPLETED|Overall Study||1570||
59619073|NCT01625286|75730268|FG000|STARTED|Overall Study||12|RANDOMIZATION CODE ALLOCATED|
59619074|NCT01625286|75730269|FG001|STARTED|Overall Study||8|RANDOMIZATION CODE ALLOCATED|
59619075|NCT01625286|75730270|FG002|STARTED|Overall Study||5|RANDOMIZATION CODE ALLOCATED|
59619076|NCT01625286|75730271|FG003|STARTED|Overall Study||7|RANDOMIZATION CODE ALLOCATED|
59619077|NCT01625286|75730272|FG004|STARTED|Overall Study||6|RANDOMIZATION CODE ALLOCATED|
59619078|NCT01625286|75730273|FG005|STARTED|Overall Study||54|RANDOMIZATION CODE ALLOCATED|
59619079|NCT01625286|75730274|FG006|STARTED|Overall Study||56|RANDOMIZATION CODE ALLOCATED|
59619080|NCT01625286|75730268|FG000|Received AZD5363/Placebo Treatment|Overall Study||12||
59619081|NCT01625286|75730269|FG001|Received AZD5363/Placebo Treatment|Overall Study||8||
59619082|NCT01625286|75730270|FG002|Received AZD5363/Placebo Treatment|Overall Study||5||
59619083|NCT01625286|75730271|FG003|Received AZD5363/Placebo Treatment|Overall Study||7||
59619084|NCT01625286|75730272|FG004|Received AZD5363/Placebo Treatment|Overall Study||6||
59619085|NCT01625286|75730273|FG005|Received AZD5363/Placebo Treatment|Overall Study||54||
59619086|NCT01625286|75730274|FG006|Received AZD5363/Placebo Treatment|Overall Study||55||
59619087|NCT01625286|75730268|FG000|Did Not Receive AZD5363/Placebo Trt|Overall Study||0||
59619088|NCT01625286|75730269|FG001|Did Not Receive AZD5363/Placebo Trt|Overall Study||0||
59619089|NCT01625286|75730270|FG002|Did Not Receive AZD5363/Placebo Trt|Overall Study||0||
59619090|NCT01625286|75730271|FG003|Did Not Receive AZD5363/Placebo Trt|Overall Study||0||
59619091|NCT01625286|75730272|FG004|Did Not Receive AZD5363/Placebo Trt|Overall Study||0||
59619092|NCT01625286|75730273|FG005|Did Not Receive AZD5363/Placebo Trt|Overall Study||0||
59619093|NCT01625286|75730274|FG006|Did Not Receive AZD5363/Placebo Trt|Overall Study||1||
59619094|NCT01625286|75730268|FG000|COMPLETED|Overall Study||6|Completed Study includes patients who were on study or treatment at the final database lock for primary analysis|
59619095|NCT01625286|75730269|FG001|COMPLETED|Overall Study||4|Completed Study includes patients who were on study or treatment at the final database lock for primary analysis|
59619096|NCT01625286|75730270|FG002|COMPLETED|Overall Study||0|Completed Study includes patients who were on study or treatment at the final database lock for primary analysis|
59619097|NCT01625286|75730271|FG003|COMPLETED|Overall Study||0|Completed Study includes patients who were on study or treatment at the final database lock for primary analysis|
59619098|NCT01625286|75730272|FG004|COMPLETED|Overall Study||0|Completed Study includes patients who were on study or treatment at the final database lock for primary analysis|
59619099|NCT01625286|75730273|FG005|COMPLETED|Overall Study||40|Completed Study includes patients who were on study or treatment at the final database lock for primary analysis|
59619100|NCT01625286|75730274|FG006|COMPLETED|Overall Study||37|Completed Study includes patients who were on study or treatment at the final database lock for primary analysis|
59619101|NCT01625286|75730268|FG000|NOT COMPLETED|Overall Study||6||
59619102|NCT01625286|75730269|FG001|NOT COMPLETED|Overall Study||4||
59619103|NCT01625286|75730270|FG002|NOT COMPLETED|Overall Study||5||
59619104|NCT01625286|75730271|FG003|NOT COMPLETED|Overall Study||7||
59619105|NCT01625286|75730272|FG004|NOT COMPLETED|Overall Study||6||
59619106|NCT01625286|75730273|FG005|NOT COMPLETED|Overall Study||14||
59619107|NCT01625286|75730274|FG006|NOT COMPLETED|Overall Study||19||
59619108|NCT03708588|75730292|FG000|STARTED|Overall Study||55||
59619109|NCT03708588|75730293|FG001|STARTED|Overall Study||57||
59619110|NCT03708588|75730292|FG000|COMPLETED|Overall Study||46||
59619111|NCT03708588|75730293|FG001|COMPLETED|Overall Study||48||
59619112|NCT03708588|75730292|FG000|NOT COMPLETED|Overall Study||9||
59619113|NCT03708588|75730293|FG001|NOT COMPLETED|Overall Study||9||
59619114|NCT04130802|75730302|FG000|STARTED|Overall Study||51||
59619115|NCT04130802|75730303|FG001|STARTED|Overall Study||51||
59619116|NCT04130802|75730304|FG002|STARTED|Overall Study||51||
59780793|NCT00746330|75901291|FG003|NOT COMPLETED|Period 1||0||
59780794|NCT00746330|75901288|FG000|STARTED|Period 2||7||
59780795|NCT00746330|75901289|FG001|STARTED|Period 2||9||
59780796|NCT00746330|75901290|FG002|STARTED|Period 2||8||
59780797|NCT00746330|75901291|FG003|STARTED|Period 2||7||
59780798|NCT00746330|75901288|FG000|COMPLETED|Period 2||7||
59780799|NCT00746330|75901289|FG001|COMPLETED|Period 2||9||
59780800|NCT00746330|75901290|FG002|COMPLETED|Period 2||8||
59780801|NCT00746330|75901291|FG003|COMPLETED|Period 2||7||
59780802|NCT00746330|75901288|FG000|NOT COMPLETED|Period 2||0||
59780803|NCT00746330|75901289|FG001|NOT COMPLETED|Period 2||0||
59780804|NCT00746330|75901290|FG002|NOT COMPLETED|Period 2||0||
59780805|NCT00746330|75901291|FG003|NOT COMPLETED|Period 2||0||
59780806|NCT00746330|75901288|FG000|STARTED|Period 3||7||
59780807|NCT00746330|75901289|FG001|STARTED|Period 3||9||
59780808|NCT00746330|75901290|FG002|STARTED|Period 3||8||
59780809|NCT00746330|75901291|FG003|STARTED|Period 3||7||
59780810|NCT00746330|75901288|FG000|COMPLETED|Period 3||7||
59780811|NCT00746330|75901289|FG001|COMPLETED|Period 3||9||
59780812|NCT00746330|75901290|FG002|COMPLETED|Period 3||8||
59780813|NCT00746330|75901291|FG003|COMPLETED|Period 3||7||
59780814|NCT00746330|75901288|FG000|NOT COMPLETED|Period 3||0||
59780815|NCT00746330|75901289|FG001|NOT COMPLETED|Period 3||0||
59780816|NCT00746330|75901290|FG002|NOT COMPLETED|Period 3||0||
59780817|NCT00746330|75901291|FG003|NOT COMPLETED|Period 3||0||
59780818|NCT00746330|75901288|FG000|STARTED|Period 4||7||
59780819|NCT00746330|75901289|FG001|STARTED|Period 4||9||
59953021|NCT04057820|76071790|FG010|NOT COMPLETED|Period 1||0||0
59953022|NCT04057820|76071791|FG011|NOT COMPLETED|Period 1||0||0
59780820|NCT00746330|75901290|FG002|STARTED|Period 4||8||
59780821|NCT00746330|75901291|FG003|STARTED|Period 4||7||
59780822|NCT00746330|75901288|FG000|COMPLETED|Period 4||7||
59780823|NCT00746330|75901289|FG001|COMPLETED|Period 4||9||
59780824|NCT00746330|75901290|FG002|COMPLETED|Period 4||8||
59780825|NCT00746330|75901291|FG003|COMPLETED|Period 4||7||
59780826|NCT00746330|75901288|FG000|NOT COMPLETED|Period 4||0||
59780827|NCT00746330|75901289|FG001|NOT COMPLETED|Period 4||0||
59780828|NCT00746330|75901290|FG002|NOT COMPLETED|Period 4||0||
59780829|NCT00746330|75901291|FG003|NOT COMPLETED|Period 4||0||
59780830|NCT00746252|75901304|FG000|STARTED|Overall Study||1||
59780831|NCT00746252|75901305|FG001|STARTED|Overall Study||2||
59780832|NCT00746252|75901304|FG000|COMPLETED|Overall Study||0||
59780833|NCT00746252|75901305|FG001|COMPLETED|Overall Study||0||
59780834|NCT00746252|75901304|FG000|NOT COMPLETED|Overall Study||1||
59780835|NCT00746252|75901305|FG001|NOT COMPLETED|Overall Study||2||
59780836|NCT00718770|75901311|FG000|STARTED|Overall Study||10||
59780837|NCT00718770|75901311|FG000|COMPLETED|Overall Study||2||
59780838|NCT00718770|75901311|FG000|NOT COMPLETED|Overall Study||8||
59780839|NCT00746096|75901317|FG000|STARTED|Overall Study||58||
59780840|NCT00746096|75901318|FG001|STARTED|Overall Study||57||
59780841|NCT00746096|75901317|FG000|COMPLETED|Overall Study||48||
59780842|NCT00746096|75901318|FG001|COMPLETED|Overall Study||54||
59780843|NCT00746096|75901317|FG000|NOT COMPLETED|Overall Study||10||
59780844|NCT00746096|75901318|FG001|NOT COMPLETED|Overall Study||3||
59780845|NCT00715026|75901324|FG000|STARTED|Overall Study|30 unilateral subjects and 1 bilateral|31||
59780846|NCT00715026|75901324|FG000|Subjects That Received Surgery|Overall Study|24 unilateral subjects and 1 bilateral|25||
59780847|NCT00715026|75901324|FG000|COMPLETED|Overall Study|20 unilateral subjects and 1 bilateral|21||
59780848|NCT00715026|75901324|FG000|NOT COMPLETED|Overall Study||10||
59780849|NCT00714948|75901328|FG000|STARTED|Overall Study||2||
59780850|NCT00714948|75901328|FG000|COMPLETED|Overall Study||0||
59780851|NCT00714948|75901328|FG000|NOT COMPLETED|Overall Study||2||
59780852|NCT00714870|75901334|FG000|STARTED|Overall Study||49||
59780853|NCT00714870|75901335|FG001|STARTED|Overall Study||27||
59780854|NCT00714870|75901334|FG000|COMPLETED|Overall Study||22||
59780855|NCT00714870|75901335|FG001|COMPLETED|Overall Study||22||
59780856|NCT00714870|75901334|FG000|NOT COMPLETED|Overall Study||27||
59780857|NCT00714870|75901335|FG001|NOT COMPLETED|Overall Study||5||
59780858|NCT00714714|75901341|FG000|STARTED|Overall Study||25||
59780859|NCT00714714|75901341|FG000|COMPLETED|Overall Study||24||
59780860|NCT00714714|75901341|FG000|NOT COMPLETED|Overall Study||1||
59780861|NCT00441337|75901351|FG000|STARTED|Overall Study||6||
59780862|NCT00441337|75901352|FG001|STARTED|Overall Study||6||
59780863|NCT00441337|75901353|FG002|STARTED|Overall Study||6||
59780864|NCT00441337|75901354|FG003|STARTED|Overall Study||21||
59780865|NCT00441337|75901351|FG000|COMPLETED|Overall Study||0||
59780866|NCT00441337|75901352|FG001|COMPLETED|Overall Study||0||
59780867|NCT00441337|75901353|FG002|COMPLETED|Overall Study||0||
59780868|NCT00441337|75901354|FG003|COMPLETED|Overall Study||0||
59780869|NCT00441337|75901351|FG000|NOT COMPLETED|Overall Study||6||
59780870|NCT00441337|75901352|FG001|NOT COMPLETED|Overall Study||6||
59780871|NCT00441337|75901353|FG002|NOT COMPLETED|Overall Study||6||
59780872|NCT00441337|75901354|FG003|NOT COMPLETED|Overall Study||21||
59780873|NCT00578877|75901374|FG000|STARTED|Overall Study||150||
59780874|NCT00578877|75901375|FG001|STARTED|Overall Study||300||
59780875|NCT00578877|75901374|FG000|COMPLETED|Overall Study||69||
59780876|NCT00578877|75901375|FG001|COMPLETED|Overall Study||172||
59780877|NCT00578877|75901374|FG000|NOT COMPLETED|Overall Study||81||
59780878|NCT00578877|75901375|FG001|NOT COMPLETED|Overall Study||128||
59780879|NCT00468481|75901383|FG000|STARTED|Overall Study|6 of these randomized subjects did not take any study medication|291||
59780880|NCT00468481|75901384|FG001|STARTED|Overall Study||94||
59780881|NCT00468481|75901383|FG000|Subjects Treated|Overall Study||285||
59780882|NCT00468481|75901384|FG001|Subjects Treated|Overall Study||94||
59780883|NCT00468481|75901383|FG000|COMPLETED|Overall Study||203||
59780884|NCT00468481|75901384|FG001|COMPLETED|Overall Study||70||
59780885|NCT00468481|75901383|FG000|NOT COMPLETED|Overall Study||88||
59780886|NCT00468481|75901384|FG001|NOT COMPLETED|Overall Study||24||
59780887|NCT00714168|75901392|FG000|STARTED|Overall Study||165||
59780888|NCT00714168|75901393|FG001|STARTED|Overall Study||198||
59780889|NCT00714168|75901392|FG000|COMPLETED|Overall Study||121||
59780890|NCT00714168|75901393|FG001|COMPLETED|Overall Study||139||
59780891|NCT00714168|75901392|FG000|NOT COMPLETED|Overall Study||44||
59780892|NCT00714168|75901393|FG001|NOT COMPLETED|Overall Study||59||
59780893|NCT00713700|75901399|FG000|STARTED|Overall Study||192||
59780894|NCT00713700|75901399|FG000|COMPLETED|Overall Study||188||
59780895|NCT00713700|75901399|FG000|NOT COMPLETED|Overall Study||4||
60072984|NCT03834142|76188191|FG001|STARTED|Overall Study||10||
60072985|NCT03834142|76188190|FG000|COMPLETED|Overall Study||10||
60072986|NCT03834142|76188191|FG001|COMPLETED|Overall Study||10||
60072987|NCT03834142|76188190|FG000|NOT COMPLETED|Overall Study||0||
60072988|NCT03834142|76188191|FG001|NOT COMPLETED|Overall Study||0||
60072989|NCT01695135|76188202|FG000|STARTED|Double-blind Treatment Phase||71||
60072990|NCT01695135|76188203|FG001|STARTED|Double-blind Treatment Phase||143||
60072991|NCT01695135|76188204|FG002|STARTED|Double-blind Treatment Phase||0||
60072992|NCT01695135|76188205|FG003|STARTED|Double-blind Treatment Phase||0||
60072993|NCT01695135|76188202|FG000|COMPLETED|Double-blind Treatment Phase||0||
60072994|NCT01695135|76188203|FG001|COMPLETED|Double-blind Treatment Phase||4||
60072995|NCT01695135|76188204|FG002|COMPLETED|Double-blind Treatment Phase||0||
60072996|NCT01695135|76188205|FG003|COMPLETED|Double-blind Treatment Phase||0||
60072997|NCT01695135|76188202|FG000|NOT COMPLETED|Double-blind Treatment Phase||71||
59780896|NCT00468169|75901405|FG000|STARTED|Overall Study||57||
59780897|NCT00468169|75901406|FG001|STARTED|Overall Study||53||
59780898|NCT00468169|75901405|FG000|COMPLETED|Overall Study||56||
59780899|NCT00468169|75901406|FG001|COMPLETED|Overall Study||53||
59780900|NCT00468169|75901405|FG000|NOT COMPLETED|Overall Study||1||
59780901|NCT00468169|75901406|FG001|NOT COMPLETED|Overall Study||0||
59780902|NCT00435487|75901416|FG000|STARTED|Overall Study|87 subjects were randomized however one additional subject originally randomized to UFH was treated.|88||
59780903|NCT00435487|75901417|FG001|STARTED|Overall Study||86||
59780904|NCT00435487|75901416|FG000|TREATED|Overall Study|One additional subject originally randomized to Unfractioned Heparin was treated with Dalteparin.|88||
59780905|NCT00435487|75901417|FG001|TREATED|Overall Study|One subject was mistakenly treated with Dalteparin, two subjects withdrew consent before treatment.|83||
59780906|NCT00435487|75901416|FG000|COMPLETED|Overall Study||76||
59780907|NCT00435487|75901417|FG001|COMPLETED|Overall Study||71||
59780908|NCT00435487|75901416|FG000|NOT COMPLETED|Overall Study||12||
59780909|NCT00435487|75901417|FG001|NOT COMPLETED|Overall Study||15||
59780910|NCT00579345|75901431|FG000|STARTED|Overall Study||549||
59780911|NCT00579345|75901432|FG001|STARTED|Overall Study||169||
59780912|NCT00579345|75901433|FG002|STARTED|Overall Study||391||
59780913|NCT00579345|75901434|FG003|STARTED|Overall Study||144||
59780914|NCT00579345|75901435|FG004|STARTED|Overall Study||90||
59780915|NCT00579345|75901436|FG005|STARTED|Overall Study||78||
59780916|NCT00579345|75901437|FG006|STARTED|Overall Study||57||
59780917|NCT00579345|75901438|FG007|STARTED|Overall Study||44||
59780918|NCT00579345|75901431|FG000|COMPLETED|Overall Study||544||
59780919|NCT00579345|75901432|FG001|COMPLETED|Overall Study||168||
59780920|NCT00579345|75901433|FG002|COMPLETED|Overall Study||389||
59780921|NCT00579345|75901434|FG003|COMPLETED|Overall Study||143||
59780922|NCT00579345|75901435|FG004|COMPLETED|Overall Study||90||
59780923|NCT00579345|75901436|FG005|COMPLETED|Overall Study||78||
59780924|NCT00579345|75901437|FG006|COMPLETED|Overall Study||57||
59780925|NCT00579345|75901438|FG007|COMPLETED|Overall Study||42||
59780926|NCT00579345|75901431|FG000|NOT COMPLETED|Overall Study||5||
59780927|NCT00579345|75901432|FG001|NOT COMPLETED|Overall Study||1||
59780928|NCT00579345|75901433|FG002|NOT COMPLETED|Overall Study||2||
59780929|NCT00579345|75901434|FG003|NOT COMPLETED|Overall Study||1||
59780930|NCT00579345|75901435|FG004|NOT COMPLETED|Overall Study||0||
59780931|NCT00579345|75901436|FG005|NOT COMPLETED|Overall Study||0||
59780932|NCT00579345|75901437|FG006|NOT COMPLETED|Overall Study||0||
59780933|NCT00579345|75901438|FG007|NOT COMPLETED|Overall Study||2||
59780934|NCT05198466|75901468|FG000|STARTED|Overall Study||10||
59780935|NCT05198466|75901469|FG001|STARTED|Overall Study||9||
59780936|NCT05198466|75901468|FG000|COMPLETED|Overall Study||10||
59780937|NCT05198466|75901469|FG001|COMPLETED|Overall Study||8||
59780938|NCT05198466|75901468|FG000|NOT COMPLETED|Overall Study||0||
59780939|NCT05198466|75901469|FG001|NOT COMPLETED|Overall Study||1||
59780940|NCT03897699|75901477|FG000|STARTED|Overall Study||21||
59780941|NCT03897699|75901478|FG001|STARTED|Overall Study||22||
59780942|NCT03897699|75901477|FG000|COMPLETED|Overall Study||16||
59780943|NCT03897699|75901478|FG001|COMPLETED|Overall Study||20||
59780944|NCT03897699|75901477|FG000|NOT COMPLETED|Overall Study||5||
59780945|NCT03897699|75901478|FG001|NOT COMPLETED|Overall Study||2||
59780946|NCT00795821|75901486|FG000|STARTED|Acute Treatment Phase||250||
59780947|NCT00795821|75901487|FG001|STARTED|Acute Treatment Phase||245||
59780948|NCT00795821|75901486|FG000|COMPLETED|Acute Treatment Phase|4 LY-treated participants in the Acute Phase chose not to enter the Long-term Extension Phase.|194||
59780949|NCT00795821|75901487|FG001|COMPLETED|Acute Treatment Phase|7 placebo-treated participants in the Acute Phase chose not to enter the Long-term Extension Phase.|214||
59780950|NCT00795821|75901486|FG000|NOT COMPLETED|Acute Treatment Phase||56||
59780951|NCT00795821|75901487|FG001|NOT COMPLETED|Acute Treatment Phase||31||
59780952|NCT00795821|75901486|FG000|STARTED|Long-term Extension Phase||190||
59780953|NCT00795821|75901487|FG001|STARTED|Long-term Extension Phase|All placebo-treated participants received LY2216684 in the Long-term Extension Phase.|207||
59619117|NCT04130802|75730302|FG000|COMPLETED|Overall Study||50||
59619118|NCT04130802|75730303|FG001|COMPLETED|Overall Study||50||
59619119|NCT04130802|75730304|FG002|COMPLETED|Overall Study||48||
59619120|NCT04130802|75730302|FG000|NOT COMPLETED|Overall Study||1||
59619121|NCT04130802|75730303|FG001|NOT COMPLETED|Overall Study||1||
59619122|NCT04130802|75730304|FG002|NOT COMPLETED|Overall Study||3||
59619123|NCT03163992|75730313|FG000|STARTED|Overall Study||60||
59619124|NCT03163992|75730313|FG000|COMPLETED|Overall Study||1||
59619125|NCT03163992|75730313|FG000|NOT COMPLETED|Overall Study||59||
59619126|NCT04083222|75730319|FG000|STARTED|Overall Study||8||
59619127|NCT04083222|75730320|FG001|STARTED|Overall Study||18||
59619128|NCT04083222|75730319|FG000|COMPLETED|Overall Study||8||
59619129|NCT04083222|75730320|FG001|COMPLETED|Overall Study||16||
59619130|NCT04083222|75730319|FG000|NOT COMPLETED|Overall Study||0||
59619131|NCT04083222|75730320|FG001|NOT COMPLETED|Overall Study||2||
59619132|NCT03286842|75730326|FG000|STARTED|Overall Study||255||
59619133|NCT03286842|75730326|FG000|COMPLETED|Overall Study||175||
59780954|NCT00795821|75901486|FG000|COMPLETED|Long-term Extension Phase||100||
59619134|NCT03286842|75730326|FG000|NOT COMPLETED|Overall Study||80||
59619135|NCT03037476|75730334|FG000|STARTED|Overall Study||414||
59619136|NCT03037476|75730335|FG001|STARTED|Overall Study||429||
59619137|NCT03037476|75730334|FG000|COMPLETED|Overall Study||351||
59619138|NCT03037476|75730335|FG001|COMPLETED|Overall Study||383||
59619139|NCT03037476|75730334|FG000|NOT COMPLETED|Overall Study||63||
59619140|NCT03037476|75730335|FG001|NOT COMPLETED|Overall Study||46||
59619141|NCT02395614|75730341|FG000|STARTED|Overall Study||88||
59619142|NCT02395614|75730341|FG000|Chlorhexidine Irrigation|Overall Study||88||
59619143|NCT02395614|75730341|FG000|Triple Antibiotic Irrigation|Overall Study||88||
59619144|NCT02395614|75730341|FG000|COMPLETED|Overall Study||88||
59619145|NCT02395614|75730341|FG000|NOT COMPLETED|Overall Study||0||
59619146|NCT00639678|75730350|FG000|STARTED|Overall Study||74||
59619147|NCT00639678|75730351|FG001|STARTED|Overall Study||6||
59619148|NCT00639678|75730352|FG002|STARTED|Overall Study||217||
59619149|NCT00639678|75730353|FG003|STARTED|Overall Study||23||
59619150|NCT00639678|75730350|FG000|COMPLETED|Overall Study||70||
59619151|NCT00639678|75730351|FG001|COMPLETED|Overall Study||5||
59619152|NCT00639678|75730352|FG002|COMPLETED|Overall Study||206||
59619153|NCT00639678|75730353|FG003|COMPLETED|Overall Study||23||
59619154|NCT00639678|75730350|FG000|NOT COMPLETED|Overall Study||4||
59619155|NCT00639678|75730351|FG001|NOT COMPLETED|Overall Study||1||
59619156|NCT00639678|75730352|FG002|NOT COMPLETED|Overall Study||11||
59619157|NCT00639678|75730353|FG003|NOT COMPLETED|Overall Study||0||
59619158|NCT02765802|75730367|FG000|STARTED|Overall Study||14||
59619159|NCT02765802|75730368|FG001|STARTED|Overall Study||19||
59619160|NCT02765802|75730367|FG000|COMPLETED|Overall Study||14||
59619161|NCT02765802|75730368|FG001|COMPLETED|Overall Study||19||
59619162|NCT02765802|75730367|FG000|NOT COMPLETED|Overall Study||0||
59619163|NCT02765802|75730368|FG001|NOT COMPLETED|Overall Study||0||
59619164|NCT00638508|75730378|FG000|STARTED|Overall Study||35||
59619165|NCT00638508|75730379|FG001|STARTED|Overall Study||32||
59619166|NCT00638508|75730378|FG000|COMPLETED|Overall Study||30||
59619167|NCT00638508|75730379|FG001|COMPLETED|Overall Study||30||
59780955|NCT00795821|75901487|FG001|COMPLETED|Long-term Extension Phase||115||
59780956|NCT00795821|75901486|FG000|NOT COMPLETED|Long-term Extension Phase||90||
59780957|NCT00795821|75901487|FG001|NOT COMPLETED|Long-term Extension Phase||92||
59780958|NCT00795821|75901486|FG000|STARTED|Taper Phase|N=240 participants entered Taper Phases: N=4 from Acute Phase; N=236 from Extension Phase.|240||
59780959|NCT00795821|75901487|FG001|STARTED|Taper Phase|N=6 participants entered only Acute Taper Phase.|6||
59780960|NCT00795821|75901486|FG000|COMPLETED|Taper Phase|N=231 participants completed Taper Phases: N=3 from Acute Phase; N=228 from Extension Phase.|231||
59780961|NCT00795821|75901487|FG001|COMPLETED|Taper Phase|N=6 participants completed only Acute Taper Phase; N=0 participants entered Extension Taper Phase.|6||
59780962|NCT00795821|75901486|FG000|NOT COMPLETED|Taper Phase||9||
59780963|NCT00795821|75901487|FG001|NOT COMPLETED|Taper Phase||0||
59780964|NCT00578643|75901503|FG000|STARTED|Overall Study||15||
59780965|NCT00578643|75901503|FG000|COMPLETED|Overall Study||13||
59780966|NCT00578643|75901503|FG000|NOT COMPLETED|Overall Study||2||
59780967|NCT00578565|75901507|FG000|STARTED|Overall Study||10||
59780968|NCT00578565|75901507|FG000|COMPLETED|Overall Study||7||
59780969|NCT00578565|75901507|FG000|NOT COMPLETED|Overall Study||3||
59780970|NCT00741260|75901519|FG000|STARTED|Overall Study||6||
59780971|NCT00741260|75901520|FG001|STARTED|Overall Study||8||
59780972|NCT00741260|75901521|FG002|STARTED|Overall Study||4||
59780973|NCT00741260|75901522|FG003|STARTED|Overall Study||6||
59780974|NCT00741260|75901523|FG004|STARTED|Overall Study||9||
59780975|NCT00741260|75901524|FG005|STARTED|Overall Study||65||
59780976|NCT00741260|75901525|FG006|STARTED|Overall Study||7||
59780977|NCT00741260|75901519|FG000|COMPLETED|Overall Study||0||
59780978|NCT00741260|75901520|FG001|COMPLETED|Overall Study||0||
59780979|NCT00741260|75901521|FG002|COMPLETED|Overall Study||0||
59780980|NCT00741260|75901522|FG003|COMPLETED|Overall Study||0||
59780981|NCT00741260|75901523|FG004|COMPLETED|Overall Study||0||
59780982|NCT00741260|75901524|FG005|COMPLETED|Overall Study||20||
59780983|NCT00741260|75901525|FG006|COMPLETED|Overall Study||0||
59780984|NCT00741260|75901519|FG000|NOT COMPLETED|Overall Study||6||
59780985|NCT00741260|75901520|FG001|NOT COMPLETED|Overall Study||8||
59780986|NCT00741260|75901521|FG002|NOT COMPLETED|Overall Study||4||
59780987|NCT00741260|75901522|FG003|NOT COMPLETED|Overall Study||6||
59780988|NCT00741260|75901523|FG004|NOT COMPLETED|Overall Study||9||
59780989|NCT00741260|75901524|FG005|NOT COMPLETED|Overall Study||45||
59780990|NCT00741260|75901525|FG006|NOT COMPLETED|Overall Study||7||
59780991|NCT00740870|75901546|FG000|STARTED|Overall Study||171||
59780992|NCT00740870|75901546|FG000|COMPLETED|Overall Study||150||
59780993|NCT00740870|75901546|FG000|NOT COMPLETED|Overall Study||21||
59780994|NCT00740792|75901557|FG000|STARTED|Overall Study||193||
60072998|NCT01695135|76188203|FG001|NOT COMPLETED|Double-blind Treatment Phase||139||
60072999|NCT01695135|76188204|FG002|NOT COMPLETED|Double-blind Treatment Phase||0||
60073000|NCT01695135|76188205|FG003|NOT COMPLETED|Double-blind Treatment Phase||0||
60073001|NCT01695135|76188202|FG000|STARTED|Open Label Extension Treatment Phase||0||
60073002|NCT01695135|76188203|FG001|STARTED|Open Label Extension Treatment Phase||0||
60073003|NCT01695135|76188204|FG002|STARTED|Open Label Extension Treatment Phase||49||
60073004|NCT01695135|76188205|FG003|STARTED|Open Label Extension Treatment Phase||80||
60073005|NCT01695135|76188202|FG000|COMPLETED|Open Label Extension Treatment Phase||0||
59780995|NCT00740792|75901558|FG001|STARTED|Overall Study||194||
59780996|NCT00740792|75901559|FG002|STARTED|Overall Study||189||
59780997|NCT00740792|75901560|FG003|STARTED|Overall Study||200||
59780998|NCT00740792|75901557|FG000|COMPLETED|Overall Study||183||
60073006|NCT01695135|76188203|FG001|COMPLETED|Open Label Extension Treatment Phase||0||
59780999|NCT00740792|75901558|FG001|COMPLETED|Overall Study||186||
59781000|NCT00740792|75901559|FG002|COMPLETED|Overall Study||180||
59781001|NCT00740792|75901560|FG003|COMPLETED|Overall Study||190||
59781002|NCT00740792|75901557|FG000|NOT COMPLETED|Overall Study||10||
59781003|NCT00740792|75901558|FG001|NOT COMPLETED|Overall Study||8||
59781004|NCT00740792|75901559|FG002|NOT COMPLETED|Overall Study||9||
59781005|NCT00740792|75901560|FG003|NOT COMPLETED|Overall Study||10||
59781006|NCT00740714|75901573|FG000|STARTED|Overall Study|Randomized throughout the recruitment period|196||
59781007|NCT00740714|75901574|FG001|STARTED|Overall Study|Randomized throughout the recruitment period|201||
59781008|NCT00740714|75901575|FG002|STARTED|Overall Study|Randomized throughout the recruitment period|203||
59781009|NCT00740714|75901573|FG000|Reaching Endpoint Before May 6, 2011|Overall Study||86||
59781010|NCT00740714|75901574|FG001|Reaching Endpoint Before May 6, 2011|Overall Study||87||
59781011|NCT00740714|75901575|FG002|Reaching Endpoint Before May 6, 2011|Overall Study||94||
59781012|NCT00740714|75901573|FG000|Active Patients at Study Termination|Overall Study||24||
59781013|NCT00740714|75901574|FG001|Active Patients at Study Termination|Overall Study||12||
59781014|NCT00740714|75901575|FG002|Active Patients at Study Termination|Overall Study||33||
59781015|NCT00740714|75901573|FG000|COMPLETED|Overall Study||179||
59781016|NCT00740714|75901574|FG001|COMPLETED|Overall Study||182||
59781017|NCT00740714|75901575|FG002|COMPLETED|Overall Study||174||
59781018|NCT00740714|75901573|FG000|NOT COMPLETED|Overall Study||17||
59781019|NCT00740714|75901574|FG001|NOT COMPLETED|Overall Study||19||
59781020|NCT00740714|75901575|FG002|NOT COMPLETED|Overall Study||29||
59781021|NCT00788957|75901587|FG000|STARTED|Part 1||11||
59781022|NCT00788957|75901588|FG001|STARTED|Part 1||0||
59781023|NCT00788957|75901589|FG002|STARTED|Part 1||0||
59781024|NCT00788957|75901590|FG003|STARTED|Part 1||0||
59781025|NCT00788957|75901591|FG004|STARTED|Part 1||0||
59781026|NCT00788957|75901592|FG005|STARTED|Part 1||0||
59781027|NCT00788957|75901587|FG000|COMPLETED|Part 1|Completed the safety follow-up visit|2||
59781028|NCT00788957|75901588|FG001|COMPLETED|Part 1||0||
59781029|NCT00788957|75901589|FG002|COMPLETED|Part 1||0||
59781030|NCT00788957|75901590|FG003|COMPLETED|Part 1||0||
60073007|NCT01695135|76188204|FG002|COMPLETED|Open Label Extension Treatment Phase||9||
60073008|NCT01695135|76188205|FG003|COMPLETED|Open Label Extension Treatment Phase||10||
60073009|NCT01695135|76188202|FG000|NOT COMPLETED|Open Label Extension Treatment Phase||0||
60073010|NCT01695135|76188203|FG001|NOT COMPLETED|Open Label Extension Treatment Phase||0||
59781031|NCT00788957|75901591|FG004|COMPLETED|Part 1||0||
59781032|NCT00788957|75901592|FG005|COMPLETED|Part 1||0||
59781033|NCT00788957|75901587|FG000|NOT COMPLETED|Part 1||9||
59781034|NCT00788957|75901588|FG001|NOT COMPLETED|Part 1||0||
59781035|NCT00788957|75901589|FG002|NOT COMPLETED|Part 1||0||
59781036|NCT00788957|75901590|FG003|NOT COMPLETED|Part 1||0||
59781037|NCT00788957|75901591|FG004|NOT COMPLETED|Part 1||0||
59781038|NCT00788957|75901592|FG005|NOT COMPLETED|Part 1||0||
59781039|NCT00788957|75901587|FG000|STARTED|Part 2||0||
59781040|NCT00788957|75901588|FG001|STARTED|Part 2||48||
59781041|NCT00788957|75901589|FG002|STARTED|Part 2||48||
59781042|NCT00788957|75901590|FG003|STARTED|Part 2||46||
59781043|NCT00788957|75901591|FG004|STARTED|Part 2||0||
59781044|NCT00788957|75901592|FG005|STARTED|Part 2||0||
59781045|NCT00788957|75901587|FG000|COMPLETED|Part 2||0||
59781046|NCT00788957|75901588|FG001|COMPLETED|Part 2|Completed the safety follow-up visit at the end of the study|6||
59781047|NCT00788957|75901589|FG002|COMPLETED|Part 2|Completed the safety follow-up visit|4||
59781048|NCT00788957|75901590|FG003|COMPLETED|Part 2|Completed the safety follow-up visit|5||
59781049|NCT00788957|75901591|FG004|COMPLETED|Part 2||0||
59781050|NCT00788957|75901592|FG005|COMPLETED|Part 2||0||
59781051|NCT00788957|75901587|FG000|NOT COMPLETED|Part 2||0||
59781052|NCT00788957|75901588|FG001|NOT COMPLETED|Part 2||42||
59781053|NCT00788957|75901589|FG002|NOT COMPLETED|Part 2||44||
59781054|NCT00788957|75901590|FG003|NOT COMPLETED|Part 2||41||
59781055|NCT00788957|75901591|FG004|NOT COMPLETED|Part 2||0||
59781056|NCT00788957|75901592|FG005|NOT COMPLETED|Part 2||0||
59781057|NCT00788957|75901587|FG000|STARTED|Part 3||0||
59781058|NCT00788957|75901588|FG001|STARTED|Part 3||0||
59781059|NCT00788957|75901589|FG002|STARTED|Part 3||0||
59781060|NCT00788957|75901590|FG003|STARTED|Part 3||0||
59781061|NCT00788957|75901591|FG004|STARTED|Part 3||13||
59781062|NCT00788957|75901592|FG005|STARTED|Part 3||12||
59781063|NCT00788957|75901587|FG000|COMPLETED|Part 3||0||
59781064|NCT00788957|75901588|FG001|COMPLETED|Part 3||0||
59781065|NCT00788957|75901589|FG002|COMPLETED|Part 3||0||
59781066|NCT00788957|75901590|FG003|COMPLETED|Part 3||0||
59781067|NCT00788957|75901591|FG004|COMPLETED|Part 3|Completed the safety follow-up visit|4||
59781068|NCT00788957|75901592|FG005|COMPLETED|Part 3|Completed the safety follow-up visit|1||
59781069|NCT00788957|75901587|FG000|NOT COMPLETED|Part 3||0||
59781070|NCT00788957|75901588|FG001|NOT COMPLETED|Part 3||0||
59781071|NCT00788957|75901589|FG002|NOT COMPLETED|Part 3||0||
59781072|NCT00788957|75901590|FG003|NOT COMPLETED|Part 3||0||
59781073|NCT00788957|75901591|FG004|NOT COMPLETED|Part 3||9||
59781074|NCT00788957|75901592|FG005|NOT COMPLETED|Part 3||11||
59781075|NCT00740636|75901611|FG000|STARTED|Overall Study||25||
59781076|NCT00740636|75901612|FG001|STARTED|Overall Study||67||
59781077|NCT00740636|75901611|FG000|COMPLETED|Overall Study||23||
59781078|NCT00740636|75901612|FG001|COMPLETED|Overall Study||63||
59781079|NCT00740636|75901611|FG000|NOT COMPLETED|Overall Study||2||
59781080|NCT00740636|75901612|FG001|NOT COMPLETED|Overall Study||4||
59781081|NCT00735254|75901622|FG000|STARTED|Overall Study||1||
59781082|NCT00735254|75901623|FG001|STARTED|Overall Study||1||
59781083|NCT00735254|75901624|FG002|STARTED|Overall Study||1||
59781084|NCT00735254|75901625|FG003|STARTED|Overall Study||0||
59781085|NCT00735254|75901622|FG000|COMPLETED|Overall Study||0||
59781086|NCT00735254|75901623|FG001|COMPLETED|Overall Study||0||
59781087|NCT00735254|75901624|FG002|COMPLETED|Overall Study||0||
59781088|NCT00735254|75901625|FG003|COMPLETED|Overall Study||0||
59781089|NCT00735254|75901622|FG000|NOT COMPLETED|Overall Study||1||
59781090|NCT00735254|75901623|FG001|NOT COMPLETED|Overall Study||1||
59781091|NCT00735254|75901624|FG002|NOT COMPLETED|Overall Study||1||
59781092|NCT00735254|75901625|FG003|NOT COMPLETED|Overall Study||0||
59781093|NCT00795509|75901635|FG000|STARTED|Overall Study||374||
59781094|NCT00795509|75901635|FG000|COMPLETED|Overall Study||343||
59781095|NCT00795509|75901635|FG000|NOT COMPLETED|Overall Study||31||
59781096|NCT00787787|75901639|FG000|STARTED|Overall Study||7||
59781097|NCT00787787|75901639|FG000|COMPLETED|Overall Study||0||
59781098|NCT00787787|75901639|FG000|NOT COMPLETED|Overall Study||7||
59781099|NCT00787319|75901643|FG000|STARTED|Overall Study||108||
59781100|NCT00787319|75901643|FG000|COMPLETED|Overall Study||45||
59781101|NCT00787319|75901643|FG000|NOT COMPLETED|Overall Study||63||
59781102|NCT00794963|75901649|FG000|STARTED|Overall Study||4||
59781103|NCT00794963|75901650|FG001|STARTED|Overall Study||4||
59781104|NCT00794963|75901649|FG000|COMPLETED|Overall Study||3||
59781105|NCT00794963|75901650|FG001|COMPLETED|Overall Study||0||
59781106|NCT00794963|75901649|FG000|NOT COMPLETED|Overall Study||1||
59781107|NCT00794963|75901650|FG001|NOT COMPLETED|Overall Study||4||
59781108|NCT00794573|75901658|FG000|STARTED|Overall Study||151||
59781109|NCT00794573|75901659|FG001|STARTED|Overall Study||151||
59781110|NCT00794573|75901658|FG000|COMPLETED|Overall Study||113||
59781111|NCT00794573|75901659|FG001|COMPLETED|Overall Study||106||
59781112|NCT00794573|75901658|FG000|NOT COMPLETED|Overall Study||38||
59781113|NCT00794573|75901659|FG001|NOT COMPLETED|Overall Study||45||
59781114|NCT00584844|75901665|FG000|STARTED|Overall Study||484||
59781115|NCT00584844|75901665|FG000|COMPLETED|Overall Study||405||
59781116|NCT00584844|75901665|FG000|NOT COMPLETED|Overall Study||79||
59781117|NCT00739934|75901673|FG000|STARTED|Voriconazole IV||40||
59781118|NCT00739934|75901673|FG000|COMPLETED|Voriconazole IV||34||
59781119|NCT00739934|75901673|FG000|NOT COMPLETED|Voriconazole IV||6||
59781120|NCT00739934|75901673|FG000|STARTED|Voriconazole Oral||34||
59781121|NCT00739934|75901673|FG000|COMPLETED|Voriconazole Oral||31||
59781122|NCT00739934|75901673|FG000|NOT COMPLETED|Voriconazole Oral||3||
59781123|NCT00739310|75901682|FG000|STARTED|Overall Study||29||
59781124|NCT00739310|75901682|FG000|COMPLETED|Overall Study||22||
59781125|NCT00739310|75901682|FG000|NOT COMPLETED|Overall Study||7||
59781126|NCT00734630|75901689|FG000|STARTED|Overall Study||258||
59781127|NCT00734630|75901690|FG001|STARTED|Overall Study||233||
59781128|NCT00734630|75901689|FG000|COMPLETED|Overall Study||229||
59781129|NCT00734630|75901690|FG001|COMPLETED|Overall Study||200||
59781130|NCT00734630|75901689|FG000|NOT COMPLETED|Overall Study||29||
59781131|NCT00734630|75901690|FG001|NOT COMPLETED|Overall Study||33||
59781132|NCT00584454|75901696|FG000|STARTED|Overall Study||10||
59781133|NCT00584454|75901696|FG000|COMPLETED|Overall Study||6||
59781134|NCT00584454|75901696|FG000|NOT COMPLETED|Overall Study||4||
59781135|NCT00578175|75901703|FG000|STARTED|Overall Study||705||
59781136|NCT00578175|75901704|FG001|STARTED|Overall Study||689||
59781137|NCT00578175|75901705|FG002|STARTED|Overall Study||389||
59781138|NCT00578175|75901703|FG000|COMPLETED|Overall Study||635||
59781139|NCT00578175|75901704|FG001|COMPLETED|Overall Study||646||
59781140|NCT00578175|75901705|FG002|COMPLETED|Overall Study||365||
59781141|NCT00578175|75901703|FG000|NOT COMPLETED|Overall Study||70||
59781142|NCT00578175|75901704|FG001|NOT COMPLETED|Overall Study||43||
59781143|NCT00578175|75901705|FG002|NOT COMPLETED|Overall Study||24||
59781144|NCT00435409|75901717|FG000|STARTED|Overall Study||221||
59781145|NCT00435409|75901718|FG001|STARTED|Overall Study||143||
59781146|NCT00435409|75901719|FG002|STARTED|Overall Study||78||
59781147|NCT00435409|75901717|FG000|Treated|Overall Study||217||
59781148|NCT00435409|75901718|FG001|Treated|Overall Study||139||
59781149|NCT00435409|75901719|FG002|Treated|Overall Study||78||
59781150|NCT00435409|75901717|FG000|COMPLETED|Overall Study||0||
59781151|NCT00435409|75901718|FG001|COMPLETED|Overall Study||0||
59781152|NCT00435409|75901719|FG002|COMPLETED|Overall Study||0||
59781153|NCT00435409|75901717|FG000|NOT COMPLETED|Overall Study||221||
59781154|NCT00435409|75901718|FG001|NOT COMPLETED|Overall Study||143||
59781155|NCT00435409|75901719|FG002|NOT COMPLETED|Overall Study||78||
59781156|NCT04581330|75901725|FG000|STARTED|Overall Study||10||10
59781157|NCT04581330|75901726|FG001|STARTED|Overall Study||10||10
59781158|NCT04581330|75901725|FG000|COMPLETED|Overall Study||10||10
59781159|NCT04581330|75901726|FG001|COMPLETED|Overall Study||10||10
59781160|NCT04581330|75901725|FG000|NOT COMPLETED|Overall Study||0||0
59781161|NCT04581330|75901726|FG001|NOT COMPLETED|Overall Study||0||0
59781162|NCT00467857|75901736|FG000|STARTED|Overall Study||146||
59781163|NCT00467857|75901737|FG001|STARTED|Overall Study||147||
59781164|NCT00467857|75901736|FG000|COMPLETED|Overall Study||143||
59781165|NCT00467857|75901737|FG001|COMPLETED|Overall Study||139||
59781166|NCT00467857|75901736|FG000|NOT COMPLETED|Overall Study||3||
59781167|NCT00467857|75901737|FG001|NOT COMPLETED|Overall Study||8||
59781168|NCT00435019|75901745|FG000|STARTED|Overall Study|Randomised|177||
59781169|NCT00435019|75901746|FG001|STARTED|Overall Study|Randomised|171||
59781170|NCT00435019|75901745|FG000|Exposed to Study Drug|Overall Study||177||
59781171|NCT00435019|75901746|FG001|Exposed to Study Drug|Overall Study|One subject withdrew before receiving study drug, and thus not included in the full analysis set.|170||
59781172|NCT00435019|75901745|FG000|COMPLETED|Overall Study||164||
59781173|NCT00435019|75901746|FG001|COMPLETED|Overall Study||161||
59781174|NCT00435019|75901745|FG000|NOT COMPLETED|Overall Study||13||
59781175|NCT00435019|75901746|FG001|NOT COMPLETED|Overall Study||10||
59781176|NCT00577863|75901754|FG000|STARTED|Overall Study||92||
59781177|NCT00577863|75901755|FG001|STARTED|Overall Study||108||
59781178|NCT00577863|75901754|FG000|Received at Least One Injection|Overall Study||92||
59781179|NCT00577863|75901755|FG001|Received at Least One Injection|Overall Study||107||
59781180|NCT00577863|75901754|FG000|COMPLETED|Overall Study||82||
59781181|NCT00577863|75901755|FG001|COMPLETED|Overall Study||94||
59781182|NCT00577863|75901754|FG000|NOT COMPLETED|Overall Study||10||
59781183|NCT00577863|75901755|FG001|NOT COMPLETED|Overall Study||14||
59781184|NCT00794417|75901765|FG000|STARTED|Phase 1: Baseline (Day 1) up to Day 751||4||
59781185|NCT00794417|75901766|FG001|STARTED|Phase 1: Baseline (Day 1) up to Day 751||7||
59781186|NCT00794417|75901767|FG002|STARTED|Phase 1: Baseline (Day 1) up to Day 751||7||
59781187|NCT00794417|75901768|FG003|STARTED|Phase 1: Baseline (Day 1) up to Day 751||0||
59781188|NCT00794417|75901765|FG000|COMPLETED|Phase 1: Baseline (Day 1) up to Day 751||1||
59781189|NCT00794417|75901766|FG001|COMPLETED|Phase 1: Baseline (Day 1) up to Day 751||4||
59781190|NCT00794417|75901767|FG002|COMPLETED|Phase 1: Baseline (Day 1) up to Day 751||4||
59781191|NCT00794417|75901768|FG003|COMPLETED|Phase 1: Baseline (Day 1) up to Day 751||0||
59781192|NCT00794417|75901765|FG000|NOT COMPLETED|Phase 1: Baseline (Day 1) up to Day 751||3||
59781193|NCT00794417|75901766|FG001|NOT COMPLETED|Phase 1: Baseline (Day 1) up to Day 751||3||
59781194|NCT00794417|75901767|FG002|NOT COMPLETED|Phase 1: Baseline (Day 1) up to Day 751||3||
59781195|NCT00794417|75901768|FG003|NOT COMPLETED|Phase 1: Baseline (Day 1) up to Day 751||0||
59781196|NCT00794417|75901765|FG000|STARTED|Phase 2: Baseline (Day 421) to Day 972|Participants enrolled in phase 1 were not eligible for enrollment in phase 2.|0||
59953023|NCT04057820|76071792|FG012|NOT COMPLETED|Period 1||0||0
59781197|NCT00794417|75901766|FG001|STARTED|Phase 2: Baseline (Day 421) to Day 972|Participants enrolled in phase 1 were not eligible for enrollment in phase 2.|0||
59781198|NCT00794417|75901767|FG002|STARTED|Phase 2: Baseline (Day 421) to Day 972|Participants enrolled in phase 1 were not eligible for enrollment in phase 2.|0||
59781199|NCT00794417|75901768|FG003|STARTED|Phase 2: Baseline (Day 421) to Day 972||42||
59781200|NCT00794417|75901765|FG000|COMPLETED|Phase 2: Baseline (Day 421) to Day 972||0||
59781201|NCT00794417|75901766|FG001|COMPLETED|Phase 2: Baseline (Day 421) to Day 972||0||
59781202|NCT00794417|75901767|FG002|COMPLETED|Phase 2: Baseline (Day 421) to Day 972||0||
59781203|NCT00794417|75901768|FG003|COMPLETED|Phase 2: Baseline (Day 421) to Day 972||7||
59781204|NCT00794417|75901765|FG000|NOT COMPLETED|Phase 2: Baseline (Day 421) to Day 972||0||
59781205|NCT00794417|75901766|FG001|NOT COMPLETED|Phase 2: Baseline (Day 421) to Day 972||0||
59781206|NCT00794417|75901767|FG002|NOT COMPLETED|Phase 2: Baseline (Day 421) to Day 972||0||
59781207|NCT00794417|75901768|FG003|NOT COMPLETED|Phase 2: Baseline (Day 421) to Day 972||35||
59781208|NCT00790907|75901783|FG000|STARTED|Overall Study||1209||
59781209|NCT00790907|75901784|FG001|STARTED|Overall Study||1024||
59781210|NCT00790907|75901785|FG002|STARTED|Overall Study||1002||
59781211|NCT00790907|75901783|FG000|COMPLETED|Overall Study||754||
59781212|NCT00790907|75901784|FG001|COMPLETED|Overall Study||684||
59781213|NCT00790907|75901785|FG002|COMPLETED|Overall Study||663||
59781214|NCT00790907|75901783|FG000|NOT COMPLETED|Overall Study||455||
59781215|NCT00790907|75901784|FG001|NOT COMPLETED|Overall Study||340||
59781216|NCT00790907|75901785|FG002|NOT COMPLETED|Overall Study||339||
59781217|NCT04071795|75901794|FG000|STARTED|Overall Study||58||
59781218|NCT04071795|75901795|FG001|STARTED|Overall Study||240||
59781219|NCT04071795|75901796|FG002|STARTED|Overall Study||82||
59781220|NCT04071795|75901797|FG003|STARTED|Overall Study||303||
59781221|NCT04071795|75901794|FG000|COMPLETED|Overall Study||34||
59781222|NCT04071795|75901795|FG001|COMPLETED|Overall Study||240||
59781223|NCT04071795|75901796|FG002|COMPLETED|Overall Study||55||
59781224|NCT04071795|75901797|FG003|COMPLETED|Overall Study||303||
59781225|NCT04071795|75901794|FG000|NOT COMPLETED|Overall Study||24||
59781226|NCT04071795|75901795|FG001|NOT COMPLETED|Overall Study||0||
59781227|NCT04071795|75901796|FG002|NOT COMPLETED|Overall Study||27||
59781228|NCT04071795|75901797|FG003|NOT COMPLETED|Overall Study||0||
59781229|NCT00793871|75901803|FG000|STARTED|Overall Study||60||
59781230|NCT00793871|75901803|FG000|Received Treatment|Overall Study||59||
59619168|NCT00638508|75730378|FG000|NOT COMPLETED|Overall Study||5||
59619169|NCT00638508|75730379|FG001|NOT COMPLETED|Overall Study||2||
59619170|NCT00637806|75730392|FG000|STARTED|Double-blind Phase||2||
59619171|NCT00637806|75730393|FG001|STARTED|Double-blind Phase||0||
59619172|NCT00637806|75730394|FG002|STARTED|Double-blind Phase||2||
59619173|NCT00637806|75730395|FG003|STARTED|Double-blind Phase||0||
59619174|NCT00637806|75730392|FG000|COMPLETED|Double-blind Phase||0||
59619175|NCT00637806|75730393|FG001|COMPLETED|Double-blind Phase||0||
59619176|NCT00637806|75730394|FG002|COMPLETED|Double-blind Phase||1||
59619177|NCT00637806|75730395|FG003|COMPLETED|Double-blind Phase||0||
59619178|NCT00637806|75730392|FG000|NOT COMPLETED|Double-blind Phase||2||
59619179|NCT00637806|75730393|FG001|NOT COMPLETED|Double-blind Phase||0||
59619180|NCT00637806|75730394|FG002|NOT COMPLETED|Double-blind Phase||1||
59619181|NCT00637806|75730395|FG003|NOT COMPLETED|Double-blind Phase||0||
59619182|NCT00637806|75730392|FG000|STARTED|Extension Phase||0||
59619183|NCT00637806|75730393|FG001|STARTED|Extension Phase||0||
59619184|NCT00637806|75730394|FG002|STARTED|Extension Phase||0||
59619185|NCT00637806|75730395|FG003|STARTED|Extension Phase||1||
59619186|NCT00637806|75730392|FG000|COMPLETED|Extension Phase||0||
59619187|NCT00637806|75730393|FG001|COMPLETED|Extension Phase||0||
59619188|NCT00637806|75730394|FG002|COMPLETED|Extension Phase||0||
59619189|NCT00637806|75730395|FG003|COMPLETED|Extension Phase||0||
59619190|NCT00637806|75730392|FG000|NOT COMPLETED|Extension Phase||0||
59619191|NCT00637806|75730393|FG001|NOT COMPLETED|Extension Phase||0||
59619192|NCT00637806|75730394|FG002|NOT COMPLETED|Extension Phase||0||
59619193|NCT00637806|75730395|FG003|NOT COMPLETED|Extension Phase||1||
59619194|NCT00637728|75730406|FG000|STARTED|Double-blind Phase||4||
59619195|NCT00637728|75730407|FG001|STARTED|Double-blind Phase||1||
59619196|NCT00637728|75730408|FG002|STARTED|Double-blind Phase||0||
59619197|NCT00637728|75730406|FG000|COMPLETED|Double-blind Phase||0||
59619198|NCT00637728|75730407|FG001|COMPLETED|Double-blind Phase||0||
59619199|NCT00637728|75730408|FG002|COMPLETED|Double-blind Phase||0||
59619200|NCT00637728|75730406|FG000|NOT COMPLETED|Double-blind Phase||4||
59619201|NCT00637728|75730407|FG001|NOT COMPLETED|Double-blind Phase||1||
59619202|NCT00637728|75730408|FG002|NOT COMPLETED|Double-blind Phase||0||
59619203|NCT00637728|75730406|FG000|STARTED|Extension Phase||0||
59619204|NCT00637728|75730407|FG001|STARTED|Extension Phase||0||
59619205|NCT00637728|75730408|FG002|STARTED|Extension Phase||0||
59619206|NCT00637728|75730406|FG000|COMPLETED|Extension Phase||0||
59619207|NCT00637728|75730407|FG001|COMPLETED|Extension Phase||0||
59619208|NCT00637728|75730408|FG002|COMPLETED|Extension Phase||0||
59619209|NCT00637728|75730406|FG000|NOT COMPLETED|Extension Phase||0||
59619210|NCT00637728|75730407|FG001|NOT COMPLETED|Extension Phase||0||
59619211|NCT00637728|75730408|FG002|NOT COMPLETED|Extension Phase||0||
59619212|NCT00637572|75730417|FG000|STARTED|Overall Study||32||
59619213|NCT00637572|75730418|FG001|STARTED|Overall Study||31||
59781231|NCT00793871|75901803|FG000|COMPLETED|Overall Study||0||
59781232|NCT00793871|75901803|FG000|NOT COMPLETED|Overall Study||60||
59781233|NCT04503564|75901807|FG000|STARTED|Achilles Infusion Set w/Saline- Week 1||20||
59781234|NCT04503564|75901807|FG000|COMPLETED|Achilles Infusion Set w/Saline- Week 1||20||
59781235|NCT04503564|75901807|FG000|NOT COMPLETED|Achilles Infusion Set w/Saline- Week 1||0||
59781236|NCT04503564|75901807|FG000|STARTED|Achilles Infusion Set w/Insulin Week 2||20||
59781237|NCT04503564|75901807|FG000|COMPLETED|Achilles Infusion Set w/Insulin Week 2||20||
59781238|NCT04503564|75901807|FG000|NOT COMPLETED|Achilles Infusion Set w/Insulin Week 2||0||
59781239|NCT04503564|75901807|FG000|STARTED|Achilles Infusion Set w/Insulin Week 3||20||
59781240|NCT04503564|75901807|FG000|COMPLETED|Achilles Infusion Set w/Insulin Week 3||20||
59781241|NCT04503564|75901807|FG000|NOT COMPLETED|Achilles Infusion Set w/Insulin Week 3||0||
59781242|NCT00577707|75901811|FG000|STARTED|Overall Study||9||
59781243|NCT00577707|75901811|FG000|COMPLETED|Overall Study||6||
59781244|NCT00577707|75901811|FG000|NOT COMPLETED|Overall Study||3||
59781245|NCT00713349|75901815|FG000|STARTED|Overall Study||25||
59781246|NCT00713349|75901815|FG000|COMPLETED|Overall Study||24||
59781247|NCT00713349|75901815|FG000|NOT COMPLETED|Overall Study||1||
59781248|NCT00712959|75901823|FG000|STARTED|Overall Study||361||
59781249|NCT00712959|75901824|FG001|STARTED|Overall Study||407||
59781250|NCT00712959|75901823|FG000|COMPLETED|Overall Study||342||
59781251|NCT00712959|75901824|FG001|COMPLETED|Overall Study||404||
59781252|NCT00712959|75901823|FG000|NOT COMPLETED|Overall Study||19||
59781253|NCT00712959|75901824|FG001|NOT COMPLETED|Overall Study||3||
59781254|NCT00712725|75901838|FG000|STARTED|Overall Study||169||
59781255|NCT00712725|75901839|FG001|STARTED|Overall Study||39||
59781256|NCT00712725|75901840|FG002|STARTED|Overall Study||57||
59781257|NCT00712725|75901841|FG003|STARTED|Overall Study||84||
59781258|NCT00712725|75901842|FG004|STARTED|Overall Study||86||
59781259|NCT00712725|75901843|FG005|STARTED|Overall Study||84||
59781260|NCT00712725|75901844|FG006|STARTED|Overall Study||83||
59781261|NCT00712725|75901845|FG007|STARTED|Overall Study||74||
59781262|NCT00712725|75901838|FG000|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|140||
59781263|NCT00712725|75901839|FG001|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|33||
59781264|NCT00712725|75901840|FG002|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|47||
59781265|NCT00712725|75901841|FG003|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|67||
59781266|NCT00712725|75901842|FG004|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|67||
59781267|NCT00712725|75901843|FG005|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|68||
59781268|NCT00712725|75901844|FG006|COMPLETED|Overall Study|One patient received study drug. The remaining patients discontinued prior to receiving study drug.|61||
59781269|NCT00712725|75901845|FG007|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|63||
59781270|NCT00712725|75901838|FG000|NOT COMPLETED|Overall Study||29||
59781271|NCT00712725|75901839|FG001|NOT COMPLETED|Overall Study||6||
59781272|NCT00712725|75901840|FG002|NOT COMPLETED|Overall Study||10||
59781273|NCT00712725|75901841|FG003|NOT COMPLETED|Overall Study||17||
59781274|NCT00712725|75901842|FG004|NOT COMPLETED|Overall Study||19||
59781275|NCT00712725|75901843|FG005|NOT COMPLETED|Overall Study||16||
59781276|NCT00712725|75901844|FG006|NOT COMPLETED|Overall Study||22||
59781277|NCT00712725|75901845|FG007|NOT COMPLETED|Overall Study||11||
59781278|NCT00712335|75901868|FG000|STARTED|Overall Study||8||
59781279|NCT00712335|75901869|FG001|STARTED|Overall Study||32||
59781280|NCT00712335|75901870|FG002|STARTED|Overall Study||11||
59781281|NCT00712335|75901871|FG003|STARTED|Overall Study||24||
59781282|NCT00712335|75901872|FG004|STARTED|Overall Study||30||
59781283|NCT00712335|75901868|FG000|COMPLETED|Overall Study||5||
59781284|NCT00712335|75901869|FG001|COMPLETED|Overall Study||15||
59781285|NCT00712335|75901870|FG002|COMPLETED|Overall Study||6||
59781286|NCT00712335|75901871|FG003|COMPLETED|Overall Study||19||
59781287|NCT00712335|75901872|FG004|COMPLETED|Overall Study||30||
59781288|NCT00712335|75901868|FG000|NOT COMPLETED|Overall Study||3||
59781289|NCT00712335|75901869|FG001|NOT COMPLETED|Overall Study||17||
59781290|NCT00712335|75901870|FG002|NOT COMPLETED|Overall Study||5||
59781291|NCT00712335|75901871|FG003|NOT COMPLETED|Overall Study||5||
59781292|NCT00712335|75901872|FG004|NOT COMPLETED|Overall Study||0||
59781293|NCT00577629|75901884|FG000|STARTED|Treatment Period||39||
59781294|NCT00577629|75901884|FG000|COMPLETED|Treatment Period||38||
59781295|NCT00577629|75901884|FG000|NOT COMPLETED|Treatment Period||1||
59781296|NCT00577629|75901884|FG000|STARTED|Long Term Follow-Up||38||
59781297|NCT00577629|75901884|FG000|COMPLETED|Long Term Follow-Up||13||
59781298|NCT00577629|75901884|FG000|NOT COMPLETED|Long Term Follow-Up||25||
59781299|NCT00710385|75901890|FG000|STARTED|Overall Study|19 participants signed consent for the study 2 withdrew before any study procedures were initiated.|17||
59781300|NCT00710385|75901890|FG000|COMPLETED|Overall Study||12||
59781301|NCT00710385|75901890|FG000|NOT COMPLETED|Overall Study||5||
59781302|NCT00701415|75901902|FG000|STARTED|Overall Study||16||
59781303|NCT00701415|75901903|FG001|STARTED|Overall Study||15||
59781304|NCT00701415|75901902|FG000|COMPLETED|Overall Study||15||
59781305|NCT00701415|75901903|FG001|COMPLETED|Overall Study||14||
59781306|NCT00701415|75901902|FG000|NOT COMPLETED|Overall Study||1||
59781307|NCT00701415|75901903|FG001|NOT COMPLETED|Overall Study||1||
59781308|NCT00700011|75901911|FG000|STARTED|Overall Study||8||
59781309|NCT00700011|75901912|FG001|STARTED|Overall Study||2||
59781310|NCT00700011|75901911|FG000|COMPLETED|Overall Study||8||
59781311|NCT00700011|75901912|FG001|COMPLETED|Overall Study||1||
59781312|NCT00700011|75901911|FG000|NOT COMPLETED|Overall Study||0||
59781313|NCT00700011|75901912|FG001|NOT COMPLETED|Overall Study||1||
59781314|NCT00707031|75901920|FG000|STARTED|Overall Study|Randomized|320||
59781315|NCT00707031|75901921|FG001|STARTED|Overall Study||319||
59781316|NCT00707031|75901920|FG000|Treated/Safety Population|Overall Study|All patients who received at least 1 dose, regardless of amount of treatment administered.|318||
59781317|NCT00707031|75901921|FG001|Treated/Safety Population|Overall Study||316||
59781318|NCT00707031|75901920|FG000|Modified Intent-to-Treat Population|Overall Study|All patients who received at least 1 dose;had baseline;at least 1 post-baseline efficacy assessment.|315||
59781319|NCT00707031|75901921|FG001|Modified Intent-to-Treat Population|Overall Study||315||
59781320|NCT00707031|75901920|FG000|COMPLETED|Overall Study||216||
59781321|NCT00707031|75901921|FG001|COMPLETED|Overall Study||220||
59781322|NCT00707031|75901920|FG000|NOT COMPLETED|Overall Study||104||
59781323|NCT00707031|75901921|FG001|NOT COMPLETED|Overall Study||99||
59781324|NCT00711477|75901930|FG000|STARTED|Overall Study||23||
59781325|NCT00711477|75901931|FG001|STARTED|Overall Study||23||
59781326|NCT00711477|75901930|FG000|COMPLETED|Overall Study||20||
59781327|NCT00711477|75901931|FG001|COMPLETED|Overall Study||20||
59781328|NCT00711477|75901930|FG000|NOT COMPLETED|Overall Study||3||
59781329|NCT00711477|75901931|FG001|NOT COMPLETED|Overall Study||3||
59781330|NCT00699699|75901939|FG000|STARTED|Overall Study||1280||
59781331|NCT00699699|75901939|FG000|COMPLETED|Overall Study||1223||
59781332|NCT00699699|75901939|FG000|NOT COMPLETED|Overall Study||57||
59781333|NCT00734474|75901952|FG000|STARTED|Overall Study||15||
59781334|NCT00734474|75901953|FG001|STARTED|Overall Study||30||
59781335|NCT00734474|75901954|FG002|STARTED|Overall Study||304||
59781336|NCT00734474|75901955|FG003|STARTED|Overall Study||10||
59781337|NCT00734474|75901956|FG004|STARTED|Overall Study||302||
59781338|NCT00734474|75901957|FG005|STARTED|Overall Study||25||
59781339|NCT00734474|75901958|FG006|STARTED|Overall Study||24||
59781340|NCT00734474|75901959|FG007|STARTED|Overall Study||315||
59781341|NCT00734474|75901960|FG008|STARTED|Overall Study||177||
59781342|NCT00734474|75901952|FG000|Received at Least 1 Dose of Study Drug|Overall Study||15||
59781343|NCT00734474|75901953|FG001|Received at Least 1 Dose of Study Drug|Overall Study||30||
59781344|NCT00734474|75901954|FG002|Received at Least 1 Dose of Study Drug|Overall Study||304||
59781345|NCT00734474|75901955|FG003|Received at Least 1 Dose of Study Drug|Overall Study||10||
59781346|NCT00734474|75901956|FG004|Received at Least 1 Dose of Study Drug|Overall Study||302||
59781347|NCT00734474|75901957|FG005|Received at Least 1 Dose of Study Drug|Overall Study||25||
59781348|NCT00734474|75901958|FG006|Received at Least 1 Dose of Study Drug|Overall Study||24||
59781349|NCT00734474|75901959|FG007|Received at Least 1 Dose of Study Drug|Overall Study||315||
59781350|NCT00734474|75901960|FG008|Received at Least 1 Dose of Study Drug|Overall Study||177||
59781351|NCT00734474|75901952|FG000|Entered Study Before Dose Decision Point|Overall Study||15||
59781352|NCT00734474|75901953|FG001|Entered Study Before Dose Decision Point|Overall Study||30||
59781353|NCT00734474|75901954|FG002|Entered Study Before Dose Decision Point|Overall Study||25||
59781354|NCT00734474|75901955|FG003|Entered Study Before Dose Decision Point|Overall Study||10||
59781355|NCT00734474|75901956|FG004|Entered Study Before Dose Decision Point|Overall Study||21||
59781356|NCT00734474|75901957|FG005|Entered Study Before Dose Decision Point|Overall Study||25||
59781357|NCT00734474|75901958|FG006|Entered Study Before Dose Decision Point|Overall Study||24||
59781358|NCT00734474|75901959|FG007|Entered Study Before Dose Decision Point|Overall Study||42||
59781359|NCT00734474|75901960|FG008|Entered Study Before Dose Decision Point|Overall Study||38||
59781360|NCT00734474|75901952|FG000|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|8||
59781361|NCT00734474|75901953|FG001|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|25||
59781362|NCT00734474|75901954|FG002|Completed Up to Dose Decision Point|Overall Study|These participants continued the study after the dose decision point (selected arm).|24||
59781363|NCT00734474|75901955|FG003|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|8||
59781364|NCT00734474|75901956|FG004|Completed Up to Dose Decision Point|Overall Study|These participants continued the study after the dose decision point (selected arm).|21||
59781365|NCT00734474|75901957|FG005|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|21||
59781366|NCT00734474|75901958|FG006|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|23||
59953024|NCT04057820|76071793|FG013|NOT COMPLETED|Period 1||0||0
59781367|NCT00734474|75901959|FG007|Completed Up to Dose Decision Point|Overall Study|These participants continued the study after the dose decision point (comparator arm).|42||
59781368|NCT00734474|75901960|FG008|Completed Up to Dose Decision Point|Overall Study|These participants continued the study after the dose decision point (comparator arm).|34||
59781369|NCT00734474|75901952|FG000|Entered Study After Dose Decision Point|Overall Study||0||
59781370|NCT00734474|75901953|FG001|Entered Study After Dose Decision Point|Overall Study||0||
59781371|NCT00734474|75901954|FG002|Entered Study After Dose Decision Point|Overall Study||279||
59781372|NCT00734474|75901955|FG003|Entered Study After Dose Decision Point|Overall Study||0||
59781373|NCT00734474|75901956|FG004|Entered Study After Dose Decision Point|Overall Study||281||
59781374|NCT00734474|75901957|FG005|Entered Study After Dose Decision Point|Overall Study||0||
59781375|NCT00734474|75901958|FG006|Entered Study After Dose Decision Point|Overall Study||0||
59781376|NCT00734474|75901959|FG007|Entered Study After Dose Decision Point|Overall Study||273||
59781377|NCT00734474|75901960|FG008|Entered Study After Dose Decision Point|Overall Study||139||
59781378|NCT00734474|75901952|FG000|Completed 26-Week Visit|Overall Study||0||
59781379|NCT00734474|75901953|FG001|Completed 26-Week Visit|Overall Study||0||
59781380|NCT00734474|75901954|FG002|Completed 26-Week Visit|Overall Study||258||
59781381|NCT00734474|75901955|FG003|Completed 26-Week Visit|Overall Study||2||
59781382|NCT00734474|75901956|FG004|Completed 26-Week Visit|Overall Study||268||
59781383|NCT00734474|75901957|FG005|Completed 26-Week Visit|Overall Study||2||
59781384|NCT00734474|75901958|FG006|Completed 26-Week Visit|Overall Study||2||
59781385|NCT00734474|75901959|FG007|Completed 26-Week Visit|Overall Study||270||
59781386|NCT00734474|75901960|FG008|Completed 26-Week Visit|Overall Study||124||
59781387|NCT00734474|75901952|FG000|Completed 52-Week Visit|Overall Study||0||
59781388|NCT00734474|75901953|FG001|Completed 52-Week Visit|Overall Study||0||
59781389|NCT00734474|75901954|FG002|Completed 52-Week Visit|Overall Study||238||
59781390|NCT00734474|75901955|FG003|Completed 52-Week Visit|Overall Study||0||
59781391|NCT00734474|75901956|FG004|Completed 52-Week Visit|Overall Study||243||
59781392|NCT00734474|75901957|FG005|Completed 52-Week Visit|Overall Study||0||
59781393|NCT00734474|75901958|FG006|Completed 52-Week Visit|Overall Study||0||
59781394|NCT00734474|75901959|FG007|Completed 52-Week Visit|Overall Study||238||
59781395|NCT00734474|75901960|FG008|Completed 52-Week Visit|Overall Study||112||
59781396|NCT00734474|75901952|FG000|COMPLETED|Overall Study||0||
59781397|NCT00734474|75901953|FG001|COMPLETED|Overall Study||0||
59781398|NCT00734474|75901954|FG002|COMPLETED|Overall Study||192||
59781399|NCT00734474|75901955|FG003|COMPLETED|Overall Study||0||
59781400|NCT00734474|75901956|FG004|COMPLETED|Overall Study||184||
59781401|NCT00734474|75901957|FG005|COMPLETED|Overall Study||0||
59781402|NCT00734474|75901958|FG006|COMPLETED|Overall Study||0||
59781403|NCT00734474|75901959|FG007|COMPLETED|Overall Study||186||
59781404|NCT00734474|75901960|FG008|COMPLETED|Overall Study||95||
59781405|NCT00734474|75901952|FG000|NOT COMPLETED|Overall Study||15||
59781406|NCT00734474|75901953|FG001|NOT COMPLETED|Overall Study||30||
59781407|NCT00734474|75901954|FG002|NOT COMPLETED|Overall Study||112||
59781408|NCT00734474|75901955|FG003|NOT COMPLETED|Overall Study||10||
59781409|NCT00734474|75901956|FG004|NOT COMPLETED|Overall Study||118||
59781410|NCT00734474|75901957|FG005|NOT COMPLETED|Overall Study||25||
59781411|NCT00734474|75901958|FG006|NOT COMPLETED|Overall Study||24||
59781412|NCT00734474|75901959|FG007|NOT COMPLETED|Overall Study||129||
59781413|NCT00734474|75901960|FG008|NOT COMPLETED|Overall Study||82||
59781414|NCT00583362|75901986|FG000|STARTED|Overall Study||298||
59781415|NCT00583362|75901986|FG000|COMPLETED|Overall Study||96||
59781416|NCT00583362|75901986|FG000|NOT COMPLETED|Overall Study||202||
59781417|NCT00577473|75901992|FG000|STARTED|Overall Study||154||
59781418|NCT00577473|75901993|FG001|STARTED|Overall Study||147||
59781419|NCT00577473|75901992|FG000|ITT Population|Overall Study||150||
59781420|NCT00577473|75901993|FG001|ITT Population|Overall Study||136||
59781421|NCT00577473|75901992|FG000|COMPLETED|Overall Study||133||
59781422|NCT00577473|75901993|FG001|COMPLETED|Overall Study||123||
59781423|NCT00577473|75901992|FG000|NOT COMPLETED|Overall Study||21||
59781424|NCT00577473|75901993|FG001|NOT COMPLETED|Overall Study||24||
59781425|NCT00785291|75902002|FG000|STARTED|Overall Study||283||
59781426|NCT00785291|75902003|FG001|STARTED|Overall Study||271||
59781427|NCT00785291|75902004|FG002|STARTED|Overall Study||245||
59781428|NCT00785291|75902002|FG000|COMPLETED|Overall Study||147||
59781429|NCT00785291|75902003|FG001|COMPLETED|Overall Study||122||
59781430|NCT00785291|75902004|FG002|COMPLETED|Overall Study||139||
59781431|NCT00785291|75902002|FG000|NOT COMPLETED|Overall Study||136||
59781432|NCT00785291|75902003|FG001|NOT COMPLETED|Overall Study||149||
59781433|NCT00785291|75902004|FG002|NOT COMPLETED|Overall Study||106||
59781434|NCT00705939|75902015|FG000|STARTED|Overall Study||12||
59781435|NCT00705939|75902016|FG001|STARTED|Overall Study||14||
59781436|NCT00705939|75902017|FG002|STARTED|Overall Study|1 subject enrolled but not treated in this protocol.|18||
59781437|NCT00705939|75902015|FG000|COMPLETED|Overall Study||12||
59781438|NCT00705939|75902016|FG001|COMPLETED|Overall Study||12||
59781439|NCT00705939|75902017|FG002|COMPLETED|Overall Study||14||
59781440|NCT00705939|75902015|FG000|NOT COMPLETED|Overall Study||0||
59781441|NCT00705939|75902016|FG001|NOT COMPLETED|Overall Study||2||
59781442|NCT00705939|75902017|FG002|NOT COMPLETED|Overall Study||4||
59781443|NCT00785213|75902026|FG000|STARTED|Rosiglitazone Alone||23||
59781444|NCT00785213|75902026|FG000|COMPLETED|Rosiglitazone Alone||23||
59781445|NCT00785213|75902026|FG000|NOT COMPLETED|Rosiglitazone Alone||0||
59781446|NCT00785213|75902026|FG000|STARTED|2 Day Washout Period||23||
59781447|NCT00785213|75902026|FG000|COMPLETED|2 Day Washout Period||23||
59781448|NCT00785213|75902026|FG000|NOT COMPLETED|2 Day Washout Period||0||
59781449|NCT00785213|75902026|FG000|STARTED|Quinine Sulfate Alone||23||
59781450|NCT00785213|75902026|FG000|COMPLETED|Quinine Sulfate Alone||19||
59781451|NCT00785213|75902026|FG000|NOT COMPLETED|Quinine Sulfate Alone||4||
59781452|NCT00785213|75902026|FG000|STARTED|Rosiglitazone With Quinine Sulfate||19||
59781453|NCT00785213|75902026|FG000|COMPLETED|Rosiglitazone With Quinine Sulfate||18||
59781454|NCT00785213|75902026|FG000|NOT COMPLETED|Rosiglitazone With Quinine Sulfate||1||
59781455|NCT00577317|75902035|FG000|STARTED|Overall Study||0||
59781456|NCT00577317|75902036|FG001|STARTED|Overall Study||2||
59781457|NCT00577317|75902035|FG000|COMPLETED|Overall Study||0||
59781458|NCT00577317|75902036|FG001|COMPLETED|Overall Study||0||
59781459|NCT00577317|75902035|FG000|NOT COMPLETED|Overall Study||0||
59781460|NCT00577317|75902036|FG001|NOT COMPLETED|Overall Study||2||
59781461|NCT00734162|75902046|FG000|STARTED|Randomized Phase (Through Week 72)||10||
59781462|NCT00734162|75902047|FG001|STARTED|Randomized Phase (Through Week 72)||42||
59781463|NCT00734162|75902048|FG002|STARTED|Randomized Phase (Through Week 72)||13||
59781464|NCT00734162|75902049|FG003|STARTED|Randomized Phase (Through Week 72)||41||
59781465|NCT00734162|75902046|FG000|COMPLETED|Randomized Phase (Through Week 72)||10||
59781466|NCT00734162|75902047|FG001|COMPLETED|Randomized Phase (Through Week 72)||41||
59781467|NCT00734162|75902048|FG002|COMPLETED|Randomized Phase (Through Week 72)||13||
59781468|NCT00734162|75902049|FG003|COMPLETED|Randomized Phase (Through Week 72)||37||
59781469|NCT00734162|75902046|FG000|NOT COMPLETED|Randomized Phase (Through Week 72)||0||
59781470|NCT00734162|75902047|FG001|NOT COMPLETED|Randomized Phase (Through Week 72)||1||
59781471|NCT00734162|75902048|FG002|NOT COMPLETED|Randomized Phase (Through Week 72)||0||
59781472|NCT00734162|75902049|FG003|NOT COMPLETED|Randomized Phase (Through Week 72)||4||
59781473|NCT00734162|75902046|FG000|STARTED|Open-Label Phase||10||
59781474|NCT00734162|75902047|FG001|STARTED|Open-Label Phase||41||
59781475|NCT00734162|75902048|FG002|STARTED|Open-Label Phase||13||
59781476|NCT00734162|75902049|FG003|STARTED|Open-Label Phase|2 participants switched to open-label treatment before completing double-blind period (elevated ALT)|39||
59781477|NCT00734162|75902046|FG000|COMPLETED|Open-Label Phase||7||
59781478|NCT00734162|75902047|FG001|COMPLETED|Open-Label Phase||39||
59781479|NCT00734162|75902048|FG002|COMPLETED|Open-Label Phase||12||
59781480|NCT00734162|75902049|FG003|COMPLETED|Open-Label Phase||36||
59781481|NCT00734162|75902046|FG000|NOT COMPLETED|Open-Label Phase||3||
59781482|NCT00734162|75902047|FG001|NOT COMPLETED|Open-Label Phase||2||
59781483|NCT00734162|75902048|FG002|NOT COMPLETED|Open-Label Phase||1||
59781484|NCT00734162|75902049|FG003|NOT COMPLETED|Open-Label Phase||3||
59781485|NCT00790751|75902067|FG000|STARTED|Overall Study||162||
59781486|NCT00790751|75902068|FG001|STARTED|Overall Study||161||
59781487|NCT00790751|75902069|FG002|STARTED|Overall Study||161||
59781488|NCT00790751|75902070|FG003|STARTED|Overall Study||162||
59781489|NCT00790751|75902067|FG000|COMPLETED|Overall Study||137||
59781490|NCT00790751|75902068|FG001|COMPLETED|Overall Study||131||
59781491|NCT00790751|75902069|FG002|COMPLETED|Overall Study||141||
59781492|NCT00790751|75902070|FG003|COMPLETED|Overall Study||141||
59781493|NCT00790751|75902067|FG000|NOT COMPLETED|Overall Study||25||
59781494|NCT00790751|75902068|FG001|NOT COMPLETED|Overall Study||30||
59781495|NCT00790751|75902069|FG002|NOT COMPLETED|Overall Study||20||
59781496|NCT00790751|75902070|FG003|NOT COMPLETED|Overall Study||21||
59781497|NCT00784979|75902080|FG000|STARTED|Overall Study||26||
59781498|NCT00784979|75902080|FG000|COMPLETED|Overall Study||20||
59781499|NCT00784979|75902080|FG000|NOT COMPLETED|Overall Study||6||
59781500|NCT00738920|75902087|FG000|STARTED|Baseline to 2-Week Follow-Up||145||
59781501|NCT00738920|75902088|FG001|STARTED|Baseline to 2-Week Follow-Up||146||
59781502|NCT00738920|75902089|FG002|STARTED|Baseline to 2-Week Follow-Up||145||
59781503|NCT00738920|75902087|FG000|COMPLETED|Baseline to 2-Week Follow-Up||129||
59781504|NCT00738920|75902088|FG001|COMPLETED|Baseline to 2-Week Follow-Up||123||
59781505|NCT00738920|75902089|FG002|COMPLETED|Baseline to 2-Week Follow-Up||130||
59781506|NCT00738920|75902087|FG000|NOT COMPLETED|Baseline to 2-Week Follow-Up||16||
59781507|NCT00738920|75902088|FG001|NOT COMPLETED|Baseline to 2-Week Follow-Up||23||
59781508|NCT00738920|75902089|FG002|NOT COMPLETED|Baseline to 2-Week Follow-Up||15||
59781509|NCT00738920|75902087|FG000|STARTED|2-Week Follow-Up to 3-Month Follow-Up||129||
59781510|NCT00738920|75902088|FG001|STARTED|2-Week Follow-Up to 3-Month Follow-Up||123||
59781511|NCT00738920|75902089|FG002|STARTED|2-Week Follow-Up to 3-Month Follow-Up||130||
59781512|NCT00738920|75902087|FG000|COMPLETED|2-Week Follow-Up to 3-Month Follow-Up||121||
59781513|NCT00738920|75902088|FG001|COMPLETED|2-Week Follow-Up to 3-Month Follow-Up||111||
59781514|NCT00738920|75902089|FG002|COMPLETED|2-Week Follow-Up to 3-Month Follow-Up||118||
59781515|NCT00738920|75902087|FG000|NOT COMPLETED|2-Week Follow-Up to 3-Month Follow-Up||8||
59781516|NCT00738920|75902088|FG001|NOT COMPLETED|2-Week Follow-Up to 3-Month Follow-Up||12||
59781517|NCT00738920|75902089|FG002|NOT COMPLETED|2-Week Follow-Up to 3-Month Follow-Up||12||
59781518|NCT00738920|75902087|FG000|STARTED|3-Month Follow-Up to 6-Month Follow-Up||121||
59781519|NCT00738920|75902088|FG001|STARTED|3-Month Follow-Up to 6-Month Follow-Up||111||
59781520|NCT00738920|75902089|FG002|STARTED|3-Month Follow-Up to 6-Month Follow-Up||118||
59781521|NCT00738920|75902087|FG000|COMPLETED|3-Month Follow-Up to 6-Month Follow-Up||117||
59781522|NCT00738920|75902088|FG001|COMPLETED|3-Month Follow-Up to 6-Month Follow-Up||111||
59781523|NCT00738920|75902089|FG002|COMPLETED|3-Month Follow-Up to 6-Month Follow-Up||115||
59781524|NCT00738920|75902087|FG000|NOT COMPLETED|3-Month Follow-Up to 6-Month Follow-Up||4||
59781525|NCT00738920|75902088|FG001|NOT COMPLETED|3-Month Follow-Up to 6-Month Follow-Up||0||
59781526|NCT00738920|75902089|FG002|NOT COMPLETED|3-Month Follow-Up to 6-Month Follow-Up||3||
59781527|NCT00738920|75902087|FG000|STARTED|6-Month Follow-Up to 9-Month Follow-Up||117||
59781528|NCT00738920|75902088|FG001|STARTED|6-Month Follow-Up to 9-Month Follow-Up||111||
59781529|NCT00738920|75902089|FG002|STARTED|6-Month Follow-Up to 9-Month Follow-Up||115||
59781530|NCT00738920|75902087|FG000|COMPLETED|6-Month Follow-Up to 9-Month Follow-Up||113||
59781531|NCT00738920|75902088|FG001|COMPLETED|6-Month Follow-Up to 9-Month Follow-Up||104||
59781532|NCT00738920|75902089|FG002|COMPLETED|6-Month Follow-Up to 9-Month Follow-Up||103||
59781533|NCT00738920|75902087|FG000|NOT COMPLETED|6-Month Follow-Up to 9-Month Follow-Up||4||
59781534|NCT00738920|75902088|FG001|NOT COMPLETED|6-Month Follow-Up to 9-Month Follow-Up||7||
59781535|NCT00738920|75902089|FG002|NOT COMPLETED|6-Month Follow-Up to 9-Month Follow-Up||12||
59781536|NCT00738920|75902087|FG000|STARTED|9-Month Follow-Up to 12-Month Follow-Up||113||
59781537|NCT00738920|75902088|FG001|STARTED|9-Month Follow-Up to 12-Month Follow-Up||104||
59781538|NCT00738920|75902089|FG002|STARTED|9-Month Follow-Up to 12-Month Follow-Up||103||
59781539|NCT00738920|75902087|FG000|COMPLETED|9-Month Follow-Up to 12-Month Follow-Up||112||
59781540|NCT00738920|75902088|FG001|COMPLETED|9-Month Follow-Up to 12-Month Follow-Up||103||
59781541|NCT00738920|75902089|FG002|COMPLETED|9-Month Follow-Up to 12-Month Follow-Up||102||
59781542|NCT00738920|75902087|FG000|NOT COMPLETED|9-Month Follow-Up to 12-Month Follow-Up||1||
59781543|NCT00738920|75902088|FG001|NOT COMPLETED|9-Month Follow-Up to 12-Month Follow-Up||1||
59781544|NCT00738920|75902089|FG002|NOT COMPLETED|9-Month Follow-Up to 12-Month Follow-Up||1||
59781545|NCT00582972|75902097|FG000|STARTED|Overall Study||23||
59781546|NCT00582972|75902097|FG000|COMPLETED|Overall Study||21||
59781547|NCT00582972|75902097|FG000|NOT COMPLETED|Overall Study||2||
59781548|NCT04319718|75902104|FG000|STARTED|Overall Study||25||
59781549|NCT04319718|75902105|FG001|STARTED|Overall Study||12||
59781550|NCT04319718|75902104|FG000|COMPLETED|Overall Study||24||
59781551|NCT04319718|75902105|FG001|COMPLETED|Overall Study||10||
59781552|NCT04319718|75902104|FG000|NOT COMPLETED|Overall Study||1||
59781553|NCT04319718|75902105|FG001|NOT COMPLETED|Overall Study||2||
59781554|NCT04372602|75902113|FG000|STARTED|Overall Study||15||
59781555|NCT04372602|75902114|FG001|STARTED|Overall Study||13||
59781556|NCT04372602|75902113|FG000|COMPLETED|Overall Study||14||
59781557|NCT04372602|75902114|FG001|COMPLETED|Overall Study||10||
59781558|NCT04372602|75902113|FG000|NOT COMPLETED|Overall Study||1||
59781559|NCT04372602|75902114|FG001|NOT COMPLETED|Overall Study||3||
59781560|NCT00733304|75902123|FG000|STARTED|Overall Study||19||
59781561|NCT00733304|75902124|FG001|STARTED|Overall Study||15||
59781562|NCT00733304|75902125|FG002|STARTED|Overall Study||8||
59781563|NCT00733304|75902123|FG000|COMPLETED|Overall Study||12||
59781564|NCT00733304|75902124|FG001|COMPLETED|Overall Study||12||
59781565|NCT00733304|75902125|FG002|COMPLETED|Overall Study||3||
59781566|NCT00733304|75902123|FG000|NOT COMPLETED|Overall Study||7||
59781567|NCT00733304|75902124|FG001|NOT COMPLETED|Overall Study||3||
59781568|NCT00733304|75902125|FG002|NOT COMPLETED|Overall Study||5||
59781569|NCT00711243|75902139|FG000|STARTED|Registed and Started Treatment||3||
59781570|NCT00711243|75902140|FG001|STARTED|Registed and Started Treatment||3||
59781571|NCT00711243|75902141|FG002|STARTED|Registed and Started Treatment||3||
59781572|NCT00711243|75902142|FG003|STARTED|Registed and Started Treatment||3||
59781573|NCT00711243|75902143|FG004|STARTED|Registed and Started Treatment||3||
59781574|NCT00711243|75902144|FG005|STARTED|Registed and Started Treatment||44||
59781575|NCT00711243|75902139|FG000|Registered to Study|Registed and Started Treatment||3||
59781576|NCT00711243|75902140|FG001|Registered to Study|Registed and Started Treatment||3||
59781577|NCT00711243|75902141|FG002|Registered to Study|Registed and Started Treatment||3||
59781578|NCT00711243|75902142|FG003|Registered to Study|Registed and Started Treatment||3||
59781579|NCT00711243|75902143|FG004|Registered to Study|Registed and Started Treatment||3||
59781580|NCT00711243|75902144|FG005|Registered to Study|Registed and Started Treatment||44||
59781581|NCT00711243|75902139|FG000|Started Treatment|Registed and Started Treatment||3||
59781582|NCT00711243|75902140|FG001|Started Treatment|Registed and Started Treatment||3||
59781583|NCT00711243|75902141|FG002|Started Treatment|Registed and Started Treatment||3||
59781584|NCT00711243|75902142|FG003|Started Treatment|Registed and Started Treatment||3||
59781585|NCT00711243|75902143|FG004|Started Treatment|Registed and Started Treatment||3||
59781586|NCT00711243|75902144|FG005|Started Treatment|Registed and Started Treatment||43||
59781587|NCT00711243|75902139|FG000|COMPLETED|Registed and Started Treatment||3||
59781588|NCT00711243|75902140|FG001|COMPLETED|Registed and Started Treatment||3||
59781589|NCT00711243|75902141|FG002|COMPLETED|Registed and Started Treatment||3||
59781590|NCT00711243|75902142|FG003|COMPLETED|Registed and Started Treatment||3||
59781591|NCT00711243|75902143|FG004|COMPLETED|Registed and Started Treatment||3||
59781592|NCT00711243|75902144|FG005|COMPLETED|Registed and Started Treatment||43||
59781593|NCT00711243|75902139|FG000|NOT COMPLETED|Registed and Started Treatment||0||
59781594|NCT00711243|75902140|FG001|NOT COMPLETED|Registed and Started Treatment||0||
59781595|NCT00711243|75902141|FG002|NOT COMPLETED|Registed and Started Treatment||0||
59781596|NCT00711243|75902142|FG003|NOT COMPLETED|Registed and Started Treatment||0||
59781597|NCT00711243|75902143|FG004|NOT COMPLETED|Registed and Started Treatment||0||
59781598|NCT00711243|75902144|FG005|NOT COMPLETED|Registed and Started Treatment||1||
59781599|NCT00711243|75902139|FG000|STARTED|Reached First Response/4 Cycles||3||
59781600|NCT00711243|75902140|FG001|STARTED|Reached First Response/4 Cycles||3||
59781601|NCT00711243|75902141|FG002|STARTED|Reached First Response/4 Cycles||3||
59781602|NCT00711243|75902142|FG003|STARTED|Reached First Response/4 Cycles||3||
59781603|NCT00711243|75902143|FG004|STARTED|Reached First Response/4 Cycles||3||
59781604|NCT00711243|75902144|FG005|STARTED|Reached First Response/4 Cycles||43||
59781605|NCT00711243|75902139|FG000|COMPLETED|Reached First Response/4 Cycles||3||
59781606|NCT00711243|75902140|FG001|COMPLETED|Reached First Response/4 Cycles||3||
59781607|NCT00711243|75902141|FG002|COMPLETED|Reached First Response/4 Cycles||3||
59781608|NCT00711243|75902142|FG003|COMPLETED|Reached First Response/4 Cycles||2||
59781609|NCT00711243|75902143|FG004|COMPLETED|Reached First Response/4 Cycles||3||
59781610|NCT00711243|75902144|FG005|COMPLETED|Reached First Response/4 Cycles||41||
59781611|NCT00711243|75902139|FG000|NOT COMPLETED|Reached First Response/4 Cycles||0||
59781612|NCT00711243|75902140|FG001|NOT COMPLETED|Reached First Response/4 Cycles||0||
59781613|NCT00711243|75902141|FG002|NOT COMPLETED|Reached First Response/4 Cycles||0||
59781614|NCT00711243|75902142|FG003|NOT COMPLETED|Reached First Response/4 Cycles||1||
59781615|NCT00711243|75902143|FG004|NOT COMPLETED|Reached First Response/4 Cycles||0||
59781616|NCT00711243|75902144|FG005|NOT COMPLETED|Reached First Response/4 Cycles||2||
59781617|NCT00711243|75902139|FG000|STARTED|Treated Cycle 5 After First Response||3||
59781618|NCT00711243|75902140|FG001|STARTED|Treated Cycle 5 After First Response||3||
59781619|NCT00711243|75902141|FG002|STARTED|Treated Cycle 5 After First Response||3||
59781620|NCT00711243|75902142|FG003|STARTED|Treated Cycle 5 After First Response||2||
59781621|NCT00711243|75902143|FG004|STARTED|Treated Cycle 5 After First Response||3||
59781622|NCT00711243|75902144|FG005|STARTED|Treated Cycle 5 After First Response||41||
59781623|NCT00711243|75902139|FG000|COMPLETED|Treated Cycle 5 After First Response||2||
59781624|NCT00711243|75902140|FG001|COMPLETED|Treated Cycle 5 After First Response||1||
59781625|NCT00711243|75902141|FG002|COMPLETED|Treated Cycle 5 After First Response||3||
59781626|NCT00711243|75902142|FG003|COMPLETED|Treated Cycle 5 After First Response||2||
59781627|NCT00711243|75902143|FG004|COMPLETED|Treated Cycle 5 After First Response||2||
59781628|NCT00711243|75902144|FG005|COMPLETED|Treated Cycle 5 After First Response||37||
59781629|NCT00711243|75902139|FG000|NOT COMPLETED|Treated Cycle 5 After First Response||1||
59781630|NCT00711243|75902140|FG001|NOT COMPLETED|Treated Cycle 5 After First Response||2||
59781631|NCT00711243|75902141|FG002|NOT COMPLETED|Treated Cycle 5 After First Response||0||
59781632|NCT00711243|75902142|FG003|NOT COMPLETED|Treated Cycle 5 After First Response||0||
59781633|NCT00711243|75902143|FG004|NOT COMPLETED|Treated Cycle 5 After First Response||1||
59781634|NCT00711243|75902144|FG005|NOT COMPLETED|Treated Cycle 5 After First Response||4||
59781635|NCT00711243|75902139|FG000|STARTED|Follow up Every 3 Months Until Death||3|All patients that are treated on study go into follow up|
59781636|NCT00711243|75902140|FG001|STARTED|Follow up Every 3 Months Until Death||3|All patients that are treated on study go into follow up|
59781637|NCT00711243|75902141|FG002|STARTED|Follow up Every 3 Months Until Death||3|All patients that are treated on study go into follow up|
59781638|NCT00711243|75902142|FG003|STARTED|Follow up Every 3 Months Until Death||3|All patients that are treated on study go into follow up|
59781639|NCT00711243|75902143|FG004|STARTED|Follow up Every 3 Months Until Death||3|All patients that are treated on study go into follow up|
59781640|NCT00711243|75902144|FG005|STARTED|Follow up Every 3 Months Until Death|4 patients died whilst on study and 1 patient did not get treated on study|39|All patients that are treated on study go into follow up|
59781641|NCT00711243|75902139|FG000|COMPLETED|Follow up Every 3 Months Until Death||3||
59781642|NCT00711243|75902140|FG001|COMPLETED|Follow up Every 3 Months Until Death||3||
59781643|NCT00711243|75902141|FG002|COMPLETED|Follow up Every 3 Months Until Death||3||
59781644|NCT00711243|75902142|FG003|COMPLETED|Follow up Every 3 Months Until Death||3||
59781645|NCT00711243|75902143|FG004|COMPLETED|Follow up Every 3 Months Until Death||3||
59781646|NCT00711243|75902144|FG005|COMPLETED|Follow up Every 3 Months Until Death||37||
59781647|NCT00711243|75902139|FG000|NOT COMPLETED|Follow up Every 3 Months Until Death||0||
59781648|NCT00711243|75902140|FG001|NOT COMPLETED|Follow up Every 3 Months Until Death||0||
59781649|NCT00711243|75902141|FG002|NOT COMPLETED|Follow up Every 3 Months Until Death||0||
59781650|NCT00711243|75902142|FG003|NOT COMPLETED|Follow up Every 3 Months Until Death||0||
59781651|NCT00711243|75902143|FG004|NOT COMPLETED|Follow up Every 3 Months Until Death||0||
59781652|NCT00711243|75902144|FG005|NOT COMPLETED|Follow up Every 3 Months Until Death||2||
59781653|NCT00733226|75902162|FG000|STARTED|Overall Study||40||
59781654|NCT00733226|75902163|FG001|STARTED|Overall Study||40||
59522331|NCT01143883|75616718|FG000|STARTED|Overall Study||55||
59522332|NCT01143883|75616719|FG001|STARTED|Overall Study||55||
59522333|NCT01143883|75616718|FG000|COMPLETED|Overall Study||55||
59522334|NCT01143883|75616719|FG001|COMPLETED|Overall Study||55||
59522335|NCT01143883|75616718|FG000|NOT COMPLETED|Overall Study||0||
59522336|NCT01143883|75616719|FG001|NOT COMPLETED|Overall Study||0||
59781655|NCT00733226|75902162|FG000|COMPLETED|Overall Study||35||
59781656|NCT00733226|75902163|FG001|COMPLETED|Overall Study||40||
59781657|NCT00733226|75902162|FG000|NOT COMPLETED|Overall Study||5||
59781658|NCT00733226|75902163|FG001|NOT COMPLETED|Overall Study||0||
59781659|NCT00732992|75902171|FG000|STARTED|Overall Study||6||
59781660|NCT00732992|75902172|FG001|STARTED|Overall Study||6||
59781661|NCT00732992|75902171|FG000|COMPLETED|Overall Study||0||
59781662|NCT00732992|75902172|FG001|COMPLETED|Overall Study||0||
59781663|NCT00732992|75902171|FG000|NOT COMPLETED|Overall Study||6||
59781664|NCT00732992|75902172|FG001|NOT COMPLETED|Overall Study||6||
59781665|NCT00732758|75902181|FG000|STARTED|Overall Study||78||
59781666|NCT00732758|75902182|FG001|STARTED|Overall Study||79||
59781667|NCT00732758|75902181|FG000|COMPLETED|Overall Study||70||
59781668|NCT00732758|75902182|FG001|COMPLETED|Overall Study||63||
59781669|NCT00732758|75902181|FG000|NOT COMPLETED|Overall Study||8||
59781670|NCT00732758|75902182|FG001|NOT COMPLETED|Overall Study||16||
59781671|NCT00699153|75902190|FG000|STARTED|Overall Study|Intent to treat population|203||
59781672|NCT00699153|75902191|FG001|STARTED|Overall Study|Intent to treat population|202||
59781673|NCT00699153|75902190|FG000|COMPLETED|Overall Study||200||
59781674|NCT00699153|75902191|FG001|COMPLETED|Overall Study||200||
59781675|NCT00699153|75902190|FG000|NOT COMPLETED|Overall Study||3||
59781676|NCT00699153|75902191|FG001|NOT COMPLETED|Overall Study||2||
59781677|NCT00698997|75902199|FG000|STARTED|Overall Study|1 enrollment|55||
59781678|NCT00698997|75902200|FG001|STARTED|Overall Study|1 enrollment|63||
59781679|NCT00698997|75902199|FG000|COMPLETED|Overall Study|45 - final participant assessment completed|45||
59781680|NCT00698997|75902200|FG001|COMPLETED|Overall Study|36 - final assessment completed|36||
59781681|NCT00698997|75902199|FG000|NOT COMPLETED|Overall Study||10||
59781682|NCT00698997|75902200|FG001|NOT COMPLETED|Overall Study||27||
59781683|NCT00711087|75902209|FG000|STARTED|Overall Study||1||
59781684|NCT00711087|75902210|FG001|STARTED|Overall Study||0||
59781685|NCT00711087|75902209|FG000|COMPLETED|Overall Study||0||
59781686|NCT00711087|75902210|FG001|COMPLETED|Overall Study||0||
59781687|NCT00711087|75902209|FG000|NOT COMPLETED|Overall Study||1||
59781688|NCT00711087|75902210|FG001|NOT COMPLETED|Overall Study||0||
59781689|NCT00738530|75902218|FG000|STARTED|Overall Study||327||
59781690|NCT00738530|75902219|FG001|STARTED|Overall Study||322||
59781691|NCT00738530|75902218|FG000|Treated|Overall Study||325||
59781692|NCT00738530|75902219|FG001|Treated|Overall Study||316||
59781693|NCT00738530|75902218|FG000|COMPLETED|Overall Study||93||
59781694|NCT00738530|75902219|FG001|COMPLETED|Overall Study||84||
59781695|NCT00738530|75902218|FG000|NOT COMPLETED|Overall Study||234||
59781696|NCT00738530|75902219|FG001|NOT COMPLETED|Overall Study||238||
59781697|NCT00711009|75902227|FG000|STARTED|Overall Study||105||
59781698|NCT00711009|75902228|FG001|STARTED|Overall Study||101||
59781699|NCT00711009|75902227|FG000|COMPLETED|Overall Study||90||
59781700|NCT00711009|75902228|FG001|COMPLETED|Overall Study||82||
59781701|NCT00711009|75902227|FG000|NOT COMPLETED|Overall Study||15||
59781702|NCT00711009|75902228|FG001|NOT COMPLETED|Overall Study||19||
59781703|NCT00577005|75902236|FG000|STARTED|Overall Study||16||
59781704|NCT00577005|75902237|FG001|STARTED|Overall Study||12||
59781705|NCT00577005|75902236|FG000|COMPLETED|Overall Study||11||
59781706|NCT00577005|75902237|FG001|COMPLETED|Overall Study||9||
59781707|NCT00577005|75902236|FG000|NOT COMPLETED|Overall Study||5||
59781708|NCT00577005|75902237|FG001|NOT COMPLETED|Overall Study||3||
59781709|NCT00576927|75902248|FG000|STARTED|Clinical Assessment||79||
59781710|NCT00576927|75902248|FG000|COMPLETED|Clinical Assessment||43||
59781711|NCT00576927|75902248|FG000|NOT COMPLETED|Clinical Assessment||36||
59781712|NCT00576927|75902248|FG000|STARTED|Baseline||43||
59781713|NCT00576927|75902248|FG000|COMPLETED|Baseline||30||
59781714|NCT00576927|75902248|FG000|NOT COMPLETED|Baseline||13||
59781715|NCT00576927|75902248|FG000|STARTED|Sleep Hygiene Behavioral Intervention||30||
59781716|NCT00576927|75902248|FG000|COMPLETED|Sleep Hygiene Behavioral Intervention||23||
59781717|NCT00576927|75902248|FG000|NOT COMPLETED|Sleep Hygiene Behavioral Intervention||7||
59953025|NCT04057820|76071794|FG014|NOT COMPLETED|Period 1||0||0
59953026|NCT04057820|76071795|FG015|NOT COMPLETED|Period 1||0||0
59781718|NCT00576927|75902248|FG000|STARTED|Sleep Hygiene With the Placebo||23||
59781719|NCT00576927|75902248|FG000|COMPLETED|Sleep Hygiene With the Placebo||22||
59781720|NCT00576927|75902248|FG000|NOT COMPLETED|Sleep Hygiene With the Placebo||1||
59781721|NCT00576927|75902248|FG000|STARTED|Sleep Hygiene With Study Drug||22||
59995477|NCT02152995|76111310|FG001|COMPLETED|Overall Study||9||
59781722|NCT00576927|75902248|FG000|COMPLETED|Sleep Hygiene With Study Drug||22||
59781723|NCT00576927|75902248|FG000|NOT COMPLETED|Sleep Hygiene With Study Drug||0||
59781724|NCT00576927|75902248|FG000|STARTED|Randomization 1:1 Placebo or Active Drug||22||
59781725|NCT00576927|75902248|FG000|COMPLETED|Randomization 1:1 Placebo or Active Drug||22||
59781726|NCT00576927|75902248|FG000|NOT COMPLETED|Randomization 1:1 Placebo or Active Drug||0||
59781727|NCT00698841|75902254|FG000|STARTED|Overall Study||51||
59781728|NCT00698841|75902254|FG000|COMPLETED|Overall Study||33||
59781729|NCT00698841|75902254|FG000|NOT COMPLETED|Overall Study||18||
59781730|NCT00577395|75902260|FG000|STARTED|Overall Study|67 planned for Treatment 2, but due to enrollment difficulties this was not met.|7||
59781731|NCT00577395|75902261|FG001|STARTED|Overall Study|67 were planned for Treatment 1, but due to enrollment difficulties this was not met.|6||
59781732|NCT00577395|75902260|FG000|COMPLETED|Overall Study|The study was terminated early by the Sponsor for lack of enrollment|0||
59781733|NCT00577395|75902261|FG001|COMPLETED|Overall Study|The study was terminated early by the Sponsor for lack of enrollment|0||
59781734|NCT00577395|75902260|FG000|NOT COMPLETED|Overall Study||7||
59781735|NCT00577395|75902261|FG001|NOT COMPLETED|Overall Study||6||
59781736|NCT00738374|75902270|FG000|STARTED|Induction Treatment Phase||97||
59781737|NCT00738374|75902271|FG001|STARTED|Induction Treatment Phase||0||
59781738|NCT00738374|75902272|FG002|STARTED|Induction Treatment Phase|Participants were randomized at the end of the Induction Treatment Phase.|0||
59781739|NCT00738374|75902273|FG003|STARTED|Induction Treatment Phase|Participants were randomized at the end of the Induction Treatment Phase.|0||
59781740|NCT00738374|75902270|FG000|COMPLETED|Induction Treatment Phase||73||
59781741|NCT00738374|75902271|FG001|COMPLETED|Induction Treatment Phase||0||
59781742|NCT00738374|75902272|FG002|COMPLETED|Induction Treatment Phase||0||
59781743|NCT00738374|75902273|FG003|COMPLETED|Induction Treatment Phase||0||
59781744|NCT00738374|75902270|FG000|NOT COMPLETED|Induction Treatment Phase||24||
59781745|NCT00738374|75902271|FG001|NOT COMPLETED|Induction Treatment Phase||0||
59781746|NCT00738374|75902272|FG002|NOT COMPLETED|Induction Treatment Phase||0||
59781747|NCT00738374|75902273|FG003|NOT COMPLETED|Induction Treatment Phase||0||
59781748|NCT00738374|75902270|FG000|STARTED|Maintenance Treatment/Observation Phase|Participants were randomized to either maintenance therapy or observation at the end of induction.|0||
59781749|NCT00738374|75902271|FG001|STARTED|Maintenance Treatment/Observation Phase||7||
59781750|NCT00738374|75902272|FG002|STARTED|Maintenance Treatment/Observation Phase||34||
59781751|NCT00738374|75902273|FG003|STARTED|Maintenance Treatment/Observation Phase||32||
59781752|NCT00738374|75902270|FG000|COMPLETED|Maintenance Treatment/Observation Phase||0||
59781753|NCT00738374|75902271|FG001|COMPLETED|Maintenance Treatment/Observation Phase||0||
59781754|NCT00738374|75902272|FG002|COMPLETED|Maintenance Treatment/Observation Phase||27||
59781755|NCT00738374|75902273|FG003|COMPLETED|Maintenance Treatment/Observation Phase||20||
59781756|NCT00738374|75902270|FG000|NOT COMPLETED|Maintenance Treatment/Observation Phase||0||
59781757|NCT00738374|75902271|FG001|NOT COMPLETED|Maintenance Treatment/Observation Phase||7||
59781758|NCT00738374|75902272|FG002|NOT COMPLETED|Maintenance Treatment/Observation Phase||7||
59781759|NCT00738374|75902273|FG003|NOT COMPLETED|Maintenance Treatment/Observation Phase||12||
59781760|NCT00697593|75902282|FG000|STARTED|Overall Study||70||
59781761|NCT00697593|75902282|FG000|COMPLETED|Overall Study||51||
59781762|NCT00697593|75902282|FG000|NOT COMPLETED|Overall Study||19||
59781763|NCT00697515|75902286|FG000|STARTED|Dose Optimization Period||142||
59781764|NCT00697515|75902287|FG001|STARTED|Dose Optimization Period||0||
59781765|NCT00697515|75902286|FG000|COMPLETED|Dose Optimization Period||127||
59781766|NCT00697515|75902287|FG001|COMPLETED|Dose Optimization Period||0||
59781767|NCT00697515|75902286|FG000|NOT COMPLETED|Dose Optimization Period||15||
59781768|NCT00697515|75902287|FG001|NOT COMPLETED|Dose Optimization Period||0||
59781769|NCT00697515|75902286|FG000|STARTED|First Intervention (Crossover Period)||63||
59781770|NCT00697515|75902287|FG001|STARTED|First Intervention (Crossover Period)||64||
59781771|NCT00697515|75902286|FG000|COMPLETED|First Intervention (Crossover Period)||53||
59781772|NCT00697515|75902287|FG001|COMPLETED|First Intervention (Crossover Period)||52||
59781773|NCT00697515|75902286|FG000|NOT COMPLETED|First Intervention (Crossover Period)||10||
59781774|NCT00697515|75902287|FG001|NOT COMPLETED|First Intervention (Crossover Period)||12||
59781775|NCT00697515|75902286|FG000|STARTED|Second Intervention (Crossover Period)||53||
59781776|NCT00697515|75902287|FG001|STARTED|Second Intervention (Crossover Period)||52||
59781777|NCT00697515|75902286|FG000|COMPLETED|Second Intervention (Crossover Period)||52||
59781778|NCT00697515|75902287|FG001|COMPLETED|Second Intervention (Crossover Period)||51||
59781779|NCT00697515|75902286|FG000|NOT COMPLETED|Second Intervention (Crossover Period)||1||
59781780|NCT00697515|75902287|FG001|NOT COMPLETED|Second Intervention (Crossover Period)||1||
59781781|NCT00738062|75902296|FG000|STARTED|Open Label Treatment||103||
59781782|NCT00738062|75902297|FG001|STARTED|Open Label Treatment||0||
59781783|NCT00738062|75902298|FG002|STARTED|Open Label Treatment||0||
59781784|NCT00738062|75902296|FG000|COMPLETED|Open Label Treatment||75||
59781785|NCT00738062|75902297|FG001|COMPLETED|Open Label Treatment||0||
59781786|NCT00738062|75902298|FG002|COMPLETED|Open Label Treatment||0||
59781787|NCT00738062|75902296|FG000|NOT COMPLETED|Open Label Treatment||28||
59781788|NCT00738062|75902297|FG001|NOT COMPLETED|Open Label Treatment||0||
59781789|NCT00738062|75902298|FG002|NOT COMPLETED|Open Label Treatment||0||
59781790|NCT00738062|75902296|FG000|STARTED|2 Week Randomized Withdrawal|Patients completing the open label titration phase were randomized to either Droxidopa or Placebo|0||
59781791|NCT00738062|75902297|FG001|STARTED|2 Week Randomized Withdrawal||38||
59781792|NCT00738062|75902298|FG002|STARTED|2 Week Randomized Withdrawal||37||
59781793|NCT00738062|75902296|FG000|COMPLETED|2 Week Randomized Withdrawal||0||
60073011|NCT01695135|76188204|FG002|NOT COMPLETED|Open Label Extension Treatment Phase||40||
60073012|NCT01695135|76188205|FG003|NOT COMPLETED|Open Label Extension Treatment Phase||70||
60073013|NCT01610414|76188215|FG000|STARTED|Study Start - Month 13||922||
60073014|NCT01610414|76188216|FG001|STARTED|Study Start - Month 13||924||
60073015|NCT01610414|76188215|FG000|COMPLETED|Study Start - Month 13||807||
60073016|NCT01610414|76188216|FG001|COMPLETED|Study Start - Month 13||795||
60073017|NCT01610414|76188215|FG000|NOT COMPLETED|Study Start - Month 13||115||
60073018|NCT01610414|76188216|FG001|NOT COMPLETED|Study Start - Month 13||129||
60073019|NCT01610414|76188215|FG000|STARTED|Month 13 - Month 25||922||
59522337|NCT01187017|75616725|FG000|STARTED|Overall Study||1||
60073020|NCT01610414|76188216|FG001|STARTED|Month 13 - Month 25||924||
60073021|NCT01610414|76188215|FG000|COMPLETED|Month 13 - Month 25||857||
60073022|NCT01610414|76188216|FG001|COMPLETED|Month 13 - Month 25||854||
60073023|NCT01610414|76188215|FG000|NOT COMPLETED|Month 13 - Month 25||65||
60073024|NCT01610414|76188216|FG001|NOT COMPLETED|Month 13 - Month 25||70||
60073025|NCT01610414|76188215|FG000|STARTED|After Month 25||922||
60073026|NCT01610414|76188216|FG001|STARTED|After Month 25||924||
60073027|NCT01610414|76188215|FG000|COMPLETED|After Month 25||874||
60073028|NCT01610414|76188216|FG001|COMPLETED|After Month 25||871||
60073029|NCT01610414|76188215|FG000|NOT COMPLETED|After Month 25||48||
60073030|NCT01610414|76188216|FG001|NOT COMPLETED|After Month 25||53||
60073031|NCT03832114|76188225|FG000|STARTED|Run-in Phase||16||
60073032|NCT03832114|76188226|FG001|STARTED|Run-in Phase||11||
60073033|NCT03832114|76188227|FG002|STARTED|Run-in Phase||0||
60073034|NCT03832114|76188228|FG003|STARTED|Run-in Phase||0||
60073035|NCT03832114|76188225|FG000|COMPLETED|Run-in Phase||16||
60073036|NCT03832114|76188226|FG001|COMPLETED|Run-in Phase||11||
60073037|NCT03832114|76188227|FG002|COMPLETED|Run-in Phase||0||
60073038|NCT03832114|76188228|FG003|COMPLETED|Run-in Phase||0||
59522338|NCT01187017|75616725|FG000|COMPLETED|Overall Study||1||
59522339|NCT01187017|75616725|FG000|NOT COMPLETED|Overall Study||0||
59522340|NCT01145833|75616733|FG000|STARTED|Overall Study||25||
59522341|NCT01145833|75616734|FG001|STARTED|Overall Study||25||
59522342|NCT01145833|75616733|FG000|COMPLETED|Overall Study||22||
59522343|NCT01145833|75616734|FG001|COMPLETED|Overall Study||25||
59522344|NCT01145833|75616733|FG000|NOT COMPLETED|Overall Study||3||
59522345|NCT01145833|75616734|FG001|NOT COMPLETED|Overall Study||0||
59522346|NCT04035694|75616742|FG000|STARTED|Overall Study||374||
59522347|NCT04035694|75616743|FG001|STARTED|Overall Study||216||
59522348|NCT04035694|75616742|FG000|COMPLETED|Overall Study||374||
59522349|NCT04035694|75616743|FG001|COMPLETED|Overall Study||216||
59522350|NCT04035694|75616742|FG000|NOT COMPLETED|Overall Study||0||
59522351|NCT04035694|75616743|FG001|NOT COMPLETED|Overall Study||0||
59522352|NCT01224145|75616749|FG000|STARTED|Overall Study||10||
59522353|NCT01224145|75616749|FG000|COMPLETED|Overall Study||10||
59522354|NCT01224145|75616749|FG000|NOT COMPLETED|Overall Study||0||
59522355|NCT01187095|75616756|FG000|STARTED|Overall Study||153||
59522356|NCT01187095|75616757|FG001|STARTED|Overall Study||142||
59522357|NCT01187095|75616756|FG000|COMPLETED|Overall Study||108||
59522358|NCT01187095|75616757|FG001|COMPLETED|Overall Study||108||
59522359|NCT01187095|75616756|FG000|NOT COMPLETED|Overall Study||45||
59522360|NCT01187095|75616757|FG001|NOT COMPLETED|Overall Study||34||
59522361|NCT01187329|75616765|FG000|STARTED|Overall Study||50||
59522362|NCT01187329|75616766|FG001|STARTED|Overall Study||50||
60073039|NCT03832114|76188225|FG000|NOT COMPLETED|Run-in Phase||0||
60073040|NCT03832114|76188226|FG001|NOT COMPLETED|Run-in Phase||0||
60073041|NCT03832114|76188227|FG002|NOT COMPLETED|Run-in Phase||0||
60073042|NCT03832114|76188228|FG003|NOT COMPLETED|Run-in Phase||0||
60073043|NCT03832114|76188225|FG000|STARTED|Dose Escalation/200mg b.i.d Treatment||0||
60073044|NCT03832114|76188226|FG001|STARTED|Dose Escalation/200mg b.i.d Treatment||0||
60073045|NCT03832114|76188227|FG002|STARTED|Dose Escalation/200mg b.i.d Treatment||16||
60073046|NCT03832114|76188228|FG003|STARTED|Dose Escalation/200mg b.i.d Treatment||11||
60073047|NCT03832114|76188225|FG000|COMPLETED|Dose Escalation/200mg b.i.d Treatment||0||
60073048|NCT03832114|76188226|FG001|COMPLETED|Dose Escalation/200mg b.i.d Treatment||0||
60073049|NCT03832114|76188227|FG002|COMPLETED|Dose Escalation/200mg b.i.d Treatment||16||
60073050|NCT03832114|76188228|FG003|COMPLETED|Dose Escalation/200mg b.i.d Treatment||11||
59522363|NCT01187329|75616765|FG000|COMPLETED|Overall Study||49||
59522364|NCT01187329|75616766|FG001|COMPLETED|Overall Study||48||
59522365|NCT01187329|75616765|FG000|NOT COMPLETED|Overall Study||1||
59522366|NCT01187329|75616766|FG001|NOT COMPLETED|Overall Study||2||
59522367|NCT01146379|75616776|FG000|STARTED|Overall Study||21||
59522368|NCT01146379|75616777|FG001|STARTED|Overall Study||22||
59522369|NCT01146379|75616778|FG002|STARTED|Overall Study||21||
59522370|NCT01146379|75616779|FG003|STARTED|Overall Study||21||
59522371|NCT01146379|75616776|FG000|COMPLETED|Overall Study||20||
59522372|NCT01146379|75616777|FG001|COMPLETED|Overall Study||21||
59522373|NCT01146379|75616778|FG002|COMPLETED|Overall Study||21||
59522374|NCT01146379|75616779|FG003|COMPLETED|Overall Study||20||
60073051|NCT03832114|76188225|FG000|NOT COMPLETED|Dose Escalation/200mg b.i.d Treatment||0||
60073052|NCT03832114|76188226|FG001|NOT COMPLETED|Dose Escalation/200mg b.i.d Treatment||0||
60073053|NCT03832114|76188227|FG002|NOT COMPLETED|Dose Escalation/200mg b.i.d Treatment||0||
60073054|NCT03832114|76188228|FG003|NOT COMPLETED|Dose Escalation/200mg b.i.d Treatment||0||
60073055|NCT01564407|76188252|FG000|STARTED|Overall Study||4||
60073056|NCT01564407|76188253|FG001|STARTED|Overall Study||5||
60073057|NCT01564407|76188254|FG002|STARTED|Overall Study||4||
60073058|NCT01564407|76188255|FG003|STARTED|Overall Study||2||
59781794|NCT00738062|75902297|FG001|COMPLETED|2 Week Randomized Withdrawal||38||
59781795|NCT00738062|75902298|FG002|COMPLETED|2 Week Randomized Withdrawal||37||
59781796|NCT00738062|75902296|FG000|NOT COMPLETED|2 Week Randomized Withdrawal||0||
59781797|NCT00738062|75902297|FG001|NOT COMPLETED|2 Week Randomized Withdrawal||0||
59781798|NCT00738062|75902298|FG002|NOT COMPLETED|2 Week Randomized Withdrawal||0||
59781799|NCT00738062|75902296|FG000|STARTED|Open-Label Extension|One patient completed double blind randomization but did not enter the open label extension|74||
59781800|NCT00738062|75902297|FG001|STARTED|Open-Label Extension||0||
59781801|NCT00738062|75902298|FG002|STARTED|Open-Label Extension||0||
59781802|NCT00738062|75902296|FG000|COMPLETED|Open-Label Extension||57||
59781803|NCT00738062|75902297|FG001|COMPLETED|Open-Label Extension||0||
59781804|NCT00738062|75902298|FG002|COMPLETED|Open-Label Extension||0||
59781805|NCT00738062|75902296|FG000|NOT COMPLETED|Open-Label Extension||17||
59781806|NCT00738062|75902297|FG001|NOT COMPLETED|Open-Label Extension||0||
59781807|NCT00738062|75902298|FG002|NOT COMPLETED|Open-Label Extension||0||
59781808|NCT04245345|75902307|FG000|STARTED|Overall Study||157||
59781809|NCT04245345|75902307|FG000|Implanted|Overall Study||152||
59781810|NCT04245345|75902307|FG000|1-month Visit|Overall Study||139||
59781811|NCT04245345|75902307|FG000|Complete Heart Block at 1-month|Overall Study||56||
59781812|NCT04245345|75902307|FG000|At Least 500 Evaluable Beats|Overall Study||54||
59781813|NCT04245345|75902307|FG000|COMPLETED|Overall Study||54||
59781814|NCT04245345|75902307|FG000|NOT COMPLETED|Overall Study||103||
59781815|NCT00698685|75902313|FG000|STARTED|Overall Study||14||
59781816|NCT00698685|75902313|FG000|COMPLETED|Overall Study||12||
59781817|NCT00698685|75902313|FG000|NOT COMPLETED|Overall Study||2||
59781818|NCT00737672|75902319|FG000|STARTED|Overall Study||145||
59781819|NCT00737672|75902320|FG001|STARTED|Overall Study||148||
59781820|NCT00737672|75902319|FG000|Exclusions Due to Protocol Deviations|Overall Study||14||
59781821|NCT00737672|75902320|FG001|Exclusions Due to Protocol Deviations|Overall Study||10||
59781822|NCT00737672|75902319|FG000|Per Protocol Population|Overall Study||131||
59781823|NCT00737672|75902320|FG001|Per Protocol Population|Overall Study||138||
59781824|NCT00737672|75902319|FG000|COMPLETED|Overall Study||65||
59781825|NCT00737672|75902320|FG001|COMPLETED|Overall Study||65||
59781826|NCT00737672|75902319|FG000|NOT COMPLETED|Overall Study||80||
59781827|NCT00737672|75902320|FG001|NOT COMPLETED|Overall Study||83||
59781828|NCT00737438|75902326|FG000|STARTED|Overall Study||23||
59781829|NCT00737438|75902326|FG000|COMPLETED|Overall Study||20||
59781830|NCT00737438|75902326|FG000|NOT COMPLETED|Overall Study||3||
59781831|NCT00737282|75902332|FG000|STARTED|Overall Study||175||
59781832|NCT00737282|75902332|FG000|COMPLETED|Overall Study||0||
59781833|NCT00737282|75902332|FG000|NOT COMPLETED|Overall Study||175||
59781834|NCT03884478|75902341|FG000|STARTED|Baseline to 2 Months Post-intervention||144||
59781835|NCT03884478|75902342|FG001|STARTED|Baseline to 2 Months Post-intervention||179||
59781836|NCT03884478|75902343|FG002|STARTED|Baseline to 2 Months Post-intervention||177||
59781837|NCT03884478|75902341|FG000|COMPLETED|Baseline to 2 Months Post-intervention||113||
59781838|NCT03884478|75902342|FG001|COMPLETED|Baseline to 2 Months Post-intervention||146||
59781839|NCT03884478|75902343|FG002|COMPLETED|Baseline to 2 Months Post-intervention||141||
59781840|NCT03884478|75902341|FG000|NOT COMPLETED|Baseline to 2 Months Post-intervention||31||
59781841|NCT03884478|75902342|FG001|NOT COMPLETED|Baseline to 2 Months Post-intervention||33||
59781842|NCT03884478|75902343|FG002|NOT COMPLETED|Baseline to 2 Months Post-intervention||36||
59781843|NCT03884478|75902341|FG000|STARTED|Baseline to 4 Months Post-intervention||144||
59781844|NCT03884478|75902342|FG001|STARTED|Baseline to 4 Months Post-intervention||179||
59781845|NCT03884478|75902343|FG002|STARTED|Baseline to 4 Months Post-intervention||177||
59781846|NCT03884478|75902341|FG000|COMPLETED|Baseline to 4 Months Post-intervention||101||
59781847|NCT03884478|75902342|FG001|COMPLETED|Baseline to 4 Months Post-intervention||129||
59781848|NCT03884478|75902343|FG002|COMPLETED|Baseline to 4 Months Post-intervention||126||
59781849|NCT03884478|75902341|FG000|NOT COMPLETED|Baseline to 4 Months Post-intervention||43||
59781850|NCT03884478|75902342|FG001|NOT COMPLETED|Baseline to 4 Months Post-intervention||50||
59781851|NCT03884478|75902343|FG002|NOT COMPLETED|Baseline to 4 Months Post-intervention||51||
59781852|NCT03414372|75902354|FG000|STARTED|Overall Study||53||
59781853|NCT03414372|75902355|FG001|STARTED|Overall Study||51||
60073059|NCT01564407|76188256|FG004|STARTED|Overall Study||0||
59781854|NCT03414372|75902356|FG002|STARTED|Overall Study||52||
59781855|NCT03414372|75902354|FG000|COMPLETED|Overall Study||43||
59781856|NCT03414372|75902355|FG001|COMPLETED|Overall Study||42||
59781857|NCT03414372|75902356|FG002|COMPLETED|Overall Study||44||
59781858|NCT03414372|75902354|FG000|NOT COMPLETED|Overall Study||10||
59781859|NCT03414372|75902355|FG001|NOT COMPLETED|Overall Study||9||
59781860|NCT03414372|75902356|FG002|NOT COMPLETED|Overall Study||8||
59781861|NCT00582816|75902364|FG000|STARTED|Overall Study||9||
59781862|NCT00582816|75902364|FG000|COMPLETED|Overall Study|"Completed here means patients stably engrafted with donor cells."|6||
59781863|NCT00582816|75902364|FG000|NOT COMPLETED|Overall Study||3||
59781864|NCT00737048|75902371|FG000|STARTED|Overall Study||132||
59781865|NCT00737048|75902372|FG001|STARTED|Overall Study||66||
59781866|NCT00737048|75902373|FG002|STARTED|Overall Study||130||
59781867|NCT00737048|75902371|FG000|COMPLETED|Overall Study||129||
59781868|NCT00737048|75902372|FG001|COMPLETED|Overall Study||60||
59781869|NCT00737048|75902373|FG002|COMPLETED|Overall Study||126||
59781870|NCT00737048|75902371|FG000|NOT COMPLETED|Overall Study||3||
59781871|NCT00737048|75902372|FG001|NOT COMPLETED|Overall Study||6||
59781872|NCT00737048|75902373|FG002|NOT COMPLETED|Overall Study||4||
59781873|NCT00731822|75902383|FG000|STARTED|Overall Study||20||
59781874|NCT00731822|75902384|FG001|STARTED|Overall Study||40||
59781875|NCT00731822|75902383|FG000|COMPLETED|Overall Study||16||
59781876|NCT00731822|75902384|FG001|COMPLETED|Overall Study||39||
59781877|NCT00731822|75902383|FG000|NOT COMPLETED|Overall Study||4||
59781878|NCT00731822|75902384|FG001|NOT COMPLETED|Overall Study||1||
59781879|NCT00731666|75902390|FG000|STARTED|Overall Study||40||
59781880|NCT00731666|75902390|FG000|COMPLETED|Overall Study||28||
59781881|NCT00731666|75902390|FG000|NOT COMPLETED|Overall Study||12||
59781882|NCT00731120|75902397|FG000|STARTED|Overall Study||153||
59781883|NCT00731120|75902398|FG001|STARTED|Overall Study||152||
59781884|NCT00731120|75902399|FG002|STARTED|Overall Study||152||
59781885|NCT00731120|75902397|FG000|Treated|Overall Study||153||
59781886|NCT00731120|75902398|FG001|Treated|Overall Study||151||
59781887|NCT00731120|75902399|FG002|Treated|Overall Study||152||
59781888|NCT00731120|75902397|FG000|COMPLETED|Overall Study||111||
59781889|NCT00731120|75902398|FG001|COMPLETED|Overall Study||109||
59781890|NCT00731120|75902399|FG002|COMPLETED|Overall Study||116||
59781891|NCT00731120|75902397|FG000|NOT COMPLETED|Overall Study||42||
59781892|NCT00731120|75902398|FG001|NOT COMPLETED|Overall Study||43||
59781893|NCT00731120|75902399|FG002|NOT COMPLETED|Overall Study||36||
59781894|NCT00731042|75902409|FG000|STARTED|First Intervention||16||
59781895|NCT00731042|75902410|FG001|STARTED|First Intervention||17||
59781896|NCT00731042|75902409|FG000|COMPLETED|First Intervention||16||
59781897|NCT00731042|75902410|FG001|COMPLETED|First Intervention||17||
59781898|NCT00731042|75902409|FG000|NOT COMPLETED|First Intervention||0||
59781899|NCT00731042|75902410|FG001|NOT COMPLETED|First Intervention||0||
59781900|NCT00731042|75902409|FG000|STARTED|Wash-out||16||
59781901|NCT00731042|75902410|FG001|STARTED|Wash-out||17||
59781902|NCT00731042|75902409|FG000|COMPLETED|Wash-out||16||
59781903|NCT00731042|75902410|FG001|COMPLETED|Wash-out||17||
59781904|NCT00731042|75902409|FG000|NOT COMPLETED|Wash-out||0||
59781905|NCT00731042|75902410|FG001|NOT COMPLETED|Wash-out||0||
59781906|NCT00731042|75902409|FG000|STARTED|Second Intervention||16||
59781907|NCT00731042|75902410|FG001|STARTED|Second Intervention||17||
59781908|NCT00731042|75902409|FG000|COMPLETED|Second Intervention||16||
59781909|NCT00731042|75902410|FG001|COMPLETED|Second Intervention|2 subjects did not met inclusion criteria for Period 2 Visual scoring skin condition|15||
59781910|NCT00731042|75902409|FG000|NOT COMPLETED|Second Intervention||0||
59781911|NCT00731042|75902410|FG001|NOT COMPLETED|Second Intervention||2||
59781912|NCT00726986|75902416|FG000|STARTED|Induction Phase||18||
59781913|NCT00726986|75902416|FG000|Maintance|Induction Phase||3||
59781914|NCT00726986|75902416|FG000|COMPLETED|Induction Phase||3||
59781915|NCT00726986|75902416|FG000|NOT COMPLETED|Induction Phase||15||
59781916|NCT00726986|75902416|FG000|STARTED|Maintenance Phase||3||
59781917|NCT00726986|75902416|FG000|COMPLETED|Maintenance Phase||0||
59781918|NCT00726986|75902416|FG000|NOT COMPLETED|Maintenance Phase||3||
59781919|NCT00696657|75902429|FG000|STARTED|Overall Study||46|STARTED = Randomised.|
59995478|NCT02152995|76111309|FG000|NOT COMPLETED|Overall Study||1||
59995479|NCT02152995|76111310|FG001|NOT COMPLETED|Overall Study||0||
59995480|NCT02026908|76111317|FG000|STARTED|Overall Study||45||
59995481|NCT02026908|76111317|FG000|COMPLETED|Overall Study||45||
59995482|NCT02026908|76111317|FG000|NOT COMPLETED|Overall Study||0||
59995483|NCT01867606|76111324|FG000|STARTED|Overall Study||26||
59995484|NCT01867606|76111325|FG001|STARTED|Overall Study||32||
59995485|NCT01867606|76111324|FG000|COMPLETED|Overall Study||16||
59995486|NCT01867606|76111325|FG001|COMPLETED|Overall Study||17||
59995487|NCT01867606|76111324|FG000|NOT COMPLETED|Overall Study||10||
59995488|NCT01867606|76111325|FG001|NOT COMPLETED|Overall Study||15||
59995489|NCT01828112|76111339|FG000|STARTED|Overall Study||115||
59995490|NCT01828112|76111340|FG001|STARTED|Overall Study||116||
59995491|NCT01828112|76111339|FG000|Entered Extension Treatment Phase|Overall Study||0||
59995492|NCT01828112|76111340|FG001|Entered Extension Treatment Phase|Overall Study||74||
59995493|NCT01828112|76111339|FG000|Entered Post-treatment Follow-up Phase|Overall Study||7||
59781920|NCT00696657|75902430|FG001|STARTED|Overall Study||47|STARTED = Randomised.|
59781921|NCT00696657|75902431|FG002|STARTED|Overall Study||44|STARTED = Randomised.|
59781922|NCT00696657|75902432|FG003|STARTED|Overall Study||49|STARTED = Randomised.|
59781923|NCT00696657|75902433|FG004|STARTED|Overall Study||44|STARTED = Randomised.|
59781924|NCT00696657|75902434|FG005|STARTED|Overall Study||45|STARTED = Randomised.|
59781925|NCT00696657|75902435|FG006|STARTED|Overall Study||45|STARTED = Randomised.|
59781926|NCT00696657|75902436|FG007|STARTED|Overall Study||45|STARTED = Randomised.|
59781927|NCT00696657|75902437|FG008|STARTED|Overall Study||50|STARTED = Randomised.|
59781928|NCT00696657|75902429|FG000|EXPOSED|Overall Study||46||
59781929|NCT00696657|75902430|FG001|EXPOSED|Overall Study||47||
59781930|NCT00696657|75902431|FG002|EXPOSED|Overall Study||43||
59781931|NCT00696657|75902432|FG003|EXPOSED|Overall Study||48||
59781932|NCT00696657|75902433|FG004|EXPOSED|Overall Study||44||
59781933|NCT00696657|75902434|FG005|EXPOSED|Overall Study||43||
59781934|NCT00696657|75902435|FG006|EXPOSED|Overall Study||45||
59781935|NCT00696657|75902436|FG007|EXPOSED|Overall Study||45||
59781936|NCT00696657|75902437|FG008|EXPOSED|Overall Study||50||
59781937|NCT00696657|75902429|FG000|COMPLETED|Overall Study||45||
59781938|NCT00696657|75902430|FG001|COMPLETED|Overall Study||42||
59781939|NCT00696657|75902431|FG002|COMPLETED|Overall Study||36||
59781940|NCT00696657|75902432|FG003|COMPLETED|Overall Study||38||
59781941|NCT00696657|75902433|FG004|COMPLETED|Overall Study||34||
59781942|NCT00696657|75902434|FG005|COMPLETED|Overall Study||33||
59781943|NCT00696657|75902435|FG006|COMPLETED|Overall Study||30||
59781944|NCT00696657|75902436|FG007|COMPLETED|Overall Study||42||
59781945|NCT00696657|75902437|FG008|COMPLETED|Overall Study||41||
59781946|NCT00696657|75902429|FG000|NOT COMPLETED|Overall Study||1||
59781947|NCT00696657|75902430|FG001|NOT COMPLETED|Overall Study||5||
59781948|NCT00696657|75902431|FG002|NOT COMPLETED|Overall Study||8||
59781949|NCT00696657|75902432|FG003|NOT COMPLETED|Overall Study||11||
59781950|NCT00696657|75902433|FG004|NOT COMPLETED|Overall Study||10||
59781951|NCT00696657|75902434|FG005|NOT COMPLETED|Overall Study||12||
59781952|NCT00696657|75902435|FG006|NOT COMPLETED|Overall Study||15||
59781953|NCT00696657|75902436|FG007|NOT COMPLETED|Overall Study||3||
59781954|NCT00696657|75902437|FG008|NOT COMPLETED|Overall Study||9||
59781955|NCT00730886|75902459|FG000|STARTED|Overall Study||2||
59781956|NCT00730886|75902460|FG001|STARTED|Overall Study|no subjects enrolled in this arm. Study enrollment terminated early.|0||
59781957|NCT00730886|75902459|FG000|COMPLETED|Overall Study||0||
59781958|NCT00730886|75902460|FG001|COMPLETED|Overall Study|no subjects enrolled in this arm. Study enrollment terminated early.|0||
59781959|NCT00730886|75902459|FG000|NOT COMPLETED|Overall Study||2||
59781960|NCT00730886|75902460|FG001|NOT COMPLETED|Overall Study||0||
59781961|NCT00726752|75902466|FG000|STARTED|Overall Study||6||
59781962|NCT00726752|75902466|FG000|COMPLETED|Overall Study||0||
59781963|NCT00726752|75902466|FG000|NOT COMPLETED|Overall Study||6||
59781964|NCT02664558|75902472|FG000|STARTED|Overall Study||41||
59781965|NCT02664558|75902473|FG001|STARTED|Overall Study||20||
59781966|NCT02664558|75902472|FG000|COMPLETED|Overall Study||36||
59781967|NCT02664558|75902473|FG001|COMPLETED|Overall Study||18||
59781968|NCT02664558|75902472|FG000|NOT COMPLETED|Overall Study||5||
59781969|NCT02664558|75902473|FG001|NOT COMPLETED|Overall Study||2||
59781970|NCT00730028|75902484|FG000|STARTED|Overall Study||264||
59781971|NCT00730028|75902485|FG001|STARTED|Overall Study||260||
59781972|NCT00730028|75902486|FG002|STARTED|Overall Study||266||
59781973|NCT00730028|75902487|FG003|STARTED|Overall Study||263||
59781974|NCT00730028|75902488|FG004|STARTED|Overall Study||257||
59781975|NCT00730028|75902484|FG000|COMPLETED|Overall Study||204||
59781976|NCT00730028|75902485|FG001|COMPLETED|Overall Study||194||
59619214|NCT00637572|75730417|FG000|COMPLETED|Overall Study||29||
59619215|NCT00637572|75730418|FG001|COMPLETED|Overall Study||24||
59619216|NCT00637572|75730417|FG000|NOT COMPLETED|Overall Study||3||
59619217|NCT00637572|75730418|FG001|NOT COMPLETED|Overall Study||7||
59619218|NCT00637416|75730426|FG000|STARTED|Overall Study||4||
59619219|NCT00637416|75730427|FG001|STARTED|Overall Study||5||
59619220|NCT00637416|75730426|FG000|COMPLETED|Overall Study||3||
59619221|NCT00637416|75730427|FG001|COMPLETED|Overall Study||3||
59619222|NCT00637416|75730426|FG000|NOT COMPLETED|Overall Study||1||
59619223|NCT00637416|75730427|FG001|NOT COMPLETED|Overall Study||2||
59619224|NCT00636792|75730433|FG000|STARTED|Overall Study||73||
59619225|NCT00636792|75730433|FG000|COMPLETED|Overall Study||40||
59619226|NCT00636792|75730433|FG000|NOT COMPLETED|Overall Study||33||
59619227|NCT03108924|75730441|FG000|STARTED|Overall Study||6||
59619228|NCT03108924|75730442|FG001|STARTED|Overall Study||6||
59619229|NCT03108924|75730443|FG002|STARTED|Overall Study||6||
59781977|NCT00730028|75902486|FG002|COMPLETED|Overall Study||221||
59781978|NCT00730028|75902487|FG003|COMPLETED|Overall Study||207||
59781979|NCT00730028|75902488|FG004|COMPLETED|Overall Study||175||
59619230|NCT03108924|75730444|FG003|STARTED|Overall Study||6||
59619231|NCT03108924|75730441|FG000|COMPLETED|Overall Study||6||
59619232|NCT03108924|75730442|FG001|COMPLETED|Overall Study||6||
59619233|NCT03108924|75730443|FG002|COMPLETED|Overall Study||6||
59619234|NCT03108924|75730444|FG003|COMPLETED|Overall Study||6||
59781980|NCT00730028|75902484|FG000|NOT COMPLETED|Overall Study||60||
59781981|NCT00730028|75902485|FG001|NOT COMPLETED|Overall Study||66||
59781982|NCT00730028|75902486|FG002|NOT COMPLETED|Overall Study||45||
59781983|NCT00730028|75902487|FG003|NOT COMPLETED|Overall Study||56||
59781984|NCT00730028|75902488|FG004|NOT COMPLETED|Overall Study||82||
59781985|NCT00736502|75902500|FG000|STARTED|Overall Study|Entered and treated.|278||
59781986|NCT00736502|75902500|FG000|COMPLETED|Overall Study||213||
59781987|NCT00736502|75902500|FG000|NOT COMPLETED|Overall Study||65||
59781988|NCT00729560|75902504|FG000|STARTED|Overall Study|Arm assignment can not be determined as study was ended prior to unblinding and no key found.|8||
59781989|NCT00729560|75902504|FG000|COMPLETED|Overall Study||5||
59781990|NCT00729560|75902504|FG000|NOT COMPLETED|Overall Study||3||
59781991|NCT00736190|75902508|FG000|STARTED|Overall Study||90||
59781992|NCT00736190|75902508|FG000|COMPLETED|Overall Study||87||
59781993|NCT00736190|75902508|FG000|NOT COMPLETED|Overall Study||3||
59781994|NCT00729326|75902514|FG000|STARTED|Overall Study||41||
59781995|NCT00729326|75902515|FG001|STARTED|Overall Study||42||
59781996|NCT00729326|75902514|FG000|COMPLETED|Overall Study||31||
59781997|NCT00729326|75902515|FG001|COMPLETED|Overall Study||33||
59781998|NCT00729326|75902514|FG000|NOT COMPLETED|Overall Study||10||
59781999|NCT00729326|75902515|FG001|NOT COMPLETED|Overall Study||9||
59782000|NCT00729248|75902521|FG000|STARTED|Overall Study||12||
59782001|NCT00729248|75902521|FG000|COMPLETED|Overall Study||10||
59782002|NCT00729248|75902521|FG000|NOT COMPLETED|Overall Study||2||
59782003|NCT00696423|75902528|FG000|STARTED|Overall Study||244||
59782004|NCT00696423|75902529|FG001|STARTED|Overall Study||223||
59782005|NCT00696423|75902528|FG000|COMPLETED|Overall Study||244||
59782006|NCT00696423|75902529|FG001|COMPLETED|Overall Study||218||
59782007|NCT00696423|75902528|FG000|NOT COMPLETED|Overall Study||0||
59782008|NCT00696423|75902529|FG001|NOT COMPLETED|Overall Study||5||
59782009|NCT00736034|75902535|FG000|STARTED|Overall Study||18||
59782010|NCT00736034|75902535|FG000|COMPLETED|Overall Study||16||
59782011|NCT00736034|75902535|FG000|NOT COMPLETED|Overall Study||2||
59782012|NCT00576693|75902541|FG000|STARTED|Overall Study||224||
59782013|NCT00576693|75902542|FG001|STARTED|Overall Study||227||
59782014|NCT00576693|75902541|FG000|COMPLETED|Overall Study||214||
59782015|NCT00576693|75902542|FG001|COMPLETED|Overall Study||203||
59782016|NCT00576693|75902541|FG000|NOT COMPLETED|Overall Study||10||
59782017|NCT00576693|75902542|FG001|NOT COMPLETED|Overall Study||24||
59782018|NCT00698451|75902548|FG000|STARTED|Overall Study||54||
59782019|NCT00698451|75902548|FG000|COMPLETED|Overall Study||15||
59782020|NCT00698451|75902548|FG000|NOT COMPLETED|Overall Study||39||
59782021|NCT00697827|75902554|FG000|STARTED|Overall Study||28||
59782022|NCT00697827|75902555|FG001|STARTED|Overall Study||16||
59782023|NCT00697827|75902554|FG000|COMPLETED|Overall Study||26||
59782024|NCT00697827|75902555|FG001|COMPLETED|Overall Study||15||
59782025|NCT00697827|75902554|FG000|NOT COMPLETED|Overall Study||2||
59782026|NCT00697827|75902555|FG001|NOT COMPLETED|Overall Study||1||
59782027|NCT00728936|75902568|FG000|STARTED|Overall Study||10||
59782028|NCT00728936|75902569|FG001|STARTED|Overall Study||8||
59782029|NCT00728936|75902570|FG002|STARTED|Overall Study||9||
59782030|NCT00728936|75902571|FG003|STARTED|Overall Study||8||
59782031|NCT00728936|75902572|FG004|STARTED|Overall Study||8||
59782032|NCT00728936|75902573|FG005|STARTED|Overall Study||8||
59782033|NCT00728936|75902574|FG006|STARTED|Overall Study||7||
59782034|NCT00728936|75902568|FG000|COMPLETED|Overall Study||10||
59782035|NCT00728936|75902569|FG001|COMPLETED|Overall Study||8||
59782036|NCT00728936|75902570|FG002|COMPLETED|Overall Study||9||
59782037|NCT00728936|75902571|FG003|COMPLETED|Overall Study||8||
59782038|NCT00728936|75902572|FG004|COMPLETED|Overall Study||8||
59782039|NCT00728936|75902573|FG005|COMPLETED|Overall Study||7||
59782040|NCT00728936|75902574|FG006|COMPLETED|Overall Study||7||
59782041|NCT00728936|75902568|FG000|NOT COMPLETED|Overall Study||0||
59782042|NCT00728936|75902569|FG001|NOT COMPLETED|Overall Study||0||
59782043|NCT00728936|75902570|FG002|NOT COMPLETED|Overall Study||0||
59782044|NCT00728936|75902571|FG003|NOT COMPLETED|Overall Study||0||
59782045|NCT00728936|75902572|FG004|NOT COMPLETED|Overall Study||0||
59782046|NCT00728936|75902573|FG005|NOT COMPLETED|Overall Study||1||
59782047|NCT00728936|75902574|FG006|NOT COMPLETED|Overall Study||0||
59782048|NCT00693693|75902593|FG000|STARTED|Overall Study||7||
59782049|NCT00693693|75902594|FG001|STARTED|Overall Study||9||
59782050|NCT00693693|75902595|FG002|STARTED|Overall Study||9||
59782051|NCT00693693|75902593|FG000|COMPLETED|Overall Study||6||
59782052|NCT00693693|75902594|FG001|COMPLETED|Overall Study||8||
59782053|NCT00693693|75902595|FG002|COMPLETED|Overall Study||7||
59782054|NCT00693693|75902593|FG000|NOT COMPLETED|Overall Study||1||
59782055|NCT00693693|75902594|FG001|NOT COMPLETED|Overall Study||1||
59782056|NCT00693693|75902595|FG002|NOT COMPLETED|Overall Study||2||
59782057|NCT00728468|75902603|FG000|STARTED|Overall Study||16||
59782058|NCT00728468|75902603|FG000|Treated|Overall Study||15||
59782059|NCT00728468|75902603|FG000|COMPLETED|Overall Study||0||
59782060|NCT00728468|75902603|FG000|NOT COMPLETED|Overall Study||16||
59782061|NCT00727844|75902609|FG000|STARTED|Initial Randomization|2 patients withdrawn before receiving any linezolid owing to baseline neuropathy|21||
59782062|NCT00727844|75902610|FG001|STARTED|Initial Randomization||20||
59782063|NCT00727844|75902611|FG002|STARTED|Initial Randomization||0||
59782064|NCT00727844|75902612|FG003|STARTED|Initial Randomization||0||
59782065|NCT00727844|75902609|FG000|Included in MITT Analysis|Initial Randomization||19||
59782066|NCT00727844|75902610|FG001|Included in MITT Analysis|Initial Randomization||20||
59782067|NCT00727844|75902611|FG002|Included in MITT Analysis|Initial Randomization||0||
59782068|NCT00727844|75902612|FG003|Included in MITT Analysis|Initial Randomization||0||
59782069|NCT00727844|75902609|FG000|COMPLETED|Initial Randomization||19||
59782070|NCT00727844|75902610|FG001|COMPLETED|Initial Randomization||20||
59782071|NCT00727844|75902611|FG002|COMPLETED|Initial Randomization||0||
59782072|NCT00727844|75902612|FG003|COMPLETED|Initial Randomization||0||
59782073|NCT00727844|75902609|FG000|NOT COMPLETED|Initial Randomization||2||
59782074|NCT00727844|75902610|FG001|NOT COMPLETED|Initial Randomization||0||
59782075|NCT00727844|75902611|FG002|NOT COMPLETED|Initial Randomization||0||
59782076|NCT00727844|75902612|FG003|NOT COMPLETED|Initial Randomization||0||
59782077|NCT00727844|75902609|FG000|STARTED|Second Randomization||0||
59782078|NCT00727844|75902610|FG001|STARTED|Second Randomization||0||
59782079|NCT00727844|75902611|FG002|STARTED|Second Randomization|6 patients excluded before 2nd randomization: 2 had withdrawn and 4 already dose reduced due to AE|17||
59782080|NCT00727844|75902612|FG003|STARTED|Second Randomization|6 patients excluded before 2nd randomization: 2 had withdrawn and 4 already dose reduced due to AE|16||
59782081|NCT00727844|75902609|FG000|COMPLETED|Second Randomization||0||
59782082|NCT00727844|75902610|FG001|COMPLETED|Second Randomization||0||
59782083|NCT00727844|75902611|FG002|COMPLETED|Second Randomization||17||
59782084|NCT00727844|75902612|FG003|COMPLETED|Second Randomization||16||
59782085|NCT00727844|75902609|FG000|NOT COMPLETED|Second Randomization||0||
59782086|NCT00727844|75902610|FG001|NOT COMPLETED|Second Randomization||0||
59782087|NCT00727844|75902611|FG002|NOT COMPLETED|Second Randomization||0||
59782088|NCT00727844|75902612|FG003|NOT COMPLETED|Second Randomization||0||
59782089|NCT00735878|75902620|FG000|STARTED|Phase I- Dose Determination|13 subjects enrolled. One subject withdrew consent prior to receiving therapy & was replaced.|1||
59782090|NCT00735878|75902621|FG001|STARTED|Phase I- Dose Determination||7||
59782091|NCT00735878|75902622|FG002|STARTED|Phase I- Dose Determination||5||
59782092|NCT00735878|75902620|FG000|COMPLETED|Phase I- Dose Determination|12 subjects received at least one cycle of treatment and were evaluable per the protocol.|1||
59782093|NCT00735878|75902621|FG001|COMPLETED|Phase I- Dose Determination||7||
59782094|NCT00735878|75902622|FG002|COMPLETED|Phase I- Dose Determination||4||
59782095|NCT00735878|75902620|FG000|NOT COMPLETED|Phase I- Dose Determination||0||
59782096|NCT00735878|75902621|FG001|NOT COMPLETED|Phase I- Dose Determination||0||
59782097|NCT00735878|75902622|FG002|NOT COMPLETED|Phase I- Dose Determination||1||
59782098|NCT00735878|75902620|FG000|STARTED|Phase II- Determined Dose||0||
59782099|NCT00735878|75902621|FG001|STARTED|Phase II- Determined Dose||7||
59782100|NCT00735878|75902622|FG002|STARTED|Phase II- Determined Dose||0||
59782101|NCT00735878|75902620|FG000|COMPLETED|Phase II- Determined Dose|Seven subjects completed therapy within the Phase II portion of the trial.|0||
59782102|NCT00735878|75902621|FG001|COMPLETED|Phase II- Determined Dose||7||
59782103|NCT00735878|75902622|FG002|COMPLETED|Phase II- Determined Dose||0||
59782104|NCT00735878|75902620|FG000|NOT COMPLETED|Phase II- Determined Dose||0||
59782105|NCT00735878|75902621|FG001|NOT COMPLETED|Phase II- Determined Dose||0||
59782106|NCT00735878|75902622|FG002|NOT COMPLETED|Phase II- Determined Dose||0||
59782107|NCT00695955|75902633|FG000|STARTED|Cohort 1||362||
59782108|NCT00695955|75902633|FG000|COMPLETED|Cohort 1||260||
59782109|NCT00695955|75902633|FG000|NOT COMPLETED|Cohort 1||102||
59782110|NCT00695955|75902633|FG000|STARTED|Cohort 2||307||
59782111|NCT00695955|75902633|FG000|COMPLETED|Cohort 2||203||
59782112|NCT00695955|75902633|FG000|NOT COMPLETED|Cohort 2||104||
59782113|NCT00693225|75902641|FG000|STARTED|Overall Study||43||
59782114|NCT00693225|75902642|FG001|STARTED|Overall Study||48||
59782115|NCT00693225|75902641|FG000|COMPLETED|Overall Study||41||
59782116|NCT00693225|75902642|FG001|COMPLETED|Overall Study||43||
59782117|NCT00693225|75902641|FG000|NOT COMPLETED|Overall Study||2||
59782118|NCT00693225|75902642|FG001|NOT COMPLETED|Overall Study||5||
59782119|NCT00735644|75902653|FG000|STARTED|Overall Study||303||
59782120|NCT00735644|75902654|FG001|STARTED|Overall Study||300||
59782121|NCT00735644|75902655|FG002|STARTED|Overall Study||296||
59782122|NCT00735644|75902656|FG003|STARTED|Overall Study||199||
59782123|NCT00735644|75902657|FG004|STARTED|Overall Study||102||
59782124|NCT00735644|75902653|FG000|COMPLETED|Overall Study||303||
59782125|NCT00735644|75902654|FG001|COMPLETED|Overall Study||298||
59782126|NCT00735644|75902655|FG002|COMPLETED|Overall Study||295||
59782127|NCT00735644|75902656|FG003|COMPLETED|Overall Study||198||
59782128|NCT00735644|75902657|FG004|COMPLETED|Overall Study||102||
59782129|NCT00735644|75902653|FG000|NOT COMPLETED|Overall Study||0||
59782130|NCT00735644|75902654|FG001|NOT COMPLETED|Overall Study||2||
59782131|NCT00735644|75902655|FG002|NOT COMPLETED|Overall Study||1||
59782132|NCT00735644|75902656|FG003|NOT COMPLETED|Overall Study||1||
59782133|NCT00735644|75902657|FG004|NOT COMPLETED|Overall Study||0||
59782134|NCT03718299|75902676|FG000|STARTED|Overall Study||55||
59782135|NCT03718299|75902676|FG000|COMPLETED|Overall Study||45||
59782136|NCT03718299|75902676|FG000|NOT COMPLETED|Overall Study||10||
59782137|NCT00724958|75902680|FG000|STARTED|Overall Study||348||
59782138|NCT00724958|75902680|FG000|COMPLETED|Overall Study||166||
59782139|NCT00724958|75902680|FG000|NOT COMPLETED|Overall Study||182||
59782140|NCT00695565|75902686|FG000|STARTED|Overall Study||90||
59782141|NCT00695565|75902687|FG001|STARTED|Overall Study||90||
59782142|NCT00695565|75902686|FG000|COMPLETED|Overall Study||77||
59782143|NCT00695565|75902687|FG001|COMPLETED|Overall Study||81||
59782144|NCT00695565|75902686|FG000|NOT COMPLETED|Overall Study||13||
59782145|NCT00695565|75902687|FG001|NOT COMPLETED|Overall Study||9||
59782146|NCT00727532|75902693|FG000|STARTED|Overall Study||9||
59782147|NCT00727532|75902693|FG000|COMPLETED|Overall Study||7||
59782148|NCT00727532|75902693|FG000|NOT COMPLETED|Overall Study||2||
59782149|NCT00721214|75902697|FG000|STARTED|Overall Study||16||
59782150|NCT00721214|75902697|FG000|COMPLETED|Overall Study||12||
59782151|NCT00721214|75902697|FG000|NOT COMPLETED|Overall Study||4||
59782152|NCT00720902|75902703|FG000|STARTED|Overall Study||4||
59782153|NCT00720902|75902704|FG001|STARTED|Overall Study||3||
59782154|NCT00720902|75902703|FG000|COMPLETED|Overall Study||0||
59782155|NCT00720902|75902704|FG001|COMPLETED|Overall Study||3||
59782156|NCT00720902|75902703|FG000|NOT COMPLETED|Overall Study||4||
59782157|NCT00720902|75902704|FG001|NOT COMPLETED|Overall Study||0||
59782158|NCT00695019|75902713|FG000|STARTED|Overall Study||59||
59782159|NCT00695019|75902714|FG001|STARTED|Overall Study||53||
59782160|NCT00695019|75902715|FG002|STARTED|Overall Study||57||
59782161|NCT00695019|75902713|FG000|COMPLETED|Overall Study||46||
59782162|NCT00695019|75902714|FG001|COMPLETED|Overall Study||39||
59782163|NCT00695019|75902715|FG002|COMPLETED|Overall Study||47||
59782164|NCT00695019|75902713|FG000|NOT COMPLETED|Overall Study||13||
59782165|NCT00695019|75902714|FG001|NOT COMPLETED|Overall Study||14||
59782166|NCT00695019|75902715|FG002|NOT COMPLETED|Overall Study||10||
59782167|NCT00694707|75902728|FG000|STARTED|Overall Study||151||
59782168|NCT00694707|75902729|FG001|STARTED|Overall Study||145||
59782169|NCT00694707|75902730|FG002|STARTED|Overall Study||147||
59782170|NCT00694707|75902731|FG003|STARTED|Overall Study||148||
59782171|NCT00694707|75902732|FG004|STARTED|Overall Study||141||
59782172|NCT00694707|75902728|FG000|COMPLETED|Overall Study||79||
59782173|NCT00694707|75902729|FG001|COMPLETED|Overall Study||90||
59782174|NCT00694707|75902730|FG002|COMPLETED|Overall Study||96||
59782175|NCT00694707|75902731|FG003|COMPLETED|Overall Study||98||
59782176|NCT00694707|75902732|FG004|COMPLETED|Overall Study||101||
59782177|NCT00694707|75902728|FG000|NOT COMPLETED|Overall Study||72||
59782178|NCT00694707|75902729|FG001|NOT COMPLETED|Overall Study||55||
59782179|NCT00694707|75902730|FG002|NOT COMPLETED|Overall Study||51||
59782180|NCT00694707|75902731|FG003|NOT COMPLETED|Overall Study||50||
59782181|NCT00694707|75902732|FG004|NOT COMPLETED|Overall Study||40||
59782182|NCT00692913|75902746|FG000|STARTED|Overall Study||257||
59782183|NCT00692913|75902747|FG001|STARTED|Overall Study||258||
59782184|NCT00692913|75902746|FG000|COMPLETED|Overall Study||228||
59782185|NCT00692913|75902747|FG001|COMPLETED|Overall Study||228||
59782186|NCT00692913|75902746|FG000|NOT COMPLETED|Overall Study||29||
59782187|NCT00692913|75902747|FG001|NOT COMPLETED|Overall Study||30||
59782188|NCT00694551|75902756|FG000|STARTED|Overall Study||10||
59782189|NCT00694551|75902757|FG001|STARTED|Overall Study||10||
59782190|NCT00694551|75902758|FG002|STARTED|Overall Study||9||
59782191|NCT00694551|75902756|FG000|COMPLETED|Overall Study||9||
59782192|NCT00694551|75902757|FG001|COMPLETED|Overall Study||10||
59782193|NCT00694551|75902758|FG002|COMPLETED|Overall Study||8||
59782194|NCT00694551|75902756|FG000|NOT COMPLETED|Overall Study||1||
59782195|NCT00694551|75902757|FG001|NOT COMPLETED|Overall Study||0||
59782196|NCT00694551|75902758|FG002|NOT COMPLETED|Overall Study||1||
59782197|NCT00689871|75902771|FG000|STARTED|Overall Study|908 Implants|455||
59782198|NCT00689871|75902772|FG001|STARTED|Overall Study|127 Implants|98||
59782199|NCT00689871|75902773|FG002|STARTED|Overall Study|288 Implants|147||
59782200|NCT00689871|75902774|FG003|STARTED|Overall Study|25 Implants|15||
59782201|NCT00689871|75902771|FG000|COMPLETED|Overall Study|35 Patients discontinued|280||
59782202|NCT00689871|75902772|FG001|COMPLETED|Overall Study|35 Patients discontinued|46||
59782203|NCT00689871|75902773|FG002|COMPLETED|Overall Study|28 Patients discontinued|74||
59782204|NCT00689871|75902774|FG003|COMPLETED|Overall Study|4 Patients discontinued|8||
59782205|NCT00689871|75902771|FG000|NOT COMPLETED|Overall Study||175||
59782206|NCT00689871|75902772|FG001|NOT COMPLETED|Overall Study||52||
59782207|NCT00689871|75902773|FG002|NOT COMPLETED|Overall Study||73||
59782208|NCT00689871|75902774|FG003|NOT COMPLETED|Overall Study||7||
59782209|NCT00793793|75902796|FG000|STARTED|Overall Study||8||
59782210|NCT00793793|75902797|FG001|STARTED|Overall Study||6||
59782211|NCT00793793|75902798|FG002|STARTED|Overall Study||7||
59782212|NCT00793793|75902799|FG003|STARTED|Overall Study||7||
59782213|NCT00793793|75902800|FG004|STARTED|Overall Study||6||
59782214|NCT00793793|75902801|FG005|STARTED|Overall Study||6||
59782215|NCT00793793|75902802|FG006|STARTED|Overall Study||7||
59782216|NCT00793793|75902803|FG007|STARTED|Overall Study||6||
59782217|NCT00793793|75902804|FG008|STARTED|Overall Study||15||
59782218|NCT00793793|75902805|FG009|STARTED|Overall Study||15||
59782219|NCT00793793|75902806|FG010|STARTED|Overall Study||6||
59782220|NCT00793793|75902807|FG011|STARTED|Overall Study||7||
59782221|NCT00793793|75902796|FG000|COMPLETED|Overall Study||8||
59782222|NCT00793793|75902797|FG001|COMPLETED|Overall Study||5||
59782223|NCT00793793|75902798|FG002|COMPLETED|Overall Study||5||
59782224|NCT00793793|75902799|FG003|COMPLETED|Overall Study||4||
59782225|NCT00793793|75902800|FG004|COMPLETED|Overall Study||4||
59782226|NCT00793793|75902801|FG005|COMPLETED|Overall Study||4||
59782227|NCT00793793|75902802|FG006|COMPLETED|Overall Study||3||
59782228|NCT00793793|75902803|FG007|COMPLETED|Overall Study||6||
59782229|NCT00793793|75902804|FG008|COMPLETED|Overall Study||6||
59782230|NCT00793793|75902805|FG009|COMPLETED|Overall Study||6||
59782231|NCT00793793|75902806|FG010|COMPLETED|Overall Study||3||
59782232|NCT00793793|75902807|FG011|COMPLETED|Overall Study||1||
59782233|NCT00793793|75902796|FG000|NOT COMPLETED|Overall Study||0||
59782234|NCT00793793|75902797|FG001|NOT COMPLETED|Overall Study||1||
59782235|NCT00793793|75902798|FG002|NOT COMPLETED|Overall Study||2||
59782236|NCT00793793|75902799|FG003|NOT COMPLETED|Overall Study||3||
59782237|NCT00793793|75902800|FG004|NOT COMPLETED|Overall Study||2||
59782238|NCT00793793|75902801|FG005|NOT COMPLETED|Overall Study||2||
59782239|NCT00793793|75902802|FG006|NOT COMPLETED|Overall Study||4||
59522375|NCT01146379|75616776|FG000|NOT COMPLETED|Overall Study||1||
59522376|NCT01146379|75616777|FG001|NOT COMPLETED|Overall Study||1||
59522377|NCT01146379|75616778|FG002|NOT COMPLETED|Overall Study||0||
59522378|NCT01146379|75616779|FG003|NOT COMPLETED|Overall Study||1||
59522379|NCT01188109|75616789|FG000|STARTED|Overall Study||22||
59522380|NCT01188109|75616789|FG000|COMPLETED|Overall Study||22||
59522381|NCT01188109|75616789|FG000|NOT COMPLETED|Overall Study||0||
59522382|NCT03980470|75616793|FG000|STARTED|Overall Study||50||
59522383|NCT03980470|75616793|FG000|COMPLETED|Overall Study||50||
59522384|NCT03980470|75616793|FG000|NOT COMPLETED|Overall Study||0||
59522385|NCT01146457|75616805|FG000|STARTED|Overall Study||19||
59522386|NCT01146457|75616806|FG001|STARTED|Overall Study||17||
59522387|NCT01146457|75616807|FG002|STARTED|Overall Study||21||
59522388|NCT01146457|75616808|FG003|STARTED|Overall Study||13||
59522389|NCT01146457|75616809|FG004|STARTED|Overall Study||13||
59522390|NCT01146457|75616805|FG000|COMPLETED|Overall Study||19||
59522391|NCT01146457|75616806|FG001|COMPLETED|Overall Study||17||
59522392|NCT01146457|75616807|FG002|COMPLETED|Overall Study||20||
59522393|NCT01146457|75616808|FG003|COMPLETED|Overall Study||13||
59522394|NCT01146457|75616809|FG004|COMPLETED|Overall Study||13||
59522395|NCT01146457|75616805|FG000|NOT COMPLETED|Overall Study||0||
59522396|NCT01146457|75616806|FG001|NOT COMPLETED|Overall Study||0||
59522397|NCT01146457|75616807|FG002|NOT COMPLETED|Overall Study||1||
59522398|NCT01146457|75616808|FG003|NOT COMPLETED|Overall Study||0||
59522399|NCT01146457|75616809|FG004|NOT COMPLETED|Overall Study||0||
59522400|NCT04018924|75616821|FG000|STARTED|Overall Study|The total number of participants is 90 and the patient is control of themselves.|90||
59522401|NCT04018924|75616821|FG000|Standard Of Care Intervention|Overall Study||90||
59522402|NCT04018924|75616821|FG000|EmoLED Intervention|Overall Study||90||
59522403|NCT04018924|75616821|FG000|COMPLETED|Overall Study||84||
59522404|NCT04018924|75616821|FG000|NOT COMPLETED|Overall Study||6||
59522405|NCT04011436|75616827|FG000|STARTED|Overall Study||20||
59522406|NCT04011436|75616828|FG001|STARTED|Overall Study||20||
59522407|NCT04011436|75616827|FG000|COMPLETED|Overall Study||19||
59522408|NCT04011436|75616828|FG001|COMPLETED|Overall Study||19||
59522409|NCT04011436|75616827|FG000|NOT COMPLETED|Overall Study||1||
59522410|NCT04011436|75616828|FG001|NOT COMPLETED|Overall Study||1||
59522411|NCT04011592|75616836|FG000|STARTED|Overall Study||1||
59522412|NCT04011592|75616837|FG001|STARTED|Overall Study||0||
59522413|NCT04011592|75616836|FG000|COMPLETED|Overall Study||1||
59522414|NCT04011592|75616837|FG001|COMPLETED|Overall Study||0||
59522415|NCT04011592|75616836|FG000|NOT COMPLETED|Overall Study||0||
59522416|NCT04011592|75616837|FG001|NOT COMPLETED|Overall Study||0||
59522417|NCT04098172|75616843|FG000|STARTED|Overall Study||39||
59522418|NCT04098172|75616843|FG000|COMPLETED|Overall Study||39||
59522419|NCT04098172|75616843|FG000|NOT COMPLETED|Overall Study||0||
59782240|NCT00793793|75902803|FG007|NOT COMPLETED|Overall Study||0||
59522420|NCT04019626|75616853|FG000|STARTED|Overall Study||42||
59522421|NCT04019626|75616854|FG001|STARTED|Overall Study||42||
59522422|NCT04019626|75616855|FG002|STARTED|Overall Study||45||
59522423|NCT04019626|75616856|FG003|STARTED|Overall Study||46||
59522424|NCT04019626|75616857|FG004|STARTED|Overall Study||44||
59522425|NCT04019626|75616858|FG005|STARTED|Overall Study||21||
59522426|NCT04019626|75616853|FG000|COMPLETED|Overall Study||36||
59522427|NCT04019626|75616854|FG001|COMPLETED|Overall Study||32||
59522428|NCT04019626|75616855|FG002|COMPLETED|Overall Study||37||
59522429|NCT04019626|75616856|FG003|COMPLETED|Overall Study||39||
59522430|NCT04019626|75616857|FG004|COMPLETED|Overall Study||38||
59522431|NCT04019626|75616858|FG005|COMPLETED|Overall Study||20||
59522432|NCT04019626|75616853|FG000|NOT COMPLETED|Overall Study||6||
59782241|NCT00793793|75902804|FG008|NOT COMPLETED|Overall Study||9||
59782242|NCT00793793|75902805|FG009|NOT COMPLETED|Overall Study||9||
59782243|NCT00793793|75902806|FG010|NOT COMPLETED|Overall Study||3||
59782244|NCT00793793|75902807|FG011|NOT COMPLETED|Overall Study||6||
59782245|NCT00776789|75902855|FG000|STARTED|Overall Study||20||
59782246|NCT00776789|75902856|FG001|STARTED|Overall Study||21||
59782247|NCT00776789|75902855|FG000|COMPLETED|Overall Study||17||
59782248|NCT00776789|75902856|FG001|COMPLETED|Overall Study||18||
59782249|NCT00776789|75902855|FG000|NOT COMPLETED|Overall Study||3||
59782250|NCT00776789|75902856|FG001|NOT COMPLETED|Overall Study||3||
59782251|NCT00776555|75902866|FG000|STARTED|Overall Study||3||
59782252|NCT00776555|75902867|FG001|STARTED|Overall Study||0||
59782253|NCT00776555|75902866|FG000|COMPLETED|Overall Study||0||
59782254|NCT00776555|75902867|FG001|COMPLETED|Overall Study||0||
59782255|NCT00776555|75902866|FG000|NOT COMPLETED|Overall Study||3||
59782256|NCT00776555|75902867|FG001|NOT COMPLETED|Overall Study||0||
59782257|NCT00720434|75902877|FG000|STARTED|Double-Blind Period (Week 1-4)||10||
59782258|NCT00720434|75902878|FG001|STARTED|Double-Blind Period (Week 1-4)||9||
59782259|NCT00720434|75902879|FG002|STARTED|Double-Blind Period (Week 1-4)||8||
59782260|NCT00720434|75902880|FG003|STARTED|Double-Blind Period (Week 1-4)||8||
59782261|NCT00720434|75902877|FG000|COMPLETED|Double-Blind Period (Week 1-4)||10||
59782262|NCT00720434|75902878|FG001|COMPLETED|Double-Blind Period (Week 1-4)||8||
59782263|NCT00720434|75902879|FG002|COMPLETED|Double-Blind Period (Week 1-4)||8||
59782264|NCT00720434|75902880|FG003|COMPLETED|Double-Blind Period (Week 1-4)||8||
59782265|NCT00720434|75902877|FG000|NOT COMPLETED|Double-Blind Period (Week 1-4)||0||
59782266|NCT00720434|75902878|FG001|NOT COMPLETED|Double-Blind Period (Week 1-4)||1||
59782267|NCT00720434|75902879|FG002|NOT COMPLETED|Double-Blind Period (Week 1-4)||0||
59782268|NCT00720434|75902880|FG003|NOT COMPLETED|Double-Blind Period (Week 1-4)||0||
59782269|NCT00720434|75902877|FG000|STARTED|Open-Label Period (Week 5-72)||10||
59782270|NCT00720434|75902878|FG001|STARTED|Open-Label Period (Week 5-72)||8||
59782271|NCT00720434|75902879|FG002|STARTED|Open-Label Period (Week 5-72)||8||
59782272|NCT00720434|75902880|FG003|STARTED|Open-Label Period (Week 5-72)||8||
59782273|NCT00720434|75902877|FG000|COMPLETED|Open-Label Period (Week 5-72)||4||
59782274|NCT00720434|75902878|FG001|COMPLETED|Open-Label Period (Week 5-72)||5||
59782275|NCT00720434|75902879|FG002|COMPLETED|Open-Label Period (Week 5-72)||4||
59782276|NCT00720434|75902880|FG003|COMPLETED|Open-Label Period (Week 5-72)||4||
59782277|NCT00720434|75902877|FG000|NOT COMPLETED|Open-Label Period (Week 5-72)||6||
59782278|NCT00720434|75902878|FG001|NOT COMPLETED|Open-Label Period (Week 5-72)||3||
59782279|NCT00720434|75902879|FG002|NOT COMPLETED|Open-Label Period (Week 5-72)||4||
59782280|NCT00720434|75902880|FG003|NOT COMPLETED|Open-Label Period (Week 5-72)||4||
59782281|NCT00776009|75902896|FG000|STARTED|Period 1: First Intervention||26||
59782282|NCT00776009|75902897|FG001|STARTED|Period 1: First Intervention||28||
59782283|NCT00776009|75902898|FG002|STARTED|Period 1: First Intervention||29||
59782284|NCT00776009|75902899|FG003|STARTED|Period 1: First Intervention||27||
59782285|NCT00776009|75902900|FG004|STARTED|Period 1: First Intervention||28||
59782286|NCT00776009|75902901|FG005|STARTED|Period 1: First Intervention||27||
59782287|NCT00776009|75902896|FG000|COMPLETED|Period 1: First Intervention||26||
59782288|NCT00776009|75902897|FG001|COMPLETED|Period 1: First Intervention||27||
59782289|NCT00776009|75902898|FG002|COMPLETED|Period 1: First Intervention||28||
59782290|NCT00776009|75902899|FG003|COMPLETED|Period 1: First Intervention||27||
59782291|NCT00776009|75902900|FG004|COMPLETED|Period 1: First Intervention||26||
59782292|NCT00776009|75902901|FG005|COMPLETED|Period 1: First Intervention||27||
59782293|NCT00776009|75902896|FG000|NOT COMPLETED|Period 1: First Intervention||0||
59782294|NCT00776009|75902897|FG001|NOT COMPLETED|Period 1: First Intervention||1||
59782295|NCT00776009|75902898|FG002|NOT COMPLETED|Period 1: First Intervention||1||
59782296|NCT00776009|75902899|FG003|NOT COMPLETED|Period 1: First Intervention||0||
59782297|NCT00776009|75902900|FG004|NOT COMPLETED|Period 1: First Intervention||2||
59782298|NCT00776009|75902901|FG005|NOT COMPLETED|Period 1: First Intervention||0||
59782299|NCT00776009|75902896|FG000|STARTED|Period 2: Second Intervention||26||
59782300|NCT00776009|75902897|FG001|STARTED|Period 2: Second Intervention||27||
59782301|NCT00776009|75902898|FG002|STARTED|Period 2: Second Intervention||28||
59782302|NCT00776009|75902899|FG003|STARTED|Period 2: Second Intervention||27||
59782303|NCT00776009|75902900|FG004|STARTED|Period 2: Second Intervention||26||
59782304|NCT00776009|75902901|FG005|STARTED|Period 2: Second Intervention||27||
59782305|NCT00776009|75902896|FG000|COMPLETED|Period 2: Second Intervention||25||
59782306|NCT00776009|75902897|FG001|COMPLETED|Period 2: Second Intervention||27||
59782307|NCT00776009|75902898|FG002|COMPLETED|Period 2: Second Intervention||27||
59782308|NCT00776009|75902899|FG003|COMPLETED|Period 2: Second Intervention||27||
59782309|NCT00776009|75902900|FG004|COMPLETED|Period 2: Second Intervention||26||
59782310|NCT00776009|75902901|FG005|COMPLETED|Period 2: Second Intervention||26||
59782311|NCT00776009|75902896|FG000|NOT COMPLETED|Period 2: Second Intervention||1||
59782312|NCT00776009|75902897|FG001|NOT COMPLETED|Period 2: Second Intervention||0||
59782313|NCT00776009|75902898|FG002|NOT COMPLETED|Period 2: Second Intervention||1||
59782314|NCT00776009|75902899|FG003|NOT COMPLETED|Period 2: Second Intervention||0||
59782315|NCT00776009|75902900|FG004|NOT COMPLETED|Period 2: Second Intervention||0||
59782316|NCT00776009|75902901|FG005|NOT COMPLETED|Period 2: Second Intervention||1||
59782317|NCT00776009|75902896|FG000|STARTED|Period 3: Third Intervention||25||
59782318|NCT00776009|75902897|FG001|STARTED|Period 3: Third Intervention||27||
59782319|NCT00776009|75902898|FG002|STARTED|Period 3: Third Intervention||27||
59782320|NCT00776009|75902899|FG003|STARTED|Period 3: Third Intervention||27||
59782321|NCT00776009|75902900|FG004|STARTED|Period 3: Third Intervention||26||
59782322|NCT00776009|75902901|FG005|STARTED|Period 3: Third Intervention||26||
59782323|NCT00776009|75902896|FG000|COMPLETED|Period 3: Third Intervention||24||
59782324|NCT00776009|75902897|FG001|COMPLETED|Period 3: Third Intervention||27||
59782325|NCT00776009|75902898|FG002|COMPLETED|Period 3: Third Intervention||27||
59782326|NCT00776009|75902899|FG003|COMPLETED|Period 3: Third Intervention||27||
59782327|NCT00776009|75902900|FG004|COMPLETED|Period 3: Third Intervention||26||
59782328|NCT00776009|75902901|FG005|COMPLETED|Period 3: Third Intervention||26||
59782329|NCT00776009|75902896|FG000|NOT COMPLETED|Period 3: Third Intervention||1||
59782330|NCT00776009|75902897|FG001|NOT COMPLETED|Period 3: Third Intervention||0||
59782331|NCT00776009|75902898|FG002|NOT COMPLETED|Period 3: Third Intervention||0||
59782332|NCT00776009|75902899|FG003|NOT COMPLETED|Period 3: Third Intervention||0||
59782333|NCT00776009|75902900|FG004|NOT COMPLETED|Period 3: Third Intervention||0||
59782334|NCT00776009|75902901|FG005|NOT COMPLETED|Period 3: Third Intervention||0||
59782335|NCT00694161|75902909|FG000|STARTED|Part 1 (up to Week 6)||35||
59782336|NCT00694161|75902909|FG000|COMPLETED|Part 1 (up to Week 6)||35||
59782337|NCT00694161|75902909|FG000|NOT COMPLETED|Part 1 (up to Week 6)||0||
59782338|NCT00694161|75902909|FG000|STARTED|Part 2 (After Week 6 up to Month 12)||35||
59782339|NCT00694161|75902909|FG000|COMPLETED|Part 2 (After Week 6 up to Month 12)||32||
59782340|NCT00694161|75902909|FG000|NOT COMPLETED|Part 2 (After Week 6 up to Month 12)||3||
59782341|NCT00720356|75902913|FG000|STARTED|Registration to Study||115||
59782342|NCT00720356|75902913|FG000|Completed Registration Step 1|Registration to Study||115||
59782343|NCT00720356|75902913|FG000|Completed Registration Step 2|Registration to Study||48||
59782344|NCT00720356|75902913|FG000|COMPLETED|Registration to Study||48||
59782345|NCT00720356|75902913|FG000|NOT COMPLETED|Registration to Study||67||
59782346|NCT00720356|75902913|FG000|STARTED|Reached 1st Response/2 Cycles||48||
59782347|NCT00720356|75902913|FG000|COMPLETED|Reached 1st Response/2 Cycles||46||
59782348|NCT00720356|75902913|FG000|NOT COMPLETED|Reached 1st Response/2 Cycles||2||
59782349|NCT00720356|75902913|FG000|STARTED|Went on to be Treated Cycle 3||46||
59782350|NCT00720356|75902913|FG000|COMPLETED|Went on to be Treated Cycle 3||44||
59782351|NCT00720356|75902913|FG000|NOT COMPLETED|Went on to be Treated Cycle 3||2||
59782352|NCT00720356|75902913|FG000|STARTED|Follow up Until Death|All patients that are treated on study go into the follow up period|48||
59782353|NCT00720356|75902913|FG000|COMPLETED|Follow up Until Death||43||
59782354|NCT00720356|75902913|FG000|NOT COMPLETED|Follow up Until Death||5||
59782355|NCT00720278|75902920|FG000|STARTED|Overall Study|1 subject was randomized in error|178||
59782356|NCT00720278|75902921|FG001|STARTED|Overall Study|1 subject was randomized in error|170||
59782357|NCT00720278|75902922|FG002|STARTED|Overall Study|1 subject was randomized in error|178||
59782358|NCT00720278|75902920|FG000|COMPLETED|Overall Study||171||
59782359|NCT00720278|75902921|FG001|COMPLETED|Overall Study||166||
59782360|NCT00720278|75902922|FG002|COMPLETED|Overall Study||172||
59782361|NCT00720278|75902920|FG000|NOT COMPLETED|Overall Study||7||
59782362|NCT00720278|75902921|FG001|NOT COMPLETED|Overall Study||4||
59782363|NCT00720278|75902922|FG002|NOT COMPLETED|Overall Study||6||
59782364|NCT00720122|75902930|FG000|STARTED|Overall Study||28||
59782365|NCT00720122|75902930|FG000|COMPLETED|Overall Study||19||
59782366|NCT00720122|75902930|FG000|NOT COMPLETED|Overall Study||9||
59782367|NCT00717860|75902936|FG000|STARTED|Overall Study||61||
59782368|NCT00717860|75902937|FG001|STARTED|Overall Study||60||
59782369|NCT00717860|75902936|FG000|COMPLETED|Overall Study||34||
59782370|NCT00717860|75902937|FG001|COMPLETED|Overall Study||32||
59782371|NCT00717860|75902936|FG000|NOT COMPLETED|Overall Study||27||
59782372|NCT00717860|75902937|FG001|NOT COMPLETED|Overall Study||28||
59782373|NCT00717314|75902945|FG000|STARTED|Overall Study||43||
59782374|NCT00717314|75902946|FG001|STARTED|Overall Study||44||
59782375|NCT00717314|75902945|FG000|COMPLETED|Overall Study||37||
59782376|NCT00717314|75902946|FG001|COMPLETED|Overall Study||34||
59782377|NCT00717314|75902945|FG000|NOT COMPLETED|Overall Study||6||
59782378|NCT00717314|75902946|FG001|NOT COMPLETED|Overall Study||10||
59782379|NCT00689793|75902954|FG000|STARTED|Overall Study||78||
59782380|NCT00689793|75902955|FG001|STARTED|Overall Study||76||
59782381|NCT00689793|75902954|FG000|COMPLETED|Overall Study||74||
59994913|NCT03420781|76110738|FG000|Safety Population|Treatment Period (40 Weeks)||235|Safety Population included all participants in the Intent-to-treat (ITT) population who received ≥1 administration of study treatment.|
59782382|NCT00689793|75902955|FG001|COMPLETED|Overall Study||71||
59782383|NCT00689793|75902954|FG000|NOT COMPLETED|Overall Study||4||
59782384|NCT00689793|75902955|FG001|NOT COMPLETED|Overall Study||5||
59782385|NCT00723944|75902965|FG000|STARTED|Implant Placement Surgery|number of individual implant units is 148|52||
59782386|NCT00723944|75902966|FG001|STARTED|Implant Placement Surgery|number of individual implant units is 138|50||
59782387|NCT00723944|75902965|FG000|COMPLETED|Implant Placement Surgery|number of individual implant units completing is 148|52||
59782388|NCT00723944|75902966|FG001|COMPLETED|Implant Placement Surgery|number of individual implant units completing is 138|50||
59782389|NCT00723944|75902965|FG000|NOT COMPLETED|Implant Placement Surgery||0||
59782390|NCT00723944|75902966|FG001|NOT COMPLETED|Implant Placement Surgery||0||
59782391|NCT00723944|75902965|FG000|STARTED|Permanent Prosthesis Placement|number of individual implant units is 148|52||
59782392|NCT00723944|75902966|FG001|STARTED|Permanent Prosthesis Placement|number of individual implant units is 138|50||
59782393|NCT00723944|75902965|FG000|COMPLETED|Permanent Prosthesis Placement|number of individual implant units completing is 134|49||
59782394|NCT00723944|75902966|FG001|COMPLETED|Permanent Prosthesis Placement|number of individual implant units completing is 112|41||
59782395|NCT00723944|75902965|FG000|NOT COMPLETED|Permanent Prosthesis Placement||3||
59782396|NCT00723944|75902966|FG001|NOT COMPLETED|Permanent Prosthesis Placement||9||
59782397|NCT00723944|75902965|FG000|STARTED|One Year Post Placement Follow-up|number of individual implant units is 134|49||
59782398|NCT00723944|75902966|FG001|STARTED|One Year Post Placement Follow-up|number of individual implant units is 112|41||
59782399|NCT00723944|75902965|FG000|COMPLETED|One Year Post Placement Follow-up|number of individual implant units completing is 130|48||
59782400|NCT00723944|75902966|FG001|COMPLETED|One Year Post Placement Follow-up|number of individual implant units completing is 108|37||
59782401|NCT00723944|75902965|FG000|NOT COMPLETED|One Year Post Placement Follow-up||1||
59782402|NCT00723944|75902966|FG001|NOT COMPLETED|One Year Post Placement Follow-up||4||
59782403|NCT00723944|75902965|FG000|STARTED|Two Year Post Placement Follow-up|number of individual implant units is 130|48||
59782404|NCT00723944|75902966|FG001|STARTED|Two Year Post Placement Follow-up|number of individual implant units is 108|37||
59782405|NCT00723944|75902965|FG000|COMPLETED|Two Year Post Placement Follow-up|number of individual implant units completing is 130|48||
59782406|NCT00723944|75902966|FG001|COMPLETED|Two Year Post Placement Follow-up|number of individual implant units completing is 108|37||
59782407|NCT00723944|75902965|FG000|NOT COMPLETED|Two Year Post Placement Follow-up||0||
59782408|NCT00723944|75902966|FG001|NOT COMPLETED|Two Year Post Placement Follow-up||0||
59782409|NCT00689481|75902974|FG000|STARTED|Overall Study||214||
59782410|NCT00689481|75902975|FG001|STARTED|Overall Study||109||
59782411|NCT00689481|75902974|FG000|COMPLETED|Overall Study||190||
59782412|NCT00689481|75902975|FG001|COMPLETED|Overall Study||95||
59782413|NCT00689481|75902974|FG000|NOT COMPLETED|Overall Study||24||
59782414|NCT00689481|75902975|FG001|NOT COMPLETED|Overall Study||14||
59782415|NCT00688701|75902984|FG000|STARTED|Overall Study|Randomized|61||
59782416|NCT00688701|75902985|FG001|STARTED|Overall Study||61||
59782417|NCT00688701|75902986|FG002|STARTED|Overall Study||120||
59782418|NCT00688701|75902987|FG003|STARTED|Overall Study||119||
59782419|NCT00688701|75902984|FG000|Treated/Safety Population|Overall Study|All patients who received at least 1 dose, regardless of amount of treatment administered.|61||
59782420|NCT00688701|75902985|FG001|Treated/Safety Population|Overall Study||61||
59782421|NCT00688701|75902986|FG002|Treated/Safety Population|Overall Study||120||
59782422|NCT00688701|75902987|FG003|Treated/Safety Population|Overall Study||119||
59782423|NCT00688701|75902984|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|61||
59782424|NCT00688701|75902985|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||60||
59782425|NCT00688701|75902986|FG002|Modified Intent-to-Treat(mITT)Population|Overall Study||120||
60073060|NCT01564407|76188252|FG000|COMPLETED|Overall Study||4||
60073061|NCT01564407|76188253|FG001|COMPLETED|Overall Study||3||
60073062|NCT01564407|76188254|FG002|COMPLETED|Overall Study||4||
59782426|NCT00688701|75902987|FG003|Modified Intent-to-Treat(mITT)Population|Overall Study||118||
59782427|NCT00688701|75902984|FG000|Subgroup for Standardized Meal Test|Overall Study|Patients at selected sites where standardized meal test was performed.|27||
59782428|NCT00688701|75902985|FG001|Subgroup for Standardized Meal Test|Overall Study||35||
59782429|NCT00688701|75902986|FG002|Subgroup for Standardized Meal Test|Overall Study||60||
59782430|NCT00688701|75902987|FG003|Subgroup for Standardized Meal Test|Overall Study||65||
59782431|NCT00688701|75902984|FG000|COMPLETED|Overall Study||57||
59782432|NCT00688701|75902985|FG001|COMPLETED|Overall Study||56||
59782433|NCT00688701|75902986|FG002|COMPLETED|Overall Study||110||
59782434|NCT00688701|75902987|FG003|COMPLETED|Overall Study||108||
59782435|NCT00688701|75902984|FG000|NOT COMPLETED|Overall Study||4||
59782436|NCT00688701|75902985|FG001|NOT COMPLETED|Overall Study||5||
59782437|NCT00688701|75902986|FG002|NOT COMPLETED|Overall Study||10||
59782438|NCT00688701|75902987|FG003|NOT COMPLETED|Overall Study||11||
59782439|NCT00999609|75903000|FG000|STARTED|Overall Study|Before intervention|21||
59782440|NCT00999609|75903001|FG001|STARTED|Overall Study||10||
59782441|NCT00999609|75903000|FG000|COMPLETED|Overall Study|1 year post intervention|20||
59782442|NCT00999609|75903001|FG001|COMPLETED|Overall Study|1 year post intervention|9||
59782443|NCT00999609|75903000|FG000|NOT COMPLETED|Overall Study||1||
59782444|NCT00999609|75903001|FG001|NOT COMPLETED|Overall Study||1||
59953027|NCT04057820|76071780|FG000|STARTED|Period 2|"Block 1 with 4 sites transitioned from Usual Care to ESC during Period 2; therefore no infants were being enrolled and the total number of sites enrolling infants was 22.~For this stepped wedge study design, a new cohort of infants is enrolled during each period except the transition period. Therefore, the number of infants to start a period is unlikely to equal the number of infants who completed the previous period."|0||0
59953028|NCT04057820|76071781|FG001|STARTED|Period 2||0||0
59953029|NCT04057820|76071782|FG002|STARTED|Period 2|For this stepped wedge study design, a new cohort of infants is enrolled during each period except the transition period. Therefore, the number of infants to start a period is unlikely to equal the number of infants who completed the previous period.|5||2
59953030|NCT04057820|76071783|FG003|STARTED|Period 2||0||0
59953031|NCT04057820|76071784|FG004|STARTED|Period 2||11||3
60073063|NCT01564407|76188255|FG003|COMPLETED|Overall Study||1||
60073064|NCT01564407|76188256|FG004|COMPLETED|Overall Study||0||
60073065|NCT01564407|76188252|FG000|NOT COMPLETED|Overall Study||0||
59782445|NCT00688623|75903007|FG000|STARTED|Overall Study|Intent to treat (ITT)|73||
59782446|NCT00688623|75903007|FG000|Safety Analysis Set|Overall Study|received at least one dose of study drug and had at least one post-baseline safety assessment|73||
59782447|NCT00688623|75903007|FG000|Per Protocol (PP)|Overall Study|no major protocol deviation and 50% of planned dose of 8 weeks or d/c due to disease progression|60||
59782448|NCT00688623|75903007|FG000|COMPLETED|Overall Study||18||
59782449|NCT00688623|75903007|FG000|NOT COMPLETED|Overall Study||55||
59782450|NCT00717236|75903013|FG000|STARTED|Double-Blind Period||851||
59782451|NCT00717236|75903014|FG001|STARTED|Double-Blind Period||212||
59782452|NCT00717236|75903013|FG000|COMPLETED|Double-Blind Period||771||
59782453|NCT00717236|75903014|FG001|COMPLETED|Double-Blind Period||184||
59782454|NCT00717236|75903013|FG000|NOT COMPLETED|Double-Blind Period||80||
59782455|NCT00717236|75903014|FG001|NOT COMPLETED|Double-Blind Period||28||
59782456|NCT00717236|75903013|FG000|STARTED|Open-Label Period||771||
59782457|NCT00717236|75903014|FG001|STARTED|Open-Label Period||184||
59782458|NCT00717236|75903013|FG000|COMPLETED|Open-Label Period||646||
59782459|NCT00717236|75903014|FG001|COMPLETED|Open-Label Period||163||
59782460|NCT00717236|75903013|FG000|NOT COMPLETED|Open-Label Period||125||
59782461|NCT00717236|75903014|FG001|NOT COMPLETED|Open-Label Period||21||
59782462|NCT00719810|75903025|FG000|STARTED|Overall Study||49||
59782463|NCT00719810|75903026|FG001|STARTED|Overall Study||51||
59782464|NCT00719810|75903027|FG002|STARTED|Overall Study||50||
59782465|NCT00719810|75903025|FG000|COMPLETED|Overall Study||46||
59782466|NCT00719810|75903026|FG001|COMPLETED|Overall Study||47||
59782467|NCT00719810|75903027|FG002|COMPLETED|Overall Study||42||
59782468|NCT00719810|75903025|FG000|NOT COMPLETED|Overall Study||3||
59782469|NCT00719810|75903026|FG001|NOT COMPLETED|Overall Study||4||
59782470|NCT00719810|75903027|FG002|NOT COMPLETED|Overall Study||8||
59782471|NCT00719732|75903035|FG000|STARTED|Overall Study||218||
59782472|NCT00719732|75903035|FG000|COMPLETED|Overall Study||196||
59782473|NCT00719732|75903035|FG000|NOT COMPLETED|Overall Study||22||
59782474|NCT00723710|75903039|FG000|STARTED|Overall Study||294||
59782475|NCT00723710|75903039|FG000|COMPLETED|Overall Study||120||
59782476|NCT00723710|75903039|FG000|NOT COMPLETED|Overall Study||174||
59782477|NCT00688545|75903045|FG000|STARTED|Overall Study||55||
59782478|NCT00688545|75903046|FG001|STARTED|Overall Study||219||
59782479|NCT00688545|75903045|FG000|Switched Treatment at Least Once|Overall Study||6||
59782480|NCT00688545|75903046|FG001|Switched Treatment at Least Once|Overall Study||13||
59782481|NCT00688545|75903045|FG000|COMPLETED|Overall Study||50||
59782482|NCT00688545|75903046|FG001|COMPLETED|Overall Study||204||
59782483|NCT00688545|75903045|FG000|NOT COMPLETED|Overall Study||5||
59782484|NCT00688545|75903046|FG001|NOT COMPLETED|Overall Study||15||
59782485|NCT00688467|75903056|FG000|STARTED|Treatment Period 1||9||
59782486|NCT00688467|75903057|FG001|STARTED|Treatment Period 1||10||
59782487|NCT00688467|75903056|FG000|COMPLETED|Treatment Period 1||7||
59782488|NCT00688467|75903057|FG001|COMPLETED|Treatment Period 1||8||
59782489|NCT00688467|75903056|FG000|NOT COMPLETED|Treatment Period 1||2||
59782490|NCT00688467|75903057|FG001|NOT COMPLETED|Treatment Period 1||2||
59782491|NCT00688467|75903056|FG000|STARTED|Treatment Period 2||7||
59782492|NCT00688467|75903057|FG001|STARTED|Treatment Period 2||8||
59782493|NCT00688467|75903056|FG000|COMPLETED|Treatment Period 2||7||
59782494|NCT00688467|75903057|FG001|COMPLETED|Treatment Period 2||6||
59782495|NCT00688467|75903056|FG000|NOT COMPLETED|Treatment Period 2||0||
59782496|NCT00688467|75903057|FG001|NOT COMPLETED|Treatment Period 2||2||
59782497|NCT00688155|75903067|FG000|STARTED|Overall Study||18||
59782498|NCT00688155|75903068|FG001|STARTED|Overall Study||18||
59782499|NCT00688155|75903069|FG002|STARTED|Overall Study||19||
59782500|NCT00688155|75903070|FG003|STARTED|Overall Study||18||
59782501|NCT00688155|75903067|FG000|COMPLETED|Overall Study||16||
59782502|NCT00688155|75903068|FG001|COMPLETED|Overall Study||16||
59782503|NCT00688155|75903069|FG002|COMPLETED|Overall Study||18||
59782504|NCT00688155|75903070|FG003|COMPLETED|Overall Study||17||
59782505|NCT00688155|75903067|FG000|NOT COMPLETED|Overall Study||2||
59782506|NCT00688155|75903068|FG001|NOT COMPLETED|Overall Study||2||
59782507|NCT00688155|75903069|FG002|NOT COMPLETED|Overall Study||1||
59782508|NCT00688155|75903070|FG003|NOT COMPLETED|Overall Study||1||
59782509|NCT00690573|75903080|FG000|STARTED|Overall Study||25||
59782510|NCT00690573|75903080|FG000|COMPLETED|Overall Study||16||
59782511|NCT00690573|75903080|FG000|NOT COMPLETED|Overall Study||9||
59782512|NCT00719264|75903086|FG000|STARTED|Overall Study||182||
59782513|NCT00719264|75903087|FG001|STARTED|Overall Study||183||
59782514|NCT00719264|75903086|FG000|Full Analysis Set|Overall Study||182||
59782515|NCT00719264|75903087|FG001|Full Analysis Set|Overall Study||183||
59782516|NCT00719264|75903086|FG000|Safety Set|Overall Study||180||
59782517|NCT00719264|75903087|FG001|Safety Set|Overall Study||181||
59782518|NCT00719264|75903086|FG000|COMPLETED|Overall Study||0||
59782519|NCT00719264|75903087|FG001|COMPLETED|Overall Study||0||
59782520|NCT00719264|75903086|FG000|NOT COMPLETED|Overall Study||182||
59782521|NCT00719264|75903087|FG001|NOT COMPLETED|Overall Study||183||
59782522|NCT00687609|75903093|FG000|STARTED|Overall Study||7||
59782523|NCT00687609|75903093|FG000|COMPLETED|Overall Study||4||
59782524|NCT00687609|75903093|FG000|NOT COMPLETED|Overall Study||3||
59782525|NCT00723554|75903097|FG000|STARTED|Overall Study||63||
59782526|NCT00723554|75903097|FG000|COMPLETED|Overall Study||34||
59782527|NCT00723554|75903097|FG000|NOT COMPLETED|Overall Study||29||
59782528|NCT00687219|75903103|FG000|STARTED|Overall Study||102||
59782529|NCT00687219|75903103|FG000|COMPLETED|Overall Study||51||
59782530|NCT00687219|75903103|FG000|NOT COMPLETED|Overall Study||51||
59782531|NCT00723398|75903112|FG000|STARTED|Overall Study||53||
59782532|NCT00723398|75903113|FG001|STARTED|Overall Study||53||
59782533|NCT00723398|75903114|FG002|STARTED|Overall Study||53||
59782534|NCT00723398|75903115|FG003|STARTED|Overall Study||54||
59782535|NCT00723398|75903116|FG004|STARTED|Overall Study||53||
59782536|NCT00723398|75903112|FG000|COMPLETED|Overall Study||47||
59782537|NCT00723398|75903113|FG001|COMPLETED|Overall Study||38||
59782538|NCT00723398|75903114|FG002|COMPLETED|Overall Study||36||
59782539|NCT00723398|75903115|FG003|COMPLETED|Overall Study||49||
59782540|NCT00723398|75903116|FG004|COMPLETED|Overall Study||44||
59782541|NCT00723398|75903112|FG000|NOT COMPLETED|Overall Study||6||
59782542|NCT00723398|75903113|FG001|NOT COMPLETED|Overall Study||15||
59782543|NCT00723398|75903114|FG002|NOT COMPLETED|Overall Study||17||
59782544|NCT00723398|75903115|FG003|NOT COMPLETED|Overall Study||5||
59782545|NCT00723398|75903116|FG004|NOT COMPLETED|Overall Study||9||
59782546|NCT00716456|75903131|FG000|STARTED|Overall Study||3||
59782547|NCT00716456|75903132|FG001|STARTED|Overall Study||5||
59782548|NCT00716456|75903133|FG002|STARTED|Overall Study||13||
59782549|NCT00716456|75903131|FG000|COMPLETED|Overall Study||3||
59782550|NCT00716456|75903132|FG001|COMPLETED|Overall Study||3||
59782551|NCT00716456|75903133|FG002|COMPLETED|Overall Study||13||
59782552|NCT00716456|75903131|FG000|NOT COMPLETED|Overall Study||0||
59782553|NCT00716456|75903132|FG001|NOT COMPLETED|Overall Study||2||
59782554|NCT00716456|75903133|FG002|NOT COMPLETED|Overall Study||0||
59782555|NCT00684645|75903141|FG000|STARTED|Overall Study||186||
59782556|NCT00684645|75903141|FG000|COMPLETED|Overall Study||72||
59782557|NCT00684645|75903141|FG000|NOT COMPLETED|Overall Study||114||
59782558|NCT00716144|75903149|FG000|STARTED|Overall Study||41||
59782559|NCT00716144|75903150|FG001|STARTED|Overall Study||45||
59782560|NCT00716144|75903151|FG002|STARTED|Overall Study||45||
59782561|NCT00716144|75903152|FG003|STARTED|Overall Study||45||
59782562|NCT00716144|75903149|FG000|COMPLETED|Overall Study||32||
59782563|NCT00716144|75903150|FG001|COMPLETED|Overall Study||38||
59782564|NCT00716144|75903151|FG002|COMPLETED|Overall Study||33||
59782565|NCT00716144|75903152|FG003|COMPLETED|Overall Study||33||
59782566|NCT00716144|75903149|FG000|NOT COMPLETED|Overall Study||9||
59782567|NCT00716144|75903150|FG001|NOT COMPLETED|Overall Study||7||
59782568|NCT00716144|75903151|FG002|NOT COMPLETED|Overall Study||12||
59782569|NCT00716144|75903152|FG003|NOT COMPLETED|Overall Study||12||
59782570|NCT00576381|75903162|FG000|STARTED|Overall Study||30||
59782571|NCT00576381|75903162|FG000|COMPLETED|Overall Study||23||
59782572|NCT00576381|75903162|FG000|NOT COMPLETED|Overall Study||7||
59782573|NCT00684567|75903166|FG000|STARTED|Concomitant Radiotherapy Period||30||
59782574|NCT00684567|75903166|FG000|COMPLETED|Concomitant Radiotherapy Period||28||
59782575|NCT00684567|75903166|FG000|NOT COMPLETED|Concomitant Radiotherapy Period||2||
59782576|NCT00684567|75903166|FG000|STARTED|Monotherapy Period|5 subjects completed radiotherapy combined therapy phase but did not proceed to monotherapy phase.|23||
59782577|NCT00684567|75903166|FG000|COMPLETED|Monotherapy Period||9||
59782578|NCT00684567|75903166|FG000|NOT COMPLETED|Monotherapy Period||14||
59782579|NCT00684411|75903170|FG000|STARTED|Overall Study||12||
59782580|NCT00684411|75903170|FG000|Disease Evaluable|Overall Study||11||
59782581|NCT00684411|75903170|FG000|COMPLETED|Overall Study||0||
59782582|NCT00684411|75903170|FG000|NOT COMPLETED|Overall Study||12||
59782583|NCT00686829|75903174|FG000|STARTED|Overall Study||79|Number of participants who were previously enrolled in study ACTG A5211 who received ≥1 dose of VCV in P04100.|
59782584|NCT00686829|75903174|FG000|COMPLETED|Overall Study||0||
59782585|NCT00686829|75903174|FG000|NOT COMPLETED|Overall Study||79||
59782586|NCT00687297|75903180|FG000|STARTED|Randomization||80||
59782587|NCT00687297|75903181|FG001|STARTED|Randomization||82||
59782588|NCT00687297|75903180|FG000|COMPLETED|Randomization||77||
59782589|NCT00687297|75903181|FG001|COMPLETED|Randomization||81||
59782590|NCT00687297|75903180|FG000|NOT COMPLETED|Randomization||3||
59782591|NCT00687297|75903181|FG001|NOT COMPLETED|Randomization||1||
59782592|NCT00687297|75903180|FG000|STARTED|Induction||77||
59782593|NCT00687297|75903181|FG001|STARTED|Induction||81||
59782594|NCT00687297|75903180|FG000|COMPLETED|Induction||32||
59782595|NCT00687297|75903181|FG001|COMPLETED|Induction||26||
59782596|NCT00687297|75903180|FG000|NOT COMPLETED|Induction||45||
59782597|NCT00687297|75903181|FG001|NOT COMPLETED|Induction||55||
59782598|NCT00687297|75903180|FG000|STARTED|Maintenance||32||
59782599|NCT00687297|75903181|FG001|STARTED|Maintenance||26||
59782600|NCT00687297|75903180|FG000|COMPLETED|Maintenance||29||
59782601|NCT00687297|75903181|FG001|COMPLETED|Maintenance||25||
59782602|NCT00687297|75903180|FG000|NOT COMPLETED|Maintenance||3||
59782603|NCT00687297|75903181|FG001|NOT COMPLETED|Maintenance||1||
59782604|NCT00684177|75903191|FG000|STARTED|Overall Study||343||
59782605|NCT00684177|75903192|FG001|STARTED|Overall Study||164||
59782606|NCT00684177|75903191|FG000|COMPLETED|Overall Study||322||
59782607|NCT00684177|75903192|FG001|COMPLETED|Overall Study||141||
59782608|NCT00684177|75903191|FG000|NOT COMPLETED|Overall Study||21||
59782609|NCT00684177|75903192|FG001|NOT COMPLETED|Overall Study||23||
59782610|NCT00684021|75903202|FG000|STARTED|Overall Study||43||
59782611|NCT00684021|75903203|FG001|STARTED|Overall Study||24||
59782612|NCT00684021|75903204|FG002|STARTED|Overall Study||36||
59782613|NCT00684021|75903205|FG003|STARTED|Overall Study||17||
59782614|NCT00684021|75903202|FG000|COMPLETED|Overall Study||41||
59782615|NCT00684021|75903203|FG001|COMPLETED|Overall Study||22||
59782616|NCT00684021|75903204|FG002|COMPLETED|Overall Study||34||
59782617|NCT00684021|75903205|FG003|COMPLETED|Overall Study||15||
59782618|NCT00684021|75903202|FG000|NOT COMPLETED|Overall Study||2||
59782619|NCT00684021|75903203|FG001|NOT COMPLETED|Overall Study||2||
59782620|NCT00684021|75903204|FG002|NOT COMPLETED|Overall Study||2||
59782621|NCT00684021|75903205|FG003|NOT COMPLETED|Overall Study||2||
59782622|NCT00576303|75903215|FG000|STARTED|Dose Titration Period||200||
59782623|NCT00576303|75903215|FG000|COMPLETED|Dose Titration Period||183||
59782624|NCT00576303|75903215|FG000|NOT COMPLETED|Dose Titration Period||17||
59782625|NCT00576303|75903215|FG000|STARTED|Efficacy Evaluation Period||183||
59782626|NCT00576303|75903215|FG000|COMPLETED|Efficacy Evaluation Period||178||
59782627|NCT00576303|75903215|FG000|NOT COMPLETED|Efficacy Evaluation Period||5||
59782628|NCT00576303|75903215|FG000|STARTED|Long Term Safety Period||178||
59782629|NCT00576303|75903215|FG000|COMPLETED|Long Term Safety Period||162||
59782630|NCT00576303|75903215|FG000|NOT COMPLETED|Long Term Safety Period||16||
59782631|NCT00686517|75903222|FG000|STARTED|Treatment||44||
59782632|NCT00686517|75903223|FG001|STARTED|Treatment||43||
59782633|NCT00686517|75903224|FG002|STARTED|Treatment||43||
59782634|NCT00686517|75903222|FG000|Completed Final Treatment Visit|Treatment|Included 6 that discontinued the treatment before completion,but performed the Final Treatment Visit|44||
59782635|NCT00686517|75903223|FG001|Completed Final Treatment Visit|Treatment|Included 3 that discontinued the treatment before completion,but performed the Final Treatment Visit|43||
59782636|NCT00686517|75903224|FG002|Completed Final Treatment Visit|Treatment|Included 1 that discontinued the treatment before completion,but performed the Final Treatment Visit|43||
59782637|NCT00686517|75903222|FG000|COMPLETED|Treatment||38||
59782638|NCT00686517|75903223|FG001|COMPLETED|Treatment||40||
59782639|NCT00686517|75903224|FG002|COMPLETED|Treatment||42||
59782640|NCT00686517|75903222|FG000|NOT COMPLETED|Treatment||6||
59782641|NCT00686517|75903223|FG001|NOT COMPLETED|Treatment||3||
59782642|NCT00686517|75903224|FG002|NOT COMPLETED|Treatment||1||
59782643|NCT00686517|75903222|FG000|STARTED|Follow-up||37||
59782644|NCT00686517|75903223|FG001|STARTED|Follow-up||38||
59782645|NCT00686517|75903224|FG002|STARTED|Follow-up||39||
59782646|NCT00686517|75903222|FG000|COMPLETED|Follow-up||29||
59782647|NCT00686517|75903223|FG001|COMPLETED|Follow-up||28||
59782648|NCT00686517|75903224|FG002|COMPLETED|Follow-up||29||
59782649|NCT00686517|75903222|FG000|NOT COMPLETED|Follow-up||8||
59782650|NCT00686517|75903223|FG001|NOT COMPLETED|Follow-up||10||
59782651|NCT00686517|75903224|FG002|NOT COMPLETED|Follow-up||10||
59782652|NCT00686205|75903234|FG000|STARTED|Overall Study||21606||
59782653|NCT00686205|75903235|FG001|STARTED|Overall Study||2505||
59782654|NCT00686205|75903234|FG000|COMPLETED|Overall Study||15599||
59782655|NCT00686205|75903235|FG001|COMPLETED|Overall Study||1524||
59782656|NCT00686205|75903234|FG000|NOT COMPLETED|Overall Study||6007||
59782657|NCT00686205|75903235|FG001|NOT COMPLETED|Overall Study||981||
59782658|NCT00571701|75903243|FG000|STARTED|First Intervention 12 Months||19||
59782659|NCT00571701|75903244|FG001|STARTED|First Intervention 12 Months||22||
59782660|NCT00571701|75903243|FG000|COMPLETED|First Intervention 12 Months||16||
59782661|NCT00571701|75903244|FG001|COMPLETED|First Intervention 12 Months||21||
59782662|NCT00571701|75903243|FG000|NOT COMPLETED|First Intervention 12 Months||3||
59782663|NCT00571701|75903244|FG001|NOT COMPLETED|First Intervention 12 Months||1||
59782664|NCT00571701|75903243|FG000|STARTED|Second Intervention 12 Months||16||
59782665|NCT00571701|75903244|FG001|STARTED|Second Intervention 12 Months||21||
59782666|NCT00571701|75903243|FG000|COMPLETED|Second Intervention 12 Months||13||
59782667|NCT00571701|75903244|FG001|COMPLETED|Second Intervention 12 Months||20||
59782668|NCT00571701|75903243|FG000|NOT COMPLETED|Second Intervention 12 Months||3||
59782669|NCT00571701|75903244|FG001|NOT COMPLETED|Second Intervention 12 Months||1||
59782670|NCT00686127|75903270|FG000|STARTED|Overall Study||14||
59782671|NCT00686127|75903271|FG001|STARTED|Overall Study||7||
59782672|NCT00686127|75903270|FG000|COMPLETED|Overall Study|Patients withdrew from the study because they did not like wearing the patch.|0||
59782673|NCT00686127|75903271|FG001|COMPLETED|Overall Study||1||
59782674|NCT00686127|75903270|FG000|NOT COMPLETED|Overall Study||14||
59782675|NCT00686127|75903271|FG001|NOT COMPLETED|Overall Study||6||
59782676|NCT00718718|75903284|FG000|STARTED|Prior to Week 12||19||
59782677|NCT00718718|75903285|FG001|STARTED|Prior to Week 12||0||
59782678|NCT00718718|75903286|FG002|STARTED|Prior to Week 12||17||
59782679|NCT00718718|75903287|FG003|STARTED|Prior to Week 12||0||
59782680|NCT00718718|75903288|FG004|STARTED|Prior to Week 12||30||
59782681|NCT00718718|75903289|FG005|STARTED|Prior to Week 12||0||
59782682|NCT00718718|75903290|FG006|STARTED|Prior to Week 12||30||
59782683|NCT00718718|75903291|FG007|STARTED|Prior to Week 12||30||
59782684|NCT00718718|75903292|FG008|STARTED|Prior to Week 12||30||
59782685|NCT00718718|75903293|FG009|STARTED|Prior to Week 12||31||
59782686|NCT00718718|75903284|FG000|COMPLETED|Prior to Week 12||18||
59782687|NCT00718718|75903285|FG001|COMPLETED|Prior to Week 12||0||
59782688|NCT00718718|75903286|FG002|COMPLETED|Prior to Week 12||16||
59782689|NCT00718718|75903287|FG003|COMPLETED|Prior to Week 12||0||
59782690|NCT00718718|75903288|FG004|COMPLETED|Prior to Week 12||27||
59782691|NCT00718718|75903289|FG005|COMPLETED|Prior to Week 12||0||
59782692|NCT00718718|75903290|FG006|COMPLETED|Prior to Week 12||29||
59782693|NCT00718718|75903291|FG007|COMPLETED|Prior to Week 12||28||
59782694|NCT00718718|75903292|FG008|COMPLETED|Prior to Week 12||28||
59782695|NCT00718718|75903293|FG009|COMPLETED|Prior to Week 12||31||
59782696|NCT00718718|75903284|FG000|NOT COMPLETED|Prior to Week 12||1||
59782697|NCT00718718|75903285|FG001|NOT COMPLETED|Prior to Week 12||0||
59782698|NCT00718718|75903286|FG002|NOT COMPLETED|Prior to Week 12||1||
59782699|NCT00718718|75903287|FG003|NOT COMPLETED|Prior to Week 12||0||
59782700|NCT00718718|75903288|FG004|NOT COMPLETED|Prior to Week 12||3||
59782701|NCT00718718|75903289|FG005|NOT COMPLETED|Prior to Week 12||0||
59782702|NCT00718718|75903290|FG006|NOT COMPLETED|Prior to Week 12||1||
59782703|NCT00718718|75903291|FG007|NOT COMPLETED|Prior to Week 12||2||
59782704|NCT00718718|75903292|FG008|NOT COMPLETED|Prior to Week 12||2||
59782705|NCT00718718|75903293|FG009|NOT COMPLETED|Prior to Week 12||0||
59619235|NCT03108924|75730441|FG000|NOT COMPLETED|Overall Study||0||
59619236|NCT03108924|75730442|FG001|NOT COMPLETED|Overall Study||0||
59619237|NCT03108924|75730443|FG002|NOT COMPLETED|Overall Study||0||
59619238|NCT03108924|75730444|FG003|NOT COMPLETED|Overall Study||0||
59619239|NCT00636636|75730465|FG000|STARTED|Overall Study||221||
59619240|NCT00636636|75730466|FG001|STARTED|Overall Study||231||
59619241|NCT00636636|75730465|FG000|Safety & Efficacy of Gabapentin ER|Overall Study||186||
59619242|NCT00636636|75730466|FG001|Safety & Efficacy of Gabapentin ER|Overall Study|1 patient randomized twice, not included in ITT, but completed medication and counted as completer|194||
59619243|NCT00636636|75730465|FG000|379|Overall Study||186||
59619244|NCT00636636|75730466|FG001|379|Overall Study|1 patient randomized twice, not included in ITT, but completed medication and counted as completer|194||
59619245|NCT00636636|75730465|FG000|COMPLETED|Overall Study||185||
59619246|NCT00636636|75730466|FG001|COMPLETED|Overall Study||192||
59619247|NCT00636636|75730465|FG000|NOT COMPLETED|Overall Study||36||
59619248|NCT00636636|75730466|FG001|NOT COMPLETED|Overall Study||39||
59619249|NCT00635778|75730479|FG000|STARTED|Overall Study||1||
59619250|NCT00635778|75730480|FG001|STARTED|Overall Study||3||
59619251|NCT00635778|75730481|FG002|STARTED|Overall Study||3||
59619252|NCT00635778|75730482|FG003|STARTED|Overall Study||8||
59619253|NCT00635778|75730483|FG004|STARTED|Overall Study||8||
59619254|NCT00635778|75730484|FG005|STARTED|Overall Study||21||
59619255|NCT00635778|75730485|FG006|STARTED|Overall Study||6||
59619256|NCT00635778|75730479|FG000|COMPLETED|Overall Study||0||
59619257|NCT00635778|75730480|FG001|COMPLETED|Overall Study||0||
59619258|NCT00635778|75730481|FG002|COMPLETED|Overall Study||0||
59782706|NCT00718718|75903284|FG000|STARTED|Week 12 to End of Study||0||
59782707|NCT00718718|75903285|FG001|STARTED|Week 12 to End of Study||18||
59782708|NCT00718718|75903286|FG002|STARTED|Week 12 to End of Study||0||
59782709|NCT00718718|75903287|FG003|STARTED|Week 12 to End of Study||16||
59782710|NCT00718718|75903288|FG004|STARTED|Week 12 to End of Study||0||
59782711|NCT00718718|75903289|FG005|STARTED|Week 12 to End of Study||27||
59782712|NCT00718718|75903290|FG006|STARTED|Week 12 to End of Study||29||
59782713|NCT00718718|75903291|FG007|STARTED|Week 12 to End of Study||28||
59782714|NCT00718718|75903292|FG008|STARTED|Week 12 to End of Study||28||
59782715|NCT00718718|75903293|FG009|STARTED|Week 12 to End of Study||31||
59782716|NCT00718718|75903284|FG000|Treated|Week 12 to End of Study||0||
59782717|NCT00718718|75903285|FG001|Treated|Week 12 to End of Study||18||
59782718|NCT00718718|75903286|FG002|Treated|Week 12 to End of Study||0||
59782719|NCT00718718|75903287|FG003|Treated|Week 12 to End of Study||16||
59782720|NCT00718718|75903288|FG004|Treated|Week 12 to End of Study||0||
59782721|NCT00718718|75903289|FG005|Treated|Week 12 to End of Study||26||
59782722|NCT00718718|75903290|FG006|Treated|Week 12 to End of Study||29||
59782723|NCT00718718|75903291|FG007|Treated|Week 12 to End of Study||28||
59782724|NCT00718718|75903292|FG008|Treated|Week 12 to End of Study||28||
59782725|NCT00718718|75903293|FG009|Treated|Week 12 to End of Study||31||
59782726|NCT00718718|75903284|FG000|COMPLETED|Week 12 to End of Study||0||
59782727|NCT00718718|75903285|FG001|COMPLETED|Week 12 to End of Study||17||
59782728|NCT00718718|75903286|FG002|COMPLETED|Week 12 to End of Study||0||
59782729|NCT00718718|75903287|FG003|COMPLETED|Week 12 to End of Study||15||
59782730|NCT00718718|75903288|FG004|COMPLETED|Week 12 to End of Study||0||
59782731|NCT00718718|75903289|FG005|COMPLETED|Week 12 to End of Study||24||
59619259|NCT00635778|75730482|FG003|COMPLETED|Overall Study||0||
59619260|NCT00635778|75730483|FG004|COMPLETED|Overall Study||0||
59619261|NCT00635778|75730484|FG005|COMPLETED|Overall Study||0||
59619262|NCT00635778|75730485|FG006|COMPLETED|Overall Study||0||
59619263|NCT00635778|75730479|FG000|NOT COMPLETED|Overall Study||1||
59619264|NCT00635778|75730480|FG001|NOT COMPLETED|Overall Study||3||
59782732|NCT00718718|75903290|FG006|COMPLETED|Week 12 to End of Study||27||
59782733|NCT00718718|75903291|FG007|COMPLETED|Week 12 to End of Study||27||
59782734|NCT00718718|75903292|FG008|COMPLETED|Week 12 to End of Study||27||
59782735|NCT00718718|75903293|FG009|COMPLETED|Week 12 to End of Study||31||
59782736|NCT00718718|75903284|FG000|NOT COMPLETED|Week 12 to End of Study||0||
59619265|NCT00635778|75730481|FG002|NOT COMPLETED|Overall Study||3||
59782737|NCT00718718|75903285|FG001|NOT COMPLETED|Week 12 to End of Study||1||
59782738|NCT00718718|75903286|FG002|NOT COMPLETED|Week 12 to End of Study||0||
59782739|NCT00718718|75903287|FG003|NOT COMPLETED|Week 12 to End of Study||1||
59782740|NCT00718718|75903288|FG004|NOT COMPLETED|Week 12 to End of Study||0||
59782741|NCT00718718|75903289|FG005|NOT COMPLETED|Week 12 to End of Study||3||
59782742|NCT00718718|75903290|FG006|NOT COMPLETED|Week 12 to End of Study||2||
59782743|NCT00718718|75903291|FG007|NOT COMPLETED|Week 12 to End of Study||1||
59782744|NCT00718718|75903292|FG008|NOT COMPLETED|Week 12 to End of Study||1||
59782745|NCT00718718|75903293|FG009|NOT COMPLETED|Week 12 to End of Study||0||
59782746|NCT00683787|75903322|FG000|STARTED|Overall Study||3||
59782747|NCT00683787|75903323|FG001|STARTED|Overall Study||3||
59782748|NCT00683787|75903324|FG002|STARTED|Overall Study||2||
59782749|NCT00683787|75903322|FG000|COMPLETED|Overall Study||0||
59782750|NCT00683787|75903323|FG001|COMPLETED|Overall Study||0||
59782751|NCT00683787|75903324|FG002|COMPLETED|Overall Study||0||
59782752|NCT00683787|75903322|FG000|NOT COMPLETED|Overall Study||3||
59782753|NCT00683787|75903323|FG001|NOT COMPLETED|Overall Study||3||
59782754|NCT00683787|75903324|FG002|NOT COMPLETED|Overall Study||2||
59782755|NCT00723008|75903334|FG000|STARTED|Enrollment||11||
59782756|NCT00723008|75903335|FG001|STARTED|Enrollment||9||
59782757|NCT00723008|75903334|FG000|COMPLETED|Enrollment||10||
59782758|NCT00723008|75903335|FG001|COMPLETED|Enrollment||9||
59782759|NCT00723008|75903334|FG000|NOT COMPLETED|Enrollment||1||
59782760|NCT00723008|75903335|FG001|NOT COMPLETED|Enrollment||0||
59782761|NCT00723008|75903334|FG000|STARTED|4-Week Double Blinded||10||
59782762|NCT00723008|75903335|FG001|STARTED|4-Week Double Blinded||9||
59782763|NCT00723008|75903334|FG000|COMPLETED|4-Week Double Blinded||5||
59782764|NCT00723008|75903335|FG001|COMPLETED|4-Week Double Blinded||4||
59782765|NCT00723008|75903334|FG000|NOT COMPLETED|4-Week Double Blinded||5||
59782766|NCT00723008|75903335|FG001|NOT COMPLETED|4-Week Double Blinded||5||
59782767|NCT00723008|75903334|FG000|STARTED|4-Week Unblinded Treatment||5||
59782768|NCT00723008|75903335|FG001|STARTED|4-Week Unblinded Treatment||4||
59782769|NCT00723008|75903334|FG000|COMPLETED|4-Week Unblinded Treatment||4||
59782770|NCT00723008|75903335|FG001|COMPLETED|4-Week Unblinded Treatment||3||
59782771|NCT00723008|75903334|FG000|NOT COMPLETED|4-Week Unblinded Treatment||1||
59782772|NCT00723008|75903335|FG001|NOT COMPLETED|4-Week Unblinded Treatment||1||
59782773|NCT00718640|75903349|FG000|STARTED|Overall Study||10||
59782774|NCT00718640|75903349|FG000|COMPLETED|Overall Study||3||
59782775|NCT00718640|75903349|FG000|NOT COMPLETED|Overall Study||7||
59782776|NCT00715910|75903357|FG000|STARTED|Year 1||433||
59782777|NCT00715910|75903358|FG001|STARTED|Year 1||147||
59782778|NCT00715910|75903359|FG002|STARTED|Year 1||68||
59782779|NCT00715910|75903360|FG003|STARTED|Year 1|Group not applicable during Year 1 Persistence phase|0||
59782780|NCT00715910|75903361|FG004|STARTED|Year 1|Group not applicable during Year 1 Persistence phase|0||
59782781|NCT00715910|75903362|FG005|STARTED|Year 1|Group not applicable during Year 1 Persistence phase|0||
59782782|NCT00715910|75903357|FG000|COMPLETED|Year 1||433||
59782783|NCT00715910|75903358|FG001|COMPLETED|Year 1||147||
59782784|NCT00715910|75903359|FG002|COMPLETED|Year 1||68||
59782785|NCT00715910|75903360|FG003|COMPLETED|Year 1|Group not applicable during Year 1 Persistence phase|0||
59782786|NCT00715910|75903361|FG004|COMPLETED|Year 1|Group not applicable during Year 1 Persistence phase|0||
59782787|NCT00715910|75903362|FG005|COMPLETED|Year 1|Group not applicable during Year 1 Persistence phase|0||
59782788|NCT00715910|75903357|FG000|NOT COMPLETED|Year 1||0||
59782789|NCT00715910|75903358|FG001|NOT COMPLETED|Year 1||0||
59782790|NCT00715910|75903359|FG002|NOT COMPLETED|Year 1||0||
59782791|NCT00715910|75903360|FG003|NOT COMPLETED|Year 1||0||
59782792|NCT00715910|75903361|FG004|NOT COMPLETED|Year 1||0||
59782793|NCT00715910|75903362|FG005|NOT COMPLETED|Year 1||0||
59782794|NCT00715910|75903357|FG000|STARTED|Year 3||345||
59782795|NCT00715910|75903358|FG001|STARTED|Year 3||86||
59782796|NCT00715910|75903359|FG002|STARTED|Year 3||56||
59953032|NCT04057820|76071785|FG005|STARTED|Period 2||0||0
59782797|NCT00715910|75903360|FG003|STARTED|Year 3|Group not applicable during Year 3 Persistence phase|0||
59782798|NCT00715910|75903361|FG004|STARTED|Year 3|Group not applicable during Year 3 Persistence phase|0||
59782799|NCT00715910|75903362|FG005|STARTED|Year 3|Group not applicable during Year 3 Persistence phase|0||
59782800|NCT00715910|75903357|FG000|COMPLETED|Year 3||345||
59782801|NCT00715910|75903358|FG001|COMPLETED|Year 3||86||
59782802|NCT00715910|75903359|FG002|COMPLETED|Year 3||56||
59782803|NCT00715910|75903360|FG003|COMPLETED|Year 3|Group not applicable during Year 3 Persistence phase|0||
59782804|NCT00715910|75903361|FG004|COMPLETED|Year 3|Group not applicable during Year 3 Persistence phase|0||
59782805|NCT00715910|75903362|FG005|COMPLETED|Year 3|Group not applicable during Year 3 Persistence phase|0||
59782806|NCT00715910|75903357|FG000|NOT COMPLETED|Year 3||0||
59782807|NCT00715910|75903358|FG001|NOT COMPLETED|Year 3||0||
59782808|NCT00715910|75903359|FG002|NOT COMPLETED|Year 3||0||
59953033|NCT04057820|76071786|FG006|STARTED|Period 2||12||3
59953034|NCT04057820|76071787|FG007|STARTED|Period 2||0||0
59782809|NCT00715910|75903360|FG003|NOT COMPLETED|Year 3||0||
59782810|NCT00715910|75903361|FG004|NOT COMPLETED|Year 3||0||
59953035|NCT04057820|76071788|FG008|STARTED|Period 2||47||4
59953036|NCT04057820|76071789|FG009|STARTED|Period 2||0||0
59782811|NCT00715910|75903362|FG005|NOT COMPLETED|Year 3||0||
59782812|NCT00715910|75903357|FG000|STARTED|Year 5||218||
59782813|NCT00715910|75903358|FG001|STARTED|Year 5||56||
59782814|NCT00715910|75903359|FG002|STARTED|Year 5||38||
59782815|NCT00715910|75903360|FG003|STARTED|Year 5|Group not applicable during Year 5 Persistence phase|0||
59782816|NCT00715910|75903361|FG004|STARTED|Year 5|Group not applicable during Year 5 Persistence phase|0||
59782817|NCT00715910|75903362|FG005|STARTED|Year 5|Group not applicable during Year 5 Persistence phase|0||
59782818|NCT00715910|75903357|FG000|COMPLETED|Year 5||218||
59782819|NCT00715910|75903358|FG001|COMPLETED|Year 5||56||
59782820|NCT00715910|75903359|FG002|COMPLETED|Year 5||38||
59522433|NCT04019626|75616854|FG001|NOT COMPLETED|Overall Study||10||
59522434|NCT04019626|75616855|FG002|NOT COMPLETED|Overall Study||8||
59522435|NCT04019626|75616856|FG003|NOT COMPLETED|Overall Study||7||
59522436|NCT04019626|75616857|FG004|NOT COMPLETED|Overall Study||6||
59522437|NCT04019626|75616858|FG005|NOT COMPLETED|Overall Study||1||
59522438|NCT04022668|75616875|FG000|STARTED|Overall Study||1000||
59522439|NCT04022668|75616876|FG001|STARTED|Overall Study||1000||
59522440|NCT04022668|75616877|FG002|STARTED|Overall Study||1000||
59522441|NCT04022668|75616875|FG000|COMPLETED|Overall Study||986||
59522442|NCT04022668|75616876|FG001|COMPLETED|Overall Study||973||
59522443|NCT04022668|75616877|FG002|COMPLETED|Overall Study||1000||
59522444|NCT04022668|75616875|FG000|NOT COMPLETED|Overall Study||14||
59522445|NCT04022668|75616876|FG001|NOT COMPLETED|Overall Study||27||
59522446|NCT04022668|75616877|FG002|NOT COMPLETED|Overall Study||0||
59522447|NCT03725098|75616887|FG000|STARTED|Overall Study||53|1 additional subject enrolled due to delay in reporting function of electronic database.|
59522448|NCT03725098|75616888|FG001|STARTED|Overall Study||52|1 additional subject enrolled due to delay in reporting function of electronic database.|
59522449|NCT03725098|75616887|FG000|COMPLETED|Overall Study||53||
59522450|NCT03725098|75616888|FG001|COMPLETED|Overall Study||52||
59522451|NCT03725098|75616887|FG000|NOT COMPLETED|Overall Study||0||
59522452|NCT03725098|75616888|FG001|NOT COMPLETED|Overall Study||0||
59522453|NCT04111276|75616894|FG000|STARTED|Overall Study||23||
59522454|NCT04111276|75616894|FG000|COMPLETED|Overall Study||20||
59522455|NCT04111276|75616894|FG000|NOT COMPLETED|Overall Study||3||
59522456|NCT02559414|75616901|FG000|STARTED|Overall Study||11||
59522457|NCT02559414|75616902|FG001|STARTED|Overall Study||22||
59522458|NCT02559414|75616903|FG002|STARTED|Overall Study||22||
59522459|NCT02559414|75616901|FG000|COMPLETED|Overall Study||10||
59522460|NCT02559414|75616902|FG001|COMPLETED|Overall Study||20||
59522461|NCT02559414|75616903|FG002|COMPLETED|Overall Study||20||
59522462|NCT02559414|75616901|FG000|NOT COMPLETED|Overall Study||1||
59522463|NCT02559414|75616902|FG001|NOT COMPLETED|Overall Study||2||
59522464|NCT02559414|75616903|FG002|NOT COMPLETED|Overall Study||2||
59522465|NCT03527264|75616924|FG000|STARTED|Overall Study||3||
59522466|NCT03527264|75616925|FG001|STARTED|Overall Study||1||
59522467|NCT03527264|75616926|FG002|STARTED|Overall Study||0||
59522468|NCT03527264|75616927|FG003|STARTED|Overall Study||0||
59522469|NCT03527264|75616924|FG000|COMPLETED|Overall Study||3||
59522470|NCT03527264|75616925|FG001|COMPLETED|Overall Study||1||
59522471|NCT03527264|75616926|FG002|COMPLETED|Overall Study||0||
59522472|NCT03527264|75616927|FG003|COMPLETED|Overall Study||0||
59522473|NCT03527264|75616924|FG000|NOT COMPLETED|Overall Study||0||
59522474|NCT03527264|75616925|FG001|NOT COMPLETED|Overall Study||0||
59522475|NCT03527264|75616926|FG002|NOT COMPLETED|Overall Study||0||
59522476|NCT03527264|75616927|FG003|NOT COMPLETED|Overall Study||0||
59522477|NCT04160260|75616933|FG000|STARTED|Overall Study||18||
59522478|NCT04160260|75616933|FG000|COMPLETED|Overall Study||18||
59522479|NCT04160260|75616933|FG000|NOT COMPLETED|Overall Study||0||
59522480|NCT03995680|75616939|FG000|STARTED|Overall Study||199||
59522481|NCT03995680|75616940|FG001|STARTED|Overall Study||198||
59522482|NCT03995680|75616939|FG000|COMPLETED|Overall Study||197||
59522483|NCT03995680|75616940|FG001|COMPLETED|Overall Study||196||
59522484|NCT03995680|75616939|FG000|NOT COMPLETED|Overall Study||2||
59522485|NCT03995680|75616940|FG001|NOT COMPLETED|Overall Study||2||
59522486|NCT04005586|75616946|FG000|STARTED|Overall Study||25||
59619266|NCT00635778|75730482|FG003|NOT COMPLETED|Overall Study||8||
59619267|NCT00635778|75730483|FG004|NOT COMPLETED|Overall Study||8||
59619268|NCT00635778|75730484|FG005|NOT COMPLETED|Overall Study||21||
59619269|NCT00635778|75730485|FG006|NOT COMPLETED|Overall Study||6||
59619270|NCT00634920|75730505|FG000|STARTED|Period 1 - Pre-Randomization||0||
59619271|NCT00634920|75730506|FG001|STARTED|Period 1 - Pre-Randomization||0||
59619272|NCT00634920|75730507|FG002|STARTED|Period 1 - Pre-Randomization|Total number of Enrolled patients|341||
59782821|NCT00715910|75903360|FG003|COMPLETED|Year 5|Group not applicable during Year 5 Persistence phase|0||
59782822|NCT00715910|75903361|FG004|COMPLETED|Year 5|Group not applicable during Year 5 Persistence phase|0||
59522487|NCT04005586|75616946|FG000|COMPLETED|Overall Study||25||
59522488|NCT04005586|75616946|FG000|NOT COMPLETED|Overall Study||0||
59522489|NCT03990298|75616950|FG000|STARTED|Overall Study||16||
59522490|NCT03990298|75616950|FG000|COMPLETED|Overall Study||16||
59522491|NCT03990298|75616950|FG000|NOT COMPLETED|Overall Study||0||
59522492|NCT03505372|75616954|FG000|STARTED|Overall Study||5||
59522493|NCT03505372|75616954|FG000|COMPLETED|Overall Study||5||
59522494|NCT03505372|75616954|FG000|NOT COMPLETED|Overall Study||0||
59782823|NCT00715910|75903362|FG005|COMPLETED|Year 5|Group not applicable during Year 5 Persistence phase|0||
59782824|NCT00715910|75903357|FG000|NOT COMPLETED|Year 5||0||
59782825|NCT00715910|75903358|FG001|NOT COMPLETED|Year 5||0||
59782826|NCT00715910|75903359|FG002|NOT COMPLETED|Year 5||0||
59782827|NCT00715910|75903360|FG003|NOT COMPLETED|Year 5||0||
59782828|NCT00715910|75903361|FG004|NOT COMPLETED|Year 5||0||
59782829|NCT00715910|75903362|FG005|NOT COMPLETED|Year 5||0||
59782830|NCT00715910|75903357|FG000|STARTED|Booster and ESFU Phase|Group not applicable during booster phase|0||
59782831|NCT00715910|75903358|FG001|STARTED|Booster and ESFU Phase|Group not applicable during booster phase|0||
59782832|NCT00715910|75903359|FG002|STARTED|Booster and ESFU Phase|Group not applicable during booster phase|0||
59782833|NCT00715910|75903360|FG003|STARTED|Booster and ESFU Phase||183||
59782834|NCT00715910|75903361|FG004|STARTED|Booster and ESFU Phase||38||
59782835|NCT00715910|75903362|FG005|STARTED|Booster and ESFU Phase||101||
59782836|NCT00715910|75903357|FG000|COMPLETED|Booster and ESFU Phase|Group not applicable during booster phase|0||
59782837|NCT00715910|75903358|FG001|COMPLETED|Booster and ESFU Phase|Group not applicable during booster phase|0||
59782838|NCT00715910|75903359|FG002|COMPLETED|Booster and ESFU Phase|Group not applicable during booster phase|0||
59782839|NCT00715910|75903360|FG003|COMPLETED|Booster and ESFU Phase||172||
59782840|NCT00715910|75903361|FG004|COMPLETED|Booster and ESFU Phase||36||
59782841|NCT00715910|75903362|FG005|COMPLETED|Booster and ESFU Phase||88||
59782842|NCT00715910|75903357|FG000|NOT COMPLETED|Booster and ESFU Phase||0||
59782843|NCT00715910|75903358|FG001|NOT COMPLETED|Booster and ESFU Phase||0||
59782844|NCT00715910|75903359|FG002|NOT COMPLETED|Booster and ESFU Phase||0||
59782845|NCT00715910|75903360|FG003|NOT COMPLETED|Booster and ESFU Phase||11||
59782846|NCT00715910|75903361|FG004|NOT COMPLETED|Booster and ESFU Phase||2||
59782847|NCT00715910|75903362|FG005|NOT COMPLETED|Booster and ESFU Phase||13||
59782848|NCT00715676|75903381|FG000|STARTED|Overall Study|1 additional subject was enrolled in the placebo group but discontinued before taking any study drug|49||
59782849|NCT00715676|75903382|FG001|STARTED|Overall Study||54||
59782850|NCT00715676|75903383|FG002|STARTED|Overall Study||53||
59782851|NCT00715676|75903381|FG000|COMPLETED|Overall Study||43||
59782852|NCT00715676|75903382|FG001|COMPLETED|Overall Study||43||
59782853|NCT00715676|75903383|FG002|COMPLETED|Overall Study||21||
59782854|NCT00715676|75903381|FG000|NOT COMPLETED|Overall Study||6||
59782855|NCT00715676|75903382|FG001|NOT COMPLETED|Overall Study||11||
59782856|NCT00715676|75903383|FG002|NOT COMPLETED|Overall Study||32||
59782857|NCT00718328|75903393|FG000|STARTED|Overall Study||1||
59782858|NCT00718328|75903394|FG001|STARTED|Overall Study||0||
59782859|NCT00718328|75903393|FG000|COMPLETED|Overall Study|Prematurely terminated due to poor enrollment|0||
59782860|NCT00718328|75903394|FG001|COMPLETED|Overall Study|Terminated due to poor enrollment|0||
59782861|NCT00718328|75903393|FG000|NOT COMPLETED|Overall Study||1||
59782862|NCT00718328|75903394|FG001|NOT COMPLETED|Overall Study||0||
59782863|NCT00715520|75903403|FG000|STARTED|Overall Study||20||
59782864|NCT00715520|75903404|FG001|STARTED|Overall Study||10||
59782865|NCT00715520|75903405|FG002|STARTED|Overall Study||3||
59782866|NCT00715520|75903403|FG000|COMPLETED|Overall Study||10||
59782867|NCT00715520|75903404|FG001|COMPLETED|Overall Study||9||
59782868|NCT00715520|75903405|FG002|COMPLETED|Overall Study||1||
59782869|NCT00715520|75903403|FG000|NOT COMPLETED|Overall Study||10||
59782870|NCT00715520|75903404|FG001|NOT COMPLETED|Overall Study||1||
59782871|NCT00715520|75903405|FG002|NOT COMPLETED|Overall Study||2||
59782872|NCT00790205|75903415|FG000|STARTED|Overall Study||7332||
59782873|NCT00790205|75903416|FG001|STARTED|Overall Study||7339||
59782874|NCT00790205|75903415|FG000|Treated|Overall Study||7266||
59782875|NCT00790205|75903416|FG001|Treated|Overall Study||7274||
59782876|NCT00790205|75903415|FG000|COMPLETED|Overall Study||6972||
59782877|NCT00790205|75903416|FG001|COMPLETED|Overall Study||6905||
59782878|NCT00790205|75903415|FG000|NOT COMPLETED|Overall Study||360||
59782879|NCT00790205|75903416|FG001|NOT COMPLETED|Overall Study||434||
59782880|NCT00715208|75903424|FG000|STARTED|Overall Study||7||
59782881|NCT00715208|75903425|FG001|STARTED|Overall Study||48||
59782882|NCT00715208|75903424|FG000|COMPLETED|Overall Study||6||
59782883|NCT00715208|75903425|FG001|COMPLETED|Overall Study||39||
59782884|NCT00715208|75903424|FG000|NOT COMPLETED|Overall Study||1||
59782885|NCT00715208|75903425|FG001|NOT COMPLETED|Overall Study||9||
59782886|NCT00587795|75903433|FG000|STARTED|Overall Study||1||
59782887|NCT00587795|75903434|FG001|STARTED|Overall Study||0||
59782888|NCT00587795|75903433|FG000|COMPLETED|Overall Study||0||
59782889|NCT00587795|75903434|FG001|COMPLETED|Overall Study||0||
59782890|NCT00587795|75903433|FG000|NOT COMPLETED|Overall Study||1||
59782891|NCT00587795|75903434|FG001|NOT COMPLETED|Overall Study||0||
59782892|NCT00587639|75903440|FG000|STARTED|Overall Study||8||
59782893|NCT00587639|75903440|FG000|COMPLETED|Overall Study||7||
59782894|NCT00587639|75903440|FG000|NOT COMPLETED|Overall Study||1||
59782895|NCT00774995|75903448|FG000|STARTED|Overall Study||9||
59782896|NCT00774995|75903449|FG001|STARTED|Overall Study||16||
59782897|NCT00774995|75903450|FG002|STARTED|Overall Study||8||
59782898|NCT00774995|75903451|FG003|STARTED|Overall Study||16||
59782899|NCT00774995|75903448|FG000|COMPLETED|Overall Study||9||
59782900|NCT00774995|75903449|FG001|COMPLETED|Overall Study||16||
59782901|NCT00774995|75903450|FG002|COMPLETED|Overall Study||7||
59782902|NCT00774995|75903451|FG003|COMPLETED|Overall Study||16||
59782903|NCT00774995|75903448|FG000|NOT COMPLETED|Overall Study||0||
59782904|NCT00774995|75903449|FG001|NOT COMPLETED|Overall Study||0||
59782905|NCT00774995|75903450|FG002|NOT COMPLETED|Overall Study||1||
59782906|NCT00774995|75903451|FG003|NOT COMPLETED|Overall Study||0||
59782907|NCT00713648|75903461|FG000|STARTED|Overall Study||41||
59782908|NCT00713648|75903461|FG000|COMPLETED|Overall Study||33||
59782909|NCT00713648|75903461|FG000|NOT COMPLETED|Overall Study||8||
59782910|NCT00768053|75903465|FG000|STARTED|Overall Study||108||
59782911|NCT00768053|75903465|FG000|COMPLETED|Overall Study||97||
59782912|NCT00768053|75903465|FG000|NOT COMPLETED|Overall Study||11||
59782913|NCT00683475|75903471|FG000|STARTED|Overall Study||69||
59782914|NCT00683475|75903472|FG001|STARTED|Overall Study||69||
59782915|NCT00683475|75903471|FG000|Received Any Quantity of Study Drug|Overall Study||66||
59782916|NCT00683475|75903472|FG001|Received Any Quantity of Study Drug|Overall Study||66||
59782917|NCT00683475|75903471|FG000|COMPLETED|Overall Study||65||
59782918|NCT00683475|75903472|FG001|COMPLETED|Overall Study||66||
59782919|NCT00683475|75903471|FG000|NOT COMPLETED|Overall Study||4||
59782920|NCT00683475|75903472|FG001|NOT COMPLETED|Overall Study||3||
59782921|NCT00685035|75903479|FG000|STARTED|Period 1: First Intervention: 30 Minutes||9||
59782922|NCT00685035|75903480|FG001|STARTED|Period 1: First Intervention: 30 Minutes||8||
59782923|NCT00685035|75903479|FG000|COMPLETED|Period 1: First Intervention: 30 Minutes||8||
59782924|NCT00685035|75903480|FG001|COMPLETED|Period 1: First Intervention: 30 Minutes||8||
59782925|NCT00685035|75903479|FG000|NOT COMPLETED|Period 1: First Intervention: 30 Minutes||1||
59782926|NCT00685035|75903480|FG001|NOT COMPLETED|Period 1: First Intervention: 30 Minutes||0||
59782927|NCT00685035|75903479|FG000|STARTED|Period 2: 2-day Washout||8||
59782928|NCT00685035|75903480|FG001|STARTED|Period 2: 2-day Washout||8||
59782929|NCT00685035|75903479|FG000|COMPLETED|Period 2: 2-day Washout||8||
59782930|NCT00685035|75903480|FG001|COMPLETED|Period 2: 2-day Washout||8||
59782931|NCT00685035|75903479|FG000|NOT COMPLETED|Period 2: 2-day Washout||0||
59782932|NCT00685035|75903480|FG001|NOT COMPLETED|Period 2: 2-day Washout||0||
59782933|NCT00685035|75903479|FG000|STARTED|Period 3: 2nd Intervention||8||
59782934|NCT00685035|75903480|FG001|STARTED|Period 3: 2nd Intervention||8||
59782935|NCT00685035|75903479|FG000|COMPLETED|Period 3: 2nd Intervention||8||
59782936|NCT00685035|75903480|FG001|COMPLETED|Period 3: 2nd Intervention||8||
59782937|NCT00685035|75903479|FG000|NOT COMPLETED|Period 3: 2nd Intervention||0||
59782938|NCT00685035|75903480|FG001|NOT COMPLETED|Period 3: 2nd Intervention||0||
59782939|NCT00773747|75903506|FG000|STARTED|Overall Study||317||
59782940|NCT00773747|75903507|FG001|STARTED|Overall Study||320||
59782941|NCT00773747|75903506|FG000|Treated|Overall Study||315||
59782942|NCT00773747|75903507|FG001|Treated|Overall Study||320||
59782943|NCT00773747|75903506|FG000|COMPLETED|Overall Study||20||
59782944|NCT00773747|75903507|FG001|COMPLETED|Overall Study||24||
59782945|NCT00773747|75903506|FG000|NOT COMPLETED|Overall Study||297||
59782946|NCT00773747|75903507|FG001|NOT COMPLETED|Overall Study||296||
59782947|NCT00784277|75903517|FG000|STARTED|IR Treatment||148||
59782948|NCT00784277|75903518|FG001|STARTED|IR Treatment||151||
59782949|NCT00784277|75903519|FG002|STARTED|IR Treatment||154||
59782950|NCT00784277|75903520|FG003|STARTED|IR Treatment||143||
59782951|NCT00784277|75903521|FG004|STARTED|IR Treatment|"0 in ER column indicates this reporting group is not relevant to IR phase."|0||
59782952|NCT00784277|75903522|FG005|STARTED|IR Treatment|"0 in ER column indicates this reporting group is not relevant to IR phase."|0||
59782953|NCT00784277|75903523|FG006|STARTED|IR Treatment|"0 in ER column indicates this reporting group is not relevant to IR phase."|0||
59782954|NCT00784277|75903517|FG000|COMPLETED|IR Treatment||132||
59782955|NCT00784277|75903518|FG001|COMPLETED|IR Treatment||134||
59782956|NCT00784277|75903519|FG002|COMPLETED|IR Treatment||126||
59782957|NCT00784277|75903520|FG003|COMPLETED|IR Treatment||100||
59782958|NCT00784277|75903521|FG004|COMPLETED|IR Treatment||0||
59782959|NCT00784277|75903522|FG005|COMPLETED|IR Treatment||0||
59782960|NCT00784277|75903523|FG006|COMPLETED|IR Treatment||0||
59782961|NCT00784277|75903517|FG000|NOT COMPLETED|IR Treatment||16||
59782962|NCT00784277|75903518|FG001|NOT COMPLETED|IR Treatment||17||
59782963|NCT00784277|75903519|FG002|NOT COMPLETED|IR Treatment||28||
59782964|NCT00784277|75903520|FG003|NOT COMPLETED|IR Treatment||43||
59782965|NCT00784277|75903521|FG004|NOT COMPLETED|IR Treatment||0||
59782966|NCT00784277|75903522|FG005|NOT COMPLETED|IR Treatment||0||
59782967|NCT00784277|75903523|FG006|NOT COMPLETED|IR Treatment||0||
59782968|NCT00784277|75903517|FG000|STARTED|ER Treatment|"0 in IR column indicates this reporting group is not relevant to ER phase."|0||
59782969|NCT00784277|75903518|FG001|STARTED|ER Treatment|"0 in IR column indicates this reporting group is not relevant to ER phase."|0||
59782970|NCT00784277|75903519|FG002|STARTED|ER Treatment|"0 in IR column indicates this reporting group is not relevant to ER phase."|0||
59782971|NCT00784277|75903520|FG003|STARTED|ER Treatment|"0 in IR column indicates this reporting group is not relevant to ER phase."|0||
59782972|NCT00784277|75903521|FG004|STARTED|ER Treatment|10 participants who had completed IR treatment have not taken any ER treatment.|122||
59782973|NCT00784277|75903522|FG005|STARTED|ER Treatment|10 participants who had completed IR treatment have not taken any ER treatment.|250||
59782974|NCT00784277|75903523|FG006|STARTED|ER Treatment|9 participants who had completed IR treatment have not taken any ER treatment.|91||
59782975|NCT00784277|75903517|FG000|COMPLETED|ER Treatment||0||
59782976|NCT00784277|75903518|FG001|COMPLETED|ER Treatment||0||
59782977|NCT00784277|75903519|FG002|COMPLETED|ER Treatment||0||
59782978|NCT00784277|75903520|FG003|COMPLETED|ER Treatment||0||
59782979|NCT00784277|75903521|FG004|COMPLETED|ER Treatment||113||
59782980|NCT00784277|75903522|FG005|COMPLETED|ER Treatment||226||
59782981|NCT00784277|75903523|FG006|COMPLETED|ER Treatment||76||
59782982|NCT00784277|75903517|FG000|NOT COMPLETED|ER Treatment||0||
59782983|NCT00784277|75903518|FG001|NOT COMPLETED|ER Treatment||0||
59782984|NCT00784277|75903519|FG002|NOT COMPLETED|ER Treatment||0||
59782985|NCT00784277|75903520|FG003|NOT COMPLETED|ER Treatment||0||
59782986|NCT00784277|75903521|FG004|NOT COMPLETED|ER Treatment||9||
59782987|NCT00784277|75903522|FG005|NOT COMPLETED|ER Treatment||24||
59782988|NCT00784277|75903523|FG006|NOT COMPLETED|ER Treatment||15||
59782989|NCT00682929|75903539|FG000|STARTED|Overall Study||13||
59782990|NCT00682929|75903540|FG001|STARTED|Overall Study||14||
59782991|NCT00682929|75903541|FG002|STARTED|Overall Study||14||
59782992|NCT00682929|75903539|FG000|COMPLETED|Overall Study||7||
59782993|NCT00682929|75903540|FG001|COMPLETED|Overall Study||9||
59782994|NCT00682929|75903541|FG002|COMPLETED|Overall Study||12||
59522495|NCT03429712|75616958|FG000|STARTED|Overall Study||19||
59522496|NCT03429712|75616958|FG000|COMPLETED|Overall Study||10||
59522497|NCT03429712|75616958|FG000|NOT COMPLETED|Overall Study||9||
59522498|NCT03352882|75616962|FG000|STARTED|Overall Study||1||
59522499|NCT03352882|75616962|FG000|COMPLETED|Overall Study||1||
59522500|NCT03352882|75616962|FG000|NOT COMPLETED|Overall Study||0||
59782995|NCT00682929|75903539|FG000|NOT COMPLETED|Overall Study||6||
59782996|NCT00682929|75903540|FG001|NOT COMPLETED|Overall Study||5||
59782997|NCT00682929|75903541|FG002|NOT COMPLETED|Overall Study||2||
59782998|NCT00680745|75903553|FG000|STARTED|Overall Study|Safety Analysis Set|154||
59782999|NCT00680745|75903554|FG001|STARTED|Overall Study|Safety Analysis Set|145||
59783000|NCT00680745|75903555|FG002|STARTED|Overall Study|Safety Analysis Set|151||
59783001|NCT00680745|75903556|FG003|STARTED|Overall Study|Safety Analysis Set|146||
59783002|NCT00680745|75903553|FG000|COMPLETED|Overall Study||140||
59783003|NCT00680745|75903554|FG001|COMPLETED|Overall Study||132||
59783004|NCT00680745|75903555|FG002|COMPLETED|Overall Study||141||
59783005|NCT00680745|75903556|FG003|COMPLETED|Overall Study||133||
59783006|NCT00680745|75903553|FG000|NOT COMPLETED|Overall Study||14||
59783007|NCT00680745|75903554|FG001|NOT COMPLETED|Overall Study||13||
59953037|NCT04057820|76071790|FG010|STARTED|Period 2||17||4
59783008|NCT00680745|75903555|FG002|NOT COMPLETED|Overall Study||10||
59783009|NCT00680745|75903556|FG003|NOT COMPLETED|Overall Study||13||
59783010|NCT00680121|75903569|FG000|STARTED|Overall Study||60||
59783011|NCT00680121|75903570|FG001|STARTED|Overall Study||60||
59783012|NCT00680121|75903569|FG000|COMPLETED|Overall Study||33||
59783013|NCT00680121|75903570|FG001|COMPLETED|Overall Study||37||
59783014|NCT00680121|75903569|FG000|NOT COMPLETED|Overall Study||27||
59783015|NCT00680121|75903570|FG001|NOT COMPLETED|Overall Study||23||
59783016|NCT00767819|75903579|FG000|STARTED|Overall Study||37||
59783017|NCT00767819|75903580|FG001|STARTED|Overall Study||24||
59783018|NCT00767819|75903581|FG002|STARTED|Overall Study||10||
59783019|NCT00767819|75903579|FG000|Intent to Treat (ITT) Analysis Set|Overall Study||37||
59783020|NCT00767819|75903580|FG001|Intent to Treat (ITT) Analysis Set|Overall Study||24||
59783021|NCT00767819|75903581|FG002|Intent to Treat (ITT) Analysis Set|Overall Study||10||
59783022|NCT00767819|75903579|FG000|Safety Analysis Set (SAF)|Overall Study||37||
59783023|NCT00767819|75903580|FG001|Safety Analysis Set (SAF)|Overall Study||24||
59783024|NCT00767819|75903581|FG002|Safety Analysis Set (SAF)|Overall Study||10||
59953038|NCT04057820|76071791|FG011|STARTED|Period 2||0||0
59953039|NCT04057820|76071792|FG012|STARTED|Period 2||10||3
59953040|NCT04057820|76071793|FG013|STARTED|Period 2||0||0
59783025|NCT00767819|75903579|FG000|COMPLETED|Overall Study||12||
59953041|NCT04057820|76071794|FG014|STARTED|Period 2||18||3
59953042|NCT04057820|76071795|FG015|STARTED|Period 2||0||0
59953043|NCT04057820|76071780|FG000|COMPLETED|Period 2||0||0
59953044|NCT04057820|76071781|FG001|COMPLETED|Period 2||0||0
59522501|NCT03325114|75616966|FG000|STARTED|Overall Study||1||
59783026|NCT00767819|75903580|FG001|COMPLETED|Overall Study||5||
59783027|NCT00767819|75903581|FG002|COMPLETED|Overall Study||10||
59783028|NCT00767819|75903579|FG000|NOT COMPLETED|Overall Study||25||
59783029|NCT00767819|75903580|FG001|NOT COMPLETED|Overall Study||19||
59783030|NCT00767819|75903581|FG002|NOT COMPLETED|Overall Study||0||
59783031|NCT00584870|75903592|FG000|STARTED|Overall Study||88||
59783032|NCT00584870|75903593|FG001|STARTED|Overall Study||89||
59783033|NCT00584870|75903594|FG002|STARTED|Overall Study||43||
59783034|NCT00584870|75903592|FG000|Treated|Overall Study||88||
59783035|NCT00584870|75903593|FG001|Treated|Overall Study||88||
59783036|NCT00584870|75903594|FG002|Treated|Overall Study||41||
59953045|NCT04057820|76071782|FG002|COMPLETED|Period 2||5||2
59522502|NCT03325114|75616966|FG000|COMPLETED|Overall Study||0||
59522503|NCT03325114|75616966|FG000|NOT COMPLETED|Overall Study||1||
59783037|NCT00584870|75903592|FG000|COMPLETED|Overall Study||59||
59783038|NCT00584870|75903593|FG001|COMPLETED|Overall Study||64||
59783039|NCT00584870|75903594|FG002|COMPLETED|Overall Study||25||
59783040|NCT00584870|75903592|FG000|NOT COMPLETED|Overall Study||29||
59783041|NCT00584870|75903593|FG001|NOT COMPLETED|Overall Study||25||
59783042|NCT00584870|75903594|FG002|NOT COMPLETED|Overall Study||18||
59783043|NCT00679341|75903604|FG000|STARTED|Overall Study||67||
59783044|NCT00679341|75903605|FG001|STARTED|Overall Study||70||
59783045|NCT00679341|75903604|FG000|COMPLETED|Overall Study||14||
59783046|NCT00679341|75903605|FG001|COMPLETED|Overall Study||19||
59783047|NCT00679341|75903604|FG000|NOT COMPLETED|Overall Study||53||
59783048|NCT00679341|75903605|FG001|NOT COMPLETED|Overall Study||51||
59783049|NCT00679263|75903615|FG000|STARTED|Visit 3/Dose 2||10||
59783050|NCT00679263|75903616|FG001|STARTED|Visit 3/Dose 2||11||
59783051|NCT00679263|75903617|FG002|STARTED|Visit 3/Dose 2||11||
59783052|NCT00679263|75903615|FG000|COMPLETED|Visit 3/Dose 2||9||
59783053|NCT00679263|75903616|FG001|COMPLETED|Visit 3/Dose 2||6||
59783054|NCT00679263|75903617|FG002|COMPLETED|Visit 3/Dose 2||11||
59783055|NCT00679263|75903615|FG000|NOT COMPLETED|Visit 3/Dose 2||1||
59783056|NCT00679263|75903616|FG001|NOT COMPLETED|Visit 3/Dose 2||5||
59783057|NCT00679263|75903617|FG002|NOT COMPLETED|Visit 3/Dose 2||0||
59783058|NCT00679263|75903615|FG000|STARTED|Visit 2/Dose 1||11||
59783059|NCT00679263|75903616|FG001|STARTED|Visit 2/Dose 1||6||
59783060|NCT00679263|75903617|FG002|STARTED|Visit 2/Dose 1||11||
59783061|NCT00679263|75903615|FG000|COMPLETED|Visit 2/Dose 1||9||
59783062|NCT00679263|75903616|FG001|COMPLETED|Visit 2/Dose 1||5||
59783063|NCT00679263|75903617|FG002|COMPLETED|Visit 2/Dose 1||11||
59783064|NCT00679263|75903615|FG000|NOT COMPLETED|Visit 2/Dose 1||2||
59783065|NCT00679263|75903616|FG001|NOT COMPLETED|Visit 2/Dose 1||1||
59783066|NCT00679263|75903617|FG002|NOT COMPLETED|Visit 2/Dose 1||0||
59783067|NCT00680043|75903628|FG000|STARTED|Overall Study||39||
59783068|NCT00680043|75903629|FG001|STARTED|Overall Study||37||
59783069|NCT00680043|75903630|FG002|STARTED|Overall Study||38||
59783070|NCT00680043|75903628|FG000|COMPLETED|Overall Study||37||
59783071|NCT00680043|75903629|FG001|COMPLETED|Overall Study||36||
59783072|NCT00680043|75903630|FG002|COMPLETED|Overall Study||34||
59783073|NCT00680043|75903628|FG000|NOT COMPLETED|Overall Study||2||
59783074|NCT00680043|75903629|FG001|NOT COMPLETED|Overall Study||1||
59783075|NCT00680043|75903630|FG002|NOT COMPLETED|Overall Study||4||
59783076|NCT00682539|75903641|FG000|STARTED|Bevacizumab vs Triamcinolone||18||
59783077|NCT00682539|75903642|FG001|STARTED|Bevacizumab vs Triamcinolone||16||
59783078|NCT00682539|75903643|FG002|STARTED|Bevacizumab vs Triamcinolone||0||
59783079|NCT00682539|75903641|FG000|COMPLETED|Bevacizumab vs Triamcinolone||15||
59783080|NCT00682539|75903642|FG001|COMPLETED|Bevacizumab vs Triamcinolone||15||
59783081|NCT00682539|75903643|FG002|COMPLETED|Bevacizumab vs Triamcinolone||0||
59783082|NCT00682539|75903641|FG000|NOT COMPLETED|Bevacizumab vs Triamcinolone||3||
59783083|NCT00682539|75903642|FG001|NOT COMPLETED|Bevacizumab vs Triamcinolone||1||
59783084|NCT00682539|75903643|FG002|NOT COMPLETED|Bevacizumab vs Triamcinolone||0||
59783085|NCT00682539|75903641|FG000|STARTED|Ranibizumab vs Triamcinolone|Two independent periods.|0||
59783086|NCT00682539|75903642|FG001|STARTED|Ranibizumab vs Triamcinolone|None of the patients of the 1st period was included in the second period.|18||
59783087|NCT00682539|75903643|FG002|STARTED|Ranibizumab vs Triamcinolone|Both periods recruited independently following the same criteria.|18||
59783088|NCT00682539|75903641|FG000|COMPLETED|Ranibizumab vs Triamcinolone||0||
59783089|NCT00682539|75903642|FG001|COMPLETED|Ranibizumab vs Triamcinolone||15||
59783090|NCT00682539|75903643|FG002|COMPLETED|Ranibizumab vs Triamcinolone||10||
59783091|NCT00682539|75903641|FG000|NOT COMPLETED|Ranibizumab vs Triamcinolone||0||
59783092|NCT00682539|75903642|FG001|NOT COMPLETED|Ranibizumab vs Triamcinolone||3||
59783093|NCT00682539|75903643|FG002|NOT COMPLETED|Ranibizumab vs Triamcinolone||8||
59522504|NCT03992014|75616970|FG000|STARTED|Treatment Period 1 (8 Days)||6||
59783094|NCT00682461|75903653|FG000|STARTED|Overall Study||100||
59783095|NCT00682461|75903654|FG001|STARTED|Overall Study||100||
59783096|NCT00682461|75903653|FG000|COMPLETED|Overall Study||75||
59783097|NCT00682461|75903654|FG001|COMPLETED|Overall Study||69||
59783098|NCT00682461|75903653|FG000|NOT COMPLETED|Overall Study||25||
59783099|NCT00682461|75903654|FG001|NOT COMPLETED|Overall Study||31||
59783100|NCT00677235|75903663|FG000|STARTED|Overall Study||138||
59783101|NCT00677235|75903664|FG001|STARTED|Overall Study||132||
59783102|NCT00677235|75903663|FG000|COMPLETED|Overall Study||97||
59783103|NCT00677235|75903664|FG001|COMPLETED|Overall Study||94||
59783104|NCT00677235|75903663|FG000|NOT COMPLETED|Overall Study||41||
59783105|NCT00677235|75903664|FG001|NOT COMPLETED|Overall Study||38||
59953046|NCT04057820|76071783|FG003|COMPLETED|Period 2||0||0
59953047|NCT04057820|76071784|FG004|COMPLETED|Period 2||11||3
59953048|NCT04057820|76071785|FG005|COMPLETED|Period 2||0||0
59522505|NCT03992014|75616970|FG000|COMPLETED|Treatment Period 1 (8 Days)||6||
59783106|NCT00676689|75903670|FG000|STARTED|Overall Study||81||
59783107|NCT00676689|75903670|FG000|Procedure|Overall Study|Two enrolled patients did not meet eligibility criteria and did not undergo the study procedure.|79||
59783108|NCT00676689|75903670|FG000|30 Day Follow-up|Overall Study||78||
59783109|NCT00676689|75903670|FG000|1 Year Follow-up|Overall Study||64||
59783110|NCT00676689|75903670|FG000|COMPLETED|Overall Study||20||
59783111|NCT00676689|75903670|FG000|NOT COMPLETED|Overall Study||61||
59783112|NCT00678795|75903676|FG000|STARTED|Overall Study||67||
59783113|NCT00678795|75903677|FG001|STARTED|Overall Study||68||
59783114|NCT00678795|75903676|FG000|COMPLETED|Overall Study||56||
59783115|NCT00678795|75903677|FG001|COMPLETED|Overall Study||62||
59783116|NCT00678795|75903676|FG000|NOT COMPLETED|Overall Study||11||
59783117|NCT00678795|75903677|FG001|NOT COMPLETED|Overall Study||6||
59953049|NCT04057820|76071786|FG006|COMPLETED|Period 2||12||3
59783118|NCT00678639|75903685|FG000|STARTED|Overall Study||53||
59783119|NCT00678639|75903686|FG001|STARTED|Overall Study||57||
59783120|NCT00678639|75903685|FG000|Hospital Discharge|Overall Study||53||
59783121|NCT00678639|75903686|FG001|Hospital Discharge|Overall Study||57||
59783122|NCT00678639|75903685|FG000|COMPLETED|Overall Study||51||
59783123|NCT00678639|75903686|FG001|COMPLETED|Overall Study||57||
59783124|NCT00678639|75903685|FG000|NOT COMPLETED|Overall Study||2||
59783125|NCT00678639|75903686|FG001|NOT COMPLETED|Overall Study||0||
59783126|NCT03417687|75903695|FG000|STARTED|Overall Study|4 subjects were randomized to the 129Xe before 133Xe group but discontinued prior to receiving the first treatment.|18||
59783127|NCT03417687|75903696|FG001|STARTED|Overall Study||20||
59783128|NCT03417687|75903695|FG000|Received 129Xe|Overall Study||14||
59783129|NCT03417687|75903696|FG001|Received 129Xe|Overall Study||20||
59783130|NCT03417687|75903695|FG000|Received 133Xe|Overall Study||13||
59783131|NCT03417687|75903696|FG001|Received 133Xe|Overall Study||20||
59783132|NCT03417687|75903695|FG000|COMPLETED|Overall Study||14||
59783133|NCT03417687|75903696|FG001|COMPLETED|Overall Study||20||
59783134|NCT03417687|75903695|FG000|NOT COMPLETED|Overall Study||4||
59783135|NCT03417687|75903696|FG001|NOT COMPLETED|Overall Study||0||
59783136|NCT04767698|75903712|FG000|STARTED|Overall Study||1||
59783137|NCT04767698|75903713|FG001|STARTED|Overall Study||2||
59783138|NCT04767698|75903712|FG000|COMPLETED|Overall Study||0|Study was terminated|
59783139|NCT04767698|75903713|FG001|COMPLETED|Overall Study||0|Study was terminated|
59783140|NCT04767698|75903712|FG000|NOT COMPLETED|Overall Study||1||
59783141|NCT04767698|75903713|FG001|NOT COMPLETED|Overall Study||2||
59783142|NCT04707573|75903721|FG000|STARTED|Overall Study||10||
59783143|NCT04707573|75903722|FG001|STARTED|Overall Study||12||
59783144|NCT04707573|75903721|FG000|COMPLETED|Overall Study||10||
59783145|NCT04707573|75903722|FG001|COMPLETED|Overall Study||12||
59783146|NCT04707573|75903721|FG000|NOT COMPLETED|Overall Study||0||
59783147|NCT04707573|75903722|FG001|NOT COMPLETED|Overall Study||0||
59783148|NCT00678561|75903736|FG000|STARTED|Overall Study||6||
59783149|NCT00678561|75903737|FG001|STARTED|Overall Study||6||
59783150|NCT00678561|75903738|FG002|STARTED|Overall Study||8||
59783151|NCT00678561|75903739|FG003|STARTED|Overall Study||4||
59783152|NCT00678561|75903740|FG004|STARTED|Overall Study||17||
59783153|NCT00678561|75903741|FG005|STARTED|Overall Study||17||
59783154|NCT00678561|75903742|FG006|STARTED|Overall Study||15||
59783155|NCT00678561|75903743|FG007|STARTED|Overall Study||8||
59783156|NCT00678561|75903736|FG000|COMPLETED|Overall Study||6||
59783157|NCT00678561|75903737|FG001|COMPLETED|Overall Study||5||
59783158|NCT00678561|75903738|FG002|COMPLETED|Overall Study||7||
59783159|NCT00678561|75903739|FG003|COMPLETED|Overall Study||4||
59783160|NCT00678561|75903740|FG004|COMPLETED|Overall Study||15||
59783161|NCT00678561|75903741|FG005|COMPLETED|Overall Study||16||
59783162|NCT00678561|75903742|FG006|COMPLETED|Overall Study||15||
59783163|NCT00678561|75903743|FG007|COMPLETED|Overall Study||7||
59783164|NCT00678561|75903736|FG000|NOT COMPLETED|Overall Study||0||
59783165|NCT00678561|75903737|FG001|NOT COMPLETED|Overall Study||1||
59783166|NCT00678561|75903738|FG002|NOT COMPLETED|Overall Study||1||
59783167|NCT00678561|75903739|FG003|NOT COMPLETED|Overall Study||0||
59783168|NCT00678561|75903740|FG004|NOT COMPLETED|Overall Study||2||
59783169|NCT00678561|75903741|FG005|NOT COMPLETED|Overall Study||1||
59783170|NCT00678561|75903742|FG006|NOT COMPLETED|Overall Study||0||
59783171|NCT00678561|75903743|FG007|NOT COMPLETED|Overall Study||1||
59783172|NCT00676143|75903770|FG000|STARTED|Overall Study||441||
59783173|NCT00676143|75903771|FG001|STARTED|Overall Study||658||
59783174|NCT00676143|75903770|FG000|Treated|Overall Study||439||
59783175|NCT00676143|75903771|FG001|Treated|Overall Study||654||
59783176|NCT00676143|75903770|FG000|COMPLETED|Overall Study||285||
59783177|NCT00676143|75903771|FG001|COMPLETED|Overall Study||398||
59783178|NCT00676143|75903770|FG000|NOT COMPLETED|Overall Study||156||
59783179|NCT00676143|75903771|FG001|NOT COMPLETED|Overall Study||260||
59783180|NCT04585022|75903780|FG000|STARTED|Overall Study||39||
59783181|NCT04585022|75903781|FG001|STARTED|Overall Study||36||
59783182|NCT04585022|75903780|FG000|COMPLETED|Overall Study||33||
59783183|NCT04585022|75903781|FG001|COMPLETED|Overall Study||25||
59783184|NCT04585022|75903780|FG000|NOT COMPLETED|Overall Study||6||
59783185|NCT04585022|75903781|FG001|NOT COMPLETED|Overall Study||11||
59783186|NCT02903355|75903789|FG000|STARTED|Overall Study||186||
59783187|NCT02903355|75903790|FG001|STARTED|Overall Study||165||
59783188|NCT02903355|75903789|FG000|COMPLETED|Overall Study||142||
59783189|NCT02903355|75903790|FG001|COMPLETED|Overall Study||124||
59783190|NCT02903355|75903789|FG000|NOT COMPLETED|Overall Study||44||
59783191|NCT02903355|75903790|FG001|NOT COMPLETED|Overall Study||41||
59783192|NCT00675597|75903796|FG000|STARTED|Overall Study||26||
59783193|NCT00675597|75903796|FG000|COMPLETED|Overall Study||23||
59783194|NCT00675597|75903796|FG000|NOT COMPLETED|Overall Study||3||
59783195|NCT04292301|75903800|FG000|STARTED|Overall Study||92||
59783196|NCT04292301|75903800|FG000|COMPLETED|Overall Study||89||
59783197|NCT04292301|75903800|FG000|NOT COMPLETED|Overall Study||3||
59783198|NCT00675441|75903804|FG000|STARTED|Overall Study||5||
59783199|NCT00675441|75903804|FG000|COMPLETED|Overall Study||2||
59783200|NCT00675441|75903804|FG000|NOT COMPLETED|Overall Study||3||
59783201|NCT01413399|75903810|FG000|STARTED|Overall Study||208||
59783202|NCT01413399|75903811|FG001|STARTED|Overall Study||334||
59783203|NCT01413399|75903810|FG000|COMPLETED|Overall Study||208||
59783204|NCT01413399|75903811|FG001|COMPLETED|Overall Study||334||
59783205|NCT01413399|75903810|FG000|NOT COMPLETED|Overall Study||0||
59783206|NCT01413399|75903811|FG001|NOT COMPLETED|Overall Study||0||
59783207|NCT00674973|75903819|FG000|STARTED|Overall Study||103||
59783208|NCT00674973|75903820|FG001|STARTED|Overall Study||104||
59783209|NCT00674973|75903819|FG000|Switch to Open-Label Erlotinib|Overall Study|Participants with PD were given opportunity to switch.|57||
59783210|NCT00674973|75903820|FG001|Switch to Open-Label Erlotinib|Overall Study||0||
59783211|NCT00674973|75903819|FG000|COMPLETED|Overall Study|Completed double-blind treatment.|3||
59783212|NCT00674973|75903820|FG001|COMPLETED|Overall Study|Completed double-blind treatment.|2||
59783213|NCT00674973|75903819|FG000|NOT COMPLETED|Overall Study||100||
59783214|NCT00674973|75903820|FG001|NOT COMPLETED|Overall Study||102||
59783215|NCT00673179|75903828|FG000|STARTED|Overall Study||7||
59783216|NCT00673179|75903829|FG001|STARTED|Overall Study||0||
59783217|NCT00673179|75903828|FG000|COMPLETED|Overall Study||4||
59783218|NCT00673179|75903829|FG001|COMPLETED|Overall Study||0||
59783219|NCT00673179|75903828|FG000|NOT COMPLETED|Overall Study||3||
59783220|NCT00673179|75903829|FG001|NOT COMPLETED|Overall Study||0||
59783221|NCT00584012|75903835|FG000|STARTED|Overall Study||9||
59783222|NCT00584012|75903835|FG000|COMPLETED|Overall Study||8||
59783223|NCT00584012|75903835|FG000|NOT COMPLETED|Overall Study||1||
59783224|NCT00674817|75903839|FG000|STARTED|Period 1||44||
59783225|NCT00674817|75903839|FG000|COMPLETED|Period 1||41||
59783226|NCT00674817|75903839|FG000|NOT COMPLETED|Period 1||3||
59783227|NCT00674817|75903839|FG000|STARTED|Period 2||41||
59783228|NCT00674817|75903839|FG000|COMPLETED|Period 2||41||
59783229|NCT00674817|75903839|FG000|NOT COMPLETED|Period 2||0||
59783230|NCT00674817|75903839|FG000|STARTED|Period 3||41||
59783231|NCT00674817|75903839|FG000|COMPLETED|Period 3||39||
59783232|NCT00674817|75903839|FG000|NOT COMPLETED|Period 3||2||
59783233|NCT00674817|75903839|FG000|STARTED|Period 4||39||
59783234|NCT00674817|75903839|FG000|COMPLETED|Period 4||38||
59783235|NCT00674817|75903839|FG000|NOT COMPLETED|Period 4||1||
59783236|NCT00674817|75903839|FG000|STARTED|Period 5||38||
59783237|NCT00674817|75903839|FG000|COMPLETED|Period 5||38||
59783238|NCT00674817|75903839|FG000|NOT COMPLETED|Period 5||0||
59783239|NCT00674817|75903839|FG000|STARTED|Period 6||38||
59783240|NCT00674817|75903839|FG000|COMPLETED|Period 6||38||
59783241|NCT00674817|75903839|FG000|NOT COMPLETED|Period 6||0||
59783242|NCT00672633|75903855|FG000|STARTED|Overall Study||12||
59783243|NCT00672633|75903856|FG001|STARTED|Overall Study||13||
59783244|NCT00672633|75903855|FG000|COMPLETED|Overall Study||12||
59783245|NCT00672633|75903856|FG001|COMPLETED|Overall Study||12||
59783246|NCT00672633|75903855|FG000|NOT COMPLETED|Overall Study||0||
59783247|NCT00672633|75903856|FG001|NOT COMPLETED|Overall Study||1||
59783248|NCT00672555|75903862|FG000|STARTED|Overall Study||70||
59783249|NCT00672555|75903862|FG000|COMPLETED|Overall Study|All patients were seen at 3 weeks in the outpatient clinic.|64||
59783250|NCT00672555|75903862|FG000|NOT COMPLETED|Overall Study||6||
59783251|NCT00672477|75903868|FG000|STARTED|Overall Study|120 subjects were randomized to this group, but only 116 subjects received study drug.|116||
59783252|NCT00672477|75903869|FG001|STARTED|Overall Study|117 subjects were randomized to this group, but only 114 subjects received study drug.|114||
59783253|NCT00672477|75903868|FG000|COMPLETED|Overall Study|One subject had missing data as reason for study termination - not counted as early termination.|89||
59783254|NCT00672477|75903869|FG001|COMPLETED|Overall Study||88||
59783255|NCT00672477|75903868|FG000|NOT COMPLETED|Overall Study||27||
59783256|NCT00672477|75903869|FG001|NOT COMPLETED|Overall Study||26||
59783257|NCT00674661|75903877|FG000|STARTED|Overall Study||67||
59783258|NCT00674661|75903878|FG001|STARTED|Overall Study||63||
59783259|NCT00674661|75903877|FG000|COMPLETED|Overall Study||56||
59783260|NCT00674661|75903878|FG001|COMPLETED|Overall Study||48||
59783261|NCT00674661|75903877|FG000|NOT COMPLETED|Overall Study||11||
59783262|NCT00674661|75903878|FG001|NOT COMPLETED|Overall Study||15||
59783263|NCT00671931|75903889|FG000|STARTED|Overall Study||9||
59783264|NCT00671931|75903890|FG001|STARTED|Overall Study||8||
59783265|NCT00671931|75903891|FG002|STARTED|Overall Study||9||
59783266|NCT00671931|75903892|FG003|STARTED|Overall Study||10||
59783267|NCT00671931|75903893|FG004|STARTED|Overall Study||8||
59783268|NCT00671931|75903889|FG000|COMPLETED|Overall Study|Nueromonitoring equipment falure|8||
59783269|NCT00671931|75903890|FG001|COMPLETED|Overall Study|All completed|8||
59783270|NCT00671931|75903891|FG002|COMPLETED|Overall Study|all completed|9||
59783271|NCT00671931|75903892|FG003|COMPLETED|Overall Study|Prepositioning - Neuromonitoring required|8||
59783272|NCT00671931|75903893|FG004|COMPLETED|Overall Study|Low heart rate requiring treatment|7||
59783273|NCT00671931|75903889|FG000|NOT COMPLETED|Overall Study||1||
59783274|NCT00671931|75903890|FG001|NOT COMPLETED|Overall Study||0||
59783275|NCT00671931|75903891|FG002|NOT COMPLETED|Overall Study||0||
59783276|NCT00671931|75903892|FG003|NOT COMPLETED|Overall Study||2||
59783277|NCT00671931|75903893|FG004|NOT COMPLETED|Overall Study||1||
59783278|NCT04295720|75903905|FG000|STARTED|Overall Study||1||
59783279|NCT04295720|75903905|FG000|COMPLETED|Overall Study||1||
59783280|NCT04295720|75903905|FG000|NOT COMPLETED|Overall Study||0||
59783281|NCT00673881|75903909|FG000|STARTED|Overall Study||25||
59783282|NCT00673881|75903909|FG000|COMPLETED|Overall Study||24||
59783283|NCT00673881|75903909|FG000|NOT COMPLETED|Overall Study||1||
59783284|NCT00671853|75903915|FG000|STARTED|Overall Study||46||
59783285|NCT00671853|75903916|FG001|STARTED|Overall Study||45||
59783286|NCT00671853|75903915|FG000|COMPLETED|Overall Study||26||
59953050|NCT04057820|76071787|FG007|COMPLETED|Period 2||0||0
59953051|NCT04057820|76071788|FG008|COMPLETED|Period 2||47||4
59953052|NCT04057820|76071789|FG009|COMPLETED|Period 2||0||0
59783287|NCT00671853|75903916|FG001|COMPLETED|Overall Study||18||
59783288|NCT00671853|75903915|FG000|NOT COMPLETED|Overall Study||20||
59783289|NCT00671853|75903916|FG001|NOT COMPLETED|Overall Study||27||
59783290|NCT00570921|75903924|FG000|STARTED|Overall Study||33||
59783291|NCT00570921|75903924|FG000|COMPLETED|Overall Study||31||
59783292|NCT00570921|75903924|FG000|NOT COMPLETED|Overall Study||2||
59783293|NCT00670449|75903932|FG000|STARTED|Overall Study||47||
59783294|NCT00670449|75903933|FG001|STARTED|Overall Study||46||
59783295|NCT00670449|75903934|FG002|STARTED|Overall Study||27||
59783296|NCT00670449|75903935|FG003|STARTED|Overall Study||23||
59783297|NCT00670449|75903932|FG000|Switched to 0.5mg (Open Label)|Overall Study||45||
59783298|NCT00670449|75903933|FG001|Switched to 0.5mg (Open Label)|Overall Study|Following protocol amendment, study became open-label with all patients receiving FTY720 0.5 mg/day|41||
59783299|NCT00670449|75903934|FG002|Switched to 0.5mg (Open Label)|Overall Study||23||
59783300|NCT00670449|75903935|FG003|Switched to 0.5mg (Open Label)|Overall Study|Following protocol amendment, study became open-label with all patients receiving FTY720 0.5 mg/day|17||
59783301|NCT00670449|75903932|FG000|COMPLETED|Overall Study||38||
59783302|NCT00670449|75903933|FG001|COMPLETED|Overall Study||36||
59783303|NCT00670449|75903934|FG002|COMPLETED|Overall Study||18||
59783304|NCT00670449|75903935|FG003|COMPLETED|Overall Study||15||
59783305|NCT00670449|75903932|FG000|NOT COMPLETED|Overall Study||9||
59783306|NCT00670449|75903933|FG001|NOT COMPLETED|Overall Study||10||
59783307|NCT00670449|75903934|FG002|NOT COMPLETED|Overall Study||9||
59783308|NCT00670449|75903935|FG003|NOT COMPLETED|Overall Study||8||
59783309|NCT00668733|75903946|FG000|STARTED|Overall Study||89||
59783310|NCT00668733|75903947|FG001|STARTED|Overall Study||90||
59783311|NCT00668733|75903946|FG000|COMPLETED|Overall Study||87||
59783312|NCT00668733|75903947|FG001|COMPLETED|Overall Study||83||
59783313|NCT00668733|75903946|FG000|NOT COMPLETED|Overall Study||2||
59783314|NCT00668733|75903947|FG001|NOT COMPLETED|Overall Study||7||
59783315|NCT00673257|75903953|FG000|STARTED|Overall Study||107||
59783316|NCT00673257|75903953|FG000|COMPLETED|Overall Study||102||
59783317|NCT00673257|75903953|FG000|NOT COMPLETED|Overall Study||5||
59783318|NCT00667875|75903960|FG000|STARTED|Overall Study|3 subjects had no data after randomization and were excluded from analysis|23||
59783319|NCT00667875|75903961|FG001|STARTED|Overall Study||21||
59783320|NCT00667875|75903962|FG002|STARTED|Overall Study|2 subjects had no data following randomization and were excluded from the analysis.|21||
59783321|NCT00667875|75903960|FG000|Subjects Included in Analysisd|Overall Study||20||
59783322|NCT00667875|75903961|FG001|Subjects Included in Analysisd|Overall Study||21||
59783323|NCT00667875|75903962|FG002|Subjects Included in Analysisd|Overall Study||19||
59783324|NCT00667875|75903960|FG000|COMPLETED|Overall Study|Subjects who dropped out during treatment are considered completed if they provide end of study data|13||
59783325|NCT00667875|75903961|FG001|COMPLETED|Overall Study||10||
59783326|NCT00667875|75903962|FG002|COMPLETED|Overall Study||8||
59783327|NCT00667875|75903960|FG000|NOT COMPLETED|Overall Study||10||
59783328|NCT00667875|75903961|FG001|NOT COMPLETED|Overall Study||11||
59783329|NCT00667875|75903962|FG002|NOT COMPLETED|Overall Study||13||
59783330|NCT03468998|75903982|FG000|STARTED|Overall Study||7||8
59783331|NCT03468998|75903983|FG001|STARTED|Overall Study||7||7
59783332|NCT03468998|75903984|FG002|STARTED|Overall Study||1||2
59783333|NCT03468998|75903985|FG003|STARTED|Overall Study||10||10
59783334|NCT03468998|75903986|FG004|STARTED|Overall Study||10||10
59783335|NCT03468998|75903987|FG005|STARTED|Overall Study||2||4
59783336|NCT03468998|75903982|FG000|COMPLETED|Overall Study||6||7
59783337|NCT03468998|75903983|FG001|COMPLETED|Overall Study||6||6
59783338|NCT03468998|75903984|FG002|COMPLETED|Overall Study||1||2
59783339|NCT03468998|75903985|FG003|COMPLETED|Overall Study||6||6
59783340|NCT03468998|75903986|FG004|COMPLETED|Overall Study||9||9
59783341|NCT03468998|75903987|FG005|COMPLETED|Overall Study||2||4
59783342|NCT03468998|75903982|FG000|NOT COMPLETED|Overall Study||1||1
59783343|NCT03468998|75903983|FG001|NOT COMPLETED|Overall Study||1||1
59783344|NCT03468998|75903984|FG002|NOT COMPLETED|Overall Study||0||0
59783345|NCT03468998|75903985|FG003|NOT COMPLETED|Overall Study||4||4
59783346|NCT03468998|75903986|FG004|NOT COMPLETED|Overall Study||1||1
59783347|NCT03468998|75903987|FG005|NOT COMPLETED|Overall Study||0||0
59783348|NCT00667251|75904001|FG000|STARTED|Overall Study||326||
59783349|NCT00667251|75904002|FG001|STARTED|Overall Study||326||
59783350|NCT00667251|75904001|FG000|Combination Rx|Overall Study||322||
59783351|NCT00667251|75904002|FG001|Combination Rx|Overall Study||325||
59783352|NCT00667251|75904001|FG000|Monotherapy|Overall Study||225||
59783353|NCT00667251|75904002|FG001|Monotherapy|Overall Study||232||
59783354|NCT00667251|75904001|FG000|Not Started|Overall Study||4||
59783355|NCT00667251|75904002|FG001|Not Started|Overall Study||1||
59783356|NCT00667251|75904001|FG000|COMPLETED|Overall Study||256||
59783357|NCT00667251|75904002|FG001|COMPLETED|Overall Study||231||
59783358|NCT00667251|75904001|FG000|NOT COMPLETED|Overall Study||70||
59783359|NCT00667251|75904002|FG001|NOT COMPLETED|Overall Study||95||
59783360|NCT04063124|75904008|FG000|STARTED|Overall Study||5||
59783361|NCT04063124|75904008|FG000|COMPLETED|Overall Study||5||
59783362|NCT04063124|75904008|FG000|NOT COMPLETED|Overall Study||0||
59783363|NCT04054544|75904012|FG000|STARTED|Overall Study||18||
59783364|NCT04054544|75904012|FG000|COMPLETED|Overall Study||18||
59783365|NCT04054544|75904012|FG000|NOT COMPLETED|Overall Study||0||
59783366|NCT00669903|75904020|FG000|STARTED|Overall Study||23||
59783367|NCT00669903|75904021|FG001|STARTED|Overall Study||37||
59783368|NCT00669903|75904022|FG002|STARTED|Overall Study||18||
59783369|NCT00669903|75904023|FG003|STARTED|Overall Study||22||
59783370|NCT00669903|75904020|FG000|Completed Treatment Period|Overall Study||23||
59783371|NCT00669903|75904021|FG001|Completed Treatment Period|Overall Study||33||
59783372|NCT00669903|75904022|FG002|Completed Treatment Period|Overall Study||13||
59783373|NCT00669903|75904023|FG003|Completed Treatment Period|Overall Study||19||
59783374|NCT00669903|75904020|FG000|COMPLETED|Overall Study||22||
59783375|NCT00669903|75904021|FG001|COMPLETED|Overall Study||32||
59783376|NCT00669903|75904022|FG002|COMPLETED|Overall Study||13||
59783377|NCT00669903|75904023|FG003|COMPLETED|Overall Study||18||
59783378|NCT00669903|75904020|FG000|NOT COMPLETED|Overall Study||1||
59783379|NCT00669903|75904021|FG001|NOT COMPLETED|Overall Study||5||
59783380|NCT00669903|75904022|FG002|NOT COMPLETED|Overall Study||5||
59783381|NCT00669903|75904023|FG003|NOT COMPLETED|Overall Study||4||
59783382|NCT03759392|75904035|FG000|STARTED|Overall Study||185||
59783383|NCT03759392|75904036|FG001|STARTED|Overall Study||91||
59783384|NCT03759392|75904035|FG000|COMPLETED|Overall Study||164||
59783385|NCT03759392|75904036|FG001|COMPLETED|Overall Study||85||
59783386|NCT03759392|75904035|FG000|NOT COMPLETED|Overall Study||21||
59783387|NCT03759392|75904036|FG001|NOT COMPLETED|Overall Study||6||
59783388|NCT00667719|75904042|FG000|STARTED|Overall Study||564||
59783389|NCT00667719|75904042|FG000|COMPLETED|Overall Study||493||
59783390|NCT00667719|75904042|FG000|NOT COMPLETED|Overall Study||71||
59783391|NCT00669669|75904051|FG000|STARTED|Overall Study||12||
59783392|NCT00669669|75904051|FG000|COMPLETED|Overall Study||11||
59783393|NCT00669669|75904051|FG000|NOT COMPLETED|Overall Study||1||
59783394|NCT00467779|75904070|FG000|STARTED|Stage 1||4||
59783395|NCT00467779|75904071|FG001|STARTED|Stage 1||3||
59783396|NCT00467779|75904072|FG002|STARTED|Stage 1||3||
59783397|NCT00467779|75904073|FG003|STARTED|Stage 1||3||
59783398|NCT00467779|75904074|FG004|STARTED|Stage 1||3||
59783399|NCT00467779|75904075|FG005|STARTED|Stage 1||6||
59783400|NCT00467779|75904076|FG006|STARTED|Stage 1||7||
59783401|NCT00467779|75904077|FG007|STARTED|Stage 1||7||
59783402|NCT00467779|75904078|FG008|STARTED|Stage 1||0||
59783403|NCT00467779|75904079|FG009|STARTED|Stage 1||0||
59783404|NCT00467779|75904080|FG010|STARTED|Stage 1||0||
59783405|NCT00467779|75904081|FG011|STARTED|Stage 1||0||
59783406|NCT00467779|75904082|FG012|STARTED|Stage 1||0||
59783407|NCT00467779|75904083|FG013|STARTED|Stage 1||0||
59783408|NCT00467779|75904084|FG014|STARTED|Stage 1||0||
59783409|NCT00467779|75904070|FG000|COMPLETED|Stage 1||0||
59783410|NCT00467779|75904071|FG001|COMPLETED|Stage 1||0||
59783411|NCT00467779|75904072|FG002|COMPLETED|Stage 1||0||
59783412|NCT00467779|75904073|FG003|COMPLETED|Stage 1||0||
59783413|NCT00467779|75904074|FG004|COMPLETED|Stage 1||0||
59783414|NCT00467779|75904075|FG005|COMPLETED|Stage 1||1||
59783415|NCT00467779|75904076|FG006|COMPLETED|Stage 1||0||
59783416|NCT00467779|75904077|FG007|COMPLETED|Stage 1||0||
59783417|NCT00467779|75904078|FG008|COMPLETED|Stage 1||0||
59783418|NCT00467779|75904079|FG009|COMPLETED|Stage 1||0||
59783419|NCT00467779|75904080|FG010|COMPLETED|Stage 1||0||
59783420|NCT00467779|75904081|FG011|COMPLETED|Stage 1||0||
59783421|NCT00467779|75904082|FG012|COMPLETED|Stage 1||0||
59783422|NCT00467779|75904083|FG013|COMPLETED|Stage 1||0||
59783423|NCT00467779|75904084|FG014|COMPLETED|Stage 1||0||
59783424|NCT00467779|75904070|FG000|NOT COMPLETED|Stage 1||4||
59783425|NCT00467779|75904071|FG001|NOT COMPLETED|Stage 1||3||
59783426|NCT00467779|75904072|FG002|NOT COMPLETED|Stage 1||3||
59783427|NCT00467779|75904073|FG003|NOT COMPLETED|Stage 1||3||
59783428|NCT00467779|75904074|FG004|NOT COMPLETED|Stage 1||3||
59783429|NCT00467779|75904075|FG005|NOT COMPLETED|Stage 1||5||
59783430|NCT00467779|75904076|FG006|NOT COMPLETED|Stage 1||7||
59783431|NCT00467779|75904077|FG007|NOT COMPLETED|Stage 1||7||
59783432|NCT00467779|75904078|FG008|NOT COMPLETED|Stage 1||0||
59783433|NCT00467779|75904079|FG009|NOT COMPLETED|Stage 1||0||
59783434|NCT00467779|75904080|FG010|NOT COMPLETED|Stage 1||0||
59783435|NCT00467779|75904081|FG011|NOT COMPLETED|Stage 1||0||
59783436|NCT00467779|75904082|FG012|NOT COMPLETED|Stage 1||0||
59783437|NCT00467779|75904083|FG013|NOT COMPLETED|Stage 1||0||
59783438|NCT00467779|75904084|FG014|NOT COMPLETED|Stage 1||0||
59783439|NCT00467779|75904070|FG000|STARTED|Stage 1A||0||
59783440|NCT00467779|75904071|FG001|STARTED|Stage 1A||0||
59783441|NCT00467779|75904072|FG002|STARTED|Stage 1A||0||
59783442|NCT00467779|75904073|FG003|STARTED|Stage 1A||0||
59783443|NCT00467779|75904074|FG004|STARTED|Stage 1A||0||
59783444|NCT00467779|75904075|FG005|STARTED|Stage 1A||0||
59783445|NCT00467779|75904076|FG006|STARTED|Stage 1A||0||
59783446|NCT00467779|75904077|FG007|STARTED|Stage 1A||0||
59783447|NCT00467779|75904078|FG008|STARTED|Stage 1A||0||
59783448|NCT00467779|75904079|FG009|STARTED|Stage 1A||3||
59783449|NCT00467779|75904080|FG010|STARTED|Stage 1A||3||
59783450|NCT00467779|75904081|FG011|STARTED|Stage 1A||8||
59783451|NCT00467779|75904082|FG012|STARTED|Stage 1A||6||
59783452|NCT00467779|75904083|FG013|STARTED|Stage 1A||0||
59783453|NCT00467779|75904084|FG014|STARTED|Stage 1A||0||
59783454|NCT00467779|75904070|FG000|COMPLETED|Stage 1A||0||
59783455|NCT00467779|75904071|FG001|COMPLETED|Stage 1A||0||
59783456|NCT00467779|75904072|FG002|COMPLETED|Stage 1A||0||
59783457|NCT00467779|75904073|FG003|COMPLETED|Stage 1A||0||
59783458|NCT00467779|75904074|FG004|COMPLETED|Stage 1A||0||
59783459|NCT00467779|75904075|FG005|COMPLETED|Stage 1A||0||
59783460|NCT00467779|75904076|FG006|COMPLETED|Stage 1A||0||
59783461|NCT00467779|75904077|FG007|COMPLETED|Stage 1A||0||
59783462|NCT00467779|75904078|FG008|COMPLETED|Stage 1A||0||
59783463|NCT00467779|75904079|FG009|COMPLETED|Stage 1A||0||
59783464|NCT00467779|75904080|FG010|COMPLETED|Stage 1A||0||
59783465|NCT00467779|75904081|FG011|COMPLETED|Stage 1A||0||
59783466|NCT00467779|75904082|FG012|COMPLETED|Stage 1A||0||
59783467|NCT00467779|75904083|FG013|COMPLETED|Stage 1A||0||
59783468|NCT00467779|75904084|FG014|COMPLETED|Stage 1A||0||
59783469|NCT00467779|75904070|FG000|NOT COMPLETED|Stage 1A||0||
59783470|NCT00467779|75904071|FG001|NOT COMPLETED|Stage 1A||0||
59783471|NCT00467779|75904072|FG002|NOT COMPLETED|Stage 1A||0||
59783472|NCT00467779|75904073|FG003|NOT COMPLETED|Stage 1A||0||
59783473|NCT00467779|75904074|FG004|NOT COMPLETED|Stage 1A||0||
59783474|NCT00467779|75904075|FG005|NOT COMPLETED|Stage 1A||0||
59783475|NCT00467779|75904076|FG006|NOT COMPLETED|Stage 1A||0||
59783476|NCT00467779|75904077|FG007|NOT COMPLETED|Stage 1A||0||
59783477|NCT00467779|75904078|FG008|NOT COMPLETED|Stage 1A||0||
59783478|NCT00467779|75904079|FG009|NOT COMPLETED|Stage 1A||3||
59783479|NCT00467779|75904080|FG010|NOT COMPLETED|Stage 1A||3||
59783480|NCT00467779|75904081|FG011|NOT COMPLETED|Stage 1A||8||
59783481|NCT00467779|75904082|FG012|NOT COMPLETED|Stage 1A||6||
59783482|NCT00467779|75904083|FG013|NOT COMPLETED|Stage 1A||0||
59783483|NCT00467779|75904084|FG014|NOT COMPLETED|Stage 1A||0||
59783484|NCT00467779|75904070|FG000|STARTED|Stage 2||0||
59783485|NCT00467779|75904071|FG001|STARTED|Stage 2||0||
59783486|NCT00467779|75904072|FG002|STARTED|Stage 2||0||
59783487|NCT00467779|75904073|FG003|STARTED|Stage 2||0||
59783488|NCT00467779|75904074|FG004|STARTED|Stage 2||0||
59783489|NCT00467779|75904075|FG005|STARTED|Stage 2||0||
59783490|NCT00467779|75904076|FG006|STARTED|Stage 2||0||
59783491|NCT00467779|75904077|FG007|STARTED|Stage 2||0||
59783492|NCT00467779|75904078|FG008|STARTED|Stage 2||21||
59783493|NCT00467779|75904079|FG009|STARTED|Stage 2||0||
59783494|NCT00467779|75904080|FG010|STARTED|Stage 2||0||
59783495|NCT00467779|75904081|FG011|STARTED|Stage 2||0||
59783496|NCT00467779|75904082|FG012|STARTED|Stage 2||0||
59783497|NCT00467779|75904083|FG013|STARTED|Stage 2||0||
59783498|NCT00467779|75904084|FG014|STARTED|Stage 2||0||
59783499|NCT00467779|75904070|FG000|COMPLETED|Stage 2||0||
59783500|NCT00467779|75904071|FG001|COMPLETED|Stage 2||0||
59783501|NCT00467779|75904072|FG002|COMPLETED|Stage 2||0||
59783502|NCT00467779|75904073|FG003|COMPLETED|Stage 2||0||
59783503|NCT00467779|75904074|FG004|COMPLETED|Stage 2||0||
59783504|NCT00467779|75904075|FG005|COMPLETED|Stage 2||0||
59783505|NCT00467779|75904076|FG006|COMPLETED|Stage 2||0||
59783506|NCT00467779|75904077|FG007|COMPLETED|Stage 2||0||
59783507|NCT00467779|75904078|FG008|COMPLETED|Stage 2||0||
59783508|NCT00467779|75904079|FG009|COMPLETED|Stage 2||0||
59783509|NCT00467779|75904080|FG010|COMPLETED|Stage 2||0||
59783510|NCT00467779|75904081|FG011|COMPLETED|Stage 2||0||
59783511|NCT00467779|75904082|FG012|COMPLETED|Stage 2||0||
59783512|NCT00467779|75904083|FG013|COMPLETED|Stage 2||0||
59783513|NCT00467779|75904084|FG014|COMPLETED|Stage 2||0||
59783514|NCT00467779|75904070|FG000|NOT COMPLETED|Stage 2||0||
59783515|NCT00467779|75904071|FG001|NOT COMPLETED|Stage 2||0||
59783516|NCT00467779|75904072|FG002|NOT COMPLETED|Stage 2||0||
59783517|NCT00467779|75904073|FG003|NOT COMPLETED|Stage 2||0||
59783518|NCT00467779|75904074|FG004|NOT COMPLETED|Stage 2||0||
59783519|NCT00467779|75904075|FG005|NOT COMPLETED|Stage 2||0||
59783520|NCT00467779|75904076|FG006|NOT COMPLETED|Stage 2||0||
59783521|NCT00467779|75904077|FG007|NOT COMPLETED|Stage 2||0||
59783522|NCT00467779|75904078|FG008|NOT COMPLETED|Stage 2||21||
59783523|NCT00467779|75904079|FG009|NOT COMPLETED|Stage 2||0||
59783524|NCT00467779|75904080|FG010|NOT COMPLETED|Stage 2||0||
59783525|NCT00467779|75904081|FG011|NOT COMPLETED|Stage 2||0||
59783526|NCT00467779|75904082|FG012|NOT COMPLETED|Stage 2||0||
59783527|NCT00467779|75904083|FG013|NOT COMPLETED|Stage 2||0||
59783528|NCT00467779|75904084|FG014|NOT COMPLETED|Stage 2||0||
59783529|NCT00467779|75904070|FG000|STARTED|Stage 2A||0||
59783530|NCT00467779|75904071|FG001|STARTED|Stage 2A||0||
59783531|NCT00467779|75904072|FG002|STARTED|Stage 2A||0||
59783532|NCT00467779|75904073|FG003|STARTED|Stage 2A||0||
59783533|NCT00467779|75904074|FG004|STARTED|Stage 2A||0||
59783534|NCT00467779|75904075|FG005|STARTED|Stage 2A||0||
59783535|NCT00467779|75904076|FG006|STARTED|Stage 2A||0||
59783536|NCT00467779|75904077|FG007|STARTED|Stage 2A||0||
59783537|NCT00467779|75904078|FG008|STARTED|Stage 2A||0||
59783538|NCT00467779|75904079|FG009|STARTED|Stage 2A||0||
59783539|NCT00467779|75904080|FG010|STARTED|Stage 2A||0||
59783540|NCT00467779|75904081|FG011|STARTED|Stage 2A||0||
59783541|NCT00467779|75904082|FG012|STARTED|Stage 2A||0||
59783542|NCT00467779|75904083|FG013|STARTED|Stage 2A||22||
59783543|NCT00467779|75904084|FG014|STARTED|Stage 2A||0||
59783544|NCT00467779|75904070|FG000|COMPLETED|Stage 2A||0||
59783545|NCT00467779|75904071|FG001|COMPLETED|Stage 2A||0||
59783546|NCT00467779|75904072|FG002|COMPLETED|Stage 2A||0||
59783547|NCT00467779|75904073|FG003|COMPLETED|Stage 2A||0||
59783548|NCT00467779|75904074|FG004|COMPLETED|Stage 2A||0||
59783549|NCT00467779|75904075|FG005|COMPLETED|Stage 2A||0||
59783550|NCT00467779|75904076|FG006|COMPLETED|Stage 2A||0||
59783551|NCT00467779|75904077|FG007|COMPLETED|Stage 2A||0||
59783552|NCT00467779|75904078|FG008|COMPLETED|Stage 2A||0||
59783553|NCT00467779|75904079|FG009|COMPLETED|Stage 2A||0||
59783554|NCT00467779|75904080|FG010|COMPLETED|Stage 2A||0||
59783555|NCT00467779|75904081|FG011|COMPLETED|Stage 2A||0||
59783556|NCT00467779|75904082|FG012|COMPLETED|Stage 2A||0||
59783557|NCT00467779|75904083|FG013|COMPLETED|Stage 2A||1||
59783558|NCT00467779|75904084|FG014|COMPLETED|Stage 2A||0||
59783559|NCT00467779|75904070|FG000|NOT COMPLETED|Stage 2A||0||
59783560|NCT00467779|75904071|FG001|NOT COMPLETED|Stage 2A||0||
59783561|NCT00467779|75904072|FG002|NOT COMPLETED|Stage 2A||0||
59783562|NCT00467779|75904073|FG003|NOT COMPLETED|Stage 2A||0||
59783563|NCT00467779|75904074|FG004|NOT COMPLETED|Stage 2A||0||
59783564|NCT00467779|75904075|FG005|NOT COMPLETED|Stage 2A||0||
59783565|NCT00467779|75904076|FG006|NOT COMPLETED|Stage 2A||0||
59783566|NCT00467779|75904077|FG007|NOT COMPLETED|Stage 2A||0||
59783567|NCT00467779|75904078|FG008|NOT COMPLETED|Stage 2A||0||
59783568|NCT00467779|75904079|FG009|NOT COMPLETED|Stage 2A||0||
59783569|NCT00467779|75904080|FG010|NOT COMPLETED|Stage 2A||0||
59783570|NCT00467779|75904081|FG011|NOT COMPLETED|Stage 2A||0||
59783571|NCT00467779|75904082|FG012|NOT COMPLETED|Stage 2A||0||
59783572|NCT00467779|75904083|FG013|NOT COMPLETED|Stage 2A||21||
59783573|NCT00467779|75904084|FG014|NOT COMPLETED|Stage 2A||0||
59783574|NCT00467779|75904070|FG000|STARTED|Stage 3||0||
59783575|NCT00467779|75904071|FG001|STARTED|Stage 3||0||
59783576|NCT00467779|75904072|FG002|STARTED|Stage 3||0||
59783577|NCT00467779|75904073|FG003|STARTED|Stage 3||0||
59783578|NCT00467779|75904074|FG004|STARTED|Stage 3||0||
59783579|NCT00467779|75904075|FG005|STARTED|Stage 3||0||
59783580|NCT00467779|75904076|FG006|STARTED|Stage 3||0||
59783581|NCT00467779|75904077|FG007|STARTED|Stage 3||0||
59783582|NCT00467779|75904078|FG008|STARTED|Stage 3||0||
59783583|NCT00467779|75904079|FG009|STARTED|Stage 3||0||
59783584|NCT00467779|75904080|FG010|STARTED|Stage 3||0||
59783585|NCT00467779|75904081|FG011|STARTED|Stage 3||0||
59783586|NCT00467779|75904082|FG012|STARTED|Stage 3||0||
59783587|NCT00467779|75904083|FG013|STARTED|Stage 3||0||
59783588|NCT00467779|75904084|FG014|STARTED|Stage 3||20||
59783589|NCT00467779|75904070|FG000|COMPLETED|Stage 3||0||
59783590|NCT00467779|75904071|FG001|COMPLETED|Stage 3||0||
59783591|NCT00467779|75904072|FG002|COMPLETED|Stage 3||0||
59783592|NCT00467779|75904073|FG003|COMPLETED|Stage 3||0||
59783593|NCT00467779|75904074|FG004|COMPLETED|Stage 3||0||
59783594|NCT00467779|75904075|FG005|COMPLETED|Stage 3||0||
59783595|NCT00467779|75904076|FG006|COMPLETED|Stage 3||0||
59783596|NCT00467779|75904077|FG007|COMPLETED|Stage 3||0||
59783597|NCT00467779|75904078|FG008|COMPLETED|Stage 3||0||
59783598|NCT00467779|75904079|FG009|COMPLETED|Stage 3||0||
59783599|NCT00467779|75904080|FG010|COMPLETED|Stage 3||0||
59783600|NCT00467779|75904081|FG011|COMPLETED|Stage 3||0||
59783601|NCT00467779|75904082|FG012|COMPLETED|Stage 3||0||
59783602|NCT00467779|75904083|FG013|COMPLETED|Stage 3||0||
59783603|NCT00467779|75904084|FG014|COMPLETED|Stage 3||3||
59783604|NCT00467779|75904070|FG000|NOT COMPLETED|Stage 3||0||
59783605|NCT00467779|75904071|FG001|NOT COMPLETED|Stage 3||0||
59783606|NCT00467779|75904072|FG002|NOT COMPLETED|Stage 3||0||
59783607|NCT00467779|75904073|FG003|NOT COMPLETED|Stage 3||0||
59783608|NCT00467779|75904074|FG004|NOT COMPLETED|Stage 3||0||
59783609|NCT00467779|75904075|FG005|NOT COMPLETED|Stage 3||0||
59783610|NCT00467779|75904076|FG006|NOT COMPLETED|Stage 3||0||
59783611|NCT00467779|75904077|FG007|NOT COMPLETED|Stage 3||0||
59783612|NCT00467779|75904078|FG008|NOT COMPLETED|Stage 3||0||
59783613|NCT00467779|75904079|FG009|NOT COMPLETED|Stage 3||0||
59783614|NCT00467779|75904080|FG010|NOT COMPLETED|Stage 3||0||
59783615|NCT00467779|75904081|FG011|NOT COMPLETED|Stage 3||0||
59783616|NCT00467779|75904082|FG012|NOT COMPLETED|Stage 3||0||
59783617|NCT00467779|75904083|FG013|NOT COMPLETED|Stage 3||0||
59783618|NCT00467779|75904084|FG014|NOT COMPLETED|Stage 3||17||
59783619|NCT00570687|75904124|FG000|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||0||
59783620|NCT00570687|75904125|FG001|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||0||
59783621|NCT00570687|75904126|FG002|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||0||
59783622|NCT00570687|75904127|FG003|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||0||
59783623|NCT00570687|75904128|FG004|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3||
59783624|NCT00570687|75904129|FG005|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3||
59783625|NCT00570687|75904130|FG006|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3||
59783626|NCT00570687|75904131|FG007|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3||
59783627|NCT00570687|75904132|FG008|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3||
59783628|NCT00570687|75904133|FG009|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3||
59783629|NCT00570687|75904124|FG000|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0||
59783630|NCT00570687|75904125|FG001|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0||
59783631|NCT00570687|75904126|FG002|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0||
59783632|NCT00570687|75904127|FG003|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0||
59783633|NCT00570687|75904128|FG004|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3||
59783634|NCT00570687|75904129|FG005|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3||
59783635|NCT00570687|75904130|FG006|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3||
59783636|NCT00570687|75904131|FG007|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3||
59783637|NCT00570687|75904132|FG008|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3||
59783638|NCT00570687|75904133|FG009|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3||
59783639|NCT00570687|75904124|FG000|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0||
59783640|NCT00570687|75904125|FG001|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0||
59783641|NCT00570687|75904126|FG002|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0||
59783642|NCT00570687|75904127|FG003|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0||
59783643|NCT00570687|75904128|FG004|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0||
59783644|NCT00570687|75904129|FG005|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0||
59783645|NCT00570687|75904130|FG006|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0||
59783646|NCT00570687|75904131|FG007|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0||
59783647|NCT00570687|75904132|FG008|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0||
59783648|NCT00570687|75904133|FG009|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0||
59783649|NCT00570687|75904124|FG000|STARTED|Washout 1 (7-21 Days) - Orig Protocol||0||
59783650|NCT00570687|75904125|FG001|STARTED|Washout 1 (7-21 Days) - Orig Protocol||0||
59783651|NCT00570687|75904126|FG002|STARTED|Washout 1 (7-21 Days) - Orig Protocol||0||
59783652|NCT00570687|75904127|FG003|STARTED|Washout 1 (7-21 Days) - Orig Protocol||0||
59783653|NCT00570687|75904128|FG004|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3||
59783654|NCT00570687|75904129|FG005|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3||
59783655|NCT00570687|75904130|FG006|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3||
59783656|NCT00570687|75904131|FG007|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3||
59783657|NCT00570687|75904132|FG008|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3||
59783658|NCT00570687|75904133|FG009|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3||
59783659|NCT00570687|75904124|FG000|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0||
59783660|NCT00570687|75904125|FG001|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0||
59783661|NCT00570687|75904126|FG002|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0||
59783662|NCT00570687|75904127|FG003|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0||
59783663|NCT00570687|75904128|FG004|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3||
59783664|NCT00570687|75904129|FG005|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3||
59783665|NCT00570687|75904130|FG006|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3||
59783666|NCT00570687|75904131|FG007|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3||
59783667|NCT00570687|75904132|FG008|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3||
59783668|NCT00570687|75904133|FG009|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3||
59783669|NCT00570687|75904124|FG000|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0||
59783670|NCT00570687|75904125|FG001|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0||
59783671|NCT00570687|75904126|FG002|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0||
59783672|NCT00570687|75904127|FG003|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0||
59783673|NCT00570687|75904128|FG004|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0||
59783674|NCT00570687|75904129|FG005|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0||
59783675|NCT00570687|75904130|FG006|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0||
59783676|NCT00570687|75904131|FG007|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0||
59783677|NCT00570687|75904132|FG008|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0||
59783678|NCT00570687|75904133|FG009|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0||
59783679|NCT00570687|75904124|FG000|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||0||
59783680|NCT00570687|75904125|FG001|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||0||
59783681|NCT00570687|75904126|FG002|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||0||
59783682|NCT00570687|75904127|FG003|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||0||
59783683|NCT00570687|75904128|FG004|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3||
59783684|NCT00570687|75904129|FG005|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3||
59783685|NCT00570687|75904130|FG006|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3||
59783686|NCT00570687|75904131|FG007|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3||
59783687|NCT00570687|75904132|FG008|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3||
59783688|NCT00570687|75904133|FG009|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3||
59783689|NCT00570687|75904124|FG000|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0||
59783690|NCT00570687|75904125|FG001|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0||
59783691|NCT00570687|75904126|FG002|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0||
59783692|NCT00570687|75904127|FG003|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0||
59783693|NCT00570687|75904128|FG004|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3||
59783694|NCT00570687|75904129|FG005|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3||
59783695|NCT00570687|75904130|FG006|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3||
59783696|NCT00570687|75904131|FG007|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3||
59783697|NCT00570687|75904132|FG008|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3||
59783698|NCT00570687|75904133|FG009|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3||
59783699|NCT00570687|75904124|FG000|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0||
59783700|NCT00570687|75904125|FG001|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0||
59783701|NCT00570687|75904126|FG002|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0||
59783702|NCT00570687|75904127|FG003|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0||
59783703|NCT00570687|75904128|FG004|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0||
59783704|NCT00570687|75904129|FG005|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0||
59783705|NCT00570687|75904130|FG006|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0||
59783706|NCT00570687|75904131|FG007|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0||
59783707|NCT00570687|75904132|FG008|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0||
59783708|NCT00570687|75904133|FG009|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0||
59783709|NCT00570687|75904124|FG000|STARTED|Washout 2 (7-21 Days) - Orig Protocol||0||
59783710|NCT00570687|75904125|FG001|STARTED|Washout 2 (7-21 Days) - Orig Protocol||0||
59783711|NCT00570687|75904126|FG002|STARTED|Washout 2 (7-21 Days) - Orig Protocol||0||
59783712|NCT00570687|75904127|FG003|STARTED|Washout 2 (7-21 Days) - Orig Protocol||0||
59783713|NCT00570687|75904128|FG004|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3||
59783714|NCT00570687|75904129|FG005|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3||
59783715|NCT00570687|75904130|FG006|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3||
59783716|NCT00570687|75904131|FG007|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3||
59783717|NCT00570687|75904132|FG008|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3||
59783718|NCT00570687|75904133|FG009|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3||
59783719|NCT00570687|75904124|FG000|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0||
59783720|NCT00570687|75904125|FG001|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0||
59783721|NCT00570687|75904126|FG002|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0||
59783722|NCT00570687|75904127|FG003|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0||
59783723|NCT00570687|75904128|FG004|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3||
59783724|NCT00570687|75904129|FG005|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3||
59783725|NCT00570687|75904130|FG006|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3||
59783726|NCT00570687|75904131|FG007|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3||
59783727|NCT00570687|75904132|FG008|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3||
59783728|NCT00570687|75904133|FG009|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3||
60073066|NCT01564407|76188253|FG001|NOT COMPLETED|Overall Study||2||
60073067|NCT01564407|76188254|FG002|NOT COMPLETED|Overall Study||0||
60073068|NCT01564407|76188255|FG003|NOT COMPLETED|Overall Study||1||
59783729|NCT00570687|75904124|FG000|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0||
59783730|NCT00570687|75904125|FG001|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0||
59783731|NCT00570687|75904126|FG002|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0||
59783732|NCT00570687|75904127|FG003|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0||
59783733|NCT00570687|75904128|FG004|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0||
59783734|NCT00570687|75904129|FG005|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0||
59783735|NCT00570687|75904130|FG006|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0||
59783736|NCT00570687|75904131|FG007|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0||
59783737|NCT00570687|75904132|FG008|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0||
59783738|NCT00570687|75904133|FG009|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0||
59783739|NCT00570687|75904124|FG000|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||0||
59783740|NCT00570687|75904125|FG001|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||0||
59783741|NCT00570687|75904126|FG002|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||0||
59783742|NCT00570687|75904127|FG003|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||0||
59783743|NCT00570687|75904128|FG004|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3||
59783744|NCT00570687|75904129|FG005|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3||
59783745|NCT00570687|75904130|FG006|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3||
59783746|NCT00570687|75904131|FG007|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3||
59783747|NCT00570687|75904132|FG008|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3||
59953053|NCT04057820|76071790|FG010|COMPLETED|Period 2||17||4
60073069|NCT01564407|76188256|FG004|NOT COMPLETED|Overall Study||0||
59783748|NCT00570687|75904133|FG009|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3||
59783749|NCT00570687|75904124|FG000|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0||
59783750|NCT00570687|75904125|FG001|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0||
59783751|NCT00570687|75904126|FG002|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0||
59783752|NCT00570687|75904127|FG003|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0||
59783753|NCT00570687|75904128|FG004|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3||
59783754|NCT00570687|75904129|FG005|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3||
59783755|NCT00570687|75904130|FG006|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3||
59783756|NCT00570687|75904131|FG007|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3||
59783757|NCT00570687|75904132|FG008|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3||
59783758|NCT00570687|75904133|FG009|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3||
59783759|NCT00570687|75904124|FG000|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0||
59783760|NCT00570687|75904125|FG001|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0||
59783761|NCT00570687|75904126|FG002|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0||
59783762|NCT00570687|75904127|FG003|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0||
59783763|NCT00570687|75904128|FG004|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0||
59783764|NCT00570687|75904129|FG005|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0||
59783765|NCT00570687|75904130|FG006|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0||
59783766|NCT00570687|75904131|FG007|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0||
59783767|NCT00570687|75904132|FG008|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0||
59783768|NCT00570687|75904133|FG009|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0||
59783769|NCT00570687|75904124|FG000|STARTED|Washout 3 (7-21 Days) - Orig Protocol||0||
59783770|NCT00570687|75904125|FG001|STARTED|Washout 3 (7-21 Days) - Orig Protocol||0||
59783771|NCT00570687|75904126|FG002|STARTED|Washout 3 (7-21 Days) - Orig Protocol||0||
59783772|NCT00570687|75904127|FG003|STARTED|Washout 3 (7-21 Days) - Orig Protocol||0||
59783773|NCT00570687|75904128|FG004|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3||
59783774|NCT00570687|75904129|FG005|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3||
59783775|NCT00570687|75904130|FG006|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3||
59783776|NCT00570687|75904131|FG007|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3||
59783777|NCT00570687|75904132|FG008|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3||
59783778|NCT00570687|75904133|FG009|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3||
59783779|NCT00570687|75904124|FG000|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0||
59783780|NCT00570687|75904125|FG001|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0||
59783781|NCT00570687|75904126|FG002|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0||
59783782|NCT00570687|75904127|FG003|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0||
59783783|NCT00570687|75904128|FG004|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0||
59783784|NCT00570687|75904129|FG005|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0||
59783785|NCT00570687|75904130|FG006|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||1||
59783786|NCT00570687|75904131|FG007|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0||
59783787|NCT00570687|75904132|FG008|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||1||
59783788|NCT00570687|75904133|FG009|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0||
59783789|NCT00570687|75904124|FG000|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0||
59783790|NCT00570687|75904125|FG001|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0||
59783791|NCT00570687|75904126|FG002|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0||
59783792|NCT00570687|75904127|FG003|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0||
59783793|NCT00570687|75904128|FG004|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||3||
59783794|NCT00570687|75904129|FG005|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||3||
59783795|NCT00570687|75904130|FG006|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||2||
59783796|NCT00570687|75904131|FG007|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||3||
59783797|NCT00570687|75904132|FG008|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||2||
59783798|NCT00570687|75904133|FG009|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||3||
59783799|NCT00570687|75904124|FG000|STARTED|Clamp 1 (1 Day) - Orig Protocol||0||
59783800|NCT00570687|75904125|FG001|STARTED|Clamp 1 (1 Day) - Orig Protocol||0||
59783801|NCT00570687|75904126|FG002|STARTED|Clamp 1 (1 Day) - Orig Protocol||0||
59783802|NCT00570687|75904127|FG003|STARTED|Clamp 1 (1 Day) - Orig Protocol||0||
59783803|NCT00570687|75904128|FG004|STARTED|Clamp 1 (1 Day) - Orig Protocol||0||
59783804|NCT00570687|75904129|FG005|STARTED|Clamp 1 (1 Day) - Orig Protocol||0||
59783805|NCT00570687|75904130|FG006|STARTED|Clamp 1 (1 Day) - Orig Protocol||1||
59783806|NCT00570687|75904131|FG007|STARTED|Clamp 1 (1 Day) - Orig Protocol||0||
59783807|NCT00570687|75904132|FG008|STARTED|Clamp 1 (1 Day) - Orig Protocol||1||
59783808|NCT00570687|75904133|FG009|STARTED|Clamp 1 (1 Day) - Orig Protocol||0||
59783809|NCT00570687|75904124|FG000|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0||
59783810|NCT00570687|75904125|FG001|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0||
59783811|NCT00570687|75904126|FG002|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0||
59783812|NCT00570687|75904127|FG003|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0||
59783813|NCT00570687|75904128|FG004|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0||
59783814|NCT00570687|75904129|FG005|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0||
59783815|NCT00570687|75904130|FG006|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||1||
59783816|NCT00570687|75904131|FG007|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0||
59783817|NCT00570687|75904132|FG008|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||1||
59783818|NCT00570687|75904133|FG009|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0||
59783819|NCT00570687|75904124|FG000|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0||
59783820|NCT00570687|75904125|FG001|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0||
59783821|NCT00570687|75904126|FG002|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0||
59783822|NCT00570687|75904127|FG003|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0||
59783823|NCT00570687|75904128|FG004|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0||
59783824|NCT00570687|75904129|FG005|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0||
59783825|NCT00570687|75904130|FG006|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0||
59783826|NCT00570687|75904131|FG007|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0||
59783827|NCT00570687|75904132|FG008|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0||
59783828|NCT00570687|75904133|FG009|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0||
59783829|NCT00570687|75904124|FG000|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0||
59783830|NCT00570687|75904125|FG001|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0||
59783831|NCT00570687|75904126|FG002|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0||
59783832|NCT00570687|75904127|FG003|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0||
59783833|NCT00570687|75904128|FG004|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0||
59783834|NCT00570687|75904129|FG005|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0||
59783835|NCT00570687|75904130|FG006|STARTED|Washout 4 (7-21 Days) - Orig Protocol||1||
59783836|NCT00570687|75904131|FG007|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0||
59783837|NCT00570687|75904132|FG008|STARTED|Washout 4 (7-21 Days) - Orig Protocol||1||
59783838|NCT00570687|75904133|FG009|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0||
59783839|NCT00570687|75904124|FG000|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0||
59783840|NCT00570687|75904125|FG001|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0||
59783841|NCT00570687|75904126|FG002|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0||
59783842|NCT00570687|75904127|FG003|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0||
59783843|NCT00570687|75904128|FG004|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0||
59783844|NCT00570687|75904129|FG005|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0||
59783845|NCT00570687|75904130|FG006|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||1||
59783846|NCT00570687|75904131|FG007|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0||
59783847|NCT00570687|75904132|FG008|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0||
59783848|NCT00570687|75904133|FG009|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0||
59783849|NCT00570687|75904124|FG000|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0||
59783850|NCT00570687|75904125|FG001|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0||
59783851|NCT00570687|75904126|FG002|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0||
59783852|NCT00570687|75904127|FG003|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0||
59783853|NCT00570687|75904128|FG004|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0||
59783854|NCT00570687|75904129|FG005|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0||
59783855|NCT00570687|75904130|FG006|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0||
59783856|NCT00570687|75904131|FG007|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0||
59783857|NCT00570687|75904132|FG008|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||1||
59783858|NCT00570687|75904133|FG009|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0||
59783859|NCT00570687|75904124|FG000|STARTED|Clamp 2 (1 Day) - Orig Protocol||0||
59783860|NCT00570687|75904125|FG001|STARTED|Clamp 2 (1 Day) - Orig Protocol||0||
59783861|NCT00570687|75904126|FG002|STARTED|Clamp 2 (1 Day) - Orig Protocol||0||
59783862|NCT00570687|75904127|FG003|STARTED|Clamp 2 (1 Day) - Orig Protocol||0||
59783863|NCT00570687|75904128|FG004|STARTED|Clamp 2 (1 Day) - Orig Protocol||0||
59783864|NCT00570687|75904129|FG005|STARTED|Clamp 2 (1 Day) - Orig Protocol||0||
59783865|NCT00570687|75904130|FG006|STARTED|Clamp 2 (1 Day) - Orig Protocol||1||
59783866|NCT00570687|75904131|FG007|STARTED|Clamp 2 (1 Day) - Orig Protocol||0||
59783867|NCT00570687|75904132|FG008|STARTED|Clamp 2 (1 Day) - Orig Protocol||0||
59783868|NCT00570687|75904133|FG009|STARTED|Clamp 2 (1 Day) - Orig Protocol||0||
59783869|NCT00570687|75904124|FG000|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0||
59783870|NCT00570687|75904125|FG001|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0||
59783871|NCT00570687|75904126|FG002|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0||
59783872|NCT00570687|75904127|FG003|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0||
59953054|NCT04057820|76071791|FG011|COMPLETED|Period 2||0||0
59953055|NCT04057820|76071792|FG012|COMPLETED|Period 2||10||3
59953056|NCT04057820|76071793|FG013|COMPLETED|Period 2||0||0
59953057|NCT04057820|76071794|FG014|COMPLETED|Period 2||18||3
59783873|NCT00570687|75904128|FG004|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0||
59783874|NCT00570687|75904129|FG005|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0||
59783875|NCT00570687|75904130|FG006|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||1||
59783876|NCT00570687|75904131|FG007|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0||
59783877|NCT00570687|75904132|FG008|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0||
59783878|NCT00570687|75904133|FG009|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0||
59783879|NCT00570687|75904124|FG000|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0||
59783880|NCT00570687|75904125|FG001|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0||
59783881|NCT00570687|75904126|FG002|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0||
59783882|NCT00570687|75904127|FG003|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0||
59953058|NCT04057820|76071795|FG015|COMPLETED|Period 2||0||0
59953059|NCT04057820|76071780|FG000|NOT COMPLETED|Period 2||0||0
59783883|NCT00570687|75904128|FG004|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0||
59783884|NCT00570687|75904129|FG005|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0||
59783885|NCT00570687|75904130|FG006|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0||
59783886|NCT00570687|75904131|FG007|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0||
59783887|NCT00570687|75904132|FG008|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0||
59783888|NCT00570687|75904133|FG009|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0||
59783889|NCT00570687|75904124|FG000|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0||
59783890|NCT00570687|75904125|FG001|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0||
59783891|NCT00570687|75904126|FG002|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0||
59783892|NCT00570687|75904127|FG003|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0||
59783893|NCT00570687|75904128|FG004|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0||
59783894|NCT00570687|75904129|FG005|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0||
59783895|NCT00570687|75904130|FG006|STARTED|Washout 5 (7-21 Days) - Orig Protocol||1||
59783896|NCT00570687|75904131|FG007|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0||
59783897|NCT00570687|75904132|FG008|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0||
59783898|NCT00570687|75904133|FG009|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0||
59783899|NCT00570687|75904124|FG000|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0||
59783900|NCT00570687|75904125|FG001|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0||
59783901|NCT00570687|75904126|FG002|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0||
59783902|NCT00570687|75904127|FG003|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0||
59783903|NCT00570687|75904128|FG004|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0||
59522506|NCT03992014|75616970|FG000|NOT COMPLETED|Treatment Period 1 (8 Days)||0||
59522507|NCT03992014|75616970|FG000|STARTED|Washout Period (7 Days)||6||
59522508|NCT03992014|75616970|FG000|COMPLETED|Washout Period (7 Days)||6||
59522509|NCT03992014|75616970|FG000|NOT COMPLETED|Washout Period (7 Days)||0||
59522510|NCT03992014|75616970|FG000|STARTED|Treatment Period 2 (8 Days)||6||
59522511|NCT03992014|75616970|FG000|COMPLETED|Treatment Period 2 (8 Days)||6||
59522512|NCT03992014|75616970|FG000|NOT COMPLETED|Treatment Period 2 (8 Days)||0||
59522513|NCT02558790|75616978|FG000|STARTED|Overall Study|20 subjects signed consent to participate in the study. 15 subjects began taking L-TAMS.|20||
59522514|NCT02558790|75616978|FG000|Treated|Overall Study||15||
59522515|NCT02558790|75616978|FG000|COMPLETED|Overall Study||13||
59522516|NCT02558790|75616978|FG000|NOT COMPLETED|Overall Study||7||
59522517|NCT03992482|75616984|FG000|STARTED|Overall Study||13||
59522518|NCT03992482|75616985|FG001|STARTED|Overall Study||14||
59522519|NCT03992482|75616984|FG000|COMPLETED|Overall Study||13||
59522520|NCT03992482|75616985|FG001|COMPLETED|Overall Study||14||
59522521|NCT03992482|75616984|FG000|NOT COMPLETED|Overall Study||0||
59522522|NCT03992482|75616985|FG001|NOT COMPLETED|Overall Study||0||
59522523|NCT03269968|75616993|FG000|STARTED|Overall Study||0||
59522524|NCT03269968|75616994|FG001|STARTED|Overall Study||0||
59522525|NCT03269968|75616993|FG000|COMPLETED|Overall Study||0||
59522526|NCT03269968|75616994|FG001|COMPLETED|Overall Study||0||
59522527|NCT03269968|75616993|FG000|NOT COMPLETED|Overall Study||0||
59522528|NCT03269968|75616994|FG001|NOT COMPLETED|Overall Study||0||
59522529|NCT04166032|75617000|FG000|STARTED|Overall Study||15||
59522530|NCT04166032|75617000|FG000|COMPLETED|Overall Study||14||
59522531|NCT04166032|75617000|FG000|NOT COMPLETED|Overall Study||1||
59522532|NCT02556138|75617004|FG000|STARTED|Overall Study||8||
59522533|NCT02556138|75617004|FG000|COMPLETED|Overall Study|One patient withdrew from the study due to intolerance of the balloon after 1 month.|7||
59522534|NCT02556138|75617004|FG000|NOT COMPLETED|Overall Study||1||
59522535|NCT04303156|75617010|FG000|STARTED|Overall Study||6||
59522536|NCT04303156|75617011|FG001|STARTED|Overall Study||6||
59522537|NCT04303156|75617010|FG000|COMPLETED|Overall Study||6||
59522538|NCT04303156|75617011|FG001|COMPLETED|Overall Study||6||
59522539|NCT04303156|75617010|FG000|NOT COMPLETED|Overall Study||0||
59522540|NCT04303156|75617011|FG001|NOT COMPLETED|Overall Study||0||
59783904|NCT00570687|75904129|FG005|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0||
59953060|NCT04057820|76071781|FG001|NOT COMPLETED|Period 2||0||0
59522541|NCT03150160|75617020|FG000|STARTED|Overall Study||0||
59522542|NCT03150160|75617021|FG001|STARTED|Overall Study||1||
59522543|NCT03150160|75617020|FG000|COMPLETED|Overall Study||0||
59522544|NCT03150160|75617021|FG001|COMPLETED|Overall Study||1||
59522545|NCT03150160|75617020|FG000|NOT COMPLETED|Overall Study||0||
59522546|NCT03150160|75617021|FG001|NOT COMPLETED|Overall Study||0||
59522547|NCT03988426|75617027|FG000|STARTED|Overall Study||25||
59522548|NCT03988426|75617027|FG000|COMPLETED|Overall Study||24||
59783905|NCT00570687|75904130|FG006|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0||
59953061|NCT04057820|76071782|FG002|NOT COMPLETED|Period 2||0||0
59522549|NCT03988426|75617027|FG000|NOT COMPLETED|Overall Study||1||
59522550|NCT03123328|75617033|FG000|STARTED|Overall Study||380||
59522551|NCT03123328|75617033|FG000|COMPLETED|Overall Study||351||
59522552|NCT03123328|75617033|FG000|NOT COMPLETED|Overall Study||29||
59522553|NCT01500772|75617037|FG000|STARTED|Overall Study||6||
59522554|NCT01500772|75617037|FG000|COMPLETED|Overall Study||0||
59522555|NCT01500772|75617037|FG000|NOT COMPLETED|Overall Study||6||
59522556|NCT03984838|75617041|FG000|STARTED|Overall Study||16||
59522557|NCT03984838|75617041|FG000|COMPLETED|Overall Study||16||
59522558|NCT03984838|75617041|FG000|NOT COMPLETED|Overall Study||0||
59783906|NCT00570687|75904131|FG007|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0||
59783907|NCT00570687|75904132|FG008|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0||
59783908|NCT00570687|75904133|FG009|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0||
59783909|NCT00570687|75904124|FG000|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0||
59783910|NCT00570687|75904125|FG001|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0||
59783911|NCT00570687|75904126|FG002|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0||
59783912|NCT00570687|75904127|FG003|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0||
59783913|NCT00570687|75904128|FG004|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0||
59783914|NCT00570687|75904129|FG005|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0||
59783915|NCT00570687|75904130|FG006|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||1||
59783916|NCT00570687|75904131|FG007|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0||
59783917|NCT00570687|75904132|FG008|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0||
59783918|NCT00570687|75904133|FG009|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0||
59783919|NCT00570687|75904124|FG000|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||4||
59783920|NCT00570687|75904125|FG001|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||2||
59783921|NCT00570687|75904126|FG002|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||2||
59783922|NCT00570687|75904127|FG003|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||4||
59783923|NCT00570687|75904128|FG004|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0||
59783924|NCT00570687|75904129|FG005|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0||
59783925|NCT00570687|75904130|FG006|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0||
59783926|NCT00570687|75904131|FG007|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0||
59783927|NCT00570687|75904132|FG008|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0||
59783928|NCT00570687|75904133|FG009|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0||
59783929|NCT00570687|75904124|FG000|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||4||
59783930|NCT00570687|75904125|FG001|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||2||
59783931|NCT00570687|75904126|FG002|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||2||
59783932|NCT00570687|75904127|FG003|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||4||
59783933|NCT00570687|75904128|FG004|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0||
59783934|NCT00570687|75904129|FG005|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0||
59783935|NCT00570687|75904130|FG006|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0||
59783936|NCT00570687|75904131|FG007|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0||
59783937|NCT00570687|75904132|FG008|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0||
59783938|NCT00570687|75904133|FG009|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0||
59783939|NCT00570687|75904124|FG000|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0||
59783940|NCT00570687|75904125|FG001|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0||
59783941|NCT00570687|75904126|FG002|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0||
59783942|NCT00570687|75904127|FG003|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0||
59783943|NCT00570687|75904128|FG004|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0||
59783944|NCT00570687|75904129|FG005|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0||
59783945|NCT00570687|75904130|FG006|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0||
59783946|NCT00570687|75904131|FG007|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0||
59783947|NCT00570687|75904132|FG008|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0||
59783948|NCT00570687|75904133|FG009|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0||
59783949|NCT00570687|75904124|FG000|STARTED|Washout 1 (7-21 Days) - Amendment 1||4||
59783950|NCT00570687|75904125|FG001|STARTED|Washout 1 (7-21 Days) - Amendment 1||2||
59783951|NCT00570687|75904126|FG002|STARTED|Washout 1 (7-21 Days) - Amendment 1||2||
59783952|NCT00570687|75904127|FG003|STARTED|Washout 1 (7-21 Days) - Amendment 1||4||
59783953|NCT00570687|75904128|FG004|STARTED|Washout 1 (7-21 Days) - Amendment 1||0||
59783954|NCT00570687|75904129|FG005|STARTED|Washout 1 (7-21 Days) - Amendment 1||0||
59783955|NCT00570687|75904130|FG006|STARTED|Washout 1 (7-21 Days) - Amendment 1||0||
59783956|NCT00570687|75904131|FG007|STARTED|Washout 1 (7-21 Days) - Amendment 1||0||
59783957|NCT00570687|75904132|FG008|STARTED|Washout 1 (7-21 Days) - Amendment 1||0||
59783958|NCT00570687|75904133|FG009|STARTED|Washout 1 (7-21 Days) - Amendment 1||0||
59783959|NCT00570687|75904124|FG000|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||4||
59783960|NCT00570687|75904125|FG001|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||2||
59783961|NCT00570687|75904126|FG002|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||2||
59783962|NCT00570687|75904127|FG003|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||4||
59783963|NCT00570687|75904128|FG004|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0||
59783964|NCT00570687|75904129|FG005|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0||
59783965|NCT00570687|75904130|FG006|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0||
59783966|NCT00570687|75904131|FG007|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0||
59783967|NCT00570687|75904132|FG008|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0||
59783968|NCT00570687|75904133|FG009|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0||
59783969|NCT00570687|75904124|FG000|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0||
59783970|NCT00570687|75904125|FG001|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0||
59783971|NCT00570687|75904126|FG002|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0||
59783972|NCT00570687|75904127|FG003|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0||
59783973|NCT00570687|75904128|FG004|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0||
59783974|NCT00570687|75904129|FG005|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0||
60073070|NCT01590771|76188279|FG000|STARTED|Overall Study||249||
60073071|NCT01590771|76188280|FG001|STARTED|Overall Study||249||
60073072|NCT01590771|76188279|FG000|COMPLETED|Overall Study||230||
60073073|NCT01590771|76188280|FG001|COMPLETED|Overall Study||210||
59522559|NCT03979066|75617047|FG000|STARTED|Overall Study||0||
59522560|NCT03979066|75617048|FG001|STARTED|Overall Study||0||
59522561|NCT03979066|75617047|FG000|COMPLETED|Overall Study||0||
59522562|NCT03979066|75617048|FG001|COMPLETED|Overall Study||0||
59522563|NCT03979066|75617047|FG000|NOT COMPLETED|Overall Study||0||
59522564|NCT03979066|75617048|FG001|NOT COMPLETED|Overall Study||0||
59522565|NCT03968848|75617056|FG000|STARTED|Overall Study||8||
59522566|NCT03968848|75617057|FG001|STARTED|Overall Study||8||
59522567|NCT03968848|75617056|FG000|COMPLETED|Overall Study||8||
59522568|NCT03968848|75617057|FG001|COMPLETED|Overall Study||8||
59522569|NCT03968848|75617056|FG000|NOT COMPLETED|Overall Study||0||
59522570|NCT03968848|75617057|FG001|NOT COMPLETED|Overall Study||0||
59619273|NCT00634920|75730505|FG000|COMPLETED|Period 1 - Pre-Randomization||0||
59619274|NCT00634920|75730506|FG001|COMPLETED|Period 1 - Pre-Randomization||0||
59619275|NCT00634920|75730507|FG002|COMPLETED|Period 1 - Pre-Randomization|Total number of patients who became randomized|204||
59619276|NCT00634920|75730505|FG000|NOT COMPLETED|Period 1 - Pre-Randomization||0||
59619277|NCT00634920|75730506|FG001|NOT COMPLETED|Period 1 - Pre-Randomization||0||
59619278|NCT00634920|75730507|FG002|NOT COMPLETED|Period 1 - Pre-Randomization||137||
59619279|NCT00634920|75730505|FG000|STARTED|Period 2 - Post-Randomization|2 patients randomized in this group did not receive at least one dose of study drug.|104||
59619280|NCT00634920|75730506|FG001|STARTED|Period 2 - Post-Randomization||100||
59619281|NCT00634920|75730507|FG002|STARTED|Period 2 - Post-Randomization|This group included patients who had renal TX but did not qualify for randomization at Visit 2.|0||
59619282|NCT00634920|75730505|FG000|Full Analysis Set (FAS)|Period 2 - Post-Randomization||92||
59619283|NCT00634920|75730506|FG001|Full Analysis Set (FAS)|Period 2 - Post-Randomization||90||
59619284|NCT00634920|75730507|FG002|Full Analysis Set (FAS)|Period 2 - Post-Randomization||0||
59619285|NCT00634920|75730505|FG000|COMPLETED|Period 2 - Post-Randomization||43||
59619286|NCT00634920|75730506|FG001|COMPLETED|Period 2 - Post-Randomization||68||
59619287|NCT00634920|75730507|FG002|COMPLETED|Period 2 - Post-Randomization||0||
59619288|NCT00634920|75730505|FG000|NOT COMPLETED|Period 2 - Post-Randomization||61||
59619289|NCT00634920|75730506|FG001|NOT COMPLETED|Period 2 - Post-Randomization||32||
59619290|NCT00634920|75730507|FG002|NOT COMPLETED|Period 2 - Post-Randomization||0||
59619291|NCT00634842|75730515|FG000|STARTED|Overall Study||122||
59619292|NCT00634842|75730516|FG001|STARTED|Overall Study||122||
59619293|NCT00634842|75730515|FG000|COMPLETED|Overall Study||107||
59619294|NCT00634842|75730516|FG001|COMPLETED|Overall Study||104||
59619295|NCT00634842|75730515|FG000|NOT COMPLETED|Overall Study||15||
59619296|NCT00634842|75730516|FG001|NOT COMPLETED|Overall Study||18||
59619297|NCT00633984|75730524|FG000|STARTED|Overall Study||87||
59619298|NCT00633984|75730525|FG001|STARTED|Overall Study||82||
59619299|NCT00633984|75730524|FG000|COMPLETED|Overall Study||78||
59619300|NCT00633984|75730525|FG001|COMPLETED|Overall Study||69||
59619301|NCT00633984|75730524|FG000|NOT COMPLETED|Overall Study||9||
59619302|NCT00633984|75730525|FG001|NOT COMPLETED|Overall Study||13||
59619303|NCT01923480|75730534|FG000|STARTED|Period 1 (Hours 1-7)||1||
59619304|NCT01923480|75730535|FG001|STARTED|Period 1 (Hours 1-7)||2||
59619305|NCT01923480|75730536|FG002|STARTED|Period 1 (Hours 1-7)||2||
59619306|NCT01923480|75730537|FG003|STARTED|Period 1 (Hours 1-7)||2||
59619307|NCT01923480|75730538|FG004|STARTED|Period 1 (Hours 1-7)||2||
59619308|NCT01923480|75730539|FG005|STARTED|Period 1 (Hours 1-7)||2||
59619309|NCT01923480|75730534|FG000|COMPLETED|Period 1 (Hours 1-7)||1||
59619310|NCT01923480|75730535|FG001|COMPLETED|Period 1 (Hours 1-7)|One subject completed Period 1, but withdrew from the study prior to the start of Period 2.|2||
59619311|NCT01923480|75730536|FG002|COMPLETED|Period 1 (Hours 1-7)||2||
59619312|NCT01923480|75730537|FG003|COMPLETED|Period 1 (Hours 1-7)||2||
59619313|NCT01923480|75730538|FG004|COMPLETED|Period 1 (Hours 1-7)||2||
59619314|NCT01923480|75730539|FG005|COMPLETED|Period 1 (Hours 1-7)||2||
59619315|NCT01923480|75730534|FG000|NOT COMPLETED|Period 1 (Hours 1-7)||0||
59619316|NCT01923480|75730535|FG001|NOT COMPLETED|Period 1 (Hours 1-7)||0||
59619317|NCT01923480|75730536|FG002|NOT COMPLETED|Period 1 (Hours 1-7)||0||
59619318|NCT01923480|75730537|FG003|NOT COMPLETED|Period 1 (Hours 1-7)||0||
59619319|NCT01923480|75730538|FG004|NOT COMPLETED|Period 1 (Hours 1-7)||0||
59619320|NCT01923480|75730539|FG005|NOT COMPLETED|Period 1 (Hours 1-7)||0||
59619321|NCT01923480|75730534|FG000|STARTED|Period 2 (Hours 1-7)||1||
59619322|NCT01923480|75730535|FG001|STARTED|Period 2 (Hours 1-7)|One subject completed Period 1, but withdrew from the study prior to the start of Period 2.|1||
59619323|NCT01923480|75730536|FG002|STARTED|Period 2 (Hours 1-7)||2||
59619324|NCT01923480|75730537|FG003|STARTED|Period 2 (Hours 1-7)||2||
59619325|NCT01923480|75730538|FG004|STARTED|Period 2 (Hours 1-7)||2||
59619326|NCT01923480|75730539|FG005|STARTED|Period 2 (Hours 1-7)||2||
59619327|NCT01923480|75730534|FG000|COMPLETED|Period 2 (Hours 1-7)||1||
59619328|NCT01923480|75730535|FG001|COMPLETED|Period 2 (Hours 1-7)||1||
59619329|NCT01923480|75730536|FG002|COMPLETED|Period 2 (Hours 1-7)||2||
59619330|NCT01923480|75730537|FG003|COMPLETED|Period 2 (Hours 1-7)||2||
60073074|NCT01590771|76188279|FG000|NOT COMPLETED|Overall Study||19||
60073075|NCT01590771|76188280|FG001|NOT COMPLETED|Overall Study||39||
59783975|NCT00570687|75904130|FG006|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0||
59783976|NCT00570687|75904131|FG007|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0||
59783977|NCT00570687|75904132|FG008|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0||
59783978|NCT00570687|75904133|FG009|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0||
59783979|NCT00570687|75904124|FG000|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||4||
59783980|NCT00570687|75904125|FG001|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||2||
59783981|NCT00570687|75904126|FG002|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||2||
59783982|NCT00570687|75904127|FG003|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||4||
59783983|NCT00570687|75904128|FG004|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0||
59783984|NCT00570687|75904129|FG005|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0||
59619331|NCT01923480|75730538|FG004|COMPLETED|Period 2 (Hours 1-7)||2||
59619332|NCT01923480|75730539|FG005|COMPLETED|Period 2 (Hours 1-7)||2||
59619333|NCT01923480|75730534|FG000|NOT COMPLETED|Period 2 (Hours 1-7)||0||
59619334|NCT01923480|75730535|FG001|NOT COMPLETED|Period 2 (Hours 1-7)||0||
59619335|NCT01923480|75730536|FG002|NOT COMPLETED|Period 2 (Hours 1-7)||0||
59619336|NCT01923480|75730537|FG003|NOT COMPLETED|Period 2 (Hours 1-7)||0||
59783985|NCT00570687|75904130|FG006|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0||
59783986|NCT00570687|75904131|FG007|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0||
59783987|NCT00570687|75904132|FG008|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0||
59783988|NCT00570687|75904133|FG009|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0||
59783989|NCT00570687|75904124|FG000|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||4||
59783990|NCT00570687|75904125|FG001|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||2||
59783991|NCT00570687|75904126|FG002|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||2||
59783992|NCT00570687|75904127|FG003|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||4||
59783993|NCT00570687|75904128|FG004|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0||
59783994|NCT00570687|75904129|FG005|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0||
59783995|NCT00570687|75904130|FG006|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0||
59783996|NCT00570687|75904131|FG007|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0||
59783997|NCT00570687|75904132|FG008|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0||
59783998|NCT00570687|75904133|FG009|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0||
59783999|NCT00570687|75904124|FG000|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0||
59784000|NCT00570687|75904125|FG001|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0||
59784001|NCT00570687|75904126|FG002|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0||
59784002|NCT00570687|75904127|FG003|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0||
59784003|NCT00570687|75904128|FG004|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0||
59784004|NCT00570687|75904129|FG005|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0||
59784005|NCT00570687|75904130|FG006|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0||
59784006|NCT00570687|75904131|FG007|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0||
59784007|NCT00570687|75904132|FG008|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0||
59784008|NCT00570687|75904133|FG009|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0||
59784009|NCT00570687|75904124|FG000|STARTED|Washout 2 (8 Weeks) - Amendment 1||4||
59784010|NCT00570687|75904125|FG001|STARTED|Washout 2 (8 Weeks) - Amendment 1||2||
59784011|NCT00570687|75904126|FG002|STARTED|Washout 2 (8 Weeks) - Amendment 1||2||
59619337|NCT01923480|75730538|FG004|NOT COMPLETED|Period 2 (Hours 1-7)||0||
59619338|NCT01923480|75730539|FG005|NOT COMPLETED|Period 2 (Hours 1-7)||0||
59784012|NCT00570687|75904127|FG003|STARTED|Washout 2 (8 Weeks) - Amendment 1||4||
59784013|NCT00570687|75904128|FG004|STARTED|Washout 2 (8 Weeks) - Amendment 1||0||
59784014|NCT00570687|75904129|FG005|STARTED|Washout 2 (8 Weeks) - Amendment 1||0||
59784015|NCT00570687|75904130|FG006|STARTED|Washout 2 (8 Weeks) - Amendment 1||0||
59784016|NCT00570687|75904131|FG007|STARTED|Washout 2 (8 Weeks) - Amendment 1||0||
59784017|NCT00570687|75904132|FG008|STARTED|Washout 2 (8 Weeks) - Amendment 1||0||
59784018|NCT00570687|75904133|FG009|STARTED|Washout 2 (8 Weeks) - Amendment 1||0||
59784019|NCT00570687|75904124|FG000|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||4||
59784020|NCT00570687|75904125|FG001|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||2||
59784021|NCT00570687|75904126|FG002|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||2||
59784022|NCT00570687|75904127|FG003|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||4||
59784023|NCT00570687|75904128|FG004|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0||
59784024|NCT00570687|75904129|FG005|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0||
59784025|NCT00570687|75904130|FG006|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0||
59784026|NCT00570687|75904131|FG007|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0||
59784027|NCT00570687|75904132|FG008|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0||
59784028|NCT00570687|75904133|FG009|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0||
59784029|NCT00570687|75904124|FG000|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0||
59784030|NCT00570687|75904125|FG001|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0||
59784031|NCT00570687|75904126|FG002|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0||
59784032|NCT00570687|75904127|FG003|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0||
59784033|NCT00570687|75904128|FG004|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0||
59619339|NCT01921218|75730553|FG000|STARTED|Overall Study||6||
59619340|NCT01921218|75730554|FG001|STARTED|Overall Study||7||
59619341|NCT01921218|75730553|FG000|COMPLETED|Overall Study||3||
59784034|NCT00570687|75904129|FG005|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0||
59784035|NCT00570687|75904130|FG006|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0||
59784036|NCT00570687|75904131|FG007|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0||
59784037|NCT00570687|75904132|FG008|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0||
59784038|NCT00570687|75904133|FG009|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0||
59784039|NCT00570687|75904124|FG000|STARTED|Clamp 1 (1 Day) - Amendment 1||4||
59784040|NCT00570687|75904125|FG001|STARTED|Clamp 1 (1 Day) - Amendment 1||2||
59784041|NCT00570687|75904126|FG002|STARTED|Clamp 1 (1 Day) - Amendment 1||2||
59784042|NCT00570687|75904127|FG003|STARTED|Clamp 1 (1 Day) - Amendment 1||4||
59784043|NCT00570687|75904128|FG004|STARTED|Clamp 1 (1 Day) - Amendment 1||0||
59784044|NCT00570687|75904129|FG005|STARTED|Clamp 1 (1 Day) - Amendment 1||0||
59784045|NCT00570687|75904130|FG006|STARTED|Clamp 1 (1 Day) - Amendment 1||0||
59784046|NCT00570687|75904131|FG007|STARTED|Clamp 1 (1 Day) - Amendment 1||0||
59784047|NCT00570687|75904132|FG008|STARTED|Clamp 1 (1 Day) - Amendment 1||0||
59784048|NCT00570687|75904133|FG009|STARTED|Clamp 1 (1 Day) - Amendment 1||0||
59784049|NCT00570687|75904124|FG000|COMPLETED|Clamp 1 (1 Day) - Amendment 1||4||
59784050|NCT00570687|75904125|FG001|COMPLETED|Clamp 1 (1 Day) - Amendment 1||2||
59784051|NCT00570687|75904126|FG002|COMPLETED|Clamp 1 (1 Day) - Amendment 1||2||
59784052|NCT00570687|75904127|FG003|COMPLETED|Clamp 1 (1 Day) - Amendment 1||4||
59784053|NCT00570687|75904128|FG004|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0||
59784054|NCT00570687|75904129|FG005|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0||
59784055|NCT00570687|75904130|FG006|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0||
59784056|NCT00570687|75904131|FG007|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0||
59784057|NCT00570687|75904132|FG008|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0||
59784058|NCT00570687|75904133|FG009|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0||
59784059|NCT00570687|75904124|FG000|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0||
59784060|NCT00570687|75904125|FG001|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0||
59784061|NCT00570687|75904126|FG002|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0||
59784062|NCT00570687|75904127|FG003|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0||
59784063|NCT00570687|75904128|FG004|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0||
59784064|NCT00570687|75904129|FG005|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0||
59784065|NCT00570687|75904130|FG006|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0||
59784066|NCT00570687|75904131|FG007|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0||
59784067|NCT00570687|75904132|FG008|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0||
59784068|NCT00570687|75904133|FG009|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0||
59784069|NCT00570687|75904124|FG000|STARTED|Washout 3 (7-21 Days) - Amendment 1||4||
59784070|NCT00570687|75904125|FG001|STARTED|Washout 3 (7-21 Days) - Amendment 1||2||
59784071|NCT00570687|75904126|FG002|STARTED|Washout 3 (7-21 Days) - Amendment 1||2||
59784072|NCT00570687|75904127|FG003|STARTED|Washout 3 (7-21 Days) - Amendment 1||4||
59784073|NCT00570687|75904128|FG004|STARTED|Washout 3 (7-21 Days) - Amendment 1||0||
59784074|NCT00570687|75904129|FG005|STARTED|Washout 3 (7-21 Days) - Amendment 1||0||
59784075|NCT00570687|75904130|FG006|STARTED|Washout 3 (7-21 Days) - Amendment 1||0||
59784076|NCT00570687|75904131|FG007|STARTED|Washout 3 (7-21 Days) - Amendment 1||0||
59784077|NCT00570687|75904132|FG008|STARTED|Washout 3 (7-21 Days) - Amendment 1||0||
59784078|NCT00570687|75904133|FG009|STARTED|Washout 3 (7-21 Days) - Amendment 1||0||
59784079|NCT00570687|75904124|FG000|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||4||
59784080|NCT00570687|75904125|FG001|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||2||
59784081|NCT00570687|75904126|FG002|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||2||
59784082|NCT00570687|75904127|FG003|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||4||
59784083|NCT00570687|75904128|FG004|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0||
59784084|NCT00570687|75904129|FG005|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0||
59784085|NCT00570687|75904130|FG006|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0||
59784086|NCT00570687|75904131|FG007|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0||
59784087|NCT00570687|75904132|FG008|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0||
59784088|NCT00570687|75904133|FG009|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0||
59784089|NCT00570687|75904124|FG000|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0||
59784090|NCT00570687|75904125|FG001|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0||
59784091|NCT00570687|75904126|FG002|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0||
59784092|NCT00570687|75904127|FG003|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0||
59784093|NCT00570687|75904128|FG004|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0||
59784094|NCT00570687|75904129|FG005|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0||
59784095|NCT00570687|75904130|FG006|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0||
59784096|NCT00570687|75904131|FG007|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0||
59784097|NCT00570687|75904132|FG008|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0||
59784098|NCT00570687|75904133|FG009|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0||
59784099|NCT00570687|75904124|FG000|STARTED|Clamp 2 (1 Day) - Amendment 1||4||
59784100|NCT00570687|75904125|FG001|STARTED|Clamp 2 (1 Day) - Amendment 1||2||
59784101|NCT00570687|75904126|FG002|STARTED|Clamp 2 (1 Day) - Amendment 1||2||
59784102|NCT00570687|75904127|FG003|STARTED|Clamp 2 (1 Day) - Amendment 1||4||
59784103|NCT00570687|75904128|FG004|STARTED|Clamp 2 (1 Day) - Amendment 1||0||
59784104|NCT00570687|75904129|FG005|STARTED|Clamp 2 (1 Day) - Amendment 1||0||
59784105|NCT00570687|75904130|FG006|STARTED|Clamp 2 (1 Day) - Amendment 1||0||
59784106|NCT00570687|75904131|FG007|STARTED|Clamp 2 (1 Day) - Amendment 1||0||
59784107|NCT00570687|75904132|FG008|STARTED|Clamp 2 (1 Day) - Amendment 1||0||
59784108|NCT00570687|75904133|FG009|STARTED|Clamp 2 (1 Day) - Amendment 1||0||
59784109|NCT00570687|75904124|FG000|COMPLETED|Clamp 2 (1 Day) - Amendment 1||4||
59784110|NCT00570687|75904125|FG001|COMPLETED|Clamp 2 (1 Day) - Amendment 1||2||
59784111|NCT00570687|75904126|FG002|COMPLETED|Clamp 2 (1 Day) - Amendment 1||2||
59784112|NCT00570687|75904127|FG003|COMPLETED|Clamp 2 (1 Day) - Amendment 1||4||
59784113|NCT00570687|75904128|FG004|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0||
59784114|NCT00570687|75904129|FG005|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0||
59784115|NCT00570687|75904130|FG006|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0||
59784116|NCT00570687|75904131|FG007|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0||
59784117|NCT00570687|75904132|FG008|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0||
59522571|NCT01484314|75617063|FG000|STARTED|Overall Study||1||
59522572|NCT01484314|75617063|FG000|COMPLETED|Overall Study||1||
59522573|NCT01484314|75617063|FG000|NOT COMPLETED|Overall Study||0||
59522574|NCT03020446|75617067|FG000|STARTED|Overall Study||3||
59522575|NCT03020446|75617067|FG000|COMPLETED|Overall Study||0||
59522576|NCT03020446|75617067|FG000|NOT COMPLETED|Overall Study||3||
59522577|NCT01479010|75617071|FG000|STARTED|Overall Study||2||
59522578|NCT01479010|75617071|FG000|COMPLETED|Overall Study||1||
59522579|NCT01479010|75617071|FG000|NOT COMPLETED|Overall Study||1||
59522580|NCT01472692|75617077|FG000|STARTED|Overall Study||0||
59522581|NCT01472692|75617078|FG001|STARTED|Overall Study||0||
59522582|NCT01472692|75617077|FG000|COMPLETED|Overall Study||0||
59522583|NCT01472692|75617078|FG001|COMPLETED|Overall Study||0||
59522584|NCT01472692|75617077|FG000|NOT COMPLETED|Overall Study||0||
59522585|NCT01472692|75617078|FG001|NOT COMPLETED|Overall Study||0||
59522586|NCT02558400|75617087|FG000|STARTED|Overall Study||238||
59522587|NCT02558400|75617088|FG001|STARTED|Overall Study||244||
59522588|NCT02558400|75617089|FG002|STARTED|Overall Study||236||
59522589|NCT02558400|75617087|FG000|COMPLETED|Overall Study||159||
59522590|NCT02558400|75617088|FG001|COMPLETED|Overall Study||148||
59522591|NCT02558400|75617089|FG002|COMPLETED|Overall Study||203||
59619342|NCT01921218|75730554|FG001|COMPLETED|Overall Study||3||
59619343|NCT01921218|75730553|FG000|NOT COMPLETED|Overall Study||3||
59619344|NCT01921218|75730554|FG001|NOT COMPLETED|Overall Study||4||
59619345|NCT00633750|75730560|FG000|STARTED|Overall Study||47||
59619346|NCT00633750|75730560|FG000|COMPLETED|Overall Study||42||
59619347|NCT00633750|75730560|FG000|NOT COMPLETED|Overall Study||5||
59619348|NCT00633360|75730568|FG000|STARTED|Overall Study||16||
59619349|NCT00633360|75730569|FG001|STARTED|Overall Study||16||
59522592|NCT02558400|75617087|FG000|NOT COMPLETED|Overall Study||79||
59522593|NCT02558400|75617088|FG001|NOT COMPLETED|Overall Study||96||
59522594|NCT02558400|75617089|FG002|NOT COMPLETED|Overall Study||33||
59522595|NCT01446250|75617100|FG000|STARTED|Treatment Period 1||5||
59522596|NCT01446250|75617101|FG001|STARTED|Treatment Period 1||3||
59522597|NCT01446250|75617102|FG002|STARTED|Treatment Period 1||0||
59522598|NCT01446250|75617103|FG003|STARTED|Treatment Period 1||0||
59522599|NCT01446250|75617100|FG000|COMPLETED|Treatment Period 1||5||
59522600|NCT01446250|75617101|FG001|COMPLETED|Treatment Period 1||2||
59522601|NCT01446250|75617102|FG002|COMPLETED|Treatment Period 1||0||
59522602|NCT01446250|75617103|FG003|COMPLETED|Treatment Period 1||0||
59522603|NCT01446250|75617100|FG000|NOT COMPLETED|Treatment Period 1||0||
59522604|NCT01446250|75617101|FG001|NOT COMPLETED|Treatment Period 1||1||
59522605|NCT01446250|75617102|FG002|NOT COMPLETED|Treatment Period 1||0||
59522606|NCT01446250|75617103|FG003|NOT COMPLETED|Treatment Period 1||0||
59522607|NCT01446250|75617100|FG000|STARTED|Clinical Hold||0||
59522608|NCT01446250|75617101|FG001|STARTED|Clinical Hold||2||
59522609|NCT01446250|75617102|FG002|STARTED|Clinical Hold||5||
59522610|NCT01446250|75617103|FG003|STARTED|Clinical Hold||0||
59619350|NCT00633360|75730568|FG000|COMPLETED|Overall Study||12||
59619351|NCT00633360|75730569|FG001|COMPLETED|Overall Study||13||
59619352|NCT00633360|75730568|FG000|NOT COMPLETED|Overall Study||4||
59522611|NCT01446250|75617100|FG000|COMPLETED|Clinical Hold||0||
59619353|NCT00633360|75730569|FG001|NOT COMPLETED|Overall Study||3||
59709582|NCT01237223|75828366|FG005|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0||
59709583|NCT01237223|75828361|FG000|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||398||
59522612|NCT01446250|75617101|FG001|COMPLETED|Clinical Hold||2||
59522613|NCT01446250|75617102|FG002|COMPLETED|Clinical Hold||5||
59522614|NCT01446250|75617103|FG003|COMPLETED|Clinical Hold||0||
59709584|NCT01237223|75828362|FG001|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0||
59709585|NCT01237223|75828363|FG002|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0||
59709586|NCT01237223|75828364|FG003|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0||
59709587|NCT01237223|75828365|FG004|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0||
59709588|NCT01237223|75828366|FG005|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0||
59709589|NCT01237223|75828361|FG000|STARTED|Double Blind (Treatment Period, 8 Weeks)||153||
59709590|NCT01237223|75828362|FG001|STARTED|Double Blind (Treatment Period, 8 Weeks)||157||
59709591|NCT01237223|75828363|FG002|STARTED|Double Blind (Treatment Period, 8 Weeks)||158||
59709592|NCT01237223|75828364|FG003|STARTED|Double Blind (Treatment Period, 8 Weeks)||158||
59709593|NCT01237223|75828365|FG004|STARTED|Double Blind (Treatment Period, 8 Weeks)||159||
59709594|NCT01237223|75828366|FG005|STARTED|Double Blind (Treatment Period, 8 Weeks)||159||
59784118|NCT00570687|75904133|FG009|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0||
59784119|NCT00570687|75904124|FG000|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0||
59784120|NCT00570687|75904125|FG001|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0||
59784121|NCT00570687|75904126|FG002|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0||
59784122|NCT00570687|75904127|FG003|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0||
59784123|NCT00570687|75904128|FG004|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0||
59784124|NCT00570687|75904129|FG005|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0||
59784125|NCT00570687|75904130|FG006|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0||
59784126|NCT00570687|75904131|FG007|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0||
59784127|NCT00570687|75904132|FG008|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0||
59784128|NCT00570687|75904133|FG009|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0||
59784129|NCT03836677|75904147|FG000|STARTED|Period 1||13||
59784130|NCT03836677|75904148|FG001|STARTED|Period 1||10||
59784131|NCT03836677|75904147|FG000|COMPLETED|Period 1||13||
59784132|NCT03836677|75904148|FG001|COMPLETED|Period 1||9||
59784133|NCT03836677|75904147|FG000|NOT COMPLETED|Period 1||0||
59784134|NCT03836677|75904148|FG001|NOT COMPLETED|Period 1||1||
59784135|NCT03836677|75904147|FG000|STARTED|Washout||13||
59784136|NCT03836677|75904148|FG001|STARTED|Washout||9||
59784137|NCT03836677|75904147|FG000|COMPLETED|Washout||13||
59784138|NCT03836677|75904148|FG001|COMPLETED|Washout||9||
59784139|NCT03836677|75904147|FG000|NOT COMPLETED|Washout||0||
59784140|NCT03836677|75904148|FG001|NOT COMPLETED|Washout||0||
59784141|NCT03836677|75904147|FG000|STARTED|Period 2||13||
59784142|NCT03836677|75904148|FG001|STARTED|Period 2||9||
59784143|NCT03836677|75904147|FG000|COMPLETED|Period 2||12||
59784144|NCT03836677|75904148|FG001|COMPLETED|Period 2||9||
59784145|NCT03836677|75904147|FG000|NOT COMPLETED|Period 2||1||
59784146|NCT03836677|75904148|FG001|NOT COMPLETED|Period 2||0||
59784147|NCT03374072|75904156|FG000|STARTED|4 Months||10||
59784148|NCT03374072|75904157|FG001|STARTED|4 Months||9||
59784149|NCT03374072|75904156|FG000|COMPLETED|4 Months||8||
59784150|NCT03374072|75904157|FG001|COMPLETED|4 Months||9||
59784151|NCT03374072|75904156|FG000|NOT COMPLETED|4 Months||2||
59784152|NCT03374072|75904157|FG001|NOT COMPLETED|4 Months||0||
59784153|NCT03374072|75904156|FG000|STARTED|7 Months||8||
59784154|NCT03374072|75904157|FG001|STARTED|7 Months||9||
59784155|NCT03374072|75904156|FG000|COMPLETED|7 Months||8||
59784156|NCT03374072|75904157|FG001|COMPLETED|7 Months||9||
59784157|NCT03374072|75904156|FG000|NOT COMPLETED|7 Months||0||
59784158|NCT03374072|75904157|FG001|NOT COMPLETED|7 Months||0||
59784159|NCT03610646|75904165|FG000|STARTED|Overall Study||179||
59784160|NCT03610646|75904166|FG001|STARTED|Overall Study||176||
59784161|NCT03610646|75904165|FG000|Treated|Overall Study||178||
59784162|NCT03610646|75904166|FG001|Treated|Overall Study||176||
59784163|NCT03610646|75904165|FG000|COMPLETED|Overall Study||161||
59784164|NCT03610646|75904166|FG001|COMPLETED|Overall Study||158||
59784165|NCT03610646|75904165|FG000|NOT COMPLETED|Overall Study||18||
59784166|NCT03610646|75904166|FG001|NOT COMPLETED|Overall Study||18||
59784167|NCT00434161|75904179|FG000|STARTED|Overall Study||109||
59784168|NCT00434161|75904180|FG001|STARTED|Overall Study||57||
59784169|NCT00434161|75904181|FG002|STARTED|Overall Study||115||
59784170|NCT00434161|75904179|FG000|COMPLETED|Overall Study||99||
59784171|NCT00434161|75904180|FG001|COMPLETED|Overall Study||54||
59784172|NCT00434161|75904181|FG002|COMPLETED|Overall Study||104||
59784173|NCT00434161|75904179|FG000|NOT COMPLETED|Overall Study||10||
59784174|NCT00434161|75904180|FG001|NOT COMPLETED|Overall Study||3||
59784175|NCT00434161|75904181|FG002|NOT COMPLETED|Overall Study||11||
59784176|NCT00441103|75904198|FG000|STARTED|Overall Study|Intent to treat (ITT) population: all participants who received at least one dose of study drug.|120||
59784177|NCT00441103|75904199|FG001|STARTED|Overall Study|Intent to treat (ITT) population: all participants who received at least one dose of study drug.|60||
59784178|NCT00441103|75904198|FG000|COMPLETED|Overall Study||109||
59953062|NCT04057820|76071783|FG003|NOT COMPLETED|Period 2||0||0
59953063|NCT04057820|76071784|FG004|NOT COMPLETED|Period 2||0||0
59953064|NCT04057820|76071785|FG005|NOT COMPLETED|Period 2||0||0
59953065|NCT04057820|76071786|FG006|NOT COMPLETED|Period 2||0||0
59953066|NCT04057820|76071787|FG007|NOT COMPLETED|Period 2||0||0
59953067|NCT04057820|76071788|FG008|NOT COMPLETED|Period 2||0||0
59953068|NCT04057820|76071789|FG009|NOT COMPLETED|Period 2||0||0
59784179|NCT00441103|75904199|FG001|COMPLETED|Overall Study||56||
59784180|NCT00441103|75904198|FG000|NOT COMPLETED|Overall Study||11||
59784181|NCT00441103|75904199|FG001|NOT COMPLETED|Overall Study||4||
59784182|NCT00433771|75904206|FG000|STARTED|Overall Study|74 enrolled patients(signed an Informed Consent Form)were screened.58 were eligible(intent to treat)|74||
59784183|NCT00433771|75904206|FG000|COMPLETED|Overall Study|55 out of 58 patients were evaluable(had a stent placed and had at least 1 week of follow up)|55||
59784184|NCT00433771|75904206|FG000|NOT COMPLETED|Overall Study||19||
59784185|NCT00433537|75904210|FG000|STARTED|Step 1 - VcR-CVAD Induction||45||
59784186|NCT00433537|75904211|FG001|STARTED|Step 1 - VcR-CVAD Induction||22||
59784187|NCT00433537|75904212|FG002|STARTED|Step 1 - VcR-CVAD Induction||10||
59784188|NCT00433537|75904210|FG000|Eligible and Treated|Step 1 - VcR-CVAD Induction||44||
59953069|NCT04057820|76071790|FG010|NOT COMPLETED|Period 2||0||0
59953070|NCT04057820|76071791|FG011|NOT COMPLETED|Period 2||0||0
59784189|NCT00433537|75904211|FG001|Eligible and Treated|Step 1 - VcR-CVAD Induction||22||
59784190|NCT00433537|75904212|FG002|Eligible and Treated|Step 1 - VcR-CVAD Induction||9||
59784191|NCT00433537|75904210|FG000|COMPLETED|Step 1 - VcR-CVAD Induction||44||
59784192|NCT00433537|75904211|FG001|COMPLETED|Step 1 - VcR-CVAD Induction||22||
59784193|NCT00433537|75904212|FG002|COMPLETED|Step 1 - VcR-CVAD Induction||1||
59784194|NCT00433537|75904210|FG000|NOT COMPLETED|Step 1 - VcR-CVAD Induction||1||
59784195|NCT00433537|75904211|FG001|NOT COMPLETED|Step 1 - VcR-CVAD Induction||0||
59784196|NCT00433537|75904212|FG002|NOT COMPLETED|Step 1 - VcR-CVAD Induction||9||
59784197|NCT00433537|75904210|FG000|STARTED|Step 2 - Maintenance Rituximab or ASCT|This included all treated patients regardless of eligibility.|45||
59784198|NCT00433537|75904211|FG001|STARTED|Step 2 - Maintenance Rituximab or ASCT||22||
59784199|NCT00433537|75904212|FG002|STARTED|Step 2 - Maintenance Rituximab or ASCT|One patient completed VcR-CVAD and then withdrew from the study.|0||
59784200|NCT00433537|75904210|FG000|Eligible and Treated|Step 2 - Maintenance Rituximab or ASCT||44||
59784201|NCT00433537|75904211|FG001|Eligible and Treated|Step 2 - Maintenance Rituximab or ASCT||22||
59784202|NCT00433537|75904212|FG002|Eligible and Treated|Step 2 - Maintenance Rituximab or ASCT||0||
59784203|NCT00433537|75904210|FG000|COMPLETED|Step 2 - Maintenance Rituximab or ASCT||29||
59784204|NCT00433537|75904211|FG001|COMPLETED|Step 2 - Maintenance Rituximab or ASCT||22||
59784205|NCT00433537|75904212|FG002|COMPLETED|Step 2 - Maintenance Rituximab or ASCT||0||
59784206|NCT00433537|75904210|FG000|NOT COMPLETED|Step 2 - Maintenance Rituximab or ASCT||16||
59784207|NCT00433537|75904211|FG001|NOT COMPLETED|Step 2 - Maintenance Rituximab or ASCT||0||
59784208|NCT00433537|75904212|FG002|NOT COMPLETED|Step 2 - Maintenance Rituximab or ASCT||0||
59784209|NCT00570765|75904222|FG000|STARTED|DB Phase||20||
59784210|NCT00570765|75904223|FG001|STARTED|DB Phase||16||
59784211|NCT00570765|75904224|FG002|STARTED|DB Phase||24||
59784212|NCT00570765|75904225|FG003|STARTED|DB Phase||0||
59784213|NCT00570765|75904222|FG000|Received at Least 1 Dose of Study Drug|DB Phase||20||
59784214|NCT00570765|75904223|FG001|Received at Least 1 Dose of Study Drug|DB Phase||16||
59784215|NCT00570765|75904224|FG002|Received at Least 1 Dose of Study Drug|DB Phase||23||
59784216|NCT00570765|75904225|FG003|Received at Least 1 Dose of Study Drug|DB Phase||0||
59784217|NCT00570765|75904222|FG000|Safety Population|DB Phase||20||
59784218|NCT00570765|75904223|FG001|Safety Population|DB Phase||16||
59784219|NCT00570765|75904224|FG002|Safety Population|DB Phase||23||
59784220|NCT00570765|75904225|FG003|Safety Population|DB Phase||0||
59784221|NCT00570765|75904222|FG000|COMPLETED|DB Phase||16||
59784222|NCT00570765|75904223|FG001|COMPLETED|DB Phase||9||
59784223|NCT00570765|75904224|FG002|COMPLETED|DB Phase||23||
59784224|NCT00570765|75904225|FG003|COMPLETED|DB Phase||0||
59784225|NCT00570765|75904222|FG000|NOT COMPLETED|DB Phase||4||
59784226|NCT00570765|75904223|FG001|NOT COMPLETED|DB Phase||7||
59784227|NCT00570765|75904224|FG002|NOT COMPLETED|DB Phase||1||
59784228|NCT00570765|75904225|FG003|NOT COMPLETED|DB Phase||0||
59784229|NCT00570765|75904222|FG000|STARTED|LTSE Phase|Eligible participants who completed the DB phase enrolled in the LTSE phase.|0||
59784230|NCT00570765|75904223|FG001|STARTED|LTSE Phase|Eligible participants who completed the DB phase enrolled in the LTSE phase.|0||
59784231|NCT00570765|75904224|FG002|STARTED|LTSE Phase|Eligible participants who completed the DB phase enrolled in the LTSE phase.|0||
59784232|NCT00570765|75904225|FG003|STARTED|LTSE Phase|Eligible participants who completed the DB phase enrolled in the LTSE phase.|28||
59784233|NCT00570765|75904222|FG000|Received at Least 1 Dose of Study Drug|LTSE Phase||0||
59784234|NCT00570765|75904223|FG001|Received at Least 1 Dose of Study Drug|LTSE Phase||0||
59784235|NCT00570765|75904224|FG002|Received at Least 1 Dose of Study Drug|LTSE Phase||0||
59784236|NCT00570765|75904225|FG003|Received at Least 1 Dose of Study Drug|LTSE Phase||28||
59784237|NCT00570765|75904222|FG000|Safety Population|LTSE Phase||0||
59784238|NCT00570765|75904223|FG001|Safety Population|LTSE Phase||0||
59784239|NCT00570765|75904224|FG002|Safety Population|LTSE Phase||0||
59784240|NCT00570765|75904225|FG003|Safety Population|LTSE Phase||28||
59784241|NCT00570765|75904222|FG000|COMPLETED|LTSE Phase||0||
59784242|NCT00570765|75904223|FG001|COMPLETED|LTSE Phase||0||
59784243|NCT00570765|75904224|FG002|COMPLETED|LTSE Phase||0||
59784244|NCT00570765|75904225|FG003|COMPLETED|LTSE Phase||16||
59784245|NCT00570765|75904222|FG000|NOT COMPLETED|LTSE Phase||0||
59784246|NCT00570765|75904223|FG001|NOT COMPLETED|LTSE Phase||0||
59784247|NCT00570765|75904224|FG002|NOT COMPLETED|LTSE Phase||0||
59784248|NCT00570765|75904225|FG003|NOT COMPLETED|LTSE Phase||12||
59784249|NCT00667563|75904236|FG000|STARTED|Overall Study||150||
59784250|NCT00667563|75904236|FG000|COMPLETED|Overall Study||126||
59784251|NCT00667563|75904236|FG000|NOT COMPLETED|Overall Study||24||
59784252|NCT00667095|75904242|FG000|STARTED|Overall Study||11||
59784253|NCT00667095|75904243|FG001|STARTED|Overall Study||10||
59784254|NCT00667095|75904242|FG000|COMPLETED|Overall Study||11||
59784255|NCT00667095|75904243|FG001|COMPLETED|Overall Study||9||
59784256|NCT00667095|75904242|FG000|NOT COMPLETED|Overall Study||0||
59784257|NCT00667095|75904243|FG001|NOT COMPLETED|Overall Study||1||
59784258|NCT00433381|75904251|FG000|STARTED|Overall Study||63||
59784259|NCT00433381|75904252|FG001|STARTED|Overall Study||60||
59784260|NCT00433381|75904251|FG000|COMPLETED|Overall Study|Subjects contributing data to [the primary] analysis are considered to have completed the study.|60||
59784261|NCT00433381|75904252|FG001|COMPLETED|Overall Study||57||
59784262|NCT00433381|75904251|FG000|NOT COMPLETED|Overall Study||3||
59784263|NCT00433381|75904252|FG001|NOT COMPLETED|Overall Study||3||
59784264|NCT00667017|75904266|FG000|STARTED|Overall Study||1||
59784265|NCT00667017|75904266|FG000|COMPLETED|Overall Study||0||
59784266|NCT00667017|75904266|FG000|NOT COMPLETED|Overall Study||1||
59784267|NCT00666705|75904270|FG000|STARTED|Overall Study||18||
59784268|NCT00666705|75904270|FG000|Raltegravir Alone (Days 1 - 3)|Overall Study|400 mg Raltegravir every 12 hours (AM dose on Day 3)|18||
59784269|NCT00666705|75904270|FG000|Washout (Days 4 - 5)|Overall Study||18||
59784270|NCT00666705|75904270|FG000|Maraviroc Alone (Days 6 - 11)|Overall Study|300 mg Maraviroc every 12 hours|18||
59784271|NCT00666705|75904270|FG000|Raltegravir + Maraviroc (Days 12 - 14)|Overall Study|400 mg Raltegravir every 12 hours plus 300 mg Maraviroc every 12 hours (AM doses only on Day 14)|17||
59784272|NCT00666705|75904270|FG000|COMPLETED|Overall Study||17||
59784273|NCT00666705|75904270|FG000|NOT COMPLETED|Overall Study||1||
59784274|NCT00433147|75904283|FG000|STARTED|Overall Study||7||
59784275|NCT00433147|75904284|FG001|STARTED|Overall Study||7||
59784276|NCT00433147|75904285|FG002|STARTED|Overall Study||9||
59784277|NCT00433147|75904286|FG003|STARTED|Overall Study||7||
59784278|NCT00433147|75904283|FG000|Safety Population|Overall Study||7|All participants who received at least 1 dose of study drug.|
59784279|NCT00433147|75904284|FG001|Safety Population|Overall Study||7|All participants who received at least 1 dose of study drug.|
59784280|NCT00433147|75904285|FG002|Safety Population|Overall Study||9|All participants who received at least 1 dose of study drug.|
59784281|NCT00433147|75904286|FG003|Safety Population|Overall Study||7|All participants who received at least 1 dose of study drug.|
59784282|NCT00433147|75904283|FG000|PD Population|Overall Study||7|Participants in the Safety Population with a baseline and at least 1 post-baseline PD measurement.|
59784283|NCT00433147|75904284|FG001|PD Population|Overall Study||6|Participants in the Safety Population with a baseline and at least 1 post-baseline PD measurement.|
59784284|NCT00433147|75904285|FG002|PD Population|Overall Study||9|Participants in the Safety Population with a baseline and at least 1 post-baseline PD measurement.|
59784285|NCT00433147|75904286|FG003|PD Population|Overall Study||7|Participants in the Safety Population with a baseline and at least 1 post-baseline PD measurement.|
59784286|NCT00433147|75904283|FG000|Received at Least One Dose of Study Drug|Overall Study||7||
59784287|NCT00433147|75904284|FG001|Received at Least One Dose of Study Drug|Overall Study||7||
59784288|NCT00433147|75904285|FG002|Received at Least One Dose of Study Drug|Overall Study||9||
59784289|NCT00433147|75904286|FG003|Received at Least One Dose of Study Drug|Overall Study||7||
59784290|NCT00433147|75904283|FG000|COMPLETED|Overall Study||7||
59784291|NCT00433147|75904284|FG001|COMPLETED|Overall Study||6||
59784292|NCT00433147|75904285|FG002|COMPLETED|Overall Study||9||
59784293|NCT00433147|75904286|FG003|COMPLETED|Overall Study||7||
59784294|NCT00433147|75904283|FG000|NOT COMPLETED|Overall Study||0||
59784295|NCT00433147|75904284|FG001|NOT COMPLETED|Overall Study||1||
59784296|NCT00433147|75904285|FG002|NOT COMPLETED|Overall Study||0||
59784297|NCT00433147|75904286|FG003|NOT COMPLETED|Overall Study||0||
59784298|NCT00666237|75904298|FG000|STARTED|Overall Study||125||
59784299|NCT00666237|75904299|FG001|STARTED|Overall Study||117||
59784300|NCT00666237|75904298|FG000|COMPLETED|Overall Study||91||
59784301|NCT00666237|75904299|FG001|COMPLETED|Overall Study||87||
59784302|NCT00666237|75904298|FG000|NOT COMPLETED|Overall Study||34||
59784303|NCT00666237|75904299|FG001|NOT COMPLETED|Overall Study||30||
59784304|NCT00662025|75904305|FG000|STARTED|Overall Study|All 63 participants were included in Full Analysis Set population.|63||
59784305|NCT00662025|75904305|FG000|COMPLETED|Overall Study||0||
59784306|NCT00662025|75904305|FG000|NOT COMPLETED|Overall Study||63||
59784307|NCT00440947|75904309|FG000|STARTED|36-Week Induction Phase||515||
59784308|NCT00440947|75904310|FG001|STARTED|36-Week Induction Phase||0||
59784309|NCT00440947|75904311|FG002|STARTED|36-Week Induction Phase||0||
59784310|NCT00440947|75904312|FG003|STARTED|36-Week Induction Phase||0||
59784311|NCT00440947|75904313|FG004|STARTED|36-Week Induction Phase||0||
59784312|NCT00440947|75904309|FG000|COMPLETED|36-Week Induction Phase|23 PAR without confirmed HIV-RNA<50c/mL prior to Wk 36 couldn't be randomized but weren't withdrawn.|442||
59784313|NCT00440947|75904310|FG001|COMPLETED|36-Week Induction Phase||0||
59784314|NCT00440947|75904311|FG002|COMPLETED|36-Week Induction Phase||0||
59784315|NCT00440947|75904312|FG003|COMPLETED|36-Week Induction Phase||0||
59784316|NCT00440947|75904313|FG004|COMPLETED|36-Week Induction Phase||0||
59784317|NCT00440947|75904309|FG000|NOT COMPLETED|36-Week Induction Phase||73||
59784318|NCT00440947|75904310|FG001|NOT COMPLETED|36-Week Induction Phase||0||
59784319|NCT00440947|75904311|FG002|NOT COMPLETED|36-Week Induction Phase||0||
59784320|NCT00440947|75904312|FG003|NOT COMPLETED|36-Week Induction Phase||0||
59784321|NCT00440947|75904313|FG004|NOT COMPLETED|36-Week Induction Phase||0||
59784322|NCT00440947|75904309|FG000|STARTED|48-Week Randomization Phase||0||
59784323|NCT00440947|75904310|FG001|STARTED|48-Week Randomization Phase||210||
59784324|NCT00440947|75904311|FG002|STARTED|48-Week Randomization Phase||209||
59784325|NCT00440947|75904312|FG003|STARTED|48-Week Randomization Phase||0||
59784326|NCT00440947|75904313|FG004|STARTED|48-Week Randomization Phase||0||
59784327|NCT00440947|75904309|FG000|COMPLETED|48-Week Randomization Phase||0||
59784328|NCT00440947|75904310|FG001|COMPLETED|48-Week Randomization Phase||194||
59784329|NCT00440947|75904311|FG002|COMPLETED|48-Week Randomization Phase||185||
59784330|NCT00440947|75904312|FG003|COMPLETED|48-Week Randomization Phase||0||
59784331|NCT00440947|75904313|FG004|COMPLETED|48-Week Randomization Phase||0||
59784332|NCT00440947|75904309|FG000|NOT COMPLETED|48-Week Randomization Phase||0||
59784333|NCT00440947|75904310|FG001|NOT COMPLETED|48-Week Randomization Phase||16||
59784334|NCT00440947|75904311|FG002|NOT COMPLETED|48-Week Randomization Phase||24||
59784335|NCT00440947|75904312|FG003|NOT COMPLETED|48-Week Randomization Phase||0||
59784336|NCT00440947|75904313|FG004|NOT COMPLETED|48-Week Randomization Phase||0||
59784337|NCT00440947|75904309|FG000|STARTED|Optional 60-Week Extension Phase||0||
59784338|NCT00440947|75904310|FG001|STARTED|Optional 60-Week Extension Phase||0||
59784339|NCT00440947|75904311|FG002|STARTED|Optional 60-Week Extension Phase||0||
59784340|NCT00440947|75904312|FG003|STARTED|Optional 60-Week Extension Phase||189||
59784341|NCT00440947|75904313|FG004|STARTED|Optional 60-Week Extension Phase||180||
59784342|NCT00440947|75904309|FG000|COMPLETED|Optional 60-Week Extension Phase||0||
59784343|NCT00440947|75904310|FG001|COMPLETED|Optional 60-Week Extension Phase||0||
59784344|NCT00440947|75904311|FG002|COMPLETED|Optional 60-Week Extension Phase||0||
59784345|NCT00440947|75904312|FG003|COMPLETED|Optional 60-Week Extension Phase||160||
59784346|NCT00440947|75904313|FG004|COMPLETED|Optional 60-Week Extension Phase||154||
59784347|NCT00440947|75904309|FG000|NOT COMPLETED|Optional 60-Week Extension Phase||0||
59784348|NCT00440947|75904310|FG001|NOT COMPLETED|Optional 60-Week Extension Phase||0||
59784349|NCT00440947|75904311|FG002|NOT COMPLETED|Optional 60-Week Extension Phase||0||
59784350|NCT00440947|75904312|FG003|NOT COMPLETED|Optional 60-Week Extension Phase||29||
59784351|NCT00440947|75904313|FG004|NOT COMPLETED|Optional 60-Week Extension Phase||26||
59784352|NCT02557945|75904327|FG000|STARTED|Overall Study||3||
59784353|NCT02557945|75904328|FG001|STARTED|Overall Study||3||
59784354|NCT02557945|75904327|FG000|COMPLETED|Overall Study||3||
59784355|NCT02557945|75904328|FG001|COMPLETED|Overall Study||3||
59784356|NCT02557945|75904327|FG000|NOT COMPLETED|Overall Study||0||
59784357|NCT02557945|75904328|FG001|NOT COMPLETED|Overall Study||0||
59784358|NCT00664521|75904336|FG000|STARTED|Overall Study||18||
59784359|NCT00664521|75904337|FG001|STARTED|Overall Study||9||
59784360|NCT00664521|75904336|FG000|COMPLETED|Overall Study||12||
59784361|NCT00664521|75904337|FG001|COMPLETED|Overall Study||8||
59784362|NCT00664521|75904336|FG000|NOT COMPLETED|Overall Study||6||
59784363|NCT00664521|75904337|FG001|NOT COMPLETED|Overall Study||1||
59784364|NCT00664209|75904343|FG000|STARTED|Motor Fluctuations Screen||13||
59784365|NCT00664209|75904343|FG000|COMPLETED|Motor Fluctuations Screen||6||
59784366|NCT00664209|75904343|FG000|NOT COMPLETED|Motor Fluctuations Screen||7||
59784367|NCT00664209|75904343|FG000|STARTED|Study Treatment Period||6||
59784368|NCT00664209|75904343|FG000|COMPLETED|Study Treatment Period||0||
59784369|NCT00664209|75904343|FG000|NOT COMPLETED|Study Treatment Period||6||
59784370|NCT00440557|75904351|FG000|STARTED|Overall Study|Safety population defined as all subjects who received at least 1 injection of study drug.|123||
59784371|NCT00440557|75904352|FG001|STARTED|Overall Study|Safety population defined as all subjects who received at least 1 injection of study drug.|125||
59784372|NCT00440557|75904353|FG002|STARTED|Overall Study|Safety population defined as all subjects who received at least 1 injection of study drug.|125||
59784373|NCT00440557|75904351|FG000|COMPLETED|Overall Study||98||
59784374|NCT00440557|75904352|FG001|COMPLETED|Overall Study||96||
59784375|NCT00440557|75904353|FG002|COMPLETED|Overall Study||90||
59784376|NCT00440557|75904351|FG000|NOT COMPLETED|Overall Study||25||
59784377|NCT00440557|75904352|FG001|NOT COMPLETED|Overall Study||29||
59784378|NCT00440557|75904353|FG002|NOT COMPLETED|Overall Study||35||
59784379|NCT02430194|75904371|FG000|STARTED|Overall Study||4||
59784380|NCT02430194|75904372|FG001|STARTED|Overall Study||4||
59784381|NCT02430194|75904373|FG002|STARTED|Overall Study||5||
59784382|NCT02430194|75904374|FG003|STARTED|Overall Study||3||
59784383|NCT02430194|75904375|FG004|STARTED|Overall Study||3||
59784384|NCT02430194|75904376|FG005|STARTED|Overall Study||6||
59784385|NCT02430194|75904377|FG006|STARTED|Overall Study||13||
59784386|NCT02430194|75904378|FG007|STARTED|Overall Study||5||
59784387|NCT02430194|75904379|FG008|STARTED|Overall Study||7||
59784388|NCT02430194|75904380|FG009|STARTED|Overall Study||5||
59784389|NCT02430194|75904371|FG000|COMPLETED|Overall Study||3||
59784390|NCT02430194|75904372|FG001|COMPLETED|Overall Study||3||
59784391|NCT02430194|75904373|FG002|COMPLETED|Overall Study||3||
59784392|NCT02430194|75904374|FG003|COMPLETED|Overall Study||3||
59784393|NCT02430194|75904375|FG004|COMPLETED|Overall Study||3||
59784394|NCT02430194|75904376|FG005|COMPLETED|Overall Study||6||
59784395|NCT02430194|75904377|FG006|COMPLETED|Overall Study||11||
59784396|NCT02430194|75904378|FG007|COMPLETED|Overall Study||4||
59784397|NCT02430194|75904379|FG008|COMPLETED|Overall Study||3||
59784398|NCT02430194|75904380|FG009|COMPLETED|Overall Study||5||
59784399|NCT02430194|75904371|FG000|NOT COMPLETED|Overall Study||1||
59784400|NCT02430194|75904372|FG001|NOT COMPLETED|Overall Study||1||
59784401|NCT02430194|75904373|FG002|NOT COMPLETED|Overall Study||2||
59784402|NCT02430194|75904374|FG003|NOT COMPLETED|Overall Study||0||
59784403|NCT02430194|75904375|FG004|NOT COMPLETED|Overall Study||0||
59784404|NCT02430194|75904376|FG005|NOT COMPLETED|Overall Study||0||
59784405|NCT02430194|75904377|FG006|NOT COMPLETED|Overall Study||2||
59784406|NCT02430194|75904378|FG007|NOT COMPLETED|Overall Study||1||
59784407|NCT02430194|75904379|FG008|NOT COMPLETED|Overall Study||4||
59784408|NCT02430194|75904380|FG009|NOT COMPLETED|Overall Study||0||
59784409|NCT00582608|75904413|FG000|STARTED|Overall Study||12||
59784410|NCT00582608|75904413|FG000|COMPLETED|Overall Study||0||
59784411|NCT00582608|75904413|FG000|NOT COMPLETED|Overall Study||12||
59784412|NCT03014570|75904419|FG000|STARTED|Overall Study|All of the intervention activities have been completed the date of completion was March 2020|248||
59784413|NCT03014570|75904420|FG001|STARTED|Overall Study|all of the intervention activities have been completed. the date of completion was march 2020|305||
59784414|NCT03014570|75904419|FG000|COMPLETED|Overall Study|All intervention activities were completed March 2020.|123||
59784415|NCT03014570|75904420|FG001|COMPLETED|Overall Study|all intervention activities were completed march 2020|174||
59784416|NCT03014570|75904419|FG000|NOT COMPLETED|Overall Study||125||
59784417|NCT03014570|75904420|FG001|NOT COMPLETED|Overall Study||131||
59784418|NCT00427999|75904427|FG000|STARTED|Overall Study||65||
59784419|NCT00427999|75904427|FG000|Intent to Treat (ITT)|Overall Study||61||
59784420|NCT00427999|75904427|FG000|Extension Follow-up|Overall Study||19||
59784421|NCT00427999|75904427|FG000|COMPLETED|Overall Study||33||
59784422|NCT00427999|75904427|FG000|NOT COMPLETED|Overall Study||32||
59784423|NCT00661713|75904440|FG000|STARTED|Overall Study||128||
59784424|NCT00661713|75904441|FG001|STARTED|Overall Study||247||
59784425|NCT00661713|75904442|FG002|STARTED|Overall Study||128||
59784426|NCT00661713|75904443|FG003|STARTED|Overall Study||247||
59784427|NCT00661713|75904444|FG004|STARTED|Overall Study||127||
59784428|NCT00661713|75904445|FG005|STARTED|Overall Study||253||
59784429|NCT00661713|75904446|FG006|STARTED|Overall Study||373||
59784430|NCT00661713|75904447|FG007|STARTED|Overall Study||128||
59784431|NCT00661713|75904440|FG000|COMPLETED|Overall Study||112||
59784432|NCT00661713|75904441|FG001|COMPLETED|Overall Study||208||
59784433|NCT00661713|75904442|FG002|COMPLETED|Overall Study||111||
59784434|NCT00661713|75904443|FG003|COMPLETED|Overall Study||219||
59784435|NCT00661713|75904444|FG004|COMPLETED|Overall Study||107||
59784436|NCT00661713|75904445|FG005|COMPLETED|Overall Study||216||
59784437|NCT00661713|75904446|FG006|COMPLETED|Overall Study||309||
59784438|NCT00661713|75904447|FG007|COMPLETED|Overall Study||117||
59784439|NCT00661713|75904440|FG000|NOT COMPLETED|Overall Study||16||
59784440|NCT00661713|75904441|FG001|NOT COMPLETED|Overall Study||39||
59784441|NCT00661713|75904442|FG002|NOT COMPLETED|Overall Study||17||
59784442|NCT00661713|75904443|FG003|NOT COMPLETED|Overall Study||28||
59784443|NCT00661713|75904444|FG004|NOT COMPLETED|Overall Study||20||
59784444|NCT00661713|75904445|FG005|NOT COMPLETED|Overall Study||37||
59784445|NCT00661713|75904446|FG006|NOT COMPLETED|Overall Study||64||
59784446|NCT00661713|75904447|FG007|NOT COMPLETED|Overall Study||11||
59784447|NCT03835975|75904472|FG000|STARTED|Overall Study||253||
59784448|NCT03835975|75904473|FG001|STARTED|Overall Study||122||
59784449|NCT03835975|75904474|FG002|STARTED|Overall Study||248||
59784450|NCT03835975|75904475|FG003|STARTED|Overall Study||127||
59784451|NCT03835975|75904476|FG004|STARTED|Overall Study||125||
59784452|NCT03835975|75904472|FG000|Vaccinated|Overall Study||253||
59784453|NCT03835975|75904473|FG001|Vaccinated|Overall Study||122||
59784454|NCT03835975|75904474|FG002|Vaccinated|Overall Study||246||
59784455|NCT03835975|75904475|FG003|Vaccinated|Overall Study||127||
59784456|NCT03835975|75904476|FG004|Vaccinated|Overall Study||125||
59784457|NCT03835975|75904472|FG000|Safety Population|Overall Study||253||
59784458|NCT03835975|75904473|FG001|Safety Population|Overall Study||122||
59784459|NCT03835975|75904474|FG002|Safety Population|Overall Study||246||
59784460|NCT03835975|75904475|FG003|Safety Population|Overall Study||127||
59784461|NCT03835975|75904476|FG004|Safety Population|Overall Study||125||
59784462|NCT03835975|75904472|FG000|Evaluable Immunogenicity Population (for 20vPnC Cohorts)|Overall Study||247||
59784463|NCT03835975|75904473|FG001|Evaluable Immunogenicity Population (for 20vPnC Cohorts)|Overall Study||0||
59784464|NCT03835975|75904474|FG002|Evaluable Immunogenicity Population (for 20vPnC Cohorts)|Overall Study||243||
59784465|NCT03835975|75904475|FG003|Evaluable Immunogenicity Population (for 20vPnC Cohorts)|Overall Study||0||
59784466|NCT03835975|75904476|FG004|Evaluable Immunogenicity Population (for 20vPnC Cohorts)|Overall Study||121||
59784467|NCT03835975|75904472|FG000|COMPLETED|Overall Study||250||
59784468|NCT03835975|75904473|FG001|COMPLETED|Overall Study||119||
59784469|NCT03835975|75904474|FG002|COMPLETED|Overall Study||245||
59784470|NCT03835975|75904475|FG003|COMPLETED|Overall Study||126||
59784471|NCT03835975|75904476|FG004|COMPLETED|Overall Study||125||
59784472|NCT03835975|75904472|FG000|NOT COMPLETED|Overall Study||3||
59784473|NCT03835975|75904473|FG001|NOT COMPLETED|Overall Study||3||
59784474|NCT03835975|75904474|FG002|NOT COMPLETED|Overall Study||3||
59784475|NCT03835975|75904475|FG003|NOT COMPLETED|Overall Study||1||
59784476|NCT03835975|75904476|FG004|NOT COMPLETED|Overall Study||0||
59784477|NCT00427921|75904490|FG000|STARTED|Overall Study||304||
59784478|NCT00427921|75904490|FG000|COMPLETED|Overall Study||254||
59784479|NCT00427921|75904490|FG000|NOT COMPLETED|Overall Study||50||
59784480|NCT00432991|75904496|FG000|STARTED|Overall Study||22||
59784481|NCT00432991|75904497|FG001|STARTED|Overall Study||31||
59784482|NCT00432991|75904496|FG000|COMPLETED|Overall Study||15||
59784483|NCT00432991|75904497|FG001|COMPLETED|Overall Study||19||
59784484|NCT00432991|75904496|FG000|NOT COMPLETED|Overall Study||7||
59784485|NCT00432991|75904497|FG001|NOT COMPLETED|Overall Study||12||
59784486|NCT00432835|75904505|FG000|STARTED|Overall Study||28||
59784487|NCT00432835|75904506|FG001|STARTED|Overall Study||30||
59784488|NCT00432835|75904505|FG000|Completed 1st Intervention|Overall Study||22||
59784489|NCT00432835|75904506|FG001|Completed 1st Intervention|Overall Study||23||
59784490|NCT00432835|75904505|FG000|Completed 2nd Intervention|Overall Study||22||
59784491|NCT00432835|75904506|FG001|Completed 2nd Intervention|Overall Study||23||
59784492|NCT00432835|75904505|FG000|COMPLETED|Overall Study|These 22 patients completed the entire 8 day protocol.|22||
59784493|NCT00432835|75904506|FG001|COMPLETED|Overall Study|These 23 patients completed the entire 8 day protocol.|23||
59784494|NCT00432835|75904505|FG000|NOT COMPLETED|Overall Study||6||
59784495|NCT00432835|75904506|FG001|NOT COMPLETED|Overall Study||7||
59784496|NCT00580970|75904514|FG000|STARTED|Pre-treatment||73||
59784497|NCT00580970|75904514|FG000|COMPLETED|Pre-treatment||72||
59784498|NCT00580970|75904514|FG000|NOT COMPLETED|Pre-treatment||1||
59784499|NCT00580970|75904514|FG000|STARTED|Treatment (Lovastatin)||72||
59784500|NCT00580970|75904514|FG000|6 Months of Treatment|Treatment (Lovastatin)|Subjects evaluable for analysis|53||
59784501|NCT00580970|75904514|FG000|COMPLETED|Treatment (Lovastatin)||53||
59784502|NCT00580970|75904514|FG000|NOT COMPLETED|Treatment (Lovastatin)||19||
59784503|NCT00665925|75904522|FG000|STARTED|Overall Study|Participants randomized|77||
59784504|NCT00665925|75904523|FG001|STARTED|Overall Study|Participants randomized|76||
59784505|NCT00665925|75904524|FG002|STARTED|Overall Study|Participants randomized|152||
59784506|NCT00665925|75904525|FG003|STARTED|Overall Study|Participants randomized|152||
59784507|NCT00665925|75904522|FG000|COMPLETED|Overall Study|Participants completed the study|62||
59784508|NCT00665925|75904523|FG001|COMPLETED|Overall Study|Participants completed the study|59||
59784509|NCT00665925|75904524|FG002|COMPLETED|Overall Study|Participants completed the study|126||
59784510|NCT00665925|75904525|FG003|COMPLETED|Overall Study|Participants completed the study|131||
59784511|NCT00665925|75904522|FG000|NOT COMPLETED|Overall Study||15||
59784512|NCT00665925|75904523|FG001|NOT COMPLETED|Overall Study||17||
59784513|NCT00665925|75904524|FG002|NOT COMPLETED|Overall Study||26||
59784514|NCT00665925|75904525|FG003|NOT COMPLETED|Overall Study||21||
59784515|NCT00426751|75904538|FG000|STARTED|Overall Study||226||
59784516|NCT00426751|75904539|FG001|STARTED|Overall Study||203||
59784517|NCT00426751|75904538|FG000|COMPLETED|Overall Study||204||
59784518|NCT00426751|75904539|FG001|COMPLETED|Overall Study||183||
59784519|NCT00426751|75904538|FG000|NOT COMPLETED|Overall Study||22||
59784520|NCT00426751|75904539|FG001|NOT COMPLETED|Overall Study||20||
59784521|NCT00440401|75904547|FG000|STARTED|Overall Study||59||
59784522|NCT00440401|75904548|FG001|STARTED|Overall Study||60||
59784523|NCT00440401|75904547|FG000|COMPLETED|Overall Study||55||
59784524|NCT00440401|75904548|FG001|COMPLETED|Overall Study||54||
59784525|NCT00440401|75904547|FG000|NOT COMPLETED|Overall Study||4||
59784526|NCT00440401|75904548|FG001|NOT COMPLETED|Overall Study||6||
59784527|NCT02598960|75904567|FG000|STARTED|Treatment Period||4|= Starting Initial Treatment Period|
59784528|NCT02598960|75904568|FG001|STARTED|Treatment Period||6|= Starting Initial Treatment Period|
59784529|NCT02598960|75904569|FG002|STARTED|Treatment Period||4|= Starting Initial Treatment Period|
59784530|NCT02598960|75904570|FG003|STARTED|Treatment Period||6|= Starting Initial Treatment Period|
59784531|NCT02598960|75904571|FG004|STARTED|Treatment Period||9|= Starting Initial Treatment Period|
59784532|NCT02598960|75904572|FG005|STARTED|Treatment Period||3|= Starting Initial Treatment Period|
59784533|NCT02598960|75904573|FG006|STARTED|Treatment Period||2|= Starting Initial Treatment Period|
59784534|NCT02598960|75904574|FG007|STARTED|Treatment Period||3|= Starting Initial Treatment Period|
59784535|NCT02598960|75904575|FG008|STARTED|Treatment Period||9|= Starting Initial Treatment Period|
59784536|NCT02598960|75904576|FG009|STARTED|Treatment Period||14|= Starting Initial Treatment Period|
59784537|NCT02598960|75904577|FG010|STARTED|Treatment Period||11|= Starting Initial Treatment Period|
59784538|NCT02598960|75904578|FG011|STARTED|Treatment Period||188|= Starting Initial Treatment Period|
59784539|NCT02598960|75904579|FG012|STARTED|Treatment Period||33|= Starting Initial Treatment Period|
59784540|NCT02598960|75904567|FG000|COMPLETED|Treatment Period||0|= completing initial treatment period|
59784541|NCT02598960|75904568|FG001|COMPLETED|Treatment Period||0|= completing initial treatment period|
59784542|NCT02598960|75904569|FG002|COMPLETED|Treatment Period||0|= completing initial treatment period|
59784543|NCT02598960|75904570|FG003|COMPLETED|Treatment Period||0|= completing initial treatment period|
59784544|NCT02598960|75904571|FG004|COMPLETED|Treatment Period||0|= completing initial treatment period|
59784545|NCT02598960|75904572|FG005|COMPLETED|Treatment Period||1|= completing initial treatment period|
59784546|NCT02598960|75904573|FG006|COMPLETED|Treatment Period||0|= completing initial treatment period|
59784547|NCT02598960|75904574|FG007|COMPLETED|Treatment Period||0|= completing initial treatment period|
59784548|NCT02598960|75904575|FG008|COMPLETED|Treatment Period||2|= completing initial treatment period|
59784549|NCT02598960|75904576|FG009|COMPLETED|Treatment Period||3|= completing initial treatment period|
59784550|NCT02598960|75904577|FG010|COMPLETED|Treatment Period||3|= completing initial treatment period|
59784551|NCT02598960|75904578|FG011|COMPLETED|Treatment Period||23|= completing initial treatment period|
59784552|NCT02598960|75904579|FG012|COMPLETED|Treatment Period||7|= completing initial treatment period|
59784553|NCT02598960|75904567|FG000|NOT COMPLETED|Treatment Period||4||
59784554|NCT02598960|75904568|FG001|NOT COMPLETED|Treatment Period||6||
59784555|NCT02598960|75904569|FG002|NOT COMPLETED|Treatment Period||4||
59784556|NCT02598960|75904570|FG003|NOT COMPLETED|Treatment Period||6||
59784557|NCT02598960|75904571|FG004|NOT COMPLETED|Treatment Period||9||
59784558|NCT02598960|75904572|FG005|NOT COMPLETED|Treatment Period||2||
59784559|NCT02598960|75904573|FG006|NOT COMPLETED|Treatment Period||2||
59784560|NCT02598960|75904574|FG007|NOT COMPLETED|Treatment Period||3||
59784561|NCT02598960|75904575|FG008|NOT COMPLETED|Treatment Period||7||
59784562|NCT02598960|75904576|FG009|NOT COMPLETED|Treatment Period||11||
59784563|NCT02598960|75904577|FG010|NOT COMPLETED|Treatment Period||8||
59784564|NCT02598960|75904578|FG011|NOT COMPLETED|Treatment Period||165||
59784565|NCT02598960|75904579|FG012|NOT COMPLETED|Treatment Period||26||
59784566|NCT02598960|75904567|FG000|STARTED|Participants Entering Follow Up Period||4|= participants entering follow up period|
59784567|NCT02598960|75904568|FG001|STARTED|Participants Entering Follow Up Period||6|= participants entering follow up period|
59784568|NCT02598960|75904569|FG002|STARTED|Participants Entering Follow Up Period||4|= participants entering follow up period|
59784569|NCT02598960|75904570|FG003|STARTED|Participants Entering Follow Up Period||6|= participants entering follow up period|
59784570|NCT02598960|75904571|FG004|STARTED|Participants Entering Follow Up Period||9|= participants entering follow up period|
59784571|NCT02598960|75904572|FG005|STARTED|Participants Entering Follow Up Period||3|= participants entering follow up period|
59784572|NCT02598960|75904573|FG006|STARTED|Participants Entering Follow Up Period||2|= participants entering follow up period|
59784573|NCT02598960|75904574|FG007|STARTED|Participants Entering Follow Up Period||3|= participants entering follow up period|
59784574|NCT02598960|75904575|FG008|STARTED|Participants Entering Follow Up Period||9|= participants entering follow up period|
59784575|NCT02598960|75904576|FG009|STARTED|Participants Entering Follow Up Period||14|= participants entering follow up period|
59784576|NCT02598960|75904577|FG010|STARTED|Participants Entering Follow Up Period||11|= participants entering follow up period|
59784577|NCT02598960|75904578|FG011|STARTED|Participants Entering Follow Up Period||188|= participants entering follow up period|
59784578|NCT02598960|75904579|FG012|STARTED|Participants Entering Follow Up Period||33|= participants entering follow up period|
59784579|NCT02598960|75904567|FG000|COMPLETED|Participants Entering Follow Up Period||3||
59784580|NCT02598960|75904568|FG001|COMPLETED|Participants Entering Follow Up Period||6||
59784581|NCT02598960|75904569|FG002|COMPLETED|Participants Entering Follow Up Period||4||
59784582|NCT02598960|75904570|FG003|COMPLETED|Participants Entering Follow Up Period||6||
59784583|NCT02598960|75904571|FG004|COMPLETED|Participants Entering Follow Up Period||9||
59784584|NCT02598960|75904572|FG005|COMPLETED|Participants Entering Follow Up Period||3||
59784585|NCT02598960|75904573|FG006|COMPLETED|Participants Entering Follow Up Period||2||
59784586|NCT02598960|75904574|FG007|COMPLETED|Participants Entering Follow Up Period||3||
59784587|NCT02598960|75904575|FG008|COMPLETED|Participants Entering Follow Up Period||9||
59784588|NCT02598960|75904576|FG009|COMPLETED|Participants Entering Follow Up Period||13||
59784589|NCT02598960|75904577|FG010|COMPLETED|Participants Entering Follow Up Period||10||
59784590|NCT02598960|75904578|FG011|COMPLETED|Participants Entering Follow Up Period||159||
59784591|NCT02598960|75904579|FG012|COMPLETED|Participants Entering Follow Up Period||28||
59784592|NCT02598960|75904567|FG000|NOT COMPLETED|Participants Entering Follow Up Period||1||
59784593|NCT02598960|75904568|FG001|NOT COMPLETED|Participants Entering Follow Up Period||0||
59784594|NCT02598960|75904569|FG002|NOT COMPLETED|Participants Entering Follow Up Period||0||
59784595|NCT02598960|75904570|FG003|NOT COMPLETED|Participants Entering Follow Up Period||0||
59784596|NCT02598960|75904571|FG004|NOT COMPLETED|Participants Entering Follow Up Period||0||
59784597|NCT02598960|75904572|FG005|NOT COMPLETED|Participants Entering Follow Up Period||0||
59784598|NCT02598960|75904573|FG006|NOT COMPLETED|Participants Entering Follow Up Period||0||
59784599|NCT02598960|75904574|FG007|NOT COMPLETED|Participants Entering Follow Up Period||0||
59784600|NCT02598960|75904575|FG008|NOT COMPLETED|Participants Entering Follow Up Period||0||
59784601|NCT02598960|75904576|FG009|NOT COMPLETED|Participants Entering Follow Up Period||1||
59784602|NCT02598960|75904577|FG010|NOT COMPLETED|Participants Entering Follow Up Period||1||
59784603|NCT02598960|75904578|FG011|NOT COMPLETED|Participants Entering Follow Up Period||29||
59784604|NCT02598960|75904579|FG012|NOT COMPLETED|Participants Entering Follow Up Period||5||
59784605|NCT00426361|75904610|FG000|STARTED|Overall Study||248||
59784606|NCT00426361|75904611|FG001|STARTED|Overall Study||255||
59784607|NCT00426361|75904612|FG002|STARTED|Overall Study||248||
59784608|NCT00426361|75904610|FG000|COMPLETED|Overall Study||244||
59784609|NCT00426361|75904611|FG001|COMPLETED|Overall Study||250||
59784610|NCT00426361|75904612|FG002|COMPLETED|Overall Study||243||
59784611|NCT00426361|75904610|FG000|NOT COMPLETED|Overall Study||4||
59784612|NCT00426361|75904611|FG001|NOT COMPLETED|Overall Study||5||
59784613|NCT00426361|75904612|FG002|NOT COMPLETED|Overall Study||5||
59784614|NCT00665847|75904620|FG000|STARTED|Overall Study||101||
59784615|NCT00665847|75904620|FG000|COMPLETED|Overall Study||76||
59784616|NCT00665847|75904620|FG000|NOT COMPLETED|Overall Study||25||
59784617|NCT00426127|75904624|FG000|STARTED|Overall Study||2||
59784618|NCT00426127|75904624|FG000|COMPLETED|Overall Study||0||
59953071|NCT04057820|76071792|FG012|NOT COMPLETED|Period 2||0||0
59953072|NCT04057820|76071793|FG013|NOT COMPLETED|Period 2||0||0
59953073|NCT04057820|76071794|FG014|NOT COMPLETED|Period 2||0||0
59784619|NCT00426127|75904624|FG000|NOT COMPLETED|Overall Study||2||
59784620|NCT00425503|75904628|FG000|STARTED|Overall Study||40||
59784621|NCT00425503|75904628|FG000|COMPLETED|Overall Study||37||
59784622|NCT00425503|75904628|FG000|NOT COMPLETED|Overall Study||3||
59784623|NCT00425269|75904634|FG000|STARTED|Overall Study||101||
59784624|NCT00425269|75904635|FG001|STARTED|Overall Study||97||
59784625|NCT00425269|75904634|FG000|COMPLETED|Overall Study||82||
59784626|NCT00425269|75904635|FG001|COMPLETED|Overall Study||77||
59619354|NCT00633126|75730577|FG000|STARTED|Overall Study||9||
59619355|NCT00633126|75730577|FG000|COMPLETED|Overall Study||8||
59619356|NCT00633126|75730577|FG000|NOT COMPLETED|Overall Study||1||
59619357|NCT00989664|75730581|FG000|STARTED|Dosimetric and Therapeutic Treatment||61||
59619358|NCT00989664|75730581|FG000|COMPLETED|Dosimetric and Therapeutic Treatment||0||
59619359|NCT00989664|75730581|FG000|NOT COMPLETED|Dosimetric and Therapeutic Treatment||61||
59784627|NCT00425269|75904634|FG000|NOT COMPLETED|Overall Study||19||
59784628|NCT00425269|75904635|FG001|NOT COMPLETED|Overall Study||20||
59784629|NCT00430573|75904641|FG000|STARTED|Overall Study||10||
59784630|NCT00430573|75904641|FG000|COMPLETED|Overall Study|Only 5 took study drug on at least one occasion and 8 completed the baseline ASI.|5||
59784631|NCT00430573|75904641|FG000|NOT COMPLETED|Overall Study||5||
59784632|NCT02460900|75904650|FG000|STARTED|Overall Study||46||
59784633|NCT02460900|75904651|FG001|STARTED|Overall Study||47||
59784634|NCT02460900|75904652|FG002|STARTED|Overall Study||42||
59784635|NCT02460900|75904653|FG003|STARTED|Overall Study||49||
59784636|NCT02460900|75904650|FG000|COMPLETED|Overall Study||36||
59784637|NCT02460900|75904651|FG001|COMPLETED|Overall Study||37||
59784638|NCT02460900|75904652|FG002|COMPLETED|Overall Study||28||
59784639|NCT02460900|75904653|FG003|COMPLETED|Overall Study||30||
59784640|NCT02460900|75904650|FG000|NOT COMPLETED|Overall Study||10||
59784641|NCT02460900|75904651|FG001|NOT COMPLETED|Overall Study||10||
59784642|NCT02460900|75904652|FG002|NOT COMPLETED|Overall Study||14||
59784643|NCT02460900|75904653|FG003|NOT COMPLETED|Overall Study||19||
59784644|NCT00430495|75904667|FG000|STARTED|Overall Study||64||
59784645|NCT00430495|75904668|FG001|STARTED|Overall Study||66||
59784646|NCT00430495|75904669|FG002|STARTED|Overall Study||62||
59784647|NCT00430495|75904670|FG003|STARTED|Overall Study||64||
59784648|NCT00430495|75904667|FG000|Treated|Overall Study||62||
59784649|NCT00430495|75904668|FG001|Treated|Overall Study||66||
59784650|NCT00430495|75904669|FG002|Treated|Overall Study||62||
59619360|NCT00989664|75730581|FG000|STARTED|Long-Term Follow-Up|14 of the 61 participants withdrawing from Study BEX104504 enrolled in the LTFU study.|14||
59619361|NCT00989664|75730581|FG000|COMPLETED|Long-Term Follow-Up||11||
59619362|NCT00989664|75730581|FG000|NOT COMPLETED|Long-Term Follow-Up||3||
59619363|NCT00632736|75730587|FG000|STARTED|Overall Study||419||
59619364|NCT00632736|75730587|FG000|COMPLETED|Overall Study||151||
59619365|NCT00632736|75730587|FG000|NOT COMPLETED|Overall Study||268||
59619366|NCT00989196|75730591|FG000|STARTED|PK Crossover Period||10||
59619367|NCT00989196|75730592|FG001|STARTED|PK Crossover Period||12||
59619368|NCT00989196|75730591|FG000|COMPLETED|PK Crossover Period||10||
59619369|NCT00989196|75730592|FG001|COMPLETED|PK Crossover Period||12||
59619370|NCT00989196|75730591|FG000|NOT COMPLETED|PK Crossover Period||0||
59619371|NCT00989196|75730592|FG001|NOT COMPLETED|PK Crossover Period||0||
59619372|NCT00989196|75730591|FG000|STARTED|Treatment Period||10||
59619373|NCT00989196|75730592|FG001|STARTED|Treatment Period||12||
59619374|NCT00989196|75730591|FG000|COMPLETED|Treatment Period||9||
59619375|NCT00989196|75730592|FG001|COMPLETED|Treatment Period||12||
59619376|NCT00989196|75730591|FG000|NOT COMPLETED|Treatment Period||1||
59619377|NCT00989196|75730592|FG001|NOT COMPLETED|Treatment Period||0||
59619378|NCT00632502|75730600|FG000|STARTED|Overall Study||25||
59619379|NCT00632502|75730601|FG001|STARTED|Overall Study||12||
59619380|NCT00632502|75730600|FG000|Treated|Overall Study||22||
59619381|NCT00632502|75730601|FG001|Treated|Overall Study||12||
59619382|NCT00632502|75730600|FG000|Completed Treatment|Overall Study||19||
59619383|NCT00632502|75730601|FG001|Completed Treatment|Overall Study||9||
59619384|NCT00632502|75730600|FG000|COMPLETED|Overall Study||22||
59619385|NCT00632502|75730601|FG001|COMPLETED|Overall Study||11||
59619386|NCT00632502|75730600|FG000|NOT COMPLETED|Overall Study||3||
59619387|NCT00632502|75730601|FG001|NOT COMPLETED|Overall Study||1||
59619388|NCT00632424|75730611|FG000|STARTED|Overall Study||18||
59619389|NCT00632424|75730611|FG000|COMPLETED|Overall Study||0||
59619390|NCT00632424|75730611|FG000|NOT COMPLETED|Overall Study||18||
59619391|NCT00631488|75730628|FG000|STARTED|Overall Study||48||
59619392|NCT00631488|75730629|FG001|STARTED|Overall Study||49||
59619393|NCT00631488|75730630|FG002|STARTED|Overall Study||49||
59619394|NCT00631488|75730628|FG000|Completed Post-Treatment Period|Overall Study||44||
59619395|NCT00631488|75730629|FG001|Completed Post-Treatment Period|Overall Study||47||
59619396|NCT00631488|75730630|FG002|Completed Post-Treatment Period|Overall Study||47||
59619397|NCT00631488|75730628|FG000|COMPLETED|Overall Study||44||
59619398|NCT00631488|75730629|FG001|COMPLETED|Overall Study||47||
59619399|NCT00631488|75730630|FG002|COMPLETED|Overall Study||47||
59619400|NCT00631488|75730628|FG000|NOT COMPLETED|Overall Study||4||
59619401|NCT00631488|75730629|FG001|NOT COMPLETED|Overall Study||2||
59619402|NCT00631488|75730630|FG002|NOT COMPLETED|Overall Study||2||
59619403|NCT00988884|75730640|FG000|STARTED|Overall Study||621||
59619404|NCT00988884|75730641|FG001|STARTED|Overall Study||620||
59784651|NCT00430495|75904670|FG003|Treated|Overall Study||64||
59619405|NCT00988884|75730640|FG000|COMPLETED|Overall Study||586||
59619406|NCT00988884|75730641|FG001|COMPLETED|Overall Study||584||
59619407|NCT00988884|75730640|FG000|NOT COMPLETED|Overall Study||35||
59619408|NCT00988884|75730641|FG001|NOT COMPLETED|Overall Study||36||
59784652|NCT00430495|75904667|FG000|COMPLETED|Overall Study||50||
59784653|NCT00430495|75904668|FG001|COMPLETED|Overall Study||59||
59784654|NCT00430495|75904669|FG002|COMPLETED|Overall Study||49||
59784655|NCT00430495|75904670|FG003|COMPLETED|Overall Study||60||
59784656|NCT00430495|75904667|FG000|NOT COMPLETED|Overall Study||14||
59784657|NCT00430495|75904668|FG001|NOT COMPLETED|Overall Study||7||
59784658|NCT00430495|75904669|FG002|NOT COMPLETED|Overall Study||13||
59784659|NCT00430495|75904670|FG003|NOT COMPLETED|Overall Study||4||
59784660|NCT00425113|75904682|FG000|STARTED|Overall Study||17||
59784661|NCT00425113|75904683|FG001|STARTED|Overall Study||18||
59784662|NCT00425113|75904682|FG000|Exposed to Study Drug|Overall Study||16||
59784663|NCT00425113|75904683|FG001|Exposed to Study Drug|Overall Study||17||
59784664|NCT00425113|75904682|FG000|COMPLETED|Overall Study|Included in modified intent-to-treat analysis|15||
59784665|NCT00425113|75904683|FG001|COMPLETED|Overall Study|Included in modified intent-to-treat analysis|16||
59784666|NCT00425113|75904682|FG000|NOT COMPLETED|Overall Study||2||
59784667|NCT00425113|75904683|FG001|NOT COMPLETED|Overall Study||2||
59784668|NCT00440011|75904692|FG000|STARTED|Overall Study||131||
59784669|NCT00440011|75904693|FG001|STARTED|Overall Study||135||
59784670|NCT00440011|75904692|FG000|COMPLETED|Overall Study||127||
59784671|NCT00440011|75904693|FG001|COMPLETED|Overall Study||132||
59784672|NCT00440011|75904692|FG000|NOT COMPLETED|Overall Study||4||
59784673|NCT00440011|75904693|FG001|NOT COMPLETED|Overall Study||3||
59784674|NCT00877448|75904706|FG000|STARTED|Overall Study||10||
59784675|NCT00877448|75904707|FG001|STARTED|Overall Study||10||
59784676|NCT00877448|75904708|FG002|STARTED|Overall Study||10||
59784677|NCT00877448|75904709|FG003|STARTED|Overall Study||10||
59784678|NCT00877448|75904710|FG004|STARTED|Overall Study||10||
59784679|NCT00877448|75904711|FG005|STARTED|Overall Study||10||
59784680|NCT00877448|75904712|FG006|STARTED|Overall Study||3||
59784681|NCT00877448|75904706|FG000|COMPLETED|Overall Study||10||
59784682|NCT00877448|75904707|FG001|COMPLETED|Overall Study||9||
59784683|NCT00877448|75904708|FG002|COMPLETED|Overall Study||10||
59784684|NCT00877448|75904709|FG003|COMPLETED|Overall Study||9||
59784685|NCT00877448|75904710|FG004|COMPLETED|Overall Study||10||
59784686|NCT00877448|75904711|FG005|COMPLETED|Overall Study||9||
59784687|NCT00877448|75904712|FG006|COMPLETED|Overall Study||3||
59784688|NCT00877448|75904706|FG000|NOT COMPLETED|Overall Study||0||
59784689|NCT00877448|75904707|FG001|NOT COMPLETED|Overall Study||1||
59784690|NCT00877448|75904708|FG002|NOT COMPLETED|Overall Study||0||
59784691|NCT00877448|75904709|FG003|NOT COMPLETED|Overall Study||1||
59784692|NCT00877448|75904710|FG004|NOT COMPLETED|Overall Study||0||
59784693|NCT00877448|75904711|FG005|NOT COMPLETED|Overall Study||1||
59784694|NCT00877448|75904712|FG006|NOT COMPLETED|Overall Study||0||
59784695|NCT00663117|75904730|FG000|STARTED|Overall Study||20||
59784696|NCT00663117|75904731|FG001|STARTED|Overall Study||20||
59784697|NCT00663117|75904730|FG000|COMPLETED|Overall Study|One patient in placebo flared and was unblinded and crossed over to active drug|19||
59784698|NCT00663117|75904731|FG001|COMPLETED|Overall Study||20||
59784699|NCT00663117|75904730|FG000|NOT COMPLETED|Overall Study||1||
59784700|NCT00663117|75904731|FG001|NOT COMPLETED|Overall Study||0||
59784701|NCT00495716|75904745|FG000|STARTED|Overall Study||35||
59784702|NCT00495716|75904746|FG001|STARTED|Overall Study||37||
59784703|NCT00495716|75904745|FG000|COMPLETED|Overall Study||20||
59784704|NCT00495716|75904746|FG001|COMPLETED|Overall Study||24||
59784705|NCT00495716|75904745|FG000|NOT COMPLETED|Overall Study||15||
59784706|NCT00495716|75904746|FG001|NOT COMPLETED|Overall Study||13||
59784707|NCT00570141|75904752|FG000|STARTED|Overall Study||13||
59784708|NCT00570141|75904752|FG000|COMPLETED|Overall Study||10||
59784709|NCT00570141|75904752|FG000|NOT COMPLETED|Overall Study||3||
59784710|NCT00579254|75904756|FG000|STARTED|Overall Study||112||
59784711|NCT00579254|75904756|FG000|COMPLETED|Overall Study||0||
59784712|NCT00579254|75904756|FG000|NOT COMPLETED|Overall Study||112||
59784713|NCT00661089|75904762|FG000|STARTED|Overall Study||10||
59784714|NCT00661089|75904763|FG001|STARTED|Overall Study||11||
59784715|NCT00661089|75904762|FG000|COMPLETED|Overall Study||10||
59784716|NCT00661089|75904763|FG001|COMPLETED|Overall Study||9||
59784717|NCT00661089|75904762|FG000|NOT COMPLETED|Overall Study||0||
59784718|NCT00661089|75904763|FG001|NOT COMPLETED|Overall Study||2||
59784719|NCT03098082|75904770|FG000|STARTED|Overall Study||394||
59784720|NCT03098082|75904770|FG000|COMPLETED|Overall Study||254||
59784721|NCT03098082|75904770|FG000|NOT COMPLETED|Overall Study||140||
59784722|NCT00582426|75904776|FG000|STARTED|Overall Study|"Patient in both arms belongs to started indicates safety and intent to treat (ITT) populations."|68||
59784723|NCT00582426|75904777|FG001|STARTED|Overall Study||71||
59784724|NCT00582426|75904776|FG000|COMPLETED|Overall Study||48||
59784725|NCT00582426|75904777|FG001|COMPLETED|Overall Study||58||
59784726|NCT00582426|75904776|FG000|NOT COMPLETED|Overall Study||20||
59784727|NCT00582426|75904777|FG001|NOT COMPLETED|Overall Study||13||
59784728|NCT02387970|75904785|FG000|STARTED|Overall Study||27||
59784729|NCT02387970|75904786|FG001|STARTED|Overall Study||25||
59784730|NCT02387970|75904785|FG000|COMPLETED|Overall Study||26||
59784731|NCT02387970|75904786|FG001|COMPLETED|Overall Study||23||
59784732|NCT02387970|75904785|FG000|NOT COMPLETED|Overall Study||1||
59784733|NCT02387970|75904786|FG001|NOT COMPLETED|Overall Study||2||
59784734|NCT00580034|75904792|FG000|STARTED|Overall Study||88||
59784735|NCT00580034|75904793|FG001|STARTED|Overall Study||88||
59784736|NCT00580034|75904792|FG000|COMPLETED|Overall Study||78||
59784737|NCT00580034|75904793|FG001|COMPLETED|Overall Study||88||
59784738|NCT00580034|75904792|FG000|NOT COMPLETED|Overall Study||10||
59784739|NCT00580034|75904793|FG001|NOT COMPLETED|Overall Study||0||
59784740|NCT00773513|75904799|FG000|STARTED|Overall Study||1413|Randomized with informed consent|
59784741|NCT00773513|75904800|FG001|STARTED|Overall Study||1412|Randomized with informed consent|
59784742|NCT00773513|75904799|FG000|Received Study Treatment|Overall Study||1409||
60073076|NCT01563237|76188286|FG000|STARTED|Overall Study||64|69 Participants and 74 eyes were enrolled|69
59522615|NCT01446250|75617100|FG000|NOT COMPLETED|Clinical Hold||0||
59522616|NCT01446250|75617101|FG001|NOT COMPLETED|Clinical Hold||0||
59522617|NCT01446250|75617102|FG002|NOT COMPLETED|Clinical Hold||0||
59522618|NCT01446250|75617103|FG003|NOT COMPLETED|Clinical Hold||0||
59522619|NCT01446250|75617100|FG000|STARTED|Treatment Period 2||0||
59522620|NCT01446250|75617101|FG001|STARTED|Treatment Period 2||7||
59522621|NCT01446250|75617102|FG002|STARTED|Treatment Period 2||0||
59522622|NCT01446250|75617103|FG003|STARTED|Treatment Period 2||0||
59522623|NCT01446250|75617100|FG000|COMPLETED|Treatment Period 2||0||
59522624|NCT01446250|75617101|FG001|COMPLETED|Treatment Period 2||6||
59522625|NCT01446250|75617102|FG002|COMPLETED|Treatment Period 2||0||
59522626|NCT01446250|75617103|FG003|COMPLETED|Treatment Period 2||0||
59522627|NCT01446250|75617100|FG000|NOT COMPLETED|Treatment Period 2||0||
59522628|NCT01446250|75617101|FG001|NOT COMPLETED|Treatment Period 2||1||
59522629|NCT01446250|75617102|FG002|NOT COMPLETED|Treatment Period 2||0||
59522630|NCT01446250|75617103|FG003|NOT COMPLETED|Treatment Period 2||0||
59522631|NCT01446250|75617100|FG000|STARTED|Follow-up||0||
59522632|NCT01446250|75617101|FG001|STARTED|Follow-up||0||
59522633|NCT01446250|75617102|FG002|STARTED|Follow-up||0||
59522634|NCT01446250|75617103|FG003|STARTED|Follow-up||6||
59522635|NCT01446250|75617100|FG000|COMPLETED|Follow-up||0||
59522636|NCT01446250|75617101|FG001|COMPLETED|Follow-up||0||
59522637|NCT01446250|75617102|FG002|COMPLETED|Follow-up||0||
59522638|NCT01446250|75617103|FG003|COMPLETED|Follow-up||0||
59522639|NCT01446250|75617100|FG000|NOT COMPLETED|Follow-up||0||
59522640|NCT01446250|75617101|FG001|NOT COMPLETED|Follow-up||0||
59784743|NCT00773513|75904800|FG001|Received Study Treatment|Overall Study||1409||
59784744|NCT00773513|75904799|FG000|COMPLETED|Overall Study||312||
60073077|NCT01563237|76188287|FG001|STARTED|Overall Study||5|69 Participants and 74 eyes were enrolled|5
60073078|NCT01563237|76188286|FG000|COMPLETED|Overall Study||54|59 participants and 64 eyes completed the study|59
60073079|NCT01563237|76188287|FG001|COMPLETED|Overall Study||5|59 participants and 64 eyes completed the study|5
60073080|NCT01563237|76188286|FG000|NOT COMPLETED|Overall Study||10||10
60073081|NCT01563237|76188287|FG001|NOT COMPLETED|Overall Study||0||0
60073082|NCT03735316|76188294|FG000|STARTED|Overall Study||4||
60073083|NCT03735316|76188295|FG001|STARTED|Overall Study||4||
60073084|NCT03735316|76188294|FG000|COMPLETED|Overall Study||4||
60073085|NCT03735316|76188295|FG001|COMPLETED|Overall Study||4||
60073086|NCT03735316|76188294|FG000|NOT COMPLETED|Overall Study||0||
59784745|NCT00773513|75904800|FG001|COMPLETED|Overall Study||303||
59784746|NCT00773513|75904799|FG000|NOT COMPLETED|Overall Study||1101||
59784747|NCT00773513|75904800|FG001|NOT COMPLETED|Overall Study||1109||
59784748|NCT00767039|75904808|FG000|STARTED|Overall Study|Two early deaths and 3 late deaths occurred in this group|27||
60073087|NCT03735316|76188295|FG001|NOT COMPLETED|Overall Study||0||
60073088|NCT01694433|76188303|FG000|STARTED|Overall Study||33||
59522641|NCT01446250|75617102|FG002|NOT COMPLETED|Follow-up||0||
59522642|NCT01446250|75617103|FG003|NOT COMPLETED|Follow-up||6||
59522643|NCT02936206|75617113|FG000|STARTED|Overall Study||0||
59522644|NCT02936206|75617114|FG001|STARTED|Overall Study||2||
59784749|NCT00767039|75904809|FG001|STARTED|Overall Study||25||
59784750|NCT00767039|75904808|FG000|COMPLETED|Overall Study||22||
59784751|NCT00767039|75904809|FG001|COMPLETED|Overall Study||23||
59784752|NCT00767039|75904808|FG000|NOT COMPLETED|Overall Study||5||
59784753|NCT00767039|75904809|FG001|NOT COMPLETED|Overall Study||2||
59784754|NCT00662649|75904819|FG000|STARTED|Core Study (24 Months)||429||
59784755|NCT00662649|75904820|FG001|STARTED|Core Study (24 Months)||425||
59784756|NCT00662649|75904821|FG002|STARTED|Core Study (24 Months)||418||
59784757|NCT00662649|75904822|FG003|STARTED|Core Study (24 Months)|This reporting group is used only in extension study.|0||
59784758|NCT00662649|75904823|FG004|STARTED|Core Study (24 Months)|This reporting group is used only in extension study.|0||
59784759|NCT00662649|75904819|FG000|Intent to Treat (ITT)|Core Study (24 Months)||429||
59784760|NCT00662649|75904820|FG001|Intent to Treat (ITT)|Core Study (24 Months)||425||
59784761|NCT00662649|75904821|FG002|Intent to Treat (ITT)|Core Study (24 Months)||418||
59784762|NCT00662649|75904822|FG003|Intent to Treat (ITT)|Core Study (24 Months)||0||
59784763|NCT00662649|75904823|FG004|Intent to Treat (ITT)|Core Study (24 Months)||0||
59784764|NCT00662649|75904819|FG000|COMPLETED|Core Study (24 Months)||332||
59784765|NCT00662649|75904820|FG001|COMPLETED|Core Study (24 Months)||369||
59784766|NCT00662649|75904821|FG002|COMPLETED|Core Study (24 Months)||332||
59784767|NCT00662649|75904822|FG003|COMPLETED|Core Study (24 Months)||0||
59784768|NCT00662649|75904823|FG004|COMPLETED|Core Study (24 Months)||0||
59784769|NCT00662649|75904819|FG000|NOT COMPLETED|Core Study (24 Months)||97||
59784770|NCT00662649|75904820|FG001|NOT COMPLETED|Core Study (24 Months)||56||
59784771|NCT00662649|75904821|FG002|NOT COMPLETED|Core Study (24 Months)||86||
59784772|NCT00662649|75904822|FG003|NOT COMPLETED|Core Study (24 Months)||0||
59784773|NCT00662649|75904823|FG004|NOT COMPLETED|Core Study (24 Months)||0||
59784774|NCT00662649|75904819|FG000|STARTED|Extension Study (Month 24 to 60)||289||
59784775|NCT00662649|75904820|FG001|STARTED|Extension Study (Month 24 to 60)||331||
59784776|NCT00662649|75904821|FG002|STARTED|Extension Study (Month 24 to 60)|This reporting group is used only for core study|0||
59784777|NCT00662649|75904822|FG003|STARTED|Extension Study (Month 24 to 60)||145||
59784778|NCT00662649|75904823|FG004|STARTED|Extension Study (Month 24 to 60)||155||
59784779|NCT00662649|75904819|FG000|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||287||
59784780|NCT00662649|75904820|FG001|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||330||
59784781|NCT00662649|75904821|FG002|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||0||
59784782|NCT00662649|75904822|FG003|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||145||
59784783|NCT00662649|75904823|FG004|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||154||
59784784|NCT00662649|75904819|FG000|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||289||
59784785|NCT00662649|75904820|FG001|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||331||
59784786|NCT00662649|75904821|FG002|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||0||
59784787|NCT00662649|75904822|FG003|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||145||
59784788|NCT00662649|75904823|FG004|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||155||
59784789|NCT00662649|75904819|FG000|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||276||
59784790|NCT00662649|75904820|FG001|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||324||
59784791|NCT00662649|75904821|FG002|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||0||
59784792|NCT00662649|75904822|FG003|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||136||
59784793|NCT00662649|75904823|FG004|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||152||
59784794|NCT00662649|75904819|FG000|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||270||
59784795|NCT00662649|75904820|FG001|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||311||
59784796|NCT00662649|75904821|FG002|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||0||
59784797|NCT00662649|75904822|FG003|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||130||
59784798|NCT00662649|75904823|FG004|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||145||
59784799|NCT00662649|75904819|FG000|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||254||
59784800|NCT00662649|75904820|FG001|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||301||
59784801|NCT00662649|75904821|FG002|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||0||
59784802|NCT00662649|75904822|FG003|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||120||
59784803|NCT00662649|75904823|FG004|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||136||
59784804|NCT00662649|75904819|FG000|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||125||
59784805|NCT00662649|75904820|FG001|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||152||
59784806|NCT00662649|75904821|FG002|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||0||
59784807|NCT00662649|75904822|FG003|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||58||
59784808|NCT00662649|75904823|FG004|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||67||
59784809|NCT00662649|75904819|FG000|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||31||
59784810|NCT00662649|75904820|FG001|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||32||
59784811|NCT00662649|75904821|FG002|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||0||
59784812|NCT00662649|75904822|FG003|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||11||
59953074|NCT04057820|76071795|FG015|NOT COMPLETED|Period 2||0||0
59784813|NCT00662649|75904823|FG004|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||13||
59784814|NCT00662649|75904819|FG000|COMPLETED|Extension Study (Month 24 to 60)|"completed refers to patients that completed extension study in different time points."|245||
59784815|NCT00662649|75904820|FG001|COMPLETED|Extension Study (Month 24 to 60)||290||
59784816|NCT00662649|75904821|FG002|COMPLETED|Extension Study (Month 24 to 60)||0||
59784817|NCT00662649|75904822|FG003|COMPLETED|Extension Study (Month 24 to 60)||112||
59784818|NCT00662649|75904823|FG004|COMPLETED|Extension Study (Month 24 to 60)||126||
59784819|NCT00662649|75904819|FG000|NOT COMPLETED|Extension Study (Month 24 to 60)||44||
59784820|NCT00662649|75904820|FG001|NOT COMPLETED|Extension Study (Month 24 to 60)||41||
59784821|NCT00662649|75904821|FG002|NOT COMPLETED|Extension Study (Month 24 to 60)||0||
59784822|NCT00662649|75904822|FG003|NOT COMPLETED|Extension Study (Month 24 to 60)||33||
59784823|NCT00662649|75904823|FG004|NOT COMPLETED|Extension Study (Month 24 to 60)||29||
59784824|NCT00766493|75904837|FG000|STARTED|Pre-Discharge||250||
59784825|NCT00766493|75904837|FG000|COMPLETED|Pre-Discharge||250||
59784826|NCT00766493|75904837|FG000|NOT COMPLETED|Pre-Discharge||0||
59784827|NCT00766493|75904837|FG000|STARTED|30 Days Post-Procedure||250||
59784828|NCT00766493|75904837|FG000|COMPLETED|30 Days Post-Procedure||238||
59784829|NCT00766493|75904837|FG000|NOT COMPLETED|30 Days Post-Procedure||12||
59784830|NCT03070392|75904843|FG000|STARTED|Overall Study||252||
59784831|NCT03070392|75904844|FG001|STARTED|Overall Study||7||
59784832|NCT03070392|75904845|FG002|STARTED|Overall Study||16||
59784833|NCT03070392|75904846|FG003|STARTED|Overall Study||103||
59784834|NCT03070392|75904843|FG000|COMPLETED|Overall Study||0||
59784835|NCT03070392|75904844|FG001|COMPLETED|Overall Study||0||
59784836|NCT03070392|75904845|FG002|COMPLETED|Overall Study||10||
59784837|NCT03070392|75904846|FG003|COMPLETED|Overall Study||0||
59784838|NCT03070392|75904843|FG000|NOT COMPLETED|Overall Study||252||
59784839|NCT03070392|75904844|FG001|NOT COMPLETED|Overall Study||7||
59784840|NCT03070392|75904845|FG002|NOT COMPLETED|Overall Study||6||
59784841|NCT03070392|75904846|FG003|NOT COMPLETED|Overall Study||103||
59784842|NCT00784043|75904854|FG000|STARTED|Overall Study||31||
59784843|NCT00784043|75904855|FG001|STARTED|Overall Study||6||
59784844|NCT00784043|75904854|FG000|COMPLETED|Overall Study||0||
59784845|NCT00784043|75904855|FG001|COMPLETED|Overall Study||0||
59784846|NCT00784043|75904854|FG000|NOT COMPLETED|Overall Study||31||
59784847|NCT00784043|75904855|FG001|NOT COMPLETED|Overall Study||6||
59784848|NCT00773279|75904861|FG000|STARTED|Period 1||121||
59784849|NCT00773279|75904862|FG001|STARTED|Period 1||121||
59784850|NCT00773279|75904861|FG000|COMPLETED|Period 1||114||
59784851|NCT00773279|75904862|FG001|COMPLETED|Period 1||117||
59784852|NCT00773279|75904861|FG000|NOT COMPLETED|Period 1||7||
59784853|NCT00773279|75904862|FG001|NOT COMPLETED|Period 1||4||
59784854|NCT00773279|75904861|FG000|STARTED|Period 2||114||
59784855|NCT00773279|75904862|FG001|STARTED|Period 2||117||
59784856|NCT00773279|75904861|FG000|COMPLETED|Period 2||111||
59784857|NCT00773279|75904862|FG001|COMPLETED|Period 2||111||
59784858|NCT00773279|75904861|FG000|NOT COMPLETED|Period 2||3||
59784859|NCT00773279|75904862|FG001|NOT COMPLETED|Period 2||6||
59784860|NCT00766415|75904871|FG000|STARTED|Overall Study||25||
59784861|NCT00766415|75904872|FG001|STARTED|Overall Study||27||
59784862|NCT00766415|75904871|FG000|COMPLETED|Overall Study||25||
59784863|NCT00766415|75904872|FG001|COMPLETED|Overall Study||26||
59784864|NCT00766415|75904871|FG000|NOT COMPLETED|Overall Study||0||
59784865|NCT00766415|75904872|FG001|NOT COMPLETED|Overall Study||1||
59784866|NCT00772967|75904878|FG000|STARTED|Crossover Treatment 1||3||
59784867|NCT00772967|75904879|FG001|STARTED|Crossover Treatment 1||5||
59784868|NCT00772967|75904880|FG002|STARTED|Crossover Treatment 1||3||
59784869|NCT00772967|75904881|FG003|STARTED|Crossover Treatment 1||4||
59784870|NCT00772967|75904882|FG004|STARTED|Crossover Treatment 1||4||
59784871|NCT00772967|75904883|FG005|STARTED|Crossover Treatment 1||3||
59784872|NCT00772967|75904878|FG000|COMPLETED|Crossover Treatment 1||3||
59784873|NCT00772967|75904879|FG001|COMPLETED|Crossover Treatment 1||5||
59784874|NCT00772967|75904880|FG002|COMPLETED|Crossover Treatment 1||3||
59784875|NCT00772967|75904881|FG003|COMPLETED|Crossover Treatment 1|The withdrawal is not included in any outcomes; but is part of the Adverse Event group for placebo|3||
59784876|NCT00772967|75904882|FG004|COMPLETED|Crossover Treatment 1||4||
59784877|NCT00772967|75904883|FG005|COMPLETED|Crossover Treatment 1||3||
59784878|NCT00772967|75904878|FG000|NOT COMPLETED|Crossover Treatment 1||0||
59784879|NCT00772967|75904879|FG001|NOT COMPLETED|Crossover Treatment 1||0||
59784880|NCT00772967|75904880|FG002|NOT COMPLETED|Crossover Treatment 1||0||
59784881|NCT00772967|75904881|FG003|NOT COMPLETED|Crossover Treatment 1||1||
59784882|NCT00772967|75904882|FG004|NOT COMPLETED|Crossover Treatment 1||0||
59784883|NCT00772967|75904883|FG005|NOT COMPLETED|Crossover Treatment 1||0||
59784884|NCT00772967|75904878|FG000|STARTED|Break 1 (4-7 Days)||3||
59784885|NCT00772967|75904879|FG001|STARTED|Break 1 (4-7 Days)||5||
59784886|NCT00772967|75904880|FG002|STARTED|Break 1 (4-7 Days)||3||
59784887|NCT00772967|75904881|FG003|STARTED|Break 1 (4-7 Days)||3||
59784888|NCT00772967|75904882|FG004|STARTED|Break 1 (4-7 Days)||4||
59784889|NCT00772967|75904883|FG005|STARTED|Break 1 (4-7 Days)||3||
59784890|NCT00772967|75904878|FG000|COMPLETED|Break 1 (4-7 Days)||3||
59784891|NCT00772967|75904879|FG001|COMPLETED|Break 1 (4-7 Days)||4||
59784892|NCT00772967|75904880|FG002|COMPLETED|Break 1 (4-7 Days)||3||
59784893|NCT00772967|75904881|FG003|COMPLETED|Break 1 (4-7 Days)||3||
59784894|NCT00772967|75904882|FG004|COMPLETED|Break 1 (4-7 Days)||4||
59784895|NCT00772967|75904883|FG005|COMPLETED|Break 1 (4-7 Days)||3||
59784896|NCT00772967|75904878|FG000|NOT COMPLETED|Break 1 (4-7 Days)||0||
59784897|NCT00772967|75904879|FG001|NOT COMPLETED|Break 1 (4-7 Days)||1||
59784898|NCT00772967|75904880|FG002|NOT COMPLETED|Break 1 (4-7 Days)||0||
59784899|NCT00772967|75904881|FG003|NOT COMPLETED|Break 1 (4-7 Days)||0||
59784900|NCT00772967|75904882|FG004|NOT COMPLETED|Break 1 (4-7 Days)||0||
59784901|NCT00772967|75904883|FG005|NOT COMPLETED|Break 1 (4-7 Days)||0||
59784902|NCT00772967|75904878|FG000|STARTED|Crossover Treatment 2||3||
59784903|NCT00772967|75904879|FG001|STARTED|Crossover Treatment 2||4||
59784904|NCT00772967|75904880|FG002|STARTED|Crossover Treatment 2||3||
59784905|NCT00772967|75904881|FG003|STARTED|Crossover Treatment 2||3||
59784906|NCT00772967|75904882|FG004|STARTED|Crossover Treatment 2||4||
59784907|NCT00772967|75904883|FG005|STARTED|Crossover Treatment 2||3||
59784908|NCT00772967|75904878|FG000|COMPLETED|Crossover Treatment 2||3||
59784909|NCT00772967|75904879|FG001|COMPLETED|Crossover Treatment 2||4||
59784910|NCT00772967|75904880|FG002|COMPLETED|Crossover Treatment 2||3||
59784911|NCT00772967|75904881|FG003|COMPLETED|Crossover Treatment 2||3||
59784912|NCT00772967|75904882|FG004|COMPLETED|Crossover Treatment 2||4||
59784913|NCT00772967|75904883|FG005|COMPLETED|Crossover Treatment 2||3||
59784914|NCT00772967|75904878|FG000|NOT COMPLETED|Crossover Treatment 2||0||
59784915|NCT00772967|75904879|FG001|NOT COMPLETED|Crossover Treatment 2||0||
59784916|NCT00772967|75904880|FG002|NOT COMPLETED|Crossover Treatment 2||0||
59784917|NCT00772967|75904881|FG003|NOT COMPLETED|Crossover Treatment 2||0||
59784918|NCT00772967|75904882|FG004|NOT COMPLETED|Crossover Treatment 2||0||
59784919|NCT00772967|75904883|FG005|NOT COMPLETED|Crossover Treatment 2||0||
59784920|NCT00772967|75904878|FG000|STARTED|Break 2 (4-7 Days)||3||
59784921|NCT00772967|75904879|FG001|STARTED|Break 2 (4-7 Days)||4||
59784922|NCT00772967|75904880|FG002|STARTED|Break 2 (4-7 Days)||3||
59784923|NCT00772967|75904881|FG003|STARTED|Break 2 (4-7 Days)||3||
59784924|NCT00772967|75904882|FG004|STARTED|Break 2 (4-7 Days)||4||
59784925|NCT00772967|75904883|FG005|STARTED|Break 2 (4-7 Days)||3||
59784926|NCT00772967|75904878|FG000|COMPLETED|Break 2 (4-7 Days)||3||
59784927|NCT00772967|75904879|FG001|COMPLETED|Break 2 (4-7 Days)||4||
59784928|NCT00772967|75904880|FG002|COMPLETED|Break 2 (4-7 Days)||3||
59784929|NCT00772967|75904881|FG003|COMPLETED|Break 2 (4-7 Days)||3||
59784930|NCT00772967|75904882|FG004|COMPLETED|Break 2 (4-7 Days)||4||
59784931|NCT00772967|75904883|FG005|COMPLETED|Break 2 (4-7 Days)||3||
59784932|NCT00772967|75904878|FG000|NOT COMPLETED|Break 2 (4-7 Days)||0||
59784933|NCT00772967|75904879|FG001|NOT COMPLETED|Break 2 (4-7 Days)||0||
59784934|NCT00772967|75904880|FG002|NOT COMPLETED|Break 2 (4-7 Days)||0||
59784935|NCT00772967|75904881|FG003|NOT COMPLETED|Break 2 (4-7 Days)||0||
59784936|NCT00772967|75904882|FG004|NOT COMPLETED|Break 2 (4-7 Days)||0||
59784937|NCT00772967|75904883|FG005|NOT COMPLETED|Break 2 (4-7 Days)||0||
59784938|NCT00772967|75904878|FG000|STARTED|Crossover Treatment 3||3||
59784939|NCT00772967|75904879|FG001|STARTED|Crossover Treatment 3||4||
59784940|NCT00772967|75904880|FG002|STARTED|Crossover Treatment 3||3||
59784941|NCT00772967|75904881|FG003|STARTED|Crossover Treatment 3||3||
59784942|NCT00772967|75904882|FG004|STARTED|Crossover Treatment 3||4||
59784943|NCT00772967|75904883|FG005|STARTED|Crossover Treatment 3||3||
59784944|NCT00772967|75904878|FG000|COMPLETED|Crossover Treatment 3||3||
59784945|NCT00772967|75904879|FG001|COMPLETED|Crossover Treatment 3||4||
59784946|NCT00772967|75904880|FG002|COMPLETED|Crossover Treatment 3||3||
59953075|NCT04057820|76071780|FG000|STARTED|Period 3||0||0
59953076|NCT04057820|76071781|FG001|STARTED|Period 3|For this stepped wedge study design, a new cohort of infants is enrolled during each period except the transition period. Therefore, the number of infants to start a period is unlikely to equal the number of infants who completed the previous period.|25||4
60073089|NCT01694433|76188304|FG001|STARTED|Overall Study||33||
59522645|NCT02936206|75617113|FG000|COMPLETED|Overall Study||0||
59784947|NCT00772967|75904881|FG003|COMPLETED|Crossover Treatment 3||3||
59784948|NCT00772967|75904882|FG004|COMPLETED|Crossover Treatment 3||3||
59784949|NCT00772967|75904883|FG005|COMPLETED|Crossover Treatment 3||3||
59784950|NCT00772967|75904878|FG000|NOT COMPLETED|Crossover Treatment 3||0||
59784951|NCT00772967|75904879|FG001|NOT COMPLETED|Crossover Treatment 3||0||
59784952|NCT00772967|75904880|FG002|NOT COMPLETED|Crossover Treatment 3||0||
59784953|NCT00772967|75904881|FG003|NOT COMPLETED|Crossover Treatment 3||0||
59784954|NCT00772967|75904882|FG004|NOT COMPLETED|Crossover Treatment 3||1||
59784955|NCT00772967|75904883|FG005|NOT COMPLETED|Crossover Treatment 3||0||
59784956|NCT02363010|75904894|FG000|STARTED|Overall Study||110||
59784957|NCT02363010|75904895|FG001|STARTED|Overall Study||105||
59784958|NCT02363010|75904896|FG002|STARTED|Overall Study||105||
59784959|NCT02363010|75904894|FG000|COMPLETED|Overall Study||88||
59784960|NCT02363010|75904895|FG001|COMPLETED|Overall Study||94||
59784961|NCT02363010|75904896|FG002|COMPLETED|Overall Study||89||
59784962|NCT02363010|75904894|FG000|NOT COMPLETED|Overall Study||22||
59784963|NCT02363010|75904895|FG001|NOT COMPLETED|Overall Study||11||
59784964|NCT02363010|75904896|FG002|NOT COMPLETED|Overall Study||16||
59784965|NCT00662259|75904906|FG000|STARTED|Overall Study||21||
59784966|NCT00662259|75904907|FG001|STARTED|Overall Study||11||
59784967|NCT00662259|75904906|FG000|COMPLETED|Overall Study||19||
59784968|NCT00662259|75904907|FG001|COMPLETED|Overall Study||11||
59784969|NCT00662259|75904906|FG000|NOT COMPLETED|Overall Study||2||
59784970|NCT00662259|75904907|FG001|NOT COMPLETED|Overall Study||0||
59784971|NCT00660699|75904913|FG000|STARTED|Overall Study||50||
59784972|NCT00660699|75904913|FG000|COMPLETED|Overall Study||48||
59784973|NCT00660699|75904913|FG000|NOT COMPLETED|Overall Study||2||
59784974|NCT00582114|75904919|FG000|STARTED|Overall Study||100||
59784975|NCT00582114|75904920|FG001|STARTED|Overall Study||100||
59784976|NCT00582114|75904919|FG000|COMPLETED|Overall Study||58||
59784977|NCT00582114|75904920|FG001|COMPLETED|Overall Study||46||
59784978|NCT00582114|75904919|FG000|NOT COMPLETED|Overall Study||42||
59784979|NCT00582114|75904920|FG001|NOT COMPLETED|Overall Study||54||
59784980|NCT00582036|75904928|FG000|STARTED|Overall Study||5||
59784981|NCT00582036|75904929|FG001|STARTED|Overall Study||6||
59784982|NCT00582036|75904928|FG000|COMPLETED|Overall Study||5||
59784983|NCT00582036|75904929|FG001|COMPLETED|Overall Study|One patient withdrew consent|5||
59784984|NCT00582036|75904928|FG000|NOT COMPLETED|Overall Study||0||
59784985|NCT00582036|75904929|FG001|NOT COMPLETED|Overall Study||1||
59784986|NCT00581360|75904935|FG000|STARTED|Overall Study||10||
59784987|NCT00581360|75904935|FG000|COMPLETED|Overall Study||9||
59784988|NCT00581360|75904935|FG000|NOT COMPLETED|Overall Study||1||
59784989|NCT00660387|75904941|FG000|STARTED|Overall Study||37||
59784990|NCT00660387|75904942|FG001|STARTED|Overall Study||34||
59784991|NCT00660387|75904941|FG000|COMPLETED|Overall Study||35||
59784992|NCT00660387|75904942|FG001|COMPLETED|Overall Study||31||
59784993|NCT00660387|75904941|FG000|NOT COMPLETED|Overall Study||2||
59784994|NCT00660387|75904942|FG001|NOT COMPLETED|Overall Study||3||
59784995|NCT00582738|75904950|FG000|STARTED|Overall Study||21||
59784996|NCT00582738|75904951|FG001|STARTED|Overall Study||22||
59784997|NCT00582738|75904950|FG000|COMPLETED|Overall Study||12||
59784998|NCT00582738|75904951|FG001|COMPLETED|Overall Study||4||
59784999|NCT00582738|75904950|FG000|NOT COMPLETED|Overall Study||9||
59619409|NCT00631020|75730647|FG000|STARTED|Overall Study||34||
59619410|NCT00631020|75730647|FG000|COMPLETED|Overall Study||26||
59619411|NCT00631020|75730647|FG000|NOT COMPLETED|Overall Study||8||
59619412|NCT00987402|75730653|FG000|STARTED|Overall Study|January 2007, with crossover every 2 months|1682||
59619413|NCT00987402|75730654|FG001|STARTED|Overall Study|January 2007 with crossover every 2 months|1635||
59619414|NCT00987402|75730653|FG000|COMPLETED|Overall Study|86 patients did not have some data, and could not be evaluated|1596||
59619415|NCT00987402|75730654|FG001|COMPLETED|Overall Study|98 patients did not have sufficient data|1537||
59619416|NCT00987402|75730653|FG000|NOT COMPLETED|Overall Study||86||
59619417|NCT00987402|75730654|FG001|NOT COMPLETED|Overall Study||98||
59619418|NCT00630864|75730660|FG000|STARTED|Part 1 (up to Week 6)||21||
59619419|NCT00630864|75730660|FG000|COMPLETED|Part 1 (up to Week 6)||20||
59619420|NCT00630864|75730660|FG000|NOT COMPLETED|Part 1 (up to Week 6)||1||
59619421|NCT00630864|75730660|FG000|STARTED|Part 2 (After Week 6 up to Month 12)||20||
59619422|NCT00630864|75730660|FG000|COMPLETED|Part 2 (After Week 6 up to Month 12)||18||
59619423|NCT00630864|75730660|FG000|NOT COMPLETED|Part 2 (After Week 6 up to Month 12)||2||
59619424|NCT00630786|75730667|FG000|STARTED|Overall Study|Includes 2 patients enrolled in Part 1 and 17 patients enrolled in Part 2.|19||
59619425|NCT00630786|75730668|FG001|STARTED|Overall Study|Includes 3 patients enrolled in Part 1 and 22 patients enrolled in Part 2.|25||
59619426|NCT00630786|75730669|FG002|STARTED|Overall Study|All patients were enrolled in Part 2.|9||
59619427|NCT00630786|75730667|FG000|Received Study Medication|Overall Study||19||
59619428|NCT00630786|75730668|FG001|Received Study Medication|Overall Study||25||
59619429|NCT00630786|75730669|FG002|Received Study Medication|Overall Study||8||
59619430|NCT00630786|75730667|FG000|COMPLETED|Overall Study|Completed study defined as participant death|18||
59619431|NCT00630786|75730668|FG001|COMPLETED|Overall Study|Completed study defined as participant death|23||
59619432|NCT00630786|75730669|FG002|COMPLETED|Overall Study|Completed study defined as participant death|7||
59619433|NCT00630786|75730667|FG000|NOT COMPLETED|Overall Study||1||
59619434|NCT00630786|75730668|FG001|NOT COMPLETED|Overall Study||2||
59619435|NCT00630786|75730669|FG002|NOT COMPLETED|Overall Study||2||
59619436|NCT00630396|75730675|FG000|STARTED|Overall Study||60||
59619437|NCT00630396|75730675|FG000|COMPLETED|Overall Study||53||
59619438|NCT00630396|75730675|FG000|NOT COMPLETED|Overall Study||7||
59619439|NCT00985686|75730683|FG000|STARTED|Overall Study||18||
59619440|NCT00985686|75730684|FG001|STARTED|Overall Study||16||
59619441|NCT00985686|75730685|FG002|STARTED|Overall Study||13||
59619442|NCT00985686|75730686|FG003|STARTED|Overall Study||16||
59619443|NCT00985686|75730683|FG000|Visit 1: Baseline Data Collection|Overall Study||18||
59619444|NCT00985686|75730684|FG001|Visit 1: Baseline Data Collection|Overall Study||15||
59619445|NCT00985686|75730685|FG002|Visit 1: Baseline Data Collection|Overall Study||13||
59619446|NCT00985686|75730686|FG003|Visit 1: Baseline Data Collection|Overall Study||16||
59619447|NCT00985686|75730683|FG000|Visit 2: Data Collection at 8 Weeks|Overall Study||18||
59619448|NCT00985686|75730684|FG001|Visit 2: Data Collection at 8 Weeks|Overall Study||15||
59785000|NCT00582738|75904951|FG001|NOT COMPLETED|Overall Study||18||
59785001|NCT00772889|75904966|FG000|STARTED|Overall Study||375||
59785002|NCT00772889|75904967|FG001|STARTED|Overall Study||393||
59785003|NCT00772889|75904968|FG002|STARTED|Overall Study||203||
59785004|NCT00772889|75904966|FG000|Completed at Day 21|Overall Study||374||
59785005|NCT00772889|75904967|FG001|Completed at Day 21|Overall Study||390||
59785006|NCT00772889|75904968|FG002|Completed at Day 21|Overall Study||203||
59785007|NCT00772889|75904966|FG000|COMPLETED|Overall Study||353||
59785008|NCT00772889|75904967|FG001|COMPLETED|Overall Study||375||
59785009|NCT00772889|75904968|FG002|COMPLETED|Overall Study||187||
59785010|NCT00772889|75904966|FG000|NOT COMPLETED|Overall Study||22||
59785011|NCT00772889|75904967|FG001|NOT COMPLETED|Overall Study||18||
59785012|NCT00772889|75904968|FG002|NOT COMPLETED|Overall Study||16||
59785013|NCT01247324|75904978|FG000|STARTED|Overall Study||411||
59785014|NCT01247324|75904979|FG001|STARTED|Overall Study||410||
59785015|NCT01247324|75904978|FG000|COMPLETED|Overall Study||340||
59785016|NCT01247324|75904979|FG001|COMPLETED|Overall Study||366||
59785017|NCT01247324|75904978|FG000|NOT COMPLETED|Overall Study||71||
59785018|NCT01247324|75904979|FG001|NOT COMPLETED|Overall Study||44||
59785019|NCT00772577|75904988|FG000|STARTED|Overall Study||193||
59785020|NCT00772577|75904989|FG001|STARTED|Overall Study||193||
59785021|NCT00772577|75904988|FG000|COMPLETED|Overall Study||170||
59785022|NCT00772577|75904989|FG001|COMPLETED|Overall Study||170||
59785023|NCT00772577|75904988|FG000|NOT COMPLETED|Overall Study||23||
59785024|NCT00772577|75904989|FG001|NOT COMPLETED|Overall Study||23||
59785025|NCT02345850|75904998|FG000|STARTED|Overall Study||114||
59785026|NCT02345850|75904999|FG001|STARTED|Overall Study||114||
59785027|NCT02345850|75905000|FG002|STARTED|Overall Study||118||
59785028|NCT02345850|75904998|FG000|COMPLETED|Overall Study||101||
59785029|NCT02345850|75904999|FG001|COMPLETED|Overall Study||106||
59785030|NCT02345850|75905000|FG002|COMPLETED|Overall Study||112||
59785031|NCT02345850|75904998|FG000|NOT COMPLETED|Overall Study||13||
59785032|NCT02345850|75904999|FG001|NOT COMPLETED|Overall Study||8||
59785033|NCT02345850|75905000|FG002|NOT COMPLETED|Overall Study||6||
59785034|NCT00659607|75905008|FG000|STARTED|Overall Study||3932||
59785035|NCT00659607|75905008|FG000|COMPLETED|Overall Study||3616||
59785036|NCT00659607|75905008|FG000|NOT COMPLETED|Overall Study||316||
59785037|NCT02848092|75905016|FG000|STARTED|1-month Post-training Follow-up||76||
59785038|NCT02848092|75905017|FG001|STARTED|1-month Post-training Follow-up||76||
59785039|NCT02848092|75905016|FG000|COMPLETED|1-month Post-training Follow-up||64||
59785040|NCT02848092|75905017|FG001|COMPLETED|1-month Post-training Follow-up||71||
59785041|NCT02848092|75905016|FG000|NOT COMPLETED|1-month Post-training Follow-up||12||
59785042|NCT02848092|75905017|FG001|NOT COMPLETED|1-month Post-training Follow-up||5||
59785043|NCT02848092|75905016|FG000|STARTED|6-month Post-training Follow-up||76|All randomized participants, irrespective of whether they completed the 1-month post-training follow-up, were recruited to complete the 6-month post-training follow-up.|
59785044|NCT02848092|75905017|FG001|STARTED|6-month Post-training Follow-up||76|All randomized participants, irrespective of whether they completed the 1-month post-training follow-up, were recruited to complete the 6-month post-training follow-up.|
59785045|NCT02848092|75905016|FG000|COMPLETED|6-month Post-training Follow-up||63||
59785046|NCT02848092|75905017|FG001|COMPLETED|6-month Post-training Follow-up||72||
59785047|NCT02848092|75905016|FG000|NOT COMPLETED|6-month Post-training Follow-up||13||
59785048|NCT02848092|75905017|FG001|NOT COMPLETED|6-month Post-training Follow-up||4||
59785049|NCT02848092|75905016|FG000|STARTED|12-month Naturalistic Driving||76|Note that this assessment point reflects 12-months of naturalistic driving beginning at the end of training and ending 1-year post-training.|
59785050|NCT02848092|75905017|FG001|STARTED|12-month Naturalistic Driving||76|Note that this assessment point reflects 12-months of naturalistic driving beginning at the end of training and ending 1-year post-training.|
59785051|NCT02848092|75905016|FG000|COMPLETED|12-month Naturalistic Driving||73||
59785052|NCT02848092|75905017|FG001|COMPLETED|12-month Naturalistic Driving||74||
59785053|NCT02848092|75905016|FG000|NOT COMPLETED|12-month Naturalistic Driving||3||
59785054|NCT02848092|75905017|FG001|NOT COMPLETED|12-month Naturalistic Driving||2||
59785055|NCT00660309|75905025|FG000|STARTED|Overall Study|Represents participants who received one dose of Captopril.|23||
59785056|NCT00660309|75905026|FG001|STARTED|Overall Study|Represents participants who received one dose of Captopril.|22||
59785057|NCT00660309|75905025|FG000|Treated With Aliskiren or Irbesartan|Overall Study||22||
59785058|NCT00660309|75905026|FG001|Treated With Aliskiren or Irbesartan|Overall Study||21||
59785059|NCT00660309|75905025|FG000|Pharmacodynamic Analysis Set|Overall Study||22||
59785060|NCT00660309|75905026|FG001|Pharmacodynamic Analysis Set|Overall Study||20||
59785061|NCT00660309|75905025|FG000|COMPLETED|Overall Study||21||
59785062|NCT00660309|75905026|FG001|COMPLETED|Overall Study||19||
59785063|NCT00660309|75905025|FG000|NOT COMPLETED|Overall Study||2||
59785064|NCT00660309|75905026|FG001|NOT COMPLETED|Overall Study||3||
59785065|NCT00581100|75905035|FG000|STARTED|Overall Study||38||
59785066|NCT00581100|75905036|FG001|STARTED|Overall Study||34||
59785067|NCT00581100|75905035|FG000|Modified Intent-To-Treat Population|Overall Study|At least one dose of study medication, and had baseline and post-baseline data.|36||
59785068|NCT00581100|75905036|FG001|Modified Intent-To-Treat Population|Overall Study|At least one dose of study medication, and had baseline and post-baseline data.|33||
59785069|NCT00581100|75905035|FG000|COMPLETED|Overall Study||31||
59785070|NCT00581100|75905036|FG001|COMPLETED|Overall Study||29||
59785071|NCT00581100|75905035|FG000|NOT COMPLETED|Overall Study||7||
59785072|NCT00581100|75905036|FG001|NOT COMPLETED|Overall Study||5||
59785073|NCT00579098|75905044|FG000|STARTED|Overall Study||62||
59785074|NCT00579098|75905045|FG001|STARTED|Overall Study||63||
59785075|NCT00579098|75905044|FG000|COMPLETED|Overall Study||53||
59785076|NCT00579098|75905045|FG001|COMPLETED|Overall Study||55||
59785077|NCT00579098|75905044|FG000|NOT COMPLETED|Overall Study||9||
59785078|NCT00579098|75905045|FG001|NOT COMPLETED|Overall Study||8||
59785079|NCT00772109|75905055|FG000|STARTED|Overall Study||956||
59785080|NCT00772109|75905056|FG001|STARTED|Overall Study||953||
59785081|NCT00772109|75905057|FG002|STARTED|Overall Study||955||
59785082|NCT00772109|75905058|FG003|STARTED|Overall Study||1428||
59785083|NCT00772109|75905055|FG000|COMPLETED|Overall Study||935||
59785084|NCT00772109|75905056|FG001|COMPLETED|Overall Study||934||
59785085|NCT00772109|75905057|FG002|COMPLETED|Overall Study||936||
59785086|NCT00772109|75905058|FG003|COMPLETED|Overall Study||1397||
59785087|NCT00772109|75905055|FG000|NOT COMPLETED|Overall Study||21||
59785088|NCT00772109|75905056|FG001|NOT COMPLETED|Overall Study||19||
59785089|NCT00772109|75905057|FG002|NOT COMPLETED|Overall Study||19||
59785090|NCT00772109|75905058|FG003|NOT COMPLETED|Overall Study||31||
59785091|NCT00772031|75905070|FG000|STARTED|Overall Study||96||
59785092|NCT00772031|75905071|FG001|STARTED|Overall Study||95||
59785093|NCT00772031|75905070|FG000|COMPLETED|Overall Study||64||
59785094|NCT00772031|75905071|FG001|COMPLETED|Overall Study||52||
59785095|NCT00772031|75905070|FG000|NOT COMPLETED|Overall Study||32||
59785096|NCT00772031|75905071|FG001|NOT COMPLETED|Overall Study||43||
59785097|NCT00580866|75905085|FG000|STARTED|Overall Study||10||
59785098|NCT00580866|75905086|FG001|STARTED|Overall Study||7||
59785099|NCT00580866|75905085|FG000|COMPLETED|Overall Study||8||
59785100|NCT00580866|75905086|FG001|COMPLETED|Overall Study||5||
59785101|NCT00580866|75905085|FG000|NOT COMPLETED|Overall Study||2||
59785102|NCT00580866|75905086|FG001|NOT COMPLETED|Overall Study||2||
59785103|NCT00771953|75905094|FG000|STARTED|Overall Study||36||
59785104|NCT00771953|75905095|FG001|STARTED|Overall Study||36||
59785105|NCT00771953|75905094|FG000|COMPLETED|Overall Study||26||
59785106|NCT00771953|75905095|FG001|COMPLETED|Overall Study||26||
59785107|NCT00771953|75905094|FG000|NOT COMPLETED|Overall Study||10||
59785108|NCT00771953|75905095|FG001|NOT COMPLETED|Overall Study||10||
59785109|NCT00621244|75905107|FG000|STARTED|Overall Study||86||
59785110|NCT00621244|75905108|FG001|STARTED|Overall Study||34||
59785111|NCT00621244|75905109|FG002|STARTED|Overall Study||33||
59785112|NCT00621244|75905110|FG003|STARTED|Overall Study||23||
59785113|NCT00621244|75905107|FG000|COMPLETED|Overall Study||0||
59785114|NCT00621244|75905108|FG001|COMPLETED|Overall Study||0||
59785115|NCT00621244|75905109|FG002|COMPLETED|Overall Study||0||
59785116|NCT00621244|75905110|FG003|COMPLETED|Overall Study||0||
59785117|NCT00621244|75905107|FG000|NOT COMPLETED|Overall Study||86||
59785118|NCT00621244|75905108|FG001|NOT COMPLETED|Overall Study||34||
59785119|NCT00621244|75905109|FG002|NOT COMPLETED|Overall Study||33||
59785120|NCT00621244|75905110|FG003|NOT COMPLETED|Overall Study||23||
59785121|NCT00659529|75905184|FG000|STARTED|Overall Study|There were 9 screen failures (subjects who did not meet inclusion/exclusion criteria)|36||
59785122|NCT00659529|75905184|FG000|Received at Least One Dose of Study Drug|Overall Study|Received at least one dose of study drug|27||
59785123|NCT00659529|75905184|FG000|COMPLETED|Overall Study|4 patients withdrew as a result of side effects. 3 subjects were withdrawn by the investigator.|20||
59785124|NCT00659529|75905184|FG000|NOT COMPLETED|Overall Study||16||
59785125|NCT00578942|75905188|FG000|STARTED|Overall Study||48||
59785126|NCT00578942|75905188|FG000|COMPLETED|Overall Study||47||
59785127|NCT00578942|75905188|FG000|NOT COMPLETED|Overall Study||1||
59785128|NCT00765245|75905194|FG000|STARTED|Overall Study||22||
59785129|NCT00765245|75905195|FG001|STARTED|Overall Study||22||
59785130|NCT00765245|75905194|FG000|COMPLETED|Overall Study||9||
59785131|NCT00765245|75905195|FG001|COMPLETED|Overall Study||20||
59785132|NCT00765245|75905194|FG000|NOT COMPLETED|Overall Study||13||
59785133|NCT00765245|75905195|FG001|NOT COMPLETED|Overall Study||2||
59785134|NCT00782795|75905203|FG000|STARTED|Overall Study||17||
59785135|NCT00782795|75905204|FG001|STARTED|Overall Study||8||
59785136|NCT00782795|75905203|FG000|6 Weeks (1st Apptment)|Overall Study||16||
59785137|NCT00782795|75905204|FG001|6 Weeks (1st Apptment)|Overall Study||7||
59785138|NCT00782795|75905203|FG000|24 Week Appointment|Overall Study||16||
59785139|NCT00782795|75905204|FG001|24 Week Appointment|Overall Study||7||
59785140|NCT00782795|75905203|FG000|COMPLETED|Overall Study||16||
59785141|NCT00782795|75905204|FG001|COMPLETED|Overall Study||6||
59785142|NCT00782795|75905203|FG000|NOT COMPLETED|Overall Study||1||
59785143|NCT00782795|75905204|FG001|NOT COMPLETED|Overall Study||2||
59785144|NCT00656799|75905210|FG000|STARTED|Overall Study||6||
59785145|NCT00656799|75905210|FG000|COMPLETED|Overall Study||4||
59785146|NCT00656799|75905210|FG000|NOT COMPLETED|Overall Study||2||
59785147|NCT00764699|75905214|FG000|STARTED|Overall Study||3||
59785148|NCT00764699|75905214|FG000|COMPLETED|Overall Study||0||
59785149|NCT00764699|75905214|FG000|NOT COMPLETED|Overall Study||3||
59785150|NCT00782717|75905220|FG000|STARTED|Overall Study||133||
59785151|NCT00782717|75905221|FG001|STARTED|Overall Study||130||
59785152|NCT00782717|75905220|FG000|COMPLETED|Overall Study||118||
59785153|NCT00782717|75905221|FG001|COMPLETED|Overall Study||102||
59785154|NCT00782717|75905220|FG000|NOT COMPLETED|Overall Study||15||
59785155|NCT00782717|75905221|FG001|NOT COMPLETED|Overall Study||28||
59785156|NCT00656175|75905229|FG000|STARTED|Overall Study||18||
59785157|NCT00656175|75905230|FG001|STARTED|Overall Study||21||
59785158|NCT00656175|75905229|FG000|COMPLETED|Overall Study||17||
59785159|NCT00656175|75905230|FG001|COMPLETED|Overall Study||20||
59785160|NCT00656175|75905229|FG000|NOT COMPLETED|Overall Study||1||
59785161|NCT00656175|75905230|FG001|NOT COMPLETED|Overall Study||1||
59785162|NCT00620776|75905238|FG000|STARTED|Overall Study|29 patients (of the 77 that were randomly assigned to add on CBT) consented to this option.|29||
59785163|NCT00620776|75905239|FG001|STARTED|Overall Study|All 40 patients that were randomly assigned to not be offered CBT consented to this option.|40||
59785164|NCT00620776|75905238|FG000|Received at Least One Session/Dose|Overall Study|26 out of 29 that consented to the combined treatment option received at least one session of CBT.|26||
59785165|NCT00620776|75905239|FG001|Received at Least One Session/Dose|Overall Study|35 out of 40 that consented to receive medication alone received at least one dose of medication.|35||
59785166|NCT00620776|75905238|FG000|COMPLETED|Overall Study|17 out of 26 attended the week 24 (last) assessment.|17||
59785167|NCT00620776|75905239|FG001|COMPLETED|Overall Study|24 out of 35 attended the week 24 (last) assessment.|24||
59522646|NCT02936206|75617114|FG001|COMPLETED|Overall Study||2||
59785168|NCT00620776|75905238|FG000|NOT COMPLETED|Overall Study||12||
59785169|NCT00620776|75905239|FG001|NOT COMPLETED|Overall Study||16||
59785170|NCT00656019|75905249|FG000|STARTED|Overall Study||29||
59785171|NCT00656019|75905250|FG001|STARTED|Overall Study||19||
59785172|NCT00656019|75905251|FG002|STARTED|Overall Study||11||
59785173|NCT00656019|75905252|FG003|STARTED|Overall Study||4||
59785174|NCT00656019|75905249|FG000|COMPLETED|Overall Study||15||
59785175|NCT00656019|75905250|FG001|COMPLETED|Overall Study||18||
59785176|NCT00656019|75905251|FG002|COMPLETED|Overall Study||11||
59785177|NCT00656019|75905252|FG003|COMPLETED|Overall Study||4||
59785178|NCT00656019|75905249|FG000|NOT COMPLETED|Overall Study||14||
59785179|NCT00656019|75905250|FG001|NOT COMPLETED|Overall Study||1||
59785180|NCT00656019|75905251|FG002|NOT COMPLETED|Overall Study||0||
59785181|NCT00656019|75905252|FG003|NOT COMPLETED|Overall Study||0||
59785182|NCT00782483|75905262|FG000|STARTED|Overall Study|6 subjects enrolled beginning on 04/27/2009 with last enrollment on 04/13/2010.|6||
59785183|NCT00782483|75905262|FG000|COMPLETED|Overall Study||0||
59785184|NCT00782483|75905262|FG000|NOT COMPLETED|Overall Study||6||
59785185|NCT00782171|75905268|FG000|STARTED|Overall Study||146||
59785186|NCT00782171|75905269|FG001|STARTED|Overall Study||134||
59785187|NCT00782171|75905268|FG000|20-23 Weeks|Overall Study||135||
59785188|NCT00782171|75905269|FG001|20-23 Weeks|Overall Study||124||
59785189|NCT00782171|75905268|FG000|1 Year|Overall Study||131||
59785190|NCT00782171|75905269|FG001|1 Year|Overall Study||120||
59785191|NCT00782171|75905268|FG000|Surgery (Baseline)|Overall Study||138|Includes patients who fulfilled all eligibility criteria and received a study implant|
59785192|NCT00782171|75905269|FG001|Surgery (Baseline)|Overall Study||128|Includes patients who fulfilled all eligibility criteria and received a study implant|
59785193|NCT00782171|75905268|FG000|COMPLETED|Overall Study||124||
59785194|NCT00782171|75905269|FG001|COMPLETED|Overall Study||115||
59785195|NCT00782171|75905268|FG000|NOT COMPLETED|Overall Study||22||
59785196|NCT00782171|75905269|FG001|NOT COMPLETED|Overall Study||19||
59785197|NCT00764465|75905281|FG000|STARTED|Overall Study||9||
59785198|NCT00764465|75905282|FG001|STARTED|Overall Study||7||
60073090|NCT01694433|76188303|FG000|Baseline Visit|Overall Study||33||
60073091|NCT01694433|76188304|FG001|Baseline Visit|Overall Study||32||
59785199|NCT00764465|75905283|FG002|STARTED|Overall Study||7||
59785200|NCT00764465|75905284|FG003|STARTED|Overall Study||7||
59785201|NCT00764465|75905285|FG004|STARTED|Overall Study||7||
59785202|NCT00764465|75905286|FG005|STARTED|Overall Study||8||
59953077|NCT04057820|76071782|FG002|STARTED|Period 3|Block 2 with 2 sites transitioned from Usual Care to ESC during Period 3; therefore no infants were being enrolled and the total number of sites enrolling infants was 24..|0||0
59953078|NCT04057820|76071783|FG003|STARTED|Period 3||0||0
59953079|NCT04057820|76071784|FG004|STARTED|Period 3||7||3
59953080|NCT04057820|76071785|FG005|STARTED|Period 3||0||0
59953081|NCT04057820|76071786|FG006|STARTED|Period 3||19||3
60073092|NCT01694433|76188303|FG000|COMPLETED|Overall Study||22||
60073093|NCT01694433|76188304|FG001|COMPLETED|Overall Study||29||
59785203|NCT00764465|75905281|FG000|COMPLETED|Overall Study||7||
59785204|NCT00764465|75905282|FG001|COMPLETED|Overall Study||6||
59785205|NCT00764465|75905283|FG002|COMPLETED|Overall Study||6||
59785206|NCT00764465|75905284|FG003|COMPLETED|Overall Study||6||
59785207|NCT00764465|75905285|FG004|COMPLETED|Overall Study||6||
59785208|NCT00764465|75905286|FG005|COMPLETED|Overall Study||7||
59785209|NCT00764465|75905281|FG000|NOT COMPLETED|Overall Study||2||
59953082|NCT04057820|76071787|FG007|STARTED|Period 3||0||0
60073094|NCT01694433|76188303|FG000|NOT COMPLETED|Overall Study||11||
59785210|NCT00764465|75905282|FG001|NOT COMPLETED|Overall Study||1||
59785211|NCT00764465|75905283|FG002|NOT COMPLETED|Overall Study||1||
59785212|NCT00764465|75905284|FG003|NOT COMPLETED|Overall Study||1||
59785213|NCT00764465|75905285|FG004|NOT COMPLETED|Overall Study||1||
59953083|NCT04057820|76071788|FG008|STARTED|Period 3||32||4
59953084|NCT04057820|76071789|FG009|STARTED|Period 3||0||0
59785214|NCT00764465|75905286|FG005|NOT COMPLETED|Overall Study||1||
59785215|NCT00655863|75905306|FG000|STARTED|Overall Study||24||
59785216|NCT00655863|75905307|FG001|STARTED|Overall Study||25||
59785217|NCT00655863|75905308|FG002|STARTED|Overall Study||22||
59785218|NCT00655863|75905306|FG000|COMPLETED|Overall Study||24||
59785219|NCT00655863|75905307|FG001|COMPLETED|Overall Study||25||
59785220|NCT00655863|75905308|FG002|COMPLETED|Overall Study||21||
59785221|NCT00655863|75905306|FG000|NOT COMPLETED|Overall Study||0||
59785222|NCT00655863|75905307|FG001|NOT COMPLETED|Overall Study||0||
59785223|NCT00655863|75905308|FG002|NOT COMPLETED|Overall Study||1||
59785224|NCT00781937|75905318|FG000|STARTED|Main Trial Period Through Week 56||212||
59785225|NCT00781937|75905319|FG001|STARTED|Main Trial Period Through Week 56||210||
59785226|NCT00781937|75905318|FG000|COMPLETED|Main Trial Period Through Week 56||159||
59785227|NCT00781937|75905319|FG001|COMPLETED|Main Trial Period Through Week 56||146||
59785228|NCT00781937|75905318|FG000|NOT COMPLETED|Main Trial Period Through Week 56||53||
59785229|NCT00781937|75905319|FG001|NOT COMPLETED|Main Trial Period Through Week 56||64||
59785230|NCT00781937|75905318|FG000|STARTED|Follow up Period (Week 56-68)||159||
59785231|NCT00781937|75905319|FG001|STARTED|Follow up Period (Week 56-68)||146||
59785232|NCT00781937|75905318|FG000|COMPLETED|Follow up Period (Week 56-68)||153||
59785233|NCT00781937|75905319|FG001|COMPLETED|Follow up Period (Week 56-68)||141||
59785234|NCT00781937|75905318|FG000|NOT COMPLETED|Follow up Period (Week 56-68)||6||
59785235|NCT00781937|75905319|FG001|NOT COMPLETED|Follow up Period (Week 56-68)||5||
59785236|NCT00659373|75905327|FG000|STARTED|Overall Study||25||
59785237|NCT00659373|75905328|FG001|STARTED|Overall Study||61||
59785238|NCT00659373|75905327|FG000|COMPLETED|Overall Study||20||
59785239|NCT00659373|75905328|FG001|COMPLETED|Overall Study||54||
59785240|NCT00659373|75905327|FG000|NOT COMPLETED|Overall Study||5||
59785241|NCT00659373|75905328|FG001|NOT COMPLETED|Overall Study||7||
59785242|NCT00439777|75905336|FG000|STARTED|Treatment Period||2420||
59785243|NCT00439777|75905337|FG001|STARTED|Treatment Period||2413||
59785244|NCT00439777|75905336|FG000|Participants Received Treatment|Treatment Period||2412||
59785245|NCT00439777|75905337|FG001|Participants Received Treatment|Treatment Period||2405||
59785246|NCT00439777|75905336|FG000|COMPLETED|Treatment Period||2001||
59785247|NCT00439777|75905337|FG001|COMPLETED|Treatment Period||1954||
59785248|NCT00439777|75905336|FG000|NOT COMPLETED|Treatment Period||419||
59785249|NCT00439777|75905337|FG001|NOT COMPLETED|Treatment Period||459||
59785250|NCT00439777|75905336|FG000|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|2206||
59785251|NCT00439777|75905337|FG001|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|2197||
59785252|NCT00439777|75905336|FG000|COMPLETED|Observational Period||2165||
59785253|NCT00439777|75905337|FG001|COMPLETED|Observational Period||2156||
59785254|NCT00439777|75905336|FG000|NOT COMPLETED|Observational Period||41||
59785255|NCT00439777|75905337|FG001|NOT COMPLETED|Observational Period||41||
59785256|NCT00620854|75905349|FG000|STARTED|Period 1||4||
59785257|NCT00620854|75905350|FG001|STARTED|Period 1||4||
59785258|NCT00620854|75905351|FG002|STARTED|Period 1||4||
59785259|NCT00620854|75905352|FG003|STARTED|Period 1||4||
59785260|NCT00620854|75905353|FG004|STARTED|Period 1||4||
59785261|NCT00620854|75905354|FG005|STARTED|Period 1||4||
59785262|NCT00620854|75905349|FG000|COMPLETED|Period 1||4||
59785263|NCT00620854|75905350|FG001|COMPLETED|Period 1||4||
59785264|NCT00620854|75905351|FG002|COMPLETED|Period 1||4||
59785265|NCT00620854|75905352|FG003|COMPLETED|Period 1||4||
59785266|NCT00620854|75905353|FG004|COMPLETED|Period 1||4||
59785267|NCT00620854|75905354|FG005|COMPLETED|Period 1||4||
59785268|NCT00620854|75905349|FG000|NOT COMPLETED|Period 1||0||
59785269|NCT00620854|75905350|FG001|NOT COMPLETED|Period 1||0||
59785270|NCT00620854|75905351|FG002|NOT COMPLETED|Period 1||0||
59785271|NCT00620854|75905352|FG003|NOT COMPLETED|Period 1||0||
59785272|NCT00620854|75905353|FG004|NOT COMPLETED|Period 1||0||
59785273|NCT00620854|75905354|FG005|NOT COMPLETED|Period 1||0||
59785274|NCT00620854|75905349|FG000|STARTED|Washout 1||4||
59785275|NCT00620854|75905350|FG001|STARTED|Washout 1||4||
59785276|NCT00620854|75905351|FG002|STARTED|Washout 1||4||
59785277|NCT00620854|75905352|FG003|STARTED|Washout 1||4||
59785278|NCT00620854|75905353|FG004|STARTED|Washout 1||4||
59785279|NCT00620854|75905354|FG005|STARTED|Washout 1||4||
59785280|NCT00620854|75905349|FG000|COMPLETED|Washout 1||4||
59785281|NCT00620854|75905350|FG001|COMPLETED|Washout 1||4||
59785282|NCT00620854|75905351|FG002|COMPLETED|Washout 1||3||
59785283|NCT00620854|75905352|FG003|COMPLETED|Washout 1||3||
59785284|NCT00620854|75905353|FG004|COMPLETED|Washout 1||4||
59785285|NCT00620854|75905354|FG005|COMPLETED|Washout 1||4||
59785286|NCT00620854|75905349|FG000|NOT COMPLETED|Washout 1||0||
59785287|NCT00620854|75905350|FG001|NOT COMPLETED|Washout 1||0||
59785288|NCT00620854|75905351|FG002|NOT COMPLETED|Washout 1||1||
59785289|NCT00620854|75905352|FG003|NOT COMPLETED|Washout 1||1||
59785290|NCT00620854|75905353|FG004|NOT COMPLETED|Washout 1||0||
59785291|NCT00620854|75905354|FG005|NOT COMPLETED|Washout 1||0||
59785292|NCT00620854|75905349|FG000|STARTED|Period 2||4||
59785293|NCT00620854|75905350|FG001|STARTED|Period 2||4||
59785294|NCT00620854|75905351|FG002|STARTED|Period 2||3||
59785295|NCT00620854|75905352|FG003|STARTED|Period 2||3||
59785296|NCT00620854|75905353|FG004|STARTED|Period 2||4||
59785297|NCT00620854|75905354|FG005|STARTED|Period 2||4||
59785298|NCT00620854|75905349|FG000|COMPLETED|Period 2||4||
59785299|NCT00620854|75905350|FG001|COMPLETED|Period 2||4||
59785300|NCT00620854|75905351|FG002|COMPLETED|Period 2||3||
59785301|NCT00620854|75905352|FG003|COMPLETED|Period 2||3||
59785302|NCT00620854|75905353|FG004|COMPLETED|Period 2||4||
59785303|NCT00620854|75905354|FG005|COMPLETED|Period 2||4||
59785304|NCT00620854|75905349|FG000|NOT COMPLETED|Period 2||0||
59785305|NCT00620854|75905350|FG001|NOT COMPLETED|Period 2||0||
59785306|NCT00620854|75905351|FG002|NOT COMPLETED|Period 2||0||
59785307|NCT00620854|75905352|FG003|NOT COMPLETED|Period 2||0||
59619449|NCT00985686|75730685|FG002|Visit 2: Data Collection at 8 Weeks|Overall Study||13||
59619450|NCT00985686|75730686|FG003|Visit 2: Data Collection at 8 Weeks|Overall Study||16||
59619451|NCT00985686|75730683|FG000|Visit 3: Data Collection at 16 Weeks|Overall Study||17||
59619452|NCT00985686|75730684|FG001|Visit 3: Data Collection at 16 Weeks|Overall Study||15||
59619453|NCT00985686|75730685|FG002|Visit 3: Data Collection at 16 Weeks|Overall Study||13||
59785308|NCT00620854|75905353|FG004|NOT COMPLETED|Period 2||0||
59785309|NCT00620854|75905354|FG005|NOT COMPLETED|Period 2||0||
59785310|NCT00620854|75905349|FG000|STARTED|Washout 2||4||
59785311|NCT00620854|75905350|FG001|STARTED|Washout 2||4||
59785312|NCT00620854|75905351|FG002|STARTED|Washout 2||3||
59785313|NCT00620854|75905352|FG003|STARTED|Washout 2||3||
59785314|NCT00620854|75905353|FG004|STARTED|Washout 2||4||
59785315|NCT00620854|75905354|FG005|STARTED|Washout 2||4||
59785316|NCT00620854|75905349|FG000|COMPLETED|Washout 2||4||
59785317|NCT00620854|75905350|FG001|COMPLETED|Washout 2||4||
59785318|NCT00620854|75905351|FG002|COMPLETED|Washout 2||3||
59785319|NCT00620854|75905352|FG003|COMPLETED|Washout 2||3||
59785320|NCT00620854|75905353|FG004|COMPLETED|Washout 2||4||
59785321|NCT00620854|75905354|FG005|COMPLETED|Washout 2||4||
59785322|NCT00620854|75905349|FG000|NOT COMPLETED|Washout 2||0||
59785323|NCT00620854|75905350|FG001|NOT COMPLETED|Washout 2||0||
59785324|NCT00620854|75905351|FG002|NOT COMPLETED|Washout 2||0||
59785325|NCT00620854|75905352|FG003|NOT COMPLETED|Washout 2||0||
59785326|NCT00620854|75905353|FG004|NOT COMPLETED|Washout 2||0||
59785327|NCT00620854|75905354|FG005|NOT COMPLETED|Washout 2||0||
59785328|NCT00620854|75905349|FG000|STARTED|Period 3||4||
59785329|NCT00620854|75905350|FG001|STARTED|Period 3||4||
59785330|NCT00620854|75905351|FG002|STARTED|Period 3||3||
59785331|NCT00620854|75905352|FG003|STARTED|Period 3||3||
59785332|NCT00620854|75905353|FG004|STARTED|Period 3||4||
59785333|NCT00620854|75905354|FG005|STARTED|Period 3||4||
59785334|NCT00620854|75905349|FG000|COMPLETED|Period 3||4||
59619454|NCT00985686|75730686|FG003|Visit 3: Data Collection at 16 Weeks|Overall Study||16||
59619455|NCT00985686|75730683|FG000|Visit 4: Data Collection at 24 Weeks|Overall Study||17||
59619456|NCT00985686|75730684|FG001|Visit 4: Data Collection at 24 Weeks|Overall Study||15||
59619457|NCT00985686|75730685|FG002|Visit 4: Data Collection at 24 Weeks|Overall Study||13||
59619458|NCT00985686|75730686|FG003|Visit 4: Data Collection at 24 Weeks|Overall Study||14||
59619459|NCT00985686|75730683|FG000|COMPLETED|Overall Study||17||
59619460|NCT00985686|75730684|FG001|COMPLETED|Overall Study||15||
59619461|NCT00985686|75730685|FG002|COMPLETED|Overall Study||13||
59619462|NCT00985686|75730686|FG003|COMPLETED|Overall Study||14||
59619463|NCT00985686|75730683|FG000|NOT COMPLETED|Overall Study||1||
59619464|NCT00985686|75730684|FG001|NOT COMPLETED|Overall Study||1||
59619465|NCT00985686|75730685|FG002|NOT COMPLETED|Overall Study||0||
59619466|NCT00985686|75730686|FG003|NOT COMPLETED|Overall Study||2||
59619467|NCT03098394|75730696|FG000|STARTED|Overall Study||30||
59619468|NCT03098394|75730697|FG001|STARTED|Overall Study||34||
59619469|NCT03098394|75730696|FG000|COMPLETED|Overall Study||30||
59619470|NCT03098394|75730697|FG001|COMPLETED|Overall Study||33||
59619471|NCT03098394|75730696|FG000|NOT COMPLETED|Overall Study||0||
59785335|NCT00620854|75905350|FG001|COMPLETED|Period 3||4||
59785336|NCT00620854|75905351|FG002|COMPLETED|Period 3||3||
59785337|NCT00620854|75905352|FG003|COMPLETED|Period 3||3||
59785338|NCT00620854|75905353|FG004|COMPLETED|Period 3||4||
59785339|NCT00620854|75905354|FG005|COMPLETED|Period 3||4||
59785340|NCT00620854|75905349|FG000|NOT COMPLETED|Period 3||0||
59785341|NCT00620854|75905350|FG001|NOT COMPLETED|Period 3||0||
59785342|NCT00620854|75905351|FG002|NOT COMPLETED|Period 3||0||
59785343|NCT00620854|75905352|FG003|NOT COMPLETED|Period 3||0||
59785344|NCT00620854|75905353|FG004|NOT COMPLETED|Period 3||0||
59785345|NCT00620854|75905354|FG005|NOT COMPLETED|Period 3||0||
59785346|NCT00430027|75905365|FG000|STARTED|Overall Study||8||
59785347|NCT00430027|75905365|FG000|COMPLETED|Overall Study||0||
59785348|NCT00430027|75905365|FG000|NOT COMPLETED|Overall Study||8||
59785349|NCT00429793|75905369|FG000|STARTED|Overall Study||60||
59619472|NCT03098394|75730697|FG001|NOT COMPLETED|Overall Study||1||
59785350|NCT00429793|75905369|FG000|COMPLETED|Overall Study||54||
59785351|NCT00429793|75905369|FG000|NOT COMPLETED|Overall Study||6||
59785352|NCT00424645|75905380|FG000|STARTED|Overall Study||3||
59785353|NCT00424645|75905381|FG001|STARTED|Overall Study||0||
59785354|NCT00424645|75905380|FG000|COMPLETED|Overall Study||2||
59785355|NCT00424645|75905381|FG001|COMPLETED|Overall Study||0||
59785356|NCT00424645|75905380|FG000|NOT COMPLETED|Overall Study||1||
59785357|NCT00424645|75905381|FG001|NOT COMPLETED|Overall Study||0||
59785358|NCT00763451|75905391|FG000|STARTED|Overall Study|Randomized.|80||
59785359|NCT00763451|75905392|FG001|STARTED|Overall Study||82||
59785360|NCT00763451|75905393|FG002|STARTED|Overall Study||161||
59785361|NCT00763451|75905394|FG003|STARTED|Overall Study||161||
59785362|NCT00763451|75905391|FG000|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|79||
59785363|NCT00763451|75905392|FG001|Treated/Safety Population|Overall Study||81||
59785364|NCT00763451|75905393|FG002|Treated/Safety Population|Overall Study||161||
59785365|NCT00763451|75905394|FG003|Treated/Safety Population|Overall Study||161||
59785366|NCT00763451|75905391|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|79||
59785367|NCT00763451|75905392|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||80||
59785368|NCT00763451|75905393|FG002|Modified Intent-to-Treat(mITT)Population|Overall Study||160||
59785369|NCT00763451|75905394|FG003|Modified Intent-to-Treat(mITT)Population|Overall Study||160||
59785370|NCT00763451|75905391|FG000|COMPLETED|Overall Study||67||
59785371|NCT00763451|75905392|FG001|COMPLETED|Overall Study||60||
59785372|NCT00763451|75905393|FG002|COMPLETED|Overall Study||121||
59785373|NCT00763451|75905394|FG003|COMPLETED|Overall Study||131||
59785374|NCT00763451|75905391|FG000|NOT COMPLETED|Overall Study||13||
59785375|NCT00763451|75905392|FG001|NOT COMPLETED|Overall Study||22||
59785376|NCT00763451|75905393|FG002|NOT COMPLETED|Overall Study||40||
59785377|NCT00763451|75905394|FG003|NOT COMPLETED|Overall Study||30||
59785378|NCT00762762|75905407|FG000|STARTED|Overall Study||30||
59785379|NCT00762762|75905408|FG001|STARTED|Overall Study||30||
59785380|NCT00762762|75905407|FG000|COMPLETED|Overall Study||24||
59785381|NCT00762762|75905408|FG001|COMPLETED|Overall Study||22||
59785382|NCT00762762|75905407|FG000|NOT COMPLETED|Overall Study||6||
59785383|NCT00762762|75905408|FG001|NOT COMPLETED|Overall Study||8||
59619473|NCT00984594|75730708|FG000|STARTED|Overall Study||2||
59619474|NCT00984594|75730709|FG001|STARTED|Overall Study|One patient withdrew consent and left the study before treatment.|2||
59619475|NCT00984594|75730708|FG000|COMPLETED|Overall Study||1||
59619476|NCT00984594|75730709|FG001|COMPLETED|Overall Study||1||
59619477|NCT00984594|75730708|FG000|NOT COMPLETED|Overall Study||1||
59619478|NCT00984594|75730709|FG001|NOT COMPLETED|Overall Study||1||
59619479|NCT00984204|75730717|FG000|STARTED|Overall Study||188||
59619480|NCT00984204|75730717|FG000|COMPLETED|Overall Study|"Seven subjects of the ten Lack of efficacy were acute failures that had no block after 30 min"|173||
59619481|NCT00984204|75730717|FG000|NOT COMPLETED|Overall Study||15||
59619482|NCT00983892|75730723|FG000|STARTED|Overall Study||66||
59619483|NCT00983892|75730724|FG001|STARTED|Overall Study||68||
59619484|NCT00983892|75730723|FG000|COMPLETED|Overall Study||56||
59619485|NCT00983892|75730724|FG001|COMPLETED|Overall Study||56||
59619486|NCT00983892|75730723|FG000|NOT COMPLETED|Overall Study||10||
59785384|NCT00424489|75905416|FG000|STARTED|Overall Study||9||
59785385|NCT00424489|75905416|FG000|COMPLETED|Overall Study||6||
59785386|NCT00424489|75905416|FG000|NOT COMPLETED|Overall Study||3||
59785387|NCT00578864|75905422|FG000|STARTED|Overall Study||7||
59785388|NCT00578864|75905423|FG001|STARTED|Overall Study||6||
59785389|NCT00578864|75905422|FG000|COMPLETED|Overall Study|died of complications of surgery after 2 cycles|6||
59785390|NCT00578864|75905423|FG001|COMPLETED|Overall Study||6||
59785391|NCT00578864|75905422|FG000|NOT COMPLETED|Overall Study||1||
59785392|NCT00578864|75905423|FG001|NOT COMPLETED|Overall Study||0||
59785393|NCT00631566|75905432|FG000|STARTED|Overall Study||21||
59785394|NCT00631566|75905433|FG001|STARTED|Overall Study||28||
59785395|NCT00631566|75905434|FG002|STARTED|Overall Study||501||
59785396|NCT00631566|75905432|FG000|COMPLETED|Overall Study||19||
59785397|NCT00631566|75905433|FG001|COMPLETED|Overall Study||24||
59785398|NCT00631566|75905434|FG002|COMPLETED|Overall Study||501||
59785399|NCT00631566|75905432|FG000|NOT COMPLETED|Overall Study||2||
59785400|NCT00631566|75905433|FG001|NOT COMPLETED|Overall Study||4||
59785401|NCT00631566|75905434|FG002|NOT COMPLETED|Overall Study||0||
59785402|NCT00770315|75905446|FG000|STARTED|Overall Study||197||
59785403|NCT00770315|75905447|FG001|STARTED|Overall Study||195||
59785404|NCT00770315|75905448|FG002|STARTED|Overall Study||194||
59785405|NCT00770315|75905449|FG003|STARTED|Overall Study||198||
59785406|NCT00770315|75905446|FG000|COMPLETED|Overall Study||157||
59785407|NCT00770315|75905447|FG001|COMPLETED|Overall Study||152||
59785408|NCT00770315|75905448|FG002|COMPLETED|Overall Study||137||
59785409|NCT00770315|75905449|FG003|COMPLETED|Overall Study||160||
59785410|NCT00770315|75905446|FG000|NOT COMPLETED|Overall Study||40||
59785411|NCT00770315|75905447|FG001|NOT COMPLETED|Overall Study||43||
59785412|NCT00770315|75905448|FG002|NOT COMPLETED|Overall Study||57||
59785413|NCT00770315|75905449|FG003|NOT COMPLETED|Overall Study||38||
59785414|NCT00587171|75905461|FG000|STARTED|Overall Study||9||
59785415|NCT00587171|75905462|FG001|STARTED|Overall Study||10||
59785416|NCT00587171|75905461|FG000|COMPLETED|Overall Study||8||
59785417|NCT00587171|75905462|FG001|COMPLETED|Overall Study||9||
59785418|NCT00587171|75905461|FG000|NOT COMPLETED|Overall Study||1||
59785419|NCT00587171|75905462|FG001|NOT COMPLETED|Overall Study||1||
59785420|NCT00763139|75905468|FG000|STARTED|Overall Study||17||
59785421|NCT00763139|75905469|FG001|STARTED|Overall Study||17||
59785422|NCT00763139|75905468|FG000|COMPLETED|Overall Study||12||
59785423|NCT00763139|75905469|FG001|COMPLETED|Overall Study||14||
59785424|NCT00763139|75905468|FG000|NOT COMPLETED|Overall Study||5||
59785425|NCT00763139|75905469|FG001|NOT COMPLETED|Overall Study||3||
59785426|NCT01366092|75905480|FG000|STARTED|Overall Study||35||
59785427|NCT01366092|75905480|FG000|COMPLETED|Overall Study||31||
59785428|NCT01366092|75905480|FG000|NOT COMPLETED|Overall Study||4||
59785429|NCT00781859|75905486|FG000|STARTED|Overall Study||219||
59785430|NCT00781859|75905487|FG001|STARTED|Overall Study||107||
59785431|NCT00781859|75905486|FG000|COMPLETED|Overall Study||200||
59785432|NCT00781859|75905487|FG001|COMPLETED|Overall Study||98||
59785433|NCT00781859|75905486|FG000|NOT COMPLETED|Overall Study||19||
59785434|NCT00781859|75905487|FG001|NOT COMPLETED|Overall Study||9||
59785435|NCT00580788|75905497|FG000|STARTED|Overall Study||3||
59785436|NCT00580788|75905498|FG001|STARTED|Overall Study||6||
59785437|NCT00580788|75905499|FG002|STARTED|Overall Study||3||
59785438|NCT00580788|75905500|FG003|STARTED|Overall Study||2||
59785439|NCT00580788|75905497|FG000|COMPLETED|Overall Study||3||
59785440|NCT00580788|75905498|FG001|COMPLETED|Overall Study||6||
59785441|NCT00580788|75905499|FG002|COMPLETED|Overall Study||3||
59785442|NCT00580788|75905500|FG003|COMPLETED|Overall Study|One subject was stopped early for hypertension. One subject completed but was not analyzed.|1||
59785443|NCT00580788|75905497|FG000|NOT COMPLETED|Overall Study||0||
59785444|NCT00580788|75905498|FG001|NOT COMPLETED|Overall Study||0||
59785445|NCT00580788|75905499|FG002|NOT COMPLETED|Overall Study||0||
59785446|NCT00580788|75905500|FG003|NOT COMPLETED|Overall Study||1||
59785447|NCT00417079|75905519|FG000|STARTED|Overall Study|Randomized patients|377||
59785448|NCT00417079|75905520|FG001|STARTED|Overall Study|Randomized patients|378||
59785449|NCT00417079|75905519|FG000|COMPLETED|Overall Study|Randomized patients|46||
59785450|NCT00417079|75905520|FG001|COMPLETED|Overall Study|Randomized patients|105||
59953085|NCT04057820|76071790|FG010|STARTED|Period 3||15||4
59953086|NCT04057820|76071791|FG011|STARTED|Period 3||0||0
59785451|NCT00417079|75905519|FG000|NOT COMPLETED|Overall Study||331||
59785452|NCT00417079|75905520|FG001|NOT COMPLETED|Overall Study||273||
59785453|NCT00429169|75905528|FG000|STARTED|Overall Study||38||
59785454|NCT00429169|75905529|FG001|STARTED|Overall Study||40||
59785455|NCT00429169|75905528|FG000|COMPLETED|Overall Study|2 subjects excluded due to re-diagnosis/ineligibility.|36||
59785456|NCT00429169|75905529|FG001|COMPLETED|Overall Study|2 subjects excluded: re-diagnosis/ineligibility (1), and did not return after randomization (1).|38||
59785457|NCT00429169|75905528|FG000|NOT COMPLETED|Overall Study||2||
59785458|NCT00429169|75905529|FG001|NOT COMPLETED|Overall Study||2||
59785459|NCT00416455|75905539|FG000|STARTED|Overall Study|This is a diagnostic imaging study.|169||
59785460|NCT00416455|75905540|FG001|STARTED|Overall Study|This is a diagnostic imaging study.|215||
59785461|NCT00416455|75905539|FG000|COMPLETED|Overall Study|Number of patients with adequate imaging and pathology|153||
59785462|NCT00416455|75905540|FG001|COMPLETED|Overall Study|Number of patients with adequate imaging and pathology|207||
59785463|NCT00416455|75905539|FG000|NOT COMPLETED|Overall Study||16||
59785464|NCT00416455|75905540|FG001|NOT COMPLETED|Overall Study||8||
59785465|NCT00415909|75905557|FG000|STARTED|Overall Study||3||
59785466|NCT00415909|75905557|FG000|COMPLETED|Overall Study||0||
59785467|NCT00415909|75905557|FG000|NOT COMPLETED|Overall Study||3||
59785468|NCT00415597|75905561|FG000|STARTED|Enrollment||467||
59785469|NCT00415597|75905561|FG000|COMPLETED|Enrollment||465||
59785470|NCT00415597|75905561|FG000|NOT COMPLETED|Enrollment||2||
59785471|NCT00415597|75905561|FG000|STARTED|Treatment||465||
59785472|NCT00415597|75905561|FG000|COMPLETED|Treatment||160||
59785473|NCT00415597|75905561|FG000|NOT COMPLETED|Treatment||305||
59785474|NCT00620542|75905567|FG000|STARTED|Part A (Run-in - 2 Weeks)|Of 1167 randomized, N=783 received treatment.|1167||
59785475|NCT00620542|75905568|FG001|STARTED|Part A (Run-in - 2 Weeks)|Of 1166 randomized, N=795 received treatment.|1166||
59785476|NCT00620542|75905569|FG002|STARTED|Part A (Run-in - 2 Weeks)||0||
59785477|NCT00620542|75905570|FG003|STARTED|Part A (Run-in - 2 Weeks)||0||
59785478|NCT00620542|75905567|FG000|Received Treatment|Part A (Run-in - 2 Weeks)||783||
59785479|NCT00620542|75905568|FG001|Received Treatment|Part A (Run-in - 2 Weeks)||795||
59785480|NCT00620542|75905569|FG002|Received Treatment|Part A (Run-in - 2 Weeks)||0||
59785481|NCT00620542|75905570|FG003|Received Treatment|Part A (Run-in - 2 Weeks)||0||
59785482|NCT00620542|75905567|FG000|COMPLETED|Part A (Run-in - 2 Weeks)||695||
59785483|NCT00620542|75905568|FG001|COMPLETED|Part A (Run-in - 2 Weeks)||690||
59785484|NCT00620542|75905569|FG002|COMPLETED|Part A (Run-in - 2 Weeks)||0||
59785485|NCT00620542|75905570|FG003|COMPLETED|Part A (Run-in - 2 Weeks)||0||
59785486|NCT00620542|75905567|FG000|NOT COMPLETED|Part A (Run-in - 2 Weeks)||472||
59785487|NCT00620542|75905568|FG001|NOT COMPLETED|Part A (Run-in - 2 Weeks)||476||
59785488|NCT00620542|75905569|FG002|NOT COMPLETED|Part A (Run-in - 2 Weeks)||0||
59785489|NCT00620542|75905570|FG003|NOT COMPLETED|Part A (Run-in - 2 Weeks)||0||
59785490|NCT00620542|75905567|FG000|STARTED|Part B (2 Year Core Study)||0||
59785491|NCT00620542|75905568|FG001|STARTED|Part B (2 Year Core Study)||0||
59785492|NCT00620542|75905569|FG002|STARTED|Part B (2 Year Core Study)|Of 694 patients randomized, N=691 received treatment.|694||
59785493|NCT00620542|75905570|FG003|STARTED|Part B (2 Year Core Study)|Of 691 patients randomized, N=689 received treatment.|691||
59785494|NCT00620542|75905567|FG000|Received Treatment|Part B (2 Year Core Study)||0||
59785495|NCT00620542|75905568|FG001|Received Treatment|Part B (2 Year Core Study)||0||
59785496|NCT00620542|75905569|FG002|Received Treatment|Part B (2 Year Core Study)||691||
59785497|NCT00620542|75905570|FG003|Received Treatment|Part B (2 Year Core Study)||689||
59785498|NCT00620542|75905567|FG000|Intent-to-treat Population|Part B (2 Year Core Study)||0||
59785499|NCT00620542|75905568|FG001|Intent-to-treat Population|Part B (2 Year Core Study)||0||
59785500|NCT00620542|75905569|FG002|Intent-to-treat Population|Part B (2 Year Core Study)|Patients who received treatment and had a baseline and end of study (Week 104) IVUS|520||
59785501|NCT00620542|75905570|FG003|Intent-to-treat Population|Part B (2 Year Core Study)|Patients who received treatment and had a baseline and end of study (Week 104) IVUS|519||
59785502|NCT00620542|75905567|FG000|COMPLETED|Part B (2 Year Core Study)||0||
59785503|NCT00620542|75905568|FG001|COMPLETED|Part B (2 Year Core Study)||0||
59785504|NCT00620542|75905569|FG002|COMPLETED|Part B (2 Year Core Study)||546||
59785505|NCT00620542|75905570|FG003|COMPLETED|Part B (2 Year Core Study)||547||
59522647|NCT02936206|75617113|FG000|NOT COMPLETED|Overall Study||0||
59785506|NCT00620542|75905567|FG000|NOT COMPLETED|Part B (2 Year Core Study)||0||
59785507|NCT00620542|75905568|FG001|NOT COMPLETED|Part B (2 Year Core Study)||0||
59785508|NCT00620542|75905569|FG002|NOT COMPLETED|Part B (2 Year Core Study)||148||
59785509|NCT00620542|75905570|FG003|NOT COMPLETED|Part B (2 Year Core Study)||144||
59785510|NCT05096208|75905582|FG000|STARTED|Overall Study||247||
59785511|NCT05096208|75905583|FG001|STARTED|Overall Study||249||
59785512|NCT05096208|75905584|FG002|STARTED|Overall Study||247||
59785513|NCT05096208|75905585|FG003|STARTED|Overall Study||250||
59785514|NCT05096208|75905582|FG000|Vaccinated|Overall Study||247||
59785515|NCT05096208|75905583|FG001|Vaccinated|Overall Study||249||
59785516|NCT05096208|75905584|FG002|Vaccinated|Overall Study||247||
59785517|NCT05096208|75905585|FG003|Vaccinated|Overall Study||249||
59785518|NCT05096208|75905582|FG000|COMPLETED|Overall Study||243||
59785519|NCT05096208|75905583|FG001|COMPLETED|Overall Study||243||
59785520|NCT05096208|75905584|FG002|COMPLETED|Overall Study||239||
59785521|NCT05096208|75905585|FG003|COMPLETED|Overall Study||245||
59785522|NCT05096208|75905582|FG000|NOT COMPLETED|Overall Study||4||
59785523|NCT05096208|75905583|FG001|NOT COMPLETED|Overall Study||6||
59785524|NCT05096208|75905584|FG002|NOT COMPLETED|Overall Study||8||
59785525|NCT05096208|75905585|FG003|NOT COMPLETED|Overall Study||5||
59785526|NCT04895293|75905597|FG000|STARTED|Overall Study||5||
59785527|NCT04895293|75905597|FG000|COMPLETED|Overall Study||5||
59785528|NCT04895293|75905597|FG000|NOT COMPLETED|Overall Study||0||
59785529|NCT04555616|75905604|FG000|STARTED|Overall Study||10|All numbers in this table represent dyads. One dyad is patient and their caregiver (total participants = 2 per dyad).|
59785530|NCT04555616|75905605|FG001|STARTED|Overall Study||10|All numbers in this table represent dyads. One dyad is patient and their caregiver (total participants = 2 per dyad).|
59785531|NCT04555616|75905606|FG002|STARTED|Overall Study||10|All numbers in this table represent dyads. One dyad is patient and their caregiver (total participants = 2 per dyad).|
59785532|NCT04555616|75905604|FG000|COMPLETED|Overall Study||7|"2 deaths report patient death."|
59785533|NCT04555616|75905605|FG001|COMPLETED|Overall Study||9|"2 deaths report patient death."|
59785534|NCT04555616|75905606|FG002|COMPLETED|Overall Study||9|"2 deaths report patient death."|
59785535|NCT04555616|75905604|FG000|NOT COMPLETED|Overall Study||3||
59785536|NCT04555616|75905605|FG001|NOT COMPLETED|Overall Study||1||
59785537|NCT04555616|75905606|FG002|NOT COMPLETED|Overall Study||1||
59785538|NCT04368455|75905617|FG000|STARTED|Overall Study||97||
59785539|NCT04368455|75905618|FG001|STARTED|Overall Study||27||
59785540|NCT04368455|75905619|FG002|STARTED|Overall Study||37||
59785541|NCT04368455|75905617|FG000|COMPLETED|Overall Study||93||
59785542|NCT04368455|75905618|FG001|COMPLETED|Overall Study||27||
59785543|NCT04368455|75905619|FG002|COMPLETED|Overall Study||32||
59785544|NCT04368455|75905617|FG000|NOT COMPLETED|Overall Study||4||
59785545|NCT04368455|75905618|FG001|NOT COMPLETED|Overall Study||0||
59785546|NCT04368455|75905619|FG002|NOT COMPLETED|Overall Study||5||
59785547|NCT04177758|75905630|FG000|STARTED|Overall Study||69||
59785548|NCT04177758|75905631|FG001|STARTED|Overall Study||68||
59785549|NCT04177758|75905630|FG000|COMPLETED|Overall Study||50||
59785550|NCT04177758|75905631|FG001|COMPLETED|Overall Study||57||
59785551|NCT04177758|75905630|FG000|NOT COMPLETED|Overall Study||19||
59785552|NCT04177758|75905631|FG001|NOT COMPLETED|Overall Study||11||
59785553|NCT04003103|75905640|FG000|STARTED|Overall Study||97||
59785554|NCT04003103|75905641|FG001|STARTED|Overall Study||97||
59785555|NCT04003103|75905642|FG002|STARTED|Overall Study||48||
59785556|NCT04003103|75905640|FG000|COMPLETED|Overall Study||82||
59785557|NCT04003103|75905641|FG001|COMPLETED|Overall Study||91||
59785558|NCT04003103|75905642|FG002|COMPLETED|Overall Study||45||
59785559|NCT04003103|75905640|FG000|NOT COMPLETED|Overall Study||15||
59785560|NCT04003103|75905641|FG001|NOT COMPLETED|Overall Study||6||
59785561|NCT04003103|75905642|FG002|NOT COMPLETED|Overall Study||3||
59785562|NCT03971617|75905652|FG000|STARTED|Overall Study||1||
59785563|NCT03971617|75905653|FG001|STARTED|Overall Study||1||
59785564|NCT03971617|75905652|FG000|COMPLETED|Overall Study||1||
59785565|NCT03971617|75905653|FG001|COMPLETED|Overall Study||1||
59785566|NCT03971617|75905652|FG000|NOT COMPLETED|Overall Study||0||
59785567|NCT03971617|75905653|FG001|NOT COMPLETED|Overall Study||0||
59785568|NCT03959683|75905661|FG000|STARTED|Overall Study||49||
59785569|NCT03959683|75905662|FG001|STARTED|Overall Study||51||
59785570|NCT03959683|75905661|FG000|COMPLETED|Overall Study||49||
59785571|NCT03959683|75905662|FG001|COMPLETED|Overall Study||51||
59785572|NCT03959683|75905661|FG000|NOT COMPLETED|Overall Study||0||
59785573|NCT03959683|75905662|FG001|NOT COMPLETED|Overall Study||0||
59785574|NCT03930524|75905673|FG000|STARTED|Stage 1||300||
59785575|NCT03930524|75905674|FG001|STARTED|Stage 1||295||
59785576|NCT03930524|75905675|FG002|STARTED|Stage 1||0||
59785577|NCT03930524|75905676|FG003|STARTED|Stage 1||0||
59785578|NCT03930524|75905677|FG004|STARTED|Stage 1||296||
59785579|NCT03930524|75905678|FG005|STARTED|Stage 1||0||
59785580|NCT03930524|75905679|FG006|STARTED|Stage 1||0||
59785581|NCT03930524|75905673|FG000|COMPLETED|Stage 1||274||
59785582|NCT03930524|75905674|FG001|COMPLETED|Stage 1||254||
59785583|NCT03930524|75905675|FG002|COMPLETED|Stage 1||0||
59785584|NCT03930524|75905676|FG003|COMPLETED|Stage 1||0||
59785585|NCT03930524|75905677|FG004|COMPLETED|Stage 1||253||
59785586|NCT03930524|75905678|FG005|COMPLETED|Stage 1||0||
59785587|NCT03930524|75905679|FG006|COMPLETED|Stage 1||0||
59785588|NCT03930524|75905673|FG000|NOT COMPLETED|Stage 1||26||
59785589|NCT03930524|75905674|FG001|NOT COMPLETED|Stage 1||41||
59785590|NCT03930524|75905675|FG002|NOT COMPLETED|Stage 1||0||
59785591|NCT03930524|75905676|FG003|NOT COMPLETED|Stage 1||0||
59785592|NCT03930524|75905677|FG004|NOT COMPLETED|Stage 1||43||
59785593|NCT03930524|75905678|FG005|NOT COMPLETED|Stage 1||0||
59785594|NCT03930524|75905679|FG006|NOT COMPLETED|Stage 1||0||
59785595|NCT03930524|75905673|FG000|STARTED|"Stage 2 (Heavy Drinkers)"||0||
59785596|NCT03930524|75905674|FG001|STARTED|"Stage 2 (Heavy Drinkers)"||0||
59785597|NCT03930524|75905675|FG002|STARTED|"Stage 2 (Heavy Drinkers)"||38||
59785598|NCT03930524|75905676|FG003|STARTED|"Stage 2 (Heavy Drinkers)"||37||
59785599|NCT03930524|75905677|FG004|STARTED|"Stage 2 (Heavy Drinkers)"||0||
59785600|NCT03930524|75905678|FG005|STARTED|"Stage 2 (Heavy Drinkers)"||40||
59785601|NCT03930524|75905679|FG006|STARTED|"Stage 2 (Heavy Drinkers)"||43||
59785602|NCT03930524|75905673|FG000|COMPLETED|"Stage 2 (Heavy Drinkers)"||0||
59785603|NCT03930524|75905674|FG001|COMPLETED|"Stage 2 (Heavy Drinkers)"||0||
59785604|NCT03930524|75905675|FG002|COMPLETED|"Stage 2 (Heavy Drinkers)"||36||
59785605|NCT03930524|75905676|FG003|COMPLETED|"Stage 2 (Heavy Drinkers)"||34||
59785606|NCT03930524|75905677|FG004|COMPLETED|"Stage 2 (Heavy Drinkers)"||0||
59785607|NCT03930524|75905678|FG005|COMPLETED|"Stage 2 (Heavy Drinkers)"||33||
59785608|NCT03930524|75905679|FG006|COMPLETED|"Stage 2 (Heavy Drinkers)"||40||
59785609|NCT03930524|75905673|FG000|NOT COMPLETED|"Stage 2 (Heavy Drinkers)"||0||
59785610|NCT03930524|75905674|FG001|NOT COMPLETED|"Stage 2 (Heavy Drinkers)"||0||
59785611|NCT03930524|75905675|FG002|NOT COMPLETED|"Stage 2 (Heavy Drinkers)"||2||
59785612|NCT03930524|75905676|FG003|NOT COMPLETED|"Stage 2 (Heavy Drinkers)"||3||
59785613|NCT03930524|75905677|FG004|NOT COMPLETED|"Stage 2 (Heavy Drinkers)"||0||
59785614|NCT03930524|75905678|FG005|NOT COMPLETED|"Stage 2 (Heavy Drinkers)"||7||
59785615|NCT03930524|75905679|FG006|NOT COMPLETED|"Stage 2 (Heavy Drinkers)"||3||
59785616|NCT03921528|75905691|FG000|STARTED|Overall Study||11||
59785617|NCT03921528|75905692|FG001|STARTED|Overall Study||12||
59785618|NCT03921528|75905693|FG002|STARTED|Overall Study||15||
59785619|NCT03921528|75905694|FG003|STARTED|Overall Study||10||
59785620|NCT03921528|75905695|FG004|STARTED|Overall Study||10||
59785621|NCT03921528|75905691|FG000|COMPLETED|Overall Study||11||
59785622|NCT03921528|75905692|FG001|COMPLETED|Overall Study||11||
59785623|NCT03921528|75905693|FG002|COMPLETED|Overall Study||15||
59785624|NCT03921528|75905694|FG003|COMPLETED|Overall Study||10||
59785625|NCT03921528|75905695|FG004|COMPLETED|Overall Study||10||
59785626|NCT03921528|75905691|FG000|NOT COMPLETED|Overall Study||0||
59785627|NCT03921528|75905692|FG001|NOT COMPLETED|Overall Study||1||
59785628|NCT03921528|75905693|FG002|NOT COMPLETED|Overall Study||0||
59785629|NCT03921528|75905694|FG003|NOT COMPLETED|Overall Study||0||
59785630|NCT03921528|75905695|FG004|NOT COMPLETED|Overall Study||0||
59785631|NCT03917420|75905707|FG000|STARTED|Overall Study||10||
59785632|NCT03917420|75905707|FG000|COMPLETED|Overall Study||10||
59785633|NCT03917420|75905707|FG000|NOT COMPLETED|Overall Study||0||
59785634|NCT03832322|75905713|FG000|STARTED|Overall Study||89||
59785635|NCT03832322|75905714|FG001|STARTED|Overall Study||87||
59785636|NCT03832322|75905713|FG000|COMPLETED|Overall Study||86||
59785637|NCT03832322|75905714|FG001|COMPLETED|Overall Study||86||
59785638|NCT03832322|75905713|FG000|NOT COMPLETED|Overall Study||3||
59785639|NCT03832322|75905714|FG001|NOT COMPLETED|Overall Study||1||
59785640|NCT03720119|75905722|FG000|STARTED|Overall Study||78||
59785641|NCT03720119|75905722|FG000|COMPLETED|Overall Study||69||
59785642|NCT03720119|75905722|FG000|NOT COMPLETED|Overall Study||9||
59785643|NCT03708562|75905726|FG000|STARTED|Overall Study||24||
59785644|NCT03708562|75905726|FG000|COMPLETED|Overall Study||12||
59785645|NCT03708562|75905726|FG000|NOT COMPLETED|Overall Study||12||
59785646|NCT03642990|75905730|FG000|STARTED|300 mg/Day for One Week||5||
59785647|NCT03642990|75905730|FG000|COMPLETED|300 mg/Day for One Week||4||
59785648|NCT03642990|75905730|FG000|NOT COMPLETED|300 mg/Day for One Week||1||
59785649|NCT03642990|75905730|FG000|STARTED|1000 mg/Day for Weeks 2-12||4||
59785650|NCT03642990|75905730|FG000|COMPLETED|1000 mg/Day for Weeks 2-12||0||
59785651|NCT03642990|75905730|FG000|NOT COMPLETED|1000 mg/Day for Weeks 2-12||4||
59785652|NCT03639311|75905736|FG000|STARTED|Overall Study||90||
59785653|NCT03639311|75905737|FG001|STARTED|Overall Study||7||
59785654|NCT03639311|75905736|FG000|COMPLETED|Overall Study||0||
59785655|NCT03639311|75905737|FG001|COMPLETED|Overall Study||7||
59785656|NCT03639311|75905736|FG000|NOT COMPLETED|Overall Study||90||
59785657|NCT03639311|75905737|FG001|NOT COMPLETED|Overall Study||0||
59785658|NCT03633825|75905748|FG000|STARTED|Enrollment||19838|Randomized and assessed for eligibility.|
59785659|NCT03633825|75905749|FG001|STARTED|Enrollment||19612|Randomized and assessed for eligibility.|
59785660|NCT03633825|75905748|FG000|COMPLETED|Enrollment||805||
59785661|NCT03633825|75905749|FG001|COMPLETED|Enrollment||775||
59785662|NCT03633825|75905748|FG000|NOT COMPLETED|Enrollment||19033||
59785663|NCT03633825|75905749|FG001|NOT COMPLETED|Enrollment||18837||
59785664|NCT03633825|75905748|FG000|STARTED|Allocation||805|Allocated and received intervention.|
59785665|NCT03633825|75905749|FG001|STARTED|Allocation||775|Allocated and received intervention.|
59785666|NCT03633825|75905748|FG000|COMPLETED|Allocation||805||
59785667|NCT03633825|75905749|FG001|COMPLETED|Allocation||775||
59785668|NCT03633825|75905748|FG000|NOT COMPLETED|Allocation||0||
59785669|NCT03633825|75905749|FG001|NOT COMPLETED|Allocation||0||
59785670|NCT03633825|75905748|FG000|STARTED|Follow up||805||
59785671|NCT03633825|75905749|FG001|STARTED|Follow up||775||
59785672|NCT03633825|75905748|FG000|COMPLETED|Follow up||327||
59785673|NCT03633825|75905749|FG001|COMPLETED|Follow up||325||
59785674|NCT03633825|75905748|FG000|NOT COMPLETED|Follow up||478||
59785675|NCT03633825|75905749|FG001|NOT COMPLETED|Follow up||450||
59785676|NCT03633825|75905748|FG000|STARTED|Analysis||327||
59785677|NCT03633825|75905749|FG001|STARTED|Analysis||325||
59785678|NCT03633825|75905748|FG000|COMPLETED|Analysis||327||
59785679|NCT03633825|75905749|FG001|COMPLETED|Analysis||325||
59785680|NCT03633825|75905748|FG000|NOT COMPLETED|Analysis||0||
59619487|NCT00983892|75730724|FG001|NOT COMPLETED|Overall Study||12||
59619488|NCT00983580|75730732|FG000|STARTED|Overall Study||54||
59619489|NCT00983580|75730733|FG001|STARTED|Overall Study||53||
59619490|NCT00983580|75730732|FG000|COMPLETED|Overall Study||49||
59619491|NCT00983580|75730733|FG001|COMPLETED|Overall Study||49||
59619492|NCT00983580|75730732|FG000|NOT COMPLETED|Overall Study||5||
59619493|NCT00983580|75730733|FG001|NOT COMPLETED|Overall Study||4||
59619494|NCT00982878|75730740|FG000|STARTED|Overall Study||13||
59619495|NCT00982878|75730740|FG000|COMPLETED|Overall Study||12||
59619496|NCT00982878|75730740|FG000|NOT COMPLETED|Overall Study||1||
59619497|NCT00982488|75730749|FG000|STARTED|Overall Study|Received treatment|185||
59619498|NCT00982488|75730750|FG001|STARTED|Overall Study|Received treatment|14||
59619499|NCT00982488|75730751|FG002|STARTED|Overall Study|Received treatment|34||
59619500|NCT00982488|75730752|FG003|STARTED|Overall Study|Received treatment|3||
59619501|NCT00982488|75730753|FG004|STARTED|Overall Study|Received treatment|1||
59619502|NCT00982488|75730749|FG000|COMPLETED|Overall Study|Still receiving treatment|0||
59619503|NCT00982488|75730750|FG001|COMPLETED|Overall Study|Still receiving treatment|0||
59619504|NCT00982488|75730751|FG002|COMPLETED|Overall Study|Still receiving treatment|0||
59619505|NCT00982488|75730752|FG003|COMPLETED|Overall Study|Still receiving treatment|0||
59619506|NCT00982488|75730753|FG004|COMPLETED|Overall Study|Still receiving treatment|0||
59619507|NCT00982488|75730749|FG000|NOT COMPLETED|Overall Study||185||
59619508|NCT00982488|75730750|FG001|NOT COMPLETED|Overall Study||14||
59619509|NCT00982488|75730751|FG002|NOT COMPLETED|Overall Study||34||
59785681|NCT03633825|75905749|FG001|NOT COMPLETED|Analysis||0||
59619510|NCT00982488|75730752|FG003|NOT COMPLETED|Overall Study||3||
59619511|NCT00982488|75730753|FG004|NOT COMPLETED|Overall Study||1||
59619512|NCT00982410|75730767|FG000|STARTED|3-month Follow-up Assessment||65||
59619513|NCT00982410|75730768|FG001|STARTED|3-month Follow-up Assessment||66||
59619514|NCT00982410|75730767|FG000|COMPLETED|3-month Follow-up Assessment||56||
59619515|NCT00982410|75730768|FG001|COMPLETED|3-month Follow-up Assessment||53||
59619516|NCT00982410|75730767|FG000|NOT COMPLETED|3-month Follow-up Assessment||9||
59619517|NCT00982410|75730768|FG001|NOT COMPLETED|3-month Follow-up Assessment||13||
59619518|NCT00982410|75730767|FG000|STARTED|6-month Follow-up Assessment|n=65 : intent to treat. Some persons missed follow-up assessment without withdrawing from study.|65||
59619519|NCT00982410|75730768|FG001|STARTED|6-month Follow-up Assessment|n=2 persons withdrew before 3-mo. f/u, reducing pool of participants to N=64 with intent to treat.|64||
59619520|NCT00982410|75730767|FG000|COMPLETED|6-month Follow-up Assessment||59||
59619521|NCT00982410|75730768|FG001|COMPLETED|6-month Follow-up Assessment||53||
59619522|NCT00982410|75730767|FG000|NOT COMPLETED|6-month Follow-up Assessment||6||
59619523|NCT00982410|75730768|FG001|NOT COMPLETED|6-month Follow-up Assessment||11||
59619524|NCT00982410|75730767|FG000|STARTED|12-month Follow-up Assessment|n=65 : intent to treat. Some persons missed follow-up assessment without withdrawing from study.|65||
59619525|NCT00982410|75730768|FG001|STARTED|12-month Follow-up Assessment|n=2 persons withdrew before 3-mo. f/u, reducing pool of participants to N=64 with intent to treat.|64||
59619526|NCT00982410|75730767|FG000|COMPLETED|12-month Follow-up Assessment||56||
59619527|NCT00982410|75730768|FG001|COMPLETED|12-month Follow-up Assessment||55||
59619528|NCT00982410|75730767|FG000|NOT COMPLETED|12-month Follow-up Assessment||9||
59619529|NCT00982410|75730768|FG001|NOT COMPLETED|12-month Follow-up Assessment||9||
59619530|NCT00982020|75730777|FG000|STARTED|Overall Study||102||
59619531|NCT00982020|75730778|FG001|STARTED|Overall Study||101||
59619532|NCT00982020|75730777|FG000|Received at Least 1 Dose of Study Drug|Overall Study||102||
59619533|NCT00982020|75730778|FG001|Received at Least 1 Dose of Study Drug|Overall Study||101||
59619534|NCT00982020|75730777|FG000|COMPLETED|Overall Study||45||
59619535|NCT00982020|75730778|FG001|COMPLETED|Overall Study||37||
59619536|NCT00982020|75730777|FG000|NOT COMPLETED|Overall Study||57||
59619537|NCT00982020|75730778|FG001|NOT COMPLETED|Overall Study||64||
59619538|NCT00981084|75730791|FG000|STARTED|First Intervention (One Day)||16||
59619539|NCT00981084|75730792|FG001|STARTED|First Intervention (One Day)||17||
59619540|NCT00981084|75730791|FG000|COMPLETED|First Intervention (One Day)||16||
59619541|NCT00981084|75730792|FG001|COMPLETED|First Intervention (One Day)||17||
59619542|NCT00981084|75730791|FG000|NOT COMPLETED|First Intervention (One Day)||0||
59619543|NCT00981084|75730792|FG001|NOT COMPLETED|First Intervention (One Day)||0||
59619544|NCT00981084|75730791|FG000|STARTED|Washout Period (7 Days)||16||
59619545|NCT00981084|75730792|FG001|STARTED|Washout Period (7 Days)||17||
59785682|NCT05427539|75905755|FG000|STARTED|Period 1||31||
59785683|NCT05427539|75905756|FG001|STARTED|Period 1||34||
59785684|NCT05427539|75905755|FG000|COMPLETED|Period 1||29||
59619546|NCT00981084|75730791|FG000|COMPLETED|Washout Period (7 Days)||16||
59619547|NCT00981084|75730792|FG001|COMPLETED|Washout Period (7 Days)||17||
59619548|NCT00981084|75730791|FG000|NOT COMPLETED|Washout Period (7 Days)||0||
59619549|NCT00981084|75730792|FG001|NOT COMPLETED|Washout Period (7 Days)||0||
59785685|NCT05427539|75905756|FG001|COMPLETED|Period 1||33||
59619550|NCT00981084|75730791|FG000|STARTED|Second Intervention (One Day)||16||
59619551|NCT00981084|75730792|FG001|STARTED|Second Intervention (One Day)||17||
59619552|NCT00981084|75730791|FG000|COMPLETED|Second Intervention (One Day)||16||
59785686|NCT05427539|75905755|FG000|NOT COMPLETED|Period 1||2||
59785687|NCT05427539|75905756|FG001|NOT COMPLETED|Period 1||1||
59785688|NCT05427539|75905755|FG000|STARTED|Period 2||29||
59785689|NCT05427539|75905756|FG001|STARTED|Period 2||33||
59785690|NCT05427539|75905755|FG000|COMPLETED|Period 2||29||
59785691|NCT05427539|75905756|FG001|COMPLETED|Period 2||33||
59785692|NCT05427539|75905755|FG000|NOT COMPLETED|Period 2||0||
59785693|NCT05427539|75905756|FG001|NOT COMPLETED|Period 2||0||
59785694|NCT05144945|75905764|FG000|STARTED|Overall Study||150||
59785695|NCT05144945|75905765|FG001|STARTED|Overall Study||151||
59785696|NCT05144945|75905764|FG000|Safety Analysis Set|Overall Study||149|Participants who received a dose of the study vaccine and were analyzed according to the vaccine they actually received.|
59785697|NCT05144945|75905765|FG001|Safety Analysis Set|Overall Study||151|Participants who received a dose of the study vaccine and were analyzed according to the vaccine they actually received.|
59785698|NCT05144945|75905764|FG000|COMPLETED|Overall Study||149||
59785699|NCT05144945|75905765|FG001|COMPLETED|Overall Study||151||
59785700|NCT05144945|75905764|FG000|NOT COMPLETED|Overall Study||1||
59785701|NCT05144945|75905765|FG001|NOT COMPLETED|Overall Study||0||
59785702|NCT05064332|75905771|FG000|STARTED|Period 1||10||
59785703|NCT05064332|75905771|FG000|COMPLETED|Period 1||10||
59785704|NCT05064332|75905771|FG000|NOT COMPLETED|Period 1||0||
59785705|NCT05064332|75905771|FG000|STARTED|Period 2||10||
59785706|NCT05064332|75905771|FG000|COMPLETED|Period 2||10||
59785707|NCT05064332|75905771|FG000|NOT COMPLETED|Period 2||0||
59785708|NCT04439318|75905781|FG000|STARTED|Overall Study||50||
59785709|NCT04439318|75905781|FG000|Eligible|Overall Study||49||
59785710|NCT04439318|75905781|FG000|Eligible and Started Protocol Therapy|Overall Study||46|Three patients never started treatment. This is the primary analysis population.|
59785711|NCT04439318|75905781|FG000|COMPLETED|Overall Study||0||
59785712|NCT04439318|75905781|FG000|NOT COMPLETED|Overall Study||50||
59785713|NCT04171700|75905787|FG000|STARTED|Overall Study||63||
59785714|NCT04171700|75905788|FG001|STARTED|Overall Study||20||
59785715|NCT04171700|75905787|FG000|COMPLETED|Overall Study||63||
59785716|NCT04171700|75905788|FG001|COMPLETED|Overall Study||20||
59785717|NCT04171700|75905787|FG000|NOT COMPLETED|Overall Study||0||
59785718|NCT04171700|75905788|FG001|NOT COMPLETED|Overall Study||0||
59785719|NCT03876808|75905797|FG000|STARTED|Overall Study||6||
59785720|NCT03876808|75905798|FG001|STARTED|Overall Study||4||
59785721|NCT03876808|75905797|FG000|COMPLETED|Overall Study||6||
59785722|NCT03876808|75905798|FG001|COMPLETED|Overall Study||4||
59785723|NCT03876808|75905797|FG000|NOT COMPLETED|Overall Study||0||
59785724|NCT03876808|75905798|FG001|NOT COMPLETED|Overall Study||0||
59785725|NCT03777709|75905806|FG000|STARTED|Overall Study||41||8
59785726|NCT03777709|75905807|FG001|STARTED|Overall Study||44||8
59785727|NCT03777709|75905806|FG000|COMPLETED|Overall Study||34||8
59785728|NCT03777709|75905807|FG001|COMPLETED|Overall Study||42||8
59785729|NCT03777709|75905806|FG000|NOT COMPLETED|Overall Study||7||0
59785730|NCT03777709|75905807|FG001|NOT COMPLETED|Overall Study||2||0
59785731|NCT03768336|75905813|FG000|STARTED|Overall Study||35|This is total number enrolled (signed consent and completed baseline)|
59785732|NCT03768336|75905814|FG001|STARTED|Overall Study||37|This is total number enrolled (signed consent and completed baseline)|
59785733|NCT03768336|75905813|FG000|Baseline Completion|Overall Study||35||
59785734|NCT03768336|75905814|FG001|Baseline Completion|Overall Study||37||
59785735|NCT03768336|75905813|FG000|Remained Eligible|Overall Study|n=2 people who were randomized to the intervention had cancer recurrences, causing them to become ineligible.|33||
59785736|NCT03768336|75905814|FG001|Remained Eligible|Overall Study||37||
59785737|NCT03768336|75905813|FG000|Program Initiation|Overall Study||29||
59785738|NCT03768336|75905814|FG001|Program Initiation|Overall Study||35||
59785739|NCT03768336|75905813|FG000|Follow up Survey #1|Overall Study||29||
59785740|NCT03768336|75905814|FG001|Follow up Survey #1|Overall Study||35||
59785741|NCT03768336|75905813|FG000|Follow up Survey #2|Overall Study||29||
59785742|NCT03768336|75905814|FG001|Follow up Survey #2|Overall Study||34||
59785743|NCT03768336|75905813|FG000|COMPLETED|Overall Study||29||
59785744|NCT03768336|75905814|FG001|COMPLETED|Overall Study||34||
59785745|NCT03768336|75905813|FG000|NOT COMPLETED|Overall Study||6||
59785746|NCT03768336|75905814|FG001|NOT COMPLETED|Overall Study||3||
59785747|NCT03742141|75905821|FG000|STARTED|Overall Study||125||
59785748|NCT03742141|75905821|FG000|COMPLETED|Overall Study||75||
59785749|NCT03742141|75905821|FG000|NOT COMPLETED|Overall Study||50||
59785750|NCT02968849|75905827|FG000|STARTED|Overall Study||2704||
59785751|NCT02968849|75905828|FG001|STARTED|Overall Study||2700||
59785752|NCT02968849|75905827|FG000|Modified Intent-to-Treat (MITT) Cohort|Overall Study||2695||
59785753|NCT02968849|75905828|FG001|Modified Intent-to-Treat (MITT) Cohort|Overall Study||2689||
59785754|NCT02968849|75905827|FG000|MITT Infected Cohort|Overall Study||151||
59785755|NCT02968849|75905828|FG001|MITT Infected Cohort|Overall Study||143||
59785756|NCT02968849|75905827|FG000|Week 26 At-Risk Cohort|Overall Study||2430||
59785757|NCT02968849|75905828|FG001|Week 26 At-Risk Cohort|Overall Study||2393||
59785758|NCT02968849|75905827|FG000|Immunogenicity Cohort|Overall Study||120||
59785759|NCT02968849|75905828|FG001|Immunogenicity Cohort|Overall Study||10||
59785760|NCT02968849|75905827|FG000|COMPLETED|Overall Study||2557||
59785761|NCT02968849|75905828|FG001|COMPLETED|Overall Study||2557||
59785762|NCT02968849|75905827|FG000|NOT COMPLETED|Overall Study||147||
59785763|NCT02968849|75905828|FG001|NOT COMPLETED|Overall Study||143||
59785764|NCT02795104|75905840|FG000|STARTED|Overall Study||389||
59785765|NCT02795104|75905841|FG001|STARTED|Overall Study||395||
59785766|NCT02795104|75905842|FG002|STARTED|Overall Study||201||
59785767|NCT02795104|75905840|FG000|COMPLETED|Overall Study||382||
59785768|NCT02795104|75905841|FG001|COMPLETED|Overall Study||388||
59785769|NCT02795104|75905842|FG002|COMPLETED|Overall Study||193||
59785770|NCT02795104|75905840|FG000|NOT COMPLETED|Overall Study||7||
59785771|NCT02795104|75905841|FG001|NOT COMPLETED|Overall Study||7||
59785772|NCT02795104|75905842|FG002|NOT COMPLETED|Overall Study||8||
59619553|NCT00981084|75730792|FG001|COMPLETED|Second Intervention (One Day)||17||
59619554|NCT00981084|75730791|FG000|NOT COMPLETED|Second Intervention (One Day)||0||
59619555|NCT00981084|75730792|FG001|NOT COMPLETED|Second Intervention (One Day)||0||
59619556|NCT00981084|75730791|FG000|STARTED|Post Intervention (Data Analysis)||16||
59619557|NCT00981084|75730792|FG001|STARTED|Post Intervention (Data Analysis)||17||
59619558|NCT00981084|75730791|FG000|COMPLETED|Post Intervention (Data Analysis)||14||
59619559|NCT00981084|75730792|FG001|COMPLETED|Post Intervention (Data Analysis)||16||
59619560|NCT00981084|75730791|FG000|NOT COMPLETED|Post Intervention (Data Analysis)||2||
59785773|NCT02675244|75905855|FG000|STARTED|Overall Study||203||
59785774|NCT02675244|75905856|FG001|STARTED|Overall Study||198||
59785775|NCT02675244|75905855|FG000|COMPLETED|Overall Study||0||
59785776|NCT02675244|75905856|FG001|COMPLETED|Overall Study||0||
59785777|NCT02675244|75905855|FG000|NOT COMPLETED|Overall Study||203||
59785778|NCT02675244|75905856|FG001|NOT COMPLETED|Overall Study||198||
59785779|NCT02351791|75905870|FG000|STARTED|Overall Study||12||
59785780|NCT02351791|75905871|FG001|STARTED|Overall Study||10||
59785781|NCT02351791|75905870|FG000|COMPLETED|Overall Study||12||
59785782|NCT02351791|75905871|FG001|COMPLETED|Overall Study||10||
59785783|NCT02351791|75905870|FG000|NOT COMPLETED|Overall Study||0||
59785784|NCT02351791|75905871|FG001|NOT COMPLETED|Overall Study||0||
59785785|NCT01594047|75905902|FG000|STARTED|Overall Study||29||
59785786|NCT01594047|75905903|FG001|STARTED|Overall Study||30||
59785787|NCT01594047|75905904|FG002|STARTED|Overall Study||27||
59785788|NCT01594047|75905905|FG003|STARTED|Overall Study||27||
59785789|NCT01594047|75905902|FG000|COMPLETED|Overall Study||24||
59785790|NCT01594047|75905903|FG001|COMPLETED|Overall Study||25||
59785791|NCT01594047|75905904|FG002|COMPLETED|Overall Study||23||
59785792|NCT01594047|75905905|FG003|COMPLETED|Overall Study||24||
59785793|NCT01594047|75905902|FG000|NOT COMPLETED|Overall Study||5||
59785794|NCT01594047|75905903|FG001|NOT COMPLETED|Overall Study||5||
59785795|NCT01594047|75905904|FG002|NOT COMPLETED|Overall Study||4||
59785796|NCT01594047|75905905|FG003|NOT COMPLETED|Overall Study||3||
59785797|NCT01496313|75905917|FG000|STARTED|Overall Study||40||
59785798|NCT01496313|75905918|FG001|STARTED|Overall Study||41||
59785799|NCT01496313|75905917|FG000|COMPLETED|Overall Study||35||
59785800|NCT01496313|75905918|FG001|COMPLETED|Overall Study||26||
59785801|NCT01496313|75905917|FG000|NOT COMPLETED|Overall Study||5||
59785802|NCT01496313|75905918|FG001|NOT COMPLETED|Overall Study||15||
59785803|NCT01298323|75905926|FG000|STARTED|Overall Study||102||
59785804|NCT01298323|75905927|FG001|STARTED|Overall Study||103||
59785805|NCT01298323|75905926|FG000|Ongoing|Overall Study||55||
59785806|NCT01298323|75905927|FG001|Ongoing|Overall Study||55||
59785807|NCT01298323|75905926|FG000|COMPLETED|Overall Study||16||
59785808|NCT01298323|75905927|FG001|COMPLETED|Overall Study||15||
59785809|NCT01298323|75905926|FG000|NOT COMPLETED|Overall Study||86||
59785810|NCT01298323|75905927|FG001|NOT COMPLETED|Overall Study||88||
59785811|NCT01268579|75905933|FG000|STARTED|Overall Study||9||
59785812|NCT01268579|75905933|FG000|COMPLETED|Overall Study||6||
59785813|NCT01268579|75905933|FG000|NOT COMPLETED|Overall Study||3||
59785814|NCT01056523|75905937|FG000|STARTED|Overall Study||4||
59785815|NCT01056523|75905938|FG001|STARTED|Overall Study||3||
59785816|NCT01056523|75905939|FG002|STARTED|Overall Study||5||
59785817|NCT01056523|75905940|FG003|STARTED|Overall Study||6||
59785818|NCT01056523|75905941|FG004|STARTED|Overall Study||3||
59785819|NCT01056523|75905942|FG005|STARTED|Overall Study||3||
59785820|NCT01056523|75905943|FG006|STARTED|Overall Study||5||
59785821|NCT01056523|75905937|FG000|COMPLETED|Overall Study||3||
59785822|NCT01056523|75905938|FG001|COMPLETED|Overall Study||3||
59785823|NCT01056523|75905939|FG002|COMPLETED|Overall Study||3||
59785824|NCT01056523|75905940|FG003|COMPLETED|Overall Study||3||
59785825|NCT01056523|75905941|FG004|COMPLETED|Overall Study||3||
59785826|NCT01056523|75905942|FG005|COMPLETED|Overall Study||3||
59785827|NCT01056523|75905943|FG006|COMPLETED|Overall Study||4||
59785828|NCT01056523|75905937|FG000|NOT COMPLETED|Overall Study||1||
59785829|NCT01056523|75905938|FG001|NOT COMPLETED|Overall Study||0||
59785830|NCT01056523|75905939|FG002|NOT COMPLETED|Overall Study||2||
59785831|NCT01056523|75905940|FG003|NOT COMPLETED|Overall Study||3||
59785832|NCT01056523|75905941|FG004|NOT COMPLETED|Overall Study||0||
59785833|NCT01056523|75905942|FG005|NOT COMPLETED|Overall Study||0||
59785834|NCT01056523|75905943|FG006|NOT COMPLETED|Overall Study||1||
59785835|NCT00579878|75905951|FG000|STARTED|Overall Study||22||
59785836|NCT00579878|75905952|FG001|STARTED|Overall Study||23||
59785837|NCT00579878|75905953|FG002|STARTED|Overall Study||24||
59785838|NCT00579878|75905951|FG000|COMPLETED|Overall Study||15||
59785839|NCT00579878|75905952|FG001|COMPLETED|Overall Study||20||
59785840|NCT00579878|75905953|FG002|COMPLETED|Overall Study||14||
59785841|NCT00579878|75905951|FG000|NOT COMPLETED|Overall Study||7||
59785842|NCT00579878|75905952|FG001|NOT COMPLETED|Overall Study||3||
59785843|NCT00579878|75905953|FG002|NOT COMPLETED|Overall Study||10||
59785844|NCT00554788|75905964|FG000|STARTED|Overall Study||21||
59785845|NCT00554788|75905965|FG001|STARTED|Overall Study||18||
59785846|NCT00554788|75905966|FG002|STARTED|Overall Study||21||
59785847|NCT00554788|75905964|FG000|COMPLETED|Overall Study||14||
59785848|NCT00554788|75905965|FG001|COMPLETED|Overall Study||12||
59785849|NCT00554788|75905966|FG002|COMPLETED|Overall Study||7||
59785850|NCT00554788|75905964|FG000|NOT COMPLETED|Overall Study||7||
59785851|NCT00554788|75905965|FG001|NOT COMPLETED|Overall Study||6||
59785852|NCT00554788|75905966|FG002|NOT COMPLETED|Overall Study||14||
59785853|NCT00410761|75905977|FG000|STARTED|Overall Study|randomised patients|231||
59785854|NCT00410761|75905978|FG001|STARTED|Overall Study|randomised patients|100||
59785855|NCT00410761|75905977|FG000|COMPLETED|Overall Study|ongoing study treatment at data cut-off|111||
59785856|NCT00410761|75905978|FG001|COMPLETED|Overall Study|ongoing study treatment at data cut-off|28||
59785857|NCT00410761|75905977|FG000|NOT COMPLETED|Overall Study||120||
59785858|NCT00410761|75905978|FG001|NOT COMPLETED|Overall Study||72||
59785859|NCT00374595|75905984|FG000|STARTED|Overall Study||338||
59785860|NCT00374595|75905984|FG000|COMPLETED|Overall Study||268||
59785861|NCT00374595|75905984|FG000|NOT COMPLETED|Overall Study||70||
59785862|NCT03465540|75905994|FG000|STARTED|Overall Study||2||
59785863|NCT03465540|75905995|FG001|STARTED|Overall Study||6||
59785864|NCT03465540|75905996|FG002|STARTED|Overall Study||4||
59785865|NCT03465540|75905997|FG003|STARTED|Overall Study||4||
59785866|NCT03465540|75905998|FG004|STARTED|Overall Study||5||
59785867|NCT03465540|75905999|FG005|STARTED|Overall Study||3||
59785868|NCT03465540|75905994|FG000|Received AMG 397|Overall Study||2||
59785869|NCT03465540|75905995|FG001|Received AMG 397|Overall Study||6||
59785870|NCT03465540|75905996|FG002|Received AMG 397|Overall Study||4||
59785871|NCT03465540|75905997|FG003|Received AMG 397|Overall Study||4||
59785872|NCT03465540|75905998|FG004|Received AMG 397|Overall Study||5||
59785873|NCT03465540|75905999|FG005|Received AMG 397|Overall Study||3||
59785874|NCT03465540|75905994|FG000|COMPLETED|Overall Study||1|Completed Study|
59785875|NCT03465540|75905995|FG001|COMPLETED|Overall Study||2|Completed Study|
59785876|NCT03465540|75905996|FG002|COMPLETED|Overall Study||1|Completed Study|
59785877|NCT03465540|75905997|FG003|COMPLETED|Overall Study||1|Completed Study|
59785878|NCT03465540|75905998|FG004|COMPLETED|Overall Study||1|Completed Study|
59785879|NCT03465540|75905999|FG005|COMPLETED|Overall Study||1|Completed Study|
59785880|NCT03465540|75905994|FG000|NOT COMPLETED|Overall Study||1||
59785881|NCT03465540|75905995|FG001|NOT COMPLETED|Overall Study||4||
59785882|NCT03465540|75905996|FG002|NOT COMPLETED|Overall Study||3||
59619561|NCT00981084|75730792|FG001|NOT COMPLETED|Post Intervention (Data Analysis)||1||
59619562|NCT00980148|75730802|FG000|STARTED|Overall Study||284||
59619563|NCT00980148|75730803|FG001|STARTED|Overall Study||283||
59619564|NCT00980148|75730802|FG000|COMPLETED|Overall Study|Completed primary evaluation at study visit # 2 (day 28 after therapy started)|155||
59619565|NCT00980148|75730803|FG001|COMPLETED|Overall Study|Completed primary evaluation at study visit # 2 (day 28 after therapy started)|155||
59619566|NCT00980148|75730802|FG000|NOT COMPLETED|Overall Study||129||
59619567|NCT00980148|75730803|FG001|NOT COMPLETED|Overall Study||128||
59619568|NCT04552470|75730813|FG000|STARTED|Overall Study||9||
59619569|NCT04552470|75730814|FG001|STARTED|Overall Study||10||
59619570|NCT04552470|75730815|FG002|STARTED|Overall Study||9||
59619571|NCT04552470|75730816|FG003|STARTED|Overall Study||9||
59619572|NCT04552470|75730813|FG000|COMPLETED|Overall Study||9||
59619573|NCT04552470|75730814|FG001|COMPLETED|Overall Study||10||
59619574|NCT04552470|75730815|FG002|COMPLETED|Overall Study||9||
59619575|NCT04552470|75730816|FG003|COMPLETED|Overall Study||9||
59619576|NCT04552470|75730813|FG000|NOT COMPLETED|Overall Study||0||
59619577|NCT04552470|75730814|FG001|NOT COMPLETED|Overall Study||0||
59619578|NCT04552470|75730815|FG002|NOT COMPLETED|Overall Study||0||
59619579|NCT04552470|75730816|FG003|NOT COMPLETED|Overall Study||0||
59619580|NCT03423342|75730831|FG000|STARTED|Overall Study||20||
59619581|NCT03423342|75730832|FG001|STARTED|Overall Study||10||
59619582|NCT03423342|75730831|FG000|COMPLETED|Overall Study||20||
59619583|NCT03423342|75730832|FG001|COMPLETED|Overall Study||10||
59619584|NCT03423342|75730831|FG000|NOT COMPLETED|Overall Study||0||
59785883|NCT03465540|75905997|FG003|NOT COMPLETED|Overall Study||3||
59619585|NCT03423342|75730832|FG001|NOT COMPLETED|Overall Study||0||
59619586|NCT04553406|75730840|FG000|STARTED|Overall Study||1||
59619587|NCT04553406|75730841|FG001|STARTED|Overall Study||1||
59785884|NCT03465540|75905998|FG004|NOT COMPLETED|Overall Study||4||
59785885|NCT03465540|75905999|FG005|NOT COMPLETED|Overall Study||2||
59785886|NCT03319407|75906018|FG000|STARTED|Overall Study||21||
59785887|NCT03319407|75906018|FG000|COMPLETED|Overall Study||0||
59785888|NCT03319407|75906018|FG000|NOT COMPLETED|Overall Study||21||
59785889|NCT03185455|75906024|FG000|STARTED|Overall Study||103||
59619588|NCT04553406|75730840|FG000|COMPLETED|Overall Study||1||
59619589|NCT04553406|75730841|FG001|COMPLETED|Overall Study||0||
59619590|NCT04553406|75730840|FG000|NOT COMPLETED|Overall Study||0||
59619591|NCT04553406|75730841|FG001|NOT COMPLETED|Overall Study||1||
59619592|NCT03033576|75730849|FG000|STARTED|Overall Study||24||
59785890|NCT03185455|75906025|FG001|STARTED|Overall Study||103||
59785891|NCT03185455|75906024|FG000|COMPLETED|Overall Study||103||
59785892|NCT03185455|75906025|FG001|COMPLETED|Overall Study||103||
59785893|NCT03185455|75906024|FG000|NOT COMPLETED|Overall Study||0||
59785894|NCT03185455|75906025|FG001|NOT COMPLETED|Overall Study||0||
59785895|NCT03141255|75906033|FG000|STARTED|Overall Study||10||
59785896|NCT03141255|75906034|FG001|STARTED|Overall Study||10||
59785897|NCT03141255|75906033|FG000|COMPLETED|Overall Study||10||
59785898|NCT03141255|75906034|FG001|COMPLETED|Overall Study||10||
59785899|NCT03141255|75906033|FG000|NOT COMPLETED|Overall Study||0||
59785900|NCT03141255|75906034|FG001|NOT COMPLETED|Overall Study||0||
59785901|NCT03055897|75906041|FG000|STARTED|Overall Study||15||
59785902|NCT03055897|75906041|FG000|COMPLETED|Overall Study||15||
59785903|NCT03055897|75906041|FG000|NOT COMPLETED|Overall Study||0||
59785904|NCT03055832|75906047|FG000|STARTED|Baseline||71||
59785905|NCT03055832|75906048|FG001|STARTED|Baseline||71||
59785906|NCT03055832|75906047|FG000|COMPLETED|Baseline||71||
59785907|NCT03055832|75906048|FG001|COMPLETED|Baseline||71||
59785908|NCT03055832|75906047|FG000|NOT COMPLETED|Baseline||0||
59785909|NCT03055832|75906048|FG001|NOT COMPLETED|Baseline||0||
59785910|NCT03055832|75906047|FG000|STARTED|Immediately Post-Procedure (Hour 1)||71||
59785911|NCT03055832|75906048|FG001|STARTED|Immediately Post-Procedure (Hour 1)||71||
59785912|NCT03055832|75906047|FG000|COMPLETED|Immediately Post-Procedure (Hour 1)||71||
59785913|NCT03055832|75906048|FG001|COMPLETED|Immediately Post-Procedure (Hour 1)||71||
60073095|NCT01694433|76188304|FG001|NOT COMPLETED|Overall Study||4||
60073096|NCT01694121|76188312|FG000|STARTED|Overall Study||228||
60073097|NCT01694121|76188313|FG001|STARTED|Overall Study||227||
60073098|NCT01694121|76188312|FG000|COMPLETED|Overall Study||227||
60073099|NCT01694121|76188313|FG001|COMPLETED|Overall Study||227||
59619593|NCT03033576|75730850|FG001|STARTED|Overall Study||70||
59619594|NCT03033576|75730849|FG000|Eligible|Overall Study||23||
59619595|NCT03033576|75730850|FG001|Eligible|Overall Study||69||
59619596|NCT03033576|75730849|FG000|Received Protocol-directed Therapy|Overall Study||23||
59785914|NCT03055832|75906047|FG000|NOT COMPLETED|Immediately Post-Procedure (Hour 1)||0||
59785915|NCT03055832|75906048|FG001|NOT COMPLETED|Immediately Post-Procedure (Hour 1)||0||
59785916|NCT03055832|75906047|FG000|STARTED|Day 1||71||
59785917|NCT03055832|75906048|FG001|STARTED|Day 1||71||
59785918|NCT03055832|75906047|FG000|COMPLETED|Day 1||71||
59619597|NCT03033576|75730850|FG001|Received Protocol-directed Therapy|Overall Study||68||
59619598|NCT03033576|75730849|FG000|COMPLETED|Overall Study||8||
59619599|NCT03033576|75730850|FG001|COMPLETED|Overall Study||0||
59619600|NCT03033576|75730849|FG000|NOT COMPLETED|Overall Study||16||
59619601|NCT03033576|75730850|FG001|NOT COMPLETED|Overall Study||70||
59619602|NCT04129944|75730860|FG000|STARTED|Overall Study||46||
59619603|NCT04129944|75730861|FG001|STARTED|Overall Study||45||
59619604|NCT04129944|75730862|FG002|STARTED|Overall Study||46||
59619605|NCT04129944|75730863|FG003|STARTED|Overall Study||46||
59619606|NCT04129944|75730860|FG000|COMPLETED|Overall Study||44||
59619607|NCT04129944|75730861|FG001|COMPLETED|Overall Study||45||
59619608|NCT04129944|75730862|FG002|COMPLETED|Overall Study||45||
59785919|NCT03055832|75906048|FG001|COMPLETED|Day 1||71||
59785920|NCT03055832|75906047|FG000|NOT COMPLETED|Day 1||0||
59785921|NCT03055832|75906048|FG001|NOT COMPLETED|Day 1||0||
60073100|NCT01694121|76188312|FG000|NOT COMPLETED|Overall Study||1||
60073101|NCT01694121|76188313|FG001|NOT COMPLETED|Overall Study||0||
60073102|NCT01562613|76188319|FG000|STARTED|Overall Study||533||
60073103|NCT01562613|76188319|FG000|COMPLETED|Overall Study||529||
60073104|NCT01562613|76188319|FG000|NOT COMPLETED|Overall Study||4||
60073105|NCT01693185|76188325|FG000|STARTED|Overall Study||27||
60073106|NCT01693185|76188326|FG001|STARTED|Overall Study||33||
60073107|NCT01693185|76188325|FG000|COMPLETED|Overall Study||27||
59619609|NCT04129944|75730863|FG003|COMPLETED|Overall Study||43||
59619610|NCT04129944|75730860|FG000|NOT COMPLETED|Overall Study||2||
59619611|NCT04129944|75730861|FG001|NOT COMPLETED|Overall Study||0||
59619612|NCT04129944|75730862|FG002|NOT COMPLETED|Overall Study||1||
59619613|NCT04129944|75730863|FG003|NOT COMPLETED|Overall Study||3||
59619614|NCT02972424|75730875|FG000|STARTED|3 Month Endpoints- Blinded Portion||18||
59619615|NCT02972424|75730876|FG001|STARTED|3 Month Endpoints- Blinded Portion||17||
59619616|NCT02972424|75730875|FG000|COMPLETED|3 Month Endpoints- Blinded Portion||17||
59619617|NCT02972424|75730876|FG001|COMPLETED|3 Month Endpoints- Blinded Portion||12||
59619618|NCT02972424|75730875|FG000|NOT COMPLETED|3 Month Endpoints- Blinded Portion||1||
59619619|NCT02972424|75730876|FG001|NOT COMPLETED|3 Month Endpoints- Blinded Portion||5||
59619620|NCT02972424|75730875|FG000|STARTED|Open Label Extension 3 to 12 Months||17||
59619621|NCT02972424|75730876|FG001|STARTED|Open Label Extension 3 to 12 Months||12||
59619622|NCT02972424|75730875|FG000|COMPLETED|Open Label Extension 3 to 12 Months||12||
59619623|NCT02972424|75730876|FG001|COMPLETED|Open Label Extension 3 to 12 Months||9||
59785922|NCT03055832|75906047|FG000|STARTED|Week 2||71||
59785923|NCT03055832|75906048|FG001|STARTED|Week 2||71||
59785924|NCT03055832|75906047|FG000|COMPLETED|Week 2||70||
59785925|NCT03055832|75906048|FG001|COMPLETED|Week 2||71||
59785926|NCT03055832|75906047|FG000|NOT COMPLETED|Week 2||1||
59785927|NCT03055832|75906048|FG001|NOT COMPLETED|Week 2||0||
60073108|NCT01693185|76188326|FG001|COMPLETED|Overall Study||27||
60073109|NCT01693185|76188325|FG000|NOT COMPLETED|Overall Study||0||
59619624|NCT02972424|75730875|FG000|NOT COMPLETED|Open Label Extension 3 to 12 Months||5||
59619625|NCT02972424|75730876|FG001|NOT COMPLETED|Open Label Extension 3 to 12 Months||3||
59619626|NCT02316366|75730885|FG000|STARTED|Overall Study||40||
59785928|NCT03055832|75906047|FG000|STARTED|Week 4||70||
59785929|NCT03055832|75906048|FG001|STARTED|Week 4||71||
59785930|NCT03055832|75906047|FG000|COMPLETED|Week 4||70||
59785931|NCT03055832|75906048|FG001|COMPLETED|Week 4||71||
59785932|NCT03055832|75906047|FG000|NOT COMPLETED|Week 4||0||
59785933|NCT03055832|75906048|FG001|NOT COMPLETED|Week 4||0||
59785934|NCT02951351|75906070|FG000|STARTED|Overall Study||19||
59785935|NCT02951351|75906071|FG001|STARTED|Overall Study||17||
59785936|NCT02951351|75906070|FG000|COMPLETED|Overall Study||19||
59522648|NCT02936206|75617114|FG001|NOT COMPLETED|Overall Study||0||
59522649|NCT01426516|75617122|FG000|STARTED|Overall Study||12||
59522650|NCT01426516|75617123|FG001|STARTED|Overall Study||17||
59522651|NCT01426516|75617122|FG000|COMPLETED|Overall Study||12||
59522652|NCT01426516|75617123|FG001|COMPLETED|Overall Study||17||
59522653|NCT01426516|75617122|FG000|NOT COMPLETED|Overall Study||0||
59522654|NCT01426516|75617123|FG001|NOT COMPLETED|Overall Study||0||
59522655|NCT02819908|75617131|FG000|STARTED|Overall Study||12|25 patients total of 50 eyes|
59522656|NCT02819908|75617132|FG001|STARTED|Overall Study||13|25 patients total of 50 eyes|
59522657|NCT02819908|75617131|FG000|COMPLETED|Overall Study||12||
59522658|NCT02819908|75617132|FG001|COMPLETED|Overall Study||13||
59522659|NCT02819908|75617131|FG000|NOT COMPLETED|Overall Study||0||
59619627|NCT02316366|75730886|FG001|STARTED|Overall Study||40||
59619628|NCT02316366|75730885|FG000|COMPLETED|Overall Study||40||
59619629|NCT02316366|75730886|FG001|COMPLETED|Overall Study||40||
59619630|NCT02316366|75730885|FG000|NOT COMPLETED|Overall Study||0||
59619631|NCT02316366|75730886|FG001|NOT COMPLETED|Overall Study||0||
59619632|NCT02315352|75730894|FG000|STARTED|First Intervention (Day 1)||24||
59619633|NCT02315352|75730895|FG001|STARTED|First Intervention (Day 1)||24||
59619634|NCT02315352|75730896|FG002|STARTED|First Intervention (Day 1)||0||
59619635|NCT02315352|75730897|FG003|STARTED|First Intervention (Day 1)||0||
59619636|NCT02315352|75730898|FG004|STARTED|First Intervention (Day 1)||0||
59619637|NCT02315352|75730899|FG005|STARTED|First Intervention (Day 1)||0||
59619638|NCT02315352|75730900|FG006|STARTED|First Intervention (Day 1)||0||
59619639|NCT02315352|75730901|FG007|STARTED|First Intervention (Day 1)||0||
59522660|NCT02819908|75617132|FG001|NOT COMPLETED|Overall Study||0||
59522661|NCT01406860|75617142|FG000|STARTED|Overall Study||11||
59522662|NCT01406860|75617143|FG001|STARTED|Overall Study||8||
59522663|NCT01406860|75617142|FG000|COMPLETED|Overall Study||11||
59522664|NCT01406860|75617143|FG001|COMPLETED|Overall Study||8||
59522665|NCT01406860|75617142|FG000|NOT COMPLETED|Overall Study||0||
59522666|NCT01406860|75617143|FG001|NOT COMPLETED|Overall Study||0||
59522667|NCT02773576|75617152|FG000|STARTED|Overall Study||0||
59522668|NCT02773576|75617153|FG001|STARTED|Overall Study||0||
59522669|NCT02773576|75617152|FG000|COMPLETED|Overall Study||0||
59522670|NCT02773576|75617153|FG001|COMPLETED|Overall Study||0||
59522671|NCT02773576|75617152|FG000|NOT COMPLETED|Overall Study||0||
59522672|NCT02773576|75617153|FG001|NOT COMPLETED|Overall Study||0||
59522673|NCT01394926|75617159|FG000|STARTED|Overall Study||21||
59522674|NCT01394926|75617159|FG000|COMPLETED|Overall Study||21||
59522675|NCT01394926|75617159|FG000|NOT COMPLETED|Overall Study||0||
59522676|NCT01350232|75617168|FG000|STARTED|Overall Study||2||
59522677|NCT01350232|75617168|FG000|COMPLETED|Overall Study||2||
59522678|NCT01350232|75617168|FG000|NOT COMPLETED|Overall Study||0||
59522679|NCT02758132|75617174|FG000|STARTED|Overall Study||0||
59522680|NCT02758132|75617175|FG001|STARTED|Overall Study||1||
59522681|NCT02758132|75617174|FG000|COMPLETED|Overall Study||0||
59522682|NCT02758132|75617175|FG001|COMPLETED|Overall Study||0||
59522683|NCT02758132|75617174|FG000|NOT COMPLETED|Overall Study||0||
59522684|NCT02758132|75617175|FG001|NOT COMPLETED|Overall Study||1||
59522685|NCT01313416|75617181|FG000|STARTED|Overall Study||2||
59522686|NCT01313416|75617181|FG000|COMPLETED|Overall Study||2||
59619640|NCT02315352|75730894|FG000|COMPLETED|First Intervention (Day 1)||24||
59785937|NCT02951351|75906071|FG001|COMPLETED|Overall Study||17||
59785938|NCT02951351|75906070|FG000|NOT COMPLETED|Overall Study||0||
59785939|NCT02951351|75906071|FG001|NOT COMPLETED|Overall Study||0||
59785940|NCT02915705|75906079|FG000|STARTED|Treatment Period||32||
59785941|NCT02915705|75906080|FG001|STARTED|Treatment Period||29||
59522687|NCT01313416|75617181|FG000|NOT COMPLETED|Overall Study||0||
59522688|NCT01269034|75617189|FG000|STARTED|Overall Study||1||
59619641|NCT02315352|75730895|FG001|COMPLETED|First Intervention (Day 1)||24||
59785942|NCT02915705|75906079|FG000|Completed Week 40|Treatment Period||32||
59619642|NCT02315352|75730896|FG002|COMPLETED|First Intervention (Day 1)||0||
59619643|NCT02315352|75730897|FG003|COMPLETED|First Intervention (Day 1)||0||
59619644|NCT02315352|75730898|FG004|COMPLETED|First Intervention (Day 1)||0||
59619645|NCT02315352|75730899|FG005|COMPLETED|First Intervention (Day 1)||0||
59619646|NCT02315352|75730900|FG006|COMPLETED|First Intervention (Day 1)||0||
59619647|NCT02315352|75730901|FG007|COMPLETED|First Intervention (Day 1)||0||
59619648|NCT02315352|75730894|FG000|NOT COMPLETED|First Intervention (Day 1)||0||
59619649|NCT02315352|75730895|FG001|NOT COMPLETED|First Intervention (Day 1)||0||
59619650|NCT02315352|75730896|FG002|NOT COMPLETED|First Intervention (Day 1)||0||
59619651|NCT02315352|75730897|FG003|NOT COMPLETED|First Intervention (Day 1)||0||
59619652|NCT02315352|75730898|FG004|NOT COMPLETED|First Intervention (Day 1)||0||
59619653|NCT02315352|75730899|FG005|NOT COMPLETED|First Intervention (Day 1)||0||
59619654|NCT02315352|75730900|FG006|NOT COMPLETED|First Intervention (Day 1)||0||
59619655|NCT02315352|75730901|FG007|NOT COMPLETED|First Intervention (Day 1)||0||
59619656|NCT02315352|75730894|FG000|STARTED|Second Intervention (Day 1)||24||
59619657|NCT02315352|75730895|FG001|STARTED|Second Intervention (Day 1)||24||
59619658|NCT02315352|75730896|FG002|STARTED|Second Intervention (Day 1)||0||
59619659|NCT02315352|75730897|FG003|STARTED|Second Intervention (Day 1)||0||
59619660|NCT02315352|75730898|FG004|STARTED|Second Intervention (Day 1)||0||
59619661|NCT02315352|75730899|FG005|STARTED|Second Intervention (Day 1)||0||
59619662|NCT02315352|75730900|FG006|STARTED|Second Intervention (Day 1)||0||
59619663|NCT02315352|75730901|FG007|STARTED|Second Intervention (Day 1)||0||
59619664|NCT02315352|75730894|FG000|COMPLETED|Second Intervention (Day 1)|Out of 24 subjects completing this period, 1 discontinued before assignment to any sequence on Day 2|24||
59619665|NCT02315352|75730895|FG001|COMPLETED|Second Intervention (Day 1)||24||
59619666|NCT02315352|75730896|FG002|COMPLETED|Second Intervention (Day 1)||0||
59619667|NCT02315352|75730897|FG003|COMPLETED|Second Intervention (Day 1)||0||
59619668|NCT02315352|75730898|FG004|COMPLETED|Second Intervention (Day 1)||0||
59619669|NCT02315352|75730899|FG005|COMPLETED|Second Intervention (Day 1)||0||
59619670|NCT02315352|75730900|FG006|COMPLETED|Second Intervention (Day 1)||0||
59619671|NCT02315352|75730901|FG007|COMPLETED|Second Intervention (Day 1)||0||
59619672|NCT02315352|75730894|FG000|NOT COMPLETED|Second Intervention (Day 1)||0||
59619673|NCT02315352|75730895|FG001|NOT COMPLETED|Second Intervention (Day 1)||0||
59619674|NCT02315352|75730896|FG002|NOT COMPLETED|Second Intervention (Day 1)||0||
59619675|NCT02315352|75730897|FG003|NOT COMPLETED|Second Intervention (Day 1)||0||
59619676|NCT02315352|75730898|FG004|NOT COMPLETED|Second Intervention (Day 1)||0||
59619677|NCT02315352|75730899|FG005|NOT COMPLETED|Second Intervention (Day 1)||0||
59619678|NCT02315352|75730900|FG006|NOT COMPLETED|Second Intervention (Day 1)||0||
59619679|NCT02315352|75730901|FG007|NOT COMPLETED|Second Intervention (Day 1)||0||
59619680|NCT02315352|75730894|FG000|STARTED|Third Intervention (Day 2)||0||
59619681|NCT02315352|75730895|FG001|STARTED|Third Intervention (Day 2)||0||
59619682|NCT02315352|75730896|FG002|STARTED|Third Intervention (Day 2)||7||
59619683|NCT02315352|75730897|FG003|STARTED|Third Intervention (Day 2)||8||
59619684|NCT02315352|75730898|FG004|STARTED|Third Intervention (Day 2)||8||
59619685|NCT02315352|75730899|FG005|STARTED|Third Intervention (Day 2)||7||
59619686|NCT02315352|75730900|FG006|STARTED|Third Intervention (Day 2)||9||
59619687|NCT02315352|75730901|FG007|STARTED|Third Intervention (Day 2)||8||
59619688|NCT02315352|75730894|FG000|COMPLETED|Third Intervention (Day 2)||0||
59619689|NCT02315352|75730895|FG001|COMPLETED|Third Intervention (Day 2)||0||
59619690|NCT02315352|75730896|FG002|COMPLETED|Third Intervention (Day 2)||7||
59619691|NCT02315352|75730897|FG003|COMPLETED|Third Intervention (Day 2)||8||
59619692|NCT02315352|75730898|FG004|COMPLETED|Third Intervention (Day 2)||8||
59619693|NCT02315352|75730899|FG005|COMPLETED|Third Intervention (Day 2)||7||
59619694|NCT02315352|75730900|FG006|COMPLETED|Third Intervention (Day 2)||9||
59619695|NCT02315352|75730901|FG007|COMPLETED|Third Intervention (Day 2)||8||
59619696|NCT02315352|75730894|FG000|NOT COMPLETED|Third Intervention (Day 2)||0||
59619697|NCT02315352|75730895|FG001|NOT COMPLETED|Third Intervention (Day 2)||0||
59619698|NCT02315352|75730896|FG002|NOT COMPLETED|Third Intervention (Day 2)||0||
59619699|NCT02315352|75730897|FG003|NOT COMPLETED|Third Intervention (Day 2)||0||
59619700|NCT02315352|75730898|FG004|NOT COMPLETED|Third Intervention (Day 2)||0||
59619701|NCT02315352|75730899|FG005|NOT COMPLETED|Third Intervention (Day 2)||0||
59619702|NCT02315352|75730900|FG006|NOT COMPLETED|Third Intervention (Day 2)||0||
59619703|NCT02315352|75730901|FG007|NOT COMPLETED|Third Intervention (Day 2)||0||
59619704|NCT02315352|75730894|FG000|STARTED|Fourth Intervention (Day 2)||0||
59619705|NCT02315352|75730895|FG001|STARTED|Fourth Intervention (Day 2)||0||
59619706|NCT02315352|75730896|FG002|STARTED|Fourth Intervention (Day 2)||7||
59619707|NCT02315352|75730897|FG003|STARTED|Fourth Intervention (Day 2)||8||
59619708|NCT02315352|75730898|FG004|STARTED|Fourth Intervention (Day 2)||8||
59619709|NCT02315352|75730899|FG005|STARTED|Fourth Intervention (Day 2)||7||
59785943|NCT02915705|75906080|FG001|Completed Week 40|Treatment Period||29||
59619710|NCT02315352|75730900|FG006|STARTED|Fourth Intervention (Day 2)||9||
59619711|NCT02315352|75730901|FG007|STARTED|Fourth Intervention (Day 2)||8||
59619712|NCT02315352|75730894|FG000|COMPLETED|Fourth Intervention (Day 2)||0||
59619713|NCT02315352|75730895|FG001|COMPLETED|Fourth Intervention (Day 2)||0||
59619714|NCT02315352|75730896|FG002|COMPLETED|Fourth Intervention (Day 2)||7||
59785944|NCT02915705|75906079|FG000|Completed Week 64|Treatment Period||32||
59785945|NCT02915705|75906080|FG001|Completed Week 64|Treatment Period||29||
59785946|NCT02915705|75906079|FG000|COMPLETED|Treatment Period||32||
59785947|NCT02915705|75906080|FG001|COMPLETED|Treatment Period||29||
59785948|NCT02915705|75906079|FG000|NOT COMPLETED|Treatment Period||0||
59785949|NCT02915705|75906080|FG001|NOT COMPLETED|Treatment Period||0||
59785950|NCT02915705|75906079|FG000|STARTED|Long Term Extension Period|6 participants did not enter the extension period|26||
59785951|NCT02915705|75906080|FG001|STARTED|Long Term Extension Period|4 participants did not enter the extension period|25||
59785952|NCT02915705|75906079|FG000|COMPLETED|Long Term Extension Period||26||
59785953|NCT02915705|75906080|FG001|COMPLETED|Long Term Extension Period||25||
59785954|NCT02915705|75906079|FG000|NOT COMPLETED|Long Term Extension Period||0||
59785955|NCT02915705|75906080|FG001|NOT COMPLETED|Long Term Extension Period||0||
59785956|NCT02768870|75906089|FG000|STARTED|Overall Study||26|Enrolled in Study|
59785957|NCT02768870|75906089|FG000|Implanted With Device|Overall Study||24||
59785958|NCT02768870|75906089|FG000|Discharge|Overall Study||26||
59785959|NCT02768870|75906089|FG000|30 Days|Overall Study||26||
59785960|NCT02768870|75906089|FG000|6 Months|Overall Study||25||
59785961|NCT02768870|75906089|FG000|12 Months|Overall Study||23||
59785962|NCT02768870|75906089|FG000|18 Months|Overall Study||23||
59785963|NCT02768870|75906089|FG000|24 Months|Overall Study||21||
59785964|NCT02768870|75906089|FG000|30 Months|Overall Study||19||
59785965|NCT02768870|75906089|FG000|36 Months|Overall Study||17||
59785966|NCT02768870|75906089|FG000|48 Months|Overall Study||15||
59785967|NCT02768870|75906089|FG000|60 Months|Overall Study||14||
59785968|NCT02768870|75906089|FG000|COMPLETED|Overall Study||14||
59785969|NCT02768870|75906089|FG000|NOT COMPLETED|Overall Study||12||
59785970|NCT02750618|75906093|FG000|STARTED|Overall Study||13||
59785971|NCT02750618|75906093|FG000|Completed Week 40|Overall Study||13||
59785972|NCT02750618|75906093|FG000|Completed Week 64|Overall Study||13||
59785973|NCT02750618|75906093|FG000|COMPLETED|Overall Study||12||
59785974|NCT02750618|75906093|FG000|NOT COMPLETED|Overall Study||1||
59785975|NCT02537431|75906097|FG000|STARTED|Open-Label Period (Week 0 to Week 48)|Screened and received at least 1 dose of study drug.|14||
59785976|NCT02537431|75906097|FG000|COMPLETED|Open-Label Period (Week 0 to Week 48)|Completed Open-Label Period (Week 0 - Week 48)|13||
59785977|NCT02537431|75906097|FG000|NOT COMPLETED|Open-Label Period (Week 0 to Week 48)||1||
59785978|NCT02537431|75906097|FG000|STARTED|Treatment Extension Period I||13||
59785979|NCT02537431|75906097|FG000|COMPLETED|Treatment Extension Period I||13||
59785980|NCT02537431|75906097|FG000|NOT COMPLETED|Treatment Extension Period I||0||
59785981|NCT02537431|75906097|FG000|STARTED|Treatment Extension Period II|5 participants completing Treatment Extension Period I did not enter Treatment Extension Period II|8||
59785982|NCT02537431|75906097|FG000|COMPLETED|Treatment Extension Period II||8||
59785983|NCT02537431|75906097|FG000|NOT COMPLETED|Treatment Extension Period II||0||
59785984|NCT02526160|75906103|FG000|STARTED|Double-Blind (Placebo-Controlled) Period||66||
59785985|NCT02526160|75906104|FG001|STARTED|Double-Blind (Placebo-Controlled) Period||68||
59785986|NCT02526160|75906103|FG000|COMPLETED|Double-Blind (Placebo-Controlled) Period||66||
59785987|NCT02526160|75906104|FG001|COMPLETED|Double-Blind (Placebo-Controlled) Period||67||
59785988|NCT02526160|75906103|FG000|NOT COMPLETED|Double-Blind (Placebo-Controlled) Period||0||
59785989|NCT02526160|75906104|FG001|NOT COMPLETED|Double-Blind (Placebo-Controlled) Period||1||
59785990|NCT02526160|75906103|FG000|STARTED|Open-label Treatment Continuation Period||66||
59785991|NCT02526160|75906104|FG001|STARTED|Open-label Treatment Continuation Period||67||
59785992|NCT02526160|75906103|FG000|COMPLETED|Open-label Treatment Continuation Period||63||
59785993|NCT02526160|75906104|FG001|COMPLETED|Open-label Treatment Continuation Period||63||
59785994|NCT02526160|75906103|FG000|NOT COMPLETED|Open-label Treatment Continuation Period||3||
59785995|NCT02526160|75906104|FG001|NOT COMPLETED|Open-label Treatment Continuation Period||4||
59785996|NCT02526160|75906103|FG000|STARTED|Open-Label Treatment Extension Period I||63||
59785997|NCT02526160|75906104|FG001|STARTED|Open-Label Treatment Extension Period I||63||
59785998|NCT02526160|75906103|FG000|COMPLETED|Open-Label Treatment Extension Period I||60||
59785999|NCT02526160|75906104|FG001|COMPLETED|Open-Label Treatment Extension Period I||59||
59786000|NCT02526160|75906103|FG000|NOT COMPLETED|Open-Label Treatment Extension Period I||3||
59786001|NCT02526160|75906104|FG001|NOT COMPLETED|Open-Label Treatment Extension Period I||4||
59786002|NCT02526160|75906103|FG000|STARTED|Open-Label Treatment Extension Period II||52||
59786003|NCT02526160|75906104|FG001|STARTED|Open-Label Treatment Extension Period II||49||
59786004|NCT02526160|75906103|FG000|COMPLETED|Open-Label Treatment Extension Period II||51||
59786005|NCT02526160|75906104|FG001|COMPLETED|Open-Label Treatment Extension Period II||49||
59786006|NCT02526160|75906103|FG000|NOT COMPLETED|Open-Label Treatment Extension Period II||1||
59786007|NCT02526160|75906104|FG001|NOT COMPLETED|Open-Label Treatment Extension Period II||0||
59786008|NCT02163577|75906117|FG000|STARTED|Overall Study||26||
59786009|NCT02163577|75906118|FG001|STARTED|Overall Study||26||
59786010|NCT02163577|75906117|FG000|COMPLETED|Overall Study||26||
59786011|NCT02163577|75906118|FG001|COMPLETED|Overall Study||26||
59786012|NCT02163577|75906117|FG000|NOT COMPLETED|Overall Study||0||
59786013|NCT02163577|75906118|FG001|NOT COMPLETED|Overall Study||0||
59786014|NCT02157610|75906126|FG000|STARTED|Overall Study||100||
59786015|NCT02157610|75906127|FG001|STARTED|Overall Study||102||
59786016|NCT02157610|75906126|FG000|COMPLETED|Overall Study||96||
59786017|NCT02157610|75906127|FG001|COMPLETED|Overall Study||98||
59786018|NCT02157610|75906126|FG000|NOT COMPLETED|Overall Study||4||
59786019|NCT02157610|75906127|FG001|NOT COMPLETED|Overall Study||4||
59786020|NCT02078869|75906135|FG000|STARTED|Overall Study||17||
59786021|NCT02078869|75906136|FG001|STARTED|Overall Study||17||
59786022|NCT02078869|75906135|FG000|COMPLETED|Overall Study||17||
59786023|NCT02078869|75906136|FG001|COMPLETED|Overall Study||17||
59786024|NCT02078869|75906135|FG000|NOT COMPLETED|Overall Study||0||
59786025|NCT02078869|75906136|FG001|NOT COMPLETED|Overall Study||0||
59786026|NCT01718873|75906144|FG000|STARTED|Overall Study||115||
59786027|NCT01718873|75906145|FG001|STARTED|Overall Study||115||
59786028|NCT01718873|75906144|FG000|COMPLETED|Overall Study||115||
59786029|NCT01718873|75906145|FG001|COMPLETED|Overall Study||115||
59786030|NCT01718873|75906144|FG000|NOT COMPLETED|Overall Study||0||
59786031|NCT01718873|75906145|FG001|NOT COMPLETED|Overall Study||0||
59786032|NCT01511250|75906161|FG000|STARTED|Overall Study||24||
59786033|NCT01511250|75906162|FG001|STARTED|Overall Study||14||
59786034|NCT01511250|75906163|FG002|STARTED|Overall Study||22||
59786035|NCT01511250|75906164|FG003|STARTED|Overall Study||14||
59786036|NCT01511250|75906165|FG004|STARTED|Overall Study||21||
59786037|NCT01511250|75906166|FG005|STARTED|Overall Study||17||
59786038|NCT01511250|75906167|FG006|STARTED|Overall Study||23||
59786039|NCT01511250|75906168|FG007|STARTED|Overall Study||13||
59786040|NCT01511250|75906169|FG008|STARTED|Overall Study||159||
59786041|NCT01511250|75906170|FG009|STARTED|Overall Study||53||
59786042|NCT01511250|75906161|FG000|COMPLETED|Overall Study||15||
59786043|NCT01511250|75906162|FG001|COMPLETED|Overall Study||9||
59786044|NCT01511250|75906163|FG002|COMPLETED|Overall Study||18||
59786045|NCT01511250|75906164|FG003|COMPLETED|Overall Study||11||
59786046|NCT01511250|75906165|FG004|COMPLETED|Overall Study||21||
59786047|NCT01511250|75906166|FG005|COMPLETED|Overall Study||17||
59786048|NCT01511250|75906167|FG006|COMPLETED|Overall Study||21||
59786049|NCT01511250|75906168|FG007|COMPLETED|Overall Study||9||
59786050|NCT01511250|75906169|FG008|COMPLETED|Overall Study||145||
59786051|NCT01511250|75906170|FG009|COMPLETED|Overall Study||48||
59786052|NCT01511250|75906161|FG000|NOT COMPLETED|Overall Study||9||
59786053|NCT01511250|75906162|FG001|NOT COMPLETED|Overall Study||5||
59786054|NCT01511250|75906163|FG002|NOT COMPLETED|Overall Study||4||
59786055|NCT01511250|75906164|FG003|NOT COMPLETED|Overall Study||3||
59786056|NCT01511250|75906165|FG004|NOT COMPLETED|Overall Study||0||
59786057|NCT01511250|75906166|FG005|NOT COMPLETED|Overall Study||0||
59786058|NCT01511250|75906167|FG006|NOT COMPLETED|Overall Study||2||
59786059|NCT01511250|75906168|FG007|NOT COMPLETED|Overall Study||4||
59786060|NCT01511250|75906169|FG008|NOT COMPLETED|Overall Study||14||
59786061|NCT01511250|75906170|FG009|NOT COMPLETED|Overall Study||5||
59786062|NCT01424566|75906192|FG000|STARTED|Single-blind Treatment||406||
59786063|NCT01424566|75906193|FG001|STARTED|Single-blind Treatment|Participants were not enrolled in this arm in the single-blind period.|0||
59786064|NCT01424566|75906194|FG002|STARTED|Single-blind Treatment|Participants were not enrolled in this arm in the single-blind period.|0||
59786065|NCT01424566|75906192|FG000|Received at Least 1 Dose of Study Drug|Single-blind Treatment|Two participants did not administer any study drug.|404||
59786066|NCT01424566|75906193|FG001|Received at Least 1 Dose of Study Drug|Single-blind Treatment||0||
59786067|NCT01424566|75906194|FG002|Received at Least 1 Dose of Study Drug|Single-blind Treatment||0||
59786068|NCT01424566|75906192|FG000|Single-blind Safety Population|Single-blind Treatment||404||
59786069|NCT01424566|75906193|FG001|Single-blind Safety Population|Single-blind Treatment||0||
59786070|NCT01424566|75906194|FG002|Single-blind Safety Population|Single-blind Treatment||0||
59786071|NCT01424566|75906192|FG000|Met Randomization Criteria|Single-blind Treatment||206||
59786072|NCT01424566|75906193|FG001|Met Randomization Criteria|Single-blind Treatment||0||
59786073|NCT01424566|75906194|FG002|Met Randomization Criteria|Single-blind Treatment||0||
59786074|NCT01424566|75906192|FG000|COMPLETED|Single-blind Treatment||206||
59786075|NCT01424566|75906193|FG001|COMPLETED|Single-blind Treatment||0||
59786076|NCT01424566|75906194|FG002|COMPLETED|Single-blind Treatment||0||
59786077|NCT01424566|75906192|FG000|NOT COMPLETED|Single-blind Treatment||200||
59786078|NCT01424566|75906193|FG001|NOT COMPLETED|Single-blind Treatment||0||
59786079|NCT01424566|75906194|FG002|NOT COMPLETED|Single-blind Treatment||0||
59786080|NCT01424566|75906192|FG000|STARTED|Double-blind Treatment|Participants were not enrolled in this arm in the double-blind period.|0||
59786081|NCT01424566|75906193|FG001|STARTED|Double-blind Treatment|Participants were not enrolled in this arm in the single-blind period.|103||
59786082|NCT01424566|75906194|FG002|STARTED|Double-blind Treatment|Participants were not enrolled in this arm in the single-blind period.|103||
59786083|NCT01424566|75906192|FG000|Received at Least 1 Dose of Study Drug|Double-blind Treatment||0||
59786084|NCT01424566|75906193|FG001|Received at Least 1 Dose of Study Drug|Double-blind Treatment||103||
59786085|NCT01424566|75906194|FG002|Received at Least 1 Dose of Study Drug|Double-blind Treatment||103||
59786086|NCT01424566|75906192|FG000|Randomized Safety Population|Double-blind Treatment||0||
59786087|NCT01424566|75906193|FG001|Randomized Safety Population|Double-blind Treatment||103||
59786088|NCT01424566|75906194|FG002|Randomized Safety Population|Double-blind Treatment||103||
59786089|NCT01424566|75906192|FG000|ITT Population|Double-blind Treatment||0||
59786090|NCT01424566|75906193|FG001|ITT Population|Double-blind Treatment||103||
59786091|NCT01424566|75906194|FG002|ITT Population|Double-blind Treatment||103||
59786092|NCT01424566|75906192|FG000|COMPLETED|Double-blind Treatment||0||
59786093|NCT01424566|75906193|FG001|COMPLETED|Double-blind Treatment||78||
59786094|NCT01424566|75906194|FG002|COMPLETED|Double-blind Treatment||88||
59786095|NCT01424566|75906192|FG000|NOT COMPLETED|Double-blind Treatment||0||
59786096|NCT01424566|75906193|FG001|NOT COMPLETED|Double-blind Treatment||25||
59786097|NCT01424566|75906194|FG002|NOT COMPLETED|Double-blind Treatment||15||
59786098|NCT01361607|75906203|FG000|STARTED|Overall Study|Two participants randomized to nabiximols did not receive any study drug|200||
59786099|NCT01361607|75906204|FG001|STARTED|Overall Study||199||
59786100|NCT01361607|75906203|FG000|Received at Least 1 Dose of Study Drug|Overall Study||198||
59786101|NCT01361607|75906204|FG001|Received at Least 1 Dose of Study Drug|Overall Study||199||
59786102|NCT01361607|75906203|FG000|Safety Population|Overall Study|One participant randomized to nabiximols received placebo Day 22 but analyzed as nabiximols-treated|199||
59786103|NCT01361607|75906204|FG001|Safety Population|Overall Study|One participant randomized to placebo received nabiximols Day 1 but analyzed as nabiximols-treated|198||
59786104|NCT01361607|75906203|FG000|ITT Population|Overall Study||198||
59786105|NCT01361607|75906204|FG001|ITT Population|Overall Study|One participant randomized to placebo received nabiximols Day 1 but analyzed as placebo-treated|199||
59786106|NCT01361607|75906203|FG000|COMPLETED|Overall Study||136||
59786107|NCT01361607|75906204|FG001|COMPLETED|Overall Study||158||
59786108|NCT01361607|75906203|FG000|NOT COMPLETED|Overall Study||64||
59786109|NCT01361607|75906204|FG001|NOT COMPLETED|Overall Study||41||
59786110|NCT01337089|75906211|FG000|STARTED|Overall Study||660||
59786111|NCT01337089|75906211|FG000|Received at Least 1 Dose of Study Drug|Overall Study||660||
59786112|NCT01337089|75906211|FG000|Safety Population|Overall Study||660||
59786113|NCT01337089|75906211|FG000|Efficacy Dataset|Overall Study|One participant withdrew after administering nabiximols, but no efficacy data were collected.|659||
59786114|NCT01337089|75906211|FG000|COMPLETED|Overall Study||256||
59786115|NCT01337089|75906211|FG000|NOT COMPLETED|Overall Study||404||
59786116|NCT01276587|75906215|FG000|STARTED|Overall Study||4||
59786117|NCT01276587|75906215|FG000|COMPLETED|Overall Study||4||
59786118|NCT01276587|75906215|FG000|NOT COMPLETED|Overall Study||0||
59786119|NCT00279500|75906219|FG000|STARTED|Overall Study|6 patients treated|6||
59786120|NCT00279500|75906219|FG000|COMPLETED|Overall Study|6 patients treated|6||
59786121|NCT00279500|75906219|FG000|NOT COMPLETED|Overall Study||0||
59786122|NCT00114530|75906225|FG000|STARTED|Overall Study||36||
59786123|NCT00114530|75906226|FG001|STARTED|Overall Study||39||
59786124|NCT00114530|75906225|FG000|COMPLETED|Overall Study|Completed 72 mo, 54 mo after failure, or at least 54 mo at study end (last patient's 54 mo visit)|27||
59786125|NCT00114530|75906226|FG001|COMPLETED|Overall Study|Completed 72 mo, 54 mo after failure, or at least 54 mo at study end (last patient's 54 mo visit)|19||
59786126|NCT00114530|75906225|FG000|NOT COMPLETED|Overall Study||9||
59786127|NCT00114530|75906226|FG001|NOT COMPLETED|Overall Study||20||
59786128|NCT00107744|75906239|FG000|STARTED|Intervention 1 (8 Weeks)||117||
59786129|NCT00107744|75906240|FG001|STARTED|Intervention 1 (8 Weeks)||117||
59786130|NCT00107744|75906241|FG002|STARTED|Intervention 1 (8 Weeks)||118||
59786131|NCT00107744|75906239|FG000|COMPLETED|Intervention 1 (8 Weeks)||101||
59786132|NCT00107744|75906240|FG001|COMPLETED|Intervention 1 (8 Weeks)||104||
59786133|NCT00107744|75906241|FG002|COMPLETED|Intervention 1 (8 Weeks)||101||
59786134|NCT00107744|75906239|FG000|NOT COMPLETED|Intervention 1 (8 Weeks)||16||
59786135|NCT00107744|75906240|FG001|NOT COMPLETED|Intervention 1 (8 Weeks)||13||
59786136|NCT00107744|75906241|FG002|NOT COMPLETED|Intervention 1 (8 Weeks)||17||
59786137|NCT00107744|75906239|FG000|STARTED|Intervention 2 (8 Weeks)||101||
59786138|NCT00107744|75906240|FG001|STARTED|Intervention 2 (8 Weeks)||104||
59786139|NCT00107744|75906241|FG002|STARTED|Intervention 2 (8 Weeks)||101||
59786140|NCT00107744|75906239|FG000|COMPLETED|Intervention 2 (8 Weeks)||93||
59786141|NCT00107744|75906240|FG001|COMPLETED|Intervention 2 (8 Weeks)||92||
59786142|NCT00107744|75906241|FG002|COMPLETED|Intervention 2 (8 Weeks)||88||
59786143|NCT00107744|75906239|FG000|NOT COMPLETED|Intervention 2 (8 Weeks)||8||
59786144|NCT00107744|75906240|FG001|NOT COMPLETED|Intervention 2 (8 Weeks)||12||
59786145|NCT00107744|75906241|FG002|NOT COMPLETED|Intervention 2 (8 Weeks)||13||
59786146|NCT00107744|75906239|FG000|STARTED|Intervention 3 (8 Weeks)||93||
59786147|NCT00107744|75906240|FG001|STARTED|Intervention 3 (8 Weeks)||92||
59786148|NCT00107744|75906241|FG002|STARTED|Intervention 3 (8 Weeks)||88||
59786149|NCT00107744|75906239|FG000|COMPLETED|Intervention 3 (8 Weeks)||93||
59786150|NCT00107744|75906240|FG001|COMPLETED|Intervention 3 (8 Weeks)||92||
59786151|NCT00107744|75906241|FG002|COMPLETED|Intervention 3 (8 Weeks)||88||
59786152|NCT00107744|75906239|FG000|NOT COMPLETED|Intervention 3 (8 Weeks)||0||
59786153|NCT00107744|75906240|FG001|NOT COMPLETED|Intervention 3 (8 Weeks)||0||
59786154|NCT00107744|75906241|FG002|NOT COMPLETED|Intervention 3 (8 Weeks)||0||
59817849|NCT04488770|75940327|FG001|COMPLETED|Part 1-Cohort 1: Period 4 (Up to 5 Days)||2||
59817850|NCT04488770|75940328|FG002|COMPLETED|Part 1-Cohort 1: Period 4 (Up to 5 Days)||2||
59817851|NCT04488770|75940329|FG003|COMPLETED|Part 1-Cohort 1: Period 4 (Up to 5 Days)||2||
59817852|NCT04488770|75940330|FG004|COMPLETED|Part 1-Cohort 1: Period 4 (Up to 5 Days)||0||
59817853|NCT04488770|75940331|FG005|COMPLETED|Part 1-Cohort 1: Period 4 (Up to 5 Days)||0||
59817854|NCT04488770|75940332|FG006|COMPLETED|Part 1-Cohort 1: Period 4 (Up to 5 Days)||0||
59817855|NCT04488770|75940333|FG007|COMPLETED|Part 1-Cohort 1: Period 4 (Up to 5 Days)||0||
59817856|NCT04488770|75940334|FG008|COMPLETED|Part 1-Cohort 1: Period 4 (Up to 5 Days)||0||
59786155|NCT00618982|75906249|FG000|STARTED|Overall Study||83||
59786156|NCT00618982|75906249|FG000|COMPLETED|Overall Study||33||
59786157|NCT00618982|75906249|FG000|NOT COMPLETED|Overall Study||50||
59786158|NCT00578786|75906259|FG000|STARTED|Overall Study||96||
59786159|NCT00578786|75906260|FG001|STARTED|Overall Study||190||
59786160|NCT00578786|75906261|FG002|STARTED|Overall Study||97||
59786161|NCT00578786|75906259|FG000|COMPLETED|Overall Study||57||
59786162|NCT00578786|75906260|FG001|COMPLETED|Overall Study||124||
59786163|NCT00578786|75906261|FG002|COMPLETED|Overall Study||67||
59786164|NCT00578786|75906259|FG000|NOT COMPLETED|Overall Study||39||
59786165|NCT00578786|75906260|FG001|NOT COMPLETED|Overall Study||66||
59786166|NCT00578786|75906261|FG002|NOT COMPLETED|Overall Study||30||
59786167|NCT00424255|75906281|FG000|STARTED|Overall Study||342||
59786168|NCT00424255|75906282|FG001|STARTED|Overall Study||346||
59786169|NCT00424255|75906281|FG000|COMPLETED|Overall Study||0||
59786170|NCT00424255|75906282|FG001|COMPLETED|Overall Study||0||
59786171|NCT00424255|75906281|FG000|NOT COMPLETED|Overall Study||342||
59786172|NCT00424255|75906282|FG001|NOT COMPLETED|Overall Study||346||
59786173|NCT00620074|75906288|FG000|STARTED|Overall Study||6||
59786174|NCT00620074|75906288|FG000|COMPLETED|Overall Study||5||
59786175|NCT00620074|75906288|FG000|NOT COMPLETED|Overall Study||1||
59786176|NCT00424177|75906292|FG000|STARTED|Cycle 1: Eltrombopag 50 mg Starting Dose||66||
59786177|NCT00424177|75906292|FG000|COMPLETED|Cycle 1: Eltrombopag 50 mg Starting Dose||55||
59786178|NCT00424177|75906292|FG000|NOT COMPLETED|Cycle 1: Eltrombopag 50 mg Starting Dose||11||
59786179|NCT00424177|75906292|FG000|STARTED|Cycle 2: Eltrombopag 50 or 75 mg||55||
59786180|NCT00424177|75906292|FG000|COMPLETED|Cycle 2: Eltrombopag 50 or 75 mg||51||
59786181|NCT00424177|75906292|FG000|NOT COMPLETED|Cycle 2: Eltrombopag 50 or 75 mg||4||
59786182|NCT00424177|75906292|FG000|STARTED|Cycle 3: Eltrombopag 50 or 75 mg||51||
59786183|NCT00424177|75906292|FG000|COMPLETED|Cycle 3: Eltrombopag 50 or 75 mg||48||
59786184|NCT00424177|75906292|FG000|NOT COMPLETED|Cycle 3: Eltrombopag 50 or 75 mg||3||
59786185|NCT00618826|75906304|FG000|STARTED|Overall Study||14||
59786186|NCT00618826|75906304|FG000|COMPLETED|Overall Study||13||
59786187|NCT00618826|75906304|FG000|NOT COMPLETED|Overall Study||1||
59786188|NCT00578448|75906309|FG000|STARTED|Day 1 up to 3 Years of Planned Study||12||
59786189|NCT00578448|75906309|FG000|COMPLETED|Day 1 up to 3 Years of Planned Study||9||
59786190|NCT00578448|75906309|FG000|NOT COMPLETED|Day 1 up to 3 Years of Planned Study||3||
59786191|NCT00578448|75906309|FG000|STARTED|1 Year Long Term Extension (LTE)||9||
59786192|NCT00578448|75906309|FG000|COMPLETED|1 Year Long Term Extension (LTE)||8||
59786193|NCT00578448|75906309|FG000|NOT COMPLETED|1 Year Long Term Extension (LTE)||1||
59786194|NCT00578318|75906317|FG000|STARTED|Overall Study||8||
59786195|NCT00578318|75906318|FG001|STARTED|Overall Study||8||
59786196|NCT00578318|75906317|FG000|COMPLETED|Overall Study||5||
59786197|NCT00578318|75906318|FG001|COMPLETED|Overall Study||8||
59786198|NCT00578318|75906317|FG000|NOT COMPLETED|Overall Study||3||
59786199|NCT00578318|75906318|FG001|NOT COMPLETED|Overall Study||0||
60073110|NCT01693185|76188326|FG001|NOT COMPLETED|Overall Study||6||
60073111|NCT03629080|76188338|FG000|STARTED|Overall Study||12||
60073112|NCT03629080|76188339|FG001|STARTED|Overall Study||5||
60073113|NCT03629080|76188340|FG002|STARTED|Overall Study||35||
60073114|NCT03629080|76188341|FG003|STARTED|Overall Study||17||
59786200|NCT00618748|75906327|FG000|STARTED|Overall Study||56||
59786201|NCT00618748|75906328|FG001|STARTED|Overall Study||25||
59786202|NCT00618748|75906329|FG002|STARTED|Overall Study||20||
59786203|NCT00618748|75906327|FG000|COMPLETED|Overall Study||45||
59786204|NCT00618748|75906328|FG001|COMPLETED|Overall Study||20||
59786205|NCT00618748|75906329|FG002|COMPLETED|Overall Study||6||
59786206|NCT00618748|75906327|FG000|NOT COMPLETED|Overall Study||11||
59786207|NCT00618748|75906328|FG001|NOT COMPLETED|Overall Study||5||
59786208|NCT00618748|75906329|FG002|NOT COMPLETED|Overall Study||14||
60073115|NCT03629080|76188342|FG004|STARTED|Overall Study||10||
59786209|NCT00658359|75906340|FG000|STARTED|Overall Study||64||
59786210|NCT00658359|75906341|FG001|STARTED|Overall Study||60||
59786211|NCT00658359|75906342|FG002|STARTED|Overall Study||54||
59786212|NCT00658359|75906340|FG000|COMPLETED|Overall Study||36||
59786213|NCT00658359|75906341|FG001|COMPLETED|Overall Study||15||
59786214|NCT00658359|75906342|FG002|COMPLETED|Overall Study||8||
60073116|NCT03629080|76188343|FG005|STARTED|Overall Study||4||
60073117|NCT03629080|76188338|FG000|COMPLETED|Overall Study||10||
60073118|NCT03629080|76188339|FG001|COMPLETED|Overall Study||4||
60073119|NCT03629080|76188340|FG002|COMPLETED|Overall Study||22||
60073120|NCT03629080|76188341|FG003|COMPLETED|Overall Study||16||
60073121|NCT03629080|76188342|FG004|COMPLETED|Overall Study||6||
59786215|NCT00658359|75906340|FG000|NOT COMPLETED|Overall Study||28||
59786216|NCT00658359|75906341|FG001|NOT COMPLETED|Overall Study||45||
59786217|NCT00658359|75906342|FG002|NOT COMPLETED|Overall Study||46||
59786218|NCT00619918|75906354|FG000|STARTED|Overall Study||230||
59786219|NCT00619918|75906355|FG001|STARTED|Overall Study||217||
59786220|NCT00619918|75906354|FG000|COMPLETED|Overall Study||210||
59786221|NCT00619918|75906355|FG001|COMPLETED|Overall Study||195||
59786222|NCT00619918|75906354|FG000|NOT COMPLETED|Overall Study||20||
60073122|NCT03629080|76188343|FG005|COMPLETED|Overall Study||3||
59786223|NCT00619918|75906355|FG001|NOT COMPLETED|Overall Study||22||
60073123|NCT03629080|76188338|FG000|NOT COMPLETED|Overall Study||2||
59786224|NCT01005914|75906361|FG000|STARTED|Overall Study||11||
59786225|NCT01005914|75906361|FG000|COMPLETED|Overall Study||1||
59786226|NCT01005914|75906361|FG000|NOT COMPLETED|Overall Study||10||
59786227|NCT03650088|75906365|FG000|STARTED|Overall Study||18||
59786228|NCT03650088|75906365|FG000|COMPLETED|Overall Study||17||
59786229|NCT03650088|75906365|FG000|NOT COMPLETED|Overall Study||1||
59786230|NCT00618514|75906372|FG000|STARTED|Overall Study||36||
59786231|NCT00618514|75906373|FG001|STARTED|Overall Study||38||
59786232|NCT00618514|75906374|FG002|STARTED|Overall Study||16||
59786233|NCT00618514|75906372|FG000|COMPLETED|Overall Study||25||
59786234|NCT00618514|75906373|FG001|COMPLETED|Overall Study||26||
59786235|NCT00618514|75906374|FG002|COMPLETED|Overall Study||12||
59786236|NCT00618514|75906372|FG000|NOT COMPLETED|Overall Study||11||
59786237|NCT00618514|75906373|FG001|NOT COMPLETED|Overall Study||12||
59786238|NCT00618514|75906374|FG002|NOT COMPLETED|Overall Study||4||
59786239|NCT00655629|75906382|FG000|STARTED|Overall Study||172||
59786240|NCT00655629|75906383|FG001|STARTED|Overall Study||167||
59786241|NCT00655629|75906382|FG000|Participants Received Treatment|Overall Study|1 patient could not verify drug ingestion. (safety population)|171||
59786242|NCT00655629|75906383|FG001|Participants Received Treatment|Overall Study|1 patient could not verify drug ingestion.(safety population)|166||
59786243|NCT00655629|75906382|FG000|COMPLETED|Overall Study||151||
59786244|NCT00655629|75906383|FG001|COMPLETED|Overall Study||144||
59786245|NCT00655629|75906382|FG000|NOT COMPLETED|Overall Study||21||
59786246|NCT00655629|75906383|FG001|NOT COMPLETED|Overall Study||23||
59786247|NCT00578292|75906389|FG000|STARTED|Overall Study||10||
59786248|NCT00578292|75906389|FG000|COMPLETED|Overall Study||7||
59786249|NCT00578292|75906389|FG000|NOT COMPLETED|Overall Study||3||
59786250|NCT00570063|75906395|FG000|STARTED|Overall Study||24||
59786251|NCT00570063|75906396|FG001|STARTED|Overall Study||11||
59786252|NCT00570063|75906395|FG000|COMPLETED|Overall Study||9||
59786253|NCT00570063|75906396|FG001|COMPLETED|Overall Study||3||
59786254|NCT00570063|75906395|FG000|NOT COMPLETED|Overall Study||15||
59786255|NCT00570063|75906396|FG001|NOT COMPLETED|Overall Study||8||
59786256|NCT03401918|75906404|FG000|STARTED|Overall Study||25||
59786257|NCT03401918|75906405|FG001|STARTED|Overall Study||16||
59786258|NCT03401918|75906404|FG000|COMPLETED|Overall Study||25||
59786259|NCT03401918|75906405|FG001|COMPLETED|Overall Study||16||
59786260|NCT03401918|75906404|FG000|NOT COMPLETED|Overall Study||0||
59786261|NCT03401918|75906405|FG001|NOT COMPLETED|Overall Study||0||
59786262|NCT00577772|75906413|FG000|STARTED|Overall Study||10||
59786263|NCT00577772|75906414|FG001|STARTED|Overall Study||7||
59786264|NCT00577772|75906413|FG000|COMPLETED|Overall Study||10||
59786265|NCT00577772|75906414|FG001|COMPLETED|Overall Study||6||
59786266|NCT00577772|75906413|FG000|NOT COMPLETED|Overall Study||0||
59786267|NCT00577772|75906414|FG001|NOT COMPLETED|Overall Study||1||
60073124|NCT03629080|76188339|FG001|NOT COMPLETED|Overall Study||1||
60073125|NCT03629080|76188340|FG002|NOT COMPLETED|Overall Study||13||
60073126|NCT03629080|76188341|FG003|NOT COMPLETED|Overall Study||1||
60073127|NCT03629080|76188342|FG004|NOT COMPLETED|Overall Study||4||
60073128|NCT03629080|76188343|FG005|NOT COMPLETED|Overall Study||1||
60073129|NCT00003820|76188357|FG000|STARTED|Cycle 1 (Initial Treatment)||23||
60073130|NCT00003820|76188358|FG001|STARTED|Cycle 1 (Initial Treatment)||16||
60073131|NCT00003820|76188357|FG000|COMPLETED|Cycle 1 (Initial Treatment)||23||
59786268|NCT00578136|75906422|FG000|STARTED|Overall Study||27||
59786269|NCT00578136|75906423|FG001|STARTED|Overall Study||27||
59786270|NCT00578136|75906422|FG000|COMPLETED|Overall Study||26||
59786271|NCT00578136|75906423|FG001|COMPLETED|Overall Study||26||
59786272|NCT00578136|75906422|FG000|NOT COMPLETED|Overall Study||1||
59786273|NCT00578136|75906423|FG001|NOT COMPLETED|Overall Study||1||
59786274|NCT00655551|75906432|FG000|STARTED|All Periods Combined||25||
59786275|NCT00655551|75906433|FG001|STARTED|All Periods Combined||50||
59786276|NCT00655551|75906434|FG002|STARTED|All Periods Combined||25||
59786277|NCT00655551|75906432|FG000|COMPLETED|All Periods Combined||25||
59786278|NCT00655551|75906433|FG001|COMPLETED|All Periods Combined||47||
59786279|NCT00655551|75906434|FG002|COMPLETED|All Periods Combined||21||
60073132|NCT00003820|76188358|FG001|COMPLETED|Cycle 1 (Initial Treatment)||16||
60073133|NCT00003820|76188357|FG000|NOT COMPLETED|Cycle 1 (Initial Treatment)||0||
60073134|NCT00003820|76188358|FG001|NOT COMPLETED|Cycle 1 (Initial Treatment)||0||
60073135|NCT00003820|76188357|FG000|STARTED|Cycle 2 (Maintenance Treatment)|Initial Group of participants only received 1 cycle of treatment|0||
60073136|NCT00003820|76188358|FG001|STARTED|Cycle 2 (Maintenance Treatment)|Pts with treatment response/stable disease at 6 mos, & eligible to continue.|16||
60073137|NCT00003820|76188357|FG000|COMPLETED|Cycle 2 (Maintenance Treatment)||0||
59786280|NCT00655551|75906432|FG000|NOT COMPLETED|All Periods Combined||0||
59786281|NCT00655551|75906433|FG001|NOT COMPLETED|All Periods Combined||3||
59786282|NCT00655551|75906434|FG002|NOT COMPLETED|All Periods Combined||4||
59786283|NCT00655551|75906432|FG000|STARTED|Period 1 (up to 7 Days)||25||
59786284|NCT00655551|75906433|FG001|STARTED|Period 1 (up to 7 Days)||0||
59786285|NCT00655551|75906434|FG002|STARTED|Period 1 (up to 7 Days)||0||
59786286|NCT00655551|75906432|FG000|COMPLETED|Period 1 (up to 7 Days)||25||
59786287|NCT00655551|75906433|FG001|COMPLETED|Period 1 (up to 7 Days)||0||
59786288|NCT00655551|75906434|FG002|COMPLETED|Period 1 (up to 7 Days)||0||
59786289|NCT00655551|75906432|FG000|NOT COMPLETED|Period 1 (up to 7 Days)||0||
59786290|NCT00655551|75906433|FG001|NOT COMPLETED|Period 1 (up to 7 Days)||0||
59786291|NCT00655551|75906434|FG002|NOT COMPLETED|Period 1 (up to 7 Days)||0||
59786292|NCT00655551|75906432|FG000|STARTED|Period 2 (up to 7 Days)||0||
59786293|NCT00655551|75906433|FG001|STARTED|Period 2 (up to 7 Days)||25||
59786294|NCT00655551|75906434|FG002|STARTED|Period 2 (up to 7 Days)||0||
59786295|NCT00655551|75906432|FG000|COMPLETED|Period 2 (up to 7 Days)||0||
59786296|NCT00655551|75906433|FG001|COMPLETED|Period 2 (up to 7 Days)||24||
59786297|NCT00655551|75906434|FG002|COMPLETED|Period 2 (up to 7 Days)||0||
59786298|NCT00655551|75906432|FG000|NOT COMPLETED|Period 2 (up to 7 Days)||0||
59786299|NCT00655551|75906433|FG001|NOT COMPLETED|Period 2 (up to 7 Days)||1||
59786300|NCT00655551|75906434|FG002|NOT COMPLETED|Period 2 (up to 7 Days)||0||
59786301|NCT00655551|75906432|FG000|STARTED|Period 3 (up to 7 Days)||0||
59786302|NCT00655551|75906433|FG001|STARTED|Period 3 (up to 7 Days)||0||
60073138|NCT00003820|76188358|FG001|COMPLETED|Cycle 2 (Maintenance Treatment)|Patients with treatment assessment at 12 months|16||
60073139|NCT00003820|76188357|FG000|NOT COMPLETED|Cycle 2 (Maintenance Treatment)||0||
60073140|NCT00003820|76188358|FG001|NOT COMPLETED|Cycle 2 (Maintenance Treatment)||0||
60073141|NCT00003820|76188357|FG000|STARTED|Cycle 3 (Maintenance Treatment)|Initial Group of participants only received 1 cycle of treatment|0||
60073142|NCT00003820|76188358|FG001|STARTED|Cycle 3 (Maintenance Treatment)|Patients with treatment response/stable disease at 12 months|16||
60073143|NCT00003820|76188357|FG000|COMPLETED|Cycle 3 (Maintenance Treatment)||0||
60073144|NCT00003820|76188358|FG001|COMPLETED|Cycle 3 (Maintenance Treatment)|Patients with treatment assessment at 18 months|16||
60073145|NCT00003820|76188357|FG000|NOT COMPLETED|Cycle 3 (Maintenance Treatment)||0||
59786303|NCT00655551|75906434|FG002|STARTED|Period 3 (up to 7 Days)||25||
59786304|NCT00655551|75906432|FG000|COMPLETED|Period 3 (up to 7 Days)||0||
59786305|NCT00655551|75906433|FG001|COMPLETED|Period 3 (up to 7 Days)||0||
59786306|NCT00655551|75906434|FG002|COMPLETED|Period 3 (up to 7 Days)||21||
59786307|NCT00655551|75906432|FG000|NOT COMPLETED|Period 3 (up to 7 Days)||0||
59786308|NCT00655551|75906433|FG001|NOT COMPLETED|Period 3 (up to 7 Days)||0||
59786309|NCT00655551|75906434|FG002|NOT COMPLETED|Period 3 (up to 7 Days)||4||
59786310|NCT00655551|75906432|FG000|STARTED|Period 4 (up to 7 Days)||0||
59786311|NCT00655551|75906433|FG001|STARTED|Period 4 (up to 7 Days)||25||
59786312|NCT00655551|75906434|FG002|STARTED|Period 4 (up to 7 Days)||0||
59786313|NCT00655551|75906432|FG000|COMPLETED|Period 4 (up to 7 Days)||0||
59786314|NCT00655551|75906433|FG001|COMPLETED|Period 4 (up to 7 Days)||23||
59786315|NCT00655551|75906434|FG002|COMPLETED|Period 4 (up to 7 Days)||0||
59786316|NCT00655551|75906432|FG000|NOT COMPLETED|Period 4 (up to 7 Days)||0||
59786317|NCT00655551|75906433|FG001|NOT COMPLETED|Period 4 (up to 7 Days)||2||
59786318|NCT00655551|75906434|FG002|NOT COMPLETED|Period 4 (up to 7 Days)||0||
59786319|NCT00312728|75906442|FG000|STARTED|Overall Study||115||
59786320|NCT00312728|75906442|FG000|COMPLETED|Overall Study||5||
59786321|NCT00312728|75906442|FG000|NOT COMPLETED|Overall Study||110||
59786322|NCT00577824|75906449|FG000|STARTED|Overall Study|Started=Randomized|72||
59786323|NCT00577824|75906450|FG001|STARTED|Overall Study||73||
59786324|NCT00577824|75906451|FG002|STARTED|Overall Study||36||
59786325|NCT00577824|75906449|FG000|Full Analysis Set|Overall Study|Full Analysis Set=subject received at least one dose of study medication (active or placebo)|72||
59786326|NCT00577824|75906450|FG001|Full Analysis Set|Overall Study||72||
59786327|NCT00577824|75906451|FG002|Full Analysis Set|Overall Study||35||
59786328|NCT00577824|75906449|FG000|COMPLETED|Overall Study||65||
59786329|NCT00577824|75906450|FG001|COMPLETED|Overall Study||53||
59786330|NCT00577824|75906451|FG002|COMPLETED|Overall Study||34||
59786331|NCT00577824|75906449|FG000|NOT COMPLETED|Overall Study||7||
59786332|NCT00577824|75906450|FG001|NOT COMPLETED|Overall Study||20||
59786333|NCT00577824|75906451|FG002|NOT COMPLETED|Overall Study||2||
59786334|NCT00617344|75906462|FG000|STARTED|Overall Study||104||
59786335|NCT00617344|75906463|FG001|STARTED|Overall Study||103||
59786336|NCT00617344|75906464|FG002|STARTED|Overall Study||53||
59786337|NCT00617344|75906462|FG000|Received Vaccination 1|Overall Study||104||
59786338|NCT00617344|75906463|FG001|Received Vaccination 1|Overall Study||103||
59786339|NCT00617344|75906464|FG002|Received Vaccination 1|Overall Study||53||
59786340|NCT00617344|75906462|FG000|Received Vaccination 2|Overall Study||86||
59786341|NCT00617344|75906463|FG001|Received Vaccination 2|Overall Study||85||
59786342|NCT00617344|75906464|FG002|Received Vaccination 2|Overall Study||46||
59786343|NCT00617344|75906462|FG000|Received Vaccination 3|Overall Study||79||
59786344|NCT00617344|75906463|FG001|Received Vaccination 3|Overall Study||81||
59786345|NCT00617344|75906464|FG002|Received Vaccination 3|Overall Study||45||
59786346|NCT00617344|75906462|FG000|COMPLETED|Overall Study||79||
60073146|NCT00003820|76188358|FG001|NOT COMPLETED|Cycle 3 (Maintenance Treatment)||0||
60103568|NCT01290640|76221809|FG001|STARTED|Overall Study||10||
59786347|NCT00617344|75906463|FG001|COMPLETED|Overall Study||81||
59786348|NCT00617344|75906464|FG002|COMPLETED|Overall Study||45||
59786349|NCT00617344|75906462|FG000|NOT COMPLETED|Overall Study||25||
59786350|NCT00617344|75906463|FG001|NOT COMPLETED|Overall Study||22||
59786351|NCT00617344|75906464|FG002|NOT COMPLETED|Overall Study||8||
59786352|NCT00321698|75906477|FG000|STARTED|Phase I, Rad Only & Dose 1-3||3||
59786353|NCT00321698|75906478|FG001|STARTED|Phase I, Rad Only & Dose 1-3||3||
59786354|NCT00321698|75906479|FG002|STARTED|Phase I, Rad Only & Dose 1-3||3||
59786355|NCT00321698|75906480|FG003|STARTED|Phase I, Rad Only & Dose 1-3||3||
59786356|NCT00321698|75906481|FG004|STARTED|Phase I, Rad Only & Dose 1-3||0||
59786357|NCT00321698|75906477|FG000|COMPLETED|Phase I, Rad Only & Dose 1-3||3||
59786358|NCT00321698|75906478|FG001|COMPLETED|Phase I, Rad Only & Dose 1-3||3||
59786359|NCT00321698|75906479|FG002|COMPLETED|Phase I, Rad Only & Dose 1-3||3||
59786360|NCT00321698|75906480|FG003|COMPLETED|Phase I, Rad Only & Dose 1-3||3||
59786361|NCT00321698|75906481|FG004|COMPLETED|Phase I, Rad Only & Dose 1-3||0||
59786362|NCT00321698|75906477|FG000|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0||
59786363|NCT00321698|75906478|FG001|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0||
59786364|NCT00321698|75906479|FG002|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0||
59786365|NCT00321698|75906480|FG003|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0||
59786366|NCT00321698|75906481|FG004|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0||
59786367|NCT00321698|75906477|FG000|STARTED|Phase II, MTD Dose||0||
59786368|NCT00321698|75906478|FG001|STARTED|Phase II, MTD Dose||0||
59786369|NCT00321698|75906479|FG002|STARTED|Phase II, MTD Dose||0||
59786370|NCT00321698|75906480|FG003|STARTED|Phase II, MTD Dose||0||
59786371|NCT00321698|75906481|FG004|STARTED|Phase II, MTD Dose|+1 screen failure|13||
59786372|NCT00321698|75906477|FG000|COMPLETED|Phase II, MTD Dose||0||
59786373|NCT00321698|75906478|FG001|COMPLETED|Phase II, MTD Dose||0||
59786374|NCT00321698|75906479|FG002|COMPLETED|Phase II, MTD Dose||0||
59786375|NCT00321698|75906480|FG003|COMPLETED|Phase II, MTD Dose||0||
59786376|NCT00321698|75906481|FG004|COMPLETED|Phase II, MTD Dose||13||
59786377|NCT00321698|75906477|FG000|NOT COMPLETED|Phase II, MTD Dose||0||
59786378|NCT00321698|75906478|FG001|NOT COMPLETED|Phase II, MTD Dose||0||
59786379|NCT00321698|75906479|FG002|NOT COMPLETED|Phase II, MTD Dose||0||
59786380|NCT00321698|75906480|FG003|NOT COMPLETED|Phase II, MTD Dose||0||
59786381|NCT00321698|75906481|FG004|NOT COMPLETED|Phase II, MTD Dose||0||
59786382|NCT00654381|75906497|FG000|STARTED|1st Stage||39||
59786383|NCT00654381|75906498|FG001|STARTED|1st Stage||41||
59786384|NCT00654381|75906499|FG002|STARTED|1st Stage||159||
59786385|NCT00654381|75906500|FG003|STARTED|1st Stage||160||
59786386|NCT00654381|75906501|FG004|STARTED|1st Stage||81||
59786387|NCT00654381|75906502|FG005|STARTED|1st Stage||81||
59786388|NCT00654381|75906497|FG000|COMPLETED|1st Stage||36||
59786389|NCT00654381|75906498|FG001|COMPLETED|1st Stage||38||
59786390|NCT00654381|75906499|FG002|COMPLETED|1st Stage||156||
59786391|NCT00654381|75906500|FG003|COMPLETED|1st Stage||155||
59786392|NCT00654381|75906501|FG004|COMPLETED|1st Stage||79||
59786393|NCT00654381|75906502|FG005|COMPLETED|1st Stage||79||
59786394|NCT00654381|75906497|FG000|NOT COMPLETED|1st Stage||3||
59786395|NCT00654381|75906498|FG001|NOT COMPLETED|1st Stage||3||
59786396|NCT00654381|75906499|FG002|NOT COMPLETED|1st Stage||3||
59786397|NCT00654381|75906500|FG003|NOT COMPLETED|1st Stage||5||
59786398|NCT00654381|75906501|FG004|NOT COMPLETED|1st Stage||2||
59786399|NCT00654381|75906502|FG005|NOT COMPLETED|1st Stage||2||
59786400|NCT00654381|75906497|FG000|STARTED|2nd Stage||36||
59786401|NCT00654381|75906498|FG001|STARTED|2nd Stage||38||
59786402|NCT00654381|75906499|FG002|STARTED|2nd Stage||156||
59786403|NCT00654381|75906500|FG003|STARTED|2nd Stage||155||
59786404|NCT00654381|75906501|FG004|STARTED|2nd Stage||79||
59786405|NCT00654381|75906502|FG005|STARTED|2nd Stage||79||
59786406|NCT00654381|75906497|FG000|COMPLETED|2nd Stage||34||
59786407|NCT00654381|75906498|FG001|COMPLETED|2nd Stage||38||
59786408|NCT00654381|75906499|FG002|COMPLETED|2nd Stage||153||
59786409|NCT00654381|75906500|FG003|COMPLETED|2nd Stage||151||
59786410|NCT00654381|75906501|FG004|COMPLETED|2nd Stage||71||
59786411|NCT00654381|75906502|FG005|COMPLETED|2nd Stage||76||
59786412|NCT00654381|75906497|FG000|NOT COMPLETED|2nd Stage||2||
59786413|NCT00654381|75906498|FG001|NOT COMPLETED|2nd Stage||0||
59786414|NCT00654381|75906499|FG002|NOT COMPLETED|2nd Stage||3||
59786415|NCT00654381|75906500|FG003|NOT COMPLETED|2nd Stage||4||
59786416|NCT00654381|75906501|FG004|NOT COMPLETED|2nd Stage||8||
59786417|NCT00654381|75906502|FG005|NOT COMPLETED|2nd Stage||3||
59786418|NCT00654381|75906497|FG000|STARTED|Extension Stage||34||
59786419|NCT00654381|75906498|FG001|STARTED|Extension Stage||38||
59786420|NCT00654381|75906499|FG002|STARTED|Extension Stage||153||
59786421|NCT00654381|75906500|FG003|STARTED|Extension Stage||151||
59786422|NCT00654381|75906501|FG004|STARTED|Extension Stage||71||
59786423|NCT00654381|75906502|FG005|STARTED|Extension Stage||76||
59786424|NCT00654381|75906497|FG000|COMPLETED|Extension Stage||33||
59786425|NCT00654381|75906498|FG001|COMPLETED|Extension Stage||36||
59786426|NCT00654381|75906499|FG002|COMPLETED|Extension Stage||142||
59786427|NCT00654381|75906500|FG003|COMPLETED|Extension Stage||142||
59786428|NCT00654381|75906501|FG004|COMPLETED|Extension Stage||68||
59786429|NCT00654381|75906502|FG005|COMPLETED|Extension Stage||73||
59786430|NCT00654381|75906497|FG000|NOT COMPLETED|Extension Stage||1||
59786431|NCT00654381|75906498|FG001|NOT COMPLETED|Extension Stage||2||
59786432|NCT00654381|75906499|FG002|NOT COMPLETED|Extension Stage||11||
59786433|NCT00654381|75906500|FG003|NOT COMPLETED|Extension Stage||9||
59786434|NCT00654381|75906501|FG004|NOT COMPLETED|Extension Stage||3||
59786435|NCT00654381|75906502|FG005|NOT COMPLETED|Extension Stage||3||
59786436|NCT04474314|75906522|FG000|STARTED|Overall Study||49||
59786437|NCT04474314|75906523|FG001|STARTED|Overall Study||34||
59786438|NCT04474314|75906524|FG002|STARTED|Overall Study||32||
59786439|NCT04474314|75906522|FG000|COMPLETED|Overall Study||2||
59786440|NCT04474314|75906523|FG001|COMPLETED|Overall Study||6||
59786441|NCT04474314|75906524|FG002|COMPLETED|Overall Study||8||
59786442|NCT04474314|75906522|FG000|NOT COMPLETED|Overall Study||47||
59786443|NCT04474314|75906523|FG001|NOT COMPLETED|Overall Study||28||
59786444|NCT04474314|75906524|FG002|NOT COMPLETED|Overall Study||24||
59786445|NCT00657267|75906532|FG000|STARTED|Overall Study||58||
59786446|NCT00657267|75906532|FG000|COMPLETED|Overall Study||4||
59786447|NCT00657267|75906532|FG000|NOT COMPLETED|Overall Study||54||
59786448|NCT00653991|75906540|FG000|STARTED|3 Month Follow-up||444||
59786449|NCT00653991|75906541|FG001|STARTED|3 Month Follow-up||491||
59786450|NCT00653991|75906540|FG000|COMPLETED|3 Month Follow-up||294||
59786451|NCT00653991|75906541|FG001|COMPLETED|3 Month Follow-up||334||
59786452|NCT00653991|75906540|FG000|NOT COMPLETED|3 Month Follow-up||150||
59786453|NCT00653991|75906541|FG001|NOT COMPLETED|3 Month Follow-up||157||
59786454|NCT00653991|75906540|FG000|STARTED|6 Month Follow-up|Completion of 3 month follow-up was not required for 6-month eligibility.|444||
59786455|NCT00653991|75906541|FG001|STARTED|6 Month Follow-up|Completion of 3 month follow-up was not required for 6-month eligibility.|491||
59786456|NCT00653991|75906540|FG000|COMPLETED|6 Month Follow-up||311||
59786457|NCT00653991|75906541|FG001|COMPLETED|6 Month Follow-up||350||
59786458|NCT00653991|75906540|FG000|NOT COMPLETED|6 Month Follow-up||133||
59786459|NCT00653991|75906541|FG001|NOT COMPLETED|6 Month Follow-up||141||
59786460|NCT00652899|75906549|FG000|STARTED|Overall Study||14||
59786461|NCT00652899|75906549|FG000|COMPLETED|Overall Study||12||
59786462|NCT00652899|75906549|FG000|NOT COMPLETED|Overall Study||2||
59786463|NCT00617890|75906561|FG000|STARTED|Overall Study||35||
59786464|NCT00617890|75906562|FG001|STARTED|Overall Study||33||
59786465|NCT00617890|75906563|FG002|STARTED|Overall Study||35||
59786466|NCT00617890|75906564|FG003|STARTED|Overall Study||116||
59786467|NCT00617890|75906561|FG000|Received Treatment|Overall Study||34||
59786468|NCT00617890|75906562|FG001|Received Treatment|Overall Study||33||
59786469|NCT00617890|75906563|FG002|Received Treatment|Overall Study||34||
59786470|NCT00617890|75906564|FG003|Received Treatment|Overall Study||115||
59786471|NCT00617890|75906561|FG000|COMPLETED|Overall Study||4||
59786472|NCT00617890|75906562|FG001|COMPLETED|Overall Study||5||
59786473|NCT00617890|75906563|FG002|COMPLETED|Overall Study||0||
59786474|NCT00617890|75906564|FG003|COMPLETED|Overall Study||1||
59786475|NCT00617890|75906561|FG000|NOT COMPLETED|Overall Study||31||
59786476|NCT00617890|75906562|FG001|NOT COMPLETED|Overall Study||28||
59786477|NCT00617890|75906563|FG002|NOT COMPLETED|Overall Study||35||
59786478|NCT00617890|75906564|FG003|NOT COMPLETED|Overall Study||115||
59786479|NCT00712166|75906579|FG000|STARTED|Overall Study||81||
59786480|NCT00712166|75906580|FG001|STARTED|Overall Study||76||
59786481|NCT00712166|75906579|FG000|COMPLETED|Overall Study||81||
59786482|NCT00712166|75906580|FG001|COMPLETED|Overall Study||75||
59786483|NCT00712166|75906579|FG000|NOT COMPLETED|Overall Study||0||
59786484|NCT00712166|75906580|FG001|NOT COMPLETED|Overall Study||1||
59786485|NCT00652743|75906591|FG000|STARTED|Months 12-18||219||
59786486|NCT00652743|75906592|FG001|STARTED|Months 12-18||188||
59786487|NCT00652743|75906593|FG002|STARTED|Months 12-18||437||
59786488|NCT00652743|75906591|FG000|COMPLETED|Months 12-18||218||
59786489|NCT00652743|75906592|FG001|COMPLETED|Months 12-18||186||
59786490|NCT00652743|75906593|FG002|COMPLETED|Months 12-18||430||
59786491|NCT00652743|75906591|FG000|NOT COMPLETED|Months 12-18||1||
59786492|NCT00652743|75906592|FG001|NOT COMPLETED|Months 12-18||2||
59786493|NCT00652743|75906593|FG002|NOT COMPLETED|Months 12-18||7||
59786494|NCT00652743|75906591|FG000|STARTED|Months 24-30||212||
59786495|NCT00652743|75906592|FG001|STARTED|Months 24-30||186||
59786496|NCT00652743|75906593|FG002|STARTED|Months 24-30||433||
59786497|NCT00652743|75906591|FG000|COMPLETED|Months 24-30||207||
59786498|NCT00652743|75906592|FG001|COMPLETED|Months 24-30||185||
59786499|NCT00652743|75906593|FG002|COMPLETED|Months 24-30||422||
59786500|NCT00652743|75906591|FG000|NOT COMPLETED|Months 24-30||5||
59786501|NCT00652743|75906592|FG001|NOT COMPLETED|Months 24-30||1||
59786502|NCT00652743|75906593|FG002|NOT COMPLETED|Months 24-30||11||
59786503|NCT00652743|75906591|FG000|STARTED|Months 36-42||216||
59786504|NCT00652743|75906592|FG001|STARTED|Months 36-42||185||
59786505|NCT00652743|75906593|FG002|STARTED|Months 36-42||390||
59786506|NCT00652743|75906591|FG000|COMPLETED|Months 36-42||210||
59786507|NCT00652743|75906592|FG001|COMPLETED|Months 36-42||180||
59786508|NCT00652743|75906593|FG002|COMPLETED|Months 36-42||381||
59786509|NCT00652743|75906591|FG000|NOT COMPLETED|Months 36-42||6||
59786510|NCT00652743|75906592|FG001|NOT COMPLETED|Months 36-42||5||
59786511|NCT00652743|75906593|FG002|NOT COMPLETED|Months 36-42||9||
59786512|NCT00652743|75906591|FG000|STARTED|Months 42-48||196||
59786513|NCT00652743|75906592|FG001|STARTED|Months 42-48||170||
59786514|NCT00652743|75906593|FG002|STARTED|Months 42-48||367||
59786515|NCT00652743|75906591|FG000|COMPLETED|Months 42-48||196||
59786516|NCT00652743|75906592|FG001|COMPLETED|Months 42-48||170||
59786517|NCT00652743|75906593|FG002|COMPLETED|Months 42-48||367||
59786518|NCT00652743|75906591|FG000|NOT COMPLETED|Months 42-48||0||
59786519|NCT00652743|75906592|FG001|NOT COMPLETED|Months 42-48||0||
59786520|NCT00652743|75906593|FG002|NOT COMPLETED|Months 42-48||0||
59786521|NCT00712010|75906604|FG000|STARTED|1st Protein Testing (1 Day)|1 subject withdrew his consent form before to starting the 1st intervention|24||
59786522|NCT00712010|75906604|FG000|COMPLETED|1st Protein Testing (1 Day)||24||
59786523|NCT00712010|75906604|FG000|NOT COMPLETED|1st Protein Testing (1 Day)||0||
59786524|NCT00712010|75906604|FG000|STARTED|Washout (7 Days)||24||
59786525|NCT00712010|75906604|FG000|COMPLETED|Washout (7 Days)||24||
59786526|NCT00712010|75906604|FG000|NOT COMPLETED|Washout (7 Days)||0||
59786527|NCT00712010|75906604|FG000|STARTED|2nd Protein Testing (1 Day)||24||
59786528|NCT00712010|75906604|FG000|COMPLETED|2nd Protein Testing (1 Day)||24||
59786529|NCT00712010|75906604|FG000|NOT COMPLETED|2nd Protein Testing (1 Day)||0||
59786530|NCT00712010|75906604|FG000|STARTED|Washout (7 Days)||24||
59786531|NCT00712010|75906604|FG000|COMPLETED|Washout (7 Days)||24||
59786532|NCT00712010|75906604|FG000|NOT COMPLETED|Washout (7 Days)||0||
59786533|NCT00712010|75906604|FG000|STARTED|3rd Protein Testing (1 Day)||24||
59786534|NCT00712010|75906604|FG000|COMPLETED|3rd Protein Testing (1 Day)||24||
59786535|NCT00712010|75906604|FG000|NOT COMPLETED|3rd Protein Testing (1 Day)||0||
59786536|NCT00712010|75906604|FG000|STARTED|Washout (7 Days)||24||
59786537|NCT00712010|75906604|FG000|COMPLETED|Washout (7 Days)||24||
59786538|NCT00712010|75906604|FG000|NOT COMPLETED|Washout (7 Days)||0||
59786539|NCT00712010|75906604|FG000|STARTED|4th Protein Testing (1 Day)||24||
59786540|NCT00712010|75906604|FG000|COMPLETED|4th Protein Testing (1 Day)||24||
59786541|NCT00712010|75906604|FG000|NOT COMPLETED|4th Protein Testing (1 Day)||0||
59786542|NCT00712010|75906604|FG000|STARTED|Washout (7 Days)||24||
59786543|NCT00712010|75906604|FG000|COMPLETED|Washout (7 Days)||23||
59786544|NCT00712010|75906604|FG000|NOT COMPLETED|Washout (7 Days)||1||
59786545|NCT00712010|75906604|FG000|STARTED|5th Protein Testing (1 Day)||23||
59786546|NCT00712010|75906604|FG000|COMPLETED|5th Protein Testing (1 Day)||23||
59786547|NCT00712010|75906604|FG000|NOT COMPLETED|5th Protein Testing (1 Day)||0||
59786548|NCT00712010|75906604|FG000|STARTED|Washout (7 Days)||23||
59786549|NCT00712010|75906604|FG000|COMPLETED|Washout (7 Days)||23||
59786550|NCT00712010|75906604|FG000|NOT COMPLETED|Washout (7 Days)||0||
59786551|NCT00712010|75906604|FG000|STARTED|6th Protein Testing (1 Day)||23||
59786552|NCT00712010|75906604|FG000|COMPLETED|6th Protein Testing (1 Day)||23||
59786553|NCT00712010|75906604|FG000|NOT COMPLETED|6th Protein Testing (1 Day)||0||
59786554|NCT00712010|75906604|FG000|STARTED|Washout (7 Days)||23||
59786555|NCT00712010|75906604|FG000|COMPLETED|Washout (7 Days)||23||
59786556|NCT00712010|75906604|FG000|NOT COMPLETED|Washout (7 Days)||0||
59786557|NCT00712010|75906604|FG000|STARTED|7th and Last Protein Testing (1 Day)||23||
59786558|NCT00712010|75906604|FG000|COMPLETED|7th and Last Protein Testing (1 Day)||23||
59786559|NCT00712010|75906604|FG000|NOT COMPLETED|7th and Last Protein Testing (1 Day)||0||
59786560|NCT00653523|75906620|FG000|STARTED|Overall Study||151||
59786561|NCT00653523|75906620|FG000|COMPLETED|Overall Study||132||
59786562|NCT00653523|75906620|FG000|NOT COMPLETED|Overall Study||19||
59786563|NCT02717442|75906626|FG000|STARTED|Overall Study||88||
59786564|NCT02717442|75906627|FG001|STARTED|Overall Study||88||
59786565|NCT02717442|75906626|FG000|COMPLETED|Overall Study||53||
59786566|NCT02717442|75906627|FG001|COMPLETED|Overall Study||59||
59786567|NCT02717442|75906626|FG000|NOT COMPLETED|Overall Study||35||
59786568|NCT02717442|75906627|FG001|NOT COMPLETED|Overall Study||29||
59786569|NCT05260333|75906640|FG000|STARTED|Overall Study||30|The patients acted as there own control. 30 patients were enrolled, but a total of 60 exams (1 TPUS and 1 SVE) were performed.|
59786570|NCT05260333|75906640|FG000|Transperineal Ultrasound|Overall Study||30|The patients acted as there own control. 30 patients were enrolled, but a total of 60 exams (1 TPUS and 1 SVE) were performed.|
59786571|NCT05260333|75906640|FG000|Digital Cervical Exam|Overall Study||30|The patients acted as there own control. 30 patients were enrolled, but a total of 60 exams (1 TPUS and 1 SVE) were performed.|
59786572|NCT05260333|75906640|FG000|COMPLETED|Overall Study||30|The patients acted as there own control. 30 patients were enrolled, but a total of 60 exams (1 TPUS and 1 SVE) were performed.|
59786573|NCT05260333|75906640|FG000|NOT COMPLETED|Overall Study||0||
59786574|NCT05233085|75906652|FG000|STARTED|Overall Study||9||
59786575|NCT05233085|75906653|FG001|STARTED|Overall Study||9||
59786576|NCT05233085|75906654|FG002|STARTED|Overall Study||9||
59786577|NCT05233085|75906655|FG003|STARTED|Overall Study||9||
59786578|NCT05233085|75906652|FG000|COMPLETED|Overall Study||8||
59786579|NCT05233085|75906653|FG001|COMPLETED|Overall Study||9||
59786580|NCT05233085|75906654|FG002|COMPLETED|Overall Study||9||
59786581|NCT05233085|75906655|FG003|COMPLETED|Overall Study||9||
59786582|NCT05233085|75906652|FG000|NOT COMPLETED|Overall Study||1||
59786583|NCT05233085|75906653|FG001|NOT COMPLETED|Overall Study||0||
59786584|NCT05233085|75906654|FG002|NOT COMPLETED|Overall Study||0||
59786585|NCT05233085|75906655|FG003|NOT COMPLETED|Overall Study||0||
59786586|NCT05052580|75906667|FG000|STARTED|Overall Study||4733||
59786587|NCT05052580|75906667|FG000|COMPLETED|Overall Study|Analysis eligible population: participants who were tested positive or had a negative follow-up test at day 5 or later, and completed follow-up among those enrolled|3489||
59786588|NCT05052580|75906667|FG000|NOT COMPLETED|Overall Study||1244||
59786589|NCT04738734|75906673|FG000|STARTED|Overall Study||75||
59786590|NCT04738734|75906674|FG001|STARTED|Overall Study||75||
59786591|NCT04738734|75906673|FG000|COMPLETED|Overall Study||68||
59786592|NCT04738734|75906674|FG001|COMPLETED|Overall Study||67||
59786593|NCT04738734|75906673|FG000|NOT COMPLETED|Overall Study||7||
59786594|NCT04738734|75906674|FG001|NOT COMPLETED|Overall Study||8||
59786595|NCT04707196|75906682|FG000|STARTED|Overall Study||137||
59786596|NCT04707196|75906683|FG001|STARTED|Overall Study||63||
59786597|NCT04707196|75906682|FG000|Received at Least 1 Dose of Study Drug|Overall Study||137||
59786598|NCT04707196|75906683|FG001|Received at Least 1 Dose of Study Drug|Overall Study||63||
59786599|NCT04707196|75906682|FG000|COMPLETED|Overall Study||108|Participants who completed 6 cycles of study intervention were considered completers.|
59786600|NCT04707196|75906683|FG001|COMPLETED|Overall Study||43|Participants who completed 6 cycles of study intervention were considered completers.|
59786601|NCT04707196|75906682|FG000|NOT COMPLETED|Overall Study||29||
59786602|NCT04707196|75906683|FG001|NOT COMPLETED|Overall Study||20||
59786603|NCT04553497|75906691|FG000|STARTED|Overall Study||17||
59786604|NCT04553497|75906692|FG001|STARTED|Overall Study||18||
59786605|NCT04553497|75906691|FG000|COMPLETED|Overall Study||15||
59786606|NCT04553497|75906692|FG001|COMPLETED|Overall Study||17||
59786607|NCT04553497|75906691|FG000|NOT COMPLETED|Overall Study||2||
59786608|NCT04553497|75906692|FG001|NOT COMPLETED|Overall Study||1||
59786609|NCT04551963|75906701|FG000|STARTED|Overall Study||13||
60073147|NCT00003820|76188357|FG000|STARTED|Cycle 4 (Maintenance Treatment)|Initial Group of participants only received 1 cycle of treatment|0||
60073148|NCT00003820|76188358|FG001|STARTED|Cycle 4 (Maintenance Treatment)|Patients with treatment response/stable disease at 18 months|16||
60073149|NCT00003820|76188357|FG000|COMPLETED|Cycle 4 (Maintenance Treatment)||0||
60073150|NCT00003820|76188358|FG001|COMPLETED|Cycle 4 (Maintenance Treatment)|Patients with treatment assessment at 24 months|16||
60073151|NCT00003820|76188357|FG000|NOT COMPLETED|Cycle 4 (Maintenance Treatment)||0||
59786610|NCT04551963|75906702|FG001|STARTED|Overall Study||13||
59786611|NCT04551963|75906701|FG000|COMPLETED|Overall Study||11||
59786612|NCT04551963|75906702|FG001|COMPLETED|Overall Study||12||
59786613|NCT04551963|75906701|FG000|NOT COMPLETED|Overall Study||2||
59786614|NCT04551963|75906702|FG001|NOT COMPLETED|Overall Study||1||
59786615|NCT04416555|75906712|FG000|STARTED|Overall Study||55||
59786616|NCT04416555|75906713|FG001|STARTED|Overall Study||58||
59786617|NCT04416555|75906712|FG000|COMPLETED|Overall Study||55||
59786618|NCT04416555|75906713|FG001|COMPLETED|Overall Study||55||
59786619|NCT04416555|75906712|FG000|NOT COMPLETED|Overall Study||0||
59786620|NCT04416555|75906713|FG001|NOT COMPLETED|Overall Study||3||
59786621|NCT04102007|75906719|FG000|STARTED|Overall Study||244||
59786622|NCT04102007|75906719|FG000|COMPLETED|Overall Study||205||
59786623|NCT04102007|75906719|FG000|NOT COMPLETED|Overall Study||39||
59786624|NCT03898960|75906723|FG000|STARTED|Overall Study||54||
59786625|NCT03898960|75906723|FG000|COMPLETED|Overall Study||44||
59786626|NCT03898960|75906723|FG000|NOT COMPLETED|Overall Study||10||
59786627|NCT03758118|75906729|FG000|STARTED|Overall Study||20||
59786628|NCT03758118|75906730|FG001|STARTED|Overall Study||20||
59786629|NCT03758118|75906729|FG000|COMPLETED|Overall Study||19||
59786630|NCT03758118|75906730|FG001|COMPLETED|Overall Study||17||
59786631|NCT03758118|75906729|FG000|NOT COMPLETED|Overall Study||1||
59786632|NCT03758118|75906730|FG001|NOT COMPLETED|Overall Study||3||
59786633|NCT03734237|75906739|FG000|STARTED|Overall Study||5145||
59786634|NCT03734237|75906740|FG001|STARTED|Overall Study||5150||
59953087|NCT04057820|76071792|FG012|STARTED|Period 3||22||3
59953088|NCT04057820|76071793|FG013|STARTED|Period 3||0||0
59953089|NCT04057820|76071794|FG014|STARTED|Period 3||24||3
59953090|NCT04057820|76071795|FG015|STARTED|Period 3||0||0
59953091|NCT04057820|76071780|FG000|COMPLETED|Period 3||0||0
59953092|NCT04057820|76071781|FG001|COMPLETED|Period 3||25||4
59953093|NCT04057820|76071782|FG002|COMPLETED|Period 3||0||0
59953094|NCT04057820|76071783|FG003|COMPLETED|Period 3||0||0
59953095|NCT04057820|76071784|FG004|COMPLETED|Period 3||7||3
60073152|NCT00003820|76188358|FG001|NOT COMPLETED|Cycle 4 (Maintenance Treatment)||0||
60073153|NCT01693029|76188366|FG000|STARTED|Overall Study||217|437 patients were randomized but 2 were excluded from analyses due to improper ICF signature process|
60073154|NCT01693029|76188367|FG001|STARTED|Overall Study||218|437 patients were randomized but 2 were excluded from analyses due to improper ICF signature process|
59522689|NCT01269034|75617190|FG001|STARTED|Overall Study||2||
59522690|NCT01269034|75617191|FG002|STARTED|Overall Study||1||
59786635|NCT03734237|75906741|FG002|STARTED|Overall Study||5137||
59786636|NCT03734237|75906739|FG000|COMPLETED|Overall Study||5137||
59786637|NCT03734237|75906740|FG001|COMPLETED|Overall Study||5138||
59786638|NCT03734237|75906741|FG002|COMPLETED|Overall Study||5127||
59953096|NCT04057820|76071785|FG005|COMPLETED|Period 3||0||0
59953097|NCT04057820|76071786|FG006|COMPLETED|Period 3||19||3
60073155|NCT01693029|76188366|FG000|COMPLETED|Overall Study||173||
60073156|NCT01693029|76188367|FG001|COMPLETED|Overall Study||161||
60073157|NCT01693029|76188366|FG000|NOT COMPLETED|Overall Study||44||
60073158|NCT01693029|76188367|FG001|NOT COMPLETED|Overall Study||57||
60073159|NCT01589445|76188373|FG000|STARTED|001 (Pioglitazone) -3 Months||77||
59786639|NCT03734237|75906739|FG000|NOT COMPLETED|Overall Study||8||
59786640|NCT03734237|75906740|FG001|NOT COMPLETED|Overall Study||12||
59786641|NCT03734237|75906741|FG002|NOT COMPLETED|Overall Study||10||
59953098|NCT04057820|76071787|FG007|COMPLETED|Period 3||0||0
59953099|NCT04057820|76071788|FG008|COMPLETED|Period 3||32||4
59953100|NCT04057820|76071789|FG009|COMPLETED|Period 3||0||0
59786642|NCT03654898|75906763|FG000|STARTED|Overall Study|Two participants were disqualified after enrollment. Both were disqualified because they were already on ART. Therefore, the baseline characteristics for 393 participants are reported in this arm.|395||
59786643|NCT03654898|75906764|FG001|STARTED|Overall Study|Four participants were disqualified after enrollment. Reasons for disqualification were that women 1) were already on ART (n=2); 2) participated in the VITAL Start pilot (n=1); 3) not pregnant at follow-up ANC visit five weeks after study enrollment (n=1). Therefore, the baseline characteristics for 401 participants are reported in this arm.|405||
59786644|NCT03654898|75906763|FG000|COMPLETED|Overall Study||304||
59786645|NCT03654898|75906764|FG001|COMPLETED|Overall Study||314||
59786646|NCT03654898|75906763|FG000|NOT COMPLETED|Overall Study||91||
59786647|NCT03654898|75906764|FG001|NOT COMPLETED|Overall Study||91||
59786648|NCT03584464|75906770|FG000|STARTED|Overall Study||205||
59786649|NCT03584464|75906770|FG000|COMPLETED|Overall Study|Number of subjects that competed 1 year follow up or had a CEC event|204||
59786650|NCT03584464|75906770|FG000|NOT COMPLETED|Overall Study||1||
59786651|NCT03531320|75906779|FG000|STARTED|Overall Study||4||
59786652|NCT03531320|75906780|FG001|STARTED|Overall Study||3||
59786653|NCT03531320|75906781|FG002|STARTED|Overall Study||3||
59786654|NCT03531320|75906782|FG003|STARTED|Overall Study||6||
59786655|NCT03531320|75906783|FG004|STARTED|Overall Study||3||
59786656|NCT03531320|75906779|FG000|COMPLETED|Overall Study||3||
59786657|NCT03531320|75906780|FG001|COMPLETED|Overall Study||3||
59786658|NCT03531320|75906781|FG002|COMPLETED|Overall Study||3||
59786659|NCT03531320|75906782|FG003|COMPLETED|Overall Study||6||
59786660|NCT03531320|75906783|FG004|COMPLETED|Overall Study||3||
59786661|NCT03531320|75906779|FG000|NOT COMPLETED|Overall Study||1||
59786662|NCT03531320|75906780|FG001|NOT COMPLETED|Overall Study||0||
59786663|NCT03531320|75906781|FG002|NOT COMPLETED|Overall Study||0||
59786664|NCT03531320|75906782|FG003|NOT COMPLETED|Overall Study||0||
59786665|NCT03531320|75906783|FG004|NOT COMPLETED|Overall Study||0||
59786666|NCT03496623|75906801|FG000|STARTED|Run-In Period (2 Weeks)||108||
59786667|NCT03496623|75906802|FG001|STARTED|Run-In Period (2 Weeks)||0||
59786668|NCT03496623|75906803|FG002|STARTED|Run-In Period (2 Weeks)||0||
59786669|NCT03496623|75906804|FG003|STARTED|Run-In Period (2 Weeks)||0||
59786670|NCT03496623|75906805|FG004|STARTED|Run-In Period (2 Weeks)||0||
59786671|NCT03496623|75906801|FG000|Received At Least 1 Dose of Study Drug|Run-In Period (2 Weeks)||108||
59786672|NCT03496623|75906802|FG001|Received At Least 1 Dose of Study Drug|Run-In Period (2 Weeks)||0||
59786673|NCT03496623|75906803|FG002|Received At Least 1 Dose of Study Drug|Run-In Period (2 Weeks)||0||
59786674|NCT03496623|75906804|FG003|Received At Least 1 Dose of Study Drug|Run-In Period (2 Weeks)||0||
59786675|NCT03496623|75906805|FG004|Received At Least 1 Dose of Study Drug|Run-In Period (2 Weeks)||0||
59786676|NCT03496623|75906801|FG000|COMPLETED|Run-In Period (2 Weeks)||76||
59786677|NCT03496623|75906802|FG001|COMPLETED|Run-In Period (2 Weeks)||0||
59786678|NCT03496623|75906803|FG002|COMPLETED|Run-In Period (2 Weeks)||0||
59786679|NCT03496623|75906804|FG003|COMPLETED|Run-In Period (2 Weeks)||0||
59786680|NCT03496623|75906805|FG004|COMPLETED|Run-In Period (2 Weeks)||0||
59786681|NCT03496623|75906801|FG000|NOT COMPLETED|Run-In Period (2 Weeks)||32||
59786682|NCT03496623|75906802|FG001|NOT COMPLETED|Run-In Period (2 Weeks)||0||
59786683|NCT03496623|75906803|FG002|NOT COMPLETED|Run-In Period (2 Weeks)||0||
59786684|NCT03496623|75906804|FG003|NOT COMPLETED|Run-In Period (2 Weeks)||0||
59786685|NCT03496623|75906805|FG004|NOT COMPLETED|Run-In Period (2 Weeks)||0||
59786686|NCT03496623|75906801|FG000|STARTED|Period 1 (12 Weeks)|108 participants enrolled to receive a low dose of treprostinil for 2 weeks during safety Run-In (before randomization) as part of screening. Data for this cohort are only included in Mortality and Adverse Events.|0||
59786687|NCT03496623|75906802|FG001|STARTED|Period 1 (12 Weeks)||32||
59786688|NCT03496623|75906803|FG002|STARTED|Period 1 (12 Weeks)||32||
59786689|NCT03496623|75906804|FG003|STARTED|Period 1 (12 Weeks)||6||
59786690|NCT03496623|75906805|FG004|STARTED|Period 1 (12 Weeks)||6||
59786691|NCT03496623|75906801|FG000|Received At Least 1 Dose of Study Drug|Period 1 (12 Weeks)||0||
59786692|NCT03496623|75906802|FG001|Received At Least 1 Dose of Study Drug|Period 1 (12 Weeks)||32||
59786693|NCT03496623|75906803|FG002|Received At Least 1 Dose of Study Drug|Period 1 (12 Weeks)||32||
59786694|NCT03496623|75906804|FG003|Received At Least 1 Dose of Study Drug|Period 1 (12 Weeks)||6||
59786695|NCT03496623|75906805|FG004|Received At Least 1 Dose of Study Drug|Period 1 (12 Weeks)||6||
59786696|NCT03496623|75906801|FG000|COMPLETED|Period 1 (12 Weeks)||0||
59786697|NCT03496623|75906802|FG001|COMPLETED|Period 1 (12 Weeks)||26||
59786698|NCT03496623|75906803|FG002|COMPLETED|Period 1 (12 Weeks)||29||
59786699|NCT03496623|75906804|FG003|COMPLETED|Period 1 (12 Weeks)||5||
59786700|NCT03496623|75906805|FG004|COMPLETED|Period 1 (12 Weeks)||4||
59786701|NCT03496623|75906801|FG000|NOT COMPLETED|Period 1 (12 Weeks)||0||
59786702|NCT03496623|75906802|FG001|NOT COMPLETED|Period 1 (12 Weeks)||6||
59786703|NCT03496623|75906803|FG002|NOT COMPLETED|Period 1 (12 Weeks)||3||
59786704|NCT03496623|75906804|FG003|NOT COMPLETED|Period 1 (12 Weeks)||1||
59786705|NCT03496623|75906805|FG004|NOT COMPLETED|Period 1 (12 Weeks)||2||
59786706|NCT03496623|75906801|FG000|STARTED|Period 2 (12 Weeks)|108 participants enrolled to receive a low dose of treprostinil for 2 weeks during the safety Run-In (before randomization) as part of screening. Data for this cohort are only included in Mortality and Adverse Events.|0||
59786707|NCT03496623|75906802|FG001|STARTED|Period 2 (12 Weeks)||26||
59786708|NCT03496623|75906803|FG002|STARTED|Period 2 (12 Weeks)||29||
59786709|NCT03496623|75906804|FG003|STARTED|Period 2 (12 Weeks)|No participants were planned for Period 2 in this cohort|0||
59786710|NCT03496623|75906805|FG004|STARTED|Period 2 (12 Weeks)|No participants were planned for Period 2 in this cohort|0||
59786711|NCT03496623|75906801|FG000|Received At Least 1 Dose of Study Drug|Period 2 (12 Weeks)||0||
59786712|NCT03496623|75906802|FG001|Received At Least 1 Dose of Study Drug|Period 2 (12 Weeks)||20||
59786713|NCT03496623|75906803|FG002|Received At Least 1 Dose of Study Drug|Period 2 (12 Weeks)||28||
59786714|NCT03496623|75906804|FG003|Received At Least 1 Dose of Study Drug|Period 2 (12 Weeks)||0||
59786715|NCT03496623|75906805|FG004|Received At Least 1 Dose of Study Drug|Period 2 (12 Weeks)||0||
59786716|NCT03496623|75906801|FG000|COMPLETED|Period 2 (12 Weeks)||0||
59786717|NCT03496623|75906802|FG001|COMPLETED|Period 2 (12 Weeks)||19||
59786718|NCT03496623|75906803|FG002|COMPLETED|Period 2 (12 Weeks)||21||
59786719|NCT03496623|75906804|FG003|COMPLETED|Period 2 (12 Weeks)||0||
59786720|NCT03496623|75906805|FG004|COMPLETED|Period 2 (12 Weeks)||0||
59786721|NCT03496623|75906801|FG000|NOT COMPLETED|Period 2 (12 Weeks)||0||
59786722|NCT03496623|75906802|FG001|NOT COMPLETED|Period 2 (12 Weeks)||7||
59786723|NCT03496623|75906803|FG002|NOT COMPLETED|Period 2 (12 Weeks)||8||
59786724|NCT03496623|75906804|FG003|NOT COMPLETED|Period 2 (12 Weeks)||0||
59786725|NCT03496623|75906805|FG004|NOT COMPLETED|Period 2 (12 Weeks)||0||
59786726|NCT03473561|75906818|FG000|STARTED|Overall Study||31||
59786727|NCT03473561|75906818|FG000|COMPLETED|Overall Study||31||
59786728|NCT03473561|75906818|FG000|NOT COMPLETED|Overall Study||0||
59786729|NCT03431168|75906824|FG000|STARTED|Overall Study||155||
59786730|NCT03431168|75906825|FG001|STARTED|Overall Study||153||
59786731|NCT03431168|75906824|FG000|COMPLETED|Overall Study||132||
59786732|NCT03431168|75906825|FG001|COMPLETED|Overall Study||129||
59786733|NCT03431168|75906824|FG000|NOT COMPLETED|Overall Study||23||
59786734|NCT03431168|75906825|FG001|NOT COMPLETED|Overall Study||24||
59786735|NCT03412630|75906831|FG000|STARTED|Overall Study||1||
59786736|NCT03412630|75906831|FG000|COMPLETED|Overall Study||1||
59786737|NCT03412630|75906831|FG000|NOT COMPLETED|Overall Study||0||
59786738|NCT03224507|75906837|FG000|STARTED|Overall Study||123||
59786739|NCT03224507|75906838|FG001|STARTED|Overall Study||0||
59786740|NCT03224507|75906837|FG000|COMPLETED|Overall Study||108||
59786741|NCT03224507|75906838|FG001|COMPLETED|Overall Study||0||
59786742|NCT03224507|75906837|FG000|NOT COMPLETED|Overall Study||15||
59786743|NCT03224507|75906838|FG001|NOT COMPLETED|Overall Study||0||
59786744|NCT02759835|75906847|FG000|STARTED|Overall Study||25||
59786745|NCT02759835|75906848|FG001|STARTED|Overall Study||9||
59786746|NCT02759835|75906849|FG002|STARTED|Overall Study||3||
59786747|NCT02759835|75906847|FG000|COMPLETED|Overall Study||25||
59786748|NCT02759835|75906848|FG001|COMPLETED|Overall Study||9||
59786749|NCT02759835|75906849|FG002|COMPLETED|Overall Study||3||
59786750|NCT02759835|75906847|FG000|NOT COMPLETED|Overall Study||0||
59786751|NCT02759835|75906848|FG001|NOT COMPLETED|Overall Study||0||
59786752|NCT02759835|75906849|FG002|NOT COMPLETED|Overall Study||0||
59786753|NCT02720094|75906880|FG000|STARTED|Overall Study||2283||
59786754|NCT02720094|75906881|FG001|STARTED|Overall Study||2287||
59786755|NCT02720094|75906880|FG000|Ongoing|Overall Study||2210|Ongoing in the study indicates the participant has not terminated study.|
60073160|NCT01589445|76188373|FG000|COMPLETED|001 (Pioglitazone) -3 Months|dropped out 7 patients|70||
60073161|NCT01589445|76188373|FG000|NOT COMPLETED|001 (Pioglitazone) -3 Months||7||
60073162|NCT01589445|76188373|FG000|STARTED|002 (Metformin)-3 Months|70 patients participated for trial of drug 002.|70||
59619715|NCT02315352|75730897|FG003|COMPLETED|Fourth Intervention (Day 2)||8||
59619716|NCT02315352|75730898|FG004|COMPLETED|Fourth Intervention (Day 2)||8||
59619717|NCT02315352|75730899|FG005|COMPLETED|Fourth Intervention (Day 2)||7||
59619718|NCT02315352|75730900|FG006|COMPLETED|Fourth Intervention (Day 2)||9||
59619719|NCT02315352|75730901|FG007|COMPLETED|Fourth Intervention (Day 2)||8||
59619720|NCT02315352|75730894|FG000|NOT COMPLETED|Fourth Intervention (Day 2)||0||
59619721|NCT02315352|75730895|FG001|NOT COMPLETED|Fourth Intervention (Day 2)||0||
59619722|NCT02315352|75730896|FG002|NOT COMPLETED|Fourth Intervention (Day 2)||0||
59619723|NCT02315352|75730897|FG003|NOT COMPLETED|Fourth Intervention (Day 2)||0||
59619724|NCT02315352|75730898|FG004|NOT COMPLETED|Fourth Intervention (Day 2)||0||
59786756|NCT02720094|75906881|FG001|Ongoing|Overall Study||2203|Ongoing in the study indicates the participant has not terminated study.|
59786757|NCT02720094|75906880|FG000|Terminated From the Study|Overall Study||67|Excludes participants who completed the study.|
59619725|NCT02315352|75730899|FG005|NOT COMPLETED|Fourth Intervention (Day 2)||0||
59619726|NCT02315352|75730900|FG006|NOT COMPLETED|Fourth Intervention (Day 2)||0||
59619727|NCT02315352|75730901|FG007|NOT COMPLETED|Fourth Intervention (Day 2)||0||
59619728|NCT02315352|75730894|FG000|STARTED|Fifth Intervention (Day 2)||0||
59786758|NCT02720094|75906881|FG001|Terminated From the Study|Overall Study||78|Excludes participants who completed the study.|
59786759|NCT02720094|75906880|FG000|COMPLETED|Overall Study||7|Completed the study indicates a participant has seroconverted or has entered Step 3 after reaching Week 145 visit and was subsequently followed for 48 weeks in Step 3 without prior IP discontinuation or study termination or has entered Step 3 after discontinuation of IP and was subsequently followed for 48 weeks and was followed for a total of 3 years from enrollment.|
59817857|NCT04488770|75940335|FG009|COMPLETED|Part 1-Cohort 1: Period 4 (Up to 5 Days)||0||
59619729|NCT02315352|75730895|FG001|STARTED|Fifth Intervention (Day 2)||0||
59953101|NCT04057820|76071790|FG010|COMPLETED|Period 3||15||4
59953102|NCT04057820|76071791|FG011|COMPLETED|Period 3||0||0
59953103|NCT04057820|76071792|FG012|COMPLETED|Period 3||22||3
59786760|NCT02720094|75906881|FG001|COMPLETED|Overall Study||6|Completed the study indicates a participant has seroconverted or has entered Step 3 after reaching Week 145 visit and was subsequently followed for 48 weeks in Step 3 without prior IP discontinuation or study termination or has entered Step 3 after discontinuation of IP and was subsequently followed for 48 weeks and was followed for a total of 3 years from enrollment.|
59786761|NCT02720094|75906880|FG000|NOT COMPLETED|Overall Study||2276||
59786762|NCT02720094|75906881|FG001|NOT COMPLETED|Overall Study||2281||
59786763|NCT02695498|75906891|FG000|STARTED|Overall Study||45||
59786764|NCT02695498|75906892|FG001|STARTED|Overall Study||44||
59786765|NCT02695498|75906891|FG000|COMPLETED|Overall Study||45||
59786766|NCT02695498|75906892|FG001|COMPLETED|Overall Study||44||
59786767|NCT02695498|75906891|FG000|NOT COMPLETED|Overall Study||0||
59786768|NCT02695498|75906892|FG001|NOT COMPLETED|Overall Study||0||
59786769|NCT02688777|75906900|FG000|STARTED|Overall Study||32||
59786770|NCT02688777|75906901|FG001|STARTED|Overall Study||30||
59786771|NCT02688777|75906900|FG000|COMPLETED|Overall Study||25||
59786772|NCT02688777|75906901|FG001|COMPLETED|Overall Study||19||
59786773|NCT02688777|75906900|FG000|NOT COMPLETED|Overall Study||7||
59786774|NCT02688777|75906901|FG001|NOT COMPLETED|Overall Study||11||
59786775|NCT02646618|75906909|FG000|STARTED|Overall Study||167||
59786776|NCT02646618|75906910|FG001|STARTED|Overall Study||162||
59786777|NCT02646618|75906909|FG000|6 Month Follow-up|Overall Study||152||
59786778|NCT02646618|75906910|FG001|6 Month Follow-up|Overall Study||150||
59786779|NCT02646618|75906909|FG000|COMPLETED|Overall Study||157||
59786780|NCT02646618|75906910|FG001|COMPLETED|Overall Study||148||
59786781|NCT02646618|75906909|FG000|NOT COMPLETED|Overall Study||10||
59786782|NCT02646618|75906910|FG001|NOT COMPLETED|Overall Study||14||
59786783|NCT02609425|75906918|FG000|STARTED|Overall Study||30||
59786784|NCT02609425|75906918|FG000|COMPLETED|Overall Study||30||
59786785|NCT02609425|75906918|FG000|NOT COMPLETED|Overall Study||0||
59786786|NCT02564068|75906923|FG000|STARTED|Overall Study||8||
59786787|NCT02564068|75906923|FG000|COMPLETED|Overall Study||8||
59786788|NCT02564068|75906923|FG000|NOT COMPLETED|Overall Study||0||
59786789|NCT02362464|75906927|FG000|STARTED|Overall Study||14||
59786790|NCT02362464|75906927|FG000|COMPLETED|Overall Study||8||
59786791|NCT02362464|75906927|FG000|NOT COMPLETED|Overall Study||6||
59786792|NCT02285114|75906934|FG000|STARTED|Overall Study||29||
59786793|NCT02285114|75906935|FG001|STARTED|Overall Study||9||
59786794|NCT02285114|75906936|FG002|STARTED|Overall Study||3||
59786795|NCT02285114|75906934|FG000|COMPLETED|Overall Study||7||
59786796|NCT02285114|75906935|FG001|COMPLETED|Overall Study||2||
59786797|NCT02285114|75906936|FG002|COMPLETED|Overall Study||0||
59786798|NCT02285114|75906934|FG000|NOT COMPLETED|Overall Study||22||
59786799|NCT02285114|75906935|FG001|NOT COMPLETED|Overall Study||7||
59786800|NCT02285114|75906936|FG002|NOT COMPLETED|Overall Study||3||
59786801|NCT01952366|75906950|FG000|STARTED|Overall Study||169||
59786802|NCT01952366|75906950|FG000|COMPLETED|Overall Study||138||
59786803|NCT01952366|75906950|FG000|NOT COMPLETED|Overall Study||31||
59786804|NCT01626079|75906960|FG000|STARTED|Overall Study||302||
59786805|NCT01626079|75906961|FG001|STARTED|Overall Study||312||
59786806|NCT01626079|75906962|FG002|STARTED|Overall Study||162||
59786807|NCT01626079|75906960|FG000|COMPLETED|Overall Study||104||
59786808|NCT01626079|75906961|FG001|COMPLETED|Overall Study||75||
59786809|NCT01626079|75906962|FG002|COMPLETED|Overall Study||110||
59786810|NCT01626079|75906960|FG000|NOT COMPLETED|Overall Study||198||
59786811|NCT01626079|75906961|FG001|NOT COMPLETED|Overall Study||237||
59786812|NCT01626079|75906962|FG002|NOT COMPLETED|Overall Study||52||
59786813|NCT01349959|75906973|FG000|STARTED|Overall Study||40||
59786814|NCT01349959|75906973|FG000|COMPLETED|Overall Study||33||
59786815|NCT01349959|75906973|FG000|NOT COMPLETED|Overall Study||7||
59786816|NCT01331681|75906980|FG000|STARTED|Overall Study|randomized|136||
59786817|NCT01331681|75906981|FG001|STARTED|Overall Study|randomized|135||
59786818|NCT01331681|75906982|FG002|STARTED|Overall Study|randomized|135||
59786819|NCT01331681|75906980|FG000|Participants Received Treatment|Overall Study|safety population|136||
59786820|NCT01331681|75906981|FG001|Participants Received Treatment|Overall Study|safety population|135||
59786821|NCT01331681|75906982|FG002|Participants Received Treatment|Overall Study|safety population|133||
59786822|NCT01331681|75906980|FG000|Completed Week 52|Overall Study||125||
59786823|NCT01331681|75906981|FG001|Completed Week 52|Overall Study||121||
59786824|NCT01331681|75906982|FG002|Completed Week 52|Overall Study||115||
59786825|NCT01331681|75906980|FG000|Completed Week 100|Overall Study||115||
59786826|NCT01331681|75906981|FG001|Completed Week 100|Overall Study||110||
59786827|NCT01331681|75906982|FG002|Completed Week 100|Overall Study||105||
59786828|NCT01331681|75906980|FG000|Completed Week 148|Overall Study||101||
59786829|NCT01331681|75906981|FG001|Completed Week 148|Overall Study||101||
59786830|NCT01331681|75906982|FG002|Completed Week 148|Overall Study||100||
59786831|NCT01331681|75906980|FG000|COMPLETED|Overall Study|Completed Week 148|101||
59786832|NCT01331681|75906981|FG001|COMPLETED|Overall Study|Completed Week 148|101||
59786833|NCT01331681|75906982|FG002|COMPLETED|Overall Study|Completed Week 148|100||
59786834|NCT01331681|75906980|FG000|NOT COMPLETED|Overall Study||35||
59786835|NCT01331681|75906981|FG001|NOT COMPLETED|Overall Study||34||
59786836|NCT01331681|75906982|FG002|NOT COMPLETED|Overall Study||35||
59786837|NCT01286272|75906992|FG000|STARTED|Overall Study||67||
59786838|NCT01286272|75906993|FG001|STARTED|Overall Study||65||
59786839|NCT01286272|75906992|FG000|COMPLETED|Overall Study||66||
59786840|NCT01286272|75906993|FG001|COMPLETED|Overall Study||62||
59786841|NCT01286272|75906992|FG000|NOT COMPLETED|Overall Study||1||
59786842|NCT01286272|75906993|FG001|NOT COMPLETED|Overall Study||3||
60073163|NCT01589445|76188373|FG000|COMPLETED|002 (Metformin)-3 Months|61 patients completed the drug 002.9 patients dropped out.|61||
60073164|NCT01589445|76188373|FG000|NOT COMPLETED|002 (Metformin)-3 Months||9||
60073165|NCT01588509|76188383|FG000|STARTED|Overall Study||30||
60073166|NCT01588509|76188384|FG001|STARTED|Overall Study||30||
60073167|NCT01588509|76188383|FG000|Received Treatment|Overall Study||30||
60073168|NCT01588509|76188384|FG001|Received Treatment|Overall Study||30||
59786849|NCT01215136|75907005|FG000|STARTED|Overall Study||7||
59786850|NCT01215136|75907006|FG001|STARTED|Overall Study||29||
59786851|NCT01215136|75907005|FG000|COMPLETED|Overall Study||1||
59786852|NCT01215136|75907006|FG001|COMPLETED|Overall Study||2||
59786853|NCT01215136|75907005|FG000|NOT COMPLETED|Overall Study||6||
59786854|NCT01215136|75907006|FG001|NOT COMPLETED|Overall Study||27||
59786855|NCT01142401|75907014|FG000|STARTED|Randomized Phase||59||
59786856|NCT01142401|75907015|FG001|STARTED|Randomized Phase||59||
59786857|NCT01142401|75907016|FG002|STARTED|Randomized Phase||0||
59786858|NCT01142401|75907014|FG000|COMPLETED|Randomized Phase||59||
59786859|NCT01142401|75907015|FG001|COMPLETED|Randomized Phase||57||
59522691|NCT01269034|75617192|FG003|STARTED|Overall Study||9||
59522692|NCT01269034|75617189|FG000|COMPLETED|Overall Study||0||
59522693|NCT01269034|75617190|FG001|COMPLETED|Overall Study||2||
59522694|NCT01269034|75617191|FG002|COMPLETED|Overall Study||1||
59522695|NCT01269034|75617192|FG003|COMPLETED|Overall Study||9||
59522696|NCT01269034|75617189|FG000|NOT COMPLETED|Overall Study||1||
59522697|NCT01269034|75617190|FG001|NOT COMPLETED|Overall Study||0||
59522698|NCT01269034|75617191|FG002|NOT COMPLETED|Overall Study||0||
59522699|NCT01269034|75617192|FG003|NOT COMPLETED|Overall Study||0||
59786860|NCT01142401|75907016|FG002|COMPLETED|Randomized Phase||0||
59786861|NCT01142401|75907014|FG000|NOT COMPLETED|Randomized Phase||0||
59786862|NCT01142401|75907015|FG001|NOT COMPLETED|Randomized Phase||2||
59786863|NCT01142401|75907016|FG002|NOT COMPLETED|Randomized Phase||0||
59786864|NCT01142401|75907014|FG000|STARTED|Crossover Phase||0||
59786865|NCT01142401|75907015|FG001|STARTED|Crossover Phase||0||
59786866|NCT01142401|75907016|FG002|STARTED|Crossover Phase||27||
59786867|NCT01142401|75907014|FG000|COMPLETED|Crossover Phase||0||
59522700|NCT02663752|75617202|FG000|STARTED|Overall Study||1||
59522701|NCT02663752|75617202|FG000|COMPLETED|Overall Study||1||
59522702|NCT02663752|75617202|FG000|NOT COMPLETED|Overall Study||0||
59522703|NCT02654782|75617208|FG000|STARTED|Overall Study||5||
59786868|NCT01142401|75907015|FG001|COMPLETED|Crossover Phase||0||
59786869|NCT01142401|75907016|FG002|COMPLETED|Crossover Phase||27||
59786870|NCT01142401|75907014|FG000|NOT COMPLETED|Crossover Phase||0||
59786871|NCT01142401|75907015|FG001|NOT COMPLETED|Crossover Phase||0||
59786872|NCT01142401|75907016|FG002|NOT COMPLETED|Crossover Phase||0||
59786873|NCT01142388|75907031|FG000|STARTED|Overall Study||47||
59786874|NCT01142388|75907032|FG001|STARTED|Overall Study||47||
59786875|NCT01142388|75907031|FG000|Eligible|Overall Study||43||
59786876|NCT01142388|75907032|FG001|Eligible|Overall Study||44||
59786877|NCT01142388|75907031|FG000|Treated|Overall Study||40||
59786878|NCT01142388|75907032|FG001|Treated|Overall Study||44||
59786879|NCT01142388|75907031|FG000|COMPLETED|Overall Study|Treatment continued until disease progression or intolerable toxicity.|0||
59786880|NCT01142388|75907032|FG001|COMPLETED|Overall Study||0||
59786881|NCT01142388|75907031|FG000|NOT COMPLETED|Overall Study||47||
59786882|NCT01142388|75907032|FG001|NOT COMPLETED|Overall Study||47||
59786883|NCT01134614|75907040|FG000|STARTED|Overall Study||123||
59786884|NCT01134614|75907041|FG001|STARTED|Overall Study||122||
59786885|NCT01134614|75907040|FG000|Treated|Overall Study||119||
59522704|NCT02654782|75617209|FG001|STARTED|Overall Study||5||
59522705|NCT02654782|75617208|FG000|COMPLETED|Overall Study||5||
59522706|NCT02654782|75617209|FG001|COMPLETED|Overall Study||5||
59522707|NCT02654782|75617208|FG000|NOT COMPLETED|Overall Study||0||
59786886|NCT01134614|75907041|FG001|Treated|Overall Study||121||
59786887|NCT01134614|75907040|FG000|Treated and Toxicity Assessed|Overall Study||118||
59786888|NCT01134614|75907041|FG001|Treated and Toxicity Assessed|Overall Study||120||
59786889|NCT01134614|75907040|FG000|COMPLETED|Overall Study|Treatment continues until disease progression or unacceptable toxicity.|0||
59786890|NCT01134614|75907041|FG001|COMPLETED|Overall Study|Treatment continues until disease progression or unacceptable toxicities|0||
59786891|NCT01134614|75907040|FG000|NOT COMPLETED|Overall Study||123||
59786892|NCT01134614|75907041|FG001|NOT COMPLETED|Overall Study||122||
59786893|NCT00960401|75907049|FG000|STARTED|Overall Study||9||
59786894|NCT00960401|75907050|FG001|STARTED|Overall Study||11||
59786895|NCT00960401|75907049|FG000|COMPLETED|Overall Study||9||
59786896|NCT00960401|75907050|FG001|COMPLETED|Overall Study||11||
59786897|NCT00960401|75907049|FG000|NOT COMPLETED|Overall Study||0||
59786898|NCT00960401|75907050|FG001|NOT COMPLETED|Overall Study||0||
59786899|NCT00616018|75907055|FG000|STARTED|Overall Study||27||
59786900|NCT00616018|75907055|FG000|COMPLETED|Overall Study||24||
59786901|NCT00616018|75907055|FG000|NOT COMPLETED|Overall Study||3||
59786902|NCT00424021|75907064|FG000|STARTED|NCT00046319 Study Period||16||
59786903|NCT00424021|75907065|FG001|STARTED|NCT00046319 Study Period||19||
59786904|NCT00424021|75907066|FG002|STARTED|NCT00046319 Study Period||16||
59786905|NCT00424021|75907067|FG003|STARTED|NCT00046319 Study Period||13||
59786906|NCT00424021|75907064|FG000|COMPLETED|NCT00046319 Study Period||15||
59786907|NCT00424021|75907065|FG001|COMPLETED|NCT00046319 Study Period||16||
59786908|NCT00424021|75907066|FG002|COMPLETED|NCT00046319 Study Period||15||
59786909|NCT00424021|75907067|FG003|COMPLETED|NCT00046319 Study Period||12||
59786910|NCT00424021|75907064|FG000|NOT COMPLETED|NCT00046319 Study Period||1||
59786911|NCT00424021|75907065|FG001|NOT COMPLETED|NCT00046319 Study Period||3||
59786912|NCT00424021|75907066|FG002|NOT COMPLETED|NCT00046319 Study Period||1||
59786913|NCT00424021|75907067|FG003|NOT COMPLETED|NCT00046319 Study Period||1||
59786914|NCT00424021|75907064|FG000|STARTED|AMB-220-E Study Period||2||
59786915|NCT00424021|75907065|FG001|STARTED|AMB-220-E Study Period||7||
59786916|NCT00424021|75907066|FG002|STARTED|AMB-220-E Study Period||19||
59786917|NCT00424021|75907067|FG003|STARTED|AMB-220-E Study Period||26||
59786918|NCT00424021|75907064|FG000|COMPLETED|AMB-220-E Study Period||1||
59786919|NCT00424021|75907065|FG001|COMPLETED|AMB-220-E Study Period||5||
59786920|NCT00424021|75907066|FG002|COMPLETED|AMB-220-E Study Period||14||
59786921|NCT00424021|75907067|FG003|COMPLETED|AMB-220-E Study Period||16||
59786922|NCT00424021|75907064|FG000|NOT COMPLETED|AMB-220-E Study Period||1||
59786923|NCT00424021|75907065|FG001|NOT COMPLETED|AMB-220-E Study Period||2||
59786924|NCT00424021|75907066|FG002|NOT COMPLETED|AMB-220-E Study Period||5||
59786925|NCT00424021|75907067|FG003|NOT COMPLETED|AMB-220-E Study Period||10||
59786926|NCT00617734|75907086|FG000|STARTED|Overall Study||49||
59786927|NCT00617734|75907087|FG001|STARTED|Overall Study||48||
59786928|NCT00617734|75907086|FG000|Received at Least 1 Dose of Study Drug|Overall Study||47||
59786929|NCT00617734|75907087|FG001|Received at Least 1 Dose of Study Drug|Overall Study||44||
59786930|NCT00617734|75907086|FG000|COMPLETED|Overall Study||41||
59786931|NCT00617734|75907087|FG001|COMPLETED|Overall Study||42||
59786932|NCT00617734|75907086|FG000|NOT COMPLETED|Overall Study||8||
59786933|NCT00617734|75907087|FG001|NOT COMPLETED|Overall Study||6||
59786934|NCT00577460|75907096|FG000|STARTED|Overall Study||129||
59786935|NCT00577460|75907097|FG001|STARTED|Overall Study||123||
59786936|NCT00577460|75907098|FG002|STARTED|Overall Study||139||
59786937|NCT00577460|75907096|FG000|COMPLETED|Overall Study||113||
59786938|NCT00577460|75907097|FG001|COMPLETED|Overall Study||104||
59786939|NCT00577460|75907098|FG002|COMPLETED|Overall Study||112||
59786940|NCT00577460|75907096|FG000|NOT COMPLETED|Overall Study||16||
59786941|NCT00577460|75907097|FG001|NOT COMPLETED|Overall Study||19||
59786942|NCT00577460|75907098|FG002|NOT COMPLETED|Overall Study||27||
59786943|NCT00415519|75907115|FG000|STARTED|Overall Study||13||
59786944|NCT00415519|75907116|FG001|STARTED|Overall Study||12||
59786945|NCT00415519|75907115|FG000|COMPLETED|Overall Study||9||
59786946|NCT00415519|75907116|FG001|COMPLETED|Overall Study||12||
59786947|NCT00415519|75907115|FG000|NOT COMPLETED|Overall Study||4||
59786948|NCT00415519|75907116|FG001|NOT COMPLETED|Overall Study||0||
59786949|NCT00423943|75907124|FG000|STARTED|Overall Study||19||
59786950|NCT00423943|75907125|FG001|STARTED|Overall Study||14||
59786951|NCT00423943|75907124|FG000|COMPLETED|Overall Study||16||
59786952|NCT00423943|75907125|FG001|COMPLETED|Overall Study||13||
59786953|NCT00423943|75907124|FG000|NOT COMPLETED|Overall Study||3||
60073169|NCT01588509|76188383|FG000|COMPLETED|Overall Study||29||
59786954|NCT00423943|75907125|FG001|NOT COMPLETED|Overall Study||1||
59786955|NCT00428389|75907133|FG000|STARTED|Core Phase||131||
59786956|NCT00428389|75907134|FG001|STARTED|Core Phase||131||
59786957|NCT00428389|75907133|FG000|Intent-to-treat Population|Core Phase||131||
59786958|NCT00428389|75907134|FG001|Intent-to-treat Population|Core Phase|1 patient was discontinued from the study the same day as randomization & excluded from all analyses|130||
59786959|NCT00428389|75907133|FG000|COMPLETED|Core Phase||120||
59786960|NCT00428389|75907134|FG001|COMPLETED|Core Phase||120||
59786961|NCT00428389|75907133|FG000|NOT COMPLETED|Core Phase||11||
59786962|NCT00428389|75907134|FG001|NOT COMPLETED|Core Phase||11||
59786963|NCT00428389|75907133|FG000|STARTED|Extension Phase|Participants were required to sign a separate informed consent prior to entering the extension phase|117||
59786964|NCT00428389|75907134|FG001|STARTED|Extension Phase||117||
59786965|NCT00428389|75907133|FG000|COMPLETED|Extension Phase||85||
59786966|NCT00428389|75907134|FG001|COMPLETED|Extension Phase||91||
59786967|NCT00428389|75907133|FG000|NOT COMPLETED|Extension Phase||32||
59786968|NCT00428389|75907134|FG001|NOT COMPLETED|Extension Phase||26||
59786969|NCT00616642|75907142|FG000|STARTED|Overall Study||0||
59786970|NCT00616642|75907143|FG001|STARTED|Overall Study||1||
59786971|NCT00616642|75907142|FG000|COMPLETED|Overall Study||0||
59786972|NCT00616642|75907143|FG001|COMPLETED|Overall Study||0||
59786973|NCT00616642|75907142|FG000|NOT COMPLETED|Overall Study||0||
60073170|NCT01588509|76188384|FG001|COMPLETED|Overall Study||30||
59786974|NCT00616642|75907143|FG001|NOT COMPLETED|Overall Study||1||
59786975|NCT00406315|75907149|FG000|STARTED|Overall Study|Started = Treated|241||
59786976|NCT00406315|75907149|FG000|COMPLETED|Overall Study||100||
59786977|NCT00406315|75907149|FG000|NOT COMPLETED|Overall Study||141||
59786978|NCT00711594|75907157|FG000|STARTED|Overall Study||3||
59786979|NCT00711594|75907158|FG001|STARTED|Overall Study||3||
59786980|NCT00711594|75907159|FG002|STARTED|Overall Study||6||
59786981|NCT00711594|75907160|FG003|STARTED|Overall Study||62||
59786982|NCT00711594|75907157|FG000|COMPLETED|Overall Study||0||
59786983|NCT00711594|75907158|FG001|COMPLETED|Overall Study||0||
59786984|NCT00711594|75907159|FG002|COMPLETED|Overall Study||0||
59786985|NCT00711594|75907160|FG003|COMPLETED|Overall Study||0||
59786986|NCT00711594|75907157|FG000|NOT COMPLETED|Overall Study||3||
59786987|NCT00711594|75907158|FG001|NOT COMPLETED|Overall Study||3||
59786988|NCT00711594|75907159|FG002|NOT COMPLETED|Overall Study||6||
59786989|NCT00711594|75907160|FG003|NOT COMPLETED|Overall Study||62||
59786990|NCT00710762|75907174|FG000|STARTED|Overall Study||44||
59786991|NCT00710762|75907175|FG001|STARTED|Overall Study||40||
59786992|NCT00710762|75907174|FG000|COMPLETED|Overall Study||5||
59786993|NCT00710762|75907175|FG001|COMPLETED|Overall Study||0||
59786994|NCT00710762|75907174|FG000|NOT COMPLETED|Overall Study||39||
59786995|NCT00710762|75907175|FG001|NOT COMPLETED|Overall Study||40||
59786996|NCT00573430|75907184|FG000|STARTED|Overall Study|randomized|40||
59786997|NCT00573430|75907185|FG001|STARTED|Overall Study|randomized|45||
59786998|NCT00573430|75907186|FG002|STARTED|Overall Study|randomized|43||
59786999|NCT00573430|75907184|FG000|COMPLETED|Overall Study||39||
59787000|NCT00573430|75907185|FG001|COMPLETED|Overall Study||40||
59787001|NCT00573430|75907186|FG002|COMPLETED|Overall Study||33||
59787002|NCT00573430|75907184|FG000|NOT COMPLETED|Overall Study||1||
59787003|NCT00573430|75907185|FG001|NOT COMPLETED|Overall Study||5||
59787004|NCT00573430|75907186|FG002|NOT COMPLETED|Overall Study||10||
59787005|NCT00711516|75907196|FG000|STARTED|Overall Study||21||
59787006|NCT00711516|75907197|FG001|STARTED|Overall Study||19||
59787007|NCT00711516|75907196|FG000|COMPLETED|Overall Study||20||
59787008|NCT00711516|75907197|FG001|COMPLETED|Overall Study||16||
59787009|NCT00711516|75907196|FG000|NOT COMPLETED|Overall Study||1||
59787010|NCT00711516|75907197|FG001|NOT COMPLETED|Overall Study||3||
59787011|NCT00615550|75907205|FG000|STARTED|Overall Study||229||
59787012|NCT00615550|75907206|FG001|STARTED|Overall Study||236||
59787013|NCT00615550|75907205|FG000|COMPLETED|Overall Study||223||
59787014|NCT00615550|75907206|FG001|COMPLETED|Overall Study||235||
59787015|NCT00615550|75907205|FG000|NOT COMPLETED|Overall Study||6||
59787016|NCT00615550|75907206|FG001|NOT COMPLETED|Overall Study||1||
59787017|NCT00577382|75907214|FG000|STARTED|Overall Study||21||
59787018|NCT00577382|75907215|FG001|STARTED|Overall Study||31||
59787019|NCT00577382|75907214|FG000|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0||
59787020|NCT00577382|75907215|FG001|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0||
59787021|NCT00577382|75907214|FG000|NOT COMPLETED|Overall Study||21||
59787022|NCT00577382|75907215|FG001|NOT COMPLETED|Overall Study||31||
59953104|NCT04057820|76071793|FG013|COMPLETED|Period 3||0||0
59953105|NCT04057820|76071794|FG014|COMPLETED|Period 3||24||3
59953106|NCT04057820|76071795|FG015|COMPLETED|Period 3||0||0
59953107|NCT04057820|76071780|FG000|NOT COMPLETED|Period 3||0||0
59953108|NCT04057820|76071781|FG001|NOT COMPLETED|Period 3||0||0
59953109|NCT04057820|76071782|FG002|NOT COMPLETED|Period 3||0||0
59953110|NCT04057820|76071783|FG003|NOT COMPLETED|Period 3||0||0
60073171|NCT01588509|76188383|FG000|NOT COMPLETED|Overall Study||1||
60073172|NCT01588509|76188384|FG001|NOT COMPLETED|Overall Study||0||
60073173|NCT01588353|76188393|FG000|STARTED|Step1||6||
60073174|NCT01588353|76188394|FG001|STARTED|Step1||0||
60073175|NCT01588353|76188395|FG002|STARTED|Step1||0||
59787023|NCT00614926|75907223|FG000|STARTED|Overall Study||25||
59787024|NCT00614926|75907224|FG001|STARTED|Overall Study||7||
59787025|NCT00614926|75907223|FG000|COMPLETED|Overall Study||21||
59787026|NCT00614926|75907224|FG001|COMPLETED|Overall Study||7||
59787027|NCT00614926|75907223|FG000|NOT COMPLETED|Overall Study||4||
59787028|NCT00614926|75907224|FG001|NOT COMPLETED|Overall Study||0||
59787029|NCT00423319|75907232|FG000|STARTED|Overall Study|Randomized|2708||
59787030|NCT00423319|75907233|FG001|STARTED|Overall Study|Randomized|2699||
59787031|NCT00423319|75907232|FG000|Participants Who Received Treatment|Overall Study||2673||
59953111|NCT04057820|76071784|FG004|NOT COMPLETED|Period 3||0||0
59953112|NCT04057820|76071785|FG005|NOT COMPLETED|Period 3||0||0
60073176|NCT01588353|76188393|FG000|COMPLETED|Step1||6||
60073177|NCT01588353|76188394|FG001|COMPLETED|Step1||0||
59787032|NCT00423319|75907233|FG001|Participants Who Received Treatment|Overall Study||2659||
59787033|NCT00423319|75907232|FG000|COMPLETED|Overall Study||2484||
59787034|NCT00423319|75907233|FG001|COMPLETED|Overall Study||2447||
59787035|NCT00423319|75907232|FG000|NOT COMPLETED|Overall Study||224||
59787036|NCT00423319|75907233|FG001|NOT COMPLETED|Overall Study||252||
59787037|NCT00710684|75907243|FG000|STARTED|Overall Study||225||
59787038|NCT00710684|75907244|FG001|STARTED|Overall Study||221||
59787039|NCT00710684|75907245|FG002|STARTED|Overall Study||236||
60073178|NCT01588353|76188395|FG002|COMPLETED|Step1||0||
59953113|NCT04057820|76071786|FG006|NOT COMPLETED|Period 3||0||0
59953114|NCT04057820|76071787|FG007|NOT COMPLETED|Period 3||0||0
59953115|NCT04057820|76071788|FG008|NOT COMPLETED|Period 3||0||0
59953116|NCT04057820|76071789|FG009|NOT COMPLETED|Period 3||0||0
59953117|NCT04057820|76071790|FG010|NOT COMPLETED|Period 3||0||0
59953118|NCT04057820|76071791|FG011|NOT COMPLETED|Period 3||0||0
59953119|NCT04057820|76071792|FG012|NOT COMPLETED|Period 3||0||0
59953120|NCT04057820|76071793|FG013|NOT COMPLETED|Period 3||0||0
59953121|NCT04057820|76071794|FG014|NOT COMPLETED|Period 3||0||0
59953122|NCT04057820|76071795|FG015|NOT COMPLETED|Period 3||0||0
59953123|NCT04057820|76071780|FG000|STARTED|Period 4||0||0
59953124|NCT04057820|76071781|FG001|STARTED|Period 4|For this stepped wedge study design, a new cohort of infants is enrolled during each period except the transition period. Therefore, the number of infants to start a period is unlikely to equal the number of infants who completed the previous period.|22||4
59953125|NCT04057820|76071782|FG002|STARTED|Period 4||0||0
59953126|NCT04057820|76071783|FG003|STARTED|Period 4||8||2
59953127|NCT04057820|76071784|FG004|STARTED|Period 4|Block 3 with 3 transitioned from Usual Care to ESC during Period 4; therefore no infants were being enrolled and the total number of sites enrolling infant was 23.|0||0
59953128|NCT04057820|76071785|FG005|STARTED|Period 4||0||0
59953129|NCT04057820|76071786|FG006|STARTED|Period 4||16||3
59953130|NCT04057820|76071787|FG007|STARTED|Period 4||0||0
59953131|NCT04057820|76071788|FG008|STARTED|Period 4||33||4
59953132|NCT04057820|76071789|FG009|STARTED|Period 4||0||0
59953133|NCT04057820|76071790|FG010|STARTED|Period 4||19||4
59953134|NCT04057820|76071791|FG011|STARTED|Period 4||0||0
59953135|NCT04057820|76071792|FG012|STARTED|Period 4||19||3
59953136|NCT04057820|76071793|FG013|STARTED|Period 4||0||0
59953137|NCT04057820|76071794|FG014|STARTED|Period 4||22||3
59953138|NCT04057820|76071795|FG015|STARTED|Period 4||0||0
59953139|NCT04057820|76071780|FG000|COMPLETED|Period 4||0||0
59953140|NCT04057820|76071781|FG001|COMPLETED|Period 4||22||4
59953141|NCT04057820|76071782|FG002|COMPLETED|Period 4||0||0
59953142|NCT04057820|76071783|FG003|COMPLETED|Period 4||8||2
59953143|NCT04057820|76071784|FG004|COMPLETED|Period 4||0||0
59953144|NCT04057820|76071785|FG005|COMPLETED|Period 4||0||0
59953145|NCT04057820|76071786|FG006|COMPLETED|Period 4||16||3
59953146|NCT04057820|76071787|FG007|COMPLETED|Period 4||0||0
59953147|NCT04057820|76071788|FG008|COMPLETED|Period 4||33||4
59953148|NCT04057820|76071789|FG009|COMPLETED|Period 4||0||0
59953149|NCT04057820|76071790|FG010|COMPLETED|Period 4||19||4
59953150|NCT04057820|76071791|FG011|COMPLETED|Period 4||0||0
59953151|NCT04057820|76071792|FG012|COMPLETED|Period 4||19||3
59953152|NCT04057820|76071793|FG013|COMPLETED|Period 4||0||0
59953153|NCT04057820|76071794|FG014|COMPLETED|Period 4||22||3
59953154|NCT04057820|76071795|FG015|COMPLETED|Period 4||0||0
59953155|NCT04057820|76071780|FG000|NOT COMPLETED|Period 4||0||0
59953156|NCT04057820|76071781|FG001|NOT COMPLETED|Period 4||0||0
59953157|NCT04057820|76071782|FG002|NOT COMPLETED|Period 4||0||0
59953158|NCT04057820|76071783|FG003|NOT COMPLETED|Period 4||0||0
59953159|NCT04057820|76071784|FG004|NOT COMPLETED|Period 4||0||0
59953160|NCT04057820|76071785|FG005|NOT COMPLETED|Period 4||0||0
59953161|NCT04057820|76071786|FG006|NOT COMPLETED|Period 4||0||0
59953162|NCT04057820|76071787|FG007|NOT COMPLETED|Period 4||0||0
59953163|NCT04057820|76071788|FG008|NOT COMPLETED|Period 4||0||0
59953164|NCT04057820|76071789|FG009|NOT COMPLETED|Period 4||0||0
59953165|NCT04057820|76071790|FG010|NOT COMPLETED|Period 4||0||0
59953166|NCT04057820|76071791|FG011|NOT COMPLETED|Period 4||0||0
59953167|NCT04057820|76071792|FG012|NOT COMPLETED|Period 4||0||0
59953168|NCT04057820|76071793|FG013|NOT COMPLETED|Period 4||0||0
59953169|NCT04057820|76071794|FG014|NOT COMPLETED|Period 4||0||0
59787040|NCT00710684|75907243|FG000|COMPLETED|Overall Study||151||
59787041|NCT00710684|75907244|FG001|COMPLETED|Overall Study||147||
59787042|NCT00710684|75907245|FG002|COMPLETED|Overall Study||172||
59787043|NCT00710684|75907243|FG000|NOT COMPLETED|Overall Study||74||
59787044|NCT00710684|75907244|FG001|NOT COMPLETED|Overall Study||74||
59787045|NCT00710684|75907245|FG002|NOT COMPLETED|Overall Study||64||
59787046|NCT00710606|75907261|FG000|STARTED|Overall Study||20||
59953170|NCT04057820|76071795|FG015|NOT COMPLETED|Period 4||0||0
59953171|NCT04057820|76071780|FG000|STARTED|Period 5||0||0
59953172|NCT04057820|76071781|FG001|STARTED|Period 5|For this stepped wedge study design, a new cohort of infants is enrolled during each period except the transition period. Therefore, the number of infants to start a period is unlikely to equal the number of infants who completed the previous period.|25||4
59953173|NCT04057820|76071782|FG002|STARTED|Period 5||0||0
59953174|NCT04057820|76071783|FG003|STARTED|Period 5||8||2
59953175|NCT04057820|76071784|FG004|STARTED|Period 5||0||0
59953176|NCT04057820|76071785|FG005|STARTED|Period 5||12||3
59953177|NCT04057820|76071786|FG006|STARTED|Period 5|Block 4 with 3 sites transitioned from Usual Care to ESC during Period 5; therefore no infants were being enrolled and the total number of sites enrolling infants was 23.|0||0
59953178|NCT04057820|76071787|FG007|STARTED|Period 5||0||0
59953179|NCT04057820|76071788|FG008|STARTED|Period 5||16||4
59953180|NCT04057820|76071789|FG009|STARTED|Period 5||0||0
59953181|NCT04057820|76071790|FG010|STARTED|Period 5||19||4
59953182|NCT04057820|76071791|FG011|STARTED|Period 5||0||0
59953183|NCT04057820|76071792|FG012|STARTED|Period 5||16||3
59953184|NCT04057820|76071793|FG013|STARTED|Period 5||0||0
59953185|NCT04057820|76071794|FG014|STARTED|Period 5||17||3
59953186|NCT04057820|76071795|FG015|STARTED|Period 5||0||0
59953187|NCT04057820|76071780|FG000|COMPLETED|Period 5||0||0
59953188|NCT04057820|76071781|FG001|COMPLETED|Period 5||25||4
59953189|NCT04057820|76071782|FG002|COMPLETED|Period 5||0||0
59953190|NCT04057820|76071783|FG003|COMPLETED|Period 5||8||2
59787047|NCT00710606|75907262|FG001|STARTED|Overall Study||20||
59787048|NCT00710606|75907261|FG000|COMPLETED|Overall Study||20||
59787049|NCT00710606|75907262|FG001|COMPLETED|Overall Study||18||
59787050|NCT00710606|75907261|FG000|NOT COMPLETED|Overall Study||0||
59787051|NCT00710606|75907262|FG001|NOT COMPLETED|Overall Study||2||
59787052|NCT00713544|75907276|FG000|STARTED|Overall Study||52||
59787053|NCT00713544|75907277|FG001|STARTED|Overall Study||52||
59787054|NCT00713544|75907278|FG002|STARTED|Overall Study|Participants randomised. One of these participants did not subsequently receive treatment.|52||
59787055|NCT00713544|75907279|FG003|STARTED|Overall Study||76||
59787056|NCT00713544|75907280|FG004|STARTED|Overall Study||65||
59953191|NCT04057820|76071784|FG004|COMPLETED|Period 5||0||0
59953192|NCT04057820|76071785|FG005|COMPLETED|Period 5||12||3
59953193|NCT04057820|76071786|FG006|COMPLETED|Period 5||0||0
59953194|NCT04057820|76071787|FG007|COMPLETED|Period 5||0||0
59953195|NCT04057820|76071788|FG008|COMPLETED|Period 5||16||4
59953196|NCT04057820|76071789|FG009|COMPLETED|Period 5||0||0
59953197|NCT04057820|76071790|FG010|COMPLETED|Period 5||19||4
59953198|NCT04057820|76071791|FG011|COMPLETED|Period 5||0||0
59953199|NCT04057820|76071792|FG012|COMPLETED|Period 5||16||3
59953200|NCT04057820|76071793|FG013|COMPLETED|Period 5||0||0
59953201|NCT04057820|76071794|FG014|COMPLETED|Period 5||17||3
59953202|NCT04057820|76071795|FG015|COMPLETED|Period 5||0||0
59953203|NCT04057820|76071780|FG000|NOT COMPLETED|Period 5||0||0
59953204|NCT04057820|76071781|FG001|NOT COMPLETED|Period 5||0||0
59953205|NCT04057820|76071782|FG002|NOT COMPLETED|Period 5||0||0
59953206|NCT04057820|76071783|FG003|NOT COMPLETED|Period 5||0||0
59953207|NCT04057820|76071784|FG004|NOT COMPLETED|Period 5||0||0
59953208|NCT04057820|76071785|FG005|NOT COMPLETED|Period 5||0||0
59953209|NCT04057820|76071786|FG006|NOT COMPLETED|Period 5||0||0
59953210|NCT04057820|76071787|FG007|NOT COMPLETED|Period 5||0||0
59953211|NCT04057820|76071788|FG008|NOT COMPLETED|Period 5||0||0
59953212|NCT04057820|76071789|FG009|NOT COMPLETED|Period 5||0||0
59953213|NCT04057820|76071790|FG010|NOT COMPLETED|Period 5||0||0
59953214|NCT04057820|76071791|FG011|NOT COMPLETED|Period 5||0||0
59953215|NCT04057820|76071792|FG012|NOT COMPLETED|Period 5||0||0
59953216|NCT04057820|76071793|FG013|NOT COMPLETED|Period 5||0||0
59953217|NCT04057820|76071794|FG014|NOT COMPLETED|Period 5||0||0
59953218|NCT04057820|76071795|FG015|NOT COMPLETED|Period 5||0||0
59953219|NCT04057820|76071780|FG000|STARTED|Period 6||0||0
59953220|NCT04057820|76071781|FG001|STARTED|Period 6|For this stepped wedge study design, a new cohort of infants is enrolled during each period except the transition period. Therefore, the number of infants to start a period is unlikely to equal the number of infants who completed the previous period.|24||4
59953221|NCT04057820|76071782|FG002|STARTED|Period 6||0||0
59953222|NCT04057820|76071783|FG003|STARTED|Period 6||5||2
59953223|NCT04057820|76071784|FG004|STARTED|Period 6||0||0
59787057|NCT00713544|75907281|FG005|STARTED|Overall Study|Participants randomised. One of these participants did not subsequently receive treatment.|76||
59787058|NCT00713544|75907276|FG000|COMPLETED|Overall Study||45||
59787059|NCT00713544|75907277|FG001|COMPLETED|Overall Study||46||
59787060|NCT00713544|75907278|FG002|COMPLETED|Overall Study||41||
59787061|NCT00713544|75907279|FG003|COMPLETED|Overall Study||66||
59787062|NCT00713544|75907280|FG004|COMPLETED|Overall Study||57||
59787063|NCT00713544|75907281|FG005|COMPLETED|Overall Study||67||
59787064|NCT00713544|75907276|FG000|NOT COMPLETED|Overall Study||7||
59787065|NCT00713544|75907277|FG001|NOT COMPLETED|Overall Study||6||
59787066|NCT00713544|75907278|FG002|NOT COMPLETED|Overall Study||11||
59787067|NCT00713544|75907279|FG003|NOT COMPLETED|Overall Study||10||
59787068|NCT00713544|75907280|FG004|NOT COMPLETED|Overall Study||8||
59787069|NCT00713544|75907281|FG005|NOT COMPLETED|Overall Study||9||
59787070|NCT00415363|75907297|FG000|STARTED|Overall Study||55||
59787071|NCT00415363|75907298|FG001|STARTED|Overall Study||54||
59787072|NCT00415363|75907297|FG000|Safety Population|Overall Study||54||
59787073|NCT00415363|75907298|FG001|Safety Population|Overall Study||53||
59787074|NCT00415363|75907297|FG000|COMPLETED|Overall Study||0||
59787075|NCT00415363|75907298|FG001|COMPLETED|Overall Study||0||
59787076|NCT00415363|75907297|FG000|NOT COMPLETED|Overall Study||55||
59787077|NCT00415363|75907298|FG001|NOT COMPLETED|Overall Study||54||
59787078|NCT00415051|75907305|FG000|STARTED|Overall Study||20||
59787079|NCT00415051|75907305|FG000|COMPLETED|Overall Study||19||
59787080|NCT00415051|75907305|FG000|NOT COMPLETED|Overall Study||1||
59787081|NCT00713258|75907311|FG000|STARTED|Overall Study||41||
59787082|NCT00713258|75907312|FG001|STARTED|Overall Study||34||
59787083|NCT00713258|75907311|FG000|COMPLETED|Overall Study||36||
59787084|NCT00713258|75907312|FG001|COMPLETED|Overall Study||28||
59787085|NCT00713258|75907311|FG000|NOT COMPLETED|Overall Study||5||
59787086|NCT00713258|75907312|FG001|NOT COMPLETED|Overall Study||6||
59787087|NCT00710034|75907320|FG000|STARTED|Completed 6 Weeks of Treatment||195||
59787088|NCT00710034|75907321|FG001|STARTED|Completed 6 Weeks of Treatment||196||
59787089|NCT00710034|75907320|FG000|COMPLETED|Completed 6 Weeks of Treatment|Completed 6 weeks of treatment for primary outcome assessment: N=154|154||
59787090|NCT00710034|75907321|FG001|COMPLETED|Completed 6 Weeks of Treatment|Completed 6 weeks of treatment for primary outcome assessment: N=149|149||
59787091|NCT00710034|75907320|FG000|NOT COMPLETED|Completed 6 Weeks of Treatment||41||
59787092|NCT00710034|75907321|FG001|NOT COMPLETED|Completed 6 Weeks of Treatment||47||
59787093|NCT00710034|75907320|FG000|STARTED|Completed 12 Weeks of Treatment||154||
59787094|NCT00710034|75907321|FG001|STARTED|Completed 12 Weeks of Treatment||149||
59787095|NCT00710034|75907320|FG000|COMPLETED|Completed 12 Weeks of Treatment||141||
59787096|NCT00710034|75907321|FG001|COMPLETED|Completed 12 Weeks of Treatment||138||
59787097|NCT00710034|75907320|FG000|NOT COMPLETED|Completed 12 Weeks of Treatment||13||
59787098|NCT00710034|75907321|FG001|NOT COMPLETED|Completed 12 Weeks of Treatment||11||
59787099|NCT00414973|75907331|FG000|STARTED|Overall Study||218||
59787100|NCT00414973|75907332|FG001|STARTED|Overall Study||109||
59787101|NCT00414973|75907333|FG002|STARTED|Overall Study||24||
59787102|NCT00414973|75907334|FG003|STARTED|Overall Study||11||
59787103|NCT00414973|75907331|FG000|COMPLETED|Overall Study||190||
59787104|NCT00414973|75907332|FG001|COMPLETED|Overall Study||99||
59787105|NCT00414973|75907333|FG002|COMPLETED|Overall Study||21||
59787106|NCT00414973|75907334|FG003|COMPLETED|Overall Study||11||
59787107|NCT00414973|75907331|FG000|NOT COMPLETED|Overall Study||28||
59787108|NCT00414973|75907332|FG001|NOT COMPLETED|Overall Study||10||
59787109|NCT00414973|75907333|FG002|NOT COMPLETED|Overall Study||3||
59787110|NCT00414973|75907334|FG003|NOT COMPLETED|Overall Study||0||
59787111|NCT00423085|75907347|FG000|STARTED|24-Week Double-Blind Treatment Phase||288||
59787112|NCT00423085|75907348|FG001|STARTED|24-Week Double-Blind Treatment Phase||284||
59787113|NCT00423085|75907349|FG002|STARTED|24-Week Double-Blind Treatment Phase||287||
59787114|NCT00423085|75907350|FG003|STARTED|24-Week Double-Blind Treatment Phase||0||
59787115|NCT00423085|75907347|FG000|COMPLETED|24-Week Double-Blind Treatment Phase||242||
59787116|NCT00423085|75907348|FG001|COMPLETED|24-Week Double-Blind Treatment Phase||220||
59787117|NCT00423085|75907349|FG002|COMPLETED|24-Week Double-Blind Treatment Phase||228||
59787118|NCT00423085|75907350|FG003|COMPLETED|24-Week Double-Blind Treatment Phase||0||
59787119|NCT00423085|75907347|FG000|NOT COMPLETED|24-Week Double-Blind Treatment Phase||46||
59787120|NCT00423085|75907348|FG001|NOT COMPLETED|24-Week Double-Blind Treatment Phase||64||
59787121|NCT00423085|75907349|FG002|NOT COMPLETED|24-Week Double-Blind Treatment Phase||59||
59787122|NCT00423085|75907350|FG003|NOT COMPLETED|24-Week Double-Blind Treatment Phase||0||
59787123|NCT00423085|75907347|FG000|STARTED|52-Week Open-Label Extension Phase||0||
59787124|NCT00423085|75907348|FG001|STARTED|52-Week Open-Label Extension Phase||0||
59787125|NCT00423085|75907349|FG002|STARTED|52-Week Open-Label Extension Phase||0||
59787126|NCT00423085|75907350|FG003|STARTED|52-Week Open-Label Extension Phase|Patients who completed the 24-wk treatment phase were eligible to enroll in the open-label extension|637||
59787127|NCT00423085|75907347|FG000|COMPLETED|52-Week Open-Label Extension Phase||0||
59787128|NCT00423085|75907348|FG001|COMPLETED|52-Week Open-Label Extension Phase||0||
59787129|NCT00423085|75907349|FG002|COMPLETED|52-Week Open-Label Extension Phase||0||
59787130|NCT00423085|75907350|FG003|COMPLETED|52-Week Open-Label Extension Phase||474||
59787131|NCT00423085|75907347|FG000|NOT COMPLETED|52-Week Open-Label Extension Phase||0||
59787132|NCT00423085|75907348|FG001|NOT COMPLETED|52-Week Open-Label Extension Phase||0||
59787133|NCT00423085|75907349|FG002|NOT COMPLETED|52-Week Open-Label Extension Phase||0||
59787134|NCT00423085|75907350|FG003|NOT COMPLETED|52-Week Open-Label Extension Phase||163||
59787135|NCT00414661|75907364|FG000|STARTED|Overall Study||48||
59787136|NCT00414661|75907365|FG001|STARTED|Overall Study||89||
59787137|NCT00414661|75907366|FG002|STARTED|Overall Study||22||
59787138|NCT00414661|75907367|FG003|STARTED|Overall Study||3||
59787139|NCT00414661|75907364|FG000|COMPLETED|Overall Study||34||
59787140|NCT00414661|75907365|FG001|COMPLETED|Overall Study||75||
59787141|NCT00414661|75907366|FG002|COMPLETED|Overall Study||20||
59787142|NCT00414661|75907367|FG003|COMPLETED|Overall Study||0||
59787143|NCT00414661|75907364|FG000|NOT COMPLETED|Overall Study||14||
59787144|NCT00414661|75907365|FG001|NOT COMPLETED|Overall Study||14||
59787145|NCT00414661|75907366|FG002|NOT COMPLETED|Overall Study||2||
59787146|NCT00414661|75907367|FG003|NOT COMPLETED|Overall Study||3||
59787147|NCT00405067|75907380|FG000|STARTED|Overall Study||28||
59787148|NCT00405067|75907381|FG001|STARTED|Overall Study||28||
59787149|NCT00405067|75907382|FG002|STARTED|Overall Study||29||
59787150|NCT00405067|75907380|FG000|COMPLETED|Overall Study||24||
59787151|NCT00405067|75907381|FG001|COMPLETED|Overall Study||19||
59787152|NCT00405067|75907382|FG002|COMPLETED|Overall Study||24||
59787153|NCT00405067|75907380|FG000|NOT COMPLETED|Overall Study||4||
59787154|NCT00405067|75907381|FG001|NOT COMPLETED|Overall Study||9||
59787155|NCT00405067|75907382|FG002|NOT COMPLETED|Overall Study||5||
59787156|NCT00708708|75907390|FG000|STARTED|Overall Study||955||
59787157|NCT00708708|75907390|FG000|COMPLETED|Overall Study|Included participants completed total observation period and participants with planned study end.|213||
59787158|NCT00708708|75907390|FG000|NOT COMPLETED|Overall Study||742||
59787159|NCT00404755|75907397|FG000|STARTED|Phase I (Bupropion)|3 went directly into Phase II (intolerant of bupropion), 1 withdrew consent and 4 did not return|17||
59787160|NCT00404755|75907397|FG000|COMPLETED|Phase I (Bupropion)||13||
59787161|NCT00404755|75907397|FG000|NOT COMPLETED|Phase I (Bupropion)||4||
59787162|NCT00404755|75907397|FG000|STARTED|Phase II (Escitalopram)||11|Escitalopram 10mg/d RX to those not improved in PhaseI for 1 wk, then to 20, maximal dose of 40mg/d|
59787163|NCT00404755|75907397|FG000|COMPLETED|Phase II (Escitalopram)||9||
59787164|NCT00404755|75907397|FG000|NOT COMPLETED|Phase II (Escitalopram)||2||
59787165|NCT00404755|75907397|FG000|STARTED|Phase III (Imipramine)||3|imipramine 50mg/d increasing twice wkly by 50mg upto 200mg/d, to maxdose of 300mg/d II nonremitters|
59787166|NCT00404755|75907397|FG000|COMPLETED|Phase III (Imipramine)||3||
59787167|NCT00404755|75907397|FG000|NOT COMPLETED|Phase III (Imipramine)||0||
59787168|NCT00614614|75907407|FG000|STARTED|Primary Vaccination Phase||1272||
59787169|NCT00614614|75907408|FG001|STARTED|Primary Vaccination Phase||282||
59787170|NCT00614614|75907409|FG002|STARTED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0||
59787171|NCT00614614|75907410|FG003|STARTED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0||
59787172|NCT00614614|75907411|FG004|STARTED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0||
59787173|NCT00614614|75907407|FG000|COMPLETED|Primary Vaccination Phase||1182||
59787174|NCT00614614|75907408|FG001|COMPLETED|Primary Vaccination Phase||265||
59787175|NCT00614614|75907409|FG002|COMPLETED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0||
59787176|NCT00614614|75907410|FG003|COMPLETED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0||
59787177|NCT00614614|75907411|FG004|COMPLETED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0||
59787178|NCT00614614|75907407|FG000|NOT COMPLETED|Primary Vaccination Phase||90||
59787179|NCT00614614|75907408|FG001|NOT COMPLETED|Primary Vaccination Phase||17||
59787180|NCT00614614|75907409|FG002|NOT COMPLETED|Primary Vaccination Phase||0||
59787181|NCT00614614|75907410|FG003|NOT COMPLETED|Primary Vaccination Phase||0||
59787182|NCT00614614|75907411|FG004|NOT COMPLETED|Primary Vaccination Phase||0||
59787183|NCT00614614|75907407|FG000|STARTED|Booster Vaccination Phase|Menhibrix 1 Group was re-randomized to Nimenrix 1,Menhibrix 2 and Nimenrix 2 Groups in booster phase|0||
59787184|NCT00614614|75907408|FG001|STARTED|Booster Vaccination Phase||233||
59787185|NCT00614614|75907409|FG002|STARTED|Booster Vaccination Phase||432||
59787186|NCT00614614|75907410|FG003|STARTED|Booster Vaccination Phase||229||
59787187|NCT00614614|75907411|FG004|STARTED|Booster Vaccination Phase||409||
59787188|NCT00614614|75907407|FG000|COMPLETED|Booster Vaccination Phase|Menhibrix 1 Group was re-randomized to Nimenrix 1,Menhibrix 2 and Nimenrix 2 Groups in booster phase|0||
59787189|NCT00614614|75907408|FG001|COMPLETED|Booster Vaccination Phase||227||
59787190|NCT00614614|75907409|FG002|COMPLETED|Booster Vaccination Phase||405||
59787191|NCT00614614|75907410|FG003|COMPLETED|Booster Vaccination Phase||210||
59787192|NCT00614614|75907411|FG004|COMPLETED|Booster Vaccination Phase||396||
59787193|NCT00614614|75907407|FG000|NOT COMPLETED|Booster Vaccination Phase||0||
59787194|NCT00614614|75907408|FG001|NOT COMPLETED|Booster Vaccination Phase||6||
59787195|NCT00614614|75907409|FG002|NOT COMPLETED|Booster Vaccination Phase||27||
59787196|NCT00614614|75907410|FG003|NOT COMPLETED|Booster Vaccination Phase||19||
59787197|NCT00614614|75907411|FG004|NOT COMPLETED|Booster Vaccination Phase||13||
59787198|NCT00713310|75907428|FG000|STARTED|Overall Study||41||
59787199|NCT00713310|75907429|FG001|STARTED|Overall Study||42||
59787200|NCT00713310|75907428|FG000|mITT Population|Overall Study||41||
59787201|NCT00713310|75907429|FG001|mITT Population|Overall Study|1 subject randomized to high dose not dosed so not included in the mITT population.|41||
59787202|NCT00713310|75907428|FG000|COMPLETED|Overall Study||36||
59787203|NCT00713310|75907429|FG001|COMPLETED|Overall Study||36||
59787204|NCT00713310|75907428|FG000|NOT COMPLETED|Overall Study||5||
59787205|NCT00713310|75907429|FG001|NOT COMPLETED|Overall Study||6||
59787206|NCT00422461|75907439|FG000|STARTED|Overall Study||35||
59787207|NCT00422461|75907440|FG001|STARTED|Overall Study||35||
59787208|NCT00422461|75907441|FG002|STARTED|Overall Study||32||
59787209|NCT00422461|75907442|FG003|STARTED|Overall Study||33||
59787210|NCT00422461|75907439|FG000|Treated|Overall Study||34||
59787211|NCT00422461|75907440|FG001|Treated|Overall Study||34||
59787212|NCT00422461|75907441|FG002|Treated|Overall Study||32||
59787213|NCT00422461|75907442|FG003|Treated|Overall Study||33||
59787214|NCT00422461|75907439|FG000|Full Analysis Set|Overall Study||34||
59787215|NCT00422461|75907440|FG001|Full Analysis Set|Overall Study||34||
59787216|NCT00422461|75907441|FG002|Full Analysis Set|Overall Study||31||
59787217|NCT00422461|75907442|FG003|Full Analysis Set|Overall Study||33||
59787218|NCT00422461|75907439|FG000|COMPLETED|Overall Study||32||
59787219|NCT00422461|75907440|FG001|COMPLETED|Overall Study||32||
59787220|NCT00422461|75907441|FG002|COMPLETED|Overall Study||31||
59787221|NCT00422461|75907442|FG003|COMPLETED|Overall Study||30||
59787222|NCT00422461|75907439|FG000|NOT COMPLETED|Overall Study||3||
59787223|NCT00422461|75907440|FG001|NOT COMPLETED|Overall Study||3||
59787224|NCT00422461|75907441|FG002|NOT COMPLETED|Overall Study||1||
59787225|NCT00422461|75907442|FG003|NOT COMPLETED|Overall Study||3||
59787226|NCT00712920|75907455|FG000|STARTED|Overall Study||192||
59787227|NCT00712920|75907456|FG001|STARTED|Overall Study|3 subjects were randomized in error|197||
59787228|NCT00712920|75907457|FG002|STARTED|Overall Study||192||
59787229|NCT00712920|75907455|FG000|COMPLETED|Overall Study||175||
59787230|NCT00712920|75907456|FG001|COMPLETED|Overall Study||180||
59787231|NCT00712920|75907457|FG002|COMPLETED|Overall Study||180||
59787232|NCT00712920|75907455|FG000|NOT COMPLETED|Overall Study||17||
59787233|NCT00712920|75907456|FG001|NOT COMPLETED|Overall Study||17||
59787234|NCT00712920|75907457|FG002|NOT COMPLETED|Overall Study||12||
59787235|NCT04180540|75907467|FG000|STARTED|Overall Study||55||
59787236|NCT04180540|75907468|FG001|STARTED|Overall Study||54||
59787237|NCT04180540|75907467|FG000|COMPLETED|Overall Study||53||
59787238|NCT04180540|75907468|FG001|COMPLETED|Overall Study||54||
59787239|NCT04180540|75907467|FG000|NOT COMPLETED|Overall Study||2||
59787240|NCT04180540|75907468|FG001|NOT COMPLETED|Overall Study||0||
59787241|NCT00612586|75907476|FG000|STARTED|Overall Study||58||
59787242|NCT00612586|75907477|FG001|STARTED|Overall Study||59||
59787243|NCT00612586|75907476|FG000|Received at Least 1 Dose|Overall Study||57||
59787244|NCT00612586|75907477|FG001|Received at Least 1 Dose|Overall Study||58||
59787245|NCT00612586|75907476|FG000|COMPLETED|Overall Study||15||
59787246|NCT00612586|75907477|FG001|COMPLETED|Overall Study||18||
59787247|NCT00612586|75907476|FG000|NOT COMPLETED|Overall Study||43||
59787248|NCT00612586|75907477|FG001|NOT COMPLETED|Overall Study||41||
59787249|NCT00614380|75907488|FG000|STARTED|Overall Study||564||
59787250|NCT00614380|75907489|FG001|STARTED|Overall Study||206||
59787251|NCT00614380|75907490|FG002|STARTED|Overall Study||25||
59787252|NCT00614380|75907491|FG003|STARTED|Overall Study||181||
59787253|NCT00614380|75907488|FG000|COMPLETED|Overall Study||529||
59787254|NCT00614380|75907489|FG001|COMPLETED|Overall Study||198||
59787255|NCT00614380|75907490|FG002|COMPLETED|Overall Study||24||
59787256|NCT00614380|75907491|FG003|COMPLETED|Overall Study||179||
59787257|NCT00614380|75907488|FG000|NOT COMPLETED|Overall Study||35||
59787258|NCT00614380|75907489|FG001|NOT COMPLETED|Overall Study||8||
59787259|NCT00614380|75907490|FG002|NOT COMPLETED|Overall Study||1||
59787260|NCT00614380|75907491|FG003|NOT COMPLETED|Overall Study||2||
59787261|NCT00612508|75907508|FG000|STARTED|Overall Study||7||
59787262|NCT00612508|75907509|FG001|STARTED|Overall Study||7||
59787263|NCT00612508|75907508|FG000|COMPLETED|Overall Study|5 desogen users returned for the 84 day biopsy|4||
59787264|NCT00612508|75907509|FG001|COMPLETED|Overall Study|6 nuvaring users returned for the 84 day biopsy|3||
59787265|NCT00612508|75907508|FG000|NOT COMPLETED|Overall Study||3||
59787266|NCT00612508|75907509|FG001|NOT COMPLETED|Overall Study||4||
59787267|NCT00613834|75907519|FG000|STARTED|Overall Study||29||
59787268|NCT00613834|75907520|FG001|STARTED|Overall Study||29||
59787269|NCT00613834|75907519|FG000|COMPLETED|Overall Study||29||
59787270|NCT00613834|75907520|FG001|COMPLETED|Overall Study||26||
59787271|NCT00613834|75907519|FG000|NOT COMPLETED|Overall Study||0||
59787272|NCT00613834|75907520|FG001|NOT COMPLETED|Overall Study||3||
59787273|NCT03912298|75907528|FG000|STARTED|Overall Study||7||
59787274|NCT03912298|75907528|FG000|COMPLETED|Overall Study||7||
59787275|NCT03912298|75907528|FG000|NOT COMPLETED|Overall Study||0||
59787276|NCT00613366|75907534|FG000|STARTED|Overall Study||20||
59787277|NCT00613366|75907535|FG001|STARTED|Overall Study||20||
59787278|NCT00613366|75907534|FG000|COMPLETED|Overall Study||17||
59787279|NCT00613366|75907535|FG001|COMPLETED|Overall Study||18||
59787280|NCT00613366|75907534|FG000|NOT COMPLETED|Overall Study||3||
59787281|NCT00613366|75907535|FG001|NOT COMPLETED|Overall Study||2||
59787282|NCT00612352|75907543|FG000|STARTED|Overall Study||65||
59787283|NCT00612352|75907544|FG001|STARTED|Overall Study||115||
59787284|NCT00612352|75907543|FG000|40%mg & 100%mg|Overall Study||1|Subjects that completed 2 test days (40%mg ethanol & 100%mg ethanol)|
59787285|NCT00612352|75907544|FG001|40%mg & 100%mg|Overall Study||1|Subjects that completed 2 test days (40%mg ethanol & 100%mg ethanol)|
59787286|NCT00612352|75907543|FG000|Placebo & 100%mg|Overall Study||1|Subjects that completed 2 test days (placebo & 100%mg ethanol)|
59787287|NCT00612352|75907544|FG001|Placebo & 100%mg|Overall Study||0|Subjects that completed 2 test days (placebo & 100%mg ethanol)|
59787288|NCT00612352|75907543|FG000|100%mg|Overall Study||2|Subjects that completed 1 test day (100%mg ethanol)|
59787289|NCT00612352|75907544|FG001|100%mg|Overall Study||1|Subjects that completed 1 test day (100%mg ethanol)|
59787290|NCT00612352|75907543|FG000|40%mg|Overall Study||1|Subjects that completed 1 test day (40%mg ethanol)|
59787291|NCT00612352|75907544|FG001|40%mg|Overall Study||0|Subjects that completed 1 test day (40%mg ethanol)|
59787292|NCT00612352|75907543|FG000|Placebo|Overall Study||4|Subjects that completed 1 test day (placebo)|
59787293|NCT00612352|75907544|FG001|Placebo|Overall Study||4|Subjects that completed 1 test day (placebo)|
59787294|NCT00612352|75907543|FG000|COMPLETED|Overall Study||56|Completed all three test dates.|
59787295|NCT00612352|75907544|FG001|COMPLETED|Overall Study||109|Completed all three test dates.|
59787296|NCT00612352|75907543|FG000|NOT COMPLETED|Overall Study||9||
59787297|NCT00612352|75907544|FG001|NOT COMPLETED|Overall Study||6||
59787298|NCT00704730|75907552|FG000|STARTED|Overall Study|Randomized|219||
59787299|NCT00704730|75907553|FG001|STARTED|Overall Study|Randomized|111||
59787300|NCT00704730|75907552|FG000|COMPLETED|Overall Study|Continuing treatment at data cutoff for primary analysis, but subsequently discontinued study|98||
59787301|NCT00704730|75907553|FG001|COMPLETED|Overall Study|Continuing study treatment at the time of data cut-off.|15||
59787302|NCT00704730|75907552|FG000|NOT COMPLETED|Overall Study||121||
59787303|NCT00704730|75907553|FG001|NOT COMPLETED|Overall Study||96||
59787304|NCT00651261|75907562|FG000|STARTED|Overall Study||360||
59787305|NCT00651261|75907563|FG001|STARTED|Overall Study||357||
59787306|NCT00651261|75907562|FG000|COMPLETED|Overall Study||69||
59787307|NCT00651261|75907563|FG001|COMPLETED|Overall Study||51||
59787308|NCT00651261|75907562|FG000|NOT COMPLETED|Overall Study||291||
59787309|NCT00651261|75907563|FG001|NOT COMPLETED|Overall Study||306||
59787310|NCT00651183|75907571|FG000|STARTED|Overall Study|"For one patient the information was not given, therefore, the patient was listed missing"|189||
59787311|NCT00651183|75907572|FG001|STARTED|Overall Study||97||
59787312|NCT00651183|75907571|FG000|COMPLETED|Overall Study|Case Report Form (CRF) listed reasons for early termination, of which one was|169||
59787313|NCT00651183|75907572|FG001|COMPLETED|Overall Study|"other reasons. No explanation was required to be given by the physicians"|87||
59787314|NCT00651183|75907571|FG000|NOT COMPLETED|Overall Study||20||
59787315|NCT00651183|75907572|FG001|NOT COMPLETED|Overall Study||10||
59787316|NCT00699972|75907581|FG000|STARTED|Overall Study||122||
59787317|NCT00699972|75907582|FG001|STARTED|Overall Study||133||
59787318|NCT00699972|75907583|FG002|STARTED|Overall Study||135||
59787319|NCT00699972|75907581|FG000|COMPLETED|Overall Study||106||
59787320|NCT00699972|75907582|FG001|COMPLETED|Overall Study||114||
59787321|NCT00699972|75907583|FG002|COMPLETED|Overall Study||100||
59787322|NCT00699972|75907581|FG000|NOT COMPLETED|Overall Study||16||
59787323|NCT00699972|75907582|FG001|NOT COMPLETED|Overall Study||19||
59787324|NCT00699972|75907583|FG002|NOT COMPLETED|Overall Study||35||
59787325|NCT00642759|75907591|FG000|STARTED|Overall Study||36||
59787326|NCT00642759|75907591|FG000|COMPLETED|Overall Study||35||
59787327|NCT00642759|75907591|FG000|NOT COMPLETED|Overall Study||1||
59787328|NCT00611026|75907599|FG000|STARTED|Randomized to Double-blind Treatment||480||
59787329|NCT00611026|75907600|FG001|STARTED|Randomized to Double-blind Treatment||974||
59787330|NCT00611026|75907601|FG002|STARTED|Randomized to Double-blind Treatment||963||
59787331|NCT00611026|75907599|FG000|COMPLETED|Randomized to Double-blind Treatment||478||
59787332|NCT00611026|75907600|FG001|COMPLETED|Randomized to Double-blind Treatment||973||
59787333|NCT00611026|75907601|FG002|COMPLETED|Randomized to Double-blind Treatment||960||
59787334|NCT00611026|75907599|FG000|NOT COMPLETED|Randomized to Double-blind Treatment||2||
59787335|NCT00611026|75907600|FG001|NOT COMPLETED|Randomized to Double-blind Treatment||1||
59787336|NCT00611026|75907601|FG002|NOT COMPLETED|Randomized to Double-blind Treatment||3||
59787337|NCT00611026|75907599|FG000|STARTED|Double-blind Treatment Period||478||
59787338|NCT00611026|75907600|FG001|STARTED|Double-blind Treatment Period||973||
59787339|NCT00611026|75907601|FG002|STARTED|Double-blind Treatment Period||960||
59787340|NCT00611026|75907599|FG000|COMPLETED|Double-blind Treatment Period||431||
59787341|NCT00611026|75907600|FG001|COMPLETED|Double-blind Treatment Period||885||
59787342|NCT00611026|75907601|FG002|COMPLETED|Double-blind Treatment Period||862||
59787343|NCT00611026|75907599|FG000|NOT COMPLETED|Double-blind Treatment Period||47||
59787344|NCT00611026|75907600|FG001|NOT COMPLETED|Double-blind Treatment Period||88||
59787345|NCT00611026|75907601|FG002|NOT COMPLETED|Double-blind Treatment Period||98||
59787346|NCT00646113|75907611|FG000|STARTED|Overall Study|3 of the 72 enrolled participants were excluded before surgery.|69|Completed surgery|97
59787347|NCT00646113|75907611|FG000|COMPLETED|Overall Study||61||86
59787348|NCT00646113|75907611|FG000|NOT COMPLETED|Overall Study||8||11
59787349|NCT00422383|75907620|FG000|STARTED|Overall Study||134||
59787350|NCT00422383|75907621|FG001|STARTED|Overall Study||120||
59787351|NCT00422383|75907622|FG002|STARTED|Overall Study||93||
59787352|NCT00422383|75907623|FG003|STARTED|Overall Study||6||
59787353|NCT00422383|75907624|FG004|STARTED|Overall Study||25||
59787354|NCT00422383|75907620|FG000|COMPLETED|Overall Study||119||
59787355|NCT00422383|75907621|FG001|COMPLETED|Overall Study||106||
59787356|NCT00422383|75907622|FG002|COMPLETED|Overall Study||89||
59787357|NCT00422383|75907623|FG003|COMPLETED|Overall Study||4||
59787358|NCT00422383|75907624|FG004|COMPLETED|Overall Study||22||
59787359|NCT00422383|75907620|FG000|NOT COMPLETED|Overall Study||15||
59787360|NCT00422383|75907621|FG001|NOT COMPLETED|Overall Study||14||
59787361|NCT00422383|75907622|FG002|NOT COMPLETED|Overall Study||4||
59787362|NCT00422383|75907623|FG003|NOT COMPLETED|Overall Study||2||
59787363|NCT00422383|75907624|FG004|NOT COMPLETED|Overall Study||3||
59787364|NCT00612040|75907645|FG000|STARTED|Overall Study||60||
59787365|NCT00612040|75907646|FG001|STARTED|Overall Study||59||
59787366|NCT00612040|75907647|FG002|STARTED|Overall Study||59||
59787367|NCT00612040|75907645|FG000|Exposed|Overall Study||60||
59787368|NCT00612040|75907646|FG001|Exposed|Overall Study||59||
59787369|NCT00612040|75907647|FG002|Exposed|Overall Study||59||
59787370|NCT00612040|75907645|FG000|COMPLETED|Overall Study||55||
59787371|NCT00612040|75907646|FG001|COMPLETED|Overall Study||52||
59787372|NCT00612040|75907647|FG002|COMPLETED|Overall Study||52||
59787373|NCT00612040|75907645|FG000|NOT COMPLETED|Overall Study||5||
59787374|NCT00612040|75907646|FG001|NOT COMPLETED|Overall Study||7||
59787375|NCT00612040|75907647|FG002|NOT COMPLETED|Overall Study||7||
59787376|NCT00422227|75907657|FG000|STARTED|Overall Study||197||
59787377|NCT00422227|75907658|FG001|STARTED|Overall Study||103||
59787378|NCT00422227|75907657|FG000|COMPLETED|Overall Study||193||
59787379|NCT00422227|75907658|FG001|COMPLETED|Overall Study||88||
59787380|NCT00422227|75907657|FG000|NOT COMPLETED|Overall Study||4||
59787381|NCT00422227|75907658|FG001|NOT COMPLETED|Overall Study||15||
59787382|NCT00421993|75907668|FG000|STARTED|Overall Study||419||
59787383|NCT00421993|75907669|FG001|STARTED|Overall Study||418||
59787384|NCT00421993|75907670|FG002|STARTED|Overall Study||415||
59787385|NCT00421993|75907671|FG003|STARTED|Overall Study||418||
59787386|NCT00421993|75907668|FG000|COMPLETED|Overall Study||366||
59787387|NCT00421993|75907669|FG001|COMPLETED|Overall Study||369||
59787388|NCT00421993|75907670|FG002|COMPLETED|Overall Study||363||
59787389|NCT00421993|75907671|FG003|COMPLETED|Overall Study||361||
59787390|NCT00421993|75907668|FG000|NOT COMPLETED|Overall Study||53||
59787391|NCT00421993|75907669|FG001|NOT COMPLETED|Overall Study||49||
59787392|NCT00421993|75907670|FG002|NOT COMPLETED|Overall Study||52||
59787393|NCT00421993|75907671|FG003|NOT COMPLETED|Overall Study||57||
59787394|NCT00413959|75907681|FG000|STARTED|Overall Study||12||
59787395|NCT00413959|75907681|FG000|COMPLETED|Overall Study||11||
59787396|NCT00413959|75907681|FG000|NOT COMPLETED|Overall Study||1||
59787397|NCT00645567|75907685|FG000|STARTED|Overall Study||5||
59787398|NCT00645567|75907685|FG000|COMPLETED|Overall Study|One individual provided consent & was dropped due to an unrelated injury to his hand at his home.|4||
59787399|NCT00645567|75907685|FG000|NOT COMPLETED|Overall Study||1||
59787400|NCT00611884|75907697|FG000|STARTED|Overall Study||61||
59787401|NCT00611884|75907698|FG001|STARTED|Overall Study||60||
59787402|NCT00611884|75907699|FG002|STARTED|Overall Study||62||
59787403|NCT00611884|75907700|FG003|STARTED|Overall Study||62||
59787404|NCT00611884|75907697|FG000|Exposed|Overall Study|Three subjects withdrew prior to exposure to trial drug|58||
59787405|NCT00611884|75907698|FG001|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|59||
59787406|NCT00611884|75907699|FG002|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|61||
59787407|NCT00611884|75907700|FG003|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|61||
59787408|NCT00611884|75907697|FG000|COMPLETED|Overall Study||52||
59787409|NCT00611884|75907698|FG001|COMPLETED|Overall Study||51||
59787410|NCT00611884|75907699|FG002|COMPLETED|Overall Study||58||
59787411|NCT00611884|75907700|FG003|COMPLETED|Overall Study||56||
59787412|NCT00611884|75907697|FG000|NOT COMPLETED|Overall Study||9||
59787413|NCT00611884|75907698|FG001|NOT COMPLETED|Overall Study||9||
59787414|NCT00611884|75907699|FG002|NOT COMPLETED|Overall Study||4||
59787415|NCT00611884|75907700|FG003|NOT COMPLETED|Overall Study||6||
59787416|NCT00420745|75907712|FG000|STARTED|Overall Study||670||
59787417|NCT00420745|75907713|FG001|STARTED|Overall Study||339||
59787418|NCT00420745|75907712|FG000|COMPLETED|Overall Study||655||
59787419|NCT00420745|75907713|FG001|COMPLETED|Overall Study||333||
59787420|NCT00420745|75907712|FG000|NOT COMPLETED|Overall Study||15||
59787421|NCT00420745|75907713|FG001|NOT COMPLETED|Overall Study||6||
59787422|NCT00611806|75907721|FG000|STARTED|Overall Study||94||
59787423|NCT00611806|75907722|FG001|STARTED|Overall Study||46||
59787424|NCT00611806|75907721|FG000|COMPLETED|Overall Study||78||
59787425|NCT00611806|75907722|FG001|COMPLETED|Overall Study||43||
59787426|NCT00611806|75907721|FG000|NOT COMPLETED|Overall Study||16||
59787427|NCT00611806|75907722|FG001|NOT COMPLETED|Overall Study||3||
59787428|NCT00413413|75907731|FG000|STARTED|Single-Blind|In single-blind period participants were only enrolled to Valsartan 80 mg arm.|0||
59787429|NCT00413413|75907732|FG001|STARTED|Single-Blind||1134||
59787430|NCT00413413|75907733|FG002|STARTED|Single-Blind|In single-blind period participants were only enrolled to Valsartan 80 mg arm.|0||
59787431|NCT00413413|75907731|FG000|COMPLETED|Single-Blind||0||
59787432|NCT00413413|75907732|FG001|COMPLETED|Single-Blind||918||
59787433|NCT00413413|75907733|FG002|COMPLETED|Single-Blind||0||
59787434|NCT00413413|75907731|FG000|NOT COMPLETED|Single-Blind||0||
59787435|NCT00413413|75907732|FG001|NOT COMPLETED|Single-Blind||216||
59787436|NCT00413413|75907733|FG002|NOT COMPLETED|Single-Blind||0||
59787437|NCT00413413|75907731|FG000|STARTED|Double-Blind||308||
59787438|NCT00413413|75907732|FG001|STARTED|Double-Blind||307||
59787439|NCT00413413|75907733|FG002|STARTED|Double-Blind||303||
59787440|NCT00413413|75907731|FG000|COMPLETED|Double-Blind||293||
59787441|NCT00413413|75907732|FG001|COMPLETED|Double-Blind||293||
59787442|NCT00413413|75907733|FG002|COMPLETED|Double-Blind||285||
59787443|NCT00413413|75907731|FG000|NOT COMPLETED|Double-Blind||15||
59787444|NCT00413413|75907732|FG001|NOT COMPLETED|Double-Blind||14||
59787445|NCT00413413|75907733|FG002|NOT COMPLETED|Double-Blind||18||
59787446|NCT00610714|75907743|FG000|STARTED|Overall Study||105||
59787447|NCT00610714|75907744|FG001|STARTED|Overall Study||106||
59787448|NCT00610714|75907743|FG000|COMPLETED|Overall Study||79||
59787449|NCT00610714|75907744|FG001|COMPLETED|Overall Study||82||
59787450|NCT00610714|75907743|FG000|NOT COMPLETED|Overall Study||26||
59787451|NCT00610714|75907744|FG001|NOT COMPLETED|Overall Study||24||
59787452|NCT00403585|75907750|FG000|STARTED|Initial Treatment Phase||104||
59787453|NCT00403585|75907750|FG000|COMPLETED|Initial Treatment Phase||102||
59787454|NCT00403585|75907750|FG000|NOT COMPLETED|Initial Treatment Phase||2||
59787455|NCT00403585|75907750|FG000|STARTED|Open-Label Phase; Extension Study|80 of 102 participants completing Study 103814 enrolled in extension (22 didn't continue medication)|80||
59787456|NCT00403585|75907750|FG000|COMPLETED|Open-Label Phase; Extension Study||74||
59787457|NCT00403585|75907750|FG000|NOT COMPLETED|Open-Label Phase; Extension Study||6||
59787458|NCT00645411|75907758|FG000|STARTED|Overall Study||656||
59787459|NCT00645411|75907759|FG001|STARTED|Overall Study||318||
59787460|NCT00645411|75907760|FG002|STARTED|Overall Study||1608||
59787461|NCT00645411|75907761|FG003|STARTED|Overall Study||1022||
59787462|NCT00645411|75907758|FG000|COMPLETED|Overall Study||643||
59787463|NCT00645411|75907759|FG001|COMPLETED|Overall Study||312||
59787464|NCT00645411|75907760|FG002|COMPLETED|Overall Study||1457||
59787465|NCT00645411|75907761|FG003|COMPLETED|Overall Study||919||
59787466|NCT00645411|75907758|FG000|NOT COMPLETED|Overall Study||13||
59787467|NCT00645411|75907759|FG001|NOT COMPLETED|Overall Study||6||
59787468|NCT00645411|75907760|FG002|NOT COMPLETED|Overall Study||151||
59787469|NCT00645411|75907761|FG003|NOT COMPLETED|Overall Study||103||
59787470|NCT00403273|75907780|FG000|STARTED|Overall Study||25||
59787471|NCT00403273|75907781|FG001|STARTED|Overall Study||29||
59787472|NCT00403273|75907780|FG000|COMPLETED|Overall Study||22||
59787473|NCT00403273|75907781|FG001|COMPLETED|Overall Study||25||
59787474|NCT00403273|75907780|FG000|NOT COMPLETED|Overall Study||3||
59787475|NCT00403273|75907781|FG001|NOT COMPLETED|Overall Study||4||
59787476|NCT03835546|75907792|FG000|STARTED|Overall Study||15||
59787477|NCT03835546|75907793|FG001|STARTED|Overall Study||15||
59787478|NCT03835546|75907794|FG002|STARTED|Overall Study||15||
59787479|NCT03835546|75907792|FG000|COMPLETED|Overall Study||12||
59787480|NCT03835546|75907793|FG001|COMPLETED|Overall Study||15||
59953224|NCT04057820|76071785|FG005|STARTED|Period 6||14||3
59953225|NCT04057820|76071786|FG006|STARTED|Period 6||0||0
59953226|NCT04057820|76071787|FG007|STARTED|Period 6||15||3
60073179|NCT01588353|76188393|FG000|NOT COMPLETED|Step1||0||
59522708|NCT02654782|75617209|FG001|NOT COMPLETED|Overall Study||0||
59619730|NCT02315352|75730896|FG002|STARTED|Fifth Intervention (Day 2)||7||
59787481|NCT03835546|75907794|FG002|COMPLETED|Overall Study||15||
59787482|NCT03835546|75907792|FG000|NOT COMPLETED|Overall Study||3||
59787483|NCT03835546|75907793|FG001|NOT COMPLETED|Overall Study||0||
59619731|NCT02315352|75730897|FG003|STARTED|Fifth Intervention (Day 2)||8||
59619732|NCT02315352|75730898|FG004|STARTED|Fifth Intervention (Day 2)||8||
59619733|NCT02315352|75730899|FG005|STARTED|Fifth Intervention (Day 2)||7||
59619734|NCT02315352|75730900|FG006|STARTED|Fifth Intervention (Day 2)||9||
59953227|NCT04057820|76071788|FG008|STARTED|Period 6|Block 5 with 4 sites transitioned from Usual Care to ESC during Period 6; therefore no infants were being enrolled and the total number of sites enrolling infants was 22.|0||0
59953228|NCT04057820|76071789|FG009|STARTED|Period 6||0||0
59953229|NCT04057820|76071790|FG010|STARTED|Period 6||13||4
59787484|NCT03835546|75907794|FG002|NOT COMPLETED|Overall Study||0||
59787485|NCT00402727|75907804|FG000|STARTED|Overall Study||432||
59787486|NCT00402727|75907805|FG001|STARTED|Overall Study||381||
59787487|NCT00402727|75907804|FG000|Achieving End Of Treatment (EOT)|Overall Study||408||
59787488|NCT00402727|75907805|FG001|Achieving End Of Treatment (EOT)|Overall Study||355||
60073180|NCT01588353|76188394|FG001|NOT COMPLETED|Step1||0||
59619735|NCT02315352|75730901|FG007|STARTED|Fifth Intervention (Day 2)||8||
59619736|NCT02315352|75730894|FG000|COMPLETED|Fifth Intervention (Day 2)||0||
59787489|NCT00402727|75907804|FG000|Achieving Test Of Cure (TOC)|Overall Study||390||
59787490|NCT00402727|75907805|FG001|Achieving Test Of Cure (TOC)|Overall Study||347||
59787491|NCT00402727|75907804|FG000|COMPLETED|Overall Study||390||
59787492|NCT00402727|75907805|FG001|COMPLETED|Overall Study||347||
60073181|NCT01588353|76188395|FG002|NOT COMPLETED|Step1||0||
60073182|NCT01588353|76188393|FG000|STARTED|Step2||0||
60073183|NCT01588353|76188394|FG001|STARTED|Step2||71||
60073184|NCT01588353|76188395|FG002|STARTED|Step2||0||
60073185|NCT01588353|76188393|FG000|COMPLETED|Step2||0||
60073186|NCT01588353|76188394|FG001|COMPLETED|Step2||70||
59787493|NCT00402727|75907804|FG000|NOT COMPLETED|Overall Study||42||
59787494|NCT00402727|75907805|FG001|NOT COMPLETED|Overall Study||34||
59787495|NCT00402649|75907811|FG000|STARTED|Overall Study||35||
59787496|NCT00402649|75907811|FG000|COMPLETED|Overall Study||33||
59787497|NCT00402649|75907811|FG000|NOT COMPLETED|Overall Study||2||
59787498|NCT00402337|75907820|FG000|STARTED|Overall Study||59||
60073187|NCT01588353|76188395|FG002|COMPLETED|Step2||0||
60073188|NCT01588353|76188393|FG000|NOT COMPLETED|Step2||0||
60073189|NCT01588353|76188394|FG001|NOT COMPLETED|Step2||1||
60073190|NCT01588353|76188395|FG002|NOT COMPLETED|Step2||0||
60073191|NCT01588353|76188393|FG000|STARTED|Step3||0||
60073192|NCT01588353|76188394|FG001|STARTED|Step3||0||
60073193|NCT01588353|76188395|FG002|STARTED|Step3||25||
60073194|NCT01588353|76188393|FG000|COMPLETED|Step3||0||
60073195|NCT01588353|76188394|FG001|COMPLETED|Step3||0||
60073196|NCT01588353|76188395|FG002|COMPLETED|Step3||23||
60073197|NCT01588353|76188393|FG000|NOT COMPLETED|Step3||0||
60073198|NCT01588353|76188394|FG001|NOT COMPLETED|Step3||0||
60073199|NCT01588353|76188395|FG002|NOT COMPLETED|Step3||2||
60073200|NCT01588197|76188404|FG000|STARTED|Overall Study||10||
60073201|NCT01588197|76188405|FG001|STARTED|Overall Study||10||
60073202|NCT01588197|76188404|FG000|COMPLETED|Overall Study||9||
60073203|NCT01588197|76188405|FG001|COMPLETED|Overall Study||9||
60073204|NCT01588197|76188404|FG000|NOT COMPLETED|Overall Study||1||
60073205|NCT01588197|76188405|FG001|NOT COMPLETED|Overall Study||1||
60073206|NCT01561989|76188413|FG000|STARTED|Overall Study||5||
60073207|NCT01561989|76188414|FG001|STARTED|Overall Study||6||
60073208|NCT01561989|76188413|FG000|COMPLETED|Overall Study||0||
60073209|NCT01561989|76188414|FG001|COMPLETED|Overall Study||0||
60073210|NCT01561989|76188413|FG000|NOT COMPLETED|Overall Study||5||
60073211|NCT01561989|76188414|FG001|NOT COMPLETED|Overall Study||6||
60073212|NCT00004054|76188422|FG000|STARTED|Overall Study||197||
60073213|NCT00004054|76188423|FG001|STARTED|Overall Study||200||
60073214|NCT00004054|76188422|FG000|COMPLETED|Overall Study||197||
59787499|NCT00402337|75907821|FG001|STARTED|Overall Study||57||
59787500|NCT00402337|75907822|FG002|STARTED|Overall Study||62||
59787501|NCT00402337|75907823|FG003|STARTED|Overall Study||63||
59787502|NCT00402337|75907824|FG004|STARTED|Overall Study||69||
60073215|NCT00004054|76188423|FG001|COMPLETED|Overall Study||200||
60073216|NCT00004054|76188422|FG000|NOT COMPLETED|Overall Study||0||
60073217|NCT00004054|76188423|FG001|NOT COMPLETED|Overall Study||0||
60073218|NCT01587885|76188429|FG000|STARTED|Treatment Period 1||26||
60073219|NCT01587885|76188430|FG001|STARTED|Treatment Period 1||22||
60073220|NCT01587885|76188429|FG000|COMPLETED|Treatment Period 1||26||
60073221|NCT01587885|76188430|FG001|COMPLETED|Treatment Period 1||19||
60073222|NCT01587885|76188429|FG000|NOT COMPLETED|Treatment Period 1||0||
60073223|NCT01587885|76188430|FG001|NOT COMPLETED|Treatment Period 1||3||
60073224|NCT01587885|76188429|FG000|STARTED|Treatment Period 2||26||
60073225|NCT01587885|76188430|FG001|STARTED|Treatment Period 2||19||
60073226|NCT01587885|76188429|FG000|COMPLETED|Treatment Period 2||26||
60073227|NCT01587885|76188430|FG001|COMPLETED|Treatment Period 2||19||
59619737|NCT02315352|75730895|FG001|COMPLETED|Fifth Intervention (Day 2)||0||
59619738|NCT02315352|75730896|FG002|COMPLETED|Fifth Intervention (Day 2)||7||
60073228|NCT01587885|76188429|FG000|NOT COMPLETED|Treatment Period 2||0||
59619739|NCT02315352|75730897|FG003|COMPLETED|Fifth Intervention (Day 2)||8||
59619740|NCT02315352|75730898|FG004|COMPLETED|Fifth Intervention (Day 2)||8||
59619741|NCT02315352|75730899|FG005|COMPLETED|Fifth Intervention (Day 2)||7||
59619742|NCT02315352|75730900|FG006|COMPLETED|Fifth Intervention (Day 2)||9||
59619743|NCT02315352|75730901|FG007|COMPLETED|Fifth Intervention (Day 2)||8||
59619744|NCT02315352|75730894|FG000|NOT COMPLETED|Fifth Intervention (Day 2)||0||
59787503|NCT00402337|75907820|FG000|COMPLETED|Overall Study||54||
59787504|NCT00402337|75907821|FG001|COMPLETED|Overall Study||51||
59787505|NCT00402337|75907822|FG002|COMPLETED|Overall Study||58||
59787506|NCT00402337|75907823|FG003|COMPLETED|Overall Study||51||
60073229|NCT01587885|76188430|FG001|NOT COMPLETED|Treatment Period 2||0||
60073230|NCT01587651|76188440|FG000|STARTED|Overall Study||34||
60073231|NCT01587651|76188441|FG001|STARTED|Overall Study||41||
60073232|NCT01587651|76188442|FG002|STARTED|Overall Study||35||
60073233|NCT01587651|76188440|FG000|COMPLETED|Overall Study||34||
59787507|NCT00402337|75907824|FG004|COMPLETED|Overall Study||61||
59787508|NCT00402337|75907820|FG000|NOT COMPLETED|Overall Study||5||
59787509|NCT00402337|75907821|FG001|NOT COMPLETED|Overall Study||6||
59787510|NCT00402337|75907822|FG002|NOT COMPLETED|Overall Study||4||
59787511|NCT00402337|75907823|FG003|NOT COMPLETED|Overall Study||12||
59787512|NCT00402337|75907824|FG004|NOT COMPLETED|Overall Study||8||
59787513|NCT00650091|75907838|FG000|STARTED|Initial Study Design - Interim Analysis||81||
59787514|NCT00650091|75907839|FG001|STARTED|Initial Study Design - Interim Analysis||78||
59787515|NCT00650091|75907840|FG002|STARTED|Initial Study Design - Interim Analysis||77||
60073234|NCT01587651|76188441|FG001|COMPLETED|Overall Study||38||
60073235|NCT01587651|76188442|FG002|COMPLETED|Overall Study||34||
60073236|NCT01587651|76188440|FG000|NOT COMPLETED|Overall Study||0||
60073237|NCT01587651|76188441|FG001|NOT COMPLETED|Overall Study||3||
60073238|NCT01587651|76188442|FG002|NOT COMPLETED|Overall Study||1||
60073239|NCT03602560|76188454|FG000|STARTED|Overall Study||89||
60073240|NCT03602560|76188455|FG001|STARTED|Overall Study||89||
60073241|NCT03602560|76188456|FG002|STARTED|Overall Study||87||
60073242|NCT03602560|76188454|FG000|COMPLETED|Overall Study||1||
60073243|NCT03602560|76188455|FG001|COMPLETED|Overall Study||1||
60073244|NCT03602560|76188456|FG002|COMPLETED|Overall Study||1||
60073245|NCT03602560|76188454|FG000|NOT COMPLETED|Overall Study||88||
60073246|NCT03602560|76188455|FG001|NOT COMPLETED|Overall Study||88||
60073247|NCT03602560|76188456|FG002|NOT COMPLETED|Overall Study||86||
60073248|NCT01691859|76188464|FG000|STARTED|Overall Study||347||
60073249|NCT01691859|76188464|FG000|COMPLETED|Overall Study||0||
60073250|NCT01691859|76188464|FG000|NOT COMPLETED|Overall Study||347||
60073251|NCT01414192|76188472|FG000|STARTED|Overall Study||490||
60073252|NCT01414192|76188473|FG001|STARTED|Overall Study||575||
60073253|NCT01414192|76188474|FG002|STARTED|Overall Study||424||
60073254|NCT01414192|76188475|FG003|STARTED|Overall Study||1726||
60073255|NCT01414192|76188472|FG000|COMPLETED|Overall Study||490||
60073256|NCT01414192|76188473|FG001|COMPLETED|Overall Study||575||
60073257|NCT01414192|76188474|FG002|COMPLETED|Overall Study||424||
60073258|NCT01414192|76188475|FG003|COMPLETED|Overall Study||1726||
60073259|NCT01414192|76188472|FG000|NOT COMPLETED|Overall Study||0||
60073260|NCT01414192|76188473|FG001|NOT COMPLETED|Overall Study||0||
60073261|NCT01414192|76188474|FG002|NOT COMPLETED|Overall Study||0||
60073262|NCT01414192|76188475|FG003|NOT COMPLETED|Overall Study||0||
60073263|NCT00779116|76188489|FG000|STARTED|First Intervention||109||
60073264|NCT00779116|76188490|FG001|STARTED|First Intervention||108||
60073265|NCT00779116|76188489|FG000|COMPLETED|First Intervention||109||
60073266|NCT00779116|76188490|FG001|COMPLETED|First Intervention||108||
60073267|NCT00779116|76188489|FG000|NOT COMPLETED|First Intervention||0||
60073268|NCT00779116|76188490|FG001|NOT COMPLETED|First Intervention||0||
60073269|NCT00779116|76188489|FG000|STARTED|Interval Between Doses (8-10 Minutes)||109||
60073270|NCT00779116|76188490|FG001|STARTED|Interval Between Doses (8-10 Minutes)||108||
60073271|NCT00779116|76188489|FG000|COMPLETED|Interval Between Doses (8-10 Minutes)||109||
60073272|NCT00779116|76188490|FG001|COMPLETED|Interval Between Doses (8-10 Minutes)||108||
60073273|NCT00779116|76188489|FG000|NOT COMPLETED|Interval Between Doses (8-10 Minutes)||0||
60073274|NCT00779116|76188490|FG001|NOT COMPLETED|Interval Between Doses (8-10 Minutes)||0||
60073275|NCT00779116|76188489|FG000|STARTED|Second Intervention||109||
60073276|NCT00779116|76188490|FG001|STARTED|Second Intervention||108||
60073277|NCT00779116|76188489|FG000|COMPLETED|Second Intervention||109||
60073278|NCT00779116|76188490|FG001|COMPLETED|Second Intervention||108||
60073279|NCT00779116|76188489|FG000|NOT COMPLETED|Second Intervention||0||
60073280|NCT00779116|76188490|FG001|NOT COMPLETED|Second Intervention||0||
60073281|NCT02073435|76188499|FG000|STARTED|Overall Study||81||
59787516|NCT00650091|75907838|FG000|COMPLETED|Initial Study Design - Interim Analysis||81||
59787517|NCT00650091|75907839|FG001|COMPLETED|Initial Study Design - Interim Analysis||78||
59787518|NCT00650091|75907840|FG002|COMPLETED|Initial Study Design - Interim Analysis||77||
59787519|NCT00650091|75907838|FG000|NOT COMPLETED|Initial Study Design - Interim Analysis||0||
59787520|NCT00650091|75907839|FG001|NOT COMPLETED|Initial Study Design - Interim Analysis||0||
59787521|NCT00650091|75907840|FG002|NOT COMPLETED|Initial Study Design - Interim Analysis||0||
60073282|NCT02073435|76188500|FG001|STARTED|Overall Study||96||
60073283|NCT02073435|76188499|FG000|COMPLETED|Overall Study||81||
60073284|NCT02073435|76188500|FG001|COMPLETED|Overall Study||96||
60073285|NCT02073435|76188499|FG000|NOT COMPLETED|Overall Study||0||
60073286|NCT02073435|76188500|FG001|NOT COMPLETED|Overall Study||0||
60073287|NCT01691781|76188508|FG000|STARTED|Overall Study||19||
60073288|NCT01691781|76188509|FG001|STARTED|Overall Study||22||
60073289|NCT01691781|76188508|FG000|COMPLETED|Overall Study||12||
60073290|NCT01691781|76188509|FG001|COMPLETED|Overall Study||15||
60073291|NCT01691781|76188508|FG000|NOT COMPLETED|Overall Study||7||
60073292|NCT01691781|76188509|FG001|NOT COMPLETED|Overall Study||7||
60073293|NCT01561755|76188517|FG000|STARTED|Overall Study||6||
60073294|NCT01561755|76188518|FG001|STARTED|Overall Study||6||
60073295|NCT01561755|76188517|FG000|COMPLETED|Overall Study||6||
60073296|NCT01561755|76188518|FG001|COMPLETED|Overall Study||5||
60073297|NCT01561755|76188517|FG000|NOT COMPLETED|Overall Study||0||
60073298|NCT01561755|76188518|FG001|NOT COMPLETED|Overall Study||1||
60073299|NCT03789214|76188527|FG000|STARTED|Overall Study||12||
59522709|NCT01253668|75617215|FG000|STARTED|Overall Study||0|The study was terminated, and the PI has left the institution. Despite all possible efforts to contact the PI/study team members, no data are available to be reported.|
59565809|NCT02335242|75668229|FG000|STARTED|Open-label Phase (20 Weeks)|1 participant did not continue to the open-label phase.|6||
59787522|NCT00650091|75907838|FG000|STARTED|Amended Study Design||133||
59787523|NCT00650091|75907839|FG001|STARTED|Amended Study Design||131||
59787524|NCT00650091|75907840|FG002|STARTED|Amended Study Design|Study Drug was discontinued for all subjects due to safety concerns.|0||
59787525|NCT00650091|75907838|FG000|COMPLETED|Amended Study Design||110||
59787526|NCT00650091|75907839|FG001|COMPLETED|Amended Study Design||111||
59787527|NCT00650091|75907840|FG002|COMPLETED|Amended Study Design||0||
59787528|NCT00650091|75907838|FG000|NOT COMPLETED|Amended Study Design||23||
59787529|NCT00650091|75907839|FG001|NOT COMPLETED|Amended Study Design||20||
59787530|NCT00650091|75907840|FG002|NOT COMPLETED|Amended Study Design||0||
59787531|NCT00642369|75907850|FG000|STARTED|Overall Study||30||
59787532|NCT00642369|75907851|FG001|STARTED|Overall Study||30||
59787533|NCT00642369|75907850|FG000|COMPLETED|Overall Study||25||
59787534|NCT00642369|75907851|FG001|COMPLETED|Overall Study||24||
59787535|NCT00642369|75907850|FG000|NOT COMPLETED|Overall Study||5||
59787536|NCT00642369|75907851|FG001|NOT COMPLETED|Overall Study||6||
59787537|NCT01154335|75907862|FG000|STARTED|Overall Study||7||
59787538|NCT01154335|75907863|FG001|STARTED|Overall Study||6||
59787539|NCT01154335|75907864|FG002|STARTED|Overall Study||5||
59787540|NCT01154335|75907862|FG000|COMPLETED|Overall Study|Patients continued treatment until disease progression or unacceptable toxicity occurred.|0||
59787541|NCT01154335|75907863|FG001|COMPLETED|Overall Study|Patients continued treatment until disease progression or unacceptable toxicity occurred.|0||
59787542|NCT01154335|75907864|FG002|COMPLETED|Overall Study|Patients continued treatment until disease progression or unacceptable toxicity occurred.|0||
59787543|NCT01154335|75907862|FG000|NOT COMPLETED|Overall Study||7||
59787544|NCT01154335|75907863|FG001|NOT COMPLETED|Overall Study||6||
59787545|NCT01154335|75907864|FG002|NOT COMPLETED|Overall Study||5||
59787546|NCT00645099|75907876|FG000|STARTED|Overall Study||239||
59787547|NCT00645099|75907877|FG001|STARTED|Overall Study||220||
59787548|NCT00645099|75907876|FG000|COMPLETED|Overall Study||168||
60073300|NCT03789214|76188528|FG001|STARTED|Overall Study||14||
60073301|NCT03789214|76188529|FG002|STARTED|Overall Study||12||
60073302|NCT03789214|76188527|FG000|COMPLETED|Overall Study||8||
60073303|NCT03789214|76188528|FG001|COMPLETED|Overall Study||9||
60073304|NCT03789214|76188529|FG002|COMPLETED|Overall Study||9||
60073305|NCT03789214|76188527|FG000|NOT COMPLETED|Overall Study||4||
60073306|NCT03789214|76188528|FG001|NOT COMPLETED|Overall Study||5||
60073307|NCT03789214|76188529|FG002|NOT COMPLETED|Overall Study||3||
60073308|NCT01585155|76188538|FG000|STARTED|Overall Study||21||
60073309|NCT01585155|76188538|FG000|COMPLETED|Overall Study||16||
60073310|NCT01585155|76188538|FG000|NOT COMPLETED|Overall Study||5||
60073311|NCT01560507|76188545|FG000|STARTED|Overall Study||5||
59787549|NCT00645099|75907877|FG001|COMPLETED|Overall Study||178||
59787550|NCT00645099|75907876|FG000|NOT COMPLETED|Overall Study||71||
60073312|NCT01560507|76188546|FG001|STARTED|Overall Study||2||
60073313|NCT01560507|76188547|FG002|STARTED|Overall Study||2||
60073314|NCT01560507|76188545|FG000|COMPLETED|Overall Study||1||
60073315|NCT01560507|76188546|FG001|COMPLETED|Overall Study||0||
60073316|NCT01560507|76188547|FG002|COMPLETED|Overall Study||0||
60073317|NCT01560507|76188545|FG000|NOT COMPLETED|Overall Study||4||
60073318|NCT01560507|76188546|FG001|NOT COMPLETED|Overall Study||2||
60073319|NCT01560507|76188547|FG002|NOT COMPLETED|Overall Study||2||
60073320|NCT01584843|76188562|FG000|STARTED|First Treatment Period||3||
59787551|NCT00645099|75907877|FG001|NOT COMPLETED|Overall Study||42||
59787552|NCT00420511|75907885|FG000|STARTED|Overall Study||10||
59787553|NCT00420511|75907886|FG001|STARTED|Overall Study||11||
60073321|NCT01584843|76188563|FG001|STARTED|First Treatment Period||4||
60073322|NCT01584843|76188564|FG002|STARTED|First Treatment Period||3||
60073323|NCT01584843|76188565|FG003|STARTED|First Treatment Period||10||
60073324|NCT01584843|76188566|FG004|STARTED|First Treatment Period||10||
60073325|NCT01584843|76188567|FG005|STARTED|First Treatment Period||11||
60073326|NCT01584843|76188562|FG000|COMPLETED|First Treatment Period||3||
59787554|NCT00420511|75907885|FG000|COMPLETED|Overall Study||8||
59787555|NCT00420511|75907886|FG001|COMPLETED|Overall Study||10||
59787556|NCT00420511|75907885|FG000|NOT COMPLETED|Overall Study||2||
59787557|NCT00420511|75907886|FG001|NOT COMPLETED|Overall Study||1||
59787558|NCT00420199|75907896|FG000|STARTED|Overall Study||27||
59787559|NCT00420199|75907897|FG001|STARTED|Overall Study||23||
59787560|NCT00420199|75907896|FG000|COMPLETED|Overall Study||26||
59787561|NCT00420199|75907897|FG001|COMPLETED|Overall Study||23||
59787562|NCT00420199|75907896|FG000|NOT COMPLETED|Overall Study||1||
59787563|NCT00420199|75907897|FG001|NOT COMPLETED|Overall Study||0||
59787564|NCT00649389|75907912|FG000|STARTED|Overall Study||628||
59787565|NCT00649389|75907913|FG001|STARTED|Overall Study||637||
59787566|NCT00649389|75907914|FG002|STARTED|Overall Study||600||
59787567|NCT00649389|75907915|FG003|STARTED|Overall Study||627||
59787568|NCT00649389|75907912|FG000|COMPLETED|Overall Study||557||
59787569|NCT00649389|75907913|FG001|COMPLETED|Overall Study||531||
59787570|NCT00649389|75907914|FG002|COMPLETED|Overall Study||512||
59787571|NCT00649389|75907915|FG003|COMPLETED|Overall Study||516||
59787572|NCT00649389|75907912|FG000|NOT COMPLETED|Overall Study||71||
59787573|NCT00649389|75907913|FG001|NOT COMPLETED|Overall Study||106||
59787574|NCT00649389|75907914|FG002|NOT COMPLETED|Overall Study||88||
59787575|NCT00649389|75907915|FG003|NOT COMPLETED|Overall Study||111||
59787576|NCT00402103|75907927|FG000|STARTED|Overall Study||470||
59787577|NCT00402103|75907928|FG001|STARTED|Overall Study||86||
59787578|NCT00402103|75907927|FG000|COMPLETED|Overall Study||379||
59787579|NCT00402103|75907928|FG001|COMPLETED|Overall Study||73||
59787580|NCT00402103|75907927|FG000|NOT COMPLETED|Overall Study||91||
59953230|NCT04057820|76071791|FG011|STARTED|Period 6||0||0
59787581|NCT00402103|75907928|FG001|NOT COMPLETED|Overall Study||13||
59787582|NCT00641667|75907938|FG000|STARTED|Overall Study||66||
59787583|NCT00641667|75907938|FG000|COMPLETED|Overall Study||60||
59787584|NCT00641667|75907938|FG000|NOT COMPLETED|Overall Study||6||
59787585|NCT00704184|75907947|FG000|STARTED|Double-Blind Treatment||20||
59787586|NCT00704184|75907948|FG001|STARTED|Double-Blind Treatment||18||
59787587|NCT00704184|75907949|FG002|STARTED|Double-Blind Treatment||20||
59787588|NCT00704184|75907950|FG003|STARTED|Double-Blind Treatment||18||
59787589|NCT00704184|75907951|FG004|STARTED|Double-Blind Treatment||19||
59787590|NCT00704184|75907947|FG000|Treated|Double-Blind Treatment|One participant was randomized to placebo but withdrew prior to receiving study medication.|19||
59787591|NCT00704184|75907948|FG001|Treated|Double-Blind Treatment||18||
59787592|NCT00704184|75907949|FG002|Treated|Double-Blind Treatment||20||
59787593|NCT00704184|75907950|FG003|Treated|Double-Blind Treatment||18||
59787594|NCT00704184|75907951|FG004|Treated|Double-Blind Treatment||19||
59787595|NCT00704184|75907947|FG000|COMPLETED|Double-Blind Treatment||19||
59787596|NCT00704184|75907948|FG001|COMPLETED|Double-Blind Treatment||18||
59787597|NCT00704184|75907949|FG002|COMPLETED|Double-Blind Treatment||20||
59787598|NCT00704184|75907950|FG003|COMPLETED|Double-Blind Treatment||18||
59787599|NCT00704184|75907951|FG004|COMPLETED|Double-Blind Treatment||19||
59787600|NCT00704184|75907947|FG000|NOT COMPLETED|Double-Blind Treatment||1||
59787601|NCT00704184|75907948|FG001|NOT COMPLETED|Double-Blind Treatment||0||
59787602|NCT00704184|75907949|FG002|NOT COMPLETED|Double-Blind Treatment||0||
59787603|NCT00704184|75907950|FG003|NOT COMPLETED|Double-Blind Treatment||0||
59787604|NCT00704184|75907951|FG004|NOT COMPLETED|Double-Blind Treatment||0||
59787605|NCT00704184|75907947|FG000|STARTED|Open-Label Treatment||19||
59787606|NCT00704184|75907948|FG001|STARTED|Open-Label Treatment||18||
59787607|NCT00704184|75907949|FG002|STARTED|Open-Label Treatment||20||
59953231|NCT04057820|76071792|FG012|STARTED|Period 6||17||3
59953232|NCT04057820|76071793|FG013|STARTED|Period 6||0||0
59953233|NCT04057820|76071794|FG014|STARTED|Period 6||18||3
59953234|NCT04057820|76071795|FG015|STARTED|Period 6||0||0
59787608|NCT00704184|75907950|FG003|STARTED|Open-Label Treatment||18||
59787609|NCT00704184|75907951|FG004|STARTED|Open-Label Treatment||19||
59787610|NCT00704184|75907947|FG000|COMPLETED|Open-Label Treatment||18||
59787611|NCT00704184|75907948|FG001|COMPLETED|Open-Label Treatment||16||
59787612|NCT00704184|75907949|FG002|COMPLETED|Open-Label Treatment||16||
59787613|NCT00704184|75907950|FG003|COMPLETED|Open-Label Treatment||13||
59787614|NCT00704184|75907951|FG004|COMPLETED|Open-Label Treatment||16||
59787615|NCT00704184|75907947|FG000|NOT COMPLETED|Open-Label Treatment||1||
59787616|NCT00704184|75907948|FG001|NOT COMPLETED|Open-Label Treatment||2||
59787617|NCT00704184|75907949|FG002|NOT COMPLETED|Open-Label Treatment||4||
59787618|NCT00704184|75907950|FG003|NOT COMPLETED|Open-Label Treatment||5||
59787619|NCT00704184|75907951|FG004|NOT COMPLETED|Open-Label Treatment||3||
59787620|NCT00641043|75907965|FG000|STARTED|Overall Study|number who started treatment|130||
59787621|NCT00641043|75907966|FG001|STARTED|Overall Study|number who started treatment|259||
59787622|NCT00641043|75907965|FG000|COMPLETED|Overall Study|number who completed treatment|111||
59787623|NCT00641043|75907966|FG001|COMPLETED|Overall Study|number who completed treatment|244||
59787624|NCT00641043|75907965|FG000|NOT COMPLETED|Overall Study||19||
59787625|NCT00641043|75907966|FG001|NOT COMPLETED|Overall Study||15||
59787626|NCT00402025|75907975|FG000|STARTED|Overall Study||3||
59953235|NCT04057820|76071780|FG000|COMPLETED|Period 6||0||0
59787627|NCT00402025|75907976|FG001|STARTED|Overall Study||4||
59787628|NCT00402025|75907977|FG002|STARTED|Overall Study||10||
59787629|NCT00402025|75907975|FG000|COMPLETED|Overall Study||1||
59787630|NCT00402025|75907976|FG001|COMPLETED|Overall Study||1||
59787631|NCT00402025|75907977|FG002|COMPLETED|Overall Study||0||
59787632|NCT00402025|75907975|FG000|NOT COMPLETED|Overall Study||2||
59787633|NCT00402025|75907976|FG001|NOT COMPLETED|Overall Study||3||
59787634|NCT00402025|75907977|FG002|NOT COMPLETED|Overall Study||10||
59787635|NCT00609622|75907987|FG000|STARTED|Overall Study||96||
59787636|NCT00609622|75907988|FG001|STARTED|Overall Study||95||
59787637|NCT00609622|75907987|FG000|COMPLETED|Overall Study||0||
59787638|NCT00609622|75907988|FG001|COMPLETED|Overall Study||0||
59787639|NCT00609622|75907987|FG000|NOT COMPLETED|Overall Study||96||
59787640|NCT00609622|75907988|FG001|NOT COMPLETED|Overall Study||95||
59787641|NCT00699660|75907996|FG000|STARTED|Overall Study||190||
59787642|NCT00699660|75907997|FG001|STARTED|Overall Study||216||
59787643|NCT00699660|75907996|FG000|COMPLETED|Overall Study||176||
59787644|NCT00699660|75907997|FG001|COMPLETED|Overall Study||208||
59787645|NCT00699660|75907996|FG000|NOT COMPLETED|Overall Study||14||
59787646|NCT00699660|75907997|FG001|NOT COMPLETED|Overall Study||8||
59787647|NCT00627705|75908005|FG000|STARTED|Overall Study||15||
59787648|NCT00627705|75908006|FG001|STARTED|Overall Study||18||
59787649|NCT00627705|75908005|FG000|COMPLETED|Overall Study||13||
59787650|NCT00627705|75908006|FG001|COMPLETED|Overall Study||12||
59787651|NCT00627705|75908005|FG000|NOT COMPLETED|Overall Study||2||
59787652|NCT00627705|75908006|FG001|NOT COMPLETED|Overall Study||6||
59787653|NCT00610168|75908014|FG000|STARTED|Overall Study||75||
59787654|NCT00610168|75908015|FG001|STARTED|Overall Study||7||
59787655|NCT00610168|75908014|FG000|COMPLETED|Overall Study||73||
59787656|NCT00610168|75908015|FG001|COMPLETED|Overall Study||7||
59787657|NCT00610168|75908014|FG000|NOT COMPLETED|Overall Study||2||
59787658|NCT00610168|75908015|FG001|NOT COMPLETED|Overall Study||0||
59787659|NCT00644787|75908021|FG000|STARTED|Period 1: Titration Phase||156||
59787660|NCT00644787|75908022|FG001|STARTED|Period 1: Titration Phase||0||
59787661|NCT00644787|75908023|FG002|STARTED|Period 1: Titration Phase||0||
59787662|NCT00644787|75908021|FG000|COMPLETED|Period 1: Titration Phase||129||
59787663|NCT00644787|75908022|FG001|COMPLETED|Period 1: Titration Phase||0||
59787664|NCT00644787|75908023|FG002|COMPLETED|Period 1: Titration Phase||0||
59787665|NCT00644787|75908021|FG000|NOT COMPLETED|Period 1: Titration Phase||27||
59787666|NCT00644787|75908022|FG001|NOT COMPLETED|Period 1: Titration Phase||0||
59787667|NCT00644787|75908023|FG002|NOT COMPLETED|Period 1: Titration Phase||0||
59787668|NCT00644787|75908021|FG000|STARTED|Period 2: Double Blind Phase||0||
59787669|NCT00644787|75908022|FG001|STARTED|Period 2: Double Blind Phase||58||
59787670|NCT00644787|75908023|FG002|STARTED|Period 2: Double Blind Phase||62||
59787671|NCT00644787|75908021|FG000|COMPLETED|Period 2: Double Blind Phase||0||
59787672|NCT00644787|75908022|FG001|COMPLETED|Period 2: Double Blind Phase||49||
59787673|NCT00644787|75908023|FG002|COMPLETED|Period 2: Double Blind Phase||55||
59787674|NCT00644787|75908021|FG000|NOT COMPLETED|Period 2: Double Blind Phase||0||
59787675|NCT00644787|75908022|FG001|NOT COMPLETED|Period 2: Double Blind Phase||9||
59787676|NCT00644787|75908023|FG002|NOT COMPLETED|Period 2: Double Blind Phase||7||
59787677|NCT00699582|75908034|FG000|STARTED|Overall Study||138||
59787678|NCT00699582|75908035|FG001|STARTED|Overall Study||130||
59787679|NCT00699582|75908036|FG002|STARTED|Overall Study||121||
59787680|NCT00699582|75908034|FG000|COMPLETED|Overall Study||120||
59787681|NCT00699582|75908035|FG001|COMPLETED|Overall Study||108||
59787682|NCT00699582|75908036|FG002|COMPLETED|Overall Study||93||
59787683|NCT00699582|75908034|FG000|NOT COMPLETED|Overall Study||18||
59787684|NCT00699582|75908035|FG001|NOT COMPLETED|Overall Study||22||
59787685|NCT00699582|75908036|FG002|NOT COMPLETED|Overall Study||28||
59787686|NCT00640341|75908047|FG000|STARTED|Overall Study|All Starting participants were dispensed lenses|170||
59787687|NCT00640341|75908048|FG001|STARTED|Overall Study||170||
59787688|NCT00640341|75908049|FG002|STARTED|Overall Study||170||
59787689|NCT00640341|75908047|FG000|Eligible Participants at Baseline|Overall Study||165||
59787690|NCT00640341|75908048|FG001|Eligible Participants at Baseline|Overall Study||167||
59787691|NCT00640341|75908049|FG002|Eligible Participants at Baseline|Overall Study||168||
59787692|NCT00640341|75908047|FG000|COMPLETED|Overall Study||149||
59787693|NCT00640341|75908048|FG001|COMPLETED|Overall Study||165||
59787694|NCT00640341|75908049|FG002|COMPLETED|Overall Study||163||
59787695|NCT00640341|75908047|FG000|NOT COMPLETED|Overall Study||21||
59787696|NCT00640341|75908048|FG001|NOT COMPLETED|Overall Study||5||
59787697|NCT00640341|75908049|FG002|NOT COMPLETED|Overall Study||7||
59787698|NCT00699348|75908057|FG000|STARTED|Overall Study||351||
59787699|NCT00699348|75908057|FG000|COMPLETED|Overall Study||261||
59787700|NCT00699348|75908057|FG000|NOT COMPLETED|Overall Study||90||
59787701|NCT00643851|75908064|FG000|STARTED|Overall Study||194||
59787702|NCT00643851|75908065|FG001|STARTED|Overall Study||203||
59787703|NCT00643851|75908066|FG002|STARTED|Overall Study||201||
59787704|NCT00643851|75908064|FG000|COMPLETED|Overall Study||177||
59787705|NCT00643851|75908065|FG001|COMPLETED|Overall Study||170||
59787706|NCT00643851|75908066|FG002|COMPLETED|Overall Study||171||
59787707|NCT00643851|75908064|FG000|NOT COMPLETED|Overall Study||17||
59787708|NCT00643851|75908065|FG001|NOT COMPLETED|Overall Study||33||
59787709|NCT00643851|75908066|FG002|NOT COMPLETED|Overall Study||30||
59817858|NCT04488770|75940336|FG010|COMPLETED|Part 1-Cohort 1: Period 4 (Up to 5 Days)||0||
59787710|NCT03667690|75908076|FG000|STARTED|Overall Study||100|Subjects were randomly assigned (1:1 ratio) to receive either rezafungin for injection or caspofungin. Randomization was stratified based on diagnosis (candidemia only; invasive candidiasis) and by Acute Physiology and Chronic Health Evaluation (APACHE II) score/absolute neutrophil count (ANC) (APACHE II score ≥20 OR ANC <500 cells/microliter; APACHE II score <20 AND ANC ≥500 cells/microliter) at screening.|
59787711|NCT03667690|75908077|FG001|STARTED|Overall Study||99|Subjects were randomly assigned (1:1 ratio) to receive either rezafungin for injection or caspofungin. Randomization was stratified based on diagnosis (candidemia only; invasive candidiasis) and by Acute Physiology and Chronic Health Evaluation (APACHE II) score/absolute neutrophil count (ANC) (APACHE II score ≥20 OR ANC <500 cells/microliter; APACHE II score <20 AND ANC ≥500 cells/microliter) at screening.|
59787712|NCT03667690|75908076|FG000|Completed Study Drug Regimen Through Study Day 14|Overall Study||66|Discontinuations of study drug prior to Day 14 occurred in 34 and 28 subjects in the rezafungin for injection and caspofungin treatment groups, respectively. The primary reasons for study drug discontinuation prior to Day 14 were death and adverse events. Other reasons for study drug discontinuation prior to Day 14 were singular in nature and did not have a clear pattern for reason or relationship to treatment assignment.|
59787713|NCT03667690|75908077|FG001|Completed Study Drug Regimen Through Study Day 14|Overall Study||71|Discontinuations of study drug prior to Day 14 occurred in 34 and 28 subjects in the rezafungin for injection and caspofungin treatment groups, respectively. The primary reasons for study drug discontinuation prior to Day 14 were death and adverse events. Other reasons for study drug discontinuation prior to Day 14 were singular in nature and did not have a clear pattern for reason or relationship to treatment assignment.|
59787714|NCT03667690|75908076|FG000|COMPLETED|Overall Study||59||
59787715|NCT03667690|75908077|FG001|COMPLETED|Overall Study||59||
59787716|NCT03667690|75908076|FG000|NOT COMPLETED|Overall Study||41||
59787717|NCT03667690|75908077|FG001|NOT COMPLETED|Overall Study||40||
59787718|NCT00627393|75908085|FG000|STARTED|Intention-To-Treat Analysis||58||
59787719|NCT00627393|75908086|FG001|STARTED|Intention-To-Treat Analysis||56||
59787720|NCT00627393|75908085|FG000|COMPLETED|Intention-To-Treat Analysis||49||
59787721|NCT00627393|75908086|FG001|COMPLETED|Intention-To-Treat Analysis||48||
59787722|NCT00627393|75908085|FG000|NOT COMPLETED|Intention-To-Treat Analysis||9||
59787723|NCT00627393|75908086|FG001|NOT COMPLETED|Intention-To-Treat Analysis||8||
59787724|NCT00627393|75908085|FG000|STARTED|Per-Protocol Analysis||49||
59787725|NCT00627393|75908086|FG001|STARTED|Per-Protocol Analysis||48||
59787726|NCT00627393|75908085|FG000|COMPLETED|Per-Protocol Analysis||39||
59787727|NCT00627393|75908086|FG001|COMPLETED|Per-Protocol Analysis||35||
59787728|NCT00627393|75908085|FG000|NOT COMPLETED|Per-Protocol Analysis||10||
59787729|NCT00627393|75908086|FG001|NOT COMPLETED|Per-Protocol Analysis||13||
59787730|NCT00696774|75908097|FG000|STARTED|Period II||115||
59787731|NCT00696774|75908098|FG001|STARTED|Period II||91||
59787732|NCT00696774|75908099|FG002|STARTED|Period II|1 participant did not receive study drug and was not included in the safety analyses.|36||
59787733|NCT00696774|75908097|FG000|COMPLETED|Period II||115||
59787734|NCT00696774|75908098|FG001|COMPLETED|Period II||91||
59787735|NCT00696774|75908099|FG002|COMPLETED|Period II||0||
59787736|NCT00696774|75908097|FG000|NOT COMPLETED|Period II||0||
59787737|NCT00696774|75908098|FG001|NOT COMPLETED|Period II||0||
59787738|NCT00696774|75908099|FG002|NOT COMPLETED|Period II||36||
59787739|NCT00696774|75908097|FG000|STARTED|Period III|115 reported at Week 4; 113 started Period 3 (1 lost to follow-up and 1 protocol violation).|113||
59787740|NCT00696774|75908098|FG001|STARTED|Period III|91 reported at Week 4; 88 start Period 3 (1 adverse event, 1 protocol violation, 1 lack of efficacy)|88||
59787741|NCT00696774|75908099|FG002|STARTED|Period III||0||
59787742|NCT00696774|75908097|FG000|COMPLETED|Period III||106||
59787743|NCT00696774|75908098|FG001|COMPLETED|Period III|82 participants were reported at Week 8; 81 completed Week 8 as 1 participant decided to withdraw.|81||
59787744|NCT00696774|75908099|FG002|COMPLETED|Period III||0||
59787745|NCT00696774|75908097|FG000|NOT COMPLETED|Period III||7||
59787746|NCT00696774|75908098|FG001|NOT COMPLETED|Period III||7||
59787747|NCT00696774|75908099|FG002|NOT COMPLETED|Period III||0||
59787748|NCT00608842|75908111|FG000|STARTED|Overall Study||15||
59787749|NCT00608842|75908112|FG001|STARTED|Overall Study||15||
59787750|NCT00608842|75908113|FG002|STARTED|Overall Study||15||
59787751|NCT00608842|75908114|FG003|STARTED|Overall Study||17||
59787752|NCT00608842|75908111|FG000|COMPLETED|Overall Study||14||
59787753|NCT00608842|75908112|FG001|COMPLETED|Overall Study||14||
59787754|NCT00608842|75908113|FG002|COMPLETED|Overall Study||13||
59787755|NCT00608842|75908114|FG003|COMPLETED|Overall Study||16||
59787756|NCT00608842|75908111|FG000|NOT COMPLETED|Overall Study||1||
59787757|NCT00608842|75908112|FG001|NOT COMPLETED|Overall Study||1||
59787758|NCT00608842|75908113|FG002|NOT COMPLETED|Overall Study||2||
59787759|NCT00608842|75908114|FG003|NOT COMPLETED|Overall Study||1||
59787760|NCT00626925|75908126|FG000|STARTED|Overall Study||67||
59787761|NCT00626925|75908127|FG001|STARTED|Overall Study||71||
59787762|NCT00626925|75908126|FG000|COMPLETED|Overall Study||55||
59787763|NCT00626925|75908127|FG001|COMPLETED|Overall Study||62||
59787764|NCT00626925|75908126|FG000|NOT COMPLETED|Overall Study||12||
59787765|NCT00626925|75908127|FG001|NOT COMPLETED|Overall Study||9||
59787766|NCT00698646|75908150|FG000|STARTED|Overall Study||128||
59787767|NCT00698646|75908151|FG001|STARTED|Overall Study||128||
59787768|NCT00698646|75908152|FG002|STARTED|Overall Study||128||
59787769|NCT00698646|75908150|FG000|COMPLETED|Overall Study||92||
59787770|NCT00698646|75908151|FG001|COMPLETED|Overall Study||97||
59787771|NCT00698646|75908152|FG002|COMPLETED|Overall Study||99||
59787772|NCT00698646|75908150|FG000|NOT COMPLETED|Overall Study||36||
59787773|NCT00698646|75908151|FG001|NOT COMPLETED|Overall Study||31||
59787774|NCT00698646|75908152|FG002|NOT COMPLETED|Overall Study||29||
59787775|NCT00609466|75908163|FG000|STARTED|Overall Study||96||
59787776|NCT00609466|75908164|FG001|STARTED|Overall Study||96||
59787777|NCT00609466|75908165|FG002|STARTED|Overall Study||99||
59787778|NCT00609466|75908163|FG000|COMPLETED|Overall Study||94||
59787779|NCT00609466|75908164|FG001|COMPLETED|Overall Study||90||
59787780|NCT00609466|75908165|FG002|COMPLETED|Overall Study||95||
59787781|NCT00609466|75908163|FG000|NOT COMPLETED|Overall Study||2||
59787782|NCT00609466|75908164|FG001|NOT COMPLETED|Overall Study||6||
59787783|NCT00609466|75908165|FG002|NOT COMPLETED|Overall Study||4||
59787784|NCT00608530|75908177|FG000|STARTED|Study 1 Psychologist-delivered Treatment|Randomized|33||
59787785|NCT00608530|75908178|FG001|STARTED|Study 1 Psychologist-delivered Treatment|Randomized|33||
59787786|NCT00608530|75908179|FG002|STARTED|Study 1 Psychologist-delivered Treatment||0||
59787787|NCT00608530|75908180|FG003|STARTED|Study 1 Psychologist-delivered Treatment||0||
59787788|NCT00608530|75908177|FG000|Attended > 0 Treatment Sessions|Study 1 Psychologist-delivered Treatment||28||
59787789|NCT00608530|75908178|FG001|Attended > 0 Treatment Sessions|Study 1 Psychologist-delivered Treatment||31||
59787790|NCT00608530|75908179|FG002|Attended > 0 Treatment Sessions|Study 1 Psychologist-delivered Treatment||0||
59787791|NCT00608530|75908180|FG003|Attended > 0 Treatment Sessions|Study 1 Psychologist-delivered Treatment||0||
59787792|NCT00608530|75908177|FG000|COMPLETED|Study 1 Psychologist-delivered Treatment||22||
59787793|NCT00608530|75908178|FG001|COMPLETED|Study 1 Psychologist-delivered Treatment||28||
59787794|NCT00608530|75908179|FG002|COMPLETED|Study 1 Psychologist-delivered Treatment||0||
59787795|NCT00608530|75908180|FG003|COMPLETED|Study 1 Psychologist-delivered Treatment||0||
59787796|NCT00608530|75908177|FG000|NOT COMPLETED|Study 1 Psychologist-delivered Treatment||11||
59787797|NCT00608530|75908178|FG001|NOT COMPLETED|Study 1 Psychologist-delivered Treatment||5||
59787798|NCT00608530|75908179|FG002|NOT COMPLETED|Study 1 Psychologist-delivered Treatment||0||
59787799|NCT00608530|75908180|FG003|NOT COMPLETED|Study 1 Psychologist-delivered Treatment||0||
59787800|NCT00608530|75908177|FG000|STARTED|Study 2 Nurse-delivered Treatments||0||
59787801|NCT00608530|75908178|FG001|STARTED|Study 2 Nurse-delivered Treatments||0||
59787802|NCT00608530|75908179|FG002|STARTED|Study 2 Nurse-delivered Treatments||33||
59787803|NCT00608530|75908180|FG003|STARTED|Study 2 Nurse-delivered Treatments||34||
59787804|NCT00608530|75908177|FG000|Attended > 0 Treatments|Study 2 Nurse-delivered Treatments||0||
59787805|NCT00608530|75908178|FG001|Attended > 0 Treatments|Study 2 Nurse-delivered Treatments||0||
59787806|NCT00608530|75908179|FG002|Attended > 0 Treatments|Study 2 Nurse-delivered Treatments||30||
59787807|NCT00608530|75908180|FG003|Attended > 0 Treatments|Study 2 Nurse-delivered Treatments||31||
59787808|NCT00608530|75908177|FG000|COMPLETED|Study 2 Nurse-delivered Treatments||0||
59787809|NCT00608530|75908178|FG001|COMPLETED|Study 2 Nurse-delivered Treatments||0||
59787810|NCT00608530|75908179|FG002|COMPLETED|Study 2 Nurse-delivered Treatments||21||
59522710|NCT01253668|75617215|FG000|COMPLETED|Overall Study||0|The study was terminated, and the PI has left the institution. Despite all possible efforts to contact the PI/study team members, no data are available to be reported|
59787811|NCT00608530|75908180|FG003|COMPLETED|Study 2 Nurse-delivered Treatments||27||
59787812|NCT00608530|75908177|FG000|NOT COMPLETED|Study 2 Nurse-delivered Treatments||0||
59787813|NCT00608530|75908178|FG001|NOT COMPLETED|Study 2 Nurse-delivered Treatments||0||
59787814|NCT00608530|75908179|FG002|NOT COMPLETED|Study 2 Nurse-delivered Treatments||12||
59787815|NCT00608530|75908180|FG003|NOT COMPLETED|Study 2 Nurse-delivered Treatments||7||
59787816|NCT00642993|75908197|FG000|STARTED|Overall Study||267||
59787817|NCT00642993|75908198|FG001|STARTED|Overall Study||134||
59787818|NCT00642993|75908197|FG000|COMPLETED|Overall Study||161||
59787819|NCT00642993|75908198|FG001|COMPLETED|Overall Study||118||
59787820|NCT00642993|75908197|FG000|NOT COMPLETED|Overall Study||106||
59787821|NCT00642993|75908198|FG001|NOT COMPLETED|Overall Study||16||
59787822|NCT00696696|75908204|FG000|STARTED|Overall Study||44||
59787823|NCT00696696|75908204|FG000|COMPLETED|Overall Study|number of patients off treatment due to progression of disease only|26||
59787824|NCT00696696|75908204|FG000|NOT COMPLETED|Overall Study||18||
59787825|NCT00699192|75908211|FG000|STARTED|Overall Study||275||
59787826|NCT00699192|75908212|FG001|STARTED|Overall Study||272||
59787827|NCT00699192|75908213|FG002|STARTED|Overall Study||272||
59787828|NCT00699192|75908211|FG000|COMPLETED|Overall Study||259||
59787829|NCT00699192|75908212|FG001|COMPLETED|Overall Study||260||
59787830|NCT00699192|75908213|FG002|COMPLETED|Overall Study||261||
59787831|NCT00699192|75908211|FG000|NOT COMPLETED|Overall Study||16||
59787832|NCT00699192|75908212|FG001|NOT COMPLETED|Overall Study||12||
59787833|NCT00699192|75908213|FG002|NOT COMPLETED|Overall Study||11||
59787834|NCT00401245|75908225|FG000|STARTED|Double Blind Titration Phase||126||
59787835|NCT00401245|75908226|FG001|STARTED|Double Blind Titration Phase||121||
59787836|NCT00401245|75908227|FG002|STARTED|Double Blind Titration Phase||124||
59787837|NCT00401245|75908228|FG003|STARTED|Double Blind Titration Phase||122||
59787838|NCT00401245|75908229|FG004|STARTED|Double Blind Titration Phase||0||
59787839|NCT00401245|75908230|FG005|STARTED|Double Blind Titration Phase||0||
59787840|NCT00401245|75908231|FG006|STARTED|Double Blind Titration Phase||0||
59787841|NCT00401245|75908232|FG007|STARTED|Double Blind Titration Phase||0||
59787842|NCT00401245|75908225|FG000|COMPLETED|Double Blind Titration Phase||122||
59787843|NCT00401245|75908226|FG001|COMPLETED|Double Blind Titration Phase||118||
59787844|NCT00401245|75908227|FG002|COMPLETED|Double Blind Titration Phase||118||
59787845|NCT00401245|75908228|FG003|COMPLETED|Double Blind Titration Phase||107||
59787846|NCT00401245|75908229|FG004|COMPLETED|Double Blind Titration Phase||0||
59787847|NCT00401245|75908230|FG005|COMPLETED|Double Blind Titration Phase||0||
59787848|NCT00401245|75908231|FG006|COMPLETED|Double Blind Titration Phase||0||
59787849|NCT00401245|75908232|FG007|COMPLETED|Double Blind Titration Phase||0||
59787850|NCT00401245|75908225|FG000|NOT COMPLETED|Double Blind Titration Phase||4||
59787851|NCT00401245|75908226|FG001|NOT COMPLETED|Double Blind Titration Phase||3||
59787852|NCT00401245|75908227|FG002|NOT COMPLETED|Double Blind Titration Phase||6||
59787853|NCT00401245|75908228|FG003|NOT COMPLETED|Double Blind Titration Phase||15||
59787854|NCT00401245|75908229|FG004|NOT COMPLETED|Double Blind Titration Phase||0||
59787855|NCT00401245|75908230|FG005|NOT COMPLETED|Double Blind Titration Phase||0||
59787856|NCT00401245|75908231|FG006|NOT COMPLETED|Double Blind Titration Phase||0||
59787857|NCT00401245|75908232|FG007|NOT COMPLETED|Double Blind Titration Phase||0||
59787858|NCT00401245|75908225|FG000|STARTED|Between Titration and Open Label Phase||122||
59787859|NCT00401245|75908226|FG001|STARTED|Between Titration and Open Label Phase||118||
59787860|NCT00401245|75908227|FG002|STARTED|Between Titration and Open Label Phase||118||
59787861|NCT00401245|75908228|FG003|STARTED|Between Titration and Open Label Phase||107||
59787862|NCT00401245|75908229|FG004|STARTED|Between Titration and Open Label Phase||0||
59787863|NCT00401245|75908230|FG005|STARTED|Between Titration and Open Label Phase||0||
59787864|NCT00401245|75908231|FG006|STARTED|Between Titration and Open Label Phase||0||
59787865|NCT00401245|75908232|FG007|STARTED|Between Titration and Open Label Phase||0||
59787866|NCT00401245|75908225|FG000|COMPLETED|Between Titration and Open Label Phase||122||
59787867|NCT00401245|75908226|FG001|COMPLETED|Between Titration and Open Label Phase||116||
59787868|NCT00401245|75908227|FG002|COMPLETED|Between Titration and Open Label Phase||118||
59787869|NCT00401245|75908228|FG003|COMPLETED|Between Titration and Open Label Phase||105||
59787870|NCT00401245|75908229|FG004|COMPLETED|Between Titration and Open Label Phase||0||
59787871|NCT00401245|75908230|FG005|COMPLETED|Between Titration and Open Label Phase||0||
59787872|NCT00401245|75908231|FG006|COMPLETED|Between Titration and Open Label Phase||0||
60073327|NCT01584843|76188563|FG001|COMPLETED|First Treatment Period||4||
60073328|NCT01584843|76188564|FG002|COMPLETED|First Treatment Period||2||
60073329|NCT01584843|76188565|FG003|COMPLETED|First Treatment Period||10||
60073330|NCT01584843|76188566|FG004|COMPLETED|First Treatment Period||10||
60073331|NCT01584843|76188567|FG005|COMPLETED|First Treatment Period||9||
60073332|NCT01584843|76188562|FG000|NOT COMPLETED|First Treatment Period||0||
59787873|NCT00401245|75908232|FG007|COMPLETED|Between Titration and Open Label Phase||0||
59787874|NCT00401245|75908225|FG000|NOT COMPLETED|Between Titration and Open Label Phase||0||
59787875|NCT00401245|75908226|FG001|NOT COMPLETED|Between Titration and Open Label Phase||2||
59787876|NCT00401245|75908227|FG002|NOT COMPLETED|Between Titration and Open Label Phase||0||
59787877|NCT00401245|75908228|FG003|NOT COMPLETED|Between Titration and Open Label Phase||2||
59787878|NCT00401245|75908229|FG004|NOT COMPLETED|Between Titration and Open Label Phase||0||
59787879|NCT00401245|75908230|FG005|NOT COMPLETED|Between Titration and Open Label Phase||0||
59787880|NCT00401245|75908231|FG006|NOT COMPLETED|Between Titration and Open Label Phase||0||
59787881|NCT00401245|75908232|FG007|NOT COMPLETED|Between Titration and Open Label Phase||0||
59787882|NCT00401245|75908225|FG000|STARTED|Open Label Phase||122||
59787883|NCT00401245|75908226|FG001|STARTED|Open Label Phase||116||
59787884|NCT00401245|75908227|FG002|STARTED|Open Label Phase||118||
59787885|NCT00401245|75908228|FG003|STARTED|Open Label Phase||105||
59787886|NCT00401245|75908229|FG004|STARTED|Open Label Phase||0||
59787887|NCT00401245|75908230|FG005|STARTED|Open Label Phase||0||
59787888|NCT00401245|75908231|FG006|STARTED|Open Label Phase||0||
59787889|NCT00401245|75908232|FG007|STARTED|Open Label Phase||0||
59787890|NCT00401245|75908225|FG000|COMPLETED|Open Label Phase||101||
59787891|NCT00401245|75908226|FG001|COMPLETED|Open Label Phase||81||
60073333|NCT01584843|76188563|FG001|NOT COMPLETED|First Treatment Period||0||
60073334|NCT01584843|76188564|FG002|NOT COMPLETED|First Treatment Period||1||
60073335|NCT01584843|76188565|FG003|NOT COMPLETED|First Treatment Period||0||
60073336|NCT01584843|76188566|FG004|NOT COMPLETED|First Treatment Period||0||
60073337|NCT01584843|76188567|FG005|NOT COMPLETED|First Treatment Period||2||
60073338|NCT01584843|76188562|FG000|STARTED|Second Treatment Period||2||
60073339|NCT01584843|76188563|FG001|STARTED|Second Treatment Period||1||
59522711|NCT01253668|75617215|FG000|NOT COMPLETED|Overall Study||0||
59787892|NCT00401245|75908227|FG002|COMPLETED|Open Label Phase||95||
59787893|NCT00401245|75908228|FG003|COMPLETED|Open Label Phase||84||
59787894|NCT00401245|75908229|FG004|COMPLETED|Open Label Phase||0||
59787895|NCT00401245|75908230|FG005|COMPLETED|Open Label Phase||0||
59787896|NCT00401245|75908231|FG006|COMPLETED|Open Label Phase||0||
59787897|NCT00401245|75908232|FG007|COMPLETED|Open Label Phase||0||
59787898|NCT00401245|75908225|FG000|NOT COMPLETED|Open Label Phase||21||
59787899|NCT00401245|75908226|FG001|NOT COMPLETED|Open Label Phase||35||
59787900|NCT00401245|75908227|FG002|NOT COMPLETED|Open Label Phase||23||
59787901|NCT00401245|75908228|FG003|NOT COMPLETED|Open Label Phase||21||
59787902|NCT00401245|75908229|FG004|NOT COMPLETED|Open Label Phase||0||
59787903|NCT00401245|75908230|FG005|NOT COMPLETED|Open Label Phase||0||
59787904|NCT00401245|75908231|FG006|NOT COMPLETED|Open Label Phase||0||
59619745|NCT02315352|75730895|FG001|NOT COMPLETED|Fifth Intervention (Day 2)||0||
59619746|NCT02315352|75730896|FG002|NOT COMPLETED|Fifth Intervention (Day 2)||0||
59619747|NCT02315352|75730897|FG003|NOT COMPLETED|Fifth Intervention (Day 2)||0||
59619748|NCT02315352|75730898|FG004|NOT COMPLETED|Fifth Intervention (Day 2)||0||
59619749|NCT02315352|75730899|FG005|NOT COMPLETED|Fifth Intervention (Day 2)||0||
59619750|NCT02315352|75730900|FG006|NOT COMPLETED|Fifth Intervention (Day 2)||0||
59619751|NCT02315352|75730901|FG007|NOT COMPLETED|Fifth Intervention (Day 2)||0||
59619752|NCT02315430|75730913|FG000|STARTED|Overall Study||13||
59619753|NCT02315430|75730913|FG000|COMPLETED|Overall Study||13||
59619754|NCT02315430|75730913|FG000|NOT COMPLETED|Overall Study||0||
59619755|NCT02953548|75730917|FG000|STARTED|Overall Study||5||
59619756|NCT02953548|75730918|FG001|STARTED|Overall Study||4||
59619757|NCT02953548|75730917|FG000|COMPLETED|Overall Study||5||
59619758|NCT02953548|75730918|FG001|COMPLETED|Overall Study||4||
59619759|NCT02953548|75730917|FG000|NOT COMPLETED|Overall Study||0||
59619760|NCT02953548|75730918|FG001|NOT COMPLETED|Overall Study||0||
59619761|NCT03829332|75730927|FG000|STARTED|Overall Study||309||
59619762|NCT03829332|75730928|FG001|STARTED|Overall Study||314||
59619763|NCT03829332|75730927|FG000|Treated|Overall Study||309||
59619764|NCT03829332|75730928|FG001|Treated|Overall Study||312||
59619765|NCT03829332|75730927|FG000|COMPLETED|Overall Study||0||
59619766|NCT03829332|75730928|FG001|COMPLETED|Overall Study||0||
59619767|NCT03829332|75730927|FG000|NOT COMPLETED|Overall Study||309||
59619768|NCT03829332|75730928|FG001|NOT COMPLETED|Overall Study||314||
59619769|NCT02950818|75730936|FG000|STARTED|Overall Study||228||
59619770|NCT02950818|75730937|FG001|STARTED|Overall Study||225||
59619771|NCT02950818|75730936|FG000|COMPLETED|Overall Study||161||
59619772|NCT02950818|75730937|FG001|COMPLETED|Overall Study||201||
59619773|NCT02950818|75730936|FG000|NOT COMPLETED|Overall Study||67||
59619774|NCT02950818|75730937|FG001|NOT COMPLETED|Overall Study||24||
59619775|NCT02914314|75730948|FG000|STARTED|Core Phase (Up to 20 Weeks)||4||
59619776|NCT02914314|75730949|FG001|STARTED|Core Phase (Up to 20 Weeks)||5||
59619777|NCT02914314|75730950|FG002|STARTED|Core Phase (Up to 20 Weeks)||9||
59619778|NCT02914314|75730951|FG003|STARTED|Core Phase (Up to 20 Weeks)||3||
59619779|NCT02914314|75730948|FG000|Participants Who Did Not Take EIAED|Core Phase (Up to 20 Weeks)||4||
59619780|NCT02914314|75730949|FG001|Participants Who Did Not Take EIAED|Core Phase (Up to 20 Weeks)||3||
59619781|NCT02914314|75730950|FG002|Participants Who Did Not Take EIAED|Core Phase (Up to 20 Weeks)||5||
59619782|NCT02914314|75730951|FG003|Participants Who Did Not Take EIAED|Core Phase (Up to 20 Weeks)||1||
59619783|NCT02914314|75730948|FG000|Participants Who Took EIAED|Core Phase (Up to 20 Weeks)||0||
59619784|NCT02914314|75730949|FG001|Participants Who Took EIAED|Core Phase (Up to 20 Weeks)||2||
59619785|NCT02914314|75730950|FG002|Participants Who Took EIAED|Core Phase (Up to 20 Weeks)||4||
59619786|NCT02914314|75730951|FG003|Participants Who Took EIAED|Core Phase (Up to 20 Weeks)||2||
59619787|NCT02914314|75730948|FG000|COMPLETED|Core Phase (Up to 20 Weeks)||4||
59619788|NCT02914314|75730949|FG001|COMPLETED|Core Phase (Up to 20 Weeks)||5||
59619789|NCT02914314|75730950|FG002|COMPLETED|Core Phase (Up to 20 Weeks)||8||
59619790|NCT02914314|75730951|FG003|COMPLETED|Core Phase (Up to 20 Weeks)||1||
59619791|NCT02914314|75730948|FG000|NOT COMPLETED|Core Phase (Up to 20 Weeks)||0||
59619792|NCT02914314|75730949|FG001|NOT COMPLETED|Core Phase (Up to 20 Weeks)||0||
59619793|NCT02914314|75730950|FG002|NOT COMPLETED|Core Phase (Up to 20 Weeks)||1||
59619794|NCT02914314|75730951|FG003|NOT COMPLETED|Core Phase (Up to 20 Weeks)||2||
59619795|NCT02914314|75730948|FG000|STARTED|Extension Phase (Up to 32 Weeks)|All participants who completed core phase entered extension phase.|4||
59619796|NCT02914314|75730949|FG001|STARTED|Extension Phase (Up to 32 Weeks)|All participants who completed core phase entered extension phase.|5||
59619797|NCT02914314|75730950|FG002|STARTED|Extension Phase (Up to 32 Weeks)|All participants who completed core phase entered extension phase.|8||
59619798|NCT02914314|75730951|FG003|STARTED|Extension Phase (Up to 32 Weeks)|All participants who completed core phase entered extension phase.|1||
59619799|NCT02914314|75730948|FG000|COMPLETED|Extension Phase (Up to 32 Weeks)||4||
59619800|NCT02914314|75730949|FG001|COMPLETED|Extension Phase (Up to 32 Weeks)||5||
59619801|NCT02914314|75730950|FG002|COMPLETED|Extension Phase (Up to 32 Weeks)||6||
59619802|NCT02914314|75730951|FG003|COMPLETED|Extension Phase (Up to 32 Weeks)||1||
59619803|NCT02914314|75730948|FG000|NOT COMPLETED|Extension Phase (Up to 32 Weeks)||0||
59619804|NCT02914314|75730949|FG001|NOT COMPLETED|Extension Phase (Up to 32 Weeks)||0||
59619805|NCT02914314|75730950|FG002|NOT COMPLETED|Extension Phase (Up to 32 Weeks)||2||
59619806|NCT02914314|75730951|FG003|NOT COMPLETED|Extension Phase (Up to 32 Weeks)||0||
59619807|NCT02775162|75730967|FG000|STARTED|Overall Study||136||
59619808|NCT02775162|75730968|FG001|STARTED|Overall Study||131||
59619809|NCT02775162|75730967|FG000|COMPLETED|Overall Study||122||
59619810|NCT02775162|75730968|FG001|COMPLETED|Overall Study||121||
59619811|NCT02775162|75730967|FG000|NOT COMPLETED|Overall Study||14||
59619812|NCT02775162|75730968|FG001|NOT COMPLETED|Overall Study||10||
59619813|NCT02509260|75730976|FG000|STARTED|Overall Study||149||
59619814|NCT02509260|75730977|FG001|STARTED|Overall Study||149||
59619815|NCT02509260|75730976|FG000|COMPLETED|Overall Study||149||
59619816|NCT02509260|75730977|FG001|COMPLETED|Overall Study||149||
59619817|NCT02509260|75730976|FG000|NOT COMPLETED|Overall Study||0||
59619818|NCT02509260|75730977|FG001|NOT COMPLETED|Overall Study||0||
59619819|NCT02743728|75730983|FG000|STARTED|Overall Study||20||
59787905|NCT00401245|75908232|FG007|NOT COMPLETED|Open Label Phase||0||
59787906|NCT00401245|75908225|FG000|STARTED|Double Blind Tapering Phase||0||
59787907|NCT00401245|75908226|FG001|STARTED|Double Blind Tapering Phase||0||
59787908|NCT00401245|75908227|FG002|STARTED|Double Blind Tapering Phase||0||
59787909|NCT00401245|75908228|FG003|STARTED|Double Blind Tapering Phase||0||
59787910|NCT00401245|75908229|FG004|STARTED|Double Blind Tapering Phase||101||
59787911|NCT00401245|75908230|FG005|STARTED|Double Blind Tapering Phase||94||
59787912|NCT00401245|75908231|FG006|STARTED|Double Blind Tapering Phase||87||
59787913|NCT00401245|75908232|FG007|STARTED|Double Blind Tapering Phase||102||
59787914|NCT00401245|75908225|FG000|COMPLETED|Double Blind Tapering Phase||0||
59787915|NCT00401245|75908226|FG001|COMPLETED|Double Blind Tapering Phase||0||
59787916|NCT00401245|75908227|FG002|COMPLETED|Double Blind Tapering Phase||0||
59787917|NCT00401245|75908228|FG003|COMPLETED|Double Blind Tapering Phase||0||
59787918|NCT00401245|75908229|FG004|COMPLETED|Double Blind Tapering Phase||97||
59787919|NCT00401245|75908230|FG005|COMPLETED|Double Blind Tapering Phase||90||
59787920|NCT00401245|75908231|FG006|COMPLETED|Double Blind Tapering Phase||80||
59787921|NCT00401245|75908232|FG007|COMPLETED|Double Blind Tapering Phase||95||
59787922|NCT00401245|75908225|FG000|NOT COMPLETED|Double Blind Tapering Phase||0||
59787923|NCT00401245|75908226|FG001|NOT COMPLETED|Double Blind Tapering Phase||0||
59787924|NCT00401245|75908227|FG002|NOT COMPLETED|Double Blind Tapering Phase||0||
59787925|NCT00401245|75908228|FG003|NOT COMPLETED|Double Blind Tapering Phase||0||
59787926|NCT00401245|75908229|FG004|NOT COMPLETED|Double Blind Tapering Phase||4||
59787927|NCT00401245|75908230|FG005|NOT COMPLETED|Double Blind Tapering Phase||4||
59787928|NCT00401245|75908231|FG006|NOT COMPLETED|Double Blind Tapering Phase||7||
59787929|NCT00401245|75908232|FG007|NOT COMPLETED|Double Blind Tapering Phase||7||
59787930|NCT00696384|75908252|FG000|STARTED|Open Label Phase||418||
59787931|NCT00696384|75908253|FG001|STARTED|Open Label Phase||0||
59787932|NCT00696384|75908254|FG002|STARTED|Open Label Phase||0||
59787933|NCT00696384|75908252|FG000|COMPLETED|Open Label Phase||299||
59787934|NCT00696384|75908253|FG001|COMPLETED|Open Label Phase||0||
59787935|NCT00696384|75908254|FG002|COMPLETED|Open Label Phase||0||
59787936|NCT00696384|75908252|FG000|NOT COMPLETED|Open Label Phase||119||
59787937|NCT00696384|75908253|FG001|NOT COMPLETED|Open Label Phase||0||
59787938|NCT00696384|75908254|FG002|NOT COMPLETED|Open Label Phase||0||
59787939|NCT00696384|75908252|FG000|STARTED|Double Blind Phase||0||
59787940|NCT00696384|75908253|FG001|STARTED|Double Blind Phase||148||
59787941|NCT00696384|75908254|FG002|STARTED|Double Blind Phase||151||
59953236|NCT04057820|76071781|FG001|COMPLETED|Period 6||24||4
59953237|NCT04057820|76071782|FG002|COMPLETED|Period 6||0||0
59953238|NCT04057820|76071783|FG003|COMPLETED|Period 6||5||2
59787942|NCT00696384|75908252|FG000|COMPLETED|Double Blind Phase||0||
59787943|NCT00696384|75908253|FG001|COMPLETED|Double Blind Phase||137||
59787944|NCT00696384|75908254|FG002|COMPLETED|Double Blind Phase||145||
59953239|NCT04057820|76071784|FG004|COMPLETED|Period 6||0||0
59787945|NCT00696384|75908252|FG000|NOT COMPLETED|Double Blind Phase||0||
59787946|NCT00696384|75908253|FG001|NOT COMPLETED|Double Blind Phase||11||
59787947|NCT00696384|75908254|FG002|NOT COMPLETED|Double Blind Phase||6||
59787948|NCT00636675|75908265|FG000|STARTED|Overall Study||951||
59787949|NCT00636675|75908266|FG001|STARTED|Overall Study||775||
59787950|NCT00636675|75908265|FG000|COMPLETED|Overall Study||811||
59787951|NCT00636675|75908266|FG001|COMPLETED|Overall Study||734||
59787952|NCT00636675|75908265|FG000|NOT COMPLETED|Overall Study||140||
59787953|NCT00636675|75908266|FG001|NOT COMPLETED|Overall Study||41||
59787954|NCT00699998|75908276|FG000|STARTED|Overall Study||3620||
59787955|NCT00699998|75908277|FG001|STARTED|Overall Study||1043||
59787956|NCT00699998|75908278|FG002|STARTED|Overall Study||3623||
59787957|NCT00699998|75908279|FG003|STARTED|Overall Study||1040||
59787958|NCT00699998|75908276|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3590||
59787959|NCT00699998|75908277|FG001|Received at Least 1 Dose of Study Drug|Overall Study||1033||
59787960|NCT00699998|75908278|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3590||
59787961|NCT00699998|75908279|FG003|Received at Least 1 Dose of Study Drug|Overall Study||1027||
59787962|NCT00699998|75908276|FG000|COMPLETED|Overall Study||3421||
59787963|NCT00699998|75908277|FG001|COMPLETED|Overall Study||957||
59787964|NCT00699998|75908278|FG002|COMPLETED|Overall Study||3417||
59787965|NCT00699998|75908279|FG003|COMPLETED|Overall Study||958||
59787966|NCT00699998|75908276|FG000|NOT COMPLETED|Overall Study||199||
59787967|NCT00699998|75908277|FG001|NOT COMPLETED|Overall Study||86||
59787968|NCT00699998|75908278|FG002|NOT COMPLETED|Overall Study||206||
59787969|NCT00699998|75908279|FG003|NOT COMPLETED|Overall Study||82||
59787970|NCT00696072|75908296|FG000|STARTED|Overall Study||57||
59787971|NCT00696072|75908297|FG001|STARTED|Overall Study||63||
59953240|NCT04057820|76071785|FG005|COMPLETED|Period 6||14||3
59787972|NCT00696072|75908296|FG000|COMPLETED|Overall Study||0||
59787973|NCT00696072|75908297|FG001|COMPLETED|Overall Study||0||
59787974|NCT00696072|75908296|FG000|NOT COMPLETED|Overall Study||57||
59787975|NCT00696072|75908297|FG001|NOT COMPLETED|Overall Study||63||
59787976|NCT00634647|75908304|FG000|STARTED|Overall Study||24||
59787977|NCT00634647|75908304|FG000|COMPLETED|Overall Study||17||
59787978|NCT00634647|75908304|FG000|NOT COMPLETED|Overall Study||7||
59787979|NCT00576732|75908311|FG000|STARTED|DOUBLE BLIND||35||
59953241|NCT04057820|76071786|FG006|COMPLETED|Period 6||0||0
59787980|NCT00576732|75908312|FG001|STARTED|DOUBLE BLIND||30||
59787981|NCT00576732|75908313|FG002|STARTED|DOUBLE BLIND||31||
59787982|NCT00576732|75908314|FG003|STARTED|DOUBLE BLIND||0||
59787983|NCT00576732|75908315|FG004|STARTED|DOUBLE BLIND||0||
59787984|NCT00576732|75908316|FG005|STARTED|DOUBLE BLIND||0||
59787985|NCT00576732|75908311|FG000|COMPLETED|DOUBLE BLIND||27||
59787986|NCT00576732|75908312|FG001|COMPLETED|DOUBLE BLIND||25||
59787987|NCT00576732|75908313|FG002|COMPLETED|DOUBLE BLIND||25||
59787988|NCT00576732|75908314|FG003|COMPLETED|DOUBLE BLIND||0||
59787989|NCT00576732|75908315|FG004|COMPLETED|DOUBLE BLIND||0||
59787990|NCT00576732|75908316|FG005|COMPLETED|DOUBLE BLIND||0||
59787991|NCT00576732|75908311|FG000|NOT COMPLETED|DOUBLE BLIND||8||
59787992|NCT00576732|75908312|FG001|NOT COMPLETED|DOUBLE BLIND||5||
59787993|NCT00576732|75908313|FG002|NOT COMPLETED|DOUBLE BLIND||6||
59787994|NCT00576732|75908314|FG003|NOT COMPLETED|DOUBLE BLIND||0||
59787995|NCT00576732|75908315|FG004|NOT COMPLETED|DOUBLE BLIND||0||
59787996|NCT00576732|75908316|FG005|NOT COMPLETED|DOUBLE BLIND||0||
59787997|NCT00576732|75908311|FG000|STARTED|OPEN LABEL||0||
59787998|NCT00576732|75908312|FG001|STARTED|OPEN LABEL||0||
59787999|NCT00576732|75908313|FG002|STARTED|OPEN LABEL||0||
59788000|NCT00576732|75908314|FG003|STARTED|OPEN LABEL|26 of 27 double-blind placebo completers and 4 of 8 placebo non-completers entered open-label.|30||
59788001|NCT00576732|75908315|FG004|STARTED|OPEN LABEL|24 of 25 double-blind RIS low dose completers and 0 RIS low dose non-completers entered open-label.|24||
59788002|NCT00576732|75908316|FG005|STARTED|OPEN LABEL|All 25 double-blind RIS high dose completers and 0 RIS high dose non-completers entered open-label.|25||
59788003|NCT00576732|75908311|FG000|COMPLETED|OPEN LABEL||0||
59788004|NCT00576732|75908312|FG001|COMPLETED|OPEN LABEL||0||
59788005|NCT00576732|75908313|FG002|COMPLETED|OPEN LABEL||0||
59788006|NCT00576732|75908314|FG003|COMPLETED|OPEN LABEL||19||
59788007|NCT00576732|75908315|FG004|COMPLETED|OPEN LABEL||20||
59788008|NCT00576732|75908316|FG005|COMPLETED|OPEN LABEL||17||
59788009|NCT00576732|75908311|FG000|NOT COMPLETED|OPEN LABEL||0||
59788010|NCT00576732|75908312|FG001|NOT COMPLETED|OPEN LABEL||0||
59788011|NCT00576732|75908313|FG002|NOT COMPLETED|OPEN LABEL||0||
59788012|NCT00576732|75908314|FG003|NOT COMPLETED|OPEN LABEL||11||
59788013|NCT00576732|75908315|FG004|NOT COMPLETED|OPEN LABEL||4||
59788014|NCT00576732|75908316|FG005|NOT COMPLETED|OPEN LABEL||8||
59788015|NCT00697788|75908328|FG000|STARTED|Dexmedetomidine Bolus 1 mcg/kg||8||
59788016|NCT00697788|75908329|FG001|STARTED|Dexmedetomidine Bolus 1 mcg/kg|One participant did not begin infusion due to hypotension (mean pressure <50)|0||
59788017|NCT00697788|75908330|FG002|STARTED|Dexmedetomidine Bolus 1 mcg/kg|2 participants did not begin the ascending (1.0 mcg/kg/hr) due to MAP<50|0||
59788018|NCT00697788|75908331|FG003|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0||
59788019|NCT00697788|75908332|FG004|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0||
59788020|NCT00697788|75908333|FG005|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0||
59788021|NCT00697788|75908334|FG006|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0||
59788022|NCT00697788|75908335|FG007|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0||
59788023|NCT00697788|75908328|FG000|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||8||
59788024|NCT00697788|75908329|FG001|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0||
59788025|NCT00697788|75908330|FG002|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0||
59788026|NCT00697788|75908331|FG003|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0||
59788027|NCT00697788|75908332|FG004|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0||
59788028|NCT00697788|75908333|FG005|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0||
59788029|NCT00697788|75908334|FG006|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0||
59788030|NCT00697788|75908335|FG007|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0||
59788031|NCT00697788|75908328|FG000|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0||
59788032|NCT00697788|75908329|FG001|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0||
59788033|NCT00697788|75908330|FG002|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0||
59788034|NCT00697788|75908331|FG003|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0||
59788035|NCT00697788|75908332|FG004|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0||
59788036|NCT00697788|75908333|FG005|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0||
59788037|NCT00697788|75908334|FG006|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0||
59788038|NCT00697788|75908335|FG007|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0||
59788039|NCT00697788|75908328|FG000|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0||
59788040|NCT00697788|75908329|FG001|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion|1 participant did not begin infusion due to hypotension (MAP<50)|7||
59788041|NCT00697788|75908330|FG002|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0||
59788042|NCT00697788|75908331|FG003|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0||
59788043|NCT00697788|75908332|FG004|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0||
59788044|NCT00697788|75908333|FG005|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0||
59788045|NCT00697788|75908334|FG006|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0||
59788046|NCT00697788|75908335|FG007|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0||
59788047|NCT00697788|75908328|FG000|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0||
59788048|NCT00697788|75908329|FG001|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||5||
59788049|NCT00697788|75908330|FG002|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0||
59788050|NCT00697788|75908331|FG003|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0||
59788051|NCT00697788|75908332|FG004|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0||
59788052|NCT00697788|75908333|FG005|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0||
59788053|NCT00697788|75908334|FG006|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0||
59788054|NCT00697788|75908335|FG007|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0||
59788055|NCT00697788|75908328|FG000|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0||
59788056|NCT00697788|75908329|FG001|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||2||
59788057|NCT00697788|75908330|FG002|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0||
59788058|NCT00697788|75908331|FG003|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0||
59788059|NCT00697788|75908332|FG004|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0||
59788060|NCT00697788|75908333|FG005|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0||
59788061|NCT00697788|75908334|FG006|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0||
59788062|NCT00697788|75908335|FG007|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0||
59788063|NCT00697788|75908328|FG000|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0||
59788064|NCT00697788|75908329|FG001|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0||
59788065|NCT00697788|75908330|FG002|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion|2 participants did not begin this infusion due to hypotension (MAP<50)|3||
59788066|NCT00697788|75908331|FG003|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0||
59788067|NCT00697788|75908332|FG004|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0||
59788068|NCT00697788|75908333|FG005|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0||
59788069|NCT00697788|75908334|FG006|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0||
59788070|NCT00697788|75908335|FG007|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0||
59788071|NCT00697788|75908328|FG000|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0||
59788072|NCT00697788|75908329|FG001|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0||
59788073|NCT00697788|75908330|FG002|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||3||
59788074|NCT00697788|75908331|FG003|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0||
59788075|NCT00697788|75908332|FG004|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0||
59788076|NCT00697788|75908333|FG005|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0||
59788077|NCT00697788|75908334|FG006|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0||
59788078|NCT00697788|75908335|FG007|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0||
59788079|NCT00697788|75908328|FG000|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0||
59788080|NCT00697788|75908329|FG001|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0||
59788081|NCT00697788|75908330|FG002|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0||
59788082|NCT00697788|75908331|FG003|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0||
59788083|NCT00697788|75908332|FG004|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0||
59788084|NCT00697788|75908333|FG005|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0||
59788085|NCT00697788|75908334|FG006|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0||
59788086|NCT00697788|75908335|FG007|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0||
59788087|NCT00697788|75908328|FG000|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0||
59788088|NCT00697788|75908329|FG001|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0||
59788089|NCT00697788|75908330|FG002|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0||
59788090|NCT00697788|75908331|FG003|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||3||
59788091|NCT00697788|75908332|FG004|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0||
59788092|NCT00697788|75908333|FG005|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0||
59788093|NCT00697788|75908334|FG006|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0||
59788094|NCT00697788|75908335|FG007|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0||
59788095|NCT00697788|75908328|FG000|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0||
59788096|NCT00697788|75908329|FG001|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0||
59788097|NCT00697788|75908330|FG002|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0||
59788098|NCT00697788|75908331|FG003|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||3||
59788099|NCT00697788|75908332|FG004|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0||
59788100|NCT00697788|75908333|FG005|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0||
59953242|NCT04057820|76071787|FG007|COMPLETED|Period 6||15||3
59953243|NCT04057820|76071788|FG008|COMPLETED|Period 6||0||0
59788101|NCT00697788|75908334|FG006|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0||
59788102|NCT00697788|75908335|FG007|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0||
59788103|NCT00697788|75908328|FG000|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0||
59788104|NCT00697788|75908329|FG001|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0||
59788105|NCT00697788|75908330|FG002|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0||
59788106|NCT00697788|75908331|FG003|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0||
59788107|NCT00697788|75908332|FG004|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0||
59953244|NCT04057820|76071789|FG009|COMPLETED|Period 6||0||0
59953245|NCT04057820|76071790|FG010|COMPLETED|Period 6||13||4
59788108|NCT00697788|75908333|FG005|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0||
59788109|NCT00697788|75908334|FG006|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0||
59788110|NCT00697788|75908335|FG007|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0||
59788111|NCT00697788|75908328|FG000|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0||
59788112|NCT00697788|75908329|FG001|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0||
59788113|NCT00697788|75908330|FG002|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0||
59788114|NCT00697788|75908331|FG003|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0||
59788115|NCT00697788|75908332|FG004|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||3||
59788116|NCT00697788|75908333|FG005|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0||
59788117|NCT00697788|75908334|FG006|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0||
59788118|NCT00697788|75908335|FG007|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0||
59788119|NCT00697788|75908328|FG000|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0||
59788120|NCT00697788|75908329|FG001|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0||
59788121|NCT00697788|75908330|FG002|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0||
59788122|NCT00697788|75908331|FG003|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0||
59788123|NCT00697788|75908332|FG004|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||2||
59788124|NCT00697788|75908333|FG005|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0||
59788125|NCT00697788|75908334|FG006|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0||
59788126|NCT00697788|75908335|FG007|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0||
59788127|NCT00697788|75908328|FG000|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0||
59788128|NCT00697788|75908329|FG001|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0||
59788129|NCT00697788|75908330|FG002|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0||
59788130|NCT00697788|75908331|FG003|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0||
59788131|NCT00697788|75908332|FG004|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||1||
59788132|NCT00697788|75908333|FG005|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0||
59788133|NCT00697788|75908334|FG006|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0||
59788134|NCT00697788|75908335|FG007|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0||
59788135|NCT00697788|75908328|FG000|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0||
59788136|NCT00697788|75908329|FG001|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0||
59788137|NCT00697788|75908330|FG002|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0||
59788138|NCT00697788|75908331|FG003|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0||
59788139|NCT00697788|75908332|FG004|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0||
59788140|NCT00697788|75908333|FG005|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||2||
59788141|NCT00697788|75908334|FG006|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0||
59788142|NCT00697788|75908335|FG007|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0||
59788143|NCT00697788|75908328|FG000|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0||
59788144|NCT00697788|75908329|FG001|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0||
59788145|NCT00697788|75908330|FG002|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0||
59788146|NCT00697788|75908331|FG003|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0||
59788147|NCT00697788|75908332|FG004|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0||
59788148|NCT00697788|75908333|FG005|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||2||
59788149|NCT00697788|75908334|FG006|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0||
59788150|NCT00697788|75908335|FG007|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0||
59788151|NCT00697788|75908328|FG000|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0||
59788152|NCT00697788|75908329|FG001|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0||
59788153|NCT00697788|75908330|FG002|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0||
59788154|NCT00697788|75908331|FG003|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0||
59788155|NCT00697788|75908332|FG004|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0||
59788156|NCT00697788|75908333|FG005|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0||
59788157|NCT00697788|75908334|FG006|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0||
59788158|NCT00697788|75908335|FG007|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0||
59788159|NCT00697788|75908328|FG000|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0||
59788160|NCT00697788|75908329|FG001|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0||
59788161|NCT00697788|75908330|FG002|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0||
59788162|NCT00697788|75908331|FG003|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0||
59788163|NCT00697788|75908332|FG004|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0||
59788164|NCT00697788|75908333|FG005|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0||
59788165|NCT00697788|75908334|FG006|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||2||
59788166|NCT00697788|75908335|FG007|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0||
60073340|NCT01584843|76188564|FG002|STARTED|Second Treatment Period||2||
60073341|NCT01584843|76188565|FG003|STARTED|Second Treatment Period||6||
60073342|NCT01584843|76188566|FG004|STARTED|Second Treatment Period||3||
59788167|NCT00697788|75908328|FG000|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0||
59788168|NCT00697788|75908329|FG001|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0||
59788169|NCT00697788|75908330|FG002|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0||
59788170|NCT00697788|75908331|FG003|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0||
59788171|NCT00697788|75908332|FG004|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0||
59788172|NCT00697788|75908333|FG005|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0||
59788173|NCT00697788|75908334|FG006|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||2||
59788174|NCT00697788|75908335|FG007|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0||
59788175|NCT00697788|75908328|FG000|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0||
59788176|NCT00697788|75908329|FG001|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0||
59788177|NCT00697788|75908330|FG002|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0||
59788178|NCT00697788|75908331|FG003|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0||
59788179|NCT00697788|75908332|FG004|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0||
59788180|NCT00697788|75908333|FG005|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0||
59788181|NCT00697788|75908334|FG006|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0||
59788182|NCT00697788|75908335|FG007|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0||
59788183|NCT00697788|75908328|FG000|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0||
59788184|NCT00697788|75908329|FG001|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0||
59788185|NCT00697788|75908330|FG002|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0||
59788186|NCT00697788|75908331|FG003|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0||
59788187|NCT00697788|75908332|FG004|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0||
59788188|NCT00697788|75908333|FG005|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0||
59788189|NCT00697788|75908334|FG006|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0||
59788190|NCT00697788|75908335|FG007|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||2||
59788191|NCT00697788|75908328|FG000|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0||
59788192|NCT00697788|75908329|FG001|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0||
59788193|NCT00697788|75908330|FG002|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0||
59788194|NCT00697788|75908331|FG003|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0||
59788195|NCT00697788|75908332|FG004|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0||
59788196|NCT00697788|75908333|FG005|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0||
59788197|NCT00697788|75908334|FG006|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0||
59788198|NCT00697788|75908335|FG007|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||2||
59788199|NCT00697788|75908328|FG000|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0||
59788200|NCT00697788|75908329|FG001|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0||
59788201|NCT00697788|75908330|FG002|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0||
59788202|NCT00697788|75908331|FG003|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0||
59788203|NCT00697788|75908332|FG004|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0||
59788204|NCT00697788|75908333|FG005|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0||
59788205|NCT00697788|75908334|FG006|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0||
59788206|NCT00697788|75908335|FG007|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0||
59788207|NCT00400153|75908365|FG000|STARTED|Overall Study||486||
59788208|NCT00400153|75908366|FG001|STARTED|Overall Study||491||
59788209|NCT00400153|75908367|FG002|STARTED|Overall Study||483||
59788210|NCT00400153|75908365|FG000|COMPLETED|Overall Study||438||
59788211|NCT00400153|75908366|FG001|COMPLETED|Overall Study||436||
59788212|NCT00400153|75908367|FG002|COMPLETED|Overall Study||422||
59788213|NCT00400153|75908365|FG000|NOT COMPLETED|Overall Study||48||
59788214|NCT00400153|75908366|FG001|NOT COMPLETED|Overall Study||55||
59788215|NCT00400153|75908367|FG002|NOT COMPLETED|Overall Study||61||
59788216|NCT00631917|75908382|FG000|STARTED|Overall Study||375||
59788217|NCT00631917|75908383|FG001|STARTED|Overall Study||399||
59788218|NCT00631917|75908382|FG000|COMPLETED|Overall Study||287||
59788219|NCT00631917|75908383|FG001|COMPLETED|Overall Study||291||
59788220|NCT00631917|75908382|FG000|NOT COMPLETED|Overall Study||88||
59788221|NCT00631917|75908383|FG001|NOT COMPLETED|Overall Study||108||
59788222|NCT04514523|75908391|FG000|STARTED|Overall Study||84||
59788223|NCT04514523|75908392|FG001|STARTED|Overall Study||7||
59788224|NCT04514523|75908391|FG000|Completed Video or Audio|Overall Study||68||
59788225|NCT04514523|75908392|FG001|Completed Video or Audio|Overall Study||7||
59788226|NCT04514523|75908391|FG000|Completed Post Visit Questionnaire|Overall Study||58||
59788227|NCT04514523|75908392|FG001|Completed Post Visit Questionnaire|Overall Study||7||
59788228|NCT04514523|75908391|FG000|COMPLETED|Overall Study||58||
59788229|NCT04514523|75908392|FG001|COMPLETED|Overall Study||7||
59788230|NCT04514523|75908391|FG000|NOT COMPLETED|Overall Study||26||
59788231|NCT04514523|75908392|FG001|NOT COMPLETED|Overall Study||0||
59788232|NCT00419341|75908400|FG000|STARTED|Wash in/Wash Out Period||49||
59788233|NCT00419341|75908400|FG000|COMPLETED|Wash in/Wash Out Period||38||
59788234|NCT00419341|75908400|FG000|NOT COMPLETED|Wash in/Wash Out Period||11||
59788235|NCT00419341|75908400|FG000|STARTED|Efficacy Period||38||
59788236|NCT00419341|75908400|FG000|COMPLETED|Efficacy Period||28||
59788237|NCT00419341|75908400|FG000|NOT COMPLETED|Efficacy Period||10||
59788238|NCT00694122|75908406|FG000|STARTED|First Intervention (3-4 Weeks)|Started Lantus then on NPH.|20||
59788239|NCT00694122|75908407|FG001|STARTED|First Intervention (3-4 Weeks)|Started on NPH then on Lantus.|7||
59788240|NCT00694122|75908406|FG000|COMPLETED|First Intervention (3-4 Weeks)||10||
59788241|NCT00694122|75908407|FG001|COMPLETED|First Intervention (3-4 Weeks)||5||
59788242|NCT00694122|75908406|FG000|NOT COMPLETED|First Intervention (3-4 Weeks)||10||
59788243|NCT00694122|75908407|FG001|NOT COMPLETED|First Intervention (3-4 Weeks)||2||
59788244|NCT00694122|75908406|FG000|STARTED|Washout (1 Day)||10||
59788245|NCT00694122|75908407|FG001|STARTED|Washout (1 Day)||5||
59788246|NCT00694122|75908406|FG000|COMPLETED|Washout (1 Day)||10||
59788247|NCT00694122|75908407|FG001|COMPLETED|Washout (1 Day)||5||
59788248|NCT00694122|75908406|FG000|NOT COMPLETED|Washout (1 Day)||0||
59788249|NCT00694122|75908407|FG001|NOT COMPLETED|Washout (1 Day)||0||
59788250|NCT00694122|75908406|FG000|STARTED|Second Intervention (3-4 Weeks)||10||
59788251|NCT00694122|75908407|FG001|STARTED|Second Intervention (3-4 Weeks)||5||
59788252|NCT00694122|75908406|FG000|COMPLETED|Second Intervention (3-4 Weeks)||10||
59788253|NCT00694122|75908407|FG001|COMPLETED|Second Intervention (3-4 Weeks)||5||
59788254|NCT00694122|75908406|FG000|NOT COMPLETED|Second Intervention (3-4 Weeks)||0||
59788255|NCT00694122|75908407|FG001|NOT COMPLETED|Second Intervention (3-4 Weeks)||0||
59788256|NCT03922620|75908420|FG000|STARTED|Overall Study||1||
59788257|NCT03922620|75908421|FG001|STARTED|Overall Study||0||
59788258|NCT03922620|75908420|FG000|COMPLETED|Overall Study||0||
59788259|NCT03922620|75908421|FG001|COMPLETED|Overall Study||0||
59788260|NCT03922620|75908420|FG000|NOT COMPLETED|Overall Study||1||
59788261|NCT03922620|75908421|FG001|NOT COMPLETED|Overall Study||0||
59788262|NCT00419263|75908430|FG000|STARTED|Overall Study||115||
59788263|NCT00419263|75908431|FG001|STARTED|Overall Study||114||
59788264|NCT00419263|75908432|FG002|STARTED|Overall Study||115||
59788265|NCT00419263|75908430|FG000|COMPLETED|Overall Study||112||
59788266|NCT00419263|75908431|FG001|COMPLETED|Overall Study||112||
59788267|NCT00419263|75908432|FG002|COMPLETED|Overall Study||112||
59788268|NCT00419263|75908430|FG000|NOT COMPLETED|Overall Study||3||
59788269|NCT00419263|75908431|FG001|NOT COMPLETED|Overall Study||2||
59788270|NCT00419263|75908432|FG002|NOT COMPLETED|Overall Study||3||
59788271|NCT00399763|75908443|FG000|STARTED|Overall Study||35||
59788272|NCT00399763|75908444|FG001|STARTED|Overall Study||35||
59788273|NCT00399763|75908443|FG000|COMPLETED|Overall Study||33||
59788274|NCT00399763|75908444|FG001|COMPLETED|Overall Study||32||
59788275|NCT00399763|75908443|FG000|NOT COMPLETED|Overall Study||2||
59788276|NCT00399763|75908444|FG001|NOT COMPLETED|Overall Study||3||
59788277|NCT00699842|75908453|FG000|STARTED|Overall Study||3||
59788278|NCT00699842|75908454|FG001|STARTED|Overall Study||5||
59788279|NCT00699842|75908455|FG002|STARTED|Overall Study||0||
59522712|NCT01662648|75617221|FG000|STARTED|Overall Study||520||
59522713|NCT01662648|75617222|FG001|STARTED|Overall Study||597||
59522714|NCT01662648|75617221|FG000|COMPLETED|Overall Study||373||
59522715|NCT01662648|75617222|FG001|COMPLETED|Overall Study||419||
59522716|NCT01662648|75617221|FG000|NOT COMPLETED|Overall Study||147||
59522717|NCT01662648|75617222|FG001|NOT COMPLETED|Overall Study||178||
59522718|NCT01231750|75617230|FG000|STARTED|Overall Study||3||
59522719|NCT01231750|75617231|FG001|STARTED|Overall Study||4||
59522720|NCT01231750|75617230|FG000|COMPLETED|Overall Study||3||
59522721|NCT01231750|75617231|FG001|COMPLETED|Overall Study||4||
59522722|NCT01231750|75617230|FG000|NOT COMPLETED|Overall Study||0||
59522723|NCT01231750|75617231|FG001|NOT COMPLETED|Overall Study||0||
59522724|NCT02549716|75617239|FG000|STARTED|Overall Study||1||
59522725|NCT02549716|75617240|FG001|STARTED|Overall Study||2||
59522726|NCT02549716|75617239|FG000|COMPLETED|Overall Study||1||
59522727|NCT02549716|75617240|FG001|COMPLETED|Overall Study||2||
59522728|NCT02549716|75617239|FG000|NOT COMPLETED|Overall Study||0||
59788280|NCT00699842|75908453|FG000|COMPLETED|Overall Study||3||
59788281|NCT00699842|75908454|FG001|COMPLETED|Overall Study||4||
59788282|NCT00699842|75908455|FG002|COMPLETED|Overall Study||0||
59788283|NCT00699842|75908453|FG000|NOT COMPLETED|Overall Study||0||
59522729|NCT02549716|75617240|FG001|NOT COMPLETED|Overall Study||0||
59522730|NCT02540434|75617248|FG000|STARTED|Overall Study||1|Out of the total 19 subjects that underwent surgery (-3 WD before surgery), only 1 was randomized.|
59522731|NCT02540434|75617249|FG001|STARTED|Overall Study||1|Out of the total 19 subjects that underwent surgery (-3 WD before surgery), only 1 was randomized.|
59522732|NCT02540434|75617248|FG000|COMPLETED|Overall Study||1||
59522733|NCT02540434|75617249|FG001|COMPLETED|Overall Study||1||
59522734|NCT02540434|75617248|FG000|NOT COMPLETED|Overall Study||0||
59522735|NCT02540434|75617249|FG001|NOT COMPLETED|Overall Study||0||
59522736|NCT01207726|75617259|FG000|STARTED|Overall Study||7||
59522737|NCT01207726|75617260|FG001|STARTED|Overall Study||6||
59522738|NCT01207726|75617259|FG000|COMPLETED|Overall Study||7||
59788284|NCT00699842|75908454|FG001|NOT COMPLETED|Overall Study||1||
59788285|NCT00699842|75908455|FG002|NOT COMPLETED|Overall Study||0||
59788286|NCT00399529|75908463|FG000|STARTED|Overall Study||22||
59788287|NCT00399529|75908463|FG000|COMPLETED|Overall Study||20||
59788288|NCT00399529|75908463|FG000|NOT COMPLETED|Overall Study||2||
59788289|NCT00712712|75908468|FG000|STARTED|Overall Study||78||
59788290|NCT00712712|75908468|FG000|COMPLETED|Overall Study||55||
59788291|NCT00712712|75908468|FG000|NOT COMPLETED|Overall Study||23||
59788292|NCT00411151|75908472|FG000|STARTED|Overall Study||52||
59788293|NCT00411151|75908472|FG000|COMPLETED|Overall Study||5||
59788294|NCT00411151|75908472|FG000|NOT COMPLETED|Overall Study||47||
59788295|NCT00607048|75908478|FG000|STARTED|Overall Study||3||
59788296|NCT00607048|75908479|FG001|STARTED|Overall Study||6||
59522739|NCT01207726|75617260|FG001|COMPLETED|Overall Study||6||
59522740|NCT01207726|75617259|FG000|NOT COMPLETED|Overall Study||0||
59522741|NCT01207726|75617260|FG001|NOT COMPLETED|Overall Study||0||
59522742|NCT02534038|75617272|FG000|STARTED|Period 1 (6 Weeks)||1||
59522743|NCT02534038|75617273|FG001|STARTED|Period 1 (6 Weeks)||0||
59788297|NCT00607048|75908480|FG002|STARTED|Overall Study||7||
59788298|NCT00607048|75908481|FG003|STARTED|Overall Study||3||
59788299|NCT00607048|75908482|FG004|STARTED|Overall Study||6||
59788300|NCT00607048|75908483|FG005|STARTED|Overall Study||7||
59788301|NCT00607048|75908478|FG000|COMPLETED|Overall Study||0||
59522744|NCT02534038|75617272|FG000|COMPLETED|Period 1 (6 Weeks)||1||
59522745|NCT02534038|75617273|FG001|COMPLETED|Period 1 (6 Weeks)||0||
59522746|NCT02534038|75617272|FG000|NOT COMPLETED|Period 1 (6 Weeks)||0||
59788302|NCT00607048|75908479|FG001|COMPLETED|Overall Study||2||
59788303|NCT00607048|75908480|FG002|COMPLETED|Overall Study||3||
59788304|NCT00607048|75908481|FG003|COMPLETED|Overall Study||0||
59788305|NCT00607048|75908482|FG004|COMPLETED|Overall Study||0||
59788306|NCT00607048|75908483|FG005|COMPLETED|Overall Study||2||
59788307|NCT00607048|75908478|FG000|NOT COMPLETED|Overall Study||3||
59788308|NCT00607048|75908479|FG001|NOT COMPLETED|Overall Study||4||
59788309|NCT00607048|75908480|FG002|NOT COMPLETED|Overall Study||4||
59788310|NCT00607048|75908481|FG003|NOT COMPLETED|Overall Study||3||
59788311|NCT00607048|75908482|FG004|NOT COMPLETED|Overall Study||6||
59788312|NCT00607048|75908483|FG005|NOT COMPLETED|Overall Study||5||
59788313|NCT00699608|75908499|FG000|STARTED|First Intervention||16||
59788314|NCT00699608|75908500|FG001|STARTED|First Intervention||15||
59788315|NCT00699608|75908501|FG002|STARTED|First Intervention||15||
59788316|NCT00699608|75908502|FG003|STARTED|First Intervention||15||
59788317|NCT00699608|75908503|FG004|STARTED|First Intervention||15||
59788318|NCT00699608|75908504|FG005|STARTED|First Intervention||15||
59788319|NCT00699608|75908499|FG000|COMPLETED|First Intervention||16||
59788320|NCT00699608|75908500|FG001|COMPLETED|First Intervention||15||
59788321|NCT00699608|75908501|FG002|COMPLETED|First Intervention||14||
59788322|NCT00699608|75908502|FG003|COMPLETED|First Intervention||15||
59788323|NCT00699608|75908503|FG004|COMPLETED|First Intervention||14||
59788324|NCT00699608|75908504|FG005|COMPLETED|First Intervention||15||
59788325|NCT00699608|75908499|FG000|NOT COMPLETED|First Intervention||0||
59788326|NCT00699608|75908500|FG001|NOT COMPLETED|First Intervention||0||
59788327|NCT00699608|75908501|FG002|NOT COMPLETED|First Intervention||1||
59788328|NCT00699608|75908502|FG003|NOT COMPLETED|First Intervention||0||
59788329|NCT00699608|75908503|FG004|NOT COMPLETED|First Intervention||1||
59788330|NCT00699608|75908504|FG005|NOT COMPLETED|First Intervention||0||
59788331|NCT00699608|75908499|FG000|STARTED|First 4-14 Day Washout Period||16||
59788332|NCT00699608|75908500|FG001|STARTED|First 4-14 Day Washout Period||15||
59788333|NCT00699608|75908501|FG002|STARTED|First 4-14 Day Washout Period||14||
59788334|NCT00699608|75908502|FG003|STARTED|First 4-14 Day Washout Period||15||
59788335|NCT00699608|75908503|FG004|STARTED|First 4-14 Day Washout Period||14||
59788336|NCT00699608|75908504|FG005|STARTED|First 4-14 Day Washout Period||15||
59788337|NCT00699608|75908499|FG000|COMPLETED|First 4-14 Day Washout Period||16||
59788338|NCT00699608|75908500|FG001|COMPLETED|First 4-14 Day Washout Period||15||
59788339|NCT00699608|75908501|FG002|COMPLETED|First 4-14 Day Washout Period||14||
59788340|NCT00699608|75908502|FG003|COMPLETED|First 4-14 Day Washout Period||15||
59788341|NCT00699608|75908503|FG004|COMPLETED|First 4-14 Day Washout Period||14||
59788342|NCT00699608|75908504|FG005|COMPLETED|First 4-14 Day Washout Period||15||
59788343|NCT00699608|75908499|FG000|NOT COMPLETED|First 4-14 Day Washout Period||0||
59788344|NCT00699608|75908500|FG001|NOT COMPLETED|First 4-14 Day Washout Period||0||
59522747|NCT02534038|75617273|FG001|NOT COMPLETED|Period 1 (6 Weeks)||0||
59522748|NCT02534038|75617272|FG000|STARTED|Period 2 (6 Weeks)||1||
59522749|NCT02534038|75617273|FG001|STARTED|Period 2 (6 Weeks)||0||
59522750|NCT02534038|75617272|FG000|COMPLETED|Period 2 (6 Weeks)||1||
59522751|NCT02534038|75617273|FG001|COMPLETED|Period 2 (6 Weeks)||0||
59522752|NCT02534038|75617272|FG000|NOT COMPLETED|Period 2 (6 Weeks)||0||
59522753|NCT02534038|75617273|FG001|NOT COMPLETED|Period 2 (6 Weeks)||0||
59522754|NCT01202110|75617280|FG000|STARTED|Overall Study||10||
59522755|NCT01202110|75617281|FG001|STARTED|Overall Study||0||
59522756|NCT01202110|75617280|FG000|COMPLETED|Overall Study||10||
59522757|NCT01202110|75617281|FG001|COMPLETED|Overall Study||0||
59522758|NCT01202110|75617280|FG000|NOT COMPLETED|Overall Study||0||
59522759|NCT01202110|75617281|FG001|NOT COMPLETED|Overall Study||0||
59522760|NCT02556918|75617287|FG000|STARTED|Overall Study||100||
59522761|NCT02556918|75617288|FG001|STARTED|Overall Study||101||
59522762|NCT02556918|75617287|FG000|COMPLETED|Overall Study||91||
59522763|NCT02556918|75617288|FG001|COMPLETED|Overall Study||91||
59522764|NCT02556918|75617287|FG000|NOT COMPLETED|Overall Study||9||
59522765|NCT02556918|75617288|FG001|NOT COMPLETED|Overall Study||10||
59788345|NCT00699608|75908501|FG002|NOT COMPLETED|First 4-14 Day Washout Period||0||
59788346|NCT00699608|75908502|FG003|NOT COMPLETED|First 4-14 Day Washout Period||0||
59788347|NCT00699608|75908503|FG004|NOT COMPLETED|First 4-14 Day Washout Period||0||
59788348|NCT00699608|75908504|FG005|NOT COMPLETED|First 4-14 Day Washout Period||0||
59788349|NCT00699608|75908499|FG000|STARTED|Second Intervention||16||
59788350|NCT00699608|75908500|FG001|STARTED|Second Intervention||15||
59788351|NCT00699608|75908501|FG002|STARTED|Second Intervention||14||
59788352|NCT00699608|75908502|FG003|STARTED|Second Intervention||15||
59522766|NCT02518750|75617295|FG000|STARTED|Overall Study||3||
59522767|NCT02518750|75617295|FG000|COMPLETED|Overall Study||1||
59522768|NCT02518750|75617295|FG000|NOT COMPLETED|Overall Study||2||
59522769|NCT01194856|75617301|FG000|STARTED|Overall Study||1||
59788353|NCT00699608|75908503|FG004|STARTED|Second Intervention||14||
59522770|NCT01194856|75617302|FG001|STARTED|Overall Study||0||
59522771|NCT01194856|75617301|FG000|COMPLETED|Overall Study||0||
59522772|NCT01194856|75617302|FG001|COMPLETED|Overall Study||0||
59522773|NCT01194856|75617301|FG000|NOT COMPLETED|Overall Study||1||
59522774|NCT01194856|75617302|FG001|NOT COMPLETED|Overall Study||0||
59522775|NCT01182610|75617308|FG000|STARTED|Overall Study||1||
59788354|NCT00699608|75908504|FG005|STARTED|Second Intervention||15||
59788355|NCT00699608|75908499|FG000|COMPLETED|Second Intervention||16||
59788356|NCT00699608|75908500|FG001|COMPLETED|Second Intervention||15||
59788357|NCT00699608|75908501|FG002|COMPLETED|Second Intervention||13||
59788358|NCT00699608|75908502|FG003|COMPLETED|Second Intervention||14||
59788359|NCT00699608|75908503|FG004|COMPLETED|Second Intervention||14||
59788360|NCT00699608|75908504|FG005|COMPLETED|Second Intervention||15||
59788361|NCT00699608|75908499|FG000|NOT COMPLETED|Second Intervention||0||
59788362|NCT00699608|75908500|FG001|NOT COMPLETED|Second Intervention||0||
60073343|NCT01584843|76188567|FG005|STARTED|Second Treatment Period||1||
60073344|NCT01584843|76188562|FG000|COMPLETED|Second Treatment Period||2||
59522776|NCT01182610|75617308|FG000|COMPLETED|Overall Study||1||
59522777|NCT01182610|75617308|FG000|NOT COMPLETED|Overall Study||0||
59522778|NCT01165450|75617312|FG000|STARTED|Overall Study||2||
59522779|NCT01165450|75617312|FG000|COMPLETED|Overall Study||2||
59522780|NCT01165450|75617312|FG000|NOT COMPLETED|Overall Study||0||
59522781|NCT01148056|75617316|FG000|STARTED|Overall Study||2||
59522782|NCT01148056|75617316|FG000|COMPLETED|Overall Study||2||
59522783|NCT01148056|75617316|FG000|NOT COMPLETED|Overall Study||0||
59522784|NCT02414698|75617322|FG000|STARTED|Overall Study||3||
59522785|NCT02414698|75617323|FG001|STARTED|Overall Study||1||
59522786|NCT02414698|75617322|FG000|COMPLETED|Overall Study||3||
59522787|NCT02414698|75617323|FG001|COMPLETED|Overall Study||1||
59522788|NCT02414698|75617322|FG000|NOT COMPLETED|Overall Study||0||
59522789|NCT02414698|75617323|FG001|NOT COMPLETED|Overall Study||0||
59522790|NCT02415166|75617333|FG000|STARTED|Overall Study||6||
59522791|NCT02415166|75617334|FG001|STARTED|Overall Study||0||
59788363|NCT00699608|75908501|FG002|NOT COMPLETED|Second Intervention||1||
59788364|NCT00699608|75908502|FG003|NOT COMPLETED|Second Intervention||1||
59788365|NCT00699608|75908503|FG004|NOT COMPLETED|Second Intervention||0||
59788366|NCT00699608|75908504|FG005|NOT COMPLETED|Second Intervention||0||
59788367|NCT00699608|75908499|FG000|STARTED|Second 4-14 Day Washout Period||16||
59788368|NCT00699608|75908500|FG001|STARTED|Second 4-14 Day Washout Period||15||
59788369|NCT00699608|75908501|FG002|STARTED|Second 4-14 Day Washout Period||13||
59788370|NCT00699608|75908502|FG003|STARTED|Second 4-14 Day Washout Period||14||
59788371|NCT00699608|75908503|FG004|STARTED|Second 4-14 Day Washout Period||14||
59788372|NCT00699608|75908504|FG005|STARTED|Second 4-14 Day Washout Period||15||
59788373|NCT00699608|75908499|FG000|COMPLETED|Second 4-14 Day Washout Period||16||
59788374|NCT00699608|75908500|FG001|COMPLETED|Second 4-14 Day Washout Period||15||
59788375|NCT00699608|75908501|FG002|COMPLETED|Second 4-14 Day Washout Period||13||
59788376|NCT00699608|75908502|FG003|COMPLETED|Second 4-14 Day Washout Period||14||
59788377|NCT00699608|75908503|FG004|COMPLETED|Second 4-14 Day Washout Period||14||
59788378|NCT00699608|75908504|FG005|COMPLETED|Second 4-14 Day Washout Period||15||
59788379|NCT00699608|75908499|FG000|NOT COMPLETED|Second 4-14 Day Washout Period||0||
59788380|NCT00699608|75908500|FG001|NOT COMPLETED|Second 4-14 Day Washout Period||0||
59788381|NCT00699608|75908501|FG002|NOT COMPLETED|Second 4-14 Day Washout Period||0||
59788382|NCT00699608|75908502|FG003|NOT COMPLETED|Second 4-14 Day Washout Period||0||
59788383|NCT00699608|75908503|FG004|NOT COMPLETED|Second 4-14 Day Washout Period||0||
59522792|NCT02415166|75617335|FG002|STARTED|Overall Study||0||
59522793|NCT02415166|75617336|FG003|STARTED|Overall Study||0||
59522794|NCT02415166|75617333|FG000|COMPLETED|Overall Study||6||
59522795|NCT02415166|75617334|FG001|COMPLETED|Overall Study||0||
59522796|NCT02415166|75617335|FG002|COMPLETED|Overall Study||0||
59522797|NCT02415166|75617336|FG003|COMPLETED|Overall Study||0||
59522798|NCT02415166|75617333|FG000|NOT COMPLETED|Overall Study||0||
59522799|NCT02415166|75617334|FG001|NOT COMPLETED|Overall Study||0||
59522800|NCT02415166|75617335|FG002|NOT COMPLETED|Overall Study||0||
59522801|NCT02415166|75617336|FG003|NOT COMPLETED|Overall Study||0||
59522802|NCT02403154|75617350|FG000|STARTED|Overall Study||2||
59788384|NCT00699608|75908504|FG005|NOT COMPLETED|Second 4-14 Day Washout Period||0||
60073345|NCT01584843|76188563|FG001|COMPLETED|Second Treatment Period||1||
59522803|NCT02403154|75617351|FG001|STARTED|Overall Study||0||
59788385|NCT00699608|75908499|FG000|STARTED|Third Intervention||16||
59788386|NCT00699608|75908500|FG001|STARTED|Third Intervention||15||
59788387|NCT00699608|75908501|FG002|STARTED|Third Intervention||13||
59522804|NCT02403154|75617352|FG002|STARTED|Overall Study||1||
59522805|NCT02403154|75617353|FG003|STARTED|Overall Study||1||
59522806|NCT02403154|75617350|FG000|COMPLETED|Overall Study||0||
59522807|NCT02403154|75617351|FG001|COMPLETED|Overall Study||0||
59522808|NCT02403154|75617352|FG002|COMPLETED|Overall Study||0||
59522809|NCT02403154|75617353|FG003|COMPLETED|Overall Study||0||
59522810|NCT02403154|75617350|FG000|NOT COMPLETED|Overall Study||2||
59522811|NCT02403154|75617351|FG001|NOT COMPLETED|Overall Study||0||
59522812|NCT02403154|75617352|FG002|NOT COMPLETED|Overall Study||1||
59522813|NCT02403154|75617353|FG003|NOT COMPLETED|Overall Study||1||
59788388|NCT00699608|75908502|FG003|STARTED|Third Intervention||14||
59788389|NCT00699608|75908503|FG004|STARTED|Third Intervention||14||
59788390|NCT00699608|75908504|FG005|STARTED|Third Intervention||15||
59788391|NCT00699608|75908499|FG000|COMPLETED|Third Intervention||16||
59788392|NCT00699608|75908500|FG001|COMPLETED|Third Intervention||15||
59788393|NCT00699608|75908501|FG002|COMPLETED|Third Intervention||13||
59788394|NCT00699608|75908502|FG003|COMPLETED|Third Intervention||14||
59788395|NCT00699608|75908503|FG004|COMPLETED|Third Intervention||14||
59788396|NCT00699608|75908504|FG005|COMPLETED|Third Intervention||15||
59788397|NCT00699608|75908499|FG000|NOT COMPLETED|Third Intervention||0||
59788398|NCT00699608|75908500|FG001|NOT COMPLETED|Third Intervention||0||
59788399|NCT00699608|75908501|FG002|NOT COMPLETED|Third Intervention||0||
59788400|NCT00699608|75908502|FG003|NOT COMPLETED|Third Intervention||0||
59788401|NCT00699608|75908503|FG004|NOT COMPLETED|Third Intervention||0||
59788402|NCT00699608|75908504|FG005|NOT COMPLETED|Third Intervention||0||
59788403|NCT03823404|75908515|FG000|STARTED|Overall Study||214||
59788404|NCT03823404|75908516|FG001|STARTED|Overall Study||212||
59788405|NCT03823404|75908517|FG002|STARTED|Overall Study||217||
59788406|NCT03823404|75908515|FG000|COMPLETED|Overall Study||129||
59788407|NCT03823404|75908516|FG001|COMPLETED|Overall Study||127||
59788408|NCT03823404|75908517|FG002|COMPLETED|Overall Study||163||
59788409|NCT03823404|75908515|FG000|NOT COMPLETED|Overall Study||85||
59788410|NCT03823404|75908516|FG001|NOT COMPLETED|Overall Study||85||
59788411|NCT03823404|75908517|FG002|NOT COMPLETED|Overall Study||54||
59788412|NCT00706706|75908525|FG000|STARTED|Overall Study||105||
59788413|NCT00706706|75908525|FG000|COMPLETED|Overall Study||0||
59788414|NCT00706706|75908525|FG000|NOT COMPLETED|Overall Study||105||
59788415|NCT00410605|75908529|FG000|STARTED|Overall Study||39||
59788416|NCT00410605|75908529|FG000|COMPLETED|Overall Study||14||
59788417|NCT00410605|75908529|FG000|NOT COMPLETED|Overall Study||25||
59788418|NCT00418717|75908533|FG000|STARTED|Treatment Period A - Weeks 1-4||42||
59788419|NCT00418717|75908533|FG000|COMPLETED|Treatment Period A - Weeks 1-4||41||
59788420|NCT00418717|75908533|FG000|NOT COMPLETED|Treatment Period A - Weeks 1-4||1||
59788421|NCT00418717|75908533|FG000|STARTED|Treatment Period B - Weeks 5-12||41||
59788422|NCT00418717|75908533|FG000|COMPLETED|Treatment Period B - Weeks 5-12||39||
59788423|NCT00418717|75908533|FG000|NOT COMPLETED|Treatment Period B - Weeks 5-12||2||
59788424|NCT00572572|75908539|FG000|STARTED|Overall Study||35||
59788425|NCT00572572|75908540|FG001|STARTED|Overall Study||34||
59788426|NCT00572572|75908539|FG000|COMPLETED|Overall Study||32||
59788427|NCT00572572|75908540|FG001|COMPLETED|Overall Study||28||
59788428|NCT00572572|75908539|FG000|NOT COMPLETED|Overall Study||3||
59788429|NCT00572572|75908540|FG001|NOT COMPLETED|Overall Study||6||
59788430|NCT00418561|75908549|FG000|STARTED|Overall Study||4||
59788431|NCT00418561|75908550|FG001|STARTED|Overall Study||5||
59788432|NCT00418561|75908551|FG002|STARTED|Overall Study||4||
60073346|NCT01584843|76188564|FG002|COMPLETED|Second Treatment Period||2||
60073347|NCT01584843|76188565|FG003|COMPLETED|Second Treatment Period||6||
59788433|NCT00418561|75908549|FG000|COMPLETED|Overall Study||4||
59788434|NCT00418561|75908550|FG001|COMPLETED|Overall Study||4||
59788435|NCT00418561|75908551|FG002|COMPLETED|Overall Study||4||
59788436|NCT00418561|75908549|FG000|NOT COMPLETED|Overall Study||0||
59788437|NCT00418561|75908550|FG001|NOT COMPLETED|Overall Study||1||
59788438|NCT00418561|75908551|FG002|NOT COMPLETED|Overall Study||0||
59788439|NCT00398047|75908559|FG000|STARTED|Overall Study||3||
59788440|NCT00398047|75908559|FG000|COMPLETED|Overall Study|all three patients progressed before completing|0||
59788441|NCT00398047|75908559|FG000|NOT COMPLETED|Overall Study||3||
59788442|NCT00631371|75908566|FG000|STARTED|Overall Study||400||
59788443|NCT00631371|75908567|FG001|STARTED|Overall Study||391||
59788444|NCT00631371|75908566|FG000|Treated|Overall Study||393||
59788445|NCT00631371|75908567|FG001|Treated|Overall Study||391||
59788446|NCT00631371|75908566|FG000|COMPLETED|Overall Study||0||
59788447|NCT00631371|75908567|FG001|COMPLETED|Overall Study||0||
59788448|NCT00631371|75908566|FG000|NOT COMPLETED|Overall Study||400||
59788449|NCT00631371|75908567|FG001|NOT COMPLETED|Overall Study||391||
59788450|NCT00409747|75908573|FG000|STARTED|Overall Study||11||
59788451|NCT00409747|75908573|FG000|COMPLETED|Overall Study||10||
59788452|NCT00409747|75908573|FG000|NOT COMPLETED|Overall Study||1||
59788453|NCT00630747|75908577|FG000|STARTED|Overall Study||94||
59788454|NCT00630747|75908577|FG000|Participants Treated in Phase I of Study|Overall Study||94||
59788455|NCT00630747|75908577|FG000|COMPLETED|Overall Study||85||
59788456|NCT00630747|75908577|FG000|NOT COMPLETED|Overall Study||9||
59788457|NCT00397891|75908586|FG000|STARTED|Overall Study||6||
59788458|NCT00397891|75908587|FG001|STARTED|Overall Study||6||
59788459|NCT00397891|75908588|FG002|STARTED|Overall Study||6||
59788460|NCT00397891|75908589|FG003|STARTED|Overall Study||6||
59788461|NCT00397891|75908590|FG004|STARTED|Overall Study||8||
59788462|NCT00397891|75908586|FG000|COMPLETED|Overall Study||5||
59788463|NCT00397891|75908587|FG001|COMPLETED|Overall Study||6||
59788464|NCT00397891|75908588|FG002|COMPLETED|Overall Study||6||
59788465|NCT00397891|75908589|FG003|COMPLETED|Overall Study||6||
59788466|NCT00397891|75908590|FG004|COMPLETED|Overall Study||7||
59788467|NCT00397891|75908586|FG000|NOT COMPLETED|Overall Study||1||
59788468|NCT00397891|75908587|FG001|NOT COMPLETED|Overall Study||0||
59788469|NCT00397891|75908588|FG002|NOT COMPLETED|Overall Study||0||
59788470|NCT00397891|75908589|FG003|NOT COMPLETED|Overall Study||0||
59788471|NCT00397891|75908590|FG004|NOT COMPLETED|Overall Study||1||
59788472|NCT00397189|75908604|FG000|STARTED|3 Weeks Period||394||
59788473|NCT00397189|75908605|FG001|STARTED|3 Weeks Period||395||
59788474|NCT00397189|75908604|FG000|COMPLETED|3 Weeks Period|out of 373, 360 were included in the ITT population detailed in the Baseline Characteristics.|373||
59788475|NCT00397189|75908605|FG001|COMPLETED|3 Weeks Period|out of 373, 362 were included in the ITT population detailed in the Baseline Characteristics|373||
59788476|NCT00397189|75908604|FG000|NOT COMPLETED|3 Weeks Period||21||
59788477|NCT00397189|75908605|FG001|NOT COMPLETED|3 Weeks Period||22||
59788478|NCT00397189|75908604|FG000|STARTED|Extension Period|Not all completers continued to extension as only patients who wished to proceed were randomized.|534||
59788479|NCT00397189|75908605|FG001|STARTED|Extension Period|Please note randomization ratio in extension is 3:1|177||
59788480|NCT00397189|75908604|FG000|COMPLETED|Extension Period||421||
59788481|NCT00397189|75908605|FG001|COMPLETED|Extension Period||134||
59788482|NCT00397189|75908604|FG000|NOT COMPLETED|Extension Period||113||
59788483|NCT00397189|75908605|FG001|NOT COMPLETED|Extension Period||43||
59788484|NCT00606034|75908613|FG000|STARTED|Overall Study||21||
59788485|NCT00606034|75908613|FG000|COMPLETED|Overall Study||20||
59788486|NCT00606034|75908613|FG000|NOT COMPLETED|Overall Study||1||
59788487|NCT00397033|75908622|FG000|STARTED|Overall Study||107||
59788488|NCT00397033|75908623|FG001|STARTED|Overall Study||109||
59788489|NCT00397033|75908624|FG002|STARTED|Overall Study||100||
59788490|NCT00397033|75908622|FG000|Safety Population: >= 1 Dose of Drug|Overall Study||107||
59788491|NCT00397033|75908623|FG001|Safety Population: >= 1 Dose of Drug|Overall Study||108||
59788492|NCT00397033|75908624|FG002|Safety Population: >= 1 Dose of Drug|Overall Study||98||
59788493|NCT00397033|75908622|FG000|ITT Population|Overall Study||107||
59788494|NCT00397033|75908623|FG001|ITT Population|Overall Study||105||
59788495|NCT00397033|75908624|FG002|ITT Population|Overall Study||98||
59788496|NCT00397033|75908622|FG000|COMPLETED|Overall Study||63||
59788497|NCT00397033|75908623|FG001|COMPLETED|Overall Study||72||
59788498|NCT00397033|75908624|FG002|COMPLETED|Overall Study||77||
59788499|NCT00397033|75908622|FG000|NOT COMPLETED|Overall Study||44||
59788500|NCT00397033|75908623|FG001|NOT COMPLETED|Overall Study||37||
59788501|NCT00397033|75908624|FG002|NOT COMPLETED|Overall Study||23||
59788502|NCT00572728|75908632|FG000|STARTED|Overall Study|Registered|90||
59788503|NCT00572728|75908632|FG000|Eligible|Overall Study||87||
59788504|NCT00572728|75908632|FG000|Enrolled Under Amendment 5 or Later|Overall Study||82||
59788505|NCT00572728|75908632|FG000|Did Not Withdraw|Overall Study||72||
59788506|NCT00572728|75908632|FG000|On Study|Overall Study||71||
59788507|NCT00572728|75908632|FG000|Completed FLT1 Scan|Overall Study||67||
59788508|NCT00572728|75908632|FG000|First Therapy Initiated|Overall Study||65||
59788509|NCT00572728|75908632|FG000|Completed FLT2 Scan|Overall Study||60||
59788510|NCT00572728|75908632|FG000|Second Chemotherapy Initiated|Overall Study||59||
59788511|NCT00572728|75908632|FG000|Second Chemotherapy Initiated After FLT2|Overall Study||52||
59788512|NCT00572728|75908632|FG000|Pathology Complete|Overall Study||51||
59788513|NCT00572728|75908632|FG000|Completed FLT3 Scan|Overall Study|Secondary analysis milestone: 43 pts had FLT-3 performed.|43||
59788514|NCT00572728|75908632|FG000|LN Evaluation After NAC|Overall Study|Secondary:38 patients were available for histopathological LN evaluation after NAC|38||
59788515|NCT00572728|75908632|FG000|RCB Evaluation|Overall Study|Secondary: histopathology was available in 35 patients for RCB evaluation|35||
59788516|NCT00572728|75908632|FG000|COMPLETED|Overall Study|51 patients eligible for primary objective analysis|51||
59788517|NCT00572728|75908632|FG000|NOT COMPLETED|Overall Study||39||
59788518|NCT00699374|75908640|FG000|STARTED|Overall Study||530||
59788519|NCT00699374|75908641|FG001|STARTED|Overall Study||544||
59788520|NCT00699374|75908640|FG000|Treated|Overall Study||526||
59788521|NCT00699374|75908641|FG001|Treated|Overall Study||542||
59788522|NCT00699374|75908640|FG000|COMPLETED|Overall Study||0||
59788523|NCT00699374|75908641|FG001|COMPLETED|Overall Study||0||
59788524|NCT00699374|75908640|FG000|NOT COMPLETED|Overall Study||530||
59788525|NCT00699374|75908641|FG001|NOT COMPLETED|Overall Study||544||
59788526|NCT00606892|75908647|FG000|STARTED|Adaptation||9||
59788527|NCT00606892|75908648|FG001|STARTED|Adaptation||8||
59788528|NCT00606892|75908647|FG000|COMPLETED|Adaptation||9||
59953246|NCT04057820|76071791|FG011|COMPLETED|Period 6||0||0
60073348|NCT01584843|76188566|FG004|COMPLETED|Second Treatment Period||3||
59788529|NCT00606892|75908648|FG001|COMPLETED|Adaptation||8||
59788530|NCT00606892|75908647|FG000|NOT COMPLETED|Adaptation||0||
59788531|NCT00606892|75908648|FG001|NOT COMPLETED|Adaptation||0||
59788532|NCT00606892|75908647|FG000|STARTED|First Intervention||9||
59788533|NCT00606892|75908648|FG001|STARTED|First Intervention||8||
59788534|NCT00606892|75908647|FG000|COMPLETED|First Intervention||8||
59788535|NCT00606892|75908648|FG001|COMPLETED|First Intervention||4||
59788536|NCT00606892|75908647|FG000|NOT COMPLETED|First Intervention||1||
59788537|NCT00606892|75908648|FG001|NOT COMPLETED|First Intervention||4||
59788538|NCT00606892|75908647|FG000|STARTED|Washout Period||8||
59788539|NCT00606892|75908648|FG001|STARTED|Washout Period||4||
59788540|NCT00606892|75908647|FG000|COMPLETED|Washout Period||8||
59788541|NCT00606892|75908648|FG001|COMPLETED|Washout Period||4||
59953247|NCT04057820|76071792|FG012|COMPLETED|Period 6||17||3
59788542|NCT00606892|75908647|FG000|NOT COMPLETED|Washout Period||0||
59788543|NCT00606892|75908648|FG001|NOT COMPLETED|Washout Period||0||
59788544|NCT00606892|75908647|FG000|STARTED|Second Intervention||8||
59788545|NCT00606892|75908648|FG001|STARTED|Second Intervention||4||
59788546|NCT00606892|75908647|FG000|COMPLETED|Second Intervention||8||
59788547|NCT00606892|75908648|FG001|COMPLETED|Second Intervention||4||
59788548|NCT00606892|75908647|FG000|NOT COMPLETED|Second Intervention||0||
59788549|NCT00606892|75908648|FG001|NOT COMPLETED|Second Intervention||0||
59788550|NCT00625443|75908683|FG000|STARTED|Overall Study||12||
59788551|NCT00625443|75908684|FG001|STARTED|Overall Study||26||
59788552|NCT00625443|75908685|FG002|STARTED|Overall Study||15||
59788553|NCT00625443|75908683|FG000|COMPLETED|Overall Study||10||
59788554|NCT00625443|75908684|FG001|COMPLETED|Overall Study||15||
59788555|NCT00625443|75908685|FG002|COMPLETED|Overall Study||10||
59788556|NCT00625443|75908683|FG000|NOT COMPLETED|Overall Study||2||
59788557|NCT00625443|75908684|FG001|NOT COMPLETED|Overall Study||11||
59788558|NCT00625443|75908685|FG002|NOT COMPLETED|Overall Study||5||
59788559|NCT00625365|75908696|FG000|STARTED|Overall Study||1060||
59788560|NCT00625365|75908696|FG000|COMPLETED|Overall Study|Participants who were analyzed for safety|1053||
59788561|NCT00625365|75908696|FG000|NOT COMPLETED|Overall Study||7||
59788562|NCT00606580|75908703|FG000|STARTED|Overall Study||125||
59788563|NCT00606580|75908704|FG001|STARTED|Overall Study||125||
59788564|NCT00606580|75908705|FG002|STARTED|Overall Study||125||
59788565|NCT00606580|75908703|FG000|COMPLETED|Overall Study||123||
59788566|NCT00606580|75908704|FG001|COMPLETED|Overall Study||122||
59788567|NCT00606580|75908705|FG002|COMPLETED|Overall Study||103||
59788568|NCT00606580|75908703|FG000|NOT COMPLETED|Overall Study||2||
59788569|NCT00606580|75908704|FG001|NOT COMPLETED|Overall Study||3||
59788570|NCT00606580|75908705|FG002|NOT COMPLETED|Overall Study||22||
59788571|NCT00629265|75908715|FG000|STARTED|Overall Study||116||
59788572|NCT00629265|75908716|FG001|STARTED|Overall Study||54||
59788573|NCT00629265|75908715|FG000|COMPLETED|Overall Study||84||
59788574|NCT00629265|75908716|FG001|COMPLETED|Overall Study||34||
59788575|NCT00629265|75908715|FG000|NOT COMPLETED|Overall Study||32||
59788576|NCT00629265|75908716|FG001|NOT COMPLETED|Overall Study||20||
59788577|NCT00606502|75908724|FG000|STARTED|Randomization||100||
59788578|NCT00606502|75908725|FG001|STARTED|Randomization||101||
59788579|NCT00606502|75908724|FG000|COMPLETED|Randomization||97||
59788580|NCT00606502|75908725|FG001|COMPLETED|Randomization||101||
59788581|NCT00606502|75908724|FG000|NOT COMPLETED|Randomization||3||
59788582|NCT00606502|75908725|FG001|NOT COMPLETED|Randomization||0||
59788583|NCT00606502|75908724|FG000|STARTED|Treatment||97||
59788584|NCT00606502|75908725|FG001|STARTED|Treatment||101||
59788585|NCT00606502|75908724|FG000|COMPLETED|Treatment||97||
59788586|NCT00606502|75908725|FG001|COMPLETED|Treatment||98||
59788587|NCT00606502|75908724|FG000|NOT COMPLETED|Treatment||0||
59788588|NCT00606502|75908725|FG001|NOT COMPLETED|Treatment||3||
59788589|NCT00605722|75908731|FG000|STARTED|Overall Study||51||
59788590|NCT00605722|75908731|FG000|COMPLETED|Overall Study|Completed=Completed Treatment.|0||
59788591|NCT00605722|75908731|FG000|NOT COMPLETED|Overall Study||51||
59788592|NCT00605566|75908735|FG000|STARTED|Overall Study||22||
60073349|NCT01584843|76188567|FG005|COMPLETED|Second Treatment Period||0||
60073350|NCT01584843|76188562|FG000|NOT COMPLETED|Second Treatment Period||0||
60073351|NCT01584843|76188563|FG001|NOT COMPLETED|Second Treatment Period||0||
59788593|NCT00605566|75908735|FG000|COMPLETED|Overall Study||19||
59788594|NCT00605566|75908735|FG000|NOT COMPLETED|Overall Study||3||
59788595|NCT00396877|75908741|FG000|STARTED|Overall Study|Randomized|439||
59788596|NCT00396877|75908742|FG001|STARTED|Overall Study|Randomized|467||
59788597|NCT00396877|75908741|FG000|Treated|Overall Study||436||
59788598|NCT00396877|75908742|FG001|Treated|Overall Study||464||
59788599|NCT00396877|75908741|FG000|Completed Treatment|Overall Study||356||
60073352|NCT01584843|76188564|FG002|NOT COMPLETED|Second Treatment Period||0||
60073353|NCT01584843|76188565|FG003|NOT COMPLETED|Second Treatment Period||0||
60073354|NCT01584843|76188566|FG004|NOT COMPLETED|Second Treatment Period||0||
59788600|NCT00396877|75908742|FG001|Completed Treatment|Overall Study||352||
59788601|NCT00396877|75908741|FG000|COMPLETED|Overall Study|Completed follow-up|433||
59788602|NCT00396877|75908742|FG001|COMPLETED|Overall Study|Completed follow-up|459||
59788603|NCT00396877|75908741|FG000|NOT COMPLETED|Overall Study||6||
59788604|NCT00396877|75908742|FG001|NOT COMPLETED|Overall Study||8||
59788605|NCT00628251|75908751|FG000|STARTED|Randomised Part|Patients randomised|32||
59788606|NCT00628251|75908752|FG001|STARTED|Randomised Part|Patients randomised|32||
59788607|NCT00628251|75908753|FG002|STARTED|Randomised Part|Patients randomised|33||
59788608|NCT00628251|75908751|FG000|COMPLETED|Randomised Part|Patients who received olaparib treatment|32||
59788609|NCT00628251|75908752|FG001|COMPLETED|Randomised Part|Patients who received olaparib treatment|32||
59788610|NCT00628251|75908753|FG002|COMPLETED|Randomised Part|1 of 33 patients did not receive Liposomal Doxorubicin. Patient voluntarily discontinued|32||
59788611|NCT00628251|75908751|FG000|NOT COMPLETED|Randomised Part||0||
59788612|NCT00628251|75908752|FG001|NOT COMPLETED|Randomised Part||0||
59788613|NCT00628251|75908753|FG002|NOT COMPLETED|Randomised Part||1||
59788614|NCT00628251|75908751|FG000|STARTED|Ongoing Initial Study Treatment at DCO|Patients who received treatment|32||
59817859|NCT04488770|75940337|FG011|COMPLETED|Part 1-Cohort 1: Period 4 (Up to 5 Days)||0||
59788615|NCT00628251|75908752|FG001|STARTED|Ongoing Initial Study Treatment at DCO|Patients who received treatment|32||
59788616|NCT00628251|75908753|FG002|STARTED|Ongoing Initial Study Treatment at DCO|Patients who received Liposomal doxorubicin 50 mg/m2|32||
59788617|NCT00628251|75908751|FG000|Discontinued Initial Study Treatment|Ongoing Initial Study Treatment at DCO||22||
59788618|NCT00628251|75908752|FG001|Discontinued Initial Study Treatment|Ongoing Initial Study Treatment at DCO||20||
59788619|NCT00628251|75908753|FG002|Discontinued Initial Study Treatment|Ongoing Initial Study Treatment at DCO||25||
59788620|NCT00628251|75908751|FG000|Crossover to Olaparib|Ongoing Initial Study Treatment at DCO||0||
59788621|NCT00628251|75908752|FG001|Crossover to Olaparib|Ongoing Initial Study Treatment at DCO||0||
59788622|NCT00628251|75908753|FG002|Crossover to Olaparib|Ongoing Initial Study Treatment at DCO|Crossover dosage was 400 mg bd Olaparib|14||
59788623|NCT00628251|75908751|FG000|Ongoing Crossover at DCO|Ongoing Initial Study Treatment at DCO||0||
59788624|NCT00628251|75908752|FG001|Ongoing Crossover at DCO|Ongoing Initial Study Treatment at DCO||0||
59788625|NCT00628251|75908753|FG002|Ongoing Crossover at DCO|Ongoing Initial Study Treatment at DCO||5||
59788626|NCT00628251|75908751|FG000|Discontinued Crossover|Ongoing Initial Study Treatment at DCO||0||
59788627|NCT00628251|75908752|FG001|Discontinued Crossover|Ongoing Initial Study Treatment at DCO||0||
59788628|NCT00628251|75908753|FG002|Discontinued Crossover|Ongoing Initial Study Treatment at DCO||9||
59788629|NCT00628251|75908751|FG000|COMPLETED|Ongoing Initial Study Treatment at DCO|Ongoing initial study treatment at primary data cut-off|10||
59788630|NCT00628251|75908752|FG001|COMPLETED|Ongoing Initial Study Treatment at DCO|Ongoing initial study treatment at primary data cut-off|12||
59788631|NCT00628251|75908753|FG002|COMPLETED|Ongoing Initial Study Treatment at DCO|Patients ongoing initial study treatment (Liposomal doxorubicin)|7||
59788632|NCT00628251|75908751|FG000|NOT COMPLETED|Ongoing Initial Study Treatment at DCO||22||
59788633|NCT00628251|75908752|FG001|NOT COMPLETED|Ongoing Initial Study Treatment at DCO||20||
59788634|NCT00628251|75908753|FG002|NOT COMPLETED|Ongoing Initial Study Treatment at DCO||25||
59788635|NCT00625131|75908765|FG000|STARTED|Overall Study||38||
59788636|NCT00625131|75908766|FG001|STARTED|Overall Study||44||
59788637|NCT00625131|75908767|FG002|STARTED|Overall Study|These participants were not included in any analyses.|5||
59788638|NCT00625131|75908765|FG000|COMPLETED|Overall Study||34||
59788639|NCT00625131|75908766|FG001|COMPLETED|Overall Study||42||
59788640|NCT00625131|75908767|FG002|COMPLETED|Overall Study||0||
59788641|NCT00625131|75908765|FG000|NOT COMPLETED|Overall Study||4||
59788642|NCT00625131|75908766|FG001|NOT COMPLETED|Overall Study||2||
59788643|NCT00625131|75908767|FG002|NOT COMPLETED|Overall Study||5||
59788644|NCT00408499|75908773|FG000|STARTED|Phase 1: Dose Levels 1-4||4||
59788645|NCT00408499|75908774|FG001|STARTED|Phase 1: Dose Levels 1-4||7||
59788646|NCT00408499|75908775|FG002|STARTED|Phase 1: Dose Levels 1-4||3||
59788647|NCT00408499|75908776|FG003|STARTED|Phase 1: Dose Levels 1-4||6||
59788648|NCT00408499|75908777|FG004|STARTED|Phase 1: Dose Levels 1-4||0||
59788649|NCT00408499|75908773|FG000|COMPLETED|Phase 1: Dose Levels 1-4||2||
59788650|NCT00408499|75908774|FG001|COMPLETED|Phase 1: Dose Levels 1-4||5||
59788651|NCT00408499|75908775|FG002|COMPLETED|Phase 1: Dose Levels 1-4||2||
59788652|NCT00408499|75908776|FG003|COMPLETED|Phase 1: Dose Levels 1-4||6||
59788653|NCT00408499|75908777|FG004|COMPLETED|Phase 1: Dose Levels 1-4||0||
59788654|NCT00408499|75908773|FG000|NOT COMPLETED|Phase 1: Dose Levels 1-4||2||
59788655|NCT00408499|75908774|FG001|NOT COMPLETED|Phase 1: Dose Levels 1-4||2||
59788656|NCT00408499|75908775|FG002|NOT COMPLETED|Phase 1: Dose Levels 1-4||1||
59788657|NCT00408499|75908776|FG003|NOT COMPLETED|Phase 1: Dose Levels 1-4||0||
59788658|NCT00408499|75908777|FG004|NOT COMPLETED|Phase 1: Dose Levels 1-4||0||
59953248|NCT04057820|76071793|FG013|COMPLETED|Period 6||0||0
59953249|NCT04057820|76071794|FG014|COMPLETED|Period 6||18||3
59953250|NCT04057820|76071795|FG015|COMPLETED|Period 6||0||0
59788659|NCT00408499|75908773|FG000|STARTED|Phase II- MTD Expansion||0||
59788660|NCT00408499|75908774|FG001|STARTED|Phase II- MTD Expansion||0||
59788661|NCT00408499|75908775|FG002|STARTED|Phase II- MTD Expansion||0||
59788662|NCT00408499|75908776|FG003|STARTED|Phase II- MTD Expansion||0||
59788663|NCT00408499|75908777|FG004|STARTED|Phase II- MTD Expansion||44||
59788664|NCT00408499|75908773|FG000|COMPLETED|Phase II- MTD Expansion||0||
59788665|NCT00408499|75908774|FG001|COMPLETED|Phase II- MTD Expansion||0||
59788666|NCT00408499|75908775|FG002|COMPLETED|Phase II- MTD Expansion||0||
59788667|NCT00408499|75908776|FG003|COMPLETED|Phase II- MTD Expansion||0||
59788668|NCT00408499|75908777|FG004|COMPLETED|Phase II- MTD Expansion||24||
59788669|NCT00408499|75908773|FG000|NOT COMPLETED|Phase II- MTD Expansion||0||
59788670|NCT00408499|75908774|FG001|NOT COMPLETED|Phase II- MTD Expansion||0||
59788671|NCT00408499|75908775|FG002|NOT COMPLETED|Phase II- MTD Expansion||0||
59788672|NCT00408499|75908776|FG003|NOT COMPLETED|Phase II- MTD Expansion||0||
59953251|NCT04057820|76071780|FG000|NOT COMPLETED|Period 6||0||0
59953252|NCT04057820|76071781|FG001|NOT COMPLETED|Period 6||0||0
60073355|NCT01584843|76188567|FG005|NOT COMPLETED|Second Treatment Period||1||
59788673|NCT00408499|75908777|FG004|NOT COMPLETED|Phase II- MTD Expansion||20||
59788674|NCT04044183|75908788|FG000|STARTED|Overall Study||10||
59788675|NCT04044183|75908789|FG001|STARTED|Overall Study||11||
59788676|NCT04044183|75908788|FG000|COMPLETED|Overall Study||8||
59788677|NCT04044183|75908789|FG001|COMPLETED|Overall Study||11||
59788678|NCT04044183|75908788|FG000|NOT COMPLETED|Overall Study||2||
59953253|NCT04057820|76071782|FG002|NOT COMPLETED|Period 6||0||0
60073356|NCT01560429|76188585|FG000|STARTED|Overall Study||26||
59788679|NCT04044183|75908789|FG001|NOT COMPLETED|Overall Study||0||
59788680|NCT00621777|75908797|FG000|STARTED|Open Phase||203||
59788681|NCT00621777|75908798|FG001|STARTED|Open Phase|During this open label phase, all study participants received varenicline|0||
59788682|NCT00621777|75908797|FG000|COMPLETED|Open Phase||87||
59788683|NCT00621777|75908798|FG001|COMPLETED|Open Phase||0||
59788684|NCT00621777|75908797|FG000|NOT COMPLETED|Open Phase||116||
59788685|NCT00621777|75908798|FG001|NOT COMPLETED|Open Phase||0||
59788686|NCT00621777|75908797|FG000|STARTED|Randomized Phase|87 open phase participants were continuously abstinent for at least 14 days and were randomized|40||
59788687|NCT00621777|75908798|FG001|STARTED|Randomized Phase||47||
59788688|NCT00621777|75908797|FG000|COMPLETED|Randomized Phase||33||
59788689|NCT00621777|75908798|FG001|COMPLETED|Randomized Phase||28||
59788690|NCT00621777|75908797|FG000|NOT COMPLETED|Randomized Phase||7||
59788691|NCT00621777|75908798|FG001|NOT COMPLETED|Randomized Phase||19||
59788692|NCT00408421|75908808|FG000|STARTED|Treatment Initial Randomization||120||
59788693|NCT00408421|75908809|FG001|STARTED|Treatment Initial Randomization||111||
59788694|NCT00408421|75908810|FG002|STARTED|Treatment Initial Randomization||0||
59788695|NCT00408421|75908808|FG000|COMPLETED|Treatment Initial Randomization|Pre-Re-Randomization (Visit 4)|103||
59788696|NCT00408421|75908809|FG001|COMPLETED|Treatment Initial Randomization|Pre-Re-Randomization (Visit 4)|89||
59788697|NCT00408421|75908810|FG002|COMPLETED|Treatment Initial Randomization|Patients weren't randomized to Duloxetine 120 mg until Visit 4.|0||
59788698|NCT00408421|75908808|FG000|NOT COMPLETED|Treatment Initial Randomization||17||
59788699|NCT00408421|75908809|FG001|NOT COMPLETED|Treatment Initial Randomization||22||
59788700|NCT00408421|75908810|FG002|NOT COMPLETED|Treatment Initial Randomization||0||
59788701|NCT00408421|75908808|FG000|STARTED|Treatment Re-Randomization||103||
59788702|NCT00408421|75908809|FG001|STARTED|Treatment Re-Randomization||46||
59788703|NCT00408421|75908810|FG002|STARTED|Treatment Re-Randomization||43||
59788704|NCT00408421|75908808|FG000|COMPLETED|Treatment Re-Randomization||96||
59788705|NCT00408421|75908809|FG001|COMPLETED|Treatment Re-Randomization||39||
59788706|NCT00408421|75908810|FG002|COMPLETED|Treatment Re-Randomization||38||
59788707|NCT00408421|75908808|FG000|NOT COMPLETED|Treatment Re-Randomization||7||
59788708|NCT00408421|75908809|FG001|NOT COMPLETED|Treatment Re-Randomization||7||
59788709|NCT00408421|75908810|FG002|NOT COMPLETED|Treatment Re-Randomization||5||
59788710|NCT00604786|75908820|FG000|STARTED|Overall Study||14||
59788711|NCT00604786|75908821|FG001|STARTED|Overall Study||4||
59788712|NCT00604786|75908820|FG000|COMPLETED|Overall Study||12||
59788713|NCT00604786|75908821|FG001|COMPLETED|Overall Study||4||
59788714|NCT00604786|75908820|FG000|NOT COMPLETED|Overall Study||2||
59788715|NCT00604786|75908821|FG001|NOT COMPLETED|Overall Study||0||
59788716|NCT00604708|75908829|FG000|STARTED|Overall Study||430||
59788717|NCT00604708|75908830|FG001|STARTED|Overall Study||437||
59788718|NCT00604708|75908829|FG000|COMPLETED|Overall Study||399||
59788719|NCT00604708|75908830|FG001|COMPLETED|Overall Study||397||
59788720|NCT00604708|75908829|FG000|NOT COMPLETED|Overall Study||31||
59788721|NCT00604708|75908830|FG001|NOT COMPLETED|Overall Study||40||
59788722|NCT00407797|75908836|FG000|STARTED|Overall Study||136||
59788723|NCT00407797|75908836|FG000|Full Analysis Set|Overall Study|At least 1 dose of study medication and had a baseline and at least 1 post-baseline measurement.|135||
59788724|NCT00407797|75908836|FG000|COMPLETED|Overall Study||118||
59788725|NCT00407797|75908836|FG000|NOT COMPLETED|Overall Study||18||
59788726|NCT00568126|75908842|FG000|STARTED|Overall Study||24||
59788727|NCT00568126|75908843|FG001|STARTED|Overall Study||21||
59788728|NCT00568126|75908842|FG000|COMPLETED|Overall Study||13||
59788729|NCT00568126|75908843|FG001|COMPLETED|Overall Study||12||
59788730|NCT00568126|75908842|FG000|NOT COMPLETED|Overall Study||11||
59788731|NCT00568126|75908843|FG001|NOT COMPLETED|Overall Study||9||
59788732|NCT00407563|75908849|FG000|STARTED|Overall Study||48||
59788733|NCT00407563|75908849|FG000|COMPLETED|Overall Study|One patient remains on study treatment.|47||
59788734|NCT00407563|75908849|FG000|NOT COMPLETED|Overall Study||1||
59788735|NCT00567892|75908855|FG000|STARTED|First Treatment (2 or 4 Weeks)||7||
59788736|NCT00567892|75908856|FG001|STARTED|First Treatment (2 or 4 Weeks)||7||
59788737|NCT00567892|75908857|FG002|STARTED|First Treatment (2 or 4 Weeks)||10||
59788738|NCT00567892|75908858|FG003|STARTED|First Treatment (2 or 4 Weeks)||10||
59788739|NCT00567892|75908855|FG000|COMPLETED|First Treatment (2 or 4 Weeks)||7||
59788740|NCT00567892|75908856|FG001|COMPLETED|First Treatment (2 or 4 Weeks)||7||
59788741|NCT00567892|75908857|FG002|COMPLETED|First Treatment (2 or 4 Weeks)||9||
59788742|NCT00567892|75908858|FG003|COMPLETED|First Treatment (2 or 4 Weeks)||6||
59788743|NCT00567892|75908855|FG000|NOT COMPLETED|First Treatment (2 or 4 Weeks)||0||
59788744|NCT00567892|75908856|FG001|NOT COMPLETED|First Treatment (2 or 4 Weeks)||0||
59788745|NCT00567892|75908857|FG002|NOT COMPLETED|First Treatment (2 or 4 Weeks)||1||
59788746|NCT00567892|75908858|FG003|NOT COMPLETED|First Treatment (2 or 4 Weeks)||4||
59788747|NCT00567892|75908855|FG000|STARTED|Washout (2 Weeks)||7||
59788748|NCT00567892|75908856|FG001|STARTED|Washout (2 Weeks)||7||
59788749|NCT00567892|75908857|FG002|STARTED|Washout (2 Weeks)||9||
59788750|NCT00567892|75908858|FG003|STARTED|Washout (2 Weeks)||6||
59788751|NCT00567892|75908855|FG000|COMPLETED|Washout (2 Weeks)||7||
59788752|NCT00567892|75908856|FG001|COMPLETED|Washout (2 Weeks)||7||
59788753|NCT00567892|75908857|FG002|COMPLETED|Washout (2 Weeks)||9||
59788754|NCT00567892|75908858|FG003|COMPLETED|Washout (2 Weeks)||6||
59788755|NCT00567892|75908855|FG000|NOT COMPLETED|Washout (2 Weeks)||0||
59788756|NCT00567892|75908856|FG001|NOT COMPLETED|Washout (2 Weeks)||0||
59788757|NCT00567892|75908857|FG002|NOT COMPLETED|Washout (2 Weeks)||0||
59788758|NCT00567892|75908858|FG003|NOT COMPLETED|Washout (2 Weeks)||0||
59788759|NCT00567892|75908855|FG000|STARTED|Second Treatment (2 or 4 Weeks)||7||
59788760|NCT00567892|75908856|FG001|STARTED|Second Treatment (2 or 4 Weeks)||7||
59788761|NCT00567892|75908857|FG002|STARTED|Second Treatment (2 or 4 Weeks)||9||
59788762|NCT00567892|75908858|FG003|STARTED|Second Treatment (2 or 4 Weeks)||6||
59788763|NCT00567892|75908855|FG000|COMPLETED|Second Treatment (2 or 4 Weeks)||7||
59788764|NCT00567892|75908856|FG001|COMPLETED|Second Treatment (2 or 4 Weeks)||7||
59788765|NCT00567892|75908857|FG002|COMPLETED|Second Treatment (2 or 4 Weeks)||9||
59788766|NCT00567892|75908858|FG003|COMPLETED|Second Treatment (2 or 4 Weeks)||5||
59788767|NCT00567892|75908855|FG000|NOT COMPLETED|Second Treatment (2 or 4 Weeks)||0||
59788768|NCT00567892|75908856|FG001|NOT COMPLETED|Second Treatment (2 or 4 Weeks)||0||
59788769|NCT00567892|75908857|FG002|NOT COMPLETED|Second Treatment (2 or 4 Weeks)||0||
59788770|NCT00567892|75908858|FG003|NOT COMPLETED|Second Treatment (2 or 4 Weeks)||1||
59788771|NCT00623103|75908872|FG000|STARTED|Overall Study||295||
59788772|NCT00623103|75908873|FG001|STARTED|Overall Study||288||
59788773|NCT00623103|75908872|FG000|Safety Set: Received Study Drug|Overall Study|One randomized participant did not receive study drug and was not included in the Safety set.|294||
59788774|NCT00623103|75908873|FG001|Safety Set: Received Study Drug|Overall Study||288||
59788775|NCT00623103|75908872|FG000|COMPLETED|Overall Study||184||
59788776|NCT00623103|75908873|FG001|COMPLETED|Overall Study||175||
59788777|NCT00623103|75908872|FG000|NOT COMPLETED|Overall Study||111||
59788778|NCT00623103|75908873|FG001|NOT COMPLETED|Overall Study||113||
59788779|NCT00396565|75908882|FG000|STARTED|Overall Study||136||
59788780|NCT00396565|75908883|FG001|STARTED|Overall Study||138||
59788781|NCT00396565|75908884|FG002|STARTED|Overall Study||47||
59788782|NCT00396565|75908882|FG000|COMPLETED|Overall Study||88||
59788783|NCT00396565|75908883|FG001|COMPLETED|Overall Study||47||
59788784|NCT00396565|75908884|FG002|COMPLETED|Overall Study||30||
59788785|NCT00396565|75908882|FG000|NOT COMPLETED|Overall Study||48||
59788786|NCT00396565|75908883|FG001|NOT COMPLETED|Overall Study||91||
59788787|NCT00396565|75908884|FG002|NOT COMPLETED|Overall Study||17||
59788788|NCT00394771|75908896|FG000|STARTED|Overall Study|Safety population of treated participants|140||
59788789|NCT00394771|75908897|FG001|STARTED|Overall Study|Safety population of treated participants|136||
59788790|NCT00394771|75908898|FG002|STARTED|Overall Study|Safety population of treated participants|143||
59788791|NCT00394771|75908899|FG003|STARTED|Overall Study|Safety population of treated participants|148||
59788792|NCT00394771|75908896|FG000|Intent to Treat (ITT) Population|Overall Study|At least one completed 91 day cycle of treatment|110||
59788793|NCT00394771|75908897|FG001|Intent to Treat (ITT) Population|Overall Study|At least one completed 91 day cycle of treatment|110||
59788794|NCT00394771|75908898|FG002|Intent to Treat (ITT) Population|Overall Study|At least one completed 91 day cycle of treatment|108||
59788795|NCT00394771|75908899|FG003|Intent to Treat (ITT) Population|Overall Study|At least one completed 91 day cycle of treatment|120||
59788796|NCT00394771|75908896|FG000|COMPLETED|Overall Study||99||
59788797|NCT00394771|75908897|FG001|COMPLETED|Overall Study||102||
59788798|NCT00394771|75908898|FG002|COMPLETED|Overall Study||96||
59788799|NCT00394771|75908899|FG003|COMPLETED|Overall Study||109||
59788800|NCT00394771|75908896|FG000|NOT COMPLETED|Overall Study||41||
59788801|NCT00394771|75908897|FG001|NOT COMPLETED|Overall Study||34||
59788802|NCT00394771|75908898|FG002|NOT COMPLETED|Overall Study||47||
59788803|NCT00394771|75908899|FG003|NOT COMPLETED|Overall Study||39||
59788804|NCT00396409|75908911|FG000|STARTED|Period 1 - 2007||65||
59788805|NCT00396409|75908912|FG001|STARTED|Period 1 - 2007||63||
59788806|NCT00396409|75908911|FG000|COMPLETED|Period 1 - 2007||62||
59788807|NCT00396409|75908912|FG001|COMPLETED|Period 1 - 2007||57||
59788808|NCT00396409|75908911|FG000|NOT COMPLETED|Period 1 - 2007||3||
59788809|NCT00396409|75908912|FG001|NOT COMPLETED|Period 1 - 2007||6||
59788810|NCT00396409|75908911|FG000|STARTED|Between Period 1 and Period 2||62||
59788811|NCT00396409|75908912|FG001|STARTED|Between Period 1 and Period 2||57||
59788812|NCT00396409|75908911|FG000|COMPLETED|Between Period 1 and Period 2||59||
59788813|NCT00396409|75908912|FG001|COMPLETED|Between Period 1 and Period 2||55||
59788814|NCT00396409|75908911|FG000|NOT COMPLETED|Between Period 1 and Period 2||3||
59788815|NCT00396409|75908912|FG001|NOT COMPLETED|Between Period 1 and Period 2||2||
59788816|NCT00396409|75908911|FG000|STARTED|Period 2 - 2008||59||
59788817|NCT00396409|75908912|FG001|STARTED|Period 2 - 2008||55||
59788818|NCT00396409|75908911|FG000|COMPLETED|Period 2 - 2008||52||
59788819|NCT00396409|75908912|FG001|COMPLETED|Period 2 - 2008||53||
59788820|NCT00396409|75908911|FG000|NOT COMPLETED|Period 2 - 2008||7||
59788821|NCT00396409|75908912|FG001|NOT COMPLETED|Period 2 - 2008||2||
59788822|NCT02924376|75908924|FG000|STARTED|Overall Study||108||
59788823|NCT02924376|75908925|FG001|STARTED|Overall Study||20||
59788824|NCT02924376|75908926|FG002|STARTED|Overall Study||17||
59788825|NCT02924376|75908927|FG003|STARTED|Overall Study||2||
59788826|NCT02924376|75908924|FG000|COMPLETED|Overall Study||0||
59788827|NCT02924376|75908925|FG001|COMPLETED|Overall Study||0||
59788828|NCT02924376|75908926|FG002|COMPLETED|Overall Study||0||
59788829|NCT02924376|75908927|FG003|COMPLETED|Overall Study||0||
59788830|NCT02924376|75908924|FG000|NOT COMPLETED|Overall Study||108||
59788831|NCT02924376|75908925|FG001|NOT COMPLETED|Overall Study||20||
59788832|NCT02924376|75908926|FG002|NOT COMPLETED|Overall Study||17||
59788833|NCT02924376|75908927|FG003|NOT COMPLETED|Overall Study||2||
59788834|NCT00693420|75908942|FG000|STARTED|Overall Study||137||
59788835|NCT00693420|75908943|FG001|STARTED|Overall Study||141||
59788836|NCT00693420|75908942|FG000|COMPLETED|Overall Study||131||
59788837|NCT00693420|75908943|FG001|COMPLETED|Overall Study||126||
59788838|NCT00693420|75908942|FG000|NOT COMPLETED|Overall Study||6||
59788839|NCT00693420|75908943|FG001|NOT COMPLETED|Overall Study||15||
59788840|NCT00695136|75908949|FG000|STARTED|Overall Study|7|7||
59788841|NCT00695136|75908949|FG000|COMPLETED|Overall Study||5||
59788842|NCT00695136|75908949|FG000|NOT COMPLETED|Overall Study||2||
59788843|NCT02710890|75908955|FG000|STARTED|Overall Study||48||
59788844|NCT02710890|75908956|FG001|STARTED|Overall Study||55||
59788845|NCT02710890|75908955|FG000|COMPLETED|Overall Study||48||
59788846|NCT02710890|75908956|FG001|COMPLETED|Overall Study||55||
59788847|NCT02710890|75908955|FG000|NOT COMPLETED|Overall Study||0||
59788848|NCT02710890|75908956|FG001|NOT COMPLETED|Overall Study||0||
59788849|NCT00605176|75908965|FG000|STARTED|Overall Study||160||
59788850|NCT00605176|75908966|FG001|STARTED|Overall Study||160||
59788851|NCT00605176|75908967|FG002|STARTED|Overall Study||159||
59788852|NCT00605176|75908965|FG000|COMPLETED|Overall Study||149||
59788853|NCT00605176|75908966|FG001|COMPLETED|Overall Study||154||
59788854|NCT00605176|75908967|FG002|COMPLETED|Overall Study||150||
59788855|NCT00605176|75908965|FG000|NOT COMPLETED|Overall Study||11||
59788856|NCT00605176|75908966|FG001|NOT COMPLETED|Overall Study||6||
59788857|NCT00605176|75908967|FG002|NOT COMPLETED|Overall Study||9||
59788858|NCT00694356|75908978|FG000|STARTED|Overall Study||3||
59788859|NCT00694356|75908979|FG001|STARTED|Overall Study||6||
59788860|NCT00694356|75908980|FG002|STARTED|Overall Study||6||
59788861|NCT00694356|75908978|FG000|COMPLETED|Overall Study||0||
59788862|NCT00694356|75908979|FG001|COMPLETED|Overall Study||0||
59788863|NCT00694356|75908980|FG002|COMPLETED|Overall Study||0||
59788864|NCT00694356|75908978|FG000|NOT COMPLETED|Overall Study||3||
59788865|NCT00694356|75908979|FG001|NOT COMPLETED|Overall Study||6||
59788866|NCT00694356|75908980|FG002|NOT COMPLETED|Overall Study||6||
59788867|NCT00692406|75908988|FG000|STARTED|Overall Study|Initially this group was assigned to quit smoking before the second scan.|80||
59788868|NCT00692406|75908988|FG000|COMPLETED|Overall Study|This group quit smoking before their second scan.|23||
59788869|NCT00692406|75908988|FG000|NOT COMPLETED|Overall Study||57||
59953254|NCT04057820|76071783|FG003|NOT COMPLETED|Period 6||0||0
59788870|NCT03415464|75908994|FG000|STARTED|Overall Study||64||
59788871|NCT03415464|75908995|FG001|STARTED|Overall Study||41||
59788872|NCT03415464|75908994|FG000|COMPLETED|Overall Study||64||
59788873|NCT03415464|75908995|FG001|COMPLETED|Overall Study||41||
59788874|NCT03415464|75908994|FG000|NOT COMPLETED|Overall Study||0||
59788875|NCT03415464|75908995|FG001|NOT COMPLETED|Overall Study||0||
59788876|NCT00567502|75909005|FG000|STARTED|Overall Study||804||
59788877|NCT00567502|75909006|FG001|STARTED|Overall Study||141||
59788878|NCT00567502|75909007|FG002|STARTED|Overall Study||2666||
59788879|NCT00567502|75909008|FG003|STARTED|Overall Study||110||
59788880|NCT00567502|75909005|FG000|Initiated Treatment|Overall Study||804||
59788881|NCT00567502|75909006|FG001|Initiated Treatment|Overall Study||141||
59953255|NCT04057820|76071784|FG004|NOT COMPLETED|Period 6||0||0
59953256|NCT04057820|76071785|FG005|NOT COMPLETED|Period 6||0||0
59953257|NCT04057820|76071786|FG006|NOT COMPLETED|Period 6||0||0
59953258|NCT04057820|76071787|FG007|NOT COMPLETED|Period 6||0||0
59953259|NCT04057820|76071788|FG008|NOT COMPLETED|Period 6||0||0
59953260|NCT04057820|76071789|FG009|NOT COMPLETED|Period 6||0||0
59953261|NCT04057820|76071790|FG010|NOT COMPLETED|Period 6||0||0
59953262|NCT04057820|76071791|FG011|NOT COMPLETED|Period 6||0||0
59953263|NCT04057820|76071792|FG012|NOT COMPLETED|Period 6||0||0
59953264|NCT04057820|76071793|FG013|NOT COMPLETED|Period 6||0||0
59522814|NCT02381626|75617366|FG000|STARTED|Overall Study||17||
59788882|NCT00567502|75909007|FG002|Initiated Treatment|Overall Study||2666||
59788883|NCT00567502|75909008|FG003|Initiated Treatment|Overall Study||38||
59788884|NCT00567502|75909005|FG000|COMPLETED|Overall Study||563||
59788885|NCT00567502|75909006|FG001|COMPLETED|Overall Study||108||
59788886|NCT00567502|75909007|FG002|COMPLETED|Overall Study||1758||
59788887|NCT00567502|75909008|FG003|COMPLETED|Overall Study||23||
59788888|NCT00567502|75909005|FG000|NOT COMPLETED|Overall Study||241||
59788889|NCT00567502|75909006|FG001|NOT COMPLETED|Overall Study||33||
59788890|NCT00567502|75909007|FG002|NOT COMPLETED|Overall Study||908||
59788891|NCT00567502|75909008|FG003|NOT COMPLETED|Overall Study||87||
59788892|NCT00396331|75909033|FG000|STARTED|Overall Study||100||
59788893|NCT00396331|75909033|FG000|Number of Participants Treated|Overall Study||100||
59788894|NCT00396331|75909033|FG000|Number of Participants Transplanted|Overall Study|7 participants had two transplants|87||
59788895|NCT00396331|75909033|FG000|COMPLETED|Overall Study||68||
59788896|NCT00396331|75909033|FG000|NOT COMPLETED|Overall Study||32||
59788897|NCT00396253|75909045|FG000|STARTED|Overall Study||223||
59953265|NCT04057820|76071794|FG014|NOT COMPLETED|Period 6||0||0
59953266|NCT04057820|76071795|FG015|NOT COMPLETED|Period 6||0||0
59953267|NCT04057820|76071780|FG000|STARTED|Period 7||0||0
59953268|NCT04057820|76071781|FG001|STARTED|Period 7||24||4
59788898|NCT00396253|75909045|FG000|COMPLETED|Overall Study||210||
59788899|NCT00396253|75909045|FG000|NOT COMPLETED|Overall Study||13||
59788900|NCT00604162|75909049|FG000|STARTED|Overall Study||332||
59788901|NCT00604162|75909049|FG000|COMPLETED|Overall Study||328||
59788902|NCT00604162|75909049|FG000|NOT COMPLETED|Overall Study||4||
59788903|NCT00396097|75909058|FG000|STARTED|Overall Study|4 participants randomized to Individualized Dose, received Standard Dose throughout the study.|114||
59953269|NCT04057820|76071782|FG002|STARTED|Period 7||0||0
59788904|NCT00396097|75909059|FG001|STARTED|Overall Study||202||
59788905|NCT00396097|75909058|FG000|COMPLETED|Overall Study||88||
59788906|NCT00396097|75909059|FG001|COMPLETED|Overall Study||156||
59788907|NCT00396097|75909058|FG000|NOT COMPLETED|Overall Study||26||
59788908|NCT00396097|75909059|FG001|NOT COMPLETED|Overall Study||46||
59788909|NCT00375505|75909071|FG000|STARTED|Overall Study||36||
59788910|NCT00375505|75909072|FG001|STARTED|Overall Study||34||
59788911|NCT00375505|75909071|FG000|COMPLETED|Overall Study||35||
59788912|NCT00375505|75909072|FG001|COMPLETED|Overall Study||32||
59788913|NCT00375505|75909071|FG000|NOT COMPLETED|Overall Study||1||
59788914|NCT00375505|75909072|FG001|NOT COMPLETED|Overall Study||2||
59788915|NCT00375427|75909080|FG000|STARTED|Overall Study|Total enrollment was 430 but five patients were screened but not treated.|209||
59788916|NCT00375427|75909081|FG001|STARTED|Overall Study||216||
59788917|NCT00375427|75909080|FG000|COMPLETED|Overall Study||149||
59788918|NCT00375427|75909081|FG001|COMPLETED|Overall Study||142||
59788919|NCT00375427|75909080|FG000|NOT COMPLETED|Overall Study||60||
59788920|NCT00375427|75909081|FG001|NOT COMPLETED|Overall Study||74||
59788921|NCT00393913|75909087|FG000|STARTED|Initial Assessment||144||
59788922|NCT00393913|75909087|FG000|COMPLETED|Initial Assessment||107||
59788923|NCT00393913|75909087|FG000|NOT COMPLETED|Initial Assessment||37||
59788924|NCT00393913|75909087|FG000|STARTED|CPAP|Excludes normal volunteers without OSA|100||
59788925|NCT00393913|75909087|FG000|COMPLETED|CPAP||93||
59788926|NCT00393913|75909087|FG000|NOT COMPLETED|CPAP||7||
59788927|NCT00393913|75909087|FG000|STARTED|CPAP Withdrawal|Includes only subjects with good CPAP adherence|42||
59788928|NCT00393913|75909087|FG000|CPAP Compliance|CPAP Withdrawal|Only subjects with sufficient CPAP complaince (>4 hrs/night) were included.|42||
59788929|NCT00393913|75909087|FG000|COMPLETED|CPAP Withdrawal||42||
59788930|NCT00393913|75909087|FG000|NOT COMPLETED|CPAP Withdrawal||0||
59788931|NCT00567268|75909092|FG000|STARTED|Overall Study||1194||
59788932|NCT00567268|75909092|FG000|COMPLETED|Overall Study||1144||
59788933|NCT00567268|75909092|FG000|NOT COMPLETED|Overall Study||50||
59788934|NCT03976648|75909133|FG000|STARTED|Overall Study||21||
59788935|NCT03976648|75909134|FG001|STARTED|Overall Study||10||
59788936|NCT03976648|75909133|FG000|COMPLETED|Overall Study||0||
59788937|NCT03976648|75909134|FG001|COMPLETED|Overall Study||0||
59788938|NCT03976648|75909133|FG000|NOT COMPLETED|Overall Study||21||
59788939|NCT03976648|75909134|FG001|NOT COMPLETED|Overall Study||10||
59788940|NCT00566254|75909142|FG000|STARTED|Overall Study||100||
59788941|NCT00566254|75909143|FG001|STARTED|Overall Study||107||
59788942|NCT00566254|75909142|FG000|COMPLETED|Overall Study||90||
59788943|NCT00566254|75909143|FG001|COMPLETED|Overall Study||93||
59788944|NCT00566254|75909142|FG000|NOT COMPLETED|Overall Study||10||
59788945|NCT00566254|75909143|FG001|NOT COMPLETED|Overall Study||14||
59788946|NCT00393523|75909154|FG000|STARTED|Overall Study||376||
59788947|NCT00393523|75909155|FG001|STARTED|Overall Study||375||
59788948|NCT00393523|75909156|FG002|STARTED|Overall Study||353||
59788949|NCT00393523|75909157|FG003|STARTED|Overall Study||354||
59788950|NCT00393523|75909158|FG004|STARTED|Overall Study||20||
59788951|NCT00393523|75909154|FG000|Vaccination Visit 1|Overall Study||374||
59788952|NCT00393523|75909155|FG001|Vaccination Visit 1|Overall Study||375||
59788953|NCT00393523|75909156|FG002|Vaccination Visit 1|Overall Study||349||
59788954|NCT00393523|75909157|FG003|Vaccination Visit 1|Overall Study||352||
59788955|NCT00393523|75909158|FG004|Vaccination Visit 1|Overall Study||20||
59788956|NCT00393523|75909154|FG000|COMPLETED|Overall Study||364||
59788957|NCT00393523|75909155|FG001|COMPLETED|Overall Study||366||
59788958|NCT00393523|75909156|FG002|COMPLETED|Overall Study||349||
59788959|NCT00393523|75909157|FG003|COMPLETED|Overall Study||348||
59788960|NCT00393523|75909158|FG004|COMPLETED|Overall Study||19||
59788961|NCT00393523|75909154|FG000|NOT COMPLETED|Overall Study||12||
59788962|NCT00393523|75909155|FG001|NOT COMPLETED|Overall Study||9||
59788963|NCT00393523|75909156|FG002|NOT COMPLETED|Overall Study||4||
59788964|NCT00393523|75909157|FG003|NOT COMPLETED|Overall Study||6||
59788965|NCT00393523|75909158|FG004|NOT COMPLETED|Overall Study||1||
59788966|NCT00393367|75909171|FG000|STARTED|Overall Study||91||
59788967|NCT00393367|75909172|FG001|STARTED|Overall Study||88||
59788968|NCT00393367|75909171|FG000|COMPLETED|Overall Study||89||
59788969|NCT00393367|75909172|FG001|COMPLETED|Overall Study||81||
59788970|NCT00393367|75909171|FG000|NOT COMPLETED|Overall Study||2||
59788971|NCT00393367|75909172|FG001|NOT COMPLETED|Overall Study||7||
59788972|NCT00395863|75909182|FG000|STARTED|Overall Study||23||
59788973|NCT00395863|75909183|FG001|STARTED|Overall Study||23||
59788974|NCT00395863|75909182|FG000|COMPLETED|Overall Study||21||
59788975|NCT00395863|75909183|FG001|COMPLETED|Overall Study||20||
59788976|NCT00395863|75909182|FG000|NOT COMPLETED|Overall Study||2||
59788977|NCT00395863|75909183|FG001|NOT COMPLETED|Overall Study||3||
59788978|NCT00395629|75909195|FG000|STARTED|Core Study||11||
59953270|NCT04057820|76071783|FG003|STARTED|Period 7||9||2
59788979|NCT00395629|75909196|FG001|STARTED|Core Study||15||
59788980|NCT00395629|75909197|FG002|STARTED|Core Study||23||
59788981|NCT00395629|75909195|FG000|COMPLETED|Core Study||10||
59788982|NCT00395629|75909196|FG001|COMPLETED|Core Study||11||
59788983|NCT00395629|75909197|FG002|COMPLETED|Core Study||16||
59788984|NCT00395629|75909195|FG000|NOT COMPLETED|Core Study||1||
59953271|NCT04057820|76071784|FG004|STARTED|Period 7||0||0
59953272|NCT04057820|76071785|FG005|STARTED|Period 7||14||3
59788985|NCT00395629|75909196|FG001|NOT COMPLETED|Core Study||4||
59788986|NCT00395629|75909197|FG002|NOT COMPLETED|Core Study||7||
59788987|NCT00395629|75909195|FG000|STARTED|Extension Study||9||
59788988|NCT00395629|75909196|FG001|STARTED|Extension Study||6||
59788989|NCT00395629|75909197|FG002|STARTED|Extension Study||11||
59788990|NCT00395629|75909195|FG000|COMPLETED|Extension Study||9||
59788991|NCT00395629|75909196|FG001|COMPLETED|Extension Study||6||
59788992|NCT00395629|75909197|FG002|COMPLETED|Extension Study||8||
59788993|NCT00395629|75909195|FG000|NOT COMPLETED|Extension Study||0||
59788994|NCT00395629|75909196|FG001|NOT COMPLETED|Extension Study||0||
59788995|NCT00395629|75909197|FG002|NOT COMPLETED|Extension Study||3||
59788996|NCT00392665|75909210|FG000|STARTED|Overall Study||18||
59788997|NCT00392665|75909211|FG001|STARTED|Overall Study||18||
59788998|NCT00392665|75909210|FG000|COMPLETED|Overall Study||1||
59788999|NCT00392665|75909211|FG001|COMPLETED|Overall Study||3||
59789000|NCT00392665|75909210|FG000|NOT COMPLETED|Overall Study||17||
59789001|NCT00392665|75909211|FG001|NOT COMPLETED|Overall Study||15||
59789002|NCT00622869|75909220|FG000|STARTED|Overall Study||245||
59789003|NCT00622869|75909221|FG001|STARTED|Overall Study||231||
59789004|NCT00622869|75909222|FG002|STARTED|Overall Study||243||
59789005|NCT00622869|75909220|FG000|COMPLETED|Overall Study||202||
59789006|NCT00622869|75909221|FG001|COMPLETED|Overall Study||174||
59789007|NCT00622869|75909222|FG002|COMPLETED|Overall Study||204||
59789008|NCT00622869|75909220|FG000|NOT COMPLETED|Overall Study||43||
59789009|NCT00622869|75909221|FG001|NOT COMPLETED|Overall Study||57||
59789010|NCT00622869|75909222|FG002|NOT COMPLETED|Overall Study||39||
59789011|NCT00395083|75909232|FG000|STARTED|Overall Study||217||
59789012|NCT00395083|75909233|FG001|STARTED|Overall Study||209||
59789013|NCT00395083|75909232|FG000|COMPLETED|Overall Study||207||
59789014|NCT00395083|75909233|FG001|COMPLETED|Overall Study||201||
59789015|NCT00395083|75909232|FG000|NOT COMPLETED|Overall Study||10||
59789016|NCT00395083|75909233|FG001|NOT COMPLETED|Overall Study||8||
59789017|NCT00366457|75909239|FG000|STARTED|Overall Study||32||
59789018|NCT00366457|75909239|FG000|COMPLETED|Overall Study||30||
59789019|NCT00366457|75909239|FG000|NOT COMPLETED|Overall Study||2||
59789020|NCT00624819|75909247|FG000|STARTED|Follow-up Period: Year 1||391||
59789021|NCT00624819|75909248|FG001|STARTED|Follow-up Period: Year 1||31||
59789022|NCT00624819|75909249|FG002|STARTED|Follow-up Period: Year 1||102||
59789023|NCT00624819|75909250|FG003|STARTED|Follow-up Period: Year 1||0||
59789024|NCT00624819|75909247|FG000|COMPLETED|Follow-up Period: Year 1||391||
59789025|NCT00624819|75909248|FG001|COMPLETED|Follow-up Period: Year 1||31||
59789026|NCT00624819|75909249|FG002|COMPLETED|Follow-up Period: Year 1||102||
59789027|NCT00624819|75909250|FG003|COMPLETED|Follow-up Period: Year 1||0||
59789028|NCT00624819|75909247|FG000|NOT COMPLETED|Follow-up Period: Year 1||0||
59789029|NCT00624819|75909248|FG001|NOT COMPLETED|Follow-up Period: Year 1||0||
59789030|NCT00624819|75909249|FG002|NOT COMPLETED|Follow-up Period: Year 1||0||
59789031|NCT00624819|75909250|FG003|NOT COMPLETED|Follow-up Period: Year 1||0||
59953273|NCT04057820|76071786|FG006|STARTED|Period 7||0||0
60073357|NCT01560429|76188586|FG001|STARTED|Overall Study||26||
59789032|NCT00624819|75909247|FG000|STARTED|Follow-up Period: Year 2||370||
59789033|NCT00624819|75909248|FG001|STARTED|Follow-up Period: Year 2||31||
59789034|NCT00624819|75909249|FG002|STARTED|Follow-up Period: Year 2||96||
59789035|NCT00624819|75909250|FG003|STARTED|Follow-up Period: Year 2||0||
59789036|NCT00624819|75909247|FG000|COMPLETED|Follow-up Period: Year 2||370||
59789037|NCT00624819|75909248|FG001|COMPLETED|Follow-up Period: Year 2||31||
59789038|NCT00624819|75909249|FG002|COMPLETED|Follow-up Period: Year 2||96||
59789039|NCT00624819|75909250|FG003|COMPLETED|Follow-up Period: Year 2||0||
59789040|NCT00624819|75909247|FG000|NOT COMPLETED|Follow-up Period: Year 2||0||
59789041|NCT00624819|75909248|FG001|NOT COMPLETED|Follow-up Period: Year 2||0||
59789042|NCT00624819|75909249|FG002|NOT COMPLETED|Follow-up Period: Year 2||0||
59789043|NCT00624819|75909250|FG003|NOT COMPLETED|Follow-up Period: Year 2||0||
59789044|NCT00624819|75909247|FG000|STARTED|Follow-up Period: Year 4||264||
59789045|NCT00624819|75909248|FG001|STARTED|Follow-up Period: Year 4||20||
60073358|NCT01560429|76188585|FG000|COMPLETED|Overall Study||23||
59789046|NCT00624819|75909249|FG002|STARTED|Follow-up Period: Year 4||65||
59789047|NCT00624819|75909250|FG003|STARTED|Follow-up Period: Year 4||100||
59953274|NCT04057820|76071787|FG007|STARTED|Period 7||15||3
59953275|NCT04057820|76071788|FG008|STARTED|Period 7||0||0
59789048|NCT00624819|75909247|FG000|COMPLETED|Follow-up Period: Year 4||263||
59953276|NCT04057820|76071789|FG009|STARTED|Period 7||34||4
59789049|NCT00624819|75909248|FG001|COMPLETED|Follow-up Period: Year 4||19||
59789050|NCT00624819|75909249|FG002|COMPLETED|Follow-up Period: Year 4||64||
59789051|NCT00624819|75909250|FG003|COMPLETED|Follow-up Period: Year 4||100||
59789052|NCT00624819|75909247|FG000|NOT COMPLETED|Follow-up Period: Year 4||1||
60073359|NCT01560429|76188586|FG001|COMPLETED|Overall Study||20||
59953277|NCT04057820|76071790|FG010|STARTED|Period 7|Block 6 with 4 sites transitioned from Usual Care to ESC during Period 7; therefore no infants were being enrolled and the total number of sites enrolling infants was 22.|0||0
59953278|NCT04057820|76071791|FG011|STARTED|Period 7||0||0
59789053|NCT00624819|75909248|FG001|NOT COMPLETED|Follow-up Period: Year 4||1||
59789054|NCT00624819|75909249|FG002|NOT COMPLETED|Follow-up Period: Year 4||1||
59789055|NCT00624819|75909250|FG003|NOT COMPLETED|Follow-up Period: Year 4||0||
59789056|NCT03832387|75909262|FG000|STARTED|Overall Study||38||
59789057|NCT03832387|75909263|FG001|STARTED|Overall Study||39||
59789058|NCT03832387|75909262|FG000|COMPLETED|Overall Study||33||
59789059|NCT03832387|75909263|FG001|COMPLETED|Overall Study||32||
59789060|NCT03832387|75909262|FG000|NOT COMPLETED|Overall Study||5||
59789061|NCT03832387|75909263|FG001|NOT COMPLETED|Overall Study||7||
59789062|NCT00366301|75909273|FG000|STARTED|Overall Study||124||
59789063|NCT00366301|75909274|FG001|STARTED|Overall Study||126||
59789064|NCT00366301|75909275|FG002|STARTED|Overall Study||126||
59789065|NCT00366301|75909276|FG003|STARTED|Overall Study||124||
59789066|NCT00366301|75909273|FG000|Either 6W or 14W CRP Obtained|Overall Study||120||
59789067|NCT00366301|75909274|FG001|Either 6W or 14W CRP Obtained|Overall Study||124||
59789068|NCT00366301|75909275|FG002|Either 6W or 14W CRP Obtained|Overall Study||124||
59789069|NCT00366301|75909276|FG003|Either 6W or 14W CRP Obtained|Overall Study||119||
59789070|NCT00366301|75909273|FG000|COMPLETED|Overall Study||116||
59789071|NCT00366301|75909274|FG001|COMPLETED|Overall Study||120||
59789072|NCT00366301|75909275|FG002|COMPLETED|Overall Study||122||
59789073|NCT00366301|75909276|FG003|COMPLETED|Overall Study||116||
59789074|NCT00366301|75909273|FG000|NOT COMPLETED|Overall Study||8||
59789075|NCT00366301|75909274|FG001|NOT COMPLETED|Overall Study||6||
59789076|NCT00366301|75909275|FG002|NOT COMPLETED|Overall Study||4||
59789077|NCT00366301|75909276|FG003|NOT COMPLETED|Overall Study||8||
59789078|NCT00365989|75909286|FG000|STARTED|Overall Study||50||
59789079|NCT00365989|75909286|FG000|COMPLETED|Overall Study||48||
59789080|NCT00365989|75909286|FG000|NOT COMPLETED|Overall Study||2||
59789081|NCT00622713|75909291|FG000|STARTED|Overall Study||228||
59789082|NCT00622713|75909291|FG000|Exposed to Study Drug|Overall Study||226||
59789083|NCT00622713|75909291|FG000|Intent to Treat (ITT) Population|Overall Study||218||
59789084|NCT00622713|75909291|FG000|COMPLETED|Overall Study||169||
59789085|NCT00622713|75909291|FG000|NOT COMPLETED|Overall Study||59||
59789086|NCT00392197|75909297|FG000|STARTED|Overall Study||48||
59789087|NCT00392197|75909298|FG001|STARTED|Overall Study||63||
59789088|NCT00392197|75909297|FG000|COMPLETED|Overall Study||27||
59789089|NCT00392197|75909298|FG001|COMPLETED|Overall Study||33||
59789090|NCT00392197|75909297|FG000|NOT COMPLETED|Overall Study||21||
59789091|NCT00392197|75909298|FG001|NOT COMPLETED|Overall Study||30||
59789092|NCT00391807|75909304|FG000|STARTED|Overall Study||1683||
59789093|NCT00391807|75909304|FG000|COMPLETED|Overall Study||968||
59789094|NCT00391807|75909304|FG000|NOT COMPLETED|Overall Study||715||
59789095|NCT00624585|75909308|FG000|STARTED|Overall Study||18||
59789096|NCT00624585|75909308|FG000|COMPLETED|Overall Study||6||
59789097|NCT00624585|75909308|FG000|NOT COMPLETED|Overall Study||12||
59789098|NCT00622635|75909312|FG000|STARTED|Treatment Period 1||13||
59789099|NCT00622635|75909313|FG001|STARTED|Treatment Period 1||11||
59789100|NCT00622635|75909314|FG002|STARTED|Treatment Period 1||11||
59789101|NCT00622635|75909315|FG003|STARTED|Treatment Period 1||13||
59789102|NCT00622635|75909316|FG004|STARTED|Treatment Period 1||10||
59789103|NCT00622635|75909317|FG005|STARTED|Treatment Period 1||10||
59789104|NCT00622635|75909312|FG000|COMPLETED|Treatment Period 1||13||
59789105|NCT00622635|75909313|FG001|COMPLETED|Treatment Period 1||10||
59789106|NCT00622635|75909314|FG002|COMPLETED|Treatment Period 1||10||
59789107|NCT00622635|75909315|FG003|COMPLETED|Treatment Period 1||13||
59789108|NCT00622635|75909316|FG004|COMPLETED|Treatment Period 1||9||
59789109|NCT00622635|75909317|FG005|COMPLETED|Treatment Period 1||10||
59789110|NCT00622635|75909312|FG000|NOT COMPLETED|Treatment Period 1||0||
59789111|NCT00622635|75909313|FG001|NOT COMPLETED|Treatment Period 1||1||
59789112|NCT00622635|75909314|FG002|NOT COMPLETED|Treatment Period 1||1||
59789113|NCT00622635|75909315|FG003|NOT COMPLETED|Treatment Period 1||0||
59789114|NCT00622635|75909316|FG004|NOT COMPLETED|Treatment Period 1||1||
59789115|NCT00622635|75909317|FG005|NOT COMPLETED|Treatment Period 1||0||
59789116|NCT00622635|75909312|FG000|STARTED|Treatment Period 2||13||
59789117|NCT00622635|75909313|FG001|STARTED|Treatment Period 2||10||
59789118|NCT00622635|75909314|FG002|STARTED|Treatment Period 2||10||
59789119|NCT00622635|75909315|FG003|STARTED|Treatment Period 2||13||
59789120|NCT00622635|75909316|FG004|STARTED|Treatment Period 2||9||
59789121|NCT00622635|75909317|FG005|STARTED|Treatment Period 2||10||
59789122|NCT00622635|75909312|FG000|COMPLETED|Treatment Period 2||12||
59789123|NCT00622635|75909313|FG001|COMPLETED|Treatment Period 2||10||
59789124|NCT00622635|75909314|FG002|COMPLETED|Treatment Period 2||10||
59789125|NCT00622635|75909315|FG003|COMPLETED|Treatment Period 2||13||
59789126|NCT00622635|75909316|FG004|COMPLETED|Treatment Period 2||9||
59789127|NCT00622635|75909317|FG005|COMPLETED|Treatment Period 2||10||
59789128|NCT00622635|75909312|FG000|NOT COMPLETED|Treatment Period 2||1||
59789129|NCT00622635|75909313|FG001|NOT COMPLETED|Treatment Period 2||0||
59789130|NCT00622635|75909314|FG002|NOT COMPLETED|Treatment Period 2||0||
59789131|NCT00622635|75909315|FG003|NOT COMPLETED|Treatment Period 2||0||
59789132|NCT00622635|75909316|FG004|NOT COMPLETED|Treatment Period 2||0||
59789133|NCT00622635|75909317|FG005|NOT COMPLETED|Treatment Period 2||0||
59789134|NCT00622635|75909312|FG000|STARTED|Treatment Period 3||12||
59789135|NCT00622635|75909313|FG001|STARTED|Treatment Period 3||10||
59789136|NCT00622635|75909314|FG002|STARTED|Treatment Period 3||10||
59522815|NCT02381626|75617367|FG001|STARTED|Overall Study||16||
59522816|NCT02381626|75617368|FG002|STARTED|Overall Study||6||
59522817|NCT02381626|75617366|FG000|COMPLETED|Overall Study||17||
59522818|NCT02381626|75617367|FG001|COMPLETED|Overall Study||16||
59522819|NCT02381626|75617368|FG002|COMPLETED|Overall Study||6||
59522820|NCT02381626|75617366|FG000|NOT COMPLETED|Overall Study||0||
59522821|NCT02381626|75617367|FG001|NOT COMPLETED|Overall Study||0||
59522822|NCT02381626|75617368|FG002|NOT COMPLETED|Overall Study||0||
59522823|NCT01147042|75617378|FG000|STARTED|Overall Study||2||
59522824|NCT01147042|75617379|FG001|STARTED|Overall Study||0||
59522825|NCT01147042|75617378|FG000|COMPLETED|Overall Study||2||
59522826|NCT01147042|75617379|FG001|COMPLETED|Overall Study||0||
59522827|NCT01147042|75617378|FG000|NOT COMPLETED|Overall Study||0||
59522828|NCT01147042|75617379|FG001|NOT COMPLETED|Overall Study||0||
59522829|NCT01136668|75617386|FG000|STARTED|Overall Study||7||
59522830|NCT01136668|75617387|FG001|STARTED|Overall Study||6||
59522831|NCT01136668|75617386|FG000|COMPLETED|Overall Study||7||
59522832|NCT01136668|75617387|FG001|COMPLETED|Overall Study||6||
59522833|NCT01136668|75617386|FG000|NOT COMPLETED|Overall Study||0||
59522834|NCT01136668|75617387|FG001|NOT COMPLETED|Overall Study||0||
59522835|NCT01108666|75617393|FG000|STARTED|Overall Study|Despite all possible efforts to contact the PI/study, data per dose-level are not available to be reported|7||
59522836|NCT01108666|75617393|FG000|COMPLETED|Overall Study|Despite all possible efforts to contact the PI/study, data per dose-level are not available to be reported|7||
59522837|NCT01108666|75617393|FG000|NOT COMPLETED|Overall Study||0||
59522838|NCT02317276|75617397|FG000|STARTED|Overall Study||11||
59522839|NCT02317276|75617397|FG000|COMPLETED|Overall Study||5||
59522840|NCT02317276|75617397|FG000|NOT COMPLETED|Overall Study||6||
59522841|NCT01662492|75617404|FG000|STARTED|Overall Study||45||
59522842|NCT01662492|75617405|FG001|STARTED|Overall Study||43||
59522843|NCT01662492|75617406|FG002|STARTED|Overall Study||37||
59522844|NCT01662492|75617404|FG000|COMPLETED|Overall Study||42||
59522845|NCT01662492|75617405|FG001|COMPLETED|Overall Study||42||
59522846|NCT01662492|75617406|FG002|COMPLETED|Overall Study||31||
59522847|NCT01662492|75617404|FG000|NOT COMPLETED|Overall Study||3||
59522848|NCT01662492|75617405|FG001|NOT COMPLETED|Overall Study||1||
59522849|NCT01662492|75617406|FG002|NOT COMPLETED|Overall Study||6||
59522850|NCT02297230|75617418|FG000|STARTED|Overall Study||11||
59522851|NCT02297230|75617419|FG001|STARTED|Overall Study||11||
59522852|NCT02297230|75617420|FG002|STARTED|Overall Study||11||
59522853|NCT02297230|75617421|FG003|STARTED|Overall Study||11||
59522854|NCT02297230|75617418|FG000|COMPLETED|Overall Study||11||
59522855|NCT02297230|75617419|FG001|COMPLETED|Overall Study||11||
59522856|NCT02297230|75617420|FG002|COMPLETED|Overall Study||11||
59522857|NCT02297230|75617421|FG003|COMPLETED|Overall Study||11||
59522858|NCT02297230|75617418|FG000|NOT COMPLETED|Overall Study||0||
59522859|NCT02297230|75617419|FG001|NOT COMPLETED|Overall Study||0||
59522860|NCT02297230|75617420|FG002|NOT COMPLETED|Overall Study||0||
59522861|NCT02297230|75617421|FG003|NOT COMPLETED|Overall Study||0||
59522862|NCT02282332|75617437|FG000|STARTED|Overall Study|The PI has left the institution and no results data is available. Efforts were made to contact the PI/study team members, as well as to review data on shared drives, IRB historical records and published resources, but were unsuccessful. No study data are available|0||
59522863|NCT02282332|75617437|FG000|COMPLETED|Overall Study|The PI has left the institution and no results data is available. Efforts were made to contact the PI/study team members, as well as to review data on shared drives, IRB historical records and published resources, but were unsuccessful. No study data are available|0||
59522864|NCT02282332|75617437|FG000|NOT COMPLETED|Overall Study||0||
59522865|NCT04016844|75617441|FG000|STARTED|Overall Study||4||
59522866|NCT04016844|75617441|FG000|COMPLETED|Overall Study||4||
59522867|NCT04016844|75617441|FG000|NOT COMPLETED|Overall Study||0||
59522868|NCT02287636|75617448|FG000|STARTED|Overall Study||13||
59522869|NCT02287636|75617448|FG000|COMPLETED|Overall Study||13||
59522870|NCT02287636|75617448|FG000|NOT COMPLETED|Overall Study||0||
59522871|NCT01083472|75617454|FG000|STARTED|Overall Study||18||
59522872|NCT01083472|75617455|FG001|STARTED|Overall Study||19||
59522873|NCT01083472|75617454|FG000|COMPLETED|Overall Study||18||
59522874|NCT01083472|75617455|FG001|COMPLETED|Overall Study||19||
59522875|NCT01083472|75617454|FG000|NOT COMPLETED|Overall Study||0||
59522876|NCT01083472|75617455|FG001|NOT COMPLETED|Overall Study||0||
59522877|NCT02253394|75617461|FG000|STARTED|Overall Study||0|First ambrisentan 5 or 10 mg QD + Spiro 50 mg QD (90 d), then washout (21 d), then +placebo (90 d)|
59522878|NCT02253394|75617462|FG001|STARTED|Overall Study|Ambrisentan 5 or 10 mg QD + placebo (90 d) first, then washout (21 d), then +Spiro 50 mg QD (90 d).|2|First ambrisentan 5 or 10 mg QD + Spiro 50 mg QD (90 d), then washout (21 d), then +placebo (90 d)|
59789137|NCT00622635|75909315|FG003|STARTED|Treatment Period 3||13||
59789138|NCT00622635|75909316|FG004|STARTED|Treatment Period 3||9||
59789139|NCT00622635|75909317|FG005|STARTED|Treatment Period 3||10||
59789140|NCT00622635|75909312|FG000|COMPLETED|Treatment Period 3||12||
59789141|NCT00622635|75909313|FG001|COMPLETED|Treatment Period 3||10||
59789142|NCT00622635|75909314|FG002|COMPLETED|Treatment Period 3||10||
59789143|NCT00622635|75909315|FG003|COMPLETED|Treatment Period 3||10||
59789144|NCT00622635|75909316|FG004|COMPLETED|Treatment Period 3||9||
59789145|NCT00622635|75909317|FG005|COMPLETED|Treatment Period 3||10||
59789146|NCT00622635|75909312|FG000|NOT COMPLETED|Treatment Period 3||0||
59789147|NCT00622635|75909313|FG001|NOT COMPLETED|Treatment Period 3||0||
59789148|NCT00622635|75909314|FG002|NOT COMPLETED|Treatment Period 3||0||
59789149|NCT00622635|75909315|FG003|NOT COMPLETED|Treatment Period 3||3||
59789150|NCT00622635|75909316|FG004|NOT COMPLETED|Treatment Period 3||0||
59789151|NCT00622635|75909317|FG005|NOT COMPLETED|Treatment Period 3||0||
59953279|NCT04057820|76071792|FG012|STARTED|Period 7||12||3
59953280|NCT04057820|76071793|FG013|STARTED|Period 7||0||0
59953281|NCT04057820|76071794|FG014|STARTED|Period 7||19||3
59953282|NCT04057820|76071795|FG015|STARTED|Period 7||0||0
59953283|NCT04057820|76071780|FG000|COMPLETED|Period 7||0||0
59953284|NCT04057820|76071781|FG001|COMPLETED|Period 7||24||4
59953285|NCT04057820|76071782|FG002|COMPLETED|Period 7||0||0
59953286|NCT04057820|76071783|FG003|COMPLETED|Period 7||9||2
59953287|NCT04057820|76071784|FG004|COMPLETED|Period 7||0||0
59953288|NCT04057820|76071785|FG005|COMPLETED|Period 7||14||3
59953289|NCT04057820|76071786|FG006|COMPLETED|Period 7||0||0
59953290|NCT04057820|76071787|FG007|COMPLETED|Period 7||15||3
59953291|NCT04057820|76071788|FG008|COMPLETED|Period 7||0||0
59953292|NCT04057820|76071789|FG009|COMPLETED|Period 7||34||4
59953293|NCT04057820|76071790|FG010|COMPLETED|Period 7||0||0
59953294|NCT04057820|76071791|FG011|COMPLETED|Period 7||0||0
59953295|NCT04057820|76071792|FG012|COMPLETED|Period 7||12||3
60073360|NCT01560429|76188585|FG000|NOT COMPLETED|Overall Study||3||
59789152|NCT00391027|75909327|FG000|STARTED|Overall Study|Full Analysis Set = 134; 1 subject excluded; missing a baseline or postbaseline HbA1c measurement.|135||
59789153|NCT00391027|75909328|FG001|STARTED|Overall Study|Full Analysis Set = 121; 1 subject excluded; missing a baseline or postbaseline HbA1c measurement.|122||
59789154|NCT00391027|75909327|FG000|COMPLETED|Overall Study||110||
59789155|NCT00391027|75909328|FG001|COMPLETED|Overall Study||110||
59789156|NCT00391027|75909327|FG000|NOT COMPLETED|Overall Study||25||
59789157|NCT00391027|75909328|FG001|NOT COMPLETED|Overall Study||12||
59789158|NCT00622401|75909337|FG000|STARTED|Overall Study||6||
59789159|NCT00622401|75909338|FG001|STARTED|Overall Study||2||
59789160|NCT00622401|75909339|FG002|STARTED|Overall Study|Never Opened|0||
59789161|NCT00622401|75909337|FG000|COMPLETED|Overall Study||3||
59789162|NCT00622401|75909338|FG001|COMPLETED|Overall Study||0||
59789163|NCT00622401|75909339|FG002|COMPLETED|Overall Study||0||
59789164|NCT00622401|75909337|FG000|NOT COMPLETED|Overall Study||3||
59789165|NCT00622401|75909338|FG001|NOT COMPLETED|Overall Study||2||
59789166|NCT00622401|75909339|FG002|NOT COMPLETED|Overall Study||0||
59789167|NCT00621621|75909349|FG000|STARTED|Overall Study|Date of Post- Approval Study protocol approval|105||
59789168|NCT00621621|75909350|FG001|STARTED|Overall Study||705||
59789169|NCT00621621|75909349|FG000|COMPLETED|Overall Study|Treated with the experimental catheter|75||
59789170|NCT00621621|75909350|FG001|COMPLETED|Overall Study||705||
59789171|NCT00621621|75909349|FG000|NOT COMPLETED|Overall Study||30||
59789172|NCT00621621|75909350|FG001|NOT COMPLETED|Overall Study||0||
59789173|NCT00621543|75909358|FG000|STARTED|Overall Study||120||
59789174|NCT00621543|75909358|FG000|COMPLETED|Overall Study||97||
59789175|NCT00621543|75909358|FG000|NOT COMPLETED|Overall Study||23||
59789176|NCT00623805|75909364|FG000|STARTED|Overall Study||62||
59789177|NCT00623805|75909365|FG001|STARTED|Overall Study||61||
59953296|NCT04057820|76071793|FG013|COMPLETED|Period 7||0||0
59953297|NCT04057820|76071794|FG014|COMPLETED|Period 7||19||3
59953298|NCT04057820|76071795|FG015|COMPLETED|Period 7||0||0
59953299|NCT04057820|76071780|FG000|NOT COMPLETED|Period 7||0||0
59953300|NCT04057820|76071781|FG001|NOT COMPLETED|Period 7||0||0
60073361|NCT01560429|76188586|FG001|NOT COMPLETED|Overall Study||6||
60073362|NCT01582971|76188596|FG000|STARTED|Overall Study||128||
59789178|NCT00623805|75909364|FG000|COMPLETED|Overall Study||42||
59789179|NCT00623805|75909365|FG001|COMPLETED|Overall Study||39||
59953301|NCT04057820|76071782|FG002|NOT COMPLETED|Period 7||0||0
60073363|NCT01582971|76188597|FG001|STARTED|Overall Study||128||
59789180|NCT00623805|75909364|FG000|NOT COMPLETED|Overall Study||20||
59789181|NCT00623805|75909365|FG001|NOT COMPLETED|Overall Study||22||
59789182|NCT00621309|75909371|FG000|STARTED|Overall Study||6||
59789183|NCT00621309|75909372|FG001|STARTED|Overall Study||4||
59789184|NCT00621309|75909373|FG002|STARTED|Overall Study||5||
59789185|NCT00621309|75909374|FG003|STARTED|Overall Study||6||
59789186|NCT00621309|75909375|FG004|STARTED|Overall Study||4||
59789187|NCT00621309|75909376|FG005|STARTED|Overall Study||4||
59789188|NCT00621309|75909371|FG000|COMPLETED|Overall Study||4||
60073364|NCT01582971|76188596|FG000|COMPLETED|Overall Study||89||
59789189|NCT00621309|75909372|FG001|COMPLETED|Overall Study||4||
59953302|NCT04057820|76071783|FG003|NOT COMPLETED|Period 7||0||0
59953303|NCT04057820|76071784|FG004|NOT COMPLETED|Period 7||0||0
60073365|NCT01582971|76188597|FG001|COMPLETED|Overall Study||91||
59789190|NCT00621309|75909373|FG002|COMPLETED|Overall Study||4||
59789191|NCT00621309|75909374|FG003|COMPLETED|Overall Study||5||
59953304|NCT04057820|76071785|FG005|NOT COMPLETED|Period 7||0||0
59953305|NCT04057820|76071786|FG006|NOT COMPLETED|Period 7||0||0
59953306|NCT04057820|76071787|FG007|NOT COMPLETED|Period 7||0||0
59953307|NCT04057820|76071788|FG008|NOT COMPLETED|Period 7||0||0
59789192|NCT00621309|75909375|FG004|COMPLETED|Overall Study||3||
59789193|NCT00621309|75909376|FG005|COMPLETED|Overall Study||3||
59789194|NCT00621309|75909371|FG000|NOT COMPLETED|Overall Study||2||
59789195|NCT00621309|75909372|FG001|NOT COMPLETED|Overall Study||0||
59789196|NCT00621309|75909373|FG002|NOT COMPLETED|Overall Study||1||
59789197|NCT00621309|75909374|FG003|NOT COMPLETED|Overall Study||1||
59789198|NCT00621309|75909375|FG004|NOT COMPLETED|Overall Study||1||
59789199|NCT00621309|75909376|FG005|NOT COMPLETED|Overall Study||1||
59789200|NCT00567190|75909384|FG000|STARTED|Overall Study||402|Intent-to-Treat (ITT) Population|
59789201|NCT00567190|75909385|FG001|STARTED|Overall Study||406|Intent-to-Treat (ITT) Population|
59789202|NCT00567190|75909384|FG000|Did Not Receive Any Study Treatment|Overall Study||2||
59789203|NCT00567190|75909385|FG001|Did Not Receive Any Study Treatment|Overall Study||2||
59789204|NCT00567190|75909384|FG000|Received at Least One Dose of Pertuzumab|Overall Study||399|Safety Population (Pertuzumab)|
59789205|NCT00567190|75909385|FG001|Received at Least One Dose of Pertuzumab|Overall Study|9 participants randomized to the Placebo arm actually received at least one dose of pertuzumab.|9|Safety Population (Pertuzumab)|
59789206|NCT00567190|75909384|FG000|Received at Least One Dose of Placebo|Overall Study|1 participant randomized to the Pertuzumab arm actually received placebo at every treatment cycle.|1|Safety Population (Placebo)|
59789207|NCT00567190|75909385|FG001|Received at Least One Dose of Placebo|Overall Study||395|Safety Population (Placebo)|
59789208|NCT00567190|75909384|FG000|Crossover From Placebo to Pertuzumab|Overall Study||0||
59789209|NCT00567190|75909385|FG001|Crossover From Placebo to Pertuzumab|Overall Study|From July 2012, 50 participants randomized to Placebo arm crossed over to open-label pertuzumab.|50||
59789210|NCT00567190|75909384|FG000|COMPLETED|Overall Study||119|Alive and in Survival Follow-up at End of Study|
59789211|NCT00567190|75909385|FG001|COMPLETED|Overall Study||73|Alive and in Survival Follow-up at End of Study|
59789212|NCT00567190|75909384|FG000|NOT COMPLETED|Overall Study||283||
59789213|NCT00567190|75909385|FG001|NOT COMPLETED|Overall Study||333||
59789214|NCT00691938|75909403|FG000|STARTED|Overall Study||5||
59789215|NCT00691938|75909404|FG001|STARTED|Overall Study||3||
59789216|NCT00691938|75909405|FG002|STARTED|Overall Study||6||
59789217|NCT00691938|75909406|FG003|STARTED|Overall Study||8||
59789218|NCT00691938|75909407|FG004|STARTED|Overall Study||10||
59789219|NCT00691938|75909408|FG005|STARTED|Overall Study||6||
59789220|NCT00691938|75909409|FG006|STARTED|Overall Study||14||
59789221|NCT00691938|75909403|FG000|COMPLETED|Overall Study||4||
59789222|NCT00691938|75909404|FG001|COMPLETED|Overall Study||3||
59789223|NCT00691938|75909405|FG002|COMPLETED|Overall Study||6||
59789224|NCT00691938|75909406|FG003|COMPLETED|Overall Study||8||
59789225|NCT00691938|75909407|FG004|COMPLETED|Overall Study||10||
59789226|NCT00691938|75909408|FG005|COMPLETED|Overall Study||6||
59789227|NCT00691938|75909409|FG006|COMPLETED|Overall Study||14||
59789228|NCT00691938|75909403|FG000|NOT COMPLETED|Overall Study||1||
59789229|NCT00691938|75909404|FG001|NOT COMPLETED|Overall Study||0||
59789230|NCT00691938|75909405|FG002|NOT COMPLETED|Overall Study||0||
59789231|NCT00691938|75909406|FG003|NOT COMPLETED|Overall Study||0||
59789232|NCT00691938|75909407|FG004|NOT COMPLETED|Overall Study||0||
59789233|NCT00691938|75909408|FG005|NOT COMPLETED|Overall Study||0||
59789234|NCT00691938|75909409|FG006|NOT COMPLETED|Overall Study||0||
59789235|NCT00365365|75909423|FG000|STARTED|Overall Study||78||
59789236|NCT00365365|75909424|FG001|STARTED|Overall Study||77||
59789237|NCT00365365|75909425|FG002|STARTED|Overall Study||59||
59789238|NCT00365365|75909423|FG000|TREATED (SAFETY POPULATION)|Overall Study||78||
59789239|NCT00365365|75909424|FG001|TREATED (SAFETY POPULATION)|Overall Study||75||
59789240|NCT00365365|75909425|FG002|TREATED (SAFETY POPULATION)|Overall Study||59||
59789241|NCT00365365|75909423|FG000|COMPLETED TREATMENT|Overall Study||38||
59789242|NCT00365365|75909424|FG001|COMPLETED TREATMENT|Overall Study||36||
59789243|NCT00365365|75909425|FG002|COMPLETED TREATMENT|Overall Study||45||
59789244|NCT00365365|75909423|FG000|COMPLETED|Overall Study||44||
59953308|NCT04057820|76071789|FG009|NOT COMPLETED|Period 7||0||0
59953309|NCT04057820|76071790|FG010|NOT COMPLETED|Period 7||0||0
59953310|NCT04057820|76071791|FG011|NOT COMPLETED|Period 7||0||0
59953311|NCT04057820|76071792|FG012|NOT COMPLETED|Period 7||0||0
59953312|NCT04057820|76071793|FG013|NOT COMPLETED|Period 7||0||0
59789245|NCT00365365|75909424|FG001|COMPLETED|Overall Study||41||
59789246|NCT00365365|75909425|FG002|COMPLETED|Overall Study||44||
59789247|NCT00365365|75909423|FG000|NOT COMPLETED|Overall Study||34||
59789248|NCT00365365|75909424|FG001|NOT COMPLETED|Overall Study||36||
59789249|NCT00365365|75909425|FG002|NOT COMPLETED|Overall Study||15||
59789250|NCT00623727|75909435|FG000|STARTED|Double Blind (DB)|only 67 participants are applicable for baseline characteristic evaluation|70||
59789251|NCT00623727|75909436|FG001|STARTED|Double Blind (DB)|only 72 participants are applicable for baseline characteristic evaluation|73||
59789252|NCT00623727|75909435|FG000|Participants Received Treatment|Double Blind (DB)||67||
59789253|NCT00623727|75909436|FG001|Participants Received Treatment|Double Blind (DB)||72||
59789254|NCT00623727|75909435|FG000|COMPLETED|Double Blind (DB)||34||
59789255|NCT00623727|75909436|FG001|COMPLETED|Double Blind (DB)||41||
59789256|NCT00623727|75909435|FG000|NOT COMPLETED|Double Blind (DB)||36||
59789257|NCT00623727|75909436|FG001|NOT COMPLETED|Double Blind (DB)||32||
59789258|NCT00623727|75909435|FG000|STARTED|Open Label Follow-up||0||
59789259|NCT00623727|75909436|FG001|STARTED|Open Label Follow-up|13 Participants from each group after DB period terminated entered open label follow up.|26||
59789260|NCT00623727|75909435|FG000|COMPLETED|Open Label Follow-up||0||
59789261|NCT00623727|75909436|FG001|COMPLETED|Open Label Follow-up||18||
59789262|NCT00623727|75909435|FG000|NOT COMPLETED|Open Label Follow-up||0||
59789263|NCT00623727|75909436|FG001|NOT COMPLETED|Open Label Follow-up||8||
59789264|NCT00623727|75909435|FG000|STARTED|Open Label Extension Period|10 participants of each group entered open-label extension period after completion of DB study|20||
59789265|NCT00623727|75909436|FG001|STARTED|Open Label Extension Period||0||
59789266|NCT00623727|75909435|FG000|COMPLETED|Open Label Extension Period||20||
59789267|NCT00623727|75909436|FG001|COMPLETED|Open Label Extension Period||0||
59789268|NCT00623727|75909435|FG000|NOT COMPLETED|Open Label Extension Period||0||
59789269|NCT00623727|75909436|FG001|NOT COMPLETED|Open Label Extension Period||0||
59789270|NCT00372775|75909444|FG000|STARTED|Overall Study||66||
59789271|NCT00372775|75909444|FG000|Received Treatment|Overall Study||64||
59789272|NCT00372775|75909444|FG000|COMPLETED|Overall Study||3||
59789273|NCT00372775|75909444|FG000|NOT COMPLETED|Overall Study||63||
59789274|NCT00372697|75909450|FG000|STARTED|Overall Study||16||
59789275|NCT00372697|75909451|FG001|STARTED|Overall Study||12||
59789276|NCT00372697|75909450|FG000|COMPLETED|Overall Study||15||
59789277|NCT00372697|75909451|FG001|COMPLETED|Overall Study||11||
59789278|NCT00372697|75909450|FG000|NOT COMPLETED|Overall Study||1||
59522879|NCT02253394|75617461|FG000|COMPLETED|Overall Study||0||
59522880|NCT02253394|75617462|FG001|COMPLETED|Overall Study||2||
59522881|NCT02253394|75617461|FG000|NOT COMPLETED|Overall Study||0||
59522882|NCT02253394|75617462|FG001|NOT COMPLETED|Overall Study||0||
59789279|NCT00372697|75909451|FG001|NOT COMPLETED|Overall Study||1||
59789280|NCT02226276|75909457|FG000|STARTED|Overall Study||10||
59789281|NCT02226276|75909457|FG000|COMPLETED|Overall Study||10||
59789282|NCT02226276|75909457|FG000|NOT COMPLETED|Overall Study||0||
59789283|NCT00690378|75909463|FG000|STARTED|Overall Study|Randomized|69||
59789284|NCT00690378|75909464|FG001|STARTED|Overall Study|Randomized|68||
59789285|NCT00690378|75909463|FG000|Treated|Overall Study||68||
59789286|NCT00690378|75909464|FG001|Treated|Overall Study||67||
59789287|NCT00690378|75909463|FG000|COMPLETED|Overall Study|Up to Late follow up (LFU) visit|49||
59789288|NCT00690378|75909464|FG001|COMPLETED|Overall Study|Up to LFU visit|54||
59789289|NCT00690378|75909463|FG000|NOT COMPLETED|Overall Study||20||
59789290|NCT00690378|75909464|FG001|NOT COMPLETED|Overall Study||14||
59789291|NCT00574275|75909472|FG000|STARTED|Overall Study||275||
59789292|NCT00574275|75909473|FG001|STARTED|Overall Study||271||
59789293|NCT00574275|75909472|FG000|TREATED|Overall Study||273||
59789294|NCT00574275|75909473|FG001|TREATED|Overall Study||268||
59789295|NCT00574275|75909472|FG000|SAFETY POPULATION|Overall Study|Excludes 2 participants who received 1 dose of Aflibercept|271||
59789296|NCT00574275|75909473|FG001|SAFETY POPULATION|Overall Study|Includes 2 participants from the Placebo and Gemcitabine arm who received 1 dose of Aflibercept|270||
59789297|NCT00574275|75909472|FG000|COMPLETED|Overall Study|All participants stopped when they met treatment discontinuation criteria or by DMC recommendation|0||
59789298|NCT00574275|75909473|FG001|COMPLETED|Overall Study|All participants stopped when they met treatment discontinuation criteria or by DMC recommendation|0||
59789299|NCT00574275|75909472|FG000|NOT COMPLETED|Overall Study||275||
59789300|NCT00574275|75909473|FG001|NOT COMPLETED|Overall Study||271||
59789301|NCT00567112|75909479|FG000|STARTED|Treatment Period 1 (3 Days)||7||
59789302|NCT00567112|75909480|FG001|STARTED|Treatment Period 1 (3 Days)||8||
59789303|NCT00567112|75909481|FG002|STARTED|Treatment Period 1 (3 Days)||0||
59789304|NCT00567112|75909479|FG000|COMPLETED|Treatment Period 1 (3 Days)||7||
59789305|NCT00567112|75909480|FG001|COMPLETED|Treatment Period 1 (3 Days)||8||
59789306|NCT00567112|75909481|FG002|COMPLETED|Treatment Period 1 (3 Days)||0||
59789307|NCT00567112|75909479|FG000|NOT COMPLETED|Treatment Period 1 (3 Days)||0||
59789308|NCT00567112|75909480|FG001|NOT COMPLETED|Treatment Period 1 (3 Days)||0||
59789309|NCT00567112|75909481|FG002|NOT COMPLETED|Treatment Period 1 (3 Days)||0||
59789310|NCT00567112|75909479|FG000|STARTED|Washout Period 1 (3 Days)||7||
59789311|NCT00567112|75909480|FG001|STARTED|Washout Period 1 (3 Days)||8||
59789312|NCT00567112|75909481|FG002|STARTED|Washout Period 1 (3 Days)||0||
59789313|NCT00567112|75909479|FG000|COMPLETED|Washout Period 1 (3 Days)||7||
59789314|NCT00567112|75909480|FG001|COMPLETED|Washout Period 1 (3 Days)||8||
59789315|NCT00567112|75909481|FG002|COMPLETED|Washout Period 1 (3 Days)||0||
59789316|NCT00567112|75909479|FG000|NOT COMPLETED|Washout Period 1 (3 Days)||0||
59789317|NCT00567112|75909480|FG001|NOT COMPLETED|Washout Period 1 (3 Days)||0||
59789318|NCT00567112|75909481|FG002|NOT COMPLETED|Washout Period 1 (3 Days)||0||
59789319|NCT00567112|75909479|FG000|STARTED|Treatment Period 2 (3 Days)||7||
59789320|NCT00567112|75909480|FG001|STARTED|Treatment Period 2 (3 Days)||8||
59789321|NCT00567112|75909481|FG002|STARTED|Treatment Period 2 (3 Days)|3 new participants added to Treatment Group ABCD & received treatment sequence BCD for Periods 2-4|3||
59789322|NCT00567112|75909479|FG000|COMPLETED|Treatment Period 2 (3 Days)||7||
59789323|NCT00567112|75909480|FG001|COMPLETED|Treatment Period 2 (3 Days)||7||
59789324|NCT00567112|75909481|FG002|COMPLETED|Treatment Period 2 (3 Days)||3||
59789325|NCT00567112|75909479|FG000|NOT COMPLETED|Treatment Period 2 (3 Days)||0||
59522883|NCT02236546|75617468|FG000|STARTED|Overall Study||3||
59522884|NCT02236546|75617468|FG000|COMPLETED|Overall Study||3||
59522885|NCT02236546|75617468|FG000|NOT COMPLETED|Overall Study||0||
59522886|NCT02175628|75617474|FG000|STARTED|Overall Study||6||
59522887|NCT02175628|75617475|FG001|STARTED|Overall Study||17||
59522888|NCT02175628|75617474|FG000|COMPLETED|Overall Study||6||
59522889|NCT02175628|75617475|FG001|COMPLETED|Overall Study||17||
59522890|NCT02175628|75617474|FG000|NOT COMPLETED|Overall Study||0||
59522891|NCT02175628|75617475|FG001|NOT COMPLETED|Overall Study||0||
59522892|NCT02184520|75617483|FG000|STARTED|Overall Study||0||
59522893|NCT02184520|75617484|FG001|STARTED|Overall Study||0||
59522894|NCT02184520|75617483|FG000|COMPLETED|Overall Study||0||
59522895|NCT02184520|75617484|FG001|COMPLETED|Overall Study||0||
59522896|NCT02184520|75617483|FG000|NOT COMPLETED|Overall Study||0||
59522897|NCT02184520|75617484|FG001|NOT COMPLETED|Overall Study||0||
59522898|NCT01011634|75617492|FG000|STARTED|Overall Study||9||
59522899|NCT01011634|75617493|FG001|STARTED|Overall Study||9||
59522900|NCT01011634|75617492|FG000|COMPLETED|Overall Study||9||
59522901|NCT01011634|75617493|FG001|COMPLETED|Overall Study||8||
59522902|NCT01011634|75617492|FG000|NOT COMPLETED|Overall Study||0||
59522903|NCT01011634|75617493|FG001|NOT COMPLETED|Overall Study||1||
59522904|NCT02137096|75617499|FG000|STARTED|Overall Study||1||
59522905|NCT02137096|75617499|FG000|COMPLETED|Overall Study||1||
59522906|NCT02137096|75617499|FG000|NOT COMPLETED|Overall Study||0||
59522907|NCT02132884|75617505|FG000|STARTED|Overall Study||0||
59522908|NCT02132884|75617506|FG001|STARTED|Overall Study||0||
59789326|NCT00567112|75909480|FG001|NOT COMPLETED|Treatment Period 2 (3 Days)||1||
59789327|NCT00567112|75909481|FG002|NOT COMPLETED|Treatment Period 2 (3 Days)||0||
59789328|NCT00567112|75909479|FG000|STARTED|Washout Period 2 (3 Days)||7||
59789329|NCT00567112|75909480|FG001|STARTED|Washout Period 2 (3 Days)||7||
59789330|NCT00567112|75909481|FG002|STARTED|Washout Period 2 (3 Days)||3||
59789331|NCT00567112|75909479|FG000|COMPLETED|Washout Period 2 (3 Days)||7||
59789332|NCT00567112|75909480|FG001|COMPLETED|Washout Period 2 (3 Days)||7||
59789333|NCT00567112|75909481|FG002|COMPLETED|Washout Period 2 (3 Days)||3||
59789334|NCT00567112|75909479|FG000|NOT COMPLETED|Washout Period 2 (3 Days)||0||
59789335|NCT00567112|75909480|FG001|NOT COMPLETED|Washout Period 2 (3 Days)||0||
59789336|NCT00567112|75909481|FG002|NOT COMPLETED|Washout Period 2 (3 Days)||0||
59789337|NCT00567112|75909479|FG000|STARTED|Treatment Period 3 (3 Days)||7||
60073366|NCT01582971|76188596|FG000|NOT COMPLETED|Overall Study||39||
60073367|NCT01582971|76188597|FG001|NOT COMPLETED|Overall Study||37||
60073368|NCT01690299|76188612|FG000|STARTED|Placebo-controlled Phase (Weeks 0-16)||84||
60073369|NCT01690299|76188613|FG001|STARTED|Placebo-controlled Phase (Weeks 0-16)||83||
60073370|NCT01690299|76188614|FG002|STARTED|Placebo-controlled Phase (Weeks 0-16)||83||
60073371|NCT01690299|76188615|FG003|STARTED|Placebo-controlled Phase (Weeks 0-16)||0||
60073372|NCT01690299|76188616|FG004|STARTED|Placebo-controlled Phase (Weeks 0-16)||0||
60073373|NCT01690299|76188617|FG005|STARTED|Placebo-controlled Phase (Weeks 0-16)||0||
60073374|NCT01690299|76188612|FG000|Safety Population|Placebo-controlled Phase (Weeks 0-16)|Safety population includes all participants who received at least one dose of study drug.|84||
60073375|NCT01690299|76188613|FG001|Safety Population|Placebo-controlled Phase (Weeks 0-16)|Safety population includes all participants who received at least one dose of study drug.|83||
60073376|NCT01690299|76188614|FG002|Safety Population|Placebo-controlled Phase (Weeks 0-16)|Safety population includes all participants who received at least one dose of study drug.|83||
60073377|NCT01690299|76188615|FG003|Safety Population|Placebo-controlled Phase (Weeks 0-16)||0||
60073378|NCT01690299|76188616|FG004|Safety Population|Placebo-controlled Phase (Weeks 0-16)||0||
59789338|NCT00567112|75909480|FG001|STARTED|Treatment Period 3 (3 Days)||7||
59789339|NCT00567112|75909481|FG002|STARTED|Treatment Period 3 (3 Days)||3||
59789340|NCT00567112|75909479|FG000|COMPLETED|Treatment Period 3 (3 Days)||7||
59789341|NCT00567112|75909480|FG001|COMPLETED|Treatment Period 3 (3 Days)||7||
59789342|NCT00567112|75909481|FG002|COMPLETED|Treatment Period 3 (3 Days)||3||
59789343|NCT00567112|75909479|FG000|NOT COMPLETED|Treatment Period 3 (3 Days)||0||
59789344|NCT00567112|75909480|FG001|NOT COMPLETED|Treatment Period 3 (3 Days)||0||
59789345|NCT00567112|75909481|FG002|NOT COMPLETED|Treatment Period 3 (3 Days)||0||
59789346|NCT00567112|75909479|FG000|STARTED|Washout Period 3 (3 Days)||7||
59789347|NCT00567112|75909480|FG001|STARTED|Washout Period 3 (3 Days)||7||
59789348|NCT00567112|75909481|FG002|STARTED|Washout Period 3 (3 Days)||3||
59789349|NCT00567112|75909479|FG000|COMPLETED|Washout Period 3 (3 Days)||4||
59789350|NCT00567112|75909480|FG001|COMPLETED|Washout Period 3 (3 Days)||7||
59789351|NCT00567112|75909481|FG002|COMPLETED|Washout Period 3 (3 Days)||3||
59522909|NCT02132884|75617505|FG000|COMPLETED|Overall Study||0||
59522910|NCT02132884|75617506|FG001|COMPLETED|Overall Study||0||
59522911|NCT02132884|75617505|FG000|NOT COMPLETED|Overall Study||0||
59522912|NCT02132884|75617506|FG001|NOT COMPLETED|Overall Study||0||
59522913|NCT02130622|75617514|FG000|STARTED|Overall Study||2||
59522914|NCT02130622|75617515|FG001|STARTED|Overall Study||1||
59522915|NCT02130622|75617514|FG000|COMPLETED|Overall Study||2||
59522916|NCT02130622|75617515|FG001|COMPLETED|Overall Study||1||
59522917|NCT02130622|75617514|FG000|NOT COMPLETED|Overall Study||0||
59522918|NCT02130622|75617515|FG001|NOT COMPLETED|Overall Study||0||
59522919|NCT02134912|75617523|FG000|STARTED|Overall Study||0||
59789352|NCT00567112|75909479|FG000|NOT COMPLETED|Washout Period 3 (3 Days)||3||
59789353|NCT00567112|75909480|FG001|NOT COMPLETED|Washout Period 3 (3 Days)||0||
59789354|NCT00567112|75909481|FG002|NOT COMPLETED|Washout Period 3 (3 Days)||0||
59789355|NCT00567112|75909479|FG000|STARTED|Treatment Period 4 (3 Days)||4||
59789356|NCT00567112|75909480|FG001|STARTED|Treatment Period 4 (3 Days)||7||
59789357|NCT00567112|75909481|FG002|STARTED|Treatment Period 4 (3 Days)||3||
59789358|NCT00567112|75909479|FG000|COMPLETED|Treatment Period 4 (3 Days)||4||
59789359|NCT00567112|75909480|FG001|COMPLETED|Treatment Period 4 (3 Days)||7||
59789360|NCT00567112|75909481|FG002|COMPLETED|Treatment Period 4 (3 Days)||3||
59789361|NCT00567112|75909479|FG000|NOT COMPLETED|Treatment Period 4 (3 Days)||0||
59789362|NCT00567112|75909480|FG001|NOT COMPLETED|Treatment Period 4 (3 Days)||0||
59789363|NCT00567112|75909481|FG002|NOT COMPLETED|Treatment Period 4 (3 Days)||0||
59789364|NCT01742832|75909492|FG000|STARTED|Overall Study||20||
59789365|NCT01742832|75909493|FG001|STARTED|Overall Study||28||
59789366|NCT01742832|75909492|FG000|COMPLETED|Overall Study||19||
59789367|NCT01742832|75909493|FG001|COMPLETED|Overall Study||23||
59953313|NCT04057820|76071794|FG014|NOT COMPLETED|Period 7||0||0
59953314|NCT04057820|76071795|FG015|NOT COMPLETED|Period 7||0||0
59789368|NCT01742832|75909492|FG000|NOT COMPLETED|Overall Study||1||
59789369|NCT01742832|75909493|FG001|NOT COMPLETED|Overall Study||5||
59789370|NCT01618656|75909501|FG000|STARTED|Overall Study||46||
59789371|NCT01618656|75909502|FG001|STARTED|Overall Study||24||
59789372|NCT01618656|75909501|FG000|COMPLETED|Overall Study||38||
59789373|NCT01618656|75909502|FG001|COMPLETED|Overall Study||20||
59789374|NCT01618656|75909501|FG000|NOT COMPLETED|Overall Study||8||
59953315|NCT04057820|76071780|FG000|STARTED|Period 8||0||0
59953316|NCT04057820|76071781|FG001|STARTED|Period 8|For this stepped wedge study design, a new cohort of infants is enrolled during each period except the transition period. Therefore, the number of infants to start a period is unlikely to equal the number of infants who completed the previous period.|21||4
59953317|NCT04057820|76071782|FG002|STARTED|Period 8||0||0
59953318|NCT04057820|76071783|FG003|STARTED|Period 8||10||2
59953319|NCT04057820|76071784|FG004|STARTED|Period 8||0||0
60103569|NCT01290640|76221808|FG000|COMPLETED|Overall Study||12||
59789375|NCT01618656|75909502|FG001|NOT COMPLETED|Overall Study||4||
59789376|NCT03978832|75909508|FG000|STARTED|Overall Study|69 participants signed the ICF and entered screening; 25 met eligibility criteria and were enrolled.|69||
59789377|NCT03978832|75909508|FG000|Stabilization Period|Overall Study||25||
59789378|NCT03978832|75909508|FG000|Treatment Period|Overall Study||23||
59789379|NCT03978832|75909508|FG000|COMPLETED|Overall Study||15||
59789380|NCT03978832|75909508|FG000|NOT COMPLETED|Overall Study||54||
59789381|NCT00566722|75909515|FG000|STARTED|Overall Study||41||
59789382|NCT00566722|75909516|FG001|STARTED|Overall Study||29||
59789383|NCT00566722|75909517|FG002|STARTED|Overall Study||82||
59789384|NCT00566722|75909515|FG000|COMPLETED|Overall Study||39||
59789385|NCT00566722|75909516|FG001|COMPLETED|Overall Study||24||
59789386|NCT00566722|75909517|FG002|COMPLETED|Overall Study||73||
59789387|NCT00566722|75909515|FG000|NOT COMPLETED|Overall Study||2||
59789388|NCT00566722|75909516|FG001|NOT COMPLETED|Overall Study||5||
59789389|NCT00566722|75909517|FG002|NOT COMPLETED|Overall Study||9||
59789390|NCT00691704|75909528|FG000|STARTED|Induction Therapy||18||
59789391|NCT00691704|75909528|FG000|COMPLETED|Induction Therapy||16||
59789392|NCT00691704|75909528|FG000|NOT COMPLETED|Induction Therapy||2||
59789393|NCT00691704|75909528|FG000|STARTED|Two Years of Maintenance Therapy||16||
59789394|NCT00691704|75909528|FG000|COMPLETED|Two Years of Maintenance Therapy||3||
59789395|NCT00691704|75909528|FG000|NOT COMPLETED|Two Years of Maintenance Therapy||13||
59789396|NCT00566020|75909532|FG000|STARTED|6-week Dosage Adjustment Phase||92||
59789397|NCT00566020|75909533|FG001|STARTED|6-week Dosage Adjustment Phase||0||
59789398|NCT00566020|75909532|FG000|COMPLETED|6-week Dosage Adjustment Phase||85||
59789399|NCT00566020|75909533|FG001|COMPLETED|6-week Dosage Adjustment Phase||0||
59789400|NCT00566020|75909532|FG000|NOT COMPLETED|6-week Dosage Adjustment Phase||7||
59789401|NCT00566020|75909533|FG001|NOT COMPLETED|6-week Dosage Adjustment Phase||0||
59789402|NCT00566020|75909532|FG000|STARTED|46-week Long-term Administration Phase||0||
59789403|NCT00566020|75909533|FG001|STARTED|46-week Long-term Administration Phase||85||
59789404|NCT00566020|75909532|FG000|COMPLETED|46-week Long-term Administration Phase||0||
59789405|NCT00566020|75909533|FG001|COMPLETED|46-week Long-term Administration Phase||68||
59789406|NCT00566020|75909532|FG000|NOT COMPLETED|46-week Long-term Administration Phase||0||
59789407|NCT00566020|75909533|FG001|NOT COMPLETED|46-week Long-term Administration Phase||17||
59789408|NCT00564070|75909540|FG000|STARTED|Overall Study||42||
59789409|NCT00564070|75909541|FG001|STARTED|Overall Study||45||
59789410|NCT00564070|75909540|FG000|COMPLETED|Overall Study||30||
59789411|NCT00564070|75909541|FG001|COMPLETED|Overall Study||38||
59789412|NCT00564070|75909540|FG000|NOT COMPLETED|Overall Study||12||
59789413|NCT00564070|75909541|FG001|NOT COMPLETED|Overall Study||7||
59789414|NCT00690612|75909547|FG000|STARTED|Overall Study||35||
59789415|NCT00690612|75909547|FG000|COMPLETED|Overall Study||32||
59789416|NCT00690612|75909547|FG000|NOT COMPLETED|Overall Study||3||
59789417|NCT00621153|75909553|FG000|STARTED|Overall Study|randomised|117||
59789418|NCT00621153|75909554|FG001|STARTED|Overall Study|randomised|116||
59789419|NCT00621153|75909553|FG000|Discontinued|Overall Study||20||
59789420|NCT00621153|75909554|FG001|Discontinued|Overall Study||15||
59789421|NCT00621153|75909553|FG000|COMPLETED|Overall Study|completed|97||
59789422|NCT00621153|75909554|FG001|COMPLETED|Overall Study|completed|101||
59789423|NCT00621153|75909553|FG000|NOT COMPLETED|Overall Study||20||
59789424|NCT00621153|75909554|FG001|NOT COMPLETED|Overall Study||15||
59619820|NCT02743728|75730983|FG000|COMPLETED|Overall Study||20||
59619821|NCT02743728|75730983|FG000|NOT COMPLETED|Overall Study||0||
59619822|NCT02085720|75730987|FG000|STARTED|Overall Study||819||
59619823|NCT02085720|75730987|FG000|COMPLETED|Overall Study||819||
59619824|NCT02085720|75730987|FG000|NOT COMPLETED|Overall Study||0||
59789425|NCT00574119|75909560|FG000|STARTED|Overall Study||16||
59789426|NCT00574119|75909560|FG000|COMPLETED|Overall Study||12||
59789427|NCT00574119|75909560|FG000|NOT COMPLETED|Overall Study||4||
59789428|NCT00705614|75909566|FG000|STARTED|Initial Intervention||1541||
59789429|NCT00705614|75909567|FG001|STARTED|Initial Intervention||1121||
59789430|NCT00705614|75909566|FG000|COMPLETED|Initial Intervention||1023||
59789431|NCT00705614|75909567|FG001|COMPLETED|Initial Intervention||800||
59789432|NCT00705614|75909566|FG000|NOT COMPLETED|Initial Intervention||518||
59789433|NCT00705614|75909567|FG001|NOT COMPLETED|Initial Intervention||321||
59789434|NCT00705614|75909566|FG000|STARTED|Switch to Remicade||0||
59789435|NCT00705614|75909567|FG001|STARTED|Switch to Remicade||298||
59789436|NCT00705614|75909566|FG000|COMPLETED|Switch to Remicade||0||
59789437|NCT00705614|75909567|FG001|COMPLETED|Switch to Remicade||249||
59789438|NCT00705614|75909566|FG000|NOT COMPLETED|Switch to Remicade||0||
59789439|NCT00705614|75909567|FG001|NOT COMPLETED|Switch to Remicade||49||
59789440|NCT00620763|75909575|FG000|STARTED|Period: First Intervention||10||
59789441|NCT00620763|75909576|FG001|STARTED|Period: First Intervention||12||
59789442|NCT00620763|75909575|FG000|COMPLETED|Period: First Intervention||10||
59789443|NCT00620763|75909576|FG001|COMPLETED|Period: First Intervention||7||
59789444|NCT00620763|75909575|FG000|NOT COMPLETED|Period: First Intervention||0||
59789445|NCT00620763|75909576|FG001|NOT COMPLETED|Period: First Intervention||5||
59789446|NCT00620763|75909575|FG000|STARTED|Period: Washout Period of 1 Week||10||
59619825|NCT02716974|75730995|FG000|STARTED|Overall Study||26||
59619826|NCT02716974|75730995|FG000|COMPLETED|Overall Study||26||
59619827|NCT02716974|75730995|FG000|NOT COMPLETED|Overall Study||0||
59619828|NCT02680314|75731001|FG000|STARTED|Overall Study||120||
59619829|NCT02680314|75731002|FG001|STARTED|Overall Study||123||
59619830|NCT02680314|75731001|FG000|COMPLETED|Overall Study||120||
59619831|NCT02680314|75731002|FG001|COMPLETED|Overall Study||123||
59619832|NCT02680314|75731001|FG000|NOT COMPLETED|Overall Study||0||
59619833|NCT02680314|75731002|FG001|NOT COMPLETED|Overall Study||0||
59619834|NCT02707692|75731014|FG000|STARTED|Cycle 1 (30 Days)||9||
59619835|NCT02707692|75731015|FG001|STARTED|Cycle 1 (30 Days)||9||
59619836|NCT02707692|75731016|FG002|STARTED|Cycle 1 (30 Days)||9||
59619837|NCT02707692|75731017|FG003|STARTED|Cycle 1 (30 Days)||9||
59619838|NCT02707692|75731018|FG004|STARTED|Cycle 1 (30 Days)||9||
59619839|NCT02707692|75731019|FG005|STARTED|Cycle 1 (30 Days)||9||
59619840|NCT02707692|75731014|FG000|COMPLETED|Cycle 1 (30 Days)||8||
59619841|NCT02707692|75731015|FG001|COMPLETED|Cycle 1 (30 Days)||6||
59619842|NCT02707692|75731016|FG002|COMPLETED|Cycle 1 (30 Days)||8||
59619843|NCT02707692|75731017|FG003|COMPLETED|Cycle 1 (30 Days)||9||
59619844|NCT02707692|75731018|FG004|COMPLETED|Cycle 1 (30 Days)||8||
59619845|NCT02707692|75731019|FG005|COMPLETED|Cycle 1 (30 Days)||8||
59619846|NCT02707692|75731014|FG000|NOT COMPLETED|Cycle 1 (30 Days)||1||
59619847|NCT02707692|75731015|FG001|NOT COMPLETED|Cycle 1 (30 Days)||3||
59619848|NCT02707692|75731016|FG002|NOT COMPLETED|Cycle 1 (30 Days)||1||
59619849|NCT02707692|75731017|FG003|NOT COMPLETED|Cycle 1 (30 Days)||0||
59619850|NCT02707692|75731018|FG004|NOT COMPLETED|Cycle 1 (30 Days)||1||
59619851|NCT02707692|75731019|FG005|NOT COMPLETED|Cycle 1 (30 Days)||1||
59619852|NCT02707692|75731014|FG000|STARTED|Washout Between Cycles 1 and 2 (>=6 Wks)||8||
59619853|NCT02707692|75731015|FG001|STARTED|Washout Between Cycles 1 and 2 (>=6 Wks)||6||
59619854|NCT02707692|75731016|FG002|STARTED|Washout Between Cycles 1 and 2 (>=6 Wks)||9||
59619855|NCT02707692|75731017|FG003|STARTED|Washout Between Cycles 1 and 2 (>=6 Wks)||9||
59619856|NCT02707692|75731018|FG004|STARTED|Washout Between Cycles 1 and 2 (>=6 Wks)||8||
59619857|NCT02707692|75731019|FG005|STARTED|Washout Between Cycles 1 and 2 (>=6 Wks)||8||
59619858|NCT02707692|75731014|FG000|COMPLETED|Washout Between Cycles 1 and 2 (>=6 Wks)||7||
59789447|NCT00620763|75909576|FG001|STARTED|Period: Washout Period of 1 Week||7||
59789448|NCT00620763|75909575|FG000|COMPLETED|Period: Washout Period of 1 Week||10||
59789449|NCT00620763|75909576|FG001|COMPLETED|Period: Washout Period of 1 Week||7||
59789450|NCT00620763|75909575|FG000|NOT COMPLETED|Period: Washout Period of 1 Week||0||
59789451|NCT00620763|75909576|FG001|NOT COMPLETED|Period: Washout Period of 1 Week||0||
59789452|NCT00620763|75909575|FG000|STARTED|Period: Second Intervention||10||
59789453|NCT00620763|75909576|FG001|STARTED|Period: Second Intervention||7||
59789454|NCT00620763|75909575|FG000|COMPLETED|Period: Second Intervention||9||
59789455|NCT00620763|75909576|FG001|COMPLETED|Period: Second Intervention||7||
59789456|NCT00620763|75909575|FG000|NOT COMPLETED|Period: Second Intervention||1||
59789457|NCT00620763|75909576|FG001|NOT COMPLETED|Period: Second Intervention||0||
59789458|NCT00562978|75909584|FG000|STARTED|Overall Study||6||
59789459|NCT00562978|75909585|FG001|STARTED|Overall Study||48||
59789460|NCT00562978|75909584|FG000|COMPLETED|Overall Study||5||
59789461|NCT00562978|75909585|FG001|COMPLETED|Overall Study||37||
59789462|NCT00562978|75909584|FG000|NOT COMPLETED|Overall Study||1||
59789463|NCT00562978|75909585|FG001|NOT COMPLETED|Overall Study||11||
59789464|NCT00620373|75909591|FG000|STARTED|Overall Study||969||
59789465|NCT00620373|75909591|FG000|COMPLETED|Overall Study||936||
59789466|NCT00620373|75909591|FG000|NOT COMPLETED|Overall Study||33||
59789467|NCT00372619|75909605|FG000|STARTED|Overall Study||8||
59789468|NCT00372619|75909606|FG001|STARTED|Overall Study||2||
59789469|NCT00372619|75909607|FG002|STARTED|Overall Study||3||
59789470|NCT00372619|75909608|FG003|STARTED|Overall Study||10||
59789471|NCT00372619|75909609|FG004|STARTED|Overall Study||7||
59789472|NCT00372619|75909610|FG005|STARTED|Overall Study||42||
59789473|NCT00372619|75909611|FG006|STARTED|Overall Study||2||
59789474|NCT00372619|75909605|FG000|COMPLETED|Overall Study||8||
59789475|NCT00372619|75909606|FG001|COMPLETED|Overall Study||2||
59789476|NCT00372619|75909607|FG002|COMPLETED|Overall Study||3||
59789477|NCT00372619|75909608|FG003|COMPLETED|Overall Study||10||
59789478|NCT00372619|75909609|FG004|COMPLETED|Overall Study||7||
59789479|NCT00372619|75909610|FG005|COMPLETED|Overall Study||39||
59789480|NCT00372619|75909611|FG006|COMPLETED|Overall Study||2||
59789481|NCT00372619|75909605|FG000|NOT COMPLETED|Overall Study||0||
59789482|NCT00372619|75909606|FG001|NOT COMPLETED|Overall Study||0||
59789483|NCT00372619|75909607|FG002|NOT COMPLETED|Overall Study||0||
59789484|NCT00372619|75909608|FG003|NOT COMPLETED|Overall Study||0||
59789485|NCT00372619|75909609|FG004|NOT COMPLETED|Overall Study||0||
59789486|NCT00372619|75909610|FG005|NOT COMPLETED|Overall Study||3||
59789487|NCT00372619|75909611|FG006|NOT COMPLETED|Overall Study||0||
59789488|NCT00562588|75909629|FG000|STARTED|Overall Study||260||
59789489|NCT00562588|75909630|FG001|STARTED|Overall Study||283||
59789490|NCT00562588|75909629|FG000|COMPLETED|Overall Study||168||
59789491|NCT00562588|75909630|FG001|COMPLETED|Overall Study||184||
59789492|NCT00562588|75909629|FG000|NOT COMPLETED|Overall Study||92||
59789493|NCT00562588|75909630|FG001|NOT COMPLETED|Overall Study||99||
59789494|NCT00622167|75909636|FG000|STARTED|Overall Study||24||
59789495|NCT00622167|75909636|FG000|COMPLETED|Overall Study||4||
59789496|NCT00622167|75909636|FG000|NOT COMPLETED|Overall Study||20||
59789497|NCT00562354|75909642|FG000|STARTED|Overall Study||134||
59789498|NCT00562354|75909643|FG001|STARTED|Overall Study||137||
59789499|NCT00562354|75909642|FG000|Received Study Treatment|Overall Study||134||
59953320|NCT04057820|76071785|FG005|STARTED|Period 8||14||3
59789500|NCT00562354|75909643|FG001|Received Study Treatment|Overall Study||136||
59789501|NCT00562354|75909642|FG000|Evaluable Immunogenicity Population|Overall Study||134||
59789502|NCT00562354|75909643|FG001|Evaluable Immunogenicity Population|Overall Study||134||
59789503|NCT00562354|75909642|FG000|COMPLETED|Overall Study||134||
59789504|NCT00562354|75909643|FG001|COMPLETED|Overall Study||135||
59789505|NCT00562354|75909642|FG000|NOT COMPLETED|Overall Study||0||
59789506|NCT00562354|75909643|FG001|NOT COMPLETED|Overall Study||2||
59789507|NCT00372385|75909655|FG000|STARTED|Overall Study||82||
59789508|NCT00372385|75909656|FG001|STARTED|Overall Study||81||
59789509|NCT00372385|75909657|FG002|STARTED|Overall Study||82||
59789510|NCT00372385|75909658|FG003|STARTED|Overall Study||78||
59789511|NCT00372385|75909655|FG000|COMPLETED|Overall Study||49||
59789512|NCT00372385|75909656|FG001|COMPLETED|Overall Study||61||
59789513|NCT00372385|75909657|FG002|COMPLETED|Overall Study||72||
59789514|NCT00372385|75909658|FG003|COMPLETED|Overall Study||70||
59789515|NCT00372385|75909655|FG000|NOT COMPLETED|Overall Study||33||
59789516|NCT00372385|75909656|FG001|NOT COMPLETED|Overall Study||20||
59789517|NCT00372385|75909657|FG002|NOT COMPLETED|Overall Study||10||
59789518|NCT00372385|75909658|FG003|NOT COMPLETED|Overall Study||8||
59789519|NCT03830281|75909671|FG000|STARTED|Lead-in Period (2 Weeks)||471||
59789520|NCT03830281|75909672|FG001|STARTED|Lead-in Period (2 Weeks)||0||
59789521|NCT03830281|75909671|FG000|COMPLETED|Lead-in Period (2 Weeks)||432||
59789522|NCT03830281|75909672|FG001|COMPLETED|Lead-in Period (2 Weeks)||0||
59953321|NCT04057820|76071786|FG006|STARTED|Period 8||0||0
59953322|NCT04057820|76071787|FG007|STARTED|Period 8||18||3
59953323|NCT04057820|76071788|FG008|STARTED|Period 8||0||0
59953324|NCT04057820|76071789|FG009|STARTED|Period 8||32||4
59953325|NCT04057820|76071790|FG010|STARTED|Period 8||0||0
59953326|NCT04057820|76071791|FG011|STARTED|Period 8||9||4
59953327|NCT04057820|76071792|FG012|STARTED|Period 8|Block 7 with 3 sites transitioned from Usual Care to ESC during Period 8; therefore no infants were being enrolled and the total number of sites enrolling infants was 23.|0||0
59789523|NCT03830281|75909671|FG000|NOT COMPLETED|Lead-in Period (2 Weeks)||39||
59789524|NCT03830281|75909672|FG001|NOT COMPLETED|Lead-in Period (2 Weeks)||0||
59789525|NCT03830281|75909671|FG000|STARTED|Treatment Period (16 Weeks)|Pts who completed lead-in period randomized to Humalog or Ultra-Rapid Lispro in treatment period.|217||
59789526|NCT03830281|75909672|FG001|STARTED|Treatment Period (16 Weeks)|Pts who completed lead-in period randomized to Humalog or Ultra-Rapid Lispro in treatment period.|215||
59789527|NCT03830281|75909671|FG000|COMPLETED|Treatment Period (16 Weeks)||205||
59789528|NCT03830281|75909672|FG001|COMPLETED|Treatment Period (16 Weeks)||198||
59789529|NCT03830281|75909671|FG000|NOT COMPLETED|Treatment Period (16 Weeks)||12||
59789530|NCT03830281|75909672|FG001|NOT COMPLETED|Treatment Period (16 Weeks)||17||
59789531|NCT00563368|75909686|FG000|STARTED|Overall Study||109||
59789532|NCT00563368|75909687|FG001|STARTED|Overall Study||109||
59789533|NCT00563368|75909688|FG002|STARTED|Overall Study||108||
59953328|NCT04057820|76071793|FG013|STARTED|Period 8||0||0
59789534|NCT00563368|75909689|FG003|STARTED|Overall Study||107||
59953329|NCT04057820|76071794|FG014|STARTED|Period 8||22||3
59953330|NCT04057820|76071795|FG015|STARTED|Period 8||0||0
59953331|NCT04057820|76071780|FG000|COMPLETED|Period 8||0||0
59953332|NCT04057820|76071781|FG001|COMPLETED|Period 8||21||4
59953333|NCT04057820|76071782|FG002|COMPLETED|Period 8||0||0
59953334|NCT04057820|76071783|FG003|COMPLETED|Period 8||10||2
59953335|NCT04057820|76071784|FG004|COMPLETED|Period 8||0||0
59953336|NCT04057820|76071785|FG005|COMPLETED|Period 8||14||3
59953337|NCT04057820|76071786|FG006|COMPLETED|Period 8||0||0
59953338|NCT04057820|76071787|FG007|COMPLETED|Period 8||18||3
59789535|NCT00563368|75909690|FG004|STARTED|Overall Study||108||
59789536|NCT00563368|75909691|FG005|STARTED|Overall Study||107||
59789537|NCT00563368|75909692|FG006|STARTED|Overall Study||108||
59789538|NCT00563368|75909686|FG000|COMPLETED|Overall Study||74||
59789539|NCT00563368|75909687|FG001|COMPLETED|Overall Study||79||
59789540|NCT00563368|75909688|FG002|COMPLETED|Overall Study||78||
59789541|NCT00563368|75909689|FG003|COMPLETED|Overall Study||78||
59789542|NCT00563368|75909690|FG004|COMPLETED|Overall Study||80||
59789543|NCT00563368|75909691|FG005|COMPLETED|Overall Study||77||
59789544|NCT00563368|75909692|FG006|COMPLETED|Overall Study||75||
59789545|NCT00563368|75909686|FG000|NOT COMPLETED|Overall Study||35||
59789546|NCT00563368|75909687|FG001|NOT COMPLETED|Overall Study||30||
59789547|NCT00563368|75909688|FG002|NOT COMPLETED|Overall Study||30||
59789548|NCT00563368|75909689|FG003|NOT COMPLETED|Overall Study||29||
59789549|NCT00563368|75909690|FG004|NOT COMPLETED|Overall Study||28||
59789550|NCT00563368|75909691|FG005|NOT COMPLETED|Overall Study||30||
59789551|NCT00563368|75909692|FG006|NOT COMPLETED|Overall Study||33||
59789552|NCT00390013|75909711|FG000|STARTED|Phase 1||0||
59789553|NCT00390013|75909712|FG001|STARTED|Phase 1||0||
59789554|NCT00390013|75909713|FG002|STARTED|Phase 1||2||
59789555|NCT00390013|75909714|FG003|STARTED|Phase 1||2||
59789556|NCT00390013|75909711|FG000|COMPLETED|Phase 1||0||
59789557|NCT00390013|75909712|FG001|COMPLETED|Phase 1||0||
59789558|NCT00390013|75909713|FG002|COMPLETED|Phase 1||2||
59789559|NCT00390013|75909714|FG003|COMPLETED|Phase 1||1||
59789560|NCT00390013|75909711|FG000|NOT COMPLETED|Phase 1||0||
59789561|NCT00390013|75909712|FG001|NOT COMPLETED|Phase 1||0||
59789562|NCT00390013|75909713|FG002|NOT COMPLETED|Phase 1||0||
59789563|NCT00390013|75909714|FG003|NOT COMPLETED|Phase 1||1||
59953339|NCT04057820|76071788|FG008|COMPLETED|Period 8||0||0
59953340|NCT04057820|76071789|FG009|COMPLETED|Period 8||32||4
59953341|NCT04057820|76071790|FG010|COMPLETED|Period 8||0||0
59953342|NCT04057820|76071791|FG011|COMPLETED|Period 8||9||4
59953343|NCT04057820|76071792|FG012|COMPLETED|Period 8||0||0
59953344|NCT04057820|76071793|FG013|COMPLETED|Period 8||0||0
60073379|NCT01690299|76188617|FG005|Safety Population|Placebo-controlled Phase (Weeks 0-16)||0||
60073380|NCT01690299|76188612|FG000|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||75||
60073381|NCT01690299|76188613|FG001|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||77||
60073382|NCT01690299|76188614|FG002|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||81||
59789564|NCT00390013|75909711|FG000|STARTED|Phase 2 First Treatment||3||
59789565|NCT00390013|75909712|FG001|STARTED|Phase 2 First Treatment||2||
59789566|NCT00390013|75909713|FG002|STARTED|Phase 2 First Treatment||0||
59789567|NCT00390013|75909714|FG003|STARTED|Phase 2 First Treatment||0||
59789568|NCT00390013|75909711|FG000|COMPLETED|Phase 2 First Treatment||2||
59789569|NCT00390013|75909712|FG001|COMPLETED|Phase 2 First Treatment||1||
59789570|NCT00390013|75909713|FG002|COMPLETED|Phase 2 First Treatment||0||
59789571|NCT00390013|75909714|FG003|COMPLETED|Phase 2 First Treatment||0||
59789572|NCT00390013|75909711|FG000|NOT COMPLETED|Phase 2 First Treatment||1||
59789573|NCT00390013|75909712|FG001|NOT COMPLETED|Phase 2 First Treatment||1||
59789574|NCT00390013|75909713|FG002|NOT COMPLETED|Phase 2 First Treatment||0||
59789575|NCT00390013|75909714|FG003|NOT COMPLETED|Phase 2 First Treatment||0||
59789576|NCT00390013|75909711|FG000|STARTED|Phase 2 Second Treatment||2||
59789577|NCT00390013|75909712|FG001|STARTED|Phase 2 Second Treatment||1||
59789578|NCT00390013|75909713|FG002|STARTED|Phase 2 Second Treatment||0||
59953345|NCT04057820|76071794|FG014|COMPLETED|Period 8||22||3
59789579|NCT00390013|75909714|FG003|STARTED|Phase 2 Second Treatment||0||
59789580|NCT00390013|75909711|FG000|COMPLETED|Phase 2 Second Treatment||2||
59789581|NCT00390013|75909712|FG001|COMPLETED|Phase 2 Second Treatment||1||
59789582|NCT00390013|75909713|FG002|COMPLETED|Phase 2 Second Treatment||0||
59789583|NCT00390013|75909714|FG003|COMPLETED|Phase 2 Second Treatment||0||
59789584|NCT00390013|75909711|FG000|NOT COMPLETED|Phase 2 Second Treatment||0||
59789585|NCT00390013|75909712|FG001|NOT COMPLETED|Phase 2 Second Treatment||0||
59789586|NCT00390013|75909713|FG002|NOT COMPLETED|Phase 2 Second Treatment||0||
59789587|NCT00390013|75909714|FG003|NOT COMPLETED|Phase 2 Second Treatment||0||
59789588|NCT00561652|75909722|FG000|STARTED|Overall Study||10||
59789589|NCT00561652|75909723|FG001|STARTED|Overall Study||20||
59953346|NCT04057820|76071795|FG015|COMPLETED|Period 8||0||0
59953347|NCT04057820|76071780|FG000|NOT COMPLETED|Period 8||0||0
59789590|NCT00561652|75909722|FG000|COMPLETED|Overall Study||10||
59789591|NCT00561652|75909723|FG001|COMPLETED|Overall Study||19||
59789592|NCT00561652|75909722|FG000|NOT COMPLETED|Overall Study||0||
59789593|NCT00561652|75909723|FG001|NOT COMPLETED|Overall Study||1||
59953348|NCT04057820|76071781|FG001|NOT COMPLETED|Period 8||0||0
59953349|NCT04057820|76071782|FG002|NOT COMPLETED|Period 8||0||0
59789594|NCT00697346|75909732|FG000|STARTED|Overall Study||28||
59789595|NCT00697346|75909733|FG001|STARTED|Overall Study||28||
59789596|NCT00697346|75909734|FG002|STARTED|Overall Study||2||
59789597|NCT00697346|75909732|FG000|COMPLETED|Overall Study|Completed = participants who completed study treatment.|0||
59789598|NCT00697346|75909733|FG001|COMPLETED|Overall Study|2 participants were ongoing as of primary completion date 27 Dec 2011 and have now completed.|2||
59789599|NCT00697346|75909734|FG002|COMPLETED|Overall Study|1 participant was ongoing as of primary completion date 27 Dec 2011 and has now completed.|1||
59789600|NCT00697346|75909732|FG000|NOT COMPLETED|Overall Study||28||
59789601|NCT00697346|75909733|FG001|NOT COMPLETED|Overall Study||26||
59789602|NCT00697346|75909734|FG002|NOT COMPLETED|Overall Study||1||
59789603|NCT00562120|75909761|FG000|STARTED|First Intervention Period||6||
59789604|NCT00562120|75909762|FG001|STARTED|First Intervention Period||5||
59789605|NCT00562120|75909763|FG002|STARTED|First Intervention Period||5||
59789606|NCT00562120|75909764|FG003|STARTED|First Intervention Period||5||
59789607|NCT00562120|75909761|FG000|Treated|First Intervention Period||5||
59789608|NCT00562120|75909762|FG001|Treated|First Intervention Period||5||
59789609|NCT00562120|75909763|FG002|Treated|First Intervention Period||5||
59789610|NCT00562120|75909764|FG003|Treated|First Intervention Period||5||
59789611|NCT00562120|75909761|FG000|COMPLETED|First Intervention Period||4||
59789612|NCT00562120|75909762|FG001|COMPLETED|First Intervention Period||5||
59789613|NCT00562120|75909763|FG002|COMPLETED|First Intervention Period||5||
59789614|NCT00562120|75909764|FG003|COMPLETED|First Intervention Period||5||
59789615|NCT00562120|75909761|FG000|NOT COMPLETED|First Intervention Period||2||
59789616|NCT00562120|75909762|FG001|NOT COMPLETED|First Intervention Period||0||
59789617|NCT00562120|75909763|FG002|NOT COMPLETED|First Intervention Period||0||
59789618|NCT00562120|75909764|FG003|NOT COMPLETED|First Intervention Period||0||
59789619|NCT00562120|75909761|FG000|STARTED|Washout Period 1 (At Least 14 Days)||4||
59789620|NCT00562120|75909762|FG001|STARTED|Washout Period 1 (At Least 14 Days)||5||
59789621|NCT00562120|75909763|FG002|STARTED|Washout Period 1 (At Least 14 Days)||5||
59789622|NCT00562120|75909764|FG003|STARTED|Washout Period 1 (At Least 14 Days)||5||
59789623|NCT00562120|75909761|FG000|COMPLETED|Washout Period 1 (At Least 14 Days)||4||
59789624|NCT00562120|75909762|FG001|COMPLETED|Washout Period 1 (At Least 14 Days)||5||
59789625|NCT00562120|75909763|FG002|COMPLETED|Washout Period 1 (At Least 14 Days)||5||
59789626|NCT00562120|75909764|FG003|COMPLETED|Washout Period 1 (At Least 14 Days)||5||
59789627|NCT00562120|75909761|FG000|NOT COMPLETED|Washout Period 1 (At Least 14 Days)||0||
59789628|NCT00562120|75909762|FG001|NOT COMPLETED|Washout Period 1 (At Least 14 Days)||0||
59789629|NCT00562120|75909763|FG002|NOT COMPLETED|Washout Period 1 (At Least 14 Days)||0||
59789630|NCT00562120|75909764|FG003|NOT COMPLETED|Washout Period 1 (At Least 14 Days)||0||
59789631|NCT00562120|75909761|FG000|STARTED|Second Intervention Period||4||
59789632|NCT00562120|75909762|FG001|STARTED|Second Intervention Period||5||
59789633|NCT00562120|75909763|FG002|STARTED|Second Intervention Period||5||
59789634|NCT00562120|75909764|FG003|STARTED|Second Intervention Period||5||
59789635|NCT00562120|75909761|FG000|COMPLETED|Second Intervention Period||4||
59789636|NCT00562120|75909762|FG001|COMPLETED|Second Intervention Period||5||
59789637|NCT00562120|75909763|FG002|COMPLETED|Second Intervention Period||5||
59789638|NCT00562120|75909764|FG003|COMPLETED|Second Intervention Period||5||
59789639|NCT00562120|75909761|FG000|NOT COMPLETED|Second Intervention Period||0||
59789640|NCT00562120|75909762|FG001|NOT COMPLETED|Second Intervention Period||0||
59789641|NCT00562120|75909763|FG002|NOT COMPLETED|Second Intervention Period||0||
59789642|NCT00562120|75909764|FG003|NOT COMPLETED|Second Intervention Period||0||
59789643|NCT00562120|75909761|FG000|STARTED|Washout Period 2 (At Least 14 Days)||4||
59789644|NCT00562120|75909762|FG001|STARTED|Washout Period 2 (At Least 14 Days)||5||
59789645|NCT00562120|75909763|FG002|STARTED|Washout Period 2 (At Least 14 Days)||5||
59789646|NCT00562120|75909764|FG003|STARTED|Washout Period 2 (At Least 14 Days)||5||
59953350|NCT04057820|76071783|FG003|NOT COMPLETED|Period 8||0||0
59953351|NCT04057820|76071784|FG004|NOT COMPLETED|Period 8||0||0
59953352|NCT04057820|76071785|FG005|NOT COMPLETED|Period 8||0||0
59953353|NCT04057820|76071786|FG006|NOT COMPLETED|Period 8||0||0
59953354|NCT04057820|76071787|FG007|NOT COMPLETED|Period 8||0||0
59953355|NCT04057820|76071788|FG008|NOT COMPLETED|Period 8||0||0
59789647|NCT00562120|75909761|FG000|COMPLETED|Washout Period 2 (At Least 14 Days)||4||
59789648|NCT00562120|75909762|FG001|COMPLETED|Washout Period 2 (At Least 14 Days)||5||
59789649|NCT00562120|75909763|FG002|COMPLETED|Washout Period 2 (At Least 14 Days)||5||
59789650|NCT00562120|75909764|FG003|COMPLETED|Washout Period 2 (At Least 14 Days)||5||
59789651|NCT00562120|75909761|FG000|NOT COMPLETED|Washout Period 2 (At Least 14 Days)||0||
59789652|NCT00562120|75909762|FG001|NOT COMPLETED|Washout Period 2 (At Least 14 Days)||0||
59789653|NCT00562120|75909763|FG002|NOT COMPLETED|Washout Period 2 (At Least 14 Days)||0||
59789654|NCT00562120|75909764|FG003|NOT COMPLETED|Washout Period 2 (At Least 14 Days)||0||
59789655|NCT00562120|75909761|FG000|STARTED|Third Intervention Period||4||
59789656|NCT00562120|75909762|FG001|STARTED|Third Intervention Period||5||
59789657|NCT00562120|75909763|FG002|STARTED|Third Intervention Period||5||
59789658|NCT00562120|75909764|FG003|STARTED|Third Intervention Period||5||
59789659|NCT00562120|75909761|FG000|COMPLETED|Third Intervention Period||4||
59953356|NCT04057820|76071789|FG009|NOT COMPLETED|Period 8||0||0
59953357|NCT04057820|76071790|FG010|NOT COMPLETED|Period 8||0||0
59789660|NCT00562120|75909762|FG001|COMPLETED|Third Intervention Period||5||
59789661|NCT00562120|75909763|FG002|COMPLETED|Third Intervention Period||5||
59789662|NCT00562120|75909764|FG003|COMPLETED|Third Intervention Period||5||
59789663|NCT00562120|75909761|FG000|NOT COMPLETED|Third Intervention Period||0||
59789664|NCT00562120|75909762|FG001|NOT COMPLETED|Third Intervention Period||0||
59789665|NCT00562120|75909763|FG002|NOT COMPLETED|Third Intervention Period||0||
59789666|NCT00562120|75909764|FG003|NOT COMPLETED|Third Intervention Period||0||
59789667|NCT00562120|75909761|FG000|STARTED|Washout Period 3 (At Least 14 Days)||4||
59789668|NCT00562120|75909762|FG001|STARTED|Washout Period 3 (At Least 14 Days)||5||
59789669|NCT00562120|75909763|FG002|STARTED|Washout Period 3 (At Least 14 Days)||5||
59789670|NCT00562120|75909764|FG003|STARTED|Washout Period 3 (At Least 14 Days)||5||
59789671|NCT00562120|75909761|FG000|COMPLETED|Washout Period 3 (At Least 14 Days)||4||
59789672|NCT00562120|75909762|FG001|COMPLETED|Washout Period 3 (At Least 14 Days)||5||
59789673|NCT00562120|75909763|FG002|COMPLETED|Washout Period 3 (At Least 14 Days)||5||
59789674|NCT00562120|75909764|FG003|COMPLETED|Washout Period 3 (At Least 14 Days)||5||
59789675|NCT00562120|75909761|FG000|NOT COMPLETED|Washout Period 3 (At Least 14 Days)||0||
59789676|NCT00562120|75909762|FG001|NOT COMPLETED|Washout Period 3 (At Least 14 Days)||0||
60073383|NCT01690299|76188615|FG003|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0||
60073384|NCT01690299|76188616|FG004|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0||
60073385|NCT01690299|76188617|FG005|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0||
60073386|NCT01690299|76188612|FG000|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||9||
60073387|NCT01690299|76188613|FG001|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||6||
60073388|NCT01690299|76188614|FG002|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||2||
60073389|NCT01690299|76188615|FG003|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0||
60073390|NCT01690299|76188616|FG004|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0||
60073391|NCT01690299|76188617|FG005|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0||
60073392|NCT01690299|76188612|FG000|STARTED|Apremilast Extension Phase (Weeks16-104)||0||
60073393|NCT01690299|76188613|FG001|STARTED|Apremilast Extension Phase (Weeks16-104)||0||
59522920|NCT02134912|75617524|FG001|STARTED|Overall Study||0||
59789677|NCT00562120|75909763|FG002|NOT COMPLETED|Washout Period 3 (At Least 14 Days)||0||
59789678|NCT00562120|75909764|FG003|NOT COMPLETED|Washout Period 3 (At Least 14 Days)||0||
59789679|NCT00562120|75909761|FG000|STARTED|Fourth Intervention Period||4||
59789680|NCT00562120|75909762|FG001|STARTED|Fourth Intervention Period||5||
59789681|NCT00562120|75909763|FG002|STARTED|Fourth Intervention Period||5||
59789682|NCT00562120|75909764|FG003|STARTED|Fourth Intervention Period||5||
59789683|NCT00562120|75909761|FG000|COMPLETED|Fourth Intervention Period||4||
59789684|NCT00562120|75909762|FG001|COMPLETED|Fourth Intervention Period||5||
59789685|NCT00562120|75909763|FG002|COMPLETED|Fourth Intervention Period||5||
59789686|NCT00562120|75909764|FG003|COMPLETED|Fourth Intervention Period||5||
59789687|NCT00562120|75909761|FG000|NOT COMPLETED|Fourth Intervention Period||0||
59789688|NCT00562120|75909762|FG001|NOT COMPLETED|Fourth Intervention Period||0||
59789689|NCT00562120|75909763|FG002|NOT COMPLETED|Fourth Intervention Period||0||
59789690|NCT00562120|75909764|FG003|NOT COMPLETED|Fourth Intervention Period||0||
59789691|NCT00561730|75909774|FG000|STARTED|Overall Study||1995||
59789692|NCT00561730|75909774|FG000|COMPLETED|Overall Study||1986||
59789693|NCT00561730|75909774|FG000|NOT COMPLETED|Overall Study||9||
59789694|NCT00697112|75909780|FG000|STARTED|Overall Study||53||
59789695|NCT00697112|75909780|FG000|Met the Inclusion Criteria|Overall Study||52||
59789696|NCT00697112|75909780|FG000|COMPLETED|Overall Study||43||
59789697|NCT00697112|75909780|FG000|NOT COMPLETED|Overall Study||10||
59789698|NCT00621855|75909789|FG000|STARTED|Overall Study|Started means randomised to treatment|372||
59789699|NCT00621855|75909790|FG001|STARTED|Overall Study|Started means randomised to treatment|371||
59789700|NCT00621855|75909791|FG002|STARTED|Overall Study|Started means randomised to treatment|411||
59789701|NCT00621855|75909792|FG003|STARTED|Overall Study|Started means randomised to treatment|351||
59789702|NCT00621855|75909793|FG004|STARTED|Overall Study|Started means randomised to treatment|373||
59789703|NCT00621855|75909789|FG000|COMPLETED|Overall Study|Completed means completed treatment|296||
59789704|NCT00621855|75909790|FG001|COMPLETED|Overall Study|Completed means completed treatment|310||
59789705|NCT00621855|75909791|FG002|COMPLETED|Overall Study|Completed means completed treatment|330||
59789706|NCT00621855|75909792|FG003|COMPLETED|Overall Study|Completed means completed treatment|284||
59789707|NCT00621855|75909793|FG004|COMPLETED|Overall Study|Completed means completed treatment|318||
59789708|NCT00621855|75909789|FG000|NOT COMPLETED|Overall Study||76||
59789709|NCT00621855|75909790|FG001|NOT COMPLETED|Overall Study||61||
59789710|NCT00621855|75909791|FG002|NOT COMPLETED|Overall Study||81||
59789711|NCT00621855|75909792|FG003|NOT COMPLETED|Overall Study||67||
59789712|NCT00621855|75909793|FG004|NOT COMPLETED|Overall Study||55||
59789713|NCT00561574|75909807|FG000|STARTED|Overall Study||128||
59789714|NCT00561574|75909808|FG001|STARTED|Overall Study||131||
60073394|NCT01690299|76188614|FG002|STARTED|Apremilast Extension Phase (Weeks16-104)||0||
60073395|NCT01690299|76188615|FG003|STARTED|Apremilast Extension Phase (Weeks16-104)|There are fewer participants in this period because some stopped the study at or prior to Week 16.|73||
60073396|NCT01690299|76188616|FG004|STARTED|Apremilast Extension Phase (Weeks16-104)|There are fewer participants in this period because some stopped the study at or prior to Week 16.|74||
59789715|NCT00561574|75909807|FG000|COMPLETED|Overall Study||80||
59789716|NCT00561574|75909808|FG001|COMPLETED|Overall Study||73||
59789717|NCT00561574|75909807|FG000|NOT COMPLETED|Overall Study||48||
59789718|NCT00561574|75909808|FG001|NOT COMPLETED|Overall Study||58||
59789719|NCT00619827|75909816|FG000|STARTED|Overall Study||45||
59789720|NCT00619827|75909817|FG001|STARTED|Overall Study||44||
59789721|NCT00619827|75909816|FG000|COMPLETED|Overall Study||42||
59789722|NCT00619827|75909817|FG001|COMPLETED|Overall Study||40||
59789723|NCT00619827|75909816|FG000|NOT COMPLETED|Overall Study||3||
59789724|NCT00619827|75909817|FG001|NOT COMPLETED|Overall Study||4||
59789725|NCT00687804|75909826|FG000|STARTED|Core Study||116||
59789726|NCT00687804|75909827|FG001|STARTED|Core Study||118||
59789727|NCT00687804|75909828|FG002|STARTED|Core Study||111||
59789728|NCT00687804|75909826|FG000|COMPLETED|Core Study||102||
59789729|NCT00687804|75909827|FG001|COMPLETED|Core Study||103||
59953358|NCT04057820|76071791|FG011|NOT COMPLETED|Period 8||0||0
59953359|NCT04057820|76071792|FG012|NOT COMPLETED|Period 8||0||0
59953360|NCT04057820|76071793|FG013|NOT COMPLETED|Period 8||0||0
59789730|NCT00687804|75909828|FG002|COMPLETED|Core Study||98||
59789731|NCT00687804|75909826|FG000|NOT COMPLETED|Core Study||14||
59789732|NCT00687804|75909827|FG001|NOT COMPLETED|Core Study||15||
59789733|NCT00687804|75909828|FG002|NOT COMPLETED|Core Study||13||
59789734|NCT00687804|75909826|FG000|STARTED|Open-Label Extension Study||83||
59789735|NCT00687804|75909827|FG001|STARTED|Open-Label Extension Study||83||
59789736|NCT00687804|75909828|FG002|STARTED|Open-Label Extension Study||74||
59789737|NCT00687804|75909826|FG000|Did Not Receive Ranibizumab in Extension|Open-Label Extension Study||16||
59789738|NCT00687804|75909827|FG001|Did Not Receive Ranibizumab in Extension|Open-Label Extension Study||21||
59789739|NCT00687804|75909828|FG002|Did Not Receive Ranibizumab in Extension|Open-Label Extension Study||15||
59789740|NCT00687804|75909826|FG000|COMPLETED|Open-Label Extension Study||73||
59789741|NCT00687804|75909827|FG001|COMPLETED|Open-Label Extension Study||72||
59789742|NCT00687804|75909828|FG002|COMPLETED|Open-Label Extension Study||63||
59789743|NCT00687804|75909826|FG000|NOT COMPLETED|Open-Label Extension Study||10||
59789744|NCT00687804|75909827|FG001|NOT COMPLETED|Open-Label Extension Study||11||
59789745|NCT00687804|75909828|FG002|NOT COMPLETED|Open-Label Extension Study||11||
59789746|NCT00727090|75909844|FG000|STARTED|Overall Study||3||
59789747|NCT00727090|75909845|FG001|STARTED|Overall Study||3||
59789748|NCT00727090|75909844|FG000|COMPLETED|Overall Study||3||
59789749|NCT00727090|75909845|FG001|COMPLETED|Overall Study||3||
59789750|NCT00727090|75909844|FG000|NOT COMPLETED|Overall Study||0||
59789751|NCT00727090|75909845|FG001|NOT COMPLETED|Overall Study||0||
59789752|NCT00689052|75909855|FG000|STARTED|Overall Study||31||
59789753|NCT00689052|75909856|FG001|STARTED|Overall Study||30||
59789754|NCT00689052|75909855|FG000|COMPLETED|Overall Study||0||
59789755|NCT00689052|75909856|FG001|COMPLETED|Overall Study||0||
59789756|NCT00689052|75909855|FG000|NOT COMPLETED|Overall Study||31||
59789757|NCT00689052|75909856|FG001|NOT COMPLETED|Overall Study||30||
59789758|NCT00560950|75909866|FG000|STARTED|Overall Study||72||
59789759|NCT00560950|75909867|FG001|STARTED|Overall Study||71||
59789760|NCT00560950|75909866|FG000|COMPLETED|Overall Study||71||
59789761|NCT00560950|75909867|FG001|COMPLETED|Overall Study||71||
59789762|NCT00560950|75909866|FG000|NOT COMPLETED|Overall Study||1||
59953361|NCT04057820|76071794|FG014|NOT COMPLETED|Period 8||0||0
59953362|NCT04057820|76071795|FG015|NOT COMPLETED|Period 8||0||0
59953363|NCT04057820|76071780|FG000|STARTED|Period 9||0||0
59522921|NCT02134912|75617523|FG000|COMPLETED|Overall Study||0||
59789763|NCT00560950|75909867|FG001|NOT COMPLETED|Overall Study||0||
59789764|NCT00576758|75909877|FG000|STARTED|Induction Treatment Period||87||
59789765|NCT00576758|75909878|FG001|STARTED|Induction Treatment Period||88||
59789766|NCT00576758|75909877|FG000|Received Treatment|Induction Treatment Period||86||
59789767|NCT00576758|75909878|FG001|Received Treatment|Induction Treatment Period||87||
59789768|NCT00576758|75909877|FG000|COMPLETED|Induction Treatment Period||79||
59789769|NCT00576758|75909878|FG001|COMPLETED|Induction Treatment Period||83||
59789770|NCT00576758|75909877|FG000|NOT COMPLETED|Induction Treatment Period||8||
59789771|NCT00576758|75909878|FG001|NOT COMPLETED|Induction Treatment Period||5||
59789772|NCT00576758|75909877|FG000|STARTED|Extension Treatment Period|6 patients did not enter extended treatment phase/follow-up + 1 patient entered follow-up.|72||
59789773|NCT00576758|75909878|FG001|STARTED|Extension Treatment Period|8 patients did not enter extended treatment phase/follow-up phase + 2 patients entered follow-up.|73||
59953364|NCT04057820|76071781|FG001|STARTED|Period 9|For this stepped wedge study design, a new cohort of infants is enrolled during each period except the transition period. Therefore, the number of infants to start a period is unlikely to equal the number of infants who completed the previous period.|18||4
59953365|NCT04057820|76071782|FG002|STARTED|Period 9||0||0
59789774|NCT00576758|75909877|FG000|COMPLETED|Extension Treatment Period|+ 2 patients (pts) who withdrew prior to receiving study drug.|30||
59789775|NCT00576758|75909878|FG001|COMPLETED|Extension Treatment Period||30||
60073397|NCT01690299|76188617|FG005|STARTED|Apremilast Extension Phase (Weeks16-104)|There are fewer participants in this period because some stopped the study at or prior to Week 16.|80||
59789776|NCT00576758|75909877|FG000|NOT COMPLETED|Extension Treatment Period||42||
59789777|NCT00576758|75909878|FG001|NOT COMPLETED|Extension Treatment Period||43||
59789778|NCT00576758|75909877|FG000|STARTED|Follow-up Period|Includes 23 pts who entered follow-up after induction and didn't enter the extended treatment phase.|55||
59789779|NCT00576758|75909878|FG001|STARTED|Follow-up Period|Includes 21 pts who entered follow-up after induction and didn't enter the extended treatment phase.|51||
59789780|NCT00576758|75909877|FG000|COMPLETED|Follow-up Period||28||
59789781|NCT00576758|75909878|FG001|COMPLETED|Follow-up Period||34||
59789782|NCT00576758|75909877|FG000|NOT COMPLETED|Follow-up Period||27||
59789783|NCT00576758|75909878|FG001|NOT COMPLETED|Follow-up Period||17||
59789784|NCT00560794|75909885|FG000|STARTED|Overall Study||21||
59789785|NCT00560794|75909885|FG000|Completed 1 Treatment Cycle|Overall Study||20||
59789786|NCT00560794|75909885|FG000|COMPLETED|Overall Study||10||
59789787|NCT00560794|75909885|FG000|NOT COMPLETED|Overall Study||11||
59789788|NCT00619359|75909893|FG000|STARTED|Overall Study||1147||
59789789|NCT00619359|75909894|FG001|STARTED|Overall Study||1175||
59789790|NCT00619359|75909893|FG000|COMPLETED|Overall Study||1080||
59789791|NCT00619359|75909894|FG001|COMPLETED|Overall Study||1094||
59789792|NCT00619359|75909893|FG000|NOT COMPLETED|Overall Study||67||
59789793|NCT00619359|75909894|FG001|NOT COMPLETED|Overall Study||81||
59789794|NCT00372229|75909902|FG000|STARTED|Study Phase||148||
59789795|NCT00372229|75909903|FG001|STARTED|Study Phase||151||
59789796|NCT00372229|75909902|FG000|COMPLETED|Study Phase||117||
59789797|NCT00372229|75909903|FG001|COMPLETED|Study Phase||122||
59789798|NCT00372229|75909902|FG000|NOT COMPLETED|Study Phase||31||
59789799|NCT00372229|75909903|FG001|NOT COMPLETED|Study Phase||29||
59789800|NCT00372229|75909902|FG000|STARTED|Follow-Up Phase||117||
59789801|NCT00372229|75909903|FG001|STARTED|Follow-Up Phase||122||
59789802|NCT00372229|75909902|FG000|COMPLETED|Follow-Up Phase||71||
59789803|NCT00372229|75909903|FG001|COMPLETED|Follow-Up Phase||70||
59789804|NCT00372229|75909902|FG000|NOT COMPLETED|Follow-Up Phase||46||
59789805|NCT00372229|75909903|FG001|NOT COMPLETED|Follow-Up Phase||52||
59789806|NCT00698828|75909916|FG000|STARTED|Overall Study||76||
59789807|NCT00698828|75909917|FG001|STARTED|Overall Study||75||
59789808|NCT00698828|75909918|FG002|STARTED|Overall Study||76||
59789809|NCT00698828|75909916|FG000|COMPLETED|Overall Study||67||
59789810|NCT00698828|75909917|FG001|COMPLETED|Overall Study||60||
59789811|NCT00698828|75909918|FG002|COMPLETED|Overall Study||65||
59789812|NCT00698828|75909916|FG000|NOT COMPLETED|Overall Study||9||
59789813|NCT00698828|75909917|FG001|NOT COMPLETED|Overall Study||15||
59789814|NCT00698828|75909918|FG002|NOT COMPLETED|Overall Study||11||
59789815|NCT00619515|75909926|FG000|STARTED|Overall Study||73||
59789816|NCT00619515|75909926|FG000|COMPLETED|Overall Study||0||
59789817|NCT00619515|75909926|FG000|NOT COMPLETED|Overall Study||73||
59789818|NCT03167606|75909932|FG000|STARTED|Overall Study||382||
59789819|NCT03167606|75909933|FG001|STARTED|Overall Study||381||
59789820|NCT03167606|75909932|FG000|COMPLETED|Overall Study||303||
59789821|NCT03167606|75909933|FG001|COMPLETED|Overall Study||310||
59789822|NCT03167606|75909932|FG000|NOT COMPLETED|Overall Study||79||
59789823|NCT03167606|75909933|FG001|NOT COMPLETED|Overall Study||71||
59789824|NCT00688740|75909941|FG000|STARTED|Overall Study||745||
59789825|NCT00688740|75909942|FG001|STARTED|Overall Study||746||
59789826|NCT00688740|75909941|FG000|COMPLETED|Overall Study||679||
59789827|NCT00688740|75909942|FG001|COMPLETED|Overall Study||711||
59789828|NCT00688740|75909941|FG000|NOT COMPLETED|Overall Study||66||
59789829|NCT00688740|75909942|FG001|NOT COMPLETED|Overall Study||35||
59789830|NCT00552760|75909950|FG000|STARTED|Overall Study||42||
59789831|NCT00552760|75909951|FG001|STARTED|Overall Study||41||
59789832|NCT00552760|75909950|FG000|COMPLETED|Overall Study||16||
59789833|NCT00552760|75909951|FG001|COMPLETED|Overall Study||8||
59789834|NCT00552760|75909950|FG000|NOT COMPLETED|Overall Study||26||
59789835|NCT00552760|75909951|FG001|NOT COMPLETED|Overall Study||33||
59789836|NCT00686790|75909957|FG000|STARTED|Overall Study||48||
59789837|NCT00686790|75909957|FG000|COMPLETED|Overall Study||32||
60073398|NCT01690299|76188612|FG000|Safety Population|Apremilast Extension Phase (Weeks16-104)||0||
60103570|NCT01290640|76221809|FG001|COMPLETED|Overall Study||10||
59789838|NCT00686790|75909957|FG000|NOT COMPLETED|Overall Study||16||
59789839|NCT00686712|75909964|FG000|STARTED|Overall Study||30||
59789840|NCT00686712|75909965|FG001|STARTED|Overall Study||25||
59789841|NCT00686712|75909966|FG002|STARTED|Overall Study||30||
59789842|NCT00686712|75909964|FG000|COMPLETED|Overall Study||20||
59789843|NCT00686712|75909965|FG001|COMPLETED|Overall Study||14||
59789844|NCT00686712|75909966|FG002|COMPLETED|Overall Study||17||
59789845|NCT00686712|75909964|FG000|NOT COMPLETED|Overall Study||10||
59789846|NCT00686712|75909965|FG001|NOT COMPLETED|Overall Study||11||
59789847|NCT00686712|75909966|FG002|NOT COMPLETED|Overall Study||13||
59789848|NCT00686634|75909977|FG000|STARTED|Overall Study||108||
59789849|NCT00686634|75909977|FG000|COMPLETED|Overall Study||102||
59789850|NCT00686634|75909977|FG000|NOT COMPLETED|Overall Study||6||
59789851|NCT00560404|75909984|FG000|STARTED|Overall Study||112||
59789852|NCT00560404|75909985|FG001|STARTED|Overall Study||121||
59789853|NCT00560404|75909984|FG000|COMPLETED|Overall Study||76||
59789854|NCT00560404|75909985|FG001|COMPLETED|Overall Study||100||
59789855|NCT00560404|75909984|FG000|NOT COMPLETED|Overall Study||36||
59789856|NCT00560404|75909985|FG001|NOT COMPLETED|Overall Study||21||
59789857|NCT03967444|75909993|FG000|STARTED|Overall Study||19||
59789858|NCT03967444|75909994|FG001|STARTED|Overall Study||40||
59789859|NCT03967444|75909993|FG000|COMPLETED|Overall Study||18||
59789860|NCT03967444|75909994|FG001|COMPLETED|Overall Study||38||
59789861|NCT03967444|75909993|FG000|NOT COMPLETED|Overall Study||1||
59789862|NCT03967444|75909994|FG001|NOT COMPLETED|Overall Study||2||
59789863|NCT00619983|75910004|FG000|STARTED|Test Drug Alone||5||
59789864|NCT00619983|75910005|FG001|STARTED|Test Drug Alone||5||
59789865|NCT00619983|75910006|FG002|STARTED|Test Drug Alone||6||
59789866|NCT00619983|75910007|FG003|STARTED|Test Drug Alone||6||
59789867|NCT00619983|75910004|FG000|COMPLETED|Test Drug Alone||3||
59789868|NCT00619983|75910005|FG001|COMPLETED|Test Drug Alone||4||
59789869|NCT00619983|75910006|FG002|COMPLETED|Test Drug Alone||4||
59789870|NCT00619983|75910007|FG003|COMPLETED|Test Drug Alone||3||
59789871|NCT00619983|75910004|FG000|NOT COMPLETED|Test Drug Alone||2||
59789872|NCT00619983|75910005|FG001|NOT COMPLETED|Test Drug Alone||1||
59789873|NCT00619983|75910006|FG002|NOT COMPLETED|Test Drug Alone||2||
59789874|NCT00619983|75910007|FG003|NOT COMPLETED|Test Drug Alone||3||
59789875|NCT00619983|75910004|FG000|STARTED|Test Drug Plus Gabapentin||3||
59789876|NCT00619983|75910005|FG001|STARTED|Test Drug Plus Gabapentin||4||
59789877|NCT00619983|75910006|FG002|STARTED|Test Drug Plus Gabapentin||4||
59789878|NCT00619983|75910007|FG003|STARTED|Test Drug Plus Gabapentin||3||
59789879|NCT00619983|75910004|FG000|COMPLETED|Test Drug Plus Gabapentin||3||
59789880|NCT00619983|75910005|FG001|COMPLETED|Test Drug Plus Gabapentin||4||
59789881|NCT00619983|75910006|FG002|COMPLETED|Test Drug Plus Gabapentin||4||
59789882|NCT00619983|75910007|FG003|COMPLETED|Test Drug Plus Gabapentin||3||
59789883|NCT00619983|75910004|FG000|NOT COMPLETED|Test Drug Plus Gabapentin||0||
59789884|NCT00619983|75910005|FG001|NOT COMPLETED|Test Drug Plus Gabapentin||0||
59789885|NCT00619983|75910006|FG002|NOT COMPLETED|Test Drug Plus Gabapentin||0||
59789886|NCT00619983|75910007|FG003|NOT COMPLETED|Test Drug Plus Gabapentin||0||
59789887|NCT00619983|75910004|FG000|STARTED|Gabapentin Alone||3||
59789888|NCT00619983|75910005|FG001|STARTED|Gabapentin Alone||4||
59789889|NCT00619983|75910006|FG002|STARTED|Gabapentin Alone||4||
59789890|NCT00619983|75910007|FG003|STARTED|Gabapentin Alone||3||
59789891|NCT00619983|75910004|FG000|COMPLETED|Gabapentin Alone||3||
59953366|NCT04057820|76071783|FG003|STARTED|Period 9||3||2
59953367|NCT04057820|76071784|FG004|STARTED|Period 9||0||0
59953368|NCT04057820|76071785|FG005|STARTED|Period 9||5||3
59953369|NCT04057820|76071786|FG006|STARTED|Period 9||0||0
59953370|NCT04057820|76071787|FG007|STARTED|Period 9||17||3
59953371|NCT04057820|76071788|FG008|STARTED|Period 9||0||0
59953372|NCT04057820|76071789|FG009|STARTED|Period 9||28||4
59953373|NCT04057820|76071790|FG010|STARTED|Period 9||0||0
59953374|NCT04057820|76071791|FG011|STARTED|Period 9||15||4
59953375|NCT04057820|76071792|FG012|STARTED|Period 9||0||0
59953376|NCT04057820|76071793|FG013|STARTED|Period 9||14||3
59953377|NCT04057820|76071794|FG014|STARTED|Period 9|Block 8 with 3 sites transitioned from Usual Care to ESC during Period 9; therefore no infants were being enrolled and the total number of sites enrolling infants was 23.|0||0
59789892|NCT00619983|75910005|FG001|COMPLETED|Gabapentin Alone||4||
59789893|NCT00619983|75910006|FG002|COMPLETED|Gabapentin Alone||4||
59789894|NCT00619983|75910007|FG003|COMPLETED|Gabapentin Alone||3||
59789895|NCT00619983|75910004|FG000|NOT COMPLETED|Gabapentin Alone||0||
59953378|NCT04057820|76071795|FG015|STARTED|Period 9||0||0
59953379|NCT04057820|76071780|FG000|COMPLETED|Period 9||0||0
59953380|NCT04057820|76071781|FG001|COMPLETED|Period 9||18||4
59953381|NCT04057820|76071782|FG002|COMPLETED|Period 9||0||0
59522922|NCT02134912|75617524|FG001|COMPLETED|Overall Study||0||
59789896|NCT00619983|75910005|FG001|NOT COMPLETED|Gabapentin Alone||0||
59789897|NCT00619983|75910006|FG002|NOT COMPLETED|Gabapentin Alone||0||
59789898|NCT00619983|75910007|FG003|NOT COMPLETED|Gabapentin Alone||0||
59953382|NCT04057820|76071783|FG003|COMPLETED|Period 9||3||2
59953383|NCT04057820|76071784|FG004|COMPLETED|Period 9||0||0
59789899|NCT00576420|75910020|FG000|STARTED|Overall Study||26||
59789900|NCT00576420|75910021|FG001|STARTED|Overall Study||24||
59789901|NCT00576420|75910022|FG002|STARTED|Overall Study||23||
59789902|NCT00576420|75910020|FG000|COMPLETED|Overall Study||26||
59789903|NCT00576420|75910021|FG001|COMPLETED|Overall Study||24||
59789904|NCT00576420|75910022|FG002|COMPLETED|Overall Study||22||
59789905|NCT00576420|75910020|FG000|NOT COMPLETED|Overall Study||0||
59789906|NCT00576420|75910021|FG001|NOT COMPLETED|Overall Study||0||
59953384|NCT04057820|76071785|FG005|COMPLETED|Period 9||5||3
59953385|NCT04057820|76071786|FG006|COMPLETED|Period 9||0||0
59953386|NCT04057820|76071787|FG007|COMPLETED|Period 9||17||3
59953387|NCT04057820|76071788|FG008|COMPLETED|Period 9||0||0
59953388|NCT04057820|76071789|FG009|COMPLETED|Period 9||28||4
59953389|NCT04057820|76071790|FG010|COMPLETED|Period 9||0||0
59522923|NCT02134912|75617523|FG000|NOT COMPLETED|Overall Study||0||
59522924|NCT02134912|75617524|FG001|NOT COMPLETED|Overall Study||0||
59522925|NCT01226485|75617537|FG000|STARTED|Overall Study||3||
59522926|NCT01226485|75617538|FG001|STARTED|Overall Study||6||
59522927|NCT01226485|75617539|FG002|STARTED|Overall Study||3||
59953390|NCT04057820|76071791|FG011|COMPLETED|Period 9||15||4
59953391|NCT04057820|76071792|FG012|COMPLETED|Period 9||0||0
59953392|NCT04057820|76071793|FG013|COMPLETED|Period 9||14||3
59953393|NCT04057820|76071794|FG014|COMPLETED|Period 9||0||0
59953394|NCT04057820|76071795|FG015|COMPLETED|Period 9||0||0
59953395|NCT04057820|76071780|FG000|NOT COMPLETED|Period 9||0||0
59953396|NCT04057820|76071781|FG001|NOT COMPLETED|Period 9||0||0
59953397|NCT04057820|76071782|FG002|NOT COMPLETED|Period 9||0||0
59953398|NCT04057820|76071783|FG003|NOT COMPLETED|Period 9||0||0
59789907|NCT00576420|75910022|FG002|NOT COMPLETED|Overall Study||1||
59789908|NCT00364351|75910073|FG000|STARTED|Overall Study|randomised patients|623||
59789909|NCT00364351|75910074|FG001|STARTED|Overall Study|randomised patients|617||
59789910|NCT00364351|75910073|FG000|COMPLETED|Overall Study|Ongoing study treatment at data cut-off date 26 Sep 2008.|31||
59789911|NCT00364351|75910074|FG001|COMPLETED|Overall Study|Ongoing study treatment at data cut-off date 26 Sep 2008.|34||
59789912|NCT00364351|75910073|FG000|NOT COMPLETED|Overall Study||592||
59789913|NCT00364351|75910074|FG001|NOT COMPLETED|Overall Study||583||
59789914|NCT00388297|75910084|FG000|STARTED|Overall Study||339||
59789915|NCT00388297|75910085|FG001|STARTED|Overall Study||338||
59789916|NCT00388297|75910086|FG002|STARTED|Overall Study||265||
59789917|NCT00388297|75910087|FG003|STARTED|Overall Study||261||
59789918|NCT00388297|75910084|FG000|COMPLETED|Overall Study||323||
59789919|NCT00388297|75910085|FG001|COMPLETED|Overall Study||326||
59789920|NCT00388297|75910086|FG002|COMPLETED|Overall Study||254||
59789921|NCT00388297|75910087|FG003|COMPLETED|Overall Study||253||
59789922|NCT00388297|75910084|FG000|NOT COMPLETED|Overall Study||16||
59789923|NCT00388297|75910085|FG001|NOT COMPLETED|Overall Study||12||
59789924|NCT00388297|75910086|FG002|NOT COMPLETED|Overall Study||11||
59789925|NCT00388297|75910087|FG003|NOT COMPLETED|Overall Study||8||
59789926|NCT00686166|75910097|FG000|STARTED|Overall Study||83||
59789927|NCT00686166|75910097|FG000|Eligible|Overall Study||78||
59789928|NCT00686166|75910097|FG000|Eligible and Began Protocol Therapy|Overall Study||74||
59789929|NCT00686166|75910097|FG000|COMPLETED|Overall Study||63||
59789930|NCT00686166|75910097|FG000|NOT COMPLETED|Overall Study||20||
59789931|NCT00363649|75910108|FG000|STARTED|Overall Study||18||
59789932|NCT00363649|75910109|FG001|STARTED|Overall Study||16||
59789933|NCT00363649|75910108|FG000|Crossed Over to Arm B|Overall Study||9||
59789934|NCT00363649|75910109|FG001|Crossed Over to Arm B|Overall Study||0||
59789935|NCT00363649|75910108|FG000|Crossed Over to Arm A|Overall Study||0||
59789936|NCT00363649|75910109|FG001|Crossed Over to Arm A|Overall Study||12||
59789937|NCT00363649|75910108|FG000|Did Not Cross Over|Overall Study||2||
59789938|NCT00363649|75910109|FG001|Did Not Cross Over|Overall Study||3||
59789939|NCT00363649|75910108|FG000|COMPLETED|Overall Study||11||
59789940|NCT00363649|75910109|FG001|COMPLETED|Overall Study||15||
59953399|NCT04057820|76071784|FG004|NOT COMPLETED|Period 9||0||0
59953400|NCT04057820|76071785|FG005|NOT COMPLETED|Period 9||0||0
59953401|NCT04057820|76071786|FG006|NOT COMPLETED|Period 9||0||0
60073399|NCT01690299|76188613|FG001|Safety Population|Apremilast Extension Phase (Weeks16-104)||0||
59522928|NCT01226485|75617540|FG003|STARTED|Overall Study||6||
59522929|NCT01226485|75617541|FG004|STARTED|Overall Study||7||
59789941|NCT00363649|75910108|FG000|NOT COMPLETED|Overall Study||7||
59789942|NCT00363649|75910109|FG001|NOT COMPLETED|Overall Study||1||
59789943|NCT00684060|75910117|FG000|STARTED|Overall Study||58||
59789944|NCT00684060|75910118|FG001|STARTED|Overall Study||29||
59789945|NCT00684060|75910117|FG000|COMPLETED|Overall Study||55||
59789946|NCT00684060|75910118|FG001|COMPLETED|Overall Study||26||
59789947|NCT00684060|75910117|FG000|NOT COMPLETED|Overall Study||3||
59789948|NCT00684060|75910118|FG001|NOT COMPLETED|Overall Study||3||
59789949|NCT03131648|75910126|FG000|STARTED|Initial Treatment Period||603||
59789950|NCT03131648|75910127|FG001|STARTED|Initial Treatment Period||199||
59789951|NCT03131648|75910128|FG002|STARTED|Initial Treatment Period||0||
59789952|NCT03131648|75910129|FG003|STARTED|Initial Treatment Period||0||
59789953|NCT03131648|75910130|FG004|STARTED|Initial Treatment Period||0||
59953402|NCT04057820|76071787|FG007|NOT COMPLETED|Period 9||0||0
59953403|NCT04057820|76071788|FG008|NOT COMPLETED|Period 9||0||0
59953404|NCT04057820|76071789|FG009|NOT COMPLETED|Period 9||0||0
59953405|NCT04057820|76071790|FG010|NOT COMPLETED|Period 9||0||0
60103571|NCT01290640|76221808|FG000|NOT COMPLETED|Overall Study||0||
59953406|NCT04057820|76071791|FG011|NOT COMPLETED|Period 9||0||0
59522930|NCT01226485|75617542|FG005|STARTED|Overall Study||19||
59522931|NCT01226485|75617543|FG006|STARTED|Overall Study||40||
59953407|NCT04057820|76071792|FG012|NOT COMPLETED|Period 9||0||0
59953408|NCT04057820|76071793|FG013|NOT COMPLETED|Period 9||0||0
59953409|NCT04057820|76071794|FG014|NOT COMPLETED|Period 9||0||0
59953410|NCT04057820|76071795|FG015|NOT COMPLETED|Period 9||0||0
59789954|NCT03131648|75910131|FG005|STARTED|Initial Treatment Period||0||
59789955|NCT03131648|75910132|FG006|STARTED|Initial Treatment Period||0||
59789956|NCT03131648|75910133|FG007|STARTED|Initial Treatment Period||0||
59789957|NCT03131648|75910126|FG000|COMPLETED|Initial Treatment Period||550||
59789958|NCT03131648|75910127|FG001|COMPLETED|Initial Treatment Period||179||
59789959|NCT03131648|75910128|FG002|COMPLETED|Initial Treatment Period||0||
59789960|NCT03131648|75910129|FG003|COMPLETED|Initial Treatment Period||0||
59789961|NCT03131648|75910130|FG004|COMPLETED|Initial Treatment Period||0||
59789962|NCT03131648|75910131|FG005|COMPLETED|Initial Treatment Period||0||
59789963|NCT03131648|75910132|FG006|COMPLETED|Initial Treatment Period||0||
59789964|NCT03131648|75910133|FG007|COMPLETED|Initial Treatment Period||0||
59789965|NCT03131648|75910126|FG000|NOT COMPLETED|Initial Treatment Period||53||
59789966|NCT03131648|75910127|FG001|NOT COMPLETED|Initial Treatment Period||20||
59789967|NCT03131648|75910128|FG002|NOT COMPLETED|Initial Treatment Period||0||
59789968|NCT03131648|75910129|FG003|NOT COMPLETED|Initial Treatment Period||0||
59789969|NCT03131648|75910130|FG004|NOT COMPLETED|Initial Treatment Period||0||
59789970|NCT03131648|75910131|FG005|NOT COMPLETED|Initial Treatment Period||0||
59789971|NCT03131648|75910132|FG006|NOT COMPLETED|Initial Treatment Period||0||
59789972|NCT03131648|75910133|FG007|NOT COMPLETED|Initial Treatment Period||0||
59789973|NCT03131648|75910126|FG000|STARTED|Open-label Treatment||0|Open-label treatment period was in parallel to the maintenance treatment period.|
59789974|NCT03131648|75910127|FG001|STARTED|Open-label Treatment||0|Open-label treatment period was in parallel to the maintenance treatment period.|
59789975|NCT03131648|75910128|FG002|STARTED|Open-label Treatment||0|Open-label treatment period was in parallel to the maintenance treatment period.|
59789976|NCT03131648|75910129|FG003|STARTED|Open-label Treatment||0|Open-label treatment period was in parallel to the maintenance treatment period.|
59789977|NCT03131648|75910130|FG004|STARTED|Open-label Treatment||0|Open-label treatment period was in parallel to the maintenance treatment period.|
59789978|NCT03131648|75910131|FG005|STARTED|Open-label Treatment||0|Open-label treatment period was in parallel to the maintenance treatment period.|
59789979|NCT03131648|75910132|FG006|STARTED|Open-label Treatment||564|Open-label treatment period was in parallel to the maintenance treatment period.|
59789980|NCT03131648|75910133|FG007|STARTED|Open-label Treatment||0|Open-label treatment period was in parallel to the maintenance treatment period.|
59789981|NCT03131648|75910126|FG000|COMPLETED|Open-label Treatment||0||
59789982|NCT03131648|75910127|FG001|COMPLETED|Open-label Treatment||0||
59789983|NCT03131648|75910128|FG002|COMPLETED|Open-label Treatment||0||
59789984|NCT03131648|75910129|FG003|COMPLETED|Open-label Treatment||0||
59789985|NCT03131648|75910130|FG004|COMPLETED|Open-label Treatment||0||
59789986|NCT03131648|75910131|FG005|COMPLETED|Open-label Treatment||0||
59789987|NCT03131648|75910132|FG006|COMPLETED|Open-label Treatment||446||
59789988|NCT03131648|75910133|FG007|COMPLETED|Open-label Treatment||0||
59789989|NCT03131648|75910126|FG000|NOT COMPLETED|Open-label Treatment||0||
59789990|NCT03131648|75910127|FG001|NOT COMPLETED|Open-label Treatment||0||
59789991|NCT03131648|75910128|FG002|NOT COMPLETED|Open-label Treatment||0||
59789992|NCT03131648|75910129|FG003|NOT COMPLETED|Open-label Treatment||0||
59789993|NCT03131648|75910130|FG004|NOT COMPLETED|Open-label Treatment||0||
59789994|NCT03131648|75910131|FG005|NOT COMPLETED|Open-label Treatment||0||
59789995|NCT03131648|75910132|FG006|NOT COMPLETED|Open-label Treatment||118||
59789996|NCT03131648|75910133|FG007|NOT COMPLETED|Open-label Treatment||0||
59953411|NCT04057820|76071780|FG000|STARTED|Period 10||0||0
59953412|NCT04057820|76071781|FG001|STARTED|Period 10|For this stepped wedge study design, a new cohort of infants is enrolled during each period except the transition period. Therefore, the number of infants to start a period is unlikely to equal the number of infants who completed the previous period.|26||4
59953413|NCT04057820|76071782|FG002|STARTED|Period 10||0||0
59953414|NCT04057820|76071783|FG003|STARTED|Period 10||8||2
59953415|NCT04057820|76071784|FG004|STARTED|Period 10||0||0
59953416|NCT04057820|76071785|FG005|STARTED|Period 10||17||3
59522932|NCT01226485|75617537|FG000|Received at Least One Dose of Drug|Overall Study||3||
59522933|NCT01226485|75617538|FG001|Received at Least One Dose of Drug|Overall Study||6||
59522934|NCT01226485|75617539|FG002|Received at Least One Dose of Drug|Overall Study||3||
59522935|NCT01226485|75617540|FG003|Received at Least One Dose of Drug|Overall Study||6||
59522936|NCT01226485|75617541|FG004|Received at Least One Dose of Drug|Overall Study||7||
60073400|NCT01690299|76188614|FG002|Safety Population|Apremilast Extension Phase (Weeks16-104)||0||
60073401|NCT01690299|76188615|FG003|Safety Population|Apremilast Extension Phase (Weeks16-104)|Safety population includes all participants who received at least one dose of study drug.|73||
60073402|NCT01690299|76188616|FG004|Safety Population|Apremilast Extension Phase (Weeks16-104)|Safety population includes all participants who received at least one dose of study drug.|74||
60073403|NCT01690299|76188617|FG005|Safety Population|Apremilast Extension Phase (Weeks16-104)|Safety population includes all participants who received at least one dose of study drug.|79||
60073404|NCT01690299|76188612|FG000|COMPLETED|Apremilast Extension Phase (Weeks16-104)||0||
60073405|NCT01690299|76188613|FG001|COMPLETED|Apremilast Extension Phase (Weeks16-104)||0||
59522937|NCT01226485|75617542|FG005|Received at Least One Dose of Drug|Overall Study||19||
59522938|NCT01226485|75617543|FG006|Received at Least One Dose of Drug|Overall Study||40||
59522939|NCT01226485|75617537|FG000|COMPLETED|Overall Study||3||
59522940|NCT01226485|75617538|FG001|COMPLETED|Overall Study||6||
59522941|NCT01226485|75617539|FG002|COMPLETED|Overall Study||3||
59522942|NCT01226485|75617540|FG003|COMPLETED|Overall Study||6||
59522943|NCT01226485|75617541|FG004|COMPLETED|Overall Study||7||
59522944|NCT01226485|75617542|FG005|COMPLETED|Overall Study||19||
59522945|NCT01226485|75617543|FG006|COMPLETED|Overall Study||40||
59522946|NCT01226485|75617537|FG000|NOT COMPLETED|Overall Study||0||
59522947|NCT01226485|75617538|FG001|NOT COMPLETED|Overall Study||0||
59522948|NCT01226485|75617539|FG002|NOT COMPLETED|Overall Study||0||
59522949|NCT01226485|75617540|FG003|NOT COMPLETED|Overall Study||0||
59522950|NCT01226485|75617541|FG004|NOT COMPLETED|Overall Study||0||
59522951|NCT01226485|75617542|FG005|NOT COMPLETED|Overall Study||0||
59522952|NCT01226485|75617543|FG006|NOT COMPLETED|Overall Study||0||
59522953|NCT02094352|75617569|FG000|STARTED|Overall Study||2||
59522954|NCT02094352|75617570|FG001|STARTED|Overall Study||1||
59522955|NCT02094352|75617569|FG000|COMPLETED|Overall Study||2||
59522956|NCT02094352|75617570|FG001|COMPLETED|Overall Study||1||
59522957|NCT02094352|75617569|FG000|NOT COMPLETED|Overall Study||0||
59522958|NCT02094352|75617570|FG001|NOT COMPLETED|Overall Study||0||
59522959|NCT02552238|75617576|FG000|STARTED|Overall Study||174||
59522960|NCT02552238|75617576|FG000|COMPLETED|Overall Study|Of the 174 subjects enrolled in the study, 2 withdrew consent prior to administration of investigational product and 2 discontinued due to post-dose adverse event. Therefore, 170 subjects completed the study.|170||
59619859|NCT02707692|75731015|FG001|COMPLETED|Washout Between Cycles 1 and 2 (>=6 Wks)||6||
59619860|NCT02707692|75731016|FG002|COMPLETED|Washout Between Cycles 1 and 2 (>=6 Wks)||9||
59619861|NCT02707692|75731017|FG003|COMPLETED|Washout Between Cycles 1 and 2 (>=6 Wks)||8||
59619862|NCT02707692|75731018|FG004|COMPLETED|Washout Between Cycles 1 and 2 (>=6 Wks)||7||
59619863|NCT02707692|75731019|FG005|COMPLETED|Washout Between Cycles 1 and 2 (>=6 Wks)||8||
59619864|NCT02707692|75731014|FG000|NOT COMPLETED|Washout Between Cycles 1 and 2 (>=6 Wks)||1||
59619865|NCT02707692|75731015|FG001|NOT COMPLETED|Washout Between Cycles 1 and 2 (>=6 Wks)||0||
59619866|NCT02707692|75731016|FG002|NOT COMPLETED|Washout Between Cycles 1 and 2 (>=6 Wks)||0||
59619867|NCT02707692|75731017|FG003|NOT COMPLETED|Washout Between Cycles 1 and 2 (>=6 Wks)||1||
59619868|NCT02707692|75731018|FG004|NOT COMPLETED|Washout Between Cycles 1 and 2 (>=6 Wks)||1||
59619869|NCT02707692|75731019|FG005|NOT COMPLETED|Washout Between Cycles 1 and 2 (>=6 Wks)||0||
59619870|NCT02707692|75731014|FG000|STARTED|Cycle 2 (30 Days)||7||
59619871|NCT02707692|75731015|FG001|STARTED|Cycle 2 (30 Days)||6||
59619872|NCT02707692|75731016|FG002|STARTED|Cycle 2 (30 Days)||9||
60073406|NCT01690299|76188614|FG002|COMPLETED|Apremilast Extension Phase (Weeks16-104)||0||
60073407|NCT01690299|76188615|FG003|COMPLETED|Apremilast Extension Phase (Weeks16-104)||47||
60073408|NCT01690299|76188616|FG004|COMPLETED|Apremilast Extension Phase (Weeks16-104)||41||
60073409|NCT01690299|76188617|FG005|COMPLETED|Apremilast Extension Phase (Weeks16-104)||50||
60073410|NCT01690299|76188612|FG000|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||0||
60073411|NCT01690299|76188613|FG001|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||0||
60073412|NCT01690299|76188614|FG002|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||0||
60073413|NCT01690299|76188615|FG003|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||26||
60073414|NCT01690299|76188616|FG004|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||33||
60073415|NCT01690299|76188617|FG005|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||30||
60073416|NCT00723736|76188638|FG000|STARTED|Overall Study||100||
60073417|NCT00723736|76188638|FG000|COMPLETED|Overall Study|Subject's caregiver did not wish to continue, reasons unrelated.|99||
60073418|NCT00723736|76188638|FG000|NOT COMPLETED|Overall Study||1||
60073419|NCT00305344|76188642|FG000|STARTED|Overall Study||23||
59522961|NCT02552238|75617576|FG000|NOT COMPLETED|Overall Study||4||
59522962|NCT01188421|75617590|FG000|STARTED|Overall Study||31||
59522963|NCT01188421|75617591|FG001|STARTED|Overall Study||36||
59522964|NCT01188421|75617592|FG002|STARTED|Overall Study||36||
59522965|NCT01188421|75617590|FG000|COMPLETED|Overall Study||28||
59522966|NCT01188421|75617591|FG001|COMPLETED|Overall Study||26||
59522967|NCT01188421|75617592|FG002|COMPLETED|Overall Study||22||
59522968|NCT01188421|75617590|FG000|NOT COMPLETED|Overall Study||3||
59522969|NCT01188421|75617591|FG001|NOT COMPLETED|Overall Study||10||
59522970|NCT01188421|75617592|FG002|NOT COMPLETED|Overall Study||14||
59522971|NCT01006018|75617603|FG000|STARTED|Overall Study||0||
59522972|NCT01006018|75617604|FG001|STARTED|Overall Study||0||
59522973|NCT01006018|75617605|FG002|STARTED|Overall Study||0||
59522974|NCT01006018|75617603|FG000|COMPLETED|Overall Study||0||
59522975|NCT01006018|75617604|FG001|COMPLETED|Overall Study||0||
59522976|NCT01006018|75617605|FG002|COMPLETED|Overall Study||0||
59522977|NCT01006018|75617603|FG000|NOT COMPLETED|Overall Study||0||
59522978|NCT01006018|75617604|FG001|NOT COMPLETED|Overall Study||0||
59522979|NCT01006018|75617605|FG002|NOT COMPLETED|Overall Study||0||
59522980|NCT00996502|75617613|FG000|STARTED|Overall Study||4||
59522981|NCT00996502|75617613|FG000|COMPLETED|Overall Study||4||
59522982|NCT00996502|75617613|FG000|NOT COMPLETED|Overall Study||0||
59522983|NCT00984490|75617617|FG000|STARTED|Overall Study||5||
59522984|NCT00984490|75617617|FG000|COMPLETED|Overall Study||5||
59522985|NCT00984490|75617617|FG000|NOT COMPLETED|Overall Study||0||
59522986|NCT02027272|75617624|FG000|STARTED|Overall Study||0||
59522987|NCT02027272|75617625|FG001|STARTED|Overall Study||1||
59522988|NCT02027272|75617624|FG000|COMPLETED|Overall Study||0||
59522989|NCT02027272|75617625|FG001|COMPLETED|Overall Study||0||
59522990|NCT02027272|75617624|FG000|NOT COMPLETED|Overall Study||0||
59522991|NCT02027272|75617625|FG001|NOT COMPLETED|Overall Study||1||
59522992|NCT02012608|75617633|FG000|STARTED|Overall Study||7||
59522993|NCT02012608|75617634|FG001|STARTED|Overall Study||7||
59522994|NCT02012608|75617633|FG000|COMPLETED|Overall Study||4||
59522995|NCT02012608|75617634|FG001|COMPLETED|Overall Study||7||
59522996|NCT02012608|75617633|FG000|NOT COMPLETED|Overall Study||3||
59522997|NCT02012608|75617634|FG001|NOT COMPLETED|Overall Study||0||
59522998|NCT01996852|75617643|FG000|STARTED|Overall Study||0||
59522999|NCT01996852|75617644|FG001|STARTED|Overall Study||0||
59523000|NCT01996852|75617645|FG002|STARTED|Overall Study||0||
59523001|NCT01996852|75617643|FG000|COMPLETED|Overall Study||0||
59523002|NCT01996852|75617644|FG001|COMPLETED|Overall Study||0||
59523003|NCT01996852|75617645|FG002|COMPLETED|Overall Study||0||
59523004|NCT01996852|75617643|FG000|NOT COMPLETED|Overall Study||0||
59523005|NCT01996852|75617644|FG001|NOT COMPLETED|Overall Study||0||
59523006|NCT01996852|75617645|FG002|NOT COMPLETED|Overall Study||0||
59523007|NCT00978874|75617653|FG000|STARTED|Overall Study|The study was terminated and no data are available to be reported|0||
59523008|NCT00978874|75617653|FG000|COMPLETED|Overall Study|The study was terminated and no data are available to be reported|0||
59523009|NCT00978874|75617653|FG000|NOT COMPLETED|Overall Study||0||
59523010|NCT00970606|75617659|FG000|STARTED|Overall Study||4||
59523011|NCT00970606|75617660|FG001|STARTED|Overall Study||3||
59523012|NCT00970606|75617659|FG000|COMPLETED|Overall Study||4||
59523013|NCT00970606|75617660|FG001|COMPLETED|Overall Study||3||
59523014|NCT00970606|75617659|FG000|NOT COMPLETED|Overall Study||0||
59523015|NCT00970606|75617660|FG001|NOT COMPLETED|Overall Study||0||
59523016|NCT01973062|75617666|FG000|STARTED|Overall Study||1||
59523017|NCT01973062|75617666|FG000|COMPLETED|Overall Study||1||
59523018|NCT01973062|75617666|FG000|NOT COMPLETED|Overall Study||0||
59523019|NCT00981370|75617670|FG000|STARTED|Overall Study||0||
59523020|NCT00981370|75617670|FG000|COMPLETED|Overall Study||0||
59523021|NCT00981370|75617670|FG000|NOT COMPLETED|Overall Study||0||
59523022|NCT00979810|75617674|FG000|STARTED|Overall Study||11||
59523023|NCT00979810|75617674|FG000|COMPLETED|Overall Study||11||
59523024|NCT00979810|75617674|FG000|NOT COMPLETED|Overall Study||0||
59523025|NCT00947284|75617678|FG000|STARTED|Overall Study||0||
59523026|NCT00947284|75617679|FG001|STARTED|Overall Study||3||
59523027|NCT00947284|75617678|FG000|COMPLETED|Overall Study||0||
59523028|NCT00947284|75617679|FG001|COMPLETED|Overall Study||0||
59523029|NCT00947284|75617678|FG000|NOT COMPLETED|Overall Study||0||
59523030|NCT00947284|75617679|FG001|NOT COMPLETED|Overall Study||3||
59523031|NCT01946542|75617685|FG000|STARTED|Testing Visit 1||1||
59523032|NCT01946542|75617686|FG001|STARTED|Testing Visit 1||1||
59523033|NCT01946542|75617685|FG000|COMPLETED|Testing Visit 1||1||
59523034|NCT01946542|75617686|FG001|COMPLETED|Testing Visit 1||1||
59523035|NCT01946542|75617685|FG000|NOT COMPLETED|Testing Visit 1||0||
59523036|NCT01946542|75617686|FG001|NOT COMPLETED|Testing Visit 1||0||
59523037|NCT01946542|75617685|FG000|STARTED|Testing Visit 2||1||
59523038|NCT01946542|75617686|FG001|STARTED|Testing Visit 2||1||
59523039|NCT01946542|75617685|FG000|COMPLETED|Testing Visit 2||1||
59523040|NCT01946542|75617686|FG001|COMPLETED|Testing Visit 2||1||
59523041|NCT01946542|75617685|FG000|NOT COMPLETED|Testing Visit 2||0||
59523042|NCT01946542|75617686|FG001|NOT COMPLETED|Testing Visit 2||0||
59523043|NCT01921114|75617694|FG000|STARTED|Overall Study||0||
59523044|NCT01921114|75617695|FG001|STARTED|Overall Study||0||
59523045|NCT01921114|75617694|FG000|COMPLETED|Overall Study||0||
59523046|NCT01921114|75617695|FG001|COMPLETED|Overall Study||0||
59523047|NCT01921114|75617694|FG000|NOT COMPLETED|Overall Study||0||
59523048|NCT01921114|75617695|FG001|NOT COMPLETED|Overall Study||0||
59523049|NCT00932152|75617703|FG000|STARTED|Overall Study||1||
59523050|NCT00932152|75617704|FG001|STARTED|Overall Study||2||
59523051|NCT00932152|75617703|FG000|COMPLETED|Overall Study||0||
59523052|NCT00932152|75617704|FG001|COMPLETED|Overall Study||0||
59523053|NCT00932152|75617703|FG000|NOT COMPLETED|Overall Study||1||
59523054|NCT00932152|75617704|FG001|NOT COMPLETED|Overall Study||2||
59523055|NCT01916590|75617712|FG000|STARTED|Overall Study||4||
59523056|NCT01916590|75617713|FG001|STARTED|Overall Study||3||
59523057|NCT01916590|75617712|FG000|COMPLETED|Overall Study||4||
59523058|NCT01916590|75617713|FG001|COMPLETED|Overall Study||3||
59523059|NCT01916590|75617712|FG000|NOT COMPLETED|Overall Study||0||
59523060|NCT01916590|75617713|FG001|NOT COMPLETED|Overall Study||0||
59523061|NCT01890694|75617721|FG000|STARTED|Overall Study||1||
59523062|NCT01890694|75617722|FG001|STARTED|Overall Study||1||
59523063|NCT01890694|75617721|FG000|COMPLETED|Overall Study||0||
59523064|NCT01890694|75617722|FG001|COMPLETED|Overall Study||0||
59523065|NCT01890694|75617721|FG000|NOT COMPLETED|Overall Study||1||
59523066|NCT01890694|75617722|FG001|NOT COMPLETED|Overall Study||1||
59523067|NCT01883908|75617732|FG000|STARTED|Overall Study||3||
59523068|NCT01883908|75617733|FG001|STARTED|Overall Study||1||
59523069|NCT01883908|75617732|FG000|COMPLETED|Overall Study||3||
59523070|NCT01883908|75617733|FG001|COMPLETED|Overall Study||1||
59523071|NCT01883908|75617732|FG000|NOT COMPLETED|Overall Study||0||
59523072|NCT01883908|75617733|FG001|NOT COMPLETED|Overall Study||0||
59523073|NCT01869478|75617741|FG000|STARTED|Overall Study||0||
59523074|NCT01869478|75617742|FG001|STARTED|Overall Study||1||
59523075|NCT01869478|75617741|FG000|COMPLETED|Overall Study||0||
59523076|NCT01869478|75617742|FG001|COMPLETED|Overall Study||1||
59523077|NCT01869478|75617741|FG000|NOT COMPLETED|Overall Study||0||
59523078|NCT01869478|75617742|FG001|NOT COMPLETED|Overall Study||0||
59523079|NCT01844206|75617750|FG000|STARTED|Overall Study||2||
59523080|NCT01844206|75617751|FG001|STARTED|Overall Study||3||
59523081|NCT01844206|75617750|FG000|COMPLETED|Overall Study||2||
59523082|NCT01844206|75617751|FG001|COMPLETED|Overall Study|One patient requested that epidural catheter be removed during the first post-operative day.|2||
59523083|NCT01844206|75617750|FG000|NOT COMPLETED|Overall Study||0||
59523084|NCT01844206|75617751|FG001|NOT COMPLETED|Overall Study||1||
59523085|NCT00897910|75617757|FG000|STARTED|Overall Study|None of the blood samples were analyzed due to lack of funding. No tissue sample was collected.|6||
59523086|NCT00897910|75617757|FG000|COMPLETED|Overall Study|None of the blood samples were analyzed due to lack of funding. No tissue sample was collected|6||
59523087|NCT00897910|75617757|FG000|NOT COMPLETED|Overall Study||0||
59523088|NCT01834144|75617763|FG000|STARTED|Overall Study||1||
59523089|NCT01834144|75617764|FG001|STARTED|Overall Study||3||
59523090|NCT01834144|75617763|FG000|COMPLETED|Overall Study||1||
59523091|NCT01834144|75617764|FG001|COMPLETED|Overall Study||2||
59523092|NCT01834144|75617763|FG000|NOT COMPLETED|Overall Study||0||
59523093|NCT01834144|75617764|FG001|NOT COMPLETED|Overall Study||1||
59523094|NCT01814722|75617773|FG000|STARTED|Overall Study||36||
59523095|NCT01814722|75617774|FG001|STARTED|Overall Study||21||
59523096|NCT01814722|75617775|FG002|STARTED|Overall Study||6||
59523097|NCT01814722|75617773|FG000|COMPLETED|Overall Study||36||
59523098|NCT01814722|75617774|FG001|COMPLETED|Overall Study||21||
59523099|NCT01814722|75617775|FG002|COMPLETED|Overall Study||6||
59523100|NCT01814722|75617773|FG000|NOT COMPLETED|Overall Study||0||
59523101|NCT01814722|75617774|FG001|NOT COMPLETED|Overall Study||0||
59523102|NCT01814722|75617775|FG002|NOT COMPLETED|Overall Study||0||
59523103|NCT01830790|75617785|FG000|STARTED|Overall Study||0||
59523104|NCT01830790|75617786|FG001|STARTED|Overall Study||10||
59523105|NCT01830790|75617785|FG000|COMPLETED|Overall Study||0||
59523106|NCT01830790|75617786|FG001|COMPLETED|Overall Study||10||
60073420|NCT00305344|76188642|FG000|COMPLETED|Overall Study||23||
59523107|NCT01830790|75617785|FG000|NOT COMPLETED|Overall Study||0||
59523108|NCT01830790|75617786|FG001|NOT COMPLETED|Overall Study||0||
59523109|NCT01662102|75617794|FG000|STARTED|Overall Study||1||
59523110|NCT01662102|75617795|FG001|STARTED|Overall Study||0||
59523111|NCT01662102|75617794|FG000|COMPLETED|Overall Study||0||
59523112|NCT01662102|75617795|FG001|COMPLETED|Overall Study||0||
59523113|NCT01662102|75617794|FG000|NOT COMPLETED|Overall Study||1||
60073421|NCT00305344|76188642|FG000|NOT COMPLETED|Overall Study||0||
59523114|NCT01662102|75617795|FG001|NOT COMPLETED|Overall Study||0||
59523115|NCT01808950|75617805|FG000|STARTED|Overall Study||1||
59523116|NCT01808950|75617806|FG001|STARTED|Overall Study||3||
59523117|NCT01808950|75617807|FG002|STARTED|Overall Study||0||
59523118|NCT01808950|75617805|FG000|COMPLETED|Overall Study||1||
59523119|NCT01808950|75617806|FG001|COMPLETED|Overall Study||3||
59523120|NCT01808950|75617807|FG002|COMPLETED|Overall Study||0||
59523121|NCT01808950|75617805|FG000|NOT COMPLETED|Overall Study||0||
59523122|NCT01808950|75617806|FG001|NOT COMPLETED|Overall Study||0||
59523123|NCT01808950|75617807|FG002|NOT COMPLETED|Overall Study||0||
59523124|NCT01808794|75617820|FG000|STARTED|Overall Study||0||
59523125|NCT01808794|75617821|FG001|STARTED|Overall Study||0||
59523126|NCT01808794|75617820|FG000|COMPLETED|Overall Study||0||
59523127|NCT01808794|75617821|FG001|COMPLETED|Overall Study||0||
59523128|NCT01808794|75617820|FG000|NOT COMPLETED|Overall Study||0||
59523129|NCT01808794|75617821|FG001|NOT COMPLETED|Overall Study||0||
59523130|NCT00850720|75617827|FG000|STARTED|Overall Study||0||
59523131|NCT00850720|75617827|FG000|COMPLETED|Overall Study||0||
59523132|NCT00850720|75617827|FG000|NOT COMPLETED|Overall Study||0||
59523133|NCT00843310|75617831|FG000|STARTED|Overall Study||8||
59523134|NCT00843310|75617831|FG000|COMPLETED|Overall Study||1||
59523135|NCT00843310|75617831|FG000|NOT COMPLETED|Overall Study||7||
59523136|NCT02554656|75617835|FG000|STARTED|Overall Study||89||
59523137|NCT02554656|75617835|FG000|COMPLETED|Overall Study||86||
59523138|NCT02554656|75617835|FG000|NOT COMPLETED|Overall Study||3||
59523139|NCT00809458|75617841|FG000|STARTED|Overall Study||9||
59523140|NCT00809458|75617842|FG001|STARTED|Overall Study||6||
59523141|NCT00809458|75617841|FG000|COMPLETED|Overall Study||8||
59523142|NCT00809458|75617842|FG001|COMPLETED|Overall Study||5||
59523143|NCT00809458|75617841|FG000|NOT COMPLETED|Overall Study||1||
59523144|NCT00809458|75617842|FG001|NOT COMPLETED|Overall Study||1||
59523145|NCT01697332|75617848|FG000|STARTED|Overall Study||1||
59523146|NCT01697332|75617848|FG000|COMPLETED|Overall Study||1||
59523147|NCT01697332|75617848|FG000|NOT COMPLETED|Overall Study||0||
59523148|NCT01701622|75617852|FG000|STARTED|Overall Study||1||
59523149|NCT01701622|75617852|FG000|COMPLETED|Overall Study||1||
59523150|NCT01701622|75617852|FG000|NOT COMPLETED|Overall Study||0||
59523151|NCT01668940|75617861|FG000|STARTED|Overall Study||17||
59953417|NCT04057820|76071786|FG006|STARTED|Period 10||0||0
59953418|NCT04057820|76071787|FG007|STARTED|Period 10||7||3
59523152|NCT01668940|75617862|FG001|STARTED|Overall Study||14||
59523153|NCT01668940|75617863|FG002|STARTED|Overall Study||9||
59523154|NCT01668940|75617864|FG003|STARTED|Overall Study||14||
59523155|NCT01668940|75617861|FG000|COMPLETED|Overall Study|Data collection was completed, but data analysis did not occur due to study closure.|17||
59523156|NCT01668940|75617862|FG001|COMPLETED|Overall Study|Data collection was completed, but data analysis did not occur due to study closure.|14||
59523157|NCT01668940|75617863|FG002|COMPLETED|Overall Study|Data collection was completed, but data analysis did not occur due to study closure.|9||
59523158|NCT01668940|75617864|FG003|COMPLETED|Overall Study|Data collection was completed, but data analysis did not occur due to study closure.|14||
59523159|NCT01668940|75617861|FG000|NOT COMPLETED|Overall Study||0||
59523160|NCT01668940|75617862|FG001|NOT COMPLETED|Overall Study||0||
59523161|NCT01668940|75617863|FG002|NOT COMPLETED|Overall Study||0||
59523162|NCT01668940|75617864|FG003|NOT COMPLETED|Overall Study||0||
59523163|NCT01675960|75617876|FG000|STARTED|Overall Study||2||
59523164|NCT01675960|75617877|FG001|STARTED|Overall Study||0||
59523165|NCT01675960|75617876|FG000|COMPLETED|Overall Study||2||
59523166|NCT01675960|75617877|FG001|COMPLETED|Overall Study||0||
59523167|NCT01675960|75617876|FG000|NOT COMPLETED|Overall Study||0||
59523168|NCT01675960|75617877|FG001|NOT COMPLETED|Overall Study||0||
59523169|NCT04053868|75617883|FG000|STARTED|Overall Study||10||
59523170|NCT04053868|75617884|FG001|STARTED|Overall Study||7||
59523171|NCT04053868|75617883|FG000|COMPLETED|Overall Study||9||
59523172|NCT04053868|75617884|FG001|COMPLETED|Overall Study||7||
59523173|NCT04053868|75617883|FG000|NOT COMPLETED|Overall Study||1||
59523174|NCT04053868|75617884|FG001|NOT COMPLETED|Overall Study||0||
59523175|NCT00787618|75617894|FG000|STARTED|Overall Study||3||
59523176|NCT00787618|75617895|FG001|STARTED|Overall Study||0||
59523177|NCT00787618|75617896|FG002|STARTED|Overall Study||3||
59523178|NCT00787618|75617894|FG000|COMPLETED|Overall Study||3||
59523179|NCT00787618|75617895|FG001|COMPLETED|Overall Study||0||
59523180|NCT00787618|75617896|FG002|COMPLETED|Overall Study||3||
59523181|NCT00787618|75617894|FG000|NOT COMPLETED|Overall Study||0||
59523182|NCT00787618|75617895|FG001|NOT COMPLETED|Overall Study||0||
59523183|NCT00787618|75617896|FG002|NOT COMPLETED|Overall Study||0||
59523184|NCT00749476|75617904|FG000|STARTED|Overall Study||1||
59523185|NCT00749476|75617904|FG000|COMPLETED|Overall Study||1||
59523186|NCT00749476|75617904|FG000|NOT COMPLETED|Overall Study||0||
59523187|NCT01607320|75617908|FG000|STARTED|Overall Study|The study was randomized between the two treatments and was never unblinded,therefore unknown.|0||
59523188|NCT01607320|75617909|FG001|STARTED|Overall Study|The study was randomized between the two treatments and was never unblinded,therefore unknown.|0||
59523189|NCT01607320|75617908|FG000|COMPLETED|Overall Study|The study was randomized between the 2 treatments and was never unblinded,so unknown.|0||
59523190|NCT01607320|75617909|FG001|COMPLETED|Overall Study|The study was randomized between the two treatments and was never unblinded,therefore unknown.|0||
59523191|NCT01607320|75617908|FG000|NOT COMPLETED|Overall Study||0||
59523192|NCT01607320|75617909|FG001|NOT COMPLETED|Overall Study||0||
59523193|NCT01606150|75617915|FG000|STARTED|Overall Study||0||
59523194|NCT01606150|75617916|FG001|STARTED|Overall Study||0||
59953419|NCT04057820|76071788|FG008|STARTED|Period 10||0||0
59953420|NCT04057820|76071789|FG009|STARTED|Period 10||32||4
59953421|NCT04057820|76071790|FG010|STARTED|Period 10||0||0
59953422|NCT04057820|76071791|FG011|STARTED|Period 10||17||4
59953423|NCT04057820|76071792|FG012|STARTED|Period 10||0||0
59953424|NCT04057820|76071793|FG013|STARTED|Period 10||23||3
59523195|NCT01606150|75617915|FG000|COMPLETED|Overall Study|Enrollment was only for two months in 2012 due to technical and enrollment problems|0||
59523196|NCT01606150|75617916|FG001|COMPLETED|Overall Study|Enrollment was only for two months in 2012 due to technical and enrollment problems|0||
59523197|NCT01606150|75617915|FG000|NOT COMPLETED|Overall Study||0||
59523198|NCT01606150|75617916|FG001|NOT COMPLETED|Overall Study||0||
59953425|NCT04057820|76071794|FG014|STARTED|Period 10||0||0
59953426|NCT04057820|76071795|FG015|STARTED|Period 10||15||3
59953427|NCT04057820|76071780|FG000|COMPLETED|Period 10||0||0
59619873|NCT02707692|75731017|FG003|STARTED|Cycle 2 (30 Days)||8||
59619874|NCT02707692|75731018|FG004|STARTED|Cycle 2 (30 Days)||7||
59619875|NCT02707692|75731019|FG005|STARTED|Cycle 2 (30 Days)||8||
59619876|NCT02707692|75731014|FG000|COMPLETED|Cycle 2 (30 Days)||6||
59619877|NCT02707692|75731015|FG001|COMPLETED|Cycle 2 (30 Days)||6||
59619878|NCT02707692|75731016|FG002|COMPLETED|Cycle 2 (30 Days)||9||
59619879|NCT02707692|75731017|FG003|COMPLETED|Cycle 2 (30 Days)||7||
59619880|NCT02707692|75731018|FG004|COMPLETED|Cycle 2 (30 Days)||4||
59619881|NCT02707692|75731019|FG005|COMPLETED|Cycle 2 (30 Days)||7||
59619882|NCT02707692|75731014|FG000|NOT COMPLETED|Cycle 2 (30 Days)||1||
59619883|NCT02707692|75731015|FG001|NOT COMPLETED|Cycle 2 (30 Days)||0||
59619884|NCT02707692|75731016|FG002|NOT COMPLETED|Cycle 2 (30 Days)||0||
59619885|NCT02707692|75731017|FG003|NOT COMPLETED|Cycle 2 (30 Days)||1||
59619886|NCT02707692|75731018|FG004|NOT COMPLETED|Cycle 2 (30 Days)||3||
59619887|NCT02707692|75731019|FG005|NOT COMPLETED|Cycle 2 (30 Days)||1||
59619888|NCT02707692|75731014|FG000|STARTED|Washout Between Cycles 2 and 3 (>=6 Wks)||7||
59619889|NCT02707692|75731015|FG001|STARTED|Washout Between Cycles 2 and 3 (>=6 Wks)||6||
59619890|NCT02707692|75731016|FG002|STARTED|Washout Between Cycles 2 and 3 (>=6 Wks)||9||
59619891|NCT02707692|75731017|FG003|STARTED|Washout Between Cycles 2 and 3 (>=6 Wks)||7||
59619892|NCT02707692|75731018|FG004|STARTED|Washout Between Cycles 2 and 3 (>=6 Wks)||6||
59619893|NCT02707692|75731019|FG005|STARTED|Washout Between Cycles 2 and 3 (>=6 Wks)||7||
59619894|NCT02707692|75731014|FG000|COMPLETED|Washout Between Cycles 2 and 3 (>=6 Wks)||7||
59619895|NCT02707692|75731015|FG001|COMPLETED|Washout Between Cycles 2 and 3 (>=6 Wks)||6||
59619896|NCT02707692|75731016|FG002|COMPLETED|Washout Between Cycles 2 and 3 (>=6 Wks)||9||
59619897|NCT02707692|75731017|FG003|COMPLETED|Washout Between Cycles 2 and 3 (>=6 Wks)||5||
59619898|NCT02707692|75731018|FG004|COMPLETED|Washout Between Cycles 2 and 3 (>=6 Wks)||6||
59619899|NCT02707692|75731019|FG005|COMPLETED|Washout Between Cycles 2 and 3 (>=6 Wks)||6||
59619900|NCT02707692|75731014|FG000|NOT COMPLETED|Washout Between Cycles 2 and 3 (>=6 Wks)||0||
59619901|NCT02707692|75731015|FG001|NOT COMPLETED|Washout Between Cycles 2 and 3 (>=6 Wks)||0||
59619902|NCT02707692|75731016|FG002|NOT COMPLETED|Washout Between Cycles 2 and 3 (>=6 Wks)||0||
59619903|NCT02707692|75731017|FG003|NOT COMPLETED|Washout Between Cycles 2 and 3 (>=6 Wks)||2||
59619904|NCT02707692|75731018|FG004|NOT COMPLETED|Washout Between Cycles 2 and 3 (>=6 Wks)||0||
59619905|NCT02707692|75731019|FG005|NOT COMPLETED|Washout Between Cycles 2 and 3 (>=6 Wks)||1||
59619906|NCT02707692|75731014|FG000|STARTED|Cycle 3 (30 Days)||7||
59619907|NCT02707692|75731015|FG001|STARTED|Cycle 3 (30 Days)||6||
59619908|NCT02707692|75731016|FG002|STARTED|Cycle 3 (30 Days)||9||
59619909|NCT02707692|75731017|FG003|STARTED|Cycle 3 (30 Days)||5||
59523199|NCT00747916|75617922|FG000|STARTED|Overall Study||3||
59523200|NCT00747916|75617922|FG000|COMPLETED|Overall Study||3||
59523201|NCT00747916|75617922|FG000|NOT COMPLETED|Overall Study||0||
59523202|NCT00739024|75617928|FG000|STARTED|Overall Study||7||
59523203|NCT00739024|75617929|FG001|STARTED|Overall Study||6||
59953428|NCT04057820|76071781|FG001|COMPLETED|Period 10||26||4
59953429|NCT04057820|76071782|FG002|COMPLETED|Period 10||0||0
59953430|NCT04057820|76071783|FG003|COMPLETED|Period 10||8||2
59523204|NCT00739024|75617928|FG000|COMPLETED|Overall Study||7||
59523205|NCT00739024|75617929|FG001|COMPLETED|Overall Study||6||
59619910|NCT02707692|75731018|FG004|STARTED|Cycle 3 (30 Days)||6||
59619911|NCT02707692|75731019|FG005|STARTED|Cycle 3 (30 Days)||6||
59619912|NCT02707692|75731014|FG000|COMPLETED|Cycle 3 (30 Days)||5||
59619913|NCT02707692|75731015|FG001|COMPLETED|Cycle 3 (30 Days)||5||
59523206|NCT00739024|75617928|FG000|NOT COMPLETED|Overall Study||0||
59523207|NCT00739024|75617929|FG001|NOT COMPLETED|Overall Study||0||
59523208|NCT01602016|75617935|FG000|STARTED|Overall Study||0||
59953431|NCT04057820|76071784|FG004|COMPLETED|Period 10||0||0
59953432|NCT04057820|76071785|FG005|COMPLETED|Period 10||17||3
59953433|NCT04057820|76071786|FG006|COMPLETED|Period 10||0||0
59953434|NCT04057820|76071787|FG007|COMPLETED|Period 10||7||3
59953435|NCT04057820|76071788|FG008|COMPLETED|Period 10||0||0
59953436|NCT04057820|76071789|FG009|COMPLETED|Period 10||32||4
59953437|NCT04057820|76071790|FG010|COMPLETED|Period 10||0||0
59953438|NCT04057820|76071791|FG011|COMPLETED|Period 10||17||4
59953439|NCT04057820|76071792|FG012|COMPLETED|Period 10||0||0
59953440|NCT04057820|76071793|FG013|COMPLETED|Period 10||23||3
59953441|NCT04057820|76071794|FG014|COMPLETED|Period 10||0||0
59953442|NCT04057820|76071795|FG015|COMPLETED|Period 10||15||3
59953443|NCT04057820|76071780|FG000|NOT COMPLETED|Period 10||0||0
59953444|NCT04057820|76071781|FG001|NOT COMPLETED|Period 10||0||0
59953445|NCT04057820|76071782|FG002|NOT COMPLETED|Period 10||0||0
59953446|NCT04057820|76071783|FG003|NOT COMPLETED|Period 10||0||0
59953447|NCT04057820|76071784|FG004|NOT COMPLETED|Period 10||0||0
59953448|NCT04057820|76071785|FG005|NOT COMPLETED|Period 10||0||0
59953449|NCT04057820|76071786|FG006|NOT COMPLETED|Period 10||0||0
59953450|NCT04057820|76071787|FG007|NOT COMPLETED|Period 10||0||0
59953451|NCT04057820|76071788|FG008|NOT COMPLETED|Period 10||0||0
59953452|NCT04057820|76071789|FG009|NOT COMPLETED|Period 10||0||0
60073422|NCT01690143|76188646|FG000|STARTED|Overall Study||45||
59953453|NCT04057820|76071790|FG010|NOT COMPLETED|Period 10||0||0
59953454|NCT04057820|76071791|FG011|NOT COMPLETED|Period 10||0||0
60073423|NCT01690143|76188646|FG000|COMPLETED|Overall Study||44||
60073424|NCT01690143|76188646|FG000|NOT COMPLETED|Overall Study||1||
60073425|NCT03567850|76188653|FG000|STARTED|Overall Study||25||
60073426|NCT03567850|76188654|FG001|STARTED|Overall Study||25||
60073427|NCT03567850|76188653|FG000|COMPLETED|Overall Study||25||
60073428|NCT03567850|76188654|FG001|COMPLETED|Overall Study||25||
59619914|NCT02707692|75731016|FG002|COMPLETED|Cycle 3 (30 Days)||9||
59619915|NCT02707692|75731017|FG003|COMPLETED|Cycle 3 (30 Days)||5||
59953455|NCT04057820|76071792|FG012|NOT COMPLETED|Period 10||0||0
59953456|NCT04057820|76071793|FG013|NOT COMPLETED|Period 10||0||0
59953457|NCT04057820|76071794|FG014|NOT COMPLETED|Period 10||0||0
59953458|NCT04057820|76071795|FG015|NOT COMPLETED|Period 10||0||0
59953459|NCT04004988|76071801|FG000|STARTED|Period 1||24||
59953460|NCT04004988|76071802|FG001|STARTED|Period 1||23||
59953461|NCT04004988|76071801|FG000|Received at Least One Dose of Study Drug|Period 1||22||
59953462|NCT04004988|76071802|FG001|Received at Least One Dose of Study Drug|Period 1||23||
59953463|NCT04004988|76071801|FG000|COMPLETED|Period 1||21||
59953464|NCT04004988|76071802|FG001|COMPLETED|Period 1||20||
60073429|NCT03567850|76188653|FG000|NOT COMPLETED|Overall Study||0||
60073430|NCT03567850|76188654|FG001|NOT COMPLETED|Overall Study||0||
60073431|NCT01559259|76188665|FG000|STARTED|Overall Study||30||
60073432|NCT01559259|76188666|FG001|STARTED|Overall Study||90||
59953465|NCT04004988|76071801|FG000|NOT COMPLETED|Period 1||3||
59953466|NCT04004988|76071802|FG001|NOT COMPLETED|Period 1||3||
59523209|NCT01602016|75617935|FG000|COMPLETED|Overall Study||0||
59523210|NCT01602016|75617935|FG000|NOT COMPLETED|Overall Study||0||
59523211|NCT01591954|75617942|FG000|STARTED|Overall Study||1||
59953467|NCT04004988|76071801|FG000|STARTED|Period 2||21||
59953468|NCT04004988|76071802|FG001|STARTED|Period 2||20||
59953469|NCT04004988|76071801|FG000|Received at Least One Dose of Study Drug|Period 2||21||
59953470|NCT04004988|76071802|FG001|Received at Least One Dose of Study Drug|Period 2||20||
59953471|NCT04004988|76071801|FG000|COMPLETED|Period 2||21||
59953472|NCT04004988|76071802|FG001|COMPLETED|Period 2||20||
59953473|NCT04004988|76071801|FG000|NOT COMPLETED|Period 2||0||
59789997|NCT03131648|75910126|FG000|STARTED|Maintenance Treatment Period||0|Maintenance treatment period was in parallel to the open-label treatment period.|
59789998|NCT03131648|75910127|FG001|STARTED|Maintenance Treatment Period||0|Maintenance treatment period was in parallel to the open-label treatment period.|
59789999|NCT03131648|75910128|FG002|STARTED|Maintenance Treatment Period||71|Maintenance treatment period was in parallel to the open-label treatment period.|
59790000|NCT03131648|75910129|FG003|STARTED|Maintenance Treatment Period||78|Maintenance treatment period was in parallel to the open-label treatment period.|
59790001|NCT03131648|75910130|FG004|STARTED|Maintenance Treatment Period||36|Maintenance treatment period was in parallel to the open-label treatment period.|
59790002|NCT03131648|75910131|FG005|STARTED|Maintenance Treatment Period||29|Maintenance treatment period was in parallel to the open-label treatment period.|
59790003|NCT03131648|75910132|FG006|STARTED|Maintenance Treatment Period||0|Maintenance treatment period was in parallel to the open-label treatment period.|
59790004|NCT03131648|75910133|FG007|STARTED|Maintenance Treatment Period||0|Maintenance treatment period was in parallel to the open-label treatment period.|
59790005|NCT03131648|75910126|FG000|COMPLETED|Maintenance Treatment Period||0||
59790006|NCT03131648|75910127|FG001|COMPLETED|Maintenance Treatment Period||0||
59790007|NCT03131648|75910128|FG002|COMPLETED|Maintenance Treatment Period||44||
59790008|NCT03131648|75910129|FG003|COMPLETED|Maintenance Treatment Period||53||
59790009|NCT03131648|75910130|FG004|COMPLETED|Maintenance Treatment Period||21||
59790010|NCT03131648|75910131|FG005|COMPLETED|Maintenance Treatment Period||15||
59790011|NCT03131648|75910132|FG006|COMPLETED|Maintenance Treatment Period||0||
59790012|NCT03131648|75910133|FG007|COMPLETED|Maintenance Treatment Period||0||
59790013|NCT03131648|75910126|FG000|NOT COMPLETED|Maintenance Treatment Period||0||
59790014|NCT03131648|75910127|FG001|NOT COMPLETED|Maintenance Treatment Period||0||
59790015|NCT03131648|75910128|FG002|NOT COMPLETED|Maintenance Treatment Period||27||
59790016|NCT03131648|75910129|FG003|NOT COMPLETED|Maintenance Treatment Period||25||
59790017|NCT03131648|75910130|FG004|NOT COMPLETED|Maintenance Treatment Period||15||
59790018|NCT03131648|75910131|FG005|NOT COMPLETED|Maintenance Treatment Period||14||
59790019|NCT03131648|75910132|FG006|NOT COMPLETED|Maintenance Treatment Period||0||
59790020|NCT03131648|75910133|FG007|NOT COMPLETED|Maintenance Treatment Period||0||
59790021|NCT03131648|75910126|FG000|STARTED|Open-label (Short Term Extension)||0||
59790022|NCT03131648|75910127|FG001|STARTED|Open-label (Short Term Extension)||0||
59790023|NCT03131648|75910128|FG002|STARTED|Open-label (Short Term Extension)||0||
59790024|NCT03131648|75910129|FG003|STARTED|Open-label (Short Term Extension)||0||
59790025|NCT03131648|75910130|FG004|STARTED|Open-label (Short Term Extension)||0||
59790026|NCT03131648|75910131|FG005|STARTED|Open-label (Short Term Extension)||0||
59790027|NCT03131648|75910132|FG006|STARTED|Open-label (Short Term Extension)||0||
59790028|NCT03131648|75910133|FG007|STARTED|Open-label (Short Term Extension)||65||
59790029|NCT03131648|75910126|FG000|COMPLETED|Open-label (Short Term Extension)||0||
59790030|NCT03131648|75910127|FG001|COMPLETED|Open-label (Short Term Extension)||0||
59790031|NCT03131648|75910128|FG002|COMPLETED|Open-label (Short Term Extension)||0||
59790032|NCT03131648|75910129|FG003|COMPLETED|Open-label (Short Term Extension)||0||
59790033|NCT03131648|75910130|FG004|COMPLETED|Open-label (Short Term Extension)||0||
59790034|NCT03131648|75910131|FG005|COMPLETED|Open-label (Short Term Extension)||0||
59790035|NCT03131648|75910132|FG006|COMPLETED|Open-label (Short Term Extension)||0||
59790036|NCT03131648|75910133|FG007|COMPLETED|Open-label (Short Term Extension)||62||
59790037|NCT03131648|75910126|FG000|NOT COMPLETED|Open-label (Short Term Extension)||0||
59790038|NCT03131648|75910127|FG001|NOT COMPLETED|Open-label (Short Term Extension)||0||
59790039|NCT03131648|75910128|FG002|NOT COMPLETED|Open-label (Short Term Extension)||0||
59953474|NCT04004988|76071802|FG001|NOT COMPLETED|Period 2||0||
59953475|NCT03898700|76071809|FG000|STARTED|Overall Study||9||
59953476|NCT03898700|76071809|FG000|COMPLETED|Overall Study||7||
59953477|NCT03898700|76071809|FG000|NOT COMPLETED|Overall Study||2||
59953478|NCT03636386|76071815|FG000|STARTED|Overall Study||24||
59953479|NCT03636386|76071816|FG001|STARTED|Overall Study||24||
59953480|NCT03636386|76071815|FG000|COMPLETED|Overall Study||24||
60073433|NCT01559259|76188667|FG002|STARTED|Overall Study||93||
60073434|NCT01559259|76188668|FG003|STARTED|Overall Study||89||
59523212|NCT01591954|75617942|FG000|COMPLETED|Overall Study||1||
59523213|NCT01591954|75617942|FG000|NOT COMPLETED|Overall Study||0||
59619916|NCT02707692|75731018|FG004|COMPLETED|Cycle 3 (30 Days)||5||
59619917|NCT02707692|75731019|FG005|COMPLETED|Cycle 3 (30 Days)||5||
59619918|NCT02707692|75731014|FG000|NOT COMPLETED|Cycle 3 (30 Days)||2||
59619919|NCT02707692|75731015|FG001|NOT COMPLETED|Cycle 3 (30 Days)||1||
59619920|NCT02707692|75731016|FG002|NOT COMPLETED|Cycle 3 (30 Days)||0||
59619921|NCT02707692|75731017|FG003|NOT COMPLETED|Cycle 3 (30 Days)||0||
59619922|NCT02707692|75731018|FG004|NOT COMPLETED|Cycle 3 (30 Days)||1||
59619923|NCT02707692|75731019|FG005|NOT COMPLETED|Cycle 3 (30 Days)||1||
59619924|NCT02703948|75731027|FG000|STARTED|Overall Study||60||
59619925|NCT02703948|75731027|FG000|COMPLETED|Overall Study||57||
59619926|NCT02703948|75731027|FG000|NOT COMPLETED|Overall Study||3||
59619927|NCT02697006|75731033|FG000|STARTED|Overall Study||34||
59619928|NCT02697006|75731034|FG001|STARTED|Overall Study||13||
59619929|NCT02697006|75731033|FG000|COMPLETED|Overall Study||31||
59619930|NCT02697006|75731034|FG001|COMPLETED|Overall Study||9||
59619931|NCT02697006|75731033|FG000|NOT COMPLETED|Overall Study||3||
59619932|NCT02697006|75731034|FG001|NOT COMPLETED|Overall Study||4||
59619933|NCT02666742|75731042|FG000|STARTED|Overall Study||123||
59619934|NCT02666742|75731043|FG001|STARTED|Overall Study||123||
59619935|NCT02666742|75731042|FG000|COMPLETED|Overall Study||123||
59619936|NCT02666742|75731043|FG001|COMPLETED|Overall Study||123||
59619937|NCT02666742|75731042|FG000|NOT COMPLETED|Overall Study||0||
59619938|NCT02666742|75731043|FG001|NOT COMPLETED|Overall Study||0||
59619939|NCT02630316|75731053|FG000|STARTED|Overall Study||163||
59619940|NCT02630316|75731054|FG001|STARTED|Overall Study||163||
59619941|NCT02630316|75731053|FG000|COMPLETED|Overall Study||128||
59619942|NCT02630316|75731054|FG001|COMPLETED|Overall Study||130||
59619943|NCT02630316|75731053|FG000|NOT COMPLETED|Overall Study||35||
59619944|NCT02630316|75731054|FG001|NOT COMPLETED|Overall Study||33||
59619945|NCT02354820|75731062|FG000|STARTED|Overall Study||9667||
59619946|NCT02354820|75731063|FG001|STARTED|Overall Study||6597||
59619947|NCT02354820|75731062|FG000|COMPLETED|Overall Study||9667||
59619948|NCT02354820|75731063|FG001|COMPLETED|Overall Study||6597||
59619949|NCT02354820|75731062|FG000|NOT COMPLETED|Overall Study||0||
59619950|NCT02354820|75731063|FG001|NOT COMPLETED|Overall Study||0||
59619951|NCT02613936|75731071|FG000|STARTED|Overall Study||20||
59523214|NCT00731770|75617948|FG000|STARTED|Overall Study||5||
59523215|NCT00731770|75617949|FG001|STARTED|Overall Study||5||
59523216|NCT00731770|75617948|FG000|COMPLETED|Overall Study||5||
59523217|NCT00731770|75617949|FG001|COMPLETED|Overall Study||5||
59619952|NCT02613936|75731072|FG001|STARTED|Overall Study||20||
59619953|NCT02613936|75731071|FG000|COMPLETED|Overall Study||17||
59619954|NCT02613936|75731072|FG001|COMPLETED|Overall Study||17||
59619955|NCT02613936|75731071|FG000|NOT COMPLETED|Overall Study||3||
59619956|NCT02613936|75731072|FG001|NOT COMPLETED|Overall Study||3||
59619957|NCT02545608|75731080|FG000|STARTED|Overall Study||9||
59619958|NCT02545608|75731081|FG001|STARTED|Overall Study|Split hand study design. Total no. of subjects in Randomised group and No-treatment control is 100.|100||
59619959|NCT02545608|75731080|FG000|COMPLETED|Overall Study||9||
59619960|NCT02545608|75731081|FG001|COMPLETED|Overall Study||93||
59619961|NCT02545608|75731080|FG000|NOT COMPLETED|Overall Study||0||
59953481|NCT03636386|76071816|FG001|COMPLETED|Overall Study||24||
59953482|NCT03636386|76071815|FG000|NOT COMPLETED|Overall Study||0||
59953483|NCT03636386|76071816|FG001|NOT COMPLETED|Overall Study||0||
60073435|NCT01559259|76188669|FG004|STARTED|Overall Study||92||
59523218|NCT00731770|75617948|FG000|NOT COMPLETED|Overall Study||0||
59523219|NCT00731770|75617949|FG001|NOT COMPLETED|Overall Study||0||
59523220|NCT01589926|75617959|FG000|STARTED|Overall Study||0||
59523221|NCT01589926|75617960|FG001|STARTED|Overall Study||0||
59523222|NCT01589926|75617959|FG000|COMPLETED|Overall Study||0||
59619962|NCT02545608|75731081|FG001|NOT COMPLETED|Overall Study||7||
59619963|NCT01981044|75731088|FG000|STARTED|Overall Study||1||
59619964|NCT01981044|75731088|FG000|COMPLETED|Overall Study||1||
59619965|NCT01981044|75731088|FG000|NOT COMPLETED|Overall Study||0||
59619966|NCT02513784|75731094|FG000|STARTED|Overall Study||10||
59619967|NCT02513784|75731095|FG001|STARTED|Overall Study||10||
59619968|NCT02513784|75731094|FG000|COMPLETED|Overall Study||10||
59619969|NCT02513784|75731095|FG001|COMPLETED|Overall Study||10||
59619970|NCT02513784|75731094|FG000|NOT COMPLETED|Overall Study||0||
59523223|NCT01589926|75617960|FG001|COMPLETED|Overall Study||0||
59523224|NCT01589926|75617959|FG000|NOT COMPLETED|Overall Study||0||
59523225|NCT01589926|75617960|FG001|NOT COMPLETED|Overall Study||0||
59619971|NCT02513784|75731095|FG001|NOT COMPLETED|Overall Study||0||
59619972|NCT02369484|75731101|FG000|STARTED|Overall Study||13||
59619973|NCT02369484|75731101|FG000|COMPLETED|Overall Study||13||
59953484|NCT03586973|76071824|FG000|STARTED|Overall Study||20||
59790040|NCT03131648|75910129|FG003|NOT COMPLETED|Open-label (Short Term Extension)||0||
59790041|NCT03131648|75910130|FG004|NOT COMPLETED|Open-label (Short Term Extension)||0||
59790042|NCT03131648|75910131|FG005|NOT COMPLETED|Open-label (Short Term Extension)||0||
59790043|NCT03131648|75910132|FG006|NOT COMPLETED|Open-label (Short Term Extension)||0||
59790044|NCT03131648|75910133|FG007|NOT COMPLETED|Open-label (Short Term Extension)||3||
59790045|NCT00618813|75910150|FG000|STARTED|Overall Study||35||
59790046|NCT00618813|75910150|FG000|Completed Enrollment - Week 12 Treatment|Overall Study|Patients that complete this segment of protocol therapy are evaluated for outcome measure.|35||
59790047|NCT00618813|75910150|FG000|Completed Week 13 to Week 22 Treatment|Overall Study|Patients that complete this segment of protocol therapy are evaluated for outcome measure.|34||
59790048|NCT00618813|75910150|FG000|Completed Week 23 to Week 28 Therapy|Overall Study|Patients that complete this segment of protocol therapy are evaluated for outcome measure.|34||
59790049|NCT00618813|75910150|FG000|Completed Week 29 to Week 37 Therapy|Overall Study|Patients that complete this segment of protocol therapy are evaluated for outcome measure.|33||
59790050|NCT00618813|75910150|FG000|COMPLETED|Overall Study||31||
59790051|NCT00618813|75910150|FG000|NOT COMPLETED|Overall Study||4||
59790052|NCT00685698|75910154|FG000|STARTED|Overall Study||38||
59790053|NCT00685698|75910154|FG000|COMPLETED|Overall Study||25||
59790054|NCT00685698|75910154|FG000|NOT COMPLETED|Overall Study||13||
59790055|NCT00549328|75910170|FG000|STARTED|Overall Study||14||
59790056|NCT00549328|75910170|FG000|COMPLETED|Overall Study||0||
59790057|NCT00549328|75910170|FG000|NOT COMPLETED|Overall Study||14||
59790058|NCT00696410|75910176|FG000|STARTED|Overall Study||38||
59790059|NCT00696410|75910177|FG001|STARTED|Overall Study||10||
59790060|NCT00696410|75910176|FG000|COMPLETED|Overall Study||25||
59790061|NCT00696410|75910177|FG001|COMPLETED|Overall Study||10||
59790062|NCT00696410|75910176|FG000|NOT COMPLETED|Overall Study||13||
59790063|NCT00696410|75910177|FG001|NOT COMPLETED|Overall Study||0||
59790064|NCT00683904|75910190|FG000|STARTED|Dose Level 1||6||
59790065|NCT00683904|75910191|FG001|STARTED|Dose Level 1||0||
59790066|NCT00683904|75910190|FG000|COMPLETED|Dose Level 1||3||
59790067|NCT00683904|75910191|FG001|COMPLETED|Dose Level 1||0||
59790068|NCT00683904|75910190|FG000|NOT COMPLETED|Dose Level 1||3||
59790069|NCT00683904|75910191|FG001|NOT COMPLETED|Dose Level 1||0||
59790070|NCT00683904|75910190|FG000|STARTED|Dose Level 2||0||
59790071|NCT00683904|75910191|FG001|STARTED|Dose Level 2||6||
59790072|NCT00683904|75910190|FG000|COMPLETED|Dose Level 2||0||
59790073|NCT00683904|75910191|FG001|COMPLETED|Dose Level 2||4||
59790074|NCT00683904|75910190|FG000|NOT COMPLETED|Dose Level 2||0||
59790075|NCT00683904|75910191|FG001|NOT COMPLETED|Dose Level 2||2||
59790076|NCT00363415|75910205|FG000|STARTED|Overall Study||453||
59790077|NCT00363415|75910206|FG001|STARTED|Overall Study||455||
59790078|NCT00363415|75910205|FG000|Received at Least One Dose of Study Drug|Overall Study||433||
59790079|NCT00363415|75910206|FG001|Received at Least One Dose of Study Drug|Overall Study||447||
59790080|NCT00363415|75910205|FG000|COMPLETED|Overall Study||92||
59790081|NCT00363415|75910206|FG001|COMPLETED|Overall Study||206||
59790082|NCT00363415|75910205|FG000|NOT COMPLETED|Overall Study||361||
59790083|NCT00363415|75910206|FG001|NOT COMPLETED|Overall Study||249||
59790084|NCT00696020|75910216|FG000|STARTED|Overall Study||90||
59790085|NCT00696020|75910217|FG001|STARTED|Overall Study||89||
59790086|NCT00696020|75910218|FG002|STARTED|Overall Study||93||
59790087|NCT00696020|75910219|FG003|STARTED|Overall Study||88||
59790088|NCT00696020|75910216|FG000|COMPLETED|Overall Study||86||
60073436|NCT01559259|76188665|FG000|COMPLETED|Overall Study||30||
59523226|NCT01590394|75617966|FG000|STARTED|Overall Study||3||
59523227|NCT01590394|75617966|FG000|COMPLETED|Overall Study||3||
59523228|NCT01590394|75617966|FG000|NOT COMPLETED|Overall Study||0||
59523229|NCT00719914|75617972|FG000|STARTED|Overall Study||10||
59790089|NCT00696020|75910217|FG001|COMPLETED|Overall Study||87||
59790090|NCT00696020|75910218|FG002|COMPLETED|Overall Study||90||
59790091|NCT00696020|75910219|FG003|COMPLETED|Overall Study||84||
59790092|NCT00696020|75910216|FG000|NOT COMPLETED|Overall Study||4||
59790093|NCT00696020|75910217|FG001|NOT COMPLETED|Overall Study||2||
59790094|NCT00696020|75910218|FG002|NOT COMPLETED|Overall Study||3||
59790095|NCT00696020|75910219|FG003|NOT COMPLETED|Overall Study||4||
59790096|NCT00576576|75910231|FG000|STARTED|Overall Study||27||
59790097|NCT00576576|75910231|FG000|COMPLETED|Overall Study||20||
59790098|NCT00576576|75910231|FG000|NOT COMPLETED|Overall Study||7||
59790099|NCT00923247|75910237|FG000|STARTED|Overall Study||21||
59790100|NCT00923247|75910238|FG001|STARTED|Overall Study||1||
59790101|NCT00923247|75910237|FG000|COMPLETED|Overall Study||21||
59523230|NCT00719914|75617973|FG001|STARTED|Overall Study||7||
59790102|NCT00923247|75910238|FG001|COMPLETED|Overall Study||1||
59790103|NCT00923247|75910237|FG000|NOT COMPLETED|Overall Study||0||
59790104|NCT00923247|75910238|FG001|NOT COMPLETED|Overall Study||0||
59790105|NCT00695864|75910250|FG000|STARTED|Placebo||14||
59790106|NCT00695864|75910250|FG000|COMPLETED|Placebo||9||
59523231|NCT00719914|75617972|FG000|COMPLETED|Overall Study||10||
59790107|NCT00695864|75910250|FG000|NOT COMPLETED|Placebo||5||
59790108|NCT00695864|75910250|FG000|STARTED|Ondansetron||14||
59790109|NCT00695864|75910250|FG000|COMPLETED|Ondansetron||9||
60073437|NCT01559259|76188666|FG001|COMPLETED|Overall Study||89||
59523232|NCT00719914|75617973|FG001|COMPLETED|Overall Study||7||
59953485|NCT03586973|76071825|FG001|STARTED|Overall Study||14||
59953486|NCT03586973|76071824|FG000|COMPLETED|Overall Study||0||
59953487|NCT03586973|76071825|FG001|COMPLETED|Overall Study||0||
59953488|NCT03586973|76071824|FG000|NOT COMPLETED|Overall Study||20||
59953489|NCT03586973|76071825|FG001|NOT COMPLETED|Overall Study||14||
59994914|NCT03420781|76110739|FG001|Safety Population|Treatment Period (40 Weeks)||231|Safety Population included all participants in the Intent-to-treat (ITT) population who received ≥1 administration of study treatment.|
59790110|NCT00695864|75910250|FG000|NOT COMPLETED|Ondansetron||5||
59790111|NCT00684996|75910256|FG000|STARTED|Overall Study||5||
59790112|NCT00684996|75910256|FG000|Eligible|Overall Study||5||
59790113|NCT00684996|75910256|FG000|COMPLETED|Overall Study||0||
59790114|NCT00684996|75910256|FG000|NOT COMPLETED|Overall Study||5||
59790115|NCT00684762|75910263|FG000|STARTED|First Intervention||16||
59790116|NCT00684762|75910264|FG001|STARTED|First Intervention||16||
59790117|NCT00684762|75910263|FG000|COMPLETED|First Intervention||16||
59790118|NCT00684762|75910264|FG001|COMPLETED|First Intervention||16||
59790119|NCT00684762|75910263|FG000|NOT COMPLETED|First Intervention||0||
59790120|NCT00684762|75910264|FG001|NOT COMPLETED|First Intervention||0||
59790121|NCT00684762|75910263|FG000|STARTED|Washout Period of 7 Days||16||
59790122|NCT00684762|75910264|FG001|STARTED|Washout Period of 7 Days||16||
59790123|NCT00684762|75910263|FG000|COMPLETED|Washout Period of 7 Days||14||
59790124|NCT00684762|75910264|FG001|COMPLETED|Washout Period of 7 Days||14||
59790125|NCT00684762|75910263|FG000|NOT COMPLETED|Washout Period of 7 Days||2||
59790126|NCT00684762|75910264|FG001|NOT COMPLETED|Washout Period of 7 Days||2||
59790127|NCT00684762|75910263|FG000|STARTED|Second Intervention||14||
59790128|NCT00684762|75910264|FG001|STARTED|Second Intervention||14||
59790129|NCT00684762|75910263|FG000|COMPLETED|Second Intervention||14||
59790130|NCT00684762|75910264|FG001|COMPLETED|Second Intervention||14||
59790131|NCT00684762|75910263|FG000|NOT COMPLETED|Second Intervention||0||
59790132|NCT00684762|75910264|FG001|NOT COMPLETED|Second Intervention||0||
59790133|NCT00695786|75910274|FG000|STARTED|Overall Study||2||
59790134|NCT00695786|75910275|FG001|STARTED|Overall Study||79||
59790135|NCT00695786|75910276|FG002|STARTED|Overall Study||31||
59790136|NCT00695786|75910277|FG003|STARTED|Overall Study||44||
59790137|NCT00695786|75910274|FG000|COMPLETED|Overall Study||1||
59790138|NCT00695786|75910275|FG001|COMPLETED|Overall Study||67||
59790139|NCT00695786|75910276|FG002|COMPLETED|Overall Study||23||
59790140|NCT00695786|75910277|FG003|COMPLETED|Overall Study||36||
59790141|NCT00695786|75910274|FG000|NOT COMPLETED|Overall Study||1||
59790142|NCT00695786|75910275|FG001|NOT COMPLETED|Overall Study||12||
59790143|NCT00695786|75910276|FG002|NOT COMPLETED|Overall Study||8||
59790144|NCT00695786|75910277|FG003|NOT COMPLETED|Overall Study||8||
59790145|NCT00387127|75910289|FG000|STARTED|Overall Study||33||
59790146|NCT00387127|75910290|FG001|STARTED|Overall Study||34||
59790147|NCT00387127|75910289|FG000|COMPLETED|Overall Study||0||
59790148|NCT00387127|75910290|FG001|COMPLETED|Overall Study||0||
59790149|NCT00387127|75910289|FG000|NOT COMPLETED|Overall Study||33||
59790150|NCT00387127|75910290|FG001|NOT COMPLETED|Overall Study||34||
59790151|NCT00683592|75910300|FG000|STARTED|Overall Study||240||
59790152|NCT00683592|75910301|FG001|STARTED|Overall Study||241||
59790153|NCT00683592|75910300|FG000|Intent to Treat Population|Overall Study||231||
59790154|NCT00683592|75910301|FG001|Intent to Treat Population|Overall Study||232||
59994915|NCT03420781|76110740|FG002|Safety Population|Treatment Period (40 Weeks)||0|Safety Population included all participants in the Intent-to-treat (ITT) population who received ≥1 administration of study treatment.|
59994916|NCT03420781|76110741|FG003|Safety Population|Treatment Period (40 Weeks)||0|Safety Population included all participants in the Intent-to-treat (ITT) population who received ≥1 administration of study treatment.|
59994917|NCT03420781|76110742|FG004|Safety Population|Treatment Period (40 Weeks)||0|Safety Population included all participants in the Intent-to-treat (ITT) population who received ≥1 administration of study treatment.|
59994918|NCT03420781|76110738|FG000|COMPLETED|Treatment Period (40 Weeks)||92|Out of 197 participants who completed the Treatment Period, 193 entered the RW Period.|
59994919|NCT03420781|76110739|FG001|COMPLETED|Treatment Period (40 Weeks)||105|Out of 197 participants who completed the Treatment Period, 193 entered the RW Period.|
59790155|NCT00683592|75910300|FG000|Safety Population|Overall Study||235||
59790156|NCT00683592|75910301|FG001|Safety Population|Overall Study||233||
59790157|NCT00683592|75910300|FG000|COMPLETED|Overall Study||193||
59790158|NCT00683592|75910301|FG001|COMPLETED|Overall Study||195||
59790159|NCT00683592|75910300|FG000|NOT COMPLETED|Overall Study||47||
59790160|NCT00683592|75910301|FG001|NOT COMPLETED|Overall Study||46||
59790161|NCT00695396|75910310|FG000|STARTED|Overall Study||8||
59790162|NCT00695396|75910311|FG001|STARTED|Overall Study||8||
59790163|NCT00695396|75910312|FG002|STARTED|Overall Study||9||
59790164|NCT00695396|75910310|FG000|COMPLETED|Overall Study||1||
59790165|NCT00695396|75910311|FG001|COMPLETED|Overall Study||0||
59790166|NCT00695396|75910312|FG002|COMPLETED|Overall Study||1||
59790167|NCT00695396|75910310|FG000|NOT COMPLETED|Overall Study||7||
59790168|NCT00695396|75910311|FG001|NOT COMPLETED|Overall Study||8||
59790169|NCT00695396|75910312|FG002|NOT COMPLETED|Overall Study||8||
59790170|NCT02656706|75910320|FG000|STARTED|Overall Study||22||
59790171|NCT02656706|75910320|FG000|COMPLETED|Overall Study||21||
59790172|NCT02656706|75910320|FG000|NOT COMPLETED|Overall Study||1||
59790173|NCT00575328|75910326|FG000|STARTED|Overall Study||4||
59790174|NCT00575328|75910327|FG001|STARTED|Overall Study||4||
59523233|NCT00719914|75617972|FG000|NOT COMPLETED|Overall Study||0||
59523234|NCT00719914|75617973|FG001|NOT COMPLETED|Overall Study||0||
59523235|NCT01566370|75617981|FG000|STARTED|Overall Study||2||
59523236|NCT01566370|75617982|FG001|STARTED|Overall Study||1||
59790175|NCT00575328|75910326|FG000|COMPLETED|Overall Study||1||
59790176|NCT00575328|75910327|FG001|COMPLETED|Overall Study||2||
59790177|NCT00575328|75910326|FG000|NOT COMPLETED|Overall Study||3||
59790178|NCT00575328|75910327|FG001|NOT COMPLETED|Overall Study||2||
59790179|NCT00575094|75910333|FG000|STARTED|Overall Study||9||
59790180|NCT00575094|75910333|FG000|COMPLETED|Overall Study||6||
59790181|NCT00575094|75910333|FG000|NOT COMPLETED|Overall Study||3||
59790182|NCT00553696|75910341|FG000|STARTED|Overall Study||4||
59790183|NCT00553696|75910342|FG001|STARTED|Overall Study||16||
59790184|NCT00553696|75910343|FG002|STARTED|Overall Study||6||
59790185|NCT00553696|75910344|FG003|STARTED|Overall Study||1||
59790186|NCT00553696|75910341|FG000|COMPLETED|Overall Study||0||
59790187|NCT00553696|75910342|FG001|COMPLETED|Overall Study||0||
59790188|NCT00553696|75910343|FG002|COMPLETED|Overall Study||0||
59790189|NCT00553696|75910344|FG003|COMPLETED|Overall Study||0||
59790190|NCT00553696|75910341|FG000|NOT COMPLETED|Overall Study||4||
59790191|NCT00553696|75910342|FG001|NOT COMPLETED|Overall Study||16||
59790192|NCT00553696|75910343|FG002|NOT COMPLETED|Overall Study||6||
59790193|NCT00553696|75910344|FG003|NOT COMPLETED|Overall Study||1||
59790194|NCT00553540|75910359|FG000|STARTED|Overall Study||25||
59790195|NCT00553540|75910360|FG001|STARTED|Overall Study||25||
59790196|NCT00553540|75910359|FG000|COMPLETED|Overall Study||23||
59790197|NCT00553540|75910360|FG001|COMPLETED|Overall Study||20||
59790198|NCT00553540|75910359|FG000|NOT COMPLETED|Overall Study||2||
59790199|NCT00553540|75910360|FG001|NOT COMPLETED|Overall Study||5||
59790200|NCT00617409|75910369|FG000|STARTED|Overall Study||18||
59953490|NCT02669212|76071833|FG000|STARTED|Overall Study||25||
59953491|NCT02669212|76071834|FG001|STARTED|Overall Study||27||
59953492|NCT02669212|76071833|FG000|COMPLETED|Overall Study||21||
59953493|NCT02669212|76071834|FG001|COMPLETED|Overall Study||17||
59953494|NCT02669212|76071833|FG000|NOT COMPLETED|Overall Study||4||
59953495|NCT02669212|76071834|FG001|NOT COMPLETED|Overall Study||10||
59953496|NCT02580201|76071845|FG000|STARTED|Overall Study||50||
59953497|NCT02580201|76071846|FG001|STARTED|Overall Study||104||
59953498|NCT02580201|76071845|FG000|COMPLETED|Overall Study||50||
59953499|NCT02580201|76071846|FG001|COMPLETED|Overall Study||104||
59953500|NCT02580201|76071845|FG000|NOT COMPLETED|Overall Study||0||
59953501|NCT02580201|76071846|FG001|NOT COMPLETED|Overall Study||0||
59953502|NCT02536664|76071856|FG000|STARTED|Overall Study||312||
59953503|NCT02536664|76071857|FG001|STARTED|Overall Study||177||
59953504|NCT02536664|76071856|FG000|COMPLETED|Overall Study||205||
60073438|NCT01559259|76188667|FG002|COMPLETED|Overall Study||92||
60073439|NCT01559259|76188668|FG003|COMPLETED|Overall Study||88||
59790201|NCT00617409|75910370|FG001|STARTED|Overall Study||20||
59790202|NCT00617409|75910371|FG002|STARTED|Overall Study||31||
59790203|NCT00617409|75910369|FG000|COMPLETED|Overall Study||2||
59790204|NCT00617409|75910370|FG001|COMPLETED|Overall Study||2||
59790205|NCT00617409|75910371|FG002|COMPLETED|Overall Study||4||
59790206|NCT00617409|75910369|FG000|NOT COMPLETED|Overall Study||16||
59790207|NCT00617409|75910370|FG001|NOT COMPLETED|Overall Study||18||
59790208|NCT00617409|75910371|FG002|NOT COMPLETED|Overall Study||27||
59790209|NCT00695318|75910382|FG000|STARTED|Overall Study||10||
59790210|NCT00695318|75910383|FG001|STARTED|Overall Study||7||
59790211|NCT00695318|75910382|FG000|COMPLETED|Overall Study||5||
59953505|NCT02536664|76071857|FG001|COMPLETED|Overall Study||97||
59953506|NCT02536664|76071856|FG000|NOT COMPLETED|Overall Study||107||
59953507|NCT02536664|76071857|FG001|NOT COMPLETED|Overall Study||80||
59953508|NCT02426892|76071863|FG000|STARTED|Overall Study||24||
59953509|NCT02426892|76071863|FG000|COMPLETED|Overall Study||4||
59953510|NCT02426892|76071863|FG000|NOT COMPLETED|Overall Study||20||
59953511|NCT02312687|76071867|FG000|STARTED|Overall Study||20||
59953512|NCT02312687|76071867|FG000|COMPLETED|Overall Study||19||
59953513|NCT02312687|76071867|FG000|NOT COMPLETED|Overall Study||1||
59790212|NCT00695318|75910383|FG001|COMPLETED|Overall Study||6||
59790213|NCT00695318|75910382|FG000|NOT COMPLETED|Overall Study||5||
59790214|NCT00695318|75910383|FG001|NOT COMPLETED|Overall Study||1||
59790215|NCT00386425|75910397|FG000|STARTED|Overall Study|51 severe protein C deficiency; 176 moderate protein C deficiency|227||
59790216|NCT00386425|75910398|FG001|STARTED|Overall Study|33 severe protein C deficiency; 173 moderate protein C deficiency|206||
59790217|NCT00386425|75910399|FG002|STARTED|Overall Study||53||
59790218|NCT00386425|75910397|FG000|Received Study Drug|Overall Study||227||
59790219|NCT00386425|75910398|FG001|Received Study Drug|Overall Study||206||
59790220|NCT00386425|75910399|FG002|Received Study Drug|Overall Study||53||
59790221|NCT00386425|75910397|FG000|COMPLETED|Overall Study|51 severe protein C deficiency; 173 moderate protein C deficiency|224||
59790222|NCT00386425|75910398|FG001|COMPLETED|Overall Study|33 severe protein C deficiency; 172 moderate protein C deficiency|205||
59790223|NCT00386425|75910399|FG002|COMPLETED|Overall Study||53||
59790224|NCT00386425|75910397|FG000|NOT COMPLETED|Overall Study||3||
59790225|NCT00386425|75910398|FG001|NOT COMPLETED|Overall Study||1||
59790226|NCT00386425|75910399|FG002|NOT COMPLETED|Overall Study||0||
59790227|NCT00694304|75910411|FG000|STARTED|Overall Study||535||
59790228|NCT00694304|75910411|FG000|COMPLETED|Overall Study||328||
59790229|NCT00694304|75910411|FG000|NOT COMPLETED|Overall Study||207||
59790230|NCT00371839|75910418|FG000|STARTED|Overall Study||49||
59790231|NCT00371839|75910419|FG001|STARTED|Overall Study||20||
59790232|NCT00371839|75910420|FG002|STARTED|Overall Study||9||
59790233|NCT00371839|75910418|FG000|COMPLETED|Overall Study||32||
59790234|NCT00371839|75910419|FG001|COMPLETED|Overall Study||13||
59790235|NCT00371839|75910420|FG002|COMPLETED|Overall Study||7||
59790236|NCT00371839|75910418|FG000|NOT COMPLETED|Overall Study||17||
59790237|NCT00371839|75910419|FG001|NOT COMPLETED|Overall Study||7||
59790238|NCT00371839|75910420|FG002|NOT COMPLETED|Overall Study||2||
59953514|NCT02304367|76071871|FG000|STARTED|Overall Study|14 participants with TIO; 1 participant with ENS; 2 participants with XLH|17||
59953515|NCT02304367|76071871|FG000|Completed 48 Weeks of Study Drug|Overall Study||16||
59953516|NCT02304367|76071871|FG000|Completed 144 Weeks of Study Drug|Overall Study||12||
59790239|NCT00682890|75910428|FG000|STARTED|Overall Study||12||
59790240|NCT00682890|75910429|FG001|STARTED|Overall Study||11||
59790241|NCT00682890|75910428|FG000|COMPLETED|Overall Study||10||
59790242|NCT00682890|75910429|FG001|COMPLETED|Overall Study||9||
59790243|NCT00682890|75910428|FG000|NOT COMPLETED|Overall Study||2||
59790244|NCT00682890|75910429|FG001|NOT COMPLETED|Overall Study||2||
59790245|NCT00385723|75910438|FG000|STARTED|Overall Study||46||
59790246|NCT00385723|75910439|FG001|STARTED|Overall Study||46||
59790247|NCT00385723|75910440|FG002|STARTED|Overall Study||46||
59790248|NCT00385723|75910438|FG000|COMPLETED|Overall Study||44||
59790249|NCT00385723|75910439|FG001|COMPLETED|Overall Study||45||
59790250|NCT00385723|75910440|FG002|COMPLETED|Overall Study||44||
59790251|NCT00385723|75910438|FG000|NOT COMPLETED|Overall Study||2||
59790252|NCT00385723|75910439|FG001|NOT COMPLETED|Overall Study||1||
59790253|NCT00385723|75910440|FG002|NOT COMPLETED|Overall Study||2||
59790254|NCT00698516|75910448|FG000|STARTED|Overall Study||50||
59790255|NCT00698516|75910448|FG000|COMPLETED|Overall Study||45||
59790256|NCT00698516|75910448|FG000|NOT COMPLETED|Overall Study||5||
59790257|NCT00679302|75910458|FG000|STARTED|Overall Study||84||
59790258|NCT00679302|75910459|FG001|STARTED|Overall Study||77||
59790259|NCT00679302|75910458|FG000|COMPLETED|Overall Study||76||
59790260|NCT00679302|75910459|FG001|COMPLETED|Overall Study||73||
59790261|NCT00679302|75910458|FG000|NOT COMPLETED|Overall Study||8||
59790262|NCT00679302|75910459|FG001|NOT COMPLETED|Overall Study||4||
59790263|NCT03889028|75910468|FG000|STARTED|Overall Study||144||144
59790264|NCT03889028|75910469|FG001|STARTED|Overall Study||422||422
59790265|NCT03889028|75910470|FG002|STARTED|Overall Study||312||312
59790266|NCT03889028|75910468|FG000|COMPLETED|Overall Study||144||144
59790267|NCT03889028|75910469|FG001|COMPLETED|Overall Study||422||422
59790268|NCT03889028|75910470|FG002|COMPLETED|Overall Study||312||312
59790269|NCT03889028|75910468|FG000|NOT COMPLETED|Overall Study||0||0
59790270|NCT03889028|75910469|FG001|NOT COMPLETED|Overall Study||0||0
60073440|NCT01559259|76188669|FG004|COMPLETED|Overall Study||92||
60073441|NCT01559259|76188665|FG000|NOT COMPLETED|Overall Study||0||
60073442|NCT01559259|76188666|FG001|NOT COMPLETED|Overall Study||1||
60073443|NCT01559259|76188667|FG002|NOT COMPLETED|Overall Study||1||
60073444|NCT01559259|76188668|FG003|NOT COMPLETED|Overall Study||1||
60073445|NCT01559259|76188669|FG004|NOT COMPLETED|Overall Study||0||
60073446|NCT01676350|76188683|FG000|STARTED|Overall Study||11||
59953517|NCT02304367|76071871|FG000|COMPLETED|Overall Study||9||
59953518|NCT02304367|76071871|FG000|NOT COMPLETED|Overall Study||8||
60073447|NCT01676350|76188684|FG001|STARTED|Overall Study||11||
60073448|NCT01676350|76188683|FG000|COMPLETED|Overall Study||11||
60073449|NCT01676350|76188684|FG001|COMPLETED|Overall Study||11||
60073450|NCT01676350|76188683|FG000|NOT COMPLETED|Overall Study||0||
60073451|NCT01676350|76188684|FG001|NOT COMPLETED|Overall Study||0||
60073452|NCT01670500|76188693|FG000|STARTED|Overall Study||58||
60073453|NCT01670500|76188694|FG001|STARTED|Overall Study||60||
59790271|NCT03889028|75910470|FG002|NOT COMPLETED|Overall Study||0||0
59790272|NCT05343156|75910479|FG000|STARTED|Overall Study||99||
59790273|NCT05343156|75910480|FG001|STARTED|Overall Study||45||
59790274|NCT05343156|75910479|FG000|COMPLETED|Overall Study||91||
59790275|NCT05343156|75910480|FG001|COMPLETED|Overall Study||42||
59953519|NCT02054520|76071888|FG000|STARTED|Overall Study||11||
59953520|NCT02054520|76071889|FG001|STARTED|Overall Study||16||
59953521|NCT02054520|76071890|FG002|STARTED|Overall Study||6||
59790276|NCT05343156|75910479|FG000|NOT COMPLETED|Overall Study||8||
59790277|NCT05343156|75910480|FG001|NOT COMPLETED|Overall Study||3||
59790278|NCT00690482|75910488|FG000|STARTED|Overall Study||61||
60073454|NCT01670500|76188693|FG000|COMPLETED|Overall Study|1 patient withdrew after 3 cycles; 5 patients received additional non-protocol chemo before surgery|57|Participants received allocated intervention|
59790279|NCT00690482|75910489|FG001|STARTED|Overall Study||57||
59790280|NCT00690482|75910488|FG000|COMPLETED|Overall Study||57||
59790281|NCT00690482|75910489|FG001|COMPLETED|Overall Study||54||
59790282|NCT00690482|75910488|FG000|NOT COMPLETED|Overall Study||4||
59790283|NCT00690482|75910489|FG001|NOT COMPLETED|Overall Study||3||
59790284|NCT00385255|75910497|FG000|STARTED|Overall Study||860||
59790285|NCT00385255|75910498|FG001|STARTED|Overall Study||858||
59790286|NCT00385255|75910497|FG000|≥ 65 Years of Age (YOA) Cohort|Overall Study||112||
59790287|NCT00385255|75910498|FG001|≥ 65 Years of Age (YOA) Cohort|Overall Study||109||
59790288|NCT00385255|75910497|FG000|19-64 Years of Age (YOA) Cohort|Overall Study||748||
60103572|NCT01290640|76221809|FG001|NOT COMPLETED|Overall Study||0||
60103573|NCT01290874|76221817|FG000|STARTED|Overall Study||532||
60073455|NCT01670500|76188694|FG001|COMPLETED|Overall Study|4 pts received <4 cycles of assigned chemo; 2 pts received add'l non-protocol chemo before surgery|60|Participants received allocated intervention|
60073456|NCT01670500|76188693|FG000|NOT COMPLETED|Overall Study||1||
60073457|NCT01670500|76188694|FG001|NOT COMPLETED|Overall Study||0||
60073458|NCT02400736|76188702|FG000|STARTED|Overall Study||58||
60073459|NCT02400736|76188703|FG001|STARTED|Overall Study||61||
60073460|NCT02400736|76188702|FG000|COMPLETED|Overall Study||47||
60073461|NCT02400736|76188703|FG001|COMPLETED|Overall Study||53||
59790289|NCT00385255|75910498|FG001|19-64 Years of Age (YOA) Cohort|Overall Study||749||
59790290|NCT00385255|75910497|FG000|COMPLETED|Overall Study||839||
59790291|NCT00385255|75910498|FG001|COMPLETED|Overall Study||785||
59790292|NCT00385255|75910497|FG000|NOT COMPLETED|Overall Study||21||
59790293|NCT00385255|75910498|FG001|NOT COMPLETED|Overall Study||73||
59790294|NCT00698204|75910510|FG000|STARTED|Overall Study||20||
60073462|NCT02400736|76188702|FG000|NOT COMPLETED|Overall Study||11||
60073463|NCT02400736|76188703|FG001|NOT COMPLETED|Overall Study||8||
60073464|NCT01689519|76188715|FG000|STARTED|Intent to Treat||247||
60073465|NCT01689519|76188716|FG001|STARTED|Intent to Treat||248||
59790295|NCT00698204|75910511|FG001|STARTED|Overall Study||20||
59790296|NCT00698204|75910510|FG000|COMPLETED|Overall Study||19||
59790297|NCT00698204|75910511|FG001|COMPLETED|Overall Study||20||
59790298|NCT00698204|75910510|FG000|NOT COMPLETED|Overall Study||1||
59790299|NCT00698204|75910511|FG001|NOT COMPLETED|Overall Study||0||
59790300|NCT00549718|75910523|FG000|STARTED|Overall Study||125||
59790301|NCT00549718|75910524|FG001|STARTED|Overall Study||123||
59790302|NCT00549718|75910525|FG002|STARTED|Overall Study||124||
59790303|NCT00549718|75910526|FG003|STARTED|Overall Study||128||
59790304|NCT00549718|75910523|FG000|COMPLETED|Overall Study||84||
59790305|NCT00549718|75910524|FG001|COMPLETED|Overall Study||86||
59790306|NCT00549718|75910525|FG002|COMPLETED|Overall Study||85||
59790307|NCT00549718|75910526|FG003|COMPLETED|Overall Study||73||
59790308|NCT00549718|75910523|FG000|NOT COMPLETED|Overall Study||41||
59953522|NCT02054520|76071891|FG003|STARTED|Overall Study||6||
59953523|NCT02054520|76071892|FG004|STARTED|Overall Study||5||
59790309|NCT00549718|75910524|FG001|NOT COMPLETED|Overall Study||37||
59790310|NCT00549718|75910525|FG002|NOT COMPLETED|Overall Study||39||
59790311|NCT00549718|75910526|FG003|NOT COMPLETED|Overall Study||55||
59790312|NCT00371761|75910538|FG000|STARTED|Overall Study||13||
59790313|NCT00371761|75910539|FG001|STARTED|Overall Study||12||
59790314|NCT00371761|75910538|FG000|COMPLETED|Overall Study||5||
59790315|NCT00371761|75910539|FG001|COMPLETED|Overall Study||2||
59790316|NCT00371761|75910538|FG000|NOT COMPLETED|Overall Study||8||
59790317|NCT00371761|75910539|FG001|NOT COMPLETED|Overall Study||10||
59790318|NCT00549640|75910547|FG000|STARTED|Overall Study||40||
59790319|NCT00549640|75910548|FG001|STARTED|Overall Study||40||
59790320|NCT00549640|75910547|FG000|COMPLETED|Overall Study|For the primary endpoint, subjects who discontinued participation were assumed to be smoking.|22||
59790321|NCT00549640|75910548|FG001|COMPLETED|Overall Study||24||
59790322|NCT00549640|75910547|FG000|NOT COMPLETED|Overall Study||18||
59790323|NCT00549640|75910548|FG001|NOT COMPLETED|Overall Study||16||
59790324|NCT03897348|75910558|FG000|STARTED|ADP Session 1||1||
59790325|NCT03897348|75910559|FG001|STARTED|ADP Session 1||1||
59790326|NCT03897348|75910560|FG002|STARTED|ADP Session 1||1||
59790327|NCT03897348|75910561|FG003|STARTED|ADP Session 1||1||
59790328|NCT03897348|75910558|FG000|COMPLETED|ADP Session 1||1||
59790329|NCT03897348|75910559|FG001|COMPLETED|ADP Session 1||1||
59790330|NCT03897348|75910560|FG002|COMPLETED|ADP Session 1||1||
59790331|NCT03897348|75910561|FG003|COMPLETED|ADP Session 1||1||
59790332|NCT03897348|75910558|FG000|NOT COMPLETED|ADP Session 1||0||
59790333|NCT03897348|75910559|FG001|NOT COMPLETED|ADP Session 1||0||
59790334|NCT03897348|75910560|FG002|NOT COMPLETED|ADP Session 1||0||
59790335|NCT03897348|75910561|FG003|NOT COMPLETED|ADP Session 1||0||
59790336|NCT03897348|75910558|FG000|STARTED|ADP Session 2||1||
59790337|NCT03897348|75910559|FG001|STARTED|ADP Session 2||1||
59790338|NCT03897348|75910560|FG002|STARTED|ADP Session 2||1||
59790339|NCT03897348|75910561|FG003|STARTED|ADP Session 2||1||
59790340|NCT03897348|75910558|FG000|COMPLETED|ADP Session 2||1||
59790341|NCT03897348|75910559|FG001|COMPLETED|ADP Session 2||1||
59790342|NCT03897348|75910560|FG002|COMPLETED|ADP Session 2||1||
59790343|NCT03897348|75910561|FG003|COMPLETED|ADP Session 2||1||
59790344|NCT03897348|75910558|FG000|NOT COMPLETED|ADP Session 2||0||
59790345|NCT03897348|75910559|FG001|NOT COMPLETED|ADP Session 2||0||
59790346|NCT03897348|75910560|FG002|NOT COMPLETED|ADP Session 2||0||
59790347|NCT03897348|75910561|FG003|NOT COMPLETED|ADP Session 2||0||
59790348|NCT03897348|75910558|FG000|STARTED|ADP Session 3||1||
59790349|NCT03897348|75910559|FG001|STARTED|ADP Session 3||1||
59953524|NCT02054520|76071893|FG005|STARTED|Overall Study||3||
59953525|NCT02054520|76071888|FG000|COMPLETED|Overall Study||2||
59953526|NCT02054520|76071889|FG001|COMPLETED|Overall Study||11||
59953527|NCT02054520|76071890|FG002|COMPLETED|Overall Study||0||
59790350|NCT03897348|75910560|FG002|STARTED|ADP Session 3||0||
59790351|NCT03897348|75910561|FG003|STARTED|ADP Session 3||1||
59790352|NCT03897348|75910558|FG000|COMPLETED|ADP Session 3||1||
59790353|NCT03897348|75910559|FG001|COMPLETED|ADP Session 3||1||
59953528|NCT02054520|76071891|FG003|COMPLETED|Overall Study||0||
59953529|NCT02054520|76071892|FG004|COMPLETED|Overall Study||0||
59953530|NCT02054520|76071893|FG005|COMPLETED|Overall Study||0||
59953531|NCT02054520|76071888|FG000|NOT COMPLETED|Overall Study||9||
59790354|NCT03897348|75910560|FG002|COMPLETED|ADP Session 3||0||
59790355|NCT03897348|75910561|FG003|COMPLETED|ADP Session 3||1||
59790356|NCT03897348|75910558|FG000|NOT COMPLETED|ADP Session 3||0||
59790357|NCT03897348|75910559|FG001|NOT COMPLETED|ADP Session 3||0||
59790358|NCT03897348|75910560|FG002|NOT COMPLETED|ADP Session 3||0||
59790359|NCT03897348|75910561|FG003|NOT COMPLETED|ADP Session 3||0||
59790360|NCT00549562|75910570|FG000|STARTED|Overall Study||25||
59790361|NCT00549562|75910570|FG000|COMPLETED|Overall Study||23||
59790362|NCT00549562|75910570|FG000|NOT COMPLETED|Overall Study||2||
59790363|NCT00681564|75910576|FG000|STARTED|Overall Study||47||
59790364|NCT00681564|75910577|FG001|STARTED|Overall Study||55||
59790365|NCT00681564|75910576|FG000|COMPLETED|Overall Study||41||
59790366|NCT00681564|75910577|FG001|COMPLETED|Overall Study||47||
59790367|NCT00681564|75910576|FG000|NOT COMPLETED|Overall Study||6||
59790368|NCT00681564|75910577|FG001|NOT COMPLETED|Overall Study||8||
59790369|NCT00677352|75910585|FG000|STARTED|Treatment Phase|All 157 subjects were treated with Sertraline.|157||
59790370|NCT00677352|75910586|FG001|STARTED|Treatment Phase|2 subjects were not teated, therefore 162 subjects were treated with paroxetine.|164||
59953532|NCT02054520|76071889|FG001|NOT COMPLETED|Overall Study||5||
59953533|NCT02054520|76071890|FG002|NOT COMPLETED|Overall Study||6||
59790371|NCT00677352|75910585|FG000|COMPLETED|Treatment Phase||132||
59790372|NCT00677352|75910586|FG001|COMPLETED|Treatment Phase||122||
59790373|NCT00677352|75910585|FG000|NOT COMPLETED|Treatment Phase||25||
59790374|NCT00677352|75910586|FG001|NOT COMPLETED|Treatment Phase||42||
59790375|NCT00677352|75910585|FG000|STARTED|Tapering Phase||132||
59790376|NCT00677352|75910586|FG001|STARTED|Tapering Phase||122||
59790377|NCT00677352|75910585|FG000|COMPLETED|Tapering Phase||126||
59790378|NCT00677352|75910586|FG001|COMPLETED|Tapering Phase||112||
59790379|NCT00677352|75910585|FG000|NOT COMPLETED|Tapering Phase||6||
59790380|NCT00677352|75910586|FG001|NOT COMPLETED|Tapering Phase||10||
59790381|NCT04079452|75910592|FG000|STARTED|Overall Study||15||
59790382|NCT04079452|75910592|FG000|COMPLETED|Overall Study||15||
59790383|NCT04079452|75910592|FG000|NOT COMPLETED|Overall Study||0||
59790384|NCT00371683|75910599|FG000|STARTED|DB Treatment Period-Randomized Patients||1599||
59790385|NCT00371683|75910600|FG001|STARTED|DB Treatment Period-Randomized Patients||1596||
59790386|NCT00371683|75910599|FG000|COMPLETED|DB Treatment Period-Randomized Patients||1509||
59790387|NCT00371683|75910600|FG001|COMPLETED|DB Treatment Period-Randomized Patients||1489||
59790388|NCT00371683|75910599|FG000|NOT COMPLETED|DB Treatment Period-Randomized Patients||90||
59790389|NCT00371683|75910600|FG001|NOT COMPLETED|DB Treatment Period-Randomized Patients||107||
59790390|NCT00371683|75910599|FG000|STARTED|Follow-Up Period - Randomized Patients||1553||
59790391|NCT00371683|75910600|FG001|STARTED|Follow-Up Period - Randomized Patients||1533||
59790392|NCT00371683|75910599|FG000|COMPLETED|Follow-Up Period - Randomized Patients||1492||
59790393|NCT00371683|75910600|FG001|COMPLETED|Follow-Up Period - Randomized Patients||1461||
59790394|NCT00371683|75910599|FG000|NOT COMPLETED|Follow-Up Period - Randomized Patients||61||
59790395|NCT00371683|75910600|FG001|NOT COMPLETED|Follow-Up Period - Randomized Patients||72||
59790396|NCT03951766|75910616|FG000|STARTED|Treatment Phase||100||
59790397|NCT03951766|75910616|FG000|COMPLETED|Treatment Phase||99||
59790398|NCT03951766|75910616|FG000|NOT COMPLETED|Treatment Phase||1||
59790399|NCT03951766|75910616|FG000|STARTED|Follow-up Phase||99||
59790400|NCT03951766|75910616|FG000|COMPLETED|Follow-up Phase||89||
59790401|NCT03951766|75910616|FG000|NOT COMPLETED|Follow-up Phase||10||
59790402|NCT00371137|75910625|FG000|STARTED|Overall Study||183||
59790403|NCT00371137|75910626|FG001|STARTED|Overall Study||182||
59790404|NCT00371137|75910627|FG002|STARTED|Overall Study||183||
59790405|NCT00371137|75910625|FG000|Treated|Overall Study||183||
59790406|NCT00371137|75910626|FG001|Treated|Overall Study||182||
59790407|NCT00371137|75910627|FG002|Treated|Overall Study||182||
59790408|NCT00371137|75910625|FG000|COMPLETED|Overall Study||111||
59790409|NCT00371137|75910626|FG001|COMPLETED|Overall Study||119||
59790410|NCT00371137|75910627|FG002|COMPLETED|Overall Study||104||
59790411|NCT00371137|75910625|FG000|NOT COMPLETED|Overall Study||72||
59790412|NCT00371137|75910626|FG001|NOT COMPLETED|Overall Study||63||
59790413|NCT00371137|75910627|FG002|NOT COMPLETED|Overall Study||79||
59790414|NCT03753789|75910635|FG000|STARTED|Overall Study|Signed the informed consent form, met all inclusion/exclusion criteria, and underwent NEUWAVE microwave ablation using the Ablation Confirmation software.|38|38|47
59790415|NCT03753789|75910635|FG000|COMPLETED|Overall Study|Signed the informed consent form, met all inclusion/exclusion criteria, underwent NEUWAVE microwave ablation using the Ablation Confirmation software, and completed all follow-up study visits.|36|36|44
59790416|NCT03753789|75910635|FG000|NOT COMPLETED|Overall Study||2||3
59790417|NCT00616239|75910639|FG000|STARTED|Overall Study||20||
59790418|NCT00616239|75910639|FG000|COMPLETED|Overall Study||18||
59790419|NCT00616239|75910639|FG000|NOT COMPLETED|Overall Study||2||
59790420|NCT00547534|75910643|FG000|STARTED|Overall Study|31 patients enrolled; one patient was determined to be ineligible, and did not receive any therapy.|30||
59790421|NCT00547534|75910643|FG000|COMPLETED|Overall Study|25 patients received at least 4 cycles. 29 patients were evaluable for response.|19||
59790422|NCT00547534|75910643|FG000|NOT COMPLETED|Overall Study||11||
59790423|NCT00384397|75910651|FG000|STARTED|Overall Study||407||
59790424|NCT00384397|75910652|FG001|STARTED|Overall Study||293||
59790425|NCT00384397|75910653|FG002|STARTED|Overall Study||418||
59790426|NCT00384397|75910651|FG000|COMPLETED|Overall Study||375||
59790427|NCT00384397|75910652|FG001|COMPLETED|Overall Study||247||
59790428|NCT00384397|75910653|FG002|COMPLETED|Overall Study||385||
59790429|NCT00384397|75910651|FG000|NOT COMPLETED|Overall Study||32||
59790430|NCT00384397|75910652|FG001|NOT COMPLETED|Overall Study||46||
59790431|NCT00384397|75910653|FG002|NOT COMPLETED|Overall Study||33||
59790432|NCT00384085|75910664|FG000|STARTED|Overall Study|Randomized|195||
59790433|NCT00384085|75910665|FG001|STARTED|Overall Study|Randomized|196||
59790434|NCT00384085|75910666|FG002|STARTED|Overall Study|Randomized|197||
59790435|NCT00384085|75910664|FG000|Intent-To-Treat (ITT)|Overall Study||195||
59790436|NCT00384085|75910665|FG001|Intent-To-Treat (ITT)|Overall Study||196||
59790437|NCT00384085|75910666|FG002|Intent-To-Treat (ITT)|Overall Study||197||
59790438|NCT00384085|75910664|FG000|Treated (Safety Population)|Overall Study||194||
59790439|NCT00384085|75910665|FG001|Treated (Safety Population)|Overall Study||194||
59790440|NCT00384085|75910666|FG002|Treated (Safety Population)|Overall Study||194||
59790441|NCT00384085|75910664|FG000|Intent-To-Treat (Excluding nonGCP Sites)|Overall Study||187||
59790442|NCT00384085|75910665|FG001|Intent-To-Treat (Excluding nonGCP Sites)|Overall Study||186||
59790443|NCT00384085|75910666|FG002|Intent-To-Treat (Excluding nonGCP Sites)|Overall Study||189||
59790444|NCT00384085|75910664|FG000|COMPLETED|Overall Study|Based on the entire ITT population|156||
59953534|NCT02054520|76071891|FG003|NOT COMPLETED|Overall Study||6||
59790445|NCT00384085|75910665|FG001|COMPLETED|Overall Study|Based on the entire ITT population|150||
59790446|NCT00384085|75910666|FG002|COMPLETED|Overall Study|Based on the entire ITT population|141||
59790447|NCT00384085|75910664|FG000|NOT COMPLETED|Overall Study||39||
59790448|NCT00384085|75910665|FG001|NOT COMPLETED|Overall Study||46||
59790449|NCT00384085|75910666|FG002|NOT COMPLETED|Overall Study||56||
59790450|NCT00361231|75910676|FG000|STARTED|Overall Study||35||
59790451|NCT00361231|75910676|FG000|COMPLETED|Overall Study||1||
59790452|NCT00361231|75910676|FG000|NOT COMPLETED|Overall Study||34||
59790453|NCT00676650|75910682|FG000|STARTED|Overall Study||584||
59790454|NCT00676650|75910683|FG001|STARTED|Overall Study||289||
59790455|NCT00676650|75910682|FG000|Treated|Overall Study||581||
59790456|NCT00676650|75910683|FG001|Treated|Overall Study||285||
59790457|NCT00676650|75910682|FG000|COMPLETED|Overall Study||0||
59790458|NCT00676650|75910683|FG001|COMPLETED|Overall Study||0||
59790459|NCT00676650|75910682|FG000|NOT COMPLETED|Overall Study||584||
59790460|NCT00676650|75910683|FG001|NOT COMPLETED|Overall Study||289||
59790461|NCT00573183|75910691|FG000|STARTED|Overall Study||234||
59790462|NCT00573183|75910692|FG001|STARTED|Overall Study||237||
59790463|NCT00573183|75910691|FG000|COMPLETED|Overall Study||162||
59790464|NCT00573183|75910692|FG001|COMPLETED|Overall Study||174||
59790465|NCT00573183|75910691|FG000|NOT COMPLETED|Overall Study||72||
59790466|NCT00573183|75910692|FG001|NOT COMPLETED|Overall Study||63||
59790467|NCT00615459|75910700|FG000|STARTED|Period I||41||
59790468|NCT00615459|75910701|FG001|STARTED|Period I|1 randomized patient of this sequence was never exposed to drug. Hence, dropped out before Period I.|41||
59790469|NCT00615459|75910702|FG002|STARTED|Period I|1 randomized patient of this sequence was never exposed to drug. Hence, dropped out before Period I.|42||
59790470|NCT00615459|75910703|FG003|STARTED|Period I||43||
59790471|NCT00615459|75910700|FG000|COMPLETED|Period I||37||
59790472|NCT00615459|75910701|FG001|COMPLETED|Period I||40||
59790473|NCT00615459|75910702|FG002|COMPLETED|Period I||40||
59790474|NCT00615459|75910703|FG003|COMPLETED|Period I||42||
59790475|NCT00615459|75910700|FG000|NOT COMPLETED|Period I||4||
59790476|NCT00615459|75910701|FG001|NOT COMPLETED|Period I||1||
59790477|NCT00615459|75910702|FG002|NOT COMPLETED|Period I||2||
59790478|NCT00615459|75910703|FG003|NOT COMPLETED|Period I||1||
59790479|NCT00615459|75910700|FG000|STARTED|Period II||37||
59790480|NCT00615459|75910701|FG001|STARTED|Period II||40||
59790481|NCT00615459|75910702|FG002|STARTED|Period II||40||
59790482|NCT00615459|75910703|FG003|STARTED|Period II||42||
59790483|NCT00615459|75910700|FG000|COMPLETED|Period II||36||
59790484|NCT00615459|75910701|FG001|COMPLETED|Period II||40||
59790485|NCT00615459|75910702|FG002|COMPLETED|Period II||40||
59790486|NCT00615459|75910703|FG003|COMPLETED|Period II||41||
59790487|NCT00615459|75910700|FG000|NOT COMPLETED|Period II||1||
59790488|NCT00615459|75910701|FG001|NOT COMPLETED|Period II||0||
59790489|NCT00615459|75910702|FG002|NOT COMPLETED|Period II||0||
59790490|NCT00615459|75910703|FG003|NOT COMPLETED|Period II||1||
59790491|NCT00615459|75910700|FG000|STARTED|Period III||36||
59790492|NCT00615459|75910701|FG001|STARTED|Period III||40||
59790493|NCT00615459|75910702|FG002|STARTED|Period III||40||
59790494|NCT00615459|75910703|FG003|STARTED|Period III||41||
59790495|NCT00615459|75910700|FG000|COMPLETED|Period III||36||
59790496|NCT00615459|75910701|FG001|COMPLETED|Period III||37||
59790497|NCT00615459|75910702|FG002|COMPLETED|Period III||39||
59790498|NCT00615459|75910703|FG003|COMPLETED|Period III||41||
59790499|NCT00615459|75910700|FG000|NOT COMPLETED|Period III||0||
59790500|NCT00615459|75910701|FG001|NOT COMPLETED|Period III||3||
59790501|NCT00615459|75910702|FG002|NOT COMPLETED|Period III||1||
59790502|NCT00615459|75910703|FG003|NOT COMPLETED|Period III||0||
59790503|NCT03839511|75910713|FG000|STARTED|Overall Study||4||
59790504|NCT03839511|75910713|FG000|COMPLETED|Overall Study||4||
59790505|NCT03839511|75910713|FG000|NOT COMPLETED|Overall Study||0||
59790506|NCT00383149|75910717|FG000|STARTED|Overall Study||54||
59790507|NCT00383149|75910717|FG000|COMPLETED|Overall Study||0||
59790508|NCT00383149|75910717|FG000|NOT COMPLETED|Overall Study||54||
59790509|NCT00382993|75910723|FG000|STARTED|Migraine Attack 1 (Period 1)||84||
59790510|NCT00382993|75910724|FG001|STARTED|Migraine Attack 1 (Period 1)||85||
59790511|NCT00382993|75910723|FG000|COMPLETED|Migraine Attack 1 (Period 1)|Participant considered to have completed period if treated a migraine with investigational product.|70||
59790512|NCT00382993|75910724|FG001|COMPLETED|Migraine Attack 1 (Period 1)||67||
59790513|NCT00382993|75910723|FG000|NOT COMPLETED|Migraine Attack 1 (Period 1)||14||
59790514|NCT00382993|75910724|FG001|NOT COMPLETED|Migraine Attack 1 (Period 1)||18||
59790515|NCT00382993|75910723|FG000|STARTED|Migraine Attack 2 (Period 2)||70||
59790516|NCT00382993|75910724|FG001|STARTED|Migraine Attack 2 (Period 2)||67||
59790517|NCT00382993|75910723|FG000|COMPLETED|Migraine Attack 2 (Period 2)||68||
59790518|NCT00382993|75910724|FG001|COMPLETED|Migraine Attack 2 (Period 2)||63||
59790519|NCT00382993|75910723|FG000|NOT COMPLETED|Migraine Attack 2 (Period 2)||2||
59790520|NCT00382993|75910724|FG001|NOT COMPLETED|Migraine Attack 2 (Period 2)||4||
59790521|NCT00369967|75910732|FG000|STARTED|Overall Study||31||
59790522|NCT00369967|75910733|FG001|STARTED|Overall Study||17||
59790523|NCT00369967|75910732|FG000|COMPLETED|Overall Study||8||
59790524|NCT00369967|75910733|FG001|COMPLETED|Overall Study||5||
59790525|NCT00369967|75910732|FG000|NOT COMPLETED|Overall Study||23||
59790526|NCT00369967|75910733|FG001|NOT COMPLETED|Overall Study||12||
59790527|NCT00616629|75910748|FG000|STARTED|Overall Study|Two patients never received study drug|13||
59790528|NCT00616629|75910749|FG001|STARTED|Overall Study|Two patients never received study drug|14||
59790529|NCT00616629|75910750|FG002|STARTED|Overall Study|One patient never received study drug|14||
59790530|NCT00616629|75910751|FG003|STARTED|Overall Study||2||
59790531|NCT00616629|75910752|FG004|STARTED|Overall Study||12||
59790532|NCT00616629|75910748|FG000|COMPLETED|Overall Study||11||
59953535|NCT02054520|76071892|FG004|NOT COMPLETED|Overall Study||5||
59953536|NCT02054520|76071893|FG005|NOT COMPLETED|Overall Study||3||
59953537|NCT01922921|76071909|FG000|STARTED|Overall Study||16||
59953538|NCT01922921|76071910|FG001|STARTED|Overall Study||15||
59953539|NCT01922921|76071909|FG000|COMPLETED|Overall Study||15||
59953540|NCT01922921|76071910|FG001|COMPLETED|Overall Study||14||
59790533|NCT00616629|75910749|FG001|COMPLETED|Overall Study||12||
59790534|NCT00616629|75910750|FG002|COMPLETED|Overall Study||13||
59790535|NCT00616629|75910751|FG003|COMPLETED|Overall Study||2||
59790536|NCT00616629|75910752|FG004|COMPLETED|Overall Study||12||
59790537|NCT00616629|75910748|FG000|NOT COMPLETED|Overall Study||2||
59790538|NCT00616629|75910749|FG001|NOT COMPLETED|Overall Study||2||
59790539|NCT00616629|75910750|FG002|NOT COMPLETED|Overall Study||1||
59790540|NCT00616629|75910751|FG003|NOT COMPLETED|Overall Study||0||
59790541|NCT00616629|75910752|FG004|NOT COMPLETED|Overall Study||0||
59790542|NCT00369655|75910764|FG000|STARTED|Overall Study||21||
59790543|NCT00369655|75910764|FG000|COMPLETED|Overall Study||19||
59790544|NCT00369655|75910764|FG000|NOT COMPLETED|Overall Study||2||
59790545|NCT00615069|75910768|FG000|STARTED|Overall Study||35||
59790546|NCT00615069|75910768|FG000|COMPLETED|Overall Study||19||
59790547|NCT00615069|75910768|FG000|NOT COMPLETED|Overall Study||16||
59790548|NCT00676338|75910776|FG000|STARTED|Overall Study||248||
59790549|NCT00676338|75910777|FG001|STARTED|Overall Study||246||
59790550|NCT00676338|75910778|FG002|STARTED|Overall Study||163||
59790551|NCT00676338|75910779|FG003|STARTED|Overall Study||163||
59790552|NCT00676338|75910776|FG000|COMPLETED|Overall Study||210||
59790553|NCT00676338|75910777|FG001|COMPLETED|Overall Study||213||
59790554|NCT00676338|75910778|FG002|COMPLETED|Overall Study||133||
59790555|NCT00676338|75910779|FG003|COMPLETED|Overall Study||140||
59790556|NCT00676338|75910776|FG000|NOT COMPLETED|Overall Study||38||
59790557|NCT00676338|75910777|FG001|NOT COMPLETED|Overall Study||33||
59790558|NCT00676338|75910778|FG002|NOT COMPLETED|Overall Study||30||
59790559|NCT00676338|75910779|FG003|NOT COMPLETED|Overall Study||23||
59790560|NCT00382291|75910792|FG000|STARTED|Overall Study||18||
59790561|NCT00382291|75910793|FG001|STARTED|Overall Study||17||
59790562|NCT00382291|75910794|FG002|STARTED|Overall Study||21||
59790563|NCT00382291|75910792|FG000|COMPLETED|Overall Study||14||
59790564|NCT00382291|75910793|FG001|COMPLETED|Overall Study||10||
59790565|NCT00382291|75910794|FG002|COMPLETED|Overall Study||13||
59790566|NCT00382291|75910792|FG000|NOT COMPLETED|Overall Study||4||
59790567|NCT00382291|75910793|FG001|NOT COMPLETED|Overall Study||7||
59790568|NCT00382291|75910794|FG002|NOT COMPLETED|Overall Study||8||
59953541|NCT01922921|76071909|FG000|NOT COMPLETED|Overall Study||1||
59953542|NCT01922921|76071910|FG001|NOT COMPLETED|Overall Study||1||
59953543|NCT01546987|76071922|FG000|STARTED|Overall Study||118||
59953544|NCT01546987|76071923|FG001|STARTED|Overall Study||120||
59953545|NCT01546987|76071922|FG000|Eligible|Overall Study||115||
59953546|NCT01546987|76071923|FG001|Eligible|Overall Study||116||
59953547|NCT01546987|76071922|FG000|Eligible Participants Who Consented to Quality of Life (QOL) Component|Overall Study||103||
59953548|NCT01546987|76071923|FG001|Eligible Participants Who Consented to Quality of Life (QOL) Component|Overall Study||94||
60073466|NCT01689519|76188715|FG000|COMPLETED|Intent to Treat||0||
59523237|NCT01566370|75617981|FG000|COMPLETED|Overall Study||0||
59790569|NCT01983553|75910806|FG000|STARTED|Overall Study||2131||
59790570|NCT01983553|75910807|FG001|STARTED|Overall Study||1072||
59790571|NCT01983553|75910806|FG000|COMPLETED|Overall Study||2131||
59790572|NCT01983553|75910807|FG001|COMPLETED|Overall Study||1072||
59790573|NCT01983553|75910806|FG000|NOT COMPLETED|Overall Study||0||
59790574|NCT01983553|75910807|FG001|NOT COMPLETED|Overall Study||0||
59790575|NCT00547378|75910816|FG000|STARTED|Randomized Cohort||70||
60073467|NCT01689519|76188716|FG001|COMPLETED|Intent to Treat||0||
60073468|NCT01689519|76188715|FG000|NOT COMPLETED|Intent to Treat||247||
60073469|NCT01689519|76188716|FG001|NOT COMPLETED|Intent to Treat||248||
59790576|NCT00547378|75910817|FG001|STARTED|Randomized Cohort||77||
59790577|NCT00547378|75910818|FG002|STARTED|Randomized Cohort||0||
59790578|NCT00547378|75910816|FG000|Month 3|Randomized Cohort|This includes IST subjects reached Month 3 visit, regardless of implant or not.|62||
59790579|NCT00547378|75910817|FG001|Month 3|Randomized Cohort|This included SMT subjects who reached SMT Month 3 visit.|72||
59790580|NCT00547378|75910818|FG002|Month 3|Randomized Cohort||0||
59790581|NCT00547378|75910816|FG000|Month 6|Randomized Cohort|This includes IST subjects reached Month 6 visit, regardless of implant or not.|59||
59790582|NCT00547378|75910817|FG001|Month 6|Randomized Cohort|This included SMT subjects who reached SMT Month 6 visit.|71||
59953549|NCT01546987|76071922|FG000|COMPLETED|Overall Study||115||
59953550|NCT01546987|76071923|FG001|COMPLETED|Overall Study||116||
59953551|NCT01546987|76071922|FG000|NOT COMPLETED|Overall Study||3||
60073470|NCT01689519|76188715|FG000|STARTED|Safety Population||248||
59790583|NCT00547378|75910818|FG002|Month 6|Randomized Cohort||0||
59790584|NCT00547378|75910816|FG000|COMPLETED|Randomized Cohort||59||
59790585|NCT00547378|75910817|FG001|COMPLETED|Randomized Cohort||71||
59790586|NCT00547378|75910818|FG002|COMPLETED|Randomized Cohort||0||
59790587|NCT00547378|75910816|FG000|NOT COMPLETED|Randomized Cohort||11||
59790588|NCT00547378|75910817|FG001|NOT COMPLETED|Randomized Cohort||6||
59790589|NCT00547378|75910818|FG002|NOT COMPLETED|Randomized Cohort||0||
59790590|NCT00547378|75910816|FG000|STARTED|All Implanted Cohort|This included subjects who received full system implant after randomized to IST.|51|Subjects went through test stimulation in each group; if successful, received a full system implant.|
59790591|NCT00547378|75910817|FG001|STARTED|All Implanted Cohort|This included SMT subjects who received full system implant after completing randomization period.|40|Subjects went through test stimulation in each group; if successful, received a full system implant.|
59790592|NCT00547378|75910818|FG002|STARTED|All Implanted Cohort|This included subjects who received full system implant from non-randomized subjects.|181|Subjects went through test stimulation in each group; if successful, received a full system implant.|
59790593|NCT00547378|75910816|FG000|Month 3|All Implanted Cohort||51||
59790594|NCT00547378|75910817|FG001|Month 3|All Implanted Cohort||39||
59790595|NCT00547378|75910818|FG002|Month 3|All Implanted Cohort||178||
59790596|NCT00547378|75910816|FG000|Month 6|All Implanted Cohort||50||
59790597|NCT00547378|75910817|FG001|Month 6|All Implanted Cohort||36||
59790598|NCT00547378|75910818|FG002|Month 6|All Implanted Cohort||178||
59790599|NCT00547378|75910816|FG000|Month 12|All Implanted Cohort||48||
59790600|NCT00547378|75910817|FG001|Month 12|All Implanted Cohort||32||
59790601|NCT00547378|75910818|FG002|Month 12|All Implanted Cohort||175||
59790602|NCT00547378|75910816|FG000|Month 24|All Implanted Cohort||42||
59790603|NCT00547378|75910817|FG001|Month 24|All Implanted Cohort||30||
59790604|NCT00547378|75910818|FG002|Month 24|All Implanted Cohort||161||
59790605|NCT00547378|75910816|FG000|Month 36|All Implanted Cohort||42||
59790606|NCT00547378|75910817|FG001|Month 36|All Implanted Cohort||29||
59790607|NCT00547378|75910818|FG002|Month 36|All Implanted Cohort||146||
59790608|NCT00547378|75910816|FG000|Month 48|All Implanted Cohort||38||
59790609|NCT00547378|75910817|FG001|Month 48|All Implanted Cohort||27||
59790610|NCT00547378|75910818|FG002|Month 48|All Implanted Cohort||136||
59790611|NCT00547378|75910816|FG000|Month 60|All Implanted Cohort||36||
59790612|NCT00547378|75910817|FG001|Month 60|All Implanted Cohort||23||
59790613|NCT00547378|75910818|FG002|Month 60|All Implanted Cohort||114||
59790614|NCT00547378|75910816|FG000|COMPLETED|All Implanted Cohort||36||
59790615|NCT00547378|75910817|FG001|COMPLETED|All Implanted Cohort||22||
59790616|NCT00547378|75910818|FG002|COMPLETED|All Implanted Cohort||111||
59790617|NCT00547378|75910816|FG000|NOT COMPLETED|All Implanted Cohort||15||
59790618|NCT00547378|75910817|FG001|NOT COMPLETED|All Implanted Cohort||18||
59790619|NCT00547378|75910818|FG002|NOT COMPLETED|All Implanted Cohort||70||
59790620|NCT00381043|75910828|FG000|STARTED|Overall Study||51||
59790621|NCT00381043|75910829|FG001|STARTED|Overall Study||49||
59790622|NCT00381043|75910828|FG000|COMPLETED|Overall Study||39||
59790623|NCT00381043|75910829|FG001|COMPLETED|Overall Study||41||
59790624|NCT00381043|75910828|FG000|NOT COMPLETED|Overall Study||12||
59790625|NCT00381043|75910829|FG001|NOT COMPLETED|Overall Study||8||
59790626|NCT00614991|75910841|FG000|STARTED|Overall Study||8||
59790627|NCT00614991|75910842|FG001|STARTED|Overall Study||9||
59790628|NCT00614991|75910843|FG002|STARTED|Overall Study||7||
59790629|NCT00614991|75910844|FG003|STARTED|Overall Study||7||
59790630|NCT00614991|75910845|FG004|STARTED|Overall Study||7||
59790631|NCT00614991|75910846|FG005|STARTED|Overall Study||6||
59790632|NCT00614991|75910841|FG000|COMPLETED|Overall Study||5||
59790633|NCT00614991|75910842|FG001|COMPLETED|Overall Study||6||
59790634|NCT00614991|75910843|FG002|COMPLETED|Overall Study||7||
59790635|NCT00614991|75910844|FG003|COMPLETED|Overall Study||7||
59790636|NCT00614991|75910845|FG004|COMPLETED|Overall Study||6||
59790637|NCT00614991|75910846|FG005|COMPLETED|Overall Study||6||
59790638|NCT00614991|75910841|FG000|NOT COMPLETED|Overall Study||3||
59790639|NCT00614991|75910842|FG001|NOT COMPLETED|Overall Study||3||
59790640|NCT00614991|75910843|FG002|NOT COMPLETED|Overall Study||0||
59790641|NCT00614991|75910844|FG003|NOT COMPLETED|Overall Study||0||
59790642|NCT00614991|75910845|FG004|NOT COMPLETED|Overall Study||1||
59790643|NCT00614991|75910846|FG005|NOT COMPLETED|Overall Study||0||
59790644|NCT00360529|75910868|FG000|STARTED|Overall Study||295||
59790645|NCT00360529|75910869|FG001|STARTED|Overall Study||295||
59790646|NCT00360529|75910870|FG002|STARTED|Overall Study||290||
59790647|NCT00360529|75910868|FG000|COMPLETED|Overall Study||234||
59790648|NCT00360529|75910869|FG001|COMPLETED|Overall Study||230||
59790649|NCT00360529|75910870|FG002|COMPLETED|Overall Study||199||
59790650|NCT00360529|75910868|FG000|NOT COMPLETED|Overall Study||61||
59790651|NCT00360529|75910869|FG001|NOT COMPLETED|Overall Study||65||
59790652|NCT00360529|75910870|FG002|NOT COMPLETED|Overall Study||91||
59790653|NCT00369577|75910881|FG000|STARTED|Overall Study||43||
59790654|NCT00369577|75910882|FG001|STARTED|Overall Study||45||
59790655|NCT00369577|75910883|FG002|STARTED|Overall Study||41||
59790656|NCT00369577|75910881|FG000|COMPLETED|Overall Study||43||
59790657|NCT00369577|75910882|FG001|COMPLETED|Overall Study||45||
59790658|NCT00369577|75910883|FG002|COMPLETED|Overall Study||40||
59790659|NCT00369577|75910881|FG000|NOT COMPLETED|Overall Study||0||
59790660|NCT00369577|75910882|FG001|NOT COMPLETED|Overall Study||0||
59790661|NCT00369577|75910883|FG002|NOT COMPLETED|Overall Study||1||
59790662|NCT00678288|75910893|FG000|STARTED|Overall Study||10||
59790663|NCT00678288|75910894|FG001|STARTED|Overall Study||6||
59790664|NCT00678288|75910893|FG000|COMPLETED|Overall Study||0||
59790665|NCT00678288|75910894|FG001|COMPLETED|Overall Study||0||
59790666|NCT00678288|75910893|FG000|NOT COMPLETED|Overall Study||10||
59790667|NCT00678288|75910894|FG001|NOT COMPLETED|Overall Study||6||
59790668|NCT00369343|75910902|FG000|STARTED|Double-blind Phase||256||
59790669|NCT00369343|75910903|FG001|STARTED|Double-blind Phase||125||
59790670|NCT00369343|75910902|FG000|COMPLETED|Double-blind Phase||212||
59790671|NCT00369343|75910903|FG001|COMPLETED|Double-blind Phase||109||
59790672|NCT00369343|75910902|FG000|NOT COMPLETED|Double-blind Phase||44||
59790673|NCT00369343|75910903|FG001|NOT COMPLETED|Double-blind Phase||16||
59790674|NCT00369343|75910902|FG000|STARTED|Open-label Phase||212||
59790675|NCT00369343|75910903|FG001|STARTED|Open-label Phase||109||
59790676|NCT00369343|75910902|FG000|COMPLETED|Open-label Phase||155||
59790677|NCT00369343|75910903|FG001|COMPLETED|Open-label Phase||79||
59790678|NCT00369343|75910902|FG000|NOT COMPLETED|Open-label Phase||57||
59790679|NCT00369343|75910903|FG001|NOT COMPLETED|Open-label Phase||30||
59790680|NCT00369265|75910918|FG000|STARTED|Overall Study||4||
59790681|NCT00369265|75910919|FG001|STARTED|Overall Study||7||
59790682|NCT00369265|75910918|FG000|COMPLETED|Overall Study||0||
59790683|NCT00369265|75910919|FG001|COMPLETED|Overall Study||0||
59790684|NCT00369265|75910918|FG000|NOT COMPLETED|Overall Study||4||
59790685|NCT00369265|75910919|FG001|NOT COMPLETED|Overall Study||7||
59790686|NCT00368875|75910925|FG000|STARTED|Overall Study||6||
60073471|NCT01689519|76188716|FG001|STARTED|Safety Population||245||
59790687|NCT00368875|75910926|FG001|STARTED|Overall Study||48||
59790688|NCT00368875|75910925|FG000|COMPLETED|Overall Study||0||
59790689|NCT00368875|75910926|FG001|COMPLETED|Overall Study||0||
59790690|NCT00368875|75910925|FG000|NOT COMPLETED|Overall Study||6||
59790691|NCT00368875|75910926|FG001|NOT COMPLETED|Overall Study||48||
59790692|NCT00614055|75910935|FG000|STARTED|Overall Study||59||
59790693|NCT00614055|75910936|FG001|STARTED|Overall Study||59||
59790694|NCT00614055|75910937|FG002|STARTED|Overall Study||60||
59790695|NCT00614055|75910935|FG000|Exposed|Overall Study||59||
59790696|NCT00614055|75910936|FG001|Exposed|Overall Study||59||
59790697|NCT00614055|75910937|FG002|Exposed|Overall Study||60||
59790698|NCT00614055|75910935|FG000|COMPLETED|Overall Study||55||
59790699|NCT00614055|75910936|FG001|COMPLETED|Overall Study||53||
59790700|NCT00614055|75910937|FG002|COMPLETED|Overall Study||55||
59790701|NCT00614055|75910935|FG000|NOT COMPLETED|Overall Study||4||
59790702|NCT00614055|75910936|FG001|NOT COMPLETED|Overall Study||6||
59790703|NCT00614055|75910937|FG002|NOT COMPLETED|Overall Study||5||
59790704|NCT00613821|75910950|FG000|STARTED|Overall Study||40||
59790705|NCT00613821|75910951|FG001|STARTED|Overall Study||40||
59790706|NCT00613821|75910950|FG000|COMPLETED|Overall Study||38||
59790707|NCT00613821|75910951|FG001|COMPLETED|Overall Study||39||
59790708|NCT00613821|75910950|FG000|NOT COMPLETED|Overall Study||2||
59790709|NCT00613821|75910951|FG001|NOT COMPLETED|Overall Study||1||
59790710|NCT00548548|75910959|FG000|STARTED|Overall Study||387||
59790711|NCT00548548|75910960|FG001|STARTED|Overall Study||387||
59790712|NCT00548548|75910959|FG000|Treated|Overall Study||383||
59790713|NCT00548548|75910960|FG001|Treated|Overall Study||384||
59790714|NCT00548548|75910959|FG000|Safety Population|Overall Study|Four patients randomized to placebo received single doses of bevacizumab in error.|386||
59790715|NCT00548548|75910960|FG001|Safety Population|Overall Study||381||
59790716|NCT00548548|75910959|FG000|COMPLETED|Overall Study|Completed treatment discontinuation form was not completed; patient was counted alive on treatment.|25||
59790717|NCT00548548|75910960|FG001|COMPLETED|Overall Study||21||
59790718|NCT00548548|75910959|FG000|NOT COMPLETED|Overall Study||362||
59790719|NCT00548548|75910960|FG001|NOT COMPLETED|Overall Study||366||
59790720|NCT00613509|75910968|FG000|STARTED|Cycle 1||11||
59790721|NCT00613509|75910969|FG001|STARTED|Cycle 1||12||
60073472|NCT01689519|76188715|FG000|COMPLETED|Safety Population||0||
60073473|NCT01689519|76188716|FG001|COMPLETED|Safety Population||0||
60073474|NCT01689519|76188715|FG000|NOT COMPLETED|Safety Population||248||
59790722|NCT00613509|75910968|FG000|COMPLETED|Cycle 1|Completion of Cycle 1. 9 participants were deemed evaluable|6||
60073475|NCT01689519|76188716|FG001|NOT COMPLETED|Safety Population||245||
60073476|NCT01689363|76188722|FG000|STARTED|Overall Study||32||
60073477|NCT01689363|76188723|FG001|STARTED|Overall Study||32||
59790723|NCT00613509|75910969|FG001|COMPLETED|Cycle 1|Completion of Cycle 1. 12 participants were deemed evaluable|4||
59790724|NCT00613509|75910968|FG000|NOT COMPLETED|Cycle 1||5||
59790725|NCT00613509|75910969|FG001|NOT COMPLETED|Cycle 1||8||
59790726|NCT00613509|75910968|FG000|STARTED|Cycle 2 (Group 2 = Crossover)||11||
59790727|NCT00613509|75910969|FG001|STARTED|Cycle 2 (Group 2 = Crossover)||4||
59790728|NCT00613509|75910968|FG000|COMPLETED|Cycle 2 (Group 2 = Crossover)||11||
59790729|NCT00613509|75910969|FG001|COMPLETED|Cycle 2 (Group 2 = Crossover)||4||
59790730|NCT00613509|75910968|FG000|NOT COMPLETED|Cycle 2 (Group 2 = Crossover)||0||
59790731|NCT00613509|75910969|FG001|NOT COMPLETED|Cycle 2 (Group 2 = Crossover)||0||
60073478|NCT01689363|76188724|FG002|STARTED|Overall Study||32||
60073479|NCT01689363|76188725|FG003|STARTED|Overall Study||31||
59953552|NCT01546987|76071923|FG001|NOT COMPLETED|Overall Study||4||
59953553|NCT00261443|76071931|FG000|STARTED|1: Confirmation of Partial Nonresponse||1270||
59953554|NCT00261443|76071932|FG001|STARTED|1: Confirmation of Partial Nonresponse||0||
59953555|NCT00261443|76071933|FG002|STARTED|1: Confirmation of Partial Nonresponse||0||
59953556|NCT00261443|76071931|FG000|COMPLETED|1: Confirmation of Partial Nonresponse||686||
59953557|NCT00261443|76071932|FG001|COMPLETED|1: Confirmation of Partial Nonresponse||0||
59953558|NCT00261443|76071933|FG002|COMPLETED|1: Confirmation of Partial Nonresponse||0||
59953559|NCT00261443|76071931|FG000|NOT COMPLETED|1: Confirmation of Partial Nonresponse||584||
59523238|NCT01566370|75617982|FG001|COMPLETED|Overall Study||0||
59790732|NCT01505062|75910978|FG000|STARTED|Overall Study||3||
59790733|NCT01505062|75910979|FG001|STARTED|Overall Study||3||
59790734|NCT01505062|75910980|FG002|STARTED|Overall Study||3||
59790735|NCT01505062|75910978|FG000|COMPLETED|Overall Study||3||
59790736|NCT01505062|75910979|FG001|COMPLETED|Overall Study||3||
59790737|NCT01505062|75910980|FG002|COMPLETED|Overall Study||3||
59790738|NCT01505062|75910978|FG000|NOT COMPLETED|Overall Study||0||
59790739|NCT01505062|75910979|FG001|NOT COMPLETED|Overall Study||0||
59790740|NCT01505062|75910980|FG002|NOT COMPLETED|Overall Study||0||
59790741|NCT00961714|75910988|FG000|STARTED|Overall Study||15||
59790742|NCT00961714|75910988|FG000|COMPLETED|Overall Study||13||
59790743|NCT00961714|75910988|FG000|NOT COMPLETED|Overall Study||2||
59790744|NCT00547300|75910994|FG000|STARTED|Overall Study||25||
59790745|NCT00547300|75910995|FG001|STARTED|Overall Study|Two (2) patients were randomized in error, but no study medication taken.|26||
59790746|NCT00547300|75910994|FG000|COMPLETED|Overall Study|No patients completed because the study was administratively terminated.|0||
59790747|NCT00547300|75910995|FG001|COMPLETED|Overall Study|No patients completed because the study was administratively terminated.|0||
59790748|NCT00547300|75910994|FG000|NOT COMPLETED|Overall Study||25||
59790749|NCT00547300|75910995|FG001|NOT COMPLETED|Overall Study||26||
59790750|NCT00612807|75911003|FG000|STARTED|Overall Study||14||
59790751|NCT00612807|75911004|FG001|STARTED|Overall Study||28||
59790752|NCT00612807|75911003|FG000|COMPLETED|Overall Study||12||
59790753|NCT00612807|75911004|FG001|COMPLETED|Overall Study||28||
59790754|NCT00612807|75911003|FG000|NOT COMPLETED|Overall Study||2||
59790755|NCT00612807|75911004|FG001|NOT COMPLETED|Overall Study||0||
59790756|NCT00678210|75911014|FG000|STARTED|Overall Study||49||
59790757|NCT00678210|75911015|FG001|STARTED|Overall Study||49||
59790758|NCT00678210|75911016|FG002|STARTED|Overall Study||49||
59790759|NCT00678210|75911017|FG003|STARTED|Overall Study||50||
59790760|NCT00678210|75911014|FG000|COMPLETED|Overall Study||38||
59790761|NCT00678210|75911015|FG001|COMPLETED|Overall Study||38||
59790762|NCT00678210|75911016|FG002|COMPLETED|Overall Study||43||
59790763|NCT00678210|75911017|FG003|COMPLETED|Overall Study||30||
59790764|NCT00678210|75911014|FG000|NOT COMPLETED|Overall Study||11||
59790765|NCT00678210|75911015|FG001|NOT COMPLETED|Overall Study||11||
59790766|NCT00678210|75911016|FG002|NOT COMPLETED|Overall Study||6||
59953560|NCT00261443|76071932|FG001|NOT COMPLETED|1: Confirmation of Partial Nonresponse||0||
59953561|NCT00261443|76071933|FG002|NOT COMPLETED|1: Confirmation of Partial Nonresponse||0||
59953562|NCT00261443|76071931|FG000|STARTED|2: Stability & Maintenance of Stability||686||
59953563|NCT00261443|76071932|FG001|STARTED|2: Stability & Maintenance of Stability||0||
59953564|NCT00261443|76071933|FG002|STARTED|2: Stability & Maintenance of Stability||0||
59523239|NCT01566370|75617981|FG000|NOT COMPLETED|Overall Study||2||
59523240|NCT01566370|75617982|FG001|NOT COMPLETED|Overall Study||1||
59790767|NCT00678210|75911017|FG003|NOT COMPLETED|Overall Study||20||
59790768|NCT00611715|75911029|FG000|STARTED|Overall Study||42||
59790769|NCT00611715|75911030|FG001|STARTED|Overall Study||6||
59790770|NCT00611715|75911029|FG000|COMPLETED|Overall Study|"2 pts in Arm 1 remain on-tx. They are not accounted for in off-tx reasonor completed data fields"|1||
59790771|NCT00611715|75911030|FG001|COMPLETED|Overall Study||0||
59790772|NCT00611715|75911029|FG000|NOT COMPLETED|Overall Study||41||
59790773|NCT00611715|75911030|FG001|NOT COMPLETED|Overall Study||6||
59790774|NCT00677820|75911044|FG000|STARTED|Overall Study||240||
59790775|NCT00677820|75911045|FG001|STARTED|Overall Study||60||
59953565|NCT00261443|76071931|FG000|COMPLETED|2: Stability & Maintenance of Stability||346||
59953566|NCT00261443|76071932|FG001|COMPLETED|2: Stability & Maintenance of Stability||0||
59790776|NCT00677820|75911044|FG000|COMPLETED|Overall Study||239||
59790777|NCT00677820|75911045|FG001|COMPLETED|Overall Study||60||
59790778|NCT00677820|75911044|FG000|NOT COMPLETED|Overall Study||1||
59790779|NCT00677820|75911045|FG001|NOT COMPLETED|Overall Study||0||
59790780|NCT00611559|75911054|FG000|STARTED|Overall Study||111||
59790781|NCT00611559|75911055|FG001|STARTED|Overall Study||115||
59790782|NCT00611559|75911056|FG002|STARTED|Overall Study||57||
59953567|NCT00261443|76071933|FG002|COMPLETED|2: Stability & Maintenance of Stability||0||
59953568|NCT00261443|76071931|FG000|NOT COMPLETED|2: Stability & Maintenance of Stability||340||
59953569|NCT00261443|76071932|FG001|NOT COMPLETED|2: Stability & Maintenance of Stability||0||
59953570|NCT00261443|76071933|FG002|NOT COMPLETED|2: Stability & Maintenance of Stability||0||
59790783|NCT00611559|75911054|FG000|COMPLETED|Overall Study||110||
59790784|NCT00611559|75911055|FG001|COMPLETED|Overall Study||114||
59790785|NCT00611559|75911056|FG002|COMPLETED|Overall Study||56||
59790786|NCT00611559|75911054|FG000|NOT COMPLETED|Overall Study||1||
59790787|NCT00611559|75911055|FG001|NOT COMPLETED|Overall Study||1||
59790788|NCT00611559|75911056|FG002|NOT COMPLETED|Overall Study||1||
59790789|NCT00611247|75911066|FG000|STARTED|Overall Study||5||
59790790|NCT00611247|75911067|FG001|STARTED|Overall Study||31||
59790791|NCT00611247|75911066|FG000|COMPLETED|Overall Study||3||
59790792|NCT00611247|75911067|FG001|COMPLETED|Overall Study||10||
59953571|NCT00261443|76071931|FG000|STARTED|3: Assessment of Relapse||0||
59953572|NCT00261443|76071932|FG001|STARTED|3: Assessment of Relapse||169||
59953573|NCT00261443|76071933|FG002|STARTED|3: Assessment of Relapse||168||
59790793|NCT00611247|75911066|FG000|NOT COMPLETED|Overall Study||2||
59790794|NCT00611247|75911067|FG001|NOT COMPLETED|Overall Study||21||
59790795|NCT00675948|75911076|FG000|STARTED|Overall Study||39||
59790796|NCT00675948|75911077|FG001|STARTED|Overall Study||4||
59790797|NCT00675948|75911076|FG000|COMPLETED|Overall Study||0||
59790798|NCT00675948|75911077|FG001|COMPLETED|Overall Study||1||
59790799|NCT00675948|75911076|FG000|NOT COMPLETED|Overall Study||39||
59790800|NCT00675948|75911077|FG001|NOT COMPLETED|Overall Study||3||
59790801|NCT00610935|75911086|FG000|STARTED|Overall Study||25||
59790802|NCT00610935|75911087|FG001|STARTED|Overall Study||57||
59790803|NCT00610935|75911086|FG000|ITTI Population|Overall Study||25|Intent to treat - infected (ITTI) population included all subjects who were randomized, received at least one injection of study drug, and had proven influenza infection by at least one of the following assessments performed on a Screening/Baseline sample: positive PCR assay or positive viral culture for Influenza A or B.|
59790804|NCT00610935|75911087|FG001|ITTI Population|Overall Study||55|Intent to treat - infected (ITTI) population included all subjects who were randomized, received at least one injection of study drug, and had proven influenza infection by at least one of the following assessments performed on a Screening/Baseline sample: positive PCR assay or positive viral culture for Influenza A or B.|
59790805|NCT00610935|75911086|FG000|ITT Population|Overall Study||25|Intent to treat (ITT) population included all randomized subjects for whom data were analyzed in the respective randomized treatment groups. The ITT population = Safety Population|
59790806|NCT00610935|75911087|FG001|ITT Population|Overall Study||57|Intent to treat (ITT) population included all randomized subjects for whom data were analyzed in the respective randomized treatment groups. The ITT population = Safety Population|
59790807|NCT00610935|75911086|FG000|COMPLETED|Overall Study||24||
59790808|NCT00610935|75911087|FG001|COMPLETED|Overall Study||54||
59790809|NCT00610935|75911086|FG000|NOT COMPLETED|Overall Study||1||
59790810|NCT00610935|75911087|FG001|NOT COMPLETED|Overall Study||3||
59953574|NCT00261443|76071931|FG000|COMPLETED|3: Assessment of Relapse||0||
60073480|NCT01689363|76188726|FG004|STARTED|Overall Study||31||
60073481|NCT01689363|76188727|FG005|STARTED|Overall Study||31||
60073482|NCT01689363|76188728|FG006|STARTED|Overall Study||32||
59790811|NCT02287818|75911095|FG000|STARTED|Overall Study||60||
59790812|NCT02287818|75911096|FG001|STARTED|Overall Study||67||
59790813|NCT02287818|75911095|FG000|COMPLETED|Overall Study||53||
59790814|NCT02287818|75911096|FG001|COMPLETED|Overall Study||54||
59790815|NCT02287818|75911095|FG000|NOT COMPLETED|Overall Study||7||
59790816|NCT02287818|75911096|FG001|NOT COMPLETED|Overall Study||13||
59790817|NCT00610857|75911102|FG000|STARTED|Overall Study||37||
59790818|NCT00610857|75911102|FG000|COMPLETED|Overall Study||35||
59790819|NCT00610857|75911102|FG000|NOT COMPLETED|Overall Study||2||
59790820|NCT00672984|75911109|FG000|STARTED|First Intervention||31||
59790821|NCT00672984|75911110|FG001|STARTED|First Intervention||25||
59790822|NCT00672984|75911111|FG002|STARTED|First Intervention||27||
59790823|NCT00672984|75911109|FG000|COMPLETED|First Intervention||22||
59790824|NCT00672984|75911110|FG001|COMPLETED|First Intervention||23||
59790825|NCT00672984|75911111|FG002|COMPLETED|First Intervention||25||
59790826|NCT00672984|75911109|FG000|NOT COMPLETED|First Intervention||9||
59790827|NCT00672984|75911110|FG001|NOT COMPLETED|First Intervention||2||
59790828|NCT00672984|75911111|FG002|NOT COMPLETED|First Intervention||2||
59790829|NCT00672984|75911109|FG000|STARTED|Second Intervention||22||
59790830|NCT00672984|75911110|FG001|STARTED|Second Intervention||23||
59790831|NCT00672984|75911111|FG002|STARTED|Second Intervention||25||
59790832|NCT00672984|75911109|FG000|COMPLETED|Second Intervention||22||
59790833|NCT00672984|75911110|FG001|COMPLETED|Second Intervention||17||
59790834|NCT00672984|75911111|FG002|COMPLETED|Second Intervention||24||
59790835|NCT00672984|75911109|FG000|NOT COMPLETED|Second Intervention||0||
59790836|NCT00672984|75911110|FG001|NOT COMPLETED|Second Intervention||6||
59790837|NCT00672984|75911111|FG002|NOT COMPLETED|Second Intervention||1||
59790838|NCT00672984|75911109|FG000|STARTED|Third Intervention||22||
59790839|NCT00672984|75911110|FG001|STARTED|Third Intervention||17||
59790840|NCT00672984|75911111|FG002|STARTED|Third Intervention||24||
59790841|NCT00672984|75911109|FG000|COMPLETED|Third Intervention||21||
59953575|NCT00261443|76071932|FG001|COMPLETED|3: Assessment of Relapse||89||
59953576|NCT00261443|76071933|FG002|COMPLETED|3: Assessment of Relapse||103||
59953577|NCT00261443|76071931|FG000|NOT COMPLETED|3: Assessment of Relapse||0||
59953578|NCT00261443|76071932|FG001|NOT COMPLETED|3: Assessment of Relapse||80||
59953579|NCT00261443|76071933|FG002|NOT COMPLETED|3: Assessment of Relapse||65||
59953580|NCT00261443|76071931|FG000|STARTED|4: Extension Phase||0||
59953581|NCT00261443|76071932|FG001|STARTED|4: Extension Phase||19||
59953582|NCT00261443|76071933|FG002|STARTED|4: Extension Phase||23||
59953583|NCT00261443|76071931|FG000|COMPLETED|4: Extension Phase||0||
59953584|NCT00261443|76071932|FG001|COMPLETED|4: Extension Phase||16||
60073483|NCT01689363|76188729|FG007|STARTED|Overall Study||32||
59790842|NCT00672984|75911110|FG001|COMPLETED|Third Intervention||17||
59790843|NCT00672984|75911111|FG002|COMPLETED|Third Intervention||23||
59790844|NCT00672984|75911109|FG000|NOT COMPLETED|Third Intervention||1||
59790845|NCT00672984|75911110|FG001|NOT COMPLETED|Third Intervention||0||
59790846|NCT00672984|75911111|FG002|NOT COMPLETED|Third Intervention||1||
59790847|NCT00546364|75911124|FG000|STARTED|Overall Study||20||
59790848|NCT00546364|75911125|FG001|STARTED|Overall Study||22||
59790849|NCT00546364|75911126|FG002|STARTED|Overall Study||20||
59790850|NCT00546364|75911124|FG000|Never Treated|Overall Study||0||
59790851|NCT00546364|75911125|FG001|Never Treated|Overall Study||0||
59790852|NCT00546364|75911126|FG002|Never Treated|Overall Study||0||
59953585|NCT00261443|76071933|FG002|COMPLETED|4: Extension Phase||21||
59953586|NCT00261443|76071931|FG000|NOT COMPLETED|4: Extension Phase||0||
59953587|NCT00261443|76071932|FG001|NOT COMPLETED|4: Extension Phase||3||
59790853|NCT00546364|75911124|FG000|COMPLETED|Overall Study|Still on treatment|3||
59790854|NCT00546364|75911125|FG001|COMPLETED|Overall Study|Still on treatment|4||
59790855|NCT00546364|75911126|FG002|COMPLETED|Overall Study|Still on treatment|3||
59790856|NCT00546364|75911124|FG000|NOT COMPLETED|Overall Study||17||
59790857|NCT00546364|75911125|FG001|NOT COMPLETED|Overall Study||18||
59790858|NCT00546364|75911126|FG002|NOT COMPLETED|Overall Study||17||
59790859|NCT05044104|75911134|FG000|STARTED|Overall Study||292||
59790860|NCT05044104|75911134|FG000|COMPLETED|Overall Study||292||
59790861|NCT05044104|75911134|FG000|NOT COMPLETED|Overall Study||0||
59790862|NCT05034276|75911138|FG000|STARTED|Overall Study||28||
59790863|NCT05034276|75911138|FG000|COMPLETED|Overall Study||23||
59953588|NCT00261443|76071933|FG002|NOT COMPLETED|4: Extension Phase||2||
59953589|NCT00093379|76071944|FG000|STARTED|Overall Study||20||
59953590|NCT00093379|76071944|FG000|COMPLETED|Overall Study||20||
59953591|NCT00093379|76071944|FG000|NOT COMPLETED|Overall Study||0||
59953592|NCT02593318|76071950|FG000|STARTED|Overall Study||16||
59790864|NCT05034276|75911138|FG000|NOT COMPLETED|Overall Study||5||
59790865|NCT05020327|75911145|FG000|STARTED|Overall Study||28||
59790866|NCT05020327|75911146|FG001|STARTED|Overall Study||6||
59790867|NCT05020327|75911147|FG002|STARTED|Overall Study||6||
59790868|NCT05020327|75911145|FG000|COMPLETED|Overall Study||12||
59790869|NCT05020327|75911146|FG001|COMPLETED|Overall Study||5||
59790870|NCT05020327|75911147|FG002|COMPLETED|Overall Study||6||
59790871|NCT05020327|75911145|FG000|NOT COMPLETED|Overall Study||16||
59790872|NCT05020327|75911146|FG001|NOT COMPLETED|Overall Study||1||
59790873|NCT05020327|75911147|FG002|NOT COMPLETED|Overall Study||0||
59790874|NCT04907214|75911155|FG000|STARTED|Overall Study||16||
59790875|NCT04907214|75911155|FG000|COMPLETED|Overall Study||16||
59790876|NCT04907214|75911155|FG000|NOT COMPLETED|Overall Study||0||
59790877|NCT04907032|75911161|FG000|STARTED|Overall Study||27||
59790878|NCT04907032|75911162|FG001|STARTED|Overall Study||27||
59790879|NCT04907032|75911161|FG000|COMPLETED|Overall Study||20|withdrew because could not complete 12-week PTNS protocol.|
59790880|NCT04907032|75911162|FG001|COMPLETED|Overall Study|withdrew because could not complete 12-week PTNS protocol.|26|withdrew because could not complete 12-week PTNS protocol.|
59790881|NCT04907032|75911161|FG000|NOT COMPLETED|Overall Study||7||
59953593|NCT02593318|76071951|FG001|STARTED|Overall Study||16||
59953594|NCT02593318|76071950|FG000|COMPLETED|Overall Study||15||
59953595|NCT02593318|76071951|FG001|COMPLETED|Overall Study||15||
59953596|NCT02593318|76071950|FG000|NOT COMPLETED|Overall Study||1||
59790882|NCT04907032|75911162|FG001|NOT COMPLETED|Overall Study||1||
59790883|NCT04904809|75911168|FG000|STARTED|Overall Study||36||
59790884|NCT04904809|75911168|FG000|COMPLETED|Overall Study||36||
59790885|NCT04904809|75911168|FG000|NOT COMPLETED|Overall Study||0||
59790886|NCT04834375|75911174|FG000|STARTED|Overall Study||72||
59953597|NCT02593318|76071951|FG001|NOT COMPLETED|Overall Study||1||
59953598|NCT02343302|76071965|FG000|STARTED|Overall Study||1||
59953599|NCT02343302|76071966|FG001|STARTED|Overall Study||1||
59953600|NCT02343302|76071965|FG000|COMPLETED|Overall Study||0||
59953601|NCT02343302|76071966|FG001|COMPLETED|Overall Study||0||
60073484|NCT01689363|76188722|FG000|COMPLETED|Overall Study||32||
59790887|NCT04834375|75911175|FG001|STARTED|Overall Study||70||
59790888|NCT04834375|75911174|FG000|COMPLETED|Overall Study||72||
59790889|NCT04834375|75911175|FG001|COMPLETED|Overall Study||70||
59790890|NCT04834375|75911174|FG000|NOT COMPLETED|Overall Study||0||
59790891|NCT04834375|75911175|FG001|NOT COMPLETED|Overall Study||0||
59790892|NCT04739709|75911183|FG000|STARTED|Overall Study||181||
59953602|NCT02343302|76071965|FG000|NOT COMPLETED|Overall Study||1||
59953603|NCT02343302|76071966|FG001|NOT COMPLETED|Overall Study||1||
59790893|NCT04739709|75911184|FG001|STARTED|Overall Study||197||
59790894|NCT04739709|75911183|FG000|COMPLETED|Overall Study||180||
59790895|NCT04739709|75911184|FG001|COMPLETED|Overall Study||197||
59790896|NCT04739709|75911183|FG000|NOT COMPLETED|Overall Study||1||
59790897|NCT04739709|75911184|FG001|NOT COMPLETED|Overall Study||0||
59790898|NCT04717479|75911192|FG000|STARTED|Overall Study|41 individuals -- 22 MCIs and 19 ELLs|41||
59790899|NCT04717479|75911193|FG001|STARTED|Overall Study|39 individuals -- 22 MCIs and 17 ELLs|39||
59790900|NCT04717479|75911192|FG000|COMPLETED|Overall Study|34 individuals -- 17 MCIs and 17 ELLs|34||
59953604|NCT02590432|76071974|FG000|STARTED|Open-label Treatment Period||508||
59953605|NCT02590432|76071975|FG001|STARTED|Open-label Treatment Period||318||
59790901|NCT04717479|75911193|FG001|COMPLETED|Overall Study|35 individuals -- 21 MCIs and 14 ELLs|35||
59790902|NCT04717479|75911192|FG000|NOT COMPLETED|Overall Study||7||
59790903|NCT04717479|75911193|FG001|NOT COMPLETED|Overall Study||4||
59790904|NCT04710927|75911201|FG000|STARTED|Overall Study|Total of 10 participants in treatment arm/group 1 had more than 1 treatment interventions (6 participants had 2 treatment interventions and 4 participants with 3 treatment interventions). Only 8 participants had 1 treatment intervention. However, 3 participants from a total of 18 participants had 2 teeth assigned into treatment arm/group 1 regardless having assigned to single or more than 1 treatment group (2 and 3 treatment interventions).|18||21
59790905|NCT04710927|75911202|FG001|STARTED|Overall Study|Total of 12 participants in treatment arm/group 2 had more than 1 treatment interventions (8 participants had 2 treatment interventions and 4 participants with all 3 treatment interventions). Only 7 participants had 1 treatment intervention. However, 2 out of 8 participants from 2 treatment interventions had 2 teeth assigned for treatment arm/group 2.|19||21
59790906|NCT04710927|75911203|FG002|STARTED|Overall Study|Total of 11 participants in treatment arm/group 3 had more than 1 treatment interventions (7 participants had 2 treatment interventions and 4 participants with 3 treatment interventions). Only 9 participants had 1 treatment intervention. However, 1 out of 4 participants from 3 treatment interventions had 2 teeth assigned for treatment arm/group 3.|20||21
59790907|NCT04710927|75911201|FG000|6 Months|Overall Study|As units: 3 MIH affected molars failures to attend follow up at 6 months which involved 3 participants|15||18
59790908|NCT04710927|75911202|FG001|6 Months|Overall Study|As units: 4 MIH affected molars failures to attend follow up at 6 months which involved 3 participants|16||17
59790909|NCT04710927|75911203|FG002|6 Months|Overall Study|As units: 4 MIH affected molars failures to attend follow up at 6 months which involved 4 participants|16||17
59790910|NCT04710927|75911201|FG000|12 Months|Overall Study|As units: 8 MIH affected molars failures to attend follow up at 12 months which involved 7 participants|11||13
59790911|NCT04710927|75911202|FG001|12 Months|Overall Study|As units: 6 MIH affected molars failures to attend follow up at 12 months which involved 6 participants|13||15
59790912|NCT04710927|75911203|FG002|12 Months|Overall Study|As units: 5 MIH affected molars failures to attend follow up at 12 months which involved 5 participants|15||16
59790913|NCT04710927|75911201|FG000|COMPLETED|Overall Study||11||13
59790914|NCT04710927|75911202|FG001|COMPLETED|Overall Study||13||15
59790915|NCT04710927|75911203|FG002|COMPLETED|Overall Study||15||16
59790916|NCT04710927|75911201|FG000|NOT COMPLETED|Overall Study||7||8
59790917|NCT04710927|75911202|FG001|NOT COMPLETED|Overall Study||6||6
59790918|NCT04710927|75911203|FG002|NOT COMPLETED|Overall Study||5||5
59790919|NCT04657666|75911214|FG000|STARTED|Period 1||33||
59790920|NCT04657666|75911215|FG001|STARTED|Period 1||35||
59790921|NCT04657666|75911214|FG000|COMPLETED|Period 1||30||
59790922|NCT04657666|75911215|FG001|COMPLETED|Period 1||33||
59790923|NCT04657666|75911214|FG000|NOT COMPLETED|Period 1||3||
59790924|NCT04657666|75911215|FG001|NOT COMPLETED|Period 1||2||
59790925|NCT04657666|75911214|FG000|STARTED|Period 2||30||
59790926|NCT04657666|75911215|FG001|STARTED|Period 2||33||
59790927|NCT04657666|75911214|FG000|COMPLETED|Period 2||28||
59790928|NCT04657666|75911215|FG001|COMPLETED|Period 2||30||
59790929|NCT04657666|75911214|FG000|NOT COMPLETED|Period 2||2||
59790930|NCT04657666|75911215|FG001|NOT COMPLETED|Period 2||3||
59790931|NCT04539249|75911223|FG000|STARTED|Overall Study||50|Randomized|
59790932|NCT04539249|75911224|FG001|STARTED|Overall Study||50|Randomized|
59790933|NCT04539249|75911223|FG000|Allocation|Overall Study||50|Received allocated intervention|
59790934|NCT04539249|75911224|FG001|Allocation|Overall Study||50|Received allocated intervention|
59790935|NCT04539249|75911223|FG000|Intervention Per Protocol|Overall Study||49|Received allocated intervention per protocol|
59790936|NCT04539249|75911224|FG001|Intervention Per Protocol|Overall Study||50|Received allocated intervention per protocol|
59790937|NCT04539249|75911223|FG000|Intervention NOT Per Protocol|Overall Study||1|Did not receive allocated intervention per protocol|
59790938|NCT04539249|75911224|FG001|Intervention NOT Per Protocol|Overall Study||0|Did not receive allocated intervention per protocol|
59790939|NCT04539249|75911223|FG000|Analyzed|Overall Study||50||
59790940|NCT04539249|75911224|FG001|Analyzed|Overall Study||50||
59790941|NCT04539249|75911223|FG000|Excluded From Analysis|Overall Study||0||
59790942|NCT04539249|75911224|FG001|Excluded From Analysis|Overall Study||0||
59790943|NCT04539249|75911223|FG000|COMPLETED|Overall Study||50||
59790944|NCT04539249|75911224|FG001|COMPLETED|Overall Study||50||
59790945|NCT04539249|75911223|FG000|NOT COMPLETED|Overall Study||0||
59790946|NCT04539249|75911224|FG001|NOT COMPLETED|Overall Study||0||
59790947|NCT04495829|75911234|FG000|STARTED|Overall Study||70||
59790948|NCT04495829|75911234|FG000|COMPLETED|Overall Study||65||
59790949|NCT04495829|75911234|FG000|NOT COMPLETED|Overall Study||5||
59790950|NCT04492891|75911240|FG000|STARTED|Overall Study||30|Due to the decline of COVID-19 cases which led to slow accrual, the study was closed to enrollment on April 6, 2022. For this reason, the total number of participants reported in the Arm/Group Description and the number of participants who started in the Participant Flow of the Result Section have a discrepancy.|
59790951|NCT04492891|75911241|FG001|STARTED|Overall Study||17|Due to the decline of COVID-19 cases which led to slow accrual, the study was closed to enrollment on April 6, 2022. For this reason, the total number of participants reported in the Arm/Group Description and the number of participants who started in the Participant Flow of the Result Section have a discrepancy.|
59790952|NCT04492891|75911240|FG000|COMPLETED|Overall Study||30|Due to the decline of COVID-19 cases which led to slow accrual, the study was closed to enrollment on April 6, 2022. For this reason, the total number of participants reported in the Arm/Group Description and the number of participants who completed in the Participant Flow of the Result Section have a discrepancy.|
60073485|NCT01689363|76188723|FG001|COMPLETED|Overall Study||31||
59790953|NCT04492891|75911241|FG001|COMPLETED|Overall Study||17|Due to the decline of COVID-19 cases which led to slow accrual, the study was closed to enrollment on April 6, 2022. For this reason, the total number of participants reported in the Arm/Group Description and the number of participants who completed in the Participant Flow of the Result Section have a discrepancy.|
59790954|NCT04492891|75911240|FG000|NOT COMPLETED|Overall Study||0||
59790955|NCT04492891|75911241|FG001|NOT COMPLETED|Overall Study||0||
59790956|NCT04101721|75911249|FG000|STARTED|Overall Study||27|Randomized and Treated|50
59790957|NCT04101721|75911250|FG001|STARTED|Overall Study||93|Randomized and Treated|179
59790958|NCT04101721|75911249|FG000|COMPLETED|Overall Study||26||48
59523241|NCT01558492|75617988|FG000|STARTED|Overall Study||3||
59523242|NCT01558492|75617988|FG000|COMPLETED|Overall Study||3||
59523243|NCT01558492|75617988|FG000|NOT COMPLETED|Overall Study||0||
59523244|NCT01551082|75617992|FG000|STARTED|Overall Study||12||
59523245|NCT01551082|75617992|FG000|COMPLETED|Overall Study||12||
59523246|NCT01551082|75617992|FG000|NOT COMPLETED|Overall Study||0||
59523247|NCT00691444|75617999|FG000|STARTED|Overall Study||0||
59523248|NCT00691444|75618000|FG001|STARTED|Overall Study||0||
59523249|NCT00691444|75618001|FG002|STARTED|Overall Study||0||
59523250|NCT00691444|75617999|FG000|COMPLETED|Overall Study||0||
59523251|NCT00691444|75618000|FG001|COMPLETED|Overall Study||0||
59523252|NCT00691444|75618001|FG002|COMPLETED|Overall Study||0||
59523253|NCT00691444|75617999|FG000|NOT COMPLETED|Overall Study||0||
59523254|NCT00691444|75618000|FG001|NOT COMPLETED|Overall Study||0||
59523255|NCT00691444|75618001|FG002|NOT COMPLETED|Overall Study||0||
59523256|NCT00693628|75618011|FG000|STARTED|Overall Study|No data is available indicating to which group patients were assigned.|0||
59523257|NCT00693628|75618012|FG001|STARTED|Overall Study|No data is available indicating to which group patients were assigned .|0||
59523258|NCT00693628|75618011|FG000|COMPLETED|Overall Study|Only 4 patients enrolled in study. No data indicating their group assignment|0||
59523259|NCT00693628|75618012|FG001|COMPLETED|Overall Study|Only 4 patients enrolled in study. No data indicating their group assignment.|0||
59523260|NCT00693628|75618011|FG000|NOT COMPLETED|Overall Study||0||
59523261|NCT00693628|75618012|FG001|NOT COMPLETED|Overall Study||0||
59523262|NCT00689884|75618018|FG000|STARTED|Overall Study||7||
59523263|NCT00689884|75618018|FG000|COMPLETED|Overall Study||7||
59523264|NCT00689884|75618018|FG000|NOT COMPLETED|Overall Study||0||
59523265|NCT01530880|75618023|FG000|STARTED|Overall Study||35||
59523266|NCT01530880|75618023|FG000|COMPLETED|Overall Study||35||
59523267|NCT01530880|75618023|FG000|NOT COMPLETED|Overall Study||0||
59523268|NCT01532362|75618030|FG000|STARTED|Overall Study||1||
59523269|NCT01532362|75618031|FG001|STARTED|Overall Study||0||
59523270|NCT01532362|75618030|FG000|COMPLETED|Overall Study||1||
59523271|NCT01532362|75618031|FG001|COMPLETED|Overall Study||0||
59523272|NCT01532362|75618030|FG000|NOT COMPLETED|Overall Study||0||
59523273|NCT01532362|75618031|FG001|NOT COMPLETED|Overall Study||0||
59523274|NCT00678574|75618041|FG000|STARTED|Overall Study||18||
59523275|NCT00678574|75618042|FG001|STARTED|Overall Study||27||
59523276|NCT00678574|75618041|FG000|COMPLETED|Overall Study||18||
59523277|NCT00678574|75618042|FG001|COMPLETED|Overall Study||27||
59523278|NCT00678574|75618041|FG000|NOT COMPLETED|Overall Study||0||
59523279|NCT00678574|75618042|FG001|NOT COMPLETED|Overall Study||0||
59523280|NCT00672178|75618048|FG000|STARTED|Overall Study||1||
59523281|NCT00672178|75618048|FG000|COMPLETED|Overall Study||1||
59523282|NCT00672178|75618048|FG000|NOT COMPLETED|Overall Study||0||
59523283|NCT00634582|75618052|FG000|STARTED|Overall Study||2||
59523284|NCT00634582|75618052|FG000|COMPLETED|Overall Study||2||
59790959|NCT04101721|75911250|FG001|COMPLETED|Overall Study||87||168
59790960|NCT04101721|75911249|FG000|NOT COMPLETED|Overall Study||1||2
59523285|NCT00634582|75618052|FG000|NOT COMPLETED|Overall Study||0||
59523286|NCT02551692|75618059|FG000|STARTED|Overall Study||31||
59523287|NCT02551692|75618060|FG001|STARTED|Overall Study||27||
59523288|NCT02551692|75618061|FG002|STARTED|Overall Study||30||
59523289|NCT02551692|75618059|FG000|COMPLETED|Overall Study||30||
59523290|NCT02551692|75618060|FG001|COMPLETED|Overall Study||26||
59523291|NCT02551692|75618061|FG002|COMPLETED|Overall Study||25||
59523292|NCT02551692|75618059|FG000|NOT COMPLETED|Overall Study||1||
59523293|NCT02551692|75618060|FG001|NOT COMPLETED|Overall Study||1||
59523294|NCT02551692|75618061|FG002|NOT COMPLETED|Overall Study||5||
59953606|NCT02590432|76071976|FG002|STARTED|Open-label Treatment Period||0||
59953607|NCT02590432|76071977|FG003|STARTED|Open-label Treatment Period||0||
59953608|NCT02590432|76071978|FG004|STARTED|Open-label Treatment Period||0||
59790961|NCT04101721|75911250|FG001|NOT COMPLETED|Overall Study||6||11
59790962|NCT03864926|75911258|FG000|STARTED|Overall Study||50||
59790963|NCT03864926|75911259|FG001|STARTED|Overall Study||50||
59790964|NCT03864926|75911258|FG000|COMPLETED|Overall Study||50||
59790965|NCT03864926|75911259|FG001|COMPLETED|Overall Study||48||
59790966|NCT03864926|75911258|FG000|NOT COMPLETED|Overall Study||0||
59790967|NCT03864926|75911259|FG001|NOT COMPLETED|Overall Study||2||
59790968|NCT03760016|75911267|FG000|STARTED|Overall Study||27||
59790969|NCT03760016|75911268|FG001|STARTED|Overall Study||28||
59790970|NCT03760016|75911267|FG000|Completed 4-week Testing|Overall Study||26||
59790971|NCT03760016|75911268|FG001|Completed 4-week Testing|Overall Study||27||
59790972|NCT03760016|75911267|FG000|Completed 8-week Testing|Overall Study||23||
59790973|NCT03760016|75911268|FG001|Completed 8-week Testing|Overall Study||24||
59790974|NCT03760016|75911267|FG000|COMPLETED|Overall Study||19||
59790975|NCT03760016|75911268|FG001|COMPLETED|Overall Study||23||
59790976|NCT03760016|75911267|FG000|NOT COMPLETED|Overall Study||8||
59790977|NCT03760016|75911268|FG001|NOT COMPLETED|Overall Study||5||
59790978|NCT03623243|75911274|FG000|STARTED|Overall Study||185||
59953609|NCT02590432|76071979|FG005|STARTED|Open-label Treatment Period||0||
59953610|NCT02590432|76071980|FG006|STARTED|Open-label Treatment Period||0||
59953611|NCT02590432|76071981|FG007|STARTED|Open-label Treatment Period||0||
60073486|NCT01689363|76188724|FG002|COMPLETED|Overall Study||32||
59790979|NCT03623243|75911274|FG000|Safety Set|Overall Study||185|Safety set included all participants who received at least one dose of study treatment.|
59790980|NCT03623243|75911274|FG000|COMPLETED|Overall Study||146||
59790981|NCT03623243|75911274|FG000|NOT COMPLETED|Overall Study||39||
59790982|NCT03258853|75911280|FG000|STARTED|First Intervention (14 Days)||11||
59790983|NCT03258853|75911281|FG001|STARTED|First Intervention (14 Days)||11||
59790984|NCT03258853|75911280|FG000|COMPLETED|First Intervention (14 Days)||10||
59790985|NCT03258853|75911281|FG001|COMPLETED|First Intervention (14 Days)||10||
60073487|NCT01689363|76188725|FG003|COMPLETED|Overall Study||31||
60073488|NCT01689363|76188726|FG004|COMPLETED|Overall Study||31||
60073489|NCT01689363|76188727|FG005|COMPLETED|Overall Study||31||
60073490|NCT01689363|76188728|FG006|COMPLETED|Overall Study||32||
60073491|NCT01689363|76188729|FG007|COMPLETED|Overall Study||32||
60073492|NCT01689363|76188722|FG000|NOT COMPLETED|Overall Study||0||
60073493|NCT01689363|76188723|FG001|NOT COMPLETED|Overall Study||1||
60073494|NCT01689363|76188724|FG002|NOT COMPLETED|Overall Study||0||
60073495|NCT01689363|76188725|FG003|NOT COMPLETED|Overall Study||0||
60073496|NCT01689363|76188726|FG004|NOT COMPLETED|Overall Study||0||
60073497|NCT01689363|76188727|FG005|NOT COMPLETED|Overall Study||0||
60073498|NCT01689363|76188728|FG006|NOT COMPLETED|Overall Study||0||
60073499|NCT01689363|76188729|FG007|NOT COMPLETED|Overall Study||0||
60073500|NCT02072421|76188740|FG000|STARTED|Overall Study||2879||
60073501|NCT02072421|76188740|FG000|COMPLETED|Overall Study||2489||
60073502|NCT02072421|76188740|FG000|NOT COMPLETED|Overall Study||390||
60073503|NCT01558635|76188745|FG000|STARTED|Overall Study||17||
60073504|NCT01558635|76188745|FG000|Treated|Overall Study||17||
60073505|NCT01558635|76188745|FG000|Discharge /1 Month Post-procedure|Overall Study||15||
60073506|NCT01558635|76188745|FG000|3 Months Post-procedure|Overall Study||14||
60073507|NCT01558635|76188745|FG000|6 Months Post-procedure|Overall Study||14||
60073508|NCT01558635|76188745|FG000|COMPLETED|Overall Study||11|12 months post-procedure|
60073509|NCT01558635|76188745|FG000|NOT COMPLETED|Overall Study||6||
60073510|NCT00089986|76188759|FG000|STARTED|Overall Study||599||
59523295|NCT00547456|75618069|FG000|STARTED|Overall Study||20||
59790986|NCT03258853|75911280|FG000|NOT COMPLETED|First Intervention (14 Days)||1||
59790987|NCT03258853|75911281|FG001|NOT COMPLETED|First Intervention (14 Days)||1||
59790988|NCT03258853|75911280|FG000|STARTED|Second Intervention (14 Days)||10||
59790989|NCT03258853|75911281|FG001|STARTED|Second Intervention (14 Days)||10||
59790990|NCT03258853|75911280|FG000|COMPLETED|Second Intervention (14 Days)||10||
59790991|NCT03258853|75911281|FG001|COMPLETED|Second Intervention (14 Days)||10||
59790992|NCT03258853|75911280|FG000|NOT COMPLETED|Second Intervention (14 Days)||0||
59953612|NCT02590432|76071982|FG008|STARTED|Open-label Treatment Period||0||
60073511|NCT00089986|76188760|FG001|STARTED|Overall Study||598||
60073512|NCT00089986|76188761|FG002|STARTED|Overall Study||182||
60073513|NCT00089986|76188759|FG000|COMPLETED|Overall Study||584||
60073514|NCT00089986|76188760|FG001|COMPLETED|Overall Study||574||
60073515|NCT00089986|76188761|FG002|COMPLETED|Overall Study||172||
60073516|NCT00089986|76188759|FG000|NOT COMPLETED|Overall Study||15||
60073517|NCT00089986|76188760|FG001|NOT COMPLETED|Overall Study||24||
60073518|NCT00089986|76188761|FG002|NOT COMPLETED|Overall Study||10||
60073519|NCT03497806|76188769|FG000|STARTED|Week 8||132||
59790993|NCT03258853|75911281|FG001|NOT COMPLETED|Second Intervention (14 Days)||0||
59790994|NCT03236155|75911289|FG000|STARTED|Overall Study||143||
59790995|NCT03236155|75911290|FG001|STARTED|Overall Study||161||
59790996|NCT03236155|75911289|FG000|COMPLETED|Overall Study||143||
59790997|NCT03236155|75911290|FG001|COMPLETED|Overall Study||161||
59790998|NCT03236155|75911289|FG000|NOT COMPLETED|Overall Study||0||
59953613|NCT02590432|76071974|FG000|COMPLETED|Open-label Treatment Period|Participants were not randomized to Double-blind Treatment Period.|276|Out of 384 participants who discontinued, 114 continued to Double-blind Treatment Period.|
59523296|NCT00547456|75618069|FG000|COMPLETED|Overall Study||20||
59790999|NCT03236155|75911290|FG001|NOT COMPLETED|Overall Study||0||
59791000|NCT03192202|75911305|FG000|STARTED|Overall Study||3||
59791001|NCT03192202|75911306|FG001|STARTED|Overall Study||3||
59791002|NCT03192202|75911307|FG002|STARTED|Overall Study||3||
59791003|NCT03192202|75911308|FG003|STARTED|Overall Study||6||
59791004|NCT03192202|75911305|FG000|COMPLETED|Overall Study||3||
59791005|NCT03192202|75911306|FG001|COMPLETED|Overall Study||3||
59791006|NCT03192202|75911307|FG002|COMPLETED|Overall Study||3||
59791007|NCT03192202|75911308|FG003|COMPLETED|Overall Study||6||
59791008|NCT03192202|75911305|FG000|NOT COMPLETED|Overall Study||0||
59791009|NCT03192202|75911306|FG001|NOT COMPLETED|Overall Study||0||
59791010|NCT03192202|75911307|FG002|NOT COMPLETED|Overall Study||0||
59791011|NCT03192202|75911308|FG003|NOT COMPLETED|Overall Study||0||
59791012|NCT03068780|75911324|FG000|STARTED|Double-Blind Phase (DBP)||109||
59791013|NCT03068780|75911325|FG001|STARTED|Double-Blind Phase (DBP)||114||
59791014|NCT03068780|75911324|FG000|COMPLETED|Double-Blind Phase (DBP)||100||
59791015|NCT03068780|75911325|FG001|COMPLETED|Double-Blind Phase (DBP)||99||
59791016|NCT03068780|75911324|FG000|NOT COMPLETED|Double-Blind Phase (DBP)||9||
59791017|NCT03068780|75911325|FG001|NOT COMPLETED|Double-Blind Phase (DBP)||15||
59791018|NCT03068780|75911324|FG000|STARTED|Open-Label Phase (OLP)||100||
59791019|NCT03068780|75911325|FG001|STARTED|Open-Label Phase (OLP)|All subjects switched to Oleogel-S10 in the OLP. 6 subjects, all control gel, discontinued from DBP and entered OLP prematurely.|105||
59791020|NCT03068780|75911324|FG000|COMPLETED|Open-Label Phase (OLP)||66||
59791021|NCT03068780|75911325|FG001|COMPLETED|Open-Label Phase (OLP)||75||
59791022|NCT03068780|75911324|FG000|NOT COMPLETED|Open-Label Phase (OLP)||34||
59791023|NCT03068780|75911325|FG001|NOT COMPLETED|Open-Label Phase (OLP)||30||
59953614|NCT02590432|76071975|FG001|COMPLETED|Open-label Treatment Period|Participants were not randomized to Double-blind Treatment Period.|166|Out of 384 participants who discontinued, 114 continued to Double-blind Treatment Period.|
59953615|NCT02590432|76071976|FG002|COMPLETED|Open-label Treatment Period||0|Out of 384 participants who discontinued, 114 continued to Double-blind Treatment Period.|
59953616|NCT02590432|76071977|FG003|COMPLETED|Open-label Treatment Period||0|Out of 384 participants who discontinued, 114 continued to Double-blind Treatment Period.|
59953617|NCT02590432|76071978|FG004|COMPLETED|Open-label Treatment Period||0|Out of 384 participants who discontinued, 114 continued to Double-blind Treatment Period.|
59953618|NCT02590432|76071979|FG005|COMPLETED|Open-label Treatment Period||0|Out of 384 participants who discontinued, 114 continued to Double-blind Treatment Period.|
59953619|NCT02590432|76071980|FG006|COMPLETED|Open-label Treatment Period||0|Out of 384 participants who discontinued, 114 continued to Double-blind Treatment Period.|
59953620|NCT02590432|76071981|FG007|COMPLETED|Open-label Treatment Period||0|Out of 384 participants who discontinued, 114 continued to Double-blind Treatment Period.|
59953621|NCT02590432|76071982|FG008|COMPLETED|Open-label Treatment Period||0|Out of 384 participants who discontinued, 114 continued to Double-blind Treatment Period.|
59953622|NCT02590432|76071974|FG000|NOT COMPLETED|Open-label Treatment Period||232||
59953623|NCT02590432|76071975|FG001|NOT COMPLETED|Open-label Treatment Period||152||
59953624|NCT02590432|76071976|FG002|NOT COMPLETED|Open-label Treatment Period||0||
59953625|NCT02590432|76071977|FG003|NOT COMPLETED|Open-label Treatment Period||0||
59953626|NCT02590432|76071978|FG004|NOT COMPLETED|Open-label Treatment Period||0||
59953627|NCT02590432|76071979|FG005|NOT COMPLETED|Open-label Treatment Period||0||
59953628|NCT02590432|76071980|FG006|NOT COMPLETED|Open-label Treatment Period||0||
59953629|NCT02590432|76071981|FG007|NOT COMPLETED|Open-label Treatment Period||0||
59953630|NCT02590432|76071982|FG008|NOT COMPLETED|Open-label Treatment Period||0||
59953631|NCT02590432|76071974|FG000|STARTED|Double-blind Treatment Period||0||
59953632|NCT02590432|76071975|FG001|STARTED|Double-blind Treatment Period||0||
59953633|NCT02590432|76071976|FG002|STARTED|Double-blind Treatment Period||18||
59953634|NCT02590432|76071977|FG003|STARTED|Double-blind Treatment Period||18||
59953635|NCT02590432|76071978|FG004|STARTED|Double-blind Treatment Period||16||
59953636|NCT02590432|76071979|FG005|STARTED|Double-blind Treatment Period||32||
59953637|NCT02590432|76071980|FG006|STARTED|Double-blind Treatment Period||30||
59953638|NCT02590432|76071981|FG007|STARTED|Double-blind Treatment Period||0||
59953639|NCT02590432|76071982|FG008|STARTED|Double-blind Treatment Period||0||
59953640|NCT02590432|76071974|FG000|COMPLETED|Double-blind Treatment Period||0|Out of 88 participants who discontinued, 57 continued to Dose-reduced Open Label Treatment Period.|
59791024|NCT03006848|75911333|FG000|STARTED|Overall Study||18||
59791025|NCT03006848|75911333|FG000|COMPLETED|Overall Study||0||
59791026|NCT03006848|75911333|FG000|NOT COMPLETED|Overall Study||18||
59791027|NCT02981069|75911348|FG000|STARTED|Acute Portion of Study||25||
59791028|NCT02981069|75911349|FG001|STARTED|Acute Portion of Study||25||
59523297|NCT00547456|75618069|FG000|NOT COMPLETED|Overall Study||0||
59791029|NCT02981069|75911350|FG002|STARTED|Acute Portion of Study||25||
59791030|NCT02981069|75911351|FG003|STARTED|Acute Portion of Study||15||
59791031|NCT02981069|75911348|FG000|COMPLETED|Acute Portion of Study||25||
59791032|NCT02981069|75911349|FG001|COMPLETED|Acute Portion of Study||25||
59791033|NCT02981069|75911350|FG002|COMPLETED|Acute Portion of Study||25||
59791034|NCT02981069|75911351|FG003|COMPLETED|Acute Portion of Study||15||
59791035|NCT02981069|75911348|FG000|NOT COMPLETED|Acute Portion of Study||0||
59791036|NCT02981069|75911349|FG001|NOT COMPLETED|Acute Portion of Study||0||
59791037|NCT02981069|75911350|FG002|NOT COMPLETED|Acute Portion of Study||0||
59791038|NCT02981069|75911351|FG003|NOT COMPLETED|Acute Portion of Study||0||
59791039|NCT02981069|75911348|FG000|STARTED|16 Week Drug Administration Period||25|Since subjects are Type 2 diabetics, there was no placebo arm for this portion of the study. Only 3 arms of the study were conducted: (i) Byetta/Bydureon, (ii) Dapagliflozin (iii) Byetta/Bydureon plus Dapagliflozin.|
59791040|NCT02981069|75911349|FG001|STARTED|16 Week Drug Administration Period||25|Since subjects are Type 2 diabetics, there was no placebo arm for this portion of the study. Only 3 arms of the study were conducted: (i) Byetta/Bydureon, (ii) Dapagliflozin (iii) Byetta/Bydureon plus Dapagliflozin.|
59791041|NCT02981069|75911350|FG002|STARTED|16 Week Drug Administration Period||25|Since subjects are Type 2 diabetics, there was no placebo arm for this portion of the study. Only 3 arms of the study were conducted: (i) Byetta/Bydureon, (ii) Dapagliflozin (iii) Byetta/Bydureon plus Dapagliflozin.|
59791042|NCT02981069|75911351|FG003|STARTED|16 Week Drug Administration Period||0|Since subjects are Type 2 diabetics, there was no placebo arm for this portion of the study. Only 3 arms of the study were conducted: (i) Byetta/Bydureon, (ii) Dapagliflozin (iii) Byetta/Bydureon plus Dapagliflozin.|
59791043|NCT02981069|75911348|FG000|COMPLETED|16 Week Drug Administration Period||25||
59791044|NCT02981069|75911349|FG001|COMPLETED|16 Week Drug Administration Period||25||
59791045|NCT02981069|75911350|FG002|COMPLETED|16 Week Drug Administration Period||25||
59791046|NCT02981069|75911351|FG003|COMPLETED|16 Week Drug Administration Period||0||
59791047|NCT02981069|75911348|FG000|NOT COMPLETED|16 Week Drug Administration Period||0||
59791048|NCT02981069|75911349|FG001|NOT COMPLETED|16 Week Drug Administration Period||0||
59791049|NCT02981069|75911350|FG002|NOT COMPLETED|16 Week Drug Administration Period||0||
59791050|NCT02981069|75911351|FG003|NOT COMPLETED|16 Week Drug Administration Period||0||
59791051|NCT02810444|75911371|FG000|STARTED|Overall Study|as defined by protocol|81||
59791052|NCT02810444|75911371|FG000|Treatment Started|Overall Study||67||
59791053|NCT02810444|75911371|FG000|COMPLETED|Overall Study||60||
59791054|NCT02810444|75911371|FG000|NOT COMPLETED|Overall Study||21||
59791055|NCT02507284|75911378|FG000|STARTED|Overall Study||36||
59791056|NCT02507284|75911379|FG001|STARTED|Overall Study||34||
59791057|NCT02507284|75911380|FG002|STARTED|Overall Study||36||
59791058|NCT02507284|75911378|FG000|COMPLETED|Overall Study||25||
59791059|NCT02507284|75911379|FG001|COMPLETED|Overall Study||27||
59791060|NCT02507284|75911380|FG002|COMPLETED|Overall Study||30||
59791061|NCT02507284|75911378|FG000|NOT COMPLETED|Overall Study||11||
59791062|NCT02507284|75911379|FG001|NOT COMPLETED|Overall Study||7||
59791063|NCT02507284|75911380|FG002|NOT COMPLETED|Overall Study||6||
59791064|NCT02501096|75911397|FG000|STARTED|Overall Study||2||
59791065|NCT02501096|75911398|FG001|STARTED|Overall Study||1||
59791066|NCT02501096|75911399|FG002|STARTED|Overall Study||124||
59791067|NCT02501096|75911400|FG003|STARTED|Overall Study||145||
59791068|NCT02501096|75911401|FG004|STARTED|Overall Study||21||
59791069|NCT02501096|75911402|FG005|STARTED|Overall Study||21||
59791070|NCT02501096|75911403|FG006|STARTED|Overall Study||22||
59791071|NCT02501096|75911404|FG007|STARTED|Overall Study||20||
59791072|NCT02501096|75911405|FG008|STARTED|Overall Study||1||
59791073|NCT02501096|75911397|FG000|Phase 1b Participants Who Received, Lenvatinib 20 mg/Day + Pembrolizumab 200 mg.|Overall Study||0||
59791074|NCT02501096|75911398|FG001|Phase 1b Participants Who Received, Lenvatinib 20 mg/Day + Pembrolizumab 200 mg.|Overall Study||0||
59791075|NCT02501096|75911399|FG002|Phase 1b Participants Who Received, Lenvatinib 20 mg/Day + Pembrolizumab 200 mg.|Overall Study||2||
59791076|NCT02501096|75911400|FG003|Phase 1b Participants Who Received, Lenvatinib 20 mg/Day + Pembrolizumab 200 mg.|Overall Study||6||
59791077|NCT02501096|75911401|FG004|Phase 1b Participants Who Received, Lenvatinib 20 mg/Day + Pembrolizumab 200 mg.|Overall Study||1||
59791078|NCT02501096|75911402|FG005|Phase 1b Participants Who Received, Lenvatinib 20 mg/Day + Pembrolizumab 200 mg.|Overall Study||1||
59791079|NCT02501096|75911403|FG006|Phase 1b Participants Who Received, Lenvatinib 20 mg/Day + Pembrolizumab 200 mg.|Overall Study||0||
59791080|NCT02501096|75911404|FG007|Phase 1b Participants Who Received, Lenvatinib 20 mg/Day + Pembrolizumab 200 mg.|Overall Study||0||
59791081|NCT02501096|75911405|FG008|Phase 1b Participants Who Received, Lenvatinib 20 mg/Day + Pembrolizumab 200 mg.|Overall Study||0||
59791082|NCT02501096|75911397|FG000|Phase 2 Participants Who Received, Lenvatinib 20 mg/Day + Pembrolizumab 200 mg|Overall Study||0||
59791083|NCT02501096|75911398|FG001|Phase 2 Participants Who Received, Lenvatinib 20 mg/Day + Pembrolizumab 200 mg|Overall Study||0||
59791084|NCT02501096|75911399|FG002|Phase 2 Participants Who Received, Lenvatinib 20 mg/Day + Pembrolizumab 200 mg|Overall Study||122||
59791085|NCT02501096|75911400|FG003|Phase 2 Participants Who Received, Lenvatinib 20 mg/Day + Pembrolizumab 200 mg|Overall Study||139||
59791086|NCT02501096|75911401|FG004|Phase 2 Participants Who Received, Lenvatinib 20 mg/Day + Pembrolizumab 200 mg|Overall Study||20||
59791087|NCT02501096|75911402|FG005|Phase 2 Participants Who Received, Lenvatinib 20 mg/Day + Pembrolizumab 200 mg|Overall Study||20||
59791088|NCT02501096|75911403|FG006|Phase 2 Participants Who Received, Lenvatinib 20 mg/Day + Pembrolizumab 200 mg|Overall Study||22||
59791089|NCT02501096|75911404|FG007|Phase 2 Participants Who Received, Lenvatinib 20 mg/Day + Pembrolizumab 200 mg|Overall Study||20||
59523298|NCT00542542|75618075|FG000|STARTED|Overall Study||44||
59523299|NCT00542542|75618076|FG001|STARTED|Overall Study||44||
59523300|NCT00542542|75618075|FG000|COMPLETED|Overall Study||44||
59523301|NCT00542542|75618076|FG001|COMPLETED|Overall Study||44||
59523302|NCT00542542|75618075|FG000|NOT COMPLETED|Overall Study||0||
59523303|NCT00542542|75618076|FG001|NOT COMPLETED|Overall Study||0||
59791090|NCT02501096|75911405|FG008|Phase 2 Participants Who Received, Lenvatinib 20 mg/Day + Pembrolizumab 200 mg|Overall Study||1||
59791091|NCT02501096|75911397|FG000|COMPLETED|Overall Study||0||
59791092|NCT02501096|75911398|FG001|COMPLETED|Overall Study||0||
59791093|NCT02501096|75911399|FG002|COMPLETED|Overall Study||0||
59791094|NCT02501096|75911400|FG003|COMPLETED|Overall Study||0||
59791095|NCT02501096|75911401|FG004|COMPLETED|Overall Study||0||
59791096|NCT02501096|75911402|FG005|COMPLETED|Overall Study||0||
59791097|NCT02501096|75911403|FG006|COMPLETED|Overall Study||0||
59791098|NCT02501096|75911404|FG007|COMPLETED|Overall Study||0||
59791099|NCT02501096|75911405|FG008|COMPLETED|Overall Study||0||
59791100|NCT02501096|75911397|FG000|NOT COMPLETED|Overall Study||2||
59791101|NCT02501096|75911398|FG001|NOT COMPLETED|Overall Study||1||
59791102|NCT02501096|75911399|FG002|NOT COMPLETED|Overall Study||124||
59791103|NCT02501096|75911400|FG003|NOT COMPLETED|Overall Study||145||
59791104|NCT02501096|75911401|FG004|NOT COMPLETED|Overall Study||21||
59791105|NCT02501096|75911402|FG005|NOT COMPLETED|Overall Study||21||
59791106|NCT02501096|75911403|FG006|NOT COMPLETED|Overall Study||22||
59791107|NCT02501096|75911404|FG007|NOT COMPLETED|Overall Study||20||
59791108|NCT02501096|75911405|FG008|NOT COMPLETED|Overall Study||1||
59791109|NCT01633541|75911439|FG000|STARTED|Overall Study||36||
59791110|NCT01633541|75911440|FG001|STARTED|Overall Study||18||
59791111|NCT01633541|75911439|FG000|COMPLETED|Overall Study||35||
59791112|NCT01633541|75911440|FG001|COMPLETED|Overall Study||18||
59791113|NCT01633541|75911439|FG000|NOT COMPLETED|Overall Study||1||
59791114|NCT01633541|75911440|FG001|NOT COMPLETED|Overall Study||0||
59791115|NCT01466036|75911450|FG000|STARTED|Overall Study||20||
59791116|NCT01466036|75911451|FG001|STARTED|Overall Study||41||
59791117|NCT01466036|75911450|FG000|COMPLETED|Overall Study||0|treatment was indefinite|
59791118|NCT01466036|75911451|FG001|COMPLETED|Overall Study||0|treatment was indefinite|
59791119|NCT01466036|75911450|FG000|NOT COMPLETED|Overall Study||20||
59791120|NCT01466036|75911451|FG001|NOT COMPLETED|Overall Study||41||
59791121|NCT01399372|75911460|FG000|STARTED|Overall Study||47||
59791122|NCT01399372|75911461|FG001|STARTED|Overall Study||44||
59791123|NCT01399372|75911460|FG000|Eligible|Overall Study||44||
59791124|NCT01399372|75911461|FG001|Eligible|Overall Study||43||
59791125|NCT01399372|75911460|FG000|Eligible and Started Protocol Treatment|Overall Study||43||
59791126|NCT01399372|75911461|FG001|Eligible and Started Protocol Treatment|Overall Study||43||
59791127|NCT01399372|75911460|FG000|COMPLETED|Overall Study||44|Participants contributing data to results are considered to have completed the study|
59791128|NCT01399372|75911461|FG001|COMPLETED|Overall Study||43|Participants contributing data to results are considered to have completed the study|
59791129|NCT01399372|75911460|FG000|NOT COMPLETED|Overall Study||3||
59791130|NCT01399372|75911461|FG001|NOT COMPLETED|Overall Study||1||
59791131|NCT01063517|75911469|FG000|STARTED|Overall Study||62||
59791132|NCT01063517|75911470|FG001|STARTED|Overall Study||62||
59791133|NCT01063517|75911469|FG000|Received Randomised Treatment|Overall Study||61||
59791134|NCT01063517|75911470|FG001|Received Randomised Treatment|Overall Study||62||
59791135|NCT01063517|75911469|FG000|COMPLETED|Overall Study||4||
59791136|NCT01063517|75911470|FG001|COMPLETED|Overall Study||2||
59791137|NCT01063517|75911469|FG000|NOT COMPLETED|Overall Study||58||
59791138|NCT01063517|75911470|FG001|NOT COMPLETED|Overall Study||60||
59953641|NCT02590432|76071975|FG001|COMPLETED|Double-blind Treatment Period||0|Out of 88 participants who discontinued, 57 continued to Dose-reduced Open Label Treatment Period.|
59953642|NCT02590432|76071976|FG002|COMPLETED|Double-blind Treatment Period|Participants did not enter Dose-reduced Open Label Treatment Period.|1|Out of 88 participants who discontinued, 57 continued to Dose-reduced Open Label Treatment Period.|
59953643|NCT02590432|76071977|FG003|COMPLETED|Double-blind Treatment Period|Participants did not enter Dose-reduced Open Label Treatment Period.|3|Out of 88 participants who discontinued, 57 continued to Dose-reduced Open Label Treatment Period.|
59995232|NCT04076943|76111061|FG000|Received at Least 1 Dose of Study Drug|Overall Study||92||
59791139|NCT00920621|75911480|FG000|STARTED|Overall Study||440||
59791140|NCT00920621|75911481|FG001|STARTED|Overall Study||436||
59791141|NCT00920621|75911482|FG002|STARTED|Overall Study||440||
59791142|NCT00920621|75911483|FG003|STARTED|Overall Study||436||
59791143|NCT00920621|75911480|FG000|COMPLETED|Overall Study||386||
59791144|NCT00920621|75911481|FG001|COMPLETED|Overall Study||391||
59791145|NCT00920621|75911482|FG002|COMPLETED|Overall Study||405||
59791146|NCT00920621|75911483|FG003|COMPLETED|Overall Study||401||
59791147|NCT00920621|75911480|FG000|NOT COMPLETED|Overall Study||54||
59523304|NCT00545506|75618084|FG000|STARTED|Overall Study||3||
59791148|NCT00920621|75911481|FG001|NOT COMPLETED|Overall Study||45||
59791149|NCT00920621|75911482|FG002|NOT COMPLETED|Overall Study||35||
59791150|NCT00920621|75911483|FG003|NOT COMPLETED|Overall Study||35||
59791151|NCT00612105|75911496|FG000|STARTED|Period Title 1: 6-Week Titration Phase||125||
59791152|NCT00612105|75911497|FG001|STARTED|Period Title 1: 6-Week Titration Phase||62||
59791153|NCT00612105|75911496|FG000|COMPLETED|Period Title 1: 6-Week Titration Phase||89||
59791154|NCT00612105|75911497|FG001|COMPLETED|Period Title 1: 6-Week Titration Phase||57||
59791155|NCT00612105|75911496|FG000|NOT COMPLETED|Period Title 1: 6-Week Titration Phase||36||
59953644|NCT02590432|76071978|FG004|COMPLETED|Double-blind Treatment Period|Participants did not enter Dose-reduced Open Label Treatment Period.|7|Out of 88 participants who discontinued, 57 continued to Dose-reduced Open Label Treatment Period.|
59995233|NCT04076943|76111061|FG000|COMPLETED|Overall Study||58||
59619974|NCT02369484|75731101|FG000|NOT COMPLETED|Overall Study||0||
59619975|NCT02432742|75731105|FG000|STARTED|Overall Study||100||
59619976|NCT02432742|75731105|FG000|COMPLETED|Overall Study||95||
59619977|NCT02432742|75731105|FG000|NOT COMPLETED|Overall Study||5||
59619978|NCT02086500|75731112|FG000|STARTED|Overall Study||447||
59619979|NCT02086500|75731113|FG001|STARTED|Overall Study||456||
59619980|NCT02086500|75731112|FG000|COMPLETED|Overall Study||447||
59619981|NCT02086500|75731113|FG001|COMPLETED|Overall Study||456||
59619982|NCT02086500|75731112|FG000|NOT COMPLETED|Overall Study||0||
59619983|NCT02086500|75731113|FG001|NOT COMPLETED|Overall Study||0||
59619984|NCT01890954|75731121|FG000|STARTED|Overall Study||9||
59619985|NCT01890954|75731122|FG001|STARTED|Overall Study||8||
59619986|NCT01890954|75731121|FG000|COMPLETED|Overall Study||8||
59619987|NCT01890954|75731122|FG001|COMPLETED|Overall Study||8||
59619988|NCT01890954|75731121|FG000|NOT COMPLETED|Overall Study||1||
59619989|NCT01890954|75731122|FG001|NOT COMPLETED|Overall Study||0||
59619990|NCT02087748|75731128|FG000|STARTED|Overall Study||24||
59619991|NCT02087748|75731128|FG000|COMPLETED|Overall Study||24||
59619992|NCT02087748|75731128|FG000|NOT COMPLETED|Overall Study||0||
59619993|NCT01490502|75731138|FG000|STARTED|Overall Study||83||
59619994|NCT01490502|75731139|FG001|STARTED|Overall Study||89||
59619995|NCT01490502|75731138|FG000|Received Allocated Intervention|Overall Study||83||
59619996|NCT01490502|75731139|FG001|Received Allocated Intervention|Overall Study||88||
59619997|NCT01490502|75731138|FG000|Attended at Least 1 Follow-up Visit|Overall Study||82||
59619998|NCT01490502|75731139|FG001|Attended at Least 1 Follow-up Visit|Overall Study||83||
59619999|NCT01490502|75731138|FG000|COMPLETED|Overall Study||68||
59620000|NCT01490502|75731139|FG001|COMPLETED|Overall Study||72||
59620001|NCT01490502|75731138|FG000|NOT COMPLETED|Overall Study||15||
59620002|NCT01490502|75731139|FG001|NOT COMPLETED|Overall Study||17||
59620003|NCT02317692|75731147|FG000|STARTED|Overall Study||69||30
59620004|NCT02317692|75731148|FG001|STARTED|Overall Study||77||31
59620005|NCT02317692|75731147|FG000|COMPLETED|Overall Study||63||27
59620006|NCT02317692|75731148|FG001|COMPLETED|Overall Study||77||31
59620007|NCT02317692|75731147|FG000|NOT COMPLETED|Overall Study||6||3
59620008|NCT02317692|75731148|FG001|NOT COMPLETED|Overall Study||0||0
59620009|NCT01428024|75731156|FG000|STARTED|Overall Study||30||
59620010|NCT01428024|75731157|FG001|STARTED|Overall Study||30||
59620011|NCT01428024|75731156|FG000|COMPLETED|Overall Study||29||
59620012|NCT01428024|75731157|FG001|COMPLETED|Overall Study||29||
59620013|NCT01428024|75731156|FG000|NOT COMPLETED|Overall Study||1||
59620014|NCT01428024|75731157|FG001|NOT COMPLETED|Overall Study||1||
59620015|NCT02318550|75731174|FG000|STARTED|Overall Study||262||
59620016|NCT02318550|75731174|FG000|COMPLETED|Overall Study||262||
59620017|NCT02318550|75731174|FG000|NOT COMPLETED|Overall Study||0||
59620018|NCT02319174|75731178|FG000|STARTED|Overall Study||43||
59620019|NCT02319174|75731178|FG000|COMPLETED|Overall Study||42||
59620020|NCT02319174|75731178|FG000|NOT COMPLETED|Overall Study||1||
59620021|NCT01393314|75731185|FG000|STARTED|Overall Study||54||
59620022|NCT01393314|75731186|FG001|STARTED|Overall Study||45||
59620023|NCT01393314|75731185|FG000|COMPLETED|Overall Study||54||
59620024|NCT01393314|75731186|FG001|COMPLETED|Overall Study||45||
59620025|NCT01393314|75731185|FG000|NOT COMPLETED|Overall Study||0||
59620026|NCT01393314|75731186|FG001|NOT COMPLETED|Overall Study||0||
59620027|NCT01341444|75731195|FG000|STARTED|Overall Study||31||
59791156|NCT00612105|75911497|FG001|NOT COMPLETED|Period Title 1: 6-Week Titration Phase||5||
59620028|NCT01341444|75731196|FG001|STARTED|Overall Study||32||
59620029|NCT01341444|75731195|FG000|COMPLETED|Overall Study||26||
59620030|NCT01341444|75731196|FG001|COMPLETED|Overall Study||29||
59620031|NCT01341444|75731195|FG000|NOT COMPLETED|Overall Study||5||
59620032|NCT01341444|75731196|FG001|NOT COMPLETED|Overall Study||3||
59620033|NCT01331148|75731204|FG000|STARTED|Overall Study||23||
59620034|NCT01331148|75731205|FG001|STARTED|Overall Study||23||
59620035|NCT01331148|75731204|FG000|COMPLETED|Overall Study||20||
59791157|NCT00612105|75911496|FG000|STARTED|Period Title 2: 4-Week Maintenance Phase||89||
59791158|NCT00612105|75911497|FG001|STARTED|Period Title 2: 4-Week Maintenance Phase||57||
59791159|NCT00612105|75911496|FG000|COMPLETED|Period Title 2: 4-Week Maintenance Phase||78||
59791160|NCT00612105|75911497|FG001|COMPLETED|Period Title 2: 4-Week Maintenance Phase||55||
59791161|NCT00612105|75911496|FG000|NOT COMPLETED|Period Title 2: 4-Week Maintenance Phase||11||
59791162|NCT00612105|75911497|FG001|NOT COMPLETED|Period Title 2: 4-Week Maintenance Phase||2||
59791163|NCT00612105|75911496|FG000|STARTED|Period Title 3: 3-Week Taper Phase|Includes participants who discontinued during the titration phase and entered taper phase.|86||
59791164|NCT00612105|75911497|FG001|STARTED|Period Title 3: 3-Week Taper Phase|Includes participants who discontinued during the titration phase and entered taper phase.|58||
59791165|NCT00612105|75911496|FG000|COMPLETED|Period Title 3: 3-Week Taper Phase||85||
59791166|NCT00612105|75911497|FG001|COMPLETED|Period Title 3: 3-Week Taper Phase||58||
59791167|NCT00612105|75911496|FG000|NOT COMPLETED|Period Title 3: 3-Week Taper Phase||1||
59791168|NCT00612105|75911497|FG001|NOT COMPLETED|Period Title 3: 3-Week Taper Phase||0||
59791169|NCT00546052|75911503|FG000|STARTED|Overall Study||1738||
59791170|NCT00546052|75911503|FG000|Week 4|Overall Study||1714||
59791171|NCT00546052|75911503|FG000|Week 8|Overall Study||1680||
59791172|NCT00546052|75911503|FG000|Week 12|Overall Study||1650||
59953645|NCT02590432|76071979|FG005|COMPLETED|Double-blind Treatment Period|Participants did not enter Dose-reduced Open Label Treatment Period.|6|Out of 88 participants who discontinued, 57 continued to Dose-reduced Open Label Treatment Period.|
59953646|NCT02590432|76071980|FG006|COMPLETED|Double-blind Treatment Period|Participants did not enter Dose-reduced Open Label Treatment Period.|9|Out of 88 participants who discontinued, 57 continued to Dose-reduced Open Label Treatment Period.|
59953647|NCT02590432|76071981|FG007|COMPLETED|Double-blind Treatment Period||0|Out of 88 participants who discontinued, 57 continued to Dose-reduced Open Label Treatment Period.|
59953648|NCT02590432|76071982|FG008|COMPLETED|Double-blind Treatment Period||0|Out of 88 participants who discontinued, 57 continued to Dose-reduced Open Label Treatment Period.|
60073520|NCT03497806|76188769|FG000|COMPLETED|Week 8||123||
60073521|NCT03497806|76188769|FG000|NOT COMPLETED|Week 8||9||
60073522|NCT03497806|76188769|FG000|STARTED|Week 24||123||
59523305|NCT00545506|75618085|FG001|STARTED|Overall Study||3||
59791173|NCT00546052|75911503|FG000|Week 32|Overall Study||1583||
59791174|NCT00546052|75911503|FG000|Week 52|Overall Study||1511||
59791175|NCT00546052|75911503|FG000|COMPLETED|Overall Study||1511||
59791176|NCT00546052|75911503|FG000|NOT COMPLETED|Overall Study||227||
59791177|NCT00673920|75911518|FG000|STARTED|Baseline up to Week 48||64||
59791178|NCT00673920|75911519|FG001|STARTED|Baseline up to Week 48||117||
59791179|NCT00673920|75911520|FG002|STARTED|Baseline up to Week 48||133||
59791180|NCT00673920|75911521|FG003|STARTED|Baseline up to Week 48||0||
59791181|NCT00673920|75911522|FG004|STARTED|Baseline up to Week 48||0||
59791182|NCT00673920|75911523|FG005|STARTED|Baseline up to Week 48||0||
59791183|NCT00673920|75911524|FG006|STARTED|Baseline up to Week 48||0||
59791184|NCT00673920|75911525|FG007|STARTED|Baseline up to Week 48||0||
59791185|NCT00673920|75911518|FG000|COMPLETED|Baseline up to Week 48||60||
59791186|NCT00673920|75911519|FG001|COMPLETED|Baseline up to Week 48||114||
59791187|NCT00673920|75911520|FG002|COMPLETED|Baseline up to Week 48||126||
59791188|NCT00673920|75911521|FG003|COMPLETED|Baseline up to Week 48||0||
59791189|NCT00673920|75911522|FG004|COMPLETED|Baseline up to Week 48||0||
59791190|NCT00673920|75911523|FG005|COMPLETED|Baseline up to Week 48||0||
59791191|NCT00673920|75911524|FG006|COMPLETED|Baseline up to Week 48||0||
59791192|NCT00673920|75911525|FG007|COMPLETED|Baseline up to Week 48||0||
59791193|NCT00673920|75911518|FG000|NOT COMPLETED|Baseline up to Week 48||4||
59791194|NCT00673920|75911519|FG001|NOT COMPLETED|Baseline up to Week 48||3||
59791195|NCT00673920|75911520|FG002|NOT COMPLETED|Baseline up to Week 48||7||
59791196|NCT00673920|75911521|FG003|NOT COMPLETED|Baseline up to Week 48||0||
59791197|NCT00673920|75911522|FG004|NOT COMPLETED|Baseline up to Week 48||0||
59791198|NCT00673920|75911523|FG005|NOT COMPLETED|Baseline up to Week 48||0||
59791199|NCT00673920|75911524|FG006|NOT COMPLETED|Baseline up to Week 48||0||
59791200|NCT00673920|75911525|FG007|NOT COMPLETED|Baseline up to Week 48||0||
59791201|NCT00673920|75911518|FG000|STARTED|Week 24 to Week 48||0||
59791202|NCT00673920|75911519|FG001|STARTED|Week 24 to Week 48||0||
59791203|NCT00673920|75911520|FG002|STARTED|Week 24 to Week 48||0||
59791204|NCT00673920|75911521|FG003|STARTED|Week 24 to Week 48||61||
59791205|NCT00673920|75911522|FG004|STARTED|Week 24 to Week 48||61||
59791206|NCT00673920|75911523|FG005|STARTED|Week 24 to Week 48||109||
59791207|NCT00673920|75911524|FG006|STARTED|Week 24 to Week 48||29||
59791208|NCT00673920|75911525|FG007|STARTED|Week 24 to Week 48||28||
59791209|NCT00673920|75911518|FG000|COMPLETED|Week 24 to Week 48||0||
59791210|NCT00673920|75911519|FG001|COMPLETED|Week 24 to Week 48||0||
59791211|NCT00673920|75911520|FG002|COMPLETED|Week 24 to Week 48||0||
59791212|NCT00673920|75911521|FG003|COMPLETED|Week 24 to Week 48||60||
59791213|NCT00673920|75911522|FG004|COMPLETED|Week 24 to Week 48||61||
59791214|NCT00673920|75911523|FG005|COMPLETED|Week 24 to Week 48||106||
59791215|NCT00673920|75911524|FG006|COMPLETED|Week 24 to Week 48||28||
59791216|NCT00673920|75911525|FG007|COMPLETED|Week 24 to Week 48||28||
59791217|NCT00673920|75911518|FG000|NOT COMPLETED|Week 24 to Week 48||0||
59791218|NCT00673920|75911519|FG001|NOT COMPLETED|Week 24 to Week 48||0||
59791219|NCT00673920|75911520|FG002|NOT COMPLETED|Week 24 to Week 48||0||
59791220|NCT00673920|75911521|FG003|NOT COMPLETED|Week 24 to Week 48||1||
59791221|NCT00673920|75911522|FG004|NOT COMPLETED|Week 24 to Week 48||0||
59791222|NCT00673920|75911523|FG005|NOT COMPLETED|Week 24 to Week 48||3||
59791223|NCT00673920|75911524|FG006|NOT COMPLETED|Week 24 to Week 48||1||
59791224|NCT00673920|75911525|FG007|NOT COMPLETED|Week 24 to Week 48||0||
59791225|NCT00379795|75911552|FG000|STARTED|Overall Study||526||
59791226|NCT00379795|75911553|FG001|STARTED|Overall Study||74||
59791227|NCT00379795|75911554|FG002|STARTED|Overall Study||116||
59791228|NCT00379795|75911555|FG003|STARTED|Overall Study||74||
59791229|NCT00379795|75911556|FG004|STARTED|Overall Study||63||
59791230|NCT00379795|75911552|FG000|Received Ranibizumab in Extension Study|Overall Study||377||
59791231|NCT00379795|75911553|FG001|Received Ranibizumab in Extension Study|Overall Study||41||
59791232|NCT00379795|75911554|FG002|Received Ranibizumab in Extension Study|Overall Study||113||
59791233|NCT00379795|75911555|FG003|Received Ranibizumab in Extension Study|Overall Study||55||
59791234|NCT00379795|75911556|FG004|Received Ranibizumab in Extension Study|Overall Study||0||
59791235|NCT00379795|75911552|FG000|COMPLETED|Overall Study||50||
59791236|NCT00379795|75911553|FG001|COMPLETED|Overall Study||23||
59791237|NCT00379795|75911554|FG002|COMPLETED|Overall Study||23||
59791238|NCT00379795|75911555|FG003|COMPLETED|Overall Study||6||
59791239|NCT00379795|75911556|FG004|COMPLETED|Overall Study||14||
59791240|NCT00379795|75911552|FG000|NOT COMPLETED|Overall Study||476||
59791241|NCT00379795|75911553|FG001|NOT COMPLETED|Overall Study||51||
59791242|NCT00379795|75911554|FG002|NOT COMPLETED|Overall Study||93||
59791243|NCT00379795|75911555|FG003|NOT COMPLETED|Overall Study||68||
59791244|NCT00379795|75911556|FG004|NOT COMPLETED|Overall Study||49||
59791245|NCT00610155|75911571|FG000|STARTED|Period 1||4||
59791246|NCT00610155|75911572|FG001|STARTED|Period 1||3||
59791247|NCT00610155|75911573|FG002|STARTED|Period 1||4||
59791248|NCT00610155|75911574|FG003|STARTED|Period 1||3||
59791249|NCT00610155|75911575|FG004|STARTED|Period 1||3||
59791250|NCT00610155|75911576|FG005|STARTED|Period 1||1||
59791251|NCT00610155|75911571|FG000|COMPLETED|Period 1||4||
59791252|NCT00610155|75911572|FG001|COMPLETED|Period 1||3||
59791253|NCT00610155|75911573|FG002|COMPLETED|Period 1||3||
59791254|NCT00610155|75911574|FG003|COMPLETED|Period 1||3||
59791255|NCT00610155|75911575|FG004|COMPLETED|Period 1||3||
59791256|NCT00610155|75911576|FG005|COMPLETED|Period 1||1||
59791257|NCT00610155|75911571|FG000|NOT COMPLETED|Period 1||0||
59791258|NCT00610155|75911572|FG001|NOT COMPLETED|Period 1||0||
59791259|NCT00610155|75911573|FG002|NOT COMPLETED|Period 1||1||
59791260|NCT00610155|75911574|FG003|NOT COMPLETED|Period 1||0||
59791261|NCT00610155|75911575|FG004|NOT COMPLETED|Period 1||0||
59791262|NCT00610155|75911576|FG005|NOT COMPLETED|Period 1||0||
59791263|NCT00610155|75911571|FG000|STARTED|Washout Period 1 (7 Days)||4||
59791264|NCT00610155|75911572|FG001|STARTED|Washout Period 1 (7 Days)||3||
59791265|NCT00610155|75911573|FG002|STARTED|Washout Period 1 (7 Days)||3||
59791266|NCT00610155|75911574|FG003|STARTED|Washout Period 1 (7 Days)||3||
59791267|NCT00610155|75911575|FG004|STARTED|Washout Period 1 (7 Days)||3||
59791268|NCT00610155|75911576|FG005|STARTED|Washout Period 1 (7 Days)||1||
59791269|NCT00610155|75911571|FG000|COMPLETED|Washout Period 1 (7 Days)||4||
59791270|NCT00610155|75911572|FG001|COMPLETED|Washout Period 1 (7 Days)||3||
59791271|NCT00610155|75911573|FG002|COMPLETED|Washout Period 1 (7 Days)||3||
59791272|NCT00610155|75911574|FG003|COMPLETED|Washout Period 1 (7 Days)||3||
59791273|NCT00610155|75911575|FG004|COMPLETED|Washout Period 1 (7 Days)||3||
59791274|NCT00610155|75911576|FG005|COMPLETED|Washout Period 1 (7 Days)||1||
59791275|NCT00610155|75911571|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0||
59791276|NCT00610155|75911572|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0||
59791277|NCT00610155|75911573|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0||
59791278|NCT00610155|75911574|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0||
59791279|NCT00610155|75911575|FG004|NOT COMPLETED|Washout Period 1 (7 Days)||0||
59791280|NCT00610155|75911576|FG005|NOT COMPLETED|Washout Period 1 (7 Days)||0||
59791281|NCT00610155|75911571|FG000|STARTED|Period 2||4||
59791282|NCT00610155|75911572|FG001|STARTED|Period 2||3||
59791283|NCT00610155|75911573|FG002|STARTED|Period 2||3||
59791284|NCT00610155|75911574|FG003|STARTED|Period 2||3||
59791285|NCT00610155|75911575|FG004|STARTED|Period 2||3||
59791286|NCT00610155|75911576|FG005|STARTED|Period 2||1||
59791287|NCT00610155|75911571|FG000|COMPLETED|Period 2||4||
59791288|NCT00610155|75911572|FG001|COMPLETED|Period 2||3||
59791289|NCT00610155|75911573|FG002|COMPLETED|Period 2||3||
59791290|NCT00610155|75911574|FG003|COMPLETED|Period 2||3||
59791291|NCT00610155|75911575|FG004|COMPLETED|Period 2||3||
59791292|NCT00610155|75911576|FG005|COMPLETED|Period 2||1||
59791293|NCT00610155|75911571|FG000|NOT COMPLETED|Period 2||0||
59791294|NCT00610155|75911572|FG001|NOT COMPLETED|Period 2||0||
59791295|NCT00610155|75911573|FG002|NOT COMPLETED|Period 2||0||
59791296|NCT00610155|75911574|FG003|NOT COMPLETED|Period 2||0||
59791297|NCT00610155|75911575|FG004|NOT COMPLETED|Period 2||0||
59791298|NCT00610155|75911576|FG005|NOT COMPLETED|Period 2||0||
59791299|NCT00610155|75911571|FG000|STARTED|Washout Period 2 (7 Days)||4||
59791300|NCT00610155|75911572|FG001|STARTED|Washout Period 2 (7 Days)||3||
59791301|NCT00610155|75911573|FG002|STARTED|Washout Period 2 (7 Days)||3||
59791302|NCT00610155|75911574|FG003|STARTED|Washout Period 2 (7 Days)||3||
59791303|NCT00610155|75911575|FG004|STARTED|Washout Period 2 (7 Days)||3||
59791304|NCT00610155|75911576|FG005|STARTED|Washout Period 2 (7 Days)||1||
59791305|NCT00610155|75911571|FG000|COMPLETED|Washout Period 2 (7 Days)||4||
59791306|NCT00610155|75911572|FG001|COMPLETED|Washout Period 2 (7 Days)||3||
59791307|NCT00610155|75911573|FG002|COMPLETED|Washout Period 2 (7 Days)||3||
59791308|NCT00610155|75911574|FG003|COMPLETED|Washout Period 2 (7 Days)||3||
59791309|NCT00610155|75911575|FG004|COMPLETED|Washout Period 2 (7 Days)||3||
59791310|NCT00610155|75911576|FG005|COMPLETED|Washout Period 2 (7 Days)||1||
59791311|NCT00610155|75911571|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0||
59791312|NCT00610155|75911572|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0||
59791313|NCT00610155|75911573|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0||
59791314|NCT00610155|75911574|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0||
59791315|NCT00610155|75911575|FG004|NOT COMPLETED|Washout Period 2 (7 Days)||0||
59791316|NCT00610155|75911576|FG005|NOT COMPLETED|Washout Period 2 (7 Days)||0||
59791317|NCT00610155|75911571|FG000|STARTED|Period 3||4||
59791318|NCT00610155|75911572|FG001|STARTED|Period 3||3||
59791319|NCT00610155|75911573|FG002|STARTED|Period 3||3||
59791320|NCT00610155|75911574|FG003|STARTED|Period 3||3||
59791321|NCT00610155|75911575|FG004|STARTED|Period 3||3||
59791322|NCT00610155|75911576|FG005|STARTED|Period 3||1||
59791323|NCT00610155|75911571|FG000|COMPLETED|Period 3||3||
59791324|NCT00610155|75911572|FG001|COMPLETED|Period 3||3||
59791325|NCT00610155|75911573|FG002|COMPLETED|Period 3||3||
59791326|NCT00610155|75911574|FG003|COMPLETED|Period 3||3||
59791327|NCT00610155|75911575|FG004|COMPLETED|Period 3||3||
59791328|NCT00610155|75911576|FG005|COMPLETED|Period 3||1||
59791329|NCT00610155|75911571|FG000|NOT COMPLETED|Period 3||1||
59791330|NCT00610155|75911572|FG001|NOT COMPLETED|Period 3||0||
59791331|NCT00610155|75911573|FG002|NOT COMPLETED|Period 3||0||
59791332|NCT00610155|75911574|FG003|NOT COMPLETED|Period 3||0||
59791333|NCT00610155|75911575|FG004|NOT COMPLETED|Period 3||0||
59791334|NCT00610155|75911576|FG005|NOT COMPLETED|Period 3||0||
59791335|NCT00674700|75911587|FG000|STARTED|Year 1||170||
59791336|NCT00674700|75911588|FG001|STARTED|Year 1||169||
59791337|NCT00674700|75911589|FG002|STARTED|Year 1||170||
59791338|NCT00674700|75911587|FG000|COMPLETED|Year 1||139||
59791339|NCT00674700|75911588|FG001|COMPLETED|Year 1||135||
59953649|NCT02590432|76071974|FG000|NOT COMPLETED|Double-blind Treatment Period||0||
59953650|NCT02590432|76071975|FG001|NOT COMPLETED|Double-blind Treatment Period||0||
59953651|NCT02590432|76071976|FG002|NOT COMPLETED|Double-blind Treatment Period||17||
59791340|NCT00674700|75911589|FG002|COMPLETED|Year 1||153||
59791341|NCT00674700|75911587|FG000|NOT COMPLETED|Year 1||31||
59791342|NCT00674700|75911588|FG001|NOT COMPLETED|Year 1||34||
59791343|NCT00674700|75911589|FG002|NOT COMPLETED|Year 1||17||
59791344|NCT00674700|75911587|FG000|STARTED|Year 2 Follow-up Without Treatment||139||
59791345|NCT00674700|75911588|FG001|STARTED|Year 2 Follow-up Without Treatment||135||
59791346|NCT00674700|75911589|FG002|STARTED|Year 2 Follow-up Without Treatment||153||
59791347|NCT00674700|75911587|FG000|COMPLETED|Year 2 Follow-up Without Treatment||133||
59791348|NCT00674700|75911588|FG001|COMPLETED|Year 2 Follow-up Without Treatment||123||
59791349|NCT00674700|75911589|FG002|COMPLETED|Year 2 Follow-up Without Treatment||141||
59791350|NCT00674700|75911587|FG000|NOT COMPLETED|Year 2 Follow-up Without Treatment||6||
59791351|NCT00674700|75911588|FG001|NOT COMPLETED|Year 2 Follow-up Without Treatment||12||
59791352|NCT00674700|75911589|FG002|NOT COMPLETED|Year 2 Follow-up Without Treatment||12||
59791353|NCT00546910|75911599|FG000|STARTED|Overall Study||63||
59791354|NCT00546910|75911600|FG001|STARTED|Overall Study||62||
59953652|NCT02590432|76071977|FG003|NOT COMPLETED|Double-blind Treatment Period||15||
59953653|NCT02590432|76071978|FG004|NOT COMPLETED|Double-blind Treatment Period||9||
59953654|NCT02590432|76071979|FG005|NOT COMPLETED|Double-blind Treatment Period||26||
59953655|NCT02590432|76071980|FG006|NOT COMPLETED|Double-blind Treatment Period||21||
59953656|NCT02590432|76071981|FG007|NOT COMPLETED|Double-blind Treatment Period||0||
59953657|NCT02590432|76071982|FG008|NOT COMPLETED|Double-blind Treatment Period||0||
59791355|NCT00546910|75911599|FG000|COMPLETED|Overall Study||54||
59791356|NCT00546910|75911600|FG001|COMPLETED|Overall Study||51||
59791357|NCT00546910|75911599|FG000|NOT COMPLETED|Overall Study||9||
59791358|NCT00546910|75911600|FG001|NOT COMPLETED|Overall Study||11||
59791359|NCT00379639|75911611|FG000|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|7||
59791360|NCT00379639|75911612|FG001|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|7||
59791361|NCT00379639|75911613|FG002|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|10||
59791362|NCT00379639|75911614|FG003|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|6||
59791363|NCT00379639|75911615|FG004|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|6||
59995234|NCT04076943|76111061|FG000|NOT COMPLETED|Overall Study||34||
59791364|NCT00379639|75911611|FG000|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|6||
59791365|NCT00379639|75911612|FG001|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|7||
59791366|NCT00379639|75911613|FG002|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|7||
59791367|NCT00379639|75911614|FG003|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|4||
59791368|NCT00379639|75911615|FG004|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|3||
59791369|NCT00379639|75911611|FG000|Completed 6 Cycles of Therapy|Overall Study||4||
59791370|NCT00379639|75911612|FG001|Completed 6 Cycles of Therapy|Overall Study||2||
59791371|NCT00379639|75911613|FG002|Completed 6 Cycles of Therapy|Overall Study||1||
59791372|NCT00379639|75911614|FG003|Completed 6 Cycles of Therapy|Overall Study||0||
59791373|NCT00379639|75911615|FG004|Completed 6 Cycles of Therapy|Overall Study||0||
59791374|NCT00379639|75911611|FG000|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|4||
59791375|NCT00379639|75911612|FG001|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|2||
59791376|NCT00379639|75911613|FG002|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|1||
59791377|NCT00379639|75911614|FG003|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|0||
59791378|NCT00379639|75911615|FG004|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|0||
59791379|NCT00379639|75911611|FG000|NOT COMPLETED|Overall Study||3||
59791380|NCT00379639|75911612|FG001|NOT COMPLETED|Overall Study||5||
59791381|NCT00379639|75911613|FG002|NOT COMPLETED|Overall Study||9||
59791382|NCT00379639|75911614|FG003|NOT COMPLETED|Overall Study||6||
59791383|NCT00379639|75911615|FG004|NOT COMPLETED|Overall Study||6||
59953658|NCT02590432|76071974|FG000|STARTED|Dose-reduced Open Label Treatment Period||0||
59953659|NCT02590432|76071975|FG001|STARTED|Dose-reduced Open Label Treatment Period||0||
59953660|NCT02590432|76071976|FG002|STARTED|Dose-reduced Open Label Treatment Period||0||
59953661|NCT02590432|76071977|FG003|STARTED|Dose-reduced Open Label Treatment Period||0||
59620036|NCT01331148|75731205|FG001|COMPLETED|Overall Study||19||
59791384|NCT03948334|75911629|FG000|STARTED|Overall Study||60||
59791385|NCT03948334|75911630|FG001|STARTED|Overall Study||63||
59791386|NCT03948334|75911629|FG000|COMPLETED|Overall Study||0||
59791387|NCT03948334|75911630|FG001|COMPLETED|Overall Study||0||
59791388|NCT03948334|75911629|FG000|NOT COMPLETED|Overall Study||60||
59791389|NCT03948334|75911630|FG001|NOT COMPLETED|Overall Study||63||
59791390|NCT00609765|75911644|FG000|STARTED|Overall Study||1||
59791391|NCT00609765|75911644|FG000|COMPLETED|Overall Study||0||
59953662|NCT02590432|76071978|FG004|STARTED|Dose-reduced Open Label Treatment Period||0||
59953663|NCT02590432|76071979|FG005|STARTED|Dose-reduced Open Label Treatment Period||0||
59953664|NCT02590432|76071980|FG006|STARTED|Dose-reduced Open Label Treatment Period||0||
59953665|NCT02590432|76071981|FG007|STARTED|Dose-reduced Open Label Treatment Period||31||
59953666|NCT02590432|76071982|FG008|STARTED|Dose-reduced Open Label Treatment Period||26||
59953667|NCT02590432|76071974|FG000|COMPLETED|Dose-reduced Open Label Treatment Period||0||
59953668|NCT02590432|76071975|FG001|COMPLETED|Dose-reduced Open Label Treatment Period||0||
59953669|NCT02590432|76071976|FG002|COMPLETED|Dose-reduced Open Label Treatment Period||0||
59953670|NCT02590432|76071977|FG003|COMPLETED|Dose-reduced Open Label Treatment Period||0||
59953671|NCT02590432|76071978|FG004|COMPLETED|Dose-reduced Open Label Treatment Period||0||
59953672|NCT02590432|76071979|FG005|COMPLETED|Dose-reduced Open Label Treatment Period||0||
59953673|NCT02590432|76071980|FG006|COMPLETED|Dose-reduced Open Label Treatment Period||0||
59953674|NCT02590432|76071981|FG007|COMPLETED|Dose-reduced Open Label Treatment Period||13||
59620037|NCT01331148|75731204|FG000|NOT COMPLETED|Overall Study||3||
59620038|NCT01331148|75731205|FG001|NOT COMPLETED|Overall Study||4||
59620039|NCT01253070|75731211|FG000|STARTED|Overall Study||54||
59620040|NCT01253070|75731211|FG000|COMPLETED|Overall Study||54||
59620041|NCT01253070|75731211|FG000|NOT COMPLETED|Overall Study||0||
59620042|NCT02087514|75731222|FG000|STARTED|Overall Study||10||
59620043|NCT02087514|75731223|FG001|STARTED|Overall Study||10||
59620044|NCT02087514|75731224|FG002|STARTED|Overall Study||10||
59620045|NCT02087514|75731225|FG003|STARTED|Overall Study||10||
59620046|NCT02087514|75731226|FG004|STARTED|Overall Study||10||
59620047|NCT02087514|75731227|FG005|STARTED|Overall Study||10||
59620048|NCT02087514|75731222|FG000|COMPLETED|Overall Study||8||
59620049|NCT02087514|75731223|FG001|COMPLETED|Overall Study||10||
59620050|NCT02087514|75731224|FG002|COMPLETED|Overall Study||7||
59620051|NCT02087514|75731225|FG003|COMPLETED|Overall Study||8||
59953675|NCT02590432|76071982|FG008|COMPLETED|Dose-reduced Open Label Treatment Period||8||
59953676|NCT02590432|76071974|FG000|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0||
59791392|NCT00609765|75911644|FG000|NOT COMPLETED|Overall Study||1||
59791393|NCT00608829|75911648|FG000|STARTED|Overall Study||23||
59791394|NCT00608829|75911648|FG000|COMPLETED|Overall Study||8||
59791395|NCT00608829|75911648|FG000|NOT COMPLETED|Overall Study||15||
59791396|NCT00545818|75911654|FG000|STARTED|Overall Study||49||108
59791397|NCT00545818|75911655|FG001|STARTED|Overall Study||46||101
59791398|NCT00545818|75911654|FG000|COMPLETED|Overall Study||46||98
59791399|NCT00545818|75911655|FG001|COMPLETED|Overall Study||39||86
59791400|NCT00545818|75911654|FG000|NOT COMPLETED|Overall Study||3||10
59791401|NCT00545818|75911655|FG001|NOT COMPLETED|Overall Study||7||15
59791402|NCT00674154|75911663|FG000|STARTED|Overall Study||23||
59791403|NCT00674154|75911664|FG001|STARTED|Overall Study||23||
59791404|NCT00674154|75911663|FG000|COMPLETED|Overall Study||20||
59791405|NCT00674154|75911664|FG001|COMPLETED|Overall Study||20||
59791406|NCT00674154|75911663|FG000|NOT COMPLETED|Overall Study||3||
59791407|NCT00674154|75911664|FG001|NOT COMPLETED|Overall Study||3||
59791408|NCT00608517|75911673|FG000|STARTED|Overall Study||2||
59791409|NCT00608517|75911674|FG001|STARTED|Overall Study||3||
59791410|NCT00608517|75911675|FG002|STARTED|Overall Study||1||
59791411|NCT00608517|75911673|FG000|COMPLETED|Overall Study||1||
59791412|NCT00608517|75911674|FG001|COMPLETED|Overall Study||3||
59791413|NCT00608517|75911675|FG002|COMPLETED|Overall Study||1||
59791414|NCT00608517|75911673|FG000|NOT COMPLETED|Overall Study||1||
59791415|NCT00608517|75911674|FG001|NOT COMPLETED|Overall Study||0||
59953677|NCT02590432|76071975|FG001|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0||
59953678|NCT02590432|76071976|FG002|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0||
59953679|NCT02590432|76071977|FG003|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0||
59953680|NCT02590432|76071978|FG004|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0||
59791416|NCT00608517|75911675|FG002|NOT COMPLETED|Overall Study||0||
59791417|NCT00608205|75911686|FG000|STARTED|Overall Study||35||
59791418|NCT00608205|75911687|FG001|STARTED|Overall Study||34||
59791419|NCT00608205|75911686|FG000|COMPLETED|Overall Study||32||
59791420|NCT00608205|75911687|FG001|COMPLETED|Overall Study||31||
59791421|NCT00608205|75911686|FG000|NOT COMPLETED|Overall Study||3||
59791422|NCT00608205|75911687|FG001|NOT COMPLETED|Overall Study||3||
59791423|NCT00670800|75911697|FG000|STARTED|Overall Study||7||
59791424|NCT00670800|75911698|FG001|STARTED|Overall Study||7||
59791425|NCT00670800|75911697|FG000|COMPLETED|Overall Study||7||
59791426|NCT00670800|75911698|FG001|COMPLETED|Overall Study|Two controls were found to have insulin resistance and were excluded from analysis.|5||
59791427|NCT00670800|75911697|FG000|NOT COMPLETED|Overall Study||0||
59791428|NCT00670800|75911698|FG001|NOT COMPLETED|Overall Study||2||
59791429|NCT00607893|75911708|FG000|STARTED|Overall Study||77|Underwent Randomization|
59791430|NCT00607893|75911709|FG001|STARTED|Overall Study||76|Underwent Randomization|
59791431|NCT00607893|75911708|FG000|Completed Baseline Visit|Overall Study||74|Completed Baseline Visit|
59791432|NCT00607893|75911709|FG001|Completed Baseline Visit|Overall Study||75|Completed Baseline Visit|
59791433|NCT00607893|75911708|FG000|Completed 8 Week Visit|Overall Study||71|Completed 8 Week Visit|
59791434|NCT00607893|75911709|FG001|Completed 8 Week Visit|Overall Study||72|Completed 8 Week Visit|
59791435|NCT00607893|75911708|FG000|Completed 12 Week Visit|Overall Study|12 Week Visit only offered to participants on actual CPAP Treatment|0||
59791436|NCT00607893|75911709|FG001|Completed 12 Week Visit|Overall Study|12 Week Visit only offered to participants on actual CPAP Treatment|29||
59791437|NCT00607893|75911708|FG000|COMPLETED|Overall Study||71||
59791438|NCT00607893|75911709|FG001|COMPLETED|Overall Study||72||
59791439|NCT00607893|75911708|FG000|NOT COMPLETED|Overall Study||6||
59791440|NCT00607893|75911709|FG001|NOT COMPLETED|Overall Study||4||
59953681|NCT02590432|76071979|FG005|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0||
59791441|NCT00571038|75911719|FG000|STARTED|Overall Study||219||
59791442|NCT00571038|75911720|FG001|STARTED|Overall Study||185||
59791443|NCT00571038|75911719|FG000|6 Month Follow up|Overall Study||208||
59791444|NCT00571038|75911720|FG001|6 Month Follow up|Overall Study||176||
59791445|NCT00571038|75911719|FG000|18 Month Survey Only|Overall Study||199||
59791446|NCT00571038|75911720|FG001|18 Month Survey Only|Overall Study||163||
59791447|NCT00571038|75911719|FG000|COMPLETED|Overall Study|"7 died 2 moved~1 asked to be withdrawn~1 unable to reach"|208||
59791448|NCT00571038|75911720|FG001|COMPLETED|Overall Study|5 died 2 moved 3 asked to be withdrawn 4 unable to reach|171||
59791449|NCT00571038|75911719|FG000|NOT COMPLETED|Overall Study||11||
59791450|NCT00571038|75911720|FG001|NOT COMPLETED|Overall Study||14||
59791451|NCT00545740|75911730|FG000|STARTED|Overall Study||145||
59791452|NCT00545740|75911731|FG001|STARTED|Overall Study||145||
59791453|NCT00545740|75911732|FG002|STARTED|Overall Study||151||
59791454|NCT00545740|75911733|FG003|STARTED|Overall Study||149||
59791455|NCT00545740|75911730|FG000|COMPLETED|Overall Study||70||
59791456|NCT00545740|75911731|FG001|COMPLETED|Overall Study||62||
59791457|NCT00545740|75911732|FG002|COMPLETED|Overall Study||55||
59791458|NCT00545740|75911733|FG003|COMPLETED|Overall Study||78||
59953682|NCT02590432|76071980|FG006|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0||
59953683|NCT02590432|76071981|FG007|NOT COMPLETED|Dose-reduced Open Label Treatment Period||18||
59791459|NCT00545740|75911730|FG000|NOT COMPLETED|Overall Study||75||
59791460|NCT00545740|75911731|FG001|NOT COMPLETED|Overall Study||83||
59791461|NCT00545740|75911732|FG002|NOT COMPLETED|Overall Study||96||
59791462|NCT00545740|75911733|FG003|NOT COMPLETED|Overall Study||71||
59791463|NCT00609609|75911745|FG000|STARTED|Overall Study||30||
59791464|NCT00609609|75911746|FG001|STARTED|Overall Study||51||
59791465|NCT00609609|75911745|FG000|COMPLETED|Overall Study||24||
59791466|NCT00609609|75911746|FG001|COMPLETED|Overall Study||49||
59791467|NCT00609609|75911745|FG000|NOT COMPLETED|Overall Study||6||
59791468|NCT00609609|75911746|FG001|NOT COMPLETED|Overall Study||2||
59791469|NCT00673452|75911754|FG000|STARTED|Acute Double-Blind Phase||263||
59791470|NCT00673452|75911755|FG001|STARTED|Acute Double-Blind Phase||267||
59791471|NCT00673452|75911754|FG000|COMPLETED|Acute Double-Blind Phase||176||
59791472|NCT00673452|75911755|FG001|COMPLETED|Acute Double-Blind Phase||187||
59791473|NCT00673452|75911754|FG000|NOT COMPLETED|Acute Double-Blind Phase||87||
59791474|NCT00673452|75911755|FG001|NOT COMPLETED|Acute Double-Blind Phase||80||
59791475|NCT00673452|75911754|FG000|STARTED|Continuation Double-Blind Phase||176||
59791476|NCT00673452|75911755|FG001|STARTED|Continuation Double-Blind Phase|Patients on placebo in acute phase received 60 mg duloxetine during the continuation phase.|187||
59791477|NCT00673452|75911754|FG000|COMPLETED|Continuation Double-Blind Phase||151||
59791478|NCT00673452|75911755|FG001|COMPLETED|Continuation Double-Blind Phase||153||
59791479|NCT00673452|75911754|FG000|NOT COMPLETED|Continuation Double-Blind Phase||25||
59791480|NCT00673452|75911755|FG001|NOT COMPLETED|Continuation Double-Blind Phase||34||
59953684|NCT02590432|76071982|FG008|NOT COMPLETED|Dose-reduced Open Label Treatment Period||18||
59953685|NCT02590354|76071994|FG000|STARTED|Phase 1||114||
59953686|NCT02590354|76071994|FG000|COMPLETED|Phase 1||16||
59953687|NCT02590354|76071994|FG000|NOT COMPLETED|Phase 1||98||
59953688|NCT02590354|76071994|FG000|STARTED|Phase 2 - Treatment Interruption||16||
59953689|NCT02590354|76071994|FG000|COMPLETED|Phase 2 - Treatment Interruption||14||
59791481|NCT00545584|75911764|FG000|STARTED|Overall Study||412||
59791482|NCT00545584|75911765|FG001|STARTED|Overall Study||414||
59791483|NCT00545584|75911766|FG002|STARTED|Overall Study|306 subjects were randomized but only 305 were treated.|306||
59791484|NCT00545584|75911764|FG000|COMPLETED|Overall Study||333||
59791485|NCT00545584|75911765|FG001|COMPLETED|Overall Study||334||
59791486|NCT00545584|75911766|FG002|COMPLETED|Overall Study||250||
59791487|NCT00545584|75911764|FG000|NOT COMPLETED|Overall Study||79||
59791488|NCT00545584|75911765|FG001|NOT COMPLETED|Overall Study||80||
59791489|NCT00545584|75911766|FG002|NOT COMPLETED|Overall Study||56||
59791490|NCT00378703|75911778|FG000|STARTED|Overall Study|Number of patients randomized to this treatment arm.|89||
59791491|NCT00378703|75911779|FG001|STARTED|Overall Study|Number of patients randomized to this treatment arm.|91||
59791492|NCT00378703|75911780|FG002|STARTED|Overall Study|Number of patients randomized to this treatment arm.|90||
59791493|NCT00378703|75911781|FG003|STARTED|Overall Study|Number of patients randomized to this treatment arm.|91||
59791494|NCT00378703|75911778|FG000|Treated|Overall Study|Number of patients included in the toxicity analysis.|88||
59791495|NCT00378703|75911779|FG001|Treated|Overall Study|Number of patients included in the toxicity analysis.|86||
59791496|NCT00378703|75911780|FG002|Treated|Overall Study|Number of patients included in the toxicity analysis.|90||
59791497|NCT00378703|75911781|FG003|Treated|Overall Study|Number of patients included in the toxicity analysis.|91||
59791498|NCT00378703|75911778|FG000|Eligible and Treated|Overall Study|Number of patients included in the primary analysis.|84||
59791499|NCT00378703|75911779|FG001|Eligible and Treated|Overall Study|Number of patients included in the primary analysis.|80||
59791500|NCT00378703|75911780|FG002|Eligible and Treated|Overall Study|Number of patients included in the primary analysis.|83||
59791501|NCT00378703|75911781|FG003|Eligible and Treated|Overall Study|Number of patients included in the primary analysis.|84||
59791502|NCT00378703|75911778|FG000|COMPLETED|Overall Study|There is no limit to the number of treatment cycles allowed on any treatment arm.|0||
59791503|NCT00378703|75911779|FG001|COMPLETED|Overall Study|There is no limit to the number of treatment cycles allowed on any treatment arm.|0||
59791504|NCT00378703|75911780|FG002|COMPLETED|Overall Study|There is no limit to the number of treatment cycles allowed on any treatment arm.|0||
59791505|NCT00378703|75911781|FG003|COMPLETED|Overall Study|There is no limit to the number of treatment cycles allowed on any treatment arm.|0||
59791506|NCT00378703|75911778|FG000|NOT COMPLETED|Overall Study||89||
59791507|NCT00378703|75911779|FG001|NOT COMPLETED|Overall Study||91||
59791508|NCT00378703|75911780|FG002|NOT COMPLETED|Overall Study||90||
59791509|NCT00378703|75911781|FG003|NOT COMPLETED|Overall Study||91||
59791510|NCT03617913|75911791|FG000|STARTED|Overall Study||2||
59791511|NCT03617913|75911791|FG000|COMPLETED|Overall Study||2||
59791512|NCT03617913|75911791|FG000|NOT COMPLETED|Overall Study||0||
59953690|NCT02590354|76071994|FG000|NOT COMPLETED|Phase 2 - Treatment Interruption||2||
59523306|NCT00545506|75618084|FG000|COMPLETED|Overall Study||3||
59953691|NCT01667224|76072001|FG000|STARTED|Overall Study||40||
59953692|NCT01667224|76072002|FG001|STARTED|Overall Study||40||
59953693|NCT01667224|76072001|FG000|COMPLETED|Overall Study||36||
59953694|NCT01667224|76072002|FG001|COMPLETED|Overall Study||38||
59791513|NCT00368641|75911797|FG000|STARTED|Overall Study||6||
59791514|NCT00368641|75911798|FG001|STARTED|Overall Study||6||
59791515|NCT00368641|75911797|FG000|COMPLETED|Overall Study|study was terminated prior to completion of treatment period|0||
59791516|NCT00368641|75911798|FG001|COMPLETED|Overall Study|study was terminated prior to completion of treatment period|0||
59791517|NCT00368641|75911797|FG000|NOT COMPLETED|Overall Study||6||
59791518|NCT00368641|75911798|FG001|NOT COMPLETED|Overall Study||6||
59791519|NCT00608985|75911808|FG000|STARTED|Overall Study|Randomized and started double-blind treatment|177||
59791520|NCT00608985|75911809|FG001|STARTED|Overall Study|Randomized and started double-blind treatment|186||
59791521|NCT00608985|75911810|FG002|STARTED|Overall Study|Randomized and started double-blind treatment|176||
59791522|NCT00608985|75911811|FG003|STARTED|Overall Study|Randomized and started double-blind treatment|168||
59791523|NCT00608985|75911808|FG000|Completed Double-blind Treatment|Overall Study||163||
59791524|NCT00608985|75911809|FG001|Completed Double-blind Treatment|Overall Study||174||
59791525|NCT00608985|75911810|FG002|Completed Double-blind Treatment|Overall Study||171||
59791526|NCT00608985|75911811|FG003|Completed Double-blind Treatment|Overall Study||161||
59791527|NCT00608985|75911808|FG000|COMPLETED|Overall Study|Completed follow-up|161||
59791528|NCT00608985|75911809|FG001|COMPLETED|Overall Study|Completed follow-up|173||
59791529|NCT00608985|75911810|FG002|COMPLETED|Overall Study|Completed follow-up|170||
59791530|NCT00608985|75911811|FG003|COMPLETED|Overall Study|Completed follow-up|159||
59791531|NCT00608985|75911808|FG000|NOT COMPLETED|Overall Study||16||
59791532|NCT00608985|75911809|FG001|NOT COMPLETED|Overall Study||13||
59791533|NCT00608985|75911810|FG002|NOT COMPLETED|Overall Study||6||
59953695|NCT01667224|76072001|FG000|NOT COMPLETED|Overall Study||4||
59953696|NCT01667224|76072002|FG001|NOT COMPLETED|Overall Study||2||
59953697|NCT03923738|76072010|FG000|STARTED|Period 1||24||
59953698|NCT03923738|76072010|FG000|COMPLETED|Period 1||22||
59953699|NCT03923738|76072010|FG000|NOT COMPLETED|Period 1||2||
59953700|NCT03923738|76072010|FG000|STARTED|Period 2||22||
59953701|NCT03923738|76072010|FG000|COMPLETED|Period 2||22||
59953702|NCT03923738|76072010|FG000|NOT COMPLETED|Period 2||0||
60073523|NCT03497806|76188769|FG000|COMPLETED|Week 24||112||
60073524|NCT03497806|76188769|FG000|NOT COMPLETED|Week 24||11||
60073525|NCT01689207|76188784|FG000|STARTED|Overall Study|Subjects randomised|4||
59791534|NCT00608985|75911811|FG003|NOT COMPLETED|Overall Study||9||
59791535|NCT00368251|75911824|FG000|STARTED|Overall Study||18||
59791536|NCT00368251|75911825|FG001|STARTED|Overall Study||20||
59791537|NCT00368251|75911826|FG002|STARTED|Overall Study||18||
59791538|NCT00368251|75911824|FG000|COMPLETED|Overall Study||17||
59791539|NCT00368251|75911825|FG001|COMPLETED|Overall Study||20||
59791540|NCT00368251|75911826|FG002|COMPLETED|Overall Study||17||
59791541|NCT00368251|75911824|FG000|NOT COMPLETED|Overall Study||1||
59791542|NCT00368251|75911825|FG001|NOT COMPLETED|Overall Study||0||
59791543|NCT00368251|75911826|FG002|NOT COMPLETED|Overall Study||1||
59791544|NCT00378079|75911837|FG000|STARTED|Overall Study||70||
59791545|NCT00378079|75911838|FG001|STARTED|Overall Study||70||
59791546|NCT00378079|75911839|FG002|STARTED|Overall Study||71||
59791547|NCT00378079|75911837|FG000|COMPLETED|Overall Study||64||
59791548|NCT00378079|75911838|FG001|COMPLETED|Overall Study||69||
59791549|NCT00378079|75911839|FG002|COMPLETED|Overall Study||71||
59791550|NCT00378079|75911837|FG000|NOT COMPLETED|Overall Study||6||
59791551|NCT00378079|75911838|FG001|NOT COMPLETED|Overall Study||1||
59791552|NCT00378079|75911839|FG002|NOT COMPLETED|Overall Study||0||
59791553|NCT03936244|75911849|FG000|STARTED|Overall Study||57||
59791554|NCT03936244|75911850|FG001|STARTED|Overall Study||43||
59791555|NCT03936244|75911849|FG000|COMPLETED|Overall Study||45||
59791556|NCT03936244|75911850|FG001|COMPLETED|Overall Study||39||
59791557|NCT03936244|75911849|FG000|NOT COMPLETED|Overall Study||12||
59791558|NCT03936244|75911850|FG001|NOT COMPLETED|Overall Study||4||
59791559|NCT03923530|75911857|FG000|STARTED|Overall Study||12||
59791560|NCT03923530|75911857|FG000|COMPLETED|Overall Study||8||
59791561|NCT03923530|75911857|FG000|NOT COMPLETED|Overall Study||4||
59791562|NCT00608907|75911864|FG000|STARTED|Overall Study||30||
59791563|NCT00608907|75911865|FG001|STARTED|Overall Study||13||
59791564|NCT00608907|75911866|FG002|STARTED|Overall Study||18||
59791565|NCT00608907|75911864|FG000|COMPLETED|Overall Study||18||
59791566|NCT00608907|75911865|FG001|COMPLETED|Overall Study||13||
59791567|NCT00608907|75911866|FG002|COMPLETED|Overall Study||17||
59791568|NCT00608907|75911864|FG000|NOT COMPLETED|Overall Study||12||
59791569|NCT00608907|75911865|FG001|NOT COMPLETED|Overall Study||0||
59791570|NCT00608907|75911866|FG002|NOT COMPLETED|Overall Study||1||
59791571|NCT00377611|75911876|FG000|STARTED|Overall Study||1047||
59791572|NCT00377611|75911877|FG001|STARTED|Overall Study||2007||
59791573|NCT00377611|75911876|FG000|COMPLETED|Overall Study||1025||
59791574|NCT00377611|75911877|FG001|COMPLETED|Overall Study||1974||
59953703|NCT02588248|76072018|FG000|STARTED|Overall Study||42||
59953704|NCT02588248|76072019|FG001|STARTED|Overall Study||40||
59953705|NCT02588248|76072018|FG000|COMPLETED|Overall Study||38||
59953706|NCT02588248|76072019|FG001|COMPLETED|Overall Study||37||
59953707|NCT02588248|76072018|FG000|NOT COMPLETED|Overall Study||4||
60073526|NCT01689207|76188785|FG001|STARTED|Overall Study|Subjects randomised|8||
60073527|NCT01689207|76188786|FG002|STARTED|Overall Study|Subjects randomised|16||
60103574|NCT01290874|76221818|FG001|STARTED|Overall Study||538||
59791575|NCT00377611|75911876|FG000|NOT COMPLETED|Overall Study||22||
59791576|NCT00377611|75911877|FG001|NOT COMPLETED|Overall Study||33||
59791577|NCT00545272|75911890|FG000|STARTED|Overall Study||61||
59791578|NCT00545272|75911891|FG001|STARTED|Overall Study||68||
59791579|NCT00545272|75911892|FG002|STARTED|Overall Study||65||
59791580|NCT00545272|75911893|FG003|STARTED|Overall Study||72||
59791581|NCT00545272|75911894|FG004|STARTED|Overall Study||64||
59953708|NCT02588248|76072019|FG001|NOT COMPLETED|Overall Study||3||
59953709|NCT01328054|76072030|FG000|STARTED|Placebo on Day 1 and Day 2 (2 Days)||57||
59953710|NCT01328054|76072031|FG001|STARTED|Placebo on Day 1 and Day 2 (2 Days)||0||
59953711|NCT01328054|76072030|FG000|COMPLETED|Placebo on Day 1 and Day 2 (2 Days)||57||
59953712|NCT01328054|76072031|FG001|COMPLETED|Placebo on Day 1 and Day 2 (2 Days)||0||
59953713|NCT01328054|76072030|FG000|NOT COMPLETED|Placebo on Day 1 and Day 2 (2 Days)||0||
59953714|NCT01328054|76072031|FG001|NOT COMPLETED|Placebo on Day 1 and Day 2 (2 Days)||0||
59953715|NCT01328054|76072030|FG000|STARTED|Lapatinib on Day 3 and Day 4 (2 Days)||0||
59523307|NCT00545506|75618085|FG001|COMPLETED|Overall Study||3||
59523308|NCT00545506|75618084|FG000|NOT COMPLETED|Overall Study||0||
59523309|NCT00545506|75618085|FG001|NOT COMPLETED|Overall Study||0||
59523310|NCT02703844|75618093|FG000|STARTED|Randomized Controlled Portion||23||
59523311|NCT02703844|75618094|FG001|STARTED|Randomized Controlled Portion||23||
59953716|NCT01328054|76072031|FG001|STARTED|Lapatinib on Day 3 and Day 4 (2 Days)|One par. was double dosed with lapatinib due to a dosing error - reason for difference in # Started.|58||
59953717|NCT01328054|76072030|FG000|COMPLETED|Lapatinib on Day 3 and Day 4 (2 Days)||0||
60103575|NCT01290874|76221817|FG000|COMPLETED|Overall Study||122||
60103576|NCT01290874|76221818|FG001|COMPLETED|Overall Study||134||
60103577|NCT01290874|76221817|FG000|NOT COMPLETED|Overall Study||410||
60103578|NCT01290874|76221818|FG001|NOT COMPLETED|Overall Study||404||
60103579|NCT01344616|76221827|FG000|STARTED|Overall Study||244||
60103580|NCT01344616|76221828|FG001|STARTED|Overall Study||238||
60103581|NCT01344616|76221827|FG000|COMPLETED|Overall Study||209||
59523312|NCT02703844|75618093|FG000|COMPLETED|Randomized Controlled Portion||16||
59523313|NCT02703844|75618094|FG001|COMPLETED|Randomized Controlled Portion||17||
59791582|NCT00545272|75911895|FG005|STARTED|Overall Study||62||
60103582|NCT01344616|76221828|FG001|COMPLETED|Overall Study||194||
60103583|NCT01344616|76221827|FG000|NOT COMPLETED|Overall Study||35||
60103584|NCT01344616|76221828|FG001|NOT COMPLETED|Overall Study||44||
60103585|NCT01290952|76221836|FG000|STARTED|Overall Study||204||
60103586|NCT01290952|76221837|FG001|STARTED|Overall Study||207||
59791583|NCT00545272|75911890|FG000|COMPLETED|Overall Study||61||
59791584|NCT00545272|75911891|FG001|COMPLETED|Overall Study||67||
59791585|NCT00545272|75911892|FG002|COMPLETED|Overall Study||64||
59791586|NCT00545272|75911893|FG003|COMPLETED|Overall Study||71||
59791587|NCT00545272|75911894|FG004|COMPLETED|Overall Study||62||
59791588|NCT00545272|75911895|FG005|COMPLETED|Overall Study||59||
59791589|NCT00545272|75911890|FG000|NOT COMPLETED|Overall Study||0||
59791590|NCT00545272|75911891|FG001|NOT COMPLETED|Overall Study||1||
59995235|NCT00708643|76111067|FG000|STARTED|Overall Study||40||
59523314|NCT02703844|75618093|FG000|NOT COMPLETED|Randomized Controlled Portion||7||
59523315|NCT02703844|75618094|FG001|NOT COMPLETED|Randomized Controlled Portion||6||
59620052|NCT02087514|75731226|FG004|COMPLETED|Overall Study||10||
59791591|NCT00545272|75911892|FG002|NOT COMPLETED|Overall Study||1||
59995236|NCT00708643|76111068|FG001|STARTED|Overall Study||40||
59995237|NCT00708643|76111067|FG000|COMPLETED|Overall Study||40||
59995238|NCT00708643|76111068|FG001|COMPLETED|Overall Study||39||
59995239|NCT00708643|76111067|FG000|NOT COMPLETED|Overall Study||0||
59995240|NCT00708643|76111068|FG001|NOT COMPLETED|Overall Study||1||
59995241|NCT03049111|76111074|FG000|STARTED|Overall Study||14||
59995242|NCT03049111|76111074|FG000|COMPLETED|Overall Study||14||
59995243|NCT03049111|76111074|FG000|NOT COMPLETED|Overall Study||0||
59995244|NCT02929069|76111081|FG000|STARTED|Overall Study||100||
59995245|NCT02929069|76111082|FG001|STARTED|Overall Study||102||
59995246|NCT02929069|76111083|FG002|STARTED|Overall Study||52||
59995247|NCT02929069|76111081|FG000|Completed 4 Month Follow Up|Overall Study||83||
59995248|NCT02929069|76111082|FG001|Completed 4 Month Follow Up|Overall Study||76||
59995249|NCT02929069|76111083|FG002|Completed 4 Month Follow Up|Overall Study||43||
59995250|NCT02929069|76111081|FG000|Completed 8 Month Follow Up|Overall Study||82||
59995251|NCT02929069|76111082|FG001|Completed 8 Month Follow Up|Overall Study||77||
59995252|NCT02929069|76111083|FG002|Completed 8 Month Follow Up|Overall Study||36||
59995253|NCT02929069|76111081|FG000|Assessed STI 12 Month|Overall Study||74||
59995254|NCT02929069|76111082|FG001|Assessed STI 12 Month|Overall Study||75||
59995255|NCT02929069|76111083|FG002|Assessed STI 12 Month|Overall Study||38||
59791592|NCT00545272|75911893|FG003|NOT COMPLETED|Overall Study||1||
59791593|NCT00545272|75911894|FG004|NOT COMPLETED|Overall Study||2||
59791594|NCT00545272|75911895|FG005|NOT COMPLETED|Overall Study||3||
59791595|NCT00377455|75911909|FG000|STARTED|Overall Study||5||
59791596|NCT00377455|75911909|FG000|COMPLETED|Overall Study||4||
59791597|NCT00377455|75911909|FG000|NOT COMPLETED|Overall Study||1||
59791598|NCT00377299|75911915|FG000|STARTED|Overall Study||32||
59791599|NCT00377299|75911916|FG001|STARTED|Overall Study||28||
59791600|NCT00377299|75911915|FG000|COMPLETED|Overall Study||13||
59791601|NCT00377299|75911916|FG001|COMPLETED|Overall Study||4||
59791602|NCT00377299|75911915|FG000|NOT COMPLETED|Overall Study||19||
59791603|NCT00377299|75911916|FG001|NOT COMPLETED|Overall Study||24||
59791604|NCT03472365|75911925|FG000|STARTED|Overall Study||48||
59791605|NCT03472365|75911926|FG001|STARTED|Overall Study||19||
59791606|NCT03472365|75911925|FG000|COMPLETED|Overall Study||48||
59791607|NCT03472365|75911926|FG001|COMPLETED|Overall Study||19||
59791608|NCT03472365|75911925|FG000|NOT COMPLETED|Overall Study||0||
59791609|NCT03472365|75911926|FG001|NOT COMPLETED|Overall Study||0||
59791610|NCT00376675|75911934|FG000|STARTED|Overall Study||69||
59791611|NCT00376675|75911935|FG001|STARTED|Overall Study||70||
59791612|NCT00376675|75911934|FG000|COMPLETED|Overall Study||49||
59791613|NCT00376675|75911935|FG001|COMPLETED|Overall Study||56||
59791614|NCT00376675|75911934|FG000|NOT COMPLETED|Overall Study||20||
59791615|NCT00376675|75911935|FG001|NOT COMPLETED|Overall Study||14||
59791616|NCT03931330|75911941|FG000|STARTED|Overall Study||8||
59791617|NCT03931330|75911941|FG000|4 Weeks of Neuromodulation|Overall Study|at 4 weeks of neuromodulation|7||
59791618|NCT03931330|75911941|FG000|COMPLETED|Overall Study||7||
59791619|NCT03931330|75911941|FG000|NOT COMPLETED|Overall Study||1||
59791620|NCT00367237|75911948|FG000|STARTED|Overall Study|Number of subjects randomized|57||
59791621|NCT00367237|75911949|FG001|STARTED|Overall Study|Number of subjects randomized|58||
59791622|NCT00367237|75911948|FG000|COMPLETED|Overall Study||47||
59791623|NCT00367237|75911949|FG001|COMPLETED|Overall Study||47||
59791624|NCT00367237|75911948|FG000|NOT COMPLETED|Overall Study||10||
59791625|NCT00367237|75911949|FG001|NOT COMPLETED|Overall Study||11||
59791626|NCT00544882|75911957|FG000|STARTED|Cycle 1: Run-in Cycle||61||
59791627|NCT00544882|75911958|FG001|STARTED|Cycle 1: Run-in Cycle||0||
59791628|NCT00544882|75911959|FG002|STARTED|Cycle 1: Run-in Cycle||0||
59791629|NCT00544882|75911957|FG000|COMPLETED|Cycle 1: Run-in Cycle||58||
59791630|NCT00544882|75911958|FG001|COMPLETED|Cycle 1: Run-in Cycle||0||
59791631|NCT00544882|75911959|FG002|COMPLETED|Cycle 1: Run-in Cycle||0||
59791632|NCT00544882|75911957|FG000|NOT COMPLETED|Cycle 1: Run-in Cycle||3||
59791633|NCT00544882|75911958|FG001|NOT COMPLETED|Cycle 1: Run-in Cycle||0||
59791634|NCT00544882|75911959|FG002|NOT COMPLETED|Cycle 1: Run-in Cycle||0||
59791635|NCT00544882|75911957|FG000|STARTED|Cycle 2: Randomized Treatment Cycle||0||
59791636|NCT00544882|75911958|FG001|STARTED|Cycle 2: Randomized Treatment Cycle||29||
59791637|NCT00544882|75911959|FG002|STARTED|Cycle 2: Randomized Treatment Cycle||29||
59791638|NCT00544882|75911957|FG000|Treated|Cycle 2: Randomized Treatment Cycle||0||
59791639|NCT00544882|75911958|FG001|Treated|Cycle 2: Randomized Treatment Cycle|One participant withdrew prior to treatment|28||
59791640|NCT00544882|75911959|FG002|Treated|Cycle 2: Randomized Treatment Cycle|One participant was dropped from the study due to noncompliance prior to treatment.|28||
59791641|NCT00544882|75911957|FG000|COMPLETED|Cycle 2: Randomized Treatment Cycle||0||
59791642|NCT00544882|75911958|FG001|COMPLETED|Cycle 2: Randomized Treatment Cycle||28||
59791643|NCT00544882|75911959|FG002|COMPLETED|Cycle 2: Randomized Treatment Cycle||28||
59791644|NCT00544882|75911957|FG000|NOT COMPLETED|Cycle 2: Randomized Treatment Cycle||0||
59791645|NCT00544882|75911958|FG001|NOT COMPLETED|Cycle 2: Randomized Treatment Cycle||1||
59791646|NCT00544882|75911959|FG002|NOT COMPLETED|Cycle 2: Randomized Treatment Cycle||1||
59791647|NCT00544882|75911957|FG000|STARTED|Cycle 3: Follow-up||0||
59791648|NCT00544882|75911958|FG001|STARTED|Cycle 3: Follow-up||28||
59791649|NCT00544882|75911959|FG002|STARTED|Cycle 3: Follow-up||28||
59791650|NCT00544882|75911957|FG000|COMPLETED|Cycle 3: Follow-up||0||
59791651|NCT00544882|75911958|FG001|COMPLETED|Cycle 3: Follow-up|Completed 21 days of Cycle 3|26||
59791652|NCT00544882|75911959|FG002|COMPLETED|Cycle 3: Follow-up|Completed 21 days of Cycle 3|28||
59791653|NCT00544882|75911957|FG000|NOT COMPLETED|Cycle 3: Follow-up||0||
59791654|NCT00544882|75911958|FG001|NOT COMPLETED|Cycle 3: Follow-up||2||
59791655|NCT00544882|75911959|FG002|NOT COMPLETED|Cycle 3: Follow-up||0||
59791656|NCT00606801|75911967|FG000|STARTED|Adaptation||17||
59791657|NCT00606801|75911968|FG001|STARTED|Adaptation||17||
59791658|NCT00606801|75911967|FG000|COMPLETED|Adaptation||17||
59791659|NCT00606801|75911968|FG001|COMPLETED|Adaptation||17||
59791660|NCT00606801|75911967|FG000|NOT COMPLETED|Adaptation||0||
59791661|NCT00606801|75911968|FG001|NOT COMPLETED|Adaptation||0||
59791662|NCT00606801|75911967|FG000|STARTED|Intervention||17||
59791663|NCT00606801|75911968|FG001|STARTED|Intervention||17||
59791664|NCT00606801|75911967|FG000|COMPLETED|Intervention||14||
59791665|NCT00606801|75911968|FG001|COMPLETED|Intervention||14||
59791666|NCT00606801|75911967|FG000|NOT COMPLETED|Intervention||3||
59791667|NCT00606801|75911968|FG001|NOT COMPLETED|Intervention||3||
59791668|NCT00606177|75911980|FG000|STARTED|Overall Study||55||
59791669|NCT00606177|75911981|FG001|STARTED|Overall Study||44||
59791670|NCT00606177|75911980|FG000|COMPLETED|Overall Study||28||
59791671|NCT00606177|75911981|FG001|COMPLETED|Overall Study||19||
59791672|NCT00606177|75911980|FG000|NOT COMPLETED|Overall Study||27||
59791673|NCT00606177|75911981|FG001|NOT COMPLETED|Overall Study||25||
59791674|NCT00359281|75911996|FG000|STARTED|Overall Study||16||
59791675|NCT00359281|75911997|FG001|STARTED|Overall Study||15||
59791676|NCT00359281|75911998|FG002|STARTED|Overall Study||10||
59791677|NCT00359281|75911999|FG003|STARTED|Overall Study||10||
59791678|NCT00359281|75912000|FG004|STARTED|Overall Study||10||
59791679|NCT00359281|75912001|FG005|STARTED|Overall Study||15||
59791680|NCT00359281|75912002|FG006|STARTED|Overall Study||18||
59791681|NCT00359281|75912003|FG007|STARTED|Overall Study||15||
59791682|NCT00359281|75912004|FG008|STARTED|Overall Study||20||
59791683|NCT00359281|75911996|FG000|COMPLETED|Overall Study||15||
59791684|NCT00359281|75911997|FG001|COMPLETED|Overall Study||15||
59791685|NCT00359281|75911998|FG002|COMPLETED|Overall Study||10||
59791686|NCT00359281|75911999|FG003|COMPLETED|Overall Study||10||
59791687|NCT00359281|75912000|FG004|COMPLETED|Overall Study||10||
59791688|NCT00359281|75912001|FG005|COMPLETED|Overall Study||15||
59791689|NCT00359281|75912002|FG006|COMPLETED|Overall Study||16||
59791690|NCT00359281|75912003|FG007|COMPLETED|Overall Study||15||
59791691|NCT00359281|75912004|FG008|COMPLETED|Overall Study||20||
59791692|NCT00359281|75911996|FG000|NOT COMPLETED|Overall Study||1||
59791693|NCT00359281|75911997|FG001|NOT COMPLETED|Overall Study||0||
59791694|NCT00359281|75911998|FG002|NOT COMPLETED|Overall Study||0||
59791695|NCT00359281|75911999|FG003|NOT COMPLETED|Overall Study||0||
59791696|NCT00359281|75912000|FG004|NOT COMPLETED|Overall Study||0||
59791697|NCT00359281|75912001|FG005|NOT COMPLETED|Overall Study||0||
59791698|NCT00359281|75912002|FG006|NOT COMPLETED|Overall Study||2||
59791699|NCT00359281|75912003|FG007|NOT COMPLETED|Overall Study||0||
59791700|NCT00359281|75912004|FG008|NOT COMPLETED|Overall Study||0||
59791701|NCT00366535|75912033|FG000|STARTED|First Phase: 12 Weeks||27||
59791702|NCT00366535|75912034|FG001|STARTED|First Phase: 12 Weeks||29||
59791703|NCT00366535|75912033|FG000|COMPLETED|First Phase: 12 Weeks||24||
59791704|NCT00366535|75912034|FG001|COMPLETED|First Phase: 12 Weeks||21||
59791705|NCT00366535|75912033|FG000|NOT COMPLETED|First Phase: 12 Weeks||3||
59791706|NCT00366535|75912034|FG001|NOT COMPLETED|First Phase: 12 Weeks||8||
59791707|NCT00366535|75912033|FG000|STARTED|Washout Period (at Least a Week)||24||
59791708|NCT00366535|75912034|FG001|STARTED|Washout Period (at Least a Week)||21||
59791709|NCT00366535|75912033|FG000|COMPLETED|Washout Period (at Least a Week)||24||
59791710|NCT00366535|75912034|FG001|COMPLETED|Washout Period (at Least a Week)||21||
59791711|NCT00366535|75912033|FG000|NOT COMPLETED|Washout Period (at Least a Week)||0||
59791712|NCT00366535|75912034|FG001|NOT COMPLETED|Washout Period (at Least a Week)||0||
59791713|NCT00366535|75912033|FG000|STARTED|Second Phase: 12 Weeks||24||
59791714|NCT00366535|75912034|FG001|STARTED|Second Phase: 12 Weeks||21||
59791715|NCT00366535|75912033|FG000|COMPLETED|Second Phase: 12 Weeks||21||
59791716|NCT00366535|75912034|FG001|COMPLETED|Second Phase: 12 Weeks||18||
59791717|NCT00366535|75912033|FG000|NOT COMPLETED|Second Phase: 12 Weeks||3||
59791718|NCT00366535|75912034|FG001|NOT COMPLETED|Second Phase: 12 Weeks||3||
59791719|NCT00350545|75912048|FG000|STARTED|Overall Study||37||
59791720|NCT00350545|75912048|FG000|COMPLETED|Overall Study||35||
59791721|NCT00350545|75912048|FG000|NOT COMPLETED|Overall Study||2||
59791722|NCT00349921|75912056|FG000|STARTED|First Spinal Injection||10||
59791723|NCT00349921|75912057|FG001|STARTED|First Spinal Injection||10||
59791724|NCT00349921|75912058|FG002|STARTED|First Spinal Injection||1||
59791725|NCT00349921|75912059|FG003|STARTED|First Spinal Injection||1||
59791726|NCT00349921|75912056|FG000|COMPLETED|First Spinal Injection||9||
59791727|NCT00349921|75912057|FG001|COMPLETED|First Spinal Injection||10||
59791728|NCT00349921|75912058|FG002|COMPLETED|First Spinal Injection||0||
59791729|NCT00349921|75912059|FG003|COMPLETED|First Spinal Injection||1||
59791730|NCT00349921|75912056|FG000|NOT COMPLETED|First Spinal Injection||1||
59791731|NCT00349921|75912057|FG001|NOT COMPLETED|First Spinal Injection||0||
59791732|NCT00349921|75912058|FG002|NOT COMPLETED|First Spinal Injection||1||
59791733|NCT00349921|75912059|FG003|NOT COMPLETED|First Spinal Injection||0||
59791734|NCT00349921|75912056|FG000|STARTED|Second Spinal Injection|One patient experienced an adverse event after period one and did not participate in period two|9||
59791735|NCT00349921|75912057|FG001|STARTED|Second Spinal Injection||10||
59791736|NCT00349921|75912058|FG002|STARTED|Second Spinal Injection||0||
59791737|NCT00349921|75912059|FG003|STARTED|Second Spinal Injection||1||
59791738|NCT00349921|75912056|FG000|COMPLETED|Second Spinal Injection||9||
59791739|NCT00349921|75912057|FG001|COMPLETED|Second Spinal Injection||10||
59791740|NCT00349921|75912058|FG002|COMPLETED|Second Spinal Injection||0||
59791741|NCT00349921|75912059|FG003|COMPLETED|Second Spinal Injection||1||
59791742|NCT00349921|75912056|FG000|NOT COMPLETED|Second Spinal Injection||0||
59791743|NCT00349921|75912057|FG001|NOT COMPLETED|Second Spinal Injection||0||
59791744|NCT00349921|75912058|FG002|NOT COMPLETED|Second Spinal Injection||0||
59791745|NCT00349921|75912059|FG003|NOT COMPLETED|Second Spinal Injection||0||
59791746|NCT00606021|75912070|FG000|STARTED|Induction Phase||106||
59791747|NCT00606021|75912071|FG001|STARTED|Induction Phase||0||
59791748|NCT00606021|75912072|FG002|STARTED|Induction Phase||0||
59791749|NCT00606021|75912070|FG000|COMPLETED|Induction Phase||19||
59791750|NCT00606021|75912071|FG001|COMPLETED|Induction Phase||0||
59791751|NCT00606021|75912072|FG002|COMPLETED|Induction Phase||0||
59791752|NCT00606021|75912070|FG000|NOT COMPLETED|Induction Phase||87||
59791753|NCT00606021|75912071|FG001|NOT COMPLETED|Induction Phase||0||
59791754|NCT00606021|75912072|FG002|NOT COMPLETED|Induction Phase||0||
59791755|NCT00606021|75912070|FG000|STARTED|Maintenance Phase||0||
59791756|NCT00606021|75912071|FG001|STARTED|Maintenance Phase||28||
59791757|NCT00606021|75912072|FG002|STARTED|Maintenance Phase||27||
59791758|NCT00606021|75912070|FG000|COMPLETED|Maintenance Phase||0||
59791759|NCT00606021|75912071|FG001|COMPLETED|Maintenance Phase||5||
59953718|NCT01328054|76072031|FG001|COMPLETED|Lapatinib on Day 3 and Day 4 (2 Days)||53||
59953719|NCT01328054|76072030|FG000|NOT COMPLETED|Lapatinib on Day 3 and Day 4 (2 Days)||0||
59953720|NCT01328054|76072031|FG001|NOT COMPLETED|Lapatinib on Day 3 and Day 4 (2 Days)||5||
59953721|NCT01907360|76072045|FG000|STARTED|Overall Study||18||
59953722|NCT01907360|76072046|FG001|STARTED|Overall Study||11||
59953723|NCT01907360|76072045|FG000|COMPLETED|Overall Study||18||
59953724|NCT01907360|76072046|FG001|COMPLETED|Overall Study||11||
59953725|NCT01907360|76072045|FG000|NOT COMPLETED|Overall Study||0||
59953726|NCT01907360|76072046|FG001|NOT COMPLETED|Overall Study||0||
59953727|NCT01849250|76072054|FG000|STARTED|Overall Study||32||
59953728|NCT01849250|76072055|FG001|STARTED|Overall Study||32||
59953729|NCT01849250|76072054|FG000|COMPLETED|Overall Study||25||
59953730|NCT01849250|76072055|FG001|COMPLETED|Overall Study||29||
59953731|NCT01849250|76072054|FG000|NOT COMPLETED|Overall Study||7||
59953732|NCT01849250|76072055|FG001|NOT COMPLETED|Overall Study||3||
59953733|NCT02791191|76072065|FG000|STARTED|Overall Study||55||
59953734|NCT02791191|76072066|FG001|STARTED|Overall Study||128||
59953735|NCT02791191|76072067|FG002|STARTED|Overall Study||133||
59953736|NCT02791191|76072065|FG000|Received One Dose of Study Drug|Overall Study||55||
59953737|NCT02791191|76072066|FG001|Received One Dose of Study Drug|Overall Study||127||
59953738|NCT02791191|76072067|FG002|Received One Dose of Study Drug|Overall Study||133||
59953739|NCT02791191|76072065|FG000|COMPLETED|Overall Study||17||
59953740|NCT02791191|76072066|FG001|COMPLETED|Overall Study||17||
59953741|NCT02791191|76072067|FG002|COMPLETED|Overall Study||13||
59953742|NCT02791191|76072065|FG000|NOT COMPLETED|Overall Study||38||
59953743|NCT02791191|76072066|FG001|NOT COMPLETED|Overall Study||111||
59953744|NCT02791191|76072067|FG002|NOT COMPLETED|Overall Study||120||
59953745|NCT03012165|76072078|FG000|STARTED|Overall Study||53||
59953746|NCT03012165|76072079|FG001|STARTED|Overall Study||51||
59953747|NCT03012165|76072080|FG002|STARTED|Overall Study||50||
59953748|NCT03012165|76072078|FG000|COMPLETED|Overall Study||51||
59953749|NCT03012165|76072079|FG001|COMPLETED|Overall Study||49||
59953750|NCT03012165|76072080|FG002|COMPLETED|Overall Study||49||
59953751|NCT03012165|76072078|FG000|NOT COMPLETED|Overall Study||2||
59953752|NCT03012165|76072079|FG001|NOT COMPLETED|Overall Study||2||
59953753|NCT03012165|76072080|FG002|NOT COMPLETED|Overall Study||1||
59953754|NCT02114697|76072090|FG000|STARTED|Overall Study||5||
59953755|NCT02114697|76072091|FG001|STARTED|Overall Study||4||
59953756|NCT02114697|76072090|FG000|Completed Month 18 Visit|Overall Study||0||
59953757|NCT02114697|76072091|FG001|Completed Month 18 Visit|Overall Study||1||
59953758|NCT02114697|76072090|FG000|COMPLETED|Overall Study||0||
59953759|NCT02114697|76072091|FG001|COMPLETED|Overall Study||0||
59953760|NCT02114697|76072090|FG000|NOT COMPLETED|Overall Study||5||
59953761|NCT02114697|76072091|FG001|NOT COMPLETED|Overall Study||4||
59953762|NCT01330017|76072102|FG000|STARTED|Overall Study||109||
59953763|NCT01330017|76072103|FG001|STARTED|Overall Study||108||
59953764|NCT01330017|76072104|FG002|STARTED|Overall Study||107||
59953765|NCT01330017|76072105|FG003|STARTED|Overall Study||112||
59953766|NCT01330017|76072106|FG004|STARTED|Overall Study||103||
59565810|NCT02335242|75668230|FG001|STARTED|Open-label Phase (20 Weeks)|Participants in the sildenafil group did not enter the open-label phase, but proceeded to the follow-up period.|0||
59620053|NCT02087514|75731227|FG005|COMPLETED|Overall Study||9||
59791760|NCT00606021|75912072|FG002|COMPLETED|Maintenance Phase||10||
59791761|NCT00606021|75912070|FG000|NOT COMPLETED|Maintenance Phase||0||
59791762|NCT00606021|75912071|FG001|NOT COMPLETED|Maintenance Phase||23||
59791763|NCT00606021|75912072|FG002|NOT COMPLETED|Maintenance Phase||17||
59953767|NCT01330017|76072102|FG000|COMPLETED|Overall Study||104||
59953768|NCT01330017|76072103|FG001|COMPLETED|Overall Study||104||
59953769|NCT01330017|76072104|FG002|COMPLETED|Overall Study||99||
59953770|NCT01330017|76072105|FG003|COMPLETED|Overall Study||100||
59953771|NCT01330017|76072106|FG004|COMPLETED|Overall Study||100||
59791764|NCT00337675|75912083|FG000|STARTED|Overall Study||589||
59791765|NCT00337675|75912084|FG001|STARTED|Overall Study||591||
59791766|NCT00337675|75912085|FG002|STARTED|Overall Study||591||
59953772|NCT01330017|76072102|FG000|NOT COMPLETED|Overall Study||5||
59953773|NCT01330017|76072103|FG001|NOT COMPLETED|Overall Study||4||
59953774|NCT01330017|76072104|FG002|NOT COMPLETED|Overall Study||8||
59953775|NCT01330017|76072105|FG003|NOT COMPLETED|Overall Study||12||
59953776|NCT01330017|76072106|FG004|NOT COMPLETED|Overall Study||3||
59953777|NCT00150462|76072129|FG000|STARTED|Overall Study||3||
59953778|NCT00150462|76072130|FG001|STARTED|Overall Study||3||
59953779|NCT00150462|76072131|FG002|STARTED|Overall Study||4||
59953780|NCT00150462|76072132|FG003|STARTED|Overall Study||3||
59953781|NCT00150462|76072133|FG004|STARTED|Overall Study||3||
59953782|NCT00150462|76072134|FG005|STARTED|Overall Study||4||
59953783|NCT00150462|76072135|FG006|STARTED|Overall Study||3||
59953784|NCT00150462|76072136|FG007|STARTED|Overall Study||8||
59953785|NCT00150462|76072137|FG008|STARTED|Overall Study||6||
59953786|NCT00150462|76072138|FG009|STARTED|Overall Study||7||
59953787|NCT00150462|76072139|FG010|STARTED|Overall Study||4||
59953788|NCT00150462|76072129|FG000|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0||
59953789|NCT00150462|76072130|FG001|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0||
59953790|NCT00150462|76072131|FG002|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0||
59953791|NCT00150462|76072132|FG003|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0||
59791767|NCT00337675|75912083|FG000|COMPLETED|Overall Study||492||
59791768|NCT00337675|75912084|FG001|COMPLETED|Overall Study||488||
59791769|NCT00337675|75912085|FG002|COMPLETED|Overall Study||492||
59791770|NCT00337675|75912083|FG000|NOT COMPLETED|Overall Study||97||
59791771|NCT00337675|75912084|FG001|NOT COMPLETED|Overall Study||103||
59791772|NCT00337675|75912085|FG002|NOT COMPLETED|Overall Study||99||
59791773|NCT00337285|75912093|FG000|STARTED|Overall Study||349||
59791774|NCT00337285|75912093|FG000|COMPLETED|Overall Study||191||
59791775|NCT00337285|75912093|FG000|NOT COMPLETED|Overall Study||158||
59791776|NCT00605865|75912097|FG000|STARTED|Overall Study||2272||
59791777|NCT00605865|75912097|FG000|COMPLETED|Overall Study||2157||
59791778|NCT00605865|75912097|FG000|NOT COMPLETED|Overall Study||115||
59791779|NCT00348673|75912137|FG000|STARTED|Stage 1||6||
59791780|NCT00348673|75912138|FG001|STARTED|Stage 1||6||
59791781|NCT00348673|75912139|FG002|STARTED|Stage 1||7||
59791782|NCT00348673|75912140|FG003|STARTED|Stage 1||6||
59791783|NCT00348673|75912141|FG004|STARTED|Stage 1||4||
59791784|NCT00348673|75912142|FG005|STARTED|Stage 1||0||
59791785|NCT00348673|75912143|FG006|STARTED|Stage 1||0||
59791786|NCT00348673|75912144|FG007|STARTED|Stage 1||0||
59791787|NCT00348673|75912145|FG008|STARTED|Stage 1||0||
59791788|NCT00348673|75912137|FG000|Treated|Stage 1||6||
59791789|NCT00348673|75912138|FG001|Treated|Stage 1||6||
59953792|NCT00150462|76072133|FG004|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0||
59953793|NCT00150462|76072134|FG005|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0||
59791790|NCT00348673|75912139|FG002|Treated|Stage 1||6||
59791791|NCT00348673|75912140|FG003|Treated|Stage 1||6||
59791792|NCT00348673|75912141|FG004|Treated|Stage 1||4||
59791793|NCT00348673|75912142|FG005|Treated|Stage 1||0||
59791794|NCT00348673|75912143|FG006|Treated|Stage 1||0||
59791795|NCT00348673|75912144|FG007|Treated|Stage 1||0||
59791796|NCT00348673|75912145|FG008|Treated|Stage 1||0||
59791797|NCT00348673|75912137|FG000|COMPLETED|Stage 1||6||
59791798|NCT00348673|75912138|FG001|COMPLETED|Stage 1||6||
59791799|NCT00348673|75912139|FG002|COMPLETED|Stage 1||6||
59791800|NCT00348673|75912140|FG003|COMPLETED|Stage 1||6||
59791801|NCT00348673|75912141|FG004|COMPLETED|Stage 1||4||
59791802|NCT00348673|75912142|FG005|COMPLETED|Stage 1||0||
59791803|NCT00348673|75912143|FG006|COMPLETED|Stage 1||0||
59791804|NCT00348673|75912144|FG007|COMPLETED|Stage 1||0||
59791805|NCT00348673|75912145|FG008|COMPLETED|Stage 1||0||
59791806|NCT00348673|75912137|FG000|NOT COMPLETED|Stage 1||0||
59791807|NCT00348673|75912138|FG001|NOT COMPLETED|Stage 1||0||
59791808|NCT00348673|75912139|FG002|NOT COMPLETED|Stage 1||1||
59791809|NCT00348673|75912140|FG003|NOT COMPLETED|Stage 1||0||
59791810|NCT00348673|75912141|FG004|NOT COMPLETED|Stage 1||0||
59791811|NCT00348673|75912142|FG005|NOT COMPLETED|Stage 1||0||
59791812|NCT00348673|75912143|FG006|NOT COMPLETED|Stage 1||0||
59791813|NCT00348673|75912144|FG007|NOT COMPLETED|Stage 1||0||
59953794|NCT00150462|76072135|FG006|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0||
59953795|NCT00150462|76072136|FG007|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0||
59953796|NCT00150462|76072137|FG008|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0||
59791814|NCT00348673|75912145|FG008|NOT COMPLETED|Stage 1||0||
59791815|NCT00348673|75912137|FG000|STARTED|Stage 2||0||
59791816|NCT00348673|75912138|FG001|STARTED|Stage 2||0||
59791817|NCT00348673|75912139|FG002|STARTED|Stage 2||0||
59791818|NCT00348673|75912140|FG003|STARTED|Stage 2||0||
59791819|NCT00348673|75912141|FG004|STARTED|Stage 2||0||
59791820|NCT00348673|75912142|FG005|STARTED|Stage 2||6||
59791821|NCT00348673|75912143|FG006|STARTED|Stage 2||6||
59791822|NCT00348673|75912144|FG007|STARTED|Stage 2||6||
59791823|NCT00348673|75912145|FG008|STARTED|Stage 2||2||
59791824|NCT00348673|75912137|FG000|COMPLETED|Stage 2||0||
59791825|NCT00348673|75912138|FG001|COMPLETED|Stage 2||0||
59791826|NCT00348673|75912139|FG002|COMPLETED|Stage 2||0||
59791827|NCT00348673|75912140|FG003|COMPLETED|Stage 2||0||
59791828|NCT00348673|75912141|FG004|COMPLETED|Stage 2||0||
59791829|NCT00348673|75912142|FG005|COMPLETED|Stage 2||6||
59791830|NCT00348673|75912143|FG006|COMPLETED|Stage 2||6||
59791831|NCT00348673|75912144|FG007|COMPLETED|Stage 2||6||
59791832|NCT00348673|75912145|FG008|COMPLETED|Stage 2||2||
59791833|NCT00348673|75912137|FG000|NOT COMPLETED|Stage 2||0||
59791834|NCT00348673|75912138|FG001|NOT COMPLETED|Stage 2||0||
59791835|NCT00348673|75912139|FG002|NOT COMPLETED|Stage 2||0||
59791836|NCT00348673|75912140|FG003|NOT COMPLETED|Stage 2||0||
59791837|NCT00348673|75912141|FG004|NOT COMPLETED|Stage 2||0||
59791838|NCT00348673|75912142|FG005|NOT COMPLETED|Stage 2||0||
59791839|NCT00348673|75912143|FG006|NOT COMPLETED|Stage 2||0||
59791840|NCT00348673|75912144|FG007|NOT COMPLETED|Stage 2||0||
59791841|NCT00348673|75912145|FG008|NOT COMPLETED|Stage 2||0||
59791842|NCT00337207|75912163|FG000|STARTED|Overall Study||55||
59791843|NCT00337207|75912163|FG000|COMPLETED|Overall Study||52||
59791844|NCT00337207|75912163|FG000|NOT COMPLETED|Overall Study||3||
59791845|NCT00604695|75912170|FG000|STARTED|Overall Study||20||
59791846|NCT00604695|75912171|FG001|STARTED|Overall Study||20||
59791847|NCT00604695|75912170|FG000|COMPLETED|Overall Study||20||
59791848|NCT00604695|75912171|FG001|COMPLETED|Overall Study||16||
59791849|NCT00604695|75912170|FG000|NOT COMPLETED|Overall Study||0||
59791850|NCT00604695|75912171|FG001|NOT COMPLETED|Overall Study||4||
59791851|NCT00348595|75912179|FG000|STARTED|Overall Study||26||
59791852|NCT00348595|75912180|FG001|STARTED|Overall Study||34||
59791853|NCT00348595|75912179|FG000|COMPLETED|Overall Study||21||
59791854|NCT00348595|75912180|FG001|COMPLETED|Overall Study||26||
59791855|NCT00348595|75912179|FG000|NOT COMPLETED|Overall Study||5||
59791856|NCT00348595|75912180|FG001|NOT COMPLETED|Overall Study||8||
59791857|NCT00337129|75912186|FG000|STARTED|Overall Study||40||
59791858|NCT00337129|75912186|FG000|COMPLETED|Overall Study|Treatment is not for a fixed period and continues until discontinuation criterion is met.|0||
59791859|NCT00337129|75912186|FG000|NOT COMPLETED|Overall Study||40||
59791860|NCT00605085|75912192|FG000|STARTED|Overall Study||2012||
59791861|NCT00605085|75912193|FG001|STARTED|Overall Study||663||
59791862|NCT00605085|75912192|FG000|COMPLETED|Overall Study||1962||
59791863|NCT00605085|75912193|FG001|COMPLETED|Overall Study||638||
59791864|NCT00605085|75912192|FG000|NOT COMPLETED|Overall Study||50||
59791865|NCT00605085|75912193|FG001|NOT COMPLETED|Overall Study||25||
59791866|NCT00348283|75912201|FG000|STARTED|Induction||0||
59791867|NCT00348283|75912202|FG001|STARTED|Induction|Subjects received an open- label dose of 80 mg adalimumab at Week 2 (induction dose).|135||
59791868|NCT00348283|75912201|FG000|COMPLETED|Induction||0||
59791869|NCT00348283|75912202|FG001|COMPLETED|Induction|Subjects provided more than one reason for discontinuing during induction.|129||
59791870|NCT00348283|75912201|FG000|NOT COMPLETED|Induction||0||
59791871|NCT00348283|75912202|FG001|NOT COMPLETED|Induction||6||
59791872|NCT00348283|75912201|FG000|STARTED|Double Blind|At Week 4, subjects were randomized to either adalimumab 40 mg eow or placebo eow.|65||
59791873|NCT00348283|75912202|FG001|STARTED|Double Blind|At Week 4, subjects were randomized to either adalimumab 40 mg eow or placebo eow.|64||
59791874|NCT00348283|75912201|FG000|COMPLETED|Double Blind||60||
59791875|NCT00348283|75912202|FG001|COMPLETED|Double Blind||54||
59791876|NCT00348283|75912201|FG000|NOT COMPLETED|Double Blind||5||
59791877|NCT00348283|75912202|FG001|NOT COMPLETED|Double Blind||10||
59791878|NCT00348283|75912201|FG000|STARTED|Open Label|No comparator was used in the Open Label portion of the study.|0||
59791879|NCT00348283|75912202|FG001|STARTED|Open Label|14 subjects completed the Double Blind portion of the study but did not enter the Open Label period.|100||
59791880|NCT00348283|75912201|FG000|COMPLETED|Open Label||0||
59791881|NCT00348283|75912202|FG001|COMPLETED|Open Label||66||
59791882|NCT00348283|75912201|FG000|NOT COMPLETED|Open Label||0||
59791883|NCT00348283|75912202|FG001|NOT COMPLETED|Open Label||34||
59791884|NCT00336895|75912208|FG000|STARTED|Overall Study||30||
59791885|NCT00336895|75912208|FG000|COMPLETED|Overall Study||26||
59791886|NCT00336895|75912208|FG000|NOT COMPLETED|Overall Study||4||
59791887|NCT00336583|75912212|FG000|STARTED|Overall Study||27||
59791888|NCT00336583|75912212|FG000|COMPLETED|Overall Study||25||
59791889|NCT00336583|75912212|FG000|NOT COMPLETED|Overall Study||2||
59791890|NCT00336505|75912218|FG000|STARTED|Overall Study|All subjects who were randomized and dosed.|291||
59791891|NCT00336505|75912219|FG001|STARTED|Overall Study|All subjects who were randomized and dosed.|291||
59791892|NCT00336505|75912218|FG000|COMPLETED|Overall Study|Number of subjects completing the test of cure (TOC) visit.|254||
59791893|NCT00336505|75912219|FG001|COMPLETED|Overall Study|Number of subjects completing the test of cure (TOC) visit.|264||
59791894|NCT00336505|75912218|FG000|NOT COMPLETED|Overall Study||37||
59791895|NCT00336505|75912219|FG001|NOT COMPLETED|Overall Study||27||
59791896|NCT00357877|75912227|FG000|STARTED|Overall Study||493||
59791897|NCT00357877|75912228|FG001|STARTED|Overall Study||490||
59791898|NCT00357877|75912227|FG000|COMPLETED|Overall Study||467||
59791899|NCT00357877|75912228|FG001|COMPLETED|Overall Study||460||
59791900|NCT00357877|75912227|FG000|NOT COMPLETED|Overall Study||26||
59791901|NCT00357877|75912228|FG001|NOT COMPLETED|Overall Study||30||
59791902|NCT00335959|75912236|FG000|STARTED|Overall Study||7||
59791903|NCT00335959|75912236|FG000|Eligible|Overall Study||6||
59791904|NCT00335959|75912236|FG000|Eligible and Began Protocol Therapy|Overall Study||6||
59791905|NCT00335959|75912236|FG000|COMPLETED|Overall Study||4||
59791906|NCT00335959|75912236|FG000|NOT COMPLETED|Overall Study||3||
59791907|NCT00670488|75912251|FG000|STARTED|Overall Study||3||
59791908|NCT00670488|75912252|FG001|STARTED|Overall Study||58||
59791909|NCT00670488|75912253|FG002|STARTED|Overall Study||3||
59791910|NCT00670488|75912254|FG003|STARTED|Overall Study||7||
59791911|NCT00670488|75912255|FG004|STARTED|Overall Study||3||
59791912|NCT00670488|75912256|FG005|STARTED|Overall Study||5||
59791913|NCT00670488|75912257|FG006|STARTED|Overall Study||17||
59791914|NCT00670488|75912258|FG007|STARTED|Overall Study||3||
59791915|NCT00670488|75912259|FG008|STARTED|Overall Study||3||
59791916|NCT00670488|75912260|FG009|STARTED|Overall Study||2||
59791917|NCT00670488|75912251|FG000|COMPLETED|Overall Study||0||
59791918|NCT00670488|75912252|FG001|COMPLETED|Overall Study||0||
59791919|NCT00670488|75912253|FG002|COMPLETED|Overall Study||0||
59791920|NCT00670488|75912254|FG003|COMPLETED|Overall Study||0||
59791921|NCT00670488|75912255|FG004|COMPLETED|Overall Study||0||
59791922|NCT00670488|75912256|FG005|COMPLETED|Overall Study||0||
59791923|NCT00670488|75912257|FG006|COMPLETED|Overall Study||0||
59791924|NCT00670488|75912258|FG007|COMPLETED|Overall Study||0||
59995256|NCT02929069|76111081|FG000|Assessed HIV 12 Month|Overall Study||76||
59791925|NCT00670488|75912259|FG008|COMPLETED|Overall Study||0||
59791926|NCT00670488|75912260|FG009|COMPLETED|Overall Study||0||
59791927|NCT00670488|75912251|FG000|NOT COMPLETED|Overall Study||3||
59791928|NCT00670488|75912252|FG001|NOT COMPLETED|Overall Study||58||
59791929|NCT00670488|75912253|FG002|NOT COMPLETED|Overall Study||3||
59791930|NCT00670488|75912254|FG003|NOT COMPLETED|Overall Study||7||
59791931|NCT00670488|75912255|FG004|NOT COMPLETED|Overall Study||3||
59791932|NCT00670488|75912256|FG005|NOT COMPLETED|Overall Study||5||
59791933|NCT00670488|75912257|FG006|NOT COMPLETED|Overall Study||17||
59791934|NCT00670488|75912258|FG007|NOT COMPLETED|Overall Study||3||
59791935|NCT00670488|75912259|FG008|NOT COMPLETED|Overall Study||3||
59791936|NCT00670488|75912260|FG009|NOT COMPLETED|Overall Study||2||
59791937|NCT00671658|75912282|FG000|STARTED|Overall Study||220||
59791938|NCT00671658|75912282|FG000|COMPLETED|Overall Study||215||
59791939|NCT00671658|75912282|FG000|NOT COMPLETED|Overall Study||5||
59791940|NCT00542386|75912292|FG000|STARTED|Overall Study||104||
59791941|NCT00542386|75912293|FG001|STARTED|Overall Study||102||
59791942|NCT00542386|75912294|FG002|STARTED|Overall Study||99||
59791943|NCT00542386|75912295|FG003|STARTED|Overall Study||103||
59791944|NCT00542386|75912296|FG004|STARTED|Overall Study||102||
59791945|NCT00542386|75912297|FG005|STARTED|Overall Study||132||
59791946|NCT00542386|75912292|FG000|COMPLETED|Overall Study||61||
59791947|NCT00542386|75912293|FG001|COMPLETED|Overall Study||74||
59791948|NCT00542386|75912294|FG002|COMPLETED|Overall Study||66||
59791949|NCT00542386|75912295|FG003|COMPLETED|Overall Study||65||
59791950|NCT00542386|75912296|FG004|COMPLETED|Overall Study||62||
59791951|NCT00542386|75912297|FG005|COMPLETED|Overall Study||82||
59791952|NCT00542386|75912292|FG000|NOT COMPLETED|Overall Study||43||
59791953|NCT00542386|75912293|FG001|NOT COMPLETED|Overall Study||28||
59791954|NCT00542386|75912294|FG002|NOT COMPLETED|Overall Study||33||
59791955|NCT00542386|75912295|FG003|NOT COMPLETED|Overall Study||38||
59791956|NCT00542386|75912296|FG004|NOT COMPLETED|Overall Study||40||
59791957|NCT00542386|75912297|FG005|NOT COMPLETED|Overall Study||50||
59791958|NCT00604383|75912313|FG000|STARTED|Overall Study||345||
59791959|NCT00604383|75912314|FG001|STARTED|Overall Study||340||
59791960|NCT00604383|75912313|FG000|Received at Least 1 Dose of Study Drug|Overall Study||345||
59791961|NCT00604383|75912314|FG001|Received at Least 1 Dose of Study Drug|Overall Study||340||
59791962|NCT00604383|75912313|FG000|Received Extended Treatment|Overall Study||136||
59791963|NCT00604383|75912314|FG001|Received Extended Treatment|Overall Study||141||
59791964|NCT00604383|75912313|FG000|COMPLETED|Overall Study||258||
59791965|NCT00604383|75912314|FG001|COMPLETED|Overall Study||256||
59791966|NCT00604383|75912313|FG000|NOT COMPLETED|Overall Study||87||
59791967|NCT00604383|75912314|FG001|NOT COMPLETED|Overall Study||84||
59791968|NCT00333775|75912323|FG000|STARTED|Overall Study||241||
59791969|NCT00333775|75912324|FG001|STARTED|Overall Study||248||
59620054|NCT02087514|75731222|FG000|NOT COMPLETED|Overall Study||2||
59620055|NCT02087514|75731223|FG001|NOT COMPLETED|Overall Study||0||
59620056|NCT02087514|75731224|FG002|NOT COMPLETED|Overall Study||3||
59620057|NCT02087514|75731225|FG003|NOT COMPLETED|Overall Study||2||
59620058|NCT02087514|75731226|FG004|NOT COMPLETED|Overall Study||0||
59620059|NCT02087514|75731227|FG005|NOT COMPLETED|Overall Study||1||
59620060|NCT01212822|75731241|FG000|STARTED|Overall Study||20||
59791970|NCT00333775|75912325|FG002|STARTED|Overall Study||247||
59791971|NCT00333775|75912323|FG000|Received Treatment|Overall Study||238||
59620061|NCT01212822|75731241|FG000|COMPLETED|Overall Study||20||
59620062|NCT01212822|75731241|FG000|NOT COMPLETED|Overall Study||0||
59620063|NCT01026012|75731245|FG000|STARTED|Overall Study||40||
59620064|NCT01026012|75731245|FG000|COMPLETED|Overall Study||40||
59620065|NCT01026012|75731245|FG000|NOT COMPLETED|Overall Study||0||
59620066|NCT02088216|75731251|FG000|STARTED|Overall Study||81||
59620067|NCT02088216|75731252|FG001|STARTED|Overall Study||80||
59791972|NCT00333775|75912324|FG001|Received Treatment|Overall Study||247||
59791973|NCT00333775|75912325|FG002|Received Treatment|Overall Study||245||
59791974|NCT00333775|75912323|FG000|COMPLETED|Overall Study||0||
59791975|NCT00333775|75912324|FG001|COMPLETED|Overall Study||0||
59791976|NCT00333775|75912325|FG002|COMPLETED|Overall Study||0||
59791977|NCT00333775|75912323|FG000|NOT COMPLETED|Overall Study||241||
59791978|NCT00333775|75912324|FG001|NOT COMPLETED|Overall Study||248||
59791979|NCT00333775|75912325|FG002|NOT COMPLETED|Overall Study||247||
59791980|NCT00605475|75912343|FG000|STARTED|Overall Study||10||
59791981|NCT00605475|75912344|FG001|STARTED|Overall Study||5||
59791982|NCT00605475|75912345|FG002|STARTED|Overall Study||45||
59620068|NCT02088216|75731251|FG000|COMPLETED|Overall Study||69||
59620069|NCT02088216|75731252|FG001|COMPLETED|Overall Study||70||
59620070|NCT02088216|75731251|FG000|NOT COMPLETED|Overall Study||12||
59791983|NCT00605475|75912346|FG003|STARTED|Overall Study||45||
59791984|NCT00605475|75912347|FG004|STARTED|Overall Study||25||
59791985|NCT00605475|75912348|FG005|STARTED|Overall Study||24||
59791986|NCT00605475|75912349|FG006|STARTED|Overall Study||23||
59791987|NCT00605475|75912350|FG007|STARTED|Overall Study||24||
59791988|NCT00605475|75912351|FG008|STARTED|Overall Study||20||
59791989|NCT00605475|75912352|FG009|STARTED|Overall Study||10||
59791990|NCT00605475|75912343|FG000|COMPLETED|Overall Study||10||
59791991|NCT00605475|75912344|FG001|COMPLETED|Overall Study||5||
59791992|NCT00605475|75912345|FG002|COMPLETED|Overall Study||45||
59791993|NCT00605475|75912346|FG003|COMPLETED|Overall Study||45||
59791994|NCT00605475|75912347|FG004|COMPLETED|Overall Study||24||
59791995|NCT00605475|75912348|FG005|COMPLETED|Overall Study||22||
59791996|NCT00605475|75912349|FG006|COMPLETED|Overall Study||22||
59791997|NCT00605475|75912350|FG007|COMPLETED|Overall Study||24||
59791998|NCT00605475|75912351|FG008|COMPLETED|Overall Study||18||
59791999|NCT00605475|75912352|FG009|COMPLETED|Overall Study||8||
59792000|NCT00605475|75912343|FG000|NOT COMPLETED|Overall Study||0||
59792001|NCT00605475|75912344|FG001|NOT COMPLETED|Overall Study||0||
59792002|NCT00605475|75912345|FG002|NOT COMPLETED|Overall Study||0||
59792003|NCT00605475|75912346|FG003|NOT COMPLETED|Overall Study||0||
59792004|NCT00605475|75912347|FG004|NOT COMPLETED|Overall Study||1||
59792005|NCT00605475|75912348|FG005|NOT COMPLETED|Overall Study||2||
59792006|NCT00605475|75912349|FG006|NOT COMPLETED|Overall Study||1||
59792007|NCT00605475|75912350|FG007|NOT COMPLETED|Overall Study||0||
59792008|NCT00605475|75912351|FG008|NOT COMPLETED|Overall Study||2||
59792009|NCT00605475|75912352|FG009|NOT COMPLETED|Overall Study||2||
59792010|NCT00333619|75912397|FG000|STARTED|Overall Study||110||
59953797|NCT00150462|76072138|FG009|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of treatment.|1||
59953798|NCT00150462|76072139|FG010|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of treatment.|1||
59953799|NCT00150462|76072129|FG000|NOT COMPLETED|Overall Study||3||
59953800|NCT00150462|76072130|FG001|NOT COMPLETED|Overall Study||3||
59953801|NCT00150462|76072131|FG002|NOT COMPLETED|Overall Study||4||
59953802|NCT00150462|76072132|FG003|NOT COMPLETED|Overall Study||3||
59953803|NCT00150462|76072133|FG004|NOT COMPLETED|Overall Study||3||
59953804|NCT00150462|76072134|FG005|NOT COMPLETED|Overall Study||4||
59953805|NCT00150462|76072135|FG006|NOT COMPLETED|Overall Study||3||
59792011|NCT00333619|75912398|FG001|STARTED|Overall Study||109||
59792012|NCT00333619|75912397|FG000|Post-treatment|Overall Study||109||
59792013|NCT00333619|75912398|FG001|Post-treatment|Overall Study||109||
59792014|NCT00333619|75912397|FG000|3-month Follow-up|Overall Study||101||
59792015|NCT00333619|75912398|FG001|3-month Follow-up|Overall Study||105||
59792016|NCT00333619|75912397|FG000|COMPLETED|Overall Study||89||
59792017|NCT00333619|75912398|FG001|COMPLETED|Overall Study||99||
59792018|NCT00333619|75912397|FG000|NOT COMPLETED|Overall Study||21||
59792019|NCT00333619|75912398|FG001|NOT COMPLETED|Overall Study||10||
59792020|NCT00605319|75912406|FG000|STARTED|Overall Study||17||
59792021|NCT00605319|75912406|FG000|COMPLETED|Overall Study||11||
59792022|NCT00605319|75912406|FG000|NOT COMPLETED|Overall Study||6||
59953806|NCT00150462|76072136|FG007|NOT COMPLETED|Overall Study||8||
59953807|NCT00150462|76072137|FG008|NOT COMPLETED|Overall Study||6||
59792023|NCT00333229|75912418|FG000|STARTED|Overall Study||6||
59792024|NCT00333229|75912419|FG001|STARTED|Overall Study||5||
59792025|NCT00333229|75912418|FG000|COMPLETED|Overall Study||6||
59953808|NCT00150462|76072138|FG009|NOT COMPLETED|Overall Study||6||
59953809|NCT00150462|76072139|FG010|NOT COMPLETED|Overall Study||3||
59953810|NCT01368081|76072179|FG000|STARTED|Overall Study||136||
59953811|NCT01368081|76072180|FG001|STARTED|Overall Study||137||
59953812|NCT01368081|76072181|FG002|STARTED|Overall Study||63||
59953813|NCT01368081|76072182|FG003|STARTED|Overall Study||68||
59953814|NCT01368081|76072183|FG004|STARTED|Overall Study||65||
59953815|NCT01368081|76072184|FG005|STARTED|Overall Study||137||
59953816|NCT01368081|76072185|FG006|STARTED|Overall Study||136||
59953817|NCT01368081|76072186|FG007|STARTED|Overall Study||69||
59953818|NCT01368081|76072187|FG008|STARTED|Overall Study||70||
59792026|NCT00333229|75912419|FG001|COMPLETED|Overall Study||4||
59792027|NCT00333229|75912418|FG000|NOT COMPLETED|Overall Study||0||
59953819|NCT01368081|76072188|FG009|STARTED|Overall Study||68||
59953820|NCT01368081|76072189|FG010|STARTED|Overall Study||71||
59953821|NCT01368081|76072190|FG011|STARTED|Overall Study||70||
59953822|NCT01368081|76072191|FG012|STARTED|Overall Study||70||
59953823|NCT01368081|76072179|FG000|COMPLETED|Overall Study||126||
59792028|NCT00333229|75912419|FG001|NOT COMPLETED|Overall Study||1||
59792029|NCT00332839|75912427|FG000|STARTED|Core (Months 0 - 12)||47||
59792030|NCT00332839|75912428|FG001|STARTED|Core (Months 0 - 12)||46||
59792031|NCT00332839|75912427|FG000|Safety Set|Core (Months 0 - 12)||47||
59792032|NCT00332839|75912428|FG001|Safety Set|Core (Months 0 - 12)||46||
59792033|NCT00332839|75912427|FG000|COMPLETED|Core (Months 0 - 12)||37||
59792034|NCT00332839|75912428|FG001|COMPLETED|Core (Months 0 - 12)||28||
59792035|NCT00332839|75912427|FG000|NOT COMPLETED|Core (Months 0 - 12)||10||
59953824|NCT01368081|76072180|FG001|COMPLETED|Overall Study||128||
59953825|NCT01368081|76072181|FG002|COMPLETED|Overall Study||59||
59953826|NCT01368081|76072182|FG003|COMPLETED|Overall Study||63||
59953827|NCT01368081|76072183|FG004|COMPLETED|Overall Study||63||
59792036|NCT00332839|75912428|FG001|NOT COMPLETED|Core (Months 0 - 12)||18||
59792037|NCT00332839|75912427|FG000|STARTED|Follow-up (Months 12 - 60)|Follow-up included core participants (completed or discontinued) who wished to be followed.|33||
59792038|NCT00332839|75912428|FG001|STARTED|Follow-up (Months 12 - 60)|Follow-up included core participants (completed or discontinued) who wished to be followed.|34||
59792039|NCT00332839|75912427|FG000|COMPLETED|Follow-up (Months 12 - 60)||29||
59792040|NCT00332839|75912428|FG001|COMPLETED|Follow-up (Months 12 - 60)||31||
59792041|NCT00332839|75912427|FG000|NOT COMPLETED|Follow-up (Months 12 - 60)||4||
59792042|NCT00332839|75912428|FG001|NOT COMPLETED|Follow-up (Months 12 - 60)||3||
59792043|NCT00357097|75912436|FG000|STARTED|Overall Study|199 were randomized. Only 198 took investigational product.|199||
59792044|NCT00357097|75912437|FG001|STARTED|Overall Study||67||
59792045|NCT00357097|75912436|FG000|COMPLETED|Overall Study||145||
59792046|NCT00357097|75912437|FG001|COMPLETED|Overall Study||38||
59792047|NCT00357097|75912436|FG000|NOT COMPLETED|Overall Study||54||
59792048|NCT00357097|75912437|FG001|NOT COMPLETED|Overall Study||29||
59792049|NCT00356863|75912445|FG000|STARTED|Overall Study||504||
59792050|NCT00356863|75912446|FG001|STARTED|Overall Study||520||
59792051|NCT00356863|75912445|FG000|COMPLETED|Overall Study||412||
59792052|NCT00356863|75912446|FG001|COMPLETED|Overall Study||445||
59792053|NCT00356863|75912445|FG000|NOT COMPLETED|Overall Study||92||
59792054|NCT00356863|75912446|FG001|NOT COMPLETED|Overall Study||75||
59792055|NCT01053637|75912458|FG000|STARTED|Overall Study||43||
59792056|NCT01053637|75912459|FG001|STARTED|Overall Study||42||
59792057|NCT01053637|75912458|FG000|COMPLETED|Overall Study|2 with incomplete pain scores|43||
59792058|NCT01053637|75912459|FG001|COMPLETED|Overall Study|4 incomplete pain scores 4 proceeded to procedural sedation|42||
59792059|NCT01053637|75912458|FG000|NOT COMPLETED|Overall Study||0||
59792060|NCT01053637|75912459|FG001|NOT COMPLETED|Overall Study||0||
59792061|NCT00355615|75912469|FG000|STARTED|Randomized Double Blind Period||42||
59792062|NCT00355615|75912470|FG001|STARTED|Randomized Double Blind Period||44||
59792063|NCT00355615|75912471|FG002|STARTED|Randomized Double Blind Period||45||
59792064|NCT00355615|75912472|FG003|STARTED|Randomized Double Blind Period||46||
59792065|NCT00355615|75912473|FG004|STARTED|Randomized Double Blind Period|open label phase followed the randomized phase|0||
59792066|NCT00355615|75912469|FG000|COMPLETED|Randomized Double Blind Period|1 dropped out due to adverse event|41||
59792067|NCT00355615|75912470|FG001|COMPLETED|Randomized Double Blind Period||44||
59792068|NCT00355615|75912471|FG002|COMPLETED|Randomized Double Blind Period|45 were randomized but 1 never received drug|44||
59792069|NCT00355615|75912472|FG003|COMPLETED|Randomized Double Blind Period|1 dropped out due to an adverse event|45||
59792070|NCT00355615|75912473|FG004|COMPLETED|Randomized Double Blind Period||0||
59792071|NCT00355615|75912469|FG000|NOT COMPLETED|Randomized Double Blind Period||1||
59953828|NCT01368081|76072184|FG005|COMPLETED|Overall Study||127||
59953829|NCT01368081|76072185|FG006|COMPLETED|Overall Study||124||
60073528|NCT01689207|76188787|FG003|STARTED|Overall Study|Subjects randomised|8||
59792072|NCT00355615|75912470|FG001|NOT COMPLETED|Randomized Double Blind Period||0||
59792073|NCT00355615|75912471|FG002|NOT COMPLETED|Randomized Double Blind Period||1||
59792074|NCT00355615|75912472|FG003|NOT COMPLETED|Randomized Double Blind Period||1||
59792075|NCT00355615|75912473|FG004|NOT COMPLETED|Randomized Double Blind Period||0||
59792076|NCT00355615|75912469|FG000|STARTED|40-week Rosuvastatin Open Label Period||0||
59792077|NCT00355615|75912470|FG001|STARTED|40-week Rosuvastatin Open Label Period||0||
59792078|NCT00355615|75912471|FG002|STARTED|40-week Rosuvastatin Open Label Period||0||
59792079|NCT00355615|75912472|FG003|STARTED|40-week Rosuvastatin Open Label Period||0||
59792080|NCT00355615|75912473|FG004|STARTED|40-week Rosuvastatin Open Label Period||173||
59792081|NCT00355615|75912469|FG000|COMPLETED|40-week Rosuvastatin Open Label Period||0||
59792082|NCT00355615|75912470|FG001|COMPLETED|40-week Rosuvastatin Open Label Period||0||
59792083|NCT00355615|75912471|FG002|COMPLETED|40-week Rosuvastatin Open Label Period||0||
59792084|NCT00355615|75912472|FG003|COMPLETED|40-week Rosuvastatin Open Label Period||0||
59792085|NCT00355615|75912473|FG004|COMPLETED|40-week Rosuvastatin Open Label Period||164||
59792086|NCT00355615|75912469|FG000|NOT COMPLETED|40-week Rosuvastatin Open Label Period||0||
59792087|NCT00355615|75912470|FG001|NOT COMPLETED|40-week Rosuvastatin Open Label Period||0||
59792088|NCT00355615|75912471|FG002|NOT COMPLETED|40-week Rosuvastatin Open Label Period||0||
59792089|NCT00355615|75912472|FG003|NOT COMPLETED|40-week Rosuvastatin Open Label Period||0||
59792090|NCT00355615|75912473|FG004|NOT COMPLETED|40-week Rosuvastatin Open Label Period||9||
59792091|NCT00347269|75912486|FG000|STARTED|Overall Study||503||
59792092|NCT00347269|75912487|FG001|STARTED|Overall Study||501||
59792093|NCT00347269|75912486|FG000|COMPLETED|Overall Study||409||
59953830|NCT01368081|76072186|FG007|COMPLETED|Overall Study||62||
59953831|NCT01368081|76072187|FG008|COMPLETED|Overall Study||62||
59953832|NCT01368081|76072188|FG009|COMPLETED|Overall Study||58||
59953833|NCT01368081|76072189|FG010|COMPLETED|Overall Study||62||
59953834|NCT01368081|76072190|FG011|COMPLETED|Overall Study||67||
59953835|NCT01368081|76072191|FG012|COMPLETED|Overall Study||63||
59953836|NCT01368081|76072179|FG000|NOT COMPLETED|Overall Study||10||
60073529|NCT01689207|76188788|FG004|STARTED|Overall Study|Subjects randomised|4||
59953837|NCT01368081|76072180|FG001|NOT COMPLETED|Overall Study||9||
60073530|NCT01689207|76188789|FG005|STARTED|Overall Study|Subjects randomised|8||
60073531|NCT01689207|76188790|FG006|STARTED|Overall Study|Subjects randomised|10||
59792094|NCT00347269|75912487|FG001|COMPLETED|Overall Study||395||
59792095|NCT00347269|75912486|FG000|NOT COMPLETED|Overall Study||94||
59792096|NCT00347269|75912487|FG001|NOT COMPLETED|Overall Study||106||
59792097|NCT00544648|75912495|FG000|STARTED|Overall Study||11||
59792098|NCT00544648|75912496|FG001|STARTED|Overall Study||2||
59792099|NCT00544648|75912495|FG000|COMPLETED|Overall Study||8||
59792100|NCT00544648|75912496|FG001|COMPLETED|Overall Study||1||
59792101|NCT00544648|75912495|FG000|NOT COMPLETED|Overall Study||3||
59792102|NCT00544648|75912496|FG001|NOT COMPLETED|Overall Study||1||
59792103|NCT00346333|75912506|FG000|STARTED|Overall Study||121||
59792104|NCT00346333|75912507|FG001|STARTED|Overall Study||119||
59792105|NCT00346333|75912506|FG000|COMPLETED|Overall Study||116||
59792106|NCT00346333|75912507|FG001|COMPLETED|Overall Study||111||
59792107|NCT00346333|75912506|FG000|NOT COMPLETED|Overall Study||5||
59792108|NCT00346333|75912507|FG001|NOT COMPLETED|Overall Study||8||
59792109|NCT00330967|75912517|FG000|STARTED|Overall Study||0||
59792110|NCT00330967|75912518|FG001|STARTED|Overall Study||25||
59792111|NCT00330967|75912517|FG000|COMPLETED|Overall Study||0||
59792112|NCT00330967|75912518|FG001|COMPLETED|Overall Study||11||
59792113|NCT00330967|75912517|FG000|NOT COMPLETED|Overall Study||0||
59792114|NCT00330967|75912518|FG001|NOT COMPLETED|Overall Study||14||
59792115|NCT00330343|75912524|FG000|STARTED|Overall Study||64||
59792116|NCT00330343|75912524|FG000|COMPLETED|Overall Study||59||
59792117|NCT00330343|75912524|FG000|NOT COMPLETED|Overall Study||5||
59792118|NCT00330187|75912532|FG000|STARTED|Overall Study||37||
59792119|NCT00330187|75912533|FG001|STARTED|Overall Study||36||
59792120|NCT00330187|75912534|FG002|STARTED|Overall Study||29||
59792121|NCT00330187|75912535|FG003|STARTED|Overall Study||32||
59792122|NCT00330187|75912532|FG000|COMPLETED|Overall Study||17||
59792123|NCT00330187|75912533|FG001|COMPLETED|Overall Study||18||
59792124|NCT00330187|75912534|FG002|COMPLETED|Overall Study||11||
59792125|NCT00330187|75912535|FG003|COMPLETED|Overall Study||18||
59792126|NCT00330187|75912532|FG000|NOT COMPLETED|Overall Study||20||
59792127|NCT00330187|75912533|FG001|NOT COMPLETED|Overall Study||18||
59792128|NCT00330187|75912534|FG002|NOT COMPLETED|Overall Study||18||
59792129|NCT00330187|75912535|FG003|NOT COMPLETED|Overall Study||14||
59792130|NCT03914950|75912545|FG000|STARTED|Overall Study||174||
59792131|NCT03914950|75912545|FG000|COMPLETED|Overall Study||120||
59792132|NCT03914950|75912545|FG000|NOT COMPLETED|Overall Study||54||
59792133|NCT00329797|75912557|FG000|STARTED|Overall Study||57||
59792134|NCT00329797|75912558|FG001|STARTED|Overall Study||52||
59792135|NCT00329797|75912557|FG000|COMPLETED|Overall Study||50||
59792136|NCT00329797|75912558|FG001|COMPLETED|Overall Study||46||
59792137|NCT00329797|75912557|FG000|NOT COMPLETED|Overall Study||7||
59792138|NCT00329797|75912558|FG001|NOT COMPLETED|Overall Study||6||
59792139|NCT00541450|75912566|FG000|STARTED|Phase A||244||
59792140|NCT00541450|75912567|FG001|STARTED|Phase A||248||
59792141|NCT00541450|75912566|FG000|COMPLETED|Phase A||224||
59792142|NCT00541450|75912567|FG001|COMPLETED|Phase A||231||
59792143|NCT00541450|75912566|FG000|NOT COMPLETED|Phase A||20||
59792144|NCT00541450|75912567|FG001|NOT COMPLETED|Phase A||17||
59792145|NCT00541450|75912566|FG000|STARTED|Phase B||224||
59792146|NCT00541450|75912567|FG001|STARTED|Phase B||231||
59792147|NCT00541450|75912566|FG000|COMPLETED|Phase B||187||
59792148|NCT00541450|75912567|FG001|COMPLETED|Phase B||200||
59792149|NCT00541450|75912566|FG000|NOT COMPLETED|Phase B||37||
59792150|NCT00541450|75912567|FG001|NOT COMPLETED|Phase B||31||
59792151|NCT00355147|75912579|FG000|STARTED|Overall Study||87||
59792152|NCT00355147|75912580|FG001|STARTED|Overall Study||87||
59792153|NCT00355147|75912579|FG000|COMPLETED|Overall Study||69||
59953838|NCT01368081|76072181|FG002|NOT COMPLETED|Overall Study||4||
59953839|NCT01368081|76072182|FG003|NOT COMPLETED|Overall Study||5||
59953840|NCT01368081|76072183|FG004|NOT COMPLETED|Overall Study||2||
59792154|NCT00355147|75912580|FG001|COMPLETED|Overall Study||67||
59792155|NCT00355147|75912579|FG000|NOT COMPLETED|Overall Study||18||
59792156|NCT00355147|75912580|FG001|NOT COMPLETED|Overall Study||20||
59792157|NCT00540124|75912593|FG000|STARTED|Overall Study||51||
59792158|NCT00540124|75912594|FG001|STARTED|Overall Study||51||
59792159|NCT00540124|75912595|FG002|STARTED|Overall Study||49||
59792160|NCT00540124|75912593|FG000|COMPLETED|Overall Study||47||
59792161|NCT00540124|75912594|FG001|COMPLETED|Overall Study||48||
59792162|NCT00540124|75912595|FG002|COMPLETED|Overall Study||48||
59792163|NCT00540124|75912593|FG000|NOT COMPLETED|Overall Study||4||
59792164|NCT00540124|75912594|FG001|NOT COMPLETED|Overall Study||3||
59792165|NCT00540124|75912595|FG002|NOT COMPLETED|Overall Study||1||
59792166|NCT00540046|75912605|FG000|STARTED|Overall Study||104||
59792167|NCT00540046|75912606|FG001|STARTED|Overall Study||111||
59792168|NCT00540046|75912605|FG000|COMPLETED|Overall Study||71||
59792169|NCT00540046|75912606|FG001|COMPLETED|Overall Study||88||
59792170|NCT00540046|75912605|FG000|NOT COMPLETED|Overall Study||33||
59792171|NCT00540046|75912606|FG001|NOT COMPLETED|Overall Study||23||
59792172|NCT00689936|75912617|FG000|STARTED|Active Treatment Phase||535||
59792173|NCT00689936|75912618|FG001|STARTED|Active Treatment Phase||541||
59792174|NCT00689936|75912619|FG002|STARTED|Active Treatment Phase||547||
59792175|NCT00689936|75912617|FG000|Safety Population|Active Treatment Phase|Safety population = all randomized participants who received at least 1 dose of study treatment.|532||
59792176|NCT00689936|75912618|FG001|Safety Population|Active Treatment Phase|Safety population = all randomized participants who received at least 1 dose of study treatment.|540||
59792177|NCT00689936|75912619|FG002|Safety Population|Active Treatment Phase|Safety population = all randomized participants who received at least 1 dose of study treatment.|541||
59792178|NCT00689936|75912617|FG000|Untreated|Active Treatment Phase|Participants randomized, but did not receive any study drug treatment.|3||
59792179|NCT00689936|75912618|FG001|Untreated|Active Treatment Phase|Participants randomized, but did not receive any study drug treatment.|1||
59792180|NCT00689936|75912619|FG002|Untreated|Active Treatment Phase|Participants randomized, but did not receive any study drug treatment.|6||
59792181|NCT00689936|75912617|FG000|COMPLETED|Active Treatment Phase||0||
59792182|NCT00689936|75912618|FG001|COMPLETED|Active Treatment Phase||0||
59792183|NCT00689936|75912619|FG002|COMPLETED|Active Treatment Phase||0||
59792184|NCT00689936|75912617|FG000|NOT COMPLETED|Active Treatment Phase||535||
59792185|NCT00689936|75912618|FG001|NOT COMPLETED|Active Treatment Phase||541||
59792186|NCT00689936|75912619|FG002|NOT COMPLETED|Active Treatment Phase||547||
59792187|NCT00689936|75912617|FG000|STARTED|Progression Free Survival-PFS-Follow-Up|Includes participants who discontinued treatment for reasons other than progressive disease.|87||
59792188|NCT00689936|75912618|FG001|STARTED|Progression Free Survival-PFS-Follow-Up|Includes participants who completed 18 cycles (Rd18) and did not experience progressive disease.|300||
59792189|NCT00689936|75912619|FG002|STARTED|Progression Free Survival-PFS-Follow-Up|Includes participants who completed 12 cycles MPT and did not experience progressive disease.|273||
59792190|NCT00689936|75912617|FG000|COMPLETED|Progression Free Survival-PFS-Follow-Up||87||
59792191|NCT00689936|75912618|FG001|COMPLETED|Progression Free Survival-PFS-Follow-Up||300||
59792192|NCT00689936|75912619|FG002|COMPLETED|Progression Free Survival-PFS-Follow-Up||273||
59792193|NCT00689936|75912617|FG000|NOT COMPLETED|Progression Free Survival-PFS-Follow-Up||0||
59792194|NCT00689936|75912618|FG001|NOT COMPLETED|Progression Free Survival-PFS-Follow-Up||0||
59792195|NCT00689936|75912619|FG002|NOT COMPLETED|Progression Free Survival-PFS-Follow-Up||0||
59792196|NCT00689936|75912617|FG000|STARTED|Long-Term Follow Up Phase|Includes participants from both the active treatment phase and from the PFS follow-up phase.|382||
59792197|NCT00689936|75912618|FG001|STARTED|Long-Term Follow Up Phase|Includes participants from both the active treatment phase and from the PFS follow-up phase.|463||
59953841|NCT01368081|76072184|FG005|NOT COMPLETED|Overall Study||10||
59620071|NCT02088216|75731252|FG001|NOT COMPLETED|Overall Study||10||
59620072|NCT01014936|75731261|FG000|STARTED|Overall Study||42||
59620073|NCT01014936|75731262|FG001|STARTED|Overall Study||45||
59620074|NCT01014936|75731263|FG002|STARTED|Overall Study||62||
59620075|NCT01014936|75731261|FG000|COMPLETED|Overall Study||42||
59620076|NCT01014936|75731262|FG001|COMPLETED|Overall Study||45||
59620077|NCT01014936|75731263|FG002|COMPLETED|Overall Study||62||
59620078|NCT01014936|75731261|FG000|NOT COMPLETED|Overall Study||0||
59620079|NCT01014936|75731262|FG001|NOT COMPLETED|Overall Study||0||
59620080|NCT01014936|75731263|FG002|NOT COMPLETED|Overall Study||0||
59620081|NCT01753830|75731331|FG000|STARTED|Overall Study||37||
59620082|NCT01753830|75731332|FG001|STARTED|Overall Study||38||
59620083|NCT01753830|75731331|FG000|COMPLETED|Overall Study||30||
59620084|NCT01753830|75731332|FG001|COMPLETED|Overall Study||35||
59620085|NCT01753830|75731331|FG000|NOT COMPLETED|Overall Study||7||
59620086|NCT01753830|75731332|FG001|NOT COMPLETED|Overall Study||3||
59620087|NCT00644280|75731340|FG000|STARTED|Overall Study||6||
59620088|NCT00644280|75731341|FG001|STARTED|Overall Study||5||
59620089|NCT00644280|75731340|FG000|COMPLETED|Overall Study||6||
59620090|NCT00644280|75731341|FG001|COMPLETED|Overall Study||5||
59620091|NCT00644280|75731340|FG000|NOT COMPLETED|Overall Study||0||
59620092|NCT00644280|75731341|FG001|NOT COMPLETED|Overall Study||0||
59620093|NCT04779606|75731349|FG000|STARTED|First Phase: Tolerability and Safety||16||
59620094|NCT04779606|75731350|FG001|STARTED|First Phase: Tolerability and Safety||4||
59620095|NCT04779606|75731349|FG000|COMPLETED|First Phase: Tolerability and Safety||16||
59620096|NCT04779606|75731350|FG001|COMPLETED|First Phase: Tolerability and Safety||4||
59620097|NCT04779606|75731349|FG000|NOT COMPLETED|First Phase: Tolerability and Safety||0||
59620098|NCT04779606|75731350|FG001|NOT COMPLETED|First Phase: Tolerability and Safety||0||
59620099|NCT04779606|75731349|FG000|STARTED|Second Phase: Efficacy||68||
59620100|NCT04779606|75731350|FG001|STARTED|Second Phase: Efficacy||17||
59620101|NCT04779606|75731349|FG000|COMPLETED|Second Phase: Efficacy||68||
59620102|NCT04779606|75731350|FG001|COMPLETED|Second Phase: Efficacy||17||
59620103|NCT04779606|75731349|FG000|NOT COMPLETED|Second Phase: Efficacy||0||
59620104|NCT04779606|75731350|FG001|NOT COMPLETED|Second Phase: Efficacy||0||
59620105|NCT02316678|75731358|FG000|STARTED|Overall Study||1879||
59620106|NCT02316678|75731359|FG001|STARTED|Overall Study||7694||
59620107|NCT02316678|75731358|FG000|COMPLETED|Overall Study||1879||
59620108|NCT02316678|75731359|FG001|COMPLETED|Overall Study||7694||
59620109|NCT02316678|75731358|FG000|NOT COMPLETED|Overall Study||0||
59620110|NCT02316678|75731359|FG001|NOT COMPLETED|Overall Study||0||
59620111|NCT02089464|75731367|FG000|STARTED|Overall Study||132||
59620112|NCT02089464|75731368|FG001|STARTED|Overall Study||67||
59620113|NCT02089464|75731367|FG000|COMPLETED|Overall Study||104||
59620114|NCT02089464|75731368|FG001|COMPLETED|Overall Study||51||
59620115|NCT02089464|75731367|FG000|NOT COMPLETED|Overall Study||28||
59620116|NCT02089464|75731368|FG001|NOT COMPLETED|Overall Study||16||
59620117|NCT02090088|75731374|FG000|STARTED|Overall Study||4||
59620118|NCT02090088|75731374|FG000|Gave Birth|Overall Study||4||
59792198|NCT00689936|75912619|FG002|STARTED|Long-Term Follow Up Phase|Includes participants from both the active treatment phase and from the PFS follow-up phase.|459||
59792199|NCT00689936|75912617|FG000|COMPLETED|Long-Term Follow Up Phase||255||
59792200|NCT00689936|75912618|FG001|COMPLETED|Long-Term Follow Up Phase||275||
59792201|NCT00689936|75912619|FG002|COMPLETED|Long-Term Follow Up Phase||315||
59792202|NCT00689936|75912617|FG000|NOT COMPLETED|Long-Term Follow Up Phase||127||
59792203|NCT00689936|75912618|FG001|NOT COMPLETED|Long-Term Follow Up Phase||188||
59792204|NCT00689936|75912619|FG002|NOT COMPLETED|Long-Term Follow Up Phase||144||
59792205|NCT00671034|75912630|FG000|STARTED|Overall Study||69||
59792206|NCT00671034|75912631|FG001|STARTED|Overall Study||42||
59792207|NCT00671034|75912632|FG002|STARTED|Overall Study||55||
59792208|NCT00671034|75912630|FG000|COMPLETED|Overall Study||30||
59792209|NCT00671034|75912631|FG001|COMPLETED|Overall Study||22||
59792210|NCT00671034|75912632|FG002|COMPLETED|Overall Study||31||
59792211|NCT00671034|75912630|FG000|NOT COMPLETED|Overall Study||39||
59792212|NCT00671034|75912631|FG001|NOT COMPLETED|Overall Study||20||
59792213|NCT00671034|75912632|FG002|NOT COMPLETED|Overall Study||24||
59792214|NCT02679508|75912643|FG000|STARTED|Healing Phase||139||
59792215|NCT02679508|75912644|FG001|STARTED|Healing Phase||69||
59792216|NCT02679508|75912643|FG000|COMPLETED|Healing Phase||137||
59792217|NCT02679508|75912644|FG001|COMPLETED|Healing Phase||68||
59792218|NCT02679508|75912643|FG000|NOT COMPLETED|Healing Phase||2||
59792219|NCT02679508|75912644|FG001|NOT COMPLETED|Healing Phase||1||
59792220|NCT02679508|75912643|FG000|STARTED|Maintenance Phase||137||
59792221|NCT02679508|75912644|FG001|STARTED|Maintenance Phase||68||
59792222|NCT02679508|75912643|FG000|COMPLETED|Maintenance Phase||105||
59792223|NCT02679508|75912644|FG001|COMPLETED|Maintenance Phase||53||
59792224|NCT02679508|75912643|FG000|NOT COMPLETED|Maintenance Phase||32||
59792225|NCT02679508|75912644|FG001|NOT COMPLETED|Maintenance Phase||15||
59792226|NCT04404478|75912652|FG000|STARTED|Overall Study||26||
59792227|NCT04404478|75912653|FG001|STARTED|Overall Study||26||
59792228|NCT04404478|75912652|FG000|COMPLETED|Overall Study||25||
59792229|NCT04404478|75912653|FG001|COMPLETED|Overall Study||23||
59792230|NCT04404478|75912652|FG000|NOT COMPLETED|Overall Study||1||
59792231|NCT04404478|75912653|FG001|NOT COMPLETED|Overall Study||3||
59792232|NCT00539734|75912661|FG000|STARTED|Overall Study||26||
59792233|NCT00539734|75912661|FG000|COMPLETED|Overall Study||25||
59792234|NCT00539734|75912661|FG000|NOT COMPLETED|Overall Study||1||
59792235|NCT03907072|75912668|FG000|STARTED|Overall Study||2||
59792236|NCT03907072|75912669|FG001|STARTED|Overall Study||2||
59792237|NCT03907072|75912670|FG002|STARTED|Overall Study||2||
59792238|NCT03907072|75912668|FG000|COMPLETED|Overall Study||0||
59792239|NCT03907072|75912669|FG001|COMPLETED|Overall Study||0||
59792240|NCT03907072|75912670|FG002|COMPLETED|Overall Study||0||
59792241|NCT03907072|75912668|FG000|NOT COMPLETED|Overall Study||2||
59792242|NCT03907072|75912669|FG001|NOT COMPLETED|Overall Study||2||
59792243|NCT03907072|75912670|FG002|NOT COMPLETED|Overall Study||2||
59792244|NCT04045912|75912680|FG000|STARTED|Overall Study||10||10
59792245|NCT04045912|75912681|FG001|STARTED|Overall Study||10||10
59792246|NCT04045912|75912680|FG000|COMPLETED|Overall Study||10||10
59792247|NCT04045912|75912681|FG001|COMPLETED|Overall Study||10||10
59792248|NCT04045912|75912680|FG000|NOT COMPLETED|Overall Study||0||0
59792249|NCT04045912|75912681|FG001|NOT COMPLETED|Overall Study||0||0
59792250|NCT01093976|75912687|FG000|STARTED|Overall Study||14||
59792251|NCT01093976|75912687|FG000|COMPLETED|Overall Study||14||
59792252|NCT01093976|75912687|FG000|NOT COMPLETED|Overall Study||0||
59792253|NCT00329719|75912695|FG000|STARTED|Overall Study||12||
59792254|NCT00329719|75912696|FG001|STARTED|Overall Study||49||
59953842|NCT01368081|76072185|FG006|NOT COMPLETED|Overall Study||12||
59953843|NCT01368081|76072186|FG007|NOT COMPLETED|Overall Study||7||
59953844|NCT01368081|76072187|FG008|NOT COMPLETED|Overall Study||8||
59953845|NCT01368081|76072188|FG009|NOT COMPLETED|Overall Study||10||
59792255|NCT00329719|75912697|FG002|STARTED|Overall Study||9||
59792256|NCT00329719|75912698|FG003|STARTED|Overall Study||45||
59792257|NCT00329719|75912695|FG000|COMPLETED|Overall Study||12||
59792258|NCT00329719|75912696|FG001|COMPLETED|Overall Study||49||
59792259|NCT00329719|75912697|FG002|COMPLETED|Overall Study||9||
59953846|NCT01368081|76072189|FG010|NOT COMPLETED|Overall Study||9||
59953847|NCT01368081|76072190|FG011|NOT COMPLETED|Overall Study||3||
59792260|NCT00329719|75912698|FG003|COMPLETED|Overall Study||44||
59792261|NCT00329719|75912695|FG000|NOT COMPLETED|Overall Study||0||
59953848|NCT01368081|76072191|FG012|NOT COMPLETED|Overall Study||7||
60073532|NCT01689207|76188791|FG007|STARTED|Overall Study|Subjects randomised|10||
60073533|NCT01689207|76188792|FG008|STARTED|Overall Study|Subjects randomised|6||
59792262|NCT00329719|75912696|FG001|NOT COMPLETED|Overall Study||0||
59792263|NCT00329719|75912697|FG002|NOT COMPLETED|Overall Study||0||
59792264|NCT00329719|75912698|FG003|NOT COMPLETED|Overall Study||1||
59792265|NCT00329641|75912708|FG000|STARTED|Overall Study||25||
59792266|NCT00329641|75912708|FG000|Eligible|Overall Study||25||
59792267|NCT00329641|75912708|FG000|Eligible and Received Treatment|Overall Study||24||
59792268|NCT00329641|75912708|FG000|COMPLETED|Overall Study||19||
59792269|NCT00329641|75912708|FG000|NOT COMPLETED|Overall Study||6||
59792270|NCT03366220|75912715|FG000|STARTED|Overall Study||4||
59792271|NCT03366220|75912716|FG001|STARTED|Overall Study||4||
59953849|NCT00303498|76072221|FG000|STARTED|Run-In-Phase (10 Weeks)||128||
59953850|NCT00303498|76072222|FG001|STARTED|Run-In-Phase (10 Weeks)||64||
59953851|NCT00303498|76072221|FG000|Treated|Run-In-Phase (10 Weeks)||127||
59792272|NCT03366220|75912715|FG000|COMPLETED|Overall Study||4||
59792273|NCT03366220|75912716|FG001|COMPLETED|Overall Study||4||
59792274|NCT03366220|75912715|FG000|NOT COMPLETED|Overall Study||0||
59792275|NCT03366220|75912716|FG001|NOT COMPLETED|Overall Study||0||
59792276|NCT00329407|75912722|FG000|STARTED|Overall Study||10||
59792277|NCT00329407|75912722|FG000|COMPLETED|Overall Study||9||
59792278|NCT00329407|75912722|FG000|NOT COMPLETED|Overall Study||1||
59792279|NCT00328783|75912726|FG000|STARTED|Overall Study||112||
59792280|NCT00328783|75912726|FG000|COMPLETED|Overall Study||86||
59792281|NCT00328783|75912726|FG000|NOT COMPLETED|Overall Study||26||
59792282|NCT00567489|75912734|FG000|STARTED|Overall Study||127||
59792283|NCT00567489|75912735|FG001|STARTED|Overall Study||124||
59792284|NCT00567489|75912734|FG000|COMPLETED|Overall Study||120||
59792285|NCT00567489|75912735|FG001|COMPLETED|Overall Study||101||
59792286|NCT00567489|75912734|FG000|NOT COMPLETED|Overall Study||7||
59792287|NCT00567489|75912735|FG001|NOT COMPLETED|Overall Study||23||
59792288|NCT00669942|75912753|FG000|STARTED|Part 1||6||
59792289|NCT00669942|75912754|FG001|STARTED|Part 1||6||
59792290|NCT00669942|75912755|FG002|STARTED|Part 1||6||
59792291|NCT00669942|75912756|FG003|STARTED|Part 1||6||
59792292|NCT00669942|75912757|FG004|STARTED|Part 1||8||
59792293|NCT00669942|75912758|FG005|STARTED|Part 1||0||
59792294|NCT00669942|75912759|FG006|STARTED|Part 1||0||
59792295|NCT00669942|75912760|FG007|STARTED|Part 1||0||
59792296|NCT00669942|75912761|FG008|STARTED|Part 1||0||
59792297|NCT00669942|75912762|FG009|STARTED|Part 1||0||
59792298|NCT00669942|75912763|FG010|STARTED|Part 1||0||
59792299|NCT00669942|75912764|FG011|STARTED|Part 1||0||
59792300|NCT00669942|75912753|FG000|COMPLETED|Part 1||6||
59792301|NCT00669942|75912754|FG001|COMPLETED|Part 1||6||
59792302|NCT00669942|75912755|FG002|COMPLETED|Part 1||6||
59792303|NCT00669942|75912756|FG003|COMPLETED|Part 1||6||
59792304|NCT00669942|75912757|FG004|COMPLETED|Part 1||8||
59953852|NCT00303498|76072222|FG001|Treated|Run-In-Phase (10 Weeks)||64||
59953853|NCT00303498|76072221|FG000|COMPLETED|Run-In-Phase (10 Weeks)||104||
59953854|NCT00303498|76072222|FG001|COMPLETED|Run-In-Phase (10 Weeks)||56||
59953855|NCT00303498|76072221|FG000|NOT COMPLETED|Run-In-Phase (10 Weeks)||24||
59953856|NCT00303498|76072222|FG001|NOT COMPLETED|Run-In-Phase (10 Weeks)||8||
59953857|NCT00303498|76072221|FG000|STARTED|Maintenance Phase (24 Weeks)||104||
59792305|NCT00669942|75912758|FG005|COMPLETED|Part 1||0||
59792306|NCT00669942|75912759|FG006|COMPLETED|Part 1||0||
59792307|NCT00669942|75912760|FG007|COMPLETED|Part 1||0||
59792308|NCT00669942|75912761|FG008|COMPLETED|Part 1||0||
59792309|NCT00669942|75912762|FG009|COMPLETED|Part 1||0||
59792310|NCT00669942|75912763|FG010|COMPLETED|Part 1||0||
59792311|NCT00669942|75912764|FG011|COMPLETED|Part 1||0||
59792312|NCT00669942|75912753|FG000|NOT COMPLETED|Part 1||0||
59792313|NCT00669942|75912754|FG001|NOT COMPLETED|Part 1||0||
59792314|NCT00669942|75912755|FG002|NOT COMPLETED|Part 1||0||
59792315|NCT00669942|75912756|FG003|NOT COMPLETED|Part 1||0||
59792316|NCT00669942|75912757|FG004|NOT COMPLETED|Part 1||0||
59792317|NCT00669942|75912758|FG005|NOT COMPLETED|Part 1||0||
59792318|NCT00669942|75912759|FG006|NOT COMPLETED|Part 1||0||
59792319|NCT00669942|75912760|FG007|NOT COMPLETED|Part 1||0||
59792320|NCT00669942|75912761|FG008|NOT COMPLETED|Part 1||0||
59792321|NCT00669942|75912762|FG009|NOT COMPLETED|Part 1||0||
59792322|NCT00669942|75912763|FG010|NOT COMPLETED|Part 1||0||
59792323|NCT00669942|75912764|FG011|NOT COMPLETED|Part 1||0||
59953858|NCT00303498|76072222|FG001|STARTED|Maintenance Phase (24 Weeks)||56||
59953859|NCT00303498|76072221|FG000|COMPLETED|Maintenance Phase (24 Weeks)||90||
59953860|NCT00303498|76072222|FG001|COMPLETED|Maintenance Phase (24 Weeks)||48||
59953861|NCT00303498|76072221|FG000|NOT COMPLETED|Maintenance Phase (24 Weeks)||14||
59953862|NCT00303498|76072222|FG001|NOT COMPLETED|Maintenance Phase (24 Weeks)||8||
59953863|NCT02588092|76072238|FG000|STARTED|Overall Study||4||
59792324|NCT00669942|75912753|FG000|STARTED|Parts 2 and 3||0||
59792325|NCT00669942|75912754|FG001|STARTED|Parts 2 and 3||0||
59792326|NCT00669942|75912755|FG002|STARTED|Parts 2 and 3||0||
59792327|NCT00669942|75912756|FG003|STARTED|Parts 2 and 3||0||
59792328|NCT00669942|75912757|FG004|STARTED|Parts 2 and 3||0||
59792329|NCT00669942|75912758|FG005|STARTED|Parts 2 and 3||6||
59792330|NCT00669942|75912759|FG006|STARTED|Parts 2 and 3||6||
59792331|NCT00669942|75912760|FG007|STARTED|Parts 2 and 3||26||
59792332|NCT00669942|75912761|FG008|STARTED|Parts 2 and 3||26||
59792333|NCT00669942|75912762|FG009|STARTED|Parts 2 and 3||0||
59792334|NCT00669942|75912763|FG010|STARTED|Parts 2 and 3||0||
59792335|NCT00669942|75912764|FG011|STARTED|Parts 2 and 3||0||
59792336|NCT00669942|75912753|FG000|COMPLETED|Parts 2 and 3||0||
59792337|NCT00669942|75912754|FG001|COMPLETED|Parts 2 and 3||0||
59792338|NCT00669942|75912755|FG002|COMPLETED|Parts 2 and 3||0||
59792339|NCT00669942|75912756|FG003|COMPLETED|Parts 2 and 3||0||
59792340|NCT00669942|75912757|FG004|COMPLETED|Parts 2 and 3||0||
59792341|NCT00669942|75912758|FG005|COMPLETED|Parts 2 and 3||4||
59792342|NCT00669942|75912759|FG006|COMPLETED|Parts 2 and 3||6||
59792343|NCT00669942|75912760|FG007|COMPLETED|Parts 2 and 3||24||
59792344|NCT00669942|75912761|FG008|COMPLETED|Parts 2 and 3||23||
59792345|NCT00669942|75912762|FG009|COMPLETED|Parts 2 and 3||0||
59792346|NCT00669942|75912763|FG010|COMPLETED|Parts 2 and 3||0||
59792347|NCT00669942|75912764|FG011|COMPLETED|Parts 2 and 3||0||
59792348|NCT00669942|75912753|FG000|NOT COMPLETED|Parts 2 and 3||0||
59792349|NCT00669942|75912754|FG001|NOT COMPLETED|Parts 2 and 3||0||
59792350|NCT00669942|75912755|FG002|NOT COMPLETED|Parts 2 and 3||0||
59792351|NCT00669942|75912756|FG003|NOT COMPLETED|Parts 2 and 3||0||
59792352|NCT00669942|75912757|FG004|NOT COMPLETED|Parts 2 and 3||0||
59792353|NCT00669942|75912758|FG005|NOT COMPLETED|Parts 2 and 3||2||
59792354|NCT00669942|75912759|FG006|NOT COMPLETED|Parts 2 and 3||0||
59792355|NCT00669942|75912760|FG007|NOT COMPLETED|Parts 2 and 3||2||
59792356|NCT00669942|75912761|FG008|NOT COMPLETED|Parts 2 and 3||3||
59792357|NCT00669942|75912762|FG009|NOT COMPLETED|Parts 2 and 3||0||
59792358|NCT00669942|75912763|FG010|NOT COMPLETED|Parts 2 and 3||0||
59792359|NCT00669942|75912764|FG011|NOT COMPLETED|Parts 2 and 3||0||
59792360|NCT00669942|75912753|FG000|STARTED|Healthy Volunteers||0||
59792361|NCT00669942|75912754|FG001|STARTED|Healthy Volunteers||0||
59792362|NCT00669942|75912755|FG002|STARTED|Healthy Volunteers||0||
59792363|NCT00669942|75912756|FG003|STARTED|Healthy Volunteers||0||
59792364|NCT00669942|75912757|FG004|STARTED|Healthy Volunteers||0||
59792365|NCT00669942|75912758|FG005|STARTED|Healthy Volunteers||0||
59792366|NCT00669942|75912759|FG006|STARTED|Healthy Volunteers||0||
59792367|NCT00669942|75912760|FG007|STARTED|Healthy Volunteers||0||
59792368|NCT00669942|75912761|FG008|STARTED|Healthy Volunteers||0||
59792369|NCT00669942|75912762|FG009|STARTED|Healthy Volunteers||3||
59792370|NCT00669942|75912763|FG010|STARTED|Healthy Volunteers||3||
59792371|NCT00669942|75912764|FG011|STARTED|Healthy Volunteers||2||
59792372|NCT00669942|75912753|FG000|COMPLETED|Healthy Volunteers||0||
59792373|NCT00669942|75912754|FG001|COMPLETED|Healthy Volunteers||0||
59792374|NCT00669942|75912755|FG002|COMPLETED|Healthy Volunteers||0||
59792375|NCT00669942|75912756|FG003|COMPLETED|Healthy Volunteers||0||
59792376|NCT00669942|75912757|FG004|COMPLETED|Healthy Volunteers||0||
59792377|NCT00669942|75912758|FG005|COMPLETED|Healthy Volunteers||0||
59792378|NCT00669942|75912759|FG006|COMPLETED|Healthy Volunteers||0||
59792379|NCT00669942|75912760|FG007|COMPLETED|Healthy Volunteers||0||
59792380|NCT00669942|75912761|FG008|COMPLETED|Healthy Volunteers||0||
59792381|NCT00669942|75912762|FG009|COMPLETED|Healthy Volunteers||3||
59792382|NCT00669942|75912763|FG010|COMPLETED|Healthy Volunteers||2||
59792383|NCT00669942|75912764|FG011|COMPLETED|Healthy Volunteers||2||
59792384|NCT00669942|75912753|FG000|NOT COMPLETED|Healthy Volunteers||0||
59792385|NCT00669942|75912754|FG001|NOT COMPLETED|Healthy Volunteers||0||
59792386|NCT00669942|75912755|FG002|NOT COMPLETED|Healthy Volunteers||0||
59792387|NCT00669942|75912756|FG003|NOT COMPLETED|Healthy Volunteers||0||
59792388|NCT00669942|75912757|FG004|NOT COMPLETED|Healthy Volunteers||0||
59792389|NCT00669942|75912758|FG005|NOT COMPLETED|Healthy Volunteers||0||
59792390|NCT00669942|75912759|FG006|NOT COMPLETED|Healthy Volunteers||0||
59792391|NCT00669942|75912760|FG007|NOT COMPLETED|Healthy Volunteers||0||
59792392|NCT00669942|75912761|FG008|NOT COMPLETED|Healthy Volunteers||0||
59792393|NCT00669942|75912762|FG009|NOT COMPLETED|Healthy Volunteers||0||
59792394|NCT00669942|75912763|FG010|NOT COMPLETED|Healthy Volunteers||1||
59792395|NCT00669942|75912764|FG011|NOT COMPLETED|Healthy Volunteers||0||
59792396|NCT00669864|75912787|FG000|STARTED|Overall Study||293||
59792397|NCT00669864|75912787|FG000|COMPLETED|Overall Study||284||
59792398|NCT00669864|75912787|FG000|NOT COMPLETED|Overall Study||9||
59792399|NCT00668148|75912791|FG000|STARTED|Overall Study||113||
59792400|NCT00668148|75912791|FG000|Received at Least 1 Dose of Study Drug|Overall Study||111||
59792401|NCT00668148|75912791|FG000|COMPLETED|Overall Study||103||
59792402|NCT00668148|75912791|FG000|NOT COMPLETED|Overall Study||10||
59792403|NCT00667992|75912808|FG000|STARTED|First Intervention 100 Mcg Twice Daily||49||
59792404|NCT00667992|75912809|FG001|STARTED|First Intervention 100 Mcg Twice Daily||50||
59792405|NCT00667992|75912808|FG000|COMPLETED|First Intervention 100 Mcg Twice Daily||44||
59792406|NCT00667992|75912809|FG001|COMPLETED|First Intervention 100 Mcg Twice Daily||45||
59792407|NCT00667992|75912808|FG000|NOT COMPLETED|First Intervention 100 Mcg Twice Daily||5||
59792408|NCT00667992|75912809|FG001|NOT COMPLETED|First Intervention 100 Mcg Twice Daily||5||
59792409|NCT00667992|75912808|FG000|STARTED|Second Intervention 400 Mcg Twice Daily||44||
59792410|NCT00667992|75912809|FG001|STARTED|Second Intervention 400 Mcg Twice Daily||45||
59792411|NCT00667992|75912808|FG000|COMPLETED|Second Intervention 400 Mcg Twice Daily||41||
59792412|NCT00667992|75912809|FG001|COMPLETED|Second Intervention 400 Mcg Twice Daily||41||
59792413|NCT00667992|75912808|FG000|NOT COMPLETED|Second Intervention 400 Mcg Twice Daily||3||
59792414|NCT00667992|75912809|FG001|NOT COMPLETED|Second Intervention 400 Mcg Twice Daily||4||
59792415|NCT00667992|75912808|FG000|STARTED|Wash-out||41||
59792416|NCT00667992|75912809|FG001|STARTED|Wash-out||41||
59792417|NCT00667992|75912808|FG000|COMPLETED|Wash-out||34||
59792418|NCT00667992|75912809|FG001|COMPLETED|Wash-out||36||
59792419|NCT00667992|75912808|FG000|NOT COMPLETED|Wash-out||7||
59792420|NCT00667992|75912809|FG001|NOT COMPLETED|Wash-out||5||
59792421|NCT00667992|75912808|FG000|STARTED|Third Intervention 100 Mcg Twice Daily||34||
59792422|NCT00667992|75912809|FG001|STARTED|Third Intervention 100 Mcg Twice Daily||36||
59792423|NCT00667992|75912808|FG000|COMPLETED|Third Intervention 100 Mcg Twice Daily||33||
59792424|NCT00667992|75912809|FG001|COMPLETED|Third Intervention 100 Mcg Twice Daily||35||
59792425|NCT00667992|75912808|FG000|NOT COMPLETED|Third Intervention 100 Mcg Twice Daily||1||
59792426|NCT00667992|75912809|FG001|NOT COMPLETED|Third Intervention 100 Mcg Twice Daily||1||
59792427|NCT00667992|75912808|FG000|STARTED|Forth Intervention 400 Mcg Twice Daily||33||
59792428|NCT00667992|75912809|FG001|STARTED|Forth Intervention 400 Mcg Twice Daily||35||
59792429|NCT00667992|75912808|FG000|COMPLETED|Forth Intervention 400 Mcg Twice Daily||33||
59792430|NCT00667992|75912809|FG001|COMPLETED|Forth Intervention 400 Mcg Twice Daily||35||
59792431|NCT00667992|75912808|FG000|NOT COMPLETED|Forth Intervention 400 Mcg Twice Daily||0||
59792432|NCT00667992|75912809|FG001|NOT COMPLETED|Forth Intervention 400 Mcg Twice Daily||0||
59792433|NCT00669396|75912827|FG000|STARTED|Overall Study||23||
59792434|NCT00669396|75912828|FG001|STARTED|Overall Study||34||
59792435|NCT00669396|75912827|FG000|COMPLETED|Overall Study||13||
59792436|NCT00669396|75912828|FG001|COMPLETED|Overall Study||22||
59792437|NCT00669396|75912827|FG000|NOT COMPLETED|Overall Study||10||
59792438|NCT00669396|75912828|FG001|NOT COMPLETED|Overall Study||12||
59792439|NCT00669318|75912834|FG000|STARTED|Overall Study||41||
59792440|NCT00669318|75912834|FG000|COMPLETED|Overall Study||39||
59792441|NCT00669318|75912834|FG000|NOT COMPLETED|Overall Study||2||
59792442|NCT00669240|75912838|FG000|STARTED|Overall Study||567||
59792443|NCT00669240|75912838|FG000|Assigned to Treatment|Overall Study||566||
59792444|NCT00669240|75912838|FG000|Received Treatment|Overall Study||551||
59792445|NCT00669240|75912838|FG000|COMPLETED|Overall Study||402||
59792446|NCT00669240|75912838|FG000|NOT COMPLETED|Overall Study||165||
59792447|NCT00669162|75912842|FG000|STARTED|Overall Study||27||
59792448|NCT00669162|75912842|FG000|COMPLETED|Overall Study||26||
59792449|NCT00669162|75912842|FG000|NOT COMPLETED|Overall Study||1||
59792450|NCT00354770|75912848|FG000|STARTED|Overall Study||25||
59792451|NCT00354770|75912849|FG001|STARTED|Overall Study||25||
59792452|NCT00354770|75912848|FG000|COMPLETED|Overall Study||22||
59792453|NCT00354770|75912849|FG001|COMPLETED|Overall Study||22||
59792454|NCT00354770|75912848|FG000|NOT COMPLETED|Overall Study||3||
59792455|NCT00354770|75912849|FG001|NOT COMPLETED|Overall Study||3||
59792456|NCT00666588|75912859|FG000|STARTED|Overall Study||18||
59792457|NCT00666588|75912860|FG001|STARTED|Overall Study||6||
59792458|NCT00666588|75912861|FG002|STARTED|Overall Study||6||
59792459|NCT00666588|75912862|FG003|STARTED|Overall Study||22||
59792460|NCT00666588|75912859|FG000|COMPLETED|Overall Study||14||
59792461|NCT00666588|75912860|FG001|COMPLETED|Overall Study||6||
59792462|NCT00666588|75912861|FG002|COMPLETED|Overall Study||6||
59792463|NCT00666588|75912862|FG003|COMPLETED|Overall Study||20||
59792464|NCT00666588|75912859|FG000|NOT COMPLETED|Overall Study||4||
59792465|NCT00666588|75912860|FG001|NOT COMPLETED|Overall Study||0||
59792466|NCT00666588|75912861|FG002|NOT COMPLETED|Overall Study||0||
59792467|NCT00666588|75912862|FG003|NOT COMPLETED|Overall Study||2||
59792468|NCT00689390|75912874|FG000|STARTED|Overall Study||1907||
59792469|NCT00689390|75912875|FG001|STARTED|Overall Study||47||
59792470|NCT00689390|75912874|FG000|COMPLETED|Overall Study||1481||
59792471|NCT00689390|75912875|FG001|COMPLETED|Overall Study||37||
59792472|NCT00689390|75912874|FG000|NOT COMPLETED|Overall Study||426||
59792473|NCT00689390|75912875|FG001|NOT COMPLETED|Overall Study||10||
59792474|NCT00567879|75912892|FG000|STARTED|Overall Study||7||
59792475|NCT00567879|75912893|FG001|STARTED|Overall Study||7||
59792476|NCT00567879|75912894|FG002|STARTED|Overall Study|7 participants belonged to the dose expansion group at 20mg/m2 i.v.|21||
59792477|NCT00567879|75912895|FG003|STARTED|Overall Study||6||
59792478|NCT00567879|75912896|FG004|STARTED|Overall Study||12||
59792479|NCT00567879|75912897|FG005|STARTED|Overall Study||3||
59792480|NCT00567879|75912892|FG000|Maximum Tolerated Dose Determining Set|Overall Study||5||
59792481|NCT00567879|75912893|FG001|Maximum Tolerated Dose Determining Set|Overall Study||7||
59792482|NCT00567879|75912894|FG002|Maximum Tolerated Dose Determining Set|Overall Study|6 participants belonged to the dose expansion group at 20mg/m2 i.v.|18||
59792483|NCT00567879|75912895|FG003|Maximum Tolerated Dose Determining Set|Overall Study||6||
59792484|NCT00567879|75912896|FG004|Maximum Tolerated Dose Determining Set|Overall Study||12||
59953864|NCT02588092|76072239|FG001|STARTED|Overall Study||3||
59792485|NCT00567879|75912897|FG005|Maximum Tolerated Dose Determining Set|Overall Study||3||
59792486|NCT00567879|75912892|FG000|COMPLETED|Overall Study||0||
59792487|NCT00567879|75912893|FG001|COMPLETED|Overall Study||0||
59792488|NCT00567879|75912894|FG002|COMPLETED|Overall Study||0||
59792489|NCT00567879|75912895|FG003|COMPLETED|Overall Study||0||
59792490|NCT00567879|75912896|FG004|COMPLETED|Overall Study||0||
59792491|NCT00567879|75912897|FG005|COMPLETED|Overall Study||0||
59792492|NCT00567879|75912892|FG000|NOT COMPLETED|Overall Study||7||
59792493|NCT00567879|75912893|FG001|NOT COMPLETED|Overall Study||7||
59792494|NCT00567879|75912894|FG002|NOT COMPLETED|Overall Study||21||
59792495|NCT00567879|75912895|FG003|NOT COMPLETED|Overall Study||6||
59792496|NCT00567879|75912896|FG004|NOT COMPLETED|Overall Study||12||
59792497|NCT00567879|75912897|FG005|NOT COMPLETED|Overall Study||3||
59792498|NCT00603915|75912915|FG000|STARTED|Overall Study||20||
59792499|NCT00603915|75912915|FG000|COMPLETED|Overall Study||19||
59792500|NCT00603915|75912915|FG000|NOT COMPLETED|Overall Study||1||
59792501|NCT00603837|75912921|FG000|STARTED|Overall Study||20||
59792502|NCT00603837|75912922|FG001|STARTED|Overall Study||19||
59792503|NCT00603837|75912921|FG000|COMPLETED|Overall Study||17||
59792504|NCT00603837|75912922|FG001|COMPLETED|Overall Study||19||
59792505|NCT00603837|75912921|FG000|NOT COMPLETED|Overall Study||3||
59792506|NCT00603837|75912922|FG001|NOT COMPLETED|Overall Study||0||
59792507|NCT00667602|75912931|FG000|STARTED|Overall Study||219||
59792508|NCT00667602|75912932|FG001|STARTED|Overall Study||228||
59792509|NCT00667602|75912933|FG002|STARTED|Overall Study||215||
59792510|NCT00667602|75912931|FG000|COMPLETED|Overall Study||211||
59792511|NCT00667602|75912932|FG001|COMPLETED|Overall Study||213||
59792512|NCT00667602|75912933|FG002|COMPLETED|Overall Study||197||
59792513|NCT00667602|75912931|FG000|NOT COMPLETED|Overall Study||8||
59792514|NCT00667602|75912932|FG001|NOT COMPLETED|Overall Study||15||
59792515|NCT00667602|75912933|FG002|NOT COMPLETED|Overall Study||18||
59792516|NCT00691028|75912949|FG000|STARTED|Open-label Period||0||
59620119|NCT02090088|75731374|FG000|COMPLETED|Overall Study||4||
59620120|NCT02090088|75731374|FG000|NOT COMPLETED|Overall Study||0||
59620121|NCT01565382|75731379|FG000|STARTED|Overall Study||40||
59620122|NCT01565382|75731379|FG000|COMPLETED|Overall Study||40||
59620123|NCT01565382|75731379|FG000|NOT COMPLETED|Overall Study||0||
59620124|NCT02744430|75731386|FG000|STARTED|Overall Study||17||
59792517|NCT00691028|75912950|FG001|STARTED|Open-label Period||0||
59792518|NCT00691028|75912951|FG002|STARTED|Open-label Period||0||
59792519|NCT00691028|75912952|FG003|STARTED|Open-label Period||327||
59792520|NCT00691028|75912949|FG000|COMPLETED|Open-label Period||0||
59792521|NCT00691028|75912950|FG001|COMPLETED|Open-label Period||0||
59792522|NCT00691028|75912951|FG002|COMPLETED|Open-label Period||0||
59792523|NCT00691028|75912952|FG003|COMPLETED|Open-label Period||307||
59792524|NCT00691028|75912949|FG000|NOT COMPLETED|Open-label Period||0||
59792525|NCT00691028|75912950|FG001|NOT COMPLETED|Open-label Period||0||
59792526|NCT00691028|75912951|FG002|NOT COMPLETED|Open-label Period||0||
59792527|NCT00691028|75912952|FG003|NOT COMPLETED|Open-label Period||20||
59792528|NCT00691028|75912949|FG000|STARTED|Double-blind Period||99||
59792529|NCT00691028|75912950|FG001|STARTED|Double-blind Period||104||
59792530|NCT00691028|75912951|FG002|STARTED|Double-blind Period||104||
59792531|NCT00691028|75912952|FG003|STARTED|Double-blind Period||0||
59792532|NCT00691028|75912949|FG000|COMPLETED|Double-blind Period||86||
59792533|NCT00691028|75912950|FG001|COMPLETED|Double-blind Period||91||
59792534|NCT00691028|75912951|FG002|COMPLETED|Double-blind Period||95||
59792535|NCT00691028|75912952|FG003|COMPLETED|Double-blind Period||0||
59792536|NCT00691028|75912949|FG000|NOT COMPLETED|Double-blind Period||13||
59792537|NCT00691028|75912950|FG001|NOT COMPLETED|Double-blind Period||13||
59792538|NCT00691028|75912951|FG002|NOT COMPLETED|Double-blind Period||9||
59792539|NCT00691028|75912952|FG003|NOT COMPLETED|Double-blind Period||0||
59792540|NCT00690794|75912966|FG000|STARTED|Overall Study||363||
59792541|NCT00690794|75912967|FG001|STARTED|Overall Study||363||
59792542|NCT00690794|75912966|FG000|COMPLETED|Overall Study||342||
59792543|NCT00690794|75912967|FG001|COMPLETED|Overall Study||328||
59792544|NCT00690794|75912966|FG000|NOT COMPLETED|Overall Study||21||
59792545|NCT00690794|75912967|FG001|NOT COMPLETED|Overall Study||35||
59792546|NCT00666276|75912973|FG000|STARTED|Overall Study||1004||
59792547|NCT00666276|75912973|FG000|COMPLETED|Overall Study||970||
59792548|NCT00666276|75912973|FG000|NOT COMPLETED|Overall Study||34||
59792549|NCT00567255|75912998|FG000|STARTED|Overall Study||1001||
59792550|NCT00567255|75912999|FG001|STARTED|Overall Study||495||
59792551|NCT00567255|75912998|FG000|COMPLETED|Overall Study||538||
59792552|NCT00567255|75912999|FG001|COMPLETED|Overall Study||267||
59792553|NCT00567255|75912998|FG000|NOT COMPLETED|Overall Study||463||
59620125|NCT02744430|75731387|FG001|STARTED|Overall Study||16||
59620126|NCT02744430|75731386|FG000|COMPLETED|Overall Study||17||
59620127|NCT02744430|75731387|FG001|COMPLETED|Overall Study||16||
59792554|NCT00567255|75912999|FG001|NOT COMPLETED|Overall Study||228||
59792555|NCT00667446|75913007|FG000|STARTED|Treatment Period (36 Months)||34||
59792556|NCT00667446|75913008|FG001|STARTED|Treatment Period (36 Months)||38||
59792557|NCT00667446|75913007|FG000|COMPLETED|Treatment Period (36 Months)||11||
59792558|NCT00667446|75913008|FG001|COMPLETED|Treatment Period (36 Months)||13||
59792559|NCT00667446|75913007|FG000|NOT COMPLETED|Treatment Period (36 Months)||23||
59792560|NCT00667446|75913008|FG001|NOT COMPLETED|Treatment Period (36 Months)||25||
59620128|NCT02744430|75731386|FG000|NOT COMPLETED|Overall Study||0||
59620129|NCT02744430|75731387|FG001|NOT COMPLETED|Overall Study||0||
59620130|NCT00054756|75731393|FG000|STARTED|Overall Study||96||
59620131|NCT00054756|75731393|FG000|COMPLETED|Overall Study||94||
59620132|NCT00054756|75731393|FG000|NOT COMPLETED|Overall Study||2||
59620133|NCT02091102|75731397|FG000|STARTED|Overall Study||20||
59792561|NCT00667446|75913007|FG000|STARTED|Safety Follow-up Period (12 Weeks)||28||
59792562|NCT00667446|75913008|FG001|STARTED|Safety Follow-up Period (12 Weeks)||26||
59792563|NCT00667446|75913007|FG000|COMPLETED|Safety Follow-up Period (12 Weeks)||28||
59792564|NCT00667446|75913008|FG001|COMPLETED|Safety Follow-up Period (12 Weeks)||25||
59792565|NCT00667446|75913007|FG000|NOT COMPLETED|Safety Follow-up Period (12 Weeks)||0||
59792566|NCT00667446|75913008|FG001|NOT COMPLETED|Safety Follow-up Period (12 Weeks)||1||
59792567|NCT00688844|75913014|FG000|STARTED|Overall Study||58||
59792568|NCT00688844|75913014|FG000|COMPLETED|Overall Study||48||
59792569|NCT00688844|75913014|FG000|NOT COMPLETED|Overall Study||10||
59792570|NCT00667368|75913020|FG000|STARTED|Overall Study||682||
59792571|NCT00667368|75913021|FG001|STARTED|Overall Study||683||
59792572|NCT00667368|75913020|FG000|COMPLETED|Overall Study||482||
59792573|NCT00667368|75913021|FG001|COMPLETED|Overall Study||511||
59792574|NCT00667368|75913020|FG000|NOT COMPLETED|Overall Study||200||
59792575|NCT00667368|75913021|FG001|NOT COMPLETED|Overall Study||172||
59792576|NCT00567567|75913030|FG000|STARTED|Overall Study||210||
59792577|NCT00567567|75913031|FG001|STARTED|Overall Study||176||
59792578|NCT00567567|75913032|FG002|STARTED|Overall Study||279||
59792579|NCT00567567|75913030|FG000|COMPLETED|Overall Study||58||
59792580|NCT00567567|75913031|FG001|COMPLETED|Overall Study||42||
59792581|NCT00567567|75913032|FG002|COMPLETED|Overall Study||1||
59792582|NCT00567567|75913030|FG000|NOT COMPLETED|Overall Study||152||
59792583|NCT00567567|75913031|FG001|NOT COMPLETED|Overall Study||134||
59792584|NCT00567567|75913032|FG002|NOT COMPLETED|Overall Study||278||
59792585|NCT00666198|75913042|FG000|STARTED|Overall Study||3337||
59792586|NCT00666198|75913042|FG000|COMPLETED|Overall Study||3304||
59792587|NCT00666198|75913042|FG000|NOT COMPLETED|Overall Study||33||
59792588|NCT00664560|75913049|FG000|STARTED|Overall Study|Safety Population|247||
59792589|NCT00664560|75913050|FG001|STARTED|Overall Study|Safety Population|243||
59792590|NCT00664560|75913051|FG002|STARTED|Overall Study|Safety Population|124||
59792591|NCT00664560|75913049|FG000|COMPLETED|Overall Study||208||
59792592|NCT00664560|75913050|FG001|COMPLETED|Overall Study||208||
59792593|NCT00664560|75913051|FG002|COMPLETED|Overall Study||105||
59792594|NCT00664560|75913049|FG000|NOT COMPLETED|Overall Study||39||
59792595|NCT00664560|75913050|FG001|NOT COMPLETED|Overall Study||35||
59792596|NCT00664560|75913051|FG002|NOT COMPLETED|Overall Study||19||
59792597|NCT00566709|75913061|FG000|STARTED|Overall Study||51||
59792598|NCT00566709|75913062|FG001|STARTED|Overall Study||51||
59792599|NCT00566709|75913061|FG000|COMPLETED|Overall Study||46||
59792600|NCT00566709|75913062|FG001|COMPLETED|Overall Study||51||
59792601|NCT00566709|75913061|FG000|NOT COMPLETED|Overall Study||5||
59792602|NCT00566709|75913062|FG001|NOT COMPLETED|Overall Study||0||
59792603|NCT00688688|75913071|FG000|STARTED|Overall Study||815||
59792604|NCT00688688|75913072|FG001|STARTED|Overall Study||824||
59792605|NCT00688688|75913073|FG002|STARTED|Overall Study||813||
59792606|NCT00688688|75913071|FG000|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|812||
59792607|NCT00688688|75913072|FG001|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|820||
59792608|NCT00688688|75913073|FG002|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|812||
59792609|NCT00688688|75913071|FG000|Full Analysis Set (FAS)|Overall Study|All treated patients with a baseline and at least 1 post-baseline micturition measurement.|789||
59792610|NCT00688688|75913072|FG001|Full Analysis Set (FAS)|Overall Study|All treated patients with a baseline and at least 1 post-baseline micturition measurement.|802||
59792611|NCT00688688|75913073|FG002|Full Analysis Set (FAS)|Overall Study|All treated patients with a baseline and at least 1 post-baseline micturition measurement.|791||
59792612|NCT00688688|75913071|FG000|Full Analysis Set Incontinence (FAS-I)|Overall Study|All FAS patients who had at least 1 incontinence episode at Baseline.|479||
59792613|NCT00688688|75913072|FG001|Full Analysis Set Incontinence (FAS-I)|Overall Study|All FAS patients who had at least 1 incontinence episode at Baseline.|483||
59792614|NCT00688688|75913073|FG002|Full Analysis Set Incontinence (FAS-I)|Overall Study|All FAS patients who had at least 1 incontinence episode at Baseline.|488||
59792615|NCT00688688|75913071|FG000|COMPLETED|Overall Study||629||
59792616|NCT00688688|75913072|FG001|COMPLETED|Overall Study||645||
59792617|NCT00688688|75913073|FG002|COMPLETED|Overall Study||621||
59792618|NCT00688688|75913071|FG000|NOT COMPLETED|Overall Study||186||
59792619|NCT00688688|75913072|FG001|NOT COMPLETED|Overall Study||179||
59792620|NCT00688688|75913073|FG002|NOT COMPLETED|Overall Study||192||
59792621|NCT00664326|75913081|FG000|STARTED|Overall Study||49||
59792622|NCT00664326|75913081|FG000|COMPLETED|Overall Study|transitioned to rollover study|1||
59792623|NCT00664326|75913081|FG000|NOT COMPLETED|Overall Study||48||
60073534|NCT01689207|76188793|FG009|STARTED|Overall Study|Subjects randomised|10||
60073535|NCT01689207|76188794|FG010|STARTED|Overall Study|Subjects randomised|8||
60073536|NCT01689207|76188784|FG000|COMPLETED|Overall Study|Subjects completed study|4||
60073537|NCT01689207|76188785|FG001|COMPLETED|Overall Study|Subjects completed study|7||
59792624|NCT00686972|75913085|FG000|STARTED|Overall Study||51||
59792625|NCT00686972|75913085|FG000|COMPLETED|Overall Study||0||
59792626|NCT00686972|75913085|FG000|NOT COMPLETED|Overall Study||51||
59792627|NCT00665652|75913089|FG000|STARTED|Overall Study||8||
59792628|NCT00665652|75913089|FG000|COMPLETED|Overall Study||2||
59792629|NCT00665652|75913089|FG000|NOT COMPLETED|Overall Study||6||
59792630|NCT00566631|75913093|FG000|STARTED|Part 1: Core Treatment Phase||294||
59792631|NCT00566631|75913093|FG000|COMPLETED|Part 1: Core Treatment Phase||234||
59792632|NCT00566631|75913093|FG000|NOT COMPLETED|Part 1: Core Treatment Phase||60||
59792633|NCT00566631|75913093|FG000|STARTED|Between Treatment and Extension Phase||234||
59792634|NCT00566631|75913093|FG000|COMPLETED|Between Treatment and Extension Phase||139||
59792635|NCT00566631|75913093|FG000|NOT COMPLETED|Between Treatment and Extension Phase||95||
59792636|NCT00566631|75913093|FG000|STARTED|Part 2: Extension Phase||139||
59792637|NCT00566631|75913093|FG000|COMPLETED|Part 2: Extension Phase||57||
59792638|NCT00566631|75913093|FG000|NOT COMPLETED|Part 2: Extension Phase||82||
60073538|NCT01689207|76188786|FG002|COMPLETED|Overall Study|Subjects completed study|16||
60073539|NCT01689207|76188787|FG003|COMPLETED|Overall Study|Subjects completed study|8||
59523316|NCT02703844|75618093|FG000|STARTED|Cross-Over to Active||0|Cross-over portion was only offered to those who were randomized to placebo in the randomized portion of the study. Not all participants from the placebo group of the randomized controlled period chose to move into the cross-over period and receive active treatment|
59523317|NCT02703844|75618094|FG001|STARTED|Cross-Over to Active||14|Cross-over portion was only offered to those who were randomized to placebo in the randomized portion of the study. Not all participants from the placebo group of the randomized controlled period chose to move into the cross-over period and receive active treatment|
59523318|NCT02703844|75618093|FG000|COMPLETED|Cross-Over to Active||0|Participants were allowed to use the active study device for up to 4 months. Completed is those who used the study device for the full 4 months.|
59523319|NCT02703844|75618094|FG001|COMPLETED|Cross-Over to Active||5|Participants were allowed to use the active study device for up to 4 months. Completed is those who used the study device for the full 4 months.|
59523320|NCT02703844|75618093|FG000|NOT COMPLETED|Cross-Over to Active||0||
59523321|NCT02703844|75618094|FG001|NOT COMPLETED|Cross-Over to Active||9||
59523322|NCT02598778|75618105|FG000|STARTED|Overall Study||2||
59523323|NCT02598778|75618106|FG001|STARTED|Overall Study||4||
59523324|NCT02598778|75618107|FG002|STARTED|Overall Study||4||
59523325|NCT02598778|75618108|FG003|STARTED|Overall Study||2||
59523326|NCT02598778|75618105|FG000|COMPLETED|Overall Study||2||
59523327|NCT02598778|75618106|FG001|COMPLETED|Overall Study||4||
59523328|NCT02598778|75618107|FG002|COMPLETED|Overall Study||4||
59523329|NCT02598778|75618108|FG003|COMPLETED|Overall Study||2||
59523330|NCT02598778|75618105|FG000|NOT COMPLETED|Overall Study||0||
59523331|NCT02598778|75618106|FG001|NOT COMPLETED|Overall Study||0||
59523332|NCT02598778|75618107|FG002|NOT COMPLETED|Overall Study||0||
59523333|NCT02598778|75618108|FG003|NOT COMPLETED|Overall Study||0||
59523334|NCT00642382|75618120|FG000|STARTED|Overall Study||0||
59523335|NCT00642382|75618121|FG001|STARTED|Overall Study||0||
59523336|NCT00642382|75618120|FG000|COMPLETED|Overall Study||0||
59523337|NCT00642382|75618121|FG001|COMPLETED|Overall Study||0||
59523338|NCT00642382|75618120|FG000|NOT COMPLETED|Overall Study||0||
59523339|NCT00642382|75618121|FG001|NOT COMPLETED|Overall Study||0||
59523340|NCT00637312|75618129|FG000|STARTED|Overall Study||72||
59523341|NCT00637312|75618130|FG001|STARTED|Overall Study||36||
59523342|NCT00637312|75618129|FG000|COMPLETED|Overall Study||30||
59523343|NCT00637312|75618130|FG001|COMPLETED|Overall Study||19||
59523344|NCT00637312|75618129|FG000|NOT COMPLETED|Overall Study||42||
59523345|NCT00637312|75618130|FG001|NOT COMPLETED|Overall Study||17||
59523346|NCT00634972|75618138|FG000|STARTED|Overall Study||40||
59523347|NCT00634972|75618139|FG001|STARTED|Overall Study||43||
59523348|NCT00634972|75618138|FG000|COMPLETED|Overall Study||40||
59523349|NCT00634972|75618139|FG001|COMPLETED|Overall Study||43||
59523350|NCT00634972|75618138|FG000|NOT COMPLETED|Overall Study||0||
59523351|NCT00634972|75618139|FG001|NOT COMPLETED|Overall Study||0||
59523352|NCT02553330|75618148|FG000|STARTED|Overall Study||12||
59523353|NCT02553330|75618149|FG001|STARTED|Overall Study||39||
59523354|NCT02553330|75618150|FG002|STARTED|Overall Study||39||
59523355|NCT02553330|75618148|FG000|COMPLETED|Overall Study||7||
59523356|NCT02553330|75618149|FG001|COMPLETED|Overall Study||0||
59523357|NCT02553330|75618150|FG002|COMPLETED|Overall Study||2||
59523358|NCT02553330|75618148|FG000|NOT COMPLETED|Overall Study||5||
59523359|NCT02553330|75618149|FG001|NOT COMPLETED|Overall Study||39||
60073540|NCT01689207|76188788|FG004|COMPLETED|Overall Study|Subjects completed study|2||
60073541|NCT01689207|76188789|FG005|COMPLETED|Overall Study|Subjects completed study|7||
60073542|NCT01689207|76188790|FG006|COMPLETED|Overall Study|Subjects completed study|10||
59523360|NCT02553330|75618150|FG002|NOT COMPLETED|Overall Study||37||
59523361|NCT00529282|75618163|FG000|STARTED|Overall Study||0||
59523362|NCT00529282|75618164|FG001|STARTED|Overall Study||2||
59523363|NCT00529282|75618163|FG000|COMPLETED|Overall Study||0||
59523364|NCT00529282|75618164|FG001|COMPLETED|Overall Study||2||
59523365|NCT00529282|75618163|FG000|NOT COMPLETED|Overall Study||0||
60073543|NCT01689207|76188791|FG007|COMPLETED|Overall Study|Subjects completed study|10||
59523366|NCT00529282|75618164|FG001|NOT COMPLETED|Overall Study||0||
59523367|NCT00623974|75618174|FG000|STARTED|Overall Study||0||
59523368|NCT00623974|75618175|FG001|STARTED|Overall Study||0||
59523369|NCT00623974|75618176|FG002|STARTED|Overall Study||0||
59523370|NCT00623974|75618177|FG003|STARTED|Overall Study||0||
59523371|NCT00623974|75618174|FG000|COMPLETED|Overall Study||0||
59523372|NCT00623974|75618175|FG001|COMPLETED|Overall Study||0||
59523373|NCT00623974|75618176|FG002|COMPLETED|Overall Study||0||
59523374|NCT00623974|75618177|FG003|COMPLETED|Overall Study||0||
59523375|NCT00623974|75618174|FG000|NOT COMPLETED|Overall Study||0||
59523376|NCT00623974|75618175|FG001|NOT COMPLETED|Overall Study||0||
59523377|NCT00623974|75618176|FG002|NOT COMPLETED|Overall Study||0||
59523378|NCT00623974|75618177|FG003|NOT COMPLETED|Overall Study||0||
59523379|NCT02550288|75618192|FG000|STARTED|Overall Study||35||
59523380|NCT02550288|75618193|FG001|STARTED|Overall Study||68||
59523381|NCT02550288|75618194|FG002|STARTED|Overall Study||69||
59523382|NCT02550288|75618195|FG003|STARTED|Overall Study||68||
59523383|NCT02550288|75618196|FG004|STARTED|Overall Study||69||
59523384|NCT02550288|75618192|FG000|COMPLETED|Overall Study||33||
59792639|NCT00661830|75913099|FG000|STARTED|Overall Study||49||
59792640|NCT00661830|75913100|FG001|STARTED|Overall Study||48||
59792641|NCT00661830|75913099|FG000|COMPLETED|Overall Study||9||
59792642|NCT00661830|75913100|FG001|COMPLETED|Overall Study||6||
59792643|NCT00661830|75913099|FG000|NOT COMPLETED|Overall Study||40||
59792644|NCT00661830|75913100|FG001|NOT COMPLETED|Overall Study||42||
59792645|NCT00540592|75913116|FG000|STARTED|Overall Study||204||
59792646|NCT00540592|75913117|FG001|STARTED|Overall Study||202||
59792647|NCT00540592|75913118|FG002|STARTED|Overall Study||202||
59792648|NCT00540592|75913119|FG003|STARTED|Overall Study||202||
59792649|NCT00540592|75913120|FG004|STARTED|Overall Study||199||
59792650|NCT00540592|75913121|FG005|STARTED|Overall Study||198||
59792651|NCT00540592|75913122|FG006|STARTED|Overall Study||198||
59792652|NCT00540592|75913123|FG007|STARTED|Overall Study||199||
59792653|NCT00540592|75913124|FG008|STARTED|Overall Study||200||
59792654|NCT00540592|75913125|FG009|STARTED|Overall Study||203||
59792655|NCT00540592|75913116|FG000|Completed at Day 180|Overall Study||200||
59792656|NCT00540592|75913117|FG001|Completed at Day 180|Overall Study||201||
59792657|NCT00540592|75913118|FG002|Completed at Day 180|Overall Study||197||
59792658|NCT00540592|75913119|FG003|Completed at Day 180|Overall Study||197||
59792659|NCT00540592|75913120|FG004|Completed at Day 180|Overall Study||195||
59792660|NCT00540592|75913121|FG005|Completed at Day 180|Overall Study||198||
59792661|NCT00540592|75913122|FG006|Completed at Day 180|Overall Study||196||
59792662|NCT00540592|75913123|FG007|Completed at Day 180|Overall Study||193||
59792663|NCT00540592|75913124|FG008|Completed at Day 180|Overall Study||198||
59792664|NCT00540592|75913125|FG009|Completed at Day 180|Overall Study||189||
59792665|NCT00540592|75913116|FG000|COMPLETED|Overall Study||202||
59792666|NCT00540592|75913117|FG001|COMPLETED|Overall Study||201||
59792667|NCT00540592|75913118|FG002|COMPLETED|Overall Study||201||
59792668|NCT00540592|75913119|FG003|COMPLETED|Overall Study||201||
59792669|NCT00540592|75913120|FG004|COMPLETED|Overall Study||198||
59792670|NCT00540592|75913121|FG005|COMPLETED|Overall Study||198||
59792671|NCT00540592|75913122|FG006|COMPLETED|Overall Study||198||
59792672|NCT00540592|75913123|FG007|COMPLETED|Overall Study||198||
59792673|NCT00540592|75913124|FG008|COMPLETED|Overall Study||199||
59792674|NCT00540592|75913125|FG009|COMPLETED|Overall Study||201||
59792675|NCT00540592|75913116|FG000|NOT COMPLETED|Overall Study||2||
59792676|NCT00540592|75913117|FG001|NOT COMPLETED|Overall Study||1||
59792677|NCT00540592|75913118|FG002|NOT COMPLETED|Overall Study||1||
59792678|NCT00540592|75913119|FG003|NOT COMPLETED|Overall Study||1||
59792679|NCT00540592|75913120|FG004|NOT COMPLETED|Overall Study||1||
59792680|NCT00540592|75913121|FG005|NOT COMPLETED|Overall Study||0||
59792681|NCT00540592|75913122|FG006|NOT COMPLETED|Overall Study||0||
59792682|NCT00540592|75913123|FG007|NOT COMPLETED|Overall Study||1||
59792683|NCT00540592|75913124|FG008|NOT COMPLETED|Overall Study||1||
59792684|NCT00540592|75913125|FG009|NOT COMPLETED|Overall Study||2||
59792685|NCT03970395|75913149|FG000|STARTED|Overall Study||48||
59792686|NCT03970395|75913150|FG001|STARTED|Overall Study||48||
59792687|NCT03970395|75913149|FG000|COMPLETED|Overall Study||41||
59792688|NCT03970395|75913150|FG001|COMPLETED|Overall Study||36||
59792689|NCT03970395|75913149|FG000|NOT COMPLETED|Overall Study||7||
59792690|NCT03970395|75913150|FG001|NOT COMPLETED|Overall Study||12||
59792691|NCT00565773|75913160|FG000|STARTED|Overall Study||40||
59792692|NCT00565773|75913160|FG000|COMPLETED|Overall Study||38||
59792693|NCT00565773|75913160|FG000|NOT COMPLETED|Overall Study||2||
59792694|NCT00570492|75913166|FG000|STARTED|16-week Single-blind Baseline Period||910||
59792695|NCT00570492|75913167|FG001|STARTED|16-week Single-blind Baseline Period||0||
59792696|NCT00570492|75913168|FG002|STARTED|16-week Single-blind Baseline Period||0||
59792697|NCT00570492|75913166|FG000|COMPLETED|16-week Single-blind Baseline Period||474||
59792698|NCT00570492|75913167|FG001|COMPLETED|16-week Single-blind Baseline Period||0||
59792699|NCT00570492|75913168|FG002|COMPLETED|16-week Single-blind Baseline Period||0||
59792700|NCT00570492|75913166|FG000|NOT COMPLETED|16-week Single-blind Baseline Period||436||
59792701|NCT00570492|75913167|FG001|NOT COMPLETED|16-week Single-blind Baseline Period||0||
59792702|NCT00570492|75913168|FG002|NOT COMPLETED|16-week Single-blind Baseline Period||0||
59792703|NCT00570492|75913166|FG000|STARTED|52-week Double-blind Treatment Period||0||
59953865|NCT02588092|76072240|FG002|STARTED|Overall Study||3||
59620134|NCT02091102|75731397|FG000|COMPLETED|Overall Study||20||
59620135|NCT02091102|75731397|FG000|NOT COMPLETED|Overall Study||0||
59620136|NCT00055692|75731401|FG000|STARTED|Overall Study||46||
59620137|NCT00055692|75731401|FG000|COMPLETED|Overall Study||46||
59620138|NCT00055692|75731401|FG000|NOT COMPLETED|Overall Study||0||
59792704|NCT00570492|75913167|FG001|STARTED|52-week Double-blind Treatment Period||237||
59792705|NCT00570492|75913168|FG002|STARTED|52-week Double-blind Treatment Period||237||
59792706|NCT00570492|75913166|FG000|COMPLETED|52-week Double-blind Treatment Period||0||
59792707|NCT00570492|75913167|FG001|COMPLETED|52-week Double-blind Treatment Period||187||
59792708|NCT00570492|75913168|FG002|COMPLETED|52-week Double-blind Treatment Period||186||
59792709|NCT00570492|75913166|FG000|NOT COMPLETED|52-week Double-blind Treatment Period||0||
59792710|NCT00570492|75913167|FG001|NOT COMPLETED|52-week Double-blind Treatment Period||50||
59792711|NCT00570492|75913168|FG002|NOT COMPLETED|52-week Double-blind Treatment Period||51||
59792712|NCT00571922|75913176|FG000|STARTED|Overall Study||36||
59620139|NCT00056472|75731409|FG000|STARTED|Overall Study||129||
59620140|NCT00056472|75731410|FG001|STARTED|Overall Study||130||
59620141|NCT00056472|75731409|FG000|COMPLETED|Overall Study||81||
59792713|NCT00571922|75913177|FG001|STARTED|Overall Study||36||
59792714|NCT00571922|75913176|FG000|COMPLETED|Overall Study||0||
59792715|NCT00571922|75913177|FG001|COMPLETED|Overall Study||0||
59792716|NCT00571922|75913176|FG000|NOT COMPLETED|Overall Study||36||
59792717|NCT00571922|75913177|FG001|NOT COMPLETED|Overall Study||36||
59792718|NCT00686894|75913183|FG000|STARTED|Overall Study||7||
59792719|NCT00686894|75913183|FG000|COMPLETED|Overall Study||1||
59792720|NCT00686894|75913183|FG000|NOT COMPLETED|Overall Study||6||
59792721|NCT00328627|75913199|FG000|STARTED|Overall Study||129||
59792722|NCT00328627|75913200|FG001|STARTED|Overall Study||128||
59953866|NCT02588092|76072241|FG003|STARTED|Overall Study||3||
59792723|NCT00328627|75913201|FG002|STARTED|Overall Study||129||
59792724|NCT00328627|75913202|FG003|STARTED|Overall Study||130||
59792725|NCT00328627|75913203|FG004|STARTED|Overall Study||130||
59792726|NCT00328627|75913204|FG005|STARTED|Overall Study||130||
59792727|NCT00328627|75913205|FG006|STARTED|Overall Study||129||
59792728|NCT00328627|75913206|FG007|STARTED|Overall Study||130||
59792729|NCT00328627|75913207|FG008|STARTED|Overall Study||130||
59792730|NCT00328627|75913208|FG009|STARTED|Overall Study||129||
59792731|NCT00328627|75913209|FG010|STARTED|Overall Study||130||
59792732|NCT00328627|75913210|FG011|STARTED|Overall Study||130||
59792733|NCT00328627|75913199|FG000|Safety Set|Overall Study|All patients who took at least 1 dose of double-blind study drug.|129||
59792734|NCT00328627|75913200|FG001|Safety Set|Overall Study||128||
59792735|NCT00328627|75913201|FG002|Safety Set|Overall Study||129||
59792736|NCT00328627|75913202|FG003|Safety Set|Overall Study||129||
59792737|NCT00328627|75913203|FG004|Safety Set|Overall Study||130||
59792738|NCT00328627|75913204|FG005|Safety Set|Overall Study||130||
59792739|NCT00328627|75913205|FG006|Safety Set|Overall Study||129||
59792740|NCT00328627|75913206|FG007|Safety Set|Overall Study||130||
59792741|NCT00328627|75913207|FG008|Safety Set|Overall Study||130||
59792742|NCT00328627|75913208|FG009|Safety Set|Overall Study||129||
59792743|NCT00328627|75913209|FG010|Safety Set|Overall Study||130||
59792744|NCT00328627|75913210|FG011|Safety Set|Overall Study||130||
59792745|NCT00328627|75913199|FG000|COMPLETED|Overall Study||70||
59792746|NCT00328627|75913200|FG001|COMPLETED|Overall Study||97||
59792747|NCT00328627|75913201|FG002|COMPLETED|Overall Study||101||
59792748|NCT00328627|75913202|FG003|COMPLETED|Overall Study||93||
59792749|NCT00328627|75913203|FG004|COMPLETED|Overall Study||115||
59792750|NCT00328627|75913204|FG005|COMPLETED|Overall Study||110||
59792751|NCT00328627|75913205|FG006|COMPLETED|Overall Study||94||
59792752|NCT00328627|75913206|FG007|COMPLETED|Overall Study||116||
59792753|NCT00328627|75913207|FG008|COMPLETED|Overall Study||113||
59792754|NCT00328627|75913208|FG009|COMPLETED|Overall Study||97||
59792755|NCT00328627|75913209|FG010|COMPLETED|Overall Study||112||
59792756|NCT00328627|75913210|FG011|COMPLETED|Overall Study||114||
59792757|NCT00328627|75913199|FG000|NOT COMPLETED|Overall Study||59||
59792758|NCT00328627|75913200|FG001|NOT COMPLETED|Overall Study||31||
59792759|NCT00328627|75913201|FG002|NOT COMPLETED|Overall Study||28||
59792760|NCT00328627|75913202|FG003|NOT COMPLETED|Overall Study||37||
59792761|NCT00328627|75913203|FG004|NOT COMPLETED|Overall Study||15||
59792762|NCT00328627|75913204|FG005|NOT COMPLETED|Overall Study||20||
59792763|NCT00328627|75913205|FG006|NOT COMPLETED|Overall Study||35||
59792764|NCT00328627|75913206|FG007|NOT COMPLETED|Overall Study||14||
59792765|NCT00328627|75913207|FG008|NOT COMPLETED|Overall Study||17||
59792766|NCT00328627|75913208|FG009|NOT COMPLETED|Overall Study||32||
59792767|NCT00328627|75913209|FG010|NOT COMPLETED|Overall Study||18||
59792768|NCT00328627|75913210|FG011|NOT COMPLETED|Overall Study||16||
59953867|NCT02588092|76072242|FG004|STARTED|Overall Study||3||
59953868|NCT02588092|76072243|FG005|STARTED|Overall Study||3||
59953869|NCT02588092|76072244|FG006|STARTED|Overall Study||3||
59792769|NCT03977727|75913246|FG000|STARTED|First Treatment||20||
59792770|NCT03977727|75913247|FG001|STARTED|First Treatment||20||
59953870|NCT02588092|76072245|FG007|STARTED|Overall Study||4||
59953871|NCT02588092|76072246|FG008|STARTED|Overall Study||6||
59620142|NCT00056472|75731410|FG001|COMPLETED|Overall Study||61||
59792771|NCT03977727|75913246|FG000|Received Treatment|First Treatment||20||
59792772|NCT03977727|75913247|FG001|Received Treatment|First Treatment||20||
59792773|NCT03977727|75913246|FG000|COMPLETED|First Treatment||20||
59792774|NCT03977727|75913247|FG001|COMPLETED|First Treatment||20||
59953872|NCT02588092|76072247|FG009|STARTED|Overall Study||3||
59953873|NCT02588092|76072238|FG000|COMPLETED|Overall Study||0||
59620143|NCT00056472|75731409|FG000|NOT COMPLETED|Overall Study||48||
59792775|NCT03977727|75913246|FG000|NOT COMPLETED|First Treatment||0||
59792776|NCT03977727|75913247|FG001|NOT COMPLETED|First Treatment||0||
59792777|NCT03977727|75913246|FG000|STARTED|Second Treatment||20||
59792778|NCT03977727|75913247|FG001|STARTED|Second Treatment||20||
59792779|NCT03977727|75913246|FG000|COMPLETED|Second Treatment||20||
59792780|NCT03977727|75913247|FG001|COMPLETED|Second Treatment||17||
59792781|NCT03977727|75913246|FG000|NOT COMPLETED|Second Treatment||0||
59792782|NCT03977727|75913247|FG001|NOT COMPLETED|Second Treatment||3||
59792783|NCT00663858|75913256|FG000|STARTED|Overall Study||212||
59792784|NCT00663858|75913257|FG001|STARTED|Overall Study||106||
59792785|NCT00663858|75913258|FG002|STARTED|Overall Study||102||
59792786|NCT00663858|75913256|FG000|COMPLETED|Overall Study||178||
59792787|NCT00663858|75913257|FG001|COMPLETED|Overall Study||96||
59792788|NCT00663858|75913258|FG002|COMPLETED|Overall Study||82||
59792789|NCT00663858|75913256|FG000|NOT COMPLETED|Overall Study||34||
59792790|NCT00663858|75913257|FG001|NOT COMPLETED|Overall Study||10||
59792791|NCT00663858|75913258|FG002|NOT COMPLETED|Overall Study||20||
59792792|NCT00659880|75913266|FG000|STARTED|Overall Study||9||
59792793|NCT00659880|75913266|FG000|6 Weeks|Overall Study||9||
59792794|NCT00659880|75913266|FG000|6 Months|Overall Study||9||
59792795|NCT00659880|75913266|FG000|12 Months|Overall Study||7||
59792796|NCT00659880|75913266|FG000|24 Months|Overall Study||6||
59792797|NCT00659880|75913266|FG000|COMPLETED|Overall Study|60 months|4||
59792798|NCT00659880|75913266|FG000|NOT COMPLETED|Overall Study||5||
59792799|NCT00683774|75913273|FG000|STARTED|Overall Study||11||
59792800|NCT00683774|75913274|FG001|STARTED|Overall Study||10||
59792801|NCT00683774|75913273|FG000|COMPLETED|Overall Study||8||
59792802|NCT00683774|75913274|FG001|COMPLETED|Overall Study||9||
59792803|NCT00683774|75913273|FG000|NOT COMPLETED|Overall Study||3||
59792804|NCT00683774|75913274|FG001|NOT COMPLETED|Overall Study||1||
59792805|NCT00354679|75913280|FG000|STARTED|Overall Study||34||
59792806|NCT00354679|75913280|FG000|COMPLETED|Overall Study||33||
59792807|NCT00354679|75913280|FG000|NOT COMPLETED|Overall Study||1||
59792808|NCT00683696|75913286|FG000|STARTED|Overall Study||404||
59792809|NCT00683696|75913287|FG001|STARTED|Overall Study||405||
59792810|NCT00683696|75913286|FG000|COMPLETED|Overall Study||0||
59792811|NCT00683696|75913287|FG001|COMPLETED|Overall Study||0||
59792812|NCT00683696|75913286|FG000|NOT COMPLETED|Overall Study||404||
59792813|NCT00683696|75913287|FG001|NOT COMPLETED|Overall Study||405||
59792814|NCT00345631|75913297|FG000|STARTED|Overall Study||87||
59792815|NCT00345631|75913298|FG001|STARTED|Overall Study||267||
59792816|NCT00345631|75913299|FG002|STARTED|Overall Study||134||
59792817|NCT00345631|75913297|FG000|COMPLETED|Overall Study||83||
59792818|NCT00345631|75913298|FG001|COMPLETED|Overall Study||259||
59792819|NCT00345631|75913299|FG002|COMPLETED|Overall Study||128||
59792820|NCT00345631|75913297|FG000|NOT COMPLETED|Overall Study||4||
59792821|NCT00345631|75913298|FG001|NOT COMPLETED|Overall Study||8||
59792822|NCT00345631|75913299|FG002|NOT COMPLETED|Overall Study||6||
59792823|NCT00540514|75913311|FG000|STARTED|Overall Study|Intent-to-treat Population: all randomized patients regardless of treatment received.|521||
59792824|NCT00540514|75913312|FG001|STARTED|Overall Study|Intent-to-treat Population: all randomized patients regardless of treatment received.|531||
59792825|NCT00540514|75913311|FG000|Treated|Overall Study||514||
59792826|NCT00540514|75913312|FG001|Treated|Overall Study||524||
59792827|NCT00540514|75913311|FG000|Biomarker Population|Overall Study||35||
59953874|NCT02588092|76072239|FG001|COMPLETED|Overall Study||0||
59953875|NCT02588092|76072240|FG002|COMPLETED|Overall Study||0||
59953876|NCT02588092|76072241|FG003|COMPLETED|Overall Study||0||
59523385|NCT02550288|75618193|FG001|COMPLETED|Overall Study||65||
59792828|NCT00540514|75913312|FG001|Biomarker Population|Overall Study||36||
59953877|NCT02588092|76072242|FG004|COMPLETED|Overall Study||0||
59953878|NCT02588092|76072243|FG005|COMPLETED|Overall Study||0||
59523386|NCT02550288|75618194|FG002|COMPLETED|Overall Study||68||
60073544|NCT01689207|76188792|FG008|COMPLETED|Overall Study|Subjects completed study|5||
60073545|NCT01689207|76188793|FG009|COMPLETED|Overall Study|Subjects completed study|10||
60073546|NCT01689207|76188794|FG010|COMPLETED|Overall Study|Subjects completed study|8||
59792829|NCT00540514|75913311|FG000|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease|275||
59792830|NCT00540514|75913312|FG001|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease|265||
59792831|NCT00540514|75913311|FG000|NOT COMPLETED|Overall Study||246||
59792832|NCT00540514|75913312|FG001|NOT COMPLETED|Overall Study||266||
59792833|NCT00663702|75913321|FG000|STARTED|Overall Study||52||
59792834|NCT00663702|75913322|FG001|STARTED|Overall Study||71||
59792835|NCT00663702|75913321|FG000|COMPLETED|Overall Study||34||
59953879|NCT02588092|76072244|FG006|COMPLETED|Overall Study||0||
59953880|NCT02588092|76072245|FG007|COMPLETED|Overall Study||0||
59953881|NCT02588092|76072246|FG008|COMPLETED|Overall Study||0||
59792836|NCT00663702|75913322|FG001|COMPLETED|Overall Study||61||
59953882|NCT02588092|76072247|FG009|COMPLETED|Overall Study||0||
60073547|NCT01689207|76188784|FG000|NOT COMPLETED|Overall Study||0||
60073548|NCT01689207|76188785|FG001|NOT COMPLETED|Overall Study||1||
60073549|NCT01689207|76188786|FG002|NOT COMPLETED|Overall Study||0||
59523387|NCT02550288|75618195|FG003|COMPLETED|Overall Study||65||
59792837|NCT00663702|75913321|FG000|NOT COMPLETED|Overall Study||18||
59792838|NCT00663702|75913322|FG001|NOT COMPLETED|Overall Study||10||
59792839|NCT00683618|75913331|FG000|STARTED|Randomised Treatment Period||145||
59792840|NCT00683618|75913332|FG001|STARTED|Randomised Treatment Period||145||
59792841|NCT00683618|75913333|FG002|STARTED|Randomised Treatment Period||146||
59792842|NCT00683618|75913331|FG000|COMPLETED|Randomised Treatment Period||139||
59792843|NCT00683618|75913332|FG001|COMPLETED|Randomised Treatment Period||143||
59792844|NCT00683618|75913333|FG002|COMPLETED|Randomised Treatment Period||140||
59523388|NCT02550288|75618196|FG004|COMPLETED|Overall Study||66||
59953883|NCT02588092|76072238|FG000|NOT COMPLETED|Overall Study||4||
59792845|NCT00683618|75913331|FG000|NOT COMPLETED|Randomised Treatment Period||6||
59792846|NCT00683618|75913332|FG001|NOT COMPLETED|Randomised Treatment Period||2||
59792847|NCT00683618|75913333|FG002|NOT COMPLETED|Randomised Treatment Period||6||
59792848|NCT00683618|75913331|FG000|STARTED|Extension Treatment Period||36||
59792849|NCT00683618|75913332|FG001|STARTED|Extension Treatment Period||23||
59792850|NCT00683618|75913333|FG002|STARTED|Extension Treatment Period||0||
59792851|NCT00683618|75913331|FG000|COMPLETED|Extension Treatment Period||33||
59792852|NCT00683618|75913332|FG001|COMPLETED|Extension Treatment Period||23||
59792853|NCT00683618|75913333|FG002|COMPLETED|Extension Treatment Period||0||
59792854|NCT00683618|75913331|FG000|NOT COMPLETED|Extension Treatment Period||3||
59953884|NCT02588092|76072239|FG001|NOT COMPLETED|Overall Study||3||
59620144|NCT00056472|75731410|FG001|NOT COMPLETED|Overall Study||69||
59620145|NCT00056550|75731416|FG000|STARTED|Overall Study||14||
59792855|NCT00683618|75913332|FG001|NOT COMPLETED|Extension Treatment Period||0||
59792856|NCT00683618|75913333|FG002|NOT COMPLETED|Extension Treatment Period||0||
59792857|NCT00688064|75913345|FG000|STARTED|Overall Study||232||
59792858|NCT00688064|75913346|FG001|STARTED|Overall Study||227||
59792859|NCT00688064|75913345|FG000|COMPLETED|Overall Study||211||
59792860|NCT00688064|75913346|FG001|COMPLETED|Overall Study||201||
59792861|NCT00688064|75913345|FG000|NOT COMPLETED|Overall Study||21||
59792862|NCT00688064|75913346|FG001|NOT COMPLETED|Overall Study||26||
59792863|NCT00663234|75913352|FG000|STARTED|Overall Study||28||
59792864|NCT00663234|75913352|FG000|Dose Increased to 20 mg at Week 8|Overall Study||10||
59792865|NCT00663234|75913352|FG000|COMPLETED|Overall Study||27||
59792866|NCT00663234|75913352|FG000|NOT COMPLETED|Overall Study||1||
59792867|NCT00683384|75913360|FG000|STARTED|Overall Study||93||
59792868|NCT00683384|75913360|FG000|COMPLETED|Overall Study||91||
59792869|NCT00683384|75913360|FG000|NOT COMPLETED|Overall Study||2||
59792870|NCT00326911|75913366|FG000|STARTED|Overall Study|This number reflects all randomized patients.|30||
59792871|NCT00326911|75913367|FG001|STARTED|Overall Study|This number reflects all randomized patients.|31||
59792872|NCT00326911|75913366|FG000|COMPLETED|Overall Study|This number reflects all treated patients.|29||
59792873|NCT00326911|75913367|FG001|COMPLETED|Overall Study|This number reflects all treated patients.|29||
59792874|NCT00326911|75913366|FG000|NOT COMPLETED|Overall Study||1||
59792875|NCT00326911|75913367|FG001|NOT COMPLETED|Overall Study||2||
59792876|NCT00540436|75913373|FG000|STARTED|First 12-Week Treatment Period||25||
59792877|NCT00540436|75913373|FG000|COMPLETED|First 12-Week Treatment Period||22||
59792878|NCT00540436|75913373|FG000|NOT COMPLETED|First 12-Week Treatment Period||3||
59792879|NCT00540436|75913373|FG000|STARTED|Second 12-Week Treatment Period||22||
59792880|NCT00540436|75913373|FG000|COMPLETED|Second 12-Week Treatment Period||21||
59792881|NCT00540436|75913373|FG000|NOT COMPLETED|Second 12-Week Treatment Period||1||
59792882|NCT00687440|75913377|FG000|STARTED|Overall Study|Number of screened participants|27||
59792883|NCT00687440|75913377|FG000|COMPLETED|Overall Study||15||
59792884|NCT00687440|75913377|FG000|NOT COMPLETED|Overall Study||12||
59792885|NCT00659490|75913384|FG000|STARTED|Overall Study||61||
59792886|NCT00659490|75913385|FG001|STARTED|Overall Study||59||
59792887|NCT00659490|75913386|FG002|STARTED|Overall Study||31||
59792888|NCT00659490|75913384|FG000|COMPLETED|Overall Study||59||
59792889|NCT00659490|75913385|FG001|COMPLETED|Overall Study||59||
59792890|NCT00659490|75913386|FG002|COMPLETED|Overall Study||30||
59792891|NCT00659490|75913384|FG000|NOT COMPLETED|Overall Study||2||
59792892|NCT00659490|75913385|FG001|NOT COMPLETED|Overall Study||0||
59792893|NCT00659490|75913386|FG002|NOT COMPLETED|Overall Study||1||
59792894|NCT00539500|75913394|FG000|STARTED|Overall Study||3||
59792895|NCT00539500|75913394|FG000|COMPLETED|Overall Study||0||
59792896|NCT00539500|75913394|FG000|NOT COMPLETED|Overall Study||3||
59792897|NCT00662532|75913400|FG000|STARTED|Overall Study||22||
59792898|NCT00662532|75913401|FG001|STARTED|Overall Study||22||
59792899|NCT00662532|75913400|FG000|COMPLETED|Overall Study||22||
59792900|NCT00662532|75913401|FG001|COMPLETED|Overall Study||20||
59792901|NCT00662532|75913400|FG000|NOT COMPLETED|Overall Study||0||
59620146|NCT00056550|75731416|FG000|COMPLETED|Overall Study||14||
59620147|NCT00056550|75731416|FG000|NOT COMPLETED|Overall Study||0||
59620148|NCT00060528|75731421|FG000|STARTED|Overall Study|32 participants are reported for the phase II portion.|8||
59792902|NCT00662532|75913401|FG001|NOT COMPLETED|Overall Study||2||
59792903|NCT00686036|75913409|FG000|STARTED|Overall Study||9||
59953885|NCT02588092|76072240|FG002|NOT COMPLETED|Overall Study||3||
59953886|NCT02588092|76072241|FG003|NOT COMPLETED|Overall Study||3||
59953887|NCT02588092|76072242|FG004|NOT COMPLETED|Overall Study||3||
59620149|NCT00060528|75731422|FG001|STARTED|Overall Study||9||
59792904|NCT00686036|75913410|FG001|STARTED|Overall Study||8||
59792905|NCT00686036|75913409|FG000|COMPLETED|Overall Study||0||
59792906|NCT00686036|75913410|FG001|COMPLETED|Overall Study||2||
59792907|NCT00686036|75913409|FG000|NOT COMPLETED|Overall Study||9||
59792908|NCT00686036|75913410|FG001|NOT COMPLETED|Overall Study||6||
59792909|NCT00682448|75913418|FG000|STARTED|Overall Study||12||
59792910|NCT00682448|75913419|FG001|STARTED|Overall Study||13||
59792911|NCT00682448|75913418|FG000|COMPLETED|Overall Study||7||
59792912|NCT00682448|75913419|FG001|COMPLETED|Overall Study||7||
59792913|NCT00682448|75913418|FG000|NOT COMPLETED|Overall Study||5||
59792914|NCT00682448|75913419|FG001|NOT COMPLETED|Overall Study||6||
59953888|NCT02588092|76072243|FG005|NOT COMPLETED|Overall Study||3||
59792915|NCT00681824|75913428|FG000|STARTED|Overall Study||28||
59792916|NCT00681824|75913429|FG001|STARTED|Overall Study||13||
59792917|NCT00681824|75913430|FG002|STARTED|Overall Study||34||
59792918|NCT00681824|75913428|FG000|COMPLETED|Overall Study||27||
59792919|NCT00681824|75913429|FG001|COMPLETED|Overall Study||12||
59792920|NCT00681824|75913430|FG002|COMPLETED|Overall Study||33||
59792921|NCT00681824|75913428|FG000|NOT COMPLETED|Overall Study||1||
59792922|NCT00681824|75913429|FG001|NOT COMPLETED|Overall Study||1||
59792923|NCT00681824|75913430|FG002|NOT COMPLETED|Overall Study||1||
59792924|NCT00681668|75913438|FG000|STARTED|Overall Study||5||
59792925|NCT00681668|75913438|FG000|COMPLETED|Overall Study||3||
59792926|NCT00681668|75913438|FG000|NOT COMPLETED|Overall Study||2||
59792927|NCT00539188|75913444|FG000|STARTED|Overall Study||4||
59792928|NCT00539188|75913445|FG001|STARTED|Overall Study||2||
59792929|NCT00539188|75913444|FG000|Received Allocated Intervention|Overall Study||3||
59792930|NCT00539188|75913445|FG001|Received Allocated Intervention|Overall Study||2||
59792931|NCT00539188|75913444|FG000|COMPLETED|Overall Study||1||
59792932|NCT00539188|75913445|FG001|COMPLETED|Overall Study||1||
59792933|NCT00539188|75913444|FG000|NOT COMPLETED|Overall Study||3||
59792934|NCT00539188|75913445|FG001|NOT COMPLETED|Overall Study||1||
59792935|NCT00681590|75913453|FG000|STARTED|Overall Study||34||
59792936|NCT00681590|75913454|FG001|STARTED|Overall Study||71||
59792937|NCT00681590|75913453|FG000|COMPLETED|Overall Study||32||
59792938|NCT00681590|75913454|FG001|COMPLETED|Overall Study||59||
59792939|NCT00681590|75913453|FG000|NOT COMPLETED|Overall Study||2||
59792940|NCT00681590|75913454|FG001|NOT COMPLETED|Overall Study||12||
59792941|NCT04980456|75913462|FG000|STARTED|Period 1 (Approximately 30 Days)||122||244
59792942|NCT04980456|75913463|FG001|STARTED|Period 1 (Approximately 30 Days)||127||254
59792943|NCT04980456|75913462|FG000|COMPLETED|Period 1 (Approximately 30 Days)||119||238
59792944|NCT04980456|75913463|FG001|COMPLETED|Period 1 (Approximately 30 Days)||124||248
59792945|NCT04980456|75913462|FG000|NOT COMPLETED|Period 1 (Approximately 30 Days)||3||6
59792946|NCT04980456|75913463|FG001|NOT COMPLETED|Period 1 (Approximately 30 Days)||3||6
59792947|NCT04980456|75913462|FG000|STARTED|Period 2 (Approximately 30 Days)||119||238
59792948|NCT04980456|75913463|FG001|STARTED|Period 2 (Approximately 30 Days)|One subject (2 eyes) discontinued after completing first period and prior to exposure to second period product due to an adverse event.|123||246
59792949|NCT04980456|75913462|FG000|COMPLETED|Period 2 (Approximately 30 Days)||119||238
59792950|NCT04980456|75913463|FG001|COMPLETED|Period 2 (Approximately 30 Days)||122||244
59792951|NCT04980456|75913462|FG000|NOT COMPLETED|Period 2 (Approximately 30 Days)||0||0
59792952|NCT04980456|75913463|FG001|NOT COMPLETED|Period 2 (Approximately 30 Days)||1||2
59792953|NCT00326599|75913476|FG000|STARTED|Overall Study||6||
59792954|NCT00326599|75913477|FG001|STARTED|Overall Study||3||
59792955|NCT00326599|75913478|FG002|STARTED|Overall Study||58||
59792956|NCT00326599|75913479|FG003|STARTED|Overall Study||29||
59792957|NCT00326599|75913476|FG000|COMPLETED|Overall Study||0||
59792958|NCT00326599|75913477|FG001|COMPLETED|Overall Study||2||
59792959|NCT00326599|75913478|FG002|COMPLETED|Overall Study||5||
59792960|NCT00326599|75913479|FG003|COMPLETED|Overall Study||10||
59792961|NCT00326599|75913476|FG000|NOT COMPLETED|Overall Study||6||
59792962|NCT00326599|75913477|FG001|NOT COMPLETED|Overall Study||1||
59792963|NCT00326599|75913478|FG002|NOT COMPLETED|Overall Study||53||
59792964|NCT00326599|75913479|FG003|NOT COMPLETED|Overall Study||19||
59523389|NCT02550288|75618192|FG000|NOT COMPLETED|Overall Study||2||
59523390|NCT02550288|75618193|FG001|NOT COMPLETED|Overall Study||3||
59523391|NCT02550288|75618194|FG002|NOT COMPLETED|Overall Study||1||
59523392|NCT02550288|75618195|FG003|NOT COMPLETED|Overall Study||3||
59792965|NCT00539032|75913490|FG000|STARTED|Overall Study||153||
59792966|NCT00539032|75913491|FG001|STARTED|Overall Study||85||
59792967|NCT00539032|75913490|FG000|COMPLETED|Overall Study||151||
59792968|NCT00539032|75913491|FG001|COMPLETED|Overall Study||84||
59792969|NCT00539032|75913490|FG000|NOT COMPLETED|Overall Study||2||
59792970|NCT00539032|75913491|FG001|NOT COMPLETED|Overall Study||1||
59792971|NCT00685802|75913497|FG000|STARTED|First Intervention||16||
59792972|NCT00685802|75913498|FG001|STARTED|First Intervention||16||
59792973|NCT00685802|75913497|FG000|COMPLETED|First Intervention||16||
59792974|NCT00685802|75913498|FG001|COMPLETED|First Intervention||16||
59792975|NCT00685802|75913497|FG000|NOT COMPLETED|First Intervention||0||
59792976|NCT00685802|75913498|FG001|NOT COMPLETED|First Intervention||0||
59792977|NCT00685802|75913497|FG000|STARTED|Washout Period of 7 Days||16||
59792978|NCT00685802|75913498|FG001|STARTED|Washout Period of 7 Days||16||
59792979|NCT00685802|75913497|FG000|COMPLETED|Washout Period of 7 Days||14||
59792980|NCT00685802|75913498|FG001|COMPLETED|Washout Period of 7 Days||15||
59792981|NCT00685802|75913497|FG000|NOT COMPLETED|Washout Period of 7 Days||2||
59523393|NCT02550288|75618196|FG004|NOT COMPLETED|Overall Study||3||
59523394|NCT00610558|75618211|FG000|STARTED|Overall Study||20||
59523395|NCT00610558|75618212|FG001|STARTED|Overall Study||20||
59523396|NCT00610558|75618213|FG002|STARTED|Overall Study||20||
59792982|NCT00685802|75913498|FG001|NOT COMPLETED|Washout Period of 7 Days||1||
59792983|NCT00685802|75913497|FG000|STARTED|Second Intervention||14||
59792984|NCT00685802|75913498|FG001|STARTED|Second Intervention||15||
59523397|NCT00610558|75618211|FG000|COMPLETED|Overall Study||15||
59792985|NCT00685802|75913497|FG000|COMPLETED|Second Intervention||14||
59792986|NCT00685802|75913498|FG001|COMPLETED|Second Intervention||15||
59792987|NCT00685802|75913497|FG000|NOT COMPLETED|Second Intervention||0||
59792988|NCT00685802|75913498|FG001|NOT COMPLETED|Second Intervention||0||
59792989|NCT00354601|75913504|FG000|STARTED|Overall Study||2||
59792990|NCT00354601|75913504|FG000|COMPLETED|Overall Study||0||
59792991|NCT00354601|75913504|FG000|NOT COMPLETED|Overall Study||2||
59792992|NCT03827473|75913510|FG000|STARTED|Overall Study||1||
59792993|NCT03827473|75913511|FG001|STARTED|Overall Study||0||
59792994|NCT03827473|75913510|FG000|COMPLETED|Overall Study||0||
59792995|NCT03827473|75913511|FG001|COMPLETED|Overall Study||0||
59792996|NCT03827473|75913510|FG000|NOT COMPLETED|Overall Study||1||
59792997|NCT03827473|75913511|FG001|NOT COMPLETED|Overall Study||0||
59792998|NCT00345397|75913517|FG000|STARTED|Overall Study||7||
59792999|NCT00345397|75913517|FG000|COMPLETED|Overall Study||6||
59793000|NCT00345397|75913517|FG000|NOT COMPLETED|Overall Study||1||
59793001|NCT00326209|75913522|FG000|STARTED|Overall Study||393||
59793002|NCT00326209|75913522|FG000|Safety Population|Overall Study||388|Received at least 1 dose of study drug and had at least 1 post-baseline safety assessment.|
59793003|NCT00326209|75913522|FG000|COMPLETED|Overall Study||111||
59793004|NCT00326209|75913522|FG000|NOT COMPLETED|Overall Study||282||
59793005|NCT00537940|75913528|FG000|STARTED|Overall Study||241||
59793006|NCT00537940|75913529|FG001|STARTED|Overall Study||241||
59793007|NCT00537940|75913528|FG000|Completed Titration Phase|Overall Study||213||
59793008|NCT00537940|75913529|FG001|Completed Titration Phase|Overall Study||210||
59793009|NCT00537940|75913528|FG000|Completed Maintenance Phase|Overall Study||187||
59793010|NCT00537940|75913529|FG001|Completed Maintenance Phase|Overall Study||172||
59793011|NCT00537940|75913528|FG000|Entered Opt Blinded Continuation Phase|Overall Study||140||
59793012|NCT00537940|75913529|FG001|Entered Opt Blinded Continuation Phase|Overall Study||139||
59793013|NCT00537940|75913528|FG000|COMPLETED|Overall Study|2 participants had both treatment related and non-treatment related AE leading to discontinuation.|58||
59793014|NCT00537940|75913529|FG001|COMPLETED|Overall Study||62||
59793015|NCT00537940|75913528|FG000|NOT COMPLETED|Overall Study||183||
59793016|NCT00537940|75913529|FG001|NOT COMPLETED|Overall Study||179||
59793017|NCT00661362|75913537|FG000|STARTED|Overall Study|Randomized and treated|283||
59793018|NCT00661362|75913538|FG001|STARTED|Overall Study|Randomized and treated|287||
59793019|NCT00661362|75913537|FG000|COMPLETED|Overall Study|Completed 24 Weeks of treatment|254||
59793020|NCT00661362|75913538|FG001|COMPLETED|Overall Study|Completed 24 Weeks of treatment|247||
59793021|NCT00661362|75913537|FG000|NOT COMPLETED|Overall Study||29||
59793022|NCT00661362|75913538|FG001|NOT COMPLETED|Overall Study||40||
59793023|NCT00325897|75913546|FG000|STARTED|Overall Study||570||
59793024|NCT00325897|75913547|FG001|STARTED|Overall Study||572||
59793025|NCT00325897|75913546|FG000|COMPLETED|Overall Study||558||
59793026|NCT00325897|75913547|FG001|COMPLETED|Overall Study||559||
59793027|NCT00325897|75913546|FG000|NOT COMPLETED|Overall Study||12||
59793028|NCT00325897|75913547|FG001|NOT COMPLETED|Overall Study||13||
59793029|NCT00344773|75913556|FG000|STARTED|Overall Study||46||
59793030|NCT00344773|75913556|FG000|COMPLETED|Overall Study||25||
59793031|NCT00344773|75913556|FG000|NOT COMPLETED|Overall Study||21||
59793032|NCT00325819|75913562|FG000|STARTED|Overall Study||185||
59793033|NCT00325819|75913563|FG001|STARTED|Overall Study||189||
59793034|NCT00325819|75913562|FG000|COMPLETED|Overall Study||176||
59793035|NCT00325819|75913563|FG001|COMPLETED|Overall Study||176||
59793036|NCT00325819|75913562|FG000|NOT COMPLETED|Overall Study||9||
59793037|NCT00325819|75913563|FG001|NOT COMPLETED|Overall Study||13||
59793038|NCT00687362|75913571|FG000|STARTED|Overall Study||22||
59793039|NCT00687362|75913571|FG000|COMPLETED|Overall Study|Completed protocol at Week 24|19||
59793040|NCT00687362|75913571|FG000|NOT COMPLETED|Overall Study||3||
59793041|NCT00325195|75913578|FG000|STARTED|Randomized||90||
59793042|NCT00325195|75913579|FG001|STARTED|Randomized||89||
59793043|NCT00325195|75913580|FG002|STARTED|Randomized||46||
59793044|NCT00325195|75913578|FG000|COMPLETED|Randomized||85||
59793045|NCT00325195|75913579|FG001|COMPLETED|Randomized||84||
59793046|NCT00325195|75913580|FG002|COMPLETED|Randomized||43||
59793047|NCT00325195|75913578|FG000|NOT COMPLETED|Randomized||5||
59793048|NCT00325195|75913579|FG001|NOT COMPLETED|Randomized||5||
59793049|NCT00325195|75913580|FG002|NOT COMPLETED|Randomized||3||
59793050|NCT00325195|75913578|FG000|STARTED|Received Intervention: ITT Population||85||
59793051|NCT00325195|75913579|FG001|STARTED|Received Intervention: ITT Population||84||
59793052|NCT00325195|75913580|FG002|STARTED|Received Intervention: ITT Population||43||
59793053|NCT00325195|75913578|FG000|COMPLETED|Received Intervention: ITT Population||59||
59793054|NCT00325195|75913579|FG001|COMPLETED|Received Intervention: ITT Population||59||
59793055|NCT00325195|75913580|FG002|COMPLETED|Received Intervention: ITT Population||39||
59793056|NCT00325195|75913578|FG000|NOT COMPLETED|Received Intervention: ITT Population||26||
59793057|NCT00325195|75913579|FG001|NOT COMPLETED|Received Intervention: ITT Population||25||
59793058|NCT00325195|75913580|FG002|NOT COMPLETED|Received Intervention: ITT Population||4||
59793059|NCT03976401|75913594|FG000|STARTED|Overall Study||19||
59793060|NCT03976401|75913595|FG001|STARTED|Overall Study||20||
59793061|NCT03976401|75913596|FG002|STARTED|Overall Study||20||
59793062|NCT03976401|75913597|FG003|STARTED|Overall Study||21||
59793063|NCT03976401|75913598|FG004|STARTED|Overall Study||20||
59793064|NCT03976401|75913599|FG005|STARTED|Overall Study||10||
59793065|NCT03976401|75913594|FG000|COMPLETED|Overall Study||16||
59793066|NCT03976401|75913595|FG001|COMPLETED|Overall Study||16||
59793067|NCT03976401|75913596|FG002|COMPLETED|Overall Study||15||
59793068|NCT03976401|75913597|FG003|COMPLETED|Overall Study||19||
59793069|NCT03976401|75913598|FG004|COMPLETED|Overall Study||19||
59793070|NCT03976401|75913599|FG005|COMPLETED|Overall Study||9||
59793071|NCT03976401|75913594|FG000|NOT COMPLETED|Overall Study||3||
59793072|NCT03976401|75913595|FG001|NOT COMPLETED|Overall Study||4||
59793073|NCT03976401|75913596|FG002|NOT COMPLETED|Overall Study||5||
59793074|NCT03976401|75913597|FG003|NOT COMPLETED|Overall Study||2||
59793075|NCT03976401|75913598|FG004|NOT COMPLETED|Overall Study||1||
59793076|NCT03976401|75913599|FG005|NOT COMPLETED|Overall Study||1||
59793077|NCT00685334|75913615|FG000|STARTED|Overall Study||12||
59793078|NCT00685334|75913616|FG001|STARTED|Overall Study||10||
59793079|NCT00685334|75913615|FG000|COMPLETED|Overall Study||2||
59793080|NCT00685334|75913616|FG001|COMPLETED|Overall Study||3||
59793081|NCT00685334|75913615|FG000|NOT COMPLETED|Overall Study||10||
59793082|NCT00685334|75913616|FG001|NOT COMPLETED|Overall Study||7||
59793083|NCT00325039|75913624|FG000|STARTED|Overall Study||298||
59793084|NCT00325039|75913625|FG001|STARTED|Overall Study||299||
59793085|NCT00325039|75913624|FG000|COMPLETED|Overall Study||280||
59793086|NCT00325039|75913625|FG001|COMPLETED|Overall Study||285||
59793087|NCT00325039|75913624|FG000|NOT COMPLETED|Overall Study||18||
59793088|NCT00325039|75913625|FG001|NOT COMPLETED|Overall Study||14||
59793089|NCT00344461|75913631|FG000|STARTED|Overall Study||54||
59793090|NCT00344461|75913631|FG000|COMPLETED|Overall Study||33||
59793091|NCT00344461|75913631|FG000|NOT COMPLETED|Overall Study||21||
59793092|NCT00685178|75913640|FG000|STARTED|Overall Study||40||
59793093|NCT00685178|75913641|FG001|STARTED|Overall Study||45||
59793094|NCT00685178|75913642|FG002|STARTED|Overall Study||39||
59793095|NCT00685178|75913643|FG003|STARTED|Overall Study||47||
59793096|NCT00685178|75913640|FG000|COMPLETED|Overall Study||27||
59793097|NCT00685178|75913641|FG001|COMPLETED|Overall Study||26||
59793098|NCT00685178|75913642|FG002|COMPLETED|Overall Study||27||
59793099|NCT00685178|75913643|FG003|COMPLETED|Overall Study||33||
59793100|NCT00685178|75913640|FG000|NOT COMPLETED|Overall Study||13||
59793101|NCT00685178|75913641|FG001|NOT COMPLETED|Overall Study||19||
59793102|NCT00685178|75913642|FG002|NOT COMPLETED|Overall Study||12||
59793103|NCT00685178|75913643|FG003|NOT COMPLETED|Overall Study||14||
59793104|NCT00537394|75913656|FG000|STARTED|First Year of Follow-up||181||
59793105|NCT00537394|75913657|FG001|STARTED|First Year of Follow-up||179||
59793106|NCT00537394|75913658|FG002|STARTED|First Year of Follow-up||53||
59793107|NCT00537394|75913656|FG000|COMPLETED|First Year of Follow-up|Completed refers to completing first 48 weeks of follow-up.|169||
59793108|NCT00537394|75913657|FG001|COMPLETED|First Year of Follow-up|Completed refers to completing first 48 weeks of follow-up.|168||
59793109|NCT00537394|75913658|FG002|COMPLETED|First Year of Follow-up||50||
59793110|NCT00537394|75913656|FG000|NOT COMPLETED|First Year of Follow-up||12||
59793111|NCT00537394|75913657|FG001|NOT COMPLETED|First Year of Follow-up||11||
59793112|NCT00537394|75913658|FG002|NOT COMPLETED|First Year of Follow-up||3||
59793113|NCT00537394|75913656|FG000|STARTED|2nd Year of Follow-up||169||
59793114|NCT00537394|75913657|FG001|STARTED|2nd Year of Follow-up||168||
59793115|NCT00537394|75913658|FG002|STARTED|2nd Year of Follow-up||50||
59793116|NCT00537394|75913656|FG000|COMPLETED|2nd Year of Follow-up||158||
59793117|NCT00537394|75913657|FG001|COMPLETED|2nd Year of Follow-up||159||
59793118|NCT00537394|75913658|FG002|COMPLETED|2nd Year of Follow-up||44||
59793119|NCT00537394|75913656|FG000|NOT COMPLETED|2nd Year of Follow-up||11||
59793120|NCT00537394|75913657|FG001|NOT COMPLETED|2nd Year of Follow-up||9||
59793121|NCT00537394|75913658|FG002|NOT COMPLETED|2nd Year of Follow-up||6||
59793122|NCT00352885|75913666|FG000|STARTED|Overall Study||9||
59793123|NCT00352885|75913667|FG001|STARTED|Overall Study||11||
59793124|NCT00352885|75913666|FG000|Completed Cycle 1 of IL-2 Treatment|Overall Study||9||
59793125|NCT00352885|75913667|FG001|Completed Cycle 1 of IL-2 Treatment|Overall Study||11||
59793126|NCT00352885|75913666|FG000|Completed Cycle 2 of IL-2 Treatment|Overall Study||8||
59793127|NCT00352885|75913667|FG001|Completed Cycle 2 of IL-2 Treatment|Overall Study||9||
59793128|NCT00352885|75913666|FG000|Completed Cycle 3 of IL-2 Treatment|Overall Study||4||
59793129|NCT00352885|75913667|FG001|Completed Cycle 3 of IL-2 Treatment|Overall Study||7||
59793130|NCT00352885|75913666|FG000|COMPLETED|Overall Study||3|Completed all four cycles of IL-2 treatment|
59793131|NCT00352885|75913667|FG001|COMPLETED|Overall Study||4|Completed all four cycles of IL-2 treatment|
59793132|NCT00352885|75913666|FG000|NOT COMPLETED|Overall Study||6||
59793133|NCT00352885|75913667|FG001|NOT COMPLETED|Overall Study||7||
59793134|NCT00660660|75913675|FG000|STARTED|Overall Study|Randomized|143||
59793135|NCT00660660|75913676|FG001|STARTED|Overall Study|Randomized|133||
59793136|NCT00660660|75913675|FG000|Met Criteria for MITT Population|Overall Study||137||
59793137|NCT00660660|75913676|FG001|Met Criteria for MITT Population|Overall Study||125||
59793138|NCT00660660|75913675|FG000|COMPLETED|Overall Study|Number of completed patients is based on randomized population (143) minus withdrawals (5).|138||
59793139|NCT00660660|75913676|FG001|COMPLETED|Overall Study|Number of completed patients is based on randomized population (133) minus withdrawals (9).|124||
59793140|NCT00660660|75913675|FG000|NOT COMPLETED|Overall Study||5||
59793141|NCT00660660|75913676|FG001|NOT COMPLETED|Overall Study||9||
59793142|NCT00344305|75913684|FG000|STARTED|Overall Study||100||
59793143|NCT00344305|75913685|FG001|STARTED|Overall Study||100||
59793144|NCT00344305|75913684|FG000|COMPLETED|Overall Study||98||
59793145|NCT00344305|75913685|FG001|COMPLETED|Overall Study||99||
59793146|NCT00344305|75913684|FG000|NOT COMPLETED|Overall Study||2||
59793147|NCT00344305|75913685|FG001|NOT COMPLETED|Overall Study||1||
59953889|NCT02588092|76072244|FG006|NOT COMPLETED|Overall Study||3||
59953890|NCT02588092|76072245|FG007|NOT COMPLETED|Overall Study||4||
59953891|NCT02588092|76072246|FG008|NOT COMPLETED|Overall Study||6||
59953892|NCT02588092|76072247|FG009|NOT COMPLETED|Overall Study||3||
59953893|NCT01367847|76072275|FG000|STARTED|Overall Study||10||
59953894|NCT01367847|76072276|FG001|STARTED|Overall Study||9||
59953895|NCT01367847|76072275|FG000|COMPLETED|Overall Study||8||
59523398|NCT00610558|75618212|FG001|COMPLETED|Overall Study||14||
59523399|NCT00610558|75618213|FG002|COMPLETED|Overall Study||14||
59523400|NCT00610558|75618211|FG000|NOT COMPLETED|Overall Study||5||
59523401|NCT00610558|75618212|FG001|NOT COMPLETED|Overall Study||6||
59523402|NCT00610558|75618213|FG002|NOT COMPLETED|Overall Study||6||
59523403|NCT00500890|75618223|FG000|STARTED|Overall Study||1||
59523404|NCT00500890|75618224|FG001|STARTED|Overall Study||1||
59523405|NCT00500890|75618223|FG000|COMPLETED|Overall Study||1||
59523406|NCT00500890|75618224|FG001|COMPLETED|Overall Study||1||
59523407|NCT00500890|75618223|FG000|NOT COMPLETED|Overall Study||0||
59523408|NCT00500890|75618224|FG001|NOT COMPLETED|Overall Study||0||
59523409|NCT00437398|75618230|FG000|STARTED|Overall Study||2||
59523410|NCT00437398|75618230|FG000|COMPLETED|Overall Study||2||
59523411|NCT00437398|75618230|FG000|NOT COMPLETED|Overall Study||0||
59620150|NCT00060528|75731423|FG002|STARTED|Overall Study||7||
59620151|NCT00060528|75731424|FG003|STARTED|Overall Study||8||
59620152|NCT00060528|75731421|FG000|COMPLETED|Overall Study||8||
59620153|NCT00060528|75731422|FG001|COMPLETED|Overall Study||9||
59620154|NCT00060528|75731423|FG002|COMPLETED|Overall Study||7||
59620155|NCT00060528|75731424|FG003|COMPLETED|Overall Study||8||
59620156|NCT00060528|75731421|FG000|NOT COMPLETED|Overall Study||0||
59620157|NCT00060528|75731422|FG001|NOT COMPLETED|Overall Study||0||
59620158|NCT00060528|75731423|FG002|NOT COMPLETED|Overall Study||0||
59620159|NCT00060528|75731424|FG003|NOT COMPLETED|Overall Study||0||
59620160|NCT02255838|75731437|FG000|STARTED|Overall Study||6||
59620161|NCT02255838|75731438|FG001|STARTED|Overall Study||6||
59620162|NCT02255838|75731437|FG000|COMPLETED|Overall Study||6||
59620163|NCT02255838|75731438|FG001|COMPLETED|Overall Study||6||
59620164|NCT02255838|75731437|FG000|NOT COMPLETED|Overall Study||0||
59620165|NCT02255838|75731438|FG001|NOT COMPLETED|Overall Study||0||
59620166|NCT00060606|75731448|FG000|STARTED|Overall Study||91||
59620167|NCT00060606|75731449|FG001|STARTED|Overall Study||92||
59620168|NCT00060606|75731448|FG000|First Primary Outcome - Shunt at 12 Mont|Overall Study||91||
59523412|NCT00593320|75618236|FG000|STARTED|Overall Study||1||
59523413|NCT00593320|75618237|FG001|STARTED|Overall Study||1||
59523414|NCT00593320|75618236|FG000|COMPLETED|Overall Study||1||
59523415|NCT00593320|75618237|FG001|COMPLETED|Overall Study||1||
59523416|NCT00593320|75618236|FG000|NOT COMPLETED|Overall Study||0||
59620169|NCT00060606|75731449|FG001|First Primary Outcome - Shunt at 12 Mont|Overall Study||92||
59620170|NCT00060606|75731448|FG000|COMPLETED|Overall Study||91|Second primary outcome - 30 months|
59620171|NCT00060606|75731449|FG001|COMPLETED|Overall Study||91|Second primary outcome - 30 months|
59620172|NCT00060606|75731448|FG000|NOT COMPLETED|Overall Study||0||
59620173|NCT00060606|75731449|FG001|NOT COMPLETED|Overall Study||1||
59620174|NCT00063570|75731457|FG000|STARTED|Overall Study||52||
59620175|NCT00063570|75731458|FG001|STARTED|Overall Study||21||
59620176|NCT00063570|75731457|FG000|COMPLETED|Overall Study|Completed for this study means patient received study drug and was eligible for efficacy analysis.|52||
59620177|NCT00063570|75731458|FG001|COMPLETED|Overall Study|Completed for this study means patient received study drug and was eligible for efficacy analysis.|21||
59620178|NCT00063570|75731457|FG000|NOT COMPLETED|Overall Study||0||
59620179|NCT00063570|75731458|FG001|NOT COMPLETED|Overall Study||0||
59620180|NCT00064038|75731466|FG000|STARTED|Initial Randomization||100||
59620181|NCT00064038|75731467|FG001|STARTED|Initial Randomization||98||
59620182|NCT00064038|75731468|FG002|STARTED|Initial Randomization||0||
59620183|NCT00064038|75731466|FG000|Eligible and Analyzable|Initial Randomization||97||
59793148|NCT00660816|75913694|FG000|STARTED|Overall Study||24||
59793149|NCT00660816|75913695|FG001|STARTED|Overall Study||22||
59793150|NCT00660816|75913694|FG000|COMPLETED|Overall Study||4||
59793151|NCT00660816|75913695|FG001|COMPLETED|Overall Study||3||
59793152|NCT00660816|75913694|FG000|NOT COMPLETED|Overall Study||20||
59793153|NCT00660816|75913695|FG001|NOT COMPLETED|Overall Study||19||
59793154|NCT00576056|75913701|FG000|STARTED|Overall Study||19||
59793155|NCT00576056|75913701|FG000|COMPLETED|Overall Study||5||
59793156|NCT00576056|75913701|FG000|NOT COMPLETED|Overall Study||14||
59793157|NCT00575510|75913708|FG000|STARTED|Overall Study||114||
59793158|NCT00575510|75913709|FG001|STARTED|Overall Study||114||
59793159|NCT00575510|75913710|FG002|STARTED|Overall Study||113||
59793160|NCT00575510|75913708|FG000|COMPLETED|Overall Study||102||
59793161|NCT00575510|75913709|FG001|COMPLETED|Overall Study||101||
59953896|NCT01367847|76072276|FG001|COMPLETED|Overall Study||7||
59953897|NCT01367847|76072275|FG000|NOT COMPLETED|Overall Study||2||
59793162|NCT00575510|75913710|FG002|COMPLETED|Overall Study||96||
59793163|NCT00575510|75913708|FG000|NOT COMPLETED|Overall Study||12||
59793164|NCT00575510|75913709|FG001|NOT COMPLETED|Overall Study||13||
59793165|NCT00575510|75913710|FG002|NOT COMPLETED|Overall Study||17||
59793166|NCT02636439|75913721|FG000|STARTED|Overall Study||44||
59793167|NCT02636439|75913722|FG001|STARTED|Overall Study||44||
59793168|NCT02636439|75913721|FG000|COMPLETED|Overall Study||38||
59793169|NCT02636439|75913722|FG001|COMPLETED|Overall Study||41||
59793170|NCT02636439|75913721|FG000|NOT COMPLETED|Overall Study||6||
59793171|NCT02636439|75913722|FG001|NOT COMPLETED|Overall Study||3||
59793172|NCT00343915|75913730|FG000|STARTED|Primary Study||258||
59793173|NCT00343915|75913731|FG001|STARTED|Primary Study||126||
59793174|NCT00343915|75913730|FG000|COMPLETED|Primary Study||254||
59793175|NCT00343915|75913731|FG001|COMPLETED|Primary Study||123||
59793176|NCT00343915|75913730|FG000|NOT COMPLETED|Primary Study||4||
59793177|NCT00343915|75913731|FG001|NOT COMPLETED|Primary Study||3||
59793178|NCT00343915|75913730|FG000|STARTED|Month 30 Follow-up|Subjects, previously vaccinated, that returned for the Month 30 follow-up.|179||
59793179|NCT00343915|75913731|FG001|STARTED|Month 30 Follow-up||88||
59793180|NCT00343915|75913730|FG000|COMPLETED|Month 30 Follow-up||179||
59793181|NCT00343915|75913731|FG001|COMPLETED|Month 30 Follow-up||88||
59793182|NCT00343915|75913730|FG000|NOT COMPLETED|Month 30 Follow-up||0||
59793183|NCT00343915|75913731|FG001|NOT COMPLETED|Month 30 Follow-up||0||
59793184|NCT00343915|75913730|FG000|STARTED|Month 42 Follow-up|Subjects, previously vaccinated, that returned for the Month 42 follow-up.|174||
59793185|NCT00343915|75913731|FG001|STARTED|Month 42 Follow-up||84||
59793186|NCT00343915|75913730|FG000|COMPLETED|Month 42 Follow-up||174||
59793187|NCT00343915|75913731|FG001|COMPLETED|Month 42 Follow-up||84||
59793188|NCT00343915|75913730|FG000|NOT COMPLETED|Month 42 Follow-up||0||
59793189|NCT00343915|75913731|FG001|NOT COMPLETED|Month 42 Follow-up||0||
59953898|NCT01367847|76072276|FG001|NOT COMPLETED|Overall Study||2||
59953899|NCT00150618|76072288|FG000|STARTED|Overall Study||62||
59953900|NCT00150618|76072289|FG001|STARTED|Overall Study||65||
59953901|NCT00150618|76072290|FG002|STARTED|Overall Study||65||
59953902|NCT00150618|76072291|FG003|STARTED|Overall Study||66||
59953903|NCT00150618|76072292|FG004|STARTED|Overall Study||66||
59953904|NCT00150618|76072288|FG000|COMPLETED|Overall Study||45||
59793190|NCT00343915|75913730|FG000|STARTED|Month 54 Follow-up|Subjects, previously vaccinated, that returned for the Month 54 follow-up.|166||
59793191|NCT00343915|75913731|FG001|STARTED|Month 54 Follow-up||79||
59793192|NCT00343915|75913730|FG000|COMPLETED|Month 54 Follow-up||166||
59793193|NCT00343915|75913731|FG001|COMPLETED|Month 54 Follow-up||79||
59793194|NCT00343915|75913730|FG000|NOT COMPLETED|Month 54 Follow-up||0||
59793195|NCT00343915|75913731|FG001|NOT COMPLETED|Month 54 Follow-up||0||
59793196|NCT00343915|75913730|FG000|STARTED|Month 66 Follow-up|Subjects, previously vaccinated, that returned for the Month 66 follow-up.|158||
59793197|NCT00343915|75913731|FG001|STARTED|Month 66 Follow-up||76||
59793198|NCT00343915|75913730|FG000|COMPLETED|Month 66 Follow-up||158||
59793199|NCT00343915|75913731|FG001|COMPLETED|Month 66 Follow-up||76||
59793200|NCT00343915|75913730|FG000|NOT COMPLETED|Month 66 Follow-up||0||
59793201|NCT00343915|75913731|FG001|NOT COMPLETED|Month 66 Follow-up||0||
59793202|NCT00575666|75913742|FG000|STARTED|Overall Study||21||
59793203|NCT00575666|75913743|FG001|STARTED|Overall Study||24||
59793204|NCT00575666|75913742|FG000|COMPLETED|Overall Study||17||
59793205|NCT00575666|75913743|FG001|COMPLETED|Overall Study||21||
59793206|NCT00575666|75913742|FG000|NOT COMPLETED|Overall Study||4||
59793207|NCT00575666|75913743|FG001|NOT COMPLETED|Overall Study||3||
59793208|NCT00658632|75913751|FG000|STARTED|Overall Study|Treated|682||
59793209|NCT00658632|75913752|FG001|STARTED|Overall Study|Treated|698||
59793210|NCT00658632|75913751|FG000|COMPLETED|Overall Study||618||
59793211|NCT00658632|75913752|FG001|COMPLETED|Overall Study||633||
59793212|NCT00658632|75913751|FG000|NOT COMPLETED|Overall Study||64||
59793213|NCT00658632|75913752|FG001|NOT COMPLETED|Overall Study||65||
59793214|NCT00677534|75913758|FG000|STARTED|Washout (Weeks 1-4)||10||
59953905|NCT00150618|76072289|FG001|COMPLETED|Overall Study||47||
59953906|NCT00150618|76072290|FG002|COMPLETED|Overall Study||38||
59953907|NCT00150618|76072291|FG003|COMPLETED|Overall Study||40||
59953908|NCT00150618|76072292|FG004|COMPLETED|Overall Study||41||
59953909|NCT00150618|76072288|FG000|NOT COMPLETED|Overall Study||17||
59953910|NCT00150618|76072289|FG001|NOT COMPLETED|Overall Study||18||
60073550|NCT01689207|76188787|FG003|NOT COMPLETED|Overall Study||0||
59793215|NCT00677534|75913758|FG000|COMPLETED|Washout (Weeks 1-4)||7||
59793216|NCT00677534|75913758|FG000|NOT COMPLETED|Washout (Weeks 1-4)||3||
59793217|NCT00677534|75913758|FG000|STARTED|Cholecalciferol (Weeks 5-12)||7||
59793218|NCT00677534|75913758|FG000|COMPLETED|Cholecalciferol (Weeks 5-12)||7||
59793219|NCT00677534|75913758|FG000|NOT COMPLETED|Cholecalciferol (Weeks 5-12)||0||
59793220|NCT00677534|75913758|FG000|STARTED|After Paricalcitol Restart (Weeks 13-14)||7||
59793221|NCT00677534|75913758|FG000|COMPLETED|After Paricalcitol Restart (Weeks 13-14)||7||
59793222|NCT00677534|75913758|FG000|NOT COMPLETED|After Paricalcitol Restart (Weeks 13-14)||0||
59793223|NCT00660348|75913764|FG000|STARTED|Overall Study||1||
59793224|NCT00660348|75913765|FG001|STARTED|Overall Study||0||
59793225|NCT00660348|75913764|FG000|COMPLETED|Overall Study||0||
59953911|NCT00150618|76072290|FG002|NOT COMPLETED|Overall Study||27||
59953912|NCT00150618|76072291|FG003|NOT COMPLETED|Overall Study||26||
59793226|NCT00660348|75913765|FG001|COMPLETED|Overall Study||0||
59793227|NCT00660348|75913764|FG000|NOT COMPLETED|Overall Study||1||
59793228|NCT00660348|75913765|FG001|NOT COMPLETED|Overall Study||0||
59793229|NCT00660192|75913773|FG000|STARTED|Overall Study||12||
59793230|NCT00660192|75913774|FG001|STARTED|Overall Study||13||
59793231|NCT00660192|75913773|FG000|COMPLETED|Overall Study||10||
59793232|NCT00660192|75913774|FG001|COMPLETED|Overall Study||10||
59793233|NCT00660192|75913773|FG000|NOT COMPLETED|Overall Study||2||
59793234|NCT00660192|75913774|FG001|NOT COMPLETED|Overall Study||3||
59793235|NCT00571688|75913782|FG000|STARTED|Overall Study||25||
59793236|NCT00571688|75913783|FG001|STARTED|Overall Study||25||
59793237|NCT00571688|75913782|FG000|COMPLETED|Overall Study||20||
59793238|NCT00571688|75913783|FG001|COMPLETED|Overall Study||19||
59793239|NCT00571688|75913782|FG000|NOT COMPLETED|Overall Study||5||
59793240|NCT00571688|75913783|FG001|NOT COMPLETED|Overall Study||6||
59793241|NCT00343291|75913791|FG000|STARTED|Overall Study||60||
59793242|NCT00343291|75913792|FG001|STARTED|Overall Study||61||
59793243|NCT00343291|75913791|FG000|RECEIVED AT LEAST ONE DOSE OF STUDY DRUG|Overall Study||58||
59793244|NCT00343291|75913792|FG001|RECEIVED AT LEAST ONE DOSE OF STUDY DRUG|Overall Study||58||
59793245|NCT00343291|75913791|FG000|COMPLETED|Overall Study|Participants completed 6 cycles of treatment. Did not start subsequent weekly cetuximab monotherapy.|3||
59793246|NCT00343291|75913792|FG001|COMPLETED|Overall Study|Participants completed 6 cycles of treatment. Did not start subsequent weekly cetuximab monotherapy.|5||
59793247|NCT00343291|75913791|FG000|NOT COMPLETED|Overall Study||57||
59793248|NCT00343291|75913792|FG001|NOT COMPLETED|Overall Study||56||
59793249|NCT00658788|75913798|FG000|STARTED|Overall Study||305||
59793250|NCT00658788|75913798|FG000|COMPLETED|Overall Study||231||
59793251|NCT00658788|75913798|FG000|NOT COMPLETED|Overall Study||74||
59793252|NCT04829214|75913813|FG000|STARTED|Randomization||77||
59793253|NCT04829214|75913814|FG001|STARTED|Randomization||76||
59793254|NCT04829214|75913813|FG000|COMPLETED|Randomization||77||
59793255|NCT04829214|75913814|FG001|COMPLETED|Randomization||76||
59793256|NCT04829214|75913813|FG000|NOT COMPLETED|Randomization||0||
59793257|NCT04829214|75913814|FG001|NOT COMPLETED|Randomization||0||
59793258|NCT04829214|75913813|FG000|STARTED|Follow-up and Efficacy Analysis||77||
59793259|NCT04829214|75913814|FG001|STARTED|Follow-up and Efficacy Analysis||76||
59793260|NCT04829214|75913813|FG000|COMPLETED|Follow-up and Efficacy Analysis||70||
59793261|NCT04829214|75913814|FG001|COMPLETED|Follow-up and Efficacy Analysis||72||
59793262|NCT04829214|75913813|FG000|NOT COMPLETED|Follow-up and Efficacy Analysis||7||
59793263|NCT04829214|75913814|FG001|NOT COMPLETED|Follow-up and Efficacy Analysis||4||
59793264|NCT00562965|75913824|FG000|STARTED|Overall Study||15||
59793265|NCT00562965|75913825|FG001|STARTED|Overall Study||14||
59793266|NCT00562965|75913824|FG000|Treated|Overall Study||15||
59953913|NCT00150618|76072292|FG004|NOT COMPLETED|Overall Study||25||
59793267|NCT00562965|75913825|FG001|Treated|Overall Study||13||
59793268|NCT00562965|75913824|FG000|COMPLETED|Overall Study||12||
59793269|NCT00562965|75913825|FG001|COMPLETED|Overall Study||8||
59793270|NCT00562965|75913824|FG000|NOT COMPLETED|Overall Study||3||
59793271|NCT00562965|75913825|FG001|NOT COMPLETED|Overall Study||6||
59793272|NCT00537082|75913834|FG000|STARTED|Overall Study||57||
59793273|NCT00537082|75913835|FG001|STARTED|Overall Study||57||
59793274|NCT00537082|75913836|FG002|STARTED|Overall Study||57||
59793275|NCT00537082|75913834|FG000|COMPLETED|Overall Study||48||
59793276|NCT00537082|75913835|FG001|COMPLETED|Overall Study||48||
59793277|NCT00537082|75913836|FG002|COMPLETED|Overall Study||51||
59793278|NCT00537082|75913834|FG000|NOT COMPLETED|Overall Study||9||
59793279|NCT00537082|75913835|FG001|NOT COMPLETED|Overall Study||9||
59793280|NCT00537082|75913836|FG002|NOT COMPLETED|Overall Study||6||
59793281|NCT03828487|75913844|FG000|STARTED|Overall Study||8||
59793282|NCT03828487|75913844|FG000|COMPLETED|Overall Study||7||
59793283|NCT03828487|75913844|FG000|NOT COMPLETED|Overall Study||1||
59793284|NCT00324961|75913848|FG000|STARTED|Overall Study||533||
59793285|NCT00324961|75913848|FG000|COMPLETED|Overall Study||490||
59793286|NCT00324961|75913848|FG000|NOT COMPLETED|Overall Study||43||
59793287|NCT00324649|75913856|FG000|STARTED|Overall Study||39||
59793288|NCT00324649|75913857|FG001|STARTED|Overall Study||41||
59793289|NCT00324649|75913856|FG000|COMPLETED|Overall Study||37||
59793290|NCT00324649|75913857|FG001|COMPLETED|Overall Study||36||
59793291|NCT00324649|75913856|FG000|NOT COMPLETED|Overall Study||2||
59793292|NCT00324649|75913857|FG001|NOT COMPLETED|Overall Study||5||
59793293|NCT00656370|75913863|FG000|STARTED|Overall Study|25 subjects were assessed for eligibility and signed an Informed Consent Form.|25||
59793294|NCT00656370|75913863|FG000|COMPLETED|Overall Study|15 subjects were randomized and completed stage 1 (received both NS and LR).|15||
59793295|NCT00656370|75913863|FG000|NOT COMPLETED|Overall Study||10||
59793296|NCT00680186|75913871|FG000|STARTED|Overall Study|Started treatment.|1280||
59793297|NCT00680186|75913872|FG001|STARTED|Overall Study|Started treatment.|1288||
59793298|NCT00680186|75913871|FG000|COMPLETED|Overall Study|Completed planned observation time.|1155||
59793299|NCT00680186|75913872|FG001|COMPLETED|Overall Study|Completed planned observation time.|1172||
59793300|NCT00680186|75913871|FG000|NOT COMPLETED|Overall Study||125||
59793301|NCT00680186|75913872|FG001|NOT COMPLETED|Overall Study||116||
59793302|NCT00656292|75913880|FG000|STARTED|Overall Study||32||
59793303|NCT00656292|75913881|FG001|STARTED|Overall Study||29||
59793304|NCT00656292|75913880|FG000|COMPLETED|Overall Study||29||
59793305|NCT00656292|75913881|FG001|COMPLETED|Overall Study||24||
59793306|NCT00656292|75913880|FG000|NOT COMPLETED|Overall Study||3||
59793307|NCT00656292|75913881|FG001|NOT COMPLETED|Overall Study||5||
59793308|NCT00352417|75913889|FG000|STARTED|Overall Study||24||
59793309|NCT00352417|75913890|FG001|STARTED|Overall Study||26||
59793310|NCT00352417|75913889|FG000|COMPLETED|Overall Study||19||
59793311|NCT00352417|75913890|FG001|COMPLETED|Overall Study||21||
59793312|NCT00352417|75913889|FG000|NOT COMPLETED|Overall Study||5||
59793313|NCT00352417|75913890|FG001|NOT COMPLETED|Overall Study||5||
59793314|NCT00323869|75913896|FG000|STARTED|Overall Study|Enrollment|48||
59793315|NCT00323869|75913896|FG000|Treatment Initiation|Overall Study|One participant died before receiving therapy, not included in analysis|47||
59793316|NCT00323869|75913896|FG000|COMPLETED|Overall Study||47||
59793317|NCT00323869|75913896|FG000|NOT COMPLETED|Overall Study||1||
59793318|NCT00323557|75913902|FG000|STARTED|Overall Study|GM-CSF pre and post vaccine.|25||
59793319|NCT00323557|75913903|FG001|STARTED|Overall Study||7||
59793320|NCT00323557|75913902|FG000|COMPLETED|Overall Study||24||
59793321|NCT00323557|75913903|FG001|COMPLETED|Overall Study||7||
59793322|NCT00323557|75913902|FG000|NOT COMPLETED|Overall Study||1||
59793323|NCT00323557|75913903|FG001|NOT COMPLETED|Overall Study||0||
59793324|NCT00558363|75913912|FG000|STARTED|Overall Study||147||
59793325|NCT00558363|75913913|FG001|STARTED|Overall Study||147||
59793326|NCT00558363|75913912|FG000|COMPLETED|Overall Study||76||
59793327|NCT00558363|75913913|FG001|COMPLETED|Overall Study||111||
59793328|NCT00558363|75913912|FG000|NOT COMPLETED|Overall Study||71||
59793329|NCT00558363|75913913|FG001|NOT COMPLETED|Overall Study||36||
59793330|NCT00323479|75913919|FG000|STARTED|Overall Study||114||
59793331|NCT00323479|75913919|FG000|Safety Population|Overall Study|Patients who taken at least one dose of treatment|110||
59793332|NCT00323479|75913919|FG000|COMPLETED|Overall Study|with at least 1 evaluation for primary efficacy endpoint|106||
59793333|NCT00323479|75913919|FG000|NOT COMPLETED|Overall Study||8||
59793334|NCT00352105|75913923|FG000|STARTED|Overall Study||60||
59793335|NCT00352105|75913923|FG000|COMPLETED|Overall Study||20||
59793336|NCT00352105|75913923|FG000|NOT COMPLETED|Overall Study||40||
59793337|NCT00350779|75913929|FG000|STARTED|Overall Study||170||
59793338|NCT00350779|75913930|FG001|STARTED|Overall Study||92||
59793339|NCT00350779|75913929|FG000|COMPLETED|Overall Study||148||
59793340|NCT00350779|75913930|FG001|COMPLETED|Overall Study||71||
59793341|NCT00350779|75913929|FG000|NOT COMPLETED|Overall Study||22||
59793342|NCT00350779|75913930|FG001|NOT COMPLETED|Overall Study||21||
59793343|NCT00350623|75913941|FG000|STARTED|Overall Study||71||
59793344|NCT00350623|75913942|FG001|STARTED|Overall Study||71||
59793345|NCT00350623|75913943|FG002|STARTED|Overall Study||68||
59793346|NCT00350623|75913941|FG000|COMPLETED|Overall Study||63||
59793347|NCT00350623|75913942|FG001|COMPLETED|Overall Study||67||
59793348|NCT00350623|75913943|FG002|COMPLETED|Overall Study||62||
59793349|NCT00350623|75913941|FG000|NOT COMPLETED|Overall Study||8||
59793350|NCT00350623|75913942|FG001|NOT COMPLETED|Overall Study||4||
59793351|NCT00350623|75913943|FG002|NOT COMPLETED|Overall Study||6||
59793352|NCT00656136|75913953|FG000|STARTED|Overall Study|Randomised patients.|195||
59793353|NCT00656136|75913954|FG001|STARTED|Overall Study|Randomised patients.|390||
59793354|NCT00656136|75913953|FG000|COMPLETED|Overall Study||0||
59793355|NCT00656136|75913954|FG001|COMPLETED|Overall Study||0||
59793356|NCT00656136|75913953|FG000|NOT COMPLETED|Overall Study||195||
59793357|NCT00656136|75913954|FG001|NOT COMPLETED|Overall Study||390||
59793358|NCT00676520|75913960|FG000|STARTED|Overall Study||8040||
59793359|NCT00676520|75913960|FG000|COMPLETED|Overall Study||7309||
59793360|NCT00676520|75913960|FG000|NOT COMPLETED|Overall Study||731||
59793361|NCT00652938|75913972|FG000|STARTED|Overall Study||247||
59793362|NCT00652938|75913973|FG001|STARTED|Overall Study||247||
59793363|NCT00652938|75913974|FG002|STARTED|Overall Study||247||
59793364|NCT00652938|75913972|FG000|COMPLETED|Overall Study||246||
59793365|NCT00652938|75913973|FG001|COMPLETED|Overall Study||240||
59793366|NCT00652938|75913974|FG002|COMPLETED|Overall Study||242||
59793367|NCT00652938|75913972|FG000|NOT COMPLETED|Overall Study||1||
59793368|NCT00652938|75913973|FG001|NOT COMPLETED|Overall Study||7||
59793369|NCT00652938|75913974|FG002|NOT COMPLETED|Overall Study||5||
59793370|NCT00322621|75913982|FG000|STARTED|Period II - Acute Therapy Phase||216||
59793371|NCT00322621|75913983|FG001|STARTED|Period II - Acute Therapy Phase||0||
59793372|NCT00322621|75913984|FG002|STARTED|Period II - Acute Therapy Phase||0||
59793373|NCT00322621|75913982|FG000|COMPLETED|Period II - Acute Therapy Phase||184||
59793374|NCT00322621|75913983|FG001|COMPLETED|Period II - Acute Therapy Phase||0||
59793375|NCT00322621|75913984|FG002|COMPLETED|Period II - Acute Therapy Phase||0||
59793376|NCT00322621|75913982|FG000|NOT COMPLETED|Period II - Acute Therapy Phase||32||
59793377|NCT00322621|75913983|FG001|NOT COMPLETED|Period II - Acute Therapy Phase||0||
59793378|NCT00322621|75913984|FG002|NOT COMPLETED|Period II - Acute Therapy Phase||0||
59793379|NCT00322621|75913982|FG000|STARTED|Period III - Maintenance / Rescue Phase||0||
59793380|NCT00322621|75913983|FG001|STARTED|Period III - Maintenance / Rescue Phase||115||
59793381|NCT00322621|75913984|FG002|STARTED|Period III - Maintenance / Rescue Phase||69||
59793382|NCT00322621|75913982|FG000|COMPLETED|Period III - Maintenance / Rescue Phase||0||
59793383|NCT00322621|75913983|FG001|COMPLETED|Period III - Maintenance / Rescue Phase||86||
59793384|NCT00322621|75913984|FG002|COMPLETED|Period III - Maintenance / Rescue Phase||33||
59793385|NCT00322621|75913982|FG000|NOT COMPLETED|Period III - Maintenance / Rescue Phase||0||
59793386|NCT00322621|75913983|FG001|NOT COMPLETED|Period III - Maintenance / Rescue Phase||29||
59793387|NCT00322621|75913984|FG002|NOT COMPLETED|Period III - Maintenance / Rescue Phase||36||
59793388|NCT00575042|75913997|FG000|STARTED|Overall Study||20||
59793389|NCT00575042|75913997|FG000|COMPLETED|Overall Study|2 with side effects and 1 lost to follow-up|17||
59793390|NCT00575042|75913997|FG000|NOT COMPLETED|Overall Study||3||
59793391|NCT00676208|75914004|FG000|STARTED|Overall Study||14||
59793392|NCT00676208|75914005|FG001|STARTED|Overall Study||19||
59793393|NCT00676208|75914004|FG000|COMPLETED|Overall Study||12||
59793394|NCT00676208|75914005|FG001|COMPLETED|Overall Study||13||
59793395|NCT00676208|75914004|FG000|NOT COMPLETED|Overall Study||2||
59793396|NCT00676208|75914005|FG001|NOT COMPLETED|Overall Study||6||
59793397|NCT00656058|75914013|FG000|STARTED|Overall Study||25||
59793398|NCT00656058|75914013|FG000|COMPLETED|Overall Study||19||
59793399|NCT00656058|75914013|FG000|NOT COMPLETED|Overall Study||6||
59793400|NCT00537316|75914023|FG000|STARTED|Part 1||79||
59793401|NCT00537316|75914024|FG001|STARTED|Part 1||80||
59793402|NCT00537316|75914025|FG002|STARTED|Part 1||80||
59793403|NCT00537316|75914026|FG003|STARTED|Part 1||0||
59793404|NCT00537316|75914027|FG004|STARTED|Part 1||0||
59793405|NCT00537316|75914028|FG005|STARTED|Part 1||0||
59793406|NCT00537316|75914029|FG006|STARTED|Part 1||0||
59793407|NCT00537316|75914023|FG000|COMPLETED|Part 1||65||
59793408|NCT00537316|75914024|FG001|COMPLETED|Part 1||53||
59793409|NCT00537316|75914025|FG002|COMPLETED|Part 1||63||
59793410|NCT00537316|75914026|FG003|COMPLETED|Part 1||0||
59793411|NCT00537316|75914027|FG004|COMPLETED|Part 1||0||
59793412|NCT00537316|75914028|FG005|COMPLETED|Part 1||0||
59793413|NCT00537316|75914029|FG006|COMPLETED|Part 1||0||
59793414|NCT00537316|75914023|FG000|NOT COMPLETED|Part 1||14||
59793415|NCT00537316|75914024|FG001|NOT COMPLETED|Part 1||27||
59793416|NCT00537316|75914025|FG002|NOT COMPLETED|Part 1||17||
59793417|NCT00537316|75914026|FG003|NOT COMPLETED|Part 1||0||
59793418|NCT00537316|75914027|FG004|NOT COMPLETED|Part 1||0||
59793419|NCT00537316|75914028|FG005|NOT COMPLETED|Part 1||0||
59793420|NCT00537316|75914029|FG006|NOT COMPLETED|Part 1||0||
59793421|NCT00537316|75914023|FG000|STARTED|Part 2||37||
59793422|NCT00537316|75914024|FG001|STARTED|Part 2||10||
59793423|NCT00537316|75914025|FG002|STARTED|Part 2||48||
59793424|NCT00537316|75914026|FG003|STARTED|Part 2||5||
59793425|NCT00537316|75914027|FG004|STARTED|Part 2||2||
59793426|NCT00537316|75914028|FG005|STARTED|Part 2||4||
59793427|NCT00537316|75914029|FG006|STARTED|Part 2||2||
59793428|NCT00537316|75914023|FG000|COMPLETED|Part 2||11||
59793429|NCT00537316|75914024|FG001|COMPLETED|Part 2||1||
59793430|NCT00537316|75914025|FG002|COMPLETED|Part 2||16||
59793431|NCT00537316|75914026|FG003|COMPLETED|Part 2||2||
59793432|NCT00537316|75914027|FG004|COMPLETED|Part 2||1||
59793433|NCT00537316|75914028|FG005|COMPLETED|Part 2||0||
59793434|NCT00537316|75914029|FG006|COMPLETED|Part 2||0||
59793435|NCT00537316|75914023|FG000|NOT COMPLETED|Part 2||26||
59793436|NCT00537316|75914024|FG001|NOT COMPLETED|Part 2||9||
59793437|NCT00537316|75914025|FG002|NOT COMPLETED|Part 2||32||
59793438|NCT00537316|75914026|FG003|NOT COMPLETED|Part 2||3||
59793439|NCT00537316|75914027|FG004|NOT COMPLETED|Part 2||1||
59793440|NCT00537316|75914028|FG005|NOT COMPLETED|Part 2||4||
59793441|NCT00537316|75914029|FG006|NOT COMPLETED|Part 2||2||
59793442|NCT03827395|75914050|FG000|STARTED|Overall Study||20||
59793443|NCT03827395|75914051|FG001|STARTED|Overall Study||5||
59793444|NCT03827395|75914050|FG000|COMPLETED|Overall Study||17||
59793445|NCT03827395|75914051|FG001|COMPLETED|Overall Study||3||
59793446|NCT03827395|75914050|FG000|NOT COMPLETED|Overall Study||3||
59793447|NCT03827395|75914051|FG001|NOT COMPLETED|Overall Study||2||
59793448|NCT00655980|75914060|FG000|STARTED|Overall Study||276||
59793449|NCT00655980|75914061|FG001|STARTED|Overall Study||281||
59793450|NCT00655980|75914062|FG002|STARTED|Overall Study||130||
59793451|NCT00655980|75914060|FG000|COMPLETED|Overall Study||250||
59793452|NCT00655980|75914061|FG001|COMPLETED|Overall Study||250||
59793453|NCT00655980|75914062|FG002|COMPLETED|Overall Study||125||
59793454|NCT00655980|75914060|FG000|NOT COMPLETED|Overall Study||26||
59793455|NCT00655980|75914061|FG001|NOT COMPLETED|Overall Study||31||
59793456|NCT00655980|75914062|FG002|NOT COMPLETED|Overall Study||5||
59793457|NCT00679172|75914078|FG000|STARTED|Overall Study||37||
59793458|NCT00679172|75914079|FG001|STARTED|Overall Study||38||
59793459|NCT00679172|75914080|FG002|STARTED|Overall Study||36||
59793460|NCT00679172|75914081|FG003|STARTED|Overall Study||39||
59793461|NCT00679172|75914082|FG004|STARTED|Overall Study||37||
59793462|NCT00679172|75914078|FG000|COMPLETED|Overall Study||36||
59793463|NCT00679172|75914079|FG001|COMPLETED|Overall Study||37||
59793464|NCT00679172|75914080|FG002|COMPLETED|Overall Study||35||
59793465|NCT00679172|75914081|FG003|COMPLETED|Overall Study||38||
59793466|NCT00679172|75914082|FG004|COMPLETED|Overall Study||37||
59793467|NCT00679172|75914078|FG000|NOT COMPLETED|Overall Study||1||
59793468|NCT00679172|75914079|FG001|NOT COMPLETED|Overall Study||1||
59793469|NCT00679172|75914080|FG002|NOT COMPLETED|Overall Study||1||
59793470|NCT00679172|75914081|FG003|NOT COMPLETED|Overall Study||1||
59793471|NCT00679172|75914082|FG004|NOT COMPLETED|Overall Study||0||
59793472|NCT00676130|75914099|FG000|STARTED|Overall Study||76||
59793473|NCT00676130|75914100|FG001|STARTED|Overall Study||77||
59793474|NCT00676130|75914099|FG000|COMPLETED|Overall Study||73||
59793475|NCT00676130|75914100|FG001|COMPLETED|Overall Study||73||
59793476|NCT00676130|75914099|FG000|NOT COMPLETED|Overall Study||3||
59793477|NCT00676130|75914100|FG001|NOT COMPLETED|Overall Study||4||
59793478|NCT00676052|75914112|FG000|STARTED|Overall Study||96||
59793479|NCT00676052|75914113|FG001|STARTED|Overall Study||95||
59793480|NCT00676052|75914114|FG002|STARTED|Overall Study||96||
59793481|NCT00676052|75914115|FG003|STARTED|Overall Study||97||
59793482|NCT00676052|75914116|FG004|STARTED|Overall Study||95||
59793483|NCT00676052|75914117|FG005|STARTED|Overall Study||97||
59793484|NCT00676052|75914112|FG000|COMPLETED|Overall Study||87||
59793485|NCT00676052|75914113|FG001|COMPLETED|Overall Study||88||
59793486|NCT00676052|75914114|FG002|COMPLETED|Overall Study||90||
59793487|NCT00676052|75914115|FG003|COMPLETED|Overall Study||92||
59793488|NCT00676052|75914116|FG004|COMPLETED|Overall Study||89||
59953914|NCT01359046|76072306|FG000|STARTED|Overall Study||144||
59793489|NCT00676052|75914117|FG005|COMPLETED|Overall Study||91||
59793490|NCT00676052|75914112|FG000|NOT COMPLETED|Overall Study||9||
59793491|NCT00676052|75914113|FG001|NOT COMPLETED|Overall Study||7||
59793492|NCT00676052|75914114|FG002|NOT COMPLETED|Overall Study||6||
59793493|NCT00676052|75914115|FG003|NOT COMPLETED|Overall Study||5||
59793494|NCT00676052|75914116|FG004|NOT COMPLETED|Overall Study||6||
59793495|NCT00676052|75914117|FG005|NOT COMPLETED|Overall Study||6||
59793496|NCT00535288|75914136|FG000|STARTED|Overall Study|2 participants randomized to receive placebo did not receive placebo|314||
59793497|NCT00535288|75914137|FG001|STARTED|Overall Study||162||
59793498|NCT00535288|75914138|FG002|STARTED|Overall Study||160||
59793499|NCT00535288|75914139|FG003|STARTED|Overall Study||151||
59793500|NCT00535288|75914140|FG004|STARTED|Overall Study|One participant randomized to receive placebo received esmirtazapine 18 mg.|158||
59793501|NCT00535288|75914136|FG000|COMPLETED|Overall Study||260||
59793502|NCT00535288|75914137|FG001|COMPLETED|Overall Study||130||
59793503|NCT00535288|75914138|FG002|COMPLETED|Overall Study||127||
59793504|NCT00535288|75914139|FG003|COMPLETED|Overall Study||122||
59793505|NCT00535288|75914140|FG004|COMPLETED|Overall Study||116||
59793506|NCT00535288|75914136|FG000|NOT COMPLETED|Overall Study||54||
59793507|NCT00535288|75914137|FG001|NOT COMPLETED|Overall Study||32||
59793508|NCT00535288|75914138|FG002|NOT COMPLETED|Overall Study||33||
59793509|NCT00535288|75914139|FG003|NOT COMPLETED|Overall Study||29||
59793510|NCT00535288|75914140|FG004|NOT COMPLETED|Overall Study||42||
59793511|NCT03904420|75914159|FG000|STARTED|Overall Study||2||
59793512|NCT03904420|75914160|FG001|STARTED|Overall Study||2||
59793513|NCT03904420|75914159|FG000|COMPLETED|Overall Study||0||
59793514|NCT03904420|75914160|FG001|COMPLETED|Overall Study||0||
59793515|NCT03904420|75914159|FG000|NOT COMPLETED|Overall Study||2||
59793516|NCT03904420|75914160|FG001|NOT COMPLETED|Overall Study||2||
59793517|NCT00675506|75914168|FG000|STARTED|Overall Study||31||
59793518|NCT00675506|75914169|FG001|STARTED|Overall Study||29||
59793519|NCT00675506|75914168|FG000|Received Intervention|Overall Study|Two subjects did not start treatment: 1) disclosed cancer history, 2) declined participation.|29||
59793520|NCT00675506|75914169|FG001|Received Intervention|Overall Study||29||
59793521|NCT00675506|75914168|FG000|COMPLETED|Overall Study||19||
59793522|NCT00675506|75914169|FG001|COMPLETED|Overall Study||17||
59793523|NCT00675506|75914168|FG000|NOT COMPLETED|Overall Study||12||
59793524|NCT00675506|75914169|FG001|NOT COMPLETED|Overall Study||12||
59523417|NCT00593320|75618237|FG001|NOT COMPLETED|Overall Study||0||
59793525|NCT03895840|75914176|FG000|STARTED|Overall Study||70||
59793526|NCT03895840|75914176|FG000|6-Week Follow-Up|Overall Study||70||
59793527|NCT03895840|75914176|FG000|12-Week Follow-Up|Overall Study||65||
59793528|NCT03895840|75914176|FG000|24-Week Follow-Up|Overall Study||49||
59793529|NCT03895840|75914176|FG000|COMPLETED|Overall Study||49|Primary outcome measures were a priori defined at the 12-week follow-up, while 24-week measurements were included for extended follow-up|
59793530|NCT03895840|75914176|FG000|NOT COMPLETED|Overall Study||21||
59793531|NCT00310375|75914182|FG000|STARTED|Primary Reporting Phase||102||
59793532|NCT00310375|75914183|FG001|STARTED|Primary Reporting Phase||79||
59793533|NCT00310375|75914184|FG002|STARTED|Primary Reporting Phase||0||
59793534|NCT00310375|75914182|FG000|COMPLETED|Primary Reporting Phase||11||
59793535|NCT00310375|75914183|FG001|COMPLETED|Primary Reporting Phase||11||
59793536|NCT00310375|75914184|FG002|COMPLETED|Primary Reporting Phase||0||
59793537|NCT00310375|75914182|FG000|NOT COMPLETED|Primary Reporting Phase||91||
59793538|NCT00310375|75914183|FG001|NOT COMPLETED|Primary Reporting Phase||68||
59793539|NCT00310375|75914184|FG002|NOT COMPLETED|Primary Reporting Phase||0||
59793540|NCT00310375|75914182|FG000|STARTED|Safety Follow-up Continuation Phase||0||
59793541|NCT00310375|75914183|FG001|STARTED|Safety Follow-up Continuation Phase||0||
59793542|NCT00310375|75914184|FG002|STARTED|Safety Follow-up Continuation Phase||19||
59793543|NCT00310375|75914182|FG000|COMPLETED|Safety Follow-up Continuation Phase||0||
59523418|NCT00421954|75618243|FG000|STARTED|Overall Study||0||
59523419|NCT00421954|75618243|FG000|COMPLETED|Overall Study||0||
59793544|NCT00310375|75914183|FG001|COMPLETED|Safety Follow-up Continuation Phase||0||
59793545|NCT00310375|75914184|FG002|COMPLETED|Safety Follow-up Continuation Phase|Met the protocol defined stopping criteria|18||
59793546|NCT00310375|75914182|FG000|NOT COMPLETED|Safety Follow-up Continuation Phase||0||
59793547|NCT00310375|75914183|FG001|NOT COMPLETED|Safety Follow-up Continuation Phase||0||
59793548|NCT00310375|75914184|FG002|NOT COMPLETED|Safety Follow-up Continuation Phase||1||
59793549|NCT00309907|75914193|FG000|STARTED|Overall Study||39||
59793550|NCT00309907|75914193|FG000|COMPLETED|Overall Study||19||
59793551|NCT00309907|75914193|FG000|NOT COMPLETED|Overall Study||20||
59793552|NCT00655824|75914198|FG000|STARTED|Overall Study||92||
59793553|NCT00655824|75914198|FG000|COMPLETED|Overall Study||8||
59793554|NCT00655824|75914198|FG000|NOT COMPLETED|Overall Study||84||
59793555|NCT00575588|75914204|FG000|STARTED|Overall Study|Randomized and treated|428||
59793556|NCT00575588|75914205|FG001|STARTED|Overall Study|Randomized and treated|430||
59793557|NCT00575588|75914204|FG000|COMPLETED|Overall Study|Completed 104 weeks of treatment|165||
59793558|NCT00575588|75914205|FG001|COMPLETED|Overall Study|Completed 104 weeks of treatment|147||
59793559|NCT00575588|75914204|FG000|NOT COMPLETED|Overall Study||263||
59793560|NCT00575588|75914205|FG001|NOT COMPLETED|Overall Study||283||
59793561|NCT00675428|75914213|FG000|STARTED|Overall Study||3||
59793562|NCT00675428|75914214|FG001|STARTED|Overall Study||3||
59793563|NCT00675428|75914213|FG000|COMPLETED|Overall Study||0||
59793564|NCT00675428|75914214|FG001|COMPLETED|Overall Study||0||
59793565|NCT00675428|75914213|FG000|NOT COMPLETED|Overall Study||3||
59793566|NCT00675428|75914214|FG001|NOT COMPLETED|Overall Study||3||
59793567|NCT04913636|75914222|FG000|STARTED|Overall Study||18||
59793568|NCT04913636|75914223|FG001|STARTED|Overall Study||20||
59793569|NCT04913636|75914222|FG000|COMPLETED|Overall Study||18||
59793570|NCT04913636|75914223|FG001|COMPLETED|Overall Study||20||
59793571|NCT04913636|75914222|FG000|NOT COMPLETED|Overall Study||0||
59793572|NCT04913636|75914223|FG001|NOT COMPLETED|Overall Study||0||
59793573|NCT00557505|75914238|FG000|STARTED|Overall Study||3||
59793574|NCT00557505|75914239|FG001|STARTED|Overall Study||3||
59793575|NCT00557505|75914240|FG002|STARTED|Overall Study||4||
59793576|NCT00557505|75914241|FG003|STARTED|Overall Study||3||
59793577|NCT00557505|75914242|FG004|STARTED|Overall Study||2||
59793578|NCT00557505|75914243|FG005|STARTED|Overall Study||3||
59793579|NCT00557505|75914244|FG006|STARTED|Overall Study||3||
59793580|NCT00557505|75914245|FG007|STARTED|Overall Study||5||
59793581|NCT00557505|75914246|FG008|STARTED|Overall Study||17||
59793582|NCT00557505|75914238|FG000|COMPLETED|Overall Study||0||
59793583|NCT00557505|75914239|FG001|COMPLETED|Overall Study||0||
59793584|NCT00557505|75914240|FG002|COMPLETED|Overall Study||0||
59793585|NCT00557505|75914241|FG003|COMPLETED|Overall Study||0||
59793586|NCT00557505|75914242|FG004|COMPLETED|Overall Study||0||
59793587|NCT00557505|75914243|FG005|COMPLETED|Overall Study||0||
59793588|NCT00557505|75914244|FG006|COMPLETED|Overall Study||0||
59793589|NCT00557505|75914245|FG007|COMPLETED|Overall Study||0||
59793590|NCT00557505|75914246|FG008|COMPLETED|Overall Study||0||
59793591|NCT00557505|75914238|FG000|NOT COMPLETED|Overall Study||3||
59793592|NCT00557505|75914239|FG001|NOT COMPLETED|Overall Study||3||
59793593|NCT00557505|75914240|FG002|NOT COMPLETED|Overall Study||4||
59793594|NCT00557505|75914241|FG003|NOT COMPLETED|Overall Study||3||
59793595|NCT00557505|75914242|FG004|NOT COMPLETED|Overall Study||2||
59793596|NCT00557505|75914243|FG005|NOT COMPLETED|Overall Study||3||
59793597|NCT00557505|75914244|FG006|NOT COMPLETED|Overall Study||3||
59793598|NCT00557505|75914245|FG007|NOT COMPLETED|Overall Study||5||
59793599|NCT00557505|75914246|FG008|NOT COMPLETED|Overall Study||17||
59793600|NCT00674570|75914272|FG000|STARTED|Overall Study||37|5 participants dropped out between screening and randomization to group.|
59793601|NCT00674570|75914273|FG001|STARTED|Overall Study||34|5 participants dropped out between screening and randomization to group.|
59793602|NCT00674570|75914274|FG002|STARTED|Overall Study||35|5 participants dropped out between screening and randomization to group.|
59793603|NCT00674570|75914272|FG000|COMPLETED|Overall Study||37||
59793604|NCT00674570|75914273|FG001|COMPLETED|Overall Study||32||
59793605|NCT00674570|75914274|FG002|COMPLETED|Overall Study||35||
59793606|NCT00674570|75914272|FG000|NOT COMPLETED|Overall Study||0||
59793607|NCT00674570|75914273|FG001|NOT COMPLETED|Overall Study||2||
59793608|NCT00674570|75914274|FG002|NOT COMPLETED|Overall Study||0||
59793609|NCT00561951|75914285|FG000|STARTED|Overall Study||318||
59793610|NCT00561951|75914286|FG001|STARTED|Overall Study||320||
59793611|NCT00561951|75914287|FG002|STARTED|Overall Study||313||
59793612|NCT00561951|75914285|FG000|COMPLETED|Overall Study||285||
59793613|NCT00561951|75914286|FG001|COMPLETED|Overall Study||286||
59793614|NCT00561951|75914287|FG002|COMPLETED|Overall Study||281||
59793615|NCT00561951|75914285|FG000|NOT COMPLETED|Overall Study||33||
59793616|NCT00561951|75914286|FG001|NOT COMPLETED|Overall Study||34||
59793617|NCT00561951|75914287|FG002|NOT COMPLETED|Overall Study||32||
59523420|NCT00421954|75618243|FG000|NOT COMPLETED|Overall Study||0||
59793618|NCT00322387|75914297|FG000|STARTED|Treatment Period|Plerixafor PM=7, Plerixafor AM=6, Low CD34+ Count/Plerixafor PM=0, and Plerixafor After Chemo=1|14||
59793619|NCT00322387|75914298|FG001|STARTED|Treatment Period|Plerixafor PM=12, Plerixafor AM=9, Low CD34+ Count/Plerixafor PM=1, and Plerixafor After Chemo=4|26||
59793620|NCT00322387|75914297|FG000|COMPLETED|Treatment Period|Completed refers to completed all treatment visits.|14||
59793621|NCT00322387|75914298|FG001|COMPLETED|Treatment Period|Completed refers to completed all treatment visits.|25||
59793622|NCT00322387|75914297|FG000|NOT COMPLETED|Treatment Period||0||
59793623|NCT00322387|75914298|FG001|NOT COMPLETED|Treatment Period||1||
59793624|NCT00322387|75914297|FG000|STARTED|Follow-up Period|Participants who had transplants|14||
59793625|NCT00322387|75914298|FG001|STARTED|Follow-up Period|Participants who had transplants. One participant did not complete therapy but had a transplant.|26||
59793626|NCT00322387|75914297|FG000|COMPLETED|Follow-up Period|Follow-up visit 12 months post-transplant|12||
59793627|NCT00322387|75914298|FG001|COMPLETED|Follow-up Period|Follow-up visit 12 months post-transplant|23||
59793628|NCT00322387|75914297|FG000|NOT COMPLETED|Follow-up Period||2||
59793629|NCT00322387|75914298|FG001|NOT COMPLETED|Follow-up Period||3||
59793630|NCT00561015|75914321|FG000|STARTED|Overall Study||9||
59793631|NCT00561015|75914322|FG001|STARTED|Overall Study||5||
59793632|NCT00561015|75914323|FG002|STARTED|Overall Study||9||
59793633|NCT00561015|75914324|FG003|STARTED|Overall Study||8||
59793634|NCT00561015|75914325|FG004|STARTED|Overall Study||9||
59793635|NCT00561015|75914326|FG005|STARTED|Overall Study||9||
59793636|NCT00561015|75914321|FG000|COMPLETED|Overall Study||5||
59793637|NCT00561015|75914322|FG001|COMPLETED|Overall Study||5||
59793638|NCT00561015|75914323|FG002|COMPLETED|Overall Study||9||
59793639|NCT00561015|75914324|FG003|COMPLETED|Overall Study||7||
59793640|NCT00561015|75914325|FG004|COMPLETED|Overall Study||8||
59793641|NCT00561015|75914326|FG005|COMPLETED|Overall Study||6||
59793642|NCT00561015|75914321|FG000|NOT COMPLETED|Overall Study||4||
59793643|NCT00561015|75914322|FG001|NOT COMPLETED|Overall Study||0||
59793644|NCT00561015|75914323|FG002|NOT COMPLETED|Overall Study||0||
59793645|NCT00561015|75914324|FG003|NOT COMPLETED|Overall Study||1||
59793646|NCT00561015|75914325|FG004|NOT COMPLETED|Overall Study||1||
59793647|NCT00561015|75914326|FG005|NOT COMPLETED|Overall Study||3||
59793648|NCT00560937|75914346|FG000|STARTED|Overall Study||10||
59793649|NCT00560937|75914347|FG001|STARTED|Overall Study||11||
59953915|NCT01359046|76072307|FG001|STARTED|Overall Study||144||
59953916|NCT01359046|76072306|FG000|COMPLETED|Overall Study||137||
59953917|NCT01359046|76072307|FG001|COMPLETED|Overall Study||127||
59953918|NCT01359046|76072306|FG000|NOT COMPLETED|Overall Study||7||
59953919|NCT01359046|76072307|FG001|NOT COMPLETED|Overall Study||17||
59953920|NCT02741310|76072315|FG000|STARTED|Overall Study||12||
59953921|NCT02741310|76072316|FG001|STARTED|Overall Study||22||
59953922|NCT02741310|76072315|FG000|COMPLETED|Overall Study||10||
59953923|NCT02741310|76072316|FG001|COMPLETED|Overall Study||20||
59953924|NCT02741310|76072315|FG000|NOT COMPLETED|Overall Study||2||
59953925|NCT02741310|76072316|FG001|NOT COMPLETED|Overall Study||2||
59953926|NCT01367457|76072333|FG000|STARTED|Overall Study||193||
59953927|NCT01367457|76072334|FG001|STARTED|Overall Study||23||
59953928|NCT01367457|76072335|FG002|STARTED|Overall Study||26||
59953929|NCT01367457|76072333|FG000|COMPLETED|Overall Study||5||
59953930|NCT01367457|76072334|FG001|COMPLETED|Overall Study||23||
59953931|NCT01367457|76072335|FG002|COMPLETED|Overall Study||26||
59953932|NCT01367457|76072333|FG000|NOT COMPLETED|Overall Study||188||
59953933|NCT01367457|76072334|FG001|NOT COMPLETED|Overall Study||0||
59953934|NCT01367457|76072335|FG002|NOT COMPLETED|Overall Study||0||
59953935|NCT00235326|76072345|FG000|STARTED|Overall Study||1575||
59793650|NCT00560937|75914346|FG000|COMPLETED|Overall Study|One participant was withdrawn after 6 weeks and data were carried forward|9||
59793651|NCT00560937|75914347|FG001|COMPLETED|Overall Study||9||
59793652|NCT00560937|75914346|FG000|NOT COMPLETED|Overall Study||1||
59953936|NCT00235326|76072346|FG001|STARTED|Overall Study||2986||
59953937|NCT00235326|76072345|FG000|COMPLETED|Overall Study||829||
59953938|NCT00235326|76072346|FG001|COMPLETED|Overall Study||1586||
59953939|NCT00235326|76072345|FG000|NOT COMPLETED|Overall Study||746||
59953940|NCT00235326|76072346|FG001|NOT COMPLETED|Overall Study||1400||
59953941|NCT03065218|76072350|FG000|STARTED|Overall Study||4||
59953942|NCT03065218|76072350|FG000|COMPLETED|Overall Study||4||
59953943|NCT03065218|76072350|FG000|NOT COMPLETED|Overall Study||0||
59953944|NCT00162942|76072356|FG000|STARTED|Overall Study||157||
59953945|NCT00162942|76072357|FG001|STARTED|Overall Study||78||
59523421|NCT00392860|75618249|FG000|STARTED|Overall Study||3||
59523422|NCT00392860|75618250|FG001|STARTED|Overall Study||0||
59523423|NCT00392860|75618251|FG002|STARTED|Overall Study||1||
59523424|NCT00392860|75618249|FG000|COMPLETED|Overall Study||3||
59523425|NCT00392860|75618250|FG001|COMPLETED|Overall Study||0||
59523426|NCT00392860|75618251|FG002|COMPLETED|Overall Study||1||
59793653|NCT00560937|75914347|FG001|NOT COMPLETED|Overall Study||2||
59793654|NCT00561795|75914355|FG000|STARTED|Overall Study||6||
59793655|NCT00561795|75914356|FG001|STARTED|Overall Study||6||
59793656|NCT00561795|75914357|FG002|STARTED|Overall Study||0||
59793657|NCT00561795|75914358|FG003|STARTED|Overall Study||0||
59793658|NCT00561795|75914355|FG000|COMPLETED|Overall Study||2||
59793659|NCT00561795|75914356|FG001|COMPLETED|Overall Study||0||
59793660|NCT00561795|75914357|FG002|COMPLETED|Overall Study||0||
59793661|NCT00561795|75914358|FG003|COMPLETED|Overall Study||0||
59793662|NCT00561795|75914355|FG000|NOT COMPLETED|Overall Study||4||
59793663|NCT00561795|75914356|FG001|NOT COMPLETED|Overall Study||6||
59793664|NCT00561795|75914357|FG002|NOT COMPLETED|Overall Study||0||
59793665|NCT00561795|75914358|FG003|NOT COMPLETED|Overall Study||0||
59793666|NCT00652626|75914373|FG000|STARTED|Initial Treatment Phase||5||
59793667|NCT00652626|75914374|FG001|STARTED|Initial Treatment Phase||5||
59793668|NCT00652626|75914375|FG002|STARTED|Initial Treatment Phase||7||
59793669|NCT00652626|75914376|FG003|STARTED|Initial Treatment Phase||6||
59793670|NCT00652626|75914377|FG004|STARTED|Initial Treatment Phase||8||
59793671|NCT00652626|75914378|FG005|STARTED|Initial Treatment Phase||0||
59793672|NCT00652626|75914379|FG006|STARTED|Initial Treatment Phase||0||
59793673|NCT00652626|75914373|FG000|Received Study Drug|Initial Treatment Phase||5||
59793674|NCT00652626|75914374|FG001|Received Study Drug|Initial Treatment Phase||5||
59793675|NCT00652626|75914375|FG002|Received Study Drug|Initial Treatment Phase||6||
59793676|NCT00652626|75914376|FG003|Received Study Drug|Initial Treatment Phase||5||
59523427|NCT00392860|75618249|FG000|NOT COMPLETED|Overall Study||0||
59523428|NCT00392860|75618250|FG001|NOT COMPLETED|Overall Study||0||
59523429|NCT00392860|75618251|FG002|NOT COMPLETED|Overall Study||0||
59523430|NCT01662336|75618257|FG000|STARTED|Overall Study||173||
59523431|NCT01662336|75618257|FG000|Completed Month 6 Visit|Overall Study||142||
59523432|NCT01662336|75618257|FG000|Completed Month 12 Visit|Overall Study||109||
59523433|NCT01662336|75618257|FG000|COMPLETED|Overall Study||107||
59523434|NCT01662336|75618257|FG000|NOT COMPLETED|Overall Study||66||
59523435|NCT00387244|75618266|FG000|STARTED|Overall Study||7||
59793677|NCT00652626|75914377|FG004|Received Study Drug|Initial Treatment Phase||6||
59793678|NCT00652626|75914378|FG005|Received Study Drug|Initial Treatment Phase||0||
59793679|NCT00652626|75914379|FG006|Received Study Drug|Initial Treatment Phase||0||
59793680|NCT00652626|75914373|FG000|COMPLETED|Initial Treatment Phase||5||
59793681|NCT00652626|75914374|FG001|COMPLETED|Initial Treatment Phase||5||
59793682|NCT00652626|75914375|FG002|COMPLETED|Initial Treatment Phase||6||
59793683|NCT00652626|75914376|FG003|COMPLETED|Initial Treatment Phase||5||
59793684|NCT00652626|75914377|FG004|COMPLETED|Initial Treatment Phase||5||
59793685|NCT00652626|75914378|FG005|COMPLETED|Initial Treatment Phase||0||
59793686|NCT00652626|75914379|FG006|COMPLETED|Initial Treatment Phase||0||
59793687|NCT00652626|75914373|FG000|NOT COMPLETED|Initial Treatment Phase||0||
59953946|NCT00162942|76072356|FG000|Week 12|Overall Study||127||
59953947|NCT00162942|76072357|FG001|Week 12|Overall Study||61||
59953948|NCT00162942|76072356|FG000|COMPLETED|Overall Study||51||
59793688|NCT00652626|75914374|FG001|NOT COMPLETED|Initial Treatment Phase||0||
59793689|NCT00652626|75914375|FG002|NOT COMPLETED|Initial Treatment Phase||1||
59793690|NCT00652626|75914376|FG003|NOT COMPLETED|Initial Treatment Phase||1||
59793691|NCT00652626|75914377|FG004|NOT COMPLETED|Initial Treatment Phase||3||
59793692|NCT00652626|75914378|FG005|NOT COMPLETED|Initial Treatment Phase||0||
59793693|NCT00652626|75914379|FG006|NOT COMPLETED|Initial Treatment Phase||0||
59793694|NCT00652626|75914373|FG000|STARTED|Extension Phase||0||
59953949|NCT00162942|76072357|FG001|COMPLETED|Overall Study||26||
59953950|NCT00162942|76072356|FG000|NOT COMPLETED|Overall Study||106||
59953951|NCT00162942|76072357|FG001|NOT COMPLETED|Overall Study||52||
59793695|NCT00652626|75914374|FG001|STARTED|Extension Phase||0||
59793696|NCT00652626|75914375|FG002|STARTED|Extension Phase||0||
59793697|NCT00652626|75914376|FG003|STARTED|Extension Phase||0||
59523436|NCT00387244|75618266|FG000|End of Trial|Overall Study||0||
59523437|NCT00387244|75618266|FG000|COMPLETED|Overall Study||0||
59523438|NCT00387244|75618266|FG000|NOT COMPLETED|Overall Study||7||
59523439|NCT00572260|75618270|FG000|STARTED|Overall Study||11||
59523440|NCT00572260|75618270|FG000|COMPLETED|Overall Study||11||
59523441|NCT00572260|75618270|FG000|NOT COMPLETED|Overall Study||0||
59793698|NCT00652626|75914377|FG004|STARTED|Extension Phase||0||
59953952|NCT01121224|76072363|FG000|STARTED|Overall Study||305||
59793699|NCT00652626|75914378|FG005|STARTED|Extension Phase||14||
59793700|NCT00652626|75914379|FG006|STARTED|Extension Phase||4||
59793701|NCT00652626|75914373|FG000|COMPLETED|Extension Phase||0||
59793702|NCT00652626|75914374|FG001|COMPLETED|Extension Phase||0||
59793703|NCT00652626|75914375|FG002|COMPLETED|Extension Phase||0||
59793704|NCT00652626|75914376|FG003|COMPLETED|Extension Phase||0||
59953953|NCT01121224|76072364|FG001|STARTED|Overall Study||292||
59953954|NCT01121224|76072363|FG000|COMPLETED|Overall Study||280||
59953955|NCT01121224|76072364|FG001|COMPLETED|Overall Study||275||
59953956|NCT01121224|76072363|FG000|NOT COMPLETED|Overall Study||25||
59953957|NCT01121224|76072364|FG001|NOT COMPLETED|Overall Study||17||
59953958|NCT02786901|76072387|FG000|STARTED|Overall Study||199||
59953959|NCT02786901|76072388|FG001|STARTED|Overall Study||201||
59953960|NCT02786901|76072389|FG002|STARTED|Overall Study||200||
59953961|NCT02786901|76072387|FG000|COMPLETED|Overall Study||122||
59953962|NCT02786901|76072388|FG001|COMPLETED|Overall Study||145||
59953963|NCT02786901|76072389|FG002|COMPLETED|Overall Study||159||
59953964|NCT02786901|76072387|FG000|NOT COMPLETED|Overall Study||77||
59953965|NCT02786901|76072388|FG001|NOT COMPLETED|Overall Study||56||
59953966|NCT02786901|76072389|FG002|NOT COMPLETED|Overall Study||41||
59793705|NCT00652626|75914377|FG004|COMPLETED|Extension Phase||0||
59793706|NCT00652626|75914378|FG005|COMPLETED|Extension Phase|A participant was considered completed if they had completed 6 cycles of therapy.|2||
59793707|NCT00652626|75914379|FG006|COMPLETED|Extension Phase|A participant was considered completed if they had completed 6 cycles of therapy.|1||
59953967|NCT02137239|76072399|FG000|STARTED|Overall Study||26||
59953968|NCT02137239|76072400|FG001|STARTED|Overall Study||32||
59953969|NCT02137239|76072399|FG000|COMPLETED|Overall Study||23||
59953970|NCT02137239|76072400|FG001|COMPLETED|Overall Study||26||
59953971|NCT02137239|76072399|FG000|NOT COMPLETED|Overall Study||3||
59953972|NCT02137239|76072400|FG001|NOT COMPLETED|Overall Study||6||
59793708|NCT00652626|75914373|FG000|NOT COMPLETED|Extension Phase||0||
59793709|NCT00652626|75914374|FG001|NOT COMPLETED|Extension Phase||0||
59793710|NCT00652626|75914375|FG002|NOT COMPLETED|Extension Phase||0||
59793711|NCT00652626|75914376|FG003|NOT COMPLETED|Extension Phase||0||
59793712|NCT00652626|75914377|FG004|NOT COMPLETED|Extension Phase||0||
59793713|NCT00652626|75914378|FG005|NOT COMPLETED|Extension Phase||12||
59793714|NCT00652626|75914379|FG006|NOT COMPLETED|Extension Phase||3||
59793715|NCT00560703|75914399|FG000|STARTED|Overall Study||46||
59953973|NCT04252014|76072408|FG000|STARTED|Overall Study||414||
59953974|NCT04252014|76072409|FG001|STARTED|Overall Study||416||
59953975|NCT04252014|76072408|FG000|COMPLETED|Overall Study||325||
59953976|NCT04252014|76072409|FG001|COMPLETED|Overall Study||332||
59953977|NCT04252014|76072408|FG000|NOT COMPLETED|Overall Study||89||
59953978|NCT04252014|76072409|FG001|NOT COMPLETED|Overall Study||84||
59953979|NCT02741076|76072419|FG000|STARTED|Overall Study||13||
59953980|NCT02741076|76072420|FG001|STARTED|Overall Study||12||
59953981|NCT02741076|76072421|FG002|STARTED|Overall Study||3||
59953982|NCT02741076|76072422|FG003|STARTED|Overall Study||4||
59953983|NCT02741076|76072419|FG000|COMPLETED|Overall Study||10||
59953984|NCT02741076|76072420|FG001|COMPLETED|Overall Study||7||
59953985|NCT02741076|76072421|FG002|COMPLETED|Overall Study||1||
59953986|NCT02741076|76072422|FG003|COMPLETED|Overall Study||2||
59953987|NCT02741076|76072419|FG000|NOT COMPLETED|Overall Study||3||
59793716|NCT00560703|75914400|FG001|STARTED|Overall Study||24||
59793717|NCT00560703|75914399|FG000|COMPLETED|Overall Study||46||
59793718|NCT00560703|75914400|FG001|COMPLETED|Overall Study||18||
59793719|NCT00560703|75914399|FG000|NOT COMPLETED|Overall Study||0||
59793720|NCT00560703|75914400|FG001|NOT COMPLETED|Overall Study||6||
59793721|NCT00308737|75914409|FG000|STARTED|Overall Study||938||
59793722|NCT00308737|75914410|FG001|STARTED|Overall Study||951||
59793723|NCT00308737|75914411|FG002|STARTED|Overall Study||164||
59793724|NCT00308737|75914409|FG000|COMPLETED|Overall Study||475||
59793725|NCT00308737|75914410|FG001|COMPLETED|Overall Study||662||
59793726|NCT00308737|75914411|FG002|COMPLETED|Overall Study||127||
59793727|NCT00308737|75914409|FG000|NOT COMPLETED|Overall Study||463||
59793728|NCT00308737|75914410|FG001|NOT COMPLETED|Overall Study||289||
59953988|NCT02741076|76072420|FG001|NOT COMPLETED|Overall Study||5||
59953989|NCT02741076|76072421|FG002|NOT COMPLETED|Overall Study||2||
59953990|NCT02741076|76072422|FG003|NOT COMPLETED|Overall Study||2||
59953991|NCT01666444|76072435|FG000|STARTED|Overall Study||149||
59953992|NCT01666444|76072436|FG001|STARTED|Overall Study||148||
59953993|NCT01666444|76072435|FG000|COMPLETED|Overall Study||147||
59953994|NCT01666444|76072436|FG001|COMPLETED|Overall Study||147||
59953995|NCT01666444|76072435|FG000|NOT COMPLETED|Overall Study||2||
59953996|NCT01666444|76072436|FG001|NOT COMPLETED|Overall Study||1||
59953997|NCT05159622|76072444|FG000|STARTED|Overall Study||45||
59953998|NCT05159622|76072445|FG001|STARTED|Overall Study||47||
59953999|NCT05159622|76072444|FG000|COMPLETED|Overall Study||41||
59954000|NCT05159622|76072445|FG001|COMPLETED|Overall Study||42||
59954001|NCT05159622|76072444|FG000|NOT COMPLETED|Overall Study||4||
59954002|NCT05159622|76072445|FG001|NOT COMPLETED|Overall Study||5||
59954003|NCT01665430|76072457|FG000|STARTED|Overall Study||38||
59954004|NCT01665430|76072457|FG000|COMPLETED|Overall Study||29||
59954005|NCT01665430|76072457|FG000|NOT COMPLETED|Overall Study||9||
59954006|NCT02739594|76072463|FG000|STARTED|Overall Study||46||
59954007|NCT02739594|76072464|FG001|STARTED|Overall Study||43||
59793729|NCT00308737|75914411|FG002|NOT COMPLETED|Overall Study||37||
59793730|NCT00655746|75914419|FG000|STARTED|Overall Study||14||
59793731|NCT00655746|75914419|FG000|COMPLETED|Overall Study||13||
59793732|NCT00655746|75914419|FG000|NOT COMPLETED|Overall Study||1||
59793733|NCT00338455|75914429|FG000|STARTED|Overall Study||9||
59793734|NCT00338455|75914430|FG001|STARTED|Overall Study||7||
59793735|NCT00338455|75914429|FG000|Administered Study Drug|Overall Study||8||
59793736|NCT00338455|75914430|FG001|Administered Study Drug|Overall Study||7||
59793737|NCT00338455|75914429|FG000|COMPLETED|Overall Study||6||
59793738|NCT00338455|75914430|FG001|COMPLETED|Overall Study||6||
59793739|NCT00338455|75914429|FG000|NOT COMPLETED|Overall Study||3||
59793740|NCT00338455|75914430|FG001|NOT COMPLETED|Overall Study||1||
59793741|NCT00651924|75914438|FG000|STARTED|Overall Study||18||
59793742|NCT00651924|75914439|FG001|STARTED|Overall Study||9||
59793743|NCT00651924|75914438|FG000|COMPLETED|Overall Study||18||
59793744|NCT00651924|75914439|FG001|COMPLETED|Overall Study||2||
59793745|NCT00651924|75914438|FG000|NOT COMPLETED|Overall Study||0||
59793746|NCT00651924|75914439|FG001|NOT COMPLETED|Overall Study||7||
59793747|NCT00678392|75914447|FG000|STARTED|Overall Study||361||
59793748|NCT00678392|75914448|FG001|STARTED|Overall Study||362||
59793749|NCT00678392|75914447|FG000|Treated|Overall Study||359||
59793750|NCT00678392|75914448|FG001|Treated|Overall Study||355||
59793751|NCT00678392|75914447|FG000|COMPLETED|Overall Study||0||
59793752|NCT00678392|75914448|FG001|COMPLETED|Overall Study||0||
59793753|NCT00678392|75914447|FG000|NOT COMPLETED|Overall Study||361||
59793754|NCT00678392|75914448|FG001|NOT COMPLETED|Overall Study||362||
59793755|NCT00308581|75914454|FG000|STARTED|Induction Phase|Not applicable in this period|0||
59793756|NCT00308581|75914455|FG001|STARTED|Induction Phase|Not applicable in this period|0||
59793757|NCT00308581|75914456|FG002|STARTED|Induction Phase||539||
59793758|NCT00308581|75914454|FG000|COMPLETED|Induction Phase|Not applicable in this period|0||
59793759|NCT00308581|75914455|FG001|COMPLETED|Induction Phase|Not applicable in this period|0||
59793760|NCT00308581|75914456|FG002|COMPLETED|Induction Phase||373||
59793761|NCT00308581|75914454|FG000|NOT COMPLETED|Induction Phase||0||
59793762|NCT00308581|75914455|FG001|NOT COMPLETED|Induction Phase||0||
59793763|NCT00308581|75914456|FG002|NOT COMPLETED|Induction Phase||166||
59793764|NCT00308581|75914454|FG000|STARTED|Randomized Maintenance Phase||187||
59793765|NCT00308581|75914455|FG001|STARTED|Randomized Maintenance Phase||186||
59793766|NCT00308581|75914456|FG002|STARTED|Randomized Maintenance Phase||0||
59793767|NCT00308581|75914454|FG000|COMPLETED|Randomized Maintenance Phase||82||
59793768|NCT00308581|75914455|FG001|COMPLETED|Randomized Maintenance Phase||83||
59793769|NCT00308581|75914456|FG002|COMPLETED|Randomized Maintenance Phase||0||
59793770|NCT00308581|75914454|FG000|NOT COMPLETED|Randomized Maintenance Phase||105||
59793771|NCT00308581|75914455|FG001|NOT COMPLETED|Randomized Maintenance Phase||103||
59793772|NCT00308581|75914456|FG002|NOT COMPLETED|Randomized Maintenance Phase||0||
59793773|NCT00678080|75914466|FG000|STARTED|Overall Study||11||
59793774|NCT00678080|75914467|FG001|STARTED|Overall Study||14||
59793775|NCT00678080|75914466|FG000|COMPLETED|Overall Study||8||
59793776|NCT00678080|75914467|FG001|COMPLETED|Overall Study||13||
59793777|NCT00678080|75914466|FG000|NOT COMPLETED|Overall Study||3||
59793778|NCT00678080|75914467|FG001|NOT COMPLETED|Overall Study||1||
59793779|NCT00658320|75914475|FG000|STARTED|Core Study: 12 Months||61||
59793780|NCT00658320|75914476|FG001|STARTED|Core Study: 12 Months||61||
59793781|NCT00658320|75914475|FG000|COMPLETED|Core Study: 12 Months||56||
59793782|NCT00658320|75914476|FG001|COMPLETED|Core Study: 12 Months||58||
59793783|NCT00658320|75914475|FG000|NOT COMPLETED|Core Study: 12 Months||5||
59793784|NCT00658320|75914476|FG001|NOT COMPLETED|Core Study: 12 Months||3||
59793785|NCT00658320|75914475|FG000|STARTED|Extension Study: Month 12 to Month 24||53||
59793786|NCT00658320|75914476|FG001|STARTED|Extension Study: Month 12 to Month 24||57||
59793787|NCT00658320|75914475|FG000|Extension ITT: Received Study Drug|Extension Study: Month 12 to Month 24||50||
59793788|NCT00658320|75914476|FG001|Extension ITT: Received Study Drug|Extension Study: Month 12 to Month 24||50||
59793789|NCT00658320|75914475|FG000|COMPLETED|Extension Study: Month 12 to Month 24||47||
59793790|NCT00658320|75914476|FG001|COMPLETED|Extension Study: Month 12 to Month 24||50||
59793791|NCT00658320|75914475|FG000|NOT COMPLETED|Extension Study: Month 12 to Month 24||6||
59954008|NCT02739594|76072463|FG000|Completed at Week 44|Overall Study||11||
59793792|NCT00658320|75914476|FG001|NOT COMPLETED|Extension Study: Month 12 to Month 24||7||
59793793|NCT00658320|75914475|FG000|STARTED|Extension Study: After Month 24||44||
59793794|NCT00658320|75914476|FG001|STARTED|Extension Study: After Month 24||0||
59793795|NCT00658320|75914475|FG000|COMPLETED|Extension Study: After Month 24||42||
59793796|NCT00658320|75914476|FG001|COMPLETED|Extension Study: After Month 24||0||
59793797|NCT00658320|75914475|FG000|NOT COMPLETED|Extension Study: After Month 24||2||
59793798|NCT00658320|75914476|FG001|NOT COMPLETED|Extension Study: After Month 24||0||
59954009|NCT02739594|76072464|FG001|Completed at Week 44|Overall Study||5||
59954010|NCT02739594|76072463|FG000|Completed at Week 96|Overall Study||10||
59793799|NCT00322153|75914486|FG000|STARTED|Overall Study|Randomized to placebo|335||
59793800|NCT00322153|75914487|FG001|STARTED|Overall Study|Randomized to Memantine ER|342||
59793801|NCT00322153|75914486|FG000|SAFETY POPULATION|Overall Study|Safety population defined as all patients who took at least one dose of double-blind study drug.|335||
59793802|NCT00322153|75914487|FG001|SAFETY POPULATION|Overall Study|Safety population: one patient was randomized but did not receive double-blind study drug.|341||
59793803|NCT00322153|75914486|FG000|COMPLETED|Overall Study||272||
59793804|NCT00322153|75914487|FG001|COMPLETED|Overall Study||273||
59793805|NCT00322153|75914486|FG000|NOT COMPLETED|Overall Study||63||
59793806|NCT00322153|75914487|FG001|NOT COMPLETED|Overall Study||69||
59793807|NCT00657618|75914493|FG000|STARTED|Overall Study||77||
59793808|NCT00657618|75914493|FG000|COMPLETED|Overall Study||34||
59793809|NCT00657618|75914493|FG000|NOT COMPLETED|Overall Study||43||
59793810|NCT00657540|75914499|FG000|STARTED|Overall Study||29||
59793811|NCT00657540|75914500|FG001|STARTED|Overall Study||31||
59793812|NCT00657540|75914499|FG000|COMPLETED|Overall Study|All subjects had a known treatment failure disposition at time of loss to follow-up.|28||
59793813|NCT00657540|75914500|FG001|COMPLETED|Overall Study|All subjects had a known treatment failure disposition at time of loss to follow-up.|27||
59954011|NCT02739594|76072464|FG001|Completed at Week 96|Overall Study||10||
59954012|NCT02739594|76072463|FG000|COMPLETED|Overall Study|Includes all participants who reached the protocol-defined end of study (either Week 44 or 96).|21||
59954013|NCT02739594|76072464|FG001|COMPLETED|Overall Study|Includes all participants who reached the protocol-defined end of study (either Week 44 or 96).|15||
59954014|NCT02739594|76072463|FG000|NOT COMPLETED|Overall Study||25||
59793814|NCT00657540|75914499|FG000|NOT COMPLETED|Overall Study||1||
59793815|NCT00657540|75914500|FG001|NOT COMPLETED|Overall Study||4||
59793816|NCT00672620|75914510|FG000|STARTED|Overall Study||153||
59793817|NCT00672620|75914511|FG001|STARTED|Overall Study||153||
59793818|NCT00672620|75914512|FG002|STARTED|Overall Study||153||
59793819|NCT00672620|75914513|FG003|STARTED|Overall Study||152||
59793820|NCT00672620|75914510|FG000|Treated|Overall Study||151||
59793821|NCT00672620|75914511|FG001|Treated|Overall Study||149||
59793822|NCT00672620|75914512|FG002|Treated|Overall Study||153||
59793823|NCT00672620|75914513|FG003|Treated|Overall Study||150||
59793824|NCT00672620|75914510|FG000|COMPLETED|Overall Study||120||
59793825|NCT00672620|75914511|FG001|COMPLETED|Overall Study||99||
59793826|NCT00672620|75914512|FG002|COMPLETED|Overall Study||122||
59793827|NCT00672620|75914513|FG003|COMPLETED|Overall Study||110||
59793828|NCT00672620|75914510|FG000|NOT COMPLETED|Overall Study||33||
59793829|NCT00672620|75914511|FG001|NOT COMPLETED|Overall Study||54||
59793830|NCT00672620|75914512|FG002|NOT COMPLETED|Overall Study||31||
59793831|NCT00672620|75914513|FG003|NOT COMPLETED|Overall Study||42||
59793832|NCT00673790|75914526|FG000|STARTED|Overall Study||223||
59793833|NCT00673790|75914527|FG001|STARTED|Overall Study||212||
59793834|NCT00673790|75914528|FG002|STARTED|Overall Study||102||
59793835|NCT00673790|75914526|FG000|COMPLETED|Overall Study||178||
59793836|NCT00673790|75914527|FG001|COMPLETED|Overall Study||174||
59793837|NCT00673790|75914528|FG002|COMPLETED|Overall Study||90||
59793838|NCT00673790|75914526|FG000|NOT COMPLETED|Overall Study||45||
59793839|NCT00673790|75914527|FG001|NOT COMPLETED|Overall Study||38||
59793840|NCT00673790|75914528|FG002|NOT COMPLETED|Overall Study||12||
59793841|NCT00657150|75914539|FG000|STARTED|Overall Study||1010||
59793842|NCT00657150|75914540|FG001|STARTED|Overall Study||1003||
59793843|NCT00657150|75914539|FG000|COMPLETED|Overall Study||895||
59793844|NCT00657150|75914540|FG001|COMPLETED|Overall Study||910||
59793845|NCT00657150|75914539|FG000|NOT COMPLETED|Overall Study||115||
59793846|NCT00657150|75914540|FG001|NOT COMPLETED|Overall Study||93||
59793847|NCT00657150|75914539|FG000|STARTED|Treatment||1010||
59793848|NCT00657150|75914540|FG001|STARTED|Treatment||1003||
59793849|NCT00657150|75914539|FG000|COMPLETED|Treatment||903||
59793850|NCT00657150|75914540|FG001|COMPLETED|Treatment||906||
59793851|NCT00657150|75914539|FG000|NOT COMPLETED|Treatment||107||
59793852|NCT00657150|75914540|FG001|NOT COMPLETED|Treatment||97||
59793853|NCT00670748|75914550|FG000|STARTED|Overall Study||17||
59793854|NCT00670748|75914551|FG001|STARTED|Overall Study||16||
59793855|NCT00670748|75914552|FG002|STARTED|Overall Study||7||
59793856|NCT00670748|75914553|FG003|STARTED|Overall Study||5||
59793857|NCT00670748|75914550|FG000|COMPLETED|Overall Study||14||
59793858|NCT00670748|75914551|FG001|COMPLETED|Overall Study||14||
59793859|NCT00670748|75914552|FG002|COMPLETED|Overall Study||5||
59793860|NCT00670748|75914553|FG003|COMPLETED|Overall Study||4||
59793861|NCT00670748|75914550|FG000|NOT COMPLETED|Overall Study||3||
59793862|NCT00670748|75914551|FG001|NOT COMPLETED|Overall Study||2||
59793863|NCT00670748|75914552|FG002|NOT COMPLETED|Overall Study||2||
59793864|NCT00670748|75914553|FG003|NOT COMPLETED|Overall Study||1||
59793865|NCT00646776|75914565|FG000|STARTED|Overall Study|Treated on Day 1|15||
59793866|NCT00646776|75914566|FG001|STARTED|Overall Study|Treated on Day 1|18||
59793867|NCT00646776|75914565|FG000|COMPLETED|Overall Study||14||
59793868|NCT00646776|75914566|FG001|COMPLETED|Overall Study||5||
59793869|NCT00646776|75914565|FG000|NOT COMPLETED|Overall Study||1||
59793870|NCT00646776|75914566|FG001|NOT COMPLETED|Overall Study||13||
59793871|NCT00655668|75914575|FG000|STARTED|Overall Study|Planned enrollment: 80 participants|54||
59793872|NCT00655668|75914575|FG000|COMPLETED|Overall Study|Participants dosed up to 24 months, disease progression or unacceptable adverse events developed.|0||
59793873|NCT00655668|75914575|FG000|NOT COMPLETED|Overall Study||54||
59793874|NCT00569166|75914582|FG000|STARTED|Overall Study||30||
59793875|NCT00569166|75914583|FG001|STARTED|Overall Study||31||
59793876|NCT00569166|75914584|FG002|STARTED|Overall Study||31||
59793877|NCT00569166|75914582|FG000|COMPLETED|Overall Study||21||
59793878|NCT00569166|75914583|FG001|COMPLETED|Overall Study||25||
59793879|NCT00569166|75914584|FG002|COMPLETED|Overall Study||27||
59793880|NCT00569166|75914582|FG000|NOT COMPLETED|Overall Study||9||
59793881|NCT00569166|75914583|FG001|NOT COMPLETED|Overall Study||6||
59793882|NCT00569166|75914584|FG002|NOT COMPLETED|Overall Study||4||
59793883|NCT00655356|75914594|FG000|STARTED|Overall Study||110||
59793884|NCT00655356|75914595|FG001|STARTED|Overall Study||108||
59793885|NCT00655356|75914594|FG000|COMPLETED|Overall Study||93||
59793886|NCT00655356|75914595|FG001|COMPLETED|Overall Study||98||
59793887|NCT00655356|75914594|FG000|NOT COMPLETED|Overall Study||17||
59793888|NCT00655356|75914595|FG001|NOT COMPLETED|Overall Study||10||
59793889|NCT00571064|75914601|FG000|STARTED|Overall Study||97||
59793890|NCT00571064|75914601|FG000|COMPLETED|Overall Study||76||
59793891|NCT00571064|75914601|FG000|NOT COMPLETED|Overall Study||21||
59793892|NCT03895372|75914614|FG000|STARTED|Investigational Treatment Period||23||
59793893|NCT03895372|75914615|FG001|STARTED|Investigational Treatment Period||22||
59793894|NCT03895372|75914616|FG002|STARTED|Investigational Treatment Period||11||
59793895|NCT03895372|75914617|FG003|STARTED|Investigational Treatment Period||11||
59793896|NCT03895372|75914618|FG004|STARTED|Investigational Treatment Period||12||
59793897|NCT03895372|75914619|FG005|STARTED|Investigational Treatment Period||11||
59954015|NCT02739594|76072464|FG001|NOT COMPLETED|Overall Study||28||
59954016|NCT03989232|76072473|FG000|STARTED|Overall Study||481||
59954017|NCT03989232|76072474|FG001|STARTED|Overall Study||480||
59954018|NCT03989232|76072473|FG000|Exposed|Overall Study||480||
59954019|NCT03989232|76072474|FG001|Exposed|Overall Study||479||
59954020|NCT03989232|76072473|FG000|Safety Analysis Set (SAS)|Overall Study||480||
59954021|NCT03989232|76072474|FG001|Safety Analysis Set (SAS)|Overall Study||479||
59954022|NCT03989232|76072473|FG000|Full Analysis Set (FAS)|Overall Study||481||
59793898|NCT03895372|75914620|FG006|STARTED|Investigational Treatment Period||45||
59793899|NCT03895372|75914621|FG007|STARTED|Investigational Treatment Period||43||
59793900|NCT03895372|75914614|FG000|COMPLETED|Investigational Treatment Period||19||
59793901|NCT03895372|75914615|FG001|COMPLETED|Investigational Treatment Period||19||
59793902|NCT03895372|75914616|FG002|COMPLETED|Investigational Treatment Period||10||
59793903|NCT03895372|75914617|FG003|COMPLETED|Investigational Treatment Period||9||
59793904|NCT03895372|75914618|FG004|COMPLETED|Investigational Treatment Period||12||
59793905|NCT03895372|75914619|FG005|COMPLETED|Investigational Treatment Period||9||
59793906|NCT03895372|75914620|FG006|COMPLETED|Investigational Treatment Period||37||
59793907|NCT03895372|75914621|FG007|COMPLETED|Investigational Treatment Period||38||
59954023|NCT03989232|76072474|FG001|Full Analysis Set (FAS)|Overall Study||480||
59793908|NCT03895372|75914614|FG000|NOT COMPLETED|Investigational Treatment Period||4||
59793909|NCT03895372|75914615|FG001|NOT COMPLETED|Investigational Treatment Period||3||
59793910|NCT03895372|75914616|FG002|NOT COMPLETED|Investigational Treatment Period||1||
59793911|NCT03895372|75914617|FG003|NOT COMPLETED|Investigational Treatment Period||2||
59793912|NCT03895372|75914618|FG004|NOT COMPLETED|Investigational Treatment Period||0||
59793913|NCT03895372|75914619|FG005|NOT COMPLETED|Investigational Treatment Period||2||
59793914|NCT03895372|75914620|FG006|NOT COMPLETED|Investigational Treatment Period||8||
59793915|NCT03895372|75914621|FG007|NOT COMPLETED|Investigational Treatment Period||5||
59793916|NCT03895372|75914614|FG000|STARTED|Extension Treatment Period||19||
59793917|NCT03895372|75914615|FG001|STARTED|Extension Treatment Period||19||
59793918|NCT03895372|75914616|FG002|STARTED|Extension Treatment Period||10||
59793919|NCT03895372|75914617|FG003|STARTED|Extension Treatment Period||9||
59793920|NCT03895372|75914618|FG004|STARTED|Extension Treatment Period||12||
59793921|NCT03895372|75914619|FG005|STARTED|Extension Treatment Period||9||
59793922|NCT03895372|75914620|FG006|STARTED|Extension Treatment Period||37||
59793923|NCT03895372|75914621|FG007|STARTED|Extension Treatment Period||38||
59793924|NCT03895372|75914614|FG000|COMPLETED|Extension Treatment Period||16||
59793925|NCT03895372|75914615|FG001|COMPLETED|Extension Treatment Period||14||
59954024|NCT03989232|76072473|FG000|COMPLETED|Overall Study||471||
59954025|NCT03989232|76072474|FG001|COMPLETED|Overall Study||462||
59954026|NCT03989232|76072473|FG000|NOT COMPLETED|Overall Study||10||
59954027|NCT03989232|76072474|FG001|NOT COMPLETED|Overall Study||18||
59954028|NCT02585830|76072480|FG000|STARTED|Overall Study||25||
59793926|NCT03895372|75914616|FG002|COMPLETED|Extension Treatment Period||10||
59793927|NCT03895372|75914617|FG003|COMPLETED|Extension Treatment Period||8||
59793928|NCT03895372|75914618|FG004|COMPLETED|Extension Treatment Period||9||
59793929|NCT03895372|75914619|FG005|COMPLETED|Extension Treatment Period||8||
59793930|NCT03895372|75914620|FG006|COMPLETED|Extension Treatment Period||33||
59793931|NCT03895372|75914621|FG007|COMPLETED|Extension Treatment Period||32||
59954029|NCT02585830|76072480|FG000|COMPLETED|Overall Study||22||
59954030|NCT02585830|76072480|FG000|NOT COMPLETED|Overall Study||3||
59954031|NCT02584504|76072487|FG000|STARTED|Double-blind Treatment|Randomized|54||
59954032|NCT02584504|76072488|FG001|STARTED|Double-blind Treatment|Randomized|53||
59954033|NCT02584504|76072489|FG002|STARTED|Double-blind Treatment|Randomized|56||
59793932|NCT03895372|75914614|FG000|NOT COMPLETED|Extension Treatment Period||3||
59793933|NCT03895372|75914615|FG001|NOT COMPLETED|Extension Treatment Period||5||
59793934|NCT03895372|75914616|FG002|NOT COMPLETED|Extension Treatment Period||0||
59793935|NCT03895372|75914617|FG003|NOT COMPLETED|Extension Treatment Period||1||
59954034|NCT02584504|76072487|FG000|ITT Population|Double-blind Treatment||54||
59954035|NCT02584504|76072488|FG001|ITT Population|Double-blind Treatment||53||
59954036|NCT02584504|76072489|FG002|ITT Population|Double-blind Treatment||56||
59793936|NCT03895372|75914618|FG004|NOT COMPLETED|Extension Treatment Period||3||
59793937|NCT03895372|75914619|FG005|NOT COMPLETED|Extension Treatment Period||1||
59793938|NCT03895372|75914620|FG006|NOT COMPLETED|Extension Treatment Period||4||
59793939|NCT03895372|75914621|FG007|NOT COMPLETED|Extension Treatment Period||6||
59793940|NCT00669110|75914646|FG000|STARTED|Overall Study||20||
59793941|NCT00669110|75914647|FG001|STARTED|Overall Study||20||
59793942|NCT00669110|75914646|FG000|COMPLETED|Overall Study||12||
59793943|NCT00669110|75914647|FG001|COMPLETED|Overall Study||7||
59793944|NCT00669110|75914646|FG000|NOT COMPLETED|Overall Study||8||
59793945|NCT00669110|75914647|FG001|NOT COMPLETED|Overall Study||13||
59793946|NCT00654732|75914655|FG000|STARTED|Overall Study||26||
59793947|NCT00654732|75914656|FG001|STARTED|Overall Study||32||
59793948|NCT00654732|75914655|FG000|COMPLETED|Overall Study||22||
59793949|NCT00654732|75914656|FG001|COMPLETED|Overall Study||26||
59793950|NCT00654732|75914655|FG000|NOT COMPLETED|Overall Study||4||
59793951|NCT00654732|75914656|FG001|NOT COMPLETED|Overall Study||6||
59793952|NCT00649428|75914664|FG000|STARTED|Overall Study||100||
59793953|NCT00649428|75914665|FG001|STARTED|Overall Study||103||
59793954|NCT00649428|75914664|FG000|COMPLETED|Overall Study||80||
59793955|NCT00649428|75914665|FG001|COMPLETED|Overall Study||88||
59793956|NCT00649428|75914664|FG000|NOT COMPLETED|Overall Study||20||
59793957|NCT00649428|75914665|FG001|NOT COMPLETED|Overall Study||15||
59793958|NCT00669032|75914674|FG000|STARTED|Overall Study||153||
59793959|NCT00669032|75914675|FG001|STARTED|Overall Study||153||
59793960|NCT00669032|75914674|FG000|COMPLETED|Overall Study||109||
59793961|NCT00669032|75914675|FG001|COMPLETED|Overall Study||94||
59793962|NCT00669032|75914674|FG000|NOT COMPLETED|Overall Study||44||
59793963|NCT00669032|75914675|FG001|NOT COMPLETED|Overall Study||59||
59793964|NCT00654498|75914683|FG000|STARTED|Overall Study||203||
59793965|NCT00654498|75914684|FG001|STARTED|Overall Study||103||
59954037|NCT02584504|76072487|FG000|mITT Population|Double-blind Treatment||54||
59954038|NCT02584504|76072488|FG001|mITT Population|Double-blind Treatment||53||
59954039|NCT02584504|76072489|FG002|mITT Population|Double-blind Treatment||56||
59954040|NCT02584504|76072487|FG000|Safety Population|Double-blind Treatment||54||
59954041|NCT02584504|76072488|FG001|Safety Population|Double-blind Treatment||53||
59954042|NCT02584504|76072489|FG002|Safety Population|Double-blind Treatment||56||
59793966|NCT00654498|75914683|FG000|COMPLETED|Overall Study||189||
59793967|NCT00654498|75914684|FG001|COMPLETED|Overall Study||91||
59793968|NCT00654498|75914683|FG000|NOT COMPLETED|Overall Study||14||
59793969|NCT00654498|75914684|FG001|NOT COMPLETED|Overall Study||12||
59793970|NCT00670046|75914692|FG000|STARTED|Overall Study||7||
59954043|NCT02584504|76072487|FG000|COMPLETED|Double-blind Treatment||54||
59954044|NCT02584504|76072488|FG001|COMPLETED|Double-blind Treatment||51||
59954045|NCT02584504|76072489|FG002|COMPLETED|Double-blind Treatment||55||
59954046|NCT02584504|76072487|FG000|NOT COMPLETED|Double-blind Treatment||0||
59954047|NCT02584504|76072488|FG001|NOT COMPLETED|Double-blind Treatment||2||
59954048|NCT02584504|76072489|FG002|NOT COMPLETED|Double-blind Treatment||1||
59954049|NCT02584504|76072487|FG000|STARTED|Open-label Treatment||54||
59954050|NCT02584504|76072488|FG001|STARTED|Open-label Treatment||51||
59954051|NCT02584504|76072489|FG002|STARTED|Open-label Treatment||55||
59523442|NCT02549352|75618276|FG000|STARTED|3-day Treatment and 8-week Follow-up||209||
59793971|NCT00670046|75914693|FG001|STARTED|Overall Study||8||
59793972|NCT00670046|75914692|FG000|COMPLETED|Overall Study||6||
59793973|NCT00670046|75914693|FG001|COMPLETED|Overall Study||6||
59793974|NCT00670046|75914692|FG000|NOT COMPLETED|Overall Study||1||
59793975|NCT00670046|75914693|FG001|NOT COMPLETED|Overall Study||2||
59954052|NCT02584504|76072487|FG000|Treated|Open-label Treatment||54||
59793976|NCT00560391|75914704|FG000|STARTED|Overall Study|Participants who received treatment|6||
59793977|NCT00560391|75914705|FG001|STARTED|Overall Study|Participants who received treatment|3||
59793978|NCT00560391|75914706|FG002|STARTED|Overall Study|Participants who received treatment|3||
59793979|NCT00560391|75914707|FG003|STARTED|Overall Study|Participants who received treatment|6||
59793980|NCT00560391|75914708|FG004|STARTED|Overall Study|Participants who received treatment|17||
59793981|NCT00560391|75914704|FG000|COMPLETED|Overall Study|Completed=off treatment;Disease progression-1;Death-1;Max. clinical benefit-2;Study drug toxicity-2|6||
59954053|NCT02584504|76072488|FG001|Treated|Open-label Treatment||50||
59954054|NCT02584504|76072489|FG002|Treated|Open-label Treatment||54||
59954055|NCT02584504|76072487|FG000|COMPLETED|Open-label Treatment||52||
59954056|NCT02584504|76072488|FG001|COMPLETED|Open-label Treatment||47||
59954057|NCT02584504|76072489|FG002|COMPLETED|Open-label Treatment||47||
59954058|NCT02584504|76072487|FG000|NOT COMPLETED|Open-label Treatment||2||
59954059|NCT02584504|76072488|FG001|NOT COMPLETED|Open-label Treatment||4||
59954060|NCT02584504|76072489|FG002|NOT COMPLETED|Open-label Treatment||8||
59954061|NCT04634110|76072501|FG000|STARTED|Overall Study||1||
59793982|NCT00560391|75914705|FG001|COMPLETED|Overall Study|Completed=off treatment; Disease progression-1;Death-1; Unrelated AE-1|3||
59793983|NCT00560391|75914706|FG002|COMPLETED|Overall Study|Completed=off treatment; Disease progression-1;Maximum clinical benefit-1; Unrelated AE-1|3||
59793984|NCT00560391|75914707|FG003|COMPLETED|Overall Study|Completed=off treatment; Disease progression-2; Unrelated AE 1 and Subject request 2|5||
59793985|NCT00560391|75914708|FG004|COMPLETED|Overall Study|Completed=offtreatment;Disease progression-6;Study drug toxicity-7; Unrelated AE-1,Subject request-1|15||
59793986|NCT00560391|75914704|FG000|NOT COMPLETED|Overall Study||0||
59793987|NCT00560391|75914705|FG001|NOT COMPLETED|Overall Study||0||
59793988|NCT00560391|75914706|FG002|NOT COMPLETED|Overall Study||0||
59793989|NCT00560391|75914707|FG003|NOT COMPLETED|Overall Study||1||
59793990|NCT00560391|75914708|FG004|NOT COMPLETED|Overall Study||2||
59793991|NCT00537238|75914723|FG000|STARTED|Overall Study||254||
59793992|NCT00537238|75914724|FG001|STARTED|Overall Study||255||
59793993|NCT00537238|75914723|FG000|Completed Titration Phase|Overall Study||226||
59793994|NCT00537238|75914724|FG001|Completed Titration Phase|Overall Study||236||
59793995|NCT00537238|75914723|FG000|Completed Maintenance Phase|Overall Study|Primary analysis drawn from the population in the maintenance phase.|208||
59793996|NCT00537238|75914724|FG001|Completed Maintenance Phase|Overall Study|Primary analysis drawn from the population in the maintenance phase.|210||
59793997|NCT00537238|75914723|FG000|Entered Opt Blinded Continuation Phase|Overall Study|Participants who had clinical benefit were eligible to progress into opt blinded continuation phase.|185||
59793998|NCT00537238|75914724|FG001|Entered Opt Blinded Continuation Phase|Overall Study|Participants who had clinical benefit were eligible to progress into opt blinded continuation phase.|195||
59793999|NCT00537238|75914723|FG000|COMPLETED|Overall Study|Completed designates participants who completed the opt blinded continuation phase.|80||
59954062|NCT04634110|76072501|FG000|COMPLETED|Overall Study||0|Subject did not complete treatment|
59954063|NCT04634110|76072501|FG000|NOT COMPLETED|Overall Study||1||
59954064|NCT03956355|76072507|FG000|STARTED|Overall Study||340||
59954065|NCT03956355|76072508|FG001|STARTED|Overall Study||170||
59794000|NCT00537238|75914724|FG001|COMPLETED|Overall Study|Completed designates participants who completed the opt blinded continuation phase.|82||
59794001|NCT00537238|75914723|FG000|NOT COMPLETED|Overall Study||174||
59794002|NCT00537238|75914724|FG001|NOT COMPLETED|Overall Study||173||
59794003|NCT03966885|75914732|FG000|STARTED|Overall Study||78||
59794004|NCT03966885|75914733|FG001|STARTED|Overall Study||82||
59794005|NCT03966885|75914732|FG000|COMPLETED|Overall Study||56||
59794006|NCT03966885|75914733|FG001|COMPLETED|Overall Study||62||
59794007|NCT03966885|75914732|FG000|NOT COMPLETED|Overall Study||22||
59794008|NCT03966885|75914733|FG001|NOT COMPLETED|Overall Study||20||
59794009|NCT03965403|75914740|FG000|STARTED|Overall Study||7||
59794010|NCT03965403|75914740|FG000|COMPLETED|Overall Study||6||
59794011|NCT03965403|75914740|FG000|NOT COMPLETED|Overall Study||1||
59794012|NCT00552669|75914746|FG000|STARTED|Overall Study|patients|100||
59794013|NCT00552669|75914747|FG001|STARTED|Overall Study|patients|100||
59794014|NCT00552669|75914746|FG000|COMPLETED|Overall Study|All patients were followed for 18.3 +/- 7 months.|97||
59794015|NCT00552669|75914747|FG001|COMPLETED|Overall Study|All patients were followed for 18.3 +/- 7 months.|93||
59794016|NCT00552669|75914746|FG000|NOT COMPLETED|Overall Study||3||
59794017|NCT00552669|75914747|FG001|NOT COMPLETED|Overall Study||7||
59794018|NCT00552513|75914755|FG000|STARTED|Overall Study||1593||
59794019|NCT00552513|75914756|FG001|STARTED|Overall Study||1438||
59794020|NCT00552513|75914755|FG000|COMPLETED|Overall Study||1588||
59794021|NCT00552513|75914756|FG001|COMPLETED|Overall Study||1437||
59794022|NCT00552513|75914755|FG000|NOT COMPLETED|Overall Study||5||
59794023|NCT00552513|75914756|FG001|NOT COMPLETED|Overall Study||1||
59794024|NCT00560313|75914764|FG000|STARTED|Overall Study||54||
59794025|NCT00560313|75914764|FG000|COMPLETED|Overall Study||48||
59794026|NCT00560313|75914764|FG000|NOT COMPLETED|Overall Study||6||
59794027|NCT00667862|75914783|FG000|STARTED|Overall Study||35||
59794028|NCT00667862|75914783|FG000|COMPLETED|Overall Study||0|Completed here refers to participants who completed study treatment.|
59794029|NCT00667862|75914783|FG000|NOT COMPLETED|Overall Study||35||
59794030|NCT00535132|75914789|FG000|STARTED|Randomized Population|Number of Subjects Randomized|100||
59794031|NCT00535132|75914790|FG001|STARTED|Randomized Population|Number of Subjects Randomized|101||
59794032|NCT00535132|75914789|FG000|COMPLETED|Randomized Population||100||
59794033|NCT00535132|75914790|FG001|COMPLETED|Randomized Population||101||
59794034|NCT00535132|75914789|FG000|NOT COMPLETED|Randomized Population||0||
59794035|NCT00535132|75914790|FG001|NOT COMPLETED|Randomized Population||0||
59794036|NCT00535132|75914789|FG000|STARTED|Safety Analysis Set||100||
59794037|NCT00535132|75914790|FG001|STARTED|Safety Analysis Set||101||
59794038|NCT00535132|75914789|FG000|COMPLETED|Safety Analysis Set|Two patients were randomized but not treated.|98||
59794039|NCT00535132|75914790|FG001|COMPLETED|Safety Analysis Set|Two patients were randomized but not treated.|99||
59794040|NCT00535132|75914789|FG000|NOT COMPLETED|Safety Analysis Set||2||
59794041|NCT00535132|75914790|FG001|NOT COMPLETED|Safety Analysis Set||2||
59794042|NCT00535132|75914789|FG000|STARTED|Intent-to-Treat (ITT) Analysis Set||98||
59794043|NCT00535132|75914790|FG001|STARTED|Intent-to-Treat (ITT) Analysis Set||99||
59954066|NCT03956355|76072507|FG000|COMPLETED|Overall Study||269||
59954067|NCT03956355|76072508|FG001|COMPLETED|Overall Study||130||
59954068|NCT03956355|76072507|FG000|NOT COMPLETED|Overall Study||71||
59794044|NCT00535132|75914789|FG000|COMPLETED|Intent-to-Treat (ITT) Analysis Set|Patients who received at least one dose of study drug and have some follow-up efficacy data.|95||
59794045|NCT00535132|75914790|FG001|COMPLETED|Intent-to-Treat (ITT) Analysis Set|Patients who received at least one dose of study drug and have some follow-up efficacy data.|96||
59794046|NCT00535132|75914789|FG000|NOT COMPLETED|Intent-to-Treat (ITT) Analysis Set||3||
59794047|NCT00535132|75914790|FG001|NOT COMPLETED|Intent-to-Treat (ITT) Analysis Set||3||
59794048|NCT00570908|75914798|FG000|STARTED|Overall Study||12||
59794049|NCT00570908|75914798|FG000|COMPLETED|Overall Study|5 patients progressed during the study treatment|5||
59794050|NCT00570908|75914798|FG000|NOT COMPLETED|Overall Study||7||
59794051|NCT00321919|75914804|FG000|STARTED|Overall Study||301||
59794052|NCT00321919|75914805|FG001|STARTED|Overall Study||302||
59794053|NCT00321919|75914804|FG000|COMPLETED|Overall Study||226||
59794054|NCT00321919|75914805|FG001|COMPLETED|Overall Study||250||
59794055|NCT00321919|75914804|FG000|NOT COMPLETED|Overall Study||75||
59794056|NCT00321919|75914805|FG001|NOT COMPLETED|Overall Study||52||
59794057|NCT00781391|75914815|FG000|STARTED|Overall Study||7036||
59794058|NCT00781391|75914816|FG001|STARTED|Overall Study||7035||
59794059|NCT00781391|75914817|FG002|STARTED|Overall Study||7034||
59794060|NCT00781391|75914815|FG000|Safety Analysis Set (Received Drug)|Overall Study||7012||
59794061|NCT00781391|75914816|FG001|Safety Analysis Set (Received Drug)|Overall Study||7012||
59794062|NCT00781391|75914817|FG002|Safety Analysis Set (Received Drug)|Overall Study||7002||
59794063|NCT00781391|75914815|FG000|mITT Analysis Set (Received Drug)|Overall Study||7012||
59794064|NCT00781391|75914816|FG001|mITT Analysis Set (Received Drug)|Overall Study||7012||
59794065|NCT00781391|75914817|FG002|mITT Analysis Set (Received Drug)|Overall Study||7002||
59794066|NCT00781391|75914815|FG000|Per Protocol Analysis Set|Overall Study||6993||
59794067|NCT00781391|75914816|FG001|Per Protocol Analysis Set|Overall Study||6995||
59794068|NCT00781391|75914817|FG002|Per Protocol Analysis Set|Overall Study||6982||
59794069|NCT00781391|75914815|FG000|COMPLETED|Overall Study||6157||
59794070|NCT00781391|75914816|FG001|COMPLETED|Overall Study||6228||
59794071|NCT00781391|75914817|FG002|COMPLETED|Overall Study||6250||
59794072|NCT00781391|75914815|FG000|NOT COMPLETED|Overall Study||879||
59794073|NCT00781391|75914816|FG001|NOT COMPLETED|Overall Study||807||
59794074|NCT00781391|75914817|FG002|NOT COMPLETED|Overall Study||784||
59794075|NCT00534976|75914827|FG000|STARTED|Period 1: Placebo Run-in||33||
59794076|NCT00534976|75914828|FG001|STARTED|Period 1: Placebo Run-in||33||
59794077|NCT00534976|75914827|FG000|COMPLETED|Period 1: Placebo Run-in||33||
59794078|NCT00534976|75914828|FG001|COMPLETED|Period 1: Placebo Run-in||33||
59794079|NCT00534976|75914827|FG000|NOT COMPLETED|Period 1: Placebo Run-in||0||
59794080|NCT00534976|75914828|FG001|NOT COMPLETED|Period 1: Placebo Run-in||0||
59794081|NCT00534976|75914827|FG000|STARTED|Period 2: Treatment Montelukast/ Placebo||33||
59954069|NCT03956355|76072508|FG001|NOT COMPLETED|Overall Study||40||
59954070|NCT04354155|76072514|FG000|STARTED|Overall Study||40||
59794082|NCT00534976|75914828|FG001|STARTED|Period 2: Treatment Montelukast/ Placebo||33||
59794083|NCT00534976|75914827|FG000|COMPLETED|Period 2: Treatment Montelukast/ Placebo||33||
59794084|NCT00534976|75914828|FG001|COMPLETED|Period 2: Treatment Montelukast/ Placebo||32||
59794085|NCT00534976|75914827|FG000|NOT COMPLETED|Period 2: Treatment Montelukast/ Placebo||0||
59794086|NCT00534976|75914828|FG001|NOT COMPLETED|Period 2: Treatment Montelukast/ Placebo||1||
59794087|NCT00534976|75914827|FG000|STARTED|Period 3: Crossover Placebo/ Montelukast||33||
59794088|NCT00534976|75914828|FG001|STARTED|Period 3: Crossover Placebo/ Montelukast||32||
59794089|NCT00534976|75914827|FG000|COMPLETED|Period 3: Crossover Placebo/ Montelukast||31||
59794090|NCT00534976|75914828|FG001|COMPLETED|Period 3: Crossover Placebo/ Montelukast||32||
59794091|NCT00534976|75914827|FG000|NOT COMPLETED|Period 3: Crossover Placebo/ Montelukast||2||
59794092|NCT00534976|75914828|FG001|NOT COMPLETED|Period 3: Crossover Placebo/ Montelukast||0||
59794093|NCT00321763|75914838|FG000|STARTED|Overall Study||850||
59794094|NCT00321763|75914839|FG001|STARTED|Overall Study||850||
59794095|NCT00321763|75914840|FG002|STARTED|Overall Study||854||
59794096|NCT00321763|75914841|FG003|STARTED|Overall Study||570||
59794097|NCT00321763|75914838|FG000|COMPLETED|Overall Study||844||
59794098|NCT00321763|75914839|FG001|COMPLETED|Overall Study||848||
59954071|NCT04354155|76072514|FG000|COMPLETED|Overall Study||38||
59954072|NCT04354155|76072514|FG000|NOT COMPLETED|Overall Study||2||
59794099|NCT00321763|75914840|FG002|COMPLETED|Overall Study||848||
59794100|NCT00321763|75914841|FG003|COMPLETED|Overall Study||565||
59794101|NCT00321763|75914838|FG000|NOT COMPLETED|Overall Study||6||
59794102|NCT00321763|75914839|FG001|NOT COMPLETED|Overall Study||2||
59794103|NCT00321763|75914840|FG002|NOT COMPLETED|Overall Study||6||
59794104|NCT00321763|75914841|FG003|NOT COMPLETED|Overall Study||5||
59817860|NCT04488770|75940338|FG012|COMPLETED|Part 1-Cohort 1: Period 4 (Up to 5 Days)||0||
59817861|NCT04488770|75940326|FG000|NOT COMPLETED|Part 1-Cohort 1: Period 4 (Up to 5 Days)||0||
59817862|NCT04488770|75940327|FG001|NOT COMPLETED|Part 1-Cohort 1: Period 4 (Up to 5 Days)||0||
59817863|NCT04488770|75940328|FG002|NOT COMPLETED|Part 1-Cohort 1: Period 4 (Up to 5 Days)||0||
59954073|NCT02586064|76072520|FG000|STARTED|Overall Study||61||
59954074|NCT02586064|76072521|FG001|STARTED|Overall Study||54||
59954075|NCT02586064|76072520|FG000|COMPLETED|Overall Study||43||
59817864|NCT04488770|75940329|FG003|NOT COMPLETED|Part 1-Cohort 1: Period 4 (Up to 5 Days)||0||
59954076|NCT02586064|76072521|FG001|COMPLETED|Overall Study||26||
59954077|NCT02586064|76072520|FG000|NOT COMPLETED|Overall Study||18||
59794105|NCT00308113|75914857|FG000|STARTED|Overall Study||0||
59794106|NCT00308113|75914858|FG001|STARTED|Overall Study||0||
59794107|NCT00308113|75914859|FG002|STARTED|Overall Study||1||
59794108|NCT00308113|75914860|FG003|STARTED|Overall Study||2||
59794109|NCT00308113|75914857|FG000|COMPLETED|Overall Study||0||
59794110|NCT00308113|75914858|FG001|COMPLETED|Overall Study||0||
59794111|NCT00308113|75914859|FG002|COMPLETED|Overall Study||1||
59794112|NCT00308113|75914860|FG003|COMPLETED|Overall Study||1||
59794113|NCT00308113|75914857|FG000|NOT COMPLETED|Overall Study||0||
59794114|NCT00308113|75914858|FG001|NOT COMPLETED|Overall Study||0||
59794115|NCT00308113|75914859|FG002|NOT COMPLETED|Overall Study||0||
59794116|NCT00308113|75914860|FG003|NOT COMPLETED|Overall Study||1||
59794117|NCT03903640|75914870|FG000|STARTED|Overall Study||2||
59794118|NCT03903640|75914870|FG000|COMPLETED|Overall Study||2||
59794119|NCT03903640|75914870|FG000|NOT COMPLETED|Overall Study||0||
59794120|NCT00307801|75914876|FG000|STARTED|Overall Study||149||
59794121|NCT00307801|75914877|FG001|STARTED|Overall Study||82||
59794122|NCT00307801|75914876|FG000|Subjects Received Treatment|Overall Study||145||
59794123|NCT00307801|75914877|FG001|Subjects Received Treatment|Overall Study||81||
59794124|NCT00307801|75914876|FG000|Cycle 1, Visit 5, Baseline|Overall Study||145||
59794125|NCT00307801|75914877|FG001|Cycle 1, Visit 5, Baseline|Overall Study||81||
59794126|NCT00307801|75914876|FG000|Cycle 3, Visit 7, Treatment Day 84|Overall Study||130||
59794127|NCT00307801|75914877|FG001|Cycle 3, Visit 7, Treatment Day 84|Overall Study||71||
59794128|NCT00307801|75914876|FG000|Cycle 7, Treatment Day 196|Overall Study|Includes subjects that prematurely discontinued the study and may not be counted in earlier visits.|141||
59794129|NCT00307801|75914877|FG001|Cycle 7, Treatment Day 196|Overall Study|Includes subjects that prematurely discontinued the study and may not be counted in earlier visits.|77||
59794130|NCT00307801|75914876|FG000|COMPLETED|Overall Study||117||
59794131|NCT00307801|75914877|FG001|COMPLETED|Overall Study||65||
59794132|NCT00307801|75914876|FG000|NOT COMPLETED|Overall Study||32||
59794133|NCT00307801|75914877|FG001|NOT COMPLETED|Overall Study||17||
59794134|NCT00671060|75914886|FG000|STARTED|Overall Study||77||
59794135|NCT00671060|75914887|FG001|STARTED|Overall Study||76||
59794136|NCT00671060|75914886|FG000|COMPLETED|Overall Study|1 woman completed study but was excluded from analysis because gestational age <14 weeks.|76||
59794137|NCT00671060|75914887|FG001|COMPLETED|Overall Study|1 woman was withdrawn from the study due to preeclampsia.|75||
59794138|NCT00671060|75914886|FG000|NOT COMPLETED|Overall Study||1||
59794139|NCT00671060|75914887|FG001|NOT COMPLETED|Overall Study||1||
59794140|NCT00654420|75914897|FG000|STARTED|Phase I (Dose Escalation)||4||
59794141|NCT00654420|75914898|FG001|STARTED|Phase I (Dose Escalation)||16||
59794142|NCT00654420|75914899|FG002|STARTED|Phase I (Dose Escalation)||0||
59794143|NCT00654420|75914900|FG003|STARTED|Phase I (Dose Escalation)||0||
59794144|NCT00654420|75914897|FG000|COMPLETED|Phase I (Dose Escalation)||0||
59794145|NCT00654420|75914898|FG001|COMPLETED|Phase I (Dose Escalation)||0||
59794146|NCT00654420|75914899|FG002|COMPLETED|Phase I (Dose Escalation)||0||
59794147|NCT00654420|75914900|FG003|COMPLETED|Phase I (Dose Escalation)||0||
59794148|NCT00654420|75914897|FG000|NOT COMPLETED|Phase I (Dose Escalation)||4||
59794149|NCT00654420|75914898|FG001|NOT COMPLETED|Phase I (Dose Escalation)||16||
59794150|NCT00654420|75914899|FG002|NOT COMPLETED|Phase I (Dose Escalation)||0||
59794151|NCT00654420|75914900|FG003|NOT COMPLETED|Phase I (Dose Escalation)||0||
59794152|NCT00654420|75914897|FG000|STARTED|Phase II||0||
59794153|NCT00654420|75914898|FG001|STARTED|Phase II||0||
59794154|NCT00654420|75914899|FG002|STARTED|Phase II|New participants were enrolled in the Phase II part of the study that did not participate in Phase 1|37||
59794155|NCT00654420|75914900|FG003|STARTED|Phase II|New participants were enrolled in the Phase II part of the study that did not participate in Phase 1|38||
59794156|NCT00654420|75914897|FG000|COMPLETED|Phase II||0||
59794157|NCT00654420|75914898|FG001|COMPLETED|Phase II||0||
59794158|NCT00654420|75914899|FG002|COMPLETED|Phase II||0||
59794159|NCT00654420|75914900|FG003|COMPLETED|Phase II||0||
59794160|NCT00654420|75914897|FG000|NOT COMPLETED|Phase II||0||
59794161|NCT00654420|75914898|FG001|NOT COMPLETED|Phase II||0||
59794162|NCT00654420|75914899|FG002|NOT COMPLETED|Phase II||37||
59794163|NCT00654420|75914900|FG003|NOT COMPLETED|Phase II||38||
59794164|NCT00307489|75914912|FG000|STARTED|Baseline Through Week 48||53||
59794165|NCT00307489|75914913|FG001|STARTED|Baseline Through Week 48||52||
59794166|NCT00307489|75914912|FG000|COMPLETED|Baseline Through Week 48|16 of the 52 subjects switched to open-label FTC/TDF prior to Week 48.|52||
59794167|NCT00307489|75914913|FG001|COMPLETED|Baseline Through Week 48|9 of the 50 subjects switched to open-label FTC/TDF prior to Week 48.|50||
59794168|NCT00307489|75914912|FG000|NOT COMPLETED|Baseline Through Week 48||1||
59794169|NCT00307489|75914913|FG001|NOT COMPLETED|Baseline Through Week 48||2||
59794170|NCT00307489|75914912|FG000|STARTED|Week 48 Through Week 168||52||
59794171|NCT00307489|75914913|FG001|STARTED|Week 48 Through Week 168||50||
59794172|NCT00307489|75914912|FG000|COMPLETED|Week 48 Through Week 168|11 of the 46 subjects switched to open-label FTC/TDF prior to Week 168.|46||
59794173|NCT00307489|75914913|FG001|COMPLETED|Week 48 Through Week 168|5 of the 44 subjects switched to open-label FTC/TDF prior to Week 168.|44||
59794174|NCT00307489|75914912|FG000|NOT COMPLETED|Week 48 Through Week 168||6||
59794175|NCT00307489|75914913|FG001|NOT COMPLETED|Week 48 Through Week 168||6||
59794176|NCT00645840|75914919|FG000|STARTED|Overall Study||15||
59794177|NCT00645840|75914919|FG000|COMPLETED|Overall Study||12||
59794178|NCT00645840|75914919|FG000|NOT COMPLETED|Overall Study||3||
59794179|NCT00307333|75914925|FG000|STARTED|Overall Study||1511||
59794180|NCT00307333|75914926|FG001|STARTED|Overall Study||1492||
59794181|NCT00307333|75914925|FG000|COMPLETED|Overall Study||1500||
59794182|NCT00307333|75914926|FG001|COMPLETED|Overall Study||1489||
59794183|NCT00307333|75914925|FG000|NOT COMPLETED|Overall Study||11||
59794184|NCT00307333|75914926|FG001|NOT COMPLETED|Overall Study||3||
59794185|NCT00762359|75914934|FG000|STARTED|Overall Study||226||
59794186|NCT00762359|75914935|FG001|STARTED|Overall Study||235||
59794187|NCT00762359|75914934|FG000|COMPLETED|Overall Study||167||
59794188|NCT00762359|75914935|FG001|COMPLETED|Overall Study||178||
59794189|NCT00762359|75914934|FG000|NOT COMPLETED|Overall Study||59||
59794190|NCT00762359|75914935|FG001|NOT COMPLETED|Overall Study||57||
59794191|NCT00654186|75914941|FG000|STARTED|Overall Study||32||
59794192|NCT00654186|75914941|FG000|COMPLETED|Overall Study||27||
59794193|NCT00654186|75914941|FG000|NOT COMPLETED|Overall Study||5||
59794194|NCT00761969|75914947|FG000|STARTED|Overall Study||742||
59794195|NCT00761969|75914948|FG001|STARTED|Overall Study||713||
59794196|NCT00761969|75914947|FG000|COMPLETED|Overall Study||542||
59794197|NCT00761969|75914948|FG001|COMPLETED|Overall Study||573||
59794198|NCT00761969|75914947|FG000|NOT COMPLETED|Overall Study||200||
59794199|NCT00761969|75914948|FG001|NOT COMPLETED|Overall Study||140||
59794200|NCT03274804|75914954|FG000|STARTED|Overall Study||20||
59794201|NCT03274804|75914954|FG000|COMPLETED|Overall Study||20||
59794202|NCT03274804|75914954|FG000|NOT COMPLETED|Overall Study||0||
59794203|NCT00761891|75914959|FG000|STARTED|Overall Study||64||
59794204|NCT00761891|75914959|FG000|COMPLETED|Overall Study||54||
59794205|NCT00761891|75914959|FG000|NOT COMPLETED|Overall Study||10||
59794206|NCT00321685|75914964|FG000|STARTED|Overall Study||57||
59794207|NCT00321685|75914964|FG000|Eligible|Overall Study||55||
59954078|NCT02586064|76072521|FG001|NOT COMPLETED|Overall Study||28||
59523443|NCT02549352|75618277|FG001|STARTED|3-day Treatment and 8-week Follow-up||102||
59794208|NCT00321685|75914964|FG000|Started Protocol Therapy|Overall Study||55||
59794209|NCT00321685|75914964|FG000|Eligible and Treated|Overall Study||53||
59794210|NCT00321685|75914964|FG000|COMPLETED|Overall Study||18||
59794211|NCT00321685|75914964|FG000|NOT COMPLETED|Overall Study||39||
59794212|NCT03902392|75914970|FG000|STARTED|Overall Study||25||
59794213|NCT03902392|75914971|FG001|STARTED|Overall Study||25||
59794214|NCT03902392|75914970|FG000|COMPLETED|Overall Study||18||
59794215|NCT03902392|75914971|FG001|COMPLETED|Overall Study||18||
59794216|NCT03902392|75914970|FG000|NOT COMPLETED|Overall Study||7||
59794217|NCT03902392|75914971|FG001|NOT COMPLETED|Overall Study||7||
59794218|NCT00306787|75914979|FG000|STARTED|Overall Study||579||
59794219|NCT00306787|75914980|FG001|STARTED|Overall Study||600||
59794220|NCT00306787|75914979|FG000|Received Study Drug (Safety Population)|Overall Study||371||
59794221|NCT00306787|75914980|FG001|Received Study Drug (Safety Population)|Overall Study||385||
59794222|NCT00306787|75914979|FG000|Intent to Treat (ITT) Population|Overall Study||370||
59794223|NCT00306787|75914980|FG001|Intent to Treat (ITT) Population|Overall Study||381||
59794224|NCT00306787|75914979|FG000|COMPLETED|Overall Study||345||
59794225|NCT00306787|75914980|FG001|COMPLETED|Overall Study||359||
59794226|NCT00306787|75914979|FG000|NOT COMPLETED|Overall Study||234||
59794227|NCT00306787|75914980|FG001|NOT COMPLETED|Overall Study||241||
59794228|NCT00769067|75914988|FG000|STARTED|Overall Study||94||
59794229|NCT00769067|75914989|FG001|STARTED|Overall Study||94||
59794230|NCT00769067|75914988|FG000|Treated|Overall Study||94||
59794231|NCT00769067|75914989|FG001|Treated|Overall Study|One participant was not treated: refused treatment for reason other than an adverse event (AE).|93||
59794232|NCT00769067|75914988|FG000|COMPLETED|Overall Study||0||
59794233|NCT00769067|75914989|FG001|COMPLETED|Overall Study||0||
59794234|NCT00769067|75914988|FG000|NOT COMPLETED|Overall Study||94||
59794235|NCT00769067|75914989|FG001|NOT COMPLETED|Overall Study||94||
59794236|NCT00321373|75914999|FG000|STARTED|Overall Study||407||
59794237|NCT00321373|75915000|FG001|STARTED|Overall Study||406||
59794238|NCT00321373|75915001|FG002|STARTED|Overall Study||407||
59794239|NCT00321373|75914999|FG000|COMPLETED|Overall Study||405||
59794240|NCT00321373|75915000|FG001|COMPLETED|Overall Study||406||
59794241|NCT00321373|75915001|FG002|COMPLETED|Overall Study||404||
59794242|NCT00321373|75914999|FG000|NOT COMPLETED|Overall Study||2||
59954079|NCT03810495|76072530|FG000|STARTED|Overall Study||20||
59954080|NCT03810495|76072530|FG000|COMPLETED|Overall Study||17||
59794243|NCT00321373|75915000|FG001|NOT COMPLETED|Overall Study||0||
59794244|NCT00321373|75915001|FG002|NOT COMPLETED|Overall Study||3||
59794245|NCT00667394|75915011|FG000|STARTED|Overall Study||41||
59794246|NCT00667394|75915012|FG001|STARTED|Overall Study||1||
59794247|NCT00667394|75915011|FG000|COMPLETED|Overall Study||37||
59794248|NCT00667394|75915012|FG001|COMPLETED|Overall Study||1||
59794249|NCT00667394|75915011|FG000|NOT COMPLETED|Overall Study||4||
59794250|NCT00667394|75915012|FG001|NOT COMPLETED|Overall Study||0||
59794251|NCT00761735|75915018|FG000|STARTED|Overall Study||94||
59794252|NCT00761735|75915018|FG000|COMPLETED|Overall Study||80||
59794253|NCT00761735|75915018|FG000|NOT COMPLETED|Overall Study||14||
59794254|NCT00569946|75915026|FG000|STARTED|Overall Study||64||
59794255|NCT00569946|75915026|FG000|COMPLETED|Overall Study||5||
59794256|NCT00569946|75915026|FG000|NOT COMPLETED|Overall Study||59||
59794257|NCT00645528|75915030|FG000|STARTED|Overall Study||39||
59794258|NCT00645528|75915030|FG000|COMPLETED|Overall Study||32||
59794259|NCT00645528|75915030|FG000|NOT COMPLETED|Overall Study||7||
59794260|NCT00295633|75915037|FG000|STARTED|Overall Study||195||
59794261|NCT00295633|75915038|FG001|STARTED|Overall Study||186||
59794262|NCT00295633|75915039|FG002|STARTED|Overall Study||184||
59794263|NCT00295633|75915037|FG000|Completed Study Without Being Rescued|Overall Study||88||
59794264|NCT00295633|75915038|FG001|Completed Study Without Being Rescued|Overall Study||82||
59794265|NCT00295633|75915039|FG002|Completed Study Without Being Rescued|Overall Study||51||
59794266|NCT00295633|75915037|FG000|COMPLETED|Overall Study||133||
59794267|NCT00295633|75915038|FG001|COMPLETED|Overall Study||119||
59794268|NCT00295633|75915039|FG002|COMPLETED|Overall Study||108||
59794269|NCT00295633|75915037|FG000|NOT COMPLETED|Overall Study||62||
59794270|NCT00295633|75915038|FG001|NOT COMPLETED|Overall Study||67||
59794271|NCT00295633|75915039|FG002|NOT COMPLETED|Overall Study||76||
59794272|NCT00570674|75915047|FG000|STARTED|Overall Study||6||
59794273|NCT00570674|75915048|FG001|STARTED|Overall Study||3||
59794274|NCT00570674|75915049|FG002|STARTED|Overall Study||4||
59794275|NCT00570674|75915050|FG003|STARTED|Overall Study||3||
59794276|NCT00570674|75915051|FG004|STARTED|Overall Study||3||
59794277|NCT00570674|75915052|FG005|STARTED|Overall Study||10||
59794278|NCT00570674|75915053|FG006|STARTED|Overall Study|The study did not continue beyond phase I.|0||
59794279|NCT00570674|75915047|FG000|Treated|Overall Study||6||
59794280|NCT00570674|75915048|FG001|Treated|Overall Study||3||
59794281|NCT00570674|75915049|FG002|Treated|Overall Study||3||
59794282|NCT00570674|75915050|FG003|Treated|Overall Study||3||
59794283|NCT00570674|75915051|FG004|Treated|Overall Study||3||
59794284|NCT00570674|75915052|FG005|Treated|Overall Study||10||
59794285|NCT00570674|75915053|FG006|Treated|Overall Study||0||
59794286|NCT00570674|75915047|FG000|PEG Evaluable|Overall Study||6||
59794287|NCT00570674|75915048|FG001|PEG Evaluable|Overall Study||3||
59794288|NCT00570674|75915049|FG002|PEG Evaluable|Overall Study||3||
59794289|NCT00570674|75915050|FG003|PEG Evaluable|Overall Study||3||
59794290|NCT00570674|75915051|FG004|PEG Evaluable|Overall Study||2||
59794291|NCT00570674|75915052|FG005|PEG Evaluable|Overall Study||10||
59794292|NCT00570674|75915053|FG006|PEG Evaluable|Overall Study||0||
59794293|NCT00570674|75915047|FG000|COMPLETED|Overall Study||6||
59794294|NCT00570674|75915048|FG001|COMPLETED|Overall Study||3||
59794295|NCT00570674|75915049|FG002|COMPLETED|Overall Study||3||
59794296|NCT00570674|75915050|FG003|COMPLETED|Overall Study||3||
59794297|NCT00570674|75915051|FG004|COMPLETED|Overall Study||3||
59794298|NCT00570674|75915052|FG005|COMPLETED|Overall Study||10||
59794299|NCT00570674|75915053|FG006|COMPLETED|Overall Study||0||
59794300|NCT00570674|75915047|FG000|NOT COMPLETED|Overall Study||0||
59794301|NCT00570674|75915048|FG001|NOT COMPLETED|Overall Study||0||
59794302|NCT00570674|75915049|FG002|NOT COMPLETED|Overall Study||1||
59794303|NCT00570674|75915050|FG003|NOT COMPLETED|Overall Study||0||
59794304|NCT00570674|75915051|FG004|NOT COMPLETED|Overall Study||0||
59794305|NCT00570674|75915052|FG005|NOT COMPLETED|Overall Study||0||
59794306|NCT00570674|75915053|FG006|NOT COMPLETED|Overall Study||0||
59794307|NCT00768989|75915066|FG000|STARTED|Prior to Week 24||63||
59794308|NCT00768989|75915067|FG001|STARTED|Prior to Week 24||30||
59794309|NCT00768989|75915066|FG000|COMPLETED|Prior to Week 24||59||
59794310|NCT00768989|75915067|FG001|COMPLETED|Prior to Week 24||27||
59794311|NCT00768989|75915066|FG000|NOT COMPLETED|Prior to Week 24||4||
59794312|NCT00768989|75915067|FG001|NOT COMPLETED|Prior to Week 24||3||
59794313|NCT00768989|75915066|FG000|STARTED|Week 24 to Prior to Week 36||59||
59794314|NCT00768989|75915067|FG001|STARTED|Week 24 to Prior to Week 36||27||
59794315|NCT00768989|75915066|FG000|COMPLETED|Week 24 to Prior to Week 36||51||
59794316|NCT00768989|75915067|FG001|COMPLETED|Week 24 to Prior to Week 36||27||
59794317|NCT00768989|75915066|FG000|NOT COMPLETED|Week 24 to Prior to Week 36||8||
59794318|NCT00768989|75915067|FG001|NOT COMPLETED|Week 24 to Prior to Week 36||0||
59794319|NCT00768989|75915066|FG000|STARTED|On or After Week 36||51||
59794320|NCT00768989|75915067|FG001|STARTED|On or After Week 36||27||
59794321|NCT00768989|75915066|FG000|COMPLETED|On or After Week 36||0||
59794322|NCT00768989|75915067|FG001|COMPLETED|On or After Week 36||0||
59794323|NCT00768989|75915066|FG000|NOT COMPLETED|On or After Week 36||51||
59794324|NCT00768989|75915067|FG001|NOT COMPLETED|On or After Week 36||27||
59794325|NCT00305773|75915077|FG000|STARTED|Overall Study||15||
59794326|NCT00305773|75915078|FG001|STARTED|Overall Study||22||
59794327|NCT00305773|75915077|FG000|COMPLETED|Overall Study||1||
59794328|NCT00305773|75915078|FG001|COMPLETED|Overall Study||4||
59794329|NCT00305773|75915077|FG000|NOT COMPLETED|Overall Study||14||
59794330|NCT00305773|75915078|FG001|NOT COMPLETED|Overall Study||18||
59794331|NCT00305695|75915086|FG000|STARTED|Overall Study||81||
59794332|NCT00305695|75915087|FG001|STARTED|Overall Study||79||
59794333|NCT00305695|75915086|FG000|COMPLETED|Overall Study||40||
59794334|NCT00305695|75915087|FG001|COMPLETED|Overall Study||52||
59794335|NCT00305695|75915086|FG000|NOT COMPLETED|Overall Study||41||
59794336|NCT00305695|75915087|FG001|NOT COMPLETED|Overall Study||27||
59794337|NCT00647556|75915095|FG000|STARTED|Overall Study||15||
59794338|NCT00647556|75915096|FG001|STARTED|Overall Study||15||
59794339|NCT00647556|75915095|FG000|COMPLETED|Overall Study||12||
59794340|NCT00647556|75915096|FG001|COMPLETED|Overall Study||13||
59794341|NCT00647556|75915095|FG000|NOT COMPLETED|Overall Study||3||
59794342|NCT00647556|75915096|FG001|NOT COMPLETED|Overall Study||2||
59794343|NCT00320593|75915104|FG000|STARTED|Overall Study||59||
59794344|NCT00320593|75915105|FG001|STARTED|Overall Study||59||
59794345|NCT00320593|75915104|FG000|COMPLETED|Overall Study|Completed defined as completing the 3 year primary outcome exam|52||
59794346|NCT00320593|75915105|FG001|COMPLETED|Overall Study|Completed defined as completing the 3 year primary outcome exam|58||
59794347|NCT00320593|75915104|FG000|NOT COMPLETED|Overall Study||7||
59794348|NCT00320593|75915105|FG001|NOT COMPLETED|Overall Study||1||
59794349|NCT00320515|75915111|FG000|STARTED|Overall Study||69||
59794350|NCT00320515|75915111|FG000|COMPLETED|Overall Study||20||
59794351|NCT00320515|75915111|FG000|NOT COMPLETED|Overall Study||49||
59954081|NCT03810495|76072530|FG000|NOT COMPLETED|Overall Study||3||
59954082|NCT02782923|76072534|FG000|STARTED|Overall Study||19||
59954083|NCT02782923|76072534|FG000|COMPLETED|Overall Study||4||
59954084|NCT02782923|76072534|FG000|NOT COMPLETED|Overall Study||15||
59954085|NCT03760458|76072543|FG000|STARTED|Main Study (Through Week 48)||9||
59954086|NCT03760458|76072544|FG001|STARTED|Main Study (Through Week 48)||12||
59954087|NCT03760458|76072545|FG002|STARTED|Main Study (Through Week 48)||15||
59954088|NCT03760458|76072546|FG003|STARTED|Main Study (Through Week 48)||10||
59954089|NCT03760458|76072547|FG004|STARTED|Main Study (Through Week 48)||11||
59954090|NCT03760458|76072543|FG000|COMPLETED|Main Study (Through Week 48)||8||
59794352|NCT00662012|75915115|FG000|STARTED|Overall Study||414||
59794353|NCT00662012|75915115|FG000|COMPLETED|Overall Study||327||
59794354|NCT00662012|75915115|FG000|NOT COMPLETED|Overall Study||87||
59794355|NCT00661778|75915119|FG000|STARTED|Overall Study||50||
59794356|NCT00661778|75915119|FG000|COMPLETED|Overall Study||0||
59794357|NCT00661778|75915119|FG000|NOT COMPLETED|Overall Study||50||
59794358|NCT00319735|75915123|FG000|STARTED|Overall Study||41||
59794359|NCT00319735|75915123|FG000|COMPLETED|Overall Study||39||
59794360|NCT00319735|75915123|FG000|NOT COMPLETED|Overall Study||2||
59794361|NCT00653328|75915128|FG000|STARTED|Overall Study||15||
59794362|NCT00653328|75915128|FG000|COMPLETED|Overall Study||0||
59794363|NCT00653328|75915128|FG000|NOT COMPLETED|Overall Study||15||
59794364|NCT01664182|75915134|FG000|STARTED|Overall Study||19||
59794365|NCT01664182|75915135|FG001|STARTED|Overall Study||22||
59794366|NCT01664182|75915134|FG000|COMPLETED|Overall Study||17||
59794367|NCT01664182|75915135|FG001|COMPLETED|Overall Study||18||
59794368|NCT01664182|75915134|FG000|NOT COMPLETED|Overall Study||2||
59794369|NCT01664182|75915135|FG001|NOT COMPLETED|Overall Study||4||
59794370|NCT00642642|75915141|FG000|STARTED|Biopsy & Product Manufacture||122||
59794371|NCT00642642|75915141|FG000|COMPLETED|Biopsy & Product Manufacture|Patients biopsied and for whom study product could be produced are considered completed|109||
59523444|NCT02549352|75618276|FG000|Treated|3-day Treatment and 8-week Follow-up||209||
59523445|NCT02549352|75618277|FG001|Treated|3-day Treatment and 8-week Follow-up|1 participant was included in 0.037% in the safety analysis set as they received both IMPs in error|101||
59523446|NCT02549352|75618276|FG000|COMPLETED|3-day Treatment and 8-week Follow-up||207||
59523447|NCT02549352|75618277|FG001|COMPLETED|3-day Treatment and 8-week Follow-up||96||
59523448|NCT02549352|75618276|FG000|NOT COMPLETED|3-day Treatment and 8-week Follow-up||2||
59523449|NCT02549352|75618277|FG001|NOT COMPLETED|3-day Treatment and 8-week Follow-up||6||
59523450|NCT02549352|75618276|FG000|STARTED|12-month Follow-up||207||
59523451|NCT02549352|75618277|FG001|STARTED|12-month Follow-up||93||
59523452|NCT02549352|75618276|FG000|COMPLETED|12-month Follow-up||199||
59523453|NCT02549352|75618277|FG001|COMPLETED|12-month Follow-up||81||
59794372|NCT00642642|75915141|FG000|NOT COMPLETED|Biopsy & Product Manufacture||13||
59794373|NCT00642642|75915141|FG000|STARTED|Treatment & Follow Up||109||
59794374|NCT00642642|75915141|FG000|COMPLETED|Treatment & Follow Up||92||
59794375|NCT00642642|75915141|FG000|NOT COMPLETED|Treatment & Follow Up||17||
59954091|NCT03760458|76072544|FG001|COMPLETED|Main Study (Through Week 48)||11||
59794376|NCT00534352|75915151|FG000|STARTED|Treatment A: TMC125 + TDF/FTC||23||
59794377|NCT00534352|75915151|FG000|COMPLETED|Treatment A: TMC125 + TDF/FTC||21||
59794378|NCT00534352|75915151|FG000|NOT COMPLETED|Treatment A: TMC125 + TDF/FTC||2||
59794379|NCT00534352|75915151|FG000|STARTED|Treatment B: TMC125 + TDF/FTC + DRV/Rtv||21||
59794380|NCT00534352|75915151|FG000|COMPLETED|Treatment B: TMC125 + TDF/FTC + DRV/Rtv||21||
59794381|NCT00534352|75915151|FG000|NOT COMPLETED|Treatment B: TMC125 + TDF/FTC + DRV/Rtv||0||
59794382|NCT00534352|75915151|FG000|STARTED|Treatment C: DRV/Rtv + TDF/FTC||21||
59794383|NCT00534352|75915151|FG000|COMPLETED|Treatment C: DRV/Rtv + TDF/FTC||20||
59794384|NCT00534352|75915151|FG000|NOT COMPLETED|Treatment C: DRV/Rtv + TDF/FTC||1||
59794385|NCT00534352|75915151|FG000|STARTED|Optional Extension: DRV/Rtv + TDF/FTC||18||
59794386|NCT00534352|75915151|FG000|COMPLETED|Optional Extension: DRV/Rtv + TDF/FTC||14||
59794387|NCT00534352|75915151|FG000|NOT COMPLETED|Optional Extension: DRV/Rtv + TDF/FTC||4||
59794388|NCT00642174|75915166|FG000|STARTED|Period 1 - Initial Drug||18||
59794389|NCT00642174|75915167|FG001|STARTED|Period 1 - Initial Drug||17||
59794390|NCT00642174|75915166|FG000|COMPLETED|Period 1 - Initial Drug||18||
59794391|NCT00642174|75915167|FG001|COMPLETED|Period 1 - Initial Drug||16||
59794392|NCT00642174|75915166|FG000|NOT COMPLETED|Period 1 - Initial Drug||0||
59954092|NCT03760458|76072545|FG002|COMPLETED|Main Study (Through Week 48)||15||
59794393|NCT00642174|75915167|FG001|NOT COMPLETED|Period 1 - Initial Drug||1||
59794394|NCT00642174|75915166|FG000|STARTED|Period 2 - Crossover Drug||18||
59794395|NCT00642174|75915167|FG001|STARTED|Period 2 - Crossover Drug||16||
59794396|NCT00642174|75915166|FG000|COMPLETED|Period 2 - Crossover Drug||18||
59794397|NCT00642174|75915167|FG001|COMPLETED|Period 2 - Crossover Drug||16||
59794398|NCT00642174|75915166|FG000|NOT COMPLETED|Period 2 - Crossover Drug||0||
59794399|NCT00642174|75915167|FG001|NOT COMPLETED|Period 2 - Crossover Drug||0||
59794400|NCT00665366|75915175|FG000|STARTED|Overall Study|Participants randomized|189||
59794401|NCT00665366|75915176|FG001|STARTED|Overall Study|Participants randomized|181||
59794402|NCT00665366|75915175|FG000|COMPLETED|Overall Study||131||
59794403|NCT00665366|75915176|FG001|COMPLETED|Overall Study||122||
59794404|NCT00665366|75915175|FG000|NOT COMPLETED|Overall Study||58||
59794405|NCT00665366|75915176|FG001|NOT COMPLETED|Overall Study||59||
59794406|NCT00775684|75915185|FG000|STARTED|Overall Study||17||
59794407|NCT00775684|75915186|FG001|STARTED|Overall Study||13||
59794408|NCT00775684|75915187|FG002|STARTED|Overall Study||17||
59954093|NCT03760458|76072546|FG003|COMPLETED|Main Study (Through Week 48)||10||
59954094|NCT03760458|76072547|FG004|COMPLETED|Main Study (Through Week 48)||11||
59954095|NCT03760458|76072543|FG000|NOT COMPLETED|Main Study (Through Week 48)||1||
59794409|NCT00775684|75915185|FG000|COMPLETED|Overall Study||14||
59794410|NCT00775684|75915186|FG001|COMPLETED|Overall Study||12||
59794411|NCT00775684|75915187|FG002|COMPLETED|Overall Study||14||
59794412|NCT00775684|75915185|FG000|NOT COMPLETED|Overall Study||3||
59794413|NCT00775684|75915186|FG001|NOT COMPLETED|Overall Study||1||
59794414|NCT00775684|75915187|FG002|NOT COMPLETED|Overall Study||3||
59794415|NCT00642018|75915206|FG000|STARTED|Overall Study||52||
59794416|NCT00642018|75915207|FG001|STARTED|Overall Study||102||
59794417|NCT00642018|75915206|FG000|Received at Least One Dose of Study Drug|Overall Study||51||
59794418|NCT00642018|75915207|FG001|Received at Least One Dose of Study Drug|Overall Study||98||
59794419|NCT00642018|75915206|FG000|COMPLETED|Overall Study|Participants who completed 10 cycles of treatment.|24||
59794420|NCT00642018|75915207|FG001|COMPLETED|Overall Study|Participants who completed 10 cycles of treatment.|23||
59794421|NCT00642018|75915206|FG000|NOT COMPLETED|Overall Study||28||
59794422|NCT00642018|75915207|FG001|NOT COMPLETED|Overall Study||79||
59794423|NCT00532948|75915217|FG000|STARTED|Overall Study||4||
59794424|NCT00532948|75915218|FG001|STARTED|Overall Study||14||
59794425|NCT00532948|75915219|FG002|STARTED|Overall Study||6||
59794426|NCT00532948|75915217|FG000|COMPLETED|Overall Study||0||
59794427|NCT00532948|75915218|FG001|COMPLETED|Overall Study||9||
59794428|NCT00532948|75915219|FG002|COMPLETED|Overall Study||2||
59794429|NCT00532948|75915217|FG000|NOT COMPLETED|Overall Study||4||
59794430|NCT00532948|75915218|FG001|NOT COMPLETED|Overall Study||5||
59794431|NCT00532948|75915219|FG002|NOT COMPLETED|Overall Study||4||
59794432|NCT00641706|75915233|FG000|STARTED|Overall Study||37||
59794433|NCT00641706|75915234|FG001|STARTED|Overall Study||7||
59794434|NCT00641706|75915233|FG000|COMPLETED|Overall Study||28||
59794435|NCT00641706|75915234|FG001|COMPLETED|Overall Study||4||
59794436|NCT00641706|75915233|FG000|NOT COMPLETED|Overall Study||9||
59794437|NCT00641706|75915234|FG001|NOT COMPLETED|Overall Study||3||
59794438|NCT00644358|75915240|FG000|STARTED|Overall Study||616||
59794439|NCT00644358|75915240|FG000|COMPLETED|Overall Study||254||
59794440|NCT00644358|75915240|FG000|NOT COMPLETED|Overall Study||362||
59794441|NCT00640926|75915247|FG000|STARTED|Overall Study||53||
59794442|NCT00640926|75915248|FG001|STARTED|Overall Study||52||
59794443|NCT00640926|75915249|FG002|STARTED|Overall Study||53||
59794444|NCT00640926|75915247|FG000|COMPLETED|Overall Study||45||
59794445|NCT00640926|75915248|FG001|COMPLETED|Overall Study||46||
59794446|NCT00640926|75915249|FG002|COMPLETED|Overall Study||45||
59954096|NCT03760458|76072544|FG001|NOT COMPLETED|Main Study (Through Week 48)||1||
59954097|NCT03760458|76072545|FG002|NOT COMPLETED|Main Study (Through Week 48)||0||
59954098|NCT03760458|76072546|FG003|NOT COMPLETED|Main Study (Through Week 48)||0||
59794447|NCT00640926|75915247|FG000|NOT COMPLETED|Overall Study||8||
59794448|NCT00640926|75915248|FG001|NOT COMPLETED|Overall Study||6||
59794449|NCT00640926|75915249|FG002|NOT COMPLETED|Overall Study||8||
59794450|NCT03892564|75915257|FG000|STARTED|Overall Study||35||
59794451|NCT03892564|75915257|FG000|MC2-01 Cream + Irridiation|Overall Study||35||
59794452|NCT03892564|75915257|FG000|MC2-01 Cream + Non-irridiation|Overall Study||35||
59794453|NCT03892564|75915257|FG000|MC2-01 Vehicle + Irridiation|Overall Study||35||
59794454|NCT03892564|75915257|FG000|MC2-01 Vehicle + Non-irridiation|Overall Study||35||
59794455|NCT03892564|75915257|FG000|Control Site|Overall Study||35||
59954099|NCT03760458|76072547|FG004|NOT COMPLETED|Main Study (Through Week 48)||0||
59954100|NCT03760458|76072543|FG000|STARTED|Extended Follow-up (Weeks 48 Through 60)||0||
59794456|NCT03892564|75915257|FG000|COMPLETED|Overall Study||33||
59794457|NCT03892564|75915257|FG000|NOT COMPLETED|Overall Study||2||
59794458|NCT03891862|75915264|FG000|STARTED|Open-label Period||135||
59794459|NCT03891862|75915265|FG001|STARTED|Open-label Period||0||
59794460|NCT03891862|75915266|FG002|STARTED|Open-label Period||0||
59794461|NCT03891862|75915264|FG000|Safety Analysis Set|Open-label Period||132|The safety analysis set for the open-label valbenazine group in this period includes all participants who received at least one dose of study drug and have any post-baseline safety data collected.|
59817865|NCT04488770|75940330|FG004|NOT COMPLETED|Part 1-Cohort 1: Period 4 (Up to 5 Days)||0||
59794462|NCT03891862|75915265|FG001|Safety Analysis Set|Open-label Period||0|The safety analysis set for the open-label valbenazine group in this period includes all participants who received at least one dose of study drug and have any post-baseline safety data collected.|
59794463|NCT03891862|75915266|FG002|Safety Analysis Set|Open-label Period||0|The safety analysis set for the open-label valbenazine group in this period includes all participants who received at least one dose of study drug and have any post-baseline safety data collected.|
59794464|NCT03891862|75915264|FG000|COMPLETED|Open-label Period||119||
59794465|NCT03891862|75915265|FG001|COMPLETED|Open-label Period||0||
59794466|NCT03891862|75915266|FG002|COMPLETED|Open-label Period||0||
59794467|NCT03891862|75915264|FG000|NOT COMPLETED|Open-label Period||16||
59794468|NCT03891862|75915265|FG001|NOT COMPLETED|Open-label Period||0||
59794469|NCT03891862|75915266|FG002|NOT COMPLETED|Open-label Period||0||
59794470|NCT03891862|75915264|FG000|STARTED|Placebo-controlled Period and Follow-up||0|One participant who completed the open-label period was not randomized.|
59954101|NCT03760458|76072544|FG001|STARTED|Extended Follow-up (Weeks 48 Through 60)||0||
59620184|NCT00064038|75731467|FG001|Eligible and Analyzable|Initial Randomization||95||
59620185|NCT00064038|75731468|FG002|Eligible and Analyzable|Initial Randomization||0||
59620186|NCT00064038|75731466|FG000|Safety Population|Initial Randomization||96||
59620187|NCT00064038|75731467|FG001|Safety Population|Initial Randomization||94||
59620188|NCT00064038|75731468|FG002|Safety Population|Initial Randomization||0||
59620189|NCT00064038|75731466|FG000|COMPLETED|Initial Randomization|The study was closed early per recommedation of the Data Safety Monitoring Committee.|0||
59620190|NCT00064038|75731467|FG001|COMPLETED|Initial Randomization|The study was closed early per recommedation of the Data Safety Monitoring Committee.|0||
59620191|NCT00064038|75731468|FG002|COMPLETED|Initial Randomization||0||
59620192|NCT00064038|75731466|FG000|NOT COMPLETED|Initial Randomization||100||
59620193|NCT00064038|75731467|FG001|NOT COMPLETED|Initial Randomization||98||
59620194|NCT00064038|75731468|FG002|NOT COMPLETED|Initial Randomization||0||
59620195|NCT00064038|75731466|FG000|STARTED|Crossover to Lenalidomide+Dexamethasone||0||
59620196|NCT00064038|75731467|FG001|STARTED|Crossover to Lenalidomide+Dexamethasone|See Crossover to Lenalidomide+Dexamethasone Arm.|0||
59620197|NCT00064038|75731468|FG002|STARTED|Crossover to Lenalidomide+Dexamethasone||42||
59620198|NCT00064038|75731466|FG000|Eligible and Analyzable|Crossover to Lenalidomide+Dexamethasone||0||
59620199|NCT00064038|75731467|FG001|Eligible and Analyzable|Crossover to Lenalidomide+Dexamethasone|See Crossover to Lenalidomide+Dexamethasone Arm.|0||
59620200|NCT00064038|75731468|FG002|Eligible and Analyzable|Crossover to Lenalidomide+Dexamethasone||40||
59794471|NCT03891862|75915265|FG001|STARTED|Placebo-controlled Period and Follow-up||59|One participant who completed the open-label period was not randomized.|
59817866|NCT04488770|75940331|FG005|NOT COMPLETED|Part 1-Cohort 1: Period 4 (Up to 5 Days)||0||
59794472|NCT03891862|75915266|FG002|STARTED|Placebo-controlled Period and Follow-up||59|One participant who completed the open-label period was not randomized.|
59794473|NCT03891862|75915264|FG000|Persistence of Effect Analysis Set|Placebo-controlled Period and Follow-up||0|Persistence of Effect analysis set included all randomized participants who received at least one dose of randomized study drug and have at least one AIMS assessment during the placebo-controlled period.|
59794474|NCT03891862|75915265|FG001|Persistence of Effect Analysis Set|Placebo-controlled Period and Follow-up||58|Persistence of Effect analysis set included all randomized participants who received at least one dose of randomized study drug and have at least one AIMS assessment during the placebo-controlled period.|
59794475|NCT03891862|75915266|FG002|Persistence of Effect Analysis Set|Placebo-controlled Period and Follow-up||59|Persistence of Effect analysis set included all randomized participants who received at least one dose of randomized study drug and have at least one AIMS assessment during the placebo-controlled period.|
59794476|NCT03891862|75915264|FG000|Completed Placebo-controlled Period|Placebo-controlled Period and Follow-up||0||
59794477|NCT03891862|75915265|FG001|Completed Placebo-controlled Period|Placebo-controlled Period and Follow-up||53||
59794478|NCT03891862|75915266|FG002|Completed Placebo-controlled Period|Placebo-controlled Period and Follow-up||56||
59794479|NCT03891862|75915264|FG000|COMPLETED|Placebo-controlled Period and Follow-up||0||
59794480|NCT03891862|75915265|FG001|COMPLETED|Placebo-controlled Period and Follow-up||53||
59794481|NCT03891862|75915266|FG002|COMPLETED|Placebo-controlled Period and Follow-up||55||
59794482|NCT03891862|75915264|FG000|NOT COMPLETED|Placebo-controlled Period and Follow-up||0||
59794483|NCT03891862|75915265|FG001|NOT COMPLETED|Placebo-controlled Period and Follow-up||6||
59794484|NCT03891862|75915266|FG002|NOT COMPLETED|Placebo-controlled Period and Follow-up||4||
59794485|NCT00640614|75915275|FG000|STARTED|Overall Study||125||
59794486|NCT00640614|75915276|FG001|STARTED|Overall Study||110||
59794487|NCT00640614|75915275|FG000|COMPLETED|Overall Study||124||
59794488|NCT00640614|75915276|FG001|COMPLETED|Overall Study||110||
59794489|NCT00640614|75915275|FG000|NOT COMPLETED|Overall Study||1||
59794490|NCT00640614|75915276|FG001|NOT COMPLETED|Overall Study||0||
59794491|NCT00761657|75915314|FG000|STARTED|Part 1 (up to Day 57)||0||
59794492|NCT00761657|75915315|FG001|STARTED|Part 1 (up to Day 57)||0||
59794493|NCT00761657|75915316|FG002|STARTED|Part 1 (up to Day 57)||12||
59794494|NCT00761657|75915317|FG003|STARTED|Part 1 (up to Day 57)||10||
59794495|NCT00761657|75915318|FG004|STARTED|Part 1 (up to Day 57)||0||
59794496|NCT00761657|75915319|FG005|STARTED|Part 1 (up to Day 57)||0||
59794497|NCT00761657|75915320|FG006|STARTED|Part 1 (up to Day 57)||1||
59794498|NCT00761657|75915321|FG007|STARTED|Part 1 (up to Day 57)||2||
59794499|NCT00761657|75915322|FG008|STARTED|Part 1 (up to Day 57)||10||
59794500|NCT00761657|75915314|FG000|Safety Population|Part 1 (up to Day 57)||0|Participants who received at least 1 dose of study drug.|
59794501|NCT00761657|75915315|FG001|Safety Population|Part 1 (up to Day 57)||0|Participants who received at least 1 dose of study drug.|
59794502|NCT00761657|75915316|FG002|Safety Population|Part 1 (up to Day 57)||12|Participants who received at least 1 dose of study drug.|
59794503|NCT00761657|75915317|FG003|Safety Population|Part 1 (up to Day 57)||9|Participants who received at least 1 dose of study drug.|
59794504|NCT00761657|75915318|FG004|Safety Population|Part 1 (up to Day 57)||0|Participants who received at least 1 dose of study drug.|
59794505|NCT00761657|75915319|FG005|Safety Population|Part 1 (up to Day 57)||0|Participants who received at least 1 dose of study drug.|
59794506|NCT00761657|75915320|FG006|Safety Population|Part 1 (up to Day 57)||1|Participants who received at least 1 dose of study drug.|
59794507|NCT00761657|75915321|FG007|Safety Population|Part 1 (up to Day 57)||2|Participants who received at least 1 dose of study drug.|
59794508|NCT00761657|75915322|FG008|Safety Population|Part 1 (up to Day 57)||10|Participants who received at least 1 dose of study drug.|
59794509|NCT00761657|75915314|FG000|Efficacy Evaluable (EE) Population|Part 1 (up to Day 57)||0|Participants who were anemic at baseline (hemoglobin [Hb] ≤11.0 grams/deciliter (g/dL) and were in study treatment for at least 2.5 weeks with corresponding Hb values.|
59794510|NCT00761657|75915315|FG001|Efficacy Evaluable (EE) Population|Part 1 (up to Day 57)||0|Participants who were anemic at baseline (hemoglobin [Hb] ≤11.0 grams/deciliter (g/dL) and were in study treatment for at least 2.5 weeks with corresponding Hb values.|
59794511|NCT00761657|75915316|FG002|Efficacy Evaluable (EE) Population|Part 1 (up to Day 57)||5|Participants who were anemic at baseline (hemoglobin [Hb] ≤11.0 grams/deciliter (g/dL) and were in study treatment for at least 2.5 weeks with corresponding Hb values.|
59794512|NCT00761657|75915317|FG003|Efficacy Evaluable (EE) Population|Part 1 (up to Day 57)||5|Participants who were anemic at baseline (hemoglobin [Hb] ≤11.0 grams/deciliter (g/dL) and were in study treatment for at least 2.5 weeks with corresponding Hb values.|
59794513|NCT00761657|75915318|FG004|Efficacy Evaluable (EE) Population|Part 1 (up to Day 57)||0|Participants who were anemic at baseline (hemoglobin [Hb] ≤11.0 grams/deciliter (g/dL) and were in study treatment for at least 2.5 weeks with corresponding Hb values.|
59794514|NCT00761657|75915319|FG005|Efficacy Evaluable (EE) Population|Part 1 (up to Day 57)||0|Participants who were anemic at baseline (hemoglobin [Hb] ≤11.0 grams/deciliter (g/dL) and were in study treatment for at least 2.5 weeks with corresponding Hb values.|
59794515|NCT00761657|75915320|FG006|Efficacy Evaluable (EE) Population|Part 1 (up to Day 57)||0|Participants who were anemic at baseline (hemoglobin [Hb] ≤11.0 grams/deciliter (g/dL) and were in study treatment for at least 2.5 weeks with corresponding Hb values.|
59794516|NCT00761657|75915321|FG007|Efficacy Evaluable (EE) Population|Part 1 (up to Day 57)||1|Participants who were anemic at baseline (hemoglobin [Hb] ≤11.0 grams/deciliter (g/dL) and were in study treatment for at least 2.5 weeks with corresponding Hb values.|
59794517|NCT00761657|75915322|FG008|Efficacy Evaluable (EE) Population|Part 1 (up to Day 57)||6|Participants who were anemic at baseline (hemoglobin [Hb] ≤11.0 grams/deciliter (g/dL) and were in study treatment for at least 2.5 weeks with corresponding Hb values.|
59794518|NCT00761657|75915314|FG000|Pharmacokinetic (PK) Population|Part 1 (up to Day 57)||0|Participants treated with roxadustat at the 2 PK sites.|
59794519|NCT00761657|75915315|FG001|Pharmacokinetic (PK) Population|Part 1 (up to Day 57)||0|Participants treated with roxadustat at the 2 PK sites.|
59794520|NCT00761657|75915316|FG002|Pharmacokinetic (PK) Population|Part 1 (up to Day 57)||5|Participants treated with roxadustat at the 2 PK sites.|
59794521|NCT00761657|75915317|FG003|Pharmacokinetic (PK) Population|Part 1 (up to Day 57)||3|Participants treated with roxadustat at the 2 PK sites.|
59794522|NCT00761657|75915318|FG004|Pharmacokinetic (PK) Population|Part 1 (up to Day 57)||0|Participants treated with roxadustat at the 2 PK sites.|
59794523|NCT00761657|75915319|FG005|Pharmacokinetic (PK) Population|Part 1 (up to Day 57)||0|Participants treated with roxadustat at the 2 PK sites.|
59794524|NCT00761657|75915320|FG006|Pharmacokinetic (PK) Population|Part 1 (up to Day 57)||1|Participants treated with roxadustat at the 2 PK sites.|
59794525|NCT00761657|75915321|FG007|Pharmacokinetic (PK) Population|Part 1 (up to Day 57)||2|Participants treated with roxadustat at the 2 PK sites.|
59794526|NCT00761657|75915322|FG008|Pharmacokinetic (PK) Population|Part 1 (up to Day 57)||0|Participants treated with roxadustat at the 2 PK sites.|
59794527|NCT00761657|75915314|FG000|COMPLETED|Part 1 (up to Day 57)||0||
59794528|NCT00761657|75915315|FG001|COMPLETED|Part 1 (up to Day 57)||0||
59794529|NCT00761657|75915316|FG002|COMPLETED|Part 1 (up to Day 57)||8||
59794530|NCT00761657|75915317|FG003|COMPLETED|Part 1 (up to Day 57)||4||
59794531|NCT00761657|75915318|FG004|COMPLETED|Part 1 (up to Day 57)||0||
59794532|NCT00761657|75915319|FG005|COMPLETED|Part 1 (up to Day 57)||0||
59794533|NCT00761657|75915320|FG006|COMPLETED|Part 1 (up to Day 57)||0||
59794534|NCT00761657|75915321|FG007|COMPLETED|Part 1 (up to Day 57)||1||
59794535|NCT00761657|75915322|FG008|COMPLETED|Part 1 (up to Day 57)||9||
59954102|NCT03760458|76072545|FG002|STARTED|Extended Follow-up (Weeks 48 Through 60)||4||
59954103|NCT03760458|76072546|FG003|STARTED|Extended Follow-up (Weeks 48 Through 60)||3||
59954104|NCT03760458|76072547|FG004|STARTED|Extended Follow-up (Weeks 48 Through 60)||3||
59794536|NCT00761657|75915314|FG000|NOT COMPLETED|Part 1 (up to Day 57)||0||
59794537|NCT00761657|75915315|FG001|NOT COMPLETED|Part 1 (up to Day 57)||0||
59794538|NCT00761657|75915316|FG002|NOT COMPLETED|Part 1 (up to Day 57)||4||
59794539|NCT00761657|75915317|FG003|NOT COMPLETED|Part 1 (up to Day 57)||6||
59794540|NCT00761657|75915318|FG004|NOT COMPLETED|Part 1 (up to Day 57)||0||
59794541|NCT00761657|75915319|FG005|NOT COMPLETED|Part 1 (up to Day 57)||0||
59794542|NCT00761657|75915320|FG006|NOT COMPLETED|Part 1 (up to Day 57)||1||
59794543|NCT00761657|75915321|FG007|NOT COMPLETED|Part 1 (up to Day 57)||1||
59794544|NCT00761657|75915322|FG008|NOT COMPLETED|Part 1 (up to Day 57)||1||
59794545|NCT00761657|75915314|FG000|STARTED|Part 2 (up to Day 114)||10||
59794546|NCT00761657|75915315|FG001|STARTED|Part 2 (up to Day 114)||13||
59794547|NCT00761657|75915316|FG002|STARTED|Part 2 (up to Day 114)||0||
59794548|NCT00761657|75915317|FG003|STARTED|Part 2 (up to Day 114)||0||
59794549|NCT00761657|75915318|FG004|STARTED|Part 2 (up to Day 114)||10||
59794550|NCT00761657|75915319|FG005|STARTED|Part 2 (up to Day 114)||11||
59794551|NCT00761657|75915320|FG006|STARTED|Part 2 (up to Day 114)||10||
59794552|NCT00761657|75915321|FG007|STARTED|Part 2 (up to Day 114)||10||
59794553|NCT00761657|75915322|FG008|STARTED|Part 2 (up to Day 114)||18||
59794554|NCT00761657|75915314|FG000|Safety Population|Part 2 (up to Day 114)||10|Participants who received at least 1 dose of study drug.|
59794555|NCT00761657|75915315|FG001|Safety Population|Part 2 (up to Day 114)||13|Participants who received at least 1 dose of study drug.|
59794556|NCT00761657|75915316|FG002|Safety Population|Part 2 (up to Day 114)||0|Participants who received at least 1 dose of study drug.|
59794557|NCT00761657|75915317|FG003|Safety Population|Part 2 (up to Day 114)||0|Participants who received at least 1 dose of study drug.|
59794558|NCT00761657|75915318|FG004|Safety Population|Part 2 (up to Day 114)||10|Participants who received at least 1 dose of study drug.|
59794559|NCT00761657|75915319|FG005|Safety Population|Part 2 (up to Day 114)||11|Participants who received at least 1 dose of study drug.|
59794560|NCT00761657|75915320|FG006|Safety Population|Part 2 (up to Day 114)||10|Participants who received at least 1 dose of study drug.|
59794561|NCT00761657|75915321|FG007|Safety Population|Part 2 (up to Day 114)||10|Participants who received at least 1 dose of study drug.|
59794562|NCT00761657|75915322|FG008|Safety Population|Part 2 (up to Day 114)||18|Participants who received at least 1 dose of study drug.|
59794563|NCT00761657|75915314|FG000|EE Population|Part 2 (up to Day 114)||10|Participants who were anemic at baseline (hemoglobin [Hb] ≤11.0 grams/deciliter (g/dL) and were in study treatment for at least 2.5 weeks with corresponding Hb values.|
59794564|NCT00761657|75915315|FG001|EE Population|Part 2 (up to Day 114)||12|Participants who were anemic at baseline (hemoglobin [Hb] ≤11.0 grams/deciliter (g/dL) and were in study treatment for at least 2.5 weeks with corresponding Hb values.|
59794565|NCT00761657|75915316|FG002|EE Population|Part 2 (up to Day 114)||0|Participants who were anemic at baseline (hemoglobin [Hb] ≤11.0 grams/deciliter (g/dL) and were in study treatment for at least 2.5 weeks with corresponding Hb values.|
59794566|NCT00761657|75915317|FG003|EE Population|Part 2 (up to Day 114)||0|Participants who were anemic at baseline (hemoglobin [Hb] ≤11.0 grams/deciliter (g/dL) and were in study treatment for at least 2.5 weeks with corresponding Hb values.|
59794567|NCT00761657|75915318|FG004|EE Population|Part 2 (up to Day 114)||10|Participants who were anemic at baseline (hemoglobin [Hb] ≤11.0 grams/deciliter (g/dL) and were in study treatment for at least 2.5 weeks with corresponding Hb values.|
59954105|NCT03760458|76072543|FG000|COMPLETED|Extended Follow-up (Weeks 48 Through 60)||0||
59817867|NCT04488770|75940332|FG006|NOT COMPLETED|Part 1-Cohort 1: Period 4 (Up to 5 Days)||0||
59954106|NCT03760458|76072544|FG001|COMPLETED|Extended Follow-up (Weeks 48 Through 60)||0||
59794568|NCT00761657|75915319|FG005|EE Population|Part 2 (up to Day 114)||11|Participants who were anemic at baseline (hemoglobin [Hb] ≤11.0 grams/deciliter (g/dL) and were in study treatment for at least 2.5 weeks with corresponding Hb values.|
59794569|NCT00761657|75915320|FG006|EE Population|Part 2 (up to Day 114)||10|Participants who were anemic at baseline (hemoglobin [Hb] ≤11.0 grams/deciliter (g/dL) and were in study treatment for at least 2.5 weeks with corresponding Hb values.|
59794570|NCT00761657|75915321|FG007|EE Population|Part 2 (up to Day 114)||10|Participants who were anemic at baseline (hemoglobin [Hb] ≤11.0 grams/deciliter (g/dL) and were in study treatment for at least 2.5 weeks with corresponding Hb values.|
59794571|NCT00761657|75915322|FG008|EE Population|Part 2 (up to Day 114)||11|Participants who were anemic at baseline (hemoglobin [Hb] ≤11.0 grams/deciliter (g/dL) and were in study treatment for at least 2.5 weeks with corresponding Hb values.|
59794572|NCT00761657|75915314|FG000|PK Population|Part 2 (up to Day 114)||10|Participants who received roxadustat and had sufficient plasma data to allow calculation of PK parameters.|
59794573|NCT00761657|75915315|FG001|PK Population|Part 2 (up to Day 114)||13|Participants who received roxadustat and had sufficient plasma data to allow calculation of PK parameters.|
59794574|NCT00761657|75915316|FG002|PK Population|Part 2 (up to Day 114)||0|Participants who received roxadustat and had sufficient plasma data to allow calculation of PK parameters.|
59794575|NCT00761657|75915317|FG003|PK Population|Part 2 (up to Day 114)||0|Participants who received roxadustat and had sufficient plasma data to allow calculation of PK parameters.|
59794576|NCT00761657|75915318|FG004|PK Population|Part 2 (up to Day 114)||10|Participants who received roxadustat and had sufficient plasma data to allow calculation of PK parameters.|
59794577|NCT00761657|75915319|FG005|PK Population|Part 2 (up to Day 114)||11|Participants who received roxadustat and had sufficient plasma data to allow calculation of PK parameters.|
59794578|NCT00761657|75915320|FG006|PK Population|Part 2 (up to Day 114)||10|Participants who received roxadustat and had sufficient plasma data to allow calculation of PK parameters.|
59794579|NCT00761657|75915321|FG007|PK Population|Part 2 (up to Day 114)||10|Participants who received roxadustat and had sufficient plasma data to allow calculation of PK parameters.|
59794580|NCT00761657|75915322|FG008|PK Population|Part 2 (up to Day 114)||0|Participants who received roxadustat and had sufficient plasma data to allow calculation of PK parameters.|
59794581|NCT00761657|75915314|FG000|COMPLETED|Part 2 (up to Day 114)||10||
59794582|NCT00761657|75915315|FG001|COMPLETED|Part 2 (up to Day 114)||13||
59794583|NCT00761657|75915316|FG002|COMPLETED|Part 2 (up to Day 114)||0||
59794584|NCT00761657|75915317|FG003|COMPLETED|Part 2 (up to Day 114)||0||
59794585|NCT00761657|75915318|FG004|COMPLETED|Part 2 (up to Day 114)||10||
59794586|NCT00761657|75915319|FG005|COMPLETED|Part 2 (up to Day 114)||11||
59794587|NCT00761657|75915320|FG006|COMPLETED|Part 2 (up to Day 114)||10||
59794588|NCT00761657|75915321|FG007|COMPLETED|Part 2 (up to Day 114)||10||
59794589|NCT00761657|75915322|FG008|COMPLETED|Part 2 (up to Day 114)||17||
59794590|NCT00761657|75915314|FG000|NOT COMPLETED|Part 2 (up to Day 114)||0||
59794591|NCT00761657|75915315|FG001|NOT COMPLETED|Part 2 (up to Day 114)||0||
59794592|NCT00761657|75915316|FG002|NOT COMPLETED|Part 2 (up to Day 114)||0||
59794593|NCT00761657|75915317|FG003|NOT COMPLETED|Part 2 (up to Day 114)||0||
59794594|NCT00761657|75915318|FG004|NOT COMPLETED|Part 2 (up to Day 114)||0||
59794595|NCT00761657|75915319|FG005|NOT COMPLETED|Part 2 (up to Day 114)||0||
59794596|NCT00761657|75915320|FG006|NOT COMPLETED|Part 2 (up to Day 114)||0||
59794597|NCT00761657|75915321|FG007|NOT COMPLETED|Part 2 (up to Day 114)||0||
59794598|NCT00761657|75915322|FG008|NOT COMPLETED|Part 2 (up to Day 114)||1||
59794599|NCT00319501|75915354|FG000|STARTED|Double-blind Period|Randomized participants|124||
59794600|NCT00319501|75915355|FG001|STARTED|Double-blind Period|Randomized participants|110||
59794601|NCT00319501|75915354|FG000|Received Treatment|Double-blind Period||82||
59794602|NCT00319501|75915355|FG001|Received Treatment|Double-blind Period||81||
59794603|NCT00319501|75915354|FG000|COMPLETED|Double-blind Period||81||
59794604|NCT00319501|75915355|FG001|COMPLETED|Double-blind Period||78||
59794605|NCT00319501|75915354|FG000|NOT COMPLETED|Double-blind Period||43||
59794606|NCT00319501|75915355|FG001|NOT COMPLETED|Double-blind Period||32||
59794607|NCT00319501|75915354|FG000|STARTED|Open-label Period|Participants who continued to meet eligibility requirements|161||
59794608|NCT00319501|75915355|FG001|STARTED|Open-label Period||0||
59794609|NCT00319501|75915354|FG000|Received Treatment|Open-label Period||128||
59794610|NCT00319501|75915355|FG001|Received Treatment|Open-label Period||0||
59794611|NCT00319501|75915354|FG000|COMPLETED|Open-label Period|Competed=continuing treatment|45||
59794612|NCT00319501|75915355|FG001|COMPLETED|Open-label Period||0||
59794613|NCT00319501|75915354|FG000|NOT COMPLETED|Open-label Period||116||
59794614|NCT00319501|75915355|FG001|NOT COMPLETED|Open-label Period||0||
59794615|NCT00319501|75915354|FG000|STARTED|Open-label Extension Period|Eligible participants who chose to continue treatment|51||
59794616|NCT00319501|75915355|FG001|STARTED|Open-label Extension Period||0||
59794617|NCT00319501|75915354|FG000|Received Treatment|Open-label Extension Period||33||
59794618|NCT00319501|75915355|FG001|Received Treatment|Open-label Extension Period||0||
59794619|NCT00319501|75915354|FG000|COMPLETED|Open-label Extension Period||0||
59954107|NCT03760458|76072545|FG002|COMPLETED|Extended Follow-up (Weeks 48 Through 60)||4||
59954108|NCT03760458|76072546|FG003|COMPLETED|Extended Follow-up (Weeks 48 Through 60)||3||
59954109|NCT03760458|76072547|FG004|COMPLETED|Extended Follow-up (Weeks 48 Through 60)||3||
59954110|NCT03760458|76072543|FG000|NOT COMPLETED|Extended Follow-up (Weeks 48 Through 60)||0||
59954111|NCT03760458|76072544|FG001|NOT COMPLETED|Extended Follow-up (Weeks 48 Through 60)||0||
59794620|NCT00319501|75915355|FG001|COMPLETED|Open-label Extension Period||0||
59794621|NCT00319501|75915354|FG000|NOT COMPLETED|Open-label Extension Period||51||
59794622|NCT00319501|75915355|FG001|NOT COMPLETED|Open-label Extension Period||0||
59794623|NCT00761579|75915366|FG000|STARTED|Overall Study||190||
59794624|NCT00761579|75915366|FG000|COMPLETED|Overall Study||98||
59620201|NCT00064038|75731466|FG000|Safety Population|Crossover to Lenalidomide+Dexamethasone||0||
59620202|NCT00064038|75731467|FG001|Safety Population|Crossover to Lenalidomide+Dexamethasone|See Crossover to Lenalidomide+Dexamethasone Arm.|0||
59620203|NCT00064038|75731468|FG002|Safety Population|Crossover to Lenalidomide+Dexamethasone||40||
59620204|NCT00064038|75731466|FG000|COMPLETED|Crossover to Lenalidomide+Dexamethasone||0||
59620205|NCT00064038|75731467|FG001|COMPLETED|Crossover to Lenalidomide+Dexamethasone|See Crossover to Lenalidomide+Dexamethasone Arm.|0||
59620206|NCT00064038|75731468|FG002|COMPLETED|Crossover to Lenalidomide+Dexamethasone||40||
59620207|NCT00064038|75731466|FG000|NOT COMPLETED|Crossover to Lenalidomide+Dexamethasone||0||
59620208|NCT00064038|75731467|FG001|NOT COMPLETED|Crossover to Lenalidomide+Dexamethasone||0||
59620209|NCT00064038|75731468|FG002|NOT COMPLETED|Crossover to Lenalidomide+Dexamethasone||2||
59620210|NCT01960530|75731477|FG000|STARTED|Overall Study||14||
59620211|NCT01960530|75731477|FG000|COMPLETED|Overall Study||14||
59620212|NCT01960530|75731477|FG000|NOT COMPLETED|Overall Study||0||
59620213|NCT00067236|75731494|FG000|STARTED|Overall Study||128||
59620214|NCT00067236|75731495|FG001|STARTED|Overall Study||125||
59620215|NCT00067236|75731494|FG000|COMPLETED|Overall Study||108||
59620216|NCT00067236|75731495|FG001|COMPLETED|Overall Study||99||
59620217|NCT00067236|75731494|FG000|NOT COMPLETED|Overall Study||20||
59620218|NCT00067236|75731495|FG001|NOT COMPLETED|Overall Study||26||
59620219|NCT00007644|75731503|FG000|STARTED|Overall Study||364||
59620220|NCT00007644|75731504|FG001|STARTED|Overall Study||367||
59620221|NCT00007644|75731503|FG000|COMPLETED|Overall Study||364||
59620222|NCT00007644|75731504|FG001|COMPLETED|Overall Study||367||
59620223|NCT00007644|75731503|FG000|NOT COMPLETED|Overall Study||0||
59620224|NCT00007644|75731504|FG001|NOT COMPLETED|Overall Study||0||
59620225|NCT00068718|75731510|FG000|STARTED|Overall Study||35||
59620226|NCT00068718|75731510|FG000|COMPLETED|Overall Study||35||
59620227|NCT00068718|75731510|FG000|NOT COMPLETED|Overall Study||0||
59620228|NCT00024102|75731516|FG000|STARTED|Overall Study||326||
59620229|NCT00024102|75731517|FG001|STARTED|Overall Study||307||
59620230|NCT00024102|75731516|FG000|COMPLETED|Overall Study||326||
59620231|NCT00024102|75731517|FG001|COMPLETED|Overall Study||307||
59620232|NCT00024102|75731516|FG000|NOT COMPLETED|Overall Study||0||
59620233|NCT00024102|75731517|FG001|NOT COMPLETED|Overall Study||0||
59620234|NCT00074802|75731529|FG000|STARTED|Overall Study||29|Patients included here were the subset of enrollees completing the open trial as partial responders.|
59620235|NCT00074802|75731530|FG001|STARTED|Overall Study||32|Patients included here were the subset of enrollees completing the open trial as partial responders.|
59620236|NCT00074802|75731529|FG000|COMPLETED|Overall Study||20||
59620237|NCT00074802|75731530|FG001|COMPLETED|Overall Study||25||
59620238|NCT00074802|75731529|FG000|NOT COMPLETED|Overall Study||9||
59794625|NCT00761579|75915366|FG000|NOT COMPLETED|Overall Study||92||
59794626|NCT00627042|75915372|FG000|STARTED|Overall Study||42||
59794627|NCT00627042|75915372|FG000|Received at Least 1 Dose of Study Drug|Overall Study||42||
59794628|NCT00627042|75915372|FG000|COMPLETED|Overall Study||40||
59794629|NCT00627042|75915372|FG000|NOT COMPLETED|Overall Study||2||
59794630|NCT00319111|75915376|FG000|STARTED|Overall Study|148 patients enrolled in BENEFIT OL & 3 prematurely discontinued from BENEFIT (NCT00313222)|151||
59794631|NCT00319111|75915376|FG000|COMPLETED|Overall Study||104||
59794632|NCT00319111|75915376|FG000|NOT COMPLETED|Overall Study||47||
59794633|NCT00640224|75915384|FG000|STARTED|Overall Study||23||
59794634|NCT00640224|75915385|FG001|STARTED|Overall Study||23||
59794635|NCT00640224|75915386|FG002|STARTED|Overall Study||0||
59794636|NCT00640224|75915387|FG003|STARTED|Overall Study||0||
59794637|NCT00640224|75915384|FG000|COMPLETED|Overall Study||17||
59794638|NCT00640224|75915385|FG001|COMPLETED|Overall Study||20||
59794639|NCT00640224|75915386|FG002|COMPLETED|Overall Study||0||
59794640|NCT00640224|75915387|FG003|COMPLETED|Overall Study||0||
59794641|NCT00640224|75915384|FG000|NOT COMPLETED|Overall Study||6||
59794642|NCT00640224|75915385|FG001|NOT COMPLETED|Overall Study||3||
59794643|NCT00640224|75915386|FG002|NOT COMPLETED|Overall Study||0||
59794644|NCT00640224|75915387|FG003|NOT COMPLETED|Overall Study||0||
59794645|NCT00318643|75915402|FG000|STARTED|Overall Study||3||
59794646|NCT00318643|75915403|FG001|STARTED|Overall Study||3||
59794647|NCT00318643|75915404|FG002|STARTED|Overall Study||6||
59620239|NCT00074802|75731530|FG001|NOT COMPLETED|Overall Study||7||
59620240|NCT00156390|75731538|FG000|STARTED|Overall Study||110||
59620241|NCT00156390|75731539|FG001|STARTED|Overall Study||77||
59620242|NCT00156390|75731538|FG000|COMPLETED|Overall Study||96||
59620243|NCT00156390|75731539|FG001|COMPLETED|Overall Study||69||
59794648|NCT00318643|75915405|FG003|STARTED|Overall Study||3||
59794649|NCT00318643|75915406|FG004|STARTED|Overall Study||12||
59794650|NCT00318643|75915402|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3||
59794651|NCT00318643|75915403|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3||
59794652|NCT00318643|75915404|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6||
60073551|NCT01689207|76188788|FG004|NOT COMPLETED|Overall Study||2||
59794653|NCT00318643|75915405|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3||
59794654|NCT00318643|75915406|FG004|Received at Least 1 Dose of Study Drug|Overall Study||12||
59794655|NCT00318643|75915402|FG000|COMPLETED|Overall Study||3||
59794656|NCT00318643|75915403|FG001|COMPLETED|Overall Study||3||
59794657|NCT00318643|75915404|FG002|COMPLETED|Overall Study||6||
59794658|NCT00318643|75915405|FG003|COMPLETED|Overall Study||3||
59794659|NCT00318643|75915406|FG004|COMPLETED|Overall Study||9||
59794660|NCT00318643|75915402|FG000|NOT COMPLETED|Overall Study||0||
59794661|NCT00318643|75915403|FG001|NOT COMPLETED|Overall Study||0||
59794662|NCT00318643|75915404|FG002|NOT COMPLETED|Overall Study||0||
59794663|NCT00318643|75915405|FG003|NOT COMPLETED|Overall Study||0||
59794664|NCT00318643|75915406|FG004|NOT COMPLETED|Overall Study||3||
59794665|NCT00318565|75915419|FG000|STARTED|Overall Study||291||
59794666|NCT00318565|75915419|FG000|COMPLETED|Overall Study||267||
59794667|NCT00318565|75915419|FG000|NOT COMPLETED|Overall Study||24||
59794668|NCT00304915|75915425|FG000|STARTED|Overall Study||123||
59794669|NCT00304915|75915426|FG001|STARTED|Overall Study||126||
59794670|NCT00304915|75915425|FG000|COMPLETED|Overall Study||105||
59794671|NCT00304915|75915426|FG001|COMPLETED|Overall Study||110||
59794672|NCT00304915|75915425|FG000|NOT COMPLETED|Overall Study||18||
59794673|NCT00304915|75915426|FG001|NOT COMPLETED|Overall Study||16||
59794674|NCT03687970|75915434|FG000|STARTED|Overall Study||22||
59794675|NCT03687970|75915435|FG001|STARTED|Overall Study||20||
59794676|NCT03687970|75915434|FG000|COMPLETED|Overall Study||20||
59794677|NCT03687970|75915435|FG001|COMPLETED|Overall Study||20||
59794678|NCT03687970|75915434|FG000|NOT COMPLETED|Overall Study||2||
59794679|NCT03687970|75915435|FG001|NOT COMPLETED|Overall Study||0||
59794680|NCT00530920|75915446|FG000|STARTED|Overall Study||30||
59794681|NCT00530920|75915447|FG001|STARTED|Overall Study||27||
59794682|NCT00530920|75915448|FG002|STARTED|Overall Study||28||
59794683|NCT00530920|75915446|FG000|COMPLETED|Overall Study||30||
59794684|NCT00530920|75915447|FG001|COMPLETED|Overall Study||25||
59794685|NCT00530920|75915448|FG002|COMPLETED|Overall Study||24||
59794686|NCT00530920|75915446|FG000|NOT COMPLETED|Overall Study||0||
59794687|NCT00530920|75915447|FG001|NOT COMPLETED|Overall Study||2||
59794688|NCT00530920|75915448|FG002|NOT COMPLETED|Overall Study||4||
59794689|NCT03878758|75915457|FG000|STARTED|Overall Study||158||
59794690|NCT03878758|75915457|FG000|COMPLETED|Overall Study||154||
59794691|NCT03878758|75915457|FG000|NOT COMPLETED|Overall Study||4||
59794692|NCT03878602|75915472|FG000|STARTED|Overall Study||75||
59794693|NCT03878602|75915473|FG001|STARTED|Overall Study||67||
59794694|NCT03878602|75915472|FG000|COMPLETED|Overall Study||66||
59794695|NCT03878602|75915473|FG001|COMPLETED|Overall Study||66||
59794696|NCT03878602|75915472|FG000|NOT COMPLETED|Overall Study||9||
59794697|NCT03878602|75915473|FG001|NOT COMPLETED|Overall Study||1||
59794698|NCT00768755|75915485|FG000|STARTED|Phase 1||10||
59794699|NCT00768755|75915486|FG001|STARTED|Phase 1||0||
59794700|NCT00768755|75915487|FG002|STARTED|Phase 1||0||
59794701|NCT00768755|75915488|FG003|STARTED|Phase 1||0||
59794702|NCT00768755|75915485|FG000|COMPLETED|Phase 1||0||
59794703|NCT00768755|75915486|FG001|COMPLETED|Phase 1||0||
59794704|NCT00768755|75915487|FG002|COMPLETED|Phase 1||0||
59794705|NCT00768755|75915488|FG003|COMPLETED|Phase 1||0||
59794706|NCT00768755|75915485|FG000|NOT COMPLETED|Phase 1||10||
59794707|NCT00768755|75915486|FG001|NOT COMPLETED|Phase 1||0||
59794708|NCT00768755|75915487|FG002|NOT COMPLETED|Phase 1||0||
59794709|NCT00768755|75915488|FG003|NOT COMPLETED|Phase 1||0||
59794710|NCT00768755|75915485|FG000|STARTED|Phase 2||0||
59794711|NCT00768755|75915486|FG001|STARTED|Phase 2||55||
59794712|NCT00768755|75915487|FG002|STARTED|Phase 2||58||
59794713|NCT00768755|75915488|FG003|STARTED|Phase 2||57||
59794714|NCT00768755|75915485|FG000|Treated|Phase 2||0||
59794715|NCT00768755|75915486|FG001|Treated|Phase 2||55||
59794716|NCT00768755|75915487|FG002|Treated|Phase 2||58||
59794717|NCT00768755|75915488|FG003|Treated|Phase 2||55||
59794718|NCT00768755|75915485|FG000|COMPLETED|Phase 2||0||
59794719|NCT00768755|75915486|FG001|COMPLETED|Phase 2||0||
59794720|NCT00768755|75915487|FG002|COMPLETED|Phase 2||0||
59794721|NCT00768755|75915488|FG003|COMPLETED|Phase 2||0||
59794722|NCT00768755|75915485|FG000|NOT COMPLETED|Phase 2||0||
59794723|NCT00768755|75915486|FG001|NOT COMPLETED|Phase 2||55||
59794724|NCT00768755|75915487|FG002|NOT COMPLETED|Phase 2||58||
59794725|NCT00768755|75915488|FG003|NOT COMPLETED|Phase 2||57||
59794726|NCT00530842|75915499|FG000|STARTED|Overall Study||172||
59794727|NCT00530842|75915500|FG001|STARTED|Overall Study||172||
59794728|NCT00530842|75915499|FG000|COMPLETED|Overall Study||149||
59794729|NCT00530842|75915500|FG001|COMPLETED|Overall Study||151||
59794730|NCT00530842|75915499|FG000|NOT COMPLETED|Overall Study||23||
59794731|NCT00530842|75915500|FG001|NOT COMPLETED|Overall Study||21||
59794732|NCT00530842|75915499|FG000|STARTED|Period 1||172||
59794733|NCT00530842|75915500|FG001|STARTED|Period 1||172||
59794734|NCT00530842|75915499|FG000|COMPLETED|Period 1||158||
59794735|NCT00530842|75915500|FG001|COMPLETED|Period 1||161||
59794736|NCT00530842|75915499|FG000|NOT COMPLETED|Period 1||14||
59794737|NCT00530842|75915500|FG001|NOT COMPLETED|Period 1||11||
59794738|NCT00530842|75915499|FG000|STARTED|Period 2||157||
59794739|NCT00530842|75915500|FG001|STARTED|Period 2||160||
59794740|NCT00530842|75915499|FG000|COMPLETED|Period 2||149||
59794741|NCT00530842|75915500|FG001|COMPLETED|Period 2||151||
59794742|NCT00530842|75915499|FG000|NOT COMPLETED|Period 2||8||
59794743|NCT00530842|75915500|FG001|NOT COMPLETED|Period 2||9||
59794744|NCT03882424|75915511|FG000|STARTED|Overall Study||38||
59794745|NCT03882424|75915512|FG001|STARTED|Overall Study||38||
59794746|NCT03882424|75915513|FG002|STARTED|Overall Study||38||
59794747|NCT03882424|75915511|FG000|COMPLETED|Overall Study||34||
59794748|NCT03882424|75915512|FG001|COMPLETED|Overall Study||38||
59794749|NCT03882424|75915513|FG002|COMPLETED|Overall Study||38||
59794750|NCT03882424|75915511|FG000|NOT COMPLETED|Overall Study||4||
59794751|NCT03882424|75915512|FG001|NOT COMPLETED|Overall Study||0||
59794752|NCT03882424|75915513|FG002|NOT COMPLETED|Overall Study||0||
59794753|NCT03879772|75915526|FG000|STARTED|Overall Study||137||
59794754|NCT03879772|75915527|FG001|STARTED|Overall Study||135||
59794755|NCT03879772|75915528|FG002|STARTED|Overall Study||133||
59794756|NCT03879772|75915529|FG003|STARTED|Overall Study||138||
59794757|NCT03879772|75915530|FG004|STARTED|Overall Study||136||
59794758|NCT03879772|75915526|FG000|COMPLETED|Overall Study||133||
59794759|NCT03879772|75915527|FG001|COMPLETED|Overall Study||132||
59794760|NCT03879772|75915528|FG002|COMPLETED|Overall Study||123||
59794761|NCT03879772|75915529|FG003|COMPLETED|Overall Study||130||
59794762|NCT03879772|75915530|FG004|COMPLETED|Overall Study||128||
59794763|NCT03879772|75915526|FG000|NOT COMPLETED|Overall Study||4||
59794764|NCT03879772|75915527|FG001|NOT COMPLETED|Overall Study||3||
59794765|NCT03879772|75915528|FG002|NOT COMPLETED|Overall Study||10||
59794766|NCT03879772|75915529|FG003|NOT COMPLETED|Overall Study||8||
59794767|NCT03879772|75915530|FG004|NOT COMPLETED|Overall Study||8||
59794768|NCT00642954|75915547|FG000|STARTED|Overall Study||4||
59794769|NCT00642954|75915548|FG001|STARTED|Overall Study||4||
59794770|NCT00642954|75915549|FG002|STARTED|Overall Study||3||
59794771|NCT00642954|75915550|FG003|STARTED|Overall Study||3||
59794772|NCT00642954|75915551|FG004|STARTED|Overall Study||17||
59794773|NCT00642954|75915547|FG000|COMPLETED|Overall Study||0||
59794774|NCT00642954|75915548|FG001|COMPLETED|Overall Study||0||
59794775|NCT00642954|75915549|FG002|COMPLETED|Overall Study||0||
59794776|NCT00642954|75915550|FG003|COMPLETED|Overall Study||0||
59794777|NCT00642954|75915551|FG004|COMPLETED|Overall Study||1||
59794778|NCT00642954|75915547|FG000|NOT COMPLETED|Overall Study||4||
59794779|NCT00642954|75915548|FG001|NOT COMPLETED|Overall Study||4||
59794780|NCT00642954|75915549|FG002|NOT COMPLETED|Overall Study||3||
59794781|NCT00642954|75915550|FG003|NOT COMPLETED|Overall Study||3||
59794782|NCT00642954|75915551|FG004|NOT COMPLETED|Overall Study||16||
59794783|NCT00640146|75915565|FG000|STARTED|Overall Study||19||
59794784|NCT00640146|75915566|FG001|STARTED|Overall Study||18||
59794785|NCT00640146|75915565|FG000|Received at Least 1 Dose of Study Drug|Overall Study||18|Modified intent-to treat (MITT)/Safety population|
59794786|NCT00640146|75915566|FG001|Received at Least 1 Dose of Study Drug|Overall Study||15|Modified intent-to treat (MITT)/Safety population|
59794787|NCT00640146|75915565|FG000|COMPLETED|Overall Study||15||
59794788|NCT00640146|75915566|FG001|COMPLETED|Overall Study||12||
59794789|NCT00640146|75915565|FG000|NOT COMPLETED|Overall Study||4||
59794790|NCT00640146|75915566|FG001|NOT COMPLETED|Overall Study||6||
59794791|NCT00317473|75915578|FG000|STARTED|Overall Study||30||
59794792|NCT00317473|75915579|FG001|STARTED|Overall Study||15||
59794793|NCT00317473|75915580|FG002|STARTED|Overall Study||30||
59794794|NCT00317473|75915581|FG003|STARTED|Overall Study||15||
59954112|NCT03760458|76072545|FG002|NOT COMPLETED|Extended Follow-up (Weeks 48 Through 60)||0||
59954113|NCT03760458|76072546|FG003|NOT COMPLETED|Extended Follow-up (Weeks 48 Through 60)||0||
59954114|NCT03760458|76072547|FG004|NOT COMPLETED|Extended Follow-up (Weeks 48 Through 60)||0||
60073552|NCT01689207|76188789|FG005|NOT COMPLETED|Overall Study||1||
59794795|NCT00317473|75915582|FG004|STARTED|Overall Study||30||
59794796|NCT00317473|75915583|FG005|STARTED|Overall Study||15||
59954115|NCT02066415|76072562|FG000|STARTED|Overall Study||286||
59954116|NCT02066415|76072563|FG001|STARTED|Overall Study||191||
59954117|NCT02066415|76072564|FG002|STARTED|Overall Study||190||
59794797|NCT00317473|75915578|FG000|COMPLETED|Overall Study||26||
59794798|NCT00317473|75915579|FG001|COMPLETED|Overall Study||12||
59794799|NCT00317473|75915580|FG002|COMPLETED|Overall Study||27||
59794800|NCT00317473|75915581|FG003|COMPLETED|Overall Study||13||
59794801|NCT00317473|75915582|FG004|COMPLETED|Overall Study||22||
59794802|NCT00317473|75915583|FG005|COMPLETED|Overall Study||12||
59794803|NCT00317473|75915578|FG000|NOT COMPLETED|Overall Study||4||
59794804|NCT00317473|75915579|FG001|NOT COMPLETED|Overall Study||3||
59954118|NCT02066415|76072562|FG000|Received Study Drug|Overall Study||282||
59794805|NCT00317473|75915580|FG002|NOT COMPLETED|Overall Study||3||
59794806|NCT00317473|75915581|FG003|NOT COMPLETED|Overall Study||2||
59794807|NCT00317473|75915582|FG004|NOT COMPLETED|Overall Study||8||
59794808|NCT00317473|75915583|FG005|NOT COMPLETED|Overall Study||3||
59794809|NCT00530218|75915607|FG000|STARTED|Overall Study||61||
59794810|NCT00530218|75915607|FG000|COMPLETED|Overall Study|CMV Reactivation Was Detected|36||
59794811|NCT00530218|75915607|FG000|NOT COMPLETED|Overall Study||25||
59794812|NCT00761267|75915617|FG000|STARTED|Overall Study||20||
59794813|NCT00761267|75915618|FG001|STARTED|Overall Study||20||
59794814|NCT00761267|75915619|FG002|STARTED|Overall Study||30||
59794815|NCT00761267|75915617|FG000|Treated|Overall Study||19||
59794816|NCT00761267|75915618|FG001|Treated|Overall Study||19||
59794817|NCT00761267|75915619|FG002|Treated|Overall Study||30||
59794818|NCT00761267|75915617|FG000|COMPLETED|Overall Study||18||
59794819|NCT00761267|75915618|FG001|COMPLETED|Overall Study||16||
59794820|NCT00761267|75915619|FG002|COMPLETED|Overall Study||24||
59794821|NCT00761267|75915617|FG000|NOT COMPLETED|Overall Study||2||
59794822|NCT00761267|75915618|FG001|NOT COMPLETED|Overall Study||4||
59794823|NCT00761267|75915619|FG002|NOT COMPLETED|Overall Study||6||
59794824|NCT00303667|75915640|FG000|STARTED|Overall Study||8||
59794825|NCT00303667|75915641|FG001|STARTED|Overall Study||39||
59794826|NCT00303667|75915640|FG000|COMPLETED|Overall Study||8||
59794827|NCT00303667|75915641|FG001|COMPLETED|Overall Study|Completed = remained alive and on study through Day 0 (day of transplant)|35||
59794828|NCT00303667|75915640|FG000|NOT COMPLETED|Overall Study||0||
59794829|NCT00303667|75915641|FG001|NOT COMPLETED|Overall Study||4||
59794830|NCT00761189|75915647|FG000|STARTED|Overall Study||491||
59794831|NCT00761189|75915647|FG000|COMPLETED|Overall Study||306||
59794832|NCT00761189|75915647|FG000|NOT COMPLETED|Overall Study||185||
59794833|NCT00529516|75915654|FG000|STARTED|Overall Study||475||
59794834|NCT00529516|75915655|FG001|STARTED|Overall Study||488||
59794835|NCT00529516|75915656|FG002|STARTED|Overall Study||289||
59794836|NCT00529516|75915654|FG000|COMPLETED|Overall Study||472||
59794837|NCT00529516|75915655|FG001|COMPLETED|Overall Study||486||
59794838|NCT00529516|75915656|FG002|COMPLETED|Overall Study||288||
59794839|NCT00529516|75915654|FG000|NOT COMPLETED|Overall Study||3||
59794840|NCT00529516|75915655|FG001|NOT COMPLETED|Overall Study||2||
59794841|NCT00529516|75915656|FG002|NOT COMPLETED|Overall Study||1||
59794842|NCT00316693|75915666|FG000|STARTED|Overall Study||519||
59794843|NCT00316693|75915667|FG001|STARTED|Overall Study||521||
59794844|NCT00316693|75915666|FG000|COMPLETED|Overall Study||442||
59794845|NCT00316693|75915667|FG001|COMPLETED|Overall Study||436||
59794846|NCT00316693|75915666|FG000|NOT COMPLETED|Overall Study||77||
59794847|NCT00316693|75915667|FG001|NOT COMPLETED|Overall Study||85||
59794848|NCT00316303|75915675|FG000|STARTED|Overall Study||118||
59954119|NCT02066415|76072563|FG001|Received Study Drug|Overall Study||190||
59954120|NCT02066415|76072564|FG002|Received Study Drug|Overall Study||188||
59954121|NCT02066415|76072562|FG000|COMPLETED|Overall Study||265||
59954122|NCT02066415|76072563|FG001|COMPLETED|Overall Study||184||
59794849|NCT00316303|75915676|FG001|STARTED|Overall Study||118||
59794850|NCT00316303|75915675|FG000|COMPLETED|Overall Study||107||
59794851|NCT00316303|75915676|FG001|COMPLETED|Overall Study||102||
59794852|NCT00316303|75915675|FG000|NOT COMPLETED|Overall Study||11||
59794853|NCT00316303|75915676|FG001|NOT COMPLETED|Overall Study||16||
59794854|NCT00760877|75915687|FG000|STARTED|Overall Study||104||
59794855|NCT00760877|75915688|FG001|STARTED|Overall Study||103||
59794856|NCT00760877|75915687|FG000|Cross-over to Nilotinib|Overall Study|Not applicable: cross-over occurred from imatinib to nilotinib only.|0||
59794857|NCT00760877|75915688|FG001|Cross-over to Nilotinib|Overall Study||46||
59794858|NCT00760877|75915687|FG000|Safety Set|Overall Study||101||
59794859|NCT00760877|75915688|FG001|Safety Set|Overall Study||103||
59794860|NCT00760877|75915687|FG000|COMPLETED|Overall Study||59||
59794861|NCT00760877|75915688|FG001|COMPLETED|Overall Study||77||
59794862|NCT00760877|75915687|FG000|NOT COMPLETED|Overall Study||45||
59794863|NCT00760877|75915688|FG001|NOT COMPLETED|Overall Study||26||
59794864|NCT00302731|75915699|FG000|STARTED|Overall Study||6||
59794865|NCT00302731|75915700|FG001|STARTED|Overall Study||6||
59794866|NCT00302731|75915701|FG002|STARTED|Overall Study||5||
59794867|NCT00302731|75915702|FG003|STARTED|Overall Study||4||
59954123|NCT02066415|76072564|FG002|COMPLETED|Overall Study||182||
59954124|NCT02066415|76072562|FG000|NOT COMPLETED|Overall Study||21||
59954125|NCT02066415|76072563|FG001|NOT COMPLETED|Overall Study||7||
59954126|NCT02066415|76072564|FG002|NOT COMPLETED|Overall Study||8||
60073553|NCT01689207|76188790|FG006|NOT COMPLETED|Overall Study||0||
59794868|NCT00302731|75915699|FG000|COMPLETED|Overall Study||2||
59794869|NCT00302731|75915700|FG001|COMPLETED|Overall Study||1||
59794870|NCT00302731|75915701|FG002|COMPLETED|Overall Study||2||
59794871|NCT00302731|75915702|FG003|COMPLETED|Overall Study||4||
59794872|NCT00302731|75915699|FG000|NOT COMPLETED|Overall Study||4||
59794873|NCT00302731|75915700|FG001|NOT COMPLETED|Overall Study||5||
59794874|NCT00302731|75915701|FG002|NOT COMPLETED|Overall Study||3||
59794875|NCT00302731|75915702|FG003|NOT COMPLETED|Overall Study||0||
59794876|NCT00780143|75915712|FG000|STARTED|Overall Study||3||
59794877|NCT00780143|75915712|FG000|COMPLETED|Overall Study||0||
59794878|NCT00780143|75915712|FG000|NOT COMPLETED|Overall Study||3||
59794879|NCT00779909|75915720|FG000|STARTED|Overall Study||10||
59794880|NCT00779909|75915721|FG001|STARTED|Overall Study||9||
59794881|NCT00779909|75915722|FG002|STARTED|Overall Study||8||
59794882|NCT00779909|75915723|FG003|STARTED|Overall Study||8||
59794883|NCT00779909|75915720|FG000|COMPLETED|Overall Study||9||
59954127|NCT02583256|76072576|FG000|STARTED|Overall Study||403||
59954128|NCT02583256|76072577|FG001|STARTED|Overall Study||403||
59794884|NCT00779909|75915721|FG001|COMPLETED|Overall Study||8||
59794885|NCT00779909|75915722|FG002|COMPLETED|Overall Study||8||
59794886|NCT00779909|75915723|FG003|COMPLETED|Overall Study||7||
59794887|NCT00779909|75915720|FG000|NOT COMPLETED|Overall Study||1||
59794888|NCT00779909|75915721|FG001|NOT COMPLETED|Overall Study||1||
59794889|NCT00779909|75915722|FG002|NOT COMPLETED|Overall Study||0||
59794890|NCT00779909|75915723|FG003|NOT COMPLETED|Overall Study||1||
59794891|NCT00302107|75915742|FG000|STARTED|Overall Study||39||
59794892|NCT00302107|75915743|FG001|STARTED|Overall Study||39||
59794893|NCT00302107|75915742|FG000|COMPLETED|Overall Study||31||
59794894|NCT00302107|75915743|FG001|COMPLETED|Overall Study||30||
59794895|NCT00302107|75915742|FG000|NOT COMPLETED|Overall Study||8||
59794896|NCT00302107|75915743|FG001|NOT COMPLETED|Overall Study||9||
59794897|NCT00760487|75915749|FG000|STARTED|Overall Study||120||
59794898|NCT00760487|75915749|FG000|COMPLETED|Overall Study||117||
59794899|NCT00760487|75915749|FG000|NOT COMPLETED|Overall Study||3||
59794900|NCT00316225|75915753|FG000|STARTED|Overall Study||31||
59794901|NCT00316225|75915753|FG000|COMPLETED|Overall Study||6||
59794902|NCT00316225|75915753|FG000|NOT COMPLETED|Overall Study||25||
59794903|NCT00586703|75915757|FG000|STARTED|Overall Study||16||
59794904|NCT00586703|75915757|FG000|COMPLETED|Overall Study||4||
59794905|NCT00586703|75915757|FG000|NOT COMPLETED|Overall Study||12||
59794906|NCT00586625|75915763|FG000|STARTED|Overall Study||575||
59794907|NCT00586625|75915764|FG001|STARTED|Overall Study||286||
59794908|NCT00586625|75915763|FG000|COMPLETED|Overall Study||532||
59794909|NCT00586625|75915764|FG001|COMPLETED|Overall Study||269||
59794910|NCT00586625|75915763|FG000|NOT COMPLETED|Overall Study||43||
59794911|NCT00586625|75915764|FG001|NOT COMPLETED|Overall Study||17||
59794912|NCT00636168|75915772|FG000|STARTED|Randomized to Study Drug||475||
59794913|NCT00636168|75915773|FG001|STARTED|Randomized to Study Drug||476||
59794914|NCT00636168|75915772|FG000|COMPLETED|Randomized to Study Drug||471||
59794915|NCT00636168|75915773|FG001|COMPLETED|Randomized to Study Drug||474||
59794916|NCT00636168|75915772|FG000|NOT COMPLETED|Randomized to Study Drug||4||
59794917|NCT00636168|75915773|FG001|NOT COMPLETED|Randomized to Study Drug||2||
59794918|NCT00636168|75915772|FG000|STARTED|Treated With Study Drug||471||
59794919|NCT00636168|75915773|FG001|STARTED|Treated With Study Drug||474||
59794920|NCT00636168|75915772|FG000|COMPLETED|Treated With Study Drug||63|Normal Completion|
59794921|NCT00636168|75915773|FG001|COMPLETED|Treated With Study Drug||143|Normal Completion|
59794922|NCT00636168|75915772|FG000|NOT COMPLETED|Treated With Study Drug||408||
59794923|NCT00636168|75915773|FG001|NOT COMPLETED|Treated With Study Drug||331||
59794924|NCT00636168|75915772|FG000|STARTED|Long Term Follow-Up||141|Continuing in Long Term Follow Up|
59794925|NCT00636168|75915773|FG001|STARTED|Long Term Follow-Up||143|Continuing in Long Term Follow Up|
59794926|NCT00636168|75915772|FG000|COMPLETED|Long Term Follow-Up||130||
59794927|NCT00636168|75915773|FG001|COMPLETED|Long Term Follow-Up||129||
59794928|NCT00636168|75915772|FG000|NOT COMPLETED|Long Term Follow-Up||11||
59794929|NCT00636168|75915773|FG001|NOT COMPLETED|Long Term Follow-Up||14||
59794930|NCT00759941|75915781|FG000|STARTED|Overall Study||42||
59794931|NCT00759941|75915782|FG001|STARTED|Overall Study||44||
59794932|NCT00759941|75915781|FG000|COMPLETED|Overall Study||39||
59794933|NCT00759941|75915782|FG001|COMPLETED|Overall Study||43||
59794934|NCT00759941|75915781|FG000|NOT COMPLETED|Overall Study||3||
59794935|NCT00759941|75915782|FG001|NOT COMPLETED|Overall Study||1||
59794936|NCT00528424|75915788|FG000|STARTED|Overall Study||286||
59794937|NCT00528424|75915788|FG000|COMPLETED|Overall Study||257||
59794938|NCT00528424|75915788|FG000|NOT COMPLETED|Overall Study||29||
59794939|NCT00315445|75915795|FG000|STARTED|Overall Study||45||
59794940|NCT00315445|75915796|FG001|STARTED|Overall Study||43||
59794941|NCT00315445|75915797|FG002|STARTED|Overall Study||46||
59794942|NCT00315445|75915795|FG000|COMPLETED|Overall Study||18||
59794943|NCT00315445|75915796|FG001|COMPLETED|Overall Study||27||
59794944|NCT00315445|75915797|FG002|COMPLETED|Overall Study||22||
59794945|NCT00315445|75915795|FG000|NOT COMPLETED|Overall Study||27||
59794946|NCT00315445|75915796|FG001|NOT COMPLETED|Overall Study||16||
59794947|NCT00315445|75915797|FG002|NOT COMPLETED|Overall Study||24||
59794948|NCT03687736|75915805|FG000|STARTED|Overall Study||120||
59794949|NCT03687736|75915805|FG000|COMPLETED|Overall Study||110||
59794950|NCT03687736|75915805|FG000|NOT COMPLETED|Overall Study||10||
59794951|NCT00779675|75915811|FG000|STARTED|Treatment Period|One of the 660 participants did not receive study treatment.|660||
59794952|NCT00779675|75915811|FG000|COMPLETED|Treatment Period||328||
59794953|NCT00779675|75915811|FG000|NOT COMPLETED|Treatment Period||332||
59794954|NCT00779675|75915811|FG000|STARTED|Extended Treatment Period|Clinical responders during the treatment period could enter the extended treatment period.|193||
59794955|NCT00779675|75915811|FG000|COMPLETED|Extended Treatment Period||147||
59794956|NCT00779675|75915811|FG000|NOT COMPLETED|Extended Treatment Period||46||
59794957|NCT00759863|75915821|FG000|STARTED|Overall Study||144||
59794958|NCT00759863|75915822|FG001|STARTED|Overall Study||98||
59794959|NCT00759863|75915821|FG000|COMPLETED|Overall Study||124||
59794960|NCT00759863|75915822|FG001|COMPLETED|Overall Study||80||
59794961|NCT00759863|75915821|FG000|NOT COMPLETED|Overall Study||20||
59794962|NCT00759863|75915822|FG001|NOT COMPLETED|Overall Study||18||
59794963|NCT00759785|75915830|FG000|STARTED|Overall Study||26||
59794964|NCT00759785|75915831|FG001|STARTED|Overall Study||22||
59794965|NCT00759785|75915830|FG000|Treated|Overall Study||25||
59794966|NCT00759785|75915831|FG001|Treated|Overall Study||20||
59794967|NCT00759785|75915830|FG000|COMPLETED|Overall Study||14||
59794968|NCT00759785|75915831|FG001|COMPLETED|Overall Study||17||
59794969|NCT00759785|75915830|FG000|NOT COMPLETED|Overall Study||12||
59794970|NCT00759785|75915831|FG001|NOT COMPLETED|Overall Study||5||
59794971|NCT00300781|75915839|FG000|STARTED|Overall Study||66||
59794972|NCT00300781|75915840|FG001|STARTED|Overall Study||70||
59794973|NCT00300781|75915839|FG000|COMPLETED|Overall Study||3||
59794974|NCT00300781|75915840|FG001|COMPLETED|Overall Study||8||
59794975|NCT00300781|75915839|FG000|NOT COMPLETED|Overall Study||63||
59794976|NCT00300781|75915840|FG001|NOT COMPLETED|Overall Study||62||
59794977|NCT00315055|75915848|FG000|STARTED|Overall Study||155||
59794978|NCT00315055|75915849|FG001|STARTED|Overall Study||155||
59794979|NCT00315055|75915848|FG000|COMPLETED|Overall Study||152||
59794980|NCT00315055|75915849|FG001|COMPLETED|Overall Study||150||
59794981|NCT00315055|75915848|FG000|NOT COMPLETED|Overall Study||3||
59794982|NCT00315055|75915849|FG001|NOT COMPLETED|Overall Study||5||
59794983|NCT00528970|75915861|FG000|STARTED|Overall Study||124||
59794984|NCT00528970|75915862|FG001|STARTED|Overall Study||125||
59794985|NCT00528970|75915863|FG002|STARTED|Overall Study||125||
59794986|NCT00528970|75915861|FG000|Received at Least 1 Dose of Study Drug|Overall Study||124|Modified intent-to-treat (mITT)/Safety population|
59794987|NCT00528970|75915862|FG001|Received at Least 1 Dose of Study Drug|Overall Study||125|Modified intent-to-treat (mITT)/Safety population|
59794988|NCT00528970|75915863|FG002|Received at Least 1 Dose of Study Drug|Overall Study||124|Modified intent-to-treat (mITT)/Safety population|
59794989|NCT00528970|75915861|FG000|COMPLETED|Overall Study||110||
59794990|NCT00528970|75915862|FG001|COMPLETED|Overall Study||110||
59794991|NCT00528970|75915863|FG002|COMPLETED|Overall Study||105||
59794992|NCT00528970|75915861|FG000|NOT COMPLETED|Overall Study||14||
59794993|NCT00528970|75915862|FG001|NOT COMPLETED|Overall Study||15||
59794994|NCT00528970|75915863|FG002|NOT COMPLETED|Overall Study||20||
59794995|NCT00759395|75915873|FG000|STARTED|Overall Study||13||
59794996|NCT00759395|75915874|FG001|STARTED|Overall Study||9||
59794997|NCT00759395|75915873|FG000|COMPLETED|Overall Study||11||
59794998|NCT00759395|75915874|FG001|COMPLETED|Overall Study||7||
59794999|NCT00759395|75915873|FG000|NOT COMPLETED|Overall Study||2||
59795000|NCT00759395|75915874|FG001|NOT COMPLETED|Overall Study||2||
59795001|NCT00293293|75915882|FG000|STARTED|Overall Study||20||
59795002|NCT00293293|75915883|FG001|STARTED|Overall Study||23||
59795003|NCT00293293|75915882|FG000|COMPLETED|Overall Study||18||
59795004|NCT00293293|75915883|FG001|COMPLETED|Overall Study||21||
59795005|NCT00293293|75915882|FG000|NOT COMPLETED|Overall Study||2||
59795006|NCT00293293|75915883|FG001|NOT COMPLETED|Overall Study||2||
59795007|NCT04864639|75915890|FG000|STARTED|Overall Study||12||
59795008|NCT04864639|75915890|FG000|COMPLETED|Overall Study||10||
59795009|NCT04864639|75915890|FG000|NOT COMPLETED|Overall Study||2||
59954129|NCT02583256|76072578|FG002|STARTED|Overall Study||402||
59954130|NCT02583256|76072579|FG003|STARTED|Overall Study||393||
59954131|NCT02583256|76072576|FG000|Exposed|Overall Study||403||
59954132|NCT02583256|76072577|FG001|Exposed|Overall Study||403||
59954133|NCT02583256|76072578|FG002|Exposed|Overall Study||402||
59795010|NCT04669249|75915897|FG000|STARTED|Overall Study||8||
59795011|NCT04669249|75915898|FG001|STARTED|Overall Study||5||
59795012|NCT04669249|75915897|FG000|COMPLETED|Overall Study||7||
59795013|NCT04669249|75915898|FG001|COMPLETED|Overall Study||4||
59795014|NCT04669249|75915897|FG000|NOT COMPLETED|Overall Study||1||
59795015|NCT04669249|75915898|FG001|NOT COMPLETED|Overall Study||1||
59795016|NCT04545944|75915905|FG000|STARTED|Overall Study||20||
59795017|NCT04545944|75915905|FG000|COMPLETED|Overall Study||20||
59795018|NCT04545944|75915905|FG000|NOT COMPLETED|Overall Study||0||
59795019|NCT04343586|75915912|FG000|STARTED|Overall Study||11||
59795020|NCT04343586|75915912|FG000|COMPLETED|Overall Study||10||
59954134|NCT02583256|76072579|FG003|Exposed|Overall Study||393||
59954135|NCT02583256|76072576|FG000|COMPLETED|Overall Study||400||
59954136|NCT02583256|76072577|FG001|COMPLETED|Overall Study||401||
59795021|NCT04343586|75915912|FG000|NOT COMPLETED|Overall Study||1||
59795022|NCT04245449|75915916|FG000|STARTED|Overall Study||7||
59795023|NCT04245449|75915916|FG000|COMPLETED|Overall Study||0||
59795024|NCT04245449|75915916|FG000|NOT COMPLETED|Overall Study||7||
59795025|NCT03921866|75915920|FG000|STARTED|Overall Study||191||
59795026|NCT03921866|75915920|FG000|COMPLETED|Overall Study|Out of these 191 participants, 3 participants died. But data available before censoring date for these 3 participants were observed and included in results.|191||
59795027|NCT03921866|75915920|FG000|NOT COMPLETED|Overall Study||0||
59795028|NCT03887221|75915926|FG000|STARTED|Overall Study||12||
59954137|NCT02583256|76072578|FG002|COMPLETED|Overall Study||400||
59954138|NCT02583256|76072579|FG003|COMPLETED|Overall Study||390||
59795029|NCT03887221|75915927|FG001|STARTED|Overall Study||12||
59795030|NCT03887221|75915926|FG000|COMPLETED|Overall Study||11||
59795031|NCT03887221|75915927|FG001|COMPLETED|Overall Study||12||
59795032|NCT03887221|75915926|FG000|NOT COMPLETED|Overall Study||1||
59795033|NCT03887221|75915927|FG001|NOT COMPLETED|Overall Study||0||
59954139|NCT02583256|76072576|FG000|NOT COMPLETED|Overall Study||3||
59954140|NCT02583256|76072577|FG001|NOT COMPLETED|Overall Study||2||
59954141|NCT02583256|76072578|FG002|NOT COMPLETED|Overall Study||2||
59795034|NCT03433417|75915939|FG000|STARTED|Overall Study||12||24
59795035|NCT03433417|75915939|FG000|Treatment With TruSculpt Device|Overall Study||12||12
59795036|NCT03433417|75915939|FG000|No Treatment With TruSculpt Device|Overall Study||12||12
59795037|NCT03433417|75915939|FG000|COMPLETED|Overall Study||12||24
59795038|NCT03433417|75915939|FG000|NOT COMPLETED|Overall Study||0||0
59795039|NCT02782741|75915947|FG000|STARTED|Blinded Treatment Period: up to Week 49||51|Randomized and treated participants.|
59795040|NCT02782741|75915948|FG001|STARTED|Blinded Treatment Period: up to Week 49||49|Randomized and treated participants.|
59795041|NCT02782741|75915947|FG000|Safety Population|Blinded Treatment Period: up to Week 49||51|Included participants who received at least 1 infusion in blinded treatment period (also known as PAP) and were analyzed according to the treatment received.|
59795042|NCT02782741|75915948|FG001|Safety Population|Blinded Treatment Period: up to Week 49||49|Included participants who received at least 1 infusion in blinded treatment period (also known as PAP) and were analyzed according to the treatment received.|
59795043|NCT02782741|75915947|FG000|COMPLETED|Blinded Treatment Period: up to Week 49||51||
59795044|NCT02782741|75915948|FG001|COMPLETED|Blinded Treatment Period: up to Week 49||44||
59795045|NCT02782741|75915947|FG000|NOT COMPLETED|Blinded Treatment Period: up to Week 49||0||
59795046|NCT02782741|75915948|FG001|NOT COMPLETED|Blinded Treatment Period: up to Week 49||5||
59795047|NCT02782741|75915947|FG000|STARTED|Open-label Long-term: Week 50 to 145||51||
59795048|NCT02782741|75915948|FG001|STARTED|Open-label Long-term: Week 50 to 145||44||
59795049|NCT02782741|75915947|FG000|Safety Population|Open-label Long-term: Week 50 to 145||51|Included participants who received at least 1 infusion in open-label long-term phase and were analyzed according to the treatment received.|
59795050|NCT02782741|75915948|FG001|Safety Population|Open-label Long-term: Week 50 to 145||44|Included participants who received at least 1 infusion in open-label long-term phase and were analyzed according to the treatment received.|
59795051|NCT02782741|75915947|FG000|COMPLETED|Open-label Long-term: Week 50 to 145||0||
59795052|NCT02782741|75915948|FG001|COMPLETED|Open-label Long-term: Week 50 to 145||0||
59795053|NCT02782741|75915947|FG000|NOT COMPLETED|Open-label Long-term: Week 50 to 145||51||
59795054|NCT02782741|75915948|FG001|NOT COMPLETED|Open-label Long-term: Week 50 to 145||44||
59795055|NCT02771626|75915964|FG000|STARTED|Overall Study||8||
59795056|NCT02771626|75915965|FG001|STARTED|Overall Study||26||
59795057|NCT02771626|75915966|FG002|STARTED|Overall Study||17||
59795058|NCT02771626|75915967|FG003|STARTED|Overall Study||9||
59795059|NCT02771626|75915968|FG004|STARTED|Overall Study||37||
59795060|NCT02771626|75915969|FG005|STARTED|Overall Study||21||
59795061|NCT02771626|75915964|FG000|COMPLETED|Overall Study||0|Study was terminated early. Participants still on study at the time of the study termination (see Reason Not Completed=Study Termination by Sponsor, below) were transferred to individual patient treatment Investigational New Drug applications (INDs) per physician and participant request.|
59795062|NCT02771626|75915965|FG001|COMPLETED|Overall Study||0|Study was terminated early. Participants still on study at the time of the study termination (see Reason Not Completed=Study Termination by Sponsor, below) were transferred to individual patient treatment Investigational New Drug applications (INDs) per physician and participant request.|
59795063|NCT02771626|75915966|FG002|COMPLETED|Overall Study||0|Study was terminated early. Participants still on study at the time of the study termination (see Reason Not Completed=Study Termination by Sponsor, below) were transferred to individual patient treatment Investigational New Drug applications (INDs) per physician and participant request.|
59795064|NCT02771626|75915967|FG003|COMPLETED|Overall Study||0|Study was terminated early. Participants still on study at the time of the study termination (see Reason Not Completed=Study Termination by Sponsor, below) were transferred to individual patient treatment Investigational New Drug applications (INDs) per physician and participant request.|
59795065|NCT02771626|75915968|FG004|COMPLETED|Overall Study||0|Study was terminated early. Participants still on study at the time of the study termination (see Reason Not Completed=Study Termination by Sponsor, below) were transferred to individual patient treatment Investigational New Drug applications (INDs) per physician and participant request.|
59795066|NCT02771626|75915969|FG005|COMPLETED|Overall Study||0|Study was terminated early. Participants still on study at the time of the study termination (see Reason Not Completed=Study Termination by Sponsor, below) were transferred to individual patient treatment Investigational New Drug applications (INDs) per physician and participant request.|
59795067|NCT02771626|75915964|FG000|NOT COMPLETED|Overall Study||8||
59795068|NCT02771626|75915965|FG001|NOT COMPLETED|Overall Study||26||
59795069|NCT02771626|75915966|FG002|NOT COMPLETED|Overall Study||17||
59795070|NCT02771626|75915967|FG003|NOT COMPLETED|Overall Study||9||
59954142|NCT02583256|76072579|FG003|NOT COMPLETED|Overall Study||3||
59954143|NCT03745794|76072593|FG000|STARTED|Overall Study||52||
59954144|NCT03745794|76072594|FG001|STARTED|Overall Study||54||
59954145|NCT03745794|76072593|FG000|COMPLETED|Overall Study||52||
59954146|NCT03745794|76072594|FG001|COMPLETED|Overall Study||53||
59954147|NCT03745794|76072593|FG000|NOT COMPLETED|Overall Study||0||
59954148|NCT03745794|76072594|FG001|NOT COMPLETED|Overall Study||1||
59954149|NCT02584660|76072602|FG000|STARTED|Overall Study||51||
59954150|NCT02584660|76072603|FG001|STARTED|Overall Study||63||
59954151|NCT02584660|76072602|FG000|Treated|Overall Study||49||
59954152|NCT02584660|76072603|FG001|Treated|Overall Study||63||
59954153|NCT02584660|76072602|FG000|COMPLETED|Overall Study||44||
59954154|NCT02584660|76072603|FG001|COMPLETED|Overall Study||55||
59795071|NCT02771626|75915968|FG004|NOT COMPLETED|Overall Study||37||
59795072|NCT02771626|75915969|FG005|NOT COMPLETED|Overall Study||21||
59795073|NCT01464164|75915990|FG000|STARTED|Overall Study||3||
59795074|NCT01464164|75915991|FG001|STARTED|Overall Study||4||
59795075|NCT01464164|75915992|FG002|STARTED|Overall Study||4||
59795076|NCT01464164|75915993|FG003|STARTED|Overall Study||2||
59795077|NCT01464164|75915994|FG004|STARTED|Overall Study||3||
59795078|NCT01464164|75915995|FG005|STARTED|Overall Study||0||
59795079|NCT01464164|75915996|FG006|STARTED|Overall Study||3||
59795080|NCT01464164|75915990|FG000|COMPLETED|Overall Study||3||
59795081|NCT01464164|75915991|FG001|COMPLETED|Overall Study||2||
59795082|NCT01464164|75915992|FG002|COMPLETED|Overall Study||2||
59795083|NCT01464164|75915993|FG003|COMPLETED|Overall Study||2||
59795084|NCT01464164|75915994|FG004|COMPLETED|Overall Study||3||
59795085|NCT01464164|75915995|FG005|COMPLETED|Overall Study||0||
59795086|NCT01464164|75915996|FG006|COMPLETED|Overall Study||1||
59795087|NCT01464164|75915990|FG000|NOT COMPLETED|Overall Study||0||
59795088|NCT01464164|75915991|FG001|NOT COMPLETED|Overall Study||2||
59795089|NCT01464164|75915992|FG002|NOT COMPLETED|Overall Study||2||
59795090|NCT01464164|75915993|FG003|NOT COMPLETED|Overall Study||0||
59795091|NCT01464164|75915994|FG004|NOT COMPLETED|Overall Study||0||
59795092|NCT01464164|75915995|FG005|NOT COMPLETED|Overall Study||0||
59795093|NCT01464164|75915996|FG006|NOT COMPLETED|Overall Study||2||
59795094|NCT00602459|75916016|FG000|STARTED|Initial Registration/Randomization||138||
59795095|NCT00602459|75916017|FG001|STARTED|Initial Registration/Randomization||140||
59795096|NCT00602459|75916018|FG002|STARTED|Initial Registration/Randomization||140||
59795097|NCT00602459|75916019|FG003|STARTED|Initial Registration/Randomization||0||
59795098|NCT00602459|75916016|FG000|COMPLETED|Initial Registration/Randomization||133||
59795099|NCT00602459|75916017|FG001|COMPLETED|Initial Registration/Randomization||130||
59795100|NCT00602459|75916018|FG002|COMPLETED|Initial Registration/Randomization||137||
59795101|NCT00602459|75916019|FG003|COMPLETED|Initial Registration/Randomization||0||
59795102|NCT00602459|75916016|FG000|NOT COMPLETED|Initial Registration/Randomization||5||
59795103|NCT00602459|75916017|FG001|NOT COMPLETED|Initial Registration/Randomization||10||
59795104|NCT00602459|75916018|FG002|NOT COMPLETED|Initial Registration/Randomization||3||
59795105|NCT00602459|75916019|FG003|NOT COMPLETED|Initial Registration/Randomization||0||
59795106|NCT00602459|75916016|FG000|STARTED|Re-assignment After Del(11q22.3) Testing||123||
59795107|NCT00602459|75916017|FG001|STARTED|Re-assignment After Del(11q22.3) Testing||109||
59795108|NCT00602459|75916018|FG002|STARTED|Re-assignment After Del(11q22.3) Testing||137||
59795109|NCT00602459|75916019|FG003|STARTED|Re-assignment After Del(11q22.3) Testing||31||
59795110|NCT00602459|75916016|FG000|COMPLETED|Re-assignment After Del(11q22.3) Testing||123||
59795111|NCT00602459|75916017|FG001|COMPLETED|Re-assignment After Del(11q22.3) Testing||109||
59795112|NCT00602459|75916018|FG002|COMPLETED|Re-assignment After Del(11q22.3) Testing||137||
59795113|NCT00602459|75916019|FG003|COMPLETED|Re-assignment After Del(11q22.3) Testing||31||
59795114|NCT00602459|75916016|FG000|NOT COMPLETED|Re-assignment After Del(11q22.3) Testing||0||
59795115|NCT00602459|75916017|FG001|NOT COMPLETED|Re-assignment After Del(11q22.3) Testing||0||
59795116|NCT00602459|75916018|FG002|NOT COMPLETED|Re-assignment After Del(11q22.3) Testing||0||
59795117|NCT00602459|75916019|FG003|NOT COMPLETED|Re-assignment After Del(11q22.3) Testing||0||
59795118|NCT00568776|75916039|FG000|STARTED|Overall Study|One randomized patient withdrew consent and did not receive placebo|83||
59795119|NCT00568776|75916040|FG001|STARTED|Overall Study|One randomized patient withdrew consent and did not receive ELND005 250 mg BID|88||
59795120|NCT00568776|75916041|FG002|STARTED|Overall Study|41 patients withdrawn per interim safety review (sponsors decision); excluded in efficacy analysis.|89||
59795121|NCT00568776|75916042|FG003|STARTED|Overall Study|42 patients withdrawn per interim safety review (sponsors decision); excluded in efficacy analysis.|91||
59795122|NCT00568776|75916039|FG000|COMPLETED|Overall Study||53||
59795123|NCT00568776|75916040|FG001|COMPLETED|Overall Study||52||
59795124|NCT00568776|75916041|FG002|COMPLETED|Overall Study||15||
59795125|NCT00568776|75916042|FG003|COMPLETED|Overall Study||19||
59795126|NCT00568776|75916039|FG000|NOT COMPLETED|Overall Study||30||
59795127|NCT00568776|75916040|FG001|NOT COMPLETED|Overall Study||36||
59795128|NCT00568776|75916041|FG002|NOT COMPLETED|Overall Study||74||
59795129|NCT00568776|75916042|FG003|NOT COMPLETED|Overall Study||72||
59795130|NCT00758771|75916054|FG000|STARTED|Overall Study||18||
59795131|NCT00758771|75916055|FG001|STARTED|Overall Study||20||
59795132|NCT00758771|75916054|FG000|COMPLETED|Overall Study||15||
60073554|NCT01689207|76188791|FG007|NOT COMPLETED|Overall Study||0||
59795133|NCT00758771|75916055|FG001|COMPLETED|Overall Study||15||
59795134|NCT00758771|75916054|FG000|NOT COMPLETED|Overall Study||3||
59795135|NCT00758771|75916055|FG001|NOT COMPLETED|Overall Study||5||
59795136|NCT00635154|75916061|FG000|STARTED|Overall Study||54||
59795137|NCT00635154|75916061|FG000|COMPLETED|Overall Study||21||
59795138|NCT00635154|75916061|FG000|NOT COMPLETED|Overall Study||33||
59795139|NCT00778895|75916070|FG000|STARTED|Active Phase||164||
59795140|NCT00778895|75916071|FG001|STARTED|Active Phase||167||
59795141|NCT00778895|75916072|FG002|STARTED|Active Phase||43||
59954155|NCT02584660|76072602|FG000|NOT COMPLETED|Overall Study||7||
59954156|NCT02584660|76072603|FG001|NOT COMPLETED|Overall Study||8||
59954157|NCT01099761|76072613|FG000|STARTED|Overall Study||9||
60073555|NCT01689207|76188792|FG008|NOT COMPLETED|Overall Study||1||
59795142|NCT00778895|75916070|FG000|COMPLETED|Active Phase||157||
59795143|NCT00778895|75916071|FG001|COMPLETED|Active Phase||161||
59795144|NCT00778895|75916072|FG002|COMPLETED|Active Phase||43||
59795145|NCT00778895|75916070|FG000|NOT COMPLETED|Active Phase||7||
59795146|NCT00778895|75916071|FG001|NOT COMPLETED|Active Phase||6||
59795147|NCT00778895|75916072|FG002|NOT COMPLETED|Active Phase||0||
59795148|NCT00778895|75916070|FG000|STARTED|ESFU Phase||164||
59795149|NCT00778895|75916071|FG001|STARTED|ESFU Phase||167||
59795150|NCT00778895|75916072|FG002|STARTED|ESFU Phase||43||
59795151|NCT00778895|75916070|FG000|COMPLETED|ESFU Phase||153||
59795152|NCT00778895|75916071|FG001|COMPLETED|ESFU Phase||155||
59795153|NCT00778895|75916072|FG002|COMPLETED|ESFU Phase||41||
59795154|NCT00778895|75916070|FG000|NOT COMPLETED|ESFU Phase||11||
59795155|NCT00778895|75916071|FG001|NOT COMPLETED|ESFU Phase||12||
59795156|NCT00778895|75916072|FG002|NOT COMPLETED|ESFU Phase||2||
59795157|NCT00293215|75916083|FG000|STARTED|Overall Study||6||
59795158|NCT00293215|75916084|FG001|STARTED|Overall Study||3||
59795159|NCT00293215|75916083|FG000|COMPLETED|Overall Study||1|Completed the study as planned, i.e., received all 6 cycles of CMD-193|
59795160|NCT00293215|75916084|FG001|COMPLETED|Overall Study||0|Completed the study as planned, i.e., received all 6 cycles of CMD-193|
59795161|NCT00293215|75916083|FG000|NOT COMPLETED|Overall Study||5||
59795162|NCT00293215|75916084|FG001|NOT COMPLETED|Overall Study||3||
59795163|NCT00778817|75916090|FG000|STARTED|Overall Study||20||
59795164|NCT00778817|75916090|FG000|COMPLETED|Overall Study||16||
59795165|NCT00778817|75916090|FG000|NOT COMPLETED|Overall Study||4||
59795166|NCT00293059|75916096|FG000|STARTED|Overall Study||120||
59795167|NCT00293059|75916097|FG001|STARTED|Overall Study||70||
59795168|NCT00293059|75916096|FG000|Subjects Received Treatment|Overall Study||119||
59795169|NCT00293059|75916097|FG001|Subjects Received Treatment|Overall Study||66||
60073556|NCT01689207|76188793|FG009|NOT COMPLETED|Overall Study||0||
60073557|NCT01689207|76188794|FG010|NOT COMPLETED|Overall Study||0||
60073558|NCT00089284|76188829|FG000|STARTED|Overall Study||7||
59523454|NCT02549352|75618276|FG000|NOT COMPLETED|12-month Follow-up||8||
59523455|NCT02549352|75618277|FG001|NOT COMPLETED|12-month Follow-up||12||
59523456|NCT00271102|75618287|FG000|STARTED|Overall Study||35||
59523457|NCT00271102|75618288|FG001|STARTED|Overall Study||35||
59795170|NCT00293059|75916096|FG000|Cycle 1/Treatment Day 28|Overall Study||115||
59795171|NCT00293059|75916097|FG001|Cycle 1/Treatment Day 28|Overall Study||64||
59795172|NCT00293059|75916096|FG000|Cycle 3/Treatment Day 84|Overall Study||100||
59795173|NCT00293059|75916097|FG001|Cycle 3/Treatment Day 84|Overall Study||55||
59795174|NCT00293059|75916096|FG000|Cycle 7/Treatment Day 196|Overall Study|Includes participants that prematurely discontinued and may not be counted in earlier visits.|113||
59795175|NCT00293059|75916097|FG001|Cycle 7/Treatment Day 196|Overall Study|Includes participants that prematurely discontinued and may not be counted in earlier visits.|62||
59795176|NCT00293059|75916096|FG000|COMPLETED|Overall Study||85||
59795177|NCT00293059|75916097|FG001|COMPLETED|Overall Study||51||
59795178|NCT00293059|75916096|FG000|NOT COMPLETED|Overall Study||35||
59795179|NCT00293059|75916097|FG001|NOT COMPLETED|Overall Study||19||
59795180|NCT00756275|75916105|FG000|STARTED|Overall Study||60||
59795181|NCT00756275|75916106|FG001|STARTED|Overall Study||77||
59795182|NCT00756275|75916105|FG000|COMPLETED|Overall Study||31||
59523458|NCT00271102|75618287|FG000|COMPLETED|Overall Study||30||
59523459|NCT00271102|75618288|FG001|COMPLETED|Overall Study||30||
59523460|NCT00271102|75618287|FG000|NOT COMPLETED|Overall Study||5||
59523461|NCT00271102|75618288|FG001|NOT COMPLETED|Overall Study||5||
59795183|NCT00756275|75916106|FG001|COMPLETED|Overall Study||49||
59795184|NCT00756275|75916105|FG000|NOT COMPLETED|Overall Study||29||
59795185|NCT00756275|75916106|FG001|NOT COMPLETED|Overall Study||28||
59795186|NCT00758459|75916114|FG000|STARTED|Overall Study||35||
59795187|NCT00758459|75916115|FG001|STARTED|Overall Study||39||
59795188|NCT00758459|75916114|FG000|COMPLETED|Overall Study||32||
59795189|NCT00758459|75916115|FG001|COMPLETED|Overall Study||35||
59795190|NCT00758459|75916114|FG000|NOT COMPLETED|Overall Study||3||
59795191|NCT00758459|75916115|FG001|NOT COMPLETED|Overall Study||4||
59795192|NCT00298831|75916121|FG000|STARTED|Overall Study||224||
59795193|NCT00298831|75916121|FG000|Treated|Overall Study||197||
59795194|NCT00298831|75916121|FG000|COMPLETED|Overall Study||192||
60073559|NCT00089284|76188830|FG001|STARTED|Overall Study||3||
60073560|NCT00089284|76188831|FG002|STARTED|Overall Study||6||
60073561|NCT00089284|76188832|FG003|STARTED|Overall Study||6||
59523462|NCT02389946|75618296|FG000|STARTED|Overall Study||884||
59523463|NCT02389946|75618297|FG001|STARTED|Overall Study||450||
59523464|NCT02389946|75618296|FG000|COMPLETED|Overall Study||860||
59523465|NCT02389946|75618297|FG001|COMPLETED|Overall Study||435||
59795195|NCT00298831|75916121|FG000|NOT COMPLETED|Overall Study||32||
59795196|NCT00758069|75916128|FG000|STARTED|Overall Study|Study enrolled slightly more than the target of N=20|27||
59795197|NCT00758069|75916129|FG001|STARTED|Overall Study|Study enrolled slightly more than the target of N=20|25||
59795198|NCT00758069|75916130|FG002|STARTED|Overall Study|Study enrolled slightly more than the target of N=20|28||
59795199|NCT00758069|75916128|FG000|COMPLETED|Overall Study||26||
59795200|NCT00758069|75916129|FG001|COMPLETED|Overall Study||25||
59795201|NCT00758069|75916130|FG002|COMPLETED|Overall Study||27||
59795202|NCT00758069|75916128|FG000|NOT COMPLETED|Overall Study||1||
59795203|NCT00758069|75916129|FG001|NOT COMPLETED|Overall Study||0||
59795204|NCT00758069|75916130|FG002|NOT COMPLETED|Overall Study||1||
59795205|NCT00311623|75916141|FG000|STARTED|Overall Study||10||
59795206|NCT00311623|75916142|FG001|STARTED|Overall Study||20||
59620244|NCT00156390|75731538|FG000|NOT COMPLETED|Overall Study||14||
59954158|NCT01099761|76072614|FG001|STARTED|Overall Study||9||
59954159|NCT01099761|76072615|FG002|STARTED|Overall Study|Study terminated prior to enrolling cohort 3|0||
59795207|NCT00311623|75916143|FG002|STARTED|Overall Study||2||
59795208|NCT00311623|75916141|FG000|COMPLETED|Overall Study||10||
59954160|NCT01099761|76072616|FG003|STARTED|Overall Study||6||
59954161|NCT01099761|76072613|FG000|COMPLETED|Overall Study||9||
59954162|NCT01099761|76072614|FG001|COMPLETED|Overall Study||9||
59954163|NCT01099761|76072615|FG002|COMPLETED|Overall Study||0||
59954164|NCT01099761|76072616|FG003|COMPLETED|Overall Study||6||
59954165|NCT01099761|76072613|FG000|NOT COMPLETED|Overall Study||0||
59954166|NCT01099761|76072614|FG001|NOT COMPLETED|Overall Study||0||
59954167|NCT01099761|76072615|FG002|NOT COMPLETED|Overall Study||0||
59954168|NCT01099761|76072616|FG003|NOT COMPLETED|Overall Study||0||
59954169|NCT02582632|76072625|FG000|STARTED|Overall Study||166||
59954170|NCT02582632|76072625|FG000|COMPLETED|Overall Study||165||
59954171|NCT02582632|76072625|FG000|NOT COMPLETED|Overall Study||1||
59954172|NCT02178722|76072634|FG000|STARTED|Overall Study||4||
59954173|NCT02178722|76072635|FG001|STARTED|Overall Study||20||
59954174|NCT02178722|76072636|FG002|STARTED|Overall Study||18||
59954175|NCT02178722|76072637|FG003|STARTED|Overall Study||20||
59954176|NCT02178722|76072638|FG004|STARTED|Overall Study||382||
59954177|NCT02178722|76072634|FG000|COMPLETED|Overall Study||0||
59954178|NCT02178722|76072635|FG001|COMPLETED|Overall Study||0||
59954179|NCT02178722|76072636|FG002|COMPLETED|Overall Study||0||
59954180|NCT02178722|76072637|FG003|COMPLETED|Overall Study||0||
59954181|NCT02178722|76072638|FG004|COMPLETED|Overall Study||0||
59954182|NCT02178722|76072634|FG000|NOT COMPLETED|Overall Study||4||
59954183|NCT02178722|76072635|FG001|NOT COMPLETED|Overall Study||20||
59954184|NCT02178722|76072636|FG002|NOT COMPLETED|Overall Study||18||
59954185|NCT02178722|76072637|FG003|NOT COMPLETED|Overall Study||20||
59954186|NCT02178722|76072638|FG004|NOT COMPLETED|Overall Study||382||
59954187|NCT00972309|76072655|FG000|STARTED|Overall Study||21||
59954188|NCT00972309|76072656|FG001|STARTED|Overall Study||20||
59954189|NCT00972309|76072655|FG000|COMPLETED|Overall Study||9||
59954190|NCT00972309|76072656|FG001|COMPLETED|Overall Study||7||
59954191|NCT00972309|76072655|FG000|NOT COMPLETED|Overall Study||12||
59954192|NCT00972309|76072656|FG001|NOT COMPLETED|Overall Study||13||
59954193|NCT00594620|76072666|FG000|STARTED|Overall Study|Study was terminated early due to low accrual. Study was blinded and no data was collected|0||
59954194|NCT00594620|76072667|FG001|STARTED|Overall Study|Study was terminated early due to low accrual. Study was blinded and no data was collected|0||
59954195|NCT00594620|76072666|FG000|COMPLETED|Overall Study||0||
59954196|NCT00594620|76072667|FG001|COMPLETED|Overall Study||0||
59954197|NCT00594620|76072666|FG000|NOT COMPLETED|Overall Study||0||
59954198|NCT00594620|76072667|FG001|NOT COMPLETED|Overall Study||0||
59954199|NCT02582242|76072675|FG000|STARTED|Overall Study||220||
59954200|NCT02582242|76072676|FG001|STARTED|Overall Study||217||
59954201|NCT02582242|76072675|FG000|COMPLETED|Overall Study||200||
59954202|NCT02582242|76072676|FG001|COMPLETED|Overall Study||200||
59954203|NCT02582242|76072675|FG000|NOT COMPLETED|Overall Study||20||
59954204|NCT02582242|76072676|FG001|NOT COMPLETED|Overall Study||17||
59954205|NCT00663351|76072684|FG000|STARTED|Initial Study (Year 1 up to Year 6)||308||372
59954206|NCT00663351|76072685|FG001|STARTED|Initial Study (Year 1 up to Year 6)||148||163
59954207|NCT00663351|76072684|FG000|COMPLETED|Initial Study (Year 1 up to Year 6)||298||364
59954208|NCT00663351|76072685|FG001|COMPLETED|Initial Study (Year 1 up to Year 6)||129||144
59954209|NCT00663351|76072684|FG000|NOT COMPLETED|Initial Study (Year 1 up to Year 6)||10||8
59954210|NCT00663351|76072685|FG001|NOT COMPLETED|Initial Study (Year 1 up to Year 6)||19||19
59954211|NCT00663351|76072684|FG000|STARTED|Post-Approval Study (Year 6 to Year 10)||298||364
59954212|NCT00663351|76072685|FG001|STARTED|Post-Approval Study (Year 6 to Year 10)||129||144
59620245|NCT00156390|75731539|FG001|NOT COMPLETED|Overall Study||8||
59620246|NCT00029172|75731546|FG000|STARTED|Overall Study||188||
59620247|NCT00029172|75731546|FG000|COMPLETED|Overall Study||182||
59620248|NCT00029172|75731546|FG000|NOT COMPLETED|Overall Study||6||
59620249|NCT00030264|75731550|FG000|STARTED|Overall Study||23||
59795209|NCT00311623|75916142|FG001|COMPLETED|Overall Study||20||
59795210|NCT00311623|75916143|FG002|COMPLETED|Overall Study||0||
59795211|NCT00311623|75916141|FG000|NOT COMPLETED|Overall Study||0||
59620250|NCT00030264|75731550|FG000|COMPLETED|Overall Study||23||
59954213|NCT00663351|76072684|FG000|COMPLETED|Post-Approval Study (Year 6 to Year 10)||186||252
59954214|NCT00663351|76072685|FG001|COMPLETED|Post-Approval Study (Year 6 to Year 10)||58||73
59954215|NCT00663351|76072684|FG000|NOT COMPLETED|Post-Approval Study (Year 6 to Year 10)||112||112
59954216|NCT00663351|76072685|FG001|NOT COMPLETED|Post-Approval Study (Year 6 to Year 10)||71||71
59954217|NCT00616941|76072694|FG000|STARTED|Overall Study||4||
59954218|NCT00616941|76072695|FG001|STARTED|Overall Study||13||
59954219|NCT00616941|76072696|FG002|STARTED|Overall Study||11||
59954220|NCT00616941|76072694|FG000|COMPLETED|Overall Study||3||
59795212|NCT00311623|75916142|FG001|NOT COMPLETED|Overall Study||0||
59795213|NCT00311623|75916143|FG002|NOT COMPLETED|Overall Study||2||
59795214|NCT00528112|75916154|FG000|STARTED|Treatment up to 3 Years||1432||
59795215|NCT00528112|75916155|FG001|STARTED|Treatment up to 3 Years||1453||
59795216|NCT00528112|75916154|FG000|Participants Received Treatment|Treatment up to 3 Years|Full analysis set/Safety population|1432||
59795217|NCT00528112|75916155|FG001|Participants Received Treatment|Treatment up to 3 Years|Full analysis set/Safety population|1452||
59795218|NCT00528112|75916154|FG000|COMPLETED|Treatment up to 3 Years||819||
59795219|NCT00528112|75916155|FG001|COMPLETED|Treatment up to 3 Years||870||
59795220|NCT00528112|75916154|FG000|NOT COMPLETED|Treatment up to 3 Years||613||
59795221|NCT00528112|75916155|FG001|NOT COMPLETED|Treatment up to 3 Years||583||
59795222|NCT00528112|75916154|FG000|STARTED|Extension Phase|Only subjects in the LCS16 groups could participate in the extension phase|0||
59795223|NCT00528112|75916155|FG001|STARTED|Extension Phase||707||
59795224|NCT00528112|75916154|FG000|COMPLETED|Extension Phase||0||
59795225|NCT00528112|75916155|FG001|COMPLETED|Extension Phase||550||
59795226|NCT00528112|75916154|FG000|NOT COMPLETED|Extension Phase||0||
59795227|NCT00528112|75916155|FG001|NOT COMPLETED|Extension Phase||157||
59795228|NCT00633594|75916166|FG000|STARTED|Overall Study||5||
59795229|NCT00633594|75916167|FG001|STARTED|Overall Study||8||
59795230|NCT00633594|75916168|FG002|STARTED|Overall Study||26||
59795231|NCT00633594|75916166|FG000|COMPLETED|Overall Study||5||
59795232|NCT00633594|75916167|FG001|COMPLETED|Overall Study||3||
59795233|NCT00633594|75916168|FG002|COMPLETED|Overall Study||16||
59795234|NCT00633594|75916166|FG000|NOT COMPLETED|Overall Study||0||
59795235|NCT00633594|75916167|FG001|NOT COMPLETED|Overall Study||5||
59795236|NCT00633594|75916168|FG002|NOT COMPLETED|Overall Study||10||
59795237|NCT00755807|75916181|FG000|STARTED|Acute Phase||118||
59795238|NCT00755807|75916182|FG001|STARTED|Acute Phase||121||
59795239|NCT00755807|75916181|FG000|COMPLETED|Acute Phase||100||
59795240|NCT00755807|75916182|FG001|COMPLETED|Acute Phase||109||
59795241|NCT00755807|75916181|FG000|NOT COMPLETED|Acute Phase||18||
59795242|NCT00755807|75916182|FG001|NOT COMPLETED|Acute Phase||12||
59795243|NCT00755807|75916181|FG000|STARTED|Open-label Extension Phase||100||
59795244|NCT00755807|75916182|FG001|STARTED|Open-label Extension Phase||109||
59795245|NCT00755807|75916181|FG000|COMPLETED|Open-label Extension Phase||82||
59795246|NCT00755807|75916182|FG001|COMPLETED|Open-label Extension Phase||93||
59795247|NCT00755807|75916181|FG000|NOT COMPLETED|Open-label Extension Phase||18||
59795248|NCT00755807|75916182|FG001|NOT COMPLETED|Open-label Extension Phase||16||
59795249|NCT00631410|75916194|FG000|STARTED|Overall Study||6||
59795250|NCT00631410|75916195|FG001|STARTED|Overall Study||6||
59795251|NCT00631410|75916194|FG000|COMPLETED|Overall Study||0||
59795252|NCT00631410|75916195|FG001|COMPLETED|Overall Study||0||
59795253|NCT00631410|75916194|FG000|NOT COMPLETED|Overall Study||6||
59795254|NCT00631410|75916195|FG001|NOT COMPLETED|Overall Study||6||
59795255|NCT03686176|75916207|FG000|STARTED|Overall Study||19||
59795256|NCT03686176|75916208|FG001|STARTED|Overall Study||25||
59795257|NCT03686176|75916209|FG002|STARTED|Overall Study||20||
59795258|NCT03686176|75916207|FG000|COMPLETED|Overall Study||17||
59795259|NCT03686176|75916208|FG001|COMPLETED|Overall Study||25||
59795260|NCT03686176|75916209|FG002|COMPLETED|Overall Study||20||
59795261|NCT03686176|75916207|FG000|NOT COMPLETED|Overall Study||2||
59795262|NCT03686176|75916208|FG001|NOT COMPLETED|Overall Study||0||
59795263|NCT03686176|75916209|FG002|NOT COMPLETED|Overall Study||0||
59795264|NCT00755417|75916220|FG000|STARTED|Overall Study|Number of patients that received assigned treatment; ITT and safety populations|174||
59795265|NCT00755417|75916221|FG001|STARTED|Overall Study|Number of patients that received assigned treatment; ITT and safety populations|181||
59795266|NCT00755417|75916222|FG002|STARTED|Overall Study|Number of patients that received assigned treatment; ITT and safety populations|177||
59795267|NCT00755417|75916220|FG000|COMPLETED|Overall Study||112||
59795268|NCT00755417|75916221|FG001|COMPLETED|Overall Study||126||
59795269|NCT00755417|75916222|FG002|COMPLETED|Overall Study||135||
59795270|NCT00755417|75916220|FG000|NOT COMPLETED|Overall Study||62||
59795271|NCT00755417|75916221|FG001|NOT COMPLETED|Overall Study||55||
59795272|NCT00755417|75916222|FG002|NOT COMPLETED|Overall Study||42||
59795273|NCT03685708|75916233|FG000|STARTED|Overall Study||14||
59795274|NCT03685708|75916234|FG001|STARTED|Overall Study||18||
59795275|NCT03685708|75916235|FG002|STARTED|Overall Study||46||
59795276|NCT03685708|75916233|FG000|COMPLETED|Overall Study||13||
59795277|NCT03685708|75916234|FG001|COMPLETED|Overall Study||16||
59795278|NCT03685708|75916235|FG002|COMPLETED|Overall Study||37||
59795279|NCT03685708|75916233|FG000|NOT COMPLETED|Overall Study||1||
59795280|NCT03685708|75916234|FG001|NOT COMPLETED|Overall Study||2||
59795281|NCT03685708|75916235|FG002|NOT COMPLETED|Overall Study||9||
59795282|NCT03684928|75916243|FG000|STARTED|First Intervention||23||
59795283|NCT03684928|75916244|FG001|STARTED|First Intervention||22||
59795284|NCT03684928|75916243|FG000|COMPLETED|First Intervention||23||
59795285|NCT03684928|75916244|FG001|COMPLETED|First Intervention||19||
59795286|NCT03684928|75916243|FG000|NOT COMPLETED|First Intervention||0||
59795287|NCT03684928|75916244|FG001|NOT COMPLETED|First Intervention||3||
59795288|NCT03684928|75916243|FG000|STARTED|Second Intervention|Two participants discontinued between the first intervention and second intervention.|21||
59795289|NCT03684928|75916244|FG001|STARTED|Second Intervention||19||
59795290|NCT03684928|75916243|FG000|COMPLETED|Second Intervention||20||
59795291|NCT03684928|75916244|FG001|COMPLETED|Second Intervention||19||
59795292|NCT03684928|75916243|FG000|NOT COMPLETED|Second Intervention||1||
59795293|NCT03684928|75916244|FG001|NOT COMPLETED|Second Intervention||0||
59795294|NCT00777803|75916252|FG000|STARTED|Overall Study||284||
59795295|NCT00777803|75916253|FG001|STARTED|Overall Study||97||
59795296|NCT00777803|75916252|FG000|COMPLETED|Overall Study||269||
59795297|NCT00777803|75916253|FG001|COMPLETED|Overall Study||90||
59954221|NCT00616941|76072695|FG001|COMPLETED|Overall Study||8||
59954222|NCT00616941|76072696|FG002|COMPLETED|Overall Study||5||
59620251|NCT00030264|75731550|FG000|NOT COMPLETED|Overall Study||0||
59620252|NCT00036738|75731554|FG000|STARTED|Overall Study||28||
59620253|NCT00036738|75731554|FG000|COMPLETED|Overall Study||28||
59620254|NCT00036738|75731554|FG000|NOT COMPLETED|Overall Study||0||
59620255|NCT00038610|75731558|FG000|STARTED|Overall Study||54||
59620256|NCT00038610|75731558|FG000|COMPLETED|Overall Study||54||
59620257|NCT00038610|75731558|FG000|NOT COMPLETED|Overall Study||0||
59620258|NCT00156936|75731564|FG000|STARTED|Overall Study||92||
59620259|NCT00156936|75731565|FG001|STARTED|Overall Study||16||
59795298|NCT00777803|75916252|FG000|NOT COMPLETED|Overall Study||15||
59954223|NCT00616941|76072694|FG000|NOT COMPLETED|Overall Study||1||
59954224|NCT00616941|76072695|FG001|NOT COMPLETED|Overall Study||5||
59620260|NCT00156936|75731564|FG000|COMPLETED|Overall Study||20||
59620261|NCT00156936|75731565|FG001|COMPLETED|Overall Study||5||
59954225|NCT00616941|76072696|FG002|NOT COMPLETED|Overall Study||6||
59795299|NCT00777803|75916253|FG001|NOT COMPLETED|Overall Study||7||
59795300|NCT00527488|75916263|FG000|STARTED|Overall Study||13||
59795301|NCT00527488|75916264|FG001|STARTED|Overall Study||13||
59795302|NCT00527488|75916265|FG002|STARTED|Overall Study||13||
59795303|NCT00527488|75916266|FG003|STARTED|Overall Study||13||
59795304|NCT00527488|75916263|FG000|COMPLETED|Overall Study||13||
59795305|NCT00527488|75916264|FG001|COMPLETED|Overall Study||12||
59795306|NCT00527488|75916265|FG002|COMPLETED|Overall Study||12||
59795307|NCT00527488|75916266|FG003|COMPLETED|Overall Study||13||
59795308|NCT00527488|75916263|FG000|NOT COMPLETED|Overall Study||0||
59795309|NCT00527488|75916264|FG001|NOT COMPLETED|Overall Study||1||
59795310|NCT00527488|75916265|FG002|NOT COMPLETED|Overall Study||1||
59795311|NCT00527488|75916266|FG003|NOT COMPLETED|Overall Study||0||
59795312|NCT00527332|75916278|FG000|STARTED|Overall Study||91||
59795313|NCT00527332|75916279|FG001|STARTED|Overall Study||89||
59795314|NCT00527332|75916278|FG000|COMPLETED|Overall Study||82||
59795315|NCT00527332|75916279|FG001|COMPLETED|Overall Study||80||
59795316|NCT00527332|75916278|FG000|NOT COMPLETED|Overall Study||9||
59795317|NCT00527332|75916279|FG001|NOT COMPLETED|Overall Study||9||
59795318|NCT00752609|75916287|FG000|STARTED|Overall Study||53||
59795319|NCT00752609|75916288|FG001|STARTED|Overall Study||49||
59795320|NCT00752609|75916287|FG000|Full Analysis Set|Overall Study|One patient withdrew consent before receiving any study medication.|52||
59795321|NCT00752609|75916288|FG001|Full Analysis Set|Overall Study||49||
59795322|NCT00752609|75916287|FG000|COMPLETED|Overall Study||44||
59795323|NCT00752609|75916288|FG001|COMPLETED|Overall Study||47||
59795324|NCT00752609|75916287|FG000|NOT COMPLETED|Overall Study||9||
59795325|NCT00752609|75916288|FG001|NOT COMPLETED|Overall Study||2||
59795326|NCT03684304|75916299|FG000|STARTED|Overall Study||19||
59795327|NCT03684304|75916300|FG001|STARTED|Overall Study||17||
59795328|NCT03684304|75916299|FG000|COMPLETED|Overall Study||0||
59795329|NCT03684304|75916300|FG001|COMPLETED|Overall Study||0||
59795330|NCT03684304|75916299|FG000|NOT COMPLETED|Overall Study||19||
59795331|NCT03684304|75916300|FG001|NOT COMPLETED|Overall Study||17||
59795332|NCT00629772|75916308|FG000|STARTED|First Intervention - Day 0 - Week 14||12||
59795333|NCT00629772|75916309|FG001|STARTED|First Intervention - Day 0 - Week 14||12||
59795334|NCT00629772|75916308|FG000|COMPLETED|First Intervention - Day 0 - Week 14||12||
59795335|NCT00629772|75916309|FG001|COMPLETED|First Intervention - Day 0 - Week 14||12||
59795336|NCT00629772|75916308|FG000|NOT COMPLETED|First Intervention - Day 0 - Week 14||0||
59795337|NCT00629772|75916309|FG001|NOT COMPLETED|First Intervention - Day 0 - Week 14||0||
59795338|NCT00629772|75916308|FG000|STARTED|Second Intervention Week 14 - Week 26|Patient withdrew at Week 14 and therefore never received infliximab.|12||
59795339|NCT00629772|75916309|FG001|STARTED|Second Intervention Week 14 - Week 26||12||
59795340|NCT00629772|75916308|FG000|COMPLETED|Second Intervention Week 14 - Week 26||11||
59795341|NCT00629772|75916309|FG001|COMPLETED|Second Intervention Week 14 - Week 26||10||
59795342|NCT00629772|75916308|FG000|NOT COMPLETED|Second Intervention Week 14 - Week 26||1||
59795343|NCT00629772|75916309|FG001|NOT COMPLETED|Second Intervention Week 14 - Week 26||2||
59795344|NCT00526630|75916316|FG000|STARTED|First Intervention Period - 12 Weeks||12||
59795345|NCT00526630|75916317|FG001|STARTED|First Intervention Period - 12 Weeks||11||
59795346|NCT00526630|75916316|FG000|COMPLETED|First Intervention Period - 12 Weeks||12||
59795347|NCT00526630|75916317|FG001|COMPLETED|First Intervention Period - 12 Weeks||8||
59795348|NCT00526630|75916316|FG000|NOT COMPLETED|First Intervention Period - 12 Weeks||0||
59795349|NCT00526630|75916317|FG001|NOT COMPLETED|First Intervention Period - 12 Weeks||3||
59795350|NCT00526630|75916316|FG000|STARTED|Second Intervention Period - 12 Weeks||12||
59795351|NCT00526630|75916317|FG001|STARTED|Second Intervention Period - 12 Weeks||8||
59795352|NCT00526630|75916316|FG000|COMPLETED|Second Intervention Period - 12 Weeks||10||
59795353|NCT00526630|75916317|FG001|COMPLETED|Second Intervention Period - 12 Weeks||7||
59795354|NCT00526630|75916316|FG000|NOT COMPLETED|Second Intervention Period - 12 Weeks||2||
59795355|NCT00526630|75916317|FG001|NOT COMPLETED|Second Intervention Period - 12 Weeks||1||
59795356|NCT00755183|75916327|FG000|STARTED|Overall Study||30||
59795357|NCT00755183|75916328|FG001|STARTED|Overall Study||30||
59795358|NCT00755183|75916327|FG000|COMPLETED|Overall Study||23||
59795359|NCT00755183|75916328|FG001|COMPLETED|Overall Study||24||
59795360|NCT00755183|75916327|FG000|NOT COMPLETED|Overall Study||7||
59795361|NCT00755183|75916328|FG001|NOT COMPLETED|Overall Study||6||
59795362|NCT00755105|75916339|FG000|STARTED|Overall Study||38||
59795363|NCT00755105|75916340|FG001|STARTED|Overall Study||30||
59795364|NCT00755105|75916341|FG002|STARTED|Overall Study||9||
59795365|NCT00755105|75916339|FG000|COMPLETED|Overall Study||29||
59795366|NCT00755105|75916340|FG001|COMPLETED|Overall Study||19||
59795367|NCT00755105|75916341|FG002|COMPLETED|Overall Study||5||
59795368|NCT00755105|75916339|FG000|NOT COMPLETED|Overall Study||9||
59795369|NCT00755105|75916340|FG001|NOT COMPLETED|Overall Study||11||
59795370|NCT00755105|75916341|FG002|NOT COMPLETED|Overall Study||4||
59795371|NCT00526162|75916349|FG000|STARTED|Overall Study||83||
59795372|NCT00526162|75916349|FG000|COMPLETED|Overall Study||80||
59795373|NCT00526162|75916349|FG000|NOT COMPLETED|Overall Study||3||
59795374|NCT03875482|75916359|FG000|STARTED|Overall Study||105||
59795375|NCT03875482|75916360|FG001|STARTED|Overall Study||52||
59795376|NCT03875482|75916359|FG000|COMPLETED|Overall Study||92||
59795377|NCT03875482|75916360|FG001|COMPLETED|Overall Study||32||
59795378|NCT03875482|75916359|FG000|NOT COMPLETED|Overall Study||13||
59795379|NCT03875482|75916360|FG001|NOT COMPLETED|Overall Study||20||
59795380|NCT00754793|75916368|FG000|STARTED|Overall Study||1||
59795381|NCT00754793|75916369|FG001|STARTED|Overall Study||2||
59795382|NCT00754793|75916368|FG000|COMPLETED|Overall Study||1||
59795383|NCT00754793|75916369|FG001|COMPLETED|Overall Study||1||
59795384|NCT00754793|75916368|FG000|NOT COMPLETED|Overall Study||0||
59795385|NCT00754793|75916369|FG001|NOT COMPLETED|Overall Study||1||
59795386|NCT00586469|75916377|FG000|STARTED|Overall Study||500||
59795387|NCT00586469|75916378|FG001|STARTED|Overall Study||500||
59795388|NCT00586469|75916377|FG000|COMPLETED|Overall Study||500||
59795389|NCT00586469|75916378|FG001|COMPLETED|Overall Study||499||
59795390|NCT00586469|75916377|FG000|NOT COMPLETED|Overall Study||0||
59795391|NCT00586469|75916378|FG001|NOT COMPLETED|Overall Study||1||
59795392|NCT00626028|75916386|FG000|STARTED|Overall Study||68||
59795393|NCT00626028|75916387|FG001|STARTED|Overall Study||68||
59795394|NCT00626028|75916386|FG000|COMPLETED|Overall Study||62||
59795395|NCT00626028|75916387|FG001|COMPLETED|Overall Study||59||
59795396|NCT00626028|75916386|FG000|NOT COMPLETED|Overall Study||6||
59795397|NCT00626028|75916387|FG001|NOT COMPLETED|Overall Study||9||
59795398|NCT00777257|75916396|FG000|STARTED|Overall Study||444||
59795399|NCT00777257|75916397|FG001|STARTED|Overall Study||450||
59795400|NCT00777257|75916398|FG002|STARTED|Overall Study||451||
59795401|NCT00777257|75916396|FG000|COMPLETED|Overall Study||433||
59795402|NCT00777257|75916397|FG001|COMPLETED|Overall Study||438||
59795403|NCT00777257|75916398|FG002|COMPLETED|Overall Study||442||
59954226|NCT00105560|76072704|FG000|STARTED|Overall Study||59||
59954227|NCT00105560|76072704|FG000|COMPLETED|Overall Study||58||
59954228|NCT00105560|76072704|FG000|NOT COMPLETED|Overall Study||1||
59954229|NCT02577718|76072717|FG000|STARTED|Overall Study||60||
59954230|NCT02577718|76072717|FG000|COMPLETED|Overall Study||52||
59954231|NCT02577718|76072717|FG000|NOT COMPLETED|Overall Study||8||
59795404|NCT00777257|75916396|FG000|NOT COMPLETED|Overall Study||11||
59795405|NCT00777257|75916397|FG001|NOT COMPLETED|Overall Study||12||
59795406|NCT00777257|75916398|FG002|NOT COMPLETED|Overall Study||9||
59795407|NCT00628758|75916408|FG000|STARTED|Overall Study||209||
59795408|NCT00628758|75916409|FG001|STARTED|Overall Study||221||
59795409|NCT00628758|75916408|FG000|COMPLETED|Overall Study||165||
59795410|NCT00628758|75916409|FG001|COMPLETED|Overall Study||179||
59795411|NCT00628758|75916408|FG000|NOT COMPLETED|Overall Study||44||
59795412|NCT00628758|75916409|FG001|NOT COMPLETED|Overall Study||42||
59795413|NCT04491604|75916417|FG000|STARTED|Overall Study|"Each subject provided one pair of primary target wounds, with one wound from each pair randomized to be treated with B-VEC and the other wound with placebo. The total primary wounds selected were 62 (=2x31), in which 31 each received B-VEC and Placebo, respectively. Additional wounds (Secondary Wounds) were selected using the remaining weekly B-VEC dose. The number of Secondary Wounds treated depended on wound areas. The Secondary Wounds related data were not analyzed per protocol."|31||62
59795414|NCT04491604|75916417|FG000|B-VEC|Overall Study||31||31
59795415|NCT04491604|75916417|FG000|Placebo|Overall Study||31||31
59954232|NCT00520533|76072723|FG000|STARTED|Overall Study||8||
59954233|NCT00520533|76072723|FG000|COMPLETED|Overall Study||4||
59954234|NCT00520533|76072723|FG000|NOT COMPLETED|Overall Study||4||
59954235|NCT05340244|76072728|FG000|STARTED|Overall Study||8||
59954236|NCT05340244|76072728|FG000|COMPLETED|Overall Study||8||
59954237|NCT05340244|76072728|FG000|NOT COMPLETED|Overall Study||0||
59954238|NCT01664104|76072732|FG000|STARTED|Overall Study||136||
59795416|NCT04491604|75916417|FG000|COMPLETED|Overall Study||28||56
59954239|NCT01664104|76072732|FG000|COMPLETED|Overall Study||120||
59954240|NCT01664104|76072732|FG000|NOT COMPLETED|Overall Study||16||
59954241|NCT02739984|76072740|FG000|STARTED|Overall Study||143||
59795417|NCT04491604|75916417|FG000|NOT COMPLETED|Overall Study||3||6
59795418|NCT00628446|75916422|FG000|STARTED|Overall Study||45||
59954242|NCT02739984|76072741|FG001|STARTED|Overall Study||281||
59954243|NCT02739984|76072740|FG000|Received Study Drug|Overall Study||141||
59954244|NCT02739984|76072741|FG001|Received Study Drug|Overall Study||280||
59795419|NCT00628446|75916422|FG000|COMPLETED|Overall Study||38||
59795420|NCT00628446|75916422|FG000|NOT COMPLETED|Overall Study||7||
59795421|NCT00754559|75916427|FG000|STARTED|Overall Study||286||
59954245|NCT02739984|76072740|FG000|COMPLETED|Overall Study||138||
59954246|NCT02739984|76072741|FG001|COMPLETED|Overall Study||279||
59795422|NCT00754559|75916427|FG000|COMPLETED|Overall Study||239||
59795423|NCT00754559|75916427|FG000|NOT COMPLETED|Overall Study||47||
59795424|NCT00525148|75916438|FG000|STARTED|Overall Study|entered and treated|23||
59954247|NCT02739984|76072740|FG000|NOT COMPLETED|Overall Study||5||
59954248|NCT02739984|76072741|FG001|NOT COMPLETED|Overall Study||2||
59954249|NCT00496730|76072749|FG000|STARTED|Overall Study||130||
59795425|NCT00525148|75916439|FG001|STARTED|Overall Study|entered and treated|38||
59795426|NCT00525148|75916440|FG002|STARTED|Overall Study|entered and treated|7||
59795427|NCT00525148|75916441|FG003|STARTED|Overall Study|entered and treated|61||
59954250|NCT00496730|76072750|FG001|STARTED|Overall Study||126||
59954251|NCT00496730|76072749|FG000|COMPLETED|Overall Study||124||
59954252|NCT00496730|76072750|FG001|COMPLETED|Overall Study||121||
59954253|NCT00496730|76072749|FG000|NOT COMPLETED|Overall Study||6||
59954254|NCT00496730|76072750|FG001|NOT COMPLETED|Overall Study||5||
59954255|NCT02739828|76072756|FG000|STARTED|Overall Study||24||
59954256|NCT02739828|76072756|FG000|COMPLETED|Overall Study||19||
59954257|NCT02739828|76072756|FG000|NOT COMPLETED|Overall Study||5||
59954258|NCT03388502|76072762|FG000|STARTED|Overall Study||76||
59620262|NCT00156936|75731564|FG000|NOT COMPLETED|Overall Study||72||
59620263|NCT00156936|75731565|FG001|NOT COMPLETED|Overall Study||11||
59620264|NCT00076050|75731573|FG000|STARTED|Overall Study||122||
59620265|NCT00076050|75731574|FG001|STARTED|Overall Study||126||
59620266|NCT00076050|75731573|FG000|COMPLETED|Overall Study||99||
59620267|NCT00076050|75731574|FG001|COMPLETED|Overall Study||83||
59620268|NCT00076050|75731573|FG000|NOT COMPLETED|Overall Study||23||
59620269|NCT00076050|75731574|FG001|NOT COMPLETED|Overall Study||43||
59620270|NCT00046566|75731583|FG000|STARTED|Intervention 1 (8 Weeks)|Soy protein 8 weeks|117||
59620271|NCT00046566|75731584|FG001|STARTED|Intervention 1 (8 Weeks)|Milk protein 8 weeks|117||
59620272|NCT00046566|75731585|FG002|STARTED|Intervention 1 (8 Weeks)|Carbohydrate 8 weeks|118||
59620273|NCT00046566|75731583|FG000|COMPLETED|Intervention 1 (8 Weeks)||101||
59620274|NCT00046566|75731584|FG001|COMPLETED|Intervention 1 (8 Weeks)||104||
59620275|NCT00046566|75731585|FG002|COMPLETED|Intervention 1 (8 Weeks)||101||
59620276|NCT00046566|75731583|FG000|NOT COMPLETED|Intervention 1 (8 Weeks)||16||
59620277|NCT00046566|75731584|FG001|NOT COMPLETED|Intervention 1 (8 Weeks)||13||
59620278|NCT00046566|75731585|FG002|NOT COMPLETED|Intervention 1 (8 Weeks)||17||
59620279|NCT00046566|75731583|FG000|STARTED|Intervention 2 (8 Weeks)|Milk protein 8 weeks|101||
59620280|NCT00046566|75731584|FG001|STARTED|Intervention 2 (8 Weeks)|Carbohydrate 8 weeks|104||
59620281|NCT00046566|75731585|FG002|STARTED|Intervention 2 (8 Weeks)|Soy protein 8 weeks|101||
59620282|NCT00046566|75731583|FG000|COMPLETED|Intervention 2 (8 Weeks)||93||
59620283|NCT00046566|75731584|FG001|COMPLETED|Intervention 2 (8 Weeks)||92||
59620284|NCT00046566|75731585|FG002|COMPLETED|Intervention 2 (8 Weeks)||88||
59620285|NCT00046566|75731583|FG000|NOT COMPLETED|Intervention 2 (8 Weeks)||8||
59620286|NCT00046566|75731584|FG001|NOT COMPLETED|Intervention 2 (8 Weeks)||12||
59620287|NCT00046566|75731585|FG002|NOT COMPLETED|Intervention 2 (8 Weeks)||13||
59620288|NCT00046566|75731583|FG000|STARTED|Intervention 3 (8 Weeks)||93||
59620289|NCT00046566|75731584|FG001|STARTED|Intervention 3 (8 Weeks)||92||
59620290|NCT00046566|75731585|FG002|STARTED|Intervention 3 (8 Weeks)||88||
59620291|NCT00046566|75731583|FG000|COMPLETED|Intervention 3 (8 Weeks)||93||
59620292|NCT00046566|75731584|FG001|COMPLETED|Intervention 3 (8 Weeks)||92||
59620293|NCT00046566|75731585|FG002|COMPLETED|Intervention 3 (8 Weeks)||88||
59620294|NCT00046566|75731583|FG000|NOT COMPLETED|Intervention 3 (8 Weeks)||0||
59795428|NCT00525148|75916438|FG000|COMPLETED|Overall Study||0||
59620295|NCT00046566|75731584|FG001|NOT COMPLETED|Intervention 3 (8 Weeks)||0||
59620296|NCT00046566|75731585|FG002|NOT COMPLETED|Intervention 3 (8 Weeks)||0||
59620297|NCT00077922|75731594|FG000|STARTED|Overall Study||15||
59620298|NCT00077922|75731594|FG000|COMPLETED|Overall Study||15||
59620299|NCT00077922|75731594|FG000|NOT COMPLETED|Overall Study||0||
59620300|NCT00161382|75731600|FG000|STARTED|Overall Study|Number of students allocated to intervention group|598||
59954259|NCT03388502|76072763|FG001|STARTED|Overall Study||83||
59954260|NCT03388502|76072762|FG000|COMPLETED|Overall Study||76||
59954261|NCT03388502|76072763|FG001|COMPLETED|Overall Study||83||
59954262|NCT03388502|76072762|FG000|NOT COMPLETED|Overall Study||0||
59954263|NCT03388502|76072763|FG001|NOT COMPLETED|Overall Study||0||
59954264|NCT04435808|76072771|FG000|STARTED|Overall Study||0||
59954265|NCT04435808|76072772|FG001|STARTED|Overall Study||1||
59954266|NCT04435808|76072771|FG000|COMPLETED|Overall Study||0||
59795429|NCT00525148|75916439|FG001|COMPLETED|Overall Study||0||
59795430|NCT00525148|75916440|FG002|COMPLETED|Overall Study||0||
59795431|NCT00525148|75916441|FG003|COMPLETED|Overall Study||0||
59795432|NCT00525148|75916438|FG000|NOT COMPLETED|Overall Study||23||
59795433|NCT00525148|75916439|FG001|NOT COMPLETED|Overall Study||38||
59795434|NCT00525148|75916440|FG002|NOT COMPLETED|Overall Study||7||
59795435|NCT00525148|75916441|FG003|NOT COMPLETED|Overall Study||61||
59795436|NCT00754325|75916453|FG000|STARTED|Initial Treatment||50||
59795437|NCT00754325|75916454|FG001|STARTED|Initial Treatment||49||
59795438|NCT00754325|75916453|FG000|COMPLETED|Initial Treatment||0||
59795439|NCT00754325|75916454|FG001|COMPLETED|Initial Treatment||0||
59795440|NCT00754325|75916453|FG000|NOT COMPLETED|Initial Treatment||50||
59795441|NCT00754325|75916454|FG001|NOT COMPLETED|Initial Treatment||49||
59795442|NCT00754325|75916453|FG000|STARTED|Progression and Cross-over|Arm 1 participants with dasatinib-related toxicity stop dasatinib, continue fulvestrant (Arm 1b).|0||
59795443|NCT00754325|75916454|FG001|STARTED|Progression and Cross-over|Progressive disease participants in Arm 2 could add dasatinib (Arm 2b) at investigator discretion.|21||
59795444|NCT00754325|75916453|FG000|COMPLETED|Progression and Cross-over||0||
59795445|NCT00754325|75916454|FG001|COMPLETED|Progression and Cross-over||0||
59795446|NCT00754325|75916453|FG000|NOT COMPLETED|Progression and Cross-over||0||
59795447|NCT00754325|75916454|FG001|NOT COMPLETED|Progression and Cross-over||21||
59795448|NCT00524680|75916465|FG000|STARTED|Overall Study||37||
59795449|NCT00524680|75916466|FG001|STARTED|Overall Study||35||
59795450|NCT00524680|75916467|FG002|STARTED|Overall Study||36||
59795451|NCT00524680|75916468|FG003|STARTED|Overall Study||40||
59795452|NCT00524680|75916465|FG000|COMPLETED|Overall Study||34||
59795453|NCT00524680|75916466|FG001|COMPLETED|Overall Study||34||
59795454|NCT00524680|75916467|FG002|COMPLETED|Overall Study||33||
59795455|NCT00524680|75916468|FG003|COMPLETED|Overall Study||34||
59954267|NCT04435808|76072772|FG001|COMPLETED|Overall Study|Study stopped prior to any data collection for this lone participant|0||
59954268|NCT04435808|76072771|FG000|NOT COMPLETED|Overall Study||0||
59954269|NCT04435808|76072772|FG001|NOT COMPLETED|Overall Study||1||
59954270|NCT03817606|76072780|FG000|STARTED|Overall Study||2||
59954271|NCT03817606|76072781|FG001|STARTED|Overall Study||2||
59954272|NCT03817606|76072780|FG000|COMPLETED|Overall Study||0||
59954273|NCT03817606|76072781|FG001|COMPLETED|Overall Study||0||
59954274|NCT03817606|76072780|FG000|NOT COMPLETED|Overall Study||2||
59954275|NCT03817606|76072781|FG001|NOT COMPLETED|Overall Study||2||
59954276|NCT04132804|76072791|FG000|STARTED|Overall Study||31||
59954277|NCT04132804|76072791|FG000|COMPLETED|Overall Study||20||
59954278|NCT04132804|76072791|FG000|NOT COMPLETED|Overall Study||11||
59954279|NCT01664494|76072795|FG000|STARTED|Overall Study||563||
59954280|NCT01664494|76072795|FG000|COMPLETED|Overall Study||370||
59954281|NCT01664494|76072795|FG000|NOT COMPLETED|Overall Study||193||
59954282|NCT02577016|76072801|FG000|STARTED|Overall Study||70||
59954283|NCT02577016|76072802|FG001|STARTED|Overall Study||71||
59954284|NCT02577016|76072801|FG000|COMPLETED|Overall Study||68||
59795456|NCT00524680|75916465|FG000|NOT COMPLETED|Overall Study||3||
59795457|NCT00524680|75916466|FG001|NOT COMPLETED|Overall Study||1||
59795458|NCT00524680|75916467|FG002|NOT COMPLETED|Overall Study||3||
59795459|NCT00524680|75916468|FG003|NOT COMPLETED|Overall Study||6||
59795460|NCT00628212|75916482|FG000|STARTED|Overall Study||80||
59795461|NCT00628212|75916483|FG001|STARTED|Overall Study||84||
59795462|NCT00628212|75916484|FG002|STARTED|Overall Study||79||
59795463|NCT00628212|75916485|FG003|STARTED|Overall Study||81||
59795464|NCT00628212|75916482|FG000|COMPLETED|Overall Study||77||
59795465|NCT00628212|75916483|FG001|COMPLETED|Overall Study||83||
59795466|NCT00628212|75916484|FG002|COMPLETED|Overall Study||76||
59795467|NCT00628212|75916485|FG003|COMPLETED|Overall Study||76||
59795468|NCT00628212|75916482|FG000|NOT COMPLETED|Overall Study||3||
59795469|NCT00628212|75916483|FG001|NOT COMPLETED|Overall Study||1||
59795470|NCT00628212|75916484|FG002|NOT COMPLETED|Overall Study||3||
59795471|NCT00628212|75916485|FG003|NOT COMPLETED|Overall Study||5||
59795472|NCT00298363|75916498|FG000|STARTED|Overall Study||45||
59795473|NCT00298363|75916499|FG001|STARTED|Overall Study||45||
59795474|NCT00298363|75916500|FG002|STARTED|Overall Study||22||
59817868|NCT04488770|75940333|FG007|NOT COMPLETED|Part 1-Cohort 1: Period 4 (Up to 5 Days)||0||
59954285|NCT02577016|76072802|FG001|COMPLETED|Overall Study||69||
59954286|NCT02577016|76072801|FG000|NOT COMPLETED|Overall Study||2||
59954287|NCT02577016|76072802|FG001|NOT COMPLETED|Overall Study||2||
59795475|NCT00298363|75916498|FG000|COMPLETED|Overall Study|22 completed while taking DB TDF; 6 completed following switch from DB TDF to OL FTC/TDF.|28||
59795476|NCT00298363|75916499|FG001|COMPLETED|Overall Study|34 completed while taking DB FTC/TDF; 3 completed following switch from DB TDF to OL FTC/TDF.|37||
59795477|NCT00298363|75916500|FG002|COMPLETED|Overall Study|13 completed while taking DB ETV; 3 completed following switch from DB ETV to OL FTC/TDF.|16||
59795478|NCT00298363|75916498|FG000|NOT COMPLETED|Overall Study||17||
59795479|NCT00298363|75916499|FG001|NOT COMPLETED|Overall Study||8||
59795480|NCT00298363|75916500|FG002|NOT COMPLETED|Overall Study||6||
59795481|NCT00524368|75916516|FG000|STARTED|Overall Study||294||
59795482|NCT00524368|75916517|FG001|STARTED|Overall Study||296||
59795483|NCT00524368|75916516|FG000|COMPLETED|Overall Study||253||
59795484|NCT00524368|75916517|FG001|COMPLETED|Overall Study||248||
59795485|NCT00524368|75916516|FG000|NOT COMPLETED|Overall Study||41||
59795486|NCT00524368|75916517|FG001|NOT COMPLETED|Overall Study||48||
59795487|NCT00777101|75916525|FG000|STARTED|Overall Study||117||
59795488|NCT00777101|75916526|FG001|STARTED|Overall Study||116||
59795489|NCT00777101|75916525|FG000|Treated|Overall Study||116||
59795490|NCT00777101|75916526|FG001|Treated|Overall Study||115||
59795491|NCT00777101|75916525|FG000|COMPLETED|Overall Study||55||
59795492|NCT00777101|75916526|FG001|COMPLETED|Overall Study||65||
59795493|NCT00777101|75916525|FG000|NOT COMPLETED|Overall Study||62||
59795494|NCT00777101|75916526|FG001|NOT COMPLETED|Overall Study||51||
59795495|NCT00297427|75916535|FG000|STARTED|Phase 1: Initial Intervention|Intention-to-treat analysis; all randomized subjects were included in analysis|64||
59795496|NCT00297427|75916536|FG001|STARTED|Phase 1: Initial Intervention|Intention-to-treat analysis; all randomized subjects were included in analysis|63||
59795497|NCT00297427|75916535|FG000|COMPLETED|Phase 1: Initial Intervention||56||
59795498|NCT00297427|75916536|FG001|COMPLETED|Phase 1: Initial Intervention||54||
59795499|NCT00297427|75916535|FG000|NOT COMPLETED|Phase 1: Initial Intervention||8||
59795500|NCT00297427|75916536|FG001|NOT COMPLETED|Phase 1: Initial Intervention||9||
59795501|NCT00297427|75916535|FG000|STARTED|Phase 2: Optional Crossover for Sham||54||
59795502|NCT00297427|75916536|FG001|STARTED|Phase 2: Optional Crossover for Sham|There was no cross-over to sham acupuncture as this was a wait list control design|0||
59795503|NCT00297427|75916535|FG000|Crossed Over to True Acupuncture|Phase 2: Optional Crossover for Sham|54 subjects completed the sham acupuncture & were offered the opportunity to cross-over; 12 declined|42||
59795504|NCT00297427|75916536|FG001|Crossed Over to True Acupuncture|Phase 2: Optional Crossover for Sham|There was no cross-over to sham acupuncture as this was a wait list control design|0||
59795505|NCT00297427|75916535|FG000|COMPLETED|Phase 2: Optional Crossover for Sham||38||
59795506|NCT00297427|75916536|FG001|COMPLETED|Phase 2: Optional Crossover for Sham|There was no cross-over to sham acupuncture as this was a wait list control design|0||
59795507|NCT00297427|75916535|FG000|NOT COMPLETED|Phase 2: Optional Crossover for Sham||16||
59795508|NCT00297427|75916536|FG001|NOT COMPLETED|Phase 2: Optional Crossover for Sham||0||
59795509|NCT00297427|75916535|FG000|STARTED|Phase 3: Follow-up Post-True Acupuncture||94||
59795510|NCT00297427|75916536|FG001|STARTED|Phase 3: Follow-up Post-True Acupuncture|Only subjects who received true acupuncture initially or after cross-over entered follow-up|0||
59795511|NCT00297427|75916535|FG000|COMPLETED|Phase 3: Follow-up Post-True Acupuncture|Subjects who completed=/>1 follow-up visits and were evaluated for booster acupuncture|60||
59795512|NCT00297427|75916536|FG001|COMPLETED|Phase 3: Follow-up Post-True Acupuncture|Only subjects who received true acupuncture initially or after cross-over entered follow-up|0||
59795513|NCT00297427|75916535|FG000|NOT COMPLETED|Phase 3: Follow-up Post-True Acupuncture||34||
59795514|NCT00297427|75916536|FG001|NOT COMPLETED|Phase 3: Follow-up Post-True Acupuncture||0||
59795515|NCT00524134|75916550|FG000|STARTED|Overall Study||6||
59795516|NCT00524134|75916550|FG000|COMPLETED|Overall Study||4||
59795517|NCT00524134|75916550|FG000|NOT COMPLETED|Overall Study||2||
59795518|NCT00777023|75916557|FG000|STARTED|Overall Study|192 patients were randomized, but only 186 received study treatment.|186||
59795519|NCT00777023|75916558|FG001|STARTED|Overall Study|190 patients were randomized, and 190 received study treatment.|190||
59795520|NCT00777023|75916559|FG002|STARTED|Overall Study|183 patients were randomized, and 183 received study treatment.|183||
59795521|NCT00777023|75916557|FG000|COMPLETED|Overall Study||151||
59795522|NCT00777023|75916558|FG001|COMPLETED|Overall Study||149||
59795523|NCT00777023|75916559|FG002|COMPLETED|Overall Study||146||
59795524|NCT00777023|75916557|FG000|NOT COMPLETED|Overall Study||35||
59795525|NCT00777023|75916558|FG001|NOT COMPLETED|Overall Study||41||
59795526|NCT00777023|75916559|FG002|NOT COMPLETED|Overall Study||37||
59795527|NCT00297037|75916569|FG000|STARTED|Overall Study||10||
59795528|NCT00297037|75916570|FG001|STARTED|Overall Study||11||
59795529|NCT00297037|75916569|FG000|COMPLETED|Overall Study||8||
59795530|NCT00297037|75916570|FG001|COMPLETED|Overall Study||11||
59795531|NCT00297037|75916569|FG000|NOT COMPLETED|Overall Study||2||
59795532|NCT00297037|75916570|FG001|NOT COMPLETED|Overall Study||0||
59795533|NCT00292981|75916578|FG000|STARTED|Overall Study||57||
59795534|NCT00292981|75916578|FG000|COMPLETED|Overall Study||18||
59795535|NCT00292981|75916578|FG000|NOT COMPLETED|Overall Study||39||
59795536|NCT00296725|75916582|FG000|STARTED|Phase 1: Fluoxetine (1-12 Weeks)||17|Follow reviewers suggestion, added 2 periods to avoid double counting. Period 1 started with 17|
59795537|NCT00296725|75916582|FG000|COMPLETED|Phase 1: Fluoxetine (1-12 Weeks)||12||
59795538|NCT00296725|75916582|FG000|NOT COMPLETED|Phase 1: Fluoxetine (1-12 Weeks)||5||
59795539|NCT00296725|75916582|FG000|STARTED|Phase 2: Imipramine (1-6 Weeks)||8|8 participants available and eligible to participate in period 2|
59795540|NCT00296725|75916582|FG000|COMPLETED|Phase 2: Imipramine (1-6 Weeks)||7||
59795541|NCT00296725|75916582|FG000|NOT COMPLETED|Phase 2: Imipramine (1-6 Weeks)||1||
59795542|NCT00625872|75916590|FG000|STARTED|Overall Study||12||
59795543|NCT00625872|75916591|FG001|STARTED|Overall Study||11||
59795544|NCT00625872|75916590|FG000|Treated|Overall Study||12||
59795545|NCT00625872|75916591|FG001|Treated|Overall Study||10||
59795546|NCT00625872|75916590|FG000|COMPLETED|Overall Study||8||
59795547|NCT00625872|75916591|FG001|COMPLETED|Overall Study||5||
59795548|NCT00625872|75916590|FG000|NOT COMPLETED|Overall Study||4||
59795549|NCT00625872|75916591|FG001|NOT COMPLETED|Overall Study||6||
59795550|NCT00523978|75916599|FG000|STARTED|Overall Study||171||
59795551|NCT00523978|75916600|FG001|STARTED|Overall Study||87||
59795552|NCT00523978|75916599|FG000|COMPLETED|Overall Study||162||
59795553|NCT00523978|75916600|FG001|COMPLETED|Overall Study||79||
59795554|NCT00523978|75916599|FG000|NOT COMPLETED|Overall Study||9||
59795555|NCT00523978|75916600|FG001|NOT COMPLETED|Overall Study||8||
59795556|NCT00296647|75916612|FG000|STARTED|Overall Study||282||
59795557|NCT00296647|75916613|FG001|STARTED|Overall Study||261||
59795558|NCT00296647|75916614|FG002|STARTED|Overall Study||256||
59795559|NCT00296647|75916615|FG003|STARTED|Overall Study||279||
59795560|NCT00296647|75916616|FG004|STARTED|Overall Study||268||
59795561|NCT00296647|75916612|FG000|COMPLETED|Overall Study||250||
59795562|NCT00296647|75916613|FG001|COMPLETED|Overall Study||233||
59795563|NCT00296647|75916614|FG002|COMPLETED|Overall Study||222||
59795564|NCT00296647|75916615|FG003|COMPLETED|Overall Study||262||
59795565|NCT00296647|75916616|FG004|COMPLETED|Overall Study||248||
59795566|NCT00296647|75916612|FG000|NOT COMPLETED|Overall Study||32||
59795567|NCT00296647|75916613|FG001|NOT COMPLETED|Overall Study||28||
59795568|NCT00296647|75916614|FG002|NOT COMPLETED|Overall Study||34||
59795569|NCT00296647|75916615|FG003|NOT COMPLETED|Overall Study||17||
59795570|NCT00296647|75916616|FG004|NOT COMPLETED|Overall Study||20||
59795571|NCT00754013|75916630|FG000|STARTED|Overall Study||4||
59795572|NCT00754013|75916631|FG001|STARTED|Overall Study||5||
59795573|NCT00754013|75916630|FG000|COMPLETED|Overall Study||0||
59795574|NCT00754013|75916631|FG001|COMPLETED|Overall Study||0||
59795575|NCT00754013|75916630|FG000|NOT COMPLETED|Overall Study||4||
59795576|NCT00754013|75916631|FG001|NOT COMPLETED|Overall Study||5||
59795577|NCT00523744|75916637|FG000|STARTED|Phase 1 - Amlodipine+Olmesartan||257||
59795578|NCT00523744|75916637|FG000|COMPLETED|Phase 1 - Amlodipine+Olmesartan||251||
59795579|NCT00523744|75916637|FG000|NOT COMPLETED|Phase 1 - Amlodipine+Olmesartan||6||
59795580|NCT00523744|75916637|FG000|STARTED|Phase 2 - Amlodipine+Valsartan|Only patients with mean sitting diastolic BP ≥ 90 mmHg at the end of Phase 1 entered this phase.|176||
59795581|NCT00523744|75916637|FG000|COMPLETED|Phase 2 - Amlodipine+Valsartan||173||
59795582|NCT00523744|75916637|FG000|NOT COMPLETED|Phase 2 - Amlodipine+Valsartan||3||
59795583|NCT00523744|75916637|FG000|STARTED|Phase 3 - Amlodipine+Valsartan+HCTZ|Only patients with systolic BP ≥ 140 mmHg or diastolic BP ≥ 90 mmHg at the end of Phase 2.|91||
59795584|NCT00523744|75916637|FG000|COMPLETED|Phase 3 - Amlodipine+Valsartan+HCTZ||91||
59795585|NCT00523744|75916637|FG000|NOT COMPLETED|Phase 3 - Amlodipine+Valsartan+HCTZ||0||
59795586|NCT04352140|75916646|FG000|STARTED|Overall Study||30||
59795587|NCT04352140|75916647|FG001|STARTED|Overall Study||30||
59795588|NCT04352140|75916646|FG000|COMPLETED|Overall Study||30||
59795589|NCT04352140|75916647|FG001|COMPLETED|Overall Study||30||
59795590|NCT04352140|75916646|FG000|NOT COMPLETED|Overall Study||0||
59795591|NCT04352140|75916647|FG001|NOT COMPLETED|Overall Study||0||
59795592|NCT00752219|75916655|FG000|STARTED|Overall Study||102||
59795593|NCT00752219|75916656|FG001|STARTED|Overall Study||102||
59795594|NCT00752219|75916655|FG000|Treated|Overall Study||101||
59795595|NCT00752219|75916656|FG001|Treated|Overall Study||102||
59795596|NCT00752219|75916655|FG000|COMPLETED|Overall Study||91||
59954288|NCT05101252|76072810|FG000|STARTED|Overall Study||37||
59954289|NCT05101252|76072811|FG001|STARTED|Overall Study||37||
59954290|NCT05101252|76072810|FG000|COMPLETED|Overall Study||35||
59795597|NCT00752219|75916656|FG001|COMPLETED|Overall Study||96||
59795598|NCT00752219|75916655|FG000|NOT COMPLETED|Overall Study||11||
59795599|NCT00752219|75916656|FG001|NOT COMPLETED|Overall Study||6||
59795600|NCT00622908|75916664|FG000|STARTED|Overall Study|Intent to treat population|137||
59795601|NCT00622908|75916665|FG001|STARTED|Overall Study|Intent to treat population|132||
59795602|NCT00622908|75916664|FG000|COMPLETED|Overall Study||134||
59795603|NCT00622908|75916665|FG001|COMPLETED|Overall Study||122||
59795604|NCT00622908|75916664|FG000|NOT COMPLETED|Overall Study||3||
59795605|NCT00622908|75916665|FG001|NOT COMPLETED|Overall Study||10||
59795606|NCT00296491|75916675|FG000|STARTED|Overall Study|Please note: Outcome Measures generally conducts analysis of 2 of the 4 Arms at a time.|182||
59795607|NCT00296491|75916676|FG001|STARTED|Overall Study||182||
59795608|NCT00296491|75916677|FG002|STARTED|Overall Study||180||
59795609|NCT00296491|75916678|FG003|STARTED|Overall Study||181||
59795610|NCT00296491|75916675|FG000|COMPLETED|Overall Study||140||
59795611|NCT00296491|75916676|FG001|COMPLETED|Overall Study||129||
59795612|NCT00296491|75916677|FG002|COMPLETED|Overall Study||137||
59795613|NCT00296491|75916678|FG003|COMPLETED|Overall Study||138||
59795614|NCT00296491|75916675|FG000|NOT COMPLETED|Overall Study||42||
59795615|NCT00296491|75916676|FG001|NOT COMPLETED|Overall Study||53||
59795616|NCT00296491|75916677|FG002|NOT COMPLETED|Overall Study||43||
59954291|NCT05101252|76072811|FG001|COMPLETED|Overall Study||34||
59795617|NCT00296491|75916678|FG003|NOT COMPLETED|Overall Study||43||
59795618|NCT00747617|75916697|FG000|STARTED|Overall Study||13||
59795619|NCT00747617|75916698|FG001|STARTED|Overall Study||12||
59795620|NCT00747617|75916697|FG000|COMPLETED|Overall Study||10||
59795621|NCT00747617|75916698|FG001|COMPLETED|Overall Study||11||
59795622|NCT00747617|75916697|FG000|NOT COMPLETED|Overall Study||3||
59795623|NCT00747617|75916698|FG001|NOT COMPLETED|Overall Study||1||
59795624|NCT00296335|75916706|FG000|STARTED|Overall Study||424||
59795625|NCT00296335|75916707|FG001|STARTED|Overall Study||431||
59795626|NCT00296335|75916706|FG000|COMPLETED|Overall Study||394||
59795627|NCT00296335|75916707|FG001|COMPLETED|Overall Study||309||
59795628|NCT00296335|75916706|FG000|NOT COMPLETED|Overall Study||30||
59795629|NCT00296335|75916707|FG001|NOT COMPLETED|Overall Study||122||
59795630|NCT00747461|75916715|FG000|STARTED|Overall Study||5||
59795631|NCT00747461|75916715|FG000|COMPLETED|Overall Study||0||
59795632|NCT00747461|75916715|FG000|NOT COMPLETED|Overall Study||5||
59795633|NCT03683758|75916722|FG000|STARTED|Overall Study||11||
59795634|NCT03683758|75916723|FG001|STARTED|Overall Study||10||
59795635|NCT03683758|75916722|FG000|COMPLETED|Overall Study||8||
59795636|NCT03683758|75916723|FG001|COMPLETED|Overall Study||7||
59795637|NCT03683758|75916722|FG000|NOT COMPLETED|Overall Study||3||
59795638|NCT03683758|75916723|FG001|NOT COMPLETED|Overall Study||3||
59795639|NCT00522418|75916731|FG000|STARTED|Overall Study||59||
59795640|NCT00522418|75916732|FG001|STARTED|Overall Study||63||
59795641|NCT00522418|75916731|FG000|Safety Set|Overall Study|Data of 5 randomized patients removed due to lack of ICF approval by site's local ethics committee.|54||
59795642|NCT00522418|75916732|FG001|Safety Set|Overall Study|Data of 5 randomized patients removed due to lack of ICF approval by site's local ethics committee.|58||
59795643|NCT00522418|75916731|FG000|Efficacy Set|Overall Study|6 pts. data excluded: exited prior to collection of baseline data & one postbaseline followup QOLIE|48||
59795644|NCT00522418|75916732|FG001|Efficacy Set|Overall Study|10 pts. data excluded: exited prior to collection of baseline data & one postbaseline followup QOLIE|48||
59795645|NCT00522418|75916731|FG000|Baseline and Month 3|Overall Study|Completed Baseline and Month 3|47||
59795646|NCT00522418|75916732|FG001|Baseline and Month 3|Overall Study|Completed Baseline and Month 3|47||
59795647|NCT00522418|75916731|FG000|Baseline and Month 6|Overall Study|Completed Baseline and Month 6|38||
59795648|NCT00522418|75916732|FG001|Baseline and Month 6|Overall Study|Completed Baseline and Month 6|45||
59795649|NCT00522418|75916731|FG000|Baseline and Month 9|Overall Study|Completed Baseline and Month 9|33||
59795650|NCT00522418|75916732|FG001|Baseline and Month 9|Overall Study|Completed Baseline and Month 9|35||
59795651|NCT00522418|75916731|FG000|Baseline and Month 12|Overall Study|Completed Baseline and Month 12|31||
59795652|NCT00522418|75916732|FG001|Baseline and Month 12|Overall Study|Completed Baseline and Month 12|29||
59795653|NCT00522418|75916731|FG000|COMPLETED|Overall Study|Completed 2-year follow-up|2||
59795654|NCT00522418|75916732|FG001|COMPLETED|Overall Study|Completed 2-year follow-up|5||
59795655|NCT00522418|75916731|FG000|NOT COMPLETED|Overall Study||57||
59795656|NCT00522418|75916732|FG001|NOT COMPLETED|Overall Study||58||
59795657|NCT00624780|75916746|FG000|STARTED|Treatment Optimization (Up to Week 12)||154||
59795658|NCT00624780|75916747|FG001|STARTED|Treatment Optimization (Up to Week 12)||52||
59795659|NCT00624780|75916748|FG002|STARTED|Treatment Optimization (Up to Week 12)||154||
59795660|NCT00624780|75916749|FG003|STARTED|Treatment Optimization (Up to Week 12)||52||
59795661|NCT00624780|75916750|FG004|STARTED|Treatment Optimization (Up to Week 12)||153||
59795662|NCT00624780|75916751|FG005|STARTED|Treatment Optimization (Up to Week 12)||50||
59795663|NCT00624780|75916746|FG000|COMPLETED|Treatment Optimization (Up to Week 12)||121||
59795664|NCT00624780|75916747|FG001|COMPLETED|Treatment Optimization (Up to Week 12)||39||
59795665|NCT00624780|75916748|FG002|COMPLETED|Treatment Optimization (Up to Week 12)||112||
59795666|NCT00624780|75916749|FG003|COMPLETED|Treatment Optimization (Up to Week 12)||38||
59795667|NCT00624780|75916750|FG004|COMPLETED|Treatment Optimization (Up to Week 12)||114||
59795668|NCT00624780|75916751|FG005|COMPLETED|Treatment Optimization (Up to Week 12)||39||
59795669|NCT00624780|75916746|FG000|NOT COMPLETED|Treatment Optimization (Up to Week 12)||33||
59795670|NCT00624780|75916747|FG001|NOT COMPLETED|Treatment Optimization (Up to Week 12)||13||
59795671|NCT00624780|75916748|FG002|NOT COMPLETED|Treatment Optimization (Up to Week 12)||42||
59795672|NCT00624780|75916749|FG003|NOT COMPLETED|Treatment Optimization (Up to Week 12)||14||
60073562|NCT00089284|76188833|FG004|STARTED|Overall Study|No patients were accrued to this cohort of 6-24% involvement due to lack of eligible patients.|0||
60073563|NCT00089284|76188834|FG005|STARTED|Overall Study|No patients were accrued to this cohort of 6-24% involvement due to lack of eligible patients.|0||
60073564|NCT00089284|76188835|FG006|STARTED|Overall Study||8||
60073565|NCT00089284|76188829|FG000|COMPLETED|Overall Study||7||
59795673|NCT00624780|75916750|FG004|NOT COMPLETED|Treatment Optimization (Up to Week 12)||39||
59795674|NCT00624780|75916751|FG005|NOT COMPLETED|Treatment Optimization (Up to Week 12)||11||
59795675|NCT00624780|75916746|FG000|STARTED|Fixed Dosing (Week 13 to Week 24)||121||
59795676|NCT00624780|75916747|FG001|STARTED|Fixed Dosing (Week 13 to Week 24)||39||
59795677|NCT00624780|75916748|FG002|STARTED|Fixed Dosing (Week 13 to Week 24)||112||
59795678|NCT00624780|75916749|FG003|STARTED|Fixed Dosing (Week 13 to Week 24)||38||
59795679|NCT00624780|75916750|FG004|STARTED|Fixed Dosing (Week 13 to Week 24)||114||
59795680|NCT00624780|75916751|FG005|STARTED|Fixed Dosing (Week 13 to Week 24)||39||
59795681|NCT00624780|75916746|FG000|COMPLETED|Fixed Dosing (Week 13 to Week 24)||106||
59795682|NCT00624780|75916747|FG001|COMPLETED|Fixed Dosing (Week 13 to Week 24)||28||
59795683|NCT00624780|75916748|FG002|COMPLETED|Fixed Dosing (Week 13 to Week 24)||94||
59795684|NCT00624780|75916749|FG003|COMPLETED|Fixed Dosing (Week 13 to Week 24)||27||
59795685|NCT00624780|75916750|FG004|COMPLETED|Fixed Dosing (Week 13 to Week 24)||95||
59795686|NCT00624780|75916751|FG005|COMPLETED|Fixed Dosing (Week 13 to Week 24)||30||
59795687|NCT00624780|75916746|FG000|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||15||
59795688|NCT00624780|75916747|FG001|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||11||
59795689|NCT00624780|75916748|FG002|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||18||
59795690|NCT00624780|75916749|FG003|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||11||
59795691|NCT00624780|75916750|FG004|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||19||
59795692|NCT00624780|75916751|FG005|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||9||
59795693|NCT00624780|75916746|FG000|STARTED|Treatment Discontinuation (Week 25)||106||
59795694|NCT00624780|75916747|FG001|STARTED|Treatment Discontinuation (Week 25)||28||
59795695|NCT00624780|75916748|FG002|STARTED|Treatment Discontinuation (Week 25)||94||
59795696|NCT00624780|75916749|FG003|STARTED|Treatment Discontinuation (Week 25)||27||
59795697|NCT00624780|75916750|FG004|STARTED|Treatment Discontinuation (Week 25)||95||
59795698|NCT00624780|75916751|FG005|STARTED|Treatment Discontinuation (Week 25)||30||
59795699|NCT00624780|75916746|FG000|COMPLETED|Treatment Discontinuation (Week 25)||104||
59795700|NCT00624780|75916747|FG001|COMPLETED|Treatment Discontinuation (Week 25)||28||
59795701|NCT00624780|75916748|FG002|COMPLETED|Treatment Discontinuation (Week 25)||91||
59795702|NCT00624780|75916749|FG003|COMPLETED|Treatment Discontinuation (Week 25)||26||
59795703|NCT00624780|75916750|FG004|COMPLETED|Treatment Discontinuation (Week 25)||95||
59795704|NCT00624780|75916751|FG005|COMPLETED|Treatment Discontinuation (Week 25)||29||
59795705|NCT00624780|75916746|FG000|NOT COMPLETED|Treatment Discontinuation (Week 25)||2||
59795706|NCT00624780|75916747|FG001|NOT COMPLETED|Treatment Discontinuation (Week 25)||0||
59795707|NCT00624780|75916748|FG002|NOT COMPLETED|Treatment Discontinuation (Week 25)||3||
59795708|NCT00624780|75916749|FG003|NOT COMPLETED|Treatment Discontinuation (Week 25)||1||
59795709|NCT00624780|75916750|FG004|NOT COMPLETED|Treatment Discontinuation (Week 25)||0||
59795710|NCT00624780|75916751|FG005|NOT COMPLETED|Treatment Discontinuation (Week 25)||1||
59795711|NCT00624780|75916746|FG000|STARTED|Follow-up (Week 26)||104||
59795712|NCT00624780|75916747|FG001|STARTED|Follow-up (Week 26)||28||
59795713|NCT00624780|75916748|FG002|STARTED|Follow-up (Week 26)||91||
59795714|NCT00624780|75916749|FG003|STARTED|Follow-up (Week 26)||26||
59795715|NCT00624780|75916750|FG004|STARTED|Follow-up (Week 26)||95||
59795716|NCT00624780|75916751|FG005|STARTED|Follow-up (Week 26)||29||
59795717|NCT00624780|75916746|FG000|COMPLETED|Follow-up (Week 26)||102||
59795718|NCT00624780|75916747|FG001|COMPLETED|Follow-up (Week 26)||27||
59795719|NCT00624780|75916748|FG002|COMPLETED|Follow-up (Week 26)||89||
59795720|NCT00624780|75916749|FG003|COMPLETED|Follow-up (Week 26)||26||
59795721|NCT00624780|75916750|FG004|COMPLETED|Follow-up (Week 26)||93||
59795722|NCT00624780|75916751|FG005|COMPLETED|Follow-up (Week 26)||29||
59795723|NCT00624780|75916746|FG000|NOT COMPLETED|Follow-up (Week 26)||2||
59795724|NCT00624780|75916747|FG001|NOT COMPLETED|Follow-up (Week 26)||1||
59795725|NCT00624780|75916748|FG002|NOT COMPLETED|Follow-up (Week 26)||2||
59795726|NCT00624780|75916749|FG003|NOT COMPLETED|Follow-up (Week 26)||0||
59795727|NCT00624780|75916750|FG004|NOT COMPLETED|Follow-up (Week 26)||2||
59795728|NCT00624780|75916751|FG005|NOT COMPLETED|Follow-up (Week 26)||0||
59795729|NCT00750893|75916768|FG000|STARTED|Overall Study||3111||
59795730|NCT00750893|75916768|FG000|COMPLETED|Overall Study||2569||
59795731|NCT00750893|75916768|FG000|NOT COMPLETED|Overall Study||542||
59795732|NCT00753623|75916774|FG000|STARTED|Phase I (14 Days)||11||
59795733|NCT00753623|75916775|FG001|STARTED|Phase I (14 Days)||12||
59795734|NCT00753623|75916774|FG000|COMPLETED|Phase I (14 Days)||9||
59795735|NCT00753623|75916775|FG001|COMPLETED|Phase I (14 Days)||8||
59795736|NCT00753623|75916774|FG000|NOT COMPLETED|Phase I (14 Days)||2||
59795737|NCT00753623|75916775|FG001|NOT COMPLETED|Phase I (14 Days)||4||
59795738|NCT00753623|75916774|FG000|STARTED|Washout (7 Days)||9||
59795739|NCT00753623|75916775|FG001|STARTED|Washout (7 Days)||8||
59795740|NCT00753623|75916774|FG000|COMPLETED|Washout (7 Days)||8||
59795741|NCT00753623|75916775|FG001|COMPLETED|Washout (7 Days)||8||
59795742|NCT00753623|75916774|FG000|NOT COMPLETED|Washout (7 Days)||1||
59795743|NCT00753623|75916775|FG001|NOT COMPLETED|Washout (7 Days)||0||
59795744|NCT00753623|75916774|FG000|STARTED|Phase II (14 Days)||8||
59795745|NCT00753623|75916775|FG001|STARTED|Phase II (14 Days)||8||
59795746|NCT00753623|75916774|FG000|COMPLETED|Phase II (14 Days)||8||
59795747|NCT00753623|75916775|FG001|COMPLETED|Phase II (14 Days)||7||
59795748|NCT00753623|75916774|FG000|NOT COMPLETED|Phase II (14 Days)||0||
59795749|NCT00753623|75916775|FG001|NOT COMPLETED|Phase II (14 Days)||1||
59795750|NCT00750737|75916783|FG000|STARTED|Overall Study||24||
59795751|NCT00750737|75916784|FG001|STARTED|Overall Study||22||
59795752|NCT00750737|75916783|FG000|COMPLETED|Overall Study||21||
59795753|NCT00750737|75916784|FG001|COMPLETED|Overall Study||19||
59954292|NCT05101252|76072810|FG000|NOT COMPLETED|Overall Study||2||
59795754|NCT00750737|75916783|FG000|NOT COMPLETED|Overall Study||3||
59795755|NCT00750737|75916784|FG001|NOT COMPLETED|Overall Study||3||
59795756|NCT00622440|75916792|FG000|STARTED|Baseline - Week 12 (Treatment)||35||
59795757|NCT00622440|75916793|FG001|STARTED|Baseline - Week 12 (Treatment)||35||
59795758|NCT00622440|75916792|FG000|COMPLETED|Baseline - Week 12 (Treatment)||31||
59795759|NCT00622440|75916793|FG001|COMPLETED|Baseline - Week 12 (Treatment)||34||
59795760|NCT00622440|75916792|FG000|NOT COMPLETED|Baseline - Week 12 (Treatment)||4||
59795761|NCT00622440|75916793|FG001|NOT COMPLETED|Baseline - Week 12 (Treatment)||1||
59795762|NCT00622440|75916792|FG000|STARTED|Week 12 - Week 48 (Treatment)||31||
59795763|NCT00622440|75916793|FG001|STARTED|Week 12 - Week 48 (Treatment)||34||
59795764|NCT00622440|75916792|FG000|COMPLETED|Week 12 - Week 48 (Treatment)||28||
59795765|NCT00622440|75916793|FG001|COMPLETED|Week 12 - Week 48 (Treatment)||28||
59795766|NCT00622440|75916792|FG000|NOT COMPLETED|Week 12 - Week 48 (Treatment)||3||
59795767|NCT00622440|75916793|FG001|NOT COMPLETED|Week 12 - Week 48 (Treatment)||6||
59795768|NCT00622440|75916792|FG000|STARTED|Week 60 (Post-treatment Follow-up Visit)||28||
59795769|NCT00622440|75916793|FG001|STARTED|Week 60 (Post-treatment Follow-up Visit)||28||
59795770|NCT00622440|75916792|FG000|COMPLETED|Week 60 (Post-treatment Follow-up Visit)||28||
59795771|NCT00622440|75916793|FG001|COMPLETED|Week 60 (Post-treatment Follow-up Visit)||27||
59795772|NCT00622440|75916792|FG000|NOT COMPLETED|Week 60 (Post-treatment Follow-up Visit)||0||
59795773|NCT00622440|75916793|FG001|NOT COMPLETED|Week 60 (Post-treatment Follow-up Visit)||1||
59795774|NCT00744653|75916799|FG000|STARTED|Overall Study||17||
59795775|NCT00744653|75916799|FG000|COMPLETED|Overall Study||1||
59795776|NCT00744653|75916799|FG000|NOT COMPLETED|Overall Study||16||
59795777|NCT00311311|75916806|FG000|STARTED|Overall Study||37||
59620301|NCT00161382|75731601|FG001|STARTED|Overall Study|Number of students allocated to comparison group|847||
59620302|NCT00161382|75731600|FG000|COMPLETED|Overall Study|Number of intervention students included in the analyzed cohort (i.e., completed 9th-grade survey)|349||
59620303|NCT00161382|75731601|FG001|COMPLETED|Overall Study|Number of control students included in the analyzed cohort (i.e., completed 9th-grade survey)|558||
59620304|NCT00161382|75731600|FG000|NOT COMPLETED|Overall Study||249||
59620305|NCT00161382|75731601|FG001|NOT COMPLETED|Overall Study||289||
59620306|NCT00079326|75731609|FG000|STARTED|Overall Study||15||
59620307|NCT00079326|75731610|FG001|STARTED|Overall Study||24||
59620308|NCT00079326|75731609|FG000|COMPLETED|Overall Study||15||
59620309|NCT00079326|75731610|FG001|COMPLETED|Overall Study||24||
59620310|NCT00079326|75731609|FG000|NOT COMPLETED|Overall Study||0||
59620311|NCT00079326|75731610|FG001|NOT COMPLETED|Overall Study||0||
59620312|NCT00051168|75731615|FG000|STARTED|Overall Study||502||
59620313|NCT00051168|75731615|FG000|COMPLETED|Overall Study||367||
59620314|NCT00051168|75731615|FG000|NOT COMPLETED|Overall Study||135||
59620315|NCT00083382|75731619|FG000|STARTED|Overall Study||83||
59620316|NCT00083382|75731619|FG000|COMPLETED|Overall Study||83||
59620317|NCT00083382|75731619|FG000|NOT COMPLETED|Overall Study||0||
59620318|NCT00167388|75731627|FG000|STARTED|Overall Study||5||
59620319|NCT00167388|75731628|FG001|STARTED|Overall Study||5||
59620320|NCT00167388|75731629|FG002|STARTED|Overall Study||6||
59620321|NCT00167388|75731630|FG003|STARTED|Overall Study||6||
59620322|NCT00167388|75731627|FG000|Completed Doppler Study|Overall Study||5||
59620323|NCT00167388|75731628|FG001|Completed Doppler Study|Overall Study||5||
59620324|NCT00167388|75731629|FG002|Completed Doppler Study|Overall Study||6||
59620325|NCT00167388|75731630|FG003|Completed Doppler Study|Overall Study||6||
59620326|NCT00167388|75731627|FG000|COMPLETED|Overall Study||5||
59620327|NCT00167388|75731628|FG001|COMPLETED|Overall Study||5||
59620328|NCT00167388|75731629|FG002|COMPLETED|Overall Study||6||
59620329|NCT00167388|75731630|FG003|COMPLETED|Overall Study||6||
59620330|NCT00167388|75731627|FG000|NOT COMPLETED|Overall Study||0||
59620331|NCT00167388|75731628|FG001|NOT COMPLETED|Overall Study||0||
59620332|NCT00167388|75731629|FG002|NOT COMPLETED|Overall Study||0||
59620333|NCT00167388|75731630|FG003|NOT COMPLETED|Overall Study||0||
59620334|NCT00167544|75731640|FG000|STARTED|Overall Study||31||
59620335|NCT00167544|75731641|FG001|STARTED|Overall Study||33||
59620336|NCT00167544|75731640|FG000|COMPLETED|Overall Study||30||
59620337|NCT00167544|75731641|FG001|COMPLETED|Overall Study||33||
59620338|NCT00167544|75731640|FG000|NOT COMPLETED|Overall Study||1||
59620339|NCT00167544|75731641|FG001|NOT COMPLETED|Overall Study||0||
59795778|NCT00311311|75916807|FG001|STARTED|Overall Study||35||
59795779|NCT00311311|75916806|FG000|COMPLETED|Overall Study||29||
59795780|NCT00311311|75916807|FG001|COMPLETED|Overall Study||26||
59795781|NCT00311311|75916806|FG000|NOT COMPLETED|Overall Study||8||
59795782|NCT00311311|75916807|FG001|NOT COMPLETED|Overall Study||9||
59795783|NCT00521404|75916813|FG000|STARTED|Overall Study||62||
59795784|NCT00521404|75916813|FG000|COMPLETED|Overall Study||0||
59795785|NCT00521404|75916813|FG000|NOT COMPLETED|Overall Study||62||
59795786|NCT00311155|75916817|FG000|STARTED|Overall Study||694||
59795787|NCT00311155|75916817|FG000|COMPLETED|Overall Study|Some participants had multiple reasons for discontinuation|601||
59795788|NCT00311155|75916817|FG000|NOT COMPLETED|Overall Study||93||
59795789|NCT00274651|75916823|FG000|STARTED|Overall Study||29||
59795790|NCT00274651|75916824|FG001|STARTED|Overall Study||24||
59620340|NCT00167934|75731649|FG000|STARTED|Overall Study||82||
59620341|NCT00167934|75731650|FG001|STARTED|Overall Study||82||
59620342|NCT00167934|75731649|FG000|COMPLETED|Overall Study||82||
59620343|NCT00167934|75731650|FG001|COMPLETED|Overall Study||82||
59620344|NCT00167934|75731649|FG000|NOT COMPLETED|Overall Study||0||
59620345|NCT00167934|75731650|FG001|NOT COMPLETED|Overall Study||0||
59620346|NCT00168324|75731659|FG000|STARTED|Double-Blind Period||201||
59795791|NCT00274651|75916823|FG000|COMPLETED|Overall Study||1||
59795792|NCT00274651|75916824|FG001|COMPLETED|Overall Study||4||
59795793|NCT00274651|75916823|FG000|NOT COMPLETED|Overall Study||28||
59795794|NCT00274651|75916824|FG001|NOT COMPLETED|Overall Study||20||
59795795|NCT00274261|75916833|FG000|STARTED|Overall Study||932||
59795796|NCT00274261|75916834|FG001|STARTED|Overall Study||633||
59795797|NCT00274261|75916833|FG000|COMPLETED|Overall Study||443||
59795798|NCT00274261|75916834|FG001|COMPLETED|Overall Study||296||
59795799|NCT00274261|75916833|FG000|NOT COMPLETED|Overall Study||489||
59795800|NCT00274261|75916834|FG001|NOT COMPLETED|Overall Study||337||
59795801|NCT00624468|75916844|FG000|STARTED|Double-blind Period||17||
59795802|NCT00624468|75916845|FG001|STARTED|Double-blind Period||17||
59795803|NCT00624468|75916846|FG002|STARTED|Double-blind Period||0||
59795804|NCT00624468|75916847|FG003|STARTED|Double-blind Period||0||
59795805|NCT00624468|75916844|FG000|COMPLETED|Double-blind Period||3||
59795806|NCT00624468|75916845|FG001|COMPLETED|Double-blind Period||4||
59795807|NCT00624468|75916846|FG002|COMPLETED|Double-blind Period||0||
59795808|NCT00624468|75916847|FG003|COMPLETED|Double-blind Period||0||
59795809|NCT00624468|75916844|FG000|NOT COMPLETED|Double-blind Period||14||
59795810|NCT00624468|75916845|FG001|NOT COMPLETED|Double-blind Period||13||
59795811|NCT00624468|75916846|FG002|NOT COMPLETED|Double-blind Period||0||
59795812|NCT00624468|75916847|FG003|NOT COMPLETED|Double-blind Period||0||
59795813|NCT00624468|75916844|FG000|STARTED|Safety Follow-up (SFU) Period||0||
59795814|NCT00624468|75916845|FG001|STARTED|Safety Follow-up (SFU) Period||0||
59795815|NCT00624468|75916846|FG002|STARTED|Safety Follow-up (SFU) Period||13||
59795816|NCT00624468|75916847|FG003|STARTED|Safety Follow-up (SFU) Period||14||
59795817|NCT00624468|75916844|FG000|COMPLETED|Safety Follow-up (SFU) Period||0||
59795818|NCT00624468|75916845|FG001|COMPLETED|Safety Follow-up (SFU) Period||0||
59795819|NCT00624468|75916846|FG002|COMPLETED|Safety Follow-up (SFU) Period||11||
59795820|NCT00624468|75916847|FG003|COMPLETED|Safety Follow-up (SFU) Period||11||
59795821|NCT00624468|75916844|FG000|NOT COMPLETED|Safety Follow-up (SFU) Period||0||
59795822|NCT00624468|75916845|FG001|NOT COMPLETED|Safety Follow-up (SFU) Period||0||
59795823|NCT00624468|75916846|FG002|NOT COMPLETED|Safety Follow-up (SFU) Period||2||
59795824|NCT00624468|75916847|FG003|NOT COMPLETED|Safety Follow-up (SFU) Period||3||
59795825|NCT00521014|75916855|FG000|STARTED|Overall Study||14||
59795826|NCT00521014|75916855|FG000|COMPLETED|Overall Study||13||
59795827|NCT00521014|75916855|FG000|NOT COMPLETED|Overall Study||1||
59795828|NCT00560235|75916862|FG000|STARTED|Phase 1||10||
59795829|NCT00560235|75916863|FG001|STARTED|Phase 1||0||
59795830|NCT00560235|75916864|FG002|STARTED|Phase 1||0||
59795831|NCT00560235|75916862|FG000|COMPLETED|Phase 1||2||
59795832|NCT00560235|75916863|FG001|COMPLETED|Phase 1||0||
59795833|NCT00560235|75916864|FG002|COMPLETED|Phase 1||0||
59795834|NCT00560235|75916862|FG000|NOT COMPLETED|Phase 1||8||
59795835|NCT00560235|75916863|FG001|NOT COMPLETED|Phase 1||0||
59795836|NCT00560235|75916864|FG002|NOT COMPLETED|Phase 1||0||
59795837|NCT00560235|75916862|FG000|STARTED|Phase 1B||0||
59795838|NCT00560235|75916863|FG001|STARTED|Phase 1B||21||
59795839|NCT00560235|75916864|FG002|STARTED|Phase 1B||0||
59795840|NCT00560235|75916862|FG000|COMPLETED|Phase 1B||0||
59954293|NCT05101252|76072811|FG001|NOT COMPLETED|Overall Study||3||
59954294|NCT03316586|76072817|FG000|STARTED|Overall Study||18||
59795841|NCT00560235|75916863|FG001|COMPLETED|Phase 1B||2||
59795842|NCT00560235|75916864|FG002|COMPLETED|Phase 1B||0||
59795843|NCT00560235|75916862|FG000|NOT COMPLETED|Phase 1B||0||
59795844|NCT00560235|75916863|FG001|NOT COMPLETED|Phase 1B||19||
59795845|NCT00560235|75916864|FG002|NOT COMPLETED|Phase 1B||0||
59795846|NCT00560235|75916862|FG000|STARTED|Phase 2||0||
59954295|NCT03316586|76072817|FG000|COMPLETED|Overall Study||0||
59954296|NCT03316586|76072817|FG000|NOT COMPLETED|Overall Study||18||
59954297|NCT00107991|76072821|FG000|STARTED|Eligibility Assessment||38||
59954298|NCT00107991|76072821|FG000|COMPLETED|Eligibility Assessment||15||
59795847|NCT00560235|75916863|FG001|STARTED|Phase 2||0||
59795848|NCT00560235|75916864|FG002|STARTED|Phase 2||107||
59795849|NCT00560235|75916862|FG000|COMPLETED|Phase 2||0||
59795850|NCT00560235|75916863|FG001|COMPLETED|Phase 2||0||
59795851|NCT00560235|75916864|FG002|COMPLETED|Phase 2||10||
59795852|NCT00560235|75916862|FG000|NOT COMPLETED|Phase 2||0||
59795853|NCT00560235|75916863|FG001|NOT COMPLETED|Phase 2||0||
59795854|NCT00560235|75916864|FG002|NOT COMPLETED|Phase 2||97||
59795855|NCT00291577|75916882|FG000|STARTED|Overall Study||22||
59795856|NCT00291577|75916882|FG000|COMPLETED|Overall Study|Subject End of Study=Completed; not per protocol reason. PI reason=withdrawn during active treatment|1||
59795857|NCT00291577|75916882|FG000|NOT COMPLETED|Overall Study||21||
59795858|NCT00520936|75916894|FG000|STARTED|Overall Study|75 participants entered the study and 72 were enrolled and received study drug.|10||
59795859|NCT00520936|75916895|FG001|STARTED|Overall Study||11||
59795860|NCT00520936|75916896|FG002|STARTED|Overall Study||9||
59795861|NCT00520936|75916897|FG003|STARTED|Overall Study||5||
59795862|NCT00520936|75916898|FG004|STARTED|Overall Study||6||
59795863|NCT00520936|75916899|FG005|STARTED|Overall Study||10||
59795864|NCT00520936|75916900|FG006|STARTED|Overall Study||11||
59795865|NCT00520936|75916901|FG007|STARTED|Overall Study||10||
59795866|NCT00520936|75916894|FG000|COMPLETED|Overall Study|Study completion defined as treated until disease progression. Completed=progressive disease.|10||
59795867|NCT00520936|75916895|FG001|COMPLETED|Overall Study||7||
59795868|NCT00520936|75916896|FG002|COMPLETED|Overall Study||7||
59795869|NCT00520936|75916897|FG003|COMPLETED|Overall Study||5||
59795870|NCT00520936|75916898|FG004|COMPLETED|Overall Study||5||
59795871|NCT00520936|75916899|FG005|COMPLETED|Overall Study||10||
59795872|NCT00520936|75916900|FG006|COMPLETED|Overall Study||7||
59795873|NCT00520936|75916901|FG007|COMPLETED|Overall Study||9||
59795874|NCT00520936|75916894|FG000|NOT COMPLETED|Overall Study||0||
59795875|NCT00520936|75916895|FG001|NOT COMPLETED|Overall Study||4||
59795876|NCT00520936|75916896|FG002|NOT COMPLETED|Overall Study||2||
59795877|NCT00520936|75916897|FG003|NOT COMPLETED|Overall Study||0||
59795878|NCT00520936|75916898|FG004|NOT COMPLETED|Overall Study||1||
59795879|NCT00520936|75916899|FG005|NOT COMPLETED|Overall Study||0||
59795880|NCT00520936|75916900|FG006|NOT COMPLETED|Overall Study||4||
59795881|NCT00520936|75916901|FG007|NOT COMPLETED|Overall Study||1||
59795882|NCT03867760|75916914|FG000|STARTED|Overall Study||55||
59795883|NCT03867760|75916915|FG001|STARTED|Overall Study||54||
59795884|NCT03867760|75916914|FG000|COMPLETED|Overall Study||49||
59795885|NCT03867760|75916915|FG001|COMPLETED|Overall Study||46||
59795886|NCT03867760|75916914|FG000|NOT COMPLETED|Overall Study||6||
59795887|NCT03867760|75916915|FG001|NOT COMPLETED|Overall Study||8||
59795888|NCT03865732|75916925|FG000|STARTED|Overall Study||11||
59795889|NCT03865732|75916926|FG001|STARTED|Overall Study||10||
59795890|NCT03865732|75916925|FG000|COMPLETED|Overall Study||11||
59795891|NCT03865732|75916926|FG001|COMPLETED|Overall Study||9||
59795892|NCT03865732|75916925|FG000|NOT COMPLETED|Overall Study||0||
59795893|NCT03865732|75916926|FG001|NOT COMPLETED|Overall Study||1||
59795894|NCT00520546|75916933|FG000|STARTED|Overall Study||44||
59795895|NCT00520546|75916933|FG000|COMPLETED|Overall Study||38||
59795896|NCT00520546|75916933|FG000|NOT COMPLETED|Overall Study||6||
59795897|NCT00555009|75916944|FG000|STARTED|Overall Study||4||
59795898|NCT00555009|75916945|FG001|STARTED|Overall Study||6||
59795899|NCT00555009|75916944|FG000|COMPLETED|Overall Study||2||
59795900|NCT00555009|75916945|FG001|COMPLETED|Overall Study||0||
59795901|NCT00555009|75916944|FG000|NOT COMPLETED|Overall Study||2||
59795902|NCT00555009|75916945|FG001|NOT COMPLETED|Overall Study||6||
59795903|NCT00623766|75916953|FG000|STARTED|Induction Phase (Day 1 to Week 24)|Participants who received treatment|51||
59795904|NCT00623766|75916954|FG001|STARTED|Induction Phase (Day 1 to Week 24)|Participants who received treatment|21||
59795905|NCT00623766|75916953|FG000|COMPLETED|Induction Phase (Day 1 to Week 24)|4 patients completed Induction but did not enter Maintenance; they were only followed up with scans.|15||
59795906|NCT00623766|75916954|FG001|COMPLETED|Induction Phase (Day 1 to Week 24)|3 patients completed Induction but did not enter Maintenance; they were only followed up with scans.|5||
59795907|NCT00623766|75916953|FG000|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||36||
59795908|NCT00623766|75916954|FG001|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||16||
59795909|NCT00623766|75916953|FG000|STARTED|Maintenance Phase (Week 24 to Year 2)||11||
59795910|NCT00623766|75916954|FG001|STARTED|Maintenance Phase (Week 24 to Year 2)||2||
59795911|NCT00623766|75916953|FG000|COMPLETED|Maintenance Phase (Week 24 to Year 2)|Inadvertently not noted as discontinued (disease progression); data collection error at site closure|1||
59795912|NCT00623766|75916954|FG001|COMPLETED|Maintenance Phase (Week 24 to Year 2)||0||
59795913|NCT00623766|75916953|FG000|NOT COMPLETED|Maintenance Phase (Week 24 to Year 2)||10||
59795914|NCT00623766|75916954|FG001|NOT COMPLETED|Maintenance Phase (Week 24 to Year 2)||2||
59795915|NCT00550407|75916966|FG000|STARTED|8-16 Week Preliminary (Open-Label) Phase||215||
59795916|NCT00550407|75916967|FG001|STARTED|8-16 Week Preliminary (Open-Label) Phase||0||
59795917|NCT00550407|75916968|FG002|STARTED|8-16 Week Preliminary (Open-Label) Phase||0||
59795918|NCT00550407|75916966|FG000|COMPLETED|8-16 Week Preliminary (Open-Label) Phase||103||
59795919|NCT00550407|75916967|FG001|COMPLETED|8-16 Week Preliminary (Open-Label) Phase||0||
59795920|NCT00550407|75916968|FG002|COMPLETED|8-16 Week Preliminary (Open-Label) Phase||0||
59795921|NCT00550407|75916966|FG000|NOT COMPLETED|8-16 Week Preliminary (Open-Label) Phase||112||
59795922|NCT00550407|75916967|FG001|NOT COMPLETED|8-16 Week Preliminary (Open-Label) Phase||0||
59795923|NCT00550407|75916968|FG002|NOT COMPLETED|8-16 Week Preliminary (Open-Label) Phase||0||
59795924|NCT00550407|75916966|FG000|STARTED|26-Week Randomized Phase||0||
59795925|NCT00550407|75916967|FG001|STARTED|26-Week Randomized Phase||58||
60073566|NCT00089284|76188830|FG001|COMPLETED|Overall Study||3||
59795926|NCT00550407|75916968|FG002|STARTED|26-Week Randomized Phase||45||
59795927|NCT00550407|75916966|FG000|COMPLETED|26-Week Randomized Phase||0||
59795928|NCT00550407|75916967|FG001|COMPLETED|26-Week Randomized Phase||15||
59795929|NCT00550407|75916968|FG002|COMPLETED|26-Week Randomized Phase||21||
59795930|NCT00550407|75916966|FG000|NOT COMPLETED|26-Week Randomized Phase||0||
59795931|NCT00550407|75916967|FG001|NOT COMPLETED|26-Week Randomized Phase||43||
59795932|NCT00550407|75916968|FG002|NOT COMPLETED|26-Week Randomized Phase||24||
59795933|NCT00531934|75916978|FG000|STARTED|Overall Study||73||
59795934|NCT00531934|75916979|FG001|STARTED|Overall Study||74||
59795935|NCT00531934|75916978|FG000|COMPLETED|Overall Study||7||
59795936|NCT00531934|75916979|FG001|COMPLETED|Overall Study||11||
59795937|NCT00531934|75916978|FG000|NOT COMPLETED|Overall Study||66||
59795938|NCT00531934|75916979|FG001|NOT COMPLETED|Overall Study||63||
59795939|NCT00549939|75916988|FG000|STARTED|12-week Double Blind Treatment Period|29 (Alfuzosin 0.1 mg/kg/day matching placebo) + 28 (Alfuzosin 0.2 mg/kg/day matching placebo)|57||
59795940|NCT00549939|75916989|FG001|STARTED|12-week Double Blind Treatment Period||57||
59795941|NCT00549939|75916990|FG002|STARTED|12-week Double Blind Treatment Period||58||
59795942|NCT00549939|75916988|FG000|COMPLETED|12-week Double Blind Treatment Period||56||
59795943|NCT00549939|75916989|FG001|COMPLETED|12-week Double Blind Treatment Period||55||
59795944|NCT00549939|75916990|FG002|COMPLETED|12-week Double Blind Treatment Period||56||
59795945|NCT00549939|75916988|FG000|NOT COMPLETED|12-week Double Blind Treatment Period||1||
59795946|NCT00549939|75916989|FG001|NOT COMPLETED|12-week Double Blind Treatment Period||2||
59795947|NCT00549939|75916990|FG002|NOT COMPLETED|12-week Double Blind Treatment Period||2||
59795948|NCT00549939|75916988|FG000|STARTED|40-week Open Label Treatment Period|54 patients continued and switched to Alfuzosin: 26 to 0.1 mg/kg/day and 28 to 0.2 mg/kg/day.|0||
59795949|NCT00549939|75916989|FG001|STARTED|40-week Open Label Treatment Period|54 patients continued Alfuzosin 0.1 mg/kg/day and 26 patients started Alfuzosin 0.1 mg/kg/day.|80||
59795950|NCT00549939|75916990|FG002|STARTED|40-week Open Label Treatment Period|55 patients continued Alfuzosin 0.2 mg/kg/day and 28 patients started Alfuzosin 0.2 mg/kg/day.|83||
59795951|NCT00549939|75916988|FG000|COMPLETED|40-week Open Label Treatment Period||0||
59795952|NCT00549939|75916989|FG001|COMPLETED|40-week Open Label Treatment Period||75||
59795953|NCT00549939|75916990|FG002|COMPLETED|40-week Open Label Treatment Period||78||
59795954|NCT00549939|75916988|FG000|NOT COMPLETED|40-week Open Label Treatment Period||0||
59795955|NCT00549939|75916989|FG001|NOT COMPLETED|40-week Open Label Treatment Period||5||
59795956|NCT00549939|75916990|FG002|NOT COMPLETED|40-week Open Label Treatment Period||5||
59795957|NCT00272779|75917002|FG000|STARTED|Baseline Through Week 48|Number of participants randomized to ATV|440||
59795958|NCT00272779|75917003|FG001|STARTED|Baseline Through Week 48|Number of participants randomized to LPV|443||
59795959|NCT00272779|75917002|FG000|RECEIVED ANY TREATMENT|Baseline Through Week 48|1 participant randomized to LPV received ATV instead (treatment error)|441||
59795960|NCT00272779|75917003|FG001|RECEIVED ANY TREATMENT|Baseline Through Week 48|3 participants received ATV instead of LPV (treatment error), 3 participants never treated with LPV|437||
59795961|NCT00272779|75917002|FG000|TREATED AS RANDOMIZED|Baseline Through Week 48||438||
59795962|NCT00272779|75917003|FG001|TREATED AS RANDOMIZED|Baseline Through Week 48||440||
59795963|NCT00272779|75917002|FG000|Discontinued Before Week 48|Baseline Through Week 48||39||
59795964|NCT00272779|75917003|FG001|Discontinued Before Week 48|Baseline Through Week 48||58||
59795965|NCT00272779|75917002|FG000|Discontinued on or After Week 48|Baseline Through Week 48||14||
59795966|NCT00272779|75917003|FG001|Discontinued on or After Week 48|Baseline Through Week 48||14||
59795967|NCT00272779|75917002|FG000|STILL ON TREATMENT|Baseline Through Week 48||385||
59795968|NCT00272779|75917003|FG001|STILL ON TREATMENT|Baseline Through Week 48||368||
59795969|NCT00272779|75917002|FG000|COMPLETED|Baseline Through Week 48||0||
59795970|NCT00272779|75917003|FG001|COMPLETED|Baseline Through Week 48||0||
59795971|NCT00272779|75917002|FG000|NOT COMPLETED|Baseline Through Week 48||440||
59795972|NCT00272779|75917003|FG001|NOT COMPLETED|Baseline Through Week 48||443||
59795973|NCT00272779|75917002|FG000|STARTED|Baseline Through Week 96|Number randomized to ATV|440||
59795974|NCT00272779|75917003|FG001|STARTED|Baseline Through Week 96|Number randomized to LPV|443||
59795975|NCT00272779|75917002|FG000|RECEIVED ANY TREATMENT|Baseline Through Week 96|1 participant randomized to LPV received ATV instead (treatment error)|441||
59795976|NCT00272779|75917003|FG001|RECEIVED ANY TREATMENT|Baseline Through Week 96|3 participants received ATV instead of LPV (treatment error) and 3 participants never treated|437||
59795977|NCT00272779|75917002|FG000|COMPLETED|Baseline Through Week 96||301||
59795978|NCT00272779|75917003|FG001|COMPLETED|Baseline Through Week 96||307||
59795979|NCT00272779|75917002|FG000|NOT COMPLETED|Baseline Through Week 96||139||
59795980|NCT00272779|75917003|FG001|NOT COMPLETED|Baseline Through Week 96||136||
59795981|NCT00511810|75917012|FG000|STARTED|Overall Study||8||
59795982|NCT00511810|75917013|FG001|STARTED|Overall Study||12||
59795983|NCT00511810|75917012|FG000|COMPLETED|Overall Study||7||
59795984|NCT00511810|75917013|FG001|COMPLETED|Overall Study|2 terminated for worsening symptoms;1 refused a scan;2 lost to follow up (could not be contacted)|7||
59795985|NCT00511810|75917012|FG000|NOT COMPLETED|Overall Study||1||
59795986|NCT00511810|75917013|FG001|NOT COMPLETED|Overall Study||5||
59795987|NCT00291499|75917021|FG000|STARTED|Overall Study||81||
59795988|NCT00291499|75917022|FG001|STARTED|Overall Study||82||
59795989|NCT00291499|75917021|FG000|Intention to Treat (ITT)|Overall Study||80||
59795990|NCT00291499|75917022|FG001|Intention to Treat (ITT)|Overall Study||82||
59795991|NCT00291499|75917021|FG000|Per Protocol (PP)|Overall Study||72||
59795992|NCT00291499|75917022|FG001|Per Protocol (PP)|Overall Study||67||
59795993|NCT00291499|75917021|FG000|Safety Population|Overall Study||81||
59795994|NCT00291499|75917022|FG001|Safety Population|Overall Study||82||
59795995|NCT00291499|75917021|FG000|COMPLETED|Overall Study||72||
59795996|NCT00291499|75917022|FG001|COMPLETED|Overall Study||67||
59795997|NCT00291499|75917021|FG000|NOT COMPLETED|Overall Study||9||
59795998|NCT00291499|75917022|FG001|NOT COMPLETED|Overall Study||15||
59795999|NCT00553605|75917030|FG000|STARTED|Overall Study||176||
59796000|NCT00553605|75917031|FG001|STARTED|Overall Study||164||
59796001|NCT00553605|75917030|FG000|Treated|Overall Study||174||
59796002|NCT00553605|75917031|FG001|Treated|Overall Study||164||
59796003|NCT00553605|75917030|FG000|COMPLETED|Overall Study||172||
59796004|NCT00553605|75917031|FG001|COMPLETED|Overall Study||161||
59796005|NCT00553605|75917030|FG000|NOT COMPLETED|Overall Study||4||
59796006|NCT00553605|75917031|FG001|NOT COMPLETED|Overall Study||3||
59796007|NCT00621582|75917037|FG000|STARTED|Overall Study||4918||
59796008|NCT00621582|75917037|FG000|COMPLETED|Overall Study||4812||
59796009|NCT00621582|75917037|FG000|NOT COMPLETED|Overall Study||106||
59796010|NCT00744497|75917043|FG000|STARTED|Overall Study|Randomized|760||
59796011|NCT00744497|75917044|FG001|STARTED|Overall Study|Randomized|762||
59796012|NCT00744497|75917043|FG000|Received Treatment|Overall Study||757||
59796013|NCT00744497|75917044|FG001|Received Treatment|Overall Study||761||
59796014|NCT00744497|75917043|FG000|COMPLETED|Overall Study||0||
59796015|NCT00744497|75917044|FG001|COMPLETED|Overall Study||0||
59796016|NCT00744497|75917043|FG000|NOT COMPLETED|Overall Study||760||
59796017|NCT00744497|75917044|FG001|NOT COMPLETED|Overall Study||762||
59796018|NCT00747227|75917052|FG000|STARTED|Overall Study||126||
59796019|NCT00747227|75917053|FG001|STARTED|Overall Study||124||
59796020|NCT00747227|75917052|FG000|COMPLETED|Overall Study||120||
59796021|NCT00747227|75917053|FG001|COMPLETED|Overall Study||120||
59796022|NCT00747227|75917052|FG000|NOT COMPLETED|Overall Study||6||
59796023|NCT00747227|75917053|FG001|NOT COMPLETED|Overall Study||4||
59796024|NCT00747149|75917061|FG000|STARTED|Overall Study||154||
59796025|NCT00747149|75917062|FG001|STARTED|Overall Study||444||
59796026|NCT00747149|75917061|FG000|COMPLETED|Overall Study||153||
59796027|NCT00747149|75917062|FG001|COMPLETED|Overall Study||401||
59796028|NCT00747149|75917061|FG000|NOT COMPLETED|Overall Study||1||
59796029|NCT00747149|75917062|FG001|NOT COMPLETED|Overall Study||43||
59796030|NCT00271609|75917076|FG000|STARTED|Overall Study||56||
59796031|NCT00271609|75917077|FG001|STARTED|Overall Study||32||
59796032|NCT00271609|75917076|FG000|COMPLETED|Overall Study||43||
59796033|NCT00271609|75917077|FG001|COMPLETED|Overall Study||29||
59796034|NCT00271609|75917076|FG000|NOT COMPLETED|Overall Study||13||
59796035|NCT00271609|75917077|FG001|NOT COMPLETED|Overall Study||3||
59796036|NCT00548847|75917083|FG000|STARTED|Overall Study||15||
59796037|NCT00548847|75917083|FG000|COMPLETED|Overall Study||8||
59796038|NCT00548847|75917083|FG000|NOT COMPLETED|Overall Study||7||
59796039|NCT00290407|75917087|FG000|STARTED|Overall Study||2||
59796040|NCT00290407|75917087|FG000|COMPLETED|Overall Study||0||
59796041|NCT00290407|75917087|FG000|NOT COMPLETED|Overall Study||2||
59796042|NCT00749411|75917093|FG000|STARTED|Overall Study||21||
59796043|NCT00749411|75917094|FG001|STARTED|Overall Study||40||
59796044|NCT00749411|75917093|FG000|COMPLETED|Overall Study||20||
59796045|NCT00749411|75917094|FG001|COMPLETED|Overall Study||35||
59796046|NCT00749411|75917093|FG000|NOT COMPLETED|Overall Study||1||
59796047|NCT00749411|75917094|FG001|NOT COMPLETED|Overall Study||5||
59796048|NCT03958149|75917102|FG000|STARTED|Overall Study||20||
59796049|NCT03958149|75917103|FG001|STARTED|Overall Study||18||
59796050|NCT03958149|75917102|FG000|COMPLETED|Overall Study||20||
59796051|NCT03958149|75917103|FG001|COMPLETED|Overall Study||17||
59796052|NCT03958149|75917102|FG000|NOT COMPLETED|Overall Study||0||
59796053|NCT03958149|75917103|FG001|NOT COMPLETED|Overall Study||1||
59796054|NCT00549549|75917117|FG000|STARTED|Overall Study||101||
59796055|NCT00549549|75917118|FG001|STARTED|Overall Study||99||
59796056|NCT00549549|75917119|FG002|STARTED|Overall Study||99||
59796057|NCT00549549|75917120|FG003|STARTED|Overall Study||103||
59796058|NCT00549549|75917117|FG000|Treated|Overall Study||101||
59796059|NCT00549549|75917118|FG001|Treated|Overall Study||99||
59796060|NCT00549549|75917119|FG002|Treated|Overall Study||98||
59796061|NCT00549549|75917120|FG003|Treated|Overall Study||102||
59796062|NCT00549549|75917117|FG000|COMPLETED|Overall Study||77||
59796063|NCT00549549|75917118|FG001|COMPLETED|Overall Study||77||
59796064|NCT00549549|75917119|FG002|COMPLETED|Overall Study||82||
59796065|NCT00549549|75917120|FG003|COMPLETED|Overall Study||78||
59796066|NCT00549549|75917117|FG000|NOT COMPLETED|Overall Study||24||
59796067|NCT00549549|75917118|FG001|NOT COMPLETED|Overall Study||22||
59796068|NCT00549549|75917119|FG002|NOT COMPLETED|Overall Study||17||
59796069|NCT00549549|75917120|FG003|NOT COMPLETED|Overall Study||25||
59796070|NCT00270205|75917134|FG000|STARTED|Overall Study||6||
59796071|NCT00270205|75917135|FG001|STARTED|Overall Study|7 participants enrolled. One never started study vaccination and was excluded from all analyses.|6||
59796072|NCT00270205|75917136|FG002|STARTED|Overall Study||6||
59796073|NCT00270205|75917137|FG003|STARTED|Overall Study||7||
59796074|NCT00270205|75917134|FG000|COMPLETED|Overall Study||5||
59796075|NCT00270205|75917135|FG001|COMPLETED|Overall Study||6||
59796076|NCT00270205|75917136|FG002|COMPLETED|Overall Study||6||
59796077|NCT00270205|75917137|FG003|COMPLETED|Overall Study||6||
59796078|NCT00270205|75917134|FG000|NOT COMPLETED|Overall Study||1||
59796079|NCT00270205|75917135|FG001|NOT COMPLETED|Overall Study||0||
59796080|NCT00270205|75917136|FG002|NOT COMPLETED|Overall Study||0||
59796081|NCT00270205|75917137|FG003|NOT COMPLETED|Overall Study||1||
59796082|NCT00622284|75917149|FG000|STARTED|Overall Study|Number who started treatment. One patient in the Linagliptin group was randomized but not treated.|776||
59796083|NCT00622284|75917150|FG001|STARTED|Overall Study|Number who started treatment.|775||
59796084|NCT00622284|75917149|FG000|COMPLETED|Overall Study|Number who completed treatment.|587||
59796085|NCT00622284|75917150|FG001|COMPLETED|Overall Study|Number who completed treatment.|604||
59796086|NCT00622284|75917149|FG000|NOT COMPLETED|Overall Study||189||
59796087|NCT00622284|75917150|FG001|NOT COMPLETED|Overall Study||171||
59796088|NCT00269113|75917158|FG000|STARTED|Overall Study||177||
59796089|NCT00269113|75917159|FG001|STARTED|Overall Study||183||
59796090|NCT00269113|75917158|FG000|COMPLETED|Overall Study||103||
59796091|NCT00269113|75917159|FG001|COMPLETED|Overall Study||146||
59796092|NCT00269113|75917158|FG000|NOT COMPLETED|Overall Study||74||
59796093|NCT00269113|75917159|FG001|NOT COMPLETED|Overall Study||37||
59796094|NCT00291187|75917169|FG000|STARTED|Overall Study||103||
59796095|NCT00291187|75917170|FG001|STARTED|Overall Study||100||
59796096|NCT00291187|75917171|FG002|STARTED|Overall Study||103||
59796097|NCT00291187|75917172|FG003|STARTED|Overall Study||106||
59796098|NCT00291187|75917169|FG000|COMPLETED|Overall Study||103||
59796099|NCT00291187|75917170|FG001|COMPLETED|Overall Study||100||
59796100|NCT00291187|75917171|FG002|COMPLETED|Overall Study||102||
59796101|NCT00291187|75917172|FG003|COMPLETED|Overall Study||106||
59796102|NCT00291187|75917169|FG000|NOT COMPLETED|Overall Study||0||
59796103|NCT00291187|75917170|FG001|NOT COMPLETED|Overall Study||0||
59796104|NCT00291187|75917171|FG002|NOT COMPLETED|Overall Study||1||
59796105|NCT00291187|75917172|FG003|NOT COMPLETED|Overall Study||0||
59796106|NCT00546819|75917188|FG000|STARTED|Overall Study||207||
59796107|NCT00546819|75917189|FG001|STARTED|Overall Study||102||
59796108|NCT00546819|75917188|FG000|VACCINATED|Overall Study||206||
59796109|NCT00546819|75917189|FG001|VACCINATED|Overall Study||100||
59796110|NCT00546819|75917188|FG000|COMPLETED|Overall Study||199||
59796111|NCT00546819|75917189|FG001|COMPLETED|Overall Study||96||
59796112|NCT00546819|75917188|FG000|NOT COMPLETED|Overall Study||8||
59796113|NCT00546819|75917189|FG001|NOT COMPLETED|Overall Study||6||
59796114|NCT00621504|75917197|FG000|STARTED|Overall Study||299||
59796115|NCT00621504|75917198|FG001|STARTED|Overall Study||307||
59796116|NCT00621504|75917197|FG000|COMPLETED|Overall Study||273||
59796117|NCT00621504|75917198|FG001|COMPLETED|Overall Study||282||
59796118|NCT00621504|75917197|FG000|NOT COMPLETED|Overall Study||26||
59796119|NCT00621504|75917198|FG001|NOT COMPLETED|Overall Study||25||
59796120|NCT00548145|75917206|FG000|STARTED|Overall Study||18||
59796121|NCT00548145|75917207|FG001|STARTED|Overall Study||20||
59796122|NCT00548145|75917206|FG000|COMPLETED|Overall Study||17||
59796123|NCT00548145|75917207|FG001|COMPLETED|Overall Study||16||
59796124|NCT00548145|75917206|FG000|NOT COMPLETED|Overall Study||1||
59796125|NCT00548145|75917207|FG001|NOT COMPLETED|Overall Study||4||
59796126|NCT00547911|75917217|FG000|STARTED|Overall Study||2||
59796127|NCT00547911|75917218|FG001|STARTED|Overall Study||2||
59796128|NCT00547911|75917219|FG002|STARTED|Overall Study||2||
59796129|NCT00547911|75917220|FG003|STARTED|Overall Study||2||
59796130|NCT00547911|75917221|FG004|STARTED|Overall Study||3||
59796131|NCT00547911|75917222|FG005|STARTED|Overall Study||3||
59796132|NCT00547911|75917217|FG000|COMPLETED|Overall Study||2||
59796133|NCT00547911|75917218|FG001|COMPLETED|Overall Study||2||
59796134|NCT00547911|75917219|FG002|COMPLETED|Overall Study||2||
59796135|NCT00547911|75917220|FG003|COMPLETED|Overall Study||1||
59796136|NCT00547911|75917221|FG004|COMPLETED|Overall Study||3||
59796137|NCT00547911|75917222|FG005|COMPLETED|Overall Study||3||
59796138|NCT00547911|75917217|FG000|NOT COMPLETED|Overall Study||0||
59796139|NCT00547911|75917218|FG001|NOT COMPLETED|Overall Study||0||
59796140|NCT00547911|75917219|FG002|NOT COMPLETED|Overall Study||0||
59954299|NCT00107991|76072821|FG000|NOT COMPLETED|Eligibility Assessment||23||
59954300|NCT00107991|76072821|FG000|STARTED|12 Week Treatment Period||15||
59954301|NCT00107991|76072821|FG000|COMPLETED|12 Week Treatment Period||10||
59954302|NCT00107991|76072821|FG000|NOT COMPLETED|12 Week Treatment Period||5||
59796141|NCT00547911|75917220|FG003|NOT COMPLETED|Overall Study||1||
59796142|NCT00547911|75917221|FG004|NOT COMPLETED|Overall Study||0||
59796143|NCT00547911|75917222|FG005|NOT COMPLETED|Overall Study||0||
59796144|NCT00289783|75917237|FG000|STARTED|Primary Phase||3136||
59796145|NCT00289783|75917238|FG001|STARTED|Primary Phase||1044||
59796146|NCT00289783|75917237|FG000|COMPLETED|Primary Phase||2888||
59796147|NCT00289783|75917238|FG001|COMPLETED|Primary Phase||961||
59796148|NCT00289783|75917237|FG000|NOT COMPLETED|Primary Phase||248||
59796149|NCT00289783|75917238|FG001|NOT COMPLETED|Primary Phase||83||
59796150|NCT00289783|75917237|FG000|STARTED|Fourth Dose Phase||2769||
59796151|NCT00289783|75917238|FG001|STARTED|Fourth Dose Phase||923||
59796152|NCT00289783|75917237|FG000|COMPLETED|Fourth Dose Phase||2682||
59954303|NCT00107991|76072821|FG000|STARTED|18-Week Post Treatment Assessment||10||
59954304|NCT00107991|76072821|FG000|COMPLETED|18-Week Post Treatment Assessment||8||
60073567|NCT00089284|76188831|FG002|COMPLETED|Overall Study||6||
59796153|NCT00289783|75917238|FG001|COMPLETED|Fourth Dose Phase||899||
59796154|NCT00289783|75917237|FG000|NOT COMPLETED|Fourth Dose Phase||87||
59796155|NCT00289783|75917238|FG001|NOT COMPLETED|Fourth Dose Phase||24||
59796156|NCT00574080|75917254|FG000|STARTED|Overall Study||10||
59796157|NCT00574080|75917255|FG001|STARTED|Overall Study||10||
59796158|NCT00574080|75917254|FG000|COMPLETED|Overall Study||0||
59796159|NCT00574080|75917255|FG001|COMPLETED|Overall Study||0||
59796160|NCT00574080|75917254|FG000|NOT COMPLETED|Overall Study||10||
59796161|NCT00574080|75917255|FG001|NOT COMPLETED|Overall Study||10||
59796162|NCT00267865|75917261|FG000|STARTED|Induction Treatment||12||
59796163|NCT00267865|75917261|FG000|COMPLETED|Induction Treatment||9||
59796164|NCT00267865|75917261|FG000|NOT COMPLETED|Induction Treatment||3||
59796165|NCT00267865|75917261|FG000|STARTED|Consolidation Treatment||5||
59796166|NCT00267865|75917261|FG000|COMPLETED|Consolidation Treatment||5||
59796167|NCT00267865|75917261|FG000|NOT COMPLETED|Consolidation Treatment||0||
59796168|NCT00546117|75917267|FG000|STARTED|Overall Study||9||
59796169|NCT00546117|75917268|FG001|STARTED|Overall Study||7||
59796170|NCT00546117|75917267|FG000|COMPLETED|Overall Study||5||
59796171|NCT00546117|75917268|FG001|COMPLETED|Overall Study||7||
59796172|NCT00546117|75917267|FG000|NOT COMPLETED|Overall Study||4||
59796173|NCT00546117|75917268|FG001|NOT COMPLETED|Overall Study||0||
59796174|NCT00251719|75917279|FG000|STARTED|Overall Study||694||
59796175|NCT00251719|75917280|FG001|STARTED|Overall Study||687||
59796176|NCT00251719|75917281|FG002|STARTED|Overall Study||673||
59796177|NCT00251719|75917279|FG000|COMPLETED|Overall Study||641||
59796178|NCT00251719|75917280|FG001|COMPLETED|Overall Study||642||
59796179|NCT00251719|75917281|FG002|COMPLETED|Overall Study||643||
59796180|NCT00251719|75917279|FG000|NOT COMPLETED|Overall Study||53||
59796181|NCT00251719|75917280|FG001|NOT COMPLETED|Overall Study||45||
59796182|NCT00251719|75917281|FG002|NOT COMPLETED|Overall Study||30||
59796183|NCT03952143|75917291|FG000|STARTED|Lead-In Period||628||
59796184|NCT03952143|75917292|FG001|STARTED|Lead-In Period||0||
59796185|NCT03952143|75917293|FG002|STARTED|Lead-In Period||0||
59796186|NCT03952143|75917291|FG000|Participants Who Received at Least One Dose|Lead-In Period||628||
59796187|NCT03952143|75917292|FG001|Participants Who Received at Least One Dose|Lead-In Period||0||
59523466|NCT02389946|75618296|FG000|NOT COMPLETED|Overall Study||24||
59523467|NCT02389946|75618297|FG001|NOT COMPLETED|Overall Study||15||
59523468|NCT00245128|75618303|FG000|STARTED|Overall Study||10||
59523469|NCT00245128|75618303|FG000|COMPLETED|Overall Study||0||
59523470|NCT00245128|75618303|FG000|NOT COMPLETED|Overall Study||10||
59523471|NCT00268450|75618307|FG000|STARTED|Overall Study||21||
59523472|NCT00268450|75618307|FG000|COMPLETED|Overall Study||21||
59523473|NCT00268450|75618307|FG000|NOT COMPLETED|Overall Study||0||
59523474|NCT00177970|75618313|FG000|STARTED|Overall Study|No results available record destroyed due to age of study. no publications|0||
59523475|NCT00177970|75618314|FG001|STARTED|Overall Study|No results available record destroyed due to age of study. no publications|0||
59523476|NCT00177970|75618313|FG000|COMPLETED|Overall Study|No results available record destroyed due to age of study. no publications|0||
59523477|NCT00177970|75618314|FG001|COMPLETED|Overall Study|No results available record destroyed due to age of study. no publications|0||
59523478|NCT00177970|75618313|FG000|NOT COMPLETED|Overall Study||0||
59523479|NCT00177970|75618314|FG001|NOT COMPLETED|Overall Study||0||
59523480|NCT00088972|75618322|FG000|STARTED|Overall Study||3||
59523481|NCT00088972|75618323|FG001|STARTED|Overall Study||5||
59523482|NCT00088972|75618322|FG000|COMPLETED|Overall Study||1||
59523483|NCT00088972|75618323|FG001|COMPLETED|Overall Study||1||
59523484|NCT00088972|75618322|FG000|NOT COMPLETED|Overall Study||2||
59523485|NCT00088972|75618323|FG001|NOT COMPLETED|Overall Study||4||
59523486|NCT00089128|75618329|FG000|STARTED|Overall Study||16||
59796188|NCT03952143|75917293|FG002|Participants Who Received at Least One Dose|Lead-In Period||0||
59796189|NCT03952143|75917291|FG000|COMPLETED|Lead-In Period||595||
59796190|NCT03952143|75917292|FG001|COMPLETED|Lead-In Period||0||
59523487|NCT00089128|75618329|FG000|COMPLETED|Overall Study||16||
59523488|NCT00089128|75618329|FG000|NOT COMPLETED|Overall Study||0||
59523489|NCT00014560|75618333|FG000|STARTED|Overall Study||3||
59796191|NCT03952143|75917293|FG002|COMPLETED|Lead-In Period||0||
59796192|NCT03952143|75917291|FG000|NOT COMPLETED|Lead-In Period||33||
59796193|NCT03952143|75917292|FG001|NOT COMPLETED|Lead-In Period||0||
59796194|NCT03952143|75917293|FG002|NOT COMPLETED|Lead-In Period||0||
59796195|NCT03952143|75917291|FG000|STARTED|Treatment Period|Participants received Insulin Lispro during Lead-in Period|0||
59796196|NCT03952143|75917292|FG001|STARTED|Treatment Period|Participants were randomized to either Insulin lispro or LY900014 in Treatment Period.|200||
59796197|NCT03952143|75917293|FG002|STARTED|Treatment Period|Participants were randomized to either Insulin lispro or LY900014 in Treatment Period.|395||
59796198|NCT03952143|75917291|FG000|Participants Who Received at Least One Dose|Treatment Period||0||
59796199|NCT03952143|75917292|FG001|Participants Who Received at Least One Dose|Treatment Period||200||
59796200|NCT03952143|75917293|FG002|Participants Who Received at Least One Dose|Treatment Period||395||
59796201|NCT03952143|75917291|FG000|COMPLETED|Treatment Period||0||
59523490|NCT00014560|75618333|FG000|COMPLETED|Overall Study||0||
59523491|NCT00014560|75618333|FG000|NOT COMPLETED|Overall Study||3||
59796202|NCT03952143|75917292|FG001|COMPLETED|Treatment Period||191||
59796203|NCT03952143|75917293|FG002|COMPLETED|Treatment Period||359||
59796204|NCT03952143|75917291|FG000|NOT COMPLETED|Treatment Period||0||
59796205|NCT03952143|75917292|FG001|NOT COMPLETED|Treatment Period||9||
59796206|NCT03952143|75917293|FG002|NOT COMPLETED|Treatment Period||36||
59796207|NCT00267007|75917302|FG000|STARTED|Overall Study|2 additional patients were randomized but never received study medication and no data were collected|19||
59796208|NCT00267007|75917303|FG001|STARTED|Overall Study||11||
59796209|NCT00267007|75917302|FG000|COMPLETED|Overall Study||11||
59796210|NCT00267007|75917303|FG001|COMPLETED|Overall Study||10||
59796211|NCT00267007|75917302|FG000|NOT COMPLETED|Overall Study||8||
59796212|NCT00267007|75917303|FG001|NOT COMPLETED|Overall Study||1||
59796213|NCT03943095|75917311|FG000|STARTED|Overall Study||52||
59796214|NCT03943095|75917312|FG001|STARTED|Overall Study||52||
59796215|NCT03943095|75917311|FG000|COMPLETED|Overall Study||51||
59796216|NCT03943095|75917312|FG001|COMPLETED|Overall Study||51||
59796217|NCT03943095|75917311|FG000|NOT COMPLETED|Overall Study||1||
59796218|NCT03943095|75917312|FG001|NOT COMPLETED|Overall Study||1||
59796219|NCT00251641|75917321|FG000|STARTED|Overall Study||653||
59796220|NCT00251641|75917322|FG001|STARTED|Overall Study||215||
59796221|NCT00251641|75917321|FG000|COMPLETED|Overall Study||541||
59796222|NCT00251641|75917322|FG001|COMPLETED|Overall Study||127||
59796223|NCT00251641|75917321|FG000|NOT COMPLETED|Overall Study||112||
59796224|NCT00251641|75917322|FG001|NOT COMPLETED|Overall Study||88||
59796225|NCT00250705|75917330|FG000|STARTED|Overall Study||12||
59796226|NCT00250705|75917330|FG000|COMPLETED|Overall Study||10||
59796227|NCT00250705|75917330|FG000|NOT COMPLETED|Overall Study||2||
59796228|NCT00266695|75917336|FG000|STARTED|Overall Study||203||
59796229|NCT00266695|75917336|FG000|COMPLETED|Overall Study||174||
59796230|NCT00266695|75917336|FG000|NOT COMPLETED|Overall Study||29||
59796231|NCT00620022|75917340|FG000|STARTED|Treatment Period 1||46||
59796232|NCT00620022|75917341|FG001|STARTED|Treatment Period 1|Of 44 randomized patients, 1 patient discontinued before receiving any study treatment.|43||
59796233|NCT00620022|75917340|FG000|COMPLETED|Treatment Period 1||41||
59796234|NCT00620022|75917341|FG001|COMPLETED|Treatment Period 1||37||
59796235|NCT00620022|75917340|FG000|NOT COMPLETED|Treatment Period 1||5||
59796236|NCT00620022|75917341|FG001|NOT COMPLETED|Treatment Period 1||6||
59796237|NCT00620022|75917340|FG000|STARTED|Treatment Period 2||41||
59796238|NCT00620022|75917341|FG001|STARTED|Treatment Period 2||37||
59796239|NCT00620022|75917340|FG000|COMPLETED|Treatment Period 2||39||
59796240|NCT00620022|75917341|FG001|COMPLETED|Treatment Period 2||35||
59796241|NCT00620022|75917340|FG000|NOT COMPLETED|Treatment Period 2||2||
59796242|NCT00620022|75917341|FG001|NOT COMPLETED|Treatment Period 2||2||
59796243|NCT00547521|75917349|FG000|STARTED|Short Term Study (4 Months)|Number of participants treated.|51||
59796244|NCT00547521|75917350|FG001|STARTED|Short Term Study (4 Months)|Number of participants treated.|49||
59796245|NCT00547521|75917349|FG000|COMPLETED|Short Term Study (4 Months)||50||
59796246|NCT00547521|75917350|FG001|COMPLETED|Short Term Study (4 Months)||45||
59796247|NCT00547521|75917349|FG000|NOT COMPLETED|Short Term Study (4 Months)||1||
59796248|NCT00547521|75917350|FG001|NOT COMPLETED|Short Term Study (4 Months)||4||
59796249|NCT00547521|75917349|FG000|STARTED|Long Term Extension (LTE) Study|ST Study had 2 arms, LTE Study pooled all participants who had abatacept injection.|0||
59796250|NCT00547521|75917350|FG001|STARTED|Long Term Extension (LTE) Study|ST Study had 2 arms, LTE Study pooled all participants who had abatacept injection.|90||
59796251|NCT00547521|75917349|FG000|COMPLETED|Long Term Extension (LTE) Study||0||
59796252|NCT00547521|75917350|FG001|COMPLETED|Long Term Extension (LTE) Study||59||
59796253|NCT00547521|75917349|FG000|NOT COMPLETED|Long Term Extension (LTE) Study||0||
59796254|NCT00547521|75917350|FG001|NOT COMPLETED|Long Term Extension (LTE) Study||31||
59796255|NCT00266227|75917365|FG000|STARTED|Initial Treatment||0||
59796256|NCT00266227|75917366|FG001|STARTED|Initial Treatment||0||
59796257|NCT00266227|75917367|FG002|STARTED|Initial Treatment||559||
60073568|NCT00089284|76188832|FG003|COMPLETED|Overall Study||6||
60073569|NCT00089284|76188833|FG004|COMPLETED|Overall Study||0||
60073570|NCT00089284|76188834|FG005|COMPLETED|Overall Study||0||
60073571|NCT00089284|76188835|FG006|COMPLETED|Overall Study||7||
59796258|NCT00266227|75917365|FG000|COMPLETED|Initial Treatment||0||
59796259|NCT00266227|75917366|FG001|COMPLETED|Initial Treatment||0||
59796260|NCT00266227|75917367|FG002|COMPLETED|Initial Treatment||482||
59796261|NCT00266227|75917365|FG000|NOT COMPLETED|Initial Treatment||0||
59796262|NCT00266227|75917366|FG001|NOT COMPLETED|Initial Treatment||0||
59796263|NCT00266227|75917367|FG002|NOT COMPLETED|Initial Treatment||77||
59796264|NCT00266227|75917365|FG000|STARTED|Retreatment: Up to Week 48||318||
59796265|NCT00266227|75917366|FG001|STARTED|Retreatment: Up to Week 48||157||
59796266|NCT00266227|75917367|FG002|STARTED|Retreatment: Up to Week 48||0||
59796267|NCT00266227|75917365|FG000|COMPLETED|Retreatment: Up to Week 48||291||
59796268|NCT00266227|75917366|FG001|COMPLETED|Retreatment: Up to Week 48||134||
59796269|NCT00266227|75917367|FG002|COMPLETED|Retreatment: Up to Week 48||0||
59796270|NCT00266227|75917365|FG000|NOT COMPLETED|Retreatment: Up to Week 48||27||
59796271|NCT00266227|75917366|FG001|NOT COMPLETED|Retreatment: Up to Week 48||23||
59796272|NCT00266227|75917367|FG002|NOT COMPLETED|Retreatment: Up to Week 48||0||
59796273|NCT00266227|75917365|FG000|STARTED|Retreatment: Week 48 to Week 72||291||
59796274|NCT00266227|75917366|FG001|STARTED|Retreatment: Week 48 to Week 72||134||
59796275|NCT00266227|75917367|FG002|STARTED|Retreatment: Week 48 to Week 72||0||
59796276|NCT00266227|75917365|FG000|COMPLETED|Retreatment: Week 48 to Week 72||227||
60073572|NCT00089284|76188829|FG000|NOT COMPLETED|Overall Study||0||
59796277|NCT00266227|75917366|FG001|COMPLETED|Retreatment: Week 48 to Week 72||92||
59796278|NCT00266227|75917367|FG002|COMPLETED|Retreatment: Week 48 to Week 72||0||
59796279|NCT00266227|75917365|FG000|NOT COMPLETED|Retreatment: Week 48 to Week 72||64||
59796280|NCT00266227|75917366|FG001|NOT COMPLETED|Retreatment: Week 48 to Week 72||42||
59796281|NCT00266227|75917367|FG002|NOT COMPLETED|Retreatment: Week 48 to Week 72||0||
59796282|NCT00287365|75917376|FG000|STARTED|Overall Study||25||
59796283|NCT00287365|75917376|FG000|COMPLETED|Overall Study||12||
59796284|NCT00287365|75917376|FG000|NOT COMPLETED|Overall Study||13||
59796285|NCT00573768|75917384|FG000|STARTED|Overall Study||89||
59796286|NCT00573768|75917385|FG001|STARTED|Overall Study||91||
59796287|NCT00573768|75917386|FG002|STARTED|Overall Study||91||
59796288|NCT00573768|75917384|FG000|COMPLETED|Overall Study||87||
59796289|NCT00573768|75917385|FG001|COMPLETED|Overall Study||89||
59796290|NCT00573768|75917386|FG002|COMPLETED|Overall Study||87||
59796291|NCT00573768|75917384|FG000|NOT COMPLETED|Overall Study||2||
59796292|NCT00573768|75917385|FG001|NOT COMPLETED|Overall Study||2||
59796293|NCT00573768|75917386|FG002|NOT COMPLETED|Overall Study||4||
59796294|NCT00547365|75917394|FG000|STARTED|Overall Study||10||
59796295|NCT00547365|75917394|FG000|COMPLETED|Overall Study||2||
59796296|NCT00547365|75917394|FG000|NOT COMPLETED|Overall Study||8||
59796297|NCT00619866|75917402|FG000|STARTED|Weeks 1 - 12||52||
59796298|NCT00619866|75917403|FG001|STARTED|Weeks 1 - 12||51||
59796299|NCT00619866|75917404|FG002|STARTED|Weeks 1 - 12||52||
59796300|NCT00619866|75917405|FG003|STARTED|Weeks 1 - 12||0||
59796301|NCT00619866|75917406|FG004|STARTED|Weeks 1 - 12||0||
59796302|NCT00619866|75917402|FG000|COMPLETED|Weeks 1 - 12||38||
59796303|NCT00619866|75917403|FG001|COMPLETED|Weeks 1 - 12||45||
59796304|NCT00619866|75917404|FG002|COMPLETED|Weeks 1 - 12||42||
59796305|NCT00619866|75917405|FG003|COMPLETED|Weeks 1 - 12||0||
59796306|NCT00619866|75917406|FG004|COMPLETED|Weeks 1 - 12||0||
59796307|NCT00619866|75917402|FG000|NOT COMPLETED|Weeks 1 - 12||14||
59796308|NCT00619866|75917403|FG001|NOT COMPLETED|Weeks 1 - 12||6||
59796309|NCT00619866|75917404|FG002|NOT COMPLETED|Weeks 1 - 12||10||
59796310|NCT00619866|75917405|FG003|NOT COMPLETED|Weeks 1 - 12||0||
59796311|NCT00619866|75917406|FG004|NOT COMPLETED|Weeks 1 - 12||0||
59796312|NCT00619866|75917402|FG000|STARTED|Weeks 13 - 24||0||
59796313|NCT00619866|75917403|FG001|STARTED|Weeks 13 - 24||45||
59796314|NCT00619866|75917404|FG002|STARTED|Weeks 13 - 24||42||
59796315|NCT00619866|75917405|FG003|STARTED|Weeks 13 - 24||18||
59796316|NCT00619866|75917406|FG004|STARTED|Weeks 13 - 24||20||
59796317|NCT00619866|75917402|FG000|COMPLETED|Weeks 13 - 24||0||
59796318|NCT00619866|75917403|FG001|COMPLETED|Weeks 13 - 24||38||
59796319|NCT00619866|75917404|FG002|COMPLETED|Weeks 13 - 24||37||
59796320|NCT00619866|75917405|FG003|COMPLETED|Weeks 13 - 24||14||
59796321|NCT00619866|75917406|FG004|COMPLETED|Weeks 13 - 24||18||
59796322|NCT00619866|75917402|FG000|NOT COMPLETED|Weeks 13 - 24||0||
59796323|NCT00619866|75917403|FG001|NOT COMPLETED|Weeks 13 - 24||7||
59796324|NCT00619866|75917404|FG002|NOT COMPLETED|Weeks 13 - 24||5||
59796325|NCT00619866|75917405|FG003|NOT COMPLETED|Weeks 13 - 24||4||
59796326|NCT00619866|75917406|FG004|NOT COMPLETED|Weeks 13 - 24||2||
59796327|NCT01095003|75917420|FG000|STARTED|Overall Study||384||
59796328|NCT01095003|75917421|FG001|STARTED|Overall Study||386||
59796329|NCT01095003|75917420|FG000|COMPLETED|Overall Study||0||
59796330|NCT01095003|75917421|FG001|COMPLETED|Overall Study||0||
59796331|NCT01095003|75917420|FG000|NOT COMPLETED|Overall Study||384||
59796332|NCT01095003|75917421|FG001|NOT COMPLETED|Overall Study||386||
59796333|NCT03937479|75917434|FG000|STARTED|Overall Study||83||
59796334|NCT03937479|75917435|FG001|STARTED|Overall Study||85||
59796335|NCT03937479|75917436|FG002|STARTED|Overall Study||82||
59954305|NCT00107991|76072821|FG000|NOT COMPLETED|18-Week Post Treatment Assessment||2||
59954306|NCT00492856|76072825|FG000|STARTED|Induction||105||
59954307|NCT00492856|76072826|FG001|STARTED|Induction||0||
59796336|NCT03937479|75917437|FG003|STARTED|Overall Study||82||
59796337|NCT03937479|75917438|FG004|STARTED|Overall Study||84||
59796338|NCT03937479|75917434|FG000|Received Treatment|Overall Study||83||
59796339|NCT03937479|75917435|FG001|Received Treatment|Overall Study||83||
59796340|NCT03937479|75917436|FG002|Received Treatment|Overall Study||81||
59796341|NCT03937479|75917437|FG003|Received Treatment|Overall Study||82||
59796342|NCT03937479|75917438|FG004|Received Treatment|Overall Study||84||
59796343|NCT03937479|75917434|FG000|COMPLETED|Overall Study||73||
59796344|NCT03937479|75917435|FG001|COMPLETED|Overall Study||70||
59796345|NCT03937479|75917436|FG002|COMPLETED|Overall Study||75||
59796346|NCT03937479|75917437|FG003|COMPLETED|Overall Study||76||
59796347|NCT03937479|75917438|FG004|COMPLETED|Overall Study||79||
59796348|NCT03937479|75917434|FG000|NOT COMPLETED|Overall Study||10||
59796349|NCT03937479|75917435|FG001|NOT COMPLETED|Overall Study||15||
59796350|NCT03937479|75917436|FG002|NOT COMPLETED|Overall Study||7||
59796351|NCT03937479|75917437|FG003|NOT COMPLETED|Overall Study||6||
59796352|NCT03937479|75917438|FG004|NOT COMPLETED|Overall Study||5||
59796353|NCT00619476|75917454|FG000|STARTED|Overall Study||95||
59796354|NCT00619476|75917455|FG001|STARTED|Overall Study||107||
59796355|NCT00619476|75917456|FG002|STARTED|Overall Study||84||
59796356|NCT00619476|75917457|FG003|STARTED|Overall Study||90||
59796357|NCT00619476|75917454|FG000|Intent-to-Treat Population|Overall Study||95||
59954308|NCT00492856|76072827|FG002|STARTED|Induction||0||
59796358|NCT00619476|75917455|FG001|Intent-to-Treat Population|Overall Study||107||
59796359|NCT00619476|75917456|FG002|Intent-to-Treat Population|Overall Study||82||
59796360|NCT00619476|75917457|FG003|Intent-to-Treat Population|Overall Study||87||
59796361|NCT00619476|75917454|FG000|Safety Population|Overall Study||95||
59796362|NCT00619476|75917455|FG001|Safety Population|Overall Study||107||
59796363|NCT00619476|75917456|FG002|Safety Population|Overall Study||82||
59796364|NCT00619476|75917457|FG003|Safety Population|Overall Study||87||
59796365|NCT00619476|75917454|FG000|COMPLETED|Overall Study||64||
59796366|NCT00619476|75917455|FG001|COMPLETED|Overall Study||85||
59796367|NCT00619476|75917456|FG002|COMPLETED|Overall Study||60||
59796368|NCT00619476|75917457|FG003|COMPLETED|Overall Study||56||
59796369|NCT00619476|75917454|FG000|NOT COMPLETED|Overall Study||31||
59796370|NCT00619476|75917455|FG001|NOT COMPLETED|Overall Study||22||
59796371|NCT00619476|75917456|FG002|NOT COMPLETED|Overall Study||24||
59796372|NCT00619476|75917457|FG003|NOT COMPLETED|Overall Study||34||
59796373|NCT00618072|75917470|FG000|STARTED|Overall Study||16||
59796374|NCT00618072|75917471|FG001|STARTED|Overall Study||15||
59796375|NCT00618072|75917472|FG002|STARTED|Overall Study||15||
59796376|NCT00618072|75917470|FG000|COMPLETED|Overall Study||14||
59796377|NCT00618072|75917471|FG001|COMPLETED|Overall Study||14||
59796378|NCT00618072|75917472|FG002|COMPLETED|Overall Study||11||
59796379|NCT00618072|75917470|FG000|NOT COMPLETED|Overall Study||2||
59796380|NCT00618072|75917471|FG001|NOT COMPLETED|Overall Study||1||
59796381|NCT00618072|75917472|FG002|NOT COMPLETED|Overall Study||4||
59796382|NCT00666926|75917480|FG000|STARTED|Overall Study||2||
59796383|NCT00666926|75917481|FG001|STARTED|Overall Study||4||
59796384|NCT00666926|75917482|FG002|STARTED|Overall Study||3||
59796385|NCT00666926|75917483|FG003|STARTED|Overall Study||4||
59796386|NCT00666926|75917484|FG004|STARTED|Overall Study||3||
59796387|NCT00666926|75917485|FG005|STARTED|Overall Study||4||
59796388|NCT00666926|75917486|FG006|STARTED|Overall Study||4||
59796389|NCT00666926|75917487|FG007|STARTED|Overall Study||1||
59796390|NCT00666926|75917488|FG008|STARTED|Overall Study||3||
59796391|NCT00666926|75917489|FG009|STARTED|Overall Study||10||
59796392|NCT00666926|75917490|FG010|STARTED|Overall Study||6||
59796393|NCT00666926|75917491|FG011|STARTED|Overall Study||33||
59796394|NCT00666926|75917492|FG012|STARTED|Overall Study||3||
59796395|NCT00666926|75917493|FG013|STARTED|Overall Study||4||
59796396|NCT00666926|75917494|FG014|STARTED|Overall Study||7||
59796397|NCT00666926|75917495|FG015|STARTED|Overall Study||8||
59796398|NCT00666926|75917480|FG000|COMPLETED|Overall Study||0||
59796399|NCT00666926|75917481|FG001|COMPLETED|Overall Study||0||
59796400|NCT00666926|75917482|FG002|COMPLETED|Overall Study||0||
59796401|NCT00666926|75917483|FG003|COMPLETED|Overall Study||0||
59796402|NCT00666926|75917484|FG004|COMPLETED|Overall Study||0||
59796403|NCT00666926|75917485|FG005|COMPLETED|Overall Study||0||
59796404|NCT00666926|75917486|FG006|COMPLETED|Overall Study||0||
59796405|NCT00666926|75917487|FG007|COMPLETED|Overall Study||0||
59796406|NCT00666926|75917488|FG008|COMPLETED|Overall Study||0||
59796407|NCT00666926|75917489|FG009|COMPLETED|Overall Study||0||
59796408|NCT00666926|75917490|FG010|COMPLETED|Overall Study||0||
59796409|NCT00666926|75917491|FG011|COMPLETED|Overall Study||0||
59796410|NCT00666926|75917492|FG012|COMPLETED|Overall Study||0||
59796411|NCT00666926|75917493|FG013|COMPLETED|Overall Study||0||
59796412|NCT00666926|75917494|FG014|COMPLETED|Overall Study||0||
59796413|NCT00666926|75917495|FG015|COMPLETED|Overall Study||0||
59796414|NCT00666926|75917480|FG000|NOT COMPLETED|Overall Study||2||
59796415|NCT00666926|75917481|FG001|NOT COMPLETED|Overall Study||4||
59796416|NCT00666926|75917482|FG002|NOT COMPLETED|Overall Study||3||
59796417|NCT00666926|75917483|FG003|NOT COMPLETED|Overall Study||4||
59796418|NCT00666926|75917484|FG004|NOT COMPLETED|Overall Study||3||
59796419|NCT00666926|75917485|FG005|NOT COMPLETED|Overall Study||4||
59796420|NCT00666926|75917486|FG006|NOT COMPLETED|Overall Study||4||
59796421|NCT00666926|75917487|FG007|NOT COMPLETED|Overall Study||1||
59796422|NCT00666926|75917488|FG008|NOT COMPLETED|Overall Study||3||
59796423|NCT00666926|75917489|FG009|NOT COMPLETED|Overall Study||10||
59796424|NCT00666926|75917490|FG010|NOT COMPLETED|Overall Study||6||
59796425|NCT00666926|75917491|FG011|NOT COMPLETED|Overall Study||33||
59796426|NCT00666926|75917492|FG012|NOT COMPLETED|Overall Study||3||
59796427|NCT00666926|75917493|FG013|NOT COMPLETED|Overall Study||4||
59796428|NCT00666926|75917494|FG014|NOT COMPLETED|Overall Study||7||
59796429|NCT00666926|75917495|FG015|NOT COMPLETED|Overall Study||8||
59796430|NCT03861052|75917550|FG000|STARTED|Overall Study||159||
59796431|NCT03861052|75917551|FG001|STARTED|Overall Study||158||
59796432|NCT03861052|75917552|FG002|STARTED|Overall Study||160||
59796433|NCT03861052|75917553|FG003|STARTED|Overall Study||159||
59796434|NCT03861052|75917550|FG000|Received at Least One Dose of Study Drug|Overall Study||159||
59796435|NCT03861052|75917551|FG001|Received at Least One Dose of Study Drug|Overall Study||158||
59796436|NCT03861052|75917552|FG002|Received at Least One Dose of Study Drug|Overall Study||160||
59796437|NCT03861052|75917553|FG003|Received at Least One Dose of Study Drug|Overall Study||159||
59796438|NCT03861052|75917550|FG000|COMPLETED|Overall Study||155||
59796439|NCT03861052|75917551|FG001|COMPLETED|Overall Study||151||
59796440|NCT03861052|75917552|FG002|COMPLETED|Overall Study||155||
59796441|NCT03861052|75917553|FG003|COMPLETED|Overall Study||154||
59954309|NCT00492856|76072828|FG003|STARTED|Induction||0||
59620347|NCT00168324|75731660|FG001|STARTED|Double-Blind Period||196||
59620348|NCT00168324|75731661|FG002|STARTED|Double-Blind Period||202||
59620349|NCT00168324|75731659|FG000|COMPLETED|Double-Blind Period||189||
59620350|NCT00168324|75731660|FG001|COMPLETED|Double-Blind Period||189||
59620351|NCT00168324|75731661|FG002|COMPLETED|Double-Blind Period||189||
59620352|NCT00168324|75731659|FG000|NOT COMPLETED|Double-Blind Period||12||
59620353|NCT00168324|75731660|FG001|NOT COMPLETED|Double-Blind Period||7||
59620354|NCT00168324|75731661|FG002|NOT COMPLETED|Double-Blind Period||13||
59620355|NCT00168324|75731659|FG000|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|164||
59620356|NCT00168324|75731660|FG001|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|155||
59620357|NCT00168324|75731661|FG002|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|158||
59620358|NCT00168324|75731659|FG000|COMPLETED|Open-Label Period||160||
59620359|NCT00168324|75731660|FG001|COMPLETED|Open-Label Period||147||
59620360|NCT00168324|75731661|FG002|COMPLETED|Open-Label Period||152||
59620361|NCT00168324|75731659|FG000|NOT COMPLETED|Open-Label Period||4||
59620362|NCT00168324|75731660|FG001|NOT COMPLETED|Open-Label Period||8||
59620363|NCT00168324|75731661|FG002|NOT COMPLETED|Open-Label Period||6||
59620364|NCT00084552|75731671|FG000|STARTED|Overall Study||54||
59620365|NCT00084552|75731672|FG001|STARTED|Overall Study||62||
59620366|NCT00084552|75731671|FG000|COMPLETED|Overall Study||54||
59620367|NCT00084552|75731672|FG001|COMPLETED|Overall Study||62||
59620368|NCT00084552|75731671|FG000|NOT COMPLETED|Overall Study||0||
59620369|NCT00084552|75731672|FG001|NOT COMPLETED|Overall Study||0||
59620370|NCT02091882|75731678|FG000|STARTED|Overall Study||30||
59620371|NCT02091882|75731678|FG000|COMPLETED|Overall Study||30||
59620372|NCT02091882|75731678|FG000|NOT COMPLETED|Overall Study||0||
59620373|NCT00085254|75731685|FG000|STARTED|Overall Study||18||
59620374|NCT00085254|75731686|FG001|STARTED|Overall Study||46||
59620375|NCT00085254|75731687|FG002|STARTED|Overall Study||48||
59620376|NCT00085254|75731685|FG000|COMPLETED|Overall Study||18||
59620377|NCT00085254|75731686|FG001|COMPLETED|Overall Study||46||
59620378|NCT00085254|75731687|FG002|COMPLETED|Overall Study||48||
59620379|NCT00085254|75731685|FG000|NOT COMPLETED|Overall Study||0||
59620380|NCT00085254|75731686|FG001|NOT COMPLETED|Overall Study||0||
59620381|NCT00085254|75731687|FG002|NOT COMPLETED|Overall Study||0||
59620382|NCT00253890|75731703|FG000|STARTED|Overall Study||69||
59620383|NCT00253890|75731704|FG001|STARTED|Overall Study||68||
59620384|NCT00253890|75731703|FG000|COMPLETED|Overall Study||62||
59620385|NCT00253890|75731704|FG001|COMPLETED|Overall Study||61||
59620386|NCT00253890|75731703|FG000|NOT COMPLETED|Overall Study||7||
59620387|NCT00253890|75731704|FG001|NOT COMPLETED|Overall Study||7||
59620388|NCT00254592|75731710|FG000|STARTED|Overall Study||43||
59620389|NCT00254592|75731710|FG000|COMPLETED|Overall Study||41||
59620390|NCT00254592|75731710|FG000|NOT COMPLETED|Overall Study||2||
59620391|NCT00255684|75731714|FG000|STARTED|Overall Study||16||
59954310|NCT00492856|76072825|FG000|COMPLETED|Induction||99||
59954311|NCT00492856|76072826|FG001|COMPLETED|Induction||0||
59954312|NCT00492856|76072827|FG002|COMPLETED|Induction||0||
59954313|NCT00492856|76072828|FG003|COMPLETED|Induction||0||
59954314|NCT00492856|76072825|FG000|NOT COMPLETED|Induction||6||
59954315|NCT00492856|76072826|FG001|NOT COMPLETED|Induction||0||
59954316|NCT00492856|76072827|FG002|NOT COMPLETED|Induction||0||
59954317|NCT00492856|76072828|FG003|NOT COMPLETED|Induction||0||
59954318|NCT00492856|76072825|FG000|STARTED|Consolidation|Patients in CR (CRm), CRi, or PR after induction, register for consolidation and are eligible.|92||
59954319|NCT00492856|76072826|FG001|STARTED|Consolidation||0||
59954320|NCT00492856|76072827|FG002|STARTED|Consolidation||0||
59620392|NCT00255684|75731714|FG000|COMPLETED|Overall Study||16||
59620393|NCT00255684|75731714|FG000|NOT COMPLETED|Overall Study||0||
59620394|NCT00256776|75731720|FG000|STARTED|Overall Study||135||
59620395|NCT00256776|75731721|FG001|STARTED|Overall Study||134||
59620396|NCT00256776|75731720|FG000|COMPLETED|Overall Study||52||
59620397|NCT00256776|75731721|FG001|COMPLETED|Overall Study||54||
59954321|NCT00492856|76072828|FG003|STARTED|Consolidation||0||
59954322|NCT00492856|76072825|FG000|COMPLETED|Consolidation||83||
59954323|NCT00492856|76072826|FG001|COMPLETED|Consolidation||0||
59954324|NCT00492856|76072827|FG002|COMPLETED|Consolidation||0||
59954325|NCT00492856|76072828|FG003|COMPLETED|Consolidation||0||
59954326|NCT00492856|76072825|FG000|NOT COMPLETED|Consolidation||9||
59954327|NCT00492856|76072826|FG001|NOT COMPLETED|Consolidation||0||
59954328|NCT00492856|76072827|FG002|NOT COMPLETED|Consolidation||0||
59954329|NCT00492856|76072828|FG003|NOT COMPLETED|Consolidation||0||
59954330|NCT00492856|76072825|FG000|STARTED|Post-consolidation|Patients who achieve CRm, are randomized to the treatment arm, and are eligible.|0||
59620398|NCT00256776|75731720|FG000|NOT COMPLETED|Overall Study||83||
59620399|NCT00256776|75731721|FG001|NOT COMPLETED|Overall Study||80||
59620400|NCT00257322|75731729|FG000|STARTED|Overall Study|20 subjects accrued.|20||
59954331|NCT00492856|76072826|FG001|STARTED|Post-consolidation||41||
59620401|NCT00257322|75731729|FG000|COMPLETED|Overall Study|4 subjects withdrew from this study.|16||
59620402|NCT00257322|75731729|FG000|NOT COMPLETED|Overall Study||4||
59620403|NCT00258180|75731733|FG000|STARTED|Overall Study||2||
59796442|NCT03861052|75917550|FG000|NOT COMPLETED|Overall Study||4||
59796443|NCT03861052|75917551|FG001|NOT COMPLETED|Overall Study||7||
59796444|NCT03861052|75917552|FG002|NOT COMPLETED|Overall Study||5||
59796445|NCT03861052|75917553|FG003|NOT COMPLETED|Overall Study||5||
59796446|NCT00664742|75917568|FG000|STARTED|Overall Study||607||
59796447|NCT00664742|75917568|FG000|COMPLETED|Overall Study||481||
59796448|NCT00664742|75917568|FG000|NOT COMPLETED|Overall Study||126||
59796449|NCT00511342|75917574|FG000|STARTED|Overall Study||56||
59796450|NCT00511342|75917575|FG001|STARTED|Overall Study||54||
59796451|NCT00511342|75917574|FG000|COMPLETED|Overall Study||43||
59796452|NCT00511342|75917575|FG001|COMPLETED|Overall Study||32||
59796453|NCT00511342|75917574|FG000|NOT COMPLETED|Overall Study||13||
59796454|NCT00511342|75917575|FG001|NOT COMPLETED|Overall Study||22||
59796455|NCT03931785|75917585|FG000|STARTED|Overall Study||97||
59796456|NCT03931785|75917586|FG001|STARTED|Overall Study||97||
59796457|NCT03931785|75917587|FG002|STARTED|Overall Study||97||
59796458|NCT03931785|75917588|FG003|STARTED|Overall Study||97||
59796459|NCT03931785|75917585|FG000|COMPLETED|Overall Study||92||
59796460|NCT03931785|75917586|FG001|COMPLETED|Overall Study||90||
59796461|NCT03931785|75917587|FG002|COMPLETED|Overall Study||84||
59796462|NCT03931785|75917588|FG003|COMPLETED|Overall Study||86||
59796463|NCT03931785|75917585|FG000|NOT COMPLETED|Overall Study||5||
59796464|NCT03931785|75917586|FG001|NOT COMPLETED|Overall Study||7||
59796465|NCT03931785|75917587|FG002|NOT COMPLETED|Overall Study||13||
59796466|NCT03931785|75917588|FG003|NOT COMPLETED|Overall Study||11||
59796467|NCT00666536|75917600|FG000|STARTED|Overall Study||369||
59796468|NCT00666536|75917601|FG001|STARTED|Overall Study||359||
59796469|NCT00666536|75917600|FG000|COMPLETED|Overall Study||336||
59796470|NCT00666536|75917601|FG001|COMPLETED|Overall Study||322||
59796471|NCT00666536|75917600|FG000|NOT COMPLETED|Overall Study||33||
59796472|NCT00666536|75917601|FG001|NOT COMPLETED|Overall Study||37||
59796473|NCT00519532|75917607|FG000|STARTED|Overall Study||84||
59796474|NCT00519532|75917607|FG000|COMPLETED|Overall Study||66||
59796475|NCT00519532|75917607|FG000|NOT COMPLETED|Overall Study||18||
59796476|NCT00666458|75917613|FG000|STARTED|Overall Study|Randomized and treated|403||
59796477|NCT00666458|75917614|FG001|STARTED|Overall Study|Randomized and treated|398||
59796478|NCT00666458|75917613|FG000|COMPLETED|Overall Study|Completed 18 weeks of treatment|365||
59796479|NCT00666458|75917614|FG001|COMPLETED|Overall Study|Completed 18 weeks of treatment|374||
59796480|NCT00666458|75917613|FG000|NOT COMPLETED|Overall Study||38||
59796481|NCT00666458|75917614|FG001|NOT COMPLETED|Overall Study||24||
59796482|NCT00511108|75917624|FG000|STARTED|Overall Study||52||
59796483|NCT00511108|75917625|FG001|STARTED|Overall Study||54||
59796484|NCT00511108|75917626|FG002|STARTED|Overall Study||52||
59796485|NCT00511108|75917627|FG003|STARTED|Overall Study||53||
59796486|NCT00511108|75917624|FG000|COMPLETED|Overall Study||46||
59796487|NCT00511108|75917625|FG001|COMPLETED|Overall Study||52||
59796488|NCT00511108|75917626|FG002|COMPLETED|Overall Study||47||
59954332|NCT00492856|76072827|FG002|STARTED|Post-consolidation||27||
59954333|NCT00492856|76072828|FG003|STARTED|Post-consolidation||1||
59954334|NCT00492856|76072825|FG000|COMPLETED|Post-consolidation||0||
59954335|NCT00492856|76072826|FG001|COMPLETED|Post-consolidation||29||
59954336|NCT00492856|76072827|FG002|COMPLETED|Post-consolidation||0||
59796489|NCT00511108|75917627|FG003|COMPLETED|Overall Study||48||
59796490|NCT00511108|75917624|FG000|NOT COMPLETED|Overall Study||6||
59796491|NCT00511108|75917625|FG001|NOT COMPLETED|Overall Study||2||
59796492|NCT00511108|75917626|FG002|NOT COMPLETED|Overall Study||5||
59796493|NCT00511108|75917627|FG003|NOT COMPLETED|Overall Study||5||
59796494|NCT00510952|75917639|FG000|STARTED|Overall Study||235||
59796495|NCT00510952|75917640|FG001|STARTED|Overall Study||236||
59796496|NCT00510952|75917639|FG000|Full Analysis Set (Intent to Treat)|Overall Study||229||
59796497|NCT00510952|75917640|FG001|Full Analysis Set (Intent to Treat)|Overall Study||229||
59796498|NCT00510952|75917639|FG000|COMPLETED|Overall Study||209||
59796499|NCT00510952|75917640|FG001|COMPLETED|Overall Study||220||
59796500|NCT00510952|75917639|FG000|NOT COMPLETED|Overall Study||26||
59796501|NCT00510952|75917640|FG001|NOT COMPLETED|Overall Study||16||
59796502|NCT00617604|75917648|FG000|STARTED|Overall Study||110||
59796503|NCT00617604|75917649|FG001|STARTED|Overall Study||108||
59796504|NCT00617604|75917648|FG000|Received Treatment|Overall Study||107||
59796505|NCT00617604|75917649|FG001|Received Treatment|Overall Study||105||
59796506|NCT00617604|75917648|FG000|Completed 12 Weeks of Treatment|Overall Study||89||
59796507|NCT00617604|75917649|FG001|Completed 12 Weeks of Treatment|Overall Study||83||
59796508|NCT00617604|75917648|FG000|COMPLETED|Overall Study|Completed Month 6 assessment|92||
59796509|NCT00617604|75917649|FG001|COMPLETED|Overall Study|Completed Month 6 assessment|88||
59796510|NCT00617604|75917648|FG000|NOT COMPLETED|Overall Study||18||
59796511|NCT00617604|75917649|FG001|NOT COMPLETED|Overall Study||20||
59796512|NCT00661622|75917657|FG000|STARTED|Overall Study||26||
59796513|NCT00661622|75917658|FG001|STARTED|Overall Study||27||
59796514|NCT00661622|75917657|FG000|COMPLETED|Overall Study||25||
59796515|NCT00661622|75917658|FG001|COMPLETED|Overall Study||27||
59796516|NCT00661622|75917657|FG000|NOT COMPLETED|Overall Study||1||
59796517|NCT00661622|75917658|FG001|NOT COMPLETED|Overall Study||0||
59796518|NCT04093752|75917669|FG000|STARTED|Overall Study||230||
59796519|NCT04093752|75917670|FG001|STARTED|Overall Study||228||
59796520|NCT04093752|75917671|FG002|STARTED|Overall Study||229||
59796521|NCT04093752|75917672|FG003|STARTED|Overall Study||230||
59796522|NCT04093752|75917669|FG000|Received At Least One Dose of Study Drug|Overall Study||230||
59796523|NCT04093752|75917670|FG001|Received At Least One Dose of Study Drug|Overall Study||228||
59796524|NCT04093752|75917671|FG002|Received At Least One Dose of Study Drug|Overall Study||229||
59796525|NCT04093752|75917672|FG003|Received At Least One Dose of Study Drug|Overall Study||220||
59796526|NCT04093752|75917669|FG000|COMPLETED|Overall Study||213||
59796527|NCT04093752|75917670|FG001|COMPLETED|Overall Study||201||
59796528|NCT04093752|75917671|FG002|COMPLETED|Overall Study||200||
59796529|NCT04093752|75917672|FG003|COMPLETED|Overall Study||201||
59796530|NCT04093752|75917669|FG000|NOT COMPLETED|Overall Study||17||
59796531|NCT04093752|75917670|FG001|NOT COMPLETED|Overall Study||27||
59796532|NCT04093752|75917671|FG002|NOT COMPLETED|Overall Study||29||
59796533|NCT04093752|75917672|FG003|NOT COMPLETED|Overall Study||29||
59796534|NCT03928821|75917690|FG000|STARTED|Overall Study||6||
59796535|NCT03928821|75917691|FG001|STARTED|Overall Study||6||
59796536|NCT03928821|75917692|FG002|STARTED|Overall Study||6||
59796537|NCT03928821|75917693|FG003|STARTED|Overall Study||9||
59796538|NCT03928821|75917690|FG000|COMPLETED|Overall Study||6||
59796539|NCT03928821|75917691|FG001|COMPLETED|Overall Study||3||
59796540|NCT03928821|75917692|FG002|COMPLETED|Overall Study||3||
59796541|NCT03928821|75917693|FG003|COMPLETED|Overall Study||8||
59796542|NCT03928821|75917690|FG000|NOT COMPLETED|Overall Study||0||
59796543|NCT03928821|75917691|FG001|NOT COMPLETED|Overall Study||3||
59796544|NCT03928821|75917692|FG002|NOT COMPLETED|Overall Study||3||
59796545|NCT03928821|75917693|FG003|NOT COMPLETED|Overall Study||1||
59796546|NCT00666224|75917705|FG000|STARTED|Double-Blind||243||
59796547|NCT00666224|75917706|FG001|STARTED|Double-Blind||238||
59796548|NCT00666224|75917705|FG000|COMPLETED|Double-Blind|78 completed 3 years treatment, 66 converted to CDMS, 54 switched to OL as per DMC|198||
59796549|NCT00666224|75917706|FG001|COMPLETED|Double-Blind|55 completed 3 years treatment, 109 converted to CDMS, 47 switched to OL as per DMC|211||
59796550|NCT00666224|75917705|FG000|NOT COMPLETED|Double-Blind||45||
59796551|NCT00666224|75917706|FG001|NOT COMPLETED|Double-Blind||27||
59796552|NCT00666224|75917705|FG000|STARTED|Open-Label|454 participants took at least one dose of GA including 45 who didn't continue into the OL.|198||
59796553|NCT00666224|75917706|FG001|STARTED|Open-Label||211||
59796554|NCT00666224|75917705|FG000|COMPLETED|Open-Label||163||
59796555|NCT00666224|75917706|FG001|COMPLETED|Open-Label||126||
59796556|NCT00666224|75917705|FG000|NOT COMPLETED|Open-Label||35||
59796557|NCT00666224|75917706|FG001|NOT COMPLETED|Open-Label||85||
59796558|NCT00663962|75917715|FG000|STARTED|Overall Study||7||
59796559|NCT00663962|75917716|FG001|STARTED|Overall Study||8||
59796560|NCT00663962|75917715|FG000|COMPLETED|Overall Study|1 patient excluded for somnolence and unblinded--in 300mg group|6||
59796561|NCT00663962|75917716|FG001|COMPLETED|Overall Study||8||
59796562|NCT00663962|75917715|FG000|NOT COMPLETED|Overall Study||1||
59796563|NCT00663962|75917716|FG001|NOT COMPLETED|Overall Study||0||
59796564|NCT00265759|75917728|FG000|STARTED|Overall Study||124||
59796565|NCT00265759|75917729|FG001|STARTED|Overall Study||128||
59796566|NCT00265759|75917730|FG002|STARTED|Overall Study||125||
59796567|NCT00265759|75917731|FG003|STARTED|Overall Study||245||
59796568|NCT00265759|75917728|FG000|COMPLETED|Overall Study||124||
59796569|NCT00265759|75917729|FG001|COMPLETED|Overall Study||127||
59796570|NCT00265759|75917730|FG002|COMPLETED|Overall Study||123||
59796571|NCT00265759|75917731|FG003|COMPLETED|Overall Study||236||
59796572|NCT00265759|75917728|FG000|NOT COMPLETED|Overall Study||0||
59796573|NCT00265759|75917729|FG001|NOT COMPLETED|Overall Study||1||
59954337|NCT00492856|76072828|FG003|COMPLETED|Post-consolidation||0||
59954338|NCT00492856|76072825|FG000|NOT COMPLETED|Post-consolidation||0||
59954339|NCT00492856|76072826|FG001|NOT COMPLETED|Post-consolidation||12||
59954340|NCT00492856|76072827|FG002|NOT COMPLETED|Post-consolidation||27||
59954341|NCT00492856|76072828|FG003|NOT COMPLETED|Post-consolidation||1||
59954342|NCT02782377|76072840|FG000|STARTED|Overall Study||40||
59954343|NCT02782377|76072840|FG000|COMPLETED|Overall Study|data from five of the patients were excluded due to interpretation difficulties|35||
59796574|NCT00265759|75917730|FG002|NOT COMPLETED|Overall Study||2||
59796575|NCT00265759|75917731|FG003|NOT COMPLETED|Overall Study||9||
59796576|NCT00744263|75917744|FG000|STARTED|Overall Study||42240||
59796577|NCT00744263|75917745|FG001|STARTED|Overall Study||42256||
59796578|NCT00744263|75917744|FG000|COMPLETED|Overall Study||37004||
59796579|NCT00744263|75917745|FG001|COMPLETED|Overall Study||36936||
59796580|NCT00744263|75917744|FG000|NOT COMPLETED|Overall Study||5236||
59796581|NCT00744263|75917745|FG001|NOT COMPLETED|Overall Study||5320||
59796582|NCT00618774|75917755|FG000|STARTED|Overall Study||211||
59796583|NCT00618774|75917756|FG001|STARTED|Overall Study||48||
59796584|NCT00618774|75917755|FG000|COMPLETED|Overall Study||205||
59796585|NCT00618774|75917756|FG001|COMPLETED|Overall Study||45||
59796586|NCT00618774|75917755|FG000|NOT COMPLETED|Overall Study||6||
59796587|NCT00618774|75917756|FG001|NOT COMPLETED|Overall Study||3||
59796588|NCT00545571|75917762|FG000|STARTED|Overall Study||120||
59796589|NCT00545571|75917762|FG000|COMPLETED|Overall Study||53||
59796590|NCT00545571|75917762|FG000|NOT COMPLETED|Overall Study||67||
59796591|NCT00748709|75917766|FG000|STARTED|Overall Study|Treated|20||
59796592|NCT00748709|75917766|FG000|COMPLETED|Overall Study||0||
59796593|NCT00748709|75917766|FG000|NOT COMPLETED|Overall Study||20||
59796594|NCT00263887|75917772|FG000|STARTED|Overall Study||38||
59796595|NCT00263887|75917773|FG001|STARTED|Overall Study||39||
59796596|NCT00263887|75917772|FG000|COMPLETED|Overall Study||35||
59796597|NCT00263887|75917773|FG001|COMPLETED|Overall Study||32||
59796598|NCT00263887|75917772|FG000|NOT COMPLETED|Overall Study||3||
59796599|NCT00263887|75917773|FG001|NOT COMPLETED|Overall Study||7||
59796600|NCT00748553|75917781|FG000|STARTED|Overall Study||16||
59796601|NCT00748553|75917782|FG001|STARTED|Overall Study||14||
59796602|NCT00748553|75917781|FG000|COMPLETED|Overall Study||13||
59796603|NCT00748553|75917782|FG001|COMPLETED|Overall Study||13||
59796604|NCT00748553|75917781|FG000|NOT COMPLETED|Overall Study||3||
59796605|NCT00748553|75917782|FG001|NOT COMPLETED|Overall Study||1||
59796606|NCT00661388|75917787|FG000|STARTED|Overall Study||75||
59796607|NCT00661388|75917787|FG000|COMPLETED|Overall Study||51||
59796608|NCT00661388|75917787|FG000|NOT COMPLETED|Overall Study||24||
59796609|NCT00743483|75917791|FG000|STARTED|Baseline Period||15||
59796610|NCT00743483|75917791|FG000|COMPLETED|Baseline Period||14||
59796611|NCT00743483|75917791|FG000|NOT COMPLETED|Baseline Period||1||
59796612|NCT00743483|75917791|FG000|STARTED|Treatment Period||14||
59796613|NCT00743483|75917791|FG000|COMPLETED|Treatment Period||13||
59796614|NCT00743483|75917791|FG000|NOT COMPLETED|Treatment Period||1||
59796615|NCT00263575|75917795|FG000|STARTED|Titration Period||139||
59796616|NCT00263575|75917795|FG000|COMPLETED|Titration Period||96||
59796617|NCT00263575|75917795|FG000|NOT COMPLETED|Titration Period||43||
59796618|NCT00263575|75917795|FG000|STARTED|Maintence Period||96||
59796619|NCT00263575|75917795|FG000|COMPLETED|Maintence Period||19||
59796620|NCT00263575|75917795|FG000|NOT COMPLETED|Maintence Period||77||
59796621|NCT00748241|75917801|FG000|STARTED|Overall Study||19||
59796622|NCT00748241|75917801|FG000|COMPLETED|Overall Study||11||
59796623|NCT00748241|75917801|FG000|NOT COMPLETED|Overall Study||8||
59796624|NCT00570128|75917807|FG000|STARTED|Overall Study||64||
59796625|NCT00570128|75917808|FG001|STARTED|Overall Study||65||
59796626|NCT00570128|75917807|FG000|Intent to Treat (ITT) Population|Overall Study||62||
59796627|NCT00570128|75917808|FG001|Intent to Treat (ITT) Population|Overall Study||65||
59796628|NCT00570128|75917807|FG000|COMPLETED|Overall Study||60||
59796629|NCT00570128|75917808|FG001|COMPLETED|Overall Study||65||
59796630|NCT00570128|75917807|FG000|NOT COMPLETED|Overall Study||4||
59796631|NCT00570128|75917808|FG001|NOT COMPLETED|Overall Study||0||
59796632|NCT00743249|75917816|FG000|STARTED|Overall Study||30||
59796633|NCT00743249|75917817|FG001|STARTED|Overall Study||30||
59796634|NCT00743249|75917816|FG000|COMPLETED|Overall Study||28||
59796635|NCT00743249|75917817|FG001|COMPLETED|Overall Study||24||
59796636|NCT00743249|75917816|FG000|NOT COMPLETED|Overall Study||2||
59796637|NCT00743249|75917817|FG001|NOT COMPLETED|Overall Study||6||
59796638|NCT00262951|75917823|FG000|STARTED|Overall Study||23||
59796639|NCT00262951|75917823|FG000|COMPLETED|Overall Study||7||
59796640|NCT00262951|75917823|FG000|NOT COMPLETED|Overall Study||16||
59796641|NCT00262873|75917827|FG000|STARTED|Overall Study||8||
59796642|NCT00262873|75917827|FG000|COMPLETED|Overall Study||0||
59796643|NCT00262873|75917827|FG000|NOT COMPLETED|Overall Study||8||
59796644|NCT00573534|75917831|FG000|STARTED|Overall Study||8||
59796645|NCT00573534|75917831|FG000|COMPLETED|Overall Study||5||
59796646|NCT00573534|75917831|FG000|NOT COMPLETED|Overall Study||3||
59796647|NCT00260533|75917838|FG000|STARTED|Overall Study||14||
59796648|NCT00260533|75917839|FG001|STARTED|Overall Study||13||
59796649|NCT00260533|75917838|FG000|COMPLETED|Overall Study||11||
59796650|NCT00260533|75917839|FG001|COMPLETED|Overall Study||10||
59796651|NCT00260533|75917838|FG000|NOT COMPLETED|Overall Study||3||
59796652|NCT00260533|75917839|FG001|NOT COMPLETED|Overall Study||3||
59796653|NCT03945981|75917845|FG000|STARTED|Overall Study||131||
59796654|NCT03945981|75917845|FG000|COMPLETED|Overall Study||108||
59796655|NCT03945981|75917845|FG000|NOT COMPLETED|Overall Study||23||
59796656|NCT03926598|75917854|FG000|STARTED|Overall Study||1||
59796657|NCT03926598|75917855|FG001|STARTED|Overall Study||1||
59796658|NCT03926598|75917856|FG002|STARTED|Overall Study|Not Completed|0||
59796659|NCT03926598|75917857|FG003|STARTED|Overall Study||2||
59796660|NCT03926598|75917858|FG004|STARTED|Overall Study||2||
59796661|NCT03926598|75917854|FG000|COMPLETED|Overall Study||1||
59796662|NCT03926598|75917855|FG001|COMPLETED|Overall Study||1||
59796663|NCT03926598|75917856|FG002|COMPLETED|Overall Study|Not Completed|0||
59796664|NCT03926598|75917857|FG003|COMPLETED|Overall Study||2||
59796665|NCT03926598|75917858|FG004|COMPLETED|Overall Study||2||
59796666|NCT03926598|75917854|FG000|NOT COMPLETED|Overall Study||0||
59796667|NCT03926598|75917855|FG001|NOT COMPLETED|Overall Study||0||
59796668|NCT03926598|75917856|FG002|NOT COMPLETED|Overall Study||0||
59796669|NCT03926598|75917857|FG003|NOT COMPLETED|Overall Study||0||
59796670|NCT03926598|75917858|FG004|NOT COMPLETED|Overall Study||0||
59796671|NCT00745901|75917872|FG000|STARTED|Overall Study|Number of Patients Randomized|178||
59796672|NCT00745901|75917873|FG001|STARTED|Overall Study|Number of Patients Randomized|177||
59796673|NCT00745901|75917872|FG000|COMPLETED|Overall Study||154||
59796674|NCT00745901|75917873|FG001|COMPLETED|Overall Study||156||
59796675|NCT00745901|75917872|FG000|NOT COMPLETED|Overall Study||24||
59796676|NCT00745901|75917873|FG001|NOT COMPLETED|Overall Study||21||
59796677|NCT00286429|75917882|FG000|STARTED|Overall Study||130||
59796678|NCT00286429|75917883|FG001|STARTED|Overall Study||131||
59796679|NCT00286429|75917884|FG002|STARTED|Overall Study||129||
59796680|NCT00286429|75917882|FG000|COMPLETED|Overall Study||55||
59796681|NCT00286429|75917883|FG001|COMPLETED|Overall Study||83||
59796682|NCT00286429|75917884|FG002|COMPLETED|Overall Study||77||
59796683|NCT00286429|75917882|FG000|NOT COMPLETED|Overall Study||75||
59796684|NCT00286429|75917883|FG001|NOT COMPLETED|Overall Study||48||
59796685|NCT00286429|75917884|FG002|NOT COMPLETED|Overall Study||52||
59796686|NCT00665444|75917892|FG000|STARTED|Overall Study||3||
59796687|NCT00665444|75917892|FG000|COMPLETED|Overall Study||1||
59796688|NCT00665444|75917892|FG000|NOT COMPLETED|Overall Study||2||
59796689|NCT03926169|75917899|FG000|STARTED|Period A||82|Randomized|
59796690|NCT03926169|75917900|FG001|STARTED|Period A||80|Randomized|
59796691|NCT03926169|75917901|FG002|STARTED|Period A||81|Randomized|
59796692|NCT03926169|75917899|FG000|Never Received Study Drug|Period A||0||
59796693|NCT03926169|75917900|FG001|Never Received Study Drug|Period A||0||
59796694|NCT03926169|75917901|FG002|Never Received Study Drug|Period A||1||
59796695|NCT03926169|75917899|FG000|COMPLETED|Period A||74|Completed Week 16|
59796696|NCT03926169|75917900|FG001|COMPLETED|Period A||70|Completed Week 16|
59796697|NCT03926169|75917901|FG002|COMPLETED|Period A||75|Completed Week 16|
59796698|NCT03926169|75917899|FG000|NOT COMPLETED|Period A||8||
59796699|NCT03926169|75917900|FG001|NOT COMPLETED|Period A||10||
59796700|NCT03926169|75917901|FG002|NOT COMPLETED|Period A||6||
59796701|NCT03926169|75917899|FG000|STARTED|Period B||74|Entered Period B|
59796702|NCT03926169|75917900|FG001|STARTED|Period B||70|Entered Period B|
59796703|NCT03926169|75917901|FG002|STARTED|Period B||75|Entered Period B|
59796704|NCT03926169|75917899|FG000|Entered Period B and Received Study Drug|Period B||74||
59796705|NCT03926169|75917900|FG001|Entered Period B and Received Study Drug|Period B||70||
59796706|NCT03926169|75917901|FG002|Entered Period B and Received Study Drug|Period B||74||
59796707|NCT03926169|75917899|FG000|COMPLETED|Period B||4|Completed study|
59796708|NCT03926169|75917900|FG001|COMPLETED|Period B||7|Completed study|
59796709|NCT03926169|75917901|FG002|COMPLETED|Period B||4|Completed study|
59796710|NCT03926169|75917899|FG000|NOT COMPLETED|Period B||70||
59796711|NCT03926169|75917900|FG001|NOT COMPLETED|Period B||63||
59796712|NCT03926169|75917901|FG002|NOT COMPLETED|Period B||71||
59796713|NCT00285649|75917915|FG000|STARTED|Overall Study||72||
59796714|NCT00285649|75917916|FG001|STARTED|Overall Study||72||
59796715|NCT00285649|75917917|FG002|STARTED|Overall Study||48||
59796716|NCT00285649|75917915|FG000|COMPLETED|Overall Study||63||
59796717|NCT00285649|75917916|FG001|COMPLETED|Overall Study||66||
59796718|NCT00285649|75917917|FG002|COMPLETED|Overall Study||42||
59796719|NCT00285649|75917915|FG000|NOT COMPLETED|Overall Study||9||
59796720|NCT00285649|75917916|FG001|NOT COMPLETED|Overall Study||6||
59796721|NCT00285649|75917917|FG002|NOT COMPLETED|Overall Study||6||
59796722|NCT00745823|75917927|FG000|STARTED|Overall Study||386||
59796723|NCT00745823|75917928|FG001|STARTED|Overall Study||389||
59796724|NCT00745823|75917927|FG000|TREATED Week 0 - 96|Overall Study||382||
59796725|NCT00745823|75917928|FG001|TREATED Week 0 - 96|Overall Study||388||
59796726|NCT00745823|75917927|FG000|COMPLETED|Overall Study||1||
59796727|NCT00745823|75917928|FG001|COMPLETED|Overall Study||3||
59796728|NCT00745823|75917927|FG000|NOT COMPLETED|Overall Study||385||
59796729|NCT00745823|75917928|FG001|NOT COMPLETED|Overall Study||386||
59796730|NCT00663260|75917939|FG000|STARTED|Overall Study||84||
59796731|NCT00663260|75917940|FG001|STARTED|Overall Study||83||
59796732|NCT00663260|75917941|FG002|STARTED|Overall Study||85||
59796733|NCT00663260|75917939|FG000|COMPLETED|Overall Study||63||
59796734|NCT00663260|75917940|FG001|COMPLETED|Overall Study||72||
59796735|NCT00663260|75917941|FG002|COMPLETED|Overall Study||69||
59796736|NCT00663260|75917939|FG000|NOT COMPLETED|Overall Study||21||
59796737|NCT00663260|75917940|FG001|NOT COMPLETED|Overall Study||11||
59796738|NCT00663260|75917941|FG002|NOT COMPLETED|Overall Study||16||
59620404|NCT00258180|75731733|FG000|COMPLETED|Overall Study||2||
59796739|NCT00740597|75917949|FG000|STARTED|Overall Study||1||
59796740|NCT00740597|75917949|FG000|COMPLETED|Overall Study||0||
59796741|NCT00740597|75917949|FG000|NOT COMPLETED|Overall Study||1||
59796742|NCT00284089|75917957|FG000|STARTED|Single Dose Phase||6||
59796743|NCT00284089|75917958|FG001|STARTED|Single Dose Phase||6||
59796744|NCT00284089|75917959|FG002|STARTED|Single Dose Phase|Group B patients did not participate in the Single Dose Phase of the study.|0||
59796745|NCT00284089|75917960|FG003|STARTED|Single Dose Phase|Group B patients did not participate in the Single Dose Phase of the study.|0||
59796746|NCT00284089|75917957|FG000|COMPLETED|Single Dose Phase||6||
59796747|NCT00284089|75917958|FG001|COMPLETED|Single Dose Phase||6||
59796748|NCT00284089|75917959|FG002|COMPLETED|Single Dose Phase||0||
59796749|NCT00284089|75917960|FG003|COMPLETED|Single Dose Phase||0||
59796750|NCT00284089|75917957|FG000|NOT COMPLETED|Single Dose Phase||0||
59796751|NCT00284089|75917958|FG001|NOT COMPLETED|Single Dose Phase||0||
59796752|NCT00284089|75917959|FG002|NOT COMPLETED|Single Dose Phase||0||
59796753|NCT00284089|75917960|FG003|NOT COMPLETED|Single Dose Phase||0||
59796754|NCT00284089|75917957|FG000|STARTED|Multiple Dose Phase|1 subject chose to receive other treatment & discontinued before starting the multiple dose phase.|5||
59796755|NCT00284089|75917958|FG001|STARTED|Multiple Dose Phase||6||
59796756|NCT00284089|75917959|FG002|STARTED|Multiple Dose Phase||35||
59796757|NCT00284089|75917960|FG003|STARTED|Multiple Dose Phase||41||
59796758|NCT00284089|75917957|FG000|COMPLETED|Multiple Dose Phase||4||
59796759|NCT00284089|75917958|FG001|COMPLETED|Multiple Dose Phase||6||
59796760|NCT00284089|75917959|FG002|COMPLETED|Multiple Dose Phase||31||
59796761|NCT00284089|75917960|FG003|COMPLETED|Multiple Dose Phase||37||
59796762|NCT00284089|75917957|FG000|NOT COMPLETED|Multiple Dose Phase||1||
59796763|NCT00284089|75917958|FG001|NOT COMPLETED|Multiple Dose Phase||0||
59796764|NCT00284089|75917959|FG002|NOT COMPLETED|Multiple Dose Phase||4||
59796765|NCT00284089|75917960|FG003|NOT COMPLETED|Multiple Dose Phase||4||
59796766|NCT00284089|75917957|FG000|STARTED|Extension Phase|Patients providing written consent & satisfying eligibility criteria could enter the extension phase|3||
59796767|NCT00284089|75917958|FG001|STARTED|Extension Phase|Patients providing written consent & satisfying eligibility criteria could enter the extension phase|6||
59796768|NCT00284089|75917959|FG002|STARTED|Extension Phase|Patients providing written consent & satisfying eligibility criteria could enter the extension phase|28||
59796769|NCT00284089|75917960|FG003|STARTED|Extension Phase|Patients providing written consent & satisfying eligibility criteria could enter the extension phase|33||
59796770|NCT00284089|75917957|FG000|COMPLETED|Extension Phase||1||
59796771|NCT00284089|75917958|FG001|COMPLETED|Extension Phase||6||
59796772|NCT00284089|75917959|FG002|COMPLETED|Extension Phase||22||
59796773|NCT00284089|75917960|FG003|COMPLETED|Extension Phase||21||
59796774|NCT00284089|75917957|FG000|NOT COMPLETED|Extension Phase||2||
59796775|NCT00284089|75917958|FG001|NOT COMPLETED|Extension Phase||0||
59796776|NCT00284089|75917959|FG002|NOT COMPLETED|Extension Phase||6||
59796777|NCT00284089|75917960|FG003|NOT COMPLETED|Extension Phase||12||
59796778|NCT00659984|75917970|FG000|STARTED|Overall Study||15||
59954344|NCT02782377|76072840|FG000|NOT COMPLETED|Overall Study||5||
59954345|NCT02410629|76072847|FG000|STARTED|Overall Study||8||
59954346|NCT02410629|76072848|FG001|STARTED|Overall Study||9||
59796779|NCT00659984|75917970|FG000|COMPLETED|Overall Study||14||
59796780|NCT00659984|75917970|FG000|NOT COMPLETED|Overall Study||1||
59796781|NCT00864474|75917980|FG000|STARTED|Overall Study||68||
59796782|NCT00864474|75917980|FG000|COMPLETED|Overall Study||68||
59796783|NCT00864474|75917980|FG000|NOT COMPLETED|Overall Study||0||
59796784|NCT00283387|75917984|FG000|STARTED|First Intervention||6||
59796785|NCT00283387|75917985|FG001|STARTED|First Intervention||7||
59796786|NCT00283387|75917984|FG000|COMPLETED|First Intervention||5||
59796787|NCT00283387|75917985|FG001|COMPLETED|First Intervention||5||
59796788|NCT00283387|75917984|FG000|NOT COMPLETED|First Intervention||1||
59796789|NCT00283387|75917985|FG001|NOT COMPLETED|First Intervention||2||
59796790|NCT00283387|75917984|FG000|STARTED|Washout Period of 2 Months||5||
59796791|NCT00283387|75917985|FG001|STARTED|Washout Period of 2 Months||5||
59796792|NCT00283387|75917984|FG000|COMPLETED|Washout Period of 2 Months||5||
59796793|NCT00283387|75917985|FG001|COMPLETED|Washout Period of 2 Months||5||
59796794|NCT00283387|75917984|FG000|NOT COMPLETED|Washout Period of 2 Months||0||
59796795|NCT00283387|75917985|FG001|NOT COMPLETED|Washout Period of 2 Months||0||
59954347|NCT02410629|76072847|FG000|COMPLETED|Overall Study|5 subjects from the music glove group were crossed over to conventional hand exercise group.|5||
59954348|NCT02410629|76072848|FG001|COMPLETED|Overall Study|6 subjects from the conventional hand exercise group were crossed over to music glove group.|6||
59954349|NCT02410629|76072847|FG000|NOT COMPLETED|Overall Study||3||
59954350|NCT02410629|76072848|FG001|NOT COMPLETED|Overall Study||3||
59954351|NCT02252211|76072856|FG000|STARTED|Overall Study||5||
59954352|NCT02252211|76072857|FG001|STARTED|Overall Study||3||
59796796|NCT00283387|75917984|FG000|STARTED|Second Intervention||5||
59796797|NCT00283387|75917985|FG001|STARTED|Second Intervention||5||
59796798|NCT00283387|75917984|FG000|COMPLETED|Second Intervention||5||
59796799|NCT00283387|75917985|FG001|COMPLETED|Second Intervention||5||
59796800|NCT00283387|75917984|FG000|NOT COMPLETED|Second Intervention||0||
59796801|NCT00283387|75917985|FG001|NOT COMPLETED|Second Intervention||0||
59796802|NCT00282919|75917991|FG000|STARTED|Overall Study||110||
59796803|NCT00282919|75917991|FG000|COMPLETED|Overall Study||103||
59796804|NCT00282919|75917991|FG000|NOT COMPLETED|Overall Study||7||
59796805|NCT00282295|75917998|FG000|STARTED|Overall Study||446||
59796806|NCT00282295|75917999|FG001|STARTED|Overall Study||446||
59796807|NCT00282295|75918000|FG002|STARTED|Overall Study||449||
59796808|NCT00282295|75917998|FG000|COMPLETED|Overall Study||443||
59796809|NCT00282295|75917999|FG001|COMPLETED|Overall Study||429||
59796810|NCT00282295|75918000|FG002|COMPLETED|Overall Study||441||
59796811|NCT00282295|75917998|FG000|NOT COMPLETED|Overall Study||3||
59796812|NCT00282295|75917999|FG001|NOT COMPLETED|Overall Study||17||
59796813|NCT00282295|75918000|FG002|NOT COMPLETED|Overall Study||8||
59796814|NCT00742781|75918013|FG000|STARTED|Overall Study||21||
59796815|NCT00742781|75918013|FG000|COMPLETED|Overall Study||18||
59796816|NCT00742781|75918013|FG000|NOT COMPLETED|Overall Study||3||
59796817|NCT00663026|75918021|FG000|STARTED|Overall Study||19||
59796818|NCT00663026|75918022|FG001|STARTED|Overall Study||29||
59796819|NCT00663026|75918023|FG002|STARTED|Overall Study||31||
59796820|NCT00663026|75918021|FG000|COMPLETED|Overall Study||17||
59796821|NCT00663026|75918022|FG001|COMPLETED|Overall Study||23||
59796822|NCT00663026|75918023|FG002|COMPLETED|Overall Study||27||
59796823|NCT00663026|75918021|FG000|NOT COMPLETED|Overall Study||2||
59796824|NCT00663026|75918022|FG001|NOT COMPLETED|Overall Study||6||
59796825|NCT00663026|75918023|FG002|NOT COMPLETED|Overall Study||4||
59796826|NCT00280735|75918033|FG000|STARTED|Overall Study||75||
59796827|NCT00280735|75918033|FG000|Received Treatment|Overall Study||72||
59796828|NCT00280735|75918033|FG000|Received Adequate Exposure|Overall Study||57|Defined as receiving 4 cycles of therapy within 12 weeks of initiating the first dose.|
59796829|NCT00280735|75918033|FG000|COMPLETED|Overall Study||57||
59796830|NCT00280735|75918033|FG000|NOT COMPLETED|Overall Study||18||
59796831|NCT00260065|75918041|FG000|STARTED|Overall Study||99||
59796832|NCT00260065|75918041|FG000|COMPLETED|Overall Study||6||
59796833|NCT00260065|75918041|FG000|NOT COMPLETED|Overall Study||93||
59796834|NCT00506350|75918054|FG000|STARTED|Overall Study||36||
59796835|NCT00506350|75918055|FG001|STARTED|Overall Study||40||
59796836|NCT00506350|75918056|FG002|STARTED|Overall Study||37||
59796837|NCT00506350|75918057|FG003|STARTED|Overall Study||36||
59796838|NCT00506350|75918058|FG004|STARTED|Overall Study||50||
59796839|NCT00506350|75918059|FG005|STARTED|Overall Study||40||
59796840|NCT00506350|75918060|FG006|STARTED|Overall Study||35||
59796841|NCT00506350|75918061|FG007|STARTED|Overall Study||41||
59796842|NCT00506350|75918062|FG008|STARTED|Overall Study||35||
59796843|NCT00506350|75918054|FG000|COMPLETED|Overall Study||33||
59796844|NCT00506350|75918055|FG001|COMPLETED|Overall Study||37||
59796845|NCT00506350|75918056|FG002|COMPLETED|Overall Study||31||
59796846|NCT00506350|75918057|FG003|COMPLETED|Overall Study||34||
59796847|NCT00506350|75918058|FG004|COMPLETED|Overall Study||40||
59796848|NCT00506350|75918059|FG005|COMPLETED|Overall Study||38||
59796849|NCT00506350|75918060|FG006|COMPLETED|Overall Study||33||
59796850|NCT00506350|75918061|FG007|COMPLETED|Overall Study||36||
59796851|NCT00506350|75918062|FG008|COMPLETED|Overall Study||30||
59796852|NCT00506350|75918054|FG000|NOT COMPLETED|Overall Study||3||
59796853|NCT00506350|75918055|FG001|NOT COMPLETED|Overall Study||3||
59796854|NCT00506350|75918056|FG002|NOT COMPLETED|Overall Study||6||
59796855|NCT00506350|75918057|FG003|NOT COMPLETED|Overall Study||2||
59796856|NCT00506350|75918058|FG004|NOT COMPLETED|Overall Study||10||
59796857|NCT00506350|75918059|FG005|NOT COMPLETED|Overall Study||2||
59796858|NCT00506350|75918060|FG006|NOT COMPLETED|Overall Study||2||
59796859|NCT00506350|75918061|FG007|NOT COMPLETED|Overall Study||5||
59796860|NCT00506350|75918062|FG008|NOT COMPLETED|Overall Study||5||
59796861|NCT00258895|75918091|FG000|STARTED|Overall Study||487||
59796862|NCT00258895|75918092|FG001|STARTED|Overall Study||162||
59796863|NCT00258895|75918091|FG000|COMPLETED|Overall Study||477||
59796864|NCT00258895|75918092|FG001|COMPLETED|Overall Study||159||
59796865|NCT00258895|75918091|FG000|NOT COMPLETED|Overall Study||10||
59796866|NCT00258895|75918092|FG001|NOT COMPLETED|Overall Study||3||
59796867|NCT00742625|75918098|FG000|STARTED|Remission Induction||95||
59796868|NCT00742625|75918098|FG000|COMPLETED|Remission Induction||41||
59796869|NCT00742625|75918098|FG000|NOT COMPLETED|Remission Induction||54||
59796870|NCT00742625|75918098|FG000|STARTED|Consolidation||41||
59796871|NCT00742625|75918098|FG000|COMPLETED|Consolidation||20||
59796872|NCT00742625|75918098|FG000|NOT COMPLETED|Consolidation||21||
59796873|NCT00618618|75918109|FG000|STARTED|Overall Study||24||
59796874|NCT00618618|75918110|FG001|STARTED|Overall Study||14||
59796875|NCT00618618|75918111|FG002|STARTED|Overall Study||21||
59796876|NCT00618618|75918112|FG003|STARTED|Overall Study||14||
59796877|NCT00618618|75918109|FG000|Received Treatment|Overall Study||24||
59796878|NCT00618618|75918110|FG001|Received Treatment|Overall Study||13||
59796879|NCT00618618|75918111|FG002|Received Treatment|Overall Study||20||
59796880|NCT00618618|75918112|FG003|Received Treatment|Overall Study||14||
59796881|NCT00618618|75918109|FG000|COMPLETED|Overall Study||20||
59796882|NCT00618618|75918110|FG001|COMPLETED|Overall Study||11||
59796883|NCT00618618|75918111|FG002|COMPLETED|Overall Study||18||
59796884|NCT00618618|75918112|FG003|COMPLETED|Overall Study||13||
59796885|NCT00618618|75918109|FG000|NOT COMPLETED|Overall Study||4||
59796886|NCT00618618|75918110|FG001|NOT COMPLETED|Overall Study||3||
59796887|NCT00618618|75918111|FG002|NOT COMPLETED|Overall Study||3||
59796888|NCT00618618|75918112|FG003|NOT COMPLETED|Overall Study||1||
59796889|NCT00246805|75918125|FG000|STARTED|Phase 1||34||
59796890|NCT00246805|75918126|FG001|STARTED|Phase 1||33||
59796891|NCT00246805|75918125|FG000|COMPLETED|Phase 1||33||
59796892|NCT00246805|75918126|FG001|COMPLETED|Phase 1||33||
59796893|NCT00246805|75918125|FG000|NOT COMPLETED|Phase 1||1||
59796894|NCT00246805|75918126|FG001|NOT COMPLETED|Phase 1||0||
59796895|NCT00246805|75918125|FG000|STARTED|Phase 2||33||
59796896|NCT00246805|75918126|FG001|STARTED|Phase 2||33||
59796897|NCT00246805|75918125|FG000|COMPLETED|Phase 2||33||
59796898|NCT00246805|75918126|FG001|COMPLETED|Phase 2||33||
59796899|NCT00246805|75918125|FG000|NOT COMPLETED|Phase 2||0||
59796900|NCT00246805|75918126|FG001|NOT COMPLETED|Phase 2||0||
59796901|NCT00519376|75918132|FG000|STARTED|Treatment Period 1||2||
59796902|NCT00519376|75918133|FG001|STARTED|Treatment Period 1||2||
59796903|NCT00519376|75918134|FG002|STARTED|Treatment Period 1||2||
59796904|NCT00519376|75918135|FG003|STARTED|Treatment Period 1||2||
59796905|NCT00519376|75918136|FG004|STARTED|Treatment Period 1||1||
59796906|NCT00519376|75918137|FG005|STARTED|Treatment Period 1||1||
59796907|NCT00519376|75918138|FG006|STARTED|Treatment Period 1||1||
59796908|NCT00519376|75918139|FG007|STARTED|Treatment Period 1||1||
59796909|NCT00519376|75918140|FG008|STARTED|Treatment Period 1||1||
59796910|NCT00519376|75918141|FG009|STARTED|Treatment Period 1||1||
59796911|NCT00519376|75918142|FG010|STARTED|Treatment Period 1||1||
59796912|NCT00519376|75918143|FG011|STARTED|Treatment Period 1||1||
59796913|NCT00519376|75918144|FG012|STARTED|Treatment Period 1||1||
59796914|NCT00519376|75918145|FG013|STARTED|Treatment Period 1||1||
59796915|NCT00519376|75918146|FG014|STARTED|Treatment Period 1||1||
59796916|NCT00519376|75918147|FG015|STARTED|Treatment Period 1||1||
59796917|NCT00519376|75918132|FG000|COMPLETED|Treatment Period 1||2||
59796918|NCT00519376|75918133|FG001|COMPLETED|Treatment Period 1||2||
59796919|NCT00519376|75918134|FG002|COMPLETED|Treatment Period 1||2||
59796920|NCT00519376|75918135|FG003|COMPLETED|Treatment Period 1||2||
59796921|NCT00519376|75918136|FG004|COMPLETED|Treatment Period 1||1||
59796922|NCT00519376|75918137|FG005|COMPLETED|Treatment Period 1||1||
59796923|NCT00519376|75918138|FG006|COMPLETED|Treatment Period 1||1||
59796924|NCT00519376|75918139|FG007|COMPLETED|Treatment Period 1||1||
59796925|NCT00519376|75918140|FG008|COMPLETED|Treatment Period 1||1||
59796926|NCT00519376|75918141|FG009|COMPLETED|Treatment Period 1||1||
59796927|NCT00519376|75918142|FG010|COMPLETED|Treatment Period 1||1||
59796928|NCT00519376|75918143|FG011|COMPLETED|Treatment Period 1||1||
59796929|NCT00519376|75918144|FG012|COMPLETED|Treatment Period 1||1||
59796930|NCT00519376|75918145|FG013|COMPLETED|Treatment Period 1||1||
59796931|NCT00519376|75918146|FG014|COMPLETED|Treatment Period 1||1||
59796932|NCT00519376|75918147|FG015|COMPLETED|Treatment Period 1||1||
59796933|NCT00519376|75918132|FG000|NOT COMPLETED|Treatment Period 1||0||
59796934|NCT00519376|75918133|FG001|NOT COMPLETED|Treatment Period 1||0||
59796935|NCT00519376|75918134|FG002|NOT COMPLETED|Treatment Period 1||0||
59796936|NCT00519376|75918135|FG003|NOT COMPLETED|Treatment Period 1||0||
59796937|NCT00519376|75918136|FG004|NOT COMPLETED|Treatment Period 1||0||
59796938|NCT00519376|75918137|FG005|NOT COMPLETED|Treatment Period 1||0||
59796939|NCT00519376|75918138|FG006|NOT COMPLETED|Treatment Period 1||0||
59796940|NCT00519376|75918139|FG007|NOT COMPLETED|Treatment Period 1||0||
59796941|NCT00519376|75918140|FG008|NOT COMPLETED|Treatment Period 1||0||
59796942|NCT00519376|75918141|FG009|NOT COMPLETED|Treatment Period 1||0||
59796943|NCT00519376|75918142|FG010|NOT COMPLETED|Treatment Period 1||0||
59796944|NCT00519376|75918143|FG011|NOT COMPLETED|Treatment Period 1||0||
59796945|NCT00519376|75918144|FG012|NOT COMPLETED|Treatment Period 1||0||
59796946|NCT00519376|75918145|FG013|NOT COMPLETED|Treatment Period 1||0||
59796947|NCT00519376|75918146|FG014|NOT COMPLETED|Treatment Period 1||0||
59796948|NCT00519376|75918147|FG015|NOT COMPLETED|Treatment Period 1||0||
59796949|NCT00519376|75918132|FG000|STARTED|Washout Period 1||2||
59796950|NCT00519376|75918133|FG001|STARTED|Washout Period 1||2||
59796951|NCT00519376|75918134|FG002|STARTED|Washout Period 1||2||
59796952|NCT00519376|75918135|FG003|STARTED|Washout Period 1||2||
59796953|NCT00519376|75918136|FG004|STARTED|Washout Period 1||1||
59796954|NCT00519376|75918137|FG005|STARTED|Washout Period 1||1||
59796955|NCT00519376|75918138|FG006|STARTED|Washout Period 1||1||
59796956|NCT00519376|75918139|FG007|STARTED|Washout Period 1||1||
59796957|NCT00519376|75918140|FG008|STARTED|Washout Period 1||1||
59796958|NCT00519376|75918141|FG009|STARTED|Washout Period 1||1||
59796959|NCT00519376|75918142|FG010|STARTED|Washout Period 1||1||
59796960|NCT00519376|75918143|FG011|STARTED|Washout Period 1||1||
59796961|NCT00519376|75918144|FG012|STARTED|Washout Period 1||1||
59796962|NCT00519376|75918145|FG013|STARTED|Washout Period 1||1||
59796963|NCT00519376|75918146|FG014|STARTED|Washout Period 1||1||
59796964|NCT00519376|75918147|FG015|STARTED|Washout Period 1||1||
59796965|NCT00519376|75918132|FG000|COMPLETED|Washout Period 1||2||
59796966|NCT00519376|75918133|FG001|COMPLETED|Washout Period 1||2||
59796967|NCT00519376|75918134|FG002|COMPLETED|Washout Period 1||2||
59796968|NCT00519376|75918135|FG003|COMPLETED|Washout Period 1||2||
59796969|NCT00519376|75918136|FG004|COMPLETED|Washout Period 1||1||
59796970|NCT00519376|75918137|FG005|COMPLETED|Washout Period 1||1||
59796971|NCT00519376|75918138|FG006|COMPLETED|Washout Period 1||1||
59796972|NCT00519376|75918139|FG007|COMPLETED|Washout Period 1||1||
59796973|NCT00519376|75918140|FG008|COMPLETED|Washout Period 1||1||
59796974|NCT00519376|75918141|FG009|COMPLETED|Washout Period 1||1||
59796975|NCT00519376|75918142|FG010|COMPLETED|Washout Period 1||1||
59796976|NCT00519376|75918143|FG011|COMPLETED|Washout Period 1||1||
59796977|NCT00519376|75918144|FG012|COMPLETED|Washout Period 1||1||
59796978|NCT00519376|75918145|FG013|COMPLETED|Washout Period 1||1||
59796979|NCT00519376|75918146|FG014|COMPLETED|Washout Period 1||1||
59796980|NCT00519376|75918147|FG015|COMPLETED|Washout Period 1||1||
59796981|NCT00519376|75918132|FG000|NOT COMPLETED|Washout Period 1||0||
59796982|NCT00519376|75918133|FG001|NOT COMPLETED|Washout Period 1||0||
59796983|NCT00519376|75918134|FG002|NOT COMPLETED|Washout Period 1||0||
59796984|NCT00519376|75918135|FG003|NOT COMPLETED|Washout Period 1||0||
59796985|NCT00519376|75918136|FG004|NOT COMPLETED|Washout Period 1||0||
59796986|NCT00519376|75918137|FG005|NOT COMPLETED|Washout Period 1||0||
59796987|NCT00519376|75918138|FG006|NOT COMPLETED|Washout Period 1||0||
59796988|NCT00519376|75918139|FG007|NOT COMPLETED|Washout Period 1||0||
59796989|NCT00519376|75918140|FG008|NOT COMPLETED|Washout Period 1||0||
59796990|NCT00519376|75918141|FG009|NOT COMPLETED|Washout Period 1||0||
59796991|NCT00519376|75918142|FG010|NOT COMPLETED|Washout Period 1||0||
59796992|NCT00519376|75918143|FG011|NOT COMPLETED|Washout Period 1||0||
59796993|NCT00519376|75918144|FG012|NOT COMPLETED|Washout Period 1||0||
59796994|NCT00519376|75918145|FG013|NOT COMPLETED|Washout Period 1||0||
60073573|NCT00089284|76188830|FG001|NOT COMPLETED|Overall Study||0||
60073574|NCT00089284|76188831|FG002|NOT COMPLETED|Overall Study||0||
60073575|NCT00089284|76188832|FG003|NOT COMPLETED|Overall Study||0||
60073576|NCT00089284|76188833|FG004|NOT COMPLETED|Overall Study||0||
60073577|NCT00089284|76188834|FG005|NOT COMPLETED|Overall Study||0||
60073578|NCT00089284|76188835|FG006|NOT COMPLETED|Overall Study||1||
60073579|NCT01688973|76188859|FG000|STARTED|Overall Study||27||
60073580|NCT01688973|76188860|FG001|STARTED|Overall Study||28||
60073581|NCT01688973|76188859|FG000|Eligible/Evaluable Patients|Overall Study||25||
60073582|NCT01688973|76188860|FG001|Eligible/Evaluable Patients|Overall Study||25||
60073583|NCT01688973|76188859|FG000|COMPLETED|Overall Study||25||
60073584|NCT01688973|76188860|FG001|COMPLETED|Overall Study||25||
60073585|NCT01688973|76188859|FG000|NOT COMPLETED|Overall Study||2||
60073586|NCT01688973|76188860|FG001|NOT COMPLETED|Overall Study||3||
60073587|NCT00087646|76188871|FG000|STARTED|Overall Study||317||
60073588|NCT00087646|76188872|FG001|STARTED|Overall Study||156||
60073589|NCT00087646|76188873|FG002|STARTED|Overall Study||156||
60073590|NCT00087646|76188874|FG003|STARTED|Overall Study||313||
60073591|NCT00087646|76188871|FG000|COMPLETED|Overall Study||182||
60073592|NCT00087646|76188872|FG001|COMPLETED|Overall Study||114||
60073593|NCT00087646|76188873|FG002|COMPLETED|Overall Study||91||
60073594|NCT00087646|76188874|FG003|COMPLETED|Overall Study||229||
60073595|NCT00087646|76188871|FG000|NOT COMPLETED|Overall Study||135||
60073596|NCT00087646|76188872|FG001|NOT COMPLETED|Overall Study||42||
60073597|NCT00087646|76188873|FG002|NOT COMPLETED|Overall Study||65||
60073598|NCT00087646|76188874|FG003|NOT COMPLETED|Overall Study||84||
59796995|NCT00519376|75918146|FG014|NOT COMPLETED|Washout Period 1||0||
59796996|NCT00519376|75918147|FG015|NOT COMPLETED|Washout Period 1||0||
59796997|NCT00519376|75918132|FG000|STARTED|Treatment Period 2||2||
59796998|NCT00519376|75918133|FG001|STARTED|Treatment Period 2||2||
59796999|NCT00519376|75918134|FG002|STARTED|Treatment Period 2||2||
59797000|NCT00519376|75918135|FG003|STARTED|Treatment Period 2||2||
59797001|NCT00519376|75918136|FG004|STARTED|Treatment Period 2||1||
59797002|NCT00519376|75918137|FG005|STARTED|Treatment Period 2||1||
60073599|NCT00087568|76188891|FG000|STARTED|Overall Study||32||
60073600|NCT00087568|76188892|FG001|STARTED|Overall Study||25||
60073601|NCT00087568|76188891|FG000|COMPLETED|Overall Study||2||
60073602|NCT00087568|76188892|FG001|COMPLETED|Overall Study||23||
60073603|NCT00087568|76188891|FG000|NOT COMPLETED|Overall Study||30||
60073604|NCT00087568|76188892|FG001|NOT COMPLETED|Overall Study||2||
60073605|NCT00085540|76188900|FG000|STARTED|Overall Study||8||
60073606|NCT00085540|76188901|FG001|STARTED|Overall Study||42||
60073607|NCT00085540|76188900|FG000|COMPLETED|Overall Study||8||
60073608|NCT00085540|76188901|FG001|COMPLETED|Overall Study||40||
60073609|NCT00085540|76188900|FG000|NOT COMPLETED|Overall Study||0||
60073610|NCT00085540|76188901|FG001|NOT COMPLETED|Overall Study||2||
60073611|NCT01688739|76188917|FG000|STARTED|Overall Study||13||
60073612|NCT01688739|76188918|FG001|STARTED|Overall Study||3||
60073613|NCT01688739|76188919|FG002|STARTED|Overall Study||3||
60073614|NCT01688739|76188920|FG003|STARTED|Overall Study||6||
60073615|NCT01688739|76188921|FG004|STARTED|Overall Study||6||
60073616|NCT01688739|76188922|FG005|STARTED|Overall Study||6||
59523492|NCT00020722|75618337|FG000|STARTED|Overall Study||7||
59523493|NCT00020722|75618337|FG000|COMPLETED|Overall Study||7||
59523494|NCT00020722|75618337|FG000|NOT COMPLETED|Overall Study||0||
59523495|NCT04051996|75618344|FG000|STARTED|Overall Study||1||
59523496|NCT04051996|75618345|FG001|STARTED|Overall Study||0||
59523497|NCT04051996|75618344|FG000|COMPLETED|Overall Study||1||
59523498|NCT04051996|75618345|FG001|COMPLETED|Overall Study||0||
59523499|NCT04051996|75618344|FG000|NOT COMPLETED|Overall Study||0||
59523500|NCT04051996|75618345|FG001|NOT COMPLETED|Overall Study||0||
59523501|NCT02385292|75618353|FG000|STARTED|Overall Study||0||
59523502|NCT02385292|75618354|FG001|STARTED|Overall Study||0||
59523503|NCT02385292|75618353|FG000|COMPLETED|Overall Study||0||
59523504|NCT02385292|75618354|FG001|COMPLETED|Overall Study||0||
59523505|NCT02385292|75618353|FG000|NOT COMPLETED|Overall Study||0||
59523506|NCT02385292|75618354|FG001|NOT COMPLETED|Overall Study||0||
59523507|NCT02126878|75618363|FG000|STARTED|Overall Study||0||
59523508|NCT02126878|75618364|FG001|STARTED|Overall Study||0||
59523509|NCT02126878|75618365|FG002|STARTED|Overall Study||0||
59523510|NCT02126878|75618363|FG000|COMPLETED|Overall Study||0||
59523511|NCT02126878|75618364|FG001|COMPLETED|Overall Study||0||
59523512|NCT02126878|75618365|FG002|COMPLETED|Overall Study||0||
59523513|NCT02126878|75618363|FG000|NOT COMPLETED|Overall Study||0||
59523514|NCT02126878|75618364|FG001|NOT COMPLETED|Overall Study||0||
59523515|NCT02126878|75618365|FG002|NOT COMPLETED|Overall Study||0||
59523516|NCT02376946|75618375|FG000|STARTED|Overall Study|study terminated prior to being conducted|0||
59523517|NCT02376946|75618376|FG001|STARTED|Overall Study|study terminated prior to being conducted|0||
59523518|NCT02376946|75618375|FG000|COMPLETED|Overall Study|study terminated prior to being conducted|0||
59523519|NCT02376946|75618376|FG001|COMPLETED|Overall Study|study terminated prior to being conducted|0||
59523520|NCT02376946|75618375|FG000|NOT COMPLETED|Overall Study||0||
59523521|NCT02376946|75618376|FG001|NOT COMPLETED|Overall Study||0||
59954353|NCT02252211|76072858|FG002|STARTED|Overall Study||1||
59954354|NCT02252211|76072856|FG000|Received Dose 1 (Day 1)|Overall Study||4||
59523522|NCT01780636|75618382|FG000|STARTED|Overall Study||7||
59523523|NCT01780636|75618382|FG000|COMPLETED|Overall Study||7||
59523524|NCT01780636|75618382|FG000|NOT COMPLETED|Overall Study||0||
59523525|NCT01561378|75618388|FG000|STARTED|Overall Study||11||
59523526|NCT01561378|75618389|FG001|STARTED|Overall Study||11||
59523527|NCT01561378|75618388|FG000|COMPLETED|Overall Study||11||
59523528|NCT01561378|75618389|FG001|COMPLETED|Overall Study||11||
59523529|NCT01561378|75618388|FG000|NOT COMPLETED|Overall Study||0||
59523530|NCT01561378|75618389|FG001|NOT COMPLETED|Overall Study||0||
59523531|NCT03236662|75618395|FG000|STARTED|Overall Study||2||
59523532|NCT03236662|75618395|FG000|COMPLETED|Overall Study||2||
59523533|NCT03236662|75618395|FG000|NOT COMPLETED|Overall Study||0||
59523534|NCT04017754|75618399|FG000|STARTED|Overall Study||267||
59523535|NCT04017754|75618400|FG001|STARTED|Overall Study||185||
59523536|NCT04017754|75618399|FG000|COMPLETED|Overall Study||267||
59523537|NCT04017754|75618400|FG001|COMPLETED|Overall Study||185||
59523538|NCT04017754|75618399|FG000|NOT COMPLETED|Overall Study||0||
59523539|NCT04017754|75618400|FG001|NOT COMPLETED|Overall Study||0||
59523540|NCT02268656|75618445|FG000|STARTED|Overall Study||20||
59523541|NCT02268656|75618446|FG001|STARTED|Overall Study||20||
59523542|NCT02268656|75618445|FG000|COMPLETED|Overall Study||20||
59523543|NCT02268656|75618446|FG001|COMPLETED|Overall Study||20||
59523544|NCT02268656|75618445|FG000|NOT COMPLETED|Overall Study||0||
59620405|NCT00258180|75731733|FG000|NOT COMPLETED|Overall Study||0||
59620406|NCT00258882|75731740|FG000|STARTED|Adacel Recipients Historic Cohort Method||124139||
59954355|NCT02252211|76072857|FG001|Received Dose 1 (Day 1)|Overall Study||3||
59954356|NCT02252211|76072858|FG002|Received Dose 1 (Day 1)|Overall Study||0||
59954357|NCT02252211|76072856|FG000|Received Dose 2 (Day 8)|Overall Study||4||
59954358|NCT02252211|76072857|FG001|Received Dose 2 (Day 8)|Overall Study||3||
59954359|NCT02252211|76072858|FG002|Received Dose 2 (Day 8)|Overall Study||0||
59954360|NCT02252211|76072856|FG000|Received Dose 3 (Day 22)|Overall Study||3||
59523545|NCT02268656|75618446|FG001|NOT COMPLETED|Overall Study||0||
59523546|NCT02554890|75618454|FG000|STARTED|Double-blind||444|Randomized|
59523547|NCT02554890|75618455|FG001|STARTED|Double-blind||443|Randomized|
59523548|NCT02554890|75618454|FG000|Treated Patients|Double-blind||436|Treated|
59523549|NCT02554890|75618455|FG001|Treated Patients|Double-blind||439|Treated|
59523550|NCT02554890|75618454|FG000|COMPLETED|Double-blind||348|Continued study treatment during double-blind phase|
59523551|NCT02554890|75618455|FG001|COMPLETED|Double-blind||352|Continued study treatment during double-blind phase|
59523552|NCT02554890|75618454|FG000|NOT COMPLETED|Double-blind||96||
59523553|NCT02554890|75618455|FG001|NOT COMPLETED|Double-blind||91||
59523554|NCT02554890|75618454|FG000|STARTED|Open-label||0|Randomized|
59620407|NCT00258882|75731741|FG001|STARTED|Adacel Recipients Historic Cohort Method||203154||
59523555|NCT02554890|75618455|FG001|STARTED|Open-label||887|Randomized|
59523556|NCT02554890|75618454|FG000|COMPLETED|Open-label||0|Continued study treatment during open-label phase|
59523557|NCT02554890|75618455|FG001|COMPLETED|Open-label||835|Continued study treatment during open-label phase|
59523558|NCT02554890|75618454|FG000|NOT COMPLETED|Open-label||0||
59954361|NCT02252211|76072857|FG001|Received Dose 3 (Day 22)|Overall Study||3||
59954362|NCT02252211|76072858|FG002|Received Dose 3 (Day 22)|Overall Study||0||
60073617|NCT01688739|76188923|FG006|STARTED|Overall Study||6||
60073618|NCT01688739|76188924|FG007|STARTED|Overall Study||6||
60073619|NCT01688739|76188925|FG008|STARTED|Overall Study||6||
60073620|NCT01688739|76188926|FG009|STARTED|Overall Study||6||
60073621|NCT01688739|76188917|FG000|Received Study Drug|Overall Study||12||
60073622|NCT01688739|76188918|FG001|Received Study Drug|Overall Study||3||
60073623|NCT01688739|76188919|FG002|Received Study Drug|Overall Study||3||
60073624|NCT01688739|76188920|FG003|Received Study Drug|Overall Study||6||
60073625|NCT01688739|76188921|FG004|Received Study Drug|Overall Study||6||
60073626|NCT01688739|76188922|FG005|Received Study Drug|Overall Study||6||
60073627|NCT01688739|76188923|FG006|Received Study Drug|Overall Study||6||
60073628|NCT01688739|76188924|FG007|Received Study Drug|Overall Study||6||
60073629|NCT01688739|76188925|FG008|Received Study Drug|Overall Study||6||
60073630|NCT01688739|76188926|FG009|Received Study Drug|Overall Study||6||
60073631|NCT01688739|76188917|FG000|COMPLETED|Overall Study||12||
60073632|NCT01688739|76188918|FG001|COMPLETED|Overall Study||3||
60073633|NCT01688739|76188919|FG002|COMPLETED|Overall Study||3||
60073634|NCT01688739|76188920|FG003|COMPLETED|Overall Study||6||
60073635|NCT01688739|76188921|FG004|COMPLETED|Overall Study||6||
60073636|NCT01688739|76188922|FG005|COMPLETED|Overall Study||6||
60073637|NCT01688739|76188923|FG006|COMPLETED|Overall Study||6||
60073638|NCT01688739|76188924|FG007|COMPLETED|Overall Study||6||
60073639|NCT01688739|76188925|FG008|COMPLETED|Overall Study||6||
60073640|NCT01688739|76188926|FG009|COMPLETED|Overall Study||6||
60073641|NCT01688739|76188917|FG000|NOT COMPLETED|Overall Study||1||
60073642|NCT01688739|76188918|FG001|NOT COMPLETED|Overall Study||0||
60073643|NCT01688739|76188919|FG002|NOT COMPLETED|Overall Study||0||
60073644|NCT01688739|76188920|FG003|NOT COMPLETED|Overall Study||0||
60073645|NCT01688739|76188921|FG004|NOT COMPLETED|Overall Study||0||
60073646|NCT01688739|76188922|FG005|NOT COMPLETED|Overall Study||0||
60073647|NCT01688739|76188923|FG006|NOT COMPLETED|Overall Study||0||
60073648|NCT01688739|76188924|FG007|NOT COMPLETED|Overall Study||0||
60073649|NCT01688739|76188925|FG008|NOT COMPLETED|Overall Study||0||
60073650|NCT01688739|76188926|FG009|NOT COMPLETED|Overall Study||0||
60073651|NCT00084838|76188956|FG000|STARTED|Overall Study||25||
60073652|NCT00084838|76188956|FG000|Eligible and Treated|Overall Study|4 ineligible pts upon central path review (n=3) and per DFCI IRB (n=1); 1 pt withdrew before rcv trt|20||
60073653|NCT00084838|76188956|FG000|COMPLETED|Overall Study||12||
60073654|NCT00084838|76188956|FG000|NOT COMPLETED|Overall Study||13||
60073655|NCT01558089|76188962|FG000|STARTED|Overall Study||76||
60073656|NCT01558089|76188962|FG000|COMPLETED|Overall Study||63||
60073657|NCT01558089|76188962|FG000|NOT COMPLETED|Overall Study||13||
60073658|NCT01581021|76188968|FG000|STARTED|Overall Study||29||
60073659|NCT01581021|76188969|FG001|STARTED|Overall Study||29||
60073660|NCT01581021|76188968|FG000|COMPLETED|Overall Study||19||
60073661|NCT01581021|76188969|FG001|COMPLETED|Overall Study||18||
60073662|NCT01581021|76188968|FG000|NOT COMPLETED|Overall Study||10||
60073663|NCT01581021|76188969|FG001|NOT COMPLETED|Overall Study||11||
60073664|NCT00084682|76188975|FG000|STARTED|Overall Study||14||
60073665|NCT00084682|76188975|FG000|COMPLETED|Overall Study||13||
60073666|NCT00084682|76188975|FG000|NOT COMPLETED|Overall Study||1||
60073667|NCT01556997|76188983|FG000|STARTED|Overall Study||279||
60073668|NCT01556997|76188984|FG001|STARTED|Overall Study||280||
60073669|NCT01556997|76188985|FG002|STARTED|Overall Study||278||
60073670|NCT01556997|76188983|FG000|COMPLETED|Overall Study||253||
60073671|NCT01556997|76188984|FG001|COMPLETED|Overall Study||252||
60073672|NCT01556997|76188985|FG002|COMPLETED|Overall Study||246||
60073673|NCT01556997|76188983|FG000|NOT COMPLETED|Overall Study||26||
60073674|NCT01556997|76188984|FG001|NOT COMPLETED|Overall Study||28||
60073675|NCT01556997|76188985|FG002|NOT COMPLETED|Overall Study||32||
60073676|NCT00082888|76188996|FG000|STARTED|Overall Study||42||
60073677|NCT00082888|76188997|FG001|STARTED|Overall Study||15||
60073678|NCT00082888|76188998|FG002|STARTED|Overall Study||36||
60073679|NCT00082888|76188996|FG000|COMPLETED|Overall Study||41||
60073680|NCT00082888|76188997|FG001|COMPLETED|Overall Study||15||
60073681|NCT00082888|76188998|FG002|COMPLETED|Overall Study||36||
60073682|NCT00082888|76188996|FG000|NOT COMPLETED|Overall Study||1||
60073683|NCT00082888|76188997|FG001|NOT COMPLETED|Overall Study||0||
60073684|NCT00082888|76188998|FG002|NOT COMPLETED|Overall Study||0||
60073685|NCT00082810|76189007|FG000|STARTED|Overall Study||33||
60073686|NCT00082810|76189007|FG000|COMPLETED|Overall Study||2||
60073687|NCT00082810|76189007|FG000|NOT COMPLETED|Overall Study||31||
60073688|NCT01577745|76189018|FG000|STARTED|Overall Study||3||
60073689|NCT01577745|76189019|FG001|STARTED|Overall Study||3||
60073690|NCT01577745|76189020|FG002|STARTED|Overall Study||3||
60073691|NCT01577745|76189021|FG003|STARTED|Overall Study||6||
60073692|NCT01577745|76189022|FG004|STARTED|Overall Study||5||
60073693|NCT01577745|76189023|FG005|STARTED|Overall Study||5||
60073694|NCT01577745|76189018|FG000|COMPLETED|Overall Study||0||
60073695|NCT01577745|76189019|FG001|COMPLETED|Overall Study||0||
60073696|NCT01577745|76189020|FG002|COMPLETED|Overall Study||1||
60073697|NCT01577745|76189021|FG003|COMPLETED|Overall Study||0||
60073698|NCT01577745|76189022|FG004|COMPLETED|Overall Study||0||
60073699|NCT01577745|76189023|FG005|COMPLETED|Overall Study||1||
60073700|NCT01577745|76189018|FG000|NOT COMPLETED|Overall Study||3||
60073701|NCT01577745|76189019|FG001|NOT COMPLETED|Overall Study||3||
60073702|NCT01577745|76189020|FG002|NOT COMPLETED|Overall Study||2||
60073703|NCT01577745|76189021|FG003|NOT COMPLETED|Overall Study||6||
59797003|NCT00519376|75918138|FG006|STARTED|Treatment Period 2||1||
59797004|NCT00519376|75918139|FG007|STARTED|Treatment Period 2||1||
59797005|NCT00519376|75918140|FG008|STARTED|Treatment Period 2||1||
59797006|NCT00519376|75918141|FG009|STARTED|Treatment Period 2||1||
59797007|NCT00519376|75918142|FG010|STARTED|Treatment Period 2||1||
59797008|NCT00519376|75918143|FG011|STARTED|Treatment Period 2||1||
59797009|NCT00519376|75918144|FG012|STARTED|Treatment Period 2||1||
59797010|NCT00519376|75918145|FG013|STARTED|Treatment Period 2||1||
59797011|NCT00519376|75918146|FG014|STARTED|Treatment Period 2||1||
59797012|NCT00519376|75918147|FG015|STARTED|Treatment Period 2||1||
59797013|NCT00519376|75918132|FG000|COMPLETED|Treatment Period 2||2||
59797014|NCT00519376|75918133|FG001|COMPLETED|Treatment Period 2||2||
59797015|NCT00519376|75918134|FG002|COMPLETED|Treatment Period 2||2||
59797016|NCT00519376|75918135|FG003|COMPLETED|Treatment Period 2||2||
59797017|NCT00519376|75918136|FG004|COMPLETED|Treatment Period 2||1||
59797018|NCT00519376|75918137|FG005|COMPLETED|Treatment Period 2||1||
59797019|NCT00519376|75918138|FG006|COMPLETED|Treatment Period 2||1||
59797020|NCT00519376|75918139|FG007|COMPLETED|Treatment Period 2||1||
59797021|NCT00519376|75918140|FG008|COMPLETED|Treatment Period 2||1||
59797022|NCT00519376|75918141|FG009|COMPLETED|Treatment Period 2||1||
59797023|NCT00519376|75918142|FG010|COMPLETED|Treatment Period 2||1||
59797024|NCT00519376|75918143|FG011|COMPLETED|Treatment Period 2||1||
59797025|NCT00519376|75918144|FG012|COMPLETED|Treatment Period 2||0||
59797026|NCT00519376|75918145|FG013|COMPLETED|Treatment Period 2||1||
59797027|NCT00519376|75918146|FG014|COMPLETED|Treatment Period 2||1||
59797028|NCT00519376|75918147|FG015|COMPLETED|Treatment Period 2||1||
59797029|NCT00519376|75918132|FG000|NOT COMPLETED|Treatment Period 2||0||
59797030|NCT00519376|75918133|FG001|NOT COMPLETED|Treatment Period 2||0||
59797031|NCT00519376|75918134|FG002|NOT COMPLETED|Treatment Period 2||0||
59797032|NCT00519376|75918135|FG003|NOT COMPLETED|Treatment Period 2||0||
59797033|NCT00519376|75918136|FG004|NOT COMPLETED|Treatment Period 2||0||
59797034|NCT00519376|75918137|FG005|NOT COMPLETED|Treatment Period 2||0||
59797035|NCT00519376|75918138|FG006|NOT COMPLETED|Treatment Period 2||0||
59797036|NCT00519376|75918139|FG007|NOT COMPLETED|Treatment Period 2||0||
59797037|NCT00519376|75918140|FG008|NOT COMPLETED|Treatment Period 2||0||
59797038|NCT00519376|75918141|FG009|NOT COMPLETED|Treatment Period 2||0||
59797039|NCT00519376|75918142|FG010|NOT COMPLETED|Treatment Period 2||0||
59797040|NCT00519376|75918143|FG011|NOT COMPLETED|Treatment Period 2||0||
59797041|NCT00519376|75918144|FG012|NOT COMPLETED|Treatment Period 2||1||
59797042|NCT00519376|75918145|FG013|NOT COMPLETED|Treatment Period 2||0||
59797043|NCT00519376|75918146|FG014|NOT COMPLETED|Treatment Period 2||0||
59797044|NCT00519376|75918147|FG015|NOT COMPLETED|Treatment Period 2||0||
59797045|NCT00519376|75918132|FG000|STARTED|Washout Period 2||2||
59797046|NCT00519376|75918133|FG001|STARTED|Washout Period 2||2||
59797047|NCT00519376|75918134|FG002|STARTED|Washout Period 2||2||
59797048|NCT00519376|75918135|FG003|STARTED|Washout Period 2||2||
59797049|NCT00519376|75918136|FG004|STARTED|Washout Period 2||1||
59797050|NCT00519376|75918137|FG005|STARTED|Washout Period 2||1||
59797051|NCT00519376|75918138|FG006|STARTED|Washout Period 2||1||
59797052|NCT00519376|75918139|FG007|STARTED|Washout Period 2||1||
59797053|NCT00519376|75918140|FG008|STARTED|Washout Period 2||1||
59797054|NCT00519376|75918141|FG009|STARTED|Washout Period 2||1||
59797055|NCT00519376|75918142|FG010|STARTED|Washout Period 2||1||
59797056|NCT00519376|75918143|FG011|STARTED|Washout Period 2||1||
59797057|NCT00519376|75918144|FG012|STARTED|Washout Period 2||0||
59797058|NCT00519376|75918145|FG013|STARTED|Washout Period 2||1||
59797059|NCT00519376|75918146|FG014|STARTED|Washout Period 2||1||
60073704|NCT01577745|76189022|FG004|NOT COMPLETED|Overall Study||5||
60073705|NCT01577745|76189023|FG005|NOT COMPLETED|Overall Study||4||
60073706|NCT01688037|76189045|FG000|STARTED|Double-Blind Period (Week 0 to 6)||54||
60073707|NCT01688037|76189046|FG001|STARTED|Double-Blind Period (Week 0 to 6)||28||
60073708|NCT01688037|76189047|FG002|STARTED|Double-Blind Period (Week 0 to 6)||27||
60073709|NCT01688037|76189045|FG000|COMPLETED|Double-Blind Period (Week 0 to 6)||47||
60073710|NCT01688037|76189046|FG001|COMPLETED|Double-Blind Period (Week 0 to 6)||25||
60073711|NCT01688037|76189047|FG002|COMPLETED|Double-Blind Period (Week 0 to 6)||21||
60073712|NCT01688037|76189045|FG000|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||7||
59797060|NCT00519376|75918147|FG015|STARTED|Washout Period 2||1||
59797061|NCT00519376|75918132|FG000|COMPLETED|Washout Period 2||2||
59797062|NCT00519376|75918133|FG001|COMPLETED|Washout Period 2||2||
59797063|NCT00519376|75918134|FG002|COMPLETED|Washout Period 2||2||
59797064|NCT00519376|75918135|FG003|COMPLETED|Washout Period 2||2||
59797065|NCT00519376|75918136|FG004|COMPLETED|Washout Period 2||1||
59797066|NCT00519376|75918137|FG005|COMPLETED|Washout Period 2||1||
59797067|NCT00519376|75918138|FG006|COMPLETED|Washout Period 2||1||
59797068|NCT00519376|75918139|FG007|COMPLETED|Washout Period 2||1||
59797069|NCT00519376|75918140|FG008|COMPLETED|Washout Period 2||1||
59797070|NCT00519376|75918141|FG009|COMPLETED|Washout Period 2||1||
59797071|NCT00519376|75918142|FG010|COMPLETED|Washout Period 2||1||
59797072|NCT00519376|75918143|FG011|COMPLETED|Washout Period 2||1||
59797073|NCT00519376|75918144|FG012|COMPLETED|Washout Period 2||0||
59797074|NCT00519376|75918145|FG013|COMPLETED|Washout Period 2||1||
59797075|NCT00519376|75918146|FG014|COMPLETED|Washout Period 2||1||
59797076|NCT00519376|75918147|FG015|COMPLETED|Washout Period 2||1||
59797077|NCT00519376|75918132|FG000|NOT COMPLETED|Washout Period 2||0||
59797078|NCT00519376|75918133|FG001|NOT COMPLETED|Washout Period 2||0||
59797079|NCT00519376|75918134|FG002|NOT COMPLETED|Washout Period 2||0||
59797080|NCT00519376|75918135|FG003|NOT COMPLETED|Washout Period 2||0||
59797081|NCT00519376|75918136|FG004|NOT COMPLETED|Washout Period 2||0||
59797082|NCT00519376|75918137|FG005|NOT COMPLETED|Washout Period 2||0||
59797083|NCT00519376|75918138|FG006|NOT COMPLETED|Washout Period 2||0||
59797084|NCT00519376|75918139|FG007|NOT COMPLETED|Washout Period 2||0||
59797085|NCT00519376|75918140|FG008|NOT COMPLETED|Washout Period 2||0||
59797086|NCT00519376|75918141|FG009|NOT COMPLETED|Washout Period 2||0||
59797087|NCT00519376|75918142|FG010|NOT COMPLETED|Washout Period 2||0||
59797088|NCT00519376|75918143|FG011|NOT COMPLETED|Washout Period 2||0||
59797089|NCT00519376|75918144|FG012|NOT COMPLETED|Washout Period 2||0||
59797090|NCT00519376|75918145|FG013|NOT COMPLETED|Washout Period 2||0||
59797091|NCT00519376|75918146|FG014|NOT COMPLETED|Washout Period 2||0||
59797092|NCT00519376|75918147|FG015|NOT COMPLETED|Washout Period 2||0||
59797093|NCT00519376|75918132|FG000|STARTED|Treatment Period 3||2||
59797094|NCT00519376|75918133|FG001|STARTED|Treatment Period 3||2||
59797095|NCT00519376|75918134|FG002|STARTED|Treatment Period 3||2||
59797096|NCT00519376|75918135|FG003|STARTED|Treatment Period 3||2||
59797097|NCT00519376|75918136|FG004|STARTED|Treatment Period 3||1||
59797098|NCT00519376|75918137|FG005|STARTED|Treatment Period 3||1||
59797099|NCT00519376|75918138|FG006|STARTED|Treatment Period 3||1||
59797100|NCT00519376|75918139|FG007|STARTED|Treatment Period 3||1||
59797101|NCT00519376|75918140|FG008|STARTED|Treatment Period 3||1||
59797102|NCT00519376|75918141|FG009|STARTED|Treatment Period 3||1||
59797103|NCT00519376|75918142|FG010|STARTED|Treatment Period 3||1||
59797104|NCT00519376|75918143|FG011|STARTED|Treatment Period 3||1||
59797105|NCT00519376|75918144|FG012|STARTED|Treatment Period 3||0||
59797106|NCT00519376|75918145|FG013|STARTED|Treatment Period 3||1||
59797107|NCT00519376|75918146|FG014|STARTED|Treatment Period 3||1||
59797108|NCT00519376|75918147|FG015|STARTED|Treatment Period 3||1||
59797109|NCT00519376|75918132|FG000|COMPLETED|Treatment Period 3||2||
59797110|NCT00519376|75918133|FG001|COMPLETED|Treatment Period 3||2||
59797111|NCT00519376|75918134|FG002|COMPLETED|Treatment Period 3||2||
59797112|NCT00519376|75918135|FG003|COMPLETED|Treatment Period 3||2||
59797113|NCT00519376|75918136|FG004|COMPLETED|Treatment Period 3||1||
59797114|NCT00519376|75918137|FG005|COMPLETED|Treatment Period 3||1||
59797115|NCT00519376|75918138|FG006|COMPLETED|Treatment Period 3||1||
59797116|NCT00519376|75918139|FG007|COMPLETED|Treatment Period 3||1||
59797117|NCT00519376|75918140|FG008|COMPLETED|Treatment Period 3||1||
59797118|NCT00519376|75918141|FG009|COMPLETED|Treatment Period 3||1||
59797119|NCT00519376|75918142|FG010|COMPLETED|Treatment Period 3||1||
59797120|NCT00519376|75918143|FG011|COMPLETED|Treatment Period 3||1||
59797121|NCT00519376|75918144|FG012|COMPLETED|Treatment Period 3||0||
59954363|NCT02252211|76072856|FG000|Received Dose 4 (Day 36)|Overall Study||1||
59954364|NCT02252211|76072857|FG001|Received Dose 4 (Day 36)|Overall Study||1||
59797122|NCT00519376|75918145|FG013|COMPLETED|Treatment Period 3||1||
59797123|NCT00519376|75918146|FG014|COMPLETED|Treatment Period 3||1||
59797124|NCT00519376|75918147|FG015|COMPLETED|Treatment Period 3||1||
59797125|NCT00519376|75918132|FG000|NOT COMPLETED|Treatment Period 3||0||
59797126|NCT00519376|75918133|FG001|NOT COMPLETED|Treatment Period 3||0||
59797127|NCT00519376|75918134|FG002|NOT COMPLETED|Treatment Period 3||0||
59954365|NCT02252211|76072858|FG002|Received Dose 4 (Day 36)|Overall Study||0||
59954366|NCT02252211|76072856|FG000|Received Further Doses (Through Dose 24)|Overall Study||1||
60103587|NCT01290952|76221836|FG000|COMPLETED|Overall Study||192||
59797128|NCT00519376|75918135|FG003|NOT COMPLETED|Treatment Period 3||0||
59797129|NCT00519376|75918136|FG004|NOT COMPLETED|Treatment Period 3||0||
59797130|NCT00519376|75918137|FG005|NOT COMPLETED|Treatment Period 3||0||
59797131|NCT00519376|75918138|FG006|NOT COMPLETED|Treatment Period 3||0||
59797132|NCT00519376|75918139|FG007|NOT COMPLETED|Treatment Period 3||0||
59797133|NCT00519376|75918140|FG008|NOT COMPLETED|Treatment Period 3||0||
59797134|NCT00519376|75918141|FG009|NOT COMPLETED|Treatment Period 3||0||
59797135|NCT00519376|75918142|FG010|NOT COMPLETED|Treatment Period 3||0||
59797136|NCT00519376|75918143|FG011|NOT COMPLETED|Treatment Period 3||0||
59797137|NCT00519376|75918144|FG012|NOT COMPLETED|Treatment Period 3||0||
59797138|NCT00519376|75918145|FG013|NOT COMPLETED|Treatment Period 3||0||
59797139|NCT00519376|75918146|FG014|NOT COMPLETED|Treatment Period 3||0||
59797140|NCT00519376|75918147|FG015|NOT COMPLETED|Treatment Period 3||0||
59797141|NCT00519376|75918132|FG000|STARTED|Washout Period 3||2||
59797142|NCT00519376|75918133|FG001|STARTED|Washout Period 3||2||
59797143|NCT00519376|75918134|FG002|STARTED|Washout Period 3||2||
59797144|NCT00519376|75918135|FG003|STARTED|Washout Period 3||2||
59797145|NCT00519376|75918136|FG004|STARTED|Washout Period 3||1||
59797146|NCT00519376|75918137|FG005|STARTED|Washout Period 3||1||
59797147|NCT00519376|75918138|FG006|STARTED|Washout Period 3||1||
59797148|NCT00519376|75918139|FG007|STARTED|Washout Period 3||1||
59797149|NCT00519376|75918140|FG008|STARTED|Washout Period 3||1||
59797150|NCT00519376|75918141|FG009|STARTED|Washout Period 3||1||
59797151|NCT00519376|75918142|FG010|STARTED|Washout Period 3||1||
59797152|NCT00519376|75918143|FG011|STARTED|Washout Period 3||1||
59797153|NCT00519376|75918144|FG012|STARTED|Washout Period 3||0||
59797154|NCT00519376|75918145|FG013|STARTED|Washout Period 3||1||
59797155|NCT00519376|75918146|FG014|STARTED|Washout Period 3||1||
59797156|NCT00519376|75918147|FG015|STARTED|Washout Period 3||1||
59797157|NCT00519376|75918132|FG000|COMPLETED|Washout Period 3||2||
59797158|NCT00519376|75918133|FG001|COMPLETED|Washout Period 3||2||
59797159|NCT00519376|75918134|FG002|COMPLETED|Washout Period 3||2||
59797160|NCT00519376|75918135|FG003|COMPLETED|Washout Period 3||2||
59797161|NCT00519376|75918136|FG004|COMPLETED|Washout Period 3||1||
59797162|NCT00519376|75918137|FG005|COMPLETED|Washout Period 3||1||
59797163|NCT00519376|75918138|FG006|COMPLETED|Washout Period 3||1||
59954367|NCT02252211|76072857|FG001|Received Further Doses (Through Dose 24)|Overall Study||0||
59954368|NCT02252211|76072858|FG002|Received Further Doses (Through Dose 24)|Overall Study||0||
59954369|NCT02252211|76072856|FG000|COMPLETED|Overall Study||0|Completed the study as planned per protocol|
59954370|NCT02252211|76072857|FG001|COMPLETED|Overall Study||0|Completed the study as planned per protocol|
59954371|NCT02252211|76072858|FG002|COMPLETED|Overall Study||0|Completed the study as planned per protocol|
59954372|NCT02252211|76072856|FG000|NOT COMPLETED|Overall Study||5||
59954373|NCT02252211|76072857|FG001|NOT COMPLETED|Overall Study||3||
59954374|NCT02252211|76072858|FG002|NOT COMPLETED|Overall Study||1||
59954375|NCT02776683|76072865|FG000|STARTED|Pre-switch Period|Assigned to trial medication or enrolled/treated|123|Only the BI 695502 arm was applicable for Period 1|
59954376|NCT02776683|76072866|FG001|STARTED|Pre-switch Period||0|Only the BI 695502 arm was applicable for Period 1|
59954377|NCT02776683|76072865|FG000|COMPLETED|Pre-switch Period|Entered into Switch Set|43||
59797164|NCT00519376|75918139|FG007|COMPLETED|Washout Period 3||1||
59797165|NCT00519376|75918140|FG008|COMPLETED|Washout Period 3||1||
59797166|NCT00519376|75918141|FG009|COMPLETED|Washout Period 3||1||
59797167|NCT00519376|75918142|FG010|COMPLETED|Washout Period 3||1||
59797168|NCT00519376|75918143|FG011|COMPLETED|Washout Period 3||1||
59797169|NCT00519376|75918144|FG012|COMPLETED|Washout Period 3||0||
59797170|NCT00519376|75918145|FG013|COMPLETED|Washout Period 3||1||
59797171|NCT00519376|75918146|FG014|COMPLETED|Washout Period 3||1||
59797172|NCT00519376|75918147|FG015|COMPLETED|Washout Period 3||1||
59797173|NCT00519376|75918132|FG000|NOT COMPLETED|Washout Period 3||0||
59797174|NCT00519376|75918133|FG001|NOT COMPLETED|Washout Period 3||0||
59797175|NCT00519376|75918134|FG002|NOT COMPLETED|Washout Period 3||0||
59797176|NCT00519376|75918135|FG003|NOT COMPLETED|Washout Period 3||0||
59797177|NCT00519376|75918136|FG004|NOT COMPLETED|Washout Period 3||0||
59797178|NCT00519376|75918137|FG005|NOT COMPLETED|Washout Period 3||0||
59797179|NCT00519376|75918138|FG006|NOT COMPLETED|Washout Period 3||0||
59797180|NCT00519376|75918139|FG007|NOT COMPLETED|Washout Period 3||0||
59797181|NCT00519376|75918140|FG008|NOT COMPLETED|Washout Period 3||0||
59797182|NCT00519376|75918141|FG009|NOT COMPLETED|Washout Period 3||0||
59797183|NCT00519376|75918142|FG010|NOT COMPLETED|Washout Period 3||0||
59797184|NCT00519376|75918143|FG011|NOT COMPLETED|Washout Period 3||0||
59797185|NCT00519376|75918144|FG012|NOT COMPLETED|Washout Period 3||0||
59797186|NCT00519376|75918145|FG013|NOT COMPLETED|Washout Period 3||0||
59797187|NCT00519376|75918146|FG014|NOT COMPLETED|Washout Period 3||0||
59797188|NCT00519376|75918147|FG015|NOT COMPLETED|Washout Period 3||0||
59797189|NCT00519376|75918132|FG000|STARTED|Treatment Period 4||2||
59797190|NCT00519376|75918133|FG001|STARTED|Treatment Period 4||2||
59954378|NCT02776683|76072866|FG001|COMPLETED|Pre-switch Period||0||
59954379|NCT02776683|76072865|FG000|NOT COMPLETED|Pre-switch Period||80||
59797191|NCT00519376|75918134|FG002|STARTED|Treatment Period 4||2||
59797192|NCT00519376|75918135|FG003|STARTED|Treatment Period 4||2||
59797193|NCT00519376|75918136|FG004|STARTED|Treatment Period 4||1||
59797194|NCT00519376|75918137|FG005|STARTED|Treatment Period 4||1||
59797195|NCT00519376|75918138|FG006|STARTED|Treatment Period 4||1||
59797196|NCT00519376|75918139|FG007|STARTED|Treatment Period 4||1||
59797197|NCT00519376|75918140|FG008|STARTED|Treatment Period 4||1||
59797198|NCT00519376|75918141|FG009|STARTED|Treatment Period 4||1||
59797199|NCT00519376|75918142|FG010|STARTED|Treatment Period 4||1||
59797200|NCT00519376|75918143|FG011|STARTED|Treatment Period 4||1||
59797201|NCT00519376|75918144|FG012|STARTED|Treatment Period 4||0||
59797202|NCT00519376|75918145|FG013|STARTED|Treatment Period 4||1||
59797203|NCT00519376|75918146|FG014|STARTED|Treatment Period 4||1||
59797204|NCT00519376|75918147|FG015|STARTED|Treatment Period 4||1||
59797205|NCT00519376|75918132|FG000|COMPLETED|Treatment Period 4||2||
59797206|NCT00519376|75918133|FG001|COMPLETED|Treatment Period 4||2||
59797207|NCT00519376|75918134|FG002|COMPLETED|Treatment Period 4||1||
59954380|NCT02776683|76072866|FG001|NOT COMPLETED|Pre-switch Period||0||
59954381|NCT02776683|76072865|FG000|STARTED|Post-switch Period||0|Only the BI 695502 to Avastin arm was applicable to Period 2|
59954382|NCT02776683|76072866|FG001|STARTED|Post-switch Period|Entered into Switch Set|43|Only the BI 695502 to Avastin arm was applicable to Period 2|
59954383|NCT02776683|76072865|FG000|COMPLETED|Post-switch Period||0||
59523559|NCT02554890|75618455|FG001|NOT COMPLETED|Open-label||52||
59523560|NCT02086682|75618465|FG000|STARTED|Overall Study||156||
59523561|NCT02086682|75618466|FG001|STARTED|Overall Study||182||
59523562|NCT02086682|75618465|FG000|COMPLETED|Overall Study||156||
59523563|NCT02086682|75618466|FG001|COMPLETED|Overall Study||182||
59523564|NCT02086682|75618465|FG000|NOT COMPLETED|Overall Study||0||
59523565|NCT02086682|75618466|FG001|NOT COMPLETED|Overall Study||0||
59523566|NCT02552316|75618472|FG000|STARTED|Overall Study||34||
59523567|NCT02552316|75618472|FG000|COMPLETED|Overall Study||32||
59523568|NCT02552316|75618472|FG000|NOT COMPLETED|Overall Study||2||
59523569|NCT02543346|75618520|FG000|STARTED|First Priming Visit||26||
59954384|NCT02776683|76072866|FG001|COMPLETED|Post-switch Period||0||
59954385|NCT02776683|76072865|FG000|NOT COMPLETED|Post-switch Period||0||
59523570|NCT02543346|75618521|FG001|STARTED|First Priming Visit||25||
59523571|NCT02543346|75618522|FG002|STARTED|First Priming Visit||24||
59523572|NCT02543346|75618523|FG003|STARTED|First Priming Visit||23||
59523573|NCT02543346|75618520|FG000|COMPLETED|First Priming Visit||26||
59523574|NCT02543346|75618521|FG001|COMPLETED|First Priming Visit||25||
59523575|NCT02543346|75618522|FG002|COMPLETED|First Priming Visit||24||
59523576|NCT02543346|75618523|FG003|COMPLETED|First Priming Visit||23||
59954386|NCT02776683|76072866|FG001|NOT COMPLETED|Post-switch Period||43||
59954387|NCT02731742|76072874|FG000|STARTED|Overall Study||3||
59954388|NCT02731742|76072875|FG001|STARTED|Overall Study||3||
59954389|NCT02731742|76072876|FG002|STARTED|Overall Study||6||
59954390|NCT02731742|76072877|FG003|STARTED|Overall Study||2||
59954391|NCT02731742|76072874|FG000|COMPLETED|Overall Study||0||
59954392|NCT02731742|76072875|FG001|COMPLETED|Overall Study||0||
59954393|NCT02731742|76072876|FG002|COMPLETED|Overall Study||0||
59954394|NCT02731742|76072877|FG003|COMPLETED|Overall Study||0||
59954395|NCT02731742|76072874|FG000|NOT COMPLETED|Overall Study||3||
59954396|NCT02731742|76072875|FG001|NOT COMPLETED|Overall Study||3||
59954397|NCT02731742|76072876|FG002|NOT COMPLETED|Overall Study||6||
59954398|NCT02731742|76072877|FG003|NOT COMPLETED|Overall Study||2||
59954399|NCT02963714|76072889|FG000|STARTED|Overall Study||176||
59523577|NCT02543346|75618520|FG000|NOT COMPLETED|First Priming Visit||0||
59523578|NCT02543346|75618521|FG001|NOT COMPLETED|First Priming Visit||0||
59523579|NCT02543346|75618522|FG002|NOT COMPLETED|First Priming Visit||0||
59523580|NCT02543346|75618523|FG003|NOT COMPLETED|First Priming Visit||0||
59523581|NCT02543346|75618520|FG000|STARTED|First Treatment Visit||26||
59523582|NCT02543346|75618521|FG001|STARTED|First Treatment Visit||25||
59523583|NCT02543346|75618522|FG002|STARTED|First Treatment Visit||24||
59523584|NCT02543346|75618523|FG003|STARTED|First Treatment Visit||23||
59523585|NCT02543346|75618520|FG000|COMPLETED|First Treatment Visit||26||
59523586|NCT02543346|75618521|FG001|COMPLETED|First Treatment Visit||25||
59523587|NCT02543346|75618522|FG002|COMPLETED|First Treatment Visit||24||
59523588|NCT02543346|75618523|FG003|COMPLETED|First Treatment Visit||23||
59523589|NCT02543346|75618520|FG000|NOT COMPLETED|First Treatment Visit||0||
59523590|NCT02543346|75618521|FG001|NOT COMPLETED|First Treatment Visit||0||
59523591|NCT02543346|75618522|FG002|NOT COMPLETED|First Treatment Visit||0||
59523592|NCT02543346|75618523|FG003|NOT COMPLETED|First Treatment Visit||0||
59523593|NCT02543346|75618520|FG000|STARTED|Washout (at Least 14 Days)||26||
59523594|NCT02543346|75618521|FG001|STARTED|Washout (at Least 14 Days)||25||
59523595|NCT02543346|75618522|FG002|STARTED|Washout (at Least 14 Days)||24||
59523596|NCT02543346|75618523|FG003|STARTED|Washout (at Least 14 Days)||23||
59523597|NCT02543346|75618520|FG000|COMPLETED|Washout (at Least 14 Days)||26||
59523598|NCT02543346|75618521|FG001|COMPLETED|Washout (at Least 14 Days)||25||
59523599|NCT02543346|75618522|FG002|COMPLETED|Washout (at Least 14 Days)||24||
59523600|NCT02543346|75618523|FG003|COMPLETED|Washout (at Least 14 Days)||23||
59523601|NCT02543346|75618520|FG000|NOT COMPLETED|Washout (at Least 14 Days)||0||
59523602|NCT02543346|75618521|FG001|NOT COMPLETED|Washout (at Least 14 Days)||0||
59523603|NCT02543346|75618522|FG002|NOT COMPLETED|Washout (at Least 14 Days)||0||
59523604|NCT02543346|75618523|FG003|NOT COMPLETED|Washout (at Least 14 Days)||0||
59523605|NCT02543346|75618520|FG000|STARTED|Second Priming Visit||26||
59523606|NCT02543346|75618521|FG001|STARTED|Second Priming Visit||25||
59523607|NCT02543346|75618522|FG002|STARTED|Second Priming Visit||24||
59523608|NCT02543346|75618523|FG003|STARTED|Second Priming Visit||23||
59523609|NCT02543346|75618520|FG000|COMPLETED|Second Priming Visit||25||
59523610|NCT02543346|75618521|FG001|COMPLETED|Second Priming Visit||23||
59523611|NCT02543346|75618522|FG002|COMPLETED|Second Priming Visit||22||
59523612|NCT02543346|75618523|FG003|COMPLETED|Second Priming Visit||21||
59523613|NCT02543346|75618520|FG000|NOT COMPLETED|Second Priming Visit||1||
59523614|NCT02543346|75618521|FG001|NOT COMPLETED|Second Priming Visit||2||
59523615|NCT02543346|75618522|FG002|NOT COMPLETED|Second Priming Visit||2||
59523616|NCT02543346|75618523|FG003|NOT COMPLETED|Second Priming Visit||2||
59523617|NCT02543346|75618520|FG000|STARTED|Second Treatment Visit||25||
59797208|NCT00519376|75918135|FG003|COMPLETED|Treatment Period 4||2||
59797209|NCT00519376|75918136|FG004|COMPLETED|Treatment Period 4||1||
59797210|NCT00519376|75918137|FG005|COMPLETED|Treatment Period 4||1||
59797211|NCT00519376|75918138|FG006|COMPLETED|Treatment Period 4||1||
59797212|NCT00519376|75918139|FG007|COMPLETED|Treatment Period 4||1||
59797213|NCT00519376|75918140|FG008|COMPLETED|Treatment Period 4||1||
59797214|NCT00519376|75918141|FG009|COMPLETED|Treatment Period 4||1||
59797215|NCT00519376|75918142|FG010|COMPLETED|Treatment Period 4||1||
59797216|NCT00519376|75918143|FG011|COMPLETED|Treatment Period 4||1||
59797217|NCT00519376|75918144|FG012|COMPLETED|Treatment Period 4||0||
59797218|NCT00519376|75918145|FG013|COMPLETED|Treatment Period 4||1||
59797219|NCT00519376|75918146|FG014|COMPLETED|Treatment Period 4||1||
59797220|NCT00519376|75918147|FG015|COMPLETED|Treatment Period 4||1||
59797221|NCT00519376|75918132|FG000|NOT COMPLETED|Treatment Period 4||0||
59797222|NCT00519376|75918133|FG001|NOT COMPLETED|Treatment Period 4||0||
59797223|NCT00519376|75918134|FG002|NOT COMPLETED|Treatment Period 4||1||
59797224|NCT00519376|75918135|FG003|NOT COMPLETED|Treatment Period 4||0||
59797225|NCT00519376|75918136|FG004|NOT COMPLETED|Treatment Period 4||0||
59797226|NCT00519376|75918137|FG005|NOT COMPLETED|Treatment Period 4||0||
59797227|NCT00519376|75918138|FG006|NOT COMPLETED|Treatment Period 4||0||
59797228|NCT00519376|75918139|FG007|NOT COMPLETED|Treatment Period 4||0||
59797229|NCT00519376|75918140|FG008|NOT COMPLETED|Treatment Period 4||0||
59797230|NCT00519376|75918141|FG009|NOT COMPLETED|Treatment Period 4||0||
59797231|NCT00519376|75918142|FG010|NOT COMPLETED|Treatment Period 4||0||
59797232|NCT00519376|75918143|FG011|NOT COMPLETED|Treatment Period 4||0||
59797233|NCT00519376|75918144|FG012|NOT COMPLETED|Treatment Period 4||0||
59797234|NCT00519376|75918145|FG013|NOT COMPLETED|Treatment Period 4||0||
59797235|NCT00519376|75918146|FG014|NOT COMPLETED|Treatment Period 4||0||
59797236|NCT00519376|75918147|FG015|NOT COMPLETED|Treatment Period 4||0||
59797237|NCT00745121|75918161|FG000|STARTED|Overall Study||20||63
59797238|NCT00745121|75918162|FG001|STARTED|Overall Study||28||85
59797239|NCT00745121|75918161|FG000|COMPLETED|Overall Study||11||37
59797240|NCT00745121|75918162|FG001|COMPLETED|Overall Study||26||77
59797241|NCT00745121|75918161|FG000|NOT COMPLETED|Overall Study||9||26
59797242|NCT00745121|75918162|FG001|NOT COMPLETED|Overall Study||2||8
59797243|NCT00740051|75918170|FG000|STARTED|Overall Study||76||
59797244|NCT00740051|75918171|FG001|STARTED|Overall Study||151||
59797245|NCT00740051|75918170|FG000|COMPLETED|Overall Study||58||
59797246|NCT00740051|75918171|FG001|COMPLETED|Overall Study||119||
59797247|NCT00740051|75918170|FG000|NOT COMPLETED|Overall Study||18||
59797248|NCT00740051|75918171|FG001|NOT COMPLETED|Overall Study||32||
59797249|NCT00518986|75918180|FG000|STARTED|Overall Study|One subject discontinued before treatment, only 124 subjects in each treatment group were dosed.|125||
59797250|NCT00518986|75918181|FG001|STARTED|Overall Study||124||
59797251|NCT00518986|75918180|FG000|COMPLETED|Overall Study||99||
59797252|NCT00518986|75918181|FG001|COMPLETED|Overall Study||98||
59797253|NCT00518986|75918180|FG000|NOT COMPLETED|Overall Study||26||
59797254|NCT00518986|75918181|FG001|NOT COMPLETED|Overall Study||26||
59797255|NCT00742391|75918189|FG000|STARTED|Overall Study||126||
59797256|NCT00742391|75918190|FG001|STARTED|Overall Study||129||
59797257|NCT00742391|75918189|FG000|COMPLETED|Overall Study||122||
59797258|NCT00742391|75918190|FG001|COMPLETED|Overall Study||128||
59797259|NCT00742391|75918189|FG000|NOT COMPLETED|Overall Study||4||
59797260|NCT00742391|75918190|FG001|NOT COMPLETED|Overall Study||1||
59797261|NCT00742235|75918198|FG000|STARTED|Overall Study||32||
59797262|NCT00742235|75918199|FG001|STARTED|Overall Study||67||
59797263|NCT00742235|75918198|FG000|COMPLETED|Overall Study||32||
59797264|NCT00742235|75918199|FG001|COMPLETED|Overall Study||36||
59797265|NCT00742235|75918198|FG000|NOT COMPLETED|Overall Study||0||
59797266|NCT00742235|75918199|FG001|NOT COMPLETED|Overall Study||31||
59797267|NCT00742079|75918207|FG000|STARTED|Overall Study||11||
59797268|NCT00742079|75918208|FG001|STARTED|Overall Study||10||
59797269|NCT00742079|75918207|FG000|Baseline/Week 1 (Received Dose 1)|Overall Study||11||
59797270|NCT00742079|75918208|FG001|Baseline/Week 1 (Received Dose 1)|Overall Study||9||
59797271|NCT00742079|75918207|FG000|Week 2 (Received Dose 2)|Overall Study||11||
59797272|NCT00742079|75918208|FG001|Week 2 (Received Dose 2)|Overall Study||9||
59797273|NCT00742079|75918207|FG000|COMPLETED|Overall Study||11||
59797274|NCT00742079|75918208|FG001|COMPLETED|Overall Study||9||
59797275|NCT00742079|75918207|FG000|NOT COMPLETED|Overall Study||0||
59797276|NCT00742079|75918208|FG001|NOT COMPLETED|Overall Study||1||
59797277|NCT00662792|75918214|FG000|STARTED|Period 1||34||
59797278|NCT00662792|75918215|FG001|STARTED|Period 1||38||
59797279|NCT00662792|75918216|FG002|STARTED|Period 1||36||
59797280|NCT00662792|75918217|FG003|STARTED|Period 1||39||
59797281|NCT00662792|75918214|FG000|Treated|Period 1||34||
59797282|NCT00662792|75918215|FG001|Treated|Period 1||37||
59797283|NCT00662792|75918216|FG002|Treated|Period 1||36||
59797284|NCT00662792|75918217|FG003|Treated|Period 1||39||
59797285|NCT00662792|75918214|FG000|COMPLETED|Period 1||32|Not prematurely discontinued study medication|
59797286|NCT00662792|75918215|FG001|COMPLETED|Period 1||31|Not prematurely discontinued study medication|
59797287|NCT00662792|75918216|FG002|COMPLETED|Period 1||32|Not prematurely discontinued study medication|
59797288|NCT00662792|75918217|FG003|COMPLETED|Period 1||39|Not prematurely discontinued study medication|
59797289|NCT00662792|75918214|FG000|NOT COMPLETED|Period 1||2||
59797290|NCT00662792|75918215|FG001|NOT COMPLETED|Period 1||7||
59797291|NCT00662792|75918216|FG002|NOT COMPLETED|Period 1||4||
59797292|NCT00662792|75918217|FG003|NOT COMPLETED|Period 1||0||
59797293|NCT00662792|75918214|FG000|STARTED|Period 2||32||
59797294|NCT00662792|75918215|FG001|STARTED|Period 2||31||
59797295|NCT00662792|75918216|FG002|STARTED|Period 2||32||
59797296|NCT00662792|75918217|FG003|STARTED|Period 2||39||
59797297|NCT00662792|75918214|FG000|Treated|Period 2||32||
59797298|NCT00662792|75918215|FG001|Treated|Period 2||31||
59797299|NCT00662792|75918216|FG002|Treated|Period 2||32||
59797300|NCT00662792|75918217|FG003|Treated|Period 2||39||
59797301|NCT00662792|75918214|FG000|COMPLETED|Period 2||31|Not prematurely discontinued from study medication|
59797302|NCT00662792|75918215|FG001|COMPLETED|Period 2||31|Not prematurely discontinued from study medication|
59797303|NCT00662792|75918216|FG002|COMPLETED|Period 2||32|Not prematurely discontinued from study medication|
59797304|NCT00662792|75918217|FG003|COMPLETED|Period 2||36|Not prematurely discontinued from study medication|
59797305|NCT00662792|75918214|FG000|NOT COMPLETED|Period 2||1||
59797306|NCT00662792|75918215|FG001|NOT COMPLETED|Period 2||0||
59797307|NCT00662792|75918216|FG002|NOT COMPLETED|Period 2||0||
59797308|NCT00662792|75918217|FG003|NOT COMPLETED|Period 2||3||
59797309|NCT00662792|75918214|FG000|STARTED|Period 3||31||
59797310|NCT00662792|75918215|FG001|STARTED|Period 3||31||
59797311|NCT00662792|75918216|FG002|STARTED|Period 3||32||
59797312|NCT00662792|75918217|FG003|STARTED|Period 3||36||
59797313|NCT00662792|75918214|FG000|Treated|Period 3||31||
59797314|NCT00662792|75918215|FG001|Treated|Period 3||31||
59797315|NCT00662792|75918216|FG002|Treated|Period 3||32||
59797316|NCT00662792|75918217|FG003|Treated|Period 3||36||
59797317|NCT00662792|75918214|FG000|COMPLETED|Period 3||30|Not prematurely discontinued from study medication|
59797318|NCT00662792|75918215|FG001|COMPLETED|Period 3||31|Not prematurely discontinued from study medication|
59797319|NCT00662792|75918216|FG002|COMPLETED|Period 3||30|Not prematurely discontinued from study medication|
59797320|NCT00662792|75918217|FG003|COMPLETED|Period 3||35|Not prematurely discontinued from study medication|
59797321|NCT00662792|75918214|FG000|NOT COMPLETED|Period 3||1||
59797322|NCT00662792|75918215|FG001|NOT COMPLETED|Period 3||0||
59797323|NCT00662792|75918216|FG002|NOT COMPLETED|Period 3||2||
59797324|NCT00662792|75918217|FG003|NOT COMPLETED|Period 3||1||
59797325|NCT00662792|75918214|FG000|STARTED|Period 4||30||
59797326|NCT00662792|75918215|FG001|STARTED|Period 4||31||
59797327|NCT00662792|75918216|FG002|STARTED|Period 4||30||
59797328|NCT00662792|75918217|FG003|STARTED|Period 4||35||
59797329|NCT00662792|75918214|FG000|Treated|Period 4||30||
59797330|NCT00662792|75918215|FG001|Treated|Period 4||31||
59797331|NCT00662792|75918216|FG002|Treated|Period 4||30||
59797332|NCT00662792|75918217|FG003|Treated|Period 4||35||
59797333|NCT00662792|75918214|FG000|COMPLETED|Period 4||29|Not prematurely discontinued from study medication|
59797334|NCT00662792|75918215|FG001|COMPLETED|Period 4||30|Not prematurely discontinued from study medication|
59797335|NCT00662792|75918216|FG002|COMPLETED|Period 4||30|Not prematurely discontinued from study medication|
59797336|NCT00662792|75918217|FG003|COMPLETED|Period 4||34|Not prematurely discontinued from study medication|
59797337|NCT00662792|75918214|FG000|NOT COMPLETED|Period 4||1||
59797338|NCT00662792|75918215|FG001|NOT COMPLETED|Period 4||1||
59797339|NCT00662792|75918216|FG002|NOT COMPLETED|Period 4||0||
59797340|NCT00662792|75918217|FG003|NOT COMPLETED|Period 4||1||
59797341|NCT00742001|75918232|FG000|STARTED|Overall Study||4||
59797342|NCT00742001|75918233|FG001|STARTED|Overall Study||4||
59797343|NCT00742001|75918234|FG002|STARTED|Overall Study||4||
59797344|NCT00742001|75918232|FG000|COMPLETED|Overall Study||4||
59797345|NCT00742001|75918233|FG001|COMPLETED|Overall Study||4||
59797346|NCT00742001|75918234|FG002|COMPLETED|Overall Study||3||
59797347|NCT00742001|75918232|FG000|NOT COMPLETED|Overall Study||0||
59797348|NCT00742001|75918233|FG001|NOT COMPLETED|Overall Study||0||
59797349|NCT00742001|75918234|FG002|NOT COMPLETED|Overall Study||1||
59797350|NCT00616902|75918247|FG000|STARTED|Overall Study||6||
59797351|NCT00616902|75918248|FG001|STARTED|Overall Study||6||
59797352|NCT00616902|75918247|FG000|COMPLETED|Overall Study||0||
59797353|NCT00616902|75918248|FG001|COMPLETED|Overall Study||0||
59797354|NCT00616902|75918247|FG000|NOT COMPLETED|Overall Study||6||
59797355|NCT00616902|75918248|FG001|NOT COMPLETED|Overall Study||6||
59797356|NCT00741611|75918257|FG000|STARTED|Overall Study||4||
59797357|NCT00741611|75918258|FG001|STARTED|Overall Study||3||
59797358|NCT00741611|75918259|FG002|STARTED|Overall Study||29||
59797359|NCT00741611|75918257|FG000|COMPLETED|Overall Study||4||
59797360|NCT00741611|75918258|FG001|COMPLETED|Overall Study||1||
59797361|NCT00741611|75918259|FG002|COMPLETED|Overall Study||26||
59797362|NCT00741611|75918257|FG000|NOT COMPLETED|Overall Study||0||
59797363|NCT00741611|75918258|FG001|NOT COMPLETED|Overall Study||2||
59797364|NCT00741611|75918259|FG002|NOT COMPLETED|Overall Study||3||
59797365|NCT00662558|75918270|FG000|STARTED|Overall Study||398||
59797366|NCT00662558|75918271|FG001|STARTED|Overall Study||404||
59797367|NCT00662558|75918270|FG000|Received Treatment|Overall Study||396||
59797368|NCT00662558|75918271|FG001|Received Treatment|Overall Study||396||
59797369|NCT00662558|75918270|FG000|COMPLETED|Overall Study||342||
59797370|NCT00662558|75918271|FG001|COMPLETED|Overall Study||294||
59797371|NCT00662558|75918270|FG000|NOT COMPLETED|Overall Study||56||
59797372|NCT00662558|75918271|FG001|NOT COMPLETED|Overall Study||110||
59797373|NCT00739973|75918286|FG000|STARTED|Single-blind Period (2 to 4 Weeks)|In this period, participants were enrolled to only Placebo arm.|2694||
59797374|NCT00739973|75918287|FG001|STARTED|Single-blind Period (2 to 4 Weeks)||0||
59797375|NCT00739973|75918288|FG002|STARTED|Single-blind Period (2 to 4 Weeks)||0||
59797376|NCT00739973|75918289|FG003|STARTED|Single-blind Period (2 to 4 Weeks)||0||
59797377|NCT00739973|75918290|FG004|STARTED|Single-blind Period (2 to 4 Weeks)||0||
59797378|NCT00739973|75918291|FG005|STARTED|Single-blind Period (2 to 4 Weeks)||0||
59797379|NCT00739973|75918292|FG006|STARTED|Single-blind Period (2 to 4 Weeks)||0||
59797380|NCT00739973|75918293|FG007|STARTED|Single-blind Period (2 to 4 Weeks)||0||
59797381|NCT00739973|75918294|FG008|STARTED|Single-blind Period (2 to 4 Weeks)||0||
59797382|NCT00739973|75918286|FG000|COMPLETED|Single-blind Period (2 to 4 Weeks)||1685||
59797383|NCT00739973|75918287|FG001|COMPLETED|Single-blind Period (2 to 4 Weeks)||0||
59797384|NCT00739973|75918288|FG002|COMPLETED|Single-blind Period (2 to 4 Weeks)||0||
59797385|NCT00739973|75918289|FG003|COMPLETED|Single-blind Period (2 to 4 Weeks)||0||
59797386|NCT00739973|75918290|FG004|COMPLETED|Single-blind Period (2 to 4 Weeks)||0||
59797387|NCT00739973|75918291|FG005|COMPLETED|Single-blind Period (2 to 4 Weeks)||0||
59797388|NCT00739973|75918292|FG006|COMPLETED|Single-blind Period (2 to 4 Weeks)||0||
59797389|NCT00739973|75918293|FG007|COMPLETED|Single-blind Period (2 to 4 Weeks)||0||
59797390|NCT00739973|75918294|FG008|COMPLETED|Single-blind Period (2 to 4 Weeks)||0||
59797391|NCT00739973|75918286|FG000|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||1009||
59797392|NCT00739973|75918287|FG001|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0||
59797393|NCT00739973|75918288|FG002|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0||
59797394|NCT00739973|75918289|FG003|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0||
59797395|NCT00739973|75918290|FG004|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0||
59797396|NCT00739973|75918291|FG005|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0||
59797397|NCT00739973|75918292|FG006|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0||
59797398|NCT00739973|75918293|FG007|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0||
59797399|NCT00739973|75918294|FG008|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0||
59797400|NCT00739973|75918286|FG000|STARTED|Double-blind:Randomized Period (8 Weeks)||198||
59797401|NCT00739973|75918287|FG001|STARTED|Double-blind:Randomized Period (8 Weeks)|One pt. was mis-randomized, so discontinued from single-blind and was untreated in the double-blind.|195||
59797402|NCT00739973|75918288|FG002|STARTED|Double-blind:Randomized Period (8 Weeks)||203||
59797403|NCT00739973|75918289|FG003|STARTED|Double-blind:Randomized Period (8 Weeks)||185||
59797404|NCT00739973|75918290|FG004|STARTED|Double-blind:Randomized Period (8 Weeks)||181||
59797405|NCT00739973|75918291|FG005|STARTED|Double-blind:Randomized Period (8 Weeks)||181||
59797406|NCT00739973|75918292|FG006|STARTED|Double-blind:Randomized Period (8 Weeks)|2 pts. were mis-randomized, so discontinued from single-blind and were untreated in double-blind.|183||
59797407|NCT00739973|75918293|FG007|STARTED|Double-blind:Randomized Period (8 Weeks)||178||
59797408|NCT00739973|75918294|FG008|STARTED|Double-blind:Randomized Period (8 Weeks)||184||
59797409|NCT00739973|75918286|FG000|COMPLETED|Double-blind:Randomized Period (8 Weeks)||168||
59797410|NCT00739973|75918287|FG001|COMPLETED|Double-blind:Randomized Period (8 Weeks)||175||
59797411|NCT00739973|75918288|FG002|COMPLETED|Double-blind:Randomized Period (8 Weeks)||184||
59797412|NCT00739973|75918289|FG003|COMPLETED|Double-blind:Randomized Period (8 Weeks)||173||
59797413|NCT00739973|75918290|FG004|COMPLETED|Double-blind:Randomized Period (8 Weeks)||162||
59797414|NCT00739973|75918291|FG005|COMPLETED|Double-blind:Randomized Period (8 Weeks)||169||
59797415|NCT00739973|75918292|FG006|COMPLETED|Double-blind:Randomized Period (8 Weeks)||170||
59797416|NCT00739973|75918293|FG007|COMPLETED|Double-blind:Randomized Period (8 Weeks)||168||
59797417|NCT00739973|75918294|FG008|COMPLETED|Double-blind:Randomized Period (8 Weeks)||170||
59797418|NCT00739973|75918286|FG000|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||30||
59797419|NCT00739973|75918287|FG001|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||20||
59797420|NCT00739973|75918288|FG002|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||19||
59797421|NCT00739973|75918289|FG003|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||12||
59797422|NCT00739973|75918290|FG004|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||19||
59797423|NCT00739973|75918291|FG005|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||12||
59797424|NCT00739973|75918292|FG006|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||13||
59797425|NCT00739973|75918293|FG007|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||10||
59797426|NCT00739973|75918294|FG008|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||14||
59797427|NCT00510874|75918329|FG000|STARTED|Overall Study||78||
59797428|NCT00510874|75918330|FG001|STARTED|Overall Study||152||
59797429|NCT00510874|75918331|FG002|STARTED|Overall Study||151||
59797430|NCT00510874|75918332|FG003|STARTED|Overall Study||151||
59797431|NCT00510874|75918333|FG004|STARTED|Overall Study||148||
59797432|NCT00510874|75918334|FG005|STARTED|Overall Study||50||
59797433|NCT00510874|75918335|FG006|STARTED|Overall Study||50||
59797434|NCT00510874|75918329|FG000|COMPLETED|Overall Study|Upto Day 182|75||
59797435|NCT00510874|75918330|FG001|COMPLETED|Overall Study|Upto Day 182|148||
59797436|NCT00510874|75918331|FG002|COMPLETED|Overall Study|Upto Day 182|150||
59797437|NCT00510874|75918332|FG003|COMPLETED|Overall Study|Upto Day 182|148||
59797438|NCT00510874|75918333|FG004|COMPLETED|Overall Study|Upto Day 182|141||
59797439|NCT00510874|75918334|FG005|COMPLETED|Overall Study|Upto Day 182|50||
59797440|NCT00510874|75918335|FG006|COMPLETED|Overall Study|Upto Day 182|49||
59797441|NCT00510874|75918329|FG000|NOT COMPLETED|Overall Study||3||
59797442|NCT00510874|75918330|FG001|NOT COMPLETED|Overall Study||4||
59797443|NCT00510874|75918331|FG002|NOT COMPLETED|Overall Study||1||
59797444|NCT00510874|75918332|FG003|NOT COMPLETED|Overall Study||3||
59797445|NCT00510874|75918333|FG004|NOT COMPLETED|Overall Study||7||
59797446|NCT00510874|75918334|FG005|NOT COMPLETED|Overall Study||0||
59797447|NCT00510874|75918335|FG006|NOT COMPLETED|Overall Study||1||
59797448|NCT00739661|75918354|FG000|STARTED|Overall Study||52||
59797449|NCT00739661|75918355|FG001|STARTED|Overall Study||52||
59797450|NCT00739661|75918354|FG000|COMPLETED|Overall Study||6||
59797451|NCT00739661|75918355|FG001|COMPLETED|Overall Study||10||
59797452|NCT00739661|75918354|FG000|NOT COMPLETED|Overall Study||46||
59797453|NCT00739661|75918355|FG001|NOT COMPLETED|Overall Study||42||
59797454|NCT00615030|75918361|FG000|STARTED|Period I||9||
59797455|NCT00615030|75918362|FG001|STARTED|Period I||8||
59797456|NCT00615030|75918363|FG002|STARTED|Period I||9||
59797457|NCT00615030|75918364|FG003|STARTED|Period I||8||
59797458|NCT00615030|75918365|FG004|STARTED|Period I||9||
59797459|NCT00615030|75918366|FG005|STARTED|Period I|1 randomized patient in this sequence dropped out before exposure to study drug in Period I.|6||
59797460|NCT00615030|75918367|FG006|STARTED|Period I||7||
59797461|NCT00615030|75918368|FG007|STARTED|Period I||7||
59797462|NCT00615030|75918369|FG008|STARTED|Period I||9||
59797463|NCT00615030|75918370|FG009|STARTED|Period I||8||
59797464|NCT00615030|75918371|FG010|STARTED|Period I||8||
59797465|NCT00615030|75918372|FG011|STARTED|Period I||7||
59797466|NCT00615030|75918361|FG000|COMPLETED|Period I||8||
59797467|NCT00615030|75918362|FG001|COMPLETED|Period I||8||
59797468|NCT00615030|75918363|FG002|COMPLETED|Period I||9||
59797469|NCT00615030|75918364|FG003|COMPLETED|Period I||8||
59797470|NCT00615030|75918365|FG004|COMPLETED|Period I||8||
59797471|NCT00615030|75918366|FG005|COMPLETED|Period I||5||
59797472|NCT00615030|75918367|FG006|COMPLETED|Period I||7||
59797473|NCT00615030|75918368|FG007|COMPLETED|Period I||7||
59797474|NCT00615030|75918369|FG008|COMPLETED|Period I||8||
59797475|NCT00615030|75918370|FG009|COMPLETED|Period I||8||
59797476|NCT00615030|75918371|FG010|COMPLETED|Period I||7||
59797477|NCT00615030|75918372|FG011|COMPLETED|Period I||6||
59797478|NCT00615030|75918361|FG000|NOT COMPLETED|Period I||1||
59797479|NCT00615030|75918362|FG001|NOT COMPLETED|Period I||0||
59797480|NCT00615030|75918363|FG002|NOT COMPLETED|Period I||0||
59797481|NCT00615030|75918364|FG003|NOT COMPLETED|Period I||0||
59797482|NCT00615030|75918365|FG004|NOT COMPLETED|Period I||1||
59797483|NCT00615030|75918366|FG005|NOT COMPLETED|Period I||1||
59797484|NCT00615030|75918367|FG006|NOT COMPLETED|Period I||0||
59797485|NCT00615030|75918368|FG007|NOT COMPLETED|Period I||0||
59797486|NCT00615030|75918369|FG008|NOT COMPLETED|Period I||1||
59797487|NCT00615030|75918370|FG009|NOT COMPLETED|Period I||0||
59797488|NCT00615030|75918371|FG010|NOT COMPLETED|Period I||1||
59797489|NCT00615030|75918372|FG011|NOT COMPLETED|Period I||1||
59797490|NCT00615030|75918361|FG000|STARTED|Period II||8||
59797491|NCT00615030|75918362|FG001|STARTED|Period II||8||
59797492|NCT00615030|75918363|FG002|STARTED|Period II||9||
59797493|NCT00615030|75918364|FG003|STARTED|Period II||8||
59797494|NCT00615030|75918365|FG004|STARTED|Period II||8||
59797495|NCT00615030|75918366|FG005|STARTED|Period II||5||
59954400|NCT02963714|76072890|FG001|STARTED|Overall Study||176||
59954401|NCT02963714|76072889|FG000|COMPLETED|Overall Study||126||
59954402|NCT02963714|76072890|FG001|COMPLETED|Overall Study||126||
59954403|NCT02963714|76072889|FG000|NOT COMPLETED|Overall Study||50||
59797496|NCT00615030|75918367|FG006|STARTED|Period II||7||
59797497|NCT00615030|75918368|FG007|STARTED|Period II||7||
59797498|NCT00615030|75918369|FG008|STARTED|Period II||8||
59797499|NCT00615030|75918370|FG009|STARTED|Period II||8||
59797500|NCT00615030|75918371|FG010|STARTED|Period II||7||
59797501|NCT00615030|75918372|FG011|STARTED|Period II||6||
59797502|NCT00615030|75918361|FG000|COMPLETED|Period II||8||
59797503|NCT00615030|75918362|FG001|COMPLETED|Period II||8||
59797504|NCT00615030|75918363|FG002|COMPLETED|Period II||8||
59797505|NCT00615030|75918364|FG003|COMPLETED|Period II||7||
59797506|NCT00615030|75918365|FG004|COMPLETED|Period II||8||
59797507|NCT00615030|75918366|FG005|COMPLETED|Period II||5||
59797508|NCT00615030|75918367|FG006|COMPLETED|Period II||6||
59954404|NCT02963714|76072890|FG001|NOT COMPLETED|Overall Study||50||
59797509|NCT00615030|75918368|FG007|COMPLETED|Period II||7||
59797510|NCT00615030|75918369|FG008|COMPLETED|Period II||7||
59797511|NCT00615030|75918370|FG009|COMPLETED|Period II||8||
59797512|NCT00615030|75918371|FG010|COMPLETED|Period II||7||
59797513|NCT00615030|75918372|FG011|COMPLETED|Period II||6||
59797514|NCT00615030|75918361|FG000|NOT COMPLETED|Period II||0||
59797515|NCT00615030|75918362|FG001|NOT COMPLETED|Period II||0||
59797516|NCT00615030|75918363|FG002|NOT COMPLETED|Period II||1||
59797517|NCT00615030|75918364|FG003|NOT COMPLETED|Period II||1||
59797518|NCT00615030|75918365|FG004|NOT COMPLETED|Period II||0||
59797519|NCT00615030|75918366|FG005|NOT COMPLETED|Period II||0||
59797520|NCT00615030|75918367|FG006|NOT COMPLETED|Period II||1||
59797521|NCT00615030|75918368|FG007|NOT COMPLETED|Period II||0||
59797522|NCT00615030|75918369|FG008|NOT COMPLETED|Period II||1||
59523618|NCT02543346|75618521|FG001|STARTED|Second Treatment Visit||23||
59523619|NCT02543346|75618522|FG002|STARTED|Second Treatment Visit||22||
59523620|NCT02543346|75618523|FG003|STARTED|Second Treatment Visit||21||
59523621|NCT02543346|75618520|FG000|COMPLETED|Second Treatment Visit||25||
59523622|NCT02543346|75618521|FG001|COMPLETED|Second Treatment Visit||23||
59523623|NCT02543346|75618522|FG002|COMPLETED|Second Treatment Visit||22||
59797523|NCT00615030|75918370|FG009|NOT COMPLETED|Period II||0||
59797524|NCT00615030|75918371|FG010|NOT COMPLETED|Period II||0||
59797525|NCT00615030|75918372|FG011|NOT COMPLETED|Period II||0||
59523624|NCT02543346|75618523|FG003|COMPLETED|Second Treatment Visit||21||
59523625|NCT02543346|75618520|FG000|NOT COMPLETED|Second Treatment Visit||0||
59523626|NCT02543346|75618521|FG001|NOT COMPLETED|Second Treatment Visit||0||
59523627|NCT02543346|75618522|FG002|NOT COMPLETED|Second Treatment Visit||0||
59523628|NCT02543346|75618523|FG003|NOT COMPLETED|Second Treatment Visit||0||
59523629|NCT02549196|75618537|FG000|STARTED|Overall Study||8||
59523630|NCT02549196|75618538|FG001|STARTED|Overall Study||1||
59523631|NCT02549196|75618539|FG002|STARTED|Overall Study||6||
59954405|NCT02324816|76072896|FG000|STARTED|Overall Study||19||
59954406|NCT02324816|76072896|FG000|COMPLETED|Overall Study||19||
59954407|NCT02324816|76072896|FG000|NOT COMPLETED|Overall Study||0||
59954408|NCT00104871|76072900|FG000|STARTED|Overall Study||22||
59797526|NCT00615030|75918361|FG000|STARTED|Period III||8||
59797527|NCT00615030|75918362|FG001|STARTED|Period III||8||
59797528|NCT00615030|75918363|FG002|STARTED|Period III||8||
59797529|NCT00615030|75918364|FG003|STARTED|Period III||7||
59797530|NCT00615030|75918365|FG004|STARTED|Period III||8||
59797531|NCT00615030|75918366|FG005|STARTED|Period III||5||
59954409|NCT00104871|76072900|FG000|COMPLETED|Overall Study||21||
59523632|NCT02549196|75618540|FG003|STARTED|Overall Study||13||
59523633|NCT02549196|75618537|FG000|COMPLETED|Overall Study||7||
59523634|NCT02549196|75618538|FG001|COMPLETED|Overall Study||1||
59523635|NCT02549196|75618539|FG002|COMPLETED|Overall Study||5||
59523636|NCT02549196|75618540|FG003|COMPLETED|Overall Study||12||
59523637|NCT02549196|75618537|FG000|NOT COMPLETED|Overall Study||1||
59523638|NCT02549196|75618538|FG001|NOT COMPLETED|Overall Study||0||
59523639|NCT02549196|75618539|FG002|NOT COMPLETED|Overall Study||1||
59523640|NCT02549196|75618540|FG003|NOT COMPLETED|Overall Study||1||
59523641|NCT02904954|75618552|FG000|STARTED|Neoadjuvant (Preoperative) to Surgery||30||
59523642|NCT02904954|75618553|FG001|STARTED|Neoadjuvant (Preoperative) to Surgery||30||
59523643|NCT02904954|75618552|FG000|COMPLETED|Neoadjuvant (Preoperative) to Surgery|30 participants completed 2 neoadjuvant cycles. Surgical resection was not performed in 4 participants.|26||
59523644|NCT02904954|75618553|FG001|COMPLETED|Neoadjuvant (Preoperative) to Surgery|30 participants completed the first neoadjuvant Durvalumab cycle combined with SBRT. Three subjects did not receive the 2nd cycle. Surgical resection was not performed in 4 participants.|26||
59523645|NCT02904954|75618552|FG000|NOT COMPLETED|Neoadjuvant (Preoperative) to Surgery||4||
59523646|NCT02904954|75618553|FG001|NOT COMPLETED|Neoadjuvant (Preoperative) to Surgery||4||
59523647|NCT02904954|75618552|FG000|STARTED|Adjuvant Durvalumab||26||
59523648|NCT02904954|75618553|FG001|STARTED|Adjuvant Durvalumab||26||
59523649|NCT02904954|75618552|FG000|COMPLETED|Adjuvant Durvalumab||6||
59523650|NCT02904954|75618553|FG001|COMPLETED|Adjuvant Durvalumab||11||
59523651|NCT02904954|75618552|FG000|NOT COMPLETED|Adjuvant Durvalumab||20||
59523652|NCT02904954|75618553|FG001|NOT COMPLETED|Adjuvant Durvalumab||15||
59523653|NCT01188499|75618567|FG000|STARTED|Overall Study||24||
59523654|NCT01188499|75618568|FG001|STARTED|Overall Study||83||
59523655|NCT01188499|75618569|FG002|STARTED|Overall Study||33||
59523656|NCT01188499|75618570|FG003|STARTED|Overall Study||18||
59523657|NCT01188499|75618571|FG004|STARTED|Overall Study||18||
59797532|NCT00615030|75918367|FG006|STARTED|Period III||6||
59797533|NCT00615030|75918368|FG007|STARTED|Period III||7||
59797534|NCT00615030|75918369|FG008|STARTED|Period III||7||
59797535|NCT00615030|75918370|FG009|STARTED|Period III||8||
59797536|NCT00615030|75918371|FG010|STARTED|Period III||7||
59797537|NCT00615030|75918372|FG011|STARTED|Period III||6||
59797538|NCT00615030|75918361|FG000|COMPLETED|Period III||7||
59797539|NCT00615030|75918362|FG001|COMPLETED|Period III||8||
59797540|NCT00615030|75918363|FG002|COMPLETED|Period III||8||
59797541|NCT00615030|75918364|FG003|COMPLETED|Period III||6||
59797542|NCT00615030|75918365|FG004|COMPLETED|Period III||8||
59797543|NCT00615030|75918366|FG005|COMPLETED|Period III||5||
59797544|NCT00615030|75918367|FG006|COMPLETED|Period III||6||
59797545|NCT00615030|75918368|FG007|COMPLETED|Period III||7||
59797546|NCT00615030|75918369|FG008|COMPLETED|Period III||7||
59797547|NCT00615030|75918370|FG009|COMPLETED|Period III||8||
59797548|NCT00615030|75918371|FG010|COMPLETED|Period III||7||
59797549|NCT00615030|75918372|FG011|COMPLETED|Period III||6||
59797550|NCT00615030|75918361|FG000|NOT COMPLETED|Period III||1||
59797551|NCT00615030|75918362|FG001|NOT COMPLETED|Period III||0||
59797552|NCT00615030|75918363|FG002|NOT COMPLETED|Period III||0||
59797553|NCT00615030|75918364|FG003|NOT COMPLETED|Period III||1||
59797554|NCT00615030|75918365|FG004|NOT COMPLETED|Period III||0||
59797555|NCT00615030|75918366|FG005|NOT COMPLETED|Period III||0||
59797556|NCT00615030|75918367|FG006|NOT COMPLETED|Period III||0||
59797557|NCT00615030|75918368|FG007|NOT COMPLETED|Period III||0||
59797558|NCT00615030|75918369|FG008|NOT COMPLETED|Period III||0||
59797559|NCT00615030|75918370|FG009|NOT COMPLETED|Period III||0||
59797560|NCT00615030|75918371|FG010|NOT COMPLETED|Period III||0||
59797561|NCT00615030|75918372|FG011|NOT COMPLETED|Period III||0||
59797562|NCT00518284|75918390|FG000|STARTED|Overall Study||0||
59797563|NCT00518284|75918391|FG001|STARTED|Overall Study||3||
59797564|NCT00518284|75918392|FG002|STARTED|Overall Study||1||
59797565|NCT00518284|75918393|FG003|STARTED|Overall Study||2||
59797566|NCT00518284|75918390|FG000|COMPLETED|Overall Study||0||
59797567|NCT00518284|75918391|FG001|COMPLETED|Overall Study||0||
59797568|NCT00518284|75918392|FG002|COMPLETED|Overall Study||0||
59797569|NCT00518284|75918393|FG003|COMPLETED|Overall Study||0||
59797570|NCT00518284|75918390|FG000|NOT COMPLETED|Overall Study||0||
59797571|NCT00518284|75918391|FG001|NOT COMPLETED|Overall Study||3||
59797572|NCT00518284|75918392|FG002|NOT COMPLETED|Overall Study||1||
59797573|NCT00518284|75918393|FG003|NOT COMPLETED|Overall Study||2||
59797574|NCT00614874|75918403|FG000|STARTED|Overall Study||16||
59797575|NCT00614874|75918403|FG000|COMPLETED|Overall Study||14||
59797576|NCT00614874|75918403|FG000|NOT COMPLETED|Overall Study||2||
59797577|NCT00727415|75918407|FG000|STARTED|Phase I||9||
59797578|NCT00727415|75918407|FG000|COMPLETED|Phase I||7||
59797579|NCT00727415|75918407|FG000|NOT COMPLETED|Phase I||2||
59797580|NCT00727415|75918407|FG000|STARTED|Phase II||33||
59797581|NCT00727415|75918407|FG000|COMPLETED|Phase II||33||
59797582|NCT00727415|75918407|FG000|NOT COMPLETED|Phase II||0||
59797583|NCT00544557|75918411|FG000|STARTED|Overall Study||1685||
59797584|NCT00544557|75918411|FG000|COMPLETED|Overall Study||1251||
59797585|NCT00544557|75918411|FG000|NOT COMPLETED|Overall Study||434||
59797586|NCT00727259|75918415|FG000|STARTED|Overall Study||1995||
59797587|NCT00727259|75918415|FG000|COMPLETED|Overall Study||940||
59797588|NCT00727259|75918415|FG000|NOT COMPLETED|Overall Study||1055||
59797589|NCT00735371|75918424|FG000|STARTED|Overall Study||78||
59797590|NCT00735371|75918425|FG001|STARTED|Overall Study||79||
59797591|NCT00735371|75918426|FG002|STARTED|Overall Study||78||
59797592|NCT00735371|75918427|FG003|STARTED|Overall Study||79||
59954410|NCT00104871|76072900|FG000|NOT COMPLETED|Overall Study||1||
60073713|NCT01688037|76189046|FG001|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||3||
59797593|NCT00735371|75918424|FG000|COMPLETED|Overall Study||63||
59797594|NCT00735371|75918425|FG001|COMPLETED|Overall Study||66||
59797595|NCT00735371|75918426|FG002|COMPLETED|Overall Study||67||
59797596|NCT00735371|75918427|FG003|COMPLETED|Overall Study||69||
59797597|NCT00735371|75918424|FG000|NOT COMPLETED|Overall Study||15||
59797598|NCT00735371|75918425|FG001|NOT COMPLETED|Overall Study||13||
59797599|NCT00735371|75918426|FG002|NOT COMPLETED|Overall Study||11||
59797600|NCT00735371|75918427|FG003|NOT COMPLETED|Overall Study||10||
59797601|NCT00518206|75918439|FG000|STARTED|Overall Study||27||
59797602|NCT00518206|75918440|FG001|STARTED|Overall Study||19||
59797603|NCT00518206|75918439|FG000|COMPLETED|Overall Study||16||
59797604|NCT00518206|75918440|FG001|COMPLETED|Overall Study||13||
59797605|NCT00518206|75918439|FG000|NOT COMPLETED|Overall Study||11||
59797606|NCT00518206|75918440|FG001|NOT COMPLETED|Overall Study||6||
59797607|NCT00586313|75918446|FG000|STARTED|Overall Study||21||
59797608|NCT00586313|75918446|FG000|COMPLETED|Overall Study||19||
59797609|NCT00586313|75918446|FG000|NOT COMPLETED|Overall Study||2||
59797610|NCT00734747|75918450|FG000|STARTED|SRS Procedure||72||
59797611|NCT00734747|75918450|FG000|COMPLETED|SRS Procedure||69||
59797612|NCT00734747|75918450|FG000|NOT COMPLETED|SRS Procedure||3||
59797613|NCT00734747|75918450|FG000|STARTED|6 Month Follow-up||69||
59797614|NCT00734747|75918450|FG000|COMPLETED|6 Month Follow-up||66||
59797615|NCT00734747|75918450|FG000|NOT COMPLETED|6 Month Follow-up||3||
59797616|NCT00726557|75918454|FG000|STARTED|Overall Study||246||
59797617|NCT00726557|75918454|FG000|COMPLETED|Overall Study|Completed is defined as those who finished the follow-up period.|118||
59797618|NCT00726557|75918454|FG000|NOT COMPLETED|Overall Study||128||
59797619|NCT00738881|75918461|FG000|STARTED|Overall Study||11||
59797620|NCT00738881|75918462|FG001|STARTED|Overall Study||12||
59797621|NCT00738881|75918461|FG000|COMPLETED|Overall Study||11||
59797622|NCT00738881|75918462|FG001|COMPLETED|Overall Study||10||
59797623|NCT00738881|75918461|FG000|NOT COMPLETED|Overall Study||0||
59797624|NCT00738881|75918462|FG001|NOT COMPLETED|Overall Study||2||
59797625|NCT00657020|75918468|FG000|STARTED|PERIOD 1||11||
59797626|NCT00657020|75918469|FG001|STARTED|PERIOD 1||12||
59797627|NCT00657020|75918468|FG000|COMPLETED|PERIOD 1||11||
59797628|NCT00657020|75918469|FG001|COMPLETED|PERIOD 1||11||
59797629|NCT00657020|75918468|FG000|NOT COMPLETED|PERIOD 1||0||
59797630|NCT00657020|75918469|FG001|NOT COMPLETED|PERIOD 1||1||
59797631|NCT00657020|75918468|FG000|STARTED|PERIOD 2||11||
59797632|NCT00657020|75918469|FG001|STARTED|PERIOD 2||11||
59797633|NCT00657020|75918468|FG000|COMPLETED|PERIOD 2||11||
59797634|NCT00657020|75918469|FG001|COMPLETED|PERIOD 2||11||
59797635|NCT00657020|75918468|FG000|NOT COMPLETED|PERIOD 2||0||
59797636|NCT00657020|75918469|FG001|NOT COMPLETED|PERIOD 2||0||
59797637|NCT03921723|75918481|FG000|STARTED|Period 1 (4 Days)||22||
59797638|NCT03921723|75918481|FG000|COMPLETED|Period 1 (4 Days)||22||
59797639|NCT03921723|75918481|FG000|NOT COMPLETED|Period 1 (4 Days)||0||
59797640|NCT03921723|75918481|FG000|STARTED|Period 2 (4 Days)||22||
59797641|NCT03921723|75918481|FG000|COMPLETED|Period 2 (4 Days)||19||
59797642|NCT03921723|75918481|FG000|NOT COMPLETED|Period 2 (4 Days)||3||
59797643|NCT03921723|75918481|FG000|STARTED|Period 3 (4 Days)||19||
59797644|NCT03921723|75918481|FG000|COMPLETED|Period 3 (4 Days)||18||
59797645|NCT03921723|75918481|FG000|NOT COMPLETED|Period 3 (4 Days)||1||
59797646|NCT00544167|75918489|FG000|STARTED|Overall Study||45||
59797647|NCT00544167|75918489|FG000|COMPLETED|Overall Study||16||
59797648|NCT00544167|75918489|FG000|NOT COMPLETED|Overall Study||29||
59797649|NCT00659438|75918495|FG000|STARTED|Overall Study||47||
59797650|NCT00659438|75918496|FG001|STARTED|Overall Study||48||
59797651|NCT00659438|75918495|FG000|Assessable Set : Primary Analysis|Overall Study||44||
59797652|NCT00659438|75918496|FG001|Assessable Set : Primary Analysis|Overall Study||45||
59797653|NCT00659438|75918495|FG000|Secondary Analysis Set|Overall Study||47||
59797654|NCT00659438|75918496|FG001|Secondary Analysis Set|Overall Study||48||
59797655|NCT00659438|75918495|FG000|Safety Analysis Set|Overall Study|One patient randomized to placebo was accounted in vandetanib group as he mistakenly received drug|48||
59797656|NCT00659438|75918496|FG001|Safety Analysis Set|Overall Study||47||
59797657|NCT00659438|75918495|FG000|COMPLETED|Overall Study||33||
59797658|NCT00659438|75918496|FG001|COMPLETED|Overall Study||40||
59797659|NCT00659438|75918495|FG000|NOT COMPLETED|Overall Study||14||
59797660|NCT00659438|75918496|FG001|NOT COMPLETED|Overall Study||8||
59797661|NCT00543855|75918506|FG000|STARTED|Overall Study||35||
59797662|NCT00543855|75918507|FG001|STARTED|Overall Study||33||
59797663|NCT00543855|75918508|FG002|STARTED|Overall Study||37||
59797664|NCT00543855|75918509|FG003|STARTED|Overall Study||34||
59797665|NCT00543855|75918506|FG000|COMPLETED|Overall Study||31||
59797666|NCT00543855|75918507|FG001|COMPLETED|Overall Study||31||
59797667|NCT00543855|75918508|FG002|COMPLETED|Overall Study||31||
59797668|NCT00543855|75918509|FG003|COMPLETED|Overall Study||30||
59797669|NCT00543855|75918506|FG000|NOT COMPLETED|Overall Study||4||
59797670|NCT00543855|75918507|FG001|NOT COMPLETED|Overall Study||2||
59797671|NCT00543855|75918508|FG002|NOT COMPLETED|Overall Study||6||
59797672|NCT00543855|75918509|FG003|NOT COMPLETED|Overall Study||4||
59797673|NCT00656474|75918519|FG000|STARTED|Overall Study||12||
59797674|NCT00656474|75918519|FG000|COMPLETED|Overall Study||11||
59797675|NCT00656474|75918519|FG000|NOT COMPLETED|Overall Study||1||
59797676|NCT00656084|75918524|FG000|STARTED|Overall Study||16||
59797677|NCT00656084|75918524|FG000|COMPLETED|Overall Study||9||
59797678|NCT00656084|75918524|FG000|NOT COMPLETED|Overall Study||7||
59797679|NCT00613938|75918532|FG000|STARTED|Overall Study||69||
59797680|NCT00613938|75918533|FG001|STARTED|Overall Study||275||
59797681|NCT00613938|75918534|FG002|STARTED|Overall Study||278||
59797682|NCT00613938|75918535|FG003|STARTED|Overall Study|one patient did not have a valid baseline score therefore excluded from above|279||
59797683|NCT00613938|75918532|FG000|COMPLETED|Overall Study||49||
59797684|NCT00613938|75918533|FG001|COMPLETED|Overall Study||247||
59797685|NCT00613938|75918534|FG002|COMPLETED|Overall Study||255||
59797686|NCT00613938|75918535|FG003|COMPLETED|Overall Study||253||
59797687|NCT00613938|75918532|FG000|NOT COMPLETED|Overall Study||20||
59797688|NCT00613938|75918533|FG001|NOT COMPLETED|Overall Study||28||
59797689|NCT00613938|75918534|FG002|NOT COMPLETED|Overall Study||23||
59797690|NCT00613938|75918535|FG003|NOT COMPLETED|Overall Study||26||
59797691|NCT00655928|75918547|FG000|STARTED|Overall Study||26||
59797692|NCT00655928|75918548|FG001|STARTED|Overall Study||26||
59797693|NCT00655928|75918547|FG000|COMPLETED|Overall Study||23||
59797694|NCT00655928|75918548|FG001|COMPLETED|Overall Study||24||
59797695|NCT00655928|75918547|FG000|NOT COMPLETED|Overall Study||3||
59797696|NCT00655928|75918548|FG001|NOT COMPLETED|Overall Study||2||
59797697|NCT00655850|75918554|FG000|STARTED|Overall Study||39||
59797698|NCT00655850|75918554|FG000|COMPLETED|Overall Study||36||
59797699|NCT00655850|75918554|FG000|NOT COMPLETED|Overall Study||3||
59797700|NCT00726323|75918562|FG000|STARTED|Overall Study||37||
59797701|NCT00726323|75918563|FG001|STARTED|Overall Study||37||
59797702|NCT00726323|75918562|FG000|COMPLETED|Overall Study||0||
59797703|NCT00726323|75918563|FG001|COMPLETED|Overall Study||6||
59797704|NCT00726323|75918562|FG000|NOT COMPLETED|Overall Study||37||
59797705|NCT00726323|75918563|FG001|NOT COMPLETED|Overall Study||31||
59797706|NCT00246571|75918571|FG000|STARTED|Overall Study||113||
59797707|NCT00246571|75918572|FG001|STARTED|Overall Study||104||
59797708|NCT00246571|75918571|FG000|Randomized But Not Treated|Overall Study||3||
59797709|NCT00246571|75918572|FG001|Randomized But Not Treated|Overall Study||1||
59797710|NCT00246571|75918571|FG000|COMPLETED|Overall Study||0||
59797711|NCT00246571|75918572|FG001|COMPLETED|Overall Study||0||
59797712|NCT00246571|75918571|FG000|NOT COMPLETED|Overall Study||113||
59797713|NCT00246571|75918572|FG001|NOT COMPLETED|Overall Study||104||
59797714|NCT00734591|75918580|FG000|STARTED|Retrospective Period||3875||
59797715|NCT00734591|75918581|FG001|STARTED|Retrospective Period||3564||
59797716|NCT00734591|75918580|FG000|COMPLETED|Retrospective Period||3875||
59797717|NCT00734591|75918581|FG001|COMPLETED|Retrospective Period||3564||
59797718|NCT00734591|75918580|FG000|NOT COMPLETED|Retrospective Period||0||
59797719|NCT00734591|75918581|FG001|NOT COMPLETED|Retrospective Period||0||
59797720|NCT00734591|75918580|FG000|STARTED|Screening for Prospective Period||3875||
59797721|NCT00734591|75918581|FG001|STARTED|Screening for Prospective Period||3564||
59797722|NCT00734591|75918580|FG000|COMPLETED|Screening for Prospective Period||1358||
59797723|NCT00734591|75918581|FG001|COMPLETED|Screening for Prospective Period||1273||
59797724|NCT00734591|75918580|FG000|NOT COMPLETED|Screening for Prospective Period||2517||
59797725|NCT00734591|75918581|FG001|NOT COMPLETED|Screening for Prospective Period||2291||
59797726|NCT00734591|75918580|FG000|STARTED|Prospective Period||1358||
59797727|NCT00734591|75918581|FG001|STARTED|Prospective Period||1273||
59797728|NCT00734591|75918580|FG000|COMPLETED|Prospective Period||1307||
59797729|NCT00734591|75918581|FG001|COMPLETED|Prospective Period||1229||
59797730|NCT00734591|75918580|FG000|NOT COMPLETED|Prospective Period||51||
59797731|NCT00734591|75918581|FG001|NOT COMPLETED|Prospective Period||44||
59797732|NCT00569270|75918587|FG000|STARTED|Period: First Intervention|randomized cross over study|15||
59797733|NCT00569270|75918588|FG001|STARTED|Period: First Intervention||15||
59797734|NCT00569270|75918587|FG000|COMPLETED|Period: First Intervention||15||
59797735|NCT00569270|75918588|FG001|COMPLETED|Period: First Intervention||14||
59797736|NCT00569270|75918587|FG000|NOT COMPLETED|Period: First Intervention||0||
59797737|NCT00569270|75918588|FG001|NOT COMPLETED|Period: First Intervention||1||
59797738|NCT00569270|75918587|FG000|STARTED|Period: Second Intervention||15||
59797739|NCT00569270|75918588|FG001|STARTED|Period: Second Intervention||14||
59797740|NCT00569270|75918587|FG000|29 Days|Period: Second Intervention||15||
59797741|NCT00569270|75918588|FG001|29 Days|Period: Second Intervention||14||
59797742|NCT00569270|75918587|FG000|COMPLETED|Period: Second Intervention||15||
59797743|NCT00569270|75918588|FG001|COMPLETED|Period: Second Intervention||14||
59797744|NCT00569270|75918587|FG000|NOT COMPLETED|Period: Second Intervention||0||
59797745|NCT00569270|75918588|FG001|NOT COMPLETED|Period: Second Intervention||0||
59797746|NCT00545103|75918607|FG000|STARTED|Overall Study||148||
59797747|NCT00545103|75918608|FG001|STARTED|Overall Study||148||
59797748|NCT00545103|75918609|FG002|STARTED|Overall Study||150||
59797749|NCT00545103|75918610|FG003|STARTED|Overall Study||146||
59797750|NCT00545103|75918607|FG000|COMPLETED|Overall Study||73||
59797751|NCT00545103|75918608|FG001|COMPLETED|Overall Study||70||
59797752|NCT00545103|75918609|FG002|COMPLETED|Overall Study||74||
59797753|NCT00545103|75918610|FG003|COMPLETED|Overall Study||76||
59797754|NCT00545103|75918607|FG000|NOT COMPLETED|Overall Study||75||
59797755|NCT00545103|75918608|FG001|NOT COMPLETED|Overall Study||78||
59797756|NCT00545103|75918609|FG002|NOT COMPLETED|Overall Study||76||
59797757|NCT00545103|75918610|FG003|NOT COMPLETED|Overall Study||70||
59797758|NCT00586157|75918620|FG000|STARTED|First Intervention||15||
59797759|NCT00586157|75918621|FG001|STARTED|First Intervention||15||
59797760|NCT00586157|75918620|FG000|COMPLETED|First Intervention||14||
59797761|NCT00586157|75918621|FG001|COMPLETED|First Intervention||15||
59797762|NCT00586157|75918620|FG000|NOT COMPLETED|First Intervention||1||
59954411|NCT03487796|76072908|FG000|STARTED|Overall Study||41|Started: individuals - 46 MySTYLE, 33 Control|
59954412|NCT03487796|76072909|FG001|STARTED|Overall Study||31|Started: individuals - 46 MySTYLE, 33 Control|
59954413|NCT03487796|76072908|FG000|2 Month Follow-up|Overall Study||24|2 Month Follow-up: individuals- 27 MySTYLE, 28 Control|
59797763|NCT00586157|75918621|FG001|NOT COMPLETED|First Intervention||0||
59797764|NCT00586157|75918620|FG000|STARTED|Second Intervention||14||
59797765|NCT00586157|75918621|FG001|STARTED|Second Intervention||15||
59797766|NCT00586157|75918620|FG000|COMPLETED|Second Intervention||12||
59797767|NCT00586157|75918621|FG001|COMPLETED|Second Intervention||14||
59797768|NCT00586157|75918620|FG000|NOT COMPLETED|Second Intervention||2||
59797769|NCT00586157|75918621|FG001|NOT COMPLETED|Second Intervention||1||
59797770|NCT00246337|75918636|FG000|STARTED|Overall Study||147||
59797771|NCT00246337|75918637|FG001|STARTED|Overall Study||16||
59797772|NCT00246337|75918638|FG002|STARTED|Overall Study||18||
59797773|NCT00246337|75918639|FG003|STARTED|Overall Study||17||
59797774|NCT00246337|75918640|FG004|STARTED|Overall Study||16||
59797775|NCT00246337|75918641|FG005|STARTED|Overall Study||54||
59797776|NCT00246337|75918642|FG006|STARTED|Overall Study||54||
59797777|NCT00246337|75918643|FG007|STARTED|Overall Study||53||
59797778|NCT00246337|75918644|FG008|STARTED|Overall Study||45||
59797779|NCT00246337|75918636|FG000|Completed Period (Initial Dose)|Overall Study||46||
59797780|NCT00246337|75918637|FG001|Completed Period (Initial Dose)|Overall Study||4||
59797781|NCT00246337|75918638|FG002|Completed Period (Initial Dose)|Overall Study||9||
59797782|NCT00246337|75918639|FG003|Completed Period (Initial Dose)|Overall Study||5||
59797783|NCT00246337|75918640|FG004|Completed Period (Initial Dose)|Overall Study||8||
59797784|NCT00246337|75918641|FG005|Completed Period (Initial Dose)|Overall Study||29||
59797785|NCT00246337|75918642|FG006|Completed Period (Initial Dose)|Overall Study||29||
59797786|NCT00246337|75918643|FG007|Completed Period (Initial Dose)|Overall Study||27||
59797787|NCT00246337|75918644|FG008|Completed Period (Initial Dose)|Overall Study||19||
59797788|NCT00246337|75918636|FG000|Completed Period (Both Doses)|Overall Study||69||
59797789|NCT00246337|75918637|FG001|Completed Period (Both Doses)|Overall Study||10||
59797790|NCT00246337|75918638|FG002|Completed Period (Both Doses)|Overall Study||6||
59797791|NCT00246337|75918639|FG003|Completed Period (Both Doses)|Overall Study||11||
59797792|NCT00246337|75918640|FG004|Completed Period (Both Doses)|Overall Study||4||
59797793|NCT00246337|75918641|FG005|Completed Period (Both Doses)|Overall Study||10||
59797794|NCT00246337|75918642|FG006|Completed Period (Both Doses)|Overall Study||16||
59797795|NCT00246337|75918643|FG007|Completed Period (Both Doses)|Overall Study||13||
59797796|NCT00246337|75918644|FG008|Completed Period (Both Doses)|Overall Study||15||
59797797|NCT00246337|75918636|FG000|COMPLETED|Overall Study||115||
59797798|NCT00246337|75918637|FG001|COMPLETED|Overall Study||14||
59797799|NCT00246337|75918638|FG002|COMPLETED|Overall Study||15||
59797800|NCT00246337|75918639|FG003|COMPLETED|Overall Study||16||
59797801|NCT00246337|75918640|FG004|COMPLETED|Overall Study||12||
59797802|NCT00246337|75918641|FG005|COMPLETED|Overall Study||39||
59797803|NCT00246337|75918642|FG006|COMPLETED|Overall Study||45||
59797804|NCT00246337|75918643|FG007|COMPLETED|Overall Study||40||
59797805|NCT00246337|75918644|FG008|COMPLETED|Overall Study||34||
59797806|NCT00246337|75918636|FG000|NOT COMPLETED|Overall Study||32||
59797807|NCT00246337|75918637|FG001|NOT COMPLETED|Overall Study||2||
59797808|NCT00246337|75918638|FG002|NOT COMPLETED|Overall Study||3||
59797809|NCT00246337|75918639|FG003|NOT COMPLETED|Overall Study||1||
59797810|NCT00246337|75918640|FG004|NOT COMPLETED|Overall Study||4||
59797811|NCT00246337|75918641|FG005|NOT COMPLETED|Overall Study||15||
59797812|NCT00246337|75918642|FG006|NOT COMPLETED|Overall Study||9||
59797813|NCT00246337|75918643|FG007|NOT COMPLETED|Overall Study||13||
59797814|NCT00246337|75918644|FG008|NOT COMPLETED|Overall Study||11||
59797815|NCT00243919|75918667|FG000|STARTED|Overall Study||139||
59797816|NCT00243919|75918668|FG001|STARTED|Overall Study||143||
59797817|NCT00243919|75918669|FG002|STARTED|Overall Study||126||
59797818|NCT00243919|75918667|FG000|COMPLETED|Overall Study||122||
59797819|NCT00243919|75918668|FG001|COMPLETED|Overall Study||125||
59797820|NCT00243919|75918669|FG002|COMPLETED|Overall Study||115||
59797821|NCT00243919|75918667|FG000|NOT COMPLETED|Overall Study||17||
59797822|NCT00243919|75918668|FG001|NOT COMPLETED|Overall Study||18||
59797823|NCT00243919|75918669|FG002|NOT COMPLETED|Overall Study||11||
59797824|NCT00725621|75918677|FG000|STARTED|Overall Study|Started was defined as the number of participants who received at least one infusion of Remicade.|516||
59797825|NCT00725621|75918677|FG000|COMPLETED|Overall Study|Completed was defined as the number of participants who received 9 consecutive Remicade infusions.|245||
59797826|NCT00725621|75918677|FG000|NOT COMPLETED|Overall Study||271||
59797827|NCT00613626|75918688|FG000|STARTED|Overall Study||33||
59797828|NCT00613626|75918689|FG001|STARTED|Overall Study||34||
59797829|NCT00613626|75918690|FG002|STARTED|Overall Study|These participants provided the toxicity data to determine if ZD6474+Etopiside+Cisplatin was safe.|7||
59797830|NCT00613626|75918688|FG000|1st Dose ZD6474|Overall Study||33||
59797831|NCT00613626|75918689|FG001|1st Dose ZD6474|Overall Study||34||
59797832|NCT00613626|75918690|FG002|1st Dose ZD6474|Overall Study||7||
59797833|NCT00613626|75918688|FG000|COMPLETED|Overall Study||33||
59797834|NCT00613626|75918689|FG001|COMPLETED|Overall Study||33||
59797835|NCT00613626|75918690|FG002|COMPLETED|Overall Study||7||
60103588|NCT01290952|76221837|FG001|COMPLETED|Overall Study||193||
59523658|NCT01188499|75618567|FG000|COMPLETED|Overall Study||24||
59797836|NCT00613626|75918688|FG000|NOT COMPLETED|Overall Study||0||
59797837|NCT00613626|75918689|FG001|NOT COMPLETED|Overall Study||1||
59797838|NCT00613626|75918690|FG002|NOT COMPLETED|Overall Study||0||
59797839|NCT00725543|75918697|FG000|STARTED|Overall Study||358||
59797840|NCT00725543|75918697|FG000|COMPLETED|Overall Study|Completed was defined as the number of participants who received 9 consecutive Remicade infusions.|205||
59797841|NCT00725543|75918697|FG000|NOT COMPLETED|Overall Study||153||
59797842|NCT00239005|75918703|FG000|STARTED|Overall Study||69||
59797843|NCT00239005|75918704|FG001|STARTED|Overall Study||65||
59797844|NCT00239005|75918703|FG000|Intention-to-treat Population (ITT)|Overall Study||68||
59797845|NCT00239005|75918704|FG001|Intention-to-treat Population (ITT)|Overall Study||61||
59797846|NCT00239005|75918703|FG000|COMPLETED|Overall Study||57||
59523659|NCT01188499|75618568|FG001|COMPLETED|Overall Study||83||
59797847|NCT00239005|75918704|FG001|COMPLETED|Overall Study||53||
59797848|NCT00239005|75918703|FG000|NOT COMPLETED|Overall Study||12||
59797849|NCT00239005|75918704|FG001|NOT COMPLETED|Overall Study||12||
59797850|NCT00616434|75918712|FG000|STARTED|Overall Study||62||
59797851|NCT00616434|75918713|FG001|STARTED|Overall Study||61||
59797852|NCT00616434|75918712|FG000|COMPLETED|Overall Study||56||
59797853|NCT00616434|75918713|FG001|COMPLETED|Overall Study||53||
59797854|NCT00616434|75918712|FG000|NOT COMPLETED|Overall Study||6||
59797855|NCT00616434|75918713|FG001|NOT COMPLETED|Overall Study||8||
59797856|NCT00652340|75918721|FG000|STARTED|Overall Study||78||
59797857|NCT00652340|75918722|FG001|STARTED|Overall Study||42||
59797858|NCT00652340|75918721|FG000|COMPLETED|Overall Study|4 patients remained on study at database lock.|74||
59797859|NCT00652340|75918722|FG001|COMPLETED|Overall Study|3 patients remained on study at database lock.|39||
59797860|NCT00652340|75918721|FG000|NOT COMPLETED|Overall Study||4||
59797861|NCT00652340|75918722|FG001|NOT COMPLETED|Overall Study||3||
59797862|NCT00613314|75918728|FG000|STARTED|Overall Study||15268||
59797863|NCT00613314|75918728|FG000|COMPLETED|Overall Study||15113||
59797864|NCT00613314|75918728|FG000|NOT COMPLETED|Overall Study||155||
59797865|NCT00257725|75918732|FG000|STARTED|Overall Study||11||
59797866|NCT00257725|75918732|FG000|COMPLETED|Overall Study||8||
59797867|NCT00257725|75918732|FG000|NOT COMPLETED|Overall Study||3||
59797868|NCT00544869|75918740|FG000|STARTED|Overall Study||36||
59797869|NCT00544869|75918741|FG001|STARTED|Overall Study||14||
59797870|NCT00544869|75918742|FG002|STARTED|Overall Study||2||
59797871|NCT00544869|75918740|FG000|COMPLETED|Overall Study||24||
59797872|NCT00544869|75918741|FG001|COMPLETED|Overall Study||12||
59797873|NCT00544869|75918742|FG002|COMPLETED|Overall Study||2||
59797874|NCT00544869|75918740|FG000|NOT COMPLETED|Overall Study||12||
59797875|NCT00544869|75918741|FG001|NOT COMPLETED|Overall Study||2||
59797876|NCT00544869|75918742|FG002|NOT COMPLETED|Overall Study||0||
59797877|NCT00725075|75918753|FG000|STARTED|Overall Study||72||
59797878|NCT00725075|75918754|FG001|STARTED|Overall Study||73||
59797879|NCT00725075|75918755|FG002|STARTED|Overall Study||70||
59797880|NCT00725075|75918753|FG000|Treated|Overall Study||71||
59797881|NCT00725075|75918754|FG001|Treated|Overall Study||73||
59797882|NCT00725075|75918755|FG002|Treated|Overall Study||70||
59797883|NCT00725075|75918753|FG000|COMPLETED|Overall Study||61||
59797884|NCT00725075|75918754|FG001|COMPLETED|Overall Study||65||
59797885|NCT00725075|75918755|FG002|COMPLETED|Overall Study||61||
59797886|NCT00725075|75918753|FG000|NOT COMPLETED|Overall Study||11||
59954414|NCT03487796|76072909|FG001|2 Month Follow-up|Overall Study||26|2 Month Follow-up: individuals- 27 MySTYLE, 28 Control|
59954415|NCT03487796|76072908|FG000|COMPLETED|Overall Study||23|Completed: Individuals- 27 MySTYLE, 27 Control|
59797887|NCT00725075|75918754|FG001|NOT COMPLETED|Overall Study||8||
59797888|NCT00725075|75918755|FG002|NOT COMPLETED|Overall Study||9||
59797889|NCT00733499|75918765|FG000|STARTED|Pre-operative||102||
59797890|NCT00733499|75918766|FG001|STARTED|Pre-operative|A death occurred prior to surgery which left a total of 102 participants|103||
59797891|NCT00733499|75918765|FG000|COMPLETED|Pre-operative||102||
59797892|NCT00733499|75918766|FG001|COMPLETED|Pre-operative||102||
59797893|NCT00733499|75918765|FG000|NOT COMPLETED|Pre-operative||0||
59797894|NCT00733499|75918766|FG001|NOT COMPLETED|Pre-operative||1||
59797895|NCT00733499|75918765|FG000|STARTED|3 Months Follow-up||102||
59797896|NCT00733499|75918766|FG001|STARTED|3 Months Follow-up||102||
59797897|NCT00733499|75918765|FG000|COMPLETED|3 Months Follow-up||101||
59797898|NCT00733499|75918766|FG001|COMPLETED|3 Months Follow-up||100||
59797899|NCT00733499|75918765|FG000|NOT COMPLETED|3 Months Follow-up||1||
59797900|NCT00733499|75918766|FG001|NOT COMPLETED|3 Months Follow-up||2||
59797901|NCT00733499|75918765|FG000|STARTED|6 Months Follow-up||101||
59797902|NCT00733499|75918766|FG001|STARTED|6 Months Follow-up||100||
59797903|NCT00733499|75918765|FG000|COMPLETED|6 Months Follow-up||101||
59797904|NCT00733499|75918766|FG001|COMPLETED|6 Months Follow-up||97||
59797905|NCT00733499|75918765|FG000|NOT COMPLETED|6 Months Follow-up||0||
59797906|NCT00733499|75918766|FG001|NOT COMPLETED|6 Months Follow-up||3||
59797907|NCT00733499|75918765|FG000|STARTED|12 Months Follow-up||101||
59797908|NCT00733499|75918766|FG001|STARTED|12 Months Follow-up||97||
59797909|NCT00733499|75918765|FG000|COMPLETED|12 Months Follow-up||99||
59797910|NCT00733499|75918766|FG001|COMPLETED|12 Months Follow-up||96||
59797911|NCT00733499|75918765|FG000|NOT COMPLETED|12 Months Follow-up||2||
59797912|NCT00733499|75918766|FG001|NOT COMPLETED|12 Months Follow-up||1||
59797913|NCT00733499|75918765|FG000|STARTED|24 Months Follow-up||99||
59797914|NCT00733499|75918766|FG001|STARTED|24 Months Follow-up||96||
59797915|NCT00733499|75918765|FG000|COMPLETED|24 Months Follow-up||99||
59797916|NCT00733499|75918766|FG001|COMPLETED|24 Months Follow-up||95||
59797917|NCT00733499|75918765|FG000|NOT COMPLETED|24 Months Follow-up||0||
59797918|NCT00733499|75918766|FG001|NOT COMPLETED|24 Months Follow-up||1||
59797919|NCT00733499|75918765|FG000|STARTED|5 Year Followup||91||
59797920|NCT00733499|75918766|FG001|STARTED|5 Year Followup||78||
59797921|NCT00733499|75918765|FG000|COMPLETED|5 Year Followup||70||
59797922|NCT00733499|75918766|FG001|COMPLETED|5 Year Followup||53||
59797923|NCT00733499|75918765|FG000|NOT COMPLETED|5 Year Followup||21||
59797924|NCT00733499|75918766|FG001|NOT COMPLETED|5 Year Followup||25||
59797925|NCT00733499|75918765|FG000|STARTED|10 Year Followup||46||
59797926|NCT00733499|75918766|FG001|STARTED|10 Year Followup||32||
59797927|NCT00733499|75918765|FG000|COMPLETED|10 Year Followup||26||
59797928|NCT00733499|75918766|FG001|COMPLETED|10 Year Followup||13||
59797929|NCT00733499|75918765|FG000|NOT COMPLETED|10 Year Followup||20||
59797930|NCT00733499|75918766|FG001|NOT COMPLETED|10 Year Followup||19||
59797931|NCT00652028|75918776|FG000|STARTED|Overall Study||16||
59797932|NCT00652028|75918777|FG001|STARTED|Overall Study||14||
59797933|NCT00652028|75918778|FG002|STARTED|Overall Study||15||
59954416|NCT03487796|76072909|FG001|COMPLETED|Overall Study||25|Completed: Individuals- 27 MySTYLE, 27 Control|
59954417|NCT03487796|76072908|FG000|NOT COMPLETED|Overall Study||18||
59954418|NCT03487796|76072909|FG001|NOT COMPLETED|Overall Study||6||
59797934|NCT00652028|75918779|FG003|STARTED|Overall Study||14||
59797935|NCT00652028|75918776|FG000|COMPLETED|Overall Study||15||
59797936|NCT00652028|75918777|FG001|COMPLETED|Overall Study||13||
59797937|NCT00652028|75918778|FG002|COMPLETED|Overall Study||14||
59797938|NCT00652028|75918779|FG003|COMPLETED|Overall Study||14||
59797939|NCT00652028|75918776|FG000|NOT COMPLETED|Overall Study||1||
59797940|NCT00652028|75918777|FG001|NOT COMPLETED|Overall Study||1||
59797941|NCT00652028|75918778|FG002|NOT COMPLETED|Overall Study||1||
59797942|NCT00652028|75918779|FG003|NOT COMPLETED|Overall Study||0||
59797943|NCT00738101|75918789|FG000|STARTED|Overall Study||293||
59797944|NCT00738101|75918789|FG000|COMPLETED|Overall Study|7 exclusions. 5 primary liver or unrelated disease, 1 died before Omegaven, 1 repeat enrollment|286||
59797945|NCT00738101|75918789|FG000|NOT COMPLETED|Overall Study||7||
59797946|NCT00733421|75918795|FG000|STARTED|Overall Study|November 2008|50||
59797947|NCT00733421|75918796|FG001|STARTED|Overall Study|November 2008|50||
59797948|NCT00733421|75918795|FG000|COMPLETED|Overall Study|All but one randomsied patient|49||
59797949|NCT00733421|75918796|FG001|COMPLETED|Overall Study|All but one randomised patient|49||
59797950|NCT00733421|75918795|FG000|NOT COMPLETED|Overall Study||1||
59797951|NCT00733421|75918796|FG001|NOT COMPLETED|Overall Study||1||
59797952|NCT00613080|75918802|FG000|STARTED|Overall Study||79||
59797953|NCT00613080|75918802|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|68||
59797954|NCT00613080|75918802|FG000|NOT COMPLETED|Overall Study||11||
59797955|NCT00732875|75918806|FG000|STARTED|Overall Study||92||
59797956|NCT00732875|75918806|FG000|COMPLETED|Overall Study|These participants continued treatment until trial was completed by Sponsor.|57||
59797957|NCT00732875|75918806|FG000|NOT COMPLETED|Overall Study||35||
59797958|NCT00810446|75918810|FG000|STARTED|Overall Study||72||
59797959|NCT00810446|75918810|FG000|COMPLETED|Overall Study||72||
59954419|NCT02148705|76072924|FG000|STARTED|Overall Study||75||
59954420|NCT02148705|76072925|FG001|STARTED|Overall Study||25||
59954421|NCT02148705|76072926|FG002|STARTED|Overall Study||75||
59954422|NCT02148705|76072924|FG000|Treated|Overall Study|Two patients randomized to SOC were treated with NexoBrid and are included in the safety (treated) population|77||
59797960|NCT00810446|75918810|FG000|NOT COMPLETED|Overall Study||0||
59797961|NCT00615264|75918816|FG000|STARTED|Overall Study||225||
59797962|NCT00615264|75918817|FG001|STARTED|Overall Study||232||
59797963|NCT00615264|75918816|FG000|Received at Least One Dose (ITT)|Overall Study||225||
59797964|NCT00615264|75918817|FG001|Received at Least One Dose (ITT)|Overall Study||231||
59797965|NCT00615264|75918816|FG000|ITT Patients Who Met Inc/Excl (MITT)|Overall Study||209||
59797966|NCT00615264|75918817|FG001|ITT Patients Who Met Inc/Excl (MITT)|Overall Study||213||
59797967|NCT00615264|75918816|FG000|COMPLETED|Overall Study||175||
59797968|NCT00615264|75918817|FG001|COMPLETED|Overall Study||180||
59797969|NCT00615264|75918816|FG000|NOT COMPLETED|Overall Study||50||
59797970|NCT00615264|75918817|FG001|NOT COMPLETED|Overall Study||52||
59797971|NCT00732641|75918825|FG000|STARTED|Overall Study||123||
59797972|NCT00732641|75918826|FG001|STARTED|Overall Study||121||
59797973|NCT00732641|75918825|FG000|COMPLETED|Overall Study||17||
59797974|NCT00732641|75918826|FG001|COMPLETED|Overall Study||9||
59797975|NCT00732641|75918825|FG000|NOT COMPLETED|Overall Study||106||
59797976|NCT00732641|75918826|FG001|NOT COMPLETED|Overall Study||112||
59797977|NCT00737711|75918832|FG000|STARTED|Overall Study||189||
59797978|NCT00737711|75918832|FG000|COMPLETED|Overall Study||158||
59797979|NCT00737711|75918832|FG000|NOT COMPLETED|Overall Study||31||
59797980|NCT00615108|75918836|FG000|STARTED|Overall Study||3148||
59954423|NCT02148705|76072925|FG001|Treated|Overall Study||24||
59954424|NCT02148705|76072926|FG002|Treated|Overall Study||68||
59797981|NCT00615108|75918836|FG000|COMPLETED|Overall Study||2641||
59797982|NCT00615108|75918836|FG000|NOT COMPLETED|Overall Study||507||
59797983|NCT00238303|75918845|FG000|STARTED|Overall Study||68||
59797984|NCT00238303|75918846|FG001|STARTED|Overall Study||15||
59797985|NCT00238303|75918847|FG002|STARTED|Overall Study||20||
59797986|NCT00238303|75918845|FG000|COMPLETED|Overall Study||53||
59797987|NCT00238303|75918846|FG001|COMPLETED|Overall Study||13||
59797988|NCT00238303|75918847|FG002|COMPLETED|Overall Study||11||
59797989|NCT00238303|75918845|FG000|NOT COMPLETED|Overall Study||15||
59797990|NCT00238303|75918846|FG001|NOT COMPLETED|Overall Study||2||
59797991|NCT00238303|75918847|FG002|NOT COMPLETED|Overall Study||9||
59797992|NCT00737633|75918858|FG000|STARTED|Overall Study||44||
59797993|NCT00737633|75918859|FG001|STARTED|Overall Study||57||
59797994|NCT00737633|75918858|FG000|COMPLETED|Overall Study||0||
59797995|NCT00737633|75918859|FG001|COMPLETED|Overall Study||0||
59797996|NCT00737633|75918858|FG000|NOT COMPLETED|Overall Study||44||
59797997|NCT00737633|75918859|FG001|NOT COMPLETED|Overall Study||57||
59797998|NCT00732251|75918865|FG000|STARTED|Overall Study||8||
59797999|NCT00732251|75918865|FG000|COMPLETED|Overall Study||1||
59798000|NCT00732251|75918865|FG000|NOT COMPLETED|Overall Study||7||
59798001|NCT00737477|75918869|FG000|STARTED|Overall Study||96||
59798002|NCT00737477|75918869|FG000|COMPLETED|Overall Study||62||
59798003|NCT00737477|75918869|FG000|NOT COMPLETED|Overall Study||34||
59798004|NCT00256867|75918881|FG000|STARTED|Overall Study||47||
59798005|NCT00256867|75918882|FG001|STARTED|Overall Study||44||
59798006|NCT00256867|75918883|FG002|STARTED|Overall Study||45||
59798007|NCT00256867|75918884|FG003|STARTED|Overall Study||46||
59798008|NCT00256867|75918885|FG004|STARTED|Overall Study||48||
59798009|NCT00256867|75918886|FG005|STARTED|Overall Study||46||
59798010|NCT00256867|75918887|FG006|STARTED|Overall Study||46||
59798011|NCT00256867|75918888|FG007|STARTED|Overall Study||47||
59798012|NCT00256867|75918881|FG000|COMPLETED|Overall Study||45||
59798013|NCT00256867|75918882|FG001|COMPLETED|Overall Study||39||
59798014|NCT00256867|75918883|FG002|COMPLETED|Overall Study||40||
59798015|NCT00256867|75918884|FG003|COMPLETED|Overall Study||40||
59798016|NCT00256867|75918885|FG004|COMPLETED|Overall Study||41||
59798017|NCT00256867|75918886|FG005|COMPLETED|Overall Study||40||
59798018|NCT00256867|75918887|FG006|COMPLETED|Overall Study||41||
59798019|NCT00256867|75918888|FG007|COMPLETED|Overall Study||36||
59798020|NCT00256867|75918881|FG000|NOT COMPLETED|Overall Study||2||
59798021|NCT00256867|75918882|FG001|NOT COMPLETED|Overall Study||5||
59798022|NCT00256867|75918883|FG002|NOT COMPLETED|Overall Study||5||
59798023|NCT00256867|75918884|FG003|NOT COMPLETED|Overall Study||6||
59798024|NCT00256867|75918885|FG004|NOT COMPLETED|Overall Study||7||
59798025|NCT00256867|75918886|FG005|NOT COMPLETED|Overall Study||6||
59798026|NCT00256867|75918887|FG006|NOT COMPLETED|Overall Study||5||
59798027|NCT00256867|75918888|FG007|NOT COMPLETED|Overall Study||11||
59798028|NCT00731939|75918911|FG000|STARTED|Overall Study||124||
59798029|NCT00731939|75918911|FG000|COMPLETED|Overall Study||90||
59954425|NCT02148705|76072924|FG000|Completed Acute Phase|Overall Study||67||
59954426|NCT02148705|76072925|FG001|Completed Acute Phase|Overall Study||23||
59954427|NCT02148705|76072926|FG002|Completed Acute Phase|Overall Study||63||
59798030|NCT00731939|75918911|FG000|NOT COMPLETED|Overall Study||34||
59798031|NCT00731783|75918917|FG000|STARTED|One Month Follow-Up Visit||92||
59798032|NCT00731783|75918918|FG001|STARTED|One Month Follow-Up Visit||91||
59798033|NCT00731783|75918917|FG000|COMPLETED|One Month Follow-Up Visit||78||
59798034|NCT00731783|75918918|FG001|COMPLETED|One Month Follow-Up Visit||69||
59798035|NCT00731783|75918917|FG000|NOT COMPLETED|One Month Follow-Up Visit||14||
59798036|NCT00731783|75918918|FG001|NOT COMPLETED|One Month Follow-Up Visit||22||
59798037|NCT00731783|75918917|FG000|STARTED|Three Month Follow-Up Visit||79||
59798038|NCT00731783|75918918|FG001|STARTED|Three Month Follow-Up Visit||73||
59798039|NCT00731783|75918917|FG000|COMPLETED|Three Month Follow-Up Visit||72||
59798040|NCT00731783|75918918|FG001|COMPLETED|Three Month Follow-Up Visit||57||
59798041|NCT00731783|75918917|FG000|NOT COMPLETED|Three Month Follow-Up Visit||7||
59798042|NCT00731783|75918918|FG001|NOT COMPLETED|Three Month Follow-Up Visit||16||
59798043|NCT00731783|75918917|FG000|STARTED|Six Month Follow-Up Visit||77||
59798044|NCT00731783|75918918|FG001|STARTED|Six Month Follow-Up Visit||67||
59798045|NCT00731783|75918917|FG000|COMPLETED|Six Month Follow-Up Visit||71||
59798046|NCT00731783|75918918|FG001|COMPLETED|Six Month Follow-Up Visit||64||
59798047|NCT00731783|75918917|FG000|NOT COMPLETED|Six Month Follow-Up Visit||6||
59798048|NCT00731783|75918918|FG001|NOT COMPLETED|Six Month Follow-Up Visit||3||
59798049|NCT00731783|75918917|FG000|STARTED|12 Month Follow-Up Visit||74||
59798050|NCT00731783|75918918|FG001|STARTED|12 Month Follow-Up Visit||65||
59798051|NCT00731783|75918917|FG000|COMPLETED|12 Month Follow-Up Visit||68||
59798052|NCT00731783|75918918|FG001|COMPLETED|12 Month Follow-Up Visit||58||
59798053|NCT00731783|75918917|FG000|NOT COMPLETED|12 Month Follow-Up Visit||6||
59798054|NCT00731783|75918918|FG001|NOT COMPLETED|12 Month Follow-Up Visit||7||
59798055|NCT00724451|75918924|FG000|STARTED|Overall Study||1128||
59798056|NCT00724451|75918924|FG000|Received Antiviral Treatment|Overall Study||500||
59798057|NCT00724451|75918924|FG000|COMPLETED|Overall Study|Completed defined as participants who completed anti-viral treatment.|326||
59798058|NCT00724451|75918924|FG000|NOT COMPLETED|Overall Study||802||
59798059|NCT00724373|75918928|FG000|STARTED|Overall Study||442||
59798060|NCT00724373|75918928|FG000|COMPLETED|Overall Study||271||
59798061|NCT00724373|75918928|FG000|NOT COMPLETED|Overall Study||171||
59798062|NCT00724061|75918932|FG000|STARTED|Dose Escalation Phase||7||
59798063|NCT00724061|75918932|FG000|COMPLETED|Dose Escalation Phase||2||
59798064|NCT00724061|75918932|FG000|NOT COMPLETED|Dose Escalation Phase||5||
59798065|NCT00724061|75918932|FG000|STARTED|Maintenance Therapy||2||
59798066|NCT00724061|75918932|FG000|COMPLETED|Maintenance Therapy||2||
59798067|NCT00724061|75918932|FG000|NOT COMPLETED|Maintenance Therapy||0||
59798068|NCT00731549|75918936|FG000|STARTED|Overall Study||1081||
59798069|NCT00731549|75918936|FG000|COMPLETED|Overall Study||858||
59798070|NCT00731549|75918936|FG000|NOT COMPLETED|Overall Study||223||
59798071|NCT03964649|75918950|FG000|STARTED|Overall Study||349||
59798072|NCT03964649|75918951|FG001|STARTED|Overall Study||304||
59798073|NCT03964649|75918952|FG002|STARTED|Overall Study||2728||
59798074|NCT03964649|75918953|FG003|STARTED|Overall Study||192||
59798075|NCT03964649|75918954|FG004|STARTED|Overall Study||1948||
59798076|NCT03964649|75918955|FG005|STARTED|Overall Study||349||
59798077|NCT03964649|75918956|FG006|STARTED|Overall Study||376||
59798078|NCT03964649|75918957|FG007|STARTED|Overall Study||325||
59798079|NCT03964649|75918958|FG008|STARTED|Overall Study||204||
59798080|NCT03964649|75918959|FG009|STARTED|Overall Study||533||
59798081|NCT03964649|75918950|FG000|COMPLETED|Overall Study||349||
59798082|NCT03964649|75918951|FG001|COMPLETED|Overall Study||304||
59798083|NCT03964649|75918952|FG002|COMPLETED|Overall Study||2728||
59798084|NCT03964649|75918953|FG003|COMPLETED|Overall Study||192||
59798085|NCT03964649|75918954|FG004|COMPLETED|Overall Study||1948||
59798086|NCT03964649|75918955|FG005|COMPLETED|Overall Study||349||
59798087|NCT03964649|75918956|FG006|COMPLETED|Overall Study||376||
59798088|NCT03964649|75918957|FG007|COMPLETED|Overall Study||325||
59798089|NCT03964649|75918958|FG008|COMPLETED|Overall Study||204||
59798090|NCT03964649|75918959|FG009|COMPLETED|Overall Study||533||
59798091|NCT03964649|75918950|FG000|NOT COMPLETED|Overall Study||0||
59798092|NCT03964649|75918951|FG001|NOT COMPLETED|Overall Study||0||
59798093|NCT03964649|75918952|FG002|NOT COMPLETED|Overall Study||0||
59798094|NCT03964649|75918953|FG003|NOT COMPLETED|Overall Study||0||
59798095|NCT03964649|75918954|FG004|NOT COMPLETED|Overall Study||0||
59798096|NCT03964649|75918955|FG005|NOT COMPLETED|Overall Study||0||
59798097|NCT03964649|75918956|FG006|NOT COMPLETED|Overall Study||0||
59798098|NCT03964649|75918957|FG007|NOT COMPLETED|Overall Study||0||
59798099|NCT03964649|75918958|FG008|NOT COMPLETED|Overall Study||0||
59798100|NCT03964649|75918959|FG009|NOT COMPLETED|Overall Study||0||
59798101|NCT00730925|75918981|FG000|STARTED|Overall Study||41||
59798102|NCT00730925|75918981|FG000|COMPLETED|Overall Study|On treatment at analysis cut-off date|0||
59798103|NCT00730925|75918981|FG000|NOT COMPLETED|Overall Study||41||
59798104|NCT00236899|75918989|FG000|STARTED|Overall Study||60||
59798105|NCT00236899|75918990|FG001|STARTED|Overall Study||64||
59954428|NCT02148705|76072924|FG000|Completed 12M FU Period|Overall Study||57||
59954429|NCT02148705|76072925|FG001|Completed 12M FU Period|Overall Study||20||
59954430|NCT02148705|76072926|FG002|Completed 12M FU Period|Overall Study||58||
59954431|NCT02148705|76072924|FG000|COMPLETED|Overall Study||57||
59954432|NCT02148705|76072925|FG001|COMPLETED|Overall Study||20||
59954433|NCT02148705|76072926|FG002|COMPLETED|Overall Study||58||
59954434|NCT02148705|76072924|FG000|NOT COMPLETED|Overall Study||18||
59954435|NCT02148705|76072925|FG001|NOT COMPLETED|Overall Study||5||
59954436|NCT02148705|76072926|FG002|NOT COMPLETED|Overall Study||17||
60073714|NCT01688037|76189047|FG002|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||6||
60073715|NCT01688037|76189045|FG000|STARTED|Open-Label Period (Week 6 to 12)||47||
60073716|NCT01688037|76189046|FG001|STARTED|Open-Label Period (Week 6 to 12)||25||
60073717|NCT01688037|76189047|FG002|STARTED|Open-Label Period (Week 6 to 12)||21||
60073718|NCT01688037|76189045|FG000|COMPLETED|Open-Label Period (Week 6 to 12)||42||
60073719|NCT01688037|76189046|FG001|COMPLETED|Open-Label Period (Week 6 to 12)||22||
59798106|NCT00236899|75918991|FG002|STARTED|Overall Study||58||
59798107|NCT00236899|75918992|FG003|STARTED|Overall Study||59||
59798108|NCT00236899|75918989|FG000|COMPLETED|Overall Study||18||
59798109|NCT00236899|75918990|FG001|COMPLETED|Overall Study||24||
59798110|NCT00236899|75918991|FG002|COMPLETED|Overall Study||14||
59798111|NCT00236899|75918992|FG003|COMPLETED|Overall Study||19||
59798112|NCT00236899|75918989|FG000|NOT COMPLETED|Overall Study||42||
59798113|NCT00236899|75918990|FG001|NOT COMPLETED|Overall Study||40||
59798114|NCT00236899|75918991|FG002|NOT COMPLETED|Overall Study||44||
59798115|NCT00236899|75918992|FG003|NOT COMPLETED|Overall Study||40||
59798116|NCT00611130|75919011|FG000|STARTED|Overall Study||92||
59798117|NCT00611130|75919012|FG001|STARTED|Overall Study||94||
59798118|NCT00611130|75919011|FG000|Completed 12 Week Treatment Phase|Overall Study||61||
59798119|NCT00611130|75919012|FG001|Completed 12 Week Treatment Phase|Overall Study||64||
59798120|NCT00611130|75919011|FG000|COMPLETED|Overall Study||43||
59798121|NCT00611130|75919012|FG001|COMPLETED|Overall Study||47||
59798122|NCT00611130|75919011|FG000|NOT COMPLETED|Overall Study||49||
59798123|NCT00611130|75919012|FG001|NOT COMPLETED|Overall Study||47||
59798124|NCT00256243|75919019|FG000|STARTED|Overall Study||48||
59798125|NCT00256243|75919019|FG000|COMPLETED|Overall Study||38||
59798126|NCT00256243|75919019|FG000|NOT COMPLETED|Overall Study||10||
59798127|NCT00236197|75919026|FG000|STARTED|Overall Study||312||
59798128|NCT00236197|75919027|FG001|STARTED|Overall Study||307||
59798129|NCT00236197|75919026|FG000|COMPLETED|Overall Study||307||
59798130|NCT00236197|75919027|FG001|COMPLETED|Overall Study||293||
59798131|NCT00236197|75919026|FG000|NOT COMPLETED|Overall Study||5||
59798132|NCT00236197|75919027|FG001|NOT COMPLETED|Overall Study||14||
59798133|NCT00278629|75919033|FG000|STARTED|Overall Study||80||
59798134|NCT00278629|75919033|FG000|COMPLETED|Overall Study||66||
59798135|NCT00278629|75919033|FG000|NOT COMPLETED|Overall Study||14||
59798136|NCT00612690|75919040|FG000|STARTED|Overall Study||275||
59798137|NCT00612690|75919041|FG001|STARTED|Overall Study||207||
59798138|NCT00612690|75919040|FG000|COMPLETED|Overall Study||160||
59798139|NCT00612690|75919041|FG001|COMPLETED|Overall Study||89||
59798140|NCT00612690|75919040|FG000|NOT COMPLETED|Overall Study||115||
59798141|NCT00612690|75919041|FG001|NOT COMPLETED|Overall Study||118||
59798142|NCT00278473|75919051|FG000|STARTED|Overall Study||45||
59798143|NCT00278473|75919052|FG001|STARTED|Overall Study||43||
59798144|NCT00278473|75919051|FG000|COMPLETED|Overall Study||41||
59798145|NCT00278473|75919052|FG001|COMPLETED|Overall Study||40||
59798146|NCT00278473|75919051|FG000|NOT COMPLETED|Overall Study||4||
59798147|NCT00278473|75919052|FG001|NOT COMPLETED|Overall Study||3||
59798148|NCT00278395|75919058|FG000|STARTED|Overall Study||14||
59798149|NCT00278395|75919058|FG000|COMPLETED|Overall Study||11||
59798150|NCT00278395|75919058|FG000|NOT COMPLETED|Overall Study||3||
59798151|NCT00612534|75919069|FG000|STARTED|Overall Study||24||
59798152|NCT00612534|75919070|FG001|STARTED|Overall Study||26||
59798153|NCT00612534|75919071|FG002|STARTED|Overall Study||20||
59798154|NCT00612534|75919072|FG003|STARTED|Overall Study||24||
59798155|NCT00612534|75919069|FG000|COMPLETED|Overall Study||11||
59798156|NCT00612534|75919070|FG001|COMPLETED|Overall Study||9||
59798157|NCT00612534|75919071|FG002|COMPLETED|Overall Study||13||
59798158|NCT00612534|75919072|FG003|COMPLETED|Overall Study||7||
59798159|NCT00612534|75919069|FG000|NOT COMPLETED|Overall Study||13||
59798160|NCT00612534|75919070|FG001|NOT COMPLETED|Overall Study||17||
59798161|NCT00612534|75919071|FG002|NOT COMPLETED|Overall Study||7||
59798162|NCT00612534|75919072|FG003|NOT COMPLETED|Overall Study||17||
59798163|NCT00736853|75919082|FG000|STARTED|Open-Label Period||319||
59798164|NCT00736853|75919083|FG001|STARTED|Open-Label Period||0||
59798165|NCT00736853|75919084|FG002|STARTED|Open-Label Period||0||
59798166|NCT00736853|75919082|FG000|Treated|Open-Label Period||277||
59798167|NCT00736853|75919083|FG001|Treated|Open-Label Period||0||
59798168|NCT00736853|75919084|FG002|Treated|Open-Label Period||0||
59798169|NCT00736853|75919082|FG000|COMPLETED|Open-Label Period||187||
59798170|NCT00736853|75919083|FG001|COMPLETED|Open-Label Period||0||
59798171|NCT00736853|75919084|FG002|COMPLETED|Open-Label Period||0||
59798172|NCT00736853|75919082|FG000|NOT COMPLETED|Open-Label Period||132||
59798173|NCT00736853|75919083|FG001|NOT COMPLETED|Open-Label Period||0||
59798174|NCT00736853|75919084|FG002|NOT COMPLETED|Open-Label Period||0||
59798175|NCT00736853|75919082|FG000|STARTED|Double-Blind Period||0||
59798176|NCT00736853|75919083|FG001|STARTED|Double-Blind Period||94||
59798177|NCT00736853|75919084|FG002|STARTED|Double-Blind Period||93||
59798178|NCT00736853|75919082|FG000|COMPLETED|Double-Blind Period||0||
59798179|NCT00736853|75919083|FG001|COMPLETED|Double-Blind Period||70||
59798180|NCT00736853|75919084|FG002|COMPLETED|Double-Blind Period||45||
59798181|NCT00736853|75919082|FG000|NOT COMPLETED|Double-Blind Period||0||
59798182|NCT00736853|75919083|FG001|NOT COMPLETED|Double-Blind Period||24||
59798183|NCT00736853|75919084|FG002|NOT COMPLETED|Double-Blind Period||48||
59798184|NCT00730847|75919093|FG000|STARTED|Overall Study||596||
59798185|NCT00730847|75919093|FG000|COMPLETED|Overall Study||465||
59798186|NCT00730847|75919093|FG000|NOT COMPLETED|Overall Study||131||
59798187|NCT00573066|75919097|FG000|STARTED|Overall Study||56||
59798188|NCT00573066|75919097|FG000|COMPLETED|Overall Study||36||
59798189|NCT00573066|75919097|FG000|NOT COMPLETED|Overall Study||20||
59798190|NCT00612456|75919104|FG000|STARTED|Overall Study||27||
59798191|NCT00612456|75919105|FG001|STARTED|Overall Study||27||
59798192|NCT00612456|75919106|FG002|STARTED|Overall Study||16||
59798193|NCT00612456|75919104|FG000|COMPLETED|Overall Study||25||
59798194|NCT00612456|75919105|FG001|COMPLETED|Overall Study||25||
59798195|NCT00612456|75919106|FG002|COMPLETED|Overall Study||16||
59798196|NCT00612456|75919104|FG000|NOT COMPLETED|Overall Study||2||
59798197|NCT00612456|75919105|FG001|NOT COMPLETED|Overall Study||2||
59798198|NCT00612456|75919106|FG002|NOT COMPLETED|Overall Study||0||
59798199|NCT00730691|75919121|FG000|STARTED|Overall Study||157||
59798200|NCT00730691|75919122|FG001|STARTED|Overall Study||156||
59798201|NCT00730691|75919123|FG002|STARTED|Overall Study|One participant was randomized by error. Reason not completed is reported as Other.|156||
59798202|NCT00730691|75919124|FG003|STARTED|Overall Study||156||
59798203|NCT00730691|75919125|FG004|STARTED|Overall Study||156||
59798204|NCT00730691|75919121|FG000|COMPLETED|Overall Study||121||
59798205|NCT00730691|75919122|FG001|COMPLETED|Overall Study||120||
59798206|NCT00730691|75919123|FG002|COMPLETED|Overall Study||117||
59798207|NCT00730691|75919124|FG003|COMPLETED|Overall Study||111||
59798208|NCT00730691|75919125|FG004|COMPLETED|Overall Study||106||
59798209|NCT00730691|75919121|FG000|NOT COMPLETED|Overall Study||36||
59798210|NCT00730691|75919122|FG001|NOT COMPLETED|Overall Study||36||
59798211|NCT00730691|75919123|FG002|NOT COMPLETED|Overall Study||39||
59798212|NCT00730691|75919124|FG003|NOT COMPLETED|Overall Study||45||
59798213|NCT00730691|75919125|FG004|NOT COMPLETED|Overall Study||50||
59798214|NCT00235495|75919139|FG000|STARTED|Overall Study||422||
59798215|NCT00235495|75919140|FG001|STARTED|Overall Study||419||
59798216|NCT00235495|75919139|FG000|COMPLETED|Overall Study||354||
59798217|NCT00235495|75919140|FG001|COMPLETED|Overall Study||351||
59798218|NCT00235495|75919139|FG000|NOT COMPLETED|Overall Study||68||
59798219|NCT00235495|75919140|FG001|NOT COMPLETED|Overall Study||68||
59798220|NCT00278161|75919146|FG000|STARTED|Overall Study||81||
59798221|NCT00278161|75919146|FG000|COMPLETED|Overall Study||70||
59798222|NCT00278161|75919146|FG000|NOT COMPLETED|Overall Study||11||
59798223|NCT00255151|75919153|FG000|STARTED|Overall Study||140||
59798224|NCT00255151|75919154|FG001|STARTED|Overall Study||159||
59798225|NCT00255151|75919155|FG002|STARTED|Overall Study||152||
59798226|NCT00255151|75919153|FG000|COMPLETED|Overall Study||17||
59798227|NCT00255151|75919154|FG001|COMPLETED|Overall Study||110||
59798228|NCT00255151|75919155|FG002|COMPLETED|Overall Study||103||
59798229|NCT00255151|75919153|FG000|NOT COMPLETED|Overall Study||123||
59798230|NCT00255151|75919154|FG001|NOT COMPLETED|Overall Study||49||
59798231|NCT00255151|75919155|FG002|NOT COMPLETED|Overall Study||49||
59798232|NCT00658658|75919168|FG000|STARTED|Overall Study||6||
59798233|NCT00658658|75919169|FG001|STARTED|Overall Study||7||
59798234|NCT00658658|75919170|FG002|STARTED|Overall Study||4||
59798235|NCT00658658|75919171|FG003|STARTED|Overall Study||6||
59798236|NCT00658658|75919172|FG004|STARTED|Overall Study||8||
59798237|NCT00658658|75919168|FG000|COMPLETED|Overall Study||1||
59798238|NCT00658658|75919169|FG001|COMPLETED|Overall Study||5||
59798239|NCT00658658|75919170|FG002|COMPLETED|Overall Study||4||
59798240|NCT00658658|75919171|FG003|COMPLETED|Overall Study||4||
59798241|NCT00658658|75919172|FG004|COMPLETED|Overall Study||3||
59798242|NCT00658658|75919168|FG000|NOT COMPLETED|Overall Study||5||
59798243|NCT00658658|75919169|FG001|NOT COMPLETED|Overall Study||2||
59798244|NCT00658658|75919170|FG002|NOT COMPLETED|Overall Study||0||
59798245|NCT00658658|75919171|FG003|NOT COMPLETED|Overall Study||2||
59798246|NCT00658658|75919172|FG004|NOT COMPLETED|Overall Study||5||
59798247|NCT00723203|75919184|FG000|STARTED|Overall Study||16||
59798248|NCT00723203|75919184|FG000|COMPLETED|Overall Study||13||
59798249|NCT00723203|75919184|FG000|NOT COMPLETED|Overall Study||3||
59798250|NCT00233389|75919190|FG000|STARTED|Overall Study||154||
59798251|NCT00233389|75919191|FG001|STARTED|Overall Study||147||
59798252|NCT00233389|75919190|FG000|COMPLETED|Overall Study||136||
59798253|NCT00233389|75919191|FG001|COMPLETED|Overall Study||131||
59798254|NCT00233389|75919190|FG000|NOT COMPLETED|Overall Study||18||
59798255|NCT00233389|75919191|FG001|NOT COMPLETED|Overall Study||16||
59798256|NCT00649220|75919197|FG000|STARTED|Overall Study||19||
59798257|NCT00649220|75919197|FG000|COMPLETED|Overall Study||16||
59798258|NCT00649220|75919197|FG000|NOT COMPLETED|Overall Study||3||
59798259|NCT00654368|75919204|FG000|STARTED|Overall Study||53||
59798260|NCT00654368|75919205|FG001|STARTED|Overall Study||98||
59798261|NCT00654368|75919206|FG002|STARTED|Overall Study||107||
59798262|NCT00654368|75919204|FG000|COMPLETED|Overall Study||0||
59798263|NCT00654368|75919205|FG001|COMPLETED|Overall Study||50||
59798264|NCT00654368|75919206|FG002|COMPLETED|Overall Study||75||
59798265|NCT00654368|75919204|FG000|NOT COMPLETED|Overall Study||53||
59798266|NCT00654368|75919205|FG001|NOT COMPLETED|Overall Study||48||
59798267|NCT00654368|75919206|FG002|NOT COMPLETED|Overall Study||32||
59798268|NCT00647426|75919213|FG000|STARTED|Overall Study||7||
59798269|NCT00647426|75919213|FG000|COMPLETED|Overall Study||5||
59798270|NCT00647426|75919213|FG000|NOT COMPLETED|Overall Study||2||
59798271|NCT00647348|75919220|FG000|STARTED|Overall Study||70||
59798272|NCT00647348|75919221|FG001|STARTED|Overall Study||70||
59798273|NCT00647348|75919220|FG000|COMPLETED|Overall Study||67||
59798274|NCT00647348|75919221|FG001|COMPLETED|Overall Study||64||
59798275|NCT00647348|75919220|FG000|NOT COMPLETED|Overall Study||3||
59798276|NCT00647348|75919221|FG001|NOT COMPLETED|Overall Study||6||
59798277|NCT00647270|75919230|FG000|STARTED|Period 1, Placebo-control (12 Weeks)|Placebo subjects in Period 1 received adalimumab 40 mg every other week in Period 2.|56||
59798278|NCT00647270|75919231|FG001|STARTED|Period 1, Placebo-control (12 Weeks)||159||
59798279|NCT00647270|75919232|FG002|STARTED|Period 1, Placebo-control (12 Weeks)||205||
59798280|NCT00647270|75919230|FG000|COMPLETED|Period 1, Placebo-control (12 Weeks)||48||
59798281|NCT00647270|75919231|FG001|COMPLETED|Period 1, Placebo-control (12 Weeks)||146||
59798282|NCT00647270|75919232|FG002|COMPLETED|Period 1, Placebo-control (12 Weeks)||182||
59798283|NCT00647270|75919230|FG000|NOT COMPLETED|Period 1, Placebo-control (12 Weeks)||8||
59798284|NCT00647270|75919231|FG001|NOT COMPLETED|Period 1, Placebo-control (12 Weeks)||13||
59798285|NCT00647270|75919232|FG002|NOT COMPLETED|Period 1, Placebo-control (12 Weeks)||23||
59798286|NCT00647270|75919230|FG000|STARTED|Period 2, Placebo Switched to Adalimumab|Placebo subjects in Period 1 received adalimumab 40 mg eow in Period 2|48||
59798287|NCT00647270|75919231|FG001|STARTED|Period 2, Placebo Switched to Adalimumab||146||
59798288|NCT00647270|75919232|FG002|STARTED|Period 2, Placebo Switched to Adalimumab||182||
59798289|NCT00647270|75919230|FG000|COMPLETED|Period 2, Placebo Switched to Adalimumab||45||
59798290|NCT00647270|75919231|FG001|COMPLETED|Period 2, Placebo Switched to Adalimumab||137||
59798291|NCT00647270|75919232|FG002|COMPLETED|Period 2, Placebo Switched to Adalimumab||175||
59798292|NCT00647270|75919230|FG000|NOT COMPLETED|Period 2, Placebo Switched to Adalimumab||3||
59798293|NCT00647270|75919231|FG001|NOT COMPLETED|Period 2, Placebo Switched to Adalimumab||9||
59798294|NCT00647270|75919232|FG002|NOT COMPLETED|Period 2, Placebo Switched to Adalimumab||7||
59798295|NCT00645944|75919245|FG000|STARTED|Randomized||20||
59798296|NCT00645944|75919246|FG001|STARTED|Randomized||19||
59798297|NCT00645944|75919245|FG000|COMPLETED|Randomized||19||
59798298|NCT00645944|75919246|FG001|COMPLETED|Randomized||17||
59798299|NCT00645944|75919245|FG000|NOT COMPLETED|Randomized||1||
59798300|NCT00645944|75919246|FG001|NOT COMPLETED|Randomized||2||
59798301|NCT00645944|75919245|FG000|STARTED|Received Medication||19||
59798302|NCT00645944|75919246|FG001|STARTED|Received Medication||17||
59798303|NCT00645944|75919245|FG000|COMPLETED|Received Medication||13||
59798304|NCT00645944|75919246|FG001|COMPLETED|Received Medication||14||
59798305|NCT00645944|75919245|FG000|NOT COMPLETED|Received Medication||6||
59798306|NCT00645944|75919246|FG001|NOT COMPLETED|Received Medication||3||
59798307|NCT00646958|75919255|FG000|STARTED|Overall Study|Number (No.) Participants Randomized|51||
59798308|NCT00646958|75919256|FG001|STARTED|Overall Study|No. Participants Randomized|50||
59798309|NCT00646958|75919257|FG002|STARTED|Overall Study|No. Participants Randomized|49||
59798310|NCT00646958|75919255|FG000|COMPLETED|Overall Study||40||
59798311|NCT00646958|75919256|FG001|COMPLETED|Overall Study||41||
59798312|NCT00646958|75919257|FG002|COMPLETED|Overall Study||40||
59798313|NCT00646958|75919255|FG000|NOT COMPLETED|Overall Study||11||
59798314|NCT00646958|75919256|FG001|NOT COMPLETED|Overall Study||9||
59798315|NCT00646958|75919257|FG002|NOT COMPLETED|Overall Study||9||
59798316|NCT00642746|75919267|FG000|STARTED|Overall Study||10||
59798317|NCT00642746|75919268|FG001|STARTED|Overall Study||1||
59798318|NCT00642746|75919267|FG000|COMPLETED|Overall Study||9||
59798319|NCT00642746|75919268|FG001|COMPLETED|Overall Study||1||
59798320|NCT00642746|75919267|FG000|NOT COMPLETED|Overall Study||1||
59798321|NCT00642746|75919268|FG001|NOT COMPLETED|Overall Study||0||
59798322|NCT00642668|75919274|FG000|STARTED|Overall Study||35||
59798323|NCT00642668|75919274|FG000|COMPLETED|Overall Study||21||
59798324|NCT00642668|75919274|FG000|NOT COMPLETED|Overall Study||14||
59798325|NCT00729833|75919278|FG000|STARTED|Overall Study||20||
59798326|NCT00729833|75919279|FG001|STARTED|Overall Study||7||
59798327|NCT00729833|75919280|FG002|STARTED|Overall Study||12||
59798328|NCT00729833|75919281|FG003|STARTED|Overall Study||6||
59798329|NCT00729833|75919278|FG000|COMPLETED|Overall Study||0||
59798330|NCT00729833|75919279|FG001|COMPLETED|Overall Study||0||
59798331|NCT00729833|75919280|FG002|COMPLETED|Overall Study||0||
59798332|NCT00729833|75919281|FG003|COMPLETED|Overall Study||0||
59798333|NCT00729833|75919278|FG000|NOT COMPLETED|Overall Study||20||
59798334|NCT00729833|75919279|FG001|NOT COMPLETED|Overall Study||7||
59798335|NCT00729833|75919280|FG002|NOT COMPLETED|Overall Study||12||
59798336|NCT00729833|75919281|FG003|NOT COMPLETED|Overall Study||6||
59798337|NCT00645788|75919296|FG000|STARTED|Overall Study||94||
59798338|NCT00645788|75919297|FG001|STARTED|Overall Study||94||
59798339|NCT00645788|75919298|FG002|STARTED|Overall Study||65||
59798340|NCT00645788|75919299|FG003|STARTED|Overall Study||35||
59798341|NCT00645788|75919296|FG000|Participants Receive Treatment|Overall Study||93||
59798342|NCT00645788|75919297|FG001|Participants Receive Treatment|Overall Study||93||
59798343|NCT00645788|75919298|FG002|Participants Receive Treatment|Overall Study||65||
59798344|NCT00645788|75919299|FG003|Participants Receive Treatment|Overall Study||35||
59798345|NCT00645788|75919296|FG000|COMPLETED|Overall Study||74||
59798346|NCT00645788|75919297|FG001|COMPLETED|Overall Study||67||
59798347|NCT00645788|75919298|FG002|COMPLETED|Overall Study||47||
59798348|NCT00645788|75919299|FG003|COMPLETED|Overall Study||21||
59798349|NCT00645788|75919296|FG000|NOT COMPLETED|Overall Study||20||
59798350|NCT00645788|75919297|FG001|NOT COMPLETED|Overall Study||27||
59798351|NCT00645788|75919298|FG002|NOT COMPLETED|Overall Study||18||
59798352|NCT00645788|75919299|FG003|NOT COMPLETED|Overall Study||14||
59798353|NCT00642356|75919311|FG000|STARTED|Overall Study||7||
59798354|NCT00642356|75919312|FG001|STARTED|Overall Study||7||
59798355|NCT00642356|75919311|FG000|COMPLETED|Overall Study||5||
60103589|NCT01290952|76221836|FG000|NOT COMPLETED|Overall Study||12||
59798356|NCT00642356|75919312|FG001|COMPLETED|Overall Study||4||
59798357|NCT00642356|75919311|FG000|NOT COMPLETED|Overall Study||2||
59798358|NCT00642356|75919312|FG001|NOT COMPLETED|Overall Study||3||
59798359|NCT00642278|75919325|FG000|STARTED|Overall Study||65||
59798360|NCT00642278|75919326|FG001|STARTED|Overall Study||64||
59798361|NCT00642278|75919327|FG002|STARTED|Overall Study||64||
59798362|NCT00642278|75919328|FG003|STARTED|Overall Study||65||
59798363|NCT00642278|75919329|FG004|STARTED|Overall Study||64||
59798364|NCT00642278|75919330|FG005|STARTED|Overall Study||64||
59798365|NCT00642278|75919331|FG006|STARTED|Overall Study||65||
59798366|NCT00642278|75919325|FG000|COMPLETED|Overall Study||55||
59798367|NCT00642278|75919326|FG001|COMPLETED|Overall Study||59||
59798368|NCT00642278|75919327|FG002|COMPLETED|Overall Study||59||
59798369|NCT00642278|75919328|FG003|COMPLETED|Overall Study||56||
59798370|NCT00642278|75919329|FG004|COMPLETED|Overall Study||56||
59798371|NCT00642278|75919330|FG005|COMPLETED|Overall Study||57||
59798372|NCT00642278|75919331|FG006|COMPLETED|Overall Study||60||
59798373|NCT00642278|75919325|FG000|NOT COMPLETED|Overall Study||10||
59798374|NCT00642278|75919326|FG001|NOT COMPLETED|Overall Study||5||
59798375|NCT00642278|75919327|FG002|NOT COMPLETED|Overall Study||5||
59798376|NCT00642278|75919328|FG003|NOT COMPLETED|Overall Study||9||
59798377|NCT00642278|75919329|FG004|NOT COMPLETED|Overall Study||8||
59798378|NCT00642278|75919330|FG005|NOT COMPLETED|Overall Study||7||
59798379|NCT00642278|75919331|FG006|NOT COMPLETED|Overall Study||5||
59798380|NCT00543543|75919351|FG000|STARTED|Base Study||315||
59798381|NCT00543543|75919352|FG001|STARTED|Base Study||7106||
59798382|NCT00543543|75919353|FG002|STARTED|Base Study||310||
59798383|NCT00543543|75919354|FG003|STARTED|Base Study||7109||
59798384|NCT00543543|75919351|FG000|Completed 3 Vaccinations|Base Study||300||
59798385|NCT00543543|75919352|FG001|Completed 3 Vaccinations|Base Study||6928||
59798386|NCT00543543|75919353|FG002|Completed 3 Vaccinations|Base Study||297||
59798387|NCT00543543|75919354|FG003|Completed 3 Vaccinations|Base Study||6934||
59798388|NCT00543543|75919351|FG000|COMPLETED|Base Study|Follow-up was up to 7 months|295||
59798389|NCT00543543|75919352|FG001|COMPLETED|Base Study|Follow-up was up to 54 months|5854||
59798390|NCT00543543|75919353|FG002|COMPLETED|Base Study|Follow-up was up to 7 months|296||
59798391|NCT00543543|75919354|FG003|COMPLETED|Base Study|Follow-up was up to 54 months|5887||
59798392|NCT00543543|75919351|FG000|NOT COMPLETED|Base Study||20||
59798393|NCT00543543|75919352|FG001|NOT COMPLETED|Base Study||1252||
59798394|NCT00543543|75919353|FG002|NOT COMPLETED|Base Study||14||
59798395|NCT00543543|75919354|FG003|NOT COMPLETED|Base Study||1222||
59798396|NCT00543543|75919351|FG000|STARTED|Extension Study|This group did not participate in the Extension Study|0||
59798397|NCT00543543|75919352|FG001|STARTED|Extension Study|Cohort 1|150||
59798398|NCT00543543|75919353|FG002|STARTED|Extension Study|This group did not participate in the Extension Study|0||
59798399|NCT00543543|75919354|FG003|STARTED|Extension Study|Cohort 2|3050||
59798400|NCT00543543|75919351|FG000|COMPLETED|Extension Study||0||
59798401|NCT00543543|75919352|FG001|COMPLETED|Extension Study||150||
59798402|NCT00543543|75919353|FG002|COMPLETED|Extension Study||0||
59798403|NCT00543543|75919354|FG003|COMPLETED|Extension Study||2824||
59798404|NCT00543543|75919351|FG000|NOT COMPLETED|Extension Study||0||
59798405|NCT00543543|75919352|FG001|NOT COMPLETED|Extension Study||0||
59798406|NCT00543543|75919353|FG002|NOT COMPLETED|Extension Study||0||
59798407|NCT00543543|75919354|FG003|NOT COMPLETED|Extension Study||226||
59798408|NCT00645164|75919369|FG000|STARTED|Overall Study||59||
59798409|NCT00645164|75919369|FG000|COMPLETED|Overall Study||52||
59798410|NCT00645164|75919369|FG000|NOT COMPLETED|Overall Study||7||
59798411|NCT00723125|75919375|FG000|STARTED|Overall Study|33 pts Neo-adjuvant, 28 evaluable,DDAC: Of 28 pts,27 treated DDAC Avastin:Of 27,15 Avastin post-op|33||
59798412|NCT00723125|75919376|FG001|STARTED|Overall Study|27 evaluable Neo-adjuvant Of 27 patients neo-adjuvant, 24 DDAC Of 24 DDAC, 21 Avastin post-op|27||
59798413|NCT00723125|75919375|FG000|COMPLETED|Overall Study||15||
59798414|NCT00723125|75919376|FG001|COMPLETED|Overall Study||21||
59798415|NCT00723125|75919375|FG000|NOT COMPLETED|Overall Study||18||
59798416|NCT00723125|75919376|FG001|NOT COMPLETED|Overall Study||6||
59798417|NCT00722423|75919390|FG000|STARTED|Overall Study||182||
59798418|NCT00722423|75919391|FG001|STARTED|Overall Study||182||
59798419|NCT00722423|75919390|FG000|COMPLETED|Overall Study||182||
59798420|NCT00722423|75919391|FG001|COMPLETED|Overall Study||181||
59798421|NCT00722423|75919390|FG000|NOT COMPLETED|Overall Study||0||
59798422|NCT00722423|75919391|FG001|NOT COMPLETED|Overall Study||1||
59798423|NCT00640562|75919401|FG000|STARTED|Overall Study||109||
59798424|NCT00640562|75919402|FG001|STARTED|Overall Study||107||
59798425|NCT00640562|75919401|FG000|COMPLETED|Overall Study||91||
59798426|NCT00640562|75919402|FG001|COMPLETED|Overall Study||81||
59798427|NCT00640562|75919401|FG000|NOT COMPLETED|Overall Study||18||
59798428|NCT00640562|75919402|FG001|NOT COMPLETED|Overall Study||26||
59798429|NCT00585923|75919410|FG000|STARTED|Overall Study||56||
59798430|NCT00585923|75919411|FG001|STARTED|Overall Study||59||
59798431|NCT00585923|75919410|FG000|COMPLETED|Overall Study||25||
59798432|NCT00585923|75919411|FG001|COMPLETED|Overall Study||26||
59798433|NCT00585923|75919410|FG000|NOT COMPLETED|Overall Study||31||
60073720|NCT01688037|76189047|FG002|COMPLETED|Open-Label Period (Week 6 to 12)||17||
59798434|NCT00585923|75919411|FG001|NOT COMPLETED|Overall Study||33||
59798435|NCT00721955|75919420|FG000|STARTED|Overall Study||105||
59798436|NCT00721955|75919421|FG001|STARTED|Overall Study||104||
59798437|NCT00721955|75919422|FG002|STARTED|Overall Study||105||
59798438|NCT00721955|75919420|FG000|COMPLETED|Overall Study||105||
59798439|NCT00721955|75919421|FG001|COMPLETED|Overall Study||104||
59798440|NCT00721955|75919422|FG002|COMPLETED|Overall Study||103||
59798441|NCT00721955|75919420|FG000|NOT COMPLETED|Overall Study||0||
59798442|NCT00721955|75919421|FG001|NOT COMPLETED|Overall Study||0||
59620408|NCT00258882|75731740|FG000|COMPLETED|Adacel Recipients Historic Cohort Method||124139||
59798443|NCT00721955|75919422|FG002|NOT COMPLETED|Overall Study||2||
59798444|NCT00585689|75919430|FG000|STARTED|Overall Study||29||
59798445|NCT00585689|75919430|FG000|COMPLETED|Overall Study||22||
59798446|NCT00585689|75919430|FG000|NOT COMPLETED|Overall Study||7||
59798447|NCT00721799|75919434|FG000|STARTED|Overall Study||33||
59798448|NCT00721799|75919434|FG000|Recieved FLT PET Scan 1|Overall Study||26||
59798449|NCT00721799|75919434|FG000|Received FLT PET Scan #2|Overall Study||25||
59798450|NCT00721799|75919434|FG000|COMPLETED|Overall Study||25||
59798451|NCT00721799|75919434|FG000|NOT COMPLETED|Overall Study||8||
59798452|NCT00729365|75919441|FG000|STARTED|Overall Study||33||
59798453|NCT00729365|75919442|FG001|STARTED|Overall Study||6||
59798454|NCT00729365|75919443|FG002|STARTED|Overall Study||7||
59798455|NCT00729365|75919441|FG000|COMPLETED|Overall Study|Study terminated|0||
59798456|NCT00729365|75919442|FG001|COMPLETED|Overall Study|Study Terminated|0||
59798457|NCT00729365|75919443|FG002|COMPLETED|Overall Study|Study terminated|0||
59798458|NCT00729365|75919441|FG000|NOT COMPLETED|Overall Study||33||
59798459|NCT00729365|75919442|FG001|NOT COMPLETED|Overall Study||6||
59798460|NCT00729365|75919443|FG002|NOT COMPLETED|Overall Study||7||
59798461|NCT00254293|75919459|FG000|STARTED|Short Term (12 Week) Randomized Dosing||7||
59798462|NCT00254293|75919460|FG001|STARTED|Short Term (12 Week) Randomized Dosing||4||
59798463|NCT00254293|75919461|FG002|STARTED|Short Term (12 Week) Randomized Dosing||29||
59798464|NCT00254293|75919462|FG003|STARTED|Short Term (12 Week) Randomized Dosing||6||
59798465|NCT00254293|75919463|FG004|STARTED|Short Term (12 Week) Randomized Dosing||5||
59798466|NCT00254293|75919464|FG005|STARTED|Short Term (12 Week) Randomized Dosing|2, 2, 9, 2, and 2 were randomized to placebo in body weight Groups 1, 2, 3, 4, 5, respectively.|17||
59798467|NCT00254293|75919465|FG006|STARTED|Short Term (12 Week) Randomized Dosing||0||
59798468|NCT00254293|75919459|FG000|COMPLETED|Short Term (12 Week) Randomized Dosing||7||
59798469|NCT00254293|75919460|FG001|COMPLETED|Short Term (12 Week) Randomized Dosing||3||
59798470|NCT00254293|75919461|FG002|COMPLETED|Short Term (12 Week) Randomized Dosing||26||
59798471|NCT00254293|75919462|FG003|COMPLETED|Short Term (12 Week) Randomized Dosing||5||
59798472|NCT00254293|75919463|FG004|COMPLETED|Short Term (12 Week) Randomized Dosing||5||
59798473|NCT00254293|75919464|FG005|COMPLETED|Short Term (12 Week) Randomized Dosing||17||
59798474|NCT00254293|75919465|FG006|COMPLETED|Short Term (12 Week) Randomized Dosing||0||
59798475|NCT00254293|75919459|FG000|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||0||
59798476|NCT00254293|75919460|FG001|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||1||
59798477|NCT00254293|75919461|FG002|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||3||
59798478|NCT00254293|75919462|FG003|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||1||
59798479|NCT00254293|75919463|FG004|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||0||
59798480|NCT00254293|75919464|FG005|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||0||
59798481|NCT00254293|75919465|FG006|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||0||
59798482|NCT00254293|75919459|FG000|STARTED|LTE Open Label Variable SC Dosing|Participants who received ST placebo rolled over to 75mg SC dose group (by body weight, <60kg).|11||
60073721|NCT01688037|76189045|FG000|NOT COMPLETED|Open-Label Period (Week 6 to 12)||5||
59798483|NCT00254293|75919460|FG001|STARTED|LTE Open Label Variable SC Dosing|Participants rolled over to 125mg dose group summarized as one group (body weight <60 to >100 kg).|0||
59798484|NCT00254293|75919461|FG002|STARTED|LTE Open Label Variable SC Dosing|Variable SC dose group: 125 mg Weekly, body weight <60 to >100kg (Groups 2, 3, 4 in ST Period).|42||
59798485|NCT00254293|75919462|FG003|STARTED|LTE Open Label Variable SC Dosing|Participants rolled over to 125mg dose group summarized as one group (body weight <60 to >100 kg).|0||
59798486|NCT00254293|75919463|FG004|STARTED|LTE Open Label Variable SC Dosing|Participants who received ST placebo rolled over to variable SC dose group (by body weight, >100kg).|10||
59798487|NCT00254293|75919464|FG005|STARTED|LTE Open Label Variable SC Dosing|Participants rolled over to a variable SC dose group of 75, 125 or 200 mg Weekly by body weight.|0||
59954437|NCT03446612|76072936|FG000|STARTED|Overall Study||2||
59954438|NCT03446612|76072937|FG001|STARTED|Overall Study||3||
60073722|NCT01688037|76189046|FG001|NOT COMPLETED|Open-Label Period (Week 6 to 12)||3||
60073723|NCT01688037|76189047|FG002|NOT COMPLETED|Open-Label Period (Week 6 to 12)||4||
60073724|NCT01688037|76189045|FG000|STARTED|Follow-up Period (Week 12 to 16)||42||
59954439|NCT03446612|76072936|FG000|COMPLETED|Overall Study||2||
59954440|NCT03446612|76072937|FG001|COMPLETED|Overall Study||2||
59954441|NCT03446612|76072936|FG000|NOT COMPLETED|Overall Study||0||
59954442|NCT03446612|76072937|FG001|NOT COMPLETED|Overall Study||1||
59954443|NCT02730728|76072948|FG000|STARTED|Overall Study||53||
59954444|NCT02730728|76072949|FG001|STARTED|Overall Study||53||
59954445|NCT02730728|76072950|FG002|STARTED|Overall Study||53||
60073725|NCT01688037|76189046|FG001|STARTED|Follow-up Period (Week 12 to 16)||22||
60073726|NCT01688037|76189047|FG002|STARTED|Follow-up Period (Week 12 to 16)||17||
60073727|NCT01688037|76189045|FG000|COMPLETED|Follow-up Period (Week 12 to 16)||42||
60073728|NCT01688037|76189046|FG001|COMPLETED|Follow-up Period (Week 12 to 16)||21||
59798488|NCT00254293|75919465|FG006|STARTED|LTE Open Label Variable SC Dosing|Participant rolled over from LTE (Variable Dose Period) to LTE (Fixed Dose Period).|0||
59798489|NCT00254293|75919459|FG000|COMPLETED|LTE Open Label Variable SC Dosing||8||
59798490|NCT00254293|75919460|FG001|COMPLETED|LTE Open Label Variable SC Dosing||0||
59798491|NCT00254293|75919461|FG002|COMPLETED|LTE Open Label Variable SC Dosing||32||
59798492|NCT00254293|75919462|FG003|COMPLETED|LTE Open Label Variable SC Dosing||0||
59798493|NCT00254293|75919463|FG004|COMPLETED|LTE Open Label Variable SC Dosing||8||
59798494|NCT00254293|75919464|FG005|COMPLETED|LTE Open Label Variable SC Dosing||0||
59798495|NCT00254293|75919465|FG006|COMPLETED|LTE Open Label Variable SC Dosing||0||
59798496|NCT00254293|75919459|FG000|NOT COMPLETED|LTE Open Label Variable SC Dosing||3||
59798497|NCT00254293|75919460|FG001|NOT COMPLETED|LTE Open Label Variable SC Dosing||0||
59798498|NCT00254293|75919461|FG002|NOT COMPLETED|LTE Open Label Variable SC Dosing||10||
59798499|NCT00254293|75919462|FG003|NOT COMPLETED|LTE Open Label Variable SC Dosing||0||
59798500|NCT00254293|75919463|FG004|NOT COMPLETED|LTE Open Label Variable SC Dosing||2||
59798501|NCT00254293|75919464|FG005|NOT COMPLETED|LTE Open Label Variable SC Dosing||0||
59798502|NCT00254293|75919465|FG006|NOT COMPLETED|LTE Open Label Variable SC Dosing||0||
59798503|NCT00254293|75919459|FG000|STARTED|LTE Open Label Fixed Dosing||0||
59798504|NCT00254293|75919460|FG001|STARTED|LTE Open Label Fixed Dosing||0||
59798505|NCT00254293|75919461|FG002|STARTED|LTE Open Label Fixed Dosing||0||
59798506|NCT00254293|75919462|FG003|STARTED|LTE Open Label Fixed Dosing||0||
59798507|NCT00254293|75919463|FG004|STARTED|LTE Open Label Fixed Dosing||0||
59798508|NCT00254293|75919464|FG005|STARTED|LTE Open Label Fixed Dosing||0||
59798509|NCT00254293|75919465|FG006|STARTED|LTE Open Label Fixed Dosing||48||
59798510|NCT00254293|75919459|FG000|COMPLETED|LTE Open Label Fixed Dosing||0||
59798511|NCT00254293|75919460|FG001|COMPLETED|LTE Open Label Fixed Dosing||0||
59798512|NCT00254293|75919461|FG002|COMPLETED|LTE Open Label Fixed Dosing||0||
59798513|NCT00254293|75919462|FG003|COMPLETED|LTE Open Label Fixed Dosing||0||
59798514|NCT00254293|75919463|FG004|COMPLETED|LTE Open Label Fixed Dosing||0||
59798515|NCT00254293|75919464|FG005|COMPLETED|LTE Open Label Fixed Dosing||0||
59798516|NCT00254293|75919465|FG006|COMPLETED|LTE Open Label Fixed Dosing||35||
59798517|NCT00254293|75919459|FG000|NOT COMPLETED|LTE Open Label Fixed Dosing||0||
59798518|NCT00254293|75919460|FG001|NOT COMPLETED|LTE Open Label Fixed Dosing||0||
59798519|NCT00254293|75919461|FG002|NOT COMPLETED|LTE Open Label Fixed Dosing||0||
59798520|NCT00254293|75919462|FG003|NOT COMPLETED|LTE Open Label Fixed Dosing||0||
59798521|NCT00254293|75919463|FG004|NOT COMPLETED|LTE Open Label Fixed Dosing||0||
59798522|NCT00254293|75919464|FG005|NOT COMPLETED|LTE Open Label Fixed Dosing||0||
59798523|NCT00254293|75919465|FG006|NOT COMPLETED|LTE Open Label Fixed Dosing||13||
59798524|NCT00585221|75919508|FG000|STARTED|Overall Study||8||
59798525|NCT00585221|75919508|FG000|COMPLETED|Overall Study||0||
60073729|NCT01688037|76189047|FG002|COMPLETED|Follow-up Period (Week 12 to 16)||17||
60073730|NCT01688037|76189045|FG000|NOT COMPLETED|Follow-up Period (Week 12 to 16)||0||
60073731|NCT01688037|76189046|FG001|NOT COMPLETED|Follow-up Period (Week 12 to 16)||1||
59798526|NCT00585221|75919508|FG000|NOT COMPLETED|Overall Study||8||
59798527|NCT00253747|75919514|FG000|STARTED|Overall Study||127||
59798528|NCT00253747|75919515|FG001|STARTED|Overall Study||128||
59798529|NCT00253747|75919514|FG000|COMPLETED|Overall Study||103||
60073732|NCT01688037|76189047|FG002|NOT COMPLETED|Follow-up Period (Week 12 to 16)||0||
60073733|NCT01610336|76189070|FG000|STARTED|Overall Study||5||
60073734|NCT01610336|76189071|FG001|STARTED|Overall Study||7||
60073735|NCT01610336|76189072|FG002|STARTED|Overall Study||6||
59798530|NCT00253747|75919515|FG001|COMPLETED|Overall Study||101||
59798531|NCT00253747|75919514|FG000|NOT COMPLETED|Overall Study||24||
59798532|NCT00253747|75919515|FG001|NOT COMPLETED|Overall Study||27||
59798533|NCT00252733|75919533|FG000|STARTED|Overall Study||711||
59798534|NCT00252733|75919534|FG001|STARTED|Overall Study||710||
59798535|NCT00252733|75919533|FG000|COMPLETED|Overall Study||605||
59798536|NCT00252733|75919534|FG001|COMPLETED|Overall Study||618||
59798537|NCT00252733|75919533|FG000|NOT COMPLETED|Overall Study||106||
59798538|NCT00252733|75919534|FG001|NOT COMPLETED|Overall Study||92||
59798539|NCT00275821|75919543|FG000|STARTED|Overall Study||120||
59798540|NCT00275821|75919544|FG001|STARTED|Overall Study||118||
59798541|NCT00275821|75919545|FG002|STARTED|Overall Study||115||
59798542|NCT00275821|75919543|FG000|COMPLETED|Overall Study||106||
59798543|NCT00275821|75919544|FG001|COMPLETED|Overall Study||95||
59798544|NCT00275821|75919545|FG002|COMPLETED|Overall Study||103||
59798545|NCT00275821|75919543|FG000|NOT COMPLETED|Overall Study||14||
59798546|NCT00275821|75919544|FG001|NOT COMPLETED|Overall Study||23||
59798547|NCT00275821|75919545|FG002|NOT COMPLETED|Overall Study||12||
59798548|NCT00275509|75919555|FG000|STARTED|Overall Study||30||
59798549|NCT00275509|75919556|FG001|STARTED|Overall Study||26||
59798550|NCT00275509|75919555|FG000|COMPLETED|Overall Study||30||
59798551|NCT00275509|75919556|FG001|COMPLETED|Overall Study||25||
60073736|NCT01610336|76189073|FG003|STARTED|Overall Study||7||
59798552|NCT00275509|75919555|FG000|NOT COMPLETED|Overall Study||0||
59798553|NCT00275509|75919556|FG001|NOT COMPLETED|Overall Study||1||
59798554|NCT00252577|75919562|FG000|STARTED|Overall Study||130||
59798555|NCT00252577|75919562|FG000|COMPLETED|Overall Study||110||
59798556|NCT00252577|75919562|FG000|NOT COMPLETED|Overall Study||20||
59954446|NCT02730728|76072948|FG000|COMPLETED|Overall Study||53||
59798557|NCT00252499|75919569|FG000|STARTED|Overall Study||5||
59798558|NCT00252499|75919570|FG001|STARTED|Overall Study||2||
59798559|NCT00252499|75919571|FG002|STARTED|Overall Study||6||
59798560|NCT00252499|75919569|FG000|COMPLETED|Overall Study||4||
59798561|NCT00252499|75919570|FG001|COMPLETED|Overall Study||2||
59798562|NCT00252499|75919571|FG002|COMPLETED|Overall Study||6||
59798563|NCT00252499|75919569|FG000|NOT COMPLETED|Overall Study||1||
59798564|NCT00252499|75919570|FG001|NOT COMPLETED|Overall Study||0||
59798565|NCT00252499|75919571|FG002|NOT COMPLETED|Overall Study||0||
59798566|NCT00252187|75919581|FG000|STARTED|Overall Study||24||
59798567|NCT00252187|75919582|FG001|STARTED|Overall Study||21||
59798568|NCT00252187|75919581|FG000|COMPLETED|Overall Study||20||
59798569|NCT00252187|75919582|FG001|COMPLETED|Overall Study||20||
59798570|NCT00252187|75919581|FG000|NOT COMPLETED|Overall Study||4||
59798571|NCT00252187|75919582|FG001|NOT COMPLETED|Overall Study||1||
59798572|NCT00572910|75919594|FG000|STARTED|Overall Study||19||
59798573|NCT00572910|75919595|FG001|STARTED|Overall Study||18||
59798574|NCT00572910|75919596|FG002|STARTED|Overall Study||19||
59798575|NCT00572910|75919597|FG003|STARTED|Overall Study||18||
59798576|NCT00572910|75919598|FG004|STARTED|Overall Study||19||
59798577|NCT00572910|75919599|FG005|STARTED|Overall Study||19||
59798578|NCT00572910|75919600|FG006|STARTED|Overall Study||19||
59798579|NCT00572910|75919601|FG007|STARTED|Overall Study||19||
59798580|NCT00572910|75919602|FG008|STARTED|Overall Study||19||
59798581|NCT00572910|75919603|FG009|STARTED|Overall Study||19||
59798582|NCT00572910|75919604|FG010|STARTED|Overall Study||18||
59798583|NCT00572910|75919594|FG000|COMPLETED|Overall Study||15||
59798584|NCT00572910|75919595|FG001|COMPLETED|Overall Study||15||
59798585|NCT00572910|75919596|FG002|COMPLETED|Overall Study||17||
59798586|NCT00572910|75919597|FG003|COMPLETED|Overall Study||14||
59798587|NCT00572910|75919598|FG004|COMPLETED|Overall Study||17||
59798588|NCT00572910|75919599|FG005|COMPLETED|Overall Study||16||
59798589|NCT00572910|75919600|FG006|COMPLETED|Overall Study||15||
59798590|NCT00572910|75919601|FG007|COMPLETED|Overall Study||15||
59798591|NCT00572910|75919602|FG008|COMPLETED|Overall Study||16||
59798592|NCT00572910|75919603|FG009|COMPLETED|Overall Study||13||
59798593|NCT00572910|75919604|FG010|COMPLETED|Overall Study||15||
59798594|NCT00572910|75919594|FG000|NOT COMPLETED|Overall Study||4||
59798595|NCT00572910|75919595|FG001|NOT COMPLETED|Overall Study||3||
59798596|NCT00572910|75919596|FG002|NOT COMPLETED|Overall Study||2||
59798597|NCT00572910|75919597|FG003|NOT COMPLETED|Overall Study||4||
59798598|NCT00572910|75919598|FG004|NOT COMPLETED|Overall Study||2||
59798599|NCT00572910|75919599|FG005|NOT COMPLETED|Overall Study||3||
59798600|NCT00572910|75919600|FG006|NOT COMPLETED|Overall Study||4||
59798601|NCT00572910|75919601|FG007|NOT COMPLETED|Overall Study||4||
59798602|NCT00572910|75919602|FG008|NOT COMPLETED|Overall Study||3||
59798603|NCT00572910|75919603|FG009|NOT COMPLETED|Overall Study||6||
59798604|NCT00572910|75919604|FG010|NOT COMPLETED|Overall Study||3||
59798605|NCT00163657|75919642|FG000|STARTED|Overall Study||80||
59798606|NCT00163657|75919643|FG001|STARTED|Overall Study||79||
59798607|NCT00163657|75919644|FG002|STARTED|Overall Study||153||
59954447|NCT02730728|76072949|FG001|COMPLETED|Overall Study||51||
59954448|NCT02730728|76072950|FG002|COMPLETED|Overall Study||52||
59954449|NCT02730728|76072948|FG000|NOT COMPLETED|Overall Study||0||
59798608|NCT00163657|75919642|FG000|COMPLETED|Overall Study||60||
59798609|NCT00163657|75919643|FG001|COMPLETED|Overall Study||56||
59798610|NCT00163657|75919644|FG002|COMPLETED|Overall Study||116||
59798611|NCT00163657|75919642|FG000|NOT COMPLETED|Overall Study||20||
59798612|NCT00163657|75919643|FG001|NOT COMPLETED|Overall Study||23||
59798613|NCT00163657|75919644|FG002|NOT COMPLETED|Overall Study||37||
59798614|NCT00609492|75919655|FG000|STARTED|Overall Study||44||
59798615|NCT00609492|75919656|FG001|STARTED|Overall Study||72||
59798616|NCT00609492|75919657|FG002|STARTED|Overall Study||129||
59798617|NCT00609492|75919655|FG000|COMPLETED|Overall Study||43||
59798618|NCT00609492|75919656|FG001|COMPLETED|Overall Study||69||
59798619|NCT00609492|75919657|FG002|COMPLETED|Overall Study||122||
59798620|NCT00609492|75919655|FG000|NOT COMPLETED|Overall Study||1||
59798621|NCT00609492|75919656|FG001|NOT COMPLETED|Overall Study||3||
59798622|NCT00609492|75919657|FG002|NOT COMPLETED|Overall Study||7||
59798623|NCT00230971|75919669|FG000|STARTED|Randomization||235||
59798624|NCT00230971|75919670|FG001|STARTED|Randomization||238||
59798625|NCT00230971|75919669|FG000|COMPLETED|Randomization||232||
59798626|NCT00230971|75919670|FG001|COMPLETED|Randomization||235||
59798627|NCT00230971|75919669|FG000|NOT COMPLETED|Randomization||3||
59798628|NCT00230971|75919670|FG001|NOT COMPLETED|Randomization||3||
59798629|NCT00230971|75919669|FG000|STARTED|Baseline Participants||232||
59798630|NCT00230971|75919670|FG001|STARTED|Baseline Participants||235||
59798631|NCT00230971|75919669|FG000|COMPLETED|Baseline Participants||210||
59798632|NCT00230971|75919670|FG001|COMPLETED|Baseline Participants||216||
59798633|NCT00230971|75919669|FG000|NOT COMPLETED|Baseline Participants||22||
59798634|NCT00230971|75919670|FG001|NOT COMPLETED|Baseline Participants||19||
59798635|NCT00211081|75919676|FG000|STARTED|Overall Study||12||
59798636|NCT00211081|75919676|FG000|COMPLETED|Overall Study||10||
59798637|NCT00211081|75919676|FG000|NOT COMPLETED|Overall Study||2||
59798638|NCT00609336|75919680|FG000|STARTED|Overall Study||35||
59798639|NCT00609336|75919680|FG000|Surgery|Overall Study||22||
59798640|NCT00609336|75919680|FG000|COMPLETED|Overall Study||22||
59798641|NCT00609336|75919680|FG000|NOT COMPLETED|Overall Study||13||
59798642|NCT00612066|75919685|FG000|STARTED|Overall Study||2||
59798643|NCT00612066|75919685|FG000|COMPLETED|Overall Study||1||
59798644|NCT00612066|75919685|FG000|NOT COMPLETED|Overall Study||1||
59798645|NCT00573144|75919691|FG000|STARTED|Overall Study||30||
59798646|NCT00573144|75919692|FG001|STARTED|Overall Study||28||
59798647|NCT00573144|75919691|FG000|COMPLETED|Overall Study||28||
59798648|NCT00573144|75919692|FG001|COMPLETED|Overall Study||25||
59798649|NCT00573144|75919691|FG000|NOT COMPLETED|Overall Study||2||
59798650|NCT00573144|75919692|FG001|NOT COMPLETED|Overall Study||3||
59798651|NCT00640328|75919704|FG000|STARTED|First Treatment Period (Weeks 0-24)||8||
59798652|NCT00640328|75919705|FG001|STARTED|First Treatment Period (Weeks 0-24)||11||
59798653|NCT00640328|75919706|FG002|STARTED|First Treatment Period (Weeks 0-24)||7||
59798654|NCT00640328|75919707|FG003|STARTED|First Treatment Period (Weeks 0-24)||4||
59798655|NCT00640328|75919708|FG004|STARTED|First Treatment Period (Weeks 0-24)||4||
59798656|NCT00640328|75919709|FG005|STARTED|First Treatment Period (Weeks 0-24)||4||
59798657|NCT00640328|75919704|FG000|COMPLETED|First Treatment Period (Weeks 0-24)||8||
59798658|NCT00640328|75919705|FG001|COMPLETED|First Treatment Period (Weeks 0-24)||10||
59798659|NCT00640328|75919706|FG002|COMPLETED|First Treatment Period (Weeks 0-24)||7||
59798660|NCT00640328|75919707|FG003|COMPLETED|First Treatment Period (Weeks 0-24)||4||
59798661|NCT00640328|75919708|FG004|COMPLETED|First Treatment Period (Weeks 0-24)||4||
59798662|NCT00640328|75919709|FG005|COMPLETED|First Treatment Period (Weeks 0-24)||4||
59798663|NCT00640328|75919704|FG000|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0||
59798664|NCT00640328|75919705|FG001|NOT COMPLETED|First Treatment Period (Weeks 0-24)||1||
59798665|NCT00640328|75919706|FG002|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0||
59798666|NCT00640328|75919707|FG003|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0||
59798667|NCT00640328|75919708|FG004|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0||
59798668|NCT00640328|75919709|FG005|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0||
59798669|NCT00640328|75919704|FG000|STARTED|Second Treatment Period (Weeks 24-48)||8||
59798670|NCT00640328|75919705|FG001|STARTED|Second Treatment Period (Weeks 24-48)||10||
59798671|NCT00640328|75919706|FG002|STARTED|Second Treatment Period (Weeks 24-48)||7||
59798672|NCT00640328|75919707|FG003|STARTED|Second Treatment Period (Weeks 24-48)||4||
59798673|NCT00640328|75919708|FG004|STARTED|Second Treatment Period (Weeks 24-48)||4||
59798674|NCT00640328|75919709|FG005|STARTED|Second Treatment Period (Weeks 24-48)||4||
59798675|NCT00640328|75919704|FG000|COMPLETED|Second Treatment Period (Weeks 24-48)||8||
59798676|NCT00640328|75919705|FG001|COMPLETED|Second Treatment Period (Weeks 24-48)||10||
59798677|NCT00640328|75919706|FG002|COMPLETED|Second Treatment Period (Weeks 24-48)||7||
59798678|NCT00640328|75919707|FG003|COMPLETED|Second Treatment Period (Weeks 24-48)||4||
59798679|NCT00640328|75919708|FG004|COMPLETED|Second Treatment Period (Weeks 24-48)||3||
59798680|NCT00640328|75919709|FG005|COMPLETED|Second Treatment Period (Weeks 24-48)||4||
59798681|NCT00640328|75919704|FG000|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0||
59798682|NCT00640328|75919705|FG001|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0||
59798683|NCT00640328|75919706|FG002|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0||
59798684|NCT00640328|75919707|FG003|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0||
59798685|NCT00640328|75919708|FG004|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||1||
59798686|NCT00640328|75919709|FG005|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0||
59798687|NCT00640328|75919704|FG000|STARTED|IFUP (Week 48 to Individual Termination)||8||
59798688|NCT00640328|75919705|FG001|STARTED|IFUP (Week 48 to Individual Termination)||11||
59798689|NCT00640328|75919706|FG002|STARTED|IFUP (Week 48 to Individual Termination)||7||
59798690|NCT00640328|75919707|FG003|STARTED|IFUP (Week 48 to Individual Termination)||4||
59798691|NCT00640328|75919708|FG004|STARTED|IFUP (Week 48 to Individual Termination)||4||
59798692|NCT00640328|75919709|FG005|STARTED|IFUP (Week 48 to Individual Termination)||4||
59798693|NCT00640328|75919704|FG000|COMPLETED|IFUP (Week 48 to Individual Termination)||8||
59798694|NCT00640328|75919705|FG001|COMPLETED|IFUP (Week 48 to Individual Termination)||10||
59798695|NCT00640328|75919706|FG002|COMPLETED|IFUP (Week 48 to Individual Termination)||6||
59798696|NCT00640328|75919707|FG003|COMPLETED|IFUP (Week 48 to Individual Termination)||3||
59798697|NCT00640328|75919708|FG004|COMPLETED|IFUP (Week 48 to Individual Termination)||4||
59798698|NCT00640328|75919709|FG005|COMPLETED|IFUP (Week 48 to Individual Termination)||4||
59798699|NCT00640328|75919704|FG000|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||0||
59798700|NCT00640328|75919705|FG001|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||1||
59798701|NCT00640328|75919706|FG002|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||1||
59798702|NCT00640328|75919707|FG003|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||1||
59798703|NCT00640328|75919708|FG004|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||0||
59798704|NCT00640328|75919709|FG005|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||0||
59798705|NCT00163189|75919730|FG000|STARTED|Overall Study||98||
59798706|NCT00163189|75919730|FG000|COMPLETED|Overall Study||35||
59798707|NCT00163189|75919730|FG000|NOT COMPLETED|Overall Study||63||
59798708|NCT00162097|75919738|FG000|STARTED|Overall Study|Treated on Day 1|6||
59798709|NCT00162097|75919739|FG001|STARTED|Overall Study|Treated on Day 1|2||
59798710|NCT00162097|75919740|FG002|STARTED|Overall Study|Treated on Day 1|1||
59798711|NCT00162097|75919741|FG003|STARTED|Overall Study|Treated on Day 1. One participant enrolled twice in the study and is hence counted twice|7||
59798712|NCT00162097|75919738|FG000|COMPLETED|Overall Study||6||
59798713|NCT00162097|75919739|FG001|COMPLETED|Overall Study||2||
59798714|NCT00162097|75919740|FG002|COMPLETED|Overall Study||1||
59798715|NCT00162097|75919741|FG003|COMPLETED|Overall Study||6||
59798716|NCT00162097|75919738|FG000|NOT COMPLETED|Overall Study||0||
59798717|NCT00162097|75919739|FG001|NOT COMPLETED|Overall Study||0||
59798718|NCT00162097|75919740|FG002|NOT COMPLETED|Overall Study||0||
59798719|NCT00162097|75919741|FG003|NOT COMPLETED|Overall Study||1||
59798720|NCT00640016|75919761|FG000|STARTED|Overall Study||3||
59798721|NCT00640016|75919762|FG001|STARTED|Overall Study||3||
59798722|NCT00640016|75919763|FG002|STARTED|Overall Study||4||
59798723|NCT00640016|75919764|FG003|STARTED|Overall Study||4||
59798724|NCT00640016|75919761|FG000|Treated|Overall Study||3||
59798725|NCT00640016|75919762|FG001|Treated|Overall Study||2||
59798726|NCT00640016|75919763|FG002|Treated|Overall Study||4||
59798727|NCT00640016|75919764|FG003|Treated|Overall Study||4||
59798728|NCT00640016|75919761|FG000|COMPLETED|Overall Study||1||
59798729|NCT00640016|75919762|FG001|COMPLETED|Overall Study||1||
59798730|NCT00640016|75919763|FG002|COMPLETED|Overall Study||1||
59798731|NCT00640016|75919764|FG003|COMPLETED|Overall Study||1||
59798732|NCT00640016|75919761|FG000|NOT COMPLETED|Overall Study||2||
59798733|NCT00640016|75919762|FG001|NOT COMPLETED|Overall Study||2||
59798734|NCT00640016|75919763|FG002|NOT COMPLETED|Overall Study||3||
59798735|NCT00640016|75919764|FG003|NOT COMPLETED|Overall Study||3||
59798736|NCT00608868|75919781|FG000|STARTED|Overall Study||156||
59798737|NCT00608868|75919781|FG000|Enrolled|Overall Study||156||
59798738|NCT00608868|75919781|FG000|Safety Population|Overall Study|2 patients who received no study treatment were excluded|154||
59798739|NCT00608868|75919781|FG000|Treatment Completed|Overall Study||141||
59798740|NCT00608868|75919781|FG000|Intention to Treat (ITT) Population|Overall Study|8 patients who had no target lesion and 8 who had no tumor assessment after baseline were excluded|138||
59798741|NCT00608868|75919781|FG000|Per Protocol (PP) Population|Overall Study||121||
59798742|NCT00608868|75919781|FG000|COMPLETED|Overall Study||141||
59798743|NCT00608868|75919781|FG000|NOT COMPLETED|Overall Study||15||
59798744|NCT00608322|75919787|FG000|STARTED|Overall Study||26||
59798745|NCT00608322|75919788|FG001|STARTED|Overall Study||23||
59798746|NCT00608322|75919787|FG000|COMPLETED|Overall Study||24||
59798747|NCT00608322|75919788|FG001|COMPLETED|Overall Study||22||
59798748|NCT00608322|75919787|FG000|NOT COMPLETED|Overall Study||2||
59798749|NCT00608322|75919788|FG001|NOT COMPLETED|Overall Study||1||
59798750|NCT00608244|75919794|FG000|STARTED|Overall Study||59||
59798751|NCT00608244|75919794|FG000|COMPLETED|Overall Study||57||
59798752|NCT00608244|75919794|FG000|NOT COMPLETED|Overall Study||2||
59798753|NCT00605280|75919804|FG000|STARTED|Year 1||145||
59798754|NCT00605280|75919805|FG001|STARTED|Year 1||22||
59798755|NCT00605280|75919806|FG002|STARTED|Year 1||7||
59798756|NCT00605280|75919807|FG003|STARTED|Year 1||143||
59798757|NCT00605280|75919804|FG000|Received 0.3 mg Treatment|Year 1||144||
59798758|NCT00605280|75919805|FG001|Received 0.3 mg Treatment|Year 1||13||
59954450|NCT02730728|76072949|FG001|NOT COMPLETED|Overall Study||2||
59954451|NCT02730728|76072950|FG002|NOT COMPLETED|Overall Study||1||
59954452|NCT00104637|76072958|FG000|STARTED|Period 1: ( TREATMENT: 4 Weeks)||6||
59954453|NCT00104637|76072959|FG001|STARTED|Period 1: ( TREATMENT: 4 Weeks)||4||
59954454|NCT00104637|76072958|FG000|COMPLETED|Period 1: ( TREATMENT: 4 Weeks)||5||
59954455|NCT00104637|76072959|FG001|COMPLETED|Period 1: ( TREATMENT: 4 Weeks)||4||
59954456|NCT00104637|76072958|FG000|NOT COMPLETED|Period 1: ( TREATMENT: 4 Weeks)||1||
59954457|NCT00104637|76072959|FG001|NOT COMPLETED|Period 1: ( TREATMENT: 4 Weeks)||0||
60073737|NCT01610336|76189074|FG004|STARTED|Overall Study||4||
59798759|NCT00605280|75919806|FG002|Received 0.3 mg Treatment|Year 1||3||
59798760|NCT00605280|75919807|FG003|Received 0.3 mg Treatment|Year 1||0||
59798761|NCT00605280|75919804|FG000|COMPLETED|Year 1||126||
59798762|NCT00605280|75919805|FG001|COMPLETED|Year 1||11||
59798763|NCT00605280|75919806|FG002|COMPLETED|Year 1||6||
59798764|NCT00605280|75919807|FG003|COMPLETED|Year 1||124||
59798765|NCT00605280|75919804|FG000|NOT COMPLETED|Year 1||19||
59798766|NCT00605280|75919805|FG001|NOT COMPLETED|Year 1||11||
59798767|NCT00605280|75919806|FG002|NOT COMPLETED|Year 1||1||
59798768|NCT00605280|75919807|FG003|NOT COMPLETED|Year 1||19||
59798769|NCT00605280|75919804|FG000|STARTED|Year 2||126||
59954458|NCT00104637|76072958|FG000|STARTED|Period 2 (WASHOUT: 1 Week)||5||
59954459|NCT00104637|76072959|FG001|STARTED|Period 2 (WASHOUT: 1 Week)||4||
60073738|NCT01610336|76189075|FG005|STARTED|Overall Study||12||
59798770|NCT00605280|75919805|FG001|STARTED|Year 2||11||
59798771|NCT00605280|75919806|FG002|STARTED|Year 2||6||
59798772|NCT00605280|75919807|FG003|STARTED|Year 2||124||
59798773|NCT00605280|75919804|FG000|Received 0.3 mg Treatment|Year 2||126||
59798774|NCT00605280|75919805|FG001|Received 0.3 mg Treatment|Year 2||3||
59798775|NCT00605280|75919806|FG002|Received 0.3 mg Treatment|Year 2||2||
59798776|NCT00605280|75919807|FG003|Received 0.3 mg Treatment|Year 2||0||
59798777|NCT00605280|75919804|FG000|COMPLETED|Year 2||102||
59798778|NCT00605280|75919805|FG001|COMPLETED|Year 2||5||
59798779|NCT00605280|75919806|FG002|COMPLETED|Year 2||0||
59798780|NCT00605280|75919807|FG003|COMPLETED|Year 2||102||
59798781|NCT00605280|75919804|FG000|NOT COMPLETED|Year 2||24||
59798782|NCT00605280|75919805|FG001|NOT COMPLETED|Year 2||6||
59798783|NCT00605280|75919806|FG002|NOT COMPLETED|Year 2||6||
59798784|NCT00605280|75919807|FG003|NOT COMPLETED|Year 2||22||
59798785|NCT00605280|75919804|FG000|STARTED|Year 3 Extension||46||
59798786|NCT00605280|75919805|FG001|STARTED|Year 3 Extension||0||
59798787|NCT00605280|75919806|FG002|STARTED|Year 3 Extension||0||
59798788|NCT00605280|75919807|FG003|STARTED|Year 3 Extension||54||
59798789|NCT00605280|75919804|FG000|Received 0.3 mg Treatment|Year 3 Extension||46||
59798790|NCT00605280|75919805|FG001|Received 0.3 mg Treatment|Year 3 Extension||0||
59798791|NCT00605280|75919806|FG002|Received 0.3 mg Treatment|Year 3 Extension||0||
59798792|NCT00605280|75919807|FG003|Received 0.3 mg Treatment|Year 3 Extension||54||
59798793|NCT00605280|75919804|FG000|COMPLETED|Year 3 Extension||38||
59798794|NCT00605280|75919805|FG001|COMPLETED|Year 3 Extension||0||
59798795|NCT00605280|75919806|FG002|COMPLETED|Year 3 Extension||0||
59798796|NCT00605280|75919807|FG003|COMPLETED|Year 3 Extension||45||
59798797|NCT00605280|75919804|FG000|NOT COMPLETED|Year 3 Extension||8||
59798798|NCT00605280|75919805|FG001|NOT COMPLETED|Year 3 Extension||0||
59798799|NCT00605280|75919806|FG002|NOT COMPLETED|Year 3 Extension||0||
59798800|NCT00605280|75919807|FG003|NOT COMPLETED|Year 3 Extension||9||
59798801|NCT00607386|75919817|FG000|STARTED|Overall Study||28||
59798802|NCT00607386|75919817|FG000|COMPLETED|Overall Study||27||
59798803|NCT00607386|75919817|FG000|NOT COMPLETED|Overall Study||1||
59798804|NCT00638690|75919823|FG000|STARTED|Overall Study||797||
59798805|NCT00638690|75919824|FG001|STARTED|Overall Study||398||
59798806|NCT00638690|75919823|FG000|COMPLETED|Overall Study||116||
59798807|NCT00638690|75919824|FG001|COMPLETED|Overall Study||56||
59798808|NCT00638690|75919823|FG000|NOT COMPLETED|Overall Study||681||
59798809|NCT00638690|75919824|FG001|NOT COMPLETED|Overall Study||342||
59798810|NCT00543387|75919840|FG000|STARTED|Panel 1 + Panel 2||3||
59798811|NCT00543387|75919841|FG001|STARTED|Panel 1 + Panel 2||3||
59798812|NCT00543387|75919842|FG002|STARTED|Panel 1 + Panel 2||3||
59798813|NCT00543387|75919843|FG003|STARTED|Panel 1 + Panel 2||3||
59798814|NCT00543387|75919844|FG004|STARTED|Panel 1 + Panel 2||3||
59798815|NCT00543387|75919845|FG005|STARTED|Panel 1 + Panel 2||3||
59798816|NCT00543387|75919846|FG006|STARTED|Panel 1 + Panel 2||6||
59798817|NCT00543387|75919847|FG007|STARTED|Panel 1 + Panel 2||6||
59798818|NCT00543387|75919848|FG008|STARTED|Panel 1 + Panel 2||5||
59798819|NCT00543387|75919849|FG009|STARTED|Panel 1 + Panel 2||0||
59798820|NCT00543387|75919850|FG010|STARTED|Panel 1 + Panel 2||0||
59798821|NCT00543387|75919840|FG000|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0||
59798822|NCT00543387|75919841|FG001|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||1||
59798823|NCT00543387|75919842|FG002|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0||
59798824|NCT00543387|75919843|FG003|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0||
59798825|NCT00543387|75919844|FG004|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||2||
59798826|NCT00543387|75919845|FG005|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||1||
59798827|NCT00543387|75919846|FG006|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0||
59798828|NCT00543387|75919847|FG007|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0||
59798829|NCT00543387|75919848|FG008|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0||
59798830|NCT00543387|75919849|FG009|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0||
59798831|NCT00543387|75919850|FG010|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0||
59798832|NCT00543387|75919840|FG000|COMPLETED|Panel 1 + Panel 2||0||
59798833|NCT00543387|75919841|FG001|COMPLETED|Panel 1 + Panel 2||0||
59798834|NCT00543387|75919842|FG002|COMPLETED|Panel 1 + Panel 2||0||
59798835|NCT00543387|75919843|FG003|COMPLETED|Panel 1 + Panel 2||0||
59798836|NCT00543387|75919844|FG004|COMPLETED|Panel 1 + Panel 2||0||
59798837|NCT00543387|75919845|FG005|COMPLETED|Panel 1 + Panel 2||0||
59798838|NCT00543387|75919846|FG006|COMPLETED|Panel 1 + Panel 2||0||
59798839|NCT00543387|75919847|FG007|COMPLETED|Panel 1 + Panel 2||0||
59798840|NCT00543387|75919848|FG008|COMPLETED|Panel 1 + Panel 2||0||
59798841|NCT00543387|75919849|FG009|COMPLETED|Panel 1 + Panel 2||0||
59798842|NCT00543387|75919850|FG010|COMPLETED|Panel 1 + Panel 2||0||
59798843|NCT00543387|75919840|FG000|NOT COMPLETED|Panel 1 + Panel 2||3||
59798844|NCT00543387|75919841|FG001|NOT COMPLETED|Panel 1 + Panel 2||3||
59798845|NCT00543387|75919842|FG002|NOT COMPLETED|Panel 1 + Panel 2||3||
59798846|NCT00543387|75919843|FG003|NOT COMPLETED|Panel 1 + Panel 2||3||
59798847|NCT00543387|75919844|FG004|NOT COMPLETED|Panel 1 + Panel 2||3||
59798848|NCT00543387|75919845|FG005|NOT COMPLETED|Panel 1 + Panel 2||3||
59798849|NCT00543387|75919846|FG006|NOT COMPLETED|Panel 1 + Panel 2||6||
59798850|NCT00543387|75919847|FG007|NOT COMPLETED|Panel 1 + Panel 2||6||
59798851|NCT00543387|75919848|FG008|NOT COMPLETED|Panel 1 + Panel 2||5||
59798852|NCT00543387|75919849|FG009|NOT COMPLETED|Panel 1 + Panel 2||0||
59798853|NCT00543387|75919850|FG010|NOT COMPLETED|Panel 1 + Panel 2||0||
59798854|NCT00543387|75919840|FG000|STARTED|Crossover Participants||0||
59798855|NCT00543387|75919841|FG001|STARTED|Crossover Participants||0||
59798856|NCT00543387|75919842|FG002|STARTED|Crossover Participants||0||
59798857|NCT00543387|75919843|FG003|STARTED|Crossover Participants||0||
59798858|NCT00543387|75919844|FG004|STARTED|Crossover Participants||0||
59798859|NCT00543387|75919845|FG005|STARTED|Crossover Participants||0||
59798860|NCT00543387|75919846|FG006|STARTED|Crossover Participants||0||
59798861|NCT00543387|75919847|FG007|STARTED|Crossover Participants||0||
59798862|NCT00543387|75919848|FG008|STARTED|Crossover Participants||0||
59798863|NCT00543387|75919849|FG009|STARTED|Crossover Participants|Participant originally treated in MK-5108 400 mg BID (Panel 1) in Period 1|1||
59798864|NCT00543387|75919850|FG010|STARTED|Crossover Participants|3 participants originally treated with 1500 (2) and 1800 mg (1) MK-5108 in Panel 1 Period 1|3||
59798865|NCT00543387|75919840|FG000|COMPLETED|Crossover Participants||0||
59798866|NCT00543387|75919841|FG001|COMPLETED|Crossover Participants||0||
59798867|NCT00543387|75919842|FG002|COMPLETED|Crossover Participants||0||
59798868|NCT00543387|75919843|FG003|COMPLETED|Crossover Participants||0||
59798869|NCT00543387|75919844|FG004|COMPLETED|Crossover Participants||0||
59798870|NCT00543387|75919845|FG005|COMPLETED|Crossover Participants||0||
59798871|NCT00543387|75919846|FG006|COMPLETED|Crossover Participants||0||
59798872|NCT00543387|75919847|FG007|COMPLETED|Crossover Participants||0||
59798873|NCT00543387|75919848|FG008|COMPLETED|Crossover Participants||0||
59798874|NCT00543387|75919849|FG009|COMPLETED|Crossover Participants||0||
59798875|NCT00543387|75919850|FG010|COMPLETED|Crossover Participants||0||
59798876|NCT00543387|75919840|FG000|NOT COMPLETED|Crossover Participants||0||
59798877|NCT00543387|75919841|FG001|NOT COMPLETED|Crossover Participants||0||
59798878|NCT00543387|75919842|FG002|NOT COMPLETED|Crossover Participants||0||
59798879|NCT00543387|75919843|FG003|NOT COMPLETED|Crossover Participants||0||
59798880|NCT00543387|75919844|FG004|NOT COMPLETED|Crossover Participants||0||
59798881|NCT00543387|75919845|FG005|NOT COMPLETED|Crossover Participants||0||
59798882|NCT00543387|75919846|FG006|NOT COMPLETED|Crossover Participants||0||
59798883|NCT00543387|75919847|FG007|NOT COMPLETED|Crossover Participants||0||
59798884|NCT00543387|75919848|FG008|NOT COMPLETED|Crossover Participants||0||
59798885|NCT00543387|75919849|FG009|NOT COMPLETED|Crossover Participants||1||
59798886|NCT00543387|75919850|FG010|NOT COMPLETED|Crossover Participants||3||
59798887|NCT03455556|75919874|FG000|STARTED|Overall Study||1||
59798888|NCT03455556|75919874|FG000|COMPLETED|Overall Study||1||
59798889|NCT03455556|75919874|FG000|NOT COMPLETED|Overall Study||0||
59798890|NCT00635570|75919880|FG000|STARTED|Overall Study||136||
59798891|NCT00635570|75919881|FG001|STARTED|Overall Study||137||
59798892|NCT00635570|75919880|FG000|COMPLETED|Overall Study||121||
59798893|NCT00635570|75919881|FG001|COMPLETED|Overall Study||126||
59798894|NCT00635570|75919880|FG000|NOT COMPLETED|Overall Study||15||
59798895|NCT00635570|75919881|FG001|NOT COMPLETED|Overall Study||11||
59798896|NCT00635492|75919889|FG000|STARTED|Overall Study|This population consists of the analysis population.|1114||
59798897|NCT00635492|75919890|FG001|STARTED|Overall Study|This population consists of the analysis population.|1274||
59798898|NCT00635492|75919889|FG000|COMPLETED|Overall Study|This population consists of patients that completed the 24 month study.|835||
59798899|NCT00635492|75919890|FG001|COMPLETED|Overall Study|This population consists of patients that completed the 24 month study.|992||
59798900|NCT00635492|75919889|FG000|NOT COMPLETED|Overall Study||279||
59798901|NCT00635492|75919890|FG001|NOT COMPLETED|Overall Study||282||
59798902|NCT00543309|75919903|FG000|STARTED|Overall Study||35||
59798903|NCT00543309|75919904|FG001|STARTED|Overall Study||36||
59798904|NCT00543309|75919905|FG002|STARTED|Overall Study||35||
59798905|NCT00543309|75919903|FG000|COMPLETED|Overall Study||35||
59798906|NCT00543309|75919904|FG001|COMPLETED|Overall Study||35||
59798907|NCT00543309|75919905|FG002|COMPLETED|Overall Study||35||
59798908|NCT00543309|75919903|FG000|NOT COMPLETED|Overall Study||0||
59798909|NCT00543309|75919904|FG001|NOT COMPLETED|Overall Study||1||
59798910|NCT00543309|75919905|FG002|NOT COMPLETED|Overall Study||0||
59798911|NCT00569582|75919914|FG000|STARTED|Overall Study||50||
59798912|NCT00569582|75919914|FG000|COMPLETED|Overall Study||34||
59798913|NCT00569582|75919914|FG000|NOT COMPLETED|Overall Study||16||
59798914|NCT00721409|75919921|FG000|STARTED|Overall Study||12||
59798915|NCT00721409|75919922|FG001|STARTED|Overall Study||84||
59798916|NCT00721409|75919923|FG002|STARTED|Overall Study||81||
59798917|NCT00721409|75919921|FG000|Treated|Overall Study||12||
59798918|NCT00721409|75919922|FG001|Treated|Overall Study||83||
59798919|NCT00721409|75919923|FG002|Treated|Overall Study||77||
59798920|NCT00721409|75919921|FG000|COMPLETED|Overall Study||0||
59798921|NCT00721409|75919922|FG001|COMPLETED|Overall Study||2||
59798922|NCT00721409|75919923|FG002|COMPLETED|Overall Study||2||
59798923|NCT00721409|75919921|FG000|NOT COMPLETED|Overall Study||12||
59798924|NCT00721409|75919922|FG001|NOT COMPLETED|Overall Study||82||
59798925|NCT00721409|75919923|FG002|NOT COMPLETED|Overall Study||79||
59798926|NCT00542997|75919947|FG000|STARTED|Wash in / Wash Out Period||51||
59798927|NCT00542997|75919947|FG000|COMPLETED|Wash in / Wash Out Period||46||
59798928|NCT00542997|75919947|FG000|NOT COMPLETED|Wash in / Wash Out Period||5||
59798929|NCT00542997|75919947|FG000|STARTED|Efficacy Period||46||
59798930|NCT00542997|75919947|FG000|COMPLETED|Efficacy Period||43||
59798931|NCT00542997|75919947|FG000|NOT COMPLETED|Efficacy Period||3||
59798932|NCT00572832|75919956|FG000|STARTED|Overall Study||100||
59798933|NCT00572832|75919957|FG001|STARTED|Overall Study||100||
59798934|NCT00572832|75919956|FG000|COMPLETED|Overall Study||100||
59798935|NCT00572832|75919957|FG001|COMPLETED|Overall Study||88||
59798936|NCT00572832|75919956|FG000|NOT COMPLETED|Overall Study||0||
59798937|NCT00572832|75919957|FG001|NOT COMPLETED|Overall Study||12||
59798938|NCT03917823|75919965|FG000|STARTED|Overall Study||2||
59798939|NCT03917823|75919966|FG001|STARTED|Overall Study||2||
59798940|NCT03917823|75919965|FG000|COMPLETED|Overall Study||1||
59798941|NCT03917823|75919966|FG001|COMPLETED|Overall Study||0||
59798942|NCT03917823|75919965|FG000|NOT COMPLETED|Overall Study||1||
59798943|NCT03917823|75919966|FG001|NOT COMPLETED|Overall Study||2||
59798944|NCT00229723|75919979|FG000|STARTED|Concomitant Phase|Received randomized treatment|60||
59798945|NCT00229723|75919980|FG001|STARTED|Concomitant Phase|Received randomized treatment|24||
59798946|NCT00229723|75919981|FG002|STARTED|Concomitant Phase|Received randomized treatment|31||
59798947|NCT00229723|75919982|FG003|STARTED|Concomitant Phase|Received randomized treatment|31||
59798948|NCT00229723|75919983|FG004|STARTED|Concomitant Phase|Received randomized treatment|24||
59798949|NCT00229723|75919984|FG005|STARTED|Concomitant Phase|Received randomized treatment|34||
59798950|NCT00229723|75919985|FG006|STARTED|Concomitant Phase|Received randomized treatment|22||
59798951|NCT00229723|75919979|FG000|COMPLETED|Concomitant Phase||50||
59798952|NCT00229723|75919980|FG001|COMPLETED|Concomitant Phase||19||
59798953|NCT00229723|75919981|FG002|COMPLETED|Concomitant Phase||25||
59798954|NCT00229723|75919982|FG003|COMPLETED|Concomitant Phase||26||
59798955|NCT00229723|75919983|FG004|COMPLETED|Concomitant Phase||22||
59798956|NCT00229723|75919984|FG005|COMPLETED|Concomitant Phase||31||
59798957|NCT00229723|75919985|FG006|COMPLETED|Concomitant Phase||19||
59798958|NCT00229723|75919979|FG000|NOT COMPLETED|Concomitant Phase||10||
59798959|NCT00229723|75919980|FG001|NOT COMPLETED|Concomitant Phase||5||
59798960|NCT00229723|75919981|FG002|NOT COMPLETED|Concomitant Phase||6||
59798961|NCT00229723|75919982|FG003|NOT COMPLETED|Concomitant Phase||5||
59798962|NCT00229723|75919983|FG004|NOT COMPLETED|Concomitant Phase||2||
59798963|NCT00229723|75919984|FG005|NOT COMPLETED|Concomitant Phase||3||
59798964|NCT00229723|75919985|FG006|NOT COMPLETED|Concomitant Phase||3||
59798965|NCT00229723|75919979|FG000|STARTED|Maintenance Phase||50||
59798966|NCT00229723|75919980|FG001|STARTED|Maintenance Phase||19||
59798967|NCT00229723|75919981|FG002|STARTED|Maintenance Phase||25||
59798968|NCT00229723|75919982|FG003|STARTED|Maintenance Phase||26||
59798969|NCT00229723|75919983|FG004|STARTED|Maintenance Phase||22||
59798970|NCT00229723|75919984|FG005|STARTED|Maintenance Phase||31||
59798971|NCT00229723|75919985|FG006|STARTED|Maintenance Phase||19||
59798972|NCT00229723|75919979|FG000|COMPLETED|Maintenance Phase|Completed study on randomized treatment|25||
59798973|NCT00229723|75919980|FG001|COMPLETED|Maintenance Phase|Completed study on randomized treatment|5||
59798974|NCT00229723|75919981|FG002|COMPLETED|Maintenance Phase|Completed study on randomized treatment|16||
59798975|NCT00229723|75919982|FG003|COMPLETED|Maintenance Phase|Completed study on randomized treatment|9||
59798976|NCT00229723|75919983|FG004|COMPLETED|Maintenance Phase|Completed study on randomized treatment|7||
59798977|NCT00229723|75919984|FG005|COMPLETED|Maintenance Phase|Completed study on randomized treatment|12||
59798978|NCT00229723|75919985|FG006|COMPLETED|Maintenance Phase|Completed study on randomized treatment|9||
59798979|NCT00229723|75919979|FG000|NOT COMPLETED|Maintenance Phase||25||
59798980|NCT00229723|75919980|FG001|NOT COMPLETED|Maintenance Phase||14||
59798981|NCT00229723|75919981|FG002|NOT COMPLETED|Maintenance Phase||9||
59798982|NCT00229723|75919982|FG003|NOT COMPLETED|Maintenance Phase||17||
59798983|NCT00229723|75919983|FG004|NOT COMPLETED|Maintenance Phase||15||
59798984|NCT00229723|75919984|FG005|NOT COMPLETED|Maintenance Phase||19||
59798985|NCT00229723|75919985|FG006|NOT COMPLETED|Maintenance Phase||10||
59798986|NCT00606684|75920007|FG000|STARTED|2-week Single-Blind Run-in Period||851||
59798987|NCT00606684|75920008|FG001|STARTED|2-week Single-Blind Run-in Period||0||
59798988|NCT00606684|75920009|FG002|STARTED|2-week Single-Blind Run-in Period||0||
59798989|NCT00606684|75920010|FG003|STARTED|2-week Single-Blind Run-in Period||0||
59798990|NCT00606684|75920011|FG004|STARTED|2-week Single-Blind Run-in Period||0||
59798991|NCT00606684|75920012|FG005|STARTED|2-week Single-Blind Run-in Period||0||
59798992|NCT00606684|75920013|FG006|STARTED|2-week Single-Blind Run-in Period||0||
59798993|NCT00606684|75920007|FG000|COMPLETED|2-week Single-Blind Run-in Period||605||
59798994|NCT00606684|75920008|FG001|COMPLETED|2-week Single-Blind Run-in Period||0||
59798995|NCT00606684|75920009|FG002|COMPLETED|2-week Single-Blind Run-in Period||0||
59798996|NCT00606684|75920010|FG003|COMPLETED|2-week Single-Blind Run-in Period||0||
59798997|NCT00606684|75920011|FG004|COMPLETED|2-week Single-Blind Run-in Period||0||
59798998|NCT00606684|75920012|FG005|COMPLETED|2-week Single-Blind Run-in Period||0||
59798999|NCT00606684|75920013|FG006|COMPLETED|2-week Single-Blind Run-in Period||0||
59799000|NCT00606684|75920007|FG000|NOT COMPLETED|2-week Single-Blind Run-in Period||246||
59799001|NCT00606684|75920008|FG001|NOT COMPLETED|2-week Single-Blind Run-in Period||0||
59799002|NCT00606684|75920009|FG002|NOT COMPLETED|2-week Single-Blind Run-in Period||0||
59799003|NCT00606684|75920010|FG003|NOT COMPLETED|2-week Single-Blind Run-in Period||0||
59799004|NCT00606684|75920011|FG004|NOT COMPLETED|2-week Single-Blind Run-in Period||0||
59799005|NCT00606684|75920012|FG005|NOT COMPLETED|2-week Single-Blind Run-in Period||0||
59799006|NCT00606684|75920013|FG006|NOT COMPLETED|2-week Single-Blind Run-in Period||0||
59799007|NCT00606684|75920007|FG000|STARTED|Double-Blind Treatment Period||0||
59799008|NCT00606684|75920008|FG001|STARTED|Double-Blind Treatment Period||101||
59799009|NCT00606684|75920009|FG002|STARTED|Double-Blind Treatment Period||99||
59799010|NCT00606684|75920010|FG003|STARTED|Double-Blind Treatment Period||101||
59799011|NCT00606684|75920011|FG004|STARTED|Double-Blind Treatment Period||101||
59799012|NCT00606684|75920012|FG005|STARTED|Double-Blind Treatment Period||101||
59523660|NCT01188499|75618569|FG002|COMPLETED|Overall Study||33||
59523661|NCT01188499|75618570|FG003|COMPLETED|Overall Study||18||
59523662|NCT01188499|75618571|FG004|COMPLETED|Overall Study||18||
59523663|NCT01188499|75618567|FG000|NOT COMPLETED|Overall Study||0||
59523664|NCT01188499|75618568|FG001|NOT COMPLETED|Overall Study||0||
59799013|NCT00606684|75920013|FG006|STARTED|Double-Blind Treatment Period||99||
59799014|NCT00606684|75920007|FG000|COMPLETED|Double-Blind Treatment Period||0||
59799015|NCT00606684|75920008|FG001|COMPLETED|Double-Blind Treatment Period||85||
59954460|NCT00104637|76072958|FG000|COMPLETED|Period 2 (WASHOUT: 1 Week)||5||
59954461|NCT00104637|76072959|FG001|COMPLETED|Period 2 (WASHOUT: 1 Week)||4||
59799016|NCT00606684|75920009|FG002|COMPLETED|Double-Blind Treatment Period||88||
59799017|NCT00606684|75920010|FG003|COMPLETED|Double-Blind Treatment Period||91||
59799018|NCT00606684|75920011|FG004|COMPLETED|Double-Blind Treatment Period||92||
59799019|NCT00606684|75920012|FG005|COMPLETED|Double-Blind Treatment Period||92||
59799020|NCT00606684|75920013|FG006|COMPLETED|Double-Blind Treatment Period||91||
59799021|NCT00606684|75920007|FG000|NOT COMPLETED|Double-Blind Treatment Period||0||
59799022|NCT00606684|75920008|FG001|NOT COMPLETED|Double-Blind Treatment Period||16||
59799023|NCT00606684|75920009|FG002|NOT COMPLETED|Double-Blind Treatment Period||11||
59799024|NCT00606684|75920010|FG003|NOT COMPLETED|Double-Blind Treatment Period||10||
59799025|NCT00606684|75920011|FG004|NOT COMPLETED|Double-Blind Treatment Period||9||
59799026|NCT00606684|75920012|FG005|NOT COMPLETED|Double-Blind Treatment Period||9||
59799027|NCT00606684|75920013|FG006|NOT COMPLETED|Double-Blind Treatment Period||8||
59799028|NCT00627926|75920030|FG000|STARTED|Overall Study||361||
59799029|NCT00627926|75920031|FG001|STARTED|Overall Study||364||
59799030|NCT00627926|75920032|FG002|STARTED|Overall Study||363||
59799031|NCT00627926|75920030|FG000|COMPLETED|Overall Study||202||
59799032|NCT00627926|75920031|FG001|COMPLETED|Overall Study||260||
59799033|NCT00627926|75920032|FG002|COMPLETED|Overall Study||268||
59799034|NCT00627926|75920030|FG000|NOT COMPLETED|Overall Study||159||
59799035|NCT00627926|75920031|FG001|NOT COMPLETED|Overall Study||104||
59799036|NCT00627926|75920032|FG002|NOT COMPLETED|Overall Study||95||
59799037|NCT00228553|75920040|FG000|STARTED|Overall Study||743||
59799038|NCT00228553|75920040|FG000|COMPLETED|Overall Study||313||
59799039|NCT00228553|75920040|FG000|NOT COMPLETED|Overall Study||430||
59799040|NCT00643916|75920050|FG000|STARTED|Overall Study||55||
59799041|NCT00643916|75920051|FG001|STARTED|Overall Study||67||
59799042|NCT00643916|75920052|FG002|STARTED|Overall Study||68||
59799043|NCT00643916|75920053|FG003|STARTED|Overall Study||62||
59799044|NCT00643916|75920054|FG004|STARTED|Overall Study||59||
59799045|NCT00643916|75920055|FG005|STARTED|Overall Study||67||
59799046|NCT00643916|75920050|FG000|COMPLETED|Overall Study||51||
59799047|NCT00643916|75920051|FG001|COMPLETED|Overall Study||61||
59799048|NCT00643916|75920052|FG002|COMPLETED|Overall Study||62||
59799049|NCT00643916|75920053|FG003|COMPLETED|Overall Study||60||
59799050|NCT00643916|75920054|FG004|COMPLETED|Overall Study||57||
59799051|NCT00643916|75920055|FG005|COMPLETED|Overall Study||66||
59799052|NCT00643916|75920050|FG000|NOT COMPLETED|Overall Study||4||
59799053|NCT00643916|75920051|FG001|NOT COMPLETED|Overall Study||6||
59799054|NCT00643916|75920052|FG002|NOT COMPLETED|Overall Study||6||
59799055|NCT00643916|75920053|FG003|NOT COMPLETED|Overall Study||2||
59799056|NCT00643916|75920054|FG004|NOT COMPLETED|Overall Study||2||
59954462|NCT00104637|76072958|FG000|NOT COMPLETED|Period 2 (WASHOUT: 1 Week)||0||
59954463|NCT00104637|76072959|FG001|NOT COMPLETED|Period 2 (WASHOUT: 1 Week)||0||
59799057|NCT00643916|75920055|FG005|NOT COMPLETED|Overall Study||1||
59799058|NCT00160693|75920069|FG000|STARTED|Overall Study||402||
59799059|NCT00160693|75920069|FG000|COMPLETED|Overall Study||167||
59799060|NCT00160693|75920069|FG000|NOT COMPLETED|Overall Study||235||
59799061|NCT00643760|75920078|FG000|STARTED|Overall Study||120||
59799062|NCT00643760|75920079|FG001|STARTED|Overall Study||62||
59799063|NCT00643760|75920080|FG002|STARTED|Overall Study||56||
59799064|NCT00643760|75920081|FG003|STARTED|Overall Study||117||
59799065|NCT00643760|75920082|FG004|STARTED|Overall Study||66||
59799066|NCT00643760|75920078|FG000|Safety Population/Treated With Drug|Overall Study||120||
59954464|NCT00104637|76072958|FG000|STARTED|Period 3 ( TREATMENT: 4 Weeks)||5||
59954465|NCT00104637|76072959|FG001|STARTED|Period 3 ( TREATMENT: 4 Weeks)||4||
59954466|NCT00104637|76072958|FG000|COMPLETED|Period 3 ( TREATMENT: 4 Weeks)||5||
59954467|NCT00104637|76072959|FG001|COMPLETED|Period 3 ( TREATMENT: 4 Weeks)||4||
59523665|NCT01188499|75618569|FG002|NOT COMPLETED|Overall Study||0||
59523666|NCT01188499|75618570|FG003|NOT COMPLETED|Overall Study||0||
59523667|NCT01188499|75618571|FG004|NOT COMPLETED|Overall Study||0||
59523668|NCT00982865|75618587|FG000|STARTED|Overall Study||49||
59523669|NCT00982865|75618588|FG001|STARTED|Overall Study||82||
59523670|NCT00982865|75618589|FG002|STARTED|Overall Study||15||
59799067|NCT00643760|75920079|FG001|Safety Population/Treated With Drug|Overall Study||62||
59799068|NCT00643760|75920080|FG002|Safety Population/Treated With Drug|Overall Study||56||
59799069|NCT00643760|75920081|FG003|Safety Population/Treated With Drug|Overall Study||116||
59799070|NCT00643760|75920082|FG004|Safety Population/Treated With Drug|Overall Study||66||
59799071|NCT00643760|75920078|FG000|ITT Population|Overall Study||120||
59799072|NCT00643760|75920079|FG001|ITT Population|Overall Study||62||
59799073|NCT00643760|75920080|FG002|ITT Population|Overall Study||56||
59799074|NCT00643760|75920081|FG003|ITT Population|Overall Study||116||
59799075|NCT00643760|75920082|FG004|ITT Population|Overall Study||66||
59799076|NCT00643760|75920078|FG000|COMPLETED|Overall Study||90||
59799077|NCT00643760|75920079|FG001|COMPLETED|Overall Study||47||
59799078|NCT00643760|75920080|FG002|COMPLETED|Overall Study||37||
59799079|NCT00643760|75920081|FG003|COMPLETED|Overall Study||79||
59799080|NCT00643760|75920082|FG004|COMPLETED|Overall Study||47||
59799081|NCT00643760|75920078|FG000|NOT COMPLETED|Overall Study||30||
59799082|NCT00643760|75920079|FG001|NOT COMPLETED|Overall Study||15||
59799083|NCT00643760|75920080|FG002|NOT COMPLETED|Overall Study||19||
59799084|NCT00643760|75920081|FG003|NOT COMPLETED|Overall Study||38||
59799085|NCT00643760|75920082|FG004|NOT COMPLETED|Overall Study||19||
59799086|NCT00643682|75920096|FG000|STARTED|Overall Study||999||
59799087|NCT00643682|75920097|FG001|STARTED|Overall Study||1001||
59799088|NCT00643682|75920096|FG000|COMPLETED|Overall Study||477||
59799089|NCT00643682|75920097|FG001|COMPLETED|Overall Study||492||
59799090|NCT00643682|75920096|FG000|NOT COMPLETED|Overall Study||522||
59799091|NCT00643682|75920097|FG001|NOT COMPLETED|Overall Study||509||
59799092|NCT00603798|75920106|FG000|STARTED|Overall Study||162||
59799093|NCT00603798|75920107|FG001|STARTED|Overall Study||164||
59799094|NCT00603798|75920108|FG002|STARTED|Overall Study||164||
59799095|NCT00603798|75920106|FG000|COMPLETED|Overall Study||152||
59799096|NCT00603798|75920107|FG001|COMPLETED|Overall Study||157||
59799097|NCT00603798|75920108|FG002|COMPLETED|Overall Study||154||
59799098|NCT00603798|75920106|FG000|NOT COMPLETED|Overall Study||10||
59954468|NCT00104637|76072958|FG000|NOT COMPLETED|Period 3 ( TREATMENT: 4 Weeks)||0||
59954469|NCT00104637|76072959|FG001|NOT COMPLETED|Period 3 ( TREATMENT: 4 Weeks)||0||
59799099|NCT00603798|75920107|FG001|NOT COMPLETED|Overall Study||7||
59799100|NCT00603798|75920108|FG002|NOT COMPLETED|Overall Study||10||
59799101|NCT00630812|75920118|FG000|STARTED|Randomisation to First Dose||192||
59799102|NCT00630812|75920119|FG001|STARTED|Randomisation to First Dose||126||
59799103|NCT00630812|75920118|FG000|COMPLETED|Randomisation to First Dose||184||
59799104|NCT00630812|75920119|FG001|COMPLETED|Randomisation to First Dose||121||
59799105|NCT00630812|75920118|FG000|NOT COMPLETED|Randomisation to First Dose||8||
59799106|NCT00630812|75920119|FG001|NOT COMPLETED|Randomisation to First Dose||5||
59799107|NCT00630812|75920118|FG000|STARTED|Double Blind Treatment Period||184|Randomised and received first dose (mITT population). Patients not starting treatment are excluded|
59799108|NCT00630812|75920119|FG001|STARTED|Double Blind Treatment Period||121|Randomised and received first dose (mITT population). Patients not starting treatment are excluded|
59799109|NCT00630812|75920118|FG000|COMPLETED|Double Blind Treatment Period||153||
59799110|NCT00630812|75920119|FG001|COMPLETED|Double Blind Treatment Period||107||
59799111|NCT00630812|75920118|FG000|NOT COMPLETED|Double Blind Treatment Period||31||
59799112|NCT00630812|75920119|FG001|NOT COMPLETED|Double Blind Treatment Period||14||
59954470|NCT02768103|76072968|FG000|STARTED|Overall Study||5||
59954471|NCT02768103|76072968|FG000|COMPLETED|Overall Study||4||
59954472|NCT02768103|76072968|FG000|NOT COMPLETED|Overall Study||1||
59954473|NCT02767323|76072977|FG000|STARTED|Overall Study||83||
59954474|NCT02767323|76072978|FG001|STARTED|Overall Study||42||
59954475|NCT02767323|76072979|FG002|STARTED|Overall Study||58||
59799113|NCT00629798|75920125|FG000|STARTED|Overall Study||64||
59799114|NCT00629798|75920125|FG000|COMPLETED|Overall Study||60||
59799115|NCT00629798|75920125|FG000|NOT COMPLETED|Overall Study||4||
59799116|NCT00160615|75920131|FG000|STARTED|Overall Study||50||
59799117|NCT00160615|75920132|FG001|STARTED|Overall Study||101||
59799118|NCT00160615|75920131|FG000|COMPLETED|Overall Study||32||
59799119|NCT00160615|75920132|FG001|COMPLETED|Overall Study||56||
59799120|NCT00160615|75920131|FG000|NOT COMPLETED|Overall Study||18||
59799121|NCT00160615|75920132|FG001|NOT COMPLETED|Overall Study||45||
59799122|NCT00643448|75920143|FG000|STARTED|Overall Study||21||
59799123|NCT00643448|75920144|FG001|STARTED|Overall Study||22||
59799124|NCT00643448|75920145|FG002|STARTED|Overall Study||22||
59799125|NCT00643448|75920143|FG000|COMPLETED|Overall Study||17||
59799126|NCT00643448|75920144|FG001|COMPLETED|Overall Study||17||
59799127|NCT00643448|75920145|FG002|COMPLETED|Overall Study||16||
59799128|NCT00643448|75920143|FG000|NOT COMPLETED|Overall Study||4||
59799129|NCT00643448|75920144|FG001|NOT COMPLETED|Overall Study||5||
59799130|NCT00643448|75920145|FG002|NOT COMPLETED|Overall Study||6||
59799131|NCT00604500|75920155|FG000|STARTED|Overall Study||272||
59799132|NCT00604500|75920155|FG000|COMPLETED|Overall Study|There were 233 participants who took at least 90% of the labeled actuations (Completer Population).|261||
59799133|NCT00604500|75920155|FG000|NOT COMPLETED|Overall Study||11||
59799134|NCT00627458|75920162|FG000|STARTED|Overall Study||127||
59799135|NCT00627458|75920163|FG001|STARTED|Overall Study||137||
59799136|NCT00627458|75920164|FG002|STARTED|Overall Study||139||
59799137|NCT00627458|75920162|FG000|COMPLETED|Overall Study||123||
59799138|NCT00627458|75920163|FG001|COMPLETED|Overall Study||130||
59799139|NCT00627458|75920164|FG002|COMPLETED|Overall Study||133||
59954476|NCT02767323|76072980|FG003|STARTED|Overall Study||1||
59954477|NCT02767323|76072977|FG000|COMPLETED|Overall Study||49||
59799140|NCT00627458|75920162|FG000|NOT COMPLETED|Overall Study||4||
59799141|NCT00627458|75920163|FG001|NOT COMPLETED|Overall Study||7||
59799142|NCT00627458|75920164|FG002|NOT COMPLETED|Overall Study||6||
59799143|NCT00542919|75920176|FG000|STARTED|Overall Study||23||
59799144|NCT00542919|75920177|FG001|STARTED|Overall Study||19||
59799145|NCT00542919|75920178|FG002|STARTED|Overall Study||15||
59799146|NCT00542919|75920176|FG000|Received At Least One Dose of Study Drug|Overall Study||23||
59799147|NCT00542919|75920177|FG001|Received At Least One Dose of Study Drug|Overall Study||19||
59799148|NCT00542919|75920178|FG002|Received At Least One Dose of Study Drug|Overall Study||15||
59799149|NCT00542919|75920176|FG000|Progressive Disease|Overall Study||15||
59799150|NCT00542919|75920177|FG001|Progressive Disease|Overall Study||11||
59799151|NCT00542919|75920178|FG002|Progressive Disease|Overall Study||7||
59799152|NCT00542919|75920176|FG000|Death|Overall Study||1||
59799153|NCT00542919|75920177|FG001|Death|Overall Study||1||
59799154|NCT00542919|75920178|FG002|Death|Overall Study||2||
59799155|NCT00542919|75920176|FG000|COMPLETED|Overall Study||16||
59799156|NCT00542919|75920177|FG001|COMPLETED|Overall Study||12||
59799157|NCT00542919|75920178|FG002|COMPLETED|Overall Study||9||
59799158|NCT00542919|75920176|FG000|NOT COMPLETED|Overall Study||7||
59799159|NCT00542919|75920177|FG001|NOT COMPLETED|Overall Study||7||
59799160|NCT00542919|75920178|FG002|NOT COMPLETED|Overall Study||6||
59799161|NCT00159913|75920205|FG000|STARTED|Overall Study||42||
59799162|NCT00159913|75920206|FG001|STARTED|Overall Study||55||
59799163|NCT00159913|75920207|FG002|STARTED|Overall Study||77||
59799164|NCT00159913|75920208|FG003|STARTED|Overall Study||60||
59799165|NCT00159913|75920205|FG000|COMPLETED|Overall Study||40||
59799166|NCT00159913|75920206|FG001|COMPLETED|Overall Study||55||
59799167|NCT00159913|75920207|FG002|COMPLETED|Overall Study||75||
59799168|NCT00159913|75920208|FG003|COMPLETED|Overall Study||58||
59799169|NCT00159913|75920205|FG000|NOT COMPLETED|Overall Study||2||
59799170|NCT00159913|75920206|FG001|NOT COMPLETED|Overall Study||0||
59799171|NCT00159913|75920207|FG002|NOT COMPLETED|Overall Study||2||
59799172|NCT00159913|75920208|FG003|NOT COMPLETED|Overall Study||2||
59799173|NCT00604188|75920222|FG000|STARTED|Overall Study||93||
59799174|NCT00604188|75920223|FG001|STARTED|Overall Study|The ITT population for Subutex-to-Suboxone Induction is 94 participants|95||
59799175|NCT00604188|75920222|FG000|COMPLETED|Overall Study||66||
59799176|NCT00604188|75920223|FG001|COMPLETED|Overall Study||70||
59799177|NCT00604188|75920222|FG000|NOT COMPLETED|Overall Study||27||
59799178|NCT00604188|75920223|FG001|NOT COMPLETED|Overall Study||25||
59799179|NCT03913377|75920231|FG000|STARTED|Period 1||21||
59799180|NCT03913377|75920232|FG001|STARTED|Period 1||22||
59799181|NCT03913377|75920233|FG002|STARTED|Period 1||22||
59799182|NCT03913377|75920231|FG000|COMPLETED|Period 1||21||
59799183|NCT03913377|75920232|FG001|COMPLETED|Period 1||21||
59799184|NCT03913377|75920233|FG002|COMPLETED|Period 1||21||
59799185|NCT03913377|75920231|FG000|NOT COMPLETED|Period 1||0||
59799186|NCT03913377|75920232|FG001|NOT COMPLETED|Period 1||1||
59799187|NCT03913377|75920233|FG002|NOT COMPLETED|Period 1||1||
59799188|NCT03913377|75920231|FG000|STARTED|Period 2||0||
59799189|NCT03913377|75920232|FG001|STARTED|Period 2||21||
59799190|NCT03913377|75920233|FG002|STARTED|Period 2||21||
59799191|NCT03913377|75920231|FG000|COMPLETED|Period 2||0||
59954478|NCT02767323|76072978|FG001|COMPLETED|Overall Study||17||
59799192|NCT03913377|75920232|FG001|COMPLETED|Period 2||21||
59799193|NCT03913377|75920233|FG002|COMPLETED|Period 2||21||
59799194|NCT03913377|75920231|FG000|NOT COMPLETED|Period 2||0||
59799195|NCT03913377|75920232|FG001|NOT COMPLETED|Period 2||0||
59799196|NCT03913377|75920233|FG002|NOT COMPLETED|Period 2||0||
59799197|NCT00227539|75920240|FG000|STARTED|Overall Study||25||
59799198|NCT00227539|75920240|FG000|COMPLETED|Overall Study||24||
59799199|NCT00227539|75920240|FG000|NOT COMPLETED|Overall Study||1||
59799200|NCT00227305|75920244|FG000|STARTED|Overall Study|enrolled|381||
59799201|NCT00227305|75920244|FG000|Drug Received|Overall Study|safety population|380||
59799202|NCT00227305|75920244|FG000|COMPLETED|Overall Study|Completed 26 weeks|237||
59799203|NCT00227305|75920244|FG000|NOT COMPLETED|Overall Study||144||
59799204|NCT00720941|75920250|FG000|STARTED|Overall Study||557||
59799205|NCT00720941|75920251|FG001|STARTED|Overall Study||553||
59799206|NCT00720941|75920250|FG000|Ongoing|Overall Study||34||
59799207|NCT00720941|75920251|FG001|Ongoing|Overall Study||23||
59799208|NCT00720941|75920250|FG000|COMPLETED|Overall Study||144||
59799209|NCT00720941|75920251|FG001|COMPLETED|Overall Study||138||
59799210|NCT00720941|75920250|FG000|NOT COMPLETED|Overall Study||413||
59799211|NCT00720941|75920251|FG001|NOT COMPLETED|Overall Study||415||
59799212|NCT00585533|75920257|FG000|STARTED|Overall Study||40||
59799213|NCT00585533|75920257|FG000|COMPLETED|Overall Study||31||
59799214|NCT00585533|75920257|FG000|NOT COMPLETED|Overall Study||9||
59799215|NCT00628862|75920264|FG000|STARTED|Overall Study|randomised patients|206||
59799216|NCT00628862|75920265|FG001|STARTED|Overall Study|randomised patients|199||
59954479|NCT02767323|76072979|FG002|COMPLETED|Overall Study||28||
59954480|NCT02767323|76072980|FG003|COMPLETED|Overall Study||1||
59799217|NCT00628862|75920266|FG002|STARTED|Overall Study|randomised patients|208||
59799218|NCT00628862|75920264|FG000|COMPLETED|Overall Study|randomised patients|195||
59799219|NCT00628862|75920265|FG001|COMPLETED|Overall Study|randomised patients|182||
59954481|NCT02767323|76072977|FG000|NOT COMPLETED|Overall Study||34||
59799220|NCT00628862|75920266|FG002|COMPLETED|Overall Study|randomised patients|186||
59799221|NCT00628862|75920264|FG000|NOT COMPLETED|Overall Study||11||
59799222|NCT00628862|75920265|FG001|NOT COMPLETED|Overall Study||17||
59799223|NCT00628862|75920266|FG002|NOT COMPLETED|Overall Study||22||
59799224|NCT00584987|75920278|FG000|STARTED|Overall Study||15||
59799225|NCT00584987|75920279|FG001|STARTED|Overall Study||16||
59799226|NCT00584987|75920280|FG002|STARTED|Overall Study||17||
59799227|NCT00584987|75920281|FG003|STARTED|Overall Study||16||
59799228|NCT00584987|75920278|FG000|COMPLETED|Overall Study||14||
59799229|NCT00584987|75920279|FG001|COMPLETED|Overall Study||15||
59799230|NCT00584987|75920280|FG002|COMPLETED|Overall Study||16||
59799231|NCT00584987|75920281|FG003|COMPLETED|Overall Study||15||
59799232|NCT00584987|75920278|FG000|NOT COMPLETED|Overall Study||1||
59799233|NCT00584987|75920279|FG001|NOT COMPLETED|Overall Study||1||
59799234|NCT00584987|75920280|FG002|NOT COMPLETED|Overall Study||1||
59799235|NCT00584987|75920281|FG003|NOT COMPLETED|Overall Study||1||
59799236|NCT00727961|75920291|FG000|STARTED|Overall Study||58||
59799237|NCT00727961|75920291|FG000|COMPLETED|Overall Study||21||
59799238|NCT00727961|75920291|FG000|NOT COMPLETED|Overall Study||37||
59799239|NCT00568958|75920297|FG000|STARTED|Allocation||70||
59799240|NCT00568958|75920298|FG001|STARTED|Allocation||70||
59799241|NCT00568958|75920297|FG000|COMPLETED|Allocation||61||
59799242|NCT00568958|75920298|FG001|COMPLETED|Allocation||67||
59799243|NCT00568958|75920297|FG000|NOT COMPLETED|Allocation||9||
59799244|NCT00568958|75920298|FG001|NOT COMPLETED|Allocation||3||
59799245|NCT00568958|75920297|FG000|STARTED|Follow-Up||61||
59799246|NCT00568958|75920298|FG001|STARTED|Follow-Up||67||
59799247|NCT00568958|75920297|FG000|COMPLETED|Follow-Up||52||
59799248|NCT00568958|75920298|FG001|COMPLETED|Follow-Up||60||
59799249|NCT00568958|75920297|FG000|NOT COMPLETED|Follow-Up||9||
59799250|NCT00568958|75920298|FG001|NOT COMPLETED|Follow-Up||7||
59799251|NCT00727649|75920306|FG000|STARTED|First Intervention (4-weeks)||37||
59799252|NCT00727649|75920307|FG001|STARTED|First Intervention (4-weeks)||43||
59799253|NCT00727649|75920306|FG000|COMPLETED|First Intervention (4-weeks)||34||
59799254|NCT00727649|75920307|FG001|COMPLETED|First Intervention (4-weeks)||40||
59799255|NCT00727649|75920306|FG000|NOT COMPLETED|First Intervention (4-weeks)||3||
59799256|NCT00727649|75920307|FG001|NOT COMPLETED|First Intervention (4-weeks)||3||
59799257|NCT00727649|75920306|FG000|STARTED|Wash-out (2-weeks)||34||
59799258|NCT00727649|75920307|FG001|STARTED|Wash-out (2-weeks)||40||
59523671|NCT00982865|75618590|FG003|STARTED|Overall Study||34||
59799259|NCT00727649|75920306|FG000|COMPLETED|Wash-out (2-weeks)||30||
59799260|NCT00727649|75920307|FG001|COMPLETED|Wash-out (2-weeks)||37||
59799261|NCT00727649|75920306|FG000|NOT COMPLETED|Wash-out (2-weeks)||4||
59799262|NCT00727649|75920307|FG001|NOT COMPLETED|Wash-out (2-weeks)||3||
59799263|NCT00727649|75920306|FG000|STARTED|Second Intervention (4-weeks)||30||
59799264|NCT00727649|75920307|FG001|STARTED|Second Intervention (4-weeks)||37||
59799265|NCT00727649|75920306|FG000|COMPLETED|Second Intervention (4-weeks)||29||
59799266|NCT00727649|75920307|FG001|COMPLETED|Second Intervention (4-weeks)||34||
59799267|NCT00727649|75920306|FG000|NOT COMPLETED|Second Intervention (4-weeks)||1||
59799268|NCT00727649|75920307|FG001|NOT COMPLETED|Second Intervention (4-weeks)||3||
59799269|NCT00568334|75920317|FG000|STARTED|Overall Study||122||
59799270|NCT00568334|75920318|FG001|STARTED|Overall Study||122||
59799271|NCT00568334|75920317|FG000|COMPLETED|Overall Study||121||
59799272|NCT00568334|75920318|FG001|COMPLETED|Overall Study||121||
59799273|NCT00568334|75920317|FG000|NOT COMPLETED|Overall Study||1||
59799274|NCT00568334|75920318|FG001|NOT COMPLETED|Overall Study||1||
59799275|NCT00727571|75920328|FG000|STARTED|Overall Study||232||
59799276|NCT00727571|75920329|FG001|STARTED|Overall Study||228||
59799277|NCT00727571|75920330|FG002|STARTED|Overall Study||165||
59799278|NCT00727571|75920331|FG003|STARTED|Overall Study||169||
59799279|NCT00727571|75920328|FG000|COMPLETED|Overall Study||231||
59799280|NCT00727571|75920329|FG001|COMPLETED|Overall Study||173||
59799281|NCT00727571|75920330|FG002|COMPLETED|Overall Study||135||
59799282|NCT00727571|75920331|FG003|COMPLETED|Overall Study||163||
59799283|NCT00727571|75920328|FG000|NOT COMPLETED|Overall Study||1||
59799284|NCT00727571|75920329|FG001|NOT COMPLETED|Overall Study||55||
59799285|NCT00727571|75920330|FG002|NOT COMPLETED|Overall Study||30||
59799286|NCT00727571|75920331|FG003|NOT COMPLETED|Overall Study||6||
59799287|NCT00225277|75920343|FG000|STARTED|Overall Study|274 subjects randomized, but four subjects did not receive drug.|274||
59523672|NCT00982865|75618587|FG000|COMPLETED|Overall Study||49||
59799288|NCT00225277|75920344|FG001|STARTED|Overall Study|Mean treatment durations were 56.3 weeks (glimepiride) and 56.5 weeks (pioglitazone).|273||
59799289|NCT00225277|75920343|FG000|COMPLETED|Overall Study||177||
59799290|NCT00225277|75920344|FG001|COMPLETED|Overall Study||178||
59799291|NCT00225277|75920343|FG000|NOT COMPLETED|Overall Study||97||
59799292|NCT00225277|75920344|FG001|NOT COMPLETED|Overall Study||95||
59954482|NCT02767323|76072978|FG001|NOT COMPLETED|Overall Study||25||
59799293|NCT00567996|75920353|FG000|STARTED|Overall Study|Randomized participants|333||
59799294|NCT00567996|75920354|FG001|STARTED|Overall Study||334||
59799295|NCT00567996|75920355|FG002|STARTED|Overall Study||335||
59799296|NCT00567996|75920353|FG000|Intent-to-treat: Received Study Drug|Overall Study||330||
59799297|NCT00567996|75920354|FG001|Intent-to-treat: Received Study Drug|Overall Study||333||
59799298|NCT00567996|75920355|FG002|Intent-to-treat: Received Study Drug|Overall Study||335||
59799299|NCT00567996|75920353|FG000|COMPLETED|Overall Study||289||
59799300|NCT00567996|75920354|FG001|COMPLETED|Overall Study||284||
59799301|NCT00567996|75920355|FG002|COMPLETED|Overall Study||265||
59799302|NCT00567996|75920353|FG000|NOT COMPLETED|Overall Study||44||
59799303|NCT00567996|75920354|FG001|NOT COMPLETED|Overall Study||50||
59799304|NCT00567996|75920355|FG002|NOT COMPLETED|Overall Study||70||
59799305|NCT04388319|75920363|FG000|STARTED|Enrolled in Study||26||
59799306|NCT04388319|75920363|FG000|COMPLETED|Enrolled in Study||24||
59799307|NCT04388319|75920363|FG000|NOT COMPLETED|Enrolled in Study||2||
59799308|NCT04388319|75920363|FG000|STARTED|Treatment Period||24||
59799309|NCT04388319|75920363|FG000|COMPLETED|Treatment Period||23||
59799310|NCT04388319|75920363|FG000|NOT COMPLETED|Treatment Period||1||
59799311|NCT00224887|75920369|FG000|STARTED|Overall Study||154||
59799312|NCT00224887|75920370|FG001|STARTED|Overall Study||153||
59799313|NCT00224887|75920369|FG000|COMPLETED|Overall Study||148||
59799314|NCT00224887|75920370|FG001|COMPLETED|Overall Study||147||
59799315|NCT00224887|75920369|FG000|NOT COMPLETED|Overall Study||6||
59799316|NCT00224887|75920370|FG001|NOT COMPLETED|Overall Study||6||
59799317|NCT00148759|75920378|FG000|STARTED|Overall Study||11||
59799318|NCT00148759|75920379|FG001|STARTED|Overall Study||12||
59799319|NCT00148759|75920378|FG000|24-hr PK Sampling|Overall Study||9||
59799320|NCT00148759|75920379|FG001|24-hr PK Sampling|Overall Study||11||
59799321|NCT00148759|75920378|FG000|COMPLETED|Overall Study||9||
59799322|NCT00148759|75920379|FG001|COMPLETED|Overall Study||11||
59799323|NCT00148759|75920378|FG000|NOT COMPLETED|Overall Study||2||
59799324|NCT00148759|75920379|FG001|NOT COMPLETED|Overall Study||1||
59799325|NCT00717275|75920385|FG000|STARTED|Overall Study||3||
59799326|NCT00717275|75920385|FG000|COMPLETED|Overall Study||0||
59799327|NCT00717275|75920385|FG000|NOT COMPLETED|Overall Study||3||
59799328|NCT00584909|75920389|FG000|STARTED|Overall Study||13||
59799329|NCT00584909|75920389|FG000|COMPLETED|Overall Study||9||
59799330|NCT00584909|75920389|FG000|NOT COMPLETED|Overall Study||4||
59799331|NCT00147823|75920395|FG000|STARTED|Overall Study||32||
59799332|NCT00147823|75920396|FG001|STARTED|Overall Study||31||
59799333|NCT00147823|75920395|FG000|Week 6 Visit|Overall Study||26||
59799334|NCT00147823|75920396|FG001|Week 6 Visit|Overall Study||28||
59799335|NCT00147823|75920395|FG000|Month 3 Visit|Overall Study||25||
59799336|NCT00147823|75920396|FG001|Month 3 Visit|Overall Study||24||
59799337|NCT00147823|75920395|FG000|Month 6 Visit|Overall Study||25||
59799338|NCT00147823|75920396|FG001|Month 6 Visit|Overall Study||21||
59799339|NCT00147823|75920395|FG000|Month 12 Visit|Overall Study||21||
59799340|NCT00147823|75920396|FG001|Month 12 Visit|Overall Study|Subjects are counted at each milestone as that is when data is collectec|25||
59799341|NCT00147823|75920395|FG000|Month 12 CT Scan|Overall Study||20||
59799342|NCT00147823|75920396|FG001|Month 12 CT Scan|Overall Study||25||
59799343|NCT00147823|75920395|FG000|Month 18 Visit|Overall Study|As stated previously ea. subject is counted at each milestone, as data is collected at ea. timepoint|21||
60073739|NCT01610336|76189076|FG006|STARTED|Overall Study||5||
59799344|NCT00147823|75920396|FG001|Month 18 Visit|Overall Study||20||
59799345|NCT00147823|75920395|FG000|Month 24 Visit|Overall Study||21||
59799346|NCT00147823|75920396|FG001|Month 24 Visit|Overall Study||18||
60073740|NCT01610336|76189077|FG007|STARTED|Overall Study||7||
60073741|NCT01610336|76189078|FG008|STARTED|Overall Study||8||
60073742|NCT01610336|76189079|FG009|STARTED|Overall Study||53||
60073743|NCT01610336|76189080|FG010|STARTED|Overall Study||47||
59799347|NCT00147823|75920395|FG000|COMPLETED|Overall Study||19||
59799348|NCT00147823|75920396|FG001|COMPLETED|Overall Study||16||
59799349|NCT00147823|75920395|FG000|NOT COMPLETED|Overall Study||13||
59799350|NCT00147823|75920396|FG001|NOT COMPLETED|Overall Study||15||
59799351|NCT00717197|75920402|FG000|STARTED|Overall Study||30||
59799352|NCT00717197|75920402|FG000|COMPLETED|Overall Study||23||
59799353|NCT00717197|75920402|FG000|NOT COMPLETED|Overall Study||7||
59799354|NCT00147745|75920409|FG000|STARTED|Overall Study||16||
59799355|NCT00147745|75920410|FG001|STARTED|Overall Study||14||
59799356|NCT00147745|75920411|FG002|STARTED|Overall Study||6||
59799357|NCT00147745|75920409|FG000|COMPLETED|Overall Study||15||
59799358|NCT00147745|75920410|FG001|COMPLETED|Overall Study||14||
59799359|NCT00147745|75920411|FG002|COMPLETED|Overall Study||6||
59799360|NCT00147745|75920409|FG000|NOT COMPLETED|Overall Study||1||
59799361|NCT00147745|75920410|FG001|NOT COMPLETED|Overall Study||0||
59799362|NCT00147745|75920411|FG002|NOT COMPLETED|Overall Study||0||
59799363|NCT00642902|75920423|FG000|STARTED|Overall Study||63||
59799364|NCT00642902|75920424|FG001|STARTED|Overall Study||63||
59799365|NCT00642902|75920425|FG002|STARTED|Overall Study||64||
59799366|NCT00642902|75920426|FG003|STARTED|Overall Study||65||
59799367|NCT00642902|75920423|FG000|Treated|Overall Study||63||
60073744|NCT01610336|76189070|FG000|COMPLETED|Overall Study||0||
60073745|NCT01610336|76189071|FG001|COMPLETED|Overall Study||0||
59799368|NCT00642902|75920424|FG001|Treated|Overall Study||63||
59799369|NCT00642902|75920425|FG002|Treated|Overall Study||63||
59799370|NCT00642902|75920426|FG003|Treated|Overall Study||65||
59799371|NCT00642902|75920423|FG000|COMPLETED|Overall Study||23||
59799372|NCT00642902|75920424|FG001|COMPLETED|Overall Study||21||
59799373|NCT00642902|75920425|FG002|COMPLETED|Overall Study||21||
59799374|NCT00642902|75920426|FG003|COMPLETED|Overall Study||25||
59799375|NCT00642902|75920423|FG000|NOT COMPLETED|Overall Study||40||
59799376|NCT00642902|75920424|FG001|NOT COMPLETED|Overall Study||42||
59799377|NCT00642902|75920425|FG002|NOT COMPLETED|Overall Study||43||
59799378|NCT00642902|75920426|FG003|NOT COMPLETED|Overall Study||40||
59799379|NCT00224107|75920438|FG000|STARTED|Overall Study||233||
59799380|NCT00224107|75920439|FG001|STARTED|Overall Study||228||
59799381|NCT00224107|75920438|FG000|COMPLETED|Overall Study||202||
59799382|NCT00224107|75920439|FG001|COMPLETED|Overall Study||214||
59799383|NCT00224107|75920438|FG000|NOT COMPLETED|Overall Study||31||
59799384|NCT00224107|75920439|FG001|NOT COMPLETED|Overall Study||14||
59799385|NCT00720083|75920447|FG000|STARTED|Overall Study||17||
59799386|NCT00720083|75920448|FG001|STARTED|Overall Study||15||
59799387|NCT00720083|75920447|FG000|COMPLETED|Overall Study|Subjects with data for the primary analysis are considered to have completed the study.|16||
59799388|NCT00720083|75920448|FG001|COMPLETED|Overall Study||13||
59799389|NCT00720083|75920447|FG000|NOT COMPLETED|Overall Study||1||
59799390|NCT00720083|75920448|FG001|NOT COMPLETED|Overall Study||2||
59799391|NCT00209131|75920456|FG000|STARTED|Overall Study|Patients enrolled for participation but did not complete the study.|15||
59799392|NCT00209131|75920457|FG001|STARTED|Overall Study|Patients enrolled for participation but did not complete the study.|11||
59799393|NCT00209131|75920456|FG000|COMPLETED|Overall Study|Lack of personnel for adequate followup and data collection.|0||
59799394|NCT00209131|75920457|FG001|COMPLETED|Overall Study|Lack of personnel for adequate followup and data collection.|0||
59799395|NCT00209131|75920456|FG000|NOT COMPLETED|Overall Study||15||
59799396|NCT00209131|75920457|FG001|NOT COMPLETED|Overall Study||11||
59799397|NCT00224029|75920463|FG000|STARTED|Overall Study||24||
59799398|NCT00224029|75920463|FG000|COMPLETED|Overall Study||18||
59799399|NCT00224029|75920463|FG000|NOT COMPLETED|Overall Study||6||
59799400|NCT00223795|75920467|FG000|STARTED|First Intervention - Eight Weeks||26||
59799401|NCT00223795|75920468|FG001|STARTED|First Intervention - Eight Weeks||27||
59799402|NCT00223795|75920467|FG000|COMPLETED|First Intervention - Eight Weeks||19||
59799403|NCT00223795|75920468|FG001|COMPLETED|First Intervention - Eight Weeks||18||
59799404|NCT00223795|75920467|FG000|NOT COMPLETED|First Intervention - Eight Weeks||7||
59799405|NCT00223795|75920468|FG001|NOT COMPLETED|First Intervention - Eight Weeks||9||
59799406|NCT00223795|75920467|FG000|STARTED|Second Intervention - All Use Canes 4 mo||19||
59799407|NCT00223795|75920468|FG001|STARTED|Second Intervention - All Use Canes 4 mo||18||
59799408|NCT00223795|75920467|FG000|COMPLETED|Second Intervention - All Use Canes 4 mo||18||
59799409|NCT00223795|75920468|FG001|COMPLETED|Second Intervention - All Use Canes 4 mo||17||
59799410|NCT00223795|75920467|FG000|NOT COMPLETED|Second Intervention - All Use Canes 4 mo||1||
59799411|NCT00223795|75920468|FG001|NOT COMPLETED|Second Intervention - All Use Canes 4 mo||1||
59799412|NCT00719849|75920477|FG000|STARTED|Overall Study||4||
59799413|NCT00719849|75920478|FG001|STARTED|Overall Study||9||
59799414|NCT00719849|75920477|FG000|COMPLETED|Overall Study||4||
59799415|NCT00719849|75920478|FG001|COMPLETED|Overall Study||8||
59799416|NCT00719849|75920477|FG000|NOT COMPLETED|Overall Study||0||
59799417|NCT00719849|75920478|FG001|NOT COMPLETED|Overall Study||1||
59799418|NCT03907683|75920484|FG000|STARTED|Overall Study||82||
59799419|NCT03907683|75920484|FG000|COMPLETED|Overall Study||80||
59799420|NCT03907683|75920484|FG000|NOT COMPLETED|Overall Study||2||
59799421|NCT00626522|75920494|FG000|STARTED|Overall Study||121||
59799422|NCT00626522|75920495|FG001|STARTED|Overall Study||120||
59799423|NCT00626522|75920496|FG002|STARTED|Overall Study||125||
59799424|NCT00626522|75920497|FG003|STARTED|Overall Study||76||
59799425|NCT00626522|75920498|FG004|STARTED|Overall Study||65||
59799426|NCT00626522|75920499|FG005|STARTED|Overall Study||59||
59799427|NCT00626522|75920494|FG000|COMPLETED|Overall Study||115||
59799428|NCT00626522|75920495|FG001|COMPLETED|Overall Study||113||
59799429|NCT00626522|75920496|FG002|COMPLETED|Overall Study||117||
59799430|NCT00626522|75920497|FG003|COMPLETED|Overall Study||74||
59799431|NCT00626522|75920498|FG004|COMPLETED|Overall Study||58||
59799432|NCT00626522|75920499|FG005|COMPLETED|Overall Study||57||
59799433|NCT00626522|75920494|FG000|NOT COMPLETED|Overall Study||6||
59799434|NCT00626522|75920495|FG001|NOT COMPLETED|Overall Study||7||
59799435|NCT00626522|75920496|FG002|NOT COMPLETED|Overall Study||8||
59799436|NCT00626522|75920497|FG003|NOT COMPLETED|Overall Study||2||
59799437|NCT00626522|75920498|FG004|NOT COMPLETED|Overall Study||7||
59799438|NCT00626522|75920499|FG005|NOT COMPLETED|Overall Study||2||
59799439|NCT03584724|75920515|FG000|STARTED|Overall Study||25||
59799440|NCT03584724|75920516|FG001|STARTED|Overall Study||24||
59799441|NCT03584724|75920515|FG000|COMPLETED|Overall Study||18||
59799442|NCT03584724|75920516|FG001|COMPLETED|Overall Study||23||
59799443|NCT03584724|75920515|FG000|NOT COMPLETED|Overall Study||7||
59799444|NCT03584724|75920516|FG001|NOT COMPLETED|Overall Study||1||
59799445|NCT00540423|75920524|FG000|STARTED|Double-Blind Treatment Period||8||
59799446|NCT00540423|75920525|FG001|STARTED|Double-Blind Treatment Period||15||
59799447|NCT00540423|75920526|FG002|STARTED|Double-Blind Treatment Period||0||
59799448|NCT00540423|75920524|FG000|COMPLETED|Double-Blind Treatment Period||8||
59799449|NCT00540423|75920525|FG001|COMPLETED|Double-Blind Treatment Period||14||
59799450|NCT00540423|75920526|FG002|COMPLETED|Double-Blind Treatment Period||0||
59799451|NCT00540423|75920524|FG000|NOT COMPLETED|Double-Blind Treatment Period||0||
59799452|NCT00540423|75920525|FG001|NOT COMPLETED|Double-Blind Treatment Period||1||
59799453|NCT00540423|75920526|FG002|NOT COMPLETED|Double-Blind Treatment Period||0||
59799454|NCT00540423|75920524|FG000|STARTED|Open-Label Treatment Period||0||
59799455|NCT00540423|75920525|FG001|STARTED|Open-Label Treatment Period||0||
59799456|NCT00540423|75920526|FG002|STARTED|Open-Label Treatment Period||22||
59799457|NCT00540423|75920524|FG000|COMPLETED|Open-Label Treatment Period||0||
59799458|NCT00540423|75920525|FG001|COMPLETED|Open-Label Treatment Period||0||
59799459|NCT00540423|75920526|FG002|COMPLETED|Open-Label Treatment Period||20||
59799460|NCT00540423|75920524|FG000|NOT COMPLETED|Open-Label Treatment Period||0||
59799461|NCT00540423|75920525|FG001|NOT COMPLETED|Open-Label Treatment Period||0||
59799462|NCT00540423|75920526|FG002|NOT COMPLETED|Open-Label Treatment Period||2||
59799463|NCT00566982|75920546|FG000|STARTED|Overall Study||63||
59799464|NCT00566982|75920547|FG001|STARTED|Overall Study||363||
59799465|NCT00566982|75920546|FG000|COMPLETED|Overall Study||55||
59799466|NCT00566982|75920547|FG001|COMPLETED|Overall Study||294||
59799467|NCT00566982|75920546|FG000|NOT COMPLETED|Overall Study||8||
59799468|NCT00566982|75920547|FG001|NOT COMPLETED|Overall Study||69||
59799469|NCT00624338|75920559|FG000|STARTED|Overall Study||159||
59799470|NCT00624338|75920560|FG001|STARTED|Overall Study||145||
59799471|NCT00624338|75920561|FG002|STARTED|Overall Study||157||
59799472|NCT00624338|75920559|FG000|Treated|Overall Study||157||
59799473|NCT00624338|75920560|FG001|Treated|Overall Study||144||
59799474|NCT00624338|75920561|FG002|Treated|Overall Study||154||
59799475|NCT00624338|75920559|FG000|COMPLETED|Overall Study||112||
59799476|NCT00624338|75920560|FG001|COMPLETED|Overall Study||62||
59799477|NCT00624338|75920561|FG002|COMPLETED|Overall Study||111||
59799478|NCT00624338|75920559|FG000|NOT COMPLETED|Overall Study||47||
59799479|NCT00624338|75920560|FG001|NOT COMPLETED|Overall Study||83||
59799480|NCT00624338|75920561|FG002|NOT COMPLETED|Overall Study||46||
59799481|NCT03977454|75920571|FG000|STARTED|Overall Study||97||
59799482|NCT03977454|75920572|FG001|STARTED|Overall Study||95||
59799483|NCT03977454|75920571|FG000|COMPLETED|Overall Study||95||
59799484|NCT03977454|75920572|FG001|COMPLETED|Overall Study||93||
59799485|NCT03977454|75920571|FG000|NOT COMPLETED|Overall Study||2||
59799486|NCT03977454|75920572|FG001|NOT COMPLETED|Overall Study||2||
59799487|NCT00538785|75920580|FG000|STARTED|Overall Study|A subject was randomized without appropriate consent in France and is not included in the results.|623||
59799488|NCT00538785|75920581|FG001|STARTED|Overall Study||612||
59799489|NCT00538785|75920580|FG000|COMPLETED|Overall Study||604||
59799490|NCT00538785|75920581|FG001|COMPLETED|Overall Study||595||
59799491|NCT00538785|75920580|FG000|NOT COMPLETED|Overall Study||19||
59799492|NCT00538785|75920581|FG001|NOT COMPLETED|Overall Study||17||
59799493|NCT00538629|75920587|FG000|STARTED|Overall Study||471||
59799494|NCT00538629|75920587|FG000|COMPLETED|Overall Study||449||
59799495|NCT00538629|75920587|FG000|NOT COMPLETED|Overall Study||22||
59799496|NCT00622700|75920594|FG000|STARTED|Core Treatment Period||197||
59799497|NCT00622700|75920595|FG001|STARTED|Core Treatment Period||205||
59799498|NCT00622700|75920596|FG002|STARTED|Core Treatment Period||216||
59799499|NCT00622700|75920597|FG003|STARTED|Core Treatment Period||0||
59799500|NCT00622700|75920598|FG004|STARTED|Core Treatment Period||0||
59799501|NCT00622700|75920599|FG005|STARTED|Core Treatment Period||0||
59799502|NCT00622700|75920600|FG006|STARTED|Core Treatment Period||0||
59799503|NCT00622700|75920594|FG000|Treated|Core Treatment Period||197||
59799504|NCT00622700|75920595|FG001|Treated|Core Treatment Period||203||
59799505|NCT00622700|75920596|FG002|Treated|Core Treatment Period||214||
59799506|NCT00622700|75920597|FG003|Treated|Core Treatment Period||0||
59799507|NCT00622700|75920598|FG004|Treated|Core Treatment Period||0||
59799508|NCT00622700|75920599|FG005|Treated|Core Treatment Period||0||
59799509|NCT00622700|75920600|FG006|Treated|Core Treatment Period||0||
59799510|NCT00622700|75920594|FG000|COMPLETED|Core Treatment Period||141||
59799511|NCT00622700|75920595|FG001|COMPLETED|Core Treatment Period||150||
59799512|NCT00622700|75920596|FG002|COMPLETED|Core Treatment Period||163||
59799513|NCT00622700|75920597|FG003|COMPLETED|Core Treatment Period||0||
59799514|NCT00622700|75920598|FG004|COMPLETED|Core Treatment Period||0||
59799515|NCT00622700|75920599|FG005|COMPLETED|Core Treatment Period||0||
59799516|NCT00622700|75920600|FG006|COMPLETED|Core Treatment Period||0||
59799517|NCT00622700|75920594|FG000|NOT COMPLETED|Core Treatment Period||56||
59799518|NCT00622700|75920595|FG001|NOT COMPLETED|Core Treatment Period||55||
59799519|NCT00622700|75920596|FG002|NOT COMPLETED|Core Treatment Period||53||
59799520|NCT00622700|75920597|FG003|NOT COMPLETED|Core Treatment Period||0||
59799521|NCT00622700|75920598|FG004|NOT COMPLETED|Core Treatment Period||0||
59799522|NCT00622700|75920599|FG005|NOT COMPLETED|Core Treatment Period||0||
59799523|NCT00622700|75920600|FG006|NOT COMPLETED|Core Treatment Period||0||
59799524|NCT00622700|75920594|FG000|STARTED|Extension Treatment Period|Participants were re-randomized in a 1:1 ratio to either teriflunomide 7 mg or 14 mg treatment arm.|0||
59799525|NCT00622700|75920595|FG001|STARTED|Extension Treatment Period||0||
59799526|NCT00622700|75920596|FG002|STARTED|Extension Treatment Period||0||
59799527|NCT00622700|75920597|FG003|STARTED|Extension Treatment Period|10 participants completed core treatment period but did not enter in extension treatment period.|64||
59799528|NCT00622700|75920598|FG004|STARTED|Extension Treatment Period|8 participants completed core treatment period but did not enter in extension treatment period.|142||
59799529|NCT00622700|75920599|FG005|STARTED|Extension Treatment Period|10 participants completed core treatment period but did not enter in extension treatment period.|67||
59799530|NCT00622700|75920600|FG006|STARTED|Extension Treatment Period|13 participants completed core treatment period but did not enter in extension treatment period.|150||
59799531|NCT00622700|75920594|FG000|COMPLETED|Extension Treatment Period||0||
59799532|NCT00622700|75920595|FG001|COMPLETED|Extension Treatment Period||0||
59799533|NCT00622700|75920596|FG002|COMPLETED|Extension Treatment Period||0||
59799534|NCT00622700|75920597|FG003|COMPLETED|Extension Treatment Period||43||
59799535|NCT00622700|75920598|FG004|COMPLETED|Extension Treatment Period||103||
59799536|NCT00622700|75920599|FG005|COMPLETED|Extension Treatment Period||50||
59799537|NCT00622700|75920600|FG006|COMPLETED|Extension Treatment Period||120||
59799538|NCT00622700|75920594|FG000|NOT COMPLETED|Extension Treatment Period||0||
59799539|NCT00622700|75920595|FG001|NOT COMPLETED|Extension Treatment Period||0||
59799540|NCT00622700|75920596|FG002|NOT COMPLETED|Extension Treatment Period||0||
59799541|NCT00622700|75920597|FG003|NOT COMPLETED|Extension Treatment Period||21||
59799542|NCT00622700|75920598|FG004|NOT COMPLETED|Extension Treatment Period||39||
59799543|NCT00622700|75920599|FG005|NOT COMPLETED|Extension Treatment Period||17||
59799544|NCT00622700|75920600|FG006|NOT COMPLETED|Extension Treatment Period||30||
59799545|NCT00538473|75920619|FG000|STARTED|Overall Study||33||
59799546|NCT00538473|75920620|FG001|STARTED|Overall Study||35||
59799547|NCT00538473|75920619|FG000|COMPLETED|Overall Study||32||
59799548|NCT00538473|75920620|FG001|COMPLETED|Overall Study||35||
59799549|NCT00538473|75920619|FG000|NOT COMPLETED|Overall Study||1||
59799550|NCT00538473|75920620|FG001|NOT COMPLETED|Overall Study||0||
59799551|NCT00622466|75920626|FG000|STARTED|Overall Study||20||
59799552|NCT00622466|75920626|FG000|COMPLETED|Overall Study||16||
59799553|NCT00622466|75920626|FG000|NOT COMPLETED|Overall Study||4||
59799554|NCT00537771|75920632|FG000|STARTED|Overall Study||178||
59799555|NCT00537771|75920633|FG001|STARTED|Overall Study||175||
59799556|NCT00537771|75920632|FG000|COMPLETED|Overall Study||149||
59799557|NCT00537771|75920633|FG001|COMPLETED|Overall Study||114||
59799558|NCT00537771|75920632|FG000|NOT COMPLETED|Overall Study||29||
59799559|NCT00537771|75920633|FG001|NOT COMPLETED|Overall Study||61||
59799560|NCT00623480|75920641|FG000|STARTED|Overall Study||42||
59799561|NCT00623480|75920642|FG001|STARTED|Overall Study||42||
59799562|NCT00623480|75920641|FG000|COMPLETED|Overall Study||35||
59799563|NCT00623480|75920642|FG001|COMPLETED|Overall Study||35||
59799564|NCT00623480|75920641|FG000|NOT COMPLETED|Overall Study||7||
59799565|NCT00623480|75920642|FG001|NOT COMPLETED|Overall Study||7||
59799566|NCT02513667|75920650|FG000|STARTED|Overall Study||8||
59799567|NCT02513667|75920651|FG001|STARTED|Overall Study||6||
59799568|NCT02513667|75920650|FG000|COMPLETED|Overall Study||8||
59799569|NCT02513667|75920651|FG001|COMPLETED|Overall Study||5||
59799570|NCT02513667|75920650|FG000|NOT COMPLETED|Overall Study||0||
59799571|NCT02513667|75920651|FG001|NOT COMPLETED|Overall Study||1||
59799572|NCT03823911|75920660|FG000|STARTED|Overall Study||43||
59799573|NCT03823911|75920661|FG001|STARTED|Overall Study||37||
59799574|NCT03823911|75920662|FG002|STARTED|Overall Study||7||
59799575|NCT03823911|75920660|FG000|COMPLETED|Overall Study||29||
59799576|NCT03823911|75920661|FG001|COMPLETED|Overall Study||24||
59799577|NCT03823911|75920662|FG002|COMPLETED|Overall Study||1||
59799578|NCT03823911|75920660|FG000|NOT COMPLETED|Overall Study||14||
59799579|NCT03823911|75920661|FG001|NOT COMPLETED|Overall Study||13||
59799580|NCT03823911|75920662|FG002|NOT COMPLETED|Overall Study||6||
59799581|NCT00621764|75920673|FG000|STARTED|Overall Study||50||
59799582|NCT00621764|75920674|FG001|STARTED|Overall Study||50||
59799583|NCT00621764|75920675|FG002|STARTED|Overall Study||101||
59799584|NCT00621764|75920676|FG003|STARTED|Overall Study||99||
59799585|NCT00621764|75920673|FG000|COMPLETED|Overall Study||50||
59799586|NCT00621764|75920674|FG001|COMPLETED|Overall Study||50||
59799587|NCT00621764|75920675|FG002|COMPLETED|Overall Study||101||
59799588|NCT00621764|75920676|FG003|COMPLETED|Overall Study||98||
59799589|NCT00621764|75920673|FG000|NOT COMPLETED|Overall Study||0||
59799590|NCT00621764|75920674|FG001|NOT COMPLETED|Overall Study||0||
59799591|NCT00621764|75920675|FG002|NOT COMPLETED|Overall Study||0||
59799592|NCT00621764|75920676|FG003|NOT COMPLETED|Overall Study||1||
59799593|NCT00510718|75920694|FG000|STARTED|Single Dose Period: 1 Week||15||
59799594|NCT00510718|75920695|FG001|STARTED|Single Dose Period: 1 Week||12||
59799595|NCT00510718|75920694|FG000|30 mg/Day|Single Dose Period: 1 Week||3||
59799596|NCT00510718|75920695|FG001|30 mg/Day|Single Dose Period: 1 Week||0||
59799597|NCT00510718|75920694|FG000|60 mg/Day|Single Dose Period: 1 Week||3||
59799598|NCT00510718|75920695|FG001|60 mg/Day|Single Dose Period: 1 Week||0||
59799599|NCT00510718|75920694|FG000|150/160 mg/Day|Single Dose Period: 1 Week||2||
59799600|NCT00510718|75920695|FG001|150/160 mg/Day|Single Dose Period: 1 Week||1||
59799601|NCT00510718|75920694|FG000|240 mg/Day|Single Dose Period: 1 Week||3||
59799602|NCT00510718|75920695|FG001|240 mg/Day|Single Dose Period: 1 Week||0||
59799603|NCT00510718|75920694|FG000|360 mg/Day|Single Dose Period: 1 Week||4||
59799604|NCT00510718|75920695|FG001|360 mg/Day|Single Dose Period: 1 Week||2||
59799605|NCT00510718|75920694|FG000|480 mg/Day|Single Dose Period: 1 Week||0||
59799606|NCT00510718|75920695|FG001|480 mg/Day|Single Dose Period: 1 Week||6||
59799607|NCT00510718|75920694|FG000|600 mg/Day|Single Dose Period: 1 Week||0||
59799608|NCT00510718|75920695|FG001|600 mg/Day|Single Dose Period: 1 Week||3||
59799609|NCT00510718|75920694|FG000|COMPLETED|Single Dose Period: 1 Week||15||
59799610|NCT00510718|75920695|FG001|COMPLETED|Single Dose Period: 1 Week||12||
59799611|NCT00510718|75920694|FG000|NOT COMPLETED|Single Dose Period: 1 Week||0||
59799612|NCT00510718|75920695|FG001|NOT COMPLETED|Single Dose Period: 1 Week||0||
59799613|NCT00510718|75920694|FG000|STARTED|Multiple Dose Period: 12 Weeks|Participants who completed single dose period + new participants enrolled in multiple dose period.|65||
59799614|NCT00510718|75920695|FG001|STARTED|Multiple Dose Period: 12 Weeks|Participants who completed single dose period + new participants enrolled in multiple dose period.|75||
59799615|NCT00510718|75920694|FG000|30 mg/Day|Multiple Dose Period: 12 Weeks||3||
59799616|NCT00510718|75920695|FG001|30 mg/Day|Multiple Dose Period: 12 Weeks||0||
59799617|NCT00510718|75920694|FG000|60 mg/Day|Multiple Dose Period: 12 Weeks||15||
59799618|NCT00510718|75920695|FG001|60 mg/Day|Multiple Dose Period: 12 Weeks||12||
59799619|NCT00510718|75920694|FG000|150/160 mg/Day|Multiple Dose Period: 12 Weeks||15||
59799620|NCT00510718|75920695|FG001|150/160 mg/Day|Multiple Dose Period: 12 Weeks||13||
59799621|NCT00510718|75920694|FG000|240 mg/Day|Multiple Dose Period: 12 Weeks||17||
59799622|NCT00510718|75920695|FG001|240 mg/Day|Multiple Dose Period: 12 Weeks||12||
59799623|NCT00510718|75920694|FG000|360 mg/Day|Multiple Dose Period: 12 Weeks||15||
59799624|NCT00510718|75920695|FG001|360 mg/Day|Multiple Dose Period: 12 Weeks||13||
59799625|NCT00510718|75920694|FG000|480 mg/Day|Multiple Dose Period: 12 Weeks||0||
59799626|NCT00510718|75920695|FG001|480 mg/Day|Multiple Dose Period: 12 Weeks||22||
59799627|NCT00510718|75920694|FG000|600 mg/Day|Multiple Dose Period: 12 Weeks||0||
59799628|NCT00510718|75920695|FG001|600 mg/Day|Multiple Dose Period: 12 Weeks||3||
59799629|NCT00510718|75920694|FG000|COMPLETED|Multiple Dose Period: 12 Weeks||50||
59799630|NCT00510718|75920695|FG001|COMPLETED|Multiple Dose Period: 12 Weeks||43||
59799631|NCT00510718|75920694|FG000|NOT COMPLETED|Multiple Dose Period: 12 Weeks||15||
59799632|NCT00510718|75920695|FG001|NOT COMPLETED|Multiple Dose Period: 12 Weeks||32||
59799633|NCT00537381|75920716|FG000|STARTED|Overall Study|11 Participants after disease progression switched to intetumumab alone (2) or D+P+ Intetumumab (9).|65||
59799634|NCT00537381|75920717|FG001|STARTED|Overall Study||66||
59799635|NCT00537381|75920716|FG000|COMPLETED|Overall Study||9||
59799636|NCT00537381|75920717|FG001|COMPLETED|Overall Study||4||
59799637|NCT00537381|75920716|FG000|NOT COMPLETED|Overall Study||56||
59799638|NCT00537381|75920717|FG001|NOT COMPLETED|Overall Study||62||
59799639|NCT03791398|75920728|FG000|STARTED|Overall Study||13||
59799640|NCT03791398|75920729|FG001|STARTED|Overall Study||0||
59799641|NCT03791398|75920730|FG002|STARTED|Overall Study||0||
59799642|NCT03791398|75920728|FG000|COMPLETED|Overall Study||11||
59799643|NCT03791398|75920729|FG001|COMPLETED|Overall Study||0||
59799644|NCT03791398|75920730|FG002|COMPLETED|Overall Study||0||
59799645|NCT03791398|75920728|FG000|NOT COMPLETED|Overall Study||2||
59799646|NCT03791398|75920729|FG001|NOT COMPLETED|Overall Study||0||
59799647|NCT03791398|75920730|FG002|NOT COMPLETED|Overall Study||0||
59799648|NCT00517192|75920736|FG000|STARTED|Overall Study||19||
59799649|NCT00517192|75920737|FG001|STARTED|Overall Study||20||
59799650|NCT00517192|75920736|FG000|COMPLETED|Overall Study||0||
59799651|NCT00517192|75920737|FG001|COMPLETED|Overall Study||0||
59799652|NCT00517192|75920736|FG000|NOT COMPLETED|Overall Study||19||
59799653|NCT00517192|75920737|FG001|NOT COMPLETED|Overall Study||20||
59799654|NCT00625820|75920743|FG000|STARTED|Overall Study||17||
60073746|NCT01610336|76189072|FG002|COMPLETED|Overall Study||0||
60073747|NCT01610336|76189073|FG003|COMPLETED|Overall Study||0||
60073748|NCT01610336|76189074|FG004|COMPLETED|Overall Study||0||
60073749|NCT01610336|76189075|FG005|COMPLETED|Overall Study||0||
60073750|NCT01610336|76189076|FG006|COMPLETED|Overall Study||0||
60073751|NCT01610336|76189077|FG007|COMPLETED|Overall Study||0||
60073752|NCT01610336|76189078|FG008|COMPLETED|Overall Study||0||
60073753|NCT01610336|76189079|FG009|COMPLETED|Overall Study||0||
60073754|NCT01610336|76189080|FG010|COMPLETED|Overall Study||0||
59799655|NCT00625820|75920743|FG000|COMPLETED|Overall Study||16||
59799656|NCT00625820|75920743|FG000|NOT COMPLETED|Overall Study||1||
59799657|NCT00145327|75920751|FG000|STARTED|Overall Study|Group Z6 and Group Z3P3 have randomized participants.|616||
59799658|NCT00145327|75920752|FG001|STARTED|Overall Study||617||
59799659|NCT00145327|75920753|FG002|STARTED|Overall Study|Group P3Z3 have non-randomized participants|1223||
59799660|NCT00145327|75920751|FG000|COMPLETED|Overall Study||474||
59799661|NCT00145327|75920752|FG001|COMPLETED|Overall Study||493||
59799662|NCT00145327|75920753|FG002|COMPLETED|Overall Study||975||
59799663|NCT00145327|75920751|FG000|NOT COMPLETED|Overall Study||142||
59799664|NCT00145327|75920752|FG001|NOT COMPLETED|Overall Study||124||
59799665|NCT00145327|75920753|FG002|NOT COMPLETED|Overall Study||248||
59799666|NCT00510484|75920763|FG000|STARTED|Period 1||16||
60073755|NCT01610336|76189070|FG000|NOT COMPLETED|Overall Study||5||
60073756|NCT01610336|76189071|FG001|NOT COMPLETED|Overall Study||7||
59799667|NCT00510484|75920764|FG001|STARTED|Period 1||16||
59799668|NCT00510484|75920763|FG000|COMPLETED|Period 1||16||
59799669|NCT00510484|75920764|FG001|COMPLETED|Period 1||16||
59799670|NCT00510484|75920763|FG000|NOT COMPLETED|Period 1||0||
59799671|NCT00510484|75920764|FG001|NOT COMPLETED|Period 1||0||
59799672|NCT00510484|75920763|FG000|STARTED|Wash-out Period||16||
59799673|NCT00510484|75920764|FG001|STARTED|Wash-out Period||16||
59799674|NCT00510484|75920763|FG000|COMPLETED|Wash-out Period||16||
59799675|NCT00510484|75920764|FG001|COMPLETED|Wash-out Period||15||
59799676|NCT00510484|75920763|FG000|NOT COMPLETED|Wash-out Period||0||
59799677|NCT00510484|75920764|FG001|NOT COMPLETED|Wash-out Period||1||
59799678|NCT00510484|75920763|FG000|STARTED|Period 2||16||
59799679|NCT00510484|75920764|FG001|STARTED|Period 2||15||
59799680|NCT00510484|75920763|FG000|COMPLETED|Period 2||16||
59799681|NCT00510484|75920764|FG001|COMPLETED|Period 2||15||
59799682|NCT00510484|75920763|FG000|NOT COMPLETED|Period 2||0||
59799683|NCT00510484|75920764|FG001|NOT COMPLETED|Period 2||0||
59799684|NCT00622388|75920770|FG000|STARTED|Overall Study||81||
59799685|NCT00622388|75920770|FG000|COMPLETED|Overall Study||9||
59799686|NCT00622388|75920770|FG000|NOT COMPLETED|Overall Study||72||
59799687|NCT01156389|75920777|FG000|STARTED|Overall Study||17||
59799688|NCT01156389|75920778|FG001|STARTED|Overall Study||17||
59799689|NCT01156389|75920777|FG000|COMPLETED|Overall Study||13||
59799690|NCT01156389|75920778|FG001|COMPLETED|Overall Study||16||
59799691|NCT01156389|75920777|FG000|NOT COMPLETED|Overall Study||4||
59799692|NCT01156389|75920778|FG001|NOT COMPLETED|Overall Study||1||
59799693|NCT01105767|75920787|FG000|STARTED|Overall Study||9315||
59799694|NCT01105767|75920788|FG001|STARTED|Overall Study||10864||
59799695|NCT01105767|75920789|FG002|STARTED|Overall Study||10030||
59799696|NCT01105767|75920787|FG000|COMPLETED|Overall Study||8155||
59799697|NCT01105767|75920788|FG001|COMPLETED|Overall Study||9250||
59799698|NCT01105767|75920789|FG002|COMPLETED|Overall Study||8846||
59799699|NCT01105767|75920787|FG000|NOT COMPLETED|Overall Study||1160||
59799700|NCT01105767|75920788|FG001|NOT COMPLETED|Overall Study||1614||
59799701|NCT01105767|75920789|FG002|NOT COMPLETED|Overall Study||1184||
59799702|NCT03693430|75920799|FG000|STARTED|Overall Study||152||
59799703|NCT03693430|75920800|FG001|STARTED|Overall Study||152||
59799704|NCT03693430|75920799|FG000|Full Analysis Set (FAS)|Overall Study||152||
59799705|NCT03693430|75920800|FG001|Full Analysis Set (FAS)|Overall Study||152||
59799706|NCT03693430|75920799|FG000|Safety Analysis Set (SAS)|Overall Study||152||
59799707|NCT03693430|75920800|FG001|Safety Analysis Set (SAS)|Overall Study||152||
59954483|NCT02767323|76072979|FG002|NOT COMPLETED|Overall Study||30||
59954484|NCT02767323|76072980|FG003|NOT COMPLETED|Overall Study||0||
59954485|NCT04304950|76072995|FG000|STARTED|Overall Study||19||
59954486|NCT04304950|76072996|FG001|STARTED|Overall Study||9||
59954487|NCT04304950|76072995|FG000|COMPLETED|Overall Study||18||
59954488|NCT04304950|76072996|FG001|COMPLETED|Overall Study||8||
59954489|NCT04304950|76072995|FG000|NOT COMPLETED|Overall Study||1||
59799708|NCT03693430|75920799|FG000|COMPLETED|Overall Study||148||
59799709|NCT03693430|75920800|FG001|COMPLETED|Overall Study||134||
59799710|NCT03693430|75920799|FG000|NOT COMPLETED|Overall Study||4||
59799711|NCT03693430|75920800|FG001|NOT COMPLETED|Overall Study||18||
59799712|NCT00625742|75920806|FG000|STARTED|Overall Study||15||
59799713|NCT00625742|75920806|FG000|COMPLETED|Overall Study||3||
59954490|NCT04304950|76072996|FG001|NOT COMPLETED|Overall Study||1||
59954491|NCT02780115|76073010|FG000|STARTED|Overall Study||28||
59954492|NCT02780115|76073011|FG001|STARTED|Overall Study||30||
59954493|NCT02780115|76073012|FG002|STARTED|Overall Study||30||
59954494|NCT02780115|76073013|FG003|STARTED|Overall Study||32||
59954495|NCT02780115|76073014|FG004|STARTED|Overall Study||31||
59954496|NCT02780115|76073010|FG000|COMPLETED|Overall Study||28||
59523673|NCT00982865|75618588|FG001|COMPLETED|Overall Study||82||
59523674|NCT00982865|75618589|FG002|COMPLETED|Overall Study||15||
59523675|NCT00982865|75618590|FG003|COMPLETED|Overall Study||34||
59523676|NCT00982865|75618587|FG000|NOT COMPLETED|Overall Study||0||
59523677|NCT00982865|75618588|FG001|NOT COMPLETED|Overall Study||0||
59523678|NCT00982865|75618589|FG002|NOT COMPLETED|Overall Study||0||
59523679|NCT00982865|75618590|FG003|NOT COMPLETED|Overall Study||0||
59523680|NCT01226719|75618637|FG000|STARTED|Overall Study||15||
59523681|NCT01226719|75618637|FG000|COMPLETED|Overall Study|Completed = patient is surgical candidate, underwent resection, received treatment to week 24.|2||
59523682|NCT01226719|75618637|FG000|NOT COMPLETED|Overall Study||13||
59799714|NCT00625742|75920806|FG000|NOT COMPLETED|Overall Study||12||
59799715|NCT01888653|75920812|FG000|STARTED|Overall Study||24||
59799716|NCT01888653|75920813|FG001|STARTED|Overall Study||26||
59799717|NCT01888653|75920812|FG000|COMPLETED|Overall Study||24||
59799718|NCT01888653|75920813|FG001|COMPLETED|Overall Study||26||
59799719|NCT01888653|75920812|FG000|NOT COMPLETED|Overall Study||0||
59799720|NCT01888653|75920813|FG001|NOT COMPLETED|Overall Study||0||
59799721|NCT00621296|75920819|FG000|STARTED|Overall Study||15||
59799722|NCT00621296|75920819|FG000|COMPLETED|Overall Study||1||
59799723|NCT00621296|75920819|FG000|NOT COMPLETED|Overall Study||14||
59799724|NCT00537303|75920825|FG000|STARTED|Overall Study||146||
59799725|NCT00537303|75920826|FG001|STARTED|Overall Study||150||
59799726|NCT00537303|75920825|FG000|COMPLETED|Overall Study||120||
59799727|NCT00537303|75920826|FG001|COMPLETED|Overall Study||125||
59799728|NCT00537303|75920825|FG000|NOT COMPLETED|Overall Study||26||
59799729|NCT00537303|75920826|FG001|NOT COMPLETED|Overall Study||25||
59799730|NCT00505414|75920834|FG000|STARTED|Titration Phase||0||
59954497|NCT02780115|76073011|FG001|COMPLETED|Overall Study||29||
59799731|NCT00505414|75920835|FG001|STARTED|Titration Phase||0||
59799732|NCT00505414|75920836|FG002|STARTED|Titration Phase||0||
59799733|NCT00505414|75920837|FG003|STARTED|Titration Phase||62||
59799734|NCT00505414|75920838|FG004|STARTED|Titration Phase||31||
59799735|NCT00505414|75920834|FG000|COMPLETED|Titration Phase||0||
59799736|NCT00505414|75920835|FG001|COMPLETED|Titration Phase||0||
59799737|NCT00505414|75920836|FG002|COMPLETED|Titration Phase||0||
59799738|NCT00505414|75920837|FG003|COMPLETED|Titration Phase||32||
59799739|NCT00505414|75920838|FG004|COMPLETED|Titration Phase||19||
59799740|NCT00505414|75920834|FG000|NOT COMPLETED|Titration Phase||0||
59799741|NCT00505414|75920835|FG001|NOT COMPLETED|Titration Phase||0||
59799742|NCT00505414|75920836|FG002|NOT COMPLETED|Titration Phase||0||
59799743|NCT00505414|75920837|FG003|NOT COMPLETED|Titration Phase||30||
59799744|NCT00505414|75920838|FG004|NOT COMPLETED|Titration Phase||12||
59799745|NCT00505414|75920834|FG000|STARTED|Maintenance Phase|18 of the 19 morphine participants continued with morphine in the maintenance phase.|18||
59799746|NCT00505414|75920835|FG001|STARTED|Maintenance Phase|15 of 32 tapentadol titration participants continued with tapentadol in the maintenance phase|15||
59799747|NCT00505414|75920836|FG002|STARTED|Maintenance Phase|14 of 32 tapentadol titration participants were treated with placebo in the maintenance phase.|14||
59799748|NCT00505414|75920837|FG003|STARTED|Maintenance Phase|29 of 32 participants were treated in the maintenance phase either with placebo or tapentadol|0||
59799749|NCT00505414|75920838|FG004|STARTED|Maintenance Phase|18 of 19 participants completing the morphine titration phase were continued on morphine.|0||
59799750|NCT00505414|75920834|FG000|Did Not Qualify for Maintenance Phase|Maintenance Phase||0||
59799751|NCT00505414|75920835|FG001|Did Not Qualify for Maintenance Phase|Maintenance Phase||0||
59799752|NCT00505414|75920836|FG002|Did Not Qualify for Maintenance Phase|Maintenance Phase||0||
59799753|NCT00505414|75920837|FG003|Did Not Qualify for Maintenance Phase|Maintenance Phase||3||
59799754|NCT00505414|75920838|FG004|Did Not Qualify for Maintenance Phase|Maintenance Phase||1||
59799755|NCT00505414|75920834|FG000|COMPLETED|Maintenance Phase||12||
59799756|NCT00505414|75920835|FG001|COMPLETED|Maintenance Phase||10||
59799757|NCT00505414|75920836|FG002|COMPLETED|Maintenance Phase||6||
59799758|NCT00505414|75920837|FG003|COMPLETED|Maintenance Phase||0||
59799759|NCT00505414|75920838|FG004|COMPLETED|Maintenance Phase||0||
59799760|NCT00505414|75920834|FG000|NOT COMPLETED|Maintenance Phase||6||
59799761|NCT00505414|75920835|FG001|NOT COMPLETED|Maintenance Phase||5||
59799762|NCT00505414|75920836|FG002|NOT COMPLETED|Maintenance Phase||8||
59799763|NCT00505414|75920837|FG003|NOT COMPLETED|Maintenance Phase||0||
60073757|NCT01610336|76189072|FG002|NOT COMPLETED|Overall Study||6||
59799764|NCT00505414|75920838|FG004|NOT COMPLETED|Maintenance Phase||0||
59799765|NCT01813227|75920850|FG000|STARTED|Overall Study||7||
59799766|NCT01813227|75920850|FG000|COMPLETED|Overall Study||7||
59799767|NCT01813227|75920850|FG000|NOT COMPLETED|Overall Study||0||
59799768|NCT01683825|75920857|FG000|STARTED|Overall Study||10||
59799769|NCT01683825|75920858|FG001|STARTED|Overall Study||6||
59799770|NCT01683825|75920859|FG002|STARTED|Overall Study||7||
59799771|NCT01683825|75920857|FG000|COMPLETED|Overall Study||10||
59799772|NCT01683825|75920858|FG001|COMPLETED|Overall Study||6||
59799773|NCT01683825|75920859|FG002|COMPLETED|Overall Study||7||
59799774|NCT01683825|75920857|FG000|NOT COMPLETED|Overall Study||0||
59799775|NCT01683825|75920858|FG001|NOT COMPLETED|Overall Study||0||
59799776|NCT01683825|75920859|FG002|NOT COMPLETED|Overall Study||0||
59799777|NCT00144781|75920872|FG000|STARTED|Overall Study||8||
59799778|NCT00144781|75920873|FG001|STARTED|Overall Study||9||
59799779|NCT00144781|75920874|FG002|STARTED|Overall Study||8||
59799780|NCT00144781|75920875|FG003|STARTED|Overall Study||9||
59799781|NCT00144781|75920872|FG000|COMPLETED|Overall Study||8||
59799782|NCT00144781|75920873|FG001|COMPLETED|Overall Study||7||
59799783|NCT00144781|75920874|FG002|COMPLETED|Overall Study||8||
59799784|NCT00144781|75920875|FG003|COMPLETED|Overall Study||9||
59799785|NCT00144781|75920872|FG000|NOT COMPLETED|Overall Study||0||
60073758|NCT01610336|76189073|FG003|NOT COMPLETED|Overall Study||7||
59799786|NCT00144781|75920873|FG001|NOT COMPLETED|Overall Study||2||
59799787|NCT00144781|75920874|FG002|NOT COMPLETED|Overall Study||0||
59799788|NCT00144781|75920875|FG003|NOT COMPLETED|Overall Study||0||
59799789|NCT05300295|75920885|FG000|STARTED|Overall Study||13||
59799790|NCT05300295|75920885|FG000|COMPLETED|Overall Study||13||
59799791|NCT05300295|75920885|FG000|NOT COMPLETED|Overall Study||0||
59799792|NCT00621140|75920891|FG000|STARTED|Overall Study|number who started treatment|167||
59799793|NCT00621140|75920892|FG001|STARTED|Overall Study|number who started treatment|336||
59799794|NCT00621140|75920891|FG000|COMPLETED|Overall Study|number who completed treatment|152||
59799795|NCT00621140|75920892|FG001|COMPLETED|Overall Study|number who completed treatment|318||
59799796|NCT00621140|75920891|FG000|NOT COMPLETED|Overall Study||15||
59799797|NCT00621140|75920892|FG001|NOT COMPLETED|Overall Study||18||
59799798|NCT00207727|75920903|FG000|STARTED|Overall Study||49||
59799799|NCT00207727|75920904|FG001|STARTED|Overall Study||50||
59799800|NCT00207727|75920905|FG002|STARTED|Overall Study||50||
59799801|NCT00207727|75920906|FG003|STARTED|Overall Study||50||
59799802|NCT00207727|75920907|FG004|STARTED|Overall Study||50||
60073759|NCT01610336|76189074|FG004|NOT COMPLETED|Overall Study||4||
60073760|NCT01610336|76189075|FG005|NOT COMPLETED|Overall Study||12||
60073761|NCT01610336|76189076|FG006|NOT COMPLETED|Overall Study||5||
59799803|NCT00207727|75920903|FG000|COMPLETED|Overall Study||11||
59799804|NCT00207727|75920904|FG001|COMPLETED|Overall Study||8||
59799805|NCT00207727|75920905|FG002|COMPLETED|Overall Study||9||
59799806|NCT00207727|75920906|FG003|COMPLETED|Overall Study||13||
59799807|NCT00207727|75920907|FG004|COMPLETED|Overall Study||16||
59799808|NCT00207727|75920903|FG000|NOT COMPLETED|Overall Study||38||
59799809|NCT00207727|75920904|FG001|NOT COMPLETED|Overall Study||42||
59954498|NCT02780115|76073012|FG002|COMPLETED|Overall Study||29||
59954499|NCT02780115|76073013|FG003|COMPLETED|Overall Study||31||
59954500|NCT02780115|76073014|FG004|COMPLETED|Overall Study||30||
59954501|NCT02780115|76073010|FG000|NOT COMPLETED|Overall Study||0||
59954502|NCT02780115|76073011|FG001|NOT COMPLETED|Overall Study||1||
59954503|NCT02780115|76073012|FG002|NOT COMPLETED|Overall Study||1||
59954504|NCT02780115|76073013|FG003|NOT COMPLETED|Overall Study||1||
59954505|NCT02780115|76073014|FG004|NOT COMPLETED|Overall Study||1||
59954506|NCT02766777|76073026|FG000|STARTED|Overall Study||87||
59954507|NCT02766777|76073026|FG000|Treated (Safety [SAF] Population)|Overall Study||87||
59954508|NCT02766777|76073026|FG000|COMPLETED|Overall Study||53||
59954509|NCT02766777|76073026|FG000|NOT COMPLETED|Overall Study||34||
59523683|NCT00983489|75618644|FG000|STARTED|Overall Study||511||
59523684|NCT00983489|75618645|FG001|STARTED|Overall Study||453||
59523685|NCT00983489|75618646|FG002|STARTED|Overall Study||447||
59523686|NCT00983489|75618644|FG000|COMPLETED|Overall Study||326||
59523687|NCT00983489|75618645|FG001|COMPLETED|Overall Study||168||
59523688|NCT00983489|75618646|FG002|COMPLETED|Overall Study||135||
59523689|NCT00983489|75618644|FG000|NOT COMPLETED|Overall Study||185||
59523690|NCT00983489|75618645|FG001|NOT COMPLETED|Overall Study||285||
59523691|NCT00983489|75618646|FG002|NOT COMPLETED|Overall Study||312||
59523692|NCT01147627|75618657|FG000|STARTED|Overall Study||142||
59523693|NCT01147627|75618658|FG001|STARTED|Overall Study||138||
59523694|NCT01147627|75618659|FG002|STARTED|Overall Study||136||
59523695|NCT01147627|75618657|FG000|COMPLETED|Overall Study||110||
59523696|NCT01147627|75618658|FG001|COMPLETED|Overall Study||114||
59523697|NCT01147627|75618659|FG002|COMPLETED|Overall Study||118||
59523698|NCT01147627|75618657|FG000|NOT COMPLETED|Overall Study||32||
59523699|NCT01147627|75618658|FG001|NOT COMPLETED|Overall Study||24||
59523700|NCT01147627|75618659|FG002|NOT COMPLETED|Overall Study||18||
59523701|NCT02548962|75618669|FG000|STARTED|Overall Study||8||
59523702|NCT02548962|75618670|FG001|STARTED|Overall Study||3||
59523703|NCT02548962|75618669|FG000|COMPLETED|Overall Study||7||
59523704|NCT02548962|75618670|FG001|COMPLETED|Overall Study||3||
59523705|NCT02548962|75618669|FG000|NOT COMPLETED|Overall Study||1||
59523706|NCT02548962|75618670|FG001|NOT COMPLETED|Overall Study||0||
59523707|NCT00983801|75618678|FG000|STARTED|Overall Study|Participants who received treatment.|52||
59523708|NCT00983801|75618678|FG000|COMPLETED|Overall Study|Participants who were taken off treatment.|52||
59523709|NCT00983801|75618678|FG000|NOT COMPLETED|Overall Study||0||
59523710|NCT01188577|75618684|FG000|STARTED|Visit 1||11||
59523711|NCT01188577|75618685|FG001|STARTED|Visit 1||12||
59523712|NCT01188577|75618684|FG000|COMPLETED|Visit 1||11||
59523713|NCT01188577|75618685|FG001|COMPLETED|Visit 1||12||
59523714|NCT01188577|75618684|FG000|NOT COMPLETED|Visit 1||0||
59523715|NCT01188577|75618685|FG001|NOT COMPLETED|Visit 1||0||
59523716|NCT01188577|75618684|FG000|STARTED|3-14 Day Washout||11||
59523717|NCT01188577|75618685|FG001|STARTED|3-14 Day Washout||12||
59799810|NCT00207727|75920905|FG002|NOT COMPLETED|Overall Study||41||
59799811|NCT00207727|75920906|FG003|NOT COMPLETED|Overall Study||37||
59799812|NCT00207727|75920907|FG004|NOT COMPLETED|Overall Study||34||
59799813|NCT00504556|75920924|FG000|STARTED|Overall Study||235||
59523718|NCT01188577|75618684|FG000|COMPLETED|3-14 Day Washout||11||
59523719|NCT01188577|75618685|FG001|COMPLETED|3-14 Day Washout||12||
59523720|NCT01188577|75618684|FG000|NOT COMPLETED|3-14 Day Washout||0||
59523721|NCT01188577|75618685|FG001|NOT COMPLETED|3-14 Day Washout||0||
59523722|NCT01188577|75618684|FG000|STARTED|Visit 2||11||
59523723|NCT01188577|75618685|FG001|STARTED|Visit 2||12||
59523724|NCT01188577|75618684|FG000|COMPLETED|Visit 2||11||
59523725|NCT01188577|75618685|FG001|COMPLETED|Visit 2||12||
59523726|NCT01188577|75618684|FG000|NOT COMPLETED|Visit 2||0||
59523727|NCT01188577|75618685|FG001|NOT COMPLETED|Visit 2||0||
59523728|NCT00984815|75618691|FG000|STARTED|Overall Study||86||
59523729|NCT00984815|75618691|FG000|COMPLETED|Overall Study||56||
59523730|NCT00984815|75618691|FG000|NOT COMPLETED|Overall Study||30||
59523731|NCT02548650|75618697|FG000|STARTED|Triple Therapy||30||
59523732|NCT02548650|75618698|FG001|STARTED|Triple Therapy||36||
59523733|NCT02548650|75618697|FG000|COMPLETED|Triple Therapy||29||
59523734|NCT02548650|75618698|FG001|COMPLETED|Triple Therapy||32||
59954510|NCT00157014|76073034|FG000|STARTED|Overall Study||52||
59954511|NCT00157014|76073035|FG001|STARTED|Overall Study||46||
59954512|NCT00157014|76073036|FG002|STARTED|Overall Study||5||
59523735|NCT02548650|75618697|FG000|NOT COMPLETED|Triple Therapy||1||
59799814|NCT00504556|75920925|FG001|STARTED|Overall Study||245||
59799815|NCT00504556|75920926|FG002|STARTED|Overall Study||235||
59799816|NCT00504556|75920927|FG003|STARTED|Overall Study||180||
59954513|NCT00157014|76073037|FG003|STARTED|Overall Study||6||
59954514|NCT00157014|76073034|FG000|COMPLETED|Overall Study||45||
59954515|NCT00157014|76073035|FG001|COMPLETED|Overall Study||41||
59954516|NCT00157014|76073036|FG002|COMPLETED|Overall Study||4||
59799817|NCT00504556|75920928|FG004|STARTED|Overall Study||251||
59799818|NCT00504556|75920924|FG000|Safety Analysis Set|Overall Study||235||
59799819|NCT00504556|75920925|FG001|Safety Analysis Set|Overall Study||244||
59799820|NCT00504556|75920926|FG002|Safety Analysis Set|Overall Study||234||
59799821|NCT00504556|75920927|FG003|Safety Analysis Set|Overall Study||180||
59799822|NCT00504556|75920928|FG004|Safety Analysis Set|Overall Study||250||
59799823|NCT00504556|75920924|FG000|Per Protocol Analysis Set|Overall Study||235||
59799824|NCT00504556|75920925|FG001|Per Protocol Analysis Set|Overall Study||243||
59799825|NCT00504556|75920926|FG002|Per Protocol Analysis Set|Overall Study||234||
59799826|NCT00504556|75920927|FG003|Per Protocol Analysis Set|Overall Study||180||
59799827|NCT00504556|75920928|FG004|Per Protocol Analysis Set|Overall Study||250||
59799828|NCT00504556|75920924|FG000|Pharmacodynamic Analysis Set|Overall Study||230||
59799829|NCT00504556|75920925|FG001|Pharmacodynamic Analysis Set|Overall Study||236||
59799830|NCT00504556|75920926|FG002|Pharmacodynamic Analysis Set|Overall Study||228||
59799831|NCT00504556|75920927|FG003|Pharmacodynamic Analysis Set|Overall Study||170||
59799832|NCT00504556|75920928|FG004|Pharmacodynamic Analysis Set|Overall Study||244||
59799833|NCT00504556|75920924|FG000|COMPLETED|Overall Study||200||
59799834|NCT00504556|75920925|FG001|COMPLETED|Overall Study||207||
59799835|NCT00504556|75920926|FG002|COMPLETED|Overall Study||204||
59799836|NCT00504556|75920927|FG003|COMPLETED|Overall Study||52||
59799837|NCT00504556|75920928|FG004|COMPLETED|Overall Study||226||
59799838|NCT00504556|75920924|FG000|NOT COMPLETED|Overall Study||35||
59799839|NCT00504556|75920925|FG001|NOT COMPLETED|Overall Study||38||
59799840|NCT00504556|75920926|FG002|NOT COMPLETED|Overall Study||31||
59799841|NCT00504556|75920927|FG003|NOT COMPLETED|Overall Study||128||
59799842|NCT00504556|75920928|FG004|NOT COMPLETED|Overall Study||25||
59799843|NCT00206323|75920942|FG000|STARTED|Overall Study||14||
59799844|NCT00206323|75920943|FG001|STARTED|Overall Study||15||
59799845|NCT00206323|75920942|FG000|COMPLETED|Overall Study||8||
59799846|NCT00206323|75920943|FG001|COMPLETED|Overall Study||12||
59799847|NCT00206323|75920942|FG000|NOT COMPLETED|Overall Study||6||
59799848|NCT00206323|75920943|FG001|NOT COMPLETED|Overall Study||3||
59799849|NCT03903159|75920949|FG000|STARTED|Overall Study||15||
59799850|NCT03903159|75920949|FG000|COMPLETED|Overall Study||10||
59799851|NCT03903159|75920949|FG000|NOT COMPLETED|Overall Study||5||
59799852|NCT00205855|75920953|FG000|STARTED|Overall Study||65||
59799853|NCT00205855|75920953|FG000|COMPLETED|Overall Study||44||
59799854|NCT00205855|75920953|FG000|NOT COMPLETED|Overall Study||21||
59799855|NCT00536991|75920957|FG000|STARTED|Overall Study||51||
59799856|NCT00536991|75920957|FG000|COMPLETED|Overall Study||38||
59799857|NCT00536991|75920957|FG000|NOT COMPLETED|Overall Study||13||
59799858|NCT00504166|75920964|FG000|STARTED|Overall Study||26||
59954517|NCT00157014|76073037|FG003|COMPLETED|Overall Study||5||
59954518|NCT00157014|76073034|FG000|NOT COMPLETED|Overall Study||7||
59954519|NCT00157014|76073035|FG001|NOT COMPLETED|Overall Study||5||
59799859|NCT00504166|75920965|FG001|STARTED|Overall Study||27||
59799860|NCT00504166|75920964|FG000|COMPLETED|Overall Study||20||
59799861|NCT00504166|75920965|FG001|COMPLETED|Overall Study||13||
59799862|NCT00504166|75920964|FG000|NOT COMPLETED|Overall Study||6||
59799863|NCT00504166|75920965|FG001|NOT COMPLETED|Overall Study||14||
59799864|NCT00509236|75920973|FG000|STARTED|Overall Study||64||
59799865|NCT00509236|75920974|FG001|STARTED|Overall Study||65||
59799866|NCT00509236|75920973|FG000|COMPLETED|Overall Study||47||
59799867|NCT00509236|75920974|FG001|COMPLETED|Overall Study||45||
59799868|NCT00509236|75920973|FG000|NOT COMPLETED|Overall Study||17||
59799869|NCT00509236|75920974|FG001|NOT COMPLETED|Overall Study||20||
59799870|NCT00508924|75920984|FG000|STARTED|Overall Study||36||
59799871|NCT00508924|75920985|FG001|STARTED|Overall Study||38||
59799872|NCT00508924|75920986|FG002|STARTED|Overall Study||32||
59799873|NCT00508924|75920987|FG003|STARTED|Overall Study||34||
59799874|NCT00508924|75920984|FG000|COMPLETED|Overall Study||36||
59799875|NCT00508924|75920985|FG001|COMPLETED|Overall Study||38||
59799876|NCT00508924|75920986|FG002|COMPLETED|Overall Study||31||
59799877|NCT00508924|75920987|FG003|COMPLETED|Overall Study||33||
59799878|NCT00508924|75920984|FG000|NOT COMPLETED|Overall Study||0||
59799879|NCT00508924|75920985|FG001|NOT COMPLETED|Overall Study||0||
59799880|NCT00508924|75920986|FG002|NOT COMPLETED|Overall Study||1||
59954520|NCT00157014|76073036|FG002|NOT COMPLETED|Overall Study||1||
59954521|NCT00157014|76073037|FG003|NOT COMPLETED|Overall Study||1||
59799881|NCT00508924|75920987|FG003|NOT COMPLETED|Overall Study||1||
59799882|NCT00620750|75920997|FG000|STARTED|Overall Study||65||
59799883|NCT00620750|75920997|FG000|COMPLETED|Overall Study||40||
59799884|NCT00620750|75920997|FG000|NOT COMPLETED|Overall Study||25||
59799885|NCT00508144|75921001|FG000|STARTED|Overall Study||64||
59799886|NCT00508144|75921001|FG000|COMPLETED|Overall Study||53||
59799887|NCT00508144|75921001|FG000|NOT COMPLETED|Overall Study||11||
59954522|NCT02778867|76073049|FG000|STARTED|Phase 1||67||
59799888|NCT00621842|75921005|FG000|STARTED|Overall Study||57||
59799889|NCT00621842|75921005|FG000|COMPLETED|Overall Study||38||
59799890|NCT00621842|75921005|FG000|NOT COMPLETED|Overall Study||19||
59799891|NCT00503776|75921013|FG000|STARTED|Overall Study||8||
59799892|NCT00503776|75921014|FG001|STARTED|Overall Study||12||
59799893|NCT00503776|75921015|FG002|STARTED|Overall Study|one patient withdrew before receiving protocol therapy|12||
59799894|NCT00503776|75921016|FG003|STARTED|Overall Study|one patient withdrew before receiving protocol therapy|10||
59799895|NCT00503776|75921013|FG000|COMPLETED|Overall Study||7||
59799896|NCT00503776|75921014|FG001|COMPLETED|Overall Study||12||
59799897|NCT00503776|75921015|FG002|COMPLETED|Overall Study||10||
59799898|NCT00503776|75921016|FG003|COMPLETED|Overall Study||8||
59799899|NCT00503776|75921013|FG000|NOT COMPLETED|Overall Study||1||
59799900|NCT00503776|75921014|FG001|NOT COMPLETED|Overall Study||0||
59799901|NCT00503776|75921015|FG002|NOT COMPLETED|Overall Study||2||
59799902|NCT00503776|75921016|FG003|NOT COMPLETED|Overall Study||2||
59799903|NCT00619112|75921033|FG000|STARTED|Overall Study||40||
59799904|NCT00619112|75921034|FG001|STARTED|Overall Study||20||
59799905|NCT00619112|75921033|FG000|COMPLETED|Overall Study|Data from patient who didn't complete study was still included in the final analysis.|39||
59799906|NCT00619112|75921034|FG001|COMPLETED|Overall Study|Data from patients who didn't complete study was still included in the final analysis.|18||
59799907|NCT00619112|75921033|FG000|NOT COMPLETED|Overall Study||1||
59799908|NCT00619112|75921034|FG001|NOT COMPLETED|Overall Study||2||
59799909|NCT00619502|75921045|FG000|STARTED|Overall Study||130||
59799910|NCT00619502|75921046|FG001|STARTED|Overall Study||124||
59799911|NCT00619502|75921045|FG000|COMPLETED|Overall Study||122||
59799912|NCT00619502|75921046|FG001|COMPLETED|Overall Study||114||
59799913|NCT00619502|75921045|FG000|NOT COMPLETED|Overall Study||8||
59799914|NCT00619502|75921046|FG001|NOT COMPLETED|Overall Study||10||
59799915|NCT00618956|75921056|FG000|STARTED|Overall Study||111||
59799916|NCT00618956|75921057|FG001|STARTED|Overall Study||210||
59799917|NCT00618956|75921056|FG000|COMPLETED|Overall Study||86||
59799918|NCT00618956|75921057|FG001|COMPLETED|Overall Study||160||
59799919|NCT00618956|75921056|FG000|NOT COMPLETED|Overall Study||25||
59799920|NCT00618956|75921057|FG001|NOT COMPLETED|Overall Study||50||
59799921|NCT00716417|75921079|FG000|STARTED|Overall Study||3||
59799922|NCT00716417|75921080|FG001|STARTED|Overall Study||6||
59799923|NCT00716417|75921081|FG002|STARTED|Overall Study||5||
59799924|NCT00716417|75921082|FG003|STARTED|Overall Study||11||
59799925|NCT00716417|75921083|FG004|STARTED|Overall Study||1||
59799926|NCT00716417|75921084|FG005|STARTED|Overall Study||3||
59799927|NCT00716417|75921085|FG006|STARTED|Overall Study||7||
59799928|NCT00716417|75921086|FG007|STARTED|Overall Study||3||
59799929|NCT00716417|75921087|FG008|STARTED|Overall Study||5||
59799930|NCT00716417|75921088|FG009|STARTED|Overall Study||3||
59799931|NCT00716417|75921079|FG000|COMPLETED|Overall Study||0||
59799932|NCT00716417|75921080|FG001|COMPLETED|Overall Study||0||
59799933|NCT00716417|75921081|FG002|COMPLETED|Overall Study||0||
59799934|NCT00716417|75921082|FG003|COMPLETED|Overall Study||0||
59799935|NCT00716417|75921083|FG004|COMPLETED|Overall Study||0||
59799936|NCT00716417|75921084|FG005|COMPLETED|Overall Study||0||
59799937|NCT00716417|75921085|FG006|COMPLETED|Overall Study||0||
59799938|NCT00716417|75921086|FG007|COMPLETED|Overall Study||0||
59799939|NCT00716417|75921087|FG008|COMPLETED|Overall Study||0||
59799940|NCT00716417|75921088|FG009|COMPLETED|Overall Study||0||
59799941|NCT00716417|75921079|FG000|NOT COMPLETED|Overall Study||3||
59799942|NCT00716417|75921080|FG001|NOT COMPLETED|Overall Study||6||
59799943|NCT00716417|75921081|FG002|NOT COMPLETED|Overall Study||5||
59523736|NCT02548650|75618698|FG001|NOT COMPLETED|Triple Therapy||4||
59523737|NCT02548650|75618697|FG000|STARTED|Double Therapy||29||
59523738|NCT02548650|75618698|FG001|STARTED|Double Therapy||32||
59523739|NCT02548650|75618697|FG000|COMPLETED|Double Therapy||28||
59523740|NCT02548650|75618698|FG001|COMPLETED|Double Therapy||30||
59523741|NCT02548650|75618697|FG000|NOT COMPLETED|Double Therapy||1||
59523742|NCT02548650|75618698|FG001|NOT COMPLETED|Double Therapy||2||
59523743|NCT01227655|75618707|FG000|STARTED|Overall Study||129||
59523744|NCT01227655|75618708|FG001|STARTED|Overall Study||154||
59523745|NCT01227655|75618709|FG002|STARTED|Overall Study||144||
59523746|NCT01227655|75618707|FG000|Safety Set|Overall Study||125||
59523747|NCT01227655|75618708|FG001|Safety Set|Overall Study||150||
59523748|NCT01227655|75618709|FG002|Safety Set|Overall Study||136||
59523749|NCT01227655|75618707|FG000|Full Analysis Set|Overall Study||125||
59523750|NCT01227655|75618708|FG001|Full Analysis Set|Overall Study||147||
59799944|NCT00716417|75921082|FG003|NOT COMPLETED|Overall Study||11||
59799945|NCT00716417|75921083|FG004|NOT COMPLETED|Overall Study||1||
59799946|NCT00716417|75921084|FG005|NOT COMPLETED|Overall Study||3||
59799947|NCT00716417|75921085|FG006|NOT COMPLETED|Overall Study||7||
59799948|NCT00716417|75921086|FG007|NOT COMPLETED|Overall Study||3||
59799949|NCT00716417|75921087|FG008|NOT COMPLETED|Overall Study||5||
59799950|NCT00716417|75921088|FG009|NOT COMPLETED|Overall Study||3||
59799951|NCT00719537|75921114|FG000|STARTED|Overall Study||2||
59799952|NCT00719537|75921115|FG001|STARTED|Overall Study||1||
59799953|NCT00719537|75921114|FG000|COMPLETED|Overall Study||1||
59799954|NCT00719537|75921115|FG001|COMPLETED|Overall Study||0||
59799955|NCT00719537|75921114|FG000|NOT COMPLETED|Overall Study||1||
59799956|NCT00719537|75921115|FG001|NOT COMPLETED|Overall Study||1||
59799957|NCT00715949|75921121|FG000|STARTED|Overall Study|4 dropped because could not finish first test|120||
59799958|NCT00715949|75921121|FG000|COMPLETED|Overall Study|116 patients completed first test|116||
59799959|NCT00715949|75921121|FG000|NOT COMPLETED|Overall Study||4||
59799960|NCT00503698|75921127|FG000|STARTED|Overall Study|Randomised|357||
59799961|NCT00503698|75921128|FG001|STARTED|Overall Study|Randomised|355||
59799962|NCT00503698|75921127|FG000|Exposed to Trial Drug|Overall Study|11 subjects randomised but not exposed to trial drug. Subjects not included in full analysis set.|346||
59799963|NCT00503698|75921128|FG001|Exposed to Trial Drug|Overall Study|6 subjects randomised but not exposed to trial drug. Subjects not included in full analysis set.|349||
59799964|NCT00503698|75921127|FG000|COMPLETED|Overall Study|Trial prematurely terminated|0||
59799965|NCT00503698|75921128|FG001|COMPLETED|Overall Study|Trial prematurely terminated|0||
59799966|NCT00503698|75921127|FG000|NOT COMPLETED|Overall Study||357||
59799967|NCT00503698|75921128|FG001|NOT COMPLETED|Overall Study||355||
59799968|NCT03941015|75921136|FG000|STARTED|Overall Study||38||
59799969|NCT03941015|75921137|FG001|STARTED|Overall Study||207||
59799970|NCT03941015|75921136|FG000|COMPLETED|Overall Study||38||
59799971|NCT03941015|75921137|FG001|COMPLETED|Overall Study||204||
59799972|NCT03941015|75921136|FG000|NOT COMPLETED|Overall Study||0||
59799973|NCT03941015|75921137|FG001|NOT COMPLETED|Overall Study||3||
59799974|NCT00573794|75921143|FG000|STARTED|Overall Study||585|ITT-1: All subjects who received ≥1 dose of study drug excluding 7 subjects at noncompliant sites.|
59799975|NCT00573794|75921143|FG000|COMPLETED|Overall Study||255||
59799976|NCT00573794|75921143|FG000|NOT COMPLETED|Overall Study||330||
59799977|NCT00715793|75921147|FG000|STARTED|Phase 1 RP2D DAC + TMZ||4||
59799978|NCT00715793|75921148|FG001|STARTED|Phase 1 RP2D DAC + TMZ||6||
59799979|NCT00715793|75921147|FG000|COMPLETED|Phase 1 RP2D DAC + TMZ||3||
59799980|NCT00715793|75921148|FG001|COMPLETED|Phase 1 RP2D DAC + TMZ||6||
59799981|NCT00715793|75921147|FG000|NOT COMPLETED|Phase 1 RP2D DAC + TMZ||1||
59799982|NCT00715793|75921148|FG001|NOT COMPLETED|Phase 1 RP2D DAC + TMZ||0||
59799983|NCT00715793|75921147|FG000|STARTED|Phase 2 DAC (0.15 mg/kg) + TMZ||0||
59799984|NCT00715793|75921148|FG001|STARTED|Phase 2 DAC (0.15 mg/kg) + TMZ||29||
59799985|NCT00715793|75921147|FG000|COMPLETED|Phase 2 DAC (0.15 mg/kg) + TMZ||0||
59799986|NCT00715793|75921148|FG001|COMPLETED|Phase 2 DAC (0.15 mg/kg) + TMZ||27||
59799987|NCT00715793|75921147|FG000|NOT COMPLETED|Phase 2 DAC (0.15 mg/kg) + TMZ||0||
59954523|NCT02778867|76073050|FG001|STARTED|Phase 1||62||
59954524|NCT02778867|76073051|FG002|STARTED|Phase 1||0||
59954525|NCT02778867|76073052|FG003|STARTED|Phase 1||0||
59799988|NCT00715793|75921148|FG001|NOT COMPLETED|Phase 2 DAC (0.15 mg/kg) + TMZ||2||
59799989|NCT00718523|75921157|FG000|STARTED|Overall Study||84||
59799990|NCT00718523|75921158|FG001|STARTED|Overall Study||86||
59799991|NCT00718523|75921157|FG000|COMPLETED|Overall Study||66||
59799992|NCT00718523|75921158|FG001|COMPLETED|Overall Study||62||
59799993|NCT00718523|75921157|FG000|NOT COMPLETED|Overall Study||18||
59799994|NCT00718523|75921158|FG001|NOT COMPLETED|Overall Study||24||
59799995|NCT00715559|75921164|FG000|STARTED|Overall Study||3||
59954526|NCT02778867|76073049|FG000|COMPLETED|Phase 1||65||
59954527|NCT02778867|76073050|FG001|COMPLETED|Phase 1||59||
59954528|NCT02778867|76073051|FG002|COMPLETED|Phase 1||0||
59954529|NCT02778867|76073052|FG003|COMPLETED|Phase 1||0||
59954530|NCT02778867|76073049|FG000|NOT COMPLETED|Phase 1||2||
59620409|NCT00258882|75731741|FG001|COMPLETED|Adacel Recipients Historic Cohort Method||203154||
59620410|NCT00258882|75731740|FG000|NOT COMPLETED|Adacel Recipients Historic Cohort Method||0||
59620411|NCT00258882|75731741|FG001|NOT COMPLETED|Adacel Recipients Historic Cohort Method||0||
59620412|NCT00258882|75731740|FG000|STARTED|Adacel Recipients-Risk Interval Method||124139||
59620413|NCT00258882|75731741|FG001|STARTED|Adacel Recipients-Risk Interval Method|Study participants served as their own controls for this analysis|0||
59620414|NCT00258882|75731740|FG000|COMPLETED|Adacel Recipients-Risk Interval Method||124139||
59620415|NCT00258882|75731741|FG001|COMPLETED|Adacel Recipients-Risk Interval Method||0||
59620416|NCT00258882|75731740|FG000|NOT COMPLETED|Adacel Recipients-Risk Interval Method||0||
59620417|NCT00258882|75731741|FG001|NOT COMPLETED|Adacel Recipients-Risk Interval Method||0||
59620418|NCT00258882|75731740|FG000|STARTED|Pregnancy Surveillance|Adacel recipients who were pregnant at the time of vaccination or within 28 days thereafter.|225||
59620419|NCT00258882|75731741|FG001|STARTED|Pregnancy Surveillance|Non-vaccinated age-matched subjects with first positive pregnancy test in the same month (± 1 month)|675||
59620420|NCT00258882|75731740|FG000|COMPLETED|Pregnancy Surveillance||225||
59620421|NCT00258882|75731741|FG001|COMPLETED|Pregnancy Surveillance||675||
59620422|NCT00258882|75731740|FG000|NOT COMPLETED|Pregnancy Surveillance||0||
59799996|NCT00715559|75921164|FG000|COMPLETED|Overall Study||2||
59799997|NCT00715559|75921164|FG000|NOT COMPLETED|Overall Study||1||
59799998|NCT00620282|75921171|FG000|STARTED|Overall Study||16||
59799999|NCT00620282|75921172|FG001|STARTED|Overall Study||16||
59800000|NCT00620282|75921173|FG002|STARTED|Overall Study||17||
59800001|NCT00620282|75921171|FG000|COMPLETED|Overall Study||16||
59800002|NCT00620282|75921172|FG001|COMPLETED|Overall Study||14||
59800003|NCT00620282|75921173|FG002|COMPLETED|Overall Study||16||
59800004|NCT00620282|75921171|FG000|NOT COMPLETED|Overall Study||0||
59800005|NCT00620282|75921172|FG001|NOT COMPLETED|Overall Study||2||
59954531|NCT02778867|76073050|FG001|NOT COMPLETED|Phase 1||3||
59954532|NCT02778867|76073051|FG002|NOT COMPLETED|Phase 1||0||
59800006|NCT00620282|75921173|FG002|NOT COMPLETED|Overall Study||1||
59800007|NCT00515086|75921185|FG000|STARTED|Overall Study||24||
59800008|NCT00515086|75921186|FG001|STARTED|Overall Study||6||
59800009|NCT00515086|75921187|FG002|STARTED|Overall Study||5||
59800010|NCT00515086|75921188|FG003|STARTED|Overall Study||6||
59800011|NCT00515086|75921185|FG000|COMPLETED|Overall Study||0||
59800012|NCT00515086|75921186|FG001|COMPLETED|Overall Study||0||
59800013|NCT00515086|75921187|FG002|COMPLETED|Overall Study||0||
59800014|NCT00515086|75921188|FG003|COMPLETED|Overall Study||0||
59800015|NCT00515086|75921185|FG000|NOT COMPLETED|Overall Study||24||
59800016|NCT00515086|75921186|FG001|NOT COMPLETED|Overall Study||6||
59800017|NCT00515086|75921187|FG002|NOT COMPLETED|Overall Study||5||
59800018|NCT00515086|75921188|FG003|NOT COMPLETED|Overall Study||6||
59800019|NCT00618410|75921204|FG000|STARTED|First Intervention||7||
59800020|NCT00618410|75921205|FG001|STARTED|First Intervention||6||
59800021|NCT00618410|75921204|FG000|COMPLETED|First Intervention||7||
59800022|NCT00618410|75921205|FG001|COMPLETED|First Intervention||6||
59800023|NCT00618410|75921204|FG000|NOT COMPLETED|First Intervention||0||
59800024|NCT00618410|75921205|FG001|NOT COMPLETED|First Intervention||0||
59800025|NCT00618410|75921204|FG000|STARTED|Washout Period (2 Weeks)||7||
59800026|NCT00618410|75921205|FG001|STARTED|Washout Period (2 Weeks)||6||
59800027|NCT00618410|75921204|FG000|COMPLETED|Washout Period (2 Weeks)||7||
59800028|NCT00618410|75921205|FG001|COMPLETED|Washout Period (2 Weeks)||5||
59800029|NCT00618410|75921204|FG000|NOT COMPLETED|Washout Period (2 Weeks)||0||
59800030|NCT00618410|75921205|FG001|NOT COMPLETED|Washout Period (2 Weeks)||1||
59800031|NCT00618410|75921204|FG000|STARTED|Second Intervention||7||
59800032|NCT00618410|75921205|FG001|STARTED|Second Intervention||5||
59800033|NCT00618410|75921204|FG000|COMPLETED|Second Intervention||7||
59800034|NCT00618410|75921205|FG001|COMPLETED|Second Intervention||5||
59800035|NCT00618410|75921204|FG000|NOT COMPLETED|Second Intervention||0||
59800036|NCT00618410|75921205|FG001|NOT COMPLETED|Second Intervention||0||
59800037|NCT00618722|75921215|FG000|STARTED|Overall Study||21||
59800038|NCT00618722|75921216|FG001|STARTED|Overall Study||20||
59800039|NCT00618722|75921217|FG002|STARTED|Overall Study||22||
59800040|NCT00618722|75921218|FG003|STARTED|Overall Study||22||
59800041|NCT00618722|75921215|FG000|Received Treatment|Overall Study||20||
60073762|NCT01610336|76189077|FG007|NOT COMPLETED|Overall Study||7||
60073763|NCT01610336|76189078|FG008|NOT COMPLETED|Overall Study||8||
60073764|NCT01610336|76189079|FG009|NOT COMPLETED|Overall Study||53||
60073765|NCT01610336|76189080|FG010|NOT COMPLETED|Overall Study||47||
60073766|NCT01613222|76189108|FG000|STARTED|Overall Study||63||
60073767|NCT01613222|76189108|FG000|COMPLETED|Overall Study||51||
60073768|NCT01613222|76189108|FG000|NOT COMPLETED|Overall Study||12||
60073769|NCT03366298|76189121|FG000|STARTED|Overall Study||3||
60073770|NCT03366298|76189122|FG001|STARTED|Overall Study||3||
60073771|NCT03366298|76189123|FG002|STARTED|Overall Study||3||
60073772|NCT03366298|76189124|FG003|STARTED|Overall Study||3||
60073773|NCT03366298|76189121|FG000|COMPLETED|Overall Study||3||
60073774|NCT03366298|76189122|FG001|COMPLETED|Overall Study||3||
60073775|NCT03366298|76189123|FG002|COMPLETED|Overall Study||3||
60073776|NCT03366298|76189124|FG003|COMPLETED|Overall Study||3||
60073777|NCT03366298|76189121|FG000|NOT COMPLETED|Overall Study||0||
60073778|NCT03366298|76189122|FG001|NOT COMPLETED|Overall Study||0||
60073779|NCT03366298|76189123|FG002|NOT COMPLETED|Overall Study||0||
60073780|NCT03366298|76189124|FG003|NOT COMPLETED|Overall Study||0||
60073781|NCT03320512|76189135|FG000|STARTED|Overall Study||82||
60073782|NCT03320512|76189136|FG001|STARTED|Overall Study||81||
60073783|NCT03320512|76189137|FG002|STARTED|Overall Study||83||
60073784|NCT03320512|76189135|FG000|Month 3 Survey Started|Overall Study||69||
60073785|NCT03320512|76189136|FG001|Month 3 Survey Started|Overall Study||72||
60073786|NCT03320512|76189137|FG002|Month 3 Survey Started|Overall Study||71||
59800042|NCT00618722|75921216|FG001|Received Treatment|Overall Study||20||
59800043|NCT00618722|75921217|FG002|Received Treatment|Overall Study||22||
59800044|NCT00618722|75921218|FG003|Received Treatment|Overall Study||22||
59800045|NCT00618722|75921215|FG000|COMPLETED|Overall Study||18||
59800046|NCT00618722|75921216|FG001|COMPLETED|Overall Study||18||
59800047|NCT00618722|75921217|FG002|COMPLETED|Overall Study||19||
59800048|NCT00618722|75921218|FG003|COMPLETED|Overall Study||18||
59800049|NCT00618722|75921215|FG000|NOT COMPLETED|Overall Study||3||
59800050|NCT00618722|75921216|FG001|NOT COMPLETED|Overall Study||2||
59800051|NCT00618722|75921217|FG002|NOT COMPLETED|Overall Study||3||
59800052|NCT00618722|75921218|FG003|NOT COMPLETED|Overall Study||4||
59800053|NCT00507442|75921232|FG000|STARTED|Overall Study||42||
59800054|NCT00507442|75921233|FG001|STARTED|Overall Study||66||
59800055|NCT00507442|75921234|FG002|STARTED|Overall Study||33||
59800056|NCT00507442|75921235|FG003|STARTED|Overall Study||17||
59800057|NCT00507442|75921232|FG000|COMPLETED|Overall Study||26||
59800058|NCT00507442|75921233|FG001|COMPLETED|Overall Study||39||
59800059|NCT00507442|75921234|FG002|COMPLETED|Overall Study||18||
60073787|NCT03320512|76189135|FG000|Month 3 Survey Completed|Overall Study||69||
60073788|NCT03320512|76189136|FG001|Month 3 Survey Completed|Overall Study||72||
60073789|NCT03320512|76189137|FG002|Month 3 Survey Completed|Overall Study||68||
59954533|NCT02778867|76073052|FG003|NOT COMPLETED|Phase 1||0||
59954534|NCT02778867|76073049|FG000|STARTED|Phase 2|1FED non-responders from Phase 1 have the option to undergo 6FED in Phase 2|0||
59954535|NCT02778867|76073050|FG001|STARTED|Phase 2|6FED non-responders from Phase 1 have the option to undergo SGC in Phase 2|0||
59523751|NCT01227655|75618709|FG002|Full Analysis Set|Overall Study||135||
59523752|NCT01227655|75618707|FG000|COMPLETED|Overall Study||118||
59523753|NCT01227655|75618708|FG001|COMPLETED|Overall Study||128||
59800060|NCT00507442|75921235|FG003|COMPLETED|Overall Study||12||
59800061|NCT00507442|75921232|FG000|NOT COMPLETED|Overall Study||16||
59800062|NCT00507442|75921233|FG001|NOT COMPLETED|Overall Study||27||
59800063|NCT00507442|75921234|FG002|NOT COMPLETED|Overall Study||15||
59800064|NCT00507442|75921235|FG003|NOT COMPLETED|Overall Study||5||
59800065|NCT00619892|75921251|FG000|STARTED|Overall Study||13||
59800066|NCT00619892|75921252|FG001|STARTED|Overall Study||13||
59800067|NCT00619892|75921251|FG000|COMPLETED|Overall Study||10||
59800068|NCT00619892|75921252|FG001|COMPLETED|Overall Study||11||
59800069|NCT00619892|75921251|FG000|NOT COMPLETED|Overall Study||3||
59800070|NCT00619892|75921252|FG001|NOT COMPLETED|Overall Study||2||
59800071|NCT00507130|75921264|FG000|STARTED|Overall Study||9||
59800072|NCT00507130|75921265|FG001|STARTED|Overall Study||9||
59800073|NCT00507130|75921266|FG002|STARTED|Overall Study||9||
59800074|NCT00507130|75921267|FG003|STARTED|Overall Study||9||
59800075|NCT00507130|75921264|FG000|COMPLETED|Overall Study||8||
59800076|NCT00507130|75921265|FG001|COMPLETED|Overall Study||9||
59800077|NCT00507130|75921266|FG002|COMPLETED|Overall Study||8||
59800078|NCT00507130|75921267|FG003|COMPLETED|Overall Study||8||
59800079|NCT00507130|75921264|FG000|NOT COMPLETED|Overall Study||1||
59800080|NCT00507130|75921265|FG001|NOT COMPLETED|Overall Study||0||
59800081|NCT00507130|75921266|FG002|NOT COMPLETED|Overall Study||1||
59800082|NCT00507130|75921267|FG003|NOT COMPLETED|Overall Study||1||
59523754|NCT01227655|75618709|FG002|COMPLETED|Overall Study||130||
59800083|NCT00503308|75921279|FG000|STARTED|Overall Study||146||
59800084|NCT00503308|75921280|FG001|STARTED|Overall Study||135||
59800085|NCT00503308|75921279|FG000|COMPLETED|Overall Study||144||
59800086|NCT00503308|75921280|FG001|COMPLETED|Overall Study||134||
59800087|NCT00503308|75921279|FG000|NOT COMPLETED|Overall Study||2||
59800088|NCT00503308|75921280|FG001|NOT COMPLETED|Overall Study||1||
59523755|NCT01227655|75618707|FG000|NOT COMPLETED|Overall Study||11||
59523756|NCT01227655|75618708|FG001|NOT COMPLETED|Overall Study||26||
59800089|NCT03893565|75921291|FG000|STARTED|Double-blind Induction Phase (10 Weeks)||27||
59800090|NCT03893565|75921292|FG001|STARTED|Double-blind Induction Phase (10 Weeks)||48||
59800091|NCT03893565|75921293|FG002|STARTED|Double-blind Induction Phase (10 Weeks)||11||
59800092|NCT03893565|75921294|FG003|STARTED|Double-blind Induction Phase (10 Weeks)||10||
59800093|NCT03893565|75921295|FG004|STARTED|Double-blind Induction Phase (10 Weeks)||8||
59523757|NCT01227655|75618709|FG002|NOT COMPLETED|Overall Study||14||
59800094|NCT03893565|75921296|FG005|STARTED|Double-blind Induction Phase (10 Weeks)||0||
59800095|NCT03893565|75921297|FG006|STARTED|Double-blind Induction Phase (10 Weeks)||0||
59800096|NCT03893565|75921298|FG007|STARTED|Double-blind Induction Phase (10 Weeks)||0||
59800097|NCT03893565|75921299|FG008|STARTED|Double-blind Induction Phase (10 Weeks)||0||
59800098|NCT03893565|75921291|FG000|COMPLETED|Double-blind Induction Phase (10 Weeks)||21||
59800099|NCT03893565|75921292|FG001|COMPLETED|Double-blind Induction Phase (10 Weeks)||32||
59800100|NCT03893565|75921293|FG002|COMPLETED|Double-blind Induction Phase (10 Weeks)||1||
59800101|NCT03893565|75921294|FG003|COMPLETED|Double-blind Induction Phase (10 Weeks)||1||
59800102|NCT03893565|75921295|FG004|COMPLETED|Double-blind Induction Phase (10 Weeks)||1||
59800103|NCT03893565|75921296|FG005|COMPLETED|Double-blind Induction Phase (10 Weeks)||0||
59800104|NCT03893565|75921297|FG006|COMPLETED|Double-blind Induction Phase (10 Weeks)||0||
59800105|NCT03893565|75921298|FG007|COMPLETED|Double-blind Induction Phase (10 Weeks)||0||
59800106|NCT03893565|75921299|FG008|COMPLETED|Double-blind Induction Phase (10 Weeks)||0||
59800107|NCT03893565|75921291|FG000|NOT COMPLETED|Double-blind Induction Phase (10 Weeks)||6||
59800108|NCT03893565|75921292|FG001|NOT COMPLETED|Double-blind Induction Phase (10 Weeks)||16||
59800109|NCT03893565|75921293|FG002|NOT COMPLETED|Double-blind Induction Phase (10 Weeks)||10||
59800110|NCT03893565|75921294|FG003|NOT COMPLETED|Double-blind Induction Phase (10 Weeks)||9||
59800111|NCT03893565|75921295|FG004|NOT COMPLETED|Double-blind Induction Phase (10 Weeks)||7||
59954536|NCT02778867|76073051|FG002|STARTED|Phase 2|Optional phase for 1FED non-responders|21||
59523758|NCT01189123|75618719|FG000|STARTED|Overall Study||52||
59523759|NCT01189123|75618720|FG001|STARTED|Overall Study||53||
59523760|NCT01189123|75618719|FG000|COMPLETED|Overall Study||50||
59523761|NCT01189123|75618720|FG001|COMPLETED|Overall Study||47||
59523762|NCT01189123|75618719|FG000|NOT COMPLETED|Overall Study||2||
59800112|NCT03893565|75921296|FG005|NOT COMPLETED|Double-blind Induction Phase (10 Weeks)||0||
59800113|NCT03893565|75921297|FG006|NOT COMPLETED|Double-blind Induction Phase (10 Weeks)||0||
59800114|NCT03893565|75921298|FG007|NOT COMPLETED|Double-blind Induction Phase (10 Weeks)||0||
59800115|NCT03893565|75921299|FG008|NOT COMPLETED|Double-blind Induction Phase (10 Weeks)||0||
59800116|NCT03893565|75921291|FG000|STARTED|Double-blind Extended Treatment(20weeks)||0||
59800117|NCT03893565|75921292|FG001|STARTED|Double-blind Extended Treatment(20weeks)||0||
59800118|NCT03893565|75921293|FG002|STARTED|Double-blind Extended Treatment(20weeks)||0||
59800119|NCT03893565|75921294|FG003|STARTED|Double-blind Extended Treatment(20weeks)||0||
59800120|NCT03893565|75921295|FG004|STARTED|Double-blind Extended Treatment(20weeks)||0||
59800121|NCT03893565|75921296|FG005|STARTED|Double-blind Extended Treatment(20weeks)||5||
59800122|NCT03893565|75921297|FG006|STARTED|Double-blind Extended Treatment(20weeks)||8||
59800123|NCT03893565|75921298|FG007|STARTED|Double-blind Extended Treatment(20weeks)||0||
59800124|NCT03893565|75921299|FG008|STARTED|Double-blind Extended Treatment(20weeks)||0||
59800125|NCT03893565|75921291|FG000|COMPLETED|Double-blind Extended Treatment(20weeks)||0||
59800126|NCT03893565|75921292|FG001|COMPLETED|Double-blind Extended Treatment(20weeks)||0||
59800127|NCT03893565|75921293|FG002|COMPLETED|Double-blind Extended Treatment(20weeks)||0||
59800128|NCT03893565|75921294|FG003|COMPLETED|Double-blind Extended Treatment(20weeks)||0||
59800129|NCT03893565|75921295|FG004|COMPLETED|Double-blind Extended Treatment(20weeks)||0||
59800130|NCT03893565|75921296|FG005|COMPLETED|Double-blind Extended Treatment(20weeks)||2||
59800131|NCT03893565|75921297|FG006|COMPLETED|Double-blind Extended Treatment(20weeks)||4||
59800132|NCT03893565|75921298|FG007|COMPLETED|Double-blind Extended Treatment(20weeks)||0||
59800133|NCT03893565|75921299|FG008|COMPLETED|Double-blind Extended Treatment(20weeks)||0||
59800134|NCT03893565|75921291|FG000|NOT COMPLETED|Double-blind Extended Treatment(20weeks)||0||
59800135|NCT03893565|75921292|FG001|NOT COMPLETED|Double-blind Extended Treatment(20weeks)||0||
59800136|NCT03893565|75921293|FG002|NOT COMPLETED|Double-blind Extended Treatment(20weeks)||0||
59800137|NCT03893565|75921294|FG003|NOT COMPLETED|Double-blind Extended Treatment(20weeks)||0||
59800138|NCT03893565|75921295|FG004|NOT COMPLETED|Double-blind Extended Treatment(20weeks)||0||
59800139|NCT03893565|75921296|FG005|NOT COMPLETED|Double-blind Extended Treatment(20weeks)||3||
59800140|NCT03893565|75921297|FG006|NOT COMPLETED|Double-blind Extended Treatment(20weeks)||4||
59800141|NCT03893565|75921298|FG007|NOT COMPLETED|Double-blind Extended Treatment(20weeks)||0||
59800142|NCT03893565|75921299|FG008|NOT COMPLETED|Double-blind Extended Treatment(20weeks)||0||
59800143|NCT03893565|75921291|FG000|STARTED|Open-label Induction Phase (10 Weeks)||0||
59800144|NCT03893565|75921292|FG001|STARTED|Open-label Induction Phase (10 Weeks)||0||
59800145|NCT03893565|75921293|FG002|STARTED|Open-label Induction Phase (10 Weeks)||0||
59800146|NCT03893565|75921294|FG003|STARTED|Open-label Induction Phase (10 Weeks)||0||
59800147|NCT03893565|75921295|FG004|STARTED|Open-label Induction Phase (10 Weeks)||0||
59800148|NCT03893565|75921296|FG005|STARTED|Open-label Induction Phase (10 Weeks)||0||
59800149|NCT03893565|75921297|FG006|STARTED|Open-label Induction Phase (10 Weeks)||0||
59800150|NCT03893565|75921298|FG007|STARTED|Open-label Induction Phase (10 Weeks)||42||
59800151|NCT03893565|75921299|FG008|STARTED|Open-label Induction Phase (10 Weeks)||0||
59523763|NCT01189123|75618720|FG001|NOT COMPLETED|Overall Study||6||
59523764|NCT01026623|75618729|FG000|STARTED|Overall Study||6||
59523765|NCT01026623|75618730|FG001|STARTED|Overall Study||5||
59800152|NCT03893565|75921291|FG000|COMPLETED|Open-label Induction Phase (10 Weeks)||0||
59800153|NCT03893565|75921292|FG001|COMPLETED|Open-label Induction Phase (10 Weeks)||0||
59800154|NCT03893565|75921293|FG002|COMPLETED|Open-label Induction Phase (10 Weeks)||0||
59800155|NCT03893565|75921294|FG003|COMPLETED|Open-label Induction Phase (10 Weeks)||0||
59800156|NCT03893565|75921295|FG004|COMPLETED|Open-label Induction Phase (10 Weeks)||0||
59800157|NCT03893565|75921296|FG005|COMPLETED|Open-label Induction Phase (10 Weeks)||0||
59800158|NCT03893565|75921297|FG006|COMPLETED|Open-label Induction Phase (10 Weeks)||0||
59954537|NCT02778867|76073052|FG003|STARTED|Phase 2|Optional phase for 6FED non-responders|11||
59523766|NCT01026623|75618731|FG002|STARTED|Overall Study||5||
59523767|NCT01026623|75618729|FG000|COMPLETED|Overall Study||6||
59523768|NCT01026623|75618730|FG001|COMPLETED|Overall Study||5||
59954538|NCT02778867|76073049|FG000|COMPLETED|Phase 2||0||
59954539|NCT02778867|76073050|FG001|COMPLETED|Phase 2||0||
59954540|NCT02778867|76073051|FG002|COMPLETED|Phase 2||20||
59954541|NCT02778867|76073052|FG003|COMPLETED|Phase 2||9||
59954542|NCT02778867|76073049|FG000|NOT COMPLETED|Phase 2||0||
59954543|NCT02778867|76073050|FG001|NOT COMPLETED|Phase 2||0||
59954544|NCT02778867|76073051|FG002|NOT COMPLETED|Phase 2||1||
59954545|NCT02778867|76073052|FG003|NOT COMPLETED|Phase 2||2||
59954546|NCT02778555|76073065|FG000|STARTED|Overall Study||186||
59954547|NCT02778555|76073066|FG001|STARTED|Overall Study||209||
59954548|NCT02778555|76073067|FG002|STARTED|Overall Study||318||
59954549|NCT02778555|76073065|FG000|COMPLETED|Overall Study||131||
59954550|NCT02778555|76073066|FG001|COMPLETED|Overall Study||177||
59954551|NCT02778555|76073067|FG002|COMPLETED|Overall Study||211||
59954552|NCT02778555|76073065|FG000|NOT COMPLETED|Overall Study||55||
59954553|NCT02778555|76073066|FG001|NOT COMPLETED|Overall Study||32||
59954554|NCT02778555|76073067|FG002|NOT COMPLETED|Overall Study||107||
59954555|NCT02778399|76073081|FG000|STARTED|Up to Week 12 Treatment Period||54||
59954556|NCT02778399|76073082|FG001|STARTED|Up to Week 12 Treatment Period||49||
59954557|NCT02778399|76073083|FG002|STARTED|Up to Week 12 Treatment Period||57||
59523769|NCT01026623|75618731|FG002|COMPLETED|Overall Study||5||
59954558|NCT02778399|76073084|FG003|STARTED|Up to Week 12 Treatment Period||58||
59954559|NCT02778399|76073085|FG004|STARTED|Up to Week 12 Treatment Period||53||
59954560|NCT02778399|76073086|FG005|STARTED|Up to Week 12 Treatment Period||57||
59523770|NCT01026623|75618729|FG000|NOT COMPLETED|Overall Study||0||
59523771|NCT01026623|75618730|FG001|NOT COMPLETED|Overall Study||0||
59523772|NCT01026623|75618731|FG002|NOT COMPLETED|Overall Study||0||
59523773|NCT01189279|75618743|FG000|STARTED|Overall Study||14||
59954561|NCT02778399|76073081|FG000|Included in SAFETY SET|Up to Week 12 Treatment Period||54||
59954562|NCT02778399|76073082|FG001|Included in SAFETY SET|Up to Week 12 Treatment Period||49||
59954563|NCT02778399|76073083|FG002|Included in SAFETY SET|Up to Week 12 Treatment Period||57||
59954564|NCT02778399|76073084|FG003|Included in SAFETY SET|Up to Week 12 Treatment Period||58||
59954565|NCT02778399|76073085|FG004|Included in SAFETY SET|Up to Week 12 Treatment Period||52||
59954566|NCT02778399|76073086|FG005|Included in SAFETY SET|Up to Week 12 Treatment Period||57||
59954567|NCT02778399|76073081|FG000|Included in FAS|Up to Week 12 Treatment Period||53||
59954568|NCT02778399|76073082|FG001|Included in FAS|Up to Week 12 Treatment Period||49||
59523774|NCT01189279|75618744|FG001|STARTED|Overall Study||14||
59523775|NCT01189279|75618745|FG002|STARTED|Overall Study||14||
59800159|NCT03893565|75921298|FG007|COMPLETED|Open-label Induction Phase (10 Weeks)||12||
59800160|NCT03893565|75921299|FG008|COMPLETED|Open-label Induction Phase (10 Weeks)||0||
59800161|NCT03893565|75921291|FG000|NOT COMPLETED|Open-label Induction Phase (10 Weeks)||0||
59800162|NCT03893565|75921292|FG001|NOT COMPLETED|Open-label Induction Phase (10 Weeks)||0||
59523776|NCT01189279|75618743|FG000|COMPLETED|Overall Study||13||
59523777|NCT01189279|75618744|FG001|COMPLETED|Overall Study||14||
59800163|NCT03893565|75921293|FG002|NOT COMPLETED|Open-label Induction Phase (10 Weeks)||0||
59800164|NCT03893565|75921294|FG003|NOT COMPLETED|Open-label Induction Phase (10 Weeks)||0||
59800165|NCT03893565|75921295|FG004|NOT COMPLETED|Open-label Induction Phase (10 Weeks)||0||
59800166|NCT03893565|75921296|FG005|NOT COMPLETED|Open-label Induction Phase (10 Weeks)||0||
59800167|NCT03893565|75921297|FG006|NOT COMPLETED|Open-label Induction Phase (10 Weeks)||0||
59800168|NCT03893565|75921298|FG007|NOT COMPLETED|Open-label Induction Phase (10 Weeks)||30||
59800169|NCT03893565|75921299|FG008|NOT COMPLETED|Open-label Induction Phase (10 Weeks)||0||
59800170|NCT03893565|75921291|FG000|STARTED|Open-label Extended Treatment (20 Weeks)||0||
59800171|NCT03893565|75921292|FG001|STARTED|Open-label Extended Treatment (20 Weeks)||0||
59800172|NCT03893565|75921293|FG002|STARTED|Open-label Extended Treatment (20 Weeks)||0||
59800173|NCT03893565|75921294|FG003|STARTED|Open-label Extended Treatment (20 Weeks)||0||
59800174|NCT03893565|75921295|FG004|STARTED|Open-label Extended Treatment (20 Weeks)||0||
59800175|NCT03893565|75921296|FG005|STARTED|Open-label Extended Treatment (20 Weeks)||0||
59800176|NCT03893565|75921297|FG006|STARTED|Open-label Extended Treatment (20 Weeks)||0||
59800177|NCT03893565|75921298|FG007|STARTED|Open-label Extended Treatment (20 Weeks)||0||
59800178|NCT03893565|75921299|FG008|STARTED|Open-label Extended Treatment (20 Weeks)||7||
59800179|NCT03893565|75921291|FG000|COMPLETED|Open-label Extended Treatment (20 Weeks)||0||
59800180|NCT03893565|75921292|FG001|COMPLETED|Open-label Extended Treatment (20 Weeks)||0||
59800181|NCT03893565|75921293|FG002|COMPLETED|Open-label Extended Treatment (20 Weeks)||0||
59800182|NCT03893565|75921294|FG003|COMPLETED|Open-label Extended Treatment (20 Weeks)||0||
59800183|NCT03893565|75921295|FG004|COMPLETED|Open-label Extended Treatment (20 Weeks)||0||
59800184|NCT03893565|75921296|FG005|COMPLETED|Open-label Extended Treatment (20 Weeks)||0||
59800185|NCT03893565|75921297|FG006|COMPLETED|Open-label Extended Treatment (20 Weeks)||0||
59800186|NCT03893565|75921298|FG007|COMPLETED|Open-label Extended Treatment (20 Weeks)||0||
59800187|NCT03893565|75921299|FG008|COMPLETED|Open-label Extended Treatment (20 Weeks)||3||
59800188|NCT03893565|75921291|FG000|NOT COMPLETED|Open-label Extended Treatment (20 Weeks)||0||
59800189|NCT03893565|75921292|FG001|NOT COMPLETED|Open-label Extended Treatment (20 Weeks)||0||
59800190|NCT03893565|75921293|FG002|NOT COMPLETED|Open-label Extended Treatment (20 Weeks)||0||
59800191|NCT03893565|75921294|FG003|NOT COMPLETED|Open-label Extended Treatment (20 Weeks)||0||
59800192|NCT03893565|75921295|FG004|NOT COMPLETED|Open-label Extended Treatment (20 Weeks)||0||
59800193|NCT03893565|75921296|FG005|NOT COMPLETED|Open-label Extended Treatment (20 Weeks)||0||
59800194|NCT03893565|75921297|FG006|NOT COMPLETED|Open-label Extended Treatment (20 Weeks)||0||
59800195|NCT03893565|75921298|FG007|NOT COMPLETED|Open-label Extended Treatment (20 Weeks)||0||
59800196|NCT03893565|75921299|FG008|NOT COMPLETED|Open-label Extended Treatment (20 Weeks)||4||
59800197|NCT00502996|75921318|FG000|STARTED|Overall Study||232||
59800198|NCT00502996|75921318|FG000|COMPLETED|Overall Study||188||
59800199|NCT00502996|75921318|FG000|NOT COMPLETED|Overall Study||44||
59800200|NCT00715403|75921329|FG000|STARTED|Overall Study||1||
59800201|NCT00715403|75921330|FG001|STARTED|Overall Study||1||
59800202|NCT00715403|75921331|FG002|STARTED|Overall Study||4||
59954569|NCT02778399|76073083|FG002|Included in FAS|Up to Week 12 Treatment Period||56||
59954570|NCT02778399|76073084|FG003|Included in FAS|Up to Week 12 Treatment Period||58||
59954571|NCT02778399|76073085|FG004|Included in FAS|Up to Week 12 Treatment Period||51||
59954572|NCT02778399|76073086|FG005|Included in FAS|Up to Week 12 Treatment Period||56||
59954573|NCT02778399|76073081|FG000|COMPLETED|Up to Week 12 Treatment Period||45||
59954574|NCT02778399|76073082|FG001|COMPLETED|Up to Week 12 Treatment Period||45||
59954575|NCT02778399|76073083|FG002|COMPLETED|Up to Week 12 Treatment Period||53||
59954576|NCT02778399|76073084|FG003|COMPLETED|Up to Week 12 Treatment Period||51||
59954577|NCT02778399|76073085|FG004|COMPLETED|Up to Week 12 Treatment Period||45||
59800203|NCT00715403|75921332|FG003|STARTED|Overall Study||9||
59800204|NCT00715403|75921333|FG004|STARTED|Overall Study||6||
59800205|NCT00715403|75921334|FG005|STARTED|Overall Study||19||
59800206|NCT00715403|75921335|FG006|STARTED|Overall Study||1||
59800207|NCT00715403|75921329|FG000|COMPLETED|Overall Study||0||
59523778|NCT01189279|75618745|FG002|COMPLETED|Overall Study||13||
59800208|NCT00715403|75921330|FG001|COMPLETED|Overall Study||0||
59800209|NCT00715403|75921331|FG002|COMPLETED|Overall Study||0||
59800210|NCT00715403|75921332|FG003|COMPLETED|Overall Study||0||
59800211|NCT00715403|75921333|FG004|COMPLETED|Overall Study||0||
59800212|NCT00715403|75921334|FG005|COMPLETED|Overall Study||0||
59800213|NCT00715403|75921335|FG006|COMPLETED|Overall Study||0||
59620423|NCT00258882|75731741|FG001|NOT COMPLETED|Pregnancy Surveillance||0||
59620424|NCT00176202|75731751|FG000|STARTED|Overall Study||32||
59620425|NCT00176202|75731752|FG001|STARTED|Overall Study||33||
59620426|NCT00176202|75731751|FG000|COMPLETED|Overall Study||27||
59620427|NCT00176202|75731752|FG001|COMPLETED|Overall Study||17||
59620428|NCT00176202|75731751|FG000|NOT COMPLETED|Overall Study||5||
59620429|NCT00176202|75731752|FG001|NOT COMPLETED|Overall Study||16||
59620430|NCT00176592|75731762|FG000|STARTED|Overall Study||36||
59620431|NCT00176592|75731763|FG001|STARTED|Overall Study||39||
59620432|NCT00176592|75731762|FG000|Followed for 1 Year|Overall Study||35||
59620433|NCT00176592|75731763|FG001|Followed for 1 Year|Overall Study||35||
59620434|NCT00176592|75731762|FG000|Followed for 2 Years|Overall Study||29||
59620435|NCT00176592|75731763|FG001|Followed for 2 Years|Overall Study||35||
59620436|NCT00176592|75731762|FG000|COMPLETED|Overall Study||36||
59620437|NCT00176592|75731763|FG001|COMPLETED|Overall Study||39||
59620438|NCT00176592|75731762|FG000|NOT COMPLETED|Overall Study||0||
59620439|NCT00176592|75731763|FG001|NOT COMPLETED|Overall Study||0||
59620440|NCT00176826|75731769|FG000|STARTED|Overall Study||22||
59620441|NCT00176826|75731769|FG000|COMPLETED|Overall Study||22||
59620442|NCT00176826|75731769|FG000|NOT COMPLETED|Overall Study||0||
59620443|NCT00176904|75731773|FG000|STARTED|Overall Study||135||
59620444|NCT00176904|75731773|FG000|COMPLETED|Overall Study||135||
59620445|NCT00176904|75731773|FG000|NOT COMPLETED|Overall Study||0||
59620446|NCT00179478|75731779|FG000|STARTED|Overall Study||81||
59620447|NCT00179478|75731780|FG001|STARTED|Overall Study||74||
59620448|NCT00179478|75731779|FG000|COMPLETED|Overall Study||68||
59620449|NCT00179478|75731780|FG001|COMPLETED|Overall Study||59||
59620450|NCT00179478|75731779|FG000|NOT COMPLETED|Overall Study||13||
59620451|NCT00179478|75731780|FG001|NOT COMPLETED|Overall Study||15||
59620452|NCT00182754|75731787|FG000|STARTED|Overall Study||16||
59620453|NCT00182754|75731788|FG001|STARTED|Overall Study||17||
59620454|NCT00182754|75731787|FG000|COMPLETED|Overall Study||16||
59620455|NCT00182754|75731788|FG001|COMPLETED|Overall Study||17||
59620456|NCT00182754|75731787|FG000|NOT COMPLETED|Overall Study||0||
59620457|NCT00182754|75731788|FG001|NOT COMPLETED|Overall Study||0||
59620458|NCT00183456|75731798|FG000|STARTED|Overall Study||85||
59620459|NCT00183456|75731799|FG001|STARTED|Overall Study||84||
59620460|NCT00183456|75731800|FG002|STARTED|Overall Study||329||
59620461|NCT00183456|75731801|FG003|STARTED|Overall Study||248||
59620462|NCT00183456|75731798|FG000|6 Month Follow-up|Overall Study||74||
59620463|NCT00183456|75731799|FG001|6 Month Follow-up|Overall Study||77||
59620464|NCT00183456|75731800|FG002|6 Month Follow-up|Overall Study||278||
59620465|NCT00183456|75731801|FG003|6 Month Follow-up|Overall Study||175||
59620466|NCT00183456|75731798|FG000|12 Month Follow-up|Overall Study||76||
59620467|NCT00183456|75731799|FG001|12 Month Follow-up|Overall Study||74||
59620468|NCT00183456|75731800|FG002|12 Month Follow-up|Overall Study||267||
59620469|NCT00183456|75731801|FG003|12 Month Follow-up|Overall Study||186||
59620470|NCT00183456|75731798|FG000|18 Month Follow-up|Overall Study||80||
59620471|NCT00183456|75731799|FG001|18 Month Follow-up|Overall Study||81||
59620472|NCT00183456|75731800|FG002|18 Month Follow-up|Overall Study||303||
59620473|NCT00183456|75731801|FG003|18 Month Follow-up|Overall Study||207||
59620474|NCT00183456|75731798|FG000|COMPLETED|Overall Study|total # of intervention participants that completed any follow-up (6, 12, or 18 month Follow-up)|82||
59620475|NCT00183456|75731799|FG001|COMPLETED|Overall Study|total # of comparison condition participants that completed any follow-up|83||
59620476|NCT00183456|75731800|FG002|COMPLETED|Overall Study|total # of network participants that completed any follow-up|313||
59620477|NCT00183456|75731801|FG003|COMPLETED|Overall Study|total # of non-randomized index participants that completed any follow-up|220||
59620478|NCT00183456|75731798|FG000|NOT COMPLETED|Overall Study||3||
59620479|NCT00183456|75731799|FG001|NOT COMPLETED|Overall Study||1||
59620480|NCT00183456|75731800|FG002|NOT COMPLETED|Overall Study||16||
59620481|NCT00183456|75731801|FG003|NOT COMPLETED|Overall Study||28||
59620482|NCT00184548|75731815|FG000|STARTED|Overall Study||226||
59620483|NCT00184548|75731816|FG001|STARTED|Overall Study||255||
59620484|NCT00184548|75731817|FG002|STARTED|Overall Study||47||
59620485|NCT00184548|75731818|FG003|STARTED|Overall Study||45||
59620486|NCT00184548|75731815|FG000|Exposed|Overall Study|Two subjects withdrew due to ineligibility. Excluded from safety analysis set|224||
59620487|NCT00184548|75731816|FG001|Exposed|Overall Study|Three subjects withdrew due to ineligibility, two subjects died. Excluded from safety analysis set|250||
59800214|NCT00715403|75921329|FG000|NOT COMPLETED|Overall Study||1||
59800215|NCT00715403|75921330|FG001|NOT COMPLETED|Overall Study||1||
59800216|NCT00715403|75921331|FG002|NOT COMPLETED|Overall Study||4||
59800217|NCT00715403|75921332|FG003|NOT COMPLETED|Overall Study||9||
59800218|NCT00715403|75921333|FG004|NOT COMPLETED|Overall Study||6||
59800219|NCT00715403|75921334|FG005|NOT COMPLETED|Overall Study||19||
59620488|NCT00184548|75731817|FG002|Exposed|Overall Study|One subject withdrew due to ineligibility. Excluded from safety analysis set|46||
59800220|NCT00715403|75921335|FG006|NOT COMPLETED|Overall Study||1||
59800221|NCT00502840|75921351|FG000|STARTED|Overall Study||193||
59800222|NCT00502840|75921351|FG000|COMPLETED|Overall Study||93||
59800223|NCT00502840|75921351|FG000|NOT COMPLETED|Overall Study||100||
59800224|NCT00515008|75921358|FG000|STARTED|Overall Study||33||
59800225|NCT00515008|75921359|FG001|STARTED|Overall Study||33||
59800226|NCT00515008|75921358|FG000|Completed 12 Week Evaluation|Overall Study||32||
59800227|NCT00515008|75921359|FG001|Completed 12 Week Evaluation|Overall Study||29||
59800228|NCT00515008|75921358|FG000|COMPLETED|Overall Study||30||
59800229|NCT00515008|75921359|FG001|COMPLETED|Overall Study||29||
59800230|NCT00515008|75921358|FG000|NOT COMPLETED|Overall Study||3||
59954578|NCT02778399|76073086|FG005|COMPLETED|Up to Week 12 Treatment Period||49||
59954579|NCT02778399|76073081|FG000|NOT COMPLETED|Up to Week 12 Treatment Period||9||
59954580|NCT02778399|76073082|FG001|NOT COMPLETED|Up to Week 12 Treatment Period||4||
59954581|NCT02778399|76073083|FG002|NOT COMPLETED|Up to Week 12 Treatment Period||4||
59954582|NCT02778399|76073084|FG003|NOT COMPLETED|Up to Week 12 Treatment Period||7||
59954583|NCT02778399|76073085|FG004|NOT COMPLETED|Up to Week 12 Treatment Period||8||
59800231|NCT00515008|75921359|FG001|NOT COMPLETED|Overall Study||4||
59800232|NCT00514540|75921368|FG000|STARTED|First-Line Chemo||113||
59800233|NCT00514540|75921368|FG000|COMPLETED|First-Line Chemo||105||
59800234|NCT00514540|75921368|FG000|NOT COMPLETED|First-Line Chemo||8||
59800235|NCT00514540|75921368|FG000|STARTED|Second-Line||105||
59800236|NCT00514540|75921368|FG000|COMPLETED|Second-Line||74||
59800237|NCT00514540|75921368|FG000|NOT COMPLETED|Second-Line||31||
59800238|NCT03121534|75921376|FG000|STARTED|Overall Study||9||
59800239|NCT03121534|75921376|FG000|COMPLETED|Overall Study||9||
59800240|NCT03121534|75921376|FG000|NOT COMPLETED|Overall Study||0||
59800241|NCT00713609|75921386|FG000|STARTED|Overall Study||106||
59800242|NCT00713609|75921387|FG001|STARTED|Overall Study||105||
59800243|NCT00713609|75921388|FG002|STARTED|Overall Study||107||
59800244|NCT00713609|75921389|FG003|STARTED|Overall Study||108||
59800245|NCT00713609|75921390|FG004|STARTED|Overall Study||106||
59800246|NCT00713609|75921391|FG005|STARTED|Overall Study||55||
59800247|NCT00713609|75921386|FG000|COMPLETED|Overall Study||85||
59800248|NCT00713609|75921387|FG001|COMPLETED|Overall Study||90||
59800249|NCT00713609|75921388|FG002|COMPLETED|Overall Study||92||
59800250|NCT00713609|75921389|FG003|COMPLETED|Overall Study||99||
59800251|NCT00713609|75921390|FG004|COMPLETED|Overall Study||87||
59800252|NCT00713609|75921391|FG005|COMPLETED|Overall Study||47||
59800253|NCT00713609|75921386|FG000|NOT COMPLETED|Overall Study||21||
59800254|NCT00713609|75921387|FG001|NOT COMPLETED|Overall Study||15||
59800255|NCT00713609|75921388|FG002|NOT COMPLETED|Overall Study||15||
59800256|NCT00713609|75921389|FG003|NOT COMPLETED|Overall Study||9||
59800257|NCT00713609|75921390|FG004|NOT COMPLETED|Overall Study||19||
59954584|NCT02778399|76073086|FG005|NOT COMPLETED|Up to Week 12 Treatment Period||8||
59954585|NCT02778399|76073081|FG000|STARTED|Week 12 to Week 24 Treatment Period||45||
59954586|NCT02778399|76073082|FG001|STARTED|Week 12 to Week 24 Treatment Period||45||
59954587|NCT02778399|76073083|FG002|STARTED|Week 12 to Week 24 Treatment Period||53||
59954588|NCT02778399|76073084|FG003|STARTED|Week 12 to Week 24 Treatment Period||51||
59954589|NCT02778399|76073085|FG004|STARTED|Week 12 to Week 24 Treatment Period||45||
59954590|NCT02778399|76073086|FG005|STARTED|Week 12 to Week 24 Treatment Period||49||
59954591|NCT02778399|76073081|FG000|COMPLETED|Week 12 to Week 24 Treatment Period||37||
59954592|NCT02778399|76073082|FG001|COMPLETED|Week 12 to Week 24 Treatment Period||41||
59954593|NCT02778399|76073083|FG002|COMPLETED|Week 12 to Week 24 Treatment Period||48||
59954594|NCT02778399|76073084|FG003|COMPLETED|Week 12 to Week 24 Treatment Period||46||
59954595|NCT02778399|76073085|FG004|COMPLETED|Week 12 to Week 24 Treatment Period||39||
59954596|NCT02778399|76073086|FG005|COMPLETED|Week 12 to Week 24 Treatment Period||42||
59954597|NCT02778399|76073081|FG000|NOT COMPLETED|Week 12 to Week 24 Treatment Period||8||
59954598|NCT02778399|76073082|FG001|NOT COMPLETED|Week 12 to Week 24 Treatment Period||4||
59954599|NCT02778399|76073083|FG002|NOT COMPLETED|Week 12 to Week 24 Treatment Period||5||
59954600|NCT02778399|76073084|FG003|NOT COMPLETED|Week 12 to Week 24 Treatment Period||5||
59954601|NCT02778399|76073085|FG004|NOT COMPLETED|Week 12 to Week 24 Treatment Period||6||
59954602|NCT02778399|76073086|FG005|NOT COMPLETED|Week 12 to Week 24 Treatment Period||7||
59954603|NCT01994980|76073107|FG000|STARTED|Overall Study||7||
59954604|NCT01994980|76073108|FG001|STARTED|Overall Study||14||
59954605|NCT01994980|76073107|FG000|COMPLETED|Overall Study||7||
59954606|NCT01994980|76073108|FG001|COMPLETED|Overall Study||14||
59800258|NCT00713609|75921391|FG005|NOT COMPLETED|Overall Study||8||
59800259|NCT00513682|75921405|FG000|STARTED|Screening Phase||9||
59800260|NCT00513682|75921405|FG000|COMPLETED|Screening Phase||9||
59800261|NCT00513682|75921405|FG000|NOT COMPLETED|Screening Phase||0||
59800262|NCT00513682|75921405|FG000|STARTED|Washout Phase||9||
59800263|NCT00513682|75921405|FG000|COMPLETED|Washout Phase||7||
59800264|NCT00513682|75921405|FG000|NOT COMPLETED|Washout Phase||2||
59800265|NCT00513682|75921405|FG000|STARTED|Treatment Phase||7||
59800266|NCT00513682|75921405|FG000|COMPLETED|Treatment Phase||7||
59800267|NCT00513682|75921405|FG000|NOT COMPLETED|Treatment Phase||0||
59800268|NCT00493012|75921414|FG000|STARTED|Overall Study||100||
59800269|NCT00493012|75921415|FG001|STARTED|Overall Study||100||
59800270|NCT00493012|75921414|FG000|COMPLETED|Overall Study||82||
59800271|NCT00493012|75921415|FG001|COMPLETED|Overall Study||83||
59800272|NCT00493012|75921414|FG000|NOT COMPLETED|Overall Study||18||
59800273|NCT00493012|75921415|FG001|NOT COMPLETED|Overall Study||17||
59800274|NCT05144477|75921423|FG000|STARTED|Overall Study||11||
59800275|NCT05144477|75921424|FG001|STARTED|Overall Study||5||
59800276|NCT05144477|75921423|FG000|COMPLETED|Overall Study||10||
59800277|NCT05144477|75921424|FG001|COMPLETED|Overall Study||4||
59800278|NCT05144477|75921423|FG000|NOT COMPLETED|Overall Study||1||
59800279|NCT05144477|75921424|FG001|NOT COMPLETED|Overall Study||1||
59800280|NCT05238233|75921432|FG000|STARTED|Overall Study||11||11
59800281|NCT05238233|75921433|FG001|STARTED|Overall Study||0||0
59800282|NCT05238233|75921432|FG000|COMPLETED|Overall Study||10||10
59800283|NCT05238233|75921433|FG001|COMPLETED|Overall Study||0||0
59800284|NCT05238233|75921432|FG000|NOT COMPLETED|Overall Study||1||1
59800285|NCT05238233|75921433|FG001|NOT COMPLETED|Overall Study||0||0
59800286|NCT00617708|75921440|FG000|STARTED|Overall Study||10||
59800287|NCT00617708|75921441|FG001|STARTED|Overall Study||60||
59800288|NCT00617708|75921442|FG002|STARTED|Overall Study||64||
59800289|NCT00617708|75921440|FG000|Eligible and Began Protocol Therapy|Overall Study||9||
59800290|NCT00617708|75921441|FG001|Eligible and Began Protocol Therapy|Overall Study||57||
59800291|NCT00617708|75921442|FG002|Eligible and Began Protocol Therapy|Overall Study||59||
59800292|NCT00617708|75921440|FG000|COMPLETED|Overall Study||0||
59800293|NCT00617708|75921441|FG001|COMPLETED|Overall Study||0||
59800294|NCT00617708|75921442|FG002|COMPLETED|Overall Study||0||
59800295|NCT00617708|75921440|FG000|NOT COMPLETED|Overall Study||10||
59800296|NCT00617708|75921441|FG001|NOT COMPLETED|Overall Study||60||
59800297|NCT00617708|75921442|FG002|NOT COMPLETED|Overall Study||64||
59800298|NCT03894969|75921457|FG000|STARTED|Overall Study||134||
59800299|NCT03894969|75921458|FG001|STARTED|Overall Study||134||
59800300|NCT03894969|75921459|FG002|STARTED|Overall Study||122||
59800301|NCT03894969|75921460|FG003|STARTED|Overall Study||135||
59800302|NCT03894969|75921461|FG004|STARTED|Overall Study||16||
59800303|NCT03894969|75921457|FG000|COMPLETED|Overall Study||129||
59800304|NCT03894969|75921458|FG001|COMPLETED|Overall Study||129||
59800305|NCT03894969|75921459|FG002|COMPLETED|Overall Study||118||
59800306|NCT03894969|75921460|FG003|COMPLETED|Overall Study||128||
59800307|NCT03894969|75921461|FG004|COMPLETED|Overall Study||2||
59800308|NCT03894969|75921457|FG000|NOT COMPLETED|Overall Study||5||
59800309|NCT03894969|75921458|FG001|NOT COMPLETED|Overall Study||5||
59800310|NCT03894969|75921459|FG002|NOT COMPLETED|Overall Study||4||
59800311|NCT03894969|75921460|FG003|NOT COMPLETED|Overall Study||7||
59800312|NCT03894969|75921461|FG004|NOT COMPLETED|Overall Study||14||
59800313|NCT03894813|75921477|FG000|STARTED|Overall Study||63||
59800314|NCT03894813|75921478|FG001|STARTED|Overall Study||63||
59800315|NCT03894813|75921477|FG000|COMPLETED|Overall Study||52||
59800316|NCT03894813|75921478|FG001|COMPLETED|Overall Study||47||
59800317|NCT03894813|75921477|FG000|NOT COMPLETED|Overall Study||11||
59800318|NCT03894813|75921478|FG001|NOT COMPLETED|Overall Study||16||
59800319|NCT00615992|75921484|FG000|STARTED|Overall Study||754||
59800320|NCT00615992|75921484|FG000|COMPLETED|Overall Study||687||
59800321|NCT00615992|75921484|FG000|NOT COMPLETED|Overall Study||67||
59800322|NCT03892707|75921490|FG000|STARTED|Overall Study||250||
59800323|NCT03892707|75921491|FG001|STARTED|Overall Study||250||
59800324|NCT03892707|75921490|FG000|Started Study Treatment at Baseline|Overall Study||244||
59800325|NCT03892707|75921491|FG001|Started Study Treatment at Baseline|Overall Study||250||
59800326|NCT03892707|75921490|FG000|COMPLETED|Overall Study||244||
59800327|NCT03892707|75921491|FG001|COMPLETED|Overall Study||244||
59800328|NCT03892707|75921490|FG000|NOT COMPLETED|Overall Study||6||
59800329|NCT03892707|75921491|FG001|NOT COMPLETED|Overall Study||6||
59800330|NCT00615914|75921498|FG000|STARTED|Overall Study|The number of patients enrolled|1645||
59800331|NCT00615914|75921498|FG000|COMPLETED|Overall Study||1008||
59800332|NCT00615914|75921498|FG000|NOT COMPLETED|Overall Study||637||
59800333|NCT00513604|75921508|FG000|STARTED|Overall Study|Cohort 1 = unselected TIL|26||
59800334|NCT00513604|75921509|FG001|STARTED|Overall Study|Cohort 2 = CD4+ depleted (selected) TIL|39||
59800335|NCT00513604|75921510|FG002|STARTED|Overall Study|Cohort 3 = CD4+ depleted (selected) TIL + 600Gy radiation|24||
59800336|NCT00513604|75921511|FG003|STARTED|Overall Study|Cohort 4 = unselected TIL - it is the SAME as cohort 1|34||
59800337|NCT00513604|75921512|FG004|STARTED|Overall Study|Cohort 5 = CD4+ depleted TIL-it is the SAME as cohort 2|35||
59800338|NCT00513604|75921508|FG000|COMPLETED|Overall Study||24||
59800339|NCT00513604|75921509|FG001|COMPLETED|Overall Study||36||
59800340|NCT00513604|75921510|FG002|COMPLETED|Overall Study||21||
59800341|NCT00513604|75921511|FG003|COMPLETED|Overall Study||34||
59800342|NCT00513604|75921512|FG004|COMPLETED|Overall Study||35||
59800343|NCT00513604|75921508|FG000|NOT COMPLETED|Overall Study||2||
59800344|NCT00513604|75921509|FG001|NOT COMPLETED|Overall Study||3||
59800345|NCT00513604|75921510|FG002|NOT COMPLETED|Overall Study||3||
59800346|NCT00513604|75921511|FG003|NOT COMPLETED|Overall Study||0||
59800347|NCT00513604|75921512|FG004|NOT COMPLETED|Overall Study||0||
59800348|NCT00534105|75921526|FG000|STARTED|Overall Study||47||
59800349|NCT00534105|75921527|FG001|STARTED|Overall Study||59||
59800350|NCT00534105|75921526|FG000|COMPLETED|Overall Study||24||
59800351|NCT00534105|75921527|FG001|COMPLETED|Overall Study||20||
59800352|NCT00534105|75921526|FG000|NOT COMPLETED|Overall Study||23||
59800353|NCT00534105|75921527|FG001|NOT COMPLETED|Overall Study||39||
59800354|NCT05084885|75921533|FG000|STARTED|Baseline||3||
59800355|NCT05084885|75921534|FG001|STARTED|Baseline||13||
59800356|NCT05084885|75921533|FG000|Treated|Baseline||2||
59800357|NCT05084885|75921534|FG001|Treated|Baseline||0||
59800358|NCT05084885|75921533|FG000|Not Treated|Baseline||1||
59800359|NCT05084885|75921534|FG001|Not Treated|Baseline||13||
59800360|NCT05084885|75921533|FG000|COMPLETED|Baseline||2||
59800361|NCT05084885|75921534|FG001|COMPLETED|Baseline||13||
59800362|NCT05084885|75921533|FG000|NOT COMPLETED|Baseline||1||
59800363|NCT05084885|75921534|FG001|NOT COMPLETED|Baseline||0||
59800364|NCT05084885|75921533|FG000|STARTED|Post Treatment||2||
59800365|NCT05084885|75921534|FG001|STARTED|Post Treatment||13||
59800366|NCT05084885|75921533|FG000|COMPLETED|Post Treatment||2||
59800367|NCT05084885|75921534|FG001|COMPLETED|Post Treatment||13||
59800368|NCT05084885|75921533|FG000|NOT COMPLETED|Post Treatment||0||
59800369|NCT05084885|75921534|FG001|NOT COMPLETED|Post Treatment||0||
59800370|NCT05084885|75921533|FG000|STARTED|Follow-up||2||
59800371|NCT05084885|75921534|FG001|STARTED|Follow-up||13||
59800372|NCT05084885|75921533|FG000|Treated|Follow-up||2||
59800373|NCT05084885|75921534|FG001|Treated|Follow-up||0||
59800374|NCT05084885|75921533|FG000|Not Treated|Follow-up||0||
59800375|NCT05084885|75921534|FG001|Not Treated|Follow-up||13||
59800376|NCT05084885|75921533|FG000|COMPLETED|Follow-up||2||
59800377|NCT05084885|75921534|FG001|COMPLETED|Follow-up||8||
59800378|NCT05084885|75921533|FG000|NOT COMPLETED|Follow-up||0||
59800379|NCT05084885|75921534|FG001|NOT COMPLETED|Follow-up||5||
59800380|NCT00573248|75921542|FG000|STARTED|Overall Study||40||
59800381|NCT00573248|75921543|FG001|STARTED|Overall Study||38||
59800382|NCT00573248|75921542|FG000|Nicotine Patches and Placebo Patches|Overall Study||25||
59800383|NCT00573248|75921543|FG001|Nicotine Patches and Placebo Patches|Overall Study||27||
59800384|NCT00573248|75921542|FG000|COMPLETED|Overall Study||25||
59800385|NCT00573248|75921543|FG001|COMPLETED|Overall Study||27||
59800386|NCT00573248|75921542|FG000|NOT COMPLETED|Overall Study||15||
59800387|NCT00573248|75921543|FG001|NOT COMPLETED|Overall Study||11||
59800388|NCT00532935|75921551|FG000|STARTED|Overall Study|Excludes 1 patient who was randomized twice at different sites.|261||
59800389|NCT00532935|75921552|FG001|STARTED|Overall Study|Excludes 1 patient who was randomized twice at different sites.|256||
59800390|NCT00532935|75921551|FG000|COMPLETED|Overall Study||210||
59800391|NCT00532935|75921552|FG001|COMPLETED|Overall Study||204||
59800392|NCT00532935|75921551|FG000|NOT COMPLETED|Overall Study||51||
59800393|NCT00532935|75921552|FG001|NOT COMPLETED|Overall Study||52||
59800394|NCT03016312|75921560|FG000|STARTED|Overall Study||391||
59800395|NCT03016312|75921561|FG001|STARTED|Overall Study||380||
59800396|NCT03016312|75921560|FG000|COMPLETED|Overall Study||150||
59800397|NCT03016312|75921561|FG001|COMPLETED|Overall Study||162||
59800398|NCT03016312|75921560|FG000|NOT COMPLETED|Overall Study||241||
59800399|NCT03016312|75921561|FG001|NOT COMPLETED|Overall Study||218||
59800400|NCT00512902|75921567|FG000|STARTED|Overall Study||20||
59800401|NCT00512902|75921567|FG000|COMPLETED|Overall Study||12||
59800402|NCT00512902|75921567|FG000|NOT COMPLETED|Overall Study||8||
59800403|NCT00492232|75921573|FG000|STARTED|Placebo Run-in||0||
59800404|NCT00492232|75921574|FG001|STARTED|Placebo Run-in|All subjects received placebo in the placebo run-in period.|205||
59800405|NCT00492232|75921573|FG000|COMPLETED|Placebo Run-in||0||
59800406|NCT00492232|75921574|FG001|COMPLETED|Placebo Run-in|These subjects successfully completed the placebo run-in period and were randomized to the DBTP.|135||
59800407|NCT00492232|75921573|FG000|NOT COMPLETED|Placebo Run-in||0||
59800408|NCT00492232|75921574|FG001|NOT COMPLETED|Placebo Run-in||70||
59800409|NCT00492232|75921573|FG000|STARTED|Double-Blind Treatment||65||
59800410|NCT00492232|75921574|FG001|STARTED|Double-Blind Treatment||70||
59800411|NCT00492232|75921573|FG000|COMPLETED|Double-Blind Treatment||47||
59800412|NCT00492232|75921574|FG001|COMPLETED|Double-Blind Treatment||45||
59800413|NCT00492232|75921573|FG000|NOT COMPLETED|Double-Blind Treatment||18||
59800414|NCT00492232|75921574|FG001|NOT COMPLETED|Double-Blind Treatment||25||
59800415|NCT00492232|75921573|FG000|STARTED|Open-Label Treatment|In the previous DBTP, 45 and 44 subjects were randomized to ramelteon and placebo, respectively.|89||
59800416|NCT00492232|75921574|FG001|STARTED|Open-Label Treatment|All subjects received ramelteon in the OLTP.|0||
59800417|NCT00492232|75921573|FG000|COMPLETED|Open-Label Treatment||88||
59800418|NCT00492232|75921574|FG001|COMPLETED|Open-Label Treatment||0||
59800419|NCT00492232|75921573|FG000|NOT COMPLETED|Open-Label Treatment||1||
59800420|NCT00492232|75921574|FG001|NOT COMPLETED|Open-Label Treatment||0||
59800421|NCT00491764|75921586|FG000|STARTED|Overall Study||37||
59800422|NCT00491764|75921587|FG001|STARTED|Overall Study||37||
59800423|NCT00491764|75921588|FG002|STARTED|Overall Study||36||
59800424|NCT00491764|75921589|FG003|STARTED|Overall Study||36||
59800425|NCT00491764|75921590|FG004|STARTED|Overall Study||36||
59800426|NCT00491764|75921591|FG005|STARTED|Overall Study||36||
59800427|NCT00491764|75921586|FG000|COMPLETED|Overall Study||32||
59800428|NCT00491764|75921587|FG001|COMPLETED|Overall Study||30||
59800429|NCT00491764|75921588|FG002|COMPLETED|Overall Study||28||
59800430|NCT00491764|75921589|FG003|COMPLETED|Overall Study||28||
59800431|NCT00491764|75921590|FG004|COMPLETED|Overall Study||33||
59800432|NCT00491764|75921591|FG005|COMPLETED|Overall Study||27||
59800433|NCT00491764|75921586|FG000|NOT COMPLETED|Overall Study||5||
59800434|NCT00491764|75921587|FG001|NOT COMPLETED|Overall Study||7||
59800435|NCT00491764|75921588|FG002|NOT COMPLETED|Overall Study||8||
59800436|NCT00491764|75921589|FG003|NOT COMPLETED|Overall Study||8||
59800437|NCT00491764|75921590|FG004|NOT COMPLETED|Overall Study||3||
59800438|NCT00491764|75921591|FG005|NOT COMPLETED|Overall Study||9||
59800439|NCT00491608|75921605|FG000|STARTED|Overall Study|Participants who received treatment|209||
59800440|NCT00491608|75921605|FG000|COMPLETED|Overall Study||206||
59800441|NCT00491608|75921605|FG000|NOT COMPLETED|Overall Study||3||
59800442|NCT00615836|75921613|FG000|STARTED|Part I of Core Study (FE992026 CS29)||163||
59800443|NCT00615836|75921614|FG001|STARTED|Part I of Core Study (FE992026 CS29)||158||
59800444|NCT00615836|75921615|FG002|STARTED|Part I of Core Study (FE992026 CS29)||158||
59800445|NCT00615836|75921616|FG003|STARTED|Part I of Core Study (FE992026 CS29)||160||
59800446|NCT00615836|75921617|FG004|STARTED|Part I of Core Study (FE992026 CS29)||160||
59800447|NCT00615836|75921613|FG000|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|155||
59800448|NCT00615836|75921614|FG001|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|152||
59800449|NCT00615836|75921615|FG002|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|148||
59800450|NCT00615836|75921616|FG003|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|146||
59800451|NCT00615836|75921617|FG004|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|156||
59800452|NCT00615836|75921613|FG000|COMPLETED|Part I of Core Study (FE992026 CS29)||144||
59800453|NCT00615836|75921614|FG001|COMPLETED|Part I of Core Study (FE992026 CS29)||148||
59800454|NCT00615836|75921615|FG002|COMPLETED|Part I of Core Study (FE992026 CS29)||138||
59800455|NCT00615836|75921616|FG003|COMPLETED|Part I of Core Study (FE992026 CS29)||135||
59800456|NCT00615836|75921617|FG004|COMPLETED|Part I of Core Study (FE992026 CS29)||145||
59800457|NCT00615836|75921613|FG000|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||19||
59800458|NCT00615836|75921614|FG001|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||10||
59800459|NCT00615836|75921615|FG002|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||20||
59800460|NCT00615836|75921616|FG003|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||25||
59800461|NCT00615836|75921617|FG004|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||15||
59800462|NCT00615836|75921613|FG000|STARTED|Extension Study (FE992026 CS31)||141||
59800463|NCT00615836|75921614|FG001|STARTED|Extension Study (FE992026 CS31)||144||
59800464|NCT00615836|75921615|FG002|STARTED|Extension Study (FE992026 CS31)||132||
59800465|NCT00615836|75921616|FG003|STARTED|Extension Study (FE992026 CS31)||137||
59800466|NCT00615836|75921617|FG004|STARTED|Extension Study (FE992026 CS31)||0||
59800467|NCT00615836|75921613|FG000|COMPLETED|Extension Study (FE992026 CS31)||0||
59800468|NCT00615836|75921614|FG001|COMPLETED|Extension Study (FE992026 CS31)||58||
59800469|NCT00615836|75921615|FG002|COMPLETED|Extension Study (FE992026 CS31)||59||
59800470|NCT00615836|75921616|FG003|COMPLETED|Extension Study (FE992026 CS31)||53||
59800471|NCT00615836|75921617|FG004|COMPLETED|Extension Study (FE992026 CS31)||0||
59800472|NCT00615836|75921613|FG000|NOT COMPLETED|Extension Study (FE992026 CS31)||141||
59800473|NCT00615836|75921614|FG001|NOT COMPLETED|Extension Study (FE992026 CS31)||86||
59800474|NCT00615836|75921615|FG002|NOT COMPLETED|Extension Study (FE992026 CS31)||73||
59800475|NCT00615836|75921616|FG003|NOT COMPLETED|Extension Study (FE992026 CS31)||84||
59800476|NCT00615836|75921617|FG004|NOT COMPLETED|Extension Study (FE992026 CS31)||0||
59800477|NCT00491530|75921636|FG000|STARTED|Overall Study||174||
59800478|NCT00491530|75921637|FG001|STARTED|Overall Study||50||
59800479|NCT00491530|75921638|FG002|STARTED|Overall Study||86||
59800480|NCT00491530|75921636|FG000|COMPLETED|Overall Study||162||
59800481|NCT00491530|75921637|FG001|COMPLETED|Overall Study||44||
59800482|NCT00491530|75921638|FG002|COMPLETED|Overall Study||81||
59800483|NCT00491530|75921636|FG000|NOT COMPLETED|Overall Study||12||
59800484|NCT00491530|75921637|FG001|NOT COMPLETED|Overall Study||6||
59800485|NCT00491530|75921638|FG002|NOT COMPLETED|Overall Study||5||
59954607|NCT01994980|76073107|FG000|NOT COMPLETED|Overall Study||0||
59954608|NCT01994980|76073108|FG001|NOT COMPLETED|Overall Study||0||
59954609|NCT03861728|76073116|FG000|STARTED|Overall Study||6||
59954610|NCT03861728|76073117|FG001|STARTED|Overall Study||5||
59954611|NCT03861728|76073116|FG000|COMPLETED|Overall Study||6||
59954612|NCT03861728|76073117|FG001|COMPLETED|Overall Study||5||
59954613|NCT03861728|76073116|FG000|NOT COMPLETED|Overall Study||0||
59954614|NCT03861728|76073117|FG001|NOT COMPLETED|Overall Study||0||
59954615|NCT03688802|76073125|FG000|STARTED|Overall Study||12||
59954616|NCT03688802|76073126|FG001|STARTED|Overall Study||6||
59954617|NCT03688802|76073125|FG000|COMPLETED|Overall Study||11||
59954618|NCT03688802|76073126|FG001|COMPLETED|Overall Study||6||
59800486|NCT00617240|75921648|FG000|STARTED|Overall Study||5||
59800487|NCT00617240|75921649|FG001|STARTED|Overall Study||4||
59800488|NCT00617240|75921648|FG000|COMPLETED|Overall Study||4||
59800489|NCT00617240|75921649|FG001|COMPLETED|Overall Study||4||
59800490|NCT00617240|75921648|FG000|NOT COMPLETED|Overall Study||1||
59800491|NCT00617240|75921649|FG001|NOT COMPLETED|Overall Study||0||
59954619|NCT03688802|76073125|FG000|NOT COMPLETED|Overall Study||1||
59800492|NCT00615290|75921655|FG000|STARTED|Overall Study||42||
59800493|NCT00615290|75921655|FG000|COMPLETED|Overall Study||34||
59800494|NCT00615290|75921655|FG000|NOT COMPLETED|Overall Study||8||
59800495|NCT00501046|75921661|FG000|STARTED|Overall Study||508||
59800496|NCT00501046|75921662|FG001|STARTED|Overall Study||507||
59800497|NCT00501046|75921661|FG000|COMPLETED|Overall Study||238||
59800498|NCT00501046|75921662|FG001|COMPLETED|Overall Study||213||
59800499|NCT00501046|75921661|FG000|NOT COMPLETED|Overall Study||270||
59800500|NCT00501046|75921662|FG001|NOT COMPLETED|Overall Study||294||
59800501|NCT00533949|75921672|FG000|STARTED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|166||
59800502|NCT00533949|75921673|FG001|STARTED|Overall Study||121||
59800503|NCT00533949|75921674|FG002|STARTED|Overall Study||147||
59800504|NCT00533949|75921675|FG003|STARTED|Overall Study||110||
59800505|NCT00533949|75921672|FG000|COMPLETED|Overall Study||151||
59800506|NCT00533949|75921673|FG001|COMPLETED|Overall Study||107||
59800507|NCT00533949|75921674|FG002|COMPLETED|Overall Study||137||
59800508|NCT00533949|75921675|FG003|COMPLETED|Overall Study||100||
59800509|NCT00533949|75921672|FG000|NOT COMPLETED|Overall Study||15||
59800510|NCT00533949|75921673|FG001|NOT COMPLETED|Overall Study||14||
59800511|NCT00533949|75921674|FG002|NOT COMPLETED|Overall Study||10||
59800512|NCT00533949|75921675|FG003|NOT COMPLETED|Overall Study||10||
59800513|NCT00485134|75921701|FG000|STARTED|Overall Study||12||
59800514|NCT00485134|75921702|FG001|STARTED|Overall Study||12||
59800515|NCT00485134|75921703|FG002|STARTED|Overall Study||12||
59800516|NCT00485134|75921704|FG003|STARTED|Overall Study||8||
59800517|NCT00485134|75921705|FG004|STARTED|Overall Study||10||
59800518|NCT00485134|75921706|FG005|STARTED|Overall Study||7||
59800519|NCT00485134|75921707|FG006|STARTED|Overall Study||31||
59800520|NCT00485134|75921708|FG007|STARTED|Overall Study||21||
59800521|NCT00485134|75921701|FG000|COMPLETED|Overall Study||11||
59800522|NCT00485134|75921702|FG001|COMPLETED|Overall Study||10||
59800523|NCT00485134|75921703|FG002|COMPLETED|Overall Study||9||
59800524|NCT00485134|75921704|FG003|COMPLETED|Overall Study||7||
59800525|NCT00485134|75921705|FG004|COMPLETED|Overall Study||7||
59800526|NCT00485134|75921706|FG005|COMPLETED|Overall Study||3||
59800527|NCT00485134|75921707|FG006|COMPLETED|Overall Study||28||
59800528|NCT00485134|75921708|FG007|COMPLETED|Overall Study||20||
59800529|NCT00485134|75921701|FG000|NOT COMPLETED|Overall Study||1||
59954620|NCT03688802|76073126|FG001|NOT COMPLETED|Overall Study||0||
59954621|NCT03656744|76073135|FG000|STARTED|Overall Study||34||
59954622|NCT03656744|76073136|FG001|STARTED|Overall Study||34||
59954623|NCT03656744|76073137|FG002|STARTED|Overall Study||33||
59954624|NCT03656744|76073135|FG000|COMPLETED|Overall Study||29||
59954625|NCT03656744|76073136|FG001|COMPLETED|Overall Study||27||
59954626|NCT03656744|76073137|FG002|COMPLETED|Overall Study||32||
59954627|NCT03656744|76073135|FG000|NOT COMPLETED|Overall Study||5||
59954628|NCT03656744|76073136|FG001|NOT COMPLETED|Overall Study||7||
59800530|NCT00485134|75921702|FG001|NOT COMPLETED|Overall Study||2||
59800531|NCT00485134|75921703|FG002|NOT COMPLETED|Overall Study||3||
59800532|NCT00485134|75921704|FG003|NOT COMPLETED|Overall Study||1||
59800533|NCT00485134|75921705|FG004|NOT COMPLETED|Overall Study||3||
59800534|NCT00485134|75921706|FG005|NOT COMPLETED|Overall Study||4||
59800535|NCT00485134|75921707|FG006|NOT COMPLETED|Overall Study||3||
59800536|NCT00485134|75921708|FG007|NOT COMPLETED|Overall Study||1||
59800537|NCT00583115|75921720|FG000|STARTED|Overall Study||1||
59800538|NCT00583115|75921720|FG000|COMPLETED|Overall Study||0||
59954629|NCT03656744|76073137|FG002|NOT COMPLETED|Overall Study||1||
59954630|NCT02739360|76073145|FG000|STARTED|Overall Study||3||
59954631|NCT02739360|76073145|FG000|COMPLETED|Overall Study||0||
59800539|NCT00583115|75921720|FG000|NOT COMPLETED|Overall Study||1||
59800540|NCT00532779|75921727|FG000|STARTED|Overall Study||578||
59800541|NCT00532779|75921728|FG001|STARTED|Overall Study||583||
59800542|NCT00532779|75921729|FG002|STARTED|Overall Study||581||
59800543|NCT00532779|75921727|FG000|COMPLETED|Overall Study||284||
59800544|NCT00532779|75921728|FG001|COMPLETED|Overall Study||296||
59800545|NCT00532779|75921729|FG002|COMPLETED|Overall Study||290||
59954632|NCT02739360|76073145|FG000|NOT COMPLETED|Overall Study||3||
59954633|NCT01822522|76073155|FG000|STARTED|Overall Study||6||
59954634|NCT01822522|76073156|FG001|STARTED|Overall Study||7||
59954635|NCT01822522|76073157|FG002|STARTED|Overall Study||7||
59954636|NCT01822522|76073158|FG003|STARTED|Overall Study||6||
59954637|NCT01822522|76073159|FG004|STARTED|Overall Study||3||
59800546|NCT00532779|75921727|FG000|NOT COMPLETED|Overall Study||294||
59800547|NCT00532779|75921728|FG001|NOT COMPLETED|Overall Study||287||
59800548|NCT00532779|75921729|FG002|NOT COMPLETED|Overall Study||291||
59800549|NCT00500266|75921737|FG000|STARTED|Overall Study||1053||
59800550|NCT00500266|75921737|FG000|Treated|Overall Study||1049||
59800551|NCT00500266|75921737|FG000|COMPLETED|Overall Study||1040||
59800552|NCT00500266|75921737|FG000|NOT COMPLETED|Overall Study||13||
59954638|NCT01822522|76073160|FG005|STARTED|Overall Study||7||
59954639|NCT01822522|76073155|FG000|COMPLETED|Overall Study||2||
59800553|NCT00500110|75921742|FG000|STARTED|Overall Study||39||
59800554|NCT00500110|75921742|FG000|COMPLETED|Overall Study||36||
59800555|NCT00500110|75921742|FG000|NOT COMPLETED|Overall Study||3||
59800556|NCT00534495|75921748|FG000|STARTED|Double Blind Placebo Phase Week 0-4||36||
59954640|NCT01822522|76073156|FG001|COMPLETED|Overall Study||6||
59954641|NCT01822522|76073157|FG002|COMPLETED|Overall Study||3||
59800557|NCT00534495|75921749|FG001|STARTED|Double Blind Placebo Phase Week 0-4||35||
59800558|NCT00534495|75921750|FG002|STARTED|Double Blind Placebo Phase Week 0-4||0||
59800559|NCT00534495|75921748|FG000|COMPLETED|Double Blind Placebo Phase Week 0-4||36||
59800560|NCT00534495|75921749|FG001|COMPLETED|Double Blind Placebo Phase Week 0-4||34||
59800561|NCT00534495|75921750|FG002|COMPLETED|Double Blind Placebo Phase Week 0-4||0||
59800562|NCT00534495|75921748|FG000|NOT COMPLETED|Double Blind Placebo Phase Week 0-4||0||
59800563|NCT00534495|75921749|FG001|NOT COMPLETED|Double Blind Placebo Phase Week 0-4||1||
59800564|NCT00534495|75921750|FG002|NOT COMPLETED|Double Blind Placebo Phase Week 0-4||0||
59800565|NCT00534495|75921748|FG000|STARTED|All Active Treatment Phase Week 4-24||36||
59800566|NCT00534495|75921749|FG001|STARTED|All Active Treatment Phase Week 4-24||34||
59800567|NCT00534495|75921750|FG002|STARTED|All Active Treatment Phase Week 4-24||0||
59800568|NCT00534495|75921748|FG000|COMPLETED|All Active Treatment Phase Week 4-24||32||
59800569|NCT00534495|75921749|FG001|COMPLETED|All Active Treatment Phase Week 4-24||25||
59800570|NCT00534495|75921750|FG002|COMPLETED|All Active Treatment Phase Week 4-24||0||
59800571|NCT00534495|75921748|FG000|NOT COMPLETED|All Active Treatment Phase Week 4-24||4||
59800572|NCT00534495|75921749|FG001|NOT COMPLETED|All Active Treatment Phase Week 4-24||9||
59800573|NCT00534495|75921750|FG002|NOT COMPLETED|All Active Treatment Phase Week 4-24||0||
59800574|NCT00534495|75921748|FG000|STARTED|Long Term Ext. Phase Week 24-month 21||0||
59800575|NCT00534495|75921749|FG001|STARTED|Long Term Ext. Phase Week 24-month 21||0||
59800576|NCT00534495|75921750|FG002|STARTED|Long Term Ext. Phase Week 24-month 21||40||
59800577|NCT00534495|75921748|FG000|COMPLETED|Long Term Ext. Phase Week 24-month 21||0||
59800578|NCT00534495|75921749|FG001|COMPLETED|Long Term Ext. Phase Week 24-month 21||0||
59800579|NCT00534495|75921750|FG002|COMPLETED|Long Term Ext. Phase Week 24-month 21||29||
59800580|NCT00534495|75921748|FG000|NOT COMPLETED|Long Term Ext. Phase Week 24-month 21||0||
59800581|NCT00534495|75921749|FG001|NOT COMPLETED|Long Term Ext. Phase Week 24-month 21||0||
59800582|NCT00534495|75921750|FG002|NOT COMPLETED|Long Term Ext. Phase Week 24-month 21||11||
59800583|NCT03827213|75921763|FG000|STARTED|Overall Study||11||
59800584|NCT03827213|75921764|FG001|STARTED|Overall Study||12||
59800585|NCT03827213|75921763|FG000|COMPLETED|Overall Study||7||
59800586|NCT03827213|75921764|FG001|COMPLETED|Overall Study||11||
59800587|NCT03827213|75921763|FG000|NOT COMPLETED|Overall Study||4||
59800588|NCT03827213|75921764|FG001|NOT COMPLETED|Overall Study||1||
59800589|NCT00484198|75921774|FG000|STARTED|Overall Study||137||
59800590|NCT00484198|75921775|FG001|STARTED|Overall Study||274||
59800591|NCT00484198|75921776|FG002|STARTED|Overall Study||750||
59800592|NCT00484198|75921777|FG003|STARTED|Overall Study||751||
59800593|NCT00484198|75921774|FG000|COMPLETED|Overall Study||96||
59800594|NCT00484198|75921775|FG001|COMPLETED|Overall Study||208||
59800595|NCT00484198|75921776|FG002|COMPLETED|Overall Study||599||
59800596|NCT00484198|75921777|FG003|COMPLETED|Overall Study||579||
59800597|NCT00484198|75921774|FG000|NOT COMPLETED|Overall Study||41||
59800598|NCT00484198|75921775|FG001|NOT COMPLETED|Overall Study||66||
59800599|NCT00484198|75921776|FG002|NOT COMPLETED|Overall Study||151||
59800600|NCT00484198|75921777|FG003|NOT COMPLETED|Overall Study||172||
59800601|NCT00499486|75921792|FG000|STARTED|Overall Study||47||
59800602|NCT00499486|75921792|FG000|COMPLETED|Overall Study||31||
59800603|NCT00499486|75921792|FG000|NOT COMPLETED|Overall Study||16||
59800604|NCT00499252|75921796|FG000|STARTED|Overall Study||51||
59800605|NCT00499252|75921796|FG000|COMPLETED|Overall Study|Patients treated until disease progression; completed defined as off treatment due to progression.|39||
59800606|NCT00499252|75921796|FG000|NOT COMPLETED|Overall Study||12||
59800607|NCT00499174|75921806|FG000|STARTED|Overall Study||78||
59800608|NCT00499174|75921807|FG001|STARTED|Overall Study||102||
59800609|NCT00499174|75921806|FG000|COMPLETED|Overall Study||0||
59800610|NCT00499174|75921807|FG001|COMPLETED|Overall Study||93||
59800611|NCT00499174|75921806|FG000|NOT COMPLETED|Overall Study||78||
59800612|NCT00499174|75921807|FG001|NOT COMPLETED|Overall Study||9||
59800613|NCT03775421|75921815|FG000|STARTED|Overall Study||111||
59800614|NCT03775421|75921815|FG000|COMPLETED|Overall Study||1||
59800615|NCT03775421|75921815|FG000|NOT COMPLETED|Overall Study||110||
59954642|NCT01822522|76073158|FG003|COMPLETED|Overall Study||4||
59954643|NCT01822522|76073159|FG004|COMPLETED|Overall Study||3||
59954644|NCT01822522|76073160|FG005|COMPLETED|Overall Study||3||
59954645|NCT01822522|76073155|FG000|NOT COMPLETED|Overall Study||4||
59954646|NCT01822522|76073156|FG001|NOT COMPLETED|Overall Study||1||
59954647|NCT01822522|76073157|FG002|NOT COMPLETED|Overall Study||4||
59954648|NCT01822522|76073158|FG003|NOT COMPLETED|Overall Study||2||
59954649|NCT01822522|76073159|FG004|NOT COMPLETED|Overall Study||0||
59954650|NCT01822522|76073160|FG005|NOT COMPLETED|Overall Study||4||
59954651|NCT00102687|76073204|FG000|STARTED|Initial Period||50||
59954652|NCT00102687|76073205|FG001|STARTED|Initial Period||50||
59954653|NCT00102687|76073206|FG002|STARTED|Initial Period|3 randomized participants did not receive treatment.|51||
59954654|NCT00102687|76073207|FG003|STARTED|Initial Period||0||
59954655|NCT00102687|76073208|FG004|STARTED|Initial Period||0||
59954656|NCT00102687|76073204|FG000|COMPLETED|Initial Period||32||
59954657|NCT00102687|76073205|FG001|COMPLETED|Initial Period||22||
59954658|NCT00102687|76073206|FG002|COMPLETED|Initial Period||25||
59954659|NCT00102687|76073207|FG003|COMPLETED|Initial Period||0||
59954660|NCT00102687|76073208|FG004|COMPLETED|Initial Period||0||
59800616|NCT00532155|75921821|FG000|STARTED|Overall Study||457||
59800617|NCT00532155|75921822|FG001|STARTED|Overall Study||456||
59800618|NCT00532155|75921821|FG000|SAFETY POPULATION|Overall Study||455||
59800619|NCT00532155|75921822|FG001|SAFETY POPULATION|Overall Study||450||
59800620|NCT00532155|75921821|FG000|COMPLETED|Overall Study|Participants continued treatment until they met treatment discontinuation criteria|0||
59800621|NCT00532155|75921822|FG001|COMPLETED|Overall Study|Participants continued treatment until they met treatment discontinuation criteria|0||
59800622|NCT00532155|75921821|FG000|NOT COMPLETED|Overall Study||457||
59800623|NCT00532155|75921822|FG001|NOT COMPLETED|Overall Study||456||
59800624|NCT00205777|75921832|FG000|STARTED|Core Study (Up to 3 Years)||1907||
59800625|NCT00205777|75921833|FG001|STARTED|Core Study (Up to 3 Years)||1904||
59800626|NCT00205777|75921834|FG002|STARTED|Core Study (Up to 3 Years)||1884||
59800627|NCT00205777|75921835|FG003|STARTED|Core Study (Up to 3 Years)||1914||
59800628|NCT00205777|75921836|FG004|STARTED|Core Study (Up to 3 Years)||0||
59800629|NCT00205777|75921837|FG005|STARTED|Core Study (Up to 3 Years)||0||
59800630|NCT00205777|75921832|FG000|TREATED|Core Study (Up to 3 Years)||1886||
59800631|NCT00205777|75921833|FG001|TREATED|Core Study (Up to 3 Years)||1872||
59800632|NCT00205777|75921834|FG002|TREATED|Core Study (Up to 3 Years)||1849||
59800633|NCT00205777|75921835|FG003|TREATED|Core Study (Up to 3 Years)||1885||
59800634|NCT00205777|75921836|FG004|TREATED|Core Study (Up to 3 Years)||0||
59800635|NCT00205777|75921837|FG005|TREATED|Core Study (Up to 3 Years)||0||
59800636|NCT00205777|75921832|FG000|COMPLETED|Core Study (Up to 3 Years)||1279||
59800637|NCT00205777|75921833|FG001|COMPLETED|Core Study (Up to 3 Years)||1245||
59800638|NCT00205777|75921834|FG002|COMPLETED|Core Study (Up to 3 Years)||1277||
59800639|NCT00205777|75921835|FG003|COMPLETED|Core Study (Up to 3 Years)||1282||
59800640|NCT00205777|75921836|FG004|COMPLETED|Core Study (Up to 3 Years)||0||
59800641|NCT00205777|75921837|FG005|COMPLETED|Core Study (Up to 3 Years)||0||
59800642|NCT00205777|75921832|FG000|NOT COMPLETED|Core Study (Up to 3 Years)||628||
59954661|NCT00102687|76073204|FG000|NOT COMPLETED|Initial Period||18||
59954662|NCT00102687|76073205|FG001|NOT COMPLETED|Initial Period||28||
59954663|NCT00102687|76073206|FG002|NOT COMPLETED|Initial Period||26||
59954664|NCT00102687|76073207|FG003|NOT COMPLETED|Initial Period||0||
59954665|NCT00102687|76073208|FG004|NOT COMPLETED|Initial Period||0||
59954666|NCT00102687|76073204|FG000|STARTED|Maintenance Period|Remained on initial treatment in the maintenance period.|13||
59954667|NCT00102687|76073205|FG001|STARTED|Maintenance Period|Remained on initial treatment in the maintenance period.|6||
59954668|NCT00102687|76073206|FG002|STARTED|Maintenance Period|Remained on initial treatment in the maintenance period.|8||
59954669|NCT00102687|76073207|FG003|STARTED|Maintenance Period|Second randomization to one of two maintenance regimens|22||
59954670|NCT00102687|76073208|FG004|STARTED|Maintenance Period|Second randomization to one of two maintenance regimens|21||
59954671|NCT00102687|76073204|FG000|COMPLETED|Maintenance Period||6||
59954672|NCT00102687|76073205|FG001|COMPLETED|Maintenance Period||2||
59954673|NCT00102687|76073206|FG002|COMPLETED|Maintenance Period||2||
59954674|NCT00102687|76073207|FG003|COMPLETED|Maintenance Period||12||
59954675|NCT00102687|76073208|FG004|COMPLETED|Maintenance Period||8||
59954676|NCT00102687|76073204|FG000|NOT COMPLETED|Maintenance Period||7||
59954677|NCT00102687|76073205|FG001|NOT COMPLETED|Maintenance Period||4||
59954678|NCT00102687|76073206|FG002|NOT COMPLETED|Maintenance Period||6||
59954679|NCT00102687|76073207|FG003|NOT COMPLETED|Maintenance Period||10||
59954680|NCT00102687|76073208|FG004|NOT COMPLETED|Maintenance Period||13||
59954681|NCT00102531|76073226|FG000|STARTED|Overall Study||7||
59954682|NCT00102531|76073227|FG001|STARTED|Overall Study||12||
59800643|NCT00205777|75921833|FG001|NOT COMPLETED|Core Study (Up to 3 Years)||659||
59800644|NCT00205777|75921834|FG002|NOT COMPLETED|Core Study (Up to 3 Years)||607||
59800645|NCT00205777|75921835|FG003|NOT COMPLETED|Core Study (Up to 3 Years)||632||
59800646|NCT00205777|75921836|FG004|NOT COMPLETED|Core Study (Up to 3 Years)||0||
59800647|NCT00205777|75921837|FG005|NOT COMPLETED|Core Study (Up to 3 Years)||0||
59800648|NCT00205777|75921832|FG000|STARTED|Completed Core Study, Entered SE I||1279||
59800649|NCT00205777|75921833|FG001|STARTED|Completed Core Study, Entered SE I||1245||
59800650|NCT00205777|75921834|FG002|STARTED|Completed Core Study, Entered SE I||1277||
59800651|NCT00205777|75921835|FG003|STARTED|Completed Core Study, Entered SE I||1282||
59800652|NCT00205777|75921836|FG004|STARTED|Completed Core Study, Entered SE I||0||
59800653|NCT00205777|75921837|FG005|STARTED|Completed Core Study, Entered SE I||0||
59800654|NCT00205777|75921832|FG000|COMPLETED|Completed Core Study, Entered SE I||1047||
59800655|NCT00205777|75921833|FG001|COMPLETED|Completed Core Study, Entered SE I||1041||
59800656|NCT00205777|75921834|FG002|COMPLETED|Completed Core Study, Entered SE I||1070||
59800657|NCT00205777|75921835|FG003|COMPLETED|Completed Core Study, Entered SE I||1058||
59800658|NCT00205777|75921836|FG004|COMPLETED|Completed Core Study, Entered SE I||0||
59954683|NCT00102531|76073226|FG000|COMPLETED|Overall Study||2||
59954684|NCT00102531|76073227|FG001|COMPLETED|Overall Study||1||
59954685|NCT00102531|76073226|FG000|NOT COMPLETED|Overall Study||5||
59954686|NCT00102531|76073227|FG001|NOT COMPLETED|Overall Study||11||
59954687|NCT02771145|76073233|FG000|STARTED|Overall Study||90||
59954688|NCT02771145|76073233|FG000|COMPLETED|Overall Study||86||
59954689|NCT02771145|76073233|FG000|NOT COMPLETED|Overall Study||4||
59954690|NCT02578186|76073253|FG000|STARTED|Period 1 (First of Crossover)||17|2 re-enrolled subjects have a count in each sequence in Started Row and a corresponding disposition.|
59800659|NCT00205777|75921837|FG005|COMPLETED|Completed Core Study, Entered SE I||0||
59800660|NCT00205777|75921832|FG000|NOT COMPLETED|Completed Core Study, Entered SE I||232||
59800661|NCT00205777|75921833|FG001|NOT COMPLETED|Completed Core Study, Entered SE I||204||
59800662|NCT00205777|75921834|FG002|NOT COMPLETED|Completed Core Study, Entered SE I||207||
59800663|NCT00205777|75921835|FG003|NOT COMPLETED|Completed Core Study, Entered SE I||224||
59800664|NCT00205777|75921836|FG004|NOT COMPLETED|Completed Core Study, Entered SE I||0||
59800665|NCT00205777|75921837|FG005|NOT COMPLETED|Completed Core Study, Entered SE I||0||
59800666|NCT00205777|75921832|FG000|STARTED|Study Extension I||1047||
59800667|NCT00205777|75921833|FG001|STARTED|Study Extension I||0||
59523779|NCT01189279|75618743|FG000|NOT COMPLETED|Overall Study||1||
59523780|NCT01189279|75618744|FG001|NOT COMPLETED|Overall Study||0||
59523781|NCT01189279|75618745|FG002|NOT COMPLETED|Overall Study||1||
59800668|NCT00205777|75921834|FG002|STARTED|Study Extension I||1070||
59800669|NCT00205777|75921835|FG003|STARTED|Study Extension I||1058||
59800670|NCT00205777|75921836|FG004|STARTED|Study Extension I||1041||
59800671|NCT00205777|75921837|FG005|STARTED|Study Extension I||0||
59800672|NCT00205777|75921832|FG000|COMPLETED|Study Extension I||833||
59800673|NCT00205777|75921833|FG001|COMPLETED|Study Extension I||0||
59523788|NCT01228435|75618765|FG000|STARTED|Overall Study||1||
59523789|NCT01228435|75618766|FG001|STARTED|Overall Study||2||
59523790|NCT01228435|75618765|FG000|COMPLETED|Overall Study||1||
59523791|NCT01228435|75618766|FG001|COMPLETED|Overall Study||2||
59523792|NCT01228435|75618765|FG000|NOT COMPLETED|Overall Study||0||
59523793|NCT01228435|75618766|FG001|NOT COMPLETED|Overall Study||0||
59523794|NCT02535000|75618774|FG000|STARTED|Overall Study||30||
59523795|NCT02535000|75618775|FG001|STARTED|Overall Study||30||
59523796|NCT02535000|75618774|FG000|COMPLETED|Overall Study||29||
59523797|NCT02535000|75618775|FG001|COMPLETED|Overall Study||28||
59523798|NCT02535000|75618774|FG000|NOT COMPLETED|Overall Study||1||
59523799|NCT02535000|75618775|FG001|NOT COMPLETED|Overall Study||2||
59523800|NCT01228903|75618783|FG000|STARTED|Overall Study||41||
59523801|NCT01228903|75618784|FG001|STARTED|Overall Study||39||
59523802|NCT01228903|75618783|FG000|COMPLETED|Overall Study||36||
59523803|NCT01228903|75618784|FG001|COMPLETED|Overall Study||34||
59523804|NCT01228903|75618783|FG000|NOT COMPLETED|Overall Study||5||
59523805|NCT01228903|75618784|FG001|NOT COMPLETED|Overall Study||5||
59523806|NCT01189747|75618792|FG000|STARTED|Overall Study||222||
59523807|NCT01189747|75618793|FG001|STARTED|Overall Study||224||
59523808|NCT01189747|75618792|FG000|COMPLETED|Overall Study||210||
59523809|NCT01189747|75618793|FG001|COMPLETED|Overall Study||206||
59523810|NCT01189747|75618792|FG000|NOT COMPLETED|Overall Study||12||
59523811|NCT01189747|75618793|FG001|NOT COMPLETED|Overall Study||18||
59523812|NCT01149733|75618801|FG000|STARTED|Overall Study||16||
59523813|NCT01149733|75618802|FG001|STARTED|Overall Study||16||
59523814|NCT01149733|75618801|FG000|COMPLETED|Overall Study||16||
59523815|NCT01149733|75618802|FG001|COMPLETED|Overall Study||16||
59523816|NCT01149733|75618801|FG000|NOT COMPLETED|Overall Study||0||
59523817|NCT01149733|75618802|FG001|NOT COMPLETED|Overall Study||0||
59523818|NCT01190527|75618808|FG000|STARTED|Overall Study||42||
59523819|NCT01190527|75618808|FG000|COMPLETED|Overall Study||42||
59523820|NCT01190527|75618808|FG000|NOT COMPLETED|Overall Study||0||
59523821|NCT01229527|75618815|FG000|STARTED|Overall Study||30||
59523822|NCT01229527|75618816|FG001|STARTED|Overall Study||30||
59523823|NCT01229527|75618817|FG002|STARTED|Overall Study||30||
59523824|NCT01229527|75618815|FG000|COMPLETED|Overall Study||30||
59523825|NCT01229527|75618816|FG001|COMPLETED|Overall Study||30||
59800674|NCT00205777|75921834|FG002|COMPLETED|Study Extension I||0||
59800675|NCT00205777|75921835|FG003|COMPLETED|Study Extension I||830||
59523826|NCT01229527|75618817|FG002|COMPLETED|Overall Study||30||
59523827|NCT01229527|75618815|FG000|NOT COMPLETED|Overall Study||0||
59523828|NCT01229527|75618816|FG001|NOT COMPLETED|Overall Study||0||
59523829|NCT01229527|75618817|FG002|NOT COMPLETED|Overall Study||0||
59523830|NCT02723162|75618829|FG000|STARTED|Overall Study||18||
59523831|NCT02723162|75618830|FG001|STARTED|Overall Study||15||
59523832|NCT02723162|75618831|FG002|STARTED|Overall Study||17||
59523833|NCT02723162|75618832|FG003|STARTED|Overall Study||17||
59523834|NCT02723162|75618829|FG000|Day 10 fMRI Visit|Overall Study||15||
59523835|NCT02723162|75618830|FG001|Day 10 fMRI Visit|Overall Study||11||
59523836|NCT02723162|75618831|FG002|Day 10 fMRI Visit|Overall Study||14||
59800676|NCT00205777|75921836|FG004|COMPLETED|Study Extension I||840||
59800677|NCT00205777|75921837|FG005|COMPLETED|Study Extension I||0||
59523837|NCT02723162|75618832|FG003|Day 10 fMRI Visit|Overall Study||15||
59523838|NCT02723162|75618829|FG000|COMPLETED|Overall Study||12||
59523839|NCT02723162|75618830|FG001|COMPLETED|Overall Study||10||
59523840|NCT02723162|75618831|FG002|COMPLETED|Overall Study||13||
59523841|NCT02723162|75618832|FG003|COMPLETED|Overall Study||12||
59523842|NCT02723162|75618829|FG000|NOT COMPLETED|Overall Study||6||
59523843|NCT02723162|75618830|FG001|NOT COMPLETED|Overall Study||5||
59523844|NCT02723162|75618831|FG002|NOT COMPLETED|Overall Study||4||
59523845|NCT02723162|75618832|FG003|NOT COMPLETED|Overall Study||5||
59523846|NCT01191541|75618844|FG000|STARTED|All the Patients||30||
59800678|NCT00205777|75921832|FG000|NOT COMPLETED|Study Extension I||214||
59800679|NCT00205777|75921833|FG001|NOT COMPLETED|Study Extension I||0||
59800680|NCT00205777|75921834|FG002|NOT COMPLETED|Study Extension I||1070||
59800681|NCT00205777|75921835|FG003|NOT COMPLETED|Study Extension I||228||
59800682|NCT00205777|75921836|FG004|NOT COMPLETED|Study Extension I||201||
59800683|NCT00205777|75921837|FG005|NOT COMPLETED|Study Extension I||0||
59800684|NCT00205777|75921832|FG000|STARTED|Completed SE I, Entered Extension SE II||833||
59800685|NCT00205777|75921833|FG001|STARTED|Completed SE I, Entered Extension SE II||0||
59800686|NCT00205777|75921834|FG002|STARTED|Completed SE I, Entered Extension SE II||0||
59800687|NCT00205777|75921835|FG003|STARTED|Completed SE I, Entered Extension SE II||830||
59800688|NCT00205777|75921836|FG004|STARTED|Completed SE I, Entered Extension SE II||840||
59800689|NCT00205777|75921837|FG005|STARTED|Completed SE I, Entered Extension SE II||0||
59800690|NCT00205777|75921832|FG000|COMPLETED|Completed SE I, Entered Extension SE II||560||
59800691|NCT00205777|75921833|FG001|COMPLETED|Completed SE I, Entered Extension SE II||0||
59800692|NCT00205777|75921834|FG002|COMPLETED|Completed SE I, Entered Extension SE II||0||
59800693|NCT00205777|75921835|FG003|COMPLETED|Completed SE I, Entered Extension SE II||590||
59800694|NCT00205777|75921836|FG004|COMPLETED|Completed SE I, Entered Extension SE II||582||
59800695|NCT00205777|75921837|FG005|COMPLETED|Completed SE I, Entered Extension SE II||0||
59800696|NCT00205777|75921832|FG000|NOT COMPLETED|Completed SE I, Entered Extension SE II||273||
59800697|NCT00205777|75921833|FG001|NOT COMPLETED|Completed SE I, Entered Extension SE II||0||
59800698|NCT00205777|75921834|FG002|NOT COMPLETED|Completed SE I, Entered Extension SE II||0||
59800699|NCT00205777|75921835|FG003|NOT COMPLETED|Completed SE I, Entered Extension SE II||240||
59800700|NCT00205777|75921836|FG004|NOT COMPLETED|Completed SE I, Entered Extension SE II||258||
59800701|NCT00205777|75921837|FG005|NOT COMPLETED|Completed SE I, Entered Extension SE II||0||
59800702|NCT00205777|75921832|FG000|STARTED|Study Extension II||0||
59800703|NCT00205777|75921833|FG001|STARTED|Study Extension II||0||
59800704|NCT00205777|75921834|FG002|STARTED|Study Extension II||0||
59800705|NCT00205777|75921835|FG003|STARTED|Study Extension II||590||
59800706|NCT00205777|75921836|FG004|STARTED|Study Extension II||0||
59800707|NCT00205777|75921837|FG005|STARTED|Study Extension II||1142||
59800708|NCT00205777|75921832|FG000|TREATED|Study Extension II||0||
59800709|NCT00205777|75921833|FG001|TREATED|Study Extension II||0||
59800710|NCT00205777|75921834|FG002|TREATED|Study Extension II||0||
59800711|NCT00205777|75921835|FG003|TREATED|Study Extension II||519||
59800712|NCT00205777|75921836|FG004|TREATED|Study Extension II||0||
59800713|NCT00205777|75921837|FG005|TREATED|Study Extension II||1011||
59954691|NCT02578186|76073254|FG001|STARTED|Period 1 (First of Crossover)||18|2 re-enrolled subjects have a count in each sequence in Started Row and a corresponding disposition.|
59800714|NCT00205777|75921832|FG000|COMPLETED|Study Extension II||0||
59800715|NCT00205777|75921833|FG001|COMPLETED|Study Extension II||0||
59800716|NCT00205777|75921834|FG002|COMPLETED|Study Extension II||0||
59800717|NCT00205777|75921835|FG003|COMPLETED|Study Extension II||441||
59800718|NCT00205777|75921836|FG004|COMPLETED|Study Extension II||0||
59800719|NCT00205777|75921837|FG005|COMPLETED|Study Extension II||860||
59800720|NCT00205777|75921832|FG000|NOT COMPLETED|Study Extension II||0||
59800721|NCT00205777|75921833|FG001|NOT COMPLETED|Study Extension II||0||
59800722|NCT00205777|75921834|FG002|NOT COMPLETED|Study Extension II||0||
59800723|NCT00205777|75921835|FG003|NOT COMPLETED|Study Extension II||149||
59800724|NCT00205777|75921836|FG004|NOT COMPLETED|Study Extension II||0||
59800725|NCT00205777|75921837|FG005|NOT COMPLETED|Study Extension II||282||
59800726|NCT00483652|75921854|FG000|STARTED|Double-blind Treatment Period||120||
59800727|NCT00483652|75921855|FG001|STARTED|Double-blind Treatment Period||119||
59800728|NCT00483652|75921854|FG000|COMPLETED|Double-blind Treatment Period||113||
59800729|NCT00483652|75921855|FG001|COMPLETED|Double-blind Treatment Period||114||
59800730|NCT00483652|75921854|FG000|NOT COMPLETED|Double-blind Treatment Period||7||
59800731|NCT00483652|75921855|FG001|NOT COMPLETED|Double-blind Treatment Period||5||
59800732|NCT00483652|75921854|FG000|STARTED|Post-study Follow-up||113||
59800733|NCT00483652|75921855|FG001|STARTED|Post-study Follow-up||114||
59800734|NCT00483652|75921854|FG000|COMPLETED|Post-study Follow-up||113||
59800735|NCT00483652|75921855|FG001|COMPLETED|Post-study Follow-up||114||
59800736|NCT00483652|75921854|FG000|NOT COMPLETED|Post-study Follow-up||0||
59800737|NCT00483652|75921855|FG001|NOT COMPLETED|Post-study Follow-up||0||
59800738|NCT00483574|75921863|FG000|STARTED|Overall Study||1053||
59800739|NCT00483574|75921864|FG001|STARTED|Overall Study||321||
59800740|NCT00483574|75921863|FG000|COMPLETED|Overall Study||951||
59800741|NCT00483574|75921864|FG001|COMPLETED|Overall Study||308||
59800742|NCT00483574|75921863|FG000|NOT COMPLETED|Overall Study||102||
59800743|NCT00483574|75921864|FG001|NOT COMPLETED|Overall Study||13||
59954692|NCT02578186|76073253|FG000|COMPLETED|Period 1 (First of Crossover)||12||
59954693|NCT02578186|76073254|FG001|COMPLETED|Period 1 (First of Crossover)||13||
59954694|NCT02578186|76073253|FG000|NOT COMPLETED|Period 1 (First of Crossover)||5||
59954695|NCT02578186|76073254|FG001|NOT COMPLETED|Period 1 (First of Crossover)||5||
59954696|NCT02578186|76073253|FG000|STARTED|Period 2 (Second of Crossover)||12||
59800744|NCT00483184|75921875|FG000|STARTED|Overall Study||27||
59800745|NCT00483184|75921876|FG001|STARTED|Overall Study||31||
59800746|NCT00483184|75921877|FG002|STARTED|Overall Study||26||
59800747|NCT00483184|75921875|FG000|COMPLETED|Overall Study||22||
59800748|NCT00483184|75921876|FG001|COMPLETED|Overall Study||27||
59800749|NCT00483184|75921877|FG002|COMPLETED|Overall Study||23||
59800750|NCT00483184|75921875|FG000|NOT COMPLETED|Overall Study||5||
59800751|NCT00483184|75921876|FG001|NOT COMPLETED|Overall Study||4||
59800752|NCT00483184|75921877|FG002|NOT COMPLETED|Overall Study||3||
59800753|NCT00482170|75921887|FG000|STARTED|Overall Study||207||
59800754|NCT00482170|75921888|FG001|STARTED|Overall Study||214||
59800755|NCT00482170|75921887|FG000|Treated|Overall Study||207||
59800756|NCT00482170|75921888|FG001|Treated|Overall Study||211||
59800757|NCT00482170|75921887|FG000|COMPLETED|Overall Study||192||
59800758|NCT00482170|75921888|FG001|COMPLETED|Overall Study||194||
59800759|NCT00482170|75921887|FG000|NOT COMPLETED|Overall Study||15||
59800760|NCT00482170|75921888|FG001|NOT COMPLETED|Overall Study||20||
59800761|NCT03883113|75921896|FG000|STARTED|Overall Study||87||
59800762|NCT03883113|75921897|FG001|STARTED|Overall Study||58||
59800763|NCT03883113|75921896|FG000|COMPLETED|Overall Study||71||
59800764|NCT03883113|75921897|FG001|COMPLETED|Overall Study||46||
59800765|NCT03883113|75921896|FG000|NOT COMPLETED|Overall Study||16||
59800766|NCT03883113|75921897|FG001|NOT COMPLETED|Overall Study||12||
59800767|NCT04218695|75921919|FG000|STARTED|Overall Study||17||
59800768|NCT04218695|75921920|FG001|STARTED|Overall Study||15||
59800769|NCT04218695|75921919|FG000|COMPLETED|Overall Study||16||
59800770|NCT04218695|75921920|FG001|COMPLETED|Overall Study||15||
59800771|NCT04218695|75921919|FG000|NOT COMPLETED|Overall Study||1||
59800772|NCT04218695|75921920|FG001|NOT COMPLETED|Overall Study||0||
59800773|NCT00490282|75921926|FG000|STARTED|Overall Study||25||
59800774|NCT00490282|75921926|FG000|COMPLETED|Overall Study||22||
59800775|NCT00490282|75921926|FG000|NOT COMPLETED|Overall Study||3||
59800776|NCT00615056|75921935|FG000|STARTED|Overall Study||49||
59800777|NCT00615056|75921936|FG001|STARTED|Overall Study||51||
59800778|NCT00615056|75921937|FG002|STARTED|Overall Study||36||
59800779|NCT00615056|75921938|FG003|STARTED|Overall Study||35||
59800780|NCT00615056|75921935|FG000|Treated|Overall Study||46||
59800781|NCT00615056|75921936|FG001|Treated|Overall Study||51||
59800782|NCT00615056|75921937|FG002|Treated|Overall Study||36||
59800783|NCT00615056|75921938|FG003|Treated|Overall Study||35||
59800784|NCT00615056|75921935|FG000|COMPLETED|Overall Study||0||
59800785|NCT00615056|75921936|FG001|COMPLETED|Overall Study||0||
59800786|NCT00615056|75921937|FG002|COMPLETED|Overall Study||0||
59800787|NCT00615056|75921938|FG003|COMPLETED|Overall Study||0||
59800788|NCT00615056|75921935|FG000|NOT COMPLETED|Overall Study||49||
59800789|NCT00615056|75921936|FG001|NOT COMPLETED|Overall Study||51||
59800790|NCT00615056|75921937|FG002|NOT COMPLETED|Overall Study||36||
59800791|NCT00615056|75921938|FG003|NOT COMPLETED|Overall Study||35||
59800792|NCT00482014|75921952|FG000|STARTED|Overall Study||9||
59800793|NCT00482014|75921953|FG001|STARTED|Overall Study||13||
59800794|NCT00482014|75921954|FG002|STARTED|Overall Study||46||
59800795|NCT00482014|75921955|FG003|STARTED|Overall Study||52||
59800796|NCT00482014|75921952|FG000|COMPLETED|Overall Study||2||
59800797|NCT00482014|75921953|FG001|COMPLETED|Overall Study||7||
59800798|NCT00482014|75921954|FG002|COMPLETED|Overall Study||35||
59800799|NCT00482014|75921955|FG003|COMPLETED|Overall Study||29||
59800800|NCT00482014|75921952|FG000|NOT COMPLETED|Overall Study||7||
59800801|NCT00482014|75921953|FG001|NOT COMPLETED|Overall Study||6||
59800802|NCT00482014|75921954|FG002|NOT COMPLETED|Overall Study||11||
59800803|NCT00482014|75921955|FG003|NOT COMPLETED|Overall Study||23||
59800804|NCT03595553|75921969|FG000|STARTED|Overall Study||370||
59800805|NCT03595553|75921970|FG001|STARTED|Overall Study||375||
59800806|NCT03595553|75921969|FG000|COMPLETED|Overall Study||312||
59800807|NCT03595553|75921970|FG001|COMPLETED|Overall Study||327||
59800808|NCT03595553|75921969|FG000|NOT COMPLETED|Overall Study||58||
59800809|NCT03595553|75921970|FG001|NOT COMPLETED|Overall Study||48||
59800810|NCT00614822|75921976|FG000|STARTED|Overall Study||50||
59800811|NCT00614822|75921976|FG000|COMPLETED|Overall Study||47||
59800812|NCT00614822|75921976|FG000|NOT COMPLETED|Overall Study||3||
59800813|NCT00529659|75921983|FG000|STARTED|Overall Study||81||
59800814|NCT00529659|75921984|FG001|STARTED|Overall Study||89||
59800815|NCT00529659|75921983|FG000|COMPLETED|Overall Study||70||
59800816|NCT00529659|75921984|FG001|COMPLETED|Overall Study||66||
59800817|NCT00529659|75921983|FG000|NOT COMPLETED|Overall Study||11||
59800818|NCT00529659|75921984|FG001|NOT COMPLETED|Overall Study||23||
59800819|NCT00143455|75921994|FG000|STARTED|Cohort 1||39||
59800820|NCT00143455|75921995|FG001|STARTED|Cohort 1||39||
59800821|NCT00143455|75921996|FG002|STARTED|Cohort 1||0||
59800822|NCT00143455|75921997|FG003|STARTED|Cohort 1||0||
59800823|NCT00143455|75921994|FG000|Received Treatment|Cohort 1||39||
59800824|NCT00143455|75921995|FG001|Received Treatment|Cohort 1||38||
59800825|NCT00143455|75921996|FG002|Received Treatment|Cohort 1||0||
59800826|NCT00143455|75921997|FG003|Received Treatment|Cohort 1||0||
59800827|NCT00143455|75921994|FG000|COMPLETED|Cohort 1||25||
59800828|NCT00143455|75921995|FG001|COMPLETED|Cohort 1||22||
59800829|NCT00143455|75921996|FG002|COMPLETED|Cohort 1||0||
59800830|NCT00143455|75921997|FG003|COMPLETED|Cohort 1||0||
59800831|NCT00143455|75921994|FG000|NOT COMPLETED|Cohort 1||14||
59800832|NCT00143455|75921995|FG001|NOT COMPLETED|Cohort 1||17||
59800833|NCT00143455|75921996|FG002|NOT COMPLETED|Cohort 1||0||
59800834|NCT00143455|75921997|FG003|NOT COMPLETED|Cohort 1||0||
59800835|NCT00143455|75921994|FG000|STARTED|Cohort 2||0||
59800836|NCT00143455|75921995|FG001|STARTED|Cohort 2||0||
59800837|NCT00143455|75921996|FG002|STARTED|Cohort 2||203||
59800838|NCT00143455|75921997|FG003|STARTED|Cohort 2||204||
59800839|NCT00143455|75921994|FG000|Received Treatment|Cohort 2||0||
59800840|NCT00143455|75921995|FG001|Received Treatment|Cohort 2||0||
59800841|NCT00143455|75921996|FG002|Received Treatment|Cohort 2||202||
59800842|NCT00143455|75921997|FG003|Received Treatment|Cohort 2||203||
59800843|NCT00143455|75921994|FG000|COMPLETED|Cohort 2||0||
59800844|NCT00143455|75921995|FG001|COMPLETED|Cohort 2||0||
59800845|NCT00143455|75921996|FG002|COMPLETED|Cohort 2||97||
59800846|NCT00143455|75921997|FG003|COMPLETED|Cohort 2||111||
59800847|NCT00143455|75921994|FG000|NOT COMPLETED|Cohort 2||0||
59800848|NCT00143455|75921995|FG001|NOT COMPLETED|Cohort 2||0||
59800849|NCT00143455|75921996|FG002|NOT COMPLETED|Cohort 2||106||
59800850|NCT00143455|75921997|FG003|NOT COMPLETED|Cohort 2||93||
59800851|NCT03529955|75922009|FG000|STARTED|Overall Study||8||
59800852|NCT03529955|75922009|FG000|COMPLETED|Overall Study||6||
59800853|NCT03529955|75922009|FG000|NOT COMPLETED|Overall Study||2||
59800854|NCT00142909|75922025|FG000|STARTED|Randomization||42||
59800855|NCT00142909|75922026|FG001|STARTED|Randomization||44||
59800856|NCT00142909|75922025|FG000|COMPLETED|Randomization||35||
59800857|NCT00142909|75922026|FG001|COMPLETED|Randomization||34||
59800858|NCT00142909|75922025|FG000|NOT COMPLETED|Randomization||7||
59800859|NCT00142909|75922026|FG001|NOT COMPLETED|Randomization||10||
59800860|NCT00142909|75922025|FG000|STARTED|Medications Begin||35||
59800861|NCT00142909|75922026|FG001|STARTED|Medications Begin||34||
59800862|NCT00142909|75922025|FG000|COMPLETED|Medications Begin||26||
59800863|NCT00142909|75922026|FG001|COMPLETED|Medications Begin||31||
59800864|NCT00142909|75922025|FG000|NOT COMPLETED|Medications Begin||9||
59954697|NCT02578186|76073254|FG001|STARTED|Period 2 (Second of Crossover)||13||
59954698|NCT02578186|76073253|FG000|COMPLETED|Period 2 (Second of Crossover)||12||
59954699|NCT02578186|76073254|FG001|COMPLETED|Period 2 (Second of Crossover)||13||
59954700|NCT02578186|76073253|FG000|NOT COMPLETED|Period 2 (Second of Crossover)||0||
59800865|NCT00142909|75922026|FG001|NOT COMPLETED|Medications Begin||3||
59800866|NCT00205699|75922035|FG000|STARTED|Overall Study||49||
59800867|NCT00205699|75922036|FG001|STARTED|Overall Study||46||
59954701|NCT02578186|76073254|FG001|NOT COMPLETED|Period 2 (Second of Crossover)||0||
59954702|NCT00103311|76073262|FG000|STARTED|Overall Study||33||
59954703|NCT00103311|76073263|FG001|STARTED|Overall Study||31||
59954704|NCT00103311|76073262|FG000|COMPLETED|Overall Study||29||
59954705|NCT00103311|76073263|FG001|COMPLETED|Overall Study||30||
59954706|NCT00103311|76073262|FG000|NOT COMPLETED|Overall Study||4||
59954707|NCT00103311|76073263|FG001|NOT COMPLETED|Overall Study||1||
59954708|NCT04967313|76073269|FG000|STARTED|Baseline||72||
59954709|NCT04967313|76073269|FG000|Ineligible After Baseline|Baseline||11||
59800868|NCT00205699|75922037|FG002|STARTED|Overall Study||49||
59800869|NCT00205699|75922035|FG000|COMPLETED|Overall Study||46||
59800870|NCT00205699|75922036|FG001|COMPLETED|Overall Study||40||
59800871|NCT00205699|75922037|FG002|COMPLETED|Overall Study||43||
59800872|NCT00205699|75922035|FG000|NOT COMPLETED|Overall Study||3||
59800873|NCT00205699|75922036|FG001|NOT COMPLETED|Overall Study||6||
59800874|NCT00205699|75922037|FG002|NOT COMPLETED|Overall Study||6||
59800875|NCT03882801|75922050|FG000|STARTED|Period 1||12||
59800876|NCT03882801|75922051|FG001|STARTED|Period 1||12||
59800877|NCT03882801|75922050|FG000|Treated|Period 1|1 participant did not receive any dose of study drug|11||
59800878|NCT03882801|75922051|FG001|Treated|Period 1||12||
59800879|NCT03882801|75922050|FG000|COMPLETED|Period 1||10||
59800880|NCT03882801|75922051|FG001|COMPLETED|Period 1||10||
59954710|NCT04967313|76073269|FG000|Did Not Sign Addendum|Baseline||1||
59954711|NCT04967313|76073269|FG000|COMPLETED|Baseline||60||
59954712|NCT04967313|76073269|FG000|NOT COMPLETED|Baseline||12||
59954713|NCT04967313|76073269|FG000|STARTED|Intervention||60||
59954714|NCT04967313|76073269|FG000|COMPLETED|Intervention||59||
59954715|NCT04967313|76073269|FG000|NOT COMPLETED|Intervention||1||
59954716|NCT02576938|76073276|FG000|STARTED|Overall Study||49||
59954717|NCT02576938|76073277|FG001|STARTED|Overall Study||37||
59954718|NCT02576938|76073278|FG002|STARTED|Overall Study||38||
59954719|NCT02576938|76073276|FG000|Received at Least One Dose of Study Drug|Overall Study||49||
59954720|NCT02576938|76073277|FG001|Received at Least One Dose of Study Drug|Overall Study||37||
59523847|NCT01191541|75618845|FG001|STARTED|All the Patients||35||
59800881|NCT03882801|75922050|FG000|NOT COMPLETED|Period 1||2||
59800882|NCT03882801|75922051|FG001|NOT COMPLETED|Period 1||2||
59800883|NCT03882801|75922050|FG000|STARTED|Washout Period||10||
59800884|NCT03882801|75922051|FG001|STARTED|Washout Period||10||
59800885|NCT03882801|75922050|FG000|COMPLETED|Washout Period||10||
59800886|NCT03882801|75922051|FG001|COMPLETED|Washout Period||9||
59800887|NCT03882801|75922050|FG000|NOT COMPLETED|Washout Period||0||
59800888|NCT03882801|75922051|FG001|NOT COMPLETED|Washout Period||1||
59800889|NCT03882801|75922050|FG000|STARTED|Period 2||10||
59800890|NCT03882801|75922051|FG001|STARTED|Period 2||9||
59800891|NCT03882801|75922050|FG000|COMPLETED|Period 2||10||
59800892|NCT03882801|75922051|FG001|COMPLETED|Period 2||8||
59800893|NCT03882801|75922050|FG000|NOT COMPLETED|Period 2||0||
59800894|NCT03882801|75922051|FG001|NOT COMPLETED|Period 2||1||
59800895|NCT03880227|75922061|FG000|STARTED|First Visit||20||
59800896|NCT03880227|75922062|FG001|STARTED|First Visit||21||
59800897|NCT03880227|75922063|FG002|STARTED|First Visit||22||
59800898|NCT03880227|75922064|FG003|STARTED|First Visit||18||
59800899|NCT03880227|75922061|FG000|COMPLETED|First Visit||19||
59800900|NCT03880227|75922062|FG001|COMPLETED|First Visit||21||
59800901|NCT03880227|75922063|FG002|COMPLETED|First Visit||22||
59800902|NCT03880227|75922064|FG003|COMPLETED|First Visit||18||
59800903|NCT03880227|75922061|FG000|NOT COMPLETED|First Visit||1||
59800904|NCT03880227|75922062|FG001|NOT COMPLETED|First Visit||0||
59800905|NCT03880227|75922063|FG002|NOT COMPLETED|First Visit||0||
59800906|NCT03880227|75922064|FG003|NOT COMPLETED|First Visit||0||
59800907|NCT03880227|75922061|FG000|STARTED|1 Week Washout/ Delay||19||
59800908|NCT03880227|75922062|FG001|STARTED|1 Week Washout/ Delay||21||
59800909|NCT03880227|75922063|FG002|STARTED|1 Week Washout/ Delay||22||
59800910|NCT03880227|75922064|FG003|STARTED|1 Week Washout/ Delay||18||
59800911|NCT03880227|75922061|FG000|COMPLETED|1 Week Washout/ Delay||19||
59800912|NCT03880227|75922062|FG001|COMPLETED|1 Week Washout/ Delay||20||
59800913|NCT03880227|75922063|FG002|COMPLETED|1 Week Washout/ Delay||19||
59800914|NCT03880227|75922064|FG003|COMPLETED|1 Week Washout/ Delay||18||
59800915|NCT03880227|75922061|FG000|NOT COMPLETED|1 Week Washout/ Delay||0||
59800916|NCT03880227|75922062|FG001|NOT COMPLETED|1 Week Washout/ Delay||1||
59800917|NCT03880227|75922063|FG002|NOT COMPLETED|1 Week Washout/ Delay||3||
59800918|NCT03880227|75922064|FG003|NOT COMPLETED|1 Week Washout/ Delay||0||
59800919|NCT03880227|75922061|FG000|STARTED|Second Visit||19||
59800920|NCT03880227|75922062|FG001|STARTED|Second Visit||20||
59800921|NCT03880227|75922063|FG002|STARTED|Second Visit||19||
59800922|NCT03880227|75922064|FG003|STARTED|Second Visit||18||
59800923|NCT03880227|75922061|FG000|COMPLETED|Second Visit||19||
59800924|NCT03880227|75922062|FG001|COMPLETED|Second Visit||20||
59800925|NCT03880227|75922063|FG002|COMPLETED|Second Visit||19||
59800926|NCT03880227|75922064|FG003|COMPLETED|Second Visit||18||
59800927|NCT03880227|75922061|FG000|NOT COMPLETED|Second Visit||0||
59800928|NCT03880227|75922062|FG001|NOT COMPLETED|Second Visit||0||
59800929|NCT03880227|75922063|FG002|NOT COMPLETED|Second Visit||0||
59800930|NCT03880227|75922064|FG003|NOT COMPLETED|Second Visit||0||
59800931|NCT03483935|75922076|FG000|STARTED|Stage 1: Dose Setting Study||7||34
59800932|NCT03483935|75922076|FG000|COMPLETED|Stage 1: Dose Setting Study||7|7 participants were recruited to the stage 1, dose finding study|34
59800933|NCT03483935|75922076|FG000|NOT COMPLETED|Stage 1: Dose Setting Study||0||0
59800934|NCT03483935|75922076|FG000|STARTED|Stage 2: Randomised Controlled Trial|Participants were randomised to receiving treatment on the left or right side.|11|Eleven participants were recruited and randomized to Stage 2. 179 AKs (93 treated, 86 untreated) were assessed.|179
59800935|NCT03483935|75922076|FG000|AKs Treated|Stage 2: Randomised Controlled Trial||11||93
59800936|NCT03483935|75922076|FG000|AKs Not Treated|Stage 2: Randomised Controlled Trial||11||86
59800937|NCT03483935|75922076|FG000|COMPLETED|Stage 2: Randomised Controlled Trial||11||179
59800938|NCT03483935|75922076|FG000|NOT COMPLETED|Stage 2: Randomised Controlled Trial||0||0
59800939|NCT00530439|75922088|FG000|STARTED|Overall Study||180||
59800940|NCT00530439|75922089|FG001|STARTED|Overall Study||180||
59800941|NCT00530439|75922088|FG000|COMPLETED|Overall Study||150||
59800942|NCT00530439|75922089|FG001|COMPLETED|Overall Study||154||
59800943|NCT00530439|75922088|FG000|NOT COMPLETED|Overall Study||30||
59800944|NCT00530439|75922089|FG001|NOT COMPLETED|Overall Study||26||
59800945|NCT00497146|75922097|FG000|STARTED|Treatment Period||115||
59800946|NCT00497146|75922098|FG001|STARTED|Treatment Period||112||
59800947|NCT00497146|75922097|FG000|COMPLETED|Treatment Period||88||
59800948|NCT00497146|75922098|FG001|COMPLETED|Treatment Period||91||
59800949|NCT00497146|75922097|FG000|NOT COMPLETED|Treatment Period||27||
59800950|NCT00497146|75922098|FG001|NOT COMPLETED|Treatment Period||21||
59800951|NCT00497146|75922097|FG000|STARTED|Long-term Follow-up Period||65||
59800952|NCT00497146|75922098|FG001|STARTED|Long-term Follow-up Period||72||
59800953|NCT00497146|75922097|FG000|COMPLETED|Long-term Follow-up Period||50||
59800954|NCT00497146|75922098|FG001|COMPLETED|Long-term Follow-up Period||66||
59800955|NCT00497146|75922097|FG000|NOT COMPLETED|Long-term Follow-up Period||15||
59800956|NCT00497146|75922098|FG001|NOT COMPLETED|Long-term Follow-up Period||6||
59800957|NCT00489970|75922109|FG000|STARTED|Persistence Year 1||1069||
59800958|NCT00489970|75922110|FG001|STARTED|Persistence Year 1||523||
59800959|NCT00489970|75922111|FG002|STARTED|Persistence Year 1||0||
59800960|NCT00489970|75922109|FG000|COMPLETED|Persistence Year 1||1069||
59800961|NCT00489970|75922110|FG001|COMPLETED|Persistence Year 1||523||
59800962|NCT00489970|75922111|FG002|COMPLETED|Persistence Year 1||0||
59800963|NCT00489970|75922109|FG000|NOT COMPLETED|Persistence Year 1||0||
59800964|NCT00489970|75922110|FG001|NOT COMPLETED|Persistence Year 1||0||
59800965|NCT00489970|75922111|FG002|NOT COMPLETED|Persistence Year 1||0||
59800966|NCT00489970|75922109|FG000|STARTED|Persistence Year 3|Number of subjects who returned at Year 3|1019||
60103590|NCT01290952|76221837|FG001|NOT COMPLETED|Overall Study||14||
59800967|NCT00489970|75922110|FG001|STARTED|Persistence Year 3|Number of subjects who returned at Year 3|486||
59800968|NCT00489970|75922111|FG002|STARTED|Persistence Year 3||0||
59800969|NCT00489970|75922109|FG000|COMPLETED|Persistence Year 3||1019||
59800970|NCT00489970|75922110|FG001|COMPLETED|Persistence Year 3||486||
59800971|NCT00489970|75922111|FG002|COMPLETED|Persistence Year 3||0||
59800972|NCT00489970|75922109|FG000|NOT COMPLETED|Persistence Year 3||0||
59800973|NCT00489970|75922110|FG001|NOT COMPLETED|Persistence Year 3||0||
59800974|NCT00489970|75922111|FG002|NOT COMPLETED|Persistence Year 3||0||
59800975|NCT00489970|75922109|FG000|STARTED|Persistence Year 5|Number of subjects who returned at Year 5|856||
59800976|NCT00489970|75922110|FG001|STARTED|Persistence Year 5|Number of subjects who returned at Year 5|401||
59800977|NCT00489970|75922111|FG002|STARTED|Persistence Year 5||0||
59800978|NCT00489970|75922109|FG000|COMPLETED|Persistence Year 5||856||
59800979|NCT00489970|75922110|FG001|COMPLETED|Persistence Year 5||401||
59800980|NCT00489970|75922111|FG002|COMPLETED|Persistence Year 5||0||
59800981|NCT00489970|75922109|FG000|NOT COMPLETED|Persistence Year 5||0||
59954721|NCT02576938|76073278|FG002|Received at Least One Dose of Study Drug|Overall Study||38||
59954722|NCT02576938|76073276|FG000|COMPLETED|Overall Study||29||
59954723|NCT02576938|76073277|FG001|COMPLETED|Overall Study||25||
59954724|NCT02576938|76073278|FG002|COMPLETED|Overall Study||26||
59954725|NCT02576938|76073276|FG000|NOT COMPLETED|Overall Study||20||
59800982|NCT00489970|75922110|FG001|NOT COMPLETED|Persistence Year 5||0||
59800983|NCT00489970|75922111|FG002|NOT COMPLETED|Persistence Year 5||0||
59800984|NCT00489970|75922109|FG000|STARTED|Persistence Year 9|Number of subjects who returned at Year 9.|309||
59800985|NCT00489970|75922110|FG001|STARTED|Persistence Year 9|Number of subjects who returned at Year 9.|138||
59800986|NCT00489970|75922111|FG002|STARTED|Persistence Year 9|Number of subjects who received the first dose at Year 9.|362||
59800987|NCT00489970|75922109|FG000|COMPLETED|Persistence Year 9||306||
59800988|NCT00489970|75922110|FG001|COMPLETED|Persistence Year 9||136||
59800989|NCT00489970|75922111|FG002|COMPLETED|Persistence Year 9||357||
59800990|NCT00489970|75922109|FG000|NOT COMPLETED|Persistence Year 9||3||
59800991|NCT00489970|75922110|FG001|NOT COMPLETED|Persistence Year 9||2||
59800992|NCT00489970|75922111|FG002|NOT COMPLETED|Persistence Year 9||5||
59800993|NCT02798471|75922124|FG000|STARTED|Overall Study||147||
59800994|NCT02798471|75922125|FG001|STARTED|Overall Study||143||
59800995|NCT02798471|75922124|FG000|Modified Intent-to-Treat Population|Overall Study||145||
59800996|NCT02798471|75922125|FG001|Modified Intent-to-Treat Population|Overall Study||141||
59800997|NCT02798471|75922124|FG000|COMPLETED|Overall Study|Due to data entry error, 1 additional patient included in this count was counted as both a study completer and as discontinued from the study; however, this patient was only included in the completer data.|128||
59800998|NCT02798471|75922125|FG001|COMPLETED|Overall Study||119||
59800999|NCT02798471|75922124|FG000|NOT COMPLETED|Overall Study||19||
59801000|NCT02798471|75922125|FG001|NOT COMPLETED|Overall Study||24||
59801001|NCT00489736|75922133|FG000|STARTED|Overall Study|Randomized and treated patients|249||
59801002|NCT00489736|75922134|FG001|STARTED|Overall Study|Randomized and treated patients|255||
59801003|NCT00489736|75922133|FG000|COMPLETED|Overall Study|completed study drug period|153||
59801004|NCT00489736|75922134|FG001|COMPLETED|Overall Study|completed study drug period|186||
59801005|NCT00489736|75922133|FG000|NOT COMPLETED|Overall Study||96||
59801006|NCT00489736|75922134|FG001|NOT COMPLETED|Overall Study||69||
59801007|NCT00617084|75922142|FG000|STARTED|Overall Study||1140||
59801008|NCT00617084|75922143|FG001|STARTED|Overall Study||1152||
59801009|NCT00617084|75922142|FG000|COMPLETED|Overall Study||1119||
59801010|NCT00617084|75922143|FG001|COMPLETED|Overall Study||1126||
59801011|NCT00617084|75922142|FG000|NOT COMPLETED|Overall Study||21||
59801012|NCT00617084|75922143|FG001|NOT COMPLETED|Overall Study||26||
59801013|NCT00489424|75922152|FG000|STARTED|Overall Study||267||
59801014|NCT00489424|75922153|FG001|STARTED|Overall Study||264||
59801015|NCT00489424|75922154|FG002|STARTED|Overall Study||262||
59801016|NCT00489424|75922152|FG000|COMPLETED|Overall Study||263||
59801017|NCT00489424|75922153|FG001|COMPLETED|Overall Study||259||
59801018|NCT00489424|75922154|FG002|COMPLETED|Overall Study||257||
59801019|NCT00489424|75922152|FG000|NOT COMPLETED|Overall Study||4||
59801020|NCT00489424|75922153|FG001|NOT COMPLETED|Overall Study||5||
59801021|NCT00489424|75922154|FG002|NOT COMPLETED|Overall Study||5||
59801022|NCT00614744|75922164|FG000|STARTED|Overall Study||83||
59801023|NCT00614744|75922165|FG001|STARTED|Overall Study||85||
59801024|NCT00614744|75922164|FG000|COMPLETED|Overall Study||78||
59801025|NCT00614744|75922165|FG001|COMPLETED|Overall Study||79||
59801026|NCT00614744|75922164|FG000|NOT COMPLETED|Overall Study||5||
59801027|NCT00614744|75922165|FG001|NOT COMPLETED|Overall Study||6||
59801028|NCT00565812|75922174|FG000|STARTED|Overall Study||485||
59801029|NCT00565812|75922175|FG001|STARTED|Overall Study||486||
59801030|NCT00565812|75922176|FG002|STARTED|Overall Study||486||
59801031|NCT00565812|75922174|FG000|COMPLETED|Overall Study||341||
59954726|NCT02576938|76073277|FG001|NOT COMPLETED|Overall Study||12||
59954727|NCT02576938|76073278|FG002|NOT COMPLETED|Overall Study||12||
59954728|NCT02576860|76073290|FG000|STARTED|Overall Study||136||
59954729|NCT02576860|76073291|FG001|STARTED|Overall Study||127||
59801032|NCT00565812|75922175|FG001|COMPLETED|Overall Study||351||
59801033|NCT00565812|75922176|FG002|COMPLETED|Overall Study||356||
59801034|NCT00565812|75922174|FG000|NOT COMPLETED|Overall Study||144||
59954730|NCT02576860|76073290|FG000|COMPLETED|Overall Study||111||
59954731|NCT02576860|76073291|FG001|COMPLETED|Overall Study||103||
59954732|NCT02576860|76073290|FG000|NOT COMPLETED|Overall Study||25||
59954733|NCT02576860|76073291|FG001|NOT COMPLETED|Overall Study||24||
59801035|NCT00565812|75922175|FG001|NOT COMPLETED|Overall Study||135||
59801036|NCT00565812|75922176|FG002|NOT COMPLETED|Overall Study||130||
59801037|NCT03974334|75922184|FG000|STARTED|Overall Study||25||
59801038|NCT03974334|75922184|FG000|COMPLETED|Overall Study||24||
59801039|NCT03974334|75922184|FG000|NOT COMPLETED|Overall Study||1||
59801040|NCT03970824|75922191|FG000|STARTED|Overall Study||103||
59801041|NCT03970824|75922192|FG001|STARTED|Overall Study||103||
59801042|NCT03970824|75922193|FG002|STARTED|Overall Study||106||
59801043|NCT03970824|75922191|FG000|COMPLETED|Overall Study||101||
59801044|NCT03970824|75922192|FG001|COMPLETED|Overall Study||100||
59801045|NCT03970824|75922193|FG002|COMPLETED|Overall Study||102||
59801046|NCT03970824|75922191|FG000|NOT COMPLETED|Overall Study||2||
59801047|NCT03970824|75922192|FG001|NOT COMPLETED|Overall Study||3||
59801048|NCT03970824|75922193|FG002|NOT COMPLETED|Overall Study||4||
59801049|NCT00564486|75922204|FG000|STARTED|Overall Study||43||
59801050|NCT00564486|75922205|FG001|STARTED|Overall Study|One subject was randomized to receive 1 g IVAPAP but was administered 650 mg IV in error|92||
59801051|NCT00564486|75922206|FG002|STARTED|Overall Study|One subject randomized to receive 1 g IVAPAP but was administered 650 mg IV in error|42||
59801052|NCT00564486|75922207|FG003|STARTED|Overall Study||67||
59801053|NCT00564486|75922204|FG000|COMPLETED|Overall Study|Includes all subjects who returned to clinic for Day 7 visit.|36||
59801054|NCT00564486|75922205|FG001|COMPLETED|Overall Study|Includes all subjects who returned to clinic for Day 7 visit.|91||
59801055|NCT00564486|75922206|FG002|COMPLETED|Overall Study|Includes all subjects who returned to clinic for Day 7 visit.|39||
59801056|NCT00564486|75922207|FG003|COMPLETED|Overall Study||60||
59801057|NCT00564486|75922204|FG000|NOT COMPLETED|Overall Study||7||
59801058|NCT00564486|75922205|FG001|NOT COMPLETED|Overall Study||1||
59801059|NCT00564486|75922206|FG002|NOT COMPLETED|Overall Study||3||
59801060|NCT00564486|75922207|FG003|NOT COMPLETED|Overall Study||7||
59801061|NCT00481078|75922223|FG000|STARTED|Overall Study||62||
59801062|NCT00481078|75922224|FG001|STARTED|Overall Study||32||
59801063|NCT00481078|75922223|FG000|COMPLETED|Overall Study||20||
59801064|NCT00481078|75922224|FG001|COMPLETED|Overall Study||12||
59801065|NCT00481078|75922223|FG000|NOT COMPLETED|Overall Study||42||
59801066|NCT00481078|75922224|FG001|NOT COMPLETED|Overall Study||20||
59801067|NCT00480532|75922234|FG000|STARTED|Overall Study||33||
59801068|NCT00480532|75922235|FG001|STARTED|Overall Study||33||
59801069|NCT00480532|75922236|FG002|STARTED|Overall Study||33||
59801070|NCT00480532|75922237|FG003|STARTED|Overall Study||32||
59801071|NCT00480532|75922234|FG000|COMPLETED|Overall Study||31||
59801072|NCT00480532|75922235|FG001|COMPLETED|Overall Study||29||
59801073|NCT00480532|75922236|FG002|COMPLETED|Overall Study||29||
59801074|NCT00480532|75922237|FG003|COMPLETED|Overall Study||31||
59801075|NCT00480532|75922234|FG000|NOT COMPLETED|Overall Study||2||
59801076|NCT00480532|75922235|FG001|NOT COMPLETED|Overall Study||4||
59801077|NCT00480532|75922236|FG002|NOT COMPLETED|Overall Study||4||
59801078|NCT00480532|75922237|FG003|NOT COMPLETED|Overall Study||1||
59801079|NCT00496366|75922247|FG000|STARTED|Overall Study||11||
59801080|NCT00496366|75922247|FG000|COMPLETED|Overall Study||10||
59954734|NCT02572570|76073298|FG000|STARTED|Overall Study||27||64
59801081|NCT00496366|75922247|FG000|NOT COMPLETED|Overall Study||1||
59801082|NCT00488644|75922251|FG000|STARTED|Overall Study||12||
59801083|NCT00488644|75922251|FG000|COMPLETED|Overall Study||10||
59801084|NCT00488644|75922251|FG000|NOT COMPLETED|Overall Study||2||
59801085|NCT00564018|75922258|FG000|STARTED|Overall Study||11||
59801086|NCT00564018|75922259|FG001|STARTED|Overall Study||10||
59801087|NCT00564018|75922260|FG002|STARTED|Overall Study||12||
59801088|NCT00564018|75922258|FG000|COMPLETED|Overall Study||9||
59801089|NCT00564018|75922259|FG001|COMPLETED|Overall Study||7||
59801090|NCT00564018|75922260|FG002|COMPLETED|Overall Study||11||
59801091|NCT00564018|75922258|FG000|NOT COMPLETED|Overall Study||2||
59801092|NCT00564018|75922259|FG001|NOT COMPLETED|Overall Study||3||
59801093|NCT00564018|75922260|FG002|NOT COMPLETED|Overall Study||1||
59801094|NCT03381287|75922272|FG000|STARTED|Overall Study||12||
59801095|NCT03381287|75922273|FG001|STARTED|Overall Study||12||
59801096|NCT03381287|75922274|FG002|STARTED|Overall Study||12||
59801097|NCT03381287|75922275|FG003|STARTED|Overall Study||14||
59954735|NCT02572570|76073298|FG000|Filtek Bulk Fill Posterior|Overall Study||27||32
59954736|NCT02572570|76073298|FG000|Filtek Supreme Ultra|Overall Study||27||32
59954737|NCT02572570|76073298|FG000|1 Year Follow-Up|Overall Study||20||46
59954738|NCT02572570|76073298|FG000|2 Year Follow-Up|Overall Study||13||34
59954739|NCT02572570|76073298|FG000|3 Year Follow-Up|Overall Study||5||12
59801098|NCT03381287|75922272|FG000|COMPLETED|Overall Study||12||
59801099|NCT03381287|75922273|FG001|COMPLETED|Overall Study||11||
59801100|NCT03381287|75922274|FG002|COMPLETED|Overall Study||12||
59801101|NCT03381287|75922275|FG003|COMPLETED|Overall Study||12||
59954740|NCT02572570|76073298|FG000|5 Year Follow-Up|Overall Study||0||0
59801102|NCT03381287|75922272|FG000|NOT COMPLETED|Overall Study||0||
59801103|NCT03381287|75922273|FG001|NOT COMPLETED|Overall Study||1||
59801104|NCT03381287|75922274|FG002|NOT COMPLETED|Overall Study||0||
59801105|NCT03381287|75922275|FG003|NOT COMPLETED|Overall Study||2||
59801106|NCT03093480|75922291|FG000|STARTED|Overall Study||16|Immune Tolerance Induction (ITI) Full Analysis Set (ITIFAS): includes all participants who received at least 1 infusion of rFVIIIFc.|
59801107|NCT03093480|75922291|FG000|Tapering Period|Overall Study||10|Tapering Period Full Analysis Set (TPFAS): includes participants entering the tapering phase of the study|
59801108|NCT03093480|75922291|FG000|Follow-up Period|Overall Study||10|Follow-Up Period Full Analysis Set: includes all participants entering the follow-up phase in the study.|
59801109|NCT03093480|75922291|FG000|COMPLETED|Overall Study||16||
59801110|NCT03093480|75922291|FG000|NOT COMPLETED|Overall Study||0||
59801111|NCT00616928|75922299|FG000|STARTED|Overall Study||2304||
59801112|NCT00616928|75922300|FG001|STARTED|Overall Study||768||
59801113|NCT00616928|75922301|FG002|STARTED|Overall Study||1118||
59801114|NCT00616928|75922302|FG003|STARTED|Overall Study||371||
59801115|NCT00616928|75922299|FG000|COMPLETED|Overall Study||2242||
59801116|NCT00616928|75922300|FG001|COMPLETED|Overall Study||750||
59801117|NCT00616928|75922301|FG002|COMPLETED|Overall Study||1101||
59801118|NCT00616928|75922302|FG003|COMPLETED|Overall Study||364||
59801119|NCT00616928|75922299|FG000|NOT COMPLETED|Overall Study||62||
59801120|NCT00616928|75922300|FG001|NOT COMPLETED|Overall Study||18||
59801121|NCT00616928|75922301|FG002|NOT COMPLETED|Overall Study||17||
59801122|NCT00616928|75922302|FG003|NOT COMPLETED|Overall Study||7||
59801123|NCT00563784|75922324|FG000|STARTED|Overall Study||68||
59801124|NCT00563784|75922324|FG000|COMPLETED|Overall Study||46||
59801125|NCT00563784|75922324|FG000|NOT COMPLETED|Overall Study||22||
59801126|NCT03291509|75922330|FG000|STARTED|Overall Study||60||
59801127|NCT03291509|75922331|FG001|STARTED|Overall Study||60||
59801128|NCT03291509|75922330|FG000|6 Months|Overall Study||53||
59801129|NCT03291509|75922331|FG001|6 Months|Overall Study||57||
59801130|NCT03291509|75922330|FG000|18 Months|Overall Study||39||
59801131|NCT03291509|75922331|FG001|18 Months|Overall Study||48||
59801132|NCT03291509|75922330|FG000|COMPLETED|Overall Study||33||
59801133|NCT03291509|75922331|FG001|COMPLETED|Overall Study||46||
59801134|NCT03291509|75922330|FG000|NOT COMPLETED|Overall Study||27||
59801135|NCT03291509|75922331|FG001|NOT COMPLETED|Overall Study||14||
59801136|NCT00203047|75922339|FG000|STARTED|Overall Study||204||
59801137|NCT00203047|75922340|FG001|STARTED|Overall Study||210||
59801138|NCT00203047|75922339|FG000|In Database as of January 29, 2009|Overall Study||199||
59801139|NCT00203047|75922340|FG001|In Database as of January 29, 2009|Overall Study||209||
59801140|NCT00203047|75922339|FG000|COMPLETED|Overall Study||13||
59801141|NCT00203047|75922340|FG001|COMPLETED|Overall Study||7||
59801142|NCT00203047|75922339|FG000|NOT COMPLETED|Overall Study||191||
59801143|NCT00203047|75922340|FG001|NOT COMPLETED|Overall Study||203||
59801144|NCT00142519|75922348|FG000|STARTED|Overall Study||25||
59801145|NCT00142519|75922349|FG001|STARTED|Overall Study||25||
59801146|NCT00142519|75922348|FG000|COMPLETED|Overall Study||7||
59801147|NCT00142519|75922349|FG001|COMPLETED|Overall Study||9||
59801148|NCT00142519|75922348|FG000|NOT COMPLETED|Overall Study||18||
59801149|NCT00142519|75922349|FG001|NOT COMPLETED|Overall Study||16||
59801150|NCT03714776|75922357|FG000|STARTED|Overall Study||8||
59801151|NCT03714776|75922358|FG001|STARTED|Overall Study||17||
59801152|NCT03714776|75922357|FG000|Safety Set|Overall Study||8|Safety Set included all participants who were randomized and received at least 1 dose of study drug.|
59801153|NCT03714776|75922358|FG001|Safety Set|Overall Study||17|Safety Set included all participants who were randomized and received at least 1 dose of study drug.|
59801154|NCT03714776|75922357|FG000|Full Analysis Set (FAS)|Overall Study||8|FAS included all randomized participants who received at least 1 injection of study drug and who had at least 1 post-Baseline efficacy or exploratory measurements.|
59801155|NCT03714776|75922358|FG001|Full Analysis Set (FAS)|Overall Study||17|FAS included all randomized participants who received at least 1 injection of study drug and who had at least 1 post-Baseline efficacy or exploratory measurements.|
59801156|NCT03714776|75922357|FG000|Per Protocol Set (PPS)|Overall Study||6|PPS included all FAS participants who received at least 5 of the 7 doses of study drug, did not receive antihypertensive medications during the Treatment Period and prior to Day 43, and had no significant protocol deviations that would have been expected to affect efficacy or exploratory assessments.|
59801157|NCT03714776|75922358|FG001|Per Protocol Set (PPS)|Overall Study||15|PPS included all FAS participants who received at least 5 of the 7 doses of study drug, did not receive antihypertensive medications during the Treatment Period and prior to Day 43, and had no significant protocol deviations that would have been expected to affect efficacy or exploratory assessments.|
59801158|NCT03714776|75922357|FG000|COMPLETED|Overall Study||8||
59801159|NCT03714776|75922358|FG001|COMPLETED|Overall Study||17||
59801160|NCT03714776|75922357|FG000|NOT COMPLETED|Overall Study||0||
59801161|NCT03714776|75922358|FG001|NOT COMPLETED|Overall Study||0||
59801162|NCT00141817|75922368|FG000|STARTED|Overall Study||7||
59801163|NCT00141817|75922369|FG001|STARTED|Overall Study||10||
59801164|NCT00141817|75922370|FG002|STARTED|Overall Study||11||
59801165|NCT00141817|75922371|FG003|STARTED|Overall Study||13||
59801166|NCT00141817|75922368|FG000|COMPLETED|Overall Study||6||
59801167|NCT00141817|75922369|FG001|COMPLETED|Overall Study||10||
59954741|NCT02572570|76073298|FG000|COMPLETED|Overall Study||0||0
59954742|NCT02572570|76073298|FG000|NOT COMPLETED|Overall Study||27||64
59954743|NCT00709202|76073307|FG000|STARTED|Overall Study||19||
59954744|NCT00709202|76073308|FG001|STARTED|Overall Study||21||
59954745|NCT00709202|76073307|FG000|COMPLETED|Overall Study||13||
59954746|NCT00709202|76073308|FG001|COMPLETED|Overall Study||15||
59801168|NCT00141817|75922370|FG002|COMPLETED|Overall Study||10||
59801169|NCT00141817|75922371|FG003|COMPLETED|Overall Study||13||
59801170|NCT00141817|75922368|FG000|NOT COMPLETED|Overall Study||1||
59801171|NCT00141817|75922369|FG001|NOT COMPLETED|Overall Study||0||
59801172|NCT00141817|75922370|FG002|NOT COMPLETED|Overall Study||1||
59801173|NCT00141817|75922371|FG003|NOT COMPLETED|Overall Study||0||
59801174|NCT00573170|75922381|FG000|STARTED|First Treatment Period||64||
59801175|NCT00573170|75922382|FG001|STARTED|First Treatment Period||60||
59801176|NCT00573170|75922383|FG002|STARTED|First Treatment Period||60||
59801177|NCT00573170|75922384|FG003|STARTED|First Treatment Period||66||
59801178|NCT00573170|75922385|FG004|STARTED|First Treatment Period||63||
59801179|NCT00573170|75922386|FG005|STARTED|First Treatment Period||62||
59801180|NCT00573170|75922381|FG000|COMPLETED|First Treatment Period||64||
59801181|NCT00573170|75922382|FG001|COMPLETED|First Treatment Period||60||
59801182|NCT00573170|75922383|FG002|COMPLETED|First Treatment Period||60||
59801183|NCT00573170|75922384|FG003|COMPLETED|First Treatment Period||66||
59801184|NCT00573170|75922385|FG004|COMPLETED|First Treatment Period||62||
59801185|NCT00573170|75922386|FG005|COMPLETED|First Treatment Period||62||
59801186|NCT00573170|75922381|FG000|NOT COMPLETED|First Treatment Period||0||
59801187|NCT00573170|75922382|FG001|NOT COMPLETED|First Treatment Period||0||
59801188|NCT00573170|75922383|FG002|NOT COMPLETED|First Treatment Period||0||
59801189|NCT00573170|75922384|FG003|NOT COMPLETED|First Treatment Period||0||
59801190|NCT00573170|75922385|FG004|NOT COMPLETED|First Treatment Period||1||
59801191|NCT00573170|75922386|FG005|NOT COMPLETED|First Treatment Period||0||
59801192|NCT00573170|75922381|FG000|STARTED|First Washout Period||64||
59801193|NCT00573170|75922382|FG001|STARTED|First Washout Period||60||
59801194|NCT00573170|75922383|FG002|STARTED|First Washout Period||60||
59801195|NCT00573170|75922384|FG003|STARTED|First Washout Period||66||
59801196|NCT00573170|75922385|FG004|STARTED|First Washout Period||62||
59801197|NCT00573170|75922386|FG005|STARTED|First Washout Period||62||
59801198|NCT00573170|75922381|FG000|COMPLETED|First Washout Period||56||
59801199|NCT00573170|75922382|FG001|COMPLETED|First Washout Period||58||
59801200|NCT00573170|75922383|FG002|COMPLETED|First Washout Period||59||
59801201|NCT00573170|75922384|FG003|COMPLETED|First Washout Period||61||
59801202|NCT00573170|75922385|FG004|COMPLETED|First Washout Period|Source data list 4 noncompleters; per number starting next period, there were only 3 noncompleters.|59||
59801203|NCT00573170|75922386|FG005|COMPLETED|First Washout Period||55||
59801204|NCT00573170|75922381|FG000|NOT COMPLETED|First Washout Period||8||
59801205|NCT00573170|75922382|FG001|NOT COMPLETED|First Washout Period||2||
59801206|NCT00573170|75922383|FG002|NOT COMPLETED|First Washout Period||1||
59801207|NCT00573170|75922384|FG003|NOT COMPLETED|First Washout Period||5||
59801208|NCT00573170|75922385|FG004|NOT COMPLETED|First Washout Period||3||
59801209|NCT00573170|75922386|FG005|NOT COMPLETED|First Washout Period||7||
59801210|NCT00573170|75922381|FG000|STARTED|Second Treatment Period||56||
59801211|NCT00573170|75922382|FG001|STARTED|Second Treatment Period||58||
59801212|NCT00573170|75922383|FG002|STARTED|Second Treatment Period||59||
59801213|NCT00573170|75922384|FG003|STARTED|Second Treatment Period||61||
59801214|NCT00573170|75922385|FG004|STARTED|Second Treatment Period||59||
59801215|NCT00573170|75922386|FG005|STARTED|Second Treatment Period||55||
59801216|NCT00573170|75922381|FG000|COMPLETED|Second Treatment Period||56||
59801217|NCT00573170|75922382|FG001|COMPLETED|Second Treatment Period||58||
59801218|NCT00573170|75922383|FG002|COMPLETED|Second Treatment Period||59||
59801219|NCT00573170|75922384|FG003|COMPLETED|Second Treatment Period||61||
59801220|NCT00573170|75922385|FG004|COMPLETED|Second Treatment Period||59||
59801221|NCT00573170|75922386|FG005|COMPLETED|Second Treatment Period||55||
59801222|NCT00573170|75922381|FG000|NOT COMPLETED|Second Treatment Period||0||
59801223|NCT00573170|75922382|FG001|NOT COMPLETED|Second Treatment Period||0||
59801224|NCT00573170|75922383|FG002|NOT COMPLETED|Second Treatment Period||0||
59801225|NCT00573170|75922384|FG003|NOT COMPLETED|Second Treatment Period||0||
59801226|NCT00573170|75922385|FG004|NOT COMPLETED|Second Treatment Period||0||
59801227|NCT00573170|75922386|FG005|NOT COMPLETED|Second Treatment Period||0||
59801228|NCT00573170|75922381|FG000|STARTED|Second Washout Period||56||
59801229|NCT00573170|75922382|FG001|STARTED|Second Washout Period||58||
59801230|NCT00573170|75922383|FG002|STARTED|Second Washout Period||59||
59801231|NCT00573170|75922384|FG003|STARTED|Second Washout Period||61||
59801232|NCT00573170|75922385|FG004|STARTED|Second Washout Period||59||
59801233|NCT00573170|75922386|FG005|STARTED|Second Washout Period||55||
59801234|NCT00573170|75922381|FG000|COMPLETED|Second Washout Period||51||
59801235|NCT00573170|75922382|FG001|COMPLETED|Second Washout Period||54||
59801236|NCT00573170|75922383|FG002|COMPLETED|Second Washout Period||55||
59801237|NCT00573170|75922384|FG003|COMPLETED|Second Washout Period||56||
59801238|NCT00573170|75922385|FG004|COMPLETED|Second Washout Period||51||
59801239|NCT00573170|75922386|FG005|COMPLETED|Second Washout Period||53||
59801240|NCT00573170|75922381|FG000|NOT COMPLETED|Second Washout Period||5||
59801241|NCT00573170|75922382|FG001|NOT COMPLETED|Second Washout Period||4||
59801242|NCT00573170|75922383|FG002|NOT COMPLETED|Second Washout Period||4||
59801243|NCT00573170|75922384|FG003|NOT COMPLETED|Second Washout Period||5||
59801244|NCT00573170|75922385|FG004|NOT COMPLETED|Second Washout Period||8||
59801245|NCT00573170|75922386|FG005|NOT COMPLETED|Second Washout Period||2||
59801246|NCT00573170|75922381|FG000|STARTED|Third Treatment Period||51||
59801247|NCT00573170|75922382|FG001|STARTED|Third Treatment Period||54||
59801248|NCT00573170|75922383|FG002|STARTED|Third Treatment Period||55||
59801249|NCT00573170|75922384|FG003|STARTED|Third Treatment Period||56||
59801250|NCT00573170|75922385|FG004|STARTED|Third Treatment Period||51||
59801251|NCT00573170|75922386|FG005|STARTED|Third Treatment Period||53||
59801252|NCT00573170|75922381|FG000|COMPLETED|Third Treatment Period||50||
59801253|NCT00573170|75922382|FG001|COMPLETED|Third Treatment Period||54||
59801254|NCT00573170|75922383|FG002|COMPLETED|Third Treatment Period||55||
59801255|NCT00573170|75922384|FG003|COMPLETED|Third Treatment Period||56||
59801256|NCT00573170|75922385|FG004|COMPLETED|Third Treatment Period||51||
59801257|NCT00573170|75922386|FG005|COMPLETED|Third Treatment Period||51||
59801258|NCT00573170|75922381|FG000|NOT COMPLETED|Third Treatment Period||1||
59801259|NCT00573170|75922382|FG001|NOT COMPLETED|Third Treatment Period||0||
59801260|NCT00573170|75922383|FG002|NOT COMPLETED|Third Treatment Period||0||
59801261|NCT00573170|75922384|FG003|NOT COMPLETED|Third Treatment Period||0||
59801262|NCT00573170|75922385|FG004|NOT COMPLETED|Third Treatment Period||0||
59801263|NCT00573170|75922386|FG005|NOT COMPLETED|Third Treatment Period||2||
59801264|NCT00201643|75922405|FG000|STARTED|Overall Study||223||
59801265|NCT00201643|75922406|FG001|STARTED|Overall Study||214||
59801266|NCT00201643|75922405|FG000|COMPLETED|Overall Study||218||
59801267|NCT00201643|75922406|FG001|COMPLETED|Overall Study||210||
59801268|NCT00201643|75922405|FG000|NOT COMPLETED|Overall Study||5||
59801269|NCT00201643|75922406|FG001|NOT COMPLETED|Overall Study||4||
59801270|NCT00130039|75922414|FG000|STARTED|Overall Study||232||
59801271|NCT00130039|75922415|FG001|STARTED|Overall Study||225||
59801272|NCT00130039|75922414|FG000|COMPLETED|Overall Study|full analysis set|202||
59801273|NCT00130039|75922415|FG001|COMPLETED|Overall Study|full analysis set|207||
59801274|NCT00130039|75922414|FG000|NOT COMPLETED|Overall Study||30||
59801275|NCT00130039|75922415|FG001|NOT COMPLETED|Overall Study||18||
59801276|NCT00475852|75922423|FG000|STARTED|Overall Study||3564||
59801277|NCT00475852|75922424|FG001|STARTED|Overall Study||3577||
59801278|NCT00475852|75922423|FG000|COMPLETED|Overall Study||3047||
59801279|NCT00475852|75922424|FG001|COMPLETED|Overall Study||3029||
59801280|NCT00475852|75922423|FG000|NOT COMPLETED|Overall Study||517||
59801281|NCT00475852|75922424|FG001|NOT COMPLETED|Overall Study||548||
59801282|NCT00141271|75922433|FG000|STARTED|Overall Study||171||
59801283|NCT00141271|75922434|FG001|STARTED|Overall Study||165||
59801284|NCT00141271|75922435|FG002|STARTED|Overall Study||168||
59801285|NCT00141271|75922433|FG000|COMPLETED|Overall Study||91||
59801286|NCT00141271|75922434|FG001|COMPLETED|Overall Study||102||
59801287|NCT00141271|75922435|FG002|COMPLETED|Overall Study||111||
59801288|NCT00141271|75922433|FG000|NOT COMPLETED|Overall Study||80||
59801289|NCT00141271|75922434|FG001|NOT COMPLETED|Overall Study||63||
59801290|NCT00141271|75922435|FG002|NOT COMPLETED|Overall Study||57||
60073790|NCT03320512|76189135|FG000|Month 3 Lab Sample Collected|Overall Study||51||
60073791|NCT03320512|76189136|FG001|Month 3 Lab Sample Collected|Overall Study||54||
60073792|NCT03320512|76189137|FG002|Month 3 Lab Sample Collected|Overall Study||51||
60073793|NCT03320512|76189135|FG000|Month 6 Survey Started|Overall Study||67||
59801291|NCT00614120|75922447|FG000|STARTED|Overall Study|Randomised|231||
59801292|NCT00614120|75922448|FG001|STARTED|Overall Study|Randomised|233||
59801293|NCT00614120|75922449|FG002|STARTED|Overall Study|Randomised|234||
59801294|NCT00614120|75922450|FG003|STARTED|Overall Study|Randomised|231||
59801295|NCT00614120|75922447|FG000|Exposed to Study Drug|Overall Study||231||
59801296|NCT00614120|75922448|FG001|Exposed to Study Drug|Overall Study||233||
59801297|NCT00614120|75922449|FG002|Exposed to Study Drug|Overall Study|Subject withdrew before exposure to study products, and thus not included in full analysis set.|233||
59801298|NCT00614120|75922450|FG003|Exposed to Study Drug|Overall Study||231||
59801299|NCT00614120|75922447|FG000|COMPLETED|Overall Study||202||
59801300|NCT00614120|75922448|FG001|COMPLETED|Overall Study||187||
59801301|NCT00614120|75922449|FG002|COMPLETED|Overall Study||175||
59801302|NCT00614120|75922450|FG003|COMPLETED|Overall Study||215||
59801303|NCT00614120|75922447|FG000|NOT COMPLETED|Overall Study||29||
59801304|NCT00614120|75922448|FG001|NOT COMPLETED|Overall Study||46||
59801305|NCT00614120|75922449|FG002|NOT COMPLETED|Overall Study||59||
60073794|NCT03320512|76189136|FG001|Month 6 Survey Started|Overall Study||72||
59801306|NCT00614120|75922450|FG003|NOT COMPLETED|Overall Study||16||
59801307|NCT00496054|75922460|FG000|STARTED|Overall Study||110||
59801308|NCT00496054|75922460|FG000|COMPLETED|Overall Study||102||
59801309|NCT00496054|75922460|FG000|NOT COMPLETED|Overall Study||8||
59801310|NCT00495820|75922466|FG000|STARTED|Overall Study||30||
59801311|NCT00495820|75922467|FG001|STARTED|Overall Study||30||
59801312|NCT00495820|75922466|FG000|COMPLETED|Overall Study||29||
59801313|NCT00495820|75922467|FG001|COMPLETED|Overall Study||29||
59801314|NCT00495820|75922466|FG000|NOT COMPLETED|Overall Study||1||
59801315|NCT00495820|75922467|FG001|NOT COMPLETED|Overall Study||1||
59801316|NCT00495586|75922475|FG000|STARTED|Overall Study||156||
59801317|NCT00495586|75922476|FG001|STARTED|Overall Study||162||
59801318|NCT00495586|75922475|FG000|COMPLETED|Overall Study||152||
59801319|NCT00495586|75922476|FG001|COMPLETED|Overall Study||158||
59801320|NCT00495586|75922475|FG000|NOT COMPLETED|Overall Study||4||
59801321|NCT00495586|75922476|FG001|NOT COMPLETED|Overall Study||4||
59954747|NCT00709202|76073307|FG000|NOT COMPLETED|Overall Study||6||
59954748|NCT00709202|76073308|FG001|NOT COMPLETED|Overall Study||6||
59954749|NCT00709124|76073317|FG000|STARTED|Overall Study||16||
59954750|NCT00709124|76073318|FG001|STARTED|Overall Study||18||
59954751|NCT00709124|76073317|FG000|COMPLETED|Overall Study||12||
59954752|NCT00709124|76073318|FG001|COMPLETED|Overall Study||17||
59801322|NCT00613730|75922484|FG000|STARTED|Overall Study||3||
59801323|NCT00613730|75922484|FG000|COMPLETED|Overall Study||0||
59801324|NCT00613730|75922484|FG000|NOT COMPLETED|Overall Study||3||
59801325|NCT00613574|75922488|FG000|STARTED|Overall Study||407||
59801326|NCT00613574|75922488|FG000|COMPLETED|Overall Study||401||
59801327|NCT00613574|75922488|FG000|NOT COMPLETED|Overall Study||6||
59801328|NCT00613106|75922494|FG000|STARTED|Overall Study||132||
59801329|NCT00613106|75922495|FG001|STARTED|Overall Study||47||
59801330|NCT00613106|75922494|FG000|COMPLETED|Overall Study||112||
59801331|NCT00613106|75922495|FG001|COMPLETED|Overall Study||38||
59954753|NCT00709124|76073317|FG000|NOT COMPLETED|Overall Study||4||
59954754|NCT00709124|76073318|FG001|NOT COMPLETED|Overall Study||1||
59954755|NCT02738580|76073330|FG000|STARTED|Overall Study|56 patients were assigned to this arms.|56||
59954756|NCT02738580|76073331|FG001|STARTED|Overall Study||56||
59954757|NCT02738580|76073330|FG000|COMPLETED|Overall Study|"3 cycles cancelled due to por response to stimullation.~1 cycle cancelled due to SAE."|52||
59954758|NCT02738580|76073331|FG001|COMPLETED|Overall Study|"2 cycles cancelled due to por response to stimullation~1 patient withdrawal~1 excluded"|52||
59954759|NCT02738580|76073330|FG000|NOT COMPLETED|Overall Study||4||
59954760|NCT02738580|76073331|FG001|NOT COMPLETED|Overall Study||4||
59954761|NCT02571244|76073339|FG000|STARTED|Overall Study||44||
59954762|NCT02571244|76073340|FG001|STARTED|Overall Study||22||
59954763|NCT02571244|76073339|FG000|COMPLETED|Overall Study||41||
59954764|NCT02571244|76073340|FG001|COMPLETED|Overall Study||21||
59801332|NCT00613106|75922494|FG000|NOT COMPLETED|Overall Study||20||
59801333|NCT00613106|75922495|FG001|NOT COMPLETED|Overall Study||9||
59801334|NCT00141037|75922503|FG000|STARTED|Overall Study||60||
59801335|NCT00141037|75922504|FG001|STARTED|Overall Study||70||
59801336|NCT00141037|75922503|FG000|COMPLETED|Overall Study|16 subjects had reduced follow-up|50||
59801337|NCT00141037|75922504|FG001|COMPLETED|Overall Study|8 subjects had reduced follow-up|52||
59801338|NCT00141037|75922503|FG000|NOT COMPLETED|Overall Study||10||
59801339|NCT00141037|75922504|FG001|NOT COMPLETED|Overall Study||18||
59954765|NCT02571244|76073339|FG000|NOT COMPLETED|Overall Study||3||
59954766|NCT02571244|76073340|FG001|NOT COMPLETED|Overall Study||1||
59954767|NCT02573350|76073351|FG000|STARTED|Overall Study||137||
59954768|NCT02573350|76073352|FG001|STARTED|Overall Study||76||
59954769|NCT02573350|76073351|FG000|Efficacy Analysis Population|Overall Study||132|Efficacy Analysis Population included all enrolled participants who had a baseline and a post-baseline measurement available for assessment of any efficacy endpoint.|
59954770|NCT02573350|76073352|FG001|Efficacy Analysis Population|Overall Study||73|Efficacy Analysis Population included all enrolled participants who had a baseline and a post-baseline measurement available for assessment of any efficacy endpoint.|
59954771|NCT02573350|76073351|FG000|Safety Population|Overall Study||137|Safety Population included all participants treated with at least one dose of Delamanid in this study.|
59954772|NCT02573350|76073352|FG001|Safety Population|Overall Study||76|Safety Population included all participants treated with at least one dose of Delamanid in this study.|
59801340|NCT00140413|75922513|FG000|STARTED|Overall Study||13||
59801341|NCT00140413|75922514|FG001|STARTED|Overall Study||7||
59801342|NCT00140413|75922513|FG000|Received at Least One Dose of GH|Overall Study||13||
59801343|NCT00140413|75922514|FG001|Received at Least One Dose of GH|Overall Study|Controls were crossed over to GH if they met criteria for growth deceleration during the study.|3||
59801344|NCT00140413|75922513|FG000|COMPLETED|Overall Study||10||
59801345|NCT00140413|75922514|FG001|COMPLETED|Overall Study|Crossed over subjects were treated as controls for purpose of intent to treat analysis.|7||
59801346|NCT00140413|75922513|FG000|NOT COMPLETED|Overall Study||3||
59801347|NCT00140413|75922514|FG001|NOT COMPLETED|Overall Study||0||
59801348|NCT00563706|75922530|FG000|STARTED|DB Treatment Period (Day 1 up to Day 28)||37||
59801349|NCT00563706|75922531|FG001|STARTED|DB Treatment Period (Day 1 up to Day 28)||18||
59801350|NCT00563706|75922532|FG002|STARTED|DB Treatment Period (Day 1 up to Day 28)||8||
59954773|NCT02573350|76073351|FG000|COMPLETED|Overall Study||121||
59954774|NCT02573350|76073352|FG001|COMPLETED|Overall Study||67||
59954775|NCT02573350|76073351|FG000|NOT COMPLETED|Overall Study||16||
59954776|NCT02573350|76073352|FG001|NOT COMPLETED|Overall Study||9||
59954777|NCT01376804|76073361|FG000|STARTED|Treatment Period||57||
59954778|NCT01376804|76073361|FG000|Received Study Drug|Treatment Period||56||
59954779|NCT01376804|76073361|FG000|COMPLETED|Treatment Period||49||
59954780|NCT01376804|76073361|FG000|NOT COMPLETED|Treatment Period||8||
59995257|NCT02929069|76111082|FG001|Assessed HIV 12 Month|Overall Study||76||
59995258|NCT02929069|76111083|FG002|Assessed HIV 12 Month|Overall Study||39||
59995259|NCT02929069|76111081|FG000|Complete 12 Month Follow Up|Overall Study||81||
59801351|NCT00563706|75922533|FG003|STARTED|DB Treatment Period (Day 1 up to Day 28)||19||
59801352|NCT00563706|75922534|FG004|STARTED|DB Treatment Period (Day 1 up to Day 28)||16||
59801353|NCT00563706|75922535|FG005|STARTED|DB Treatment Period (Day 1 up to Day 28)||19||
59801354|NCT00563706|75922536|FG006|STARTED|DB Treatment Period (Day 1 up to Day 28)||12||
59801355|NCT00563706|75922537|FG007|STARTED|DB Treatment Period (Day 1 up to Day 28)||30||
59801356|NCT00563706|75922538|FG008|STARTED|DB Treatment Period (Day 1 up to Day 28)||43||
59801357|NCT00563706|75922530|FG000|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||20||
59801358|NCT00563706|75922531|FG001|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||13||
59801359|NCT00563706|75922532|FG002|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||3||
59801360|NCT00563706|75922533|FG003|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||9||
59801361|NCT00563706|75922534|FG004|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||11||
59801362|NCT00563706|75922535|FG005|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||14||
59801363|NCT00563706|75922536|FG006|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||9||
59801364|NCT00563706|75922537|FG007|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||16||
59801365|NCT00563706|75922538|FG008|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||32||
59801366|NCT00563706|75922530|FG000|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||17||
59801367|NCT00563706|75922531|FG001|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||5||
59801368|NCT00563706|75922532|FG002|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||5||
59801369|NCT00563706|75922533|FG003|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||10||
59801370|NCT00563706|75922534|FG004|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||5||
59801371|NCT00563706|75922535|FG005|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||5||
59801372|NCT00563706|75922536|FG006|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||3||
59801373|NCT00563706|75922537|FG007|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||14||
59801374|NCT00563706|75922538|FG008|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||11||
59801375|NCT00563706|75922530|FG000|STARTED|Taper Phase (Day 29 up to Day 35)||20||
59801376|NCT00563706|75922531|FG001|STARTED|Taper Phase (Day 29 up to Day 35)||13||
59801377|NCT00563706|75922532|FG002|STARTED|Taper Phase (Day 29 up to Day 35)||3||
59801378|NCT00563706|75922533|FG003|STARTED|Taper Phase (Day 29 up to Day 35)||9||
59801379|NCT00563706|75922534|FG004|STARTED|Taper Phase (Day 29 up to Day 35)||11||
59801380|NCT00563706|75922535|FG005|STARTED|Taper Phase (Day 29 up to Day 35)||14||
59801381|NCT00563706|75922536|FG006|STARTED|Taper Phase (Day 29 up to Day 35)||9||
59801382|NCT00563706|75922537|FG007|STARTED|Taper Phase (Day 29 up to Day 35)||16||
59801383|NCT00563706|75922538|FG008|STARTED|Taper Phase (Day 29 up to Day 35)||32||
59801384|NCT00563706|75922530|FG000|COMPLETED|Taper Phase (Day 29 up to Day 35)||20||
59801385|NCT00563706|75922531|FG001|COMPLETED|Taper Phase (Day 29 up to Day 35)||13||
59801386|NCT00563706|75922532|FG002|COMPLETED|Taper Phase (Day 29 up to Day 35)||3||
59801387|NCT00563706|75922533|FG003|COMPLETED|Taper Phase (Day 29 up to Day 35)||9||
59801388|NCT00563706|75922534|FG004|COMPLETED|Taper Phase (Day 29 up to Day 35)||11||
59801389|NCT00563706|75922535|FG005|COMPLETED|Taper Phase (Day 29 up to Day 35)||14||
59801390|NCT00563706|75922536|FG006|COMPLETED|Taper Phase (Day 29 up to Day 35)||9||
59801391|NCT00563706|75922537|FG007|COMPLETED|Taper Phase (Day 29 up to Day 35)||16||
59801392|NCT00563706|75922538|FG008|COMPLETED|Taper Phase (Day 29 up to Day 35)||32||
59801393|NCT00563706|75922530|FG000|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0||
59801394|NCT00563706|75922531|FG001|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0||
59801395|NCT00563706|75922532|FG002|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0||
59801396|NCT00563706|75922533|FG003|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0||
59801397|NCT00563706|75922534|FG004|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0||
59801398|NCT00563706|75922535|FG005|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0||
59801399|NCT00563706|75922536|FG006|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0||
59801400|NCT00563706|75922537|FG007|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0||
59801401|NCT00563706|75922538|FG008|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0||
59801402|NCT00129961|75922560|FG000|STARTED|Overall Study||39||
59801403|NCT00129961|75922561|FG001|STARTED|Overall Study||47||
59801404|NCT00129961|75922560|FG000|COMPLETED|Overall Study||20||
59801405|NCT00129961|75922561|FG001|COMPLETED|Overall Study||24||
59801406|NCT00129961|75922560|FG000|NOT COMPLETED|Overall Study||19||
59801407|NCT00129961|75922561|FG001|NOT COMPLETED|Overall Study||23||
59801408|NCT00528567|75922569|FG000|STARTED|Overall Study||1301||
59801409|NCT00528567|75922570|FG001|STARTED|Overall Study||1290||
59801410|NCT00528567|75922569|FG000|Intention to Treat|Overall Study||1301||
59801411|NCT00528567|75922570|FG001|Intention to Treat|Overall Study||1290||
59801412|NCT00528567|75922569|FG000|Safety Population|Overall Study||1288||
59801413|NCT00528567|75922570|FG001|Safety Population|Overall Study||1271||
59801414|NCT00528567|75922569|FG000|COMPLETED|Overall Study||870||
59801415|NCT00528567|75922570|FG001|COMPLETED|Overall Study||982||
59801416|NCT00528567|75922569|FG000|NOT COMPLETED|Overall Study||431||
59801417|NCT00528567|75922570|FG001|NOT COMPLETED|Overall Study||308||
59801418|NCT00138151|75922583|FG000|STARTED|Overall Study||33||
59801419|NCT00138151|75922583|FG000|COMPLETED|Overall Study||29||
59801420|NCT00138151|75922583|FG000|NOT COMPLETED|Overall Study||4||
59801421|NCT00138073|75922587|FG000|STARTED|Overall Study||55||
59801422|NCT00138073|75922587|FG000|Pre-intervention Testing|Overall Study||55||
59801423|NCT00138073|75922587|FG000|COMPLETED|Overall Study||0||
59801424|NCT00138073|75922587|FG000|NOT COMPLETED|Overall Study||55||
59801425|NCT02581631|75922596|FG000|STARTED|Overall Study||42||
59801426|NCT02581631|75922597|FG001|STARTED|Overall Study||33||
59801427|NCT02581631|75922598|FG002|STARTED|Overall Study||29||
59801428|NCT02581631|75922599|FG003|STARTED|Overall Study||10||
59801429|NCT02581631|75922600|FG004|STARTED|Overall Study||30||
59801430|NCT02581631|75922596|FG000|Phase 1 DLT Evaluable Participants|Overall Study||2||
59801431|NCT02581631|75922597|FG001|Phase 1 DLT Evaluable Participants|Overall Study||1||
59801432|NCT02581631|75922598|FG002|Phase 1 DLT Evaluable Participants|Overall Study||3||
59801433|NCT02581631|75922599|FG003|Phase 1 DLT Evaluable Participants|Overall Study||0||
59801434|NCT02581631|75922600|FG004|Phase 1 DLT Evaluable Participants|Overall Study||0||
59801435|NCT02581631|75922596|FG000|Completed Phase 1 DLT Evaluation|Overall Study||2||
59801436|NCT02581631|75922597|FG001|Completed Phase 1 DLT Evaluation|Overall Study||1||
59801437|NCT02581631|75922598|FG002|Completed Phase 1 DLT Evaluation|Overall Study||3||
59801438|NCT02581631|75922599|FG003|Completed Phase 1 DLT Evaluation|Overall Study||0||
59801439|NCT02581631|75922600|FG004|Completed Phase 1 DLT Evaluation|Overall Study||0||
59801440|NCT02581631|75922596|FG000|COMPLETED|Overall Study||0||
59801441|NCT02581631|75922597|FG001|COMPLETED|Overall Study||0||
59801442|NCT02581631|75922598|FG002|COMPLETED|Overall Study||0||
59801443|NCT02581631|75922599|FG003|COMPLETED|Overall Study||0||
59801444|NCT02581631|75922600|FG004|COMPLETED|Overall Study||0||
59801445|NCT02581631|75922596|FG000|NOT COMPLETED|Overall Study||42||
59801446|NCT02581631|75922597|FG001|NOT COMPLETED|Overall Study||33||
59801447|NCT02581631|75922598|FG002|NOT COMPLETED|Overall Study||29||
59801448|NCT02581631|75922599|FG003|NOT COMPLETED|Overall Study||10||
59801449|NCT02581631|75922600|FG004|NOT COMPLETED|Overall Study||30||
59801450|NCT00529035|75922612|FG000|STARTED|Overall Study|29 enrolled|29||
59801451|NCT00529035|75922612|FG000|COMPLETED|Overall Study|28 evaluable, 1 patient withdrew participation and was not evaluable|28||
59801452|NCT00529035|75922612|FG000|NOT COMPLETED|Overall Study||1||
59801453|NCT00609674|75922625|FG000|STARTED|Overall Study||155||
59801454|NCT00609674|75922626|FG001|STARTED|Overall Study||160||
59801455|NCT00609674|75922625|FG000|COMPLETED|Overall Study||148||
59801456|NCT00609674|75922626|FG001|COMPLETED|Overall Study||153||
59801457|NCT00609674|75922625|FG000|NOT COMPLETED|Overall Study||7||
59801458|NCT00609674|75922626|FG001|NOT COMPLETED|Overall Study||7||
59801459|NCT00137839|75922632|FG000|STARTED|Overall Study||84||
59954781|NCT01376804|76073361|FG000|STARTED|Follow-up Period|6 of the 7 patients who withdrew from treatment continued to the Follow-up Period.|55||
59954782|NCT01376804|76073361|FG000|COMPLETED|Follow-up Period||55||
59954783|NCT01376804|76073361|FG000|NOT COMPLETED|Follow-up Period||0||
59954784|NCT02574520|76073369|FG000|STARTED|Overall Study||48|Subjects randomized|
59954785|NCT02574520|76073370|FG001|STARTED|Overall Study||46|Subjects randomized|
59801460|NCT00137839|75922632|FG000|Treated|Overall Study||83||
59801461|NCT00137839|75922632|FG000|COMPLETED|Overall Study|Data on Reason Not Completed reflects Reason Off-Study|0||
59801462|NCT00137839|75922632|FG000|NOT COMPLETED|Overall Study||84||
59801463|NCT00563316|75922639|FG000|STARTED|Overall Study||28||
59801464|NCT00563316|75922639|FG000|Received Investigational Product|Overall Study||27||
59801465|NCT00563316|75922639|FG000|COMPLETED|Overall Study||16||
59801466|NCT00563316|75922639|FG000|NOT COMPLETED|Overall Study||12||
59801467|NCT03178487|75922649|FG000|STARTED|Period 1||94||
59801468|NCT03178487|75922650|FG001|STARTED|Period 1||93||
59801469|NCT03178487|75922649|FG000|Received Treatment|Period 1||94||
59801470|NCT03178487|75922650|FG001|Received Treatment|Period 1||93||
59801471|NCT03178487|75922649|FG000|COMPLETED|Period 1||90|Completed Period 1|
59801472|NCT03178487|75922650|FG001|COMPLETED|Period 1||89|Completed Period 1|
59801473|NCT03178487|75922649|FG000|NOT COMPLETED|Period 1||4||
59801474|NCT03178487|75922650|FG001|NOT COMPLETED|Period 1||4||
59801475|NCT03178487|75922649|FG000|STARTED|Period 2||90||
59801476|NCT03178487|75922650|FG001|STARTED|Period 2||89||
59801477|NCT03178487|75922649|FG000|Received Treatment|Period 2||89||
59801478|NCT03178487|75922650|FG001|Received Treatment|Period 2||89||
59801479|NCT03178487|75922649|FG000|COMPLETED|Period 2||69||
59801480|NCT03178487|75922650|FG001|COMPLETED|Period 2||70||
59801481|NCT03178487|75922649|FG000|NOT COMPLETED|Period 2||21||
59801482|NCT03178487|75922650|FG001|NOT COMPLETED|Period 2||19||
59801483|NCT00528957|75922659|FG000|STARTED|Randomized Phase (Baseline to Week 48)||48||
59801484|NCT00528957|75922660|FG001|STARTED|Randomized Phase (Baseline to Week 48)||49||
59801485|NCT00528957|75922659|FG000|COMPLETED|Randomized Phase (Baseline to Week 48)||44||
59801486|NCT00528957|75922660|FG001|COMPLETED|Randomized Phase (Baseline to Week 48)||48||
59801487|NCT00528957|75922659|FG000|NOT COMPLETED|Randomized Phase (Baseline to Week 48)||4||
59801488|NCT00528957|75922660|FG001|NOT COMPLETED|Randomized Phase (Baseline to Week 48)||1||
59801489|NCT00528957|75922659|FG000|STARTED|First Extension (Week 48 to Week 144)|Six participants completed the 48-week randomized phase and did not enroll in the first extension.|38||
59801490|NCT00528957|75922660|FG001|STARTED|First Extension (Week 48 to Week 144)|Seven participants completed the 48-week randomized phase and did not enroll in the first extension.|41||
59801491|NCT00528957|75922659|FG000|COMPLETED|First Extension (Week 48 to Week 144)||35||
59801492|NCT00528957|75922660|FG001|COMPLETED|First Extension (Week 48 to Week 144)||40||
59801493|NCT00528957|75922659|FG000|NOT COMPLETED|First Extension (Week 48 to Week 144)||3||
59801494|NCT00528957|75922660|FG001|NOT COMPLETED|First Extension (Week 48 to Week 144)||1||
59801495|NCT00528957|75922659|FG000|STARTED|Second Extension (Week 144 to Week 240)|One participant completed the first extension and did not enroll in the second extension.|34||
59801496|NCT00528957|75922660|FG001|STARTED|Second Extension (Week 144 to Week 240)||40||
59801497|NCT00528957|75922659|FG000|COMPLETED|Second Extension (Week 144 to Week 240)||27||
59801498|NCT00528957|75922660|FG001|COMPLETED|Second Extension (Week 144 to Week 240)||37||
59801499|NCT00528957|75922659|FG000|NOT COMPLETED|Second Extension (Week 144 to Week 240)||7||
59801500|NCT00528957|75922660|FG001|NOT COMPLETED|Second Extension (Week 144 to Week 240)||3||
59801501|NCT00528957|75922659|FG000|STARTED|Third Extension (Week 240 to Week 336)||27||
59801502|NCT00528957|75922660|FG001|STARTED|Third Extension (Week 240 to Week 336)||37||
59801503|NCT00528957|75922659|FG000|COMPLETED|Third Extension (Week 240 to Week 336)||21||
59801504|NCT00528957|75922660|FG001|COMPLETED|Third Extension (Week 240 to Week 336)||27||
59801505|NCT00528957|75922659|FG000|NOT COMPLETED|Third Extension (Week 240 to Week 336)||6||
59801506|NCT00528957|75922660|FG001|NOT COMPLETED|Third Extension (Week 240 to Week 336)||10||
59801507|NCT00528957|75922659|FG000|STARTED|Long-Term Extension (Week 336 and On)|Two participants completed the third extension and did not enroll in the long-term extension.|19||
59801508|NCT00528957|75922660|FG001|STARTED|Long-Term Extension (Week 336 and On)|Two participants completed the third extension and did not enroll in the long-term extension.|25||
59801509|NCT00528957|75922659|FG000|COMPLETED|Long-Term Extension (Week 336 and On)||9||
59801510|NCT00528957|75922660|FG001|COMPLETED|Long-Term Extension (Week 336 and On)||8||
59801511|NCT00528957|75922659|FG000|NOT COMPLETED|Long-Term Extension (Week 336 and On)||10||
59801512|NCT00528957|75922660|FG001|NOT COMPLETED|Long-Term Extension (Week 336 and On)||17||
59801513|NCT00560508|75922678|FG000|STARTED|12 Week Double-blind Period||56||
59801514|NCT00560508|75922679|FG001|STARTED|12 Week Double-blind Period||56||
59801515|NCT00560508|75922678|FG000|COMPLETED|12 Week Double-blind Period||51||
59801516|NCT00560508|75922679|FG001|COMPLETED|12 Week Double-blind Period||53||
59801517|NCT00560508|75922678|FG000|NOT COMPLETED|12 Week Double-blind Period||5||
59801518|NCT00560508|75922679|FG001|NOT COMPLETED|12 Week Double-blind Period||3||
59801519|NCT00560508|75922678|FG000|STARTED|52-week Open-label Period Pramipexole ER|all patients received Pramipexole ER for the 52-week open-label period|51||
59801520|NCT00560508|75922679|FG001|STARTED|52-week Open-label Period Pramipexole ER|all patients received Pramipexole ER for the 52-week open-label period|53||
59801521|NCT00560508|75922678|FG000|COMPLETED|52-week Open-label Period Pramipexole ER||43||
59801522|NCT00560508|75922679|FG001|COMPLETED|52-week Open-label Period Pramipexole ER||42||
59801523|NCT00560508|75922678|FG000|NOT COMPLETED|52-week Open-label Period Pramipexole ER||8||
59801524|NCT00560508|75922679|FG001|NOT COMPLETED|52-week Open-label Period Pramipexole ER||11||
59801525|NCT03962790|75922690|FG000|STARTED|Period 1||48||
59801526|NCT03962790|75922691|FG001|STARTED|Period 1||46||
59801527|NCT03962790|75922690|FG000|COMPLETED|Period 1||45||
59801528|NCT03962790|75922691|FG001|COMPLETED|Period 1||44||
59801529|NCT03962790|75922690|FG000|NOT COMPLETED|Period 1||3||
59801530|NCT03962790|75922691|FG001|NOT COMPLETED|Period 1||2||
59801531|NCT03962790|75922690|FG000|STARTED|Period 2||45||
59801532|NCT03962790|75922691|FG001|STARTED|Period 2||44||
59801533|NCT03962790|75922690|FG000|COMPLETED|Period 2||45||
59801534|NCT03962790|75922691|FG001|COMPLETED|Period 2||44||
59801535|NCT03962790|75922690|FG000|NOT COMPLETED|Period 2||0||
59801536|NCT03962790|75922691|FG001|NOT COMPLETED|Period 2||0||
59801537|NCT00609518|75922699|FG000|STARTED|Overall Study||54||
59801538|NCT00609518|75922700|FG001|STARTED|Overall Study||57||
59801539|NCT00609518|75922699|FG000|Completed 6 Treatment Cycles|Overall Study||19||
59801540|NCT00609518|75922700|FG001|Completed 6 Treatment Cycles|Overall Study||22||
59801541|NCT00609518|75922699|FG000|COMPLETED|Overall Study||11||
59801542|NCT00609518|75922700|FG001|COMPLETED|Overall Study||17||
59801543|NCT00609518|75922699|FG000|NOT COMPLETED|Overall Study||43||
59954786|NCT02574520|76073371|FG002|STARTED|Overall Study||153|Subjects randomized|
59954787|NCT02574520|76073372|FG003|STARTED|Overall Study||152|Subjects randomized|
59954788|NCT02574520|76073369|FG000|Dosed|Overall Study||46|ITT subjects who are randomized and dosed. One subject in Part 1 was randomized to receive SABER-Bupivacaine but was treated with Saline Placebo (the safety population includes subjects as randomized).|
59954789|NCT02574520|76073370|FG001|Dosed|Overall Study||46|ITT subjects who are randomized and dosed. One subject in Part 1 was randomized to receive SABER-Bupivacaine but was treated with Saline Placebo (the safety population includes subjects as randomized).|
59801544|NCT00609518|75922700|FG001|NOT COMPLETED|Overall Study||40||
59801545|NCT00609362|75922708|FG000|STARTED|Overall Study||29||
59801546|NCT00609362|75922709|FG001|STARTED|Overall Study||28||
59801547|NCT00609362|75922708|FG000|COMPLETED|Overall Study||26||
59801548|NCT00609362|75922709|FG001|COMPLETED|Overall Study||27||
59801549|NCT00609362|75922708|FG000|NOT COMPLETED|Overall Study||3||
59801550|NCT00609362|75922709|FG001|NOT COMPLETED|Overall Study||1||
59801551|NCT00611858|75922715|FG000|STARTED|Overall Study||13||
59801552|NCT00611858|75922715|FG000|COMPLETED|Overall Study||9||
59801553|NCT00611858|75922715|FG000|NOT COMPLETED|Overall Study||4||
59801554|NCT00137449|75922723|FG000|STARTED|Overall Study||30||
59801555|NCT00137449|75922724|FG001|STARTED|Overall Study||30||
59801556|NCT00137449|75922723|FG000|COMPLETED|Overall Study||14||
59801557|NCT00137449|75922724|FG001|COMPLETED|Overall Study||12||
59801558|NCT00137449|75922723|FG000|NOT COMPLETED|Overall Study||16||
59801559|NCT00137449|75922724|FG001|NOT COMPLETED|Overall Study||18||
59801560|NCT00528879|75922735|FG000|STARTED|Short-term Period (Day 1 to Week 24)||137||
59801561|NCT00528879|75922736|FG001|STARTED|Short-term Period (Day 1 to Week 24)||137||
59801562|NCT00528879|75922737|FG002|STARTED|Short-term Period (Day 1 to Week 24)||137||
59801563|NCT00528879|75922738|FG003|STARTED|Short-term Period (Day 1 to Week 24)||135||
59801564|NCT00528879|75922735|FG000|Completed the Period|Short-term Period (Day 1 to Week 24)||119||
59801565|NCT00528879|75922736|FG001|Completed the Period|Short-term Period (Day 1 to Week 24)||121||
59801566|NCT00528879|75922737|FG002|Completed the Period|Short-term Period (Day 1 to Week 24)||122||
59801567|NCT00528879|75922738|FG003|Completed the Period|Short-term Period (Day 1 to Week 24)||121||
59801568|NCT00528879|75922735|FG000|COMPLETED|Short-term Period (Day 1 to Week 24)|Completed=entered Long-term Period|115||
59801569|NCT00528879|75922736|FG001|COMPLETED|Short-term Period (Day 1 to Week 24)|Completed=entered Long-term Period|120||
59801570|NCT00528879|75922737|FG002|COMPLETED|Short-term Period (Day 1 to Week 24)|Completed=entered Long-term Period|122||
59801571|NCT00528879|75922738|FG003|COMPLETED|Short-term Period (Day 1 to Week 24)|Completed=entered Long-term Period|119||
59954790|NCT02574520|76073371|FG002|Dosed|Overall Study||148|ITT subjects who are randomized and dosed. One subject in Part 1 was randomized to receive SABER-Bupivacaine but was treated with Saline Placebo (the safety population includes subjects as randomized).|
59995260|NCT02929069|76111082|FG001|Complete 12 Month Follow Up|Overall Study||81||
59801572|NCT00528879|75922735|FG000|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||22||
59801573|NCT00528879|75922736|FG001|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||17||
59801574|NCT00528879|75922737|FG002|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||15||
59801575|NCT00528879|75922738|FG003|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||16||
59801576|NCT00528879|75922735|FG000|STARTED|Long-term Period (Weeks 24 to 102)||115||
59801577|NCT00528879|75922736|FG001|STARTED|Long-term Period (Weeks 24 to 102)||120||
59801578|NCT00528879|75922737|FG002|STARTED|Long-term Period (Weeks 24 to 102)||122||
59801579|NCT00528879|75922738|FG003|STARTED|Long-term Period (Weeks 24 to 102)||119||
59801580|NCT00528879|75922735|FG000|COMPLETED|Long-term Period (Weeks 24 to 102)||73||
59801581|NCT00528879|75922736|FG001|COMPLETED|Long-term Period (Weeks 24 to 102)||82||
59801582|NCT00528879|75922737|FG002|COMPLETED|Long-term Period (Weeks 24 to 102)||89||
59801583|NCT00528879|75922738|FG003|COMPLETED|Long-term Period (Weeks 24 to 102)||95||
59801584|NCT00528879|75922735|FG000|NOT COMPLETED|Long-term Period (Weeks 24 to 102)||42||
59801585|NCT00528879|75922736|FG001|NOT COMPLETED|Long-term Period (Weeks 24 to 102)||38||
59801586|NCT00528879|75922737|FG002|NOT COMPLETED|Long-term Period (Weeks 24 to 102)||33||
59801587|NCT00528879|75922738|FG003|NOT COMPLETED|Long-term Period (Weeks 24 to 102)||24||
59801588|NCT00608894|75922750|FG000|STARTED|Overall Study||7||
59801589|NCT00608894|75922751|FG001|STARTED|Overall Study||6||
59801590|NCT00608894|75922750|FG000|COMPLETED|Overall Study||7||
59801591|NCT00608894|75922751|FG001|COMPLETED|Overall Study|One patient was granted permission to crossover to LCP-Tacro due to treatment intolerance|4||
59801592|NCT00608894|75922750|FG000|NOT COMPLETED|Overall Study||0||
59801593|NCT00608894|75922751|FG001|NOT COMPLETED|Overall Study||2||
59801594|NCT00557856|75922759|FG000|STARTED|Part 1: Dose Escalation Phase||7||
59801595|NCT00557856|75922760|FG001|STARTED|Part 1: Dose Escalation Phase||5||
59801596|NCT00557856|75922761|FG002|STARTED|Part 1: Dose Escalation Phase||6||
59801597|NCT00557856|75922762|FG003|STARTED|Part 1: Dose Escalation Phase||3||
59801598|NCT00557856|75922763|FG004|STARTED|Part 1: Dose Escalation Phase||4||
59801599|NCT00557856|75922764|FG005|STARTED|Part 1: Dose Escalation Phase||8||
59801600|NCT00557856|75922765|FG006|STARTED|Part 1: Dose Escalation Phase||7||
59801601|NCT00557856|75922766|FG007|STARTED|Part 1: Dose Escalation Phase||6||
59801602|NCT00557856|75922767|FG008|STARTED|Part 1: Dose Escalation Phase||0||
59801603|NCT00557856|75922759|FG000|Treated|Part 1: Dose Escalation Phase||5||
59801604|NCT00557856|75922760|FG001|Treated|Part 1: Dose Escalation Phase||5||
59801605|NCT00557856|75922761|FG002|Treated|Part 1: Dose Escalation Phase||6||
59801606|NCT00557856|75922762|FG003|Treated|Part 1: Dose Escalation Phase||3||
59801607|NCT00557856|75922763|FG004|Treated|Part 1: Dose Escalation Phase||4||
59801608|NCT00557856|75922764|FG005|Treated|Part 1: Dose Escalation Phase||8||
59801609|NCT00557856|75922765|FG006|Treated|Part 1: Dose Escalation Phase||7||
59801610|NCT00557856|75922766|FG007|Treated|Part 1: Dose Escalation Phase||6||
59801611|NCT00557856|75922767|FG008|Treated|Part 1: Dose Escalation Phase||0||
59801612|NCT00557856|75922759|FG000|COMPLETED|Part 1: Dose Escalation Phase||0||
59801613|NCT00557856|75922760|FG001|COMPLETED|Part 1: Dose Escalation Phase||0||
59801614|NCT00557856|75922761|FG002|COMPLETED|Part 1: Dose Escalation Phase||0||
59801615|NCT00557856|75922762|FG003|COMPLETED|Part 1: Dose Escalation Phase||0||
59801616|NCT00557856|75922763|FG004|COMPLETED|Part 1: Dose Escalation Phase||0||
59801617|NCT00557856|75922764|FG005|COMPLETED|Part 1: Dose Escalation Phase||0||
59801618|NCT00557856|75922765|FG006|COMPLETED|Part 1: Dose Escalation Phase||0||
59801619|NCT00557856|75922766|FG007|COMPLETED|Part 1: Dose Escalation Phase||0||
59801620|NCT00557856|75922767|FG008|COMPLETED|Part 1: Dose Escalation Phase||0||
59801621|NCT00557856|75922759|FG000|NOT COMPLETED|Part 1: Dose Escalation Phase||7||
59801622|NCT00557856|75922760|FG001|NOT COMPLETED|Part 1: Dose Escalation Phase||5||
59801623|NCT00557856|75922761|FG002|NOT COMPLETED|Part 1: Dose Escalation Phase||6||
59801624|NCT00557856|75922762|FG003|NOT COMPLETED|Part 1: Dose Escalation Phase||3||
59801625|NCT00557856|75922763|FG004|NOT COMPLETED|Part 1: Dose Escalation Phase||4||
59801626|NCT00557856|75922764|FG005|NOT COMPLETED|Part 1: Dose Escalation Phase||8||
59801627|NCT00557856|75922765|FG006|NOT COMPLETED|Part 1: Dose Escalation Phase||7||
59801628|NCT00557856|75922766|FG007|NOT COMPLETED|Part 1: Dose Escalation Phase||6||
59801629|NCT00557856|75922767|FG008|NOT COMPLETED|Part 1: Dose Escalation Phase||0||
59801630|NCT00557856|75922759|FG000|STARTED|Part 2: Exploratory Phase||0||
59995261|NCT02929069|76111083|FG002|Complete 12 Month Follow Up|Overall Study||42||
59954791|NCT02574520|76073372|FG003|Dosed|Overall Study||148|ITT subjects who are randomized and dosed. One subject in Part 1 was randomized to receive SABER-Bupivacaine but was treated with Saline Placebo (the safety population includes subjects as randomized).|
59954792|NCT02574520|76073369|FG000|COMPLETED|Overall Study||46||
59954793|NCT02574520|76073370|FG001|COMPLETED|Overall Study||46||
59954794|NCT02574520|76073371|FG002|COMPLETED|Overall Study||148||
59523848|NCT01191541|75618844|FG000|COMPLETED|All the Patients||30||
59523849|NCT01191541|75618845|FG001|COMPLETED|All the Patients||35||
59523850|NCT01191541|75618844|FG000|NOT COMPLETED|All the Patients||0||
59523851|NCT01191541|75618845|FG001|NOT COMPLETED|All the Patients||0||
59523852|NCT01191541|75618844|FG000|STARTED|the Randomized Patients||30||
59523853|NCT01191541|75618845|FG001|STARTED|the Randomized Patients||35||
59523854|NCT01191541|75618844|FG000|COMPLETED|the Randomized Patients||30||
59523855|NCT01191541|75618845|FG001|COMPLETED|the Randomized Patients||35||
59523856|NCT01191541|75618844|FG000|NOT COMPLETED|the Randomized Patients||0||
59523857|NCT01191541|75618845|FG001|NOT COMPLETED|the Randomized Patients||0||
59523858|NCT01150903|75618863|FG000|STARTED|Overall Study||24708||
59523859|NCT01150903|75618864|FG001|STARTED|Overall Study||74124||
59523860|NCT01150903|75618863|FG000|COMPLETED|Overall Study||24708||
59523861|NCT01150903|75618864|FG001|COMPLETED|Overall Study||74124||
59523862|NCT01150903|75618863|FG000|NOT COMPLETED|Overall Study||0||
59523863|NCT01150903|75618864|FG001|NOT COMPLETED|Overall Study||0||
59523864|NCT01150981|75618872|FG000|STARTED|Overall Study||20||
59523865|NCT01150981|75618873|FG001|STARTED|Overall Study||15||
59523866|NCT01150981|75618872|FG000|COMPLETED|Overall Study||16||
59523867|NCT01150981|75618873|FG001|COMPLETED|Overall Study||13||
59523868|NCT01150981|75618872|FG000|NOT COMPLETED|Overall Study||4||
59523869|NCT01150981|75618873|FG001|NOT COMPLETED|Overall Study||2||
59523870|NCT01230931|75618881|FG000|STARTED|Overall Study||10||
59620489|NCT00184548|75731818|FG003|Exposed|Overall Study|Four subjects withdrew due to ineligibility, one subject died. Excluded from safety analysis set|40||
59620490|NCT00184548|75731815|FG000|COMPLETED|Overall Study||218||
59620491|NCT00184548|75731816|FG001|COMPLETED|Overall Study||242||
59620492|NCT00184548|75731817|FG002|COMPLETED|Overall Study||44||
59620493|NCT00184548|75731818|FG003|COMPLETED|Overall Study||38||
59620494|NCT00184548|75731815|FG000|NOT COMPLETED|Overall Study||8||
59620495|NCT00184548|75731816|FG001|NOT COMPLETED|Overall Study||13||
59620496|NCT00184548|75731817|FG002|NOT COMPLETED|Overall Study||3||
59620497|NCT00184548|75731818|FG003|NOT COMPLETED|Overall Study||7||
59620498|NCT00085410|75731828|FG000|STARTED|Overall Study||20||
59620499|NCT00085410|75731828|FG000|COMPLETED|Overall Study||20||
59620500|NCT00085410|75731828|FG000|NOT COMPLETED|Overall Study||0||
59620501|NCT00186498|75731835|FG000|STARTED|Overall Study||6||
59620502|NCT00186498|75731836|FG001|STARTED|Overall Study||5||
59620503|NCT00186498|75731835|FG000|COMPLETED|Overall Study||4||
59620504|NCT00186498|75731836|FG001|COMPLETED|Overall Study||3||
59620505|NCT00186498|75731835|FG000|NOT COMPLETED|Overall Study||2||
59620506|NCT00186498|75731836|FG001|NOT COMPLETED|Overall Study||2||
59620507|NCT00265200|75731842|FG000|STARTED|Overall Study||28||
59620508|NCT00265200|75731842|FG000|COMPLETED|Overall Study||24||
59620509|NCT00265200|75731842|FG000|NOT COMPLETED|Overall Study||4||
59620510|NCT00087672|75731846|FG000|STARTED|Overall Study||41||
59620511|NCT00087672|75731846|FG000|COMPLETED|Overall Study||41||
59620512|NCT00087672|75731846|FG000|NOT COMPLETED|Overall Study||0||
59620513|NCT00265512|75731852|FG000|STARTED|Overall Study||213||
59620514|NCT00265512|75731853|FG001|STARTED|Overall Study||454||
59620515|NCT00265512|75731852|FG000|COMPLETED|Overall Study||168||
59620516|NCT00265512|75731853|FG001|COMPLETED|Overall Study||359||
59620517|NCT00265512|75731852|FG000|NOT COMPLETED|Overall Study||45||
59620518|NCT00265512|75731853|FG001|NOT COMPLETED|Overall Study||95||
59620519|NCT00265980|75731859|FG000|STARTED|Overall Study||22||
59620520|NCT00265980|75731859|FG000|Weight Initial|Overall Study||22||
59620521|NCT00265980|75731859|FG000|Weight -10% Placebo|Overall Study||22||
59620522|NCT00265980|75731859|FG000|Weight -10% Leptin|Overall Study||22||
59620523|NCT00265980|75731859|FG000|COMPLETED|Overall Study||22||
59620524|NCT00265980|75731859|FG000|NOT COMPLETED|Overall Study||0||
59954795|NCT02574520|76073372|FG003|COMPLETED|Overall Study||144||
59954796|NCT02574520|76073369|FG000|NOT COMPLETED|Overall Study||2||
59954797|NCT02574520|76073370|FG001|NOT COMPLETED|Overall Study||0||
59523871|NCT01230931|75618882|FG001|STARTED|Overall Study||10||
59523872|NCT01230931|75618881|FG000|COMPLETED|Overall Study||10||
59523873|NCT01230931|75618882|FG001|COMPLETED|Overall Study||10||
59523874|NCT01230931|75618881|FG000|NOT COMPLETED|Overall Study||0||
59523875|NCT01230931|75618882|FG001|NOT COMPLETED|Overall Study||0||
59620525|NCT00187200|75731865|FG000|STARTED|Overall Study||49||
59620526|NCT00187200|75731866|FG001|STARTED|Overall Study||44||
59620527|NCT00187200|75731865|FG000|COMPLETED|Overall Study||31||
59620528|NCT00187200|75731866|FG001|COMPLETED|Overall Study||26||
59954798|NCT02574520|76073371|FG002|NOT COMPLETED|Overall Study||5||
59954799|NCT02574520|76073372|FG003|NOT COMPLETED|Overall Study||8||
59954800|NCT00709592|76073384|FG000|STARTED|Overall Study||19||
59523876|NCT02477774|75618891|FG000|STARTED|Overall Study||29||
59620529|NCT00187200|75731865|FG000|NOT COMPLETED|Overall Study||18||
59620530|NCT00187200|75731866|FG001|NOT COMPLETED|Overall Study||18||
59620531|NCT00088218|75731876|FG000|STARTED|Overall Study||16||
59801631|NCT00557856|75922760|FG001|STARTED|Part 2: Exploratory Phase||0||
59801632|NCT00557856|75922761|FG002|STARTED|Part 2: Exploratory Phase||0||
59801633|NCT00557856|75922762|FG003|STARTED|Part 2: Exploratory Phase||0||
59801634|NCT00557856|75922763|FG004|STARTED|Part 2: Exploratory Phase||0||
59801635|NCT00557856|75922764|FG005|STARTED|Part 2: Exploratory Phase||0||
59801636|NCT00557856|75922765|FG006|STARTED|Part 2: Exploratory Phase||0||
59801637|NCT00557856|75922766|FG007|STARTED|Part 2: Exploratory Phase||0||
59801638|NCT00557856|75922767|FG008|STARTED|Part 2: Exploratory Phase||24||
59801639|NCT00557856|75922759|FG000|COMPLETED|Part 2: Exploratory Phase||0||
59801640|NCT00557856|75922760|FG001|COMPLETED|Part 2: Exploratory Phase||0||
59801641|NCT00557856|75922761|FG002|COMPLETED|Part 2: Exploratory Phase||0||
59801642|NCT00557856|75922762|FG003|COMPLETED|Part 2: Exploratory Phase||0||
59801643|NCT00557856|75922763|FG004|COMPLETED|Part 2: Exploratory Phase||0||
59801644|NCT00557856|75922764|FG005|COMPLETED|Part 2: Exploratory Phase||0||
59801645|NCT00557856|75922765|FG006|COMPLETED|Part 2: Exploratory Phase||0||
59801646|NCT00557856|75922766|FG007|COMPLETED|Part 2: Exploratory Phase||0||
59801647|NCT00557856|75922767|FG008|COMPLETED|Part 2: Exploratory Phase||0||
59801648|NCT00557856|75922759|FG000|NOT COMPLETED|Part 2: Exploratory Phase||0||
59954801|NCT00709592|76073385|FG001|STARTED|Overall Study||23||
59954802|NCT00709592|76073384|FG000|COMPLETED|Overall Study||19||
59954803|NCT00709592|76073385|FG001|COMPLETED|Overall Study||22||
59954804|NCT00709592|76073384|FG000|NOT COMPLETED|Overall Study||0||
59954805|NCT00709592|76073385|FG001|NOT COMPLETED|Overall Study||1||
59954806|NCT02570152|76073391|FG000|STARTED|Overall Study||2004|2004|
59954807|NCT02570152|76073391|FG000|COMPLETED|Overall Study||1989|1989|
59954808|NCT02570152|76073391|FG000|NOT COMPLETED|Overall Study||15||
59954809|NCT02570074|76073397|FG000|STARTED|Period 1 (First Dosing Regimen)||9||
59954810|NCT02570074|76073398|FG001|STARTED|Period 1 (First Dosing Regimen)||10||
59954811|NCT02570074|76073397|FG000|COMPLETED|Period 1 (First Dosing Regimen)||9||
59954812|NCT02570074|76073398|FG001|COMPLETED|Period 1 (First Dosing Regimen)||10||
59954813|NCT02570074|76073397|FG000|NOT COMPLETED|Period 1 (First Dosing Regimen)||0||
59954814|NCT02570074|76073398|FG001|NOT COMPLETED|Period 1 (First Dosing Regimen)||0||
59954815|NCT02570074|76073397|FG000|STARTED|Period 2 (Second Dosing Regimen)||9||
59954816|NCT02570074|76073398|FG001|STARTED|Period 2 (Second Dosing Regimen)||10||
59954817|NCT02570074|76073397|FG000|COMPLETED|Period 2 (Second Dosing Regimen)||8||
59954818|NCT02570074|76073398|FG001|COMPLETED|Period 2 (Second Dosing Regimen)||10||
59801649|NCT00557856|75922760|FG001|NOT COMPLETED|Part 2: Exploratory Phase||0||
59801650|NCT00557856|75922761|FG002|NOT COMPLETED|Part 2: Exploratory Phase||0||
59801651|NCT00557856|75922762|FG003|NOT COMPLETED|Part 2: Exploratory Phase||0||
59801652|NCT00557856|75922763|FG004|NOT COMPLETED|Part 2: Exploratory Phase||0||
59801653|NCT00557856|75922764|FG005|NOT COMPLETED|Part 2: Exploratory Phase||0||
59801654|NCT00557856|75922765|FG006|NOT COMPLETED|Part 2: Exploratory Phase||0||
59801655|NCT00557856|75922766|FG007|NOT COMPLETED|Part 2: Exploratory Phase||0||
59801656|NCT00557856|75922767|FG008|NOT COMPLETED|Part 2: Exploratory Phase||24||
59801657|NCT00191113|75922784|FG000|STARTED|Core Study||78||
59801658|NCT00191113|75922785|FG001|STARTED|Core Study||76||
59801659|NCT00191113|75922784|FG000|COMPLETED|Core Study||43||
59801660|NCT00191113|75922785|FG001|COMPLETED|Core Study||61||
59801661|NCT00191113|75922784|FG000|NOT COMPLETED|Core Study||35||
59801662|NCT00191113|75922785|FG001|NOT COMPLETED|Core Study||15||
59801663|NCT00191113|75922784|FG000|STARTED|Addendum 1||2||
59954819|NCT02570074|76073397|FG000|NOT COMPLETED|Period 2 (Second Dosing Regimen)||1||
59954820|NCT02570074|76073398|FG001|NOT COMPLETED|Period 2 (Second Dosing Regimen)||0||
59801664|NCT00191113|75922785|FG001|STARTED|Addendum 1|Not Applicable -- only Control patients were eligible for Addendum 1|0||
59954821|NCT02569996|76073416|FG000|STARTED|Overall Study||124||
59954822|NCT02569996|76073416|FG000|COMPLETED|Overall Study||69||
59523877|NCT02477774|75618892|FG001|STARTED|Overall Study||26||
59523878|NCT02477774|75618891|FG000|COMPLETED|Overall Study||29||
59523879|NCT02477774|75618892|FG001|COMPLETED|Overall Study||26||
59523880|NCT02477774|75618891|FG000|NOT COMPLETED|Overall Study||0||
59523881|NCT02477774|75618892|FG001|NOT COMPLETED|Overall Study||0||
59523882|NCT01195597|75618898|FG000|STARTED|Overall Study||40||
59523883|NCT01195597|75618898|FG000|COMPLETED|Overall Study||27||
59523884|NCT01195597|75618898|FG000|NOT COMPLETED|Overall Study||13||
59523885|NCT03110562|75618904|FG000|STARTED|Overall Study||195||
59954823|NCT02569996|76073416|FG000|NOT COMPLETED|Overall Study||55||
59954824|NCT02572882|76073420|FG000|STARTED|Overall Study||13||
59954825|NCT02572882|76073420|FG000|COMPLETED|Overall Study||11||
59954826|NCT02572882|76073420|FG000|NOT COMPLETED|Overall Study||2||
59954827|NCT00708500|76073450|FG000|STARTED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||80||
59954828|NCT00708500|76073451|FG001|STARTED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||162||
59954829|NCT00708500|76073452|FG002|STARTED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||162||
59954830|NCT00708500|76073450|FG000|Treated With PEG2b + RBV|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||80||
59954831|NCT00708500|76073451|FG001|Treated With PEG2b + RBV|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||162||
59523886|NCT03110562|75618905|FG001|STARTED|Overall Study||207||
59523887|NCT03110562|75618904|FG000|Treated|Overall Study||195||
59523888|NCT03110562|75618905|FG001|Treated|Overall Study||204||
59523889|NCT03110562|75618904|FG000|COMPLETED|Overall Study||0||
59954832|NCT00708500|76073452|FG002|Treated With PEG2b + RBV|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||161||
59954833|NCT00708500|76073450|FG000|COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||78||
59954834|NCT00708500|76073451|FG001|COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||156||
59954835|NCT00708500|76073452|FG002|COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||160||
59954836|NCT00708500|76073450|FG000|NOT COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||2||
59801665|NCT00191113|75922784|FG000|COMPLETED|Addendum 1||2||
59801666|NCT00191113|75922785|FG001|COMPLETED|Addendum 1|Not Applicable -- only Control patients were eligible for Addendum 1|0||
59801667|NCT00191113|75922784|FG000|NOT COMPLETED|Addendum 1||0||
59801668|NCT00191113|75922785|FG001|NOT COMPLETED|Addendum 1||0||
59801669|NCT00191113|75922784|FG000|STARTED|Addendum 2||28||
59801670|NCT00191113|75922785|FG001|STARTED|Addendum 2||48||
59801671|NCT00191113|75922784|FG000|COMPLETED|Addendum 2||18||
59801672|NCT00191113|75922785|FG001|COMPLETED|Addendum 2||31||
59801673|NCT00191113|75922784|FG000|NOT COMPLETED|Addendum 2||10||
59801674|NCT00191113|75922785|FG001|NOT COMPLETED|Addendum 2||17||
59801675|NCT00191113|75922784|FG000|STARTED|Addendum 3||20||
59801676|NCT00191113|75922785|FG001|STARTED|Addendum 3||37||
59801677|NCT00191113|75922784|FG000|COMPLETED|Addendum 3||20||
59801678|NCT00191113|75922785|FG001|COMPLETED|Addendum 3||37||
59801679|NCT00191113|75922784|FG000|NOT COMPLETED|Addendum 3||0||
59801680|NCT00191113|75922785|FG001|NOT COMPLETED|Addendum 3||0||
59801681|NCT00608582|75922799|FG000|STARTED|Overall Study||14||
59801682|NCT00608582|75922800|FG001|STARTED|Overall Study||11||
59801683|NCT00608582|75922799|FG000|COMPLETED|Overall Study||10||
59801684|NCT00608582|75922800|FG001|COMPLETED|Overall Study||7||
59801685|NCT00608582|75922799|FG000|NOT COMPLETED|Overall Study||4||
59801686|NCT00608582|75922800|FG001|NOT COMPLETED|Overall Study||4||
59801687|NCT03965052|75922810|FG000|STARTED|Overall Study||12||
59801688|NCT03965052|75922811|FG001|STARTED|Overall Study||12||
59954837|NCT00708500|76073451|FG001|NOT COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||6||
59954838|NCT00708500|76073452|FG002|NOT COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||2||
59954839|NCT00708500|76073450|FG000|STARTED|Tx: RECEIVING BOCEPREVIR/PLACEBO||78||
59954840|NCT00708500|76073451|FG001|STARTED|Tx: RECEIVING BOCEPREVIR/PLACEBO||156||
59954841|NCT00708500|76073452|FG002|STARTED|Tx: RECEIVING BOCEPREVIR/PLACEBO||160||
59954842|NCT00708500|76073450|FG000|COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||23||
59801689|NCT03965052|75922810|FG000|COMPLETED|Overall Study||11||
59801690|NCT03965052|75922811|FG001|COMPLETED|Overall Study||12||
59801691|NCT03965052|75922810|FG000|NOT COMPLETED|Overall Study||1||
59801692|NCT03965052|75922811|FG001|NOT COMPLETED|Overall Study||0||
59801693|NCT03964974|75922819|FG000|STARTED|Overall Study||30||
59801694|NCT03964974|75922820|FG001|STARTED|Overall Study||27||
59801695|NCT03964974|75922819|FG000|Assigned and Received Intervention|Overall Study||26||
59801696|NCT03964974|75922820|FG001|Assigned and Received Intervention|Overall Study||21||
59801697|NCT03964974|75922819|FG000|8 Week Follow Up|Overall Study||26||
59801698|NCT03964974|75922820|FG001|8 Week Follow Up|Overall Study||22||
59801699|NCT03964974|75922819|FG000|16 Week Follow Up|Overall Study||27||
59801700|NCT03964974|75922820|FG001|16 Week Follow Up|Overall Study||22||
59801701|NCT03964974|75922819|FG000|COMPLETED|Overall Study||27||
59801702|NCT03964974|75922820|FG001|COMPLETED|Overall Study||22||
59801703|NCT03964974|75922819|FG000|NOT COMPLETED|Overall Study||3||
59801704|NCT03964974|75922820|FG001|NOT COMPLETED|Overall Study||5||
59801705|NCT00606320|75922826|FG000|STARTED|Overall Study||59||
59801706|NCT00606320|75922826|FG000|COMPLETED|Overall Study||22||
59954843|NCT00708500|76073451|FG001|COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||104||
59801707|NCT00606320|75922826|FG000|NOT COMPLETED|Overall Study||37||
59801708|NCT00528411|75922833|FG000|STARTED|Overall Study||57||
59801709|NCT00528411|75922834|FG001|STARTED|Overall Study||54||
59801710|NCT00528411|75922835|FG002|STARTED|Overall Study||12||
59801711|NCT00528411|75922833|FG000|COMPLETED|Overall Study||52||
59801712|NCT00528411|75922834|FG001|COMPLETED|Overall Study||51||
59801713|NCT00528411|75922835|FG002|COMPLETED|Overall Study||11||
59801714|NCT00528411|75922833|FG000|NOT COMPLETED|Overall Study||5||
59801715|NCT00528411|75922834|FG001|NOT COMPLETED|Overall Study||3||
59801716|NCT00528411|75922835|FG002|NOT COMPLETED|Overall Study||1||
59801717|NCT00136357|75922845|FG000|STARTED|Overall Study||41||
59801718|NCT00136357|75922846|FG001|STARTED|Overall Study||41||
59801719|NCT00136357|75922845|FG000|COMPLETED|Overall Study||38||
59801720|NCT00136357|75922846|FG001|COMPLETED|Overall Study||39||
59801721|NCT00136357|75922845|FG000|NOT COMPLETED|Overall Study||3||
59801722|NCT00136357|75922846|FG001|NOT COMPLETED|Overall Study||2||
59801723|NCT00129649|75922854|FG000|STARTED|Overall Study||258||
59801724|NCT00129649|75922855|FG001|STARTED|Overall Study||246||
59954844|NCT00708500|76073452|FG002|COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||105||
59954845|NCT00708500|76073450|FG000|NOT COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||55||
59954846|NCT00708500|76073451|FG001|NOT COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||52||
59995262|NCT02929069|76111081|FG000|COMPLETED|Overall Study||81||
59995263|NCT02929069|76111082|FG001|COMPLETED|Overall Study||81||
59995264|NCT02929069|76111083|FG002|COMPLETED|Overall Study||42||
59995265|NCT02929069|76111081|FG000|NOT COMPLETED|Overall Study||19||
59995266|NCT02929069|76111082|FG001|NOT COMPLETED|Overall Study||21||
59995267|NCT02929069|76111083|FG002|NOT COMPLETED|Overall Study||10||
59954847|NCT00708500|76073452|FG002|NOT COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||55||
59954848|NCT00708500|76073450|FG000|STARTED|FOLLOWUP||77||
59954849|NCT00708500|76073451|FG001|STARTED|FOLLOWUP||151||
59954850|NCT00708500|76073452|FG002|STARTED|FOLLOWUP||158||
59801725|NCT00129649|75922854|FG000|COMPLETED|Overall Study||182||
59801726|NCT00129649|75922855|FG001|COMPLETED|Overall Study||181||
59801727|NCT00129649|75922854|FG000|NOT COMPLETED|Overall Study||76||
59801728|NCT00129649|75922855|FG001|NOT COMPLETED|Overall Study||65||
59801729|NCT00187135|75922867|FG000|STARTED|Visit One||30||
59801730|NCT00187135|75922868|FG001|STARTED|Visit One||28||
59801731|NCT00187135|75922869|FG002|STARTED|Visit One||25||
59801732|NCT00187135|75922870|FG003|STARTED|Visit One||26||
59801733|NCT00187135|75922871|FG004|STARTED|Visit One||25||
59954851|NCT00708500|76073450|FG000|COMPLETED|FOLLOWUP||37||
59954852|NCT00708500|76073451|FG001|COMPLETED|FOLLOWUP||136||
59954853|NCT00708500|76073452|FG002|COMPLETED|FOLLOWUP||143||
59801734|NCT00187135|75922872|FG005|STARTED|Visit One||28||
59801735|NCT00187135|75922867|FG000|COMPLETED|Visit One||26||
59801736|NCT00187135|75922868|FG001|COMPLETED|Visit One||27||
59801737|NCT00187135|75922869|FG002|COMPLETED|Visit One||25||
59801738|NCT00187135|75922870|FG003|COMPLETED|Visit One||26||
59801739|NCT00187135|75922871|FG004|COMPLETED|Visit One||25||
59801740|NCT00187135|75922872|FG005|COMPLETED|Visit One||26||
59801741|NCT00187135|75922867|FG000|NOT COMPLETED|Visit One||4||
59801742|NCT00187135|75922868|FG001|NOT COMPLETED|Visit One||1||
59801743|NCT00187135|75922869|FG002|NOT COMPLETED|Visit One||0||
59801744|NCT00187135|75922870|FG003|NOT COMPLETED|Visit One||0||
59801745|NCT00187135|75922871|FG004|NOT COMPLETED|Visit One||0||
59801746|NCT00187135|75922872|FG005|NOT COMPLETED|Visit One||2||
59801747|NCT00187135|75922867|FG000|STARTED|Visit Two||26||
59801748|NCT00187135|75922868|FG001|STARTED|Visit Two||27||
59801749|NCT00187135|75922869|FG002|STARTED|Visit Two||25||
59801750|NCT00187135|75922870|FG003|STARTED|Visit Two||26||
59801751|NCT00187135|75922871|FG004|STARTED|Visit Two||25||
59801752|NCT00187135|75922872|FG005|STARTED|Visit Two||26||
59801753|NCT00187135|75922867|FG000|COMPLETED|Visit Two||21||
59801754|NCT00187135|75922868|FG001|COMPLETED|Visit Two||24||
59954854|NCT00708500|76073450|FG000|NOT COMPLETED|FOLLOWUP||40||
59954855|NCT00708500|76073451|FG001|NOT COMPLETED|FOLLOWUP||15||
59954856|NCT00708500|76073452|FG002|NOT COMPLETED|FOLLOWUP||15||
59954857|NCT00673244|76073462|FG000|STARTED|Overall Study||52||
59954858|NCT00673244|76073463|FG001|STARTED|Overall Study||25||
59954859|NCT00673244|76073462|FG000|COMPLETED|Overall Study||52||
59801755|NCT00187135|75922869|FG002|COMPLETED|Visit Two||23||
59801756|NCT00187135|75922870|FG003|COMPLETED|Visit Two||18||
59801757|NCT00187135|75922871|FG004|COMPLETED|Visit Two||19||
59801758|NCT00187135|75922872|FG005|COMPLETED|Visit Two||18||
59801759|NCT00187135|75922867|FG000|NOT COMPLETED|Visit Two||5||
59801760|NCT00187135|75922868|FG001|NOT COMPLETED|Visit Two||3||
59801761|NCT00187135|75922869|FG002|NOT COMPLETED|Visit Two||2||
59954860|NCT00673244|76073463|FG001|COMPLETED|Overall Study||25||
59954861|NCT00673244|76073462|FG000|NOT COMPLETED|Overall Study||0||
59954862|NCT00673244|76073463|FG001|NOT COMPLETED|Overall Study||0||
59954863|NCT00708734|76073469|FG000|STARTED|Overall Study|94 subjects were screened, 45 did not meet criteria, and 39 declined participation after screening.|10||
59954864|NCT00708734|76073469|FG000|COMPLETED|Overall Study|Ten subjects enrolled, three completed the intervention and all follow up sessions.|3||
59954865|NCT00708734|76073469|FG000|NOT COMPLETED|Overall Study||7||
59954866|NCT04834362|76073475|FG000|STARTED|Overall Study||53||
59954867|NCT04834362|76073476|FG001|STARTED|Overall Study||52||
59954868|NCT04834362|76073475|FG000|COMPLETED|Overall Study||52||
59954869|NCT04834362|76073476|FG001|COMPLETED|Overall Study||50||
59954870|NCT04834362|76073475|FG000|NOT COMPLETED|Overall Study||1||
59954871|NCT04834362|76073476|FG001|NOT COMPLETED|Overall Study||2||
59954872|NCT00101907|76073488|FG000|STARTED|Overall Study||8||
59954873|NCT00101907|76073489|FG001|STARTED|Overall Study||8||
59801762|NCT00187135|75922870|FG003|NOT COMPLETED|Visit Two||8||
59801763|NCT00187135|75922871|FG004|NOT COMPLETED|Visit Two||6||
59801764|NCT00187135|75922872|FG005|NOT COMPLETED|Visit Two||8||
59801765|NCT00187135|75922867|FG000|STARTED|Visit Three||21||
59801766|NCT00187135|75922868|FG001|STARTED|Visit Three||24||
59801767|NCT00187135|75922869|FG002|STARTED|Visit Three||23||
59801768|NCT00187135|75922870|FG003|STARTED|Visit Three||18||
59801769|NCT00187135|75922871|FG004|STARTED|Visit Three||19||
59801770|NCT00187135|75922872|FG005|STARTED|Visit Three||18||
59801771|NCT00187135|75922867|FG000|COMPLETED|Visit Three||14||
59801772|NCT00187135|75922868|FG001|COMPLETED|Visit Three||17||
59954874|NCT00101907|76073490|FG002|STARTED|Overall Study||6||
59954875|NCT00101907|76073491|FG003|STARTED|Overall Study||6||
59801773|NCT00187135|75922869|FG002|COMPLETED|Visit Three||14||
59801774|NCT00187135|75922870|FG003|COMPLETED|Visit Three||9||
59801775|NCT00187135|75922871|FG004|COMPLETED|Visit Three||11||
59801776|NCT00187135|75922872|FG005|COMPLETED|Visit Three||12||
59801777|NCT00187135|75922867|FG000|NOT COMPLETED|Visit Three||7||
59954876|NCT00101907|76073492|FG004|STARTED|Overall Study||11||
59954877|NCT00101907|76073493|FG005|STARTED|Overall Study||2||
59954878|NCT00101907|76073488|FG000|COMPLETED|Overall Study||6||
59954879|NCT00101907|76073489|FG001|COMPLETED|Overall Study||7||
59954880|NCT00101907|76073490|FG002|COMPLETED|Overall Study||5||
59801778|NCT00187135|75922868|FG001|NOT COMPLETED|Visit Three||7||
59801779|NCT00187135|75922869|FG002|NOT COMPLETED|Visit Three||9||
59801780|NCT00187135|75922870|FG003|NOT COMPLETED|Visit Three||9||
59801781|NCT00187135|75922871|FG004|NOT COMPLETED|Visit Three||8||
59801782|NCT00187135|75922872|FG005|NOT COMPLETED|Visit Three||6||
59801783|NCT00528021|75922888|FG000|STARTED|Overall Study||59||
59801784|NCT00528021|75922889|FG001|STARTED|Overall Study||59||
59801785|NCT00528021|75922890|FG002|STARTED|Overall Study||56||
59801786|NCT00528021|75922891|FG003|STARTED|Overall Study||56||
59801787|NCT00528021|75922888|FG000|COMPLETED|Overall Study||42||
59801788|NCT00528021|75922889|FG001|COMPLETED|Overall Study||46||
59801789|NCT00528021|75922890|FG002|COMPLETED|Overall Study||49||
59801790|NCT00528021|75922891|FG003|COMPLETED|Overall Study||47||
59801791|NCT00528021|75922888|FG000|NOT COMPLETED|Overall Study||17||
59801792|NCT00528021|75922889|FG001|NOT COMPLETED|Overall Study||13||
59801793|NCT00528021|75922890|FG002|NOT COMPLETED|Overall Study||7||
59801794|NCT00528021|75922891|FG003|NOT COMPLETED|Overall Study||9||
59801795|NCT00560352|75922904|FG000|STARTED|Overall Study||7||
59801796|NCT00560352|75922905|FG001|STARTED|Overall Study||3||
59801797|NCT00560352|75922906|FG002|STARTED|Overall Study||4||
59801798|NCT00560352|75922904|FG000|COMPLETED|Overall Study||0||
59801799|NCT00560352|75922905|FG001|COMPLETED|Overall Study||0||
59801800|NCT00560352|75922906|FG002|COMPLETED|Overall Study||0||
59801801|NCT00560352|75922904|FG000|NOT COMPLETED|Overall Study||7||
59801802|NCT00560352|75922905|FG001|NOT COMPLETED|Overall Study||3||
59801803|NCT00560352|75922906|FG002|NOT COMPLETED|Overall Study||4||
59801804|NCT00527787|75922920|FG000|STARTED|Overall Study||218||
59801805|NCT00527787|75922921|FG001|STARTED|Overall Study|Safety and Intent-to-treat population (>=1 dose drug + no baseline ulcer) N=216|216||
59801806|NCT00527787|75922920|FG000|COMPLETED|Overall Study||180||
59801807|NCT00527787|75922921|FG001|COMPLETED|Overall Study||153||
59801808|NCT00527787|75922920|FG000|NOT COMPLETED|Overall Study||38||
59801809|NCT00527787|75922921|FG001|NOT COMPLETED|Overall Study||63||
59801810|NCT00608426|75922929|FG000|STARTED|Overall Study||2604||
59801811|NCT00608426|75922930|FG001|STARTED|Overall Study||2519||
59801812|NCT00608426|75922929|FG000|COMPLETED|Overall Study|This is total # of completed surveys. Not completed primary outcome.|1768||
59801813|NCT00608426|75922930|FG001|COMPLETED|Overall Study|This is total # of completed surveys. Not completed primary outcome.|1614||
59801814|NCT00608426|75922929|FG000|NOT COMPLETED|Overall Study||836||
59801815|NCT00608426|75922930|FG001|NOT COMPLETED|Overall Study||905||
59801816|NCT00557076|75922938|FG000|STARTED|Overall Study||8||
59801817|NCT00557076|75922939|FG001|STARTED|Overall Study||8||
59801818|NCT00557076|75922938|FG000|COMPLETED|Overall Study||8||
59801819|NCT00557076|75922939|FG001|COMPLETED|Overall Study|One participant was withdrawn due to unblinding|7||
59801820|NCT00557076|75922938|FG000|NOT COMPLETED|Overall Study||0||
59801821|NCT00557076|75922939|FG001|NOT COMPLETED|Overall Study||1||
59801822|NCT00129259|75922947|FG000|STARTED|Overall Study|Subjects not in the Intent-to-treat group did not have a baseline visit and are not included here|52||
59801823|NCT00129259|75922948|FG001|STARTED|Overall Study|Subjects not in the Intent-to-treat group did not have a baseline visit and are not included here|25||
59801824|NCT00129259|75922947|FG000|Received All or Part of Cycle 1|Overall Study||52||
59801825|NCT00129259|75922948|FG001|Received All or Part of Cycle 1|Overall Study||0||
59801826|NCT00129259|75922947|FG000|Received All or Part of Cycle 2|Overall Study||40||
59801827|NCT00129259|75922948|FG001|Received All or Part of Cycle 2|Overall Study||0||
59801828|NCT00129259|75922947|FG000|COMPLETED|Overall Study||49||
59801829|NCT00129259|75922948|FG001|COMPLETED|Overall Study||22||
59801830|NCT00129259|75922947|FG000|NOT COMPLETED|Overall Study||3||
59801831|NCT00129259|75922948|FG001|NOT COMPLETED|Overall Study||3||
59801832|NCT00186901|75922957|FG000|STARTED|Overall Study||134||
59801833|NCT00186901|75922958|FG001|STARTED|Overall Study||141||
59801834|NCT00186901|75922959|FG002|STARTED|Overall Study||149||
59801835|NCT00186901|75922957|FG000|Baseline|Overall Study||134||
59801836|NCT00186901|75922958|FG001|Baseline|Overall Study||141||
59801837|NCT00186901|75922959|FG002|Baseline|Overall Study||0||
59801838|NCT00186901|75922957|FG000|12 Month Follow-up|Overall Study||117||
59801839|NCT00186901|75922958|FG001|12 Month Follow-up|Overall Study||122||
59801840|NCT00186901|75922959|FG002|12 Month Follow-up|Overall Study||0||
59801841|NCT00186901|75922957|FG000|24 Month Follow-up|Overall Study||106||
59801842|NCT00186901|75922958|FG001|24 Month Follow-up|Overall Study||107||
59801843|NCT00186901|75922959|FG002|24 Month Follow-up|Overall Study||0||
59801844|NCT00186901|75922957|FG000|COMPLETED|Overall Study||85||
59801845|NCT00186901|75922958|FG001|COMPLETED|Overall Study||96||
59801846|NCT00186901|75922959|FG002|COMPLETED|Overall Study||0||
59801847|NCT00186901|75922957|FG000|NOT COMPLETED|Overall Study||49||
59801848|NCT00186901|75922958|FG001|NOT COMPLETED|Overall Study||45||
59801849|NCT00186901|75922959|FG002|NOT COMPLETED|Overall Study||149||
59801850|NCT00186121|75922996|FG000|STARTED|Overall Study||35|Consented|
59801851|NCT00186121|75922996|FG000|COMPLETED|Overall Study||32||
59801852|NCT00186121|75922996|FG000|NOT COMPLETED|Overall Study||3||
59801853|NCT00186043|75923002|FG000|STARTED|Overall Study||30||
59801854|NCT00186043|75923003|FG001|STARTED|Overall Study||25||
59801855|NCT00186043|75923002|FG000|COMPLETED|Overall Study||15||
59801856|NCT00186043|75923003|FG001|COMPLETED|Overall Study||12||
59801857|NCT00186043|75923002|FG000|NOT COMPLETED|Overall Study||15||
59801858|NCT00186043|75923003|FG001|NOT COMPLETED|Overall Study||13||
59801859|NCT00185965|75923011|FG000|STARTED|Overall Study||15||
59801860|NCT00185965|75923012|FG001|STARTED|Overall Study||15||
59801861|NCT00185965|75923011|FG000|COMPLETED|Overall Study||15||
59801862|NCT00185965|75923012|FG001|COMPLETED|Overall Study||14||
59801863|NCT00185965|75923011|FG000|NOT COMPLETED|Overall Study||0||
59801864|NCT00185965|75923012|FG001|NOT COMPLETED|Overall Study||1||
59801865|NCT00607880|75923020|FG000|STARTED|Overall Study||50||
59801866|NCT00607880|75923021|FG001|STARTED|Overall Study||50||
59801867|NCT00607880|75923020|FG000|COMPLETED|Overall Study||49||
59801868|NCT00607880|75923021|FG001|COMPLETED|Overall Study||50||
59801869|NCT00607880|75923020|FG000|NOT COMPLETED|Overall Study||1||
59801870|NCT00607880|75923021|FG001|NOT COMPLETED|Overall Study||0||
59801871|NCT00127933|75923029|FG000|STARTED|Overall Study||123||
59801872|NCT00127933|75923030|FG001|STARTED|Overall Study||34||
59954881|NCT00101907|76073491|FG003|COMPLETED|Overall Study||5||
59954882|NCT00101907|76073492|FG004|COMPLETED|Overall Study||6||
59954883|NCT00101907|76073493|FG005|COMPLETED|Overall Study||2||
59954884|NCT00101907|76073488|FG000|NOT COMPLETED|Overall Study||2||
59954885|NCT00101907|76073489|FG001|NOT COMPLETED|Overall Study||1||
59954886|NCT00101907|76073490|FG002|NOT COMPLETED|Overall Study||1||
59954887|NCT00101907|76073491|FG003|NOT COMPLETED|Overall Study||1||
59954888|NCT00101907|76073492|FG004|NOT COMPLETED|Overall Study||5||
59954889|NCT00101907|76073493|FG005|NOT COMPLETED|Overall Study||0||
59954890|NCT02565784|76073514|FG000|STARTED|First Treatment||100||
59954891|NCT02565784|76073514|FG000|6 Months Follow-up|First Treatment||99||
59954892|NCT02565784|76073514|FG000|12 Months Follow-up|First Treatment||98||
59954893|NCT02565784|76073514|FG000|COMPLETED|First Treatment||98||
60073795|NCT03320512|76189137|FG002|Month 6 Survey Started|Overall Study||69||
59801873|NCT00127933|75923029|FG000|Pathological Response|Overall Study||101||
59801874|NCT00127933|75923030|FG001|Pathological Response|Overall Study||28||
59801875|NCT00127933|75923029|FG000|Clinical Response|Overall Study||122||
59801876|NCT00127933|75923030|FG001|Clinical Response|Overall Study||34||
59801877|NCT00127933|75923029|FG000|Safety Population|Overall Study||122||
59801878|NCT00127933|75923030|FG001|Safety Population|Overall Study||34||
59801879|NCT00127933|75923029|FG000|Quality of Life Population|Overall Study||118||
59801880|NCT00127933|75923030|FG001|Quality of Life Population|Overall Study||33||
59801881|NCT00127933|75923029|FG000|Postoperative|Overall Study||98||
59801882|NCT00127933|75923030|FG001|Postoperative|Overall Study||27||
59801883|NCT00127933|75923029|FG000|COMPLETED|Overall Study||122||
59801884|NCT00127933|75923030|FG001|COMPLETED|Overall Study||34||
59801885|NCT00127933|75923029|FG000|NOT COMPLETED|Overall Study||1||
59801886|NCT00127933|75923030|FG001|NOT COMPLETED|Overall Study||0||
59801887|NCT03875313|75923041|FG000|STARTED|Overall Study||3||
59801888|NCT03875313|75923042|FG001|STARTED|Overall Study||16||
59801889|NCT03875313|75923043|FG002|STARTED|Overall Study||6||
59801890|NCT03875313|75923044|FG003|STARTED|Overall Study||4||
59801891|NCT03875313|75923045|FG004|STARTED|Overall Study||4||
59801892|NCT03875313|75923041|FG000|COMPLETED|Overall Study||0|"All participants discontinued the study, and none entered survival follow up. Reason Not Completed presents the reasons for study discontinuation."|
59801893|NCT03875313|75923042|FG001|COMPLETED|Overall Study||0|"All participants discontinued the study, and none entered survival follow up. Reason Not Completed presents the reasons for study discontinuation."|
59801894|NCT03875313|75923043|FG002|COMPLETED|Overall Study||0|"All participants discontinued the study, and none entered survival follow up. Reason Not Completed presents the reasons for study discontinuation."|
59801895|NCT03875313|75923044|FG003|COMPLETED|Overall Study||0|"All participants discontinued the study, and none entered survival follow up. Reason Not Completed presents the reasons for study discontinuation."|
59801896|NCT03875313|75923045|FG004|COMPLETED|Overall Study||0|"All participants discontinued the study, and none entered survival follow up. Reason Not Completed presents the reasons for study discontinuation."|
59801897|NCT03875313|75923041|FG000|NOT COMPLETED|Overall Study||3||
59801898|NCT03875313|75923042|FG001|NOT COMPLETED|Overall Study||16||
59801899|NCT03875313|75923043|FG002|NOT COMPLETED|Overall Study||6||
59801900|NCT03875313|75923044|FG003|NOT COMPLETED|Overall Study||4||
59801901|NCT03875313|75923045|FG004|NOT COMPLETED|Overall Study||4||
59801902|NCT05014438|75923062|FG000|STARTED|Overall Study||4||
59801903|NCT05014438|75923063|FG001|STARTED|Overall Study||3||
59801904|NCT05014438|75923064|FG002|STARTED|Overall Study||4||
59801905|NCT05014438|75923065|FG003|STARTED|Overall Study||3||
59801906|NCT05014438|75923066|FG004|STARTED|Overall Study||3||
59801907|NCT05014438|75923062|FG000|COMPLETED|Overall Study||3||
59954894|NCT02565784|76073514|FG000|NOT COMPLETED|First Treatment||2||
59954895|NCT02565784|76073514|FG000|STARTED|Second Treatment||98||
60073796|NCT03320512|76189135|FG000|Month 6 Survey Completed|Overall Study||65||
60073797|NCT03320512|76189136|FG001|Month 6 Survey Completed|Overall Study||71||
60073798|NCT03320512|76189137|FG002|Month 6 Survey Completed|Overall Study||68||
59801908|NCT05014438|75923063|FG001|COMPLETED|Overall Study||3||
59801909|NCT05014438|75923064|FG002|COMPLETED|Overall Study||3||
59954896|NCT02565784|76073514|FG000|6 Months Follow-up|Second Treatment||97||
59954897|NCT02565784|76073514|FG000|12 Months Follow-up|Second Treatment||96||
60103591|NCT04075734|76221848|FG000|STARTED|Overall Study||25||
59801910|NCT05014438|75923065|FG003|COMPLETED|Overall Study||1||
59801911|NCT05014438|75923066|FG004|COMPLETED|Overall Study||3||
59801912|NCT05014438|75923062|FG000|NOT COMPLETED|Overall Study||1||
59801913|NCT05014438|75923063|FG001|NOT COMPLETED|Overall Study||0||
59801914|NCT05014438|75923064|FG002|NOT COMPLETED|Overall Study||1||
59801915|NCT05014438|75923065|FG003|NOT COMPLETED|Overall Study||2||
59801916|NCT05014438|75923066|FG004|NOT COMPLETED|Overall Study||0||
59801917|NCT04915131|75923080|FG000|STARTED|Overall Study|Participants enrolled in the pilot phase of the study|60||
59801918|NCT04915131|75923081|FG001|STARTED|Overall Study|Participants enrolled in the pivotal phase of the study|61||
59801919|NCT04915131|75923080|FG000|Analysis Population|Overall Study|The Analysis Population includes all enrolled participants without major protocol deviation or technical failure. 4 participants were excluded from the analysis due to protocol deviation. 2 participants were excluded from the analysis due to technical failures of the clinical tools.|54||
59801920|NCT04915131|75923081|FG001|Analysis Population|Overall Study|The Analysis Population includes all enrolled participants without major protocol deviation or technical failure. 5 participants were excluded from the analysis due to protocol deviation.|56||
59801921|NCT04915131|75923080|FG000|COMPLETED|Overall Study||60||
59801922|NCT04915131|75923081|FG001|COMPLETED|Overall Study||61||
59801923|NCT04915131|75923080|FG000|NOT COMPLETED|Overall Study||0||
59801924|NCT04915131|75923081|FG001|NOT COMPLETED|Overall Study||0||
60073799|NCT03320512|76189135|FG000|Month 6 Lab Sample Collected|Overall Study||53||
59801925|NCT04796415|75923088|FG000|STARTED|Overall Study||49|Completed OASIS at starting date; eligible Home Health Care patients and initial Call|
59801926|NCT04796415|75923088|FG000|Session #1|Overall Study||35||
59801927|NCT04796415|75923088|FG000|Session #2|Overall Study||25||
59801928|NCT04796415|75923088|FG000|Session #3|Overall Study||21||
59801929|NCT04796415|75923088|FG000|Session #4|Overall Study||19||
59801930|NCT04796415|75923088|FG000|Session #5|Overall Study||19||
59801931|NCT04796415|75923088|FG000|Session #6|Overall Study||18||
59801932|NCT04796415|75923088|FG000|COMPLETED|Overall Study||18||
59801933|NCT04796415|75923088|FG000|NOT COMPLETED|Overall Study||31||
59801934|NCT04678557|75923095|FG000|STARTED|Overall Study||17||
59801935|NCT04678557|75923096|FG001|STARTED|Overall Study||14||
59801936|NCT04678557|75923095|FG000|COMPLETED|Overall Study||16||
59801937|NCT04678557|75923096|FG001|COMPLETED|Overall Study||0||
59801938|NCT04678557|75923095|FG000|NOT COMPLETED|Overall Study||1||
59801939|NCT04678557|75923096|FG001|NOT COMPLETED|Overall Study||14||
59801940|NCT04415333|75923105|FG000|STARTED|First Intervention (Single 1-Day Visit)||10|No participants received random assignment to the 80 mmol intervention first.|
59801941|NCT04415333|75923106|FG001|STARTED|First Intervention (Single 1-Day Visit)||0|No participants received random assignment to the 80 mmol intervention first.|
59801942|NCT04415333|75923107|FG002|STARTED|First Intervention (Single 1-Day Visit)||10|No participants received random assignment to the 80 mmol intervention first.|
59801943|NCT04415333|75923105|FG000|COMPLETED|First Intervention (Single 1-Day Visit)||10||
59801944|NCT04415333|75923106|FG001|COMPLETED|First Intervention (Single 1-Day Visit)||0||
59801945|NCT04415333|75923107|FG002|COMPLETED|First Intervention (Single 1-Day Visit)||10||
59801946|NCT04415333|75923105|FG000|NOT COMPLETED|First Intervention (Single 1-Day Visit)||0||
59801947|NCT04415333|75923106|FG001|NOT COMPLETED|First Intervention (Single 1-Day Visit)||0||
59801948|NCT04415333|75923107|FG002|NOT COMPLETED|First Intervention (Single 1-Day Visit)||0||
59801949|NCT04415333|75923105|FG000|STARTED|Washout (1 Week)||10||
59801950|NCT04415333|75923106|FG001|STARTED|Washout (1 Week)||0||
59801951|NCT04415333|75923107|FG002|STARTED|Washout (1 Week)||10||
59801952|NCT04415333|75923105|FG000|COMPLETED|Washout (1 Week)||10||
59801953|NCT04415333|75923106|FG001|COMPLETED|Washout (1 Week)||0||
59801954|NCT04415333|75923107|FG002|COMPLETED|Washout (1 Week)||10||
59801955|NCT04415333|75923105|FG000|NOT COMPLETED|Washout (1 Week)||0||
59801956|NCT04415333|75923106|FG001|NOT COMPLETED|Washout (1 Week)||0||
59801957|NCT04415333|75923107|FG002|NOT COMPLETED|Washout (1 Week)||0||
59801958|NCT04415333|75923105|FG000|STARTED|Second Intervention (Single 1-Day Visit)||10||
59801959|NCT04415333|75923106|FG001|STARTED|Second Intervention (Single 1-Day Visit)||0||
59801960|NCT04415333|75923107|FG002|STARTED|Second Intervention (Single 1-Day Visit)||10||
59801961|NCT04415333|75923105|FG000|COMPLETED|Second Intervention (Single 1-Day Visit)||10||
59801962|NCT04415333|75923106|FG001|COMPLETED|Second Intervention (Single 1-Day Visit)||0||
59801963|NCT04415333|75923107|FG002|COMPLETED|Second Intervention (Single 1-Day Visit)||10||
59801964|NCT04415333|75923105|FG000|NOT COMPLETED|Second Intervention (Single 1-Day Visit)||0||
59801965|NCT04415333|75923106|FG001|NOT COMPLETED|Second Intervention (Single 1-Day Visit)||0||
59801966|NCT04415333|75923107|FG002|NOT COMPLETED|Second Intervention (Single 1-Day Visit)||0||
59801967|NCT04230980|75923117|FG000|STARTED|Overall Study||36||
59801968|NCT04230980|75923118|FG001|STARTED|Overall Study||38||
59801969|NCT04230980|75923117|FG000|COMPLETED|Overall Study||35||
59801970|NCT04230980|75923118|FG001|COMPLETED|Overall Study||35||
59801971|NCT04230980|75923117|FG000|NOT COMPLETED|Overall Study||1||
59801972|NCT04230980|75923118|FG001|NOT COMPLETED|Overall Study||3||
59801973|NCT04057807|75923124|FG000|STARTED|Overall Study||12||
59801974|NCT04057807|75923124|FG000|1 Week Follow up|Overall Study|1 participant did not receive one week follow up (missed visit), resumed at 6 month follow up|11||
59801975|NCT04057807|75923124|FG000|6 Month Follow up|Overall Study||12||
59801976|NCT04057807|75923124|FG000|COMPLETED|Overall Study||12||
59801977|NCT04057807|75923124|FG000|NOT COMPLETED|Overall Study||0||
59801978|NCT04023045|75923128|FG000|STARTED|Habitual Prosthesis Condition||3||
59801979|NCT04023045|75923129|FG001|STARTED|Habitual Prosthesis Condition||0||
59801980|NCT04023045|75923130|FG002|STARTED|Habitual Prosthesis Condition||0||
59801981|NCT04023045|75923128|FG000|COMPLETED|Habitual Prosthesis Condition||3||
59954898|NCT02565784|76073514|FG000|COMPLETED|Second Treatment||96||
59954899|NCT02565784|76073514|FG000|NOT COMPLETED|Second Treatment||2||
59954900|NCT02050308|76073524|FG000|STARTED|Overall Study||127||
59954901|NCT02050308|76073525|FG001|STARTED|Overall Study||124||
59954902|NCT02050308|76073524|FG000|COMPLETED|Overall Study||28||
59954903|NCT02050308|76073525|FG001|COMPLETED|Overall Study||22||
59801982|NCT04023045|75923129|FG001|COMPLETED|Habitual Prosthesis Condition||0||
59801983|NCT04023045|75923130|FG002|COMPLETED|Habitual Prosthesis Condition||0||
59801984|NCT04023045|75923128|FG000|NOT COMPLETED|Habitual Prosthesis Condition||0||
59801985|NCT04023045|75923129|FG001|NOT COMPLETED|Habitual Prosthesis Condition||0||
59801986|NCT04023045|75923130|FG002|NOT COMPLETED|Habitual Prosthesis Condition||0||
59801987|NCT04023045|75923128|FG000|STARTED|Assist-Knee (Settings 1) Condition||0||
59801988|NCT04023045|75923129|FG001|STARTED|Assist-Knee (Settings 1) Condition||3||
59954904|NCT02050308|76073524|FG000|NOT COMPLETED|Overall Study||99||
59954905|NCT02050308|76073525|FG001|NOT COMPLETED|Overall Study||102||
59954906|NCT04790916|76073539|FG000|STARTED|Overall Study||0||
59954907|NCT04790916|76073540|FG001|STARTED|Overall Study||0||
59954908|NCT04790916|76073541|FG002|STARTED|Overall Study||0||
59954909|NCT04790916|76073539|FG000|COMPLETED|Overall Study||0||
59954910|NCT04790916|76073540|FG001|COMPLETED|Overall Study||0||
59954911|NCT04790916|76073541|FG002|COMPLETED|Overall Study||0||
59954912|NCT04790916|76073539|FG000|NOT COMPLETED|Overall Study||0||
59954913|NCT04790916|76073540|FG001|NOT COMPLETED|Overall Study||0||
59954914|NCT04790916|76073541|FG002|NOT COMPLETED|Overall Study||0||
59954915|NCT04110366|76073551|FG000|STARTED|Overall Study||40||
59954916|NCT04110366|76073552|FG001|STARTED|Overall Study||8||
59954917|NCT04110366|76073551|FG000|COMPLETED|Overall Study||40||
59954918|NCT04110366|76073552|FG001|COMPLETED|Overall Study||8||
59954919|NCT04110366|76073551|FG000|NOT COMPLETED|Overall Study||0||
59954920|NCT04110366|76073552|FG001|NOT COMPLETED|Overall Study||0||
59954921|NCT04650204|76073561|FG000|STARTED|Overall Study||3||
59954922|NCT04650204|76073562|FG001|STARTED|Overall Study||1||
59954923|NCT04650204|76073561|FG000|COMPLETED|Overall Study||1||
59954924|NCT04650204|76073562|FG001|COMPLETED|Overall Study||0||
59954925|NCT04650204|76073561|FG000|NOT COMPLETED|Overall Study||2||
59954926|NCT04650204|76073562|FG001|NOT COMPLETED|Overall Study||1||
59954927|NCT02761629|76073570|FG000|STARTED|Overall Study||90||
59954928|NCT02761629|76073571|FG001|STARTED|Overall Study||90||
59801989|NCT04023045|75923130|FG002|STARTED|Assist-Knee (Settings 1) Condition||0||
59801990|NCT04023045|75923128|FG000|COMPLETED|Assist-Knee (Settings 1) Condition||0||
59801991|NCT04023045|75923129|FG001|COMPLETED|Assist-Knee (Settings 1) Condition||3||
59801992|NCT04023045|75923130|FG002|COMPLETED|Assist-Knee (Settings 1) Condition||0||
59801993|NCT04023045|75923128|FG000|NOT COMPLETED|Assist-Knee (Settings 1) Condition||0||
59801994|NCT04023045|75923129|FG001|NOT COMPLETED|Assist-Knee (Settings 1) Condition||0||
59801995|NCT04023045|75923130|FG002|NOT COMPLETED|Assist-Knee (Settings 1) Condition||0||
59801996|NCT04023045|75923128|FG000|STARTED|Assist-Knee (Settings 2) Condition||0||
59801997|NCT04023045|75923129|FG001|STARTED|Assist-Knee (Settings 2) Condition||0||
59801998|NCT04023045|75923130|FG002|STARTED|Assist-Knee (Settings 2) Condition||3||
59801999|NCT04023045|75923128|FG000|COMPLETED|Assist-Knee (Settings 2) Condition||0||
59802000|NCT04023045|75923129|FG001|COMPLETED|Assist-Knee (Settings 2) Condition||0||
59802001|NCT04023045|75923130|FG002|COMPLETED|Assist-Knee (Settings 2) Condition||3||
59802002|NCT04023045|75923128|FG000|NOT COMPLETED|Assist-Knee (Settings 2) Condition||0||
59802003|NCT04023045|75923129|FG001|NOT COMPLETED|Assist-Knee (Settings 2) Condition||0||
59802004|NCT04023045|75923130|FG002|NOT COMPLETED|Assist-Knee (Settings 2) Condition||0||
59954929|NCT02761629|76073570|FG000|Treated|Overall Study||82||
59954930|NCT02761629|76073571|FG001|Treated|Overall Study||86||
59954931|NCT02761629|76073570|FG000|COMPLETED|Overall Study||63||
59954932|NCT02761629|76073571|FG001|COMPLETED|Overall Study||58||
59954933|NCT02761629|76073570|FG000|NOT COMPLETED|Overall Study||27||
59954934|NCT02761629|76073571|FG001|NOT COMPLETED|Overall Study||32||
59954935|NCT02760927|76073577|FG000|STARTED|Overall Study||4||
59954936|NCT02760927|76073577|FG000|COMPLETED|Overall Study||3||
59954937|NCT02760927|76073577|FG000|NOT COMPLETED|Overall Study||1||
59954938|NCT00101439|76073583|FG000|STARTED|Period 1||28||
59954939|NCT00101439|76073584|FG001|STARTED|Period 1||30||
59954940|NCT00101439|76073583|FG000|COMPLETED|Period 1||28||
59954941|NCT00101439|76073584|FG001|COMPLETED|Period 1||30||
59802005|NCT03997383|75923144|FG000|STARTED|Double-blind Treatment Period||179||
59802006|NCT03997383|75923145|FG001|STARTED|Double-blind Treatment Period||181||
59802007|NCT03997383|75923144|FG000|Treated|Double-blind Treatment Period||178||
59954942|NCT00101439|76073583|FG000|NOT COMPLETED|Period 1||0||
59954943|NCT00101439|76073584|FG001|NOT COMPLETED|Period 1||0||
59954944|NCT00101439|76073583|FG000|STARTED|Period 2||28||
59954945|NCT00101439|76073584|FG001|STARTED|Period 2||30||
59954946|NCT00101439|76073583|FG000|COMPLETED|Period 2||28||
59954947|NCT00101439|76073584|FG001|COMPLETED|Period 2||28||
59954948|NCT00101439|76073583|FG000|NOT COMPLETED|Period 2||0||
59954949|NCT00101439|76073584|FG001|NOT COMPLETED|Period 2||2||
59954950|NCT04033068|76073594|FG000|STARTED|Overall Study||14||
59954951|NCT04033068|76073595|FG001|STARTED|Overall Study||14||
59954952|NCT04033068|76073596|FG002|STARTED|Overall Study||12||
59954953|NCT04033068|76073597|FG003|STARTED|Overall Study||8||
59954954|NCT04033068|76073594|FG000|First Dose|Overall Study||14||
59954955|NCT04033068|76073595|FG001|First Dose|Overall Study||14||
59954956|NCT04033068|76073596|FG002|First Dose|Overall Study||12||
59954957|NCT04033068|76073597|FG003|First Dose|Overall Study||8||
59954958|NCT04033068|76073594|FG000|Second Dose|Overall Study||14||
59954959|NCT04033068|76073595|FG001|Second Dose|Overall Study||14||
59954960|NCT04033068|76073596|FG002|Second Dose|Overall Study||11||
59954961|NCT04033068|76073597|FG003|Second Dose|Overall Study||7||
59954962|NCT04033068|76073594|FG000|COMPLETED|Overall Study||14||
59954963|NCT04033068|76073595|FG001|COMPLETED|Overall Study||13||
59954964|NCT04033068|76073596|FG002|COMPLETED|Overall Study||11||
59954965|NCT04033068|76073597|FG003|COMPLETED|Overall Study||7||
59954966|NCT04033068|76073594|FG000|NOT COMPLETED|Overall Study||0||
59954967|NCT04033068|76073595|FG001|NOT COMPLETED|Overall Study||1||
59954968|NCT04033068|76073596|FG002|NOT COMPLETED|Overall Study||1||
59954969|NCT04033068|76073597|FG003|NOT COMPLETED|Overall Study||1||
59954970|NCT02762565|76073607|FG000|STARTED|Overall Study||89||
59954971|NCT02762565|76073607|FG000|COMPLETED|Overall Study||78||
59954972|NCT02762565|76073607|FG000|NOT COMPLETED|Overall Study||11||
59954973|NCT04166214|76073613|FG000|STARTED|Overall Study||12||
59954974|NCT04166214|76073614|FG001|STARTED|Overall Study||39||
59954975|NCT04166214|76073613|FG000|COMPLETED|Overall Study||12||
59954976|NCT04166214|76073614|FG001|COMPLETED|Overall Study||39||
59954977|NCT04166214|76073613|FG000|NOT COMPLETED|Overall Study||0||
59954978|NCT04166214|76073614|FG001|NOT COMPLETED|Overall Study||0||
59954979|NCT02757963|76073620|FG000|STARTED|Overall Study||1658||
59954980|NCT02757963|76073620|FG000|COMPLETED|Overall Study||561||
59954981|NCT02757963|76073620|FG000|NOT COMPLETED|Overall Study||1097||
59954982|NCT03111732|76073635|FG000|STARTED|Overall Study||11||
59523890|NCT03110562|75618905|FG001|COMPLETED|Overall Study||0||
59802008|NCT03997383|75923145|FG001|Treated|Double-blind Treatment Period||181||
59802009|NCT03997383|75923144|FG000|COMPLETED|Double-blind Treatment Period||166||
59802010|NCT03997383|75923145|FG001|COMPLETED|Double-blind Treatment Period||168||
59802011|NCT03997383|75923144|FG000|NOT COMPLETED|Double-blind Treatment Period||13||
59802012|NCT03997383|75923145|FG001|NOT COMPLETED|Double-blind Treatment Period||13||
59802013|NCT03997383|75923144|FG000|STARTED|Open-label Extension Period||166||
59802014|NCT03997383|75923145|FG001|STARTED|Open-label Extension Period||168||
59802015|NCT03997383|75923144|FG000|COMPLETED|Open-label Extension Period||0||
59802016|NCT03997383|75923145|FG001|COMPLETED|Open-label Extension Period||0||
59802017|NCT03997383|75923144|FG000|NOT COMPLETED|Open-label Extension Period||166||
59802018|NCT03997383|75923145|FG001|NOT COMPLETED|Open-label Extension Period||168||
59802019|NCT03873805|75923160|FG000|STARTED|Overall Study||3||
59802020|NCT03873805|75923161|FG001|STARTED|Overall Study||6||
59802021|NCT03873805|75923162|FG002|STARTED|Overall Study||5||
59802022|NCT03873805|75923160|FG000|COMPLETED|Overall Study||3||
59802023|NCT03873805|75923161|FG001|COMPLETED|Overall Study||6||
59802024|NCT03873805|75923162|FG002|COMPLETED|Overall Study||5||
59802025|NCT03873805|75923160|FG000|NOT COMPLETED|Overall Study||0||
59802026|NCT03873805|75923161|FG001|NOT COMPLETED|Overall Study||0||
59954983|NCT03111732|76073635|FG000|COMPLETED|Overall Study||6||
59954984|NCT03111732|76073635|FG000|NOT COMPLETED|Overall Study||5||
59954985|NCT01663714|76073644|FG000|STARTED|Dosimetric and Therapeutic Treatment||30||
59954986|NCT01663714|76073644|FG000|COMPLETED|Dosimetric and Therapeutic Treatment||0||
59954987|NCT01663714|76073644|FG000|NOT COMPLETED|Dosimetric and Therapeutic Treatment||30||
59954988|NCT01663714|76073644|FG000|STARTED|Long-Term Follow-Up|22 of the30 participants withdrawing from Study BEX104514 enrolled in the LTFU study.|22||
59954989|NCT01663714|76073644|FG000|COMPLETED|Long-Term Follow-Up||16||
59954990|NCT01663714|76073644|FG000|NOT COMPLETED|Long-Term Follow-Up||6||
59954991|NCT02941146|76073650|FG000|STARTED|Overall Study||15||
59954992|NCT02941146|76073650|FG000|COMPLETED|Overall Study||15||
59954993|NCT02941146|76073650|FG000|NOT COMPLETED|Overall Study||0||
59954994|NCT02255487|76073656|FG000|STARTED|Overall Study||309||
59954995|NCT02255487|76073657|FG001|STARTED|Overall Study||308||
59954996|NCT02255487|76073656|FG000|Modified Intent to Treat (mITT)|Overall Study|"Within the ITT population, subjects with unknown age entries (modified ITT or mITT) were considered non-evaluable and excluded from the analysis. The mITT population was defined as patients 18 years of age or older."|293||
59954997|NCT02255487|76073657|FG001|Modified Intent to Treat (mITT)|Overall Study|"Within the ITT population, subjects with unknown age entries (modified ITT or mITT) were considered non-evaluable and excluded from the analysis. The mITT population was defined as patients 18 years of age or older."|291||
59802027|NCT03873805|75923162|FG002|NOT COMPLETED|Overall Study||0||
59802028|NCT03714555|75923173|FG000|STARTED|Overall Study||1||
59802029|NCT03714555|75923174|FG001|STARTED|Overall Study||0||
59802030|NCT03714555|75923175|FG002|STARTED|Overall Study||0||
59802031|NCT03714555|75923173|FG000|COMPLETED|Overall Study||0||
59802032|NCT03714555|75923174|FG001|COMPLETED|Overall Study||0||
59802033|NCT03714555|75923175|FG002|COMPLETED|Overall Study||0||
59954998|NCT02255487|76073656|FG000|COMPLETED|Overall Study||218||
59954999|NCT02255487|76073657|FG001|COMPLETED|Overall Study||230||
59955000|NCT02255487|76073656|FG000|NOT COMPLETED|Overall Study||91||
59955001|NCT02255487|76073657|FG001|NOT COMPLETED|Overall Study||78||
59955002|NCT01663636|76073666|FG000|STARTED|Infant SMS Reminder Feasibility Study||160||
59955003|NCT01663636|76073667|FG001|STARTED|Infant SMS Reminder Feasibility Study||161||
59955004|NCT01663636|76073666|FG000|COMPLETED|Infant SMS Reminder Feasibility Study||135||
59955005|NCT01663636|76073667|FG001|COMPLETED|Infant SMS Reminder Feasibility Study||130||
59955006|NCT01663636|76073666|FG000|NOT COMPLETED|Infant SMS Reminder Feasibility Study||25||
59955007|NCT01663636|76073667|FG001|NOT COMPLETED|Infant SMS Reminder Feasibility Study||31||
59955008|NCT01663636|76073666|FG000|STARTED|Parent SMS Acceptability Assessment||135||
59955009|NCT01663636|76073667|FG001|STARTED|Parent SMS Acceptability Assessment||130||
59955010|NCT01663636|76073666|FG000|COMPLETED|Parent SMS Acceptability Assessment||135||
59955011|NCT01663636|76073667|FG001|COMPLETED|Parent SMS Acceptability Assessment||130||
59955012|NCT01663636|76073666|FG000|NOT COMPLETED|Parent SMS Acceptability Assessment||0||
59955013|NCT01663636|76073667|FG001|NOT COMPLETED|Parent SMS Acceptability Assessment||0||
59955014|NCT03065244|76073675|FG000|STARTED|Overall Study||50||
59955015|NCT03065244|76073676|FG001|STARTED|Overall Study||55||
59955016|NCT03065244|76073675|FG000|Participants Who Failed 1st Treatment and Crossed Over to Receive Other Treatment|Overall Study||22||
59955017|NCT03065244|76073676|FG001|Participants Who Failed 1st Treatment and Crossed Over to Receive Other Treatment|Overall Study||9||
59955018|NCT03065244|76073675|FG000|COMPLETED|Overall Study||47||
59955019|NCT03065244|76073676|FG001|COMPLETED|Overall Study||51||
59955020|NCT03065244|76073675|FG000|NOT COMPLETED|Overall Study||3||
59955021|NCT03065244|76073676|FG001|NOT COMPLETED|Overall Study||4||
59955022|NCT00100815|76073682|FG000|STARTED|Overall Study||50||
59955023|NCT00100815|76073682|FG000|COMPLETED|Overall Study||1||
59955024|NCT00100815|76073682|FG000|NOT COMPLETED|Overall Study||49||
59955025|NCT00708422|76073688|FG000|STARTED|Overall Study||116||
59955026|NCT00708422|76073689|FG001|STARTED|Overall Study||115||
59955027|NCT00708422|76073688|FG000|COMPLETED|Overall Study||112||
59955028|NCT00708422|76073689|FG001|COMPLETED|Overall Study||114||
59955029|NCT00708422|76073688|FG000|NOT COMPLETED|Overall Study||4||
59955030|NCT00708422|76073689|FG001|NOT COMPLETED|Overall Study||1||
59955031|NCT02760069|76073698|FG000|STARTED|Overall Study||40||
59955032|NCT02760069|76073699|FG001|STARTED|Overall Study||41||
59955033|NCT02760069|76073700|FG002|STARTED|Overall Study||41||
59955034|NCT02760069|76073698|FG000|COMPLETED|Overall Study||40||
59955035|NCT02760069|76073699|FG001|COMPLETED|Overall Study||40||
59955036|NCT02760069|76073700|FG002|COMPLETED|Overall Study||40||
59955037|NCT02760069|76073698|FG000|NOT COMPLETED|Overall Study||0||
59955038|NCT02760069|76073699|FG001|NOT COMPLETED|Overall Study||1||
59802034|NCT03714555|75923173|FG000|NOT COMPLETED|Overall Study||1||
59802035|NCT03714555|75923174|FG001|NOT COMPLETED|Overall Study||0||
59802036|NCT03714555|75923175|FG002|NOT COMPLETED|Overall Study||0||
59802037|NCT03701295|75923183|FG000|STARTED|Overall Study||1||
59802038|NCT03701295|75923183|FG000|COMPLETED|Overall Study||1||
59802039|NCT03701295|75923183|FG000|NOT COMPLETED|Overall Study||0||
59802040|NCT03697720|75923187|FG000|STARTED|Overall Study||26||
59802041|NCT03697720|75923187|FG000|COMPLETED|Overall Study||19||
59802042|NCT03697720|75923187|FG000|NOT COMPLETED|Overall Study||7||
59802043|NCT03635983|75923193|FG000|STARTED|Pre-Treatment Period||391|Started=randomized|
59802044|NCT03635983|75923194|FG001|STARTED|Pre-Treatment Period||392|Started=randomized|
59802045|NCT03635983|75923193|FG000|COMPLETED|Pre-Treatment Period||387|Completed=treated|
59802046|NCT03635983|75923194|FG001|COMPLETED|Pre-Treatment Period||382|Completed=treated|
59802047|NCT03635983|75923193|FG000|NOT COMPLETED|Pre-Treatment Period||4||
59802048|NCT03635983|75923194|FG001|NOT COMPLETED|Pre-Treatment Period||10||
59802049|NCT03635983|75923193|FG000|STARTED|Treatment Period||387|Started=treated|
59955039|NCT02760069|76073700|FG002|NOT COMPLETED|Overall Study||1||
59955040|NCT00707486|76073708|FG000|STARTED|Overall Study||72||
59955041|NCT00707486|76073708|FG000|COMPLETED|Overall Study||71||
59955042|NCT00707486|76073708|FG000|NOT COMPLETED|Overall Study||1||
59955043|NCT02759055|76073716|FG000|STARTED|Overall Study||12702||
59802050|NCT03635983|75923194|FG001|STARTED|Treatment Period||382|Started=treated|
59802051|NCT03635983|75923193|FG000|COMPLETED|Treatment Period||135|Completed=on-going treatment|
59802052|NCT03635983|75923194|FG001|COMPLETED|Treatment Period||135|Completed=on-going treatment|
59955044|NCT02759055|76073717|FG001|STARTED|Overall Study||8962||
59955045|NCT02759055|76073716|FG000|COMPLETED|Overall Study||10775||
59955046|NCT02759055|76073717|FG001|COMPLETED|Overall Study||7454||
59955047|NCT02759055|76073716|FG000|NOT COMPLETED|Overall Study||1927||
59955048|NCT02759055|76073717|FG001|NOT COMPLETED|Overall Study||1508||
59955049|NCT00708032|76073725|FG000|STARTED|Overall Study||36||
59955050|NCT00708032|76073726|FG001|STARTED|Overall Study||38||
59955051|NCT00708032|76073725|FG000|COMPLETED|Overall Study||26||
59802053|NCT03635983|75923193|FG000|NOT COMPLETED|Treatment Period||252||
59955052|NCT00708032|76073726|FG001|COMPLETED|Overall Study||22||
59955053|NCT00708032|76073725|FG000|NOT COMPLETED|Overall Study||10||
59955054|NCT00708032|76073726|FG001|NOT COMPLETED|Overall Study||16||
59955055|NCT00707174|76073734|FG000|STARTED|Overall Study||46||
59955056|NCT00707174|76073735|FG001|STARTED|Overall Study||44||
59955057|NCT00707174|76073734|FG000|COMPLETED|Overall Study||41||
59955058|NCT00707174|76073735|FG001|COMPLETED|Overall Study||37||
59955059|NCT00707174|76073734|FG000|NOT COMPLETED|Overall Study||5||
59955060|NCT00707174|76073735|FG001|NOT COMPLETED|Overall Study||7||
59955061|NCT02756403|76073745|FG000|STARTED|Overall Study||46||
59955062|NCT02756403|76073746|FG001|STARTED|Overall Study||45||
59955063|NCT02756403|76073747|FG002|STARTED|Overall Study||43||
59955064|NCT02756403|76073748|FG003|STARTED|Overall Study||47||
59955065|NCT02756403|76073745|FG000|COMPLETED|Overall Study||46||
59955066|NCT02756403|76073746|FG001|COMPLETED|Overall Study||42||
59955067|NCT02756403|76073747|FG002|COMPLETED|Overall Study||41||
59955068|NCT02756403|76073748|FG003|COMPLETED|Overall Study||45||
59955069|NCT02756403|76073745|FG000|NOT COMPLETED|Overall Study||0||
59955070|NCT02756403|76073746|FG001|NOT COMPLETED|Overall Study||3||
59955071|NCT02756403|76073747|FG002|NOT COMPLETED|Overall Study||2||
59955072|NCT02756403|76073748|FG003|NOT COMPLETED|Overall Study||2||
59955073|NCT02753595|76073760|FG000|STARTED|Overall Study||5||
59802054|NCT03635983|75923194|FG001|NOT COMPLETED|Treatment Period||247||
59802055|NCT03574974|75923202|FG000|STARTED|Overall Study||15||
59802056|NCT03574974|75923203|FG001|STARTED|Overall Study||12||
59802057|NCT03574974|75923202|FG000|COMPLETED|Overall Study||14||
59802058|NCT03574974|75923203|FG001|COMPLETED|Overall Study||11||
59802059|NCT03574974|75923202|FG000|NOT COMPLETED|Overall Study||1||
59802060|NCT03574974|75923203|FG001|NOT COMPLETED|Overall Study||1||
59802061|NCT03551496|75923211|FG000|STARTED|Overall Study||130||
59802062|NCT03551496|75923212|FG001|STARTED|Overall Study||71||
59802063|NCT03551496|75923211|FG000|COMPLETED|Overall Study||114||
59802064|NCT03551496|75923212|FG001|COMPLETED|Overall Study||61||
59802065|NCT03551496|75923211|FG000|NOT COMPLETED|Overall Study||16||
59802066|NCT03551496|75923212|FG001|NOT COMPLETED|Overall Study||10||
59802067|NCT03517449|75923220|FG000|STARTED|Overall Study||411||
59802068|NCT03517449|75923221|FG001|STARTED|Overall Study||416||
59802069|NCT03517449|75923220|FG000|Treated|Overall Study||406||
59802070|NCT03517449|75923221|FG001|Treated|Overall Study||388||
59802071|NCT03517449|75923220|FG000|COMPLETED|Overall Study||0||
59802072|NCT03517449|75923221|FG001|COMPLETED|Overall Study||0||
59802073|NCT03517449|75923220|FG000|NOT COMPLETED|Overall Study||411||
59802074|NCT03517449|75923221|FG001|NOT COMPLETED|Overall Study||416||
59802075|NCT03367312|75923227|FG000|STARTED|Overall Study||11||
59802076|NCT03367312|75923227|FG000|COMPLETED|Overall Study||11||
59802077|NCT03367312|75923227|FG000|NOT COMPLETED|Overall Study||0||
59802078|NCT03274414|75923231|FG000|STARTED|Overall Study||3||
59802079|NCT03274414|75923231|FG000|COMPLETED|Overall Study||3||
59802080|NCT03274414|75923231|FG000|NOT COMPLETED|Overall Study||0||
59802081|NCT03257631|75923239|FG000|STARTED|Overall Study||11||
59802082|NCT03257631|75923240|FG001|STARTED|Overall Study||9||
59802083|NCT03257631|75923241|FG002|STARTED|Overall Study||23||
59802084|NCT03257631|75923242|FG003|STARTED|Overall Study||10||
59802085|NCT03257631|75923239|FG000|Received Study Drug|Overall Study||11||
59802086|NCT03257631|75923240|FG001|Received Study Drug|Overall Study||9||
59802087|NCT03257631|75923241|FG002|Received Study Drug|Overall Study||22||
59802088|NCT03257631|75923242|FG003|Received Study Drug|Overall Study||10||
59955074|NCT02753595|76073761|FG001|STARTED|Overall Study||9||
59955075|NCT02753595|76073760|FG000|COMPLETED|Overall Study||3||
59955076|NCT02753595|76073761|FG001|COMPLETED|Overall Study||7||
59955077|NCT02753595|76073760|FG000|NOT COMPLETED|Overall Study||2||
59955078|NCT02753595|76073761|FG001|NOT COMPLETED|Overall Study||2||
59955079|NCT00707954|76073771|FG000|STARTED|Overall Study||12||
59955080|NCT00707954|76073772|FG001|STARTED|Overall Study||12||
59955081|NCT00707954|76073773|FG002|STARTED|Overall Study||14||
59955082|NCT00707954|76073774|FG003|STARTED|Overall Study||13||
59955083|NCT00707954|76073775|FG004|STARTED|Overall Study||10||
59955084|NCT00707954|76073771|FG000|COMPLETED|Overall Study||12||
59955085|NCT00707954|76073772|FG001|COMPLETED|Overall Study||12||
59955086|NCT00707954|76073773|FG002|COMPLETED|Overall Study||14||
59802089|NCT03257631|75923239|FG000|COMPLETED|Overall Study||0||
59802090|NCT03257631|75923240|FG001|COMPLETED|Overall Study||0||
59802091|NCT03257631|75923241|FG002|COMPLETED|Overall Study||0||
59802092|NCT03257631|75923242|FG003|COMPLETED|Overall Study||0||
59802093|NCT03257631|75923239|FG000|NOT COMPLETED|Overall Study||11||
59802094|NCT03257631|75923240|FG001|NOT COMPLETED|Overall Study||9||
59802095|NCT03257631|75923241|FG002|NOT COMPLETED|Overall Study||23||
59955087|NCT00707954|76073774|FG003|COMPLETED|Overall Study||13||
59955088|NCT00707954|76073775|FG004|COMPLETED|Overall Study||9||
59955089|NCT00707954|76073771|FG000|NOT COMPLETED|Overall Study||0||
59955090|NCT00707954|76073772|FG001|NOT COMPLETED|Overall Study||0||
59955091|NCT00707954|76073773|FG002|NOT COMPLETED|Overall Study||0||
59955092|NCT00707954|76073774|FG003|NOT COMPLETED|Overall Study||0||
59955093|NCT00707954|76073775|FG004|NOT COMPLETED|Overall Study||1||
59955094|NCT02561962|76073796|FG000|STARTED|Overall Study||3||
59955095|NCT02561962|76073797|FG001|STARTED|Overall Study||3||
59802096|NCT03257631|75923242|FG003|NOT COMPLETED|Overall Study||10||
59802097|NCT03055767|75923254|FG000|STARTED|Double-Blind Period||9||
59802098|NCT03055767|75923255|FG001|STARTED|Double-Blind Period||6||
59802099|NCT03055767|75923256|FG002|STARTED|Double-Blind Period||0||
59802100|NCT03055767|75923257|FG003|STARTED|Double-Blind Period||0||
59802101|NCT03055767|75923254|FG000|COMPLETED|Double-Blind Period||9||
59802102|NCT03055767|75923255|FG001|COMPLETED|Double-Blind Period||6||
59802103|NCT03055767|75923256|FG002|COMPLETED|Double-Blind Period||0||
59802104|NCT03055767|75923257|FG003|COMPLETED|Double-Blind Period||0||
59802105|NCT03055767|75923254|FG000|NOT COMPLETED|Double-Blind Period||0||
59802106|NCT03055767|75923255|FG001|NOT COMPLETED|Double-Blind Period||0||
59802107|NCT03055767|75923256|FG002|NOT COMPLETED|Double-Blind Period||0||
60073800|NCT03320512|76189136|FG001|Month 6 Lab Sample Collected|Overall Study||59||
60073801|NCT03320512|76189137|FG002|Month 6 Lab Sample Collected|Overall Study||51||
59802108|NCT03055767|75923257|FG003|NOT COMPLETED|Double-Blind Period||0||
59955096|NCT02561962|76073798|FG002|STARTED|Overall Study||3||
59955097|NCT02561962|76073799|FG003|STARTED|Overall Study||3||
59955098|NCT02561962|76073800|FG004|STARTED|Overall Study||6||
59955099|NCT02561962|76073801|FG005|STARTED|Overall Study||6||
59955100|NCT02561962|76073802|FG006|STARTED|Overall Study||5||
59955101|NCT02561962|76073803|FG007|STARTED|Overall Study||11||
59802109|NCT03055767|75923254|FG000|STARTED|Open-Label Period||0||
59802110|NCT03055767|75923255|FG001|STARTED|Open-Label Period||0||
59802111|NCT03055767|75923256|FG002|STARTED|Open-Label Period||11||
59802112|NCT03055767|75923257|FG003|STARTED|Open-Label Period||4||
59802113|NCT03055767|75923254|FG000|COMPLETED|Open-Label Period||0||
59802114|NCT03055767|75923255|FG001|COMPLETED|Open-Label Period||0||
59802115|NCT03055767|75923256|FG002|COMPLETED|Open-Label Period||9||
59802116|NCT03055767|75923257|FG003|COMPLETED|Open-Label Period||3||
59802117|NCT03055767|75923254|FG000|NOT COMPLETED|Open-Label Period||0||
59802118|NCT03055767|75923255|FG001|NOT COMPLETED|Open-Label Period||0||
59802119|NCT03055767|75923256|FG002|NOT COMPLETED|Open-Label Period||2||
59802120|NCT03055767|75923257|FG003|NOT COMPLETED|Open-Label Period||1||
59802121|NCT02702414|75923274|FG000|STARTED|Overall Study||105||
59802122|NCT02702414|75923275|FG001|STARTED|Overall Study||51||
59802123|NCT02702414|75923274|FG000|Treated|Overall Study||104||
59802124|NCT02702414|75923275|FG001|Treated|Overall Study||51||
59802125|NCT02702414|75923274|FG000|COMPLETED|Overall Study||0||
59802126|NCT02702414|75923275|FG001|COMPLETED|Overall Study||0||
59802127|NCT02702414|75923274|FG000|NOT COMPLETED|Overall Study||105||
59802128|NCT02702414|75923275|FG001|NOT COMPLETED|Overall Study||51||
59802129|NCT02491632|75923285|FG000|STARTED|Overall Study||38||
59802130|NCT02491632|75923286|FG001|STARTED|Overall Study||38||
59802131|NCT02491632|75923285|FG000|COMPLETED|Overall Study||31||
59802132|NCT02491632|75923286|FG001|COMPLETED|Overall Study||29||
59802133|NCT02491632|75923285|FG000|NOT COMPLETED|Overall Study||7||
59802134|NCT02491632|75923286|FG001|NOT COMPLETED|Overall Study||9||
59802135|NCT02086188|75923294|FG000|STARTED|Overall Study||14||
59802136|NCT02086188|75923295|FG001|STARTED|Overall Study||14||
59955102|NCT02561962|76073804|FG008|STARTED|Overall Study||2||
59955103|NCT02561962|76073796|FG000|Received Treatment|Overall Study||3||
59802137|NCT02086188|75923294|FG000|COMPLETED|Overall Study||14||
59802138|NCT02086188|75923295|FG001|COMPLETED|Overall Study||14||
59802139|NCT02086188|75923294|FG000|NOT COMPLETED|Overall Study||0||
59802140|NCT02086188|75923295|FG001|NOT COMPLETED|Overall Study||0||
59802141|NCT01064479|75923305|FG000|STARTED|Overall Study||60||
59802142|NCT01064479|75923306|FG001|STARTED|Overall Study||59||
59802143|NCT01064479|75923305|FG000|COMPLETED|Overall Study||45||
59802144|NCT01064479|75923306|FG001|COMPLETED|Overall Study||42||
59802145|NCT01064479|75923305|FG000|NOT COMPLETED|Overall Study||15||
59802146|NCT01064479|75923306|FG001|NOT COMPLETED|Overall Study||17||
59955104|NCT02561962|76073797|FG001|Received Treatment|Overall Study||3||
59955105|NCT02561962|76073798|FG002|Received Treatment|Overall Study||3||
59955106|NCT02561962|76073799|FG003|Received Treatment|Overall Study||3||
59955107|NCT02561962|76073800|FG004|Received Treatment|Overall Study||6||
60073802|NCT03320512|76189135|FG000|COMPLETED|Overall Study||82||
60073803|NCT03320512|76189136|FG001|COMPLETED|Overall Study||81||
60073804|NCT03320512|76189137|FG002|COMPLETED|Overall Study||83||
59802147|NCT00640978|75923312|FG000|STARTED|Overall Study||15||
59802148|NCT00640978|75923312|FG000|COMPLETED|Overall Study||15||
59802149|NCT00640978|75923312|FG000|NOT COMPLETED|Overall Study||0||
59802150|NCT00449748|75923316|FG000|STARTED|Overall Study||10||
59802151|NCT00449748|75923316|FG000|COMPLETED|Overall Study||10||
59802152|NCT00449748|75923316|FG000|NOT COMPLETED|Overall Study||0||
59802153|NCT00556998|75923320|FG000|STARTED|Voriconazole Intravenous (IV)||26||
59802154|NCT00556998|75923320|FG000|Treated|Voriconazole Intravenous (IV)||26||
59802155|NCT00556998|75923320|FG000|COMPLETED|Voriconazole Intravenous (IV)|One participant received 2 days of oral; then received IV again before discontinuing from study.|21||
59802156|NCT00556998|75923320|FG000|NOT COMPLETED|Voriconazole Intravenous (IV)||5||
59802157|NCT00556998|75923320|FG000|STARTED|Voriconazole Oral|One participant received voriconazole 150 mg every 12 hours during oral phase.|22||
59955108|NCT02561962|76073801|FG005|Received Treatment|Overall Study||6||
59955109|NCT02561962|76073802|FG006|Received Treatment|Overall Study||5||
59955110|NCT02561962|76073803|FG007|Received Treatment|Overall Study||9||
59802158|NCT00556998|75923320|FG000|COMPLETED|Voriconazole Oral||20||
59802159|NCT00556998|75923320|FG000|NOT COMPLETED|Voriconazole Oral||2||
59802160|NCT00528801|75923330|FG000|STARTED|Overall Study||160||
59802161|NCT00528801|75923331|FG001|STARTED|Overall Study||52||
59802162|NCT00528801|75923330|FG000|COMPLETED|Overall Study||133||
59802163|NCT00528801|75923331|FG001|COMPLETED|Overall Study||41||
59802164|NCT00528801|75923330|FG000|NOT COMPLETED|Overall Study||27||
59802165|NCT00528801|75923331|FG001|NOT COMPLETED|Overall Study||11||
59802166|NCT00527397|75923337|FG000|STARTED|Overall Study||24||
59955111|NCT02561962|76073804|FG008|Received Treatment|Overall Study||2||
59955112|NCT02561962|76073796|FG000|COMPLETED|Overall Study||1||
59955113|NCT02561962|76073797|FG001|COMPLETED|Overall Study||3||
59955114|NCT02561962|76073798|FG002|COMPLETED|Overall Study||3||
59955115|NCT02561962|76073799|FG003|COMPLETED|Overall Study||2||
59955116|NCT02561962|76073800|FG004|COMPLETED|Overall Study||4||
59955117|NCT02561962|76073801|FG005|COMPLETED|Overall Study||2||
59955118|NCT02561962|76073802|FG006|COMPLETED|Overall Study||3||
59955119|NCT02561962|76073803|FG007|COMPLETED|Overall Study||3||
59955120|NCT02561962|76073804|FG008|COMPLETED|Overall Study||1||
59955121|NCT02561962|76073796|FG000|NOT COMPLETED|Overall Study||2||
59955122|NCT02561962|76073797|FG001|NOT COMPLETED|Overall Study||0||
59955123|NCT02561962|76073798|FG002|NOT COMPLETED|Overall Study||0||
59955124|NCT02561962|76073799|FG003|NOT COMPLETED|Overall Study||1||
59955125|NCT02561962|76073800|FG004|NOT COMPLETED|Overall Study||2||
59955126|NCT02561962|76073801|FG005|NOT COMPLETED|Overall Study||4||
59955127|NCT02561962|76073802|FG006|NOT COMPLETED|Overall Study||2||
59955128|NCT02561962|76073803|FG007|NOT COMPLETED|Overall Study||8||
59955129|NCT02561962|76073804|FG008|NOT COMPLETED|Overall Study||1||
59955130|NCT02565706|76073828|FG000|STARTED|Overall Study||178||
59955131|NCT02565706|76073829|FG001|STARTED|Overall Study||172||
59802167|NCT00527397|75923337|FG000|COMPLETED|Overall Study||0||
59802168|NCT00527397|75923337|FG000|NOT COMPLETED|Overall Study||24||
59802169|NCT00527319|75923347|FG000|STARTED|Overall Study||12||
59955132|NCT02565706|76073830|FG002|STARTED|Overall Study||193||
59955133|NCT02565706|76073831|FG003|STARTED|Overall Study||201||
59955134|NCT02565706|76073828|FG000|COMPLETED|Overall Study||101||
59955135|NCT02565706|76073829|FG001|COMPLETED|Overall Study||90||
59955136|NCT02565706|76073830|FG002|COMPLETED|Overall Study||104||
59955137|NCT02565706|76073831|FG003|COMPLETED|Overall Study||116||
59955138|NCT02565706|76073828|FG000|NOT COMPLETED|Overall Study||77||
59955139|NCT02565706|76073829|FG001|NOT COMPLETED|Overall Study||82||
59955140|NCT02565706|76073830|FG002|NOT COMPLETED|Overall Study||89||
59955141|NCT02565706|76073831|FG003|NOT COMPLETED|Overall Study||85||
59955142|NCT00706628|76073850|FG000|STARTED|Overall Study||47||
59955143|NCT00706628|76073851|FG001|STARTED|Overall Study||21||
59955144|NCT00706628|76073852|FG002|STARTED|Overall Study||16||
59955145|NCT00706628|76073853|FG003|STARTED|Overall Study||3||
59955146|NCT00706628|76073850|FG000|COMPLETED|Overall Study||0||
59955147|NCT00706628|76073851|FG001|COMPLETED|Overall Study||0||
59955148|NCT00706628|76073852|FG002|COMPLETED|Overall Study||0||
59802170|NCT00527319|75923348|FG001|STARTED|Overall Study||12||
59955149|NCT00706628|76073853|FG003|COMPLETED|Overall Study||0||
59955150|NCT00706628|76073850|FG000|NOT COMPLETED|Overall Study||47||
59955151|NCT00706628|76073851|FG001|NOT COMPLETED|Overall Study||21||
59955152|NCT00706628|76073852|FG002|NOT COMPLETED|Overall Study||16||
59955153|NCT00706628|76073853|FG003|NOT COMPLETED|Overall Study||3||
59802171|NCT00527319|75923349|FG002|STARTED|Overall Study||13||
59802172|NCT00527319|75923347|FG000|COMPLETED|Overall Study||6||
59802173|NCT00527319|75923348|FG001|COMPLETED|Overall Study||8||
59955154|NCT02561806|76073868|FG000|STARTED|Induction Period||166||
59955155|NCT02561806|76073869|FG001|STARTED|Induction Period||136||
59955156|NCT02561806|76073868|FG000|Received At Least One Dose of Study Drug|Induction Period||166||
59802174|NCT00527319|75923349|FG002|COMPLETED|Overall Study||7||
59802175|NCT00527319|75923347|FG000|NOT COMPLETED|Overall Study||6||
59802176|NCT00527319|75923348|FG001|NOT COMPLETED|Overall Study||4||
59802177|NCT00527319|75923349|FG002|NOT COMPLETED|Overall Study||6||
59802178|NCT00562302|75923359|FG000|STARTED|Overall Study||170||
59802179|NCT00562302|75923360|FG001|STARTED|Overall Study||169||
59802180|NCT00562302|75923359|FG000|COMPLETED|Overall Study||150||
59802181|NCT00562302|75923360|FG001|COMPLETED|Overall Study||137||
59955157|NCT02561806|76073869|FG001|Received At Least One Dose of Study Drug|Induction Period||135||
59955158|NCT02561806|76073868|FG000|COMPLETED|Induction Period||164||
59955159|NCT02561806|76073869|FG001|COMPLETED|Induction Period||131||
59955160|NCT02561806|76073868|FG000|NOT COMPLETED|Induction Period||2||
59955161|NCT02561806|76073869|FG001|NOT COMPLETED|Induction Period||5||
59955162|NCT02561806|76073868|FG000|STARTED|Maintenance Period||164||
59955163|NCT02561806|76073869|FG001|STARTED|Maintenance Period||131||
59955164|NCT02561806|76073868|FG000|COMPLETED|Maintenance Period||151||
59955165|NCT02561806|76073869|FG001|COMPLETED|Maintenance Period||123||
59955166|NCT02561806|76073868|FG000|NOT COMPLETED|Maintenance Period||13||
59955167|NCT02561806|76073869|FG001|NOT COMPLETED|Maintenance Period||8||
59955168|NCT02561806|76073868|FG000|STARTED|Post-Treatment Follow-up|Participants who discontinued previous periods had option to enter post treatment follow-up period.|157||
59955169|NCT02561806|76073869|FG001|STARTED|Post-Treatment Follow-up|Participants who discontinued previous periods had option to enter post treatment follow-up period.|60||
59955170|NCT02561806|76073868|FG000|COMPLETED|Post-Treatment Follow-up||155||
59802182|NCT00562302|75923359|FG000|NOT COMPLETED|Overall Study||20||
59802183|NCT00562302|75923360|FG001|NOT COMPLETED|Overall Study||32||
59802184|NCT00134719|75923369|FG000|STARTED|Primary Vaccination Phase||661||
59802185|NCT00134719|75923370|FG001|STARTED|Primary Vaccination Phase||221||
59955171|NCT02561806|76073869|FG001|COMPLETED|Post-Treatment Follow-up||59||
59955172|NCT02561806|76073868|FG000|NOT COMPLETED|Post-Treatment Follow-up||2||
59955173|NCT02561806|76073869|FG001|NOT COMPLETED|Post-Treatment Follow-up||1||
59955174|NCT02561572|76073892|FG000|STARTED|Overall Study||64||
59955175|NCT02561572|76073893|FG001|STARTED|Overall Study||64||
59955176|NCT02561572|76073892|FG000|COMPLETED|Overall Study||62||
59955177|NCT02561572|76073893|FG001|COMPLETED|Overall Study||62||
59955178|NCT02561572|76073892|FG000|NOT COMPLETED|Overall Study||2||
59955179|NCT02561572|76073893|FG001|NOT COMPLETED|Overall Study||2||
59955180|NCT02180217|76073902|FG000|STARTED|Overall Study||36||
59955181|NCT02180217|76073903|FG001|STARTED|Overall Study||35||
59955182|NCT02180217|76073904|FG002|STARTED|Overall Study||66||
59955183|NCT02180217|76073902|FG000|Discontinued at/Prior to Week 12 (W12)|Overall Study||0||
59955184|NCT02180217|76073903|FG001|Discontinued at/Prior to Week 12 (W12)|Overall Study||0||
59955185|NCT02180217|76073904|FG002|Discontinued at/Prior to Week 12 (W12)|Overall Study||7||
59955186|NCT02180217|76073902|FG000|Discont. at/Prior to W26 But After W12|Overall Study||0||
59955187|NCT02180217|76073903|FG001|Discont. at/Prior to W26 But After W12|Overall Study||0||
59955188|NCT02180217|76073904|FG002|Discont. at/Prior to W26 But After W12|Overall Study||12||
59955189|NCT02180217|76073902|FG000|Discontinued Prior to W48 But After W26|Overall Study||0||
59955190|NCT02180217|76073903|FG001|Discontinued Prior to W48 But After W26|Overall Study||2||
59955191|NCT02180217|76073904|FG002|Discontinued Prior to W48 But After W26|Overall Study||3||
59955192|NCT02180217|76073902|FG000|Completed Week 48 (Core Phase)|Overall Study||36||
59955193|NCT02180217|76073903|FG001|Completed Week 48 (Core Phase)|Overall Study||33||
59955194|NCT02180217|76073904|FG002|Completed Week 48 (Core Phase)|Overall Study||44||
59955195|NCT02180217|76073902|FG000|Completed W48, Did Not Enter Ext. Phase|Overall Study||1||
59955196|NCT02180217|76073903|FG001|Completed W48, Did Not Enter Ext. Phase|Overall Study||3||
59955197|NCT02180217|76073904|FG002|Completed W48, Did Not Enter Ext. Phase|Overall Study||3||
59955198|NCT02180217|76073902|FG000|Completed W48, Entered Ext. Phase|Overall Study||35||
59955199|NCT02180217|76073903|FG001|Completed W48, Entered Ext. Phase|Overall Study||30||
59802186|NCT00134719|75923371|FG002|STARTED|Primary Vaccination Phase||221||
59802187|NCT00134719|75923369|FG000|COMPLETED|Primary Vaccination Phase||647||
59802188|NCT00134719|75923370|FG001|COMPLETED|Primary Vaccination Phase||215||
59802189|NCT00134719|75923371|FG002|COMPLETED|Primary Vaccination Phase||216||
59955200|NCT02180217|76073904|FG002|Completed W48, Entered Ext. Phase|Overall Study||41||
59955201|NCT02180217|76073902|FG000|Discontinued Extension Phase|Overall Study||12||
59955202|NCT02180217|76073903|FG001|Discontinued Extension Phase|Overall Study||6||
59955203|NCT02180217|76073904|FG002|Discontinued Extension Phase|Overall Study||16||
59955204|NCT02180217|76073902|FG000|Completed Ext. Phase|Overall Study||23||
59955205|NCT02180217|76073903|FG001|Completed Ext. Phase|Overall Study||24||
59955206|NCT02180217|76073904|FG002|Completed Ext. Phase|Overall Study||25||
59955207|NCT02180217|76073902|FG000|COMPLETED|Overall Study||24|Completed = Completed Core/Extension Phase|
59955208|NCT02180217|76073903|FG001|COMPLETED|Overall Study||27|Completed = Completed Core/Extension Phase|
59955209|NCT02180217|76073904|FG002|COMPLETED|Overall Study||28|Completed = Completed Core/Extension Phase|
59955210|NCT02180217|76073902|FG000|NOT COMPLETED|Overall Study||12||
59955211|NCT02180217|76073903|FG001|NOT COMPLETED|Overall Study||8||
59955212|NCT02180217|76073904|FG002|NOT COMPLETED|Overall Study||38||
59955213|NCT02560558|76073921|FG000|STARTED|Overall Study||84||
59955214|NCT02560558|76073922|FG001|STARTED|Overall Study||82||
59802190|NCT00134719|75923369|FG000|NOT COMPLETED|Primary Vaccination Phase||14||
59802191|NCT00134719|75923370|FG001|NOT COMPLETED|Primary Vaccination Phase||6||
59955215|NCT02560558|76073921|FG000|COMPLETED|Overall Study||77||
59955216|NCT02560558|76073922|FG001|COMPLETED|Overall Study||76||
59955217|NCT02560558|76073921|FG000|NOT COMPLETED|Overall Study||7||
59955218|NCT02560558|76073922|FG001|NOT COMPLETED|Overall Study||6||
59955219|NCT02568046|76073930|FG000|STARTED|Overall Study||5||
59955220|NCT02568046|76073931|FG001|STARTED|Overall Study||5||
59955221|NCT02568046|76073930|FG000|COMPLETED|Overall Study||0|Two (2) patients were ongoing at the time of data cut-off for Primary Completion.|
59955222|NCT02568046|76073931|FG001|COMPLETED|Overall Study||2|Two (2) patients were ongoing at the time of data cut-off for Primary Completion.|
59955223|NCT02568046|76073930|FG000|NOT COMPLETED|Overall Study||5||
59955224|NCT02568046|76073931|FG001|NOT COMPLETED|Overall Study||3||
59955225|NCT02567656|76073943|FG000|STARTED|Overall Study||4||
59955226|NCT02567656|76073944|FG001|STARTED|Overall Study||4||
59955227|NCT02567656|76073945|FG002|STARTED|Overall Study||5||
59955228|NCT02567656|76073946|FG003|STARTED|Overall Study||6||
59802192|NCT00134719|75923371|FG002|NOT COMPLETED|Primary Vaccination Phase||5||
59802193|NCT00134719|75923369|FG000|STARTED|Fourth Dose Vaccination Phase||625||
59802194|NCT00134719|75923370|FG001|STARTED|Fourth Dose Vaccination Phase||206||
59802195|NCT00134719|75923371|FG002|STARTED|Fourth Dose Vaccination Phase||204||
59802196|NCT00134719|75923369|FG000|COMPLETED|Fourth Dose Vaccination Phase||623||
59802197|NCT00134719|75923370|FG001|COMPLETED|Fourth Dose Vaccination Phase||203||
59955229|NCT02567656|76073947|FG004|STARTED|Overall Study||19||
59955230|NCT02567656|76073948|FG005|STARTED|Overall Study||20||
59955231|NCT02567656|76073943|FG000|COMPLETED|Overall Study||3||
59955232|NCT02567656|76073944|FG001|COMPLETED|Overall Study||3||
59955233|NCT02567656|76073945|FG002|COMPLETED|Overall Study||3||
59955234|NCT02567656|76073946|FG003|COMPLETED|Overall Study||6||
59802198|NCT00134719|75923371|FG002|COMPLETED|Fourth Dose Vaccination Phase||203||
59802199|NCT00134719|75923369|FG000|NOT COMPLETED|Fourth Dose Vaccination Phase||2||
59802200|NCT00134719|75923370|FG001|NOT COMPLETED|Fourth Dose Vaccination Phase||3||
59802201|NCT00134719|75923371|FG002|NOT COMPLETED|Fourth Dose Vaccination Phase||1||
59802202|NCT00526071|75923379|FG000|STARTED|Overall Study||23||
59802203|NCT00526071|75923379|FG000|Safety Population|Overall Study||23|All participants who received at least 1 dose of study drug|
59802204|NCT00526071|75923379|FG000|Pharmacodynamic (PD) Population|Overall Study||23|Received study drug and had a baseline measurement and at least 1 postbaseline PD measure|
59802205|NCT00526071|75923379|FG000|Amenable Population; Men|Overall Study||11|Amenable mutations based on the clinical trial (CT) Human Embryonic Kidney (HEK) assay|
59802206|NCT00526071|75923379|FG000|Amenable Population; Women|Overall Study||5|Amenable mutations based on the CT-HEK assay|
59802207|NCT00526071|75923379|FG000|Non-amenable Population; Men|Overall Study||3|Those without mutant forms of α-Gal A responsive to migalastat treatment based on the CT-HEK assay|
59802208|NCT00526071|75923379|FG000|Non-amenable Population; Women|Overall Study||4|Those without mutant forms of α-Gal A responsive to migalastat treatment based on the CT-HEK assay|
59802209|NCT00526071|75923379|FG000|COMPLETED|Overall Study||17||
59802210|NCT00526071|75923379|FG000|NOT COMPLETED|Overall Study||6||
59802211|NCT00525915|75923389|FG000|STARTED|Overall Study||63||
59802212|NCT00525915|75923390|FG001|STARTED|Overall Study||63||
59802213|NCT00525915|75923389|FG000|COMPLETED|Overall Study|Participants who underwent surgery.|55||
59802214|NCT00525915|75923390|FG001|COMPLETED|Overall Study||54||
59802215|NCT00525915|75923389|FG000|NOT COMPLETED|Overall Study||8||
59802216|NCT00525915|75923390|FG001|NOT COMPLETED|Overall Study||9||
59955235|NCT02567656|76073947|FG004|COMPLETED|Overall Study||19||
59802217|NCT00521079|75923398|FG000|STARTED|Overall Study||192||
59802218|NCT00521079|75923399|FG001|STARTED|Overall Study||102||
59802219|NCT00521079|75923398|FG000|Surgical Roll-In|Overall Study||9||
59802220|NCT00521079|75923399|FG001|Surgical Roll-In|Overall Study||5||
59802221|NCT00521079|75923398|FG000|COMPLETED|Overall Study||178||
59802222|NCT00521079|75923399|FG001|COMPLETED|Overall Study||97||
59802223|NCT00521079|75923398|FG000|NOT COMPLETED|Overall Study||14||
59802224|NCT00521079|75923399|FG001|NOT COMPLETED|Overall Study||5||
59802225|NCT00521001|75923405|FG000|STARTED|Overall Study||49||
59802226|NCT00521001|75923405|FG000|COMPLETED|Overall Study||48||
59955236|NCT02567656|76073948|FG005|COMPLETED|Overall Study||20||
60073805|NCT03320512|76189135|FG000|NOT COMPLETED|Overall Study||0||
59955237|NCT02567656|76073943|FG000|NOT COMPLETED|Overall Study||1||
59955238|NCT02567656|76073944|FG001|NOT COMPLETED|Overall Study||1||
59955239|NCT02567656|76073945|FG002|NOT COMPLETED|Overall Study||2||
59955240|NCT02567656|76073946|FG003|NOT COMPLETED|Overall Study||0||
59955241|NCT02567656|76073947|FG004|NOT COMPLETED|Overall Study||0||
59955242|NCT02567656|76073948|FG005|NOT COMPLETED|Overall Study||0||
59955243|NCT02560012|76073962|FG000|STARTED|Overall Study||3||
59955244|NCT02560012|76073962|FG000|COMPLETED|Overall Study||1||
59955245|NCT02560012|76073962|FG000|NOT COMPLETED|Overall Study||2||
60073806|NCT03320512|76189136|FG001|NOT COMPLETED|Overall Study||0||
60073807|NCT03320512|76189137|FG002|NOT COMPLETED|Overall Study||0||
60073808|NCT03364270|76189145|FG000|STARTED|Overall Study|First patient to undergo PET-MRI: 10/10/2018|6||
60073809|NCT03364270|76189145|FG000|COMPLETED|Overall Study|Last subject scanned: 1/9/2020|6||
60073810|NCT03364270|76189145|FG000|NOT COMPLETED|Overall Study||0||
60073811|NCT01612676|76189155|FG000|STARTED|Overall Study||6||
60073812|NCT01612676|76189156|FG001|STARTED|Overall Study||7||
60073813|NCT01612676|76189157|FG002|STARTED|Overall Study||5||
59955246|NCT02567266|76073969|FG000|STARTED|Overall Study||68||
59955247|NCT02567266|76073970|FG001|STARTED|Overall Study||60||
59955248|NCT02567266|76073971|FG002|STARTED|Overall Study||68||
59955249|NCT02567266|76073969|FG000|Midpoint (8 Weeks)|Overall Study||54||
59955250|NCT02567266|76073970|FG001|Midpoint (8 Weeks)|Overall Study||52||
59955251|NCT02567266|76073971|FG002|Midpoint (8 Weeks)|Overall Study||55||
59955252|NCT02567266|76073969|FG000|Post (16 Weeks)|Overall Study||49||
59955253|NCT02567266|76073970|FG001|Post (16 Weeks)|Overall Study||43||
59955254|NCT02567266|76073971|FG002|Post (16 Weeks)|Overall Study||53||
59955255|NCT02567266|76073969|FG000|Follow-up (28 Weeks)|Overall Study||45||
59523891|NCT03110562|75618904|FG000|NOT COMPLETED|Overall Study||195||
59523892|NCT03110562|75618905|FG001|NOT COMPLETED|Overall Study||207||
59523893|NCT01231399|75618911|FG000|STARTED|Overall Study||6||
59523894|NCT01231399|75618911|FG000|COMPLETED|Overall Study||6||
59523895|NCT01231399|75618911|FG000|NOT COMPLETED|Overall Study||0||
59523896|NCT01231633|75618918|FG000|STARTED|Overall Study||14||
59523897|NCT01231633|75618919|FG001|STARTED|Overall Study||13||
59523898|NCT01231633|75618918|FG000|COMPLETED|Overall Study||14||
59523899|NCT01231633|75618919|FG001|COMPLETED|Overall Study||13||
59523900|NCT01231633|75618918|FG000|NOT COMPLETED|Overall Study||0||
59523901|NCT01231633|75618919|FG001|NOT COMPLETED|Overall Study||0||
59523902|NCT01234207|75618927|FG000|STARTED|First Intervention||47||
59523903|NCT01234207|75618928|FG001|STARTED|First Intervention||48||
59523904|NCT01234207|75618927|FG000|COMPLETED|First Intervention||47||
59523905|NCT01234207|75618928|FG001|COMPLETED|First Intervention||48||
59523906|NCT01234207|75618927|FG000|NOT COMPLETED|First Intervention||0||
59523907|NCT01234207|75618928|FG001|NOT COMPLETED|First Intervention||0||
59523908|NCT01234207|75618927|FG000|STARTED|1-Week Washout Period||47||
59523909|NCT01234207|75618928|FG001|STARTED|1-Week Washout Period||48||
59523910|NCT01234207|75618927|FG000|COMPLETED|1-Week Washout Period||47||
59523911|NCT01234207|75618928|FG001|COMPLETED|1-Week Washout Period||48||
59523912|NCT01234207|75618927|FG000|NOT COMPLETED|1-Week Washout Period||0||
59523913|NCT01234207|75618928|FG001|NOT COMPLETED|1-Week Washout Period||0||
59523914|NCT01234207|75618927|FG000|STARTED|Second Intervention||47||
59523915|NCT01234207|75618928|FG001|STARTED|Second Intervention||48||
59523916|NCT01234207|75618927|FG000|COMPLETED|Second Intervention||47||
59523917|NCT01234207|75618928|FG001|COMPLETED|Second Intervention||48||
59523918|NCT01234207|75618927|FG000|NOT COMPLETED|Second Intervention||0||
59523919|NCT01234207|75618928|FG001|NOT COMPLETED|Second Intervention||0||
59523920|NCT01234831|75618938|FG000|STARTED|Overall Study||261||
59523921|NCT01234831|75618939|FG001|STARTED|Overall Study||202||
59523922|NCT01234831|75618938|FG000|COMPLETED|Overall Study||259||
59523923|NCT01234831|75618939|FG001|COMPLETED|Overall Study||198||
59523924|NCT01234831|75618938|FG000|NOT COMPLETED|Overall Study||2||
59523925|NCT01234831|75618939|FG001|NOT COMPLETED|Overall Study||4||
59523926|NCT02546856|75618948|FG000|STARTED|4 Months Evaluation||164||
59523927|NCT02546856|75618949|FG001|STARTED|4 Months Evaluation||156||
59523928|NCT02546856|75618948|FG000|COMPLETED|4 Months Evaluation||144||
59620532|NCT00088218|75731877|FG001|STARTED|Overall Study||79||
59620533|NCT00088218|75731876|FG000|COMPLETED|Overall Study||16||
59620534|NCT00088218|75731877|FG001|COMPLETED|Overall Study||79||
59620535|NCT00088218|75731876|FG000|NOT COMPLETED|Overall Study||0||
59620536|NCT00088218|75731877|FG001|NOT COMPLETED|Overall Study||0||
59620537|NCT00189228|75731883|FG000|STARTED|Overall Study||18||
59620538|NCT00189228|75731883|FG000|COMPLETED|Overall Study||18||
59620539|NCT00189228|75731883|FG000|NOT COMPLETED|Overall Study||0||
59523929|NCT02546856|75618949|FG001|COMPLETED|4 Months Evaluation||145||
59523930|NCT02546856|75618948|FG000|NOT COMPLETED|4 Months Evaluation||20||
59523931|NCT02546856|75618949|FG001|NOT COMPLETED|4 Months Evaluation||11||
59523932|NCT02546856|75618948|FG000|STARTED|6 Months Evaluation||144||
59523933|NCT02546856|75618949|FG001|STARTED|6 Months Evaluation||145||
59523934|NCT02546856|75618948|FG000|COMPLETED|6 Months Evaluation||136||
59523935|NCT02546856|75618949|FG001|COMPLETED|6 Months Evaluation||138||
59523936|NCT02546856|75618948|FG000|NOT COMPLETED|6 Months Evaluation||8||
59620540|NCT00091260|75731887|FG000|STARTED|Overall Study||82||
59620541|NCT00091260|75731887|FG000|COMPLETED|Overall Study||82||
59620542|NCT00091260|75731887|FG000|NOT COMPLETED|Overall Study||0||
59620543|NCT00193128|75731894|FG000|STARTED|Overall Study||10||
59620544|NCT00193128|75731895|FG001|STARTED|Overall Study||49||
59620545|NCT00193128|75731894|FG000|COMPLETED|Overall Study||10||
59620546|NCT00193128|75731895|FG001|COMPLETED|Overall Study||39||
59995268|NCT04263987|76111095|FG000|STARTED|Overall Study||30||
59523937|NCT02546856|75618949|FG001|NOT COMPLETED|6 Months Evaluation||7||
59523938|NCT01151371|75618970|FG000|STARTED|Overall Study||149||
59523939|NCT01151371|75618971|FG001|STARTED|Overall Study||150||
59523940|NCT01151371|75618972|FG002|STARTED|Overall Study||153||
59523941|NCT01151371|75618970|FG000|COMPLETED|Overall Study||144||
59523942|NCT01151371|75618971|FG001|COMPLETED|Overall Study||149||
59523943|NCT01151371|75618972|FG002|COMPLETED|Overall Study||146||
59620547|NCT00193128|75731894|FG000|NOT COMPLETED|Overall Study||0||
59620548|NCT00193128|75731895|FG001|NOT COMPLETED|Overall Study||10||
59620549|NCT00193596|75731905|FG000|STARTED|Overall Study||93||
59620550|NCT00193596|75731906|FG001|STARTED|Overall Study||105||
59620551|NCT00193596|75731905|FG000|COMPLETED|Overall Study||37||
59523944|NCT01151371|75618970|FG000|NOT COMPLETED|Overall Study||5||
59523945|NCT01151371|75618971|FG001|NOT COMPLETED|Overall Study||1||
59802227|NCT00521001|75923405|FG000|NOT COMPLETED|Overall Study||1||
59802228|NCT00134563|75923412|FG000|STARTED|Overall Study|Randomized|363||
59802229|NCT00134563|75923413|FG001|STARTED|Overall Study|Randomized|366||
59802230|NCT00134563|75923414|FG002|STARTED|Overall Study|Randomized|359||
59802231|NCT00134563|75923412|FG000|Treated|Overall Study|Two participants received doses of Teriflunomide 7 mg, one participant doses of Teriflunomide 14 mg|363||
59802232|NCT00134563|75923413|FG001|Treated|Overall Study||365||
59802233|NCT00134563|75923414|FG002|Treated|Overall Study|one participant received doses of Teriflunomide 7 mg|358||
59802234|NCT00134563|75923412|FG000|COMPLETED|Overall Study|completed treatment period|259||
59802235|NCT00134563|75923413|FG001|COMPLETED|Overall Study|completed treatment period|274||
59802236|NCT00134563|75923414|FG002|COMPLETED|Overall Study|completed treatment period|263||
59802237|NCT00134563|75923412|FG000|NOT COMPLETED|Overall Study||104||
59802238|NCT00134563|75923413|FG001|NOT COMPLETED|Overall Study||92||
59802239|NCT00134563|75923414|FG002|NOT COMPLETED|Overall Study||96||
59802240|NCT00520845|75923422|FG000|STARTED|Overall Study||23||
59802241|NCT00520845|75923422|FG000|COMPLETED|Overall Study||1||
59802242|NCT00520845|75923422|FG000|NOT COMPLETED|Overall Study||22||
59802243|NCT00185731|75923426|FG000|STARTED|Overall Study||25||
59802244|NCT00185731|75923426|FG000|COMPLETED|Overall Study||23||
59802245|NCT00185731|75923426|FG000|NOT COMPLETED|Overall Study||2||
59802246|NCT00582491|75923434|FG000|STARTED|Overall Study||11||
59802247|NCT00582491|75923435|FG001|STARTED|Overall Study||10||
59802248|NCT00582491|75923434|FG000|COMPLETED|Overall Study||10||
59802249|NCT00582491|75923435|FG001|COMPLETED|Overall Study||10||
59802250|NCT00582491|75923434|FG000|NOT COMPLETED|Overall Study||1||
59802251|NCT00582491|75923435|FG001|NOT COMPLETED|Overall Study||0||
59802252|NCT00520767|75923441|FG000|STARTED|Overall Study||35||
59802253|NCT00520767|75923441|FG000|COMPLETED|Overall Study||33||
59802254|NCT00520767|75923441|FG000|NOT COMPLETED|Overall Study||2||
59802255|NCT04679051|75923447|FG000|STARTED|Overall Study||12||
59802256|NCT04679051|75923448|FG001|STARTED|Overall Study||11||
59802257|NCT04679051|75923447|FG000|COMPLETED|Overall Study||6||
59802258|NCT04679051|75923448|FG001|COMPLETED|Overall Study||6||
59802259|NCT04679051|75923447|FG000|NOT COMPLETED|Overall Study||6||
59802260|NCT04679051|75923448|FG001|NOT COMPLETED|Overall Study||5||
59802261|NCT03873987|75923459|FG000|STARTED|Overall Study||52||
59802262|NCT03873987|75923460|FG001|STARTED|Overall Study||50||
59802263|NCT03873987|75923459|FG000|COMPLETED|Overall Study||50||
59802264|NCT03873987|75923460|FG001|COMPLETED|Overall Study||49||
59802265|NCT03873987|75923459|FG000|NOT COMPLETED|Overall Study||2||
59802266|NCT03873987|75923460|FG001|NOT COMPLETED|Overall Study||1||
59802267|NCT03018587|75923467|FG000|STARTED|Overall Study||23||
59802268|NCT03018587|75923467|FG000|COMPLETED|Overall Study||19||
59802269|NCT03018587|75923467|FG000|NOT COMPLETED|Overall Study||4||
59802270|NCT00474760|75923478|FG000|STARTED|Overall Study||3||
59802271|NCT00474760|75923479|FG001|STARTED|Overall Study||3||
59802272|NCT00474760|75923480|FG002|STARTED|Overall Study||3||
59802273|NCT00474760|75923481|FG003|STARTED|Overall Study||3||
59802274|NCT00474760|75923482|FG004|STARTED|Overall Study||13||
59802275|NCT00474760|75923483|FG005|STARTED|Overall Study||29||
59802276|NCT00474760|75923484|FG006|STARTED|Overall Study||11||
59802277|NCT00474760|75923478|FG000|COMPLETED|Overall Study||0||
59955256|NCT02567266|76073970|FG001|Follow-up (28 Weeks)|Overall Study||45||
59955257|NCT02567266|76073971|FG002|Follow-up (28 Weeks)|Overall Study||52||
59955258|NCT02567266|76073969|FG000|COMPLETED|Overall Study||45||
59955259|NCT02567266|76073970|FG001|COMPLETED|Overall Study||45||
59955260|NCT02567266|76073971|FG002|COMPLETED|Overall Study||52||
59955261|NCT02567266|76073969|FG000|NOT COMPLETED|Overall Study||23||
59955262|NCT02567266|76073970|FG001|NOT COMPLETED|Overall Study||15||
59955263|NCT02567266|76073971|FG002|NOT COMPLETED|Overall Study||16||
59955264|NCT02567188|76073979|FG000|STARTED|Overall Study||144||
59802278|NCT00474760|75923479|FG001|COMPLETED|Overall Study||0||
59802279|NCT00474760|75923480|FG002|COMPLETED|Overall Study||0||
59802280|NCT00474760|75923481|FG003|COMPLETED|Overall Study||0||
59802281|NCT00474760|75923482|FG004|COMPLETED|Overall Study||1||
59802282|NCT00474760|75923483|FG005|COMPLETED|Overall Study||0||
59802283|NCT00474760|75923484|FG006|COMPLETED|Overall Study||1||
59802284|NCT00474760|75923478|FG000|NOT COMPLETED|Overall Study||3||
59802285|NCT00474760|75923479|FG001|NOT COMPLETED|Overall Study||3||
59802286|NCT00474760|75923480|FG002|NOT COMPLETED|Overall Study||3||
59802287|NCT00474760|75923481|FG003|NOT COMPLETED|Overall Study||3||
59802288|NCT00474760|75923482|FG004|NOT COMPLETED|Overall Study||12||
59802289|NCT00474760|75923483|FG005|NOT COMPLETED|Overall Study||29||
59955265|NCT02567188|76073979|FG000|COMPLETED|Overall Study||109||
59802290|NCT00474760|75923484|FG006|NOT COMPLETED|Overall Study||10||
59802291|NCT00528645|75923507|FG000|STARTED|Overall Study||23||
59802292|NCT00528645|75923507|FG000|COMPLETED|Overall Study||20||
59802293|NCT00528645|75923507|FG000|NOT COMPLETED|Overall Study||3||
59802294|NCT00524745|75923516|FG000|STARTED|Overall Study||229||
59802295|NCT00524745|75923517|FG001|STARTED|Overall Study||206||
59955266|NCT02567188|76073979|FG000|NOT COMPLETED|Overall Study||35||
59955267|NCT00706238|76073984|FG000|STARTED|Overall Study||5||
59955268|NCT00706238|76073984|FG000|COMPLETED|Overall Study||0||
59955269|NCT00706238|76073984|FG000|NOT COMPLETED|Overall Study||5||
59955270|NCT03321968|76073991|FG000|STARTED|Overall Study||401||
59955271|NCT03321968|76073992|FG001|STARTED|Overall Study||399||
59955272|NCT03321968|76073993|FG002|STARTED|Overall Study||402||
59955273|NCT03321968|76073991|FG000|Vaccinated|Overall Study||401||
59802296|NCT00524745|75923518|FG002|STARTED|Overall Study||241||
59802297|NCT00524745|75923519|FG003|STARTED|Overall Study||227||
59802298|NCT00524745|75923516|FG000|COMPLETED|Overall Study||195||
59802299|NCT00524745|75923517|FG001|COMPLETED|Overall Study||193||
59802300|NCT00524745|75923518|FG002|COMPLETED|Overall Study||212||
59802301|NCT00524745|75923519|FG003|COMPLETED|Overall Study||205||
59802302|NCT00524745|75923516|FG000|NOT COMPLETED|Overall Study||34||
59802303|NCT00524745|75923517|FG001|NOT COMPLETED|Overall Study||13||
59802304|NCT00524745|75923518|FG002|NOT COMPLETED|Overall Study||29||
59955274|NCT03321968|76073992|FG001|Vaccinated|Overall Study||398||
59955275|NCT03321968|76073993|FG002|Vaccinated|Overall Study||401||
59955276|NCT03321968|76073991|FG000|COMPLETED|Overall Study||398||
59955277|NCT03321968|76073992|FG001|COMPLETED|Overall Study||397||
59955278|NCT03321968|76073993|FG002|COMPLETED|Overall Study||399||
59955279|NCT03321968|76073991|FG000|NOT COMPLETED|Overall Study||3||
59955280|NCT03321968|76073992|FG001|NOT COMPLETED|Overall Study||2||
59955281|NCT03321968|76073993|FG002|NOT COMPLETED|Overall Study||3||
59955282|NCT05674292|76074001|FG000|STARTED|Overall Study||25||
59955283|NCT05674292|76074001|FG000|COMPLETED|Overall Study||25||
59955284|NCT05674292|76074001|FG000|NOT COMPLETED|Overall Study||0||
59955285|NCT05338333|76074007|FG000|STARTED|Period 1, Approximately 30 Days||51||102
59955286|NCT05338333|76074008|FG001|STARTED|Period 1, Approximately 30 Days||50||100
59955287|NCT05338333|76074007|FG000|COMPLETED|Period 1, Approximately 30 Days||50||100
59955288|NCT05338333|76074008|FG001|COMPLETED|Period 1, Approximately 30 Days||50||100
59955289|NCT05338333|76074007|FG000|NOT COMPLETED|Period 1, Approximately 30 Days||1||2
59955290|NCT05338333|76074008|FG001|NOT COMPLETED|Period 1, Approximately 30 Days||0||0
59802305|NCT00524745|75923519|FG003|NOT COMPLETED|Overall Study||22||
59802306|NCT00495040|75923529|FG000|STARTED|Overall Study||38||
59802307|NCT00495040|75923529|FG000|COMPLETED|Overall Study||35||
59802308|NCT00495040|75923529|FG000|NOT COMPLETED|Overall Study||3||
59802309|NCT02664363|75923533|FG000|STARTED|Overall Study||3||
59802310|NCT02664363|75923533|FG000|COMPLETED|Overall Study||3||
59802311|NCT02664363|75923533|FG000|NOT COMPLETED|Overall Study||0||
59802312|NCT00494026|75923537|FG000|STARTED|Overall Study||4||
59802313|NCT00494026|75923537|FG000|COMPLETED|Overall Study|2 patients did receive the full study treatment prior to the study being terminated.|0||
59802314|NCT00494026|75923537|FG000|NOT COMPLETED|Overall Study||4||
59802315|NCT00524589|75923541|FG000|STARTED|Overall Study||18||
59802316|NCT00524589|75923541|FG000|COMPLETED|Overall Study||0||
59802317|NCT00524589|75923541|FG000|NOT COMPLETED|Overall Study||18||
59802318|NCT00472030|75923547|FG000|STARTED|Overall Study||2||
59802319|NCT00472030|75923548|FG001|STARTED|Overall Study||0||
59802320|NCT00472030|75923547|FG000|COMPLETED|Overall Study||1||
59802321|NCT00472030|75923548|FG001|COMPLETED|Overall Study||0||
59802322|NCT00472030|75923547|FG000|NOT COMPLETED|Overall Study||1||
59802323|NCT00472030|75923548|FG001|NOT COMPLETED|Overall Study||0||
59802324|NCT00127855|75923563|FG000|STARTED|Primary Vaccination Course||82||
59802325|NCT00127855|75923564|FG001|STARTED|Primary Vaccination Course||82||
59802326|NCT00127855|75923565|FG002|STARTED|Primary Vaccination Course||80||
59802327|NCT00127855|75923566|FG003|STARTED|Primary Vaccination Course||81||
59802328|NCT00127855|75923567|FG004|STARTED|Primary Vaccination Course||82||
59802329|NCT00127855|75923563|FG000|COMPLETED|Primary Vaccination Course||80||
59802330|NCT00127855|75923564|FG001|COMPLETED|Primary Vaccination Course||81||
59802331|NCT00127855|75923565|FG002|COMPLETED|Primary Vaccination Course||78||
59802332|NCT00127855|75923566|FG003|COMPLETED|Primary Vaccination Course||81||
59802333|NCT00127855|75923567|FG004|COMPLETED|Primary Vaccination Course||78||
59802334|NCT00127855|75923563|FG000|NOT COMPLETED|Primary Vaccination Course||2||
59802335|NCT00127855|75923564|FG001|NOT COMPLETED|Primary Vaccination Course||1||
59955291|NCT05338333|76074007|FG000|STARTED|Period 2, Approximately 30 Days||50||100
59955292|NCT05338333|76074008|FG001|STARTED|Period 2, Approximately 30 Days||50||100
59955293|NCT05338333|76074007|FG000|COMPLETED|Period 2, Approximately 30 Days||50||100
59955294|NCT05338333|76074008|FG001|COMPLETED|Period 2, Approximately 30 Days||50||100
59955295|NCT05338333|76074007|FG000|NOT COMPLETED|Period 2, Approximately 30 Days||0||0
59955296|NCT05338333|76074008|FG001|NOT COMPLETED|Period 2, Approximately 30 Days||0||0
59955297|NCT05051579|76074024|FG000|STARTED|Overall Study||50||
59802336|NCT00127855|75923565|FG002|NOT COMPLETED|Primary Vaccination Course||2||
59802337|NCT00127855|75923566|FG003|NOT COMPLETED|Primary Vaccination Course||0||
59802338|NCT00127855|75923567|FG004|NOT COMPLETED|Primary Vaccination Course||4||
59802339|NCT00127855|75923563|FG000|STARTED|Polysaccharide Challenge Dose||80||
59802340|NCT00127855|75923564|FG001|STARTED|Polysaccharide Challenge Dose||79||
59802341|NCT00127855|75923565|FG002|STARTED|Polysaccharide Challenge Dose||77||
59802342|NCT00127855|75923566|FG003|STARTED|Polysaccharide Challenge Dose||81||
59802343|NCT00127855|75923567|FG004|STARTED|Polysaccharide Challenge Dose||77||
59802344|NCT00127855|75923563|FG000|COMPLETED|Polysaccharide Challenge Dose||80||
59955298|NCT05051579|76074025|FG001|STARTED|Overall Study||53||
59955299|NCT05051579|76074026|FG002|STARTED|Overall Study||29||
59955300|NCT05051579|76074027|FG003|STARTED|Overall Study||29||
59955301|NCT05051579|76074028|FG004|STARTED|Overall Study||31||
59955302|NCT05051579|76074029|FG005|STARTED|Overall Study||30||
59955303|NCT05051579|76074030|FG006|STARTED|Overall Study||50||
59955304|NCT05051579|76074024|FG000|COMPLETED|Overall Study||44||
59955305|NCT05051579|76074025|FG001|COMPLETED|Overall Study||46||
59955306|NCT05051579|76074026|FG002|COMPLETED|Overall Study||27||
59955307|NCT05051579|76074027|FG003|COMPLETED|Overall Study||24||
59955308|NCT05051579|76074028|FG004|COMPLETED|Overall Study||23||
59955309|NCT05051579|76074029|FG005|COMPLETED|Overall Study||28||
59955310|NCT05051579|76074030|FG006|COMPLETED|Overall Study||43||
59955311|NCT05051579|76074024|FG000|NOT COMPLETED|Overall Study||6||
59955312|NCT05051579|76074025|FG001|NOT COMPLETED|Overall Study||7||
59955313|NCT05051579|76074026|FG002|NOT COMPLETED|Overall Study||2||
59955314|NCT05051579|76074027|FG003|NOT COMPLETED|Overall Study||5||
59802345|NCT00127855|75923564|FG001|COMPLETED|Polysaccharide Challenge Dose||79||
59802346|NCT00127855|75923565|FG002|COMPLETED|Polysaccharide Challenge Dose||77||
59802347|NCT00127855|75923566|FG003|COMPLETED|Polysaccharide Challenge Dose||81||
59802348|NCT00127855|75923567|FG004|COMPLETED|Polysaccharide Challenge Dose||77||
59802349|NCT00127855|75923563|FG000|NOT COMPLETED|Polysaccharide Challenge Dose||0||
59802350|NCT00127855|75923564|FG001|NOT COMPLETED|Polysaccharide Challenge Dose||0||
59802351|NCT00127855|75923565|FG002|NOT COMPLETED|Polysaccharide Challenge Dose||0||
59802352|NCT00127855|75923566|FG003|NOT COMPLETED|Polysaccharide Challenge Dose||0||
59802353|NCT00127855|75923567|FG004|NOT COMPLETED|Polysaccharide Challenge Dose||0||
59955315|NCT05051579|76074028|FG004|NOT COMPLETED|Overall Study||8||
59955316|NCT05051579|76074029|FG005|NOT COMPLETED|Overall Study||2||
59955317|NCT05051579|76074030|FG006|NOT COMPLETED|Overall Study||7||
59955318|NCT04996940|76074046|FG000|STARTED|Overall Study||28||
59955319|NCT04996940|76074047|FG001|STARTED|Overall Study||24||
59955320|NCT04996940|76074046|FG000|COMPLETED|Overall Study||28||
59955321|NCT04996940|76074047|FG001|COMPLETED|Overall Study||24||
59955322|NCT04996940|76074046|FG000|NOT COMPLETED|Overall Study||0||
59955323|NCT04996940|76074047|FG001|NOT COMPLETED|Overall Study||0||
59955324|NCT04964128|76074054|FG000|STARTED|Phase 1 (Software Release Tag 1.0)|8 subjects participated in both phases 1 and 2, and there were 10 subjects who participated in only Phase 1|18||
59955325|NCT04964128|76074054|FG000|COMPLETED|Phase 1 (Software Release Tag 1.0)||17||
59955326|NCT04964128|76074054|FG000|NOT COMPLETED|Phase 1 (Software Release Tag 1.0)||1||
59955327|NCT04964128|76074054|FG000|STARTED|Phase 2 (Software Release Tag 2.0)|8 subjects participated in both phases 1 and 2, and there were 10 subjects who participated in only Phase 2|18||
59955328|NCT04964128|76074054|FG000|COMPLETED|Phase 2 (Software Release Tag 2.0)||17||
59955329|NCT04964128|76074054|FG000|NOT COMPLETED|Phase 2 (Software Release Tag 2.0)||1||
59955330|NCT04881760|76074069|FG000|STARTED|Overall Study||70||
59955331|NCT04881760|76074070|FG001|STARTED|Overall Study||69||
59955332|NCT04881760|76074071|FG002|STARTED|Overall Study||33||
59955333|NCT04881760|76074072|FG003|STARTED|Overall Study||34||
59955334|NCT04881760|76074073|FG004|STARTED|Overall Study||35||
59955335|NCT04881760|76074074|FG005|STARTED|Overall Study||35||
59955336|NCT04881760|76074075|FG006|STARTED|Overall Study||62||
59955337|NCT04881760|76074069|FG000|Received at Least One Dose of Study Drug|Overall Study||70||
59955338|NCT04881760|76074070|FG001|Received at Least One Dose of Study Drug|Overall Study||69||
59802354|NCT00493636|75923581|FG000|STARTED|Overall Study||81||
59802355|NCT00493636|75923582|FG001|STARTED|Overall Study||79||
59802356|NCT00493636|75923581|FG000|COMPLETED|Overall Study||79||
59802357|NCT00493636|75923582|FG001|COMPLETED|Overall Study||77||
59955339|NCT04881760|76074071|FG002|Received at Least One Dose of Study Drug|Overall Study||33||
59955340|NCT04881760|76074072|FG003|Received at Least One Dose of Study Drug|Overall Study||33||
59955341|NCT04881760|76074073|FG004|Received at Least One Dose of Study Drug|Overall Study||35||
59955342|NCT04881760|76074074|FG005|Received at Least One Dose of Study Drug|Overall Study||35||
59955343|NCT04881760|76074075|FG006|Received at Least One Dose of Study Drug|Overall Study||62||
59523946|NCT01151371|75618972|FG002|NOT COMPLETED|Overall Study||7||
59523947|NCT01151449|75618980|FG000|STARTED|Overall Study||6||
59523948|NCT01151449|75618980|FG000|COMPLETED|Overall Study||6||
59523949|NCT01151449|75618980|FG000|NOT COMPLETED|Overall Study||0||
59523950|NCT02122952|75618986|FG000|STARTED|Overall Study||3||
59523951|NCT02122952|75618987|FG001|STARTED|Overall Study||12||
59523952|NCT02122952|75618986|FG000|COMPLETED|Overall Study||3||
59523953|NCT02122952|75618987|FG001|COMPLETED|Overall Study||12||
59802358|NCT00493636|75923581|FG000|NOT COMPLETED|Overall Study||2||
59802359|NCT00493636|75923582|FG001|NOT COMPLETED|Overall Study||2||
59802360|NCT00524121|75923588|FG000|STARTED|Overall Study||22||
59802361|NCT00524121|75923588|FG000|COMPLETED|Overall Study||3||
59955344|NCT04881760|76074069|FG000|COMPLETED|Overall Study||50||
59955345|NCT04881760|76074070|FG001|COMPLETED|Overall Study||60||
59955346|NCT04881760|76074071|FG002|COMPLETED|Overall Study||26||
59955347|NCT04881760|76074072|FG003|COMPLETED|Overall Study||26||
59955348|NCT04881760|76074073|FG004|COMPLETED|Overall Study||30||
59955349|NCT04881760|76074074|FG005|COMPLETED|Overall Study||29||
59523954|NCT02122952|75618986|FG000|NOT COMPLETED|Overall Study||0||
59523955|NCT02122952|75618987|FG001|NOT COMPLETED|Overall Study||0||
59955350|NCT04881760|76074075|FG006|COMPLETED|Overall Study||54||
59955351|NCT04881760|76074069|FG000|NOT COMPLETED|Overall Study||20||
59955352|NCT04881760|76074070|FG001|NOT COMPLETED|Overall Study||9||
59955353|NCT04881760|76074071|FG002|NOT COMPLETED|Overall Study||7||
59955354|NCT04881760|76074072|FG003|NOT COMPLETED|Overall Study||8||
59955355|NCT04881760|76074073|FG004|NOT COMPLETED|Overall Study||5||
59955356|NCT04881760|76074074|FG005|NOT COMPLETED|Overall Study||6||
59955357|NCT04881760|76074075|FG006|NOT COMPLETED|Overall Study||8||
59802362|NCT00524121|75923588|FG000|NOT COMPLETED|Overall Study||19||
59802363|NCT00470626|75923603|FG000|STARTED|Overall Study||129||
59802364|NCT00470626|75923603|FG000|COMPLETED|Overall Study||112||
59802365|NCT00470626|75923603|FG000|NOT COMPLETED|Overall Study||17||
59802366|NCT00132769|75923609|FG000|STARTED|Overall Study||53||
59802367|NCT00132769|75923610|FG001|STARTED|Overall Study||53||
59955358|NCT04749797|76074094|FG000|STARTED|Overall Study||3||
59955359|NCT04749797|76074095|FG001|STARTED|Overall Study||4||
59955360|NCT04749797|76074096|FG002|STARTED|Overall Study||4||
59955361|NCT04749797|76074094|FG000|COMPLETED|Overall Study||2||
59955362|NCT04749797|76074095|FG001|COMPLETED|Overall Study||4||
59955363|NCT04749797|76074096|FG002|COMPLETED|Overall Study||4||
59955364|NCT04749797|76074094|FG000|NOT COMPLETED|Overall Study||1||
59955365|NCT04749797|76074095|FG001|NOT COMPLETED|Overall Study||0||
59955366|NCT04749797|76074096|FG002|NOT COMPLETED|Overall Study||0||
59955367|NCT04747275|76074106|FG000|STARTED|Overall Study||2||
59955368|NCT04747275|76074107|FG001|STARTED|Overall Study||4||
59955369|NCT04747275|76074106|FG000|COMPLETED|Overall Study||2||
59955370|NCT04747275|76074107|FG001|COMPLETED|Overall Study||3||
59955371|NCT04747275|76074106|FG000|NOT COMPLETED|Overall Study||0||
59955372|NCT04747275|76074107|FG001|NOT COMPLETED|Overall Study||1||
59955373|NCT04556552|76074115|FG000|STARTED|Overall Study||12||
59955374|NCT04556552|76074116|FG001|STARTED|Overall Study||8||
59955375|NCT04556552|76074115|FG000|COMPLETED|Overall Study||11||
59955376|NCT04556552|76074116|FG001|COMPLETED|Overall Study||6||
59955377|NCT04556552|76074115|FG000|NOT COMPLETED|Overall Study||1||
59955378|NCT04556552|76074116|FG001|NOT COMPLETED|Overall Study||2||
59955379|NCT04496167|76074124|FG000|STARTED|Overall Study||102||
59955380|NCT04496167|76074125|FG001|STARTED|Overall Study||96||
59955381|NCT04496167|76074124|FG000|Received at Least 1 Dose of Study Drug|Overall Study||101||
59955382|NCT04496167|76074125|FG001|Received at Least 1 Dose of Study Drug|Overall Study||94||
59955383|NCT04496167|76074124|FG000|COMPLETED|Overall Study||84||
59955384|NCT04496167|76074125|FG001|COMPLETED|Overall Study||80||
59955385|NCT04496167|76074124|FG000|NOT COMPLETED|Overall Study||18||
59955386|NCT04496167|76074125|FG001|NOT COMPLETED|Overall Study||16||
59955387|NCT04485130|76074135|FG000|STARTED|Overall Study||7||
59955388|NCT04485130|76074136|FG001|STARTED|Overall Study||4||
59955389|NCT04485130|76074137|FG002|STARTED|Overall Study||0||
59955390|NCT04485130|76074138|FG003|STARTED|Overall Study||0||
59955391|NCT04485130|76074135|FG000|COMPLETED|Overall Study||7||
59955392|NCT04485130|76074136|FG001|COMPLETED|Overall Study||4||
59955393|NCT04485130|76074137|FG002|COMPLETED|Overall Study||0||
59955394|NCT04485130|76074138|FG003|COMPLETED|Overall Study||0||
59955395|NCT04485130|76074135|FG000|NOT COMPLETED|Overall Study||0||
59955396|NCT04485130|76074136|FG001|NOT COMPLETED|Overall Study||0||
59955397|NCT04485130|76074137|FG002|NOT COMPLETED|Overall Study||0||
59802368|NCT00132769|75923609|FG000|COMPLETED|Overall Study||42||
59802369|NCT00132769|75923610|FG001|COMPLETED|Overall Study||42||
59802370|NCT00132769|75923609|FG000|NOT COMPLETED|Overall Study||11||
59802371|NCT00132769|75923610|FG001|NOT COMPLETED|Overall Study||11||
59802372|NCT00520299|75923619|FG000|STARTED|Overall Study||6||
59802373|NCT00520299|75923620|FG001|STARTED|Overall Study||6||
59955398|NCT04485130|76074138|FG003|NOT COMPLETED|Overall Study||0||
59955399|NCT04458948|76074152|FG000|STARTED|Overall Study||28||
59955400|NCT04458948|76074152|FG000|COMPLETED|Overall Study||0||
59955401|NCT04458948|76074152|FG000|NOT COMPLETED|Overall Study||28||
59802374|NCT00520299|75923621|FG002|STARTED|Overall Study||19||
59802375|NCT00520299|75923619|FG000|COMPLETED|Overall Study|Defined as completion of 1 treatment cycle|6||
59802376|NCT00520299|75923620|FG001|COMPLETED|Overall Study||3||
59802377|NCT00520299|75923621|FG002|COMPLETED|Overall Study||13||
59955402|NCT04386746|76074156|FG000|STARTED|Overall Study||26||
59955403|NCT04386746|76074156|FG000|COMPLETED|Overall Study||4||
59802378|NCT00520299|75923619|FG000|NOT COMPLETED|Overall Study||0||
59802379|NCT00520299|75923620|FG001|NOT COMPLETED|Overall Study||3||
59802380|NCT00520299|75923621|FG002|NOT COMPLETED|Overall Study||6||
59802381|NCT02478255|75923631|FG000|STARTED|Overall Study||17||
59802382|NCT02478255|75923632|FG001|STARTED|Overall Study||8||
59802383|NCT02478255|75923631|FG000|COMPLETED|Overall Study||9||
59955404|NCT04386746|76074156|FG000|NOT COMPLETED|Overall Study||22||
59955405|NCT04339101|76074160|FG000|STARTED|Overall Study||59||
59955406|NCT04339101|76074160|FG000|COMPLETED|Overall Study||59||
59955407|NCT04339101|76074160|FG000|NOT COMPLETED|Overall Study||0||
59955408|NCT04238481|76074168|FG000|STARTED|Overall Study||3||
59955409|NCT04238481|76074169|FG001|STARTED|Overall Study||4||
59955410|NCT04238481|76074170|FG002|STARTED|Overall Study||3||
59955411|NCT04238481|76074171|FG003|STARTED|Overall Study||3||
59955412|NCT04238481|76074168|FG000|Treated|Overall Study||3||
59955413|NCT04238481|76074169|FG001|Treated|Overall Study||3||
59955414|NCT04238481|76074170|FG002|Treated|Overall Study||3||
59955415|NCT04238481|76074171|FG003|Treated|Overall Study||3||
59955416|NCT04238481|76074168|FG000|COMPLETED|Overall Study||3||
59955417|NCT04238481|76074169|FG001|COMPLETED|Overall Study||3||
59955418|NCT04238481|76074170|FG002|COMPLETED|Overall Study||3||
59955419|NCT04238481|76074171|FG003|COMPLETED|Overall Study||3||
59955420|NCT04238481|76074168|FG000|NOT COMPLETED|Overall Study||0||
59802384|NCT02478255|75923632|FG001|COMPLETED|Overall Study||8||
59802385|NCT02478255|75923631|FG000|NOT COMPLETED|Overall Study||8||
59802386|NCT02478255|75923632|FG001|NOT COMPLETED|Overall Study||0||
59802387|NCT00132691|75923640|FG000|STARTED|Overall Study|129 participants were assigned to implant; 122 received implant|129||
59802388|NCT00132691|75923641|FG001|STARTED|Overall Study|126 participants were assigned to systemic treatment; 121 received systemic therapy|126||
59802389|NCT00132691|75923640|FG000|COMPLETED|Overall Study|118 participants completed the 2-year anniversary visit|118||
59802390|NCT00132691|75923641|FG001|COMPLETED|Overall Study|114 participants completed the 2-year anniversary visit|114||
59802391|NCT00132691|75923640|FG000|NOT COMPLETED|Overall Study||11||
59802392|NCT00132691|75923641|FG001|NOT COMPLETED|Overall Study||12||
59802393|NCT00125359|75923652|FG000|STARTED|Overall Study||42||
59802394|NCT00125359|75923652|FG000|COMPLETED|Overall Study||19||
59802395|NCT00125359|75923652|FG000|NOT COMPLETED|Overall Study||23||
59802396|NCT00524043|75923659|FG000|STARTED|Overall Study|One patient was randomly assigned to treatment but did not receive placebo.|64||
59802397|NCT00524043|75923660|FG001|STARTED|Overall Study||70||
59802398|NCT00524043|75923661|FG002|STARTED|Overall Study||66||
59802399|NCT00524043|75923659|FG000|COMPLETED|Overall Study||34||
59802400|NCT00524043|75923660|FG001|COMPLETED|Overall Study||42||
59802401|NCT00524043|75923661|FG002|COMPLETED|Overall Study||35||
59802402|NCT00524043|75923659|FG000|NOT COMPLETED|Overall Study||30||
59802403|NCT00524043|75923660|FG001|NOT COMPLETED|Overall Study||28||
59802404|NCT00524043|75923661|FG002|NOT COMPLETED|Overall Study||31||
59802405|NCT00523419|75923669|FG000|STARTED|Overall Study||32||
59802406|NCT00523419|75923669|FG000|COMPLETED|Overall Study||0||
59802407|NCT00523419|75923669|FG000|NOT COMPLETED|Overall Study||32||
59802408|NCT03868059|75923673|FG000|STARTED|Overall Study||138||
59802409|NCT03868059|75923673|FG000|COMPLETED|Overall Study||126||
59802410|NCT03868059|75923673|FG000|NOT COMPLETED|Overall Study||12||
59802411|NCT00522951|75923677|FG000|STARTED|Period 1||86||
59802412|NCT00522951|75923678|FG001|STARTED|Period 1||79||
59802413|NCT00522951|75923677|FG000|Received Treatment|Period 1||86||
59802414|NCT00522951|75923678|FG001|Received Treatment|Period 1||78||
59802415|NCT00522951|75923677|FG000|COMPLETED|Period 1||86||
59802416|NCT00522951|75923678|FG001|COMPLETED|Period 1||78||
59802417|NCT00522951|75923677|FG000|NOT COMPLETED|Period 1||0||
59802418|NCT00522951|75923678|FG001|NOT COMPLETED|Period 1||1||
59802419|NCT00522951|75923677|FG000|STARTED|Washout Period||86||
59802420|NCT00522951|75923678|FG001|STARTED|Washout Period||78||
59802421|NCT00522951|75923677|FG000|COMPLETED|Washout Period||86||
59802422|NCT00522951|75923678|FG001|COMPLETED|Washout Period||76||
59802423|NCT00522951|75923677|FG000|NOT COMPLETED|Washout Period||0||
59802424|NCT00522951|75923678|FG001|NOT COMPLETED|Washout Period||2||
59802425|NCT00522951|75923677|FG000|STARTED|Period 2||86||
59802426|NCT00522951|75923678|FG001|STARTED|Period 2||76||
59802427|NCT00522951|75923677|FG000|Subjects Received Treatment|Period 2||84||
59802428|NCT00522951|75923678|FG001|Subjects Received Treatment|Period 2||75||
59802429|NCT00522951|75923677|FG000|COMPLETED|Period 2||84||
59802430|NCT00522951|75923678|FG001|COMPLETED|Period 2||75||
59802431|NCT00522951|75923677|FG000|NOT COMPLETED|Period 2||2||
59802432|NCT00522951|75923678|FG001|NOT COMPLETED|Period 2||1||
59802433|NCT03865953|75923690|FG000|STARTED|First Intervention (4 Weeks)||25||
59802434|NCT03865953|75923691|FG001|STARTED|First Intervention (4 Weeks)||28||
59802435|NCT03865953|75923690|FG000|COMPLETED|First Intervention (4 Weeks)||23||
59802436|NCT03865953|75923691|FG001|COMPLETED|First Intervention (4 Weeks)||27||
59802437|NCT03865953|75923690|FG000|NOT COMPLETED|First Intervention (4 Weeks)||2||
59802438|NCT03865953|75923691|FG001|NOT COMPLETED|First Intervention (4 Weeks)||1||
59802439|NCT03865953|75923690|FG000|STARTED|Washout/Baseline Period (3 Weeks)||23||
59802440|NCT03865953|75923691|FG001|STARTED|Washout/Baseline Period (3 Weeks)||27||
59802441|NCT03865953|75923690|FG000|COMPLETED|Washout/Baseline Period (3 Weeks)||23||
59802442|NCT03865953|75923691|FG001|COMPLETED|Washout/Baseline Period (3 Weeks)||27||
59955421|NCT04238481|76074169|FG001|NOT COMPLETED|Overall Study||1||
59802443|NCT03865953|75923690|FG000|NOT COMPLETED|Washout/Baseline Period (3 Weeks)||0||
59802444|NCT03865953|75923691|FG001|NOT COMPLETED|Washout/Baseline Period (3 Weeks)||0||
59802445|NCT03865953|75923690|FG000|STARTED|Second Intervention (4 Weeks)||23||
59802446|NCT03865953|75923691|FG001|STARTED|Second Intervention (4 Weeks)||27||
59802447|NCT03865953|75923690|FG000|COMPLETED|Second Intervention (4 Weeks)||23||
59802448|NCT03865953|75923691|FG001|COMPLETED|Second Intervention (4 Weeks)||25||
59802449|NCT03865953|75923690|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0||
59802450|NCT03865953|75923691|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||2||
59802451|NCT05439941|75923700|FG000|STARTED|Overall Study||104||
59955422|NCT04238481|76074170|FG002|NOT COMPLETED|Overall Study||0||
59955423|NCT04238481|76074171|FG003|NOT COMPLETED|Overall Study||0||
59955424|NCT04145700|76074183|FG000|STARTED|Overall Study||16||
59802452|NCT05439941|75923701|FG001|STARTED|Overall Study||102||
59802453|NCT05439941|75923702|FG002|STARTED|Overall Study||79||
59802454|NCT05439941|75923700|FG000|COMPLETED|Overall Study||0||
59802455|NCT05439941|75923701|FG001|COMPLETED|Overall Study||0||
59802456|NCT05439941|75923702|FG002|COMPLETED|Overall Study||0||
59802457|NCT05439941|75923700|FG000|NOT COMPLETED|Overall Study||104||
59802458|NCT05439941|75923701|FG001|NOT COMPLETED|Overall Study||102||
59802459|NCT05439941|75923702|FG002|NOT COMPLETED|Overall Study||79||
59802460|NCT05091918|75923710|FG000|STARTED|Overall Study||101||
59802461|NCT05091918|75923710|FG000|COMPLETED|Overall Study||19||
59802462|NCT05091918|75923710|FG000|NOT COMPLETED|Overall Study||82||
59802463|NCT04912895|75923717|FG000|STARTED|Overall Study||51||
59802464|NCT04912895|75923718|FG001|STARTED|Overall Study||0||
59802465|NCT04912895|75923719|FG002|STARTED|Overall Study||18||
59802466|NCT04912895|75923717|FG000|COMPLETED|Overall Study||49||
59802467|NCT04912895|75923718|FG001|COMPLETED|Overall Study||0||
59802468|NCT04912895|75923719|FG002|COMPLETED|Overall Study||18||
59802469|NCT04912895|75923717|FG000|NOT COMPLETED|Overall Study||2||
59802470|NCT04912895|75923718|FG001|NOT COMPLETED|Overall Study||0||
59802471|NCT04912895|75923719|FG002|NOT COMPLETED|Overall Study||0||
59802472|NCT04776720|75923727|FG000|STARTED|Overall Study||121||
59802473|NCT04776720|75923728|FG001|STARTED|Overall Study||119||
59802474|NCT04776720|75923727|FG000|COMPLETED|Overall Study||101||
59802475|NCT04776720|75923728|FG001|COMPLETED|Overall Study||109||
59802476|NCT04776720|75923727|FG000|NOT COMPLETED|Overall Study||20||
59802477|NCT04776720|75923728|FG001|NOT COMPLETED|Overall Study||10||
59802478|NCT04694482|75923736|FG000|STARTED|Overall Study||200||
59955425|NCT04145700|76074184|FG001|STARTED|Overall Study||7||
59955426|NCT04145700|76074183|FG000|Received at Least One Dose of Study Drug|Overall Study||16||
59955427|NCT04145700|76074184|FG001|Received at Least One Dose of Study Drug|Overall Study||6||
59955428|NCT04145700|76074183|FG000|COMPLETED|Overall Study||8||
59955429|NCT04145700|76074184|FG001|COMPLETED|Overall Study||4||
59955430|NCT04145700|76074183|FG000|NOT COMPLETED|Overall Study||8||
59955431|NCT04145700|76074184|FG001|NOT COMPLETED|Overall Study||3||
59955432|NCT04079738|76074190|FG000|STARTED|Study Treatment||8||
59955433|NCT04079738|76074191|FG001|STARTED|Study Treatment||0||
59955434|NCT04079738|76074192|FG002|STARTED|Study Treatment||0||
59955435|NCT04079738|76074193|FG003|STARTED|Study Treatment||0||
59955436|NCT04079738|76074190|FG000|COMPLETED|Study Treatment||0||
59955437|NCT04079738|76074191|FG001|COMPLETED|Study Treatment||0||
59955438|NCT04079738|76074192|FG002|COMPLETED|Study Treatment||0||
59955439|NCT04079738|76074193|FG003|COMPLETED|Study Treatment||0||
59955440|NCT04079738|76074190|FG000|NOT COMPLETED|Study Treatment||8||
59955441|NCT04079738|76074191|FG001|NOT COMPLETED|Study Treatment||0||
59955442|NCT04079738|76074192|FG002|NOT COMPLETED|Study Treatment||0||
59955443|NCT04079738|76074193|FG003|NOT COMPLETED|Study Treatment||0||
59955444|NCT04079738|76074190|FG000|STARTED|Follow up||8||
59802479|NCT04694482|75923737|FG001|STARTED|Overall Study||70||
59802480|NCT04694482|75923736|FG000|COMPLETED|Overall Study||166||
59802481|NCT04694482|75923737|FG001|COMPLETED|Overall Study||57||
59802482|NCT04694482|75923736|FG000|NOT COMPLETED|Overall Study||34||
59802483|NCT04694482|75923737|FG001|NOT COMPLETED|Overall Study||13||
59802484|NCT04675151|75923747|FG000|STARTED|Overall Study||44||
59955445|NCT04079738|76074191|FG001|STARTED|Follow up||0||
59955446|NCT04079738|76074192|FG002|STARTED|Follow up||0||
59955447|NCT04079738|76074193|FG003|STARTED|Follow up||0||
59955448|NCT04079738|76074190|FG000|COMPLETED|Follow up||0||
59955449|NCT04079738|76074191|FG001|COMPLETED|Follow up||0||
59955450|NCT04079738|76074192|FG002|COMPLETED|Follow up||0||
59802485|NCT04675151|75923748|FG001|STARTED|Overall Study||30||
59802486|NCT04675151|75923749|FG002|STARTED|Overall Study||31||
59802487|NCT04675151|75923750|FG003|STARTED|Overall Study||45||
59802488|NCT04675151|75923747|FG000|COMPLETED|Overall Study||43||
59802489|NCT04675151|75923748|FG001|COMPLETED|Overall Study||30||
59802490|NCT04675151|75923749|FG002|COMPLETED|Overall Study||31||
59802491|NCT04675151|75923750|FG003|COMPLETED|Overall Study||44||
59802492|NCT04675151|75923747|FG000|NOT COMPLETED|Overall Study||1||
59802493|NCT04675151|75923748|FG001|NOT COMPLETED|Overall Study||0||
59802494|NCT04675151|75923749|FG002|NOT COMPLETED|Overall Study||0||
59802495|NCT04675151|75923750|FG003|NOT COMPLETED|Overall Study||1||
59802496|NCT04599907|75923763|FG000|STARTED|Overall Study|All outcomes were assessed by participant, both axilla were given the same treatment and the overall result for the patient was evaluated to determine safety and efficacy.|10||
59802497|NCT04599907|75923764|FG001|STARTED|Overall Study|All outcomes were assessed by participant, both axilla were given the same treatment and the overall result for the patient was evaluated to determine safety and efficacy.|53||
59817869|NCT04488770|75940334|FG008|NOT COMPLETED|Part 1-Cohort 1: Period 4 (Up to 5 Days)||0||
59955451|NCT04079738|76074193|FG003|COMPLETED|Follow up||0||
59955452|NCT04079738|76074190|FG000|NOT COMPLETED|Follow up||8||
59955453|NCT04079738|76074191|FG001|NOT COMPLETED|Follow up||0||
59955454|NCT04079738|76074192|FG002|NOT COMPLETED|Follow up||0||
59955455|NCT04079738|76074193|FG003|NOT COMPLETED|Follow up||0||
59955456|NCT04054635|76074202|FG000|STARTED|First Visit (Baseline)||28||
59955457|NCT04054635|76074203|FG001|STARTED|First Visit (Baseline)||28||
59802498|NCT04599907|75923765|FG002|STARTED|Overall Study|All outcomes were assessed by participant, both axilla were given the same treatment and the overall result for the patient was evaluated to determine safety and efficacy.|57||
59802499|NCT04599907|75923763|FG000|COMPLETED|Overall Study||9||
59802500|NCT04599907|75923764|FG001|COMPLETED|Overall Study||45||
59802501|NCT04599907|75923765|FG002|COMPLETED|Overall Study||51||
59802502|NCT04599907|75923763|FG000|NOT COMPLETED|Overall Study||1||
59802503|NCT04599907|75923764|FG001|NOT COMPLETED|Overall Study||8||
59802504|NCT04599907|75923765|FG002|NOT COMPLETED|Overall Study||6||
59802505|NCT04596293|75923775|FG000|STARTED|Induction Phase Week 0-8||11||
59802506|NCT04596293|75923776|FG001|STARTED|Induction Phase Week 0-8||11||
59802507|NCT04596293|75923777|FG002|STARTED|Induction Phase Week 0-8||11||
59802508|NCT04596293|75923775|FG000|Safety Population|Induction Phase Week 0-8||13||
59802509|NCT04596293|75923776|FG001|Safety Population|Induction Phase Week 0-8||12||
59802510|NCT04596293|75923777|FG002|Safety Population|Induction Phase Week 0-8||13||
59802511|NCT04596293|75923775|FG000|COMPLETED|Induction Phase Week 0-8||11||
59802512|NCT04596293|75923776|FG001|COMPLETED|Induction Phase Week 0-8||11||
59802513|NCT04596293|75923777|FG002|COMPLETED|Induction Phase Week 0-8||10||
59802514|NCT04596293|75923775|FG000|NOT COMPLETED|Induction Phase Week 0-8||0||
59802515|NCT04596293|75923776|FG001|NOT COMPLETED|Induction Phase Week 0-8||0||
59802516|NCT04596293|75923777|FG002|NOT COMPLETED|Induction Phase Week 0-8||1||
59802517|NCT04596293|75923775|FG000|STARTED|Extension Phase Week 8-16||11|One subject completed induction phase of BBT-401-1S 1600mg did not participated in extension phase.|
59802518|NCT04596293|75923776|FG001|STARTED|Extension Phase Week 8-16||11|One subject completed induction phase of BBT-401-1S 1600mg did not participated in extension phase.|
59955458|NCT04054635|76074204|FG002|STARTED|First Visit (Baseline)||28||
59955459|NCT04054635|76074202|FG000|COMPLETED|First Visit (Baseline)||28||
59955460|NCT04054635|76074203|FG001|COMPLETED|First Visit (Baseline)||28||
59955461|NCT04054635|76074204|FG002|COMPLETED|First Visit (Baseline)||28||
59955462|NCT04054635|76074202|FG000|NOT COMPLETED|First Visit (Baseline)||0||
59955463|NCT04054635|76074203|FG001|NOT COMPLETED|First Visit (Baseline)||0||
59955464|NCT04054635|76074204|FG002|NOT COMPLETED|First Visit (Baseline)||0||
59955465|NCT04054635|76074202|FG000|STARTED|Second Visit (First Follow-up)||28||
59802519|NCT04596293|75923777|FG002|STARTED|Extension Phase Week 8-16||9|One subject completed induction phase of BBT-401-1S 1600mg did not participated in extension phase.|
59802520|NCT04596293|75923775|FG000|Safety Population|Extension Phase Week 8-16||6||
59802521|NCT04596293|75923776|FG001|Safety Population|Extension Phase Week 8-16||8||
59802522|NCT04596293|75923777|FG002|Safety Population|Extension Phase Week 8-16||17||
59802523|NCT04596293|75923775|FG000|COMPLETED|Extension Phase Week 8-16||11||
59802524|NCT04596293|75923776|FG001|COMPLETED|Extension Phase Week 8-16||10||
59955466|NCT04054635|76074203|FG001|STARTED|Second Visit (First Follow-up)||28||
59955467|NCT04054635|76074204|FG002|STARTED|Second Visit (First Follow-up)||28||
59955468|NCT04054635|76074202|FG000|COMPLETED|Second Visit (First Follow-up)||28||
59955469|NCT04054635|76074203|FG001|COMPLETED|Second Visit (First Follow-up)|Participants lost to follow-up were still in the study as a part of intention-to-treat analysis, where those lost to follow-up were still included (i.e., still 28 participants in regimen 2), and we acted as though there were no changes to the lesions of these participants at subsequent (missed) visits. This approach was chosen since it preserves randomization and was the best neutral response for the unknown status of lesions.|27||
59955470|NCT04054635|76074204|FG002|COMPLETED|Second Visit (First Follow-up)||28||
59955471|NCT04054635|76074202|FG000|NOT COMPLETED|Second Visit (First Follow-up)||0||
59802525|NCT04596293|75923777|FG002|COMPLETED|Extension Phase Week 8-16||8||
59802526|NCT04596293|75923775|FG000|NOT COMPLETED|Extension Phase Week 8-16||0||
59802527|NCT04596293|75923776|FG001|NOT COMPLETED|Extension Phase Week 8-16||1||
59802528|NCT04596293|75923777|FG002|NOT COMPLETED|Extension Phase Week 8-16||1||
59802529|NCT04503096|75923788|FG000|STARTED|Overall Study||24||
59955472|NCT04054635|76074203|FG001|NOT COMPLETED|Second Visit (First Follow-up)||1||
59955473|NCT04054635|76074204|FG002|NOT COMPLETED|Second Visit (First Follow-up)||0||
59955474|NCT04054635|76074202|FG000|STARTED|Third Visit (Second Follow-up)||28||
59802530|NCT04503096|75923788|FG000|COMPLETED|Overall Study||21||
59955475|NCT04054635|76074203|FG001|STARTED|Third Visit (Second Follow-up)||27||
59955476|NCT04054635|76074204|FG002|STARTED|Third Visit (Second Follow-up)||28||
59994920|NCT03420781|76110740|FG002|COMPLETED|Treatment Period (40 Weeks)||0|Out of 197 participants who completed the Treatment Period, 193 entered the RW Period.|
59994921|NCT03420781|76110741|FG003|COMPLETED|Treatment Period (40 Weeks)||0|Out of 197 participants who completed the Treatment Period, 193 entered the RW Period.|
59995269|NCT04263987|76111096|FG001|STARTED|Overall Study||30||
59995270|NCT04263987|76111095|FG000|COMPLETED|Overall Study||30||
59802531|NCT04503096|75923788|FG000|NOT COMPLETED|Overall Study||3||
59802532|NCT04270760|75923797|FG000|STARTED|Overall Study||58||
59802533|NCT04270760|75923798|FG001|STARTED|Overall Study||58||
59802534|NCT04270760|75923799|FG002|STARTED|Overall Study||56||
59802535|NCT04270760|75923800|FG003|STARTED|Overall Study||55||
59802536|NCT04270760|75923801|FG004|STARTED|Overall Study||54||
59802537|NCT04270760|75923797|FG000|Entered Extended Safety Follow-up Period|Overall Study||57||
59802538|NCT04270760|75923798|FG001|Entered Extended Safety Follow-up Period|Overall Study||57||
59802539|NCT04270760|75923799|FG002|Entered Extended Safety Follow-up Period|Overall Study||54||
59802540|NCT04270760|75923800|FG003|Entered Extended Safety Follow-up Period|Overall Study||55||
59955477|NCT04054635|76074202|FG000|COMPLETED|Third Visit (Second Follow-up)|Participants lost to follow-up were still in the study as a part of intention-to-treat analysis, where those lost to follow-up were still included (i.e., still 28 participants in regimen 1), and we acted as though there were no changes to the lesions of these participants at subsequent (missed) visits. This approach was chosen since it preserves randomization and was the best neutral response for the unknown status of lesions.|27||
59955478|NCT04054635|76074203|FG001|COMPLETED|Third Visit (Second Follow-up)||27||
59955479|NCT04054635|76074204|FG002|COMPLETED|Third Visit (Second Follow-up)||28||
59955480|NCT04054635|76074202|FG000|NOT COMPLETED|Third Visit (Second Follow-up)||1||
59955481|NCT04054635|76074203|FG001|NOT COMPLETED|Third Visit (Second Follow-up)||0||
59955482|NCT04054635|76074204|FG002|NOT COMPLETED|Third Visit (Second Follow-up)||0||
59955483|NCT03820726|76074212|FG000|STARTED|Overall Study||435||
59955484|NCT03820726|76074212|FG000|Treated|Overall Study||434||
59955485|NCT03820726|76074212|FG000|COMPLETED|Overall Study||224|Completed planned treatment period|
59955486|NCT03820726|76074212|FG000|NOT COMPLETED|Overall Study||211||
59955487|NCT03744312|76074218|FG000|STARTED|Overall Study||6||
59955488|NCT03744312|76074219|FG001|STARTED|Overall Study||3||
59955489|NCT03744312|76074218|FG000|COMPLETED|Overall Study||6||
59955490|NCT03744312|76074219|FG001|COMPLETED|Overall Study||1||
59955491|NCT03744312|76074218|FG000|NOT COMPLETED|Overall Study||0||
59955492|NCT03744312|76074219|FG001|NOT COMPLETED|Overall Study||2||
59955493|NCT03737123|76074227|FG000|STARTED|Study Treatment||6||
59955494|NCT03737123|76074228|FG001|STARTED|Study Treatment||0||
59955495|NCT03737123|76074227|FG000|COMPLETED|Study Treatment||0||
59955496|NCT03737123|76074228|FG001|COMPLETED|Study Treatment||0||
59955497|NCT03737123|76074227|FG000|NOT COMPLETED|Study Treatment||6||
59955498|NCT03737123|76074228|FG001|NOT COMPLETED|Study Treatment||0||
59955499|NCT03737123|76074227|FG000|STARTED|Follow up||6|Treatment and Follow up both are at different time period. Therefore, the number of subjects to start follow up is not equal to the number of subjects who have completed treatment.|
59955500|NCT03737123|76074228|FG001|STARTED|Follow up||0|Treatment and Follow up both are at different time period. Therefore, the number of subjects to start follow up is not equal to the number of subjects who have completed treatment.|
59955501|NCT03737123|76074227|FG000|COMPLETED|Follow up||0||
59955502|NCT03737123|76074228|FG001|COMPLETED|Follow up||0||
59955503|NCT03737123|76074227|FG000|NOT COMPLETED|Follow up||6||
59955504|NCT03737123|76074228|FG001|NOT COMPLETED|Follow up||0||
59955505|NCT03502707|76074251|FG000|STARTED|Overall Study||16||
59955506|NCT03502707|76074252|FG001|STARTED|Overall Study||8||
59955507|NCT03502707|76074253|FG002|STARTED|Overall Study||8||
59955508|NCT03502707|76074254|FG003|STARTED|Overall Study||8||
59955509|NCT03502707|76074255|FG004|STARTED|Overall Study||8||
59955510|NCT03502707|76074256|FG005|STARTED|Overall Study||8||
59955511|NCT03502707|76074257|FG006|STARTED|Overall Study||8||
59955512|NCT03502707|76074258|FG007|STARTED|Overall Study||24||
59955513|NCT03502707|76074259|FG008|STARTED|Overall Study||42||
59955514|NCT03502707|76074260|FG009|STARTED|Overall Study||42||
59955515|NCT03502707|76074261|FG010|STARTED|Overall Study||42||
59955516|NCT03502707|76074262|FG011|STARTED|Overall Study||43||
59955517|NCT03502707|76074263|FG012|STARTED|Overall Study||36||
59955518|NCT03502707|76074264|FG013|STARTED|Overall Study||36||
59955519|NCT03502707|76074265|FG014|STARTED|Overall Study||24||
59955520|NCT03502707|76074266|FG015|STARTED|Overall Study||135||
59955521|NCT03502707|76074267|FG016|STARTED|Overall Study||136||
59955522|NCT03502707|76074268|FG017|STARTED|Overall Study||45||
59955523|NCT03502707|76074251|FG000|Randomized and Vaccinated (Full Analysis Set)|Overall Study||16||
59955524|NCT03502707|76074252|FG001|Randomized and Vaccinated (Full Analysis Set)|Overall Study||8||
59955525|NCT03502707|76074253|FG002|Randomized and Vaccinated (Full Analysis Set)|Overall Study||8||
59955526|NCT03502707|76074254|FG003|Randomized and Vaccinated (Full Analysis Set)|Overall Study||8||
59955527|NCT03502707|76074255|FG004|Randomized and Vaccinated (Full Analysis Set)|Overall Study||8||
59955528|NCT03502707|76074256|FG005|Randomized and Vaccinated (Full Analysis Set)|Overall Study||8||
59955529|NCT03502707|76074257|FG006|Randomized and Vaccinated (Full Analysis Set)|Overall Study||8||
59955530|NCT03502707|76074258|FG007|Randomized and Vaccinated (Full Analysis Set)|Overall Study||24||
59955531|NCT03502707|76074259|FG008|Randomized and Vaccinated (Full Analysis Set)|Overall Study||42||
59955532|NCT03502707|76074260|FG009|Randomized and Vaccinated (Full Analysis Set)|Overall Study||42||
59955533|NCT03502707|76074261|FG010|Randomized and Vaccinated (Full Analysis Set)|Overall Study||42||
59955534|NCT03502707|76074262|FG011|Randomized and Vaccinated (Full Analysis Set)|Overall Study||42||
59955535|NCT03502707|76074263|FG012|Randomized and Vaccinated (Full Analysis Set)|Overall Study||36||
59955536|NCT03502707|76074264|FG013|Randomized and Vaccinated (Full Analysis Set)|Overall Study||36||
59955537|NCT03502707|76074265|FG014|Randomized and Vaccinated (Full Analysis Set)|Overall Study||24||
59955538|NCT03502707|76074266|FG015|Randomized and Vaccinated (Full Analysis Set)|Overall Study||135||
59955539|NCT03502707|76074267|FG016|Randomized and Vaccinated (Full Analysis Set)|Overall Study||136||
59955540|NCT03502707|76074268|FG017|Randomized and Vaccinated (Full Analysis Set)|Overall Study||44||
59955541|NCT03502707|76074251|FG000|COMPLETED|Overall Study||14||
59955542|NCT03502707|76074252|FG001|COMPLETED|Overall Study||7||
59955543|NCT03502707|76074253|FG002|COMPLETED|Overall Study||8||
59955544|NCT03502707|76074254|FG003|COMPLETED|Overall Study||7||
59955545|NCT03502707|76074255|FG004|COMPLETED|Overall Study||8||
59955546|NCT03502707|76074256|FG005|COMPLETED|Overall Study||6||
59955547|NCT03502707|76074257|FG006|COMPLETED|Overall Study||8||
59955548|NCT03502707|76074258|FG007|COMPLETED|Overall Study||16||
59955549|NCT03502707|76074259|FG008|COMPLETED|Overall Study||37||
59955550|NCT03502707|76074260|FG009|COMPLETED|Overall Study||34||
59955551|NCT03502707|76074261|FG010|COMPLETED|Overall Study||27||
59802541|NCT04270760|75923801|FG004|Entered Extended Safety Follow-up Period|Overall Study||53||
59802542|NCT04270760|75923797|FG000|COMPLETED|Overall Study||57||
59802543|NCT04270760|75923798|FG001|COMPLETED|Overall Study||55||
59802544|NCT04270760|75923799|FG002|COMPLETED|Overall Study||52||
59802545|NCT04270760|75923800|FG003|COMPLETED|Overall Study||55||
59802546|NCT04270760|75923801|FG004|COMPLETED|Overall Study||53||
59955552|NCT03502707|76074262|FG011|COMPLETED|Overall Study||17||
59955553|NCT03502707|76074263|FG012|COMPLETED|Overall Study||29||
59955554|NCT03502707|76074264|FG013|COMPLETED|Overall Study||32||
59955555|NCT03502707|76074265|FG014|COMPLETED|Overall Study||20||
59955556|NCT03502707|76074266|FG015|COMPLETED|Overall Study||76||
59955557|NCT03502707|76074267|FG016|COMPLETED|Overall Study||75||
59955558|NCT03502707|76074268|FG017|COMPLETED|Overall Study||24||
59955559|NCT03502707|76074251|FG000|NOT COMPLETED|Overall Study||2||
59955560|NCT03502707|76074252|FG001|NOT COMPLETED|Overall Study||1||
59955561|NCT03502707|76074253|FG002|NOT COMPLETED|Overall Study||0||
59955562|NCT03502707|76074254|FG003|NOT COMPLETED|Overall Study||1||
59955563|NCT03502707|76074255|FG004|NOT COMPLETED|Overall Study||0||
59955564|NCT03502707|76074256|FG005|NOT COMPLETED|Overall Study||2||
59955565|NCT03502707|76074257|FG006|NOT COMPLETED|Overall Study||0||
59955566|NCT03502707|76074258|FG007|NOT COMPLETED|Overall Study||8||
59955567|NCT03502707|76074259|FG008|NOT COMPLETED|Overall Study||5||
59802547|NCT04270760|75923797|FG000|NOT COMPLETED|Overall Study||1||
59802548|NCT04270760|75923798|FG001|NOT COMPLETED|Overall Study||3||
59802549|NCT04270760|75923799|FG002|NOT COMPLETED|Overall Study||4||
59802550|NCT04270760|75923800|FG003|NOT COMPLETED|Overall Study||0||
59802551|NCT04270760|75923801|FG004|NOT COMPLETED|Overall Study||1||
59802552|NCT04198363|75923820|FG000|STARTED|Overall Study||256||
59802553|NCT04198363|75923821|FG001|STARTED|Overall Study||254||
59802554|NCT04198363|75923820|FG000|COMPLETED|Overall Study||254||
59802555|NCT04198363|75923821|FG001|COMPLETED|Overall Study||252||
59802556|NCT04198363|75923820|FG000|NOT COMPLETED|Overall Study||2||
59802557|NCT04198363|75923821|FG001|NOT COMPLETED|Overall Study||2||
59802558|NCT04173247|75923829|FG000|STARTED|Overall Study||14||
59802559|NCT04173247|75923830|FG001|STARTED|Overall Study||14||
59802560|NCT04173247|75923829|FG000|COMPLETED|Overall Study||12||
59802561|NCT04173247|75923830|FG001|COMPLETED|Overall Study||12||
59802562|NCT04173247|75923829|FG000|NOT COMPLETED|Overall Study||2||
59802563|NCT04173247|75923830|FG001|NOT COMPLETED|Overall Study||2||
59802564|NCT04089917|75923836|FG000|STARTED|Overall Study||45||
59802565|NCT04089917|75923836|FG000|COMPLETED|Overall Study||45||
59802566|NCT04089917|75923836|FG000|NOT COMPLETED|Overall Study||0||
59802567|NCT03943446|75923843|FG000|STARTED|Overall Study||12||
59802568|NCT03943446|75923844|FG001|STARTED|Overall Study||11||
59802569|NCT03943446|75923845|FG002|STARTED|Overall Study||11||
59802570|NCT03943446|75923843|FG000|Pharmacokinetic (PK) Analysis Set|Overall Study||12|PK analysis set included participants from the safety analysis set with at least 1 reported PK concentration.|
59802571|NCT03943446|75923844|FG001|Pharmacokinetic (PK) Analysis Set|Overall Study||11|PK analysis set included participants from the safety analysis set with at least 1 reported PK concentration.|
59802572|NCT03943446|75923845|FG002|Pharmacokinetic (PK) Analysis Set|Overall Study||11|PK analysis set included participants from the safety analysis set with at least 1 reported PK concentration.|
59802573|NCT03943446|75923843|FG000|COMPLETED|Overall Study||5||
59802574|NCT03943446|75923844|FG001|COMPLETED|Overall Study||7||
59802575|NCT03943446|75923845|FG002|COMPLETED|Overall Study||4||
59802576|NCT03943446|75923843|FG000|NOT COMPLETED|Overall Study||7||
59802577|NCT03943446|75923844|FG001|NOT COMPLETED|Overall Study||4||
59802578|NCT03943446|75923845|FG002|NOT COMPLETED|Overall Study||7||
59802579|NCT03880838|75923869|FG000|STARTED|Overall Study||2434||
59802580|NCT03880838|75923870|FG001|STARTED|Overall Study||2200||
59802581|NCT03880838|75923871|FG002|STARTED|Overall Study||550||
59802582|NCT03880838|75923872|FG003|STARTED|Overall Study||550||
59802583|NCT03880838|75923873|FG004|STARTED|Overall Study||550||
59955568|NCT03502707|76074260|FG009|NOT COMPLETED|Overall Study||8||
59955569|NCT03502707|76074261|FG010|NOT COMPLETED|Overall Study||15||
59955570|NCT03502707|76074262|FG011|NOT COMPLETED|Overall Study||26||
59955571|NCT03502707|76074263|FG012|NOT COMPLETED|Overall Study||7||
59955572|NCT03502707|76074264|FG013|NOT COMPLETED|Overall Study||4||
59955573|NCT03502707|76074265|FG014|NOT COMPLETED|Overall Study||4||
59955574|NCT03502707|76074266|FG015|NOT COMPLETED|Overall Study||59||
59802584|NCT03880838|75923874|FG005|STARTED|Overall Study||550||
59802585|NCT03880838|75923875|FG006|STARTED|Overall Study||550||
59802586|NCT03880838|75923876|FG007|STARTED|Overall Study||550||
59955575|NCT03502707|76074267|FG016|NOT COMPLETED|Overall Study||61||
59955576|NCT03502707|76074268|FG017|NOT COMPLETED|Overall Study||21||
59955577|NCT03425006|76074318|FG000|STARTED|Overall Study||23||
59955578|NCT03425006|76074318|FG000|COMPLETED|Overall Study||20||
59802587|NCT03880838|75923877|FG008|STARTED|Overall Study||550||
59802588|NCT03880838|75923878|FG009|STARTED|Overall Study||550||
59802589|NCT03880838|75923879|FG010|STARTED|Overall Study||550||
59955579|NCT03425006|76074318|FG000|NOT COMPLETED|Overall Study||3||
59955580|NCT03401073|76074324|FG000|STARTED|Overall Study||10||
59955581|NCT03401073|76074325|FG001|STARTED|Overall Study||10||
59955582|NCT03401073|76074324|FG000|COMPLETED|Overall Study||9||
59955583|NCT03401073|76074325|FG001|COMPLETED|Overall Study||8||
59955584|NCT03401073|76074324|FG000|NOT COMPLETED|Overall Study||1||
59955585|NCT03401073|76074325|FG001|NOT COMPLETED|Overall Study||2||
59955586|NCT03285581|76074331|FG000|STARTED|Overall Study||39||
59955587|NCT03285581|76074331|FG000|COMPLETED|Overall Study||25||
59955588|NCT03285581|76074331|FG000|NOT COMPLETED|Overall Study||14||
59955589|NCT03173560|76074337|FG000|STARTED|Overall Study||172||
59955590|NCT03173560|76074338|FG001|STARTED|Overall Study||171||
59802590|NCT03880838|75923880|FG011|STARTED|Overall Study||550||
59802591|NCT03880838|75923881|FG012|STARTED|Overall Study||550||
59802592|NCT03880838|75923882|FG013|STARTED|Overall Study||550||
59802593|NCT03880838|75923869|FG000|COMPLETED|Overall Study||2434||
59802594|NCT03880838|75923870|FG001|COMPLETED|Overall Study||2200||
59802595|NCT03880838|75923871|FG002|COMPLETED|Overall Study||550||
59802596|NCT03880838|75923872|FG003|COMPLETED|Overall Study||550||
59802597|NCT03880838|75923873|FG004|COMPLETED|Overall Study||550||
59802598|NCT03880838|75923874|FG005|COMPLETED|Overall Study||550||
59955591|NCT03173560|76074337|FG000|Treated Participants|Overall Study||172||
59955592|NCT03173560|76074338|FG001|Treated Participants|Overall Study||169||
59955593|NCT03173560|76074337|FG000|Safety Set|Overall Study||173|One participant was randomized to lenvatinib 18 mg arm but received lenvatinib 14 mg as the starting dose and therefore was included in lenvatinib 14 mg arm in safety population.|
59955594|NCT03173560|76074338|FG001|Safety Set|Overall Study||168|One participant was randomized to lenvatinib 18 mg arm but received lenvatinib 14 mg as the starting dose and therefore was included in lenvatinib 14 mg arm in safety population.|
59955595|NCT03173560|76074337|FG000|COMPLETED|Overall Study||67||
59955596|NCT03173560|76074338|FG001|COMPLETED|Overall Study||54||
59802599|NCT03880838|75923875|FG006|COMPLETED|Overall Study||550||
59802600|NCT03880838|75923876|FG007|COMPLETED|Overall Study||550||
59802601|NCT03880838|75923877|FG008|COMPLETED|Overall Study||550||
59802602|NCT03880838|75923878|FG009|COMPLETED|Overall Study||550||
59802603|NCT03880838|75923879|FG010|COMPLETED|Overall Study||550||
59802604|NCT03880838|75923880|FG011|COMPLETED|Overall Study||550||
59955597|NCT03173560|76074337|FG000|NOT COMPLETED|Overall Study||105||
59955598|NCT03173560|76074338|FG001|NOT COMPLETED|Overall Study||117||
59955599|NCT03120325|76074347|FG000|STARTED|Overall Study||17||
59955600|NCT03120325|76074348|FG001|STARTED|Overall Study||1||
59955601|NCT03120325|76074349|FG002|STARTED|Overall Study||6||
59955602|NCT03120325|76074347|FG000|Used Device (Received Treatment)|Overall Study||15||
59955603|NCT03120325|76074348|FG001|Used Device (Received Treatment)|Overall Study||1||
59955604|NCT03120325|76074349|FG002|Used Device (Received Treatment)|Overall Study||5||
59955605|NCT03120325|76074347|FG000|COMPLETED|Overall Study||15||
59955606|NCT03120325|76074348|FG001|COMPLETED|Overall Study||1||
59955607|NCT03120325|76074349|FG002|COMPLETED|Overall Study||5||
59955608|NCT03120325|76074347|FG000|NOT COMPLETED|Overall Study||2||
59955609|NCT03120325|76074348|FG001|NOT COMPLETED|Overall Study||0||
59955610|NCT03120325|76074349|FG002|NOT COMPLETED|Overall Study||1||
59955611|NCT02915263|76074359|FG000|STARTED|Overall Study||6||
59955612|NCT02915263|76074360|FG001|STARTED|Overall Study||7||
59955613|NCT02915263|76074359|FG000|COMPLETED|Overall Study||3||
59955614|NCT02915263|76074360|FG001|COMPLETED|Overall Study||5||
59955615|NCT02915263|76074359|FG000|NOT COMPLETED|Overall Study||3||
59955616|NCT02915263|76074360|FG001|NOT COMPLETED|Overall Study||2||
59955617|NCT02343952|76074366|FG000|STARTED|Study Treatment||93||
59802605|NCT03880838|75923881|FG012|COMPLETED|Overall Study||550||
59802606|NCT03880838|75923882|FG013|COMPLETED|Overall Study||550||
59802607|NCT03880838|75923869|FG000|NOT COMPLETED|Overall Study||0||
59955618|NCT02343952|76074366|FG000|COMPLETED|Study Treatment||40||
60073814|NCT01612676|76189158|FG003|STARTED|Overall Study||13||
59955619|NCT02343952|76074366|FG000|NOT COMPLETED|Study Treatment||53||
59955620|NCT02343952|76074366|FG000|STARTED|Follow up||83||
59955621|NCT02343952|76074366|FG000|COMPLETED|Follow up||38||
59955622|NCT02343952|76074366|FG000|NOT COMPLETED|Follow up||45||
59955623|NCT01592370|76074377|FG000|STARTED|Overall Study||105|= Number of participants Treated|
59955624|NCT01592370|76074378|FG001|STARTED|Overall Study||65|= Number of participants Treated|
59955625|NCT01592370|76074379|FG002|STARTED|Overall Study||72|= Number of participants Treated|
59955626|NCT01592370|76074380|FG003|STARTED|Overall Study||6|= Number of participants Treated|
60073815|NCT01612676|76189155|FG000|Dosed|Overall Study||5||
59802608|NCT03880838|75923870|FG001|NOT COMPLETED|Overall Study||0||
59955627|NCT01592370|76074381|FG004|STARTED|Overall Study||5|= Number of participants Treated|
59955628|NCT01592370|76074382|FG005|STARTED|Overall Study||41|= Number of participants Treated|
60073816|NCT01612676|76189156|FG001|Dosed|Overall Study||7||
60073817|NCT01612676|76189157|FG002|Dosed|Overall Study||5||
60073818|NCT01612676|76189158|FG003|Dosed|Overall Study||13||
60073819|NCT01612676|76189155|FG000|COMPLETED|Overall Study||4||
59802609|NCT03880838|75923871|FG002|NOT COMPLETED|Overall Study||0||
59802610|NCT03880838|75923872|FG003|NOT COMPLETED|Overall Study||0||
59802611|NCT03880838|75923873|FG004|NOT COMPLETED|Overall Study||0||
59802612|NCT03880838|75923874|FG005|NOT COMPLETED|Overall Study||0||
59802613|NCT03880838|75923875|FG006|NOT COMPLETED|Overall Study||0||
59802614|NCT03880838|75923876|FG007|NOT COMPLETED|Overall Study||0||
59802615|NCT03880838|75923877|FG008|NOT COMPLETED|Overall Study||0||
59955629|NCT01592370|76074383|FG006|STARTED|Overall Study||22|= Number of participants Treated|
59955630|NCT01592370|76074377|FG000|COMPLETED|Overall Study||1||
59955631|NCT01592370|76074378|FG001|COMPLETED|Overall Study||40||
59955632|NCT01592370|76074379|FG002|COMPLETED|Overall Study||0||
59955633|NCT01592370|76074380|FG003|COMPLETED|Overall Study||1||
59955634|NCT01592370|76074381|FG004|COMPLETED|Overall Study||1||
59955635|NCT01592370|76074382|FG005|COMPLETED|Overall Study||7||
59955636|NCT01592370|76074383|FG006|COMPLETED|Overall Study||6||
59955637|NCT01592370|76074377|FG000|NOT COMPLETED|Overall Study||104||
59955638|NCT01592370|76074378|FG001|NOT COMPLETED|Overall Study||25||
59955639|NCT01592370|76074379|FG002|NOT COMPLETED|Overall Study||72||
59955640|NCT01592370|76074380|FG003|NOT COMPLETED|Overall Study||5||
59955641|NCT01592370|76074381|FG004|NOT COMPLETED|Overall Study||4||
59955642|NCT01592370|76074382|FG005|NOT COMPLETED|Overall Study||34||
59955643|NCT01592370|76074383|FG006|NOT COMPLETED|Overall Study||16||
59955644|NCT01093183|76074403|FG000|STARTED|Overall Study||19||
59955645|NCT01093183|76074404|FG001|STARTED|Overall Study||6||
59955646|NCT01093183|76074403|FG000|COMPLETED|Overall Study||18||
59955647|NCT01093183|76074404|FG001|COMPLETED|Overall Study||4||
59955648|NCT01093183|76074403|FG000|NOT COMPLETED|Overall Study||1||
59955649|NCT01093183|76074404|FG001|NOT COMPLETED|Overall Study||2||
59955650|NCT00777036|76074411|FG000|STARTED|On Treatment||29||
59955651|NCT00777036|76074412|FG001|STARTED|On Treatment||17||
59955652|NCT00777036|76074413|FG002|STARTED|On Treatment||84||
59955653|NCT00777036|76074411|FG000|COMPLETED|On Treatment|Completed = Still on treatment|14||
59955654|NCT00777036|76074412|FG001|COMPLETED|On Treatment|Completed = Still on treatment|1||
59955655|NCT00777036|76074413|FG002|COMPLETED|On Treatment|Completed = Still on treatment|61||
59955656|NCT00777036|76074411|FG000|NOT COMPLETED|On Treatment||15||
59955657|NCT00777036|76074412|FG001|NOT COMPLETED|On Treatment||16||
59955658|NCT00777036|76074413|FG002|NOT COMPLETED|On Treatment||23||
59955659|NCT00777036|76074411|FG000|STARTED|Follow-Up|Not all participants who discontinued treatment entered the follow-up period|14||
59955660|NCT00777036|76074412|FG001|STARTED|Follow-Up|Not all participants who discontinued treatment entered the follow-up period|13||
59955661|NCT00777036|76074413|FG002|STARTED|Follow-Up|Not all participants who discontinued treatment entered the follow-up period|23||
59955662|NCT00777036|76074411|FG000|COMPLETED|Follow-Up|Completed = Still in Follow-up|9||
59955663|NCT00777036|76074412|FG001|COMPLETED|Follow-Up|Completed = Still in Follow-up|5||
59955664|NCT00777036|76074413|FG002|COMPLETED|Follow-Up|Completed = Still in Follow-up|19||
59955665|NCT00777036|76074411|FG000|NOT COMPLETED|Follow-Up||5||
59955666|NCT00777036|76074412|FG001|NOT COMPLETED|Follow-Up||8||
59955667|NCT00777036|76074413|FG002|NOT COMPLETED|Follow-Up||4||
59955668|NCT00176644|76074428|FG000|STARTED|Overall Study||23||
59955669|NCT00176644|76074428|FG000|COMPLETED|Overall Study||22||
59955670|NCT00176644|76074428|FG000|NOT COMPLETED|Overall Study||1||
59955671|NCT00106171|76074434|FG000|STARTED|Overall Study||57||
59955672|NCT00106171|76074435|FG001|STARTED|Overall Study||56||
59955673|NCT00106171|76074434|FG000|COMPLETED|Overall Study||37||
59955674|NCT00106171|76074435|FG001|COMPLETED|Overall Study||46||
59955675|NCT00106171|76074434|FG000|NOT COMPLETED|Overall Study||20||
59955676|NCT00106171|76074435|FG001|NOT COMPLETED|Overall Study||10||
59802616|NCT03880838|75923878|FG009|NOT COMPLETED|Overall Study||0||
59802617|NCT03880838|75923879|FG010|NOT COMPLETED|Overall Study||0||
59802618|NCT03880838|75923880|FG011|NOT COMPLETED|Overall Study||0||
59955677|NCT04649164|76074446|FG000|STARTED|Overall Study||19||
59955678|NCT04649164|76074447|FG001|STARTED|Overall Study||36||
59955679|NCT04649164|76074448|FG002|STARTED|Overall Study||32||
59955680|NCT04649164|76074446|FG000|COMPLETED|Overall Study||18||
59955681|NCT04649164|76074447|FG001|COMPLETED|Overall Study||35||
59955682|NCT04649164|76074448|FG002|COMPLETED|Overall Study||28||
59955683|NCT04649164|76074446|FG000|NOT COMPLETED|Overall Study||1||
59955684|NCT04649164|76074447|FG001|NOT COMPLETED|Overall Study||1||
59955685|NCT04649164|76074448|FG002|NOT COMPLETED|Overall Study||4||
59955686|NCT03325790|76074459|FG000|STARTED|Overall Study||42||
59955687|NCT03325790|76074460|FG001|STARTED|Overall Study||42||
59955688|NCT03325790|76074461|FG002|STARTED|Overall Study||42||
59955689|NCT03325790|76074459|FG000|COMPLETED|Overall Study||41||
59802619|NCT03880838|75923881|FG012|NOT COMPLETED|Overall Study||0||
59955690|NCT03325790|76074460|FG001|COMPLETED|Overall Study||41||
59955691|NCT03325790|76074461|FG002|COMPLETED|Overall Study||38||
59955692|NCT03325790|76074459|FG000|NOT COMPLETED|Overall Study||1||
59955693|NCT03325790|76074460|FG001|NOT COMPLETED|Overall Study||1||
59955694|NCT03325790|76074461|FG002|NOT COMPLETED|Overall Study||4||
59955695|NCT02186457|76074473|FG000|STARTED|Overall Study||95||
59802620|NCT03880838|75923882|FG013|NOT COMPLETED|Overall Study||0||
59802621|NCT03632993|75923922|FG000|STARTED|Overall Study|Treated in both buttocks|7||14
59802622|NCT03632993|75923923|FG001|STARTED|Overall Study|Treated in both thighs|6||12
59955696|NCT02186457|76074474|FG001|STARTED|Overall Study||95||
59955697|NCT02186457|76074473|FG000|COMPLETED|Overall Study||95||
59955698|NCT02186457|76074474|FG001|COMPLETED|Overall Study||95||
59955699|NCT02186457|76074473|FG000|NOT COMPLETED|Overall Study||0||
59955700|NCT02186457|76074474|FG001|NOT COMPLETED|Overall Study||0||
59955701|NCT04335279|76074482|FG000|STARTED|Overall Study||86||
59955702|NCT04335279|76074483|FG001|STARTED|Overall Study||86||
59955703|NCT04335279|76074482|FG000|Completed Measures Post-intervention|Overall Study||78|Completion of outcome measures post-intervention|
59955704|NCT04335279|76074483|FG001|Completed Measures Post-intervention|Overall Study||83|Completion of outcome measures post-intervention|
59955705|NCT04335279|76074482|FG000|COMPLETED|Overall Study||75|Completion of outcome measures 6-weeks post-intervention|
59955706|NCT04335279|76074483|FG001|COMPLETED|Overall Study||76|Completion of outcome measures 6-weeks post-intervention|
59955707|NCT04335279|76074482|FG000|NOT COMPLETED|Overall Study||11||
59955708|NCT04335279|76074483|FG001|NOT COMPLETED|Overall Study||10||
59955709|NCT00706004|76074489|FG000|STARTED|Overall Study||9||
59955710|NCT00706004|76074489|FG000|COMPLETED|Overall Study||7||
59955711|NCT00706004|76074489|FG000|NOT COMPLETED|Overall Study||2||
59955712|NCT02724644|76074496|FG000|STARTED|Overall Study||189||
59955713|NCT02724644|76074497|FG001|STARTED|Overall Study||186||
59955714|NCT02724644|76074496|FG000|COMPLETED|Overall Study||168||
59955715|NCT02724644|76074497|FG001|COMPLETED|Overall Study||182||
59955716|NCT02724644|76074496|FG000|NOT COMPLETED|Overall Study||21||
59955717|NCT02724644|76074497|FG001|NOT COMPLETED|Overall Study||4||
59955718|NCT02725268|76074507|FG000|STARTED|Overall Study||90||
59955719|NCT02725268|76074508|FG001|STARTED|Overall Study||90||
59955720|NCT02725268|76074509|FG002|STARTED|Overall Study||41||
59955721|NCT02725268|76074510|FG003|STARTED|Overall Study||20||
59955722|NCT02725268|76074507|FG000|Started|Overall Study||90||
59955723|NCT02725268|76074508|FG001|Started|Overall Study||90||
59955724|NCT02725268|76074509|FG002|Started|Overall Study||41||
59955725|NCT02725268|76074510|FG003|Started|Overall Study||20||
59955726|NCT02725268|76074507|FG000|Completed|Overall Study||18||
59955727|NCT02725268|76074508|FG001|Completed|Overall Study||20||
59955728|NCT02725268|76074509|FG002|Completed|Overall Study||3||
59955729|NCT02725268|76074510|FG003|Completed|Overall Study||2||
59955730|NCT02725268|76074507|FG000|COMPLETED|Overall Study||18||
59955731|NCT02725268|76074508|FG001|COMPLETED|Overall Study||20||
59955732|NCT02725268|76074509|FG002|COMPLETED|Overall Study||3||
59955733|NCT02725268|76074510|FG003|COMPLETED|Overall Study||2||
59955734|NCT02725268|76074507|FG000|NOT COMPLETED|Overall Study||72||
59955735|NCT02725268|76074508|FG001|NOT COMPLETED|Overall Study||70||
59955736|NCT02725268|76074509|FG002|NOT COMPLETED|Overall Study||38||
59955737|NCT02725268|76074510|FG003|NOT COMPLETED|Overall Study||18||
59955738|NCT02724956|76074522|FG000|STARTED|Overall Study||27||
59955739|NCT02724956|76074523|FG001|STARTED|Overall Study||26||
59955740|NCT02724956|76074522|FG000|COMPLETED|Overall Study||26||
59955741|NCT02724956|76074523|FG001|COMPLETED|Overall Study||24||
59955742|NCT02724956|76074522|FG000|NOT COMPLETED|Overall Study||1||
59955743|NCT02724956|76074523|FG001|NOT COMPLETED|Overall Study||2||
59955744|NCT00705536|76074531|FG000|STARTED|Start Period 1||6||
59955745|NCT00705536|76074532|FG001|STARTED|Start Period 1||6||
59955746|NCT00705536|76074533|FG002|STARTED|Start Period 1||7||
59955747|NCT00705536|76074534|FG003|STARTED|Start Period 1||7||
59955748|NCT00705536|76074531|FG000|Received at Least 1 Dose of Study Drug|Start Period 1||6||
59955749|NCT00705536|76074532|FG001|Received at Least 1 Dose of Study Drug|Start Period 1||6||
59955750|NCT00705536|76074533|FG002|Received at Least 1 Dose of Study Drug|Start Period 1||7||
59955751|NCT00705536|76074534|FG003|Received at Least 1 Dose of Study Drug|Start Period 1||7||
59955752|NCT00705536|76074531|FG000|COMPLETED|Start Period 1||6||
59955753|NCT00705536|76074532|FG001|COMPLETED|Start Period 1||6||
59955754|NCT00705536|76074533|FG002|COMPLETED|Start Period 1||7||
59955755|NCT00705536|76074534|FG003|COMPLETED|Start Period 1||6||
59955756|NCT00705536|76074531|FG000|NOT COMPLETED|Start Period 1||0||
59955757|NCT00705536|76074532|FG001|NOT COMPLETED|Start Period 1||0||
59955758|NCT00705536|76074533|FG002|NOT COMPLETED|Start Period 1||0||
59955759|NCT00705536|76074534|FG003|NOT COMPLETED|Start Period 1||1||
59955760|NCT00705536|76074531|FG000|STARTED|Washout Period of at Least 6 Days||6||
59955761|NCT00705536|76074532|FG001|STARTED|Washout Period of at Least 6 Days||6||
59955762|NCT00705536|76074533|FG002|STARTED|Washout Period of at Least 6 Days||7||
59955763|NCT00705536|76074534|FG003|STARTED|Washout Period of at Least 6 Days||6||
59955764|NCT00705536|76074531|FG000|COMPLETED|Washout Period of at Least 6 Days||6||
59955765|NCT00705536|76074532|FG001|COMPLETED|Washout Period of at Least 6 Days||6||
59955766|NCT00705536|76074533|FG002|COMPLETED|Washout Period of at Least 6 Days||7||
59955767|NCT00705536|76074534|FG003|COMPLETED|Washout Period of at Least 6 Days||6||
59955768|NCT00705536|76074531|FG000|NOT COMPLETED|Washout Period of at Least 6 Days||0||
59955769|NCT00705536|76074532|FG001|NOT COMPLETED|Washout Period of at Least 6 Days||0||
59955770|NCT00705536|76074533|FG002|NOT COMPLETED|Washout Period of at Least 6 Days||0||
59955771|NCT00705536|76074534|FG003|NOT COMPLETED|Washout Period of at Least 6 Days||0||
59955772|NCT00705536|76074531|FG000|STARTED|Start Period 2||6||
59955773|NCT00705536|76074532|FG001|STARTED|Start Period 2||6||
59955774|NCT00705536|76074533|FG002|STARTED|Start Period 2||7||
59955775|NCT00705536|76074534|FG003|STARTED|Start Period 2||6||
59955776|NCT00705536|76074531|FG000|COMPLETED|Start Period 2||6||
59955777|NCT00705536|76074532|FG001|COMPLETED|Start Period 2||6||
59955778|NCT00705536|76074533|FG002|COMPLETED|Start Period 2||7||
59955779|NCT00705536|76074534|FG003|COMPLETED|Start Period 2||6||
59955780|NCT00705536|76074531|FG000|NOT COMPLETED|Start Period 2||0||
59955781|NCT00705536|76074532|FG001|NOT COMPLETED|Start Period 2||0||
59955782|NCT00705536|76074533|FG002|NOT COMPLETED|Start Period 2||0||
59955783|NCT00705536|76074534|FG003|NOT COMPLETED|Start Period 2||0||
59955784|NCT00705536|76074531|FG000|STARTED|Completed Study||6||
59955785|NCT00705536|76074532|FG001|STARTED|Completed Study||6||
59955786|NCT00705536|76074533|FG002|STARTED|Completed Study||7||
59955787|NCT00705536|76074534|FG003|STARTED|Completed Study||6||
59955788|NCT00705536|76074531|FG000|COMPLETED|Completed Study||6||
59955789|NCT00705536|76074532|FG001|COMPLETED|Completed Study||6||
59955790|NCT00705536|76074533|FG002|COMPLETED|Completed Study||7||
59955791|NCT00705536|76074534|FG003|COMPLETED|Completed Study||6||
59955792|NCT00705536|76074531|FG000|NOT COMPLETED|Completed Study||0||
59955793|NCT00705536|76074532|FG001|NOT COMPLETED|Completed Study||0||
59955794|NCT00705536|76074533|FG002|NOT COMPLETED|Completed Study||0||
59955795|NCT00705536|76074534|FG003|NOT COMPLETED|Completed Study||0||
59955796|NCT02724020|76074556|FG000|STARTED|Overall Study||32||
59955797|NCT02724020|76074557|FG001|STARTED|Overall Study||32||
59955798|NCT02724020|76074558|FG002|STARTED|Overall Study||32||
59955799|NCT02724020|76074556|FG000|Treated (Safety Analysis Set)|Overall Study||32||
59955800|NCT02724020|76074557|FG001|Treated (Safety Analysis Set)|Overall Study||32||
59955801|NCT02724020|76074558|FG002|Treated (Safety Analysis Set)|Overall Study||31||
59955802|NCT02724020|76074556|FG000|COMPLETED|Overall Study||0||
59955803|NCT02724020|76074557|FG001|COMPLETED|Overall Study||0||
59955804|NCT02724020|76074558|FG002|COMPLETED|Overall Study||0||
59523956|NCT01151761|75618993|FG000|STARTED|Overall Study||2||
59523957|NCT01151761|75618993|FG000|COMPLETED|Overall Study||2||
59802623|NCT03632993|75923924|FG002|STARTED|Overall Study|Treated in both buttocks|6||12
59802624|NCT03632993|75923925|FG003|STARTED|Overall Study||7||14
59802625|NCT03632993|75923926|FG004|STARTED|Overall Study|Treated in both buttocks|6||12
59802626|NCT03632993|75923927|FG005|STARTED|Overall Study|Treated in both thighs|6||12
59802627|NCT03632993|75923928|FG006|STARTED|Overall Study||6||12
59802628|NCT03632993|75923929|FG007|STARTED|Overall Study||7||14
59802629|NCT03632993|75923930|FG008|STARTED|Overall Study||7||14
59802630|NCT03632993|75923931|FG009|STARTED|Overall Study||6||12
59802631|NCT03632993|75923922|FG000|COMPLETED|Overall Study||6||12
59802632|NCT03632993|75923923|FG001|COMPLETED|Overall Study||5||10
59802633|NCT03632993|75923924|FG002|COMPLETED|Overall Study||6||12
59802634|NCT03632993|75923925|FG003|COMPLETED|Overall Study||7||14
59802635|NCT03632993|75923926|FG004|COMPLETED|Overall Study||6||12
59802636|NCT03632993|75923927|FG005|COMPLETED|Overall Study||4||8
59802637|NCT03632993|75923928|FG006|COMPLETED|Overall Study||6||12
59802638|NCT03632993|75923929|FG007|COMPLETED|Overall Study||5||10
59802639|NCT03632993|75923930|FG008|COMPLETED|Overall Study||7||14
59802640|NCT03632993|75923931|FG009|COMPLETED|Overall Study||5||10
59802641|NCT03632993|75923922|FG000|NOT COMPLETED|Overall Study||1||2
59802642|NCT03632993|75923923|FG001|NOT COMPLETED|Overall Study||1||2
59802643|NCT03632993|75923924|FG002|NOT COMPLETED|Overall Study||0||0
59802644|NCT03632993|75923925|FG003|NOT COMPLETED|Overall Study||0||0
59802645|NCT03632993|75923926|FG004|NOT COMPLETED|Overall Study||0||0
59802646|NCT03632993|75923927|FG005|NOT COMPLETED|Overall Study||2||4
59802647|NCT03632993|75923928|FG006|NOT COMPLETED|Overall Study||0||0
59802648|NCT03632993|75923929|FG007|NOT COMPLETED|Overall Study||2||4
59802649|NCT03632993|75923930|FG008|NOT COMPLETED|Overall Study||0||0
59955805|NCT02724020|76074556|FG000|NOT COMPLETED|Overall Study||32||
59955806|NCT02724020|76074557|FG001|NOT COMPLETED|Overall Study||32||
59955807|NCT02724020|76074558|FG002|NOT COMPLETED|Overall Study||32||
59955808|NCT02660034|76074580|FG000|STARTED|Overall Study||12||
59955809|NCT02660034|76074581|FG001|STARTED|Overall Study||12||
59955810|NCT02660034|76074582|FG002|STARTED|Overall Study||6||
59955811|NCT02660034|76074583|FG003|STARTED|Overall Study||13||
59955812|NCT02660034|76074584|FG004|STARTED|Overall Study||6||
59955813|NCT02660034|76074585|FG005|STARTED|Overall Study||23||
59955814|NCT02660034|76074586|FG006|STARTED|Overall Study||23||
59955815|NCT02660034|76074587|FG007|STARTED|Overall Study||19||
59955816|NCT02660034|76074588|FG008|STARTED|Overall Study||20||
59955817|NCT02660034|76074589|FG009|STARTED|Overall Study||23||
59955818|NCT02660034|76074590|FG010|STARTED|Overall Study||20||
59955819|NCT02660034|76074591|FG011|STARTED|Overall Study||21||
59955820|NCT02660034|76074592|FG012|STARTED|Overall Study||21||
59523958|NCT01151761|75618993|FG000|NOT COMPLETED|Overall Study||0||
59802650|NCT03632993|75923931|FG009|NOT COMPLETED|Overall Study||1||2
59955821|NCT02660034|76074593|FG013|STARTED|Overall Study||10||
59955822|NCT02660034|76074580|FG000|Received At Least 1 Dose of Study Drug(s)|Overall Study||12|Safety Analysis Set|
59955823|NCT02660034|76074581|FG001|Received At Least 1 Dose of Study Drug(s)|Overall Study||12|Safety Analysis Set|
59955824|NCT02660034|76074582|FG002|Received At Least 1 Dose of Study Drug(s)|Overall Study||6|Safety Analysis Set|
59955825|NCT02660034|76074583|FG003|Received At Least 1 Dose of Study Drug(s)|Overall Study||13|Safety Analysis Set|
59802656|NCT03493282|75923960|FG000|STARTED|Primary Double-blind Study (180 Days)||8||
59802657|NCT03493282|75923961|FG001|STARTED|Primary Double-blind Study (180 Days)||8||
59802658|NCT03493282|75923962|FG002|STARTED|Primary Double-blind Study (180 Days)||7||
59802659|NCT03493282|75923960|FG000|COMPLETED|Primary Double-blind Study (180 Days)||5||
59955826|NCT02660034|76074584|FG004|Received At Least 1 Dose of Study Drug(s)|Overall Study||6|Safety Analysis Set|
59955827|NCT02660034|76074585|FG005|Received At Least 1 Dose of Study Drug(s)|Overall Study||23|Safety Analysis Set|
59955828|NCT02660034|76074586|FG006|Received At Least 1 Dose of Study Drug(s)|Overall Study||23|Safety Analysis Set|
59955829|NCT02660034|76074587|FG007|Received At Least 1 Dose of Study Drug(s)|Overall Study||19|Safety Analysis Set|
59955830|NCT02660034|76074588|FG008|Received At Least 1 Dose of Study Drug(s)|Overall Study||20|Safety Analysis Set|
59955831|NCT02660034|76074589|FG009|Received At Least 1 Dose of Study Drug(s)|Overall Study||23|Safety Analysis Set|
59955832|NCT02660034|76074590|FG010|Received At Least 1 Dose of Study Drug(s)|Overall Study||20|Safety Analysis Set|
59955833|NCT02660034|76074591|FG011|Received At Least 1 Dose of Study Drug(s)|Overall Study||21|Safety Analysis Set|
59955834|NCT02660034|76074592|FG012|Received At Least 1 Dose of Study Drug(s)|Overall Study||21|Safety Analysis Set|
59955835|NCT02660034|76074593|FG013|Received At Least 1 Dose of Study Drug(s)|Overall Study||10|Safety Analysis Set|
59955836|NCT02660034|76074580|FG000|COMPLETED|Overall Study||0||
59955837|NCT02660034|76074581|FG001|COMPLETED|Overall Study||0||
59955838|NCT02660034|76074582|FG002|COMPLETED|Overall Study||0||
59955839|NCT02660034|76074583|FG003|COMPLETED|Overall Study||0||
59955840|NCT02660034|76074584|FG004|COMPLETED|Overall Study||0||
59955841|NCT02660034|76074585|FG005|COMPLETED|Overall Study||0||
59955842|NCT02660034|76074586|FG006|COMPLETED|Overall Study||0||
59955843|NCT02660034|76074587|FG007|COMPLETED|Overall Study||0||
59955844|NCT02660034|76074588|FG008|COMPLETED|Overall Study||0||
59955845|NCT02660034|76074589|FG009|COMPLETED|Overall Study||0||
59955846|NCT02660034|76074590|FG010|COMPLETED|Overall Study||0||
59955847|NCT02660034|76074591|FG011|COMPLETED|Overall Study||0||
59955848|NCT02660034|76074592|FG012|COMPLETED|Overall Study||0||
59955849|NCT02660034|76074593|FG013|COMPLETED|Overall Study||0||
59955850|NCT02660034|76074580|FG000|NOT COMPLETED|Overall Study||12||
59955851|NCT02660034|76074581|FG001|NOT COMPLETED|Overall Study||12||
59955852|NCT02660034|76074582|FG002|NOT COMPLETED|Overall Study||6||
59955853|NCT02660034|76074583|FG003|NOT COMPLETED|Overall Study||13||
59955854|NCT02660034|76074584|FG004|NOT COMPLETED|Overall Study||6||
59955855|NCT02660034|76074585|FG005|NOT COMPLETED|Overall Study||23||
59955856|NCT02660034|76074586|FG006|NOT COMPLETED|Overall Study||23||
59955857|NCT02660034|76074587|FG007|NOT COMPLETED|Overall Study||19||
59955858|NCT02660034|76074588|FG008|NOT COMPLETED|Overall Study||20||
59955859|NCT02660034|76074589|FG009|NOT COMPLETED|Overall Study||23||
59620552|NCT00193596|75731906|FG001|COMPLETED|Overall Study||39||
59620553|NCT00193596|75731905|FG000|NOT COMPLETED|Overall Study||56||
59620554|NCT00193596|75731906|FG001|NOT COMPLETED|Overall Study||66||
59620555|NCT00091962|75731915|FG000|STARTED|Overall Study||150||
59620556|NCT00091962|75731916|FG001|STARTED|Overall Study||152||
59620557|NCT00091962|75731917|FG002|STARTED|Overall Study||151||
59620558|NCT00091962|75731915|FG000|COMPLETED|Overall Study||150||
59620559|NCT00091962|75731916|FG001|COMPLETED|Overall Study||152||
59620560|NCT00091962|75731917|FG002|COMPLETED|Overall Study||151||
59620561|NCT00091962|75731915|FG000|NOT COMPLETED|Overall Study||0||
59620562|NCT00091962|75731916|FG001|NOT COMPLETED|Overall Study||0||
59620563|NCT00091962|75731917|FG002|NOT COMPLETED|Overall Study||0||
59620564|NCT00194532|75731930|FG000|STARTED|Overall Study||150||
59620565|NCT00194532|75731931|FG001|STARTED|Overall Study||150||
59620566|NCT00194532|75731930|FG000|COMPLETED|Overall Study||150||
59620567|NCT00194532|75731931|FG001|COMPLETED|Overall Study||150||
59620568|NCT00194532|75731930|FG000|NOT COMPLETED|Overall Study||0||
59620569|NCT00194532|75731931|FG001|NOT COMPLETED|Overall Study||0||
59620570|NCT00194610|75731939|FG000|STARTED|Overall Study||11||
59620571|NCT00194610|75731940|FG001|STARTED|Overall Study||9||
59620572|NCT00194610|75731939|FG000|COMPLETED|Overall Study||11||
59620573|NCT00194610|75731940|FG001|COMPLETED|Overall Study||9||
59620574|NCT00194610|75731939|FG000|NOT COMPLETED|Overall Study||0||
59955860|NCT02660034|76074590|FG010|NOT COMPLETED|Overall Study||20||
59620575|NCT00194610|75731940|FG001|NOT COMPLETED|Overall Study||0||
59620576|NCT00093756|75731948|FG000|STARTED|Overall Study||27||
59620577|NCT00093756|75731949|FG001|STARTED|Overall Study||21||
59620578|NCT00093756|75731948|FG000|COMPLETED|Overall Study||27||
59620579|NCT00093756|75731949|FG001|COMPLETED|Overall Study||21||
59620580|NCT00093756|75731948|FG000|NOT COMPLETED|Overall Study||0||
59620581|NCT00093756|75731949|FG001|NOT COMPLETED|Overall Study||0||
59955861|NCT02660034|76074591|FG011|NOT COMPLETED|Overall Study||21||
59955862|NCT02660034|76074592|FG012|NOT COMPLETED|Overall Study||21||
59955863|NCT02660034|76074593|FG013|NOT COMPLETED|Overall Study||10||
59955864|NCT02816736|76074629|FG000|STARTED|Overall Study||179|Started is defined as randomized|
59955865|NCT02816736|76074630|FG001|STARTED|Overall Study||186|Started is defined as randomized|
59955866|NCT02816736|76074629|FG000|COMPLETED|Overall Study||164|Completed is defined as all patients that died or completed follow-up.|
59955867|NCT02816736|76074630|FG001|COMPLETED|Overall Study||166|Completed is defined as all patients that died or completed follow-up.|
59955868|NCT02816736|76074629|FG000|NOT COMPLETED|Overall Study||15||
59802660|NCT03493282|75923961|FG001|COMPLETED|Primary Double-blind Study (180 Days)||6||
59802661|NCT03493282|75923962|FG002|COMPLETED|Primary Double-blind Study (180 Days)||6||
59802662|NCT03493282|75923960|FG000|NOT COMPLETED|Primary Double-blind Study (180 Days)||3||
59802663|NCT03493282|75923961|FG001|NOT COMPLETED|Primary Double-blind Study (180 Days)||2||
59802664|NCT03493282|75923962|FG002|NOT COMPLETED|Primary Double-blind Study (180 Days)||1||
59802665|NCT03493282|75923960|FG000|STARTED|Double-blind Extension Study (180 Days)||3||
59802666|NCT03493282|75923961|FG001|STARTED|Double-blind Extension Study (180 Days)||6||
59802667|NCT03493282|75923962|FG002|STARTED|Double-blind Extension Study (180 Days)||4||
59802668|NCT03493282|75923960|FG000|COMPLETED|Double-blind Extension Study (180 Days)||3||
59802669|NCT03493282|75923961|FG001|COMPLETED|Double-blind Extension Study (180 Days)||6||
59802670|NCT03493282|75923962|FG002|COMPLETED|Double-blind Extension Study (180 Days)||4||
59955869|NCT02816736|76074630|FG001|NOT COMPLETED|Overall Study||20||
59955870|NCT02193867|76074636|FG000|STARTED|Overall Study||10||
59955871|NCT02193867|76074636|FG000|Received At Least 1 Dose Of Study Drug|Overall Study||10|Full Analysis Set (FAS)|
59955872|NCT02193867|76074636|FG000|Completed 18 Months Of Treatment|Overall Study||8|Treatment was to be at least 18 months; participants could continue treatment for up to 3 years|
59802671|NCT03493282|75923960|FG000|NOT COMPLETED|Double-blind Extension Study (180 Days)||0||
59802672|NCT03493282|75923961|FG001|NOT COMPLETED|Double-blind Extension Study (180 Days)||0||
59802673|NCT03493282|75923962|FG002|NOT COMPLETED|Double-blind Extension Study (180 Days)||0||
59955873|NCT02193867|76074636|FG000|COMPLETED|Overall Study||6|All participants continued to receive commercial therapy after study completion/Sponsor termination|
59955874|NCT02193867|76074636|FG000|NOT COMPLETED|Overall Study||4||
59955875|NCT02368002|76074647|FG000|STARTED|Stage 1 Intervention (Up to 20 Weeks)||233||
59955876|NCT02368002|76074648|FG001|STARTED|Stage 1 Intervention (Up to 20 Weeks)||0||
59955877|NCT02368002|76074649|FG002|STARTED|Stage 1 Intervention (Up to 20 Weeks)||0||
59955878|NCT02368002|76074650|FG003|STARTED|Stage 1 Intervention (Up to 20 Weeks)||235||
59955879|NCT02368002|76074651|FG004|STARTED|Stage 1 Intervention (Up to 20 Weeks)||0||
59955880|NCT02368002|76074652|FG005|STARTED|Stage 1 Intervention (Up to 20 Weeks)||0||
59955881|NCT02368002|76074647|FG000|COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||228||
59955882|NCT02368002|76074648|FG001|COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||0||
59955883|NCT02368002|76074649|FG002|COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||0||
59955884|NCT02368002|76074650|FG003|COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||214||
59955885|NCT02368002|76074651|FG004|COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||0||
59802674|NCT03389750|75923976|FG000|STARTED|Overall Study||16||
59802675|NCT03389750|75923976|FG000|Oxycodone|Overall Study||8||
59802676|NCT03389750|75923976|FG000|Oxymorphone|Overall Study||8||
59802677|NCT03389750|75923976|FG000|Hydromorphone|Overall Study||8||
59802678|NCT03389750|75923976|FG000|Placebo|Overall Study||8||
59802679|NCT03389750|75923976|FG000|COMPLETED|Overall Study||8||
59802680|NCT03389750|75923976|FG000|NOT COMPLETED|Overall Study||8||
59955886|NCT02368002|76074652|FG005|COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||0||
59802681|NCT03301467|75924006|FG000|STARTED|Overall Study||29||
59802682|NCT03301467|75924007|FG001|STARTED|Overall Study||28||
59802683|NCT03301467|75924006|FG000|COMPLETED|Overall Study||25||
59802684|NCT03301467|75924007|FG001|COMPLETED|Overall Study||25||
59802685|NCT03301467|75924006|FG000|NOT COMPLETED|Overall Study||4||
59802686|NCT03301467|75924007|FG001|NOT COMPLETED|Overall Study||3||
59955887|NCT02368002|76074647|FG000|NOT COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||5||
59955888|NCT02368002|76074648|FG001|NOT COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||0||
59955889|NCT02368002|76074649|FG002|NOT COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||0||
59523959|NCT01196377|75619001|FG000|STARTED|Overall Study||4||
59523960|NCT01196377|75619002|FG001|STARTED|Overall Study||4||
59523961|NCT01196377|75619003|FG002|STARTED|Overall Study||4||
59523962|NCT01196377|75619004|FG003|STARTED|Overall Study||4||
59523963|NCT01196377|75619001|FG000|COMPLETED|Overall Study||4||
59523964|NCT01196377|75619002|FG001|COMPLETED|Overall Study||4||
59802687|NCT02998203|75924015|FG000|STARTED|First Period (40 Days)||67||3
59802688|NCT02998203|75924016|FG001|STARTED|First Period (40 Days)||124||3
59802689|NCT02998203|75924015|FG000|COMPLETED|First Period (40 Days)||43||3
59802690|NCT02998203|75924016|FG001|COMPLETED|First Period (40 Days)||124||3
59523965|NCT01196377|75619003|FG002|COMPLETED|Overall Study||4||
59523966|NCT01196377|75619004|FG003|COMPLETED|Overall Study||4||
59523967|NCT01196377|75619001|FG000|NOT COMPLETED|Overall Study||0||
59523968|NCT01196377|75619002|FG001|NOT COMPLETED|Overall Study||0||
59523969|NCT01196377|75619003|FG002|NOT COMPLETED|Overall Study||0||
59523970|NCT01196377|75619004|FG003|NOT COMPLETED|Overall Study||0||
59523971|NCT01152307|75619016|FG000|STARTED|Overall Study||191||
59523972|NCT01152307|75619017|FG001|STARTED|Overall Study||214||
59523973|NCT01152307|75619016|FG000|COMPLETED|Overall Study||191||
59523974|NCT01152307|75619017|FG001|COMPLETED|Overall Study||214||
59523975|NCT01152307|75619016|FG000|NOT COMPLETED|Overall Study||0||
59523976|NCT01152307|75619017|FG001|NOT COMPLETED|Overall Study||0||
59523977|NCT01235377|75619025|FG000|STARTED|Overall Study||11||
59523978|NCT01235377|75619026|FG001|STARTED|Overall Study||9||
59523979|NCT01235377|75619025|FG000|COMPLETED|Overall Study||10||
59523980|NCT01235377|75619026|FG001|COMPLETED|Overall Study||8||
59523981|NCT01235377|75619025|FG000|NOT COMPLETED|Overall Study||1||
59523982|NCT01235377|75619026|FG001|NOT COMPLETED|Overall Study||1||
59523983|NCT01196533|75619032|FG000|STARTED|Overall Study||94||
59523984|NCT01196533|75619032|FG000|COMPLETED|Overall Study||94||
59523985|NCT01196533|75619032|FG000|NOT COMPLETED|Overall Study||0||
59523986|NCT01196923|75619036|FG000|STARTED|Overall Study||20||
59523987|NCT01196923|75619036|FG000|COMPLETED|Overall Study||20||
59523988|NCT01196923|75619036|FG000|NOT COMPLETED|Overall Study||0||
59523989|NCT00985517|75619044|FG000|STARTED|Overall Study||3||
59523990|NCT00985517|75619045|FG001|STARTED|Overall Study||3||
59523991|NCT00985517|75619046|FG002|STARTED|Overall Study||24||
59523992|NCT00985517|75619047|FG003|STARTED|Overall Study||27||
59523993|NCT00985517|75619044|FG000|COMPLETED|Overall Study||3||
59523994|NCT00985517|75619045|FG001|COMPLETED|Overall Study||3||
59523995|NCT00985517|75619046|FG002|COMPLETED|Overall Study||23||
59523996|NCT00985517|75619047|FG003|COMPLETED|Overall Study||24||
59523997|NCT00985517|75619044|FG000|NOT COMPLETED|Overall Study||0||
59523998|NCT00985517|75619045|FG001|NOT COMPLETED|Overall Study||0||
59523999|NCT00985517|75619046|FG002|NOT COMPLETED|Overall Study||1||
59802691|NCT02998203|75924015|FG000|NOT COMPLETED|First Period (40 Days)||24||0
59524000|NCT00985517|75619047|FG003|NOT COMPLETED|Overall Study||3||
59524001|NCT02451176|75619060|FG000|STARTED|Overall Study||126||
59524002|NCT02451176|75619061|FG001|STARTED|Overall Study||127||
59524003|NCT02451176|75619060|FG000|COMPLETED|Overall Study||126||
59802692|NCT02998203|75924016|FG001|NOT COMPLETED|First Period (40 Days)||0||0
59802693|NCT02998203|75924015|FG000|STARTED|Second Period (40 Days)||43||3
59802694|NCT02998203|75924016|FG001|STARTED|Second Period (40 Days)||124||3
59524004|NCT02451176|75619061|FG001|COMPLETED|Overall Study||127||
59524005|NCT02451176|75619060|FG000|NOT COMPLETED|Overall Study||0||
59524006|NCT02451176|75619061|FG001|NOT COMPLETED|Overall Study||0||
59524007|NCT02696616|75619074|FG000|STARTED|Overall Study||12||
59524008|NCT02696616|75619075|FG001|STARTED|Overall Study||5||
59524009|NCT02696616|75619076|FG002|STARTED|Overall Study||6||
59524010|NCT02696616|75619077|FG003|STARTED|Overall Study||6||
59802695|NCT02998203|75924015|FG000|COMPLETED|Second Period (40 Days)||43||3
59802696|NCT02998203|75924016|FG001|COMPLETED|Second Period (40 Days)||106||3
59802697|NCT02998203|75924015|FG000|NOT COMPLETED|Second Period (40 Days)||0||0
59955890|NCT02368002|76074650|FG003|NOT COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||21||
59524011|NCT02696616|75619078|FG004|STARTED|Overall Study||6||
59955891|NCT02368002|76074651|FG004|NOT COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||0||
60073820|NCT01612676|76189156|FG001|COMPLETED|Overall Study||3||
60073821|NCT01612676|76189157|FG002|COMPLETED|Overall Study||4||
59524012|NCT02696616|75619079|FG005|STARTED|Overall Study||6||
59524013|NCT02696616|75619080|FG006|STARTED|Overall Study||6||
59524014|NCT02696616|75619074|FG000|COMPLETED|Overall Study||12||
59524015|NCT02696616|75619075|FG001|COMPLETED|Overall Study||4||
59802698|NCT02998203|75924016|FG001|NOT COMPLETED|Second Period (40 Days)||18||0
59955892|NCT02368002|76074652|FG005|NOT COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||0||
59955893|NCT02368002|76074647|FG000|STARTED|Stage 2 Intervention (Up to 17 Weeks)||88||
59955894|NCT02368002|76074648|FG001|STARTED|Stage 2 Intervention (Up to 17 Weeks)||70||
59955895|NCT02368002|76074649|FG002|STARTED|Stage 2 Intervention (Up to 17 Weeks)||70||
59955896|NCT02368002|76074650|FG003|STARTED|Stage 2 Intervention (Up to 17 Weeks)||0||
59955897|NCT02368002|76074651|FG004|STARTED|Stage 2 Intervention (Up to 17 Weeks)||0||
59955898|NCT02368002|76074652|FG005|STARTED|Stage 2 Intervention (Up to 17 Weeks)||0||
59955899|NCT02368002|76074647|FG000|COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||86||
59955900|NCT02368002|76074648|FG001|COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||60||
59955901|NCT02368002|76074649|FG002|COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||64||
59955902|NCT02368002|76074650|FG003|COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||0||
59955903|NCT02368002|76074651|FG004|COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||0||
59955904|NCT02368002|76074652|FG005|COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||0||
59955905|NCT02368002|76074647|FG000|NOT COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||2||
59955906|NCT02368002|76074648|FG001|NOT COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||10||
59955907|NCT02368002|76074649|FG002|NOT COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||6||
59955908|NCT02368002|76074650|FG003|NOT COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||0||
59955909|NCT02368002|76074651|FG004|NOT COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||0||
59955910|NCT02368002|76074652|FG005|NOT COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||0||
59955911|NCT02368002|76074647|FG000|STARTED|Stage 2 Intervention (Up to 13 Weeks)||0||
59955912|NCT02368002|76074648|FG001|STARTED|Stage 2 Intervention (Up to 13 Weeks)||0||
59955913|NCT02368002|76074649|FG002|STARTED|Stage 2 Intervention (Up to 13 Weeks)||0||
59955914|NCT02368002|76074650|FG003|STARTED|Stage 2 Intervention (Up to 13 Weeks)||95||
59955915|NCT02368002|76074651|FG004|STARTED|Stage 2 Intervention (Up to 13 Weeks)||57||
59955916|NCT02368002|76074652|FG005|STARTED|Stage 2 Intervention (Up to 13 Weeks)||62||
59955917|NCT02368002|76074647|FG000|COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||0||
59955918|NCT02368002|76074648|FG001|COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||0||
59955919|NCT02368002|76074649|FG002|COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||0||
59955920|NCT02368002|76074650|FG003|COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||94||
60073822|NCT01612676|76189158|FG003|COMPLETED|Overall Study||10||
60073823|NCT01612676|76189155|FG000|NOT COMPLETED|Overall Study||2||
60073824|NCT01612676|76189156|FG001|NOT COMPLETED|Overall Study||4||
59620582|NCT00267696|75731957|FG000|STARTED|Overall Study||45||
59620583|NCT00267696|75731957|FG000|COMPLETED|Overall Study||45||
59620584|NCT00267696|75731957|FG000|NOT COMPLETED|Overall Study||0||
59620585|NCT00267774|75731963|FG000|STARTED|Overall Study||509||
59620586|NCT00267774|75731964|FG001|STARTED|Overall Study||496||
59620587|NCT00267774|75731963|FG000|COMPLETED|Overall Study||509||
59620588|NCT00267774|75731964|FG001|COMPLETED|Overall Study||496||
60073825|NCT01612676|76189157|FG002|NOT COMPLETED|Overall Study||1||
59955921|NCT02368002|76074651|FG004|COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||53||
59955922|NCT02368002|76074652|FG005|COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||59||
59955923|NCT02368002|76074647|FG000|NOT COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||0||
59955924|NCT02368002|76074648|FG001|NOT COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||0||
59955925|NCT02368002|76074649|FG002|NOT COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||0||
59955926|NCT02368002|76074650|FG003|NOT COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||1||
59955927|NCT02368002|76074651|FG004|NOT COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||4||
59955928|NCT02368002|76074652|FG005|NOT COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||3||
59955929|NCT02200770|76074664|FG000|STARTED|Randomized-controlled Period (RCP)||56||
59955930|NCT02200770|76074665|FG001|STARTED|Randomized-controlled Period (RCP)||175||
59620589|NCT00267774|75731963|FG000|NOT COMPLETED|Overall Study||0||
59620590|NCT00267774|75731964|FG001|NOT COMPLETED|Overall Study||0||
59620591|NCT00195624|75731972|FG000|STARTED|Overall Study||5||
59620592|NCT00195624|75731973|FG001|STARTED|Overall Study||42||
59620593|NCT00195624|75731972|FG000|COMPLETED|Overall Study||5||
59620594|NCT00195624|75731973|FG001|COMPLETED|Overall Study||42||
59620595|NCT00195624|75731972|FG000|NOT COMPLETED|Overall Study||0||
59620596|NCT00195624|75731973|FG001|NOT COMPLETED|Overall Study||0||
59620597|NCT00195702|75731982|FG000|STARTED|Double-blind Phase|For all groups, started indicates when the subjects entered the 52-week double-blind phase.|212||
59620598|NCT00195702|75731983|FG001|STARTED|Double-blind Phase||207||
59955931|NCT02200770|76074664|FG000|Treated|Randomized-controlled Period (RCP)||56||
59955932|NCT02200770|76074665|FG001|Treated|Randomized-controlled Period (RCP)||174||
59955933|NCT02200770|76074664|FG000|COMPLETED|Randomized-controlled Period (RCP)||54||
59955934|NCT02200770|76074665|FG001|COMPLETED|Randomized-controlled Period (RCP)||169||
59955935|NCT02200770|76074664|FG000|NOT COMPLETED|Randomized-controlled Period (RCP)||2||
59802705|NCT02873338|75924051|FG000|STARTED|Overall Study||26||
59802706|NCT02873338|75924052|FG001|STARTED|Overall Study||25||
59802707|NCT02873338|75924053|FG002|STARTED|Overall Study||24||
59955936|NCT02200770|76074665|FG001|NOT COMPLETED|Randomized-controlled Period (RCP)||6||
59955937|NCT02200770|76074664|FG000|STARTED|Open-label Period (OLP)|3 participants completed RCP but did not roll over to OLP.|51||
59955938|NCT02200770|76074665|FG001|STARTED|Open-label Period (OLP)|4 participants completed RCP but did not roll over to OLP.|165||
59955939|NCT02200770|76074664|FG000|COMPLETED|Open-label Period (OLP)||43||
59802708|NCT02873338|75924051|FG000|COMPLETED|Overall Study||8||
59802709|NCT02873338|75924052|FG001|COMPLETED|Overall Study||4||
59802710|NCT02873338|75924053|FG002|COMPLETED|Overall Study||6||
59802711|NCT02873338|75924051|FG000|NOT COMPLETED|Overall Study||18||
59802712|NCT02873338|75924052|FG001|NOT COMPLETED|Overall Study||21||
59802713|NCT02873338|75924053|FG002|NOT COMPLETED|Overall Study||18||
59802714|NCT02751788|75924064|FG000|STARTED|Overall Study||112||
59802715|NCT02751788|75924064|FG000|COMPLETED|Overall Study||49||
59802716|NCT02751788|75924064|FG000|NOT COMPLETED|Overall Study||63||
59802717|NCT02725567|75924068|FG000|STARTED|Part A (Up to 5 Days)||19||
59802718|NCT02725567|75924069|FG001|STARTED|Part A (Up to 5 Days)||0||
59802719|NCT02725567|75924068|FG000|COMPLETED|Part A (Up to 5 Days)||19||
59955940|NCT02200770|76074665|FG001|COMPLETED|Open-label Period (OLP)||131||
59955941|NCT02200770|76074664|FG000|NOT COMPLETED|Open-label Period (OLP)||8||
59955942|NCT02200770|76074665|FG001|NOT COMPLETED|Open-label Period (OLP)||34||
59955943|NCT03534063|76074675|FG000|STARTED|Overall Study||173||
59802720|NCT02725567|75924069|FG001|COMPLETED|Part A (Up to 5 Days)||0||
59802721|NCT02725567|75924068|FG000|NOT COMPLETED|Part A (Up to 5 Days)||0||
59802722|NCT02725567|75924069|FG001|NOT COMPLETED|Part A (Up to 5 Days)||0||
59802723|NCT02725567|75924068|FG000|STARTED|Part B + A/B ( Up to 24 Weeks)||0||
59802724|NCT02725567|75924069|FG001|STARTED|Part B + A/B ( Up to 24 Weeks)|"Out of the 19 participants in the reporting arm Part A, 5 also participated in the reporting arm Part B + Part A/B."|43||
59802725|NCT02725567|75924068|FG000|COMPLETED|Part B + A/B ( Up to 24 Weeks)||0||
59802726|NCT02725567|75924069|FG001|COMPLETED|Part B + A/B ( Up to 24 Weeks)||40||
59802727|NCT02725567|75924068|FG000|NOT COMPLETED|Part B + A/B ( Up to 24 Weeks)||0||
59802728|NCT02725567|75924069|FG001|NOT COMPLETED|Part B + A/B ( Up to 24 Weeks)||3||
59802729|NCT02209545|75924080|FG000|STARTED|Overall Study||13||
59802730|NCT02209545|75924081|FG001|STARTED|Overall Study||26||
59802731|NCT02209545|75924080|FG000|COMPLETED|Overall Study||13||
59802732|NCT02209545|75924081|FG001|COMPLETED|Overall Study||26||
59802733|NCT02209545|75924080|FG000|NOT COMPLETED|Overall Study||0||
59955944|NCT03534063|76074676|FG001|STARTED|Overall Study||87||
59802734|NCT02209545|75924081|FG001|NOT COMPLETED|Overall Study||0||
59802735|NCT02186509|75924089|FG000|STARTED|Overall Study||17||
59802736|NCT02186509|75924089|FG000|COMPLETED|Overall Study||17||
59802737|NCT02186509|75924089|FG000|NOT COMPLETED|Overall Study||0||
59802738|NCT02108964|75924101|FG000|STARTED|Overall Study||17||
59802739|NCT02108964|75924102|FG001|STARTED|Overall Study||38||
59802740|NCT02108964|75924103|FG002|STARTED|Overall Study||73||
59802741|NCT02108964|75924104|FG003|STARTED|Overall Study||8||
59802742|NCT02108964|75924105|FG004|STARTED|Overall Study||28||
59955945|NCT03534063|76074675|FG000|COMPLETED|Overall Study||154||
59802743|NCT02108964|75924106|FG005|STARTED|Overall Study||5||
59802744|NCT02108964|75924107|FG006|STARTED|Overall Study||11||
59802745|NCT02108964|75924108|FG007|STARTED|Overall Study||45||
59802746|NCT02108964|75924101|FG000|COMPLETED|Overall Study||3|Ongoing at the time of the data cut-off date 22-Mar-2018|
59802747|NCT02108964|75924102|FG001|COMPLETED|Overall Study||6|Ongoing at the time of the data cut-off date 22-Mar-2018|
59802748|NCT02108964|75924103|FG002|COMPLETED|Overall Study||8|Ongoing at the time of the data cut-off date 22-Mar-2018|
59802749|NCT02108964|75924104|FG003|COMPLETED|Overall Study||2|Ongoing at the time of the data cut-off date 22-Mar-2018|
59802750|NCT02108964|75924105|FG004|COMPLETED|Overall Study||3|Ongoing at the time of the data cut-off date 22-Mar-2018|
59802751|NCT02108964|75924106|FG005|COMPLETED|Overall Study||0|Ongoing at the time of the data cut-off date 22-Mar-2018|
59802752|NCT02108964|75924107|FG006|COMPLETED|Overall Study||0|Ongoing at the time of the data cut-off date 22-Mar-2018|
59802753|NCT02108964|75924108|FG007|COMPLETED|Overall Study||33|Ongoing at the time of the data cut-off date 22-Mar-2018|
59802754|NCT02108964|75924101|FG000|NOT COMPLETED|Overall Study||14||
59802755|NCT02108964|75924102|FG001|NOT COMPLETED|Overall Study||32||
59802756|NCT02108964|75924103|FG002|NOT COMPLETED|Overall Study||65||
59802757|NCT02108964|75924104|FG003|NOT COMPLETED|Overall Study||6||
59802758|NCT02108964|75924105|FG004|NOT COMPLETED|Overall Study||25||
59802759|NCT02108964|75924106|FG005|NOT COMPLETED|Overall Study||5||
59802760|NCT02108964|75924107|FG006|NOT COMPLETED|Overall Study||11||
59802761|NCT02108964|75924108|FG007|NOT COMPLETED|Overall Study||12||
59802762|NCT01909453|75924132|FG000|STARTED|Overall Study||192||
59802763|NCT01909453|75924133|FG001|STARTED|Overall Study||194||
59802764|NCT01909453|75924134|FG002|STARTED|Overall Study||191||
59802765|NCT01909453|75924135|FG003|STARTED|Overall Study||258||
59802766|NCT01909453|75924136|FG004|STARTED|Overall Study||86||
59802767|NCT01909453|75924132|FG000|COMPLETED|Overall Study||0||
59802768|NCT01909453|75924133|FG001|COMPLETED|Overall Study||0||
59802769|NCT01909453|75924134|FG002|COMPLETED|Overall Study||0||
59802770|NCT01909453|75924135|FG003|COMPLETED|Overall Study||0||
59802771|NCT01909453|75924136|FG004|COMPLETED|Overall Study||0||
59802772|NCT01909453|75924132|FG000|NOT COMPLETED|Overall Study||192||
59802773|NCT01909453|75924133|FG001|NOT COMPLETED|Overall Study||194||
59802774|NCT01909453|75924134|FG002|NOT COMPLETED|Overall Study||191||
59802775|NCT01909453|75924135|FG003|NOT COMPLETED|Overall Study||258||
59802776|NCT01909453|75924136|FG004|NOT COMPLETED|Overall Study||86||
59802777|NCT01882803|75924154|FG000|STARTED|Overall Study||129||
59802778|NCT01882803|75924154|FG000|Received at Least 1 Dose of Study Drug|Overall Study|Participant received treatment in 28-day cycles until disease progression or unacceptable toxicity.|129||
59802779|NCT01882803|75924154|FG000|COMPLETED|Overall Study||0||
59802780|NCT01882803|75924154|FG000|NOT COMPLETED|Overall Study||129||
59802781|NCT01472562|75924159|FG000|STARTED|Induction Phase (Week 1- 48)||38||
59802782|NCT01472562|75924159|FG000|COMPLETED|Induction Phase (Week 1- 48)||27||
59802783|NCT01472562|75924159|FG000|NOT COMPLETED|Induction Phase (Week 1- 48)||11||
59802784|NCT01472562|75924159|FG000|STARTED|Maintenance Phase (Week 49 to PD)||27||
59802785|NCT01472562|75924159|FG000|COMPLETED|Maintenance Phase (Week 49 to PD)||4||
59802786|NCT01472562|75924159|FG000|NOT COMPLETED|Maintenance Phase (Week 49 to PD)||23||
59802787|NCT01196390|75924165|FG000|STARTED|Overall Study||102||
59802788|NCT01196390|75924166|FG001|STARTED|Overall Study||101||
59802789|NCT01196390|75924165|FG000|Eligible|Overall Study||98||
59802790|NCT01196390|75924166|FG001|Eligible|Overall Study||96||
59802791|NCT01196390|75924165|FG000|Eligible and Started Study Treatment|Overall Study||95||
59802792|NCT01196390|75924166|FG001|Eligible and Started Study Treatment|Overall Study||96||
59802793|NCT01196390|75924165|FG000|Eligible and Had Surgery|Overall Study||82||
59802794|NCT01196390|75924166|FG001|Eligible and Had Surgery|Overall Study||78||
59802795|NCT01196390|75924165|FG000|Eligible and Consented to Quality of Life Component|Overall Study||88||
59802796|NCT01196390|75924166|FG001|Eligible and Consented to Quality of Life Component|Overall Study||83||
59802797|NCT01196390|75924165|FG000|COMPLETED|Overall Study||98|Participants contributing data to results are considered to have completed the study|
59802798|NCT01196390|75924166|FG001|COMPLETED|Overall Study||96|Participants contributing data to results are considered to have completed the study|
59802799|NCT01196390|75924165|FG000|NOT COMPLETED|Overall Study||4||
59802800|NCT01196390|75924166|FG001|NOT COMPLETED|Overall Study||5||
59802801|NCT00905515|75924177|FG000|STARTED|Overall Study||21||
59802802|NCT00905515|75924178|FG001|STARTED|Overall Study||20||
59802803|NCT00905515|75924179|FG002|STARTED|Overall Study||22||
59802804|NCT00905515|75924177|FG000|COMPLETED|Overall Study||19||
59802805|NCT00905515|75924178|FG001|COMPLETED|Overall Study||20||
59802806|NCT00905515|75924179|FG002|COMPLETED|Overall Study||20||
59802807|NCT00905515|75924177|FG000|NOT COMPLETED|Overall Study||2||
59802808|NCT00905515|75924178|FG001|NOT COMPLETED|Overall Study||0||
59802809|NCT00905515|75924179|FG002|NOT COMPLETED|Overall Study||2||
59802810|NCT00659126|75924189|FG000|STARTED|Overall Study||15||
59802811|NCT00659126|75924190|FG001|STARTED|Overall Study||25||
59802812|NCT00659126|75924189|FG000|COMPLETED|Overall Study||12||
59802813|NCT00659126|75924190|FG001|COMPLETED|Overall Study||21||
59802814|NCT00659126|75924189|FG000|NOT COMPLETED|Overall Study||3||
59802815|NCT00659126|75924190|FG001|NOT COMPLETED|Overall Study||4||
59802816|NCT00581139|75924200|FG000|STARTED|Overall Study||61||
59802817|NCT00581139|75924201|FG001|STARTED|Overall Study||68||
59802818|NCT00581139|75924202|FG002|STARTED|Overall Study||54||
59802819|NCT00581139|75924203|FG003|STARTED|Overall Study||58||
59802820|NCT00581139|75924200|FG000|COMPLETED|Overall Study||61||
59802821|NCT00581139|75924201|FG001|COMPLETED|Overall Study||68||
59802822|NCT00581139|75924202|FG002|COMPLETED|Overall Study||54||
59802823|NCT00581139|75924203|FG003|COMPLETED|Overall Study||58||
59802824|NCT00581139|75924200|FG000|NOT COMPLETED|Overall Study||0||
59802825|NCT00581139|75924201|FG001|NOT COMPLETED|Overall Study||0||
59802826|NCT00581139|75924202|FG002|NOT COMPLETED|Overall Study||0||
59802827|NCT00581139|75924203|FG003|NOT COMPLETED|Overall Study||0||
59802828|NCT00493831|75924213|FG000|STARTED|Overall Study|24 subjects were consented but only 20 continued to the treatment phase. Of these 12 completed. The study was terminated as the analyses proved infeasible prior to the other subjects completed|20||
59802829|NCT00493831|75924213|FG000|COMPLETED|Overall Study||12||
59802830|NCT00493831|75924213|FG000|NOT COMPLETED|Overall Study||8||
59802831|NCT00482690|75924217|FG000|STARTED|Overall Study||35||
59802832|NCT00482690|75924217|FG000|COMPLETED|Overall Study||17||
59802833|NCT00482690|75924217|FG000|NOT COMPLETED|Overall Study||18||
59802834|NCT00152503|75924221|FG000|STARTED|Overall Study||59||
59802835|NCT00152503|75924221|FG000|COMPLETED|Overall Study||55||
59802836|NCT00152503|75924221|FG000|NOT COMPLETED|Overall Study||4||
59955946|NCT03534063|76074676|FG001|COMPLETED|Overall Study||80||
59955947|NCT03534063|76074675|FG000|NOT COMPLETED|Overall Study||19||
59955948|NCT03534063|76074676|FG001|NOT COMPLETED|Overall Study||7||
59955949|NCT01186848|76074687|FG000|STARTED|Overall Study||30||
59955950|NCT01186848|76074687|FG000|COMPLETED|Overall Study||22||
59955951|NCT01186848|76074687|FG000|NOT COMPLETED|Overall Study||8||
59955952|NCT01024608|76074695|FG000|STARTED|Overall Study||169||
59955953|NCT01024608|76074696|FG001|STARTED|Overall Study||171||
59955954|NCT01024608|76074695|FG000|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment|167||
59955955|NCT01024608|76074696|FG001|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment|171||
59955956|NCT01024608|76074695|FG000|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|167||
59955957|NCT01024608|76074696|FG001|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|171||
59955958|NCT01024608|76074695|FG000|COMPLETED|Overall Study||165||
59955959|NCT01024608|76074696|FG001|COMPLETED|Overall Study||167||
59955960|NCT01024608|76074695|FG000|NOT COMPLETED|Overall Study||4||
59955961|NCT01024608|76074696|FG001|NOT COMPLETED|Overall Study||4||
59955962|NCT00910650|76074702|FG000|STARTED|Overall Study||14||
59955963|NCT00910650|76074702|FG000|COMPLETED|Overall Study||12||
59955964|NCT00910650|76074702|FG000|NOT COMPLETED|Overall Study||2||
59955965|NCT02956434|76074710|FG000|STARTED|Overall Study||10||
59802837|NCT03865407|75924227|FG000|STARTED|Overall Study||10||
59802838|NCT03865407|75924228|FG001|STARTED|Overall Study||7||
59802839|NCT03865407|75924227|FG000|COMPLETED|Overall Study||7||
59802840|NCT03865407|75924228|FG001|COMPLETED|Overall Study||7||
59802841|NCT03865407|75924227|FG000|NOT COMPLETED|Overall Study||3||
59802842|NCT03865407|75924228|FG001|NOT COMPLETED|Overall Study||0||
59802843|NCT00487942|75924238|FG000|STARTED|Overall Study||15||
59802844|NCT00487942|75924239|FG001|STARTED|Overall Study||15||
59802845|NCT00487942|75924240|FG002|STARTED|Overall Study||15||
59802846|NCT00487942|75924241|FG003|STARTED|Overall Study|One subject randomized to placebo discontinued prior to receiving any study drug, leaving 14.|15||
59802847|NCT00487942|75924238|FG000|COMPLETED|Overall Study||12||
59802848|NCT00487942|75924239|FG001|COMPLETED|Overall Study||12||
59802849|NCT00487942|75924240|FG002|COMPLETED|Overall Study||12||
59802850|NCT00487942|75924241|FG003|COMPLETED|Overall Study||13||
59802851|NCT00487942|75924238|FG000|NOT COMPLETED|Overall Study||3||
59802852|NCT00487942|75924239|FG001|NOT COMPLETED|Overall Study||3||
59802853|NCT00487942|75924240|FG002|NOT COMPLETED|Overall Study||3||
59802854|NCT00487942|75924241|FG003|NOT COMPLETED|Overall Study||2||
59802855|NCT00132301|75924253|FG000|STARTED|Overall Study||141||
59802856|NCT00132301|75924254|FG001|STARTED|Overall Study||157||
59802857|NCT00132301|75924253|FG000|COMPLETED|Overall Study||121|1 participant was excluded from all analysis by the DMC|
59802858|NCT00132301|75924254|FG001|COMPLETED|Overall Study||144|1 participant was excluded from all analysis by the DMC|
59802859|NCT00132301|75924253|FG000|NOT COMPLETED|Overall Study||20||
59524016|NCT02696616|75619076|FG002|COMPLETED|Overall Study||6||
59524017|NCT02696616|75619077|FG003|COMPLETED|Overall Study||6||
59524018|NCT02696616|75619078|FG004|COMPLETED|Overall Study||6||
59524019|NCT02696616|75619079|FG005|COMPLETED|Overall Study||6||
59524020|NCT02696616|75619080|FG006|COMPLETED|Overall Study||6||
59524021|NCT02696616|75619074|FG000|NOT COMPLETED|Overall Study||0||
59524022|NCT02696616|75619075|FG001|NOT COMPLETED|Overall Study||1||
59524023|NCT02696616|75619076|FG002|NOT COMPLETED|Overall Study||0||
59524024|NCT02696616|75619077|FG003|NOT COMPLETED|Overall Study||0||
59524025|NCT02696616|75619078|FG004|NOT COMPLETED|Overall Study||0||
59524026|NCT02696616|75619079|FG005|NOT COMPLETED|Overall Study||0||
59524027|NCT02696616|75619080|FG006|NOT COMPLETED|Overall Study||0||
59802860|NCT00132301|75924254|FG001|NOT COMPLETED|Overall Study||13||
59802861|NCT00522873|75924262|FG000|STARTED|Overall Study||490||
59802862|NCT00522873|75924263|FG001|STARTED|Overall Study||172||
59802863|NCT00522873|75924262|FG000|Received Treatment|Overall Study||489||
59802864|NCT00522873|75924263|FG001|Received Treatment|Overall Study||172||
59802865|NCT00522873|75924262|FG000|COMPLETED|Overall Study|394 women completed study medication. 398 women completed the study.|394||
59802866|NCT00522873|75924263|FG001|COMPLETED|Overall Study|128 women completed study medication. 129 women completed the study.|128||
59802867|NCT00522873|75924262|FG000|NOT COMPLETED|Overall Study||96||
59802868|NCT00522873|75924263|FG001|NOT COMPLETED|Overall Study||44||
59802869|NCT03684057|75924271|FG000|STARTED|Overall Study||40||
59802870|NCT03684057|75924272|FG001|STARTED|Overall Study||40||
59955966|NCT02956434|76074711|FG001|STARTED|Overall Study||10||
59955967|NCT02956434|76074712|FG002|STARTED|Overall Study||10||
59955968|NCT02956434|76074713|FG003|STARTED|Overall Study||10||
59955969|NCT02956434|76074710|FG000|COMPLETED|Overall Study||10||
59955970|NCT02956434|76074711|FG001|COMPLETED|Overall Study||10||
59955971|NCT02956434|76074712|FG002|COMPLETED|Overall Study||10||
59955972|NCT02956434|76074713|FG003|COMPLETED|Overall Study||10||
59955973|NCT02956434|76074710|FG000|NOT COMPLETED|Overall Study||0||
59524028|NCT01027559|75619105|FG000|STARTED|Overall Study||26||
59524029|NCT01027559|75619106|FG001|STARTED|Overall Study||34||
59524030|NCT01027559|75619107|FG002|STARTED|Overall Study||31||
59524031|NCT01027559|75619105|FG000|COMPLETED|Overall Study||20||
59955974|NCT02956434|76074711|FG001|NOT COMPLETED|Overall Study||0||
59955975|NCT02956434|76074712|FG002|NOT COMPLETED|Overall Study||0||
59955976|NCT02956434|76074713|FG003|NOT COMPLETED|Overall Study||0||
59955977|NCT03999411|76074724|FG000|STARTED|Overall Study||13||
59955978|NCT03999411|76074725|FG001|STARTED|Overall Study||13||
59955979|NCT03999411|76074726|FG002|STARTED|Overall Study||13||
59955980|NCT03999411|76074724|FG000|COMPLETED|Overall Study||12||
59955981|NCT03999411|76074725|FG001|COMPLETED|Overall Study||11||
59955982|NCT03999411|76074726|FG002|COMPLETED|Overall Study||13||
59955983|NCT03999411|76074724|FG000|NOT COMPLETED|Overall Study||1||
59955984|NCT03999411|76074725|FG001|NOT COMPLETED|Overall Study||2||
59955985|NCT03999411|76074726|FG002|NOT COMPLETED|Overall Study||0||
59955986|NCT03996876|76074737|FG000|STARTED|Overall Study||14||
59955987|NCT03996876|76074738|FG001|STARTED|Overall Study||14||
59955988|NCT03996876|76074737|FG000|COMPLETED|Overall Study||12||
59955989|NCT03996876|76074738|FG001|COMPLETED|Overall Study||10||
59955990|NCT03996876|76074737|FG000|NOT COMPLETED|Overall Study||2||
59955991|NCT03996876|76074738|FG001|NOT COMPLETED|Overall Study||4||
60073826|NCT01612676|76189158|FG003|NOT COMPLETED|Overall Study||3||
59802871|NCT03684057|75924271|FG000|COMPLETED|Overall Study||36||
59802872|NCT03684057|75924272|FG001|COMPLETED|Overall Study||35||
59802873|NCT03684057|75924271|FG000|NOT COMPLETED|Overall Study||4||
59802874|NCT03684057|75924272|FG001|NOT COMPLETED|Overall Study||5||
59802875|NCT03864627|75924281|FG000|STARTED|Overall Study||11||
59802876|NCT03864627|75924282|FG001|STARTED|Overall Study||22||
59802877|NCT03864627|75924281|FG000|COMPLETED|Overall Study||7||
59802878|NCT03864627|75924282|FG001|COMPLETED|Overall Study||10||
59802879|NCT03864627|75924281|FG000|NOT COMPLETED|Overall Study||4||
59802880|NCT03864627|75924282|FG001|NOT COMPLETED|Overall Study||12||
59802881|NCT00519831|75924289|FG000|STARTED|Overall Study||16||
59802882|NCT00519831|75924289|FG000|COMPLETED|Overall Study||13||
59802883|NCT00519831|75924289|FG000|NOT COMPLETED|Overall Study||3||
59802884|NCT04303845|75924293|FG000|STARTED|Overall Study||2||
59802885|NCT04303845|75924293|FG000|COMPLETED|Overall Study||2||
59802886|NCT04303845|75924293|FG000|NOT COMPLETED|Overall Study||0||
59802887|NCT00131911|75924299|FG000|STARTED|Overall Study||51||
59802888|NCT00131911|75924300|FG001|STARTED|Overall Study||42||
59802889|NCT00131911|75924299|FG000|COMPLETED|Overall Study||50||
59802890|NCT00131911|75924300|FG001|COMPLETED|Overall Study||42||
59802891|NCT00131911|75924299|FG000|NOT COMPLETED|Overall Study||1||
59802892|NCT00131911|75924300|FG001|NOT COMPLETED|Overall Study||0||
59802893|NCT00184093|75924305|FG000|STARTED|Overall Study|Phase 1 participants = 6 Phase 2 participants = 29|35||
59802894|NCT00184093|75924305|FG000|COMPLETED|Overall Study||26||
59802895|NCT00184093|75924305|FG000|NOT COMPLETED|Overall Study||9||
59802896|NCT00183625|75924311|FG000|STARTED|Overall Study||27||
59802897|NCT00183625|75924312|FG001|STARTED|Overall Study||28||
59955992|NCT01460160|76074745|FG000|STARTED|Treatment Phase||106||
59955993|NCT01460160|76074745|FG000|COMPLETED|Treatment Phase||78||
59955994|NCT01460160|76074745|FG000|NOT COMPLETED|Treatment Phase||28||
59955995|NCT01460160|76074745|FG000|STARTED|Follow-up Phase|Some of the participants who did not completed the Treatment Phase were still moved to the Follow-up Phase|100||
59955996|NCT01460160|76074745|FG000|COMPLETED|Follow-up Phase||0|Completed = continuing in the follow-up phase|
59955997|NCT01460160|76074745|FG000|NOT COMPLETED|Follow-up Phase||100||
59955998|NCT01170702|76074753|FG000|STARTED|Overall Study||34||
59955999|NCT01170702|76074754|FG001|STARTED|Overall Study||32||
59956000|NCT01170702|76074755|FG002|STARTED|Overall Study||25||
59956001|NCT01170702|76074756|FG003|STARTED|Overall Study||29||
59802898|NCT00183625|75924313|FG002|STARTED|Overall Study||28||
59956002|NCT01170702|76074753|FG000|COMPLETED|Overall Study||33||
59956003|NCT01170702|76074754|FG001|COMPLETED|Overall Study||30||
59956004|NCT01170702|76074755|FG002|COMPLETED|Overall Study||25||
59956005|NCT01170702|76074756|FG003|COMPLETED|Overall Study||27||
59956006|NCT01170702|76074753|FG000|NOT COMPLETED|Overall Study||1||
59956007|NCT01170702|76074754|FG001|NOT COMPLETED|Overall Study||2||
59802899|NCT00183625|75924314|FG003|STARTED|Overall Study||24||
59802900|NCT00183625|75924311|FG000|Obtained Employment|Overall Study||21||
59802901|NCT00183625|75924312|FG001|Obtained Employment|Overall Study||18||
59802902|NCT00183625|75924313|FG002|Obtained Employment|Overall Study||14||
59802903|NCT00183625|75924314|FG003|Obtained Employment|Overall Study||14||
59802904|NCT00183625|75924311|FG000|COMPLETED|Overall Study||9||
59802905|NCT00183625|75924312|FG001|COMPLETED|Overall Study||10||
59802906|NCT00183625|75924313|FG002|COMPLETED|Overall Study||9||
59802907|NCT00183625|75924314|FG003|COMPLETED|Overall Study||10||
59802908|NCT00183625|75924311|FG000|NOT COMPLETED|Overall Study||18||
59802909|NCT00183625|75924312|FG001|NOT COMPLETED|Overall Study||18||
59802910|NCT00183625|75924313|FG002|NOT COMPLETED|Overall Study||19||
59802911|NCT00183625|75924314|FG003|NOT COMPLETED|Overall Study||14||
59956008|NCT01170702|76074755|FG002|NOT COMPLETED|Overall Study||0||
59956009|NCT01170702|76074756|FG003|NOT COMPLETED|Overall Study||2||
59956010|NCT02880540|76074768|FG000|STARTED|Overall Study||13||
59956011|NCT02880540|76074769|FG001|STARTED|Overall Study||13||
59956012|NCT02880540|76074768|FG000|COMPLETED|Overall Study||13||
59956013|NCT02880540|76074769|FG001|COMPLETED|Overall Study||13||
60073827|NCT01869764|76189172|FG000|STARTED|Overall Study||28||
59956014|NCT02880540|76074768|FG000|NOT COMPLETED|Overall Study||0||
59956015|NCT02880540|76074769|FG001|NOT COMPLETED|Overall Study||0||
59956016|NCT01109004|76074778|FG000|STARTED|Overall Study||247||
59956017|NCT01109004|76074779|FG001|STARTED|Overall Study||254||
59956018|NCT01109004|76074780|FG002|STARTED|Overall Study||257||
59956019|NCT01109004|76074778|FG000|COMPLETED|Overall Study||247||
59956020|NCT01109004|76074779|FG001|COMPLETED|Overall Study||254||
59956021|NCT01109004|76074780|FG002|COMPLETED|Overall Study||257||
59956022|NCT01109004|76074778|FG000|NOT COMPLETED|Overall Study||0||
59956023|NCT01109004|76074779|FG001|NOT COMPLETED|Overall Study||0||
59956024|NCT01109004|76074780|FG002|NOT COMPLETED|Overall Study||0||
59956025|NCT02723864|76074795|FG000|STARTED|Overall Study||3||
59956026|NCT02723864|76074796|FG001|STARTED|Overall Study||3||
59956027|NCT02723864|76074797|FG002|STARTED|Overall Study||6||
59956028|NCT02723864|76074798|FG003|STARTED|Overall Study||7||
59956029|NCT02723864|76074799|FG004|STARTED|Overall Study||3||
59956030|NCT02723864|76074800|FG005|STARTED|Overall Study||25||
59956031|NCT02723864|76074801|FG006|STARTED|Overall Study||6||
59956032|NCT02723864|76074795|FG000|COMPLETED|Overall Study||2||
59802912|NCT00511875|75924324|FG000|STARTED|Overall Study||15||
59802913|NCT00511875|75924325|FG001|STARTED|Overall Study||15||
59802914|NCT00511875|75924324|FG000|COMPLETED|Overall Study||10||
59802915|NCT00511875|75924325|FG001|COMPLETED|Overall Study||15||
59802916|NCT00511875|75924324|FG000|NOT COMPLETED|Overall Study||5||
59802917|NCT00511875|75924325|FG001|NOT COMPLETED|Overall Study||0||
59802918|NCT00183391|75924333|FG000|STARTED|Block 1 - 5 Weeks||108||
59802919|NCT00183391|75924334|FG001|STARTED|Block 1 - 5 Weeks||124||
59802920|NCT00183391|75924333|FG000|COMPLETED|Block 1 - 5 Weeks||95||
59802921|NCT00183391|75924334|FG001|COMPLETED|Block 1 - 5 Weeks||110||
59802922|NCT00183391|75924333|FG000|NOT COMPLETED|Block 1 - 5 Weeks||13||
59802923|NCT00183391|75924334|FG001|NOT COMPLETED|Block 1 - 5 Weeks||14||
59802924|NCT00183391|75924333|FG000|STARTED|Crossover Placebo - 2 Weeks||95||
59802925|NCT00183391|75924334|FG001|STARTED|Crossover Placebo - 2 Weeks||110||
59802926|NCT00183391|75924333|FG000|COMPLETED|Crossover Placebo - 2 Weeks||95||
59802927|NCT00183391|75924334|FG001|COMPLETED|Crossover Placebo - 2 Weeks||110||
59802928|NCT00183391|75924333|FG000|NOT COMPLETED|Crossover Placebo - 2 Weeks||0||
59802929|NCT00183391|75924334|FG001|NOT COMPLETED|Crossover Placebo - 2 Weeks||0||
59802930|NCT00183391|75924333|FG000|STARTED|Block 2 - 5 Weeks||95||
59802931|NCT00183391|75924334|FG001|STARTED|Block 2 - 5 Weeks||110||
59802932|NCT00183391|75924333|FG000|COMPLETED|Block 2 - 5 Weeks||91||
59956033|NCT02723864|76074796|FG001|COMPLETED|Overall Study||2||
59956034|NCT02723864|76074797|FG002|COMPLETED|Overall Study||5||
59956035|NCT02723864|76074798|FG003|COMPLETED|Overall Study||7||
59956036|NCT02723864|76074799|FG004|COMPLETED|Overall Study||2||
59956037|NCT02723864|76074800|FG005|COMPLETED|Overall Study||14||
59956038|NCT02723864|76074801|FG006|COMPLETED|Overall Study||4||
59956039|NCT02723864|76074795|FG000|NOT COMPLETED|Overall Study||1||
59956040|NCT02723864|76074796|FG001|NOT COMPLETED|Overall Study||1||
59956041|NCT02723864|76074797|FG002|NOT COMPLETED|Overall Study||1||
59956042|NCT02723864|76074798|FG003|NOT COMPLETED|Overall Study||0||
59956043|NCT02723864|76074799|FG004|NOT COMPLETED|Overall Study||1||
59956044|NCT02723864|76074800|FG005|NOT COMPLETED|Overall Study||11||
59956045|NCT02723864|76074801|FG006|NOT COMPLETED|Overall Study||2||
59956046|NCT00705146|76074840|FG000|STARTED|Overall Study||32||
59524032|NCT01027559|75619106|FG001|COMPLETED|Overall Study||26||
59524033|NCT01027559|75619107|FG002|COMPLETED|Overall Study||22||
59524034|NCT01027559|75619105|FG000|NOT COMPLETED|Overall Study||6||
59524035|NCT01027559|75619106|FG001|NOT COMPLETED|Overall Study||8||
59524036|NCT01027559|75619107|FG002|NOT COMPLETED|Overall Study||9||
59524037|NCT00985829|75619116|FG000|STARTED|Overall Study||28||
59524038|NCT00985829|75619116|FG000|COMPLETED|Overall Study||28||
59524039|NCT00985829|75619116|FG000|NOT COMPLETED|Overall Study||0||
59802933|NCT00183391|75924334|FG001|COMPLETED|Block 2 - 5 Weeks||108||
59524040|NCT01661790|75619123|FG000|STARTED|Overall Study||36||
59524041|NCT01661790|75619124|FG001|STARTED|Overall Study||36||
59802934|NCT00183391|75924333|FG000|NOT COMPLETED|Block 2 - 5 Weeks||4||
59802935|NCT00183391|75924334|FG001|NOT COMPLETED|Block 2 - 5 Weeks||2||
59524042|NCT01661790|75619123|FG000|COMPLETED|Overall Study||36||
59802936|NCT00493246|75924350|FG000|STARTED|Overall Study||2||
59802937|NCT00493246|75924351|FG001|STARTED|Overall Study||1||
59524043|NCT01661790|75619124|FG001|COMPLETED|Overall Study||34||
59956047|NCT00705146|76074841|FG001|STARTED|Overall Study||24||
59524044|NCT01661790|75619123|FG000|NOT COMPLETED|Overall Study||0||
59524045|NCT01661790|75619124|FG001|NOT COMPLETED|Overall Study||2||
59524046|NCT00985907|75619130|FG000|STARTED|Overall Study||13||
59524047|NCT00985907|75619130|FG000|COMPLETED|Overall Study||0||
59802938|NCT00493246|75924352|FG002|STARTED|Overall Study||12||
59802939|NCT00493246|75924353|FG003|STARTED|Overall Study||13||
59956048|NCT00705146|76074840|FG000|COMPLETED|Overall Study||31||
59956049|NCT00705146|76074841|FG001|COMPLETED|Overall Study||23||
59956050|NCT00705146|76074840|FG000|NOT COMPLETED|Overall Study||1||
59956051|NCT00705146|76074841|FG001|NOT COMPLETED|Overall Study||1||
59956052|NCT03203642|76074849|FG000|STARTED|Overall Study||40||
59956053|NCT03203642|76074850|FG001|STARTED|Overall Study||40||
59956054|NCT03203642|76074849|FG000|Treated|Overall Study||38||
59802940|NCT00493246|75924354|FG004|STARTED|Overall Study|All subjects who were randomized.Excludes 1 subject who was randomized in error.|9||
59802941|NCT00493246|75924355|FG005|STARTED|Overall Study|All subjects who were randomized.|16||
59802942|NCT00493246|75924356|FG006|STARTED|Overall Study|All subjects who were randomized.|12||
59802943|NCT00493246|75924357|FG007|STARTED|Overall Study|All subjects who were randomized.|10||
59802944|NCT00493246|75924350|FG000|COMPLETED|Overall Study|Completed study 30 days after the last dose|2||
59802945|NCT00493246|75924351|FG001|COMPLETED|Overall Study|Completed study 30 days after the last dose|1||
59802946|NCT00493246|75924352|FG002|COMPLETED|Overall Study|Completed study 30 days after the last dose|12||
59802947|NCT00493246|75924353|FG003|COMPLETED|Overall Study|Completed study 30 days after the last dose|13||
59802948|NCT00493246|75924354|FG004|COMPLETED|Overall Study|Completed study 30 days after the last dose|8||
59802949|NCT00493246|75924355|FG005|COMPLETED|Overall Study|Completed study 30 days after the last dose|15||
59956055|NCT03203642|76074850|FG001|Treated|Overall Study||40||
59956056|NCT03203642|76074849|FG000|COMPLETED|Overall Study||25||
59956057|NCT03203642|76074850|FG001|COMPLETED|Overall Study||29||
59956058|NCT03203642|76074849|FG000|NOT COMPLETED|Overall Study||15||
59956059|NCT03203642|76074850|FG001|NOT COMPLETED|Overall Study||11||
59956060|NCT02737722|76074860|FG000|STARTED|Overall Study||8||
59956061|NCT02737722|76074861|FG001|STARTED|Overall Study||8||
59956062|NCT02737722|76074862|FG002|STARTED|Overall Study||8||
59956063|NCT02737722|76074863|FG003|STARTED|Overall Study||6||
59956064|NCT02737722|76074860|FG000|COMPLETED|Overall Study||8||
59956065|NCT02737722|76074861|FG001|COMPLETED|Overall Study||8||
59956066|NCT02737722|76074862|FG002|COMPLETED|Overall Study||7||
59956067|NCT02737722|76074863|FG003|COMPLETED|Overall Study||6||
59956068|NCT02737722|76074860|FG000|NOT COMPLETED|Overall Study||0||
59956069|NCT02737722|76074861|FG001|NOT COMPLETED|Overall Study||0||
59956070|NCT02737722|76074862|FG002|NOT COMPLETED|Overall Study||1||
59620599|NCT00195702|75731984|FG002|STARTED|Double-blind Phase||200||
59956071|NCT02737722|76074863|FG003|NOT COMPLETED|Overall Study||0||
59956072|NCT03792750|76074873|FG000|STARTED|Overall Study||12||
59956073|NCT03792750|76074873|FG000|COMPLETED|Overall Study||9||
59956074|NCT03792750|76074873|FG000|NOT COMPLETED|Overall Study||3||
59956075|NCT02750709|76074878|FG000|STARTED|Treatment Period 1||4||
59956076|NCT02750709|76074879|FG001|STARTED|Treatment Period 1||4||
59956077|NCT02750709|76074880|FG002|STARTED|Treatment Period 1||4||
59620600|NCT00195702|75731985|FG003|STARTED|Double-blind Phase||0||
59620601|NCT00195702|75731986|FG004|STARTED|Double-blind Phase||0||
59620602|NCT00195702|75731987|FG005|STARTED|Double-blind Phase||0||
59620603|NCT00195702|75731982|FG000|COMPLETED|Double-blind Phase||168||
59620604|NCT00195702|75731983|FG001|COMPLETED|Double-blind Phase||159||
59620605|NCT00195702|75731984|FG002|COMPLETED|Double-blind Phase||140||
59620606|NCT00195702|75731985|FG003|COMPLETED|Double-blind Phase||0||
59620607|NCT00195702|75731986|FG004|COMPLETED|Double-blind Phase||0||
59620608|NCT00195702|75731987|FG005|COMPLETED|Double-blind Phase||0||
59620609|NCT00195702|75731982|FG000|NOT COMPLETED|Double-blind Phase||44||
59620610|NCT00195702|75731983|FG001|NOT COMPLETED|Double-blind Phase||48||
59620611|NCT00195702|75731984|FG002|NOT COMPLETED|Double-blind Phase||60||
59620612|NCT00195702|75731985|FG003|NOT COMPLETED|Double-blind Phase||0||
59620613|NCT00195702|75731986|FG004|NOT COMPLETED|Double-blind Phase||0||
59620614|NCT00195702|75731987|FG005|NOT COMPLETED|Double-blind Phase||0||
59620615|NCT00195702|75731982|FG000|STARTED|Open-label Extension Phase||0||
59620616|NCT00195702|75731983|FG001|STARTED|Open-label Extension Phase||0||
59620617|NCT00195702|75731984|FG002|STARTED|Open-label Extension Phase||0||
59620618|NCT00195702|75731985|FG003|STARTED|Open-label Extension Phase|3 subjects completed the double-blind phase but did not enter the open-label extension phase.|165||
59620619|NCT00195702|75731986|FG004|STARTED|Open-label Extension Phase|1 subject completed the double-blind phase but did not enter the open-label extension phase.|158||
59620620|NCT00195702|75731987|FG005|STARTED|Open-label Extension Phase|6 subjects completed the double-blind phase but did not enter the open-label extension phase.|134||
59620621|NCT00195702|75731982|FG000|COMPLETED|Open-label Extension Phase||0||
59620622|NCT00195702|75731983|FG001|COMPLETED|Open-label Extension Phase||0||
59620623|NCT00195702|75731984|FG002|COMPLETED|Open-label Extension Phase||0||
59802950|NCT00493246|75924356|FG006|COMPLETED|Overall Study|Completed study 30 days after the last dose|11||
59802951|NCT00493246|75924357|FG007|COMPLETED|Overall Study|Completed study 30 days after the last dose|10||
59802952|NCT00493246|75924350|FG000|NOT COMPLETED|Overall Study||0||
59956078|NCT02750709|76074881|FG003|STARTED|Treatment Period 1||4||
59956079|NCT02750709|76074882|FG004|STARTED|Treatment Period 1||4||
59956080|NCT02750709|76074883|FG005|STARTED|Treatment Period 1||4||
59956081|NCT02750709|76074878|FG000|COMPLETED|Treatment Period 1||4||
59956082|NCT02750709|76074879|FG001|COMPLETED|Treatment Period 1||4||
59956083|NCT02750709|76074880|FG002|COMPLETED|Treatment Period 1||4||
59956084|NCT02750709|76074881|FG003|COMPLETED|Treatment Period 1||4||
59956085|NCT02750709|76074882|FG004|COMPLETED|Treatment Period 1||4||
59956086|NCT02750709|76074883|FG005|COMPLETED|Treatment Period 1||3||
59956087|NCT02750709|76074878|FG000|NOT COMPLETED|Treatment Period 1||0||
59956088|NCT02750709|76074879|FG001|NOT COMPLETED|Treatment Period 1||0||
59956089|NCT02750709|76074880|FG002|NOT COMPLETED|Treatment Period 1||0||
59956090|NCT02750709|76074881|FG003|NOT COMPLETED|Treatment Period 1||0||
59956091|NCT02750709|76074882|FG004|NOT COMPLETED|Treatment Period 1||0||
59802953|NCT00493246|75924351|FG001|NOT COMPLETED|Overall Study||0||
59802954|NCT00493246|75924352|FG002|NOT COMPLETED|Overall Study||0||
59802955|NCT00493246|75924353|FG003|NOT COMPLETED|Overall Study||0||
59802956|NCT00493246|75924354|FG004|NOT COMPLETED|Overall Study||1||
59802957|NCT00493246|75924355|FG005|NOT COMPLETED|Overall Study||1||
59802958|NCT00493246|75924356|FG006|NOT COMPLETED|Overall Study||1||
59802959|NCT00493246|75924357|FG007|NOT COMPLETED|Overall Study||0||
59802960|NCT02281955|75924375|FG000|STARTED|Overall Study||114||
59802961|NCT02281955|75924375|FG000|COMPLETED|Overall Study||113||
59802962|NCT02281955|75924375|FG000|NOT COMPLETED|Overall Study||1||
59802963|NCT00511797|75924383|FG000|STARTED|Overall Study||62||
59802964|NCT00511797|75924384|FG001|STARTED|Overall Study||63||
59956092|NCT02750709|76074883|FG005|NOT COMPLETED|Treatment Period 1||1||
59956093|NCT02750709|76074878|FG000|STARTED|Treatment Period 2||4||
59956094|NCT02750709|76074879|FG001|STARTED|Treatment Period 2||4||
59956095|NCT02750709|76074880|FG002|STARTED|Treatment Period 2||4||
59956096|NCT02750709|76074881|FG003|STARTED|Treatment Period 2||4||
59956097|NCT02750709|76074882|FG004|STARTED|Treatment Period 2||4||
59802965|NCT00511797|75924385|FG002|STARTED|Overall Study||62||
59802966|NCT00511797|75924386|FG003|STARTED|Overall Study||62||
59802967|NCT00511797|75924383|FG000|Subjects Dispensed Drugs|Overall Study||61||
59802968|NCT00511797|75924384|FG001|Subjects Dispensed Drugs|Overall Study||63||
59802969|NCT00511797|75924385|FG002|Subjects Dispensed Drugs|Overall Study||61||
59802970|NCT00511797|75924386|FG003|Subjects Dispensed Drugs|Overall Study||59||
59956098|NCT02750709|76074883|FG005|STARTED|Treatment Period 2||3||
59956099|NCT02750709|76074878|FG000|COMPLETED|Treatment Period 2||4||
59956100|NCT02750709|76074879|FG001|COMPLETED|Treatment Period 2||4||
59956101|NCT02750709|76074880|FG002|COMPLETED|Treatment Period 2||4||
59956102|NCT02750709|76074881|FG003|COMPLETED|Treatment Period 2||4||
59956103|NCT02750709|76074882|FG004|COMPLETED|Treatment Period 2||4||
59802971|NCT00511797|75924383|FG000|Subjects Received Treatment|Overall Study|FAS|61||
59802972|NCT00511797|75924384|FG001|Subjects Received Treatment|Overall Study|FAS|62||
59802973|NCT00511797|75924385|FG002|Subjects Received Treatment|Overall Study|FAS|61||
59802974|NCT00511797|75924386|FG003|Subjects Received Treatment|Overall Study|FAS|58||
59802975|NCT00511797|75924383|FG000|COMPLETED|Overall Study||55||
59802976|NCT00511797|75924384|FG001|COMPLETED|Overall Study||55||
59802977|NCT00511797|75924385|FG002|COMPLETED|Overall Study||51||
59802978|NCT00511797|75924386|FG003|COMPLETED|Overall Study||47||
59802979|NCT00511797|75924383|FG000|NOT COMPLETED|Overall Study||7||
59802980|NCT00511797|75924384|FG001|NOT COMPLETED|Overall Study||8||
59802981|NCT00511797|75924385|FG002|NOT COMPLETED|Overall Study||11||
59802982|NCT00511797|75924386|FG003|NOT COMPLETED|Overall Study||15||
59802983|NCT00487552|75924396|FG000|STARTED|Overall Study||18||
59802984|NCT00487552|75924396|FG000|COMPLETED|Overall Study||12||
59802985|NCT00487552|75924396|FG000|NOT COMPLETED|Overall Study||6||
59802986|NCT00182689|75924403|FG000|STARTED|Overall Study||40||
59802987|NCT00182689|75924404|FG001|STARTED|Overall Study||49||
59956104|NCT02750709|76074883|FG005|COMPLETED|Treatment Period 2||3||
59956105|NCT02750709|76074878|FG000|NOT COMPLETED|Treatment Period 2||0||
59524048|NCT00985907|75619130|FG000|NOT COMPLETED|Overall Study||13||
59524049|NCT00986453|75619134|FG000|STARTED|Overall Study||45||
59524050|NCT00986453|75619134|FG000|COMPLETED|Overall Study||43||
59524051|NCT00986453|75619134|FG000|NOT COMPLETED|Overall Study||2||
59524052|NCT02085980|75619140|FG000|STARTED|Overall Study||30||
59524053|NCT02085980|75619140|FG000|COMPLETED|Overall Study||27||
59524054|NCT02085980|75619140|FG000|NOT COMPLETED|Overall Study||3||
59802988|NCT00182689|75924403|FG000|Eligible|Overall Study||39||
59802989|NCT00182689|75924404|FG001|Eligible|Overall Study||45||
59802990|NCT00182689|75924403|FG000|Eligible and Began Protocol Therapy|Overall Study||38||
59802991|NCT00182689|75924404|FG001|Eligible and Began Protocol Therapy|Overall Study||45||
59802992|NCT00182689|75924403|FG000|COMPLETED|Overall Study||0||
59802993|NCT00182689|75924404|FG001|COMPLETED|Overall Study||0||
59802994|NCT00182689|75924403|FG000|NOT COMPLETED|Overall Study||40||
59524055|NCT02546544|75619144|FG000|STARTED|Overall Study||16||
59802995|NCT00182689|75924404|FG001|NOT COMPLETED|Overall Study||49||
59802996|NCT03860259|75924416|FG000|STARTED|Overall Study||25||
59802997|NCT03860259|75924417|FG001|STARTED|Overall Study||25||
59802998|NCT03860259|75924416|FG000|COMPLETED|Overall Study||19||
59956106|NCT02750709|76074879|FG001|NOT COMPLETED|Treatment Period 2||0||
59956107|NCT02750709|76074880|FG002|NOT COMPLETED|Treatment Period 2||0||
59956108|NCT02750709|76074881|FG003|NOT COMPLETED|Treatment Period 2||0||
59802999|NCT03860259|75924417|FG001|COMPLETED|Overall Study||20||
59803000|NCT03860259|75924416|FG000|NOT COMPLETED|Overall Study||6||
59803001|NCT03860259|75924417|FG001|NOT COMPLETED|Overall Study||5||
59803002|NCT00131365|75924423|FG000|STARTED|Overall Study|Only safety data was reported due to early closure of the study due to device obsolescence.|9||
59956109|NCT02750709|76074882|FG004|NOT COMPLETED|Treatment Period 2||0||
59524056|NCT02546544|75619144|FG000|Received Allocated Intervention|Overall Study||16||
59956110|NCT02750709|76074883|FG005|NOT COMPLETED|Treatment Period 2||0||
59956111|NCT02750709|76074878|FG000|STARTED|Treatment Period 3||4||
59956112|NCT02750709|76074879|FG001|STARTED|Treatment Period 3||4||
59956113|NCT02750709|76074880|FG002|STARTED|Treatment Period 3||4||
59956114|NCT02750709|76074881|FG003|STARTED|Treatment Period 3||4||
59956115|NCT02750709|76074882|FG004|STARTED|Treatment Period 3||4||
59956116|NCT02750709|76074883|FG005|STARTED|Treatment Period 3||3||
59956117|NCT02750709|76074878|FG000|COMPLETED|Treatment Period 3||4||
59956118|NCT02750709|76074879|FG001|COMPLETED|Treatment Period 3||4||
59956119|NCT02750709|76074880|FG002|COMPLETED|Treatment Period 3||4||
59803003|NCT00131365|75924423|FG000|COMPLETED|Overall Study||5|5 out of 9 enrolled participants were followed through the month 36 visit.|
59803004|NCT00131365|75924423|FG000|NOT COMPLETED|Overall Study||4||
59803005|NCT00487240|75924430|FG000|STARTED|Overall Study||195||
59803006|NCT00487240|75924431|FG001|STARTED|Overall Study||192||
59803007|NCT00487240|75924430|FG000|Full Analysis Set (ITT Population)|Overall Study||192||
59803008|NCT00487240|75924431|FG001|Full Analysis Set (ITT Population)|Overall Study||189||
59803009|NCT00487240|75924430|FG000|COMPLETED|Overall Study||164||
59803010|NCT00487240|75924431|FG001|COMPLETED|Overall Study||166||
59803011|NCT00487240|75924430|FG000|NOT COMPLETED|Overall Study||31||
59803012|NCT00487240|75924431|FG001|NOT COMPLETED|Overall Study||26||
59803013|NCT02224391|75924439|FG000|STARTED|Overall Study||124||
59803014|NCT02224391|75924440|FG001|STARTED|Overall Study||122||
59803015|NCT02224391|75924439|FG000|COMPLETED|Overall Study||92||
59803016|NCT02224391|75924440|FG001|COMPLETED|Overall Study||98||
59803017|NCT02224391|75924439|FG000|NOT COMPLETED|Overall Study||32||
59803018|NCT02224391|75924440|FG001|NOT COMPLETED|Overall Study||24||
59803019|NCT00487162|75924448|FG000|STARTED|Overall Study||30||
59803020|NCT00487162|75924449|FG001|STARTED|Overall Study||26||
59803021|NCT00487162|75924448|FG000|COMPLETED|Overall Study||28||
59803022|NCT00487162|75924449|FG001|COMPLETED|Overall Study||21||
59803023|NCT00487162|75924448|FG000|NOT COMPLETED|Overall Study||2||
59956120|NCT02750709|76074881|FG003|COMPLETED|Treatment Period 3||4||
59956121|NCT02750709|76074882|FG004|COMPLETED|Treatment Period 3||4||
59956122|NCT02750709|76074883|FG005|COMPLETED|Treatment Period 3||3||
59956123|NCT02750709|76074878|FG000|NOT COMPLETED|Treatment Period 3||0||
59956124|NCT02750709|76074879|FG001|NOT COMPLETED|Treatment Period 3||0||
59956125|NCT02750709|76074880|FG002|NOT COMPLETED|Treatment Period 3||0||
59956126|NCT02750709|76074881|FG003|NOT COMPLETED|Treatment Period 3||0||
59803024|NCT00487162|75924449|FG001|NOT COMPLETED|Overall Study||5||
59803025|NCT00487084|75924458|FG000|STARTED|Overall Study||33||
59803026|NCT00487084|75924459|FG001|STARTED|Overall Study||33||
59803027|NCT00487084|75924460|FG002|STARTED|Overall Study||33||
59803028|NCT00487084|75924458|FG000|COMPLETED|Overall Study||29||
59803029|NCT00487084|75924459|FG001|COMPLETED|Overall Study||30||
59803030|NCT00487084|75924460|FG002|COMPLETED|Overall Study||28||
59803031|NCT00487084|75924458|FG000|NOT COMPLETED|Overall Study||4||
59803032|NCT00487084|75924459|FG001|NOT COMPLETED|Overall Study||3||
59803033|NCT00487084|75924460|FG002|NOT COMPLETED|Overall Study||5||
59803034|NCT00466726|75924468|FG000|STARTED|Overall Study||57||
59803035|NCT00466726|75924468|FG000|COMPLETED|Overall Study||43||
59803036|NCT00466726|75924468|FG000|NOT COMPLETED|Overall Study||14||
59956127|NCT02750709|76074882|FG004|NOT COMPLETED|Treatment Period 3||0||
59956128|NCT02750709|76074883|FG005|NOT COMPLETED|Treatment Period 3||0||
59956129|NCT02723786|76074891|FG000|STARTED|Overall Study||7||
59956130|NCT02723786|76074891|FG000|COMPLETED|Overall Study||6||
59956131|NCT02723786|76074891|FG000|NOT COMPLETED|Overall Study||1||
59956132|NCT02996864|76074897|FG000|STARTED|Overall Study||150||
59956133|NCT02996864|76074898|FG001|STARTED|Overall Study||150||
59956134|NCT02996864|76074897|FG000|COMPLETED|Overall Study||142||
59956135|NCT02996864|76074898|FG001|COMPLETED|Overall Study||136||
59956136|NCT02996864|76074897|FG000|NOT COMPLETED|Overall Study||8||
59956137|NCT02996864|76074898|FG001|NOT COMPLETED|Overall Study||14||
59956138|NCT02872701|76074904|FG000|STARTED|Overall Study||100||
59956139|NCT02872701|76074904|FG000|COMPLETED|Overall Study||97||
59956140|NCT02872701|76074904|FG000|NOT COMPLETED|Overall Study||3||
59956141|NCT02723084|76074910|FG000|STARTED|Overall Study||90||
59956142|NCT02723084|76074911|FG001|STARTED|Overall Study||46||
59803037|NCT01721291|75924474|FG000|STARTED|Overall Study||14||
59803038|NCT01721291|75924475|FG001|STARTED|Overall Study||12||
59803039|NCT01721291|75924474|FG000|COMPLETED|Overall Study||12||
59803040|NCT01721291|75924475|FG001|COMPLETED|Overall Study||12||
59803041|NCT01721291|75924474|FG000|NOT COMPLETED|Overall Study||2||
59803042|NCT01721291|75924475|FG001|NOT COMPLETED|Overall Study||0||
59803043|NCT00486226|75924501|FG000|STARTED|Overall Study||105||
59803044|NCT00486226|75924501|FG000|COMPLETED|Overall Study||92||
59803045|NCT00486226|75924501|FG000|NOT COMPLETED|Overall Study||13||
59803046|NCT00485758|75924510|FG000|STARTED|Overall Study||454||
59803047|NCT00485758|75924511|FG001|STARTED|Overall Study||342||
59803048|NCT00485758|75924510|FG000|COMPLETED|Overall Study||298||
59803049|NCT00485758|75924511|FG001|COMPLETED|Overall Study||277||
59803050|NCT00485758|75924510|FG000|NOT COMPLETED|Overall Study||156||
59803051|NCT00485758|75924511|FG001|NOT COMPLETED|Overall Study||65||
59803052|NCT00469612|75924519|FG000|STARTED|Overall Study||2||
59803053|NCT00469612|75924520|FG001|STARTED|Overall Study||0||
59817870|NCT04488770|75940335|FG009|NOT COMPLETED|Part 1-Cohort 1: Period 4 (Up to 5 Days)||0||
59956143|NCT02723084|76074910|FG000|COMPLETED|Overall Study||86||
59803054|NCT00469612|75924519|FG000|COMPLETED|Overall Study|Subjects enrolled, but no data collected. Study terminated before data collection.|0||
59803055|NCT00469612|75924520|FG001|COMPLETED|Overall Study||0||
59803056|NCT00469612|75924519|FG000|NOT COMPLETED|Overall Study||2||
59803057|NCT00469612|75924520|FG001|NOT COMPLETED|Overall Study||0||
59803058|NCT00469456|75924528|FG000|STARTED|Overall Study|Safety Population defined as all patients who took at least one dose of double-blind study drug|129||
59803059|NCT00469456|75924529|FG001|STARTED|Overall Study|Safety Population defined as all patients who took at least one dose of double-blind study drug.|135||
59803060|NCT00469456|75924528|FG000|COMPLETED|Overall Study||120||
59803061|NCT00469456|75924529|FG001|COMPLETED|Overall Study||131||
59956144|NCT02723084|76074911|FG001|COMPLETED|Overall Study||45||
59956145|NCT02723084|76074910|FG000|NOT COMPLETED|Overall Study||4||
59956146|NCT02723084|76074911|FG001|NOT COMPLETED|Overall Study||1||
59803062|NCT00469456|75924528|FG000|NOT COMPLETED|Overall Study||9||
59803063|NCT00469456|75924529|FG001|NOT COMPLETED|Overall Study||4||
59803064|NCT00581555|75924537|FG000|STARTED|Overall Study||62||
59803065|NCT00581555|75924538|FG001|STARTED|Overall Study||58||
59803066|NCT00581555|75924537|FG000|COMPLETED|Overall Study||19||
59803067|NCT00581555|75924538|FG001|COMPLETED|Overall Study||38||
59803068|NCT00581555|75924537|FG000|NOT COMPLETED|Overall Study||43||
59803069|NCT00581555|75924538|FG001|NOT COMPLETED|Overall Study||20||
59803070|NCT00469144|75924546|FG000|STARTED|Overall Study|Eight assigned to Fixed Dose without randomization.|114||
59803071|NCT00469144|75924547|FG001|STARTED|Overall Study||111||
59803072|NCT00469144|75924546|FG000|COMPLETED|Overall Study||108||
59803073|NCT00469144|75924547|FG001|COMPLETED|Overall Study||105||
59803074|NCT00469144|75924546|FG000|NOT COMPLETED|Overall Study||6||
59803075|NCT00469144|75924547|FG001|NOT COMPLETED|Overall Study||6||
59803076|NCT00468910|75924559|FG000|STARTED|Overall Study||40||
59803077|NCT00468910|75924560|FG001|STARTED|Overall Study||39||
59803078|NCT00468910|75924559|FG000|Randomization|Overall Study||40||
59803079|NCT00468910|75924560|FG001|Randomization|Overall Study||39||
59803080|NCT00468910|75924559|FG000|Treatment|Overall Study||36||
59803081|NCT00468910|75924560|FG001|Treatment|Overall Study||36||
59803082|NCT00468910|75924559|FG000|Post-Treatment Biopsy|Overall Study||36||
59803083|NCT00468910|75924560|FG001|Post-Treatment Biopsy|Overall Study||36||
59956147|NCT02750943|76074919|FG000|STARTED|Overall Study||125||
59956148|NCT02750943|76074920|FG001|STARTED|Overall Study||128||
59956149|NCT02750943|76074919|FG000|COMPLETED|Overall Study||119||
59956150|NCT02750943|76074920|FG001|COMPLETED|Overall Study||119||
59956151|NCT02750943|76074919|FG000|NOT COMPLETED|Overall Study||6||
59956152|NCT02750943|76074920|FG001|NOT COMPLETED|Overall Study||9||
59956153|NCT06076681|76074930|FG000|STARTED|Overall Study||10||
59956154|NCT06076681|76074931|FG001|STARTED|Overall Study||10||
59956155|NCT06076681|76074932|FG002|STARTED|Overall Study||10||
59956156|NCT06076681|76074933|FG003|STARTED|Overall Study||10||
59956157|NCT06076681|76074930|FG000|COMPLETED|Overall Study||10||
59956158|NCT06076681|76074931|FG001|COMPLETED|Overall Study||10||
59956159|NCT06076681|76074932|FG002|COMPLETED|Overall Study||10||
59956160|NCT06076681|76074933|FG003|COMPLETED|Overall Study||10||
59956161|NCT06076681|76074930|FG000|NOT COMPLETED|Overall Study||0||
59524057|NCT02546544|75619144|FG000|COMPLETED|Overall Study||0||
59524058|NCT02546544|75619144|FG000|NOT COMPLETED|Overall Study||16||
59956162|NCT06076681|76074931|FG001|NOT COMPLETED|Overall Study||0||
59956163|NCT06076681|76074932|FG002|NOT COMPLETED|Overall Study||0||
59956164|NCT06076681|76074933|FG003|NOT COMPLETED|Overall Study||0||
59956165|NCT05177094|76074945|FG000|STARTED|Overall Study||103||
59956166|NCT05177094|76074946|FG001|STARTED|Overall Study||52||
59956167|NCT05177094|76074945|FG000|Received at Least One Dose of Study Drug (Safety Population Week 1-4)|Overall Study||102||
59956168|NCT05177094|76074946|FG001|Received at Least One Dose of Study Drug (Safety Population Week 1-4)|Overall Study||52||
59524059|NCT01027793|75619150|FG000|STARTED|Overall Study||17||
59524060|NCT01027793|75619151|FG001|STARTED|Overall Study||15||
59524061|NCT01027793|75619150|FG000|COMPLETED|Overall Study||10||
59524062|NCT01027793|75619151|FG001|COMPLETED|Overall Study||12||
59524063|NCT01027793|75619150|FG000|NOT COMPLETED|Overall Study||7||
59524064|NCT01027793|75619151|FG001|NOT COMPLETED|Overall Study||3||
59524065|NCT01029587|75619157|FG000|STARTED|Overall Study||1||
59524066|NCT01029587|75619157|FG000|COMPLETED|Overall Study||1||
59524067|NCT01029587|75619157|FG000|NOT COMPLETED|Overall Study||0||
59524068|NCT00988013|75619165|FG000|STARTED|Overall Study||3||
59803084|NCT00468910|75924559|FG000|Follow-up|Overall Study||36||
59803085|NCT00468910|75924560|FG001|Follow-up|Overall Study||36||
59803086|NCT00468910|75924559|FG000|COMPLETED|Overall Study||36||
59803087|NCT00468910|75924560|FG001|COMPLETED|Overall Study||36||
59956169|NCT05177094|76074945|FG000|Safety Population Week 5-8|Overall Study||95|All participants who took at least 1 dose of study drug and who did not discontinue at or prior to week 4.|
59956170|NCT05177094|76074946|FG001|Safety Population Week 5-8|Overall Study||46|All participants who took at least 1 dose of study drug and who did not discontinue at or prior to week 4.|
59956171|NCT05177094|76074945|FG000|COMPLETED|Overall Study||88||
59956172|NCT05177094|76074946|FG001|COMPLETED|Overall Study||43||
59956173|NCT05177094|76074945|FG000|NOT COMPLETED|Overall Study||15||
59956174|NCT05177094|76074946|FG001|NOT COMPLETED|Overall Study||9||
59803088|NCT00468910|75924559|FG000|NOT COMPLETED|Overall Study||4||
59803089|NCT00468910|75924560|FG001|NOT COMPLETED|Overall Study||3||
59803090|NCT01412333|75924569|FG000|STARTED|Overall Study||418||
59803091|NCT01412333|75924570|FG001|STARTED|Overall Study||417||
59956175|NCT05104749|76074956|FG000|STARTED|Overall Study||38||
59956176|NCT05104749|76074957|FG001|STARTED|Overall Study||39||
59956177|NCT05104749|76074956|FG000|COMPLETED|Overall Study||36||
59803092|NCT01412333|75924569|FG000|COMPLETED|Overall Study||320||
59803093|NCT01412333|75924570|FG001|COMPLETED|Overall Study||360||
59803094|NCT01412333|75924569|FG000|NOT COMPLETED|Overall Study||98||
59803095|NCT01412333|75924570|FG001|NOT COMPLETED|Overall Study||57||
59803096|NCT00519285|75924579|FG000|STARTED|Overall Study|Randomized|612||
59803097|NCT00519285|75924580|FG001|STARTED|Overall Study|Randomized|612||
59803098|NCT00519285|75924579|FG000|TREATED|Overall Study|Received at least part of one dose of placebo|604||
59803099|NCT00519285|75924580|FG001|TREATED|Overall Study|Received at least part of one dose of aflibercept|605||
59803100|NCT00519285|75924579|FG000|Still Treated at Cut-off Date|Overall Study|The cut-off date for analysis was defined as 07 February 2012, date at which 873 deaths has occurred|1||
59803101|NCT00519285|75924580|FG001|Still Treated at Cut-off Date|Overall Study||2||
59803102|NCT00519285|75924579|FG000|COMPLETED|Overall Study|Participants were treated until progressive disease, unacceptable toxicity, or refusal of treatment|0||
59803103|NCT00519285|75924580|FG001|COMPLETED|Overall Study||0||
59803104|NCT00519285|75924579|FG000|NOT COMPLETED|Overall Study||612||
59803105|NCT00519285|75924580|FG001|NOT COMPLETED|Overall Study||612||
59803106|NCT00464620|75924586|FG000|STARTED|Overall Study||50||
59803107|NCT00464620|75924587|FG001|STARTED|Overall Study||200||
59803108|NCT00464620|75924588|FG002|STARTED|Overall Study||116||
59956178|NCT05104749|76074957|FG001|COMPLETED|Overall Study||36||
59956179|NCT05104749|76074956|FG000|NOT COMPLETED|Overall Study||2||
59956180|NCT05104749|76074957|FG001|NOT COMPLETED|Overall Study||3||
59956181|NCT05098041|76074963|FG000|STARTED|Period 1 (1 Day)||15||
59956182|NCT05098041|76074963|FG000|COMPLETED|Period 1 (1 Day)||14||
59956183|NCT05098041|76074963|FG000|NOT COMPLETED|Period 1 (1 Day)||1||
59956184|NCT05098041|76074963|FG000|STARTED|Washout Period (4 Days)||14||
59956185|NCT05098041|76074963|FG000|COMPLETED|Washout Period (4 Days)||14||
59956186|NCT05098041|76074963|FG000|NOT COMPLETED|Washout Period (4 Days)||0||
59956187|NCT05098041|76074963|FG000|STARTED|Period 2 (13 Days)||14||
59956188|NCT05098041|76074963|FG000|COMPLETED|Period 2 (13 Days)||14||
59956189|NCT05098041|76074963|FG000|NOT COMPLETED|Period 2 (13 Days)||0||
59956190|NCT05027282|76074974|FG000|STARTED|Overall Study||28||
59956191|NCT05027282|76074974|FG000|COMPLETED|Overall Study||28||
59956192|NCT05027282|76074974|FG000|NOT COMPLETED|Overall Study||0||
59956193|NCT04735705|76074978|FG000|STARTED|Overall Study||50||
59956194|NCT04735705|76074978|FG000|COMPLETED|Overall Study||47||
59956195|NCT04735705|76074978|FG000|NOT COMPLETED|Overall Study||3||
59956196|NCT04648241|76074984|FG000|STARTED|Overall Study||100||
59956197|NCT04648241|76074985|FG001|STARTED|Overall Study||65||
59956198|NCT04648241|76074984|FG000|COMPLETED|Overall Study||99||
59956199|NCT04648241|76074985|FG001|COMPLETED|Overall Study||65||
59956200|NCT04648241|76074984|FG000|NOT COMPLETED|Overall Study||1||
59956201|NCT04648241|76074985|FG001|NOT COMPLETED|Overall Study||0||
59956202|NCT04589832|76074994|FG000|STARTED|Overall Study||6||
59803109|NCT00464620|75924586|FG000|COMPLETED|Overall Study|48 patients were evaluable.|48||
59803110|NCT00464620|75924587|FG001|COMPLETED|Overall Study||198||
59803111|NCT00464620|75924588|FG002|COMPLETED|Overall Study||109||
59803112|NCT00464620|75924586|FG000|NOT COMPLETED|Overall Study||2||
59803113|NCT00464620|75924587|FG001|NOT COMPLETED|Overall Study||2||
59803114|NCT00464620|75924588|FG002|NOT COMPLETED|Overall Study||7||
59803115|NCT00464542|75924601|FG000|STARTED|Pre-treatment||12||
59803116|NCT00464542|75924601|FG000|COMPLETED|Pre-treatment||10||
59803117|NCT00464542|75924601|FG000|NOT COMPLETED|Pre-treatment||2||
59803118|NCT00464542|75924601|FG000|STARTED|Post-treatment||10||
59803119|NCT00464542|75924601|FG000|COMPLETED|Post-treatment||10||
59803120|NCT00464542|75924601|FG000|NOT COMPLETED|Post-treatment||0||
59803121|NCT00468676|75924607|FG000|STARTED|Overall Study||108||
59803122|NCT00468676|75924608|FG001|STARTED|Overall Study||106||
59956203|NCT04589832|76074994|FG000|COMPLETED|Overall Study||6||
59956204|NCT04589832|76074994|FG000|NOT COMPLETED|Overall Study||0||
59956205|NCT04487834|76075000|FG000|STARTED|Overall Study||33||
59956206|NCT04487834|76075001|FG001|STARTED|Overall Study||54||
59956207|NCT04487834|76075000|FG000|COMPLETED|Overall Study||33||
59956208|NCT04487834|76075001|FG001|COMPLETED|Overall Study||54||
59803123|NCT00468676|75924607|FG000|COMPLETED|Overall Study||92||
59803124|NCT00468676|75924608|FG001|COMPLETED|Overall Study||94||
59803125|NCT00468676|75924607|FG000|NOT COMPLETED|Overall Study||16||
59803126|NCT00468676|75924608|FG001|NOT COMPLETED|Overall Study||12||
59803127|NCT00464308|75924619|FG000|STARTED|Overall Study||464||
59803128|NCT00464308|75924620|FG001|STARTED|Overall Study||469||
59803129|NCT00464308|75924621|FG002|STARTED|Overall Study||459||
59803130|NCT00464308|75924619|FG000|COMPLETED|Overall Study||395||
59956209|NCT04487834|76075000|FG000|NOT COMPLETED|Overall Study||0||
59956210|NCT04487834|76075001|FG001|NOT COMPLETED|Overall Study||0||
59956211|NCT04366726|76075007|FG000|STARTED|Overall Study||22||
59956212|NCT04366726|76075007|FG000|Received at Least 1 Dose of Study Drug|Overall Study||22||
59956213|NCT04366726|76075007|FG000|COMPLETED|Overall Study||22||
59956214|NCT04366726|76075007|FG000|NOT COMPLETED|Overall Study||0||
59956215|NCT04184999|76075013|FG000|STARTED|Overall Study||40||40
59956216|NCT04184999|76075014|FG001|STARTED|Overall Study||40||40
59956217|NCT04184999|76075013|FG000|3 Week Tear Film Osmolarity Testing|Overall Study||40||40
59956218|NCT04184999|76075014|FG001|3 Week Tear Film Osmolarity Testing|Overall Study||40||40
59956219|NCT04184999|76075013|FG000|COMPLETED|Overall Study||40||40
59956220|NCT04184999|76075014|FG001|COMPLETED|Overall Study||40||40
59956221|NCT04184999|76075013|FG000|NOT COMPLETED|Overall Study||0||0
59956222|NCT04184999|76075014|FG001|NOT COMPLETED|Overall Study||0||0
59956223|NCT04124952|76075020|FG000|STARTED|Overall Study||30||
59956224|NCT04124952|76075020|FG000|COMPLETED|Overall Study||29||
59956225|NCT04124952|76075020|FG000|NOT COMPLETED|Overall Study||1||
59956226|NCT04058990|76075027|FG000|STARTED|Overall Study||101||
59956227|NCT04058990|76075028|FG001|STARTED|Overall Study||49||
59956228|NCT04058990|76075029|FG002|STARTED|Overall Study||30||
59956229|NCT04058990|76075027|FG000|COMPLETED|Overall Study||100||
59956230|NCT04058990|76075028|FG001|COMPLETED|Overall Study||49||
59956231|NCT04058990|76075029|FG002|COMPLETED|Overall Study||30||
59956232|NCT04058990|76075027|FG000|NOT COMPLETED|Overall Study||1||
59956233|NCT04058990|76075028|FG001|NOT COMPLETED|Overall Study||0||
59956234|NCT04058990|76075029|FG002|NOT COMPLETED|Overall Study||0||
59956235|NCT03999203|76075041|FG000|STARTED|Overall Study||22||
59803131|NCT00464308|75924620|FG001|COMPLETED|Overall Study||406||
59803132|NCT00464308|75924621|FG002|COMPLETED|Overall Study||400||
59803133|NCT00464308|75924619|FG000|NOT COMPLETED|Overall Study||69||
59956236|NCT03999203|76075042|FG001|STARTED|Overall Study||6||
59956237|NCT03999203|76075043|FG002|STARTED|Overall Study||19||
59956238|NCT03999203|76075044|FG003|STARTED|Overall Study||14||
59956239|NCT03999203|76075041|FG000|COMPLETED|Overall Study||22||
59956240|NCT03999203|76075042|FG001|COMPLETED|Overall Study||6||
59956241|NCT03999203|76075043|FG002|COMPLETED|Overall Study||19||
59956242|NCT03999203|76075044|FG003|COMPLETED|Overall Study||14||
59956243|NCT03999203|76075041|FG000|NOT COMPLETED|Overall Study||0||
59956244|NCT03999203|76075042|FG001|NOT COMPLETED|Overall Study||0||
59956245|NCT03999203|76075043|FG002|NOT COMPLETED|Overall Study||0||
59956246|NCT03999203|76075044|FG003|NOT COMPLETED|Overall Study||0||
59956247|NCT03792347|76075054|FG000|STARTED|Overall Study||20||
59956248|NCT03792347|76075054|FG000|COMPLETED|Overall Study||20||
59956249|NCT03792347|76075054|FG000|NOT COMPLETED|Overall Study||0||
59956250|NCT03677596|76075061|FG000|STARTED|Overall Study||64||
59956251|NCT03677596|76075062|FG001|STARTED|Overall Study||38||
59956252|NCT03677596|76075061|FG000|COMPLETED|Overall Study||41||
59956253|NCT03677596|76075062|FG001|COMPLETED|Overall Study||19||
59956254|NCT03677596|76075061|FG000|NOT COMPLETED|Overall Study||23||
59956255|NCT03677596|76075062|FG001|NOT COMPLETED|Overall Study||19||
59956256|NCT03448718|76075073|FG000|STARTED|Overall Study||19||
59956257|NCT03448718|76075073|FG000|COMPLETED|Overall Study||19||
59956258|NCT03448718|76075073|FG000|NOT COMPLETED|Overall Study||0||
59956259|NCT03422627|76075082|FG000|STARTED|Overall Study||7||
59956260|NCT03422627|76075083|FG001|STARTED|Overall Study||7||
59956261|NCT03422627|76075084|FG002|STARTED|Overall Study||7||
59956262|NCT03422627|76075085|FG003|STARTED|Overall Study||6||
59956263|NCT03422627|76075086|FG004|STARTED|Overall Study||5||
59956264|NCT03422627|76075082|FG000|Completed up to Week 52 and Opted for Extended Dosing|Overall Study||2||
59803134|NCT00464308|75924620|FG001|NOT COMPLETED|Overall Study||63||
59803135|NCT00464308|75924621|FG002|NOT COMPLETED|Overall Study||59||
59803136|NCT00468286|75924631|FG000|STARTED|Overall Study|Started=Intention to treat (ITT) population.|67||
59956265|NCT03422627|76075083|FG001|Completed up to Week 52 and Opted for Extended Dosing|Overall Study||1||
59803137|NCT00468286|75924632|FG001|STARTED|Overall Study||66||
59803138|NCT00468286|75924631|FG000|COMPLETED|Overall Study||60||
59803139|NCT00468286|75924632|FG001|COMPLETED|Overall Study||54||
59956266|NCT03422627|76075084|FG002|Completed up to Week 52 and Opted for Extended Dosing|Overall Study||2||
59956267|NCT03422627|76075085|FG003|Completed up to Week 52 and Opted for Extended Dosing|Overall Study||3||
59956268|NCT03422627|76075086|FG004|Completed up to Week 52 and Opted for Extended Dosing|Overall Study||0||
59956269|NCT03422627|76075082|FG000|Completed up to Week 52 and Did Not Opt for Extended Dosing|Overall Study||0||
59956270|NCT03422627|76075083|FG001|Completed up to Week 52 and Did Not Opt for Extended Dosing|Overall Study||1||
59956271|NCT03422627|76075084|FG002|Completed up to Week 52 and Did Not Opt for Extended Dosing|Overall Study||1||
59803140|NCT00468286|75924631|FG000|NOT COMPLETED|Overall Study||7||
59803141|NCT00468286|75924632|FG001|NOT COMPLETED|Overall Study||12||
59803142|NCT00463840|75924638|FG000|STARTED|Overall Study||24||
59803143|NCT00463840|75924638|FG000|COMPLETED|Overall Study||12||
59956272|NCT03422627|76075085|FG003|Completed up to Week 52 and Did Not Opt for Extended Dosing|Overall Study||0||
59956273|NCT03422627|76075086|FG004|Completed up to Week 52 and Did Not Opt for Extended Dosing|Overall Study||1||
59956274|NCT03422627|76075082|FG000|COMPLETED|Overall Study||2||
59956275|NCT03422627|76075083|FG001|COMPLETED|Overall Study||2||
59956276|NCT03422627|76075084|FG002|COMPLETED|Overall Study||3||
59956277|NCT03422627|76075085|FG003|COMPLETED|Overall Study||3||
59956278|NCT03422627|76075086|FG004|COMPLETED|Overall Study||1||
59956279|NCT03422627|76075082|FG000|NOT COMPLETED|Overall Study||5||
59956280|NCT03422627|76075083|FG001|NOT COMPLETED|Overall Study||5||
60073828|NCT01869764|76189173|FG001|STARTED|Overall Study||29||
60073829|NCT01869764|76189172|FG000|COMPLETED|Overall Study||28||
60073830|NCT01869764|76189173|FG001|COMPLETED|Overall Study||27||
59803144|NCT00463840|75924638|FG000|NOT COMPLETED|Overall Study||12||
59803145|NCT00129389|75924644|FG000|STARTED|Overall Study||974||
59803146|NCT00129389|75924645|FG001|STARTED|Overall Study||951||
59803147|NCT00129389|75924644|FG000|COMPLETED|Overall Study|1 patient was crossed from arm A to B by error. 16 patients were crossed from arm B, to A by error.|941||
59803148|NCT00129389|75924645|FG001|COMPLETED|Overall Study|16 patients were crossed from arm B to A by error. 1 patient was crossed from arm A to B by error.|811||
59803149|NCT00129389|75924644|FG000|NOT COMPLETED|Overall Study||33||
59803150|NCT00129389|75924645|FG001|NOT COMPLETED|Overall Study||140||
59803151|NCT00468052|75924653|FG000|STARTED|Overall Study|1 subject withdrew consent.Surgery was cancelled for 2. 4 subjects eliminated for break in protocol|68||
60073831|NCT01869764|76189172|FG000|NOT COMPLETED|Overall Study||0||
60073832|NCT01869764|76189173|FG001|NOT COMPLETED|Overall Study||2||
60073833|NCT01842620|76189179|FG000|STARTED|Period 1||13||
60073834|NCT01842620|76189180|FG001|STARTED|Period 1||12||
60073835|NCT01842620|76189179|FG000|COMPLETED|Period 1||12||
60073836|NCT01842620|76189180|FG001|COMPLETED|Period 1||12||
60073837|NCT01842620|76189179|FG000|NOT COMPLETED|Period 1||1||
60073838|NCT01842620|76189180|FG001|NOT COMPLETED|Period 1||0||
60073839|NCT01842620|76189179|FG000|STARTED|Washout Period||12||
60073840|NCT01842620|76189180|FG001|STARTED|Washout Period||12||
60073841|NCT01842620|76189179|FG000|COMPLETED|Washout Period||12||
60073842|NCT01842620|76189180|FG001|COMPLETED|Washout Period||12||
59620624|NCT00195702|75731985|FG003|COMPLETED|Open-label Extension Phase||66||
59620625|NCT00195702|75731986|FG004|COMPLETED|Open-label Extension Phase||80||
59620626|NCT00195702|75731987|FG005|COMPLETED|Open-label Extension Phase||56||
59620627|NCT00195702|75731982|FG000|NOT COMPLETED|Open-label Extension Phase||0||
59620628|NCT00195702|75731983|FG001|NOT COMPLETED|Open-label Extension Phase||0||
59620629|NCT00195702|75731984|FG002|NOT COMPLETED|Open-label Extension Phase||0||
59620630|NCT00195702|75731985|FG003|NOT COMPLETED|Open-label Extension Phase||99||
59620631|NCT00195702|75731986|FG004|NOT COMPLETED|Open-label Extension Phase||78||
59620632|NCT00195702|75731987|FG005|NOT COMPLETED|Open-label Extension Phase||78||
59620633|NCT00196716|75732000|FG000|STARTED|1.0 mg/kg Period||21||
59620634|NCT00196716|75732000|FG000|COMPLETED|1.0 mg/kg Period||21||
59620635|NCT00196716|75732000|FG000|NOT COMPLETED|1.0 mg/kg Period||0||
59620636|NCT00196716|75732000|FG000|STARTED|0.3 mg/kg Period||21||
59620637|NCT00196716|75732000|FG000|COMPLETED|0.3 mg/kg Period||21||
59620638|NCT00196716|75732000|FG000|NOT COMPLETED|0.3 mg/kg Period||0||
59620639|NCT00197184|75732008|FG000|STARTED|Overall Study||139||
59620640|NCT00197184|75732009|FG001|STARTED|Overall Study||137||
59620641|NCT00197184|75732008|FG000|COMPLETED|Overall Study||139||
59620642|NCT00197184|75732009|FG001|COMPLETED|Overall Study||137||
59620643|NCT00197184|75732008|FG000|NOT COMPLETED|Overall Study||0||
59620644|NCT00197184|75732009|FG001|NOT COMPLETED|Overall Study||0||
59620645|NCT00198042|75732015|FG000|STARTED|Overall Study||18||
59620646|NCT00198042|75732015|FG000|COMPLETED|Overall Study||18||
59620647|NCT00198042|75732015|FG000|NOT COMPLETED|Overall Study||0||
59620648|NCT00201240|75732019|FG000|STARTED|Overall Study||47||
59620649|NCT00201240|75732019|FG000|COMPLETED|Overall Study||44||
59620650|NCT00201240|75732019|FG000|NOT COMPLETED|Overall Study||3||
59620651|NCT00098670|75732024|FG000|STARTED|Overall Study||102||
59620652|NCT00098670|75732024|FG000|COMPLETED|Overall Study||102||
59620653|NCT00098670|75732024|FG000|NOT COMPLETED|Overall Study||0||
59620654|NCT00099372|75732031|FG000|STARTED|Enrolled in Extended CARE Trial||104||
59620655|NCT00099372|75732032|FG001|STARTED|Enrolled in Extended CARE Trial||111||
59620656|NCT00099372|75732031|FG000|COMPLETED|Enrolled in Extended CARE Trial||104||
59620657|NCT00099372|75732032|FG001|COMPLETED|Enrolled in Extended CARE Trial||111||
59620658|NCT00099372|75732031|FG000|NOT COMPLETED|Enrolled in Extended CARE Trial||0||
59620659|NCT00099372|75732032|FG001|NOT COMPLETED|Enrolled in Extended CARE Trial||0||
59620660|NCT00099372|75732031|FG000|STARTED|Followed up 5 Years After Index Surgery||104||
59620661|NCT00099372|75732032|FG001|STARTED|Followed up 5 Years After Index Surgery||111||
59620662|NCT00099372|75732031|FG000|COMPLETED|Followed up 5 Years After Index Surgery||89||
59620663|NCT00099372|75732032|FG001|COMPLETED|Followed up 5 Years After Index Surgery||92||
59620664|NCT00099372|75732031|FG000|NOT COMPLETED|Followed up 5 Years After Index Surgery||15||
59620665|NCT00099372|75732032|FG001|NOT COMPLETED|Followed up 5 Years After Index Surgery||19||
59620666|NCT00099372|75732031|FG000|STARTED|Followed up 7 Years After Index Surgery||89||
59803152|NCT00468052|75924654|FG001|STARTED|Overall Study|One had an intraoperative complication and was withdrawn. 7 eliminated for a break in protocol.|69||
59956281|NCT03422627|76075084|FG002|NOT COMPLETED|Overall Study||4||
59956282|NCT03422627|76075085|FG003|NOT COMPLETED|Overall Study||3||
59956283|NCT03422627|76075086|FG004|NOT COMPLETED|Overall Study||4||
59956284|NCT03403621|76075098|FG000|STARTED|Overall Study||6||6
60073843|NCT01842620|76189179|FG000|NOT COMPLETED|Washout Period||0||
60073844|NCT01842620|76189180|FG001|NOT COMPLETED|Washout Period||0||
59956285|NCT03403621|76075099|FG001|STARTED|Overall Study||6||6
59956286|NCT03403621|76075098|FG000|COMPLETED|Overall Study||4||4
59956287|NCT03403621|76075099|FG001|COMPLETED|Overall Study||4||4
59956288|NCT03403621|76075098|FG000|NOT COMPLETED|Overall Study||2||2
59956289|NCT03403621|76075099|FG001|NOT COMPLETED|Overall Study||2||2
59956290|NCT03225105|76075109|FG000|STARTED|Overall Study||3||
59956291|NCT03225105|76075110|FG001|STARTED|Overall Study||4||
59956292|NCT03225105|76075111|FG002|STARTED|Overall Study||5||
59956293|NCT03225105|76075112|FG003|STARTED|Overall Study||3||
59956294|NCT03225105|76075109|FG000|COMPLETED|Overall Study||0||
59956295|NCT03225105|76075110|FG001|COMPLETED|Overall Study||0||
59956296|NCT03225105|76075111|FG002|COMPLETED|Overall Study||0||
59956297|NCT03225105|76075112|FG003|COMPLETED|Overall Study||0||
59956298|NCT03225105|76075109|FG000|NOT COMPLETED|Overall Study||3||
59956299|NCT03225105|76075110|FG001|NOT COMPLETED|Overall Study||4||
59956300|NCT03225105|76075111|FG002|NOT COMPLETED|Overall Study||5||
59956301|NCT03225105|76075112|FG003|NOT COMPLETED|Overall Study||3||
59956302|NCT03042936|76075123|FG000|STARTED|Overall Study||33||
59956303|NCT03042936|76075123|FG000|COMPLETED|Overall Study||28||
59956304|NCT03042936|76075123|FG000|NOT COMPLETED|Overall Study||5||
59956305|NCT03029884|76075127|FG000|STARTED|Inactive DBS Run in Period (6 Months)||4||
59956306|NCT03029884|76075127|FG000|COMPLETED|Inactive DBS Run in Period (6 Months)||4||
59956307|NCT03029884|76075127|FG000|NOT COMPLETED|Inactive DBS Run in Period (6 Months)||0||
59956308|NCT03029884|76075127|FG000|STARTED|Open-Loop DBS (6 Weeks)||4||
59956309|NCT03029884|76075127|FG000|COMPLETED|Open-Loop DBS (6 Weeks)||4||
59803153|NCT00468052|75924653|FG000|Target Enrollment|Overall Study||70||
59803154|NCT00468052|75924654|FG001|Target Enrollment|Overall Study||70||
59803155|NCT00468052|75924653|FG000|COMPLETED|Overall Study||61||
59956310|NCT03029884|76075127|FG000|NOT COMPLETED|Open-Loop DBS (6 Weeks)||0||
59956311|NCT03029884|76075127|FG000|STARTED|Closed-Loop DBS (6 Weeks)||4||
59956312|NCT03029884|76075127|FG000|COMPLETED|Closed-Loop DBS (6 Weeks)||4||
59803156|NCT00468052|75924654|FG001|COMPLETED|Overall Study||61||
59803157|NCT00468052|75924653|FG000|NOT COMPLETED|Overall Study||7||
59803158|NCT00468052|75924654|FG001|NOT COMPLETED|Overall Study||8||
59803159|NCT00453310|75924662|FG000|STARTED|Overall Study||10||
59803160|NCT00453310|75924662|FG000|COMPLETED|Overall Study||0||
59803161|NCT00453310|75924662|FG000|NOT COMPLETED|Overall Study||10||
59956313|NCT03029884|76075127|FG000|NOT COMPLETED|Closed-Loop DBS (6 Weeks)||0||
59956314|NCT03029884|76075127|FG000|STARTED|Sham DBS (3 Weeks)||4||
59956315|NCT03029884|76075127|FG000|COMPLETED|Sham DBS (3 Weeks)||4||
59956316|NCT03029884|76075127|FG000|NOT COMPLETED|Sham DBS (3 Weeks)||0||
59956317|NCT03027388|76075137|FG000|STARTED|Overall Study||7||
59956318|NCT03027388|76075137|FG000|COMPLETED|Overall Study||7||
59956319|NCT03027388|76075137|FG000|NOT COMPLETED|Overall Study||0||
59956320|NCT02900976|76075143|FG000|STARTED|Overall Study||2||
59956321|NCT02900976|76075144|FG001|STARTED|Overall Study||16||
59956322|NCT02900976|76075143|FG000|COMPLETED|Overall Study||2||
59956323|NCT02900976|76075144|FG001|COMPLETED|Overall Study||7||
59956324|NCT02900976|76075143|FG000|NOT COMPLETED|Overall Study||0||
59956325|NCT02900976|76075144|FG001|NOT COMPLETED|Overall Study||9||
59956326|NCT02654015|76075151|FG000|STARTED|Overall Study||50||
59956327|NCT02654015|76075151|FG000|COMPLETED|Overall Study||35||
59956328|NCT02654015|76075151|FG000|NOT COMPLETED|Overall Study||15||
59956329|NCT02542696|76075155|FG000|STARTED|Overall Study||496||
59956330|NCT02542696|76075155|FG000|Titration Full Analysis Population|Overall Study||449||
59803162|NCT00124657|75924669|FG000|STARTED|Overall Study||18||
59803163|NCT00124657|75924670|FG001|STARTED|Overall Study||5||
59803164|NCT00124657|75924671|FG002|STARTED|Overall Study||39||
59803165|NCT00124657|75924669|FG000|COMPLETED|Overall Study||2||
59803166|NCT00124657|75924670|FG001|COMPLETED|Overall Study||0||
59803167|NCT00124657|75924671|FG002|COMPLETED|Overall Study||7||
59803168|NCT00124657|75924669|FG000|NOT COMPLETED|Overall Study||16||
59803169|NCT00124657|75924670|FG001|NOT COMPLETED|Overall Study||5||
59803170|NCT00124657|75924671|FG002|NOT COMPLETED|Overall Study||32||
59803171|NCT00581945|75924694|FG000|STARTED|Overall Study||74||
59803172|NCT00581945|75924695|FG001|STARTED|Overall Study||73||
59803173|NCT00581945|75924694|FG000|COMPLETED|Overall Study||65||
59803174|NCT00581945|75924695|FG001|COMPLETED|Overall Study||63||
59956331|NCT02542696|76075155|FG000|LTS Phase Full Analysis Population|Overall Study||426||
59803175|NCT00581945|75924694|FG000|NOT COMPLETED|Overall Study||9||
59803176|NCT00581945|75924695|FG001|NOT COMPLETED|Overall Study||10||
59803177|NCT00555906|75924704|FG000|STARTED|Phase 1||3||
59956332|NCT02542696|76075155|FG000|COMPLETED|Overall Study||120||
59956333|NCT02542696|76075155|FG000|NOT COMPLETED|Overall Study||376||
59956334|NCT02339740|76075162|FG000|STARTED|Overall Study||101||
59956335|NCT02339740|76075163|FG001|STARTED|Overall Study||57||
59956336|NCT02339740|76075162|FG000|COMPLETED|Overall Study||92||
59956337|NCT02339740|76075163|FG001|COMPLETED|Overall Study||53||
59956338|NCT02339740|76075162|FG000|NOT COMPLETED|Overall Study||9||
59956339|NCT02339740|76075163|FG001|NOT COMPLETED|Overall Study||4||
59956340|NCT02163395|76075169|FG000|STARTED|Overall Study||44||
59956341|NCT02163395|76075169|FG000|COMPLETED|Overall Study||39||
59803178|NCT00555906|75924705|FG001|STARTED|Phase 1||6||
59803179|NCT00555906|75924706|FG002|STARTED|Phase 1||7||
59803180|NCT00555906|75924707|FG003|STARTED|Phase 1||5||
59803181|NCT00555906|75924708|FG004|STARTED|Phase 1||0||
59956342|NCT02163395|76075169|FG000|NOT COMPLETED|Overall Study||5||
59956343|NCT01911897|76075173|FG000|STARTED|Overall Study||30||
59956344|NCT01911897|76075173|FG000|COMPLETED|Overall Study||27||
59956345|NCT01911897|76075173|FG000|NOT COMPLETED|Overall Study||3||
59956346|NCT01589302|76075177|FG000|STARTED|Overall Study||154|2 patients were not eligible for study and did not being treatment|
59956347|NCT01589302|76075177|FG000|Del17p Patients|Overall Study||76||
59956348|NCT01589302|76075177|FG000|Non-Del17p Patients|Overall Study||76||
59956349|NCT01589302|76075177|FG000|COMPLETED|Overall Study||152||
59956350|NCT01589302|76075177|FG000|NOT COMPLETED|Overall Study||2||
59956351|NCT01397552|76075184|FG000|STARTED|Overall Study||4||
59956352|NCT01397552|76075185|FG001|STARTED|Overall Study||4||
59956353|NCT01397552|76075184|FG000|COMPLETED|Overall Study||1||
59956354|NCT01397552|76075185|FG001|COMPLETED|Overall Study||3||
59956355|NCT01397552|76075184|FG000|NOT COMPLETED|Overall Study||3||
59956356|NCT01397552|76075185|FG001|NOT COMPLETED|Overall Study||1||
59803182|NCT00555906|75924704|FG000|COMPLETED|Phase 1||0||
59803183|NCT00555906|75924705|FG001|COMPLETED|Phase 1||0||
59803184|NCT00555906|75924706|FG002|COMPLETED|Phase 1||0||
59956357|NCT01256710|76075191|FG000|STARTED|Overall Study||1151||
59956358|NCT01256710|76075191|FG000|COMPLETED|Overall Study||227||
59956359|NCT01256710|76075191|FG000|NOT COMPLETED|Overall Study||924||
59956360|NCT01096368|76075202|FG000|STARTED|Overall Study||37||
59956361|NCT01096368|76075203|FG001|STARTED|Overall Study||167||
59956362|NCT01096368|76075204|FG002|STARTED|Overall Study||163||
59956363|NCT01096368|76075205|FG003|STARTED|Overall Study||63||
59956364|NCT01096368|76075206|FG004|STARTED|Overall Study||49||
59956365|NCT01096368|76075202|FG000|COMPLETED|Overall Study||37||
59956366|NCT01096368|76075203|FG001|COMPLETED|Overall Study||88||
59956367|NCT01096368|76075204|FG002|COMPLETED|Overall Study||154||
59956368|NCT01096368|76075205|FG003|COMPLETED|Overall Study||39||
59956369|NCT01096368|76075206|FG004|COMPLETED|Overall Study||0||
59956370|NCT01096368|76075202|FG000|NOT COMPLETED|Overall Study||0||
59956371|NCT01096368|76075203|FG001|NOT COMPLETED|Overall Study||79||
59956372|NCT01096368|76075204|FG002|NOT COMPLETED|Overall Study||9||
59956373|NCT01096368|76075205|FG003|NOT COMPLETED|Overall Study||24||
59956374|NCT01096368|76075206|FG004|NOT COMPLETED|Overall Study||49||
59956375|NCT01020903|76075223|FG000|STARTED|Overall Study|Please be advised that the investigator of the study left the institution in 2011.|100||
59956376|NCT01020903|76075224|FG001|STARTED|Overall Study|Please be advised that the investigator of the study left the institution in 2011.|100||
59956377|NCT01020903|76075223|FG000|COMPLETED|Overall Study|Please be advised that the investigator of the study left the institution in 2011.|100||
59956378|NCT01020903|76075224|FG001|COMPLETED|Overall Study|Please be advised that the investigator of the study entitled left the institution in 2011.|100||
59956379|NCT01020903|76075223|FG000|NOT COMPLETED|Overall Study||0||
59803185|NCT00555906|75924707|FG003|COMPLETED|Phase 1||0||
59956380|NCT01020903|76075224|FG001|NOT COMPLETED|Overall Study||0||
59956381|NCT00938587|76075234|FG000|STARTED|Overall Study||21||
59956382|NCT00938587|76075235|FG001|STARTED|Overall Study||22||
59956383|NCT00938587|76075236|FG002|STARTED|Overall Study||21||
59956384|NCT00938587|76075237|FG003|STARTED|Overall Study||22||
59956385|NCT00938587|76075234|FG000|COMPLETED|Overall Study||18||
59956386|NCT00938587|76075235|FG001|COMPLETED|Overall Study||21||
59956387|NCT00938587|76075236|FG002|COMPLETED|Overall Study||20||
59956388|NCT00938587|76075237|FG003|COMPLETED|Overall Study||20||
59956389|NCT00938587|76075234|FG000|NOT COMPLETED|Overall Study||3||
59956390|NCT00938587|76075235|FG001|NOT COMPLETED|Overall Study||1||
59956391|NCT00938587|76075236|FG002|NOT COMPLETED|Overall Study||1||
59956392|NCT00938587|76075237|FG003|NOT COMPLETED|Overall Study||2||
59956393|NCT00937937|76075247|FG000|STARTED|Overall Study||72||
59803186|NCT00555906|75924708|FG004|COMPLETED|Phase 1||0||
59803187|NCT00555906|75924704|FG000|NOT COMPLETED|Phase 1||3||
59803188|NCT00555906|75924705|FG001|NOT COMPLETED|Phase 1||6||
59803189|NCT00555906|75924706|FG002|NOT COMPLETED|Phase 1||7||
59803190|NCT00555906|75924707|FG003|NOT COMPLETED|Phase 1||5||
59803191|NCT00555906|75924708|FG004|NOT COMPLETED|Phase 1||0||
59803192|NCT00555906|75924704|FG000|STARTED|Phase 2||0||
59956394|NCT00937937|76075247|FG000|COMPLETED|Overall Study||0||
59956395|NCT00937937|76075247|FG000|NOT COMPLETED|Overall Study||72||
59956396|NCT00810693|76075255|FG000|STARTED|Treatment Period||254||
59956397|NCT00810693|76075256|FG001|STARTED|Treatment Period|1 randomized but not treated|64||
59956398|NCT00810693|76075257|FG002|STARTED|Treatment Period|1 randomized but not treated|127||
59956399|NCT00810693|76075255|FG000|Participants Received Treatment|Treatment Period||254||
59956400|NCT00810693|76075256|FG001|Participants Received Treatment|Treatment Period||63||
59956401|NCT00810693|76075257|FG002|Participants Received Treatment|Treatment Period||126||
59803193|NCT00555906|75924705|FG001|STARTED|Phase 2||0||
59803194|NCT00555906|75924706|FG002|STARTED|Phase 2||0||
59803195|NCT00555906|75924707|FG003|STARTED|Phase 2||0||
59803196|NCT00555906|75924708|FG004|STARTED|Phase 2||32||
59803197|NCT00555906|75924704|FG000|Treated|Phase 2||0||
59803198|NCT00555906|75924705|FG001|Treated|Phase 2||0||
59956402|NCT00810693|76075255|FG000|COMPLETED|Treatment Period||237||
59956403|NCT00810693|76075256|FG001|COMPLETED|Treatment Period||57||
59956404|NCT00810693|76075257|FG002|COMPLETED|Treatment Period||111||
59956405|NCT00810693|76075255|FG000|NOT COMPLETED|Treatment Period||17||
59956406|NCT00810693|76075256|FG001|NOT COMPLETED|Treatment Period||7||
59956407|NCT00810693|76075257|FG002|NOT COMPLETED|Treatment Period||16||
59803199|NCT00555906|75924706|FG002|Treated|Phase 2||0||
59803200|NCT00555906|75924707|FG003|Treated|Phase 2||0||
59803201|NCT00555906|75924708|FG004|Treated|Phase 2||30||
59803202|NCT00555906|75924704|FG000|COMPLETED|Phase 2||0||
59803203|NCT00555906|75924705|FG001|COMPLETED|Phase 2||0||
59803204|NCT00555906|75924706|FG002|COMPLETED|Phase 2||0||
59803205|NCT00555906|75924707|FG003|COMPLETED|Phase 2||0||
59803206|NCT00555906|75924708|FG004|COMPLETED|Phase 2||0||
59803207|NCT00555906|75924704|FG000|NOT COMPLETED|Phase 2||0||
59803208|NCT00555906|75924705|FG001|NOT COMPLETED|Phase 2||0||
59803209|NCT00555906|75924706|FG002|NOT COMPLETED|Phase 2||0||
59803210|NCT00555906|75924707|FG003|NOT COMPLETED|Phase 2||0||
59803211|NCT00555906|75924708|FG004|NOT COMPLETED|Phase 2||32||
59803212|NCT03817879|75924725|FG000|STARTED|Overall Study||35||
59803213|NCT03817879|75924726|FG001|STARTED|Overall Study||35||
59803214|NCT03817879|75924725|FG000|COMPLETED|Overall Study||30||
59803215|NCT03817879|75924726|FG001|COMPLETED|Overall Study||22||
59803216|NCT03817879|75924725|FG000|NOT COMPLETED|Overall Study||5||
59803217|NCT03817879|75924726|FG001|NOT COMPLETED|Overall Study||13||
59803218|NCT00555672|75924734|FG000|STARTED|Overall Study||24||
59803219|NCT00555672|75924735|FG001|STARTED|Overall Study||10||
59803220|NCT00555672|75924734|FG000|COMPLETED|Overall Study||0||
59803221|NCT00555672|75924735|FG001|COMPLETED|Overall Study||0||
59803222|NCT00555672|75924734|FG000|NOT COMPLETED|Overall Study||24||
59803223|NCT00555672|75924735|FG001|NOT COMPLETED|Overall Study||10||
59803224|NCT03958656|75924745|FG000|STARTED|Overall Study||3||
59803225|NCT03958656|75924746|FG001|STARTED|Overall Study||4||
59803226|NCT03958656|75924747|FG002|STARTED|Overall Study||5||
59803227|NCT03958656|75924748|FG003|STARTED|Overall Study||1||
59803228|NCT03958656|75924745|FG000|COMPLETED|Overall Study||3||
59803229|NCT03958656|75924746|FG001|COMPLETED|Overall Study||3||
59803230|NCT03958656|75924747|FG002|COMPLETED|Overall Study||3||
59803231|NCT03958656|75924748|FG003|COMPLETED|Overall Study||1||
59803232|NCT03958656|75924745|FG000|NOT COMPLETED|Overall Study||0||
59803233|NCT03958656|75924746|FG001|NOT COMPLETED|Overall Study||1||
59803234|NCT03958656|75924747|FG002|NOT COMPLETED|Overall Study||2||
59524069|NCT00988013|75619166|FG001|STARTED|Overall Study||3||
59524070|NCT00988013|75619167|FG002|STARTED|Overall Study||6||
59803235|NCT03958656|75924748|FG003|NOT COMPLETED|Overall Study||0||
59803236|NCT00561912|75924758|FG000|STARTED|Overall Study||2||
59803237|NCT00561912|75924758|FG000|COMPLETED|Overall Study||1||
59803238|NCT00561912|75924758|FG000|NOT COMPLETED|Overall Study||1||
59803239|NCT00561678|75924764|FG000|STARTED|Overall Study||197||
59803240|NCT00561678|75924765|FG001|STARTED|Overall Study||207||
59803241|NCT00561678|75924764|FG000|COMPLETED|Overall Study||189||
59803242|NCT00561678|75924765|FG001|COMPLETED|Overall Study||201||
59803243|NCT00561678|75924764|FG000|NOT COMPLETED|Overall Study||8||
59956408|NCT00810693|76075255|FG000|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|23||
59956409|NCT00810693|76075256|FG001|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|7||
59956410|NCT00810693|76075257|FG002|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|16||
59956411|NCT00810693|76075255|FG000|COMPLETED|Follow-up Period (FUP)||15||
59956412|NCT00810693|76075256|FG001|COMPLETED|Follow-up Period (FUP)||4||
59956413|NCT00810693|76075257|FG002|COMPLETED|Follow-up Period (FUP)||12||
59956414|NCT00810693|76075255|FG000|NOT COMPLETED|Follow-up Period (FUP)||8||
59956415|NCT00810693|76075256|FG001|NOT COMPLETED|Follow-up Period (FUP)||3||
59803244|NCT00561678|75924765|FG001|NOT COMPLETED|Overall Study||6||
59803245|NCT00463684|75924771|FG000|STARTED|Overall Study||278||
59803246|NCT00463684|75924771|FG000|COMPLETED|Overall Study||274||
59803247|NCT00463684|75924771|FG000|NOT COMPLETED|Overall Study||4||
59803248|NCT00463606|75924778|FG000|STARTED|Overall Study||253||
59803249|NCT00463606|75924779|FG001|STARTED|Overall Study||254||
59803250|NCT00463606|75924780|FG002|STARTED|Overall Study||251||
59803251|NCT00463606|75924778|FG000|COMPLETED|Overall Study||212||
59803252|NCT00463606|75924779|FG001|COMPLETED|Overall Study||220||
59803253|NCT00463606|75924780|FG002|COMPLETED|Overall Study||231||
59803254|NCT00463606|75924778|FG000|NOT COMPLETED|Overall Study||41||
59803255|NCT00463606|75924779|FG001|NOT COMPLETED|Overall Study||34||
59803256|NCT00463606|75924780|FG002|NOT COMPLETED|Overall Study||20||
59524071|NCT00988013|75619168|FG003|STARTED|Overall Study||2||
59524072|NCT00988013|75619165|FG000|COMPLETED|Overall Study||3||
59803257|NCT03961308|75924790|FG000|STARTED|Overall Study||102||
59803258|NCT03961308|75924791|FG001|STARTED|Overall Study||102||
59803259|NCT03961308|75924790|FG000|COMPLETED|Overall Study||100||
59803260|NCT03961308|75924791|FG001|COMPLETED|Overall Study||100||
59803261|NCT03961308|75924790|FG000|NOT COMPLETED|Overall Study||2||
59803262|NCT03961308|75924791|FG001|NOT COMPLETED|Overall Study||2||
59803263|NCT00174187|75924799|FG000|STARTED|Period 1 (up to 3 Years)||15||
59803264|NCT00174187|75924800|FG001|STARTED|Period 1 (up to 3 Years)||15||
59803265|NCT00174187|75924801|FG002|STARTED|Period 1 (up to 3 Years)||0||
59803266|NCT00174187|75924799|FG000|COMPLETED|Period 1 (up to 3 Years)||15||
59803267|NCT00174187|75924800|FG001|COMPLETED|Period 1 (up to 3 Years)||11||
59803268|NCT00174187|75924801|FG002|COMPLETED|Period 1 (up to 3 Years)||0||
59803269|NCT00174187|75924799|FG000|NOT COMPLETED|Period 1 (up to 3 Years)||0||
59803270|NCT00174187|75924800|FG001|NOT COMPLETED|Period 1 (up to 3 Years)||4||
59803271|NCT00174187|75924801|FG002|NOT COMPLETED|Period 1 (up to 3 Years)||0||
59803272|NCT00174187|75924799|FG000|STARTED|Between Period 1 and Period 2||0||
59803273|NCT00174187|75924800|FG001|STARTED|Between Period 1 and Period 2||0||
59803274|NCT00174187|75924801|FG002|STARTED|Between Period 1 and Period 2||26||
59803275|NCT00174187|75924799|FG000|Consented|Between Period 1 and Period 2||0||
59803276|NCT00174187|75924800|FG001|Consented|Between Period 1 and Period 2||0||
59803277|NCT00174187|75924801|FG002|Consented|Between Period 1 and Period 2||24||
59803278|NCT00174187|75924799|FG000|COMPLETED|Between Period 1 and Period 2||0||
59803279|NCT00174187|75924800|FG001|COMPLETED|Between Period 1 and Period 2||0||
59803280|NCT00174187|75924801|FG002|COMPLETED|Between Period 1 and Period 2||21||
59803281|NCT00174187|75924799|FG000|NOT COMPLETED|Between Period 1 and Period 2||0||
59803282|NCT00174187|75924800|FG001|NOT COMPLETED|Between Period 1 and Period 2||0||
59803283|NCT00174187|75924801|FG002|NOT COMPLETED|Between Period 1 and Period 2||5||
59803284|NCT00174187|75924799|FG000|STARTED|Period 2 (After 3 Years)||0||
59803285|NCT00174187|75924800|FG001|STARTED|Period 2 (After 3 Years)||0||
59803286|NCT00174187|75924801|FG002|STARTED|Period 2 (After 3 Years)||21||
59803287|NCT00174187|75924799|FG000|COMPLETED|Period 2 (After 3 Years)||0||
59803288|NCT00174187|75924800|FG001|COMPLETED|Period 2 (After 3 Years)||0||
59803289|NCT00174187|75924801|FG002|COMPLETED|Period 2 (After 3 Years)||13||
59803290|NCT00174187|75924799|FG000|NOT COMPLETED|Period 2 (After 3 Years)||0||
59803291|NCT00174187|75924800|FG001|NOT COMPLETED|Period 2 (After 3 Years)||0||
59803292|NCT00174187|75924801|FG002|NOT COMPLETED|Period 2 (After 3 Years)||8||
59803293|NCT01011335|75924813|FG000|STARTED|Overall Study||11||
59803294|NCT01011335|75924814|FG001|STARTED|Overall Study||12||
59803295|NCT01011335|75924815|FG002|STARTED|Overall Study||12||
59803296|NCT01011335|75924816|FG003|STARTED|Overall Study||12||
59803297|NCT01011335|75924817|FG004|STARTED|Overall Study||13||
59803298|NCT01011335|75924818|FG005|STARTED|Overall Study||12||
59803299|NCT01011335|75924819|FG006|STARTED|Overall Study||12||
59803300|NCT01011335|75924820|FG007|STARTED|Overall Study||12||
59803301|NCT01011335|75924821|FG008|STARTED|Overall Study||12||
59803302|NCT01011335|75924822|FG009|STARTED|Overall Study||12||
59803303|NCT01011335|75924823|FG010|STARTED|Overall Study||12||
59803304|NCT01011335|75924824|FG011|STARTED|Overall Study||22||
59803305|NCT01011335|75924825|FG012|STARTED|Overall Study||22||
59803306|NCT01011335|75924813|FG000|COMPLETED|Overall Study||10||
59803307|NCT01011335|75924814|FG001|COMPLETED|Overall Study||11||
59803308|NCT01011335|75924815|FG002|COMPLETED|Overall Study||11||
59803309|NCT01011335|75924816|FG003|COMPLETED|Overall Study||10||
59803310|NCT01011335|75924817|FG004|COMPLETED|Overall Study||12||
59803311|NCT01011335|75924818|FG005|COMPLETED|Overall Study||11||
59803312|NCT01011335|75924819|FG006|COMPLETED|Overall Study||9||
59803313|NCT01011335|75924820|FG007|COMPLETED|Overall Study||10||
59803314|NCT01011335|75924821|FG008|COMPLETED|Overall Study||10||
59803315|NCT01011335|75924822|FG009|COMPLETED|Overall Study||12||
59803316|NCT01011335|75924823|FG010|COMPLETED|Overall Study||6||
59803317|NCT01011335|75924824|FG011|COMPLETED|Overall Study||21||
59803318|NCT01011335|75924825|FG012|COMPLETED|Overall Study||19||
59803319|NCT01011335|75924813|FG000|NOT COMPLETED|Overall Study||1||
59803320|NCT01011335|75924814|FG001|NOT COMPLETED|Overall Study||1||
59803321|NCT01011335|75924815|FG002|NOT COMPLETED|Overall Study||1||
59803322|NCT01011335|75924816|FG003|NOT COMPLETED|Overall Study||2||
59803323|NCT01011335|75924817|FG004|NOT COMPLETED|Overall Study||1||
59803324|NCT01011335|75924818|FG005|NOT COMPLETED|Overall Study||1||
59803325|NCT01011335|75924819|FG006|NOT COMPLETED|Overall Study||3||
59803326|NCT01011335|75924820|FG007|NOT COMPLETED|Overall Study||2||
59803327|NCT01011335|75924821|FG008|NOT COMPLETED|Overall Study||2||
59803328|NCT01011335|75924822|FG009|NOT COMPLETED|Overall Study||0||
59803329|NCT01011335|75924823|FG010|NOT COMPLETED|Overall Study||6||
59803330|NCT01011335|75924824|FG011|NOT COMPLETED|Overall Study||1||
59803331|NCT01011335|75924825|FG012|NOT COMPLETED|Overall Study||3||
59803332|NCT00467896|75924862|FG000|STARTED|Overall Study||62||
59803333|NCT00467896|75924862|FG000|COMPLETED|Overall Study||11||
59803334|NCT00467896|75924862|FG000|NOT COMPLETED|Overall Study||51||
59803335|NCT00579059|75924870|FG000|STARTED|Overall Study|Enrollment was incomplete due to study cancellation.|21||
59803336|NCT00579059|75924871|FG001|STARTED|Overall Study|Enrollment was incomplete due to study cancellation.|10||
59803337|NCT00579059|75924870|FG000|Immediate Post-Op|Overall Study|1 Patient didn't return for follow-up.|20||
59803338|NCT00579059|75924871|FG001|Immediate Post-Op|Overall Study|1 Patient didn't return for follow-up.|9||
59803339|NCT00579059|75924870|FG000|6 Months|Overall Study|10 Patients didn't return for follow-up.|11||
59803340|NCT00579059|75924871|FG001|6 Months|Overall Study|6 patients didn't return for follow-up.|4||
59803341|NCT00579059|75924870|FG000|1 Year|Overall Study|13 patients didn't return for follow-up.|8||
59803342|NCT00579059|75924871|FG001|1 Year|Overall Study|7 patients didn't return for follow-up.|3||
59803343|NCT00579059|75924870|FG000|3 Years|Overall Study|Incomplete due to study closure at 1-year of follow-up.|0||
59817871|NCT04488770|75940336|FG010|NOT COMPLETED|Part 1-Cohort 1: Period 4 (Up to 5 Days)||0||
59803344|NCT00579059|75924871|FG001|3 Years|Overall Study|Incomplete due to study closure at 1-year of follow-up.|0||
59803345|NCT00579059|75924870|FG000|5 Years|Overall Study|Incomplete due to study closure at 1-year of follow-up.|0||
59803346|NCT00579059|75924871|FG001|5 Years|Overall Study|Incomplete due to study closure at 1-year of follow-up.|0||
59803347|NCT00579059|75924870|FG000|COMPLETED|Overall Study|No Patients completed through 5 years due to study closure at 1-year of follow-up.|0||
59803348|NCT00579059|75924871|FG001|COMPLETED|Overall Study|No Patients completed through 5 years due to study closure at 1-year of follow-up.|0||
59803349|NCT00579059|75924870|FG000|NOT COMPLETED|Overall Study||21||
59803350|NCT00579059|75924871|FG001|NOT COMPLETED|Overall Study||10||
59803351|NCT00467818|75924879|FG000|STARTED|Overall Study||9||
59803352|NCT00467818|75924880|FG001|STARTED|Overall Study||8||
59803353|NCT00467818|75924879|FG000|COMPLETED|Overall Study||6||
59803354|NCT00467818|75924880|FG001|COMPLETED|Overall Study||6||
59803355|NCT00467818|75924879|FG000|NOT COMPLETED|Overall Study||3||
59803356|NCT00467818|75924880|FG001|NOT COMPLETED|Overall Study||2||
59803357|NCT00467740|75924893|FG000|STARTED|Overall Study||54||
59803358|NCT00467740|75924894|FG001|STARTED|Overall Study||61||
59803359|NCT00467740|75924895|FG002|STARTED|Overall Study||60||
59803360|NCT00467740|75924896|FG003|STARTED|Overall Study||60||
59803361|NCT00467740|75924897|FG004|STARTED|Overall Study||61||
59803362|NCT00467740|75924893|FG000|COMPLETED|Overall Study||53||
59803363|NCT00467740|75924894|FG001|COMPLETED|Overall Study||58||
59803364|NCT00467740|75924895|FG002|COMPLETED|Overall Study||58||
59803365|NCT00467740|75924896|FG003|COMPLETED|Overall Study||59||
59803366|NCT00467740|75924897|FG004|COMPLETED|Overall Study||61||
59803367|NCT00467740|75924893|FG000|NOT COMPLETED|Overall Study||1||
59803368|NCT00467740|75924894|FG001|NOT COMPLETED|Overall Study||3||
59803369|NCT00467740|75924895|FG002|NOT COMPLETED|Overall Study||2||
59803370|NCT00467740|75924896|FG003|NOT COMPLETED|Overall Study||1||
59803371|NCT00467740|75924897|FG004|NOT COMPLETED|Overall Study||0||
59803372|NCT00553254|75924911|FG000|STARTED|Overall Study||6||
59803373|NCT00553254|75924912|FG001|STARTED|Overall Study||6||
59803374|NCT00553254|75924913|FG002|STARTED|Overall Study||43||
59803375|NCT00553254|75924911|FG000|COMPLETED|Overall Study||0||
59803376|NCT00553254|75924912|FG001|COMPLETED|Overall Study||0||
59803377|NCT00553254|75924913|FG002|COMPLETED|Overall Study||0||
59803378|NCT00553254|75924911|FG000|NOT COMPLETED|Overall Study||6||
59803379|NCT00553254|75924912|FG001|NOT COMPLETED|Overall Study||6||
59803380|NCT00553254|75924913|FG002|NOT COMPLETED|Overall Study||43||
59803381|NCT00168805|75924928|FG000|STARTED|Overall Study||679||
59803382|NCT00168805|75924929|FG001|STARTED|Overall Study||703||
59803383|NCT00168805|75924930|FG002|STARTED|Overall Study||694||
59803384|NCT00168805|75924928|FG000|COMPLETED|Overall Study||608||
59803385|NCT00168805|75924929|FG001|COMPLETED|Overall Study||625||
59803386|NCT00168805|75924930|FG002|COMPLETED|Overall Study||616||
59803387|NCT00168805|75924928|FG000|NOT COMPLETED|Overall Study||71||
59803388|NCT00168805|75924929|FG001|NOT COMPLETED|Overall Study||78||
59803389|NCT00168805|75924930|FG002|NOT COMPLETED|Overall Study||78||
59803390|NCT00168805|75924928|FG000|STARTED|Treatment||679||
59803391|NCT00168805|75924929|FG001|STARTED|Treatment||703||
59803392|NCT00168805|75924930|FG002|STARTED|Treatment||694||
59803393|NCT00168805|75924928|FG000|COMPLETED|Treatment||630||
59803394|NCT00168805|75924929|FG001|COMPLETED|Treatment||647||
59803395|NCT00168805|75924930|FG002|COMPLETED|Treatment||632||
59803396|NCT00168805|75924928|FG000|NOT COMPLETED|Treatment||49||
59803397|NCT00168805|75924929|FG001|NOT COMPLETED|Treatment||56||
59803398|NCT00168805|75924930|FG002|NOT COMPLETED|Treatment||62||
59803399|NCT00467584|75924941|FG000|STARTED|Overall Study||21||
59803400|NCT00467584|75924942|FG001|STARTED|Overall Study||20||
59803401|NCT00467584|75924943|FG002|STARTED|Overall Study||21||
59803402|NCT00467584|75924941|FG000|COMPLETED|Overall Study||17||
59803403|NCT00467584|75924942|FG001|COMPLETED|Overall Study||15||
59803404|NCT00467584|75924943|FG002|COMPLETED|Overall Study||20||
59803405|NCT00467584|75924941|FG000|NOT COMPLETED|Overall Study||4||
59803406|NCT00467584|75924942|FG001|NOT COMPLETED|Overall Study||5||
59803407|NCT00467584|75924943|FG002|NOT COMPLETED|Overall Study||1||
59803408|NCT03839212|75924951|FG000|STARTED|Overall Study||18||
59803409|NCT03839212|75924951|FG000|COMPLETED|Overall Study||14||
59803410|NCT03839212|75924951|FG000|NOT COMPLETED|Overall Study||4||
59803411|NCT00168103|75924958|FG000|STARTED|Overall Study||40||
59803412|NCT00168103|75924959|FG001|STARTED|Overall Study||43||
59803413|NCT00168103|75924960|FG002|STARTED|Overall Study||42||
59803414|NCT00168103|75924961|FG003|STARTED|Overall Study||1||
59803415|NCT00168103|75924958|FG000|COMPLETED|Overall Study|1 randomized subject received open-label rescue medication before receiving randomized treatment.|38||
59803416|NCT00168103|75924959|FG001|COMPLETED|Overall Study||38||
59803417|NCT00168103|75924960|FG002|COMPLETED|Overall Study||41||
59803418|NCT00168103|75924961|FG003|COMPLETED|Overall Study||1||
59803419|NCT00168103|75924958|FG000|NOT COMPLETED|Overall Study||2||
59803420|NCT00168103|75924959|FG001|NOT COMPLETED|Overall Study||5||
59803421|NCT00168103|75924960|FG002|NOT COMPLETED|Overall Study||1||
59803422|NCT00168103|75924961|FG003|NOT COMPLETED|Overall Study||0||
59803423|NCT00463060|75924971|FG000|STARTED|Phase 1-Radiation 40 Gy + Sunitinib 25mg||3||
59803424|NCT00463060|75924971|FG000|COMPLETED|Phase 1-Radiation 40 Gy + Sunitinib 25mg||3||
59803425|NCT00463060|75924971|FG000|NOT COMPLETED|Phase 1-Radiation 40 Gy + Sunitinib 25mg||0||
59803426|NCT00463060|75924971|FG000|STARTED|Phase 1-Radiation 40 Gy+Sunitinib 37.5mg||3||
59803427|NCT00463060|75924971|FG000|COMPLETED|Phase 1-Radiation 40 Gy+Sunitinib 37.5mg||3||
59803428|NCT00463060|75924971|FG000|NOT COMPLETED|Phase 1-Radiation 40 Gy+Sunitinib 37.5mg||0||
59803429|NCT00463060|75924971|FG000|STARTED|Phase 1-Radiation 50 Gy+Sunitinib 37.5mg||10||
59803430|NCT00463060|75924971|FG000|COMPLETED|Phase 1-Radiation 50 Gy+Sunitinib 37.5mg||10||
59803431|NCT00463060|75924971|FG000|NOT COMPLETED|Phase 1-Radiation 50 Gy+Sunitinib 37.5mg||0||
59803432|NCT00463060|75924971|FG000|STARTED|Phase 1-Radiation 50Gy +Sunitinib 50mg||5||
59803433|NCT00463060|75924971|FG000|COMPLETED|Phase 1-Radiation 50Gy +Sunitinib 50mg||0||
59803434|NCT00463060|75924971|FG000|NOT COMPLETED|Phase 1-Radiation 50Gy +Sunitinib 50mg||5||
59803435|NCT00463060|75924971|FG000|STARTED|Phase 2-Radiation 50Gy +Sunitinib 37.5mg|Not all patients participated in both Phase 1 and Phase II|26||
59803436|NCT00463060|75924971|FG000|COMPLETED|Phase 2-Radiation 50Gy +Sunitinib 37.5mg||25||
59803437|NCT00463060|75924971|FG000|NOT COMPLETED|Phase 2-Radiation 50Gy +Sunitinib 37.5mg||1||
59803438|NCT00462982|75924980|FG000|STARTED|Overall Study||8||
59803439|NCT00462982|75924980|FG000|COMPLETED|Overall Study||5||
59803440|NCT00462982|75924980|FG000|NOT COMPLETED|Overall Study||3||
59803441|NCT02573597|75924988|FG000|STARTED|Overall Study||8||
59803442|NCT02573597|75924989|FG001|STARTED|Overall Study||6||
59803443|NCT02573597|75924990|FG002|STARTED|Overall Study||9||
59803444|NCT02573597|75924991|FG003|STARTED|Overall Study||8||
59803445|NCT02573597|75924988|FG000|Met Reject Critera|Overall Study||4||
59803446|NCT02573597|75924989|FG001|Met Reject Critera|Overall Study||1||
59803447|NCT02573597|75924990|FG002|Met Reject Critera|Overall Study||3||
59803448|NCT02573597|75924991|FG003|Met Reject Critera|Overall Study||2||
59803449|NCT02573597|75924988|FG000|Analyzable Data Set|Overall Study||4||
59803450|NCT02573597|75924989|FG001|Analyzable Data Set|Overall Study||5||
59803451|NCT02573597|75924990|FG002|Analyzable Data Set|Overall Study||6||
59803452|NCT02573597|75924991|FG003|Analyzable Data Set|Overall Study||6||
59803453|NCT02573597|75924988|FG000|COMPLETED|Overall Study||8||
59803454|NCT02573597|75924989|FG001|COMPLETED|Overall Study||6||
59803455|NCT02573597|75924990|FG002|COMPLETED|Overall Study||9||
59803456|NCT02573597|75924991|FG003|COMPLETED|Overall Study||8||
59803457|NCT02573597|75924988|FG000|NOT COMPLETED|Overall Study||0||
59803458|NCT02573597|75924989|FG001|NOT COMPLETED|Overall Study||0||
59803459|NCT02573597|75924990|FG002|NOT COMPLETED|Overall Study||0||
59803460|NCT02573597|75924991|FG003|NOT COMPLETED|Overall Study||0||
59803461|NCT00462904|75925001|FG000|STARTED|Overall Study||4||
59803462|NCT00462904|75925001|FG000|COMPLETED|Overall Study||3||
60073845|NCT01842620|76189179|FG000|STARTED|Period 2||12||
60073846|NCT01842620|76189180|FG001|STARTED|Period 2||12||
60073847|NCT01842620|76189179|FG000|COMPLETED|Period 2||12||
60073848|NCT01842620|76189180|FG001|COMPLETED|Period 2||12||
60073849|NCT01842620|76189179|FG000|NOT COMPLETED|Period 2||0||
60073850|NCT01842620|76189180|FG001|NOT COMPLETED|Period 2||0||
60073851|NCT03359356|76189188|FG000|STARTED|Overall Study||20||
60073852|NCT03359356|76189189|FG001|STARTED|Overall Study||40||
60073853|NCT03359356|76189188|FG000|COMPLETED|Overall Study||20||
60073854|NCT03359356|76189189|FG001|COMPLETED|Overall Study||40||
60073855|NCT03359356|76189188|FG000|NOT COMPLETED|Overall Study||0||
60073856|NCT03359356|76189189|FG001|NOT COMPLETED|Overall Study||0||
60073857|NCT01931839|76189206|FG000|STARTED|Overall Study||335||
60073858|NCT01931839|76189207|FG001|STARTED|Overall Study||178||
60073859|NCT01931839|76189208|FG002|STARTED|Overall Study||340||
60073860|NCT01931839|76189209|FG003|STARTED|Overall Study||176||
60073861|NCT01931839|76189210|FG004|STARTED|Overall Study||19||
59803463|NCT00462904|75925001|FG000|NOT COMPLETED|Overall Study||1||
59803464|NCT00467272|75925005|FG000|STARTED|Overall Study||41||
59803465|NCT00467272|75925005|FG000|COMPLETED|Overall Study||38||
59803466|NCT00467272|75925005|FG000|NOT COMPLETED|Overall Study||3||
59803467|NCT00462826|75925009|FG000|STARTED|Overall Study||49||
59803468|NCT00462826|75925009|FG000|COMPLETED|Overall Study||44||
59803469|NCT00462826|75925009|FG000|NOT COMPLETED|Overall Study||5||
59803470|NCT00551616|75925021|FG000|STARTED|Overall Study||1104||
59803471|NCT00551616|75925022|FG001|STARTED|Overall Study||1117||
59803472|NCT00551616|75925021|FG000|COMPLETED|Overall Study||1056||
60073862|NCT01931839|76189211|FG005|STARTED|Overall Study||55||
59803473|NCT00551616|75925022|FG001|COMPLETED|Overall Study||1077||
60073863|NCT01931839|76189212|FG006|STARTED|Overall Study||60||
60073864|NCT01931839|76189206|FG000|Full Analysis Set (As Randomized)|Overall Study||334||
60073865|NCT01931839|76189207|FG001|Full Analysis Set (As Randomized)|Overall Study||179||
60073866|NCT01931839|76189208|FG002|Full Analysis Set (As Randomized)|Overall Study||340||
59803474|NCT00551616|75925021|FG000|NOT COMPLETED|Overall Study||48||
59803475|NCT00551616|75925022|FG001|NOT COMPLETED|Overall Study||40||
60073867|NCT01931839|76189209|FG003|Full Analysis Set (As Randomized)|Overall Study||176||
60073868|NCT01931839|76189210|FG004|Full Analysis Set (As Randomized)|Overall Study||19||
60073869|NCT01931839|76189211|FG005|Full Analysis Set (As Randomized)|Overall Study||55||
60073870|NCT01931839|76189212|FG006|Full Analysis Set (As Randomized)|Overall Study||60||
60073871|NCT01931839|76189206|FG000|Safety Analysis Set (As Dosed)|Overall Study||335||
60073872|NCT01931839|76189207|FG001|Safety Analysis Set (As Dosed)|Overall Study||178||
60103592|NCT04075734|76221849|FG001|STARTED|Overall Study||25||
59524073|NCT00988013|75619166|FG001|COMPLETED|Overall Study||3||
59803476|NCT00452530|75925030|FG000|STARTED|Overall Study|Randomized|1528||
59803477|NCT00452530|75925031|FG001|STARTED|Overall Study|Randomized|1529||
59803478|NCT00452530|75925030|FG000|Received Treatment|Overall Study||1501||
59803479|NCT00452530|75925031|FG001|Received Treatment|Overall Study||1508||
59803480|NCT00452530|75925030|FG000|Evaluable Participants|Overall Study||907||
59803481|NCT00452530|75925031|FG001|Evaluable Participants|Overall Study||921||
59803482|NCT00452530|75925030|FG000|Primary Participants|Overall Study||976||
59803483|NCT00452530|75925031|FG001|Primary Participants|Overall Study||997||
59803484|NCT00452530|75925030|FG000|COMPLETED|Overall Study||1392||
59956416|NCT00810693|76075257|FG002|NOT COMPLETED|Follow-up Period (FUP)||4||
59956417|NCT00381641|76075267|FG000|STARTED|Overall Study||38||
59956418|NCT00381641|76075268|FG001|STARTED|Overall Study||25||
59956419|NCT00381641|76075267|FG000|COMPLETED|Overall Study||38||
59956420|NCT00381641|76075268|FG001|COMPLETED|Overall Study||23||
59956421|NCT00381641|76075267|FG000|NOT COMPLETED|Overall Study||0||
59956422|NCT00381641|76075268|FG001|NOT COMPLETED|Overall Study||2||
59956423|NCT00334815|76075276|FG000|STARTED|Overall Study||16||
59956424|NCT00334815|76075277|FG001|STARTED|Overall Study||13||
59956425|NCT00334815|76075276|FG000|COMPLETED|Overall Study||9||
59956426|NCT00334815|76075277|FG001|COMPLETED|Overall Study||3||
59956427|NCT00334815|76075276|FG000|NOT COMPLETED|Overall Study||7||
59956428|NCT00334815|76075277|FG001|NOT COMPLETED|Overall Study||10||
59956429|NCT05032612|76075287|FG000|STARTED|Overall Study||17||
59956430|NCT05032612|76075288|FG001|STARTED|Overall Study||15||
59956431|NCT05032612|76075287|FG000|COMPLETED|Overall Study||17||
59956432|NCT05032612|76075288|FG001|COMPLETED|Overall Study||15||
59956433|NCT05032612|76075287|FG000|NOT COMPLETED|Overall Study||0||
59956434|NCT05032612|76075288|FG001|NOT COMPLETED|Overall Study||0||
59956435|NCT04730349|76075296|FG000|STARTED|Overall Study||8|Started = Started treatment|
59956436|NCT04730349|76075297|FG001|STARTED|Overall Study||7|Started = Started treatment|
59956437|NCT04730349|76075296|FG000|COMPLETED|Overall Study||1|Completed = Completed treatment|
59956438|NCT04730349|76075297|FG001|COMPLETED|Overall Study||2|Completed = Completed treatment|
59956439|NCT04730349|76075296|FG000|NOT COMPLETED|Overall Study||7||
59956440|NCT04730349|76075297|FG001|NOT COMPLETED|Overall Study||5||
59956441|NCT04517396|76075305|FG000|STARTED|Overall Study||351||
59956442|NCT04517396|76075306|FG001|STARTED|Overall Study||350||
59956443|NCT04517396|76075305|FG000|COMPLETED|Overall Study||347||
59956444|NCT04517396|76075306|FG001|COMPLETED|Overall Study||347||
59956445|NCT04517396|76075305|FG000|NOT COMPLETED|Overall Study||4||
59956446|NCT04517396|76075306|FG001|NOT COMPLETED|Overall Study||3||
59956447|NCT04311424|76075312|FG000|STARTED|Overall Study||6||
59956448|NCT04311424|76075312|FG000|COMPLETED|Overall Study||6||
59956449|NCT04311424|76075312|FG000|NOT COMPLETED|Overall Study||0||
59956450|NCT04307394|76075316|FG000|STARTED|Overall Study||10||
59956451|NCT04307394|76075316|FG000|COMPLETED|Overall Study||5||
59956452|NCT04307394|76075316|FG000|NOT COMPLETED|Overall Study||5||
59956453|NCT04075721|76075323|FG000|STARTED|Overall Study||2||
59956454|NCT04075721|76075324|FG001|STARTED|Overall Study||4||
59956455|NCT04075721|76075325|FG002|STARTED|Overall Study||4||
59956456|NCT04075721|76075323|FG000|Pharmacokinetic (PK) Analysis Set|Overall Study||2||
59956457|NCT04075721|76075324|FG001|Pharmacokinetic (PK) Analysis Set|Overall Study|1 participant received actual dose of 10 mg in Cycle 1 Day 1 instead of planned 20 mg and was summarized with the 10 mg dose level for PK analysis set.|5||
59956458|NCT04075721|76075325|FG002|Pharmacokinetic (PK) Analysis Set|Overall Study||3||
59956459|NCT04075721|76075323|FG000|Pharmacodynamics (Pd) Analysis Set|Overall Study||2||
59956460|NCT04075721|76075324|FG001|Pharmacodynamics (Pd) Analysis Set|Overall Study|1 participant received actual dose of 10 mg in Cycle 1 Day 1 instead of planned 20 mg and was summarized with the 10 mg dose level for Pd analysis set.|5||
59956461|NCT04075721|76075325|FG002|Pharmacodynamics (Pd) Analysis Set|Overall Study||3||
59956462|NCT04075721|76075323|FG000|COMPLETED|Overall Study||2||
59956463|NCT04075721|76075324|FG001|COMPLETED|Overall Study||4||
59956464|NCT04075721|76075325|FG002|COMPLETED|Overall Study||4||
59956465|NCT04075721|76075323|FG000|NOT COMPLETED|Overall Study||0||
59956466|NCT04075721|76075324|FG001|NOT COMPLETED|Overall Study||0||
59956467|NCT04075721|76075325|FG002|NOT COMPLETED|Overall Study||0||
59956468|NCT03940742|76075342|FG000|STARTED|Overall Study||13||
59956469|NCT03940742|76075343|FG001|STARTED|Overall Study||6||
59956470|NCT03940742|76075344|FG002|STARTED|Overall Study||6||
59956471|NCT03940742|76075345|FG003|STARTED|Overall Study||7||
59956472|NCT03940742|76075342|FG000|Received at Least One Dose of Study Drug|Overall Study||13||
59956473|NCT03940742|76075343|FG001|Received at Least One Dose of Study Drug|Overall Study||6||
59956474|NCT03940742|76075344|FG002|Received at Least One Dose of Study Drug|Overall Study||6||
59956475|NCT03940742|76075345|FG003|Received at Least One Dose of Study Drug|Overall Study||7||
59956476|NCT03940742|76075342|FG000|COMPLETED|Overall Study||13||
59956477|NCT03940742|76075343|FG001|COMPLETED|Overall Study||6||
59956478|NCT03940742|76075344|FG002|COMPLETED|Overall Study||6||
59956479|NCT03940742|76075345|FG003|COMPLETED|Overall Study||6||
59956480|NCT03940742|76075342|FG000|NOT COMPLETED|Overall Study||0||
59803485|NCT00452530|75925031|FG001|COMPLETED|Overall Study||1393||
59803486|NCT00452530|75925030|FG000|NOT COMPLETED|Overall Study||136||
59956481|NCT03940742|76075343|FG001|NOT COMPLETED|Overall Study||0||
59956482|NCT03940742|76075344|FG002|NOT COMPLETED|Overall Study||0||
59956483|NCT03940742|76075345|FG003|NOT COMPLETED|Overall Study||1||
59956484|NCT03917654|76075367|FG000|STARTED|Year 1||15||
59956485|NCT03917654|76075368|FG001|STARTED|Year 1||15||
59956486|NCT03917654|76075369|FG002|STARTED|Year 1||15||
59956487|NCT03917654|76075370|FG003|STARTED|Year 1||15||
59956488|NCT03917654|76075371|FG004|STARTED|Year 1||99||
59956489|NCT03917654|76075372|FG005|STARTED|Year 1||87||
59956490|NCT03917654|76075373|FG006|STARTED|Year 1||192||
59803487|NCT00452530|75925031|FG001|NOT COMPLETED|Overall Study||136||
59803488|NCT00549198|75925043|FG000|STARTED|Overall Study|Three participants were randomized but were not exposed to study drug (ABC/3TC).|195||
59956491|NCT03917654|76075374|FG007|STARTED|Year 1||177||
59956492|NCT03917654|76075375|FG008|STARTED|Year 1||227||
59956493|NCT03917654|76075376|FG009|STARTED|Year 1||267||
59956494|NCT03917654|76075377|FG010|STARTED|Year 1||97||
59956495|NCT03917654|76075378|FG011|STARTED|Year 1||95||
59956496|NCT03917654|76075367|FG000|COMPLETED|Year 1||14||
59956497|NCT03917654|76075368|FG001|COMPLETED|Year 1||13||
59956498|NCT03917654|76075369|FG002|COMPLETED|Year 1||13||
59956499|NCT03917654|76075370|FG003|COMPLETED|Year 1||15||
59956500|NCT03917654|76075371|FG004|COMPLETED|Year 1||94||
59956501|NCT03917654|76075372|FG005|COMPLETED|Year 1||82||
59956502|NCT03917654|76075373|FG006|COMPLETED|Year 1||173||
59956503|NCT03917654|76075374|FG007|COMPLETED|Year 1||162||
59956504|NCT03917654|76075375|FG008|COMPLETED|Year 1||218||
59956505|NCT03917654|76075376|FG009|COMPLETED|Year 1||257||
59956506|NCT03917654|76075377|FG010|COMPLETED|Year 1||92||
59956507|NCT03917654|76075378|FG011|COMPLETED|Year 1||87||
59956508|NCT03917654|76075367|FG000|NOT COMPLETED|Year 1||1||
59956509|NCT03917654|76075368|FG001|NOT COMPLETED|Year 1||2||
59956510|NCT03917654|76075369|FG002|NOT COMPLETED|Year 1||2||
59956511|NCT03917654|76075370|FG003|NOT COMPLETED|Year 1||0||
59956512|NCT03917654|76075371|FG004|NOT COMPLETED|Year 1||5||
59956513|NCT03917654|76075372|FG005|NOT COMPLETED|Year 1||5||
59956514|NCT03917654|76075373|FG006|NOT COMPLETED|Year 1||19||
59956515|NCT03917654|76075374|FG007|NOT COMPLETED|Year 1||15||
59956516|NCT03917654|76075375|FG008|NOT COMPLETED|Year 1||9||
59956517|NCT03917654|76075376|FG009|NOT COMPLETED|Year 1||10||
59956518|NCT03917654|76075377|FG010|NOT COMPLETED|Year 1||5||
59956519|NCT03917654|76075378|FG011|NOT COMPLETED|Year 1||8||
59956520|NCT03917654|76075367|FG000|STARTED|Year 2||13|Year 2 participants did not equal Year 1 participants for each arm, due to a number of participants electing not to rescreen for Year 2.|
59956521|NCT03917654|76075368|FG001|STARTED|Year 2||10|Year 2 participants did not equal Year 1 participants for each arm, due to a number of participants electing not to rescreen for Year 2.|
59956522|NCT03917654|76075369|FG002|STARTED|Year 2||13|Year 2 participants did not equal Year 1 participants for each arm, due to a number of participants electing not to rescreen for Year 2.|
59620667|NCT00099372|75732032|FG001|STARTED|Followed up 7 Years After Index Surgery||92||
59620668|NCT00099372|75732031|FG000|COMPLETED|Followed up 7 Years After Index Surgery||66||
59620669|NCT00099372|75732032|FG001|COMPLETED|Followed up 7 Years After Index Surgery||60||
59620670|NCT00099372|75732031|FG000|NOT COMPLETED|Followed up 7 Years After Index Surgery||23||
59803489|NCT00549198|75925044|FG001|STARTED|Overall Study|Four participants were randomized but were not exposed to study drug (TDF/FTC).|197||
59803490|NCT00549198|75925043|FG000|COMPLETED|Overall Study||115||
59803491|NCT00549198|75925044|FG001|COMPLETED|Overall Study||134||
59803492|NCT00549198|75925043|FG000|NOT COMPLETED|Overall Study||80||
59803493|NCT00549198|75925044|FG001|NOT COMPLETED|Overall Study||63||
59803494|NCT00607724|75925057|FG000|STARTED|Stage 1: Dose Escalation||7||
59803495|NCT00607724|75925058|FG001|STARTED|Stage 1: Dose Escalation||9||
59803496|NCT00607724|75925059|FG002|STARTED|Stage 1: Dose Escalation||4||
59803497|NCT00607724|75925060|FG003|STARTED|Stage 1: Dose Escalation||0||
59803498|NCT00607724|75925061|FG004|STARTED|Stage 1: Dose Escalation||0||
59803499|NCT00607724|75925062|FG005|STARTED|Stage 1: Dose Escalation||0||
59803500|NCT00607724|75925063|FG006|STARTED|Stage 1: Dose Escalation||0||
59803501|NCT00607724|75925057|FG000|COMPLETED|Stage 1: Dose Escalation||0||
59803502|NCT00607724|75925058|FG001|COMPLETED|Stage 1: Dose Escalation|Participants still on treatment at time of study closure were considered 'completers'.|1||
59803503|NCT00607724|75925059|FG002|COMPLETED|Stage 1: Dose Escalation||0||
59956523|NCT03917654|76075370|FG003|STARTED|Year 2||14|Year 2 participants did not equal Year 1 participants for each arm, due to a number of participants electing not to rescreen for Year 2.|
59803504|NCT00607724|75925060|FG003|COMPLETED|Stage 1: Dose Escalation||0||
59803505|NCT00607724|75925061|FG004|COMPLETED|Stage 1: Dose Escalation||0||
59956524|NCT03917654|76075371|FG004|STARTED|Year 2||86|Year 2 participants did not equal Year 1 participants for each arm, due to a number of participants electing not to rescreen for Year 2.|
59956525|NCT03917654|76075372|FG005|STARTED|Year 2||77|Year 2 participants did not equal Year 1 participants for each arm, due to a number of participants electing not to rescreen for Year 2.|
59956526|NCT03917654|76075373|FG006|STARTED|Year 2||152|Year 2 participants did not equal Year 1 participants for each arm, due to a number of participants electing not to rescreen for Year 2.|
59956527|NCT03917654|76075374|FG007|STARTED|Year 2||147|Year 2 participants did not equal Year 1 participants for each arm, due to a number of participants electing not to rescreen for Year 2.|
59956528|NCT03917654|76075375|FG008|STARTED|Year 2||199|Year 2 participants did not equal Year 1 participants for each arm, due to a number of participants electing not to rescreen for Year 2.|
59803506|NCT00607724|75925062|FG005|COMPLETED|Stage 1: Dose Escalation||0||
59803507|NCT00607724|75925063|FG006|COMPLETED|Stage 1: Dose Escalation||0||
59803508|NCT00607724|75925057|FG000|NOT COMPLETED|Stage 1: Dose Escalation||7||
59803509|NCT00607724|75925058|FG001|NOT COMPLETED|Stage 1: Dose Escalation||8||
59803510|NCT00607724|75925059|FG002|NOT COMPLETED|Stage 1: Dose Escalation||4||
59803511|NCT00607724|75925060|FG003|NOT COMPLETED|Stage 1: Dose Escalation||0||
59803512|NCT00607724|75925061|FG004|NOT COMPLETED|Stage 1: Dose Escalation||0||
59803513|NCT00607724|75925062|FG005|NOT COMPLETED|Stage 1: Dose Escalation||0||
59803514|NCT00607724|75925063|FG006|NOT COMPLETED|Stage 1: Dose Escalation||0||
59803515|NCT00607724|75925057|FG000|STARTED|Stage 2: Expanded Cohort||0||
59803516|NCT00607724|75925058|FG001|STARTED|Stage 2: Expanded Cohort||0||
59803517|NCT00607724|75925059|FG002|STARTED|Stage 2: Expanded Cohort||0||
59803518|NCT00607724|75925060|FG003|STARTED|Stage 2: Expanded Cohort||6||
59803519|NCT00607724|75925061|FG004|STARTED|Stage 2: Expanded Cohort||14||
59803520|NCT00607724|75925062|FG005|STARTED|Stage 2: Expanded Cohort||12||
59803521|NCT00607724|75925063|FG006|STARTED|Stage 2: Expanded Cohort||16||
59803522|NCT00607724|75925057|FG000|COMPLETED|Stage 2: Expanded Cohort||0||
59803523|NCT00607724|75925058|FG001|COMPLETED|Stage 2: Expanded Cohort||0||
59803524|NCT00607724|75925059|FG002|COMPLETED|Stage 2: Expanded Cohort||0||
59803525|NCT00607724|75925060|FG003|COMPLETED|Stage 2: Expanded Cohort|Participants still on treatment at time of study closure were considered 'completers'.|1||
59803526|NCT00607724|75925061|FG004|COMPLETED|Stage 2: Expanded Cohort|Participants still on treatment at time of study closure were considered 'completers'.|5||
59803527|NCT00607724|75925062|FG005|COMPLETED|Stage 2: Expanded Cohort||0||
59803528|NCT00607724|75925063|FG006|COMPLETED|Stage 2: Expanded Cohort|Participants still on treatment at time of study closure were considered 'completers'.|5||
59803529|NCT00607724|75925057|FG000|NOT COMPLETED|Stage 2: Expanded Cohort||0||
59803530|NCT00607724|75925058|FG001|NOT COMPLETED|Stage 2: Expanded Cohort||0||
59803531|NCT00607724|75925059|FG002|NOT COMPLETED|Stage 2: Expanded Cohort||0||
59803532|NCT00607724|75925060|FG003|NOT COMPLETED|Stage 2: Expanded Cohort||5||
59803533|NCT00607724|75925061|FG004|NOT COMPLETED|Stage 2: Expanded Cohort||9||
59803534|NCT00607724|75925062|FG005|NOT COMPLETED|Stage 2: Expanded Cohort||12||
59956529|NCT03917654|76075376|FG009|STARTED|Year 2||238|Year 2 participants did not equal Year 1 participants for each arm, due to a number of participants electing not to rescreen for Year 2.|
59956530|NCT03917654|76075377|FG010|STARTED|Year 2||90|Year 2 participants did not equal Year 1 participants for each arm, due to a number of participants electing not to rescreen for Year 2.|
59956531|NCT03917654|76075378|FG011|STARTED|Year 2||87|Year 2 participants did not equal Year 1 participants for each arm, due to a number of participants electing not to rescreen for Year 2.|
59956532|NCT03917654|76075367|FG000|Did Not Rescreen|Year 2||1||
59803535|NCT00607724|75925063|FG006|NOT COMPLETED|Stage 2: Expanded Cohort||11||
59803536|NCT00506415|75925087|FG000|STARTED|Initial Open Label (Maximum 48 Weeks)|Enrolled patients.|1584||
59803537|NCT00506415|75925088|FG001|STARTED|Initial Open Label (Maximum 48 Weeks)||0||
59803538|NCT00506415|75925089|FG002|STARTED|Initial Open Label (Maximum 48 Weeks)||0||
59803539|NCT00506415|75925090|FG003|STARTED|Initial Open Label (Maximum 48 Weeks)||0||
59803540|NCT00506415|75925087|FG000|Exposed to Study Drug|Initial Open Label (Maximum 48 Weeks)||1582||
59803541|NCT00506415|75925088|FG001|Exposed to Study Drug|Initial Open Label (Maximum 48 Weeks)||0||
59803542|NCT00506415|75925089|FG002|Exposed to Study Drug|Initial Open Label (Maximum 48 Weeks)||0||
59803543|NCT00506415|75925090|FG003|Exposed to Study Drug|Initial Open Label (Maximum 48 Weeks)||0||
59803544|NCT00506415|75925087|FG000|COMPLETED|Initial Open Label (Maximum 48 Weeks)||1085||
59803545|NCT00506415|75925088|FG001|COMPLETED|Initial Open Label (Maximum 48 Weeks)||0||
59803546|NCT00506415|75925089|FG002|COMPLETED|Initial Open Label (Maximum 48 Weeks)||0||
59803547|NCT00506415|75925090|FG003|COMPLETED|Initial Open Label (Maximum 48 Weeks)||0||
59803548|NCT00506415|75925087|FG000|NOT COMPLETED|Initial Open Label (Maximum 48 Weeks)||499||
59803549|NCT00506415|75925088|FG001|NOT COMPLETED|Initial Open Label (Maximum 48 Weeks)||0||
59803550|NCT00506415|75925089|FG002|NOT COMPLETED|Initial Open Label (Maximum 48 Weeks)||0||
59803551|NCT00506415|75925090|FG003|NOT COMPLETED|Initial Open Label (Maximum 48 Weeks)||0||
59803552|NCT00506415|75925087|FG000|STARTED|Double Blind (Maximum 48 Weeks )||0||
59803553|NCT00506415|75925088|FG001|STARTED|Double Blind (Maximum 48 Weeks )|1 patient was randomized in error and did not receive study drug, hence excluded from this arm.|286||
59803554|NCT00506415|75925089|FG002|STARTED|Double Blind (Maximum 48 Weeks )||280||
59803555|NCT00506415|75925090|FG003|STARTED|Double Blind (Maximum 48 Weeks )||0||
59803556|NCT00506415|75925087|FG000|COMPLETED|Double Blind (Maximum 48 Weeks )||0||
59803557|NCT00506415|75925088|FG001|COMPLETED|Double Blind (Maximum 48 Weeks )||203||
59803558|NCT00506415|75925089|FG002|COMPLETED|Double Blind (Maximum 48 Weeks )||207||
59803559|NCT00506415|75925090|FG003|COMPLETED|Double Blind (Maximum 48 Weeks )||0||
59803560|NCT00506415|75925087|FG000|NOT COMPLETED|Double Blind (Maximum 48 Weeks )||0||
59803561|NCT00506415|75925088|FG001|NOT COMPLETED|Double Blind (Maximum 48 Weeks )||83||
59803562|NCT00506415|75925089|FG002|NOT COMPLETED|Double Blind (Maximum 48 Weeks )||73||
59803563|NCT00506415|75925090|FG003|NOT COMPLETED|Double Blind (Maximum 48 Weeks )||0||
59803564|NCT00506415|75925087|FG000|STARTED|Extended Open Label (Maximum 48 Weeks)||0||
59803565|NCT00506415|75925088|FG001|STARTED|Extended Open Label (Maximum 48 Weeks)||0||
59803566|NCT00506415|75925089|FG002|STARTED|Extended Open Label (Maximum 48 Weeks)||0||
59956533|NCT03917654|76075368|FG001|Did Not Rescreen|Year 2||3||
59956534|NCT03917654|76075369|FG002|Did Not Rescreen|Year 2||0||
59803567|NCT00506415|75925090|FG003|STARTED|Extended Open Label (Maximum 48 Weeks)|Two participants did not receive study drug, hence excluded from this arm.|457||
59803568|NCT00506415|75925087|FG000|COMPLETED|Extended Open Label (Maximum 48 Weeks)||0||
59803569|NCT00506415|75925088|FG001|COMPLETED|Extended Open Label (Maximum 48 Weeks)||0||
59803570|NCT00506415|75925089|FG002|COMPLETED|Extended Open Label (Maximum 48 Weeks)||0||
59803571|NCT00506415|75925090|FG003|COMPLETED|Extended Open Label (Maximum 48 Weeks)||395||
59803572|NCT00506415|75925087|FG000|NOT COMPLETED|Extended Open Label (Maximum 48 Weeks)||0||
59803573|NCT00506415|75925088|FG001|NOT COMPLETED|Extended Open Label (Maximum 48 Weeks)||0||
59803574|NCT00506415|75925089|FG002|NOT COMPLETED|Extended Open Label (Maximum 48 Weeks)||0||
59803575|NCT00506415|75925090|FG003|NOT COMPLETED|Extended Open Label (Maximum 48 Weeks)||62||
59803576|NCT00452452|75925106|FG000|STARTED|Overall Study||90||
59803577|NCT00452452|75925107|FG001|STARTED|Overall Study||112||
59803578|NCT00452452|75925108|FG002|STARTED|Overall Study||153||
59803579|NCT00452452|75925106|FG000|Vaccinated Dose 1|Overall Study||90||
59803580|NCT00452452|75925107|FG001|Vaccinated Dose 1|Overall Study||112||
59803581|NCT00452452|75925108|FG002|Vaccinated Dose 1|Overall Study||152||
59803582|NCT00452452|75925106|FG000|Vaccinated Dose 2|Overall Study||90||
59956535|NCT03917654|76075370|FG003|Did Not Rescreen|Year 2||1||
59956536|NCT03917654|76075371|FG004|Did Not Rescreen|Year 2||8||
59956537|NCT03917654|76075372|FG005|Did Not Rescreen|Year 2||5||
59956538|NCT03917654|76075373|FG006|Did Not Rescreen|Year 2||21||
59956539|NCT03917654|76075374|FG007|Did Not Rescreen|Year 2||15||
59956540|NCT03917654|76075375|FG008|Did Not Rescreen|Year 2||19||
59956541|NCT03917654|76075376|FG009|Did Not Rescreen|Year 2||19||
59956542|NCT03917654|76075377|FG010|Did Not Rescreen|Year 2||2||
59956543|NCT03917654|76075378|FG011|Did Not Rescreen|Year 2||0||
59956544|NCT03917654|76075367|FG000|COMPLETED|Year 2||10||
59956545|NCT03917654|76075368|FG001|COMPLETED|Year 2||9||
59956546|NCT03917654|76075369|FG002|COMPLETED|Year 2||13||
59956547|NCT03917654|76075370|FG003|COMPLETED|Year 2||14||
59956548|NCT03917654|76075371|FG004|COMPLETED|Year 2||82||
59956549|NCT03917654|76075372|FG005|COMPLETED|Year 2||75||
59956550|NCT03917654|76075373|FG006|COMPLETED|Year 2||138||
59956551|NCT03917654|76075374|FG007|COMPLETED|Year 2||139||
59956552|NCT03917654|76075375|FG008|COMPLETED|Year 2||185||
59956553|NCT03917654|76075376|FG009|COMPLETED|Year 2||226||
59956554|NCT03917654|76075377|FG010|COMPLETED|Year 2||89||
59956555|NCT03917654|76075378|FG011|COMPLETED|Year 2||83||
59956556|NCT03917654|76075367|FG000|NOT COMPLETED|Year 2||3||
59956557|NCT03917654|76075368|FG001|NOT COMPLETED|Year 2||1||
59956558|NCT03917654|76075369|FG002|NOT COMPLETED|Year 2||0||
59956559|NCT03917654|76075370|FG003|NOT COMPLETED|Year 2||0||
59956560|NCT03917654|76075371|FG004|NOT COMPLETED|Year 2||4||
59956561|NCT03917654|76075372|FG005|NOT COMPLETED|Year 2||2||
59956562|NCT03917654|76075373|FG006|NOT COMPLETED|Year 2||14||
59956563|NCT03917654|76075374|FG007|NOT COMPLETED|Year 2||8||
59956564|NCT03917654|76075375|FG008|NOT COMPLETED|Year 2||14||
59956565|NCT03917654|76075376|FG009|NOT COMPLETED|Year 2||12||
59956566|NCT03917654|76075377|FG010|NOT COMPLETED|Year 2||1||
59956567|NCT03917654|76075378|FG011|NOT COMPLETED|Year 2||4||
59956568|NCT03875274|76075406|FG000|STARTED|Overall Study||35||
59956569|NCT03875274|76075407|FG001|STARTED|Overall Study||35||
59956570|NCT03875274|76075406|FG000|COMPLETED|Overall Study||35||
59803583|NCT00452452|75925107|FG001|Vaccinated Dose 2|Overall Study||112||
59803584|NCT00452452|75925108|FG002|Vaccinated Dose 2|Overall Study||0||
59803585|NCT00452452|75925106|FG000|Vaccinated Dose 3|Overall Study||89||
59803586|NCT00452452|75925107|FG001|Vaccinated Dose 3|Overall Study||0||
59803587|NCT00452452|75925108|FG002|Vaccinated Dose 3|Overall Study||0||
59803588|NCT00452452|75925106|FG000|COMPLETED|Overall Study||88||
59803589|NCT00452452|75925107|FG001|COMPLETED|Overall Study||112||
59803590|NCT00452452|75925108|FG002|COMPLETED|Overall Study||152||
59803591|NCT00452452|75925106|FG000|NOT COMPLETED|Overall Study||2||
59956571|NCT03875274|76075407|FG001|COMPLETED|Overall Study||35||
59956572|NCT03875274|76075406|FG000|NOT COMPLETED|Overall Study||0||
59956573|NCT03875274|76075407|FG001|NOT COMPLETED|Overall Study||0||
59956574|NCT03060577|76075415|FG000|STARTED|Overall Study||290|All enrolled participants|
59956575|NCT03060577|76075416|FG001|STARTED|Overall Study||92|All enrolled participants|
60073873|NCT01931839|76189208|FG002|Safety Analysis Set (As Dosed)|Overall Study||340||
60073874|NCT01931839|76189209|FG003|Safety Analysis Set (As Dosed)|Overall Study||176||
60073875|NCT01931839|76189210|FG004|Safety Analysis Set (As Dosed)|Overall Study||19||
60073876|NCT01931839|76189211|FG005|Safety Analysis Set (As Dosed)|Overall Study||55||
59956576|NCT03060577|76075415|FG000|Safety Analysis Set|Overall Study||284|All enrolled participants who received at least one dose of study treatment|
59956577|NCT03060577|76075416|FG001|Safety Analysis Set|Overall Study||90|All enrolled participants who received at least one dose of study treatment|
59956578|NCT03060577|76075415|FG000|COMPLETED|Overall Study||233||
59956579|NCT03060577|76075416|FG001|COMPLETED|Overall Study||80||
59956580|NCT03060577|76075415|FG000|NOT COMPLETED|Overall Study||57||
59956581|NCT03060577|76075416|FG001|NOT COMPLETED|Overall Study||12||
59803592|NCT00452452|75925107|FG001|NOT COMPLETED|Overall Study||0||
59803593|NCT00452452|75925108|FG002|NOT COMPLETED|Overall Study||1||
59803594|NCT00510783|75925124|FG000|STARTED|Overall Study||82||
59956582|NCT02872714|76075427|FG000|STARTED|Overall Study||103||
59956583|NCT02872714|76075428|FG001|STARTED|Overall Study||44||
59956584|NCT02872714|76075429|FG002|STARTED|Overall Study||9||
59956585|NCT02872714|76075430|FG003|STARTED|Overall Study||101||
59956586|NCT02872714|76075431|FG004|STARTED|Overall Study||3||
59956587|NCT02872714|76075427|FG000|COMPLETED|Overall Study||10||
59956588|NCT02872714|76075428|FG001|COMPLETED|Overall Study||2||
59956589|NCT02872714|76075429|FG002|COMPLETED|Overall Study||1||
59956590|NCT02872714|76075430|FG003|COMPLETED|Overall Study||13||
59956591|NCT02872714|76075431|FG004|COMPLETED|Overall Study||1||
59803595|NCT00510783|75925125|FG001|STARTED|Overall Study||76||
59803596|NCT00510783|75925124|FG000|COMPLETED|Overall Study||51||
59803597|NCT00510783|75925125|FG001|COMPLETED|Overall Study||47||
59956592|NCT02872714|76075427|FG000|NOT COMPLETED|Overall Study||93||
59956593|NCT02872714|76075428|FG001|NOT COMPLETED|Overall Study||42||
59956594|NCT02872714|76075429|FG002|NOT COMPLETED|Overall Study||8||
59956595|NCT02872714|76075430|FG003|NOT COMPLETED|Overall Study||88||
59956596|NCT02872714|76075431|FG004|NOT COMPLETED|Overall Study||2||
59956597|NCT02787005|76075451|FG000|STARTED|Overall Study||133||
59956598|NCT02787005|76075452|FG001|STARTED|Overall Study||69||
59956599|NCT02787005|76075453|FG002|STARTED|Overall Study||58||
59956600|NCT02787005|76075454|FG003|STARTED|Overall Study||81||
59803598|NCT00510783|75925124|FG000|NOT COMPLETED|Overall Study||31||
59803599|NCT00510783|75925125|FG001|NOT COMPLETED|Overall Study||29||
59803600|NCT00518973|75925133|FG000|STARTED|Overall Study||9||
59803601|NCT00518973|75925134|FG001|STARTED|Overall Study||6||
59803602|NCT00518973|75925133|FG000|COMPLETED|Overall Study||6||
59803603|NCT00518973|75925134|FG001|COMPLETED|Overall Study||4||
59956601|NCT02787005|76075455|FG004|STARTED|Overall Study||47||
59803604|NCT00518973|75925133|FG000|NOT COMPLETED|Overall Study||3||
59803605|NCT00518973|75925134|FG001|NOT COMPLETED|Overall Study||2||
59803606|NCT00462670|75925142|FG000|STARTED|Overall Study||57||
59803607|NCT00462670|75925143|FG001|STARTED|Overall Study||53||
59803608|NCT00462670|75925142|FG000|COMPLETED|Overall Study||52||
59803609|NCT00462670|75925143|FG001|COMPLETED|Overall Study||46||
59803610|NCT00462670|75925142|FG000|NOT COMPLETED|Overall Study||5||
59803611|NCT00462670|75925143|FG001|NOT COMPLETED|Overall Study||7||
59803612|NCT00606086|75925151|FG000|STARTED|Overall Study||72||
59803613|NCT00606086|75925152|FG001|STARTED|Overall Study||68||
59803614|NCT00606086|75925151|FG000|COMPLETED|Overall Study||60||
59803615|NCT00606086|75925152|FG001|COMPLETED|Overall Study||53||
59803616|NCT00606086|75925151|FG000|NOT COMPLETED|Overall Study||12||
59803617|NCT00606086|75925152|FG001|NOT COMPLETED|Overall Study||15||
59803618|NCT00609986|75925160|FG000|STARTED|Overall Study||52||
59803619|NCT00609986|75925161|FG001|STARTED|Overall Study||52||
59803620|NCT00609986|75925160|FG000|Received Transplant|Overall Study||44||
59803621|NCT00609986|75925161|FG001|Received Transplant|Overall Study||49||
59803622|NCT00609986|75925160|FG000|COMPLETED|Overall Study||44||
59803623|NCT00609986|75925161|FG001|COMPLETED|Overall Study||49||
59803624|NCT00609986|75925160|FG000|NOT COMPLETED|Overall Study||8||
59803625|NCT00609986|75925161|FG001|NOT COMPLETED|Overall Study||3||
59803626|NCT00451906|75925167|FG000|STARTED|Overall Study||2252||
59803627|NCT00451906|75925167|FG000|COMPLETED|Overall Study||13||
59803628|NCT00451906|75925167|FG000|NOT COMPLETED|Overall Study||2239||
59803629|NCT00451282|75925173|FG000|STARTED|Overall Study||46||
59803630|NCT00451282|75925174|FG001|STARTED|Overall Study||39||
59803631|NCT00451282|75925173|FG000|COMPLETED|Overall Study||40||
59803632|NCT00451282|75925174|FG001|COMPLETED|Overall Study||34||
59803633|NCT00451282|75925173|FG000|NOT COMPLETED|Overall Study||6||
59803634|NCT00451282|75925174|FG001|NOT COMPLETED|Overall Study||5||
59803635|NCT03838198|75925182|FG000|STARTED|Phase 1: Safety Plan (SP) vs. SP w/Texts|Because it was a SMART trial, no participants were allocated to receive booster calls until Phase 2.|0||
59803636|NCT03838198|75925183|FG001|STARTED|Phase 1: Safety Plan (SP) vs. SP w/Texts||40||
59956602|NCT02787005|76075451|FG000|Treated|Overall Study||133||
59956603|NCT02787005|76075452|FG001|Treated|Overall Study||67||
59956604|NCT02787005|76075453|FG002|Treated|Overall Study||58||
59956605|NCT02787005|76075454|FG003|Treated|Overall Study||81||
59803637|NCT03838198|75925184|FG002|STARTED|Phase 1: Safety Plan (SP) vs. SP w/Texts|Because it was a SMART trial, no participants were allocated to receive booster calls until Phase 2.|0||
59803638|NCT03838198|75925185|FG003|STARTED|Phase 1: Safety Plan (SP) vs. SP w/Texts||40||
59803639|NCT03838198|75925182|FG000|COMPLETED|Phase 1: Safety Plan (SP) vs. SP w/Texts||0||
59803640|NCT03838198|75925183|FG001|COMPLETED|Phase 1: Safety Plan (SP) vs. SP w/Texts||40||
59803641|NCT03838198|75925184|FG002|COMPLETED|Phase 1: Safety Plan (SP) vs. SP w/Texts||0||
59803642|NCT03838198|75925185|FG003|COMPLETED|Phase 1: Safety Plan (SP) vs. SP w/Texts||40||
59803643|NCT03838198|75925182|FG000|NOT COMPLETED|Phase 1: Safety Plan (SP) vs. SP w/Texts||0||
59803644|NCT03838198|75925183|FG001|NOT COMPLETED|Phase 1: Safety Plan (SP) vs. SP w/Texts||0||
59803645|NCT03838198|75925184|FG002|NOT COMPLETED|Phase 1: Safety Plan (SP) vs. SP w/Texts||0||
59803646|NCT03838198|75925185|FG003|NOT COMPLETED|Phase 1: Safety Plan (SP) vs. SP w/Texts||0||
59956606|NCT02787005|76075455|FG004|Treated|Overall Study||45||
59956607|NCT02787005|76075451|FG000|Received 2nd Course|Overall Study||1||
59956608|NCT02787005|76075452|FG001|Received 2nd Course|Overall Study||0||
59956609|NCT02787005|76075453|FG002|Received 2nd Course|Overall Study||0||
59956610|NCT02787005|76075454|FG003|Received 2nd Course|Overall Study||0||
59956611|NCT02787005|76075455|FG004|Received 2nd Course|Overall Study||0||
59956612|NCT02787005|76075451|FG000|COMPLETED|Overall Study||0||
59956613|NCT02787005|76075452|FG001|COMPLETED|Overall Study||0||
59803647|NCT03838198|75925182|FG000|STARTED|Phase 2: Added Booster Call or Not|These participants continued with Phase 1 intervention (Safety plan and text) with added booster call.|18|Started here means randomized in Phase 2 to either booster call or no booster call.|
59803648|NCT03838198|75925183|FG001|STARTED|Phase 2: Added Booster Call or Not|These participants continued with Phase 1 intervention (Safety plan and text) with no added booster call.|22|Started here means randomized in Phase 2 to either booster call or no booster call.|
59803649|NCT03838198|75925184|FG002|STARTED|Phase 2: Added Booster Call or Not|These participants continued with Phase 1 intervention (Safety plan only) with added booster call.|18|Started here means randomized in Phase 2 to either booster call or no booster call.|
59956614|NCT02787005|76075453|FG002|COMPLETED|Overall Study||0||
59956615|NCT02787005|76075454|FG003|COMPLETED|Overall Study||0||
59956616|NCT02787005|76075455|FG004|COMPLETED|Overall Study||0||
59956617|NCT02787005|76075451|FG000|NOT COMPLETED|Overall Study||133||
59956618|NCT02787005|76075452|FG001|NOT COMPLETED|Overall Study||69||
59956619|NCT02787005|76075453|FG002|NOT COMPLETED|Overall Study||58||
59956620|NCT02787005|76075454|FG003|NOT COMPLETED|Overall Study||81||
59956621|NCT02787005|76075455|FG004|NOT COMPLETED|Overall Study||47||
59956622|NCT02755467|76075478|FG000|STARTED|Overall Study||22||
59956623|NCT02755467|76075478|FG000|COMPLETED|Overall Study||21||
59956624|NCT02755467|76075478|FG000|NOT COMPLETED|Overall Study||1||
59956625|NCT02673333|76075482|FG000|STARTED|Overall Study||39||
59956626|NCT02673333|76075482|FG000|COMPLETED|Overall Study||39||
59956627|NCT02673333|76075482|FG000|NOT COMPLETED|Overall Study||0||
59803650|NCT03838198|75925185|FG003|STARTED|Phase 2: Added Booster Call or Not|These participants continued with Phase 1 intervention (Safety plan only) with no added booster call in Phase 2|22|Started here means randomized in Phase 2 to either booster call or no booster call.|
59803651|NCT03838198|75925182|FG000|COMPLETED|Phase 2: Added Booster Call or Not|All 18 completed the safety plan; but only 14 had both parent and adolescent completing the call; 1 had parent only; 1 had adolescent only; 2 were unable to be reached.|18||
59803652|NCT03838198|75925183|FG001|COMPLETED|Phase 2: Added Booster Call or Not||0||
59803653|NCT03838198|75925184|FG002|COMPLETED|Phase 2: Added Booster Call or Not|Of the 17 who completed the safety plan, only 15 had both parent and adolescent completing the call; 1 had parent only; 1 was unable to be reached.|17||
59803654|NCT03838198|75925185|FG003|COMPLETED|Phase 2: Added Booster Call or Not||0||
59803655|NCT03838198|75925182|FG000|NOT COMPLETED|Phase 2: Added Booster Call or Not||0||
59803656|NCT03838198|75925183|FG001|NOT COMPLETED|Phase 2: Added Booster Call or Not||22||
59803657|NCT03838198|75925184|FG002|NOT COMPLETED|Phase 2: Added Booster Call or Not||1||
59803658|NCT03838198|75925185|FG003|NOT COMPLETED|Phase 2: Added Booster Call or Not||22||
59803659|NCT03838198|75925182|FG000|STARTED|1 Month Follow up Period||18||
59803660|NCT03838198|75925183|FG001|STARTED|1 Month Follow up Period|All participants from Phase 1 and 2 were followed unless they withdrew.|22||
59803661|NCT03838198|75925184|FG002|STARTED|1 Month Follow up Period||17||
59803662|NCT03838198|75925185|FG003|STARTED|1 Month Follow up Period|All participants from Phase 1 and 2 were followed unless they withdrew.|22||
59803663|NCT03838198|75925182|FG000|Adolescent Surveys Completed|1 Month Follow up Period||16||
59803664|NCT03838198|75925183|FG001|Adolescent Surveys Completed|1 Month Follow up Period||22||
59803665|NCT03838198|75925184|FG002|Adolescent Surveys Completed|1 Month Follow up Period||16||
59803666|NCT03838198|75925185|FG003|Adolescent Surveys Completed|1 Month Follow up Period||22||
59803667|NCT03838198|75925182|FG000|COMPLETED|1 Month Follow up Period||16|Completed means parent survey completed|
59803668|NCT03838198|75925183|FG001|COMPLETED|1 Month Follow up Period||22|Completed means parent survey completed|
59956628|NCT02514083|76075486|FG000|STARTED|Overall Study||29||
59956629|NCT02514083|76075486|FG000|COMPLETED|Overall Study||28||
59956630|NCT02514083|76075486|FG000|NOT COMPLETED|Overall Study||1||
59956631|NCT02395848|76075490|FG000|STARTED|Overall Study||31||
59956632|NCT02395848|76075490|FG000|COMPLETED|Overall Study||29||
59956633|NCT02395848|76075490|FG000|NOT COMPLETED|Overall Study||2||
59956634|NCT02340585|76075495|FG000|STARTED|Anterior Cohort||182||
59803669|NCT03838198|75925184|FG002|COMPLETED|1 Month Follow up Period||16|Completed means parent survey completed|
59803670|NCT03838198|75925185|FG003|COMPLETED|1 Month Follow up Period||21|Completed means parent survey completed|
59803671|NCT03838198|75925182|FG000|NOT COMPLETED|1 Month Follow up Period||2||
59803672|NCT03838198|75925183|FG001|NOT COMPLETED|1 Month Follow up Period||0||
59803673|NCT03838198|75925184|FG002|NOT COMPLETED|1 Month Follow up Period||1||
59803674|NCT03838198|75925185|FG003|NOT COMPLETED|1 Month Follow up Period||1||
59803675|NCT03838198|75925182|FG000|STARTED|3 Month Follow up Period||18|All participants (except the one who withdrew) were recontacted for 3 month follow up.|
59803676|NCT03838198|75925183|FG001|STARTED|3 Month Follow up Period||22|All participants (except the one who withdrew) were recontacted for 3 month follow up.|
59817872|NCT04488770|75940337|FG011|NOT COMPLETED|Part 1-Cohort 1: Period 4 (Up to 5 Days)||0||
59956635|NCT02340585|76075495|FG000|COMPLETED|Anterior Cohort||182||
59956636|NCT02340585|76075495|FG000|NOT COMPLETED|Anterior Cohort||0||
59956637|NCT02340585|76075495|FG000|STARTED|Posterior Cohort||116||
59956638|NCT02340585|76075495|FG000|COMPLETED|Posterior Cohort||116||
59956639|NCT02340585|76075495|FG000|NOT COMPLETED|Posterior Cohort||0||
59956640|NCT02340585|76075495|FG000|STARTED|Post-approval Study (PAS)||298||
59956641|NCT02340585|76075495|FG000|COMPLETED|Post-approval Study (PAS)||298||
59956642|NCT02340585|76075495|FG000|NOT COMPLETED|Post-approval Study (PAS)||0||
59956643|NCT02061761|76075507|FG000|STARTED|Overall Study||3|Started treatment|
59956644|NCT02061761|76075508|FG001|STARTED|Overall Study||9|Started treatment|
59956645|NCT02061761|76075509|FG002|STARTED|Overall Study||6|Started treatment|
59956646|NCT02061761|76075510|FG003|STARTED|Overall Study||9|Started treatment|
59956647|NCT02061761|76075511|FG004|STARTED|Overall Study||11|Started treatment|
59956648|NCT02061761|76075512|FG005|STARTED|Overall Study||7|Started treatment|
59956649|NCT02061761|76075513|FG006|STARTED|Overall Study||1|Started treatment|
59956650|NCT02061761|76075514|FG007|STARTED|Overall Study||4|Started treatment|
59956651|NCT02061761|76075515|FG008|STARTED|Overall Study||56|Started treatment|
59956652|NCT02061761|76075507|FG000|Chronic Lymphocytic Leukemia (CLL)|Overall Study||0|Tumor type eligible for expansion|
59956653|NCT02061761|76075508|FG001|Chronic Lymphocytic Leukemia (CLL)|Overall Study||0|Tumor type eligible for expansion|
59956654|NCT02061761|76075509|FG002|Chronic Lymphocytic Leukemia (CLL)|Overall Study||0|Tumor type eligible for expansion|
59956655|NCT02061761|76075510|FG003|Chronic Lymphocytic Leukemia (CLL)|Overall Study||0|Tumor type eligible for expansion|
59956656|NCT02061761|76075511|FG004|Chronic Lymphocytic Leukemia (CLL)|Overall Study||2|Tumor type eligible for expansion|
59956657|NCT02061761|76075512|FG005|Chronic Lymphocytic Leukemia (CLL)|Overall Study||0|Tumor type eligible for expansion|
59956658|NCT02061761|76075513|FG006|Chronic Lymphocytic Leukemia (CLL)|Overall Study||0|Tumor type eligible for expansion|
59956659|NCT02061761|76075514|FG007|Chronic Lymphocytic Leukemia (CLL)|Overall Study||0|Tumor type eligible for expansion|
59956660|NCT02061761|76075515|FG008|Chronic Lymphocytic Leukemia (CLL)|Overall Study||0|Tumor type eligible for expansion|
59956661|NCT02061761|76075507|FG000|Diffuse Large B-Cell Lymphoma (DLBCL)|Overall Study||0|Tumor type eligible for expansion|
59956662|NCT02061761|76075508|FG001|Diffuse Large B-Cell Lymphoma (DLBCL)|Overall Study||0|Tumor type eligible for expansion|
59956663|NCT02061761|76075509|FG002|Diffuse Large B-Cell Lymphoma (DLBCL)|Overall Study||0|Tumor type eligible for expansion|
59956664|NCT02061761|76075510|FG003|Diffuse Large B-Cell Lymphoma (DLBCL)|Overall Study||0|Tumor type eligible for expansion|
59956665|NCT02061761|76075511|FG004|Diffuse Large B-Cell Lymphoma (DLBCL)|Overall Study||2|Tumor type eligible for expansion|
59956666|NCT02061761|76075512|FG005|Diffuse Large B-Cell Lymphoma (DLBCL)|Overall Study||0|Tumor type eligible for expansion|
59956667|NCT02061761|76075513|FG006|Diffuse Large B-Cell Lymphoma (DLBCL)|Overall Study||0|Tumor type eligible for expansion|
59956668|NCT02061761|76075514|FG007|Diffuse Large B-Cell Lymphoma (DLBCL)|Overall Study||0|Tumor type eligible for expansion|
59956669|NCT02061761|76075515|FG008|Diffuse Large B-Cell Lymphoma (DLBCL)|Overall Study||15|Tumor type eligible for expansion|
59956670|NCT02061761|76075507|FG000|Indolent Non-Hodgkin Lymphoma (iNHL)|Overall Study||0|Tumor type eligible for expansion|
59956671|NCT02061761|76075508|FG001|Indolent Non-Hodgkin Lymphoma (iNHL)|Overall Study||0|Tumor type eligible for expansion|
59956672|NCT02061761|76075509|FG002|Indolent Non-Hodgkin Lymphoma (iNHL)|Overall Study||0|Tumor type eligible for expansion|
59956673|NCT02061761|76075510|FG003|Indolent Non-Hodgkin Lymphoma (iNHL)|Overall Study||0|Tumor type eligible for expansion|
59956674|NCT02061761|76075511|FG004|Indolent Non-Hodgkin Lymphoma (iNHL)|Overall Study||4|Tumor type eligible for expansion|
59956675|NCT02061761|76075512|FG005|Indolent Non-Hodgkin Lymphoma (iNHL)|Overall Study||0|Tumor type eligible for expansion|
59956676|NCT02061761|76075513|FG006|Indolent Non-Hodgkin Lymphoma (iNHL)|Overall Study||0|Tumor type eligible for expansion|
59956677|NCT02061761|76075514|FG007|Indolent Non-Hodgkin Lymphoma (iNHL)|Overall Study||0|Tumor type eligible for expansion|
59956678|NCT02061761|76075515|FG008|Indolent Non-Hodgkin Lymphoma (iNHL)|Overall Study||0|Tumor type eligible for expansion|
59956679|NCT02061761|76075507|FG000|Hodgkin Lymphoma (HL)|Overall Study||0|Tumor type eligible for expansion|
59956680|NCT02061761|76075508|FG001|Hodgkin Lymphoma (HL)|Overall Study||0|Tumor type eligible for expansion|
59956681|NCT02061761|76075509|FG002|Hodgkin Lymphoma (HL)|Overall Study||0|Tumor type eligible for expansion|
59956682|NCT02061761|76075510|FG003|Hodgkin Lymphoma (HL)|Overall Study||0|Tumor type eligible for expansion|
59956683|NCT02061761|76075511|FG004|Hodgkin Lymphoma (HL)|Overall Study||3|Tumor type eligible for expansion|
59956684|NCT02061761|76075512|FG005|Hodgkin Lymphoma (HL)|Overall Study||0|Tumor type eligible for expansion|
59956685|NCT02061761|76075513|FG006|Hodgkin Lymphoma (HL)|Overall Study||0|Tumor type eligible for expansion|
59956686|NCT02061761|76075514|FG007|Hodgkin Lymphoma (HL)|Overall Study||0|Tumor type eligible for expansion|
59956687|NCT02061761|76075515|FG008|Hodgkin Lymphoma (HL)|Overall Study||0|Tumor type eligible for expansion|
59956688|NCT02061761|76075507|FG000|HL-anti-PD-1 Naive|Overall Study||0|Tumor type eligible for expansion|
59956689|NCT02061761|76075508|FG001|HL-anti-PD-1 Naive|Overall Study||0|Tumor type eligible for expansion|
59956690|NCT02061761|76075509|FG002|HL-anti-PD-1 Naive|Overall Study||0|Tumor type eligible for expansion|
59956691|NCT02061761|76075510|FG003|HL-anti-PD-1 Naive|Overall Study||0|Tumor type eligible for expansion|
59956692|NCT02061761|76075511|FG004|HL-anti-PD-1 Naive|Overall Study||0|Tumor type eligible for expansion|
59956693|NCT02061761|76075512|FG005|HL-anti-PD-1 Naive|Overall Study||0|Tumor type eligible for expansion|
59956694|NCT02061761|76075513|FG006|HL-anti-PD-1 Naive|Overall Study||0|Tumor type eligible for expansion|
59956695|NCT02061761|76075514|FG007|HL-anti-PD-1 Naive|Overall Study||0|Tumor type eligible for expansion|
59956696|NCT02061761|76075515|FG008|HL-anti-PD-1 Naive|Overall Study||21|Tumor type eligible for expansion|
59956697|NCT02061761|76075507|FG000|HL-anti-PD-1 Progressed|Overall Study||0|Tumor type eligible for expansion|
59956698|NCT02061761|76075508|FG001|HL-anti-PD-1 Progressed|Overall Study||0|Tumor type eligible for expansion|
59956699|NCT02061761|76075509|FG002|HL-anti-PD-1 Progressed|Overall Study||0|Tumor type eligible for expansion|
59956700|NCT02061761|76075510|FG003|HL-anti-PD-1 Progressed|Overall Study||0|Tumor type eligible for expansion|
59956701|NCT02061761|76075511|FG004|HL-anti-PD-1 Progressed|Overall Study||0|Tumor type eligible for expansion|
59956702|NCT02061761|76075512|FG005|HL-anti-PD-1 Progressed|Overall Study||0|Tumor type eligible for expansion|
59956703|NCT02061761|76075513|FG006|HL-anti-PD-1 Progressed|Overall Study||0|Tumor type eligible for expansion|
59956704|NCT02061761|76075514|FG007|HL-anti-PD-1 Progressed|Overall Study||0|Tumor type eligible for expansion|
59956705|NCT02061761|76075515|FG008|HL-anti-PD-1 Progressed|Overall Study||20|Tumor type eligible for expansion|
59956706|NCT02061761|76075507|FG000|COMPLETED|Overall Study||0|Completed treatment|
59956707|NCT02061761|76075508|FG001|COMPLETED|Overall Study||1|Completed treatment|
59956708|NCT02061761|76075509|FG002|COMPLETED|Overall Study||0|Completed treatment|
59956709|NCT02061761|76075510|FG003|COMPLETED|Overall Study||0|Completed treatment|
59956710|NCT02061761|76075511|FG004|COMPLETED|Overall Study||0|Completed treatment|
59956711|NCT02061761|76075512|FG005|COMPLETED|Overall Study||2|Completed treatment|
59956712|NCT02061761|76075513|FG006|COMPLETED|Overall Study||0|Completed treatment|
59956713|NCT02061761|76075514|FG007|COMPLETED|Overall Study||0|Completed treatment|
59956714|NCT02061761|76075515|FG008|COMPLETED|Overall Study||5|Completed treatment|
59956715|NCT02061761|76075507|FG000|NOT COMPLETED|Overall Study||3||
59956716|NCT02061761|76075508|FG001|NOT COMPLETED|Overall Study||8||
59956717|NCT02061761|76075509|FG002|NOT COMPLETED|Overall Study||6||
59956718|NCT02061761|76075510|FG003|NOT COMPLETED|Overall Study||9||
59956719|NCT02061761|76075511|FG004|NOT COMPLETED|Overall Study||11||
59956720|NCT02061761|76075512|FG005|NOT COMPLETED|Overall Study||5||
59956721|NCT02061761|76075513|FG006|NOT COMPLETED|Overall Study||1||
59956722|NCT02061761|76075514|FG007|NOT COMPLETED|Overall Study||4||
59956723|NCT02061761|76075515|FG008|NOT COMPLETED|Overall Study||51||
59956724|NCT01927068|76075543|FG000|STARTED|Overall Study||370||
59956725|NCT01927068|76075544|FG001|STARTED|Overall Study||129||
59956726|NCT01927068|76075543|FG000|COMPLETED|Overall Study||262||
59956727|NCT01927068|76075544|FG001|COMPLETED|Overall Study||121||
59956728|NCT01927068|76075543|FG000|NOT COMPLETED|Overall Study||108||
59956729|NCT01927068|76075544|FG001|NOT COMPLETED|Overall Study||8||
59956730|NCT01309230|76075553|FG000|STARTED|Overall Study||28||
59956731|NCT01309230|76075554|FG001|STARTED|Overall Study||11||
59956732|NCT01309230|76075553|FG000|COMPLETED|Overall Study||28||
59956733|NCT01309230|76075554|FG001|COMPLETED|Overall Study||7||
59956734|NCT01309230|76075553|FG000|NOT COMPLETED|Overall Study||0||
60073877|NCT01931839|76189212|FG006|Safety Analysis Set (As Dosed)|Overall Study||60||
60073878|NCT01931839|76189206|FG000|COMPLETED|Overall Study||294||
60073879|NCT01931839|76189207|FG001|COMPLETED|Overall Study||152||
59956735|NCT01309230|76075554|FG001|NOT COMPLETED|Overall Study||4||
59956736|NCT00819832|76075566|FG000|STARTED|Overall Study|No patient data analysis.|3||
59956737|NCT00819832|76075567|FG001|STARTED|Overall Study||0||
59956738|NCT00819832|76075568|FG002|STARTED|Overall Study||0||
59956739|NCT00819832|76075569|FG003|STARTED|Overall Study||0||
59956740|NCT00819832|76075570|FG004|STARTED|Overall Study||0||
59956741|NCT00819832|76075571|FG005|STARTED|Overall Study||0||
59956742|NCT00819832|76075566|FG000|COMPLETED|Overall Study||0||
59956743|NCT00819832|76075567|FG001|COMPLETED|Overall Study||0||
59956744|NCT00819832|76075568|FG002|COMPLETED|Overall Study||0||
59956745|NCT00819832|76075569|FG003|COMPLETED|Overall Study||0||
59956746|NCT00819832|76075570|FG004|COMPLETED|Overall Study||0||
59956747|NCT00819832|76075571|FG005|COMPLETED|Overall Study||0||
59956748|NCT00819832|76075566|FG000|NOT COMPLETED|Overall Study||3||
59956749|NCT00819832|76075567|FG001|NOT COMPLETED|Overall Study||0||
59956750|NCT00819832|76075568|FG002|NOT COMPLETED|Overall Study||0||
59956751|NCT00819832|76075569|FG003|NOT COMPLETED|Overall Study||0||
59956752|NCT00819832|76075570|FG004|NOT COMPLETED|Overall Study||0||
59956753|NCT00819832|76075571|FG005|NOT COMPLETED|Overall Study||0||
59956754|NCT00704522|76075587|FG000|STARTED|Overall Study||481||
60073880|NCT01931839|76189208|FG002|COMPLETED|Overall Study||301||
60073881|NCT01931839|76189209|FG003|COMPLETED|Overall Study||162||
60073882|NCT01931839|76189210|FG004|COMPLETED|Overall Study||18||
60073883|NCT01931839|76189211|FG005|COMPLETED|Overall Study||50||
59956755|NCT00704522|76075588|FG001|STARTED|Overall Study||120||
59956756|NCT00704522|76075587|FG000|COMPLETED|Overall Study||298||
59956757|NCT00704522|76075588|FG001|COMPLETED|Overall Study||75||
60073884|NCT01931839|76189212|FG006|COMPLETED|Overall Study||56||
60073885|NCT01931839|76189206|FG000|NOT COMPLETED|Overall Study||41||
60073886|NCT01931839|76189207|FG001|NOT COMPLETED|Overall Study||26||
59956758|NCT00704522|76075587|FG000|NOT COMPLETED|Overall Study||183||
59956759|NCT00704522|76075588|FG001|NOT COMPLETED|Overall Study||45||
59956760|NCT02232477|76075593|FG000|STARTED|Overall Study||6||
59956761|NCT02232477|76075593|FG000|COMPLETED|Overall Study||4||
59956762|NCT02232477|76075593|FG000|NOT COMPLETED|Overall Study||2||
59956763|NCT02723630|76075603|FG000|STARTED|Intervention Period 1||10||
59956764|NCT02723630|76075604|FG001|STARTED|Intervention Period 1||10||
59956765|NCT02723630|76075605|FG002|STARTED|Intervention Period 1||10||
59956766|NCT02723630|76075606|FG003|STARTED|Intervention Period 1||10||
59956767|NCT02723630|76075607|FG004|STARTED|Intervention Period 1||10||
59956768|NCT02723630|76075608|FG005|STARTED|Intervention Period 1||10||
60073887|NCT01931839|76189208|FG002|NOT COMPLETED|Overall Study||39||
60073888|NCT01931839|76189209|FG003|NOT COMPLETED|Overall Study||14||
59956769|NCT02723630|76075603|FG000|COMPLETED|Intervention Period 1||9||
59956770|NCT02723630|76075604|FG001|COMPLETED|Intervention Period 1||10||
59956771|NCT02723630|76075605|FG002|COMPLETED|Intervention Period 1||10||
59956772|NCT02723630|76075606|FG003|COMPLETED|Intervention Period 1||10||
59956773|NCT02723630|76075607|FG004|COMPLETED|Intervention Period 1||10||
59956774|NCT02723630|76075608|FG005|COMPLETED|Intervention Period 1||10||
59956775|NCT02723630|76075603|FG000|NOT COMPLETED|Intervention Period 1||1||
59956776|NCT02723630|76075604|FG001|NOT COMPLETED|Intervention Period 1||0||
59956777|NCT02723630|76075605|FG002|NOT COMPLETED|Intervention Period 1||0||
59956778|NCT02723630|76075606|FG003|NOT COMPLETED|Intervention Period 1||0||
59956779|NCT02723630|76075607|FG004|NOT COMPLETED|Intervention Period 1||0||
59956780|NCT02723630|76075608|FG005|NOT COMPLETED|Intervention Period 1||0||
59956781|NCT02723630|76075603|FG000|STARTED|Intervention Period 2||9||
59956782|NCT02723630|76075604|FG001|STARTED|Intervention Period 2||10||
59956783|NCT02723630|76075605|FG002|STARTED|Intervention Period 2||10||
59956784|NCT02723630|76075606|FG003|STARTED|Intervention Period 2||10||
59956785|NCT02723630|76075607|FG004|STARTED|Intervention Period 2||10||
59956786|NCT02723630|76075608|FG005|STARTED|Intervention Period 2||10||
59956787|NCT02723630|76075603|FG000|COMPLETED|Intervention Period 2||9||
59956788|NCT02723630|76075604|FG001|COMPLETED|Intervention Period 2||10||
59956789|NCT02723630|76075605|FG002|COMPLETED|Intervention Period 2||10||
59956790|NCT02723630|76075606|FG003|COMPLETED|Intervention Period 2||10||
59956791|NCT02723630|76075607|FG004|COMPLETED|Intervention Period 2||10||
59956792|NCT02723630|76075608|FG005|COMPLETED|Intervention Period 2||10||
59956793|NCT02723630|76075603|FG000|NOT COMPLETED|Intervention Period 2||0||
59956794|NCT02723630|76075604|FG001|NOT COMPLETED|Intervention Period 2||0||
59956795|NCT02723630|76075605|FG002|NOT COMPLETED|Intervention Period 2||0||
59956796|NCT02723630|76075606|FG003|NOT COMPLETED|Intervention Period 2||0||
59956797|NCT02723630|76075607|FG004|NOT COMPLETED|Intervention Period 2||0||
59956798|NCT02723630|76075608|FG005|NOT COMPLETED|Intervention Period 2||0||
59956799|NCT02723630|76075603|FG000|STARTED|Intervention Period 3||9||
59956800|NCT02723630|76075604|FG001|STARTED|Intervention Period 3||10||
59956801|NCT02723630|76075605|FG002|STARTED|Intervention Period 3||10||
59956802|NCT02723630|76075606|FG003|STARTED|Intervention Period 3||10||
59956803|NCT02723630|76075607|FG004|STARTED|Intervention Period 3||10||
59956804|NCT02723630|76075608|FG005|STARTED|Intervention Period 3||10||
59956805|NCT02723630|76075603|FG000|COMPLETED|Intervention Period 3||9||
59956806|NCT02723630|76075604|FG001|COMPLETED|Intervention Period 3||9||
59956807|NCT02723630|76075605|FG002|COMPLETED|Intervention Period 3||10||
59956808|NCT02723630|76075606|FG003|COMPLETED|Intervention Period 3||10||
59956809|NCT02723630|76075607|FG004|COMPLETED|Intervention Period 3||10||
59956810|NCT02723630|76075608|FG005|COMPLETED|Intervention Period 3||10||
59956811|NCT02723630|76075603|FG000|NOT COMPLETED|Intervention Period 3||0||
59956812|NCT02723630|76075604|FG001|NOT COMPLETED|Intervention Period 3||1||
59956813|NCT02723630|76075605|FG002|NOT COMPLETED|Intervention Period 3||0||
59956814|NCT02723630|76075606|FG003|NOT COMPLETED|Intervention Period 3||0||
59956815|NCT02723630|76075607|FG004|NOT COMPLETED|Intervention Period 3||0||
59956816|NCT02723630|76075608|FG005|NOT COMPLETED|Intervention Period 3||0||
59956817|NCT04319445|76075621|FG000|STARTED|Overall Study||144||
59956818|NCT04319445|76075621|FG000|COMPLETED|Overall Study||144||
59956819|NCT04319445|76075621|FG000|NOT COMPLETED|Overall Study||0||
59956820|NCT02008292|76075627|FG000|STARTED|Overall Study|Total expected Healthy Control 1210010989 = 50 participants|43||
59956821|NCT02008292|76075628|FG001|STARTED|Overall Study|Total expected Smoking Healthy Control 1210010989 = 50 participants|37||
59956822|NCT02008292|76075627|FG000|COMPLETED|Overall Study||43||
59956823|NCT02008292|76075628|FG001|COMPLETED|Overall Study||37||
59956824|NCT02008292|76075627|FG000|NOT COMPLETED|Overall Study||0||
59956825|NCT02008292|76075628|FG001|NOT COMPLETED|Overall Study||0||
59956826|NCT03030222|76075638|FG000|STARTED|Overall Study||33||
59956827|NCT03030222|76075639|FG001|STARTED|Overall Study||32||
59956828|NCT03030222|76075638|FG000|COMPLETED|Overall Study||33||
59956829|NCT03030222|76075639|FG001|COMPLETED|Overall Study||32||
59956830|NCT03030222|76075638|FG000|NOT COMPLETED|Overall Study||0||
59956831|NCT03030222|76075639|FG001|NOT COMPLETED|Overall Study||0||
59956832|NCT04089735|76075651|FG000|STARTED|Overall Study||22||
59956833|NCT04089735|76075652|FG001|STARTED|Overall Study||23||
59956834|NCT04089735|76075653|FG002|STARTED|Overall Study||22||
59956835|NCT04089735|76075654|FG003|STARTED|Overall Study||22||
59956836|NCT04089735|76075655|FG004|STARTED|Overall Study||22||
59956837|NCT04089735|76075656|FG005|STARTED|Overall Study||21||
59956838|NCT04089735|76075651|FG000|COMPLETED|Overall Study||21||
59956839|NCT04089735|76075652|FG001|COMPLETED|Overall Study||17||
59956840|NCT04089735|76075653|FG002|COMPLETED|Overall Study||20||
59956841|NCT04089735|76075654|FG003|COMPLETED|Overall Study||16||
59956842|NCT04089735|76075655|FG004|COMPLETED|Overall Study||21||
59956843|NCT04089735|76075656|FG005|COMPLETED|Overall Study||15||
59956844|NCT04089735|76075651|FG000|NOT COMPLETED|Overall Study||1||
59956845|NCT04089735|76075652|FG001|NOT COMPLETED|Overall Study||6||
59956846|NCT04089735|76075653|FG002|NOT COMPLETED|Overall Study||2||
59956847|NCT04089735|76075654|FG003|NOT COMPLETED|Overall Study||6||
59956848|NCT04089735|76075655|FG004|NOT COMPLETED|Overall Study||1||
59956849|NCT04089735|76075656|FG005|NOT COMPLETED|Overall Study||6||
59956850|NCT01876784|76075672|FG000|STARTED|Overall Study||119||
59956851|NCT01876784|76075673|FG001|STARTED|Overall Study||119||
59956852|NCT01876784|76075672|FG000|Treated|Overall Study||117||
59803677|NCT03838198|75925184|FG002|STARTED|3 Month Follow up Period||17|All participants (except the one who withdrew) were recontacted for 3 month follow up.|
59803678|NCT03838198|75925185|FG003|STARTED|3 Month Follow up Period||22|All participants (except the one who withdrew) were recontacted for 3 month follow up.|
59803679|NCT03838198|75925182|FG000|Adolescent Survey Completed|3 Month Follow up Period||16||
59803680|NCT03838198|75925183|FG001|Adolescent Survey Completed|3 Month Follow up Period||21||
59803681|NCT03838198|75925184|FG002|Adolescent Survey Completed|3 Month Follow up Period||15||
59803682|NCT03838198|75925185|FG003|Adolescent Survey Completed|3 Month Follow up Period||21||
59803683|NCT03838198|75925182|FG000|COMPLETED|3 Month Follow up Period||15|Completed means parent survey completed|
59803684|NCT03838198|75925183|FG001|COMPLETED|3 Month Follow up Period||19|Completed means parent survey completed|
59956853|NCT01876784|76075673|FG001|Treated|Overall Study||118||
59956854|NCT01876784|76075672|FG000|COMPLETED|Overall Study||0||
59956855|NCT01876784|76075673|FG001|COMPLETED|Overall Study||0||
59956856|NCT01876784|76075672|FG000|NOT COMPLETED|Overall Study||119||
59956857|NCT01876784|76075673|FG001|NOT COMPLETED|Overall Study||119||
59956858|NCT04205162|76075681|FG000|STARTED|Overall Study||18||36
59956859|NCT04205162|76075682|FG001|STARTED|Overall Study||18||36
59956860|NCT04205162|76075681|FG000|COMPLETED|Overall Study||14||28
59956861|NCT04205162|76075682|FG001|COMPLETED|Overall Study||18||36
59956862|NCT04205162|76075681|FG000|NOT COMPLETED|Overall Study||4||8
59956863|NCT04205162|76075682|FG001|NOT COMPLETED|Overall Study||0||0
59956864|NCT03519711|76075691|FG000|STARTED|Treatment Period 1 (7 Days)||4||
59956865|NCT03519711|76075692|FG001|STARTED|Treatment Period 1 (7 Days)||4||
59956866|NCT03519711|76075691|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 1 (7 Days)||4||
59956867|NCT03519711|76075692|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 1 (7 Days)||4||
59956868|NCT03519711|76075691|FG000|COMPLETED|Treatment Period 1 (7 Days)||4||
59956869|NCT03519711|76075692|FG001|COMPLETED|Treatment Period 1 (7 Days)||4||
59956870|NCT03519711|76075691|FG000|NOT COMPLETED|Treatment Period 1 (7 Days)||0||
59956871|NCT03519711|76075692|FG001|NOT COMPLETED|Treatment Period 1 (7 Days)||0||
59956872|NCT03519711|76075691|FG000|STARTED|Treatment Period 2 (7 Days)||4||
59803685|NCT03838198|75925184|FG002|COMPLETED|3 Month Follow up Period||14|Completed means parent survey completed|
59803686|NCT03838198|75925185|FG003|COMPLETED|3 Month Follow up Period||18|Completed means parent survey completed|
59803687|NCT03838198|75925182|FG000|NOT COMPLETED|3 Month Follow up Period||3||
59803688|NCT03838198|75925183|FG001|NOT COMPLETED|3 Month Follow up Period||3||
59803689|NCT03838198|75925184|FG002|NOT COMPLETED|3 Month Follow up Period||3||
59803690|NCT03838198|75925185|FG003|NOT COMPLETED|3 Month Follow up Period||4||
59956873|NCT03519711|76075692|FG001|STARTED|Treatment Period 2 (7 Days)||4||
59956874|NCT03519711|76075691|FG000|COMPLETED|Treatment Period 2 (7 Days)||4||
59956875|NCT03519711|76075692|FG001|COMPLETED|Treatment Period 2 (7 Days)||4||
59956876|NCT03519711|76075691|FG000|NOT COMPLETED|Treatment Period 2 (7 Days)||0||
59956877|NCT03519711|76075692|FG001|NOT COMPLETED|Treatment Period 2 (7 Days)||0||
59956878|NCT01329939|76075707|FG000|STARTED|Overall Study||7||
59956879|NCT01329939|76075708|FG001|STARTED|Overall Study||5||
59956880|NCT01329939|76075709|FG002|STARTED|Overall Study||5||
59956881|NCT01329939|76075710|FG003|STARTED|Overall Study||9||
59956882|NCT01329939|76075707|FG000|COMPLETED|Overall Study||4||
59956883|NCT01329939|76075708|FG001|COMPLETED|Overall Study||4||
59956884|NCT01329939|76075709|FG002|COMPLETED|Overall Study||4||
59803691|NCT00115765|75925200|FG000|STARTED|Overall Study||115||
59803692|NCT00115765|75925201|FG001|STARTED|Overall Study||413||
59803693|NCT00115765|75925202|FG002|STARTED|Overall Study||410||
59803694|NCT00115765|75925203|FG003|STARTED|Overall Study||115||
59803695|NCT00115765|75925200|FG000|COMPLETED|Overall Study|Participants who were on study at closure or died|80||
59803696|NCT00115765|75925201|FG001|COMPLETED|Overall Study|Participants who were on study at closure or died|313||
59803697|NCT00115765|75925202|FG002|COMPLETED|Overall Study|Participants who were on study at closure or died|289||
59803698|NCT00115765|75925203|FG003|COMPLETED|Overall Study|Participants who were on study at closure or died|84||
59956885|NCT01329939|76075710|FG003|COMPLETED|Overall Study||4||
59956886|NCT01329939|76075707|FG000|NOT COMPLETED|Overall Study||3||
59956887|NCT01329939|76075708|FG001|NOT COMPLETED|Overall Study||1||
59956888|NCT01329939|76075709|FG002|NOT COMPLETED|Overall Study||1||
59956889|NCT01329939|76075710|FG003|NOT COMPLETED|Overall Study||5||
59956890|NCT02499900|76075722|FG000|STARTED|Core Study Period||430|Intent to treat|
59956891|NCT02499900|76075723|FG001|STARTED|Core Study Period||431|Intent to treat|
59956892|NCT02499900|76075722|FG000|Safety Analysis Set|Core Study Period||427||
59956893|NCT02499900|76075723|FG001|Safety Analysis Set|Core Study Period||430||
59956894|NCT02499900|76075722|FG000|COMPLETED|Core Study Period||395|Completed core phase of the study|
59956895|NCT02499900|76075723|FG001|COMPLETED|Core Study Period||399|Completed core phase of the study|
59956896|NCT02499900|76075722|FG000|NOT COMPLETED|Core Study Period||35||
59956897|NCT02499900|76075723|FG001|NOT COMPLETED|Core Study Period||32||
59956898|NCT02499900|76075722|FG000|STARTED|Completed Core, Continued Into Extension||395||
59956899|NCT02499900|76075723|FG001|STARTED|Completed Core, Continued Into Extension||399||
59956900|NCT02499900|76075722|FG000|COMPLETED|Completed Core, Continued Into Extension||392||
59956901|NCT02499900|76075723|FG001|COMPLETED|Completed Core, Continued Into Extension||397||
59956902|NCT02499900|76075722|FG000|NOT COMPLETED|Completed Core, Continued Into Extension||3||
59956903|NCT02499900|76075723|FG001|NOT COMPLETED|Completed Core, Continued Into Extension||2||
59956904|NCT02499900|76075722|FG000|STARTED|Extension Study Period||392||
59803699|NCT00115765|75925200|FG000|NOT COMPLETED|Overall Study||35||
59803700|NCT00115765|75925201|FG001|NOT COMPLETED|Overall Study||100||
59803701|NCT00115765|75925202|FG002|NOT COMPLETED|Overall Study||121||
59803702|NCT00115765|75925203|FG003|NOT COMPLETED|Overall Study||31||
59803703|NCT00606008|75925211|FG000|STARTED|Overall Study||30||
59803704|NCT00606008|75925211|FG000|COMPLETED|Overall Study||25||
59803705|NCT00606008|75925211|FG000|NOT COMPLETED|Overall Study||5||
59803706|NCT03837184|75925219|FG000|STARTED|Overall Study||2||
59803707|NCT03837184|75925219|FG000|COMPLETED|Overall Study||2||
59803708|NCT03837184|75925219|FG000|NOT COMPLETED|Overall Study||0||
59803709|NCT00461812|75925223|FG000|STARTED|Overall Study||10||
59803710|NCT00461812|75925223|FG000|COMPLETED|Overall Study||0||
59956905|NCT02499900|76075723|FG001|STARTED|Extension Study Period||397||
59956906|NCT02499900|76075722|FG000|Safety Analysis Set|Extension Study Period||392||
59956907|NCT02499900|76075723|FG001|Safety Analysis Set|Extension Study Period|One participant was not treated in the Extension Study Period|396||
59956908|NCT02499900|76075722|FG000|COMPLETED|Extension Study Period||380||
59956909|NCT02499900|76075723|FG001|COMPLETED|Extension Study Period||377||
59803711|NCT00461812|75925223|FG000|NOT COMPLETED|Overall Study||10||
59803712|NCT00123955|75925230|FG000|STARTED|Overall Study||42||
59803713|NCT00123955|75925231|FG001|STARTED|Overall Study||38||
59803714|NCT00123955|75925230|FG000|COMPLETED|Overall Study||37||
59803715|NCT00123955|75925231|FG001|COMPLETED|Overall Study||34||
59956910|NCT02499900|76075722|FG000|NOT COMPLETED|Extension Study Period||12||
59956911|NCT02499900|76075723|FG001|NOT COMPLETED|Extension Study Period||20||
59956912|NCT03505749|76075737|FG000|STARTED|Overall Study||38||
59956913|NCT03505749|76075738|FG001|STARTED|Overall Study||45||
59956914|NCT03505749|76075737|FG000|COMPLETED|Overall Study||22||
59956915|NCT03505749|76075738|FG001|COMPLETED|Overall Study||28||
59956916|NCT03505749|76075737|FG000|NOT COMPLETED|Overall Study||16||
59956917|NCT03505749|76075738|FG001|NOT COMPLETED|Overall Study||17||
59956918|NCT03901430|76075747|FG000|STARTED|Overall Study||21||
59956919|NCT03901430|76075747|FG000|COMPLETED|Overall Study||21||
59956920|NCT03901430|76075747|FG000|NOT COMPLETED|Overall Study||0||
59956921|NCT01111110|76075753|FG000|STARTED|Overall Study||3||
59956922|NCT01111110|76075754|FG001|STARTED|Overall Study||4||
59956923|NCT01111110|76075753|FG000|COMPLETED|Overall Study||3||
59956924|NCT01111110|76075754|FG001|COMPLETED|Overall Study||4||
59956925|NCT01111110|76075753|FG000|NOT COMPLETED|Overall Study||0||
59956926|NCT01111110|76075754|FG001|NOT COMPLETED|Overall Study||0||
59803716|NCT00123955|75925230|FG000|NOT COMPLETED|Overall Study||5||
59803717|NCT00123955|75925231|FG001|NOT COMPLETED|Overall Study||4||
59803718|NCT03837028|75925241|FG000|STARTED|Overall Study||35||
59803719|NCT03837028|75925242|FG001|STARTED|Overall Study||34||
59803720|NCT03837028|75925243|FG002|STARTED|Overall Study||33||
59803721|NCT03837028|75925244|FG003|STARTED|Overall Study||25||
59803722|NCT03837028|75925241|FG000|COMPLETED|Overall Study||19||
59803723|NCT03837028|75925242|FG001|COMPLETED|Overall Study||23||
59803724|NCT03837028|75925243|FG002|COMPLETED|Overall Study||20||
59803725|NCT03837028|75925244|FG003|COMPLETED|Overall Study||18||
59803726|NCT03837028|75925241|FG000|NOT COMPLETED|Overall Study||16||
59803727|NCT03837028|75925242|FG001|NOT COMPLETED|Overall Study||11||
59803728|NCT03837028|75925243|FG002|NOT COMPLETED|Overall Study||13||
59803729|NCT03837028|75925244|FG003|NOT COMPLETED|Overall Study||7||
59803730|NCT00115063|75925256|FG000|STARTED|Overall Study||200||
59803731|NCT00115063|75925257|FG001|STARTED|Overall Study||190||
59803732|NCT00115063|75925256|FG000|COMPLETED|Overall Study||101||
59803733|NCT00115063|75925257|FG001|COMPLETED|Overall Study||86||
59803734|NCT00115063|75925256|FG000|NOT COMPLETED|Overall Study||99||
59803735|NCT00115063|75925257|FG001|NOT COMPLETED|Overall Study||104||
59803736|NCT00461500|75925265|FG000|STARTED|Overall Study||37||
59803737|NCT00461500|75925266|FG001|STARTED|Overall Study||44||
59956927|NCT03436797|76075760|FG000|STARTED|Overall Study|47 subjects were enrolled in this study and received at least one dose of the study drug. 45 of these subjects had at least one post-baseline assessment of the primary efficacy variable and were reported in the baseline period.|47||
59956928|NCT03436797|76075760|FG000|COMPLETED|Overall Study||37||
59956929|NCT03436797|76075760|FG000|NOT COMPLETED|Overall Study||10||
59803738|NCT00461500|75925265|FG000|COMPLETED|Overall Study||30||
59803739|NCT00461500|75925266|FG001|COMPLETED|Overall Study||38||
59803740|NCT00461500|75925265|FG000|NOT COMPLETED|Overall Study||7||
59803741|NCT00461500|75925266|FG001|NOT COMPLETED|Overall Study||6||
59803742|NCT00167245|75925274|FG000|STARTED|Overall Study||83||
59803743|NCT00167245|75925275|FG001|STARTED|Overall Study||87||
59803744|NCT00167245|75925274|FG000|COMPLETED|Overall Study||54||
59803745|NCT00167245|75925275|FG001|COMPLETED|Overall Study||46||
59956930|NCT03710642|76075769|FG000|STARTED|Overall Study||27||
59956931|NCT03710642|76075770|FG001|STARTED|Overall Study||8||
59524074|NCT00988013|75619167|FG002|COMPLETED|Overall Study||6||
59524075|NCT00988013|75619168|FG003|COMPLETED|Overall Study||2||
59524076|NCT00988013|75619165|FG000|NOT COMPLETED|Overall Study||0||
59524077|NCT00988013|75619166|FG001|NOT COMPLETED|Overall Study||0||
59524078|NCT00988013|75619167|FG002|NOT COMPLETED|Overall Study||0||
59524079|NCT00988013|75619168|FG003|NOT COMPLETED|Overall Study||0||
59524080|NCT00988325|75619183|FG000|STARTED|Overall Study||40||
59524081|NCT00988325|75619184|FG001|STARTED|Overall Study||20||
59524082|NCT00988325|75619185|FG002|STARTED|Overall Study||5||
59524083|NCT00988325|75619183|FG000|COMPLETED|Overall Study||40||
59524084|NCT00988325|75619184|FG001|COMPLETED|Overall Study||20||
59524085|NCT00988325|75619185|FG002|COMPLETED|Overall Study||5||
59524086|NCT00988325|75619183|FG000|NOT COMPLETED|Overall Study||0||
59524087|NCT00988325|75619184|FG001|NOT COMPLETED|Overall Study||0||
59524088|NCT00988325|75619185|FG002|NOT COMPLETED|Overall Study||0||
59524089|NCT02161133|75619199|FG000|STARTED|Overall Study||135||
59524090|NCT02161133|75619200|FG001|STARTED|Overall Study||133||
59524091|NCT02161133|75619199|FG000|COMPLETED|Overall Study||116||
59524092|NCT02161133|75619200|FG001|COMPLETED|Overall Study||122||
59524093|NCT02161133|75619199|FG000|NOT COMPLETED|Overall Study||19||
59524094|NCT02161133|75619200|FG001|NOT COMPLETED|Overall Study||11||
59524095|NCT01030289|75619206|FG000|STARTED|Overall Study||9||
59524096|NCT01030289|75619207|FG001|STARTED|Overall Study||10||
59524097|NCT01030289|75619206|FG000|COMPLETED|Overall Study||9||
59524098|NCT01030289|75619207|FG001|COMPLETED|Overall Study||10||
59524099|NCT01030289|75619206|FG000|NOT COMPLETED|Overall Study||0||
59524100|NCT01030289|75619207|FG001|NOT COMPLETED|Overall Study||0||
59524101|NCT01236391|75619214|FG000|STARTED|Overall Study|Participants who received study treatment|111||
59524102|NCT01236391|75619214|FG000|COMPLETED|Overall Study|Participants who were on treatment or discontinued treatment due to disease progression or death|95||
59524103|NCT01236391|75619214|FG000|NOT COMPLETED|Overall Study||16||
59524104|NCT02167217|75619221|FG000|STARTED|Overall Study||25||
59524105|NCT02167217|75619221|FG000|COMPLETED|Overall Study||23||
59524106|NCT02167217|75619221|FG000|NOT COMPLETED|Overall Study||2||
59524107|NCT01152697|75619225|FG000|STARTED|Overall Study||30||
59524108|NCT01152697|75619225|FG000|COMPLETED|Overall Study||11||
59524109|NCT01152697|75619225|FG000|NOT COMPLETED|Overall Study||19||
59524110|NCT01197547|75619229|FG000|STARTED|Overall Study||1014||
59524111|NCT01197547|75619229|FG000|COMPLETED|Overall Study|992 Intent-To-Treat (ITT) 931 evaluable subjects|992||
59524112|NCT01197547|75619229|FG000|NOT COMPLETED|Overall Study||22||
59524113|NCT00990509|75619235|FG000|STARTED|Overall Study||5||
59524114|NCT00990509|75619236|FG001|STARTED|Overall Study||9||
59524115|NCT00990509|75619235|FG000|COMPLETED|Overall Study||5||
59524116|NCT00990509|75619236|FG001|COMPLETED|Overall Study||8||
59524117|NCT00990509|75619235|FG000|NOT COMPLETED|Overall Study||0||
59524118|NCT00990509|75619236|FG001|NOT COMPLETED|Overall Study||1||
59524119|NCT01238341|75619242|FG000|STARTED|Overall Study||7||
59524120|NCT01238341|75619242|FG000|COMPLETED|Overall Study||7||
59524121|NCT01238341|75619242|FG000|NOT COMPLETED|Overall Study||0||
59956932|NCT03710642|76075769|FG000|COMPLETED|Overall Study||17||
59956933|NCT03710642|76075770|FG001|COMPLETED|Overall Study||3||
59956934|NCT03710642|76075769|FG000|NOT COMPLETED|Overall Study||10||
59524122|NCT00992927|75619248|FG000|STARTED|Overall Study||32||
59524123|NCT00992927|75619249|FG001|STARTED|Overall Study||22||
59956935|NCT03710642|76075770|FG001|NOT COMPLETED|Overall Study||5||
59956936|NCT00705224|76075776|FG000|STARTED|Overall Study||250||
59956937|NCT00705224|76075776|FG000|COMPLETED|Overall Study||239||
59956938|NCT00705224|76075776|FG000|NOT COMPLETED|Overall Study||11||
59956939|NCT02722148|76075783|FG000|STARTED|Overall Study||24||
59524124|NCT00992927|75619248|FG000|COMPLETED|Overall Study||32||
59524125|NCT00992927|75619249|FG001|COMPLETED|Overall Study||22||
59524126|NCT00992927|75619248|FG000|NOT COMPLETED|Overall Study||0||
59524127|NCT00992927|75619249|FG001|NOT COMPLETED|Overall Study||0||
59524128|NCT01198327|75619255|FG000|STARTED|Overall Study||66||
59524129|NCT01198327|75619255|FG000|COMPLETED|Overall Study||56||
59524130|NCT01198327|75619255|FG000|NOT COMPLETED|Overall Study||10||
59524131|NCT00994175|75619262|FG000|STARTED|First Intervention||6||
59956940|NCT02722148|76075783|FG000|COMPLETED|Overall Study||19||
59956941|NCT02722148|76075783|FG000|NOT COMPLETED|Overall Study||5||
59956942|NCT00704132|76075789|FG000|STARTED|Overall Study||26||
60073889|NCT01931839|76189210|FG004|NOT COMPLETED|Overall Study||1||
60073890|NCT01931839|76189211|FG005|NOT COMPLETED|Overall Study||5||
59524132|NCT00994175|75619263|FG001|STARTED|First Intervention||9||
59524133|NCT00994175|75619262|FG000|COMPLETED|First Intervention||4||
59524134|NCT00994175|75619263|FG001|COMPLETED|First Intervention||8||
59524135|NCT00994175|75619262|FG000|NOT COMPLETED|First Intervention||2||
59524136|NCT00994175|75619263|FG001|NOT COMPLETED|First Intervention||1||
59524137|NCT00994175|75619262|FG000|STARTED|Second Intervention||4||
59524138|NCT00994175|75619263|FG001|STARTED|Second Intervention||8||
59956943|NCT00704132|76075790|FG001|STARTED|Overall Study||24||
59956944|NCT00704132|76075789|FG000|COMPLETED|Overall Study||25||
59956945|NCT00704132|76075790|FG001|COMPLETED|Overall Study||22||
59803746|NCT00167245|75925274|FG000|NOT COMPLETED|Overall Study||29||
59803747|NCT00167245|75925275|FG001|NOT COMPLETED|Overall Study||41||
59803748|NCT00443560|75925286|FG000|STARTED|Overall Study||1081||
59803749|NCT00443560|75925287|FG001|STARTED|Overall Study||1081||
59803750|NCT00443560|75925286|FG000|COMPLETED|Overall Study||1021||
59803751|NCT00443560|75925287|FG001|COMPLETED|Overall Study||1051||
59956946|NCT00704132|76075789|FG000|NOT COMPLETED|Overall Study||1||
59956947|NCT00704132|76075790|FG001|NOT COMPLETED|Overall Study||2||
59956948|NCT03527238|76075798|FG000|STARTED|Overall Study||31||
59956949|NCT03527238|76075799|FG001|STARTED|Overall Study||31||
59956950|NCT03527238|76075798|FG000|COMPLETED|Overall Study||29||
59956951|NCT03527238|76075799|FG001|COMPLETED|Overall Study||27||
59956952|NCT03527238|76075798|FG000|NOT COMPLETED|Overall Study||2||
59956953|NCT03527238|76075799|FG001|NOT COMPLETED|Overall Study||4||
59956954|NCT01329549|76075805|FG000|STARTED|Overall Study||2||
59956955|NCT01329549|76075805|FG000|COMPLETED|Overall Study||0||
59956956|NCT01329549|76075805|FG000|NOT COMPLETED|Overall Study||2||
59956957|NCT02736474|76075811|FG000|STARTED|Overall Study||11||
59956958|NCT02736474|76075812|FG001|STARTED|Overall Study||11||
59956959|NCT02736474|76075811|FG000|COMPLETED|Overall Study||11||
59956960|NCT02736474|76075812|FG001|COMPLETED|Overall Study||10||
59956961|NCT02736474|76075811|FG000|NOT COMPLETED|Overall Study||0||
59956962|NCT02736474|76075812|FG001|NOT COMPLETED|Overall Study||1||
59956963|NCT03712137|76075820|FG000|STARTED|Control Period||49||
59956964|NCT03712137|76075821|FG001|STARTED|Control Period||157||
59956965|NCT03712137|76075820|FG000|Participants Treated as Randomized|Control Period||49||
59956966|NCT03712137|76075821|FG001|Participants Treated as Randomized|Control Period||156||
59956967|NCT03712137|76075820|FG000|Participants Not Treated as Randomized|Control Period||0|Participant was randomized to the treatment group (VOLUX XC) but subsequently found to not meet inclusion criteria and was discontinued at randomization without receiving treatment.|
59956968|NCT03712137|76075821|FG001|Participants Not Treated as Randomized|Control Period||1|Participant was randomized to the treatment group (VOLUX XC) but subsequently found to not meet inclusion criteria and was discontinued at randomization without receiving treatment.|
59956969|NCT03712137|76075820|FG000|COMPLETED|Control Period||47||
59956970|NCT03712137|76075821|FG001|COMPLETED|Control Period||149||
59956971|NCT03712137|76075820|FG000|NOT COMPLETED|Control Period||2||
59956972|NCT03712137|76075821|FG001|NOT COMPLETED|Control Period||8||
59956973|NCT03712137|76075820|FG000|STARTED|Opt VOLUX Treatment Follow Up Period||42|Participants that were randomized to the No-Treatment Control arm that received optional VOLUX treatment after the Control Period|
60073891|NCT01931839|76189212|FG006|NOT COMPLETED|Overall Study||4||
59803752|NCT00443560|75925286|FG000|NOT COMPLETED|Overall Study||60||
59803753|NCT00443560|75925287|FG001|NOT COMPLETED|Overall Study||30||
59803754|NCT00451204|75925295|FG000|STARTED|Overall Study||82||
59803755|NCT00451204|75925296|FG001|STARTED|Overall Study||76||
59803756|NCT00451204|75925295|FG000|COMPLETED|Overall Study|60 completed the study but 3 stopped study drug(s) early|60||
59803757|NCT00451204|75925296|FG001|COMPLETED|Overall Study||56||
59956974|NCT03712137|76075821|FG001|STARTED|Opt VOLUX Treatment Follow Up Period||0|Participants that were randomized to the No-Treatment Control arm that received optional VOLUX treatment after the Control Period|
59956975|NCT03712137|76075820|FG000|COMPLETED|Opt VOLUX Treatment Follow Up Period||35||
60073892|NCT01842308|76189237|FG000|STARTED|Overall Study||6||
60073893|NCT01842308|76189238|FG001|STARTED|Overall Study||3||
60073894|NCT01842308|76189239|FG002|STARTED|Overall Study||3||
60073895|NCT01842308|76189240|FG003|STARTED|Overall Study||2||
59803758|NCT00451204|75925295|FG000|NOT COMPLETED|Overall Study||22||
59803759|NCT00451204|75925296|FG001|NOT COMPLETED|Overall Study||20||
59803760|NCT00605540|75925305|FG000|STARTED|Overall Study||133||
59803761|NCT00605540|75925305|FG000|COMPLETED|Overall Study||95||
59803762|NCT00605540|75925305|FG000|NOT COMPLETED|Overall Study||38||
59803763|NCT00605306|75925311|FG000|STARTED|Overall Study||14||
59803764|NCT00605306|75925312|FG001|STARTED|Overall Study||14||
59803765|NCT00605306|75925311|FG000|COMPLETED|Overall Study||14||
59956976|NCT03712137|76075821|FG001|COMPLETED|Opt VOLUX Treatment Follow Up Period||0||
59956977|NCT03712137|76075820|FG000|NOT COMPLETED|Opt VOLUX Treatment Follow Up Period||7||
59956978|NCT03712137|76075821|FG001|NOT COMPLETED|Opt VOLUX Treatment Follow Up Period||0||
59956979|NCT03712137|76075820|FG000|STARTED|VOLUX Maintenance Treatment Period||0|Participants in the VOLUX XC treatment population who received VOLUX maintenance treatment|
59956980|NCT03712137|76075821|FG001|STARTED|VOLUX Maintenance Treatment Period||87|Participants in the VOLUX XC treatment population who received VOLUX maintenance treatment|
59956981|NCT03712137|76075820|FG000|COMPLETED|VOLUX Maintenance Treatment Period||0||
59956982|NCT03712137|76075821|FG001|COMPLETED|VOLUX Maintenance Treatment Period||85||
60073896|NCT01842308|76189241|FG004|STARTED|Overall Study||36||
60073897|NCT01842308|76189237|FG000|COMPLETED|Overall Study||6||
60073898|NCT01842308|76189238|FG001|COMPLETED|Overall Study||3||
59803766|NCT00605306|75925312|FG001|COMPLETED|Overall Study||13||
59803767|NCT00605306|75925311|FG000|NOT COMPLETED|Overall Study||0||
59803768|NCT00605306|75925312|FG001|NOT COMPLETED|Overall Study||1||
59803769|NCT00607022|75925321|FG000|STARTED|Overall Study||7||
59803770|NCT00607022|75925322|FG001|STARTED|Overall Study||15||
59803771|NCT00607022|75925323|FG002|STARTED|Overall Study||19||
59803772|NCT00607022|75925321|FG000|COMPLETED|Overall Study||6||
59803773|NCT00607022|75925322|FG001|COMPLETED|Overall Study||15||
59956983|NCT03712137|76075820|FG000|NOT COMPLETED|VOLUX Maintenance Treatment Period||0||
59956984|NCT03712137|76075821|FG001|NOT COMPLETED|VOLUX Maintenance Treatment Period||2||
59956985|NCT03916458|76075830|FG000|STARTED|Overall Study||62||
59956986|NCT03916458|76075830|FG000|COMPLETED|Overall Study|Out of these 62 participants, 2 participants died. But data available before censoring date for these 2 participants were observed and included in results.|62||
59803774|NCT00607022|75925323|FG002|COMPLETED|Overall Study||19||
59803775|NCT00607022|75925321|FG000|NOT COMPLETED|Overall Study||1||
59803776|NCT00607022|75925322|FG001|NOT COMPLETED|Overall Study||0||
59803777|NCT00607022|75925323|FG002|NOT COMPLETED|Overall Study||0||
59803778|NCT00606632|75925331|FG000|STARTED|Overall Study||226||
59803779|NCT00606632|75925331|FG000|COMPLETED|Overall Study||204||
59803780|NCT00606632|75925331|FG000|NOT COMPLETED|Overall Study||22||
59803781|NCT00450814|75925350|FG000|STARTED|Overall Study||3||
59803782|NCT00450814|75925351|FG001|STARTED|Overall Study||3||
59803783|NCT00450814|75925352|FG002|STARTED|Overall Study||3||
59803784|NCT00450814|75925353|FG003|STARTED|Overall Study||4||
59803785|NCT00450814|75925354|FG004|STARTED|Overall Study||4||
59956987|NCT03916458|76075830|FG000|NOT COMPLETED|Overall Study||0||
59956988|NCT00702650|76075834|FG000|STARTED|Overall Study||155||
59956989|NCT00702650|76075834|FG000|COMPLETED|Overall Study||135||
59956990|NCT00702650|76075834|FG000|NOT COMPLETED|Overall Study||20||
59956991|NCT03230916|76075849|FG000|STARTED|Overall Study||7||
59956992|NCT03230916|76075850|FG001|STARTED|Overall Study||6||
59956993|NCT03230916|76075851|FG002|STARTED|Overall Study||6||
59956994|NCT03230916|76075852|FG003|STARTED|Overall Study||4||
59956995|NCT03230916|76075853|FG004|STARTED|Overall Study||4||
59956996|NCT03230916|76075854|FG005|STARTED|Overall Study||6||
59956997|NCT03230916|76075855|FG006|STARTED|Overall Study||3||
59803786|NCT00450814|75925355|FG005|STARTED|Overall Study||7||
59803787|NCT00450814|75925356|FG006|STARTED|Overall Study||3||
59803788|NCT00450814|75925357|FG007|STARTED|Overall Study||3||
59803789|NCT00450814|75925358|FG008|STARTED|Overall Study||2||
59803790|NCT00450814|75925359|FG009|STARTED|Overall Study||12||
59803791|NCT00450814|75925360|FG010|STARTED|Overall Study||4||
59803792|NCT00450814|75925350|FG000|COMPLETED|Overall Study||3||
59803793|NCT00450814|75925351|FG001|COMPLETED|Overall Study||3||
59803794|NCT00450814|75925352|FG002|COMPLETED|Overall Study||3||
59803795|NCT00450814|75925353|FG003|COMPLETED|Overall Study||3||
59803796|NCT00450814|75925354|FG004|COMPLETED|Overall Study||3||
59803797|NCT00450814|75925355|FG005|COMPLETED|Overall Study||6||
59803798|NCT00450814|75925356|FG006|COMPLETED|Overall Study||3||
59803799|NCT00450814|75925357|FG007|COMPLETED|Overall Study||3||
59803800|NCT00450814|75925358|FG008|COMPLETED|Overall Study||2||
59956998|NCT03230916|76075856|FG007|STARTED|Overall Study||2||
59803801|NCT00450814|75925359|FG009|COMPLETED|Overall Study||11||
59803802|NCT00450814|75925360|FG010|COMPLETED|Overall Study||4||
59803803|NCT00450814|75925350|FG000|NOT COMPLETED|Overall Study||0||
59803804|NCT00450814|75925351|FG001|NOT COMPLETED|Overall Study||0||
59803805|NCT00450814|75925352|FG002|NOT COMPLETED|Overall Study||0||
59803806|NCT00450814|75925353|FG003|NOT COMPLETED|Overall Study||1||
59803807|NCT00450814|75925354|FG004|NOT COMPLETED|Overall Study||1||
59803808|NCT00450814|75925355|FG005|NOT COMPLETED|Overall Study||1||
59803809|NCT00450814|75925356|FG006|NOT COMPLETED|Overall Study||0||
59803810|NCT00450814|75925357|FG007|NOT COMPLETED|Overall Study||0||
59803811|NCT00450814|75925358|FG008|NOT COMPLETED|Overall Study||0||
59803812|NCT00450814|75925359|FG009|NOT COMPLETED|Overall Study||1||
59803813|NCT00450814|75925360|FG010|NOT COMPLETED|Overall Study||0||
59803814|NCT00518115|75925395|FG000|STARTED|Overall Study||52||
59803815|NCT00518115|75925396|FG001|STARTED|Overall Study||35||
59803816|NCT00518115|75925397|FG002|STARTED|Overall Study||36||
59803817|NCT00518115|75925398|FG003|STARTED|Overall Study||35||
59803818|NCT00518115|75925399|FG004|STARTED|Overall Study||31||
59803819|NCT00518115|75925400|FG005|STARTED|Overall Study||34||
59803820|NCT00518115|75925401|FG006|STARTED|Overall Study||33||
59803821|NCT00518115|75925402|FG007|STARTED|Overall Study||35||
59803822|NCT00518115|75925403|FG008|STARTED|Overall Study||35||
59803823|NCT00518115|75925404|FG009|STARTED|Overall Study||35||
59803824|NCT00518115|75925395|FG000|Safety Population|Overall Study|These participants received at least one dose of study drug.|51||
59956999|NCT03230916|76075857|FG008|STARTED|Overall Study||2||
59957000|NCT03230916|76075858|FG009|STARTED|Overall Study||3||
59957001|NCT03230916|76075859|FG010|STARTED|Overall Study||4||
59957002|NCT03230916|76075849|FG000|Treated|Overall Study||7||
59957003|NCT03230916|76075850|FG001|Treated|Overall Study||6||
59957004|NCT03230916|76075851|FG002|Treated|Overall Study||6||
59957005|NCT03230916|76075852|FG003|Treated|Overall Study||4||
59803825|NCT00518115|75925396|FG001|Safety Population|Overall Study|These participants received at least one dose of study drug.|35||
59803826|NCT00518115|75925397|FG002|Safety Population|Overall Study|These participants received at least one dose of study drug.|35||
59803827|NCT00518115|75925398|FG003|Safety Population|Overall Study|These participants received at least one dose of study drug.|35||
59803828|NCT00518115|75925399|FG004|Safety Population|Overall Study|These participants received at least one dose of study drug.|31||
59817873|NCT04488770|75940338|FG012|NOT COMPLETED|Part 1-Cohort 1: Period 4 (Up to 5 Days)||0||
59957006|NCT03230916|76075853|FG004|Treated|Overall Study||4||
59803829|NCT00518115|75925400|FG005|Safety Population|Overall Study|These participants received at least one dose of study drug.|33||
59803830|NCT00518115|75925401|FG006|Safety Population|Overall Study|These participants received at least one dose of study drug.|32||
59803831|NCT00518115|75925402|FG007|Safety Population|Overall Study|These participants received at least one dose of study drug.|35||
59803832|NCT00518115|75925403|FG008|Safety Population|Overall Study|These participants received at least one dose of study drug.|35||
59803833|NCT00518115|75925404|FG009|Safety Population|Overall Study|These participants received at least one dose of study drug.|34||
59803834|NCT00518115|75925395|FG000|COMPLETED|Overall Study||40||
59803835|NCT00518115|75925396|FG001|COMPLETED|Overall Study||29||
59803836|NCT00518115|75925397|FG002|COMPLETED|Overall Study||19||
59803837|NCT00518115|75925398|FG003|COMPLETED|Overall Study||24||
59803838|NCT00518115|75925399|FG004|COMPLETED|Overall Study||21||
59803839|NCT00518115|75925400|FG005|COMPLETED|Overall Study||19||
59803840|NCT00518115|75925401|FG006|COMPLETED|Overall Study||25||
59803841|NCT00518115|75925402|FG007|COMPLETED|Overall Study||20||
59803842|NCT00518115|75925403|FG008|COMPLETED|Overall Study||30||
59803843|NCT00518115|75925404|FG009|COMPLETED|Overall Study||20||
59803844|NCT00518115|75925395|FG000|NOT COMPLETED|Overall Study||12||
59803845|NCT00518115|75925396|FG001|NOT COMPLETED|Overall Study||6||
59803846|NCT00518115|75925397|FG002|NOT COMPLETED|Overall Study||17||
59803847|NCT00518115|75925398|FG003|NOT COMPLETED|Overall Study||11||
59803848|NCT00518115|75925399|FG004|NOT COMPLETED|Overall Study||10||
59803849|NCT00518115|75925400|FG005|NOT COMPLETED|Overall Study||15||
59803850|NCT00518115|75925401|FG006|NOT COMPLETED|Overall Study||8||
59803851|NCT00518115|75925402|FG007|NOT COMPLETED|Overall Study||15||
59803852|NCT00518115|75925403|FG008|NOT COMPLETED|Overall Study||5||
59803853|NCT00518115|75925404|FG009|NOT COMPLETED|Overall Study||15||
59803854|NCT00450658|75925429|FG000|STARTED|Overall Study||415||
59803855|NCT00450658|75925430|FG001|STARTED|Overall Study||212||
59803856|NCT00450658|75925429|FG000|COMPLETED|Overall Study||272||
59803857|NCT00450658|75925430|FG001|COMPLETED|Overall Study||122||
59803858|NCT00450658|75925429|FG000|NOT COMPLETED|Overall Study||143||
59803859|NCT00450658|75925430|FG001|NOT COMPLETED|Overall Study||90||
59803860|NCT00517881|75925436|FG000|STARTED|Overall Study||29||
59803861|NCT00517881|75925436|FG000|COMPLETED|Overall Study||24||
59803862|NCT00517881|75925436|FG000|NOT COMPLETED|Overall Study||5||
59803863|NCT03525886|75925444|FG000|STARTED|Cohort 1 (50 mg QHS)||8||
59803864|NCT03525886|75925445|FG001|STARTED|Cohort 1 (50 mg QHS)||0||
59803865|NCT03525886|75925446|FG002|STARTED|Cohort 1 (50 mg QHS)||0||
59803866|NCT03525886|75925447|FG003|STARTED|Cohort 1 (50 mg QHS)||0||
59803867|NCT03525886|75925444|FG000|COMPLETED|Cohort 1 (50 mg QHS)||8||
59803868|NCT03525886|75925445|FG001|COMPLETED|Cohort 1 (50 mg QHS)||0||
59803869|NCT03525886|75925446|FG002|COMPLETED|Cohort 1 (50 mg QHS)||0||
59803870|NCT03525886|75925447|FG003|COMPLETED|Cohort 1 (50 mg QHS)||0||
59803871|NCT03525886|75925444|FG000|NOT COMPLETED|Cohort 1 (50 mg QHS)||0||
59803872|NCT03525886|75925445|FG001|NOT COMPLETED|Cohort 1 (50 mg QHS)||0||
59803873|NCT03525886|75925446|FG002|NOT COMPLETED|Cohort 1 (50 mg QHS)||0||
59803874|NCT03525886|75925447|FG003|NOT COMPLETED|Cohort 1 (50 mg QHS)||0||
59803875|NCT03525886|75925444|FG000|STARTED|Cohort 2 (100 mg QHS)||0||
59803876|NCT03525886|75925445|FG001|STARTED|Cohort 2 (100 mg QHS)||7||
59803877|NCT03525886|75925446|FG002|STARTED|Cohort 2 (100 mg QHS)||0||
59803878|NCT03525886|75925447|FG003|STARTED|Cohort 2 (100 mg QHS)||0||
59803879|NCT03525886|75925444|FG000|COMPLETED|Cohort 2 (100 mg QHS)||0||
59803880|NCT03525886|75925445|FG001|COMPLETED|Cohort 2 (100 mg QHS)||7||
59803881|NCT03525886|75925446|FG002|COMPLETED|Cohort 2 (100 mg QHS)||0||
59803882|NCT03525886|75925447|FG003|COMPLETED|Cohort 2 (100 mg QHS)||0||
59803883|NCT03525886|75925444|FG000|NOT COMPLETED|Cohort 2 (100 mg QHS)||0||
59803884|NCT03525886|75925445|FG001|NOT COMPLETED|Cohort 2 (100 mg QHS)||0||
59803885|NCT03525886|75925446|FG002|NOT COMPLETED|Cohort 2 (100 mg QHS)||0||
59803886|NCT03525886|75925447|FG003|NOT COMPLETED|Cohort 2 (100 mg QHS)||0||
59803887|NCT03525886|75925444|FG000|STARTED|Cohort 3 (100 mg QPM)||0|Cohort 3 included 8 subjects who had participated in other cohorts.|
59803888|NCT03525886|75925445|FG001|STARTED|Cohort 3 (100 mg QPM)||0|Cohort 3 included 8 subjects who had participated in other cohorts.|
59803889|NCT03525886|75925446|FG002|STARTED|Cohort 3 (100 mg QPM)||8|Cohort 3 included 8 subjects who had participated in other cohorts.|
59803890|NCT03525886|75925447|FG003|STARTED|Cohort 3 (100 mg QPM)||0|Cohort 3 included 8 subjects who had participated in other cohorts.|
59803891|NCT03525886|75925444|FG000|COMPLETED|Cohort 3 (100 mg QPM)||0||
59803892|NCT03525886|75925445|FG001|COMPLETED|Cohort 3 (100 mg QPM)||0||
59803893|NCT03525886|75925446|FG002|COMPLETED|Cohort 3 (100 mg QPM)||8||
59957007|NCT03230916|76075854|FG005|Treated|Overall Study||5||
59957008|NCT03230916|76075855|FG006|Treated|Overall Study||3||
59957009|NCT03230916|76075856|FG007|Treated|Overall Study||2||
59803894|NCT03525886|75925447|FG003|COMPLETED|Cohort 3 (100 mg QPM)||0||
59803895|NCT03525886|75925444|FG000|NOT COMPLETED|Cohort 3 (100 mg QPM)||0||
59803896|NCT03525886|75925445|FG001|NOT COMPLETED|Cohort 3 (100 mg QPM)||0||
59803897|NCT03525886|75925446|FG002|NOT COMPLETED|Cohort 3 (100 mg QPM)||0||
59957010|NCT03230916|76075857|FG008|Treated|Overall Study||2||
59803898|NCT03525886|75925447|FG003|NOT COMPLETED|Cohort 3 (100 mg QPM)||0||
59817874|NCT04488770|75940326|FG000|STARTED|Part 1-Cohort 2: Period 1 (Up to 5 Days)||0||
59957011|NCT03230916|76075858|FG009|Treated|Overall Study||3||
59957012|NCT03230916|76075859|FG010|Treated|Overall Study||4||
59957013|NCT03230916|76075849|FG000|COMPLETED|Overall Study||7||
59957014|NCT03230916|76075850|FG001|COMPLETED|Overall Study||6||
59957015|NCT03230916|76075851|FG002|COMPLETED|Overall Study||6||
59957016|NCT03230916|76075852|FG003|COMPLETED|Overall Study||4||
59803899|NCT03525886|75925444|FG000|STARTED|Cohort 4 (100 mg BID)||0|Cohort 4 included 5 subjects who had participated in other cohorts.|
59803900|NCT03525886|75925445|FG001|STARTED|Cohort 4 (100 mg BID)||0|Cohort 4 included 5 subjects who had participated in other cohorts.|
59803901|NCT03525886|75925446|FG002|STARTED|Cohort 4 (100 mg BID)||0|Cohort 4 included 5 subjects who had participated in other cohorts.|
59803902|NCT03525886|75925447|FG003|STARTED|Cohort 4 (100 mg BID)||8|Cohort 4 included 5 subjects who had participated in other cohorts.|
59803903|NCT03525886|75925444|FG000|COMPLETED|Cohort 4 (100 mg BID)||0||
59803904|NCT03525886|75925445|FG001|COMPLETED|Cohort 4 (100 mg BID)||0||
59803905|NCT03525886|75925446|FG002|COMPLETED|Cohort 4 (100 mg BID)||0||
59803906|NCT03525886|75925447|FG003|COMPLETED|Cohort 4 (100 mg BID)||8||
59803907|NCT03525886|75925444|FG000|NOT COMPLETED|Cohort 4 (100 mg BID)||0||
59803908|NCT03525886|75925445|FG001|NOT COMPLETED|Cohort 4 (100 mg BID)||0||
59803909|NCT03525886|75925446|FG002|NOT COMPLETED|Cohort 4 (100 mg BID)||0||
59803910|NCT03525886|75925447|FG003|NOT COMPLETED|Cohort 4 (100 mg BID)||0||
59803911|NCT00517413|75925457|FG000|STARTED|Overall Study||163||
59803912|NCT00517413|75925457|FG000|COMPLETED|Overall Study||102||
59803913|NCT00517413|75925457|FG000|NOT COMPLETED|Overall Study||61||
59957017|NCT03230916|76075853|FG004|COMPLETED|Overall Study||4||
59957018|NCT03230916|76075854|FG005|COMPLETED|Overall Study||5||
59957019|NCT03230916|76075855|FG006|COMPLETED|Overall Study||3||
59803914|NCT03714178|75925461|FG000|STARTED|Overall Study||71||
59803915|NCT03714178|75925461|FG000|COMPLETED|Overall Study||71||
59803916|NCT03714178|75925461|FG000|NOT COMPLETED|Overall Study||0||
59803917|NCT03709342|75925465|FG000|STARTED|Overall Study||7||
59803918|NCT03709342|75925465|FG000|COMPLETED|Overall Study||7||
59803919|NCT03709342|75925465|FG000|NOT COMPLETED|Overall Study||0||
59803920|NCT00604214|75925471|FG000|STARTED|Baseline to Day 28||851||
59803921|NCT00604214|75925472|FG001|STARTED|Baseline to Day 28||845||
59803922|NCT00604214|75925471|FG000|Received Study Drug|Baseline to Day 28||833||
59803923|NCT00604214|75925472|FG001|Received Study Drug|Baseline to Day 28||833||
59803924|NCT00604214|75925471|FG000|COMPLETED|Baseline to Day 28||623||
59803925|NCT00604214|75925472|FG001|COMPLETED|Baseline to Day 28||632||
59803926|NCT00604214|75925471|FG000|NOT COMPLETED|Baseline to Day 28||228||
59803927|NCT00604214|75925472|FG001|NOT COMPLETED|Baseline to Day 28||213||
59803928|NCT00604214|75925471|FG000|STARTED|Day 29 to Day 90||623||
59803929|NCT00604214|75925472|FG001|STARTED|Day 29 to Day 90||632||
59803930|NCT00604214|75925471|FG000|COMPLETED|Day 29 to Day 90||555||
59803931|NCT00604214|75925472|FG001|COMPLETED|Day 29 to Day 90||553||
59803932|NCT00604214|75925471|FG000|NOT COMPLETED|Day 29 to Day 90||68||
59803933|NCT00604214|75925472|FG001|NOT COMPLETED|Day 29 to Day 90||79||
59803934|NCT00604214|75925471|FG000|STARTED|Day 91 to Day 180||555||
59803935|NCT00604214|75925472|FG001|STARTED|Day 91 to Day 180||553||
59803936|NCT00604214|75925471|FG000|COMPLETED|Day 91 to Day 180||529||
59803937|NCT00604214|75925472|FG001|COMPLETED|Day 91 to Day 180||521||
59803938|NCT00604214|75925471|FG000|NOT COMPLETED|Day 91 to Day 180||26||
59803939|NCT00604214|75925472|FG001|NOT COMPLETED|Day 91 to Day 180||32||
59803940|NCT00450580|75925480|FG000|STARTED|Overall Study||106||
59803941|NCT00450580|75925481|FG001|STARTED|Overall Study||106||
59957020|NCT03230916|76075856|FG007|COMPLETED|Overall Study||2||
59957021|NCT03230916|76075857|FG008|COMPLETED|Overall Study||2||
59957022|NCT03230916|76075858|FG009|COMPLETED|Overall Study||3||
59957023|NCT03230916|76075859|FG010|COMPLETED|Overall Study||4||
59957024|NCT03230916|76075849|FG000|NOT COMPLETED|Overall Study||0||
59957025|NCT03230916|76075850|FG001|NOT COMPLETED|Overall Study||0||
59957026|NCT03230916|76075851|FG002|NOT COMPLETED|Overall Study||0||
59957027|NCT03230916|76075852|FG003|NOT COMPLETED|Overall Study||0||
59803942|NCT00450580|75925480|FG000|COMPLETED|Overall Study||90||
59803943|NCT00450580|75925481|FG001|COMPLETED|Overall Study||90||
59803944|NCT00450580|75925480|FG000|NOT COMPLETED|Overall Study||16||
59803945|NCT00450580|75925481|FG001|NOT COMPLETED|Overall Study||16||
59803946|NCT00123487|75925489|FG000|STARTED|Randomized||306||
59803947|NCT00123487|75925490|FG001|STARTED|Randomized||305||
59803948|NCT00123487|75925489|FG000|COMPLETED|Randomized||305||
59803949|NCT00123487|75925490|FG001|COMPLETED|Randomized||304||
59803950|NCT00123487|75925489|FG000|NOT COMPLETED|Randomized||1||
59803951|NCT00123487|75925490|FG001|NOT COMPLETED|Randomized||1||
59803952|NCT00123487|75925489|FG000|STARTED|Treated With Study Drug|1 participant randomized to QD but received BID in error. 304 represents actual QD treatment.|304||
59803953|NCT00123487|75925490|FG001|STARTED|Treated With Study Drug|1 participant randomized to QD but received BID in error. 305 represents actual BID treatment.|305||
59803954|NCT00123487|75925489|FG000|COMPLETED|Treated With Study Drug||0||
59803955|NCT00123487|75925490|FG001|COMPLETED|Treated With Study Drug||0||
59803956|NCT00123487|75925489|FG000|NOT COMPLETED|Treated With Study Drug||304||
59957028|NCT03230916|76075853|FG004|NOT COMPLETED|Overall Study||0||
59957029|NCT03230916|76075854|FG005|NOT COMPLETED|Overall Study||1||
59957030|NCT03230916|76075855|FG006|NOT COMPLETED|Overall Study||0||
59957031|NCT03230916|76075856|FG007|NOT COMPLETED|Overall Study||0||
59957032|NCT03230916|76075857|FG008|NOT COMPLETED|Overall Study||0||
59803957|NCT00123487|75925490|FG001|NOT COMPLETED|Treated With Study Drug||305||
59803958|NCT00509925|75925497|FG000|STARTED|Overall Study||12||
59803959|NCT00509925|75925498|FG001|STARTED|Overall Study||11||
59803960|NCT00509925|75925497|FG000|COMPLETED|Overall Study||12||
59803961|NCT00509925|75925498|FG001|COMPLETED|Overall Study||10||
59803962|NCT00509925|75925497|FG000|NOT COMPLETED|Overall Study||0||
59803963|NCT00509925|75925498|FG001|NOT COMPLETED|Overall Study||1||
59803964|NCT00504777|75925506|FG000|STARTED|Overall Study||36||
59803965|NCT00504777|75925506|FG000|COMPLETED|Overall Study||35||
59803966|NCT00504777|75925506|FG000|NOT COMPLETED|Overall Study||1||
59803967|NCT00509769|75925510|FG000|STARTED|Overall Study||112||
59803968|NCT00509769|75925510|FG000|COMPLETED|Overall Study||21||
59803969|NCT00509769|75925510|FG000|NOT COMPLETED|Overall Study||91||
59803970|NCT00114127|75925516|FG000|STARTED|Overall Study||13||
59803971|NCT00114127|75925517|FG001|STARTED|Overall Study||15||
59803972|NCT00114127|75925516|FG000|COMPLETED|Overall Study||9||
59803973|NCT00114127|75925517|FG001|COMPLETED|Overall Study||11||
59803974|NCT00114127|75925516|FG000|NOT COMPLETED|Overall Study||4||
59803975|NCT00114127|75925517|FG001|NOT COMPLETED|Overall Study||4||
59803976|NCT05158179|75925523|FG000|STARTED|Overall Study||13||
59803977|NCT05158179|75925523|FG000|COMPLETED|Overall Study||13||
59803978|NCT05158179|75925523|FG000|NOT COMPLETED|Overall Study||0||
59803979|NCT00572624|75925529|FG000|STARTED|Overall Study||37||
59803980|NCT00572624|75925530|FG001|STARTED|Overall Study||14||
59803981|NCT00572624|75925529|FG000|COMPLETED|Overall Study||20||
59803982|NCT00572624|75925530|FG001|COMPLETED|Overall Study||10||
59803983|NCT00572624|75925529|FG000|NOT COMPLETED|Overall Study||17||
59803984|NCT00572624|75925530|FG001|NOT COMPLETED|Overall Study||4||
59803985|NCT00122317|75925536|FG000|STARTED|Overall Study||187||
59803986|NCT00122317|75925536|FG000|COMPLETED|Overall Study||176||
59803987|NCT00122317|75925536|FG000|NOT COMPLETED|Overall Study||11||
59803988|NCT03870555|75925543|FG000|STARTED|Period 1 (2 Days)||2||
59803989|NCT03870555|75925544|FG001|STARTED|Period 1 (2 Days)||2||
59957033|NCT03230916|76075858|FG009|NOT COMPLETED|Overall Study||0||
59957034|NCT03230916|76075859|FG010|NOT COMPLETED|Overall Study||0||
59957035|NCT01337115|76075902|FG000|STARTED|Overall Study||25||
59957036|NCT01337115|76075903|FG001|STARTED|Overall Study||25||
59957037|NCT01337115|76075902|FG000|COMPLETED|Overall Study|2 patients could not be assessed after 12h because of catheter dislocation|23||
59957038|NCT01337115|76075903|FG001|COMPLETED|Overall Study||25||
59957039|NCT01337115|76075902|FG000|NOT COMPLETED|Overall Study||2||
59957040|NCT01337115|76075903|FG001|NOT COMPLETED|Overall Study||0||
59957041|NCT03761784|76075913|FG000|STARTED|Overall Study||281||
59957042|NCT03761784|76075914|FG001|STARTED|Overall Study||143||
59957043|NCT03761784|76075913|FG000|Received at Least 1 Dose of Study Drug|Overall Study||274||
59957044|NCT03761784|76075914|FG001|Received at Least 1 Dose of Study Drug|Overall Study||139||
59803990|NCT03870555|75925545|FG002|STARTED|Period 1 (2 Days)||2||
59803991|NCT03870555|75925543|FG000|COMPLETED|Period 1 (2 Days)||2||
59803992|NCT03870555|75925544|FG001|COMPLETED|Period 1 (2 Days)||2||
59803993|NCT03870555|75925545|FG002|COMPLETED|Period 1 (2 Days)||2||
59803994|NCT03870555|75925543|FG000|NOT COMPLETED|Period 1 (2 Days)||0||
59957045|NCT03761784|76075913|FG000|COMPLETED|Overall Study||249||
59957046|NCT03761784|76075914|FG001|COMPLETED|Overall Study||131||
59957047|NCT03761784|76075913|FG000|NOT COMPLETED|Overall Study||32||
59957048|NCT03761784|76075914|FG001|NOT COMPLETED|Overall Study||12||
59957049|NCT03195894|76075922|FG000|STARTED|Overall Study||59||
59957050|NCT03195894|76075923|FG001|STARTED|Overall Study||56||
59957051|NCT03195894|76075922|FG000|COMPLETED|Overall Study||26||
59803995|NCT03870555|75925544|FG001|NOT COMPLETED|Period 1 (2 Days)||0||
59803996|NCT03870555|75925545|FG002|NOT COMPLETED|Period 1 (2 Days)||0||
59803997|NCT03870555|75925543|FG000|STARTED|Washout Period (at Least 16 Days)||2||
59803998|NCT03870555|75925544|FG001|STARTED|Washout Period (at Least 16 Days)||2||
59803999|NCT03870555|75925545|FG002|STARTED|Washout Period (at Least 16 Days)||2||
59804000|NCT03870555|75925543|FG000|COMPLETED|Washout Period (at Least 16 Days)||2||
59804001|NCT03870555|75925544|FG001|COMPLETED|Washout Period (at Least 16 Days)||2||
59804002|NCT03870555|75925545|FG002|COMPLETED|Washout Period (at Least 16 Days)||2||
59804003|NCT03870555|75925543|FG000|NOT COMPLETED|Washout Period (at Least 16 Days)||0||
59804004|NCT03870555|75925544|FG001|NOT COMPLETED|Washout Period (at Least 16 Days)||0||
59804005|NCT03870555|75925545|FG002|NOT COMPLETED|Washout Period (at Least 16 Days)||0||
59804006|NCT03870555|75925543|FG000|STARTED|Period 2 (2 Days)||2||
59804007|NCT03870555|75925544|FG001|STARTED|Period 2 (2 Days)||2||
59804008|NCT03870555|75925545|FG002|STARTED|Period 2 (2 Days)||2||
59804009|NCT03870555|75925543|FG000|COMPLETED|Period 2 (2 Days)||2||
59804010|NCT03870555|75925544|FG001|COMPLETED|Period 2 (2 Days)||2||
59957052|NCT03195894|76075923|FG001|COMPLETED|Overall Study||28||
59957053|NCT03195894|76075922|FG000|NOT COMPLETED|Overall Study||33||
59957054|NCT03195894|76075923|FG001|NOT COMPLETED|Overall Study||28||
59957055|NCT01337973|76075935|FG000|STARTED|Overall Study||60||
59957056|NCT01337973|76075936|FG001|STARTED|Overall Study||60||
59957057|NCT01337973|76075937|FG002|STARTED|Overall Study||60||
59957058|NCT01337973|76075935|FG000|COMPLETED|Overall Study||44||
59957059|NCT01337973|76075936|FG001|COMPLETED|Overall Study||45||
59957060|NCT01337973|76075937|FG002|COMPLETED|Overall Study||49||
59957061|NCT01337973|76075935|FG000|NOT COMPLETED|Overall Study||16||
59957062|NCT01337973|76075936|FG001|NOT COMPLETED|Overall Study||15||
59957063|NCT01337973|76075937|FG002|NOT COMPLETED|Overall Study||11||
59957064|NCT02929056|76075947|FG000|STARTED|Overall Study||1||
59957065|NCT02929056|76075948|FG001|STARTED|Overall Study||1||
59957066|NCT02929056|76075947|FG000|COMPLETED|Overall Study||1||
59957067|NCT02929056|76075948|FG001|COMPLETED|Overall Study||0||
59957068|NCT02929056|76075947|FG000|NOT COMPLETED|Overall Study||0||
59957069|NCT02929056|76075948|FG001|NOT COMPLETED|Overall Study||1||
59957070|NCT02769000|76075956|FG000|STARTED|Overall Study||5||
59957071|NCT02769000|76075957|FG001|STARTED|Overall Study||0||
59957072|NCT02769000|76075956|FG000|COMPLETED|Overall Study||5||
59957073|NCT02769000|76075957|FG001|COMPLETED|Overall Study||0||
59957074|NCT02769000|76075956|FG000|NOT COMPLETED|Overall Study||0||
59957075|NCT02769000|76075957|FG001|NOT COMPLETED|Overall Study||0||
59957076|NCT00545766|76075961|FG000|STARTED|Overall Study||41||
59957077|NCT00545766|76075961|FG000|COMPLETED|Overall Study||36||
59957078|NCT00545766|76075961|FG000|NOT COMPLETED|Overall Study||5||
59957079|NCT00157755|76075967|FG000|STARTED|Overall Study||26||
59957080|NCT00157755|76075968|FG001|STARTED|Overall Study||19||
59957081|NCT00157755|76075969|FG002|STARTED|Overall Study||10||
59957082|NCT00157755|76075970|FG003|STARTED|Overall Study||15||
59957083|NCT00157755|76075971|FG004|STARTED|Overall Study||12||
59957084|NCT00157755|76075972|FG005|STARTED|Overall Study||5||
59957085|NCT00157755|76075967|FG000|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|24||
59957086|NCT00157755|76075968|FG001|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|15||
59957087|NCT00157755|76075969|FG002|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|3||
59957088|NCT00157755|76075970|FG003|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|11||
59957089|NCT00157755|76075971|FG004|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|10||
59804011|NCT03870555|75925545|FG002|COMPLETED|Period 2 (2 Days)||2||
59804012|NCT03870555|75925543|FG000|NOT COMPLETED|Period 2 (2 Days)||0||
59804013|NCT03870555|75925544|FG001|NOT COMPLETED|Period 2 (2 Days)||0||
59804014|NCT03870555|75925545|FG002|NOT COMPLETED|Period 2 (2 Days)||0||
59804015|NCT03870555|75925543|FG000|STARTED|Washout Period (at Least 16 Days)||2||
59804016|NCT03870555|75925544|FG001|STARTED|Washout Period (at Least 16 Days)||2||
59804017|NCT03870555|75925545|FG002|STARTED|Washout Period (at Least 16 Days)||2||
59804018|NCT03870555|75925543|FG000|COMPLETED|Washout Period (at Least 16 Days)||2||
59804019|NCT03870555|75925544|FG001|COMPLETED|Washout Period (at Least 16 Days)||2||
59804020|NCT03870555|75925545|FG002|COMPLETED|Washout Period (at Least 16 Days)||2||
59804021|NCT03870555|75925543|FG000|NOT COMPLETED|Washout Period (at Least 16 Days)||0||
59804022|NCT03870555|75925544|FG001|NOT COMPLETED|Washout Period (at Least 16 Days)||0||
59804023|NCT03870555|75925545|FG002|NOT COMPLETED|Washout Period (at Least 16 Days)||0||
59804024|NCT03870555|75925543|FG000|STARTED|Period 3 (2 Days)||2||
59804025|NCT03870555|75925544|FG001|STARTED|Period 3 (2 Days)||2||
59804026|NCT03870555|75925545|FG002|STARTED|Period 3 (2 Days)||2||
59804027|NCT03870555|75925543|FG000|COMPLETED|Period 3 (2 Days)||1||
59804028|NCT03870555|75925544|FG001|COMPLETED|Period 3 (2 Days)||2||
59804029|NCT03870555|75925545|FG002|COMPLETED|Period 3 (2 Days)||2||
59804030|NCT03870555|75925543|FG000|NOT COMPLETED|Period 3 (2 Days)||1||
59804031|NCT03870555|75925544|FG001|NOT COMPLETED|Period 3 (2 Days)||0||
59804032|NCT03870555|75925545|FG002|NOT COMPLETED|Period 3 (2 Days)||0||
59804033|NCT03870477|75925556|FG000|STARTED|Overall Study||1||
59804034|NCT03870477|75925556|FG000|COMPLETED|Overall Study||0||
59804035|NCT03870477|75925556|FG000|NOT COMPLETED|Overall Study||1||
59957090|NCT00157755|76075972|FG005|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|0||
59957091|NCT00157755|76075967|FG000|NOT COMPLETED|Overall Study||2||
59957092|NCT00157755|76075968|FG001|NOT COMPLETED|Overall Study||4||
59957093|NCT00157755|76075969|FG002|NOT COMPLETED|Overall Study||7||
59957094|NCT00157755|76075970|FG003|NOT COMPLETED|Overall Study||4||
59804036|NCT00165841|75925562|FG000|STARTED|Overall Study||103||
59957095|NCT00157755|76075971|FG004|NOT COMPLETED|Overall Study||2||
59957096|NCT00157755|76075972|FG005|NOT COMPLETED|Overall Study||5||
59957097|NCT02723006|76075981|FG000|STARTED|Overall Study||1||
59957098|NCT02723006|76075982|FG001|STARTED|Overall Study||9||
59957099|NCT02723006|76075983|FG002|STARTED|Overall Study||12||
59957100|NCT02723006|76075981|FG000|COMPLETED|Overall Study||0||
59804037|NCT00165841|75925563|FG001|STARTED|Overall Study||97||
59804038|NCT00165841|75925562|FG000|COMPLETED|Overall Study||73||
59804039|NCT00165841|75925563|FG001|COMPLETED|Overall Study||35||
59804040|NCT00165841|75925562|FG000|NOT COMPLETED|Overall Study||30||
59804041|NCT00165841|75925563|FG001|NOT COMPLETED|Overall Study||62||
59804042|NCT00509223|75925571|FG000|STARTED|Overall Study||207||
59957101|NCT02723006|76075982|FG001|COMPLETED|Overall Study||2||
59957102|NCT02723006|76075983|FG002|COMPLETED|Overall Study||5||
59957103|NCT02723006|76075981|FG000|NOT COMPLETED|Overall Study||1||
59804043|NCT00509223|75925572|FG001|STARTED|Overall Study||209||
59804044|NCT00509223|75925571|FG000|COMPLETED|Overall Study||119||
59804045|NCT00509223|75925572|FG001|COMPLETED|Overall Study||137||
59804046|NCT00509223|75925571|FG000|NOT COMPLETED|Overall Study||88||
59804047|NCT00509223|75925572|FG001|NOT COMPLETED|Overall Study||72||
59804048|NCT00460798|75925578|FG000|STARTED|Overall Study||448||
59804049|NCT00460798|75925578|FG000|Treated|Overall Study|Subjects with complete dosing information were recorded as 'Treated'|421||
59804050|NCT00460798|75925578|FG000|COMPLETED|Overall Study||108||
59804051|NCT00460798|75925578|FG000|NOT COMPLETED|Overall Study||340||
59804052|NCT00603980|75925582|FG000|STARTED|Study Qualification||31||
59804053|NCT00603980|75925582|FG000|COMPLETED|Study Qualification||15||
59804054|NCT00603980|75925582|FG000|NOT COMPLETED|Study Qualification||16||
59804055|NCT00603980|75925582|FG000|STARTED|Main Study||15||
59804056|NCT00603980|75925582|FG000|COMPLETED|Main Study||14||
59804057|NCT00603980|75925582|FG000|NOT COMPLETED|Main Study||1||
59804058|NCT00450190|75925602|FG000|STARTED|Overall Study||20||
59804059|NCT00450190|75925602|FG000|COMPLETED|Overall Study||18||
59804060|NCT00450190|75925602|FG000|NOT COMPLETED|Overall Study||2||
59804061|NCT00450112|75925608|FG000|STARTED|Overall Study||125||
59804062|NCT00450112|75925609|FG001|STARTED|Overall Study||77||
59804063|NCT00450112|75925608|FG000|Received Injection|Overall Study||125||
59804064|NCT00450112|75925609|FG001|Received Injection|Overall Study||74||
59804065|NCT00450112|75925608|FG000|Analyzed Participants|Overall Study|3 subjects removed from ITT analyses because of no post treatment data (pre-defined criteria).|122||
59804066|NCT00450112|75925609|FG001|Analyzed Participants|Overall Study||74||
59804067|NCT00450112|75925608|FG000|COMPLETED|Overall Study||112||
59804068|NCT00450112|75925609|FG001|COMPLETED|Overall Study||71||
59804069|NCT00450112|75925608|FG000|NOT COMPLETED|Overall Study||13||
59804070|NCT00450112|75925609|FG001|NOT COMPLETED|Overall Study||6||
59804071|NCT00449956|75925618|FG000|STARTED|Overall Study||189||
59957104|NCT02723006|76075982|FG001|NOT COMPLETED|Overall Study||7||
59957105|NCT02723006|76075983|FG002|NOT COMPLETED|Overall Study||7||
59957106|NCT00702962|76075993|FG000|STARTED|Overall Study|One initiated treatment. Milestones not achieved due to premature closing due to low accrual.|1||
59957107|NCT00702962|76075994|FG001|STARTED|Overall Study|Three treated. Milestone not met as Phase I closed prematurely as NCI research established the MTD.|3||
59957108|NCT00702962|76075993|FG000|COMPLETED|Overall Study|The one participant off treatment after 2 doses due to concurrent health disorder.|0||
59957109|NCT00702962|76075994|FG001|COMPLETED|Overall Study|Two completed all required cycles. One experienced progressive disease after 2 cycles|2||
59957110|NCT00702962|76075993|FG000|NOT COMPLETED|Overall Study||1||
59957111|NCT00702962|76075994|FG001|NOT COMPLETED|Overall Study||1||
59957112|NCT01379508|76076006|FG000|STARTED|Treatment to Week 104||99||
59957113|NCT01379508|76076007|FG001|STARTED|Treatment to Week 104||22||
59957114|NCT01379508|76076008|FG002|STARTED|Treatment to Week 104||109||
59957115|NCT01379508|76076009|FG003|STARTED|Treatment to Week 104||11||
59957116|NCT01379508|76076006|FG000|Completed Wk 24|Treatment to Week 104||93||
59957117|NCT01379508|76076007|FG001|Completed Wk 24|Treatment to Week 104||22||
59957118|NCT01379508|76076008|FG002|Completed Wk 24|Treatment to Week 104||107||
59957119|NCT01379508|76076009|FG003|Completed Wk 24|Treatment to Week 104||11||
59957120|NCT01379508|76076006|FG000|Treatment Exposure ≥ 52 Weeks|Treatment to Week 104||91||
60073899|NCT01842308|76189239|FG002|COMPLETED|Overall Study||3||
60073900|NCT01842308|76189240|FG003|COMPLETED|Overall Study||2||
59804072|NCT00449956|75925619|FG001|STARTED|Overall Study||92||
59804073|NCT00449956|75925620|FG002|STARTED|Overall Study||193||
59804074|NCT00449956|75925618|FG000|COMPLETED|Overall Study||179||
59804075|NCT00449956|75925619|FG001|COMPLETED|Overall Study||88||
59804076|NCT00449956|75925620|FG002|COMPLETED|Overall Study||184||
59804077|NCT00449956|75925618|FG000|NOT COMPLETED|Overall Study||10||
59804078|NCT00449956|75925619|FG001|NOT COMPLETED|Overall Study||4||
59804079|NCT00449956|75925620|FG002|NOT COMPLETED|Overall Study||9||
59804080|NCT00509145|75925630|FG000|STARTED|Overall Study||550||
59804081|NCT00509145|75925631|FG001|STARTED|Overall Study||556||
59804082|NCT00509145|75925630|FG000|COMPLETED|Overall Study||437||
59804083|NCT00509145|75925631|FG001|COMPLETED|Overall Study||427||
59804084|NCT00509145|75925630|FG000|NOT COMPLETED|Overall Study||113||
59804085|NCT00509145|75925631|FG001|NOT COMPLETED|Overall Study||129||
59804086|NCT00509067|75925639|FG000|STARTED|Overall Study||19||
59804087|NCT00509067|75925640|FG001|STARTED|Overall Study||24||
59804088|NCT00509067|75925639|FG000|COMPLETED|Overall Study||15||
59804089|NCT00509067|75925640|FG001|COMPLETED|Overall Study||19||
59804090|NCT00509067|75925639|FG000|NOT COMPLETED|Overall Study||4||
59804091|NCT00509067|75925640|FG001|NOT COMPLETED|Overall Study||5||
59804092|NCT00504309|75925656|FG000|STARTED|Overall Study||7||
59804093|NCT00504309|75925657|FG001|STARTED|Overall Study||5||
59804094|NCT00504309|75925658|FG002|STARTED|Overall Study||2||
59804095|NCT00504309|75925659|FG003|STARTED|Overall Study||3||
59804096|NCT00504309|75925660|FG004|STARTED|Overall Study||8||
59804097|NCT00504309|75925661|FG005|STARTED|Overall Study||3||
59804098|NCT00504309|75925656|FG000|COMPLETED|Overall Study||7||
59804099|NCT00504309|75925657|FG001|COMPLETED|Overall Study||5||
59804100|NCT00504309|75925658|FG002|COMPLETED|Overall Study|Participant dropped out during second period|1||
59804101|NCT00504309|75925659|FG003|COMPLETED|Overall Study||3||
59804102|NCT00504309|75925660|FG004|COMPLETED|Overall Study|Participant died during washout after 2nd period|7||
59804103|NCT00504309|75925661|FG005|COMPLETED|Overall Study||3||
59804104|NCT00504309|75925656|FG000|NOT COMPLETED|Overall Study||0||
59804105|NCT00504309|75925657|FG001|NOT COMPLETED|Overall Study||0||
59957121|NCT01379508|76076007|FG001|Treatment Exposure ≥ 52 Weeks|Treatment to Week 104||21||
59957122|NCT01379508|76076008|FG002|Treatment Exposure ≥ 52 Weeks|Treatment to Week 104||105||
59957123|NCT01379508|76076009|FG003|Treatment Exposure ≥ 52 Weeks|Treatment to Week 104||11||
59957124|NCT01379508|76076006|FG000|COMPLETED|Treatment to Week 104||80||
59957125|NCT01379508|76076007|FG001|COMPLETED|Treatment to Week 104||19||
59957126|NCT01379508|76076008|FG002|COMPLETED|Treatment to Week 104||96||
59957127|NCT01379508|76076009|FG003|COMPLETED|Treatment to Week 104||11||
59957128|NCT01379508|76076006|FG000|NOT COMPLETED|Treatment to Week 104||19||
59957129|NCT01379508|76076007|FG001|NOT COMPLETED|Treatment to Week 104||3||
59957130|NCT01379508|76076008|FG002|NOT COMPLETED|Treatment to Week 104||13||
59957131|NCT01379508|76076009|FG003|NOT COMPLETED|Treatment to Week 104||0||
59957132|NCT01379508|76076006|FG000|STARTED|Extension Period Weeks 109-156||64||
59957133|NCT01379508|76076007|FG001|STARTED|Extension Period Weeks 109-156||17||
59804106|NCT00504309|75925658|FG002|NOT COMPLETED|Overall Study||1||
59804107|NCT00504309|75925659|FG003|NOT COMPLETED|Overall Study||0||
59804108|NCT00504309|75925660|FG004|NOT COMPLETED|Overall Study||1||
59804109|NCT00504309|75925661|FG005|NOT COMPLETED|Overall Study||0||
59804110|NCT00508755|75925673|FG000|STARTED|Overall Study||6||
59804111|NCT00508755|75925673|FG000|COMPLETED|Overall Study||5||
59804112|NCT00508755|75925673|FG000|NOT COMPLETED|Overall Study||1||
59804113|NCT00504231|75925683|FG000|STARTED|Overall Study||65||
59804114|NCT00504231|75925684|FG001|STARTED|Overall Study||64||
59804115|NCT00504231|75925685|FG002|STARTED|Overall Study||64||
59804116|NCT00504231|75925686|FG003|STARTED|Overall Study||65||
59804117|NCT00504231|75925683|FG000|COMPLETED|Overall Study||65||
59804118|NCT00504231|75925684|FG001|COMPLETED|Overall Study||64||
59804119|NCT00504231|75925685|FG002|COMPLETED|Overall Study||63||
59804120|NCT00504231|75925686|FG003|COMPLETED|Overall Study||65||
59804121|NCT00504231|75925683|FG000|NOT COMPLETED|Overall Study||0||
59804122|NCT00504231|75925684|FG001|NOT COMPLETED|Overall Study||0||
59804123|NCT00504231|75925685|FG002|NOT COMPLETED|Overall Study||1||
59957134|NCT01379508|76076008|FG002|STARTED|Extension Period Weeks 109-156||79||
59957135|NCT01379508|76076009|FG003|STARTED|Extension Period Weeks 109-156||10||
59957136|NCT01379508|76076006|FG000|COMPLETED|Extension Period Weeks 109-156||45||
59957137|NCT01379508|76076007|FG001|COMPLETED|Extension Period Weeks 109-156||14||
59957138|NCT01379508|76076008|FG002|COMPLETED|Extension Period Weeks 109-156||65||
59957139|NCT01379508|76076009|FG003|COMPLETED|Extension Period Weeks 109-156||10||
59957140|NCT01379508|76076006|FG000|NOT COMPLETED|Extension Period Weeks 109-156||19||
59957141|NCT01379508|76076007|FG001|NOT COMPLETED|Extension Period Weeks 109-156||3||
59957142|NCT01379508|76076008|FG002|NOT COMPLETED|Extension Period Weeks 109-156||14||
59804124|NCT00504231|75925686|FG003|NOT COMPLETED|Overall Study||0||
59804125|NCT02430077|75925700|FG000|STARTED|First Intervention 4 Months||5||
59957143|NCT01379508|76076009|FG003|NOT COMPLETED|Extension Period Weeks 109-156||0||
59957144|NCT02722928|76076025|FG000|STARTED|Overall Study||49||
59957145|NCT02722928|76076026|FG001|STARTED|Overall Study||51||
59957146|NCT02722928|76076025|FG000|COMPLETED|Overall Study||39||
59957147|NCT02722928|76076026|FG001|COMPLETED|Overall Study||31||
59957148|NCT02722928|76076025|FG000|NOT COMPLETED|Overall Study||10||
59957149|NCT02722928|76076026|FG001|NOT COMPLETED|Overall Study||20||
59957150|NCT05067270|76076036|FG000|STARTED|Period 1||8||
59957151|NCT05067270|76076037|FG001|STARTED|Period 1||8||
59957152|NCT05067270|76076038|FG002|STARTED|Period 1||8||
59957153|NCT05067270|76076039|FG003|STARTED|Period 1||8||
59957154|NCT05067270|76076040|FG004|STARTED|Period 1||8||
59957155|NCT05067270|76076036|FG000|Received At Least One Infusion|Period 1||8||
59957156|NCT05067270|76076037|FG001|Received At Least One Infusion|Period 1||8||
59957157|NCT05067270|76076038|FG002|Received At Least One Infusion|Period 1||8||
59957158|NCT05067270|76076039|FG003|Received At Least One Infusion|Period 1||8||
59957159|NCT05067270|76076040|FG004|Received At Least One Infusion|Period 1||8||
59957160|NCT05067270|76076036|FG000|COMPLETED|Period 1||8||
59957161|NCT05067270|76076037|FG001|COMPLETED|Period 1||8||
59804126|NCT02430077|75925701|FG001|STARTED|First Intervention 4 Months||5||
59804127|NCT02430077|75925700|FG000|COMPLETED|First Intervention 4 Months||5||
59804128|NCT02430077|75925701|FG001|COMPLETED|First Intervention 4 Months||5||
59804129|NCT02430077|75925700|FG000|NOT COMPLETED|First Intervention 4 Months||0||
59804130|NCT02430077|75925701|FG001|NOT COMPLETED|First Intervention 4 Months||0||
59804131|NCT02430077|75925700|FG000|STARTED|Washout 4 Months||5||
59804132|NCT02430077|75925701|FG001|STARTED|Washout 4 Months||5||
59804133|NCT02430077|75925700|FG000|COMPLETED|Washout 4 Months||5||
59804134|NCT02430077|75925701|FG001|COMPLETED|Washout 4 Months||5||
59804135|NCT02430077|75925700|FG000|NOT COMPLETED|Washout 4 Months||0||
59804136|NCT02430077|75925701|FG001|NOT COMPLETED|Washout 4 Months||0||
59804137|NCT02430077|75925700|FG000|STARTED|Second Intervention 4 Months||5||
59804138|NCT02430077|75925701|FG001|STARTED|Second Intervention 4 Months||5||
59804139|NCT02430077|75925700|FG000|COMPLETED|Second Intervention 4 Months||5||
59804140|NCT02430077|75925701|FG001|COMPLETED|Second Intervention 4 Months||5||
59957162|NCT05067270|76076038|FG002|COMPLETED|Period 1||8||
59957163|NCT05067270|76076039|FG003|COMPLETED|Period 1||8||
59957164|NCT05067270|76076040|FG004|COMPLETED|Period 1||8||
59957165|NCT05067270|76076036|FG000|NOT COMPLETED|Period 1||0||
59957166|NCT05067270|76076037|FG001|NOT COMPLETED|Period 1||0||
59957167|NCT05067270|76076038|FG002|NOT COMPLETED|Period 1||0||
59957168|NCT05067270|76076039|FG003|NOT COMPLETED|Period 1||0||
59957169|NCT05067270|76076040|FG004|NOT COMPLETED|Period 1||0||
59957170|NCT05067270|76076036|FG000|STARTED|Period 2||8||
59957171|NCT05067270|76076037|FG001|STARTED|Period 2||8||
59957172|NCT05067270|76076038|FG002|STARTED|Period 2||8||
59957173|NCT05067270|76076039|FG003|STARTED|Period 2||8||
59957174|NCT05067270|76076040|FG004|STARTED|Period 2||8||
59957175|NCT05067270|76076036|FG000|Received At Least One Infusion|Period 2||8||
59957176|NCT05067270|76076037|FG001|Received At Least One Infusion|Period 2||8||
59957177|NCT05067270|76076038|FG002|Received At Least One Infusion|Period 2||8||
59957178|NCT05067270|76076039|FG003|Received At Least One Infusion|Period 2||8||
59957179|NCT05067270|76076040|FG004|Received At Least One Infusion|Period 2||8||
59957180|NCT05067270|76076036|FG000|COMPLETED|Period 2||8||
59957181|NCT05067270|76076037|FG001|COMPLETED|Period 2||8||
59957182|NCT05067270|76076038|FG002|COMPLETED|Period 2||8||
59957183|NCT05067270|76076039|FG003|COMPLETED|Period 2||8||
59957184|NCT05067270|76076040|FG004|COMPLETED|Period 2||8||
59804141|NCT02430077|75925700|FG000|NOT COMPLETED|Second Intervention 4 Months||0||
59804142|NCT02430077|75925701|FG001|NOT COMPLETED|Second Intervention 4 Months||0||
59957185|NCT05067270|76076036|FG000|NOT COMPLETED|Period 2||0||
59957186|NCT05067270|76076037|FG001|NOT COMPLETED|Period 2||0||
59957187|NCT05067270|76076038|FG002|NOT COMPLETED|Period 2||0||
59957188|NCT05067270|76076039|FG003|NOT COMPLETED|Period 2||0||
59957189|NCT05067270|76076040|FG004|NOT COMPLETED|Period 2||0||
59957190|NCT05067270|76076036|FG000|STARTED|Period 3||8||
59957191|NCT05067270|76076037|FG001|STARTED|Period 3||8||
59957192|NCT05067270|76076038|FG002|STARTED|Period 3||8||
59957193|NCT05067270|76076039|FG003|STARTED|Period 3||8||
59957194|NCT05067270|76076040|FG004|STARTED|Period 3||8||
59957195|NCT05067270|76076036|FG000|Received At Least One Infusion|Period 3||8||
59957196|NCT05067270|76076037|FG001|Received At Least One Infusion|Period 3||8||
59957197|NCT05067270|76076038|FG002|Received At Least One Infusion|Period 3||8||
59957198|NCT05067270|76076039|FG003|Received At Least One Infusion|Period 3||8||
59957199|NCT05067270|76076040|FG004|Received At Least One Infusion|Period 3||8||
59524139|NCT00994175|75619262|FG000|COMPLETED|Second Intervention||4||
59524140|NCT00994175|75619263|FG001|COMPLETED|Second Intervention||8||
59524141|NCT00994175|75619262|FG000|NOT COMPLETED|Second Intervention||0||
59524142|NCT00994175|75619263|FG001|NOT COMPLETED|Second Intervention||0||
59957200|NCT05067270|76076036|FG000|COMPLETED|Period 3||8||
59957201|NCT05067270|76076037|FG001|COMPLETED|Period 3||8||
59957202|NCT05067270|76076038|FG002|COMPLETED|Period 3||8||
59957203|NCT05067270|76076039|FG003|COMPLETED|Period 3||8||
59957204|NCT05067270|76076040|FG004|COMPLETED|Period 3||8||
59957205|NCT05067270|76076036|FG000|NOT COMPLETED|Period 3||0||
59957206|NCT05067270|76076037|FG001|NOT COMPLETED|Period 3||0||
59957207|NCT05067270|76076038|FG002|NOT COMPLETED|Period 3||0||
59957208|NCT05067270|76076039|FG003|NOT COMPLETED|Period 3||0||
59957209|NCT05067270|76076040|FG004|NOT COMPLETED|Period 3||0||
59957210|NCT05067270|76076036|FG000|STARTED|Period 4||8||
59957211|NCT05067270|76076037|FG001|STARTED|Period 4||8||
59957212|NCT05067270|76076038|FG002|STARTED|Period 4||8||
59957213|NCT05067270|76076039|FG003|STARTED|Period 4||8||
59957214|NCT05067270|76076040|FG004|STARTED|Period 4||8||
59957215|NCT05067270|76076036|FG000|Received At Least One Infusion|Period 4||8||
59957216|NCT05067270|76076037|FG001|Received At Least One Infusion|Period 4||8||
59957217|NCT05067270|76076038|FG002|Received At Least One Infusion|Period 4||8||
59957218|NCT05067270|76076039|FG003|Received At Least One Infusion|Period 4||8||
59524143|NCT02403986|75619271|FG000|STARTED|Overall Study||26||
59524144|NCT02403986|75619272|FG001|STARTED|Overall Study||27||
59524145|NCT02403986|75619271|FG000|COMPLETED|Overall Study||21||
59524146|NCT02403986|75619272|FG001|COMPLETED|Overall Study||23||
59620671|NCT00099372|75732032|FG001|NOT COMPLETED|Followed up 7 Years After Index Surgery||32||
59957219|NCT05067270|76076040|FG004|Received At Least One Infusion|Period 4||8||
59957220|NCT05067270|76076036|FG000|COMPLETED|Period 4||8||
59957221|NCT05067270|76076037|FG001|COMPLETED|Period 4||8||
59957222|NCT05067270|76076038|FG002|COMPLETED|Period 4||8||
59524147|NCT02403986|75619271|FG000|NOT COMPLETED|Overall Study||5||
59524148|NCT02403986|75619272|FG001|NOT COMPLETED|Overall Study||4||
59957223|NCT05067270|76076039|FG003|COMPLETED|Period 4||8||
59957224|NCT05067270|76076040|FG004|COMPLETED|Period 4||8||
59957225|NCT05067270|76076036|FG000|NOT COMPLETED|Period 4||0||
59957226|NCT05067270|76076037|FG001|NOT COMPLETED|Period 4||0||
59957227|NCT05067270|76076038|FG002|NOT COMPLETED|Period 4||0||
59957228|NCT05067270|76076039|FG003|NOT COMPLETED|Period 4||0||
59957229|NCT05067270|76076040|FG004|NOT COMPLETED|Period 4||0||
59957230|NCT05067270|76076036|FG000|STARTED|Period 5||8||
59957231|NCT05067270|76076037|FG001|STARTED|Period 5||8||
59957232|NCT05067270|76076038|FG002|STARTED|Period 5||8||
59957233|NCT05067270|76076039|FG003|STARTED|Period 5||8||
59957234|NCT05067270|76076040|FG004|STARTED|Period 5||8||
59957235|NCT05067270|76076036|FG000|Received At Least One Infusion|Period 5||8||
59957236|NCT05067270|76076037|FG001|Received At Least One Infusion|Period 5||8||
59957237|NCT05067270|76076038|FG002|Received At Least One Infusion|Period 5||8||
59957238|NCT05067270|76076039|FG003|Received At Least One Infusion|Period 5||8||
59957239|NCT05067270|76076040|FG004|Received At Least One Infusion|Period 5||8||
59957240|NCT05067270|76076036|FG000|COMPLETED|Period 5||8||
59957241|NCT05067270|76076037|FG001|COMPLETED|Period 5||8||
59957242|NCT05067270|76076038|FG002|COMPLETED|Period 5||8||
59957243|NCT05067270|76076039|FG003|COMPLETED|Period 5||8||
59957244|NCT05067270|76076040|FG004|COMPLETED|Period 5||8||
59957245|NCT05067270|76076036|FG000|NOT COMPLETED|Period 5||0||
59957246|NCT05067270|76076037|FG001|NOT COMPLETED|Period 5||0||
59957247|NCT05067270|76076038|FG002|NOT COMPLETED|Period 5||0||
59957248|NCT05067270|76076039|FG003|NOT COMPLETED|Period 5||0||
59957249|NCT05067270|76076040|FG004|NOT COMPLETED|Period 5||0||
59957250|NCT02722304|76076057|FG000|STARTED|Overall Study||1||
59957251|NCT02722304|76076058|FG001|STARTED|Overall Study||0||
59957252|NCT02722304|76076059|FG002|STARTED|Overall Study||2||
59957253|NCT02722304|76076060|FG003|STARTED|Overall Study||2||
60073901|NCT01842308|76189241|FG004|COMPLETED|Overall Study||35||
59524149|NCT01239355|75619278|FG000|STARTED|Overall Study||15||
59524150|NCT01239355|75619278|FG000|COMPLETED|Overall Study||15||
59524151|NCT01239355|75619278|FG000|NOT COMPLETED|Overall Study||0||
59524152|NCT02168153|75619284|FG000|STARTED|Overall Study||60||
59524153|NCT02168153|75619285|FG001|STARTED|Overall Study||60||
59524154|NCT02168153|75619284|FG000|COMPLETED|Overall Study||57||
59524155|NCT02168153|75619285|FG001|COMPLETED|Overall Study||60||
59524156|NCT02168153|75619284|FG000|NOT COMPLETED|Overall Study||3||
60073902|NCT01842308|76189237|FG000|NOT COMPLETED|Overall Study||0||
59524157|NCT02168153|75619285|FG001|NOT COMPLETED|Overall Study||0||
59524158|NCT02168309|75619293|FG000|STARTED|Overall Study||25||
59524159|NCT02168309|75619294|FG001|STARTED|Overall Study||25||
59524160|NCT02168309|75619293|FG000|COMPLETED|Overall Study||25||
59524161|NCT02168309|75619294|FG001|COMPLETED|Overall Study||25||
59620672|NCT00100230|75732042|FG000|STARTED|Overall Study||41||
59620673|NCT00100230|75732043|FG001|STARTED|Overall Study||37||
59620674|NCT00100230|75732042|FG000|COMPLETED|Overall Study||29||
59620675|NCT00100230|75732043|FG001|COMPLETED|Overall Study||22||
59620676|NCT00100230|75732042|FG000|NOT COMPLETED|Overall Study||12||
59620677|NCT00100230|75732043|FG001|NOT COMPLETED|Overall Study||15||
59620678|NCT00201864|75732051|FG000|STARTED|Overall Study||40||
59620679|NCT00201864|75732051|FG000|COMPLETED|Overall Study||40||
59620680|NCT00201864|75732051|FG000|NOT COMPLETED|Overall Study||0||
59804171|NCT03050489|75925729|FG000|STARTED|Overall Study||128||
59804172|NCT03050489|75925730|FG001|STARTED|Overall Study||181||
59957254|NCT02722304|76076061|FG004|STARTED|Overall Study||2||
59957255|NCT02722304|76076057|FG000|Treated|Overall Study||1||
59957256|NCT02722304|76076058|FG001|Treated|Overall Study||0||
59957257|NCT02722304|76076059|FG002|Treated|Overall Study||1||
59524162|NCT02168309|75619293|FG000|NOT COMPLETED|Overall Study||0||
59620681|NCT00202722|75732057|FG000|STARTED|Overall Study||41||
59957258|NCT02722304|76076060|FG003|Treated|Overall Study||1||
59957259|NCT02722304|76076061|FG004|Treated|Overall Study||2||
59957260|NCT02722304|76076057|FG000|COMPLETED|Overall Study||0||
59957261|NCT02722304|76076058|FG001|COMPLETED|Overall Study||0||
59957262|NCT02722304|76076059|FG002|COMPLETED|Overall Study||0||
59957263|NCT02722304|76076060|FG003|COMPLETED|Overall Study||0||
59957264|NCT02722304|76076061|FG004|COMPLETED|Overall Study||0||
59957265|NCT02722304|76076057|FG000|NOT COMPLETED|Overall Study||1||
59957266|NCT02722304|76076058|FG001|NOT COMPLETED|Overall Study||0||
59957267|NCT02722304|76076059|FG002|NOT COMPLETED|Overall Study||2||
59957268|NCT02722304|76076060|FG003|NOT COMPLETED|Overall Study||2||
59957269|NCT02722304|76076061|FG004|NOT COMPLETED|Overall Study||2||
59957270|NCT00709956|76076077|FG000|STARTED|Overall Study|Day 1 Single-blind placebo run-in|33||
59957271|NCT00709956|76076078|FG001|STARTED|Overall Study|Day 1 Single-blind placebo run-in|37||
59957272|NCT00709956|76076077|FG000|Double-blind Crossover-period|Overall Study|Days 2 and 3|31||
59957273|NCT00709956|76076078|FG001|Double-blind Crossover-period|Overall Study|Days 2 and 3|33||
59957274|NCT00709956|76076077|FG000|COMPLETED|Overall Study||30||
59957275|NCT00709956|76076078|FG001|COMPLETED|Overall Study||33||
59957276|NCT00709956|76076077|FG000|NOT COMPLETED|Overall Study||3||
59957277|NCT00709956|76076078|FG001|NOT COMPLETED|Overall Study||4||
59957278|NCT03223350|76076088|FG000|STARTED|Overall Study||17||
59957279|NCT03223350|76076089|FG001|STARTED|Overall Study||13||
59804173|NCT03050489|75925731|FG002|STARTED|Overall Study||27||
59804174|NCT03050489|75925729|FG000|COMPLETED|Overall Study||128||
59804175|NCT03050489|75925730|FG001|COMPLETED|Overall Study||175||
59804176|NCT03050489|75925731|FG002|COMPLETED|Overall Study||27||
59804177|NCT03050489|75925729|FG000|NOT COMPLETED|Overall Study||0||
59804178|NCT03050489|75925730|FG001|NOT COMPLETED|Overall Study||6||
59804179|NCT03050489|75925731|FG002|NOT COMPLETED|Overall Study||0||
59804180|NCT00568178|75925747|FG000|STARTED|Double Blind Base Study||122||
59804181|NCT00568178|75925748|FG001|STARTED|Double Blind Base Study||124||
59804182|NCT00568178|75925749|FG002|STARTED|Double Blind Base Study||30||
59804183|NCT00568178|75925750|FG003|STARTED|Double Blind Base Study||30||
59804184|NCT00568178|75925751|FG004|STARTED|Double Blind Base Study||0||
59804185|NCT00568178|75925752|FG005|STARTED|Double Blind Base Study||0||
59804186|NCT00568178|75925747|FG000|COMPLETED|Double Blind Base Study||116||
59804187|NCT00568178|75925748|FG001|COMPLETED|Double Blind Base Study||118||
59804188|NCT00568178|75925749|FG002|COMPLETED|Double Blind Base Study||29||
59804189|NCT00568178|75925750|FG003|COMPLETED|Double Blind Base Study||25||
59804190|NCT00568178|75925751|FG004|COMPLETED|Double Blind Base Study||0||
59804191|NCT00568178|75925752|FG005|COMPLETED|Double Blind Base Study||0||
59804192|NCT00568178|75925747|FG000|NOT COMPLETED|Double Blind Base Study||6||
59804193|NCT00568178|75925748|FG001|NOT COMPLETED|Double Blind Base Study||6||
59804194|NCT00568178|75925749|FG002|NOT COMPLETED|Double Blind Base Study||1||
59804195|NCT00568178|75925750|FG003|NOT COMPLETED|Double Blind Base Study||5||
59804196|NCT00568178|75925751|FG004|NOT COMPLETED|Double Blind Base Study||0||
59804197|NCT00568178|75925752|FG005|NOT COMPLETED|Double Blind Base Study||0||
59804198|NCT00568178|75925747|FG000|STARTED|Open Label Extension||0||
59804199|NCT00568178|75925748|FG001|STARTED|Open Label Extension||0||
59804200|NCT00568178|75925749|FG002|STARTED|Open Label Extension||0||
59804201|NCT00568178|75925750|FG003|STARTED|Open Label Extension||0||
59804202|NCT00568178|75925751|FG004|STARTED|Open Label Extension||134||
59804203|NCT00568178|75925752|FG005|STARTED|Open Label Extension||134||
59804204|NCT00568178|75925747|FG000|COMPLETED|Open Label Extension||0||
59804205|NCT00568178|75925748|FG001|COMPLETED|Open Label Extension||0||
59804206|NCT00568178|75925749|FG002|COMPLETED|Open Label Extension||0||
59804207|NCT00568178|75925750|FG003|COMPLETED|Open Label Extension||0||
59804208|NCT00568178|75925751|FG004|COMPLETED|Open Label Extension||55||
59804209|NCT00568178|75925752|FG005|COMPLETED|Open Label Extension||54||
59804210|NCT00568178|75925747|FG000|NOT COMPLETED|Open Label Extension||0||
59804211|NCT00568178|75925748|FG001|NOT COMPLETED|Open Label Extension||0||
59804212|NCT00568178|75925749|FG002|NOT COMPLETED|Open Label Extension||0||
59957280|NCT03223350|76076088|FG000|COMPLETED|Overall Study||17||
59957281|NCT03223350|76076089|FG001|COMPLETED|Overall Study||13||
59957282|NCT03223350|76076088|FG000|NOT COMPLETED|Overall Study||0||
59957283|NCT03223350|76076089|FG001|NOT COMPLETED|Overall Study||0||
59957284|NCT02724774|76076097|FG000|STARTED|Overall Study||127||
59957285|NCT02724774|76076098|FG001|STARTED|Overall Study||125||
59957286|NCT02724774|76076097|FG000|Infant 6 Months|Overall Study||122||
59957287|NCT02724774|76076098|FG001|Infant 6 Months|Overall Study||122||
59957288|NCT02724774|76076097|FG000|Infant 12 Months|Overall Study||120||
59957289|NCT02724774|76076098|FG001|Infant 12 Months|Overall Study||123||
59957290|NCT02724774|76076097|FG000|COMPLETED|Overall Study||120||
59957291|NCT02724774|76076098|FG001|COMPLETED|Overall Study||123||
59957292|NCT02724774|76076097|FG000|NOT COMPLETED|Overall Study||7||
59957293|NCT02724774|76076098|FG001|NOT COMPLETED|Overall Study||2||
59957294|NCT02719028|76076108|FG000|STARTED|Overall Study||30||
59957295|NCT02719028|76076109|FG001|STARTED|Overall Study||30||
59804213|NCT00568178|75925750|FG003|NOT COMPLETED|Open Label Extension||0||
59804214|NCT00568178|75925751|FG004|NOT COMPLETED|Open Label Extension||79||
59804215|NCT00568178|75925752|FG005|NOT COMPLETED|Open Label Extension||80||
59804216|NCT00577889|75925769|FG000|STARTED|Overall Study||9||
59804217|NCT00577889|75925770|FG001|STARTED|Overall Study||6||
59957296|NCT02719028|76076110|FG002|STARTED|Overall Study||30||
59957297|NCT02719028|76076111|FG003|STARTED|Overall Study||30||
59957298|NCT02719028|76076108|FG000|COMPLETED|Overall Study||28||
59957299|NCT02719028|76076109|FG001|COMPLETED|Overall Study||28||
59957300|NCT02719028|76076110|FG002|COMPLETED|Overall Study||24||
59957301|NCT02719028|76076111|FG003|COMPLETED|Overall Study||20||
59957302|NCT02719028|76076108|FG000|NOT COMPLETED|Overall Study||2||
59957303|NCT02719028|76076109|FG001|NOT COMPLETED|Overall Study||2||
59957304|NCT02719028|76076110|FG002|NOT COMPLETED|Overall Study||6||
59804218|NCT00577889|75925771|FG002|STARTED|Overall Study||6||
59804219|NCT00577889|75925769|FG000|COMPLETED|Overall Study||8||
59804220|NCT00577889|75925770|FG001|COMPLETED|Overall Study||6||
59804221|NCT00577889|75925771|FG002|COMPLETED|Overall Study||6||
59804222|NCT00577889|75925769|FG000|NOT COMPLETED|Overall Study||1||
59804223|NCT00577889|75925770|FG001|NOT COMPLETED|Overall Study||0||
59804224|NCT00577889|75925771|FG002|NOT COMPLETED|Overall Study||0||
59804225|NCT00460564|75925783|FG000|STARTED|Double-Blind Phase (12 Weeks)||51||
59804226|NCT00460564|75925784|FG001|STARTED|Double-Blind Phase (12 Weeks)||26||
59804227|NCT00460564|75925785|FG002|STARTED|Double-Blind Phase (12 Weeks)||21||
59804228|NCT00460564|75925786|FG003|STARTED|Double-Blind Phase (12 Weeks)||11||
59804229|NCT00460564|75925787|FG004|STARTED|Double-Blind Phase (12 Weeks)||0||
59957305|NCT02719028|76076111|FG003|NOT COMPLETED|Overall Study||10||
59957306|NCT02720510|76076123|FG000|STARTED|Overall Study||3||
59957307|NCT02720510|76076124|FG001|STARTED|Overall Study||3||
59957308|NCT02720510|76076123|FG000|COMPLETED|Overall Study||0||
59957309|NCT02720510|76076124|FG001|COMPLETED|Overall Study||0||
59957310|NCT02720510|76076123|FG000|NOT COMPLETED|Overall Study||3||
59957311|NCT02720510|76076124|FG001|NOT COMPLETED|Overall Study||3||
59957312|NCT02720198|76076132|FG000|STARTED|Overall Study||29||
59957313|NCT02720198|76076133|FG001|STARTED|Overall Study||31||
59957314|NCT02720198|76076132|FG000|COMPLETED|Overall Study||29||
59957315|NCT02720198|76076133|FG001|COMPLETED|Overall Study||30||
59957316|NCT02720198|76076132|FG000|NOT COMPLETED|Overall Study||0||
59804230|NCT00460564|75925788|FG005|STARTED|Double-Blind Phase (12 Weeks)||0||
59804231|NCT00460564|75925789|FG006|STARTED|Double-Blind Phase (12 Weeks)||0||
59804232|NCT00460564|75925790|FG007|STARTED|Double-Blind Phase (12 Weeks)||0||
59804233|NCT00460564|75925783|FG000|COMPLETED|Double-Blind Phase (12 Weeks)||47||
59804234|NCT00460564|75925784|FG001|COMPLETED|Double-Blind Phase (12 Weeks)||25||
59804235|NCT00460564|75925785|FG002|COMPLETED|Double-Blind Phase (12 Weeks)||21||
59804236|NCT00460564|75925786|FG003|COMPLETED|Double-Blind Phase (12 Weeks)||11||
59804237|NCT00460564|75925787|FG004|COMPLETED|Double-Blind Phase (12 Weeks)||0||
59804238|NCT00460564|75925788|FG005|COMPLETED|Double-Blind Phase (12 Weeks)||0||
59804239|NCT00460564|75925789|FG006|COMPLETED|Double-Blind Phase (12 Weeks)||0||
59804240|NCT00460564|75925790|FG007|COMPLETED|Double-Blind Phase (12 Weeks)||0||
59804241|NCT00460564|75925783|FG000|NOT COMPLETED|Double-Blind Phase (12 Weeks)||4||
59804242|NCT00460564|75925784|FG001|NOT COMPLETED|Double-Blind Phase (12 Weeks)||1||
59804243|NCT00460564|75925785|FG002|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0||
59804244|NCT00460564|75925786|FG003|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0||
59804245|NCT00460564|75925787|FG004|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0||
59804246|NCT00460564|75925788|FG005|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0||
59804247|NCT00460564|75925789|FG006|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0||
59804248|NCT00460564|75925790|FG007|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0||
59957317|NCT02720198|76076133|FG001|NOT COMPLETED|Overall Study||1||
59957318|NCT01365195|76076142|FG000|STARTED|Overall Study||6||
59957319|NCT01365195|76076143|FG001|STARTED|Overall Study||8||
59957320|NCT01365195|76076144|FG002|STARTED|Overall Study||7||
59957321|NCT01365195|76076142|FG000|COMPLETED|Overall Study||6||
59957322|NCT01365195|76076143|FG001|COMPLETED|Overall Study||8||
59957323|NCT01365195|76076144|FG002|COMPLETED|Overall Study||7||
59957324|NCT01365195|76076142|FG000|NOT COMPLETED|Overall Study||0||
59957325|NCT01365195|76076143|FG001|NOT COMPLETED|Overall Study||0||
59957326|NCT01365195|76076144|FG002|NOT COMPLETED|Overall Study||0||
59957327|NCT00703118|76076155|FG000|STARTED|Overall Study||266||
59957328|NCT00703118|76076156|FG001|STARTED|Overall Study||264||
59957329|NCT00703118|76076157|FG002|STARTED|Overall Study||132||
59957330|NCT00703118|76076155|FG000|COMPLETED|Overall Study||245||
59957331|NCT00703118|76076156|FG001|COMPLETED|Overall Study||248||
59957332|NCT00703118|76076157|FG002|COMPLETED|Overall Study||110||
60073903|NCT01842308|76189238|FG001|NOT COMPLETED|Overall Study||0||
59804249|NCT00460564|75925783|FG000|STARTED|Open-Label Phase (36 Weeks)||0||
59804250|NCT00460564|75925784|FG001|STARTED|Open-Label Phase (36 Weeks)||0||
59804251|NCT00460564|75925785|FG002|STARTED|Open-Label Phase (36 Weeks)||0||
59804252|NCT00460564|75925786|FG003|STARTED|Open-Label Phase (36 Weeks)||0||
60073904|NCT01842308|76189239|FG002|NOT COMPLETED|Overall Study||0||
59804253|NCT00460564|75925787|FG004|STARTED|Open-Label Phase (36 Weeks)||47||
59804254|NCT00460564|75925788|FG005|STARTED|Open-Label Phase (36 Weeks)||25||
59804255|NCT00460564|75925789|FG006|STARTED|Open-Label Phase (36 Weeks)||21||
59957333|NCT00703118|76076155|FG000|NOT COMPLETED|Overall Study||21||
59957334|NCT00703118|76076156|FG001|NOT COMPLETED|Overall Study||16||
59957335|NCT00703118|76076157|FG002|NOT COMPLETED|Overall Study||22||
59957336|NCT01850082|76076170|FG000|STARTED|Overall Study||576||
59957337|NCT01850082|76076171|FG001|STARTED|Overall Study||574||
59957338|NCT01850082|76076170|FG000|COMPLETED|Overall Study||576||
59957339|NCT01850082|76076171|FG001|COMPLETED|Overall Study||574||
59957340|NCT01850082|76076170|FG000|NOT COMPLETED|Overall Study||0||
59957341|NCT01850082|76076171|FG001|NOT COMPLETED|Overall Study||0||
59957342|NCT00909753|76076179|FG000|STARTED|Period: First Intervention||46||
59957343|NCT00909753|76076180|FG001|STARTED|Period: First Intervention||46||
59957344|NCT00909753|76076179|FG000|COMPLETED|Period: First Intervention||46||
59620682|NCT00202722|75732057|FG000|COMPLETED|Overall Study||41||
59620683|NCT00202722|75732057|FG000|NOT COMPLETED|Overall Study||0||
59620684|NCT00100698|75732064|FG000|STARTED|Overall Study||27||
59620685|NCT00100698|75732065|FG001|STARTED|Overall Study||29||
59620686|NCT00100698|75732064|FG000|COMPLETED|Overall Study||21||
59620687|NCT00100698|75732065|FG001|COMPLETED|Overall Study||27||
59620688|NCT00100698|75732064|FG000|NOT COMPLETED|Overall Study||6||
59620689|NCT00100698|75732065|FG001|NOT COMPLETED|Overall Study||2||
59804256|NCT00460564|75925790|FG007|STARTED|Open-Label Phase (36 Weeks)||11||
59804257|NCT00460564|75925783|FG000|COMPLETED|Open-Label Phase (36 Weeks)||0||
59804258|NCT00460564|75925784|FG001|COMPLETED|Open-Label Phase (36 Weeks)||0||
59804259|NCT00460564|75925785|FG002|COMPLETED|Open-Label Phase (36 Weeks)||0||
59804260|NCT00460564|75925786|FG003|COMPLETED|Open-Label Phase (36 Weeks)||0||
59804261|NCT00460564|75925787|FG004|COMPLETED|Open-Label Phase (36 Weeks)||38||
59804262|NCT00460564|75925788|FG005|COMPLETED|Open-Label Phase (36 Weeks)||19||
59804263|NCT00460564|75925789|FG006|COMPLETED|Open-Label Phase (36 Weeks)||19||
59804264|NCT00460564|75925790|FG007|COMPLETED|Open-Label Phase (36 Weeks)||11||
59804265|NCT00460564|75925783|FG000|NOT COMPLETED|Open-Label Phase (36 Weeks)||0||
59804266|NCT00460564|75925784|FG001|NOT COMPLETED|Open-Label Phase (36 Weeks)||0||
59804267|NCT00460564|75925785|FG002|NOT COMPLETED|Open-Label Phase (36 Weeks)||0||
59804268|NCT00460564|75925786|FG003|NOT COMPLETED|Open-Label Phase (36 Weeks)||0||
59804269|NCT00460564|75925787|FG004|NOT COMPLETED|Open-Label Phase (36 Weeks)||9||
59804270|NCT00460564|75925788|FG005|NOT COMPLETED|Open-Label Phase (36 Weeks)||6||
59804271|NCT00460564|75925789|FG006|NOT COMPLETED|Open-Label Phase (36 Weeks)||2||
59804272|NCT00460564|75925790|FG007|NOT COMPLETED|Open-Label Phase (36 Weeks)||0||
59804273|NCT00567476|75925812|FG000|STARTED|Overall Study||78||
59804274|NCT00567476|75925813|FG001|STARTED|Overall Study||38||
59804275|NCT00567476|75925812|FG000|COMPLETED|Overall Study||70||
59804276|NCT00567476|75925813|FG001|COMPLETED|Overall Study||34||
59804277|NCT00567476|75925812|FG000|NOT COMPLETED|Overall Study||8||
59804278|NCT00567476|75925813|FG001|NOT COMPLETED|Overall Study||4||
59804279|NCT00516321|75925821|FG000|STARTED|Open-label (OL) Pre-Antiviral Treatment||715||
59804280|NCT00516321|75925822|FG001|STARTED|Open-label (OL) Pre-Antiviral Treatment||0||
59804281|NCT00516321|75925823|FG002|STARTED|Open-label (OL) Pre-Antiviral Treatment||0||
59804282|NCT00516321|75925821|FG000|COMPLETED|Open-label (OL) Pre-Antiviral Treatment||682||
59804283|NCT00516321|75925822|FG001|COMPLETED|Open-label (OL) Pre-Antiviral Treatment||0||
59804284|NCT00516321|75925823|FG002|COMPLETED|Open-label (OL) Pre-Antiviral Treatment||0||
59804285|NCT00516321|75925821|FG000|NOT COMPLETED|Open-label (OL) Pre-Antiviral Treatment||33||
59804286|NCT00516321|75925822|FG001|NOT COMPLETED|Open-label (OL) Pre-Antiviral Treatment||0||
59804287|NCT00516321|75925823|FG002|NOT COMPLETED|Open-label (OL) Pre-Antiviral Treatment||0||
59804288|NCT00516321|75925821|FG000|STARTED|Double-blind (DB) Antiviral Treatment||0||
59804289|NCT00516321|75925822|FG001|STARTED|Double-blind (DB) Antiviral Treatment||232||
59804290|NCT00516321|75925823|FG002|STARTED|Double-blind (DB) Antiviral Treatment||450||
59804291|NCT00516321|75925821|FG000|COMPLETED|Double-blind (DB) Antiviral Treatment||0||
59804292|NCT00516321|75925822|FG001|COMPLETED|Double-blind (DB) Antiviral Treatment||197||
59957345|NCT00909753|76076180|FG001|COMPLETED|Period: First Intervention||46||
59957346|NCT00909753|76076179|FG000|NOT COMPLETED|Period: First Intervention||0||
59957347|NCT00909753|76076180|FG001|NOT COMPLETED|Period: First Intervention||0||
60073905|NCT01842308|76189240|FG003|NOT COMPLETED|Overall Study||0||
59620690|NCT00103116|75732071|FG000|STARTED|Overall Study||32||
59620691|NCT00103116|75732071|FG000|COMPLETED|Overall Study||32||
59620692|NCT00103116|75732071|FG000|NOT COMPLETED|Overall Study||0||
59620693|NCT00205374|75732077|FG000|STARTED|Overall Study||10||
59620694|NCT00205374|75732078|FG001|STARTED|Overall Study||9||
59620695|NCT00205374|75732077|FG000|COMPLETED|Overall Study||10||
59620696|NCT00205374|75732078|FG001|COMPLETED|Overall Study||9||
59620697|NCT00205374|75732077|FG000|NOT COMPLETED|Overall Study||0||
59620698|NCT00205374|75732078|FG001|NOT COMPLETED|Overall Study||0||
59620699|NCT00103194|75732084|FG000|STARTED|Overall Study||49||
59620700|NCT00103194|75732084|FG000|Treated|Overall Study||49||
59620701|NCT00103194|75732084|FG000|Eligible|Overall Study||35||
59804293|NCT00516321|75925823|FG002|COMPLETED|Double-blind (DB) Antiviral Treatment||396||
59957348|NCT00909753|76076179|FG000|STARTED|Period: Washout of 28 Days||46||
59957349|NCT00909753|76076180|FG001|STARTED|Period: Washout of 28 Days||46||
59804294|NCT00516321|75925821|FG000|NOT COMPLETED|Double-blind (DB) Antiviral Treatment||0||
59804295|NCT00516321|75925822|FG001|NOT COMPLETED|Double-blind (DB) Antiviral Treatment||35||
59957350|NCT00909753|76076179|FG000|COMPLETED|Period: Washout of 28 Days||44||
59620702|NCT00103194|75732084|FG000|Eligible and Treated|Overall Study||35||
59620703|NCT00103194|75732084|FG000|COMPLETED|Overall Study||18||
59957351|NCT00909753|76076180|FG001|COMPLETED|Period: Washout of 28 Days||43||
59804296|NCT00516321|75925823|FG002|NOT COMPLETED|Double-blind (DB) Antiviral Treatment||54||
59804297|NCT00460408|75925835|FG000|STARTED|Overall Study||403||
59804298|NCT00460408|75925836|FG001|STARTED|Overall Study||16||
59804299|NCT00460408|75925837|FG002|STARTED|Overall Study||75||
59804300|NCT00460408|75925838|FG003|STARTED|Overall Study||7||
59804301|NCT00460408|75925835|FG000|COMPLETED|Overall Study||336||
59804302|NCT00460408|75925836|FG001|COMPLETED|Overall Study||13||
59804303|NCT00460408|75925837|FG002|COMPLETED|Overall Study||69||
59804304|NCT00460408|75925838|FG003|COMPLETED|Overall Study||7||
59804305|NCT00460408|75925835|FG000|NOT COMPLETED|Overall Study||67||
59804306|NCT00460408|75925836|FG001|NOT COMPLETED|Overall Study||3||
59804307|NCT00460408|75925837|FG002|NOT COMPLETED|Overall Study||6||
59804308|NCT00460408|75925838|FG003|NOT COMPLETED|Overall Study||0||
59804309|NCT00507819|75925848|FG000|STARTED|First Intervention (6 Weeks)||14||
59804310|NCT00507819|75925849|FG001|STARTED|First Intervention (6 Weeks)||14||
59804311|NCT00507819|75925848|FG000|COMPLETED|First Intervention (6 Weeks)||14||
59804312|NCT00507819|75925849|FG001|COMPLETED|First Intervention (6 Weeks)||14||
59804313|NCT00507819|75925848|FG000|NOT COMPLETED|First Intervention (6 Weeks)||0||
59804314|NCT00507819|75925849|FG001|NOT COMPLETED|First Intervention (6 Weeks)||0||
59804315|NCT00507819|75925848|FG000|STARTED|Washout (6 Weeks)||14||
59804316|NCT00507819|75925849|FG001|STARTED|Washout (6 Weeks)||14||
59804317|NCT00507819|75925848|FG000|COMPLETED|Washout (6 Weeks)||13||
59804318|NCT00507819|75925849|FG001|COMPLETED|Washout (6 Weeks)||14||
59804319|NCT00507819|75925848|FG000|NOT COMPLETED|Washout (6 Weeks)||1||
59804320|NCT00507819|75925849|FG001|NOT COMPLETED|Washout (6 Weeks)||0||
59804321|NCT00507819|75925848|FG000|STARTED|Second Intervention (6 Weeks)||13||
59804322|NCT00507819|75925849|FG001|STARTED|Second Intervention (6 Weeks)||14||
59804323|NCT00507819|75925848|FG000|COMPLETED|Second Intervention (6 Weeks)||13||
59804324|NCT00507819|75925849|FG001|COMPLETED|Second Intervention (6 Weeks)||14||
59804325|NCT00507819|75925848|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0||
59804326|NCT00507819|75925849|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||0||
59804327|NCT03449667|75925857|FG000|STARTED|Initial Treatment||71||
59804328|NCT03449667|75925858|FG001|STARTED|Initial Treatment||73||
59804329|NCT03449667|75925857|FG000|COMPLETED|Initial Treatment||71||
59804330|NCT03449667|75925858|FG001|COMPLETED|Initial Treatment||73||
59804331|NCT03449667|75925857|FG000|NOT COMPLETED|Initial Treatment||0||
59804332|NCT03449667|75925858|FG001|NOT COMPLETED|Initial Treatment||0||
59804333|NCT03449667|75925857|FG000|STARTED|Optional Crossover Treatment||71||
59804334|NCT03449667|75925858|FG001|STARTED|Optional Crossover Treatment||73||
59804335|NCT03449667|75925857|FG000|COMPLETED|Optional Crossover Treatment||42||
59804336|NCT03449667|75925858|FG001|COMPLETED|Optional Crossover Treatment||49||
59804337|NCT03449667|75925857|FG000|NOT COMPLETED|Optional Crossover Treatment||29||
59804338|NCT03449667|75925858|FG001|NOT COMPLETED|Optional Crossover Treatment||24||
59804339|NCT00442936|75925879|FG000|STARTED|Overall Study||333||
59804340|NCT00442936|75925880|FG001|STARTED|Overall Study||354||
59804341|NCT00442936|75925881|FG002|STARTED|Overall Study||345||
59957352|NCT00909753|76076179|FG000|NOT COMPLETED|Period: Washout of 28 Days||2||
59957353|NCT00909753|76076180|FG001|NOT COMPLETED|Period: Washout of 28 Days||3||
59957354|NCT00909753|76076179|FG000|STARTED|Period: Second Intervention||44||
59957355|NCT00909753|76076180|FG001|STARTED|Period: Second Intervention||43||
59957356|NCT00909753|76076179|FG000|COMPLETED|Period: Second Intervention||43||
59957357|NCT00909753|76076180|FG001|COMPLETED|Period: Second Intervention||43||
59957358|NCT00909753|76076179|FG000|NOT COMPLETED|Period: Second Intervention||1||
59957359|NCT00909753|76076180|FG001|NOT COMPLETED|Period: Second Intervention||0||
59957360|NCT03715764|76076186|FG000|STARTED|Baseline (Randomized (n=69)||35||
59957361|NCT03715764|76076187|FG001|STARTED|Baseline (Randomized (n=69)||34||
59957362|NCT03715764|76076186|FG000|COMPLETED|Baseline (Randomized (n=69)||33||
59957363|NCT03715764|76076187|FG001|COMPLETED|Baseline (Randomized (n=69)||31||
60073906|NCT01842308|76189241|FG004|NOT COMPLETED|Overall Study||1||
59804342|NCT00442936|75925882|FG003|STARTED|Overall Study||348||
59804343|NCT00442936|75925879|FG000|COMPLETED|Overall Study||332||
59957364|NCT03715764|76076186|FG000|NOT COMPLETED|Baseline (Randomized (n=69)||2||
59957365|NCT03715764|76076187|FG001|NOT COMPLETED|Baseline (Randomized (n=69)||3||
59957366|NCT03715764|76076186|FG000|STARTED|3 Month Follow-up||33||
59957367|NCT03715764|76076187|FG001|STARTED|3 Month Follow-up||31||
59804344|NCT00442936|75925880|FG001|COMPLETED|Overall Study||354||
59957368|NCT03715764|76076186|FG000|COMPLETED|3 Month Follow-up||30||
59957369|NCT03715764|76076187|FG001|COMPLETED|3 Month Follow-up||28||
59957370|NCT03715764|76076186|FG000|NOT COMPLETED|3 Month Follow-up||3||
59957371|NCT03715764|76076187|FG001|NOT COMPLETED|3 Month Follow-up||3||
59957372|NCT03715764|76076186|FG000|STARTED|6 Month Follow-up||30||
59804345|NCT00442936|75925881|FG002|COMPLETED|Overall Study||344||
59804346|NCT00442936|75925882|FG003|COMPLETED|Overall Study||347||
59804347|NCT00442936|75925879|FG000|NOT COMPLETED|Overall Study||1||
59804348|NCT00442936|75925880|FG001|NOT COMPLETED|Overall Study||0||
59804349|NCT00442936|75925881|FG002|NOT COMPLETED|Overall Study||1||
59804350|NCT00442936|75925882|FG003|NOT COMPLETED|Overall Study||1||
59804351|NCT00577655|75925894|FG000|STARTED|Overall Study|This number represents the number of participants randomized.|52||
59957373|NCT03715764|76076187|FG001|STARTED|6 Month Follow-up||28||
59804352|NCT00577655|75925895|FG001|STARTED|Overall Study|This number represents the number of participants randomized.|51||
59804353|NCT00577655|75925894|FG000|COMPLETED|Overall Study||51||
59804354|NCT00577655|75925895|FG001|COMPLETED|Overall Study||47||
59804355|NCT00577655|75925894|FG000|NOT COMPLETED|Overall Study||1||
59804356|NCT00577655|75925895|FG001|NOT COMPLETED|Overall Study||4||
59804357|NCT00113269|75925906|FG000|STARTED|Overall Study||76||
59804358|NCT00113269|75925907|FG001|STARTED|Overall Study||70||
59804359|NCT00113269|75925908|FG002|STARTED|Overall Study||175||
59804360|NCT00113269|75925909|FG003|STARTED|Overall Study||180||
59804361|NCT00113269|75925906|FG000|Received Treatment|Overall Study||70||
59804362|NCT00113269|75925907|FG001|Received Treatment|Overall Study||69||
59804363|NCT00113269|75925908|FG002|Received Treatment|Overall Study||164||
59804364|NCT00113269|75925909|FG003|Received Treatment|Overall Study||171||
59804365|NCT00113269|75925906|FG000|COMPLETED|Overall Study||51||
59804366|NCT00113269|75925907|FG001|COMPLETED|Overall Study||48||
59804367|NCT00113269|75925908|FG002|COMPLETED|Overall Study||134||
59804368|NCT00113269|75925909|FG003|COMPLETED|Overall Study||140||
59804369|NCT00113269|75925906|FG000|NOT COMPLETED|Overall Study||25||
59804370|NCT00113269|75925907|FG001|NOT COMPLETED|Overall Study||22||
59804371|NCT00113269|75925908|FG002|NOT COMPLETED|Overall Study||41||
59804372|NCT00113269|75925909|FG003|NOT COMPLETED|Overall Study||40||
59804373|NCT00515619|75925919|FG000|STARTED|Overall Study||376||
59804374|NCT00515619|75925919|FG000|Safety Set|Overall Study||376||
59804375|NCT00515619|75925919|FG000|COMPLETED|Overall Study||160||
59804376|NCT00515619|75925919|FG000|NOT COMPLETED|Overall Study||216||
59804377|NCT00449644|75925927|FG000|STARTED|Overall Study||23||
59804378|NCT00449644|75925928|FG001|STARTED|Overall Study||24||
59804379|NCT00449644|75925929|FG002|STARTED|Overall Study||79||
59804380|NCT00449644|75925930|FG003|STARTED|Overall Study||81||
59804381|NCT00449644|75925927|FG000|Rollover|Overall Study||0||
59804382|NCT00449644|75925928|FG001|Rollover|Overall Study||0||
59804383|NCT00449644|75925929|FG002|Rollover|Overall Study||0||
59804384|NCT00449644|75925930|FG003|Rollover|Overall Study||1||
59804385|NCT00449644|75925927|FG000|COMPLETED|Overall Study||13||
59804386|NCT00449644|75925928|FG001|COMPLETED|Overall Study||11||
59804387|NCT00449644|75925929|FG002|COMPLETED|Overall Study||50||
59804388|NCT00449644|75925930|FG003|COMPLETED|Overall Study|After Week 24, 1 patient rolled over to treatment with TMC207 and was not completed or discontinued.|49||
59804389|NCT00449644|75925927|FG000|NOT COMPLETED|Overall Study||10||
59804390|NCT00449644|75925928|FG001|NOT COMPLETED|Overall Study||13||
59804391|NCT00449644|75925929|FG002|NOT COMPLETED|Overall Study||29||
59804392|NCT00449644|75925930|FG003|NOT COMPLETED|Overall Study||32||
59804393|NCT00515541|75925947|FG000|STARTED|Overall Study||10||
59804394|NCT00515541|75925948|FG001|STARTED|Overall Study||12||
59804395|NCT00515541|75925949|FG002|STARTED|Overall Study||10||
59804396|NCT00515541|75925950|FG003|STARTED|Overall Study||11||
59804397|NCT00515541|75925947|FG000|6 Weeks (1 gm Lovaza)|Overall Study||10||
59804398|NCT00515541|75925948|FG001|6 Weeks (1 gm Lovaza)|Overall Study|One subject pulled after baseline. One subject pulled due to no show for appt.after baseline|10||
59804399|NCT00515541|75925949|FG002|6 Weeks (1 gm Lovaza)|Overall Study||10||
59804400|NCT00515541|75925950|FG003|6 Weeks (1 gm Lovaza)|Overall Study|One subject pulled due to no show for appt. after baseline.|10||
59804401|NCT00515541|75925947|FG000|12 Weeks (2 gm Lovaza)|Overall Study||10||
59804402|NCT00515541|75925948|FG001|12 Weeks (2 gm Lovaza)|Overall Study||10||
59804403|NCT00515541|75925949|FG002|12 Weeks (2 gm Lovaza)|Overall Study||10||
59804404|NCT00515541|75925950|FG003|12 Weeks (2 gm Lovaza)|Overall Study||10||
59804405|NCT00515541|75925947|FG000|18 Weeks (4 gm Lovaza)|Overall Study||10||
59804406|NCT00515541|75925948|FG001|18 Weeks (4 gm Lovaza)|Overall Study|One subject withdrew at 12 weeks due to acquired bleeding disorder present before enrolling.|9||
59804407|NCT00515541|75925949|FG002|18 Weeks (4 gm Lovaza)|Overall Study||10||
59804408|NCT00515541|75925950|FG003|18 Weeks (4 gm Lovaza)|Overall Study|One subject withdrew at 14 weeks with GI problems.|9||
59804409|NCT00515541|75925947|FG000|24 Weeks (8 gm Lovaza)|Overall Study||10||
59804410|NCT00515541|75925948|FG001|24 Weeks (8 gm Lovaza)|Overall Study|Two subjects withdrew at 20 and 21 weeks due to nausea. Subjects were closed out early.|7||
59804411|NCT00515541|75925949|FG002|24 Weeks (8 gm Lovaza)|Overall Study||10||
59804412|NCT00515541|75925950|FG003|24 Weeks (8 gm Lovaza)|Overall Study|Three subjects withdrew after 18 weeks (1 GI problem, 1 undefined medical problem, 1 no show)|6||
59804413|NCT00515541|75925947|FG000|COMPLETED|Overall Study|All subjects completed 24 weeks.|10||
59804414|NCT00515541|75925948|FG001|COMPLETED|Overall Study||7||
59804415|NCT00515541|75925949|FG002|COMPLETED|Overall Study|All subjects completed 24 weeks.|10||
59804416|NCT00515541|75925950|FG003|COMPLETED|Overall Study||6||
59804417|NCT00515541|75925947|FG000|NOT COMPLETED|Overall Study||0||
59804418|NCT00515541|75925948|FG001|NOT COMPLETED|Overall Study||5||
59804419|NCT00515541|75925949|FG002|NOT COMPLETED|Overall Study||0||
59804420|NCT00515541|75925950|FG003|NOT COMPLETED|Overall Study||5||
59804421|NCT00112489|75925960|FG000|STARTED|Overall Study|All patients enrolled on study|55||
59804422|NCT00112489|75925960|FG000|COMPLETED|Overall Study|Completed regimen due to progression|15||
59804423|NCT00112489|75925960|FG000|NOT COMPLETED|Overall Study||40||
59804424|NCT00711971|75925973|FG000|STARTED|Overall Study||42||
59804425|NCT00711971|75925974|FG001|STARTED|Overall Study||42||
59804426|NCT00711971|75925975|FG002|STARTED|Overall Study||42||
59804427|NCT00711971|75925973|FG000|COMPLETED|Overall Study||39||
59804428|NCT00711971|75925974|FG001|COMPLETED|Overall Study||38||
59804429|NCT00711971|75925975|FG002|COMPLETED|Overall Study||41||
59804430|NCT00711971|75925973|FG000|NOT COMPLETED|Overall Study||3||
59804431|NCT00711971|75925974|FG001|NOT COMPLETED|Overall Study||4||
59804432|NCT00711971|75925975|FG002|NOT COMPLETED|Overall Study||1||
59804433|NCT00515463|75925989|FG000|STARTED|Overall Study||155||
59804434|NCT00515463|75925990|FG001|STARTED|Overall Study||156||
59804435|NCT00515463|75925989|FG000|Received Study Medication|Overall Study||154||
59804436|NCT00515463|75925990|FG001|Received Study Medication|Overall Study||156||
59804437|NCT00515463|75925989|FG000|COMPLETED|Overall Study||141||
59804438|NCT00515463|75925990|FG001|COMPLETED|Overall Study||142||
59804439|NCT00515463|75925989|FG000|NOT COMPLETED|Overall Study||14||
59804440|NCT00515463|75925990|FG001|NOT COMPLETED|Overall Study||14||
59804441|NCT00507507|75925999|FG000|STARTED|Treatment Period||64||
59804442|NCT00507507|75926000|FG001|STARTED|Treatment Period||62||
59804443|NCT00507507|75925999|FG000|Completed 192 Weeks of Treatment|Treatment Period||52||
59804444|NCT00507507|75926000|FG001|Completed 192 Weeks of Treatment|Treatment Period||52||
59804445|NCT00507507|75925999|FG000|COMPLETED|Treatment Period||12||
59804446|NCT00507507|75926000|FG001|COMPLETED|Treatment Period||9||
59804447|NCT00507507|75925999|FG000|NOT COMPLETED|Treatment Period||52||
59804448|NCT00507507|75926000|FG001|NOT COMPLETED|Treatment Period||53||
59804449|NCT00507507|75925999|FG000|STARTED|24-week Treatment-free Follow-up Period|Participants who discontinued treatment early may have entered the treatment-free follow-up period.|26||
59804450|NCT00507507|75926000|FG001|STARTED|24-week Treatment-free Follow-up Period|Participants who discontinued treatment early may have entered the treatment-free follow-up period.|29||
59804451|NCT00507507|75925999|FG000|COMPLETED|24-week Treatment-free Follow-up Period||16||
59804452|NCT00507507|75926000|FG001|COMPLETED|24-week Treatment-free Follow-up Period||12||
59804453|NCT00507507|75925999|FG000|NOT COMPLETED|24-week Treatment-free Follow-up Period||10||
59804454|NCT00507507|75926000|FG001|NOT COMPLETED|24-week Treatment-free Follow-up Period||17||
59957374|NCT03715764|76076186|FG000|COMPLETED|6 Month Follow-up||27||
59957375|NCT03715764|76076187|FG001|COMPLETED|6 Month Follow-up||28||
59957376|NCT03715764|76076186|FG000|NOT COMPLETED|6 Month Follow-up||3||
59957377|NCT03715764|76076187|FG001|NOT COMPLETED|6 Month Follow-up||0||
59957378|NCT03715764|76076186|FG000|STARTED|12 Month Follow-up||27||
59957379|NCT03715764|76076187|FG001|STARTED|12 Month Follow-up||28||
59957380|NCT03715764|76076186|FG000|COMPLETED|12 Month Follow-up||21||
59957381|NCT03715764|76076187|FG001|COMPLETED|12 Month Follow-up||23||
59957382|NCT03715764|76076186|FG000|NOT COMPLETED|12 Month Follow-up||6||
59957383|NCT03715764|76076187|FG001|NOT COMPLETED|12 Month Follow-up||5||
59957384|NCT02718326|76076196|FG000|STARTED|Overall Study||133||133
59957385|NCT02718326|76076197|FG001|STARTED|Overall Study||135||135
59957386|NCT02718326|76076198|FG002|STARTED|Overall Study||134||134
59957387|NCT02718326|76076196|FG000|Completed Week 52|Overall Study||109||109
59957388|NCT02718326|76076197|FG001|Completed Week 52|Overall Study||122||122
59957389|NCT02718326|76076198|FG002|Completed Week 52|Overall Study||124||124
59957390|NCT02718326|76076196|FG000|COMPLETED|Overall Study||97|Week 100 (End of Study)|97
59957391|NCT02718326|76076197|FG001|COMPLETED|Overall Study||111|Week 100 (End of Study)|111
59957392|NCT02718326|76076198|FG002|COMPLETED|Overall Study||112|Week 100 (End of Study)|112
59957393|NCT02718326|76076196|FG000|NOT COMPLETED|Overall Study||36||36
59957394|NCT02718326|76076197|FG001|NOT COMPLETED|Overall Study||24||24
59957395|NCT02718326|76076198|FG002|NOT COMPLETED|Overall Study||22||22
59957396|NCT03600714|76076208|FG000|STARTED|Overall Study||26||
59957397|NCT03600714|76076208|FG000|COMPLETED|Overall Study||25||
59957398|NCT03600714|76076208|FG000|NOT COMPLETED|Overall Study||1||
59957399|NCT03112902|76076222|FG000|STARTED|Overall Study||2||
59957400|NCT03112902|76076223|FG001|STARTED|Overall Study||2||
59804455|NCT00459706|75926010|FG000|STARTED|Overall Study||325||
59804456|NCT00459706|75926011|FG001|STARTED|Overall Study||315||
59804457|NCT00459706|75926010|FG000|MODIFIED INTENT-TO-TREAT POPULATION|Overall Study|1 participant had no evaluation after the first injection|324||
59804458|NCT00459706|75926011|FG001|MODIFIED INTENT-TO-TREAT POPULATION|Overall Study|2 participants withdrew consent before the first injection|313||
59804459|NCT00459706|75926010|FG000|COMPLETED|Overall Study||299||
59804460|NCT00459706|75926011|FG001|COMPLETED|Overall Study||294||
59804461|NCT00459706|75926010|FG000|NOT COMPLETED|Overall Study||26||
59804462|NCT00459706|75926011|FG001|NOT COMPLETED|Overall Study||21||
59804463|NCT00507429|75926019|FG000|STARTED|Treatment Phase|Randomized|55||
59957401|NCT03112902|76076224|FG002|STARTED|Overall Study||3||
59957402|NCT03112902|76076225|FG003|STARTED|Overall Study||1||
59957403|NCT03112902|76076226|FG004|STARTED|Overall Study||1||
59957404|NCT03112902|76076227|FG005|STARTED|Overall Study||3||
59957405|NCT03112902|76076228|FG006|STARTED|Overall Study||9||
59804464|NCT00507429|75926020|FG001|STARTED|Treatment Phase|Randomized|25||
59957406|NCT03112902|76076229|FG007|STARTED|Overall Study||3||
59957407|NCT03112902|76076230|FG008|STARTED|Overall Study||0||
59957408|NCT03112902|76076231|FG009|STARTED|Overall Study||0||
59804465|NCT00507429|75926019|FG000|COMPLETED|Treatment Phase||18||
59804466|NCT00507429|75926020|FG001|COMPLETED|Treatment Phase||7||
59804467|NCT00507429|75926019|FG000|NOT COMPLETED|Treatment Phase||37||
59804468|NCT00507429|75926020|FG001|NOT COMPLETED|Treatment Phase||18||
59804469|NCT00507429|75926019|FG000|STARTED|Maintenance Phase|2 subjects did not enter maintenance: 1/18 progressive disease; 1/18 lost to follow-up.|16||
59804470|NCT00507429|75926020|FG001|STARTED|Maintenance Phase|Control arm subjects followed for survival only; not enrolled in Maintenance period|0||
59804471|NCT00507429|75926019|FG000|COMPLETED|Maintenance Phase|14 subjects were withdrawn due to progressive disease, 2 subjects continued beyond data cut-off|2||
59804472|NCT00507429|75926020|FG001|COMPLETED|Maintenance Phase||0||
59957409|NCT03112902|76076222|FG000|COMPLETED|Overall Study||0||
59957410|NCT03112902|76076223|FG001|COMPLETED|Overall Study||2||
59957411|NCT03112902|76076224|FG002|COMPLETED|Overall Study||2||
59957412|NCT03112902|76076225|FG003|COMPLETED|Overall Study||0||
59957413|NCT03112902|76076226|FG004|COMPLETED|Overall Study||1||
59957414|NCT03112902|76076227|FG005|COMPLETED|Overall Study||0||
59804473|NCT00507429|75926019|FG000|NOT COMPLETED|Maintenance Phase||14||
59804474|NCT00507429|75926020|FG001|NOT COMPLETED|Maintenance Phase||0||
59804475|NCT00449176|75926031|FG000|STARTED|Overall Study|3 randomly assigned to this treatment group did not take drug (of 321 subjects initially randomized)|318||
59804476|NCT00449176|75926032|FG001|STARTED|Overall Study|6 randomly assigned to this treatment group did not take drug (of 334 subjects initially randomized)|328||
59804477|NCT00449176|75926033|FG002|STARTED|Overall Study|5 randomly assigned to this group did not receive drug, 2 enrolled twice(of 326 subjects randomized)|319||
59804478|NCT00449176|75926031|FG000|COMPLETED|Overall Study||166||
59804479|NCT00449176|75926032|FG001|COMPLETED|Overall Study||133||
59804480|NCT00449176|75926033|FG002|COMPLETED|Overall Study||152||
59804481|NCT00449176|75926031|FG000|NOT COMPLETED|Overall Study||152||
59804482|NCT00449176|75926032|FG001|NOT COMPLETED|Overall Study||195||
59804483|NCT00449176|75926033|FG002|NOT COMPLETED|Overall Study||167||
59804484|NCT00515073|75926041|FG000|STARTED|Overall Study||30||
59957415|NCT03112902|76076228|FG006|COMPLETED|Overall Study||1||
59957416|NCT03112902|76076229|FG007|COMPLETED|Overall Study||1||
59957417|NCT03112902|76076230|FG008|COMPLETED|Overall Study||0||
59957418|NCT03112902|76076231|FG009|COMPLETED|Overall Study||0||
59957419|NCT03112902|76076222|FG000|NOT COMPLETED|Overall Study||2||
59957420|NCT03112902|76076223|FG001|NOT COMPLETED|Overall Study||0||
59957421|NCT03112902|76076224|FG002|NOT COMPLETED|Overall Study||1||
59957422|NCT03112902|76076225|FG003|NOT COMPLETED|Overall Study||1||
59957423|NCT03112902|76076226|FG004|NOT COMPLETED|Overall Study||0||
59804485|NCT00515073|75926041|FG000|COMPLETED|Overall Study||28||
59804486|NCT00515073|75926041|FG000|NOT COMPLETED|Overall Study||2||
59804487|NCT00710021|75926048|FG000|STARTED|Overall Study||19||
59804488|NCT00710021|75926049|FG001|STARTED|Overall Study||19||
59804489|NCT00710021|75926050|FG002|STARTED|Overall Study||19||
59804490|NCT00710021|75926048|FG000|Modified Intent-to-Treat (mITT)|Overall Study||19||
59804491|NCT00710021|75926049|FG001|Modified Intent-to-Treat (mITT)|Overall Study|2 subjects who did not take study drug were excluded from mITT|17||
59804492|NCT00710021|75926050|FG002|Modified Intent-to-Treat (mITT)|Overall Study|1 subject who did not take study drug was excluded from mITT|18||
59804493|NCT00710021|75926048|FG000|COMPLETED|Overall Study||18||
59804494|NCT00710021|75926049|FG001|COMPLETED|Overall Study||16||
59804495|NCT00710021|75926050|FG002|COMPLETED|Overall Study||18||
59804496|NCT00710021|75926048|FG000|NOT COMPLETED|Overall Study||1||
59804497|NCT00710021|75926049|FG001|NOT COMPLETED|Overall Study||3||
59804498|NCT00710021|75926050|FG002|NOT COMPLETED|Overall Study||1||
59804499|NCT00504153|75926059|FG000|STARTED|Overall Study||19||
59804500|NCT00504153|75926059|FG000|COMPLETED|Overall Study||13||
59804501|NCT00504153|75926059|FG000|NOT COMPLETED|Overall Study||6||
59804502|NCT00442702|75926065|FG000|STARTED|Titration Period||114||
59804503|NCT00442702|75926066|FG001|STARTED|Titration Period||114||
59804504|NCT00442702|75926065|FG000|Safety Population|Titration Period|One patient was randomized to darbepoetin alfa but treated by mistake with Mircera|115||
59804505|NCT00442702|75926066|FG001|Safety Population|Titration Period||113||
59804506|NCT00442702|75926065|FG000|COMPLETED|Titration Period||102||
59804507|NCT00442702|75926066|FG001|COMPLETED|Titration Period||111||
59804508|NCT00442702|75926065|FG000|NOT COMPLETED|Titration Period||12||
59804509|NCT00442702|75926066|FG001|NOT COMPLETED|Titration Period||3||
59804510|NCT00442702|75926065|FG000|STARTED|Evaluation Period||102||
59804511|NCT00442702|75926066|FG001|STARTED|Evaluation Period||111||
59957424|NCT03112902|76076227|FG005|NOT COMPLETED|Overall Study||3||
59957425|NCT03112902|76076228|FG006|NOT COMPLETED|Overall Study||8||
59957426|NCT03112902|76076229|FG007|NOT COMPLETED|Overall Study||2||
59957427|NCT03112902|76076230|FG008|NOT COMPLETED|Overall Study||0||
59957428|NCT03112902|76076231|FG009|NOT COMPLETED|Overall Study||0||
59957429|NCT02720042|76076247|FG000|STARTED|Overall Study||84||
59957430|NCT02720042|76076247|FG000|COMPLETED|Overall Study||69||
59957431|NCT02720042|76076247|FG000|NOT COMPLETED|Overall Study||15||
59957432|NCT01352793|76076253|FG000|STARTED|Overall Study||3804||
59957433|NCT01352793|76076254|FG001|STARTED|Overall Study||1908||
59957434|NCT01352793|76076253|FG000|Vaccination 1|Overall Study||3796||
59957435|NCT01352793|76076254|FG001|Vaccination 1|Overall Study||1908||
59957436|NCT01352793|76076253|FG000|Vaccination 2|Overall Study||3530||
59957437|NCT01352793|76076254|FG001|Vaccination 2|Overall Study||1806||
60073907|NCT01931059|76189256|FG000|STARTED|Day 1||6||
59957438|NCT01352793|76076253|FG000|Vaccination 3|Overall Study||3314||
59957439|NCT01352793|76076254|FG001|Vaccination 3|Overall Study||1710||
59957440|NCT01352793|76076253|FG000|COMPLETED|Overall Study||3219||
59804512|NCT00442702|75926065|FG000|COMPLETED|Evaluation Period||97||
59804513|NCT00442702|75926066|FG001|COMPLETED|Evaluation Period||107||
59804514|NCT00442702|75926065|FG000|NOT COMPLETED|Evaluation Period||5||
59804515|NCT00442702|75926066|FG001|NOT COMPLETED|Evaluation Period||4||
59804516|NCT00514917|75926074|FG000|STARTED|Overall Study||207||
59804517|NCT00514917|75926075|FG001|STARTED|Overall Study||206||
59804518|NCT00514917|75926074|FG000|Treated|Overall Study||196||
59804519|NCT00514917|75926075|FG001|Treated|Overall Study||204||
59804520|NCT00514917|75926074|FG000|Completed Study Treatment|Overall Study||170||
59804521|NCT00514917|75926075|FG001|Completed Study Treatment|Overall Study||182||
59804522|NCT00514917|75926074|FG000|Testosterone-Specific Evaluable|Overall Study||122||
59957441|NCT01352793|76076254|FG001|COMPLETED|Overall Study||1663||
59957442|NCT01352793|76076253|FG000|NOT COMPLETED|Overall Study||585||
59957443|NCT01352793|76076254|FG001|NOT COMPLETED|Overall Study||245||
59804523|NCT00514917|75926075|FG001|Testosterone-Specific Evaluable|Overall Study||124||
59804524|NCT00514917|75926074|FG000|COMPLETED|Overall Study||81||
59804525|NCT00514917|75926075|FG001|COMPLETED|Overall Study||91||
59804526|NCT00514917|75926074|FG000|NOT COMPLETED|Overall Study||126||
59804527|NCT00514917|75926075|FG001|NOT COMPLETED|Overall Study||115||
59804528|NCT00711425|75926083|FG000|STARTED|Overall Study|Implant placement in 45 patients. Implant loading (baseline) in 44 patients.|45||
59804529|NCT00711425|75926083|FG000|COMPLETED|Overall Study||41||
59804530|NCT00711425|75926083|FG000|NOT COMPLETED|Overall Study||4||
59804531|NCT00504075|75926087|FG000|STARTED|Overall Study||35||
59804532|NCT00504075|75926087|FG000|COMPLETED|Overall Study||27||
59804533|NCT00504075|75926087|FG000|NOT COMPLETED|Overall Study||8||
59804534|NCT00503997|75926092|FG000|STARTED|Overall Study||42||
59804535|NCT00503997|75926092|FG000|COMPLETED|Overall Study||34||
59804536|NCT00503997|75926092|FG000|NOT COMPLETED|Overall Study||8||
59804537|NCT00096265|75926099|FG000|STARTED|Overall Study||45||
59804538|NCT00096265|75926100|FG001|STARTED|Overall Study||40||
59804539|NCT00096265|75926101|FG002|STARTED|Overall Study||41||
59804540|NCT00096265|75926099|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|44||
59804541|NCT00096265|75926100|FG001|COMPLETED|Overall Study||40||
59804542|NCT00096265|75926101|FG002|COMPLETED|Overall Study||41||
59804543|NCT00096265|75926099|FG000|NOT COMPLETED|Overall Study||1||
59804544|NCT00096265|75926100|FG001|NOT COMPLETED|Overall Study||0||
59804545|NCT00096265|75926101|FG002|NOT COMPLETED|Overall Study||0||
59804546|NCT00711191|75926113|FG000|STARTED|Overall Study||3||
59804547|NCT00711191|75926114|FG001|STARTED|Overall Study||6||
59804548|NCT00711191|75926115|FG002|STARTED|Overall Study||13||
59957444|NCT02717546|76076260|FG000|STARTED|Overall Study||32||
59957445|NCT02717546|76076260|FG000|COMPLETED|Overall Study||20||
59957446|NCT02717546|76076260|FG000|NOT COMPLETED|Overall Study||12||
59957447|NCT01378962|76076264|FG000|STARTED|Overall Study||50||
59957448|NCT01378962|76076264|FG000|COMPLETED|Overall Study||33||
59957449|NCT01378962|76076264|FG000|NOT COMPLETED|Overall Study||17||
59957450|NCT00890409|76076270|FG000|STARTED|Overall Study||116||
59957451|NCT00890409|76076271|FG001|STARTED|Overall Study||140||
59957452|NCT00890409|76076270|FG000|COMPLETED|Overall Study||96||
59957453|NCT00890409|76076271|FG001|COMPLETED|Overall Study||119||
59957454|NCT00890409|76076270|FG000|NOT COMPLETED|Overall Study||20||
59957455|NCT00890409|76076271|FG001|NOT COMPLETED|Overall Study||21||
59957456|NCT04495478|76076282|FG000|STARTED|Overall Study||3||
59957457|NCT04495478|76076283|FG001|STARTED|Overall Study||7||
59620704|NCT00103194|75732084|FG000|NOT COMPLETED|Overall Study||31||
59620705|NCT00277446|75732088|FG000|STARTED|Overall Study||13||
59620706|NCT00277446|75732088|FG000|COMPLETED|Overall Study||13||
59620707|NCT00277446|75732088|FG000|NOT COMPLETED|Overall Study||0||
59620708|NCT00277524|75732092|FG000|STARTED|Overall Study||621||
59620709|NCT00277524|75732093|FG001|STARTED|Overall Study||324||
59620710|NCT00277524|75732094|FG002|STARTED|Overall Study||1088||
59804549|NCT00711191|75926113|FG000|COMPLETED|Overall Study||0||
59804550|NCT00711191|75926114|FG001|COMPLETED|Overall Study||1||
59620711|NCT00277524|75732095|FG003|STARTED|Overall Study||850||
59804551|NCT00711191|75926115|FG002|COMPLETED|Overall Study||1||
59804552|NCT00711191|75926113|FG000|NOT COMPLETED|Overall Study||3||
59804553|NCT00711191|75926114|FG001|NOT COMPLETED|Overall Study||5||
59804554|NCT00711191|75926115|FG002|NOT COMPLETED|Overall Study||12||
59804555|NCT00706511|75926130|FG000|STARTED|Overall Study||10||
59804556|NCT00706511|75926131|FG001|STARTED|Overall Study||4||
59804557|NCT00706511|75926132|FG002|STARTED|Overall Study||3||
59957458|NCT04495478|76076284|FG002|STARTED|Overall Study||12||
59957459|NCT04495478|76076285|FG003|STARTED|Overall Study||7||
59957460|NCT04495478|76076286|FG004|STARTED|Overall Study||7||
59957461|NCT04495478|76076287|FG005|STARTED|Overall Study||7||
59957462|NCT04495478|76076288|FG006|STARTED|Overall Study||7||
59804558|NCT00706511|75926133|FG003|STARTED|Overall Study||10||
59804559|NCT00706511|75926130|FG000|COMPLETED|Overall Study||9||
59995271|NCT04263987|76111096|FG001|COMPLETED|Overall Study||30||
59804560|NCT00706511|75926131|FG001|COMPLETED|Overall Study||4||
59804561|NCT00706511|75926132|FG002|COMPLETED|Overall Study||3||
59804562|NCT00706511|75926133|FG003|COMPLETED|Overall Study||10||
59804563|NCT00706511|75926130|FG000|NOT COMPLETED|Overall Study||1||
59804564|NCT00706511|75926131|FG001|NOT COMPLETED|Overall Study||0||
59804565|NCT00706511|75926132|FG002|NOT COMPLETED|Overall Study||0||
59804566|NCT00706511|75926133|FG003|NOT COMPLETED|Overall Study||0||
59804567|NCT00448864|75926144|FG000|STARTED|Overall Study||27||
59804568|NCT00448864|75926145|FG001|STARTED|Overall Study||29||
59804569|NCT00448864|75926146|FG002|STARTED|Overall Study||19||
59804570|NCT00448864|75926144|FG000|Received at Least 1 Dose of Study Drug|Overall Study||26||
59804571|NCT00448864|75926145|FG001|Received at Least 1 Dose of Study Drug|Overall Study||25||
59804572|NCT00448864|75926146|FG002|Received at Least 1 Dose of Study Drug|Overall Study||18||
59804573|NCT00448864|75926144|FG000|Started Post-operative Period|Overall Study||26||
59804574|NCT00448864|75926145|FG001|Started Post-operative Period|Overall Study||25||
59804575|NCT00448864|75926146|FG002|Started Post-operative Period|Overall Study||18||
59804576|NCT00448864|75926144|FG000|Completed Post-operative Period|Overall Study||26||
59804577|NCT00448864|75926145|FG001|Completed Post-operative Period|Overall Study||25||
59804578|NCT00448864|75926146|FG002|Completed Post-operative Period|Overall Study||18||
59804579|NCT00448864|75926144|FG000|COMPLETED|Overall Study||22||
59804580|NCT00448864|75926145|FG001|COMPLETED|Overall Study||24||
59804581|NCT00448864|75926146|FG002|COMPLETED|Overall Study||18||
59804582|NCT00448864|75926144|FG000|NOT COMPLETED|Overall Study||5||
59804583|NCT00448864|75926145|FG001|NOT COMPLETED|Overall Study||5||
59804584|NCT00448864|75926146|FG002|NOT COMPLETED|Overall Study||1||
59804585|NCT00567398|75926158|FG000|STARTED|Overall Study||127||
59804586|NCT00567398|75926159|FG001|STARTED|Overall Study||124||
59804587|NCT00567398|75926158|FG000|COMPLETED|Overall Study||120||
59804588|NCT00567398|75926159|FG001|COMPLETED|Overall Study||101||
59804589|NCT00567398|75926158|FG000|NOT COMPLETED|Overall Study||7||
59957463|NCT04495478|76076282|FG000|Received at Least One Dose of Study Drug|Overall Study||3||
59957464|NCT04495478|76076283|FG001|Received at Least One Dose of Study Drug|Overall Study||7||
59957465|NCT04495478|76076284|FG002|Received at Least One Dose of Study Drug|Overall Study||12||
59957466|NCT04495478|76076285|FG003|Received at Least One Dose of Study Drug|Overall Study||7||
59957467|NCT04495478|76076286|FG004|Received at Least One Dose of Study Drug|Overall Study||7||
59957468|NCT04495478|76076287|FG005|Received at Least One Dose of Study Drug|Overall Study||7||
59804590|NCT00567398|75926159|FG001|NOT COMPLETED|Overall Study||23||
59804591|NCT00448708|75926167|FG000|STARTED|Overall Study||112||
59804592|NCT00448708|75926168|FG001|STARTED|Overall Study||110||
59804593|NCT00448708|75926167|FG000|COMPLETED|Overall Study||77||
59804594|NCT00448708|75926168|FG001|COMPLETED|Overall Study||79||
59804595|NCT00448708|75926167|FG000|NOT COMPLETED|Overall Study||35||
59804596|NCT00448708|75926168|FG001|NOT COMPLETED|Overall Study||31||
59804597|NCT00706355|75926178|FG000|STARTED|Period 1: PF-04217903 50 mg||3||
59957469|NCT04495478|76076288|FG006|Received at Least One Dose of Study Drug|Overall Study||7||
59957470|NCT04495478|76076282|FG000|COMPLETED|Overall Study||3||
59957471|NCT04495478|76076283|FG001|COMPLETED|Overall Study||6||
59957472|NCT04495478|76076284|FG002|COMPLETED|Overall Study||12||
59957473|NCT04495478|76076285|FG003|COMPLETED|Overall Study||6||
59957474|NCT04495478|76076286|FG004|COMPLETED|Overall Study||6||
59957475|NCT04495478|76076287|FG005|COMPLETED|Overall Study||7||
59957476|NCT04495478|76076288|FG006|COMPLETED|Overall Study||7||
59957477|NCT04495478|76076282|FG000|NOT COMPLETED|Overall Study||0||
59957478|NCT04495478|76076283|FG001|NOT COMPLETED|Overall Study||1||
59957479|NCT04495478|76076284|FG002|NOT COMPLETED|Overall Study||0||
59957480|NCT04495478|76076285|FG003|NOT COMPLETED|Overall Study||1||
59620712|NCT00277524|75732092|FG000|COMPLETED|Overall Study||621||
59620713|NCT00277524|75732093|FG001|COMPLETED|Overall Study||324||
59620714|NCT00277524|75732094|FG002|COMPLETED|Overall Study||1088||
59804598|NCT00706355|75926179|FG001|STARTED|Period 1: PF-04217903 50 mg||0||
59804599|NCT00706355|75926180|FG002|STARTED|Period 1: PF-04217903 50 mg||0||
59804600|NCT00706355|75926181|FG003|STARTED|Period 1: PF-04217903 50 mg||0||
59804601|NCT00706355|75926178|FG000|COMPLETED|Period 1: PF-04217903 50 mg||0||
59804602|NCT00706355|75926179|FG001|COMPLETED|Period 1: PF-04217903 50 mg||0||
59804603|NCT00706355|75926180|FG002|COMPLETED|Period 1: PF-04217903 50 mg||0||
59804604|NCT00706355|75926181|FG003|COMPLETED|Period 1: PF-04217903 50 mg||0||
59957481|NCT04495478|76076286|FG004|NOT COMPLETED|Overall Study||1||
59957482|NCT04495478|76076287|FG005|NOT COMPLETED|Overall Study||0||
59957483|NCT04495478|76076288|FG006|NOT COMPLETED|Overall Study||0||
59957484|NCT00152763|76076314|FG000|STARTED|Overall Study||77||
59957485|NCT00152763|76076315|FG001|STARTED|Overall Study||19||
59957486|NCT00152763|76076316|FG002|STARTED|Overall Study||20||
59957487|NCT00152763|76076317|FG003|STARTED|Overall Study||77||
59957488|NCT00152763|76076314|FG000|COMPLETED|Overall Study||67||
59957489|NCT00152763|76076315|FG001|COMPLETED|Overall Study||14||
59957490|NCT00152763|76076316|FG002|COMPLETED|Overall Study||16||
59957491|NCT00152763|76076317|FG003|COMPLETED|Overall Study||63||
59957492|NCT00152763|76076314|FG000|NOT COMPLETED|Overall Study||10||
59620715|NCT00277524|75732095|FG003|COMPLETED|Overall Study||850||
59957493|NCT00152763|76076315|FG001|NOT COMPLETED|Overall Study||5||
59620716|NCT00277524|75732092|FG000|NOT COMPLETED|Overall Study||0||
59620717|NCT00277524|75732093|FG001|NOT COMPLETED|Overall Study||0||
59804605|NCT00706355|75926178|FG000|NOT COMPLETED|Period 1: PF-04217903 50 mg||3||
59804606|NCT00706355|75926179|FG001|NOT COMPLETED|Period 1: PF-04217903 50 mg||0||
59804607|NCT00706355|75926180|FG002|NOT COMPLETED|Period 1: PF-04217903 50 mg||0||
59804608|NCT00706355|75926181|FG003|NOT COMPLETED|Period 1: PF-04217903 50 mg||0||
59804609|NCT00706355|75926178|FG000|STARTED|Period 2: PF-04217903 100 mg||0||
59804610|NCT00706355|75926179|FG001|STARTED|Period 2: PF-04217903 100 mg||7||
59804611|NCT00706355|75926180|FG002|STARTED|Period 2: PF-04217903 100 mg||0||
59804612|NCT00706355|75926181|FG003|STARTED|Period 2: PF-04217903 100 mg||0||
59804613|NCT00706355|75926178|FG000|COMPLETED|Period 2: PF-04217903 100 mg||0||
59804614|NCT00706355|75926179|FG001|COMPLETED|Period 2: PF-04217903 100 mg||0||
59957494|NCT00152763|76076316|FG002|NOT COMPLETED|Overall Study||4||
59957495|NCT00152763|76076317|FG003|NOT COMPLETED|Overall Study||14||
59957496|NCT03181542|76076331|FG000|STARTED|Overall Study||80||
59957497|NCT03181542|76076332|FG001|STARTED|Overall Study||80||
59957498|NCT03181542|76076331|FG000|COMPLETED|Overall Study||79||
59957499|NCT03181542|76076332|FG001|COMPLETED|Overall Study||80||
59957500|NCT03181542|76076331|FG000|NOT COMPLETED|Overall Study||1||
59957501|NCT03181542|76076332|FG001|NOT COMPLETED|Overall Study||0||
59957502|NCT00806403|76076340|FG000|STARTED|Overall Study||104||
59957503|NCT00806403|76076341|FG001|STARTED|Overall Study||101||
59957504|NCT00806403|76076340|FG000|COMPLETED|Overall Study||100||
59957505|NCT00806403|76076341|FG001|COMPLETED|Overall Study||98||
59957506|NCT00806403|76076340|FG000|NOT COMPLETED|Overall Study||4||
59957507|NCT00806403|76076341|FG001|NOT COMPLETED|Overall Study||3||
59957508|NCT00803517|76076347|FG000|STARTED|Overall Study||12||
59957509|NCT00803517|76076348|FG001|STARTED|Overall Study||12||
59957510|NCT00803517|76076347|FG000|COMPLETED|Overall Study||12||
59957511|NCT00803517|76076348|FG001|COMPLETED|Overall Study||12||
59957512|NCT00803517|76076347|FG000|NOT COMPLETED|Overall Study||0||
59957513|NCT00803517|76076348|FG001|NOT COMPLETED|Overall Study||0||
59957514|NCT01912950|76076352|FG000|STARTED|Overall Study||11||22
59957515|NCT01912950|76076352|FG000|Treated Areas on the Forearm|Overall Study||11||11
59957516|NCT01912950|76076352|FG000|Untreated Areas on the Forearm|Overall Study||11||11
59957517|NCT01912950|76076352|FG000|COMPLETED|Overall Study||7||14
59957518|NCT01912950|76076352|FG000|NOT COMPLETED|Overall Study||4||8
59957519|NCT00701558|76076358|FG000|STARTED|Overall Study||19||
59957520|NCT00701558|76076358|FG000|COMPLETED|Overall Study||4||
59957521|NCT00701558|76076358|FG000|NOT COMPLETED|Overall Study||15||
59957522|NCT03882177|76076366|FG000|STARTED|Overall Study||10||
59957523|NCT03882177|76076367|FG001|STARTED|Overall Study||6||
59957524|NCT03882177|76076368|FG002|STARTED|Overall Study||0||
59957525|NCT03882177|76076369|FG003|STARTED|Overall Study||0||
59957526|NCT03882177|76076366|FG000|COMPLETED|Overall Study||10||
59957527|NCT03882177|76076367|FG001|COMPLETED|Overall Study||6||
59620718|NCT00277524|75732094|FG002|NOT COMPLETED|Overall Study||0||
59620719|NCT00277524|75732095|FG003|NOT COMPLETED|Overall Study||0||
59620720|NCT00278538|75732113|FG000|STARTED|Overall Study||32||
59620721|NCT00278538|75732113|FG000|COMPLETED|Overall Study||30||
59620722|NCT00278538|75732113|FG000|NOT COMPLETED|Overall Study||2||
59620723|NCT00208026|75732117|FG000|STARTED|Overall Study||3||
59620724|NCT00208026|75732117|FG000|COMPLETED|Overall Study||3||
59620725|NCT00208026|75732117|FG000|NOT COMPLETED|Overall Study||0||
59620726|NCT00208494|75732125|FG000|STARTED|Overall Study||194||
59620727|NCT00208494|75732126|FG001|STARTED|Overall Study||196||
59620728|NCT00208494|75732125|FG000|COMPLETED|Overall Study||164||
59620729|NCT00208494|75732126|FG001|COMPLETED|Overall Study||162||
59620730|NCT00208494|75732125|FG000|NOT COMPLETED|Overall Study||30||
59620731|NCT00208494|75732126|FG001|NOT COMPLETED|Overall Study||34||
59957528|NCT03882177|76076368|FG002|COMPLETED|Overall Study||0||
59620732|NCT00106392|75732134|FG000|STARTED|Overall Study||62||
59620733|NCT00106392|75732135|FG001|STARTED|Overall Study||69||
59620734|NCT00106392|75732134|FG000|Baseline Participants|Overall Study|3 patients withdrew: 2 prior to surgery and study drug; 1 took study drug but did not have surgery|59||
59620735|NCT00106392|75732135|FG001|Baseline Participants|Overall Study|4 patients withdrew: all prior to surgery and study drug|65||
59620736|NCT00106392|75732134|FG000|Full Analysis Set (FAS)|Overall Study||53||
59620737|NCT00106392|75732135|FG001|Full Analysis Set (FAS)|Overall Study||61||
59620738|NCT00106392|75732134|FG000|COMPLETED|Overall Study||36||
59620739|NCT00106392|75732135|FG001|COMPLETED|Overall Study||42||
59620740|NCT00106392|75732134|FG000|NOT COMPLETED|Overall Study||26||
59804615|NCT00706355|75926180|FG002|COMPLETED|Period 2: PF-04217903 100 mg||0||
59957529|NCT03882177|76076369|FG003|COMPLETED|Overall Study||0||
59957530|NCT03882177|76076366|FG000|NOT COMPLETED|Overall Study||0||
59957531|NCT03882177|76076367|FG001|NOT COMPLETED|Overall Study||0||
59957532|NCT03882177|76076368|FG002|NOT COMPLETED|Overall Study||0||
59957533|NCT03882177|76076369|FG003|NOT COMPLETED|Overall Study||0||
59957534|NCT01663402|76076381|FG000|STARTED|Overall Study||9462||
60073908|NCT01931059|76189257|FG001|STARTED|Day 1||5||
59957535|NCT01663402|76076382|FG001|STARTED|Overall Study||9462||
59957536|NCT01663402|76076381|FG000|Treated|Overall Study||9443||
59957537|NCT01663402|76076382|FG001|Treated|Overall Study||9451||
60073909|NCT01931059|76189256|FG000|COMPLETED|Day 1||6||
59804616|NCT00706355|75926181|FG003|COMPLETED|Period 2: PF-04217903 100 mg||0||
59804617|NCT00706355|75926178|FG000|NOT COMPLETED|Period 2: PF-04217903 100 mg||0||
59804618|NCT00706355|75926179|FG001|NOT COMPLETED|Period 2: PF-04217903 100 mg||7||
59804619|NCT00706355|75926180|FG002|NOT COMPLETED|Period 2: PF-04217903 100 mg||0||
59804620|NCT00706355|75926181|FG003|NOT COMPLETED|Period 2: PF-04217903 100 mg||0||
59957538|NCT01663402|76076381|FG000|COMPLETED|Overall Study||7947||
59957539|NCT01663402|76076382|FG001|COMPLETED|Overall Study||7378||
59957540|NCT01663402|76076381|FG000|NOT COMPLETED|Overall Study||1515||
59957541|NCT01663402|76076382|FG001|NOT COMPLETED|Overall Study||2084||
59957542|NCT03223298|76076390|FG000|STARTED|Overall Study||38||
59957543|NCT03223298|76076391|FG001|STARTED|Overall Study||37||
59957544|NCT03223298|76076390|FG000|Pre-op|Overall Study||38||
59957545|NCT03223298|76076391|FG001|Pre-op|Overall Study||37||
59957546|NCT03223298|76076390|FG000|Month 1 Post-op|Overall Study||34||
59957547|NCT03223298|76076391|FG001|Month 1 Post-op|Overall Study||32||
59957548|NCT03223298|76076390|FG000|Month 2 Post-op|Overall Study||22||
59957549|NCT03223298|76076391|FG001|Month 2 Post-op|Overall Study||28||
59957550|NCT03223298|76076390|FG000|Month 3 Post-op|Overall Study||23||
59957551|NCT03223298|76076391|FG001|Month 3 Post-op|Overall Study||27||
59957552|NCT03223298|76076390|FG000|COMPLETED|Overall Study||23||
59957553|NCT03223298|76076391|FG001|COMPLETED|Overall Study||27||
59957554|NCT03223298|76076390|FG000|NOT COMPLETED|Overall Study||15||
59957555|NCT03223298|76076391|FG001|NOT COMPLETED|Overall Study||10||
59957556|NCT00859521|76076399|FG000|STARTED|First Intervention||15||
59957557|NCT00859521|76076400|FG001|STARTED|First Intervention||15||
59957558|NCT00859521|76076399|FG000|COMPLETED|First Intervention||15||
59957559|NCT00859521|76076400|FG001|COMPLETED|First Intervention||15||
59957560|NCT00859521|76076399|FG000|NOT COMPLETED|First Intervention||0||
59957561|NCT00859521|76076400|FG001|NOT COMPLETED|First Intervention||0||
59957562|NCT00859521|76076399|FG000|STARTED|Washout||15||
59957563|NCT00859521|76076400|FG001|STARTED|Washout||15||
59957564|NCT00859521|76076399|FG000|COMPLETED|Washout||15||
59957565|NCT00859521|76076400|FG001|COMPLETED|Washout||14||
59957566|NCT00859521|76076399|FG000|NOT COMPLETED|Washout||0||
59957567|NCT00859521|76076400|FG001|NOT COMPLETED|Washout||1||
59804621|NCT00706355|75926178|FG000|STARTED|Period 3: PF-04217903 200 mg||0||
59804622|NCT00706355|75926179|FG001|STARTED|Period 3: PF-04217903 200 mg||0||
59804623|NCT00706355|75926180|FG002|STARTED|Period 3: PF-04217903 200 mg||2||
59957568|NCT00859521|76076399|FG000|STARTED|Second Intervention||15||
59957569|NCT00859521|76076400|FG001|STARTED|Second Intervention||14||
59957570|NCT00859521|76076399|FG000|COMPLETED|Second Intervention||15||
59957571|NCT00859521|76076400|FG001|COMPLETED|Second Intervention||14||
59957572|NCT00859521|76076399|FG000|NOT COMPLETED|Second Intervention||0||
59957573|NCT00859521|76076400|FG001|NOT COMPLETED|Second Intervention||0||
59804624|NCT00706355|75926181|FG003|STARTED|Period 3: PF-04217903 200 mg||0||
59804625|NCT00706355|75926178|FG000|COMPLETED|Period 3: PF-04217903 200 mg||0||
59804626|NCT00706355|75926179|FG001|COMPLETED|Period 3: PF-04217903 200 mg||0||
59804627|NCT00706355|75926180|FG002|COMPLETED|Period 3: PF-04217903 200 mg||0||
59804628|NCT00706355|75926181|FG003|COMPLETED|Period 3: PF-04217903 200 mg||0||
59957574|NCT04649775|76076406|FG000|STARTED|Overall Study||5||
59957575|NCT04649775|76076407|FG001|STARTED|Overall Study||6||
59804629|NCT00706355|75926178|FG000|NOT COMPLETED|Period 3: PF-04217903 200 mg||0||
59804630|NCT00706355|75926179|FG001|NOT COMPLETED|Period 3: PF-04217903 200 mg||0||
59804631|NCT00706355|75926180|FG002|NOT COMPLETED|Period 3: PF-04217903 200 mg||2||
59804632|NCT00706355|75926181|FG003|NOT COMPLETED|Period 3: PF-04217903 200 mg||0||
59804633|NCT00706355|75926178|FG000|STARTED|Period 4: PF-04217903 150 mg||0||
59804634|NCT00706355|75926179|FG001|STARTED|Period 4: PF-04217903 150 mg||0||
59804635|NCT00706355|75926180|FG002|STARTED|Period 4: PF-04217903 150 mg||0||
59804636|NCT00706355|75926181|FG003|STARTED|Period 4: PF-04217903 150 mg||4||
59804637|NCT00706355|75926178|FG000|COMPLETED|Period 4: PF-04217903 150 mg||0||
59804638|NCT00706355|75926179|FG001|COMPLETED|Period 4: PF-04217903 150 mg||0||
59804639|NCT00706355|75926180|FG002|COMPLETED|Period 4: PF-04217903 150 mg||0||
59957576|NCT04649775|76076406|FG000|COMPLETED|Overall Study||5||
59957577|NCT04649775|76076407|FG001|COMPLETED|Overall Study||6||
59957578|NCT04649775|76076406|FG000|NOT COMPLETED|Overall Study||0||
59957579|NCT04649775|76076407|FG001|NOT COMPLETED|Overall Study||0||
59957580|NCT00841815|76076415|FG000|STARTED|Period 1||14||
59957581|NCT00841815|76076416|FG001|STARTED|Period 1||14||
59957582|NCT00841815|76076415|FG000|COMPLETED|Period 1||14||
59957583|NCT00841815|76076416|FG001|COMPLETED|Period 1||14||
59957584|NCT00841815|76076415|FG000|NOT COMPLETED|Period 1||0||
59957585|NCT00841815|76076416|FG001|NOT COMPLETED|Period 1||0||
59957586|NCT00841815|76076415|FG000|STARTED|Washout||14||
59957587|NCT00841815|76076416|FG001|STARTED|Washout||14||
59957588|NCT00841815|76076415|FG000|COMPLETED|Washout||14||
59957589|NCT00841815|76076416|FG001|COMPLETED|Washout||13||
59957590|NCT00841815|76076415|FG000|NOT COMPLETED|Washout||0||
59957591|NCT00841815|76076416|FG001|NOT COMPLETED|Washout||1||
59957592|NCT00841815|76076415|FG000|STARTED|Period 2||14||
59957593|NCT00841815|76076416|FG001|STARTED|Period 2||13||
59957594|NCT00841815|76076415|FG000|COMPLETED|Period 2||14||
59957595|NCT00841815|76076416|FG001|COMPLETED|Period 2||13||
59804640|NCT00706355|75926181|FG003|COMPLETED|Period 4: PF-04217903 150 mg||0||
59804641|NCT00706355|75926178|FG000|NOT COMPLETED|Period 4: PF-04217903 150 mg||0||
59804642|NCT00706355|75926179|FG001|NOT COMPLETED|Period 4: PF-04217903 150 mg||0||
59957596|NCT00841815|76076415|FG000|NOT COMPLETED|Period 2||0||
59957597|NCT00841815|76076416|FG001|NOT COMPLETED|Period 2||0||
59957598|NCT00841659|76076423|FG000|STARTED|First Intervention||12||
59957599|NCT00841659|76076424|FG001|STARTED|First Intervention||12||
59957600|NCT00841659|76076423|FG000|COMPLETED|First Intervention||12||
59957601|NCT00841659|76076424|FG001|COMPLETED|First Intervention||12||
59957602|NCT00841659|76076423|FG000|NOT COMPLETED|First Intervention||0||
59957603|NCT00841659|76076424|FG001|NOT COMPLETED|First Intervention||0||
59957604|NCT00841659|76076423|FG000|STARTED|Washout: 2 Weeks||12||
59957605|NCT00841659|76076424|FG001|STARTED|Washout: 2 Weeks||12||
59957606|NCT00841659|76076423|FG000|COMPLETED|Washout: 2 Weeks||11||
59957607|NCT00841659|76076424|FG001|COMPLETED|Washout: 2 Weeks||12||
59957608|NCT00841659|76076423|FG000|NOT COMPLETED|Washout: 2 Weeks||1||
59957609|NCT00841659|76076424|FG001|NOT COMPLETED|Washout: 2 Weeks||0||
59957610|NCT00841659|76076423|FG000|STARTED|Second Intervention||11||
59804643|NCT00706355|75926180|FG002|NOT COMPLETED|Period 4: PF-04217903 150 mg||0||
59804644|NCT00706355|75926181|FG003|NOT COMPLETED|Period 4: PF-04217903 150 mg||4||
59804645|NCT00711113|75926193|FG000|STARTED|Overall Study||47||
59804646|NCT00711113|75926193|FG000|COMPLETED|Overall Study||36||
59804647|NCT00711113|75926193|FG000|NOT COMPLETED|Overall Study||11||
59804648|NCT03784898|75926197|FG000|STARTED|Overall Study||13||
59804649|NCT03784898|75926197|FG000|COMPLETED|Overall Study||13||
59804650|NCT03784898|75926197|FG000|NOT COMPLETED|Overall Study||0||
59804651|NCT00710879|75926203|FG000|STARTED|Overall Study||60||
59804652|NCT00710879|75926204|FG001|STARTED|Overall Study||117||
59804653|NCT00710879|75926203|FG000|COMPLETED|Overall Study||58||
59804654|NCT00710879|75926204|FG001|COMPLETED|Overall Study||113||
59804655|NCT00710879|75926203|FG000|NOT COMPLETED|Overall Study||2||
59804656|NCT00710879|75926204|FG001|NOT COMPLETED|Overall Study||4||
59804657|NCT03979274|75926210|FG000|STARTED|Treatment Period 1||22||
59804658|NCT03979274|75926211|FG001|STARTED|Treatment Period 1||22||
59804659|NCT03979274|75926210|FG000|COMPLETED|Treatment Period 1||22||
59804660|NCT03979274|75926211|FG001|COMPLETED|Treatment Period 1||22||
59804661|NCT03979274|75926210|FG000|NOT COMPLETED|Treatment Period 1||0||
59804662|NCT03979274|75926211|FG001|NOT COMPLETED|Treatment Period 1||0||
59804663|NCT03979274|75926210|FG000|STARTED|Treatment Period 2||22||
59957611|NCT00841659|76076424|FG001|STARTED|Second Intervention||12||
59957612|NCT00841659|76076423|FG000|COMPLETED|Second Intervention||11||
59957613|NCT00841659|76076424|FG001|COMPLETED|Second Intervention||12||
59957614|NCT00841659|76076423|FG000|NOT COMPLETED|Second Intervention||0||
59957615|NCT00841659|76076424|FG001|NOT COMPLETED|Second Intervention||0||
59957616|NCT02716298|76076428|FG000|STARTED|First Intervention (1 Month)||25||
59957617|NCT02716298|76076429|FG001|STARTED|First Intervention (1 Month)||24||
59804664|NCT03979274|75926211|FG001|STARTED|Treatment Period 2||22||
59804665|NCT03979274|75926210|FG000|COMPLETED|Treatment Period 2||22||
59804666|NCT03979274|75926211|FG001|COMPLETED|Treatment Period 2||21||
59804667|NCT03979274|75926210|FG000|NOT COMPLETED|Treatment Period 2||0||
59804668|NCT03979274|75926211|FG001|NOT COMPLETED|Treatment Period 2||1||
59804669|NCT00459316|75926221|FG000|STARTED|Steps 1 & 2||280||
59804670|NCT00459316|75926222|FG001|STARTED|Steps 1 & 2||39||
59804671|NCT00459316|75926223|FG002|STARTED|Steps 1 & 2||59||
59804672|NCT00459316|75926221|FG000|COMPLETED|Steps 1 & 2||259||
59804673|NCT00459316|75926222|FG001|COMPLETED|Steps 1 & 2||32||
59804674|NCT00459316|75926223|FG002|COMPLETED|Steps 1 & 2||57||
59804675|NCT00459316|75926221|FG000|NOT COMPLETED|Steps 1 & 2||21||
59804676|NCT00459316|75926222|FG001|NOT COMPLETED|Steps 1 & 2||7||
59957618|NCT02716298|76076428|FG000|COMPLETED|First Intervention (1 Month)||24||
59957619|NCT02716298|76076429|FG001|COMPLETED|First Intervention (1 Month)||23||
59957620|NCT02716298|76076428|FG000|NOT COMPLETED|First Intervention (1 Month)||1||
59957621|NCT02716298|76076429|FG001|NOT COMPLETED|First Intervention (1 Month)||1||
59957622|NCT02716298|76076428|FG000|STARTED|Second Intervention (1 Month)||24||
59957623|NCT02716298|76076429|FG001|STARTED|Second Intervention (1 Month)||23||
59957624|NCT02716298|76076428|FG000|COMPLETED|Second Intervention (1 Month)||24||
59804677|NCT00459316|75926223|FG002|NOT COMPLETED|Steps 1 & 2||2||
59804678|NCT00459316|75926221|FG000|STARTED|Step 3|Not all participants from Steps 1/2 were eligible for Step 3|152||
59804679|NCT00459316|75926222|FG001|STARTED|Step 3|Group 2 participants were not eligible for Step 3|0||
59804680|NCT00459316|75926223|FG002|STARTED|Step 3|Not all participants from Steps 1/2 were eligible for Step 3|40||
59804681|NCT00459316|75926221|FG000|COMPLETED|Step 3||149||
59804682|NCT00459316|75926222|FG001|COMPLETED|Step 3||0||
59804683|NCT00459316|75926223|FG002|COMPLETED|Step 3||39||
59957625|NCT02716298|76076429|FG001|COMPLETED|Second Intervention (1 Month)||23||
59957626|NCT02716298|76076428|FG000|NOT COMPLETED|Second Intervention (1 Month)||0||
59957627|NCT02716298|76076429|FG001|NOT COMPLETED|Second Intervention (1 Month)||0||
59957628|NCT00840879|76076442|FG000|STARTED|First Intervention||14||
59957629|NCT00840879|76076443|FG001|STARTED|First Intervention||14||
59804684|NCT00459316|75926221|FG000|NOT COMPLETED|Step 3||3||
59957630|NCT00840879|76076442|FG000|COMPLETED|First Intervention||14||
59804685|NCT00459316|75926222|FG001|NOT COMPLETED|Step 3||0||
59804686|NCT00459316|75926223|FG002|NOT COMPLETED|Step 3||1||
59804687|NCT05445557|75926246|FG000|STARTED|Double Blind Part||12|RZL-012|24
59804688|NCT05445557|75926246|FG000|Flanks Treated With RZL-012|Double Blind Part||12||12
59804689|NCT05445557|75926246|FG000|Flanks Treated With Placebo|Double Blind Part||12||12
59957631|NCT00840879|76076443|FG001|COMPLETED|First Intervention||14||
59957632|NCT00840879|76076442|FG000|NOT COMPLETED|First Intervention||0||
59957633|NCT00840879|76076443|FG001|NOT COMPLETED|First Intervention||0||
59804690|NCT05445557|75926246|FG000|COMPLETED|Double Blind Part||11||22
59804691|NCT05445557|75926246|FG000|NOT COMPLETED|Double Blind Part||1||2
59804692|NCT05445557|75926246|FG000|STARTED|Open Label - Active Only||9||9
59804693|NCT05445557|75926246|FG000|COMPLETED|Open Label - Active Only||9||9
59804694|NCT05445557|75926246|FG000|NOT COMPLETED|Open Label - Active Only||0||0
59804695|NCT05343585|75926261|FG000|STARTED|Overall Study||24||
59957634|NCT00840879|76076442|FG000|STARTED|Washout: 14 Days||14||
59957635|NCT00840879|76076443|FG001|STARTED|Washout: 14 Days||14||
59957636|NCT00840879|76076442|FG000|COMPLETED|Washout: 14 Days||14||
59957637|NCT00840879|76076443|FG001|COMPLETED|Washout: 14 Days||14||
59957638|NCT00840879|76076442|FG000|NOT COMPLETED|Washout: 14 Days||0||
59957639|NCT00840879|76076443|FG001|NOT COMPLETED|Washout: 14 Days||0||
59957640|NCT00840879|76076442|FG000|STARTED|Second Intervention||14||
59957641|NCT00840879|76076443|FG001|STARTED|Second Intervention||14||
59957642|NCT00840879|76076442|FG000|COMPLETED|Second Intervention||13||
59957643|NCT00840879|76076443|FG001|COMPLETED|Second Intervention||14||
59957644|NCT00840879|76076442|FG000|NOT COMPLETED|Second Intervention||1||
59957645|NCT00840879|76076443|FG001|NOT COMPLETED|Second Intervention||0||
59957646|NCT02163434|76076449|FG000|STARTED|Overall Study||15||
59957647|NCT02163434|76076450|FG001|STARTED|Overall Study||16||
59957648|NCT02163434|76076449|FG000|COMPLETED|Overall Study||12||
59957649|NCT02163434|76076450|FG001|COMPLETED|Overall Study||9||
59957650|NCT02163434|76076449|FG000|NOT COMPLETED|Overall Study||3||
59957651|NCT02163434|76076450|FG001|NOT COMPLETED|Overall Study||7||
59957652|NCT00840411|76076458|FG000|STARTED|First Intervention||33||
59957653|NCT00840411|76076459|FG001|STARTED|First Intervention||33||
59957654|NCT00840411|76076458|FG000|COMPLETED|First Intervention||32||
59957655|NCT00840411|76076459|FG001|COMPLETED|First Intervention||33||
59957656|NCT00840411|76076458|FG000|NOT COMPLETED|First Intervention||1||
59957657|NCT00840411|76076459|FG001|NOT COMPLETED|First Intervention||0||
59957658|NCT00840411|76076458|FG000|STARTED|Washout||32||
59957659|NCT00840411|76076459|FG001|STARTED|Washout||33||
59957660|NCT00840411|76076458|FG000|COMPLETED|Washout||31||
59957661|NCT00840411|76076459|FG001|COMPLETED|Washout||33||
59524163|NCT02168309|75619294|FG001|NOT COMPLETED|Overall Study||0||
59524164|NCT01199965|75619302|FG000|STARTED|Overall Study||23||
59957662|NCT00840411|76076458|FG000|NOT COMPLETED|Washout||1||
59524165|NCT01199965|75619303|FG001|STARTED|Overall Study||24||
59524166|NCT01199965|75619302|FG000|COMPLETED|Overall Study||22||
59524167|NCT01199965|75619303|FG001|COMPLETED|Overall Study||24||
59524168|NCT01199965|75619302|FG000|NOT COMPLETED|Overall Study||1||
59524169|NCT01199965|75619303|FG001|NOT COMPLETED|Overall Study||0||
59524170|NCT00995501|75619325|FG000|STARTED|Overall Study||52||
59524171|NCT00995501|75619326|FG001|STARTED|Overall Study||51||
59524172|NCT00995501|75619327|FG002|STARTED|Overall Study||47||
59524173|NCT00995501|75619328|FG003|STARTED|Overall Study||46||
59524174|NCT00995501|75619329|FG004|STARTED|Overall Study||46||
59524175|NCT00995501|75619330|FG005|STARTED|Overall Study||44||
59804696|NCT05343585|75926261|FG000|COMPLETED|Overall Study||24||
59804697|NCT05343585|75926261|FG000|NOT COMPLETED|Overall Study||0||
59524176|NCT00995501|75619331|FG006|STARTED|Overall Study||49||
59804698|NCT05130593|75926267|FG000|STARTED|Overall Study||10||
59804699|NCT05130593|75926268|FG001|STARTED|Overall Study||10||
59804700|NCT05130593|75926267|FG000|COMPLETED|Overall Study||10||
59804701|NCT05130593|75926268|FG001|COMPLETED|Overall Study||10||
59804702|NCT05130593|75926267|FG000|NOT COMPLETED|Overall Study||0||
59804703|NCT05130593|75926268|FG001|NOT COMPLETED|Overall Study||0||
59957663|NCT00840411|76076459|FG001|NOT COMPLETED|Washout||0||
59524177|NCT00995501|75619332|FG007|STARTED|Overall Study||46||
59804704|NCT05074498|75926280|FG000|STARTED|Part 1 (Upto Day 104)||7||
59804705|NCT05074498|75926281|FG001|STARTED|Part 1 (Upto Day 104)||6||
59957664|NCT00840411|76076458|FG000|STARTED|Second Intervention||31||
59957665|NCT00840411|76076459|FG001|STARTED|Second Intervention||33||
59957666|NCT00840411|76076458|FG000|COMPLETED|Second Intervention||31||
59524178|NCT00995501|75619325|FG000|COMPLETED|Overall Study||52||
59524179|NCT00995501|75619326|FG001|COMPLETED|Overall Study||51||
59804706|NCT05074498|75926282|FG002|STARTED|Part 1 (Upto Day 104)||6||
59524180|NCT00995501|75619327|FG002|COMPLETED|Overall Study||47||
59804707|NCT05074498|75926283|FG003|STARTED|Part 1 (Upto Day 104)||6||
59804708|NCT05074498|75926284|FG004|STARTED|Part 1 (Upto Day 104)||0||
59957667|NCT00840411|76076459|FG001|COMPLETED|Second Intervention||33||
59957668|NCT00840411|76076458|FG000|NOT COMPLETED|Second Intervention||0||
59957669|NCT00840411|76076459|FG001|NOT COMPLETED|Second Intervention||0||
59957670|NCT00840099|76076465|FG000|STARTED|Period 1||24||
59957671|NCT00840099|76076466|FG001|STARTED|Period 1||24||
59957672|NCT00840099|76076465|FG000|COMPLETED|Period 1||24||
59804709|NCT05074498|75926285|FG005|STARTED|Part 1 (Upto Day 104)||0||
59804710|NCT05074498|75926280|FG000|COMPLETED|Part 1 (Upto Day 104)||6||
59804711|NCT05074498|75926281|FG001|COMPLETED|Part 1 (Upto Day 104)||6||
59957673|NCT00840099|76076466|FG001|COMPLETED|Period 1||24||
59957674|NCT00840099|76076465|FG000|NOT COMPLETED|Period 1||0||
59957675|NCT00840099|76076466|FG001|NOT COMPLETED|Period 1||0||
59804712|NCT05074498|75926282|FG002|COMPLETED|Part 1 (Upto Day 104)||6||
59804713|NCT05074498|75926283|FG003|COMPLETED|Part 1 (Upto Day 104)||5||
59804714|NCT05074498|75926284|FG004|COMPLETED|Part 1 (Upto Day 104)||0||
59804715|NCT05074498|75926285|FG005|COMPLETED|Part 1 (Upto Day 104)||0||
59804716|NCT05074498|75926280|FG000|NOT COMPLETED|Part 1 (Upto Day 104)||1||
59804717|NCT05074498|75926281|FG001|NOT COMPLETED|Part 1 (Upto Day 104)||0||
59804718|NCT05074498|75926282|FG002|NOT COMPLETED|Part 1 (Upto Day 104)||0||
59804719|NCT05074498|75926283|FG003|NOT COMPLETED|Part 1 (Upto Day 104)||1||
59804720|NCT05074498|75926284|FG004|NOT COMPLETED|Part 1 (Upto Day 104)||0||
59804721|NCT05074498|75926285|FG005|NOT COMPLETED|Part 1 (Upto Day 104)||0||
59804722|NCT05074498|75926280|FG000|STARTED|Part 2 (Upto Day 104)||0||
59804723|NCT05074498|75926281|FG001|STARTED|Part 2 (Upto Day 104)||0||
59804724|NCT05074498|75926282|FG002|STARTED|Part 2 (Upto Day 104)||0||
59804725|NCT05074498|75926283|FG003|STARTED|Part 2 (Upto Day 104)||0||
59804726|NCT05074498|75926284|FG004|STARTED|Part 2 (Upto Day 104)||63||
59804727|NCT05074498|75926285|FG005|STARTED|Part 2 (Upto Day 104)||66||
59804728|NCT05074498|75926280|FG000|COMPLETED|Part 2 (Upto Day 104)||0||
59804729|NCT05074498|75926281|FG001|COMPLETED|Part 2 (Upto Day 104)||0||
59804730|NCT05074498|75926282|FG002|COMPLETED|Part 2 (Upto Day 104)||0||
59804731|NCT05074498|75926283|FG003|COMPLETED|Part 2 (Upto Day 104)||0||
59804732|NCT05074498|75926284|FG004|COMPLETED|Part 2 (Upto Day 104)||58||
59804733|NCT05074498|75926285|FG005|COMPLETED|Part 2 (Upto Day 104)||64||
59957676|NCT00840099|76076465|FG000|STARTED|Period 2|3 subjects were dismissed from study prior to period 2 dosing|21||
59957677|NCT00840099|76076466|FG001|STARTED|Period 2||24||
59957678|NCT00840099|76076465|FG000|COMPLETED|Period 2||21||
59957679|NCT00840099|76076466|FG001|COMPLETED|Period 2||24||
59957680|NCT00840099|76076465|FG000|NOT COMPLETED|Period 2||0||
59957681|NCT00840099|76076466|FG001|NOT COMPLETED|Period 2||0||
59957682|NCT00836901|76076472|FG000|STARTED|First Intervention||24||
59957683|NCT00836901|76076473|FG001|STARTED|First Intervention||28||
59957684|NCT00836901|76076472|FG000|COMPLETED|First Intervention||23||
59957685|NCT00836901|76076473|FG001|COMPLETED|First Intervention||28||
59957686|NCT00836901|76076472|FG000|NOT COMPLETED|First Intervention||1||
59957687|NCT00836901|76076473|FG001|NOT COMPLETED|First Intervention||0||
59957688|NCT00836901|76076472|FG000|STARTED|Second Intervention||23||
59957689|NCT00836901|76076473|FG001|STARTED|Second Intervention||28||
59957690|NCT00836901|76076472|FG000|COMPLETED|Second Intervention||23||
59957691|NCT00836901|76076473|FG001|COMPLETED|Second Intervention||28||
59957692|NCT00836901|76076472|FG000|NOT COMPLETED|Second Intervention||0||
59957693|NCT00836901|76076473|FG001|NOT COMPLETED|Second Intervention||0||
59957694|NCT04466384|76076477|FG000|STARTED|First Phase||14||
59957695|NCT04466384|76076478|FG001|STARTED|First Phase||10||
59804734|NCT05074498|75926280|FG000|NOT COMPLETED|Part 2 (Upto Day 104)||0||
59804735|NCT05074498|75926281|FG001|NOT COMPLETED|Part 2 (Upto Day 104)||0||
59804736|NCT05074498|75926282|FG002|NOT COMPLETED|Part 2 (Upto Day 104)||0||
59804737|NCT05074498|75926283|FG003|NOT COMPLETED|Part 2 (Upto Day 104)||0||
59804738|NCT05074498|75926284|FG004|NOT COMPLETED|Part 2 (Upto Day 104)||5||
59804739|NCT05074498|75926285|FG005|NOT COMPLETED|Part 2 (Upto Day 104)||2||
59804740|NCT05017974|75926301|FG000|STARTED|Overall Study||26||
59957696|NCT04466384|76076477|FG000|COMPLETED|First Phase||12||
59957697|NCT04466384|76076478|FG001|COMPLETED|First Phase||10||
59957698|NCT04466384|76076477|FG000|NOT COMPLETED|First Phase||2||
59957699|NCT04466384|76076478|FG001|NOT COMPLETED|First Phase||0||
59957700|NCT04466384|76076477|FG000|STARTED|Cross Over Phase||14||
59957701|NCT04466384|76076478|FG001|STARTED|Cross Over Phase||10||
59957702|NCT04466384|76076477|FG000|COMPLETED|Cross Over Phase||13||
59957703|NCT04466384|76076478|FG001|COMPLETED|Cross Over Phase||9||
59957704|NCT04466384|76076477|FG000|NOT COMPLETED|Cross Over Phase||1||
59957705|NCT04466384|76076478|FG001|NOT COMPLETED|Cross Over Phase||1||
59957706|NCT03050814|76076489|FG000|STARTED|Overall Study||10||
59957707|NCT03050814|76076490|FG001|STARTED|Overall Study||16||
59957708|NCT03050814|76076491|FG002|STARTED|Overall Study||4||
59804741|NCT05017974|75926302|FG001|STARTED|Overall Study||26||
59804742|NCT05017974|75926301|FG000|COMPLETED|Overall Study||24||
59804743|NCT05017974|75926302|FG001|COMPLETED|Overall Study||24||
59804744|NCT05017974|75926301|FG000|NOT COMPLETED|Overall Study||2||
59804745|NCT05017974|75926302|FG001|NOT COMPLETED|Overall Study||2||
59804746|NCT05004077|75926310|FG000|STARTED|Overall Study||2||
59804747|NCT05004077|75926311|FG001|STARTED|Overall Study||1||
59804748|NCT05004077|75926310|FG000|COMPLETED|Overall Study||2||
59804749|NCT05004077|75926311|FG001|COMPLETED|Overall Study||1||
59804750|NCT05004077|75926310|FG000|NOT COMPLETED|Overall Study||0||
59804751|NCT05004077|75926311|FG001|NOT COMPLETED|Overall Study||0||
59804752|NCT04871113|75926322|FG000|STARTED|Part1:Monotherapy Phase(up to Day 84)||8||
59804753|NCT04871113|75926323|FG001|STARTED|Part1:Monotherapy Phase(up to Day 84)||6||
59804754|NCT04871113|75926324|FG002|STARTED|Part1:Monotherapy Phase(up to Day 84)||0||
59957709|NCT03050814|76076489|FG000|COMPLETED|Overall Study||10||
59957710|NCT03050814|76076490|FG001|COMPLETED|Overall Study||16||
59957711|NCT03050814|76076491|FG002|COMPLETED|Overall Study||0||
59957712|NCT03050814|76076489|FG000|NOT COMPLETED|Overall Study||0||
59957713|NCT03050814|76076490|FG001|NOT COMPLETED|Overall Study||0||
59957714|NCT03050814|76076491|FG002|NOT COMPLETED|Overall Study||4||
59957715|NCT00835575|76076499|FG000|STARTED|First Intervention||16||
59957716|NCT00835575|76076500|FG001|STARTED|First Intervention||16||
59957717|NCT00835575|76076499|FG000|COMPLETED|First Intervention||16||
59957718|NCT00835575|76076500|FG001|COMPLETED|First Intervention||16||
59957719|NCT00835575|76076499|FG000|NOT COMPLETED|First Intervention||0||
59957720|NCT00835575|76076500|FG001|NOT COMPLETED|First Intervention||0||
59957721|NCT00835575|76076499|FG000|STARTED|Washout of 14 Days||16||
59957722|NCT00835575|76076500|FG001|STARTED|Washout of 14 Days||16||
59957723|NCT00835575|76076499|FG000|COMPLETED|Washout of 14 Days||15||
59957724|NCT00835575|76076500|FG001|COMPLETED|Washout of 14 Days||16||
59957725|NCT00835575|76076499|FG000|NOT COMPLETED|Washout of 14 Days||1||
59957726|NCT00835575|76076500|FG001|NOT COMPLETED|Washout of 14 Days||0||
59957727|NCT00835575|76076499|FG000|STARTED|Second Intervention||15||
59620741|NCT00106392|75732135|FG001|NOT COMPLETED|Overall Study||27||
59620742|NCT00211692|75732143|FG000|STARTED|Overall Study||33||
59620743|NCT00211692|75732144|FG001|STARTED|Overall Study||31||
59620744|NCT00211692|75732143|FG000|COMPLETED|Overall Study||33||
59620745|NCT00211692|75732144|FG001|COMPLETED|Overall Study||31||
59620746|NCT00211692|75732143|FG000|NOT COMPLETED|Overall Study||0||
59620747|NCT00211692|75732144|FG001|NOT COMPLETED|Overall Study||0||
59620748|NCT00214890|75732152|FG000|STARTED|Overall Study||10||
59620749|NCT00214890|75732153|FG001|STARTED|Overall Study||11||
59620750|NCT00214890|75732152|FG000|COMPLETED|Overall Study||10||
59620751|NCT00214890|75732153|FG001|COMPLETED|Overall Study||11||
59620752|NCT00214890|75732152|FG000|NOT COMPLETED|Overall Study||0||
59804755|NCT04871113|75926325|FG003|STARTED|Part1:Monotherapy Phase(up to Day 84)||0||
59804756|NCT04871113|75926326|FG004|STARTED|Part1:Monotherapy Phase(up to Day 84)||0||
59804757|NCT04871113|75926327|FG005|STARTED|Part1:Monotherapy Phase(up to Day 84)||0||
59804758|NCT04871113|75926328|FG006|STARTED|Part1:Monotherapy Phase(up to Day 84)||0||
59957728|NCT00835575|76076500|FG001|STARTED|Second Intervention||16||
59957729|NCT00835575|76076499|FG000|COMPLETED|Second Intervention||15||
59957730|NCT00835575|76076500|FG001|COMPLETED|Second Intervention||16||
59957731|NCT00835575|76076499|FG000|NOT COMPLETED|Second Intervention||0||
59957732|NCT00835575|76076500|FG001|NOT COMPLETED|Second Intervention||0||
59957733|NCT04601194|76076504|FG000|STARTED|Overall Study||29||
59957734|NCT04601194|76076504|FG000|COMPLETED|Overall Study||22||
59957735|NCT04601194|76076504|FG000|NOT COMPLETED|Overall Study||7||
59620753|NCT00214890|75732153|FG001|NOT COMPLETED|Overall Study||0||
59804759|NCT04871113|75926329|FG007|STARTED|Part1:Monotherapy Phase(up to Day 84)||0||
59804760|NCT04871113|75926330|FG008|STARTED|Part1:Monotherapy Phase(up to Day 84)||0||
59957736|NCT00835497|76076510|FG000|STARTED|First Intervention||20||
59957737|NCT00835497|76076511|FG001|STARTED|First Intervention||20||
59957738|NCT00835497|76076510|FG000|COMPLETED|First Intervention||20||
59957739|NCT00835497|76076511|FG001|COMPLETED|First Intervention||20||
59804761|NCT04871113|75926331|FG009|STARTED|Part1:Monotherapy Phase(up to Day 84)||0||
59804762|NCT04871113|75926322|FG000|COMPLETED|Part1:Monotherapy Phase(up to Day 84)||8||
59804763|NCT04871113|75926323|FG001|COMPLETED|Part1:Monotherapy Phase(up to Day 84)||6||
59804764|NCT04871113|75926324|FG002|COMPLETED|Part1:Monotherapy Phase(up to Day 84)||0||
59804765|NCT04871113|75926325|FG003|COMPLETED|Part1:Monotherapy Phase(up to Day 84)||0||
59804766|NCT04871113|75926326|FG004|COMPLETED|Part1:Monotherapy Phase(up to Day 84)||0||
59804767|NCT04871113|75926327|FG005|COMPLETED|Part1:Monotherapy Phase(up to Day 84)||0||
59804768|NCT04871113|75926328|FG006|COMPLETED|Part1:Monotherapy Phase(up to Day 84)||0||
59804769|NCT04871113|75926329|FG007|COMPLETED|Part1:Monotherapy Phase(up to Day 84)||0||
59804770|NCT04871113|75926330|FG008|COMPLETED|Part1:Monotherapy Phase(up to Day 84)||0||
59804771|NCT04871113|75926331|FG009|COMPLETED|Part1:Monotherapy Phase(up to Day 84)||0||
59804772|NCT04871113|75926322|FG000|NOT COMPLETED|Part1:Monotherapy Phase(up to Day 84)||0||
59804773|NCT04871113|75926323|FG001|NOT COMPLETED|Part1:Monotherapy Phase(up to Day 84)||0||
59804774|NCT04871113|75926324|FG002|NOT COMPLETED|Part1:Monotherapy Phase(up to Day 84)||0||
59804775|NCT04871113|75926325|FG003|NOT COMPLETED|Part1:Monotherapy Phase(up to Day 84)||0||
59804776|NCT04871113|75926326|FG004|NOT COMPLETED|Part1:Monotherapy Phase(up to Day 84)||0||
59804777|NCT04871113|75926327|FG005|NOT COMPLETED|Part1:Monotherapy Phase(up to Day 84)||0||
59804778|NCT04871113|75926328|FG006|NOT COMPLETED|Part1:Monotherapy Phase(up to Day 84)||0||
59957740|NCT00835497|76076510|FG000|NOT COMPLETED|First Intervention||0||
59957741|NCT00835497|76076511|FG001|NOT COMPLETED|First Intervention||0||
59957742|NCT00835497|76076510|FG000|STARTED|Washout: 7 Days||20||
59957743|NCT00835497|76076511|FG001|STARTED|Washout: 7 Days||20||
59957744|NCT00835497|76076510|FG000|COMPLETED|Washout: 7 Days||20||
59957745|NCT00835497|76076511|FG001|COMPLETED|Washout: 7 Days||20||
59804779|NCT04871113|75926329|FG007|NOT COMPLETED|Part1:Monotherapy Phase(up to Day 84)||0||
59804780|NCT04871113|75926330|FG008|NOT COMPLETED|Part1:Monotherapy Phase(up to Day 84)||0||
59804781|NCT04871113|75926331|FG009|NOT COMPLETED|Part1:Monotherapy Phase(up to Day 84)||0||
59957746|NCT00835497|76076510|FG000|NOT COMPLETED|Washout: 7 Days||0||
59957747|NCT00835497|76076511|FG001|NOT COMPLETED|Washout: 7 Days||0||
59957748|NCT00835497|76076510|FG000|STARTED|Second Intervention||20||
59957749|NCT00835497|76076511|FG001|STARTED|Second Intervention||20||
59957750|NCT00835497|76076510|FG000|COMPLETED|Second Intervention||20||
59957751|NCT00835497|76076511|FG001|COMPLETED|Second Intervention||20||
59957752|NCT00835497|76076510|FG000|NOT COMPLETED|Second Intervention||0||
59957753|NCT00835497|76076511|FG001|NOT COMPLETED|Second Intervention||0||
59957754|NCT00835263|76076517|FG000|STARTED|First Intervention||16||
59957755|NCT00835263|76076518|FG001|STARTED|First Intervention||16||
59957756|NCT00835263|76076517|FG000|COMPLETED|First Intervention||16||
59957757|NCT00835263|76076518|FG001|COMPLETED|First Intervention||16||
59957758|NCT00835263|76076517|FG000|NOT COMPLETED|First Intervention||0||
59524181|NCT00995501|75619328|FG003|COMPLETED|Overall Study||46||
59804782|NCT04871113|75926322|FG000|STARTED|Part2:Monotherapy Phase(up to Day 84)||0||
59804783|NCT04871113|75926323|FG001|STARTED|Part2:Monotherapy Phase(up to Day 84)||0||
59957759|NCT00835263|76076518|FG001|NOT COMPLETED|First Intervention||0||
59620754|NCT00216060|75732161|FG000|STARTED|Overall Study||32||
59620755|NCT00216060|75732162|FG001|STARTED|Overall Study||31||
59620756|NCT00216060|75732161|FG000|COMPLETED|Overall Study||32||
59620757|NCT00216060|75732162|FG001|COMPLETED|Overall Study||31||
59620758|NCT00216060|75732161|FG000|NOT COMPLETED|Overall Study||0||
59620759|NCT00216060|75732162|FG001|NOT COMPLETED|Overall Study||0||
59957760|NCT00835263|76076517|FG000|STARTED|Second Intervention||16||
59957761|NCT00835263|76076518|FG001|STARTED|Second Intervention||16||
59957762|NCT00835263|76076517|FG000|COMPLETED|Second Intervention||15||
59524182|NCT00995501|75619329|FG004|COMPLETED|Overall Study||46||
59804784|NCT04871113|75926324|FG002|STARTED|Part2:Monotherapy Phase(up to Day 84)|Part 2 enrolled new participants and the dosing for part 2 was based on the part 1 data.|16||
59804785|NCT04871113|75926325|FG003|STARTED|Part2:Monotherapy Phase(up to Day 84)|Part 2 enrolled new participants and the dosing for part 2 was based on the part 1 data.|16||
59804786|NCT04871113|75926326|FG004|STARTED|Part2:Monotherapy Phase(up to Day 84)|Part 2 enrolled new participants and the dosing for part 2 was based on the part 1 data.|16||
59804787|NCT04871113|75926327|FG005|STARTED|Part2:Monotherapy Phase(up to Day 84)||0||
59804788|NCT04871113|75926328|FG006|STARTED|Part2:Monotherapy Phase(up to Day 84)||0||
59804789|NCT04871113|75926329|FG007|STARTED|Part2:Monotherapy Phase(up to Day 84)||0||
59957763|NCT00835263|76076518|FG001|COMPLETED|Second Intervention||16||
59957764|NCT00835263|76076517|FG000|NOT COMPLETED|Second Intervention||1||
59957765|NCT00835263|76076518|FG001|NOT COMPLETED|Second Intervention||0||
59957766|NCT02639910|76076524|FG000|STARTED|Overall Study||11||
59524183|NCT00995501|75619330|FG005|COMPLETED|Overall Study||44||
59620760|NCT00106938|75732172|FG000|STARTED|Overall Study||1089||
59804790|NCT04871113|75926330|FG008|STARTED|Part2:Monotherapy Phase(up to Day 84)||0||
59804791|NCT04871113|75926331|FG009|STARTED|Part2:Monotherapy Phase(up to Day 84)||0||
59957767|NCT02639910|76076525|FG001|STARTED|Overall Study||13||
59957768|NCT02639910|76076524|FG000|COMPLETED|Overall Study||7||
59957769|NCT02639910|76076525|FG001|COMPLETED|Overall Study||5||
59957770|NCT02639910|76076524|FG000|NOT COMPLETED|Overall Study||4||
59957771|NCT02639910|76076525|FG001|NOT COMPLETED|Overall Study||8||
59957772|NCT00950937|76076533|FG000|STARTED|Overall Study||14||
59804792|NCT04871113|75926322|FG000|COMPLETED|Part2:Monotherapy Phase(up to Day 84)||0||
59804793|NCT04871113|75926323|FG001|COMPLETED|Part2:Monotherapy Phase(up to Day 84)||0||
59957773|NCT00950937|76076534|FG001|STARTED|Overall Study||14||
59957774|NCT00950937|76076533|FG000|COMPLETED|Overall Study||14||
59957775|NCT00950937|76076534|FG001|COMPLETED|Overall Study||14||
59957776|NCT00950937|76076533|FG000|NOT COMPLETED|Overall Study||0||
59957777|NCT00950937|76076534|FG001|NOT COMPLETED|Overall Study||0||
59957778|NCT00948753|76076541|FG000|STARTED|Phase 1||7||
59804794|NCT04871113|75926324|FG002|COMPLETED|Part2:Monotherapy Phase(up to Day 84)||16||
59804795|NCT04871113|75926325|FG003|COMPLETED|Part2:Monotherapy Phase(up to Day 84)||16||
59804796|NCT04871113|75926326|FG004|COMPLETED|Part2:Monotherapy Phase(up to Day 84)||16||
59957779|NCT00948753|76076542|FG001|STARTED|Phase 1||6||
59957780|NCT00948753|76076543|FG002|STARTED|Phase 1||0||
59957781|NCT00948753|76076541|FG000|COMPLETED|Phase 1||7||
59957782|NCT00948753|76076542|FG001|COMPLETED|Phase 1||6||
59957783|NCT00948753|76076543|FG002|COMPLETED|Phase 1||0||
59957784|NCT00948753|76076541|FG000|NOT COMPLETED|Phase 1||0||
59957785|NCT00948753|76076542|FG001|NOT COMPLETED|Phase 1||0||
59957786|NCT00948753|76076543|FG002|NOT COMPLETED|Phase 1||0||
59957787|NCT00948753|76076541|FG000|STARTED|Phase 2||0||
59957788|NCT00948753|76076542|FG001|STARTED|Phase 2||0||
59957789|NCT00948753|76076543|FG002|STARTED|Phase 2||25||
59957790|NCT00948753|76076541|FG000|COMPLETED|Phase 2||0||
59957791|NCT00948753|76076542|FG001|COMPLETED|Phase 2||0||
59957792|NCT00948753|76076543|FG002|COMPLETED|Phase 2||25||
59957793|NCT00948753|76076541|FG000|NOT COMPLETED|Phase 2||0||
59957794|NCT00948753|76076542|FG001|NOT COMPLETED|Phase 2||0||
59957795|NCT00948753|76076543|FG002|NOT COMPLETED|Phase 2||0||
59957796|NCT01963208|76076556|FG000|STARTED|Treatment Phase 1 (Up to Week 14)||24||
59957797|NCT01963208|76076557|FG001|STARTED|Treatment Phase 1 (Up to Week 14)||22||
59957798|NCT01963208|76076558|FG002|STARTED|Treatment Phase 1 (Up to Week 14)||179||
59957799|NCT01963208|76076559|FG003|STARTED|Treatment Phase 1 (Up to Week 14)||180||
59957800|NCT01963208|76076560|FG004|STARTED|Treatment Phase 1 (Up to Week 14)||0||
59957801|NCT01963208|76076561|FG005|STARTED|Treatment Phase 1 (Up to Week 14)||0||
59957802|NCT01963208|76076556|FG000|COMPLETED|Treatment Phase 1 (Up to Week 14)||23||
59957803|NCT01963208|76076557|FG001|COMPLETED|Treatment Phase 1 (Up to Week 14)||19||
59804797|NCT04871113|75926327|FG005|COMPLETED|Part2:Monotherapy Phase(up to Day 84)||0||
59804798|NCT04871113|75926328|FG006|COMPLETED|Part2:Monotherapy Phase(up to Day 84)||0||
59804799|NCT04871113|75926329|FG007|COMPLETED|Part2:Monotherapy Phase(up to Day 84)||0||
59804800|NCT04871113|75926330|FG008|COMPLETED|Part2:Monotherapy Phase(up to Day 84)||0||
59804801|NCT04871113|75926331|FG009|COMPLETED|Part2:Monotherapy Phase(up to Day 84)||0||
59804802|NCT04871113|75926322|FG000|NOT COMPLETED|Part2:Monotherapy Phase(up to Day 84)||0||
59804803|NCT04871113|75926323|FG001|NOT COMPLETED|Part2:Monotherapy Phase(up to Day 84)||0||
59804804|NCT04871113|75926324|FG002|NOT COMPLETED|Part2:Monotherapy Phase(up to Day 84)||0||
59804805|NCT04871113|75926325|FG003|NOT COMPLETED|Part2:Monotherapy Phase(up to Day 84)||0||
59804806|NCT04871113|75926326|FG004|NOT COMPLETED|Part2:Monotherapy Phase(up to Day 84)||0||
59804807|NCT04871113|75926327|FG005|NOT COMPLETED|Part2:Monotherapy Phase(up to Day 84)||0||
59804808|NCT04871113|75926328|FG006|NOT COMPLETED|Part2:Monotherapy Phase(up to Day 84)||0||
59804809|NCT04871113|75926329|FG007|NOT COMPLETED|Part2:Monotherapy Phase(up to Day 84)||0||
59804810|NCT04871113|75926330|FG008|NOT COMPLETED|Part2:Monotherapy Phase(up to Day 84)||0||
59804811|NCT04871113|75926331|FG009|NOT COMPLETED|Part2:Monotherapy Phase(up to Day 84)||0||
59804812|NCT04871113|75926322|FG000|STARTED|SOC Follow-up (SOC Day 1 to 27 Months)||0||
59804813|NCT04871113|75926323|FG001|STARTED|SOC Follow-up (SOC Day 1 to 27 Months)||0||
59804814|NCT04871113|75926324|FG002|STARTED|SOC Follow-up (SOC Day 1 to 27 Months)||0||
59804815|NCT04871113|75926325|FG003|STARTED|SOC Follow-up (SOC Day 1 to 27 Months)||0||
59804816|NCT04871113|75926326|FG004|STARTED|SOC Follow-up (SOC Day 1 to 27 Months)||0||
59804817|NCT04871113|75926327|FG005|STARTED|SOC Follow-up (SOC Day 1 to 27 Months)|Participants are transferred from GSK3810109A 40 mg/kg IV arm.|8||
59804818|NCT04871113|75926328|FG006|STARTED|SOC Follow-up (SOC Day 1 to 27 Months)|Participants are transferred from GSK3810109A 280 mg IV arm.|6||
59957804|NCT01963208|76076558|FG002|COMPLETED|Treatment Phase 1 (Up to Week 14)||135||
59957805|NCT01963208|76076559|FG003|COMPLETED|Treatment Phase 1 (Up to Week 14)||154||
59957806|NCT01963208|76076560|FG004|COMPLETED|Treatment Phase 1 (Up to Week 14)||0||
59957807|NCT01963208|76076561|FG005|COMPLETED|Treatment Phase 1 (Up to Week 14)||0||
59957808|NCT01963208|76076556|FG000|NOT COMPLETED|Treatment Phase 1 (Up to Week 14)||1||
59817875|NCT04488770|75940327|FG001|STARTED|Part 1-Cohort 2: Period 1 (Up to 5 Days)||0||
59957809|NCT01963208|76076557|FG001|NOT COMPLETED|Treatment Phase 1 (Up to Week 14)||3||
59957810|NCT01963208|76076558|FG002|NOT COMPLETED|Treatment Phase 1 (Up to Week 14)||44||
59957811|NCT01963208|76076559|FG003|NOT COMPLETED|Treatment Phase 1 (Up to Week 14)||26||
59957812|NCT01963208|76076560|FG004|NOT COMPLETED|Treatment Phase 1 (Up to Week 14)||0||
59957813|NCT01963208|76076561|FG005|NOT COMPLETED|Treatment Phase 1 (Up to Week 14)||0||
59957814|NCT01963208|76076556|FG000|STARTED|Treatment Phase 2 (Up to Week 68)||0||
59957815|NCT01963208|76076557|FG001|STARTED|Treatment Phase 2 (Up to Week 68)||0||
59957816|NCT01963208|76076558|FG002|STARTED|Treatment Phase 2 (Up to Week 68)||0||
59957817|NCT01963208|76076559|FG003|STARTED|Treatment Phase 2 (Up to Week 68)||0||
59957818|NCT01963208|76076560|FG004|STARTED|Treatment Phase 2 (Up to Week 68)||158||
59957819|NCT01963208|76076561|FG005|STARTED|Treatment Phase 2 (Up to Week 68)||173||
59957820|NCT01963208|76076556|FG000|COMPLETED|Treatment Phase 2 (Up to Week 68)||0||
59957821|NCT01963208|76076557|FG001|COMPLETED|Treatment Phase 2 (Up to Week 68)||0||
59957822|NCT01963208|76076558|FG002|COMPLETED|Treatment Phase 2 (Up to Week 68)||0||
59957823|NCT01963208|76076559|FG003|COMPLETED|Treatment Phase 2 (Up to Week 68)||0||
59957824|NCT01963208|76076560|FG004|COMPLETED|Treatment Phase 2 (Up to Week 68)||57||
59957825|NCT01963208|76076561|FG005|COMPLETED|Treatment Phase 2 (Up to Week 68)||44||
59957826|NCT01963208|76076556|FG000|NOT COMPLETED|Treatment Phase 2 (Up to Week 68)||0||
59957827|NCT01963208|76076557|FG001|NOT COMPLETED|Treatment Phase 2 (Up to Week 68)||0||
59957828|NCT01963208|76076558|FG002|NOT COMPLETED|Treatment Phase 2 (Up to Week 68)||0||
59957829|NCT01963208|76076559|FG003|NOT COMPLETED|Treatment Phase 2 (Up to Week 68)||0||
59957830|NCT01963208|76076560|FG004|NOT COMPLETED|Treatment Phase 2 (Up to Week 68)||101||
59957831|NCT01963208|76076561|FG005|NOT COMPLETED|Treatment Phase 2 (Up to Week 68)||129||
59957832|NCT00834873|76076573|FG000|STARTED|First Intervention||12||
59957833|NCT00834873|76076574|FG001|STARTED|First Intervention||12||
59957834|NCT00834873|76076573|FG000|COMPLETED|First Intervention||12||
59957835|NCT00834873|76076574|FG001|COMPLETED|First Intervention||11||
59957836|NCT00834873|76076573|FG000|NOT COMPLETED|First Intervention||0||
59957837|NCT00834873|76076574|FG001|NOT COMPLETED|First Intervention||1||
59957838|NCT00834873|76076573|FG000|STARTED|Washout: 7 Days||12||
59957839|NCT00834873|76076574|FG001|STARTED|Washout: 7 Days||11||
59957840|NCT00834873|76076573|FG000|COMPLETED|Washout: 7 Days||12||
59957841|NCT00834873|76076574|FG001|COMPLETED|Washout: 7 Days||11||
59957842|NCT00834873|76076573|FG000|NOT COMPLETED|Washout: 7 Days||0||
59957843|NCT00834873|76076574|FG001|NOT COMPLETED|Washout: 7 Days||0||
59957844|NCT00834873|76076573|FG000|STARTED|Second Intervention||12||
59620761|NCT00106938|75732173|FG001|STARTED|Overall Study||364||
59620762|NCT00106938|75732172|FG000|COMPLETED|Overall Study||913||
59620763|NCT00106938|75732173|FG001|COMPLETED|Overall Study||293||
59620764|NCT00106938|75732172|FG000|NOT COMPLETED|Overall Study||176||
59620765|NCT00106938|75732173|FG001|NOT COMPLETED|Overall Study||71||
59620766|NCT02100072|75732179|FG000|STARTED|Overall Study||5||
59620767|NCT02100072|75732179|FG000|COMPLETED|Overall Study||5||
59620768|NCT02100072|75732179|FG000|NOT COMPLETED|Overall Study||0||
59620769|NCT00110136|75732183|FG000|STARTED|Overall Study||9||
59620770|NCT00110136|75732183|FG000|COMPLETED|Overall Study||9||
59620771|NCT00110136|75732183|FG000|NOT COMPLETED|Overall Study||0||
59620772|NCT00282282|75732188|FG000|STARTED|Overall Study|31 patients enrolled but 2 patients did not go through with transplant|29||
59957845|NCT00834873|76076574|FG001|STARTED|Second Intervention||11||
59957846|NCT00834873|76076573|FG000|COMPLETED|Second Intervention||12||
59957847|NCT00834873|76076574|FG001|COMPLETED|Second Intervention||11||
59957848|NCT00834873|76076573|FG000|NOT COMPLETED|Second Intervention||0||
59957849|NCT00834873|76076574|FG001|NOT COMPLETED|Second Intervention||0||
59957850|NCT01377480|76076582|FG000|STARTED|Overall Study|Includes 2 participants randomized to POS + BNZ but who only received POS|32||
59957851|NCT01377480|76076583|FG001|STARTED|Overall Study||30||
59957852|NCT01377480|76076584|FG002|STARTED|Overall Study|2 participants received only POS and were analyzed as part of the posaconazole group|28||
59957853|NCT01377480|76076585|FG003|STARTED|Overall Study||30||
59957854|NCT01377480|76076582|FG000|COMPLETED|Overall Study||32||
59620773|NCT00282282|75732188|FG000|COMPLETED|Overall Study||29||
59620774|NCT00282282|75732188|FG000|NOT COMPLETED|Overall Study||0||
59620775|NCT00282672|75732197|FG000|STARTED|1 Year||22||
59620776|NCT00282672|75732198|FG001|STARTED|1 Year||42||
59620777|NCT00282672|75732199|FG002|STARTED|1 Year||21||
59620778|NCT00282672|75732200|FG003|STARTED|1 Year||42||
59620779|NCT00282672|75732197|FG000|COMPLETED|1 Year||19||
59620780|NCT00282672|75732198|FG001|COMPLETED|1 Year||40||
59620781|NCT00282672|75732199|FG002|COMPLETED|1 Year||20||
59620782|NCT00282672|75732200|FG003|COMPLETED|1 Year||38||
59620783|NCT00282672|75732197|FG000|NOT COMPLETED|1 Year||3||
59620784|NCT00282672|75732198|FG001|NOT COMPLETED|1 Year||2||
59620785|NCT00282672|75732199|FG002|NOT COMPLETED|1 Year||1||
59620786|NCT00282672|75732200|FG003|NOT COMPLETED|1 Year||4||
59620787|NCT00282672|75732197|FG000|STARTED|2 Year: Sham Crossed Over to RFA|19 crossed over to RFA treatment|19||
59620788|NCT00282672|75732198|FG001|STARTED|2 Year: Sham Crossed Over to RFA||40||
59620789|NCT00282672|75732199|FG002|STARTED|2 Year: Sham Crossed Over to RFA|16 Crossed over to RFA treatment|16||
59620790|NCT00282672|75732200|FG003|STARTED|2 Year: Sham Crossed Over to RFA||38||
59620791|NCT00282672|75732197|FG000|COMPLETED|2 Year: Sham Crossed Over to RFA||16||
59620792|NCT00282672|75732198|FG001|COMPLETED|2 Year: Sham Crossed Over to RFA||39||
59620793|NCT00282672|75732199|FG002|COMPLETED|2 Year: Sham Crossed Over to RFA||15||
59620794|NCT00282672|75732200|FG003|COMPLETED|2 Year: Sham Crossed Over to RFA||36||
59620795|NCT00282672|75732197|FG000|NOT COMPLETED|2 Year: Sham Crossed Over to RFA||3||
59620796|NCT00282672|75732198|FG001|NOT COMPLETED|2 Year: Sham Crossed Over to RFA||1||
59620797|NCT00282672|75732199|FG002|NOT COMPLETED|2 Year: Sham Crossed Over to RFA||1||
59957855|NCT01377480|76076583|FG001|COMPLETED|Overall Study||29||
59957856|NCT01377480|76076584|FG002|COMPLETED|Overall Study||18||
59957857|NCT01377480|76076585|FG003|COMPLETED|Overall Study||19||
59957858|NCT01377480|76076582|FG000|NOT COMPLETED|Overall Study||0||
59957859|NCT01377480|76076583|FG001|NOT COMPLETED|Overall Study||1||
59804819|NCT04871113|75926329|FG007|STARTED|SOC Follow-up (SOC Day 1 to 27 Months)|Participants are transferred from GSK3810109A 700 mg IV arm.|16||
59804820|NCT04871113|75926330|FG008|STARTED|SOC Follow-up (SOC Day 1 to 27 Months)|Participants are transferred from GSK3810109A 70 mg IV arm.|16||
59804821|NCT04871113|75926331|FG009|STARTED|SOC Follow-up (SOC Day 1 to 27 Months)|Participants are transferred from GSK3810109A 700 mg SC arm.|16||
59804822|NCT04871113|75926322|FG000|COMPLETED|SOC Follow-up (SOC Day 1 to 27 Months)||0||
59804823|NCT04871113|75926323|FG001|COMPLETED|SOC Follow-up (SOC Day 1 to 27 Months)||0||
59804824|NCT04871113|75926324|FG002|COMPLETED|SOC Follow-up (SOC Day 1 to 27 Months)||0||
59804825|NCT04871113|75926325|FG003|COMPLETED|SOC Follow-up (SOC Day 1 to 27 Months)||0||
59804826|NCT04871113|75926326|FG004|COMPLETED|SOC Follow-up (SOC Day 1 to 27 Months)||0||
59804827|NCT04871113|75926327|FG005|COMPLETED|SOC Follow-up (SOC Day 1 to 27 Months)||1||
59804828|NCT04871113|75926328|FG006|COMPLETED|SOC Follow-up (SOC Day 1 to 27 Months)||0||
59804829|NCT04871113|75926329|FG007|COMPLETED|SOC Follow-up (SOC Day 1 to 27 Months)||0||
59804830|NCT04871113|75926330|FG008|COMPLETED|SOC Follow-up (SOC Day 1 to 27 Months)||0||
59804831|NCT04871113|75926331|FG009|COMPLETED|SOC Follow-up (SOC Day 1 to 27 Months)||0||
59804832|NCT04871113|75926322|FG000|NOT COMPLETED|SOC Follow-up (SOC Day 1 to 27 Months)||0||
59804833|NCT04871113|75926323|FG001|NOT COMPLETED|SOC Follow-up (SOC Day 1 to 27 Months)||0||
59804834|NCT04871113|75926324|FG002|NOT COMPLETED|SOC Follow-up (SOC Day 1 to 27 Months)||0||
59804835|NCT04871113|75926325|FG003|NOT COMPLETED|SOC Follow-up (SOC Day 1 to 27 Months)||0||
59804836|NCT04871113|75926326|FG004|NOT COMPLETED|SOC Follow-up (SOC Day 1 to 27 Months)||0||
59804837|NCT04871113|75926327|FG005|NOT COMPLETED|SOC Follow-up (SOC Day 1 to 27 Months)||7||
59804838|NCT04871113|75926328|FG006|NOT COMPLETED|SOC Follow-up (SOC Day 1 to 27 Months)||6||
59804839|NCT04871113|75926329|FG007|NOT COMPLETED|SOC Follow-up (SOC Day 1 to 27 Months)||16||
59804840|NCT04871113|75926330|FG008|NOT COMPLETED|SOC Follow-up (SOC Day 1 to 27 Months)||16||
59804841|NCT04871113|75926331|FG009|NOT COMPLETED|SOC Follow-up (SOC Day 1 to 27 Months)||16||
59804842|NCT04783415|75926348|FG000|STARTED|Overall Study||12||
59804843|NCT04783415|75926348|FG000|COMPLETED|Overall Study||12||
59804844|NCT04783415|75926348|FG000|NOT COMPLETED|Overall Study||0||
59804845|NCT04715230|75926355|FG000|STARTED|Overall Study||8||
59804846|NCT04715230|75926356|FG001|STARTED|Overall Study||8||
59804847|NCT04715230|75926357|FG002|STARTED|Overall Study||4||
59804848|NCT04715230|75926355|FG000|COMPLETED|Overall Study||7||
59804849|NCT04715230|75926356|FG001|COMPLETED|Overall Study||3||
59804850|NCT04715230|75926357|FG002|COMPLETED|Overall Study||3||
59957860|NCT01377480|76076584|FG002|NOT COMPLETED|Overall Study||10||
59957861|NCT01377480|76076585|FG003|NOT COMPLETED|Overall Study||11||
59957862|NCT00834795|76076597|FG000|STARTED|First Intervention||18||
59804851|NCT04715230|75926355|FG000|NOT COMPLETED|Overall Study||1||
59804852|NCT04715230|75926356|FG001|NOT COMPLETED|Overall Study||5||
59804853|NCT04715230|75926357|FG002|NOT COMPLETED|Overall Study||1||
59804854|NCT04710368|75926365|FG000|STARTED|Overall Study||137||
59804855|NCT04710368|75926365|FG000|COMPLETED|Overall Study||110||
59804856|NCT04710368|75926365|FG000|NOT COMPLETED|Overall Study||27||
59804857|NCT04704375|75926373|FG000|STARTED|Overall Study||10||
59804858|NCT04704375|75926374|FG001|STARTED|Overall Study||10||
59804859|NCT04704375|75926375|FG002|STARTED|Overall Study||10||
59804860|NCT04704375|75926376|FG003|STARTED|Overall Study||10||
59957863|NCT00834795|76076598|FG001|STARTED|First Intervention||18||
59957864|NCT00834795|76076597|FG000|COMPLETED|First Intervention||18||
59957865|NCT00834795|76076598|FG001|COMPLETED|First Intervention||18||
59620798|NCT00282672|75732200|FG003|NOT COMPLETED|2 Year: Sham Crossed Over to RFA||2||
59957866|NCT00834795|76076597|FG000|NOT COMPLETED|First Intervention||0||
59957867|NCT00834795|76076598|FG001|NOT COMPLETED|First Intervention||0||
59957868|NCT00834795|76076597|FG000|STARTED|Washout: 7 Days||18||
59957869|NCT00834795|76076598|FG001|STARTED|Washout: 7 Days||18||
59957870|NCT00834795|76076597|FG000|COMPLETED|Washout: 7 Days||18||
59957871|NCT00834795|76076598|FG001|COMPLETED|Washout: 7 Days||17||
59957872|NCT00834795|76076597|FG000|NOT COMPLETED|Washout: 7 Days||0||
59957873|NCT00834795|76076598|FG001|NOT COMPLETED|Washout: 7 Days||1||
59957874|NCT00834795|76076597|FG000|STARTED|Second Intervention||18||
59957875|NCT00834795|76076598|FG001|STARTED|Second Intervention||17||
59957876|NCT00834795|76076597|FG000|COMPLETED|Second Intervention||17||
59957877|NCT00834795|76076598|FG001|COMPLETED|Second Intervention||17||
59957878|NCT00834795|76076597|FG000|NOT COMPLETED|Second Intervention||1||
59957879|NCT00834795|76076598|FG001|NOT COMPLETED|Second Intervention||0||
59620799|NCT00282672|75732197|FG000|STARTED|5 Year: Follow up|1 withdrew|15||
59620800|NCT00282672|75732198|FG001|STARTED|5 Year: Follow up|7 withdrew|32||
59620801|NCT00282672|75732199|FG002|STARTED|5 Year: Follow up|3 withdrew|12||
59804861|NCT04704375|75926373|FG000|COMPLETED|Overall Study||10||
59957880|NCT00834717|76076604|FG000|STARTED|First Intervention||20||
59957881|NCT00834717|76076605|FG001|STARTED|First Intervention||20||
59957882|NCT00834717|76076604|FG000|COMPLETED|First Intervention||19||
59957883|NCT00834717|76076605|FG001|COMPLETED|First Intervention||19||
59620802|NCT00282672|75732200|FG003|STARTED|5 Year: Follow up|11 withdrew|25||
59620803|NCT00282672|75732197|FG000|COMPLETED|5 Year: Follow up||14||
59620804|NCT00282672|75732198|FG001|COMPLETED|5 Year: Follow up||27||
59620805|NCT00282672|75732199|FG002|COMPLETED|5 Year: Follow up||12||
59957884|NCT00834717|76076604|FG000|NOT COMPLETED|First Intervention||1||
59957885|NCT00834717|76076605|FG001|NOT COMPLETED|First Intervention||1||
59957886|NCT00834717|76076604|FG000|STARTED|Second Intervention||19||
59957887|NCT00834717|76076605|FG001|STARTED|Second Intervention||19||
59957888|NCT00834717|76076604|FG000|COMPLETED|Second Intervention||19||
59957889|NCT00834717|76076605|FG001|COMPLETED|Second Intervention||19||
59957890|NCT00834717|76076604|FG000|NOT COMPLETED|Second Intervention||0||
59957891|NCT00834717|76076605|FG001|NOT COMPLETED|Second Intervention||0||
59957892|NCT00834639|76076611|FG000|STARTED|First Intervention||12||
59957893|NCT00834639|76076612|FG001|STARTED|First Intervention||12||
59957894|NCT00834639|76076611|FG000|COMPLETED|First Intervention||12||
59957895|NCT00834639|76076612|FG001|COMPLETED|First Intervention||12||
59957896|NCT00834639|76076611|FG000|NOT COMPLETED|First Intervention||0||
59957897|NCT00834639|76076612|FG001|NOT COMPLETED|First Intervention||0||
59804862|NCT04704375|75926374|FG001|COMPLETED|Overall Study||10||
59804863|NCT04704375|75926375|FG002|COMPLETED|Overall Study||10||
59804864|NCT04704375|75926376|FG003|COMPLETED|Overall Study||10||
59804865|NCT04704375|75926373|FG000|NOT COMPLETED|Overall Study||0||
59804866|NCT04704375|75926374|FG001|NOT COMPLETED|Overall Study||0||
59804867|NCT04704375|75926375|FG002|NOT COMPLETED|Overall Study||0||
59804868|NCT04704375|75926376|FG003|NOT COMPLETED|Overall Study||0||
59804869|NCT04684641|75926388|FG000|STARTED|Overall Study||4||
59804870|NCT04684641|75926389|FG001|STARTED|Overall Study||4||
59804871|NCT04684641|75926388|FG000|COMPLETED|Overall Study||4||
59804872|NCT04684641|75926389|FG001|COMPLETED|Overall Study||2||
59804873|NCT04684641|75926388|FG000|NOT COMPLETED|Overall Study||0||
59804874|NCT04684641|75926389|FG001|NOT COMPLETED|Overall Study||2||
59804875|NCT04590963|75926397|FG000|STARTED|Overall Study||247||
59804876|NCT04590963|75926398|FG001|STARTED|Overall Study||123||
59804877|NCT04590963|75926397|FG000|Treated|Overall Study||246||
59804878|NCT04590963|75926398|FG001|Treated|Overall Study||122||
59804879|NCT04590963|75926397|FG000|COMPLETED|Overall Study||0||
59804880|NCT04590963|75926398|FG001|COMPLETED|Overall Study||0||
59804881|NCT04590963|75926397|FG000|NOT COMPLETED|Overall Study||247||
59804882|NCT04590963|75926398|FG001|NOT COMPLETED|Overall Study||123||
59804883|NCT04493216|75926408|FG000|STARTED|Overall Study||40||
59804884|NCT04493216|75926409|FG001|STARTED|Overall Study||43||
59804885|NCT04493216|75926410|FG002|STARTED|Overall Study||42||
59804886|NCT04493216|75926411|FG003|STARTED|Overall Study||36||
59804887|NCT04493216|75926408|FG000|COMPLETED|Overall Study||0||
59804888|NCT04493216|75926409|FG001|COMPLETED|Overall Study||0||
59804889|NCT04493216|75926410|FG002|COMPLETED|Overall Study||0||
59804890|NCT04493216|75926411|FG003|COMPLETED|Overall Study||0||
59804891|NCT04493216|75926408|FG000|NOT COMPLETED|Overall Study||40||
59804892|NCT04493216|75926409|FG001|NOT COMPLETED|Overall Study||43||
59804893|NCT04493216|75926410|FG002|NOT COMPLETED|Overall Study||42||
59804894|NCT04493216|75926411|FG003|NOT COMPLETED|Overall Study||36||
59804895|NCT04409873|75926426|FG000|STARTED|Overall Study||12||
59804896|NCT04409873|75926427|FG001|STARTED|Overall Study||11||
59804897|NCT04409873|75926428|FG002|STARTED|Overall Study||12||
59804898|NCT04409873|75926429|FG003|STARTED|Overall Study||12||
59804899|NCT04409873|75926430|FG004|STARTED|Overall Study||7||
59957898|NCT00834639|76076611|FG000|STARTED|Washout of 7 Days||12||
59957899|NCT00834639|76076612|FG001|STARTED|Washout of 7 Days||12||
59957900|NCT00834639|76076611|FG000|COMPLETED|Washout of 7 Days||12||
59957901|NCT00834639|76076612|FG001|COMPLETED|Washout of 7 Days||12||
59957902|NCT00834639|76076611|FG000|NOT COMPLETED|Washout of 7 Days||0||
59957903|NCT00834639|76076612|FG001|NOT COMPLETED|Washout of 7 Days||0||
59957904|NCT00834639|76076611|FG000|STARTED|Second Intervention||12||
59957905|NCT00834639|76076612|FG001|STARTED|Second Intervention||12||
59957906|NCT00834639|76076611|FG000|COMPLETED|Second Intervention||12||
59804900|NCT04409873|75926426|FG000|COMPLETED|Overall Study||12||
59804901|NCT04409873|75926427|FG001|COMPLETED|Overall Study||8||
59804902|NCT04409873|75926428|FG002|COMPLETED|Overall Study||11||
59804903|NCT04409873|75926429|FG003|COMPLETED|Overall Study||12||
59804904|NCT04409873|75926430|FG004|COMPLETED|Overall Study||6||
59804905|NCT04409873|75926426|FG000|NOT COMPLETED|Overall Study||0||
59804906|NCT04409873|75926427|FG001|NOT COMPLETED|Overall Study||3||
59804907|NCT04409873|75926428|FG002|NOT COMPLETED|Overall Study||1||
59804908|NCT04409873|75926429|FG003|NOT COMPLETED|Overall Study||0||
59804909|NCT04409873|75926430|FG004|NOT COMPLETED|Overall Study||1||
59804910|NCT04329949|75926442|FG000|STARTED|Overall Study||43||
59804911|NCT04329949|75926442|FG000|COMPLETED|Overall Study||0||
59804912|NCT04329949|75926442|FG000|NOT COMPLETED|Overall Study||43||
59804913|NCT04290624|75926448|FG000|STARTED|Overall Study||24||
59957907|NCT00834639|76076612|FG001|COMPLETED|Second Intervention||10||
59804914|NCT04290624|75926449|FG001|STARTED|Overall Study||25||
59804915|NCT04290624|75926448|FG000|COMPLETED|Overall Study||23||
59804916|NCT04290624|75926449|FG001|COMPLETED|Overall Study||25||
59804917|NCT04290624|75926448|FG000|NOT COMPLETED|Overall Study||1||
59804918|NCT04290624|75926449|FG001|NOT COMPLETED|Overall Study||0||
59804919|NCT04288115|75926457|FG000|STARTED|Overall Study||24||
59804920|NCT04288115|75926458|FG001|STARTED|Overall Study||26||
59804921|NCT04288115|75926457|FG000|COMPLETED|Overall Study||21||
59804922|NCT04288115|75926458|FG001|COMPLETED|Overall Study||23||
59957908|NCT00834639|76076611|FG000|NOT COMPLETED|Second Intervention||0||
59957909|NCT00834639|76076612|FG001|NOT COMPLETED|Second Intervention||2||
59957910|NCT00834561|76076618|FG000|STARTED|First Intervention||16||
59957911|NCT00834561|76076619|FG001|STARTED|First Intervention||16||
59957912|NCT00834561|76076618|FG000|COMPLETED|First Intervention||16||
59957913|NCT00834561|76076619|FG001|COMPLETED|First Intervention||16||
59524184|NCT00995501|75619331|FG006|COMPLETED|Overall Study||49||
59524185|NCT00995501|75619332|FG007|COMPLETED|Overall Study||46||
59524186|NCT00995501|75619325|FG000|NOT COMPLETED|Overall Study||0||
59804923|NCT04288115|75926457|FG000|NOT COMPLETED|Overall Study||3||
59804924|NCT04288115|75926458|FG001|NOT COMPLETED|Overall Study||3||
59804925|NCT04287868|75926469|FG000|STARTED|Overall Study||48||
59804926|NCT04287868|75926470|FG001|STARTED|Overall Study||3||
59804927|NCT04287868|75926469|FG000|COMPLETED|Overall Study||47||
59804928|NCT04287868|75926470|FG001|COMPLETED|Overall Study||3||
59524187|NCT00995501|75619326|FG001|NOT COMPLETED|Overall Study||0||
59524188|NCT00995501|75619327|FG002|NOT COMPLETED|Overall Study||0||
59524189|NCT00995501|75619328|FG003|NOT COMPLETED|Overall Study||0||
59804929|NCT04287868|75926469|FG000|NOT COMPLETED|Overall Study||1||
59804930|NCT04287868|75926470|FG001|NOT COMPLETED|Overall Study||0||
59804931|NCT04276935|75926481|FG000|STARTED|Overall Study||20||
59804932|NCT04276935|75926481|FG000|Round 1|Overall Study||10||
59804933|NCT04276935|75926481|FG000|Round 2|Overall Study||7||
59804934|NCT04276935|75926481|FG000|COMPLETED|Overall Study||17||
59804935|NCT04276935|75926481|FG000|NOT COMPLETED|Overall Study||3||
59804936|NCT04191096|75926487|FG000|STARTED|Overall Study||626||
59804937|NCT04191096|75926488|FG001|STARTED|Overall Study||625||
59804938|NCT04191096|75926487|FG000|COMPLETED|Overall Study||0||
59804939|NCT04191096|75926488|FG001|COMPLETED|Overall Study||0||
59804940|NCT04191096|75926487|FG000|NOT COMPLETED|Overall Study||626||
59804941|NCT04191096|75926488|FG001|NOT COMPLETED|Overall Study||625||
59804942|NCT04145531|75926498|FG000|STARTED|Part A||33||
59804943|NCT04145531|75926499|FG001|STARTED|Part A||83||
59804944|NCT04145531|75926500|FG002|STARTED|Part A||51||
59804945|NCT04145531|75926501|FG003|STARTED|Part A||0||
59804946|NCT04145531|75926498|FG000|Safety Analysis Set|Part A||33||
59804947|NCT04145531|75926499|FG001|Safety Analysis Set|Part A||83||
59804948|NCT04145531|75926500|FG002|Safety Analysis Set|Part A||51||
59804949|NCT04145531|75926501|FG003|Safety Analysis Set|Part A||0||
59804950|NCT04145531|75926498|FG000|Efficacy Analysis Set|Part A||32||
59804951|NCT04145531|75926499|FG001|Efficacy Analysis Set|Part A||83||
59804952|NCT04145531|75926500|FG002|Efficacy Analysis Set|Part A||50||
59804953|NCT04145531|75926501|FG003|Efficacy Analysis Set|Part A||0||
59804954|NCT04145531|75926498|FG000|COMPLETED|Part A||27||
59804955|NCT04145531|75926499|FG001|COMPLETED|Part A||62||
59804956|NCT04145531|75926500|FG002|COMPLETED|Part A||39||
59804957|NCT04145531|75926501|FG003|COMPLETED|Part A||0||
59804958|NCT04145531|75926498|FG000|NOT COMPLETED|Part A||6||
59804959|NCT04145531|75926499|FG001|NOT COMPLETED|Part A||21||
59804960|NCT04145531|75926500|FG002|NOT COMPLETED|Part A||12||
59804961|NCT04145531|75926501|FG003|NOT COMPLETED|Part A||0||
59804962|NCT04145531|75926498|FG000|STARTED|Part B||0||
59804963|NCT04145531|75926499|FG001|STARTED|Part B||0||
59804964|NCT04145531|75926500|FG002|STARTED|Part B||0||
59804965|NCT04145531|75926501|FG003|STARTED|Part B||62||
59804966|NCT04145531|75926498|FG000|Safety Analysis Set|Part B||0||
59804967|NCT04145531|75926499|FG001|Safety Analysis Set|Part B||0||
59804968|NCT04145531|75926500|FG002|Safety Analysis Set|Part B||0||
59804969|NCT04145531|75926501|FG003|Safety Analysis Set|Part B||61||
59804970|NCT04145531|75926498|FG000|Efficacy Analysis Set|Part B||0||
59804971|NCT04145531|75926499|FG001|Efficacy Analysis Set|Part B||0||
59804972|NCT04145531|75926500|FG002|Efficacy Analysis Set|Part B||0||
59804973|NCT04145531|75926501|FG003|Efficacy Analysis Set|Part B||59||
59804974|NCT04145531|75926498|FG000|COMPLETED|Part B||0||
59804975|NCT04145531|75926499|FG001|COMPLETED|Part B||0||
59804976|NCT04145531|75926500|FG002|COMPLETED|Part B||0||
59804977|NCT04145531|75926501|FG003|COMPLETED|Part B||27||
59957914|NCT00834561|76076618|FG000|NOT COMPLETED|First Intervention||0||
59524190|NCT00995501|75619329|FG004|NOT COMPLETED|Overall Study||0||
59524191|NCT00995501|75619330|FG005|NOT COMPLETED|Overall Study||0||
59524192|NCT00995501|75619331|FG006|NOT COMPLETED|Overall Study||0||
59524193|NCT00995501|75619332|FG007|NOT COMPLETED|Overall Study||0||
59804978|NCT04145531|75926498|FG000|NOT COMPLETED|Part B||0||
59804979|NCT04145531|75926499|FG001|NOT COMPLETED|Part B||0||
59804980|NCT04145531|75926500|FG002|NOT COMPLETED|Part B||0||
59804981|NCT04145531|75926501|FG003|NOT COMPLETED|Part B||35||
59957915|NCT00834561|76076619|FG001|NOT COMPLETED|First Intervention||0||
59957916|NCT00834561|76076618|FG000|STARTED|Second Intervention||16||
59804982|NCT04124692|75926513|FG000|STARTED|Overall Study||52||
59804983|NCT04124692|75926514|FG001|STARTED|Overall Study||97||
59804984|NCT04124692|75926513|FG000|COMPLETED|Overall Study||46||
59804985|NCT04124692|75926514|FG001|COMPLETED|Overall Study||88||
59804986|NCT04124692|75926513|FG000|NOT COMPLETED|Overall Study||6||
59524194|NCT01942694|75619352|FG000|STARTED|Overall Study||1212||
59804987|NCT04124692|75926514|FG001|NOT COMPLETED|Overall Study||9||
59804988|NCT04029883|75926526|FG000|STARTED|Overall Study||20||
59957917|NCT00834561|76076619|FG001|STARTED|Second Intervention||16||
59524195|NCT01942694|75619353|FG001|STARTED|Overall Study||1211||
59524196|NCT01942694|75619352|FG000|COMPLETED|Overall Study||1211||
59524197|NCT01942694|75619353|FG001|COMPLETED|Overall Study||1211||
59524198|NCT01942694|75619352|FG000|NOT COMPLETED|Overall Study||1||
59957918|NCT00834561|76076618|FG000|COMPLETED|Second Intervention||16||
59957919|NCT00834561|76076619|FG001|COMPLETED|Second Intervention||16||
59957920|NCT00834561|76076618|FG000|NOT COMPLETED|Second Intervention||0||
59957921|NCT00834561|76076619|FG001|NOT COMPLETED|Second Intervention||0||
59957922|NCT00834405|76076625|FG000|STARTED|Overall Study||20||
59957923|NCT00834405|76076626|FG001|STARTED|Overall Study||17||
59957924|NCT00834405|76076625|FG000|COMPLETED|Overall Study||20||
59957925|NCT00834405|76076626|FG001|COMPLETED|Overall Study||17||
59957926|NCT00834405|76076625|FG000|NOT COMPLETED|Overall Study||0||
59957927|NCT00834405|76076626|FG001|NOT COMPLETED|Overall Study||0||
59957928|NCT00834249|76076632|FG000|STARTED|First Intervention||9||
59957929|NCT00834249|76076633|FG001|STARTED|First Intervention||9||
59957930|NCT00834249|76076632|FG000|COMPLETED|First Intervention||9||
59957931|NCT00834249|76076633|FG001|COMPLETED|First Intervention||9||
59957932|NCT00834249|76076632|FG000|NOT COMPLETED|First Intervention||0||
59957933|NCT00834249|76076633|FG001|NOT COMPLETED|First Intervention||0||
59957934|NCT00834249|76076632|FG000|STARTED|Washout: 7 Days||9||
59957935|NCT00834249|76076633|FG001|STARTED|Washout: 7 Days||9||
59957936|NCT00834249|76076632|FG000|COMPLETED|Washout: 7 Days||8||
59957937|NCT00834249|76076633|FG001|COMPLETED|Washout: 7 Days||8||
59957938|NCT00834249|76076632|FG000|NOT COMPLETED|Washout: 7 Days||1||
59957939|NCT00834249|76076633|FG001|NOT COMPLETED|Washout: 7 Days||1||
59957940|NCT00834249|76076632|FG000|STARTED|Second Intervention||8||
59957941|NCT00834249|76076633|FG001|STARTED|Second Intervention||8||
59957942|NCT00834249|76076632|FG000|COMPLETED|Second Intervention||7||
59957943|NCT00834249|76076633|FG001|COMPLETED|Second Intervention||8||
59957944|NCT00834249|76076632|FG000|NOT COMPLETED|Second Intervention||1||
59957945|NCT00834249|76076633|FG001|NOT COMPLETED|Second Intervention||0||
59957946|NCT00833937|76076639|FG000|STARTED|First Intervention||12||
59957947|NCT00833937|76076640|FG001|STARTED|First Intervention||12||
59957948|NCT00833937|76076639|FG000|COMPLETED|First Intervention||12||
59957949|NCT00833937|76076640|FG001|COMPLETED|First Intervention||12||
59957950|NCT00833937|76076639|FG000|NOT COMPLETED|First Intervention||0||
59957951|NCT00833937|76076640|FG001|NOT COMPLETED|First Intervention||0||
59957952|NCT00833937|76076639|FG000|STARTED|Washout||12||
59957953|NCT00833937|76076640|FG001|STARTED|Washout||12||
59957954|NCT00833937|76076639|FG000|COMPLETED|Washout||11||
59957955|NCT00833937|76076640|FG001|COMPLETED|Washout||12||
59957956|NCT00833937|76076639|FG000|NOT COMPLETED|Washout||1||
59957957|NCT00833937|76076640|FG001|NOT COMPLETED|Washout||0||
59957958|NCT00833937|76076639|FG000|STARTED|Second Intervention||11||
59957959|NCT00833937|76076640|FG001|STARTED|Second Intervention||12||
59957960|NCT00833937|76076639|FG000|COMPLETED|Second Intervention||11||
59957961|NCT00833937|76076640|FG001|COMPLETED|Second Intervention||12||
59957962|NCT00833937|76076639|FG000|NOT COMPLETED|Second Intervention||0||
60073910|NCT01931059|76189257|FG001|COMPLETED|Day 1||4||
60073911|NCT01931059|76189256|FG000|NOT COMPLETED|Day 1||0||
60073912|NCT01931059|76189257|FG001|NOT COMPLETED|Day 1||1||
60073913|NCT01931059|76189256|FG000|STARTED|Day2||6||
60073914|NCT01931059|76189257|FG001|STARTED|Day2||4||
60073915|NCT01931059|76189256|FG000|COMPLETED|Day2||6||
60073916|NCT01931059|76189257|FG001|COMPLETED|Day2||4||
60073917|NCT01931059|76189256|FG000|NOT COMPLETED|Day2||0||
60073918|NCT01931059|76189257|FG001|NOT COMPLETED|Day2||0||
60073919|NCT01931059|76189256|FG000|STARTED|Day3||6||
60073920|NCT01931059|76189257|FG001|STARTED|Day3||4||
60073921|NCT01931059|76189256|FG000|COMPLETED|Day3||5||
60073922|NCT01931059|76189257|FG001|COMPLETED|Day3||4||
60073923|NCT01931059|76189256|FG000|NOT COMPLETED|Day3||1||
60073924|NCT01931059|76189257|FG001|NOT COMPLETED|Day3||0||
59524199|NCT01942694|75619353|FG001|NOT COMPLETED|Overall Study||0||
59524200|NCT01153711|75619359|FG000|STARTED|Overall Study||32||
59524201|NCT01153711|75619359|FG000|COMPLETED|Overall Study||32||
59524202|NCT01153711|75619359|FG000|NOT COMPLETED|Overall Study||0||
59524203|NCT02168855|75619367|FG000|STARTED|Overall Study||181||
59524204|NCT02168855|75619368|FG001|STARTED|Overall Study||188||
59957963|NCT00833937|76076640|FG001|NOT COMPLETED|Second Intervention||0||
59957964|NCT00924170|76076646|FG000|STARTED|Overall Study||10||
59957965|NCT00924170|76076647|FG001|STARTED|Overall Study||8||
60073925|NCT01841762|76189269|FG000|STARTED|Screening Period||335||
60073926|NCT01841762|76189269|FG000|COMPLETED|Screening Period||284||
59524205|NCT02168855|75619367|FG000|COMPLETED|Overall Study||169||
59524206|NCT02168855|75619368|FG001|COMPLETED|Overall Study||177||
59957966|NCT00924170|76076646|FG000|COMPLETED|Overall Study||3||
59957967|NCT00924170|76076647|FG001|COMPLETED|Overall Study||0||
59957968|NCT00924170|76076646|FG000|NOT COMPLETED|Overall Study||7||
59957969|NCT00924170|76076647|FG001|NOT COMPLETED|Overall Study||8||
59957970|NCT00828321|76076661|FG000|STARTED|First Intervention||20||
59957971|NCT00828321|76076662|FG001|STARTED|First Intervention||20||
60073927|NCT01841762|76189269|FG000|NOT COMPLETED|Screening Period||51||
60073928|NCT01841762|76189269|FG000|STARTED|Treatment Period||284||
60073929|NCT01841762|76189269|FG000|COMPLETED|Treatment Period||252||
59957972|NCT00828321|76076661|FG000|COMPLETED|First Intervention||20||
59957973|NCT00828321|76076662|FG001|COMPLETED|First Intervention||20||
59957974|NCT00828321|76076661|FG000|NOT COMPLETED|First Intervention||0||
59957975|NCT00828321|76076662|FG001|NOT COMPLETED|First Intervention||0||
59957976|NCT00828321|76076661|FG000|STARTED|Washout of 42 Days||20||
59957977|NCT00828321|76076662|FG001|STARTED|Washout of 42 Days||20||
59957978|NCT00828321|76076661|FG000|COMPLETED|Washout of 42 Days||18||
59957979|NCT00828321|76076662|FG001|COMPLETED|Washout of 42 Days||20||
59957980|NCT00828321|76076661|FG000|NOT COMPLETED|Washout of 42 Days||2||
59957981|NCT00828321|76076662|FG001|NOT COMPLETED|Washout of 42 Days||0||
59957982|NCT00828321|76076661|FG000|STARTED|Second Intervention||18||
59957983|NCT00828321|76076662|FG001|STARTED|Second Intervention||20||
59957984|NCT00828321|76076661|FG000|COMPLETED|Second Intervention||18||
59957985|NCT00828321|76076662|FG001|COMPLETED|Second Intervention||19||
59957986|NCT00828321|76076661|FG000|NOT COMPLETED|Second Intervention||0||
59957987|NCT00828321|76076662|FG001|NOT COMPLETED|Second Intervention||1||
59957988|NCT01352715|76076668|FG000|STARTED|Overall Study||260||
59957989|NCT01352715|76076669|FG001|STARTED|Overall Study||255||
59957990|NCT01352715|76076668|FG000|COMPLETED|Overall Study||215||
59957991|NCT01352715|76076669|FG001|COMPLETED|Overall Study||209||
59957992|NCT01352715|76076668|FG000|NOT COMPLETED|Overall Study||45||
59957993|NCT01352715|76076669|FG001|NOT COMPLETED|Overall Study||46||
59957994|NCT00740727|76076675|FG000|STARTED|Overall Study||18||
59957995|NCT00740727|76076675|FG000|COMPLETED|Overall Study||18||
59957996|NCT00740727|76076675|FG000|NOT COMPLETED|Overall Study||0||
59957997|NCT00919893|76076680|FG000|STARTED|Overall Study||70||
59957998|NCT00919893|76076681|FG001|STARTED|Overall Study||69||
59957999|NCT00919893|76076680|FG000|COMPLETED|Overall Study||51||
59958000|NCT00919893|76076681|FG001|COMPLETED|Overall Study||60||
59958001|NCT00919893|76076680|FG000|NOT COMPLETED|Overall Study||19||
59958002|NCT00919893|76076681|FG001|NOT COMPLETED|Overall Study||9||
59958003|NCT02559622|76076689|FG000|STARTED|Overall Study||48||
59958004|NCT02559622|76076690|FG001|STARTED|Overall Study||54||
59958005|NCT02559622|76076691|FG002|STARTED|Overall Study||26||
59958006|NCT02559622|76076692|FG003|STARTED|Overall Study||23||
59958007|NCT02559622|76076689|FG000|COMPLETED|Overall Study||47||
59958008|NCT02559622|76076690|FG001|COMPLETED|Overall Study||49||
59958009|NCT02559622|76076691|FG002|COMPLETED|Overall Study||24||
59958010|NCT02559622|76076692|FG003|COMPLETED|Overall Study||20||
59958011|NCT02559622|76076689|FG000|NOT COMPLETED|Overall Study||1||
59958012|NCT02559622|76076690|FG001|NOT COMPLETED|Overall Study||5||
59958013|NCT02559622|76076691|FG002|NOT COMPLETED|Overall Study||2||
59958014|NCT02559622|76076692|FG003|NOT COMPLETED|Overall Study||3||
60073930|NCT01841762|76189269|FG000|NOT COMPLETED|Treatment Period||32||
60073931|NCT01841762|76189269|FG000|STARTED|Post-Treatment Safety Follow-Up Period||284||
59804989|NCT04029883|75926527|FG001|STARTED|Overall Study||20||
59804990|NCT04029883|75926528|FG002|STARTED|Overall Study||20||
59804991|NCT04029883|75926526|FG000|COMPLETED|Overall Study||17||
59804992|NCT04029883|75926527|FG001|COMPLETED|Overall Study||13||
59804993|NCT04029883|75926528|FG002|COMPLETED|Overall Study||18||
60073932|NCT01841762|76189269|FG000|COMPLETED|Post-Treatment Safety Follow-Up Period||269||
60073933|NCT01841762|76189269|FG000|NOT COMPLETED|Post-Treatment Safety Follow-Up Period||15||
59804994|NCT04029883|75926526|FG000|NOT COMPLETED|Overall Study||3||
59804995|NCT04029883|75926527|FG001|NOT COMPLETED|Overall Study||7||
60073934|NCT03301636|76189276|FG000|STARTED|Overall Study||7||
60073935|NCT03301636|76189277|FG001|STARTED|Overall Study||6||
60073936|NCT03301636|76189278|FG002|STARTED|Overall Study||8||
59958015|NCT02559310|76076708|FG000|STARTED|Overall Study||276||
59958016|NCT02559310|76076709|FG001|STARTED|Overall Study||275||
59958017|NCT02559310|76076708|FG000|COMPLETED|Overall Study||249||
59958018|NCT02559310|76076709|FG001|COMPLETED|Overall Study||256||
60073937|NCT03301636|76189276|FG000|COMPLETED|Overall Study||7||
59958019|NCT02559310|76076708|FG000|NOT COMPLETED|Overall Study||27||
59958020|NCT02559310|76076709|FG001|NOT COMPLETED|Overall Study||19||
59958021|NCT02555878|76076717|FG000|STARTED|Overall Study||421||
59958022|NCT02555878|76076718|FG001|STARTED|Overall Study||420||
59958023|NCT02555878|76076717|FG000|Treated|Overall Study||404||
59958024|NCT02555878|76076718|FG001|Treated|Overall Study||405||
60073938|NCT03301636|76189277|FG001|COMPLETED|Overall Study||6||
59804996|NCT04029883|75926528|FG002|NOT COMPLETED|Overall Study||2||
59958025|NCT02555878|76076717|FG000|COMPLETED|Overall Study||255||
59958026|NCT02555878|76076718|FG001|COMPLETED|Overall Study||270||
59958027|NCT02555878|76076717|FG000|NOT COMPLETED|Overall Study||166||
59958028|NCT02555878|76076718|FG001|NOT COMPLETED|Overall Study||150||
59958029|NCT02555722|76076726|FG000|STARTED|Lens Dispensed||60||
59804997|NCT04018066|75926536|FG000|STARTED|Overall Study|34 participants were enrolled in the study|34||
59958030|NCT02555722|76076727|FG001|STARTED|Lens Dispensed||30||
59958031|NCT02555722|76076726|FG000|COMPLETED|Lens Dispensed||60||
59958032|NCT02555722|76076727|FG001|COMPLETED|Lens Dispensed||30||
59958033|NCT02555722|76076726|FG000|NOT COMPLETED|Lens Dispensed||0||
59958034|NCT02555722|76076727|FG001|NOT COMPLETED|Lens Dispensed||0||
59958035|NCT02555722|76076726|FG000|STARTED|Week 1||60||
60073939|NCT03301636|76189278|FG002|COMPLETED|Overall Study||8||
59958036|NCT02555722|76076727|FG001|STARTED|Week 1||30||
59958037|NCT02555722|76076726|FG000|COMPLETED|Week 1||60||
59958038|NCT02555722|76076727|FG001|COMPLETED|Week 1||30||
59958039|NCT02555722|76076726|FG000|NOT COMPLETED|Week 1||0||
59958040|NCT02555722|76076727|FG001|NOT COMPLETED|Week 1||0||
59958041|NCT02555722|76076726|FG000|STARTED|Week 2||60||
59958042|NCT02555722|76076727|FG001|STARTED|Week 2||30||
59958043|NCT02555722|76076726|FG000|COMPLETED|Week 2||59||
59958044|NCT02555722|76076727|FG001|COMPLETED|Week 2||29||
59958045|NCT02555722|76076726|FG000|NOT COMPLETED|Week 2||1||
59958046|NCT02555722|76076727|FG001|NOT COMPLETED|Week 2||1||
59958047|NCT02555722|76076726|FG000|STARTED|Month 1||59||
59958048|NCT02555722|76076727|FG001|STARTED|Month 1||29||
59958049|NCT02555722|76076726|FG000|COMPLETED|Month 1||58||
59958050|NCT02555722|76076727|FG001|COMPLETED|Month 1||29||
59958051|NCT02555722|76076726|FG000|NOT COMPLETED|Month 1||1||
59958052|NCT02555722|76076727|FG001|NOT COMPLETED|Month 1||0||
59958053|NCT02555722|76076726|FG000|STARTED|Month 2||58||
59958054|NCT02555722|76076727|FG001|STARTED|Month 2||29||
59958055|NCT02555722|76076726|FG000|COMPLETED|Month 2||54||
59958056|NCT02555722|76076727|FG001|COMPLETED|Month 2||29||
59958057|NCT02555722|76076726|FG000|NOT COMPLETED|Month 2||4||
59958058|NCT02555722|76076727|FG001|NOT COMPLETED|Month 2||0||
59958059|NCT02555722|76076726|FG000|STARTED|Month 3||54||
59958060|NCT02555722|76076727|FG001|STARTED|Month 3||29||
59958061|NCT02555722|76076726|FG000|COMPLETED|Month 3||54||
59958062|NCT02555722|76076727|FG001|COMPLETED|Month 3||29||
59958063|NCT02555722|76076726|FG000|NOT COMPLETED|Month 3||0||
59958064|NCT02555722|76076727|FG001|NOT COMPLETED|Month 3||0||
59958065|NCT00003224|76076762|FG000|STARTED|Overall Study||4||
59958066|NCT00003224|76076763|FG001|STARTED|Overall Study||5||
59958067|NCT00003224|76076764|FG002|STARTED|Overall Study||4||
59958068|NCT00003224|76076765|FG003|STARTED|Overall Study||2||
59958069|NCT00003224|76076766|FG004|STARTED|Overall Study||4||
59958070|NCT00003224|76076767|FG005|STARTED|Overall Study||3||
59958071|NCT00003224|76076762|FG000|COMPLETED|Overall Study||4||
59958072|NCT00003224|76076763|FG001|COMPLETED|Overall Study||5||
60073940|NCT03301636|76189276|FG000|NOT COMPLETED|Overall Study||0||
60073941|NCT03301636|76189277|FG001|NOT COMPLETED|Overall Study||0||
59524207|NCT02168855|75619367|FG000|NOT COMPLETED|Overall Study||12||
59524208|NCT02168855|75619368|FG001|NOT COMPLETED|Overall Study||11||
59524209|NCT02168933|75619376|FG000|STARTED|Overall Study||8||
59524210|NCT02168933|75619376|FG000|COMPLETED|Overall Study||7||
59524211|NCT02168933|75619376|FG000|NOT COMPLETED|Overall Study||1||
59524212|NCT01239511|75619388|FG000|STARTED|Overall Study||47||
59524213|NCT01239511|75619389|FG001|STARTED|Overall Study||45||
59524214|NCT01239511|75619390|FG002|STARTED|Overall Study||47||
59524215|NCT01239511|75619391|FG003|STARTED|Overall Study||47||
59620806|NCT00282672|75732200|FG003|COMPLETED|5 Year: Follow up||20||
59620807|NCT00282672|75732197|FG000|NOT COMPLETED|5 Year: Follow up||1||
59620808|NCT00282672|75732198|FG001|NOT COMPLETED|5 Year: Follow up||5||
59620809|NCT00282672|75732199|FG002|NOT COMPLETED|5 Year: Follow up||0||
59620810|NCT00282672|75732200|FG003|NOT COMPLETED|5 Year: Follow up||5||
59620811|NCT00282828|75732237|FG000|STARTED|Overall Study||63||
59620812|NCT00282828|75732238|FG001|STARTED|Overall Study||59||
59524216|NCT01239511|75619388|FG000|COMPLETED|Overall Study||46||
59620813|NCT00282828|75732239|FG002|STARTED|Overall Study||59||
59524217|NCT01239511|75619389|FG001|COMPLETED|Overall Study||40||
59620814|NCT00282828|75732237|FG000|COMPLETED|Overall Study||57||
59620815|NCT00282828|75732238|FG001|COMPLETED|Overall Study||47||
59620816|NCT00282828|75732239|FG002|COMPLETED|Overall Study||50||
59620817|NCT00282828|75732237|FG000|NOT COMPLETED|Overall Study||6||
59620818|NCT00282828|75732238|FG001|NOT COMPLETED|Overall Study||12||
59620819|NCT00282828|75732239|FG002|NOT COMPLETED|Overall Study||9||
59620820|NCT00112242|75732252|FG000|STARTED|Overall Study||10||
59524218|NCT01239511|75619390|FG002|COMPLETED|Overall Study||43||
59524219|NCT01239511|75619391|FG003|COMPLETED|Overall Study||38||
59524220|NCT01239511|75619388|FG000|NOT COMPLETED|Overall Study||1||
59524221|NCT01239511|75619389|FG001|NOT COMPLETED|Overall Study||5||
59524222|NCT01239511|75619390|FG002|NOT COMPLETED|Overall Study||4||
59524223|NCT01239511|75619391|FG003|NOT COMPLETED|Overall Study||9||
59524224|NCT00997139|75619401|FG000|STARTED|Overall Study||216||
59620821|NCT00112242|75732253|FG001|STARTED|Overall Study||5||
59620822|NCT00112242|75732254|FG002|STARTED|Overall Study||5||
59958073|NCT00003224|76076764|FG002|COMPLETED|Overall Study||4||
59958074|NCT00003224|76076765|FG003|COMPLETED|Overall Study||2||
59958075|NCT00003224|76076766|FG004|COMPLETED|Overall Study||4||
59958076|NCT00003224|76076767|FG005|COMPLETED|Overall Study||3||
59958077|NCT00003224|76076762|FG000|NOT COMPLETED|Overall Study||0||
59958078|NCT00003224|76076763|FG001|NOT COMPLETED|Overall Study||0||
59958079|NCT00003224|76076764|FG002|NOT COMPLETED|Overall Study||0||
59958080|NCT00003224|76076765|FG003|NOT COMPLETED|Overall Study||0||
59958081|NCT00003224|76076766|FG004|NOT COMPLETED|Overall Study||0||
59958082|NCT00003224|76076767|FG005|NOT COMPLETED|Overall Study||0||
59958083|NCT03287960|76076779|FG000|STARTED|Titration Period (2 to 12 Weeks)||15||
59958084|NCT03287960|76076779|FG000|COMPLETED|Titration Period (2 to 12 Weeks)||15||
59958085|NCT03287960|76076779|FG000|NOT COMPLETED|Titration Period (2 to 12 Weeks)||0||
59958086|NCT03287960|76076779|FG000|STARTED|Open-Label Period (10 Weeks)||15||
59958087|NCT03287960|76076779|FG000|COMPLETED|Open-Label Period (10 Weeks)||14||
59958088|NCT03287960|76076779|FG000|NOT COMPLETED|Open-Label Period (10 Weeks)||1||
59958089|NCT03287960|76076779|FG000|STARTED|Double-Blind Withdrawal Period (8 Weeks)||14||
59958090|NCT03287960|76076779|FG000|COMPLETED|Double-Blind Withdrawal Period (8 Weeks)||14||
59958091|NCT03287960|76076779|FG000|NOT COMPLETED|Double-Blind Withdrawal Period (8 Weeks)||0||
59958092|NCT03287960|76076779|FG000|STARTED|Open-Label Period (32 Weeks)||14||
59958093|NCT03287960|76076779|FG000|COMPLETED|Open-Label Period (32 Weeks)||13||
59958094|NCT03287960|76076779|FG000|NOT COMPLETED|Open-Label Period (32 Weeks)||1||
59958095|NCT02558296|76076786|FG000|STARTED|Completed the Study Through Week 24||1133||
59804998|NCT04018066|75926536|FG000|COMPLETED|Overall Study|30 participants completed the study protocol.|30||
59804999|NCT04018066|75926536|FG000|NOT COMPLETED|Overall Study||4||
59805000|NCT03811249|75926541|FG000|STARTED|Overall Study|Subjects were allowed to enroll during any phase of the long-term follow-up study through the closure of the 60 month window. Due to the timing of study initiation, many subjects had already passed the 36 month window by the time enrollment ensued.|287||565
59805001|NCT03811249|75926541|FG000|COMPLETED|Overall Study||219||433
59805002|NCT03811249|75926541|FG000|NOT COMPLETED|Overall Study||68||132
59805003|NCT03678688|75926555|FG000|STARTED|Overall Study||14||
59805004|NCT03678688|75926556|FG001|STARTED|Overall Study||14||
59805005|NCT03678688|75926557|FG002|STARTED|Overall Study||17||
59805006|NCT03678688|75926558|FG003|STARTED|Overall Study||14||
59805007|NCT03678688|75926559|FG004|STARTED|Overall Study||17||
59805008|NCT03678688|75926560|FG005|STARTED|Overall Study||14||
59805009|NCT03678688|75926561|FG006|STARTED|Overall Study||14||
59805010|NCT03678688|75926562|FG007|STARTED|Overall Study||14||
59805011|NCT03678688|75926563|FG008|STARTED|Overall Study||4||
59805012|NCT03678688|75926555|FG000|Efficacy Analysis Set/ MITT Set|Overall Study||14|Modified Intent-to-Treat (MITT) Analysis Set included randomized participants who were agar media culture positive at baseline (either at Day -2 or at Day -1, or both), received any dose of investigational medicinal product (IMP), and had at least one post-baseline colony forming unit (CFU) count value.|
59805013|NCT03678688|75926556|FG001|Efficacy Analysis Set/ MITT Set|Overall Study||11|Modified Intent-to-Treat (MITT) Analysis Set included randomized participants who were agar media culture positive at baseline (either at Day -2 or at Day -1, or both), received any dose of investigational medicinal product (IMP), and had at least one post-baseline colony forming unit (CFU) count value.|
59805014|NCT03678688|75926557|FG002|Efficacy Analysis Set/ MITT Set|Overall Study||14|Modified Intent-to-Treat (MITT) Analysis Set included randomized participants who were agar media culture positive at baseline (either at Day -2 or at Day -1, or both), received any dose of investigational medicinal product (IMP), and had at least one post-baseline colony forming unit (CFU) count value.|
59805015|NCT03678688|75926558|FG003|Efficacy Analysis Set/ MITT Set|Overall Study||14|Modified Intent-to-Treat (MITT) Analysis Set included randomized participants who were agar media culture positive at baseline (either at Day -2 or at Day -1, or both), received any dose of investigational medicinal product (IMP), and had at least one post-baseline colony forming unit (CFU) count value.|
59805016|NCT03678688|75926559|FG004|Efficacy Analysis Set/ MITT Set|Overall Study||15|Modified Intent-to-Treat (MITT) Analysis Set included randomized participants who were agar media culture positive at baseline (either at Day -2 or at Day -1, or both), received any dose of investigational medicinal product (IMP), and had at least one post-baseline colony forming unit (CFU) count value.|
59805017|NCT03678688|75926560|FG005|Efficacy Analysis Set/ MITT Set|Overall Study||11|Modified Intent-to-Treat (MITT) Analysis Set included randomized participants who were agar media culture positive at baseline (either at Day -2 or at Day -1, or both), received any dose of investigational medicinal product (IMP), and had at least one post-baseline colony forming unit (CFU) count value.|
59805018|NCT03678688|75926561|FG006|Efficacy Analysis Set/ MITT Set|Overall Study||11|Modified Intent-to-Treat (MITT) Analysis Set included randomized participants who were agar media culture positive at baseline (either at Day -2 or at Day -1, or both), received any dose of investigational medicinal product (IMP), and had at least one post-baseline colony forming unit (CFU) count value.|
59805019|NCT03678688|75926562|FG007|Efficacy Analysis Set/ MITT Set|Overall Study||12|Modified Intent-to-Treat (MITT) Analysis Set included randomized participants who were agar media culture positive at baseline (either at Day -2 or at Day -1, or both), received any dose of investigational medicinal product (IMP), and had at least one post-baseline colony forming unit (CFU) count value.|
59805020|NCT03678688|75926563|FG008|Efficacy Analysis Set/ MITT Set|Overall Study||4|Modified Intent-to-Treat (MITT) Analysis Set included randomized participants who were agar media culture positive at baseline (either at Day -2 or at Day -1, or both), received any dose of investigational medicinal product (IMP), and had at least one post-baseline colony forming unit (CFU) count value.|
59805021|NCT03678688|75926555|FG000|Safety Analysis Set|Overall Study||14|Safety Analysis Set included participants who were randomized and took any dose of IMP.|
59805022|NCT03678688|75926556|FG001|Safety Analysis Set|Overall Study||14|Safety Analysis Set included participants who were randomized and took any dose of IMP.|
59817876|NCT04488770|75940328|FG002|STARTED|Part 1-Cohort 2: Period 1 (Up to 5 Days)||0||
59958096|NCT02558296|76076787|FG001|STARTED|Completed the Study Through Week 24||567||
59958097|NCT02558296|76076786|FG000|COMPLETED|Completed the Study Through Week 24||1089||
59958098|NCT02558296|76076787|FG001|COMPLETED|Completed the Study Through Week 24||542||
59958099|NCT02558296|76076786|FG000|NOT COMPLETED|Completed the Study Through Week 24||44||
59958100|NCT02558296|76076787|FG001|NOT COMPLETED|Completed the Study Through Week 24||25||
59958101|NCT02558296|76076786|FG000|STARTED|Completed the Study||1133|The number of participants started is equal to ITT population|
59958102|NCT02558296|76076787|FG001|STARTED|Completed the Study||567|The number of participants started is equal to ITT population|
59958103|NCT02558296|76076786|FG000|COMPLETED|Completed the Study||987||
59958104|NCT02558296|76076787|FG001|COMPLETED|Completed the Study||482||
59805023|NCT03678688|75926557|FG002|Safety Analysis Set|Overall Study||17|Safety Analysis Set included participants who were randomized and took any dose of IMP.|
59958105|NCT02558296|76076786|FG000|NOT COMPLETED|Completed the Study||146||
59958106|NCT02558296|76076787|FG001|NOT COMPLETED|Completed the Study||85||
59958107|NCT02737475|76076824|FG000|STARTED|Overall Study||4|Treated|
59958108|NCT02737475|76076825|FG001|STARTED|Overall Study||4|Treated|
59958109|NCT02737475|76076826|FG002|STARTED|Overall Study||4|Treated|
59958110|NCT02737475|76076827|FG003|STARTED|Overall Study||4|Treated|
59958111|NCT02737475|76076828|FG004|STARTED|Overall Study||4|Treated|
59958112|NCT02737475|76076829|FG005|STARTED|Overall Study||7|Treated|
59958113|NCT02737475|76076830|FG006|STARTED|Overall Study||8|Treated|
59958114|NCT02737475|76076831|FG007|STARTED|Overall Study||12|Treated|
59958115|NCT02737475|76076832|FG008|STARTED|Overall Study||8|Treated|
59958116|NCT02737475|76076833|FG009|STARTED|Overall Study||8|Treated|
59958117|NCT02737475|76076834|FG010|STARTED|Overall Study||4|Treated|
59958118|NCT02737475|76076835|FG011|STARTED|Overall Study||10|Treated|
59805024|NCT03678688|75926558|FG003|Safety Analysis Set|Overall Study||14|Safety Analysis Set included participants who were randomized and took any dose of IMP.|
59805025|NCT03678688|75926559|FG004|Safety Analysis Set|Overall Study||16|Safety Analysis Set included participants who were randomized and took any dose of IMP.|
59805026|NCT03678688|75926560|FG005|Safety Analysis Set|Overall Study||13|Safety Analysis Set included participants who were randomized and took any dose of IMP.|
59805027|NCT03678688|75926561|FG006|Safety Analysis Set|Overall Study||13|Safety Analysis Set included participants who were randomized and took any dose of IMP.|
59805028|NCT03678688|75926562|FG007|Safety Analysis Set|Overall Study||14|Safety Analysis Set included participants who were randomized and took any dose of IMP.|
59805029|NCT03678688|75926563|FG008|Safety Analysis Set|Overall Study||4|Safety Analysis Set included participants who were randomized and took any dose of IMP.|
59805030|NCT03678688|75926555|FG000|Pharmacokinetic (PK) Analysis Set|Overall Study||14|PK Analysis Set included all participants who received at least one dose of IMP and had 1 quantifiable drug concentration.|
59805031|NCT03678688|75926556|FG001|Pharmacokinetic (PK) Analysis Set|Overall Study||14|PK Analysis Set included all participants who received at least one dose of IMP and had 1 quantifiable drug concentration.|
59805032|NCT03678688|75926557|FG002|Pharmacokinetic (PK) Analysis Set|Overall Study||17|PK Analysis Set included all participants who received at least one dose of IMP and had 1 quantifiable drug concentration.|
59958119|NCT02737475|76076836|FG012|STARTED|Overall Study||7|Treated|
59958120|NCT02737475|76076837|FG013|STARTED|Overall Study||8|Treated|
59958121|NCT02737475|76076838|FG014|STARTED|Overall Study||6|Treated|
59958122|NCT02737475|76076839|FG015|STARTED|Overall Study||18|Treated|
59958123|NCT02737475|76076840|FG016|STARTED|Overall Study||12|Treated|
59958124|NCT02737475|76076841|FG017|STARTED|Overall Study||6|Treated|
59958125|NCT02737475|76076842|FG018|STARTED|Overall Study||7|Treated|
59958126|NCT02737475|76076843|FG019|STARTED|Overall Study||1|Treated|
59958127|NCT02737475|76076844|FG020|STARTED|Overall Study||6|Treated|
59958128|NCT02737475|76076845|FG021|STARTED|Overall Study||9|Treated|
59958129|NCT02737475|76076846|FG022|STARTED|Overall Study||2|Treated|
59958130|NCT02737475|76076847|FG023|STARTED|Overall Study||2|Treated|
59958131|NCT02737475|76076848|FG024|STARTED|Overall Study||2|Treated|
59958132|NCT02737475|76076849|FG025|STARTED|Overall Study||2|Treated|
59958133|NCT02737475|76076850|FG026|STARTED|Overall Study||1|Treated|
59958134|NCT02737475|76076824|FG000|COMPLETED|Overall Study||3|Participants continuing in the study|
59958135|NCT02737475|76076825|FG001|COMPLETED|Overall Study||4|Participants continuing in the study|
59958136|NCT02737475|76076826|FG002|COMPLETED|Overall Study||4|Participants continuing in the study|
59958137|NCT02737475|76076827|FG003|COMPLETED|Overall Study||3|Participants continuing in the study|
59958138|NCT02737475|76076828|FG004|COMPLETED|Overall Study||3|Participants continuing in the study|
59958139|NCT02737475|76076829|FG005|COMPLETED|Overall Study||4|Participants continuing in the study|
59958140|NCT02737475|76076830|FG006|COMPLETED|Overall Study||8|Participants continuing in the study|
59805033|NCT03678688|75926558|FG003|Pharmacokinetic (PK) Analysis Set|Overall Study||14|PK Analysis Set included all participants who received at least one dose of IMP and had 1 quantifiable drug concentration.|
59958141|NCT02737475|76076831|FG007|COMPLETED|Overall Study||10|Participants continuing in the study|
59958142|NCT02737475|76076832|FG008|COMPLETED|Overall Study||7|Participants continuing in the study|
59958143|NCT02737475|76076833|FG009|COMPLETED|Overall Study||8|Participants continuing in the study|
59958144|NCT02737475|76076834|FG010|COMPLETED|Overall Study||3|Participants continuing in the study|
59958145|NCT02737475|76076835|FG011|COMPLETED|Overall Study||6|Participants continuing in the study|
59958146|NCT02737475|76076836|FG012|COMPLETED|Overall Study||5|Participants continuing in the study|
59958147|NCT02737475|76076837|FG013|COMPLETED|Overall Study||6|Participants continuing in the study|
59958148|NCT02737475|76076838|FG014|COMPLETED|Overall Study||5|Participants continuing in the study|
59958149|NCT02737475|76076839|FG015|COMPLETED|Overall Study||15|Participants continuing in the study|
59958150|NCT02737475|76076840|FG016|COMPLETED|Overall Study||10|Participants continuing in the study|
59958151|NCT02737475|76076841|FG017|COMPLETED|Overall Study||2|Participants continuing in the study|
59995272|NCT04263987|76111095|FG000|NOT COMPLETED|Overall Study||0||
59995273|NCT04263987|76111096|FG001|NOT COMPLETED|Overall Study||0||
59995274|NCT04064229|76111102|FG000|STARTED|Overall Study||99||198
59995275|NCT04064229|76111102|FG000|COMPLETED|Overall Study||99||198
59995276|NCT04064229|76111102|FG000|NOT COMPLETED|Overall Study||0||0
59805034|NCT03678688|75926559|FG004|Pharmacokinetic (PK) Analysis Set|Overall Study||11|PK Analysis Set included all participants who received at least one dose of IMP and had 1 quantifiable drug concentration.|
59805035|NCT03678688|75926560|FG005|Pharmacokinetic (PK) Analysis Set|Overall Study||13|PK Analysis Set included all participants who received at least one dose of IMP and had 1 quantifiable drug concentration.|
59805036|NCT03678688|75926561|FG006|Pharmacokinetic (PK) Analysis Set|Overall Study||13|PK Analysis Set included all participants who received at least one dose of IMP and had 1 quantifiable drug concentration.|
59805037|NCT03678688|75926562|FG007|Pharmacokinetic (PK) Analysis Set|Overall Study||14|PK Analysis Set included all participants who received at least one dose of IMP and had 1 quantifiable drug concentration.|
59805038|NCT03678688|75926563|FG008|Pharmacokinetic (PK) Analysis Set|Overall Study||4|PK Analysis Set included all participants who received at least one dose of IMP and had 1 quantifiable drug concentration.|
59805039|NCT03678688|75926555|FG000|COMPLETED|Overall Study||14||
59805040|NCT03678688|75926556|FG001|COMPLETED|Overall Study||14||
59805041|NCT03678688|75926557|FG002|COMPLETED|Overall Study||14||
59805042|NCT03678688|75926558|FG003|COMPLETED|Overall Study||13||
59805043|NCT03678688|75926559|FG004|COMPLETED|Overall Study||16||
59805044|NCT03678688|75926560|FG005|COMPLETED|Overall Study||10||
59805045|NCT03678688|75926561|FG006|COMPLETED|Overall Study||9||
59805046|NCT03678688|75926562|FG007|COMPLETED|Overall Study||11||
59805047|NCT03678688|75926563|FG008|COMPLETED|Overall Study||4||
59805048|NCT03678688|75926555|FG000|NOT COMPLETED|Overall Study||0||
59805049|NCT03678688|75926556|FG001|NOT COMPLETED|Overall Study||0||
59805050|NCT03678688|75926557|FG002|NOT COMPLETED|Overall Study||3||
59805051|NCT03678688|75926558|FG003|NOT COMPLETED|Overall Study||1||
59805052|NCT03678688|75926559|FG004|NOT COMPLETED|Overall Study||1||
59805053|NCT03678688|75926560|FG005|NOT COMPLETED|Overall Study||4||
59805054|NCT03678688|75926561|FG006|NOT COMPLETED|Overall Study||5||
59805055|NCT03678688|75926562|FG007|NOT COMPLETED|Overall Study||3||
59805056|NCT03678688|75926563|FG008|NOT COMPLETED|Overall Study||0||
59805057|NCT03641742|75926599|FG000|STARTED|Overall Study||27||
59805058|NCT03641742|75926600|FG001|STARTED|Overall Study||98||
59805059|NCT03641742|75926599|FG000|COMPLETED|Overall Study||27||
59805060|NCT03641742|75926600|FG001|COMPLETED|Overall Study||98||
59805061|NCT03641742|75926599|FG000|NOT COMPLETED|Overall Study||0||
59958152|NCT02737475|76076842|FG018|COMPLETED|Overall Study||5|Participants continuing in the study|
59958153|NCT02737475|76076843|FG019|COMPLETED|Overall Study||1|Participants continuing in the study|
59958154|NCT02737475|76076844|FG020|COMPLETED|Overall Study||4|Participants continuing in the study|
59958155|NCT02737475|76076845|FG021|COMPLETED|Overall Study||8|Participants continuing in the study|
59958156|NCT02737475|76076846|FG022|COMPLETED|Overall Study||2|Participants continuing in the study|
59958157|NCT02737475|76076847|FG023|COMPLETED|Overall Study||1|Participants continuing in the study|
59958158|NCT02737475|76076848|FG024|COMPLETED|Overall Study||1|Participants continuing in the study|
59958159|NCT02737475|76076849|FG025|COMPLETED|Overall Study||1|Participants continuing in the study|
59958160|NCT02737475|76076850|FG026|COMPLETED|Overall Study||0|Participants continuing in the study|
59958161|NCT02737475|76076824|FG000|NOT COMPLETED|Overall Study||1||
59958162|NCT02737475|76076825|FG001|NOT COMPLETED|Overall Study||0||
59958163|NCT02737475|76076826|FG002|NOT COMPLETED|Overall Study||0||
59958164|NCT02737475|76076827|FG003|NOT COMPLETED|Overall Study||1||
59958165|NCT02737475|76076828|FG004|NOT COMPLETED|Overall Study||1||
59958166|NCT02737475|76076829|FG005|NOT COMPLETED|Overall Study||3||
59958167|NCT02737475|76076830|FG006|NOT COMPLETED|Overall Study||0||
59958168|NCT02737475|76076831|FG007|NOT COMPLETED|Overall Study||2||
59958169|NCT02737475|76076832|FG008|NOT COMPLETED|Overall Study||1||
59958170|NCT02737475|76076833|FG009|NOT COMPLETED|Overall Study||0||
59958171|NCT02737475|76076834|FG010|NOT COMPLETED|Overall Study||1||
59958172|NCT02737475|76076835|FG011|NOT COMPLETED|Overall Study||4||
59958173|NCT02737475|76076836|FG012|NOT COMPLETED|Overall Study||2||
59958174|NCT02737475|76076837|FG013|NOT COMPLETED|Overall Study||2||
59958175|NCT02737475|76076838|FG014|NOT COMPLETED|Overall Study||1||
59958176|NCT02737475|76076839|FG015|NOT COMPLETED|Overall Study||3||
59958177|NCT02737475|76076840|FG016|NOT COMPLETED|Overall Study||2||
59958178|NCT02737475|76076841|FG017|NOT COMPLETED|Overall Study||4||
59958179|NCT02737475|76076842|FG018|NOT COMPLETED|Overall Study||2||
59958180|NCT02737475|76076843|FG019|NOT COMPLETED|Overall Study||0||
59958181|NCT02737475|76076844|FG020|NOT COMPLETED|Overall Study||2||
59958182|NCT02737475|76076845|FG021|NOT COMPLETED|Overall Study||1||
59958183|NCT02737475|76076846|FG022|NOT COMPLETED|Overall Study||0||
59958184|NCT02737475|76076847|FG023|NOT COMPLETED|Overall Study||1||
59958185|NCT02737475|76076848|FG024|NOT COMPLETED|Overall Study||1||
59958186|NCT02737475|76076849|FG025|NOT COMPLETED|Overall Study||1||
59958187|NCT02737475|76076850|FG026|NOT COMPLETED|Overall Study||1||
59958188|NCT02557672|76076940|FG000|STARTED|Overall Study||53||
59958189|NCT02557672|76076941|FG001|STARTED|Overall Study||53||
59958190|NCT02557672|76076940|FG000|COMPLETED|Overall Study||49||
59958191|NCT02557672|76076941|FG001|COMPLETED|Overall Study||51||
60073942|NCT03301636|76189278|FG002|NOT COMPLETED|Overall Study||0||
60073943|NCT01841060|76189286|FG000|STARTED|Overall Study||42||
60073944|NCT01841060|76189286|FG000|COMPLETED|Overall Study||32||
60073945|NCT01841060|76189286|FG000|NOT COMPLETED|Overall Study||10||
60073946|NCT01814696|76189292|FG000|STARTED|Overall Study||15||
60073947|NCT01814696|76189293|FG001|STARTED|Overall Study||11||
60073948|NCT01814696|76189292|FG000|COMPLETED|Overall Study||13||
60073949|NCT01814696|76189293|FG001|COMPLETED|Overall Study||11||
60073950|NCT01814696|76189292|FG000|NOT COMPLETED|Overall Study||2||
60073951|NCT01814696|76189293|FG001|NOT COMPLETED|Overall Study||0||
60073952|NCT01970371|76189302|FG000|STARTED|Overall Study||18||
60073953|NCT01970371|76189303|FG001|STARTED|Overall Study||21||
59620823|NCT00112242|75732255|FG003|STARTED|Overall Study||10||
59620824|NCT00112242|75732256|FG004|STARTED|Overall Study|One patient received only 1 vaccine however this minimum dose allowed the safety evaluation|9||
59620825|NCT00112242|75732252|FG000|Cycle 1 Completed|Overall Study||10||
59805062|NCT03641742|75926600|FG001|NOT COMPLETED|Overall Study||0||
59620826|NCT00112242|75732253|FG001|Cycle 1 Completed|Overall Study||5||
59620827|NCT00112242|75732254|FG002|Cycle 1 Completed|Overall Study||5||
59620828|NCT00112242|75732255|FG003|Cycle 1 Completed|Overall Study||9||
59620829|NCT00112242|75732256|FG004|Cycle 1 Completed|Overall Study||7||
59620830|NCT00112242|75732252|FG000|Cycle 2 Completed|Overall Study||8||
59805063|NCT03624036|75926610|FG000|STARTED|Overall Study||7||
59805064|NCT03624036|75926611|FG001|STARTED|Overall Study||3||
59805065|NCT03624036|75926612|FG002|STARTED|Overall Study||3||
59805066|NCT03624036|75926613|FG003|STARTED|Overall Study||3||
59805067|NCT03624036|75926610|FG000|COMPLETED|Overall Study||0||
59805068|NCT03624036|75926611|FG001|COMPLETED|Overall Study||0||
59805069|NCT03624036|75926612|FG002|COMPLETED|Overall Study||0||
59805070|NCT03624036|75926613|FG003|COMPLETED|Overall Study||0||
59805071|NCT03624036|75926610|FG000|NOT COMPLETED|Overall Study||7||
59805072|NCT03624036|75926611|FG001|NOT COMPLETED|Overall Study||3||
59805073|NCT03624036|75926612|FG002|NOT COMPLETED|Overall Study||3||
59805074|NCT03624036|75926613|FG003|NOT COMPLETED|Overall Study||3||
59805075|NCT03602612|75926632|FG000|STARTED|Dose Escalation Phase|No participants were enrolled in this Arm/Group.|0||
59805076|NCT03602612|75926633|FG001|STARTED|Dose Escalation Phase||6||
59805077|NCT03602612|75926634|FG002|STARTED|Dose Escalation Phase||3||
59805078|NCT03602612|75926635|FG003|STARTED|Dose Escalation Phase||2||
60073954|NCT01970371|76189304|FG002|STARTED|Overall Study||30||
60073955|NCT01970371|76189302|FG000|COMPLETED|Overall Study||10||
60073956|NCT01970371|76189303|FG001|COMPLETED|Overall Study||8||
60073957|NCT01970371|76189304|FG002|COMPLETED|Overall Study||17||
60073958|NCT01970371|76189302|FG000|NOT COMPLETED|Overall Study||8||
60073959|NCT01970371|76189303|FG001|NOT COMPLETED|Overall Study||13||
60073960|NCT01970371|76189304|FG002|NOT COMPLETED|Overall Study||13||
60073961|NCT03300466|76189316|FG000|STARTED|Overall Study||10||
60073962|NCT03300466|76189317|FG001|STARTED|Overall Study||10||
60073963|NCT03300466|76189316|FG000|COMPLETED|Overall Study||9||
60073964|NCT03300466|76189317|FG001|COMPLETED|Overall Study||10||
59805079|NCT03602612|75926636|FG004|STARTED|Dose Escalation Phase||3||
59805080|NCT03602612|75926637|FG005|STARTED|Dose Escalation Phase||3||
59805081|NCT03602612|75926638|FG006|STARTED|Dose Escalation Phase||0||
59805082|NCT03602612|75926639|FG007|STARTED|Dose Escalation Phase||1||
59805083|NCT03602612|75926640|FG008|STARTED|Dose Escalation Phase||8||
59805084|NCT03602612|75926641|FG009|STARTED|Dose Escalation Phase||1||
59958192|NCT02557672|76076940|FG000|NOT COMPLETED|Overall Study||4||
59958193|NCT02557672|76076941|FG001|NOT COMPLETED|Overall Study||2||
59958194|NCT02502071|76076947|FG000|STARTED|Overall Study||45||
59958195|NCT02502071|76076947|FG000|COMPLETED|Overall Study||45||
59958196|NCT02502071|76076947|FG000|NOT COMPLETED|Overall Study||0||
59958197|NCT02714426|76076953|FG000|STARTED|Overall Study||21||
59958198|NCT02714426|76076954|FG001|STARTED|Overall Study||21||
59958199|NCT02714426|76076953|FG000|COMPLETED|Overall Study||19||
60073965|NCT03300466|76189316|FG000|NOT COMPLETED|Overall Study||1||
59620831|NCT00112242|75732253|FG001|Cycle 2 Completed|Overall Study||3||
59620832|NCT00112242|75732254|FG002|Cycle 2 Completed|Overall Study||4||
59620833|NCT00112242|75732255|FG003|Cycle 2 Completed|Overall Study||8||
59620834|NCT00112242|75732256|FG004|Cycle 2 Completed|Overall Study||4||
59620835|NCT00112242|75732252|FG000|Cycle 3 Completed|Overall Study||5||
59620836|NCT00112242|75732253|FG001|Cycle 3 Completed|Overall Study||3||
59620837|NCT00112242|75732254|FG002|Cycle 3 Completed|Overall Study||4||
59620838|NCT00112242|75732255|FG003|Cycle 3 Completed|Overall Study||4||
59620839|NCT00112242|75732256|FG004|Cycle 3 Completed|Overall Study||2||
59620840|NCT00112242|75732252|FG000|COMPLETED|Overall Study||5|Received 3 cycles of treatment|
59620841|NCT00112242|75732253|FG001|COMPLETED|Overall Study||3|Received 3 cycles of treatment|
59620842|NCT00112242|75732254|FG002|COMPLETED|Overall Study||4|Received 3 cycles of treatment|
59805085|NCT03602612|75926632|FG000|COMPLETED|Dose Escalation Phase||0||
59805086|NCT03602612|75926633|FG001|COMPLETED|Dose Escalation Phase||6||
59805087|NCT03602612|75926634|FG002|COMPLETED|Dose Escalation Phase||3||
59620843|NCT00112242|75732255|FG003|COMPLETED|Overall Study||4|Received 3 cycles of treatment|
59620844|NCT00112242|75732256|FG004|COMPLETED|Overall Study||2|Received 3 cycles of treatment|
59620845|NCT00112242|75732252|FG000|NOT COMPLETED|Overall Study||5||
59620846|NCT00112242|75732253|FG001|NOT COMPLETED|Overall Study||2||
59620847|NCT00112242|75732254|FG002|NOT COMPLETED|Overall Study||1||
59620848|NCT00112242|75732255|FG003|NOT COMPLETED|Overall Study||6||
59805088|NCT03602612|75926635|FG003|COMPLETED|Dose Escalation Phase||2||
59805089|NCT03602612|75926636|FG004|COMPLETED|Dose Escalation Phase||3||
59805090|NCT03602612|75926637|FG005|COMPLETED|Dose Escalation Phase||3||
59805091|NCT03602612|75926638|FG006|COMPLETED|Dose Escalation Phase||0||
59805092|NCT03602612|75926639|FG007|COMPLETED|Dose Escalation Phase||1||
59805093|NCT03602612|75926640|FG008|COMPLETED|Dose Escalation Phase||0||
59805094|NCT03602612|75926641|FG009|COMPLETED|Dose Escalation Phase||0||
59805095|NCT03602612|75926632|FG000|NOT COMPLETED|Dose Escalation Phase||0||
59805096|NCT03602612|75926633|FG001|NOT COMPLETED|Dose Escalation Phase||0||
59805097|NCT03602612|75926634|FG002|NOT COMPLETED|Dose Escalation Phase||0||
59805098|NCT03602612|75926635|FG003|NOT COMPLETED|Dose Escalation Phase||0||
59805099|NCT03602612|75926636|FG004|NOT COMPLETED|Dose Escalation Phase||0||
59805100|NCT03602612|75926637|FG005|NOT COMPLETED|Dose Escalation Phase||0||
59805101|NCT03602612|75926638|FG006|NOT COMPLETED|Dose Escalation Phase||0||
59805102|NCT03602612|75926639|FG007|NOT COMPLETED|Dose Escalation Phase||0||
59805103|NCT03602612|75926640|FG008|NOT COMPLETED|Dose Escalation Phase||8||
59805104|NCT03602612|75926641|FG009|NOT COMPLETED|Dose Escalation Phase||1||
59805105|NCT03602612|75926632|FG000|STARTED|Dose Expansion Phase||0||
59620849|NCT00112242|75732256|FG004|NOT COMPLETED|Overall Study||7||
59620850|NCT00284154|75732276|FG000|STARTED|Overall Study||51||
59620851|NCT00284154|75732276|FG000|COMPLETED|Overall Study||9||
59620852|NCT00284154|75732276|FG000|NOT COMPLETED|Overall Study||42||
59620853|NCT00285246|75732280|FG000|STARTED|Overall Study||838||
59620854|NCT00285246|75732280|FG000|COMPLETED|Overall Study|Number of participants who were eligible and completed at least one phase of data collection|790||
59620855|NCT00285246|75732280|FG000|NOT COMPLETED|Overall Study||48||
59620856|NCT00223236|75732286|FG000|STARTED|Overall Study|23 completed baseline assessment but 16 completed at least one treatment visit.|16||
59620857|NCT00223236|75732287|FG001|STARTED|Overall Study|21 completed baseline assessment but 18 completed at least one treatment visit.|18||
59620858|NCT00223236|75732286|FG000|COMPLETED|Overall Study|9 completed 12 week trial.|9||
59620859|NCT00223236|75732287|FG001|COMPLETED|Overall Study|4 completed 12 week trial.|4||
59620860|NCT00223236|75732286|FG000|NOT COMPLETED|Overall Study||7||
59620861|NCT00223236|75732287|FG001|NOT COMPLETED|Overall Study||14||
59620862|NCT00223704|75732296|FG000|STARTED|Overall Study||38||
59620863|NCT00223704|75732297|FG001|STARTED|Overall Study||37||
59620864|NCT00223704|75732298|FG002|STARTED|Overall Study||40||
59620865|NCT00223704|75732296|FG000|COMPLETED|Overall Study||38||
59620866|NCT00223704|75732297|FG001|COMPLETED|Overall Study||37||
59620867|NCT00223704|75732298|FG002|COMPLETED|Overall Study||40||
59805106|NCT03602612|75926633|FG001|STARTED|Dose Expansion Phase||0||
59805107|NCT03602612|75926634|FG002|STARTED|Dose Expansion Phase||0||
59805108|NCT03602612|75926635|FG003|STARTED|Dose Expansion Phase||0||
59805109|NCT03602612|75926636|FG004|STARTED|Dose Expansion Phase||0||
59620868|NCT00223704|75732296|FG000|NOT COMPLETED|Overall Study||0||
59620869|NCT00223704|75732297|FG001|NOT COMPLETED|Overall Study||0||
59805110|NCT03602612|75926637|FG005|STARTED|Dose Expansion Phase||0||
59805111|NCT03602612|75926638|FG006|STARTED|Dose Expansion Phase||8||
59805112|NCT03602612|75926639|FG007|STARTED|Dose Expansion Phase||1||
59805113|NCT03602612|75926640|FG008|STARTED|Dose Expansion Phase||0||
59805114|NCT03602612|75926641|FG009|STARTED|Dose Expansion Phase||0||
59620870|NCT00223704|75732298|FG002|NOT COMPLETED|Overall Study||0||
59620871|NCT00224952|75732309|FG000|STARTED|Overall Study||53||
59620872|NCT00224952|75732310|FG001|STARTED|Overall Study||87||
59805115|NCT03602612|75926632|FG000|COMPLETED|Dose Expansion Phase||0||
59805116|NCT03602612|75926633|FG001|COMPLETED|Dose Expansion Phase||0||
59805117|NCT03602612|75926634|FG002|COMPLETED|Dose Expansion Phase||0||
59620873|NCT00224952|75732311|FG002|STARTED|Overall Study||134||
59620874|NCT00224952|75732309|FG000|COMPLETED|Overall Study||53||
59805118|NCT03602612|75926635|FG003|COMPLETED|Dose Expansion Phase||0||
59805119|NCT03602612|75926636|FG004|COMPLETED|Dose Expansion Phase||0||
59805120|NCT03602612|75926637|FG005|COMPLETED|Dose Expansion Phase||0||
59805121|NCT03602612|75926638|FG006|COMPLETED|Dose Expansion Phase||8||
59958200|NCT02714426|76076954|FG001|COMPLETED|Overall Study||19||
59958201|NCT02714426|76076953|FG000|NOT COMPLETED|Overall Study||2||
59958202|NCT02714426|76076954|FG001|NOT COMPLETED|Overall Study||2||
59958203|NCT04500821|76076960|FG000|STARTED|Overall Study||44||88
59805122|NCT03602612|75926639|FG007|COMPLETED|Dose Expansion Phase||1||
59805123|NCT03602612|75926640|FG008|COMPLETED|Dose Expansion Phase||0||
59805124|NCT03602612|75926641|FG009|COMPLETED|Dose Expansion Phase||0||
59805125|NCT03602612|75926632|FG000|NOT COMPLETED|Dose Expansion Phase||0||
59805126|NCT03602612|75926633|FG001|NOT COMPLETED|Dose Expansion Phase||0||
59805127|NCT03602612|75926634|FG002|NOT COMPLETED|Dose Expansion Phase||0||
59805128|NCT03602612|75926635|FG003|NOT COMPLETED|Dose Expansion Phase||0||
59805129|NCT03602612|75926636|FG004|NOT COMPLETED|Dose Expansion Phase||0||
59805130|NCT03602612|75926637|FG005|NOT COMPLETED|Dose Expansion Phase||0||
59805131|NCT03602612|75926638|FG006|NOT COMPLETED|Dose Expansion Phase||0||
59805132|NCT03602612|75926639|FG007|NOT COMPLETED|Dose Expansion Phase||0||
59805133|NCT03602612|75926640|FG008|NOT COMPLETED|Dose Expansion Phase||0||
59805134|NCT03602612|75926641|FG009|NOT COMPLETED|Dose Expansion Phase||0||
59805135|NCT03489291|75926658|FG000|STARTED|Overall Study||3||
59805136|NCT03489291|75926658|FG000|COMPLETED|Overall Study||3||
59805137|NCT03489291|75926658|FG000|NOT COMPLETED|Overall Study||0||
59805138|NCT03442569|75926662|FG000|STARTED|Overall Study||56||
59805139|NCT03442569|75926662|FG000|Started Treatment|Overall Study||55||
59805140|NCT03442569|75926662|FG000|COMPLETED|Overall Study||55||
59805141|NCT03442569|75926662|FG000|NOT COMPLETED|Overall Study||1||
59805142|NCT03235544|75926670|FG000|STARTED|Overall Study||12||
59805143|NCT03235544|75926671|FG001|STARTED|Overall Study||41||
59805144|NCT03235544|75926672|FG002|STARTED|Overall Study||31||
59805145|NCT03235544|75926673|FG003|STARTED|Overall Study||77||
59805146|NCT03235544|75926670|FG000|COMPLETED|Overall Study||0||
59805147|NCT03235544|75926671|FG001|COMPLETED|Overall Study||0||
59805148|NCT03235544|75926672|FG002|COMPLETED|Overall Study||0||
59805149|NCT03235544|75926673|FG003|COMPLETED|Overall Study||0||
59620875|NCT00224952|75732310|FG001|COMPLETED|Overall Study||87||
59620876|NCT00224952|75732311|FG002|COMPLETED|Overall Study||134||
59620877|NCT00224952|75732309|FG000|NOT COMPLETED|Overall Study||0||
59805150|NCT03235544|75926670|FG000|NOT COMPLETED|Overall Study||12||
59805151|NCT03235544|75926671|FG001|NOT COMPLETED|Overall Study||41||
59805152|NCT03235544|75926672|FG002|NOT COMPLETED|Overall Study||31||
59805153|NCT03235544|75926673|FG003|NOT COMPLETED|Overall Study||77||
59805154|NCT03187353|75926686|FG000|STARTED|First Intervention (6 Weeks)||36||
59805155|NCT03187353|75926687|FG001|STARTED|First Intervention (6 Weeks)||33||
59805156|NCT03187353|75926686|FG000|COMPLETED|First Intervention (6 Weeks)||33||
59805157|NCT03187353|75926687|FG001|COMPLETED|First Intervention (6 Weeks)||30||
59805158|NCT03187353|75926686|FG000|NOT COMPLETED|First Intervention (6 Weeks)||3||
59805159|NCT03187353|75926687|FG001|NOT COMPLETED|First Intervention (6 Weeks)||3||
59805160|NCT03187353|75926686|FG000|STARTED|Washout (2 Weeks)||33||
59805161|NCT03187353|75926687|FG001|STARTED|Washout (2 Weeks)||30||
59805162|NCT03187353|75926686|FG000|COMPLETED|Washout (2 Weeks)||29||
59805163|NCT03187353|75926687|FG001|COMPLETED|Washout (2 Weeks)||29||
59805164|NCT03187353|75926686|FG000|NOT COMPLETED|Washout (2 Weeks)||4||
59805165|NCT03187353|75926687|FG001|NOT COMPLETED|Washout (2 Weeks)||1||
59805166|NCT03187353|75926686|FG000|STARTED|Second Intervention (6 Weeks)||29||
59805167|NCT03187353|75926687|FG001|STARTED|Second Intervention (6 Weeks)||29||
59805168|NCT03187353|75926686|FG000|COMPLETED|Second Intervention (6 Weeks)||28||
59805169|NCT03187353|75926687|FG001|COMPLETED|Second Intervention (6 Weeks)||29||
59805170|NCT03187353|75926686|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||1||
59805171|NCT03187353|75926687|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||0||
59805172|NCT03176693|75926699|FG000|STARTED|Overall Study||19||
59958204|NCT04500821|76076960|FG000|COMPLETED|Overall Study||44||88
59958205|NCT04500821|76076960|FG000|NOT COMPLETED|Overall Study||0||0
59958206|NCT02925923|76076967|FG000|STARTED|Overall Study||50||
59805173|NCT03176693|75926700|FG001|STARTED|Overall Study||20||
59805174|NCT03176693|75926699|FG000|COMPLETED|Overall Study||19||
59805175|NCT03176693|75926700|FG001|COMPLETED|Overall Study||20||
59805176|NCT03176693|75926699|FG000|NOT COMPLETED|Overall Study||0||
59805177|NCT03176693|75926700|FG001|NOT COMPLETED|Overall Study||0||
59805178|NCT03094052|75926706|FG000|STARTED|Overall Study||11||
59805179|NCT03094052|75926706|FG000|COMPLETED|Overall Study||11||
59805180|NCT03094052|75926706|FG000|NOT COMPLETED|Overall Study||0||
59805181|NCT03083821|75926710|FG000|STARTED|Overall Study||6||
59958207|NCT02925923|76076968|FG001|STARTED|Overall Study||50||
59805182|NCT03083821|75926710|FG000|COMPLETED|Overall Study||6||
59805183|NCT03083821|75926710|FG000|NOT COMPLETED|Overall Study||0||
59805184|NCT03071393|75926714|FG000|STARTED|First Intervention (Single Day Session)||7||
59958208|NCT02925923|76076967|FG000|COMPLETED|Overall Study||50||
59958209|NCT02925923|76076968|FG001|COMPLETED|Overall Study||48||
59958210|NCT02925923|76076967|FG000|NOT COMPLETED|Overall Study||0||
59805185|NCT03071393|75926715|FG001|STARTED|First Intervention (Single Day Session)||10||
59805186|NCT03071393|75926714|FG000|COMPLETED|First Intervention (Single Day Session)||7||
59805187|NCT03071393|75926715|FG001|COMPLETED|First Intervention (Single Day Session)||10||
59805188|NCT03071393|75926714|FG000|NOT COMPLETED|First Intervention (Single Day Session)||0||
59805189|NCT03071393|75926715|FG001|NOT COMPLETED|First Intervention (Single Day Session)||0||
59805190|NCT03071393|75926714|FG000|STARTED|Washout (at Least 7 Days)||7||
59805191|NCT03071393|75926715|FG001|STARTED|Washout (at Least 7 Days)||10||
59805192|NCT03071393|75926714|FG000|COMPLETED|Washout (at Least 7 Days)||7||
59805193|NCT03071393|75926715|FG001|COMPLETED|Washout (at Least 7 Days)||10||
59805194|NCT03071393|75926714|FG000|NOT COMPLETED|Washout (at Least 7 Days)||0||
59805195|NCT03071393|75926715|FG001|NOT COMPLETED|Washout (at Least 7 Days)||0||
59805196|NCT03071393|75926714|FG000|STARTED|Intervention 2 (Single Day Session)||7||
59805197|NCT03071393|75926715|FG001|STARTED|Intervention 2 (Single Day Session)||10||
59805198|NCT03071393|75926714|FG000|COMPLETED|Intervention 2 (Single Day Session)||7||
59805199|NCT03071393|75926715|FG001|COMPLETED|Intervention 2 (Single Day Session)||10||
59805200|NCT03071393|75926714|FG000|NOT COMPLETED|Intervention 2 (Single Day Session)||0||
59805201|NCT03071393|75926715|FG001|NOT COMPLETED|Intervention 2 (Single Day Session)||0||
59805202|NCT03056001|75926723|FG000|STARTED|Overall Study||30||
59805203|NCT03056001|75926723|FG000|COMPLETED|Overall Study||6||
59805204|NCT03056001|75926723|FG000|NOT COMPLETED|Overall Study||24||
59805205|NCT03043599|75926727|FG000|STARTED|Overall Study||21||
59805206|NCT03043599|75926727|FG000|COMPLETED|Overall Study||21||
59805207|NCT03043599|75926727|FG000|NOT COMPLETED|Overall Study||0||
59805208|NCT02998918|75926733|FG000|STARTED|Overall Study||11||
59958211|NCT02925923|76076968|FG001|NOT COMPLETED|Overall Study||2||
59958212|NCT02410343|76076976|FG000|STARTED|Core Period (24 Weeks)||6||
59958213|NCT02410343|76076977|FG001|STARTED|Core Period (24 Weeks)||8||
59958214|NCT02410343|76076976|FG000|COMPLETED|Core Period (24 Weeks)||1||
59958215|NCT02410343|76076977|FG001|COMPLETED|Core Period (24 Weeks)||1||
59958216|NCT02410343|76076976|FG000|NOT COMPLETED|Core Period (24 Weeks)||5||
59958217|NCT02410343|76076977|FG001|NOT COMPLETED|Core Period (24 Weeks)||7||
59958218|NCT02410343|76076976|FG000|STARTED|Extension Period (12 Months)||1||
59958219|NCT02410343|76076977|FG001|STARTED|Extension Period (12 Months)||1||
59958220|NCT02410343|76076976|FG000|COMPLETED|Extension Period (12 Months)||0||
59958221|NCT02410343|76076977|FG001|COMPLETED|Extension Period (12 Months)||0||
59958222|NCT02410343|76076976|FG000|NOT COMPLETED|Extension Period (12 Months)||1||
59805209|NCT02998918|75926734|FG001|STARTED|Overall Study||10||
59805210|NCT02998918|75926733|FG000|COMPLETED|Overall Study||10||
59805211|NCT02998918|75926734|FG001|COMPLETED|Overall Study||10||
59805212|NCT02998918|75926733|FG000|NOT COMPLETED|Overall Study||1||
59805213|NCT02998918|75926734|FG001|NOT COMPLETED|Overall Study||0||
59805214|NCT02990338|75926742|FG000|STARTED|Overall Study||153||
59805215|NCT02990338|75926743|FG001|STARTED|Overall Study||154||
59805216|NCT02990338|75926742|FG000|Treated|Overall Study||149||
59805217|NCT02990338|75926743|FG001|Treated|Overall Study||152||
59805218|NCT02990338|75926742|FG000|COMPLETED|Overall Study||123||
59805219|NCT02990338|75926743|FG001|COMPLETED|Overall Study||118||
59805220|NCT02990338|75926742|FG000|NOT COMPLETED|Overall Study||30||
59805221|NCT02990338|75926743|FG001|NOT COMPLETED|Overall Study||36||
59805222|NCT02875561|75926754|FG000|STARTED|Overall Study||19||
59805223|NCT02875561|75926755|FG001|STARTED|Overall Study||28||
59805224|NCT02875561|75926754|FG000|COMPLETED|Overall Study||19||
59958223|NCT02410343|76076977|FG001|NOT COMPLETED|Extension Period (12 Months)||1||
59958224|NCT03064841|76076984|FG000|STARTED|Overall Study||1537||
59958225|NCT03064841|76076984|FG000|COMPLETED|Overall Study||1520||
59958226|NCT03064841|76076984|FG000|NOT COMPLETED|Overall Study||17||
59958227|NCT02045303|76076990|FG000|STARTED|Overall Study||6||6
59958228|NCT02045303|76076991|FG001|STARTED|Overall Study||3||10
59805225|NCT02875561|75926755|FG001|COMPLETED|Overall Study||28||
59805226|NCT02875561|75926754|FG000|NOT COMPLETED|Overall Study||0||
59805227|NCT02875561|75926755|FG001|NOT COMPLETED|Overall Study||0||
59805228|NCT02742246|75926764|FG000|STARTED|Overall Study||34|Number randomized to treatment assignment|
59805229|NCT02742246|75926765|FG001|STARTED|Overall Study||32|Number randomized to treatment assignment|
59805230|NCT02742246|75926766|FG002|STARTED|Overall Study||33|Number randomized to treatment assignment|
59805231|NCT02742246|75926764|FG000|COMPLETED|Overall Study||21||
59805232|NCT02742246|75926765|FG001|COMPLETED|Overall Study||16||
59805233|NCT02742246|75926766|FG002|COMPLETED|Overall Study||22||
59805234|NCT02742246|75926764|FG000|NOT COMPLETED|Overall Study||13||
59805235|NCT02742246|75926765|FG001|NOT COMPLETED|Overall Study||16||
59805236|NCT02742246|75926766|FG002|NOT COMPLETED|Overall Study||11||
59805237|NCT02733042|75926793|FG000|STARTED|Overall Study||3||
59805238|NCT02733042|75926794|FG001|STARTED|Overall Study||3||
59958229|NCT02045303|76076992|FG002|STARTED|Overall Study||2||8
59958230|NCT02045303|76076990|FG000|COMPLETED|Overall Study||4||4
59958231|NCT02045303|76076991|FG001|COMPLETED|Overall Study||0||0
59958232|NCT02045303|76076992|FG002|COMPLETED|Overall Study||2||8
59958233|NCT02045303|76076990|FG000|NOT COMPLETED|Overall Study||2||2
59958234|NCT02045303|76076991|FG001|NOT COMPLETED|Overall Study||3||10
59805239|NCT02733042|75926795|FG002|STARTED|Overall Study||8||
59805240|NCT02733042|75926796|FG003|STARTED|Overall Study||3||
59805241|NCT02733042|75926797|FG004|STARTED|Overall Study||4||
59805242|NCT02733042|75926798|FG005|STARTED|Overall Study||3||
59805243|NCT02733042|75926799|FG006|STARTED|Overall Study||1||
59805244|NCT02733042|75926800|FG007|STARTED|Overall Study||4||
59805245|NCT02733042|75926801|FG008|STARTED|Overall Study||5||
59805246|NCT02733042|75926802|FG009|STARTED|Overall Study||10||
59805247|NCT02733042|75926803|FG010|STARTED|Overall Study||10||
59805248|NCT02733042|75926804|FG011|STARTED|Overall Study||10||
59805249|NCT02733042|75926805|FG012|STARTED|Overall Study||10||
59805250|NCT02733042|75926806|FG013|STARTED|Overall Study||5||
59805251|NCT02733042|75926807|FG014|STARTED|Overall Study||5||
59805252|NCT02733042|75926808|FG015|STARTED|Overall Study||10||
59805253|NCT02733042|75926809|FG016|STARTED|Overall Study||2||
59805254|NCT02733042|75926810|FG017|STARTED|Overall Study||5||
59805255|NCT02733042|75926811|FG018|STARTED|Overall Study||5||
59805256|NCT02733042|75926793|FG000|Participants Who Entered Follow-up Period After Completing/Discontinuing Study Treatment|Overall Study||3||
59805257|NCT02733042|75926794|FG001|Participants Who Entered Follow-up Period After Completing/Discontinuing Study Treatment|Overall Study||3||
59805258|NCT02733042|75926795|FG002|Participants Who Entered Follow-up Period After Completing/Discontinuing Study Treatment|Overall Study||6||
59805259|NCT02733042|75926796|FG003|Participants Who Entered Follow-up Period After Completing/Discontinuing Study Treatment|Overall Study||3||
59805260|NCT02733042|75926797|FG004|Participants Who Entered Follow-up Period After Completing/Discontinuing Study Treatment|Overall Study||2||
59805261|NCT02733042|75926798|FG005|Participants Who Entered Follow-up Period After Completing/Discontinuing Study Treatment|Overall Study||2||
59805262|NCT02733042|75926799|FG006|Participants Who Entered Follow-up Period After Completing/Discontinuing Study Treatment|Overall Study||0||
59805263|NCT02733042|75926800|FG007|Participants Who Entered Follow-up Period After Completing/Discontinuing Study Treatment|Overall Study||4||
59805264|NCT02733042|75926801|FG008|Participants Who Entered Follow-up Period After Completing/Discontinuing Study Treatment|Overall Study||4||
59805265|NCT02733042|75926802|FG009|Participants Who Entered Follow-up Period After Completing/Discontinuing Study Treatment|Overall Study||4||
59958235|NCT02045303|76076992|FG002|NOT COMPLETED|Overall Study||0||0
59958236|NCT01841333|76077001|FG000|STARTED|Overall Study||31||
59958237|NCT01841333|76077001|FG000|COMPLETED|Overall Study||31||
59958238|NCT01841333|76077001|FG000|NOT COMPLETED|Overall Study||0||
59958239|NCT03064451|76077005|FG000|STARTED|Overall Study||60||
59958240|NCT03064451|76077005|FG000|Safety Population|Overall Study||52||
59958241|NCT03064451|76077005|FG000|COMPLETED|Overall Study||46||
59958242|NCT03064451|76077005|FG000|NOT COMPLETED|Overall Study||14||
59958243|NCT03058679|76077011|FG000|STARTED|Baseline to Week 6|3 randomized to SCD withdrew before starting diet;2 randomized pts w/ baseline sCDAI<150 excluded.|99||
59958244|NCT03058679|76077012|FG001|STARTED|Baseline to Week 6|Due to an error 1 participant was randomized with a baseline sCDAI<150. This pt was excluded.|92||
59958245|NCT03058679|76077011|FG000|COMPLETED|Baseline to Week 6||81||
59958246|NCT03058679|76077012|FG001|COMPLETED|Baseline to Week 6||77||
59958247|NCT03058679|76077011|FG000|NOT COMPLETED|Baseline to Week 6||18||
59958248|NCT03058679|76077012|FG001|NOT COMPLETED|Baseline to Week 6||15||
59958249|NCT03058679|76077011|FG000|STARTED|Week 6 to Week 12||81||
59958250|NCT03058679|76077012|FG001|STARTED|Week 6 to Week 12||77||
59958251|NCT03058679|76077011|FG000|COMPLETED|Week 6 to Week 12||61||
59958252|NCT03058679|76077012|FG001|COMPLETED|Week 6 to Week 12||60||
59958253|NCT03058679|76077011|FG000|NOT COMPLETED|Week 6 to Week 12||20||
59958254|NCT03058679|76077012|FG001|NOT COMPLETED|Week 6 to Week 12||17||
59958255|NCT03382821|76077020|FG000|STARTED|Overall Study||60||
59958256|NCT03382821|76077021|FG001|STARTED|Overall Study||60||
59958257|NCT03382821|76077020|FG000|COMPLETED|Overall Study||60||
59958258|NCT03382821|76077021|FG001|COMPLETED|Overall Study||57||
59958259|NCT03382821|76077020|FG000|NOT COMPLETED|Overall Study||0||
59958260|NCT03382821|76077021|FG001|NOT COMPLETED|Overall Study||3||
59958261|NCT02557516|76077032|FG000|STARTED|Overall Study||3||
59958262|NCT02557516|76077033|FG001|STARTED|Overall Study||6||
59958263|NCT02557516|76077034|FG002|STARTED|Overall Study||4||
59958264|NCT02557516|76077035|FG003|STARTED|Overall Study||9||
59958265|NCT02557516|76077032|FG000|COMPLETED|Overall Study||2||
59958266|NCT02557516|76077033|FG001|COMPLETED|Overall Study||1||
59958267|NCT02557516|76077034|FG002|COMPLETED|Overall Study||0||
59958268|NCT02557516|76077035|FG003|COMPLETED|Overall Study||0||
59958269|NCT02557516|76077032|FG000|NOT COMPLETED|Overall Study||1||
59805266|NCT02733042|75926803|FG010|Participants Who Entered Follow-up Period After Completing/Discontinuing Study Treatment|Overall Study||5||
59805267|NCT02733042|75926804|FG011|Participants Who Entered Follow-up Period After Completing/Discontinuing Study Treatment|Overall Study||9||
59805268|NCT02733042|75926805|FG012|Participants Who Entered Follow-up Period After Completing/Discontinuing Study Treatment|Overall Study||9||
59805269|NCT02733042|75926806|FG013|Participants Who Entered Follow-up Period After Completing/Discontinuing Study Treatment|Overall Study||4||
59958270|NCT02557516|76077033|FG001|NOT COMPLETED|Overall Study||5||
59958271|NCT02557516|76077034|FG002|NOT COMPLETED|Overall Study||4||
59958272|NCT02557516|76077035|FG003|NOT COMPLETED|Overall Study||9||
59958273|NCT00711555|76077054|FG000|STARTED|Overall Study||22||
59958274|NCT00711555|76077054|FG000|COMPLETED|Overall Study||19||
59958275|NCT00711555|76077054|FG000|NOT COMPLETED|Overall Study||3||
59958276|NCT02713490|76077059|FG000|STARTED|Overall Study||71||
59958277|NCT02713490|76077060|FG001|STARTED|Overall Study||69||
59958278|NCT02713490|76077059|FG000|COMPLETED|Overall Study||68||
59958279|NCT02713490|76077060|FG001|COMPLETED|Overall Study||67||
59958280|NCT02713490|76077059|FG000|NOT COMPLETED|Overall Study||3||
59958281|NCT02713490|76077060|FG001|NOT COMPLETED|Overall Study||2||
59958282|NCT03772574|76077069|FG000|STARTED|Overall Study||42||
59958283|NCT03772574|76077070|FG001|STARTED|Overall Study||25||
59958284|NCT03772574|76077071|FG002|STARTED|Overall Study||24||
59958285|NCT03772574|76077069|FG000|COMPLETED|Overall Study||40||
59958286|NCT03772574|76077070|FG001|COMPLETED|Overall Study||20||
59958287|NCT03772574|76077071|FG002|COMPLETED|Overall Study||20||
59958288|NCT03772574|76077069|FG000|NOT COMPLETED|Overall Study||2||
59958289|NCT03772574|76077070|FG001|NOT COMPLETED|Overall Study||5||
59958290|NCT03772574|76077071|FG002|NOT COMPLETED|Overall Study||4||
59958291|NCT02743221|76077081|FG000|STARTED|Overall Study||77||
59958292|NCT02743221|76077082|FG001|STARTED|Overall Study||77||
59958293|NCT02743221|76077081|FG000|COMPLETED|Overall Study||21|Of note, these patients were still under treatment at the primary completion date (cut-off date).|
59958294|NCT02743221|76077082|FG001|COMPLETED|Overall Study||17|Of note, these patients were still under treatment at the primary completion date (cut-off date).|
59958295|NCT02743221|76077081|FG000|NOT COMPLETED|Overall Study||56||
59958296|NCT02743221|76077082|FG001|NOT COMPLETED|Overall Study||60||
59958297|NCT03836625|76077090|FG000|STARTED|Overall Study||99||
59958298|NCT03836625|76077091|FG001|STARTED|Overall Study||101||
59958299|NCT03836625|76077090|FG000|COMPLETED|Overall Study||84||
59958300|NCT03836625|76077091|FG001|COMPLETED|Overall Study||89||
59958301|NCT03836625|76077090|FG000|NOT COMPLETED|Overall Study||15||
59958302|NCT03836625|76077091|FG001|NOT COMPLETED|Overall Study||12||
59958303|NCT01358968|76077097|FG000|STARTED|Period 1||20||
59958304|NCT01358968|76077098|FG001|STARTED|Period 1||0||
59958305|NCT01358968|76077099|FG002|STARTED|Period 1||0||
59958306|NCT01358968|76077100|FG003|STARTED|Period 1||0||
59805270|NCT02733042|75926807|FG014|Participants Who Entered Follow-up Period After Completing/Discontinuing Study Treatment|Overall Study||1||
59805271|NCT02733042|75926808|FG015|Participants Who Entered Follow-up Period After Completing/Discontinuing Study Treatment|Overall Study||5||
59805272|NCT02733042|75926809|FG016|Participants Who Entered Follow-up Period After Completing/Discontinuing Study Treatment|Overall Study||0||
59805273|NCT02733042|75926810|FG017|Participants Who Entered Follow-up Period After Completing/Discontinuing Study Treatment|Overall Study||3||
59805274|NCT02733042|75926811|FG018|Participants Who Entered Follow-up Period After Completing/Discontinuing Study Treatment|Overall Study||2||
59805275|NCT02733042|75926793|FG000|COMPLETED|Overall Study||0||
59805276|NCT02733042|75926794|FG001|COMPLETED|Overall Study||1||
59805277|NCT02733042|75926795|FG002|COMPLETED|Overall Study||1||
59805278|NCT02733042|75926796|FG003|COMPLETED|Overall Study||0||
59805279|NCT02733042|75926797|FG004|COMPLETED|Overall Study||1||
59805280|NCT02733042|75926798|FG005|COMPLETED|Overall Study||0||
59958307|NCT01358968|76077097|FG000|Received at Least 1 Dose of Study Drug|Period 1||20||
59958308|NCT01358968|76077098|FG001|Received at Least 1 Dose of Study Drug|Period 1||0||
59805281|NCT02733042|75926799|FG006|COMPLETED|Overall Study||0||
59805282|NCT02733042|75926800|FG007|COMPLETED|Overall Study||1||
59805283|NCT02733042|75926801|FG008|COMPLETED|Overall Study||0||
59805284|NCT02733042|75926802|FG009|COMPLETED|Overall Study||6||
59805285|NCT02733042|75926803|FG010|COMPLETED|Overall Study||4||
59805286|NCT02733042|75926804|FG011|COMPLETED|Overall Study||4||
59805287|NCT02733042|75926805|FG012|COMPLETED|Overall Study||1||
59805288|NCT02733042|75926806|FG013|COMPLETED|Overall Study||1||
59958309|NCT01358968|76077099|FG002|Received at Least 1 Dose of Study Drug|Period 1||0||
59958310|NCT01358968|76077100|FG003|Received at Least 1 Dose of Study Drug|Period 1||0||
59958311|NCT01358968|76077097|FG000|COMPLETED|Period 1||20||
59958312|NCT01358968|76077098|FG001|COMPLETED|Period 1||0||
59958313|NCT01358968|76077099|FG002|COMPLETED|Period 1||0||
59958314|NCT01358968|76077100|FG003|COMPLETED|Period 1||0||
59958315|NCT01358968|76077097|FG000|NOT COMPLETED|Period 1||0||
59958316|NCT01358968|76077098|FG001|NOT COMPLETED|Period 1||0||
59958317|NCT01358968|76077099|FG002|NOT COMPLETED|Period 1||0||
59958318|NCT01358968|76077100|FG003|NOT COMPLETED|Period 1||0||
60073966|NCT03300466|76189317|FG001|NOT COMPLETED|Overall Study||0||
59805289|NCT02733042|75926807|FG014|COMPLETED|Overall Study||0||
59805290|NCT02733042|75926808|FG015|COMPLETED|Overall Study||0||
59958319|NCT01358968|76077097|FG000|STARTED|Period 2||0||
59958320|NCT01358968|76077098|FG001|STARTED|Period 2||20||
59958321|NCT01358968|76077099|FG002|STARTED|Period 2||0||
59958322|NCT01358968|76077100|FG003|STARTED|Period 2||0||
60073967|NCT01868594|76189325|FG000|STARTED|Overall Study||76||
59805291|NCT02733042|75926809|FG016|COMPLETED|Overall Study||0||
59805292|NCT02733042|75926810|FG017|COMPLETED|Overall Study||0||
59805293|NCT02733042|75926811|FG018|COMPLETED|Overall Study||1||
59958323|NCT01358968|76077097|FG000|Received at Least 1 Dose of Study Drug|Period 2||0||
59958324|NCT01358968|76077098|FG001|Received at Least 1 Dose of Study Drug|Period 2||19||
59958325|NCT01358968|76077099|FG002|Received at Least 1 Dose of Study Drug|Period 2||0||
59958326|NCT01358968|76077100|FG003|Received at Least 1 Dose of Study Drug|Period 2||0||
59958327|NCT01358968|76077097|FG000|COMPLETED|Period 2||0||
59958328|NCT01358968|76077098|FG001|COMPLETED|Period 2||19||
59958329|NCT01358968|76077099|FG002|COMPLETED|Period 2||0||
59958330|NCT01358968|76077100|FG003|COMPLETED|Period 2||0||
59958331|NCT01358968|76077097|FG000|NOT COMPLETED|Period 2||0||
59958332|NCT01358968|76077098|FG001|NOT COMPLETED|Period 2||1||
59958333|NCT01358968|76077099|FG002|NOT COMPLETED|Period 2||0||
59958334|NCT01358968|76077100|FG003|NOT COMPLETED|Period 2||0||
59958335|NCT01358968|76077097|FG000|STARTED|Continued Access Phase||0||
59958336|NCT01358968|76077098|FG001|STARTED|Continued Access Phase||0||
59958337|NCT01358968|76077099|FG002|STARTED|Continued Access Phase||12||
59958338|NCT01358968|76077100|FG003|STARTED|Continued Access Phase||7||
59958339|NCT01358968|76077097|FG000|Received at Least 1 Dose of Study Drug|Continued Access Phase||0||
59958340|NCT01358968|76077098|FG001|Received at Least 1 Dose of Study Drug|Continued Access Phase||0||
59958341|NCT01358968|76077099|FG002|Received at Least 1 Dose of Study Drug|Continued Access Phase||12||
59958342|NCT01358968|76077100|FG003|Received at Least 1 Dose of Study Drug|Continued Access Phase||7||
59958343|NCT01358968|76077097|FG000|COMPLETED|Continued Access Phase||0||
59958344|NCT01358968|76077098|FG001|COMPLETED|Continued Access Phase||0||
59958345|NCT01358968|76077099|FG002|COMPLETED|Continued Access Phase||0||
59958346|NCT01358968|76077100|FG003|COMPLETED|Continued Access Phase||0||
59958347|NCT01358968|76077097|FG000|NOT COMPLETED|Continued Access Phase||0||
59958348|NCT01358968|76077098|FG001|NOT COMPLETED|Continued Access Phase||0||
59958349|NCT01358968|76077099|FG002|NOT COMPLETED|Continued Access Phase||12||
59958350|NCT01358968|76077100|FG003|NOT COMPLETED|Continued Access Phase||7||
59958351|NCT00701090|76077112|FG000|STARTED|Overall Study||516||
59958352|NCT00701090|76077113|FG001|STARTED|Overall Study||519||
59958353|NCT00701090|76077112|FG000|COMPLETED|Overall Study||468||
59958354|NCT00701090|76077113|FG001|COMPLETED|Overall Study||468||
59958355|NCT00701090|76077112|FG000|NOT COMPLETED|Overall Study||48||
59958356|NCT00701090|76077113|FG001|NOT COMPLETED|Overall Study||51||
59958357|NCT03057977|76077121|FG000|STARTED|Discontinuation From Treatment||1867|Randomized|
59958358|NCT03057977|76077122|FG001|STARTED|Discontinuation From Treatment||1863|Randomized|
59958359|NCT03057977|76077121|FG000|Treated|Discontinuation From Treatment||1863||
59958360|NCT03057977|76077122|FG001|Treated|Discontinuation From Treatment||1863||
59958361|NCT03057977|76077121|FG000|COMPLETED|Discontinuation From Treatment||1352|Completed treatment|
59958362|NCT03057977|76077122|FG001|COMPLETED|Discontinuation From Treatment||1381|Completed treatment|
59958363|NCT03057977|76077121|FG000|NOT COMPLETED|Discontinuation From Treatment||515||
59958364|NCT03057977|76077122|FG001|NOT COMPLETED|Discontinuation From Treatment||482||
59958365|NCT03057977|76077121|FG000|STARTED|Discontinuation From Trial||1867|Randomized|
59958366|NCT03057977|76077122|FG001|STARTED|Discontinuation From Trial||1863|Randomized|
59958367|NCT03057977|76077121|FG000|Treated|Discontinuation From Trial||1863||
59958368|NCT03057977|76077122|FG001|Treated|Discontinuation From Trial||1863||
59958369|NCT03057977|76077121|FG000|COMPLETED|Discontinuation From Trial||1847||
59958370|NCT03057977|76077122|FG001|COMPLETED|Discontinuation From Trial||1841||
59958371|NCT03057977|76077121|FG000|NOT COMPLETED|Discontinuation From Trial||20||
59958372|NCT03057977|76077122|FG001|NOT COMPLETED|Discontinuation From Trial||22||
59958373|NCT00941915|76077128|FG000|STARTED|Overall Study||60||
59958374|NCT00941915|76077128|FG000|COMPLETED|Overall Study||60||
59958375|NCT00941915|76077128|FG000|NOT COMPLETED|Overall Study||0||
59958376|NCT03062891|76077134|FG000|STARTED|Overall Study||99||
59958377|NCT03062891|76077135|FG001|STARTED|Overall Study||100||
59958378|NCT03062891|76077134|FG000|Mid-intervention|Overall Study||68||
59958379|NCT03062891|76077135|FG001|Mid-intervention|Overall Study||74||
59958380|NCT03062891|76077134|FG000|End of Intervention|Overall Study||67||
59958381|NCT03062891|76077135|FG001|End of Intervention|Overall Study||78||
59958382|NCT03062891|76077134|FG000|Followup|Overall Study||47||
59958383|NCT03062891|76077135|FG001|Followup|Overall Study||62||
59958384|NCT03062891|76077134|FG000|COMPLETED|Overall Study||47||
59958385|NCT03062891|76077135|FG001|COMPLETED|Overall Study||62||
60073968|NCT01868594|76189326|FG001|STARTED|Overall Study||75||
60073969|NCT01868594|76189325|FG000|COMPLETED|Overall Study||72||
59805294|NCT02733042|75926793|FG000|NOT COMPLETED|Overall Study||3||
59805295|NCT02733042|75926794|FG001|NOT COMPLETED|Overall Study||2||
59805296|NCT02733042|75926795|FG002|NOT COMPLETED|Overall Study||7||
59805297|NCT02733042|75926796|FG003|NOT COMPLETED|Overall Study||3||
59805298|NCT02733042|75926797|FG004|NOT COMPLETED|Overall Study||3||
59805299|NCT02733042|75926798|FG005|NOT COMPLETED|Overall Study||3||
59805300|NCT02733042|75926799|FG006|NOT COMPLETED|Overall Study||1||
59805301|NCT02733042|75926800|FG007|NOT COMPLETED|Overall Study||3||
59805302|NCT02733042|75926801|FG008|NOT COMPLETED|Overall Study||5||
59958386|NCT03062891|76077134|FG000|NOT COMPLETED|Overall Study||52||
59958387|NCT03062891|76077135|FG001|NOT COMPLETED|Overall Study||38||
60073970|NCT01868594|76189326|FG001|COMPLETED|Overall Study||72||
59805303|NCT02733042|75926802|FG009|NOT COMPLETED|Overall Study||4||
59958388|NCT02552212|76077144|FG000|STARTED|Double-Blind Period (Week 0 - 52)||158||
59958389|NCT02552212|76077145|FG001|STARTED|Double-Blind Period (Week 0 - 52)||159||
59958390|NCT02552212|76077146|FG002|STARTED|Double-Blind Period (Week 0 - 52)||0||
59958391|NCT02552212|76077144|FG000|Received OL CZP|Double-Blind Period (Week 0 - 52)||96||
59958392|NCT02552212|76077145|FG001|Received OL CZP|Double-Blind Period (Week 0 - 52)||20||
59958393|NCT02552212|76077146|FG002|Received OL CZP|Double-Blind Period (Week 0 - 52)||0||
59805304|NCT02733042|75926803|FG010|NOT COMPLETED|Overall Study||6||
59805305|NCT02733042|75926804|FG011|NOT COMPLETED|Overall Study||6||
59805306|NCT02733042|75926805|FG012|NOT COMPLETED|Overall Study||9||
59805307|NCT02733042|75926806|FG013|NOT COMPLETED|Overall Study||4||
59805308|NCT02733042|75926807|FG014|NOT COMPLETED|Overall Study||5||
59805309|NCT02733042|75926808|FG015|NOT COMPLETED|Overall Study||10||
59805310|NCT02733042|75926809|FG016|NOT COMPLETED|Overall Study||2||
59805311|NCT02733042|75926810|FG017|NOT COMPLETED|Overall Study||5||
59805312|NCT02733042|75926811|FG018|NOT COMPLETED|Overall Study||4||
59805313|NCT02690558|75926860|FG000|STARTED|Overall Study||39||
59805314|NCT02690558|75926860|FG000|COMPLETED|Overall Study||39||
59805315|NCT02690558|75926860|FG000|NOT COMPLETED|Overall Study||0||
59805316|NCT02614066|75926868|FG000|STARTED|Overall Study||6||
59805317|NCT02614066|75926869|FG001|STARTED|Overall Study||28||
59805318|NCT02614066|75926870|FG002|STARTED|Overall Study||20||
59805319|NCT02614066|75926871|FG003|STARTED|Overall Study||71||
59805320|NCT02614066|75926868|FG000|COMPLETED|Overall Study||0||
59805321|NCT02614066|75926869|FG001|COMPLETED|Overall Study||0||
59805322|NCT02614066|75926870|FG002|COMPLETED|Overall Study||0||
59958394|NCT02552212|76077144|FG000|Completed Week 52 Without Starting SFE|Double-Blind Period (Week 0 - 52)||20||
59958395|NCT02552212|76077145|FG001|Completed Week 52 Without Starting SFE|Double-Blind Period (Week 0 - 52)||22||
59958396|NCT02552212|76077146|FG002|Completed Week 52 Without Starting SFE|Double-Blind Period (Week 0 - 52)||0||
59958397|NCT02552212|76077144|FG000|COMPLETED|Double-Blind Period (Week 0 - 52)||143||
59958398|NCT02552212|76077145|FG001|COMPLETED|Double-Blind Period (Week 0 - 52)||142||
59958399|NCT02552212|76077146|FG002|COMPLETED|Double-Blind Period (Week 0 - 52)||0||
59958400|NCT02552212|76077144|FG000|NOT COMPLETED|Double-Blind Period (Week 0 - 52)||15||
59958401|NCT02552212|76077145|FG001|NOT COMPLETED|Double-Blind Period (Week 0 - 52)||17||
59958402|NCT02552212|76077146|FG002|NOT COMPLETED|Double-Blind Period (Week 0 - 52)||0||
59958403|NCT02552212|76077144|FG000|STARTED|SFE Period (Week 52 - 156)||0||
59958404|NCT02552212|76077145|FG001|STARTED|SFE Period (Week 52 - 156)||0||
59958405|NCT02552212|76077146|FG002|STARTED|SFE Period (Week 52 - 156)|123 subjects from Placebo arm and 120 subjects from CZP 200 mg Q2W arm|243||
59958406|NCT02552212|76077144|FG000|COMPLETED|SFE Period (Week 52 - 156)||0||
59958407|NCT02552212|76077145|FG001|COMPLETED|SFE Period (Week 52 - 156)||0||
59958408|NCT02552212|76077146|FG002|COMPLETED|SFE Period (Week 52 - 156)||206||
59958409|NCT02552212|76077144|FG000|NOT COMPLETED|SFE Period (Week 52 - 156)||0||
59958410|NCT02552212|76077145|FG001|NOT COMPLETED|SFE Period (Week 52 - 156)||0||
59958411|NCT02552212|76077146|FG002|NOT COMPLETED|SFE Period (Week 52 - 156)||37||
59805323|NCT02614066|75926871|FG003|COMPLETED|Overall Study||0||
59805324|NCT02614066|75926868|FG000|NOT COMPLETED|Overall Study||6||
59805325|NCT02614066|75926869|FG001|NOT COMPLETED|Overall Study||28||
59958412|NCT00685919|76077166|FG000|STARTED|Overall Study|8 healthy controls were randomized to receive placebo followed by carbidopa. 1 received only 50 mg doses of carbidopa and her data were excluded.|8||
59958413|NCT00685919|76077167|FG001|STARTED|Overall Study|9 healthy controls were randomized to receive carbidopa followed by placebo.|9||
59958414|NCT00685919|76077168|FG002|STARTED|Overall Study|8 patients with POTS were randomized to receive placebo followed by carbidopa. 1 of these received only 50 mg doses of carbidopa and her data are excluded.|8||
59805326|NCT02614066|75926870|FG002|NOT COMPLETED|Overall Study||20||
59805327|NCT02614066|75926871|FG003|NOT COMPLETED|Overall Study||71||
59620878|NCT00224952|75732310|FG001|NOT COMPLETED|Overall Study||0||
59805328|NCT02599324|75926888|FG000|STARTED|Phase 1b||3||
59805329|NCT02599324|75926889|FG001|STARTED|Phase 1b||7||
59805330|NCT02599324|75926890|FG002|STARTED|Phase 1b||4||
59805331|NCT02599324|75926891|FG003|STARTED|Phase 1b||10||
59805332|NCT02599324|75926892|FG004|STARTED|Phase 1b||21||
59805333|NCT02599324|75926893|FG005|STARTED|Phase 1b||8||
59805334|NCT02599324|75926894|FG006|STARTED|Phase 1b||12||
59805335|NCT02599324|75926895|FG007|STARTED|Phase 1b||10||
59958415|NCT00685919|76077169|FG003|STARTED|Overall Study|3 patients with POTS were randomized to receive carbidopa followed by placebo.|3||
59995277|NCT01119807|76111111|FG000|STARTED|Overall Study||67||
59805336|NCT02599324|75926896|FG008|STARTED|Phase 1b||17||
59805337|NCT02599324|75926888|FG000|COMPLETED|Phase 1b||3||
59805338|NCT02599324|75926889|FG001|COMPLETED|Phase 1b||7||
59805339|NCT02599324|75926890|FG002|COMPLETED|Phase 1b||4||
59805340|NCT02599324|75926891|FG003|COMPLETED|Phase 1b||10||
59805341|NCT02599324|75926892|FG004|COMPLETED|Phase 1b||21||
59805342|NCT02599324|75926893|FG005|COMPLETED|Phase 1b||8||
59805343|NCT02599324|75926894|FG006|COMPLETED|Phase 1b||12||
59805344|NCT02599324|75926895|FG007|COMPLETED|Phase 1b||10||
59805345|NCT02599324|75926896|FG008|COMPLETED|Phase 1b||17||
59805346|NCT02599324|75926888|FG000|NOT COMPLETED|Phase 1b||0||
59805347|NCT02599324|75926889|FG001|NOT COMPLETED|Phase 1b||0||
59805348|NCT02599324|75926890|FG002|NOT COMPLETED|Phase 1b||0||
59805349|NCT02599324|75926891|FG003|NOT COMPLETED|Phase 1b||0||
59805350|NCT02599324|75926892|FG004|NOT COMPLETED|Phase 1b||0||
59805351|NCT02599324|75926893|FG005|NOT COMPLETED|Phase 1b||0||
59805352|NCT02599324|75926894|FG006|NOT COMPLETED|Phase 1b||0||
59805353|NCT02599324|75926895|FG007|NOT COMPLETED|Phase 1b||0||
59805354|NCT02599324|75926896|FG008|NOT COMPLETED|Phase 1b||0||
59958416|NCT00685919|76077166|FG000|Baseline A|Overall Study|After achieving sodium balance on 200 mEq/day sodium diet, subjects collected baseline 24hr urine. They fasted from 7pm until the next morning. In the morning, while still supine, heart rate and blood pressure were recorded and blood was drawn. Participants then stood for 10 min. Heart rate and blood pressure were measured at intervals and an upright blood sample was collected. Urine was collected to end the 24hr collection.|8||
59958417|NCT00685919|76077167|FG001|Baseline A|Overall Study|After achieving sodium balance on 200 mEq/day sodium diet, subjects collected baseline 24hr urine. They fasted from 7pm until the next morning. In the morning, while still supine, heart rate and blood pressure were recorded and blood was drawn. Participants then stood for 10 min. Heart rate and blood pressure were measured at intervals and an upright blood sample was collected. Urine was collected to end the 24hr collection. 1 patient withdrew after orthostatic symptoms during baseline.|9||
59958418|NCT00685919|76077168|FG002|Baseline A|Overall Study|After achieving sodium balance on 200 mEq/day sodium diet, subjects collected baseline 24hr urine. They fasted from 7pm until the next morning. In the morning, while still supine, heart rate and blood pressure were recorded and blood was drawn. Participants then stood for 10 min. Heart rate and blood pressure were measured at intervals and an upright blood sample was collected. Urine was collected to end the 24hr collection. 1 patient withdrew after orthostatic symptoms during baseline.|8||
59958419|NCT00685919|76077169|FG003|Baseline A|Overall Study|After achieving sodium balance on 200 mEq/day sodium diet, subjects collected baseline 24hr urine. They fasted from 7pm until the next morning. In the morning, while still supine, heart rate and blood pressure were recorded and blood was drawn. Participants then stood for 10 min. Heart rate and blood pressure were measured at intervals and an upright blood sample was collected. Urine was collected to end the 24hr collection.|3||
59958420|NCT00685919|76077166|FG000|Treatment A|Overall Study|Following the urine collection to end the baseline urine and the baseline testing, placebo was given orally. Additional doses were given every 6 hours with the last dose at 7am the following morning. Urine was collected over 24hr and supine and upright heart rates, blood pressures and blood samples were collected.|7||
59958421|NCT00685919|76077167|FG001|Treatment A|Overall Study|Following the urine collection to end the baseline urine and the baseline testing, carbidopa 200 mg was given orally. Additional doses were given every 6 hours with the last dose at 7am the following morning. Urine was collected over 24hr and supine and upright heart rates, blood pressures and blood samples were collected.|9||
59994922|NCT03420781|76110742|FG004|COMPLETED|Treatment Period (40 Weeks)||0|Out of 197 participants who completed the Treatment Period, 193 entered the RW Period.|
59805355|NCT02599324|75926888|FG000|STARTED|Phase 2 (RP2D)||0|Entered Phase 2 and received at least 1 dose of study medication.|
59805356|NCT02599324|75926889|FG001|STARTED|Phase 2 (RP2D)||38|Entered Phase 2 and received at least 1 dose of study medication.|
59805357|NCT02599324|75926890|FG002|STARTED|Phase 2 (RP2D)||0|Entered Phase 2 and received at least 1 dose of study medication.|
59805358|NCT02599324|75926891|FG003|STARTED|Phase 2 (RP2D)||55|Entered Phase 2 and received at least 1 dose of study medication.|
59805359|NCT02599324|75926892|FG004|STARTED|Phase 2 (RP2D)||31|Entered Phase 2 and received at least 1 dose of study medication.|
59805360|NCT02599324|75926893|FG005|STARTED|Phase 2 (RP2D)||0|Entered Phase 2 and received at least 1 dose of study medication.|
59805361|NCT02599324|75926894|FG006|STARTED|Phase 2 (RP2D)||44|Entered Phase 2 and received at least 1 dose of study medication.|
59805362|NCT02599324|75926895|FG007|STARTED|Phase 2 (RP2D)||33|Entered Phase 2 and received at least 1 dose of study medication.|
59805363|NCT02599324|75926896|FG008|STARTED|Phase 2 (RP2D)||13|Entered Phase 2 and received at least 1 dose of study medication.|
59805364|NCT02599324|75926888|FG000|Continued From Phase 1b|Phase 2 (RP2D)||0||
59805365|NCT02599324|75926889|FG001|Continued From Phase 1b|Phase 2 (RP2D)||6||
59805366|NCT02599324|75926890|FG002|Continued From Phase 1b|Phase 2 (RP2D)||0||
59805367|NCT02599324|75926891|FG003|Continued From Phase 1b|Phase 2 (RP2D)||6||
59805368|NCT02599324|75926892|FG004|Continued From Phase 1b|Phase 2 (RP2D)||6||
59805369|NCT02599324|75926893|FG005|Continued From Phase 1b|Phase 2 (RP2D)||0||
59805370|NCT02599324|75926894|FG006|Continued From Phase 1b|Phase 2 (RP2D)||6||
59805371|NCT02599324|75926895|FG007|Continued From Phase 1b|Phase 2 (RP2D)||8||
59805372|NCT02599324|75926896|FG008|Continued From Phase 1b|Phase 2 (RP2D)||12||
59805373|NCT02599324|75926888|FG000|Enrolled in Phase 2|Phase 2 (RP2D)||0||
59805374|NCT02599324|75926889|FG001|Enrolled in Phase 2|Phase 2 (RP2D)||32||
59805375|NCT02599324|75926890|FG002|Enrolled in Phase 2|Phase 2 (RP2D)||0||
59805376|NCT02599324|75926891|FG003|Enrolled in Phase 2|Phase 2 (RP2D)||49||
59805377|NCT02599324|75926892|FG004|Enrolled in Phase 2|Phase 2 (RP2D)||25||
59805378|NCT02599324|75926893|FG005|Enrolled in Phase 2|Phase 2 (RP2D)||0||
59805379|NCT02599324|75926894|FG006|Enrolled in Phase 2|Phase 2 (RP2D)||39||
59805380|NCT02599324|75926895|FG007|Enrolled in Phase 2|Phase 2 (RP2D)||25||
59805381|NCT02599324|75926896|FG008|Enrolled in Phase 2|Phase 2 (RP2D)||1||
59805382|NCT02599324|75926888|FG000|Enrolled and Treated in Phase 2|Phase 2 (RP2D)||0||
59805383|NCT02599324|75926889|FG001|Enrolled and Treated in Phase 2|Phase 2 (RP2D)||32||
59805384|NCT02599324|75926890|FG002|Enrolled and Treated in Phase 2|Phase 2 (RP2D)||0||
59805385|NCT02599324|75926891|FG003|Enrolled and Treated in Phase 2|Phase 2 (RP2D)||49||
59805386|NCT02599324|75926892|FG004|Enrolled and Treated in Phase 2|Phase 2 (RP2D)||25||
59805387|NCT02599324|75926893|FG005|Enrolled and Treated in Phase 2|Phase 2 (RP2D)||0||
59805388|NCT02599324|75926894|FG006|Enrolled and Treated in Phase 2|Phase 2 (RP2D)||38||
59805389|NCT02599324|75926895|FG007|Enrolled and Treated in Phase 2|Phase 2 (RP2D)||25||
59805390|NCT02599324|75926896|FG008|Enrolled and Treated in Phase 2|Phase 2 (RP2D)||1||
59805391|NCT02599324|75926888|FG000|COMPLETED|Phase 2 (RP2D)||0|Off Study|
59805392|NCT02599324|75926889|FG001|COMPLETED|Phase 2 (RP2D)||38|Off Study|
59805393|NCT02599324|75926890|FG002|COMPLETED|Phase 2 (RP2D)||0|Off Study|
59958422|NCT00685919|76077168|FG002|Treatment A|Overall Study|Following the urine collection to end the baseline urine and the baseline testing, placebo was given orally. Additional doses were given every 6 hours with the last dose at 7am the following morning. Urine was collected over 24hr and supine and upright heart rates, blood pressures and blood samples were collected.|8||
59958423|NCT00685919|76077169|FG003|Treatment A|Overall Study|Following the urine collection to end the baseline urine and the baseline testing, carbidopa 200 mg was given orally. Additional doses were given every 6 hours with the last dose at 7am the following morning. Urine was collected over 24hr and supine and upright heart rates, blood pressures and blood samples were collected.|3||
59958424|NCT00685919|76077166|FG000|24 hr Post-treatment A|Overall Study|Urine was collected for 24 hr after the last dose of Treatment A.|7||
59958425|NCT00685919|76077167|FG001|24 hr Post-treatment A|Overall Study|Urine was collected for 24 hr after the last dose of Treatment A.|9||
59958426|NCT00685919|76077168|FG002|24 hr Post-treatment A|Overall Study|Urine was collected for 24 hr after the last dose of Treatment A.|7||
59958427|NCT00685919|76077169|FG003|24 hr Post-treatment A|Overall Study|Urine was collected for 24 hr after the last dose of Treatment A.|3||
59958428|NCT00685919|76077166|FG000|Baseline B|Overall Study|After at least a 1-day washout period, patients underwent baseline procedures as described previously.|7||
59958429|NCT00685919|76077167|FG001|Baseline B|Overall Study|After at least a 1-day washout period, patients underwent baseline procedures as described previously.|9||
59958430|NCT00685919|76077168|FG002|Baseline B|Overall Study|After at least a 1-day washout period, patients underwent baseline procedures as described previously.|7||
59958431|NCT00685919|76077169|FG003|Baseline B|Overall Study|After at least a 1-day washout period, patients underwent baseline procedures as described previously.|3||
59958432|NCT00685919|76077166|FG000|Treatment B|Overall Study|Following the urine collection to end the baseline urine and the baseline testing, carbidopa 200 mg was given orally. Additional doses were given every 6 hours with the last dose at 7am the following morning. Urine was collected over 24hr and supine and upright heart rates, blood pressures and blood samples were collected.|7||
59958433|NCT00685919|76077167|FG001|Treatment B|Overall Study|Following the urine collection to end the baseline urine and the baseline testing, placebo was given orally. Additional doses were given every 6 hours with the last dose at 7am the following morning. Urine was collected over 24hr and supine and upright heart rates, blood pressures and blood samples were collected.|9||
59958434|NCT00685919|76077168|FG002|Treatment B|Overall Study|Following the urine collection to end the baseline urine and the baseline testing, carbidopa 200 mg was given orally. Additional doses were given every 6 hours with the last dose at 7am the following morning. Urine was collected over 24hr and supine and upright heart rates, blood pressures and blood samples were collected.|7||
59958435|NCT00685919|76077169|FG003|Treatment B|Overall Study|Following the urine collection to end the baseline urine and the baseline testing, placebo was given orally. Additional doses were given every 6 hours with the last dose at 7am the following morning. Urine was collected over 24hr and supine and upright heart rates, blood pressures and blood samples were collected.|3||
59958436|NCT00685919|76077166|FG000|24 hr Post Treatment B|Overall Study|Urine was collected for 24 hr after last dose of Treatment B.|7||
59958437|NCT00685919|76077167|FG001|24 hr Post Treatment B|Overall Study|Urine was collected for 24 hr after last dose of Treatment B.|9||
59958438|NCT00685919|76077168|FG002|24 hr Post Treatment B|Overall Study|Urine was collected for 24 hr after last dose of Treatment B.|7||
59958439|NCT00685919|76077169|FG003|24 hr Post Treatment B|Overall Study|Urine was collected for 24 hr after last dose of Treatment B.|3||
59958440|NCT00685919|76077166|FG000|COMPLETED|Overall Study||7||
59958441|NCT00685919|76077167|FG001|COMPLETED|Overall Study||9||
59958442|NCT00685919|76077168|FG002|COMPLETED|Overall Study||7||
59958443|NCT00685919|76077169|FG003|COMPLETED|Overall Study||3||
59958444|NCT00685919|76077166|FG000|NOT COMPLETED|Overall Study||1||
59958445|NCT00685919|76077167|FG001|NOT COMPLETED|Overall Study||0||
59958446|NCT00685919|76077168|FG002|NOT COMPLETED|Overall Study||1||
59958447|NCT00685919|76077169|FG003|NOT COMPLETED|Overall Study||0||
59958448|NCT03061331|76077181|FG000|STARTED|Treatment Period 1 (8 Weeks)||10||
59958449|NCT03061331|76077182|FG001|STARTED|Treatment Period 1 (8 Weeks)||10||
59805394|NCT02599324|75926891|FG003|COMPLETED|Phase 2 (RP2D)||55|Off Study|
59805395|NCT02599324|75926892|FG004|COMPLETED|Phase 2 (RP2D)||31|Off Study|
59805396|NCT02599324|75926893|FG005|COMPLETED|Phase 2 (RP2D)||0|Off Study|
59805397|NCT02599324|75926894|FG006|COMPLETED|Phase 2 (RP2D)||44|Off Study|
59805398|NCT02599324|75926895|FG007|COMPLETED|Phase 2 (RP2D)||33|Off Study|
59805399|NCT02599324|75926896|FG008|COMPLETED|Phase 2 (RP2D)||13|Off Study|
59805400|NCT02599324|75926888|FG000|NOT COMPLETED|Phase 2 (RP2D)||0||
59805401|NCT02599324|75926889|FG001|NOT COMPLETED|Phase 2 (RP2D)||0||
59805402|NCT02599324|75926890|FG002|NOT COMPLETED|Phase 2 (RP2D)||0||
59805403|NCT02599324|75926891|FG003|NOT COMPLETED|Phase 2 (RP2D)||0||
59805404|NCT02599324|75926892|FG004|NOT COMPLETED|Phase 2 (RP2D)||0||
59805405|NCT02599324|75926893|FG005|NOT COMPLETED|Phase 2 (RP2D)||0||
59805406|NCT02599324|75926894|FG006|NOT COMPLETED|Phase 2 (RP2D)||0||
59805407|NCT02599324|75926895|FG007|NOT COMPLETED|Phase 2 (RP2D)||0||
59805408|NCT02599324|75926896|FG008|NOT COMPLETED|Phase 2 (RP2D)||0||
59805409|NCT02504866|75926935|FG000|STARTED|3-Month Follow up||4||
59805410|NCT02504866|75926936|FG001|STARTED|3-Month Follow up||3||
59805411|NCT02504866|75926937|FG002|STARTED|3-Month Follow up||4||
59805412|NCT02504866|75926935|FG000|COMPLETED|3-Month Follow up||4||
59805413|NCT02504866|75926936|FG001|COMPLETED|3-Month Follow up||3||
59805414|NCT02504866|75926937|FG002|COMPLETED|3-Month Follow up||4||
59805415|NCT02504866|75926935|FG000|NOT COMPLETED|3-Month Follow up||0||
59805416|NCT02504866|75926936|FG001|NOT COMPLETED|3-Month Follow up||0||
59805417|NCT02504866|75926937|FG002|NOT COMPLETED|3-Month Follow up||0||
59958450|NCT03061331|76077181|FG000|COMPLETED|Treatment Period 1 (8 Weeks)||10||
59958451|NCT03061331|76077182|FG001|COMPLETED|Treatment Period 1 (8 Weeks)||10||
59958452|NCT03061331|76077181|FG000|NOT COMPLETED|Treatment Period 1 (8 Weeks)||0||
59958453|NCT03061331|76077182|FG001|NOT COMPLETED|Treatment Period 1 (8 Weeks)||0||
59958454|NCT03061331|76077181|FG000|STARTED|Washout Period (8 Weeks)||10||
59958455|NCT03061331|76077182|FG001|STARTED|Washout Period (8 Weeks)||10||
59958456|NCT03061331|76077181|FG000|COMPLETED|Washout Period (8 Weeks)||8||
59958457|NCT03061331|76077182|FG001|COMPLETED|Washout Period (8 Weeks)||9||
59958458|NCT03061331|76077181|FG000|NOT COMPLETED|Washout Period (8 Weeks)||2||
59958459|NCT03061331|76077182|FG001|NOT COMPLETED|Washout Period (8 Weeks)||1||
59958460|NCT03061331|76077181|FG000|STARTED|Treatment Period 2 (8 Weeks)||8||
59958461|NCT03061331|76077182|FG001|STARTED|Treatment Period 2 (8 Weeks)||9||
59958462|NCT03061331|76077181|FG000|COMPLETED|Treatment Period 2 (8 Weeks)||8||
59958463|NCT03061331|76077182|FG001|COMPLETED|Treatment Period 2 (8 Weeks)||9||
59958464|NCT03061331|76077181|FG000|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0||
59958465|NCT03061331|76077182|FG001|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0||
59958466|NCT00700778|76077188|FG000|STARTED|Overall Study||2||
59958467|NCT00700778|76077188|FG000|COMPLETED|Overall Study||0||
59958468|NCT00700778|76077188|FG000|NOT COMPLETED|Overall Study||2||
59958469|NCT02551666|76077194|FG000|STARTED|Overall Study||16||
59958470|NCT02551666|76077195|FG001|STARTED|Overall Study||19||
59958471|NCT02551666|76077194|FG000|COMPLETED|Overall Study||15||
59958472|NCT02551666|76077195|FG001|COMPLETED|Overall Study||16||
59805418|NCT02504866|75926935|FG000|STARTED|6-Month Follow up (CON Group Only)|First period was CON arm|1||
59805419|NCT02504866|75926936|FG001|STARTED|6-Month Follow up (CON Group Only)|First period was CON arm|2||
59805420|NCT02504866|75926937|FG002|STARTED|6-Month Follow up (CON Group Only)||0||
59805421|NCT02504866|75926935|FG000|COMPLETED|6-Month Follow up (CON Group Only)||0||
59805422|NCT02504866|75926936|FG001|COMPLETED|6-Month Follow up (CON Group Only)||2||
59805423|NCT02504866|75926937|FG002|COMPLETED|6-Month Follow up (CON Group Only)||0||
59805424|NCT02504866|75926935|FG000|NOT COMPLETED|6-Month Follow up (CON Group Only)||1||
59805425|NCT02504866|75926936|FG001|NOT COMPLETED|6-Month Follow up (CON Group Only)||0||
59805426|NCT02504866|75926937|FG002|NOT COMPLETED|6-Month Follow up (CON Group Only)||0||
59805427|NCT02459769|75926949|FG000|STARTED|Overall Study||34||
59805428|NCT02459769|75926950|FG001|STARTED|Overall Study||32||
59805429|NCT02459769|75926951|FG002|STARTED|Overall Study||34||
59805430|NCT02459769|75926952|FG003|STARTED|Overall Study||33||
59805431|NCT02459769|75926949|FG000|COMPLETED|Overall Study||26||
59805432|NCT02459769|75926950|FG001|COMPLETED|Overall Study||28||
59805433|NCT02459769|75926951|FG002|COMPLETED|Overall Study||25||
59805434|NCT02459769|75926952|FG003|COMPLETED|Overall Study||28||
59805435|NCT02459769|75926949|FG000|NOT COMPLETED|Overall Study||8||
59958473|NCT02551666|76077194|FG000|NOT COMPLETED|Overall Study||1||
59958474|NCT02551666|76077195|FG001|NOT COMPLETED|Overall Study||3||
59958475|NCT03307564|76077201|FG000|STARTED|Overall Study||6||
59958476|NCT03307564|76077201|FG000|COMPLETED|Overall Study||6||
59958477|NCT03307564|76077201|FG000|NOT COMPLETED|Overall Study||0||
59958478|NCT03061175|76077207|FG000|STARTED|Baseline||47||
59958479|NCT03061175|76077208|FG001|STARTED|Baseline||47||
59958480|NCT03061175|76077207|FG000|COMPLETED|Baseline||46||
59958481|NCT03061175|76077208|FG001|COMPLETED|Baseline||47||
59958482|NCT03061175|76077207|FG000|NOT COMPLETED|Baseline||1||
59805436|NCT02459769|75926950|FG001|NOT COMPLETED|Overall Study||4||
59805437|NCT02459769|75926951|FG002|NOT COMPLETED|Overall Study||9||
59805438|NCT02459769|75926952|FG003|NOT COMPLETED|Overall Study||5||
59805439|NCT02369016|75926964|FG000|STARTED|Overall Study||17||
59805440|NCT02369016|75926965|FG001|STARTED|Overall Study||8||
59805441|NCT02369016|75926964|FG000|Switched to Copanlisib After Study Unblinding|Overall Study||0||
59805442|NCT02369016|75926965|FG001|Switched to Copanlisib After Study Unblinding|Overall Study||7||
59958483|NCT03061175|76077208|FG001|NOT COMPLETED|Baseline||0||
59958484|NCT03061175|76077207|FG000|STARTED|Followup 1 at 2-4 Weeks Post-surgery|1 Participant dropped out of the study before the follow-up survey was to be sent|45||
59958485|NCT03061175|76077208|FG001|STARTED|Followup 1 at 2-4 Weeks Post-surgery||47||
59958486|NCT03061175|76077207|FG000|COMPLETED|Followup 1 at 2-4 Weeks Post-surgery|39 participants completed the follow-up survey out of the 45 who were sent the survey|39||
59805443|NCT02369016|75926964|FG000|COMPLETED|Overall Study||0||
59805444|NCT02369016|75926965|FG001|COMPLETED|Overall Study||0||
59805445|NCT02369016|75926964|FG000|NOT COMPLETED|Overall Study||17||
59805446|NCT02369016|75926965|FG001|NOT COMPLETED|Overall Study||8||
59805447|NCT02363959|75926978|FG000|STARTED|Overall Study||10||
59805448|NCT02363959|75926979|FG001|STARTED|Overall Study||10||
59805449|NCT02363959|75926978|FG000|COMPLETED|Overall Study||9||
59805450|NCT02363959|75926979|FG001|COMPLETED|Overall Study||10||
59805451|NCT02363959|75926978|FG000|NOT COMPLETED|Overall Study||1||
59805452|NCT02363959|75926979|FG001|NOT COMPLETED|Overall Study||0||
59805453|NCT02345265|75926987|FG000|STARTED|Overall Study||35||
59805454|NCT02345265|75926988|FG001|STARTED|Overall Study||35||
59805455|NCT02345265|75926987|FG000|COMPLETED|Overall Study||35||
59805456|NCT02345265|75926988|FG001|COMPLETED|Overall Study||35||
59805457|NCT02345265|75926987|FG000|NOT COMPLETED|Overall Study||0||
59805458|NCT02345265|75926988|FG001|NOT COMPLETED|Overall Study||0||
59805459|NCT02337829|75926999|FG000|STARTED|Overall Study||18||
59805460|NCT02337829|75927000|FG001|STARTED|Overall Study||14||
59805461|NCT02337829|75927001|FG002|STARTED|Overall Study||6||
59805462|NCT02337829|75927002|FG003|STARTED|Overall Study||10||
59805463|NCT02337829|75926999|FG000|COMPLETED|Overall Study||0||
59805464|NCT02337829|75927000|FG001|COMPLETED|Overall Study||0||
59805465|NCT02337829|75927001|FG002|COMPLETED|Overall Study||0||
59805466|NCT02337829|75927002|FG003|COMPLETED|Overall Study||0||
59805467|NCT02337829|75926999|FG000|NOT COMPLETED|Overall Study||18||
59958487|NCT03061175|76077208|FG001|COMPLETED|Followup 1 at 2-4 Weeks Post-surgery|44 participants completed the follow-up survey out of the 47 who were sent the survey|44||
59958488|NCT03061175|76077207|FG000|NOT COMPLETED|Followup 1 at 2-4 Weeks Post-surgery||6||
59958489|NCT03061175|76077208|FG001|NOT COMPLETED|Followup 1 at 2-4 Weeks Post-surgery||3||
59958490|NCT03061175|76077207|FG000|STARTED|Followup 2 at 6 Months|Participants who skipped the first follow-up survey were still sent the second FU survey|45||
59958491|NCT03061175|76077208|FG001|STARTED|Followup 2 at 6 Months|1 participant withdrew from the study in between the 1st and 2nd follow-up survey so only 46 sent|46||
59958492|NCT03061175|76077207|FG000|COMPLETED|Followup 2 at 6 Months|41 participants completed the 2nd follow-up survey out of the 45 who were sent the survey|41||
59958493|NCT03061175|76077208|FG001|COMPLETED|Followup 2 at 6 Months|39 participants completed the follow-up survey out of the 46 who were sent the survey|39||
59958494|NCT03061175|76077207|FG000|NOT COMPLETED|Followup 2 at 6 Months||4||
59958495|NCT03061175|76077208|FG001|NOT COMPLETED|Followup 2 at 6 Months||7||
59958496|NCT02359838|76077216|FG000|STARTED|Overall Study||100||
59958497|NCT02359838|76077217|FG001|STARTED|Overall Study||60||
59958498|NCT02359838|76077216|FG000|COMPLETED|Overall Study||100||
59958499|NCT02359838|76077217|FG001|COMPLETED|Overall Study||48||
59958500|NCT02359838|76077216|FG000|NOT COMPLETED|Overall Study||0||
59958501|NCT02359838|76077217|FG001|NOT COMPLETED|Overall Study||12||
59805468|NCT02337829|75927000|FG001|NOT COMPLETED|Overall Study||14||
59805469|NCT02337829|75927001|FG002|NOT COMPLETED|Overall Study||6||
59805470|NCT02337829|75927002|FG003|NOT COMPLETED|Overall Study||10||
59805471|NCT01931709|75927014|FG000|STARTED|Overall Study||35||
59805472|NCT01931709|75927014|FG000|COMPLETED|Overall Study||35||
59805473|NCT01931709|75927014|FG000|NOT COMPLETED|Overall Study||0||
59805474|NCT01824875|75927024|FG000|STARTED|Overall Study||72||
59805475|NCT01824875|75927025|FG001|STARTED|Overall Study||72||
59805476|NCT01824875|75927024|FG000|Received Treatment and Adverse Event Data Available|Overall Study||68||
59805477|NCT01824875|75927025|FG001|Received Treatment and Adverse Event Data Available|Overall Study||71||
59805478|NCT01824875|75927024|FG000|Eligible|Overall Study||65||
59805479|NCT01824875|75927025|FG001|Eligible|Overall Study||68||
59805480|NCT01824875|75927024|FG000|Eligible Patients With MGMT by IHC Data Available|Overall Study||47||
59805481|NCT01824875|75927025|FG001|Eligible Patients With MGMT by IHC Data Available|Overall Study||50||
59805482|NCT01824875|75927024|FG000|Eligible Patients With MGMT by Promoter Methylation Data Available|Overall Study||27||
59805483|NCT01824875|75927025|FG001|Eligible Patients With MGMT by Promoter Methylation Data Available|Overall Study||30||
59958508|NCT03061097|76077234|FG000|STARTED|Overall Study||4||
59958509|NCT03061097|76077235|FG001|STARTED|Overall Study||3||
59958510|NCT03061097|76077234|FG000|COMPLETED|Overall Study||4||
59958511|NCT03061097|76077235|FG001|COMPLETED|Overall Study||0||
59958512|NCT03061097|76077234|FG000|NOT COMPLETED|Overall Study||0||
59958513|NCT03061097|76077235|FG001|NOT COMPLETED|Overall Study||3||
59958514|NCT02554318|76077243|FG000|STARTED|Overall Study||75||
59958515|NCT02554318|76077244|FG001|STARTED|Overall Study||72||
59805484|NCT01824875|75927024|FG000|COMPLETED|Overall Study||26||
59805485|NCT01824875|75927025|FG001|COMPLETED|Overall Study||32||
59805486|NCT01824875|75927024|FG000|NOT COMPLETED|Overall Study||46||
59805487|NCT01824875|75927025|FG001|NOT COMPLETED|Overall Study||40||
59805488|NCT01806129|75927037|FG000|STARTED|Overall Study||278||
59805489|NCT01806129|75927038|FG001|STARTED|Overall Study||156||
59805490|NCT01806129|75927037|FG000|Eligible|Overall Study||269||
59958516|NCT02554318|76077243|FG000|COMPLETED|Overall Study||65||
59958517|NCT02554318|76077244|FG001|COMPLETED|Overall Study||64||
59958518|NCT02554318|76077243|FG000|NOT COMPLETED|Overall Study||10||
59805491|NCT01806129|75927038|FG001|Eligible|Overall Study||151||
59805492|NCT01806129|75927037|FG000|Eligible Patients That Were Evaluable for the Primary Endpoint|Overall Study||252||
59805493|NCT01806129|75927038|FG001|Eligible Patients That Were Evaluable for the Primary Endpoint|Overall Study||140||
59805494|NCT01806129|75927037|FG000|COMPLETED|Overall Study||278||
59805495|NCT01806129|75927038|FG001|COMPLETED|Overall Study||156||
59805496|NCT01806129|75927037|FG000|NOT COMPLETED|Overall Study||0||
59805497|NCT01806129|75927038|FG001|NOT COMPLETED|Overall Study||0||
59805498|NCT01756040|75927044|FG000|STARTED|IP in Preterm Infants: Cohort 1||44||
59805499|NCT01756040|75927044|FG000|COMPLETED|IP in Preterm Infants: Cohort 1||43||
60073971|NCT01868594|76189325|FG000|NOT COMPLETED|Overall Study||4||
60073972|NCT01868594|76189326|FG001|NOT COMPLETED|Overall Study||3||
59805500|NCT01756040|75927044|FG000|NOT COMPLETED|IP in Preterm Infants: Cohort 1||1||
59805501|NCT01756040|75927044|FG000|STARTED|IP in Preterm Infants: Cohort 2||167||
59805502|NCT01756040|75927044|FG000|COMPLETED|IP in Preterm Infants: Cohort 2||158||
59805503|NCT01756040|75927044|FG000|NOT COMPLETED|IP in Preterm Infants: Cohort 2||9||
59805504|NCT01500473|75927051|FG000|STARTED|Overall Study||1||
59805505|NCT01500473|75927051|FG000|COMPLETED|Overall Study||1||
59805506|NCT01500473|75927051|FG000|NOT COMPLETED|Overall Study||0||
59805507|NCT01321216|75927056|FG000|STARTED|Overall Study||1555||
59805508|NCT01321216|75927056|FG000|COMPLETED|Overall Study||1555||
59805509|NCT01321216|75927056|FG000|NOT COMPLETED|Overall Study||0||
59805510|NCT00567164|75927063|FG000|STARTED|Overall Study||1421||
59805511|NCT00567164|75927064|FG001|STARTED|Overall Study||234||
59805512|NCT00567164|75927065|FG002|STARTED|Overall Study||232||
59805513|NCT00567164|75927063|FG000|Subjects Received Treatment|Overall Study|Full Analysis Set|1406||
59805514|NCT00567164|75927064|FG001|Subjects Received Treatment|Overall Study|Full Analysis Set|232||
59805515|NCT00567164|75927065|FG002|Subjects Received Treatment|Overall Study|Full Analysis Set|226||
59805516|NCT00567164|75927063|FG000|COMPLETED|Overall Study||875||
59805517|NCT00567164|75927064|FG001|COMPLETED|Overall Study||161||
59805518|NCT00567164|75927065|FG002|COMPLETED|Overall Study||160||
59805519|NCT00567164|75927063|FG000|NOT COMPLETED|Overall Study||546||
59805520|NCT00567164|75927064|FG001|NOT COMPLETED|Overall Study||73||
59805521|NCT00567164|75927065|FG002|NOT COMPLETED|Overall Study||72||
59805522|NCT00713219|75927077|FG000|STARTED|Overall Study||14||
59620879|NCT00224952|75732311|FG002|NOT COMPLETED|Overall Study||0||
59620880|NCT00225420|75732320|FG000|STARTED|Overall Study||9||
59620881|NCT00225420|75732321|FG001|STARTED|Overall Study||6||
59620882|NCT00225420|75732322|FG002|STARTED|Overall Study||3||
59620883|NCT00225420|75732320|FG000|COMPLETED|Overall Study||9||
59620884|NCT00225420|75732321|FG001|COMPLETED|Overall Study||6||
59620885|NCT00225420|75732322|FG002|COMPLETED|Overall Study||3||
59620886|NCT00225420|75732320|FG000|NOT COMPLETED|Overall Study||0||
59620887|NCT00225420|75732321|FG001|NOT COMPLETED|Overall Study||0||
59620888|NCT00225420|75732322|FG002|NOT COMPLETED|Overall Study||0||
59620889|NCT00225498|75732329|FG000|STARTED|Overall Study||10||
59620890|NCT00225498|75732329|FG000|COMPLETED|Overall Study|The only analyses with adequate statistical power were of the 10 ziprasidone nonresponders.|10||
59805523|NCT00713219|75927077|FG000|COMPLETED|Overall Study||12||
59805524|NCT00713219|75927077|FG000|NOT COMPLETED|Overall Study||2||
59805525|NCT00712985|75927081|FG000|STARTED|Overall Study||18||
59805526|NCT00712985|75927081|FG000|COMPLETED|Overall Study||13||
59805527|NCT00712985|75927081|FG000|NOT COMPLETED|Overall Study||5||
59805528|NCT00700115|75927087|FG000|STARTED|Overall Study||40||
59805529|NCT00700115|75927088|FG001|STARTED|Overall Study||20||
59805530|NCT00700115|75927087|FG000|COMPLETED|Overall Study||39||
59805531|NCT00700115|75927088|FG001|COMPLETED|Overall Study||19||
59805532|NCT00700115|75927087|FG000|NOT COMPLETED|Overall Study||1||
59805533|NCT00700115|75927088|FG001|NOT COMPLETED|Overall Study||1||
59805534|NCT00566852|75927096|FG000|STARTED|Overall Study||278||
59805535|NCT00566852|75927097|FG001|STARTED|Overall Study||276||
59805536|NCT00566852|75927096|FG000|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|71||
59620891|NCT00225498|75732329|FG000|NOT COMPLETED|Overall Study||0||
59620892|NCT00225732|75732335|FG000|STARTED|Overall Study||153||
59620893|NCT00225732|75732336|FG001|STARTED|Overall Study||166||
59805537|NCT00566852|75927097|FG001|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|78||
59805538|NCT00566852|75927096|FG000|NOT COMPLETED|Overall Study||207||
59805539|NCT00566852|75927097|FG001|NOT COMPLETED|Overall Study||198||
59805540|NCT00442546|75927106|FG000|STARTED|Overall Study||103||
59805541|NCT00442546|75927107|FG001|STARTED|Overall Study||100||
59805542|NCT00442546|75927108|FG002|STARTED|Overall Study||104||
59805543|NCT00442546|75927106|FG000|Received Treatment|Overall Study||98||
59805544|NCT00442546|75927107|FG001|Received Treatment|Overall Study||96||
59805545|NCT00442546|75927108|FG002|Received Treatment|Overall Study||98||
59805546|NCT00442546|75927106|FG000|COMPLETED|Overall Study||77||
59805547|NCT00442546|75927107|FG001|COMPLETED|Overall Study||63||
59805548|NCT00442546|75927108|FG002|COMPLETED|Overall Study||71||
59805549|NCT00442546|75927106|FG000|NOT COMPLETED|Overall Study||26||
60073973|NCT01616953|76189336|FG000|STARTED|Overall Study||10||
60073974|NCT01616953|76189337|FG001|STARTED|Overall Study||8||
60103593|NCT04075734|76221850|FG002|STARTED|Overall Study||10||
59620894|NCT00225732|75732335|FG000|COMPLETED|Overall Study||153||
59805550|NCT00442546|75927107|FG001|NOT COMPLETED|Overall Study||37||
59805551|NCT00442546|75927108|FG002|NOT COMPLETED|Overall Study||33||
59805552|NCT00514683|75927123|FG000|STARTED|Overall Study|Randomised|87||
59805553|NCT00514683|75927124|FG001|STARTED|Overall Study|Randomised|87||
59805554|NCT00514683|75927125|FG002|STARTED|Overall Study|Randomised|86||
59805555|NCT00514683|75927126|FG003|STARTED|Overall Study|Randomised|86||
59805556|NCT00514683|75927127|FG004|STARTED|Overall Study|Randomised|86||
59805557|NCT00514683|75927123|FG000|COMPLETED|Overall Study||61||
59805558|NCT00514683|75927124|FG001|COMPLETED|Overall Study||62||
59805559|NCT00514683|75927125|FG002|COMPLETED|Overall Study||68||
59805560|NCT00514683|75927126|FG003|COMPLETED|Overall Study||72||
59805561|NCT00514683|75927127|FG004|COMPLETED|Overall Study||53||
59620895|NCT00225732|75732336|FG001|COMPLETED|Overall Study||166||
59958519|NCT02554318|76077244|FG001|NOT COMPLETED|Overall Study||8||
59958520|NCT02550106|76077250|FG000|STARTED|Overall Study||136||
59620896|NCT00225732|75732335|FG000|NOT COMPLETED|Overall Study||0||
59620897|NCT00225732|75732336|FG001|NOT COMPLETED|Overall Study||0||
59805562|NCT00514683|75927123|FG000|NOT COMPLETED|Overall Study||26||
59958521|NCT02550106|76077250|FG000|COMPLETED|Overall Study||124||
59958522|NCT02550106|76077250|FG000|NOT COMPLETED|Overall Study||12||
59958523|NCT03060551|76077256|FG000|STARTED|Overall Study||20||
59958524|NCT03060551|76077256|FG000|COMPLETED|Overall Study||18||
59958525|NCT03060551|76077256|FG000|NOT COMPLETED|Overall Study||2||
59958526|NCT01662310|76077260|FG000|STARTED|Run-In or Stabilization Phase||201||
59958527|NCT01662310|76077261|FG001|STARTED|Run-In or Stabilization Phase||0||
59958528|NCT01662310|76077262|FG002|STARTED|Run-In or Stabilization Phase||0||
59958529|NCT01662310|76077263|FG003|STARTED|Run-In or Stabilization Phase||0||
59958530|NCT01662310|76077264|FG004|STARTED|Run-In or Stabilization Phase||0||
59958531|NCT01662310|76077260|FG000|COMPLETED|Run-In or Stabilization Phase||136||
59958532|NCT01662310|76077261|FG001|COMPLETED|Run-In or Stabilization Phase||0||
59958533|NCT01662310|76077262|FG002|COMPLETED|Run-In or Stabilization Phase||0||
59958534|NCT01662310|76077263|FG003|COMPLETED|Run-In or Stabilization Phase||0||
59958535|NCT01662310|76077264|FG004|COMPLETED|Run-In or Stabilization Phase||0||
59958536|NCT01662310|76077260|FG000|NOT COMPLETED|Run-In or Stabilization Phase||65||
59958537|NCT01662310|76077261|FG001|NOT COMPLETED|Run-In or Stabilization Phase||0||
59958538|NCT01662310|76077262|FG002|NOT COMPLETED|Run-In or Stabilization Phase||0||
59958539|NCT01662310|76077263|FG003|NOT COMPLETED|Run-In or Stabilization Phase||0||
59958540|NCT01662310|76077264|FG004|NOT COMPLETED|Run-In or Stabilization Phase||0||
59958541|NCT01662310|76077260|FG000|STARTED|Double-Blind Phase||0||
59958542|NCT01662310|76077261|FG001|STARTED|Double-Blind Phase||65||
59958543|NCT01662310|76077262|FG002|STARTED|Double-Blind Phase||71||
59958544|NCT01662310|76077263|FG003|STARTED|Double-Blind Phase||0||
59958545|NCT01662310|76077264|FG004|STARTED|Double-Blind Phase||0||
59958546|NCT01662310|76077260|FG000|Treated|Double-Blind Phase||0||
59958547|NCT01662310|76077261|FG001|Treated|Double-Blind Phase||64||
59958548|NCT01662310|76077262|FG002|Treated|Double-Blind Phase||71||
59958549|NCT01662310|76077263|FG003|Treated|Double-Blind Phase||0||
59958550|NCT01662310|76077264|FG004|Treated|Double-Blind Phase||0||
59958551|NCT01662310|76077260|FG000|COMPLETED|Double-Blind Phase||0||
59958552|NCT01662310|76077261|FG001|COMPLETED|Double-Blind Phase||50||
59958553|NCT01662310|76077262|FG002|COMPLETED|Double-Blind Phase||66||
59958554|NCT01662310|76077263|FG003|COMPLETED|Double-Blind Phase||0||
59958555|NCT01662310|76077264|FG004|COMPLETED|Double-Blind Phase||0||
59805563|NCT00514683|75927124|FG001|NOT COMPLETED|Overall Study||25||
59805564|NCT00514683|75927125|FG002|NOT COMPLETED|Overall Study||18||
59805565|NCT00514683|75927126|FG003|NOT COMPLETED|Overall Study||14||
59805566|NCT00514683|75927127|FG004|NOT COMPLETED|Overall Study||33||
59805567|NCT00566696|75927143|FG000|STARTED|Overall Study||73||
59805568|NCT00566696|75927143|FG000|COMPLETED|Overall Study||31||
59805569|NCT00566696|75927143|FG000|NOT COMPLETED|Overall Study||42||
59958556|NCT01662310|76077260|FG000|NOT COMPLETED|Double-Blind Phase||0||
59958557|NCT01662310|76077261|FG001|NOT COMPLETED|Double-Blind Phase||15||
59958558|NCT01662310|76077262|FG002|NOT COMPLETED|Double-Blind Phase||5||
59805570|NCT00503841|75927147|FG000|STARTED|Overall Study||44||
59958559|NCT01662310|76077263|FG003|NOT COMPLETED|Double-Blind Phase||0||
59958560|NCT01662310|76077264|FG004|NOT COMPLETED|Double-Blind Phase||0||
59958561|NCT01662310|76077260|FG000|STARTED|Open-Label Extension Phase||0||
59958562|NCT01662310|76077261|FG001|STARTED|Open-Label Extension Phase||0||
59805571|NCT00503841|75927147|FG000|COMPLETED|Overall Study||0||
59805572|NCT00503841|75927147|FG000|NOT COMPLETED|Overall Study||44||
59805573|NCT00442468|75927153|FG000|STARTED|Overall Study||1283||
59805574|NCT00442468|75927153|FG000|COMPLETED|Overall Study||1100||
59958563|NCT01662310|76077262|FG002|STARTED|Open-Label Extension Phase||0||
59958564|NCT01662310|76077263|FG003|STARTED|Open-Label Extension Phase||47||
59958565|NCT01662310|76077264|FG004|STARTED|Open-Label Extension Phase||59||
59958566|NCT01662310|76077260|FG000|COMPLETED|Open-Label Extension Phase||0||
59958567|NCT01662310|76077261|FG001|COMPLETED|Open-Label Extension Phase||0||
59805575|NCT00442468|75927153|FG000|NOT COMPLETED|Overall Study||183||
59805576|NCT00506883|75927160|FG000|STARTED|Overall Study||52||
59805577|NCT00506883|75927161|FG001|STARTED|Overall Study||74||
59805578|NCT00506883|75927162|FG002|STARTED|Overall Study||59||
59805579|NCT00506883|75927160|FG000|COMPLETED|Overall Study||45||
59805580|NCT00506883|75927161|FG001|COMPLETED|Overall Study||71||
59805581|NCT00506883|75927162|FG002|COMPLETED|Overall Study||55||
59805582|NCT00506883|75927160|FG000|NOT COMPLETED|Overall Study||7||
59805583|NCT00506883|75927161|FG001|NOT COMPLETED|Overall Study||3||
59805584|NCT00506883|75927162|FG002|NOT COMPLETED|Overall Study||4||
59805585|NCT00503685|75927173|FG000|STARTED|Overall Study||23||
59805586|NCT00503685|75927174|FG001|STARTED|Overall Study||22||
59805587|NCT00503685|75927175|FG002|STARTED|Overall Study||20||
59805588|NCT00503685|75927173|FG000|Received at Least 1 Dose of Study Drug|Overall Study||23||
59805589|NCT00503685|75927174|FG001|Received at Least 1 Dose of Study Drug|Overall Study||21||
59805590|NCT00503685|75927175|FG002|Received at Least 1 Dose of Study Drug|Overall Study||20||
59805591|NCT00503685|75927173|FG000|COMPLETED|Overall Study||23||
59805592|NCT00503685|75927174|FG001|COMPLETED|Overall Study||19||
59805593|NCT00503685|75927175|FG002|COMPLETED|Overall Study||18||
59805594|NCT00503685|75927173|FG000|NOT COMPLETED|Overall Study||0||
59805595|NCT00503685|75927174|FG001|NOT COMPLETED|Overall Study||3||
59958568|NCT01662310|76077262|FG002|COMPLETED|Open-Label Extension Phase||0||
59958569|NCT01662310|76077263|FG003|COMPLETED|Open-Label Extension Phase||36||
59958570|NCT01662310|76077264|FG004|COMPLETED|Open-Label Extension Phase||49||
59958571|NCT01662310|76077260|FG000|NOT COMPLETED|Open-Label Extension Phase||0||
59958572|NCT01662310|76077261|FG001|NOT COMPLETED|Open-Label Extension Phase||0||
59958573|NCT01662310|76077262|FG002|NOT COMPLETED|Open-Label Extension Phase||0||
59958574|NCT01662310|76077263|FG003|NOT COMPLETED|Open-Label Extension Phase||11||
59958575|NCT01662310|76077264|FG004|NOT COMPLETED|Open-Label Extension Phase||10||
59958576|NCT00700622|76077278|FG000|STARTED|Overall Study||65||
59958577|NCT00700622|76077279|FG001|STARTED|Overall Study||65||
59958578|NCT00700622|76077278|FG000|COMPLETED|Overall Study||52||
59958579|NCT00700622|76077279|FG001|COMPLETED|Overall Study||60||
59958580|NCT00700622|76077278|FG000|NOT COMPLETED|Overall Study||13||
59958581|NCT00700622|76077279|FG001|NOT COMPLETED|Overall Study||5||
59958582|NCT02553928|76077287|FG000|STARTED|Overall Study||30||
59958583|NCT02553928|76077288|FG001|STARTED|Overall Study||32||
59958584|NCT02553928|76077287|FG000|COMPLETED|Overall Study||28||
59958585|NCT02553928|76077288|FG001|COMPLETED|Overall Study||29||
59958586|NCT02553928|76077287|FG000|NOT COMPLETED|Overall Study||2||
59958587|NCT02553928|76077288|FG001|NOT COMPLETED|Overall Study||3||
59958588|NCT03076775|76077297|FG000|STARTED|Overall Study||44||
59958589|NCT03076775|76077298|FG001|STARTED|Overall Study||42||
59958590|NCT03076775|76077297|FG000|Neonates Born During Study|Overall Study||43||
59958591|NCT03076775|76077298|FG001|Neonates Born During Study|Overall Study||42||
59958592|NCT03076775|76077297|FG000|Umbilical Cord Blood Collected|Overall Study||33||
59958593|NCT03076775|76077298|FG001|Umbilical Cord Blood Collected|Overall Study||38||
59958594|NCT03076775|76077297|FG000|COMPLETED|Overall Study||43||
59958595|NCT03076775|76077298|FG001|COMPLETED|Overall Study||42||
59958596|NCT03076775|76077297|FG000|NOT COMPLETED|Overall Study||1||
59958597|NCT03076775|76077298|FG001|NOT COMPLETED|Overall Study||0||
59958598|NCT03875495|76077308|FG000|STARTED|Overall Study||3||
59958599|NCT03875495|76077308|FG000|COMPLETED|Overall Study||0||
59958600|NCT03875495|76077308|FG000|NOT COMPLETED|Overall Study||3||
59958601|NCT03058991|76077315|FG000|STARTED|Overall Study||39||
59805596|NCT00503685|75927175|FG002|NOT COMPLETED|Overall Study||2||
59805597|NCT00712673|75927187|FG000|STARTED|Overall Study|Randomized.|85||
59805598|NCT00712673|75927188|FG001|STARTED|Overall Study||85||
59805599|NCT00712673|75927189|FG002|STARTED|Overall Study||255||
59805600|NCT00712673|75927190|FG003|STARTED|Overall Study||255||
59805601|NCT00712673|75927187|FG000|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|85||
59805602|NCT00712673|75927188|FG001|Safety Population|Overall Study||85||
59805603|NCT00712673|75927189|FG002|Safety Population|Overall Study||255||
59805604|NCT00712673|75927190|FG003|Safety Population|Overall Study||255||
59805605|NCT00712673|75927187|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|85||
59958602|NCT03058991|76077316|FG001|STARTED|Overall Study||32||
59958603|NCT03058991|76077317|FG002|STARTED|Overall Study||37||
59958604|NCT03058991|76077315|FG000|1-Week Follow Up|Overall Study||23||
59805606|NCT00712673|75927188|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||85||
59805607|NCT00712673|75927189|FG002|Modified Intent-to-Treat(mITT)Population|Overall Study||255||
59805608|NCT00712673|75927190|FG003|Modified Intent-to-Treat(mITT)Population|Overall Study||255||
59805609|NCT00712673|75927187|FG000|Subgroup for Standardized Meal Test|Overall Study|Patients from morning injection arms where standardized meal test was performed.|85||
59805610|NCT00712673|75927188|FG001|Subgroup for Standardized Meal Test|Overall Study||0||
59805611|NCT00712673|75927189|FG002|Subgroup for Standardized Meal Test|Overall Study||255||
59805612|NCT00712673|75927190|FG003|Subgroup for Standardized Meal Test|Overall Study||0||
59805613|NCT00712673|75927187|FG000|COMPLETED|Overall Study||64||
59958605|NCT03058991|76077316|FG001|1-Week Follow Up|Overall Study||27||
59958606|NCT03058991|76077317|FG002|1-Week Follow Up|Overall Study||28||
59958607|NCT03058991|76077315|FG000|COMPLETED|Overall Study||21||
59958608|NCT03058991|76077316|FG001|COMPLETED|Overall Study||20||
59958609|NCT03058991|76077317|FG002|COMPLETED|Overall Study||25||
59958610|NCT03058991|76077315|FG000|NOT COMPLETED|Overall Study||18||
59958611|NCT03058991|76077316|FG001|NOT COMPLETED|Overall Study||12||
59958612|NCT03058991|76077317|FG002|NOT COMPLETED|Overall Study||12||
59958613|NCT00700310|76077329|FG000|STARTED|Overall Study||187||
59958614|NCT00700310|76077330|FG001|STARTED|Overall Study||180||
59958615|NCT00700310|76077331|FG002|STARTED|Overall Study||174||
59958616|NCT00700310|76077332|FG003|STARTED|Overall Study||171||
59805614|NCT00712673|75927188|FG001|COMPLETED|Overall Study||64||
59805615|NCT00712673|75927189|FG002|COMPLETED|Overall Study||198||
59805616|NCT00712673|75927190|FG003|COMPLETED|Overall Study||185||
59805617|NCT00712673|75927187|FG000|NOT COMPLETED|Overall Study||21||
59805618|NCT00712673|75927188|FG001|NOT COMPLETED|Overall Study||21||
59805619|NCT00712673|75927189|FG002|NOT COMPLETED|Overall Study||57||
59805620|NCT00712673|75927190|FG003|NOT COMPLETED|Overall Study||70||
59805621|NCT03976466|75927211|FG000|STARTED|Overall Study||44||
59805622|NCT03976466|75927212|FG001|STARTED|Overall Study||43||
59805623|NCT03976466|75927211|FG000|COMPLETED|Overall Study||43||
59805624|NCT03976466|75927212|FG001|COMPLETED|Overall Study||40||
59805625|NCT03976466|75927211|FG000|NOT COMPLETED|Overall Study||1||
59958617|NCT00700310|76077329|FG000|COMPLETED|Overall Study||166||
59958618|NCT00700310|76077330|FG001|COMPLETED|Overall Study||154||
59958619|NCT00700310|76077331|FG002|COMPLETED|Overall Study||158||
59958620|NCT00700310|76077332|FG003|COMPLETED|Overall Study||145||
59958621|NCT00700310|76077329|FG000|NOT COMPLETED|Overall Study||21||
59958622|NCT00700310|76077330|FG001|NOT COMPLETED|Overall Study||26||
59958623|NCT00700310|76077331|FG002|NOT COMPLETED|Overall Study||16||
59958624|NCT00700310|76077332|FG003|NOT COMPLETED|Overall Study||26||
59958625|NCT02074436|76077344|FG000|STARTED|Overall Study||15||
59958626|NCT02074436|76077345|FG001|STARTED|Overall Study||14||
59958627|NCT02074436|76077344|FG000|COMPLETED|Overall Study||15||
59958628|NCT02074436|76077345|FG001|COMPLETED|Overall Study||14||
59958629|NCT02074436|76077344|FG000|NOT COMPLETED|Overall Study||0||
59958630|NCT02074436|76077345|FG001|NOT COMPLETED|Overall Study||0||
59958631|NCT01575548|76077353|FG000|STARTED|Overall Study||66||
59958632|NCT01575548|76077354|FG001|STARTED|Overall Study||63||
59958633|NCT01575548|76077353|FG000|Received Protocol Therapy|Overall Study||63||
59958634|NCT01575548|76077354|FG001|Received Protocol Therapy|Overall Study||61||
59958635|NCT01575548|76077353|FG000|COMPLETED|Overall Study||26||
59958636|NCT01575548|76077354|FG001|COMPLETED|Overall Study||30||
59958637|NCT01575548|76077353|FG000|NOT COMPLETED|Overall Study||40||
59958638|NCT01575548|76077354|FG001|NOT COMPLETED|Overall Study||33||
59805626|NCT03976466|75927212|FG001|NOT COMPLETED|Overall Study||3||
59805627|NCT02536755|75927220|FG000|STARTED|Overall Study||31||
59805628|NCT02536755|75927220|FG000|COMPLETED|Overall Study||27||
59805629|NCT02536755|75927220|FG000|NOT COMPLETED|Overall Study||4||
59958639|NCT03221270|76077364|FG000|STARTED|Overall Study||8||
59958640|NCT03221270|76077365|FG001|STARTED|Overall Study||6||
59958641|NCT03221270|76077366|FG002|STARTED|Overall Study||5||
60073975|NCT01616953|76189336|FG000|Implant Placement Surgery|Overall Study||9||
60073976|NCT01616953|76189337|FG001|Implant Placement Surgery|Overall Study||8||
60073977|NCT01616953|76189336|FG000|Implant Uncovery|Overall Study||8||
59805630|NCT03303105|75927229|FG000|STARTED|Overall Study||25||
59805631|NCT03303105|75927230|FG001|STARTED|Overall Study||25||
59805632|NCT03303105|75927229|FG000|COMPLETED|Overall Study||23||
59805633|NCT03303105|75927230|FG001|COMPLETED|Overall Study||21||
59805634|NCT03303105|75927229|FG000|NOT COMPLETED|Overall Study||2||
59805635|NCT03303105|75927230|FG001|NOT COMPLETED|Overall Study||4||
59805636|NCT00447694|75927236|FG000|STARTED|Overall Study||28||
59805637|NCT00447694|75927236|FG000|COMPLETED|Overall Study||22||
59805638|NCT00447694|75927236|FG000|NOT COMPLETED|Overall Study||6||
59805639|NCT00564278|75927242|FG000|STARTED|Overall Study||97||
59805640|NCT00564278|75927243|FG001|STARTED|Overall Study||98||
59958642|NCT03221270|76077367|FG003|STARTED|Overall Study||6||
59958643|NCT03221270|76077364|FG000|Completed 5-Day Treatment|Overall Study||8||
59958644|NCT03221270|76077365|FG001|Completed 5-Day Treatment|Overall Study||6||
59958645|NCT03221270|76077366|FG002|Completed 5-Day Treatment|Overall Study||5||
59958646|NCT03221270|76077367|FG003|Completed 5-Day Treatment|Overall Study||6||
59958647|NCT03221270|76077364|FG000|Completed 8-Week Maintenance|Overall Study||4||
60073978|NCT01616953|76189337|FG001|Implant Uncovery|Overall Study||8||
59805641|NCT00564278|75927242|FG000|COMPLETED|Overall Study||50||
59805642|NCT00564278|75927243|FG001|COMPLETED|Overall Study||56||
59805643|NCT00564278|75927242|FG000|NOT COMPLETED|Overall Study||47||
59805644|NCT00564278|75927243|FG001|NOT COMPLETED|Overall Study||42||
59805645|NCT00565604|75927249|FG000|STARTED|Overall Study||43||
59958648|NCT03221270|76077365|FG001|Completed 8-Week Maintenance|Overall Study||6||
59958649|NCT03221270|76077366|FG002|Completed 8-Week Maintenance|Overall Study||5||
59958650|NCT03221270|76077367|FG003|Completed 8-Week Maintenance|Overall Study||5||
59805646|NCT00565604|75927249|FG000|7 Day|Overall Study||41||
59958651|NCT03221270|76077364|FG000|COMPLETED|Overall Study||4||
59958652|NCT03221270|76077365|FG001|COMPLETED|Overall Study||6||
59958653|NCT03221270|76077366|FG002|COMPLETED|Overall Study||5||
59958654|NCT03221270|76077367|FG003|COMPLETED|Overall Study||5||
59958655|NCT03221270|76077364|FG000|NOT COMPLETED|Overall Study||4||
59958656|NCT03221270|76077365|FG001|NOT COMPLETED|Overall Study||0||
59958657|NCT03221270|76077366|FG002|NOT COMPLETED|Overall Study||0||
59958658|NCT03221270|76077367|FG003|NOT COMPLETED|Overall Study||1||
59958659|NCT02554786|76077382|FG000|STARTED|Overall Study||445||
59958660|NCT02554786|76077383|FG001|STARTED|Overall Study||439||
59958661|NCT02554786|76077384|FG002|STARTED|Overall Study||442||
59958662|NCT02554786|76077385|FG003|STARTED|Overall Study||444||
59958663|NCT02554786|76077386|FG004|STARTED|Overall Study||446||
59958664|NCT02554786|76077382|FG000|COMPLETED|Overall Study||410||
59958665|NCT02554786|76077383|FG001|COMPLETED|Overall Study||413||
59958666|NCT02554786|76077384|FG002|COMPLETED|Overall Study||412||
59958667|NCT02554786|76077385|FG003|COMPLETED|Overall Study||403||
59958668|NCT02554786|76077386|FG004|COMPLETED|Overall Study||416||
59958669|NCT02554786|76077382|FG000|NOT COMPLETED|Overall Study||35||
59958670|NCT02554786|76077383|FG001|NOT COMPLETED|Overall Study||26||
59958671|NCT02554786|76077384|FG002|NOT COMPLETED|Overall Study||30||
59958672|NCT02554786|76077385|FG003|NOT COMPLETED|Overall Study||41||
59958673|NCT02554786|76077386|FG004|NOT COMPLETED|Overall Study||30||
59958674|NCT01347645|76077407|FG000|STARTED|Overall Study||3||
59958675|NCT01347645|76077408|FG001|STARTED|Overall Study||8||
59958676|NCT01347645|76077409|FG002|STARTED|Overall Study||3||
59805647|NCT00565604|75927249|FG000|2 Week|Overall Study||41||
59805648|NCT00565604|75927249|FG000|6 Week|Overall Study||39||
59805649|NCT00565604|75927249|FG000|6 Month|Overall Study||39||
59805650|NCT00565604|75927249|FG000|COMPLETED|Overall Study||39||
59805651|NCT00565604|75927249|FG000|NOT COMPLETED|Overall Study||4||
59805652|NCT00447226|75927253|FG000|STARTED|12-Week Open-label Phase||0||
59805653|NCT00447226|75927254|FG001|STARTED|12-Week Open-label Phase||32||
59805654|NCT00447226|75927253|FG000|COMPLETED|12-Week Open-label Phase||0||
59805655|NCT00447226|75927254|FG001|COMPLETED|12-Week Open-label Phase||7||
59805656|NCT00447226|75927253|FG000|NOT COMPLETED|12-Week Open-label Phase||0||
59805657|NCT00447226|75927254|FG001|NOT COMPLETED|12-Week Open-label Phase||25||
59805658|NCT00447226|75927253|FG000|STARTED|Double-blind Phase||4||
59805659|NCT00447226|75927254|FG001|STARTED|Double-blind Phase||3||
59805660|NCT00447226|75927253|FG000|COMPLETED|Double-blind Phase||0||
59805661|NCT00447226|75927254|FG001|COMPLETED|Double-blind Phase||0||
59805662|NCT00447226|75927253|FG000|NOT COMPLETED|Double-blind Phase||4||
59958677|NCT01347645|76077410|FG003|STARTED|Overall Study||34||
59958678|NCT01347645|76077411|FG004|STARTED|Overall Study||34||
59958679|NCT01347645|76077407|FG000|COMPLETED|Overall Study||0||
59958680|NCT01347645|76077408|FG001|COMPLETED|Overall Study||0||
59958681|NCT01347645|76077409|FG002|COMPLETED|Overall Study||0||
59958682|NCT01347645|76077410|FG003|COMPLETED|Overall Study||0||
59958683|NCT01347645|76077411|FG004|COMPLETED|Overall Study||0||
59958684|NCT01347645|76077407|FG000|NOT COMPLETED|Overall Study||3||
59958685|NCT01347645|76077408|FG001|NOT COMPLETED|Overall Study||8||
60073979|NCT01616953|76189336|FG000|6 Months Post-loading|Overall Study||8||
60073980|NCT01616953|76189337|FG001|6 Months Post-loading|Overall Study||8||
59805663|NCT00447226|75927254|FG001|NOT COMPLETED|Double-blind Phase||3||
59805664|NCT00446992|75927269|FG000|STARTED|Overall Study|Beginning of Intervention|30||
59805665|NCT00446992|75927269|FG000|COMPLETED|Overall Study|Intervention Completion|14||
59805666|NCT00446992|75927269|FG000|NOT COMPLETED|Overall Study||16||
59805667|NCT00503139|75927273|FG000|STARTED|Overall Study||684||
59805668|NCT00503139|75927273|FG000|COMPLETED|Overall Study||676||
59805669|NCT00503139|75927273|FG000|NOT COMPLETED|Overall Study||8||
59805670|NCT00577031|75927277|FG000|STARTED|Overall Study||205||
59805671|NCT00577031|75927277|FG000|COMPLETED|Overall Study||0||
59805672|NCT00577031|75927277|FG000|NOT COMPLETED|Overall Study||205||
59805673|NCT00565448|75927286|FG000|STARTED|Overall Study|Intent to treat (ITT) population: all randomized participants. All were treated.|50||
59805674|NCT00565448|75927287|FG001|STARTED|Overall Study|ITT population: all randomized participants. All were treated.|25||
59805675|NCT00565448|75927286|FG000|COMPLETED|Overall Study|Completed induction period as per protocol.|47||
59805676|NCT00565448|75927287|FG001|COMPLETED|Overall Study|Completed induction period as per protocol.|23||
59805677|NCT00565448|75927286|FG000|NOT COMPLETED|Overall Study||3||
59805678|NCT00565448|75927287|FG001|NOT COMPLETED|Overall Study||2||
59805679|NCT00446446|75927296|FG000|STARTED|Overall Study||52||
59958686|NCT01347645|76077409|FG002|NOT COMPLETED|Overall Study||3||
59958687|NCT01347645|76077410|FG003|NOT COMPLETED|Overall Study||34||
59958688|NCT01347645|76077411|FG004|NOT COMPLETED|Overall Study||34||
59958689|NCT02614547|76077423|FG000|STARTED|Overall Study||11||
59958690|NCT02614547|76077424|FG001|STARTED|Overall Study||10||
59958691|NCT02614547|76077423|FG000|COMPLETED|Overall Study||11||
59958692|NCT02614547|76077424|FG001|COMPLETED|Overall Study||10||
59958693|NCT02614547|76077423|FG000|NOT COMPLETED|Overall Study||0||
59958694|NCT02614547|76077424|FG001|NOT COMPLETED|Overall Study||0||
59958695|NCT00667953|76077433|FG000|STARTED|Overall Study||32||
59958696|NCT00667953|76077433|FG000|COMPLETED|Overall Study||28||
59958697|NCT00667953|76077433|FG000|NOT COMPLETED|Overall Study||4||
59958698|NCT02424851|76077439|FG000|STARTED|Overall Study||16||
60073981|NCT01616953|76189336|FG000|COMPLETED|Overall Study||8||
59958699|NCT02424851|76077440|FG001|STARTED|Overall Study||15||
59958700|NCT02424851|76077439|FG000|COMPLETED|Overall Study||14||
59958701|NCT02424851|76077440|FG001|COMPLETED|Overall Study||12||
59805680|NCT00446446|75927296|FG000|COMPLETED|Overall Study|Participants who completed the 60-day safety visit|28||
59805681|NCT00446446|75927296|FG000|NOT COMPLETED|Overall Study||24||
59805682|NCT00514449|75927302|FG000|STARTED|Overall Study||12||
59805683|NCT00514449|75927303|FG001|STARTED|Overall Study||12||
59958702|NCT02424851|76077439|FG000|NOT COMPLETED|Overall Study||2||
59958703|NCT02424851|76077440|FG001|NOT COMPLETED|Overall Study||3||
59958704|NCT00484419|76077449|FG000|STARTED|Overall Study||57||
59958705|NCT00484419|76077450|FG001|STARTED|Overall Study||56||
59958706|NCT00484419|76077451|FG002|STARTED|Overall Study||56||
59958707|NCT00484419|76077449|FG000|COMPLETED|Overall Study||45||
59958708|NCT00484419|76077450|FG001|COMPLETED|Overall Study||51||
59958709|NCT00484419|76077451|FG002|COMPLETED|Overall Study||45||
59958710|NCT00484419|76077449|FG000|NOT COMPLETED|Overall Study||12||
59958711|NCT00484419|76077450|FG001|NOT COMPLETED|Overall Study||5||
59958712|NCT00484419|76077451|FG002|NOT COMPLETED|Overall Study||11||
59958713|NCT03220724|76077460|FG000|STARTED|Overall Study||12||
59958714|NCT03220724|76077461|FG001|STARTED|Overall Study||12||
59958715|NCT03220724|76077462|FG002|STARTED|Overall Study||12||
59958716|NCT03220724|76077463|FG003|STARTED|Overall Study||6||
59958717|NCT03220724|76077460|FG000|Month 4.5 Immunogenicity Cohort|Overall Study||11||
59958718|NCT03220724|76077461|FG001|Month 4.5 Immunogenicity Cohort|Overall Study||12||
59958719|NCT03220724|76077462|FG002|Month 4.5 Immunogenicity Cohort|Overall Study||12||
59805684|NCT00514449|75927302|FG000|COMPLETED|Overall Study||9||
59805685|NCT00514449|75927303|FG001|COMPLETED|Overall Study||8||
59805686|NCT00514449|75927302|FG000|NOT COMPLETED|Overall Study||3||
59805687|NCT00514449|75927303|FG001|NOT COMPLETED|Overall Study||4||
59805688|NCT00565136|75927312|FG000|STARTED|Overall Study||29||
59805689|NCT00565136|75927312|FG000|COMPLETED|Overall Study||26||
59958720|NCT03220724|76077463|FG003|Month 4.5 Immunogenicity Cohort|Overall Study||3||
59958721|NCT03220724|76077460|FG000|COMPLETED|Overall Study||9||
59958722|NCT03220724|76077461|FG001|COMPLETED|Overall Study||10||
59958723|NCT03220724|76077462|FG002|COMPLETED|Overall Study||11||
59958724|NCT03220724|76077463|FG003|COMPLETED|Overall Study||3||
59958725|NCT03220724|76077460|FG000|NOT COMPLETED|Overall Study||3||
59958726|NCT03220724|76077461|FG001|NOT COMPLETED|Overall Study||2||
59958727|NCT03220724|76077462|FG002|NOT COMPLETED|Overall Study||1||
59958728|NCT03220724|76077463|FG003|NOT COMPLETED|Overall Study||3||
59958729|NCT03056573|76077475|FG000|STARTED|Overall Study||45||
59958730|NCT03056573|76077476|FG001|STARTED|Overall Study||19||
59958731|NCT03056573|76077475|FG000|COMPLETED|Overall Study||40||
59524225|NCT00997139|75619401|FG000|Treated for Positive Baseline Culture|Overall Study||30||
59524226|NCT00997139|75619401|FG000|COMPLETED|Overall Study||30||
59805690|NCT00565136|75927312|FG000|NOT COMPLETED|Overall Study||3||
59805691|NCT00492921|75927316|FG000|STARTED|Overall Study||5||
59805692|NCT00492921|75927317|FG001|STARTED|Overall Study||4||
59805693|NCT00492921|75927318|FG002|STARTED|Overall Study||3||
59805694|NCT00492921|75927316|FG000|COMPLETED|Overall Study||4||
59805695|NCT00492921|75927317|FG001|COMPLETED|Overall Study||4||
59805696|NCT00492921|75927318|FG002|COMPLETED|Overall Study||2||
59805697|NCT00492921|75927316|FG000|NOT COMPLETED|Overall Study||1||
59958732|NCT03056573|76077476|FG001|COMPLETED|Overall Study||14||
59958733|NCT03056573|76077475|FG000|NOT COMPLETED|Overall Study||5||
59805698|NCT00492921|75927317|FG001|NOT COMPLETED|Overall Study||0||
59958734|NCT03056573|76077476|FG001|NOT COMPLETED|Overall Study||5||
59958735|NCT02553772|76077484|FG000|STARTED|Overall Study||120||
59958736|NCT02553772|76077485|FG001|STARTED|Overall Study||122||
59958737|NCT02553772|76077484|FG000|COMPLETED|Overall Study||114||
59958738|NCT02553772|76077485|FG001|COMPLETED|Overall Study||116||
59958739|NCT02553772|76077484|FG000|NOT COMPLETED|Overall Study||6||
59958740|NCT02553772|76077485|FG001|NOT COMPLETED|Overall Study||6||
59958741|NCT02553538|76077493|FG000|STARTED|Overall Study||792||
59958742|NCT02553538|76077494|FG001|STARTED|Overall Study||820||
59958743|NCT02553538|76077493|FG000|COMPLETED|Overall Study||605||
59958744|NCT02553538|76077494|FG001|COMPLETED|Overall Study||764||
59958745|NCT02553538|76077493|FG000|NOT COMPLETED|Overall Study||187||
59958746|NCT02553538|76077494|FG001|NOT COMPLETED|Overall Study||56||
59958747|NCT02548156|76077500|FG000|STARTED|Period 1||5||
59958748|NCT02548156|76077501|FG001|STARTED|Period 1||5||
59958749|NCT02548156|76077502|FG002|STARTED|Period 1||4||
59805699|NCT00492921|75927318|FG002|NOT COMPLETED|Overall Study||1||
59805700|NCT00502671|75927326|FG000|STARTED|Overall Study||228||
59805701|NCT00502671|75927326|FG000|COMPLETED|Overall Study||151||
59805702|NCT00502671|75927326|FG000|NOT COMPLETED|Overall Study||77||
59805703|NCT00697463|75927330|FG000|STARTED|Overall Study||22||
59805704|NCT00697463|75927330|FG000|COMPLETED|Overall Study||21||
59805705|NCT00697463|75927330|FG000|NOT COMPLETED|Overall Study||1||
59805706|NCT00492531|75927336|FG000|STARTED|Overall Study||37||
59805707|NCT00492531|75927337|FG001|STARTED|Overall Study||37||
59524227|NCT00997139|75619401|FG000|NOT COMPLETED|Overall Study||186||
59524228|NCT01241539|75619407|FG000|STARTED|Period 1||7||
59524229|NCT01241539|75619407|FG000|COMPLETED|Period 1||7||
59805708|NCT00492531|75927336|FG000|COMPLETED|Overall Study|Of 15 subjects who completed study, 13 were enrolled in Open label.|15||
59958750|NCT02548156|76077503|FG003|STARTED|Period 1||5||
59958751|NCT02548156|76077504|FG004|STARTED|Period 1||5||
59958752|NCT02548156|76077505|FG005|STARTED|Period 1||5||
59958753|NCT02548156|76077500|FG000|COMPLETED|Period 1||5||
59958754|NCT02548156|76077501|FG001|COMPLETED|Period 1||5||
59958755|NCT02548156|76077502|FG002|COMPLETED|Period 1||4||
59958756|NCT02548156|76077503|FG003|COMPLETED|Period 1||5||
59958757|NCT02548156|76077504|FG004|COMPLETED|Period 1||5||
59958758|NCT02548156|76077505|FG005|COMPLETED|Period 1||5||
59958759|NCT02548156|76077500|FG000|NOT COMPLETED|Period 1||0||
59805709|NCT00492531|75927337|FG001|COMPLETED|Overall Study|Of 14 subjects who completed study, 13 were enrolled in Open label.|14||
59805710|NCT00492531|75927336|FG000|NOT COMPLETED|Overall Study||22||
59805711|NCT00492531|75927337|FG001|NOT COMPLETED|Overall Study||23||
59958760|NCT02548156|76077501|FG001|NOT COMPLETED|Period 1||0||
59958761|NCT02548156|76077502|FG002|NOT COMPLETED|Period 1||0||
59958762|NCT02548156|76077503|FG003|NOT COMPLETED|Period 1||0||
59958763|NCT02548156|76077504|FG004|NOT COMPLETED|Period 1||0||
59958764|NCT02548156|76077505|FG005|NOT COMPLETED|Period 1||0||
59958765|NCT02548156|76077500|FG000|STARTED|Washout Period 1||5||
59958766|NCT02548156|76077501|FG001|STARTED|Washout Period 1||5||
59958767|NCT02548156|76077502|FG002|STARTED|Washout Period 1||4||
59958768|NCT02548156|76077503|FG003|STARTED|Washout Period 1||5||
59958769|NCT02548156|76077504|FG004|STARTED|Washout Period 1||5||
59958770|NCT02548156|76077505|FG005|STARTED|Washout Period 1||5||
59958771|NCT02548156|76077500|FG000|COMPLETED|Washout Period 1||5||
59958772|NCT02548156|76077501|FG001|COMPLETED|Washout Period 1||5||
59958773|NCT02548156|76077502|FG002|COMPLETED|Washout Period 1||4||
59958774|NCT02548156|76077503|FG003|COMPLETED|Washout Period 1||5||
59958775|NCT02548156|76077504|FG004|COMPLETED|Washout Period 1||4||
59958776|NCT02548156|76077505|FG005|COMPLETED|Washout Period 1||5||
59958777|NCT02548156|76077500|FG000|NOT COMPLETED|Washout Period 1||0||
59958778|NCT02548156|76077501|FG001|NOT COMPLETED|Washout Period 1||0||
59958779|NCT02548156|76077502|FG002|NOT COMPLETED|Washout Period 1||0||
59958780|NCT02548156|76077503|FG003|NOT COMPLETED|Washout Period 1||0||
59958781|NCT02548156|76077504|FG004|NOT COMPLETED|Washout Period 1||1||
59958782|NCT02548156|76077505|FG005|NOT COMPLETED|Washout Period 1||0||
59958783|NCT02548156|76077500|FG000|STARTED|Period 2||5||
59958784|NCT02548156|76077501|FG001|STARTED|Period 2||5||
59958785|NCT02548156|76077502|FG002|STARTED|Period 2||4||
59958786|NCT02548156|76077503|FG003|STARTED|Period 2||5||
59958787|NCT02548156|76077504|FG004|STARTED|Period 2||4||
59958788|NCT02548156|76077505|FG005|STARTED|Period 2||5||
59958789|NCT02548156|76077500|FG000|COMPLETED|Period 2||5||
59958790|NCT02548156|76077501|FG001|COMPLETED|Period 2||5||
59958791|NCT02548156|76077502|FG002|COMPLETED|Period 2||4||
59958792|NCT02548156|76077503|FG003|COMPLETED|Period 2||5||
59958793|NCT02548156|76077504|FG004|COMPLETED|Period 2||4||
59958794|NCT02548156|76077505|FG005|COMPLETED|Period 2||5||
59524230|NCT01241539|75619407|FG000|NOT COMPLETED|Period 1||0||
59805712|NCT00111475|75927353|FG000|STARTED|Overall Study||4||
59805713|NCT00111475|75927354|FG001|STARTED|Overall Study||4||
59805714|NCT00111475|75927355|FG002|STARTED|Overall Study||4||
59805715|NCT00111475|75927356|FG003|STARTED|Overall Study||4||
59805716|NCT00111475|75927357|FG004|STARTED|Overall Study||4||
59805717|NCT00111475|75927358|FG005|STARTED|Overall Study||4||
59805718|NCT00111475|75927359|FG006|STARTED|Overall Study||4||
59805719|NCT00111475|75927360|FG007|STARTED|Overall Study||8||
59805720|NCT00111475|75927361|FG008|STARTED|Overall Study||8||
59958795|NCT02548156|76077500|FG000|NOT COMPLETED|Period 2||0||
59958796|NCT02548156|76077501|FG001|NOT COMPLETED|Period 2||0||
59958797|NCT02548156|76077502|FG002|NOT COMPLETED|Period 2||0||
59958798|NCT02548156|76077503|FG003|NOT COMPLETED|Period 2||0||
59958799|NCT02548156|76077504|FG004|NOT COMPLETED|Period 2||0||
59958800|NCT02548156|76077505|FG005|NOT COMPLETED|Period 2||0||
59524231|NCT01241539|75619407|FG000|STARTED|Period 2|After a wash-out phase of at least 6 weeks.|7||
59805721|NCT00111475|75927362|FG009|STARTED|Overall Study||1||
59805722|NCT00111475|75927353|FG000|COMPLETED|Overall Study||4||
59805723|NCT00111475|75927354|FG001|COMPLETED|Overall Study||4||
59805724|NCT00111475|75927355|FG002|COMPLETED|Overall Study||4||
59805725|NCT00111475|75927356|FG003|COMPLETED|Overall Study||4||
59805726|NCT00111475|75927357|FG004|COMPLETED|Overall Study||4||
59805727|NCT00111475|75927358|FG005|COMPLETED|Overall Study||3||
59805728|NCT00111475|75927359|FG006|COMPLETED|Overall Study||4||
59805729|NCT00111475|75927360|FG007|COMPLETED|Overall Study||8||
59805730|NCT00111475|75927361|FG008|COMPLETED|Overall Study||8||
59805731|NCT00111475|75927362|FG009|COMPLETED|Overall Study||1||
59805732|NCT00111475|75927353|FG000|NOT COMPLETED|Overall Study||0||
59958801|NCT02548156|76077500|FG000|STARTED|Washout Period 2||5||
59958802|NCT02548156|76077501|FG001|STARTED|Washout Period 2||5||
59958803|NCT02548156|76077502|FG002|STARTED|Washout Period 2||4||
59958804|NCT02548156|76077503|FG003|STARTED|Washout Period 2||5||
59958805|NCT02548156|76077504|FG004|STARTED|Washout Period 2||4||
59958806|NCT02548156|76077505|FG005|STARTED|Washout Period 2||5||
59958807|NCT02548156|76077500|FG000|COMPLETED|Washout Period 2||5||
59805733|NCT00111475|75927354|FG001|NOT COMPLETED|Overall Study||0||
59805734|NCT00111475|75927355|FG002|NOT COMPLETED|Overall Study||0||
59805735|NCT00111475|75927356|FG003|NOT COMPLETED|Overall Study||0||
59805736|NCT00111475|75927357|FG004|NOT COMPLETED|Overall Study||0||
59958808|NCT02548156|76077501|FG001|COMPLETED|Washout Period 2||5||
59958809|NCT02548156|76077502|FG002|COMPLETED|Washout Period 2||4||
59958810|NCT02548156|76077503|FG003|COMPLETED|Washout Period 2||5||
59958811|NCT02548156|76077504|FG004|COMPLETED|Washout Period 2||4||
59958812|NCT02548156|76077505|FG005|COMPLETED|Washout Period 2||5||
59958813|NCT02548156|76077500|FG000|NOT COMPLETED|Washout Period 2||0||
59958814|NCT02548156|76077501|FG001|NOT COMPLETED|Washout Period 2||0||
59958815|NCT02548156|76077502|FG002|NOT COMPLETED|Washout Period 2||0||
59958816|NCT02548156|76077503|FG003|NOT COMPLETED|Washout Period 2||0||
59958817|NCT02548156|76077504|FG004|NOT COMPLETED|Washout Period 2||0||
59958818|NCT02548156|76077505|FG005|NOT COMPLETED|Washout Period 2||0||
59958819|NCT02548156|76077500|FG000|STARTED|Period 3||5||
59958820|NCT02548156|76077501|FG001|STARTED|Period 3||5||
59958821|NCT02548156|76077502|FG002|STARTED|Period 3||4||
59958822|NCT02548156|76077503|FG003|STARTED|Period 3||5||
59958823|NCT02548156|76077504|FG004|STARTED|Period 3||4||
59958824|NCT02548156|76077505|FG005|STARTED|Period 3||5||
59958825|NCT02548156|76077500|FG000|COMPLETED|Period 3||5||
59958826|NCT02548156|76077501|FG001|COMPLETED|Period 3||5||
59958827|NCT02548156|76077502|FG002|COMPLETED|Period 3||4||
59958828|NCT02548156|76077503|FG003|COMPLETED|Period 3||5||
59958829|NCT02548156|76077504|FG004|COMPLETED|Period 3||4||
59958830|NCT02548156|76077505|FG005|COMPLETED|Period 3||5||
59958831|NCT02548156|76077500|FG000|NOT COMPLETED|Period 3||0||
59958832|NCT02548156|76077501|FG001|NOT COMPLETED|Period 3||0||
59958833|NCT02548156|76077502|FG002|NOT COMPLETED|Period 3||0||
59958834|NCT02548156|76077503|FG003|NOT COMPLETED|Period 3||0||
59958835|NCT02548156|76077504|FG004|NOT COMPLETED|Period 3||0||
59958836|NCT02548156|76077505|FG005|NOT COMPLETED|Period 3||0||
59958837|NCT01503515|76077515|FG000|STARTED|Overall Study||145||
59958838|NCT01503515|76077516|FG001|STARTED|Overall Study||147||
59958839|NCT01503515|76077515|FG000|COMPLETED|Overall Study||124||
59958840|NCT01503515|76077516|FG001|COMPLETED|Overall Study||112||
59958841|NCT01503515|76077515|FG000|NOT COMPLETED|Overall Study||21||
59958842|NCT01503515|76077516|FG001|NOT COMPLETED|Overall Study||35||
59958843|NCT02742519|76077524|FG000|STARTED|Part 1 Treatment Period 1 (8 Weeks)||8||
59958844|NCT02742519|76077525|FG001|STARTED|Part 1 Treatment Period 1 (8 Weeks)||6||
59958845|NCT02742519|76077526|FG002|STARTED|Part 1 Treatment Period 1 (8 Weeks)||0||
59958846|NCT02742519|76077524|FG000|COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||8||
59958847|NCT02742519|76077525|FG001|COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||6||
59958848|NCT02742519|76077526|FG002|COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||0||
59958849|NCT02742519|76077524|FG000|NOT COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||0||
59958850|NCT02742519|76077525|FG001|NOT COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||0||
59958851|NCT02742519|76077526|FG002|NOT COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||0||
59958852|NCT02742519|76077524|FG000|STARTED|Part 1 Treatment Period 2 (8 Weeks)||8||
59958853|NCT02742519|76077525|FG001|STARTED|Part 1 Treatment Period 2 (8 Weeks)||6||
59958854|NCT02742519|76077526|FG002|STARTED|Part 1 Treatment Period 2 (8 Weeks)||0||
59958855|NCT02742519|76077524|FG000|COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||7||
59958856|NCT02742519|76077525|FG001|COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||5||
59958857|NCT02742519|76077526|FG002|COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||0||
59958858|NCT02742519|76077524|FG000|NOT COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||1||
59805737|NCT00111475|75927358|FG005|NOT COMPLETED|Overall Study||1||
59958859|NCT02742519|76077525|FG001|NOT COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||1||
59958860|NCT02742519|76077526|FG002|NOT COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||0||
59958861|NCT02742519|76077524|FG000|STARTED|Part 2 Open Label Period (32 Weeks)||0||
59958862|NCT02742519|76077525|FG001|STARTED|Part 2 Open Label Period (32 Weeks)||0||
59958863|NCT02742519|76077526|FG002|STARTED|Part 2 Open Label Period (32 Weeks)|Of 12 participants who completed DB period, only 10 entered OL period & 2 opted for commercial drug.|10||
59958864|NCT02742519|76077524|FG000|COMPLETED|Part 2 Open Label Period (32 Weeks)||0||
59958865|NCT02742519|76077525|FG001|COMPLETED|Part 2 Open Label Period (32 Weeks)||0||
59958866|NCT02742519|76077526|FG002|COMPLETED|Part 2 Open Label Period (32 Weeks)||0||
59958867|NCT02742519|76077524|FG000|NOT COMPLETED|Part 2 Open Label Period (32 Weeks)||0||
59958868|NCT02742519|76077525|FG001|NOT COMPLETED|Part 2 Open Label Period (32 Weeks)||0||
59958869|NCT02742519|76077526|FG002|NOT COMPLETED|Part 2 Open Label Period (32 Weeks)||10||
59958870|NCT01375010|76077536|FG000|STARTED|Overall Study||43||
59958871|NCT01375010|76077537|FG001|STARTED|Overall Study||42||
59958872|NCT01375010|76077536|FG000|COMPLETED|Overall Study||31||
59958873|NCT01375010|76077537|FG001|COMPLETED|Overall Study||38||
59958874|NCT01375010|76077536|FG000|NOT COMPLETED|Overall Study||12||
59958875|NCT01375010|76077537|FG001|NOT COMPLETED|Overall Study||4||
59805738|NCT00111475|75927359|FG006|NOT COMPLETED|Overall Study||0||
59805739|NCT00111475|75927360|FG007|NOT COMPLETED|Overall Study||0||
59805740|NCT00111475|75927361|FG008|NOT COMPLETED|Overall Study||0||
59805741|NCT00111475|75927362|FG009|NOT COMPLETED|Overall Study||0||
59958876|NCT00546273|76077548|FG000|STARTED|I||4||
59958877|NCT00546273|76077549|FG001|STARTED|I||0||
59958878|NCT00546273|76077550|FG002|STARTED|I||0||
59958879|NCT00546273|76077551|FG003|STARTED|I||0||
59805742|NCT00111241|75927391|FG000|STARTED|Overall Study||45||
59805743|NCT00111241|75927392|FG001|STARTED|Overall Study||70||
59805744|NCT00111241|75927391|FG000|COMPLETED|Overall Study||30||
59805745|NCT00111241|75927392|FG001|COMPLETED|Overall Study||62||
59805746|NCT00111241|75927391|FG000|NOT COMPLETED|Overall Study||15||
59805747|NCT00111241|75927392|FG001|NOT COMPLETED|Overall Study||8||
59805748|NCT00492297|75927400|FG000|STARTED|Treatment||83||
59805749|NCT00492297|75927400|FG000|First Stage of Simon Optimal Design|Treatment|32 subjects of 83 subjects enrolled were treated in first stage.|32||
59805750|NCT00492297|75927400|FG000|Second Stage of Simon Optimal Design|Treatment|Recruitment continued into the second stage. 51 of 83 subjects were treated in the second stage.|51||
59805751|NCT00492297|75927400|FG000|COMPLETED|Treatment||78||
59805752|NCT00492297|75927400|FG000|NOT COMPLETED|Treatment||5||
59805753|NCT00492297|75927400|FG000|STARTED|Active Follow-up 30(+4) Days Duration|AFU is 30(+4) days duration for subjects withdrawn from sorafenib due to PD.|78||
59958880|NCT00546273|76077552|FG004|STARTED|I||2||
59524232|NCT01241539|75619407|FG000|COMPLETED|Period 2||7||
59524233|NCT01241539|75619407|FG000|NOT COMPLETED|Period 2||0||
59524234|NCT01242241|75619415|FG000|STARTED|Overall Study||40||
59524235|NCT01242241|75619416|FG001|STARTED|Overall Study||40||
59524236|NCT01242241|75619415|FG000|COMPLETED|Overall Study||40||
59524237|NCT01242241|75619416|FG001|COMPLETED|Overall Study||40||
59958881|NCT00546273|76077548|FG000|COMPLETED|I||4||
59958882|NCT00546273|76077549|FG001|COMPLETED|I||0||
59805754|NCT00492297|75927400|FG000|COMPLETED|Active Follow-up 30(+4) Days Duration||59||
59805755|NCT00492297|75927400|FG000|NOT COMPLETED|Active Follow-up 30(+4) Days Duration||19||
59805756|NCT00492297|75927400|FG000|STARTED|Survival Only Follow-up||59||
59805757|NCT00492297|75927400|FG000|COMPLETED|Survival Only Follow-up||0||
59805758|NCT00492297|75927400|FG000|NOT COMPLETED|Survival Only Follow-up||59||
59805759|NCT00565058|75927406|FG000|STARTED|Overall Study||10||
59958883|NCT00546273|76077550|FG002|COMPLETED|I||0||
59958884|NCT00546273|76077551|FG003|COMPLETED|I||0||
59958885|NCT00546273|76077552|FG004|COMPLETED|I||2||
59958886|NCT00546273|76077548|FG000|NOT COMPLETED|I||0||
59958887|NCT00546273|76077549|FG001|NOT COMPLETED|I||0||
59958888|NCT00546273|76077550|FG002|NOT COMPLETED|I||0||
59958889|NCT00546273|76077551|FG003|NOT COMPLETED|I||0||
59524238|NCT01242241|75619415|FG000|NOT COMPLETED|Overall Study||0||
59524239|NCT01242241|75619416|FG001|NOT COMPLETED|Overall Study||0||
59524240|NCT02393690|75619424|FG000|STARTED|Overall Study||29||
59805760|NCT00565058|75927407|FG001|STARTED|Overall Study||15||
59958890|NCT00546273|76077552|FG004|NOT COMPLETED|I||0||
59958891|NCT00546273|76077548|FG000|STARTED|II||0||
59958892|NCT00546273|76077549|FG001|STARTED|II||4||
59958893|NCT00546273|76077550|FG002|STARTED|II||0||
59958894|NCT00546273|76077551|FG003|STARTED|II||0||
59958895|NCT00546273|76077552|FG004|STARTED|II||2||
59958896|NCT00546273|76077548|FG000|COMPLETED|II||0||
59958897|NCT00546273|76077549|FG001|COMPLETED|II||4||
59958898|NCT00546273|76077550|FG002|COMPLETED|II||0||
59958899|NCT00546273|76077551|FG003|COMPLETED|II||0||
59958900|NCT00546273|76077552|FG004|COMPLETED|II||2||
59958901|NCT00546273|76077548|FG000|NOT COMPLETED|II||0||
59958902|NCT00546273|76077549|FG001|NOT COMPLETED|II||0||
59958903|NCT00546273|76077550|FG002|NOT COMPLETED|II||0||
59958904|NCT00546273|76077551|FG003|NOT COMPLETED|II||0||
59958905|NCT00546273|76077552|FG004|NOT COMPLETED|II||0||
59958906|NCT00546273|76077548|FG000|STARTED|III||0||
59958907|NCT00546273|76077549|FG001|STARTED|III||0||
59958908|NCT00546273|76077550|FG002|STARTED|III||4||
59524241|NCT02393690|75619425|FG001|STARTED|Overall Study||31||
59805761|NCT00565058|75927406|FG000|COMPLETED|Overall Study||9||
59805762|NCT00565058|75927407|FG001|COMPLETED|Overall Study||15||
59805763|NCT00565058|75927406|FG000|NOT COMPLETED|Overall Study||1||
59805764|NCT00565058|75927407|FG001|NOT COMPLETED|Overall Study||0||
59805765|NCT00564902|75927416|FG000|STARTED|Overall Study||10||
59805766|NCT00564902|75927417|FG001|STARTED|Overall Study||25||
59805767|NCT00564902|75927418|FG002|STARTED|Overall Study||25||
59805768|NCT00564902|75927416|FG000|4 Months|Overall Study||9||
59958909|NCT00546273|76077551|FG003|STARTED|III||0||
59524242|NCT02393690|75619424|FG000|COMPLETED|Overall Study||29||
59524243|NCT02393690|75619425|FG001|COMPLETED|Overall Study||31||
59524244|NCT02393690|75619424|FG000|NOT COMPLETED|Overall Study||0||
59805769|NCT00564902|75927417|FG001|4 Months|Overall Study||24||
59805770|NCT00564902|75927418|FG002|4 Months|Overall Study||23||
59805771|NCT00564902|75927416|FG000|8 Months|Overall Study||9||
59958910|NCT00546273|76077552|FG004|STARTED|III||2||
59958911|NCT00546273|76077548|FG000|COMPLETED|III||0||
59958912|NCT00546273|76077549|FG001|COMPLETED|III||0||
59958913|NCT00546273|76077550|FG002|COMPLETED|III||4||
59958914|NCT00546273|76077551|FG003|COMPLETED|III||0||
59958915|NCT00546273|76077552|FG004|COMPLETED|III||2||
59958916|NCT00546273|76077548|FG000|NOT COMPLETED|III||0||
59958917|NCT00546273|76077549|FG001|NOT COMPLETED|III||0||
59958918|NCT00546273|76077550|FG002|NOT COMPLETED|III||0||
59958919|NCT00546273|76077551|FG003|NOT COMPLETED|III||0||
59958920|NCT00546273|76077552|FG004|NOT COMPLETED|III||0||
59958921|NCT00546273|76077548|FG000|STARTED|IV||0||
59958922|NCT00546273|76077549|FG001|STARTED|IV||0||
59958923|NCT00546273|76077550|FG002|STARTED|IV||0||
59958924|NCT00546273|76077551|FG003|STARTED|IV||4||
59958925|NCT00546273|76077552|FG004|STARTED|IV||2||
59958926|NCT00546273|76077548|FG000|COMPLETED|IV||0||
59958927|NCT00546273|76077549|FG001|COMPLETED|IV||0||
59958928|NCT00546273|76077550|FG002|COMPLETED|IV||0||
59958929|NCT00546273|76077551|FG003|COMPLETED|IV||4||
59958930|NCT00546273|76077552|FG004|COMPLETED|IV||2||
59958931|NCT00546273|76077548|FG000|NOT COMPLETED|IV||0||
59958932|NCT00546273|76077549|FG001|NOT COMPLETED|IV||0||
59958933|NCT00546273|76077550|FG002|NOT COMPLETED|IV||0||
59958934|NCT00546273|76077551|FG003|NOT COMPLETED|IV||0||
59958935|NCT00546273|76077552|FG004|NOT COMPLETED|IV||0||
59958936|NCT00659061|76077561|FG000|STARTED|Overall Study||308||
59958937|NCT00659061|76077562|FG001|STARTED|Overall Study||302||
59958938|NCT00659061|76077561|FG000|COMPLETED|Overall Study|Those with either complete or partial biochemical and anthropometric data|287||
59958939|NCT00659061|76077562|FG001|COMPLETED|Overall Study|Those with either complete or partial biochemical and anthropometric data|287||
59958940|NCT00659061|76077561|FG000|NOT COMPLETED|Overall Study||21||
59958941|NCT00659061|76077562|FG001|NOT COMPLETED|Overall Study||15||
59958942|NCT02725372|76077568|FG000|STARTED|Part 1: Blinded Tx (2 Week Run In)||78||
59958943|NCT02725372|76077569|FG001|STARTED|Part 1: Blinded Tx (2 Week Run In)||79||
59958944|NCT02725372|76077568|FG000|Participants That Actually Received Treatment|Part 1: Blinded Tx (2 Week Run In)||74|Following randomization, there were some participants that did not start treatment during this 2 week run in period that is used to determine ability to comply with using the drug/device combination treatment therapy before they are moved to the treatment dose (75 mcg/kg IBW/hr) at Week 2.|
59958945|NCT02725372|76077569|FG001|Participants That Actually Received Treatment|Part 1: Blinded Tx (2 Week Run In)||78|Following randomization, there were some participants that did not start treatment during this 2 week run in period that is used to determine ability to comply with using the drug/device combination treatment therapy before they are moved to the treatment dose (75 mcg/kg IBW/hr) at Week 2.|
59958946|NCT02725372|76077568|FG000|COMPLETED|Part 1: Blinded Tx (2 Week Run In)||52||
59958947|NCT02725372|76077569|FG001|COMPLETED|Part 1: Blinded Tx (2 Week Run In)||59||
59958948|NCT02725372|76077568|FG000|NOT COMPLETED|Part 1: Blinded Tx (2 Week Run In)||26||
59958949|NCT02725372|76077569|FG001|NOT COMPLETED|Part 1: Blinded Tx (2 Week Run In)||20||
59958950|NCT02725372|76077568|FG000|STARTED|Part 1: Blinded Tx (16 Weeks)||52||
59958951|NCT02725372|76077569|FG001|STARTED|Part 1: Blinded Tx (16 Weeks)|59 placebo subjects completed the 2 week run in period. 1 subject opted NOT to continue to the 16 week treatment period that followed and therefore, in the Blinded Tx phase there were only 58 that started.|58||
59958952|NCT02725372|76077568|FG000|COMPLETED|Part 1: Blinded Tx (16 Weeks)||40||
59958953|NCT02725372|76077569|FG001|COMPLETED|Part 1: Blinded Tx (16 Weeks)||42||
59958954|NCT02725372|76077568|FG000|NOT COMPLETED|Part 1: Blinded Tx (16 Weeks)||12||
59958955|NCT02725372|76077569|FG001|NOT COMPLETED|Part 1: Blinded Tx (16 Weeks)||16||
59958956|NCT02725372|76077568|FG000|STARTED|Part 2: Open Label Extension Period||40||
59958957|NCT02725372|76077569|FG001|STARTED|Part 2: Open Label Extension Period||42||
59958958|NCT02725372|76077568|FG000|COMPLETED|Part 2: Open Label Extension Period||40|"Completed indicates the subjects that were in Part 2 (Open Label Extension) at the time of the Interim Analysis when the study was early terminated for futility."|
59958959|NCT02725372|76077569|FG001|COMPLETED|Part 2: Open Label Extension Period||42|"Completed indicates the subjects that were in Part 2 (Open Label Extension) at the time of the Interim Analysis when the study was early terminated for futility."|
59958960|NCT02725372|76077568|FG000|NOT COMPLETED|Part 2: Open Label Extension Period||0||
59958961|NCT02725372|76077569|FG001|NOT COMPLETED|Part 2: Open Label Extension Period||0||
59958962|NCT02548078|76077579|FG000|STARTED|Overall Study||300||
59958963|NCT02548078|76077580|FG001|STARTED|Overall Study||300||
59958964|NCT02548078|76077579|FG000|COMPLETED|Overall Study||295||
59958965|NCT02548078|76077580|FG001|COMPLETED|Overall Study||294||
60073982|NCT01616953|76189337|FG001|COMPLETED|Overall Study||8||
60073983|NCT01616953|76189336|FG000|NOT COMPLETED|Overall Study||2||
60073984|NCT01616953|76189337|FG001|NOT COMPLETED|Overall Study||0||
60073985|NCT01867658|76189343|FG000|STARTED|Overall Study||112||
60073986|NCT01867658|76189343|FG000|COMPLETED|Overall Study||103||
60073987|NCT01867658|76189343|FG000|NOT COMPLETED|Overall Study||9||
60073988|NCT01867580|76189349|FG000|STARTED|Overall Study||93||
60073989|NCT01867580|76189350|FG001|STARTED|Overall Study||88||
60073990|NCT01867580|76189349|FG000|COMPLETED|Overall Study||65||
59620898|NCT02096718|75732345|FG000|STARTED|Overall Study||8||
59620899|NCT02096718|75732346|FG001|STARTED|Overall Study||8||
59620900|NCT02096718|75732347|FG002|STARTED|Overall Study||14||
59620901|NCT02096718|75732345|FG000|COMPLETED|Overall Study||8||
59620902|NCT02096718|75732346|FG001|COMPLETED|Overall Study||8||
59620903|NCT02096718|75732347|FG002|COMPLETED|Overall Study||14||
59620904|NCT02096718|75732345|FG000|NOT COMPLETED|Overall Study||0||
59620905|NCT02096718|75732346|FG001|NOT COMPLETED|Overall Study||0||
59620906|NCT02096718|75732347|FG002|NOT COMPLETED|Overall Study||0||
59620907|NCT00113022|75732358|FG000|STARTED|Overall Study||5||
59620908|NCT00113022|75732359|FG001|STARTED|Overall Study||4||
59620909|NCT00113022|75732358|FG000|COMPLETED|Overall Study||2||
59620910|NCT00113022|75732359|FG001|COMPLETED|Overall Study||2||
59620911|NCT00113022|75732358|FG000|NOT COMPLETED|Overall Study||3||
59620912|NCT00113022|75732359|FG001|NOT COMPLETED|Overall Study||2||
59958966|NCT02548078|76077579|FG000|NOT COMPLETED|Overall Study||5||
59805772|NCT00564902|75927417|FG001|8 Months|Overall Study||22||
59805773|NCT00564902|75927418|FG002|8 Months|Overall Study||21||
59805774|NCT00564902|75927416|FG000|12 Months|Overall Study||9||
59805775|NCT00564902|75927417|FG001|12 Months|Overall Study||21||
59805776|NCT00564902|75927418|FG002|12 Months|Overall Study||21||
59805777|NCT00564902|75927416|FG000|COMPLETED|Overall Study||9||
59805778|NCT00564902|75927417|FG001|COMPLETED|Overall Study||21||
59805779|NCT00564902|75927418|FG002|COMPLETED|Overall Study||21||
59805780|NCT00564902|75927416|FG000|NOT COMPLETED|Overall Study||1||
59805781|NCT00564902|75927417|FG001|NOT COMPLETED|Overall Study||4||
59805782|NCT00564902|75927418|FG002|NOT COMPLETED|Overall Study||4||
59805783|NCT00446134|75927430|FG000|STARTED|Overall Study|Includes 2 patients who did not receive study drug and was not included in any other analysis|69||
59805784|NCT00446134|75927431|FG001|STARTED|Overall Study||70||
59805785|NCT00446134|75927432|FG002|STARTED|Overall Study|Includes 1 patient who did not receive study drug and was not included in any other analysis|69||
59805786|NCT00446134|75927433|FG003|STARTED|Overall Study||70||
59805787|NCT00446134|75927430|FG000|COMPLETED|Overall Study||35||
59805788|NCT00446134|75927431|FG001|COMPLETED|Overall Study||25||
59805789|NCT00446134|75927432|FG002|COMPLETED|Overall Study||26||
59958967|NCT02548078|76077580|FG001|NOT COMPLETED|Overall Study||6||
59958968|NCT02916433|76077595|FG000|STARTED|Overall Study||3||
59958969|NCT02916433|76077596|FG001|STARTED|Overall Study||2||
59958970|NCT02916433|76077595|FG000|COMPLETED|Overall Study||1||
59958971|NCT02916433|76077596|FG001|COMPLETED|Overall Study||2||
59958972|NCT02916433|76077595|FG000|NOT COMPLETED|Overall Study||2||
59958973|NCT02916433|76077596|FG001|NOT COMPLETED|Overall Study||0||
59958974|NCT00526227|76077605|FG000|STARTED|Overall Study||81||
59958975|NCT00526227|76077605|FG000|COMPLETED|Overall Study||79||
59958976|NCT00526227|76077605|FG000|NOT COMPLETED|Overall Study||2||
59958977|NCT02547922|76077613|FG000|STARTED|Overall Study||46||
59958978|NCT02547922|76077614|FG001|STARTED|Overall Study||52||
59805790|NCT00446134|75927433|FG003|COMPLETED|Overall Study||25||
59805791|NCT00446134|75927430|FG000|NOT COMPLETED|Overall Study||34||
59805792|NCT00446134|75927431|FG001|NOT COMPLETED|Overall Study||45||
59805793|NCT00446134|75927432|FG002|NOT COMPLETED|Overall Study||43||
59805794|NCT00446134|75927433|FG003|NOT COMPLETED|Overall Study||45||
59805795|NCT00563186|75927445|FG000|STARTED|Overall Study|Patients allocated to the Novel Hospital Ward|1008||
59805796|NCT00563186|75927446|FG001|STARTED|Overall Study|Patients allocated to the Traditional Hospital Ward|679||
59805797|NCT00563186|75927445|FG000|COMPLETED|Overall Study||910|excluded if length of stay (LOS)<48 hours or incomplete data|
59958979|NCT02547922|76077615|FG002|STARTED|Overall Study||49||
59958980|NCT02547922|76077613|FG000|FAS (Full Analysis Set)|Overall Study||45|Patients did not receive IP|
59958981|NCT02547922|76077614|FG001|FAS (Full Analysis Set)|Overall Study||51|Patients did not receive IP|
59958982|NCT02547922|76077615|FG002|FAS (Full Analysis Set)|Overall Study||49|Patients did not receive IP|
59958983|NCT02547922|76077613|FG000|COMPLETED|Overall Study||18||
59958984|NCT02547922|76077614|FG001|COMPLETED|Overall Study||28||
59958985|NCT02547922|76077615|FG002|COMPLETED|Overall Study||20||
59958986|NCT02547922|76077613|FG000|NOT COMPLETED|Overall Study||28||
59805798|NCT00563186|75927446|FG001|COMPLETED|Overall Study||604|excluded if length of stay (LOS)<48 hours or incomplete data|
59805799|NCT00563186|75927445|FG000|NOT COMPLETED|Overall Study||98||
59805800|NCT00563186|75927446|FG001|NOT COMPLETED|Overall Study||75||
59805801|NCT00699413|75927457|FG000|STARTED|Overall Study||4||
59805802|NCT00699413|75927458|FG001|STARTED|Overall Study||4||
59805803|NCT00699413|75927457|FG000|COMPLETED|Overall Study||0||
59805804|NCT00699413|75927458|FG001|COMPLETED|Overall Study||0||
59958987|NCT02547922|76077614|FG001|NOT COMPLETED|Overall Study||24||
59805805|NCT00699413|75927457|FG000|NOT COMPLETED|Overall Study||4||
59805806|NCT00699413|75927458|FG001|NOT COMPLETED|Overall Study||4||
59805807|NCT04808609|75927466|FG000|STARTED|Overall Study||20||
59805808|NCT04808609|75927467|FG001|STARTED|Overall Study||20||
59805809|NCT04808609|75927466|FG000|COMPLETED|Overall Study||20||
59805810|NCT04808609|75927467|FG001|COMPLETED|Overall Study||17||
59805811|NCT04808609|75927466|FG000|NOT COMPLETED|Overall Study||0||
59805812|NCT04808609|75927467|FG001|NOT COMPLETED|Overall Study||3||
59805813|NCT00111007|75927475|FG000|STARTED|Double-blind (DB) Treatment|ITT population|135||
59805814|NCT00111007|75927476|FG001|STARTED|Double-blind (DB) Treatment|ITT population|135||
59805815|NCT00111007|75927475|FG000|Received Treatment|Double-blind (DB) Treatment|Safety population|134||
59958988|NCT02547922|76077615|FG002|NOT COMPLETED|Overall Study||29||
59805816|NCT00111007|75927476|FG001|Received Treatment|Double-blind (DB) Treatment|Safety population|134||
59805817|NCT00111007|75927475|FG000|COMPLETED|Double-blind (DB) Treatment||27||
59805818|NCT00111007|75927476|FG001|COMPLETED|Double-blind (DB) Treatment||24||
59805819|NCT00111007|75927475|FG000|NOT COMPLETED|Double-blind (DB) Treatment||108||
59805820|NCT00111007|75927476|FG001|NOT COMPLETED|Double-blind (DB) Treatment||111||
59805821|NCT00111007|75927475|FG000|STARTED|Active Follow-up|Subjects discontinued DB treatment with CR, PR and SD entered this period.|6||
59805822|NCT00111007|75927476|FG001|STARTED|Active Follow-up|Subjects discontinued DB treatment with CR, PR and SD entered this period.|4||
59958989|NCT02547766|76077629|FG000|STARTED|Overall Study||10||
59958990|NCT02547766|76077629|FG000|COMPLETED|Overall Study||9||
59958991|NCT02547766|76077629|FG000|NOT COMPLETED|Overall Study||1||
59958992|NCT00385515|76077635|FG000|STARTED|Overall Study||57||
59958993|NCT00385515|76077636|FG001|STARTED|Overall Study||24||
59958994|NCT00385515|76077635|FG000|COMPLETED|Overall Study||53||
59958995|NCT00385515|76077636|FG001|COMPLETED|Overall Study||21||
59958996|NCT00385515|76077635|FG000|NOT COMPLETED|Overall Study||4||
59958997|NCT00385515|76077636|FG001|NOT COMPLETED|Overall Study||3||
59958998|NCT02742441|76077642|FG000|STARTED|Overall Study||205||
59958999|NCT02742441|76077643|FG001|STARTED|Overall Study||204||
59959000|NCT02742441|76077642|FG000|COMPLETED|Overall Study||199||
59959001|NCT02742441|76077643|FG001|COMPLETED|Overall Study||196||
59959002|NCT02742441|76077642|FG000|NOT COMPLETED|Overall Study||6||
59959003|NCT02742441|76077643|FG001|NOT COMPLETED|Overall Study||8||
59959004|NCT02547220|76077651|FG000|STARTED|Overall Study||19||
59805823|NCT00111007|75927475|FG000|COMPLETED|Active Follow-up||0||
59805824|NCT00111007|75927476|FG001|COMPLETED|Active Follow-up||2||
59805825|NCT00111007|75927475|FG000|NOT COMPLETED|Active Follow-up||6||
59805826|NCT00111007|75927476|FG001|NOT COMPLETED|Active Follow-up||2||
59959005|NCT02547220|76077652|FG001|STARTED|Overall Study||20||
59959006|NCT02547220|76077651|FG000|COMPLETED|Overall Study||0||
59959007|NCT02547220|76077652|FG001|COMPLETED|Overall Study||0||
59524245|NCT02393690|75619425|FG001|NOT COMPLETED|Overall Study||0||
59959008|NCT02547220|76077651|FG000|NOT COMPLETED|Overall Study||19||
59959009|NCT02547220|76077652|FG001|NOT COMPLETED|Overall Study||20||
59959010|NCT02542072|76077660|FG000|STARTED|First Intervention (1 Month)||44||
59524246|NCT02189161|75619431|FG000|STARTED|Overall Study||10||
59524247|NCT02189161|75619431|FG000|COMPLETED|Overall Study||10||
59524248|NCT02189161|75619431|FG000|NOT COMPLETED|Overall Study||0||
59959011|NCT02542072|76077661|FG001|STARTED|First Intervention (1 Month)||46||
59959012|NCT02542072|76077660|FG000|COMPLETED|First Intervention (1 Month)||39||
59959013|NCT02542072|76077661|FG001|COMPLETED|First Intervention (1 Month)||43||
59959014|NCT02542072|76077660|FG000|NOT COMPLETED|First Intervention (1 Month)||5||
59959015|NCT02542072|76077661|FG001|NOT COMPLETED|First Intervention (1 Month)||3||
59959016|NCT02542072|76077660|FG000|STARTED|Second Intervention (1 Month)||39||
59959017|NCT02542072|76077661|FG001|STARTED|Second Intervention (1 Month)||43||
59959018|NCT02542072|76077660|FG000|COMPLETED|Second Intervention (1 Month)||37||
59959019|NCT02542072|76077661|FG001|COMPLETED|Second Intervention (1 Month)||43||
59959020|NCT02542072|76077660|FG000|NOT COMPLETED|Second Intervention (1 Month)||2||
59959021|NCT02542072|76077661|FG001|NOT COMPLETED|Second Intervention (1 Month)||0||
59524249|NCT05593211|75619435|FG000|STARTED|Overall Study||31||
59524250|NCT05593211|75619435|FG000|COMPLETED|Overall Study||30||
59524251|NCT05593211|75619435|FG000|NOT COMPLETED|Overall Study||1||
59524252|NCT01200433|75619441|FG000|STARTED|Overall Study||21||
59524253|NCT01200433|75619442|FG001|STARTED|Overall Study||23||
59524254|NCT01200433|75619441|FG000|COMPLETED|Overall Study||21||
59524255|NCT01200433|75619442|FG001|COMPLETED|Overall Study||23||
59959022|NCT02547454|76077687|FG000|STARTED|Overall Study||393||
59959023|NCT02547454|76077687|FG000|COMPLETED|Overall Study||221||
59959024|NCT02547454|76077687|FG000|NOT COMPLETED|Overall Study||172||
59959025|NCT00415623|76077693|FG000|STARTED|Overall Study||154||
59959026|NCT00415623|76077694|FG001|STARTED|Overall Study||151||
59959027|NCT00415623|76077693|FG000|COMPLETED|Overall Study||149||
59524256|NCT01200433|75619441|FG000|NOT COMPLETED|Overall Study||0||
59524257|NCT01200433|75619442|FG001|NOT COMPLETED|Overall Study||0||
59524258|NCT01243333|75619448|FG000|STARTED|Overall Study||26||
59524259|NCT01243333|75619448|FG000|COMPLETED|Overall Study||18||
59524260|NCT01243333|75619448|FG000|NOT COMPLETED|Overall Study||8||
59524261|NCT01243567|75619454|FG000|STARTED|Overall Study||43||
59524262|NCT01243567|75619455|FG001|STARTED|Overall Study||38||
59524263|NCT01243567|75619454|FG000|COMPLETED|Overall Study||42||
59524264|NCT01243567|75619455|FG001|COMPLETED|Overall Study||38||
59524265|NCT01243567|75619454|FG000|NOT COMPLETED|Overall Study||1||
59524266|NCT01243567|75619455|FG001|NOT COMPLETED|Overall Study||0||
59524267|NCT01001195|75619465|FG000|STARTED|Overall Study||39||
59524268|NCT01001195|75619466|FG001|STARTED|Overall Study||41||
59524269|NCT01001195|75619467|FG002|STARTED|Overall Study||44||
59524270|NCT01001195|75619468|FG003|STARTED|Overall Study||41||
59805827|NCT00111007|75927475|FG000|STARTED|Long Term Follow-up|Subjects discontinued DB treatment with DP entered this period.|101||
59805828|NCT00111007|75927476|FG001|STARTED|Long Term Follow-up|Subjects discontinued DB treatment with DP entered this period.|107||
59959028|NCT00415623|76077694|FG001|COMPLETED|Overall Study||146||
59959029|NCT00415623|76077693|FG000|NOT COMPLETED|Overall Study||5||
59959030|NCT00415623|76077694|FG001|NOT COMPLETED|Overall Study||5||
59959031|NCT01969409|76077703|FG000|STARTED|Overall Study||28||
59959032|NCT01969409|76077704|FG001|STARTED|Overall Study||30||
59524271|NCT01001195|75619465|FG000|COMPLETED|Overall Study||37||
59524272|NCT01001195|75619466|FG001|COMPLETED|Overall Study||39||
59524273|NCT01001195|75619467|FG002|COMPLETED|Overall Study||44||
59524274|NCT01001195|75619468|FG003|COMPLETED|Overall Study||41||
59524275|NCT01001195|75619465|FG000|NOT COMPLETED|Overall Study||2||
59524276|NCT01001195|75619466|FG001|NOT COMPLETED|Overall Study||2||
59524277|NCT01001195|75619467|FG002|NOT COMPLETED|Overall Study||0||
59524278|NCT01001195|75619468|FG003|NOT COMPLETED|Overall Study||0||
59959033|NCT01969409|76077703|FG000|COMPLETED|Overall Study||25||
59524279|NCT02185729|75619478|FG000|STARTED|0 Hour (Baseline) of Saline Infusion||12||
59524280|NCT02185729|75619478|FG000|COMPLETED|0 Hour (Baseline) of Saline Infusion||12||
59524281|NCT02185729|75619478|FG000|NOT COMPLETED|0 Hour (Baseline) of Saline Infusion||0||
59524282|NCT02185729|75619478|FG000|STARTED|4 Hours Into Saline Infusion||12||
59524283|NCT02185729|75619478|FG000|COMPLETED|4 Hours Into Saline Infusion||12||
59524284|NCT02185729|75619478|FG000|NOT COMPLETED|4 Hours Into Saline Infusion||0||
59524285|NCT02185729|75619478|FG000|STARTED|24 Hours Into Saline Infusion||12||
59524286|NCT02185729|75619478|FG000|COMPLETED|24 Hours Into Saline Infusion||12||
59524287|NCT02185729|75619478|FG000|NOT COMPLETED|24 Hours Into Saline Infusion||0||
59524288|NCT02185729|75619478|FG000|STARTED|0 Hour (Baseline) of Intralipid Infusion||12||
59524289|NCT02185729|75619478|FG000|COMPLETED|0 Hour (Baseline) of Intralipid Infusion||12||
59524290|NCT02185729|75619478|FG000|NOT COMPLETED|0 Hour (Baseline) of Intralipid Infusion||0||
59524291|NCT02185729|75619478|FG000|STARTED|4 Hours Into Intralipid Infusion||12||
59524292|NCT02185729|75619478|FG000|COMPLETED|4 Hours Into Intralipid Infusion||12||
59524293|NCT02185729|75619478|FG000|NOT COMPLETED|4 Hours Into Intralipid Infusion||0||
59524294|NCT02185729|75619478|FG000|STARTED|24 Hours Into Intralipid Infusion||12||
59524295|NCT02185729|75619478|FG000|COMPLETED|24 Hours Into Intralipid Infusion||12||
59524296|NCT02185729|75619478|FG000|NOT COMPLETED|24 Hours Into Intralipid Infusion||0||
59524297|NCT02185729|75619478|FG000|STARTED|0 Hour (Baseline) of ClinOleic Infusion||12||
59524298|NCT02185729|75619478|FG000|COMPLETED|0 Hour (Baseline) of ClinOleic Infusion||12||
59524299|NCT02185729|75619478|FG000|NOT COMPLETED|0 Hour (Baseline) of ClinOleic Infusion||0||
59524300|NCT02185729|75619478|FG000|STARTED|4 Hours Into ClinOleic Infusion||12||
59805829|NCT00111007|75927475|FG000|COMPLETED|Long Term Follow-up||54||
59805830|NCT00111007|75927476|FG001|COMPLETED|Long Term Follow-up||62||
59805831|NCT00111007|75927475|FG000|NOT COMPLETED|Long Term Follow-up||47||
59805832|NCT00111007|75927476|FG001|NOT COMPLETED|Long Term Follow-up||45||
59805833|NCT03975920|75927484|FG000|STARTED|Overall Study|Due to inclusion criteria protocol deviation, data from 1 participant was not used in the analysis.|84||
59805834|NCT03975920|75927485|FG001|STARTED|Overall Study|Due to inclusion criteria protocol deviation, data from 1 participant was not used in the analysis.|87||
59805835|NCT03975920|75927484|FG000|1-Month Follow-up Survey|Overall Study||80||
59805836|NCT03975920|75927485|FG001|1-Month Follow-up Survey|Overall Study||85||
59805837|NCT03975920|75927484|FG000|3-Month Follow-up Survey|Overall Study||78||
59805838|NCT03975920|75927485|FG001|3-Month Follow-up Survey|Overall Study||84||
59805839|NCT03975920|75927484|FG000|6-Month Follow-up Survey|Overall Study||80||
59805840|NCT03975920|75927485|FG001|6-Month Follow-up Survey|Overall Study||83||
59805841|NCT03975920|75927484|FG000|COMPLETED|Overall Study||80||
59805842|NCT03975920|75927485|FG001|COMPLETED|Overall Study||83||
59805843|NCT03975920|75927484|FG000|NOT COMPLETED|Overall Study||4||
59805844|NCT03975920|75927485|FG001|NOT COMPLETED|Overall Study||4||
59805845|NCT00699335|75927491|FG000|STARTED|Overall Study||5308||
59805846|NCT00699335|75927491|FG000|COMPLETED|Overall Study||5080||
59805847|NCT00699335|75927491|FG000|NOT COMPLETED|Overall Study||228||
59805848|NCT00445978|75927498|FG000|STARTED|Week 0 - Week 4 (2.5 mg/kg/Day)||32||
59805849|NCT00445978|75927498|FG000|COMPLETED|Week 0 - Week 4 (2.5 mg/kg/Day)||29||
59805850|NCT00445978|75927498|FG000|NOT COMPLETED|Week 0 - Week 4 (2.5 mg/kg/Day)||3||
59805851|NCT00445978|75927498|FG000|STARTED|Week 4 - Week 8 (5 mg/kg/Day)||29||
59805852|NCT00445978|75927498|FG000|Received Escalated Dose|Week 4 - Week 8 (5 mg/kg/Day)||29||
59805853|NCT00445978|75927498|FG000|COMPLETED|Week 4 - Week 8 (5 mg/kg/Day)||25||
59805854|NCT00445978|75927498|FG000|NOT COMPLETED|Week 4 - Week 8 (5 mg/kg/Day)||4||
59805855|NCT00445978|75927498|FG000|STARTED|Week 8 - Week 12 (10 mg/kg/Day)||25||
59805856|NCT00445978|75927498|FG000|Received Escalated Dose|Week 8 - Week 12 (10 mg/kg/Day)||25||
59805857|NCT00445978|75927498|FG000|COMPLETED|Week 8 - Week 12 (10 mg/kg/Day)||24||
59805858|NCT00445978|75927498|FG000|NOT COMPLETED|Week 8 - Week 12 (10 mg/kg/Day)||1||
59805859|NCT00445978|75927498|FG000|STARTED|Week 12 - Week 16 (20 mg/kg/Day)||24||
59805860|NCT00445978|75927498|FG000|Received Escalated Dose|Week 12 - Week 16 (20 mg/kg/Day)||21||
59805861|NCT00445978|75927498|FG000|COMPLETED|Week 12 - Week 16 (20 mg/kg/Day)||23||
59805862|NCT00445978|75927498|FG000|NOT COMPLETED|Week 12 - Week 16 (20 mg/kg/Day)||1||
59805863|NCT00566228|75927511|FG000|STARTED|Overall Study||62||
59805864|NCT00566228|75927512|FG001|STARTED|Overall Study||60||
59805865|NCT00566228|75927511|FG000|COMPLETED|Overall Study||56||
59805866|NCT00566228|75927512|FG001|COMPLETED|Overall Study||55||
59959034|NCT01969409|76077704|FG001|COMPLETED|Overall Study||26||
59524301|NCT02185729|75619478|FG000|COMPLETED|4 Hours Into ClinOleic Infusion||12||
59620913|NCT02097732|75732367|FG000|STARTED|Overall Study||1||
59620914|NCT02097732|75732368|FG001|STARTED|Overall Study||3||
59620915|NCT02097732|75732367|FG000|COMPLETED|Overall Study||1||
59620916|NCT02097732|75732368|FG001|COMPLETED|Overall Study||3||
59620917|NCT02097732|75732367|FG000|NOT COMPLETED|Overall Study||0||
59620918|NCT02097732|75732368|FG001|NOT COMPLETED|Overall Study||0||
59620919|NCT00113334|75732375|FG000|STARTED|Overall Study||6||
59620920|NCT00113334|75732375|FG000|COMPLETED|Overall Study||6||
59620921|NCT00113334|75732375|FG000|NOT COMPLETED|Overall Study||0||
59620922|NCT00286182|75732381|FG000|STARTED|Overall Study||28||
59620923|NCT00286182|75732382|FG001|STARTED|Overall Study||28||
59620924|NCT00286182|75732381|FG000|COMPLETED|Overall Study||23||
59620925|NCT00286182|75732382|FG001|COMPLETED|Overall Study||25||
59805867|NCT00566228|75927511|FG000|NOT COMPLETED|Overall Study||6||
59805868|NCT00566228|75927512|FG001|NOT COMPLETED|Overall Study||5||
59805869|NCT00698009|75927518|FG000|STARTED|Overall Study||1||
59805870|NCT00698009|75927518|FG000|COMPLETED|Overall Study||0||
59805871|NCT00698009|75927518|FG000|NOT COMPLETED|Overall Study||1||
59805872|NCT03968978|75927524|FG000|STARTED|Overall Study||111||
59805873|NCT03968978|75927525|FG001|STARTED|Overall Study||105||
59805874|NCT03968978|75927524|FG000|COMPLETED|Overall Study||110||
59805875|NCT03968978|75927525|FG001|COMPLETED|Overall Study||105||
59805876|NCT03968978|75927524|FG000|NOT COMPLETED|Overall Study||1||
59805877|NCT03968978|75927525|FG001|NOT COMPLETED|Overall Study||0||
59805878|NCT00562718|75927531|FG000|STARTED|Overall Study||50||
59805879|NCT00562718|75927531|FG000|COMPLETED|Overall Study||39||
59805880|NCT00562718|75927531|FG000|NOT COMPLETED|Overall Study||11||
59805881|NCT00697619|75927537|FG000|STARTED|Overall Study||30||
59805882|NCT00697619|75927538|FG001|STARTED|Overall Study||30||
59805883|NCT00697619|75927537|FG000|COMPLETED|Overall Study||24||
59805884|NCT00697619|75927538|FG001|COMPLETED|Overall Study||22||
59805885|NCT00697619|75927537|FG000|NOT COMPLETED|Overall Study||6||
59805886|NCT00697619|75927538|FG001|NOT COMPLETED|Overall Study||8||
59805887|NCT00445432|75927547|FG000|STARTED|Through Week 52 of NCT00445432 (M06-837)||25||
59805888|NCT00445432|75927548|FG001|STARTED|Through Week 52 of NCT00445432 (M06-837)||25||
59805889|NCT00445432|75927549|FG002|STARTED|Through Week 52 of NCT00445432 (M06-837)||32||
59805890|NCT00445432|75927550|FG003|STARTED|Through Week 52 of NCT00445432 (M06-837)|This treatment group is not applicable for this period.|0||
59805891|NCT00445432|75927547|FG000|COMPLETED|Through Week 52 of NCT00445432 (M06-837)||10||
59805892|NCT00445432|75927548|FG001|COMPLETED|Through Week 52 of NCT00445432 (M06-837)||2||
59805893|NCT00445432|75927549|FG002|COMPLETED|Through Week 52 of NCT00445432 (M06-837)||21||
59805894|NCT00445432|75927550|FG003|COMPLETED|Through Week 52 of NCT00445432 (M06-837)||0||
59805895|NCT00445432|75927547|FG000|NOT COMPLETED|Through Week 52 of NCT00445432 (M06-837)||15||
59805896|NCT00445432|75927548|FG001|NOT COMPLETED|Through Week 52 of NCT00445432 (M06-837)||23||
59805897|NCT00445432|75927549|FG002|NOT COMPLETED|Through Week 52 of NCT00445432 (M06-837)||11||
59805898|NCT00445432|75927550|FG003|NOT COMPLETED|Through Week 52 of NCT00445432 (M06-837)||0||
59805899|NCT00445432|75927547|FG000|STARTED|148 Weeks of Adalimumab Treatment|This group is not applicable for this period.|0||
59805900|NCT00445432|75927548|FG001|STARTED|148 Weeks of Adalimumab Treatment|This group is not applicable for this period.|0||
59805901|NCT00445432|75927549|FG002|STARTED|148 Weeks of Adalimumab Treatment|This group is not applicable for this period.|0||
59805902|NCT00445432|75927550|FG003|STARTED|148 Weeks of Adalimumab Treatment|3 participants discontinued while receiving double-blind placebo and never received any adalimumab|79||
59805903|NCT00445432|75927547|FG000|COMPLETED|148 Weeks of Adalimumab Treatment||0||
59805904|NCT00445432|75927548|FG001|COMPLETED|148 Weeks of Adalimumab Treatment||0||
59805905|NCT00445432|75927549|FG002|COMPLETED|148 Weeks of Adalimumab Treatment||0||
59805906|NCT00445432|75927550|FG003|COMPLETED|148 Weeks of Adalimumab Treatment||35||
59805907|NCT00445432|75927547|FG000|NOT COMPLETED|148 Weeks of Adalimumab Treatment||0||
59805908|NCT00445432|75927548|FG001|NOT COMPLETED|148 Weeks of Adalimumab Treatment||0||
59805909|NCT00445432|75927549|FG002|NOT COMPLETED|148 Weeks of Adalimumab Treatment||0||
59805910|NCT00445432|75927550|FG003|NOT COMPLETED|148 Weeks of Adalimumab Treatment||44||
59805911|NCT00696137|75927561|FG000|STARTED|Overall Study||5||
59620926|NCT00286182|75732381|FG000|NOT COMPLETED|Overall Study||5||
59805912|NCT00696137|75927561|FG000|COMPLETED|Overall Study||3||
59805913|NCT00696137|75927561|FG000|NOT COMPLETED|Overall Study||2||
59805914|NCT00441142|75927569|FG000|STARTED|Overall Study||6||
59805915|NCT00441142|75927570|FG001|STARTED|Overall Study||7||
59805916|NCT00441142|75927571|FG002|STARTED|Overall Study||29||
59805917|NCT00441142|75927572|FG003|STARTED|Overall Study||69||
59805918|NCT00441142|75927569|FG000|COMPLETED|Overall Study||0||
59805919|NCT00441142|75927570|FG001|COMPLETED|Overall Study||0||
59805920|NCT00441142|75927571|FG002|COMPLETED|Overall Study||7||
59805921|NCT00441142|75927572|FG003|COMPLETED|Overall Study||1||
59805922|NCT00441142|75927569|FG000|NOT COMPLETED|Overall Study||6||
59805923|NCT00441142|75927570|FG001|NOT COMPLETED|Overall Study||7||
60073991|NCT01867580|76189350|FG001|COMPLETED|Overall Study||64||
60073992|NCT01867580|76189349|FG000|NOT COMPLETED|Overall Study||28||
59805924|NCT00441142|75927571|FG002|NOT COMPLETED|Overall Study||22||
59805925|NCT00441142|75927572|FG003|NOT COMPLETED|Overall Study||68||
59805926|NCT04025021|75927586|FG000|STARTED|Overall Study||2||
59805927|NCT04025021|75927587|FG001|STARTED|Overall Study||1||
59805928|NCT04025021|75927586|FG000|COMPLETED|Overall Study||0||
59805929|NCT04025021|75927587|FG001|COMPLETED|Overall Study||0||
59805930|NCT04025021|75927586|FG000|NOT COMPLETED|Overall Study||2||
59805931|NCT04025021|75927587|FG001|NOT COMPLETED|Overall Study||1||
59805932|NCT03848416|75927597|FG000|STARTED|Overall Study||33||
59805933|NCT03848416|75927598|FG001|STARTED|Overall Study||33||
59805934|NCT03848416|75927599|FG002|STARTED|Overall Study||33||
59805935|NCT03848416|75927597|FG000|Received at Least One Dose of Study Drug|Overall Study||33||
59805936|NCT03848416|75927598|FG001|Received at Least One Dose of Study Drug|Overall Study||33||
59805937|NCT03848416|75927599|FG002|Received at Least One Dose of Study Drug|Overall Study||33||
59805938|NCT03848416|75927597|FG000|COMPLETED|Overall Study||32||
59805939|NCT03848416|75927598|FG001|COMPLETED|Overall Study||33||
59805940|NCT03848416|75927599|FG002|COMPLETED|Overall Study||32||
59959035|NCT01969409|76077703|FG000|NOT COMPLETED|Overall Study||3||
59959036|NCT01969409|76077704|FG001|NOT COMPLETED|Overall Study||4||
59959037|NCT00150813|76077710|FG000|STARTED|Overall Study||66||
59959038|NCT00150813|76077710|FG000|COMPLETED|Overall Study||48||
59959039|NCT00150813|76077710|FG000|NOT COMPLETED|Overall Study||18||
59959040|NCT02712788|76077716|FG000|STARTED|Overall Study||2||
59959041|NCT02712788|76077717|FG001|STARTED|Overall Study||2||
59959042|NCT02712788|76077716|FG000|COMPLETED|Overall Study||0||
59959043|NCT02712788|76077717|FG001|COMPLETED|Overall Study||2||
59959044|NCT02712788|76077716|FG000|NOT COMPLETED|Overall Study||2||
59959045|NCT02712788|76077717|FG001|NOT COMPLETED|Overall Study||0||
59959046|NCT02308111|76077725|FG000|STARTED|Overall Study||168||
59959047|NCT02308111|76077726|FG001|STARTED|Overall Study||166||
59959048|NCT02308111|76077725|FG000|Received at Least 1 Dose of Study Drug|Overall Study||168||
59959049|NCT02308111|76077726|FG001|Received at Least 1 Dose of Study Drug|Overall Study||166||
59959050|NCT02308111|76077725|FG000|COMPLETED|Overall Study||0|The discontinuation reasons from here onward reflect discontinuation for withdrawal from study visits only. Reasons for discontinuation from study IP and reasons for discontinuation from study follow-up (phone call / medical record review) were also collected but are not reported here.|
59959051|NCT02308111|76077726|FG001|COMPLETED|Overall Study||0|The discontinuation reasons from here onward reflect discontinuation for withdrawal from study visits only. Reasons for discontinuation from study IP and reasons for discontinuation from study follow-up (phone call / medical record review) were also collected but are not reported here.|
59959052|NCT02308111|76077725|FG000|NOT COMPLETED|Overall Study||168||
59959053|NCT02308111|76077726|FG001|NOT COMPLETED|Overall Study||166||
59959054|NCT01346189|76077737|FG000|STARTED|Overall Study||433||
59959055|NCT01346189|76077738|FG001|STARTED|Overall Study||358||
59959056|NCT01346189|76077739|FG002|STARTED|Overall Study||346||
59959057|NCT01346189|76077740|FG003|STARTED|Overall Study||366||
59959058|NCT01346189|76077737|FG000|COMPLETED|Overall Study|433 patients (64 primary care physicians) included in analysis|417||
59959059|NCT01346189|76077738|FG001|COMPLETED|Overall Study|358 Patients (58 primary care physicians) included in analysis|341||
59959060|NCT01346189|76077739|FG002|COMPLETED|Overall Study|346 patients (58 primary care physicians) included in analysis|332||
59959061|NCT01346189|76077740|FG003|COMPLETED|Overall Study|366 patients (58 primary care physicians) included in analysis|355||
59959062|NCT01346189|76077737|FG000|NOT COMPLETED|Overall Study||16||
59959063|NCT01346189|76077738|FG001|NOT COMPLETED|Overall Study||17||
59959064|NCT01346189|76077739|FG002|NOT COMPLETED|Overall Study||14||
59959065|NCT01346189|76077740|FG003|NOT COMPLETED|Overall Study||11||
59959066|NCT00369317|76077750|FG000|STARTED|Overall Study||205||
59959067|NCT00369317|76077750|FG000|COMPLETED|Overall Study||185||
59959068|NCT00369317|76077750|FG000|NOT COMPLETED|Overall Study||20||
59959069|NCT03193021|76077757|FG000|STARTED|Overall Study||100||
59959070|NCT03193021|76077758|FG001|STARTED|Overall Study||104||
59959071|NCT03193021|76077757|FG000|COMPLETED|Overall Study||99||
59959072|NCT03193021|76077758|FG001|COMPLETED|Overall Study||103||
59959073|NCT03193021|76077757|FG000|NOT COMPLETED|Overall Study||1||
59959074|NCT03193021|76077758|FG001|NOT COMPLETED|Overall Study||1||
59959075|NCT03913091|76077766|FG000|STARTED|Overall Study||92||
59805941|NCT03848416|75927597|FG000|NOT COMPLETED|Overall Study||1||
59805942|NCT03848416|75927598|FG001|NOT COMPLETED|Overall Study||0||
59805943|NCT03848416|75927599|FG002|NOT COMPLETED|Overall Study||1||
59805944|NCT00458302|75927609|FG000|STARTED|Overall Study||129||
59805945|NCT00458302|75927610|FG001|STARTED|Overall Study||127||
59805946|NCT00458302|75927609|FG000|COMPLETED|Overall Study||109||
59805947|NCT00458302|75927610|FG001|COMPLETED|Overall Study||103||
59959076|NCT03913091|76077767|FG001|STARTED|Overall Study||92||
59959077|NCT03913091|76077766|FG000|COMPLETED|Overall Study||72||
59959078|NCT03913091|76077767|FG001|COMPLETED|Overall Study||78||
59959079|NCT03913091|76077766|FG000|NOT COMPLETED|Overall Study||20||
59805948|NCT00458302|75927609|FG000|NOT COMPLETED|Overall Study||20||
59805949|NCT00458302|75927610|FG001|NOT COMPLETED|Overall Study||24||
59805950|NCT00444106|75927620|FG000|STARTED|Overall Study||159||
59805951|NCT00444106|75927621|FG001|STARTED|Overall Study||53||
59805952|NCT00444106|75927622|FG002|STARTED|Overall Study||53||
59805953|NCT00444106|75927620|FG000|Completed Treatment Period|Overall Study||159||
59959080|NCT03913091|76077767|FG001|NOT COMPLETED|Overall Study||14||
59959081|NCT03243071|76077775|FG000|STARTED|Overall Study||59||
59959082|NCT03243071|76077776|FG001|STARTED|Overall Study||53||
59959083|NCT03243071|76077775|FG000|COMPLETED|Overall Study||59||
59959084|NCT03243071|76077776|FG001|COMPLETED|Overall Study||53||
59959085|NCT03243071|76077775|FG000|NOT COMPLETED|Overall Study||0||
59959086|NCT03243071|76077776|FG001|NOT COMPLETED|Overall Study||0||
59959087|NCT01318499|76077791|FG000|STARTED|Overall Study||540||
59959088|NCT01318499|76077792|FG001|STARTED|Overall Study||534||
59959089|NCT01318499|76077793|FG002|STARTED|Overall Study||268||
59959090|NCT01318499|76077791|FG000|COMPLETED|Overall Study||475||
59959091|NCT01318499|76077792|FG001|COMPLETED|Overall Study||458||
59805954|NCT00444106|75927621|FG001|Completed Treatment Period|Overall Study||53||
59805955|NCT00444106|75927622|FG002|Completed Treatment Period|Overall Study||53||
59805956|NCT00444106|75927620|FG000|COMPLETED|Overall Study||157||
59805957|NCT00444106|75927621|FG001|COMPLETED|Overall Study||52||
59805958|NCT00444106|75927622|FG002|COMPLETED|Overall Study||52||
59805959|NCT00444106|75927620|FG000|NOT COMPLETED|Overall Study||2||
59805960|NCT00444106|75927621|FG001|NOT COMPLETED|Overall Study||1||
59805961|NCT00444106|75927622|FG002|NOT COMPLETED|Overall Study||1||
59805962|NCT00561470|75927635|FG000|STARTED|Overall Study||614||
59959092|NCT01318499|76077793|FG002|COMPLETED|Overall Study||121||
59959093|NCT01318499|76077791|FG000|NOT COMPLETED|Overall Study||65||
59959094|NCT01318499|76077792|FG001|NOT COMPLETED|Overall Study||76||
59959095|NCT01318499|76077793|FG002|NOT COMPLETED|Overall Study||147||
59959096|NCT01775813|76077807|FG000|STARTED|Overall Study||47|Patients that had data collected at Study Visit 1 (1st IVGTT)|
59959097|NCT01775813|76077808|FG001|STARTED|Overall Study||13|Patients that had data collected at Study Visit 1 (1st IVGTT)|
59959098|NCT01775813|76077809|FG002|STARTED|Overall Study||24|Patients that had data collected at Study Visit 1 (1st IVGTT)|
59959099|NCT01775813|76077810|FG003|STARTED|Overall Study||20|Patients that had data collected at Study Visit 1 (1st IVGTT)|
59959100|NCT01775813|76077807|FG000|Study Visit 2 (Tanner 4)|Overall Study||36||
59959101|NCT01775813|76077808|FG001|Study Visit 2 (Tanner 4)|Overall Study||4||
59959102|NCT01775813|76077809|FG002|Study Visit 2 (Tanner 4)|Overall Study||11||
59959103|NCT01775813|76077810|FG003|Study Visit 2 (Tanner 4)|Overall Study||11||
59959104|NCT01775813|76077807|FG000|Study Visit 3 (Tanner 5)|Overall Study||34||
59959105|NCT01775813|76077808|FG001|Study Visit 3 (Tanner 5)|Overall Study||8||
59959106|NCT01775813|76077809|FG002|Study Visit 3 (Tanner 5)|Overall Study||12||
59959107|NCT01775813|76077810|FG003|Study Visit 3 (Tanner 5)|Overall Study||11||
59959108|NCT01775813|76077807|FG000|Study Visit 4 (Post-Puberty)|Overall Study||10||
59959109|NCT01775813|76077808|FG001|Study Visit 4 (Post-Puberty)|Overall Study||0||
59959110|NCT01775813|76077809|FG002|Study Visit 4 (Post-Puberty)|Overall Study||13||
59959111|NCT01775813|76077810|FG003|Study Visit 4 (Post-Puberty)|Overall Study||11||
59959112|NCT01775813|76077807|FG000|COMPLETED|Overall Study||34|Patients that completed Study Visit 3 (Primary Outcome)|
59959113|NCT01775813|76077808|FG001|COMPLETED|Overall Study||8|Patients that completed Study Visit 3 (Primary Outcome)|
59959114|NCT01775813|76077809|FG002|COMPLETED|Overall Study||12|Patients that completed Study Visit 3 (Primary Outcome)|
59959115|NCT01775813|76077810|FG003|COMPLETED|Overall Study||11|Patients that completed Study Visit 3 (Primary Outcome)|
59805963|NCT00561470|75927636|FG001|STARTED|Overall Study||612||
59805964|NCT00561470|75927635|FG000|TREATED|Overall Study||609||
59805965|NCT00561470|75927636|FG001|TREATED|Overall Study||607||
59805966|NCT00561470|75927635|FG000|SAFETY POPULATION|Overall Study|Treated participants excluding 4 who received at least 1 dose of Aflibercept|605||
59805967|NCT00561470|75927636|FG001|SAFETY POPULATION|Overall Study|Treated participants including 4 from Placebo/FOLFIRI who received at least 1 dose of Aflibercept|611||
59805968|NCT00561470|75927635|FG000|ONGOING TREATMENT|Overall Study|Participants continuing treatment on the cutoff date of the final analysis|11||
59805969|NCT00561470|75927636|FG001|ONGOING TREATMENT|Overall Study|Participants continuing treatment on the cutoff date of the final analysis|14||
59805970|NCT00561470|75927635|FG000|COMPLETED|Overall Study|Participants met treatment discontinuation criteria or were ongoing treatment on the cutoff date|0||
59805971|NCT00561470|75927636|FG001|COMPLETED|Overall Study|Participants met treatment discontinuation criteria or were ongoing treatment on the cutoff date|0||
59805972|NCT00561470|75927635|FG000|NOT COMPLETED|Overall Study||614||
59805973|NCT00561470|75927636|FG001|NOT COMPLETED|Overall Study||612||
59805974|NCT00443872|75927644|FG000|STARTED|Overall Study||77||
59805975|NCT00443872|75927644|FG000|COMPLETED|Overall Study||60||
59805976|NCT00443872|75927644|FG000|NOT COMPLETED|Overall Study||17||
59959116|NCT01775813|76077807|FG000|NOT COMPLETED|Overall Study||13||
59959117|NCT01775813|76077808|FG001|NOT COMPLETED|Overall Study||5||
59959118|NCT01775813|76077809|FG002|NOT COMPLETED|Overall Study||12||
59959119|NCT01775813|76077810|FG003|NOT COMPLETED|Overall Study||9||
59959120|NCT02285595|76077827|FG000|STARTED|Overall Study||69||
59959121|NCT02285595|76077827|FG000|COMPLETED|Overall Study||54||
59959122|NCT02285595|76077827|FG000|NOT COMPLETED|Overall Study||15||
59959123|NCT01694069|76077831|FG000|STARTED|Overall Study||6||
59959124|NCT01694069|76077831|FG000|COMPLETED|Overall Study||6||
59959125|NCT01694069|76077831|FG000|NOT COMPLETED|Overall Study||0||
59959126|NCT01445327|76077840|FG000|STARTED|Overall Study||3||
59959127|NCT01445327|76077841|FG001|STARTED|Overall Study||1||
60073993|NCT01867580|76189350|FG001|NOT COMPLETED|Overall Study||24||
60073994|NCT03290326|76189356|FG000|STARTED|Overall Study||10||
59805977|NCT00441064|75927659|FG000|STARTED|Overall Study||69||
59805978|NCT00441064|75927660|FG001|STARTED|Overall Study||63||
59805979|NCT00441064|75927659|FG000|Safety Population (SP)|Overall Study||69||
59805980|NCT00441064|75927660|FG001|Safety Population (SP)|Overall Study||63||
59805981|NCT00441064|75927659|FG000|Intent-to-treat (ITT) Population|Overall Study||61||
59805982|NCT00441064|75927660|FG001|Intent-to-treat (ITT) Population|Overall Study||57||
59805983|NCT00441064|75927659|FG000|COMPLETED|Overall Study||59||
59805984|NCT00441064|75927660|FG001|COMPLETED|Overall Study||56||
59805985|NCT00441064|75927659|FG000|NOT COMPLETED|Overall Study||10||
59805986|NCT00441064|75927660|FG001|NOT COMPLETED|Overall Study||7||
59805987|NCT03962738|75927670|FG000|STARTED|Overall Study||258||
59805988|NCT03962738|75927671|FG001|STARTED|Overall Study||109||
59805989|NCT03962738|75927672|FG002|STARTED|Overall Study||261||
59524302|NCT02185729|75619478|FG000|NOT COMPLETED|4 Hours Into ClinOleic Infusion||0||
59524303|NCT02185729|75619478|FG000|STARTED|24 Hours Into ClinOleic Infusion||12||
59524304|NCT02185729|75619478|FG000|COMPLETED|24 Hours Into ClinOleic Infusion||12||
59524305|NCT02185729|75619478|FG000|NOT COMPLETED|24 Hours Into ClinOleic Infusion||0||
59524306|NCT02185729|75619478|FG000|STARTED|0 Hour (Baseline) of Dextrose Infusion||12||
59524307|NCT02185729|75619478|FG000|COMPLETED|0 Hour (Baseline) of Dextrose Infusion||12||
59524308|NCT02185729|75619478|FG000|NOT COMPLETED|0 Hour (Baseline) of Dextrose Infusion||0||
59524309|NCT02185729|75619478|FG000|STARTED|4 Hours Into Dextrose Infusion||12||
59524310|NCT02185729|75619478|FG000|COMPLETED|4 Hours Into Dextrose Infusion||12||
59524311|NCT02185729|75619478|FG000|NOT COMPLETED|4 Hours Into Dextrose Infusion||0||
59524312|NCT02185729|75619478|FG000|STARTED|24 Hours Into Dextrose Infusion||12||
59524313|NCT02185729|75619478|FG000|COMPLETED|24 Hours Into Dextrose Infusion||12||
59524314|NCT02185729|75619478|FG000|NOT COMPLETED|24 Hours Into Dextrose Infusion||0||
59524315|NCT01001975|75619487|FG000|STARTED|Overall Study||5||
59524316|NCT01001975|75619488|FG001|STARTED|Overall Study||5||
59524317|NCT01001975|75619487|FG000|COMPLETED|Overall Study||5||
59524318|NCT01001975|75619488|FG001|COMPLETED|Overall Study||5||
59524319|NCT01001975|75619487|FG000|NOT COMPLETED|Overall Study||0||
59524320|NCT01001975|75619488|FG001|NOT COMPLETED|Overall Study||0||
59524321|NCT01201057|75619498|FG000|STARTED|Overall Study||34||
59524322|NCT01201057|75619499|FG001|STARTED|Overall Study||33||
59524323|NCT01201057|75619500|FG002|STARTED|Overall Study||32||
59524324|NCT01201057|75619501|FG003|STARTED|Overall Study||33||
59524325|NCT01201057|75619498|FG000|COMPLETED|Overall Study||32||
59805990|NCT03962738|75927673|FG003|STARTED|Overall Study||218||
59805991|NCT03962738|75927670|FG000|Received At Least One Dose of Study Drug|Overall Study||214||
59805992|NCT03962738|75927671|FG001|Received At Least One Dose of Study Drug|Overall Study||87||
59959128|NCT01445327|76077842|FG002|STARTED|Overall Study||5||
59959129|NCT01445327|76077840|FG000|COMPLETED|Overall Study||3||
59959130|NCT01445327|76077841|FG001|COMPLETED|Overall Study||1||
59959131|NCT01445327|76077842|FG002|COMPLETED|Overall Study||5||
59959132|NCT01445327|76077840|FG000|NOT COMPLETED|Overall Study||0||
59524326|NCT01201057|75619499|FG001|COMPLETED|Overall Study||29||
59524327|NCT01201057|75619500|FG002|COMPLETED|Overall Study||27||
59524328|NCT01201057|75619501|FG003|COMPLETED|Overall Study||29||
59524329|NCT01201057|75619498|FG000|NOT COMPLETED|Overall Study||2||
59805993|NCT03962738|75927672|FG002|Received At Least One Dose of Study Drug|Overall Study||208||
59805994|NCT03962738|75927673|FG003|Received At Least One Dose of Study Drug|Overall Study||182||
59524330|NCT01201057|75619499|FG001|NOT COMPLETED|Overall Study||4||
59524331|NCT01201057|75619500|FG002|NOT COMPLETED|Overall Study||5||
59524332|NCT01201057|75619501|FG003|NOT COMPLETED|Overall Study||4||
59524333|NCT01002287|75619513|FG000|STARTED|Overall Study||8||
59524334|NCT01002287|75619514|FG001|STARTED|Overall Study||3||
59524335|NCT01002287|75619513|FG000|COMPLETED|Overall Study||8||
59805995|NCT03962738|75927670|FG000|COMPLETED|Overall Study||251||
59805996|NCT03962738|75927671|FG001|COMPLETED|Overall Study||109||
59959133|NCT01445327|76077841|FG001|NOT COMPLETED|Overall Study||0||
59524336|NCT01002287|75619514|FG001|COMPLETED|Overall Study||3||
59524337|NCT01002287|75619513|FG000|NOT COMPLETED|Overall Study||0||
59524338|NCT01002287|75619514|FG001|NOT COMPLETED|Overall Study||0||
59524339|NCT01202071|75619520|FG000|STARTED|Overall Study||6||
59524340|NCT01202071|75619521|FG001|STARTED|Overall Study||6||
59959134|NCT01445327|76077842|FG002|NOT COMPLETED|Overall Study||0||
59959135|NCT02712398|76077850|FG000|STARTED|Overall Study||120||
59959136|NCT02712398|76077850|FG000|COMPLETED|Overall Study||83||
59959137|NCT02712398|76077850|FG000|NOT COMPLETED|Overall Study||37||
59959138|NCT00282867|76077857|FG000|STARTED|Overall Study||24||
59959139|NCT00282867|76077858|FG001|STARTED|Overall Study||25||
59959140|NCT00282867|76077859|FG002|STARTED|Overall Study||25||
59959141|NCT00282867|76077857|FG000|COMPLETED|Overall Study||23||
59959142|NCT00282867|76077858|FG001|COMPLETED|Overall Study||24||
59959143|NCT00282867|76077859|FG002|COMPLETED|Overall Study||25||
59959144|NCT00282867|76077857|FG000|NOT COMPLETED|Overall Study||1||
59959145|NCT00282867|76077858|FG001|NOT COMPLETED|Overall Study||1||
59959146|NCT00282867|76077859|FG002|NOT COMPLETED|Overall Study||0||
59959147|NCT04375085|76077864|FG000|STARTED|Overall Study||49||
59959148|NCT04375085|76077864|FG000|COMPLETED|Overall Study||49||
59959149|NCT04375085|76077864|FG000|NOT COMPLETED|Overall Study||0||
59959150|NCT00151281|76077869|FG000|STARTED|Overall Study||25||
59959151|NCT00151281|76077869|FG000|COMPLETED|Overall Study||22||
59959152|NCT00151281|76077869|FG000|NOT COMPLETED|Overall Study||3||
59959153|NCT00231153|76077876|FG000|STARTED|Overall Study|Subjects randomized to omiganan 1% gel who received at least one dose of study treatment.|907||
59959154|NCT00231153|76077877|FG001|STARTED|Overall Study|Subjects randomized to povidone-iodine who received at least one dose of study treatment.|908||
59959155|NCT00231153|76077876|FG000|COMPLETED|Overall Study||690||
59959156|NCT00231153|76077877|FG001|COMPLETED|Overall Study||720||
59959157|NCT00231153|76077876|FG000|NOT COMPLETED|Overall Study||217||
59959158|NCT00231153|76077877|FG001|NOT COMPLETED|Overall Study||188||
59959159|NCT01318109|76077884|FG000|STARTED|Overall Study||92||
59959160|NCT01318109|76077885|FG001|STARTED|Overall Study||96||
59959161|NCT01318109|76077886|FG002|STARTED|Overall Study||100||
59959162|NCT01318109|76077884|FG000|COMPLETED|Overall Study||91||
59959163|NCT01318109|76077885|FG001|COMPLETED|Overall Study||93||
59805997|NCT03962738|75927672|FG002|COMPLETED|Overall Study||259||
59805998|NCT03962738|75927673|FG003|COMPLETED|Overall Study||217||
59805999|NCT03962738|75927670|FG000|NOT COMPLETED|Overall Study||7||
59806000|NCT03962738|75927671|FG001|NOT COMPLETED|Overall Study||0||
59806001|NCT03962738|75927672|FG002|NOT COMPLETED|Overall Study||2||
59806002|NCT03962738|75927673|FG003|NOT COMPLETED|Overall Study||1||
59806003|NCT00561392|75927691|FG000|STARTED|Overall Study||208||
59806004|NCT00561392|75927691|FG000|COMPLETED|Overall Study||155||
59806005|NCT00561392|75927691|FG000|NOT COMPLETED|Overall Study||53||
59806006|NCT00694109|75927695|FG000|STARTED|Overall Study|This does not include 2 patients from phase 2 trial with very different treatment experience.|142||
59959164|NCT01318109|76077886|FG002|COMPLETED|Overall Study||100||
59959165|NCT01318109|76077884|FG000|NOT COMPLETED|Overall Study||1||
59959166|NCT01318109|76077885|FG001|NOT COMPLETED|Overall Study||3||
59959167|NCT01318109|76077886|FG002|NOT COMPLETED|Overall Study||0||
59959168|NCT02712554|76077896|FG000|STARTED|Part A: Dose Selection Phase||12||
59959169|NCT02712554|76077897|FG001|STARTED|Part A: Dose Selection Phase||0||
59959170|NCT02712554|76077896|FG000|COMPLETED|Part A: Dose Selection Phase||12||
59959171|NCT02712554|76077897|FG001|COMPLETED|Part A: Dose Selection Phase|Subjects who participated in Dose Selection Phase were not eligible to participate in Part B.|0||
59959172|NCT02712554|76077896|FG000|NOT COMPLETED|Part A: Dose Selection Phase||0||
59959173|NCT02712554|76077897|FG001|NOT COMPLETED|Part A: Dose Selection Phase||0||
59959174|NCT02712554|76077896|FG000|STARTED|Part B: Qualification Phase||0||
59959175|NCT02712554|76077897|FG001|STARTED|Part B: Qualification Phase||61||
59959176|NCT02712554|76077896|FG000|COMPLETED|Part B: Qualification Phase||0||
59959177|NCT02712554|76077897|FG001|COMPLETED|Part B: Qualification Phase||40||
59959178|NCT02712554|76077896|FG000|NOT COMPLETED|Part B: Qualification Phase||0||
59959179|NCT02712554|76077897|FG001|NOT COMPLETED|Part B: Qualification Phase||21||
59959180|NCT02712554|76077896|FG000|STARTED|Part B: Treatment Phase||0||
59959181|NCT02712554|76077897|FG001|STARTED|Part B: Treatment Phase||40||
59959182|NCT02712554|76077896|FG000|COMPLETED|Part B: Treatment Phase||0||
59959183|NCT02712554|76077897|FG001|COMPLETED|Part B: Treatment Phase||37||
59959184|NCT02712554|76077896|FG000|NOT COMPLETED|Part B: Treatment Phase||0||
59959185|NCT02712554|76077897|FG001|NOT COMPLETED|Part B: Treatment Phase||3||
59959186|NCT02712320|76077920|FG000|STARTED|Overall Study||30||
59806007|NCT00694109|75927695|FG000|Treated|Overall Study||141||
59806008|NCT00694109|75927695|FG000|Consented 2 Years Additional Treatment|Overall Study||42||
59806009|NCT00694109|75927695|FG000|Completed Consented Length of Treatment|Overall Study||60||
59806010|NCT00694109|75927695|FG000|COMPLETED|Overall Study||25||
59806011|NCT00694109|75927695|FG000|NOT COMPLETED|Overall Study||117||
59806012|NCT03137693|75927700|FG000|STARTED|Overall Study||20||
59806013|NCT03137693|75927700|FG000|COMPLETED|Overall Study||20||
59806014|NCT03137693|75927700|FG000|NOT COMPLETED|Overall Study||0||
59806015|NCT00562484|75927706|FG000|STARTED|Overall Study||10033||
59806016|NCT00562484|75927707|FG001|STARTED|Overall Study||5011||
59806017|NCT00562484|75927706|FG000|COMPLETED|Overall Study||9827||
59959187|NCT02712320|76077920|FG000|COMPLETED|Overall Study||25||
59959188|NCT02712320|76077920|FG000|NOT COMPLETED|Overall Study||5||
59959189|NCT03052751|76077926|FG000|STARTED|Dosing Period 1||22||
59959190|NCT03052751|76077927|FG001|STARTED|Dosing Period 1||21||
59806018|NCT00562484|75927707|FG001|COMPLETED|Overall Study||4907||
59959191|NCT03052751|76077928|FG002|STARTED|Dosing Period 1||0||
59959192|NCT03052751|76077929|FG003|STARTED|Dosing Period 1||0||
59959193|NCT03052751|76077930|FG004|STARTED|Dosing Period 1||0||
59959194|NCT03052751|76077931|FG005|STARTED|Dosing Period 1||0||
59959195|NCT03052751|76077926|FG000|Completed Period 1|Dosing Period 1||22||
59959196|NCT03052751|76077927|FG001|Completed Period 1|Dosing Period 1||21||
59959197|NCT03052751|76077928|FG002|Completed Period 1|Dosing Period 1||0||
59959198|NCT03052751|76077929|FG003|Completed Period 1|Dosing Period 1||0||
59959199|NCT03052751|76077930|FG004|Completed Period 1|Dosing Period 1||0||
59959200|NCT03052751|76077931|FG005|Completed Period 1|Dosing Period 1||0||
59959201|NCT03052751|76077926|FG000|Completed Period 1 and Started Period 2|Dosing Period 1||22||
59959202|NCT03052751|76077927|FG001|Completed Period 1 and Started Period 2|Dosing Period 1||20||
59959203|NCT03052751|76077928|FG002|Completed Period 1 and Started Period 2|Dosing Period 1||0||
59959204|NCT03052751|76077929|FG003|Completed Period 1 and Started Period 2|Dosing Period 1||0||
59959205|NCT03052751|76077930|FG004|Completed Period 1 and Started Period 2|Dosing Period 1||0||
59959206|NCT03052751|76077931|FG005|Completed Period 1 and Started Period 2|Dosing Period 1||0||
59959207|NCT03052751|76077926|FG000|COMPLETED|Dosing Period 1||22||
59959208|NCT03052751|76077927|FG001|COMPLETED|Dosing Period 1||20||
59959209|NCT03052751|76077928|FG002|COMPLETED|Dosing Period 1||0||
59959210|NCT03052751|76077929|FG003|COMPLETED|Dosing Period 1||0||
59959211|NCT03052751|76077930|FG004|COMPLETED|Dosing Period 1||0||
59959212|NCT03052751|76077931|FG005|COMPLETED|Dosing Period 1||0||
59959213|NCT03052751|76077926|FG000|NOT COMPLETED|Dosing Period 1||0||
59959214|NCT03052751|76077927|FG001|NOT COMPLETED|Dosing Period 1||1||
59959215|NCT03052751|76077928|FG002|NOT COMPLETED|Dosing Period 1||0||
59959216|NCT03052751|76077929|FG003|NOT COMPLETED|Dosing Period 1||0||
59959217|NCT03052751|76077930|FG004|NOT COMPLETED|Dosing Period 1||0||
59959218|NCT03052751|76077931|FG005|NOT COMPLETED|Dosing Period 1||0||
59959219|NCT03052751|76077926|FG000|STARTED|Dosing Period 2||0||
59959220|NCT03052751|76077927|FG001|STARTED|Dosing Period 2||0||
59959221|NCT03052751|76077928|FG002|STARTED|Dosing Period 2||11||
59959222|NCT03052751|76077929|FG003|STARTED|Dosing Period 2||11||
59959223|NCT03052751|76077930|FG004|STARTED|Dosing Period 2||10||
59959224|NCT03052751|76077931|FG005|STARTED|Dosing Period 2||10||
59959225|NCT03052751|76077926|FG000|COMPLETED|Dosing Period 2||0||
59959226|NCT03052751|76077927|FG001|COMPLETED|Dosing Period 2||0||
59806019|NCT00562484|75927706|FG000|NOT COMPLETED|Overall Study||206||
59806020|NCT00562484|75927707|FG001|NOT COMPLETED|Overall Study||104||
59806021|NCT00561080|75927716|FG000|STARTED|Vaccination Period (up to Month 4)||253||
59806022|NCT00561080|75927717|FG001|STARTED|Vaccination Period (up to Month 4)||255||
59806023|NCT00561080|75927718|FG002|STARTED|Vaccination Period (up to Month 4)||251||
59806024|NCT00561080|75927716|FG000|Received at Least 1 Vaccination|Vaccination Period (up to Month 4)||253||
59959227|NCT03052751|76077928|FG002|COMPLETED|Dosing Period 2||8||
59959228|NCT03052751|76077929|FG003|COMPLETED|Dosing Period 2||11||
59959229|NCT03052751|76077930|FG004|COMPLETED|Dosing Period 2||10||
59959230|NCT03052751|76077931|FG005|COMPLETED|Dosing Period 2||10||
59959231|NCT03052751|76077926|FG000|NOT COMPLETED|Dosing Period 2||0||
59959232|NCT03052751|76077927|FG001|NOT COMPLETED|Dosing Period 2||0||
59959233|NCT03052751|76077928|FG002|NOT COMPLETED|Dosing Period 2||3||
59959234|NCT03052751|76077929|FG003|NOT COMPLETED|Dosing Period 2||0||
59959235|NCT03052751|76077930|FG004|NOT COMPLETED|Dosing Period 2||0||
59806025|NCT00561080|75927717|FG001|Received at Least 1 Vaccination|Vaccination Period (up to Month 4)||254||
59806026|NCT00561080|75927718|FG002|Received at Least 1 Vaccination|Vaccination Period (up to Month 4)||250||
59806027|NCT00561080|75927716|FG000|COMPLETED|Vaccination Period (up to Month 4)||250||
59806028|NCT00561080|75927717|FG001|COMPLETED|Vaccination Period (up to Month 4)||229||
59806029|NCT00561080|75927718|FG002|COMPLETED|Vaccination Period (up to Month 4)||225||
59806030|NCT00561080|75927716|FG000|NOT COMPLETED|Vaccination Period (up to Month 4)||3||
59806031|NCT00561080|75927717|FG001|NOT COMPLETED|Vaccination Period (up to Month 4)||26||
59959236|NCT03052751|76077931|FG005|NOT COMPLETED|Dosing Period 2||0||
59959237|NCT03052751|76077926|FG000|STARTED|Observation Period||22||
59959238|NCT03052751|76077927|FG001|STARTED|Observation Period||21||
59959239|NCT03052751|76077928|FG002|STARTED|Observation Period||11||
59959240|NCT03052751|76077929|FG003|STARTED|Observation Period||11||
59959241|NCT03052751|76077930|FG004|STARTED|Observation Period||10||
59959242|NCT03052751|76077931|FG005|STARTED|Observation Period||10||
59959243|NCT03052751|76077926|FG000|COMPLETED|Observation Period||22||
59959244|NCT03052751|76077927|FG001|COMPLETED|Observation Period||21||
59959245|NCT03052751|76077928|FG002|COMPLETED|Observation Period||11||
59806032|NCT00561080|75927718|FG002|NOT COMPLETED|Vaccination Period (up to Month 4)||26||
59959246|NCT03052751|76077929|FG003|COMPLETED|Observation Period||11||
59959247|NCT03052751|76077930|FG004|COMPLETED|Observation Period||9||
59959248|NCT03052751|76077931|FG005|COMPLETED|Observation Period||10||
59806033|NCT00561080|75927716|FG000|STARTED|12-month Post Last Dose Follow-up||250||
59959249|NCT03052751|76077926|FG000|NOT COMPLETED|Observation Period||0||
59959250|NCT03052751|76077927|FG001|NOT COMPLETED|Observation Period||0||
59959251|NCT03052751|76077928|FG002|NOT COMPLETED|Observation Period||0||
59959252|NCT03052751|76077929|FG003|NOT COMPLETED|Observation Period||0||
59959253|NCT03052751|76077930|FG004|NOT COMPLETED|Observation Period||1||
59806034|NCT00561080|75927717|FG001|STARTED|12-month Post Last Dose Follow-up||229||
59806035|NCT00561080|75927718|FG002|STARTED|12-month Post Last Dose Follow-up||225||
59806036|NCT00561080|75927716|FG000|COMPLETED|12-month Post Last Dose Follow-up||243||
59806037|NCT00561080|75927717|FG001|COMPLETED|12-month Post Last Dose Follow-up||220||
59806038|NCT00561080|75927718|FG002|COMPLETED|12-month Post Last Dose Follow-up||215||
59806039|NCT00561080|75927716|FG000|NOT COMPLETED|12-month Post Last Dose Follow-up||7||
59806040|NCT00561080|75927717|FG001|NOT COMPLETED|12-month Post Last Dose Follow-up||9||
59806041|NCT00561080|75927718|FG002|NOT COMPLETED|12-month Post Last Dose Follow-up||10||
59806042|NCT00561080|75927716|FG000|STARTED|24-month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0||
59959254|NCT03052751|76077931|FG005|NOT COMPLETED|Observation Period||0||
59959255|NCT01317797|76077944|FG000|STARTED|Overall Study||8||
59959256|NCT01317797|76077945|FG001|STARTED|Overall Study||7||
59959257|NCT01317797|76077946|FG002|STARTED|Overall Study||9||
59959258|NCT01317797|76077944|FG000|COMPLETED|Overall Study||8||
59959259|NCT01317797|76077945|FG001|COMPLETED|Overall Study||6||
59959260|NCT01317797|76077946|FG002|COMPLETED|Overall Study||8||
59959261|NCT01317797|76077944|FG000|NOT COMPLETED|Overall Study||0||
59959262|NCT01317797|76077945|FG001|NOT COMPLETED|Overall Study||1||
59959263|NCT01317797|76077946|FG002|NOT COMPLETED|Overall Study||1||
59959264|NCT01343693|76077954|FG000|STARTED|Overall Study||119||
59959265|NCT01343693|76077954|FG000|COMPLETED|Overall Study||110||
59959266|NCT01343693|76077954|FG000|NOT COMPLETED|Overall Study||9||
59959267|NCT02712008|76077961|FG000|STARTED|Baseline (Day 1) up to Week 12||50||
59959268|NCT02712008|76077962|FG001|STARTED|Baseline (Day 1) up to Week 12||100||
59959269|NCT02712008|76077963|FG002|STARTED|Baseline (Day 1) up to Week 12||152||
59959270|NCT02712008|76077964|FG003|STARTED|Baseline (Day 1) up to Week 12||0||
59959271|NCT02712008|76077965|FG004|STARTED|Baseline (Day 1) up to Week 12||0||
59806043|NCT00561080|75927717|FG001|STARTED|24-month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0||
59806044|NCT00561080|75927718|FG002|STARTED|24-month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0||
59806045|NCT00561080|75927716|FG000|COMPLETED|24-month Post Last Dose Follow-up||0||
59806046|NCT00561080|75927717|FG001|COMPLETED|24-month Post Last Dose Follow-up||0||
59806047|NCT00561080|75927718|FG002|COMPLETED|24-month Post Last Dose Follow-up||0||
59806048|NCT00561080|75927716|FG000|NOT COMPLETED|24-month Post Last Dose Follow-up||0||
59959272|NCT02712008|76077966|FG005|STARTED|Baseline (Day 1) up to Week 12||0||
59959273|NCT02712008|76077967|FG006|STARTED|Baseline (Day 1) up to Week 12||0||
59959274|NCT02712008|76077968|FG007|STARTED|Baseline (Day 1) up to Week 12||0||
59959275|NCT02712008|76077961|FG000|COMPLETED|Baseline (Day 1) up to Week 12||46||
59959276|NCT02712008|76077962|FG001|COMPLETED|Baseline (Day 1) up to Week 12||97||
59959277|NCT02712008|76077963|FG002|COMPLETED|Baseline (Day 1) up to Week 12||148||
59959278|NCT02712008|76077964|FG003|COMPLETED|Baseline (Day 1) up to Week 12||0||
59959279|NCT02712008|76077965|FG004|COMPLETED|Baseline (Day 1) up to Week 12||0||
59959280|NCT02712008|76077966|FG005|COMPLETED|Baseline (Day 1) up to Week 12||0||
59959281|NCT02712008|76077967|FG006|COMPLETED|Baseline (Day 1) up to Week 12||0||
59959282|NCT02712008|76077968|FG007|COMPLETED|Baseline (Day 1) up to Week 12||0||
59959283|NCT02712008|76077961|FG000|NOT COMPLETED|Baseline (Day 1) up to Week 12||4||
59959284|NCT02712008|76077962|FG001|NOT COMPLETED|Baseline (Day 1) up to Week 12||3||
59959285|NCT02712008|76077963|FG002|NOT COMPLETED|Baseline (Day 1) up to Week 12||4||
59959286|NCT02712008|76077964|FG003|NOT COMPLETED|Baseline (Day 1) up to Week 12||0||
59959287|NCT02712008|76077965|FG004|NOT COMPLETED|Baseline (Day 1) up to Week 12||0||
59959288|NCT02712008|76077966|FG005|NOT COMPLETED|Baseline (Day 1) up to Week 12||0||
59959289|NCT02712008|76077967|FG006|NOT COMPLETED|Baseline (Day 1) up to Week 12||0||
59959290|NCT02712008|76077968|FG007|NOT COMPLETED|Baseline (Day 1) up to Week 12||0||
59959291|NCT02712008|76077961|FG000|STARTED|From Week 12 up to Week 36|Out of 46 participants that completed Week 12, 45 re-randomized for treatment from Week 12 to 36|45||
59959292|NCT02712008|76077962|FG001|STARTED|From Week 12 up to Week 36|Out of 97 participants that completed Week 12, 96 re-randomized to REGN910-3 (6:2mg) Q8 and Q12|0||
59959293|NCT02712008|76077963|FG002|STARTED|From Week 12 up to Week 36|Out of 148 that completed Week 12,143 re-randomized to Aflibercept 2mg Q8, Q12, REGN910-3 (6:2mg) Q8|0||
59959294|NCT02712008|76077964|FG003|STARTED|From Week 12 up to Week 36|Out of 96 that were re-randomized, 44 re-randomized from REGN910-3(6:2 mg)Q4 to REGN910-3(6:2 mg)Q8|44||
59959295|NCT02712008|76077965|FG004|STARTED|From Week 12 up to Week 36|Out of 96 that were re-randomized, 52 re-randomized from REGN910-3(6:2 mg)Q4 to REGN910-3(6:2 mg)Q12|52||
59959296|NCT02712008|76077966|FG005|STARTED|From Week 12 up to Week 36|Out of 143 that were re-randomized, 46 re-randomized from Aflibercept 2mg Q4 to Aflibercept 2mg Q8|46||
59959297|NCT02712008|76077967|FG006|STARTED|From Week 12 up to Week 36|Out of 143 that were re-randomized, 48 re-randomized from Aflibercept 2mg Q4 to Aflibercept 2mg Q12|48||
59959298|NCT02712008|76077968|FG007|STARTED|From Week 12 up to Week 36|Out of 143 that were re-randomized, 49 re-randomized from Aflibercept 2mg Q4 to REGN910-3 (6:2mg) Q8|49||
59959299|NCT02712008|76077961|FG000|COMPLETED|From Week 12 up to Week 36||44||
60073995|NCT03290326|76189356|FG000|COMPLETED|Overall Study||10||
59806049|NCT00561080|75927717|FG001|NOT COMPLETED|24-month Post Last Dose Follow-up||0||
59806050|NCT00561080|75927718|FG002|NOT COMPLETED|24-month Post Last Dose Follow-up||0||
59959300|NCT02712008|76077962|FG001|COMPLETED|From Week 12 up to Week 36||0||
60073996|NCT03290326|76189356|FG000|NOT COMPLETED|Overall Study||0||
60073997|NCT01839656|76189364|FG000|STARTED|Overall Study||5||
60073998|NCT01839656|76189365|FG001|STARTED|Overall Study||16||
59806051|NCT00561080|75927716|FG000|STARTED|36 Month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0||
59806052|NCT00561080|75927717|FG001|STARTED|36 Month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0||
59806053|NCT00561080|75927718|FG002|STARTED|36 Month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0||
59806054|NCT00561080|75927716|FG000|COMPLETED|36 Month Post Last Dose Follow-up||0||
59806055|NCT00561080|75927717|FG001|COMPLETED|36 Month Post Last Dose Follow-up||0||
59806056|NCT00561080|75927718|FG002|COMPLETED|36 Month Post Last Dose Follow-up||0||
59959301|NCT02712008|76077963|FG002|COMPLETED|From Week 12 up to Week 36||0||
59959302|NCT02712008|76077964|FG003|COMPLETED|From Week 12 up to Week 36||42||
59959303|NCT02712008|76077965|FG004|COMPLETED|From Week 12 up to Week 36||50||
59959304|NCT02712008|76077966|FG005|COMPLETED|From Week 12 up to Week 36||46||
59959305|NCT02712008|76077967|FG006|COMPLETED|From Week 12 up to Week 36||43||
59959306|NCT02712008|76077968|FG007|COMPLETED|From Week 12 up to Week 36||45||
59959307|NCT02712008|76077961|FG000|NOT COMPLETED|From Week 12 up to Week 36||1||
59959308|NCT02712008|76077962|FG001|NOT COMPLETED|From Week 12 up to Week 36||0||
59959309|NCT02712008|76077963|FG002|NOT COMPLETED|From Week 12 up to Week 36||0||
59959310|NCT02712008|76077964|FG003|NOT COMPLETED|From Week 12 up to Week 36||2||
59959311|NCT02712008|76077965|FG004|NOT COMPLETED|From Week 12 up to Week 36||2||
59959312|NCT02712008|76077966|FG005|NOT COMPLETED|From Week 12 up to Week 36||0||
59959313|NCT02712008|76077967|FG006|NOT COMPLETED|From Week 12 up to Week 36||5||
59959314|NCT02712008|76077968|FG007|NOT COMPLETED|From Week 12 up to Week 36||4||
59959315|NCT03618056|76077982|FG000|STARTED|Overall Study||1||
59620927|NCT00286182|75732382|FG001|NOT COMPLETED|Overall Study||3||
59620928|NCT00286728|75732390|FG000|STARTED|Overall Study||142||
59620929|NCT00286728|75732391|FG001|STARTED|Overall Study||145||
59620930|NCT00286728|75732390|FG000|COMPLETED|Overall Study||106||
59620931|NCT00286728|75732391|FG001|COMPLETED|Overall Study||116||
59620932|NCT00286728|75732390|FG000|NOT COMPLETED|Overall Study||36||
59620933|NCT00286728|75732391|FG001|NOT COMPLETED|Overall Study||29||
59620934|NCT00113880|75732400|FG000|STARTED|Overall Study||63061||
59620935|NCT00113880|75732401|FG001|STARTED|Overall Study||71949||
59620936|NCT00113880|75732402|FG002|STARTED|Overall Study||62492||
59620937|NCT00113880|75732400|FG000|COMPLETED|Overall Study||63061||
59620938|NCT00113880|75732401|FG001|COMPLETED|Overall Study||71949||
59620939|NCT00113880|75732402|FG002|COMPLETED|Overall Study||62492||
59620940|NCT00113880|75732400|FG000|NOT COMPLETED|Overall Study||0||
59620941|NCT00113880|75732401|FG001|NOT COMPLETED|Overall Study||0||
59620942|NCT00113880|75732402|FG002|NOT COMPLETED|Overall Study||0||
59620943|NCT00226590|75732417|FG000|STARTED|Overall Study||39||
59620944|NCT00226590|75732417|FG000|COMPLETED|Overall Study||39||
59620945|NCT00226590|75732417|FG000|NOT COMPLETED|Overall Study||0||
59620946|NCT00114114|75732428|FG000|STARTED|Overall Study||26||
59620947|NCT00114114|75732429|FG001|STARTED|Overall Study||25||
59620948|NCT00114114|75732430|FG002|STARTED|Overall Study||31||
59620949|NCT00114114|75732431|FG003|STARTED|Overall Study||35||
59620950|NCT00114114|75732432|FG004|STARTED|Overall Study||29||
59620951|NCT00114114|75732433|FG005|STARTED|Overall Study||31||
59620952|NCT00114114|75732428|FG000|COMPLETED|Overall Study||21||
59620953|NCT00114114|75732429|FG001|COMPLETED|Overall Study||24||
59620954|NCT00114114|75732430|FG002|COMPLETED|Overall Study||30||
59620955|NCT00114114|75732431|FG003|COMPLETED|Overall Study||31||
59620956|NCT00114114|75732432|FG004|COMPLETED|Overall Study||27||
59620957|NCT00114114|75732433|FG005|COMPLETED|Overall Study||30||
59620958|NCT00114114|75732428|FG000|NOT COMPLETED|Overall Study||5||
59620959|NCT00114114|75732429|FG001|NOT COMPLETED|Overall Study||1||
59806057|NCT00561080|75927716|FG000|NOT COMPLETED|36 Month Post Last Dose Follow-up||0||
59806058|NCT00561080|75927717|FG001|NOT COMPLETED|36 Month Post Last Dose Follow-up||0||
59806059|NCT00561080|75927718|FG002|NOT COMPLETED|36 Month Post Last Dose Follow-up||0||
59806060|NCT00562094|75927728|FG000|STARTED|Overall Study||8616||
59806061|NCT00562094|75927728|FG000|COMPLETED|Overall Study||8554||
59806062|NCT00562094|75927728|FG000|NOT COMPLETED|Overall Study||62||
59806063|NCT03817853|75927736|FG000|STARTED|Induction Phase||113||
59806064|NCT03817853|75927737|FG001|STARTED|Induction Phase||0||
59806065|NCT03817853|75927738|FG002|STARTED|Induction Phase||0||
59959316|NCT03618056|76077982|FG000|COMPLETED|Overall Study||1||
59620960|NCT00114114|75732430|FG002|NOT COMPLETED|Overall Study||1||
59959317|NCT03618056|76077982|FG000|NOT COMPLETED|Overall Study||0||
59620961|NCT00114114|75732431|FG003|NOT COMPLETED|Overall Study||4||
59620962|NCT00114114|75732432|FG004|NOT COMPLETED|Overall Study||2||
59620963|NCT00114114|75732433|FG005|NOT COMPLETED|Overall Study||1||
59620964|NCT00227760|75732449|FG000|STARTED|Overall Study||44||
59620965|NCT00227760|75732449|FG000|COMPLETED|Overall Study||44||
59620966|NCT00227760|75732449|FG000|NOT COMPLETED|Overall Study||0||
59620967|NCT00227994|75732455|FG000|STARTED|Overall Study||20||
59620968|NCT00227994|75732456|FG001|STARTED|Overall Study||20||
59620969|NCT00227994|75732455|FG000|COMPLETED|Overall Study||13||
59959318|NCT02711306|76077988|FG000|STARTED|Overall Study||18||
59620970|NCT00227994|75732456|FG001|COMPLETED|Overall Study||13||
59620971|NCT00227994|75732455|FG000|NOT COMPLETED|Overall Study||7||
59620972|NCT00227994|75732456|FG001|NOT COMPLETED|Overall Study||7||
59620973|NCT00114504|75732464|FG000|STARTED|Overall Study||21||
59959319|NCT02711306|76077989|FG001|STARTED|Overall Study||18||
59806066|NCT03817853|75927736|FG000|COMPLETED|Induction Phase||62||
59806067|NCT03817853|75927737|FG001|COMPLETED|Induction Phase||0||
59806068|NCT03817853|75927738|FG002|COMPLETED|Induction Phase||0||
59806069|NCT03817853|75927736|FG000|NOT COMPLETED|Induction Phase||51||
59806070|NCT03817853|75927737|FG001|NOT COMPLETED|Induction Phase||0||
59806071|NCT03817853|75927738|FG002|NOT COMPLETED|Induction Phase||0||
59806072|NCT03817853|75927736|FG000|STARTED|Maintenance/ Follow-up Phase||0||
59806073|NCT03817853|75927737|FG001|STARTED|Maintenance/ Follow-up Phase||56||
59806074|NCT03817853|75927738|FG002|STARTED|Maintenance/ Follow-up Phase||17||
59806075|NCT03817853|75927736|FG000|COMPLETED|Maintenance/ Follow-up Phase||0||
59806076|NCT03817853|75927737|FG001|COMPLETED|Maintenance/ Follow-up Phase||0||
59806077|NCT03817853|75927738|FG002|COMPLETED|Maintenance/ Follow-up Phase||11||
59806078|NCT03817853|75927736|FG000|NOT COMPLETED|Maintenance/ Follow-up Phase||0||
59806079|NCT03817853|75927737|FG001|NOT COMPLETED|Maintenance/ Follow-up Phase||56||
59806080|NCT03817853|75927738|FG002|NOT COMPLETED|Maintenance/ Follow-up Phase||6||
59806081|NCT00439270|75927751|FG000|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|3||
59959320|NCT02711306|76077988|FG000|COMPLETED|Overall Study||16||
59959321|NCT02711306|76077989|FG001|COMPLETED|Overall Study||16||
59959322|NCT02711306|76077988|FG000|NOT COMPLETED|Overall Study||2||
59959323|NCT02711306|76077989|FG001|NOT COMPLETED|Overall Study||2||
59959324|NCT02710292|76077995|FG000|STARTED|Period 1, First 10 Days of Wear||47||
59806082|NCT00439270|75927752|FG001|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|3||
59806083|NCT00439270|75927753|FG002|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|3||
59806084|NCT00439270|75927754|FG003|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|4||
59806085|NCT00439270|75927755|FG004|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|3||
59806086|NCT00439270|75927751|FG000|COMPLETED|Phase 1 (18.1 Months)|Remained on study|0||
59806087|NCT00439270|75927752|FG001|COMPLETED|Phase 1 (18.1 Months)|Remained on study|0||
59806088|NCT00439270|75927753|FG002|COMPLETED|Phase 1 (18.1 Months)|Remained on study|0||
59806089|NCT00439270|75927754|FG003|COMPLETED|Phase 1 (18.1 Months)|Remained on study|4||
59806090|NCT00439270|75927755|FG004|COMPLETED|Phase 1 (18.1 Months)|Remained on study|0||
59806091|NCT00439270|75927751|FG000|NOT COMPLETED|Phase 1 (18.1 Months)||3||
59806092|NCT00439270|75927752|FG001|NOT COMPLETED|Phase 1 (18.1 Months)||3||
59806093|NCT00439270|75927753|FG002|NOT COMPLETED|Phase 1 (18.1 Months)||3||
59806094|NCT00439270|75927754|FG003|NOT COMPLETED|Phase 1 (18.1 Months)||0||
59806095|NCT00439270|75927755|FG004|NOT COMPLETED|Phase 1 (18.1 Months)||3||
59806096|NCT00439270|75927751|FG000|STARTED|Phase 2 (51.6 Months)||0||
59806097|NCT00439270|75927752|FG001|STARTED|Phase 2 (51.6 Months)||0||
59806098|NCT00439270|75927753|FG002|STARTED|Phase 2 (51.6 Months)||0||
59806099|NCT00439270|75927754|FG003|STARTED|Phase 2 (51.6 Months)|Includes 4 patients who completed Phase 1|34||
59806100|NCT00439270|75927755|FG004|STARTED|Phase 2 (51.6 Months)||0||
59806101|NCT00439270|75927751|FG000|COMPLETED|Phase 2 (51.6 Months)||0||
59806102|NCT00439270|75927752|FG001|COMPLETED|Phase 2 (51.6 Months)||0||
59806103|NCT00439270|75927753|FG002|COMPLETED|Phase 2 (51.6 Months)||0||
59806104|NCT00439270|75927754|FG003|COMPLETED|Phase 2 (51.6 Months)||0||
59806105|NCT00439270|75927755|FG004|COMPLETED|Phase 2 (51.6 Months)||0||
59806106|NCT00439270|75927751|FG000|NOT COMPLETED|Phase 2 (51.6 Months)||0||
59806107|NCT00439270|75927752|FG001|NOT COMPLETED|Phase 2 (51.6 Months)||0||
59806108|NCT00439270|75927753|FG002|NOT COMPLETED|Phase 2 (51.6 Months)||0||
59806109|NCT00439270|75927754|FG003|NOT COMPLETED|Phase 2 (51.6 Months)||34||
59806110|NCT00439270|75927755|FG004|NOT COMPLETED|Phase 2 (51.6 Months)||0||
59806111|NCT00553280|75927774|FG000|STARTED|Overall Study||123||
59806112|NCT00553280|75927774|FG000|COMPLETED|Overall Study||97||
59806113|NCT00553280|75927774|FG000|NOT COMPLETED|Overall Study||26||
59806114|NCT00440518|75927781|FG000|STARTED|Randomized /Titration Period||72||
59806115|NCT00440518|75927782|FG001|STARTED|Randomized /Titration Period||72||
59806116|NCT00440518|75927783|FG002|STARTED|Randomized /Titration Period||74||
59806117|NCT00440518|75927781|FG000|COMPLETED|Randomized /Titration Period||59||
59806118|NCT00440518|75927782|FG001|COMPLETED|Randomized /Titration Period||63||
59806119|NCT00440518|75927783|FG002|COMPLETED|Randomized /Titration Period||70||
59806120|NCT00440518|75927781|FG000|NOT COMPLETED|Randomized /Titration Period||13||
59806121|NCT00440518|75927782|FG001|NOT COMPLETED|Randomized /Titration Period||9||
59806122|NCT00440518|75927783|FG002|NOT COMPLETED|Randomized /Titration Period||4||
59806123|NCT00440518|75927781|FG000|STARTED|Maintenance and Safety Follow-up Periods||59||
59959325|NCT02710292|76077996|FG001|STARTED|Period 1, First 10 Days of Wear||52||
59959326|NCT02710292|76077995|FG000|COMPLETED|Period 1, First 10 Days of Wear||46||
59959327|NCT02710292|76077996|FG001|COMPLETED|Period 1, First 10 Days of Wear||49||
59959328|NCT02710292|76077995|FG000|NOT COMPLETED|Period 1, First 10 Days of Wear||1||
59806124|NCT00440518|75927782|FG001|STARTED|Maintenance and Safety Follow-up Periods||63||
59806125|NCT00440518|75927783|FG002|STARTED|Maintenance and Safety Follow-up Periods||70||
59806126|NCT00440518|75927781|FG000|COMPLETED|Maintenance and Safety Follow-up Periods||52||
59806127|NCT00440518|75927782|FG001|COMPLETED|Maintenance and Safety Follow-up Periods||51||
59806128|NCT00440518|75927783|FG002|COMPLETED|Maintenance and Safety Follow-up Periods||55||
59806129|NCT00440518|75927781|FG000|NOT COMPLETED|Maintenance and Safety Follow-up Periods||7||
59806130|NCT00440518|75927782|FG001|NOT COMPLETED|Maintenance and Safety Follow-up Periods||12||
59959329|NCT02710292|76077996|FG001|NOT COMPLETED|Period 1, First 10 Days of Wear||3||
59959330|NCT02710292|76077995|FG000|STARTED|Period 2, Second 10 Days of Wear||46||
59959331|NCT02710292|76077996|FG001|STARTED|Period 2, Second 10 Days of Wear||49||
59959332|NCT02710292|76077995|FG000|COMPLETED|Period 2, Second 10 Days of Wear||46||
59959333|NCT02710292|76077996|FG001|COMPLETED|Period 2, Second 10 Days of Wear||49||
59959334|NCT02710292|76077995|FG000|NOT COMPLETED|Period 2, Second 10 Days of Wear||0||
59959335|NCT02710292|76077996|FG001|NOT COMPLETED|Period 2, Second 10 Days of Wear||0||
59959336|NCT02710214|76078005|FG000|STARTED|Overall Study||12||
59959337|NCT02710214|76078006|FG001|STARTED|Overall Study||12||
59959338|NCT02710214|76078005|FG000|COMPLETED|Overall Study||11||
59959339|NCT02710214|76078006|FG001|COMPLETED|Overall Study||10||
59959340|NCT02710214|76078005|FG000|NOT COMPLETED|Overall Study||1||
59959341|NCT02710214|76078006|FG001|NOT COMPLETED|Overall Study||2||
59959342|NCT03052517|76078015|FG000|STARTED|Overall Study||1093||
59959343|NCT03052517|76078016|FG001|STARTED|Overall Study||1085||
59959344|NCT03052517|76078017|FG002|STARTED|Overall Study||360||
59959345|NCT03052517|76078015|FG000|Safety Set (SAF)|Overall Study|One patient received placebo. This patient was not included in QAW039 150 mg group in the SAF|1092|All patients who received at least one dose of study drug during this study.|
59959346|NCT03052517|76078016|FG001|Safety Set (SAF)|Overall Study|One patient had no treatment administered and thus was excluded from the SAF|1084|All patients who received at least one dose of study drug during this study.|
59959347|NCT03052517|76078017|FG002|Safety Set (SAF)|Overall Study|One patient in QAW039 150 mg group received placebo and was included in the placebo group in the SAF|361|All patients who received at least one dose of study drug during this study.|
59959348|NCT03052517|76078015|FG000|COMPLETED|Overall Study||76||
59524341|NCT01202071|75619522|FG002|STARTED|Overall Study||6||
59524342|NCT01202071|75619523|FG003|STARTED|Overall Study||6||
59806131|NCT00440518|75927783|FG002|NOT COMPLETED|Maintenance and Safety Follow-up Periods||15||
59806132|NCT00438256|75927791|FG000|STARTED|Overall Study||3||
59806133|NCT00438256|75927792|FG001|STARTED|Overall Study||3||
59806134|NCT00438256|75927793|FG002|STARTED|Overall Study||3||
59806135|NCT00438256|75927794|FG003|STARTED|Overall Study||41||
59806136|NCT00438256|75927791|FG000|Surgical Resection|Overall Study||1||
59806137|NCT00438256|75927792|FG001|Surgical Resection|Overall Study||2||
59806138|NCT00438256|75927793|FG002|Surgical Resection|Overall Study||2||
59806139|NCT00438256|75927794|FG003|Surgical Resection|Overall Study||34||
59806140|NCT00438256|75927791|FG000|COMPLETED|Overall Study||1||
59806141|NCT00438256|75927792|FG001|COMPLETED|Overall Study||2||
59806142|NCT00438256|75927793|FG002|COMPLETED|Overall Study||2||
59806143|NCT00438256|75927794|FG003|COMPLETED|Overall Study||32||
59806144|NCT00438256|75927791|FG000|NOT COMPLETED|Overall Study||2||
59806145|NCT00438256|75927792|FG001|NOT COMPLETED|Overall Study||1||
59806146|NCT00438256|75927793|FG002|NOT COMPLETED|Overall Study||1||
59806147|NCT00438256|75927794|FG003|NOT COMPLETED|Overall Study||9||
59806148|NCT02037620|75927807|FG000|STARTED|Overall Study||5||
59806149|NCT02037620|75927807|FG000|COMPLETED|Overall Study||4||
59806150|NCT02037620|75927807|FG000|NOT COMPLETED|Overall Study||1||
59806151|NCT00436852|75927813|FG000|STARTED|Overall Study||45||
59806152|NCT00436852|75927814|FG001|STARTED|Overall Study||47||
59806153|NCT00436852|75927813|FG000|COMPLETED|Overall Study||10||
59806154|NCT00436852|75927814|FG001|COMPLETED|Overall Study||2||
59959349|NCT03052517|76078016|FG001|COMPLETED|Overall Study||71||
59959350|NCT03052517|76078017|FG002|COMPLETED|Overall Study||32||
59959351|NCT03052517|76078015|FG000|NOT COMPLETED|Overall Study||1017||
59959352|NCT03052517|76078016|FG001|NOT COMPLETED|Overall Study||1014||
59959353|NCT03052517|76078017|FG002|NOT COMPLETED|Overall Study||328||
59959354|NCT02708498|76078033|FG000|STARTED|Overall Study||42||
59959355|NCT02708498|76078034|FG001|STARTED|Overall Study||40||
59524343|NCT01202071|75619520|FG000|COMPLETED|Overall Study||6||
59524344|NCT01202071|75619521|FG001|COMPLETED|Overall Study||6||
59806155|NCT00436852|75927813|FG000|NOT COMPLETED|Overall Study||35||
59806156|NCT00436852|75927814|FG001|NOT COMPLETED|Overall Study||45||
59806157|NCT00120289|75927825|FG000|STARTED|Overall Study||1718||
59806158|NCT00120289|75927826|FG001|STARTED|Overall Study||1696||
59806159|NCT00120289|75927825|FG000|COMPLETED|Overall Study||1597||
59806160|NCT00120289|75927826|FG001|COMPLETED|Overall Study||1587||
59806161|NCT00120289|75927825|FG000|NOT COMPLETED|Overall Study||121||
59806162|NCT00120289|75927826|FG001|NOT COMPLETED|Overall Study||109||
59806163|NCT00550446|75927839|FG000|STARTED|Up To Week 12||54||
59806164|NCT00550446|75927840|FG001|STARTED|Up To Week 12||52||
59806165|NCT00550446|75927841|FG002|STARTED|Up To Week 12||50||
59806166|NCT00550446|75927842|FG003|STARTED|Up To Week 12||61||
59806167|NCT00550446|75927843|FG004|STARTED|Up To Week 12||57||
59806168|NCT00550446|75927844|FG005|STARTED|Up To Week 12||53||
59806169|NCT00550446|75927845|FG006|STARTED|Up To Week 12||59||
59806170|NCT00550446|75927846|FG007|STARTED|Up To Week 12||0||
59806171|NCT00550446|75927847|FG008|STARTED|Up To Week 12||0||
59806172|NCT00550446|75927848|FG009|STARTED|Up To Week 12||0||
59806173|NCT00550446|75927849|FG010|STARTED|Up To Week 12||0||
59806174|NCT00550446|75927839|FG000|Treated|Up To Week 12||54||
59806175|NCT00550446|75927840|FG001|Treated|Up To Week 12||51||
59806176|NCT00550446|75927841|FG002|Treated|Up To Week 12||49||
59806177|NCT00550446|75927842|FG003|Treated|Up To Week 12||61||
59806178|NCT00550446|75927843|FG004|Treated|Up To Week 12||57||
59959356|NCT02708498|76078035|FG002|STARTED|Overall Study||152||
59959357|NCT02708498|76078036|FG003|STARTED|Overall Study||156||
59959358|NCT02708498|76078037|FG004|STARTED|Overall Study||363||
59959359|NCT02708498|76078038|FG005|STARTED|Overall Study||330||
59959360|NCT02708498|76078039|FG006|STARTED|Overall Study||20||
59959361|NCT02708498|76078040|FG007|STARTED|Overall Study||48||
59959362|NCT02708498|76078033|FG000|COMPLETED|Overall Study||22||
59959363|NCT02708498|76078034|FG001|COMPLETED|Overall Study||21||
59959364|NCT02708498|76078035|FG002|COMPLETED|Overall Study||90||
59806179|NCT00550446|75927844|FG005|Treated|Up To Week 12||53||
59806180|NCT00550446|75927845|FG006|Treated|Up To Week 12||59||
59806181|NCT00550446|75927846|FG007|Treated|Up To Week 12||0||
59959365|NCT02708498|76078036|FG003|COMPLETED|Overall Study||105||
59959366|NCT02708498|76078037|FG004|COMPLETED|Overall Study||167||
59959367|NCT02708498|76078038|FG005|COMPLETED|Overall Study||198||
59959368|NCT02708498|76078039|FG006|COMPLETED|Overall Study||20||
59959369|NCT02708498|76078040|FG007|COMPLETED|Overall Study||48||
59959370|NCT02708498|76078033|FG000|NOT COMPLETED|Overall Study||20||
59959371|NCT02708498|76078034|FG001|NOT COMPLETED|Overall Study||19||
59959372|NCT02708498|76078035|FG002|NOT COMPLETED|Overall Study||62||
59959373|NCT02708498|76078036|FG003|NOT COMPLETED|Overall Study||51||
59959374|NCT02708498|76078037|FG004|NOT COMPLETED|Overall Study||196||
59959375|NCT02708498|76078038|FG005|NOT COMPLETED|Overall Study||132||
59959376|NCT02708498|76078039|FG006|NOT COMPLETED|Overall Study||0||
59959377|NCT02708498|76078040|FG007|NOT COMPLETED|Overall Study||0||
59959378|NCT02710136|76078058|FG000|STARTED|Study Enrollment||10||
59959379|NCT02710136|76078059|FG001|STARTED|Study Enrollment||25||
59959380|NCT02710136|76078058|FG000|COMPLETED|Study Enrollment||10||
59959381|NCT02710136|76078059|FG001|COMPLETED|Study Enrollment||25||
59959382|NCT02710136|76078058|FG000|NOT COMPLETED|Study Enrollment||0||
59959383|NCT02710136|76078059|FG001|NOT COMPLETED|Study Enrollment||0||
59959384|NCT02710136|76078058|FG000|STARTED|Phase 1a[Refer to Arm/Group Description]||10||
59959385|NCT02710136|76078059|FG001|STARTED|Phase 1a[Refer to Arm/Group Description]||0||
59959386|NCT02710136|76078058|FG000|COMPLETED|Phase 1a[Refer to Arm/Group Description]||9||
59959387|NCT02710136|76078059|FG001|COMPLETED|Phase 1a[Refer to Arm/Group Description]||0||
59959388|NCT02710136|76078058|FG000|NOT COMPLETED|Phase 1a[Refer to Arm/Group Description]||1||
59806182|NCT00550446|75927847|FG008|Treated|Up To Week 12||0||
59806183|NCT00550446|75927848|FG009|Treated|Up To Week 12||0||
59806184|NCT00550446|75927849|FG010|Treated|Up To Week 12||0||
59806185|NCT00550446|75927839|FG000|COMPLETED|Up To Week 12||44||
59806186|NCT00550446|75927840|FG001|COMPLETED|Up To Week 12||47||
59806187|NCT00550446|75927841|FG002|COMPLETED|Up To Week 12||46||
59806188|NCT00550446|75927842|FG003|COMPLETED|Up To Week 12||58||
59806189|NCT00550446|75927843|FG004|COMPLETED|Up To Week 12||54||
59959389|NCT02710136|76078059|FG001|NOT COMPLETED|Phase 1a[Refer to Arm/Group Description]||0||
59959390|NCT02710136|76078058|FG000|STARTED|Phase 1b[Refer to Arm/Group Description]||4||
59959391|NCT02710136|76078059|FG001|STARTED|Phase 1b[Refer to Arm/Group Description]||0||
59959392|NCT02710136|76078058|FG000|COMPLETED|Phase 1b[Refer to Arm/Group Description]||4||
59959393|NCT02710136|76078059|FG001|COMPLETED|Phase 1b[Refer to Arm/Group Description]||0||
59959394|NCT02710136|76078058|FG000|NOT COMPLETED|Phase 1b[Refer to Arm/Group Description]||0||
59959395|NCT02710136|76078059|FG001|NOT COMPLETED|Phase 1b[Refer to Arm/Group Description]||0||
59959396|NCT02710136|76078058|FG000|STARTED|Phase 2 [Refer to Arm/Group Description]||0||
59959397|NCT02710136|76078059|FG001|STARTED|Phase 2 [Refer to Arm/Group Description]||25||
59959398|NCT02710136|76078058|FG000|COMPLETED|Phase 2 [Refer to Arm/Group Description]||0||
59959399|NCT02710136|76078059|FG001|COMPLETED|Phase 2 [Refer to Arm/Group Description]||25||
59959400|NCT02710136|76078058|FG000|NOT COMPLETED|Phase 2 [Refer to Arm/Group Description]||0||
59959401|NCT02710136|76078059|FG001|NOT COMPLETED|Phase 2 [Refer to Arm/Group Description]||0||
59959402|NCT03702231|76078069|FG000|STARTED|Overall Study||58||
59959403|NCT03702231|76078070|FG001|STARTED|Overall Study||30||
59959404|NCT03702231|76078071|FG002|STARTED|Overall Study||28||
59959405|NCT03702231|76078069|FG000|COMPLETED|Overall Study||56||
59959406|NCT03702231|76078070|FG001|COMPLETED|Overall Study||26||
59959407|NCT03702231|76078071|FG002|COMPLETED|Overall Study||24||
59959408|NCT03702231|76078069|FG000|NOT COMPLETED|Overall Study||2||
59959409|NCT03702231|76078070|FG001|NOT COMPLETED|Overall Study||4||
59959410|NCT03702231|76078071|FG002|NOT COMPLETED|Overall Study||4||
59806190|NCT00550446|75927844|FG005|COMPLETED|Up To Week 12||45||
59806191|NCT00550446|75927845|FG006|COMPLETED|Up To Week 12||46||
59806192|NCT00550446|75927846|FG007|COMPLETED|Up To Week 12||0||
59806193|NCT00550446|75927847|FG008|COMPLETED|Up To Week 12||0||
59806194|NCT00550446|75927848|FG009|COMPLETED|Up To Week 12||0||
59806195|NCT00550446|75927849|FG010|COMPLETED|Up To Week 12||0||
59806196|NCT00550446|75927839|FG000|NOT COMPLETED|Up To Week 12||10||
59806197|NCT00550446|75927840|FG001|NOT COMPLETED|Up To Week 12||5||
59806198|NCT00550446|75927841|FG002|NOT COMPLETED|Up To Week 12||4||
59806199|NCT00550446|75927842|FG003|NOT COMPLETED|Up To Week 12||3||
59959411|NCT02741271|76078081|FG000|STARTED|Overall Study||91||
59959412|NCT02741271|76078082|FG001|STARTED|Overall Study||90||
59806200|NCT00550446|75927843|FG004|NOT COMPLETED|Up To Week 12||3||
59806201|NCT00550446|75927844|FG005|NOT COMPLETED|Up To Week 12||8||
59806202|NCT00550446|75927845|FG006|NOT COMPLETED|Up To Week 12||13||
59959413|NCT02741271|76078081|FG000|COMPLETED|Overall Study||89||
59959414|NCT02741271|76078082|FG001|COMPLETED|Overall Study||88||
59959415|NCT02741271|76078081|FG000|NOT COMPLETED|Overall Study||2||
59959416|NCT02741271|76078082|FG001|NOT COMPLETED|Overall Study||2||
59959417|NCT02709746|76078095|FG000|STARTED|Phase A (Single-blind Treatment Period)||784||
59959418|NCT02709746|76078096|FG001|STARTED|Phase A (Single-blind Treatment Period)||0||
59959419|NCT02709746|76078097|FG002|STARTED|Phase A (Single-blind Treatment Period)||0||
59959420|NCT02709746|76078098|FG003|STARTED|Phase A (Single-blind Treatment Period)||0||
59959421|NCT02709746|76078099|FG004|STARTED|Phase A (Single-blind Treatment Period)||0||
59959422|NCT02709746|76078095|FG000|COMPLETED|Phase A (Single-blind Treatment Period)||616||
59959423|NCT02709746|76078096|FG001|COMPLETED|Phase A (Single-blind Treatment Period)||0||
59959424|NCT02709746|76078097|FG002|COMPLETED|Phase A (Single-blind Treatment Period)||0||
59806203|NCT00550446|75927846|FG007|NOT COMPLETED|Up To Week 12||0||
59806204|NCT00550446|75927847|FG008|NOT COMPLETED|Up To Week 12||0||
59806205|NCT00550446|75927848|FG009|NOT COMPLETED|Up To Week 12||0||
59806206|NCT00550446|75927849|FG010|NOT COMPLETED|Up To Week 12||0||
59959425|NCT02709746|76078098|FG003|COMPLETED|Phase A (Single-blind Treatment Period)||0||
59959426|NCT02709746|76078099|FG004|COMPLETED|Phase A (Single-blind Treatment Period)||0||
59959427|NCT02709746|76078095|FG000|NOT COMPLETED|Phase A (Single-blind Treatment Period)||168||
59959428|NCT02709746|76078096|FG001|NOT COMPLETED|Phase A (Single-blind Treatment Period)||0||
59959429|NCT02709746|76078097|FG002|NOT COMPLETED|Phase A (Single-blind Treatment Period)||0||
59959430|NCT02709746|76078098|FG003|NOT COMPLETED|Phase A (Single-blind Treatment Period)||0||
59959431|NCT02709746|76078099|FG004|NOT COMPLETED|Phase A (Single-blind Treatment Period)||0||
59959432|NCT02709746|76078095|FG000|STARTED|Phase B (Double-blind Treatment Period)||0||
59959433|NCT02709746|76078096|FG001|STARTED|Phase B (Double-blind Treatment Period)||147||
59959434|NCT02709746|76078097|FG002|STARTED|Phase B (Double-blind Treatment Period)||162||
59959435|NCT02709746|76078098|FG003|STARTED|Phase B (Double-blind Treatment Period)||153||
59959436|NCT02709746|76078099|FG004|STARTED|Phase B (Double-blind Treatment Period)||154||
59959437|NCT02709746|76078095|FG000|COMPLETED|Phase B (Double-blind Treatment Period)||0||
59959438|NCT02709746|76078096|FG001|COMPLETED|Phase B (Double-blind Treatment Period)||126||
59959439|NCT02709746|76078097|FG002|COMPLETED|Phase B (Double-blind Treatment Period)||140||
59959440|NCT02709746|76078098|FG003|COMPLETED|Phase B (Double-blind Treatment Period)||138||
59806207|NCT00550446|75927839|FG000|STARTED|Post Week 12||27||
59806208|NCT00550446|75927840|FG001|STARTED|Post Week 12||30||
59806209|NCT00550446|75927841|FG002|STARTED|Post Week 12||46||
59806210|NCT00550446|75927842|FG003|STARTED|Post Week 12||58||
59806211|NCT00550446|75927843|FG004|STARTED|Post Week 12||54||
59806212|NCT00550446|75927844|FG005|STARTED|Post Week 12||1||
59524345|NCT01202071|75619522|FG002|COMPLETED|Overall Study||6||
59620974|NCT00114504|75732465|FG001|STARTED|Overall Study||22||
59806213|NCT00550446|75927845|FG006|STARTED|Post Week 12||21||
59959441|NCT02709746|76078099|FG004|COMPLETED|Phase B (Double-blind Treatment Period)||138||
59959442|NCT02709746|76078095|FG000|NOT COMPLETED|Phase B (Double-blind Treatment Period)||0||
59959443|NCT02709746|76078096|FG001|NOT COMPLETED|Phase B (Double-blind Treatment Period)||21||
59959444|NCT02709746|76078097|FG002|NOT COMPLETED|Phase B (Double-blind Treatment Period)||22||
59959445|NCT02709746|76078098|FG003|NOT COMPLETED|Phase B (Double-blind Treatment Period)||15||
59959446|NCT02709746|76078099|FG004|NOT COMPLETED|Phase B (Double-blind Treatment Period)||16||
59959447|NCT01317641|76078120|FG000|STARTED|Overall Study||4||
59524346|NCT01202071|75619523|FG003|COMPLETED|Overall Study||6||
59524347|NCT01202071|75619520|FG000|NOT COMPLETED|Overall Study||0||
59524348|NCT01202071|75619521|FG001|NOT COMPLETED|Overall Study||0||
59524349|NCT01202071|75619522|FG002|NOT COMPLETED|Overall Study||0||
59524350|NCT01202071|75619523|FG003|NOT COMPLETED|Overall Study||0||
59620975|NCT00114504|75732464|FG000|COMPLETED|Overall Study||21||
59620976|NCT00114504|75732465|FG001|COMPLETED|Overall Study||22||
59959448|NCT01317641|76078121|FG001|STARTED|Overall Study||7||
59959449|NCT01317641|76078122|FG002|STARTED|Overall Study||3||
59959450|NCT01317641|76078123|FG003|STARTED|Overall Study||4||
59959451|NCT01317641|76078124|FG004|STARTED|Overall Study||3||
59524351|NCT01002755|75619533|FG000|STARTED|Overall Study||36||
59524352|NCT01002755|75619533|FG000|COMPLETED|Overall Study||36||
59524353|NCT01002755|75619533|FG000|NOT COMPLETED|Overall Study||0||
59524354|NCT01003067|75619539|FG000|STARTED|Overall Study||136||
59620977|NCT00114504|75732464|FG000|NOT COMPLETED|Overall Study||0||
59806214|NCT00550446|75927846|FG007|STARTED|Post Week 12||17||
59806215|NCT00550446|75927847|FG008|STARTED|Post Week 12||17||
59806216|NCT00550446|75927848|FG009|STARTED|Post Week 12||44||
59806217|NCT00550446|75927849|FG010|STARTED|Post Week 12||25||
59806218|NCT00550446|75927839|FG000|COMPLETED|Post Week 12||24||
59806219|NCT00550446|75927840|FG001|COMPLETED|Post Week 12||28||
59806220|NCT00550446|75927841|FG002|COMPLETED|Post Week 12||43||
59806221|NCT00550446|75927842|FG003|COMPLETED|Post Week 12||55||
59806222|NCT00550446|75927843|FG004|COMPLETED|Post Week 12||52||
59806223|NCT00550446|75927844|FG005|COMPLETED|Post Week 12||0||
59524355|NCT01003067|75619540|FG001|STARTED|Overall Study||131||
59806224|NCT00550446|75927845|FG006|COMPLETED|Post Week 12||19||
59806225|NCT00550446|75927846|FG007|COMPLETED|Post Week 12||16||
59806226|NCT00550446|75927847|FG008|COMPLETED|Post Week 12||15||
59806227|NCT00550446|75927848|FG009|COMPLETED|Post Week 12||37||
59806228|NCT00550446|75927849|FG010|COMPLETED|Post Week 12||24||
59806229|NCT00550446|75927839|FG000|NOT COMPLETED|Post Week 12||3||
59806230|NCT00550446|75927840|FG001|NOT COMPLETED|Post Week 12||2||
59806231|NCT00550446|75927841|FG002|NOT COMPLETED|Post Week 12||3||
59806232|NCT00550446|75927842|FG003|NOT COMPLETED|Post Week 12||3||
59806233|NCT00550446|75927843|FG004|NOT COMPLETED|Post Week 12||2||
59806234|NCT00550446|75927844|FG005|NOT COMPLETED|Post Week 12||1||
59806235|NCT00550446|75927845|FG006|NOT COMPLETED|Post Week 12||2||
59806236|NCT00550446|75927846|FG007|NOT COMPLETED|Post Week 12||1||
59806237|NCT00550446|75927847|FG008|NOT COMPLETED|Post Week 12||2||
59806238|NCT00550446|75927848|FG009|NOT COMPLETED|Post Week 12||7||
59806239|NCT00550446|75927849|FG010|NOT COMPLETED|Post Week 12||1||
59806240|NCT00436618|75927890|FG000|STARTED|Overall Study||114||
59806241|NCT00436618|75927891|FG001|STARTED|Overall Study||55||
59806242|NCT00436618|75927892|FG002|STARTED|Overall Study||107||
59806243|NCT00436618|75927890|FG000|COMPLETED|Overall Study||84||
59806244|NCT00436618|75927891|FG001|COMPLETED|Overall Study||28||
59806245|NCT00436618|75927892|FG002|COMPLETED|Overall Study||46||
59806246|NCT00436618|75927890|FG000|NOT COMPLETED|Overall Study||30||
59806247|NCT00436618|75927891|FG001|NOT COMPLETED|Overall Study||27||
59806248|NCT00436618|75927892|FG002|NOT COMPLETED|Overall Study||61||
59806249|NCT01751126|75927903|FG000|STARTED|Period I||57||
59806250|NCT01751126|75927904|FG001|STARTED|Period I||54||
59806251|NCT01751126|75927905|FG002|STARTED|Period I||58||
59806252|NCT01751126|75927903|FG000|COMPLETED|Period I||51||
59806253|NCT01751126|75927904|FG001|COMPLETED|Period I||43||
59806254|NCT01751126|75927905|FG002|COMPLETED|Period I||49||
59806255|NCT01751126|75927903|FG000|NOT COMPLETED|Period I||6||
59806256|NCT01751126|75927904|FG001|NOT COMPLETED|Period I||11||
59806257|NCT01751126|75927905|FG002|NOT COMPLETED|Period I||9||
59806258|NCT01751126|75927903|FG000|STARTED|Period II||72||
59806259|NCT01751126|75927904|FG001|STARTED|Period II||70||
59806260|NCT01751126|75927905|FG002|STARTED|Period II|Following completion of the first period of the trial, all patients were to be administered NOVA22007 (High or Low dose) for a safety 8-month follow-up period.|0||
59806261|NCT01751126|75927903|FG000|COMPLETED|Period II||72||
59806262|NCT01751126|75927904|FG001|COMPLETED|Period II||70||
59806263|NCT01751126|75927905|FG002|COMPLETED|Period II||0||
59806264|NCT01751126|75927903|FG000|NOT COMPLETED|Period II||0||
59806265|NCT01751126|75927904|FG001|NOT COMPLETED|Period II||0||
59806266|NCT01751126|75927905|FG002|NOT COMPLETED|Period II||0||
59806267|NCT00548808|75927929|FG000|STARTED|Overall Study||214||
59806268|NCT00548808|75927930|FG001|STARTED|Overall Study||212||
59806269|NCT00548808|75927929|FG000|Full Analysis Set|Overall Study||211||
59806270|NCT00548808|75927930|FG001|Full Analysis Set|Overall Study||212||
59806271|NCT00548808|75927929|FG000|Per-Protocol Set|Overall Study||177||
59806272|NCT00548808|75927930|FG001|Per-Protocol Set|Overall Study||184||
59806273|NCT00548808|75927929|FG000|COMPLETED|Overall Study||172||
59806274|NCT00548808|75927930|FG001|COMPLETED|Overall Study||186||
59806275|NCT00548808|75927929|FG000|NOT COMPLETED|Overall Study||42||
59806276|NCT00548808|75927930|FG001|NOT COMPLETED|Overall Study||26||
59806277|NCT00110617|75927938|FG000|STARTED|Overall Study||135||
59806278|NCT00110617|75927939|FG001|STARTED|Overall Study|Full Analysis Set 1 does not include 9 participants who were excluded due to GCP violations.|68||
59806279|NCT00110617|75927938|FG000|Safety Set 1; Received Study Drug|Overall Study||135||
59806280|NCT00110617|75927939|FG001|Safety Set 1; Received Study Drug|Overall Study||56||
59806281|NCT00110617|75927938|FG000|Full Analysis 2; Received ICL670|Overall Study||135||
59806282|NCT00110617|75927939|FG001|Full Analysis 2; Received ICL670|Overall Study||53||
59806283|NCT00110617|75927938|FG000|On Going at Week 24|Overall Study||126||
59806284|NCT00110617|75927939|FG001|On Going at Week 24|Overall Study||53||
59806285|NCT00110617|75927938|FG000|COMPLETED|Overall Study||96||
59806286|NCT00110617|75927939|FG001|COMPLETED|Overall Study||39||
59806287|NCT00110617|75927938|FG000|NOT COMPLETED|Overall Study||39||
59806288|NCT00110617|75927939|FG001|NOT COMPLETED|Overall Study||29||
59806289|NCT03956862|75927949|FG000|STARTED|Overall Study||50||
59806290|NCT03956862|75927950|FG001|STARTED|Overall Study||47||
59806291|NCT03956862|75927949|FG000|COMPLETED|Overall Study||48||
59806292|NCT03956862|75927950|FG001|COMPLETED|Overall Study||45||
59806293|NCT03956862|75927949|FG000|NOT COMPLETED|Overall Study||2||
59806294|NCT03956862|75927950|FG001|NOT COMPLETED|Overall Study||2||
59806295|NCT00550238|75927956|FG000|STARTED|Overall Study||459||
59806296|NCT00550238|75927956|FG000|COMPLETED|Overall Study||0||
59806297|NCT00550238|75927956|FG000|NOT COMPLETED|Overall Study||459||
59806298|NCT03956550|75927963|FG000|STARTED|Overall Study||88||
60073999|NCT01839656|76189364|FG000|Completed Loading Dose Period|Overall Study||4||
59806299|NCT03956550|75927964|FG001|STARTED|Overall Study||86||
59806300|NCT03956550|75927965|FG002|STARTED|Overall Study||85||
59806301|NCT03956550|75927963|FG000|COMPLETED|Overall Study||18||
59806302|NCT03956550|75927964|FG001|COMPLETED|Overall Study||14||
59806303|NCT03956550|75927965|FG002|COMPLETED|Overall Study||15||
59806304|NCT03956550|75927963|FG000|NOT COMPLETED|Overall Study||70||
59806305|NCT03956550|75927964|FG001|NOT COMPLETED|Overall Study||72||
59806306|NCT03956550|75927965|FG002|NOT COMPLETED|Overall Study||70||
59806307|NCT00110305|75927977|FG000|STARTED|Overall Study||279||
59806308|NCT00110305|75927978|FG001|STARTED|Overall Study||89||
59806309|NCT00110305|75927977|FG000|COMPLETED|Overall Study||165||
59806310|NCT00110305|75927978|FG001|COMPLETED|Overall Study||57||
59806311|NCT00110305|75927977|FG000|NOT COMPLETED|Overall Study||114||
59806312|NCT00110305|75927978|FG001|NOT COMPLETED|Overall Study||32||
59806313|NCT00428116|75927997|FG000|STARTED|Overall Study||21||
59806314|NCT00428116|75927998|FG001|STARTED|Overall Study||21||
59806315|NCT00428116|75927997|FG000|COMPLETED|Overall Study||18||
59806316|NCT00428116|75927998|FG001|COMPLETED|Overall Study||21||
59806317|NCT00428116|75927997|FG000|NOT COMPLETED|Overall Study||3||
59806318|NCT00428116|75927998|FG001|NOT COMPLETED|Overall Study||0||
59806319|NCT00560066|75928007|FG000|STARTED|Overall Study||396||
59806320|NCT00560066|75928008|FG001|STARTED|Overall Study||1002||
59959452|NCT01317641|76078125|FG005|STARTED|Overall Study||3||
59959453|NCT01317641|76078126|FG006|STARTED|Overall Study||38||
59959454|NCT01317641|76078127|FG007|STARTED|Overall Study||38||
59959455|NCT01317641|76078128|FG008|STARTED|Overall Study||36||
59959456|NCT01317641|76078120|FG000|COMPLETED|Overall Study||3||
59959457|NCT01317641|76078121|FG001|COMPLETED|Overall Study||6||
59959458|NCT01317641|76078122|FG002|COMPLETED|Overall Study||3||
59959459|NCT01317641|76078123|FG003|COMPLETED|Overall Study||3||
59959460|NCT01317641|76078124|FG004|COMPLETED|Overall Study||3||
59959461|NCT01317641|76078125|FG005|COMPLETED|Overall Study||3||
59806321|NCT00560066|75928007|FG000|COMPLETED|Overall Study||390||
59806322|NCT00560066|75928008|FG001|COMPLETED|Overall Study||980||
59806323|NCT00560066|75928007|FG000|NOT COMPLETED|Overall Study||6||
59806324|NCT00560066|75928008|FG001|NOT COMPLETED|Overall Study||22||
59806325|NCT00549900|75928019|FG000|STARTED|Overall Study||30||
59806326|NCT00549900|75928019|FG000|COMPLETED|Overall Study||29||
59806327|NCT00549900|75928019|FG000|NOT COMPLETED|Overall Study||1||
59806328|NCT00435994|75928026|FG000|STARTED|Overall Study||22||
59806329|NCT00435994|75928027|FG001|STARTED|Overall Study||25||
59806330|NCT00435994|75928028|FG002|STARTED|Overall Study||12||
59806331|NCT00435994|75928026|FG000|COMPLETED|Overall Study|7 of the subjects were consented and did not complete the study procedures.|15||
59959462|NCT01317641|76078126|FG006|COMPLETED|Overall Study||35||
59959463|NCT01317641|76078127|FG007|COMPLETED|Overall Study||33||
59959464|NCT01317641|76078128|FG008|COMPLETED|Overall Study||31||
59959465|NCT01317641|76078120|FG000|NOT COMPLETED|Overall Study||1||
59959466|NCT01317641|76078121|FG001|NOT COMPLETED|Overall Study||1||
59959467|NCT01317641|76078122|FG002|NOT COMPLETED|Overall Study||0||
59959468|NCT01317641|76078123|FG003|NOT COMPLETED|Overall Study||1||
59959469|NCT01317641|76078124|FG004|NOT COMPLETED|Overall Study||0||
59959470|NCT01317641|76078125|FG005|NOT COMPLETED|Overall Study||0||
59959471|NCT01317641|76078126|FG006|NOT COMPLETED|Overall Study||3||
59806332|NCT00435994|75928027|FG001|COMPLETED|Overall Study||25||
59806333|NCT00435994|75928028|FG002|COMPLETED|Overall Study||12||
59806334|NCT00435994|75928026|FG000|NOT COMPLETED|Overall Study||7||
59806335|NCT00435994|75928027|FG001|NOT COMPLETED|Overall Study||0||
59806336|NCT00435994|75928028|FG002|NOT COMPLETED|Overall Study||0||
59806337|NCT00435370|75928039|FG000|STARTED|Overall Study||90||
59806338|NCT00435370|75928040|FG001|STARTED|Overall Study|The recruitment restarted in August, 2010.|89||
59806339|NCT00435370|75928039|FG000|COMPLETED|Overall Study||68||
59806340|NCT00435370|75928040|FG001|COMPLETED|Overall Study|The entire recruitment has been completed in December, 2011.|69||
59806341|NCT00435370|75928039|FG000|NOT COMPLETED|Overall Study||22||
59806342|NCT00435370|75928040|FG001|NOT COMPLETED|Overall Study||20||
59806343|NCT00096031|75928046|FG000|STARTED|Overall Study||63||
59806344|NCT00096031|75928046|FG000|Eligible|Overall Study||57||
59959472|NCT01317641|76078127|FG007|NOT COMPLETED|Overall Study||5||
59959473|NCT01317641|76078128|FG008|NOT COMPLETED|Overall Study||5||
59959474|NCT03186794|76078164|FG000|STARTED|Overall Study||20||
59959475|NCT03186794|76078164|FG000|COMPLETED|Overall Study||16||
59959476|NCT03186794|76078164|FG000|NOT COMPLETED|Overall Study||4||
59959477|NCT02290431|76078169|FG000|STARTED|Overall Study||31||
59959478|NCT02290431|76078169|FG000|Subjects. Discont. Prematurely|Overall Study||27||
59959479|NCT02290431|76078169|FG000|Subjects Completed Study Per Protocol|Overall Study||8||
59959480|NCT02290431|76078169|FG000|Subjs. Ntered Post-treatment Eval. Phase|Overall Study||31||
59959481|NCT02290431|76078169|FG000|Subjects Entered Survival f/u Phase|Overall Study||24||
59959482|NCT02290431|76078169|FG000|Entered Treatment Phase 2|Overall Study||17||
59959483|NCT02290431|76078169|FG000|COMPLETED|Overall Study||4||
59806345|NCT00096031|75928046|FG000|Eligible and Began Protocol Therapy|Overall Study||55||
59806346|NCT00096031|75928046|FG000|COMPLETED|Overall Study||0||
59806347|NCT00096031|75928046|FG000|NOT COMPLETED|Overall Study||63||
59806348|NCT00118417|75928050|FG000|STARTED|Phase I (Weeks 0 to 6)||39||
59959484|NCT02290431|76078169|FG000|NOT COMPLETED|Overall Study||27||
59959485|NCT02707952|76078177|FG000|STARTED|Overall Study||129|This milestone represents participants randomized.|
59959486|NCT02707952|76078178|FG001|STARTED|Overall Study||53|This milestone represents participants randomized.|
59959487|NCT02707952|76078179|FG002|STARTED|Overall Study||103|This milestone represents participants randomized.|
59995278|NCT01119807|76111112|FG001|STARTED|Overall Study||51||
59995279|NCT01119807|76111113|FG002|STARTED|Overall Study||64||
59995280|NCT01119807|76111111|FG000|COMPLETED|Overall Study||67||
59995281|NCT01119807|76111112|FG001|COMPLETED|Overall Study||51||
59959488|NCT02707952|76078180|FG003|STARTED|Overall Study||10|This milestone represents participants randomized.|
59959489|NCT02707952|76078177|FG000|Participants Who Received Study Drug|Overall Study||129||
59959490|NCT02707952|76078178|FG001|Participants Who Received Study Drug|Overall Study||52||
59959491|NCT02707952|76078179|FG002|Participants Who Received Study Drug|Overall Study||103||
59959492|NCT02707952|76078180|FG003|Participants Who Received Study Drug|Overall Study||10||
59959493|NCT02707952|76078177|FG000|COMPLETED|Overall Study||127||
59959494|NCT02707952|76078178|FG001|COMPLETED|Overall Study||52||
59806349|NCT00118417|75928051|FG001|STARTED|Phase I (Weeks 0 to 6)|In Phase 1, all participants received open label SSRI - no second treatment arm.|0||
59806350|NCT00118417|75928050|FG000|COMPLETED|Phase I (Weeks 0 to 6)||21||
59806351|NCT00118417|75928051|FG001|COMPLETED|Phase I (Weeks 0 to 6)||0||
59806352|NCT00118417|75928050|FG000|NOT COMPLETED|Phase I (Weeks 0 to 6)||18||
59806353|NCT00118417|75928051|FG001|NOT COMPLETED|Phase I (Weeks 0 to 6)||0||
59806354|NCT00118417|75928050|FG000|STARTED|Phase II (Weeks 6 to 12)|Three new participants on Phase 1 endpoint doses of SSRIs entered at Phase 2.|11||
59806355|NCT00118417|75928051|FG001|STARTED|Phase II (Weeks 6 to 12)||13||
59806356|NCT00118417|75928050|FG000|COMPLETED|Phase II (Weeks 6 to 12)||9||
59806357|NCT00118417|75928051|FG001|COMPLETED|Phase II (Weeks 6 to 12)||10||
59806358|NCT00118417|75928050|FG000|NOT COMPLETED|Phase II (Weeks 6 to 12)||2||
59806359|NCT00118417|75928051|FG001|NOT COMPLETED|Phase II (Weeks 6 to 12)||3||
60074000|NCT01839656|76189365|FG001|Completed Loading Dose Period|Overall Study||15||
60074001|NCT01839656|76189364|FG000|COMPLETED|Overall Study||2||
60074002|NCT01839656|76189365|FG001|COMPLETED|Overall Study||0||
60074003|NCT01839656|76189364|FG000|NOT COMPLETED|Overall Study||3||
60074004|NCT01839656|76189365|FG001|NOT COMPLETED|Overall Study||16||
60074005|NCT01839188|76189371|FG000|STARTED|Overall Study||385||
60074006|NCT01839188|76189371|FG000|Treated|Overall Study||385||
60074007|NCT01839188|76189371|FG000|COMPLETED|Overall Study|N=1 treated participant withdrew before receiving V3|384||
60074008|NCT01839188|76189371|FG000|NOT COMPLETED|Overall Study||1||
60074009|NCT01838876|76189380|FG000|STARTED|Overall Study||442||
60074010|NCT01838876|76189380|FG000|Safety Population; Received Study Drug|Overall Study||345||
60074011|NCT01838876|76189380|FG000|Entered Safety Follow-up Period|Overall Study||287||
59959495|NCT02707952|76078179|FG002|COMPLETED|Overall Study||101||
59959496|NCT02707952|76078180|FG003|COMPLETED|Overall Study||10||
59959497|NCT02707952|76078177|FG000|NOT COMPLETED|Overall Study||2||
59959498|NCT02707952|76078178|FG001|NOT COMPLETED|Overall Study||1||
59959499|NCT02707952|76078179|FG002|NOT COMPLETED|Overall Study||2||
59959500|NCT02707952|76078180|FG003|NOT COMPLETED|Overall Study||0||
59959501|NCT03050801|76078198|FG000|STARTED|Experiment 1||3||
59959502|NCT03050801|76078199|FG001|STARTED|Experiment 1||13||
60074012|NCT01838876|76189380|FG000|COMPLETED|Overall Study||209||
60074013|NCT01838876|76189380|FG000|NOT COMPLETED|Overall Study||233||
60074014|NCT03279250|76189388|FG000|STARTED|Overall Study||34||
60074015|NCT03279250|76189389|FG001|STARTED|Overall Study||34||
59806360|NCT00118417|75928050|FG000|STARTED|Phase III (Weeks 12 to 24)||9||
59806361|NCT00118417|75928051|FG001|STARTED|Phase III (Weeks 12 to 24)||10||
59959503|NCT03050801|76078200|FG002|STARTED|Experiment 1||8||
59959504|NCT03050801|76078201|FG003|STARTED|Experiment 1||0||
59806362|NCT00118417|75928050|FG000|COMPLETED|Phase III (Weeks 12 to 24)||8||
59806363|NCT00118417|75928051|FG001|COMPLETED|Phase III (Weeks 12 to 24)||9||
59806364|NCT00118417|75928050|FG000|NOT COMPLETED|Phase III (Weeks 12 to 24)||1||
59806365|NCT00118417|75928051|FG001|NOT COMPLETED|Phase III (Weeks 12 to 24)||1||
59806366|NCT00549848|75928064|FG000|STARTED|Overall Study||206||
59806367|NCT00549848|75928065|FG001|STARTED|Overall Study||208||
59806368|NCT00549848|75928066|FG002|STARTED|Overall Study||184||
59806369|NCT00549848|75928064|FG000|COMPLETED|Overall Study||194||
59959505|NCT03050801|76078202|FG004|STARTED|Experiment 1||0||
59959506|NCT03050801|76078203|FG005|STARTED|Experiment 1||0||
60074016|NCT03279250|76189388|FG000|COMPLETED|Overall Study||34||
60074017|NCT03279250|76189389|FG001|COMPLETED|Overall Study||34||
59806370|NCT00549848|75928065|FG001|COMPLETED|Overall Study||188||
59806371|NCT00549848|75928066|FG002|COMPLETED|Overall Study||133||
59806372|NCT00549848|75928064|FG000|NOT COMPLETED|Overall Study||12||
59806373|NCT00549848|75928065|FG001|NOT COMPLETED|Overall Study||20||
59806374|NCT00549848|75928066|FG002|NOT COMPLETED|Overall Study||51||
60074018|NCT03279250|76189388|FG000|NOT COMPLETED|Overall Study||0||
60074019|NCT03279250|76189389|FG001|NOT COMPLETED|Overall Study||0||
60074020|NCT01838642|76189395|FG000|STARTED|Overall Study||3||
59806375|NCT00549770|75928090|FG000|STARTED|Overall Study||156||
59806376|NCT00549770|75928091|FG001|STARTED|Overall Study||169||
59806377|NCT00549770|75928092|FG002|STARTED|Overall Study||172||
59806378|NCT00549770|75928093|FG003|STARTED|Overall Study||163||
59806379|NCT00549770|75928094|FG004|STARTED|Overall Study||166||
59806380|NCT00549770|75928095|FG005|STARTED|Overall Study||164||
59806381|NCT00549770|75928096|FG006|STARTED|Overall Study||165||
59806382|NCT00549770|75928097|FG007|STARTED|Overall Study||173||
59806383|NCT00549770|75928090|FG000|Intent-to-treat Population|Overall Study||154||
59959507|NCT03050801|76078198|FG000|COMPLETED|Experiment 1||3||
59959508|NCT03050801|76078199|FG001|COMPLETED|Experiment 1||6||
59959509|NCT03050801|76078200|FG002|COMPLETED|Experiment 1||6||
60074021|NCT01838642|76189395|FG000|COMPLETED|Overall Study||2||
59959510|NCT03050801|76078201|FG003|COMPLETED|Experiment 1||0||
59959511|NCT03050801|76078202|FG004|COMPLETED|Experiment 1||0||
59959512|NCT03050801|76078203|FG005|COMPLETED|Experiment 1||0||
59959513|NCT03050801|76078198|FG000|NOT COMPLETED|Experiment 1||0||
59959514|NCT03050801|76078199|FG001|NOT COMPLETED|Experiment 1||7||
59959515|NCT03050801|76078200|FG002|NOT COMPLETED|Experiment 1||2||
59959516|NCT03050801|76078201|FG003|NOT COMPLETED|Experiment 1||0||
59959517|NCT03050801|76078202|FG004|NOT COMPLETED|Experiment 1||0||
59959518|NCT03050801|76078203|FG005|NOT COMPLETED|Experiment 1||0||
59959519|NCT03050801|76078198|FG000|STARTED|Experiment 2||0||
59959520|NCT03050801|76078199|FG001|STARTED|Experiment 2||0||
59959521|NCT03050801|76078200|FG002|STARTED|Experiment 2||0||
59959522|NCT03050801|76078201|FG003|STARTED|Experiment 2||21||
59959523|NCT03050801|76078202|FG004|STARTED|Experiment 2||19||
59959524|NCT03050801|76078203|FG005|STARTED|Experiment 2|Experiment 2 (Prefrontal Cortex Stimulation) was terminated early due to adverse events (intolerance of stimulation) in 2 of 4 participants.|4||
59524356|NCT01003067|75619539|FG000|COMPLETED|Overall Study||103||
59524357|NCT01003067|75619540|FG001|COMPLETED|Overall Study||107||
59524358|NCT01003067|75619539|FG000|NOT COMPLETED|Overall Study||33||
59524359|NCT01003067|75619540|FG001|NOT COMPLETED|Overall Study||24||
59524360|NCT01003301|75619548|FG000|STARTED|Overall Study||10||
59524361|NCT01003301|75619549|FG001|STARTED|Overall Study||9||
59524362|NCT01003301|75619548|FG000|COMPLETED|Overall Study||10||
59524363|NCT01003301|75619549|FG001|COMPLETED|Overall Study||9||
59524364|NCT01003301|75619548|FG000|NOT COMPLETED|Overall Study||0||
59524365|NCT01003301|75619549|FG001|NOT COMPLETED|Overall Study||0||
59524366|NCT01243957|75619555|FG000|STARTED|Overall Study||20||
59524367|NCT01243957|75619555|FG000|COMPLETED|Overall Study||20||
59806384|NCT00549770|75928091|FG001|Intent-to-treat Population|Overall Study||168||
59806385|NCT00549770|75928092|FG002|Intent-to-treat Population|Overall Study||170||
59806386|NCT00549770|75928093|FG003|Intent-to-treat Population|Overall Study||163||
59806387|NCT00549770|75928094|FG004|Intent-to-treat Population|Overall Study||163||
59806388|NCT00549770|75928095|FG005|Intent-to-treat Population|Overall Study||163||
59806389|NCT00549770|75928096|FG006|Intent-to-treat Population|Overall Study||164||
59524368|NCT01243957|75619555|FG000|NOT COMPLETED|Overall Study||0||
59620978|NCT00114504|75732465|FG001|NOT COMPLETED|Overall Study||0||
59806390|NCT00549770|75928097|FG007|Intent-to-treat Population|Overall Study||172||
59806391|NCT00549770|75928090|FG000|Ambulatory Blood Pressure Monitoring|Overall Study||48||
59806392|NCT00549770|75928091|FG001|Ambulatory Blood Pressure Monitoring|Overall Study||61||
59806393|NCT00549770|75928092|FG002|Ambulatory Blood Pressure Monitoring|Overall Study||53||
59806394|NCT00549770|75928093|FG003|Ambulatory Blood Pressure Monitoring|Overall Study||55||
59806395|NCT00549770|75928094|FG004|Ambulatory Blood Pressure Monitoring|Overall Study||49||
59806396|NCT00549770|75928095|FG005|Ambulatory Blood Pressure Monitoring|Overall Study||54||
59806397|NCT00549770|75928096|FG006|Ambulatory Blood Pressure Monitoring|Overall Study||50||
59959525|NCT03050801|76078198|FG000|COMPLETED|Experiment 2||0||
59959526|NCT03050801|76078199|FG001|COMPLETED|Experiment 2||0||
59959527|NCT03050801|76078200|FG002|COMPLETED|Experiment 2||0||
59524369|NCT01884740|75619561|FG000|STARTED|Overall Study||13||
59524370|NCT01884740|75619561|FG000|COMPLETED|Overall Study||13||
59524371|NCT01884740|75619561|FG000|NOT COMPLETED|Overall Study||0||
59524372|NCT01003769|75619566|FG000|STARTED|Overall Study||5||
59620979|NCT00118248|75732477|FG000|STARTED|Overall Study||17||
59620980|NCT00118248|75732478|FG001|STARTED|Overall Study||24||
59620981|NCT00118248|75732477|FG000|COMPLETED|Overall Study||17||
59620982|NCT00118248|75732478|FG001|COMPLETED|Overall Study||24||
59620983|NCT00118248|75732477|FG000|NOT COMPLETED|Overall Study||0||
59620984|NCT00118248|75732478|FG001|NOT COMPLETED|Overall Study||0||
59620985|NCT00230022|75732485|FG000|STARTED|Overall Study||15||
59620986|NCT00230022|75732486|FG001|STARTED|Overall Study||15||
59620987|NCT00230022|75732485|FG000|COMPLETED|Overall Study||15||
59620988|NCT00230022|75732486|FG001|COMPLETED|Overall Study||15||
59620989|NCT00230022|75732485|FG000|NOT COMPLETED|Overall Study||0||
59620990|NCT00230022|75732486|FG001|NOT COMPLETED|Overall Study||0||
59620991|NCT00230802|75732494|FG000|STARTED|Overall Study||25||
59620992|NCT00230802|75732495|FG001|STARTED|Overall Study||23||
59620993|NCT00230802|75732494|FG000|COMPLETED|Overall Study||25||
59620994|NCT00230802|75732495|FG001|COMPLETED|Overall Study||23||
59620995|NCT00230802|75732494|FG000|NOT COMPLETED|Overall Study||0||
59620996|NCT00230802|75732495|FG001|NOT COMPLETED|Overall Study||0||
59620997|NCT00288366|75732505|FG000|STARTED|Overall Study||23||
59620998|NCT00288366|75732506|FG001|STARTED|Overall Study||26||
59620999|NCT00288366|75732505|FG000|COMPLETED|Overall Study||23||
59806398|NCT00549770|75928097|FG007|Ambulatory Blood Pressure Monitoring|Overall Study||57||
59806399|NCT00549770|75928090|FG000|COMPLETED|Overall Study||149||
59806400|NCT00549770|75928091|FG001|COMPLETED|Overall Study||158||
59806401|NCT00549770|75928092|FG002|COMPLETED|Overall Study||162||
59806402|NCT00549770|75928093|FG003|COMPLETED|Overall Study||147||
59806403|NCT00549770|75928094|FG004|COMPLETED|Overall Study||149||
59806404|NCT00549770|75928095|FG005|COMPLETED|Overall Study||151||
59806405|NCT00549770|75928096|FG006|COMPLETED|Overall Study||151||
59959528|NCT03050801|76078201|FG003|COMPLETED|Experiment 2||15||
59959529|NCT03050801|76078202|FG004|COMPLETED|Experiment 2||15||
59959530|NCT03050801|76078203|FG005|COMPLETED|Experiment 2||2||
59959531|NCT03050801|76078198|FG000|NOT COMPLETED|Experiment 2||0||
59959532|NCT03050801|76078199|FG001|NOT COMPLETED|Experiment 2||0||
59959533|NCT03050801|76078200|FG002|NOT COMPLETED|Experiment 2||0||
59959534|NCT03050801|76078201|FG003|NOT COMPLETED|Experiment 2||6||
59959535|NCT03050801|76078202|FG004|NOT COMPLETED|Experiment 2||4||
59806406|NCT00549770|75928097|FG007|COMPLETED|Overall Study||148||
59806407|NCT00549770|75928090|FG000|NOT COMPLETED|Overall Study||7||
59806408|NCT00549770|75928091|FG001|NOT COMPLETED|Overall Study||11||
59806409|NCT00549770|75928092|FG002|NOT COMPLETED|Overall Study||10||
59806410|NCT00549770|75928093|FG003|NOT COMPLETED|Overall Study||16||
59806411|NCT00549770|75928094|FG004|NOT COMPLETED|Overall Study||17||
59806412|NCT00549770|75928095|FG005|NOT COMPLETED|Overall Study||13||
59806413|NCT00549770|75928096|FG006|NOT COMPLETED|Overall Study||14||
59806414|NCT00549770|75928097|FG007|NOT COMPLETED|Overall Study||25||
59806415|NCT00548184|75928115|FG000|STARTED|Overall Study||65||
59806416|NCT00548184|75928115|FG000|COMPLETED|Overall Study|65 patients were on treatment. 5 did not complete due to adverse events or other reasons.|60||
59806417|NCT00548184|75928115|FG000|NOT COMPLETED|Overall Study||5||
59806418|NCT00454636|75928123|FG000|STARTED|Overall Study||41||
59806419|NCT00454636|75928124|FG001|STARTED|Overall Study||32||
59806420|NCT00454636|75928125|FG002|STARTED|Overall Study||27||
59806421|NCT00454636|75928126|FG003|STARTED|Overall Study||58||
59806422|NCT00454636|75928123|FG000|COMPLETED|Overall Study||10||
59806423|NCT00454636|75928124|FG001|COMPLETED|Overall Study||9||
59806424|NCT00454636|75928125|FG002|COMPLETED|Overall Study||7||
59959536|NCT03050801|76078203|FG005|NOT COMPLETED|Experiment 2||2||
59959537|NCT02707640|76078222|FG000|STARTED|Overall Study||61||
59959538|NCT02707640|76078223|FG001|STARTED|Overall Study||62||
59959539|NCT02707640|76078222|FG000|COMPLETED|Overall Study||52||
59959540|NCT02707640|76078223|FG001|COMPLETED|Overall Study||55||
59959541|NCT02707640|76078222|FG000|NOT COMPLETED|Overall Study||9||
59959542|NCT02707640|76078223|FG001|NOT COMPLETED|Overall Study||7||
59959543|NCT02708966|76078231|FG000|STARTED|Overall Study||15||
59959544|NCT02708966|76078232|FG001|STARTED|Overall Study||15||
59959545|NCT02708966|76078231|FG000|COMPLETED|Overall Study||13||
59959546|NCT02708966|76078232|FG001|COMPLETED|Overall Study||13||
59959547|NCT02708966|76078231|FG000|NOT COMPLETED|Overall Study||2||
59959548|NCT02708966|76078232|FG001|NOT COMPLETED|Overall Study||2||
59959549|NCT02706938|76078240|FG000|STARTED|First Period, 6 Weeks||32||
59959550|NCT02706938|76078241|FG001|STARTED|First Period, 6 Weeks||33||
59959551|NCT02706938|76078240|FG000|COMPLETED|First Period, 6 Weeks||21||
59959552|NCT02706938|76078241|FG001|COMPLETED|First Period, 6 Weeks||31||
59959553|NCT02706938|76078240|FG000|NOT COMPLETED|First Period, 6 Weeks||11||
59959554|NCT02706938|76078241|FG001|NOT COMPLETED|First Period, 6 Weeks||2||
59959555|NCT02706938|76078240|FG000|STARTED|Second Period, 6 Weeks||21||
59959556|NCT02706938|76078241|FG001|STARTED|Second Period, 6 Weeks||31||
59959557|NCT02706938|76078240|FG000|COMPLETED|Second Period, 6 Weeks|Only data from 20 patients were finally analyzed because of missing data.|21|Because this is a crossover trial, only 39 patients who completed both interventions were analyzed.|
59959558|NCT02706938|76078241|FG001|COMPLETED|Second Period, 6 Weeks|Only data from 19 patients were finally analyzed because of missing data.|21|Because this is a crossover trial, only 39 patients who completed both interventions were analyzed.|
59959559|NCT02706938|76078240|FG000|NOT COMPLETED|Second Period, 6 Weeks||0||
59959560|NCT02706938|76078241|FG001|NOT COMPLETED|Second Period, 6 Weeks||10||
59959561|NCT03053063|76078251|FG000|STARTED|Randomized Phase||355||
59959562|NCT03053063|76078252|FG001|STARTED|Randomized Phase||354||
59959563|NCT03053063|76078253|FG002|STARTED|Randomized Phase||174||
59959564|NCT03053063|76078254|FG003|STARTED|Randomized Phase||0||
59959565|NCT03053063|76078251|FG000|COMPLETED|Randomized Phase||0||
59959566|NCT03053063|76078252|FG001|COMPLETED|Randomized Phase||0||
59959567|NCT03053063|76078253|FG002|COMPLETED|Randomized Phase||0||
59959568|NCT03053063|76078254|FG003|COMPLETED|Randomized Phase||0||
59959569|NCT03053063|76078251|FG000|NOT COMPLETED|Randomized Phase||355||
59959570|NCT03053063|76078252|FG001|NOT COMPLETED|Randomized Phase||354||
59959571|NCT03053063|76078253|FG002|NOT COMPLETED|Randomized Phase||174||
59959572|NCT03053063|76078254|FG003|NOT COMPLETED|Randomized Phase||0||
59959573|NCT03053063|76078251|FG000|STARTED|Open-Label Phase||0||
59806425|NCT00454636|75928126|FG003|COMPLETED|Overall Study||26||
59806426|NCT00454636|75928123|FG000|NOT COMPLETED|Overall Study||31||
59806427|NCT00454636|75928124|FG001|NOT COMPLETED|Overall Study||23||
59806428|NCT00454636|75928125|FG002|NOT COMPLETED|Overall Study||20||
59806429|NCT00454636|75928126|FG003|NOT COMPLETED|Overall Study||32||
59959574|NCT03053063|76078252|FG001|STARTED|Open-Label Phase||0||
59959575|NCT03053063|76078253|FG002|STARTED|Open-Label Phase||0||
59959576|NCT03053063|76078254|FG003|STARTED|Open-Label Phase|Participants who experienced a hepatic clinical event had the option to roll over into the OL Phase.|23||
59959577|NCT03053063|76078251|FG000|COMPLETED|Open-Label Phase||0||
59959578|NCT03053063|76078252|FG001|COMPLETED|Open-Label Phase||0||
59959579|NCT03053063|76078253|FG002|COMPLETED|Open-Label Phase||0||
59959580|NCT03053063|76078254|FG003|COMPLETED|Open-Label Phase||0||
59806430|NCT00427960|75928138|FG000|STARTED|Overall Study||30||
59806431|NCT00427960|75928139|FG001|STARTED|Overall Study||25||
59806432|NCT00427960|75928138|FG000|COMPLETED|Overall Study||28||
59959581|NCT03053063|76078251|FG000|NOT COMPLETED|Open-Label Phase||0||
59959582|NCT03053063|76078252|FG001|NOT COMPLETED|Open-Label Phase||0||
59959583|NCT03053063|76078253|FG002|NOT COMPLETED|Open-Label Phase||0||
59959584|NCT03053063|76078254|FG003|NOT COMPLETED|Open-Label Phase||23||
59959585|NCT00702338|76078263|FG000|STARTED|Base Study (NCT00697255)||5||
59959586|NCT00702338|76078264|FG001|STARTED|Base Study (NCT00697255)||3||
59959587|NCT00702338|76078265|FG002|STARTED|Base Study (NCT00697255)||0||
59959588|NCT00702338|76078263|FG000|COMPLETED|Base Study (NCT00697255)|To complete the study, participants must have received hCG bolus injection.|2||
59959589|NCT00702338|76078264|FG001|COMPLETED|Base Study (NCT00697255)|To complete the study, participants must have received hCG bolus injection.|1||
59959590|NCT00702338|76078265|FG002|COMPLETED|Base Study (NCT00697255)||0||
59959591|NCT00702338|76078263|FG000|NOT COMPLETED|Base Study (NCT00697255)||3||
59959592|NCT00702338|76078264|FG001|NOT COMPLETED|Base Study (NCT00697255)||2||
59959593|NCT00702338|76078265|FG002|NOT COMPLETED|Base Study (NCT00697255)||0||
59959594|NCT00702338|76078263|FG000|STARTED|Follow-up Study: Expectant Mothers FU|To enroll in follow-up study, confirmed pregnancy at ≥10 wks after hCG bolus injection was required|0||
59959595|NCT00702338|76078264|FG001|STARTED|Follow-up Study: Expectant Mothers FU|To enroll in follow-up study, confirmed pregnancy at ≥10 wks after hCG bolus injection was required|1||
59959596|NCT00702338|76078265|FG002|STARTED|Follow-up Study: Expectant Mothers FU||0||
59959597|NCT00702338|76078263|FG000|COMPLETED|Follow-up Study: Expectant Mothers FU||0||
59959598|NCT00702338|76078264|FG001|COMPLETED|Follow-up Study: Expectant Mothers FU|To complete the study, participants must have completed a follow-up visit at 4-12 weeks postpartum.|0||
59959599|NCT00702338|76078265|FG002|COMPLETED|Follow-up Study: Expectant Mothers FU||0||
59959600|NCT00702338|76078263|FG000|NOT COMPLETED|Follow-up Study: Expectant Mothers FU||0||
59959601|NCT00702338|76078264|FG001|NOT COMPLETED|Follow-up Study: Expectant Mothers FU||1||
59959602|NCT00702338|76078265|FG002|NOT COMPLETED|Follow-up Study: Expectant Mothers FU||0||
59959603|NCT00702338|76078263|FG000|STARTED|Follow-up Study: Infant FU||0||
59959604|NCT00702338|76078264|FG001|STARTED|Follow-up Study: Infant FU||0||
59959605|NCT00702338|76078265|FG002|STARTED|Follow-up Study: Infant FU|Participants died on day of delivery, did not complete follow-up visit at 4-12 weeks postpartum.|2||
59959606|NCT00702338|76078263|FG000|COMPLETED|Follow-up Study: Infant FU||0||
59959607|NCT00702338|76078264|FG001|COMPLETED|Follow-up Study: Infant FU||0||
59959608|NCT00702338|76078265|FG002|COMPLETED|Follow-up Study: Infant FU||0||
59959609|NCT00702338|76078263|FG000|NOT COMPLETED|Follow-up Study: Infant FU||0||
59959610|NCT00702338|76078264|FG001|NOT COMPLETED|Follow-up Study: Infant FU||0||
59959611|NCT00702338|76078265|FG002|NOT COMPLETED|Follow-up Study: Infant FU||2||
59959612|NCT01316939|76078276|FG000|STARTED|Overall Study||76||
59959613|NCT01316939|76078277|FG001|STARTED|Overall Study||77||
59959614|NCT01316939|76078278|FG002|STARTED|Overall Study||76||
59959615|NCT01316939|76078276|FG000|COMPLETED|Overall Study||13||
59959616|NCT01316939|76078277|FG001|COMPLETED|Overall Study||9||
59959617|NCT01316939|76078278|FG002|COMPLETED|Overall Study||7||
59959618|NCT01316939|76078276|FG000|NOT COMPLETED|Overall Study||63||
59621000|NCT00288366|75732506|FG001|COMPLETED|Overall Study||26||
59806433|NCT00427960|75928139|FG001|COMPLETED|Overall Study||21||
59806434|NCT00427960|75928138|FG000|NOT COMPLETED|Overall Study||2||
59806435|NCT00427960|75928139|FG001|NOT COMPLETED|Overall Study||4||
59959619|NCT01316939|76078277|FG001|NOT COMPLETED|Overall Study||68||
59959620|NCT01316939|76078278|FG002|NOT COMPLETED|Overall Study||69||
59959621|NCT03044249|76078288|FG000|STARTED|Overall Study||42||
59959622|NCT03044249|76078289|FG001|STARTED|Overall Study||39||
59959623|NCT03044249|76078288|FG000|Received at Least One Dose of Study Drug|Overall Study||42||
59959624|NCT03044249|76078289|FG001|Received at Least One Dose of Study Drug|Overall Study||39||
59959625|NCT03044249|76078288|FG000|COMPLETED|Overall Study||32||
59959626|NCT03044249|76078289|FG001|COMPLETED|Overall Study||25||
59959627|NCT03044249|76078288|FG000|NOT COMPLETED|Overall Study||10||
59959628|NCT03044249|76078289|FG001|NOT COMPLETED|Overall Study||14||
59959629|NCT02704130|76078302|FG000|STARTED|Overall Study||5||
59959630|NCT02704130|76078303|FG001|STARTED|Overall Study||3||
59959631|NCT02704130|76078302|FG000|COMPLETED|Overall Study||0||
59959632|NCT02704130|76078303|FG001|COMPLETED|Overall Study||0||
59959633|NCT02704130|76078302|FG000|NOT COMPLETED|Overall Study||5||
59959634|NCT02704130|76078303|FG001|NOT COMPLETED|Overall Study||3||
59959635|NCT03740009|76078309|FG000|STARTED|Overall Study||20||
59959636|NCT03740009|76078309|FG000|Consented|Overall Study||20||
59959637|NCT03740009|76078309|FG000|Received Intervention|Overall Study||10||
60074022|NCT01838642|76189395|FG000|NOT COMPLETED|Overall Study||1||
59621001|NCT00288366|75732505|FG000|NOT COMPLETED|Overall Study||0||
59621002|NCT00288366|75732506|FG001|NOT COMPLETED|Overall Study||0||
59621003|NCT00288600|75732514|FG000|STARTED|Overall Study||46||
59621004|NCT00288600|75732515|FG001|STARTED|Overall Study||46||
59621005|NCT00288600|75732514|FG000|COMPLETED|Overall Study||46||
59621006|NCT00288600|75732515|FG001|COMPLETED|Overall Study||46||
59621007|NCT00288600|75732514|FG000|NOT COMPLETED|Overall Study||0||
59621008|NCT00288600|75732515|FG001|NOT COMPLETED|Overall Study||0||
59621009|NCT00290472|75732524|FG000|STARTED|Overall Study||32||
59621010|NCT00290472|75732525|FG001|STARTED|Overall Study||39||
59621011|NCT00290472|75732526|FG002|STARTED|Overall Study||18||
59959638|NCT03740009|76078309|FG000|COMPLETED|Overall Study||10||
59959639|NCT03740009|76078309|FG000|NOT COMPLETED|Overall Study||10||
59959640|NCT03649217|76078313|FG000|STARTED|Overall Study||23||
59959641|NCT03649217|76078313|FG000|COMPLETED|Overall Study||21||
59959642|NCT03649217|76078313|FG000|NOT COMPLETED|Overall Study||2||
59959643|NCT03564353|76078321|FG000|STARTED|Overall Study||10||
59959644|NCT03564353|76078322|FG001|STARTED|Overall Study||10||
59806436|NCT00548340|75928148|FG000|STARTED|Overall Study||109||
59806437|NCT00548340|75928149|FG001|STARTED|Overall Study||109||
59806438|NCT00548340|75928150|FG002|STARTED|Overall Study||104||
59806439|NCT00548340|75928148|FG000|COMPLETED|Overall Study||101||
59806440|NCT00548340|75928149|FG001|COMPLETED|Overall Study||98||
59806441|NCT00548340|75928150|FG002|COMPLETED|Overall Study||95||
59806442|NCT00548340|75928148|FG000|NOT COMPLETED|Overall Study||8||
59806443|NCT00548340|75928149|FG001|NOT COMPLETED|Overall Study||11||
59806444|NCT00548340|75928150|FG002|NOT COMPLETED|Overall Study||9||
59959645|NCT03564353|76078323|FG002|STARTED|Overall Study||10||
59959646|NCT03564353|76078324|FG003|STARTED|Overall Study||10||
59959647|NCT03564353|76078321|FG000|COMPLETED|Overall Study||10||
59959648|NCT03564353|76078322|FG001|COMPLETED|Overall Study||10||
59959649|NCT03564353|76078323|FG002|COMPLETED|Overall Study||10||
59959650|NCT03564353|76078324|FG003|COMPLETED|Overall Study||10||
59959651|NCT03564353|76078321|FG000|NOT COMPLETED|Overall Study||0||
59959652|NCT03564353|76078322|FG001|NOT COMPLETED|Overall Study||0||
59959653|NCT03564353|76078323|FG002|NOT COMPLETED|Overall Study||0||
59959654|NCT03564353|76078324|FG003|NOT COMPLETED|Overall Study||0||
59959655|NCT03138889|76078342|FG000|STARTED|Overall Study||12||
59959656|NCT03138889|76078343|FG001|STARTED|Overall Study||23||
59959657|NCT03138889|76078344|FG002|STARTED|Overall Study||4||
59959658|NCT03138889|76078345|FG003|STARTED|Overall Study||7||
59959659|NCT03138889|76078346|FG004|STARTED|Overall Study||7||
59959660|NCT03138889|76078347|FG005|STARTED|Overall Study||75||
59959661|NCT03138889|76078348|FG006|STARTED|Overall Study||17||
59959662|NCT03138889|76078349|FG007|STARTED|Overall Study||17||
59959663|NCT03138889|76078342|FG000|COMPLETED|Overall Study||7||
59959664|NCT03138889|76078343|FG001|COMPLETED|Overall Study||18||
59959665|NCT03138889|76078344|FG002|COMPLETED|Overall Study||4||
59959666|NCT03138889|76078345|FG003|COMPLETED|Overall Study||5||
59959667|NCT03138889|76078346|FG004|COMPLETED|Overall Study||6||
59959668|NCT03138889|76078347|FG005|COMPLETED|Overall Study||72||
59806445|NCT00454246|75928161|FG000|STARTED|Overall Study||73||
59806446|NCT00454246|75928162|FG001|STARTED|Overall Study||29||
59806447|NCT00454246|75928163|FG002|STARTED|Overall Study||9||
59806448|NCT00454246|75928161|FG000|COMPLETED|Overall Study||0||
59806449|NCT00454246|75928162|FG001|COMPLETED|Overall Study||0||
59806450|NCT00454246|75928163|FG002|COMPLETED|Overall Study||0||
59806451|NCT00454246|75928161|FG000|NOT COMPLETED|Overall Study||73||
59806452|NCT00454246|75928162|FG001|NOT COMPLETED|Overall Study||29||
59806453|NCT00454246|75928163|FG002|NOT COMPLETED|Overall Study||9||
59806454|NCT00434590|75928173|FG000|STARTED|Overall Study||5||
59806455|NCT00434590|75928174|FG001|STARTED|Overall Study||5||
59806456|NCT00434590|75928173|FG000|COMPLETED|Overall Study|All patients randomized had study discontinued because of premature study termination.|0||
59806457|NCT00434590|75928174|FG001|COMPLETED|Overall Study||0||
59806458|NCT00434590|75928173|FG000|NOT COMPLETED|Overall Study||5||
59806459|NCT00434590|75928174|FG001|NOT COMPLETED|Overall Study||5||
59806460|NCT02891837|75928182|FG000|STARTED|Overall Study||99||
59806461|NCT02891837|75928183|FG001|STARTED|Overall Study||90||
59806462|NCT02891837|75928182|FG000|COMPLETED|Overall Study||96||
59806463|NCT02891837|75928183|FG001|COMPLETED|Overall Study||90||
59806464|NCT02891837|75928182|FG000|NOT COMPLETED|Overall Study||3||
59806465|NCT02891837|75928183|FG001|NOT COMPLETED|Overall Study||0||
59806466|NCT00695903|75928207|FG000|STARTED|Had End of Therapy (EOT) Assessment||19||
59959669|NCT03138889|76078348|FG006|COMPLETED|Overall Study||17||
59959670|NCT03138889|76078349|FG007|COMPLETED|Overall Study||16||
59959671|NCT03138889|76078342|FG000|NOT COMPLETED|Overall Study||5||
59959672|NCT03138889|76078343|FG001|NOT COMPLETED|Overall Study||5||
59959673|NCT03138889|76078344|FG002|NOT COMPLETED|Overall Study||0||
60074023|NCT01611194|76189402|FG000|STARTED|Overall Study||36||
59806467|NCT00695903|75928208|FG001|STARTED|Had End of Therapy (EOT) Assessment||19||
59806468|NCT00695903|75928207|FG000|Met Continuation Criteria|Had End of Therapy (EOT) Assessment||9||
59959674|NCT03138889|76078345|FG003|NOT COMPLETED|Overall Study||2||
59959675|NCT03138889|76078346|FG004|NOT COMPLETED|Overall Study||1||
59959676|NCT03138889|76078347|FG005|NOT COMPLETED|Overall Study||3||
59959677|NCT03138889|76078348|FG006|NOT COMPLETED|Overall Study||0||
59959678|NCT03138889|76078349|FG007|NOT COMPLETED|Overall Study||1||
59806469|NCT00695903|75928208|FG001|Met Continuation Criteria|Had End of Therapy (EOT) Assessment||6||
59806470|NCT00695903|75928207|FG000|COMPLETED|Had End of Therapy (EOT) Assessment||7||
59806471|NCT00695903|75928208|FG001|COMPLETED|Had End of Therapy (EOT) Assessment||4||
59959679|NCT01881763|76078371|FG000|STARTED|Overall Study||16||
59959680|NCT01881763|76078372|FG001|STARTED|Overall Study||15||
59959681|NCT01881763|76078371|FG000|COMPLETED|Overall Study||10||
59959682|NCT01881763|76078372|FG001|COMPLETED|Overall Study||11||
59959683|NCT01881763|76078371|FG000|NOT COMPLETED|Overall Study||6||
59959684|NCT01881763|76078372|FG001|NOT COMPLETED|Overall Study||4||
59959685|NCT03541499|76078382|FG000|STARTED|Overall Study||15||
59959686|NCT03541499|76078383|FG001|STARTED|Overall Study||15||
59959687|NCT03541499|76078384|FG002|STARTED|Overall Study||5||
59959688|NCT03541499|76078385|FG003|STARTED|Overall Study||15||
59959689|NCT03541499|76078382|FG000|COMPLETED|Overall Study||15||
59959690|NCT03541499|76078383|FG001|COMPLETED|Overall Study||15||
59959691|NCT03541499|76078384|FG002|COMPLETED|Overall Study||5||
59959692|NCT03541499|76078385|FG003|COMPLETED|Overall Study||15||
59959693|NCT03541499|76078382|FG000|NOT COMPLETED|Overall Study||0||
59959694|NCT03541499|76078383|FG001|NOT COMPLETED|Overall Study||0||
59959695|NCT03541499|76078384|FG002|NOT COMPLETED|Overall Study||0||
59959696|NCT03541499|76078385|FG003|NOT COMPLETED|Overall Study||0||
59959697|NCT02706392|76078401|FG000|STARTED|Overall Study||2||
59959698|NCT02706392|76078402|FG001|STARTED|Overall Study||1||
59959699|NCT02706392|76078403|FG002|STARTED|Overall Study||2||
59959700|NCT02706392|76078404|FG003|STARTED|Overall Study||3||
59959701|NCT02706392|76078405|FG004|STARTED|Overall Study||11||
59959702|NCT02706392|76078406|FG005|STARTED|Overall Study||2||
59959703|NCT02706392|76078401|FG000|COMPLETED|Overall Study||1||
59959704|NCT02706392|76078402|FG001|COMPLETED|Overall Study||1||
59959705|NCT02706392|76078403|FG002|COMPLETED|Overall Study||0||
59959706|NCT02706392|76078404|FG003|COMPLETED|Overall Study||1||
59959707|NCT02706392|76078405|FG004|COMPLETED|Overall Study||6||
59959708|NCT02706392|76078406|FG005|COMPLETED|Overall Study||0||
59806472|NCT00695903|75928207|FG000|NOT COMPLETED|Had End of Therapy (EOT) Assessment||12||
59806473|NCT00695903|75928208|FG001|NOT COMPLETED|Had End of Therapy (EOT) Assessment||15||
59806474|NCT00695903|75928207|FG000|STARTED|Had Test of Cure (TOC) Assessment||7||
59806475|NCT00695903|75928208|FG001|STARTED|Had Test of Cure (TOC) Assessment||4||
59806476|NCT00695903|75928207|FG000|COMPLETED|Had Test of Cure (TOC) Assessment||5||
59806477|NCT00695903|75928208|FG001|COMPLETED|Had Test of Cure (TOC) Assessment||3||
59959709|NCT02706392|76078401|FG000|NOT COMPLETED|Overall Study||1||
59959710|NCT02706392|76078402|FG001|NOT COMPLETED|Overall Study||0||
59959711|NCT02706392|76078403|FG002|NOT COMPLETED|Overall Study||2||
59959712|NCT02706392|76078404|FG003|NOT COMPLETED|Overall Study||2||
59959713|NCT02706392|76078405|FG004|NOT COMPLETED|Overall Study||5||
59959714|NCT02706392|76078406|FG005|NOT COMPLETED|Overall Study||2||
59959715|NCT03042767|76078422|FG000|STARTED|Overall Study||12||
59959716|NCT03042767|76078423|FG001|STARTED|Overall Study||13||
59959717|NCT03042767|76078422|FG000|COMPLETED|Overall Study||11||
59806478|NCT00695903|75928207|FG000|NOT COMPLETED|Had Test of Cure (TOC) Assessment||2||
59806479|NCT00695903|75928208|FG001|NOT COMPLETED|Had Test of Cure (TOC) Assessment||1||
59806480|NCT00548262|75928214|FG000|STARTED|Overall Study|1 participant (N) had death recorded twice; reported as 1 death in reason for discontinuation (D/C)|54||
59806481|NCT00548262|75928214|FG000|COMPLETED|Overall Study|1 N had D/C recorded as died and as lack of efficacy; reported as lack of efficacy in reason for D/C|22||
59806482|NCT00548262|75928214|FG000|NOT COMPLETED|Overall Study||32||
59806483|NCT00095173|75928218|FG000|STARTED|Open-Label Lead-In Phase (Period A)||190||
59806484|NCT00095173|75928219|FG001|STARTED|Open-Label Lead-In Phase (Period A)||0||
59806485|NCT00095173|75928220|FG002|STARTED|Open-Label Lead-In Phase (Period A)||0||
59806486|NCT00095173|75928221|FG003|STARTED|Open-Label Lead-In Phase (Period A)||0||
59806487|NCT00095173|75928222|FG004|STARTED|Open-Label Lead-In Phase (Period A)||0||
59806488|NCT00095173|75928223|FG005|STARTED|Open-Label Lead-In Phase (Period A)||0||
59806489|NCT00095173|75928218|FG000|COMPLETED|Open-Label Lead-In Phase (Period A)||170||
59806490|NCT00095173|75928219|FG001|COMPLETED|Open-Label Lead-In Phase (Period A)||0||
59806491|NCT00095173|75928220|FG002|COMPLETED|Open-Label Lead-In Phase (Period A)||0||
59806492|NCT00095173|75928221|FG003|COMPLETED|Open-Label Lead-In Phase (Period A)||0||
59959718|NCT03042767|76078423|FG001|COMPLETED|Overall Study||11||
59959719|NCT03042767|76078422|FG000|NOT COMPLETED|Overall Study||1||
59959720|NCT03042767|76078423|FG001|NOT COMPLETED|Overall Study||2||
59959721|NCT00703820|76078431|FG000|STARTED|Overall Study||133||
59959722|NCT00703820|76078432|FG001|STARTED|Overall Study||129||
59959723|NCT00703820|76078431|FG000|COMPLETED|Overall Study||98|"For purposes of this report, a living subject *completes* the study three years after completion of therapy and the study is considered *complete* when all participants have died, been taken off study, or completed the study."|
59959724|NCT00703820|76078432|FG001|COMPLETED|Overall Study||95|"For purposes of this report, a living subject *completes* the study three years after completion of therapy and the study is considered *complete* when all participants have died, been taken off study, or completed the study."|
59959725|NCT00703820|76078431|FG000|NOT COMPLETED|Overall Study||35||
59959726|NCT00703820|76078432|FG001|NOT COMPLETED|Overall Study||34||
59806493|NCT00095173|75928222|FG004|COMPLETED|Open-Label Lead-In Phase (Period A)||0||
59806494|NCT00095173|75928223|FG005|COMPLETED|Open-Label Lead-In Phase (Period A)||0||
59806495|NCT00095173|75928218|FG000|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||20||
59806496|NCT00095173|75928219|FG001|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0||
59806497|NCT00095173|75928220|FG002|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0||
59806498|NCT00095173|75928221|FG003|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0||
59959727|NCT03045887|76078450|FG000|STARTED|Part A, Period (1 Day)||7||
59959728|NCT03045887|76078451|FG001|STARTED|Part A, Period (1 Day)||4||
59959729|NCT03045887|76078452|FG002|STARTED|Part A, Period (1 Day)||5||
59806499|NCT00095173|75928222|FG004|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0||
59806500|NCT00095173|75928223|FG005|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0||
59806501|NCT00095173|75928218|FG000|STARTED|Double-Blind Phase (Period B)|All participants did not continue; responders entered Period B; non-responders re-entered Period C.|0||
59806502|NCT00095173|75928219|FG001|STARTED|Double-Blind Phase (Period B)|123 responders from Period A qualified;122 entered and were randomized to abatacept and placebo.|60||
59806503|NCT00095173|75928220|FG002|STARTED|Double-Blind Phase (Period B)|123 responders from Period A qualified;122 entered and were randomized to abatacept and placebo.|62||
59806504|NCT00095173|75928221|FG003|STARTED|Double-Blind Phase (Period B)||0||
59806505|NCT00095173|75928222|FG004|STARTED|Double-Blind Phase (Period B)||0||
59806506|NCT00095173|75928223|FG005|STARTED|Double-Blind Phase (Period B)||0||
59806507|NCT00095173|75928218|FG000|COMPLETED|Double-Blind Phase (Period B)||0||
59806508|NCT00095173|75928219|FG001|COMPLETED|Double-Blind Phase (Period B)||49||
59806509|NCT00095173|75928220|FG002|COMPLETED|Double-Blind Phase (Period B)||31||
59806510|NCT00095173|75928221|FG003|COMPLETED|Double-Blind Phase (Period B)||0||
59806511|NCT00095173|75928222|FG004|COMPLETED|Double-Blind Phase (Period B)||0||
59806512|NCT00095173|75928223|FG005|COMPLETED|Double-Blind Phase (Period B)||0||
59959730|NCT03045887|76078453|FG003|STARTED|Part A, Period (1 Day)||5||
59959731|NCT03045887|76078454|FG004|STARTED|Part A, Period (1 Day)||4||
59959732|NCT03045887|76078455|FG005|STARTED|Part A, Period (1 Day)||4||
59959733|NCT03045887|76078456|FG006|STARTED|Part A, Period (1 Day)||4||
59959734|NCT03045887|76078457|FG007|STARTED|Part A, Period (1 Day)||4||
59959735|NCT03045887|76078458|FG008|STARTED|Part A, Period (1 Day)||0||
59959736|NCT03045887|76078459|FG009|STARTED|Part A, Period (1 Day)||0||
59959737|NCT03045887|76078450|FG000|COMPLETED|Part A, Period (1 Day)||7||
59959738|NCT03045887|76078451|FG001|COMPLETED|Part A, Period (1 Day)||4||
59959739|NCT03045887|76078452|FG002|COMPLETED|Part A, Period (1 Day)||5||
59959740|NCT03045887|76078453|FG003|COMPLETED|Part A, Period (1 Day)||5||
59959741|NCT03045887|76078454|FG004|COMPLETED|Part A, Period (1 Day)||4||
59959742|NCT03045887|76078455|FG005|COMPLETED|Part A, Period (1 Day)||4||
59959743|NCT03045887|76078456|FG006|COMPLETED|Part A, Period (1 Day)||4||
59959744|NCT03045887|76078457|FG007|COMPLETED|Part A, Period (1 Day)||4||
59959745|NCT03045887|76078458|FG008|COMPLETED|Part A, Period (1 Day)||0||
59959746|NCT03045887|76078459|FG009|COMPLETED|Part A, Period (1 Day)||0||
59959747|NCT03045887|76078450|FG000|NOT COMPLETED|Part A, Period (1 Day)||0||
59959748|NCT03045887|76078451|FG001|NOT COMPLETED|Part A, Period (1 Day)||0||
59959749|NCT03045887|76078452|FG002|NOT COMPLETED|Part A, Period (1 Day)||0||
59959750|NCT03045887|76078453|FG003|NOT COMPLETED|Part A, Period (1 Day)||0||
59959751|NCT03045887|76078454|FG004|NOT COMPLETED|Part A, Period (1 Day)||0||
59959752|NCT03045887|76078455|FG005|NOT COMPLETED|Part A, Period (1 Day)||0||
59959753|NCT03045887|76078456|FG006|NOT COMPLETED|Part A, Period (1 Day)||0||
59959754|NCT03045887|76078457|FG007|NOT COMPLETED|Part A, Period (1 Day)||0||
59959755|NCT03045887|76078458|FG008|NOT COMPLETED|Part A, Period (1 Day)||0||
59959756|NCT03045887|76078459|FG009|NOT COMPLETED|Part A, Period (1 Day)||0||
59959757|NCT03045887|76078450|FG000|STARTED|Part A,Washout Period 1(4 Weeks)||7||
59959758|NCT03045887|76078451|FG001|STARTED|Part A,Washout Period 1(4 Weeks)||4||
59959759|NCT03045887|76078452|FG002|STARTED|Part A,Washout Period 1(4 Weeks)||5||
59959760|NCT03045887|76078453|FG003|STARTED|Part A,Washout Period 1(4 Weeks)||5||
59959761|NCT03045887|76078454|FG004|STARTED|Part A,Washout Period 1(4 Weeks)||4||
59959762|NCT03045887|76078455|FG005|STARTED|Part A,Washout Period 1(4 Weeks)||4||
59959763|NCT03045887|76078456|FG006|STARTED|Part A,Washout Period 1(4 Weeks)||4||
59959764|NCT03045887|76078457|FG007|STARTED|Part A,Washout Period 1(4 Weeks)||4||
59959765|NCT03045887|76078458|FG008|STARTED|Part A,Washout Period 1(4 Weeks)||0||
59959766|NCT03045887|76078459|FG009|STARTED|Part A,Washout Period 1(4 Weeks)||0||
59959767|NCT03045887|76078450|FG000|COMPLETED|Part A,Washout Period 1(4 Weeks)||4||
59959768|NCT03045887|76078451|FG001|COMPLETED|Part A,Washout Period 1(4 Weeks)||4||
59959769|NCT03045887|76078452|FG002|COMPLETED|Part A,Washout Period 1(4 Weeks)||5||
59959770|NCT03045887|76078453|FG003|COMPLETED|Part A,Washout Period 1(4 Weeks)||4||
59959771|NCT03045887|76078454|FG004|COMPLETED|Part A,Washout Period 1(4 Weeks)||4||
59806513|NCT00095173|75928218|FG000|NOT COMPLETED|Double-Blind Phase (Period B)||0||
59806514|NCT00095173|75928219|FG001|NOT COMPLETED|Double-Blind Phase (Period B)||11||
59806515|NCT00095173|75928220|FG002|NOT COMPLETED|Double-Blind Phase (Period B)||31||
59959772|NCT03045887|76078455|FG005|COMPLETED|Part A,Washout Period 1(4 Weeks)||4||
59959773|NCT03045887|76078456|FG006|COMPLETED|Part A,Washout Period 1(4 Weeks)||4||
59959774|NCT03045887|76078457|FG007|COMPLETED|Part A,Washout Period 1(4 Weeks)||4||
59959775|NCT03045887|76078458|FG008|COMPLETED|Part A,Washout Period 1(4 Weeks)||0||
59959776|NCT03045887|76078459|FG009|COMPLETED|Part A,Washout Period 1(4 Weeks)||0||
59959777|NCT03045887|76078450|FG000|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||3||
59959778|NCT03045887|76078451|FG001|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0||
59959779|NCT03045887|76078452|FG002|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0||
59959780|NCT03045887|76078453|FG003|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||1||
59959781|NCT03045887|76078454|FG004|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0||
59959782|NCT03045887|76078455|FG005|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0||
59959783|NCT03045887|76078456|FG006|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0||
59959784|NCT03045887|76078457|FG007|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0||
59959785|NCT03045887|76078458|FG008|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0||
59959786|NCT03045887|76078459|FG009|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0||
59959787|NCT03045887|76078450|FG000|STARTED|Part A, Period 2 (1 Day)||4||
59959788|NCT03045887|76078451|FG001|STARTED|Part A, Period 2 (1 Day)||4||
59959789|NCT03045887|76078452|FG002|STARTED|Part A, Period 2 (1 Day)||5||
59959790|NCT03045887|76078453|FG003|STARTED|Part A, Period 2 (1 Day)||4||
59959791|NCT03045887|76078454|FG004|STARTED|Part A, Period 2 (1 Day)||4||
59959792|NCT03045887|76078455|FG005|STARTED|Part A, Period 2 (1 Day)||4||
59959793|NCT03045887|76078456|FG006|STARTED|Part A, Period 2 (1 Day)||4||
59959794|NCT03045887|76078457|FG007|STARTED|Part A, Period 2 (1 Day)||4||
59959795|NCT03045887|76078458|FG008|STARTED|Part A, Period 2 (1 Day)||0||
59959796|NCT03045887|76078459|FG009|STARTED|Part A, Period 2 (1 Day)||0||
59959797|NCT03045887|76078450|FG000|COMPLETED|Part A, Period 2 (1 Day)||3||
59959798|NCT03045887|76078451|FG001|COMPLETED|Part A, Period 2 (1 Day)||4||
59959799|NCT03045887|76078452|FG002|COMPLETED|Part A, Period 2 (1 Day)||5||
59959800|NCT03045887|76078453|FG003|COMPLETED|Part A, Period 2 (1 Day)||4||
59959801|NCT03045887|76078454|FG004|COMPLETED|Part A, Period 2 (1 Day)||4||
59959802|NCT03045887|76078455|FG005|COMPLETED|Part A, Period 2 (1 Day)||4||
59959803|NCT03045887|76078456|FG006|COMPLETED|Part A, Period 2 (1 Day)||4||
59959804|NCT03045887|76078457|FG007|COMPLETED|Part A, Period 2 (1 Day)||4||
59959805|NCT03045887|76078458|FG008|COMPLETED|Part A, Period 2 (1 Day)||0||
59959806|NCT03045887|76078459|FG009|COMPLETED|Part A, Period 2 (1 Day)||0||
59959807|NCT03045887|76078450|FG000|NOT COMPLETED|Part A, Period 2 (1 Day)||1||
59959808|NCT03045887|76078451|FG001|NOT COMPLETED|Part A, Period 2 (1 Day)||0||
59806516|NCT00095173|75928221|FG003|NOT COMPLETED|Double-Blind Phase (Period B)||0||
59806517|NCT00095173|75928222|FG004|NOT COMPLETED|Double-Blind Phase (Period B)||0||
59806518|NCT00095173|75928223|FG005|NOT COMPLETED|Double-Blind Phase (Period B)||0||
59959809|NCT03045887|76078452|FG002|NOT COMPLETED|Part A, Period 2 (1 Day)||0||
59959810|NCT03045887|76078453|FG003|NOT COMPLETED|Part A, Period 2 (1 Day)||0||
59959811|NCT03045887|76078454|FG004|NOT COMPLETED|Part A, Period 2 (1 Day)||0||
59959812|NCT03045887|76078455|FG005|NOT COMPLETED|Part A, Period 2 (1 Day)||0||
59959813|NCT03045887|76078456|FG006|NOT COMPLETED|Part A, Period 2 (1 Day)||0||
59959814|NCT03045887|76078457|FG007|NOT COMPLETED|Part A, Period 2 (1 Day)||0||
59959815|NCT03045887|76078458|FG008|NOT COMPLETED|Part A, Period 2 (1 Day)||0||
59959816|NCT03045887|76078459|FG009|NOT COMPLETED|Part A, Period 2 (1 Day)||0||
59959817|NCT03045887|76078450|FG000|STARTED|Part A,Washout Period 2 (4 Weeks)||3||
59959818|NCT03045887|76078451|FG001|STARTED|Part A,Washout Period 2 (4 Weeks)||4||
59959819|NCT03045887|76078452|FG002|STARTED|Part A,Washout Period 2 (4 Weeks)||5||
59806519|NCT00095173|75928218|FG000|STARTED|Open-Label Extension Phase (Period C)||0||
59806520|NCT00095173|75928219|FG001|STARTED|Open-Label Extension Phase (Period C)||0||
59806521|NCT00095173|75928220|FG002|STARTED|Open-Label Extension Phase (Period C)||0||
59806522|NCT00095173|75928221|FG003|STARTED|Open-Label Extension Phase (Period C)|Participants were non-responders from Period A who re-entered in Period C.|36||
59806523|NCT00095173|75928222|FG004|STARTED|Open-Label Extension Phase (Period C)|Includes 47 who completed Period B with no flare and 11 who discontinued Period B due to a flare|58||
59806524|NCT00095173|75928223|FG005|STARTED|Open-Label Extension Phase (Period C)|Includes 33 who discontinued Period B due to a flare and 26 who completed Period B with no flare|59||
59806525|NCT00095173|75928218|FG000|COMPLETED|Open-Label Extension Phase (Period C)||0||
59806526|NCT00095173|75928219|FG001|COMPLETED|Open-Label Extension Phase (Period C)||0||
59806527|NCT00095173|75928220|FG002|COMPLETED|Open-Label Extension Phase (Period C)||0||
59806528|NCT00095173|75928221|FG003|COMPLETED|Open-Label Extension Phase (Period C)||13||
59806529|NCT00095173|75928222|FG004|COMPLETED|Open-Label Extension Phase (Period C)||29||
59806530|NCT00095173|75928223|FG005|COMPLETED|Open-Label Extension Phase (Period C)||27||
59806531|NCT00095173|75928218|FG000|NOT COMPLETED|Open-Label Extension Phase (Period C)||0||
59806532|NCT00095173|75928219|FG001|NOT COMPLETED|Open-Label Extension Phase (Period C)||0||
59806533|NCT00095173|75928220|FG002|NOT COMPLETED|Open-Label Extension Phase (Period C)||0||
59806534|NCT00095173|75928221|FG003|NOT COMPLETED|Open-Label Extension Phase (Period C)||23||
59806535|NCT00095173|75928222|FG004|NOT COMPLETED|Open-Label Extension Phase (Period C)||29||
59806536|NCT00095173|75928223|FG005|NOT COMPLETED|Open-Label Extension Phase (Period C)||32||
59806537|NCT00690443|75928239|FG000|STARTED|Overall Study||23||
59806538|NCT00690443|75928240|FG001|STARTED|Overall Study||21||
59806539|NCT00690443|75928239|FG000|COMPLETED|Overall Study||22||
59806540|NCT00690443|75928240|FG001|COMPLETED|Overall Study||19||
59806541|NCT00690443|75928239|FG000|NOT COMPLETED|Overall Study||1||
59959820|NCT03045887|76078453|FG003|STARTED|Part A,Washout Period 2 (4 Weeks)||4||
59959821|NCT03045887|76078454|FG004|STARTED|Part A,Washout Period 2 (4 Weeks)||4||
59959822|NCT03045887|76078455|FG005|STARTED|Part A,Washout Period 2 (4 Weeks)||4||
59959823|NCT03045887|76078456|FG006|STARTED|Part A,Washout Period 2 (4 Weeks)||4||
59806542|NCT00690443|75928240|FG001|NOT COMPLETED|Overall Study||2||
59806543|NCT03954834|75928250|FG000|STARTED|Overall Study||121||
59959824|NCT03045887|76078457|FG007|STARTED|Part A,Washout Period 2 (4 Weeks)||4||
59959825|NCT03045887|76078458|FG008|STARTED|Part A,Washout Period 2 (4 Weeks)||0||
59959826|NCT03045887|76078459|FG009|STARTED|Part A,Washout Period 2 (4 Weeks)||0||
59959827|NCT03045887|76078450|FG000|COMPLETED|Part A,Washout Period 2 (4 Weeks)||3||
59959828|NCT03045887|76078451|FG001|COMPLETED|Part A,Washout Period 2 (4 Weeks)||4||
59806544|NCT03954834|75928251|FG001|STARTED|Overall Study||121||
59806545|NCT03954834|75928252|FG002|STARTED|Overall Study||121||
59806546|NCT03954834|75928253|FG003|STARTED|Overall Study||115||
59806547|NCT03954834|75928250|FG000|Received at Least One Dose of Study Drug|Overall Study||121||
59806548|NCT03954834|75928251|FG001|Received at Least One Dose of Study Drug|Overall Study||121||
59806549|NCT03954834|75928252|FG002|Received at Least One Dose of Study Drug|Overall Study||121||
59806550|NCT03954834|75928253|FG003|Received at Least One Dose of Study Drug|Overall Study||115||
59806551|NCT03954834|75928250|FG000|COMPLETED|Overall Study||114||
59806552|NCT03954834|75928251|FG001|COMPLETED|Overall Study||112||
59806553|NCT03954834|75928252|FG002|COMPLETED|Overall Study||103||
59806554|NCT03954834|75928253|FG003|COMPLETED|Overall Study||99||
59806555|NCT03954834|75928250|FG000|NOT COMPLETED|Overall Study||7||
59806556|NCT03954834|75928251|FG001|NOT COMPLETED|Overall Study||9||
59806557|NCT03954834|75928252|FG002|NOT COMPLETED|Overall Study||18||
59959829|NCT03045887|76078452|FG002|COMPLETED|Part A,Washout Period 2 (4 Weeks)||4||
59959830|NCT03045887|76078453|FG003|COMPLETED|Part A,Washout Period 2 (4 Weeks)||2||
59959831|NCT03045887|76078454|FG004|COMPLETED|Part A,Washout Period 2 (4 Weeks)||4||
59959832|NCT03045887|76078455|FG005|COMPLETED|Part A,Washout Period 2 (4 Weeks)||4||
59959833|NCT03045887|76078456|FG006|COMPLETED|Part A,Washout Period 2 (4 Weeks)||4||
59959834|NCT03045887|76078457|FG007|COMPLETED|Part A,Washout Period 2 (4 Weeks)||4||
59959835|NCT03045887|76078458|FG008|COMPLETED|Part A,Washout Period 2 (4 Weeks)||0||
59959836|NCT03045887|76078459|FG009|COMPLETED|Part A,Washout Period 2 (4 Weeks)||0||
59959837|NCT03045887|76078450|FG000|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0||
59959838|NCT03045887|76078451|FG001|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0||
59959839|NCT03045887|76078452|FG002|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||1||
59959840|NCT03045887|76078453|FG003|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||2||
59959841|NCT03045887|76078454|FG004|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0||
59959842|NCT03045887|76078455|FG005|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0||
59959843|NCT03045887|76078456|FG006|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0||
59959844|NCT03045887|76078457|FG007|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0||
59959845|NCT03045887|76078458|FG008|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0||
59959846|NCT03045887|76078459|FG009|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0||
59959847|NCT03045887|76078450|FG000|STARTED|Part A, Period 3 (1 Day)||3||
59959848|NCT03045887|76078451|FG001|STARTED|Part A, Period 3 (1 Day)||4||
59959849|NCT03045887|76078452|FG002|STARTED|Part A, Period 3 (1 Day)||4||
59959850|NCT03045887|76078453|FG003|STARTED|Part A, Period 3 (1 Day)||2||
59959851|NCT03045887|76078454|FG004|STARTED|Part A, Period 3 (1 Day)||4||
59959852|NCT03045887|76078455|FG005|STARTED|Part A, Period 3 (1 Day)||4||
59959853|NCT03045887|76078456|FG006|STARTED|Part A, Period 3 (1 Day)||4||
59959854|NCT03045887|76078457|FG007|STARTED|Part A, Period 3 (1 Day)||4||
59959855|NCT03045887|76078458|FG008|STARTED|Part A, Period 3 (1 Day)||0||
59959856|NCT03045887|76078459|FG009|STARTED|Part A, Period 3 (1 Day)||0||
59959857|NCT03045887|76078450|FG000|COMPLETED|Part A, Period 3 (1 Day)||3||
59959858|NCT03045887|76078451|FG001|COMPLETED|Part A, Period 3 (1 Day)||4||
59959859|NCT03045887|76078452|FG002|COMPLETED|Part A, Period 3 (1 Day)||4||
59959860|NCT03045887|76078453|FG003|COMPLETED|Part A, Period 3 (1 Day)||2||
59959861|NCT03045887|76078454|FG004|COMPLETED|Part A, Period 3 (1 Day)||4||
59959862|NCT03045887|76078455|FG005|COMPLETED|Part A, Period 3 (1 Day)||4||
59959863|NCT03045887|76078456|FG006|COMPLETED|Part A, Period 3 (1 Day)||4||
59959864|NCT03045887|76078457|FG007|COMPLETED|Part A, Period 3 (1 Day)||4||
59959865|NCT03045887|76078458|FG008|COMPLETED|Part A, Period 3 (1 Day)||0||
59959866|NCT03045887|76078459|FG009|COMPLETED|Part A, Period 3 (1 Day)||0||
59806558|NCT03954834|75928253|FG003|NOT COMPLETED|Overall Study||16||
59806559|NCT00693017|75928265|FG000|STARTED|Overall Study||2||
59959867|NCT03045887|76078450|FG000|NOT COMPLETED|Part A, Period 3 (1 Day)||0||
59959868|NCT03045887|76078451|FG001|NOT COMPLETED|Part A, Period 3 (1 Day)||0||
59959869|NCT03045887|76078452|FG002|NOT COMPLETED|Part A, Period 3 (1 Day)||0||
59959870|NCT03045887|76078453|FG003|NOT COMPLETED|Part A, Period 3 (1 Day)||0||
59959871|NCT03045887|76078454|FG004|NOT COMPLETED|Part A, Period 3 (1 Day)||0||
59959872|NCT03045887|76078455|FG005|NOT COMPLETED|Part A, Period 3 (1 Day)||0||
59959873|NCT03045887|76078456|FG006|NOT COMPLETED|Part A, Period 3 (1 Day)||0||
59959874|NCT03045887|76078457|FG007|NOT COMPLETED|Part A, Period 3 (1 Day)||0||
60074024|NCT01611194|76189403|FG001|STARTED|Overall Study||35||
59806560|NCT00693017|75928266|FG001|STARTED|Overall Study||2||
59806561|NCT00693017|75928265|FG000|COMPLETED|Overall Study||0||
59806562|NCT00693017|75928266|FG001|COMPLETED|Overall Study||0||
59806563|NCT00693017|75928265|FG000|NOT COMPLETED|Overall Study||2||
59806564|NCT00693017|75928266|FG001|NOT COMPLETED|Overall Study||2||
59806565|NCT00692237|75928274|FG000|STARTED|Overall Study||30||
59806566|NCT00692237|75928275|FG001|STARTED|Overall Study||29||
59806567|NCT00692237|75928274|FG000|COMPLETED|Overall Study||29||
59806568|NCT00692237|75928275|FG001|COMPLETED|Overall Study||25||
59806569|NCT00692237|75928274|FG000|NOT COMPLETED|Overall Study||1||
59806570|NCT00692237|75928275|FG001|NOT COMPLETED|Overall Study||4||
59806571|NCT00110149|75928281|FG000|STARTED|Overall Study|total number that signed consent to be screened.|12||
59817877|NCT04488770|75940329|FG003|STARTED|Part 1-Cohort 2: Period 1 (Up to 5 Days)||0||
60074025|NCT01611194|76189402|FG000|COMPLETED|Overall Study||36||
59959875|NCT03045887|76078458|FG008|NOT COMPLETED|Part A, Period 3 (1 Day)||0||
59959876|NCT03045887|76078459|FG009|NOT COMPLETED|Part A, Period 3 (1 Day)||0||
59959877|NCT03045887|76078450|FG000|STARTED|Part B (14 Days)||0||
59959878|NCT03045887|76078451|FG001|STARTED|Part B (14 Days)||0||
59959879|NCT03045887|76078452|FG002|STARTED|Part B (14 Days)||0||
59959880|NCT03045887|76078453|FG003|STARTED|Part B (14 Days)||0||
59959881|NCT03045887|76078454|FG004|STARTED|Part B (14 Days)||0||
59959882|NCT03045887|76078455|FG005|STARTED|Part B (14 Days)||0||
59959883|NCT03045887|76078456|FG006|STARTED|Part B (14 Days)||0||
59959884|NCT03045887|76078457|FG007|STARTED|Part B (14 Days)||0||
59959885|NCT03045887|76078458|FG008|STARTED|Part B (14 Days)||3||
59959886|NCT03045887|76078459|FG009|STARTED|Part B (14 Days)||9||
59959887|NCT03045887|76078450|FG000|COMPLETED|Part B (14 Days)||0||
59959888|NCT03045887|76078451|FG001|COMPLETED|Part B (14 Days)||0||
59959889|NCT03045887|76078452|FG002|COMPLETED|Part B (14 Days)||0||
59959890|NCT03045887|76078453|FG003|COMPLETED|Part B (14 Days)||0||
59959891|NCT03045887|76078454|FG004|COMPLETED|Part B (14 Days)||0||
59959892|NCT03045887|76078455|FG005|COMPLETED|Part B (14 Days)||0||
59959893|NCT03045887|76078456|FG006|COMPLETED|Part B (14 Days)||0||
59959894|NCT03045887|76078457|FG007|COMPLETED|Part B (14 Days)||0||
59959895|NCT03045887|76078458|FG008|COMPLETED|Part B (14 Days)||3||
59959896|NCT03045887|76078459|FG009|COMPLETED|Part B (14 Days)||9||
59959897|NCT03045887|76078450|FG000|NOT COMPLETED|Part B (14 Days)||0||
59959898|NCT03045887|76078451|FG001|NOT COMPLETED|Part B (14 Days)||0||
59959899|NCT03045887|76078452|FG002|NOT COMPLETED|Part B (14 Days)||0||
59959900|NCT03045887|76078453|FG003|NOT COMPLETED|Part B (14 Days)||0||
59959901|NCT03045887|76078454|FG004|NOT COMPLETED|Part B (14 Days)||0||
59959902|NCT03045887|76078455|FG005|NOT COMPLETED|Part B (14 Days)||0||
59959903|NCT03045887|76078456|FG006|NOT COMPLETED|Part B (14 Days)||0||
59959904|NCT03045887|76078457|FG007|NOT COMPLETED|Part B (14 Days)||0||
59959905|NCT03045887|76078458|FG008|NOT COMPLETED|Part B (14 Days)||0||
59959906|NCT03045887|76078459|FG009|NOT COMPLETED|Part B (14 Days)||0||
59806572|NCT00110149|75928281|FG000|Received Treatment|Overall Study|total number of patient that passed screening and received treatment.|9||
59806573|NCT00110149|75928281|FG000|COMPLETED|Overall Study||9||
59806574|NCT00110149|75928281|FG000|NOT COMPLETED|Overall Study||3||
59806575|NCT03954444|75928289|FG000|STARTED|Overall Study||379||
59806576|NCT03954444|75928290|FG001|STARTED|Overall Study||382||
59806577|NCT03954444|75928291|FG002|STARTED|Overall Study||344||
59959907|NCT01564537|76078488|FG000|STARTED|Overall Study||360||
59959908|NCT01564537|76078489|FG001|STARTED|Overall Study||362||
59959909|NCT01564537|76078488|FG000|Intent-to-Treat (ITT) Population|Overall Study||360|ITT population was defined as all randomized participants.|
59959910|NCT01564537|76078489|FG001|Intent-to-Treat (ITT) Population|Overall Study||362|ITT population was defined as all randomized participants.|
59959911|NCT01564537|76078488|FG000|Safety Population|Overall Study||361|Safety population included all randomized participants who received at least 1 dose of any study drug, regardless of their randomized treatment.|
59959912|NCT01564537|76078489|FG001|Safety Population|Overall Study||359|Safety population included all randomized participants who received at least 1 dose of any study drug, regardless of their randomized treatment.|
59959913|NCT01564537|76078488|FG000|Response Evaluable Population|Overall Study||345|Response-Evaluable population included all participants who received at least 1 dose of study drug, had measurable disease at baseline, and at least 1 post-baseline response assessment.|
59959914|NCT01564537|76078489|FG001|Response Evaluable Population|Overall Study||348|Response-Evaluable population included all participants who received at least 1 dose of study drug, had measurable disease at baseline, and at least 1 post-baseline response assessment.|
59959915|NCT01564537|76078488|FG000|COMPLETED|Overall Study||259||
59959916|NCT01564537|76078489|FG001|COMPLETED|Overall Study||263||
59959917|NCT01564537|76078488|FG000|NOT COMPLETED|Overall Study||101||
59959918|NCT01564537|76078489|FG001|NOT COMPLETED|Overall Study||99||
59959919|NCT03042611|76078500|FG000|STARTED|Core Phase||308||
59959920|NCT03042611|76078501|FG001|STARTED|Core Phase||152||
59959921|NCT03042611|76078502|FG002|STARTED|Core Phase||0||
59959922|NCT03042611|76078503|FG003|STARTED|Core Phase||0||
59959923|NCT03042611|76078500|FG000|Received at Least 1 Dose of Study Drug|Core Phase||307||
59959924|NCT03042611|76078501|FG001|Received at Least 1 Dose of Study Drug|Core Phase||151||
59959925|NCT03042611|76078502|FG002|Received at Least 1 Dose of Study Drug|Core Phase||0||
59959926|NCT03042611|76078503|FG003|Received at Least 1 Dose of Study Drug|Core Phase||0||
59806578|NCT03954444|75928289|FG000|COMPLETED|Overall Study||366||
59806579|NCT03954444|75928290|FG001|COMPLETED|Overall Study||366||
59959927|NCT03042611|76078500|FG000|COMPLETED|Core Phase||52||
59959928|NCT03042611|76078501|FG001|COMPLETED|Core Phase||28||
59806580|NCT03954444|75928291|FG002|COMPLETED|Overall Study||327||
59806581|NCT03954444|75928289|FG000|NOT COMPLETED|Overall Study||13||
59806582|NCT03954444|75928290|FG001|NOT COMPLETED|Overall Study||16||
59806583|NCT03954444|75928291|FG002|NOT COMPLETED|Overall Study||17||
59806584|NCT03953820|75928299|FG000|STARTED|Two-Sequence, Two-Way Crossover||15||
59806585|NCT03953820|75928300|FG001|STARTED|Two-Sequence, Two-Way Crossover||16||
59806586|NCT03953820|75928301|FG002|STARTED|Two-Sequence, Two-Way Crossover||0||
59806587|NCT03953820|75928299|FG000|COMPLETED|Two-Sequence, Two-Way Crossover||13||
59959929|NCT03042611|76078502|FG002|COMPLETED|Core Phase||0||
59959930|NCT03042611|76078503|FG003|COMPLETED|Core Phase||0||
59959931|NCT03042611|76078500|FG000|NOT COMPLETED|Core Phase||256||
59959932|NCT03042611|76078501|FG001|NOT COMPLETED|Core Phase||124||
59959933|NCT03042611|76078502|FG002|NOT COMPLETED|Core Phase||0||
59959934|NCT03042611|76078503|FG003|NOT COMPLETED|Core Phase||0||
59959935|NCT03042611|76078500|FG000|STARTED|Extension Phase||0||
59959936|NCT03042611|76078501|FG001|STARTED|Extension Phase||0||
59959937|NCT03042611|76078502|FG002|STARTED|Extension Phase||52||
59959938|NCT03042611|76078503|FG003|STARTED|Extension Phase||28||
59959939|NCT03042611|76078500|FG000|COMPLETED|Extension Phase||0||
59806588|NCT03953820|75928300|FG001|COMPLETED|Two-Sequence, Two-Way Crossover||16||
59806589|NCT03953820|75928301|FG002|COMPLETED|Two-Sequence, Two-Way Crossover||0||
59806590|NCT03953820|75928299|FG000|NOT COMPLETED|Two-Sequence, Two-Way Crossover||2||
59806591|NCT03953820|75928300|FG001|NOT COMPLETED|Two-Sequence, Two-Way Crossover||0||
59806592|NCT03953820|75928301|FG002|NOT COMPLETED|Two-Sequence, Two-Way Crossover||0||
59806593|NCT03953820|75928299|FG000|STARTED|DBF Following High-Fat Meal|This arm did not continue in Period 2.|0||
59806594|NCT03953820|75928300|FG001|STARTED|DBF Following High-Fat Meal|This arm did not continue in Period 2.|0||
59806595|NCT03953820|75928301|FG002|STARTED|DBF Following High-Fat Meal|Participants in Period 2 completed 1 of the 2 arms in Period 1 and volunteered to continue.|10||
59806596|NCT03953820|75928299|FG000|COMPLETED|DBF Following High-Fat Meal||0||
59806597|NCT03953820|75928300|FG001|COMPLETED|DBF Following High-Fat Meal||0||
59806598|NCT03953820|75928301|FG002|COMPLETED|DBF Following High-Fat Meal||10||
59806599|NCT03953820|75928299|FG000|NOT COMPLETED|DBF Following High-Fat Meal||0||
59806600|NCT03953820|75928300|FG001|NOT COMPLETED|DBF Following High-Fat Meal||0||
59806601|NCT03953820|75928301|FG002|NOT COMPLETED|DBF Following High-Fat Meal||0||
59806602|NCT00117949|75928318|FG000|STARTED|Overall Study|Dose level terminated prematurely due to inadequate testosterone response|10||
59806603|NCT00117949|75928319|FG001|STARTED|Overall Study||24||
59959940|NCT03042611|76078501|FG001|COMPLETED|Extension Phase||0||
59959941|NCT03042611|76078502|FG002|COMPLETED|Extension Phase||0||
59959942|NCT03042611|76078503|FG003|COMPLETED|Extension Phase||0||
59959943|NCT03042611|76078500|FG000|NOT COMPLETED|Extension Phase||0||
59959944|NCT03042611|76078501|FG001|NOT COMPLETED|Extension Phase||0||
59959945|NCT03042611|76078502|FG002|NOT COMPLETED|Extension Phase||52||
59959946|NCT03042611|76078503|FG003|NOT COMPLETED|Extension Phase||28||
59959947|NCT02701634|76078511|FG000|STARTED|Overall Study||33||
59959948|NCT02701634|76078512|FG001|STARTED|Overall Study||33||
59959949|NCT02701634|76078511|FG000|COMPLETED|Overall Study||1||
59959950|NCT02701634|76078512|FG001|COMPLETED|Overall Study||2||
59959951|NCT02701634|76078511|FG000|NOT COMPLETED|Overall Study||32||
59959952|NCT02701634|76078512|FG001|NOT COMPLETED|Overall Study||31||
59959953|NCT02442765|76078522|FG000|STARTED|Stage 1- (Days 1 to 42)||194||
59806604|NCT00117949|75928320|FG002|STARTED|Overall Study||24||
59806605|NCT00117949|75928321|FG003|STARTED|Overall Study||24||
59806606|NCT00117949|75928318|FG000|COMPLETED|Overall Study||0||
59806607|NCT00117949|75928319|FG001|COMPLETED|Overall Study||0||
59806608|NCT00117949|75928320|FG002|COMPLETED|Overall Study||0||
59806609|NCT00117949|75928321|FG003|COMPLETED|Overall Study||0||
59806610|NCT00117949|75928318|FG000|NOT COMPLETED|Overall Study||10||
59806611|NCT00117949|75928319|FG001|NOT COMPLETED|Overall Study||24||
59806612|NCT00117949|75928320|FG002|NOT COMPLETED|Overall Study||24||
59959954|NCT02442765|76078523|FG001|STARTED|Stage 1- (Days 1 to 42)||96||
59806613|NCT00117949|75928321|FG003|NOT COMPLETED|Overall Study||24||
59959955|NCT02442765|76078524|FG002|STARTED|Stage 1- (Days 1 to 42)||97||
59959956|NCT02442765|76078525|FG003|STARTED|Stage 1- (Days 1 to 42)|For Stage 2, participants randomized to active treatment in Stage 1 (AVP-786-18 or AVP-786-28) continued to receive the same treatment and those randomized to placebo in Stage 1 were rerandomized to AVP-786-18, AVP-786-28, or placebo.|0||
59959957|NCT02442765|76078526|FG004|STARTED|Stage 1- (Days 1 to 42)||0||
59959958|NCT02442765|76078527|FG005|STARTED|Stage 1- (Days 1 to 42)||0||
59959959|NCT02442765|76078528|FG006|STARTED|Stage 1- (Days 1 to 42)||0||
59959960|NCT02442765|76078529|FG007|STARTED|Stage 1- (Days 1 to 42)||0||
59959961|NCT02442765|76078522|FG000|COMPLETED|Stage 1- (Days 1 to 42)||194||
59959962|NCT02442765|76078523|FG001|COMPLETED|Stage 1- (Days 1 to 42)||96||
59959963|NCT02442765|76078524|FG002|COMPLETED|Stage 1- (Days 1 to 42)||97||
59959964|NCT02442765|76078525|FG003|COMPLETED|Stage 1- (Days 1 to 42)||0||
59959965|NCT02442765|76078526|FG004|COMPLETED|Stage 1- (Days 1 to 42)||0||
59524373|NCT01003769|75619566|FG000|COMPLETED|Overall Study||5||
59806614|NCT00117793|75928331|FG000|STARTED|Overall Study||17||
59959966|NCT02442765|76078527|FG005|COMPLETED|Stage 1- (Days 1 to 42)||0||
59806615|NCT00117793|75928331|FG000|COMPLETED|Overall Study||5||
59806616|NCT00117793|75928331|FG000|NOT COMPLETED|Overall Study||12||
59806617|NCT00695669|75928340|FG000|STARTED|Overall Study||78||
59806618|NCT00695669|75928341|FG001|STARTED|Overall Study||78||
59806619|NCT00695669|75928342|FG002|STARTED|Overall Study||78||
59806620|NCT00695669|75928343|FG003|STARTED|Overall Study||78||
59959967|NCT02442765|76078528|FG006|COMPLETED|Stage 1- (Days 1 to 42)||0||
59959968|NCT02442765|76078529|FG007|COMPLETED|Stage 1- (Days 1 to 42)||0||
59959969|NCT02442765|76078522|FG000|NOT COMPLETED|Stage 1- (Days 1 to 42)||0||
59959970|NCT02442765|76078523|FG001|NOT COMPLETED|Stage 1- (Days 1 to 42)||0||
59959971|NCT02442765|76078524|FG002|NOT COMPLETED|Stage 1- (Days 1 to 42)||0||
59959972|NCT02442765|76078525|FG003|NOT COMPLETED|Stage 1- (Days 1 to 42)||0||
59959973|NCT02442765|76078526|FG004|NOT COMPLETED|Stage 1- (Days 1 to 42)||0||
59959974|NCT02442765|76078527|FG005|NOT COMPLETED|Stage 1- (Days 1 to 42)||0||
59959975|NCT02442765|76078528|FG006|NOT COMPLETED|Stage 1- (Days 1 to 42)||0||
59959976|NCT02442765|76078529|FG007|NOT COMPLETED|Stage 1- (Days 1 to 42)||0||
59959977|NCT02442765|76078522|FG000|STARTED|Stage 2- (Days 43 to 85)||0||
59959978|NCT02442765|76078523|FG001|STARTED|Stage 2- (Days 43 to 85)||0||
59959979|NCT02442765|76078524|FG002|STARTED|Stage 2- (Days 43 to 85)||0||
59959980|NCT02442765|76078525|FG003|STARTED|Stage 2- (Days 43 to 85)|For Stage 2, participants randomized to active treatment in Stage 1 (AVP-786-18 or AVP-786-28) continued to receive the same treatment and those randomized to placebo in Stage 1 were rerandomized to AVP-786-18, AVP-786-28, or placebo.|63||
59959981|NCT02442765|76078526|FG004|STARTED|Stage 2- (Days 43 to 85)||96||
59524374|NCT01003769|75619566|FG000|NOT COMPLETED|Overall Study||0||
59806621|NCT00695669|75928340|FG000|COMPLETED|Overall Study||74||
59806622|NCT00695669|75928341|FG001|COMPLETED|Overall Study||74||
59806623|NCT00695669|75928342|FG002|COMPLETED|Overall Study||75||
59806624|NCT00695669|75928343|FG003|COMPLETED|Overall Study||74||
59806625|NCT00695669|75928340|FG000|NOT COMPLETED|Overall Study||4||
59806626|NCT00695669|75928341|FG001|NOT COMPLETED|Overall Study||4||
59806627|NCT00695669|75928342|FG002|NOT COMPLETED|Overall Study||3||
59806628|NCT00695669|75928343|FG003|NOT COMPLETED|Overall Study||4||
59806629|NCT03671369|75928356|FG000|STARTED|Overall Study||669||
59806630|NCT03671369|75928356|FG000|COMPLETED|Overall Study||378||
59806631|NCT03671369|75928356|FG000|NOT COMPLETED|Overall Study||291||
59806632|NCT00692003|75928362|FG000|STARTED|Overall Study||5||
59806633|NCT00692003|75928363|FG001|STARTED|Overall Study||1||
59806634|NCT00692003|75928362|FG000|COMPLETED|Overall Study||0||
59806635|NCT00692003|75928363|FG001|COMPLETED|Overall Study||0||
59806636|NCT00692003|75928362|FG000|NOT COMPLETED|Overall Study||5||
59806637|NCT00692003|75928363|FG001|NOT COMPLETED|Overall Study||1||
59806638|NCT00434512|75928375|FG000|STARTED|Overall Study||10||
59806639|NCT00434512|75928376|FG001|STARTED|Overall Study||10||
59806640|NCT00434512|75928377|FG002|STARTED|Overall Study||10||
59806641|NCT00434512|75928378|FG003|STARTED|Overall Study||50||
59806642|NCT00434512|75928379|FG004|STARTED|Overall Study||50||
59806643|NCT00434512|75928380|FG005|STARTED|Overall Study||50||
59806644|NCT00434512|75928375|FG000|COMPLETED|Overall Study||10||
59806645|NCT00434512|75928376|FG001|COMPLETED|Overall Study||9||
59806646|NCT00434512|75928377|FG002|COMPLETED|Overall Study||10||
59806647|NCT00434512|75928378|FG003|COMPLETED|Overall Study||49||
59806648|NCT00434512|75928379|FG004|COMPLETED|Overall Study||49||
59806649|NCT00434512|75928380|FG005|COMPLETED|Overall Study||49||
59806650|NCT00434512|75928375|FG000|NOT COMPLETED|Overall Study||0||
59806651|NCT00434512|75928376|FG001|NOT COMPLETED|Overall Study||1||
59806652|NCT00434512|75928377|FG002|NOT COMPLETED|Overall Study||0||
59806653|NCT00434512|75928378|FG003|NOT COMPLETED|Overall Study||1||
59806654|NCT00434512|75928379|FG004|NOT COMPLETED|Overall Study||1||
59806655|NCT00434512|75928380|FG005|NOT COMPLETED|Overall Study||1||
59806656|NCT00427648|75928400|FG000|STARTED|Overall Study||12||
59806657|NCT00427648|75928401|FG001|STARTED|Overall Study||10||
59806658|NCT00427648|75928400|FG000|COMPLETED|Overall Study||11||
59806659|NCT00427648|75928401|FG001|COMPLETED|Overall Study||7||
59806660|NCT00427648|75928400|FG000|NOT COMPLETED|Overall Study||1||
59806661|NCT00427648|75928401|FG001|NOT COMPLETED|Overall Study||3||
59806662|NCT00416884|75928409|FG000|STARTED|Overall Study||1||
59806663|NCT00416884|75928409|FG000|COMPLETED|Overall Study||0||
59806664|NCT00416884|75928409|FG000|NOT COMPLETED|Overall Study||1||
59806665|NCT00434122|75928415|FG000|STARTED|Overall Study|Randomised|42||
59806666|NCT00434122|75928416|FG001|STARTED|Overall Study|Randomised|43||
59806667|NCT00434122|75928415|FG000|Intention-to-treat (ITT) Population|Overall Study|All randomised and exposed subjects not withdrawn before Stimulation Day 1.|39||
59806668|NCT00434122|75928416|FG001|Intention-to-treat (ITT) Population|Overall Study|All randomised and exposed subjects not withdrawn before Stimulation Day 1.|39||
59806669|NCT00434122|75928415|FG000|COMPLETED|Overall Study||36||
59806670|NCT00434122|75928416|FG001|COMPLETED|Overall Study||36||
59806671|NCT00434122|75928415|FG000|NOT COMPLETED|Overall Study||6||
59806672|NCT00434122|75928416|FG001|NOT COMPLETED|Overall Study||7||
59806673|NCT00555620|75928430|FG000|STARTED|Overall Study||6||
59806674|NCT00555620|75928431|FG001|STARTED|Overall Study||7||
59806675|NCT00555620|75928432|FG002|STARTED|Overall Study||15||
59959982|NCT02442765|76078527|FG005|STARTED|Stage 2- (Days 43 to 85)||97||
59959983|NCT02442765|76078528|FG006|STARTED|Stage 2- (Days 43 to 85)||65||
59806676|NCT00555620|75928433|FG003|STARTED|Overall Study||23||
59806677|NCT00555620|75928434|FG004|STARTED|Overall Study||3||
59806678|NCT00555620|75928435|FG005|STARTED|Overall Study||22||
59806679|NCT00555620|75928430|FG000|COMPLETED|Overall Study||0||
59806680|NCT00555620|75928431|FG001|COMPLETED|Overall Study||0||
59806681|NCT00555620|75928432|FG002|COMPLETED|Overall Study||0||
59806682|NCT00555620|75928433|FG003|COMPLETED|Overall Study||0||
59959984|NCT02442765|76078529|FG007|STARTED|Stage 2- (Days 43 to 85)||66||
59959985|NCT02442765|76078522|FG000|COMPLETED|Stage 2- (Days 43 to 85)||0||
59959986|NCT02442765|76078523|FG001|COMPLETED|Stage 2- (Days 43 to 85)||0||
59959987|NCT02442765|76078524|FG002|COMPLETED|Stage 2- (Days 43 to 85)||0||
59959988|NCT02442765|76078525|FG003|COMPLETED|Stage 2- (Days 43 to 85)||56||
59959989|NCT02442765|76078526|FG004|COMPLETED|Stage 2- (Days 43 to 85)||86||
59959990|NCT02442765|76078527|FG005|COMPLETED|Stage 2- (Days 43 to 85)||92||
59959991|NCT02442765|76078528|FG006|COMPLETED|Stage 2- (Days 43 to 85)||59||
59959992|NCT02442765|76078529|FG007|COMPLETED|Stage 2- (Days 43 to 85)||55||
59959993|NCT02442765|76078522|FG000|NOT COMPLETED|Stage 2- (Days 43 to 85)||0||
59959994|NCT02442765|76078523|FG001|NOT COMPLETED|Stage 2- (Days 43 to 85)||0||
59959995|NCT02442765|76078524|FG002|NOT COMPLETED|Stage 2- (Days 43 to 85)||0||
59959996|NCT02442765|76078525|FG003|NOT COMPLETED|Stage 2- (Days 43 to 85)||7||
59959997|NCT02442765|76078526|FG004|NOT COMPLETED|Stage 2- (Days 43 to 85)||10||
59959998|NCT02442765|76078527|FG005|NOT COMPLETED|Stage 2- (Days 43 to 85)||5||
59959999|NCT02442765|76078528|FG006|NOT COMPLETED|Stage 2- (Days 43 to 85)||6||
59960000|NCT02442765|76078529|FG007|NOT COMPLETED|Stage 2- (Days 43 to 85)||11||
59960001|NCT02699684|76078560|FG000|STARTED|Period 1, First 30 Days of Wear||37||
59960002|NCT02699684|76078561|FG001|STARTED|Period 1, First 30 Days of Wear||38||
59960003|NCT02699684|76078560|FG000|COMPLETED|Period 1, First 30 Days of Wear||37||
59960004|NCT02699684|76078561|FG001|COMPLETED|Period 1, First 30 Days of Wear||38||
59960005|NCT02699684|76078560|FG000|NOT COMPLETED|Period 1, First 30 Days of Wear||0||
59960006|NCT02699684|76078561|FG001|NOT COMPLETED|Period 1, First 30 Days of Wear||0||
59960007|NCT02699684|76078560|FG000|STARTED|Period 2, Second 30 Days of Wear||37||
59960008|NCT02699684|76078561|FG001|STARTED|Period 2, Second 30 Days of Wear||38||
59960009|NCT02699684|76078560|FG000|COMPLETED|Period 2, Second 30 Days of Wear||36||
59960010|NCT02699684|76078561|FG001|COMPLETED|Period 2, Second 30 Days of Wear||38||
59960011|NCT02699684|76078560|FG000|NOT COMPLETED|Period 2, Second 30 Days of Wear||1||
59806683|NCT00555620|75928434|FG004|COMPLETED|Overall Study||0||
59806684|NCT00555620|75928435|FG005|COMPLETED|Overall Study||0||
59806685|NCT00555620|75928430|FG000|NOT COMPLETED|Overall Study||6||
59806686|NCT00555620|75928431|FG001|NOT COMPLETED|Overall Study||7||
59806687|NCT00555620|75928432|FG002|NOT COMPLETED|Overall Study||15||
59806688|NCT00555620|75928433|FG003|NOT COMPLETED|Overall Study||23||
59806689|NCT00555620|75928434|FG004|NOT COMPLETED|Overall Study||3||
59806690|NCT00555620|75928435|FG005|NOT COMPLETED|Overall Study||22||
59806691|NCT00433966|75928455|FG000|STARTED|Pharmacology Intervention/Randomization||1800||
59806692|NCT00433966|75928456|FG001|STARTED|Pharmacology Intervention/Randomization||1802||
59806693|NCT00433966|75928457|FG002|STARTED|Pharmacology Intervention/Randomization||0||
59806694|NCT00433966|75928458|FG003|STARTED|Pharmacology Intervention/Randomization||0||
59806695|NCT00433966|75928455|FG000|30-Day Follow-up|Pharmacology Intervention/Randomization||1787||
59806696|NCT00433966|75928456|FG001|30-Day Follow-up|Pharmacology Intervention/Randomization||1791||
60074026|NCT01611194|76189403|FG001|COMPLETED|Overall Study||32||
59806697|NCT00433966|75928457|FG002|30-Day Follow-up|Pharmacology Intervention/Randomization||0||
59960012|NCT02699684|76078561|FG001|NOT COMPLETED|Period 2, Second 30 Days of Wear||0||
59960013|NCT02700698|76078570|FG000|STARTED|Overall Study||17||
59960014|NCT02700698|76078571|FG001|STARTED|Overall Study||18||
59960015|NCT02700698|76078570|FG000|COMPLETED|Overall Study||16||
59960016|NCT02700698|76078571|FG001|COMPLETED|Overall Study||18||
60074027|NCT01611194|76189402|FG000|NOT COMPLETED|Overall Study||0||
60074028|NCT01611194|76189403|FG001|NOT COMPLETED|Overall Study||3||
60074029|NCT01813058|76189411|FG000|STARTED|Overall Study||60||
60074030|NCT01813058|76189412|FG001|STARTED|Overall Study||60||
60074031|NCT01813058|76189411|FG000|COMPLETED|Overall Study||55||
60074032|NCT01813058|76189412|FG001|COMPLETED|Overall Study||56||
60074033|NCT01813058|76189411|FG000|NOT COMPLETED|Overall Study||5||
60074034|NCT01813058|76189412|FG001|NOT COMPLETED|Overall Study||4||
60074035|NCT01867424|76189420|FG000|STARTED|Overall Study||12||
60074036|NCT01867424|76189421|FG001|STARTED|Overall Study||12||
60074037|NCT01867424|76189420|FG000|COMPLETED|Overall Study||10||
60074038|NCT01867424|76189421|FG001|COMPLETED|Overall Study||11||
60074039|NCT01867424|76189420|FG000|NOT COMPLETED|Overall Study||2||
59806698|NCT00433966|75928458|FG003|30-Day Follow-up|Pharmacology Intervention/Randomization||0||
59960017|NCT02700698|76078570|FG000|NOT COMPLETED|Overall Study||1||
59960018|NCT02700698|76078571|FG001|NOT COMPLETED|Overall Study||0||
59524375|NCT01244503|75619570|FG000|STARTED|Overall Study||61||
59960019|NCT01774721|76078579|FG000|STARTED|Overall Study||227||
59960020|NCT01774721|76078580|FG001|STARTED|Overall Study||225||
59960021|NCT01774721|76078579|FG000|Treated|Overall Study||227||
59960022|NCT01774721|76078580|FG001|Treated|Overall Study||224||
59960023|NCT01774721|76078579|FG000|COMPLETED|Overall Study||0||
60074040|NCT01867424|76189421|FG001|NOT COMPLETED|Overall Study||1||
59960024|NCT01774721|76078580|FG001|COMPLETED|Overall Study||0||
59960025|NCT01774721|76078579|FG000|NOT COMPLETED|Overall Study||227||
59960026|NCT01774721|76078580|FG001|NOT COMPLETED|Overall Study||225||
59960027|NCT02699450|76078592|FG000|STARTED|Overall Study||90|Intent-to-Treat (ITT) Population|
59960028|NCT02699450|76078593|FG001|STARTED|Overall Study||55|Intent-to-Treat (ITT) Population|
60074041|NCT01811732|76189429|FG000|STARTED|Overall Study||331||
60074042|NCT01811732|76189430|FG001|STARTED|Overall Study||329||
59806699|NCT00433966|75928455|FG000|1-Year Follow-up|Pharmacology Intervention/Randomization||1696||
59806700|NCT00433966|75928456|FG001|1-Year Follow-up|Pharmacology Intervention/Randomization||1702||
59806701|NCT00433966|75928457|FG002|1-Year Follow-up|Pharmacology Intervention/Randomization||0||
59806702|NCT00433966|75928458|FG003|1-Year Follow-up|Pharmacology Intervention/Randomization||0||
59806703|NCT00433966|75928455|FG000|3-Year Follow-up|Pharmacology Intervention/Randomization||1634||
59806704|NCT00433966|75928456|FG001|3-Year Follow-up|Pharmacology Intervention/Randomization||1628||
59806705|NCT00433966|75928457|FG002|3-Year Follow-up|Pharmacology Intervention/Randomization||0||
59806706|NCT00433966|75928458|FG003|3-Year Follow-up|Pharmacology Intervention/Randomization||0||
59806707|NCT00433966|75928455|FG000|COMPLETED|Pharmacology Intervention/Randomization||1634||
59806708|NCT00433966|75928456|FG001|COMPLETED|Pharmacology Intervention/Randomization||1628||
59806709|NCT00433966|75928457|FG002|COMPLETED|Pharmacology Intervention/Randomization||0||
59806710|NCT00433966|75928458|FG003|COMPLETED|Pharmacology Intervention/Randomization||0||
59806711|NCT00433966|75928455|FG000|NOT COMPLETED|Pharmacology Intervention/Randomization||166||
59806712|NCT00433966|75928456|FG001|NOT COMPLETED|Pharmacology Intervention/Randomization||174||
59806713|NCT00433966|75928457|FG002|NOT COMPLETED|Pharmacology Intervention/Randomization||0||
59806714|NCT00433966|75928458|FG003|NOT COMPLETED|Pharmacology Intervention/Randomization||0||
59806715|NCT00433966|75928455|FG000|STARTED|Stent Intervention/Randomization||0||
59806716|NCT00433966|75928456|FG001|STARTED|Stent Intervention/Randomization||0||
59806717|NCT00433966|75928457|FG002|STARTED|Stent Intervention/Randomization||2257||
59806718|NCT00433966|75928458|FG003|STARTED|Stent Intervention/Randomization||749||
59806719|NCT00433966|75928455|FG000|1-Year Follow-up|Stent Intervention/Randomization||0||
59806720|NCT00433966|75928456|FG001|1-Year Follow-up|Stent Intervention/Randomization||0||
59806721|NCT00433966|75928457|FG002|1-Year Follow-up|Stent Intervention/Randomization||2186||
59806722|NCT00433966|75928458|FG003|1-Year Follow-up|Stent Intervention/Randomization||715||
59806723|NCT00433966|75928455|FG000|3-Year Follow-up|Stent Intervention/Randomization||0||
59806724|NCT00433966|75928456|FG001|3-Year Follow-up|Stent Intervention/Randomization||0||
59806725|NCT00433966|75928457|FG002|3-Year Follow-up|Stent Intervention/Randomization||2103||
59806726|NCT00433966|75928458|FG003|3-Year Follow-up|Stent Intervention/Randomization||687||
59806727|NCT00433966|75928455|FG000|COMPLETED|Stent Intervention/Randomization||0||
59806728|NCT00433966|75928456|FG001|COMPLETED|Stent Intervention/Randomization||0||
59806729|NCT00433966|75928457|FG002|COMPLETED|Stent Intervention/Randomization||2103||
59806730|NCT00433966|75928458|FG003|COMPLETED|Stent Intervention/Randomization||687||
59806731|NCT00433966|75928455|FG000|NOT COMPLETED|Stent Intervention/Randomization||0||
59806732|NCT00433966|75928456|FG001|NOT COMPLETED|Stent Intervention/Randomization||0||
59806733|NCT00433966|75928457|FG002|NOT COMPLETED|Stent Intervention/Randomization||154||
59806734|NCT00433966|75928458|FG003|NOT COMPLETED|Stent Intervention/Randomization||62||
59806735|NCT03952650|75928475|FG000|STARTED|Overall Study||4||
59806736|NCT03952650|75928476|FG001|STARTED|Overall Study||90||
59806737|NCT03952650|75928477|FG002|STARTED|Overall Study||4||
59806738|NCT03952650|75928478|FG003|STARTED|Overall Study||60||
59806739|NCT03952650|75928479|FG004|STARTED|Overall Study||4||
59806740|NCT03952650|75928480|FG005|STARTED|Overall Study||54||
59806741|NCT03952650|75928481|FG006|STARTED|Overall Study||36||
59806742|NCT03952650|75928475|FG000|COMPLETED|Overall Study||4||
59806743|NCT03952650|75928476|FG001|COMPLETED|Overall Study||83||
59806744|NCT03952650|75928477|FG002|COMPLETED|Overall Study||4||
59806745|NCT03952650|75928478|FG003|COMPLETED|Overall Study||53||
59806746|NCT03952650|75928479|FG004|COMPLETED|Overall Study||4||
59806747|NCT03952650|75928480|FG005|COMPLETED|Overall Study||47||
59806748|NCT03952650|75928481|FG006|COMPLETED|Overall Study||32||
59806749|NCT03952650|75928475|FG000|NOT COMPLETED|Overall Study||0||
59806750|NCT03952650|75928476|FG001|NOT COMPLETED|Overall Study||7||
59806751|NCT03952650|75928477|FG002|NOT COMPLETED|Overall Study||0||
59960029|NCT02699450|76078594|FG002|STARTED|Overall Study||82|Intent-to-Treat (ITT) Population|
59960030|NCT02699450|76078592|FG000|Received at Least One Dose of Study Drug|Overall Study||89|Safety Population|
59960031|NCT02699450|76078593|FG001|Received at Least One Dose of Study Drug|Overall Study||55|Safety Population|
60074043|NCT01811732|76189429|FG000|COMPLETED|Overall Study||276|Completed the Late Follow-Up (LFU) Visit|
60074044|NCT01811732|76189430|FG001|COMPLETED|Overall Study||271|Completed the Late Follow-Up (LFU) Visit|
60074045|NCT01811732|76189429|FG000|NOT COMPLETED|Overall Study||55||
60074046|NCT01811732|76189430|FG001|NOT COMPLETED|Overall Study||58||
59806752|NCT03952650|75928478|FG003|NOT COMPLETED|Overall Study||7||
59806753|NCT03952650|75928479|FG004|NOT COMPLETED|Overall Study||0||
59806754|NCT03952650|75928480|FG005|NOT COMPLETED|Overall Study||7||
59806755|NCT03952650|75928481|FG006|NOT COMPLETED|Overall Study||4||
59806756|NCT00691301|75928497|FG000|STARTED|Overall Study||55||
60074047|NCT01836458|76189441|FG000|STARTED|Overall Study||7||
59806757|NCT00691301|75928497|FG000|COMPLETED|Overall Study||1||
59960032|NCT02699450|76078594|FG002|Received at Least One Dose of Study Drug|Overall Study||80|Safety Population|
59960033|NCT02699450|76078592|FG000|Completed up to Week 24|Overall Study||81||
59960034|NCT02699450|76078593|FG001|Completed up to Week 24|Overall Study||53||
59960035|NCT02699450|76078594|FG002|Completed up to Week 24|Overall Study||73||
59960036|NCT02699450|76078592|FG000|COMPLETED|Overall Study||75|Completed Study (per pre-specified criteria)|
59960037|NCT02699450|76078593|FG001|COMPLETED|Overall Study||50|Completed Study (per pre-specified criteria)|
59960038|NCT02699450|76078594|FG002|COMPLETED|Overall Study||67|Completed Study (per pre-specified criteria)|
59960039|NCT02699450|76078592|FG000|NOT COMPLETED|Overall Study||15||
59960040|NCT02699450|76078593|FG001|NOT COMPLETED|Overall Study||5||
59960041|NCT02699450|76078594|FG002|NOT COMPLETED|Overall Study||15||
59960042|NCT02699996|76078605|FG000|STARTED|Overall Study||20||
59960043|NCT02699996|76078606|FG001|STARTED|Overall Study||11||
59960044|NCT02699996|76078605|FG000|COMPLETED|Overall Study||15||
59960045|NCT02699996|76078606|FG001|COMPLETED|Overall Study||9||
59960046|NCT02699996|76078605|FG000|NOT COMPLETED|Overall Study||5||
59960047|NCT02699996|76078606|FG001|NOT COMPLETED|Overall Study||2||
59960048|NCT02739321|76078615|FG000|STARTED|Overall Study||23||
59960049|NCT02739321|76078616|FG001|STARTED|Overall Study||22||
59960050|NCT02739321|76078615|FG000|COMPLETED|Overall Study||20||
59960051|NCT02739321|76078616|FG001|COMPLETED|Overall Study||18||
59960052|NCT02739321|76078615|FG000|NOT COMPLETED|Overall Study||3||
59960053|NCT02739321|76078616|FG001|NOT COMPLETED|Overall Study||4||
59960054|NCT02696798|76078634|FG000|STARTED|Blinded Treatment Dosing Period||104||
59960055|NCT02696798|76078635|FG001|STARTED|Blinded Treatment Dosing Period||114||
59960056|NCT02696798|76078636|FG002|STARTED|Blinded Treatment Dosing Period||98||
59960057|NCT02696798|76078634|FG000|COMPLETED|Blinded Treatment Dosing Period||93||
59960058|NCT02696798|76078635|FG001|COMPLETED|Blinded Treatment Dosing Period||99||
59960059|NCT02696798|76078636|FG002|COMPLETED|Blinded Treatment Dosing Period||90||
59960060|NCT02696798|76078634|FG000|NOT COMPLETED|Blinded Treatment Dosing Period||11||
59960061|NCT02696798|76078635|FG001|NOT COMPLETED|Blinded Treatment Dosing Period||15||
59960062|NCT02696798|76078636|FG002|NOT COMPLETED|Blinded Treatment Dosing Period||8||
59960063|NCT02696798|76078634|FG000|STARTED|Extended Treatment Period||93||
59960064|NCT02696798|76078635|FG001|STARTED|Extended Treatment Period|1 participant completed blinded treatment period and entered post-treatment followup period directly|98||
59960065|NCT02696798|76078636|FG002|STARTED|Extended Treatment Period||90||
59960066|NCT02696798|76078634|FG000|COMPLETED|Extended Treatment Period||81||
59960067|NCT02696798|76078635|FG001|COMPLETED|Extended Treatment Period||89||
59960068|NCT02696798|76078636|FG002|COMPLETED|Extended Treatment Period||80||
59806758|NCT00691301|75928497|FG000|NOT COMPLETED|Overall Study||54||
59806759|NCT00927563|75928507|FG000|STARTED|Overall Study||24||
59806760|NCT00927563|75928507|FG000|COMPLETED|Overall Study||22||
59806761|NCT00927563|75928507|FG000|NOT COMPLETED|Overall Study||2||
59806762|NCT00775229|75928513|FG000|STARTED|Overall Study||25||
59806763|NCT00775229|75928514|FG001|STARTED|Overall Study||26||
59806764|NCT00775229|75928513|FG000|COMPLETED|Overall Study||20||
59806765|NCT00775229|75928514|FG001|COMPLETED|Overall Study||24||
59806766|NCT00775229|75928513|FG000|NOT COMPLETED|Overall Study||5||
59806767|NCT00775229|75928514|FG001|NOT COMPLETED|Overall Study||2||
59806768|NCT00653159|75928522|FG000|STARTED|Overall Study||11||
59806769|NCT00653159|75928523|FG001|STARTED|Overall Study||12||
59806770|NCT00653159|75928522|FG000|COMPLETED|Overall Study||6||
59806771|NCT00653159|75928523|FG001|COMPLETED|Overall Study||9||
59960069|NCT02696798|76078634|FG000|NOT COMPLETED|Extended Treatment Period||12||
59960070|NCT02696798|76078635|FG001|NOT COMPLETED|Extended Treatment Period||9||
59960071|NCT02696798|76078636|FG002|NOT COMPLETED|Extended Treatment Period||10||
59960072|NCT02696798|76078634|FG000|STARTED|Post-treatment Follow-up Period|Participants who terminate RHBW early or who didn't enroll into RHBY entered Follow-Up Period.|5||
59960073|NCT02696798|76078635|FG001|STARTED|Post-treatment Follow-up Period|Participants who terminate RHBW early or who didn't enroll into RHBY entered Follow-Up Period.|34||
59960074|NCT02696798|76078636|FG002|STARTED|Post-treatment Follow-up Period|Participants who terminate RHBW early or who didn't enroll into RHBY entered Follow-Up Period.|22||
59960075|NCT02696798|76078634|FG000|COMPLETED|Post-treatment Follow-up Period||0||
59960076|NCT02696798|76078635|FG001|COMPLETED|Post-treatment Follow-up Period||8||
59960077|NCT02696798|76078636|FG002|COMPLETED|Post-treatment Follow-up Period||3||
59806772|NCT00653159|75928522|FG000|NOT COMPLETED|Overall Study||5||
59806773|NCT00653159|75928523|FG001|NOT COMPLETED|Overall Study||3||
59806774|NCT00117637|75928531|FG000|STARTED|First Intervention (Period 1)||97||
59806775|NCT00117637|75928532|FG001|STARTED|First Intervention (Period 1)||92||
59806776|NCT00117637|75928531|FG000|Subjects Received Treatment|First Intervention (Period 1)||97||
59806777|NCT00117637|75928532|FG001|Subjects Received Treatment|First Intervention (Period 1)||90||
59806778|NCT00117637|75928531|FG000|COMPLETED|First Intervention (Period 1)||79||
59806779|NCT00117637|75928532|FG001|COMPLETED|First Intervention (Period 1)||67||
59806780|NCT00117637|75928531|FG000|NOT COMPLETED|First Intervention (Period 1)||18||
59806781|NCT00117637|75928532|FG001|NOT COMPLETED|First Intervention (Period 1)||25||
59806782|NCT00117637|75928531|FG000|STARTED|Second Intervention (Period 2)|Not all patients who completed Period 1 (first progression) enter into Period 2|49||
59817878|NCT04488770|75940330|FG004|STARTED|Part 1-Cohort 2: Period 1 (Up to 5 Days)||2||
59806783|NCT00117637|75928532|FG001|STARTED|Second Intervention (Period 2)|Not all patients who completed Period 1 (first progression) enter into Period 2|61||
59806784|NCT00117637|75928531|FG000|Subjects Received Treatment|Second Intervention (Period 2)||49||
59806785|NCT00117637|75928532|FG001|Subjects Received Treatment|Second Intervention (Period 2)||61||
59806786|NCT00117637|75928531|FG000|COMPLETED|Second Intervention (Period 2)||39||
59806787|NCT00117637|75928532|FG001|COMPLETED|Second Intervention (Period 2)||39||
59806788|NCT00117637|75928531|FG000|NOT COMPLETED|Second Intervention (Period 2)||10||
59806789|NCT00117637|75928532|FG001|NOT COMPLETED|Second Intervention (Period 2)||22||
59806790|NCT00690755|75928552|FG000|STARTED|Overall Study||30||
59806791|NCT00690755|75928553|FG001|STARTED|Overall Study||0||
59806792|NCT00690755|75928554|FG002|STARTED|Overall Study||97||
59806793|NCT00690755|75928555|FG003|STARTED|Overall Study||20||
59806794|NCT00690755|75928556|FG004|STARTED|Overall Study||0||
59806795|NCT00690755|75928557|FG005|STARTED|Overall Study||10||
59806796|NCT00690755|75928558|FG006|STARTED|Overall Study||0||
59806797|NCT00690755|75928552|FG000|COMPLETED|Overall Study|Patient recruitment ended on 12/31/2010|28||
59806798|NCT00690755|75928553|FG001|COMPLETED|Overall Study||0||
59806799|NCT00690755|75928554|FG002|COMPLETED|Overall Study||51||
59806800|NCT00690755|75928555|FG003|COMPLETED|Overall Study||15||
59806801|NCT00690755|75928556|FG004|COMPLETED|Overall Study||0||
59806802|NCT00690755|75928557|FG005|COMPLETED|Overall Study||6||
59806803|NCT00690755|75928558|FG006|COMPLETED|Overall Study||0||
59806804|NCT00690755|75928552|FG000|NOT COMPLETED|Overall Study||2||
59806805|NCT00690755|75928553|FG001|NOT COMPLETED|Overall Study||0||
59960078|NCT02696798|76078634|FG000|NOT COMPLETED|Post-treatment Follow-up Period||5||
59960079|NCT02696798|76078635|FG001|NOT COMPLETED|Post-treatment Follow-up Period||26||
59960080|NCT02696798|76078636|FG002|NOT COMPLETED|Post-treatment Follow-up Period||19||
59960081|NCT02698826|76078658|FG000|STARTED|Overall Study||16||
59960082|NCT02698826|76078658|FG000|COMPLETED|Overall Study||2||
59960083|NCT02698826|76078658|FG000|NOT COMPLETED|Overall Study||14||
59960084|NCT02541604|76078676|FG000|STARTED|Overall Study||11||
59960085|NCT02541604|76078677|FG001|STARTED|Overall Study||9||
59960086|NCT02541604|76078678|FG002|STARTED|Overall Study||11||
59960087|NCT02541604|76078679|FG003|STARTED|Overall Study||3||
59960088|NCT02541604|76078680|FG004|STARTED|Overall Study||10||
59960089|NCT02541604|76078681|FG005|STARTED|Overall Study||10||
59960090|NCT02541604|76078682|FG006|STARTED|Overall Study||10||
59960091|NCT02541604|76078683|FG007|STARTED|Overall Study||10||
59960092|NCT02541604|76078684|FG008|STARTED|Overall Study||4||
59960093|NCT02541604|76078685|FG009|STARTED|Overall Study||4||
59960094|NCT02541604|76078686|FG010|STARTED|Overall Study||2||
59960095|NCT02541604|76078687|FG011|STARTED|Overall Study||3||
59960096|NCT02541604|76078676|FG000|COMPLETED|Overall Study||0||
59960097|NCT02541604|76078677|FG001|COMPLETED|Overall Study||0||
59960098|NCT02541604|76078678|FG002|COMPLETED|Overall Study||0||
59960099|NCT02541604|76078679|FG003|COMPLETED|Overall Study||0||
59960100|NCT02541604|76078680|FG004|COMPLETED|Overall Study||0||
59960101|NCT02541604|76078681|FG005|COMPLETED|Overall Study||0||
59960102|NCT02541604|76078682|FG006|COMPLETED|Overall Study||0||
59806806|NCT00690755|75928554|FG002|NOT COMPLETED|Overall Study||46||
59806807|NCT00690755|75928555|FG003|NOT COMPLETED|Overall Study||5||
59806808|NCT00690755|75928556|FG004|NOT COMPLETED|Overall Study||0||
59806809|NCT00690755|75928557|FG005|NOT COMPLETED|Overall Study||4||
59806810|NCT00690755|75928558|FG006|NOT COMPLETED|Overall Study||0||
59806811|NCT00549302|75928576|FG000|STARTED|Double-Blind||63||
59806812|NCT00549302|75928577|FG001|STARTED|Double-Blind||294||
59806813|NCT00549302|75928578|FG002|STARTED|Double-Blind||0||
59806814|NCT00549302|75928576|FG000|Received at Least One Dose of Study Drug|Double-Blind||63||
59806815|NCT00549302|75928577|FG001|Received at Least One Dose of Study Drug|Double-Blind||294||
59806816|NCT00549302|75928578|FG002|Received at Least One Dose of Study Drug|Double-Blind||0||
59806817|NCT00549302|75928576|FG000|COMPLETED|Double-Blind|Participants who completed the Double-Blind Period were eligible to enter the Open-Label Period.|52||
59806818|NCT00549302|75928577|FG001|COMPLETED|Double-Blind|Participants who completed the Double-Blind Period were eligible to enter the Open-Label Period.|241||
59806819|NCT00549302|75928578|FG002|COMPLETED|Double-Blind||0||
59806820|NCT00549302|75928576|FG000|NOT COMPLETED|Double-Blind||11||
59806821|NCT00549302|75928577|FG001|NOT COMPLETED|Double-Blind||53||
59806822|NCT00549302|75928578|FG002|NOT COMPLETED|Double-Blind||0||
59960103|NCT02541604|76078683|FG007|COMPLETED|Overall Study||0||
59960104|NCT02541604|76078684|FG008|COMPLETED|Overall Study||0||
59960105|NCT02541604|76078685|FG009|COMPLETED|Overall Study||0||
59960106|NCT02541604|76078686|FG010|COMPLETED|Overall Study||0||
59960107|NCT02541604|76078687|FG011|COMPLETED|Overall Study||0||
59960108|NCT02541604|76078676|FG000|NOT COMPLETED|Overall Study||11||
59960109|NCT02541604|76078677|FG001|NOT COMPLETED|Overall Study||9||
59960110|NCT02541604|76078678|FG002|NOT COMPLETED|Overall Study||11||
59806823|NCT00549302|75928576|FG000|STARTED|Open-Label||0||
59806824|NCT00549302|75928577|FG001|STARTED|Open-Label||0||
59960111|NCT02541604|76078679|FG003|NOT COMPLETED|Overall Study||3||
59960112|NCT02541604|76078680|FG004|NOT COMPLETED|Overall Study||10||
59960113|NCT02541604|76078681|FG005|NOT COMPLETED|Overall Study||10||
59960114|NCT02541604|76078682|FG006|NOT COMPLETED|Overall Study||10||
59960115|NCT02541604|76078683|FG007|NOT COMPLETED|Overall Study||10||
59960116|NCT02541604|76078684|FG008|NOT COMPLETED|Overall Study||4||
59960117|NCT02541604|76078685|FG009|NOT COMPLETED|Overall Study||4||
59960118|NCT02541604|76078686|FG010|NOT COMPLETED|Overall Study||2||
59960119|NCT02541604|76078687|FG011|NOT COMPLETED|Overall Study||3||
59960120|NCT02546674|76078736|FG000|STARTED|Overall Study||171||
59960121|NCT02546674|76078736|FG000|COMPLETED|Overall Study||123||
59960122|NCT02546674|76078736|FG000|NOT COMPLETED|Overall Study||48||
59960123|NCT02546362|76078741|FG000|STARTED|4-week Treatment Period||50||
59960124|NCT02546362|76078741|FG000|COMPLETED|4-week Treatment Period||47||
59806825|NCT00549302|75928578|FG002|STARTED|Open-Label|7 participants who completed the Double-Blind Period did not enter the Open-Label Period.|286||
59806826|NCT00549302|75928576|FG000|COMPLETED|Open-Label||0||
59806827|NCT00549302|75928577|FG001|COMPLETED|Open-Label||0||
59806828|NCT00549302|75928578|FG002|COMPLETED|Open-Label|Another death occurred during the 30-day follow-up period after study drug discontinuation|217||
59806829|NCT00549302|75928576|FG000|NOT COMPLETED|Open-Label||0||
59806830|NCT00549302|75928577|FG001|NOT COMPLETED|Open-Label||0||
59806831|NCT00549302|75928578|FG002|NOT COMPLETED|Open-Label||69||
59806832|NCT00117325|75928588|FG000|STARTED|Overall Study||173||
59806833|NCT00117325|75928589|FG001|STARTED|Overall Study||179||
59806834|NCT00117325|75928588|FG000|COMPLETED|Overall Study||160||
59806835|NCT00117325|75928589|FG001|COMPLETED|Overall Study||167||
59806836|NCT00117325|75928588|FG000|NOT COMPLETED|Overall Study||13||
59806837|NCT00117325|75928589|FG001|NOT COMPLETED|Overall Study||12||
59806838|NCT00108433|75928598|FG000|STARTED|Overall Study||30||
59524376|NCT01244503|75619570|FG000|COMPLETED|Overall Study||61||
59806839|NCT00108433|75928599|FG001|STARTED|Overall Study||31||
59806840|NCT00108433|75928598|FG000|COMPLETED|Overall Study||9||
59806841|NCT00108433|75928599|FG001|COMPLETED|Overall Study||14||
59806842|NCT00108433|75928598|FG000|NOT COMPLETED|Overall Study||21||
59806843|NCT00108433|75928599|FG001|NOT COMPLETED|Overall Study||17||
59806844|NCT00116779|75928607|FG000|STARTED|Overall Study|Randomized and treated; Intent-to-treat population|63||
59806845|NCT00116779|75928608|FG001|STARTED|Overall Study|Randomized and treated; intent-to-treat population|64||
59806846|NCT00116779|75928607|FG000|COMPLETED|Overall Study||42||
59806847|NCT00116779|75928608|FG001|COMPLETED|Overall Study||45||
59806848|NCT00116779|75928607|FG000|NOT COMPLETED|Overall Study||21||
59806849|NCT00116779|75928608|FG001|NOT COMPLETED|Overall Study||19||
59806850|NCT03943290|75928623|FG000|STARTED|Overall Study||7||
59806851|NCT03943290|75928624|FG001|STARTED|Overall Study||1||
59960125|NCT02546362|76078741|FG000|NOT COMPLETED|4-week Treatment Period||3||
59960126|NCT02546362|76078741|FG000|STARTED|12-week Treatment Period||47||
59960127|NCT02546362|76078741|FG000|COMPLETED|12-week Treatment Period||38||
59960128|NCT02546362|76078741|FG000|NOT COMPLETED|12-week Treatment Period||9||
59960129|NCT02698436|76078747|FG000|STARTED|Overall Study||59||
59960130|NCT02698436|76078748|FG001|STARTED|Overall Study||58||
59960131|NCT02698436|76078747|FG000|COMPLETED|Overall Study||52||
59960132|NCT02698436|76078748|FG001|COMPLETED|Overall Study||51||
59960133|NCT02698436|76078747|FG000|NOT COMPLETED|Overall Study||7||
59960134|NCT02698436|76078748|FG001|NOT COMPLETED|Overall Study||7||
59960135|NCT02694536|76078754|FG000|STARTED|Overall Study||80||
59960136|NCT02694536|76078754|FG000|COMPLETED|Overall Study||0||
59960137|NCT02694536|76078754|FG000|NOT COMPLETED|Overall Study||80||
59960138|NCT01661686|76078760|FG000|STARTED|Overall Study||49||
59960139|NCT01661686|76078761|FG001|STARTED|Overall Study||49||
59960140|NCT01661686|76078760|FG000|COMPLETED|Overall Study||47||
59960141|NCT01661686|76078761|FG001|COMPLETED|Overall Study||47||
59960142|NCT01661686|76078760|FG000|NOT COMPLETED|Overall Study||2||
59960143|NCT01661686|76078761|FG001|NOT COMPLETED|Overall Study||2||
59960144|NCT02696096|76078767|FG000|STARTED|Overall Study||21||
59960145|NCT02696096|76078767|FG000|Opioid Abstinence During Study Period|Overall Study||11||
59960146|NCT02696096|76078767|FG000|COMPLETED|Overall Study||19||
59524377|NCT01244503|75619570|FG000|NOT COMPLETED|Overall Study||0||
59524378|NCT01004393|75619574|FG000|STARTED|Overall Study||12||
59806852|NCT03943290|75928625|FG002|STARTED|Overall Study||13||
59960147|NCT02696096|76078767|FG000|NOT COMPLETED|Overall Study||2||
59960148|NCT02695628|76078775|FG000|STARTED|Overall Study||5||
59960149|NCT02695628|76078775|FG000|COMPLETED|Overall Study||4||
59960150|NCT02695628|76078775|FG000|NOT COMPLETED|Overall Study||1||
59524379|NCT01004393|75619574|FG000|COMPLETED|Overall Study||12||
59524380|NCT01004393|75619574|FG000|NOT COMPLETED|Overall Study||0||
59806853|NCT03943290|75928626|FG003|STARTED|Overall Study||6||
59806854|NCT03943290|75928627|FG004|STARTED|Overall Study||7||
59806855|NCT03943290|75928628|FG005|STARTED|Overall Study||6||
59806856|NCT03943290|75928629|FG006|STARTED|Overall Study||6||
59806857|NCT03943290|75928630|FG007|STARTED|Overall Study||8||
59806858|NCT03943290|75928631|FG008|STARTED|Overall Study||8||
59806859|NCT03943290|75928623|FG000|COMPLETED|Overall Study||0||
59806860|NCT03943290|75928624|FG001|COMPLETED|Overall Study||0||
59806861|NCT03943290|75928625|FG002|COMPLETED|Overall Study||0||
59806862|NCT03943290|75928626|FG003|COMPLETED|Overall Study||0||
59806863|NCT03943290|75928627|FG004|COMPLETED|Overall Study||0||
59806864|NCT03943290|75928628|FG005|COMPLETED|Overall Study||0||
59960151|NCT02693834|76078779|FG000|STARTED|Baseline Measurement|10 were randomized to PLS AFO first week group (2 dropped out at baseline)|12||
59995282|NCT01119807|76111113|FG002|COMPLETED|Overall Study||64||
59960152|NCT02693834|76078780|FG001|STARTED|Baseline Measurement|11 participants were assigned to DA AFO first group|11||
59960153|NCT02693834|76078779|FG000|COMPLETED|Baseline Measurement|10 particiapnts completed wearing PLS AFO during the first week and 10 during the second week|10||
59960154|NCT02693834|76078780|FG001|COMPLETED|Baseline Measurement|10 particiapnts completed wearing DA AFO during the first week and 10 the second week (1 was lost)|11||
59960155|NCT02693834|76078779|FG000|NOT COMPLETED|Baseline Measurement||2||
59960156|NCT02693834|76078780|FG001|NOT COMPLETED|Baseline Measurement||0||
59960157|NCT02693834|76078779|FG000|STARTED|Week 1 Practice|During the first week of practice, 10 participants were assigned to PLS AFO group|10||
59960158|NCT02693834|76078780|FG001|STARTED|Week 1 Practice|During the first week of practice, 11 participants were assigned to DAAFO group|11||
59524381|NCT01245439|75619578|FG000|STARTED|Overall Study||65||
59960159|NCT02693834|76078779|FG000|COMPLETED|Week 1 Practice||10||
59960160|NCT02693834|76078780|FG001|COMPLETED|Week 1 Practice||11||
59960161|NCT02693834|76078779|FG000|NOT COMPLETED|Week 1 Practice||0||
59960162|NCT02693834|76078780|FG001|NOT COMPLETED|Week 1 Practice||0||
59960163|NCT02693834|76078779|FG000|STARTED|Week 2 Practice||10||
59960164|NCT02693834|76078780|FG001|STARTED|Week 2 Practice||11||
59960165|NCT02693834|76078779|FG000|COMPLETED|Week 2 Practice||10||
59960166|NCT02693834|76078780|FG001|COMPLETED|Week 2 Practice||10||
59960167|NCT02693834|76078779|FG000|NOT COMPLETED|Week 2 Practice||0||
59806865|NCT03943290|75928629|FG006|COMPLETED|Overall Study||0||
59806866|NCT03943290|75928630|FG007|COMPLETED|Overall Study||0||
59806867|NCT03943290|75928631|FG008|COMPLETED|Overall Study||0||
59960168|NCT02693834|76078780|FG001|NOT COMPLETED|Week 2 Practice||1||
59960169|NCT02545504|76078788|FG000|STARTED|Overall Study||218||
59960170|NCT02545504|76078789|FG001|STARTED|Overall Study||214||
59960171|NCT02545504|76078788|FG000|COMPLETED|Overall Study||0||
59960172|NCT02545504|76078789|FG001|COMPLETED|Overall Study||0||
59960173|NCT02545504|76078788|FG000|NOT COMPLETED|Overall Study||218||
59960174|NCT02545504|76078789|FG001|NOT COMPLETED|Overall Study||214||
59960175|NCT02545270|76078802|FG000|STARTED|Overall Study||6||
59960176|NCT02545270|76078803|FG001|STARTED|Overall Study||5||
59960177|NCT02545270|76078804|FG002|STARTED|Overall Study||5||
59960178|NCT02545270|76078802|FG000|COMPLETED|Overall Study||6||
59960179|NCT02545270|76078803|FG001|COMPLETED|Overall Study||4||
59960180|NCT02545270|76078804|FG002|COMPLETED|Overall Study||3||
59960181|NCT02545270|76078802|FG000|NOT COMPLETED|Overall Study||0||
59960182|NCT02545270|76078803|FG001|NOT COMPLETED|Overall Study||1||
59960183|NCT02545270|76078804|FG002|NOT COMPLETED|Overall Study||2||
59960184|NCT02540668|76078813|FG000|STARTED|Period 1 - Warfarin Single Dose||15||
59960185|NCT02540668|76078814|FG001|STARTED|Period 1 - Warfarin Single Dose||0||
59960186|NCT02540668|76078813|FG000|Received at Least One Dose of Study Drug|Period 1 - Warfarin Single Dose||15||
59960187|NCT02540668|76078814|FG001|Received at Least One Dose of Study Drug|Period 1 - Warfarin Single Dose||0||
59960188|NCT02540668|76078813|FG000|COMPLETED|Period 1 - Warfarin Single Dose||15||
59960189|NCT02540668|76078814|FG001|COMPLETED|Period 1 - Warfarin Single Dose||0||
59960190|NCT02540668|76078813|FG000|NOT COMPLETED|Period 1 - Warfarin Single Dose||0||
59960191|NCT02540668|76078814|FG001|NOT COMPLETED|Period 1 - Warfarin Single Dose||0||
59806868|NCT03943290|75928623|FG000|NOT COMPLETED|Overall Study||7||
59806869|NCT03943290|75928624|FG001|NOT COMPLETED|Overall Study||1||
59806870|NCT03943290|75928625|FG002|NOT COMPLETED|Overall Study||13||
59960192|NCT02540668|76078813|FG000|STARTED|Period 2 - LY3314814 and Warfarin|Warfarin was administered alone only in Period 1.|0||
59960193|NCT02540668|76078814|FG001|STARTED|Period 2 - LY3314814 and Warfarin|Warfarin was co-administered with LY3314814 only in Period 2.|15||
59960194|NCT02540668|76078813|FG000|COMPLETED|Period 2 - LY3314814 and Warfarin||0||
59960195|NCT02540668|76078814|FG001|COMPLETED|Period 2 - LY3314814 and Warfarin||14||
59960196|NCT02540668|76078813|FG000|NOT COMPLETED|Period 2 - LY3314814 and Warfarin||0||
59960197|NCT02540668|76078814|FG001|NOT COMPLETED|Period 2 - LY3314814 and Warfarin||1||
59806871|NCT03943290|75928626|FG003|NOT COMPLETED|Overall Study||6||
59806872|NCT03943290|75928627|FG004|NOT COMPLETED|Overall Study||7||
59806873|NCT03943290|75928628|FG005|NOT COMPLETED|Overall Study||6||
59806874|NCT03943290|75928629|FG006|NOT COMPLETED|Overall Study||6||
59806875|NCT03943290|75928630|FG007|NOT COMPLETED|Overall Study||8||
59806876|NCT03943290|75928631|FG008|NOT COMPLETED|Overall Study||8||
59806877|NCT00108355|75928666|FG000|STARTED|Overall Study|Two patients met inclusion criteria not randomized, one had peritonitis , other loculated ascites.|15||
59806878|NCT00108355|75928667|FG001|STARTED|Overall Study|Two patients met inclusion criteria not randomized, one had peritonitis, other loculated ascites.|14||
59960198|NCT03943888|76078825|FG000|STARTED|Overall Study||10||
59960199|NCT03943888|76078826|FG001|STARTED|Overall Study||10||
59960200|NCT03943888|76078827|FG002|STARTED|Overall Study||10||
59960201|NCT03943888|76078828|FG003|STARTED|Overall Study||10||
59960202|NCT03943888|76078825|FG000|COMPLETED|Overall Study||10||
59524382|NCT01245439|75619578|FG000|COMPLETED|Overall Study||65||
59524383|NCT01245439|75619578|FG000|NOT COMPLETED|Overall Study||0||
59524384|NCT01004705|75619584|FG000|STARTED|Run-In||44||
59524385|NCT01004705|75619585|FG001|STARTED|Run-In||0||
59806879|NCT00108355|75928666|FG000|COMPLETED|Overall Study||13||
59960203|NCT03943888|76078826|FG001|COMPLETED|Overall Study||10||
59960204|NCT03943888|76078827|FG002|COMPLETED|Overall Study||10||
59960205|NCT03943888|76078828|FG003|COMPLETED|Overall Study||10||
59960206|NCT03943888|76078825|FG000|NOT COMPLETED|Overall Study||0||
59960207|NCT03943888|76078826|FG001|NOT COMPLETED|Overall Study||0||
59960208|NCT03943888|76078827|FG002|NOT COMPLETED|Overall Study||0||
59960209|NCT03943888|76078828|FG003|NOT COMPLETED|Overall Study||0||
59960210|NCT02535364|76078838|FG000|STARTED|Part A Screening Through Leukapheresis||82||
59960211|NCT02535364|76078838|FG000|COMPLETED|Part A Screening Through Leukapheresis||57||
59960212|NCT02535364|76078838|FG000|NOT COMPLETED|Part A Screening Through Leukapheresis||25||
59806880|NCT00108355|75928667|FG001|COMPLETED|Overall Study||12||
59806881|NCT00108355|75928666|FG000|NOT COMPLETED|Overall Study||2||
59960213|NCT02535364|76078838|FG000|STARTED|Part B Screening||57||
59524386|NCT01004705|75619586|FG002|STARTED|Run-In||0||
59524387|NCT01004705|75619584|FG000|COMPLETED|Run-In||36||
59524388|NCT01004705|75619585|FG001|COMPLETED|Run-In||0||
59524389|NCT01004705|75619586|FG002|COMPLETED|Run-In||0||
59806882|NCT00108355|75928667|FG001|NOT COMPLETED|Overall Study||2||
59806883|NCT02575976|75928676|FG000|STARTED|Overall Study||37||
59806884|NCT02575976|75928677|FG001|STARTED|Overall Study||39||
59806885|NCT02575976|75928678|FG002|STARTED|Overall Study||39||
59806886|NCT02575976|75928676|FG000|COMPLETED|Overall Study||32||
59524390|NCT01004705|75619584|FG000|NOT COMPLETED|Run-In||8||
59524391|NCT01004705|75619585|FG001|NOT COMPLETED|Run-In||0||
59524392|NCT01004705|75619586|FG002|NOT COMPLETED|Run-In||0||
59806887|NCT02575976|75928677|FG001|COMPLETED|Overall Study||31||
59806888|NCT02575976|75928678|FG002|COMPLETED|Overall Study||30||
59806889|NCT02575976|75928676|FG000|NOT COMPLETED|Overall Study||5||
59960214|NCT02535364|76078838|FG000|COMPLETED|Part B Screening||40||
59960215|NCT02535364|76078838|FG000|NOT COMPLETED|Part B Screening||17||
59960216|NCT02535364|76078838|FG000|STARTED|Study Treatment||40||
59960217|NCT02535364|76078838|FG000|COMPLETED|Study Treatment||38||
59960218|NCT02535364|76078838|FG000|NOT COMPLETED|Study Treatment||2||
59960219|NCT02535364|76078838|FG000|STARTED|12-Month Follow-up Period||38||
59960220|NCT02535364|76078838|FG000|COMPLETED|12-Month Follow-up Period||3||
59960221|NCT02535364|76078838|FG000|NOT COMPLETED|12-Month Follow-up Period||35||
59960222|NCT02540356|76078844|FG000|STARTED|Overall Study||1||
59960223|NCT02540356|76078845|FG001|STARTED|Overall Study||0||
59960224|NCT02540356|76078844|FG000|COMPLETED|Overall Study||0||
59960225|NCT02540356|76078845|FG001|COMPLETED|Overall Study||0||
59960226|NCT02540356|76078844|FG000|NOT COMPLETED|Overall Study||1||
59960227|NCT02540356|76078845|FG001|NOT COMPLETED|Overall Study||0||
59960228|NCT02534896|76078853|FG000|STARTED|Overall Study||49||
59960229|NCT02534896|76078854|FG001|STARTED|Overall Study||52||
59960230|NCT02534896|76078855|FG002|STARTED|Overall Study||49||
59960231|NCT02534896|76078853|FG000|COMPLETED|Overall Study||45||
59960232|NCT02534896|76078854|FG001|COMPLETED|Overall Study||51||
59806890|NCT02575976|75928677|FG001|NOT COMPLETED|Overall Study||8||
59806891|NCT02575976|75928678|FG002|NOT COMPLETED|Overall Study||9||
59806892|NCT00094861|75928688|FG000|STARTED|Overall Study||46||
59806893|NCT00094861|75928689|FG001|STARTED|Overall Study||49||
59806894|NCT00094861|75928688|FG000|Participants Treated|Overall Study||46||
59806895|NCT00094861|75928689|FG001|Participants Treated|Overall Study||48||
59806896|NCT00094861|75928688|FG000|COMPLETED|Overall Study|Participants who completed the acute dysphagia evaluation phase|28||
59806897|NCT00094861|75928689|FG001|COMPLETED|Overall Study|Participants who completed the acute dysphagia evaluation phase|40||
59806898|NCT00094861|75928688|FG000|NOT COMPLETED|Overall Study||18||
59806899|NCT00094861|75928689|FG001|NOT COMPLETED|Overall Study||9||
59806900|NCT00426556|75928699|FG000|STARTED|Phase I - Core Phase||6||
59806901|NCT00426556|75928700|FG001|STARTED|Phase I - Core Phase||17||
59806902|NCT00426556|75928701|FG002|STARTED|Phase I - Core Phase||10||
59806903|NCT00426556|75928702|FG003|STARTED|Phase I - Core Phase||0||
59806904|NCT00426556|75928699|FG000|COMPLETED|Phase I - Core Phase||5||
59806905|NCT00426556|75928700|FG001|COMPLETED|Phase I - Core Phase||7||
59806906|NCT00426556|75928701|FG002|COMPLETED|Phase I - Core Phase||7||
59806907|NCT00426556|75928702|FG003|COMPLETED|Phase I - Core Phase||0||
59806908|NCT00426556|75928699|FG000|NOT COMPLETED|Phase I - Core Phase||1||
59960233|NCT02534896|76078855|FG002|COMPLETED|Overall Study||48||
59960234|NCT02534896|76078853|FG000|NOT COMPLETED|Overall Study||4||
59960235|NCT02534896|76078854|FG001|NOT COMPLETED|Overall Study||1||
59960236|NCT02534896|76078855|FG002|NOT COMPLETED|Overall Study||1||
59960237|NCT02697734|76078865|FG000|STARTED|Core Phase - up to Week 48||48|treated|
59960238|NCT02697734|76078866|FG001|STARTED|Core Phase - up to Week 48||25|treated|
59960239|NCT02697734|76078865|FG000|COMPLETED|Core Phase - up to Week 48||42||
59960240|NCT02697734|76078866|FG001|COMPLETED|Core Phase - up to Week 48||23||
59960241|NCT02697734|76078865|FG000|NOT COMPLETED|Core Phase - up to Week 48||6||
59960242|NCT02697734|76078866|FG001|NOT COMPLETED|Core Phase - up to Week 48||2||
59960243|NCT02697734|76078865|FG000|STARTED|Optional Extension Phase||38||
59960244|NCT02697734|76078866|FG001|STARTED|Optional Extension Phase||22||
59960245|NCT02697734|76078865|FG000|COMPLETED|Optional Extension Phase||33||
59960246|NCT02697734|76078866|FG001|COMPLETED|Optional Extension Phase||20||
59960247|NCT02697734|76078865|FG000|NOT COMPLETED|Optional Extension Phase||5||
59960248|NCT02697734|76078866|FG001|NOT COMPLETED|Optional Extension Phase||2||
59960249|NCT02692586|76078880|FG000|STARTED|Overall Study||106||
59960250|NCT02692586|76078880|FG000|COMPLETED|Overall Study||103||
59960251|NCT02692586|76078880|FG000|NOT COMPLETED|Overall Study||3||
59806909|NCT00426556|75928700|FG001|NOT COMPLETED|Phase I - Core Phase||10||
59806910|NCT00426556|75928701|FG002|NOT COMPLETED|Phase I - Core Phase||3||
59806911|NCT00426556|75928702|FG003|NOT COMPLETED|Phase I - Core Phase||0||
59806912|NCT00426556|75928699|FG000|STARTED|Phase I - Extension Phase||5||
59806913|NCT00426556|75928700|FG001|STARTED|Phase I - Extension Phase||7||
59960252|NCT02534350|76078886|FG000|STARTED|Overall Study||41||
59806914|NCT00426556|75928701|FG002|STARTED|Phase I - Extension Phase||7||
59806915|NCT00426556|75928702|FG003|STARTED|Phase I - Extension Phase||0||
59806916|NCT00426556|75928699|FG000|COMPLETED|Phase I - Extension Phase||0||
59960253|NCT02534350|76078887|FG001|STARTED|Overall Study||20||
59960254|NCT02534350|76078886|FG000|COMPLETED|Overall Study||37||
59960255|NCT02534350|76078887|FG001|COMPLETED|Overall Study||20||
59960256|NCT02534350|76078886|FG000|NOT COMPLETED|Overall Study||4||
59960257|NCT02534350|76078887|FG001|NOT COMPLETED|Overall Study||0||
59960258|NCT02688764|76078895|FG000|STARTED|Overall Study||66||
59960259|NCT02688764|76078896|FG001|STARTED|Overall Study||19||
59960260|NCT02688764|76078895|FG000|Treated in Stage 1|Overall Study||66||
59960261|NCT02688764|76078896|FG001|Treated in Stage 1|Overall Study||19||
59960262|NCT02688764|76078895|FG000|Treated in Stage 2|Overall Study||43||
59960263|NCT02688764|76078896|FG001|Treated in Stage 2|Overall Study||8||
59960264|NCT02688764|76078895|FG000|COMPLETED|Overall Study||26||
59960265|NCT02688764|76078896|FG001|COMPLETED|Overall Study||2||
59960266|NCT02688764|76078895|FG000|NOT COMPLETED|Overall Study||40||
59960267|NCT02688764|76078896|FG001|NOT COMPLETED|Overall Study||17||
59960268|NCT02688608|76078905|FG000|STARTED|Overall Study||6||
59960269|NCT02688608|76078905|FG000|COMPLETED|Overall Study||5||
59960270|NCT02688608|76078905|FG000|NOT COMPLETED|Overall Study||1||
59960271|NCT02688530|76078913|FG000|STARTED|Overall Study||35||
59960272|NCT02688530|76078914|FG001|STARTED|Overall Study||35||
59960273|NCT02688530|76078915|FG002|STARTED|Overall Study||35||
59960274|NCT02688530|76078916|FG003|STARTED|Overall Study||35||
59960275|NCT02688530|76078913|FG000|COMPLETED|Overall Study||35||
59960276|NCT02688530|76078914|FG001|COMPLETED|Overall Study||34||
59960277|NCT02688530|76078915|FG002|COMPLETED|Overall Study||33||
59960278|NCT02688530|76078916|FG003|COMPLETED|Overall Study||35||
59960279|NCT02688530|76078913|FG000|NOT COMPLETED|Overall Study||0||
59960280|NCT02688530|76078914|FG001|NOT COMPLETED|Overall Study||1||
59960281|NCT02688530|76078915|FG002|NOT COMPLETED|Overall Study||2||
59960282|NCT02688530|76078916|FG003|NOT COMPLETED|Overall Study||0||
59960283|NCT02467270|76078933|FG000|STARTED|Overall Study||94||
59960284|NCT02467270|76078934|FG001|STARTED|Overall Study||95||
59960285|NCT02467270|76078935|FG002|STARTED|Overall Study||94||
59806917|NCT00426556|75928700|FG001|COMPLETED|Phase I - Extension Phase||1||
59806918|NCT00426556|75928701|FG002|COMPLETED|Phase I - Extension Phase||0||
59806919|NCT00426556|75928702|FG003|COMPLETED|Phase I - Extension Phase||0||
59806920|NCT00426556|75928699|FG000|NOT COMPLETED|Phase I - Extension Phase||5||
59806921|NCT00426556|75928700|FG001|NOT COMPLETED|Phase I - Extension Phase||6||
59806922|NCT00426556|75928701|FG002|NOT COMPLETED|Phase I - Extension Phase||7||
59806923|NCT00426556|75928702|FG003|NOT COMPLETED|Phase I - Extension Phase||0||
59806924|NCT00426556|75928699|FG000|STARTED|Phase II - Core Phase||0||
59806925|NCT00426556|75928700|FG001|STARTED|Phase II - Core Phase||0||
59806926|NCT00426556|75928701|FG002|STARTED|Phase II - Core Phase||0||
59806927|NCT00426556|75928702|FG003|STARTED|Phase II - Core Phase||55||
59806928|NCT00426556|75928699|FG000|COMPLETED|Phase II - Core Phase||0||
59806929|NCT00426556|75928700|FG001|COMPLETED|Phase II - Core Phase||0||
59806930|NCT00426556|75928701|FG002|COMPLETED|Phase II - Core Phase||0||
59806931|NCT00426556|75928702|FG003|COMPLETED|Phase II - Core Phase||28||
59806932|NCT00426556|75928699|FG000|NOT COMPLETED|Phase II - Core Phase||0||
59806933|NCT00426556|75928700|FG001|NOT COMPLETED|Phase II - Core Phase||0||
59806934|NCT00426556|75928701|FG002|NOT COMPLETED|Phase II - Core Phase||0||
59806935|NCT00426556|75928702|FG003|NOT COMPLETED|Phase II - Core Phase||27||
59806936|NCT00426556|75928699|FG000|STARTED|Phase II - Extension Phase||0||
59806937|NCT00426556|75928700|FG001|STARTED|Phase II - Extension Phase||0||
59806938|NCT00426556|75928701|FG002|STARTED|Phase II - Extension Phase||0||
59806939|NCT00426556|75928702|FG003|STARTED|Phase II - Extension Phase|4 patients did not enter the Extension phase.|24||
59806940|NCT00426556|75928699|FG000|COMPLETED|Phase II - Extension Phase||0||
59806941|NCT00426556|75928700|FG001|COMPLETED|Phase II - Extension Phase||0||
59806942|NCT00426556|75928701|FG002|COMPLETED|Phase II - Extension Phase||0||
59806943|NCT00426556|75928702|FG003|COMPLETED|Phase II - Extension Phase|Completed means 'Ongoing'|1||
59960286|NCT02467270|76078933|FG000|Treated (Safety Population)|Overall Study||94|Included all participants who received at least one dose of study drug.|
59960287|NCT02467270|76078934|FG001|Treated (Safety Population)|Overall Study||94|Included all participants who received at least one dose of study drug.|
59960288|NCT02467270|76078935|FG002|Treated (Safety Population)|Overall Study||94|Included all participants who received at least one dose of study drug.|
59960289|NCT02467270|76078933|FG000|COMPLETED|Overall Study||0||
59960290|NCT02467270|76078934|FG001|COMPLETED|Overall Study||0||
59960291|NCT02467270|76078935|FG002|COMPLETED|Overall Study||0||
59960292|NCT02467270|76078933|FG000|NOT COMPLETED|Overall Study||94||
59960293|NCT02467270|76078934|FG001|NOT COMPLETED|Overall Study||95||
59960294|NCT02467270|76078935|FG002|NOT COMPLETED|Overall Study||94||
59960295|NCT05083559|76078945|FG000|STARTED|Dexcom Training Visit (30 Minutes)||7||
59960296|NCT05083559|76078946|FG001|STARTED|Dexcom Training Visit (30 Minutes)||8||
59960297|NCT05083559|76078945|FG000|COMPLETED|Dexcom Training Visit (30 Minutes)||7||
59960298|NCT05083559|76078946|FG001|COMPLETED|Dexcom Training Visit (30 Minutes)||8||
59960299|NCT05083559|76078945|FG000|NOT COMPLETED|Dexcom Training Visit (30 Minutes)||0||
59960300|NCT05083559|76078946|FG001|NOT COMPLETED|Dexcom Training Visit (30 Minutes)||0||
59960301|NCT05083559|76078945|FG000|STARTED|First Rest Period (1-12 Weeks)||7||
59960302|NCT05083559|76078946|FG001|STARTED|First Rest Period (1-12 Weeks)||8||
59960303|NCT05083559|76078945|FG000|COMPLETED|First Rest Period (1-12 Weeks)||7||
59960304|NCT05083559|76078946|FG001|COMPLETED|First Rest Period (1-12 Weeks)||8||
59806944|NCT00426556|75928699|FG000|NOT COMPLETED|Phase II - Extension Phase||0||
59806945|NCT00426556|75928700|FG001|NOT COMPLETED|Phase II - Extension Phase||0||
59806946|NCT00426556|75928701|FG002|NOT COMPLETED|Phase II - Extension Phase||0||
59806947|NCT00426556|75928702|FG003|NOT COMPLETED|Phase II - Extension Phase||23||
59960305|NCT05083559|76078945|FG000|NOT COMPLETED|First Rest Period (1-12 Weeks)||0||
59960306|NCT05083559|76078946|FG001|NOT COMPLETED|First Rest Period (1-12 Weeks)||0||
59960307|NCT05083559|76078945|FG000|STARTED|First Intervention (~8 Hours)||7||
59960308|NCT05083559|76078946|FG001|STARTED|First Intervention (~8 Hours)||8||
59960309|NCT05083559|76078945|FG000|COMPLETED|First Intervention (~8 Hours)||3||
59960310|NCT05083559|76078946|FG001|COMPLETED|First Intervention (~8 Hours)||7||
59960311|NCT05083559|76078945|FG000|NOT COMPLETED|First Intervention (~8 Hours)||4||
59960312|NCT05083559|76078946|FG001|NOT COMPLETED|First Intervention (~8 Hours)||1||
59960313|NCT05083559|76078945|FG000|STARTED|Second at Home Period (3-30 Days)||7||
59960314|NCT05083559|76078946|FG001|STARTED|Second at Home Period (3-30 Days)||8||
59960315|NCT05083559|76078945|FG000|COMPLETED|Second at Home Period (3-30 Days)||5||
59960316|NCT05083559|76078946|FG001|COMPLETED|Second at Home Period (3-30 Days)||8||
59806948|NCT00107653|75928714|FG000|STARTED|Overall Study||269||
59806949|NCT00107653|75928715|FG001|STARTED|Overall Study||300||
59806950|NCT00107653|75928714|FG000|COMPLETED|Overall Study||190||
59806951|NCT00107653|75928715|FG001|COMPLETED|Overall Study||224||
59806952|NCT00107653|75928714|FG000|NOT COMPLETED|Overall Study||79||
59806953|NCT00107653|75928715|FG001|NOT COMPLETED|Overall Study||76||
59806954|NCT03950856|75928725|FG000|STARTED|Overall Study||702|Randomized|
59806955|NCT03950856|75928726|FG001|STARTED|Overall Study||704|Randomized|
59806956|NCT03950856|75928727|FG002|STARTED|Overall Study||701|Randomized|
59806957|NCT03950856|75928728|FG003|STARTED|Overall Study||233|Randomized|
59806958|NCT03950856|75928725|FG000|Vaccinated|Overall Study||698||
59806959|NCT03950856|75928726|FG001|Vaccinated|Overall Study||704||
59806960|NCT03950856|75928727|FG002|Vaccinated|Overall Study||700||
59806961|NCT03950856|75928728|FG003|Vaccinated|Overall Study||231||
59806962|NCT03950856|75928725|FG000|COMPLETED|Overall Study||683||
59806963|NCT03950856|75928726|FG001|COMPLETED|Overall Study||689||
59806964|NCT03950856|75928727|FG002|COMPLETED|Overall Study||683||
59806965|NCT03950856|75928728|FG003|COMPLETED|Overall Study||227||
59806966|NCT03950856|75928725|FG000|NOT COMPLETED|Overall Study||19||
59806967|NCT03950856|75928726|FG001|NOT COMPLETED|Overall Study||15||
59806968|NCT03950856|75928727|FG002|NOT COMPLETED|Overall Study||18||
59806969|NCT03950856|75928728|FG003|NOT COMPLETED|Overall Study||6||
59806970|NCT00433654|75928742|FG000|STARTED|Overall Study||258||
59806971|NCT00433654|75928743|FG001|STARTED|Overall Study||206||
59806972|NCT00433654|75928742|FG000|COMPLETED|Overall Study|Subjects completing the 4-month follow-up.|243||
59806973|NCT00433654|75928743|FG001|COMPLETED|Overall Study|Subjects completing the 4-month follow-up.|201||
59806974|NCT00433654|75928742|FG000|NOT COMPLETED|Overall Study||15||
59806975|NCT00433654|75928743|FG001|NOT COMPLETED|Overall Study||5||
59806976|NCT00689351|75928757|FG000|STARTED|Infant Series of Dosing||91||
59806977|NCT00689351|75928758|FG001|STARTED|Infant Series of Dosing||89||
59806978|NCT00689351|75928757|FG000|Vaccinated Dose 1|Infant Series of Dosing||88||
59806979|NCT00689351|75928758|FG001|Vaccinated Dose 1|Infant Series of Dosing||89||
59806980|NCT00689351|75928757|FG000|Vaccinated Dose 2|Infant Series of Dosing||86||
59960317|NCT05083559|76078945|FG000|NOT COMPLETED|Second at Home Period (3-30 Days)||2||
59806981|NCT00689351|75928758|FG001|Vaccinated Dose 2|Infant Series of Dosing||88||
59806982|NCT00689351|75928757|FG000|Vaccinated Dose 3|Infant Series of Dosing||85||
59806983|NCT00689351|75928758|FG001|Vaccinated Dose 3|Infant Series of Dosing||88||
59806984|NCT00689351|75928757|FG000|COMPLETED|Infant Series of Dosing||85||
59806985|NCT00689351|75928758|FG001|COMPLETED|Infant Series of Dosing||88||
59806986|NCT00689351|75928757|FG000|NOT COMPLETED|Infant Series of Dosing||6||
59806987|NCT00689351|75928758|FG001|NOT COMPLETED|Infant Series of Dosing||1||
59806988|NCT00689351|75928757|FG000|STARTED|After Infant Series||85||
59806989|NCT00689351|75928758|FG001|STARTED|After Infant Series||88||
59806990|NCT00689351|75928757|FG000|COMPLETED|After Infant Series||84||
59806991|NCT00689351|75928758|FG001|COMPLETED|After Infant Series||88||
59806992|NCT00689351|75928757|FG000|NOT COMPLETED|After Infant Series||1||
59960318|NCT05083559|76078946|FG001|NOT COMPLETED|Second at Home Period (3-30 Days)||0||
59960319|NCT05083559|76078945|FG000|STARTED|Second Intervention Visit (~8 Hours)||5||
59960320|NCT05083559|76078946|FG001|STARTED|Second Intervention Visit (~8 Hours)||8||
59960321|NCT05083559|76078945|FG000|COMPLETED|Second Intervention Visit (~8 Hours)||4||
59960322|NCT05083559|76078946|FG001|COMPLETED|Second Intervention Visit (~8 Hours)||8||
59806993|NCT00689351|75928758|FG001|NOT COMPLETED|After Infant Series||0||
59806994|NCT00689351|75928757|FG000|STARTED|Toddler Dose||84||
59806995|NCT00689351|75928758|FG001|STARTED|Toddler Dose||88||
59806996|NCT00689351|75928757|FG000|COMPLETED|Toddler Dose||84||
59806997|NCT00689351|75928758|FG001|COMPLETED|Toddler Dose||88||
59806998|NCT00689351|75928757|FG000|NOT COMPLETED|Toddler Dose||0||
59960323|NCT05083559|76078945|FG000|NOT COMPLETED|Second Intervention Visit (~8 Hours)||1||
59960324|NCT05083559|76078946|FG001|NOT COMPLETED|Second Intervention Visit (~8 Hours)||0||
59960325|NCT03037307|76078952|FG000|STARTED|Period 1||7||
59960326|NCT03037307|76078953|FG001|STARTED|Period 1||7||
59806999|NCT00689351|75928758|FG001|NOT COMPLETED|Toddler Dose||0||
59807000|NCT03950622|75928770|FG000|STARTED|Overall Study||604||
59807001|NCT03950622|75928771|FG001|STARTED|Overall Study||601||
59807002|NCT03950622|75928770|FG000|Vaccinated|Overall Study||602||
59807003|NCT03950622|75928771|FG001|Vaccinated|Overall Study||600||
59807004|NCT03950622|75928770|FG000|COMPLETED|Overall Study||596||
59807005|NCT03950622|75928771|FG001|COMPLETED|Overall Study||594||
59807006|NCT03950622|75928770|FG000|NOT COMPLETED|Overall Study||8||
59807007|NCT03950622|75928771|FG001|NOT COMPLETED|Overall Study||7||
59807008|NCT03937908|75928777|FG000|STARTED|Overall Study||2||
59807009|NCT03937908|75928778|FG001|STARTED|Overall Study||3||
59807010|NCT03937908|75928777|FG000|COMPLETED|Overall Study||2||
59960327|NCT03037307|76078954|FG002|STARTED|Period 1||8||
59960328|NCT03037307|76078955|FG003|STARTED|Period 1||7||
59960329|NCT03037307|76078956|FG004|STARTED|Period 1||7||
59960330|NCT03037307|76078957|FG005|STARTED|Period 1||8||
59960331|NCT03037307|76078952|FG000|COMPLETED|Period 1||7||
59960332|NCT03037307|76078953|FG001|COMPLETED|Period 1||7||
59807011|NCT03937908|75928778|FG001|COMPLETED|Overall Study||2||
59807012|NCT03937908|75928777|FG000|NOT COMPLETED|Overall Study||0||
59807013|NCT03937908|75928778|FG001|NOT COMPLETED|Overall Study||1||
59807014|NCT00689273|75928786|FG000|STARTED|Overall Study||79||
59807015|NCT00689273|75928787|FG001|STARTED|Overall Study||78||
59807016|NCT00689273|75928786|FG000|Treated|Overall Study||78||
59960333|NCT03037307|76078954|FG002|COMPLETED|Period 1||8||
59960334|NCT03037307|76078955|FG003|COMPLETED|Period 1||6||
59960335|NCT03037307|76078956|FG004|COMPLETED|Period 1||7||
59960336|NCT03037307|76078957|FG005|COMPLETED|Period 1||8||
59960337|NCT03037307|76078952|FG000|NOT COMPLETED|Period 1||0||
59960338|NCT03037307|76078953|FG001|NOT COMPLETED|Period 1||0||
59807017|NCT00689273|75928787|FG001|Treated|Overall Study||78||
59807018|NCT00689273|75928786|FG000|COMPLETED|Overall Study||66||
59807019|NCT00689273|75928787|FG001|COMPLETED|Overall Study||73||
59807020|NCT00689273|75928786|FG000|NOT COMPLETED|Overall Study||13||
59807021|NCT00689273|75928787|FG001|NOT COMPLETED|Overall Study||5||
59807022|NCT00553358|75928796|FG000|STARTED|Overall Study||152||
59960339|NCT03037307|76078954|FG002|NOT COMPLETED|Period 1||0||
59960340|NCT03037307|76078955|FG003|NOT COMPLETED|Period 1||1||
59807023|NCT00553358|75928797|FG001|STARTED|Overall Study||154||
59807024|NCT00553358|75928798|FG002|STARTED|Overall Study||149||
59807025|NCT00553358|75928796|FG000|COMPLETED|Overall Study||73|Completed follow-up per protocol event free. Includes subjects who had a follow-up visit or phone call ≥ 9 years + 6 months after randomization and had no EFS events|
59807026|NCT00553358|75928797|FG001|COMPLETED|Overall Study||58|Completed follow-up per protocol event free. Includes subjects who had a follow-up visit or phone call ≥ 9 years + 6 months after randomization and had no EFS events|
59807027|NCT00553358|75928798|FG002|COMPLETED|Overall Study||61|Completed follow-up per protocol event free. Includes subjects who had a follow-up visit or phone call ≥ 9 years + 6 months after randomization and had no EFS events|
59807028|NCT00553358|75928796|FG000|NOT COMPLETED|Overall Study||79||
59807029|NCT00553358|75928797|FG001|NOT COMPLETED|Overall Study||96||
59807030|NCT00553358|75928798|FG002|NOT COMPLETED|Overall Study||88||
59807031|NCT00688259|75928814|FG000|STARTED|Overall Study||44||
59807032|NCT00688259|75928815|FG001|STARTED|Overall Study||44||
59807033|NCT00688259|75928814|FG000|End to Active Treatment,|Overall Study||37|Approximately 6 months post-randomization|
59807034|NCT00688259|75928815|FG001|End to Active Treatment,|Overall Study||37|Approximately 6 months post-randomization|
59807035|NCT00688259|75928814|FG000|COMPLETED|Overall Study||37|6 month post treatment follow-up|
59807036|NCT00688259|75928815|FG001|COMPLETED|Overall Study||36|6 month post treatment follow-up|
59807037|NCT00688259|75928814|FG000|NOT COMPLETED|Overall Study||7||
59807038|NCT00688259|75928815|FG001|NOT COMPLETED|Overall Study||8||
59807039|NCT00688181|75928821|FG000|STARTED|Overall Study||36||
59807040|NCT00688181|75928821|FG000|COMPLETED|Overall Study||13||
59807041|NCT00688181|75928821|FG000|NOT COMPLETED|Overall Study||23||
59807042|NCT01634048|75928829|FG000|STARTED|Overall Study||21||
59807043|NCT01634048|75928830|FG001|STARTED|Overall Study||18||
59807044|NCT01634048|75928829|FG000|COMPLETED|Overall Study||15||
59807045|NCT01634048|75928830|FG001|COMPLETED|Overall Study||15||
59807046|NCT01634048|75928829|FG000|NOT COMPLETED|Overall Study||6||
59807047|NCT01634048|75928830|FG001|NOT COMPLETED|Overall Study||3||
59807048|NCT00689117|75928840|FG000|STARTED|Overall Study||476||
59807049|NCT00689117|75928841|FG001|STARTED|Overall Study||467||
59807050|NCT00689117|75928842|FG002|STARTED|Overall Study||464||
59807051|NCT00689117|75928843|FG003|STARTED|Overall Study||242||
59807052|NCT00689117|75928840|FG000|COMPLETED|Overall Study||414||
59807053|NCT00689117|75928841|FG001|COMPLETED|Overall Study||416||
59807054|NCT00689117|75928842|FG002|COMPLETED|Overall Study||405||
59960341|NCT03037307|76078956|FG004|NOT COMPLETED|Period 1||0||
59960342|NCT03037307|76078957|FG005|NOT COMPLETED|Period 1||0||
59960343|NCT03037307|76078952|FG000|STARTED|Wash Out Period 1||7||
59807055|NCT00689117|75928843|FG003|COMPLETED|Overall Study||211||
59807056|NCT00689117|75928840|FG000|NOT COMPLETED|Overall Study||62||
59807057|NCT00689117|75928841|FG001|NOT COMPLETED|Overall Study||51||
59807058|NCT00689117|75928842|FG002|NOT COMPLETED|Overall Study||59||
59807059|NCT00689117|75928843|FG003|NOT COMPLETED|Overall Study||31||
59807060|NCT00547248|75928857|FG000|STARTED|Overall Study||280||
59807061|NCT00547248|75928858|FG001|STARTED|Overall Study||93||
59807062|NCT00547248|75928859|FG002|STARTED|Overall Study||285||
59807063|NCT00547248|75928860|FG003|STARTED|Overall Study||98||
59807064|NCT00547248|75928857|FG000|COMPLETED|Overall Study||280||
59807065|NCT00547248|75928858|FG001|COMPLETED|Overall Study||93||
59807066|NCT00547248|75928859|FG002|COMPLETED|Overall Study||275||
59807067|NCT00547248|75928860|FG003|COMPLETED|Overall Study||96||
59807068|NCT00547248|75928857|FG000|NOT COMPLETED|Overall Study||0||
59960344|NCT03037307|76078953|FG001|STARTED|Wash Out Period 1||7||
59960345|NCT03037307|76078954|FG002|STARTED|Wash Out Period 1||8||
59960346|NCT03037307|76078955|FG003|STARTED|Wash Out Period 1||6||
59960347|NCT03037307|76078956|FG004|STARTED|Wash Out Period 1||7||
59960348|NCT03037307|76078957|FG005|STARTED|Wash Out Period 1||8||
59960349|NCT03037307|76078952|FG000|COMPLETED|Wash Out Period 1||7||
59960350|NCT03037307|76078953|FG001|COMPLETED|Wash Out Period 1||7||
59960351|NCT03037307|76078954|FG002|COMPLETED|Wash Out Period 1||8||
59960352|NCT03037307|76078955|FG003|COMPLETED|Wash Out Period 1||6||
59960353|NCT03037307|76078956|FG004|COMPLETED|Wash Out Period 1||7||
59960354|NCT03037307|76078957|FG005|COMPLETED|Wash Out Period 1||8||
59960355|NCT03037307|76078952|FG000|NOT COMPLETED|Wash Out Period 1||0||
59960356|NCT03037307|76078953|FG001|NOT COMPLETED|Wash Out Period 1||0||
59960357|NCT03037307|76078954|FG002|NOT COMPLETED|Wash Out Period 1||0||
59807069|NCT00547248|75928858|FG001|NOT COMPLETED|Overall Study||0||
59807070|NCT00547248|75928859|FG002|NOT COMPLETED|Overall Study||10||
59807071|NCT00547248|75928860|FG003|NOT COMPLETED|Overall Study||2||
59807072|NCT00688103|75928875|FG000|STARTED|Overall Study||74||
59807073|NCT00688103|75928876|FG001|STARTED|Overall Study||77||
59807074|NCT00688103|75928875|FG000|Actually Treated|Overall Study||71||
59807075|NCT00688103|75928876|FG001|Actually Treated|Overall Study||76||
59807076|NCT00688103|75928875|FG000|COMPLETED|Overall Study||44||
59807077|NCT00688103|75928876|FG001|COMPLETED|Overall Study||64||
59807078|NCT00688103|75928875|FG000|NOT COMPLETED|Overall Study||30||
59807079|NCT00688103|75928876|FG001|NOT COMPLETED|Overall Study||13||
59807080|NCT00686855|75928886|FG000|STARTED|Overall Study||28||
59807081|NCT00686855|75928887|FG001|STARTED|Overall Study||18||
59807082|NCT00686855|75928886|FG000|COMPLETED|Overall Study||27||
59807083|NCT00686855|75928887|FG001|COMPLETED|Overall Study||17||
59807084|NCT00686855|75928886|FG000|NOT COMPLETED|Overall Study||1||
59807085|NCT00686855|75928887|FG001|NOT COMPLETED|Overall Study||1||
59807086|NCT00686777|75928893|FG000|STARTED|Overall Study||75||
59960358|NCT03037307|76078955|FG003|NOT COMPLETED|Wash Out Period 1||0||
59960359|NCT03037307|76078956|FG004|NOT COMPLETED|Wash Out Period 1||0||
59960360|NCT03037307|76078957|FG005|NOT COMPLETED|Wash Out Period 1||0||
59960361|NCT03037307|76078952|FG000|STARTED|Period 2||7||
59960362|NCT03037307|76078953|FG001|STARTED|Period 2||7||
59960363|NCT03037307|76078954|FG002|STARTED|Period 2||8||
59960364|NCT03037307|76078955|FG003|STARTED|Period 2||6||
59960365|NCT03037307|76078956|FG004|STARTED|Period 2||7||
59960366|NCT03037307|76078957|FG005|STARTED|Period 2||8||
59960367|NCT03037307|76078952|FG000|COMPLETED|Period 2||7||
59960368|NCT03037307|76078953|FG001|COMPLETED|Period 2||7||
59960369|NCT03037307|76078954|FG002|COMPLETED|Period 2||8||
59960370|NCT03037307|76078955|FG003|COMPLETED|Period 2||6||
59960371|NCT03037307|76078956|FG004|COMPLETED|Period 2||7||
59960372|NCT03037307|76078957|FG005|COMPLETED|Period 2||8||
59807087|NCT00686777|75928893|FG000|Completed 24 Weeks of Treatment|Overall Study||69||
59960373|NCT03037307|76078952|FG000|NOT COMPLETED|Period 2||0||
59960374|NCT03037307|76078953|FG001|NOT COMPLETED|Period 2||0||
59960375|NCT03037307|76078954|FG002|NOT COMPLETED|Period 2||0||
59960376|NCT03037307|76078955|FG003|NOT COMPLETED|Period 2||0||
59960377|NCT03037307|76078956|FG004|NOT COMPLETED|Period 2||0||
59807088|NCT00686777|75928893|FG000|Completed 48 Weeks of Treatment|Overall Study||65||
59960378|NCT03037307|76078957|FG005|NOT COMPLETED|Period 2||0||
59960379|NCT03037307|76078952|FG000|STARTED|Wash Out Period 2||7||
59960380|NCT03037307|76078953|FG001|STARTED|Wash Out Period 2||7||
59960381|NCT03037307|76078954|FG002|STARTED|Wash Out Period 2||8||
59960382|NCT03037307|76078955|FG003|STARTED|Wash Out Period 2||6||
59960383|NCT03037307|76078956|FG004|STARTED|Wash Out Period 2||7||
59960384|NCT03037307|76078957|FG005|STARTED|Wash Out Period 2||8||
59960385|NCT03037307|76078952|FG000|COMPLETED|Wash Out Period 2||7||
59960386|NCT03037307|76078953|FG001|COMPLETED|Wash Out Period 2||7||
59960387|NCT03037307|76078954|FG002|COMPLETED|Wash Out Period 2||8||
59960388|NCT03037307|76078955|FG003|COMPLETED|Wash Out Period 2||6||
59960389|NCT03037307|76078956|FG004|COMPLETED|Wash Out Period 2||7||
59807089|NCT00686777|75928893|FG000|Included in Follow-up (All Treated)|Overall Study||75||
59807090|NCT00686777|75928893|FG000|Completed 24 Weeks of Follow-up|Overall Study||70||
59807091|NCT00686777|75928893|FG000|COMPLETED|Overall Study|Of 10 noncompleters, 6 had AEs including 4 meeting protocol prespecified AE discontinuance criteria.|65||
59807092|NCT00686777|75928893|FG000|NOT COMPLETED|Overall Study||10||
59807093|NCT00686699|75928899|FG000|STARTED|Treatment Period 1||4||
59807094|NCT00686699|75928900|FG001|STARTED|Treatment Period 1||7||
59960390|NCT03037307|76078957|FG005|COMPLETED|Wash Out Period 2||8||
59960391|NCT03037307|76078952|FG000|NOT COMPLETED|Wash Out Period 2||0||
59960392|NCT03037307|76078953|FG001|NOT COMPLETED|Wash Out Period 2||0||
59960393|NCT03037307|76078954|FG002|NOT COMPLETED|Wash Out Period 2||0||
59960394|NCT03037307|76078955|FG003|NOT COMPLETED|Wash Out Period 2||0||
59807095|NCT00686699|75928899|FG000|COMPLETED|Treatment Period 1||4||
59807096|NCT00686699|75928900|FG001|COMPLETED|Treatment Period 1||5||
59807097|NCT00686699|75928899|FG000|NOT COMPLETED|Treatment Period 1||0||
59807098|NCT00686699|75928900|FG001|NOT COMPLETED|Treatment Period 1||2||
59960395|NCT03037307|76078956|FG004|NOT COMPLETED|Wash Out Period 2||0||
59960396|NCT03037307|76078957|FG005|NOT COMPLETED|Wash Out Period 2||0||
59960397|NCT03037307|76078952|FG000|STARTED|Period 3||7||
59960398|NCT03037307|76078953|FG001|STARTED|Period 3||7||
59960399|NCT03037307|76078954|FG002|STARTED|Period 3||8||
59960400|NCT03037307|76078955|FG003|STARTED|Period 3||6||
59960401|NCT03037307|76078956|FG004|STARTED|Period 3||7||
59960402|NCT03037307|76078957|FG005|STARTED|Period 3||8||
59960403|NCT03037307|76078952|FG000|COMPLETED|Period 3||7||
59960404|NCT03037307|76078953|FG001|COMPLETED|Period 3||7||
59960405|NCT03037307|76078954|FG002|COMPLETED|Period 3||8||
59960406|NCT03037307|76078955|FG003|COMPLETED|Period 3||6||
59960407|NCT03037307|76078956|FG004|COMPLETED|Period 3||7||
59960408|NCT03037307|76078957|FG005|COMPLETED|Period 3||8||
59960409|NCT03037307|76078952|FG000|NOT COMPLETED|Period 3||0||
59960410|NCT03037307|76078953|FG001|NOT COMPLETED|Period 3||0||
59960411|NCT03037307|76078954|FG002|NOT COMPLETED|Period 3||0||
59960412|NCT03037307|76078955|FG003|NOT COMPLETED|Period 3||0||
59960413|NCT03037307|76078956|FG004|NOT COMPLETED|Period 3||0||
59960414|NCT03037307|76078957|FG005|NOT COMPLETED|Period 3||0||
59960415|NCT02538094|76078966|FG000|STARTED|Intervention 1 (5 Days Per Participant)||2||
59960416|NCT02538094|76078967|FG001|STARTED|Intervention 1 (5 Days Per Participant)||5||
59960417|NCT02538094|76078966|FG000|COMPLETED|Intervention 1 (5 Days Per Participant)||2||
59960418|NCT02538094|76078967|FG001|COMPLETED|Intervention 1 (5 Days Per Participant)||4||
59960419|NCT02538094|76078966|FG000|NOT COMPLETED|Intervention 1 (5 Days Per Participant)||0||
59960420|NCT02538094|76078967|FG001|NOT COMPLETED|Intervention 1 (5 Days Per Participant)||1||
59960421|NCT02538094|76078966|FG000|STARTED|Washout (4 Weeks)||2||
59960422|NCT02538094|76078967|FG001|STARTED|Washout (4 Weeks)||4||
59807099|NCT00686699|75928899|FG000|STARTED|Treatment Period 2||4||
59807100|NCT00686699|75928900|FG001|STARTED|Treatment Period 2||5||
59807101|NCT00686699|75928899|FG000|COMPLETED|Treatment Period 2||4||
59807102|NCT00686699|75928900|FG001|COMPLETED|Treatment Period 2||5||
59807103|NCT00686699|75928899|FG000|NOT COMPLETED|Treatment Period 2||0||
59807104|NCT00686699|75928900|FG001|NOT COMPLETED|Treatment Period 2||0||
59960423|NCT02538094|76078966|FG000|COMPLETED|Washout (4 Weeks)||2||
59960424|NCT02538094|76078967|FG001|COMPLETED|Washout (4 Weeks)||3||
59807105|NCT00106639|75928909|FG000|STARTED|Overall Study||20||
59807106|NCT00106639|75928910|FG001|STARTED|Overall Study||20||
59807107|NCT00106639|75928911|FG002|STARTED|Overall Study||21||
59807108|NCT00106639|75928909|FG000|COMPLETED|Overall Study||17||
59807109|NCT00106639|75928910|FG001|COMPLETED|Overall Study||13||
59807110|NCT00106639|75928911|FG002|COMPLETED|Overall Study||19||
59807111|NCT00106639|75928909|FG000|NOT COMPLETED|Overall Study||3||
59807112|NCT00106639|75928910|FG001|NOT COMPLETED|Overall Study||7||
59807113|NCT00106639|75928911|FG002|NOT COMPLETED|Overall Study||2||
59807114|NCT00106249|75928922|FG000|STARTED|Overall Study||14||
59807115|NCT00106249|75928923|FG001|STARTED|Overall Study||13||
59807116|NCT00106249|75928922|FG000|COMPLETED|Overall Study||11||
59807117|NCT00106249|75928923|FG001|COMPLETED|Overall Study||11||
59807118|NCT00106249|75928922|FG000|NOT COMPLETED|Overall Study||3||
59807119|NCT00106249|75928923|FG001|NOT COMPLETED|Overall Study||2||
59807120|NCT00105469|75928931|FG000|STARTED|Overall Study||365||
59807121|NCT00105469|75928932|FG001|STARTED|Overall Study||378||
59807122|NCT00105469|75928931|FG000|COMPLETED|Overall Study||343||
59960425|NCT02538094|76078966|FG000|NOT COMPLETED|Washout (4 Weeks)||0||
59960426|NCT02538094|76078967|FG001|NOT COMPLETED|Washout (4 Weeks)||1||
59960427|NCT02538094|76078966|FG000|STARTED|Intervention 2 (5 Days Per Participant)||2||
59960428|NCT02538094|76078967|FG001|STARTED|Intervention 2 (5 Days Per Participant)||3||
59960429|NCT02538094|76078966|FG000|COMPLETED|Intervention 2 (5 Days Per Participant)||2||
59960430|NCT02538094|76078967|FG001|COMPLETED|Intervention 2 (5 Days Per Participant)||3||
59960431|NCT02538094|76078966|FG000|NOT COMPLETED|Intervention 2 (5 Days Per Participant)||0||
59960432|NCT02538094|76078967|FG001|NOT COMPLETED|Intervention 2 (5 Days Per Participant)||0||
59960433|NCT02686034|76078975|FG000|STARTED|Run-In Period 1||142||
59807123|NCT00105469|75928932|FG001|COMPLETED|Overall Study||367||
59807124|NCT00105469|75928931|FG000|NOT COMPLETED|Overall Study||22||
59807125|NCT00105469|75928932|FG001|NOT COMPLETED|Overall Study||11||
59807126|NCT00105235|75928938|FG000|STARTED|Overall Study||27||
59807127|NCT00105235|75928938|FG000|COMPLETED|Overall Study||20||
59807128|NCT00105235|75928938|FG000|NOT COMPLETED|Overall Study||7||
59807129|NCT00547118|75928948|FG000|STARTED|Overall Study||8||
59960434|NCT02686034|76078976|FG001|STARTED|Run-In Period 1||143||
59960435|NCT02686034|76078975|FG000|COMPLETED|Run-In Period 1||122||
59960436|NCT02686034|76078976|FG001|COMPLETED|Run-In Period 1||126||
59960437|NCT02686034|76078975|FG000|NOT COMPLETED|Run-In Period 1||20||
59960438|NCT02686034|76078976|FG001|NOT COMPLETED|Run-In Period 1||17||
59960439|NCT02686034|76078975|FG000|STARTED|Randomized Controlled Period 2||122||
59960440|NCT02686034|76078976|FG001|STARTED|Randomized Controlled Period 2||126||
59960441|NCT02686034|76078975|FG000|COMPLETED|Randomized Controlled Period 2||117||
59807130|NCT00547118|75928949|FG001|STARTED|Overall Study||9||
59807131|NCT00547118|75928948|FG000|COMPLETED|Overall Study||0||
59807132|NCT00547118|75928949|FG001|COMPLETED|Overall Study||0||
59807133|NCT00547118|75928948|FG000|NOT COMPLETED|Overall Study||8||
59807134|NCT00547118|75928949|FG001|NOT COMPLETED|Overall Study||9||
59807135|NCT00502593|75928969|FG000|STARTED|Overall Study||51||
59807136|NCT00502593|75928970|FG001|STARTED|Overall Study||18||
59807137|NCT00502593|75928971|FG002|STARTED|Overall Study||51||
59807138|NCT00502593|75928972|FG003|STARTED|Overall Study||18||
59807139|NCT00502593|75928973|FG004|STARTED|Overall Study||51||
59807140|NCT00502593|75928974|FG005|STARTED|Overall Study||17||
59807141|NCT00502593|75928975|FG006|STARTED|Overall Study||49||
59807142|NCT00502593|75928976|FG007|STARTED|Overall Study||17||
59807143|NCT00502593|75928977|FG008|STARTED|Overall Study||49||
59807144|NCT00502593|75928978|FG009|STARTED|Overall Study||17||
59807145|NCT00502593|75928979|FG010|STARTED|Overall Study||49||
59807146|NCT00502593|75928980|FG011|STARTED|Overall Study||18||
59807147|NCT00502593|75928969|FG000|COMPLETED|Overall Study||48||
59807148|NCT00502593|75928970|FG001|COMPLETED|Overall Study||16||
59807149|NCT00502593|75928971|FG002|COMPLETED|Overall Study||41||
59807150|NCT00502593|75928972|FG003|COMPLETED|Overall Study||14||
59807151|NCT00502593|75928973|FG004|COMPLETED|Overall Study||47||
59807152|NCT00502593|75928974|FG005|COMPLETED|Overall Study||17||
59807153|NCT00502593|75928975|FG006|COMPLETED|Overall Study||44||
59807154|NCT00502593|75928976|FG007|COMPLETED|Overall Study||17||
59807155|NCT00502593|75928977|FG008|COMPLETED|Overall Study||43||
59807156|NCT00502593|75928978|FG009|COMPLETED|Overall Study||17||
59807157|NCT00502593|75928979|FG010|COMPLETED|Overall Study||47||
59807158|NCT00502593|75928980|FG011|COMPLETED|Overall Study||18||
59807159|NCT00502593|75928969|FG000|NOT COMPLETED|Overall Study||3||
59807160|NCT00502593|75928970|FG001|NOT COMPLETED|Overall Study||2||
59807161|NCT00502593|75928971|FG002|NOT COMPLETED|Overall Study||10||
59960442|NCT02686034|76078976|FG001|COMPLETED|Randomized Controlled Period 2||122||
59960443|NCT02686034|76078975|FG000|NOT COMPLETED|Randomized Controlled Period 2||5||
59960444|NCT02686034|76078976|FG001|NOT COMPLETED|Randomized Controlled Period 2||4||
59960445|NCT02686034|76078975|FG000|STARTED|Open Label Period 3||117||
59960446|NCT02686034|76078976|FG001|STARTED|Open Label Period 3||122||
59960447|NCT02686034|76078975|FG000|COMPLETED|Open Label Period 3||117||
59960448|NCT02686034|76078976|FG001|COMPLETED|Open Label Period 3||121||
59960449|NCT02686034|76078975|FG000|NOT COMPLETED|Open Label Period 3||0||
59960450|NCT02686034|76078976|FG001|NOT COMPLETED|Open Label Period 3||1||
59960451|NCT02685488|76078984|FG000|STARTED|Overall Study||12||
59960452|NCT02685488|76078985|FG001|STARTED|Overall Study||14||
59807162|NCT00502593|75928972|FG003|NOT COMPLETED|Overall Study||4||
59807163|NCT00502593|75928973|FG004|NOT COMPLETED|Overall Study||4||
59807164|NCT00502593|75928974|FG005|NOT COMPLETED|Overall Study||0||
59807165|NCT00502593|75928975|FG006|NOT COMPLETED|Overall Study||5||
59807166|NCT00502593|75928976|FG007|NOT COMPLETED|Overall Study||0||
59807167|NCT00502593|75928977|FG008|NOT COMPLETED|Overall Study||6||
59960453|NCT02685488|76078984|FG000|COMPLETED|Overall Study||12||
59960454|NCT02685488|76078985|FG001|COMPLETED|Overall Study||13||
60074048|NCT01836458|76189442|FG001|STARTED|Overall Study||4||
59807168|NCT00502593|75928978|FG009|NOT COMPLETED|Overall Study||0||
59807169|NCT00502593|75928979|FG010|NOT COMPLETED|Overall Study||2||
59807170|NCT00502593|75928980|FG011|NOT COMPLETED|Overall Study||0||
59807171|NCT00686543|75929033|FG000|STARTED|Overall Study||14||
59807172|NCT00686543|75929034|FG001|STARTED|Overall Study||21||
59807173|NCT00686543|75929035|FG002|STARTED|Overall Study||20||
59807174|NCT00686543|75929036|FG003|STARTED|Overall Study||20||
59807175|NCT00686543|75929033|FG000|COMPLETED|Overall Study||0||
59807176|NCT00686543|75929034|FG001|COMPLETED|Overall Study||20||
59807177|NCT00686543|75929035|FG002|COMPLETED|Overall Study||15||
59807178|NCT00686543|75929036|FG003|COMPLETED|Overall Study||17||
59807179|NCT00686543|75929033|FG000|NOT COMPLETED|Overall Study||14||
59807180|NCT00686543|75929034|FG001|NOT COMPLETED|Overall Study||1||
59960455|NCT02685488|76078984|FG000|NOT COMPLETED|Overall Study||0||
59960456|NCT02685488|76078985|FG001|NOT COMPLETED|Overall Study||1||
59960457|NCT02533570|76078994|FG000|STARTED|Overall Study||4||
59960458|NCT02533570|76078995|FG001|STARTED|Overall Study||8||
59960459|NCT02533570|76078996|FG002|STARTED|Overall Study||8||
59960460|NCT02533570|76078994|FG000|COMPLETED|Overall Study||4||
59960461|NCT02533570|76078995|FG001|COMPLETED|Overall Study||7||
60074049|NCT01836458|76189443|FG002|STARTED|Overall Study||7||
59807181|NCT00686543|75929035|FG002|NOT COMPLETED|Overall Study||5||
59807182|NCT00686543|75929036|FG003|NOT COMPLETED|Overall Study||3||
59807183|NCT00545688|75929050|FG000|STARTED|Neo-Adjuvant Treatment Period||107||
59807184|NCT00545688|75929051|FG001|STARTED|Neo-Adjuvant Treatment Period||107||
59807185|NCT00545688|75929052|FG002|STARTED|Neo-Adjuvant Treatment Period||108||
59807186|NCT00545688|75929053|FG003|STARTED|Neo-Adjuvant Treatment Period||94||
59807187|NCT00545688|75929050|FG000|COMPLETED|Neo-Adjuvant Treatment Period||103||
59807188|NCT00545688|75929051|FG001|COMPLETED|Neo-Adjuvant Treatment Period||102||
59807189|NCT00545688|75929052|FG002|COMPLETED|Neo-Adjuvant Treatment Period||94||
59807190|NCT00545688|75929053|FG003|COMPLETED|Neo-Adjuvant Treatment Period||88||
59807191|NCT00545688|75929050|FG000|NOT COMPLETED|Neo-Adjuvant Treatment Period||4||
59807192|NCT00545688|75929051|FG001|NOT COMPLETED|Neo-Adjuvant Treatment Period||5||
59807193|NCT00545688|75929052|FG002|NOT COMPLETED|Neo-Adjuvant Treatment Period||14||
59807194|NCT00545688|75929053|FG003|NOT COMPLETED|Neo-Adjuvant Treatment Period||6||
59807195|NCT00545688|75929050|FG000|STARTED|Adjuvant Treatment Period||103||
59807196|NCT00545688|75929051|FG001|STARTED|Adjuvant Treatment Period||102||
59807197|NCT00545688|75929052|FG002|STARTED|Adjuvant Treatment Period||94||
59807198|NCT00545688|75929053|FG003|STARTED|Adjuvant Treatment Period||88||
59807199|NCT00545688|75929050|FG000|COMPLETED|Adjuvant Treatment Period||98||
59807200|NCT00545688|75929051|FG001|COMPLETED|Adjuvant Treatment Period||94||
59807201|NCT00545688|75929052|FG002|COMPLETED|Adjuvant Treatment Period||90||
59807202|NCT00545688|75929053|FG003|COMPLETED|Adjuvant Treatment Period||74||
59807203|NCT00545688|75929050|FG000|NOT COMPLETED|Adjuvant Treatment Period||5||
59960462|NCT02533570|76078996|FG002|COMPLETED|Overall Study||7||
59960463|NCT02533570|76078994|FG000|NOT COMPLETED|Overall Study||0||
59960464|NCT02533570|76078995|FG001|NOT COMPLETED|Overall Study||1||
59960465|NCT02533570|76078996|FG002|NOT COMPLETED|Overall Study||1||
59960466|NCT03036839|76079007|FG000|STARTED|Overall Study||45||
59960467|NCT03036839|76079008|FG001|STARTED|Overall Study||31||
59960468|NCT03036839|76079009|FG002|STARTED|Overall Study||19||
59960469|NCT03036839|76079007|FG000|COMPLETED|Overall Study||42||
59960470|NCT03036839|76079008|FG001|COMPLETED|Overall Study||31||
59960471|NCT03036839|76079009|FG002|COMPLETED|Overall Study||14||
59960472|NCT03036839|76079007|FG000|NOT COMPLETED|Overall Study||3||
59960473|NCT03036839|76079008|FG001|NOT COMPLETED|Overall Study||0||
59960474|NCT03036839|76079009|FG002|NOT COMPLETED|Overall Study||5||
59960475|NCT01286207|76079020|FG000|STARTED|Overall Study||751||
59960476|NCT01286207|76079021|FG001|STARTED|Overall Study||857||
59960477|NCT01286207|76079022|FG002|STARTED|Overall Study||351||
59960478|NCT01286207|76079020|FG000|COMPLETED|Overall Study||453||
59960479|NCT01286207|76079021|FG001|COMPLETED|Overall Study||609||
59960480|NCT01286207|76079022|FG002|COMPLETED|Overall Study||261||
59960481|NCT01286207|76079020|FG000|NOT COMPLETED|Overall Study||298||
59960482|NCT01286207|76079021|FG001|NOT COMPLETED|Overall Study||248||
59960483|NCT01286207|76079022|FG002|NOT COMPLETED|Overall Study||90||
59960484|NCT02236000|76079035|FG000|STARTED|Overall Study||6||
59960485|NCT02236000|76079036|FG001|STARTED|Overall Study||10||
59960486|NCT02236000|76079037|FG002|STARTED|Overall Study||8||
59960487|NCT02236000|76079038|FG003|STARTED|Overall Study||3||
59960488|NCT02236000|76079039|FG004|STARTED|Overall Study||22||
59960489|NCT02236000|76079035|FG000|COMPLETED|Overall Study||6||
60074050|NCT01836458|76189444|FG003|STARTED|Overall Study||7||
59807204|NCT00545688|75929051|FG001|NOT COMPLETED|Adjuvant Treatment Period||8||
59807205|NCT00545688|75929052|FG002|NOT COMPLETED|Adjuvant Treatment Period||4||
59807206|NCT00545688|75929053|FG003|NOT COMPLETED|Adjuvant Treatment Period||14||
59807207|NCT00545688|75929050|FG000|STARTED|Follow-Up Period||98||
59807208|NCT00545688|75929051|FG001|STARTED|Follow-Up Period||102||
59807209|NCT00545688|75929052|FG002|STARTED|Follow-Up Period||98||
59807210|NCT00545688|75929053|FG003|STARTED|Follow-Up Period||87||
59807211|NCT00545688|75929050|FG000|COMPLETED|Follow-Up Period||77||
59807212|NCT00545688|75929051|FG001|COMPLETED|Follow-Up Period||83||
59807213|NCT00545688|75929052|FG002|COMPLETED|Follow-Up Period||78||
59807214|NCT00545688|75929053|FG003|COMPLETED|Follow-Up Period||60||
59807215|NCT00545688|75929050|FG000|NOT COMPLETED|Follow-Up Period||21||
59807216|NCT00545688|75929051|FG001|NOT COMPLETED|Follow-Up Period||19||
59807217|NCT00545688|75929052|FG002|NOT COMPLETED|Follow-Up Period||20||
59807218|NCT00545688|75929053|FG003|NOT COMPLETED|Follow-Up Period||27||
59807219|NCT00502203|75929066|FG000|STARTED|Overall Study||23||
59807220|NCT00502203|75929066|FG000|COMPLETED|Overall Study||22||
59807221|NCT00502203|75929066|FG000|NOT COMPLETED|Overall Study||1||
59807222|NCT00546078|75929072|FG000|STARTED|Overall Study||65||
59807223|NCT00546078|75929073|FG001|STARTED|Overall Study||50||
59807224|NCT00546078|75929072|FG000|Month 18|Overall Study||61||
59807225|NCT00546078|75929073|FG001|Month 18|Overall Study||45||
59807226|NCT00546078|75929072|FG000|COMPLETED|Overall Study||61||
59807227|NCT00546078|75929073|FG001|COMPLETED|Overall Study||43||
59807228|NCT00546078|75929072|FG000|NOT COMPLETED|Overall Study||4||
59807229|NCT00546078|75929073|FG001|NOT COMPLETED|Overall Study||7||
59807230|NCT00546000|75929079|FG000|STARTED|Overall Study||56||
59807231|NCT00546000|75929079|FG000|COMPLETED|Overall Study||52||
59807232|NCT00546000|75929079|FG000|NOT COMPLETED|Overall Study||4||
59807233|NCT00501969|75929083|FG000|STARTED|Overall Study||395||
59807234|NCT00501969|75929083|FG000|COMPLETED|Overall Study||189||
59807235|NCT00501969|75929083|FG000|NOT COMPLETED|Overall Study||206||
59807236|NCT03942042|75929089|FG000|STARTED|Induction Dosing Period (12 Weeks)||7||
59807237|NCT03942042|75929090|FG001|STARTED|Induction Dosing Period (12 Weeks)||5||
59807238|NCT03942042|75929089|FG000|Received at Least One Dose of Study Drug|Induction Dosing Period (12 Weeks)||7||
59807239|NCT03942042|75929090|FG001|Received at Least One Dose of Study Drug|Induction Dosing Period (12 Weeks)||5||
59960490|NCT02236000|76079036|FG001|COMPLETED|Overall Study||10||
59960491|NCT02236000|76079037|FG002|COMPLETED|Overall Study||8||
59960492|NCT02236000|76079038|FG003|COMPLETED|Overall Study||3||
59960493|NCT02236000|76079039|FG004|COMPLETED|Overall Study||22||
59960494|NCT02236000|76079035|FG000|NOT COMPLETED|Overall Study||0||
59807240|NCT03942042|75929089|FG000|Participants With GIS=1 at Week 12|Induction Dosing Period (12 Weeks)||4||
59807241|NCT03942042|75929090|FG001|Participants With GIS=1 at Week 12|Induction Dosing Period (12 Weeks)||0||
59807242|NCT03942042|75929089|FG000|Participants Who Completed Week 12 With GIS >= 2|Induction Dosing Period (12 Weeks)||2||
59807243|NCT03942042|75929090|FG001|Participants Who Completed Week 12 With GIS >= 2|Induction Dosing Period (12 Weeks)||4||
59807244|NCT03942042|75929089|FG000|COMPLETED|Induction Dosing Period (12 Weeks)||6||
59807245|NCT03942042|75929090|FG001|COMPLETED|Induction Dosing Period (12 Weeks)||4||
59807246|NCT03942042|75929089|FG000|NOT COMPLETED|Induction Dosing Period (12 Weeks)||1||
59807247|NCT03942042|75929090|FG001|NOT COMPLETED|Induction Dosing Period (12 Weeks)||1||
59807248|NCT03942042|75929089|FG000|STARTED|Maintenance Dosing Period (8 Weeks)|Only participants with GIS ≥2 at Week 12 and based on investigators' discretion continued to maintenance dosing period.|2||
59807249|NCT03942042|75929090|FG001|STARTED|Maintenance Dosing Period (8 Weeks)||4||
59807250|NCT03942042|75929089|FG000|COMPLETED|Maintenance Dosing Period (8 Weeks)||2||
59807251|NCT03942042|75929090|FG001|COMPLETED|Maintenance Dosing Period (8 Weeks)||4||
59960495|NCT02236000|76079036|FG001|NOT COMPLETED|Overall Study||0||
59960496|NCT02236000|76079037|FG002|NOT COMPLETED|Overall Study||0||
59960497|NCT02236000|76079038|FG003|NOT COMPLETED|Overall Study||0||
59960498|NCT02236000|76079039|FG004|NOT COMPLETED|Overall Study||0||
59960499|NCT00968201|76079059|FG000|STARTED|Base Study - (Period II)|Includes patients who completed Period I (2-week placebo run-in) and were randomized to placebo.|228||
59960500|NCT00968201|76079060|FG001|STARTED|Base Study - (Period II)||0||
59960501|NCT00968201|76079061|FG002|STARTED|Base Study - (Period II)|Includes patients who completed Period I (2-week placebo run-in) and were randomized to montelukast.|461||
59960502|NCT00968201|76079059|FG000|COMPLETED|Base Study - (Period II)|Patients completing Period II were eligible to enter the optional Period III|202||
59960503|NCT00968201|76079060|FG001|COMPLETED|Base Study - (Period II)||0||
59960504|NCT00968201|76079061|FG002|COMPLETED|Base Study - (Period II)|Patients completing Period II were eligible to enter the optional Period III|416||
59960505|NCT00968201|76079059|FG000|NOT COMPLETED|Base Study - (Period II)||26||
59960506|NCT00968201|76079060|FG001|NOT COMPLETED|Base Study - (Period II)||0||
59960507|NCT00968201|76079061|FG002|NOT COMPLETED|Base Study - (Period II)||45||
59960508|NCT00968201|76079059|FG000|STARTED|Extension Study - (Period III)||0||
59960509|NCT00968201|76079060|FG001|STARTED|Extension Study - (Period III)|Eligible Patients who completed Period II and entered the optional Extension Study (Period III)|157||
59960510|NCT00968201|76079061|FG002|STARTED|Extension Study - (Period III)|Eligible Patients who completed Period II and entered the optional Extension Study (Period III)|364||
59960511|NCT00968201|76079059|FG000|COMPLETED|Extension Study - (Period III)||0||
59960512|NCT00968201|76079060|FG001|COMPLETED|Extension Study - (Period III)||33||
59960513|NCT00968201|76079061|FG002|COMPLETED|Extension Study - (Period III)||84||
59960514|NCT00968201|76079059|FG000|NOT COMPLETED|Extension Study - (Period III)||0||
59960515|NCT00968201|76079060|FG001|NOT COMPLETED|Extension Study - (Period III)||124||
59960516|NCT00968201|76079061|FG002|NOT COMPLETED|Extension Study - (Period III)||280||
59960517|NCT00943397|76079072|FG000|STARTED|Overall Study||32||
59960518|NCT00943397|76079073|FG001|STARTED|Overall Study||158||
59960519|NCT00943397|76079072|FG000|COMPLETED|Overall Study|Site terminated - Merck administrative decision (11); Discontinued for other (1)|17||
59960520|NCT00943397|76079073|FG001|COMPLETED|Overall Study|Site terminated - Merck administrative decision (52); Patient moved (1); Discontinued for other (3)|86||
59960521|NCT00943397|76079072|FG000|NOT COMPLETED|Overall Study||15||
59960522|NCT00943397|76079073|FG001|NOT COMPLETED|Overall Study||72||
59960523|NCT00702845|76079081|FG000|STARTED|Overall Study||268||
59807252|NCT03942042|75929089|FG000|NOT COMPLETED|Maintenance Dosing Period (8 Weeks)||0||
59807253|NCT03942042|75929090|FG001|NOT COMPLETED|Maintenance Dosing Period (8 Weeks)||0||
59807254|NCT00104299|75929102|FG000|STARTED|Overall Study||99||
59807255|NCT00104299|75929103|FG001|STARTED|Overall Study||98||
59807256|NCT00104299|75929102|FG000|COMPLETED|Overall Study|Number of participants who completed 18 months post-randomization|90||
59807257|NCT00104299|75929103|FG001|COMPLETED|Overall Study|Number of participants who completed 18 months post-randomization|88||
59807258|NCT00104299|75929102|FG000|NOT COMPLETED|Overall Study||9||
59807259|NCT00104299|75929103|FG001|NOT COMPLETED|Overall Study||10||
59807260|NCT03939312|75929109|FG000|STARTED|OL Treatment Period (40 Weeks)||685||
59807261|NCT03939312|75929109|FG000|COMPLETED|OL Treatment Period (40 Weeks)||511||
59807262|NCT03939312|75929109|FG000|NOT COMPLETED|OL Treatment Period (40 Weeks)||174||
59807263|NCT03939312|75929109|FG000|STARTED|Safety Follow-up 4 Weeks (Up to Week 44)|Out of 685 participants, 640 participants who received treatment including 511 participants who completed the treatment entered safety follow-up period.|640||
59807264|NCT03939312|75929109|FG000|COMPLETED|Safety Follow-up 4 Weeks (Up to Week 44)||624||
59807265|NCT03939312|75929109|FG000|NOT COMPLETED|Safety Follow-up 4 Weeks (Up to Week 44)||16||
59807266|NCT00082381|75929117|FG000|STARTED|Overall Study||283||
59807267|NCT00082381|75929118|FG001|STARTED|Overall Study||268||
59807268|NCT00082381|75929117|FG000|Received Treatment (Intent to Treat)|Overall Study||282||
59960524|NCT00702845|76079082|FG001|STARTED|Overall Study|Includes one treated participant who was not randomized|129||
59960525|NCT00702845|76079081|FG000|Randomized|Overall Study||268||
59960526|NCT00702845|76079082|FG001|Randomized|Overall Study||128||
59960527|NCT00702845|76079081|FG000|COMPLETED|Overall Study||246||
59960528|NCT00702845|76079082|FG001|COMPLETED|Overall Study||121||
59960529|NCT00702845|76079081|FG000|NOT COMPLETED|Overall Study||22||
59807269|NCT00082381|75929118|FG001|Received Treatment (Intent to Treat)|Overall Study||267||
59807270|NCT00082381|75929117|FG000|COMPLETED|Overall Study||228||
59807271|NCT00082381|75929118|FG001|COMPLETED|Overall Study||242||
59807272|NCT00082381|75929117|FG000|NOT COMPLETED|Overall Study||55||
59807273|NCT00082381|75929118|FG001|NOT COMPLETED|Overall Study||26||
59807274|NCT00545844|75929124|FG000|STARTED|Overall Study||313||
59807275|NCT00545844|75929124|FG000|COMPLETED|Overall Study||301||
59807276|NCT00545844|75929124|FG000|NOT COMPLETED|Overall Study||12||
59807277|NCT00492063|75929134|FG000|STARTED|Overall Study||652||
59807278|NCT00492063|75929135|FG001|STARTED|Overall Study||648||
59807279|NCT00492063|75929136|FG002|STARTED|Overall Study||678||
59807280|NCT00492063|75929137|FG003|STARTED|Overall Study||676||
59807281|NCT00492063|75929134|FG000|COMPLETED|Overall Study||642||
59807282|NCT00492063|75929135|FG001|COMPLETED|Overall Study||634||
59807283|NCT00492063|75929136|FG002|COMPLETED|Overall Study||667||
59807284|NCT00492063|75929137|FG003|COMPLETED|Overall Study||666||
59960530|NCT00702845|76079082|FG001|NOT COMPLETED|Overall Study||8||
59960531|NCT01302847|76079096|FG000|STARTED|Overall Study||23||
59960532|NCT01302847|76079097|FG001|STARTED|Overall Study||23||
59960533|NCT01302847|76079098|FG002|STARTED|Overall Study||17||
59960534|NCT01302847|76079099|FG003|STARTED|Overall Study||15||
59960535|NCT01302847|76079100|FG004|STARTED|Overall Study||7||
59960536|NCT01302847|76079101|FG005|STARTED|Overall Study||36||
59960537|NCT01302847|76079102|FG006|STARTED|Overall Study||35||
59960538|NCT01302847|76079103|FG007|STARTED|Overall Study||25||
59960539|NCT01302847|76079096|FG000|COMPLETED|Overall Study||10|Study is ongoing. Some participants are still in follow-up. Participant Flow Overview will be updated upon study completion. Summary tables are based on data through database freeze date (March 24, 2021) for this primary results submission.|
59960540|NCT01302847|76079097|FG001|COMPLETED|Overall Study||16|Study is ongoing. Some participants are still in follow-up. Participant Flow Overview will be updated upon study completion. Summary tables are based on data through database freeze date (March 24, 2021) for this primary results submission.|
59960541|NCT01302847|76079098|FG002|COMPLETED|Overall Study||15|Study is ongoing. Some participants are still in follow-up. Participant Flow Overview will be updated upon study completion. Summary tables are based on data through database freeze date (March 24, 2021) for this primary results submission.|
59960542|NCT01302847|76079099|FG003|COMPLETED|Overall Study||14|Study is ongoing. Some participants are still in follow-up. Participant Flow Overview will be updated upon study completion. Summary tables are based on data through database freeze date (March 24, 2021) for this primary results submission.|
59807285|NCT00492063|75929134|FG000|NOT COMPLETED|Overall Study||10||
59807286|NCT00492063|75929135|FG001|NOT COMPLETED|Overall Study||14||
59807287|NCT00492063|75929136|FG002|NOT COMPLETED|Overall Study||11||
59807288|NCT00492063|75929137|FG003|NOT COMPLETED|Overall Study||10||
59807289|NCT00093145|75929147|FG000|STARTED|Overall Study||32||
59807290|NCT00093145|75929147|FG000|At Least One Response Assessment|Overall Study||31||
59807291|NCT00093145|75929147|FG000|COMPLETED|Overall Study|Treatment completed upon progressive disease|15||
59807292|NCT00093145|75929147|FG000|NOT COMPLETED|Overall Study||17||
59807293|NCT00513357|75929153|FG000|STARTED|Overall Study||38||
59807294|NCT00513357|75929154|FG001|STARTED|Overall Study||35||
59807295|NCT00513357|75929153|FG000|COMPLETED|Overall Study||23||
59807296|NCT00513357|75929154|FG001|COMPLETED|Overall Study||25||
59807297|NCT00513357|75929153|FG000|NOT COMPLETED|Overall Study||15||
59807298|NCT00513357|75929154|FG001|NOT COMPLETED|Overall Study||10||
59807299|NCT03933462|75929160|FG000|STARTED|Overall Study||10||
59807300|NCT03933462|75929161|FG001|STARTED|Overall Study||10||
59807301|NCT03933462|75929160|FG000|Crossover|Overall Study||8||
59807302|NCT03933462|75929161|FG001|Crossover|Overall Study||10||
59807303|NCT03933462|75929160|FG000|COMPLETED|Overall Study||8||
59807304|NCT03933462|75929161|FG001|COMPLETED|Overall Study||10||
59807305|NCT03933462|75929160|FG000|NOT COMPLETED|Overall Study||2||
59994923|NCT03420781|76110738|FG000|NOT COMPLETED|Treatment Period (40 Weeks)||144||
59994924|NCT03420781|76110739|FG001|NOT COMPLETED|Treatment Period (40 Weeks)||126||
59994925|NCT03420781|76110740|FG002|NOT COMPLETED|Treatment Period (40 Weeks)||0||
59994926|NCT03420781|76110741|FG003|NOT COMPLETED|Treatment Period (40 Weeks)||0||
59994927|NCT03420781|76110742|FG004|NOT COMPLETED|Treatment Period (40 Weeks)||0||
59994928|NCT03420781|76110738|FG000|STARTED|RW Period: 6 Weeks (Week 41 to Week 46)||0||
59994929|NCT03420781|76110739|FG001|STARTED|RW Period: 6 Weeks (Week 41 to Week 46)||0||
59807306|NCT03933462|75929161|FG001|NOT COMPLETED|Overall Study||0||
59807307|NCT03929562|75929169|FG000|STARTED|From Baseline to 1 Month Follow Up||26||
59994930|NCT03420781|76110740|FG002|STARTED|RW Period: 6 Weeks (Week 41 to Week 46)||91||
59807308|NCT03929562|75929170|FG001|STARTED|From Baseline to 1 Month Follow Up||25||
59807309|NCT03929562|75929169|FG000|COMPLETED|From Baseline to 1 Month Follow Up||22||
59807310|NCT03929562|75929170|FG001|COMPLETED|From Baseline to 1 Month Follow Up||24||
59807311|NCT03929562|75929169|FG000|NOT COMPLETED|From Baseline to 1 Month Follow Up||4||
59807312|NCT03929562|75929170|FG001|NOT COMPLETED|From Baseline to 1 Month Follow Up||1||
59807313|NCT03929562|75929169|FG000|STARTED|1 Month Follow Up to 4 Month Follow Up||22||
59807314|NCT03929562|75929170|FG001|STARTED|1 Month Follow Up to 4 Month Follow Up||24||
59807315|NCT03929562|75929169|FG000|COMPLETED|1 Month Follow Up to 4 Month Follow Up||20||
59807316|NCT03929562|75929170|FG001|COMPLETED|1 Month Follow Up to 4 Month Follow Up||24||
59807317|NCT03929562|75929169|FG000|NOT COMPLETED|1 Month Follow Up to 4 Month Follow Up||2||
59807318|NCT03929562|75929170|FG001|NOT COMPLETED|1 Month Follow Up to 4 Month Follow Up||0||
59807319|NCT00415636|75929184|FG000|STARTED|Overall Study||3||
59807320|NCT00415636|75929185|FG001|STARTED|Overall Study||3||
59807321|NCT00415636|75929186|FG002|STARTED|Overall Study||3||
59807322|NCT00415636|75929187|FG003|STARTED|Overall Study||13||
59807323|NCT00415636|75929188|FG004|STARTED|Overall Study||6||
59807324|NCT00415636|75929189|FG005|STARTED|Overall Study||3||
59807325|NCT00415636|75929184|FG000|COMPLETED|Overall Study|Completed = Participant received 2 cycles of treatment|2||
59807326|NCT00415636|75929185|FG001|COMPLETED|Overall Study|Completed = Participant received 2 cycles of treatment|3||
59807327|NCT00415636|75929186|FG002|COMPLETED|Overall Study|Completed = Participant received 2 cycles of treatment|2||
59807328|NCT00415636|75929187|FG003|COMPLETED|Overall Study|Completed = Participant received 2 cycles of treatment|7||
59807329|NCT00415636|75929188|FG004|COMPLETED|Overall Study|Completed = Participant received 2 cycles of treatment|4||
59807330|NCT00415636|75929189|FG005|COMPLETED|Overall Study|Completed = Participant received 2 cycles of treatment|1||
59807331|NCT00415636|75929184|FG000|NOT COMPLETED|Overall Study||1||
59807332|NCT00415636|75929185|FG001|NOT COMPLETED|Overall Study||0||
59807333|NCT00415636|75929186|FG002|NOT COMPLETED|Overall Study||1||
59807334|NCT00415636|75929187|FG003|NOT COMPLETED|Overall Study||6||
59807335|NCT00415636|75929188|FG004|NOT COMPLETED|Overall Study||2||
59807336|NCT00415636|75929189|FG005|NOT COMPLETED|Overall Study||2||
59807337|NCT00425854|75929213|FG000|STARTED|Overall Study|Treated|29||
59807338|NCT00425854|75929214|FG001|STARTED|Overall Study|Treated|21||
59807339|NCT00425854|75929213|FG000|COMPLETED|Overall Study|On treatment at analysis cut-off date (30 Sep 2009)|0||
59807340|NCT00425854|75929214|FG001|COMPLETED|Overall Study|On treatment at analysis cut-off date (30 Sep 2009)|0||
59807341|NCT00425854|75929213|FG000|NOT COMPLETED|Overall Study||29||
59807342|NCT00425854|75929214|FG001|NOT COMPLETED|Overall Study||21||
59807343|NCT00425698|75929223|FG000|STARTED|Overall Study||44||
59807344|NCT00425698|75929224|FG001|STARTED|Overall Study||44||
59807345|NCT00425698|75929223|FG000|COMPLETED|Overall Study||41||
59807346|NCT00425698|75929224|FG001|COMPLETED|Overall Study||42||
59960543|NCT01302847|76079100|FG004|COMPLETED|Overall Study||5|Study is ongoing. Some participants are still in follow-up. Participant Flow Overview will be updated upon study completion. Summary tables are based on data through database freeze date (March 24, 2021) for this primary results submission.|
59960544|NCT01302847|76079101|FG005|COMPLETED|Overall Study||6|Study is ongoing. Some participants are still in follow-up. Participant Flow Overview will be updated upon study completion. Summary tables are based on data through database freeze date (March 24, 2021) for this primary results submission.|
59960545|NCT01302847|76079102|FG006|COMPLETED|Overall Study||9|Study is ongoing. Some participants are still in follow-up. Participant Flow Overview will be updated upon study completion. Summary tables are based on data through database freeze date (March 24, 2021) for this primary results submission.|
59960546|NCT01302847|76079103|FG007|COMPLETED|Overall Study||3|Study is ongoing. Some participants are still in follow-up. Participant Flow Overview will be updated upon study completion. Summary tables are based on data through database freeze date (March 24, 2021) for this primary results submission.|
59960547|NCT01302847|76079096|FG000|NOT COMPLETED|Overall Study||13||
59960548|NCT01302847|76079097|FG001|NOT COMPLETED|Overall Study||7||
59960549|NCT01302847|76079098|FG002|NOT COMPLETED|Overall Study||2||
59960550|NCT01302847|76079099|FG003|NOT COMPLETED|Overall Study||1||
59960551|NCT01302847|76079100|FG004|NOT COMPLETED|Overall Study||2||
59960552|NCT01302847|76079101|FG005|NOT COMPLETED|Overall Study||30||
59960553|NCT01302847|76079102|FG006|NOT COMPLETED|Overall Study||26||
59960554|NCT01302847|76079103|FG007|NOT COMPLETED|Overall Study||22||
59960555|NCT03039569|76079132|FG000|STARTED|Overall Study||40||
59960556|NCT03039569|76079133|FG001|STARTED|Overall Study||39||
59960557|NCT03039569|76079132|FG000|COMPLETED|Overall Study||35||
59960558|NCT03039569|76079133|FG001|COMPLETED|Overall Study||35||
59960559|NCT03039569|76079132|FG000|NOT COMPLETED|Overall Study||5||
59960560|NCT03039569|76079133|FG001|NOT COMPLETED|Overall Study||4||
59960561|NCT02738775|76079146|FG000|STARTED|Overall Study||8||
59960562|NCT02738775|76079147|FG001|STARTED|Overall Study||8||
59960563|NCT02738775|76079148|FG002|STARTED|Overall Study||8||
59960564|NCT02738775|76079149|FG003|STARTED|Overall Study||9||
59807347|NCT00425698|75929223|FG000|NOT COMPLETED|Overall Study||3||
59807348|NCT00425698|75929224|FG001|NOT COMPLETED|Overall Study||2||
59807349|NCT00425308|75929232|FG000|STARTED|Overall Study||15||
59807350|NCT00425308|75929233|FG001|STARTED|Overall Study||15||
59807351|NCT00425308|75929232|FG000|COMPLETED|Overall Study||11||
59807352|NCT00425308|75929233|FG001|COMPLETED|Overall Study||14||
59807353|NCT00425308|75929232|FG000|NOT COMPLETED|Overall Study||4||
59807354|NCT00425308|75929233|FG001|NOT COMPLETED|Overall Study||1||
59807355|NCT00545064|75929239|FG000|STARTED|Overall Study||178||
59807356|NCT00545064|75929239|FG000|Visit 1 (Baseline)|Overall Study||178||
59807357|NCT00545064|75929239|FG000|Visit 2 (Week 4)|Overall Study||169||
59807358|NCT00545064|75929239|FG000|Visit 3 (Week 8)|Overall Study|8 patients didn't complete the 8-week period. 6 were retrieved and considered as Visit 3 (Week 8)|176||
59807359|NCT00545064|75929239|FG000|COMPLETED|Overall Study||170||
59807360|NCT00545064|75929239|FG000|NOT COMPLETED|Overall Study||8||
60074051|NCT01836458|76189441|FG000|COMPLETED|Overall Study||4||
60074052|NCT01836458|76189442|FG001|COMPLETED|Overall Study||2||
59807361|NCT00432562|75929247|FG000|STARTED|Overall Study||16||
59807362|NCT00432562|75929248|FG001|STARTED|Overall Study||15||
59960565|NCT02738775|76079150|FG004|STARTED|Overall Study||8||
59960566|NCT02738775|76079151|FG005|STARTED|Overall Study||8||
59960567|NCT02738775|76079146|FG000|Initially Treated With Placebo|Overall Study||0||
59960568|NCT02738775|76079147|FG001|Initially Treated With Placebo|Overall Study||0||
59960569|NCT02738775|76079148|FG002|Initially Treated With Placebo|Overall Study||0||
59960570|NCT02738775|76079149|FG003|Initially Treated With Placebo|Overall Study||1||
59960571|NCT02738775|76079150|FG004|Initially Treated With Placebo|Overall Study||0||
59960572|NCT02738775|76079151|FG005|Initially Treated With Placebo|Overall Study||0||
59960573|NCT02738775|76079146|FG000|COMPLETED|Overall Study||8||
59960574|NCT02738775|76079147|FG001|COMPLETED|Overall Study||6||
59960575|NCT02738775|76079148|FG002|COMPLETED|Overall Study||8||
59524393|NCT01004705|75619584|FG000|STARTED|Period 1 (12 Weeks)||0||
59524394|NCT01004705|75619585|FG001|STARTED|Period 1 (12 Weeks)||18||
59524395|NCT01004705|75619586|FG002|STARTED|Period 1 (12 Weeks)||18||
59960576|NCT02738775|76079149|FG003|COMPLETED|Overall Study||8||
59960577|NCT02738775|76079150|FG004|COMPLETED|Overall Study||8||
59524396|NCT01004705|75619584|FG000|COMPLETED|Period 1 (12 Weeks)||0||
59524397|NCT01004705|75619585|FG001|COMPLETED|Period 1 (12 Weeks)||13||
59524398|NCT01004705|75619586|FG002|COMPLETED|Period 1 (12 Weeks)||13||
59524399|NCT01004705|75619584|FG000|NOT COMPLETED|Period 1 (12 Weeks)||0||
59960578|NCT02738775|76079151|FG005|COMPLETED|Overall Study||7||
59960579|NCT02738775|76079146|FG000|NOT COMPLETED|Overall Study||0||
59960580|NCT02738775|76079147|FG001|NOT COMPLETED|Overall Study||2||
59960581|NCT02738775|76079148|FG002|NOT COMPLETED|Overall Study||0||
59960582|NCT02738775|76079149|FG003|NOT COMPLETED|Overall Study||1||
59960583|NCT02738775|76079150|FG004|NOT COMPLETED|Overall Study||0||
59960584|NCT02738775|76079151|FG005|NOT COMPLETED|Overall Study||1||
59960585|NCT00543127|76079171|FG000|STARTED|Overall Study||433||
59960586|NCT00543127|76079172|FG001|STARTED|Overall Study||437||
60074053|NCT01836458|76189443|FG002|COMPLETED|Overall Study||2||
59621012|NCT00290472|75732524|FG000|COMPLETED|Overall Study||32||
59621013|NCT00290472|75732525|FG001|COMPLETED|Overall Study||39||
59621014|NCT00290472|75732526|FG002|COMPLETED|Overall Study||18||
59621015|NCT00290472|75732524|FG000|NOT COMPLETED|Overall Study||0||
59621016|NCT00290472|75732525|FG001|NOT COMPLETED|Overall Study||0||
59621017|NCT00290472|75732526|FG002|NOT COMPLETED|Overall Study||0||
59621018|NCT00291876|75732532|FG000|STARTED|Month 138||107||
59621019|NCT00291876|75732532|FG000|COMPLETED|Month 138||107||
59621020|NCT00291876|75732532|FG000|NOT COMPLETED|Month 138||0||
59960587|NCT00543127|76079171|FG000|COMPLETED|Overall Study||303||
60074054|NCT01836458|76189444|FG003|COMPLETED|Overall Study||1||
60074055|NCT01836458|76189441|FG000|NOT COMPLETED|Overall Study||3||
60074056|NCT01836458|76189442|FG001|NOT COMPLETED|Overall Study||2||
60074057|NCT01836458|76189443|FG002|NOT COMPLETED|Overall Study||5||
60074058|NCT01836458|76189444|FG003|NOT COMPLETED|Overall Study||6||
60074059|NCT01811186|76189456|FG000|STARTED|Overall Study||132||
60074060|NCT01811186|76189457|FG001|STARTED|Overall Study||126||
60074061|NCT01811186|76189456|FG000|COMPLETED|Overall Study||61||
60074062|NCT01811186|76189457|FG001|COMPLETED|Overall Study||64||
60074063|NCT01811186|76189456|FG000|NOT COMPLETED|Overall Study||71||
60074064|NCT01811186|76189457|FG001|NOT COMPLETED|Overall Study||62||
60074065|NCT01866098|76189470|FG000|STARTED|Overall Study||51||
60074066|NCT01866098|76189471|FG001|STARTED|Overall Study||47||
60074067|NCT01866098|76189472|FG002|STARTED|Overall Study||46||
60074068|NCT01866098|76189470|FG000|COMPLETED|Overall Study||32||
60074069|NCT01866098|76189471|FG001|COMPLETED|Overall Study||20||
60074070|NCT01866098|76189472|FG002|COMPLETED|Overall Study||25||
60074071|NCT01866098|76189470|FG000|NOT COMPLETED|Overall Study||19||
60074072|NCT01866098|76189471|FG001|NOT COMPLETED|Overall Study||27||
60074073|NCT01866098|76189472|FG002|NOT COMPLETED|Overall Study||21||
60074074|NCT01865552|76189486|FG000|STARTED|Period 1||23||
60074075|NCT01865552|76189487|FG001|STARTED|Period 1||23||
60074076|NCT01865552|76189488|FG002|STARTED|Period 1||23||
60074077|NCT01865552|76189489|FG003|STARTED|Period 1||23||
60074078|NCT01865552|76189490|FG004|STARTED|Period 1||23||
60074079|NCT01865552|76189491|FG005|STARTED|Period 1||23||
60074080|NCT01865552|76189486|FG000|Discontinued From Period 1|Period 1||1||
60074081|NCT01865552|76189487|FG001|Discontinued From Period 1|Period 1||0||
60074082|NCT01865552|76189488|FG002|Discontinued From Period 1|Period 1||0||
60074083|NCT01865552|76189489|FG003|Discontinued From Period 1|Period 1||1||
60074084|NCT01865552|76189490|FG004|Discontinued From Period 1|Period 1||3||
60074085|NCT01865552|76189491|FG005|Discontinued From Period 1|Period 1||1||
60074086|NCT01865552|76189486|FG000|COMPLETED|Period 1||22||
60074087|NCT01865552|76189487|FG001|COMPLETED|Period 1||23||
60074088|NCT01865552|76189488|FG002|COMPLETED|Period 1||23||
60074089|NCT01865552|76189489|FG003|COMPLETED|Period 1||22||
59524400|NCT01004705|75619585|FG001|NOT COMPLETED|Period 1 (12 Weeks)||5||
59524401|NCT01004705|75619586|FG002|NOT COMPLETED|Period 1 (12 Weeks)||5||
59524402|NCT01004705|75619584|FG000|STARTED|Washout Period (6 Weeks)||0||
59524403|NCT01004705|75619585|FG001|STARTED|Washout Period (6 Weeks)||13||
59621021|NCT00291876|75732532|FG000|STARTED|Month 150||117||
59621022|NCT00291876|75732532|FG000|COMPLETED|Month 150||117||
60074090|NCT01865552|76189490|FG004|COMPLETED|Period 1||20||
60074091|NCT01865552|76189491|FG005|COMPLETED|Period 1||22||
59960588|NCT00543127|76079172|FG001|COMPLETED|Overall Study||350||
59960589|NCT00543127|76079171|FG000|NOT COMPLETED|Overall Study||130||
59960590|NCT00543127|76079172|FG001|NOT COMPLETED|Overall Study||87||
59960591|NCT02314923|76079188|FG000|STARTED|Overall Study||64||
59960592|NCT02314923|76079189|FG001|STARTED|Overall Study||64||
59807363|NCT00432562|75929247|FG000|COMPLETED|Overall Study||13||
59807364|NCT00432562|75929248|FG001|COMPLETED|Overall Study||15||
59807365|NCT00432562|75929247|FG000|NOT COMPLETED|Overall Study||3||
59807366|NCT00432562|75929248|FG001|NOT COMPLETED|Overall Study||0||
59807367|NCT00432172|75929258|FG000|STARTED|Overall Study||47||
59807368|NCT00432172|75929259|FG001|STARTED|Overall Study||48||
59807369|NCT00432172|75929260|FG002|STARTED|Overall Study||46||
59807370|NCT00432172|75929261|FG003|STARTED|Overall Study||48||
59807371|NCT00432172|75929258|FG000|COMPLETED|Overall Study||41||
59807372|NCT00432172|75929259|FG001|COMPLETED|Overall Study||41||
59807373|NCT00432172|75929260|FG002|COMPLETED|Overall Study||35||
59807374|NCT00432172|75929261|FG003|COMPLETED|Overall Study||41||
59807375|NCT00432172|75929258|FG000|NOT COMPLETED|Overall Study||6||
59807376|NCT00432172|75929259|FG001|NOT COMPLETED|Overall Study||7||
59807377|NCT00432172|75929260|FG002|NOT COMPLETED|Overall Study||11||
59807378|NCT00432172|75929261|FG003|NOT COMPLETED|Overall Study||7||
59807379|NCT00415168|75929273|FG000|STARTED|Overall Study||53||
59807380|NCT00415168|75929273|FG000|Completed Treatment|Overall Study||15||
59807381|NCT00415168|75929273|FG000|COMPLETED|Overall Study||1||
59807382|NCT00415168|75929273|FG000|NOT COMPLETED|Overall Study||52||
59807383|NCT00424762|75929279|FG000|STARTED|Overall Study||74||
59807384|NCT00424762|75929280|FG001|STARTED|Overall Study||76||
59807385|NCT00424762|75929279|FG000|COMPLETED|Overall Study||54||
59807386|NCT00424762|75929280|FG001|COMPLETED|Overall Study||54||
59807387|NCT00424762|75929279|FG000|NOT COMPLETED|Overall Study||20||
59807388|NCT00424762|75929280|FG001|NOT COMPLETED|Overall Study||22||
59807389|NCT00414544|75929286|FG000|STARTED|Overall Study||145||
59807390|NCT00414544|75929286|FG000|COMPLETED|Overall Study||131||
59807391|NCT00414544|75929286|FG000|NOT COMPLETED|Overall Study||14||
59807392|NCT00414466|75929296|FG000|STARTED|Overall Study||44||
59807393|NCT00414466|75929297|FG001|STARTED|Overall Study||42||
59807394|NCT00414466|75929298|FG002|STARTED|Overall Study||41||
59807395|NCT00414466|75929299|FG003|STARTED|Overall Study||43||
59807396|NCT00414466|75929296|FG000|COMPLETED|Overall Study||42||
59807397|NCT00414466|75929297|FG001|COMPLETED|Overall Study||42||
59807398|NCT00414466|75929298|FG002|COMPLETED|Overall Study||40||
59807399|NCT00414466|75929299|FG003|COMPLETED|Overall Study||42||
59807400|NCT00414466|75929296|FG000|NOT COMPLETED|Overall Study||2||
59807401|NCT00414466|75929297|FG001|NOT COMPLETED|Overall Study||0||
59807402|NCT00414466|75929298|FG002|NOT COMPLETED|Overall Study||1||
59807403|NCT00414466|75929299|FG003|NOT COMPLETED|Overall Study||1||
59807404|NCT00424528|75929315|FG000|STARTED|Overall Study||76||
59807405|NCT00424528|75929316|FG001|STARTED|Overall Study||80||
59807406|NCT00424528|75929317|FG002|STARTED|Overall Study||78||
59807407|NCT00424528|75929315|FG000|COMPLETED|Overall Study||71||
59807408|NCT00424528|75929316|FG001|COMPLETED|Overall Study||76||
59807409|NCT00424528|75929317|FG002|COMPLETED|Overall Study||74||
59807410|NCT00424528|75929315|FG000|NOT COMPLETED|Overall Study||5||
59807411|NCT00424528|75929316|FG001|NOT COMPLETED|Overall Study||4||
59807412|NCT00424528|75929317|FG002|NOT COMPLETED|Overall Study||4||
59807413|NCT00545532|75929327|FG000|STARTED|Overall Study||105||
59807414|NCT00545532|75929328|FG001|STARTED|Overall Study||110||
59807415|NCT00545532|75929327|FG000|COMPLETED|Overall Study||99||
59807416|NCT00545532|75929328|FG001|COMPLETED|Overall Study||100||
59807417|NCT00545532|75929327|FG000|NOT COMPLETED|Overall Study||6||
59960593|NCT02314923|76079190|FG002|STARTED|Overall Study||64||
59960594|NCT02314923|76079191|FG003|STARTED|Overall Study||64||
59960595|NCT02314923|76079192|FG004|STARTED|Overall Study||74||
59807418|NCT00545532|75929328|FG001|NOT COMPLETED|Overall Study||10||
59807419|NCT00544440|75929336|FG000|STARTED|Overall Study||57||
59960596|NCT02314923|76079193|FG005|STARTED|Overall Study||20||
59807420|NCT00544440|75929336|FG000|COMPLETED|Overall Study||0||
59807421|NCT00544440|75929336|FG000|NOT COMPLETED|Overall Study||57||
59807422|NCT03920670|75929342|FG000|STARTED|Overall Study||60||
59807423|NCT03920670|75929343|FG001|STARTED|Overall Study||60||
59960597|NCT02314923|76079194|FG006|STARTED|Overall Study||48||
59807424|NCT03920670|75929342|FG000|COMPLETED|Overall Study||57||
59807425|NCT03920670|75929343|FG001|COMPLETED|Overall Study||58||
59807426|NCT03920670|75929342|FG000|NOT COMPLETED|Overall Study||3||
59807427|NCT03920670|75929343|FG001|NOT COMPLETED|Overall Study||2||
59960598|NCT02314923|76079195|FG007|STARTED|Overall Study||47||
59807428|NCT00430300|75929353|FG000|STARTED|Overall Study||17||
59807429|NCT00430300|75929354|FG001|STARTED|Overall Study||18||
59807430|NCT00430300|75929355|FG002|STARTED|Overall Study||35||
59807431|NCT00430300|75929356|FG003|STARTED|Overall Study||17||
59807432|NCT00430300|75929353|FG000|COMPLETED|Overall Study||15||
59807433|NCT00430300|75929354|FG001|COMPLETED|Overall Study||16||
59807434|NCT00430300|75929355|FG002|COMPLETED|Overall Study||29||
59960599|NCT02314923|76079196|FG008|STARTED|Overall Study||48||
59960600|NCT02314923|76079197|FG009|STARTED|Overall Study||20||
59960601|NCT02314923|76079188|FG000|Treated|Overall Study||64||
59960602|NCT02314923|76079189|FG001|Treated|Overall Study||64||
59960603|NCT02314923|76079190|FG002|Treated|Overall Study||64||
59960604|NCT02314923|76079191|FG003|Treated|Overall Study||64||
59960605|NCT02314923|76079192|FG004|Treated|Overall Study||74||
59960606|NCT02314923|76079193|FG005|Treated|Overall Study||20||
59960607|NCT02314923|76079194|FG006|Treated|Overall Study|One participant did not receive vaccination due to missing blood sample at randomization.|47||
59960608|NCT02314923|76079195|FG007|Treated|Overall Study||47||
59807435|NCT00430300|75929356|FG003|COMPLETED|Overall Study||15||
59807436|NCT00430300|75929353|FG000|NOT COMPLETED|Overall Study||2||
59807437|NCT00430300|75929354|FG001|NOT COMPLETED|Overall Study||2||
59807438|NCT00430300|75929355|FG002|NOT COMPLETED|Overall Study||6||
59807439|NCT00430300|75929356|FG003|NOT COMPLETED|Overall Study||2||
59807440|NCT03927846|75929368|FG000|STARTED|Overall Study||30||
59807441|NCT03927846|75929369|FG001|STARTED|Overall Study||30||
59807442|NCT03927846|75929368|FG000|COMPLETED|Overall Study||20||
59807443|NCT03927846|75929369|FG001|COMPLETED|Overall Study||19||
59807444|NCT03927846|75929368|FG000|NOT COMPLETED|Overall Study||10||
59807445|NCT03927846|75929369|FG001|NOT COMPLETED|Overall Study||11||
59807446|NCT00545298|75929378|FG000|STARTED|Overall Study||2||
59807447|NCT00545298|75929379|FG001|STARTED|Overall Study||1||
59807448|NCT00545298|75929380|FG002|STARTED|Overall Study||1||
59960609|NCT02314923|76079196|FG008|Treated|Overall Study||48||
59960610|NCT02314923|76079197|FG009|Treated|Overall Study||20||
59960611|NCT02314923|76079188|FG000|COMPLETED|Overall Study||61||
59960612|NCT02314923|76079189|FG001|COMPLETED|Overall Study||60||
59960613|NCT02314923|76079190|FG002|COMPLETED|Overall Study||62||
59960614|NCT02314923|76079191|FG003|COMPLETED|Overall Study||63||
59960615|NCT02314923|76079192|FG004|COMPLETED|Overall Study||73||
59960616|NCT02314923|76079193|FG005|COMPLETED|Overall Study||19||
60074092|NCT01865552|76189486|FG000|NOT COMPLETED|Period 1||1||
60074093|NCT01865552|76189487|FG001|NOT COMPLETED|Period 1||0||
59807449|NCT00545298|75929378|FG000|COMPLETED|Overall Study||0||
59807450|NCT00545298|75929379|FG001|COMPLETED|Overall Study||1||
59807451|NCT00545298|75929380|FG002|COMPLETED|Overall Study||0||
59807452|NCT00545298|75929378|FG000|NOT COMPLETED|Overall Study||2||
59807453|NCT00545298|75929379|FG001|NOT COMPLETED|Overall Study||0||
59807454|NCT00545298|75929380|FG002|NOT COMPLETED|Overall Study||1||
59807455|NCT00429364|75929393|FG000|STARTED|Overall Study||303||
59807456|NCT00429364|75929394|FG001|STARTED|Overall Study||305||
59807457|NCT00429364|75929393|FG000|COMPLETED|Overall Study||271||
59807458|NCT00429364|75929394|FG001|COMPLETED|Overall Study||272||
59807459|NCT00429364|75929393|FG000|NOT COMPLETED|Overall Study||32||
59807460|NCT00429364|75929394|FG001|NOT COMPLETED|Overall Study||33||
59807461|NCT00414388|75929400|FG000|STARTED|Overall Study||22||
59807462|NCT00414388|75929400|FG000|COMPLETED|Overall Study||21||
59807463|NCT00414388|75929400|FG000|NOT COMPLETED|Overall Study||1||
59807464|NCT03920280|75929407|FG000|STARTED|Overall Study||41||82
59807465|NCT03920280|75929408|FG001|STARTED|Overall Study||78||156
59807466|NCT03920280|75929407|FG000|COMPLETED|Overall Study||38||76
59807467|NCT03920280|75929408|FG001|COMPLETED|Overall Study||72||144
59807468|NCT03920280|75929407|FG000|NOT COMPLETED|Overall Study||3||6
59960617|NCT02314923|76079194|FG006|COMPLETED|Overall Study||43||
59960618|NCT02314923|76079195|FG007|COMPLETED|Overall Study||42||
59960619|NCT02314923|76079196|FG008|COMPLETED|Overall Study||46||
59960620|NCT02314923|76079197|FG009|COMPLETED|Overall Study||20||
59960621|NCT02314923|76079188|FG000|NOT COMPLETED|Overall Study||3||
59960622|NCT02314923|76079189|FG001|NOT COMPLETED|Overall Study||4||
59960623|NCT02314923|76079190|FG002|NOT COMPLETED|Overall Study||2||
59960624|NCT02314923|76079191|FG003|NOT COMPLETED|Overall Study||1||
59960625|NCT02314923|76079192|FG004|NOT COMPLETED|Overall Study||1||
59960626|NCT02314923|76079193|FG005|NOT COMPLETED|Overall Study||1||
59960627|NCT02314923|76079194|FG006|NOT COMPLETED|Overall Study||5||
59960628|NCT02314923|76079195|FG007|NOT COMPLETED|Overall Study||5||
60074094|NCT01865552|76189488|FG002|NOT COMPLETED|Period 1||0||
60074095|NCT01865552|76189489|FG003|NOT COMPLETED|Period 1||1||
60074096|NCT01865552|76189490|FG004|NOT COMPLETED|Period 1||3||
60074097|NCT01865552|76189491|FG005|NOT COMPLETED|Period 1||1||
60074098|NCT01865552|76189486|FG000|STARTED|Period 2||22||
59807469|NCT03920280|75929408|FG001|NOT COMPLETED|Overall Study||6||12
59807470|NCT00424372|75929417|FG000|STARTED|Overall Study||126||
59807471|NCT00424372|75929417|FG000|COMPLETED|Overall Study||95||
59807472|NCT00424372|75929417|FG000|NOT COMPLETED|Overall Study||31||
59807473|NCT00414310|75929423|FG000|STARTED|Overall Study||71||
59807474|NCT00414310|75929424|FG001|STARTED|Overall Study||79||
59807475|NCT00414310|75929423|FG000|COMPLETED|Overall Study||70||
59807476|NCT00414310|75929424|FG001|COMPLETED|Overall Study||79||
59960629|NCT02314923|76079196|FG008|NOT COMPLETED|Overall Study||2||
60074099|NCT01865552|76189487|FG001|STARTED|Period 2||23||
60074100|NCT01865552|76189488|FG002|STARTED|Period 2||23||
59807477|NCT00414310|75929423|FG000|NOT COMPLETED|Overall Study||1||
59807478|NCT00414310|75929424|FG001|NOT COMPLETED|Overall Study||0||
59960630|NCT02314923|76079197|FG009|NOT COMPLETED|Overall Study||0||
59960631|NCT03023137|76079222|FG000|STARTED|Overall Study||178||
59960632|NCT03023137|76079223|FG001|STARTED|Overall Study||171||
59960633|NCT03023137|76079222|FG000|COMPLETED|Overall Study||174||
59807479|NCT00542880|75929434|FG000|STARTED|Period 1|This was a cross-over study|217||
59807480|NCT00542880|75929435|FG001|STARTED|Period 1||225||
59807481|NCT00542880|75929434|FG000|COMPLETED|Period 1||211||
59807482|NCT00542880|75929435|FG001|COMPLETED|Period 1||213||
59807483|NCT00542880|75929434|FG000|NOT COMPLETED|Period 1||6||
59807484|NCT00542880|75929435|FG001|NOT COMPLETED|Period 1||12||
59807485|NCT00542880|75929434|FG000|STARTED|Period 2||211||
59807486|NCT00542880|75929435|FG001|STARTED|Period 2||213||
59807487|NCT00542880|75929434|FG000|COMPLETED|Period 2||204||
59807488|NCT00542880|75929435|FG001|COMPLETED|Period 2||203||
59807489|NCT00542880|75929434|FG000|NOT COMPLETED|Period 2||7||
59807490|NCT00542880|75929435|FG001|NOT COMPLETED|Period 2||10||
59807491|NCT00542880|75929434|FG000|STARTED|Period 3||204||
59807492|NCT00542880|75929435|FG001|STARTED|Period 3||203||
59807493|NCT00542880|75929434|FG000|COMPLETED|Period 3||204||
59807494|NCT00542880|75929435|FG001|COMPLETED|Period 3||201||
59807495|NCT00542880|75929434|FG000|NOT COMPLETED|Period 3||0||
59807496|NCT00542880|75929435|FG001|NOT COMPLETED|Period 3||2||
59807497|NCT00414076|75929444|FG000|STARTED|Overall Study||4||
59807498|NCT00414076|75929445|FG001|STARTED|Overall Study||5||
59807499|NCT00414076|75929444|FG000|COMPLETED|Overall Study||1||
59807500|NCT00414076|75929445|FG001|COMPLETED|Overall Study||0||
59807501|NCT00414076|75929444|FG000|NOT COMPLETED|Overall Study||3||
59807502|NCT00414076|75929445|FG001|NOT COMPLETED|Overall Study||5||
59807503|NCT00092677|75929453|FG000|STARTED|Overall Study||944||
59807504|NCT00092677|75929454|FG001|STARTED|Overall Study||929||
59807505|NCT00092677|75929453|FG000|COMPLETED|Overall Study|EZ/Simva: 694 (on drug), 140 (after drug discon), 105 (at death)|939||
59807506|NCT00092677|75929454|FG001|COMPLETED|Overall Study|Placebo: 698 (on drug), 120 (after drug discon), 100 (at death)|918||
59807507|NCT00092677|75929453|FG000|NOT COMPLETED|Overall Study||5||
59807508|NCT00092677|75929454|FG001|NOT COMPLETED|Overall Study||11||
59807509|NCT00542178|75929466|FG000|STARTED|Overall Study||390||
59807510|NCT00542178|75929467|FG001|STARTED|Overall Study||412||
59807511|NCT00542178|75929468|FG002|STARTED|Overall Study||382||
59807512|NCT00542178|75929469|FG003|STARTED|Overall Study||370||
59807513|NCT00542178|75929470|FG004|STARTED|Overall Study||464||
59807514|NCT00542178|75929471|FG005|STARTED|Overall Study||495||
59807515|NCT00542178|75929472|FG006|STARTED|Overall Study||493||
59807516|NCT00542178|75929473|FG007|STARTED|Overall Study||466||
59807517|NCT00542178|75929466|FG000|COMPLETED|Overall Study||315||
59807518|NCT00542178|75929467|FG001|COMPLETED|Overall Study||332||
59807519|NCT00542178|75929468|FG002|COMPLETED|Overall Study||308||
59807520|NCT00542178|75929469|FG003|COMPLETED|Overall Study||308||
59807521|NCT00542178|75929470|FG004|COMPLETED|Overall Study||400||
59807522|NCT00542178|75929471|FG005|COMPLETED|Overall Study||406||
59807523|NCT00542178|75929472|FG006|COMPLETED|Overall Study||406||
59807524|NCT00542178|75929473|FG007|COMPLETED|Overall Study||381||
59807525|NCT00542178|75929466|FG000|NOT COMPLETED|Overall Study||75||
59807526|NCT00542178|75929467|FG001|NOT COMPLETED|Overall Study||80||
59807527|NCT00542178|75929468|FG002|NOT COMPLETED|Overall Study||74||
59807528|NCT00542178|75929469|FG003|NOT COMPLETED|Overall Study||62||
59807529|NCT00542178|75929470|FG004|NOT COMPLETED|Overall Study||64||
59807530|NCT00542178|75929471|FG005|NOT COMPLETED|Overall Study||89||
59807531|NCT00542178|75929472|FG006|NOT COMPLETED|Overall Study||87||
59807532|NCT00542178|75929473|FG007|NOT COMPLETED|Overall Study||85||
59807533|NCT00424294|75929489|FG000|STARTED|Overall Study||36||
59807534|NCT00424294|75929490|FG001|STARTED|Overall Study||34||
59807535|NCT00424294|75929489|FG000|Treated|Overall Study||35||
59807536|NCT00424294|75929490|FG001|Treated|Overall Study||34||
59807537|NCT00424294|75929489|FG000|COMPLETED|Overall Study||28||
59807538|NCT00424294|75929490|FG001|COMPLETED|Overall Study||19||
59807539|NCT00424294|75929489|FG000|NOT COMPLETED|Overall Study||8||
59807540|NCT00424294|75929490|FG001|NOT COMPLETED|Overall Study||15||
59807541|NCT00092521|75929499|FG000|STARTED|Vaccination (Day 1 Through Month 7)||2723||
59807542|NCT00092521|75929500|FG001|STARTED|Vaccination (Day 1 Through Month 7)||304||
59807543|NCT00092521|75929501|FG002|STARTED|Vaccination (Day 1 Through Month 7)||2732||
59807544|NCT00092521|75929502|FG003|STARTED|Vaccination (Day 1 Through Month 7)||0||
59807545|NCT00092521|75929499|FG000|COMPLETED|Vaccination (Day 1 Through Month 7)||2583||
59807546|NCT00092521|75929500|FG001|COMPLETED|Vaccination (Day 1 Through Month 7)||290||
59807547|NCT00092521|75929501|FG002|COMPLETED|Vaccination (Day 1 Through Month 7)||2586||
59807548|NCT00092521|75929502|FG003|COMPLETED|Vaccination (Day 1 Through Month 7)||0||
59807549|NCT00092521|75929499|FG000|NOT COMPLETED|Vaccination (Day 1 Through Month 7)||140||
59807550|NCT00092521|75929500|FG001|NOT COMPLETED|Vaccination (Day 1 Through Month 7)||14||
59807551|NCT00092521|75929501|FG002|NOT COMPLETED|Vaccination (Day 1 Through Month 7)||146||
59807552|NCT00092521|75929502|FG003|NOT COMPLETED|Vaccination (Day 1 Through Month 7)||0||
59807553|NCT00092521|75929499|FG000|STARTED|Follow-Up (After Month 7)|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up|2599||
59807554|NCT00092521|75929500|FG001|STARTED|Follow-Up (After Month 7)|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up|291||
59807555|NCT00092521|75929501|FG002|STARTED|Follow-Up (After Month 7)|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up|2607||
59807556|NCT00092521|75929502|FG003|STARTED|Follow-Up (After Month 7)||0||
59807557|NCT00092521|75929499|FG000|COMPLETED|Follow-Up (After Month 7)||2353||
59960634|NCT03023137|76079223|FG001|COMPLETED|Overall Study||162||
59960635|NCT03023137|76079222|FG000|NOT COMPLETED|Overall Study||4||
59960636|NCT03023137|76079223|FG001|NOT COMPLETED|Overall Study||9||
59807558|NCT00092521|75929500|FG001|COMPLETED|Follow-Up (After Month 7)||155||
59807559|NCT00092521|75929501|FG002|COMPLETED|Follow-Up (After Month 7)||1959||
59807560|NCT00092521|75929502|FG003|COMPLETED|Follow-Up (After Month 7)||0||
59807561|NCT00092521|75929499|FG000|NOT COMPLETED|Follow-Up (After Month 7)||246||
59807562|NCT00092521|75929500|FG001|NOT COMPLETED|Follow-Up (After Month 7)||136||
59807563|NCT00092521|75929501|FG002|NOT COMPLETED|Follow-Up (After Month 7)||648||
59807564|NCT00092521|75929502|FG003|NOT COMPLETED|Follow-Up (After Month 7)||0||
59807565|NCT00092521|75929499|FG000|STARTED|Extension Study (Group 4)||0||
59807566|NCT00092521|75929500|FG001|STARTED|Extension Study (Group 4)||0||
59807567|NCT00092521|75929501|FG002|STARTED|Extension Study (Group 4)||0||
59807568|NCT00092521|75929502|FG003|STARTED|Extension Study (Group 4)||844||
59807569|NCT00092521|75929499|FG000|Initiated Extension Study|Extension Study (Group 4)||0||
59807570|NCT00092521|75929500|FG001|Initiated Extension Study|Extension Study (Group 4)||0||
59807571|NCT00092521|75929501|FG002|Initiated Extension Study|Extension Study (Group 4)||0||
59807572|NCT00092521|75929502|FG003|Initiated Extension Study|Extension Study (Group 4)||829||
59807573|NCT00092521|75929499|FG000|Received >=1 Dose in Extension Study|Extension Study (Group 4)||0||
59807574|NCT00092521|75929500|FG001|Received >=1 Dose in Extension Study|Extension Study (Group 4)||0||
59807575|NCT00092521|75929501|FG002|Received >=1 Dose in Extension Study|Extension Study (Group 4)||0||
59807576|NCT00092521|75929502|FG003|Received >=1 Dose in Extension Study|Extension Study (Group 4)||801||
59807577|NCT00092521|75929499|FG000|COMPLETED|Extension Study (Group 4)||0||
59807578|NCT00092521|75929500|FG001|COMPLETED|Extension Study (Group 4)||0||
59807579|NCT00092521|75929501|FG002|COMPLETED|Extension Study (Group 4)||0||
59807580|NCT00092521|75929502|FG003|COMPLETED|Extension Study (Group 4)||635||
59807581|NCT00092521|75929499|FG000|NOT COMPLETED|Extension Study (Group 4)||0||
59807582|NCT00092521|75929500|FG001|NOT COMPLETED|Extension Study (Group 4)||0||
59807583|NCT00092521|75929501|FG002|NOT COMPLETED|Extension Study (Group 4)||0||
59807584|NCT00092521|75929502|FG003|NOT COMPLETED|Extension Study (Group 4)||209||
59807585|NCT03908970|75929512|FG000|STARTED|Overall Study||182||
59807586|NCT03908970|75929513|FG001|STARTED|Overall Study||182||
59807587|NCT03908970|75929512|FG000|COMPLETED|Overall Study||165||
59807588|NCT03908970|75929513|FG001|COMPLETED|Overall Study||135||
59807589|NCT03908970|75929512|FG000|NOT COMPLETED|Overall Study||17||
59807590|NCT03908970|75929513|FG001|NOT COMPLETED|Overall Study||47||
59807591|NCT00092443|75929521|FG000|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|651||
59807592|NCT00092443|75929522|FG001|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|661||
59807593|NCT00092443|75929521|FG000|Vaccinated at Visit 1|Overall Study||650||
59807594|NCT00092443|75929522|FG001|Vaccinated at Visit 1|Overall Study||660||
59807595|NCT00092443|75929521|FG000|Vaccinated at Visit 2|Overall Study||618||
59807596|NCT00092443|75929522|FG001|Vaccinated at Visit 2|Overall Study||627||
59807597|NCT00092443|75929521|FG000|Vaccinated at Visit 3|Overall Study||593||
59807598|NCT00092443|75929522|FG001|Vaccinated at Visit 3|Overall Study||608||
59807599|NCT00092443|75929521|FG000|COMPLETED|Overall Study|Subjects vaccinated and followed up 42 days after each dose, thru 1st rotavirus season post study|593||
59807600|NCT00092443|75929522|FG001|COMPLETED|Overall Study|Subjects vaccinated and followed up 42 days after each dose, thru 1st rotavirus season post study|607||
59807601|NCT00092443|75929521|FG000|NOT COMPLETED|Overall Study||58||
59807602|NCT00092443|75929522|FG001|NOT COMPLETED|Overall Study||54||
59807603|NCT00413920|75929540|FG000|STARTED|Overall Study||112||
59807604|NCT00413920|75929541|FG001|STARTED|Overall Study||110||
59807605|NCT00413920|75929540|FG000|COMPLETED|Overall Study||84||
59807606|NCT00413920|75929541|FG001|COMPLETED|Overall Study||82||
59807607|NCT00413920|75929540|FG000|NOT COMPLETED|Overall Study||28||
59807608|NCT00413920|75929541|FG001|NOT COMPLETED|Overall Study||28||
59807609|NCT00091819|75929549|FG000|STARTED|Overall Study||429||
59807610|NCT00091819|75929550|FG001|STARTED|Overall Study||433||
59807611|NCT00091819|75929549|FG000|COMPLETED|Overall Study||387||
59807612|NCT00091819|75929550|FG001|COMPLETED|Overall Study||387||
59807613|NCT00091819|75929549|FG000|NOT COMPLETED|Overall Study||42||
59807614|NCT00091819|75929550|FG001|NOT COMPLETED|Overall Study||46||
59807615|NCT00540228|75929561|FG000|STARTED|Overall Study||200||
59807616|NCT00540228|75929562|FG001|STARTED|Overall Study||198||
59960637|NCT03049813|76079234|FG000|STARTED|Randomized Control Trial Phase||38|Signed a consent form|
59807617|NCT00540228|75929563|FG002|STARTED|Overall Study||204||
59807618|NCT00540228|75929564|FG003|STARTED|Overall Study||202||
59807619|NCT00540228|75929565|FG004|STARTED|Overall Study||202||
59807620|NCT00540228|75929561|FG000|COMPLETED|Overall Study||197||
59807621|NCT00540228|75929562|FG001|COMPLETED|Overall Study||197||
59807622|NCT00540228|75929563|FG002|COMPLETED|Overall Study||204||
59807623|NCT00540228|75929564|FG003|COMPLETED|Overall Study||202||
59807624|NCT00540228|75929565|FG004|COMPLETED|Overall Study||202||
59807625|NCT00540228|75929561|FG000|NOT COMPLETED|Overall Study||3||
59807626|NCT00540228|75929562|FG001|NOT COMPLETED|Overall Study||1||
59807627|NCT00540228|75929563|FG002|NOT COMPLETED|Overall Study||0||
59807628|NCT00540228|75929564|FG003|NOT COMPLETED|Overall Study||0||
59807629|NCT00540228|75929565|FG004|NOT COMPLETED|Overall Study||0||
59807630|NCT05203185|75929581|FG000|STARTED|Overall Study||49||
59807631|NCT05203185|75929582|FG001|STARTED|Overall Study||35||
59807632|NCT05203185|75929583|FG002|STARTED|Overall Study||793||
59807633|NCT05203185|75929584|FG003|STARTED|Overall Study||735||
59807634|NCT05203185|75929581|FG000|COMPLETED|Overall Study||49||
59807635|NCT05203185|75929582|FG001|COMPLETED|Overall Study||35||
59807636|NCT05203185|75929583|FG002|COMPLETED|Overall Study||793||
59807637|NCT05203185|75929584|FG003|COMPLETED|Overall Study||735||
59807638|NCT05203185|75929581|FG000|NOT COMPLETED|Overall Study||0||
59807639|NCT05203185|75929582|FG001|NOT COMPLETED|Overall Study||0||
59807640|NCT05203185|75929583|FG002|NOT COMPLETED|Overall Study||0||
59807641|NCT05203185|75929584|FG003|NOT COMPLETED|Overall Study||0||
59807642|NCT05013385|75929590|FG000|STARTED|Overall Study||5|Patients who entered the Lead-In Period|
59807643|NCT05013385|75929590|FG000|Patients Who Entered the Randomized Blinded Treatment Period|Overall Study||0||
59807644|NCT05013385|75929590|FG000|COMPLETED|Overall Study||0||
59807645|NCT05013385|75929590|FG000|NOT COMPLETED|Overall Study||5||
59807646|NCT04687137|75929596|FG000|STARTED|Overall Study||11||
59807647|NCT04687137|75929597|FG001|STARTED|Overall Study||1||
59807648|NCT04687137|75929596|FG000|COMPLETED|Overall Study||11||
59807649|NCT04687137|75929597|FG001|COMPLETED|Overall Study||1||
59807650|NCT04687137|75929596|FG000|NOT COMPLETED|Overall Study||0||
59807651|NCT04687137|75929597|FG001|NOT COMPLETED|Overall Study||0||
59807652|NCT04254796|75929606|FG000|STARTED|Overall Study||50||
59807653|NCT04254796|75929607|FG001|STARTED|Overall Study||50||
59807654|NCT04254796|75929606|FG000|COMPLETED|Overall Study||45||
59807655|NCT04254796|75929607|FG001|COMPLETED|Overall Study||49||
59807656|NCT04254796|75929606|FG000|NOT COMPLETED|Overall Study||5||
59807657|NCT04254796|75929607|FG001|NOT COMPLETED|Overall Study||1||
59807658|NCT04250636|75929613|FG000|STARTED|Overall Study||6||
59807659|NCT04250636|75929613|FG000|COMPLETED|Overall Study||4||
59807660|NCT04250636|75929613|FG000|NOT COMPLETED|Overall Study||2||
59807661|NCT03989115|75929625|FG000|STARTED|Overall Study||8||
59807662|NCT03989115|75929626|FG001|STARTED|Overall Study||6||
59807663|NCT03989115|75929627|FG002|STARTED|Overall Study||12||
59807664|NCT03989115|75929628|FG003|STARTED|Overall Study||7||
59807665|NCT03989115|75929629|FG004|STARTED|Overall Study||65||
59807666|NCT03989115|75929630|FG005|STARTED|Overall Study||7||
59807667|NCT03989115|75929631|FG006|STARTED|Overall Study||4||
59807668|NCT03989115|75929632|FG007|STARTED|Overall Study||4||
59807669|NCT03989115|75929625|FG000|COMPLETED|Overall Study||0||
59807670|NCT03989115|75929626|FG001|COMPLETED|Overall Study||0||
59807671|NCT03989115|75929627|FG002|COMPLETED|Overall Study||0||
59807672|NCT03989115|75929628|FG003|COMPLETED|Overall Study||0||
59807673|NCT03989115|75929629|FG004|COMPLETED|Overall Study||0||
59807674|NCT03989115|75929630|FG005|COMPLETED|Overall Study||0||
59807675|NCT03989115|75929631|FG006|COMPLETED|Overall Study||0||
59807676|NCT03989115|75929632|FG007|COMPLETED|Overall Study||0||
59807677|NCT03989115|75929625|FG000|NOT COMPLETED|Overall Study||8||
59807678|NCT03989115|75929626|FG001|NOT COMPLETED|Overall Study||6||
59807679|NCT03989115|75929627|FG002|NOT COMPLETED|Overall Study||12||
59807680|NCT03989115|75929628|FG003|NOT COMPLETED|Overall Study||7||
59807681|NCT03989115|75929629|FG004|NOT COMPLETED|Overall Study||65||
59807682|NCT03989115|75929630|FG005|NOT COMPLETED|Overall Study||7||
59807683|NCT03989115|75929631|FG006|NOT COMPLETED|Overall Study||4||
59807684|NCT03989115|75929632|FG007|NOT COMPLETED|Overall Study||4||
59807685|NCT03971071|75929658|FG000|STARTED|Overall Study||206||
59807686|NCT03971071|75929659|FG001|STARTED|Overall Study||207||
59807687|NCT03971071|75929660|FG002|STARTED|Overall Study||207||
59807688|NCT03971071|75929658|FG000|Opioid-treated Cohort|Overall Study||12|> 4 days/month opioid medication use in baseline period; included for purposes of exploratory analyses only|
59807689|NCT03971071|75929659|FG001|Opioid-treated Cohort|Overall Study||12|> 4 days/month opioid medication use in baseline period; included for purposes of exploratory analyses only|
59807690|NCT03971071|75929660|FG002|Opioid-treated Cohort|Overall Study||12|> 4 days/month opioid medication use in baseline period; included for purposes of exploratory analyses only|
59807691|NCT03971071|75929658|FG000|Nonopioid-treated Cohort|Overall Study||194|≤ 4 days/month opioid medication use in baseline period|
59807692|NCT03971071|75929659|FG001|Nonopioid-treated Cohort|Overall Study||195|≤ 4 days/month opioid medication use in baseline period|
59807693|NCT03971071|75929660|FG002|Nonopioid-treated Cohort|Overall Study||195|≤ 4 days/month opioid medication use in baseline period|
59807694|NCT03971071|75929658|FG000|Received Investigational Product (IP) in DBTP|Overall Study||206||
59807695|NCT03971071|75929659|FG001|Received Investigational Product (IP) in DBTP|Overall Study||206||
59807696|NCT03971071|75929660|FG002|Received Investigational Product (IP) in DBTP|Overall Study||206||
59807697|NCT03971071|75929658|FG000|COMPLETED|Overall Study||197|Completed DBTP (Week 24)|
59807698|NCT03971071|75929659|FG001|COMPLETED|Overall Study||193|Completed DBTP (Week 24)|
59807699|NCT03971071|75929660|FG002|COMPLETED|Overall Study||201|Completed DBTP (Week 24)|
59960638|NCT03049813|76079235|FG001|STARTED|Randomized Control Trial Phase||61|Signed a consent form|
59807700|NCT03971071|75929658|FG000|NOT COMPLETED|Overall Study||9||
59807701|NCT03971071|75929659|FG001|NOT COMPLETED|Overall Study||14||
59807702|NCT03971071|75929660|FG002|NOT COMPLETED|Overall Study||6||
59807703|NCT03946748|75929668|FG000|STARTED|Overall Study||24||
59807704|NCT03946748|75929668|FG000|COMPLETED|Overall Study||24||
59807705|NCT03946748|75929668|FG000|NOT COMPLETED|Overall Study||0||
59807706|NCT03797898|75929674|FG000|STARTED|Overall Study|452 parent participants with a child ≤12 months arriving for a well child visit|452||5
59807707|NCT03797898|75929675|FG001|STARTED|Overall Study|485 parent participants with a child ≤12 months arriving for a well child visit|485||5
59807708|NCT03797898|75929674|FG000|COMPLETED|Overall Study||378||5
59807709|NCT03797898|75929675|FG001|COMPLETED|Overall Study||407||5
59960639|NCT03049813|76079236|FG002|STARTED|Randomized Control Trial Phase||44|Signed a consent form|
59960640|NCT03049813|76079237|FG003|STARTED|Randomized Control Trial Phase||0|Signed a consent form|
59960641|NCT03049813|76079234|FG000|COMPLETED|Randomized Control Trial Phase||36|Employment Outcomes Obtained by 9-Month Follow-Up|
59960642|NCT03049813|76079235|FG001|COMPLETED|Randomized Control Trial Phase||54|Employment Outcomes Obtained by 9-Month Follow-Up|
59960643|NCT03049813|76079236|FG002|COMPLETED|Randomized Control Trial Phase||41|Employment Outcomes Obtained by 9-Month Follow-Up|
59807710|NCT03797898|75929674|FG000|NOT COMPLETED|Overall Study||74||0
59807711|NCT03797898|75929675|FG001|NOT COMPLETED|Overall Study||78||0
59807712|NCT03718039|75929686|FG000|STARTED|Overall Study||30||
59807713|NCT03718039|75929687|FG001|STARTED|Overall Study||17||
59807714|NCT03718039|75929688|FG002|STARTED|Overall Study||31||
59807715|NCT03718039|75929686|FG000|COMPLETED|Overall Study||30||
59807716|NCT03718039|75929687|FG001|COMPLETED|Overall Study||17||
59807717|NCT03718039|75929688|FG002|COMPLETED|Overall Study||31||
59807718|NCT03718039|75929686|FG000|NOT COMPLETED|Overall Study||0||
59807719|NCT03718039|75929687|FG001|NOT COMPLETED|Overall Study||0||
59807720|NCT03718039|75929688|FG002|NOT COMPLETED|Overall Study||0||
59807721|NCT03559192|75929697|FG000|STARTED|Lead-in Period (3 Weeks)||181||
59807722|NCT03559192|75929698|FG001|STARTED|Lead-in Period (3 Weeks)||0||
59807723|NCT03559192|75929699|FG002|STARTED|Lead-in Period (3 Weeks)||0||
59807724|NCT03559192|75929697|FG000|COMPLETED|Lead-in Period (3 Weeks)||169||
59807725|NCT03559192|75929698|FG001|COMPLETED|Lead-in Period (3 Weeks)||0||
59807726|NCT03559192|75929699|FG002|COMPLETED|Lead-in Period (3 Weeks)||0||
59807727|NCT03559192|75929697|FG000|NOT COMPLETED|Lead-in Period (3 Weeks)||12||
59807728|NCT03559192|75929698|FG001|NOT COMPLETED|Lead-in Period (3 Weeks)||0||
59807729|NCT03559192|75929699|FG002|NOT COMPLETED|Lead-in Period (3 Weeks)||0||
59807730|NCT03559192|75929697|FG000|STARTED|DB Treatment(6 Wks) + Withdrawal(2 Wks)||0||
59807731|NCT03559192|75929698|FG001|STARTED|DB Treatment(6 Wks) + Withdrawal(2 Wks)||84||
59807732|NCT03559192|75929699|FG002|STARTED|DB Treatment(6 Wks) + Withdrawal(2 Wks)||85||
59807733|NCT03559192|75929697|FG000|Placebo Lead-in Responders|DB Treatment(6 Wks) + Withdrawal(2 Wks)||0||
59807734|NCT03559192|75929698|FG001|Placebo Lead-in Responders|DB Treatment(6 Wks) + Withdrawal(2 Wks)||22||
59807735|NCT03559192|75929699|FG002|Placebo Lead-in Responders|DB Treatment(6 Wks) + Withdrawal(2 Wks)||23||
59807736|NCT03559192|75929697|FG000|Placebo Lead-In Non-Responders|DB Treatment(6 Wks) + Withdrawal(2 Wks)||0||
59807737|NCT03559192|75929698|FG001|Placebo Lead-In Non-Responders|DB Treatment(6 Wks) + Withdrawal(2 Wks)||62||
59807738|NCT03559192|75929699|FG002|Placebo Lead-In Non-Responders|DB Treatment(6 Wks) + Withdrawal(2 Wks)||62||
59807739|NCT03559192|75929697|FG000|Completed DB Period and Entered Withdrawal|DB Treatment(6 Wks) + Withdrawal(2 Wks)||0||
59807740|NCT03559192|75929698|FG001|Completed DB Period and Entered Withdrawal|DB Treatment(6 Wks) + Withdrawal(2 Wks)||81||
59807741|NCT03559192|75929699|FG002|Completed DB Period and Entered Withdrawal|DB Treatment(6 Wks) + Withdrawal(2 Wks)||80||
59807742|NCT03559192|75929697|FG000|COMPLETED|DB Treatment(6 Wks) + Withdrawal(2 Wks)||0||
59807743|NCT03559192|75929698|FG001|COMPLETED|DB Treatment(6 Wks) + Withdrawal(2 Wks)||81||
59807744|NCT03559192|75929699|FG002|COMPLETED|DB Treatment(6 Wks) + Withdrawal(2 Wks)||79||
59807745|NCT03559192|75929697|FG000|NOT COMPLETED|DB Treatment(6 Wks) + Withdrawal(2 Wks)||0||
59807746|NCT03559192|75929698|FG001|NOT COMPLETED|DB Treatment(6 Wks) + Withdrawal(2 Wks)||3||
59807747|NCT03559192|75929699|FG002|NOT COMPLETED|DB Treatment(6 Wks) + Withdrawal(2 Wks)||6||
59807748|NCT03523585|75929710|FG000|STARTED|Overall Study||406||
59807749|NCT03523585|75929711|FG001|STARTED|Overall Study||91||
59960644|NCT03049813|76079237|FG003|COMPLETED|Randomized Control Trial Phase||0|Employment Outcomes Obtained by 9-Month Follow-Up|
59960645|NCT03049813|76079234|FG000|NOT COMPLETED|Randomized Control Trial Phase||2||
59960646|NCT03049813|76079235|FG001|NOT COMPLETED|Randomized Control Trial Phase||7||
59960647|NCT03049813|76079236|FG002|NOT COMPLETED|Randomized Control Trial Phase||3||
59960648|NCT03049813|76079237|FG003|NOT COMPLETED|Randomized Control Trial Phase||0||
59960649|NCT03049813|76079234|FG000|STARTED|Focus Group Phase||0||
59960650|NCT03049813|76079235|FG001|STARTED|Focus Group Phase||0||
59960651|NCT03049813|76079236|FG002|STARTED|Focus Group Phase||0||
59960652|NCT03049813|76079237|FG003|STARTED|Focus Group Phase||25||
59960653|NCT03049813|76079234|FG000|COMPLETED|Focus Group Phase||0||
59960654|NCT03049813|76079235|FG001|COMPLETED|Focus Group Phase||0||
59807750|NCT03523585|75929712|FG002|STARTED|Overall Study||111||
59807751|NCT03523585|75929710|FG000|Randomized|Overall Study||406||
59807752|NCT03523585|75929711|FG001|Randomized|Overall Study||91||
59960655|NCT03049813|76079236|FG002|COMPLETED|Focus Group Phase||0||
59960656|NCT03049813|76079237|FG003|COMPLETED|Focus Group Phase||25||
59960657|NCT03049813|76079234|FG000|NOT COMPLETED|Focus Group Phase||0||
59960658|NCT03049813|76079235|FG001|NOT COMPLETED|Focus Group Phase||0||
59960659|NCT03049813|76079236|FG002|NOT COMPLETED|Focus Group Phase||0||
59960660|NCT03049813|76079237|FG003|NOT COMPLETED|Focus Group Phase||0||
59960661|NCT03022981|76079248|FG000|STARTED|Overall Study||102||
59960662|NCT03022981|76079249|FG001|STARTED|Overall Study||73||
59960663|NCT03022981|76079250|FG002|STARTED|Overall Study||41||
59960664|NCT03022981|76079248|FG000|Participated in PK Lead-in (PKL) Phase|Overall Study|All 17 participants completed treatment in the PK Lead-in phase and continued into treatment phase.|17||
59960665|NCT03022981|76079249|FG001|Participated in PK Lead-in (PKL) Phase|Overall Study|All 20 participants completed treatment in the PK Lead-in phase and continued into treatment phase.|20||
59960666|NCT03022981|76079250|FG002|Participated in PK Lead-in (PKL) Phase|Overall Study|All 19 participants completed treatment in the PK Lead-in phase and continued into treatment phase.|19||
59960667|NCT03022981|76079248|FG000|COMPLETED|Overall Study||96||
59960668|NCT03022981|76079249|FG001|COMPLETED|Overall Study||69||
59960669|NCT03022981|76079250|FG002|COMPLETED|Overall Study||35||
59960670|NCT03022981|76079248|FG000|NOT COMPLETED|Overall Study||6||
59807753|NCT03523585|75929712|FG002|Randomized|Overall Study||111||
59807754|NCT03523585|75929710|FG000|Randomized But Not Treated|Overall Study||2||
59807755|NCT03523585|75929711|FG001|Randomized But Not Treated|Overall Study||4||
59807756|NCT03523585|75929712|FG002|Randomized But Not Treated|Overall Study||3||
59807757|NCT03523585|75929710|FG000|COMPLETED|Overall Study||94|Completed = Participants who are on-going study treatment as of 30 Jun 22, Not Completed = Participants who discontinued treatment and participants randomized but not treated.|
59807758|NCT03523585|75929711|FG001|COMPLETED|Overall Study||1|Completed = Participants who are on-going study treatment as of 30 Jun 22, Not Completed = Participants who discontinued treatment and participants randomized but not treated.|
59807759|NCT03523585|75929712|FG002|COMPLETED|Overall Study||4|Completed = Participants who are on-going study treatment as of 30 Jun 22, Not Completed = Participants who discontinued treatment and participants randomized but not treated.|
59807760|NCT03523585|75929710|FG000|NOT COMPLETED|Overall Study||312||
59807761|NCT03523585|75929711|FG001|NOT COMPLETED|Overall Study||90||
59807762|NCT03523585|75929712|FG002|NOT COMPLETED|Overall Study||107||
59807763|NCT03485911|75929722|FG000|STARTED|Part 1||41||
59807764|NCT03485911|75929723|FG001|STARTED|Part 1||40||
59807765|NCT03485911|75929724|FG002|STARTED|Part 1||20||
59807766|NCT03485911|75929725|FG003|STARTED|Part 1||20||
59807767|NCT03485911|75929722|FG000|COMPLETED|Part 1||37||
59807768|NCT03485911|75929723|FG001|COMPLETED|Part 1||37||
59807769|NCT03485911|75929724|FG002|COMPLETED|Part 1||17||
59807770|NCT03485911|75929725|FG003|COMPLETED|Part 1||17||
59807771|NCT03485911|75929722|FG000|NOT COMPLETED|Part 1||4||
59807772|NCT03485911|75929723|FG001|NOT COMPLETED|Part 1||3||
59807773|NCT03485911|75929724|FG002|NOT COMPLETED|Part 1||3||
59807774|NCT03485911|75929725|FG003|NOT COMPLETED|Part 1||3||
59807775|NCT03485911|75929722|FG000|STARTED|Part 2||37||
59807776|NCT03485911|75929723|FG001|STARTED|Part 2||37||
59807777|NCT03485911|75929724|FG002|STARTED|Part 2||17||
59960671|NCT03022981|76079249|FG001|NOT COMPLETED|Overall Study||4||
59960672|NCT03022981|76079250|FG002|NOT COMPLETED|Overall Study||6||
59960673|NCT03377699|76079270|FG000|STARTED|Overall Study||111|Full analysis set for all women (FASall)|
59960674|NCT03377699|76079271|FG001|STARTED|Overall Study||114|Full analysis set for all women (FASall)|
59960675|NCT03377699|76079270|FG000|Treated|Overall Study||110|Safety analysis set for all women (SASall)|
59960676|NCT03377699|76079271|FG001|Treated|Overall Study||112|Safety analysis set for all women (SASall)|
59960677|NCT03377699|76079270|FG000|SASpregnant|Overall Study||91|Safety analysis set for pregnant women (SASpregnant)|
59960678|NCT03377699|76079271|FG001|SASpregnant|Overall Study||94|Safety analysis set for pregnant women (SASpregnant)|
59960679|NCT03377699|76079270|FG000|FASpregnant|Overall Study||92|Full analysis set for pregnant women (FASpregnant)|
59960680|NCT03377699|76079271|FG001|FASpregnant|Overall Study||96|Full analysis set for pregnant women (FASpregnant)|
59960681|NCT03377699|76079270|FG000|COMPLETED|Overall Study||89||
59960682|NCT03377699|76079271|FG001|COMPLETED|Overall Study||89||
59960683|NCT03377699|76079270|FG000|NOT COMPLETED|Overall Study||22||
59960684|NCT03377699|76079271|FG001|NOT COMPLETED|Overall Study||25||
59960685|NCT01314443|76079283|FG000|STARTED|Overall Study||18||
60074101|NCT01865552|76189489|FG003|STARTED|Period 2||22||
60074102|NCT01865552|76189490|FG004|STARTED|Period 2||20||
59807778|NCT03485911|75929725|FG003|STARTED|Part 2||17||
59807779|NCT03485911|75929722|FG000|COMPLETED|Part 2||28||
59807780|NCT03485911|75929723|FG001|COMPLETED|Part 2||31||
59807781|NCT03485911|75929724|FG002|COMPLETED|Part 2||15||
59960686|NCT01314443|76079284|FG001|STARTED|Overall Study||19||
59960687|NCT01314443|76079285|FG002|STARTED|Overall Study||15||
59960688|NCT01314443|76079286|FG003|STARTED|Overall Study||15||
59807782|NCT03485911|75929725|FG003|COMPLETED|Part 2||14||
59807783|NCT03485911|75929722|FG000|NOT COMPLETED|Part 2||9||
59807784|NCT03485911|75929723|FG001|NOT COMPLETED|Part 2||6||
59807785|NCT03485911|75929724|FG002|NOT COMPLETED|Part 2||2||
59807786|NCT03485911|75929725|FG003|NOT COMPLETED|Part 2||3||
60074103|NCT01865552|76189491|FG005|STARTED|Period 2||22||
59960689|NCT01314443|76079283|FG000|COMPLETED|Overall Study||14||
59960690|NCT01314443|76079284|FG001|COMPLETED|Overall Study||16||
59960691|NCT01314443|76079285|FG002|COMPLETED|Overall Study||13||
59960692|NCT01314443|76079286|FG003|COMPLETED|Overall Study||13||
59960693|NCT01314443|76079283|FG000|NOT COMPLETED|Overall Study||4||
59960694|NCT01314443|76079284|FG001|NOT COMPLETED|Overall Study||3||
59960695|NCT01314443|76079285|FG002|NOT COMPLETED|Overall Study||2||
59960696|NCT01314443|76079286|FG003|NOT COMPLETED|Overall Study||2||
59960697|NCT02923921|76079298|FG000|STARTED|Overall Study||283||
59960698|NCT02923921|76079299|FG001|STARTED|Overall Study||284||
59960699|NCT02923921|76079298|FG000|Received at Least 1 Dose of Study Drug|Overall Study||278||
59960700|NCT02923921|76079299|FG001|Received at Least 1 Dose of Study Drug|Overall Study||251||
59960701|NCT02923921|76079298|FG000|Safety Population|Overall Study||278||
59960702|NCT02923921|76079299|FG001|Safety Population|Overall Study||251||
59960703|NCT02923921|76079298|FG000|COMPLETED|Overall Study||230||
59960704|NCT02923921|76079299|FG001|COMPLETED|Overall Study||227||
59960705|NCT02923921|76079298|FG000|NOT COMPLETED|Overall Study||53||
59960706|NCT02923921|76079299|FG001|NOT COMPLETED|Overall Study||57||
59960707|NCT03039023|76079310|FG000|STARTED|Overall Study||19||
59960708|NCT03039023|76079311|FG001|STARTED|Overall Study||20||
59960709|NCT03039023|76079312|FG002|STARTED|Overall Study||17||
59960710|NCT03039023|76079313|FG003|STARTED|Overall Study||20||
59960711|NCT03039023|76079314|FG004|STARTED|Overall Study||10||
59960712|NCT03039023|76079310|FG000|COMPLETED|Overall Study||18||
59960713|NCT03039023|76079311|FG001|COMPLETED|Overall Study||20||
59960714|NCT03039023|76079312|FG002|COMPLETED|Overall Study||16||
59960715|NCT03039023|76079313|FG003|COMPLETED|Overall Study||18||
59960716|NCT03039023|76079314|FG004|COMPLETED|Overall Study||10||
59960717|NCT03039023|76079310|FG000|NOT COMPLETED|Overall Study||1||
59960718|NCT03039023|76079311|FG001|NOT COMPLETED|Overall Study||0||
59960719|NCT03039023|76079312|FG002|NOT COMPLETED|Overall Study||1||
59960720|NCT03039023|76079313|FG003|NOT COMPLETED|Overall Study||2||
59807787|NCT03485911|75929722|FG000|STARTED|Part 3|"Two subjects completed Part 2, but did not continue treatment in Part 3 due to:~Subject non-compliance with study drug (1 subject)~Other (1 subject)"|26||
59807788|NCT03485911|75929723|FG001|STARTED|Part 3|"Five subjects completed Part 2, but did not continue treatment in Part 3 due to:~Perceived lack of efficacy (2 subjects)~Subject withdrew consent (1 subject)~Other (2 subjects)"|26||
59807789|NCT03485911|75929724|FG002|STARTED|Part 3||15||
59807790|NCT03485911|75929725|FG003|STARTED|Part 3||14||
59807791|NCT03485911|75929722|FG000|COMPLETED|Part 3||7||
59807792|NCT03485911|75929723|FG001|COMPLETED|Part 3||4||
59807793|NCT03485911|75929724|FG002|COMPLETED|Part 3||5||
59807794|NCT03485911|75929725|FG003|COMPLETED|Part 3||4||
59807795|NCT03485911|75929722|FG000|NOT COMPLETED|Part 3||19||
59807796|NCT03485911|75929723|FG001|NOT COMPLETED|Part 3||22||
59807797|NCT03485911|75929724|FG002|NOT COMPLETED|Part 3||10||
59807798|NCT03485911|75929725|FG003|NOT COMPLETED|Part 3||10||
59807799|NCT03446690|75929744|FG000|STARTED|Overall Study||33||
59807800|NCT03446690|75929745|FG001|STARTED|Overall Study||29||
59807801|NCT03446690|75929744|FG000|COMPLETED|Overall Study||26||
59807802|NCT03446690|75929745|FG001|COMPLETED|Overall Study||29||
59807803|NCT03446690|75929744|FG000|NOT COMPLETED|Overall Study||7||
59807804|NCT03446690|75929745|FG001|NOT COMPLETED|Overall Study||0||
59960721|NCT03039023|76079314|FG004|NOT COMPLETED|Overall Study||0||
59960722|NCT03022045|76079328|FG000|STARTED|Overall Study||9||
59960723|NCT03022045|76079329|FG001|STARTED|Overall Study||8||
59960724|NCT03022045|76079328|FG000|COMPLETED|Overall Study||8|As of the interim analysis data cutoff (14 December 2018)|
59960725|NCT03022045|76079329|FG001|COMPLETED|Overall Study||6|As of the interim analysis data cutoff (14 December 2018)|
59960726|NCT03022045|76079328|FG000|NOT COMPLETED|Overall Study||1||
59960727|NCT03022045|76079329|FG001|NOT COMPLETED|Overall Study||2||
59960728|NCT03037619|76079341|FG000|STARTED|Overall Study||8||
59960729|NCT03037619|76079342|FG001|STARTED|Overall Study|8 participants and 7 buddies|15||
59960730|NCT03037619|76079341|FG000|COMPLETED|Overall Study||8||
59960731|NCT03037619|76079342|FG001|COMPLETED|Overall Study|7 participants and 7 buddies|14||
59960732|NCT03037619|76079341|FG000|NOT COMPLETED|Overall Study||0||
59960733|NCT03037619|76079342|FG001|NOT COMPLETED|Overall Study||1||
59960734|NCT04771013|76079350|FG000|STARTED|Overall Study||22||
59960735|NCT04771013|76079351|FG001|STARTED|Overall Study||22||
59960736|NCT04771013|76079350|FG000|COMPLETED|Overall Study||20||
59807805|NCT03395314|75929753|FG000|STARTED|Overall Study||12||
59807806|NCT03395314|75929754|FG001|STARTED|Overall Study||10||
59960737|NCT04771013|76079351|FG001|COMPLETED|Overall Study||16||
59960738|NCT04771013|76079350|FG000|NOT COMPLETED|Overall Study||2||
59960739|NCT04771013|76079351|FG001|NOT COMPLETED|Overall Study||6||
59960740|NCT03021265|76079357|FG000|STARTED|Overall Study||676|Started are registered|
59960741|NCT03021265|76079357|FG000|COMPLETED|Overall Study||554||
59960742|NCT03021265|76079357|FG000|NOT COMPLETED|Overall Study||122||
59960743|NCT04611789|76079364|FG000|STARTED|Overall Study||4||
59960744|NCT04611789|76079365|FG001|STARTED|Overall Study||7||
59960745|NCT04611789|76079366|FG002|STARTED|Overall Study||7||
59960746|NCT04611789|76079364|FG000|COMPLETED|Overall Study||3||
59807807|NCT03395314|75929753|FG000|COMPLETED|Overall Study||12||
59807808|NCT03395314|75929754|FG001|COMPLETED|Overall Study||10||
59960747|NCT04611789|76079365|FG001|COMPLETED|Overall Study||7||
59960748|NCT04611789|76079366|FG002|COMPLETED|Overall Study||7||
59960749|NCT04611789|76079364|FG000|NOT COMPLETED|Overall Study||1||
59960750|NCT04611789|76079365|FG001|NOT COMPLETED|Overall Study||0||
59960751|NCT04611789|76079366|FG002|NOT COMPLETED|Overall Study||0||
59960752|NCT04086693|76079375|FG000|STARTED|Overall Study||175||
59960753|NCT04086693|76079376|FG001|STARTED|Overall Study||175||
59960754|NCT04086693|76079375|FG000|COMPLETED|Overall Study||174||
59960755|NCT04086693|76079376|FG001|COMPLETED|Overall Study||171||
59960756|NCT04086693|76079375|FG000|NOT COMPLETED|Overall Study||1||
59960757|NCT04086693|76079376|FG001|NOT COMPLETED|Overall Study||4||
59960758|NCT03561597|76079382|FG000|STARTED|Overall Study|Recruited|40||
59960759|NCT03561597|76079382|FG000|3 Month Follow up|Overall Study|Attended 3 month follow up|21||
59960760|NCT03561597|76079382|FG000|COMPLETED|Overall Study|Attend month 6 follow up|20||
59960761|NCT03561597|76079382|FG000|NOT COMPLETED|Overall Study||20||
59960762|NCT03148899|76079388|FG000|STARTED|Overall Study||16||
59960763|NCT03148899|76079389|FG001|STARTED|Overall Study||16||
59960764|NCT03148899|76079388|FG000|COMPLETED|Overall Study||16||
59960765|NCT03148899|76079389|FG001|COMPLETED|Overall Study||16||
59960766|NCT03148899|76079388|FG000|NOT COMPLETED|Overall Study||0||
59960767|NCT03148899|76079389|FG001|NOT COMPLETED|Overall Study||0||
59960768|NCT03036267|76079395|FG000|STARTED|Overall Study||46||
59960769|NCT03036267|76079395|FG000|COMPLETED|Overall Study||46||
59960770|NCT03036267|76079395|FG000|NOT COMPLETED|Overall Study||0||
59621023|NCT00291876|75732532|FG000|NOT COMPLETED|Month 150||0||
59960771|NCT03034967|76079405|FG000|STARTED|Overall Study||102||
59960772|NCT03034967|76079406|FG001|STARTED|Overall Study||102||
59960773|NCT03034967|76079407|FG002|STARTED|Overall Study||103||
59960774|NCT03034967|76079408|FG003|STARTED|Overall Study||103||
59960775|NCT03034967|76079409|FG004|STARTED|Overall Study||102||
59621024|NCT00291876|75732532|FG000|STARTED|Month 162||127||
59621025|NCT00291876|75732532|FG000|COMPLETED|Month 162||127||
59960776|NCT03034967|76079410|FG005|STARTED|Overall Study||102||
59960777|NCT03034967|76079405|FG000|COMPLETED|Overall Study||88||
59960778|NCT03034967|76079406|FG001|COMPLETED|Overall Study||97||
59960779|NCT03034967|76079407|FG002|COMPLETED|Overall Study||90||
59960780|NCT03034967|76079408|FG003|COMPLETED|Overall Study||92||
59960781|NCT03034967|76079409|FG004|COMPLETED|Overall Study||88||
59621026|NCT00291876|75732532|FG000|NOT COMPLETED|Month 162||0||
59621027|NCT00291876|75732532|FG000|STARTED|Month 174||127||
59621028|NCT00291876|75732532|FG000|COMPLETED|Month 174||127||
59621029|NCT00291876|75732532|FG000|NOT COMPLETED|Month 174||0||
59621030|NCT00291876|75732532|FG000|STARTED|Month 186||129||
59621031|NCT00291876|75732532|FG000|COMPLETED|Month 186||129||
59621032|NCT00291876|75732532|FG000|NOT COMPLETED|Month 186||0||
59621033|NCT00291876|75732532|FG000|STARTED|Month 198||135||
59621034|NCT00291876|75732532|FG000|COMPLETED|Month 198||135||
59621035|NCT00291876|75732532|FG000|NOT COMPLETED|Month 198||0||
59621036|NCT00291876|75732532|FG000|STARTED|Month 210||124||
59621037|NCT00291876|75732532|FG000|COMPLETED|Month 210||124||
59621038|NCT00291876|75732532|FG000|NOT COMPLETED|Month 210||0||
59621039|NCT00291876|75732532|FG000|STARTED|Month 222||114||
59621040|NCT00291876|75732532|FG000|COMPLETED|Month 222||114||
59621041|NCT00291876|75732532|FG000|NOT COMPLETED|Month 222||0||
59621042|NCT00291876|75732532|FG000|STARTED|Month 234||110||
59621043|NCT00291876|75732532|FG000|COMPLETED|Month 234||110||
59621044|NCT00291876|75732532|FG000|NOT COMPLETED|Month 234||0||
59621045|NCT00291876|75732532|FG000|STARTED|Month 246||116||
59621046|NCT00291876|75732532|FG000|COMPLETED|Month 246||116||
59621047|NCT00291876|75732532|FG000|NOT COMPLETED|Month 246||0||
59621048|NCT01899144|75732536|FG000|STARTED|Treatment Period 1||61||
59621049|NCT01899144|75732536|FG000|COMPLETED|Treatment Period 1||61||
59621050|NCT01899144|75732536|FG000|NOT COMPLETED|Treatment Period 1||0||
59621051|NCT01899144|75732536|FG000|STARTED|Treatment Period 2||61||
59621052|NCT01899144|75732536|FG000|COMPLETED|Treatment Period 2|Last treatment taken by the patient who discontinued was placebo.|60||
59621053|NCT01899144|75732536|FG000|NOT COMPLETED|Treatment Period 2||1||
59621054|NCT01899144|75732536|FG000|STARTED|Treatment Period 3||60||
59621055|NCT01899144|75732536|FG000|COMPLETED|Treatment Period 3|Last treatment taken by patients who discontinued were ABS Spiromax 180 mcg and ABS Spiromax 90 mcg.|58||
59621056|NCT01899144|75732536|FG000|NOT COMPLETED|Treatment Period 3||2||
59621057|NCT01899144|75732536|FG000|STARTED|Treatment Period 4||58||
59621058|NCT01899144|75732536|FG000|COMPLETED|Treatment Period 4||58||
59621059|NCT01899144|75732536|FG000|NOT COMPLETED|Treatment Period 4||0||
59621060|NCT01899144|75732536|FG000|STARTED|Treatment Period 5||58||
59621061|NCT01899144|75732536|FG000|COMPLETED|Treatment Period 5|Last treatment taken by the patient who discontinued was ABS Spiromax 180 mcg.|57||
59960782|NCT03034967|76079410|FG005|COMPLETED|Overall Study||87||
59960783|NCT03034967|76079405|FG000|NOT COMPLETED|Overall Study||14||
59960784|NCT03034967|76079406|FG001|NOT COMPLETED|Overall Study||5||
59960785|NCT03034967|76079407|FG002|NOT COMPLETED|Overall Study||13||
59960786|NCT03034967|76079408|FG003|NOT COMPLETED|Overall Study||11||
59960787|NCT03034967|76079409|FG004|NOT COMPLETED|Overall Study||14||
59960788|NCT03034967|76079410|FG005|NOT COMPLETED|Overall Study||15||
59960789|NCT03021187|76079433|FG000|STARTED|Overall Study||184||
59960790|NCT03021187|76079434|FG001|STARTED|Overall Study||182||
59621062|NCT01899144|75732536|FG000|NOT COMPLETED|Treatment Period 5||1||
59621063|NCT00234078|75732552|FG000|STARTED|Overall Study||72||
59960791|NCT03021187|76079435|FG002|STARTED|Overall Study||181||
59960792|NCT03021187|76079436|FG003|STARTED|Overall Study||184||
59960793|NCT03021187|76079433|FG000|Exposed|Overall Study||184||
59960794|NCT03021187|76079434|FG001|Exposed|Overall Study||181||
59960795|NCT03021187|76079435|FG002|Exposed|Overall Study||181||
59960796|NCT03021187|76079436|FG003|Exposed|Overall Study||184||
59960797|NCT03021187|76079433|FG000|Full Analysis Set (FAS)|Overall Study||184||
59960798|NCT03021187|76079434|FG001|Full Analysis Set (FAS)|Overall Study||182||
59960799|NCT03021187|76079435|FG002|Full Analysis Set (FAS)|Overall Study||181||
59807809|NCT03395314|75929753|FG000|NOT COMPLETED|Overall Study||0||
59807810|NCT03395314|75929754|FG001|NOT COMPLETED|Overall Study||0||
59807811|NCT03028103|75929762|FG000|STARTED|Overall Study||16||
59807812|NCT03028103|75929763|FG001|STARTED|Overall Study||16||
59807813|NCT03028103|75929762|FG000|COMPLETED|Overall Study||16||
59807814|NCT03028103|75929763|FG001|COMPLETED|Overall Study||16||
59960800|NCT03021187|76079436|FG003|Full Analysis Set (FAS)|Overall Study||184||
59960801|NCT03021187|76079433|FG000|Safety Analysis Set (SAS)|Overall Study||184||
59960802|NCT03021187|76079434|FG001|Safety Analysis Set (SAS)|Overall Study||181||
59960803|NCT03021187|76079435|FG002|Safety Analysis Set (SAS)|Overall Study||181||
59960804|NCT03021187|76079436|FG003|Safety Analysis Set (SAS)|Overall Study||184||
59960805|NCT03021187|76079433|FG000|COMPLETED|Overall Study||174||
59960806|NCT03021187|76079434|FG001|COMPLETED|Overall Study||173||
59960807|NCT03021187|76079435|FG002|COMPLETED|Overall Study||175||
59960808|NCT03021187|76079436|FG003|COMPLETED|Overall Study||175||
59960809|NCT03021187|76079433|FG000|NOT COMPLETED|Overall Study||10||
59960810|NCT03021187|76079434|FG001|NOT COMPLETED|Overall Study||9||
59960811|NCT03021187|76079435|FG002|NOT COMPLETED|Overall Study||6||
59960812|NCT03021187|76079436|FG003|NOT COMPLETED|Overall Study||9||
59960813|NCT04766333|76079448|FG000|STARTED|Overall Study||63||
59960814|NCT04766333|76079449|FG001|STARTED|Overall Study||1037||
59960815|NCT04766333|76079448|FG000|COMPLETED|Overall Study||23||
59960816|NCT04766333|76079449|FG001|COMPLETED|Overall Study||211||
59621064|NCT00234078|75732553|FG001|STARTED|Overall Study||72||
59621065|NCT00234078|75732554|FG002|STARTED|Overall Study||74||
59621066|NCT00234078|75732555|FG003|STARTED|Overall Study||72||
59621067|NCT00234078|75732552|FG000|COMPLETED|Overall Study||66||
59621068|NCT00234078|75732553|FG001|COMPLETED|Overall Study||63||
59621069|NCT00234078|75732554|FG002|COMPLETED|Overall Study||64||
59621070|NCT00234078|75732555|FG003|COMPLETED|Overall Study||68||
59621071|NCT00234078|75732552|FG000|NOT COMPLETED|Overall Study||6||
59621072|NCT00234078|75732553|FG001|NOT COMPLETED|Overall Study||9||
59621073|NCT00234078|75732554|FG002|NOT COMPLETED|Overall Study||10||
59621074|NCT00234078|75732555|FG003|NOT COMPLETED|Overall Study||4||
59621075|NCT00118404|75732568|FG000|STARTED|Overall Study||86||
59621076|NCT00118404|75732569|FG001|STARTED|Overall Study||86||
59621077|NCT00118404|75732570|FG002|STARTED|Overall Study||69||
59621078|NCT00118404|75732568|FG000|COMPLETED|Overall Study||62||
59621079|NCT00118404|75732569|FG001|COMPLETED|Overall Study||70||
59621080|NCT00118404|75732570|FG002|COMPLETED|Overall Study||49||
59621081|NCT00118404|75732568|FG000|NOT COMPLETED|Overall Study||24||
59621082|NCT00118404|75732569|FG001|NOT COMPLETED|Overall Study||16||
59621083|NCT00118404|75732570|FG002|NOT COMPLETED|Overall Study||20||
59621084|NCT00121836|75732578|FG000|STARTED|Overall Study||109||
59621085|NCT00121836|75732578|FG000|COMPLETED|Overall Study||54||
59621086|NCT00121836|75732578|FG000|NOT COMPLETED|Overall Study||55||
59621087|NCT00237666|75732583|FG000|STARTED|Overall Study||30||
59621088|NCT00237666|75732583|FG000|COMPLETED|Overall Study||24||
59621089|NCT00237666|75732583|FG000|NOT COMPLETED|Overall Study||6||
59621090|NCT00296322|75732589|FG000|STARTED|Overall Study||258||
59621091|NCT00296322|75732590|FG001|STARTED|Overall Study||263||
59621092|NCT00296322|75732589|FG000|COMPLETED|Overall Study||237||
59621093|NCT00296322|75732590|FG001|COMPLETED|Overall Study||184||
59960817|NCT04766333|76079448|FG000|NOT COMPLETED|Overall Study||40||
59960818|NCT04766333|76079449|FG001|NOT COMPLETED|Overall Study||826||
59960819|NCT03020641|76079457|FG000|STARTED|Overall Study||50||
59960820|NCT03020641|76079458|FG001|STARTED|Overall Study||50||
59960821|NCT03020641|76079457|FG000|COMPLETED|Overall Study||48||
59960822|NCT03020641|76079458|FG001|COMPLETED|Overall Study||47||
59960823|NCT03020641|76079457|FG000|NOT COMPLETED|Overall Study||2||
59960824|NCT03020641|76079458|FG001|NOT COMPLETED|Overall Study||3||
59960825|NCT03020407|76079469|FG000|STARTED|Overall Study||105||
59621094|NCT00296322|75732589|FG000|NOT COMPLETED|Overall Study||21||
59621095|NCT00296322|75732590|FG001|NOT COMPLETED|Overall Study||79||
59621096|NCT00297102|75732598|FG000|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|765||
59807815|NCT03028103|75929762|FG000|NOT COMPLETED|Overall Study||0||
59807816|NCT03028103|75929763|FG001|NOT COMPLETED|Overall Study||0||
59807817|NCT03020589|75929775|FG000|STARTED|Overall Study||40||
59807818|NCT03020589|75929776|FG001|STARTED|Overall Study||57||
59960826|NCT03020407|76079470|FG001|STARTED|Overall Study||106||
59960827|NCT03020407|76079469|FG000|COMPLETED|Overall Study||101||
59807819|NCT03020589|75929775|FG000|COMPLETED|Overall Study||40||
59960828|NCT03020407|76079470|FG001|COMPLETED|Overall Study||101||
59960829|NCT03020407|76079469|FG000|NOT COMPLETED|Overall Study||4||
59960830|NCT03020407|76079470|FG001|NOT COMPLETED|Overall Study||5||
59960831|NCT02536846|76079476|FG000|STARTED|Overall Study||10|35 participants were enrolled and 10 were allocated to receive olanzapine.|
59960832|NCT02536846|76079476|FG000|COMPLETED|Overall Study||9||
59960833|NCT02536846|76079476|FG000|NOT COMPLETED|Overall Study||1||
59960834|NCT03014011|76079481|FG000|STARTED|First Intervention||14|Participants randomized and started intervention visit|
59960835|NCT03014011|76079482|FG001|STARTED|First Intervention||13|Participants randomized and started intervention visit|
59960836|NCT03014011|76079481|FG000|COMPLETED|First Intervention||13|Participants who completed the intervention visit|
59960837|NCT03014011|76079482|FG001|COMPLETED|First Intervention||13|Participants who completed the intervention visit|
59960838|NCT03014011|76079481|FG000|NOT COMPLETED|First Intervention||1||
59960839|NCT03014011|76079482|FG001|NOT COMPLETED|First Intervention||0||
59960840|NCT03014011|76079481|FG000|STARTED|Washout||13|started intervention visit|
59960841|NCT03014011|76079482|FG001|STARTED|Washout||13|started intervention visit|
59960842|NCT03014011|76079481|FG000|COMPLETED|Washout||12||
59960843|NCT03014011|76079482|FG001|COMPLETED|Washout||13||
59960844|NCT03014011|76079481|FG000|NOT COMPLETED|Washout||1||
59960845|NCT03014011|76079482|FG001|NOT COMPLETED|Washout||0||
59960846|NCT03014011|76079481|FG000|STARTED|Second Intervention||12||
59960847|NCT03014011|76079482|FG001|STARTED|Second Intervention||13||
59960848|NCT03014011|76079481|FG000|COMPLETED|Second Intervention||12|completed intervention visit|
59960849|NCT03014011|76079482|FG001|COMPLETED|Second Intervention||13|completed intervention visit|
59960850|NCT03014011|76079481|FG000|NOT COMPLETED|Second Intervention||0||
59960851|NCT03014011|76079482|FG001|NOT COMPLETED|Second Intervention||0||
59960852|NCT03012841|76079488|FG000|STARTED|Overall Study||165||
59960853|NCT03012841|76079489|FG001|STARTED|Overall Study||21||
59960854|NCT03012841|76079488|FG000|COMPLETED|Overall Study||145||
59960855|NCT03012841|76079489|FG001|COMPLETED|Overall Study||0||
59960856|NCT03012841|76079488|FG000|NOT COMPLETED|Overall Study||20||
59960857|NCT03012841|76079489|FG001|NOT COMPLETED|Overall Study||21||
59960858|NCT02359864|76079496|FG000|STARTED|Overall Study||2||
59960859|NCT02359864|76079497|FG001|STARTED|Overall Study||0||
59960860|NCT02359864|76079496|FG000|COMPLETED|Overall Study||1||
59960861|NCT02359864|76079497|FG001|COMPLETED|Overall Study||0||
59960862|NCT02359864|76079496|FG000|NOT COMPLETED|Overall Study||1||
59960863|NCT02359864|76079497|FG001|NOT COMPLETED|Overall Study||0||
59807820|NCT03020589|75929776|FG001|COMPLETED|Overall Study||57||
59807821|NCT03020589|75929775|FG000|NOT COMPLETED|Overall Study||0||
59807822|NCT03020589|75929776|FG001|NOT COMPLETED|Overall Study||0||
59807823|NCT02932475|75929784|FG000|STARTED|Overall Study||416||
59807824|NCT02932475|75929785|FG001|STARTED|Overall Study||415||
59807825|NCT02932475|75929784|FG000|Randomized|Overall Study||416||
59807826|NCT02932475|75929785|FG001|Randomized|Overall Study||415||
59807827|NCT02932475|75929784|FG000|Received Intervention|Overall Study||397||
59807828|NCT02932475|75929785|FG001|Received Intervention|Overall Study||397||
59807829|NCT02932475|75929784|FG000|Liveborn Infants During Study|Overall Study||376||
59807830|NCT02932475|75929785|FG001|Liveborn Infants During Study|Overall Study||370||
59807831|NCT02932475|75929784|FG000|COMPLETED|Overall Study||386||
59807832|NCT02932475|75929785|FG001|COMPLETED|Overall Study||382||
59807833|NCT02932475|75929784|FG000|NOT COMPLETED|Overall Study||30||
59807834|NCT02932475|75929785|FG001|NOT COMPLETED|Overall Study||33||
59807835|NCT02886936|75929800|FG000|STARTED|Overall Study|This is from our first and follow up study on the transtibial.|26||
59807836|NCT02886936|75929801|FG001|STARTED|Overall Study||27||
59807837|NCT02886936|75929802|FG002|STARTED|Overall Study||18||
59960864|NCT02533258|76079503|FG000|STARTED|Overall Study||13||
59960865|NCT02533258|76079503|FG000|COMPLETED|Overall Study||5||
59960866|NCT02533258|76079503|FG000|NOT COMPLETED|Overall Study||8||
59960867|NCT05439460|76079510|FG000|STARTED|First Intervention (Approx 5h on Study)||5||
59960868|NCT05439460|76079511|FG001|STARTED|First Intervention (Approx 5h on Study)||0||
59960869|NCT05439460|76079512|FG002|STARTED|First Intervention (Approx 5h on Study)||0||
59960870|NCT05439460|76079510|FG000|COMPLETED|First Intervention (Approx 5h on Study)||5||
59960871|NCT05439460|76079511|FG001|COMPLETED|First Intervention (Approx 5h on Study)||0||
59960872|NCT05439460|76079512|FG002|COMPLETED|First Intervention (Approx 5h on Study)||0||
59960873|NCT05439460|76079510|FG000|NOT COMPLETED|First Intervention (Approx 5h on Study)||0||
59960874|NCT05439460|76079511|FG001|NOT COMPLETED|First Intervention (Approx 5h on Study)||0||
59960875|NCT05439460|76079512|FG002|NOT COMPLETED|First Intervention (Approx 5h on Study)||0||
59960876|NCT05439460|76079510|FG000|STARTED|Second Intervention (Approx 5h on Study)||0||
59960877|NCT05439460|76079511|FG001|STARTED|Second Intervention (Approx 5h on Study)||5||
59960878|NCT05439460|76079512|FG002|STARTED|Second Intervention (Approx 5h on Study)||0||
59960879|NCT05439460|76079510|FG000|COMPLETED|Second Intervention (Approx 5h on Study)||0||
59960880|NCT05439460|76079511|FG001|COMPLETED|Second Intervention (Approx 5h on Study)||5||
59960881|NCT05439460|76079512|FG002|COMPLETED|Second Intervention (Approx 5h on Study)||0||
59960882|NCT05439460|76079510|FG000|NOT COMPLETED|Second Intervention (Approx 5h on Study)||0||
59807838|NCT02886936|75929800|FG000|COMPLETED|Overall Study||22||
59807839|NCT02886936|75929801|FG001|COMPLETED|Overall Study||24||
59807840|NCT02886936|75929802|FG002|COMPLETED|Overall Study||18||
59960883|NCT05439460|76079511|FG001|NOT COMPLETED|Second Intervention (Approx 5h on Study)||0||
59960884|NCT05439460|76079512|FG002|NOT COMPLETED|Second Intervention (Approx 5h on Study)||0||
59960885|NCT05439460|76079510|FG000|STARTED|Third Intervention (Approx 5h on Study)||0||
59960886|NCT05439460|76079511|FG001|STARTED|Third Intervention (Approx 5h on Study)||0||
59960887|NCT05439460|76079512|FG002|STARTED|Third Intervention (Approx 5h on Study)||5||
59960888|NCT05439460|76079510|FG000|COMPLETED|Third Intervention (Approx 5h on Study)||0||
59960889|NCT05439460|76079511|FG001|COMPLETED|Third Intervention (Approx 5h on Study)||0||
59960890|NCT05439460|76079512|FG002|COMPLETED|Third Intervention (Approx 5h on Study)||5||
59960891|NCT05439460|76079510|FG000|NOT COMPLETED|Third Intervention (Approx 5h on Study)||0||
59960892|NCT05439460|76079511|FG001|NOT COMPLETED|Third Intervention (Approx 5h on Study)||0||
59960893|NCT05439460|76079512|FG002|NOT COMPLETED|Third Intervention (Approx 5h on Study)||0||
59960894|NCT03019627|76079522|FG000|STARTED|Overall Study||100||
59960895|NCT03019627|76079523|FG001|STARTED|Overall Study||50||
59960896|NCT03019627|76079522|FG000|COMPLETED|Overall Study||85||
59960897|NCT03019627|76079523|FG001|COMPLETED|Overall Study||42||
59524404|NCT01004705|75619586|FG002|STARTED|Washout Period (6 Weeks)||13||
59807841|NCT02886936|75929800|FG000|NOT COMPLETED|Overall Study||4||
59807842|NCT02886936|75929801|FG001|NOT COMPLETED|Overall Study||3||
59807843|NCT02886936|75929802|FG002|NOT COMPLETED|Overall Study||0||
59807844|NCT02383407|75929814|FG000|STARTED|Overall Study||1||
59807845|NCT02383407|75929815|FG001|STARTED|Overall Study||2||
59807846|NCT02383407|75929814|FG000|COMPLETED|Overall Study||1||
59807847|NCT02383407|75929815|FG001|COMPLETED|Overall Study||2||
59807848|NCT02383407|75929814|FG000|NOT COMPLETED|Overall Study||0||
59807849|NCT02383407|75929815|FG001|NOT COMPLETED|Overall Study||0||
59807850|NCT02237079|75929827|FG000|STARTED|Overall Study||10||
59807851|NCT02237079|75929828|FG001|STARTED|Overall Study||7||
59807852|NCT02237079|75929827|FG000|COMPLETED|Overall Study||7||
59807853|NCT02237079|75929828|FG001|COMPLETED|Overall Study||5||
59807854|NCT02237079|75929827|FG000|NOT COMPLETED|Overall Study||3||
59807855|NCT02237079|75929828|FG001|NOT COMPLETED|Overall Study||2||
59807856|NCT02162511|75929837|FG000|STARTED|Overall Study||0||
59807857|NCT02162511|75929838|FG001|STARTED|Overall Study||0||
59807858|NCT02162511|75929839|FG002|STARTED|Overall Study||3||
59807859|NCT02162511|75929837|FG000|Achieved Engraftment|Overall Study||0||
59807860|NCT02162511|75929838|FG001|Achieved Engraftment|Overall Study||0||
59807861|NCT02162511|75929839|FG002|Achieved Engraftment|Overall Study||1||
59807862|NCT02162511|75929837|FG000|COMPLETED|Overall Study||0||
59807863|NCT02162511|75929838|FG001|COMPLETED|Overall Study||0||
59807864|NCT02162511|75929839|FG002|COMPLETED|Overall Study||1||
59807865|NCT02162511|75929837|FG000|NOT COMPLETED|Overall Study||0||
59807866|NCT02162511|75929838|FG001|NOT COMPLETED|Overall Study||0||
59807867|NCT02162511|75929839|FG002|NOT COMPLETED|Overall Study||2||
59807868|NCT01265030|75929843|FG000|STARTED|Overall Study||9|Goal enrollment of 15 subjects|
59807869|NCT01265030|75929843|FG000|COMPLETED|Overall Study|9 of anticipated 15 patients accrued|9||
59807870|NCT01265030|75929843|FG000|NOT COMPLETED|Overall Study||0||
59807871|NCT00901511|75929856|FG000|STARTED|Overall Study||9||
59807872|NCT00901511|75929857|FG001|STARTED|Overall Study||9||
59807873|NCT00901511|75929856|FG000|COMPLETED|Overall Study||8||
59807874|NCT00901511|75929857|FG001|COMPLETED|Overall Study||8||
59807875|NCT00901511|75929856|FG000|NOT COMPLETED|Overall Study||1||
59807876|NCT00901511|75929857|FG001|NOT COMPLETED|Overall Study||1||
59807877|NCT00117143|75929868|FG000|STARTED|Overall Study||4||
59807878|NCT00117143|75929869|FG001|STARTED|Overall Study||4||
59807879|NCT00117143|75929870|FG002|STARTED|Overall Study||7||
59807880|NCT00117143|75929871|FG003|STARTED|Overall Study||1||
59807881|NCT00117143|75929868|FG000|Received First Dose|Overall Study||4||
59807882|NCT00117143|75929869|FG001|Received First Dose|Overall Study||4||
59807883|NCT00117143|75929870|FG002|Received First Dose|Overall Study||7||
59807884|NCT00117143|75929871|FG003|Received First Dose|Overall Study||1||
59807885|NCT00117143|75929868|FG000|Received Second Dose|Overall Study||4||
59960898|NCT03019627|76079522|FG000|NOT COMPLETED|Overall Study||15||
59524405|NCT01004705|75619584|FG000|COMPLETED|Washout Period (6 Weeks)||0||
59960899|NCT03019627|76079523|FG001|NOT COMPLETED|Overall Study||8||
59960900|NCT01661140|76079529|FG000|STARTED|Open-Label Period|All participants entered the study in the initial phase for 24 weeks of open label treatment.|427||
59960901|NCT01661140|76079530|FG001|STARTED|Open-Label Period||0||
59960902|NCT01661140|76079531|FG002|STARTED|Open-Label Period||0||
59807886|NCT00117143|75929869|FG001|Received Second Dose|Overall Study||4||
59807887|NCT00117143|75929870|FG002|Received Second Dose|Overall Study||6||
59807888|NCT00117143|75929871|FG003|Received Second Dose|Overall Study||0||
59807889|NCT00117143|75929868|FG000|COMPLETED|Overall Study||4||
59807890|NCT00117143|75929869|FG001|COMPLETED|Overall Study||4||
59960903|NCT01661140|76079529|FG000|COMPLETED|Open-Label Period||351||
59960904|NCT01661140|76079530|FG001|COMPLETED|Open-Label Period||0||
59960905|NCT01661140|76079531|FG002|COMPLETED|Open-Label Period||0||
59524406|NCT01004705|75619585|FG001|COMPLETED|Washout Period (6 Weeks)||13||
59807891|NCT00117143|75929870|FG002|COMPLETED|Overall Study||7||
59807892|NCT00117143|75929871|FG003|COMPLETED|Overall Study||1||
59807893|NCT00117143|75929868|FG000|NOT COMPLETED|Overall Study||0||
59807894|NCT00117143|75929869|FG001|NOT COMPLETED|Overall Study||0||
59807895|NCT00117143|75929870|FG002|NOT COMPLETED|Overall Study||0||
59807896|NCT00117143|75929871|FG003|NOT COMPLETED|Overall Study||0||
59960906|NCT01661140|76079529|FG000|NOT COMPLETED|Open-Label Period||76||
59960907|NCT01661140|76079530|FG001|NOT COMPLETED|Open-Label Period||0||
59960908|NCT01661140|76079531|FG002|NOT COMPLETED|Open-Label Period||0||
59960909|NCT01661140|76079529|FG000|STARTED|Double-Blind Period|Those with a good/moderate disease response in the initial phase were randomized to the MTX arms.|0||
59960910|NCT01661140|76079530|FG001|STARTED|Double-Blind Period|Only those with a good/moderate disease response in the initial phase were randomized.|136||
59960911|NCT01661140|76079531|FG002|STARTED|Double-Blind Period|Only those with a good/moderate disease response in the initial phase were randomized.|136||
59960912|NCT01661140|76079529|FG000|COMPLETED|Double-Blind Period||0||
59960913|NCT01661140|76079530|FG001|COMPLETED|Double-Blind Period||95||
59960914|NCT01661140|76079531|FG002|COMPLETED|Double-Blind Period||86||
59960915|NCT01661140|76079529|FG000|NOT COMPLETED|Double-Blind Period||0||
59807897|NCT00539994|75929884|FG000|STARTED|Overall Study||23||
59807898|NCT00539994|75929885|FG001|STARTED|Overall Study||19||
59807899|NCT00539994|75929886|FG002|STARTED|Overall Study||15||
59807900|NCT00539994|75929884|FG000|COMPLETED|Overall Study||20||
59807901|NCT00539994|75929885|FG001|COMPLETED|Overall Study||18||
59807902|NCT00539994|75929886|FG002|COMPLETED|Overall Study||13||
59807903|NCT00539994|75929884|FG000|NOT COMPLETED|Overall Study||3||
59807904|NCT00539994|75929885|FG001|NOT COMPLETED|Overall Study||1||
59807905|NCT00539994|75929886|FG002|NOT COMPLETED|Overall Study||2||
59807906|NCT00098839|75929903|FG000|STARTED|Overall Study||56||
59807907|NCT00098839|75929904|FG001|STARTED|Overall Study||60||
59807908|NCT00098839|75929903|FG000|COMPLETED|Overall Study||24||
59807909|NCT00098839|75929904|FG001|COMPLETED|Overall Study||27||
59807910|NCT00098839|75929903|FG000|NOT COMPLETED|Overall Study||32||
59807911|NCT00098839|75929904|FG001|NOT COMPLETED|Overall Study||33||
59807912|NCT03811093|75929913|FG000|STARTED|Overall Study||20||
59807913|NCT03811093|75929914|FG001|STARTED|Overall Study||19||
59807914|NCT03811093|75929913|FG000|COMPLETED|Overall Study||18||
59807915|NCT03811093|75929914|FG001|COMPLETED|Overall Study||15||
59960916|NCT01661140|76079530|FG001|NOT COMPLETED|Double-Blind Period||41||
59960917|NCT01661140|76079531|FG002|NOT COMPLETED|Double-Blind Period||50||
59960918|NCT03019549|76079539|FG000|STARTED|Period 1||42||
59960919|NCT03019549|76079539|FG000|Received 1 Dose of Study Drug|Period 1||42||
59960920|NCT03019549|76079539|FG000|COMPLETED|Period 1||42||
59960921|NCT03019549|76079539|FG000|NOT COMPLETED|Period 1||0||
59960922|NCT03019549|76079539|FG000|STARTED|Washout||42||
59960923|NCT03019549|76079539|FG000|COMPLETED|Washout||31||
59960924|NCT03019549|76079539|FG000|NOT COMPLETED|Washout||11||
59524407|NCT01004705|75619586|FG002|COMPLETED|Washout Period (6 Weeks)||13||
59524408|NCT01004705|75619584|FG000|NOT COMPLETED|Washout Period (6 Weeks)||0||
59524409|NCT01004705|75619585|FG001|NOT COMPLETED|Washout Period (6 Weeks)||0||
59524410|NCT01004705|75619586|FG002|NOT COMPLETED|Washout Period (6 Weeks)||0||
59524411|NCT01004705|75619584|FG000|STARTED|Period 2 (12 Weeks)||0||
59524412|NCT01004705|75619585|FG001|STARTED|Period 2 (12 Weeks)||13||
59524413|NCT01004705|75619586|FG002|STARTED|Period 2 (12 Weeks)||13||
59807916|NCT03811093|75929913|FG000|NOT COMPLETED|Overall Study||2||
59807917|NCT03811093|75929914|FG001|NOT COMPLETED|Overall Study||4||
59807918|NCT00485589|75929926|FG000|STARTED|Overall Study||210||
59807919|NCT00485589|75929927|FG001|STARTED|Overall Study||200||
59960925|NCT03019549|76079539|FG000|STARTED|Period 2||31||
59960926|NCT03019549|76079539|FG000|Received at Least 1 Dose of Study Drug|Period 2||29||
59960927|NCT03019549|76079539|FG000|COMPLETED|Period 2||26||
59960928|NCT03019549|76079539|FG000|NOT COMPLETED|Period 2||5||
59960929|NCT01661062|76079548|FG000|STARTED|Overall Study||23||
59960930|NCT01661062|76079548|FG000|COMPLETED|Overall Study||18||
59960931|NCT01661062|76079548|FG000|NOT COMPLETED|Overall Study||5||
59960932|NCT02536378|76079554|FG000|STARTED|Overall Study||632||
59960933|NCT02536378|76079555|FG001|STARTED|Overall Study||60||
59960934|NCT02536378|76079554|FG000|COMPLETED|Overall Study||625||
59960935|NCT02536378|76079555|FG001|COMPLETED|Overall Study||53||
59960936|NCT02536378|76079554|FG000|NOT COMPLETED|Overall Study||7||
59807920|NCT00485589|75929928|FG002|STARTED|Overall Study||203||
59960937|NCT02536378|76079555|FG001|NOT COMPLETED|Overall Study||7||
59960938|NCT01373151|76079570|FG000|STARTED|Period 1||61||
59960939|NCT01373151|76079571|FG001|STARTED|Period 1||59||
59960940|NCT01373151|76079572|FG002|STARTED|Period 1||60||
59524414|NCT01004705|75619584|FG000|COMPLETED|Period 2 (12 Weeks)||0||
59524415|NCT01004705|75619585|FG001|COMPLETED|Period 2 (12 Weeks)||13||
59524416|NCT01004705|75619586|FG002|COMPLETED|Period 2 (12 Weeks)||9||
59524417|NCT01004705|75619584|FG000|NOT COMPLETED|Period 2 (12 Weeks)||0||
59524418|NCT01004705|75619585|FG001|NOT COMPLETED|Period 2 (12 Weeks)||0||
59524419|NCT01004705|75619586|FG002|NOT COMPLETED|Period 2 (12 Weeks)||4||
59524420|NCT01417286|75619593|FG000|STARTED|Overall Study||67||
59524421|NCT01417286|75619593|FG000|COMPLETED|Overall Study||67||
59807921|NCT00485589|75929926|FG000|COMPLETED|Overall Study||183||
59807922|NCT00485589|75929927|FG001|COMPLETED|Overall Study||180||
59807923|NCT00485589|75929928|FG002|COMPLETED|Overall Study||185||
59807924|NCT00485589|75929926|FG000|NOT COMPLETED|Overall Study||27||
59807925|NCT00485589|75929927|FG001|NOT COMPLETED|Overall Study||20||
59960941|NCT01373151|76079573|FG003|STARTED|Period 1||60||
59960942|NCT01373151|76079574|FG004|STARTED|Period 1||59||
59960943|NCT01373151|76079575|FG005|STARTED|Period 1||60||
59807926|NCT00485589|75929928|FG002|NOT COMPLETED|Overall Study||18||
59807927|NCT00490971|75929947|FG000|STARTED|Acute/Continuation|617 participants were assigned to paliperidone, out of which 614 took the study medication.|614||
59807928|NCT00490971|75929948|FG001|STARTED|Acute/Continuation|149 participants were assigned to paliperidone, out of which 148 took the study medication.|148||
59807929|NCT00490971|75929949|FG002|STARTED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0||
59807930|NCT00490971|75929950|FG003|STARTED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0||
59807931|NCT00490971|75929951|FG004|STARTED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0||
59960944|NCT01373151|76079576|FG006|STARTED|Period 1||59||
59960945|NCT01373151|76079570|FG000|COMPLETED|Period 1||56||
59960946|NCT01373151|76079571|FG001|COMPLETED|Period 1||59||
59960947|NCT01373151|76079572|FG002|COMPLETED|Period 1||56||
59960948|NCT01373151|76079573|FG003|COMPLETED|Period 1||59||
59960949|NCT01373151|76079574|FG004|COMPLETED|Period 1||54||
59960950|NCT01373151|76079575|FG005|COMPLETED|Period 1||56||
59960951|NCT01373151|76079576|FG006|COMPLETED|Period 1||59||
59960952|NCT01373151|76079570|FG000|NOT COMPLETED|Period 1||5||
59960953|NCT01373151|76079571|FG001|NOT COMPLETED|Period 1||0||
59960954|NCT01373151|76079572|FG002|NOT COMPLETED|Period 1||4||
59960955|NCT01373151|76079573|FG003|NOT COMPLETED|Period 1||1||
59960956|NCT01373151|76079574|FG004|NOT COMPLETED|Period 1||5||
59960957|NCT01373151|76079575|FG005|NOT COMPLETED|Period 1||4||
59960958|NCT01373151|76079576|FG006|NOT COMPLETED|Period 1||0||
59960959|NCT01373151|76079570|FG000|STARTED|Period 2||56||
59960960|NCT01373151|76079571|FG001|STARTED|Period 2||58||
59960961|NCT01373151|76079572|FG002|STARTED|Period 2||56||
59960962|NCT01373151|76079573|FG003|STARTED|Period 2||59||
59960963|NCT01373151|76079574|FG004|STARTED|Period 2||54||
59960964|NCT01373151|76079575|FG005|STARTED|Period 2||55||
59960965|NCT01373151|76079576|FG006|STARTED|Period 2||59||
59960966|NCT01373151|76079570|FG000|COMPLETED|Period 2||47||
59960967|NCT01373151|76079571|FG001|COMPLETED|Period 2||57||
59960968|NCT01373151|76079572|FG002|COMPLETED|Period 2||52||
59960969|NCT01373151|76079573|FG003|COMPLETED|Period 2||54||
59960970|NCT01373151|76079574|FG004|COMPLETED|Period 2||52||
59960971|NCT01373151|76079575|FG005|COMPLETED|Period 2||55||
59960972|NCT01373151|76079576|FG006|COMPLETED|Period 2||54||
59960973|NCT01373151|76079570|FG000|NOT COMPLETED|Period 2||9||
59960974|NCT01373151|76079571|FG001|NOT COMPLETED|Period 2||1||
59960975|NCT01373151|76079572|FG002|NOT COMPLETED|Period 2||4||
59960976|NCT01373151|76079573|FG003|NOT COMPLETED|Period 2||5||
59960977|NCT01373151|76079574|FG004|NOT COMPLETED|Period 2||2||
59960978|NCT01373151|76079575|FG005|NOT COMPLETED|Period 2||0||
59524422|NCT01417286|75619593|FG000|NOT COMPLETED|Overall Study||0||
59524423|NCT01004939|75619597|FG000|STARTED|Overall Study||120||
59524424|NCT01004939|75619597|FG000|COMPLETED|Overall Study||120||
59524425|NCT01004939|75619597|FG000|NOT COMPLETED|Overall Study||0||
59807932|NCT00490971|75929947|FG000|COMPLETED|Acute/Continuation||308||
59807933|NCT00490971|75929948|FG001|COMPLETED|Acute/Continuation||86||
59807934|NCT00490971|75929949|FG002|COMPLETED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0||
59817879|NCT04488770|75940331|FG005|STARTED|Part 1-Cohort 2: Period 1 (Up to 5 Days)||2||
59960979|NCT01373151|76079576|FG006|NOT COMPLETED|Period 2||5||
59960980|NCT01660906|76079592|FG000|STARTED|Overall Study||39||
59960981|NCT01660906|76079592|FG000|COMPLETED|Overall Study||36||
59960982|NCT01660906|76079592|FG000|NOT COMPLETED|Overall Study||3||
59960983|NCT01285947|76079598|FG000|STARTED|Overall Study||10||
59960984|NCT01285947|76079599|FG001|STARTED|Overall Study||10||
59960985|NCT01285947|76079598|FG000|COMPLETED|Overall Study||10||
59960986|NCT01285947|76079599|FG001|COMPLETED|Overall Study||10||
59960987|NCT01285947|76079598|FG000|NOT COMPLETED|Overall Study||0||
59960988|NCT01285947|76079599|FG001|NOT COMPLETED|Overall Study||0||
59960989|NCT03015181|76079612|FG000|STARTED|Overall Study||4||
59960990|NCT03015181|76079613|FG001|STARTED|Overall Study||3||
59960991|NCT03015181|76079614|FG002|STARTED|Overall Study||3||
59960992|NCT03015181|76079615|FG003|STARTED|Overall Study||3||
59960993|NCT03015181|76079616|FG004|STARTED|Overall Study||3||
59960994|NCT03015181|76079617|FG005|STARTED|Overall Study||5||
59960995|NCT03015181|76079618|FG006|STARTED|Overall Study||5||
59960996|NCT03015181|76079612|FG000|Received VRC07-523LS Per Protocol|Overall Study||3||
59960997|NCT03015181|76079613|FG001|Received VRC07-523LS Per Protocol|Overall Study||3||
59960998|NCT03015181|76079614|FG002|Received VRC07-523LS Per Protocol|Overall Study||3||
59960999|NCT03015181|76079615|FG003|Received VRC07-523LS Per Protocol|Overall Study||3||
59961000|NCT03015181|76079616|FG004|Received VRC07-523LS Per Protocol|Overall Study||3||
59961001|NCT03015181|76079617|FG005|Received VRC07-523LS Per Protocol|Overall Study||4||
59961002|NCT03015181|76079618|FG006|Received VRC07-523LS Per Protocol|Overall Study||4||
59524426|NCT01245595|75619605|FG000|STARTED|Overall Study||72||
59524427|NCT01245595|75619606|FG001|STARTED|Overall Study||72||
59524428|NCT01245595|75619605|FG000|Completed Full Course of Study Drug|Overall Study||57||
59524429|NCT01245595|75619606|FG001|Completed Full Course of Study Drug|Overall Study||61||
59807935|NCT00490971|75929950|FG003|COMPLETED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0||
59961003|NCT03015181|76079612|FG000|Discontinued VRC07-523LS Administrations|Overall Study|One Group 1 subject decided not to receive the VRC07-523LS infusion|1||
59961004|NCT03015181|76079613|FG001|Discontinued VRC07-523LS Administrations|Overall Study||0||
59961005|NCT03015181|76079614|FG002|Discontinued VRC07-523LS Administrations|Overall Study||0||
59961006|NCT03015181|76079615|FG003|Discontinued VRC07-523LS Administrations|Overall Study||0||
59961007|NCT03015181|76079616|FG004|Discontinued VRC07-523LS Administrations|Overall Study||0||
59961008|NCT03015181|76079617|FG005|Discontinued VRC07-523LS Administrations|Overall Study|One Group 6 subject received only 1 of 3 scheduled doses prior to withdrawing from the study|1||
59961009|NCT03015181|76079618|FG006|Discontinued VRC07-523LS Administrations|Overall Study|One Group 7 subject received only 1 of 3 scheduled doses due to an unrelated intercurrent illness|1||
59961010|NCT03015181|76079612|FG000|COMPLETED|Overall Study||3||
59961011|NCT03015181|76079613|FG001|COMPLETED|Overall Study||3||
59961012|NCT03015181|76079614|FG002|COMPLETED|Overall Study||3||
59961013|NCT03015181|76079615|FG003|COMPLETED|Overall Study||3||
59961014|NCT03015181|76079616|FG004|COMPLETED|Overall Study||3||
59807936|NCT00490971|75929951|FG004|COMPLETED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0||
59807937|NCT00490971|75929947|FG000|NOT COMPLETED|Acute/Continuation||306||
59807938|NCT00490971|75929948|FG001|NOT COMPLETED|Acute/Continuation||62||
59807939|NCT00490971|75929949|FG002|NOT COMPLETED|Acute/Continuation||0||
59807940|NCT00490971|75929950|FG003|NOT COMPLETED|Acute/Continuation||0||
59807941|NCT00490971|75929951|FG004|NOT COMPLETED|Acute/Continuation||0||
59807942|NCT00490971|75929947|FG000|STARTED|Maintenance|"0 indicates this group is not relevant to maintenance period."|0||
59807943|NCT00490971|75929948|FG001|STARTED|Maintenance|"0 indicates this group is not relevant to maintenance period."|0||
59807944|NCT00490971|75929949|FG002|STARTED|Maintenance|148 participants were assigned to pali/placebo, out of which 147 took the study medication.|147||
59807945|NCT00490971|75929950|FG003|STARTED|Maintenance|152 participants were assigned to pali/pali, out of which 149 took the study medication.|149||
59807946|NCT00490971|75929951|FG004|STARTED|Maintenance||83||
59807947|NCT00490971|75929947|FG000|COMPLETED|Maintenance|"0 indicates this group is not relevant to maintenance period."|0||
59807948|NCT00490971|75929948|FG001|COMPLETED|Maintenance|"0 indicates this group is not relevant to maintenance period."|0||
59807949|NCT00490971|75929949|FG002|COMPLETED|Maintenance||96||
59807950|NCT00490971|75929950|FG003|COMPLETED|Maintenance||96||
59807951|NCT00490971|75929951|FG004|COMPLETED|Maintenance||44||
59807952|NCT00490971|75929947|FG000|NOT COMPLETED|Maintenance||0||
59807953|NCT00490971|75929948|FG001|NOT COMPLETED|Maintenance||0||
59807954|NCT00490971|75929949|FG002|NOT COMPLETED|Maintenance||51||
59807955|NCT00490971|75929950|FG003|NOT COMPLETED|Maintenance||53||
59807956|NCT00490971|75929951|FG004|NOT COMPLETED|Maintenance||39||
59961015|NCT03015181|76079617|FG005|COMPLETED|Overall Study|Group 6 subject who received only 1 dose chose to withdraw from study after the first administration|4||
59961016|NCT03015181|76079618|FG006|COMPLETED|Overall Study|Group 7 subject who received only 1 dose was withdrawn after unrelated intercurrent illness resolved|4||
59961017|NCT03015181|76079612|FG000|NOT COMPLETED|Overall Study||1||
59807957|NCT00686075|75929973|FG000|STARTED|Overall Study||79||
59807958|NCT00686075|75929974|FG001|STARTED|Overall Study||81||
59807959|NCT00686075|75929975|FG002|STARTED|Overall Study||80||
59961018|NCT03015181|76079613|FG001|NOT COMPLETED|Overall Study||0||
59961019|NCT03015181|76079614|FG002|NOT COMPLETED|Overall Study||0||
59961020|NCT03015181|76079615|FG003|NOT COMPLETED|Overall Study||0||
59961021|NCT03015181|76079616|FG004|NOT COMPLETED|Overall Study||0||
59961022|NCT03015181|76079617|FG005|NOT COMPLETED|Overall Study||1||
59961023|NCT03015181|76079618|FG006|NOT COMPLETED|Overall Study||1||
59961024|NCT00886691|76079656|FG000|STARTED|Overall Study||75||
59961025|NCT00886691|76079657|FG001|STARTED|Overall Study||75||
59961026|NCT00886691|76079656|FG000|COMPLETED|Overall Study||75||
59961027|NCT00886691|76079657|FG001|COMPLETED|Overall Study||75||
59961028|NCT00886691|76079656|FG000|NOT COMPLETED|Overall Study||0||
59961029|NCT00886691|76079657|FG001|NOT COMPLETED|Overall Study||0||
59961030|NCT00960297|76079667|FG000|STARTED|Overall Study||4||
59961031|NCT00960297|76079667|FG000|COMPLETED|Overall Study||1||
59961032|NCT00960297|76079667|FG000|NOT COMPLETED|Overall Study||3||
59961033|NCT03018691|76079674|FG000|STARTED|Overall Study||24||
59961034|NCT03018691|76079675|FG001|STARTED|Overall Study||25||
59961035|NCT03018691|76079676|FG002|STARTED|Overall Study||24||
59961036|NCT03018691|76079674|FG000|COMPLETED|Overall Study||22||
59961037|NCT03018691|76079675|FG001|COMPLETED|Overall Study||24||
59807960|NCT00686075|75929976|FG003|STARTED|Overall Study||80||
59807961|NCT00686075|75929977|FG004|STARTED|Overall Study||40||
59807962|NCT00686075|75929978|FG005|STARTED|Overall Study||40||
59807963|NCT00686075|75929979|FG006|STARTED|Overall Study||82||
59961038|NCT03018691|76079676|FG002|COMPLETED|Overall Study||17||
59961039|NCT03018691|76079674|FG000|NOT COMPLETED|Overall Study||2||
59961040|NCT03018691|76079675|FG001|NOT COMPLETED|Overall Study||1||
59961041|NCT03018691|76079676|FG002|NOT COMPLETED|Overall Study||7||
59961042|NCT03012061|76079689|FG000|STARTED|Overall Study||143||
59961043|NCT03012061|76079690|FG001|STARTED|Overall Study||139||
59807964|NCT00686075|75929980|FG007|STARTED|Overall Study||78||
59807965|NCT00686075|75929981|FG008|STARTED|Overall Study||81||
59807966|NCT00686075|75929982|FG009|STARTED|Overall Study||79||
59807967|NCT00686075|75929973|FG000|Treated|Overall Study||78||
59807968|NCT00686075|75929974|FG001|Treated|Overall Study||79||
59807969|NCT00686075|75929975|FG002|Treated|Overall Study||80||
59807970|NCT00686075|75929976|FG003|Treated|Overall Study||80||
59807971|NCT00686075|75929977|FG004|Treated|Overall Study||40||
59807972|NCT00686075|75929978|FG005|Treated|Overall Study||40||
59961044|NCT03012061|76079691|FG002|STARTED|Overall Study||139||
59961045|NCT03012061|76079689|FG000|COMPLETED|Overall Study||137||
59961046|NCT03012061|76079690|FG001|COMPLETED|Overall Study||130||
59961047|NCT03012061|76079691|FG002|COMPLETED|Overall Study||131||
59961048|NCT03012061|76079689|FG000|NOT COMPLETED|Overall Study||6||
59961049|NCT03012061|76079690|FG001|NOT COMPLETED|Overall Study||9||
59961050|NCT03012061|76079691|FG002|NOT COMPLETED|Overall Study||8||
59961051|NCT03010501|76079699|FG000|STARTED|Study Week 1||9||
59961052|NCT03010501|76079700|FG001|STARTED|Study Week 1||15||
59961053|NCT03010501|76079701|FG002|STARTED|Study Week 1||7||
59961054|NCT03010501|76079702|FG003|STARTED|Study Week 1||7||
59961055|NCT03010501|76079703|FG004|STARTED|Study Week 1||7||
59961056|NCT03010501|76079704|FG005|STARTED|Study Week 1||11||
59961057|NCT03010501|76079699|FG000|COMPLETED|Study Week 1||7||
59961058|NCT03010501|76079700|FG001|COMPLETED|Study Week 1||14||
59961059|NCT03010501|76079701|FG002|COMPLETED|Study Week 1||7||
59961060|NCT03010501|76079702|FG003|COMPLETED|Study Week 1||5||
59961061|NCT03010501|76079703|FG004|COMPLETED|Study Week 1||7||
59961062|NCT03010501|76079704|FG005|COMPLETED|Study Week 1||11||
59961063|NCT03010501|76079699|FG000|NOT COMPLETED|Study Week 1||2||
59807973|NCT00686075|75929979|FG006|Treated|Overall Study||82||
59807974|NCT00686075|75929980|FG007|Treated|Overall Study||77||
59807975|NCT00686075|75929981|FG008|Treated|Overall Study||80||
59807976|NCT00686075|75929982|FG009|Treated|Overall Study||78||
59807977|NCT00686075|75929973|FG000|COMPLETED|Overall Study||71||
59807978|NCT00686075|75929974|FG001|COMPLETED|Overall Study||71||
59807979|NCT00686075|75929975|FG002|COMPLETED|Overall Study||74||
59807980|NCT00686075|75929976|FG003|COMPLETED|Overall Study||71||
59807981|NCT00686075|75929977|FG004|COMPLETED|Overall Study||36||
59807982|NCT00686075|75929978|FG005|COMPLETED|Overall Study||37||
59807983|NCT00686075|75929979|FG006|COMPLETED|Overall Study||82||
59807984|NCT00686075|75929980|FG007|COMPLETED|Overall Study||76||
59807985|NCT00686075|75929981|FG008|COMPLETED|Overall Study||75||
59807986|NCT00686075|75929982|FG009|COMPLETED|Overall Study||69||
59807987|NCT00686075|75929973|FG000|NOT COMPLETED|Overall Study||8||
59807988|NCT00686075|75929974|FG001|NOT COMPLETED|Overall Study||10||
59807989|NCT00686075|75929975|FG002|NOT COMPLETED|Overall Study||6||
59807990|NCT00686075|75929976|FG003|NOT COMPLETED|Overall Study||9||
59807991|NCT00686075|75929977|FG004|NOT COMPLETED|Overall Study||4||
59807992|NCT00686075|75929978|FG005|NOT COMPLETED|Overall Study||3||
59807993|NCT00686075|75929979|FG006|NOT COMPLETED|Overall Study||0||
59807994|NCT00686075|75929980|FG007|NOT COMPLETED|Overall Study||2||
59807995|NCT00686075|75929981|FG008|NOT COMPLETED|Overall Study||6||
59807996|NCT00686075|75929982|FG009|NOT COMPLETED|Overall Study||10||
59807997|NCT00685763|75930004|FG000|STARTED|Overall Study||13||
59807998|NCT00685763|75930004|FG000|COMPLETED|Overall Study||11||
59807999|NCT00685763|75930004|FG000|NOT COMPLETED|Overall Study||2||
59808000|NCT00098293|75930011|FG000|STARTED|Double-blind (DB) Phase||177||
59808001|NCT00098293|75930012|FG001|STARTED|Double-blind (DB) Phase||368||
59808002|NCT00098293|75930013|FG002|STARTED|Double-blind (DB) Phase||372||
59808003|NCT00098293|75930014|FG003|STARTED|Double-blind (DB) Phase||0||
59808004|NCT00098293|75930015|FG004|STARTED|Double-blind (DB) Phase||0||
59808005|NCT00098293|75930011|FG000|Treated|Double-blind (DB) Phase||174||
59808006|NCT00098293|75930012|FG001|Treated|Double-blind (DB) Phase||360||
59808007|NCT00098293|75930013|FG002|Treated|Double-blind (DB) Phase||361||
59808008|NCT00098293|75930014|FG003|Treated|Double-blind (DB) Phase||0||
59808009|NCT00098293|75930015|FG004|Treated|Double-blind (DB) Phase||0||
59808010|NCT00098293|75930011|FG000|COMPLETED|Double-blind (DB) Phase||0||
59808011|NCT00098293|75930012|FG001|COMPLETED|Double-blind (DB) Phase||202||
59808012|NCT00098293|75930013|FG002|COMPLETED|Double-blind (DB) Phase||202||
59961064|NCT03010501|76079700|FG001|NOT COMPLETED|Study Week 1||1||
59961065|NCT03010501|76079701|FG002|NOT COMPLETED|Study Week 1||0||
59961066|NCT03010501|76079702|FG003|NOT COMPLETED|Study Week 1||2||
60074104|NCT01865552|76189486|FG000|COMPLETED|Period 2||22||
59808013|NCT00098293|75930014|FG003|COMPLETED|Double-blind (DB) Phase||0||
59808014|NCT00098293|75930015|FG004|COMPLETED|Double-blind (DB) Phase||0||
59808015|NCT00098293|75930011|FG000|NOT COMPLETED|Double-blind (DB) Phase||177||
59808016|NCT00098293|75930012|FG001|NOT COMPLETED|Double-blind (DB) Phase||166||
59808017|NCT00098293|75930013|FG002|NOT COMPLETED|Double-blind (DB) Phase||170||
59808018|NCT00098293|75930014|FG003|NOT COMPLETED|Double-blind (DB) Phase||0||
59961067|NCT03010501|76079703|FG004|NOT COMPLETED|Study Week 1||0||
59961068|NCT03010501|76079704|FG005|NOT COMPLETED|Study Week 1||0||
59808019|NCT00098293|75930015|FG004|NOT COMPLETED|Double-blind (DB) Phase||0||
59808020|NCT00098293|75930011|FG000|STARTED|Between DB and OL Phase||0||
59808021|NCT00098293|75930012|FG001|STARTED|Between DB and OL Phase||202||
59961069|NCT03010501|76079699|FG000|STARTED|Study Week 2||7||
59808022|NCT00098293|75930013|FG002|STARTED|Between DB and OL Phase||202||
59808023|NCT00098293|75930014|FG003|STARTED|Between DB and OL Phase||0||
59961070|NCT03010501|76079700|FG001|STARTED|Study Week 2||14||
59961071|NCT03010501|76079701|FG002|STARTED|Study Week 2||7||
59961072|NCT03010501|76079702|FG003|STARTED|Study Week 2||5||
59961073|NCT03010501|76079703|FG004|STARTED|Study Week 2||7||
59961074|NCT03010501|76079704|FG005|STARTED|Study Week 2||11||
59961075|NCT03010501|76079699|FG000|COMPLETED|Study Week 2||7||
59961076|NCT03010501|76079700|FG001|COMPLETED|Study Week 2||14||
59961077|NCT03010501|76079701|FG002|COMPLETED|Study Week 2||7||
59961078|NCT03010501|76079702|FG003|COMPLETED|Study Week 2||5||
59961079|NCT03010501|76079703|FG004|COMPLETED|Study Week 2||7||
59961080|NCT03010501|76079704|FG005|COMPLETED|Study Week 2||11||
59961081|NCT03010501|76079699|FG000|NOT COMPLETED|Study Week 2||0||
59961082|NCT03010501|76079700|FG001|NOT COMPLETED|Study Week 2||0||
59961083|NCT03010501|76079701|FG002|NOT COMPLETED|Study Week 2||0||
59961084|NCT03010501|76079702|FG003|NOT COMPLETED|Study Week 2||0||
59961085|NCT03010501|76079703|FG004|NOT COMPLETED|Study Week 2||0||
59961086|NCT03010501|76079704|FG005|NOT COMPLETED|Study Week 2||0||
59961087|NCT03010501|76079699|FG000|STARTED|Study Week 3||7||
59961088|NCT03010501|76079700|FG001|STARTED|Study Week 3||14||
59961089|NCT03010501|76079701|FG002|STARTED|Study Week 3||7||
59961090|NCT03010501|76079702|FG003|STARTED|Study Week 3||5||
59961091|NCT03010501|76079703|FG004|STARTED|Study Week 3||7||
59961092|NCT03010501|76079704|FG005|STARTED|Study Week 3||11||
59961093|NCT03010501|76079699|FG000|COMPLETED|Study Week 3||7||
59961094|NCT03010501|76079700|FG001|COMPLETED|Study Week 3||14||
59961095|NCT03010501|76079701|FG002|COMPLETED|Study Week 3||7||
59961096|NCT03010501|76079702|FG003|COMPLETED|Study Week 3||4||
59961097|NCT03010501|76079703|FG004|COMPLETED|Study Week 3||7||
59961098|NCT03010501|76079704|FG005|COMPLETED|Study Week 3||11||
59961099|NCT03010501|76079699|FG000|NOT COMPLETED|Study Week 3||0||
59961100|NCT03010501|76079700|FG001|NOT COMPLETED|Study Week 3||0||
59961101|NCT03010501|76079701|FG002|NOT COMPLETED|Study Week 3||0||
59961102|NCT03010501|76079702|FG003|NOT COMPLETED|Study Week 3||1||
59961103|NCT03010501|76079703|FG004|NOT COMPLETED|Study Week 3||0||
59961104|NCT03010501|76079704|FG005|NOT COMPLETED|Study Week 3||0||
59961105|NCT03002623|76079714|FG000|STARTED|Overall Study||4||
59961106|NCT03002623|76079715|FG001|STARTED|Overall Study||3||
59961107|NCT03002623|76079714|FG000|COMPLETED|Overall Study||2||
59961108|NCT03002623|76079715|FG001|COMPLETED|Overall Study||2||
59961109|NCT03002623|76079714|FG000|NOT COMPLETED|Overall Study||2||
59961110|NCT03002623|76079715|FG001|NOT COMPLETED|Overall Study||1||
59961111|NCT03010423|76079723|FG000|STARTED|Overall Study||8||
59961112|NCT03010423|76079723|FG000|COMPLETED|Overall Study||0||
59961113|NCT03010423|76079723|FG000|NOT COMPLETED|Overall Study||8||
59961114|NCT03002311|76079729|FG000|STARTED|Overall Study||147||
59961115|NCT03002311|76079730|FG001|STARTED|Overall Study||180||
59961116|NCT03002311|76079729|FG000|COMPLETED|Overall Study||128||
59808024|NCT00098293|75930015|FG004|STARTED|Between DB and OL Phase||0||
59808025|NCT00098293|75930011|FG000|COMPLETED|Between DB and OL Phase||0||
59808026|NCT00098293|75930012|FG001|COMPLETED|Between DB and OL Phase||202||
59961117|NCT03002311|76079730|FG001|COMPLETED|Overall Study||150||
59961118|NCT03002311|76079729|FG000|NOT COMPLETED|Overall Study||19||
59961119|NCT03002311|76079730|FG001|NOT COMPLETED|Overall Study||30||
59961120|NCT03002077|76079736|FG000|STARTED|Overall Study||617||
59961121|NCT03002077|76079736|FG000|COMPLETED|Overall Study||179||
59961122|NCT03002077|76079736|FG000|NOT COMPLETED|Overall Study||438||
59961123|NCT03008005|76079743|FG000|STARTED|Overall Study||14||
59961124|NCT03008005|76079744|FG001|STARTED|Overall Study||17||
59961125|NCT03008005|76079745|FG002|STARTED|Overall Study||15||
59961126|NCT03008005|76079743|FG000|COMPLETED|Overall Study||12||
59961127|NCT03008005|76079744|FG001|COMPLETED|Overall Study||16||
59961128|NCT03008005|76079745|FG002|COMPLETED|Overall Study||15||
59961129|NCT03008005|76079743|FG000|NOT COMPLETED|Overall Study||2||
59961130|NCT03008005|76079744|FG001|NOT COMPLETED|Overall Study||1||
59808027|NCT00098293|75930013|FG002|COMPLETED|Between DB and OL Phase||199||
59808028|NCT00098293|75930014|FG003|COMPLETED|Between DB and OL Phase||0||
59808029|NCT00098293|75930015|FG004|COMPLETED|Between DB and OL Phase||0||
59808030|NCT00098293|75930011|FG000|NOT COMPLETED|Between DB and OL Phase||0||
59961131|NCT03008005|76079745|FG002|NOT COMPLETED|Overall Study||0||
59961132|NCT03394781|76079755|FG000|STARTED|Overall Study||3||
59961133|NCT03394781|76079756|FG001|STARTED|Overall Study||2||
59961134|NCT03394781|76079755|FG000|COMPLETED|Overall Study||3||
59961135|NCT03394781|76079756|FG001|COMPLETED|Overall Study||2||
59961136|NCT03394781|76079755|FG000|NOT COMPLETED|Overall Study||0||
59961137|NCT03394781|76079756|FG001|NOT COMPLETED|Overall Study||0||
59961138|NCT02440425|76079762|FG000|STARTED|Overall Study||42||
59961139|NCT02440425|76079762|FG000|COMPLETED|Overall Study||37||
59961140|NCT02440425|76079762|FG000|NOT COMPLETED|Overall Study||5||
59961141|NCT03199079|76079768|FG000|STARTED|Overall Study||10||
59961142|NCT03199079|76079769|FG001|STARTED|Overall Study||10||
59524430|NCT01245595|75619605|FG000|COMPLETED|Overall Study||72||
59524431|NCT01245595|75619606|FG001|COMPLETED|Overall Study||72||
59524432|NCT01245595|75619605|FG000|NOT COMPLETED|Overall Study||0||
59808031|NCT00098293|75930012|FG001|NOT COMPLETED|Between DB and OL Phase||0||
59808032|NCT00098293|75930013|FG002|NOT COMPLETED|Between DB and OL Phase||3||
59808033|NCT00098293|75930014|FG003|NOT COMPLETED|Between DB and OL Phase||0||
59808034|NCT00098293|75930015|FG004|NOT COMPLETED|Between DB and OL Phase||0||
59808035|NCT00098293|75930011|FG000|STARTED|Open-label (OL) Phase||0||
59808036|NCT00098293|75930012|FG001|STARTED|Open-label (OL) Phase||202||
59524433|NCT01245595|75619606|FG001|NOT COMPLETED|Overall Study||0||
59808037|NCT00098293|75930013|FG002|STARTED|Open-label (OL) Phase||199||
59808038|NCT00098293|75930014|FG003|STARTED|Open-label (OL) Phase||130||
59808039|NCT00098293|75930015|FG004|STARTED|Open-label (OL) Phase||0||
59808040|NCT00098293|75930011|FG000|COMPLETED|Open-label (OL) Phase||0||
59808041|NCT00098293|75930012|FG001|COMPLETED|Open-label (OL) Phase||177||
59808042|NCT00098293|75930013|FG002|COMPLETED|Open-label (OL) Phase||158||
59961143|NCT03199079|76079768|FG000|COMPLETED|Overall Study||10||
59961144|NCT03199079|76079769|FG001|COMPLETED|Overall Study||10||
59961145|NCT03199079|76079768|FG000|NOT COMPLETED|Overall Study||0||
59961146|NCT03199079|76079769|FG001|NOT COMPLETED|Overall Study||0||
59961147|NCT03001219|76079777|FG000|STARTED|Proof of Concept||37||
59961148|NCT03001219|76079778|FG001|STARTED|Proof of Concept||72||
59961149|NCT03001219|76079777|FG000|COMPLETED|Proof of Concept||35||
59961150|NCT03001219|76079778|FG001|COMPLETED|Proof of Concept||65||
59961151|NCT03001219|76079777|FG000|NOT COMPLETED|Proof of Concept||2||
59961152|NCT03001219|76079778|FG001|NOT COMPLETED|Proof of Concept||7||
59961153|NCT03001219|76079777|FG000|STARTED|Extension Period Analysis||9||
59961154|NCT03001219|76079778|FG001|STARTED|Extension Period Analysis||97||
59961155|NCT03001219|76079777|FG000|COMPLETED|Extension Period Analysis||4||
59961156|NCT03001219|76079778|FG001|COMPLETED|Extension Period Analysis||52||
59961157|NCT03001219|76079777|FG000|NOT COMPLETED|Extension Period Analysis||5||
59808043|NCT00098293|75930014|FG003|COMPLETED|Open-label (OL) Phase||65||
59808044|NCT00098293|75930015|FG004|COMPLETED|Open-label (OL) Phase||0||
59808045|NCT00098293|75930011|FG000|NOT COMPLETED|Open-label (OL) Phase||0||
59808046|NCT00098293|75930012|FG001|NOT COMPLETED|Open-label (OL) Phase||25||
59808047|NCT00098293|75930013|FG002|NOT COMPLETED|Open-label (OL) Phase||41||
59808048|NCT00098293|75930014|FG003|NOT COMPLETED|Open-label (OL) Phase||65||
59808049|NCT00098293|75930015|FG004|NOT COMPLETED|Open-label (OL) Phase||0||
59808050|NCT00098293|75930011|FG000|STARTED|Supplemental Phase (SP)||0||
59808051|NCT00098293|75930012|FG001|STARTED|Supplemental Phase (SP)||0||
59808052|NCT00098293|75930013|FG002|STARTED|Supplemental Phase (SP)||0||
59808053|NCT00098293|75930014|FG003|STARTED|Supplemental Phase (SP)||0||
59808054|NCT00098293|75930015|FG004|STARTED|Supplemental Phase (SP)||127||
59808055|NCT00098293|75930011|FG000|COMPLETED|Supplemental Phase (SP)||0||
59808056|NCT00098293|75930012|FG001|COMPLETED|Supplemental Phase (SP)||0||
59808057|NCT00098293|75930013|FG002|COMPLETED|Supplemental Phase (SP)||0||
59808058|NCT00098293|75930014|FG003|COMPLETED|Supplemental Phase (SP)||0||
59961158|NCT03001219|76079778|FG001|NOT COMPLETED|Extension Period Analysis||45||
59961159|NCT03000673|76079793|FG000|STARTED|Overall Study||7||
59961160|NCT03000673|76079794|FG001|STARTED|Overall Study||9||
59961161|NCT03000673|76079795|FG002|STARTED|Overall Study||7||
59961162|NCT03000673|76079796|FG003|STARTED|Overall Study||9||
59961163|NCT03000673|76079793|FG000|COMPLETED|Overall Study||6||
59961164|NCT03000673|76079794|FG001|COMPLETED|Overall Study||9||
59961165|NCT03000673|76079795|FG002|COMPLETED|Overall Study||7||
59961166|NCT03000673|76079796|FG003|COMPLETED|Overall Study||9||
59961167|NCT03000673|76079793|FG000|NOT COMPLETED|Overall Study||1||
59961168|NCT03000673|76079794|FG001|NOT COMPLETED|Overall Study||0||
59961169|NCT03000673|76079795|FG002|NOT COMPLETED|Overall Study||0||
59961170|NCT03000673|76079796|FG003|NOT COMPLETED|Overall Study||0||
59961171|NCT02912455|76079809|FG000|STARTED|Overall Study||11||
59961172|NCT02912455|76079810|FG001|STARTED|Overall Study||5||
59961173|NCT02912455|76079809|FG000|COMPLETED|Overall Study||9||
59961174|NCT02912455|76079810|FG001|COMPLETED|Overall Study||2||
59961175|NCT02912455|76079809|FG000|NOT COMPLETED|Overall Study||2||
59961176|NCT02912455|76079810|FG001|NOT COMPLETED|Overall Study||3||
59961177|NCT04524507|76079818|FG000|STARTED|Overall Study||15||
59961178|NCT04524507|76079819|FG001|STARTED|Overall Study||41||
59524434|NCT02164721|75619612|FG000|STARTED|Overall Study||30||
59524435|NCT02164721|75619612|FG000|COMPLETED|Overall Study||30||
59524436|NCT02164721|75619612|FG000|NOT COMPLETED|Overall Study||0||
59524437|NCT02165111|75619619|FG000|STARTED|Overall Study||40||40
59524438|NCT02165111|75619620|FG001|STARTED|Overall Study||40||40
59808059|NCT00098293|75930015|FG004|COMPLETED|Supplemental Phase (SP)||94||
59808060|NCT00098293|75930011|FG000|NOT COMPLETED|Supplemental Phase (SP)||0||
59961179|NCT04524507|76079818|FG000|Received Intervention|Overall Study||14||
59524439|NCT02165111|75619619|FG000|COMPLETED|Overall Study||40||40
59524440|NCT02165111|75619620|FG001|COMPLETED|Overall Study||40||40
59961180|NCT04524507|76079819|FG001|Received Intervention|Overall Study||41||
59961181|NCT04524507|76079818|FG000|Hospital Discharge|Overall Study||13|Discharged at or before Day 28.|
59961182|NCT04524507|76079819|FG001|Hospital Discharge|Overall Study||27|Discharged at or before Day 28.|
59961183|NCT04524507|76079818|FG000|COMPLETED|Overall Study||9|Day 28|
59961184|NCT04524507|76079819|FG001|COMPLETED|Overall Study||18|Day 28|
59961185|NCT04524507|76079818|FG000|NOT COMPLETED|Overall Study||6||
59961186|NCT04524507|76079819|FG001|NOT COMPLETED|Overall Study||23||
59961187|NCT02999191|76079828|FG000|STARTED|Treatment Period 1 [1 Day]||6||
59961188|NCT02999191|76079829|FG001|STARTED|Treatment Period 1 [1 Day]||6||
59961189|NCT02999191|76079830|FG002|STARTED|Treatment Period 1 [1 Day]||6||
59961190|NCT02999191|76079828|FG000|COMPLETED|Treatment Period 1 [1 Day]||6||
59961191|NCT02999191|76079829|FG001|COMPLETED|Treatment Period 1 [1 Day]||6||
59961192|NCT02999191|76079830|FG002|COMPLETED|Treatment Period 1 [1 Day]||6||
59961193|NCT02999191|76079828|FG000|NOT COMPLETED|Treatment Period 1 [1 Day]||0||
59961194|NCT02999191|76079829|FG001|NOT COMPLETED|Treatment Period 1 [1 Day]||0||
59961195|NCT02999191|76079830|FG002|NOT COMPLETED|Treatment Period 1 [1 Day]||0||
59961196|NCT02999191|76079828|FG000|STARTED|Wash-out Period 1 [21 Days]||6||
59961197|NCT02999191|76079829|FG001|STARTED|Wash-out Period 1 [21 Days]||6||
59961198|NCT02999191|76079830|FG002|STARTED|Wash-out Period 1 [21 Days]||6||
59961199|NCT02999191|76079828|FG000|COMPLETED|Wash-out Period 1 [21 Days]||6||
59961200|NCT02999191|76079829|FG001|COMPLETED|Wash-out Period 1 [21 Days]||5||
59961201|NCT02999191|76079830|FG002|COMPLETED|Wash-out Period 1 [21 Days]||6||
59961202|NCT02999191|76079828|FG000|NOT COMPLETED|Wash-out Period 1 [21 Days]||0||
59961203|NCT02999191|76079829|FG001|NOT COMPLETED|Wash-out Period 1 [21 Days]||1||
59961204|NCT02999191|76079830|FG002|NOT COMPLETED|Wash-out Period 1 [21 Days]||0||
59961205|NCT02999191|76079828|FG000|STARTED|Treatment Period 2 [1 Day]||6||
59961206|NCT02999191|76079829|FG001|STARTED|Treatment Period 2 [1 Day]||5||
59961207|NCT02999191|76079830|FG002|STARTED|Treatment Period 2 [1 Day]||6||
59961208|NCT02999191|76079828|FG000|COMPLETED|Treatment Period 2 [1 Day]||6||
59961209|NCT02999191|76079829|FG001|COMPLETED|Treatment Period 2 [1 Day]||5||
59961210|NCT02999191|76079830|FG002|COMPLETED|Treatment Period 2 [1 Day]||6||
59961211|NCT02999191|76079828|FG000|NOT COMPLETED|Treatment Period 2 [1 Day]||0||
59961212|NCT02999191|76079829|FG001|NOT COMPLETED|Treatment Period 2 [1 Day]||0||
59961213|NCT02999191|76079830|FG002|NOT COMPLETED|Treatment Period 2 [1 Day]||0||
59961214|NCT02999191|76079828|FG000|STARTED|Wash-out Period 2 [21 Days]||6||
59808061|NCT00098293|75930012|FG001|NOT COMPLETED|Supplemental Phase (SP)||0||
59808062|NCT00098293|75930013|FG002|NOT COMPLETED|Supplemental Phase (SP)||0||
59808063|NCT00098293|75930014|FG003|NOT COMPLETED|Supplemental Phase (SP)||0||
59808064|NCT00098293|75930015|FG004|NOT COMPLETED|Supplemental Phase (SP)||33||
59808065|NCT00685685|75930026|FG000|STARTED|First Intervention||27||
59808066|NCT00685685|75930027|FG001|STARTED|First Intervention||27||
59808067|NCT00685685|75930026|FG000|COMPLETED|First Intervention||27||
59808068|NCT00685685|75930027|FG001|COMPLETED|First Intervention||27||
59808069|NCT00685685|75930026|FG000|NOT COMPLETED|First Intervention||0||
59808070|NCT00685685|75930027|FG001|NOT COMPLETED|First Intervention||0||
59808071|NCT00685685|75930026|FG000|STARTED|Washout Period of 7 Days||27||
59808072|NCT00685685|75930027|FG001|STARTED|Washout Period of 7 Days||27||
59808073|NCT00685685|75930026|FG000|COMPLETED|Washout Period of 7 Days||25||
59808074|NCT00685685|75930027|FG001|COMPLETED|Washout Period of 7 Days||26||
59808075|NCT00685685|75930026|FG000|NOT COMPLETED|Washout Period of 7 Days||2||
59961215|NCT02999191|76079829|FG001|STARTED|Wash-out Period 2 [21 Days]||5||
59961216|NCT02999191|76079830|FG002|STARTED|Wash-out Period 2 [21 Days]||6||
59961217|NCT02999191|76079828|FG000|COMPLETED|Wash-out Period 2 [21 Days]||6||
59961218|NCT02999191|76079829|FG001|COMPLETED|Wash-out Period 2 [21 Days]||5||
59808076|NCT00685685|75930027|FG001|NOT COMPLETED|Washout Period of 7 Days||1||
59808077|NCT00685685|75930026|FG000|STARTED|Second Intervention||25||
59808078|NCT00685685|75930027|FG001|STARTED|Second Intervention||26||
59961219|NCT02999191|76079830|FG002|COMPLETED|Wash-out Period 2 [21 Days]||6||
59961220|NCT02999191|76079828|FG000|NOT COMPLETED|Wash-out Period 2 [21 Days]||0||
59961221|NCT02999191|76079829|FG001|NOT COMPLETED|Wash-out Period 2 [21 Days]||0||
59961222|NCT02999191|76079830|FG002|NOT COMPLETED|Wash-out Period 2 [21 Days]||0||
59961223|NCT02999191|76079828|FG000|STARTED|Treatment Period 3 [1 Day]||6||
59961224|NCT02999191|76079829|FG001|STARTED|Treatment Period 3 [1 Day]||6||
59961225|NCT02999191|76079830|FG002|STARTED|Treatment Period 3 [1 Day]||6||
59961226|NCT02999191|76079828|FG000|COMPLETED|Treatment Period 3 [1 Day]||6||
59961227|NCT02999191|76079829|FG001|COMPLETED|Treatment Period 3 [1 Day]||6||
59961228|NCT02999191|76079830|FG002|COMPLETED|Treatment Period 3 [1 Day]||6||
59961229|NCT02999191|76079828|FG000|NOT COMPLETED|Treatment Period 3 [1 Day]||0||
59961230|NCT02999191|76079829|FG001|NOT COMPLETED|Treatment Period 3 [1 Day]||0||
59961231|NCT02999191|76079830|FG002|NOT COMPLETED|Treatment Period 3 [1 Day]||0||
59961232|NCT02531698|76079840|FG000|STARTED|Overall Study||294||
59961233|NCT02531698|76079841|FG001|STARTED|Overall Study||106||
59961234|NCT02531698|76079840|FG000|COMPLETED|Overall Study||283||
59961235|NCT02531698|76079841|FG001|COMPLETED|Overall Study||104||
59961236|NCT02531698|76079840|FG000|NOT COMPLETED|Overall Study||11||
59961237|NCT02531698|76079841|FG001|NOT COMPLETED|Overall Study||2||
59961238|NCT02998021|76079858|FG000|STARTED|Overall Study||8||
59808079|NCT00685685|75930026|FG000|COMPLETED|Second Intervention||25||
59961239|NCT02998021|76079859|FG001|STARTED|Overall Study||2||
59961240|NCT02998021|76079858|FG000|COMPLETED|Overall Study||5||
59808080|NCT00685685|75930027|FG001|COMPLETED|Second Intervention||26||
59808081|NCT00685685|75930026|FG000|NOT COMPLETED|Second Intervention||0||
59808082|NCT00685685|75930027|FG001|NOT COMPLETED|Second Intervention||0||
59808083|NCT00684671|75930036|FG000|STARTED|Overall Study||172||
59808084|NCT00684671|75930037|FG001|STARTED|Overall Study||170||
59808085|NCT00684671|75930038|FG002|STARTED|Overall Study||164||
59808086|NCT00684671|75930036|FG000|COMPLETED|Overall Study||169||
59808087|NCT00684671|75930037|FG001|COMPLETED|Overall Study||170||
59808088|NCT00684671|75930038|FG002|COMPLETED|Overall Study||164||
59961241|NCT02998021|76079859|FG001|COMPLETED|Overall Study||0||
59961242|NCT02998021|76079858|FG000|NOT COMPLETED|Overall Study||3||
59961243|NCT02998021|76079859|FG001|NOT COMPLETED|Overall Study||2||
59961244|NCT03490227|76079865|FG000|STARTED|Overall Study||10||
59961245|NCT03490227|76079865|FG000|COMPLETED|Overall Study||10||
59961246|NCT03490227|76079865|FG000|NOT COMPLETED|Overall Study||0||
59961247|NCT03034577|76079873|FG000|STARTED|Overall Study||175||
59961248|NCT03034577|76079874|FG001|STARTED|Overall Study||175||
59961249|NCT03034577|76079873|FG000|COMPLETED|Overall Study||144||
59961250|NCT03034577|76079874|FG001|COMPLETED|Overall Study||140||
59961251|NCT03034577|76079873|FG000|NOT COMPLETED|Overall Study||31||
59961252|NCT03034577|76079874|FG001|NOT COMPLETED|Overall Study||35||
59808089|NCT00684671|75930036|FG000|NOT COMPLETED|Overall Study||3||
59808090|NCT00684671|75930037|FG001|NOT COMPLETED|Overall Study||0||
59808091|NCT00684671|75930038|FG002|NOT COMPLETED|Overall Study||0||
59808092|NCT03859323|75930059|FG000|STARTED|Overall Study||5||
59808093|NCT03859323|75930060|FG001|STARTED|Overall Study||5||
59808094|NCT03859323|75930061|FG002|STARTED|Overall Study||5||
59808095|NCT03859323|75930062|FG003|STARTED|Overall Study||5||
59808096|NCT03859323|75930063|FG004|STARTED|Overall Study||5||
60074105|NCT01865552|76189487|FG001|COMPLETED|Period 2||23||
60074106|NCT01865552|76189488|FG002|COMPLETED|Period 2||23||
60074107|NCT01865552|76189489|FG003|COMPLETED|Period 2||22||
60074108|NCT01865552|76189490|FG004|COMPLETED|Period 2||20||
60074109|NCT01865552|76189491|FG005|COMPLETED|Period 2||22||
60074110|NCT01865552|76189486|FG000|NOT COMPLETED|Period 2||0||
59808097|NCT03859323|75930064|FG005|STARTED|Overall Study||5||
59808098|NCT03859323|75930065|FG006|STARTED|Overall Study||12||
59808099|NCT03859323|75930066|FG007|STARTED|Overall Study||10||
59808100|NCT03859323|75930067|FG008|STARTED|Overall Study||10||
59808101|NCT03859323|75930068|FG009|STARTED|Overall Study||10||
59808102|NCT03859323|75930069|FG010|STARTED|Overall Study||10||
59808103|NCT03859323|75930070|FG011|STARTED|Overall Study||12||
59808104|NCT03859323|75930071|FG012|STARTED|Overall Study||10||
59808105|NCT03859323|75930059|FG000|COMPLETED|Overall Study||5||
59808106|NCT03859323|75930060|FG001|COMPLETED|Overall Study||5||
59524441|NCT02165111|75619619|FG000|NOT COMPLETED|Overall Study||0||0
59524442|NCT02165111|75619620|FG001|NOT COMPLETED|Overall Study||0||0
59524443|NCT01155193|75619632|FG000|STARTED|Overall Study||10924||
59808107|NCT03859323|75930061|FG002|COMPLETED|Overall Study||4||
59808108|NCT03859323|75930062|FG003|COMPLETED|Overall Study||5||
59961253|NCT01659736|76079884|FG000|STARTED|Treatment Period||14||
59961254|NCT01659736|76079885|FG001|STARTED|Treatment Period||12||
59961255|NCT01659736|76079884|FG000|COMPLETED|Treatment Period|n = 10, but data from one completer was excluded from all analyses due to protocol violation.|9||
59961256|NCT01659736|76079885|FG001|COMPLETED|Treatment Period||10||
59961257|NCT01659736|76079884|FG000|NOT COMPLETED|Treatment Period||5||
59961258|NCT01659736|76079885|FG001|NOT COMPLETED|Treatment Period||2||
60074111|NCT01865552|76189487|FG001|NOT COMPLETED|Period 2||0||
60074112|NCT01865552|76189488|FG002|NOT COMPLETED|Period 2||0||
59808109|NCT03859323|75930063|FG004|COMPLETED|Overall Study||5||
59808110|NCT03859323|75930064|FG005|COMPLETED|Overall Study||4||
59808111|NCT03859323|75930065|FG006|COMPLETED|Overall Study||11||
59808112|NCT03859323|75930066|FG007|COMPLETED|Overall Study||10||
59808113|NCT03859323|75930067|FG008|COMPLETED|Overall Study||10||
59808114|NCT03859323|75930068|FG009|COMPLETED|Overall Study||8||
59808115|NCT03859323|75930069|FG010|COMPLETED|Overall Study||9||
59808116|NCT03859323|75930070|FG011|COMPLETED|Overall Study||10||
59808117|NCT03859323|75930071|FG012|COMPLETED|Overall Study||9||
59808118|NCT03859323|75930059|FG000|NOT COMPLETED|Overall Study||0||
59808119|NCT03859323|75930060|FG001|NOT COMPLETED|Overall Study||0||
60074113|NCT01865552|76189489|FG003|NOT COMPLETED|Period 2||0||
60074114|NCT01865552|76189490|FG004|NOT COMPLETED|Period 2||0||
60074115|NCT01865552|76189491|FG005|NOT COMPLETED|Period 2||0||
60074116|NCT01809314|76189505|FG000|STARTED|Overall Study||1167||
59808120|NCT03859323|75930061|FG002|NOT COMPLETED|Overall Study||1||
59808121|NCT03859323|75930062|FG003|NOT COMPLETED|Overall Study||0||
59808122|NCT03859323|75930063|FG004|NOT COMPLETED|Overall Study||0||
59808123|NCT03859323|75930064|FG005|NOT COMPLETED|Overall Study||1||
59808124|NCT03859323|75930065|FG006|NOT COMPLETED|Overall Study||1||
59808125|NCT03859323|75930066|FG007|NOT COMPLETED|Overall Study||0||
59808126|NCT03859323|75930067|FG008|NOT COMPLETED|Overall Study||0||
59808127|NCT03859323|75930068|FG009|NOT COMPLETED|Overall Study||2||
59808128|NCT03859323|75930069|FG010|NOT COMPLETED|Overall Study||1||
59808129|NCT03859323|75930070|FG011|NOT COMPLETED|Overall Study||2||
59808130|NCT03859323|75930071|FG012|NOT COMPLETED|Overall Study||1||
59808131|NCT03857841|75930114|FG000|STARTED|Overall Study||2||
59961259|NCT01659736|76079884|FG000|STARTED|3-month Follow-up||9||
59961260|NCT01659736|76079885|FG001|STARTED|3-month Follow-up||10||
59961261|NCT01659736|76079884|FG000|COMPLETED|3-month Follow-up||9||
59961262|NCT01659736|76079885|FG001|COMPLETED|3-month Follow-up||9||
59961263|NCT01659736|76079884|FG000|NOT COMPLETED|3-month Follow-up||0||
59961264|NCT01659736|76079885|FG001|NOT COMPLETED|3-month Follow-up||1||
59961265|NCT02997163|76079897|FG000|STARTED|Overall Study||9||
59961266|NCT02997163|76079898|FG001|STARTED|Overall Study||9||
59961267|NCT02997163|76079899|FG002|STARTED|Overall Study||8||
59961268|NCT02997163|76079900|FG003|STARTED|Overall Study||8||
59961269|NCT02997163|76079897|FG000|COMPLETED|Overall Study||8||
59961270|NCT02997163|76079898|FG001|COMPLETED|Overall Study||9||
60074117|NCT01809314|76189505|FG000|COMPLETED|Overall Study||422||
60074118|NCT01809314|76189505|FG000|NOT COMPLETED|Overall Study||745||
59621097|NCT00297102|75732599|FG001|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|758||
59621098|NCT00297102|75732598|FG000|COMPLETED|Overall Study||502||
59621099|NCT00297102|75732599|FG001|COMPLETED|Overall Study||525||
59621100|NCT00297102|75732598|FG000|NOT COMPLETED|Overall Study||263||
59621101|NCT00297102|75732599|FG001|NOT COMPLETED|Overall Study||233||
59621102|NCT00123162|75732607|FG000|STARTED|Overall Study||13||
59621103|NCT00123162|75732608|FG001|STARTED|Overall Study||12||
59621104|NCT00123162|75732607|FG000|COMPLETED|Overall Study||13||
59621105|NCT00123162|75732608|FG001|COMPLETED|Overall Study||12||
59621106|NCT00123162|75732607|FG000|NOT COMPLETED|Overall Study||0||
59621107|NCT00123162|75732608|FG001|NOT COMPLETED|Overall Study||0||
59621108|NCT00123630|75732616|FG000|STARTED|Overall Study||15||
59621109|NCT00123630|75732617|FG001|STARTED|Overall Study||15||
59621110|NCT00123630|75732616|FG000|COMPLETED|Overall Study||15||
59621111|NCT00123630|75732617|FG001|COMPLETED|Overall Study||15||
59621112|NCT00123630|75732616|FG000|NOT COMPLETED|Overall Study||0||
59621113|NCT00123630|75732617|FG001|NOT COMPLETED|Overall Study||0||
59621114|NCT00124176|75732625|FG000|STARTED|Overall Study||40||
59621115|NCT00124176|75732626|FG001|STARTED|Overall Study||41||
59621116|NCT00124176|75732625|FG000|Received Study Drug|Overall Study|3 never started on drug due to improvement but were kept in the study by intention to treat.|37||
59621117|NCT00124176|75732626|FG001|Received Study Drug|Overall Study||41||
59621118|NCT00124176|75732625|FG000|COMPLETED|Overall Study||40||
59621119|NCT00124176|75732626|FG001|COMPLETED|Overall Study||41||
59621120|NCT00124176|75732625|FG000|NOT COMPLETED|Overall Study||0||
59621121|NCT00124176|75732626|FG001|NOT COMPLETED|Overall Study||0||
59621122|NCT00240162|75732632|FG000|STARTED|Overall Study||21||
59621123|NCT00240162|75732632|FG000|COMPLETED|Overall Study||21||
59621124|NCT00240162|75732632|FG000|NOT COMPLETED|Overall Study||0||
59621125|NCT00299988|75732638|FG000|STARTED|Overall Study||16||
59621126|NCT00299988|75732639|FG001|STARTED|Overall Study||8||
59621127|NCT00299988|75732638|FG000|COMPLETED|Overall Study||16||
59621128|NCT00299988|75732639|FG001|COMPLETED|Overall Study||8||
59621129|NCT00299988|75732638|FG000|NOT COMPLETED|Overall Study||0||
59621130|NCT00299988|75732639|FG001|NOT COMPLETED|Overall Study||0||
59621131|NCT00300456|75732652|FG000|STARTED|Overall Study|"For all arms, started means treated."|119||
59621132|NCT00300456|75732653|FG001|STARTED|Overall Study||118||
59621133|NCT00300456|75732654|FG002|STARTED|Overall Study||119||
59621134|NCT00300456|75732655|FG003|STARTED|Overall Study||119||
59621135|NCT00300456|75732656|FG004|STARTED|Overall Study||116||
59621136|NCT00300456|75732657|FG005|STARTED|Overall Study||59||
59621137|NCT00300456|75732652|FG000|COMPLETED|Overall Study||103||
59621138|NCT00300456|75732653|FG001|COMPLETED|Overall Study||102||
59621139|NCT00300456|75732654|FG002|COMPLETED|Overall Study||98||
59621140|NCT00300456|75732655|FG003|COMPLETED|Overall Study||105||
59621141|NCT00300456|75732656|FG004|COMPLETED|Overall Study||99||
59621142|NCT00300456|75732657|FG005|COMPLETED|Overall Study||48||
59621143|NCT00300456|75732652|FG000|NOT COMPLETED|Overall Study||16||
59621144|NCT00300456|75732653|FG001|NOT COMPLETED|Overall Study||16||
59621145|NCT00300456|75732654|FG002|NOT COMPLETED|Overall Study||21||
59621146|NCT00300456|75732655|FG003|NOT COMPLETED|Overall Study||14||
59621147|NCT00300456|75732656|FG004|NOT COMPLETED|Overall Study||17||
59961271|NCT02997163|76079899|FG002|COMPLETED|Overall Study||8||
59961272|NCT02997163|76079900|FG003|COMPLETED|Overall Study||7||
59961273|NCT02997163|76079897|FG000|NOT COMPLETED|Overall Study||1||
59961274|NCT02997163|76079898|FG001|NOT COMPLETED|Overall Study||0||
59621148|NCT00300456|75732657|FG005|NOT COMPLETED|Overall Study||11||
59621149|NCT00125034|75732673|FG000|STARTED|Overall Study|Randomized & treated. 1 subject was not randomized correctly and was excluded in the ITT population.|170||
59621150|NCT00125034|75732674|FG001|STARTED|Overall Study|Randomized & treated|168||
59621151|NCT00125034|75732673|FG000|COMPLETED|Overall Study||170||
59621152|NCT00125034|75732674|FG001|COMPLETED|Overall Study||168||
59621153|NCT00125034|75732673|FG000|NOT COMPLETED|Overall Study||0||
59621154|NCT00125034|75732674|FG001|NOT COMPLETED|Overall Study||0||
59621155|NCT02100930|75732680|FG000|STARTED|Overall Study||69||
59621156|NCT02100930|75732680|FG000|COMPLETED|Overall Study||69||
59621157|NCT02100930|75732680|FG000|NOT COMPLETED|Overall Study||0||
59961275|NCT02997163|76079899|FG002|NOT COMPLETED|Overall Study||0||
59961276|NCT02997163|76079900|FG003|NOT COMPLETED|Overall Study||1||
60074119|NCT01803464|76189513|FG000|STARTED|Overall Study||5||
59808132|NCT03857841|75930115|FG001|STARTED|Overall Study||0||
59961277|NCT00458536|76079910|FG000|STARTED|Overall Study||38||
59961278|NCT00458536|76079910|FG000|COMPLETED|Overall Study||19||
59961279|NCT00458536|76079910|FG000|NOT COMPLETED|Overall Study||19||
59961280|NCT02526550|76079914|FG000|STARTED|Overall Study||50||
59961281|NCT02526550|76079914|FG000|COMPLETED|Overall Study||49||
59961282|NCT02526550|76079914|FG000|NOT COMPLETED|Overall Study||1||
59961283|NCT04523129|76079920|FG000|STARTED|Overall Study||423||
59961284|NCT04523129|76079921|FG001|STARTED|Overall Study||411||
59524444|NCT01155193|75619633|FG001|STARTED|Overall Study||3818||
59808133|NCT03857841|75930116|FG002|STARTED|Overall Study||0||
59808134|NCT03857841|75930117|FG003|STARTED|Overall Study||1||
59808135|NCT03857841|75930114|FG000|COMPLETED|Overall Study||0||
59808136|NCT03857841|75930115|FG001|COMPLETED|Overall Study||0||
59808137|NCT03857841|75930116|FG002|COMPLETED|Overall Study||0||
59808138|NCT03857841|75930117|FG003|COMPLETED|Overall Study||1||
59808139|NCT03857841|75930114|FG000|NOT COMPLETED|Overall Study||2||
59961285|NCT04523129|76079920|FG000|COMPLETED|Overall Study||415||
59961286|NCT04523129|76079921|FG001|COMPLETED|Overall Study||402||
59961287|NCT04523129|76079920|FG000|NOT COMPLETED|Overall Study||8||
59961288|NCT04523129|76079921|FG001|NOT COMPLETED|Overall Study||9||
59961289|NCT03030989|76079929|FG000|STARTED|Overall Study||21||
59961290|NCT03030989|76079930|FG001|STARTED|Overall Study||29||
59961291|NCT03030989|76079929|FG000|COMPLETED|Overall Study||9|Dropout due to fatigue at using wipes was high; compliance is enhanced with monitoring in hospital.|
59961292|NCT03030989|76079930|FG001|COMPLETED|Overall Study||15|Dropout due to fatigue at using wipes was high; compliance is enhanced with monitoring in hospital.|
59961293|NCT03030989|76079929|FG000|NOT COMPLETED|Overall Study||12||
59961294|NCT03030989|76079930|FG001|NOT COMPLETED|Overall Study||14||
59961295|NCT03030599|76079936|FG000|STARTED|Open Label Treatment and Titration||201||
59961296|NCT03030599|76079937|FG001|STARTED|Open Label Treatment and Titration||0||
59961297|NCT03030599|76079938|FG002|STARTED|Open Label Treatment and Titration||0||
59961298|NCT03030599|76079936|FG000|COMPLETED|Open Label Treatment and Titration||155||
59961299|NCT03030599|76079937|FG001|COMPLETED|Open Label Treatment and Titration||0||
59961300|NCT03030599|76079938|FG002|COMPLETED|Open Label Treatment and Titration||0||
59961301|NCT03030599|76079936|FG000|NOT COMPLETED|Open Label Treatment and Titration||46||
59961302|NCT03030599|76079937|FG001|NOT COMPLETED|Open Label Treatment and Titration||0||
59961303|NCT03030599|76079938|FG002|NOT COMPLETED|Open Label Treatment and Titration||0||
59961304|NCT03030599|76079936|FG000|STARTED|Stable Dose|149 subjects of the 201 entered the Stable Dose Period. Of those subjects, 136 were randomized.|149||
59961305|NCT03030599|76079937|FG001|STARTED|Stable Dose||0||
59524445|NCT01155193|75619634|FG002|STARTED|Overall Study||2260||
59524446|NCT01155193|75619635|FG003|STARTED|Overall Study||13802||
59524447|NCT01155193|75619632|FG000|COMPLETED|Overall Study|Evaluable population (participants treated between 01 September and 01 May of the following year)|10686||
59524448|NCT01155193|75619633|FG001|COMPLETED|Overall Study|Evaluable population (participants treated between 01 September and 01 May of the following year)|3805||
59524449|NCT01155193|75619634|FG002|COMPLETED|Overall Study|Evaluable population (participants treated between 01 September and 01 May of the following year)|2248||
59524450|NCT01155193|75619635|FG003|COMPLETED|Overall Study|Evaluable population (participants treated between 01 September and 01 May of the following year)|13711||
59524451|NCT01155193|75619632|FG000|NOT COMPLETED|Overall Study||238||
59808140|NCT03857841|75930115|FG001|NOT COMPLETED|Overall Study||0||
59808141|NCT03857841|75930116|FG002|NOT COMPLETED|Overall Study||0||
59808142|NCT03857841|75930117|FG003|NOT COMPLETED|Overall Study||0||
59808143|NCT00500331|75930134|FG000|STARTED|Overall Study||48||
59808144|NCT00500331|75930135|FG001|STARTED|Overall Study||47||
59808145|NCT00500331|75930136|FG002|STARTED|Overall Study||48||
59808146|NCT00500331|75930137|FG003|STARTED|Overall Study||48||
59808147|NCT00500331|75930138|FG004|STARTED|Overall Study||48||
59808148|NCT00500331|75930139|FG005|STARTED|Overall Study||47||
59808149|NCT00500331|75930140|FG006|STARTED|Overall Study||48||
59961306|NCT03030599|76079938|FG002|STARTED|Stable Dose||0||
59961307|NCT03030599|76079936|FG000|COMPLETED|Stable Dose||144||
59961308|NCT03030599|76079937|FG001|COMPLETED|Stable Dose||0||
59961309|NCT03030599|76079938|FG002|COMPLETED|Stable Dose||0||
59961310|NCT03030599|76079936|FG000|NOT COMPLETED|Stable Dose||5||
59524452|NCT01155193|75619633|FG001|NOT COMPLETED|Overall Study||13||
59524453|NCT01155193|75619634|FG002|NOT COMPLETED|Overall Study||12||
59524454|NCT01155193|75619635|FG003|NOT COMPLETED|Overall Study||91||
59524455|NCT01203319|75619653|FG000|STARTED|Overall Study||434||
59524456|NCT01203319|75619654|FG001|STARTED|Overall Study||435||
59524457|NCT01203319|75619655|FG002|STARTED|Overall Study||222||
59524458|NCT01203319|75619653|FG000|COMPLETED|Overall Study||428||
59524459|NCT01203319|75619654|FG001|COMPLETED|Overall Study||426||
59524460|NCT01203319|75619655|FG002|COMPLETED|Overall Study||217||
59524461|NCT01203319|75619653|FG000|NOT COMPLETED|Overall Study||6||
59621158|NCT00241176|75732684|FG000|STARTED|Overall Study||11||
59808150|NCT00500331|75930134|FG000|COMPLETED|Overall Study||33||
59808151|NCT00500331|75930135|FG001|COMPLETED|Overall Study||42||
59808152|NCT00500331|75930136|FG002|COMPLETED|Overall Study||43||
59808153|NCT00500331|75930137|FG003|COMPLETED|Overall Study||38||
59808154|NCT00500331|75930138|FG004|COMPLETED|Overall Study||44||
59808155|NCT00500331|75930139|FG005|COMPLETED|Overall Study||42||
59808156|NCT00500331|75930140|FG006|COMPLETED|Overall Study||46||
59808157|NCT00500331|75930134|FG000|NOT COMPLETED|Overall Study||15||
59808158|NCT00500331|75930135|FG001|NOT COMPLETED|Overall Study||5||
59961311|NCT03030599|76079937|FG001|NOT COMPLETED|Stable Dose||0||
59961312|NCT03030599|76079938|FG002|NOT COMPLETED|Stable Dose||0||
59961313|NCT03030599|76079936|FG000|STARTED|Double Blind Randomized Withdrawal||0||
59961314|NCT03030599|76079937|FG001|STARTED|Double Blind Randomized Withdrawal|134 of the 136 subjects randomized received at least 1 dose of study drug in the DB RWP.|69||
59961315|NCT03030599|76079938|FG002|STARTED|Double Blind Randomized Withdrawal|134 of the 136 subjects randomized received at least 1 dose of study drug in the DB RWP.|67||
59961316|NCT03030599|76079936|FG000|COMPLETED|Double Blind Randomized Withdrawal||0||
59961317|NCT03030599|76079937|FG001|COMPLETED|Double Blind Randomized Withdrawal||69||
59961318|NCT03030599|76079938|FG002|COMPLETED|Double Blind Randomized Withdrawal||59||
59961319|NCT03030599|76079936|FG000|NOT COMPLETED|Double Blind Randomized Withdrawal||0||
59961320|NCT03030599|76079937|FG001|NOT COMPLETED|Double Blind Randomized Withdrawal||0||
59961321|NCT03030599|76079938|FG002|NOT COMPLETED|Double Blind Randomized Withdrawal||8||
59961322|NCT03030599|76079936|FG000|STARTED|Open-label Extension||74||
59961323|NCT03030599|76079937|FG001|STARTED|Open-label Extension||0||
59961324|NCT03030599|76079938|FG002|STARTED|Open-label Extension||0||
59808159|NCT00500331|75930136|FG002|NOT COMPLETED|Overall Study||5||
59808160|NCT00500331|75930137|FG003|NOT COMPLETED|Overall Study||10||
59808161|NCT00500331|75930138|FG004|NOT COMPLETED|Overall Study||4||
59808162|NCT00500331|75930139|FG005|NOT COMPLETED|Overall Study||5||
59808163|NCT00500331|75930140|FG006|NOT COMPLETED|Overall Study||2||
59808164|NCT00499863|75930159|FG000|STARTED|Overall Study||145||
59961325|NCT03030599|76079936|FG000|COMPLETED|Open-label Extension||67||
59961326|NCT03030599|76079937|FG001|COMPLETED|Open-label Extension||0||
59961327|NCT03030599|76079938|FG002|COMPLETED|Open-label Extension||0||
59961328|NCT03030599|76079936|FG000|NOT COMPLETED|Open-label Extension||7||
59961329|NCT03030599|76079937|FG001|NOT COMPLETED|Open-label Extension||0||
59961330|NCT03030599|76079938|FG002|NOT COMPLETED|Open-label Extension||0||
59961331|NCT03028415|76079946|FG000|STARTED|Overall Study||39||
59961332|NCT03028415|76079947|FG001|STARTED|Overall Study||17||
59961333|NCT03028415|76079946|FG000|Modified Intention-to-treat (mITT) Population|Overall Study||39||
59961334|NCT03028415|76079947|FG001|Modified Intention-to-treat (mITT) Population|Overall Study||17||
59961335|NCT03028415|76079946|FG000|COMPLETED|Overall Study||31||
59961336|NCT03028415|76079947|FG001|COMPLETED|Overall Study||14||
59961337|NCT03028415|76079946|FG000|NOT COMPLETED|Overall Study||8||
59961338|NCT03028415|76079947|FG001|NOT COMPLETED|Overall Study||3||
59961339|NCT02692040|76079971|FG000|STARTED|Overall Study||10||
59961340|NCT02692040|76079972|FG001|STARTED|Overall Study||4||
59961341|NCT02692040|76079973|FG002|STARTED|Overall Study||5||
59961342|NCT02692040|76079974|FG003|STARTED|Overall Study||5||
59961343|NCT02692040|76079975|FG004|STARTED|Overall Study||4||
59961344|NCT02692040|76079976|FG005|STARTED|Overall Study||5||
59961345|NCT02692040|76079977|FG006|STARTED|Overall Study||5||
59961346|NCT02692040|76079978|FG007|STARTED|Overall Study||5||
59961347|NCT02692040|76079979|FG008|STARTED|Overall Study||5||
59961348|NCT02692040|76079980|FG009|STARTED|Overall Study||4||
59961349|NCT02692040|76079981|FG010|STARTED|Overall Study||5||
59961350|NCT02692040|76079982|FG011|STARTED|Overall Study||5||
59961351|NCT02692040|76079983|FG012|STARTED|Overall Study||6||
59808165|NCT00499863|75930160|FG001|STARTED|Overall Study||72||
59808166|NCT00499863|75930159|FG000|COMPLETED|Overall Study||95||
59808167|NCT00499863|75930160|FG001|COMPLETED|Overall Study||29||
59808168|NCT00499863|75930159|FG000|NOT COMPLETED|Overall Study||50||
59808169|NCT00499863|75930160|FG001|NOT COMPLETED|Overall Study||43||
59808170|NCT00484185|75930166|FG000|STARTED|Overall Study||183||
59808171|NCT00484185|75930166|FG000|Treated|Overall Study||178||
59808172|NCT00484185|75930166|FG000|COMPLETED|Overall Study||112||
59808173|NCT00484185|75930166|FG000|NOT COMPLETED|Overall Study||71||
59961352|NCT02692040|76079984|FG013|STARTED|Overall Study||6||
59961353|NCT02692040|76079985|FG014|STARTED|Overall Study||6||
59961354|NCT02692040|76079986|FG015|STARTED|Overall Study||6||
59961355|NCT02692040|76079987|FG016|STARTED|Overall Study||4||
59961356|NCT02692040|76079971|FG000|COMPLETED|Overall Study||10||
59961357|NCT02692040|76079972|FG001|COMPLETED|Overall Study||4||
59961358|NCT02692040|76079973|FG002|COMPLETED|Overall Study||5||
59961359|NCT02692040|76079974|FG003|COMPLETED|Overall Study||5||
59961360|NCT02692040|76079975|FG004|COMPLETED|Overall Study||4||
59961361|NCT02692040|76079976|FG005|COMPLETED|Overall Study||5||
59961362|NCT02692040|76079977|FG006|COMPLETED|Overall Study||5||
59961363|NCT02692040|76079978|FG007|COMPLETED|Overall Study||5||
59961364|NCT02692040|76079979|FG008|COMPLETED|Overall Study||5||
59961365|NCT02692040|76079980|FG009|COMPLETED|Overall Study||4||
59961366|NCT02692040|76079981|FG010|COMPLETED|Overall Study||5||
59961367|NCT02692040|76079982|FG011|COMPLETED|Overall Study||5||
59808174|NCT00097981|75930172|FG000|STARTED|Overall Study|Enrollment at randomization|113||
59808175|NCT00097981|75930173|FG001|STARTED|Overall Study|Enrollment at randomization|112||
59808176|NCT00097981|75930172|FG000|Received Study Medication|Overall Study||110||
59808177|NCT00097981|75930173|FG001|Received Study Medication|Overall Study||106||
59961368|NCT02692040|76079983|FG012|COMPLETED|Overall Study||5||
59808178|NCT00097981|75930172|FG000|COMPLETED|Overall Study|Completion of 2 or more cycles after CR or nCR, or completion of 12 cycles.|7||
59808179|NCT00097981|75930173|FG001|COMPLETED|Overall Study|Completion of 2 or more cycles after CR or nCR, or completion of 12 cycles.|12||
59808180|NCT00097981|75930172|FG000|NOT COMPLETED|Overall Study||106||
59808181|NCT00097981|75930173|FG001|NOT COMPLETED|Overall Study||100||
59808182|NCT00572195|75930179|FG000|STARTED|Overall Study||230||
59808183|NCT00572195|75930179|FG000|COMPLETED|Overall Study||162||
59961369|NCT02692040|76079984|FG013|COMPLETED|Overall Study||3||
59961370|NCT02692040|76079985|FG014|COMPLETED|Overall Study||5||
59961371|NCT02692040|76079986|FG015|COMPLETED|Overall Study||5||
59808184|NCT00572195|75930179|FG000|NOT COMPLETED|Overall Study||68||
59961372|NCT02692040|76079987|FG016|COMPLETED|Overall Study||4||
59961373|NCT02692040|76079971|FG000|NOT COMPLETED|Overall Study||0||
59961374|NCT02692040|76079972|FG001|NOT COMPLETED|Overall Study||0||
59961375|NCT02692040|76079973|FG002|NOT COMPLETED|Overall Study||0||
59961376|NCT02692040|76079974|FG003|NOT COMPLETED|Overall Study||0||
59961377|NCT02692040|76079975|FG004|NOT COMPLETED|Overall Study||0||
59961378|NCT02692040|76079976|FG005|NOT COMPLETED|Overall Study||0||
59961379|NCT02692040|76079977|FG006|NOT COMPLETED|Overall Study||0||
59961380|NCT02692040|76079978|FG007|NOT COMPLETED|Overall Study||0||
59961381|NCT02692040|76079979|FG008|NOT COMPLETED|Overall Study||0||
59961382|NCT02692040|76079980|FG009|NOT COMPLETED|Overall Study||0||
59961383|NCT02692040|76079981|FG010|NOT COMPLETED|Overall Study||0||
59961384|NCT02692040|76079982|FG011|NOT COMPLETED|Overall Study||0||
59961385|NCT02692040|76079983|FG012|NOT COMPLETED|Overall Study||1||
59961386|NCT02692040|76079984|FG013|NOT COMPLETED|Overall Study||3||
59961387|NCT02692040|76079985|FG014|NOT COMPLETED|Overall Study||1||
59961388|NCT02692040|76079986|FG015|NOT COMPLETED|Overall Study||1||
59961389|NCT02692040|76079987|FG016|NOT COMPLETED|Overall Study||0||
59961390|NCT03029819|76080066|FG000|STARTED|Overall Study||33||
59961391|NCT03029819|76080067|FG001|STARTED|Overall Study||39||
59961392|NCT03029819|76080066|FG000|COMPLETED|Overall Study||30||
59961393|NCT03029819|76080067|FG001|COMPLETED|Overall Study||33||
59961394|NCT03029819|76080066|FG000|NOT COMPLETED|Overall Study||3||
59961395|NCT03029819|76080067|FG001|NOT COMPLETED|Overall Study||6||
59961396|NCT02678390|76080078|FG000|STARTED|Control (5 Days)||10||
59961397|NCT02678390|76080079|FG001|STARTED|Control (5 Days)||10||
59961398|NCT02678390|76080078|FG000|COMPLETED|Control (5 Days)||10||
59961399|NCT02678390|76080079|FG001|COMPLETED|Control (5 Days)||10||
59961400|NCT02678390|76080078|FG000|NOT COMPLETED|Control (5 Days)||0||
59961401|NCT02678390|76080079|FG001|NOT COMPLETED|Control (5 Days)||0||
59961402|NCT02678390|76080078|FG000|STARTED|MCT (5 Days)||10||
59961403|NCT02678390|76080079|FG001|STARTED|MCT (5 Days)||10||
59961404|NCT02678390|76080078|FG000|COMPLETED|MCT (5 Days)||10||
59961405|NCT02678390|76080079|FG001|COMPLETED|MCT (5 Days)||10||
59808185|NCT00572039|75930185|FG000|STARTED|Overall Study||121||
59808186|NCT00572039|75930186|FG001|STARTED|Overall Study||120||
59808187|NCT00572039|75930185|FG000|COMPLETED|Overall Study||105||
59808188|NCT00572039|75930186|FG001|COMPLETED|Overall Study||110||
59808189|NCT00572039|75930185|FG000|NOT COMPLETED|Overall Study||16||
59808190|NCT00572039|75930186|FG001|NOT COMPLETED|Overall Study||10||
59961406|NCT02678390|76080078|FG000|NOT COMPLETED|MCT (5 Days)||0||
59961407|NCT02678390|76080079|FG001|NOT COMPLETED|MCT (5 Days)||0||
59961408|NCT02678390|76080078|FG000|STARTED|AE (1 Day)||10||
59961409|NCT02678390|76080079|FG001|STARTED|AE (1 Day)||10||
59961410|NCT02678390|76080078|FG000|COMPLETED|AE (1 Day)||10||
59961411|NCT02678390|76080079|FG001|COMPLETED|AE (1 Day)||9||
59961412|NCT02678390|76080078|FG000|NOT COMPLETED|AE (1 Day)||0||
59961413|NCT02678390|76080079|FG001|NOT COMPLETED|AE (1 Day)||1||
59961414|NCT02678390|76080078|FG000|STARTED|MCT + AE (5 Days)||10||
59961415|NCT02678390|76080079|FG001|STARTED|MCT + AE (5 Days)||9||
59961416|NCT02678390|76080078|FG000|COMPLETED|MCT + AE (5 Days)||10||
59961417|NCT02678390|76080079|FG001|COMPLETED|MCT + AE (5 Days)||9||
59961418|NCT02678390|76080078|FG000|NOT COMPLETED|MCT + AE (5 Days)||0||
59961419|NCT02678390|76080079|FG001|NOT COMPLETED|MCT + AE (5 Days)||0||
59961420|NCT03027557|76080088|FG000|STARTED|Overall Study||15||
59961421|NCT03027557|76080089|FG001|STARTED|Overall Study||16||
59961422|NCT03027557|76080090|FG002|STARTED|Overall Study||15||
59961423|NCT03027557|76080088|FG000|COMPLETED|Overall Study||14||
59808191|NCT00684593|75930196|FG000|STARTED|Overall Study||21||
59808192|NCT00684593|75930197|FG001|STARTED|Overall Study||10||
59808193|NCT00684593|75930196|FG000|COMPLETED|Overall Study||21||
59808194|NCT00684593|75930197|FG001|COMPLETED|Overall Study||8||
59808195|NCT00684593|75930196|FG000|NOT COMPLETED|Overall Study||0||
59808196|NCT00684593|75930197|FG001|NOT COMPLETED|Overall Study||2||
59961424|NCT03027557|76080089|FG001|COMPLETED|Overall Study||16||
59961425|NCT03027557|76080090|FG002|COMPLETED|Overall Study||15||
59961426|NCT03027557|76080088|FG000|NOT COMPLETED|Overall Study||1||
59961427|NCT03027557|76080089|FG001|NOT COMPLETED|Overall Study||0||
59961428|NCT03027557|76080090|FG002|NOT COMPLETED|Overall Study||0||
59961429|NCT03029585|76080100|FG000|STARTED|Overall Study||7||
59961430|NCT03029585|76080101|FG001|STARTED|Overall Study||3||
59961431|NCT03029585|76080100|FG000|COMPLETED|Overall Study||5||
59961432|NCT03029585|76080101|FG001|COMPLETED|Overall Study||2||
59961433|NCT03029585|76080100|FG000|NOT COMPLETED|Overall Study||2||
59961434|NCT03029585|76080101|FG001|NOT COMPLETED|Overall Study||1||
59961435|NCT02678000|76080112|FG000|STARTED|PART 1||7||
59961436|NCT02678000|76080113|FG001|STARTED|PART 1||4||
59961437|NCT02678000|76080114|FG002|STARTED|PART 1||0||
59961438|NCT02678000|76080115|FG003|STARTED|PART 1||0||
59961439|NCT02678000|76080116|FG004|STARTED|PART 1||0||
59961440|NCT02678000|76080112|FG000|COMPLETED|PART 1||7||
59961441|NCT02678000|76080113|FG001|COMPLETED|PART 1||4||
59961442|NCT02678000|76080114|FG002|COMPLETED|PART 1||0||
59961443|NCT02678000|76080115|FG003|COMPLETED|PART 1||0||
59961444|NCT02678000|76080116|FG004|COMPLETED|PART 1||0||
59961445|NCT02678000|76080112|FG000|NOT COMPLETED|PART 1||0||
59961446|NCT02678000|76080113|FG001|NOT COMPLETED|PART 1||0||
59961447|NCT02678000|76080114|FG002|NOT COMPLETED|PART 1||0||
59808197|NCT00685373|75930203|FG000|STARTED|Overall Study||166||
59808198|NCT00685373|75930203|FG000|COMPLETED|Overall Study||151||
59808199|NCT00685373|75930203|FG000|NOT COMPLETED|Overall Study||15||
59808200|NCT00684515|75930210|FG000|STARTED|Overall Study||33||
59808201|NCT00684515|75930211|FG001|STARTED|Overall Study||29||
59808202|NCT00684515|75930212|FG002|STARTED|Overall Study||28||
59808203|NCT00684515|75930210|FG000|COMPLETED|Overall Study||29||
59961448|NCT02678000|76080115|FG003|NOT COMPLETED|PART 1||0||
59961449|NCT02678000|76080116|FG004|NOT COMPLETED|PART 1||0||
59961450|NCT02678000|76080112|FG000|STARTED|PART 2||0||
59961451|NCT02678000|76080113|FG001|STARTED|PART 2||0||
59961452|NCT02678000|76080114|FG002|STARTED|PART 2||28||
59961453|NCT02678000|76080115|FG003|STARTED|PART 2||27||
59961454|NCT02678000|76080116|FG004|STARTED|PART 2||18||
59961455|NCT02678000|76080112|FG000|COMPLETED|PART 2||0||
59961456|NCT02678000|76080113|FG001|COMPLETED|PART 2||0||
59961457|NCT02678000|76080114|FG002|COMPLETED|PART 2||25||
59961458|NCT02678000|76080115|FG003|COMPLETED|PART 2||26||
59961459|NCT02678000|76080116|FG004|COMPLETED|PART 2||18||
59961460|NCT02678000|76080112|FG000|NOT COMPLETED|PART 2||0||
59961461|NCT02678000|76080113|FG001|NOT COMPLETED|PART 2||0||
59961462|NCT02678000|76080114|FG002|NOT COMPLETED|PART 2||3||
59961463|NCT02678000|76080115|FG003|NOT COMPLETED|PART 2||1||
59961464|NCT02678000|76080116|FG004|NOT COMPLETED|PART 2||0||
59961465|NCT02691572|76080143|FG000|STARTED|Overall Study||40||
59961466|NCT02691572|76080144|FG001|STARTED|Overall Study||40||
59961467|NCT02691572|76080143|FG000|COMPLETED|Overall Study||39||
59961468|NCT02691572|76080144|FG001|COMPLETED|Overall Study||39||
59961469|NCT02691572|76080143|FG000|NOT COMPLETED|Overall Study||1||
59524462|NCT01203319|75619654|FG001|NOT COMPLETED|Overall Study||9||
59808204|NCT00684515|75930211|FG001|COMPLETED|Overall Study||26||
59808205|NCT00684515|75930212|FG002|COMPLETED|Overall Study||27||
59808206|NCT00684515|75930210|FG000|NOT COMPLETED|Overall Study||4||
59961470|NCT02691572|76080144|FG001|NOT COMPLETED|Overall Study||1||
59961471|NCT02677844|76080152|FG000|STARTED|Period 1||5||
59961472|NCT02677844|76080153|FG001|STARTED|Period 1||5||
59961473|NCT02677844|76080154|FG002|STARTED|Period 1||5||
59961474|NCT02677844|76080155|FG003|STARTED|Period 1||5||
59961475|NCT02677844|76080156|FG004|STARTED|Period 1||0||
59961476|NCT02677844|76080157|FG005|STARTED|Period 1||0||
59961477|NCT02677844|76080158|FG006|STARTED|Period 1||0||
59961478|NCT02677844|76080152|FG000|COMPLETED|Period 1||5||
59961479|NCT02677844|76080153|FG001|COMPLETED|Period 1||5||
59524463|NCT01203319|75619655|FG002|NOT COMPLETED|Overall Study||5||
59808207|NCT00684515|75930211|FG001|NOT COMPLETED|Overall Study||3||
59961480|NCT02677844|76080154|FG002|COMPLETED|Period 1||5||
59961481|NCT02677844|76080155|FG003|COMPLETED|Period 1||5||
59961482|NCT02677844|76080156|FG004|COMPLETED|Period 1||0||
59961483|NCT02677844|76080157|FG005|COMPLETED|Period 1||0||
59961484|NCT02677844|76080158|FG006|COMPLETED|Period 1||0||
59524464|NCT01204255|75619663|FG000|STARTED|Overall Study||11||
59524465|NCT01204255|75619663|FG000|COMPLETED|Overall Study||10||
59808208|NCT00684515|75930212|FG002|NOT COMPLETED|Overall Study||1||
59808209|NCT00490815|75930222|FG000|STARTED|Overall Study||20||
60074120|NCT01803464|76189514|FG001|STARTED|Overall Study||4||
59808210|NCT00490815|75930223|FG001|STARTED|Overall Study||17||
59961485|NCT02677844|76080152|FG000|NOT COMPLETED|Period 1||0||
59961486|NCT02677844|76080153|FG001|NOT COMPLETED|Period 1||0||
59961487|NCT02677844|76080154|FG002|NOT COMPLETED|Period 1||0||
59961488|NCT02677844|76080155|FG003|NOT COMPLETED|Period 1||0||
59961489|NCT02677844|76080156|FG004|NOT COMPLETED|Period 1||0||
59961490|NCT02677844|76080157|FG005|NOT COMPLETED|Period 1||0||
59961491|NCT02677844|76080158|FG006|NOT COMPLETED|Period 1||0||
59961492|NCT02677844|76080152|FG000|STARTED|Period 2||5||
59961493|NCT02677844|76080153|FG001|STARTED|Period 2||5||
59961494|NCT02677844|76080154|FG002|STARTED|Period 2||5||
59961495|NCT02677844|76080155|FG003|STARTED|Period 2||5||
59961496|NCT02677844|76080156|FG004|STARTED|Period 2||0||
59961497|NCT02677844|76080157|FG005|STARTED|Period 2||0||
59961498|NCT02677844|76080158|FG006|STARTED|Period 2||0||
59961499|NCT02677844|76080152|FG000|COMPLETED|Period 2||5||
59961500|NCT02677844|76080153|FG001|COMPLETED|Period 2||5||
59961501|NCT02677844|76080154|FG002|COMPLETED|Period 2||5||
59961502|NCT02677844|76080155|FG003|COMPLETED|Period 2||5||
59961503|NCT02677844|76080156|FG004|COMPLETED|Period 2||0||
59961504|NCT02677844|76080157|FG005|COMPLETED|Period 2||0||
59961505|NCT02677844|76080158|FG006|COMPLETED|Period 2||0||
59961506|NCT02677844|76080152|FG000|NOT COMPLETED|Period 2||0||
59961507|NCT02677844|76080153|FG001|NOT COMPLETED|Period 2||0||
59961508|NCT02677844|76080154|FG002|NOT COMPLETED|Period 2||0||
59961509|NCT02677844|76080155|FG003|NOT COMPLETED|Period 2||0||
59961510|NCT02677844|76080156|FG004|NOT COMPLETED|Period 2||0||
59961511|NCT02677844|76080157|FG005|NOT COMPLETED|Period 2||0||
59961512|NCT02677844|76080158|FG006|NOT COMPLETED|Period 2||0||
59961513|NCT02677844|76080152|FG000|STARTED|Period 3||5||
59961514|NCT02677844|76080153|FG001|STARTED|Period 3||5||
59961515|NCT02677844|76080154|FG002|STARTED|Period 3||5||
59961516|NCT02677844|76080155|FG003|STARTED|Period 3||5||
59961517|NCT02677844|76080156|FG004|STARTED|Period 3||0||
59961518|NCT02677844|76080157|FG005|STARTED|Period 3||0||
59961519|NCT02677844|76080158|FG006|STARTED|Period 3||0||
59961520|NCT02677844|76080152|FG000|COMPLETED|Period 3||5||
59961521|NCT02677844|76080153|FG001|COMPLETED|Period 3||5||
59961522|NCT02677844|76080154|FG002|COMPLETED|Period 3||5||
59961523|NCT02677844|76080155|FG003|COMPLETED|Period 3||4||
59961524|NCT02677844|76080156|FG004|COMPLETED|Period 3||0||
59961525|NCT02677844|76080157|FG005|COMPLETED|Period 3||0||
59961526|NCT02677844|76080158|FG006|COMPLETED|Period 3||0||
59961527|NCT02677844|76080152|FG000|NOT COMPLETED|Period 3||0||
59961528|NCT02677844|76080153|FG001|NOT COMPLETED|Period 3||0||
59961529|NCT02677844|76080154|FG002|NOT COMPLETED|Period 3||0||
59961530|NCT02677844|76080155|FG003|NOT COMPLETED|Period 3||1||
59961531|NCT02677844|76080156|FG004|NOT COMPLETED|Period 3||0||
59961532|NCT02677844|76080157|FG005|NOT COMPLETED|Period 3||0||
59961533|NCT02677844|76080158|FG006|NOT COMPLETED|Period 3||0||
59961534|NCT02677844|76080152|FG000|STARTED|Period 4||5||
59961535|NCT02677844|76080153|FG001|STARTED|Period 4||5||
59961536|NCT02677844|76080154|FG002|STARTED|Period 4||5||
59961537|NCT02677844|76080155|FG003|STARTED|Period 4||4||
59961538|NCT02677844|76080156|FG004|STARTED|Period 4||0||
59961539|NCT02677844|76080157|FG005|STARTED|Period 4||0||
59961540|NCT02677844|76080158|FG006|STARTED|Period 4||0||
59961541|NCT02677844|76080152|FG000|COMPLETED|Period 4||5||
59961542|NCT02677844|76080153|FG001|COMPLETED|Period 4||5||
59961543|NCT02677844|76080154|FG002|COMPLETED|Period 4||5||
59961544|NCT02677844|76080155|FG003|COMPLETED|Period 4||4||
59961545|NCT02677844|76080156|FG004|COMPLETED|Period 4||0||
59961546|NCT02677844|76080157|FG005|COMPLETED|Period 4||0||
59961547|NCT02677844|76080158|FG006|COMPLETED|Period 4||0||
59961548|NCT02677844|76080152|FG000|NOT COMPLETED|Period 4||0||
59961549|NCT02677844|76080153|FG001|NOT COMPLETED|Period 4||0||
59961550|NCT02677844|76080154|FG002|NOT COMPLETED|Period 4||0||
59524466|NCT01204255|75619663|FG000|NOT COMPLETED|Overall Study||1||
59961551|NCT02677844|76080155|FG003|NOT COMPLETED|Period 4||0||
59961552|NCT02677844|76080156|FG004|NOT COMPLETED|Period 4||0||
59961553|NCT02677844|76080157|FG005|NOT COMPLETED|Period 4||0||
59961554|NCT02677844|76080158|FG006|NOT COMPLETED|Period 4||0||
59961555|NCT02677844|76080152|FG000|STARTED|Period 4 (DDI)||0|Participants were mutually exclusive of cohorts, Participants in Cohort 1 & 2 are different.|
59961556|NCT02677844|76080153|FG001|STARTED|Period 4 (DDI)||0|Participants were mutually exclusive of cohorts, Participants in Cohort 1 & 2 are different.|
59961557|NCT02677844|76080154|FG002|STARTED|Period 4 (DDI)||0|Participants were mutually exclusive of cohorts, Participants in Cohort 1 & 2 are different.|
59524467|NCT01156597|75619669|FG000|STARTED|Overall Study||16||
59524468|NCT01156597|75619670|FG001|STARTED|Overall Study||14||
59961558|NCT02677844|76080155|FG003|STARTED|Period 4 (DDI)||0|Participants were mutually exclusive of cohorts, Participants in Cohort 1 & 2 are different.|
59524469|NCT01156597|75619669|FG000|COMPLETED|Overall Study||13||
59524470|NCT01156597|75619670|FG001|COMPLETED|Overall Study||13||
59961559|NCT02677844|76080156|FG004|STARTED|Period 4 (DDI)||7|Participants were mutually exclusive of cohorts, Participants in Cohort 1 & 2 are different.|
59961560|NCT02677844|76080157|FG005|STARTED|Period 4 (DDI)||4|Participants were mutually exclusive of cohorts, Participants in Cohort 1 & 2 are different.|
59961561|NCT02677844|76080158|FG006|STARTED|Period 4 (DDI)||4|Participants were mutually exclusive of cohorts, Participants in Cohort 1 & 2 are different.|
59524471|NCT01156597|75619669|FG000|NOT COMPLETED|Overall Study||3||
59961562|NCT02677844|76080152|FG000|COMPLETED|Period 4 (DDI)||0||
59961563|NCT02677844|76080153|FG001|COMPLETED|Period 4 (DDI)||0||
59961564|NCT02677844|76080154|FG002|COMPLETED|Period 4 (DDI)||0||
59961565|NCT02677844|76080155|FG003|COMPLETED|Period 4 (DDI)||0||
59961566|NCT02677844|76080156|FG004|COMPLETED|Period 4 (DDI)||7||
59961567|NCT02677844|76080157|FG005|COMPLETED|Period 4 (DDI)||4||
59961568|NCT02677844|76080158|FG006|COMPLETED|Period 4 (DDI)||4||
59961569|NCT02677844|76080152|FG000|NOT COMPLETED|Period 4 (DDI)||0||
59961570|NCT02677844|76080153|FG001|NOT COMPLETED|Period 4 (DDI)||0||
59808211|NCT00490815|75930222|FG000|COMPLETED|Overall Study||12||
59808212|NCT00490815|75930223|FG001|COMPLETED|Overall Study||8||
59808213|NCT00490815|75930222|FG000|NOT COMPLETED|Overall Study||8||
59808214|NCT00490815|75930223|FG001|NOT COMPLETED|Overall Study||9||
59808215|NCT03855189|75930232|FG000|STARTED|Overall Study||113||
59808216|NCT03855189|75930233|FG001|STARTED|Overall Study||116||
59961571|NCT02677844|76080154|FG002|NOT COMPLETED|Period 4 (DDI)||0||
59961572|NCT02677844|76080155|FG003|NOT COMPLETED|Period 4 (DDI)||0||
59961573|NCT02677844|76080156|FG004|NOT COMPLETED|Period 4 (DDI)||0||
59961574|NCT02677844|76080157|FG005|NOT COMPLETED|Period 4 (DDI)||0||
59961575|NCT02677844|76080158|FG006|NOT COMPLETED|Period 4 (DDI)||0||
59961576|NCT02677844|76080152|FG000|STARTED|Period 5||0||
59961577|NCT02677844|76080153|FG001|STARTED|Period 5||0||
59961578|NCT02677844|76080154|FG002|STARTED|Period 5||0||
59961579|NCT02677844|76080155|FG003|STARTED|Period 5||0||
59961580|NCT02677844|76080156|FG004|STARTED|Period 5||7||
59961581|NCT02677844|76080157|FG005|STARTED|Period 5||4||
59961582|NCT02677844|76080158|FG006|STARTED|Period 5||4||
59808217|NCT03855189|75930234|FG002|STARTED|Overall Study||116||
59808218|NCT03855189|75930232|FG000|Treated|Overall Study|Does not include 1 participant who received first dose but was excluded from safety analysis.|112||
59808219|NCT03855189|75930233|FG001|Treated|Overall Study||116||
59808220|NCT03855189|75930234|FG002|Treated|Overall Study||116||
59808221|NCT03855189|75930232|FG000|COMPLETED|Overall Study||103||
59808222|NCT03855189|75930233|FG001|COMPLETED|Overall Study||109||
59808223|NCT03855189|75930234|FG002|COMPLETED|Overall Study||110||
59808224|NCT03855189|75930232|FG000|NOT COMPLETED|Overall Study||10||
59808225|NCT03855189|75930233|FG001|NOT COMPLETED|Overall Study||7||
59808226|NCT03855189|75930234|FG002|NOT COMPLETED|Overall Study||6||
59808227|NCT03853551|75930242|FG000|STARTED|Overall Study||60|60 patients were enrolled and received at least 1 dose of the study drug.|
59808228|NCT03853551|75930242|FG000|COMPLETED|Overall Study||51|"51 patients completed the study treatment (Cycle 1, Day 1 to Cycle 6, Day 21) and 28 days follow-up.~Each cycle consisting of 21 days."|
59808229|NCT03853551|75930242|FG000|NOT COMPLETED|Overall Study||9||
59808230|NCT00423670|75930253|FG000|STARTED|Treatment Period||104||
59808231|NCT00423670|75930254|FG001|STARTED|Treatment Period||107||
59808232|NCT00423670|75930255|FG002|STARTED|Treatment Period||103||
59808233|NCT00423670|75930256|FG003|STARTED|Treatment Period||103||
59808234|NCT00423670|75930257|FG004|STARTED|Treatment Period||103||
59808235|NCT00423670|75930258|FG005|STARTED|Treatment Period||16||
59808236|NCT00423670|75930259|FG006|STARTED|Treatment Period||59||
59808237|NCT00423670|75930260|FG007|STARTED|Treatment Period|Arm 8 were Arm 1 participants that were positive for HCV-RNA at TW 24 and had the option to switch.|36||
59808238|NCT00423670|75930253|FG000|COMPLETED|Treatment Period||52||
59808239|NCT00423670|75930254|FG001|COMPLETED|Treatment Period||77||
59808240|NCT00423670|75930255|FG002|COMPLETED|Treatment Period||76||
59808241|NCT00423670|75930256|FG003|COMPLETED|Treatment Period||63||
59808242|NCT00423670|75930257|FG004|COMPLETED|Treatment Period||76||
59808243|NCT00423670|75930258|FG005|COMPLETED|Treatment Period||8||
59808244|NCT00423670|75930259|FG006|COMPLETED|Treatment Period||28||
59961583|NCT02677844|76080152|FG000|COMPLETED|Period 5||0||
59961584|NCT02677844|76080153|FG001|COMPLETED|Period 5||0||
59961585|NCT02677844|76080154|FG002|COMPLETED|Period 5||0||
59961586|NCT02677844|76080155|FG003|COMPLETED|Period 5||0||
59961587|NCT02677844|76080156|FG004|COMPLETED|Period 5||7||
59961588|NCT02677844|76080157|FG005|COMPLETED|Period 5||4||
59961589|NCT02677844|76080158|FG006|COMPLETED|Period 5||4||
59961590|NCT02677844|76080152|FG000|NOT COMPLETED|Period 5||0||
59808245|NCT00423670|75930260|FG007|COMPLETED|Treatment Period||15||
59808246|NCT00423670|75930253|FG000|NOT COMPLETED|Treatment Period||52||
59808247|NCT00423670|75930254|FG001|NOT COMPLETED|Treatment Period||30||
59961591|NCT02677844|76080153|FG001|NOT COMPLETED|Period 5||0||
60074121|NCT01803464|76189515|FG002|STARTED|Overall Study||10||
60074122|NCT01803464|76189516|FG003|STARTED|Overall Study||10||
60074123|NCT01803464|76189513|FG000|COMPLETED|Overall Study||4||
60074124|NCT01803464|76189514|FG001|COMPLETED|Overall Study||4||
60074125|NCT01803464|76189515|FG002|COMPLETED|Overall Study||6||
60074126|NCT01803464|76189516|FG003|COMPLETED|Overall Study||10||
60074127|NCT01803464|76189513|FG000|NOT COMPLETED|Overall Study||1||
59808248|NCT00423670|75930255|FG002|NOT COMPLETED|Treatment Period||27||
59808249|NCT00423670|75930256|FG003|NOT COMPLETED|Treatment Period||40||
59808250|NCT00423670|75930257|FG004|NOT COMPLETED|Treatment Period||27||
59808251|NCT00423670|75930258|FG005|NOT COMPLETED|Treatment Period||8||
59808252|NCT00423670|75930259|FG006|NOT COMPLETED|Treatment Period||31||
59808253|NCT00423670|75930260|FG007|NOT COMPLETED|Treatment Period||21||
59808254|NCT00423670|75930253|FG000|STARTED|Follow-up Period||97||
59961592|NCT02677844|76080154|FG002|NOT COMPLETED|Period 5||0||
60074128|NCT01803464|76189514|FG001|NOT COMPLETED|Overall Study||0||
59808255|NCT00423670|75930254|FG001|STARTED|Follow-up Period||100||
59808256|NCT00423670|75930255|FG002|STARTED|Follow-up Period||96||
59961593|NCT02677844|76080155|FG003|NOT COMPLETED|Period 5||0||
59961594|NCT02677844|76080156|FG004|NOT COMPLETED|Period 5||0||
59961595|NCT02677844|76080157|FG005|NOT COMPLETED|Period 5||0||
59961596|NCT02677844|76080158|FG006|NOT COMPLETED|Period 5||0||
59961597|NCT02677844|76080152|FG000|STARTED|Period 6||0||
59961598|NCT02677844|76080153|FG001|STARTED|Period 6||0||
59961599|NCT02677844|76080154|FG002|STARTED|Period 6||0||
59961600|NCT02677844|76080155|FG003|STARTED|Period 6||0||
59961601|NCT02677844|76080156|FG004|STARTED|Period 6||7||
59808257|NCT00423670|75930256|FG003|STARTED|Follow-up Period||96||
59808258|NCT00423670|75930257|FG004|STARTED|Follow-up Period||91||
59808259|NCT00423670|75930258|FG005|STARTED|Follow-up Period||14||
59961602|NCT02677844|76080157|FG005|STARTED|Period 6||4||
59961603|NCT02677844|76080158|FG006|STARTED|Period 6||4||
59961604|NCT02677844|76080152|FG000|COMPLETED|Period 6||0||
59808260|NCT00423670|75930259|FG006|STARTED|Follow-up Period||50||
59961605|NCT02677844|76080153|FG001|COMPLETED|Period 6||0||
59961606|NCT02677844|76080154|FG002|COMPLETED|Period 6||0||
59961607|NCT02677844|76080155|FG003|COMPLETED|Period 6||0||
59961608|NCT02677844|76080156|FG004|COMPLETED|Period 6||7||
59961609|NCT02677844|76080157|FG005|COMPLETED|Period 6||4||
59808261|NCT00423670|75930260|FG007|STARTED|Follow-up Period||35||
59808262|NCT00423670|75930253|FG000|COMPLETED|Follow-up Period||94||
59808263|NCT00423670|75930254|FG001|COMPLETED|Follow-up Period||84||
59808264|NCT00423670|75930255|FG002|COMPLETED|Follow-up Period||85||
59808265|NCT00423670|75930256|FG003|COMPLETED|Follow-up Period||91||
59808266|NCT00423670|75930257|FG004|COMPLETED|Follow-up Period||89||
59808267|NCT00423670|75930258|FG005|COMPLETED|Follow-up Period||14||
59808268|NCT00423670|75930259|FG006|COMPLETED|Follow-up Period||41||
59961610|NCT02677844|76080158|FG006|COMPLETED|Period 6||4||
59961611|NCT02677844|76080152|FG000|NOT COMPLETED|Period 6||0||
59961612|NCT02677844|76080153|FG001|NOT COMPLETED|Period 6||0||
59961613|NCT02677844|76080154|FG002|NOT COMPLETED|Period 6||0||
59961614|NCT02677844|76080155|FG003|NOT COMPLETED|Period 6||0||
59961615|NCT02677844|76080156|FG004|NOT COMPLETED|Period 6||0||
59961616|NCT02677844|76080157|FG005|NOT COMPLETED|Period 6||0||
59961617|NCT02677844|76080158|FG006|NOT COMPLETED|Period 6||0||
59961618|NCT02677844|76080152|FG000|STARTED|Period 7||0||
59961619|NCT02677844|76080153|FG001|STARTED|Period 7||0||
59961620|NCT02677844|76080154|FG002|STARTED|Period 7||0||
59961621|NCT02677844|76080155|FG003|STARTED|Period 7||0||
59961622|NCT02677844|76080156|FG004|STARTED|Period 7||7||
59808269|NCT00423670|75930260|FG007|COMPLETED|Follow-up Period||32||
59808270|NCT00423670|75930253|FG000|NOT COMPLETED|Follow-up Period||3||
59808271|NCT00423670|75930254|FG001|NOT COMPLETED|Follow-up Period||16||
59808272|NCT00423670|75930255|FG002|NOT COMPLETED|Follow-up Period||11||
59808273|NCT00423670|75930256|FG003|NOT COMPLETED|Follow-up Period||5||
59961623|NCT02677844|76080157|FG005|STARTED|Period 7||4||
59961624|NCT02677844|76080158|FG006|STARTED|Period 7||4||
59961625|NCT02677844|76080152|FG000|COMPLETED|Period 7||0||
59961626|NCT02677844|76080153|FG001|COMPLETED|Period 7||0||
59961627|NCT02677844|76080154|FG002|COMPLETED|Period 7||0||
59961628|NCT02677844|76080155|FG003|COMPLETED|Period 7||0||
59961629|NCT02677844|76080156|FG004|COMPLETED|Period 7||7||
59961630|NCT02677844|76080157|FG005|COMPLETED|Period 7||4||
59961631|NCT02677844|76080158|FG006|COMPLETED|Period 7||4||
59961632|NCT02677844|76080152|FG000|NOT COMPLETED|Period 7||0||
59961633|NCT02677844|76080153|FG001|NOT COMPLETED|Period 7||0||
59961634|NCT02677844|76080154|FG002|NOT COMPLETED|Period 7||0||
59961635|NCT02677844|76080155|FG003|NOT COMPLETED|Period 7||0||
59961636|NCT02677844|76080156|FG004|NOT COMPLETED|Period 7||0||
59808274|NCT00423670|75930257|FG004|NOT COMPLETED|Follow-up Period||2||
59961637|NCT02677844|76080157|FG005|NOT COMPLETED|Period 7||0||
59961638|NCT02677844|76080158|FG006|NOT COMPLETED|Period 7||0||
59961639|NCT02691494|76080180|FG000|STARTED|Treatment Period||94|randomized and treated|
59961640|NCT02691494|76080181|FG001|STARTED|Treatment Period||95|randomized and treated|
59961641|NCT02691494|76080182|FG002|STARTED|Treatment Period||189|randomized and treated|
59961642|NCT02691494|76080180|FG000|COMPLETED|Treatment Period|completed treatment period|72||
59961643|NCT02691494|76080181|FG001|COMPLETED|Treatment Period|completed treatment period|69||
59961644|NCT02691494|76080182|FG002|COMPLETED|Treatment Period|completed treatment period|148||
59961645|NCT02691494|76080180|FG000|NOT COMPLETED|Treatment Period||22||
59961646|NCT02691494|76080181|FG001|NOT COMPLETED|Treatment Period||26||
59961647|NCT02691494|76080182|FG002|NOT COMPLETED|Treatment Period||41||
59961648|NCT02691494|76080180|FG000|STARTED|Post-Treatment Follow-Up Period||14||
59961649|NCT02691494|76080181|FG001|STARTED|Post-Treatment Follow-Up Period||25||
59961650|NCT02691494|76080182|FG002|STARTED|Post-Treatment Follow-Up Period||59||
59961651|NCT02691494|76080180|FG000|COMPLETED|Post-Treatment Follow-Up Period||9||
59961652|NCT02691494|76080181|FG001|COMPLETED|Post-Treatment Follow-Up Period||18||
59961653|NCT02691494|76080182|FG002|COMPLETED|Post-Treatment Follow-Up Period||42||
59961654|NCT02691494|76080180|FG000|NOT COMPLETED|Post-Treatment Follow-Up Period||5||
59961655|NCT02691494|76080181|FG001|NOT COMPLETED|Post-Treatment Follow-Up Period||7||
59961656|NCT02691494|76080182|FG002|NOT COMPLETED|Post-Treatment Follow-Up Period||17||
59961657|NCT02677220|76080190|FG000|STARTED|Overall Study||1||
59961658|NCT02677220|76080190|FG000|COMPLETED|Overall Study||0||
60074129|NCT01803464|76189515|FG002|NOT COMPLETED|Overall Study||4||
60074130|NCT01803464|76189516|FG003|NOT COMPLETED|Overall Study||0||
60074131|NCT01808690|76189532|FG000|STARTED|Overall Study||25||
60074132|NCT01808690|76189533|FG001|STARTED|Overall Study||23||
60074133|NCT01808690|76189532|FG000|COMPLETED|Overall Study||24||
60074134|NCT01808690|76189533|FG001|COMPLETED|Overall Study||21||
60074135|NCT01808690|76189532|FG000|NOT COMPLETED|Overall Study||1||
60074136|NCT01808690|76189533|FG001|NOT COMPLETED|Overall Study||2||
60074137|NCT01363297|76189544|FG000|STARTED|Overall Study||3||
60074138|NCT01363297|76189545|FG001|STARTED|Overall Study||12||
60074139|NCT01363297|76189546|FG002|STARTED|Overall Study||9||
60074140|NCT01363297|76189547|FG003|STARTED|Overall Study||13||
60074141|NCT01363297|76189548|FG004|STARTED|Overall Study||35||
59808275|NCT00423670|75930258|FG005|NOT COMPLETED|Follow-up Period||0||
59808276|NCT00423670|75930259|FG006|NOT COMPLETED|Follow-up Period||9||
59808277|NCT00423670|75930260|FG007|NOT COMPLETED|Follow-up Period||3||
59961659|NCT02677220|76080190|FG000|NOT COMPLETED|Overall Study||1||
59961660|NCT02682602|76080197|FG000|STARTED|Pre-operative Diseased & Normal Hips||11||
59961661|NCT02682602|76080198|FG001|STARTED|Pre-operative Diseased & Normal Hips||10||
59961662|NCT02682602|76080197|FG000|COMPLETED|Pre-operative Diseased & Normal Hips||10||
59961663|NCT02682602|76080198|FG001|COMPLETED|Pre-operative Diseased & Normal Hips||10||
59961664|NCT02682602|76080197|FG000|NOT COMPLETED|Pre-operative Diseased & Normal Hips||1||
59961665|NCT02682602|76080198|FG001|NOT COMPLETED|Pre-operative Diseased & Normal Hips||0||
59961666|NCT02682602|76080197|FG000|STARTED|Post-operative Fluoroscopy for Implanted||10||
59961667|NCT02682602|76080198|FG001|STARTED|Post-operative Fluoroscopy for Implanted||0||
59961668|NCT02682602|76080197|FG000|COMPLETED|Post-operative Fluoroscopy for Implanted||7||
59961669|NCT02682602|76080198|FG001|COMPLETED|Post-operative Fluoroscopy for Implanted|Nonimplanted subjects were not analyzed again for the second period, because this would be redundant|0||
59961670|NCT02682602|76080197|FG000|NOT COMPLETED|Post-operative Fluoroscopy for Implanted||3||
59961671|NCT02682602|76080198|FG001|NOT COMPLETED|Post-operative Fluoroscopy for Implanted||0||
59961672|NCT02681510|76080208|FG000|STARTED|Overall Study||36||
59961673|NCT02681510|76080208|FG000|COMPLETED|Overall Study||26||
59961674|NCT02681510|76080208|FG000|NOT COMPLETED|Overall Study||10||
59961675|NCT02690714|76080212|FG000|STARTED|Segment 1: Single-dose Day -4 to Day 0||9||
59961676|NCT02690714|76080212|FG000|COMPLETED|Segment 1: Single-dose Day -4 to Day 0|Six participants skipped Segment 1 as they had PK data from Phase 1 study 2002C005G.|9||
59961677|NCT02690714|76080212|FG000|NOT COMPLETED|Segment 1: Single-dose Day -4 to Day 0||0||
59961678|NCT02690714|76080212|FG000|STARTED|Segment 2: Multi-dose Day 0 to Week 12||15||
59961679|NCT02690714|76080212|FG000|COMPLETED|Segment 2: Multi-dose Day 0 to Week 12||15||
59961680|NCT02690714|76080212|FG000|NOT COMPLETED|Segment 2: Multi-dose Day 0 to Week 12||0||
59961681|NCT02690714|76080212|FG000|STARTED|Segment 3: Extended Treatment Wks 12-48||15||
59961682|NCT02690714|76080212|FG000|COMPLETED|Segment 3: Extended Treatment Wks 12-48||15||
59961683|NCT02690714|76080212|FG000|NOT COMPLETED|Segment 3: Extended Treatment Wks 12-48||0||
59961684|NCT02690714|76080212|FG000|STARTED|Post-Wk 48: Safety Week 48 to EoS Visit|3 subjects from Norway did not go past 48 weeks|12||
59961685|NCT02690714|76080212|FG000|COMPLETED|Post-Wk 48: Safety Week 48 to EoS Visit||10||
59961686|NCT02690714|76080212|FG000|NOT COMPLETED|Post-Wk 48: Safety Week 48 to EoS Visit||2||
59961687|NCT01791543|76080220|FG000|STARTED|Overall Study||76||
59961688|NCT01791543|76080220|FG000|COMPLETED|Overall Study||74||
59961689|NCT01791543|76080220|FG000|NOT COMPLETED|Overall Study||2||
59961690|NCT02925455|76080227|FG000|STARTED|Overall Study||9||
59961691|NCT02925455|76080228|FG001|STARTED|Overall Study||6||
59961692|NCT02925455|76080227|FG000|COMPLETED|Overall Study||7||
59961693|NCT02925455|76080228|FG001|COMPLETED|Overall Study||6||
59961694|NCT02925455|76080227|FG000|NOT COMPLETED|Overall Study||2||
59961695|NCT02925455|76080228|FG001|NOT COMPLETED|Overall Study||0||
59961696|NCT03033069|76080238|FG000|STARTED|Overall Study||82||
59961697|NCT03033069|76080239|FG001|STARTED|Overall Study||75||
59961698|NCT03033069|76080240|FG002|STARTED|Overall Study||81||
59961699|NCT03033069|76080241|FG003|STARTED|Overall Study||83||
59961700|NCT03033069|76080238|FG000|Safety Sample|Overall Study||80|Safety Sample included all participants who were randomized into this trial and were administered at least one dose of double-blind investigational medicinal product (IMP).|
59961701|NCT03033069|76080239|FG001|Safety Sample|Overall Study||75|Safety Sample included all participants who were randomized into this trial and were administered at least one dose of double-blind investigational medicinal product (IMP).|
59961702|NCT03033069|76080240|FG002|Safety Sample|Overall Study||79|Safety Sample included all participants who were randomized into this trial and were administered at least one dose of double-blind investigational medicinal product (IMP).|
59961703|NCT03033069|76080241|FG003|Safety Sample|Overall Study||82|Safety Sample included all participants who were randomized into this trial and were administered at least one dose of double-blind investigational medicinal product (IMP).|
59961704|NCT03033069|76080238|FG000|Intent to Treat (ITT) Sample|Overall Study||79|ITT Sample included all participants who were randomized in the trial and took at least one dose of double-blind IMP and have a Baseline and at least one post Baseline evaluation for the clinician-administered PTSD scale for diagnostic and statistical manual of mental disorders, 5th edition (DSM-5) CAPS-5 total score.|
60074142|NCT01363297|76189544|FG000|COMPLETED|Overall Study||0||
60074143|NCT01363297|76189545|FG001|COMPLETED|Overall Study||6||
59524472|NCT01156597|75619670|FG001|NOT COMPLETED|Overall Study||1||
59524473|NCT01331408|75619677|FG000|STARTED|Overall Study||61||
59524474|NCT01331408|75619677|FG000|COMPLETED|Overall Study||50||
59524475|NCT01331408|75619677|FG000|NOT COMPLETED|Overall Study||11||
59524476|NCT01156987|75619683|FG000|STARTED|Overall Study||8||
59524477|NCT01156987|75619684|FG001|STARTED|Overall Study||23||
59524478|NCT01156987|75619683|FG000|COMPLETED|Overall Study||8||
59524479|NCT01156987|75619684|FG001|COMPLETED|Overall Study||12||
59524480|NCT01156987|75619683|FG000|NOT COMPLETED|Overall Study||0||
59524481|NCT01156987|75619684|FG001|NOT COMPLETED|Overall Study||11||
59524482|NCT02170649|75619690|FG000|STARTED|Fasting Period||12||
59524483|NCT02170649|75619690|FG000|COMPLETED|Fasting Period||12||
59524484|NCT02170649|75619690|FG000|NOT COMPLETED|Fasting Period||0||
59524485|NCT02170649|75619690|FG000|STARTED|Fed Period||12||
59524486|NCT02170649|75619690|FG000|COMPLETED|Fed Period||12||
59524487|NCT02170649|75619690|FG000|NOT COMPLETED|Fed Period||0||
59524488|NCT02316470|75619698|FG000|STARTED|Overall Study||148||
59524489|NCT02316470|75619699|FG001|STARTED|Overall Study||152||
59524490|NCT02316470|75619700|FG002|STARTED|Overall Study||152||
59524491|NCT02316470|75619701|FG003|STARTED|Overall Study||48||
59524492|NCT02316470|75619698|FG000|COMPLETED|Overall Study||143||
59524493|NCT02316470|75619699|FG001|COMPLETED|Overall Study||146||
59808278|NCT00483717|75930283|FG000|STARTED|Overall Study||87||
59808279|NCT00483717|75930284|FG001|STARTED|Overall Study||86||
59808280|NCT00483717|75930283|FG000|COMPLETED|Overall Study||63||
59961705|NCT03033069|76080239|FG001|Intent to Treat (ITT) Sample|Overall Study||72|ITT Sample included all participants who were randomized in the trial and took at least one dose of double-blind IMP and have a Baseline and at least one post Baseline evaluation for the clinician-administered PTSD scale for diagnostic and statistical manual of mental disorders, 5th edition (DSM-5) CAPS-5 total score.|
59961706|NCT03033069|76080240|FG002|Intent to Treat (ITT) Sample|Overall Study||77|ITT Sample included all participants who were randomized in the trial and took at least one dose of double-blind IMP and have a Baseline and at least one post Baseline evaluation for the clinician-administered PTSD scale for diagnostic and statistical manual of mental disorders, 5th edition (DSM-5) CAPS-5 total score.|
59961707|NCT03033069|76080241|FG003|Intent to Treat (ITT) Sample|Overall Study||80|ITT Sample included all participants who were randomized in the trial and took at least one dose of double-blind IMP and have a Baseline and at least one post Baseline evaluation for the clinician-administered PTSD scale for diagnostic and statistical manual of mental disorders, 5th edition (DSM-5) CAPS-5 total score.|
59961708|NCT03033069|76080238|FG000|COMPLETED|Overall Study||58||
59961709|NCT03033069|76080239|FG001|COMPLETED|Overall Study||50||
59961710|NCT03033069|76080240|FG002|COMPLETED|Overall Study||59||
59961711|NCT03033069|76080241|FG003|COMPLETED|Overall Study||64||
59961712|NCT03033069|76080238|FG000|NOT COMPLETED|Overall Study||24||
59961713|NCT03033069|76080239|FG001|NOT COMPLETED|Overall Study||25||
59961714|NCT03033069|76080240|FG002|NOT COMPLETED|Overall Study||22||
59961715|NCT03033069|76080241|FG003|NOT COMPLETED|Overall Study||19||
59961716|NCT02917265|76080253|FG000|STARTED|Overall Study||5|11.2015|
59961717|NCT02917265|76080254|FG001|STARTED|Overall Study||2|11.2015|
59961718|NCT02917265|76080253|FG000|COMPLETED|Overall Study||3|5.2017|
59961719|NCT02917265|76080254|FG001|COMPLETED|Overall Study||2|5.2017|
59961720|NCT02917265|76080253|FG000|NOT COMPLETED|Overall Study||2||
59961721|NCT02917265|76080254|FG001|NOT COMPLETED|Overall Study||0||
59961722|NCT02136069|76080264|FG000|STARTED|Overall Study||199||
59961723|NCT02136069|76080265|FG001|STARTED|Overall Study||198||
59961724|NCT02136069|76080264|FG000|COMPLETED|Overall Study||165||
59961725|NCT02136069|76080265|FG001|COMPLETED|Overall Study||170||
59961726|NCT02136069|76080264|FG000|NOT COMPLETED|Overall Study||34||
59961727|NCT02136069|76080265|FG001|NOT COMPLETED|Overall Study||28||
59961728|NCT02917031|76080274|FG000|STARTED|Overall Study||112|Participants who received treatment|
59961729|NCT02917031|76080275|FG001|STARTED|Overall Study||115|Participants who received treatment|
59961730|NCT02917031|76080276|FG002|STARTED|Overall Study||120|Participants who received treatment|
59961731|NCT02917031|76080274|FG000|COMPLETED|Overall Study||94||
59961732|NCT02917031|76080275|FG001|COMPLETED|Overall Study||102||
59961733|NCT02917031|76080276|FG002|COMPLETED|Overall Study||105||
59961734|NCT02917031|76080274|FG000|NOT COMPLETED|Overall Study||18||
59961735|NCT02917031|76080275|FG001|NOT COMPLETED|Overall Study||13||
59961736|NCT02917031|76080276|FG002|NOT COMPLETED|Overall Study||15||
59961737|NCT01018563|76080285|FG000|STARTED|Overall Study||2||
59961738|NCT01018563|76080286|FG001|STARTED|Overall Study||1||
59961739|NCT01018563|76080285|FG000|COMPLETED|Overall Study||0||
59961740|NCT01018563|76080286|FG001|COMPLETED|Overall Study||0||
59961741|NCT01018563|76080285|FG000|NOT COMPLETED|Overall Study||2||
59961742|NCT01018563|76080286|FG001|NOT COMPLETED|Overall Study||1||
59961743|NCT02528188|76080299|FG000|STARTED|Overall Study||1008||
59961744|NCT02528188|76080300|FG001|STARTED|Overall Study||1005||
59961745|NCT02528188|76080301|FG002|STARTED|Overall Study||1008||
59961746|NCT02528188|76080299|FG000|Treated|Overall Study||1002||
59961747|NCT02528188|76080300|FG001|Treated|Overall Study||998||
59961748|NCT02528188|76080301|FG002|Treated|Overall Study||996||
59961749|NCT02528188|76080299|FG000|COMPLETED|Overall Study||741||
59961750|NCT02528188|76080300|FG001|COMPLETED|Overall Study||729||
59961751|NCT02528188|76080301|FG002|COMPLETED|Overall Study||757||
59961752|NCT02528188|76080299|FG000|NOT COMPLETED|Overall Study||267||
59961753|NCT02528188|76080300|FG001|NOT COMPLETED|Overall Study||276||
59961754|NCT02528188|76080301|FG002|NOT COMPLETED|Overall Study||251||
59961755|NCT03896165|76080309|FG000|STARTED|Overall Study||20||
59961756|NCT03896165|76080309|FG000|COMPLETED|Overall Study||18||
59961757|NCT03896165|76080309|FG000|NOT COMPLETED|Overall Study||2||
59961758|NCT02447133|76080314|FG000|STARTED|Overall Study||12||
59961759|NCT02447133|76080314|FG000|COMPLETED|Overall Study||12||
59961760|NCT02447133|76080314|FG000|NOT COMPLETED|Overall Study||0||
59961761|NCT05361304|76080322|FG000|STARTED|Overall Study||62||
59961762|NCT05361304|76080323|FG001|STARTED|Overall Study||61||
59961763|NCT05361304|76080322|FG000|COMPLETED|Overall Study||59||
59961764|NCT05361304|76080323|FG001|COMPLETED|Overall Study||59||
59961765|NCT05361304|76080322|FG000|NOT COMPLETED|Overall Study||3||
59961766|NCT05361304|76080323|FG001|NOT COMPLETED|Overall Study||2||
59961767|NCT02988401|76080334|FG000|STARTED|Overall Study||37||
59524494|NCT02316470|75619700|FG002|COMPLETED|Overall Study||147||
59808281|NCT00483717|75930284|FG001|COMPLETED|Overall Study||65||
59961768|NCT02988401|76080335|FG001|STARTED|Overall Study||33||
59808282|NCT00483717|75930283|FG000|NOT COMPLETED|Overall Study||24||
59524495|NCT02316470|75619701|FG003|COMPLETED|Overall Study||46||
59808283|NCT00483717|75930284|FG001|NOT COMPLETED|Overall Study||21||
59961769|NCT02988401|76080336|FG002|STARTED|Overall Study||35||
59961770|NCT02988401|76080334|FG000|COMPLETED|Overall Study||24|There were 69 total participants that had at least one follow-up visit up until week 24.|
59961771|NCT02988401|76080335|FG001|COMPLETED|Overall Study||17|There were 69 total participants that had at least one follow-up visit up until week 24.|
59961772|NCT02988401|76080336|FG002|COMPLETED|Overall Study||28|There were 69 total participants that had at least one follow-up visit up until week 24.|
59961773|NCT02988401|76080334|FG000|NOT COMPLETED|Overall Study||13||
59961774|NCT02988401|76080335|FG001|NOT COMPLETED|Overall Study||16||
59961775|NCT02988401|76080336|FG002|NOT COMPLETED|Overall Study||7||
59961776|NCT02269917|76080346|FG000|STARTED|BL to EOE-Test and BL to Switch-Control||766||
59961777|NCT02269917|76080347|FG001|STARTED|BL to EOE-Test and BL to Switch-Control||383||
59961778|NCT02269917|76080348|FG002|STARTED|BL to EOE-Test and BL to Switch-Control||0||
59961779|NCT02269917|76080346|FG000|Treated|BL to EOE-Test and BL to Switch-Control||763||
59961780|NCT02269917|76080347|FG001|Treated|BL to EOE-Test and BL to Switch-Control||378||
59961781|NCT02269917|76080348|FG002|Treated|BL to EOE-Test and BL to Switch-Control||0||
59961782|NCT02269917|76080346|FG000|COMPLETED|BL to EOE-Test and BL to Switch-Control||649||
59961783|NCT02269917|76080347|FG001|COMPLETED|BL to EOE-Test and BL to Switch-Control||352||
59961784|NCT02269917|76080348|FG002|COMPLETED|BL to EOE-Test and BL to Switch-Control||0||
59961785|NCT02269917|76080346|FG000|NOT COMPLETED|BL to EOE-Test and BL to Switch-Control||117||
59961786|NCT02269917|76080347|FG001|NOT COMPLETED|BL to EOE-Test and BL to Switch-Control||31||
59961787|NCT02269917|76080348|FG002|NOT COMPLETED|BL to EOE-Test and BL to Switch-Control||0||
59961788|NCT02269917|76080346|FG000|STARTED|Switch to D/C/F/TAF (Until EOE)||0||
59961789|NCT02269917|76080347|FG001|STARTED|Switch to D/C/F/TAF (Until EOE)||0||
59961790|NCT02269917|76080348|FG002|STARTED|Switch to D/C/F/TAF (Until EOE)||352||
59961791|NCT02269917|76080346|FG000|COMPLETED|Switch to D/C/F/TAF (Until EOE)||0||
59961792|NCT02269917|76080347|FG001|COMPLETED|Switch to D/C/F/TAF (Until EOE)||0||
59961793|NCT02269917|76080348|FG002|COMPLETED|Switch to D/C/F/TAF (Until EOE)||314||
59961794|NCT02269917|76080346|FG000|NOT COMPLETED|Switch to D/C/F/TAF (Until EOE)||0||
59961795|NCT02269917|76080347|FG001|NOT COMPLETED|Switch to D/C/F/TAF (Until EOE)||0||
59961796|NCT02269917|76080348|FG002|NOT COMPLETED|Switch to D/C/F/TAF (Until EOE)||38||
59961797|NCT02522494|76080359|FG000|STARTED|Overall Study||51||
59961798|NCT02522494|76080360|FG001|STARTED|Overall Study||51||
59961799|NCT02522494|76080359|FG000|Post-CVT Visit Interview|Overall Study||37||
59961800|NCT02522494|76080360|FG001|Post-CVT Visit Interview|Overall Study||48||
59961801|NCT02522494|76080359|FG000|4-Week Follow Up|Overall Study||37||
59961802|NCT02522494|76080360|FG001|4-Week Follow Up|Overall Study||46||
59961803|NCT02522494|76080359|FG000|COMPLETED|Overall Study||37||
59961804|NCT02522494|76080360|FG001|COMPLETED|Overall Study||46||
59961805|NCT02522494|76080359|FG000|NOT COMPLETED|Overall Study||14||
59961806|NCT02522494|76080360|FG001|NOT COMPLETED|Overall Study||5||
59961807|NCT01658020|76080368|FG000|STARTED|Overall Study||175||
59961808|NCT01658020|76080369|FG001|STARTED|Overall Study||167||
59961809|NCT01658020|76080368|FG000|COMPLETED|Overall Study||167||
59961810|NCT01658020|76080369|FG001|COMPLETED|Overall Study||158||
59961811|NCT01658020|76080368|FG000|NOT COMPLETED|Overall Study||8||
59961812|NCT01658020|76080369|FG001|NOT COMPLETED|Overall Study||9||
59961813|NCT04635579|76080378|FG000|STARTED|Overall Study||20||
59961814|NCT04635579|76080379|FG001|STARTED|Overall Study||20||
59961815|NCT04635579|76080378|FG000|COMPLETED|Overall Study||20||
59961816|NCT04635579|76080379|FG001|COMPLETED|Overall Study||20||
59961817|NCT04635579|76080378|FG000|NOT COMPLETED|Overall Study||0||
59961818|NCT04635579|76080379|FG001|NOT COMPLETED|Overall Study||0||
59961819|NCT03389477|76080387|FG000|STARTED|Step 1||19||
59961820|NCT03389477|76080388|FG001|STARTED|Step 1||7||
59961821|NCT03389477|76080387|FG000|COMPLETED|Step 1||18||
59961822|NCT03389477|76080388|FG001|COMPLETED|Step 1||7||
59961823|NCT03389477|76080387|FG000|NOT COMPLETED|Step 1||1||
59961824|NCT03389477|76080388|FG001|NOT COMPLETED|Step 1||0||
59961825|NCT03389477|76080387|FG000|STARTED|Step 2||18||
59961826|NCT03389477|76080388|FG001|STARTED|Step 2||7||
59961827|NCT03389477|76080387|FG000|COMPLETED|Step 2||16||
59961828|NCT03389477|76080388|FG001|COMPLETED|Step 2||3||
59961829|NCT03389477|76080387|FG000|NOT COMPLETED|Step 2||2||
59961830|NCT03389477|76080388|FG001|NOT COMPLETED|Step 2||4||
59961831|NCT03389477|76080387|FG000|STARTED|Step 3||16||
59961832|NCT03389477|76080388|FG001|STARTED|Step 3||3||
59961833|NCT03389477|76080387|FG000|COMPLETED|Step 3||11||
59961834|NCT03389477|76080388|FG001|COMPLETED|Step 3||2||
60074144|NCT01363297|76189546|FG002|COMPLETED|Overall Study||3||
59961835|NCT03389477|76080387|FG000|NOT COMPLETED|Step 3||5||
59961836|NCT03389477|76080388|FG001|NOT COMPLETED|Step 3||1||
59961837|NCT02680574|76080398|FG000|STARTED|Overall Study||862||
59961838|NCT02680574|76080399|FG001|STARTED|Overall Study||863||
59961839|NCT02680574|76080398|FG000|COMPLETED|Overall Study||704||
59961840|NCT02680574|76080399|FG001|COMPLETED|Overall Study||711||
59961841|NCT02680574|76080398|FG000|NOT COMPLETED|Overall Study||158||
60074145|NCT01363297|76189547|FG003|COMPLETED|Overall Study||3||
59961842|NCT02680574|76080399|FG001|NOT COMPLETED|Overall Study||152||
59961843|NCT02522884|76080405|FG000|STARTED|Overall Study|Intent to Treat (ITT) population.|213||
60074146|NCT01363297|76189548|FG004|COMPLETED|Overall Study||4||
60074147|NCT01363297|76189544|FG000|NOT COMPLETED|Overall Study||3||
59961844|NCT02522884|76080405|FG000|COMPLETED|Overall Study|Completed 12-month follow-up.|195||
59961845|NCT02522884|76080405|FG000|NOT COMPLETED|Overall Study||18||
59961846|NCT03739593|76080412|FG000|STARTED|Overall Study||5||
59961847|NCT03739593|76080413|FG001|STARTED|Overall Study||22||
59961848|NCT03739593|76080414|FG002|STARTED|Overall Study||22||
59961849|NCT03739593|76080412|FG000|COMPLETED|Overall Study||2||
59961850|NCT03739593|76080413|FG001|COMPLETED|Overall Study||16||
59961851|NCT03739593|76080414|FG002|COMPLETED|Overall Study||14||
59961852|NCT03739593|76080412|FG000|NOT COMPLETED|Overall Study||3||
59961853|NCT03739593|76080413|FG001|NOT COMPLETED|Overall Study||6||
59961854|NCT03739593|76080414|FG002|NOT COMPLETED|Overall Study||8||
59961855|NCT02674568|76080422|FG000|STARTED|Overall Study|Enrolled and dosed.|339||
59961856|NCT02674568|76080422|FG000|Delta-like Protein 3 (DLL3) High|Overall Study||238|"DLL3 High Participants: tumors with ≥75% of cells expressing DLL3 are classified as DLL3 high"|
59961857|NCT02674568|76080422|FG000|DLL3 Positive|Overall Study||287|"DLL3 Positive Participants: tumors with ≥25% cells expressing DLL3 are classified as DLL3 positive"|
59961858|NCT02674568|76080422|FG000|COMPLETED|Overall Study||0|'Completed'=still on study; 'Not Completed'=discontinued study|
59961859|NCT02674568|76080422|FG000|NOT COMPLETED|Overall Study||339||
59961860|NCT05313412|76080431|FG000|STARTED|Overall Study||19||
59961861|NCT05313412|76080432|FG001|STARTED|Overall Study||19||
59961862|NCT05313412|76080431|FG000|COMPLETED|Overall Study||19||
59961863|NCT05313412|76080432|FG001|COMPLETED|Overall Study||19||
59961864|NCT05313412|76080431|FG000|NOT COMPLETED|Overall Study||0||
59961865|NCT05313412|76080432|FG001|NOT COMPLETED|Overall Study||0||
59961866|NCT03022799|76080451|FG000|STARTED|Overall Study||6||
59961867|NCT03022799|76080452|FG001|STARTED|Overall Study||6||
59961868|NCT03022799|76080453|FG002|STARTED|Overall Study||6||
59961869|NCT03022799|76080454|FG003|STARTED|Overall Study||6||
59961870|NCT03022799|76080455|FG004|STARTED|Overall Study||6||
59961871|NCT03022799|76080456|FG005|STARTED|Overall Study||6||
59961872|NCT03022799|76080457|FG006|STARTED|Overall Study||12||
59961873|NCT03022799|76080458|FG007|STARTED|Overall Study||6||
59961874|NCT03022799|76080459|FG008|STARTED|Overall Study||6||
59961875|NCT03022799|76080460|FG009|STARTED|Overall Study||6||
59961876|NCT03022799|76080461|FG010|STARTED|Overall Study||6||
59961877|NCT03022799|76080462|FG011|STARTED|Overall Study||6||
59961878|NCT03022799|76080463|FG012|STARTED|Overall Study||10||
59961879|NCT03022799|76080451|FG000|COMPLETED|Overall Study||6||
59961880|NCT03022799|76080452|FG001|COMPLETED|Overall Study||6||
59961881|NCT03022799|76080453|FG002|COMPLETED|Overall Study||6||
59961882|NCT03022799|76080454|FG003|COMPLETED|Overall Study||6||
59961883|NCT03022799|76080455|FG004|COMPLETED|Overall Study||6||
59961884|NCT03022799|76080456|FG005|COMPLETED|Overall Study||6||
59961885|NCT03022799|76080457|FG006|COMPLETED|Overall Study||12||
59961886|NCT03022799|76080458|FG007|COMPLETED|Overall Study||6||
59961887|NCT03022799|76080459|FG008|COMPLETED|Overall Study||6||
59961888|NCT03022799|76080460|FG009|COMPLETED|Overall Study||5||
59961889|NCT03022799|76080461|FG010|COMPLETED|Overall Study||5||
59961890|NCT03022799|76080462|FG011|COMPLETED|Overall Study||6||
59961891|NCT03022799|76080463|FG012|COMPLETED|Overall Study||10||
59961892|NCT03022799|76080451|FG000|NOT COMPLETED|Overall Study||0||
59961893|NCT03022799|76080452|FG001|NOT COMPLETED|Overall Study||0||
59961894|NCT03022799|76080453|FG002|NOT COMPLETED|Overall Study||0||
59961895|NCT03022799|76080454|FG003|NOT COMPLETED|Overall Study||0||
59961896|NCT03022799|76080455|FG004|NOT COMPLETED|Overall Study||0||
59961897|NCT03022799|76080456|FG005|NOT COMPLETED|Overall Study||0||
59961898|NCT03022799|76080457|FG006|NOT COMPLETED|Overall Study||0||
59961899|NCT03022799|76080458|FG007|NOT COMPLETED|Overall Study||0||
59961900|NCT03022799|76080459|FG008|NOT COMPLETED|Overall Study||0||
59961901|NCT03022799|76080460|FG009|NOT COMPLETED|Overall Study||1||
59961902|NCT03022799|76080461|FG010|NOT COMPLETED|Overall Study||1||
59961903|NCT03022799|76080462|FG011|NOT COMPLETED|Overall Study||0||
59961904|NCT03022799|76080463|FG012|NOT COMPLETED|Overall Study||0||
59961905|NCT02674334|76080510|FG000|STARTED|Overall Study||47||
59961906|NCT02674334|76080511|FG001|STARTED|Overall Study||43||
59961907|NCT02674334|76080510|FG000|COMPLETED|Overall Study||40||
59961908|NCT02674334|76080511|FG001|COMPLETED|Overall Study||40||
59961909|NCT02674334|76080510|FG000|NOT COMPLETED|Overall Study||7||
59961910|NCT02674334|76080511|FG001|NOT COMPLETED|Overall Study||3||
59961911|NCT03026075|76080517|FG000|STARTED|Overall Study||47||
59961912|NCT03026075|76080517|FG000|COMPLETED|Overall Study||46||
59961913|NCT03026075|76080517|FG000|NOT COMPLETED|Overall Study||1||
59961914|NCT01373918|76080523|FG000|STARTED|Overall Study||20||
59961915|NCT01373918|76080524|FG001|STARTED|Overall Study||16||
59961916|NCT01373918|76080523|FG000|COMPLETED|Overall Study||20||
59961917|NCT01373918|76080524|FG001|COMPLETED|Overall Study||15||
59961918|NCT01373918|76080523|FG000|NOT COMPLETED|Overall Study||0||
59961919|NCT01373918|76080524|FG001|NOT COMPLETED|Overall Study||1||
59961920|NCT02667626|76080532|FG000|STARTED|Overall Study||86||
59961921|NCT02667626|76080533|FG001|STARTED|Overall Study||96||
59961922|NCT02667626|76080532|FG000|COMPLETED|Overall Study||86||
59961923|NCT02667626|76080533|FG001|COMPLETED|Overall Study||95||
59961924|NCT02667626|76080532|FG000|NOT COMPLETED|Overall Study||0||
59961925|NCT02667626|76080533|FG001|NOT COMPLETED|Overall Study||1||
59961926|NCT02522728|76080544|FG000|STARTED|Overall Study||28||
59961927|NCT02522728|76080545|FG001|STARTED|Overall Study||30||
59808284|NCT00406354|75930293|FG000|STARTED|All Randomized Patients||60||
59808285|NCT00406354|75930294|FG001|STARTED|All Randomized Patients||61||
59808286|NCT00406354|75930295|FG002|STARTED|All Randomized Patients||60||
59808287|NCT00406354|75930293|FG000|COMPLETED|All Randomized Patients||60||
59808288|NCT00406354|75930294|FG001|COMPLETED|All Randomized Patients||61||
59808289|NCT00406354|75930295|FG002|COMPLETED|All Randomized Patients|One patient was randomized but never received study treatment.|59||
59961928|NCT02522728|76080544|FG000|COMPLETED|Overall Study||16||
59961929|NCT02522728|76080545|FG001|COMPLETED|Overall Study||19||
59961930|NCT02522728|76080544|FG000|NOT COMPLETED|Overall Study||12||
59961931|NCT02522728|76080545|FG001|NOT COMPLETED|Overall Study||11||
59961932|NCT02781779|76080553|FG000|STARTED|Overall Study||78||
59961933|NCT02781779|76080554|FG001|STARTED|Overall Study||69||
59961934|NCT02781779|76080553|FG000|COMPLETED|Overall Study||78||
59961935|NCT02781779|76080554|FG001|COMPLETED|Overall Study||69||
59961936|NCT02781779|76080553|FG000|NOT COMPLETED|Overall Study||0||
59961937|NCT02781779|76080554|FG001|NOT COMPLETED|Overall Study||0||
59961938|NCT03025217|76080560|FG000|STARTED|Overall Study||31||
59808290|NCT00406354|75930293|FG000|NOT COMPLETED|All Randomized Patients||0||
59808291|NCT00406354|75930294|FG001|NOT COMPLETED|All Randomized Patients||0||
59808292|NCT00406354|75930295|FG002|NOT COMPLETED|All Randomized Patients||1||
59808293|NCT00406354|75930293|FG000|STARTED|All Randomized and Treated Patients||60||
59808294|NCT00406354|75930294|FG001|STARTED|All Randomized and Treated Patients||61||
59808295|NCT00406354|75930295|FG002|STARTED|All Randomized and Treated Patients||59||
59808296|NCT00406354|75930293|FG000|COMPLETED|All Randomized and Treated Patients||44||
59808297|NCT00406354|75930294|FG001|COMPLETED|All Randomized and Treated Patients||48||
59808298|NCT00406354|75930295|FG002|COMPLETED|All Randomized and Treated Patients||37||
59808299|NCT00406354|75930293|FG000|NOT COMPLETED|All Randomized and Treated Patients||16||
59961939|NCT03025217|76080560|FG000|COMPLETED|Overall Study||27||
59961940|NCT03025217|76080560|FG000|NOT COMPLETED|Overall Study||4||
59961941|NCT03023813|76080567|FG000|STARTED|Overall Study||39||
59961942|NCT03023813|76080568|FG001|STARTED|Overall Study||34||
59961943|NCT03023813|76080569|FG002|STARTED|Overall Study||31||
59961944|NCT03023813|76080567|FG000|COMPLETED|Overall Study||38||
59961945|NCT03023813|76080568|FG001|COMPLETED|Overall Study||32||
59961946|NCT03023813|76080569|FG002|COMPLETED|Overall Study||31||
59961947|NCT03023813|76080567|FG000|NOT COMPLETED|Overall Study||1||
59961948|NCT03023813|76080568|FG001|NOT COMPLETED|Overall Study||2||
59961949|NCT03023813|76080569|FG002|NOT COMPLETED|Overall Study||0||
59961950|NCT01365130|76080578|FG000|STARTED|Overall Study|15 patients were enrolled to the study but only 13 went on to begin treatment|15||
59808300|NCT00406354|75930294|FG001|NOT COMPLETED|All Randomized and Treated Patients||13||
59808301|NCT00406354|75930295|FG002|NOT COMPLETED|All Randomized and Treated Patients||22||
59808302|NCT00483405|75930303|FG000|STARTED|Overall Study||28||
59808303|NCT00483405|75930303|FG000|COMPLETED|Overall Study||0||
59808304|NCT00483405|75930303|FG000|NOT COMPLETED|Overall Study||28||
59808305|NCT02438410|75930307|FG000|STARTED|Overall Study||13||
59961951|NCT01365130|76080578|FG000|COMPLETED|Overall Study||13||
59961952|NCT01365130|76080578|FG000|NOT COMPLETED|Overall Study||2||
59961953|NCT01657162|76080584|FG000|STARTED|Overall Study||558|Participants who started Study BA058-05-005.|
59621159|NCT00241176|75732684|FG000|COMPLETED|Overall Study||11||
59621160|NCT00241176|75732684|FG000|NOT COMPLETED|Overall Study||0||
59621161|NCT00125658|75732691|FG000|STARTED|Overall Study||8||
59808306|NCT02438410|75930307|FG000|COMPLETED|Overall Study||13||
59808307|NCT02438410|75930307|FG000|NOT COMPLETED|Overall Study||0||
59961954|NCT01657162|76080585|FG001|STARTED|Overall Study||581|Participants who started Study BA058-05-005.|
59961955|NCT01657162|76080584|FG000|Study 003 ITT Population|Overall Study|Participants received 80 mcg abaloparatide SC during Study 003.|824|This Intent-To-Treat (ITT) population included participants who were randomized into Study 003.|
59994931|NCT03420781|76110741|FG003|STARTED|RW Period: 6 Weeks (Week 41 to Week 46)||59||
59808308|NCT00483327|75930311|FG000|STARTED|Overall Study||30||
59808309|NCT00483327|75930311|FG000|COMPLETED|Overall Study||20||
59808310|NCT00483327|75930311|FG000|NOT COMPLETED|Overall Study||10||
59808311|NCT00684203|75930323|FG000|STARTED|Overall Study||40||
59808312|NCT00684203|75930324|FG001|STARTED|Overall Study||31||
59808313|NCT00684203|75930325|FG002|STARTED|Overall Study||21||
59808314|NCT00684203|75930326|FG003|STARTED|Overall Study||6||
59808315|NCT00684203|75930327|FG004|STARTED|Overall Study||17||
59808316|NCT00684203|75930328|FG005|STARTED|Overall Study||2||
59808317|NCT00684203|75930323|FG000|COMPLETED|Overall Study||31||
59808318|NCT00684203|75930324|FG001|COMPLETED|Overall Study||23||
59808319|NCT00684203|75930325|FG002|COMPLETED|Overall Study||12||
59808320|NCT00684203|75930326|FG003|COMPLETED|Overall Study||6||
59808321|NCT00684203|75930327|FG004|COMPLETED|Overall Study||17||
59808322|NCT00684203|75930328|FG005|COMPLETED|Overall Study||2||
59808323|NCT00684203|75930323|FG000|NOT COMPLETED|Overall Study||9||
59808324|NCT00684203|75930324|FG001|NOT COMPLETED|Overall Study||8||
59808325|NCT00684203|75930325|FG002|NOT COMPLETED|Overall Study||9||
59808326|NCT00684203|75930326|FG003|NOT COMPLETED|Overall Study||0||
59808327|NCT00684203|75930327|FG004|NOT COMPLETED|Overall Study||0||
59808328|NCT00684203|75930328|FG005|NOT COMPLETED|Overall Study||0||
59808329|NCT00423592|75930349|FG000|STARTED|Overall Study|Enrolled|36||
59808330|NCT00423592|75930349|FG000|Completed Preliminary Analysis Cut-off|Overall Study|Preliminary analysis cut-off at Week 12 for primary/secondary endpoint analysis|34||
59808331|NCT00423592|75930349|FG000|COMPLETED|Overall Study|Completed study|29||
59808332|NCT00423592|75930349|FG000|NOT COMPLETED|Overall Study||7||
59808333|NCT00683657|75930355|FG000|STARTED|Overall Study||46||
59808334|NCT00683657|75930356|FG001|STARTED|Overall Study||47||
59808335|NCT00683657|75930355|FG000|Randomized Subjects Data Set|Overall Study|Randomized subjects who took at least 1 dose of double-blind study medication.|46||
59808336|NCT00683657|75930356|FG001|Randomized Subjects Data Set|Overall Study|Randomized subjects who took at least 1 dose of double-blind study medication.|47||
59808337|NCT00683657|75930355|FG000|COMPLETED|Overall Study||45||
59808338|NCT00683657|75930356|FG001|COMPLETED|Overall Study||46||
59808339|NCT00683657|75930355|FG000|NOT COMPLETED|Overall Study||1||
59808340|NCT00683657|75930356|FG001|NOT COMPLETED|Overall Study||1||
59808341|NCT00680771|75930364|FG000|STARTED|Overall Study||15||
59808342|NCT00680771|75930365|FG001|STARTED|Overall Study||13||
59808343|NCT00680771|75930364|FG000|COMPLETED|Overall Study||9||
59961956|NCT01657162|76080585|FG001|Study 003 ITT Population|Overall Study|Participants received abaloparatide-matching placebo during Study 003.|821|This Intent-To-Treat (ITT) population included participants who were randomized into Study 003.|
59961957|NCT01657162|76080584|FG000|Study 003 Modified ITT (mITT) Population|Overall Study|Participants received 80 mcg abaloparatide SC during Study 003.|690|Study003 ITT participants with Study 003 pretreatment & postbaseline evaluable radiologic assessment|
59994932|NCT03420781|76110742|FG004|STARTED|RW Period: 6 Weeks (Week 41 to Week 46)||43||
59994933|NCT03420781|76110738|FG000|COMPLETED|RW Period: 6 Weeks (Week 41 to Week 46)||0||
59524496|NCT02316470|75619698|FG000|NOT COMPLETED|Overall Study||5||
59808344|NCT00680771|75930365|FG001|COMPLETED|Overall Study||11||
59808345|NCT00680771|75930364|FG000|NOT COMPLETED|Overall Study||6||
59808346|NCT00680771|75930365|FG001|NOT COMPLETED|Overall Study||2||
59808347|NCT00482703|75930373|FG000|STARTED|Overall Study|number enrolled, randomized and treated|11||
59808348|NCT00482703|75930374|FG001|STARTED|Overall Study|number enrolled, randomized and treated|12||
59808349|NCT00482703|75930373|FG000|COMPLETED|Overall Study||10||
59808350|NCT00482703|75930374|FG001|COMPLETED|Overall Study||12||
59808351|NCT00482703|75930373|FG000|NOT COMPLETED|Overall Study||1||
59524497|NCT02316470|75619699|FG001|NOT COMPLETED|Overall Study||6||
59808352|NCT00482703|75930374|FG001|NOT COMPLETED|Overall Study||0||
59808353|NCT00482391|75930387|FG000|STARTED|Overall Study||95||
59808354|NCT00482391|75930387|FG000|COMPLETED|Overall Study||92||
59808355|NCT00482391|75930387|FG000|NOT COMPLETED|Overall Study||3||
59808356|NCT00423046|75930394|FG000|STARTED|Overall Study||553||
59808357|NCT00423046|75930395|FG001|STARTED|Overall Study||553||
59808358|NCT00423046|75930394|FG000|COMPLETED|Overall Study|Completed until Month 60|213||
59808359|NCT00423046|75930395|FG001|COMPLETED|Overall Study|Completed until Month 60|208||
59808360|NCT00423046|75930394|FG000|NOT COMPLETED|Overall Study||340||
59808361|NCT00423046|75930395|FG001|NOT COMPLETED|Overall Study||345||
59808362|NCT00496587|75930403|FG000|STARTED|Overall Study||34||
59808363|NCT00496587|75930403|FG000|COMPLETED|Overall Study||3||
59808364|NCT00496587|75930403|FG000|NOT COMPLETED|Overall Study||31||
59961958|NCT01657162|76080585|FG001|Study 003 Modified ITT (mITT) Population|Overall Study|Participants received abaloparatide-matching placebo during Study 003.|711|Study003 ITT participants with Study 003 pretreatment & postbaseline evaluable radiologic assessment|
59961959|NCT01657162|76080584|FG000|Completed Study 003|Overall Study|Participants received 80 mcg abaloparatide SC during Study 003.|606||
59961960|NCT01657162|76080585|FG001|Completed Study 003|Overall Study|Participants received abaloparatide-matching placebo during Study 003.|637||
59961961|NCT01657162|76080584|FG000|Study 005 ITT Population|Overall Study||558|All Study 003 ITT participants who enrolled in Study 005 .|
59961962|NCT01657162|76080585|FG001|Study 005 ITT Population|Overall Study||581|All Study 003 ITT participants who enrolled in Study 005 .|
59961963|NCT01657162|76080584|FG000|Study 005 Safety Population|Overall Study||553|All Study 005 ITT participants who received 1 or more doses of alendronate.|
59961964|NCT01657162|76080585|FG001|Study 005 Safety Population|Overall Study||580|All Study 005 ITT participants who received 1 or more doses of alendronate.|
59961965|NCT01657162|76080584|FG000|Study 005 mITT Population|Overall Study||544|Study 003 mITT participants with a Study 005 postbaseline evaluable radiologic test (spine X-ray)|
59808365|NCT00405652|75930407|FG000|STARTED|Overall Study||34||
59808366|NCT00405652|75930407|FG000|COMPLETED|Overall Study||30||
59808367|NCT00405652|75930407|FG000|NOT COMPLETED|Overall Study||4||
59961966|NCT01657162|76080585|FG001|Study 005 mITT Population|Overall Study||568|Study 003 mITT participants with a Study 005 postbaseline evaluable radiologic test (spine X-ray)|
59961967|NCT01657162|76080584|FG000|COMPLETED|Overall Study||499||
59961968|NCT01657162|76080585|FG001|COMPLETED|Overall Study||506||
59961969|NCT01657162|76080584|FG000|NOT COMPLETED|Overall Study||59||
59961970|NCT01657162|76080585|FG001|NOT COMPLETED|Overall Study||75||
59961971|NCT02933606|76080595|FG000|STARTED|Overall Study||49||
59961972|NCT02933606|76080596|FG001|STARTED|Overall Study||48||
59961973|NCT02933606|76080597|FG002|STARTED|Overall Study||47||
59961974|NCT02933606|76080598|FG003|STARTED|Overall Study||49||
59961975|NCT02933606|76080595|FG000|COMPLETED|Overall Study||33||
59961976|NCT02933606|76080596|FG001|COMPLETED|Overall Study||39||
59961977|NCT02933606|76080597|FG002|COMPLETED|Overall Study||33||
59961978|NCT02933606|76080598|FG003|COMPLETED|Overall Study||30||
59961979|NCT02933606|76080595|FG000|NOT COMPLETED|Overall Study||16||
59961980|NCT02933606|76080596|FG001|NOT COMPLETED|Overall Study||9||
59961981|NCT02933606|76080597|FG002|NOT COMPLETED|Overall Study||14||
59961982|NCT02933606|76080598|FG003|NOT COMPLETED|Overall Study||19||
59961983|NCT01373294|76080610|FG000|STARTED|Overall Study||15||
59961984|NCT01373294|76080611|FG001|STARTED|Overall Study||2||
59961985|NCT01373294|76080610|FG000|COMPLETED|Overall Study||14||
59961986|NCT01373294|76080611|FG001|COMPLETED|Overall Study||2||
59961987|NCT01373294|76080610|FG000|NOT COMPLETED|Overall Study||1||
59961988|NCT01373294|76080611|FG001|NOT COMPLETED|Overall Study||0||
59961989|NCT01656304|76080617|FG000|STARTED|Overall Study||16||
59808368|NCT00422734|75930413|FG000|STARTED|Overall Study||78||
59808369|NCT00422734|75930414|FG001|STARTED|Overall Study||264||
59808370|NCT00422734|75930413|FG000|COMPLETED|Overall Study||64||
59808371|NCT00422734|75930414|FG001|COMPLETED|Overall Study||243||
59808372|NCT00422734|75930413|FG000|NOT COMPLETED|Overall Study||14||
59808373|NCT00422734|75930414|FG001|NOT COMPLETED|Overall Study||21||
59808374|NCT00422422|75930420|FG000|STARTED|Overall Study||100||
59961990|NCT01656304|76080617|FG000|COMPLETED|Overall Study||15||
59808375|NCT00422422|75930420|FG000|COMPLETED|Overall Study||90||
59808376|NCT00422422|75930420|FG000|NOT COMPLETED|Overall Study||10||
59808377|NCT00413374|75930428|FG000|STARTED|Overall Study||40||40
59808378|NCT00413374|75930429|FG001|STARTED|Overall Study||80||80
59808379|NCT00413374|75930428|FG000|COMPLETED|Overall Study||34||34
59808380|NCT00413374|75930429|FG001|COMPLETED|Overall Study||80||80
59808381|NCT00413374|75930428|FG000|NOT COMPLETED|Overall Study||6||6
59808382|NCT00413374|75930429|FG001|NOT COMPLETED|Overall Study||0||0
59808383|NCT00682643|75930440|FG000|STARTED|Overall Study||182||
59808384|NCT00682643|75930441|FG001|STARTED|Overall Study||368||
59808385|NCT00682643|75930440|FG000|COMPLETED|Overall Study||104||
59961991|NCT01656304|76080617|FG000|NOT COMPLETED|Overall Study||1||
59961992|NCT03023423|76080624|FG000|STARTED|Overall Study||7||
59961993|NCT03023423|76080625|FG001|STARTED|Overall Study||46||
59961994|NCT03023423|76080626|FG002|STARTED|Overall Study||46||
59961995|NCT03023423|76080624|FG000|Treated|Overall Study||7||
59961996|NCT03023423|76080625|FG001|Treated|Overall Study||44||
59961997|NCT03023423|76080626|FG002|Treated|Overall Study||44||
59961998|NCT03023423|76080624|FG000|Crossover From Atezo to Dara + Atezo|Overall Study||0||
59961999|NCT03023423|76080625|FG001|Crossover From Atezo to Dara + Atezo|Overall Study|Participants who met crossover eligibility criteria entered to Dara + Atezo arm.|8||
60074148|NCT01363297|76189545|FG001|NOT COMPLETED|Overall Study||6||
60074149|NCT01363297|76189546|FG002|NOT COMPLETED|Overall Study||6||
60074150|NCT01363297|76189547|FG003|NOT COMPLETED|Overall Study||10||
60074151|NCT01363297|76189548|FG004|NOT COMPLETED|Overall Study||31||
60074152|NCT01908907|76189567|FG000|STARTED|Overall Study||31||
60074153|NCT01908907|76189568|FG001|STARTED|Overall Study||29||
59808386|NCT00682643|75930441|FG001|COMPLETED|Overall Study||199||
59808387|NCT00682643|75930440|FG000|NOT COMPLETED|Overall Study||78||
59808388|NCT00682643|75930441|FG001|NOT COMPLETED|Overall Study||169||
59962000|NCT03023423|76080626|FG002|Crossover From Atezo to Dara + Atezo|Overall Study||0||
59962001|NCT03023423|76080624|FG000|COMPLETED|Overall Study||0||
59962002|NCT03023423|76080625|FG001|COMPLETED|Overall Study||0||
59962003|NCT03023423|76080626|FG002|COMPLETED|Overall Study||0||
59962004|NCT03023423|76080624|FG000|NOT COMPLETED|Overall Study||7||
59962005|NCT03023423|76080625|FG001|NOT COMPLETED|Overall Study||46||
59962006|NCT03023423|76080626|FG002|NOT COMPLETED|Overall Study||46||
59962007|NCT03185741|76080641|FG000|STARTED|Baseline||246||
59962008|NCT03185741|76080642|FG001|STARTED|Baseline||272||
59962009|NCT03185741|76080643|FG002|STARTED|Baseline||249||
59808389|NCT00421408|75930450|FG000|STARTED|Overall Study||102||
59808390|NCT00421408|75930451|FG001|STARTED|Overall Study||106||
59808391|NCT00421408|75930450|FG000|COMPLETED|Overall Study||60||
59808392|NCT00421408|75930451|FG001|COMPLETED|Overall Study||61||
59808393|NCT00421408|75930450|FG000|NOT COMPLETED|Overall Study||42||
59808394|NCT00421408|75930451|FG001|NOT COMPLETED|Overall Study||45||
59962010|NCT03185741|76080641|FG000|COMPLETED|Baseline||244||
59962011|NCT03185741|76080642|FG001|COMPLETED|Baseline||267||
59962012|NCT03185741|76080643|FG002|COMPLETED|Baseline||244||
59808395|NCT00679913|75930459|FG000|STARTED|Overall Study||101||
59808396|NCT00679913|75930460|FG001|STARTED|Overall Study||99||
59808397|NCT00679913|75930459|FG000|COMPLETED|Overall Study||83||
59808398|NCT00679913|75930460|FG001|COMPLETED|Overall Study||86||
59808399|NCT00679913|75930459|FG000|NOT COMPLETED|Overall Study||18||
59808400|NCT00679913|75930460|FG001|NOT COMPLETED|Overall Study||13||
59962013|NCT03185741|76080641|FG000|NOT COMPLETED|Baseline||2||
59962014|NCT03185741|76080642|FG001|NOT COMPLETED|Baseline||5||
59962015|NCT03185741|76080643|FG002|NOT COMPLETED|Baseline||5||
59962016|NCT03185741|76080641|FG000|STARTED|3Month||244||
59962017|NCT03185741|76080642|FG001|STARTED|3Month||267||
59962018|NCT03185741|76080643|FG002|STARTED|3Month||244||
59962019|NCT03185741|76080641|FG000|COMPLETED|3Month||224||
59962020|NCT03185741|76080642|FG001|COMPLETED|3Month||242||
59962021|NCT03185741|76080643|FG002|COMPLETED|3Month||219||
59962022|NCT03185741|76080641|FG000|NOT COMPLETED|3Month||20||
59962023|NCT03185741|76080642|FG001|NOT COMPLETED|3Month||25||
59962024|NCT03185741|76080643|FG002|NOT COMPLETED|3Month||25||
59962025|NCT03185741|76080641|FG000|STARTED|6Month|Participants who started the 6Month period included those who completed the 3Month period and those who were unavailable for the 3Month period|235||
59962026|NCT03185741|76080642|FG001|STARTED|6Month|Participants who started the 6Month period included those who completed the 3Month period and those who were unavailable for the 3Month period|252||
59962027|NCT03185741|76080643|FG002|STARTED|6Month|Participants who started the 6Month period included those who completed the 3Month period and those who were unavailable for the 3Month period|230||
59962028|NCT03185741|76080641|FG000|COMPLETED|6Month||216||
59962029|NCT03185741|76080642|FG001|COMPLETED|6Month||233||
59962030|NCT03185741|76080643|FG002|COMPLETED|6Month||211||
59962031|NCT03185741|76080641|FG000|NOT COMPLETED|6Month||19||
59962032|NCT03185741|76080642|FG001|NOT COMPLETED|6Month||19||
59962033|NCT03185741|76080643|FG002|NOT COMPLETED|6Month||19||
59962034|NCT02672852|76080653|FG000|STARTED|Part A1||100||
59962035|NCT02672852|76080654|FG001|STARTED|Part A1||407||
59962036|NCT02672852|76080655|FG002|STARTED|Part A1||0||
59962037|NCT02672852|76080656|FG003|STARTED|Part A1||0||
59808401|NCT00482001|75930469|FG000|STARTED|Overall Study||11||
59808402|NCT00482001|75930470|FG001|STARTED|Overall Study||11||
59808403|NCT00482001|75930469|FG000|COMPLETED|Overall Study||10||
59808404|NCT00482001|75930470|FG001|COMPLETED|Overall Study||10||
59808405|NCT00482001|75930469|FG000|NOT COMPLETED|Overall Study||1||
59808406|NCT00482001|75930470|FG001|NOT COMPLETED|Overall Study||1||
59808407|NCT00490035|75930482|FG000|STARTED|Overall Study||100||
59808408|NCT00490035|75930483|FG001|STARTED|Overall Study||99||
59808409|NCT00490035|75930484|FG002|STARTED|Overall Study||100||
59962038|NCT02672852|76080657|FG004|STARTED|Part A1||0||
59962039|NCT02672852|76080658|FG005|STARTED|Part A1||0||
59962040|NCT02672852|76080659|FG006|STARTED|Part A1||0||
59962041|NCT02672852|76080653|FG000|COMPLETED|Part A1||97||
59962042|NCT02672852|76080654|FG001|COMPLETED|Part A1||403||
59962043|NCT02672852|76080655|FG002|COMPLETED|Part A1||0||
59962044|NCT02672852|76080656|FG003|COMPLETED|Part A1||0||
59962045|NCT02672852|76080657|FG004|COMPLETED|Part A1||0||
59962046|NCT02672852|76080658|FG005|COMPLETED|Part A1||0||
59962047|NCT02672852|76080659|FG006|COMPLETED|Part A1||0||
59962048|NCT02672852|76080653|FG000|NOT COMPLETED|Part A1||3||
59962049|NCT02672852|76080654|FG001|NOT COMPLETED|Part A1||4||
59962050|NCT02672852|76080655|FG002|NOT COMPLETED|Part A1||0||
59962051|NCT02672852|76080656|FG003|NOT COMPLETED|Part A1||0||
59808410|NCT00490035|75930485|FG003|STARTED|Overall Study||100||
59808411|NCT00490035|75930482|FG000|COMPLETED|Overall Study||92||
59962052|NCT02672852|76080657|FG004|NOT COMPLETED|Part A1||0||
59962053|NCT02672852|76080658|FG005|NOT COMPLETED|Part A1||0||
59962054|NCT02672852|76080659|FG006|NOT COMPLETED|Part A1||0||
59962055|NCT02672852|76080653|FG000|STARTED|Part A2|Participants that completed Part A1 continued on to Part A2.|0||
59962056|NCT02672852|76080654|FG001|STARTED|Part A2|Participants that completed Part A1 continued on to Part A2.|0||
59962057|NCT02672852|76080655|FG002|STARTED|Part A2|Participants that completed Part A1 continued on to Part A2.|93||
59962058|NCT02672852|76080656|FG003|STARTED|Part A2|Participants that completed Part A1 continued on to Part A2.|403||
59808412|NCT00490035|75930483|FG001|COMPLETED|Overall Study||93||
59808413|NCT00490035|75930484|FG002|COMPLETED|Overall Study||88||
59962059|NCT02672852|76080657|FG004|STARTED|Part A2||0||
59962060|NCT02672852|76080658|FG005|STARTED|Part A2||0||
59962061|NCT02672852|76080659|FG006|STARTED|Part A2||0||
59962062|NCT02672852|76080653|FG000|COMPLETED|Part A2||0||
59962063|NCT02672852|76080654|FG001|COMPLETED|Part A2||0||
59962064|NCT02672852|76080655|FG002|COMPLETED|Part A2||83||
59962065|NCT02672852|76080656|FG003|COMPLETED|Part A2||399||
59962066|NCT02672852|76080657|FG004|COMPLETED|Part A2||0||
59962067|NCT02672852|76080658|FG005|COMPLETED|Part A2||0||
59962068|NCT02672852|76080659|FG006|COMPLETED|Part A2||0||
59962069|NCT02672852|76080653|FG000|NOT COMPLETED|Part A2||0||
59962070|NCT02672852|76080654|FG001|NOT COMPLETED|Part A2||0||
59962071|NCT02672852|76080655|FG002|NOT COMPLETED|Part A2||10||
59962072|NCT02672852|76080656|FG003|NOT COMPLETED|Part A2||4||
59962073|NCT02672852|76080657|FG004|NOT COMPLETED|Part A2||0||
59962074|NCT02672852|76080658|FG005|NOT COMPLETED|Part A2||0||
59962075|NCT02672852|76080659|FG006|NOT COMPLETED|Part A2||0||
59962076|NCT02672852|76080653|FG000|STARTED|Part B||0||
59962077|NCT02672852|76080654|FG001|STARTED|Part B||0||
59962078|NCT02672852|76080655|FG002|STARTED|Part B|Participants that completed Part A2 continued on to Part B.|0||
59962079|NCT02672852|76080656|FG003|STARTED|Part B|Participants that completed Part A2 continued on to Part B.|0||
59962080|NCT02672852|76080657|FG004|STARTED|Part B|Participants that completed Part A2 continued on to Part B.|225||
59962081|NCT02672852|76080658|FG005|STARTED|Part B|Participants that completed Part A2 continued on to Part B.|111||
59962082|NCT02672852|76080659|FG006|STARTED|Part B|Participants that completed Part A2 continued on to Part B.|63||
59962083|NCT02672852|76080653|FG000|COMPLETED|Part B||0||
59962084|NCT02672852|76080654|FG001|COMPLETED|Part B||0||
59962085|NCT02672852|76080655|FG002|COMPLETED|Part B||0||
59962086|NCT02672852|76080656|FG003|COMPLETED|Part B||0||
59962087|NCT02672852|76080657|FG004|COMPLETED|Part B||209||
59962088|NCT02672852|76080658|FG005|COMPLETED|Part B||100||
59962089|NCT02672852|76080659|FG006|COMPLETED|Part B||51||
59962090|NCT02672852|76080653|FG000|NOT COMPLETED|Part B||0||
59962091|NCT02672852|76080654|FG001|NOT COMPLETED|Part B||0||
59808414|NCT00490035|75930485|FG003|COMPLETED|Overall Study||94||
59808415|NCT00490035|75930482|FG000|NOT COMPLETED|Overall Study||8||
59808416|NCT00490035|75930483|FG001|NOT COMPLETED|Overall Study||6||
59962092|NCT02672852|76080655|FG002|NOT COMPLETED|Part B||0||
59962093|NCT02672852|76080656|FG003|NOT COMPLETED|Part B||0||
59962094|NCT02672852|76080657|FG004|NOT COMPLETED|Part B||16||
59962095|NCT02672852|76080658|FG005|NOT COMPLETED|Part B||11||
59962096|NCT02672852|76080659|FG006|NOT COMPLETED|Part B||12||
59962097|NCT02671760|76080670|FG000|STARTED|Overall Study||13||
59962098|NCT02671760|76080671|FG001|STARTED|Overall Study||13||
59808417|NCT00490035|75930484|FG002|NOT COMPLETED|Overall Study||12||
59808418|NCT00490035|75930485|FG003|NOT COMPLETED|Overall Study||6||
59808419|NCT00404248|75930498|FG000|STARTED|Overall Study||3||
59808420|NCT00404248|75930499|FG001|STARTED|Overall Study||4||
59808421|NCT00404248|75930500|FG002|STARTED|Overall Study||5||
59808422|NCT00404248|75930501|FG003|STARTED|Overall Study||2||
60074154|NCT01908907|76189567|FG000|COMPLETED|Overall Study||29||
59808423|NCT00404248|75930502|FG004|STARTED|Overall Study||3||
59808424|NCT00404248|75930503|FG005|STARTED|Overall Study||3||
59808425|NCT00404248|75930504|FG006|STARTED|Overall Study||6||
59808426|NCT00404248|75930505|FG007|STARTED|Overall Study||6||
59808427|NCT00404248|75930506|FG008|STARTED|Overall Study||3||
59808428|NCT00404248|75930498|FG000|COMPLETED|Overall Study||3||
59808429|NCT00404248|75930499|FG001|COMPLETED|Overall Study||3||
59808430|NCT00404248|75930500|FG002|COMPLETED|Overall Study||5||
59808431|NCT00404248|75930501|FG003|COMPLETED|Overall Study||2||
59808432|NCT00404248|75930502|FG004|COMPLETED|Overall Study||3||
59808433|NCT00404248|75930503|FG005|COMPLETED|Overall Study||3||
59962099|NCT02671760|76080672|FG002|STARTED|Overall Study||13||
59962100|NCT02671760|76080670|FG000|COMPLETED|Overall Study||13||
59962101|NCT02671760|76080671|FG001|COMPLETED|Overall Study|1 Subject could not be contacted for f/u phone call. Data included in safety and efficacy analyses.|12||
59962102|NCT02671760|76080672|FG002|COMPLETED|Overall Study||13||
59962103|NCT02671760|76080670|FG000|NOT COMPLETED|Overall Study||0||
59962104|NCT02671760|76080671|FG001|NOT COMPLETED|Overall Study||1||
59962105|NCT02671760|76080672|FG002|NOT COMPLETED|Overall Study||0||
59962106|NCT02667236|76080682|FG000|STARTED|Overall Study||223||
59962107|NCT02667236|76080683|FG001|STARTED|Overall Study||227||
59962108|NCT02667236|76080682|FG000|COMPLETED|Overall Study||220||
59962109|NCT02667236|76080683|FG001|COMPLETED|Overall Study||226||
59962110|NCT02667236|76080682|FG000|NOT COMPLETED|Overall Study||3||
59962111|NCT02667236|76080683|FG001|NOT COMPLETED|Overall Study||1||
59962112|NCT01126749|76080693|FG000|STARTED|Phase 1b||3||
59962113|NCT01126749|76080694|FG001|STARTED|Phase 1b||6||
59962114|NCT01126749|76080695|FG002|STARTED|Phase 1b||0||
59962115|NCT01126749|76080696|FG003|STARTED|Phase 1b||0||
59962116|NCT01126749|76080693|FG000|COMPLETED|Phase 1b||0||
59808434|NCT00404248|75930504|FG006|COMPLETED|Overall Study||6||
59808435|NCT00404248|75930505|FG007|COMPLETED|Overall Study||6||
59962117|NCT01126749|76080694|FG001|COMPLETED|Phase 1b||0||
59962118|NCT01126749|76080695|FG002|COMPLETED|Phase 1b||0||
59808436|NCT00404248|75930506|FG008|COMPLETED|Overall Study||3||
59808437|NCT00404248|75930498|FG000|NOT COMPLETED|Overall Study||0||
59808438|NCT00404248|75930499|FG001|NOT COMPLETED|Overall Study||1||
59808439|NCT00404248|75930500|FG002|NOT COMPLETED|Overall Study||0||
59808440|NCT00404248|75930501|FG003|NOT COMPLETED|Overall Study||0||
59808441|NCT00404248|75930502|FG004|NOT COMPLETED|Overall Study||0||
59808442|NCT00404248|75930503|FG005|NOT COMPLETED|Overall Study||0||
59962119|NCT01126749|76080696|FG003|COMPLETED|Phase 1b||0||
59962120|NCT01126749|76080693|FG000|NOT COMPLETED|Phase 1b||3||
59962121|NCT01126749|76080694|FG001|NOT COMPLETED|Phase 1b||6||
59962122|NCT01126749|76080695|FG002|NOT COMPLETED|Phase 1b||0||
59962123|NCT01126749|76080696|FG003|NOT COMPLETED|Phase 1b||0||
59962124|NCT01126749|76080693|FG000|STARTED|Phase 2||0||
59962125|NCT01126749|76080694|FG001|STARTED|Phase 2||0||
59962126|NCT01126749|76080695|FG002|STARTED|Phase 2||42||
59962127|NCT01126749|76080696|FG003|STARTED|Phase 2||41||
59962128|NCT01126749|76080693|FG000|Safety Analysis Set (SAS)/Treated|Phase 2||0||
59962129|NCT01126749|76080694|FG001|Safety Analysis Set (SAS)/Treated|Phase 2||0||
59962130|NCT01126749|76080695|FG002|Safety Analysis Set (SAS)/Treated|Phase 2||41||
59962131|NCT01126749|76080696|FG003|Safety Analysis Set (SAS)/Treated|Phase 2||39||
59962132|NCT01126749|76080693|FG000|Modified-intent-to-treat (MITT)|Phase 2||0||
59962133|NCT01126749|76080694|FG001|Modified-intent-to-treat (MITT)|Phase 2||0||
59962134|NCT01126749|76080695|FG002|Modified-intent-to-treat (MITT)|Phase 2||40||
59962135|NCT01126749|76080696|FG003|Modified-intent-to-treat (MITT)|Phase 2||39||
59962136|NCT01126749|76080693|FG000|COMPLETED|Phase 2||0||
59808443|NCT00404248|75930504|FG006|NOT COMPLETED|Overall Study||0||
59808444|NCT00404248|75930505|FG007|NOT COMPLETED|Overall Study||0||
59808445|NCT00404248|75930506|FG008|NOT COMPLETED|Overall Study||0||
59808446|NCT00421174|75930534|FG000|STARTED|Overall Study||18||
59808447|NCT00421174|75930535|FG001|STARTED|Overall Study||19||
59808448|NCT00421174|75930534|FG000|COMPLETED|Overall Study||16||
59808449|NCT00421174|75930535|FG001|COMPLETED|Overall Study||18||
59808450|NCT00421174|75930534|FG000|NOT COMPLETED|Overall Study||2||
59524498|NCT02316470|75619700|FG002|NOT COMPLETED|Overall Study||5||
59524499|NCT02316470|75619701|FG003|NOT COMPLETED|Overall Study||2||
59524500|NCT02087306|75619714|FG000|STARTED|Overall Study||65||
59524501|NCT02087306|75619715|FG001|STARTED|Overall Study||93||
59808451|NCT00421174|75930535|FG001|NOT COMPLETED|Overall Study||1||
59808452|NCT00496197|75930541|FG000|STARTED|Overall Study||282||
59808453|NCT00496197|75930541|FG000|COMPLETED|Overall Study||160||
59808454|NCT00496197|75930541|FG000|NOT COMPLETED|Overall Study||122||
59808455|NCT00495495|75930545|FG000|STARTED|Overall Study||394||
59962137|NCT01126749|76080694|FG001|COMPLETED|Phase 2||0||
59962138|NCT01126749|76080695|FG002|COMPLETED|Phase 2||0||
59962139|NCT01126749|76080696|FG003|COMPLETED|Phase 2||0||
59962140|NCT01126749|76080693|FG000|NOT COMPLETED|Phase 2||0||
59962141|NCT01126749|76080694|FG001|NOT COMPLETED|Phase 2||0||
59962142|NCT01126749|76080695|FG002|NOT COMPLETED|Phase 2||42||
59962143|NCT01126749|76080696|FG003|NOT COMPLETED|Phase 2||41||
59962144|NCT02521948|76080706|FG000|STARTED|Overall Study||50||
59962145|NCT02521948|76080706|FG000|COMPLETED|Overall Study||37||
59962146|NCT02521948|76080706|FG000|NOT COMPLETED|Overall Study||13||
59962147|NCT04446429|76080715|FG000|STARTED|Overall Study||134||
59962148|NCT04446429|76080716|FG001|STARTED|Overall Study||134||
59962149|NCT04446429|76080715|FG000|COMPLETED|Overall Study|In placebo group, 6 patients were lost to follow-up but were included in intention-to-treat analysis.|128||
59808456|NCT00495495|75930545|FG000|COMPLETED|Overall Study||295||
59808457|NCT00495495|75930545|FG000|NOT COMPLETED|Overall Study||99||
59808458|NCT00404092|75930554|FG000|STARTED|Overall Study||9||
59808459|NCT00404092|75930555|FG001|STARTED|Overall Study||8||
59808460|NCT00404092|75930556|FG002|STARTED|Overall Study||9||
59808461|NCT00404092|75930557|FG003|STARTED|Overall Study||20||
59808462|NCT00404092|75930554|FG000|COMPLETED|Overall Study||8||
59962150|NCT04446429|76080716|FG001|COMPLETED|Overall Study||134||
59524502|NCT02087306|75619716|FG002|STARTED|Overall Study||43||
59524503|NCT02087306|75619714|FG000|COMPLETED|Overall Study||29||
59808463|NCT00404092|75930555|FG001|COMPLETED|Overall Study||8||
59808464|NCT00404092|75930556|FG002|COMPLETED|Overall Study||8||
59808465|NCT00404092|75930557|FG003|COMPLETED|Overall Study||20||
59808466|NCT00404092|75930554|FG000|NOT COMPLETED|Overall Study||1||
59808467|NCT00404092|75930555|FG001|NOT COMPLETED|Overall Study||0||
59808468|NCT00404092|75930556|FG002|NOT COMPLETED|Overall Study||1||
59962151|NCT04446429|76080715|FG000|NOT COMPLETED|Overall Study||6||
59962152|NCT04446429|76080716|FG001|NOT COMPLETED|Overall Study||0||
59962153|NCT02832687|76080724|FG000|STARTED|Overall Study||41||
59962154|NCT02832687|76080725|FG001|STARTED|Overall Study||47||
59962155|NCT02832687|76080724|FG000|Participants Who Were Included in the Analysis|Overall Study||31||
59962156|NCT02832687|76080725|FG001|Participants Who Were Included in the Analysis|Overall Study||34||
59962157|NCT02832687|76080724|FG000|COMPLETED|Overall Study||41||
59962158|NCT02832687|76080725|FG001|COMPLETED|Overall Study||45||
59962159|NCT02832687|76080724|FG000|NOT COMPLETED|Overall Study||0||
59962160|NCT02832687|76080725|FG001|NOT COMPLETED|Overall Study||2||
59962161|NCT04372017|76080735|FG000|STARTED|Overall Study||1||
59962162|NCT04372017|76080736|FG001|STARTED|Overall Study||0||
59962163|NCT04372017|76080737|FG002|STARTED|Overall Study||0||
59962164|NCT04372017|76080738|FG003|STARTED|Overall Study||0||
59962165|NCT04372017|76080735|FG000|COMPLETED|Overall Study||1||
59962166|NCT04372017|76080736|FG001|COMPLETED|Overall Study||0||
59962167|NCT04372017|76080737|FG002|COMPLETED|Overall Study||0||
59962168|NCT04372017|76080738|FG003|COMPLETED|Overall Study||0||
59962169|NCT04372017|76080735|FG000|NOT COMPLETED|Overall Study||0||
59962170|NCT04372017|76080736|FG001|NOT COMPLETED|Overall Study||0||
59962171|NCT04372017|76080737|FG002|NOT COMPLETED|Overall Study||0||
59962172|NCT04372017|76080738|FG003|NOT COMPLETED|Overall Study||0||
59962173|NCT01656850|76080750|FG000|STARTED|First Intervention (3 Months)||20||
59962174|NCT01656850|76080751|FG001|STARTED|First Intervention (3 Months)||20||
59962175|NCT01656850|76080750|FG000|COMPLETED|First Intervention (3 Months)||17||
59962176|NCT01656850|76080751|FG001|COMPLETED|First Intervention (3 Months)||16||
59962177|NCT01656850|76080750|FG000|NOT COMPLETED|First Intervention (3 Months)||3||
59962178|NCT01656850|76080751|FG001|NOT COMPLETED|First Intervention (3 Months)||4||
59962179|NCT01656850|76080750|FG000|STARTED|Washout (2 Weeks)||17||
59962180|NCT01656850|76080751|FG001|STARTED|Washout (2 Weeks)||16||
59962181|NCT01656850|76080750|FG000|COMPLETED|Washout (2 Weeks)||17||
59962182|NCT01656850|76080751|FG001|COMPLETED|Washout (2 Weeks)||16||
59962183|NCT01656850|76080750|FG000|NOT COMPLETED|Washout (2 Weeks)||0||
59808469|NCT00404092|75930557|FG003|NOT COMPLETED|Overall Study||0||
59808470|NCT00481767|75930569|FG000|STARTED|Overall Study||450||
59808471|NCT00481767|75930570|FG001|STARTED|Overall Study||226||
59808472|NCT00481767|75930569|FG000|COMPLETED|Overall Study||418||
59808473|NCT00481767|75930570|FG001|COMPLETED|Overall Study||205||
59808474|NCT00481767|75930569|FG000|NOT COMPLETED|Overall Study||32||
59808475|NCT00481767|75930570|FG001|NOT COMPLETED|Overall Study||21||
59808476|NCT00489489|75930579|FG000|STARTED|Overall Study|randomized|41||
59808477|NCT00489489|75930580|FG001|STARTED|Overall Study|randomized|37||
59808478|NCT00489489|75930581|FG002|STARTED|Overall Study|randomized|40||
59808479|NCT00489489|75930579|FG000|Treated|Overall Study||41||
59808480|NCT00489489|75930580|FG001|Treated|Overall Study||36||
59808481|NCT00489489|75930581|FG002|Treated|Overall Study|One participant received teriflunomide 7 mg instead of teriflunomide 14 mg|39||
59808482|NCT00489489|75930579|FG000|COMPLETED|Overall Study|completed treatment period|38||
59808483|NCT00489489|75930580|FG001|COMPLETED|Overall Study|completed treatment period|32||
59962184|NCT01656850|76080751|FG001|NOT COMPLETED|Washout (2 Weeks)||0||
59962185|NCT01656850|76080750|FG000|STARTED|Second Intervention (3 Months)||17||
59962186|NCT01656850|76080751|FG001|STARTED|Second Intervention (3 Months)||16||
59962187|NCT01656850|76080750|FG000|COMPLETED|Second Intervention (3 Months)||17||
59962188|NCT01656850|76080751|FG001|COMPLETED|Second Intervention (3 Months)||16||
59962189|NCT01656850|76080750|FG000|NOT COMPLETED|Second Intervention (3 Months)||0||
59962190|NCT01656850|76080751|FG001|NOT COMPLETED|Second Intervention (3 Months)||0||
59962191|NCT03116685|76080763|FG000|STARTED|Overall Study||13||
59808484|NCT00489489|75930581|FG002|COMPLETED|Overall Study|completed treatment period|37||
59808485|NCT00489489|75930579|FG000|NOT COMPLETED|Overall Study||3||
59808486|NCT00489489|75930580|FG001|NOT COMPLETED|Overall Study||5||
59808487|NCT00489489|75930581|FG002|NOT COMPLETED|Overall Study||3||
59808488|NCT00489411|75930593|FG000|STARTED|Initial Treatment Period (Weeks 1-5)||115||
59808489|NCT00489411|75930594|FG001|STARTED|Initial Treatment Period (Weeks 1-5)||116||
59808490|NCT00489411|75930593|FG000|COMPLETED|Initial Treatment Period (Weeks 1-5)||87||
59808491|NCT00489411|75930594|FG001|COMPLETED|Initial Treatment Period (Weeks 1-5)||94||
59808492|NCT00489411|75930593|FG000|NOT COMPLETED|Initial Treatment Period (Weeks 1-5)||28||
59808493|NCT00489411|75930594|FG001|NOT COMPLETED|Initial Treatment Period (Weeks 1-5)||22||
59808494|NCT00489411|75930593|FG000|STARTED|Washout Period (Weeks 6-7)||87||
59808495|NCT00489411|75930594|FG001|STARTED|Washout Period (Weeks 6-7)||94||
59808496|NCT00489411|75930593|FG000|COMPLETED|Washout Period (Weeks 6-7)||85|Reasons for why patients did not participate in the crossover treatment period were not captured.|
59808497|NCT00489411|75930594|FG001|COMPLETED|Washout Period (Weeks 6-7)||93|Reasons for why patients did not participate in the crossover treatment period were not captured.|
59808498|NCT00489411|75930593|FG000|NOT COMPLETED|Washout Period (Weeks 6-7)||2||
59808499|NCT00489411|75930594|FG001|NOT COMPLETED|Washout Period (Weeks 6-7)||1||
59808500|NCT00489411|75930593|FG000|STARTED|Crossover Treatment Period (Weeks 8-12)||85||
59808501|NCT00489411|75930594|FG001|STARTED|Crossover Treatment Period (Weeks 8-12)||93||
59808502|NCT00489411|75930593|FG000|COMPLETED|Crossover Treatment Period (Weeks 8-12)||67||
59808503|NCT00489411|75930594|FG001|COMPLETED|Crossover Treatment Period (Weeks 8-12)||74||
59808504|NCT00489411|75930593|FG000|NOT COMPLETED|Crossover Treatment Period (Weeks 8-12)||18||
59962192|NCT03116685|76080764|FG001|STARTED|Overall Study||12||
59962193|NCT03116685|76080763|FG000|COMPLETED|Overall Study||13||
59962194|NCT03116685|76080764|FG001|COMPLETED|Overall Study||11||
59962195|NCT03116685|76080763|FG000|NOT COMPLETED|Overall Study||0||
59962196|NCT03116685|76080764|FG001|NOT COMPLETED|Overall Study||1||
59962197|NCT03034863|76080772|FG000|STARTED|Overall Study||38||
59962198|NCT03034863|76080773|FG001|STARTED|Overall Study||40||
59962199|NCT03034863|76080772|FG000|Veterans|Overall Study||19||
59962200|NCT03034863|76080773|FG001|Veterans|Overall Study||20||
59962201|NCT03034863|76080772|FG000|Supporting Partners|Overall Study||19||
59962202|NCT03034863|76080773|FG001|Supporting Partners|Overall Study||20||
59962203|NCT03034863|76080772|FG000|COMPLETED|Overall Study||28||
59962204|NCT03034863|76080773|FG001|COMPLETED|Overall Study||28||
59962205|NCT03034863|76080772|FG000|NOT COMPLETED|Overall Study||10||
59962206|NCT03034863|76080773|FG001|NOT COMPLETED|Overall Study||12||
59962207|NCT02666222|76080784|FG000|STARTED|Overall Study||51||
59962208|NCT02666222|76080784|FG000|COMPLETED|Overall Study||49||
59962209|NCT02666222|76080784|FG000|NOT COMPLETED|Overall Study||2||
59962210|NCT00739401|76080788|FG000|STARTED|Overall Study||44||
59962211|NCT00739401|76080788|FG000|COMPLETED|Overall Study||3||
59962212|NCT00739401|76080788|FG000|NOT COMPLETED|Overall Study||41||
59962213|NCT01365052|76080794|FG000|STARTED|Overall Study||217||
59962214|NCT01365052|76080795|FG001|STARTED|Overall Study||109||
59962215|NCT01365052|76080794|FG000|COMPLETED|Overall Study||213||
59962216|NCT01365052|76080795|FG001|COMPLETED|Overall Study||105||
59962217|NCT01365052|76080794|FG000|NOT COMPLETED|Overall Study||4||
59962218|NCT01365052|76080795|FG001|NOT COMPLETED|Overall Study||4||
59962219|NCT01372748|76080803|FG000|STARTED|Overall Study||11045||
59962220|NCT01372748|76080804|FG001|STARTED|Overall Study||12642||
59962221|NCT01372748|76080803|FG000|COMPLETED|Overall Study|defined as having vital status|11022||
59962222|NCT01372748|76080804|FG001|COMPLETED|Overall Study|defined as having vital status|12603||
59962223|NCT01372748|76080803|FG000|NOT COMPLETED|Overall Study||23||
59962224|NCT01372748|76080804|FG001|NOT COMPLETED|Overall Study||39||
59962225|NCT02736825|76080812|FG000|STARTED|Overall Study||127||
59962226|NCT02736825|76080813|FG001|STARTED|Overall Study||135||
59962227|NCT02736825|76080812|FG000|COMPLETED|Overall Study||117||
59808505|NCT00489411|75930594|FG001|NOT COMPLETED|Crossover Treatment Period (Weeks 8-12)||19||
59808506|NCT00420784|75930604|FG000|STARTED|Overall Study||115||
59808507|NCT00420784|75930605|FG001|STARTED|Overall Study||113||
59808508|NCT00420784|75930606|FG002|STARTED|Overall Study||111||
59808509|NCT00420784|75930607|FG003|STARTED|Overall Study||114||
59808510|NCT00420784|75930604|FG000|COMPLETED|Overall Study||86||
59808511|NCT00420784|75930605|FG001|COMPLETED|Overall Study||55||
59808512|NCT00420784|75930606|FG002|COMPLETED|Overall Study||58||
59808513|NCT00420784|75930607|FG003|COMPLETED|Overall Study||36||
59808514|NCT00420784|75930604|FG000|NOT COMPLETED|Overall Study||29||
59962228|NCT02736825|76080813|FG001|COMPLETED|Overall Study||123||
59962229|NCT02736825|76080812|FG000|NOT COMPLETED|Overall Study||10||
59962230|NCT02736825|76080813|FG001|NOT COMPLETED|Overall Study||12||
59962231|NCT02670122|76080820|FG000|STARTED|Overall Study||131||
59962232|NCT02670122|76080820|FG000|COMPLETED|Overall Study|18 patients recieved liver transplantation|127||
59962233|NCT02670122|76080820|FG000|NOT COMPLETED|Overall Study||4||
59808515|NCT00420784|75930605|FG001|NOT COMPLETED|Overall Study||58||
59808516|NCT00420784|75930606|FG002|NOT COMPLETED|Overall Study||53||
59808517|NCT00420784|75930607|FG003|NOT COMPLETED|Overall Study||78||
59808518|NCT00420628|75930620|FG000|STARTED|Overall Study||72||
59962234|NCT03283371|76080833|FG000|STARTED|Placebo-controlled||34||
59962235|NCT03283371|76080834|FG001|STARTED|Placebo-controlled||33||
59962236|NCT03283371|76080835|FG002|STARTED|Placebo-controlled||0||
59962237|NCT03283371|76080836|FG003|STARTED|Placebo-controlled||0||
59962238|NCT03283371|76080833|FG000|Number of Participants Dosed|Placebo-controlled||34||
59962239|NCT03283371|76080834|FG001|Number of Participants Dosed|Placebo-controlled||32||
59962240|NCT03283371|76080835|FG002|Number of Participants Dosed|Placebo-controlled||0||
59962241|NCT03283371|76080836|FG003|Number of Participants Dosed|Placebo-controlled||0||
59962242|NCT03283371|76080833|FG000|COMPLETED|Placebo-controlled||31||
59962243|NCT03283371|76080834|FG001|COMPLETED|Placebo-controlled||30||
59524504|NCT02087306|75619715|FG001|COMPLETED|Overall Study||29||
59524505|NCT02087306|75619716|FG002|COMPLETED|Overall Study||16||
59524506|NCT02087306|75619714|FG000|NOT COMPLETED|Overall Study||36||
59524507|NCT02087306|75619715|FG001|NOT COMPLETED|Overall Study||64||
59524508|NCT02087306|75619716|FG002|NOT COMPLETED|Overall Study||27||
59524509|NCT00289094|75619725|FG000|STARTED|Overall Study||50||
59524510|NCT00289094|75619726|FG001|STARTED|Overall Study||49||
59524511|NCT00289094|75619725|FG000|COMPLETED|Overall Study||3||
59524512|NCT00289094|75619726|FG001|COMPLETED|Overall Study||2||
59524513|NCT00289094|75619725|FG000|NOT COMPLETED|Overall Study||47||
59524514|NCT00289094|75619726|FG001|NOT COMPLETED|Overall Study||47||
59524515|NCT01797458|75619735|FG000|STARTED|Overall Study||52||
59524516|NCT01797458|75619736|FG001|STARTED|Overall Study||52||
59524517|NCT01797458|75619737|FG002|STARTED|Overall Study||65||
59524518|NCT01797458|75619735|FG000|COMPLETED|Overall Study||40||
59524519|NCT01797458|75619736|FG001|COMPLETED|Overall Study||43||
59524520|NCT01797458|75619737|FG002|COMPLETED|Overall Study||58||
59524521|NCT01797458|75619735|FG000|NOT COMPLETED|Overall Study||12||
59524522|NCT01797458|75619736|FG001|NOT COMPLETED|Overall Study||9||
59524523|NCT01797458|75619737|FG002|NOT COMPLETED|Overall Study||7||
59524524|NCT01743872|75619754|FG000|STARTED|Overall Study||23||
59524525|NCT01743872|75619754|FG000|COMPLETED|Overall Study||23||
59524526|NCT01743872|75619754|FG000|NOT COMPLETED|Overall Study||0||
59524527|NCT02533674|75619774|FG000|STARTED|Dose Level I||5||
59524528|NCT02533674|75619775|FG001|STARTED|Dose Level I||0||
59524529|NCT02533674|75619776|FG002|STARTED|Dose Level I||0||
59524530|NCT02533674|75619777|FG003|STARTED|Dose Level I||0||
59524531|NCT02533674|75619778|FG004|STARTED|Dose Level I||0||
59962244|NCT03283371|76080835|FG002|COMPLETED|Placebo-controlled||0||
59621162|NCT00125658|75732692|FG001|STARTED|Overall Study||6||
59621163|NCT00125658|75732691|FG000|COMPLETED|Overall Study||8||
59621164|NCT00125658|75732692|FG001|COMPLETED|Overall Study||6||
59621165|NCT00125658|75732691|FG000|NOT COMPLETED|Overall Study||0||
59621166|NCT00125658|75732692|FG001|NOT COMPLETED|Overall Study||0||
59621167|NCT02102100|75732702|FG000|STARTED|Overall Study||32||
59621168|NCT02102100|75732703|FG001|STARTED|Overall Study||25||
59621169|NCT02102100|75732702|FG000|COMPLETED|Overall Study||23||
59621170|NCT02102100|75732703|FG001|COMPLETED|Overall Study||18||
59621171|NCT02102100|75732702|FG000|NOT COMPLETED|Overall Study||9||
59621172|NCT02102100|75732703|FG001|NOT COMPLETED|Overall Study||7||
59621173|NCT02094534|75732711|FG000|STARTED|Overall Study||15||
59621174|NCT02094534|75732712|FG001|STARTED|Overall Study||10||
59621175|NCT02094534|75732711|FG000|COMPLETED|Overall Study||15||
59621176|NCT02094534|75732712|FG001|COMPLETED|Overall Study||10||
59962245|NCT03283371|76080836|FG003|COMPLETED|Placebo-controlled||0||
59962246|NCT03283371|76080833|FG000|NOT COMPLETED|Placebo-controlled||3||
59962247|NCT03283371|76080834|FG001|NOT COMPLETED|Placebo-controlled||3||
59962248|NCT03283371|76080835|FG002|NOT COMPLETED|Placebo-controlled||0||
59962249|NCT03283371|76080836|FG003|NOT COMPLETED|Placebo-controlled||0||
59962250|NCT03283371|76080833|FG000|STARTED|Open-label Phase||0||
59962251|NCT03283371|76080834|FG001|STARTED|Open-label Phase||0||
59621177|NCT02094534|75732711|FG000|NOT COMPLETED|Overall Study||0||
59621178|NCT02094534|75732712|FG001|NOT COMPLETED|Overall Study||0||
59621179|NCT00242502|75732718|FG000|STARTED|Overall Study||59||
59621180|NCT00242502|75732718|FG000|COMPLETED|Overall Study||59||
59621181|NCT00242502|75732718|FG000|NOT COMPLETED|Overall Study||0||
59962252|NCT03283371|76080835|FG002|STARTED|Open-label Phase||31||
59962253|NCT03283371|76080836|FG003|STARTED|Open-label Phase||30||
59524532|NCT02533674|75619779|FG005|STARTED|Dose Level I||0||
59524533|NCT02533674|75619780|FG006|STARTED|Dose Level I||0||
59621182|NCT00244140|75732724|FG000|STARTED|Overall Study||412||
59621183|NCT00244140|75732725|FG001|STARTED|Overall Study||22||
59621184|NCT00244140|75732724|FG000|COMPLETED|Overall Study||412||
59524534|NCT02533674|75619781|FG007|STARTED|Dose Level I||0||
59524535|NCT02533674|75619774|FG000|COMPLETED|Dose Level I||0||
59524536|NCT02533674|75619775|FG001|COMPLETED|Dose Level I||0||
59524537|NCT02533674|75619776|FG002|COMPLETED|Dose Level I||0||
59524538|NCT02533674|75619777|FG003|COMPLETED|Dose Level I||0||
59524539|NCT02533674|75619778|FG004|COMPLETED|Dose Level I||0||
59524540|NCT02533674|75619779|FG005|COMPLETED|Dose Level I||0||
59524541|NCT02533674|75619780|FG006|COMPLETED|Dose Level I||0||
59524542|NCT02533674|75619781|FG007|COMPLETED|Dose Level I||0||
59524543|NCT02533674|75619774|FG000|NOT COMPLETED|Dose Level I||5||
59524544|NCT02533674|75619775|FG001|NOT COMPLETED|Dose Level I||0||
59524545|NCT02533674|75619776|FG002|NOT COMPLETED|Dose Level I||0||
59524546|NCT02533674|75619777|FG003|NOT COMPLETED|Dose Level I||0||
59524547|NCT02533674|75619778|FG004|NOT COMPLETED|Dose Level I||0||
59524548|NCT02533674|75619779|FG005|NOT COMPLETED|Dose Level I||0||
59524549|NCT02533674|75619780|FG006|NOT COMPLETED|Dose Level I||0||
59621185|NCT00244140|75732725|FG001|COMPLETED|Overall Study||22||
59962254|NCT03283371|76080833|FG000|COMPLETED|Open-label Phase||0||
59962255|NCT03283371|76080834|FG001|COMPLETED|Open-label Phase||0||
59962256|NCT03283371|76080835|FG002|COMPLETED|Open-label Phase||27||
59962257|NCT03283371|76080836|FG003|COMPLETED|Open-label Phase||29||
59962258|NCT03283371|76080833|FG000|NOT COMPLETED|Open-label Phase||0||
59962259|NCT03283371|76080834|FG001|NOT COMPLETED|Open-label Phase||0||
59962260|NCT03283371|76080835|FG002|NOT COMPLETED|Open-label Phase||4||
59962261|NCT03283371|76080836|FG003|NOT COMPLETED|Open-label Phase||1||
59962262|NCT03069417|76080848|FG000|STARTED|Overall Study||14||
59962263|NCT03069417|76080849|FG001|STARTED|Overall Study||9||
59962264|NCT03069417|76080848|FG000|Post-Treatment Assessment|Overall Study||12||
59962265|NCT03069417|76080849|FG001|Post-Treatment Assessment|Overall Study||6||
59962266|NCT03069417|76080848|FG000|COMPLETED|Overall Study||8||
59962267|NCT03069417|76080849|FG001|COMPLETED|Overall Study||2||
59962268|NCT03069417|76080848|FG000|NOT COMPLETED|Overall Study||6||
59962269|NCT03069417|76080849|FG001|NOT COMPLETED|Overall Study||7||
59962270|NCT04930263|76080858|FG000|STARTED|Overall Study||33||
59962271|NCT04930263|76080859|FG001|STARTED|Overall Study||33||
59808519|NCT00420628|75930621|FG001|STARTED|Overall Study||36||
59808520|NCT00420628|75930620|FG000|COMPLETED|Overall Study||63||
59808521|NCT00420628|75930621|FG001|COMPLETED|Overall Study||32||
59808522|NCT00420628|75930620|FG000|NOT COMPLETED|Overall Study||9||
59808523|NCT00420628|75930621|FG001|NOT COMPLETED|Overall Study||4||
59808524|NCT00489255|75930629|FG000|STARTED|Screening and Initial Randomization|Total randomized subjects to receive Tigan|145||
59808525|NCT00489255|75930630|FG001|STARTED|Screening and Initial Randomization|Total randomized subjects to receive placebo|49||
59808526|NCT00489255|75930629|FG000|COMPLETED|Screening and Initial Randomization||136||
59808527|NCT00489255|75930630|FG001|COMPLETED|Screening and Initial Randomization||46||
59808528|NCT00489255|75930629|FG000|NOT COMPLETED|Screening and Initial Randomization||9||
59808529|NCT00489255|75930630|FG001|NOT COMPLETED|Screening and Initial Randomization||3||
59808530|NCT00489255|75930629|FG000|STARTED|Period 1: Days 1 to 28||136||
59808531|NCT00489255|75930630|FG001|STARTED|Period 1: Days 1 to 28||46||
59808532|NCT00489255|75930629|FG000|Completed and Follow Period 2|Period 1: Days 1 to 28||94||
59808533|NCT00489255|75930630|FG001|Completed and Follow Period 2|Period 1: Days 1 to 28||29||
59808534|NCT00489255|75930629|FG000|Completed But Discontinued Study|Period 1: Days 1 to 28||13||
59808535|NCT00489255|75930630|FG001|Completed But Discontinued Study|Period 1: Days 1 to 28||5||
59808536|NCT00489255|75930629|FG000|COMPLETED|Period 1: Days 1 to 28||107||
59808537|NCT00489255|75930630|FG001|COMPLETED|Period 1: Days 1 to 28||34||
59808538|NCT00489255|75930629|FG000|NOT COMPLETED|Period 1: Days 1 to 28||29||
59808539|NCT00489255|75930630|FG001|NOT COMPLETED|Period 1: Days 1 to 28||12||
59808540|NCT00489255|75930629|FG000|STARTED|Period 2: Days 29 to 56||64||
59808541|NCT00489255|75930630|FG001|STARTED|Period 2: Days 29 to 56|Re-randomized participants is 26.Sample sizes differed due to withdrawal&re-randomization design.|59||
59808542|NCT00489255|75930629|FG000|Completed and Follow Period 3|Period 2: Days 29 to 56||58||
59808543|NCT00489255|75930630|FG001|Completed and Follow Period 3|Period 2: Days 29 to 56|Re-randomized participants is 26.Sample sizes differed due to withdrawal&re-randomization design.|52||
59808544|NCT00489255|75930629|FG000|Completed But Discontinued Study|Period 2: Days 29 to 56||3||
59808545|NCT00489255|75930630|FG001|Completed But Discontinued Study|Period 2: Days 29 to 56|Re-randomized participants is 2.Sample sizes differed due to withdrawal&re-randomization design.|3||
59808546|NCT00489255|75930629|FG000|COMPLETED|Period 2: Days 29 to 56||61||
59808547|NCT00489255|75930630|FG001|COMPLETED|Period 2: Days 29 to 56|Re-randomized participants is 26.Sample sizes differed due to withdrawal&re-randomization design.|55||
59808548|NCT00489255|75930629|FG000|NOT COMPLETED|Period 2: Days 29 to 56||3||
59962272|NCT04930263|76080858|FG000|COMPLETED|Overall Study||30||
59962273|NCT04930263|76080859|FG001|COMPLETED|Overall Study||28||
59962274|NCT04930263|76080858|FG000|NOT COMPLETED|Overall Study||3||
59962275|NCT04930263|76080859|FG001|NOT COMPLETED|Overall Study||5||
59962276|NCT02665286|76080868|FG000|STARTED|Overall Study||79||
59962277|NCT02665286|76080869|FG001|STARTED|Overall Study||80||
59962278|NCT02665286|76080870|FG002|STARTED|Overall Study||81||
59962279|NCT02665286|76080868|FG000|COMPLETED|Overall Study||76||
59962280|NCT02665286|76080869|FG001|COMPLETED|Overall Study||78||
59962281|NCT02665286|76080870|FG002|COMPLETED|Overall Study||80||
59962282|NCT02665286|76080868|FG000|NOT COMPLETED|Overall Study||3||
59808549|NCT00489255|75930630|FG001|NOT COMPLETED|Period 2: Days 29 to 56||4||
59808550|NCT00489255|75930629|FG000|STARTED|Period 3: Days 57 to 84||28||
59808551|NCT00489255|75930630|FG001|STARTED|Period 3: Days 57 to 84|Re-randomized participants is 30.Sample sizes differed due to withdrawal&re-randomization design.|82||
59808552|NCT00489255|75930629|FG000|COMPLETED|Period 3: Days 57 to 84||24||
59962283|NCT02665286|76080869|FG001|NOT COMPLETED|Overall Study||2||
59962284|NCT02665286|76080870|FG002|NOT COMPLETED|Overall Study||1||
59808553|NCT00489255|75930630|FG001|COMPLETED|Period 3: Days 57 to 84|Re-randomized participants is 27.Sample sizes differed due to withdrawal&re-randomization design.|78||
59808554|NCT00489255|75930629|FG000|NOT COMPLETED|Period 3: Days 57 to 84||4||
59962285|NCT02911519|76080880|FG000|STARTED|Overall Study||90||
59962286|NCT02911519|76080881|FG001|STARTED|Overall Study||86||
59962287|NCT02911519|76080880|FG000|COMPLETED|Overall Study||88||
59962288|NCT02911519|76080881|FG001|COMPLETED|Overall Study||82||
59962289|NCT02911519|76080880|FG000|NOT COMPLETED|Overall Study||2||
59962290|NCT02911519|76080881|FG001|NOT COMPLETED|Overall Study||4||
59962291|NCT02911285|76080889|FG000|STARTED|Overall Study||49||
59962292|NCT02911285|76080890|FG001|STARTED|Overall Study||41||
59962293|NCT02911285|76080889|FG000|COMPLETED|Overall Study||40||
59962294|NCT02911285|76080890|FG001|COMPLETED|Overall Study||36||
59962295|NCT02911285|76080889|FG000|NOT COMPLETED|Overall Study||9||
59962296|NCT02911285|76080890|FG001|NOT COMPLETED|Overall Study||5||
59962297|NCT02910739|76080902|FG000|STARTED|Overall Study||8||
59962298|NCT02910739|76080903|FG001|STARTED|Overall Study||8||
59962299|NCT02910739|76080904|FG002|STARTED|Overall Study|Participants were not enrolled in Part II as the PK criterion from the Part I IA was not met.|0||
59962300|NCT02910739|76080905|FG003|STARTED|Overall Study|Participants were not enrolled in Part II as the PK criterion from the Part I IA was not met.|0||
59962301|NCT02910739|76080902|FG000|COMPLETED|Overall Study||7||
59808555|NCT00489255|75930630|FG001|NOT COMPLETED|Period 3: Days 57 to 84||4||
59808556|NCT00413218|75930638|FG000|STARTED|Overall Study||223|Four hundred and fifty participants were randomized but 10 participants did not receive treatment.|
59808557|NCT00413218|75930639|FG001|STARTED|Overall Study||227|Four hundred and fifty participants were randomized but 10 participants did not receive treatment.|
59808558|NCT00413218|75930638|FG000|Intent to Treat Population (ITT)|Overall Study||221|The ITT consisted of all randomized participants who received at least one dose of study drug.|
59808559|NCT00413218|75930639|FG001|Intent to Treat Population (ITT)|Overall Study||219|The ITT consisted of all randomized participants who received at least one dose of study drug.|
59808560|NCT00413218|75930638|FG000|COMPLETED|Overall Study||120||
59808561|NCT00413218|75930639|FG001|COMPLETED|Overall Study||131||
59808562|NCT00413218|75930638|FG000|NOT COMPLETED|Overall Study||103||
59808563|NCT00413218|75930639|FG001|NOT COMPLETED|Overall Study||96||
59808564|NCT00420316|75930648|FG000|STARTED|Overall Study||1082||
59808565|NCT00420316|75930649|FG001|STARTED|Overall Study||531||
59808566|NCT00420316|75930648|FG000|COMPLETED|Overall Study||1070||
59808567|NCT00420316|75930649|FG001|COMPLETED|Overall Study||522||
59808568|NCT00420316|75930648|FG000|NOT COMPLETED|Overall Study||12||
59808569|NCT00420316|75930649|FG001|NOT COMPLETED|Overall Study||9||
59962302|NCT02910739|76080903|FG001|COMPLETED|Overall Study||8||
59962303|NCT02910739|76080904|FG002|COMPLETED|Overall Study|Participants were not enrolled in Part II as the PK criterion from the Part I IA was not met.|0||
59962304|NCT02910739|76080905|FG003|COMPLETED|Overall Study|Participants were not enrolled in Part II as the PK criterion from the Part I IA was not met.|0||
59962305|NCT02910739|76080902|FG000|NOT COMPLETED|Overall Study||1||
59962306|NCT02910739|76080903|FG001|NOT COMPLETED|Overall Study||0||
59962307|NCT02910739|76080904|FG002|NOT COMPLETED|Overall Study||0||
59962308|NCT02910739|76080905|FG003|NOT COMPLETED|Overall Study||0||
59962309|NCT01069939|76080913|FG000|STARTED|Randomised and Included in the Analyses||213||
59962310|NCT01069939|76080914|FG001|STARTED|Randomised and Included in the Analyses||214||
59962311|NCT01069939|76080913|FG000|COMPLETED|Randomised and Included in the Analyses||164||
59962312|NCT01069939|76080914|FG001|COMPLETED|Randomised and Included in the Analyses||137||
59808570|NCT00494871|75930657|FG000|STARTED|Double-blind (DB) Treatment Period||640||
59808571|NCT00494871|75930658|FG001|STARTED|Double-blind (DB) Treatment Period||640||
59808572|NCT00494871|75930657|FG000|Started Treatment|Double-blind (DB) Treatment Period|Safety population|639||
59808573|NCT00494871|75930658|FG001|Started Treatment|Double-blind (DB) Treatment Period|Safety population|639||
59808574|NCT00494871|75930657|FG000|COMPLETED|Double-blind (DB) Treatment Period||480||
59808575|NCT00494871|75930658|FG001|COMPLETED|Double-blind (DB) Treatment Period||468||
59808576|NCT00494871|75930657|FG000|NOT COMPLETED|Double-blind (DB) Treatment Period||160||
59808577|NCT00494871|75930658|FG001|NOT COMPLETED|Double-blind (DB) Treatment Period||172||
59808578|NCT00494871|75930657|FG000|STARTED|Follow-up (FU) Period|All treated participants were to enter FU period, whether or not they completed the DB period|639||
59808579|NCT00494871|75930658|FG001|STARTED|Follow-up (FU) Period|All treated participants were to enter FU period, whether or not they completed the DB period|639||
59808580|NCT00494871|75930657|FG000|Entered FU and Valid for Safety|Follow-up (FU) Period|Safety population|628||
59808581|NCT00494871|75930658|FG001|Entered FU and Valid for Safety|Follow-up (FU) Period|Safety population|630||
59808582|NCT00494871|75930657|FG000|COMPLETED|Follow-up (FU) Period||610||
59808583|NCT00494871|75930658|FG001|COMPLETED|Follow-up (FU) Period||616||
59808584|NCT00494871|75930657|FG000|NOT COMPLETED|Follow-up (FU) Period||29||
59808585|NCT00494871|75930658|FG001|NOT COMPLETED|Follow-up (FU) Period||23||
59808586|NCT00420238|75930668|FG000|STARTED|12 Week Double-Blind Treatment Period 1||39||
59808587|NCT00420238|75930669|FG001|STARTED|12 Week Double-Blind Treatment Period 1||43||
59808588|NCT00420238|75930668|FG000|COMPLETED|12 Week Double-Blind Treatment Period 1||38||
59808589|NCT00420238|75930669|FG001|COMPLETED|12 Week Double-Blind Treatment Period 1||39||
59808590|NCT00420238|75930668|FG000|NOT COMPLETED|12 Week Double-Blind Treatment Period 1||1||
59808591|NCT00420238|75930669|FG001|NOT COMPLETED|12 Week Double-Blind Treatment Period 1||4||
59808592|NCT00420238|75930668|FG000|STARTED|12 Week Open-Label Treatment Period 2||38||
59808593|NCT00420238|75930669|FG001|STARTED|12 Week Open-Label Treatment Period 2||39||
59808594|NCT00420238|75930668|FG000|COMPLETED|12 Week Open-Label Treatment Period 2||36||
59808595|NCT00420238|75930669|FG001|COMPLETED|12 Week Open-Label Treatment Period 2||38||
59808596|NCT00420238|75930668|FG000|NOT COMPLETED|12 Week Open-Label Treatment Period 2||2||
59962313|NCT01069939|76080913|FG000|NOT COMPLETED|Randomised and Included in the Analyses||49||
59962314|NCT01069939|76080914|FG001|NOT COMPLETED|Randomised and Included in the Analyses||77||
59962315|NCT01069939|76080913|FG000|STARTED|At Data Cut Off Date (26 Feb 2011)||213||
59962316|NCT01069939|76080914|FG001|STARTED|At Data Cut Off Date (26 Feb 2011)||214||
59962317|NCT01069939|76080913|FG000|COMPLETED|At Data Cut Off Date (26 Feb 2011)||182||
59962318|NCT01069939|76080914|FG001|COMPLETED|At Data Cut Off Date (26 Feb 2011)||182||
59962319|NCT01069939|76080913|FG000|NOT COMPLETED|At Data Cut Off Date (26 Feb 2011)||31||
59962320|NCT01069939|76080914|FG001|NOT COMPLETED|At Data Cut Off Date (26 Feb 2011)||32||
59962321|NCT01069705|76080920|FG000|STARTED|Overall Study||49||
59962322|NCT01069705|76080920|FG000|COMPLETED|Overall Study||46||
59962323|NCT01069705|76080920|FG000|NOT COMPLETED|Overall Study||3||
59962324|NCT01069627|76080924|FG000|STARTED|Overall Study||20||
59962325|NCT01069627|76080924|FG000|COMPLETED|Overall Study||0||
59962326|NCT01069627|76080924|FG000|NOT COMPLETED|Overall Study||20||
59962327|NCT03021551|76080928|FG000|STARTED|Overall Study||80||
59962328|NCT03021551|76080928|FG000|COMPLETED|Overall Study||77||
59962329|NCT03021551|76080928|FG000|NOT COMPLETED|Overall Study||3||
59962330|NCT01585025|76080935|FG000|STARTED|Overall Study||10||
59962331|NCT01585025|76080936|FG001|STARTED|Overall Study||13||
59962332|NCT01585025|76080937|FG002|STARTED|Overall Study||12||
59962333|NCT01585025|76080935|FG000|COMPLETED|Overall Study||10||
59962334|NCT01585025|76080936|FG001|COMPLETED|Overall Study||10||
59962335|NCT01585025|76080937|FG002|COMPLETED|Overall Study||8||
59962336|NCT01585025|76080935|FG000|NOT COMPLETED|Overall Study||0||
59962337|NCT01585025|76080936|FG001|NOT COMPLETED|Overall Study||3||
59962338|NCT01585025|76080937|FG002|NOT COMPLETED|Overall Study||4||
59962339|NCT01068769|76080945|FG000|STARTED|Overall Study||34||
59962340|NCT01068769|76080945|FG000|COMPLETED|Overall Study||33||
59962341|NCT01068769|76080945|FG000|NOT COMPLETED|Overall Study||1||
59962342|NCT00328653|76080952|FG000|STARTED|Period I||40||
59962343|NCT00328653|76080953|FG001|STARTED|Period I||39||
59962344|NCT00328653|76080954|FG002|STARTED|Period I||39||
59962345|NCT00328653|76080952|FG000|COMPLETED|Period I||36||
59962346|NCT00328653|76080953|FG001|COMPLETED|Period I||39||
59962347|NCT00328653|76080954|FG002|COMPLETED|Period I||36||
59962348|NCT00328653|76080952|FG000|NOT COMPLETED|Period I||4||
59962349|NCT00328653|76080953|FG001|NOT COMPLETED|Period I||0||
59962350|NCT00328653|76080954|FG002|NOT COMPLETED|Period I||3||
59962351|NCT00328653|76080952|FG000|STARTED|Period II|Following completion of the first period of the trial, all patients were to be administered NOVA22007 (i.e. CsA 0.05% or 0.1%) as four times or twice daily instillations in both eyes for an additional 3 month period.|0||
59962352|NCT00328653|76080953|FG001|STARTED|Period II||58||
59962353|NCT00328653|76080954|FG002|STARTED|Period II||53||
59962354|NCT00328653|76080952|FG000|COMPLETED|Period II||0||
59962355|NCT00328653|76080953|FG001|COMPLETED|Period II||50||
59962356|NCT00328653|76080954|FG002|COMPLETED|Period II||49||
59962357|NCT00328653|76080952|FG000|NOT COMPLETED|Period II||0||
59962358|NCT00328653|76080953|FG001|NOT COMPLETED|Period II||8||
59962359|NCT00328653|76080954|FG002|NOT COMPLETED|Period II||4||
59962360|NCT05114564|76080964|FG000|STARTED|First Intervention||34||
59962361|NCT05114564|76080965|FG001|STARTED|First Intervention||32||
59962362|NCT05114564|76080964|FG000|COMPLETED|First Intervention||33||
59962363|NCT05114564|76080965|FG001|COMPLETED|First Intervention||31||
59962364|NCT05114564|76080964|FG000|NOT COMPLETED|First Intervention||1||
59962365|NCT05114564|76080965|FG001|NOT COMPLETED|First Intervention||1||
59962366|NCT05114564|76080964|FG000|STARTED|Second Intervention||33||
59962367|NCT05114564|76080965|FG001|STARTED|Second Intervention||31||
59962368|NCT05114564|76080964|FG000|COMPLETED|Second Intervention||33||
59962369|NCT05114564|76080965|FG001|COMPLETED|Second Intervention||31||
59962370|NCT05114564|76080964|FG000|NOT COMPLETED|Second Intervention||0||
59962371|NCT05114564|76080965|FG001|NOT COMPLETED|Second Intervention||0||
59962372|NCT04706416|76080973|FG000|STARTED|Overall Study||50||
59962373|NCT04706416|76080974|FG001|STARTED|Overall Study||100||
59962374|NCT04706416|76080973|FG000|COMPLETED|Overall Study||48||
59962375|NCT04706416|76080974|FG001|COMPLETED|Overall Study||100||
59962376|NCT04706416|76080973|FG000|NOT COMPLETED|Overall Study||2||
59962377|NCT04706416|76080974|FG001|NOT COMPLETED|Overall Study||0||
59962378|NCT04683926|76080987|FG000|STARTED|Intervention 1 (1 Day)||6||
59962379|NCT04683926|76080988|FG001|STARTED|Intervention 1 (1 Day)||6||
59962380|NCT04683926|76080989|FG002|STARTED|Intervention 1 (1 Day)||6||
59962381|NCT04683926|76080990|FG003|STARTED|Intervention 1 (1 Day)||6||
59962382|NCT04683926|76080987|FG000|COMPLETED|Intervention 1 (1 Day)||6||
59962383|NCT04683926|76080988|FG001|COMPLETED|Intervention 1 (1 Day)||6||
59962384|NCT04683926|76080989|FG002|COMPLETED|Intervention 1 (1 Day)||6||
59962385|NCT04683926|76080990|FG003|COMPLETED|Intervention 1 (1 Day)||6||
59962386|NCT04683926|76080987|FG000|NOT COMPLETED|Intervention 1 (1 Day)||0||
59962387|NCT04683926|76080988|FG001|NOT COMPLETED|Intervention 1 (1 Day)||0||
59962388|NCT04683926|76080989|FG002|NOT COMPLETED|Intervention 1 (1 Day)||0||
59962389|NCT04683926|76080990|FG003|NOT COMPLETED|Intervention 1 (1 Day)||0||
59962390|NCT04683926|76080987|FG000|STARTED|Washout 1 (3 Days)||6||
59962391|NCT04683926|76080988|FG001|STARTED|Washout 1 (3 Days)||6||
59962392|NCT04683926|76080989|FG002|STARTED|Washout 1 (3 Days)||6||
59962393|NCT04683926|76080990|FG003|STARTED|Washout 1 (3 Days)||6||
59962394|NCT04683926|76080987|FG000|COMPLETED|Washout 1 (3 Days)||6||
59962395|NCT04683926|76080988|FG001|COMPLETED|Washout 1 (3 Days)||6||
59962396|NCT04683926|76080989|FG002|COMPLETED|Washout 1 (3 Days)||6||
59962397|NCT04683926|76080990|FG003|COMPLETED|Washout 1 (3 Days)||6||
59962398|NCT04683926|76080987|FG000|NOT COMPLETED|Washout 1 (3 Days)||0||
59962399|NCT04683926|76080988|FG001|NOT COMPLETED|Washout 1 (3 Days)||0||
59962400|NCT04683926|76080989|FG002|NOT COMPLETED|Washout 1 (3 Days)||0||
59962401|NCT04683926|76080990|FG003|NOT COMPLETED|Washout 1 (3 Days)||0||
59962402|NCT04683926|76080987|FG000|STARTED|Intervention 2 (1 Day)||6||
59962403|NCT04683926|76080988|FG001|STARTED|Intervention 2 (1 Day)||6||
59962404|NCT04683926|76080989|FG002|STARTED|Intervention 2 (1 Day)||6||
59962405|NCT04683926|76080990|FG003|STARTED|Intervention 2 (1 Day)||6||
59962406|NCT04683926|76080987|FG000|COMPLETED|Intervention 2 (1 Day)||6||
59962407|NCT04683926|76080988|FG001|COMPLETED|Intervention 2 (1 Day)||6||
59962408|NCT04683926|76080989|FG002|COMPLETED|Intervention 2 (1 Day)||6||
59962409|NCT04683926|76080990|FG003|COMPLETED|Intervention 2 (1 Day)||5||
59962410|NCT04683926|76080987|FG000|NOT COMPLETED|Intervention 2 (1 Day)||0||
59962411|NCT04683926|76080988|FG001|NOT COMPLETED|Intervention 2 (1 Day)||0||
59962412|NCT04683926|76080989|FG002|NOT COMPLETED|Intervention 2 (1 Day)||0||
59962413|NCT04683926|76080990|FG003|NOT COMPLETED|Intervention 2 (1 Day)||1||
59962414|NCT04683926|76080987|FG000|STARTED|Washout 2 (3 Days)||6||
59962415|NCT04683926|76080988|FG001|STARTED|Washout 2 (3 Days)||6||
59962416|NCT04683926|76080989|FG002|STARTED|Washout 2 (3 Days)||6||
59962417|NCT04683926|76080990|FG003|STARTED|Washout 2 (3 Days)||5||
59962418|NCT04683926|76080987|FG000|COMPLETED|Washout 2 (3 Days)||6||
59962419|NCT04683926|76080988|FG001|COMPLETED|Washout 2 (3 Days)||6||
59962420|NCT04683926|76080989|FG002|COMPLETED|Washout 2 (3 Days)||6||
59962421|NCT04683926|76080990|FG003|COMPLETED|Washout 2 (3 Days)||5||
59962422|NCT04683926|76080987|FG000|NOT COMPLETED|Washout 2 (3 Days)||0||
59962423|NCT04683926|76080988|FG001|NOT COMPLETED|Washout 2 (3 Days)||0||
59962424|NCT04683926|76080989|FG002|NOT COMPLETED|Washout 2 (3 Days)||0||
59962425|NCT04683926|76080990|FG003|NOT COMPLETED|Washout 2 (3 Days)||0||
59962426|NCT04683926|76080987|FG000|STARTED|Intervention 3 (1 Day)||6||
59962427|NCT04683926|76080988|FG001|STARTED|Intervention 3 (1 Day)||6||
59962428|NCT04683926|76080989|FG002|STARTED|Intervention 3 (1 Day)||6||
59962429|NCT04683926|76080990|FG003|STARTED|Intervention 3 (1 Day)||5||
59962430|NCT04683926|76080987|FG000|COMPLETED|Intervention 3 (1 Day)||6||
59962431|NCT04683926|76080988|FG001|COMPLETED|Intervention 3 (1 Day)||6||
59962432|NCT04683926|76080989|FG002|COMPLETED|Intervention 3 (1 Day)||6||
59962433|NCT04683926|76080990|FG003|COMPLETED|Intervention 3 (1 Day)||5||
59962434|NCT04683926|76080987|FG000|NOT COMPLETED|Intervention 3 (1 Day)||0||
59962435|NCT04683926|76080988|FG001|NOT COMPLETED|Intervention 3 (1 Day)||0||
59962436|NCT04683926|76080989|FG002|NOT COMPLETED|Intervention 3 (1 Day)||0||
59962437|NCT04683926|76080990|FG003|NOT COMPLETED|Intervention 3 (1 Day)||0||
59962438|NCT04683926|76080987|FG000|STARTED|Washout 3 (3 Days)||6||
59962439|NCT04683926|76080988|FG001|STARTED|Washout 3 (3 Days)||6||
59962440|NCT04683926|76080989|FG002|STARTED|Washout 3 (3 Days)||6||
59962441|NCT04683926|76080990|FG003|STARTED|Washout 3 (3 Days)||5||
59962442|NCT04683926|76080987|FG000|COMPLETED|Washout 3 (3 Days)||6||
59962443|NCT04683926|76080988|FG001|COMPLETED|Washout 3 (3 Days)||6||
59962444|NCT04683926|76080989|FG002|COMPLETED|Washout 3 (3 Days)||6||
59962445|NCT04683926|76080990|FG003|COMPLETED|Washout 3 (3 Days)||5||
59962446|NCT04683926|76080987|FG000|NOT COMPLETED|Washout 3 (3 Days)||0||
59962447|NCT04683926|76080988|FG001|NOT COMPLETED|Washout 3 (3 Days)||0||
59962448|NCT04683926|76080989|FG002|NOT COMPLETED|Washout 3 (3 Days)||0||
59962449|NCT04683926|76080990|FG003|NOT COMPLETED|Washout 3 (3 Days)||0||
59962450|NCT04683926|76080987|FG000|STARTED|Intervention 4 (1 Day)||6||
59962451|NCT04683926|76080988|FG001|STARTED|Intervention 4 (1 Day)||6||
59962452|NCT04683926|76080989|FG002|STARTED|Intervention 4 (1 Day)||6||
59962453|NCT04683926|76080990|FG003|STARTED|Intervention 4 (1 Day)||5||
59962454|NCT04683926|76080987|FG000|COMPLETED|Intervention 4 (1 Day)||6||
59962455|NCT04683926|76080988|FG001|COMPLETED|Intervention 4 (1 Day)||6||
59962456|NCT04683926|76080989|FG002|COMPLETED|Intervention 4 (1 Day)||6||
59962457|NCT04683926|76080990|FG003|COMPLETED|Intervention 4 (1 Day)||5||
59962458|NCT04683926|76080987|FG000|NOT COMPLETED|Intervention 4 (1 Day)||0||
59962459|NCT04683926|76080988|FG001|NOT COMPLETED|Intervention 4 (1 Day)||0||
59962460|NCT04683926|76080989|FG002|NOT COMPLETED|Intervention 4 (1 Day)||0||
59962461|NCT04683926|76080990|FG003|NOT COMPLETED|Intervention 4 (1 Day)||0||
59962462|NCT04343755|76081002|FG000|STARTED|Overall Study||52||
59962463|NCT04343755|76081002|FG000|COMPLETED|Overall Study||40||
59962464|NCT04343755|76081002|FG000|NOT COMPLETED|Overall Study||12||
59962465|NCT04285346|76081006|FG000|STARTED|Treatment Period (Up to 12 Weeks)||23||
60074155|NCT01908907|76189568|FG001|COMPLETED|Overall Study||29||
60074156|NCT01908907|76189567|FG000|NOT COMPLETED|Overall Study||2||
60074157|NCT01908907|76189568|FG001|NOT COMPLETED|Overall Study||0||
59962466|NCT04285346|76081007|FG001|STARTED|Treatment Period (Up to 12 Weeks)||0||
59962467|NCT04285346|76081006|FG000|COMPLETED|Treatment Period (Up to 12 Weeks)||17||
59962468|NCT04285346|76081007|FG001|COMPLETED|Treatment Period (Up to 12 Weeks)||0||
59962469|NCT04285346|76081006|FG000|NOT COMPLETED|Treatment Period (Up to 12 Weeks)||6||
59962470|NCT04285346|76081007|FG001|NOT COMPLETED|Treatment Period (Up to 12 Weeks)||0||
59962471|NCT04285346|76081006|FG000|STARTED|Open Label Period (Week 12 to 38)||0||
59962472|NCT04285346|76081007|FG001|STARTED|Open Label Period (Week 12 to 38)||9||
59962473|NCT04285346|76081006|FG000|COMPLETED|Open Label Period (Week 12 to 38)||0||
59962474|NCT04285346|76081007|FG001|COMPLETED|Open Label Period (Week 12 to 38)||9||
59962475|NCT04285346|76081006|FG000|NOT COMPLETED|Open Label Period (Week 12 to 38)||0||
59962476|NCT04285346|76081007|FG001|NOT COMPLETED|Open Label Period (Week 12 to 38)||0||
59962477|NCT04163822|76081014|FG000|STARTED|Overall Study||78||
59962478|NCT04163822|76081015|FG001|STARTED|Overall Study||178||
59962479|NCT04163822|76081014|FG000|COMPLETED|Overall Study||78||
59962480|NCT04163822|76081015|FG001|COMPLETED|Overall Study||178||
59962481|NCT04163822|76081014|FG000|NOT COMPLETED|Overall Study||0||
59962482|NCT04163822|76081015|FG001|NOT COMPLETED|Overall Study||0||
59962483|NCT04148287|76081022|FG000|STARTED|Overall Study||9||
59962484|NCT04148287|76081022|FG000|COMPLETED|Overall Study||7||
59962485|NCT04148287|76081022|FG000|NOT COMPLETED|Overall Study||2||
59962486|NCT04114604|76081026|FG000|STARTED|Overall Study||10||
59962487|NCT04114604|76081026|FG000|COMPLETED|Overall Study||10||
59962488|NCT04114604|76081026|FG000|NOT COMPLETED|Overall Study||0||
59962489|NCT03826173|76081037|FG000|STARTED|Overall Study||13||
59962490|NCT03826173|76081038|FG001|STARTED|Overall Study||30||
59962491|NCT03826173|76081039|FG002|STARTED|Overall Study||11||
59962492|NCT03826173|76081037|FG000|COMPLETED|Overall Study||12||
59962493|NCT03826173|76081038|FG001|COMPLETED|Overall Study||27||
59962494|NCT03826173|76081039|FG002|COMPLETED|Overall Study|Treatment was cut short by COVID-19|6||
59962495|NCT03826173|76081037|FG000|NOT COMPLETED|Overall Study||1||
59962496|NCT03826173|76081038|FG001|NOT COMPLETED|Overall Study||3||
59962497|NCT03826173|76081039|FG002|NOT COMPLETED|Overall Study||5||
59962498|NCT03772613|76081050|FG000|STARTED|Overall Study||61||
59962499|NCT03772613|76081051|FG001|STARTED|Overall Study||61||
59962500|NCT03772613|76081052|FG002|STARTED|Overall Study||58||
59962501|NCT03772613|76081050|FG000|COMPLETED|Overall Study||61||
59962502|NCT03772613|76081051|FG001|COMPLETED|Overall Study||60||
59962503|NCT03772613|76081052|FG002|COMPLETED|Overall Study||57||
59962504|NCT03772613|76081050|FG000|NOT COMPLETED|Overall Study||0||
59808597|NCT00420238|75930669|FG001|NOT COMPLETED|12 Week Open-Label Treatment Period 2||1||
59808598|NCT00420004|75930684|FG000|STARTED|Overall Study||269||
59808599|NCT00420004|75930685|FG001|STARTED|Overall Study||138||
59808600|NCT00420004|75930686|FG002|STARTED|Overall Study||62||
59808601|NCT00420004|75930684|FG000|Received at Least 1 Dose of Study Drug|Overall Study|Participants who received >=1 dose of study drug and had baseline and post-baseline data available|249||
59962505|NCT03772613|76081051|FG001|NOT COMPLETED|Overall Study||1||
59962506|NCT03772613|76081052|FG002|NOT COMPLETED|Overall Study||1||
59962507|NCT03739437|76081062|FG000|STARTED|Overall Study||9||
59962508|NCT03739437|76081063|FG001|STARTED|Overall Study||11||
60074158|NCT01808612|76189581|FG000|STARTED|Treatment Period||169||
60074159|NCT01808612|76189582|FG001|STARTED|Treatment Period||84||
59808602|NCT00420004|75930685|FG001|Received at Least 1 Dose of Study Drug|Overall Study|Participants who received >=1 dose of study drug and had baseline and post-baseline data available|122||
59962509|NCT03739437|76081062|FG000|COMPLETED|Overall Study||7||
59962510|NCT03739437|76081063|FG001|COMPLETED|Overall Study||6||
60074160|NCT01808612|76189583|FG002|STARTED|Treatment Period||260||
60074161|NCT01808612|76189581|FG000|Received at Least 1 Dose of Study Drug|Treatment Period|Only these participants were included in the study analyses (ie, Full Analysis Set).|168||
60074162|NCT01808612|76189582|FG001|Received at Least 1 Dose of Study Drug|Treatment Period|Only these participants were included in the study analyses (ie, Full Analysis Set).|83||
60103594|NCT04075734|76221848|FG000|COMPLETED|Overall Study||21||
59962511|NCT03739437|76081062|FG000|NOT COMPLETED|Overall Study||2||
59962512|NCT03739437|76081063|FG001|NOT COMPLETED|Overall Study||5||
59962513|NCT03701555|76081105|FG000|STARTED|Part 1 (Day 1)||3||
59962514|NCT03701555|76081106|FG001|STARTED|Part 1 (Day 1)||3||
59962515|NCT03701555|76081107|FG002|STARTED|Part 1 (Day 1)||3||
59962516|NCT03701555|76081108|FG003|STARTED|Part 1 (Day 1)||3||
59962517|NCT03701555|76081109|FG004|STARTED|Part 1 (Day 1)||3||
59962518|NCT03701555|76081110|FG005|STARTED|Part 1 (Day 1)||3||
59962519|NCT03701555|76081111|FG006|STARTED|Part 1 (Day 1)||3||
59962520|NCT03701555|76081112|FG007|STARTED|Part 1 (Day 1)||3||
59962521|NCT03701555|76081113|FG008|STARTED|Part 1 (Day 1)||3||
59962522|NCT03701555|76081114|FG009|STARTED|Part 1 (Day 1)||1||
59962523|NCT03701555|76081115|FG010|STARTED|Part 1 (Day 1)||0||
59962524|NCT03701555|76081116|FG011|STARTED|Part 1 (Day 1)||0||
59962525|NCT03701555|76081117|FG012|STARTED|Part 1 (Day 1)||0||
59962526|NCT03701555|76081118|FG013|STARTED|Part 1 (Day 1)||0||
59962527|NCT03701555|76081119|FG014|STARTED|Part 1 (Day 1)||0||
59962528|NCT03701555|76081120|FG015|STARTED|Part 1 (Day 1)||0||
59962529|NCT03701555|76081121|FG016|STARTED|Part 1 (Day 1)||0||
59962530|NCT03701555|76081122|FG017|STARTED|Part 1 (Day 1)||0||
59962531|NCT03701555|76081123|FG018|STARTED|Part 1 (Day 1)||0||
59962532|NCT03701555|76081124|FG019|STARTED|Part 1 (Day 1)||0||
59962533|NCT03701555|76081125|FG020|STARTED|Part 1 (Day 1)||0||
59962534|NCT03701555|76081126|FG021|STARTED|Part 1 (Day 1)||0||
59962535|NCT03701555|76081127|FG022|STARTED|Part 1 (Day 1)||0||
59962536|NCT03701555|76081128|FG023|STARTED|Part 1 (Day 1)||0||
59962537|NCT03701555|76081129|FG024|STARTED|Part 1 (Day 1)||0||
59962538|NCT03701555|76081130|FG025|STARTED|Part 1 (Day 1)||0||
59962539|NCT03701555|76081131|FG026|STARTED|Part 1 (Day 1)||0||
59962540|NCT03701555|76081132|FG027|STARTED|Part 1 (Day 1)||0||
59962541|NCT03701555|76081133|FG028|STARTED|Part 1 (Day 1)||0||
59962542|NCT03701555|76081134|FG029|STARTED|Part 1 (Day 1)||0||
59962543|NCT03701555|76081135|FG030|STARTED|Part 1 (Day 1)||0||
59962544|NCT03701555|76081136|FG031|STARTED|Part 1 (Day 1)||0||
59962545|NCT03701555|76081137|FG032|STARTED|Part 1 (Day 1)||0||
59962546|NCT03701555|76081138|FG033|STARTED|Part 1 (Day 1)||0||
59962547|NCT03701555|76081139|FG034|STARTED|Part 1 (Day 1)||0||
59962548|NCT03701555|76081140|FG035|STARTED|Part 1 (Day 1)||0||
59962549|NCT03701555|76081105|FG000|COMPLETED|Part 1 (Day 1)||3||
59962550|NCT03701555|76081106|FG001|COMPLETED|Part 1 (Day 1)||3||
59962551|NCT03701555|76081107|FG002|COMPLETED|Part 1 (Day 1)||3||
59962552|NCT03701555|76081108|FG003|COMPLETED|Part 1 (Day 1)||3||
59962553|NCT03701555|76081109|FG004|COMPLETED|Part 1 (Day 1)||3||
59962554|NCT03701555|76081110|FG005|COMPLETED|Part 1 (Day 1)||3||
59962555|NCT03701555|76081111|FG006|COMPLETED|Part 1 (Day 1)||3||
59962556|NCT03701555|76081112|FG007|COMPLETED|Part 1 (Day 1)||3||
59524550|NCT02533674|75619781|FG007|NOT COMPLETED|Dose Level I||0||
59524551|NCT02533674|75619774|FG000|STARTED|Dose Level II||0||
59524552|NCT02533674|75619775|FG001|STARTED|Dose Level II||7||
59524553|NCT02533674|75619776|FG002|STARTED|Dose Level II||0||
59524554|NCT02533674|75619777|FG003|STARTED|Dose Level II||0||
59524555|NCT02533674|75619778|FG004|STARTED|Dose Level II||0||
59524556|NCT02533674|75619779|FG005|STARTED|Dose Level II||0||
59524557|NCT02533674|75619780|FG006|STARTED|Dose Level II||0||
59524558|NCT02533674|75619781|FG007|STARTED|Dose Level II||0||
59524559|NCT02533674|75619774|FG000|COMPLETED|Dose Level II||0||
59808603|NCT00420004|75930686|FG002|Received at Least 1 Dose of Study Drug|Overall Study|Participants who received >=1 dose of study drug and had baseline and post-baseline data available|54||
59808604|NCT00420004|75930684|FG000|COMPLETED|Overall Study||140||
59808605|NCT00420004|75930685|FG001|COMPLETED|Overall Study||67||
59808606|NCT00420004|75930686|FG002|COMPLETED|Overall Study||30||
59808607|NCT00420004|75930684|FG000|NOT COMPLETED|Overall Study||129||
59808608|NCT00420004|75930685|FG001|NOT COMPLETED|Overall Study||71||
59808609|NCT00420004|75930686|FG002|NOT COMPLETED|Overall Study||32||
59808610|NCT00494481|75930700|FG000|STARTED|Overall Study|randomised patients|35||
59808611|NCT00494481|75930701|FG001|STARTED|Overall Study|randomised patients|29||
59808612|NCT00494481|75930700|FG000|COMPLETED|Overall Study|ongoing study treatment at data cut-off|6||
59808613|NCT00494481|75930701|FG001|COMPLETED|Overall Study|ongoing study treatment at data cut-off|5||
59808614|NCT00494481|75930700|FG000|NOT COMPLETED|Overall Study||29||
59808615|NCT00494481|75930701|FG001|NOT COMPLETED|Overall Study||24||
59808616|NCT00097591|75930709|FG000|STARTED|Overall Study|7 subjects randomized but not analyzed due to an incomplete informed consent document|6813||
59808617|NCT00097591|75930710|FG001|STARTED|Overall Study|4 subjects randomized but not analyzed due to an incomplete informed consent document|6795||
59808618|NCT00097591|75930709|FG000|COMPLETED|Overall Study||6403||
59808619|NCT00097591|75930710|FG001|COMPLETED|Overall Study||6401||
59808620|NCT00097591|75930709|FG000|NOT COMPLETED|Overall Study||410||
59808621|NCT00097591|75930710|FG001|NOT COMPLETED|Overall Study||394||
59808622|NCT00419926|75930718|FG000|STARTED|Overall Study|Intention to treat population, 150 is safety population.|155||
59808623|NCT00419926|75930719|FG001|STARTED|Overall Study|Intention to treat population, 154 is safety population.|158||
59808624|NCT00419926|75930718|FG000|COMPLETED|Overall Study||141||
59808625|NCT00419926|75930719|FG001|COMPLETED|Overall Study||148||
59808626|NCT00419926|75930718|FG000|NOT COMPLETED|Overall Study||14||
59808627|NCT00419926|75930719|FG001|NOT COMPLETED|Overall Study||10||
59808628|NCT00080119|75930729|FG000|STARTED|Overall Study||403||
59808629|NCT00080119|75930730|FG001|STARTED|Overall Study||401||
59808630|NCT00080119|75930731|FG002|STARTED|Overall Study||273||
59808631|NCT00080119|75930732|FG003|STARTED|Overall Study||274||
59808632|NCT00080119|75930729|FG000|COMPLETED|Overall Study||347||
59808633|NCT00080119|75930730|FG001|COMPLETED|Overall Study||339||
59808634|NCT00080119|75930731|FG002|COMPLETED|Overall Study||108||
59808635|NCT00080119|75930732|FG003|COMPLETED|Overall Study||111||
59808636|NCT00080119|75930729|FG000|NOT COMPLETED|Overall Study||56||
59808637|NCT00080119|75930730|FG001|NOT COMPLETED|Overall Study||62||
59808638|NCT00080119|75930731|FG002|NOT COMPLETED|Overall Study||165||
59808639|NCT00080119|75930732|FG003|NOT COMPLETED|Overall Study||163||
59962557|NCT03701555|76081113|FG008|COMPLETED|Part 1 (Day 1)||3||
59962558|NCT03701555|76081114|FG009|COMPLETED|Part 1 (Day 1)||1||
59962559|NCT03701555|76081115|FG010|COMPLETED|Part 1 (Day 1)||0||
59962560|NCT03701555|76081116|FG011|COMPLETED|Part 1 (Day 1)||0||
59962561|NCT03701555|76081117|FG012|COMPLETED|Part 1 (Day 1)||0||
59962562|NCT03701555|76081118|FG013|COMPLETED|Part 1 (Day 1)||0||
59962563|NCT03701555|76081119|FG014|COMPLETED|Part 1 (Day 1)||0||
59962564|NCT03701555|76081120|FG015|COMPLETED|Part 1 (Day 1)||0||
59524560|NCT02533674|75619775|FG001|COMPLETED|Dose Level II||0||
59524561|NCT02533674|75619776|FG002|COMPLETED|Dose Level II||0||
59524562|NCT02533674|75619777|FG003|COMPLETED|Dose Level II||0||
59808640|NCT00419380|75930746|FG000|STARTED|Overall Study||19||
59808641|NCT00419380|75930747|FG001|STARTED|Overall Study||22||
59808642|NCT00419380|75930746|FG000|COMPLETED|Overall Study||18||
59808643|NCT00419380|75930747|FG001|COMPLETED|Overall Study||12||
59962565|NCT03701555|76081121|FG016|COMPLETED|Part 1 (Day 1)||0||
59962566|NCT03701555|76081122|FG017|COMPLETED|Part 1 (Day 1)||0||
59962567|NCT03701555|76081123|FG018|COMPLETED|Part 1 (Day 1)||0||
59962568|NCT03701555|76081124|FG019|COMPLETED|Part 1 (Day 1)||0||
59962569|NCT03701555|76081125|FG020|COMPLETED|Part 1 (Day 1)||0||
59962570|NCT03701555|76081126|FG021|COMPLETED|Part 1 (Day 1)||0||
59962571|NCT03701555|76081127|FG022|COMPLETED|Part 1 (Day 1)||0||
59962572|NCT03701555|76081128|FG023|COMPLETED|Part 1 (Day 1)||0||
59962573|NCT03701555|76081129|FG024|COMPLETED|Part 1 (Day 1)||0||
59962574|NCT03701555|76081130|FG025|COMPLETED|Part 1 (Day 1)||0||
59962575|NCT03701555|76081131|FG026|COMPLETED|Part 1 (Day 1)||0||
59962576|NCT03701555|76081132|FG027|COMPLETED|Part 1 (Day 1)||0||
59962577|NCT03701555|76081133|FG028|COMPLETED|Part 1 (Day 1)||0||
59962578|NCT03701555|76081134|FG029|COMPLETED|Part 1 (Day 1)||0||
59962579|NCT03701555|76081135|FG030|COMPLETED|Part 1 (Day 1)||0||
59962580|NCT03701555|76081136|FG031|COMPLETED|Part 1 (Day 1)||0||
59962581|NCT03701555|76081137|FG032|COMPLETED|Part 1 (Day 1)||0||
59962582|NCT03701555|76081138|FG033|COMPLETED|Part 1 (Day 1)||0||
59962583|NCT03701555|76081139|FG034|COMPLETED|Part 1 (Day 1)||0||
59962584|NCT03701555|76081140|FG035|COMPLETED|Part 1 (Day 1)||0||
59962585|NCT03701555|76081105|FG000|NOT COMPLETED|Part 1 (Day 1)||0||
59962586|NCT03701555|76081106|FG001|NOT COMPLETED|Part 1 (Day 1)||0||
59962587|NCT03701555|76081107|FG002|NOT COMPLETED|Part 1 (Day 1)||0||
59962588|NCT03701555|76081108|FG003|NOT COMPLETED|Part 1 (Day 1)||0||
59962589|NCT03701555|76081109|FG004|NOT COMPLETED|Part 1 (Day 1)||0||
59962590|NCT03701555|76081110|FG005|NOT COMPLETED|Part 1 (Day 1)||0||
59962591|NCT03701555|76081111|FG006|NOT COMPLETED|Part 1 (Day 1)||0||
59962592|NCT03701555|76081112|FG007|NOT COMPLETED|Part 1 (Day 1)||0||
59962593|NCT03701555|76081113|FG008|NOT COMPLETED|Part 1 (Day 1)||0||
59962594|NCT03701555|76081114|FG009|NOT COMPLETED|Part 1 (Day 1)||0||
59962595|NCT03701555|76081115|FG010|NOT COMPLETED|Part 1 (Day 1)||0||
59962596|NCT03701555|76081116|FG011|NOT COMPLETED|Part 1 (Day 1)||0||
59962597|NCT03701555|76081117|FG012|NOT COMPLETED|Part 1 (Day 1)||0||
59962598|NCT03701555|76081118|FG013|NOT COMPLETED|Part 1 (Day 1)||0||
59962599|NCT03701555|76081119|FG014|NOT COMPLETED|Part 1 (Day 1)||0||
59962600|NCT03701555|76081120|FG015|NOT COMPLETED|Part 1 (Day 1)||0||
59962601|NCT03701555|76081121|FG016|NOT COMPLETED|Part 1 (Day 1)||0||
59962602|NCT03701555|76081122|FG017|NOT COMPLETED|Part 1 (Day 1)||0||
59962603|NCT03701555|76081123|FG018|NOT COMPLETED|Part 1 (Day 1)||0||
59962604|NCT03701555|76081124|FG019|NOT COMPLETED|Part 1 (Day 1)||0||
59962605|NCT03701555|76081125|FG020|NOT COMPLETED|Part 1 (Day 1)||0||
59962606|NCT03701555|76081126|FG021|NOT COMPLETED|Part 1 (Day 1)||0||
59962607|NCT03701555|76081127|FG022|NOT COMPLETED|Part 1 (Day 1)||0||
59962608|NCT03701555|76081128|FG023|NOT COMPLETED|Part 1 (Day 1)||0||
59962609|NCT03701555|76081129|FG024|NOT COMPLETED|Part 1 (Day 1)||0||
59962610|NCT03701555|76081130|FG025|NOT COMPLETED|Part 1 (Day 1)||0||
59962611|NCT03701555|76081131|FG026|NOT COMPLETED|Part 1 (Day 1)||0||
59962612|NCT03701555|76081132|FG027|NOT COMPLETED|Part 1 (Day 1)||0||
59962613|NCT03701555|76081133|FG028|NOT COMPLETED|Part 1 (Day 1)||0||
59962614|NCT03701555|76081134|FG029|NOT COMPLETED|Part 1 (Day 1)||0||
59962615|NCT03701555|76081135|FG030|NOT COMPLETED|Part 1 (Day 1)||0||
59962616|NCT03701555|76081136|FG031|NOT COMPLETED|Part 1 (Day 1)||0||
59962617|NCT03701555|76081137|FG032|NOT COMPLETED|Part 1 (Day 1)||0||
59962618|NCT03701555|76081138|FG033|NOT COMPLETED|Part 1 (Day 1)||0||
59962619|NCT03701555|76081139|FG034|NOT COMPLETED|Part 1 (Day 1)||0||
59962620|NCT03701555|76081140|FG035|NOT COMPLETED|Part 1 (Day 1)||0||
59962621|NCT03701555|76081105|FG000|STARTED|Part 2 (Day 1)||0||
59962622|NCT03701555|76081106|FG001|STARTED|Part 2 (Day 1)||0||
60074163|NCT01808612|76189583|FG002|Received at Least 1 Dose of Study Drug|Treatment Period|Only these participants were included in the study analyses (ie, Full Analysis Set).|259||
60074164|NCT01808612|76189581|FG000|COMPLETED|Treatment Period|67 participants who completed the Treatment Period did not enter the Discontinuation Period.|154||
59962623|NCT03701555|76081107|FG002|STARTED|Part 2 (Day 1)||0||
59962624|NCT03701555|76081108|FG003|STARTED|Part 2 (Day 1)||0||
59962625|NCT03701555|76081109|FG004|STARTED|Part 2 (Day 1)||0||
59962626|NCT03701555|76081110|FG005|STARTED|Part 2 (Day 1)||0||
59962627|NCT03701555|76081111|FG006|STARTED|Part 2 (Day 1)||0||
60103595|NCT04075734|76221849|FG001|COMPLETED|Overall Study||24||
59962628|NCT03701555|76081112|FG007|STARTED|Part 2 (Day 1)||0||
59962629|NCT03701555|76081113|FG008|STARTED|Part 2 (Day 1)||0||
59962630|NCT03701555|76081114|FG009|STARTED|Part 2 (Day 1)||0||
59962631|NCT03701555|76081115|FG010|STARTED|Part 2 (Day 1)||5||
59962632|NCT03701555|76081116|FG011|STARTED|Part 2 (Day 1)||3||
59962633|NCT03701555|76081117|FG012|STARTED|Part 2 (Day 1)||2||
59962634|NCT03701555|76081118|FG013|STARTED|Part 2 (Day 1)||3||
59962635|NCT03701555|76081119|FG014|STARTED|Part 2 (Day 1)||2||
59962636|NCT03701555|76081120|FG015|STARTED|Part 2 (Day 1)||4||
59962637|NCT03701555|76081121|FG016|STARTED|Part 2 (Day 1)||7||
59962638|NCT03701555|76081122|FG017|STARTED|Part 2 (Day 1)||7||
59962639|NCT03701555|76081123|FG018|STARTED|Part 2 (Day 1)||4||
59962640|NCT03701555|76081124|FG019|STARTED|Part 2 (Day 1)||4||
59962641|NCT03701555|76081125|FG020|STARTED|Part 2 (Day 1)||4||
59962642|NCT03701555|76081126|FG021|STARTED|Part 2 (Day 1)||4||
59962643|NCT03701555|76081127|FG022|STARTED|Part 2 (Day 1)||4||
59962644|NCT03701555|76081128|FG023|STARTED|Part 2 (Day 1)||4||
59962645|NCT03701555|76081129|FG024|STARTED|Part 2 (Day 1)||0||
59962646|NCT03701555|76081130|FG025|STARTED|Part 2 (Day 1)||0||
59962647|NCT03701555|76081131|FG026|STARTED|Part 2 (Day 1)||0||
59962648|NCT03701555|76081132|FG027|STARTED|Part 2 (Day 1)||0||
59962649|NCT03701555|76081133|FG028|STARTED|Part 2 (Day 1)||0||
59962650|NCT03701555|76081134|FG029|STARTED|Part 2 (Day 1)||0||
59962651|NCT03701555|76081135|FG030|STARTED|Part 2 (Day 1)||0||
59962652|NCT03701555|76081136|FG031|STARTED|Part 2 (Day 1)||0||
59962653|NCT03701555|76081137|FG032|STARTED|Part 2 (Day 1)||0||
59962654|NCT03701555|76081138|FG033|STARTED|Part 2 (Day 1)||0||
59962655|NCT03701555|76081139|FG034|STARTED|Part 2 (Day 1)||0||
59962656|NCT03701555|76081140|FG035|STARTED|Part 2 (Day 1)||0||
59962657|NCT03701555|76081105|FG000|COMPLETED|Part 2 (Day 1)||0||
59962658|NCT03701555|76081106|FG001|COMPLETED|Part 2 (Day 1)||0||
59962659|NCT03701555|76081107|FG002|COMPLETED|Part 2 (Day 1)||0||
59962660|NCT03701555|76081108|FG003|COMPLETED|Part 2 (Day 1)||0||
59962661|NCT03701555|76081109|FG004|COMPLETED|Part 2 (Day 1)||0||
59962662|NCT03701555|76081110|FG005|COMPLETED|Part 2 (Day 1)||0||
59962663|NCT03701555|76081111|FG006|COMPLETED|Part 2 (Day 1)||0||
59962664|NCT03701555|76081112|FG007|COMPLETED|Part 2 (Day 1)||0||
59962665|NCT03701555|76081113|FG008|COMPLETED|Part 2 (Day 1)||0||
59962666|NCT03701555|76081114|FG009|COMPLETED|Part 2 (Day 1)||0||
59962667|NCT03701555|76081115|FG010|COMPLETED|Part 2 (Day 1)||2||
59962668|NCT03701555|76081116|FG011|COMPLETED|Part 2 (Day 1)||2||
59808644|NCT00419380|75930746|FG000|NOT COMPLETED|Overall Study||1||
59808645|NCT00419380|75930747|FG001|NOT COMPLETED|Overall Study||10||
59808646|NCT00413062|75930755|FG000|STARTED|Overall Study||1666||
59962669|NCT03701555|76081117|FG012|COMPLETED|Part 2 (Day 1)||2||
59962670|NCT03701555|76081118|FG013|COMPLETED|Part 2 (Day 1)||1||
59962671|NCT03701555|76081119|FG014|COMPLETED|Part 2 (Day 1)||2||
59962672|NCT03701555|76081120|FG015|COMPLETED|Part 2 (Day 1)||2||
59962673|NCT03701555|76081121|FG016|COMPLETED|Part 2 (Day 1)||4||
59962674|NCT03701555|76081122|FG017|COMPLETED|Part 2 (Day 1)||5||
59962675|NCT03701555|76081123|FG018|COMPLETED|Part 2 (Day 1)||4||
59808647|NCT00413062|75930756|FG001|STARTED|Overall Study||554||
59808648|NCT00413062|75930755|FG000|COMPLETED|Overall Study||988||
59808649|NCT00413062|75930756|FG001|COMPLETED|Overall Study||344||
59808650|NCT00413062|75930755|FG000|NOT COMPLETED|Overall Study||678||
59808651|NCT00413062|75930756|FG001|NOT COMPLETED|Overall Study||210||
59808652|NCT00494091|75930766|FG000|STARTED|Overall Study||6||
59808653|NCT00494091|75930767|FG001|STARTED|Overall Study||76||
59808654|NCT00494091|75930766|FG000|COMPLETED|Overall Study||0||
59808655|NCT00494091|75930767|FG001|COMPLETED|Overall Study||0||
59808656|NCT00494091|75930766|FG000|NOT COMPLETED|Overall Study||6||
59808657|NCT00494091|75930767|FG001|NOT COMPLETED|Overall Study||76||
59808658|NCT00494013|75930776|FG000|STARTED|Overall Study||223||
59808659|NCT00494013|75930777|FG001|STARTED|Overall Study||219||
59808660|NCT00494013|75930776|FG000|Full Analysis Set (Intent to Treat)|Overall Study||219||
59808661|NCT00494013|75930777|FG001|Full Analysis Set (Intent to Treat)|Overall Study||210||
59808662|NCT00494013|75930776|FG000|COMPLETED|Overall Study||193||
59808663|NCT00494013|75930777|FG001|COMPLETED|Overall Study||183||
59808664|NCT00494013|75930776|FG000|NOT COMPLETED|Overall Study||30||
59962676|NCT03701555|76081124|FG019|COMPLETED|Part 2 (Day 1)||4||
59962677|NCT03701555|76081125|FG020|COMPLETED|Part 2 (Day 1)||4||
59962678|NCT03701555|76081126|FG021|COMPLETED|Part 2 (Day 1)||3||
59962679|NCT03701555|76081127|FG022|COMPLETED|Part 2 (Day 1)||4||
59962680|NCT03701555|76081128|FG023|COMPLETED|Part 2 (Day 1)||3||
59808665|NCT00494013|75930777|FG001|NOT COMPLETED|Overall Study||36||
59808666|NCT00079339|75930786|FG000|STARTED|Overall Study||5||
59808667|NCT00079339|75930787|FG001|STARTED|Overall Study||40||
59962681|NCT03701555|76081129|FG024|COMPLETED|Part 2 (Day 1)||0||
59962682|NCT03701555|76081130|FG025|COMPLETED|Part 2 (Day 1)||0||
59962683|NCT03701555|76081131|FG026|COMPLETED|Part 2 (Day 1)||0||
59962684|NCT03701555|76081132|FG027|COMPLETED|Part 2 (Day 1)||0||
59962685|NCT03701555|76081133|FG028|COMPLETED|Part 2 (Day 1)||0||
60103596|NCT04075734|76221850|FG002|COMPLETED|Overall Study||10||
59808668|NCT00079339|75930788|FG002|STARTED|Overall Study||6||
59808669|NCT00079339|75930786|FG000|Enrolled in Phase I|Overall Study||5||
59808670|NCT00079339|75930787|FG001|Enrolled in Phase I|Overall Study||6||
59962686|NCT03701555|76081134|FG029|COMPLETED|Part 2 (Day 1)||0||
59962687|NCT03701555|76081135|FG030|COMPLETED|Part 2 (Day 1)||0||
59962688|NCT03701555|76081136|FG031|COMPLETED|Part 2 (Day 1)||0||
59962689|NCT03701555|76081137|FG032|COMPLETED|Part 2 (Day 1)||0||
59962690|NCT03701555|76081138|FG033|COMPLETED|Part 2 (Day 1)||0||
59962691|NCT03701555|76081139|FG034|COMPLETED|Part 2 (Day 1)||0||
59962692|NCT03701555|76081140|FG035|COMPLETED|Part 2 (Day 1)||0||
59962693|NCT03701555|76081105|FG000|NOT COMPLETED|Part 2 (Day 1)||0||
59962694|NCT03701555|76081106|FG001|NOT COMPLETED|Part 2 (Day 1)||0||
59962695|NCT03701555|76081107|FG002|NOT COMPLETED|Part 2 (Day 1)||0||
59962696|NCT03701555|76081108|FG003|NOT COMPLETED|Part 2 (Day 1)||0||
59808671|NCT00079339|75930788|FG002|Enrolled in Phase I|Overall Study||6||
59808672|NCT00079339|75930786|FG000|Maximum Tolerated Dose (MTD) Estimation|Overall Study|2 participants enrolled in the phase I part did not complete the 8 week MTD estimation period.|3||
59808673|NCT00079339|75930787|FG001|Maximum Tolerated Dose (MTD) Estimation|Overall Study||6||
59962697|NCT03701555|76081109|FG004|NOT COMPLETED|Part 2 (Day 1)||0||
59962698|NCT03701555|76081110|FG005|NOT COMPLETED|Part 2 (Day 1)||0||
59962699|NCT03701555|76081111|FG006|NOT COMPLETED|Part 2 (Day 1)||0||
59962700|NCT03701555|76081112|FG007|NOT COMPLETED|Part 2 (Day 1)||0||
59962701|NCT03701555|76081113|FG008|NOT COMPLETED|Part 2 (Day 1)||0||
59962702|NCT03701555|76081114|FG009|NOT COMPLETED|Part 2 (Day 1)||0||
59962703|NCT03701555|76081115|FG010|NOT COMPLETED|Part 2 (Day 1)||3||
59962704|NCT03701555|76081116|FG011|NOT COMPLETED|Part 2 (Day 1)||1||
59962705|NCT03701555|76081117|FG012|NOT COMPLETED|Part 2 (Day 1)||0||
59962706|NCT03701555|76081118|FG013|NOT COMPLETED|Part 2 (Day 1)||2||
59962707|NCT03701555|76081119|FG014|NOT COMPLETED|Part 2 (Day 1)||0||
59962708|NCT03701555|76081120|FG015|NOT COMPLETED|Part 2 (Day 1)||2||
59962709|NCT03701555|76081121|FG016|NOT COMPLETED|Part 2 (Day 1)||3||
59962710|NCT03701555|76081122|FG017|NOT COMPLETED|Part 2 (Day 1)||2||
59962711|NCT03701555|76081123|FG018|NOT COMPLETED|Part 2 (Day 1)||0||
59962712|NCT03701555|76081124|FG019|NOT COMPLETED|Part 2 (Day 1)||0||
59962713|NCT03701555|76081125|FG020|NOT COMPLETED|Part 2 (Day 1)||0||
59962714|NCT03701555|76081126|FG021|NOT COMPLETED|Part 2 (Day 1)||1||
59962715|NCT03701555|76081127|FG022|NOT COMPLETED|Part 2 (Day 1)||0||
59962716|NCT03701555|76081128|FG023|NOT COMPLETED|Part 2 (Day 1)||1||
59962717|NCT03701555|76081129|FG024|NOT COMPLETED|Part 2 (Day 1)||0||
59808674|NCT00079339|75930788|FG002|Maximum Tolerated Dose (MTD) Estimation|Overall Study|One participant enrolled in the phase I part did not complete the 8 week MTD estimation period.|5||
59808675|NCT00079339|75930786|FG000|Enrolled in Phase II|Overall Study|Participants treated at the 100 mg/m2 dose level did not participate in the phase II part.|0||
59817880|NCT04488770|75940332|FG006|STARTED|Part 1-Cohort 2: Period 1 (Up to 5 Days)||2||
59962718|NCT03701555|76081130|FG025|NOT COMPLETED|Part 2 (Day 1)||0||
59962719|NCT03701555|76081131|FG026|NOT COMPLETED|Part 2 (Day 1)||0||
59962720|NCT03701555|76081132|FG027|NOT COMPLETED|Part 2 (Day 1)||0||
59962721|NCT03701555|76081133|FG028|NOT COMPLETED|Part 2 (Day 1)||0||
59962722|NCT03701555|76081134|FG029|NOT COMPLETED|Part 2 (Day 1)||0||
59962723|NCT03701555|76081135|FG030|NOT COMPLETED|Part 2 (Day 1)||0||
59962724|NCT03701555|76081136|FG031|NOT COMPLETED|Part 2 (Day 1)||0||
59962725|NCT03701555|76081137|FG032|NOT COMPLETED|Part 2 (Day 1)||0||
59962726|NCT03701555|76081138|FG033|NOT COMPLETED|Part 2 (Day 1)||0||
59962727|NCT03701555|76081139|FG034|NOT COMPLETED|Part 2 (Day 1)||0||
59962728|NCT03701555|76081140|FG035|NOT COMPLETED|Part 2 (Day 1)||0||
59962729|NCT03701555|76081105|FG000|STARTED|Part 3 (Day 1)||0||
59962730|NCT03701555|76081106|FG001|STARTED|Part 3 (Day 1)||0||
59962731|NCT03701555|76081107|FG002|STARTED|Part 3 (Day 1)||0||
59962732|NCT03701555|76081108|FG003|STARTED|Part 3 (Day 1)||0||
59962733|NCT03701555|76081109|FG004|STARTED|Part 3 (Day 1)||0||
59962734|NCT03701555|76081110|FG005|STARTED|Part 3 (Day 1)||0||
59962735|NCT03701555|76081111|FG006|STARTED|Part 3 (Day 1)||0||
59962736|NCT03701555|76081112|FG007|STARTED|Part 3 (Day 1)||0||
59962737|NCT03701555|76081113|FG008|STARTED|Part 3 (Day 1)||0||
59962738|NCT03701555|76081114|FG009|STARTED|Part 3 (Day 1)||0||
59962739|NCT03701555|76081115|FG010|STARTED|Part 3 (Day 1)||0||
59962740|NCT03701555|76081116|FG011|STARTED|Part 3 (Day 1)||0||
59962741|NCT03701555|76081117|FG012|STARTED|Part 3 (Day 1)||0||
59962742|NCT03701555|76081118|FG013|STARTED|Part 3 (Day 1)||0||
59962743|NCT03701555|76081119|FG014|STARTED|Part 3 (Day 1)||0||
59962744|NCT03701555|76081120|FG015|STARTED|Part 3 (Day 1)||0||
59962745|NCT03701555|76081121|FG016|STARTED|Part 3 (Day 1)||0||
59962746|NCT03701555|76081122|FG017|STARTED|Part 3 (Day 1)||0||
59962747|NCT03701555|76081123|FG018|STARTED|Part 3 (Day 1)||0||
59962748|NCT03701555|76081124|FG019|STARTED|Part 3 (Day 1)||0||
59962749|NCT03701555|76081125|FG020|STARTED|Part 3 (Day 1)||0||
59621186|NCT00244140|75732724|FG000|NOT COMPLETED|Overall Study||0||
59621187|NCT00244140|75732725|FG001|NOT COMPLETED|Overall Study||0||
59621188|NCT00126750|75732733|FG000|STARTED|Overall Study|Number of providers from 84 clinics|385||
59621189|NCT00126750|75732734|FG001|STARTED|Overall Study|Number of providers from 84 clinics|462||
59621190|NCT00126750|75732733|FG000|COMPLETED|Overall Study|Total providers at participating clinic locations were given the option to 'enroll'.|205||
59621191|NCT00126750|75732734|FG001|COMPLETED|Overall Study|Total providers at clinic locations were given the option to 'enroll'.|196||
59621192|NCT00126750|75732733|FG000|NOT COMPLETED|Overall Study||180||
59621193|NCT00126750|75732734|FG001|NOT COMPLETED|Overall Study||266||
59962750|NCT03701555|76081126|FG021|STARTED|Part 3 (Day 1)||0||
59962751|NCT03701555|76081127|FG022|STARTED|Part 3 (Day 1)||0||
59962752|NCT03701555|76081128|FG023|STARTED|Part 3 (Day 1)||0||
59962753|NCT03701555|76081129|FG024|STARTED|Part 3 (Day 1)||3||
59962754|NCT03701555|76081130|FG025|STARTED|Part 3 (Day 1)||5||
59962755|NCT03701555|76081131|FG026|STARTED|Part 3 (Day 1)||2||
59962756|NCT03701555|76081132|FG027|STARTED|Part 3 (Day 1)||5||
59962757|NCT03701555|76081133|FG028|STARTED|Part 3 (Day 1)||3||
59962758|NCT03701555|76081134|FG029|STARTED|Part 3 (Day 1)||4||
59962759|NCT03701555|76081135|FG030|STARTED|Part 3 (Day 1)||4||
59962760|NCT03701555|76081136|FG031|STARTED|Part 3 (Day 1)||6||
59962761|NCT03701555|76081137|FG032|STARTED|Part 3 (Day 1)||7||
59962762|NCT03701555|76081138|FG033|STARTED|Part 3 (Day 1)||9||
59962763|NCT03701555|76081139|FG034|STARTED|Part 3 (Day 1)||0||
59962764|NCT03701555|76081140|FG035|STARTED|Part 3 (Day 1)||0||
59962765|NCT03701555|76081105|FG000|COMPLETED|Part 3 (Day 1)||0||
59962766|NCT03701555|76081106|FG001|COMPLETED|Part 3 (Day 1)||0||
59962767|NCT03701555|76081107|FG002|COMPLETED|Part 3 (Day 1)||0||
59962768|NCT03701555|76081108|FG003|COMPLETED|Part 3 (Day 1)||0||
59621194|NCT00127062|75732742|FG000|STARTED|First intervention_Oxford Street||31||
59621195|NCT00127062|75732743|FG001|STARTED|First intervention_Oxford Street||29||
59621196|NCT00127062|75732742|FG000|COMPLETED|First intervention_Oxford Street||31||
59621197|NCT00127062|75732743|FG001|COMPLETED|First intervention_Oxford Street||29||
59621198|NCT00127062|75732742|FG000|NOT COMPLETED|First intervention_Oxford Street||0||
59621199|NCT00127062|75732743|FG001|NOT COMPLETED|First intervention_Oxford Street||0||
59621200|NCT00127062|75732742|FG000|STARTED|Second intervention_Hyde Park||31||
59621201|NCT00127062|75732743|FG001|STARTED|Second intervention_Hyde Park||29||
59621202|NCT00127062|75732742|FG000|COMPLETED|Second intervention_Hyde Park||31||
59621203|NCT00127062|75732743|FG001|COMPLETED|Second intervention_Hyde Park||29||
59621204|NCT00127062|75732742|FG000|NOT COMPLETED|Second intervention_Hyde Park||0||
59621205|NCT00127062|75732743|FG001|NOT COMPLETED|Second intervention_Hyde Park||0||
59621206|NCT00127218|75732755|FG000|STARTED|Overall Study||72||
59621207|NCT00127218|75732756|FG001|STARTED|Overall Study||73||
59621208|NCT00127218|75732755|FG000|COMPLETED|Overall Study||59||
59621209|NCT00127218|75732756|FG001|COMPLETED|Overall Study||58||
59621210|NCT00127218|75732755|FG000|NOT COMPLETED|Overall Study||13||
59621211|NCT00127218|75732756|FG001|NOT COMPLETED|Overall Study||15||
59621212|NCT00127530|75732766|FG000|STARTED|Overall Study||72||
59621213|NCT00127530|75732767|FG001|STARTED|Overall Study||228||
59621214|NCT00127530|75732766|FG000|COMPLETED|Overall Study||71||
59621215|NCT00127530|75732767|FG001|COMPLETED|Overall Study||207||
59621216|NCT00127530|75732766|FG000|NOT COMPLETED|Overall Study||1||
59621217|NCT00127530|75732767|FG001|NOT COMPLETED|Overall Study||21||
59621218|NCT00250926|75732773|FG000|STARTED|Overall Study||23||
59621219|NCT00250926|75732773|FG000|COMPLETED|Overall Study||23||
59621220|NCT00250926|75732773|FG000|NOT COMPLETED|Overall Study||0||
59621221|NCT00251238|75732780|FG000|STARTED|Overall Study||21||
59621222|NCT00251238|75732781|FG001|STARTED|Overall Study||20||
59621223|NCT00251238|75732780|FG000|COMPLETED|Overall Study||21||
59621224|NCT00251238|75732781|FG001|COMPLETED|Overall Study||20||
59621225|NCT00251238|75732780|FG000|NOT COMPLETED|Overall Study||0||
59808676|NCT00079339|75930787|FG001|Enrolled in Phase II|Overall Study|This number includes the 6 patients enrolled on the phase I part.|40||
59808677|NCT00079339|75930788|FG002|Enrolled in Phase II|Overall Study|Participants treated at the 150 mg/m2 dose level did not participate in the phase II part.|0||
59808678|NCT00079339|75930786|FG000|COMPLETED|Overall Study||0||
59808679|NCT00079339|75930787|FG001|COMPLETED|Overall Study||1||
59808680|NCT00079339|75930788|FG002|COMPLETED|Overall Study||0||
59808681|NCT00079339|75930786|FG000|NOT COMPLETED|Overall Study||5||
59808682|NCT00079339|75930787|FG001|NOT COMPLETED|Overall Study||39||
59808683|NCT00079339|75930788|FG002|NOT COMPLETED|Overall Study||6||
59808684|NCT00493779|75930801|FG000|STARTED|Overall Study|Number of subjects who had discontinued clopidogrel treatment and entered follow-up phase|98||
59808685|NCT00493779|75930801|FG000|COMPLETED|Overall Study|Completed follow-up phase|97||
59808686|NCT00493779|75930801|FG000|NOT COMPLETED|Overall Study||1||
59808687|NCT00541866|75930811|FG000|STARTED|Overall Study|41 started, but only 39 treated|41||
59808688|NCT00541866|75930812|FG001|STARTED|Overall Study||18||
59808689|NCT00541866|75930813|FG002|STARTED|Overall Study||17||
59808690|NCT00541866|75930814|FG003|STARTED|Overall Study||16||
59808691|NCT00541866|75930815|FG004|STARTED|Overall Study||18||
59808692|NCT00541866|75930811|FG000|COMPLETED|Overall Study||7||
59808693|NCT00541866|75930812|FG001|COMPLETED|Overall Study||0||
59808694|NCT00541866|75930813|FG002|COMPLETED|Overall Study||2||
59808695|NCT00541866|75930814|FG003|COMPLETED|Overall Study||0||
59808696|NCT00541866|75930815|FG004|COMPLETED|Overall Study||3||
59808697|NCT00541866|75930811|FG000|NOT COMPLETED|Overall Study||34||
59808698|NCT00541866|75930812|FG001|NOT COMPLETED|Overall Study||18||
59808699|NCT00541866|75930813|FG002|NOT COMPLETED|Overall Study||15||
59808700|NCT00541866|75930814|FG003|NOT COMPLETED|Overall Study||16||
59808701|NCT00541866|75930815|FG004|NOT COMPLETED|Overall Study||15||
59808702|NCT00493467|75930843|FG000|STARTED|Overall Study||31||
59808703|NCT00493467|75930843|FG000|COMPLETED|Overall Study||30||
59808704|NCT00493467|75930843|FG000|NOT COMPLETED|Overall Study||1||
59808705|NCT00090493|75930847|FG000|STARTED|Overall Study||4||
59962769|NCT03701555|76081109|FG004|COMPLETED|Part 3 (Day 1)||0||
59808706|NCT00090493|75930847|FG000|COMPLETED|Overall Study||2||
59808707|NCT00090493|75930847|FG000|NOT COMPLETED|Overall Study||2||
59962770|NCT03701555|76081110|FG005|COMPLETED|Part 3 (Day 1)||0||
59962771|NCT03701555|76081111|FG006|COMPLETED|Part 3 (Day 1)||0||
59962772|NCT03701555|76081112|FG007|COMPLETED|Part 3 (Day 1)||0||
59962773|NCT03701555|76081113|FG008|COMPLETED|Part 3 (Day 1)||0||
59621226|NCT00251238|75732781|FG001|NOT COMPLETED|Overall Study||0||
59621227|NCT00251862|75732790|FG000|STARTED|Overall Study||280||
59621228|NCT00251862|75732791|FG001|STARTED|Overall Study||269||
59621229|NCT00251862|75732792|FG002|STARTED|Overall Study||276||
59621230|NCT00251862|75732790|FG000|COMPLETED|Overall Study||280||
59621231|NCT00251862|75732791|FG001|COMPLETED|Overall Study||269||
59808708|NCT04329702|75930854|FG000|STARTED|Overall Study||16||
59808709|NCT04329702|75930855|FG001|STARTED|Overall Study||14||
59808710|NCT04329702|75930856|FG002|STARTED|Overall Study||15||
59808711|NCT04329702|75930854|FG000|COMPLETED|Overall Study||13||
59808712|NCT04329702|75930855|FG001|COMPLETED|Overall Study||8||
59962774|NCT03701555|76081114|FG009|COMPLETED|Part 3 (Day 1)||0||
59621232|NCT00251862|75732792|FG002|COMPLETED|Overall Study||276||
59621233|NCT00251862|75732790|FG000|NOT COMPLETED|Overall Study||0||
59621234|NCT00251862|75732791|FG001|NOT COMPLETED|Overall Study||0||
59621235|NCT00251862|75732792|FG002|NOT COMPLETED|Overall Study||0||
59621236|NCT00303966|75732800|FG000|STARTED|Overall Study||5||
59621237|NCT00303966|75732800|FG000|COMPLETED|Overall Study||5||
59621238|NCT00303966|75732800|FG000|NOT COMPLETED|Overall Study||0||
59621239|NCT00304512|75732807|FG000|STARTED|Treatment Period||2||
59621240|NCT00304512|75732808|FG001|STARTED|Treatment Period||4||
59621241|NCT00304512|75732809|FG002|STARTED|Treatment Period||3||
59621242|NCT00304512|75732807|FG000|Safety Population|Treatment Period||2|Received at least 1 dose of study drug|
59621243|NCT00304512|75732808|FG001|Safety Population|Treatment Period||4|Received at least 1 dose of study drug|
59621244|NCT00304512|75732809|FG002|Safety Population|Treatment Period||3|Received at least 1 dose of study drug|
59621245|NCT00304512|75732807|FG000|Pharmacokinetic (PK) Population|Treatment Period||2|Received study drug and had at least 1 postbaseline PK parameter recorded|
59621246|NCT00304512|75732808|FG001|Pharmacokinetic (PK) Population|Treatment Period||4|Received study drug and had at least 1 postbaseline PK parameter recorded|
59621247|NCT00304512|75732809|FG002|Pharmacokinetic (PK) Population|Treatment Period||3|Received study drug and had at least 1 postbaseline PK parameter recorded|
59621248|NCT00304512|75732807|FG000|Pharmacodynamic (PD) Population|Treatment Period||2|Received study drug and had at least 1 postbaseline PD parameter recorded|
59621249|NCT00304512|75732808|FG001|Pharmacodynamic (PD) Population|Treatment Period||4|Received study drug and had at least 1 postbaseline PD parameter recorded|
59621250|NCT00304512|75732809|FG002|Pharmacodynamic (PD) Population|Treatment Period||3|Received study drug and had at least 1 postbaseline PD parameter recorded|
59621251|NCT00304512|75732807|FG000|COMPLETED|Treatment Period||2||
59621252|NCT00304512|75732808|FG001|COMPLETED|Treatment Period||4||
59621253|NCT00304512|75732809|FG002|COMPLETED|Treatment Period||3||
59621254|NCT00304512|75732807|FG000|NOT COMPLETED|Treatment Period||0||
59621255|NCT00304512|75732808|FG001|NOT COMPLETED|Treatment Period||0||
59621256|NCT00304512|75732809|FG002|NOT COMPLETED|Treatment Period||0||
59621257|NCT00304512|75732807|FG000|STARTED|Extension Period||2||
59621258|NCT00304512|75732808|FG001|STARTED|Extension Period||4||
59621259|NCT00304512|75732809|FG002|STARTED|Extension Period||3||
59621260|NCT00304512|75732807|FG000|COMPLETED|Extension Period||2||
59621261|NCT00304512|75732808|FG001|COMPLETED|Extension Period||4||
59621262|NCT00304512|75732809|FG002|COMPLETED|Extension Period||3||
59621263|NCT00304512|75732807|FG000|NOT COMPLETED|Extension Period||0||
59621264|NCT00304512|75732808|FG001|NOT COMPLETED|Extension Period||0||
59962775|NCT03701555|76081115|FG010|COMPLETED|Part 3 (Day 1)||0||
59621265|NCT00304512|75732809|FG002|NOT COMPLETED|Extension Period||0||
59621266|NCT00304746|75732819|FG000|STARTED|Overall Study||50||
59621267|NCT00304746|75732820|FG001|STARTED|Overall Study||50||
59621268|NCT00304746|75732819|FG000|COMPLETED|Overall Study||50||
59621269|NCT00304746|75732820|FG001|COMPLETED|Overall Study||50||
59621270|NCT00304746|75732819|FG000|NOT COMPLETED|Overall Study||0||
59621271|NCT00304746|75732820|FG001|NOT COMPLETED|Overall Study||0||
59621272|NCT00134004|75732826|FG000|STARTED|Overall Study||210||
59621273|NCT00134004|75732826|FG000|COMPLETED|Overall Study||210||
59621274|NCT00134004|75732826|FG000|NOT COMPLETED|Overall Study||0||
59621275|NCT00135798|75732833|FG000|STARTED|Overall Study||16||
59621276|NCT00135798|75732834|FG001|STARTED|Overall Study||31||
59621277|NCT00135798|75732835|FG002|STARTED|Overall Study||32||
59621278|NCT00135798|75732833|FG000|COMPLETED|Overall Study||16||
59621279|NCT00135798|75732834|FG001|COMPLETED|Overall Study||31||
59962776|NCT03701555|76081116|FG011|COMPLETED|Part 3 (Day 1)||0||
59962777|NCT03701555|76081117|FG012|COMPLETED|Part 3 (Day 1)||0||
59962778|NCT03701555|76081118|FG013|COMPLETED|Part 3 (Day 1)||0||
59962779|NCT03701555|76081119|FG014|COMPLETED|Part 3 (Day 1)||0||
59621280|NCT00135798|75732835|FG002|COMPLETED|Overall Study||32||
59621281|NCT00135798|75732833|FG000|NOT COMPLETED|Overall Study||0||
59962780|NCT03701555|76081120|FG015|COMPLETED|Part 3 (Day 1)||0||
59962781|NCT03701555|76081121|FG016|COMPLETED|Part 3 (Day 1)||0||
59962782|NCT03701555|76081122|FG017|COMPLETED|Part 3 (Day 1)||0||
59962783|NCT03701555|76081123|FG018|COMPLETED|Part 3 (Day 1)||0||
59962784|NCT03701555|76081124|FG019|COMPLETED|Part 3 (Day 1)||0||
59962785|NCT03701555|76081125|FG020|COMPLETED|Part 3 (Day 1)||0||
59962786|NCT03701555|76081126|FG021|COMPLETED|Part 3 (Day 1)||0||
59962787|NCT03701555|76081127|FG022|COMPLETED|Part 3 (Day 1)||0||
59621282|NCT00135798|75732834|FG001|NOT COMPLETED|Overall Study||0||
59621283|NCT00135798|75732835|FG002|NOT COMPLETED|Overall Study||0||
59621284|NCT00136812|75732844|FG000|STARTED|Overall Study||111||
59621285|NCT00136812|75732845|FG001|STARTED|Overall Study||113||
59621286|NCT00136812|75732844|FG000|COMPLETED|Overall Study||111||
59962788|NCT03701555|76081128|FG023|COMPLETED|Part 3 (Day 1)||0||
59621287|NCT00136812|75732845|FG001|COMPLETED|Overall Study||113||
59962789|NCT03701555|76081129|FG024|COMPLETED|Part 3 (Day 1)||2||
59621288|NCT00136812|75732844|FG000|NOT COMPLETED|Overall Study||0||
59962790|NCT03701555|76081130|FG025|COMPLETED|Part 3 (Day 1)||4||
59962791|NCT03701555|76081131|FG026|COMPLETED|Part 3 (Day 1)||1||
59621289|NCT00136812|75732845|FG001|NOT COMPLETED|Overall Study||0||
59962792|NCT03701555|76081132|FG027|COMPLETED|Part 3 (Day 1)||5||
59962793|NCT03701555|76081133|FG028|COMPLETED|Part 3 (Day 1)||3||
59962794|NCT03701555|76081134|FG029|COMPLETED|Part 3 (Day 1)||2||
59808713|NCT04329702|75930856|FG002|COMPLETED|Overall Study||13||
59808714|NCT04329702|75930854|FG000|NOT COMPLETED|Overall Study||3||
59962795|NCT03701555|76081135|FG030|COMPLETED|Part 3 (Day 1)||3||
59962796|NCT03701555|76081136|FG031|COMPLETED|Part 3 (Day 1)||3||
59962797|NCT03701555|76081137|FG032|COMPLETED|Part 3 (Day 1)||5||
59962798|NCT03701555|76081138|FG033|COMPLETED|Part 3 (Day 1)||7||
59962799|NCT03701555|76081139|FG034|COMPLETED|Part 3 (Day 1)||0||
59962800|NCT03701555|76081140|FG035|COMPLETED|Part 3 (Day 1)||0||
59962801|NCT03701555|76081105|FG000|NOT COMPLETED|Part 3 (Day 1)||0||
59962802|NCT03701555|76081106|FG001|NOT COMPLETED|Part 3 (Day 1)||0||
59962803|NCT03701555|76081107|FG002|NOT COMPLETED|Part 3 (Day 1)||0||
59962804|NCT03701555|76081108|FG003|NOT COMPLETED|Part 3 (Day 1)||0||
59962805|NCT03701555|76081109|FG004|NOT COMPLETED|Part 3 (Day 1)||0||
59962806|NCT03701555|76081110|FG005|NOT COMPLETED|Part 3 (Day 1)||0||
59962807|NCT03701555|76081111|FG006|NOT COMPLETED|Part 3 (Day 1)||0||
59962808|NCT03701555|76081112|FG007|NOT COMPLETED|Part 3 (Day 1)||0||
59962809|NCT03701555|76081113|FG008|NOT COMPLETED|Part 3 (Day 1)||0||
59962810|NCT03701555|76081114|FG009|NOT COMPLETED|Part 3 (Day 1)||0||
59962811|NCT03701555|76081115|FG010|NOT COMPLETED|Part 3 (Day 1)||0||
59962812|NCT03701555|76081116|FG011|NOT COMPLETED|Part 3 (Day 1)||0||
59962813|NCT03701555|76081117|FG012|NOT COMPLETED|Part 3 (Day 1)||0||
59962814|NCT03701555|76081118|FG013|NOT COMPLETED|Part 3 (Day 1)||0||
59962815|NCT03701555|76081119|FG014|NOT COMPLETED|Part 3 (Day 1)||0||
59962816|NCT03701555|76081120|FG015|NOT COMPLETED|Part 3 (Day 1)||0||
59962817|NCT03701555|76081121|FG016|NOT COMPLETED|Part 3 (Day 1)||0||
59962818|NCT03701555|76081122|FG017|NOT COMPLETED|Part 3 (Day 1)||0||
59962819|NCT03701555|76081123|FG018|NOT COMPLETED|Part 3 (Day 1)||0||
59962820|NCT03701555|76081124|FG019|NOT COMPLETED|Part 3 (Day 1)||0||
59962821|NCT03701555|76081125|FG020|NOT COMPLETED|Part 3 (Day 1)||0||
59962822|NCT03701555|76081126|FG021|NOT COMPLETED|Part 3 (Day 1)||0||
59962823|NCT03701555|76081127|FG022|NOT COMPLETED|Part 3 (Day 1)||0||
59962824|NCT03701555|76081128|FG023|NOT COMPLETED|Part 3 (Day 1)||0||
59962825|NCT03701555|76081129|FG024|NOT COMPLETED|Part 3 (Day 1)||1||
59962826|NCT03701555|76081130|FG025|NOT COMPLETED|Part 3 (Day 1)||1||
59962827|NCT03701555|76081131|FG026|NOT COMPLETED|Part 3 (Day 1)||1||
59962828|NCT03701555|76081132|FG027|NOT COMPLETED|Part 3 (Day 1)||0||
59962829|NCT03701555|76081133|FG028|NOT COMPLETED|Part 3 (Day 1)||0||
59962830|NCT03701555|76081134|FG029|NOT COMPLETED|Part 3 (Day 1)||2||
59962831|NCT03701555|76081135|FG030|NOT COMPLETED|Part 3 (Day 1)||1||
59962832|NCT03701555|76081136|FG031|NOT COMPLETED|Part 3 (Day 1)||3||
59962833|NCT03701555|76081137|FG032|NOT COMPLETED|Part 3 (Day 1)||2||
59962834|NCT03701555|76081138|FG033|NOT COMPLETED|Part 3 (Day 1)||2||
59962835|NCT03701555|76081139|FG034|NOT COMPLETED|Part 3 (Day 1)||0||
59962836|NCT03701555|76081140|FG035|NOT COMPLETED|Part 3 (Day 1)||0||
59962837|NCT03701555|76081105|FG000|STARTED|Part 4, Period 1 (Days 1 to 5)||0||
59962838|NCT03701555|76081106|FG001|STARTED|Part 4, Period 1 (Days 1 to 5)||0||
59962839|NCT03701555|76081107|FG002|STARTED|Part 4, Period 1 (Days 1 to 5)||0||
59808715|NCT04329702|75930855|FG001|NOT COMPLETED|Overall Study||6||
59808716|NCT04329702|75930856|FG002|NOT COMPLETED|Overall Study||2||
59808717|NCT04221828|75930865|FG000|STARTED|Overall Study||1||
59808718|NCT04221828|75930865|FG000|COMPLETED|Overall Study||1||
59808719|NCT04221828|75930865|FG000|NOT COMPLETED|Overall Study||0||
59808720|NCT00481065|75930877|FG000|STARTED|Overall Study||51||
59808721|NCT00481065|75930878|FG001|STARTED|Overall Study||50||
59808722|NCT00481065|75930879|FG002|STARTED|Overall Study||51||
59808723|NCT00481065|75930880|FG003|STARTED|Overall Study||52||
59962840|NCT03701555|76081108|FG003|STARTED|Part 4, Period 1 (Days 1 to 5)||0||
59962841|NCT03701555|76081109|FG004|STARTED|Part 4, Period 1 (Days 1 to 5)||0||
59962842|NCT03701555|76081110|FG005|STARTED|Part 4, Period 1 (Days 1 to 5)||0||
59962843|NCT03701555|76081111|FG006|STARTED|Part 4, Period 1 (Days 1 to 5)||0||
59962844|NCT03701555|76081112|FG007|STARTED|Part 4, Period 1 (Days 1 to 5)||0||
59962845|NCT03701555|76081113|FG008|STARTED|Part 4, Period 1 (Days 1 to 5)||0||
59962846|NCT03701555|76081114|FG009|STARTED|Part 4, Period 1 (Days 1 to 5)||0||
59808724|NCT00481065|75930881|FG004|STARTED|Overall Study||51||
59808725|NCT00481065|75930882|FG005|STARTED|Overall Study||51||
59962847|NCT03701555|76081115|FG010|STARTED|Part 4, Period 1 (Days 1 to 5)||0||
59962848|NCT03701555|76081116|FG011|STARTED|Part 4, Period 1 (Days 1 to 5)||0||
59808726|NCT00481065|75930883|FG006|STARTED|Overall Study||50||
59962849|NCT03701555|76081117|FG012|STARTED|Part 4, Period 1 (Days 1 to 5)||0||
59962850|NCT03701555|76081118|FG013|STARTED|Part 4, Period 1 (Days 1 to 5)||0||
59962851|NCT03701555|76081119|FG014|STARTED|Part 4, Period 1 (Days 1 to 5)||0||
59962852|NCT03701555|76081120|FG015|STARTED|Part 4, Period 1 (Days 1 to 5)||0||
59962853|NCT03701555|76081121|FG016|STARTED|Part 4, Period 1 (Days 1 to 5)||0||
59962854|NCT03701555|76081122|FG017|STARTED|Part 4, Period 1 (Days 1 to 5)||0||
59962855|NCT03701555|76081123|FG018|STARTED|Part 4, Period 1 (Days 1 to 5)||0||
59962856|NCT03701555|76081124|FG019|STARTED|Part 4, Period 1 (Days 1 to 5)||0||
59962857|NCT03701555|76081125|FG020|STARTED|Part 4, Period 1 (Days 1 to 5)||0||
59962858|NCT03701555|76081126|FG021|STARTED|Part 4, Period 1 (Days 1 to 5)||0||
59808727|NCT00481065|75930884|FG007|STARTED|Overall Study||49||
59808728|NCT00481065|75930877|FG000|COMPLETED|Overall Study||29||
59808729|NCT00481065|75930878|FG001|COMPLETED|Overall Study||33||
59962859|NCT03701555|76081127|FG022|STARTED|Part 4, Period 1 (Days 1 to 5)||0||
59962860|NCT03701555|76081128|FG023|STARTED|Part 4, Period 1 (Days 1 to 5)||0||
59962861|NCT03701555|76081129|FG024|STARTED|Part 4, Period 1 (Days 1 to 5)||0||
59962862|NCT03701555|76081130|FG025|STARTED|Part 4, Period 1 (Days 1 to 5)||0||
59962863|NCT03701555|76081131|FG026|STARTED|Part 4, Period 1 (Days 1 to 5)||0||
59962864|NCT03701555|76081132|FG027|STARTED|Part 4, Period 1 (Days 1 to 5)||0||
59962865|NCT03701555|76081133|FG028|STARTED|Part 4, Period 1 (Days 1 to 5)||0||
59962866|NCT03701555|76081134|FG029|STARTED|Part 4, Period 1 (Days 1 to 5)||0||
59962867|NCT03701555|76081135|FG030|STARTED|Part 4, Period 1 (Days 1 to 5)||0||
59962868|NCT03701555|76081136|FG031|STARTED|Part 4, Period 1 (Days 1 to 5)||0||
59962869|NCT03701555|76081137|FG032|STARTED|Part 4, Period 1 (Days 1 to 5)||0||
59962870|NCT03701555|76081138|FG033|STARTED|Part 4, Period 1 (Days 1 to 5)||0||
59962871|NCT03701555|76081139|FG034|STARTED|Part 4, Period 1 (Days 1 to 5)|Part 4 had crossover-design where participants were enrolled in Cohort Treatment Period 1, and entered the Cohort Treatment Period 2 after 3 days of washout period.|3||
59962872|NCT03701555|76081140|FG035|STARTED|Part 4, Period 1 (Days 1 to 5)|Part 4 had crossover-design where participants were enrolled in Cohort Treatment Period 1, and entered the Cohort Treatment Period 2 after 3 days of washout period.|3||
60074165|NCT01808612|76189582|FG001|COMPLETED|Treatment Period|39 participants who completed the Treatment Period did not enter the Discontinuation Period.|77||
60074166|NCT01808612|76189583|FG002|COMPLETED|Treatment Period|101 participants who completed the Treatment Period did not enter the Discontinuation Period.|246||
59962873|NCT03701555|76081105|FG000|COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
59808730|NCT00481065|75930879|FG002|COMPLETED|Overall Study||32||
59808731|NCT00481065|75930880|FG003|COMPLETED|Overall Study||37||
59808732|NCT00481065|75930881|FG004|COMPLETED|Overall Study||28||
59808733|NCT00481065|75930882|FG005|COMPLETED|Overall Study||27||
59808734|NCT00481065|75930883|FG006|COMPLETED|Overall Study||34||
59808735|NCT00481065|75930884|FG007|COMPLETED|Overall Study||30||
59808736|NCT00481065|75930877|FG000|NOT COMPLETED|Overall Study||22||
59808737|NCT00481065|75930878|FG001|NOT COMPLETED|Overall Study||17||
59808738|NCT00481065|75930879|FG002|NOT COMPLETED|Overall Study||19||
59808739|NCT00481065|75930880|FG003|NOT COMPLETED|Overall Study||15||
59808740|NCT00481065|75930881|FG004|NOT COMPLETED|Overall Study||23||
59808741|NCT00481065|75930882|FG005|NOT COMPLETED|Overall Study||24||
59808742|NCT00481065|75930883|FG006|NOT COMPLETED|Overall Study||16||
59808743|NCT00481065|75930884|FG007|NOT COMPLETED|Overall Study||19||
59808744|NCT00493311|75930906|FG000|STARTED|Overall Study||29||
59808745|NCT00493311|75930907|FG001|STARTED|Overall Study||31||
59808746|NCT00493311|75930906|FG000|COMPLETED|Overall Study||27||
59808747|NCT00493311|75930907|FG001|COMPLETED|Overall Study||29||
59808748|NCT00493311|75930906|FG000|NOT COMPLETED|Overall Study||2||
59808749|NCT00493311|75930907|FG001|NOT COMPLETED|Overall Study||2||
59808750|NCT00571649|75930915|FG000|STARTED|Treatment Period||4050||
59808751|NCT00571649|75930916|FG001|STARTED|Treatment Period||4051||
59808752|NCT00571649|75930915|FG000|Participants Received Treatment|Treatment Period||3997||
59808753|NCT00571649|75930916|FG001|Participants Received Treatment|Treatment Period||4001||
59808754|NCT00571649|75930915|FG000|Day 10|Treatment Period||3454||
59808755|NCT00571649|75930916|FG001|Day 10|Treatment Period||3499||
59808756|NCT00571649|75930915|FG000|Day 35|Treatment Period||3033||
59808757|NCT00571649|75930916|FG001|Day 35|Treatment Period||3115||
59808758|NCT00571649|75930915|FG000|COMPLETED|Treatment Period||2958||
59808759|NCT00571649|75930916|FG001|COMPLETED|Treatment Period||3047||
59808760|NCT00571649|75930915|FG000|NOT COMPLETED|Treatment Period||1092||
59808761|NCT00571649|75930916|FG001|NOT COMPLETED|Treatment Period||1004||
59808762|NCT00571649|75930915|FG000|STARTED|Follow-up Period|Participants were required to enter follow-up even if treatment period not completed.|3583||
59808763|NCT00571649|75930916|FG001|STARTED|Follow-up Period|Participants were required to enter follow-up even if treatment period not completed.|3635||
59808764|NCT00571649|75930915|FG000|COMPLETED|Follow-up Period|Began day after last dose study drug; ended on Day 90 (+/- 7 days) .|3038||
59808765|NCT00571649|75930916|FG001|COMPLETED|Follow-up Period|Began day after last dose study drug; ended on Day 90 (+/- 7 days) .|3107||
59808766|NCT00571649|75930915|FG000|NOT COMPLETED|Follow-up Period||545||
59808767|NCT00571649|75930916|FG001|NOT COMPLETED|Follow-up Period||528||
59808768|NCT00546572|75930924|FG000|STARTED|Vax 1 / Year 0||464||
59808769|NCT00546572|75930925|FG001|STARTED|Vax 1 / Year 0||474||
59808770|NCT00546572|75930924|FG000|Received Vax 1|Vax 1 / Year 0||463||
59808771|NCT00546572|75930925|FG001|Received Vax 1|Vax 1 / Year 0||473||
59808772|NCT00546572|75930924|FG000|COMPLETED|Vax 1 / Year 0||391||
59808773|NCT00546572|75930925|FG001|COMPLETED|Vax 1 / Year 0||404||
59808774|NCT00546572|75930924|FG000|NOT COMPLETED|Vax 1 / Year 0||73||
59808775|NCT00546572|75930925|FG001|NOT COMPLETED|Vax 1 / Year 0||70||
59808776|NCT00546572|75930924|FG000|STARTED|Vax 2 / Year 1||391||
59808777|NCT00546572|75930925|FG001|STARTED|Vax 2 / Year 1||404||
59808778|NCT00546572|75930924|FG000|Received Vax 2|Vax 2 / Year 1||391||
59808779|NCT00546572|75930925|FG001|Received Vax 2|Vax 2 / Year 1||404||
59808780|NCT00546572|75930924|FG000|COMPLETED|Vax 2 / Year 1||387||
59808781|NCT00546572|75930925|FG001|COMPLETED|Vax 2 / Year 1||402||
59808782|NCT00546572|75930924|FG000|NOT COMPLETED|Vax 2 / Year 1||4||
59808783|NCT00546572|75930925|FG001|NOT COMPLETED|Vax 2 / Year 1||2||
59808784|NCT03917472|75930944|FG000|STARTED|Overall Study||346||
59808785|NCT03917472|75930945|FG001|STARTED|Overall Study||171||
59808786|NCT03917472|75930944|FG000|COMPLETED|Overall Study||311||
59962874|NCT03701555|76081106|FG001|COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
59962875|NCT03701555|76081107|FG002|COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
59962876|NCT03701555|76081108|FG003|COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
59962877|NCT03701555|76081109|FG004|COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
59962878|NCT03701555|76081110|FG005|COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
59962879|NCT03701555|76081111|FG006|COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
59962880|NCT03701555|76081112|FG007|COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
59962881|NCT03701555|76081113|FG008|COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
59962882|NCT03701555|76081114|FG009|COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
59962883|NCT03701555|76081115|FG010|COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
59962884|NCT03701555|76081116|FG011|COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
59962885|NCT03701555|76081117|FG012|COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
59962886|NCT03701555|76081118|FG013|COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
59962887|NCT03701555|76081119|FG014|COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
59962888|NCT03701555|76081120|FG015|COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
59962889|NCT03701555|76081121|FG016|COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
59962890|NCT03701555|76081122|FG017|COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
59962891|NCT03701555|76081123|FG018|COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
59962892|NCT03701555|76081124|FG019|COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
59962893|NCT03701555|76081125|FG020|COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
59962894|NCT03701555|76081126|FG021|COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
59962895|NCT03701555|76081127|FG022|COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
59962896|NCT03701555|76081128|FG023|COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
59962897|NCT03701555|76081129|FG024|COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
59962898|NCT03701555|76081130|FG025|COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
59962899|NCT03701555|76081131|FG026|COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
59962900|NCT03701555|76081132|FG027|COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
59962901|NCT03701555|76081133|FG028|COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
59962902|NCT03701555|76081134|FG029|COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
59962903|NCT03701555|76081135|FG030|COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
59962904|NCT03701555|76081136|FG031|COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
59962905|NCT03701555|76081137|FG032|COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
59962906|NCT03701555|76081138|FG033|COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
59962907|NCT03701555|76081139|FG034|COMPLETED|Part 4, Period 1 (Days 1 to 5)||3||
59962908|NCT03701555|76081140|FG035|COMPLETED|Part 4, Period 1 (Days 1 to 5)||3||
59808787|NCT03917472|75930945|FG001|COMPLETED|Overall Study||156||
59808788|NCT03917472|75930944|FG000|NOT COMPLETED|Overall Study||35||
59808789|NCT03917472|75930945|FG001|NOT COMPLETED|Overall Study||15||
59808790|NCT00681863|75930952|FG000|STARTED|Overall Study||45||
59808791|NCT00681863|75930952|FG000|COMPLETED|Overall Study||22||
59808792|NCT00681863|75930952|FG000|NOT COMPLETED|Overall Study||23||
59962909|NCT03701555|76081105|FG000|NOT COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
59962910|NCT03701555|76081106|FG001|NOT COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
59962911|NCT03701555|76081107|FG002|NOT COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
59808793|NCT00681629|75930958|FG000|STARTED|Overall Study|It was planned to recruit 100 patient|5||
59808794|NCT00681629|75930959|FG001|STARTED|Overall Study|It was planned to recruit 100 patient|2||
59808795|NCT00681629|75930958|FG000|COMPLETED|Overall Study||0||
59808796|NCT00681629|75930959|FG001|COMPLETED|Overall Study||0||
59808797|NCT00681629|75930958|FG000|NOT COMPLETED|Overall Study||5||
59808798|NCT00681629|75930959|FG001|NOT COMPLETED|Overall Study||2||
59808799|NCT00679367|75930965|FG000|STARTED|Overall Study||16||
59808800|NCT00679367|75930965|FG000|COMPLETED|Overall Study||4||
59808801|NCT00679367|75930965|FG000|NOT COMPLETED|Overall Study||12||
59808802|NCT03937778|75930970|FG000|STARTED|Overall Study||7||
59808803|NCT03937778|75930970|FG000|COMPLETED|Overall Study||5||
59808804|NCT03937778|75930970|FG000|NOT COMPLETED|Overall Study||2||
59808805|NCT03935126|75930974|FG000|STARTED|Overall Study||3||
59808806|NCT03935126|75930974|FG000|COMPLETED|Overall Study||0||
59808807|NCT03935126|75930974|FG000|NOT COMPLETED|Overall Study||3||
59808808|NCT00545714|75930978|FG000|STARTED|Induction Phase (6 Months)||86||
59962912|NCT03701555|76081108|FG003|NOT COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
59962913|NCT03701555|76081109|FG004|NOT COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
59962914|NCT03701555|76081110|FG005|NOT COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
59962915|NCT03701555|76081111|FG006|NOT COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
59962916|NCT03701555|76081112|FG007|NOT COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
59962917|NCT03701555|76081113|FG008|NOT COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
59962918|NCT03701555|76081114|FG009|NOT COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
59962919|NCT03701555|76081115|FG010|NOT COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
59962920|NCT03701555|76081116|FG011|NOT COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
59808809|NCT00545714|75930978|FG000|Safety Population|Induction Phase (6 Months)||86||
59808810|NCT00545714|75930978|FG000|Intent-to-Treat (ITT) Population|Induction Phase (6 Months)||84||
59808811|NCT00545714|75930978|FG000|COMPLETED|Induction Phase (6 Months)||74||
59808812|NCT00545714|75930978|FG000|NOT COMPLETED|Induction Phase (6 Months)||12||
59808813|NCT00545714|75930978|FG000|STARTED|Maintenance Phase (36 Months)||74||
59808814|NCT00545714|75930978|FG000|COMPLETED|Maintenance Phase (36 Months)||42||
59962921|NCT03701555|76081117|FG012|NOT COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
59962922|NCT03701555|76081118|FG013|NOT COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
59962923|NCT03701555|76081119|FG014|NOT COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
59962924|NCT03701555|76081120|FG015|NOT COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
59962925|NCT03701555|76081121|FG016|NOT COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
59962926|NCT03701555|76081122|FG017|NOT COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
59962927|NCT03701555|76081123|FG018|NOT COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
59524563|NCT02533674|75619778|FG004|COMPLETED|Dose Level II||0||
59524564|NCT02533674|75619779|FG005|COMPLETED|Dose Level II||0||
59524565|NCT02533674|75619780|FG006|COMPLETED|Dose Level II||0||
59524566|NCT02533674|75619781|FG007|COMPLETED|Dose Level II||0||
59524567|NCT02533674|75619774|FG000|NOT COMPLETED|Dose Level II||0||
59524568|NCT02533674|75619775|FG001|NOT COMPLETED|Dose Level II||7||
59524569|NCT02533674|75619776|FG002|NOT COMPLETED|Dose Level II||0||
59524570|NCT02533674|75619777|FG003|NOT COMPLETED|Dose Level II||0||
59524571|NCT02533674|75619778|FG004|NOT COMPLETED|Dose Level II||0||
59524572|NCT02533674|75619779|FG005|NOT COMPLETED|Dose Level II||0||
59524573|NCT02533674|75619780|FG006|NOT COMPLETED|Dose Level II||0||
59524574|NCT02533674|75619781|FG007|NOT COMPLETED|Dose Level II||0||
59524575|NCT02533674|75619774|FG000|STARTED|Dose Level III||0||
59524576|NCT02533674|75619775|FG001|STARTED|Dose Level III||0||
59524577|NCT02533674|75619776|FG002|STARTED|Dose Level III||4||
59524578|NCT02533674|75619777|FG003|STARTED|Dose Level III||0||
59524579|NCT02533674|75619778|FG004|STARTED|Dose Level III||0||
59524580|NCT02533674|75619779|FG005|STARTED|Dose Level III||0||
59524581|NCT02533674|75619780|FG006|STARTED|Dose Level III||0||
59524582|NCT02533674|75619781|FG007|STARTED|Dose Level III||0||
59524583|NCT02533674|75619774|FG000|COMPLETED|Dose Level III||0||
59524584|NCT02533674|75619775|FG001|COMPLETED|Dose Level III||0||
59524585|NCT02533674|75619776|FG002|COMPLETED|Dose Level III||0||
59524586|NCT02533674|75619777|FG003|COMPLETED|Dose Level III||0||
59524587|NCT02533674|75619778|FG004|COMPLETED|Dose Level III||0||
59524588|NCT02533674|75619779|FG005|COMPLETED|Dose Level III||0||
59524589|NCT02533674|75619780|FG006|COMPLETED|Dose Level III||0||
59524590|NCT02533674|75619781|FG007|COMPLETED|Dose Level III||0||
59524591|NCT02533674|75619774|FG000|NOT COMPLETED|Dose Level III||0||
59524592|NCT02533674|75619775|FG001|NOT COMPLETED|Dose Level III||0||
59524593|NCT02533674|75619776|FG002|NOT COMPLETED|Dose Level III||4||
59524594|NCT02533674|75619777|FG003|NOT COMPLETED|Dose Level III||0||
59524595|NCT02533674|75619778|FG004|NOT COMPLETED|Dose Level III||0||
59524596|NCT02533674|75619779|FG005|NOT COMPLETED|Dose Level III||0||
59524597|NCT02533674|75619780|FG006|NOT COMPLETED|Dose Level III||0||
59524598|NCT02533674|75619781|FG007|NOT COMPLETED|Dose Level III||0||
59524599|NCT02533674|75619774|FG000|STARTED|Dose Level IV||0||
59524600|NCT02533674|75619775|FG001|STARTED|Dose Level IV||0||
59524601|NCT02533674|75619776|FG002|STARTED|Dose Level IV||0||
59524602|NCT02533674|75619777|FG003|STARTED|Dose Level IV||5||
59524603|NCT02533674|75619778|FG004|STARTED|Dose Level IV||0||
59524604|NCT02533674|75619779|FG005|STARTED|Dose Level IV||0||
59524605|NCT02533674|75619780|FG006|STARTED|Dose Level IV||0||
59524606|NCT02533674|75619781|FG007|STARTED|Dose Level IV||0||
59524607|NCT02533674|75619774|FG000|COMPLETED|Dose Level IV||0||
59524608|NCT02533674|75619775|FG001|COMPLETED|Dose Level IV||0||
59524609|NCT02533674|75619776|FG002|COMPLETED|Dose Level IV||0||
59524610|NCT02533674|75619777|FG003|COMPLETED|Dose Level IV||0||
59524611|NCT02533674|75619778|FG004|COMPLETED|Dose Level IV||0||
59524612|NCT02533674|75619779|FG005|COMPLETED|Dose Level IV||0||
59962928|NCT03701555|76081124|FG019|NOT COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
59962929|NCT03701555|76081125|FG020|NOT COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
59962930|NCT03701555|76081126|FG021|NOT COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
59995283|NCT01119807|76111111|FG000|NOT COMPLETED|Overall Study||0||
59524613|NCT02533674|75619780|FG006|COMPLETED|Dose Level IV||0||
59524614|NCT02533674|75619781|FG007|COMPLETED|Dose Level IV||0||
59524615|NCT02533674|75619774|FG000|NOT COMPLETED|Dose Level IV||0||
59524616|NCT02533674|75619775|FG001|NOT COMPLETED|Dose Level IV||0||
59524617|NCT02533674|75619776|FG002|NOT COMPLETED|Dose Level IV||0||
59524618|NCT02533674|75619777|FG003|NOT COMPLETED|Dose Level IV||5||
59524619|NCT02533674|75619778|FG004|NOT COMPLETED|Dose Level IV||0||
59524620|NCT02533674|75619779|FG005|NOT COMPLETED|Dose Level IV||0||
59524621|NCT02533674|75619780|FG006|NOT COMPLETED|Dose Level IV||0||
59524622|NCT02533674|75619781|FG007|NOT COMPLETED|Dose Level IV||0||
59524623|NCT02533674|75619774|FG000|STARTED|Dose Level V||0||
59524624|NCT02533674|75619775|FG001|STARTED|Dose Level V||0||
59524625|NCT02533674|75619776|FG002|STARTED|Dose Level V||0||
59524626|NCT02533674|75619777|FG003|STARTED|Dose Level V||0||
59524627|NCT02533674|75619778|FG004|STARTED|Dose Level V||5||
59524628|NCT02533674|75619779|FG005|STARTED|Dose Level V||0||
59524629|NCT02533674|75619780|FG006|STARTED|Dose Level V||0||
59524630|NCT02533674|75619781|FG007|STARTED|Dose Level V||0||
59524631|NCT02533674|75619774|FG000|COMPLETED|Dose Level V||0||
59524632|NCT02533674|75619775|FG001|COMPLETED|Dose Level V||0||
59524633|NCT02533674|75619776|FG002|COMPLETED|Dose Level V||0||
59524634|NCT02533674|75619777|FG003|COMPLETED|Dose Level V||0||
59524635|NCT02533674|75619778|FG004|COMPLETED|Dose Level V||0||
59524636|NCT02533674|75619779|FG005|COMPLETED|Dose Level V||0||
59808815|NCT00545714|75930978|FG000|NOT COMPLETED|Maintenance Phase (36 Months)||32||
59808816|NCT00539838|75930985|FG000|STARTED|Overall Study||12||
59962931|NCT03701555|76081127|FG022|NOT COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
59962932|NCT03701555|76081128|FG023|NOT COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
59962933|NCT03701555|76081129|FG024|NOT COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
59962934|NCT03701555|76081130|FG025|NOT COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
59962935|NCT03701555|76081131|FG026|NOT COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
59962936|NCT03701555|76081132|FG027|NOT COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
59962937|NCT03701555|76081133|FG028|NOT COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
59962938|NCT03701555|76081134|FG029|NOT COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
59962939|NCT03701555|76081135|FG030|NOT COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
59962940|NCT03701555|76081136|FG031|NOT COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
59962941|NCT03701555|76081137|FG032|NOT COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
59962942|NCT03701555|76081138|FG033|NOT COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
59962943|NCT03701555|76081139|FG034|NOT COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
59962944|NCT03701555|76081140|FG035|NOT COMPLETED|Part 4, Period 1 (Days 1 to 5)||0||
59962945|NCT03701555|76081105|FG000|STARTED|Part 4, Washout Period (3 Days)||0||
59962946|NCT03701555|76081106|FG001|STARTED|Part 4, Washout Period (3 Days)||0||
59962947|NCT03701555|76081107|FG002|STARTED|Part 4, Washout Period (3 Days)||0||
59962948|NCT03701555|76081108|FG003|STARTED|Part 4, Washout Period (3 Days)||0||
59962949|NCT03701555|76081109|FG004|STARTED|Part 4, Washout Period (3 Days)||0||
59962950|NCT03701555|76081110|FG005|STARTED|Part 4, Washout Period (3 Days)||0||
59962951|NCT03701555|76081111|FG006|STARTED|Part 4, Washout Period (3 Days)||0||
59962952|NCT03701555|76081112|FG007|STARTED|Part 4, Washout Period (3 Days)||0||
59962953|NCT03701555|76081113|FG008|STARTED|Part 4, Washout Period (3 Days)||0||
59962954|NCT03701555|76081114|FG009|STARTED|Part 4, Washout Period (3 Days)||0||
59962955|NCT03701555|76081115|FG010|STARTED|Part 4, Washout Period (3 Days)||0||
59962956|NCT03701555|76081116|FG011|STARTED|Part 4, Washout Period (3 Days)||0||
59962957|NCT03701555|76081117|FG012|STARTED|Part 4, Washout Period (3 Days)||0||
59962958|NCT03701555|76081118|FG013|STARTED|Part 4, Washout Period (3 Days)||0||
59962959|NCT03701555|76081119|FG014|STARTED|Part 4, Washout Period (3 Days)||0||
59962960|NCT03701555|76081120|FG015|STARTED|Part 4, Washout Period (3 Days)||0||
59962961|NCT03701555|76081121|FG016|STARTED|Part 4, Washout Period (3 Days)||0||
59962962|NCT03701555|76081122|FG017|STARTED|Part 4, Washout Period (3 Days)||0||
59962963|NCT03701555|76081123|FG018|STARTED|Part 4, Washout Period (3 Days)||0||
59962964|NCT03701555|76081124|FG019|STARTED|Part 4, Washout Period (3 Days)||0||
59962965|NCT03701555|76081125|FG020|STARTED|Part 4, Washout Period (3 Days)||0||
59962966|NCT03701555|76081126|FG021|STARTED|Part 4, Washout Period (3 Days)||0||
59962967|NCT03701555|76081127|FG022|STARTED|Part 4, Washout Period (3 Days)||0||
59962968|NCT03701555|76081128|FG023|STARTED|Part 4, Washout Period (3 Days)||0||
59962969|NCT03701555|76081129|FG024|STARTED|Part 4, Washout Period (3 Days)||0||
59962970|NCT03701555|76081130|FG025|STARTED|Part 4, Washout Period (3 Days)||0||
59962971|NCT03701555|76081131|FG026|STARTED|Part 4, Washout Period (3 Days)||0||
59962972|NCT03701555|76081132|FG027|STARTED|Part 4, Washout Period (3 Days)||0||
59962973|NCT03701555|76081133|FG028|STARTED|Part 4, Washout Period (3 Days)||0||
59962974|NCT03701555|76081134|FG029|STARTED|Part 4, Washout Period (3 Days)||0||
59962975|NCT03701555|76081135|FG030|STARTED|Part 4, Washout Period (3 Days)||0||
59962976|NCT03701555|76081136|FG031|STARTED|Part 4, Washout Period (3 Days)||0||
59808817|NCT00539838|75930986|FG001|STARTED|Overall Study||11||
59808818|NCT00539838|75930987|FG002|STARTED|Overall Study||10||
59962977|NCT03701555|76081137|FG032|STARTED|Part 4, Washout Period (3 Days)||0||
59962978|NCT03701555|76081138|FG033|STARTED|Part 4, Washout Period (3 Days)||0||
59962979|NCT03701555|76081139|FG034|STARTED|Part 4, Washout Period (3 Days)||3||
59962980|NCT03701555|76081140|FG035|STARTED|Part 4, Washout Period (3 Days)||3||
59962981|NCT03701555|76081105|FG000|COMPLETED|Part 4, Washout Period (3 Days)||0||
59962982|NCT03701555|76081106|FG001|COMPLETED|Part 4, Washout Period (3 Days)||0||
59962983|NCT03701555|76081107|FG002|COMPLETED|Part 4, Washout Period (3 Days)||0||
59962984|NCT03701555|76081108|FG003|COMPLETED|Part 4, Washout Period (3 Days)||0||
59962985|NCT03701555|76081109|FG004|COMPLETED|Part 4, Washout Period (3 Days)||0||
59808819|NCT00539838|75930985|FG000|COMPLETED|Overall Study||5||
59808820|NCT00539838|75930986|FG001|COMPLETED|Overall Study||5||
59808821|NCT00539838|75930987|FG002|COMPLETED|Overall Study||1||
59962986|NCT03701555|76081110|FG005|COMPLETED|Part 4, Washout Period (3 Days)||0||
59962987|NCT03701555|76081111|FG006|COMPLETED|Part 4, Washout Period (3 Days)||0||
59962988|NCT03701555|76081112|FG007|COMPLETED|Part 4, Washout Period (3 Days)||0||
59962989|NCT03701555|76081113|FG008|COMPLETED|Part 4, Washout Period (3 Days)||0||
59962990|NCT03701555|76081114|FG009|COMPLETED|Part 4, Washout Period (3 Days)||0||
59962991|NCT03701555|76081115|FG010|COMPLETED|Part 4, Washout Period (3 Days)||0||
59962992|NCT03701555|76081116|FG011|COMPLETED|Part 4, Washout Period (3 Days)||0||
59962993|NCT03701555|76081117|FG012|COMPLETED|Part 4, Washout Period (3 Days)||0||
59962994|NCT03701555|76081118|FG013|COMPLETED|Part 4, Washout Period (3 Days)||0||
59962995|NCT03701555|76081119|FG014|COMPLETED|Part 4, Washout Period (3 Days)||0||
59962996|NCT03701555|76081120|FG015|COMPLETED|Part 4, Washout Period (3 Days)||0||
59962997|NCT03701555|76081121|FG016|COMPLETED|Part 4, Washout Period (3 Days)||0||
59962998|NCT03701555|76081122|FG017|COMPLETED|Part 4, Washout Period (3 Days)||0||
59962999|NCT03701555|76081123|FG018|COMPLETED|Part 4, Washout Period (3 Days)||0||
59963000|NCT03701555|76081124|FG019|COMPLETED|Part 4, Washout Period (3 Days)||0||
59963001|NCT03701555|76081125|FG020|COMPLETED|Part 4, Washout Period (3 Days)||0||
59963002|NCT03701555|76081126|FG021|COMPLETED|Part 4, Washout Period (3 Days)||0||
59963003|NCT03701555|76081127|FG022|COMPLETED|Part 4, Washout Period (3 Days)||0||
59963004|NCT03701555|76081128|FG023|COMPLETED|Part 4, Washout Period (3 Days)||0||
59963005|NCT03701555|76081129|FG024|COMPLETED|Part 4, Washout Period (3 Days)||0||
59963006|NCT03701555|76081130|FG025|COMPLETED|Part 4, Washout Period (3 Days)||0||
59963007|NCT03701555|76081131|FG026|COMPLETED|Part 4, Washout Period (3 Days)||0||
59963008|NCT03701555|76081132|FG027|COMPLETED|Part 4, Washout Period (3 Days)||0||
59963009|NCT03701555|76081133|FG028|COMPLETED|Part 4, Washout Period (3 Days)||0||
59963010|NCT03701555|76081134|FG029|COMPLETED|Part 4, Washout Period (3 Days)||0||
59963011|NCT03701555|76081135|FG030|COMPLETED|Part 4, Washout Period (3 Days)||0||
59963012|NCT03701555|76081136|FG031|COMPLETED|Part 4, Washout Period (3 Days)||0||
59963013|NCT03701555|76081137|FG032|COMPLETED|Part 4, Washout Period (3 Days)||0||
59963014|NCT03701555|76081138|FG033|COMPLETED|Part 4, Washout Period (3 Days)||0||
59963015|NCT03701555|76081139|FG034|COMPLETED|Part 4, Washout Period (3 Days)||3||
59963016|NCT03701555|76081140|FG035|COMPLETED|Part 4, Washout Period (3 Days)||3||
59621290|NCT00137280|75732853|FG000|STARTED|Overall Study||389||
59621291|NCT00137280|75732854|FG001|STARTED|Overall Study||412||
59621292|NCT00137280|75732853|FG000|COMPLETED|Overall Study||305||
59621293|NCT00137280|75732854|FG001|COMPLETED|Overall Study||357||
59621294|NCT00137280|75732853|FG000|NOT COMPLETED|Overall Study||84||
59621295|NCT00137280|75732854|FG001|NOT COMPLETED|Overall Study||55||
59621296|NCT00138294|75732860|FG000|STARTED|Overall Study||29255||
59621297|NCT00138294|75732860|FG000|COMPLETED|Overall Study||29255||
59621298|NCT00138294|75732860|FG000|NOT COMPLETED|Overall Study||0||
59621299|NCT02103114|75732868|FG000|STARTED|Overall Study||20||
59621300|NCT02103114|75732869|FG001|STARTED|Overall Study||20||
59621301|NCT02103114|75732868|FG000|COMPLETED|Overall Study||20||
59621302|NCT02103114|75732869|FG001|COMPLETED|Overall Study||19||
59621303|NCT02103114|75732868|FG000|NOT COMPLETED|Overall Study||0||
59621304|NCT02103114|75732869|FG001|NOT COMPLETED|Overall Study||1||
59621305|NCT00140244|75732876|FG000|STARTED|Intervention 1||3||
59621306|NCT00140244|75732877|FG001|STARTED|Intervention 1||4||
59621307|NCT00140244|75732876|FG000|COMPLETED|Intervention 1||3||
59621308|NCT00140244|75732877|FG001|COMPLETED|Intervention 1||4||
59621309|NCT00140244|75732876|FG000|NOT COMPLETED|Intervention 1||0||
59621310|NCT00140244|75732877|FG001|NOT COMPLETED|Intervention 1||0||
59621311|NCT00140244|75732876|FG000|STARTED|Washout||3||
59621312|NCT00140244|75732877|FG001|STARTED|Washout||4||
59621313|NCT00140244|75732876|FG000|COMPLETED|Washout||3||
59621314|NCT00140244|75732877|FG001|COMPLETED|Washout||4||
59621315|NCT00140244|75732876|FG000|NOT COMPLETED|Washout||0||
59621316|NCT00140244|75732877|FG001|NOT COMPLETED|Washout||0||
59621317|NCT00140244|75732876|FG000|STARTED|Intervention 2||3||
59621318|NCT00140244|75732877|FG001|STARTED|Intervention 2||4||
59621319|NCT00140244|75732876|FG000|COMPLETED|Intervention 2||3||
59808822|NCT00539838|75930985|FG000|NOT COMPLETED|Overall Study||7||
59963017|NCT03701555|76081105|FG000|NOT COMPLETED|Part 4, Washout Period (3 Days)||0||
59963018|NCT03701555|76081106|FG001|NOT COMPLETED|Part 4, Washout Period (3 Days)||0||
59963019|NCT03701555|76081107|FG002|NOT COMPLETED|Part 4, Washout Period (3 Days)||0||
59963020|NCT03701555|76081108|FG003|NOT COMPLETED|Part 4, Washout Period (3 Days)||0||
59963021|NCT03701555|76081109|FG004|NOT COMPLETED|Part 4, Washout Period (3 Days)||0||
59621320|NCT00140244|75732877|FG001|COMPLETED|Intervention 2||2||
59621321|NCT00140244|75732876|FG000|NOT COMPLETED|Intervention 2||0||
59621322|NCT00140244|75732877|FG001|NOT COMPLETED|Intervention 2||2||
59621323|NCT02103270|75732887|FG000|STARTED|Overall Study||60||
59963022|NCT03701555|76081110|FG005|NOT COMPLETED|Part 4, Washout Period (3 Days)||0||
59963023|NCT03701555|76081111|FG006|NOT COMPLETED|Part 4, Washout Period (3 Days)||0||
59963024|NCT03701555|76081112|FG007|NOT COMPLETED|Part 4, Washout Period (3 Days)||0||
59808823|NCT00539838|75930986|FG001|NOT COMPLETED|Overall Study||6||
59808824|NCT00539838|75930987|FG002|NOT COMPLETED|Overall Study||9||
59808825|NCT00679289|75931000|FG000|STARTED|Overall Study||6|Received at least 1 dose of KW2871 and initial treatment with HDI|
59808826|NCT00679289|75931001|FG001|STARTED|Overall Study||6|Received at least 1 dose of KW2871 and initial treatment with HDI|
59808827|NCT00679289|75931002|FG002|STARTED|Overall Study||24|Received at least 1 dose of KW2871 and initial treatment with HDI|
59808828|NCT00679289|75931000|FG000|COMPLETED|Overall Study||1||
59808829|NCT00679289|75931001|FG001|COMPLETED|Overall Study||0||
59808830|NCT00679289|75931002|FG002|COMPLETED|Overall Study||1||
59963025|NCT03701555|76081113|FG008|NOT COMPLETED|Part 4, Washout Period (3 Days)||0||
59963026|NCT03701555|76081114|FG009|NOT COMPLETED|Part 4, Washout Period (3 Days)||0||
59963027|NCT03701555|76081115|FG010|NOT COMPLETED|Part 4, Washout Period (3 Days)||0||
59963028|NCT03701555|76081116|FG011|NOT COMPLETED|Part 4, Washout Period (3 Days)||0||
59963029|NCT03701555|76081117|FG012|NOT COMPLETED|Part 4, Washout Period (3 Days)||0||
59963030|NCT03701555|76081118|FG013|NOT COMPLETED|Part 4, Washout Period (3 Days)||0||
59963031|NCT03701555|76081119|FG014|NOT COMPLETED|Part 4, Washout Period (3 Days)||0||
59963032|NCT03701555|76081120|FG015|NOT COMPLETED|Part 4, Washout Period (3 Days)||0||
59963033|NCT03701555|76081121|FG016|NOT COMPLETED|Part 4, Washout Period (3 Days)||0||
59963034|NCT03701555|76081122|FG017|NOT COMPLETED|Part 4, Washout Period (3 Days)||0||
59963035|NCT03701555|76081123|FG018|NOT COMPLETED|Part 4, Washout Period (3 Days)||0||
59963036|NCT03701555|76081124|FG019|NOT COMPLETED|Part 4, Washout Period (3 Days)||0||
59963037|NCT03701555|76081125|FG020|NOT COMPLETED|Part 4, Washout Period (3 Days)||0||
59963038|NCT03701555|76081126|FG021|NOT COMPLETED|Part 4, Washout Period (3 Days)||0||
59963039|NCT03701555|76081127|FG022|NOT COMPLETED|Part 4, Washout Period (3 Days)||0||
59963040|NCT03701555|76081128|FG023|NOT COMPLETED|Part 4, Washout Period (3 Days)||0||
59963041|NCT03701555|76081129|FG024|NOT COMPLETED|Part 4, Washout Period (3 Days)||0||
59963042|NCT03701555|76081130|FG025|NOT COMPLETED|Part 4, Washout Period (3 Days)||0||
59963043|NCT03701555|76081131|FG026|NOT COMPLETED|Part 4, Washout Period (3 Days)||0||
59963044|NCT03701555|76081132|FG027|NOT COMPLETED|Part 4, Washout Period (3 Days)||0||
59963045|NCT03701555|76081133|FG028|NOT COMPLETED|Part 4, Washout Period (3 Days)||0||
59963046|NCT03701555|76081134|FG029|NOT COMPLETED|Part 4, Washout Period (3 Days)||0||
59963047|NCT03701555|76081135|FG030|NOT COMPLETED|Part 4, Washout Period (3 Days)||0||
59963048|NCT03701555|76081136|FG031|NOT COMPLETED|Part 4, Washout Period (3 Days)||0||
59963049|NCT03701555|76081137|FG032|NOT COMPLETED|Part 4, Washout Period (3 Days)||0||
59963050|NCT03701555|76081138|FG033|NOT COMPLETED|Part 4, Washout Period (3 Days)||0||
59963051|NCT03701555|76081139|FG034|NOT COMPLETED|Part 4, Washout Period (3 Days)||0||
59963052|NCT03701555|76081140|FG035|NOT COMPLETED|Part 4, Washout Period (3 Days)||0||
59963053|NCT03701555|76081105|FG000|STARTED|Part 4, Period 2 (Days 1 to 5)||0||
59963054|NCT03701555|76081106|FG001|STARTED|Part 4, Period 2 (Days 1 to 5)||0||
59963055|NCT03701555|76081107|FG002|STARTED|Part 4, Period 2 (Days 1 to 5)||0||
59963056|NCT03701555|76081108|FG003|STARTED|Part 4, Period 2 (Days 1 to 5)||0||
59963057|NCT03701555|76081109|FG004|STARTED|Part 4, Period 2 (Days 1 to 5)||0||
59963058|NCT03701555|76081110|FG005|STARTED|Part 4, Period 2 (Days 1 to 5)||0||
59963059|NCT03701555|76081111|FG006|STARTED|Part 4, Period 2 (Days 1 to 5)||0||
59963060|NCT03701555|76081112|FG007|STARTED|Part 4, Period 2 (Days 1 to 5)||0||
59963061|NCT03701555|76081113|FG008|STARTED|Part 4, Period 2 (Days 1 to 5)||0||
59963062|NCT03701555|76081114|FG009|STARTED|Part 4, Period 2 (Days 1 to 5)||0||
59963063|NCT03701555|76081115|FG010|STARTED|Part 4, Period 2 (Days 1 to 5)||0||
59808831|NCT00679289|75931000|FG000|NOT COMPLETED|Overall Study||5||
59963064|NCT03701555|76081116|FG011|STARTED|Part 4, Period 2 (Days 1 to 5)||0||
59963065|NCT03701555|76081117|FG012|STARTED|Part 4, Period 2 (Days 1 to 5)||0||
59963066|NCT03701555|76081118|FG013|STARTED|Part 4, Period 2 (Days 1 to 5)||0||
59963067|NCT03701555|76081119|FG014|STARTED|Part 4, Period 2 (Days 1 to 5)||0||
59963068|NCT03701555|76081120|FG015|STARTED|Part 4, Period 2 (Days 1 to 5)||0||
59963069|NCT03701555|76081121|FG016|STARTED|Part 4, Period 2 (Days 1 to 5)||0||
59963070|NCT03701555|76081122|FG017|STARTED|Part 4, Period 2 (Days 1 to 5)||0||
59963071|NCT03701555|76081123|FG018|STARTED|Part 4, Period 2 (Days 1 to 5)||0||
59963072|NCT03701555|76081124|FG019|STARTED|Part 4, Period 2 (Days 1 to 5)||0||
59963073|NCT03701555|76081125|FG020|STARTED|Part 4, Period 2 (Days 1 to 5)||0||
59963074|NCT03701555|76081126|FG021|STARTED|Part 4, Period 2 (Days 1 to 5)||0||
59963075|NCT03701555|76081127|FG022|STARTED|Part 4, Period 2 (Days 1 to 5)||0||
59963076|NCT03701555|76081128|FG023|STARTED|Part 4, Period 2 (Days 1 to 5)||0||
59963077|NCT03701555|76081129|FG024|STARTED|Part 4, Period 2 (Days 1 to 5)||0||
59963078|NCT03701555|76081130|FG025|STARTED|Part 4, Period 2 (Days 1 to 5)||0||
59963079|NCT03701555|76081131|FG026|STARTED|Part 4, Period 2 (Days 1 to 5)||0||
59963080|NCT03701555|76081132|FG027|STARTED|Part 4, Period 2 (Days 1 to 5)||0||
59963081|NCT03701555|76081133|FG028|STARTED|Part 4, Period 2 (Days 1 to 5)||0||
59963082|NCT03701555|76081134|FG029|STARTED|Part 4, Period 2 (Days 1 to 5)||0||
59963083|NCT03701555|76081135|FG030|STARTED|Part 4, Period 2 (Days 1 to 5)||0||
59963084|NCT03701555|76081136|FG031|STARTED|Part 4, Period 2 (Days 1 to 5)||0||
59808832|NCT00679289|75931001|FG001|NOT COMPLETED|Overall Study||6||
59808833|NCT00679289|75931002|FG002|NOT COMPLETED|Overall Study||23||
59808834|NCT00679211|75931012|FG000|STARTED|Overall Study||110||
59963085|NCT03701555|76081137|FG032|STARTED|Part 4, Period 2 (Days 1 to 5)||0||
59963086|NCT03701555|76081138|FG033|STARTED|Part 4, Period 2 (Days 1 to 5)||0||
59963087|NCT03701555|76081139|FG034|STARTED|Part 4, Period 2 (Days 1 to 5)||3||
59963088|NCT03701555|76081140|FG035|STARTED|Part 4, Period 2 (Days 1 to 5)||3||
59963089|NCT03701555|76081105|FG000|COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
59963090|NCT03701555|76081106|FG001|COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
59963091|NCT03701555|76081107|FG002|COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
59963092|NCT03701555|76081108|FG003|COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
59963093|NCT03701555|76081109|FG004|COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
59963094|NCT03701555|76081110|FG005|COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
59963095|NCT03701555|76081111|FG006|COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
59963096|NCT03701555|76081112|FG007|COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
59963097|NCT03701555|76081113|FG008|COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
59963098|NCT03701555|76081114|FG009|COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
59963099|NCT03701555|76081115|FG010|COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
59963100|NCT03701555|76081116|FG011|COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
59963101|NCT03701555|76081117|FG012|COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
59963102|NCT03701555|76081118|FG013|COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
59963103|NCT03701555|76081119|FG014|COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
59963104|NCT03701555|76081120|FG015|COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
59963105|NCT03701555|76081121|FG016|COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
59963106|NCT03701555|76081122|FG017|COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
59963107|NCT03701555|76081123|FG018|COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
59963108|NCT03701555|76081124|FG019|COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
59963109|NCT03701555|76081125|FG020|COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
59963110|NCT03701555|76081126|FG021|COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
59963111|NCT03701555|76081127|FG022|COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
59963112|NCT03701555|76081128|FG023|COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
59963113|NCT03701555|76081129|FG024|COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
59963114|NCT03701555|76081130|FG025|COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
59963115|NCT03701555|76081131|FG026|COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
59963116|NCT03701555|76081132|FG027|COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
59963117|NCT03701555|76081133|FG028|COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
59963118|NCT03701555|76081134|FG029|COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
59963119|NCT03701555|76081135|FG030|COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
59963120|NCT03701555|76081136|FG031|COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
59963121|NCT03701555|76081137|FG032|COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
59963122|NCT03701555|76081138|FG033|COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
59963123|NCT03701555|76081139|FG034|COMPLETED|Part 4, Period 2 (Days 1 to 5)||3||
59963124|NCT03701555|76081140|FG035|COMPLETED|Part 4, Period 2 (Days 1 to 5)||3||
59963125|NCT03701555|76081105|FG000|NOT COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
59963126|NCT03701555|76081106|FG001|NOT COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
59963127|NCT03701555|76081107|FG002|NOT COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
59963128|NCT03701555|76081108|FG003|NOT COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
59963129|NCT03701555|76081109|FG004|NOT COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
59963130|NCT03701555|76081110|FG005|NOT COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
59963131|NCT03701555|76081111|FG006|NOT COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
59963132|NCT03701555|76081112|FG007|NOT COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
59963133|NCT03701555|76081113|FG008|NOT COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
59963134|NCT03701555|76081114|FG009|NOT COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
59963135|NCT03701555|76081115|FG010|NOT COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
59963136|NCT03701555|76081116|FG011|NOT COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
59963137|NCT03701555|76081117|FG012|NOT COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
59963138|NCT03701555|76081118|FG013|NOT COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
59963139|NCT03701555|76081119|FG014|NOT COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
59963140|NCT03701555|76081120|FG015|NOT COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
59963141|NCT03701555|76081121|FG016|NOT COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
59963142|NCT03701555|76081122|FG017|NOT COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
59963143|NCT03701555|76081123|FG018|NOT COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
59963144|NCT03701555|76081124|FG019|NOT COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
59963145|NCT03701555|76081125|FG020|NOT COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
59963146|NCT03701555|76081126|FG021|NOT COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
59963147|NCT03701555|76081127|FG022|NOT COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
59963148|NCT03701555|76081128|FG023|NOT COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
59963149|NCT03701555|76081129|FG024|NOT COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
59963150|NCT03701555|76081130|FG025|NOT COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
59963151|NCT03701555|76081131|FG026|NOT COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
59963152|NCT03701555|76081132|FG027|NOT COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
59963153|NCT03701555|76081133|FG028|NOT COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
59963154|NCT03701555|76081134|FG029|NOT COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
59963155|NCT03701555|76081135|FG030|NOT COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
59963156|NCT03701555|76081136|FG031|NOT COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
59963157|NCT03701555|76081137|FG032|NOT COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
59963158|NCT03701555|76081138|FG033|NOT COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
59808835|NCT00679211|75931012|FG000|COMPLETED|Overall Study||0||
59808836|NCT00679211|75931012|FG000|NOT COMPLETED|Overall Study||110||
59808837|NCT00545948|75931021|FG000|STARTED|Overall Study|Registered patients assigned to receive vinorelbine + cisplatin protocol therapy.|9||
59808838|NCT00545948|75931022|FG001|STARTED|Overall Study|Registered patients assigned to receive pemetrexed + cisplatin protocol therapy.|15||
59808839|NCT00545948|75931023|FG002|STARTED|Overall Study|Registered patients who were not assigned to receive protocol therapy.|7||
59808840|NCT00545948|75931021|FG000|Assigned Treatment|Overall Study||9||
59808841|NCT00545948|75931022|FG001|Assigned Treatment|Overall Study||15||
59808842|NCT00545948|75931023|FG002|Assigned Treatment|Overall Study||0||
59808843|NCT00545948|75931021|FG000|COMPLETED|Overall Study|Patients who received vinorelbine + cisplatin protocol therapy.|8||
59808844|NCT00545948|75931022|FG001|COMPLETED|Overall Study|Patients who received pemetrexed + cisplatin protocol therapy.|14||
59808845|NCT00545948|75931023|FG002|COMPLETED|Overall Study||0||
59808846|NCT00545948|75931021|FG000|NOT COMPLETED|Overall Study||1||
59808847|NCT00545948|75931022|FG001|NOT COMPLETED|Overall Study||1||
59808848|NCT00545948|75931023|FG002|NOT COMPLETED|Overall Study||7||
59808849|NCT00679055|75931034|FG000|STARTED|Overall Study||8||
59808850|NCT00679055|75931035|FG001|STARTED|Overall Study||6||
59808851|NCT00679055|75931034|FG000|COMPLETED|Overall Study||6||
59808852|NCT00679055|75931035|FG001|COMPLETED|Overall Study||1||
59808853|NCT00679055|75931034|FG000|NOT COMPLETED|Overall Study||2||
59808854|NCT00679055|75931035|FG001|NOT COMPLETED|Overall Study||5||
59808855|NCT03927950|75931041|FG000|STARTED|Overall Study||135||
59808856|NCT03927950|75931041|FG000|COMPLETED|Overall Study||126||
59808857|NCT03927950|75931041|FG000|NOT COMPLETED|Overall Study||9||
59808858|NCT00678899|75931046|FG000|STARTED|Overall Study||50||
59963159|NCT03701555|76081139|FG034|NOT COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
59963160|NCT03701555|76081140|FG035|NOT COMPLETED|Part 4, Period 2 (Days 1 to 5)||0||
59963161|NCT03604705|76081253|FG000|STARTED|Overall Study||21||
59963162|NCT03604705|76081253|FG000|COMPLETED|Overall Study||20||
59963163|NCT03604705|76081253|FG000|NOT COMPLETED|Overall Study||1||
59963164|NCT02178098|76081267|FG000|STARTED|Overall Study||72||
59963165|NCT02178098|76081268|FG001|STARTED|Overall Study||71||
59963166|NCT02178098|76081267|FG000|COMPLETED|Overall Study||67||
59963167|NCT02178098|76081268|FG001|COMPLETED|Overall Study||59||
59963168|NCT02178098|76081267|FG000|NOT COMPLETED|Overall Study||5||
59963169|NCT02178098|76081268|FG001|NOT COMPLETED|Overall Study||12||
59963170|NCT01915498|76081294|FG000|STARTED|Main Analysis (Sept 2013 - Sept 2017)||7||
59963171|NCT01915498|76081295|FG001|STARTED|Main Analysis (Sept 2013 - Sept 2017)||7||
59963172|NCT01915498|76081296|FG002|STARTED|Main Analysis (Sept 2013 - Sept 2017)||7||
59963173|NCT01915498|76081297|FG003|STARTED|Main Analysis (Sept 2013 - Sept 2017)||8||
59963174|NCT01915498|76081298|FG004|STARTED|Main Analysis (Sept 2013 - Sept 2017)||5||
59963175|NCT01915498|76081299|FG005|STARTED|Main Analysis (Sept 2013 - Sept 2017)||9||
59963176|NCT01915498|76081300|FG006|STARTED|Main Analysis (Sept 2013 - Sept 2017)||7||
59963177|NCT01915498|76081301|FG007|STARTED|Main Analysis (Sept 2013 - Sept 2017)||22||
59963178|NCT01915498|76081302|FG008|STARTED|Main Analysis (Sept 2013 - Sept 2017)||6||
59963179|NCT01915498|76081303|FG009|STARTED|Main Analysis (Sept 2013 - Sept 2017)||14||
59963180|NCT01915498|76081304|FG010|STARTED|Main Analysis (Sept 2013 - Sept 2017)||9||
59963181|NCT01915498|76081305|FG011|STARTED|Main Analysis (Sept 2013 - Sept 2017)||5||
59963182|NCT01915498|76081306|FG012|STARTED|Main Analysis (Sept 2013 - Sept 2017)||7||
59963183|NCT01915498|76081307|FG013|STARTED|Main Analysis (Sept 2013 - Sept 2017)||49||
59963184|NCT01915498|76081308|FG014|STARTED|Main Analysis (Sept 2013 - Sept 2017)||25||
59808859|NCT00678899|75931046|FG000|COMPLETED|Overall Study||49||
59963185|NCT01915498|76081309|FG015|STARTED|Main Analysis (Sept 2013 - Sept 2017)||25||
59963186|NCT01915498|76081310|FG016|STARTED|Main Analysis (Sept 2013 - Sept 2017)||27||
59963187|NCT01915498|76081311|FG017|STARTED|Main Analysis (Sept 2013 - Sept 2017)||106||
59963188|NCT01915498|76081312|FG018|STARTED|Main Analysis (Sept 2013 - Sept 2017)||0||
59963189|NCT01915498|76081294|FG000|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0|Completed indicates participants continuing treatment as of 01 September 2017|
59963190|NCT01915498|76081295|FG001|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0|Completed indicates participants continuing treatment as of 01 September 2017|
59963191|NCT01915498|76081296|FG002|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0|Completed indicates participants continuing treatment as of 01 September 2017|
59963192|NCT01915498|76081297|FG003|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0|Completed indicates participants continuing treatment as of 01 September 2017|
59963193|NCT01915498|76081298|FG004|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0|Completed indicates participants continuing treatment as of 01 September 2017|
59808860|NCT00678899|75931046|FG000|NOT COMPLETED|Overall Study||1||
59808861|NCT00678587|75931053|FG000|STARTED|Overall Study||147||
59808862|NCT00678587|75931054|FG001|STARTED|Overall Study||145||
59808863|NCT00678587|75931053|FG000|COMPLETED|Overall Study||127||
59808864|NCT00678587|75931054|FG001|COMPLETED|Overall Study||127||
59808865|NCT00678587|75931053|FG000|NOT COMPLETED|Overall Study||20||
59808866|NCT00678587|75931054|FG001|NOT COMPLETED|Overall Study||18||
59808867|NCT03523728|75931066|FG000|STARTED|Stage 1 (24 Months)||78||
59808868|NCT03523728|75931067|FG001|STARTED|Stage 1 (24 Months)||78||
59963194|NCT01915498|76081299|FG005|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0|Completed indicates participants continuing treatment as of 01 September 2017|
59963195|NCT01915498|76081300|FG006|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0|Completed indicates participants continuing treatment as of 01 September 2017|
59963196|NCT01915498|76081301|FG007|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||1|Completed indicates participants continuing treatment as of 01 September 2017|
59963197|NCT01915498|76081302|FG008|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0|Completed indicates participants continuing treatment as of 01 September 2017|
59963198|NCT01915498|76081303|FG009|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0|Completed indicates participants continuing treatment as of 01 September 2017|
59963199|NCT01915498|76081304|FG010|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0|Completed indicates participants continuing treatment as of 01 September 2017|
59963200|NCT01915498|76081305|FG011|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||1|Completed indicates participants continuing treatment as of 01 September 2017|
59963201|NCT01915498|76081306|FG012|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0|Completed indicates participants continuing treatment as of 01 September 2017|
59963202|NCT01915498|76081307|FG013|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||3|Completed indicates participants continuing treatment as of 01 September 2017|
59963203|NCT01915498|76081308|FG014|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0|Completed indicates participants continuing treatment as of 01 September 2017|
59963204|NCT01915498|76081309|FG015|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||2|Completed indicates participants continuing treatment as of 01 September 2017|
59963205|NCT01915498|76081310|FG016|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||3|Completed indicates participants continuing treatment as of 01 September 2017|
59963206|NCT01915498|76081311|FG017|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||6|Completed indicates participants continuing treatment as of 01 September 2017|
59963207|NCT01915498|76081312|FG018|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0|Completed indicates participants continuing treatment as of 01 September 2017|
59963208|NCT01915498|76081294|FG000|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||7||
59963209|NCT01915498|76081295|FG001|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||7||
59963210|NCT01915498|76081296|FG002|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||7||
59963211|NCT01915498|76081297|FG003|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||8||
59963212|NCT01915498|76081298|FG004|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||5||
59963213|NCT01915498|76081299|FG005|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||9||
59963214|NCT01915498|76081300|FG006|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||7||
59963215|NCT01915498|76081301|FG007|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||21||
59963216|NCT01915498|76081302|FG008|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||6||
59963217|NCT01915498|76081303|FG009|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||14||
59963218|NCT01915498|76081304|FG010|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||9||
59963219|NCT01915498|76081305|FG011|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||4||
59963220|NCT01915498|76081306|FG012|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||7||
59963221|NCT01915498|76081307|FG013|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||46||
59963222|NCT01915498|76081308|FG014|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||25||
59963223|NCT01915498|76081309|FG015|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||23||
59963224|NCT01915498|76081310|FG016|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||24||
59963225|NCT01915498|76081311|FG017|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||100||
59963226|NCT01915498|76081312|FG018|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0||
59963227|NCT01915498|76081294|FG000|STARTED|Safety Follow-up (Sept 2017 to July 2019||0||
59963228|NCT01915498|76081295|FG001|STARTED|Safety Follow-up (Sept 2017 to July 2019||0||
59963229|NCT01915498|76081296|FG002|STARTED|Safety Follow-up (Sept 2017 to July 2019||0||
59963230|NCT01915498|76081297|FG003|STARTED|Safety Follow-up (Sept 2017 to July 2019||0||
59963231|NCT01915498|76081298|FG004|STARTED|Safety Follow-up (Sept 2017 to July 2019||0||
59963232|NCT01915498|76081299|FG005|STARTED|Safety Follow-up (Sept 2017 to July 2019||0||
59963233|NCT01915498|76081300|FG006|STARTED|Safety Follow-up (Sept 2017 to July 2019||0||
59963234|NCT01915498|76081301|FG007|STARTED|Safety Follow-up (Sept 2017 to July 2019||0||
59963235|NCT01915498|76081302|FG008|STARTED|Safety Follow-up (Sept 2017 to July 2019||0||
59963236|NCT01915498|76081303|FG009|STARTED|Safety Follow-up (Sept 2017 to July 2019||0||
59963237|NCT01915498|76081304|FG010|STARTED|Safety Follow-up (Sept 2017 to July 2019||0||
59963238|NCT01915498|76081305|FG011|STARTED|Safety Follow-up (Sept 2017 to July 2019||0||
59963239|NCT01915498|76081306|FG012|STARTED|Safety Follow-up (Sept 2017 to July 2019||0||
59963240|NCT01915498|76081307|FG013|STARTED|Safety Follow-up (Sept 2017 to July 2019||0||
59963241|NCT01915498|76081308|FG014|STARTED|Safety Follow-up (Sept 2017 to July 2019||0||
59963242|NCT01915498|76081309|FG015|STARTED|Safety Follow-up (Sept 2017 to July 2019||0||
59963243|NCT01915498|76081310|FG016|STARTED|Safety Follow-up (Sept 2017 to July 2019||0||
59963244|NCT01915498|76081311|FG017|STARTED|Safety Follow-up (Sept 2017 to July 2019||0||
59963245|NCT01915498|76081312|FG018|STARTED|Safety Follow-up (Sept 2017 to July 2019||16||
59963246|NCT01915498|76081294|FG000|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0||
59963247|NCT01915498|76081295|FG001|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0||
59963248|NCT01915498|76081296|FG002|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0||
59963249|NCT01915498|76081297|FG003|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0||
59963250|NCT01915498|76081298|FG004|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0||
59963251|NCT01915498|76081299|FG005|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0||
59995284|NCT01119807|76111112|FG001|NOT COMPLETED|Overall Study||0||
59621324|NCT02103270|75732888|FG001|STARTED|Overall Study||35||
59621325|NCT02103270|75732889|FG002|STARTED|Overall Study||25||
59963252|NCT01915498|76081300|FG006|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0||
59963253|NCT01915498|76081301|FG007|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0||
59963254|NCT01915498|76081302|FG008|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0||
59963255|NCT01915498|76081303|FG009|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0||
59963256|NCT01915498|76081304|FG010|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0||
59963257|NCT01915498|76081305|FG011|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0||
59963258|NCT01915498|76081306|FG012|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0||
59963259|NCT01915498|76081307|FG013|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0||
59963260|NCT01915498|76081308|FG014|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0||
59963261|NCT01915498|76081309|FG015|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0||
59963262|NCT01915498|76081310|FG016|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0||
59963263|NCT01915498|76081311|FG017|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0||
59963264|NCT01915498|76081312|FG018|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||14||
59963265|NCT01915498|76081294|FG000|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0||
59963266|NCT01915498|76081295|FG001|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0||
59963267|NCT01915498|76081296|FG002|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0||
59963268|NCT01915498|76081297|FG003|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0||
59963269|NCT01915498|76081298|FG004|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0||
59963270|NCT01915498|76081299|FG005|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0||
59963271|NCT01915498|76081300|FG006|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0||
59963272|NCT01915498|76081301|FG007|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0||
59963273|NCT01915498|76081302|FG008|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0||
59963274|NCT01915498|76081303|FG009|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0||
59963275|NCT01915498|76081304|FG010|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0||
59963276|NCT01915498|76081305|FG011|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0||
59963277|NCT01915498|76081306|FG012|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0||
59963278|NCT01915498|76081307|FG013|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0||
59963279|NCT01915498|76081308|FG014|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0||
59963280|NCT01915498|76081309|FG015|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0||
59963281|NCT01915498|76081310|FG016|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0||
59963282|NCT01915498|76081311|FG017|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0||
59963283|NCT01915498|76081312|FG018|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||2||
59963284|NCT01885689|76081400|FG000|STARTED|Overall Study||52||
59963285|NCT01885689|76081400|FG000|COMPLETED|Overall Study||52||
59963286|NCT01885689|76081400|FG000|NOT COMPLETED|Overall Study||0||
59963287|NCT01798004|76081404|FG000|STARTED|Overall Study||150||
59963288|NCT01798004|76081404|FG000|COMPLETED|Overall Study||63||
59963289|NCT01798004|76081404|FG000|NOT COMPLETED|Overall Study||87||
59963290|NCT01630434|76081410|FG000|STARTED|Overall Study||151|Intention-to-treat population|
59963291|NCT01630434|76081411|FG001|STARTED|Overall Study||169|Intention-to-treat population|
59963292|NCT01630434|76081410|FG000|Safety Population|Overall Study||150||
59963293|NCT01630434|76081411|FG001|Safety Population|Overall Study||169||
59963294|NCT01630434|76081410|FG000|Per Protocol Population|Overall Study||141||
59963295|NCT01630434|76081411|FG001|Per Protocol Population|Overall Study||165||
59963296|NCT01630434|76081410|FG000|COMPLETED|Overall Study||121|Number of per protocol subjects that completed 24-month follow-up|
59963297|NCT01630434|76081411|FG001|COMPLETED|Overall Study||139|Number of per protocol subjects that completed 24-month follow-up|
59963298|NCT01630434|76081410|FG000|NOT COMPLETED|Overall Study||30||
59963299|NCT01630434|76081411|FG001|NOT COMPLETED|Overall Study||30||
59963300|NCT01256398|76081421|FG000|STARTED|Overall Study||66||
59963301|NCT01256398|76081421|FG000|COMPLETED|Overall Study||65||
60074167|NCT01808612|76189581|FG000|NOT COMPLETED|Treatment Period||15||
59963302|NCT01256398|76081421|FG000|NOT COMPLETED|Overall Study||1||
59963303|NCT01151423|76081429|FG000|STARTED|Overall Study||36||
59621326|NCT02103270|75732887|FG000|COMPLETED|Overall Study||51||
59621327|NCT02103270|75732888|FG001|COMPLETED|Overall Study||29||
59621328|NCT02103270|75732889|FG002|COMPLETED|Overall Study||1||
59621329|NCT02103270|75732887|FG000|NOT COMPLETED|Overall Study||9||
59621330|NCT02103270|75732888|FG001|NOT COMPLETED|Overall Study||6||
59808869|NCT03523728|75931068|FG002|STARTED|Stage 1 (24 Months)||80||
59808870|NCT03523728|75931069|FG003|STARTED|Stage 1 (24 Months)||0||
59963304|NCT01151423|76081430|FG001|STARTED|Overall Study||39||
59963305|NCT01151423|76081429|FG000|Received Study Drug|Overall Study||35||
59963306|NCT01151423|76081430|FG001|Received Study Drug|Overall Study||37||
59963307|NCT01151423|76081429|FG000|COMPLETED|Overall Study||20||
59963308|NCT01151423|76081430|FG001|COMPLETED|Overall Study||21||
59963309|NCT01151423|76081429|FG000|NOT COMPLETED|Overall Study||16||
59963310|NCT01151423|76081430|FG001|NOT COMPLETED|Overall Study||18||
59963311|NCT00587067|76081436|FG000|STARTED|Overall Study||34||
59963312|NCT00587067|76081436|FG000|COMPLETED|Overall Study||34||
59963313|NCT00587067|76081436|FG000|NOT COMPLETED|Overall Study||0||
60074168|NCT01808612|76189582|FG001|NOT COMPLETED|Treatment Period||7||
59963314|NCT00565617|76081441|FG000|STARTED|Overall Study||6||
59963315|NCT00565617|76081441|FG000|COMPLETED|Overall Study||5||
59963316|NCT00565617|76081441|FG000|NOT COMPLETED|Overall Study||1||
59963317|NCT00453154|76081448|FG000|STARTED|Combination Chemotherapy||12||
59963318|NCT00453154|76081449|FG001|STARTED|Combination Chemotherapy||144||
59808871|NCT03523728|75931070|FG004|STARTED|Stage 1 (24 Months)||0||
59808872|NCT03523728|75931066|FG000|COMPLETED|Stage 1 (24 Months)||12||
59808873|NCT03523728|75931067|FG001|COMPLETED|Stage 1 (24 Months)||10||
59963319|NCT00453154|76081450|FG002|STARTED|Combination Chemotherapy||0||
59963320|NCT00453154|76081451|FG003|STARTED|Combination Chemotherapy||0||
59963321|NCT00453154|76081448|FG000|COMPLETED|Combination Chemotherapy||12||
59963322|NCT00453154|76081449|FG001|COMPLETED|Combination Chemotherapy||95||
59963323|NCT00453154|76081450|FG002|COMPLETED|Combination Chemotherapy||0||
59963324|NCT00453154|76081451|FG003|COMPLETED|Combination Chemotherapy||0||
59963325|NCT00453154|76081448|FG000|NOT COMPLETED|Combination Chemotherapy||0||
59963326|NCT00453154|76081449|FG001|NOT COMPLETED|Combination Chemotherapy||49||
59808874|NCT03523728|75931068|FG002|COMPLETED|Stage 1 (24 Months)||12||
59808875|NCT03523728|75931069|FG003|COMPLETED|Stage 1 (24 Months)||0||
59808876|NCT03523728|75931070|FG004|COMPLETED|Stage 1 (24 Months)||0||
59963327|NCT00453154|76081450|FG002|NOT COMPLETED|Combination Chemotherapy||0||
59963328|NCT00453154|76081451|FG003|NOT COMPLETED|Combination Chemotherapy||0||
59963329|NCT00453154|76081448|FG000|STARTED|Double BIind Maintenance||0||
59963330|NCT00453154|76081449|FG001|STARTED|Double BIind Maintenance||0||
59963331|NCT00453154|76081450|FG002|STARTED|Double BIind Maintenance||46||
59963332|NCT00453154|76081451|FG003|STARTED|Double BIind Maintenance||49||
59963333|NCT00453154|76081448|FG000|COMPLETED|Double BIind Maintenance||0||
59963334|NCT00453154|76081449|FG001|COMPLETED|Double BIind Maintenance||0||
59963335|NCT00453154|76081450|FG002|COMPLETED|Double BIind Maintenance||0||
59963336|NCT00453154|76081451|FG003|COMPLETED|Double BIind Maintenance||0||
59963337|NCT00453154|76081448|FG000|NOT COMPLETED|Double BIind Maintenance||0||
59963338|NCT00453154|76081449|FG001|NOT COMPLETED|Double BIind Maintenance||0||
59963339|NCT00453154|76081450|FG002|NOT COMPLETED|Double BIind Maintenance||46||
59963340|NCT00453154|76081451|FG003|NOT COMPLETED|Double BIind Maintenance||49||
59963341|NCT00453154|76081448|FG000|STARTED|Open Label Sunitinib Crossover||0||
59963342|NCT00453154|76081449|FG001|STARTED|Open Label Sunitinib Crossover||0||
59963343|NCT00453154|76081450|FG002|STARTED|Open Label Sunitinib Crossover||18||
59963344|NCT00453154|76081451|FG003|STARTED|Open Label Sunitinib Crossover||0||
59963345|NCT00453154|76081448|FG000|COMPLETED|Open Label Sunitinib Crossover||0||
59963346|NCT00453154|76081449|FG001|COMPLETED|Open Label Sunitinib Crossover||0||
59963347|NCT00453154|76081450|FG002|COMPLETED|Open Label Sunitinib Crossover||18||
59963348|NCT00453154|76081451|FG003|COMPLETED|Open Label Sunitinib Crossover||0||
59963349|NCT00453154|76081448|FG000|NOT COMPLETED|Open Label Sunitinib Crossover||0||
59963350|NCT00453154|76081449|FG001|NOT COMPLETED|Open Label Sunitinib Crossover||0||
59963351|NCT00453154|76081450|FG002|NOT COMPLETED|Open Label Sunitinib Crossover||0||
59963352|NCT00453154|76081451|FG003|NOT COMPLETED|Open Label Sunitinib Crossover||0||
59963353|NCT00258960|76081460|FG000|STARTED|Overall Study|49 patients included but 1 is not considered due to not receive any treatment and died before start|49||
59963354|NCT00258960|76081460|FG000|COMPLETED|Overall Study||32||
59963355|NCT00258960|76081460|FG000|NOT COMPLETED|Overall Study||17||
59963356|NCT00121992|76081466|FG000|STARTED|Overall Study||521||
59963357|NCT00121992|76081467|FG001|STARTED|Overall Study||539||
59963358|NCT00121992|76081466|FG000|Hormone-receptor Positive and HER2 Positive Status Subjects|Overall Study||28||
59963359|NCT00121992|76081467|FG001|Hormone-receptor Positive and HER2 Positive Status Subjects|Overall Study||30||
59963360|NCT00121992|76081466|FG000|Hormone-receptor Negative and HER2 Positive Status Subjects|Overall Study||24||
59963361|NCT00121992|76081467|FG001|Hormone-receptor Negative and HER2 Positive Status Subjects|Overall Study||22||
59963362|NCT00121992|76081466|FG000|Hormone-receptor Positive and HER2 Negative Status Subjects|Overall Study||209||
59963363|NCT00121992|76081467|FG001|Hormone-receptor Positive and HER2 Negative Status Subjects|Overall Study||220||
59621331|NCT02103270|75732889|FG002|NOT COMPLETED|Overall Study||24||
59963364|NCT00121992|76081466|FG000|Hormone-receptor Negative and HER2 Negative Status Subjects|Overall Study||92||
60074169|NCT01808612|76189583|FG002|NOT COMPLETED|Treatment Period||14||
59621332|NCT00140556|75732900|FG000|STARTED|Pre Radiation Period: Avastin / Tarceva||28||
59621333|NCT00140556|75732900|FG000|COMPLETED|Pre Radiation Period: Avastin / Tarceva||28||
59621334|NCT00140556|75732900|FG000|NOT COMPLETED|Pre Radiation Period: Avastin / Tarceva||0||
59621335|NCT00140556|75732900|FG000|STARTED|Chemoradiotherapy Period||28||
59621336|NCT00140556|75732900|FG000|COMPLETED|Chemoradiotherapy Period||28||
59621337|NCT00140556|75732900|FG000|NOT COMPLETED|Chemoradiotherapy Period||0||
59621338|NCT00142116|75732904|FG000|STARTED|Overall Study||25||
59621339|NCT00142116|75732904|FG000|COMPLETED|Overall Study||25||
59621340|NCT00142116|75732904|FG000|NOT COMPLETED|Overall Study||0||
59621341|NCT00142506|75732911|FG000|STARTED|Overall Study||184||
59621342|NCT00142506|75732912|FG001|STARTED|Overall Study||106||
59621343|NCT00142506|75732911|FG000|COMPLETED|Overall Study||112||
59621344|NCT00142506|75732912|FG001|COMPLETED|Overall Study||77||
59621345|NCT00142506|75732911|FG000|NOT COMPLETED|Overall Study||72||
59808877|NCT03523728|75931066|FG000|NOT COMPLETED|Stage 1 (24 Months)||66||
59808878|NCT03523728|75931067|FG001|NOT COMPLETED|Stage 1 (24 Months)||68||
59963365|NCT00121992|76081467|FG001|Hormone-receptor Negative and HER2 Negative Status Subjects|Overall Study||103||
59963366|NCT00121992|76081466|FG000|COMPLETED|Overall Study||519||
59963367|NCT00121992|76081467|FG001|COMPLETED|Overall Study||528||
59963368|NCT00121992|76081466|FG000|NOT COMPLETED|Overall Study||2||
59963369|NCT00121992|76081467|FG001|NOT COMPLETED|Overall Study||11||
59963370|NCT00070564|76081479|FG000|STARTED|Overall Study||678||
59963371|NCT00070564|76081480|FG001|STARTED|Overall Study||693||
59963372|NCT00070564|76081481|FG002|STARTED|Overall Study||697||
59963373|NCT00070564|76081482|FG003|STARTED|Overall Study||648||
59963374|NCT00070564|76081483|FG004|STARTED|Overall Study||282||
59963375|NCT00070564|76081484|FG005|STARTED|Overall Study||296||
59963376|NCT00070564|76081479|FG000|COMPLETED|Overall Study||478||
59963377|NCT00070564|76081480|FG001|COMPLETED|Overall Study||490||
59963378|NCT00070564|76081481|FG002|COMPLETED|Overall Study||526||
59963379|NCT00070564|76081482|FG003|COMPLETED|Overall Study||481||
59963380|NCT00070564|76081483|FG004|COMPLETED|Overall Study||203||
59963381|NCT00070564|76081484|FG005|COMPLETED|Overall Study||244||
59963382|NCT00070564|76081479|FG000|NOT COMPLETED|Overall Study||200||
59963383|NCT00070564|76081480|FG001|NOT COMPLETED|Overall Study||203||
59963384|NCT00070564|76081481|FG002|NOT COMPLETED|Overall Study||171||
59963385|NCT00070564|76081482|FG003|NOT COMPLETED|Overall Study||167||
59963386|NCT00070564|76081483|FG004|NOT COMPLETED|Overall Study||79||
59963387|NCT00070564|76081484|FG005|NOT COMPLETED|Overall Study||52||
59963388|NCT03637959|76081504|FG000|STARTED|Overall Study||270||
59963389|NCT03637959|76081504|FG000|COMPLETED|Overall Study||270||
59963390|NCT03637959|76081504|FG000|NOT COMPLETED|Overall Study||0||
59963391|NCT02738151|76081510|FG000|STARTED|Overall Study||466||
59963392|NCT02738151|76081511|FG001|STARTED|Overall Study||463||
59963393|NCT02738151|76081510|FG000|Treated|Overall Study||462||
59963394|NCT02738151|76081511|FG001|Treated|Overall Study||462||
59963395|NCT02738151|76081510|FG000|COMPLETED|Overall Study||443||
59963396|NCT02738151|76081511|FG001|COMPLETED|Overall Study||432||
59963397|NCT02738151|76081510|FG000|NOT COMPLETED|Overall Study||23||
59963398|NCT02738151|76081511|FG001|NOT COMPLETED|Overall Study||31||
59963399|NCT02915159|76081519|FG000|STARTED|Overall Study||92||
59963400|NCT02915159|76081520|FG001|STARTED|Overall Study||95||
59963401|NCT02915159|76081519|FG000|COMPLETED|Overall Study||81||
59963402|NCT02915159|76081520|FG001|COMPLETED|Overall Study||87||
59963403|NCT02915159|76081519|FG000|NOT COMPLETED|Overall Study||11||
60074170|NCT01808612|76189581|FG000|STARTED|Discontinuation Period||87||
60074171|NCT01808612|76189582|FG001|STARTED|Discontinuation Period||38||
60074172|NCT01808612|76189583|FG002|STARTED|Discontinuation Period||145||
60074173|NCT01808612|76189581|FG000|COMPLETED|Discontinuation Period||85||
60074174|NCT01808612|76189582|FG001|COMPLETED|Discontinuation Period||37||
60074175|NCT01808612|76189583|FG002|COMPLETED|Discontinuation Period||145||
60074176|NCT01808612|76189581|FG000|NOT COMPLETED|Discontinuation Period||2||
60074177|NCT01808612|76189582|FG001|NOT COMPLETED|Discontinuation Period||1||
59963404|NCT02915159|76081520|FG001|NOT COMPLETED|Overall Study||8||
59963405|NCT02924051|76081532|FG000|STARTED|Overall Study||82||
59963406|NCT02924051|76081533|FG001|STARTED|Overall Study||106||
59963407|NCT02924051|76081532|FG000|COMPLETED|Overall Study||81||
59963408|NCT02924051|76081533|FG001|COMPLETED|Overall Study||97||
59963409|NCT02924051|76081532|FG000|NOT COMPLETED|Overall Study||1||
59963410|NCT02924051|76081533|FG001|NOT COMPLETED|Overall Study||9||
59963411|NCT04058249|76081541|FG000|STARTED|Overall Study||1||
59963412|NCT04058249|76081541|FG000|COMPLETED|Overall Study||1||
59963413|NCT04058249|76081541|FG000|NOT COMPLETED|Overall Study||0||
59963414|NCT02923427|76081547|FG000|STARTED|Overall Study||55||
59963415|NCT02923427|76081548|FG001|STARTED|Overall Study||57||
59621346|NCT00142506|75732912|FG001|NOT COMPLETED|Overall Study||29||
59621347|NCT00142818|75732922|FG000|STARTED|Overall Study||45||
59621348|NCT00142818|75732923|FG001|STARTED|Overall Study||40||
59621349|NCT00142818|75732924|FG002|STARTED|Overall Study||37||
59621350|NCT00142818|75732925|FG003|STARTED|Overall Study||42||
59621351|NCT00142818|75732922|FG000|COMPLETED|Overall Study||28||
59963416|NCT02923427|76081547|FG000|COMPLETED|Overall Study|"The reasons:~n= 2 Convert to Laparotomy n=1 Desaturation n=1 LMA-S can not be placed"|51||
59963417|NCT02923427|76081548|FG001|COMPLETED|Overall Study|"The reasons:~n = 2 Convert to Laparotomy"|55||
60074178|NCT01808612|76189583|FG002|NOT COMPLETED|Discontinuation Period||0||
60074179|NCT01908829|76189597|FG000|STARTED|Overall Study||727||
60074180|NCT01908829|76189598|FG001|STARTED|Overall Study||728||
59621352|NCT00142818|75732923|FG001|COMPLETED|Overall Study||19||
59621353|NCT00142818|75732924|FG002|COMPLETED|Overall Study||24||
59621354|NCT00142818|75732925|FG003|COMPLETED|Overall Study||20||
59963418|NCT02923427|76081547|FG000|NOT COMPLETED|Overall Study||4||
59963419|NCT02923427|76081548|FG001|NOT COMPLETED|Overall Study||2||
59963420|NCT02669264|76081561|FG000|STARTED|Overall Study||5||
59963421|NCT02669264|76081562|FG001|STARTED|Overall Study||7||
59963422|NCT02669264|76081563|FG002|STARTED|Overall Study||3||
59963423|NCT02669264|76081564|FG003|STARTED|Overall Study||4||
59963424|NCT02669264|76081565|FG004|STARTED|Overall Study||5||
59963425|NCT02669264|76081566|FG005|STARTED|Overall Study||6||
59621355|NCT00142818|75732922|FG000|NOT COMPLETED|Overall Study||17||
59963426|NCT02669264|76081567|FG006|STARTED|Overall Study||5||
60074181|NCT01908829|76189599|FG002|STARTED|Overall Study||719||
59808879|NCT03523728|75931068|FG002|NOT COMPLETED|Stage 1 (24 Months)||68||
59808880|NCT03523728|75931069|FG003|NOT COMPLETED|Stage 1 (24 Months)||0||
59808881|NCT03523728|75931070|FG004|NOT COMPLETED|Stage 1 (24 Months)||0||
59808882|NCT03523728|75931066|FG000|STARTED|Stage 2 (24 Months)||0||
59963427|NCT02669264|76081561|FG000|COMPLETED|Overall Study||0||
59963428|NCT02669264|76081562|FG001|COMPLETED|Overall Study||1||
59963429|NCT02669264|76081563|FG002|COMPLETED|Overall Study||0||
59963430|NCT02669264|76081564|FG003|COMPLETED|Overall Study||1||
59963431|NCT02669264|76081565|FG004|COMPLETED|Overall Study||0||
59963432|NCT02669264|76081566|FG005|COMPLETED|Overall Study||0||
59963433|NCT02669264|76081567|FG006|COMPLETED|Overall Study||0||
59963434|NCT02669264|76081561|FG000|NOT COMPLETED|Overall Study||5||
59963435|NCT02669264|76081562|FG001|NOT COMPLETED|Overall Study||6||
59963436|NCT02669264|76081563|FG002|NOT COMPLETED|Overall Study||3||
59963437|NCT02669264|76081564|FG003|NOT COMPLETED|Overall Study||3||
59963438|NCT02669264|76081565|FG004|NOT COMPLETED|Overall Study||5||
59963439|NCT02669264|76081566|FG005|NOT COMPLETED|Overall Study||6||
59963440|NCT02669264|76081567|FG006|NOT COMPLETED|Overall Study||5||
59963441|NCT02521870|76081593|FG000|STARTED|Phase 1: Dose Escalation||6||
59963442|NCT02521870|76081594|FG001|STARTED|Phase 1: Dose Escalation||5||
59963443|NCT02521870|76081595|FG002|STARTED|Phase 1: Dose Escalation||5||
59963444|NCT02521870|76081596|FG003|STARTED|Phase 1: Dose Escalation||6||
59963445|NCT02521870|76081597|FG004|STARTED|Phase 1: Dose Escalation||0||
59963446|NCT02521870|76081598|FG005|STARTED|Phase 1: Dose Escalation||0||
59963447|NCT02521870|76081599|FG006|STARTED|Phase 1: Dose Escalation||0||
59963448|NCT02521870|76081600|FG007|STARTED|Phase 1: Dose Escalation||0||
59963449|NCT02521870|76081601|FG008|STARTED|Phase 1: Dose Escalation||0||
59963450|NCT02521870|76081602|FG009|STARTED|Phase 1: Dose Escalation||0||
59963451|NCT02521870|76081603|FG010|STARTED|Phase 1: Dose Escalation||0||
59963452|NCT02521870|76081604|FG011|STARTED|Phase 1: Dose Escalation||0||
59963453|NCT02521870|76081593|FG000|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||3||
59963454|NCT02521870|76081594|FG001|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||3||
59963455|NCT02521870|76081595|FG002|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||0||
59963456|NCT02521870|76081596|FG003|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||1||
59963457|NCT02521870|76081597|FG004|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||0||
59963458|NCT02521870|76081598|FG005|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||0||
59963459|NCT02521870|76081599|FG006|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||0||
59963460|NCT02521870|76081600|FG007|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||0||
59963461|NCT02521870|76081601|FG008|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||0||
59963462|NCT02521870|76081602|FG009|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||0||
59963463|NCT02521870|76081603|FG010|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||0||
59963464|NCT02521870|76081604|FG011|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||0||
60074182|NCT01908829|76189597|FG000|Treated With Double-blind Drug|Overall Study||725||
60074183|NCT01908829|76189598|FG001|Treated With Double-blind Drug|Overall Study||728||
60074184|NCT01908829|76189599|FG002|Treated With Double-blind Drug|Overall Study||719||
60074185|NCT01908829|76189597|FG000|COMPLETED|Overall Study||678||
59808883|NCT03523728|75931067|FG001|STARTED|Stage 2 (24 Months)||0||
59808884|NCT03523728|75931068|FG002|STARTED|Stage 2 (24 Months)||0||
59808885|NCT03523728|75931069|FG003|STARTED|Stage 2 (24 Months)|Stage 1 and Stage 2 were separate population.|123||
59808886|NCT03523728|75931070|FG004|STARTED|Stage 2 (24 Months)|Stage 1 and Stage 2 were separate population.|119||
59808887|NCT03523728|75931066|FG000|Treated|Stage 2 (24 Months)||0||
59808888|NCT03523728|75931067|FG001|Treated|Stage 2 (24 Months)||0||
59808889|NCT03523728|75931068|FG002|Treated|Stage 2 (24 Months)||0||
59808890|NCT03523728|75931069|FG003|Treated|Stage 2 (24 Months)||122||
59808891|NCT03523728|75931070|FG004|Treated|Stage 2 (24 Months)||119||
59808892|NCT03523728|75931066|FG000|Estimated Glomerular Filtration Rate (eGFR) Between 45 and 89.9 mL/Min/1.73 m^2 at Screening|Stage 2 (24 Months)||0||
59963465|NCT02521870|76081593|FG000|COMPLETED|Phase 1: Dose Escalation||1|Completed Pembrolizumab Treatment (up to 35 doses)|
59963466|NCT02521870|76081594|FG001|COMPLETED|Phase 1: Dose Escalation||1|Completed Pembrolizumab Treatment (up to 35 doses)|
59963467|NCT02521870|76081595|FG002|COMPLETED|Phase 1: Dose Escalation||1|Completed Pembrolizumab Treatment (up to 35 doses)|
59963468|NCT02521870|76081596|FG003|COMPLETED|Phase 1: Dose Escalation||0|Completed Pembrolizumab Treatment (up to 35 doses)|
59963469|NCT02521870|76081597|FG004|COMPLETED|Phase 1: Dose Escalation||0|Completed Pembrolizumab Treatment (up to 35 doses)|
59963470|NCT02521870|76081598|FG005|COMPLETED|Phase 1: Dose Escalation||0|Completed Pembrolizumab Treatment (up to 35 doses)|
59963471|NCT02521870|76081599|FG006|COMPLETED|Phase 1: Dose Escalation||0|Completed Pembrolizumab Treatment (up to 35 doses)|
59808893|NCT03523728|75931067|FG001|Estimated Glomerular Filtration Rate (eGFR) Between 45 and 89.9 mL/Min/1.73 m^2 at Screening|Stage 2 (24 Months)||0||
59963472|NCT02521870|76081600|FG007|COMPLETED|Phase 1: Dose Escalation||0|Completed Pembrolizumab Treatment (up to 35 doses)|
59963473|NCT02521870|76081601|FG008|COMPLETED|Phase 1: Dose Escalation||0|Completed Pembrolizumab Treatment (up to 35 doses)|
59963474|NCT02521870|76081602|FG009|COMPLETED|Phase 1: Dose Escalation||0|Completed Pembrolizumab Treatment (up to 35 doses)|
59963475|NCT02521870|76081603|FG010|COMPLETED|Phase 1: Dose Escalation||0|Completed Pembrolizumab Treatment (up to 35 doses)|
59963476|NCT02521870|76081604|FG011|COMPLETED|Phase 1: Dose Escalation||0|Completed Pembrolizumab Treatment (up to 35 doses)|
59963477|NCT02521870|76081593|FG000|NOT COMPLETED|Phase 1: Dose Escalation||5||
59963478|NCT02521870|76081594|FG001|NOT COMPLETED|Phase 1: Dose Escalation||4||
59963479|NCT02521870|76081595|FG002|NOT COMPLETED|Phase 1: Dose Escalation||4||
59963480|NCT02521870|76081596|FG003|NOT COMPLETED|Phase 1: Dose Escalation||6||
59963481|NCT02521870|76081597|FG004|NOT COMPLETED|Phase 1: Dose Escalation||0||
59963482|NCT02521870|76081598|FG005|NOT COMPLETED|Phase 1: Dose Escalation||0||
59963483|NCT02521870|76081599|FG006|NOT COMPLETED|Phase 1: Dose Escalation||0||
59963484|NCT02521870|76081600|FG007|NOT COMPLETED|Phase 1: Dose Escalation||0||
59963485|NCT02521870|76081601|FG008|NOT COMPLETED|Phase 1: Dose Escalation||0||
59963486|NCT02521870|76081602|FG009|NOT COMPLETED|Phase 1: Dose Escalation||0||
59963487|NCT02521870|76081603|FG010|NOT COMPLETED|Phase 1: Dose Escalation||0||
59963488|NCT02521870|76081604|FG011|NOT COMPLETED|Phase 1: Dose Escalation||0||
59963489|NCT02521870|76081593|FG000|STARTED|Phase 2: Dose Expansion||0||
59963490|NCT02521870|76081594|FG001|STARTED|Phase 2: Dose Expansion||0||
59963491|NCT02521870|76081595|FG002|STARTED|Phase 2: Dose Expansion||0||
59963492|NCT02521870|76081596|FG003|STARTED|Phase 2: Dose Expansion||0||
59963493|NCT02521870|76081597|FG004|STARTED|Phase 2: Dose Expansion||57||
59963494|NCT02521870|76081598|FG005|STARTED|Phase 2: Dose Expansion||25||
59963495|NCT02521870|76081599|FG006|STARTED|Phase 2: Dose Expansion||23||
59963496|NCT02521870|76081600|FG007|STARTED|Phase 2: Dose Expansion||9||
59963497|NCT02521870|76081601|FG008|STARTED|Phase 2: Dose Expansion||24||
59963498|NCT02521870|76081602|FG009|STARTED|Phase 2: Dose Expansion||28||
59963499|NCT02521870|76081603|FG010|STARTED|Phase 2: Dose Expansion||23||
59963500|NCT02521870|76081604|FG011|STARTED|Phase 2: Dose Expansion||30||
59963501|NCT02521870|76081593|FG000|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||0||
59963502|NCT02521870|76081594|FG001|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||0||
59963503|NCT02521870|76081595|FG002|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||0||
59963504|NCT02521870|76081596|FG003|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||0||
59963505|NCT02521870|76081597|FG004|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||25||
59963506|NCT02521870|76081598|FG005|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||7||
59963507|NCT02521870|76081599|FG006|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||3||
59963508|NCT02521870|76081600|FG007|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||2||
59963509|NCT02521870|76081601|FG008|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||9||
59963510|NCT02521870|76081602|FG009|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||5||
59963511|NCT02521870|76081603|FG010|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||1||
59963512|NCT02521870|76081604|FG011|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||11||
59963513|NCT02521870|76081593|FG000|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0||
59963514|NCT02521870|76081594|FG001|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0||
59963515|NCT02521870|76081595|FG002|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0||
59963516|NCT02521870|76081596|FG003|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0||
59963517|NCT02521870|76081597|FG004|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||7||
59963518|NCT02521870|76081598|FG005|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||1||
59963519|NCT02521870|76081599|FG006|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0||
59963520|NCT02521870|76081600|FG007|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0||
59963521|NCT02521870|76081601|FG008|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0||
59963522|NCT02521870|76081602|FG009|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0||
59963523|NCT02521870|76081603|FG010|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0||
59995285|NCT01119807|76111113|FG002|NOT COMPLETED|Overall Study||0||
59621356|NCT00142818|75732923|FG001|NOT COMPLETED|Overall Study||21||
59621357|NCT00142818|75732924|FG002|NOT COMPLETED|Overall Study||13||
59621358|NCT00142818|75732925|FG003|NOT COMPLETED|Overall Study||22||
59621359|NCT00147030|75732941|FG000|STARTED|Overall Study||163||
59621360|NCT00147030|75732942|FG001|STARTED|Overall Study||162||
59621361|NCT00147030|75732941|FG000|COMPLETED|Overall Study||163||
59621362|NCT00147030|75732942|FG001|COMPLETED|Overall Study||162||
59621363|NCT00147030|75732941|FG000|NOT COMPLETED|Overall Study||0||
59621364|NCT00147030|75732942|FG001|NOT COMPLETED|Overall Study||0||
59621365|NCT00147966|75732950|FG000|STARTED|Overall Study||24||
59621366|NCT00147966|75732950|FG000|COMPLETED|Overall Study||24||
59621367|NCT00147966|75732950|FG000|NOT COMPLETED|Overall Study||0||
59621368|NCT00148668|75732956|FG000|STARTED|Overall Study||41||
59621369|NCT00148668|75732957|FG001|STARTED|Overall Study||40||
59621370|NCT00148668|75732956|FG000|COMPLETED|Overall Study||41||
59963524|NCT02521870|76081604|FG011|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0||
59963525|NCT02521870|76081593|FG000|COMPLETED|Phase 2: Dose Expansion||0|Completed Pembrolizumab Treatment (up to 35 doses)|
59963526|NCT02521870|76081594|FG001|COMPLETED|Phase 2: Dose Expansion||0|Completed Pembrolizumab Treatment (up to 35 doses)|
59963527|NCT02521870|76081595|FG002|COMPLETED|Phase 2: Dose Expansion||0|Completed Pembrolizumab Treatment (up to 35 doses)|
59963528|NCT02521870|76081596|FG003|COMPLETED|Phase 2: Dose Expansion||0|Completed Pembrolizumab Treatment (up to 35 doses)|
59963529|NCT02521870|76081597|FG004|COMPLETED|Phase 2: Dose Expansion||5|Completed Pembrolizumab Treatment (up to 35 doses)|
59963530|NCT02521870|76081598|FG005|COMPLETED|Phase 2: Dose Expansion||0|Completed Pembrolizumab Treatment (up to 35 doses)|
59963531|NCT02521870|76081599|FG006|COMPLETED|Phase 2: Dose Expansion||0|Completed Pembrolizumab Treatment (up to 35 doses)|
59963532|NCT02521870|76081600|FG007|COMPLETED|Phase 2: Dose Expansion||0|Completed Pembrolizumab Treatment (up to 35 doses)|
59963533|NCT02521870|76081601|FG008|COMPLETED|Phase 2: Dose Expansion|4 participants completed pembrolizumab treatment (up to 35 cycles).|2|Completed Pembrolizumab Treatment (up to 35 doses)|
59963534|NCT02521870|76081602|FG009|COMPLETED|Phase 2: Dose Expansion||0|Completed Pembrolizumab Treatment (up to 35 doses)|
59963535|NCT02521870|76081603|FG010|COMPLETED|Phase 2: Dose Expansion||0|Completed Pembrolizumab Treatment (up to 35 doses)|
59963536|NCT02521870|76081604|FG011|COMPLETED|Phase 2: Dose Expansion||0|Completed Pembrolizumab Treatment (up to 35 doses)|
59963537|NCT02521870|76081593|FG000|NOT COMPLETED|Phase 2: Dose Expansion||0||
59963538|NCT02521870|76081594|FG001|NOT COMPLETED|Phase 2: Dose Expansion||0||
59963539|NCT02521870|76081595|FG002|NOT COMPLETED|Phase 2: Dose Expansion||0||
59963540|NCT02521870|76081596|FG003|NOT COMPLETED|Phase 2: Dose Expansion||0||
59963541|NCT02521870|76081597|FG004|NOT COMPLETED|Phase 2: Dose Expansion||52||
59963542|NCT02521870|76081598|FG005|NOT COMPLETED|Phase 2: Dose Expansion||25||
59963543|NCT02521870|76081599|FG006|NOT COMPLETED|Phase 2: Dose Expansion||23||
59963544|NCT02521870|76081600|FG007|NOT COMPLETED|Phase 2: Dose Expansion||9||
59963545|NCT02521870|76081601|FG008|NOT COMPLETED|Phase 2: Dose Expansion||22||
59963546|NCT02521870|76081602|FG009|NOT COMPLETED|Phase 2: Dose Expansion||28||
59963547|NCT02521870|76081603|FG010|NOT COMPLETED|Phase 2: Dose Expansion||23||
59963548|NCT02521870|76081604|FG011|NOT COMPLETED|Phase 2: Dose Expansion||30||
59963549|NCT02923349|76081641|FG000|STARTED|Overall Study||4||
59963550|NCT02923349|76081642|FG001|STARTED|Overall Study||4||
59963551|NCT02923349|76081643|FG002|STARTED|Overall Study||22||
59963552|NCT02923349|76081644|FG003|STARTED|Overall Study||18||
59963553|NCT02923349|76081645|FG004|STARTED|Overall Study||23||
59963554|NCT02923349|76081646|FG005|STARTED|Overall Study||12||
59963555|NCT02923349|76081647|FG006|STARTED|Overall Study||4||
59963556|NCT02923349|76081641|FG000|COMPLETED|Overall Study||0||
59963557|NCT02923349|76081642|FG001|COMPLETED|Overall Study||0||
59963558|NCT02923349|76081643|FG002|COMPLETED|Overall Study||5||
59808894|NCT03523728|75931068|FG002|Estimated Glomerular Filtration Rate (eGFR) Between 45 and 89.9 mL/Min/1.73 m^2 at Screening|Stage 2 (24 Months)||0||
59808895|NCT03523728|75931069|FG003|Estimated Glomerular Filtration Rate (eGFR) Between 45 and 89.9 mL/Min/1.73 m^2 at Screening|Stage 2 (24 Months)||97||
59808896|NCT03523728|75931070|FG004|Estimated Glomerular Filtration Rate (eGFR) Between 45 and 89.9 mL/Min/1.73 m^2 at Screening|Stage 2 (24 Months)||90||
59808897|NCT03523728|75931066|FG000|eGFR Between 30 and 44.9 mL/Min/1.73 m^2 at Screening|Stage 2 (24 Months)||0||
59808898|NCT03523728|75931067|FG001|eGFR Between 30 and 44.9 mL/Min/1.73 m^2 at Screening|Stage 2 (24 Months)||0||
59808899|NCT03523728|75931068|FG002|eGFR Between 30 and 44.9 mL/Min/1.73 m^2 at Screening|Stage 2 (24 Months)||0||
59808900|NCT03523728|75931069|FG003|eGFR Between 30 and 44.9 mL/Min/1.73 m^2 at Screening|Stage 2 (24 Months)||25||
59808901|NCT03523728|75931070|FG004|eGFR Between 30 and 44.9 mL/Min/1.73 m^2 at Screening|Stage 2 (24 Months)||29||
59808902|NCT03523728|75931066|FG000|COMPLETED|Stage 2 (24 Months)||0||
59808903|NCT03523728|75931067|FG001|COMPLETED|Stage 2 (24 Months)||0||
59808904|NCT03523728|75931068|FG002|COMPLETED|Stage 2 (24 Months)||0||
59808905|NCT03523728|75931069|FG003|COMPLETED|Stage 2 (24 Months)||0||
59808906|NCT03523728|75931070|FG004|COMPLETED|Stage 2 (24 Months)||0||
59808907|NCT03523728|75931066|FG000|NOT COMPLETED|Stage 2 (24 Months)||0||
59808908|NCT03523728|75931067|FG001|NOT COMPLETED|Stage 2 (24 Months)||0||
59808909|NCT03523728|75931068|FG002|NOT COMPLETED|Stage 2 (24 Months)||0||
59808910|NCT03523728|75931069|FG003|NOT COMPLETED|Stage 2 (24 Months)||123||
59808911|NCT03523728|75931070|FG004|NOT COMPLETED|Stage 2 (24 Months)||119||
59808912|NCT00538590|75931089|FG000|STARTED|Overall Study||10||
59808913|NCT00538590|75931090|FG001|STARTED|Overall Study||10||
59808914|NCT00538590|75931089|FG000|COMPLETED|Overall Study|Deceased 8 months after surgery due to known cardiovascular co-morbidity.|9||
59963559|NCT02923349|76081644|FG003|COMPLETED|Overall Study||2||
59963560|NCT02923349|76081645|FG004|COMPLETED|Overall Study||4||
59963561|NCT02923349|76081646|FG005|COMPLETED|Overall Study||5||
59963562|NCT02923349|76081647|FG006|COMPLETED|Overall Study||1||
59963563|NCT02923349|76081641|FG000|NOT COMPLETED|Overall Study||4||
59808915|NCT00538590|75931090|FG001|COMPLETED|Overall Study||10||
60074186|NCT01908829|76189598|FG001|COMPLETED|Overall Study||679||
59808916|NCT00538590|75931089|FG000|NOT COMPLETED|Overall Study||1||
59808917|NCT00538590|75931090|FG001|NOT COMPLETED|Overall Study||0||
59808918|NCT00466947|75931098|FG000|STARTED|Primary Outcome Analysis Period||11875||
59808919|NCT00466947|75931099|FG001|STARTED|Primary Outcome Analysis Period||11863||
59808920|NCT00466947|75931098|FG000|Ongoing|Primary Outcome Analysis Period||11875||
60074187|NCT01908829|76189599|FG002|COMPLETED|Overall Study||680||
59963564|NCT02923349|76081642|FG001|NOT COMPLETED|Overall Study||4||
59963565|NCT02923349|76081643|FG002|NOT COMPLETED|Overall Study||17||
59963566|NCT02923349|76081644|FG003|NOT COMPLETED|Overall Study||16||
59963567|NCT02923349|76081645|FG004|NOT COMPLETED|Overall Study||19||
59963568|NCT02923349|76081646|FG005|NOT COMPLETED|Overall Study||7||
59963569|NCT02923349|76081647|FG006|NOT COMPLETED|Overall Study||3||
59963570|NCT02521792|76081663|FG000|STARTED|Overall Study||6||
59963571|NCT02521792|76081663|FG000|Received Treatment|Overall Study||4||
59808921|NCT00466947|75931099|FG001|Ongoing|Primary Outcome Analysis Period||11863||
59963572|NCT02521792|76081663|FG000|COMPLETED|Overall Study||0||
59963573|NCT02521792|76081663|FG000|NOT COMPLETED|Overall Study||6||
59963574|NCT03020615|76081670|FG000|STARTED|Overall Study||26||
59963575|NCT03020615|76081671|FG001|STARTED|Overall Study||25||
59963576|NCT03020615|76081672|FG002|STARTED|Overall Study||7||
59963577|NCT03020615|76081670|FG000|COMPLETED|Overall Study||19||
59963578|NCT03020615|76081671|FG001|COMPLETED|Overall Study||23||
59963579|NCT03020615|76081672|FG002|COMPLETED|Overall Study||0||
59963580|NCT03020615|76081670|FG000|NOT COMPLETED|Overall Study||7||
59963581|NCT03020615|76081671|FG001|NOT COMPLETED|Overall Study||2||
59963582|NCT03020615|76081672|FG002|NOT COMPLETED|Overall Study||7||
59963583|NCT03020069|76081685|FG000|STARTED|Overall Study||9||
59963584|NCT03020069|76081686|FG001|STARTED|Overall Study||4||
59963585|NCT03020069|76081685|FG000|COMPLETED|Overall Study||9||
59963586|NCT03020069|76081686|FG001|COMPLETED|Overall Study||3||
59963587|NCT03020069|76081685|FG000|NOT COMPLETED|Overall Study||0||
59963588|NCT03020069|76081686|FG001|NOT COMPLETED|Overall Study||1||
59963589|NCT03693170|76081692|FG000|STARTED|Overall Study||95||
59963590|NCT03693170|76081692|FG000|COMPLETED|Overall Study|Participants with study treatment ongoing at the time of cut off date (29JUN2020)|20||
59963591|NCT03693170|76081692|FG000|NOT COMPLETED|Overall Study||75||
59963592|NCT03021005|76081699|FG000|STARTED|Overall Study||102||
59963593|NCT03021005|76081700|FG001|STARTED|Overall Study||98||
59963594|NCT03021005|76081699|FG000|COMPLETED|Overall Study||63||
59963595|NCT03021005|76081700|FG001|COMPLETED|Overall Study||72||
59524637|NCT02533674|75619780|FG006|COMPLETED|Dose Level V||0||
59524638|NCT02533674|75619781|FG007|COMPLETED|Dose Level V||0||
59524639|NCT02533674|75619774|FG000|NOT COMPLETED|Dose Level V||0||
59524640|NCT02533674|75619775|FG001|NOT COMPLETED|Dose Level V||0||
59524641|NCT02533674|75619776|FG002|NOT COMPLETED|Dose Level V||0||
59524642|NCT02533674|75619777|FG003|NOT COMPLETED|Dose Level V||0||
59524643|NCT02533674|75619778|FG004|NOT COMPLETED|Dose Level V||5||
59524644|NCT02533674|75619779|FG005|NOT COMPLETED|Dose Level V||0||
59524645|NCT02533674|75619780|FG006|NOT COMPLETED|Dose Level V||0||
59524646|NCT02533674|75619781|FG007|NOT COMPLETED|Dose Level V||0||
59524647|NCT02533674|75619774|FG000|STARTED|Dose Level VI||0||
59524648|NCT02533674|75619775|FG001|STARTED|Dose Level VI||0||
59524649|NCT02533674|75619776|FG002|STARTED|Dose Level VI||0||
59524650|NCT02533674|75619777|FG003|STARTED|Dose Level VI||0||
59524651|NCT02533674|75619778|FG004|STARTED|Dose Level VI||0||
59621371|NCT00148668|75732957|FG001|COMPLETED|Overall Study||40||
59621372|NCT00148668|75732956|FG000|NOT COMPLETED|Overall Study||0||
59621373|NCT00148668|75732957|FG001|NOT COMPLETED|Overall Study||0||
59621374|NCT00149838|75732965|FG000|STARTED|Phase I||92||
59621375|NCT00149838|75732966|FG001|STARTED|Phase I||98||
59621376|NCT00149838|75732967|FG002|STARTED|Phase I||0||
59621377|NCT00149838|75732968|FG003|STARTED|Phase I||0||
59621378|NCT00149838|75732965|FG000|COMPLETED|Phase I||72||
59621379|NCT00149838|75732966|FG001|COMPLETED|Phase I||82||
59621380|NCT00149838|75732967|FG002|COMPLETED|Phase I||0||
59621381|NCT00149838|75732968|FG003|COMPLETED|Phase I||0||
59621382|NCT00149838|75732965|FG000|NOT COMPLETED|Phase I||20||
59621383|NCT00149838|75732966|FG001|NOT COMPLETED|Phase I||16||
59621384|NCT00149838|75732967|FG002|NOT COMPLETED|Phase I||0||
59963596|NCT03021005|76081699|FG000|NOT COMPLETED|Overall Study||39||
59621385|NCT00149838|75732968|FG003|NOT COMPLETED|Phase I||0||
59621386|NCT00149838|75732965|FG000|STARTED|Phase II||0||
59621387|NCT00149838|75732966|FG001|STARTED|Phase II||0||
59621388|NCT00149838|75732967|FG002|STARTED|Phase II||144||
59963597|NCT03021005|76081700|FG001|NOT COMPLETED|Overall Study||26||
59963598|NCT02914457|76081706|FG000|STARTED|Overall Study||31||
59524652|NCT02533674|75619779|FG005|STARTED|Dose Level VI||9||
59524653|NCT02533674|75619780|FG006|STARTED|Dose Level VI||0||
59621389|NCT00149838|75732968|FG003|STARTED|Phase II||0||
59621390|NCT00149838|75732965|FG000|COMPLETED|Phase II||0||
59621391|NCT00149838|75732966|FG001|COMPLETED|Phase II||0||
59621392|NCT00149838|75732967|FG002|COMPLETED|Phase II||144||
59621393|NCT00149838|75732968|FG003|COMPLETED|Phase II||0||
59963599|NCT02914457|76081706|FG000|COMPLETED|Overall Study|Subjects who completed electrophysiological study with analyzable data|25||
59963600|NCT02914457|76081706|FG000|NOT COMPLETED|Overall Study||6||
59963601|NCT02665052|76081714|FG000|STARTED|Overall Study||11||
59524654|NCT02533674|75619781|FG007|STARTED|Dose Level VI||0||
59524655|NCT02533674|75619774|FG000|COMPLETED|Dose Level VI||0||
59524656|NCT02533674|75619775|FG001|COMPLETED|Dose Level VI||0||
59524657|NCT02533674|75619776|FG002|COMPLETED|Dose Level VI||0||
59621394|NCT00149838|75732965|FG000|NOT COMPLETED|Phase II||0||
59621395|NCT00149838|75732966|FG001|NOT COMPLETED|Phase II||0||
59808922|NCT00466947|75931098|FG000|COMPLETED|Primary Outcome Analysis Period|No data on study completion and withdrawal were available at first analysis as the study was ongoing|0||
59808923|NCT00466947|75931099|FG001|COMPLETED|Primary Outcome Analysis Period|No data on study completion and withdrawal were available at first analysis as the study was ongoing|0||
59808924|NCT00466947|75931098|FG000|NOT COMPLETED|Primary Outcome Analysis Period||11875||
59963602|NCT02665052|76081715|FG001|STARTED|Overall Study||9||
59963603|NCT02665052|76081716|FG002|STARTED|Overall Study||9||
59963604|NCT02665052|76081717|FG003|STARTED|Overall Study||19||
59963605|NCT02665052|76081714|FG000|COMPLETED|Overall Study||8||
59963606|NCT02665052|76081715|FG001|COMPLETED|Overall Study||7||
59963607|NCT02665052|76081716|FG002|COMPLETED|Overall Study||9||
59963608|NCT02665052|76081717|FG003|COMPLETED|Overall Study||14||
59963609|NCT02665052|76081714|FG000|NOT COMPLETED|Overall Study||3||
59963610|NCT02665052|76081715|FG001|NOT COMPLETED|Overall Study||2||
59963611|NCT02665052|76081716|FG002|NOT COMPLETED|Overall Study||0||
59963612|NCT02665052|76081717|FG003|NOT COMPLETED|Overall Study||5||
59963613|NCT03019289|76081737|FG000|STARTED|Overall Study||5||
59963614|NCT03019289|76081738|FG001|STARTED|Overall Study||1||
59963615|NCT03019289|76081739|FG002|STARTED|Overall Study||3||
59963616|NCT03019289|76081740|FG003|STARTED|Overall Study||2||
59963617|NCT03019289|76081741|FG004|STARTED|Overall Study||1||
59963618|NCT03019289|76081742|FG005|STARTED|Overall Study||1||
59963619|NCT03019289|76081743|FG006|STARTED|Overall Study||3||
59963620|NCT03019289|76081744|FG007|STARTED|Overall Study||4||
59963621|NCT03019289|76081745|FG008|STARTED|Overall Study||3||
59963622|NCT03019289|76081737|FG000|COMPLETED|Overall Study||3||
59963623|NCT03019289|76081738|FG001|COMPLETED|Overall Study||1||
59963624|NCT03019289|76081739|FG002|COMPLETED|Overall Study||3||
59963625|NCT03019289|76081740|FG003|COMPLETED|Overall Study||2||
59963626|NCT03019289|76081741|FG004|COMPLETED|Overall Study||1||
59963627|NCT03019289|76081742|FG005|COMPLETED|Overall Study||1||
59963628|NCT03019289|76081743|FG006|COMPLETED|Overall Study||3||
59963629|NCT03019289|76081744|FG007|COMPLETED|Overall Study||4||
59963630|NCT03019289|76081745|FG008|COMPLETED|Overall Study||2||
59963631|NCT03019289|76081737|FG000|NOT COMPLETED|Overall Study||2||
59963632|NCT03019289|76081738|FG001|NOT COMPLETED|Overall Study||0||
59963633|NCT03019289|76081739|FG002|NOT COMPLETED|Overall Study||0||
59963634|NCT03019289|76081740|FG003|NOT COMPLETED|Overall Study||0||
59963635|NCT03019289|76081741|FG004|NOT COMPLETED|Overall Study||0||
59963636|NCT03019289|76081742|FG005|NOT COMPLETED|Overall Study||0||
59963637|NCT03019289|76081743|FG006|NOT COMPLETED|Overall Study||0||
59963638|NCT03019289|76081744|FG007|NOT COMPLETED|Overall Study||0||
59963639|NCT03019289|76081745|FG008|NOT COMPLETED|Overall Study||1||
59963640|NCT02520388|76081768|FG000|STARTED|Overall Study||82||
59963641|NCT02520388|76081769|FG001|STARTED|Overall Study||81||
59963642|NCT02520388|76081768|FG000|Treated|Overall Study||81||
59963643|NCT02520388|76081769|FG001|Treated|Overall Study||80||
59963644|NCT02520388|76081768|FG000|COMPLETED|Overall Study||73||
59963645|NCT02520388|76081769|FG001|COMPLETED|Overall Study||65||
59963646|NCT02520388|76081768|FG000|NOT COMPLETED|Overall Study||9||
59963647|NCT02520388|76081769|FG001|NOT COMPLETED|Overall Study||16||
59963648|NCT02668640|76081775|FG000|STARTED|Overall Study||55||
59963649|NCT02668640|76081775|FG000|COMPLETED|Overall Study||41||
59963650|NCT02668640|76081775|FG000|NOT COMPLETED|Overall Study||14||
59963651|NCT03014453|76081779|FG000|STARTED|Overall Study||187||
59963652|NCT03014453|76081779|FG000|COMPLETED|Overall Study||116||
59963653|NCT03014453|76081779|FG000|NOT COMPLETED|Overall Study||71||
59963654|NCT02664272|76081783|FG000|STARTED|Overall Study||40||41
59963655|NCT02664272|76081783|FG000|COMPLETED|Overall Study||38|There were 39 units that met the primary outcome and 41 units that met the secondary outcome.|39
59963656|NCT02664272|76081783|FG000|NOT COMPLETED|Overall Study||2||2
59963657|NCT02663882|76081789|FG000|STARTED|Overall Study||39||
59963658|NCT02663882|76081790|FG001|STARTED|Overall Study||36||
59963659|NCT02663882|76081789|FG000|COMPLETED|Overall Study||35||
59963660|NCT02663882|76081790|FG001|COMPLETED|Overall Study||34||
59963661|NCT02663882|76081789|FG000|NOT COMPLETED|Overall Study||4||
59963662|NCT02663882|76081790|FG001|NOT COMPLETED|Overall Study||2||
59963663|NCT03011333|76081803|FG000|STARTED|Overall Study||12||
59963664|NCT03011333|76081804|FG001|STARTED|Overall Study||27||
59963665|NCT03011333|76081805|FG002|STARTED|Overall Study||25||
59808925|NCT00466947|75931099|FG001|NOT COMPLETED|Primary Outcome Analysis Period||11863||
59808926|NCT00466947|75931098|FG000|STARTED|Study End Analysis Period||11798||
59808927|NCT00466947|75931099|FG001|STARTED|Study End Analysis Period||11799||
59808928|NCT00466947|75931098|FG000|COMPLETED|Study End Analysis Period||9302||
59808929|NCT00466947|75931099|FG001|COMPLETED|Study End Analysis Period||9265||
59963666|NCT03011333|76081806|FG003|STARTED|Overall Study||47||
59963667|NCT03011333|76081807|FG004|STARTED|Overall Study||50||
59963668|NCT03011333|76081808|FG005|STARTED|Overall Study||41||
59963669|NCT03011333|76081809|FG006|STARTED|Overall Study||41||
59963670|NCT03011333|76081803|FG000|COMPLETED|Overall Study||12||
59963671|NCT03011333|76081804|FG001|COMPLETED|Overall Study||26||
59963672|NCT03011333|76081805|FG002|COMPLETED|Overall Study||25||
59963673|NCT03011333|76081806|FG003|COMPLETED|Overall Study||46||
59963674|NCT03011333|76081807|FG004|COMPLETED|Overall Study||46||
59963675|NCT03011333|76081808|FG005|COMPLETED|Overall Study||37||
59963676|NCT03011333|76081809|FG006|COMPLETED|Overall Study||36||
59963677|NCT03011333|76081803|FG000|NOT COMPLETED|Overall Study||0||
59963678|NCT03011333|76081804|FG001|NOT COMPLETED|Overall Study||1||
59963679|NCT03011333|76081805|FG002|NOT COMPLETED|Overall Study||0||
59963680|NCT03011333|76081806|FG003|NOT COMPLETED|Overall Study||1||
59963681|NCT03011333|76081807|FG004|NOT COMPLETED|Overall Study||4||
59963682|NCT03011333|76081808|FG005|NOT COMPLETED|Overall Study||4||
59963683|NCT03011333|76081809|FG006|NOT COMPLETED|Overall Study||5||
59963684|NCT03011099|76081827|FG000|STARTED|Overall Study||6||
59963685|NCT03011099|76081828|FG001|STARTED|Overall Study||5||
59963686|NCT03011099|76081827|FG000|COMPLETED|Overall Study||6||
59963687|NCT03011099|76081828|FG001|COMPLETED|Overall Study||3||
59963688|NCT03011099|76081827|FG000|NOT COMPLETED|Overall Study||0||
59963689|NCT03011099|76081828|FG001|NOT COMPLETED|Overall Study||2||
59808930|NCT00466947|75931098|FG000|NOT COMPLETED|Study End Analysis Period||2496||
59808931|NCT00466947|75931099|FG001|NOT COMPLETED|Study End Analysis Period||2534||
59808932|NCT00537810|75931110|FG000|STARTED|Overall Study||26||
59808933|NCT00537810|75931111|FG001|STARTED|Overall Study||27||
59808934|NCT00537810|75931112|FG002|STARTED|Overall Study||25||
59808935|NCT00537810|75931113|FG003|STARTED|Overall Study||26||
59808936|NCT00537810|75931110|FG000|COMPLETED|Overall Study||20||
59808937|NCT00537810|75931111|FG001|COMPLETED|Overall Study||14||
59808938|NCT00537810|75931112|FG002|COMPLETED|Overall Study||21||
59808939|NCT00537810|75931113|FG003|COMPLETED|Overall Study||22||
59808940|NCT00537810|75931110|FG000|NOT COMPLETED|Overall Study||6||
59808941|NCT00537810|75931111|FG001|NOT COMPLETED|Overall Study||13||
59808942|NCT00537810|75931112|FG002|NOT COMPLETED|Overall Study||4||
59808943|NCT00537810|75931113|FG003|NOT COMPLETED|Overall Study||4||
59808944|NCT01287936|75931126|FG000|STARTED|Overall Study||6||
59808945|NCT01287936|75931127|FG001|STARTED|Overall Study||6||
59808946|NCT01287936|75931128|FG002|STARTED|Overall Study||6||
59808947|NCT01287936|75931126|FG000|COMPLETED|Overall Study||6||
59808948|NCT01287936|75931127|FG001|COMPLETED|Overall Study||5||
59808949|NCT01287936|75931128|FG002|COMPLETED|Overall Study||5||
59808950|NCT01287936|75931126|FG000|NOT COMPLETED|Overall Study||0||
59808951|NCT01287936|75931127|FG001|NOT COMPLETED|Overall Study||1||
59808952|NCT01287936|75931128|FG002|NOT COMPLETED|Overall Study||1||
59808953|NCT00090259|75931138|FG000|STARTED|Overall Study||1913||
59808954|NCT00090259|75931139|FG001|STARTED|Overall Study||1921||
59808955|NCT00090259|75931138|FG000|COMPLETED|Overall Study|Completed follow-up: 963 on drug, 223 off drug, & 665 at death (death was considered an endpoint)|1851||
59808956|NCT00090259|75931139|FG001|COMPLETED|Overall Study|Completed follow-up: 1005 on drug, 233 off drug,& 635 at death (death was considered an endpoint)|1873||
59808957|NCT00090259|75931138|FG000|NOT COMPLETED|Overall Study||62||
59808958|NCT00090259|75931139|FG001|NOT COMPLETED|Overall Study||48||
59808959|NCT00079183|75931145|FG000|STARTED|Overall Study||44||
59808960|NCT00079183|75931145|FG000|Drop Outs|Overall Study||7||
59808961|NCT00079183|75931145|FG000|COMPLETED|Overall Study||37||
59808962|NCT00079183|75931145|FG000|NOT COMPLETED|Overall Study||7||
59808963|NCT00676403|75931156|FG000|STARTED|Overall Study||23||
59808964|NCT00676403|75931157|FG001|STARTED|Overall Study||22||
59808965|NCT00676403|75931158|FG002|STARTED|Overall Study||23||
59808966|NCT00676403|75931159|FG003|STARTED|Overall Study||22||
59808967|NCT00676403|75931160|FG004|STARTED|Overall Study||24||
59808968|NCT00676403|75931161|FG005|STARTED|Overall Study||23||
59808969|NCT00676403|75931156|FG000|COMPLETED|Overall Study||21||
59808970|NCT00676403|75931157|FG001|COMPLETED|Overall Study||20||
59808971|NCT00676403|75931158|FG002|COMPLETED|Overall Study||22||
59808972|NCT00676403|75931159|FG003|COMPLETED|Overall Study||17||
59808973|NCT00676403|75931160|FG004|COMPLETED|Overall Study||23||
59808974|NCT00676403|75931161|FG005|COMPLETED|Overall Study||18||
59808975|NCT00676403|75931156|FG000|NOT COMPLETED|Overall Study||2||
59808976|NCT00676403|75931157|FG001|NOT COMPLETED|Overall Study||2||
59808977|NCT00676403|75931158|FG002|NOT COMPLETED|Overall Study||1||
59808978|NCT00676403|75931159|FG003|NOT COMPLETED|Overall Study||5||
59963690|NCT03013985|76081838|FG000|STARTED|Overall Study||108||
59963691|NCT03013985|76081839|FG001|STARTED|Overall Study||103||
59963692|NCT03013985|76081838|FG000|COMPLETED|Overall Study||92||
59963693|NCT03013985|76081839|FG001|COMPLETED|Overall Study||84||
59963694|NCT03013985|76081838|FG000|NOT COMPLETED|Overall Study||16||
59808979|NCT00676403|75931160|FG004|NOT COMPLETED|Overall Study||1||
59808980|NCT00676403|75931161|FG005|NOT COMPLETED|Overall Study||5||
59808981|NCT00078325|75931184|FG000|STARTED|Overall Study||131||
59808982|NCT00078325|75931185|FG001|STARTED|Overall Study||133||
59808983|NCT00078325|75931186|FG002|STARTED|Overall Study||131||
59808984|NCT00078325|75931184|FG000|COMPLETED|Overall Study||110||
59808985|NCT00078325|75931185|FG001|COMPLETED|Overall Study||114||
59808986|NCT00078325|75931186|FG002|COMPLETED|Overall Study||120||
59808987|NCT00078325|75931184|FG000|NOT COMPLETED|Overall Study||21||
59808988|NCT00078325|75931185|FG001|NOT COMPLETED|Overall Study||19||
59808989|NCT00078325|75931186|FG002|NOT COMPLETED|Overall Study||11||
59808990|NCT00077857|75931196|FG000|STARTED|Overall Study||235||
59808991|NCT00077857|75931197|FG001|STARTED|Overall Study||235||
59808992|NCT00077857|75931196|FG000|Received Study Drug|Overall Study||231||
59963695|NCT03013985|76081839|FG001|NOT COMPLETED|Overall Study||19||
59963696|NCT03016403|76081849|FG000|STARTED|Baseline||139||
59963697|NCT03016403|76081850|FG001|STARTED|Baseline||147||
59963698|NCT03016403|76081851|FG002|STARTED|Baseline||118||
59963699|NCT03016403|76081852|FG003|STARTED|Baseline||131||
59963700|NCT03016403|76081849|FG000|COMPLETED|Baseline||123||
59963701|NCT03016403|76081850|FG001|COMPLETED|Baseline||120||
59963702|NCT03016403|76081851|FG002|COMPLETED|Baseline||107||
59963703|NCT03016403|76081852|FG003|COMPLETED|Baseline||97||
59963704|NCT03016403|76081849|FG000|NOT COMPLETED|Baseline||16||
59963705|NCT03016403|76081850|FG001|NOT COMPLETED|Baseline||27||
59963706|NCT03016403|76081851|FG002|NOT COMPLETED|Baseline||11||
59963707|NCT03016403|76081852|FG003|NOT COMPLETED|Baseline||34||
59963708|NCT03016403|76081849|FG000|STARTED|6-week Follow-up|Anyone who had at least 1 follow-up after baseline.|123||
59963709|NCT03016403|76081850|FG001|STARTED|6-week Follow-up||120||
59963710|NCT03016403|76081851|FG002|STARTED|6-week Follow-up||107||
59963711|NCT03016403|76081852|FG003|STARTED|6-week Follow-up||97||
59963712|NCT03016403|76081849|FG000|COMPLETED|6-week Follow-up||120||
59963713|NCT03016403|76081850|FG001|COMPLETED|6-week Follow-up||107||
59963714|NCT03016403|76081851|FG002|COMPLETED|6-week Follow-up||103||
59963715|NCT03016403|76081852|FG003|COMPLETED|6-week Follow-up||88||
59963716|NCT03016403|76081849|FG000|NOT COMPLETED|6-week Follow-up||3||
59808993|NCT00077857|75931197|FG001|Received Study Drug|Overall Study||234||
59808994|NCT00077857|75931196|FG000|Safety Population: Actual Dose Received|Overall Study|14 patients in the 1250 dose arm received a lower dose and were included in the 825 arm for Safety.|217||
59808995|NCT00077857|75931197|FG001|Safety Population: Actual Dose Received|Overall Study||248||
59808996|NCT00077857|75931196|FG000|COMPLETED|Overall Study||34||
59963717|NCT03016403|76081850|FG001|NOT COMPLETED|6-week Follow-up||13||
59963718|NCT03016403|76081851|FG002|NOT COMPLETED|6-week Follow-up||4||
59963719|NCT03016403|76081852|FG003|NOT COMPLETED|6-week Follow-up||9||
59963720|NCT03016403|76081849|FG000|STARTED|3-month Follow-up and 6-month Follow-up||120||
59963721|NCT03016403|76081850|FG001|STARTED|3-month Follow-up and 6-month Follow-up||107||
59963722|NCT03016403|76081851|FG002|STARTED|3-month Follow-up and 6-month Follow-up||103||
59963723|NCT03016403|76081852|FG003|STARTED|3-month Follow-up and 6-month Follow-up||88||
59963724|NCT03016403|76081849|FG000|COMPLETED|3-month Follow-up and 6-month Follow-up||108||
59963725|NCT03016403|76081850|FG001|COMPLETED|3-month Follow-up and 6-month Follow-up||96||
59963726|NCT03016403|76081851|FG002|COMPLETED|3-month Follow-up and 6-month Follow-up||95||
59963727|NCT03016403|76081852|FG003|COMPLETED|3-month Follow-up and 6-month Follow-up||81||
59808997|NCT00077857|75931197|FG001|COMPLETED|Overall Study||31||
59808998|NCT00077857|75931196|FG000|NOT COMPLETED|Overall Study||201||
59808999|NCT00077857|75931197|FG001|NOT COMPLETED|Overall Study||204||
59809000|NCT00545402|75931205|FG000|STARTED|Overall Study||90||
59809001|NCT00545402|75931206|FG001|STARTED|Overall Study||90||
59809002|NCT00545402|75931205|FG000|COMPLETED|Overall Study||56||
59809003|NCT00545402|75931206|FG001|COMPLETED|Overall Study||61||
59809004|NCT00545402|75931205|FG000|NOT COMPLETED|Overall Study||34||
59809005|NCT00545402|75931206|FG001|NOT COMPLETED|Overall Study||29||
59809006|NCT00545792|75931212|FG000|STARTED|Overall Study||21||
59809007|NCT00545792|75931212|FG000|COMPLETED|Overall Study||20||
59809008|NCT00545792|75931212|FG000|NOT COMPLETED|Overall Study||1||
59963728|NCT03016403|76081849|FG000|NOT COMPLETED|3-month Follow-up and 6-month Follow-up||12||
59963729|NCT03016403|76081850|FG001|NOT COMPLETED|3-month Follow-up and 6-month Follow-up||11||
59809009|NCT00545168|75931219|FG000|STARTED|Overall Study||203||
59963730|NCT03016403|76081851|FG002|NOT COMPLETED|3-month Follow-up and 6-month Follow-up||8||
60074188|NCT01908829|76189597|FG000|NOT COMPLETED|Overall Study||49||
59809010|NCT00545168|75931220|FG001|STARTED|Overall Study||63||
59809011|NCT00545168|75931221|FG002|STARTED|Overall Study||214||
59809012|NCT00545168|75931219|FG000|COMPLETED|Overall Study||187||
59809013|NCT00545168|75931220|FG001|COMPLETED|Overall Study||58||
59809014|NCT00545168|75931221|FG002|COMPLETED|Overall Study||193||
59809015|NCT00545168|75931219|FG000|NOT COMPLETED|Overall Study||16||
59809016|NCT00545168|75931220|FG001|NOT COMPLETED|Overall Study||5||
59809017|NCT00545168|75931221|FG002|NOT COMPLETED|Overall Study||21||
59809018|NCT00544544|75931230|FG000|STARTED|Overall Study||14||
59809019|NCT00544544|75931230|FG000|COMPLETED|Overall Study||11||
59809020|NCT00544544|75931230|FG000|NOT COMPLETED|Overall Study||3||
59809021|NCT00541346|75931234|FG000|STARTED|Baseline||16||
59809022|NCT00541346|75931234|FG000|COMPLETED|Baseline||16||
59809023|NCT00541346|75931234|FG000|NOT COMPLETED|Baseline||0||
59809024|NCT00541346|75931234|FG000|STARTED|Follow-up||16||
59809025|NCT00541346|75931234|FG000|COMPLETED|Follow-up||15||
59809026|NCT00541346|75931234|FG000|NOT COMPLETED|Follow-up||1||
59809027|NCT00077623|75931241|FG000|STARTED|Overall Study||190||
59809028|NCT00077623|75931242|FG001|STARTED|Overall Study||191||
59809029|NCT00077623|75931243|FG002|STARTED|Overall Study||191||
59809030|NCT00077623|75931241|FG000|COMPLETED|Overall Study||154||
59809031|NCT00077623|75931242|FG001|COMPLETED|Overall Study||148||
59809032|NCT00077623|75931243|FG002|COMPLETED|Overall Study||159||
59809033|NCT00077623|75931241|FG000|NOT COMPLETED|Overall Study||36||
59809034|NCT00077623|75931242|FG001|NOT COMPLETED|Overall Study||43||
59963731|NCT03016403|76081852|FG003|NOT COMPLETED|3-month Follow-up and 6-month Follow-up||7||
59963732|NCT02520310|76081864|FG000|STARTED|At 30 Days Clinical Follow-up||30||
59963733|NCT02520310|76081864|FG000|COMPLETED|At 30 Days Clinical Follow-up||30||
59963734|NCT02520310|76081864|FG000|NOT COMPLETED|At 30 Days Clinical Follow-up||0||
59963735|NCT02520310|76081864|FG000|STARTED|At 6 Months Clinical Follow-up||30||
59963736|NCT02520310|76081864|FG000|COMPLETED|At 6 Months Clinical Follow-up||29||
59963737|NCT02520310|76081864|FG000|NOT COMPLETED|At 6 Months Clinical Follow-up||1||
59963738|NCT02520310|76081864|FG000|STARTED|At 1 Year Clinical Follow-up||29||
59963739|NCT02520310|76081864|FG000|COMPLETED|At 1 Year Clinical Follow-up||28||
59963740|NCT02520310|76081864|FG000|NOT COMPLETED|At 1 Year Clinical Follow-up||1||
59963741|NCT02520310|76081864|FG000|STARTED|At 2 Year Clinical Follow-up||28||
59963742|NCT02520310|76081864|FG000|COMPLETED|At 2 Year Clinical Follow-up||28||
59963743|NCT02520310|76081864|FG000|NOT COMPLETED|At 2 Year Clinical Follow-up||0||
59963744|NCT02520310|76081864|FG000|STARTED|AT 3 Year Clinical Follow-up||28||
59963745|NCT02520310|76081864|FG000|COMPLETED|AT 3 Year Clinical Follow-up||24||
59963746|NCT02520310|76081864|FG000|NOT COMPLETED|AT 3 Year Clinical Follow-up||4||
59963747|NCT02520310|76081864|FG000|STARTED|AT 4 Year Clinical Follow-up||24||
59963748|NCT02520310|76081864|FG000|COMPLETED|AT 4 Year Clinical Follow-up||22||
59963749|NCT02520310|76081864|FG000|NOT COMPLETED|AT 4 Year Clinical Follow-up||2||
59963750|NCT02662556|76081870|FG000|STARTED|Overall Study||140||
59963751|NCT02662556|76081870|FG000|COMPLETED|Overall Study||132||
59963752|NCT02662556|76081870|FG000|NOT COMPLETED|Overall Study||8||
59963753|NCT02516098|76081877|FG000|STARTED|Period 1||28||
59963754|NCT02516098|76081878|FG001|STARTED|Period 1||28||
59963755|NCT02516098|76081877|FG000|COMPLETED|Period 1||27||
59963756|NCT02516098|76081878|FG001|COMPLETED|Period 1||28||
59963757|NCT02516098|76081877|FG000|NOT COMPLETED|Period 1||1||
59963758|NCT02516098|76081878|FG001|NOT COMPLETED|Period 1||0||
59963759|NCT02516098|76081877|FG000|STARTED|Washout After Period 1||27||
59963760|NCT02516098|76081878|FG001|STARTED|Washout After Period 1||28||
59963761|NCT02516098|76081877|FG000|COMPLETED|Washout After Period 1||27||
59963762|NCT02516098|76081878|FG001|COMPLETED|Washout After Period 1||27||
59809035|NCT00077623|75931243|FG002|NOT COMPLETED|Overall Study||32||
59809036|NCT00541034|75931251|FG000|STARTED|Overall Study||49||
59963763|NCT02516098|76081877|FG000|NOT COMPLETED|Washout After Period 1||0||
59963764|NCT02516098|76081878|FG001|NOT COMPLETED|Washout After Period 1||1||
59963765|NCT02516098|76081877|FG000|STARTED|Period 2||27||
59809037|NCT00541034|75931251|FG000|COMPLETED|Overall Study||46||
59963766|NCT02516098|76081878|FG001|STARTED|Period 2||27||
59963767|NCT02516098|76081877|FG000|COMPLETED|Period 2||27||
59963768|NCT02516098|76081878|FG001|COMPLETED|Period 2||26||
59963769|NCT02516098|76081877|FG000|NOT COMPLETED|Period 2||0||
59963770|NCT02516098|76081878|FG001|NOT COMPLETED|Period 2||1||
59963771|NCT02516098|76081877|FG000|STARTED|Washout After Period 2||27||
59963772|NCT02516098|76081878|FG001|STARTED|Washout After Period 2||26||
59963773|NCT02516098|76081877|FG000|COMPLETED|Washout After Period 2||27||
59963774|NCT02516098|76081878|FG001|COMPLETED|Washout After Period 2||26||
59963775|NCT02516098|76081877|FG000|NOT COMPLETED|Washout After Period 2||0||
59963776|NCT02516098|76081878|FG001|NOT COMPLETED|Washout After Period 2||0||
59963777|NCT01364428|76081886|FG000|STARTED|Overall Study||186||
59963778|NCT01364428|76081887|FG001|STARTED|Overall Study||187||
59963779|NCT01364428|76081886|FG000|Exposed|Overall Study|Two subjects were randomised in error and withdrew prior to exposure to drug|184||
59963780|NCT01364428|76081887|FG001|Exposed|Overall Study||187||
59963781|NCT01364428|76081886|FG000|COMPLETED|Overall Study||166||
59963782|NCT01364428|76081887|FG001|COMPLETED|Overall Study||172||
59963783|NCT01364428|76081886|FG000|NOT COMPLETED|Overall Study||20||
59963784|NCT01364428|76081887|FG001|NOT COMPLETED|Overall Study||15||
59963785|NCT02515942|76081896|FG000|STARTED|Overall Study||36||
59963786|NCT02515942|76081897|FG001|STARTED|Overall Study||39||
59963787|NCT02515942|76081898|FG002|STARTED|Overall Study||39||
59963788|NCT02515942|76081896|FG000|Safety Analysis Set|Overall Study||36|All subjects who received any study drug|
59963789|NCT02515942|76081897|FG001|Safety Analysis Set|Overall Study||39|All subjects who received any study drug|
59963790|NCT02515942|76081898|FG002|Safety Analysis Set|Overall Study||39|All subjects who received any study drug|
59809038|NCT00541034|75931251|FG000|NOT COMPLETED|Overall Study||3||
59963791|NCT02515942|76081896|FG000|Full Analysis Set (FAS)|Overall Study||35|Subjects who received study treatment & at least 1 follow-up visit with assessment of GA lesion size|
59963792|NCT02515942|76081897|FG001|Full Analysis Set (FAS)|Overall Study||37|Subjects who received study treatment & at least 1 follow-up visit with assessment of GA lesion size|
59963793|NCT02515942|76081898|FG002|Full Analysis Set (FAS)|Overall Study||38|Subjects who received study treatment & at least 1 follow-up visit with assessment of GA lesion size|
59963794|NCT02515942|76081896|FG000|Per Protocol Analysis Set (PPS)|Overall Study||30|FAS with no critical protocol deviations & with a valid assessment of primary efficacy endpoint|
59963795|NCT02515942|76081897|FG001|Per Protocol Analysis Set (PPS)|Overall Study||35|FAS with no critical protocol deviations & with a valid assessment of primary efficacy endpoint|
59994934|NCT03420781|76110739|FG001|COMPLETED|RW Period: 6 Weeks (Week 41 to Week 46)||0||
59994935|NCT03420781|76110740|FG002|COMPLETED|RW Period: 6 Weeks (Week 41 to Week 46)||85||
59994936|NCT03420781|76110741|FG003|COMPLETED|RW Period: 6 Weeks (Week 41 to Week 46)||54||
59994937|NCT03420781|76110742|FG004|COMPLETED|RW Period: 6 Weeks (Week 41 to Week 46)||38||
59994938|NCT03420781|76110738|FG000|NOT COMPLETED|RW Period: 6 Weeks (Week 41 to Week 46)||0||
59809039|NCT00540644|75931257|FG000|STARTED|Overall Study||48||
59809040|NCT00540644|75931258|FG001|STARTED|Overall Study||22||
59809041|NCT00540644|75931257|FG000|COMPLETED|Overall Study||39||
59809042|NCT00540644|75931258|FG001|COMPLETED|Overall Study||13||
59809043|NCT00540644|75931257|FG000|NOT COMPLETED|Overall Study||9||
59963796|NCT02515942|76081898|FG002|Per Protocol Analysis Set (PPS)|Overall Study||34|FAS with no critical protocol deviations & with a valid assessment of primary efficacy endpoint|
59963797|NCT02515942|76081896|FG000|Pharmacokinetics (PK) Analysis Set|Overall Study||36|Subjects in safety set with evaluable PK data & no major protocol deviations that impacted PK data|
59963798|NCT02515942|76081897|FG001|Pharmacokinetics (PK) Analysis Set|Overall Study||39|Subjects in safety set with evaluable PK data & no major protocol deviations that impacted PK data|
59963799|NCT02515942|76081898|FG002|Pharmacokinetics (PK) Analysis Set|Overall Study||0|Subjects in safety set with evaluable PK data & no major protocol deviations that impacted PK data|
59963800|NCT02515942|76081896|FG000|Completed Day 85|Overall Study||35||
59963801|NCT02515942|76081897|FG001|Completed Day 85|Overall Study||38||
59963802|NCT02515942|76081898|FG002|Completed Day 85|Overall Study||37||
59963803|NCT02515942|76081896|FG000|Completed Day 169|Overall Study||32||
59963804|NCT02515942|76081897|FG001|Completed Day 169|Overall Study||37||
59963805|NCT02515942|76081898|FG002|Completed Day 169|Overall Study||37||
59963806|NCT02515942|76081896|FG000|Completed Day 253|Overall Study|One subject missed Day 253 visit|29||
59963807|NCT02515942|76081897|FG001|Completed Day 253|Overall Study||37||
59963808|NCT02515942|76081898|FG002|Completed Day 253|Overall Study||36||
59809044|NCT00540644|75931258|FG001|NOT COMPLETED|Overall Study||9||
59809045|NCT00543296|75931264|FG000|STARTED|Overall Study||21||
59809046|NCT00543296|75931264|FG000|COMPLETED|Overall Study||14||
59809047|NCT00543296|75931264|FG000|NOT COMPLETED|Overall Study||7||
59809048|NCT00543140|75931268|FG000|STARTED|Overall Study||303||
59809049|NCT00543140|75931268|FG000|COMPLETED|Overall Study||231||
59963809|NCT02515942|76081896|FG000|Completed Day 337|Overall Study||30||
59963810|NCT02515942|76081897|FG001|Completed Day 337|Overall Study||36||
59963811|NCT02515942|76081898|FG002|Completed Day 337|Overall Study||35||
59963812|NCT02515942|76081896|FG000|COMPLETED|Overall Study||29||
59963813|NCT02515942|76081897|FG001|COMPLETED|Overall Study||36||
59963814|NCT02515942|76081898|FG002|COMPLETED|Overall Study||35||
59963815|NCT02515942|76081896|FG000|NOT COMPLETED|Overall Study||7||
59963816|NCT02515942|76081897|FG001|NOT COMPLETED|Overall Study||3||
59963817|NCT02515942|76081898|FG002|NOT COMPLETED|Overall Study||4||
59963818|NCT02991859|76081925|FG000|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2||
59963819|NCT02991859|76081926|FG001|STARTED|Period 1,Escalation Phase 1,Upto Day 7||3||
59963820|NCT02991859|76081927|FG002|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2||
59963821|NCT02991859|76081928|FG003|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2||
59963822|NCT02991859|76081929|FG004|STARTED|Period 1,Escalation Phase 1,Upto Day 7||3||
59963823|NCT02991859|76081930|FG005|STARTED|Period 1,Escalation Phase 1,Upto Day 7||3||
59963824|NCT02991859|76081931|FG006|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2||
59963825|NCT02991859|76081932|FG007|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2||
59963826|NCT02991859|76081933|FG008|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2||
59963827|NCT02991859|76081934|FG009|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2||
59809050|NCT00543140|75931268|FG000|NOT COMPLETED|Overall Study||72||
59963828|NCT02991859|76081935|FG010|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2||
59963829|NCT02991859|76081936|FG011|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2||
59963830|NCT02991859|76081937|FG012|STARTED|Period 1,Escalation Phase 1,Upto Day 7||7||
59963831|NCT02991859|76081938|FG013|STARTED|Period 1,Escalation Phase 1,Upto Day 7||7||
59963832|NCT02991859|76081939|FG014|STARTED|Period 1,Escalation Phase 1,Upto Day 7||6||
59963833|NCT02991859|76081940|FG015|STARTED|Period 1,Escalation Phase 1,Upto Day 7||3||
60074189|NCT01908829|76189598|FG001|NOT COMPLETED|Overall Study||49||
60074190|NCT01908829|76189599|FG002|NOT COMPLETED|Overall Study||39||
60074191|NCT01773122|76189611|FG000|STARTED|Overall Study||20||
60074192|NCT01773122|76189612|FG001|STARTED|Overall Study||19||
59809051|NCT00543062|75931272|FG000|STARTED|Overall Study||12||
59809052|NCT00543062|75931273|FG001|STARTED|Overall Study||12||
59809053|NCT00543062|75931274|FG002|STARTED|Overall Study||12||
59809054|NCT00543062|75931275|FG003|STARTED|Overall Study||12||
59963834|NCT02991859|76081941|FG016|STARTED|Period 1,Escalation Phase 1,Upto Day 7||3||
59963835|NCT02991859|76081925|FG000|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2||
60074193|NCT01773122|76189613|FG002|STARTED|Overall Study||19||
60074194|NCT01773122|76189614|FG003|STARTED|Overall Study||19||
60074195|NCT01773122|76189611|FG000|COMPLETED|Overall Study||17||
60074196|NCT01773122|76189612|FG001|COMPLETED|Overall Study||18||
60074197|NCT01773122|76189613|FG002|COMPLETED|Overall Study||19||
60074198|NCT01773122|76189614|FG003|COMPLETED|Overall Study||18||
60074199|NCT01773122|76189611|FG000|NOT COMPLETED|Overall Study||3||
60074200|NCT01773122|76189612|FG001|NOT COMPLETED|Overall Study||1||
60074201|NCT01773122|76189613|FG002|NOT COMPLETED|Overall Study||0||
60074202|NCT01773122|76189614|FG003|NOT COMPLETED|Overall Study||1||
59809055|NCT00543062|75931272|FG000|COMPLETED|Overall Study||10||
59809056|NCT00543062|75931273|FG001|COMPLETED|Overall Study||11||
59809057|NCT00543062|75931274|FG002|COMPLETED|Overall Study||9||
59809058|NCT00543062|75931275|FG003|COMPLETED|Overall Study||11||
59809059|NCT00543062|75931272|FG000|NOT COMPLETED|Overall Study||2||
59809060|NCT00543062|75931273|FG001|NOT COMPLETED|Overall Study||1||
59809061|NCT00543062|75931274|FG002|NOT COMPLETED|Overall Study||3||
59963836|NCT02991859|76081926|FG001|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2||
59963837|NCT02991859|76081927|FG002|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2||
59963838|NCT02991859|76081928|FG003|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2||
59963839|NCT02991859|76081929|FG004|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2||
59963840|NCT02991859|76081930|FG005|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||3||
59963841|NCT02991859|76081931|FG006|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2||
59963842|NCT02991859|76081932|FG007|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2||
59963843|NCT02991859|76081933|FG008|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2||
59963844|NCT02991859|76081934|FG009|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2||
59963845|NCT02991859|76081935|FG010|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2||
59963846|NCT02991859|76081936|FG011|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2||
59963847|NCT02991859|76081937|FG012|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||7||
59963848|NCT02991859|76081938|FG013|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||7||
59963849|NCT02991859|76081939|FG014|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||6||
59963850|NCT02991859|76081940|FG015|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||3||
59963851|NCT02991859|76081941|FG016|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||3||
59963852|NCT02991859|76081925|FG000|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0||
59963853|NCT02991859|76081926|FG001|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||1||
59963854|NCT02991859|76081927|FG002|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0||
59963855|NCT02991859|76081928|FG003|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0||
59963856|NCT02991859|76081929|FG004|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||1||
59963857|NCT02991859|76081930|FG005|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0||
59963858|NCT02991859|76081931|FG006|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0||
59963859|NCT02991859|76081932|FG007|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0||
59963860|NCT02991859|76081933|FG008|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0||
59963861|NCT02991859|76081934|FG009|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0||
59963862|NCT02991859|76081935|FG010|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0||
59963863|NCT02991859|76081936|FG011|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0||
59963864|NCT02991859|76081937|FG012|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0||
59963865|NCT02991859|76081938|FG013|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0||
59963866|NCT02991859|76081939|FG014|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0||
59963867|NCT02991859|76081940|FG015|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0||
59963868|NCT02991859|76081941|FG016|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0||
59963869|NCT02991859|76081925|FG000|STARTED|Period 1,Escalation Phase2,Upto Day 14||2||
59963870|NCT02991859|76081926|FG001|STARTED|Period 1,Escalation Phase2,Upto Day 14||2||
59963871|NCT02991859|76081927|FG002|STARTED|Period 1,Escalation Phase2,Upto Day 14||2||
59963872|NCT02991859|76081928|FG003|STARTED|Period 1,Escalation Phase2,Upto Day 14||2||
59963873|NCT02991859|76081929|FG004|STARTED|Period 1,Escalation Phase2,Upto Day 14||2||
59963874|NCT02991859|76081930|FG005|STARTED|Period 1,Escalation Phase2,Upto Day 14||3||
59963875|NCT02991859|76081931|FG006|STARTED|Period 1,Escalation Phase2,Upto Day 14||2||
59963876|NCT02991859|76081932|FG007|STARTED|Period 1,Escalation Phase2,Upto Day 14||2||
59963877|NCT02991859|76081933|FG008|STARTED|Period 1,Escalation Phase2,Upto Day 14||2||
59963878|NCT02991859|76081934|FG009|STARTED|Period 1,Escalation Phase2,Upto Day 14||2||
59963879|NCT02991859|76081935|FG010|STARTED|Period 1,Escalation Phase2,Upto Day 14||2||
59963880|NCT02991859|76081936|FG011|STARTED|Period 1,Escalation Phase2,Upto Day 14||2||
59963881|NCT02991859|76081937|FG012|STARTED|Period 1,Escalation Phase2,Upto Day 14||7||
59963882|NCT02991859|76081938|FG013|STARTED|Period 1,Escalation Phase2,Upto Day 14||7||
59963883|NCT02991859|76081939|FG014|STARTED|Period 1,Escalation Phase2,Upto Day 14||6||
59963884|NCT02991859|76081940|FG015|STARTED|Period 1,Escalation Phase2,Upto Day 14||3||
59963885|NCT02991859|76081941|FG016|STARTED|Period 1,Escalation Phase2,Upto Day 14||3||
59963886|NCT02991859|76081925|FG000|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2||
59963887|NCT02991859|76081926|FG001|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2||
59963888|NCT02991859|76081927|FG002|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2||
59963889|NCT02991859|76081928|FG003|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2||
59963890|NCT02991859|76081929|FG004|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2||
59963891|NCT02991859|76081930|FG005|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||3||
59963892|NCT02991859|76081931|FG006|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2||
59963893|NCT02991859|76081932|FG007|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2||
59963894|NCT02991859|76081933|FG008|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2||
59963895|NCT02991859|76081934|FG009|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2||
59963896|NCT02991859|76081935|FG010|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2||
59963897|NCT02991859|76081936|FG011|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2||
59963898|NCT02991859|76081937|FG012|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||7||
59963899|NCT02991859|76081938|FG013|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||7||
59963900|NCT02991859|76081939|FG014|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||6||
59963901|NCT02991859|76081940|FG015|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||3||
59963902|NCT02991859|76081941|FG016|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||3||
59995286|NCT05425563|76111121|FG000|STARTED|Overall Study||133||
59995287|NCT05425563|76111121|FG000|COMPLETED|Overall Study||116||
59963903|NCT02991859|76081925|FG000|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0||
59963904|NCT02991859|76081926|FG001|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0||
59963905|NCT02991859|76081927|FG002|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0||
59963906|NCT02991859|76081928|FG003|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0||
59963907|NCT02991859|76081929|FG004|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0||
59963908|NCT02991859|76081930|FG005|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0||
59963909|NCT02991859|76081931|FG006|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0||
59963910|NCT02991859|76081932|FG007|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0||
59963911|NCT02991859|76081933|FG008|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0||
59963912|NCT02991859|76081934|FG009|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0||
59963913|NCT02991859|76081935|FG010|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0||
59963914|NCT02991859|76081936|FG011|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0||
59963915|NCT02991859|76081937|FG012|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0||
59963916|NCT02991859|76081938|FG013|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0||
59963917|NCT02991859|76081939|FG014|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0||
59963918|NCT02991859|76081940|FG015|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0||
59809062|NCT00543062|75931275|FG003|NOT COMPLETED|Overall Study||1||
59809063|NCT03911960|75931295|FG000|STARTED|Overall Study||9||
59809064|NCT03911960|75931296|FG001|STARTED|Overall Study||5||
59809065|NCT03911960|75931295|FG000|COMPLETED|Overall Study||4||
59809066|NCT03911960|75931296|FG001|COMPLETED|Overall Study||2||
59809067|NCT03911960|75931295|FG000|NOT COMPLETED|Overall Study||5||
59809068|NCT03911960|75931296|FG001|NOT COMPLETED|Overall Study||3||
59809069|NCT00676091|75931305|FG000|STARTED|Infant Series||177||
59963919|NCT02991859|76081941|FG016|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0||
59963920|NCT02991859|76081925|FG000|STARTED|Period1, Escalation Phase3, Upto Day21||2||
59963921|NCT02991859|76081926|FG001|STARTED|Period1, Escalation Phase3, Upto Day21||2||
59963922|NCT02991859|76081927|FG002|STARTED|Period1, Escalation Phase3, Upto Day21||2||
59963923|NCT02991859|76081928|FG003|STARTED|Period1, Escalation Phase3, Upto Day21||2||
59963924|NCT02991859|76081929|FG004|STARTED|Period1, Escalation Phase3, Upto Day21||2||
59963925|NCT02991859|76081930|FG005|STARTED|Period1, Escalation Phase3, Upto Day21||3||
59963926|NCT02991859|76081931|FG006|STARTED|Period1, Escalation Phase3, Upto Day21||2||
59809070|NCT00676091|75931306|FG001|STARTED|Infant Series||177||
59809071|NCT00676091|75931305|FG000|Vaccinated Dose 1|Infant Series||163||
59809072|NCT00676091|75931306|FG001|Vaccinated Dose 1|Infant Series||162||
59809073|NCT00676091|75931305|FG000|Vaccinated Dose 2|Infant Series||159||
59809074|NCT00676091|75931306|FG001|Vaccinated Dose 2|Infant Series||162||
59809075|NCT00676091|75931305|FG000|Vaccinated Dose 3|Infant Series||158||
59809076|NCT00676091|75931306|FG001|Vaccinated Dose 3|Infant Series||161||
59809077|NCT00676091|75931305|FG000|COMPLETED|Infant Series||157||
59809078|NCT00676091|75931306|FG001|COMPLETED|Infant Series||159||
59809079|NCT00676091|75931305|FG000|NOT COMPLETED|Infant Series||20||
59809080|NCT00676091|75931306|FG001|NOT COMPLETED|Infant Series||18||
59809081|NCT00676091|75931305|FG000|STARTED|After Infant Series||157||
59809082|NCT00676091|75931306|FG001|STARTED|After Infant Series||159||
59809083|NCT00676091|75931305|FG000|COMPLETED|After Infant Series||156||
59809084|NCT00676091|75931306|FG001|COMPLETED|After Infant Series||156||
59809085|NCT00676091|75931305|FG000|NOT COMPLETED|After Infant Series||1||
59963927|NCT02991859|76081932|FG007|STARTED|Period1, Escalation Phase3, Upto Day21||2||
60074203|NCT01808534|76189624|FG000|STARTED|Overall Study||5||
60074204|NCT01808534|76189624|FG000|COMPLETED|Overall Study||1||
60074205|NCT01808534|76189624|FG000|NOT COMPLETED|Overall Study||4||
60074206|NCT01808222|76189628|FG000|STARTED|Overall Study||25||
60074207|NCT01808222|76189628|FG000|Completed Fluciclovine PET-CT Scan|Overall Study||25||
60074208|NCT01808222|76189628|FG000|Completed mpMR Scan|Overall Study||24||
59963928|NCT02991859|76081933|FG008|STARTED|Period1, Escalation Phase3, Upto Day21||2||
59809086|NCT00676091|75931306|FG001|NOT COMPLETED|After Infant Series||3||
59963929|NCT02991859|76081934|FG009|STARTED|Period1, Escalation Phase3, Upto Day21||2||
59963930|NCT02991859|76081935|FG010|STARTED|Period1, Escalation Phase3, Upto Day21||2||
59963931|NCT02991859|76081936|FG011|STARTED|Period1, Escalation Phase3, Upto Day21||2||
59963932|NCT02991859|76081937|FG012|STARTED|Period1, Escalation Phase3, Upto Day21||7||
60074209|NCT01808222|76189628|FG000|COMPLETED|Overall Study||24||
59809087|NCT00676091|75931305|FG000|STARTED|Toddler Dose||156||
59963933|NCT02991859|76081938|FG013|STARTED|Period1, Escalation Phase3, Upto Day21||7||
59963934|NCT02991859|76081939|FG014|STARTED|Period1, Escalation Phase3, Upto Day21||6||
59963935|NCT02991859|76081940|FG015|STARTED|Period1, Escalation Phase3, Upto Day21||3||
59963936|NCT02991859|76081941|FG016|STARTED|Period1, Escalation Phase3, Upto Day21||3||
59963937|NCT02991859|76081925|FG000|COMPLETED|Period1, Escalation Phase3, Upto Day21||2||
59963938|NCT02991859|76081926|FG001|COMPLETED|Period1, Escalation Phase3, Upto Day21||2||
59963939|NCT02991859|76081927|FG002|COMPLETED|Period1, Escalation Phase3, Upto Day21||2||
59963940|NCT02991859|76081928|FG003|COMPLETED|Period1, Escalation Phase3, Upto Day21||2||
59963941|NCT02991859|76081929|FG004|COMPLETED|Period1, Escalation Phase3, Upto Day21||2||
59963942|NCT02991859|76081930|FG005|COMPLETED|Period1, Escalation Phase3, Upto Day21||3||
59963943|NCT02991859|76081931|FG006|COMPLETED|Period1, Escalation Phase3, Upto Day21||2||
59963944|NCT02991859|76081932|FG007|COMPLETED|Period1, Escalation Phase3, Upto Day21||2||
59963945|NCT02991859|76081933|FG008|COMPLETED|Period1, Escalation Phase3, Upto Day21||2||
59963946|NCT02991859|76081934|FG009|COMPLETED|Period1, Escalation Phase3, Upto Day21||2||
59963947|NCT02991859|76081935|FG010|COMPLETED|Period1, Escalation Phase3, Upto Day21||2||
59963948|NCT02991859|76081936|FG011|COMPLETED|Period1, Escalation Phase3, Upto Day21||2||
59963949|NCT02991859|76081937|FG012|COMPLETED|Period1, Escalation Phase3, Upto Day21||6||
59963950|NCT02991859|76081938|FG013|COMPLETED|Period1, Escalation Phase3, Upto Day21||6||
59963951|NCT02991859|76081939|FG014|COMPLETED|Period1, Escalation Phase3, Upto Day21||6||
59963952|NCT02991859|76081940|FG015|COMPLETED|Period1, Escalation Phase3, Upto Day21||3||
59963953|NCT02991859|76081941|FG016|COMPLETED|Period1, Escalation Phase3, Upto Day21||3||
59963954|NCT02991859|76081925|FG000|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0||
59963955|NCT02991859|76081926|FG001|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0||
59963956|NCT02991859|76081927|FG002|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0||
59963957|NCT02991859|76081928|FG003|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0||
59963958|NCT02991859|76081929|FG004|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0||
59963959|NCT02991859|76081930|FG005|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0||
59963960|NCT02991859|76081931|FG006|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0||
59963961|NCT02991859|76081932|FG007|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0||
59963962|NCT02991859|76081933|FG008|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0||
59963963|NCT02991859|76081934|FG009|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0||
59963964|NCT02991859|76081935|FG010|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0||
59963965|NCT02991859|76081936|FG011|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0||
59963966|NCT02991859|76081937|FG012|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||1||
59963967|NCT02991859|76081938|FG013|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||1||
59963968|NCT02991859|76081939|FG014|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0||
59963969|NCT02991859|76081940|FG015|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0||
59963970|NCT02991859|76081941|FG016|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0||
59963971|NCT02991859|76081925|FG000|STARTED|Period1, Escalation Phase4, Upto Day28||2||
59963972|NCT02991859|76081926|FG001|STARTED|Period1, Escalation Phase4, Upto Day28||2||
59963973|NCT02991859|76081927|FG002|STARTED|Period1, Escalation Phase4, Upto Day28||2||
59963974|NCT02991859|76081928|FG003|STARTED|Period1, Escalation Phase4, Upto Day28||2||
59963975|NCT02991859|76081929|FG004|STARTED|Period1, Escalation Phase4, Upto Day28||2||
59963976|NCT02991859|76081930|FG005|STARTED|Period1, Escalation Phase4, Upto Day28|1 Par completed Phase 3 did not enter Phase 4|2||
59963977|NCT02991859|76081931|FG006|STARTED|Period1, Escalation Phase4, Upto Day28||2||
59963978|NCT02991859|76081932|FG007|STARTED|Period1, Escalation Phase4, Upto Day28||2||
59963979|NCT02991859|76081933|FG008|STARTED|Period1, Escalation Phase4, Upto Day28||2||
59963980|NCT02991859|76081934|FG009|STARTED|Period1, Escalation Phase4, Upto Day28||2||
59963981|NCT02991859|76081935|FG010|STARTED|Period1, Escalation Phase4, Upto Day28||2||
59963982|NCT02991859|76081936|FG011|STARTED|Period1, Escalation Phase4, Upto Day28||2||
59621396|NCT00149838|75732967|FG002|NOT COMPLETED|Phase II||0||
59621397|NCT00149838|75732968|FG003|NOT COMPLETED|Phase II||0||
59621398|NCT00149838|75732965|FG000|STARTED|Phase III||0||
59621399|NCT00149838|75732966|FG001|STARTED|Phase III||0||
59963983|NCT02991859|76081937|FG012|STARTED|Period1, Escalation Phase4, Upto Day28||6||
59963984|NCT02991859|76081938|FG013|STARTED|Period1, Escalation Phase4, Upto Day28||6||
59963985|NCT02991859|76081939|FG014|STARTED|Period1, Escalation Phase4, Upto Day28||6||
59963986|NCT02991859|76081940|FG015|STARTED|Period1, Escalation Phase4, Upto Day28||3||
59963987|NCT02991859|76081941|FG016|STARTED|Period1, Escalation Phase4, Upto Day28||3||
59963988|NCT02991859|76081925|FG000|COMPLETED|Period1, Escalation Phase4, Upto Day28||2||
59963989|NCT02991859|76081926|FG001|COMPLETED|Period1, Escalation Phase4, Upto Day28||2||
59621400|NCT00149838|75732967|FG002|STARTED|Phase III||0||
59963990|NCT02991859|76081927|FG002|COMPLETED|Period1, Escalation Phase4, Upto Day28||2||
59963991|NCT02991859|76081928|FG003|COMPLETED|Period1, Escalation Phase4, Upto Day28||2||
60074210|NCT01808222|76189628|FG000|NOT COMPLETED|Overall Study||1||
59621401|NCT00149838|75732968|FG003|STARTED|Phase III||61||
59621402|NCT00149838|75732965|FG000|COMPLETED|Phase III||0||
59621403|NCT00149838|75732966|FG001|COMPLETED|Phase III||0||
59621404|NCT00149838|75732967|FG002|COMPLETED|Phase III||0||
59621405|NCT00149838|75732968|FG003|COMPLETED|Phase III||37||
59621406|NCT00149838|75732965|FG000|NOT COMPLETED|Phase III||0||
59963992|NCT02991859|76081929|FG004|COMPLETED|Period1, Escalation Phase4, Upto Day28||2||
59963993|NCT02991859|76081930|FG005|COMPLETED|Period1, Escalation Phase4, Upto Day28||2||
59963994|NCT02991859|76081931|FG006|COMPLETED|Period1, Escalation Phase4, Upto Day28||2||
59963995|NCT02991859|76081932|FG007|COMPLETED|Period1, Escalation Phase4, Upto Day28||2||
59963996|NCT02991859|76081933|FG008|COMPLETED|Period1, Escalation Phase4, Upto Day28||2||
59963997|NCT02991859|76081934|FG009|COMPLETED|Period1, Escalation Phase4, Upto Day28||2||
59963998|NCT02991859|76081935|FG010|COMPLETED|Period1, Escalation Phase4, Upto Day28||2||
59963999|NCT02991859|76081936|FG011|COMPLETED|Period1, Escalation Phase4, Upto Day28||2||
59964000|NCT02991859|76081937|FG012|COMPLETED|Period1, Escalation Phase4, Upto Day28||6||
59964001|NCT02991859|76081938|FG013|COMPLETED|Period1, Escalation Phase4, Upto Day28||6||
59964002|NCT02991859|76081939|FG014|COMPLETED|Period1, Escalation Phase4, Upto Day28||6||
59964003|NCT02991859|76081940|FG015|COMPLETED|Period1, Escalation Phase4, Upto Day28||3||
59964004|NCT02991859|76081941|FG016|COMPLETED|Period1, Escalation Phase4, Upto Day28||3||
60074211|NCT01772576|76189632|FG000|STARTED|Overall Study||167||
60074212|NCT01772576|76189632|FG000|COMPLETED|Overall Study||133||
60074213|NCT01772576|76189632|FG000|NOT COMPLETED|Overall Study||34||
60074214|NCT03192358|76189638|FG000|STARTED|Overall Study||20||
60074215|NCT03192358|76189639|FG001|STARTED|Overall Study||20||
60074216|NCT03192358|76189638|FG000|COMPLETED|Overall Study||20||
60074217|NCT03192358|76189639|FG001|COMPLETED|Overall Study||20||
59621407|NCT00149838|75732966|FG001|NOT COMPLETED|Phase III||0||
59621408|NCT00149838|75732967|FG002|NOT COMPLETED|Phase III||0||
59621409|NCT00149838|75732968|FG003|NOT COMPLETED|Phase III||24||
59809088|NCT00676091|75931306|FG001|STARTED|Toddler Dose||156||
59809089|NCT00676091|75931305|FG000|COMPLETED|Toddler Dose||153||
59809090|NCT00676091|75931306|FG001|COMPLETED|Toddler Dose||156||
59809091|NCT00676091|75931305|FG000|NOT COMPLETED|Toddler Dose||3||
59809092|NCT00676091|75931306|FG001|NOT COMPLETED|Toddler Dose||0||
59621410|NCT00324870|75732978|FG000|STARTED|Overall Study||37||
59809093|NCT00678041|75931318|FG000|STARTED|Overall Study||5||
59809094|NCT00678041|75931319|FG001|STARTED|Overall Study||5||
59809095|NCT00678041|75931318|FG000|COMPLETED|Overall Study||0||
59809096|NCT00678041|75931319|FG001|COMPLETED|Overall Study||0||
59809097|NCT00678041|75931318|FG000|NOT COMPLETED|Overall Study||5||
59809098|NCT00678041|75931319|FG001|NOT COMPLETED|Overall Study||5||
59809099|NCT03903822|75931334|FG000|STARTED|Treatment Phase (6 Weeks)||37||
59809100|NCT03903822|75931335|FG001|STARTED|Treatment Phase (6 Weeks)||37||
59809101|NCT03903822|75931336|FG002|STARTED|Treatment Phase (6 Weeks)||36||
59809102|NCT03903822|75931337|FG003|STARTED|Treatment Phase (6 Weeks)||37||
59809103|NCT03903822|75931338|FG004|STARTED|Treatment Phase (6 Weeks)||36||
59809104|NCT03903822|75931339|FG005|STARTED|Treatment Phase (6 Weeks)||36||
59809105|NCT03903822|75931340|FG006|STARTED|Treatment Phase (6 Weeks)||36||
59809106|NCT03903822|75931341|FG007|STARTED|Treatment Phase (6 Weeks)||37||
59809107|NCT03903822|75931334|FG000|COMPLETED|Treatment Phase (6 Weeks)||28||
59809108|NCT03903822|75931335|FG001|COMPLETED|Treatment Phase (6 Weeks)||27||
59809109|NCT03903822|75931336|FG002|COMPLETED|Treatment Phase (6 Weeks)||33||
59809110|NCT03903822|75931337|FG003|COMPLETED|Treatment Phase (6 Weeks)||32||
59809111|NCT03903822|75931338|FG004|COMPLETED|Treatment Phase (6 Weeks)||31||
59809112|NCT03903822|75931339|FG005|COMPLETED|Treatment Phase (6 Weeks)||25||
59809113|NCT03903822|75931340|FG006|COMPLETED|Treatment Phase (6 Weeks)||31||
59809114|NCT03903822|75931341|FG007|COMPLETED|Treatment Phase (6 Weeks)||33||
59809115|NCT03903822|75931334|FG000|NOT COMPLETED|Treatment Phase (6 Weeks)||9||
59809116|NCT03903822|75931335|FG001|NOT COMPLETED|Treatment Phase (6 Weeks)||10||
59809117|NCT03903822|75931336|FG002|NOT COMPLETED|Treatment Phase (6 Weeks)||3||
59964005|NCT02991859|76081925|FG000|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0||
59621411|NCT00324870|75732978|FG000|COMPLETED|Overall Study||37||
59964006|NCT02991859|76081926|FG001|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0||
59964007|NCT02991859|76081927|FG002|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0||
59964008|NCT02991859|76081928|FG003|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0||
59964009|NCT02991859|76081929|FG004|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0||
59964010|NCT02991859|76081930|FG005|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0||
59964011|NCT02991859|76081931|FG006|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0||
59964012|NCT02991859|76081932|FG007|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0||
59621412|NCT00324870|75732978|FG000|NOT COMPLETED|Overall Study||0||
59809118|NCT03903822|75931337|FG003|NOT COMPLETED|Treatment Phase (6 Weeks)||5||
59809119|NCT03903822|75931338|FG004|NOT COMPLETED|Treatment Phase (6 Weeks)||5||
59809120|NCT03903822|75931339|FG005|NOT COMPLETED|Treatment Phase (6 Weeks)||11||
59809121|NCT03903822|75931340|FG006|NOT COMPLETED|Treatment Phase (6 Weeks)||5||
59809122|NCT03903822|75931341|FG007|NOT COMPLETED|Treatment Phase (6 Weeks)||4||
59809123|NCT03903822|75931334|FG000|STARTED|Follow up Phase (4 Weeks)|Participants not completing treatment phase could also start this phase.|37||
59809124|NCT03903822|75931335|FG001|STARTED|Follow up Phase (4 Weeks)|Participants not completing treatment phase could also start this phase.|37||
59809125|NCT03903822|75931336|FG002|STARTED|Follow up Phase (4 Weeks)|Participants not completing treatment phase could also start this phase.|36||
59809126|NCT03903822|75931337|FG003|STARTED|Follow up Phase (4 Weeks)|Participants not completing treatment phase could also start this phase.|37||
59964013|NCT02991859|76081933|FG008|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0||
59964014|NCT02991859|76081934|FG009|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0||
59964015|NCT02991859|76081935|FG010|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0||
59964016|NCT02991859|76081936|FG011|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0||
59964017|NCT02991859|76081937|FG012|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0||
59524658|NCT02533674|75619777|FG003|COMPLETED|Dose Level VI||0||
59524659|NCT02533674|75619778|FG004|COMPLETED|Dose Level VI||0||
59809127|NCT03903822|75931338|FG004|STARTED|Follow up Phase (4 Weeks)|Participants not completing treatment phase could also start this phase.|36||
59809128|NCT03903822|75931339|FG005|STARTED|Follow up Phase (4 Weeks)|Participants not completing treatment phase could also start this phase.|36||
59809129|NCT03903822|75931340|FG006|STARTED|Follow up Phase (4 Weeks)|Participants not completing treatment phase could also start this phase.|36||
59809130|NCT03903822|75931341|FG007|STARTED|Follow up Phase (4 Weeks)|Participants not completing treatment phase could also start this phase.|37||
59964018|NCT02991859|76081938|FG013|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0||
59964019|NCT02991859|76081939|FG014|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0||
59964020|NCT02991859|76081940|FG015|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0||
59964021|NCT02991859|76081941|FG016|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0||
59964022|NCT02991859|76081925|FG000|STARTED|Period1, Escalation Phase5, Upto Day35||2||
59964023|NCT02991859|76081926|FG001|STARTED|Period1, Escalation Phase5, Upto Day35||2||
59964024|NCT02991859|76081927|FG002|STARTED|Period1, Escalation Phase5, Upto Day35||2||
59964025|NCT02991859|76081928|FG003|STARTED|Period1, Escalation Phase5, Upto Day35||2||
59964026|NCT02991859|76081929|FG004|STARTED|Period1, Escalation Phase5, Upto Day35||2||
59964027|NCT02991859|76081930|FG005|STARTED|Period1, Escalation Phase5, Upto Day35||2||
59964028|NCT02991859|76081931|FG006|STARTED|Period1, Escalation Phase5, Upto Day35||2||
59964029|NCT02991859|76081932|FG007|STARTED|Period1, Escalation Phase5, Upto Day35||2||
59964030|NCT02991859|76081933|FG008|STARTED|Period1, Escalation Phase5, Upto Day35||2||
59964031|NCT02991859|76081934|FG009|STARTED|Period1, Escalation Phase5, Upto Day35||2||
59964032|NCT02991859|76081935|FG010|STARTED|Period1, Escalation Phase5, Upto Day35|1 participant did not enter Esc Phase 5, and was not withdrawn|1||
59964033|NCT02991859|76081936|FG011|STARTED|Period1, Escalation Phase5, Upto Day35||2||
59809131|NCT03903822|75931334|FG000|COMPLETED|Follow up Phase (4 Weeks)||29||
59809132|NCT03903822|75931335|FG001|COMPLETED|Follow up Phase (4 Weeks)||29||
59809133|NCT03903822|75931336|FG002|COMPLETED|Follow up Phase (4 Weeks)||32||
59964034|NCT02991859|76081937|FG012|STARTED|Period1, Escalation Phase5, Upto Day35||6||
59964035|NCT02991859|76081938|FG013|STARTED|Period1, Escalation Phase5, Upto Day35||6||
59964036|NCT02991859|76081939|FG014|STARTED|Period1, Escalation Phase5, Upto Day35||6||
59964037|NCT02991859|76081940|FG015|STARTED|Period1, Escalation Phase5, Upto Day35||3||
59964038|NCT02991859|76081941|FG016|STARTED|Period1, Escalation Phase5, Upto Day35||3||
59964039|NCT02991859|76081925|FG000|COMPLETED|Period1, Escalation Phase5, Upto Day35||2||
59964040|NCT02991859|76081926|FG001|COMPLETED|Period1, Escalation Phase5, Upto Day35||2||
59964041|NCT02991859|76081927|FG002|COMPLETED|Period1, Escalation Phase5, Upto Day35||2||
59964042|NCT02991859|76081928|FG003|COMPLETED|Period1, Escalation Phase5, Upto Day35||2||
59964043|NCT02991859|76081929|FG004|COMPLETED|Period1, Escalation Phase5, Upto Day35||2||
59964044|NCT02991859|76081930|FG005|COMPLETED|Period1, Escalation Phase5, Upto Day35||2||
59964045|NCT02991859|76081931|FG006|COMPLETED|Period1, Escalation Phase5, Upto Day35||2||
59964046|NCT02991859|76081932|FG007|COMPLETED|Period1, Escalation Phase5, Upto Day35||2||
59964047|NCT02991859|76081933|FG008|COMPLETED|Period1, Escalation Phase5, Upto Day35||2||
59964048|NCT02991859|76081934|FG009|COMPLETED|Period1, Escalation Phase5, Upto Day35||2||
59964049|NCT02991859|76081935|FG010|COMPLETED|Period1, Escalation Phase5, Upto Day35||1||
59524660|NCT02533674|75619779|FG005|COMPLETED|Dose Level VI||0||
59524661|NCT02533674|75619780|FG006|COMPLETED|Dose Level VI||0||
59524662|NCT02533674|75619781|FG007|COMPLETED|Dose Level VI||0||
59809134|NCT03903822|75931337|FG003|COMPLETED|Follow up Phase (4 Weeks)||33||
59809135|NCT03903822|75931338|FG004|COMPLETED|Follow up Phase (4 Weeks)||32||
59964050|NCT02991859|76081936|FG011|COMPLETED|Period1, Escalation Phase5, Upto Day35||2||
59964051|NCT02991859|76081937|FG012|COMPLETED|Period1, Escalation Phase5, Upto Day35||6||
59964052|NCT02991859|76081938|FG013|COMPLETED|Period1, Escalation Phase5, Upto Day35||6||
59964053|NCT02991859|76081939|FG014|COMPLETED|Period1, Escalation Phase5, Upto Day35||6||
59964054|NCT02991859|76081940|FG015|COMPLETED|Period1, Escalation Phase5, Upto Day35||3||
59964055|NCT02991859|76081941|FG016|COMPLETED|Period1, Escalation Phase5, Upto Day35||3||
59964056|NCT02991859|76081925|FG000|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0||
59964057|NCT02991859|76081926|FG001|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0||
59964058|NCT02991859|76081927|FG002|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0||
59995288|NCT05425563|76111121|FG000|NOT COMPLETED|Overall Study||17||
59995289|NCT05097963|76111131|FG000|STARTED|Overall Study||63||
59995290|NCT05097963|76111131|FG000|COMPLETED|Overall Study||29||
59995291|NCT05097963|76111131|FG000|NOT COMPLETED|Overall Study||34||
59995292|NCT04765553|76111137|FG000|STARTED|Overall Study||6||
59995293|NCT04765553|76111138|FG001|STARTED|Overall Study||2||
59995294|NCT04765553|76111137|FG000|COMPLETED|Overall Study||6||
59995295|NCT04765553|76111138|FG001|COMPLETED|Overall Study||2||
59995296|NCT04765553|76111137|FG000|NOT COMPLETED|Overall Study||0||
59964059|NCT02991859|76081928|FG003|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0||
59964060|NCT02991859|76081929|FG004|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0||
59964061|NCT02991859|76081930|FG005|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0||
59964062|NCT02991859|76081931|FG006|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0||
59964063|NCT02991859|76081932|FG007|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0||
59964064|NCT02991859|76081933|FG008|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0||
59964065|NCT02991859|76081934|FG009|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0||
59964066|NCT02991859|76081935|FG010|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0||
59964067|NCT02991859|76081936|FG011|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0||
59964068|NCT02991859|76081937|FG012|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0||
59964069|NCT02991859|76081938|FG013|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0||
59964070|NCT02991859|76081939|FG014|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0||
59964071|NCT02991859|76081940|FG015|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0||
59964072|NCT02991859|76081941|FG016|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0||
59964073|NCT02991859|76081925|FG000|STARTED|Wash Out, Up to Day 77||2||
59964074|NCT02991859|76081926|FG001|STARTED|Wash Out, Up to Day 77||2||
59809136|NCT03903822|75931339|FG005|COMPLETED|Follow up Phase (4 Weeks)||28||
59809137|NCT03903822|75931340|FG006|COMPLETED|Follow up Phase (4 Weeks)||31||
59809138|NCT03903822|75931341|FG007|COMPLETED|Follow up Phase (4 Weeks)||31||
59809139|NCT03903822|75931334|FG000|NOT COMPLETED|Follow up Phase (4 Weeks)||8||
59809140|NCT03903822|75931335|FG001|NOT COMPLETED|Follow up Phase (4 Weeks)||8||
59809141|NCT03903822|75931336|FG002|NOT COMPLETED|Follow up Phase (4 Weeks)||4||
59809142|NCT03903822|75931337|FG003|NOT COMPLETED|Follow up Phase (4 Weeks)||4||
59809143|NCT03903822|75931338|FG004|NOT COMPLETED|Follow up Phase (4 Weeks)||4||
59809144|NCT03903822|75931339|FG005|NOT COMPLETED|Follow up Phase (4 Weeks)||8||
59809145|NCT03903822|75931340|FG006|NOT COMPLETED|Follow up Phase (4 Weeks)||5||
59964075|NCT02991859|76081927|FG002|STARTED|Wash Out, Up to Day 77||2||
59964076|NCT02991859|76081928|FG003|STARTED|Wash Out, Up to Day 77||2||
59964077|NCT02991859|76081929|FG004|STARTED|Wash Out, Up to Day 77||2||
59964078|NCT02991859|76081930|FG005|STARTED|Wash Out, Up to Day 77||2||
59964079|NCT02991859|76081931|FG006|STARTED|Wash Out, Up to Day 77||2||
59964080|NCT02991859|76081932|FG007|STARTED|Wash Out, Up to Day 77||2||
59964081|NCT02991859|76081933|FG008|STARTED|Wash Out, Up to Day 77||2||
59964082|NCT02991859|76081934|FG009|STARTED|Wash Out, Up to Day 77||2||
59964083|NCT02991859|76081935|FG010|STARTED|Wash Out, Up to Day 77||1||
59809146|NCT03903822|75931341|FG007|NOT COMPLETED|Follow up Phase (4 Weeks)||6||
59809147|NCT00677807|75931362|FG000|STARTED|Overall Study||144||
59809148|NCT00677807|75931363|FG001|STARTED|Overall Study||146||
59964084|NCT02991859|76081936|FG011|STARTED|Wash Out, Up to Day 77||2||
59809149|NCT00677807|75931364|FG002|STARTED|Overall Study||125||
59809150|NCT00677807|75931362|FG000|Safety/ITT: Received Study Drug|Overall Study||144||
59809151|NCT00677807|75931363|FG001|Safety/ITT: Received Study Drug|Overall Study||146||
59809152|NCT00677807|75931364|FG002|Safety/ITT: Received Study Drug|Overall Study|One patient did not take study medication.|124||
59809153|NCT00677807|75931362|FG000|COMPLETED|Overall Study||126||
59809154|NCT00677807|75931363|FG001|COMPLETED|Overall Study||135||
59809155|NCT00677807|75931364|FG002|COMPLETED|Overall Study||105||
59809156|NCT00677807|75931362|FG000|NOT COMPLETED|Overall Study||18||
59809157|NCT00677807|75931363|FG001|NOT COMPLETED|Overall Study||11||
59809158|NCT00677807|75931364|FG002|NOT COMPLETED|Overall Study||20||
59809159|NCT00687401|75931372|FG000|STARTED|Overall Study|215 participants enrolled in the study, of which 56 failed screening and did not receive study drug.|159||
59809160|NCT00687401|75931372|FG000|COMPLETED|Overall Study||129||
59809161|NCT00687401|75931372|FG000|NOT COMPLETED|Overall Study||30||
59964085|NCT02991859|76081937|FG012|STARTED|Wash Out, Up to Day 77|Participants did not enter washout and Period 2|0||
59964086|NCT02991859|76081938|FG013|STARTED|Wash Out, Up to Day 77|Participants did not enter washout and Period 2|0||
59964087|NCT02991859|76081939|FG014|STARTED|Wash Out, Up to Day 77|Participants did not enter washout and Period 2|0||
59964088|NCT02991859|76081940|FG015|STARTED|Wash Out, Up to Day 77|Participants did not enter washout and Period 2|0||
59964089|NCT02991859|76081941|FG016|STARTED|Wash Out, Up to Day 77|Participants did not enter washout and Period 2|0||
59964090|NCT02991859|76081925|FG000|COMPLETED|Wash Out, Up to Day 77||2||
59809162|NCT00485693|75931379|FG000|STARTED|Overall Study||34||
59809163|NCT00485693|75931380|FG001|STARTED|Overall Study||104||
59964091|NCT02991859|76081926|FG001|COMPLETED|Wash Out, Up to Day 77||2||
59964092|NCT02991859|76081927|FG002|COMPLETED|Wash Out, Up to Day 77||2||
59964093|NCT02991859|76081928|FG003|COMPLETED|Wash Out, Up to Day 77||2||
59964094|NCT02991859|76081929|FG004|COMPLETED|Wash Out, Up to Day 77||2||
59964095|NCT02991859|76081930|FG005|COMPLETED|Wash Out, Up to Day 77||1||
59809164|NCT00485693|75931379|FG000|COMPLETED|Overall Study||34||
59809165|NCT00485693|75931380|FG001|COMPLETED|Overall Study||104||
59964096|NCT02991859|76081931|FG006|COMPLETED|Wash Out, Up to Day 77||2||
59964097|NCT02991859|76081932|FG007|COMPLETED|Wash Out, Up to Day 77||2||
59964098|NCT02991859|76081933|FG008|COMPLETED|Wash Out, Up to Day 77||2||
59809166|NCT00485693|75931379|FG000|NOT COMPLETED|Overall Study||0||
59809167|NCT00485693|75931380|FG001|NOT COMPLETED|Overall Study||0||
59809168|NCT00538902|75931392|FG000|STARTED|DB Wk 0 Through 12 (Primary D/C Reasons)||60||
59964099|NCT02991859|76081934|FG009|COMPLETED|Wash Out, Up to Day 77||1||
59964100|NCT02991859|76081935|FG010|COMPLETED|Wash Out, Up to Day 77||1||
59964101|NCT02991859|76081936|FG011|COMPLETED|Wash Out, Up to Day 77||2||
59964102|NCT02991859|76081937|FG012|COMPLETED|Wash Out, Up to Day 77||0||
59964103|NCT02991859|76081938|FG013|COMPLETED|Wash Out, Up to Day 77||0||
59964104|NCT02991859|76081939|FG014|COMPLETED|Wash Out, Up to Day 77||0||
59964105|NCT02991859|76081940|FG015|COMPLETED|Wash Out, Up to Day 77||0||
59964106|NCT02991859|76081941|FG016|COMPLETED|Wash Out, Up to Day 77||0||
59964107|NCT02991859|76081925|FG000|NOT COMPLETED|Wash Out, Up to Day 77||0||
59964108|NCT02991859|76081926|FG001|NOT COMPLETED|Wash Out, Up to Day 77||0||
59964109|NCT02991859|76081927|FG002|NOT COMPLETED|Wash Out, Up to Day 77||0||
59964110|NCT02991859|76081928|FG003|NOT COMPLETED|Wash Out, Up to Day 77||0||
59964111|NCT02991859|76081929|FG004|NOT COMPLETED|Wash Out, Up to Day 77||0||
59964112|NCT02991859|76081930|FG005|NOT COMPLETED|Wash Out, Up to Day 77||1||
59964113|NCT02991859|76081931|FG006|NOT COMPLETED|Wash Out, Up to Day 77||0||
59964114|NCT02991859|76081932|FG007|NOT COMPLETED|Wash Out, Up to Day 77||0||
59964115|NCT02991859|76081933|FG008|NOT COMPLETED|Wash Out, Up to Day 77||0||
59964116|NCT02991859|76081934|FG009|NOT COMPLETED|Wash Out, Up to Day 77||1||
59964117|NCT02991859|76081935|FG010|NOT COMPLETED|Wash Out, Up to Day 77||0||
59964118|NCT02991859|76081936|FG011|NOT COMPLETED|Wash Out, Up to Day 77||0||
59964119|NCT02991859|76081937|FG012|NOT COMPLETED|Wash Out, Up to Day 77||0||
59964120|NCT02991859|76081938|FG013|NOT COMPLETED|Wash Out, Up to Day 77||0||
59964121|NCT02991859|76081939|FG014|NOT COMPLETED|Wash Out, Up to Day 77||0||
59964122|NCT02991859|76081940|FG015|NOT COMPLETED|Wash Out, Up to Day 77||0||
59964123|NCT02991859|76081941|FG016|NOT COMPLETED|Wash Out, Up to Day 77||0||
59809169|NCT00538902|75931393|FG001|STARTED|DB Wk 0 Through 12 (Primary D/C Reasons)||121||
59809170|NCT00538902|75931394|FG002|STARTED|DB Wk 0 Through 12 (Primary D/C Reasons)||121||
59809171|NCT00538902|75931392|FG000|COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||59||
59809172|NCT00538902|75931393|FG001|COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||119||
59809173|NCT00538902|75931394|FG002|COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||116||
59809174|NCT00538902|75931392|FG000|NOT COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||1||
59809175|NCT00538902|75931393|FG001|NOT COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||2||
59809176|NCT00538902|75931394|FG002|NOT COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||5||
59809177|NCT00538902|75931392|FG000|STARTED|OL Wk 24 to End (Primary D/C Reasons)||59||
59809178|NCT00538902|75931393|FG001|STARTED|OL Wk 24 to End (Primary D/C Reasons)||119||
59809179|NCT00538902|75931394|FG002|STARTED|OL Wk 24 to End (Primary D/C Reasons)||116||
59809180|NCT00538902|75931392|FG000|COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||23||
59809181|NCT00538902|75931393|FG001|COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||55||
59809182|NCT00538902|75931394|FG002|COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||52||
59809183|NCT00538902|75931392|FG000|NOT COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||36||
59809184|NCT00538902|75931393|FG001|NOT COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||64||
59809185|NCT00538902|75931394|FG002|NOT COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||64||
59809186|NCT00541970|75931408|FG000|STARTED|Month 7||240||
59809187|NCT00541970|75931409|FG001|STARTED|Month 7||241||
59809188|NCT00541970|75931410|FG002|STARTED|Month 7||240||
59809189|NCT00541970|75931411|FG003|STARTED|Month 7||239||
59809190|NCT00541970|75931408|FG000|COMPLETED|Month 7||231||
59809191|NCT00541970|75931409|FG001|COMPLETED|Month 7||228||
59809192|NCT00541970|75931410|FG002|COMPLETED|Month 7||229||
59809193|NCT00541970|75931411|FG003|COMPLETED|Month 7||234||
59809194|NCT00541970|75931408|FG000|NOT COMPLETED|Month 7||9||
59809195|NCT00541970|75931409|FG001|NOT COMPLETED|Month 7||13||
59809196|NCT00541970|75931410|FG002|NOT COMPLETED|Month 7||11||
59809197|NCT00541970|75931411|FG003|NOT COMPLETED|Month 7||5||
59809198|NCT00541970|75931408|FG000|STARTED|Month 12||240||
59809199|NCT00541970|75931409|FG001|STARTED|Month 12||241||
59809200|NCT00541970|75931410|FG002|STARTED|Month 12||240||
59809201|NCT00541970|75931411|FG003|STARTED|Month 12||239||
59809202|NCT00541970|75931408|FG000|COMPLETED|Month 12||228||
59809203|NCT00541970|75931409|FG001|COMPLETED|Month 12||219||
59809204|NCT00541970|75931410|FG002|COMPLETED|Month 12||219||
59809205|NCT00541970|75931411|FG003|COMPLETED|Month 12||223||
59809206|NCT00541970|75931408|FG000|NOT COMPLETED|Month 12||12||
59809207|NCT00541970|75931409|FG001|NOT COMPLETED|Month 12||22||
59809208|NCT00541970|75931410|FG002|NOT COMPLETED|Month 12||21||
59809209|NCT00541970|75931411|FG003|NOT COMPLETED|Month 12||16||
59964124|NCT02991859|76081925|FG000|STARTED|Period2, Escalation Phase1, Upto Day 84||2||
59964125|NCT02991859|76081926|FG001|STARTED|Period2, Escalation Phase1, Upto Day 84||2||
59964126|NCT02991859|76081927|FG002|STARTED|Period2, Escalation Phase1, Upto Day 84||2||
59964127|NCT02991859|76081928|FG003|STARTED|Period2, Escalation Phase1, Upto Day 84||2||
59964128|NCT02991859|76081929|FG004|STARTED|Period2, Escalation Phase1, Upto Day 84||2||
59964129|NCT02991859|76081930|FG005|STARTED|Period2, Escalation Phase1, Upto Day 84||1||
59964130|NCT02991859|76081931|FG006|STARTED|Period2, Escalation Phase1, Upto Day 84||2||
59964131|NCT02991859|76081932|FG007|STARTED|Period2, Escalation Phase1, Upto Day 84||2||
59964132|NCT02991859|76081933|FG008|STARTED|Period2, Escalation Phase1, Upto Day 84||2||
59994939|NCT03420781|76110739|FG001|NOT COMPLETED|RW Period: 6 Weeks (Week 41 to Week 46)||0||
59964133|NCT02991859|76081934|FG009|STARTED|Period2, Escalation Phase1, Upto Day 84|1 Par directly entered into Period 2, Esc 1|2||
59964134|NCT02991859|76081935|FG010|STARTED|Period2, Escalation Phase1, Upto Day 84|1 Par cont in P2 Esc 1 insteadP1 Esc 5, was not withdrawn|2||
59964135|NCT02991859|76081936|FG011|STARTED|Period2, Escalation Phase1, Upto Day 84||2||
59809210|NCT00541970|75931408|FG000|STARTED|Month 18||240||
59809211|NCT00541970|75931409|FG001|STARTED|Month 18||241||
59809212|NCT00541970|75931410|FG002|STARTED|Month 18||240||
59809213|NCT00541970|75931411|FG003|STARTED|Month 18||239||
59809214|NCT00541970|75931408|FG000|COMPLETED|Month 18||226||
59964136|NCT02991859|76081937|FG012|STARTED|Period2, Escalation Phase1, Upto Day 84||0||
59964137|NCT02991859|76081938|FG013|STARTED|Period2, Escalation Phase1, Upto Day 84||0||
59964138|NCT02991859|76081939|FG014|STARTED|Period2, Escalation Phase1, Upto Day 84||0||
59964139|NCT02991859|76081940|FG015|STARTED|Period2, Escalation Phase1, Upto Day 84||0||
59964140|NCT02991859|76081941|FG016|STARTED|Period2, Escalation Phase1, Upto Day 84||0||
59964141|NCT02991859|76081925|FG000|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2||
59964142|NCT02991859|76081926|FG001|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2||
59964143|NCT02991859|76081927|FG002|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2||
59964144|NCT02991859|76081928|FG003|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2||
59964145|NCT02991859|76081929|FG004|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2||
59964146|NCT02991859|76081930|FG005|COMPLETED|Period2, Escalation Phase1, Upto Day 84||1||
59964147|NCT02991859|76081931|FG006|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2||
59964148|NCT02991859|76081932|FG007|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2||
59964149|NCT02991859|76081933|FG008|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2||
60074218|NCT03192358|76189638|FG000|NOT COMPLETED|Overall Study||0||
59524663|NCT02533674|75619774|FG000|NOT COMPLETED|Dose Level VI||0||
59524664|NCT02533674|75619775|FG001|NOT COMPLETED|Dose Level VI||0||
59524665|NCT02533674|75619776|FG002|NOT COMPLETED|Dose Level VI||0||
59524666|NCT02533674|75619777|FG003|NOT COMPLETED|Dose Level VI||0||
59524667|NCT02533674|75619778|FG004|NOT COMPLETED|Dose Level VI||0||
59621413|NCT00151320|75732984|FG000|STARTED|Overall Study||76||
59809215|NCT00541970|75931409|FG001|COMPLETED|Month 18||217||
59809216|NCT00541970|75931410|FG002|COMPLETED|Month 18||215||
59809217|NCT00541970|75931411|FG003|COMPLETED|Month 18||222||
59809218|NCT00541970|75931408|FG000|NOT COMPLETED|Month 18||14||
59809219|NCT00541970|75931409|FG001|NOT COMPLETED|Month 18||24||
59809220|NCT00541970|75931410|FG002|NOT COMPLETED|Month 18||25||
59809221|NCT00541970|75931411|FG003|NOT COMPLETED|Month 18||17||
59964150|NCT02991859|76081934|FG009|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2||
59964151|NCT02991859|76081935|FG010|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2||
59964152|NCT02991859|76081936|FG011|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2||
59964153|NCT02991859|76081937|FG012|COMPLETED|Period2, Escalation Phase1, Upto Day 84||0||
59964154|NCT02991859|76081938|FG013|COMPLETED|Period2, Escalation Phase1, Upto Day 84||0||
59964155|NCT02991859|76081939|FG014|COMPLETED|Period2, Escalation Phase1, Upto Day 84||0||
59964156|NCT02991859|76081940|FG015|COMPLETED|Period2, Escalation Phase1, Upto Day 84||0||
59964157|NCT02991859|76081941|FG016|COMPLETED|Period2, Escalation Phase1, Upto Day 84||0||
59964158|NCT02991859|76081925|FG000|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0||
59964159|NCT02991859|76081926|FG001|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0||
59964160|NCT02991859|76081927|FG002|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0||
59964161|NCT02991859|76081928|FG003|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0||
59964162|NCT02991859|76081929|FG004|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0||
59964163|NCT02991859|76081930|FG005|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0||
59964164|NCT02991859|76081931|FG006|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0||
59964165|NCT02991859|76081932|FG007|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0||
59964166|NCT02991859|76081933|FG008|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0||
59964167|NCT02991859|76081934|FG009|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0||
59964168|NCT02991859|76081935|FG010|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0||
59964169|NCT02991859|76081936|FG011|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0||
59964170|NCT02991859|76081937|FG012|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0||
59964171|NCT02991859|76081938|FG013|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0||
59964172|NCT02991859|76081939|FG014|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0||
59964173|NCT02991859|76081940|FG015|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0||
59964174|NCT02991859|76081941|FG016|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0||
59964175|NCT02991859|76081925|FG000|STARTED|Period2, Escalation Phase2, Upto Day 91||2||
59964176|NCT02991859|76081926|FG001|STARTED|Period2, Escalation Phase2, Upto Day 91||2||
59964177|NCT02991859|76081927|FG002|STARTED|Period2, Escalation Phase2, Upto Day 91||2||
59964178|NCT02991859|76081928|FG003|STARTED|Period2, Escalation Phase2, Upto Day 91||2||
60074219|NCT03192358|76189639|FG001|NOT COMPLETED|Overall Study||0||
60074220|NCT01802216|76189659|FG000|STARTED|Baseline||17||
59524668|NCT02533674|75619779|FG005|NOT COMPLETED|Dose Level VI||9||
59524669|NCT02533674|75619780|FG006|NOT COMPLETED|Dose Level VI||0||
59524670|NCT02533674|75619781|FG007|NOT COMPLETED|Dose Level VI||0||
59524671|NCT02533674|75619774|FG000|STARTED|Dose Level VII||0||
59524672|NCT02533674|75619775|FG001|STARTED|Dose Level VII||0||
59809222|NCT00541970|75931408|FG000|STARTED|Month 24||240||
59524673|NCT02533674|75619776|FG002|STARTED|Dose Level VII||0||
59524674|NCT02533674|75619777|FG003|STARTED|Dose Level VII||0||
59524675|NCT02533674|75619778|FG004|STARTED|Dose Level VII||0||
59524676|NCT02533674|75619779|FG005|STARTED|Dose Level VII||0||
59524677|NCT02533674|75619780|FG006|STARTED|Dose Level VII||16||
59524678|NCT02533674|75619781|FG007|STARTED|Dose Level VII||0||
59809223|NCT00541970|75931409|FG001|STARTED|Month 24||241||
59809224|NCT00541970|75931410|FG002|STARTED|Month 24||240||
59809225|NCT00541970|75931411|FG003|STARTED|Month 24||239||
59809226|NCT00541970|75931408|FG000|COMPLETED|Month 24||211||
59809227|NCT00541970|75931409|FG001|COMPLETED|Month 24||209||
59809228|NCT00541970|75931410|FG002|COMPLETED|Month 24||208||
59809229|NCT00541970|75931411|FG003|COMPLETED|Month 24||217||
59809230|NCT00541970|75931408|FG000|NOT COMPLETED|Month 24||29||
59809231|NCT00541970|75931409|FG001|NOT COMPLETED|Month 24||32||
59809232|NCT00541970|75931410|FG002|NOT COMPLETED|Month 24||32||
59809233|NCT00541970|75931411|FG003|NOT COMPLETED|Month 24||22||
59809234|NCT00541970|75931408|FG000|STARTED|Month 36||240||
59809235|NCT00541970|75931409|FG001|STARTED|Month 36||241||
59809236|NCT00541970|75931410|FG002|STARTED|Month 36||240||
59809237|NCT00541970|75931411|FG003|STARTED|Month 36||239||
59809238|NCT00541970|75931408|FG000|COMPLETED|Month 36||179||
59809239|NCT00541970|75931409|FG001|COMPLETED|Month 36||175||
59809240|NCT00541970|75931410|FG002|COMPLETED|Month 36||174||
59809241|NCT00541970|75931411|FG003|COMPLETED|Month 36||179||
59809242|NCT00541970|75931408|FG000|NOT COMPLETED|Month 36||61||
59809243|NCT00541970|75931409|FG001|NOT COMPLETED|Month 36||66||
59809244|NCT00541970|75931410|FG002|NOT COMPLETED|Month 36||66||
59809245|NCT00541970|75931411|FG003|NOT COMPLETED|Month 36||60||
59809246|NCT00541970|75931408|FG000|STARTED|Month 48||240||
59809247|NCT00541970|75931409|FG001|STARTED|Month 48||241||
59964179|NCT02991859|76081929|FG004|STARTED|Period2, Escalation Phase2, Upto Day 91||2||
59964180|NCT02991859|76081930|FG005|STARTED|Period2, Escalation Phase2, Upto Day 91||1||
59964181|NCT02991859|76081931|FG006|STARTED|Period2, Escalation Phase2, Upto Day 91||2||
59524679|NCT02533674|75619774|FG000|COMPLETED|Dose Level VII||0||
59524680|NCT02533674|75619775|FG001|COMPLETED|Dose Level VII||0||
59524681|NCT02533674|75619776|FG002|COMPLETED|Dose Level VII||0||
59524682|NCT02533674|75619777|FG003|COMPLETED|Dose Level VII||0||
59524683|NCT02533674|75619778|FG004|COMPLETED|Dose Level VII||0||
59524684|NCT02533674|75619779|FG005|COMPLETED|Dose Level VII||0||
59524685|NCT02533674|75619780|FG006|COMPLETED|Dose Level VII||0||
59524686|NCT02533674|75619781|FG007|COMPLETED|Dose Level VII||0||
59524687|NCT02533674|75619774|FG000|NOT COMPLETED|Dose Level VII||0||
59524688|NCT02533674|75619775|FG001|NOT COMPLETED|Dose Level VII||0||
59621414|NCT00151320|75732984|FG000|COMPLETED|Overall Study||76||
59621415|NCT00151320|75732984|FG000|NOT COMPLETED|Overall Study||0||
59809248|NCT00541970|75931410|FG002|STARTED|Month 48||240||
59809249|NCT00541970|75931411|FG003|STARTED|Month 48||239||
59809250|NCT00541970|75931408|FG000|COMPLETED|Month 48||169||
59809251|NCT00541970|75931409|FG001|COMPLETED|Month 48||168||
59809252|NCT00541970|75931410|FG002|COMPLETED|Month 48||167||
59809253|NCT00541970|75931411|FG003|COMPLETED|Month 48||164||
59809254|NCT00541970|75931408|FG000|NOT COMPLETED|Month 48||71||
59809255|NCT00541970|75931409|FG001|NOT COMPLETED|Month 48||73||
59809256|NCT00541970|75931410|FG002|NOT COMPLETED|Month 48||73||
59809257|NCT00541970|75931411|FG003|NOT COMPLETED|Month 48||75||
59809258|NCT00541970|75931408|FG000|STARTED|Month 60||240||
59809259|NCT00541970|75931409|FG001|STARTED|Month 60||241||
59809260|NCT00541970|75931410|FG002|STARTED|Month 60||240||
59809261|NCT00541970|75931411|FG003|STARTED|Month 60||239||
59809262|NCT00541970|75931408|FG000|COMPLETED|Month 60||162||
59964182|NCT02991859|76081932|FG007|STARTED|Period2, Escalation Phase2, Upto Day 91||2||
59964183|NCT02991859|76081933|FG008|STARTED|Period2, Escalation Phase2, Upto Day 91||2||
59964184|NCT02991859|76081934|FG009|STARTED|Period2, Escalation Phase2, Upto Day 91||2||
59524689|NCT02533674|75619776|FG002|NOT COMPLETED|Dose Level VII||0||
59524690|NCT02533674|75619777|FG003|NOT COMPLETED|Dose Level VII||0||
59524691|NCT02533674|75619778|FG004|NOT COMPLETED|Dose Level VII||0||
59524692|NCT02533674|75619779|FG005|NOT COMPLETED|Dose Level VII||0||
59621416|NCT00326196|75732991|FG000|STARTED|Overall Study||101||
59809263|NCT00541970|75931409|FG001|COMPLETED|Month 60||164||
59809264|NCT00541970|75931410|FG002|COMPLETED|Month 60||158||
59809265|NCT00541970|75931411|FG003|COMPLETED|Month 60||167||
59809266|NCT00541970|75931408|FG000|NOT COMPLETED|Month 60||78||
59809267|NCT00541970|75931409|FG001|NOT COMPLETED|Month 60||77||
59964185|NCT02991859|76081935|FG010|STARTED|Period2, Escalation Phase2, Upto Day 91||2||
59964186|NCT02991859|76081936|FG011|STARTED|Period2, Escalation Phase2, Upto Day 91||2||
59964187|NCT02991859|76081937|FG012|STARTED|Period2, Escalation Phase2, Upto Day 91||0||
59964188|NCT02991859|76081938|FG013|STARTED|Period2, Escalation Phase2, Upto Day 91||0||
59964189|NCT02991859|76081939|FG014|STARTED|Period2, Escalation Phase2, Upto Day 91||0||
59964190|NCT02991859|76081940|FG015|STARTED|Period2, Escalation Phase2, Upto Day 91||0||
59964191|NCT02991859|76081941|FG016|STARTED|Period2, Escalation Phase2, Upto Day 91||0||
59964192|NCT02991859|76081925|FG000|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2||
59964193|NCT02991859|76081926|FG001|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2||
59964194|NCT02991859|76081927|FG002|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2||
59964195|NCT02991859|76081928|FG003|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2||
59964196|NCT02991859|76081929|FG004|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2||
59964197|NCT02991859|76081930|FG005|COMPLETED|Period2, Escalation Phase2, Upto Day 91||1||
59964198|NCT02991859|76081931|FG006|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2||
59964199|NCT02991859|76081932|FG007|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2||
59964200|NCT02991859|76081933|FG008|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2||
59964201|NCT02991859|76081934|FG009|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2||
59964202|NCT02991859|76081935|FG010|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2||
59964203|NCT02991859|76081936|FG011|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2||
59964204|NCT02991859|76081937|FG012|COMPLETED|Period2, Escalation Phase2, Upto Day 91||0||
59964205|NCT02991859|76081938|FG013|COMPLETED|Period2, Escalation Phase2, Upto Day 91||0||
59964206|NCT02991859|76081939|FG014|COMPLETED|Period2, Escalation Phase2, Upto Day 91||0||
59964207|NCT02991859|76081940|FG015|COMPLETED|Period2, Escalation Phase2, Upto Day 91||0||
59964208|NCT02991859|76081941|FG016|COMPLETED|Period2, Escalation Phase2, Upto Day 91||0||
59964209|NCT02991859|76081925|FG000|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0||
59621417|NCT00326196|75732992|FG001|STARTED|Overall Study||97||
59621418|NCT00326196|75732991|FG000|COMPLETED|Overall Study||101||
59621419|NCT00326196|75732992|FG001|COMPLETED|Overall Study||97||
59621420|NCT00326196|75732991|FG000|NOT COMPLETED|Overall Study||0||
59621421|NCT00326196|75732992|FG001|NOT COMPLETED|Overall Study||0||
59621422|NCT00328770|75732998|FG000|STARTED|Overall Study||70||
59621423|NCT00328770|75732998|FG000|COMPLETED|Overall Study||70||
59621424|NCT00328770|75732998|FG000|NOT COMPLETED|Overall Study||0||
59621425|NCT04177680|75733003|FG000|STARTED|Overall Study||49||
59621426|NCT04177680|75733004|FG001|STARTED|Overall Study||51||
59621427|NCT04177680|75733003|FG000|COMPLETED|Overall Study||47||
59621428|NCT04177680|75733004|FG001|COMPLETED|Overall Study||48||
59621429|NCT04177680|75733003|FG000|NOT COMPLETED|Overall Study||2||
59621430|NCT04177680|75733004|FG001|NOT COMPLETED|Overall Study||3||
59621431|NCT00330876|75733010|FG000|STARTED|Overall Study||449||
59621432|NCT00330876|75733011|FG001|STARTED|Overall Study||90||
59621433|NCT00330876|75733010|FG000|COMPLETED|Overall Study||378||
59621434|NCT00330876|75733011|FG001|COMPLETED|Overall Study||77||
59621435|NCT00330876|75733010|FG000|NOT COMPLETED|Overall Study||71||
59621436|NCT00330876|75733011|FG001|NOT COMPLETED|Overall Study||13||
59621437|NCT00333606|75733019|FG000|STARTED|Overall Study||30||
59621438|NCT00333606|75733020|FG001|STARTED|Overall Study||30||
59621439|NCT00333606|75733019|FG000|COMPLETED|Overall Study||30||
59621440|NCT00333606|75733020|FG001|COMPLETED|Overall Study||30||
59621441|NCT00333606|75733019|FG000|NOT COMPLETED|Overall Study||0||
59621442|NCT00333606|75733020|FG001|NOT COMPLETED|Overall Study||0||
59621443|NCT00334074|75733028|FG000|STARTED|Overall Study||30||
59621444|NCT00334074|75733028|FG000|COMPLETED|Overall Study||30||
59621445|NCT00334074|75733028|FG000|NOT COMPLETED|Overall Study||0||
59621446|NCT00335478|75733033|FG000|STARTED|Overall Study||54||
59621447|NCT00335478|75733033|FG000|COMPLETED|Overall Study||30||
59621448|NCT00335478|75733033|FG000|NOT COMPLETED|Overall Study||24||
59621449|NCT02103816|75733037|FG000|STARTED|Overall Study||21||
59621450|NCT02103816|75733037|FG000|COMPLETED|Overall Study||13||
59621451|NCT02103816|75733037|FG000|NOT COMPLETED|Overall Study||8||
59621452|NCT00337350|75733043|FG000|STARTED|Overall Study||9||
59621453|NCT00337350|75733044|FG001|STARTED|Overall Study||11||
59621454|NCT00337350|75733043|FG000|COMPLETED|Overall Study||8||
59621455|NCT00337350|75733044|FG001|COMPLETED|Overall Study||10||
59621456|NCT00337350|75733043|FG000|NOT COMPLETED|Overall Study||1||
59621457|NCT00337350|75733044|FG001|NOT COMPLETED|Overall Study||1||
59621458|NCT00338598|75733052|FG000|STARTED|Overall Study||10||
59621459|NCT00338598|75733053|FG001|STARTED|Overall Study||10||
59621460|NCT00338598|75733052|FG000|COMPLETED|Overall Study||10||
59621461|NCT00338598|75733053|FG001|COMPLETED|Overall Study||8||
59964210|NCT02991859|76081926|FG001|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0||
59621462|NCT00338598|75733052|FG000|NOT COMPLETED|Overall Study||0||
59621463|NCT00338598|75733053|FG001|NOT COMPLETED|Overall Study||2||
59621464|NCT00338988|75733059|FG000|STARTED|Overall Study||44||
59621465|NCT00338988|75733059|FG000|COMPLETED|Overall Study||43||
59964211|NCT02991859|76081927|FG002|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0||
59964212|NCT02991859|76081928|FG003|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0||
59964213|NCT02991859|76081929|FG004|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0||
59964214|NCT02991859|76081930|FG005|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0||
59964215|NCT02991859|76081931|FG006|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0||
59964216|NCT02991859|76081932|FG007|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0||
59964217|NCT02991859|76081933|FG008|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0||
59964218|NCT02991859|76081934|FG009|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0||
59964219|NCT02991859|76081935|FG010|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0||
59964220|NCT02991859|76081936|FG011|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0||
59964221|NCT02991859|76081937|FG012|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0||
59964222|NCT02991859|76081938|FG013|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0||
59964223|NCT02991859|76081939|FG014|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0||
59964224|NCT02991859|76081940|FG015|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0||
59964225|NCT02991859|76081941|FG016|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0||
59964226|NCT02991859|76081925|FG000|STARTED|Period2, Escalation Phase3, Upto Day 98||2||
59964227|NCT02991859|76081926|FG001|STARTED|Period2, Escalation Phase3, Upto Day 98||2||
59964228|NCT02991859|76081927|FG002|STARTED|Period2, Escalation Phase3, Upto Day 98||2||
59964229|NCT02991859|76081928|FG003|STARTED|Period2, Escalation Phase3, Upto Day 98||2||
59964230|NCT02991859|76081929|FG004|STARTED|Period2, Escalation Phase3, Upto Day 98||2||
59964231|NCT02991859|76081930|FG005|STARTED|Period2, Escalation Phase3, Upto Day 98||1||
59964232|NCT02991859|76081931|FG006|STARTED|Period2, Escalation Phase3, Upto Day 98||2||
59964233|NCT02991859|76081932|FG007|STARTED|Period2, Escalation Phase3, Upto Day 98||2||
59964234|NCT02991859|76081933|FG008|STARTED|Period2, Escalation Phase3, Upto Day 98||2||
59964235|NCT02991859|76081934|FG009|STARTED|Period2, Escalation Phase3, Upto Day 98||2||
59964236|NCT02991859|76081935|FG010|STARTED|Period2, Escalation Phase3, Upto Day 98||2||
59809268|NCT00541970|75931410|FG002|NOT COMPLETED|Month 60||82||
59809269|NCT00541970|75931411|FG003|NOT COMPLETED|Month 60||72||
59809270|NCT00687323|75931421|FG000|STARTED|Overall Study|Number of screened participants|195||
59809271|NCT00687323|75931421|FG000|Received Treatment|Overall Study||47||
59809272|NCT00687323|75931421|FG000|COMPLETED|Overall Study|Number of participants alive at one year|15||
59809273|NCT00687323|75931421|FG000|NOT COMPLETED|Overall Study||180||
59809274|NCT04864236|75931427|FG000|STARTED|Overall Study||39||
59809275|NCT04864236|75931428|FG001|STARTED|Overall Study||40||
59809276|NCT04864236|75931427|FG000|COMPLETED|Overall Study||39||
59809277|NCT04864236|75931428|FG001|COMPLETED|Overall Study||40||
59809278|NCT04864236|75931427|FG000|NOT COMPLETED|Overall Study||0||
59809279|NCT04864236|75931428|FG001|NOT COMPLETED|Overall Study||0||
59809280|NCT03899064|75931438|FG000|STARTED|Overall Study||58||
59809281|NCT03899064|75931438|FG000|MC2-01 Cream, Irradiation|Overall Study||58||
59809282|NCT03899064|75931438|FG000|MC2-01 Cream, No Irradiation|Overall Study||58||
59809283|NCT03899064|75931438|FG000|MC2-01 Vehicle, Irradiation|Overall Study||58||
59809284|NCT03899064|75931438|FG000|MC2-01 Vehicle, no Irradiation|Overall Study||58||
59809285|NCT03899064|75931438|FG000|Control, Irradiation|Overall Study||58||
59809286|NCT03899064|75931438|FG000|COMPLETED|Overall Study||51||
59809287|NCT03899064|75931438|FG000|NOT COMPLETED|Overall Study||7||
59809288|NCT03902574|75931445|FG000|STARTED|Overall Study||7||
59809289|NCT03902574|75931446|FG001|STARTED|Overall Study||7||
59809290|NCT03902574|75931447|FG002|STARTED|Overall Study||7||
59809291|NCT03902574|75931445|FG000|COMPLETED|Overall Study||7||
59809292|NCT03902574|75931446|FG001|COMPLETED|Overall Study||7||
59809293|NCT03902574|75931447|FG002|COMPLETED|Overall Study||6||
59809294|NCT03902574|75931445|FG000|NOT COMPLETED|Overall Study||0||
59809295|NCT03902574|75931446|FG001|NOT COMPLETED|Overall Study||0||
59809296|NCT03902574|75931447|FG002|NOT COMPLETED|Overall Study||1||
59809297|NCT01004874|75931455|FG000|STARTED|Overall Study||80||
59809298|NCT01004874|75931455|FG000|COMPLETED|Overall Study||80||
59809299|NCT01004874|75931455|FG000|NOT COMPLETED|Overall Study||0||
59809300|NCT00542828|75931459|FG000|STARTED|Overall Study|Number of participants enrolled in the study; of the 16 enrolled, 14 received study treatment.|16||
59809301|NCT00542828|75931459|FG000|COMPLETED|Overall Study|Number of participants who completed the 12-month study period.|3||
59809302|NCT00542828|75931459|FG000|NOT COMPLETED|Overall Study||13||
59809303|NCT00090103|75931466|FG000|STARTED|Four-Year Double-Blind Treatment Period||1610||
59809304|NCT00090103|75931467|FG001|STARTED|Four-Year Double-Blind Treatment Period||1623||
59809305|NCT00090103|75931468|FG002|STARTED|Four-Year Double-Blind Treatment Period||1611||
59809306|NCT00090103|75931466|FG000|COMPLETED|Four-Year Double-Blind Treatment Period||1113||
59809307|NCT00090103|75931467|FG001|COMPLETED|Four-Year Double-Blind Treatment Period||1093||
59809308|NCT00090103|75931468|FG002|COMPLETED|Four-Year Double-Blind Treatment Period||989||
59809309|NCT00090103|75931466|FG000|NOT COMPLETED|Four-Year Double-Blind Treatment Period||497||
59964237|NCT02991859|76081936|FG011|STARTED|Period2, Escalation Phase3, Upto Day 98||2||
59964238|NCT02991859|76081937|FG012|STARTED|Period2, Escalation Phase3, Upto Day 98||0||
59964239|NCT02991859|76081938|FG013|STARTED|Period2, Escalation Phase3, Upto Day 98||0||
59964240|NCT02991859|76081939|FG014|STARTED|Period2, Escalation Phase3, Upto Day 98||0||
59964241|NCT02991859|76081940|FG015|STARTED|Period2, Escalation Phase3, Upto Day 98||0||
59964242|NCT02991859|76081941|FG016|STARTED|Period2, Escalation Phase3, Upto Day 98||0||
59809310|NCT00090103|75931467|FG001|NOT COMPLETED|Four-Year Double-Blind Treatment Period||530||
59964243|NCT02991859|76081925|FG000|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2||
60074221|NCT01802216|76189660|FG001|STARTED|Baseline||34||
59524693|NCT02533674|75619780|FG006|NOT COMPLETED|Dose Level VII||16||
59524694|NCT02533674|75619781|FG007|NOT COMPLETED|Dose Level VII||0||
59524695|NCT02533674|75619774|FG000|STARTED|Dose Level VIII||0||
59524696|NCT02533674|75619775|FG001|STARTED|Dose Level VIII||0||
59524697|NCT02533674|75619776|FG002|STARTED|Dose Level VIII||0||
59524698|NCT02533674|75619777|FG003|STARTED|Dose Level VIII||0||
59524699|NCT02533674|75619778|FG004|STARTED|Dose Level VIII||0||
59524700|NCT02533674|75619779|FG005|STARTED|Dose Level VIII||0||
59524701|NCT02533674|75619780|FG006|STARTED|Dose Level VIII||0||
59524702|NCT02533674|75619781|FG007|STARTED|Dose Level VIII||6||
59524703|NCT02533674|75619774|FG000|COMPLETED|Dose Level VIII||0||
59524704|NCT02533674|75619775|FG001|COMPLETED|Dose Level VIII||0||
59524705|NCT02533674|75619776|FG002|COMPLETED|Dose Level VIII||0||
59524706|NCT02533674|75619777|FG003|COMPLETED|Dose Level VIII||0||
59524707|NCT02533674|75619778|FG004|COMPLETED|Dose Level VIII||0||
59524708|NCT02533674|75619779|FG005|COMPLETED|Dose Level VIII||0||
59524709|NCT02533674|75619780|FG006|COMPLETED|Dose Level VIII||0||
59524710|NCT02533674|75619781|FG007|COMPLETED|Dose Level VIII||0||
59524711|NCT02533674|75619774|FG000|NOT COMPLETED|Dose Level VIII||0||
59524712|NCT02533674|75619775|FG001|NOT COMPLETED|Dose Level VIII||0||
59524713|NCT02533674|75619776|FG002|NOT COMPLETED|Dose Level VIII||0||
59524714|NCT02533674|75619777|FG003|NOT COMPLETED|Dose Level VIII||0||
59524715|NCT02533674|75619778|FG004|NOT COMPLETED|Dose Level VIII||0||
59524716|NCT02533674|75619779|FG005|NOT COMPLETED|Dose Level VIII||0||
59524717|NCT02533674|75619780|FG006|NOT COMPLETED|Dose Level VIII||0||
59524718|NCT02533674|75619781|FG007|NOT COMPLETED|Dose Level VIII||6||
59524719|NCT02540850|75619802|FG000|STARTED|Overall Study||360||
59524720|NCT02540850|75619803|FG001|STARTED|Overall Study||396||
59524721|NCT02540850|75619804|FG002|STARTED|Overall Study||444||
59524722|NCT02540850|75619802|FG000|COMPLETED|Overall Study||291||
59524723|NCT02540850|75619803|FG001|COMPLETED|Overall Study||330||
59524724|NCT02540850|75619804|FG002|COMPLETED|Overall Study||410||
59524725|NCT02540850|75619802|FG000|NOT COMPLETED|Overall Study||69||
59524726|NCT02540850|75619803|FG001|NOT COMPLETED|Overall Study||66||
59524727|NCT02540850|75619804|FG002|NOT COMPLETED|Overall Study||34||
59524728|NCT01662024|75619812|FG000|STARTED|Overall Study||20||
59524729|NCT01662024|75619812|FG000|COMPLETED|Overall Study||15||
59524730|NCT01662024|75619812|FG000|NOT COMPLETED|Overall Study||5||
59524731|NCT01049945|75619821|FG000|STARTED|Overall Study||3||
59524732|NCT01049945|75619822|FG001|STARTED|Overall Study||6||
59524733|NCT01049945|75619823|FG002|STARTED|Overall Study||3||
59524734|NCT01049945|75619824|FG003|STARTED|Overall Study||6||
59524735|NCT01049945|75619825|FG004|STARTED|Overall Study||3||
59524736|NCT01049945|75619826|FG005|STARTED|Overall Study||49||
59524737|NCT01049945|75619821|FG000|COMPLETED|Overall Study||3||
59621466|NCT00338988|75733059|FG000|NOT COMPLETED|Overall Study||1||
59621467|NCT00343044|75733064|FG000|STARTED|Overall Study||40||
60074222|NCT01802216|76189659|FG000|COMPLETED|Baseline||17||
60074223|NCT01802216|76189660|FG001|COMPLETED|Baseline||34||
60074224|NCT01802216|76189659|FG000|NOT COMPLETED|Baseline||0||
60074225|NCT01802216|76189660|FG001|NOT COMPLETED|Baseline||0||
60074226|NCT01802216|76189659|FG000|STARTED|4 Month Visit||17||
60074227|NCT01802216|76189660|FG001|STARTED|4 Month Visit||34||
60074228|NCT01802216|76189659|FG000|COMPLETED|4 Month Visit||14||
60074229|NCT01802216|76189660|FG001|COMPLETED|4 Month Visit||30||
60074230|NCT01802216|76189659|FG000|NOT COMPLETED|4 Month Visit||3||
60074231|NCT01802216|76189660|FG001|NOT COMPLETED|4 Month Visit||4||
60074232|NCT01802216|76189659|FG000|STARTED|8 Month Visit||17||
60074233|NCT01802216|76189660|FG001|STARTED|8 Month Visit||34||
60074234|NCT01802216|76189659|FG000|COMPLETED|8 Month Visit||14||
60074235|NCT01802216|76189660|FG001|COMPLETED|8 Month Visit||29||
60074236|NCT01802216|76189659|FG000|NOT COMPLETED|8 Month Visit||3||
60074237|NCT01802216|76189660|FG001|NOT COMPLETED|8 Month Visit||5||
60074238|NCT01802216|76189659|FG000|STARTED|12 Month Visit||17||
60074239|NCT01802216|76189660|FG001|STARTED|12 Month Visit||34||
60074240|NCT01802216|76189659|FG000|COMPLETED|12 Month Visit||14||
60074241|NCT01802216|76189660|FG001|COMPLETED|12 Month Visit||30||
60074242|NCT01802216|76189659|FG000|NOT COMPLETED|12 Month Visit||3||
60074243|NCT01802216|76189660|FG001|NOT COMPLETED|12 Month Visit||4||
60074244|NCT01808144|76189668|FG000|STARTED|Overall Study||97||
59524738|NCT01049945|75619822|FG001|COMPLETED|Overall Study||6||
59621468|NCT00343044|75733064|FG000|COMPLETED|Overall Study||40||
59524739|NCT01049945|75619823|FG002|COMPLETED|Overall Study||3||
59524740|NCT01049945|75619824|FG003|COMPLETED|Overall Study||6||
59524741|NCT01049945|75619825|FG004|COMPLETED|Overall Study||3||
59524742|NCT01049945|75619826|FG005|COMPLETED|Overall Study||49||
59524743|NCT01049945|75619821|FG000|NOT COMPLETED|Overall Study||0||
59524744|NCT01049945|75619822|FG001|NOT COMPLETED|Overall Study||0||
59524745|NCT01049945|75619823|FG002|NOT COMPLETED|Overall Study||0||
59524746|NCT01049945|75619824|FG003|NOT COMPLETED|Overall Study||0||
59524747|NCT01049945|75619825|FG004|NOT COMPLETED|Overall Study||0||
59524748|NCT01049945|75619826|FG005|NOT COMPLETED|Overall Study||0||
59524749|NCT01050647|75619842|FG000|STARTED|Overall Study||10||
59524750|NCT01050647|75619843|FG001|STARTED|Overall Study||11||
60074245|NCT01808144|76189669|FG001|STARTED|Overall Study||99||
60074246|NCT01808144|76189668|FG000|COMPLETED|Overall Study||57||
59809311|NCT00090103|75931468|FG002|NOT COMPLETED|Four-Year Double-Blind Treatment Period||622||
59809312|NCT00090103|75931466|FG000|STARTED|16-Week Safety Follow-up Period|Some par. didn't enter the Follow-up phase or dropped out before completing the treatment phase.|1598||
59809313|NCT00090103|75931467|FG001|STARTED|16-Week Safety Follow-up Period|Some par. didn't enter the Follow-up phase or dropped out before completing the treatment phase.|1615||
59964244|NCT02991859|76081926|FG001|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2||
59964245|NCT02991859|76081927|FG002|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2||
59964246|NCT02991859|76081928|FG003|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2||
59964247|NCT02991859|76081929|FG004|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2||
59964248|NCT02991859|76081930|FG005|COMPLETED|Period2, Escalation Phase3, Upto Day 98||1||
59964249|NCT02991859|76081931|FG006|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2||
59964250|NCT02991859|76081932|FG007|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2||
59964251|NCT02991859|76081933|FG008|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2||
59964252|NCT02991859|76081934|FG009|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2||
59964253|NCT02991859|76081935|FG010|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2||
59964254|NCT02991859|76081936|FG011|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2||
59964255|NCT02991859|76081937|FG012|COMPLETED|Period2, Escalation Phase3, Upto Day 98||0||
59964256|NCT02991859|76081938|FG013|COMPLETED|Period2, Escalation Phase3, Upto Day 98||0||
59964257|NCT02991859|76081939|FG014|COMPLETED|Period2, Escalation Phase3, Upto Day 98||0||
59964258|NCT02991859|76081940|FG015|COMPLETED|Period2, Escalation Phase3, Upto Day 98||0||
59964259|NCT02991859|76081941|FG016|COMPLETED|Period2, Escalation Phase3, Upto Day 98||0||
59964260|NCT02991859|76081925|FG000|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0||
59964261|NCT02991859|76081926|FG001|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0||
59964262|NCT02991859|76081927|FG002|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0||
59964263|NCT02991859|76081928|FG003|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0||
59964264|NCT02991859|76081929|FG004|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0||
59964265|NCT02991859|76081930|FG005|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0||
59964266|NCT02991859|76081931|FG006|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0||
59964267|NCT02991859|76081932|FG007|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0||
59809314|NCT00090103|75931468|FG002|STARTED|16-Week Safety Follow-up Period|Some par. didn't enter the Follow-up phase or dropped out before completing the treatment phase.|1600||
59809315|NCT00090103|75931466|FG000|COMPLETED|16-Week Safety Follow-up Period||1224||
59964268|NCT02991859|76081933|FG008|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0||
59964269|NCT02991859|76081934|FG009|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0||
59964270|NCT02991859|76081935|FG010|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0||
59964271|NCT02991859|76081936|FG011|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0||
59964272|NCT02991859|76081937|FG012|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0||
59964273|NCT02991859|76081938|FG013|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0||
59964274|NCT02991859|76081939|FG014|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0||
59964275|NCT02991859|76081940|FG015|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0||
59964276|NCT02991859|76081941|FG016|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0||
59964277|NCT02991859|76081925|FG000|STARTED|Period2, Escalation Phase4, Upto Day 105||2||
59964278|NCT02991859|76081926|FG001|STARTED|Period2, Escalation Phase4, Upto Day 105||2||
59964279|NCT02991859|76081927|FG002|STARTED|Period2, Escalation Phase4, Upto Day 105||2||
59964280|NCT02991859|76081928|FG003|STARTED|Period2, Escalation Phase4, Upto Day 105||2||
59964281|NCT02991859|76081929|FG004|STARTED|Period2, Escalation Phase4, Upto Day 105||2||
59964282|NCT02991859|76081930|FG005|STARTED|Period2, Escalation Phase4, Upto Day 105||1||
59964283|NCT02991859|76081931|FG006|STARTED|Period2, Escalation Phase4, Upto Day 105||2||
59964284|NCT02991859|76081932|FG007|STARTED|Period2, Escalation Phase4, Upto Day 105||2||
59964285|NCT02991859|76081933|FG008|STARTED|Period2, Escalation Phase4, Upto Day 105||2||
59964286|NCT02991859|76081934|FG009|STARTED|Period2, Escalation Phase4, Upto Day 105||2||
59964287|NCT02991859|76081935|FG010|STARTED|Period2, Escalation Phase4, Upto Day 105||2||
59964288|NCT02991859|76081936|FG011|STARTED|Period2, Escalation Phase4, Upto Day 105||2||
59964289|NCT02991859|76081937|FG012|STARTED|Period2, Escalation Phase4, Upto Day 105||0||
59964290|NCT02991859|76081938|FG013|STARTED|Period2, Escalation Phase4, Upto Day 105||0||
59964291|NCT02991859|76081939|FG014|STARTED|Period2, Escalation Phase4, Upto Day 105||0||
59964292|NCT02991859|76081940|FG015|STARTED|Period2, Escalation Phase4, Upto Day 105||0||
59809316|NCT00090103|75931467|FG001|COMPLETED|16-Week Safety Follow-up Period||1205||
59809317|NCT00090103|75931468|FG002|COMPLETED|16-Week Safety Follow-up Period||1143||
59809318|NCT00090103|75931466|FG000|NOT COMPLETED|16-Week Safety Follow-up Period||374||
59809319|NCT00090103|75931467|FG001|NOT COMPLETED|16-Week Safety Follow-up Period||410||
59809320|NCT00090103|75931468|FG002|NOT COMPLETED|16-Week Safety Follow-up Period||457||
59809321|NCT00087607|75931478|FG000|STARTED|Overall Study||192||
59809322|NCT00087607|75931479|FG001|STARTED|Overall Study||193||
59964293|NCT02991859|76081941|FG016|STARTED|Period2, Escalation Phase4, Upto Day 105||0||
59964294|NCT02991859|76081925|FG000|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2||
59964295|NCT02991859|76081926|FG001|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2||
59964296|NCT02991859|76081927|FG002|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2||
59964297|NCT02991859|76081928|FG003|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2||
59964298|NCT02991859|76081929|FG004|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2||
59964299|NCT02991859|76081930|FG005|COMPLETED|Period2, Escalation Phase4, Upto Day 105||1||
59964300|NCT02991859|76081931|FG006|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2||
59964301|NCT02991859|76081932|FG007|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2||
59964302|NCT02991859|76081933|FG008|COMPLETED|Period2, Escalation Phase4, Upto Day 105||1||
59964303|NCT02991859|76081934|FG009|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2||
59964304|NCT02991859|76081935|FG010|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2||
59964305|NCT02991859|76081936|FG011|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2||
59964306|NCT02991859|76081937|FG012|COMPLETED|Period2, Escalation Phase4, Upto Day 105||0||
59964307|NCT02991859|76081938|FG013|COMPLETED|Period2, Escalation Phase4, Upto Day 105||0||
59964308|NCT02991859|76081939|FG014|COMPLETED|Period2, Escalation Phase4, Upto Day 105||0||
59964309|NCT02991859|76081940|FG015|COMPLETED|Period2, Escalation Phase4, Upto Day 105||0||
59964310|NCT02991859|76081941|FG016|COMPLETED|Period2, Escalation Phase4, Upto Day 105||0||
59964311|NCT02991859|76081925|FG000|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0||
59809323|NCT00087607|75931478|FG000|COMPLETED|Overall Study||70||
59809324|NCT00087607|75931479|FG001|COMPLETED|Overall Study||71||
59809325|NCT00087607|75931478|FG000|NOT COMPLETED|Overall Study||122||
59964312|NCT02991859|76081926|FG001|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0||
59964313|NCT02991859|76081927|FG002|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0||
59964314|NCT02991859|76081928|FG003|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0||
59964315|NCT02991859|76081929|FG004|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0||
59964316|NCT02991859|76081930|FG005|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0||
59964317|NCT02991859|76081931|FG006|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0||
59964318|NCT02991859|76081932|FG007|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0||
59964319|NCT02991859|76081933|FG008|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||1||
59964320|NCT02991859|76081934|FG009|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0||
60074247|NCT01808144|76189669|FG001|COMPLETED|Overall Study||51||
60074248|NCT01808144|76189668|FG000|NOT COMPLETED|Overall Study||40||
60074249|NCT01808144|76189669|FG001|NOT COMPLETED|Overall Study||48||
59809326|NCT00087607|75931479|FG001|NOT COMPLETED|Overall Study||122||
59809327|NCT00069823|75931491|FG000|STARTED|Overall Study|The design was for 200 participants per group, the study did not exactly meet the design.|199||
59809328|NCT00069823|75931492|FG001|STARTED|Overall Study|The design was for 200 participants per group, the study did not exactly meet the design.|203||
59809329|NCT00069823|75931491|FG000|COMPLETED|Overall Study||193||
59809330|NCT00069823|75931492|FG001|COMPLETED|Overall Study||200||
59809331|NCT00069823|75931491|FG000|NOT COMPLETED|Overall Study||6||
59809332|NCT00069823|75931492|FG001|NOT COMPLETED|Overall Study||3||
59809333|NCT01088815|75931498|FG000|STARTED|Overall Study||72||
59809334|NCT01088815|75931498|FG000|COMPLETED|Overall Study||72||
59809335|NCT01088815|75931498|FG000|NOT COMPLETED|Overall Study||0||
59809336|NCT00086515|75931504|FG000|STARTED|Phase A (Weeks 0-24)||464||
59809337|NCT00086515|75931505|FG001|STARTED|Phase A (Weeks 0-24)||237||
59809338|NCT00086515|75931504|FG000|COMPLETED|Phase A (Weeks 0-24)||415||
59809339|NCT00086515|75931505|FG001|COMPLETED|Phase A (Weeks 0-24)||192||
59809340|NCT00086515|75931504|FG000|NOT COMPLETED|Phase A (Weeks 0-24)||49||
59809341|NCT00086515|75931505|FG001|NOT COMPLETED|Phase A (Weeks 0-24)||45||
59809342|NCT00086515|75931504|FG000|STARTED|Phase A to Phase B Transition Period||415||
59809343|NCT00086515|75931505|FG001|STARTED|Phase A to Phase B Transition Period||192||
59809344|NCT00086515|75931504|FG000|COMPLETED|Phase A to Phase B Transition Period||391||
59809345|NCT00086515|75931505|FG001|COMPLETED|Phase A to Phase B Transition Period||164||
59809346|NCT00086515|75931504|FG000|NOT COMPLETED|Phase A to Phase B Transition Period||24||
59809347|NCT00086515|75931505|FG001|NOT COMPLETED|Phase A to Phase B Transition Period||28||
59809348|NCT00086515|75931504|FG000|STARTED|Phase B (Weeks 24-104)||391||
59809349|NCT00086515|75931505|FG001|STARTED|Phase B (Weeks 24-104)||164||
59809350|NCT00086515|75931504|FG000|COMPLETED|Phase B (Weeks 24-104)||201||
59809351|NCT00086515|75931505|FG001|COMPLETED|Phase B (Weeks 24-104)||109||
59809352|NCT00086515|75931504|FG000|NOT COMPLETED|Phase B (Weeks 24-104)||190||
59809353|NCT00086515|75931505|FG001|NOT COMPLETED|Phase B (Weeks 24-104)||55||
59809354|NCT00541658|75931514|FG000|STARTED|Overall Study||308||
59809355|NCT00541658|75931515|FG001|STARTED|Overall Study||307||
59809356|NCT00541658|75931516|FG002|STARTED|Overall Study||308||
59809357|NCT00541658|75931514|FG000|ITT Population|Overall Study||307||
59809358|NCT00541658|75931515|FG001|ITT Population|Overall Study||307||
59809359|NCT00541658|75931516|FG002|ITT Population|Overall Study||308||
59809360|NCT00541658|75931514|FG000|COMPLETED|Overall Study||248||
59809361|NCT00541658|75931515|FG001|COMPLETED|Overall Study||234||
59809362|NCT00541658|75931516|FG002|COMPLETED|Overall Study||240||
59809363|NCT00541658|75931514|FG000|NOT COMPLETED|Overall Study||60||
59809364|NCT00541658|75931515|FG001|NOT COMPLETED|Overall Study||73||
59809365|NCT00541658|75931516|FG002|NOT COMPLETED|Overall Study||68||
59809366|NCT04229888|75931526|FG000|STARTED|Overall Study||14|All 14 subjects total received both treatments|
59809367|NCT04229888|75931526|FG000|COMPLETED|Overall Study||14||
59809368|NCT04229888|75931526|FG000|NOT COMPLETED|Overall Study||0||
59809369|NCT04236284|75931533|FG000|STARTED|Overall Study||21||
59964321|NCT02991859|76081935|FG010|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0||
59964322|NCT02991859|76081936|FG011|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0||
59964323|NCT02991859|76081937|FG012|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0||
59964324|NCT02991859|76081938|FG013|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0||
59964325|NCT02991859|76081939|FG014|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0||
59964326|NCT02991859|76081940|FG015|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0||
59964327|NCT02991859|76081941|FG016|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0||
59964328|NCT02991859|76081925|FG000|STARTED|Period2,Escalation Phase5,Upto Day 112||2||
59964329|NCT02991859|76081926|FG001|STARTED|Period2,Escalation Phase5,Upto Day 112||2||
59964330|NCT02991859|76081927|FG002|STARTED|Period2,Escalation Phase5,Upto Day 112||2||
59964331|NCT02991859|76081928|FG003|STARTED|Period2,Escalation Phase5,Upto Day 112||2||
59964332|NCT02991859|76081929|FG004|STARTED|Period2,Escalation Phase5,Upto Day 112||2||
59964333|NCT02991859|76081930|FG005|STARTED|Period2,Escalation Phase5,Upto Day 112||1||
59964334|NCT02991859|76081931|FG006|STARTED|Period2,Escalation Phase5,Upto Day 112||2||
59964335|NCT02991859|76081932|FG007|STARTED|Period2,Escalation Phase5,Upto Day 112||2||
59964336|NCT02991859|76081933|FG008|STARTED|Period2,Escalation Phase5,Upto Day 112||1||
59964337|NCT02991859|76081934|FG009|STARTED|Period2,Escalation Phase5,Upto Day 112||2||
59964338|NCT02991859|76081935|FG010|STARTED|Period2,Escalation Phase5,Upto Day 112||2||
59964339|NCT02991859|76081936|FG011|STARTED|Period2,Escalation Phase5,Upto Day 112||2||
59964340|NCT02991859|76081937|FG012|STARTED|Period2,Escalation Phase5,Upto Day 112||0||
59964341|NCT02991859|76081938|FG013|STARTED|Period2,Escalation Phase5,Upto Day 112||0||
59964342|NCT02991859|76081939|FG014|STARTED|Period2,Escalation Phase5,Upto Day 112||0||
59964343|NCT02991859|76081940|FG015|STARTED|Period2,Escalation Phase5,Upto Day 112||0||
59964344|NCT02991859|76081941|FG016|STARTED|Period2,Escalation Phase5,Upto Day 112||0||
59964345|NCT02991859|76081925|FG000|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2||
59964346|NCT02991859|76081926|FG001|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2||
59964347|NCT02991859|76081927|FG002|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2||
59964348|NCT02991859|76081928|FG003|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2||
59964349|NCT02991859|76081929|FG004|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2||
59964350|NCT02991859|76081930|FG005|COMPLETED|Period2,Escalation Phase5,Upto Day 112||1||
59964351|NCT02991859|76081931|FG006|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2||
59964352|NCT02991859|76081932|FG007|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2||
59964353|NCT02991859|76081933|FG008|COMPLETED|Period2,Escalation Phase5,Upto Day 112||1||
59964354|NCT02991859|76081934|FG009|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2||
59964355|NCT02991859|76081935|FG010|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2||
59964356|NCT02991859|76081936|FG011|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2||
59964357|NCT02991859|76081937|FG012|COMPLETED|Period2,Escalation Phase5,Upto Day 112||0||
59964358|NCT02991859|76081938|FG013|COMPLETED|Period2,Escalation Phase5,Upto Day 112||0||
59809370|NCT04236284|75931533|FG000|Completed tDCS|Overall Study||16||
59809371|NCT04236284|75931533|FG000|Completed Prolonged Exposure Therapy|Overall Study||14||
59809372|NCT04236284|75931533|FG000|COMPLETED|Overall Study||14||
59809373|NCT04236284|75931533|FG000|NOT COMPLETED|Overall Study||7||
59809374|NCT03907280|75931540|FG000|STARTED|Treatment Period 1 + Washout Period 1||4|= Randomized to treatment sequence|
59809375|NCT03907280|75931541|FG001|STARTED|Treatment Period 1 + Washout Period 1||4|= Randomized to treatment sequence|
59809376|NCT03907280|75931542|FG002|STARTED|Treatment Period 1 + Washout Period 1||4|= Randomized to treatment sequence|
59809377|NCT03907280|75931540|FG000|Treated With BI 1265162|Treatment Period 1 + Washout Period 1||4||
59621469|NCT00343044|75733064|FG000|NOT COMPLETED|Overall Study||0||
59621470|NCT00344370|75733070|FG000|STARTED|Overall Study||143||
59621471|NCT00344370|75733071|FG001|STARTED|Overall Study||71||
59809378|NCT03907280|75931541|FG001|Treated With BI 1265162|Treatment Period 1 + Washout Period 1||4||
59809379|NCT03907280|75931542|FG002|Treated With BI 1265162|Treatment Period 1 + Washout Period 1||4||
59809380|NCT03907280|75931540|FG000|COMPLETED|Treatment Period 1 + Washout Period 1||4||
59809381|NCT03907280|75931541|FG001|COMPLETED|Treatment Period 1 + Washout Period 1||4||
59809382|NCT03907280|75931542|FG002|COMPLETED|Treatment Period 1 + Washout Period 1||4||
59809383|NCT03907280|75931540|FG000|NOT COMPLETED|Treatment Period 1 + Washout Period 1||0||
59809384|NCT03907280|75931541|FG001|NOT COMPLETED|Treatment Period 1 + Washout Period 1||0||
59809385|NCT03907280|75931542|FG002|NOT COMPLETED|Treatment Period 1 + Washout Period 1||0||
59809386|NCT03907280|75931540|FG000|STARTED|Treatment Period 2 + Washout Period 2||4|= Randomized to treatment sequence|
59809387|NCT03907280|75931541|FG001|STARTED|Treatment Period 2 + Washout Period 2||4|= Randomized to treatment sequence|
59964359|NCT02991859|76081939|FG014|COMPLETED|Period2,Escalation Phase5,Upto Day 112||0||
59809388|NCT03907280|75931542|FG002|STARTED|Treatment Period 2 + Washout Period 2||4|= Randomized to treatment sequence|
59809389|NCT03907280|75931540|FG000|Treated With BI 1265162|Treatment Period 2 + Washout Period 2||4||
59809390|NCT03907280|75931541|FG001|Treated With BI 1265162|Treatment Period 2 + Washout Period 2||4||
59809391|NCT03907280|75931542|FG002|Treated With BI 1265162|Treatment Period 2 + Washout Period 2||4||
59809392|NCT03907280|75931540|FG000|COMPLETED|Treatment Period 2 + Washout Period 2||4||
59809393|NCT03907280|75931541|FG001|COMPLETED|Treatment Period 2 + Washout Period 2||4||
59964360|NCT02991859|76081940|FG015|COMPLETED|Period2,Escalation Phase5,Upto Day 112||0||
59621472|NCT00344370|75733070|FG000|COMPLETED|Overall Study||128||
59809394|NCT03907280|75931542|FG002|COMPLETED|Treatment Period 2 + Washout Period 2||4||
59809395|NCT03907280|75931540|FG000|NOT COMPLETED|Treatment Period 2 + Washout Period 2||0||
59809396|NCT03907280|75931541|FG001|NOT COMPLETED|Treatment Period 2 + Washout Period 2||0||
59809397|NCT03907280|75931542|FG002|NOT COMPLETED|Treatment Period 2 + Washout Period 2||0||
59809398|NCT03907280|75931540|FG000|STARTED|Treatment Period 3 + Washout Period 3||4|= Randomized to treatment sequence|
59809399|NCT03907280|75931541|FG001|STARTED|Treatment Period 3 + Washout Period 3||4|= Randomized to treatment sequence|
59809400|NCT03907280|75931542|FG002|STARTED|Treatment Period 3 + Washout Period 3||4|= Randomized to treatment sequence|
59809401|NCT03907280|75931540|FG000|Treated With BI 1265162|Treatment Period 3 + Washout Period 3||4||
59809402|NCT03907280|75931541|FG001|Treated With BI 1265162|Treatment Period 3 + Washout Period 3||3||
59964361|NCT02991859|76081941|FG016|COMPLETED|Period2,Escalation Phase5,Upto Day 112||0||
59964362|NCT02991859|76081925|FG000|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0||
59964363|NCT02991859|76081926|FG001|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0||
59964364|NCT02991859|76081927|FG002|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0||
59964365|NCT02991859|76081928|FG003|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0||
59964366|NCT02991859|76081929|FG004|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0||
59964367|NCT02991859|76081930|FG005|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0||
59964368|NCT02991859|76081931|FG006|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0||
59964369|NCT02991859|76081932|FG007|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0||
59964370|NCT02991859|76081933|FG008|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0||
59964371|NCT02991859|76081934|FG009|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0||
59964372|NCT02991859|76081935|FG010|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0||
59964373|NCT02991859|76081936|FG011|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0||
59964374|NCT02991859|76081937|FG012|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0||
59964375|NCT02991859|76081938|FG013|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0||
59809403|NCT03907280|75931542|FG002|Treated With BI 1265162|Treatment Period 3 + Washout Period 3||4||
59809404|NCT03907280|75931540|FG000|COMPLETED|Treatment Period 3 + Washout Period 3||4||
59809405|NCT03907280|75931541|FG001|COMPLETED|Treatment Period 3 + Washout Period 3||3||
59809406|NCT03907280|75931542|FG002|COMPLETED|Treatment Period 3 + Washout Period 3||4||
59809407|NCT03907280|75931540|FG000|NOT COMPLETED|Treatment Period 3 + Washout Period 3||0||
59809408|NCT03907280|75931541|FG001|NOT COMPLETED|Treatment Period 3 + Washout Period 3||1||
59809409|NCT03907280|75931542|FG002|NOT COMPLETED|Treatment Period 3 + Washout Period 3||0||
59809410|NCT03907280|75931540|FG000|STARTED|Treatment Period 4: Fixed Treatment T3||4|= Randomized to treatment sequence|
59809411|NCT03907280|75931541|FG001|STARTED|Treatment Period 4: Fixed Treatment T3||4|= Randomized to treatment sequence|
59809412|NCT03907280|75931542|FG002|STARTED|Treatment Period 4: Fixed Treatment T3||4|= Randomized to treatment sequence|
59809413|NCT03907280|75931540|FG000|Treated With BI 1265162|Treatment Period 4: Fixed Treatment T3||4||
59809414|NCT03907280|75931541|FG001|Treated With BI 1265162|Treatment Period 4: Fixed Treatment T3||4||
59809415|NCT03907280|75931542|FG002|Treated With BI 1265162|Treatment Period 4: Fixed Treatment T3||4||
59809416|NCT03907280|75931540|FG000|COMPLETED|Treatment Period 4: Fixed Treatment T3||4||
59809417|NCT03907280|75931541|FG001|COMPLETED|Treatment Period 4: Fixed Treatment T3||4||
59809418|NCT03907280|75931542|FG002|COMPLETED|Treatment Period 4: Fixed Treatment T3||4||
59809419|NCT03907280|75931540|FG000|NOT COMPLETED|Treatment Period 4: Fixed Treatment T3||0||
59809420|NCT03907280|75931541|FG001|NOT COMPLETED|Treatment Period 4: Fixed Treatment T3||0||
59809421|NCT03907280|75931542|FG002|NOT COMPLETED|Treatment Period 4: Fixed Treatment T3||0||
59809422|NCT04120376|75931554|FG000|STARTED|Overall Study|The first participant was enrolled on November 13th, 2019. All adolescent participants received counseling in the ED by APP participants. (Single intervention among adolescent group completed by APPs)|108||
59809423|NCT04120376|75931555|FG001|STARTED|Overall Study|27 APPs were consented to participate and all APPs were consented during their in-person component of the training.|27||
59809424|NCT04120376|75931554|FG000|COMPLETED|Overall Study|Last participant enrolled 2/17/2021|99||
59809425|NCT04120376|75931555|FG001|COMPLETED|Overall Study||27||
59809426|NCT04120376|75931554|FG000|NOT COMPLETED|Overall Study||9||
59809427|NCT04120376|75931555|FG001|NOT COMPLETED|Overall Study||0||
59809428|NCT03905642|75931562|FG000|STARTED|Overall Study||49||
59809429|NCT03905642|75931562|FG000|COMPLETED|Overall Study||41||
59964376|NCT02991859|76081939|FG014|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0||
59964377|NCT02991859|76081940|FG015|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0||
59964378|NCT02991859|76081941|FG016|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0||
59964379|NCT03016325|76082024|FG000|STARTED|Treatment Period||48|Started = Entering treatment period|
59964380|NCT03016325|76082025|FG001|STARTED|Treatment Period||49|Started = Entering treatment period|
59964381|NCT03016325|76082026|FG002|STARTED|Treatment Period||71|Started = Entering treatment period|
59809430|NCT03905642|75931562|FG000|NOT COMPLETED|Overall Study||8||
59809431|NCT03518294|75931568|FG000|STARTED|Overall Study||10||
59809432|NCT03518294|75931569|FG001|STARTED|Overall Study||18||
59809433|NCT03518294|75931568|FG000|COMPLETED|Overall Study||8||
59809434|NCT03518294|75931569|FG001|COMPLETED|Overall Study||16||
59809435|NCT03518294|75931568|FG000|NOT COMPLETED|Overall Study||2||
59964382|NCT03016325|76082027|FG003|STARTED|Treatment Period||71|Started = Entering treatment period|
59995297|NCT04765553|76111138|FG001|NOT COMPLETED|Overall Study||0||
59809436|NCT03518294|75931569|FG001|NOT COMPLETED|Overall Study||2||
59964383|NCT03016325|76082028|FG004|STARTED|Treatment Period||72|Started = Entering treatment period|
59964384|NCT03016325|76082029|FG005|STARTED|Treatment Period||6|Started = Entering treatment period|
59964385|NCT03016325|76082030|FG006|STARTED|Treatment Period||6|Started = Entering treatment period|
59964386|NCT03016325|76082031|FG007|STARTED|Treatment Period||6|Started = Entering treatment period|
59964387|NCT03016325|76082024|FG000|COMPLETED|Treatment Period||48|Completed = Finished 120 hour treatment period|
59964388|NCT03016325|76082025|FG001|COMPLETED|Treatment Period||48|Completed = Finished 120 hour treatment period|
59964389|NCT03016325|76082026|FG002|COMPLETED|Treatment Period||70|Completed = Finished 120 hour treatment period|
59964390|NCT03016325|76082027|FG003|COMPLETED|Treatment Period||71|Completed = Finished 120 hour treatment period|
59964391|NCT03016325|76082028|FG004|COMPLETED|Treatment Period||70|Completed = Finished 120 hour treatment period|
59809437|NCT03504020|75931580|FG000|STARTED|Overall Study||200||
59809438|NCT03504020|75931581|FG001|STARTED|Overall Study||208||
59964392|NCT03016325|76082029|FG005|COMPLETED|Treatment Period||6|Completed = Finished 120 hour treatment period|
59964393|NCT03016325|76082030|FG006|COMPLETED|Treatment Period||6|Completed = Finished 120 hour treatment period|
59964394|NCT03016325|76082031|FG007|COMPLETED|Treatment Period||6|Completed = Finished 120 hour treatment period|
59964395|NCT03016325|76082024|FG000|NOT COMPLETED|Treatment Period||0||
59964396|NCT03016325|76082025|FG001|NOT COMPLETED|Treatment Period||1||
59964397|NCT03016325|76082026|FG002|NOT COMPLETED|Treatment Period||1||
59964398|NCT03016325|76082027|FG003|NOT COMPLETED|Treatment Period||0||
59964399|NCT03016325|76082028|FG004|NOT COMPLETED|Treatment Period||2||
59964400|NCT03016325|76082029|FG005|NOT COMPLETED|Treatment Period||0||
59964401|NCT03016325|76082030|FG006|NOT COMPLETED|Treatment Period||0||
59964402|NCT03016325|76082031|FG007|NOT COMPLETED|Treatment Period||0||
59964403|NCT03016325|76082024|FG000|STARTED|32-Day Follow-Up Period||48|Started = Entering treatment period|
59964404|NCT03016325|76082025|FG001|STARTED|32-Day Follow-Up Period||49|Started = Entering treatment period|
59964405|NCT03016325|76082026|FG002|STARTED|32-Day Follow-Up Period||71|Started = Entering treatment period|
59964406|NCT03016325|76082027|FG003|STARTED|32-Day Follow-Up Period||71|Started = Entering treatment period|
59964407|NCT03016325|76082028|FG004|STARTED|32-Day Follow-Up Period||72|Started = Entering treatment period|
59964408|NCT03016325|76082029|FG005|STARTED|32-Day Follow-Up Period||6|Started = Entering treatment period|
59964409|NCT03016325|76082030|FG006|STARTED|32-Day Follow-Up Period||6|Started = Entering treatment period|
59964410|NCT03016325|76082031|FG007|STARTED|32-Day Follow-Up Period||6|Started = Entering treatment period|
59964411|NCT03016325|76082024|FG000|COMPLETED|32-Day Follow-Up Period||44|Completed = Finished 32-day follow-up period|
59964412|NCT03016325|76082025|FG001|COMPLETED|32-Day Follow-Up Period||47|Completed = Finished 32-day follow-up period|
59964413|NCT03016325|76082026|FG002|COMPLETED|32-Day Follow-Up Period||62|Completed = Finished 32-day follow-up period|
59964414|NCT03016325|76082027|FG003|COMPLETED|32-Day Follow-Up Period||63|Completed = Finished 32-day follow-up period|
59964415|NCT03016325|76082028|FG004|COMPLETED|32-Day Follow-Up Period||64|Completed = Finished 32-day follow-up period|
59964416|NCT03016325|76082029|FG005|COMPLETED|32-Day Follow-Up Period||6|Completed = Finished 32-day follow-up period|
59964417|NCT03016325|76082030|FG006|COMPLETED|32-Day Follow-Up Period||5|Completed = Finished 32-day follow-up period|
59964418|NCT03016325|76082031|FG007|COMPLETED|32-Day Follow-Up Period||6|Completed = Finished 32-day follow-up period|
59964419|NCT03016325|76082024|FG000|NOT COMPLETED|32-Day Follow-Up Period||4||
59964420|NCT03016325|76082025|FG001|NOT COMPLETED|32-Day Follow-Up Period||2||
60074250|NCT01801982|76189675|FG000|STARTED|Overall Study||1||
59964421|NCT03016325|76082026|FG002|NOT COMPLETED|32-Day Follow-Up Period||9||
59964422|NCT03016325|76082027|FG003|NOT COMPLETED|32-Day Follow-Up Period||8||
59964423|NCT03016325|76082028|FG004|NOT COMPLETED|32-Day Follow-Up Period||8||
59964424|NCT03016325|76082029|FG005|NOT COMPLETED|32-Day Follow-Up Period||0||
59964425|NCT03016325|76082030|FG006|NOT COMPLETED|32-Day Follow-Up Period||1||
59964426|NCT03016325|76082031|FG007|NOT COMPLETED|32-Day Follow-Up Period||0||
59964427|NCT03016325|76082024|FG000|STARTED|182-Day Follow-Up Period||48|Started = Entering treatment period|
59964428|NCT03016325|76082025|FG001|STARTED|182-Day Follow-Up Period||49|Started = Entering treatment period|
60074251|NCT01801982|76189675|FG000|COMPLETED|Overall Study||0||
60074252|NCT01801982|76189675|FG000|NOT COMPLETED|Overall Study||1||
60074253|NCT02085070|76189681|FG000|STARTED|Overall Study||23||
60074254|NCT02085070|76189682|FG001|STARTED|Overall Study||42||
60074255|NCT02085070|76189681|FG000|COMPLETED|Overall Study||23||
60074256|NCT02085070|76189682|FG001|COMPLETED|Overall Study||42||
60074257|NCT02085070|76189681|FG000|NOT COMPLETED|Overall Study||0||
60074258|NCT02085070|76189682|FG001|NOT COMPLETED|Overall Study||0||
59809439|NCT03504020|75931580|FG000|COMPLETED|Overall Study||161||
59809440|NCT03504020|75931581|FG001|COMPLETED|Overall Study||172||
59809441|NCT03504020|75931580|FG000|NOT COMPLETED|Overall Study||39||
59809442|NCT03504020|75931581|FG001|NOT COMPLETED|Overall Study||36||
59809443|NCT04095416|75931589|FG000|STARTED|Overall Study||13||
59809444|NCT04095416|75931590|FG001|STARTED|Overall Study||19||
59809445|NCT04095416|75931589|FG000|COMPLETED|Overall Study||10||
59809446|NCT04095416|75931590|FG001|COMPLETED|Overall Study||19||
59809447|NCT04095416|75931589|FG000|NOT COMPLETED|Overall Study||3||
59809448|NCT04095416|75931590|FG001|NOT COMPLETED|Overall Study||0||
59964429|NCT03016325|76082026|FG002|STARTED|182-Day Follow-Up Period||71|Started = Entering treatment period|
59964430|NCT03016325|76082027|FG003|STARTED|182-Day Follow-Up Period||71|Started = Entering treatment period|
59964431|NCT03016325|76082028|FG004|STARTED|182-Day Follow-Up Period||72|Started = Entering treatment period|
59964432|NCT03016325|76082029|FG005|STARTED|182-Day Follow-Up Period||6|Started = Entering treatment period|
59964433|NCT03016325|76082030|FG006|STARTED|182-Day Follow-Up Period||6|Started = Entering treatment period|
59964434|NCT03016325|76082031|FG007|STARTED|182-Day Follow-Up Period||6|Started = Entering treatment period|
59964435|NCT03016325|76082024|FG000|COMPLETED|182-Day Follow-Up Period||44|Completed = Finished 182-day follow-up period|
59964436|NCT03016325|76082025|FG001|COMPLETED|182-Day Follow-Up Period||45|Completed = Finished 182-day follow-up period|
59964437|NCT03016325|76082026|FG002|COMPLETED|182-Day Follow-Up Period||60|Completed = Finished 182-day follow-up period|
59964438|NCT03016325|76082027|FG003|COMPLETED|182-Day Follow-Up Period||58|Completed = Finished 182-day follow-up period|
59964439|NCT03016325|76082028|FG004|COMPLETED|182-Day Follow-Up Period||60|Completed = Finished 182-day follow-up period|
59964440|NCT03016325|76082029|FG005|COMPLETED|182-Day Follow-Up Period||1|Completed = Finished 182-day follow-up period|
59964441|NCT03016325|76082030|FG006|COMPLETED|182-Day Follow-Up Period||2|Completed = Finished 182-day follow-up period|
59964442|NCT03016325|76082031|FG007|COMPLETED|182-Day Follow-Up Period||1|Completed = Finished 182-day follow-up period|
59964443|NCT03016325|76082024|FG000|NOT COMPLETED|182-Day Follow-Up Period||4||
59964444|NCT03016325|76082025|FG001|NOT COMPLETED|182-Day Follow-Up Period||4||
59964445|NCT03016325|76082026|FG002|NOT COMPLETED|182-Day Follow-Up Period||11||
59964446|NCT03016325|76082027|FG003|NOT COMPLETED|182-Day Follow-Up Period||13||
59964447|NCT03016325|76082028|FG004|NOT COMPLETED|182-Day Follow-Up Period||12||
59964448|NCT03016325|76082029|FG005|NOT COMPLETED|182-Day Follow-Up Period||5||
59964449|NCT03016325|76082030|FG006|NOT COMPLETED|182-Day Follow-Up Period||4||
59964450|NCT03016325|76082031|FG007|NOT COMPLETED|182-Day Follow-Up Period||5||
59964451|NCT02988115|76082054|FG000|STARTED|Overall Study||234||
59964452|NCT02988115|76082055|FG001|STARTED|Overall Study||111||
59964453|NCT02988115|76082054|FG000|COMPLETED|Overall Study||220||
59964454|NCT02988115|76082055|FG001|COMPLETED|Overall Study||107||
59964455|NCT02988115|76082054|FG000|NOT COMPLETED|Overall Study||14||
59964456|NCT02988115|76082055|FG001|NOT COMPLETED|Overall Study||4||
59964457|NCT02921425|76082061|FG000|STARTED|Overall Study||47||
59964458|NCT02921425|76082061|FG000|Second Visit|Overall Study|Participants had to wear an accelerometer and make entries into their PHR over the previous 7 days.|47||
59964459|NCT02921425|76082061|FG000|COMPLETED|Overall Study||38||
59964460|NCT02921425|76082061|FG000|NOT COMPLETED|Overall Study||9||
59964461|NCT03008915|76082065|FG000|STARTED|Treatment 1||8||
59964462|NCT03008915|76082066|FG001|STARTED|Treatment 1||7||
59964463|NCT03008915|76082065|FG000|COMPLETED|Treatment 1||8||
59964464|NCT03008915|76082066|FG001|COMPLETED|Treatment 1||6||
59964465|NCT03008915|76082065|FG000|NOT COMPLETED|Treatment 1||0||
59964466|NCT03008915|76082066|FG001|NOT COMPLETED|Treatment 1||1||
59964467|NCT03008915|76082065|FG000|STARTED|Treatment 2||8||
59964468|NCT03008915|76082066|FG001|STARTED|Treatment 2||6||
59621473|NCT00344370|75733071|FG001|COMPLETED|Overall Study||68||
59621474|NCT00344370|75733070|FG000|NOT COMPLETED|Overall Study||15||
59621475|NCT00344370|75733071|FG001|NOT COMPLETED|Overall Study||3||
59621476|NCT00344682|75733079|FG000|STARTED|Overall Study||16||
59809449|NCT02682992|75931596|FG000|STARTED|Overall Study||47||
59809450|NCT02682992|75931596|FG000|COMPLETED|Overall Study||47||
59809451|NCT02682992|75931596|FG000|NOT COMPLETED|Overall Study||0||
59621477|NCT00344682|75733080|FG001|STARTED|Overall Study||15||
59809452|NCT00412984|75931602|FG000|STARTED|Overall Study|Randomized participants|9120||
59964469|NCT03008915|76082065|FG000|COMPLETED|Treatment 2||8||
59964470|NCT03008915|76082066|FG001|COMPLETED|Treatment 2||6||
59964471|NCT03008915|76082065|FG000|NOT COMPLETED|Treatment 2||0||
59964472|NCT03008915|76082066|FG001|NOT COMPLETED|Treatment 2||0||
59964473|NCT03591380|76082073|FG000|STARTED|Overall Study||3||
59964474|NCT03591380|76082073|FG000|COMPLETED|Overall Study||3||
59964475|NCT03591380|76082073|FG000|NOT COMPLETED|Overall Study||0||
59995298|NCT04529096|76111146|FG000|STARTED|Overall Study||100||
59995299|NCT04529096|76111147|FG001|STARTED|Overall Study||49||
59621478|NCT00344682|75733079|FG000|COMPLETED|Overall Study||12||
59809453|NCT00412984|75931603|FG001|STARTED|Overall Study|Randomized participants|9081||
59809454|NCT00412984|75931602|FG000|COMPLETED|Overall Study||6810||
59809455|NCT00412984|75931603|FG001|COMPLETED|Overall Study||6588||
59809456|NCT00412984|75931602|FG000|NOT COMPLETED|Overall Study||2310||
59809457|NCT00412984|75931603|FG001|NOT COMPLETED|Overall Study||2493||
59809458|NCT00539864|75931611|FG000|STARTED|Overall Study||300||
59809459|NCT00539864|75931612|FG001|STARTED|Overall Study||302||
59809460|NCT00539864|75931611|FG000|COMPLETED|Overall Study||299||
59809461|NCT00539864|75931612|FG001|COMPLETED|Overall Study||300||
59809462|NCT00539864|75931611|FG000|NOT COMPLETED|Overall Study||1||
59995300|NCT04529096|76111146|FG000|Received at Least 1 Dose of Study Drug|Overall Study||100||
59995301|NCT04529096|76111147|FG001|Received at Least 1 Dose of Study Drug|Overall Study||49||
59995302|NCT04529096|76111146|FG000|COMPLETED|Overall Study||86||
59995303|NCT04529096|76111147|FG001|COMPLETED|Overall Study||43||
59995304|NCT04529096|76111146|FG000|NOT COMPLETED|Overall Study||14||
59964476|NCT02920957|76082077|FG000|STARTED|First Intervention : 1 Month||46||
59964477|NCT02920957|76082078|FG001|STARTED|First Intervention : 1 Month||41||
59964478|NCT02920957|76082077|FG000|COMPLETED|First Intervention : 1 Month||42||
59964479|NCT02920957|76082078|FG001|COMPLETED|First Intervention : 1 Month||41||
59964480|NCT02920957|76082077|FG000|NOT COMPLETED|First Intervention : 1 Month||4||
59964481|NCT02920957|76082078|FG001|NOT COMPLETED|First Intervention : 1 Month||0||
59964482|NCT02920957|76082077|FG000|STARTED|Second Intervention: 1 Month||42||
59964483|NCT02920957|76082078|FG001|STARTED|Second Intervention: 1 Month||41||
59964484|NCT02920957|76082077|FG000|COMPLETED|Second Intervention: 1 Month||42||
59964485|NCT02920957|76082078|FG001|COMPLETED|Second Intervention: 1 Month||40||
59964486|NCT02920957|76082077|FG000|NOT COMPLETED|Second Intervention: 1 Month||0||
59964487|NCT02920957|76082078|FG001|NOT COMPLETED|Second Intervention: 1 Month||1||
59964488|NCT03006887|76082095|FG000|STARTED|Overall Study||6||
59964489|NCT03006887|76082095|FG000|COMPLETED|Overall Study||5||
59964490|NCT03006887|76082095|FG000|NOT COMPLETED|Overall Study||1||
59964491|NCT02514772|76082101|FG000|STARTED|Overall Study||53||
59964492|NCT02514772|76082102|FG001|STARTED|Overall Study||54||
59964493|NCT02514772|76082101|FG000|COMPLETED|Overall Study||50||
59964494|NCT02514772|76082102|FG001|COMPLETED|Overall Study||52||
59964495|NCT02514772|76082101|FG000|NOT COMPLETED|Overall Study||3||
59964496|NCT02514772|76082102|FG001|NOT COMPLETED|Overall Study||2||
59964497|NCT03000179|76082110|FG000|STARTED|Overall Study||8||
59964498|NCT03000179|76082110|FG000|COMPLETED|Overall Study||6||
59964499|NCT03000179|76082110|FG000|NOT COMPLETED|Overall Study||2||
59964500|NCT02920177|76082116|FG000|STARTED|Overall Study||2||
59964501|NCT02920177|76082117|FG001|STARTED|Overall Study||2||
59964502|NCT02920177|76082116|FG000|COMPLETED|Overall Study||0||
59964503|NCT02920177|76082117|FG001|COMPLETED|Overall Study||0||
59964504|NCT02920177|76082116|FG000|NOT COMPLETED|Overall Study||2||
59964505|NCT02920177|76082117|FG001|NOT COMPLETED|Overall Study||2||
59964506|NCT03006341|76082127|FG000|STARTED|Overall Study||26199|Eligible in the claims database|
59964507|NCT03006341|76082128|FG001|STARTED|Overall Study||70071|Eligible in the claims database|
59964508|NCT03006341|76082129|FG002|STARTED|Overall Study||32595|Eligible in the claims database|
59964509|NCT03006341|76082130|FG003|STARTED|Overall Study||11322|Eligible in the claims database|
59964510|NCT03006341|76082127|FG000|COMPLETED|Overall Study||1130|Successfully linked in the EMR but not necessarily propensity score matched|
59964511|NCT03006341|76082128|FG001|COMPLETED|Overall Study||2566|Successfully linked in the EMR but not necessarily propensity score matched|
59964512|NCT03006341|76082129|FG002|COMPLETED|Overall Study||1602|Successfully linked in the EMR but not necessarily propensity score matched|
59964513|NCT03006341|76082130|FG003|COMPLETED|Overall Study||637|Successfully linked in the EMR but not necessarily propensity score matched|
59964514|NCT03006341|76082127|FG000|NOT COMPLETED|Overall Study||25069||
59964515|NCT03006341|76082128|FG001|NOT COMPLETED|Overall Study||67505||
59964516|NCT03006341|76082129|FG002|NOT COMPLETED|Overall Study||30993||
59964517|NCT03006341|76082130|FG003|NOT COMPLETED|Overall Study||10685||
59964518|NCT03935594|76082138|FG000|STARTED|Overall Study||3||
59964519|NCT03935594|76082138|FG000|PRP Treated|Overall Study||3||
59964520|NCT03935594|76082138|FG000|Control|Overall Study||3||
59964521|NCT03935594|76082138|FG000|COMPLETED|Overall Study||0||
59964522|NCT03935594|76082138|FG000|NOT COMPLETED|Overall Study||3||
59964523|NCT02512042|76082146|FG000|STARTED|Overall Study||495||
59964524|NCT02512042|76082147|FG001|STARTED|Overall Study||478||
59964525|NCT02512042|76082146|FG000|COMPLETED|Overall Study||472||
59964526|NCT02512042|76082147|FG001|COMPLETED|Overall Study||453||
59964527|NCT02512042|76082146|FG000|NOT COMPLETED|Overall Study||23||
59964528|NCT02512042|76082147|FG001|NOT COMPLETED|Overall Study||25||
59964529|NCT02911025|76082153|FG000|STARTED|Overall Study||13||
59964530|NCT02911025|76082153|FG000|COMPLETED|Overall Study||10||
59964531|NCT02911025|76082153|FG000|NOT COMPLETED|Overall Study||3||
59964532|NCT02919475|76082162|FG000|STARTED|Overall Study||52||
59964533|NCT02919475|76082163|FG001|STARTED|Overall Study||52||
59964534|NCT02919475|76082164|FG002|STARTED|Overall Study||52||
59964535|NCT02919475|76082165|FG003|STARTED|Overall Study||51||
59964536|NCT02919475|76082166|FG004|STARTED|Overall Study||52||
59964537|NCT02919475|76082162|FG000|Started Dosing|Overall Study||51||
59964538|NCT02919475|76082163|FG001|Started Dosing|Overall Study||52||
59964539|NCT02919475|76082164|FG002|Started Dosing|Overall Study||52||
59964540|NCT02919475|76082165|FG003|Started Dosing|Overall Study||51||
59964541|NCT02919475|76082166|FG004|Started Dosing|Overall Study||52||
59964542|NCT02919475|76082162|FG000|COMPLETED|Overall Study||46||
59524751|NCT01050647|75619842|FG000|COMPLETED|Overall Study||10||
59964543|NCT02919475|76082163|FG001|COMPLETED|Overall Study||44||
59964544|NCT02919475|76082164|FG002|COMPLETED|Overall Study||47||
59964545|NCT02919475|76082165|FG003|COMPLETED|Overall Study||38||
60074259|NCT01808066|76189688|FG000|STARTED|Overall Study||21||
60074260|NCT01808066|76189688|FG000|COMPLETED|Overall Study||6||
59964546|NCT02919475|76082166|FG004|COMPLETED|Overall Study||48||
59964547|NCT02919475|76082162|FG000|NOT COMPLETED|Overall Study||6||
60074261|NCT01808066|76189688|FG000|NOT COMPLETED|Overall Study||15||
59964548|NCT02919475|76082163|FG001|NOT COMPLETED|Overall Study||8||
59964549|NCT02919475|76082164|FG002|NOT COMPLETED|Overall Study||5||
59964550|NCT02919475|76082165|FG003|NOT COMPLETED|Overall Study||13||
59964551|NCT02919475|76082166|FG004|NOT COMPLETED|Overall Study||4||
59964552|NCT01066897|76082180|FG000|STARTED|Overall Study||7||
59964553|NCT01066897|76082181|FG001|STARTED|Overall Study||9||
59964554|NCT01066897|76082180|FG000|COMPLETED|Overall Study||5||
59964555|NCT01066897|76082181|FG001|COMPLETED|Overall Study||9||
59964556|NCT01066897|76082180|FG000|NOT COMPLETED|Overall Study||2||
59964557|NCT01066897|76082181|FG001|NOT COMPLETED|Overall Study||0||
59964558|NCT02985541|76082188|FG000|STARTED|Overall Study||364||
59964559|NCT02985541|76082188|FG000|Valid for FAS|Overall Study||362||
59964560|NCT02985541|76082188|FG000|Continued Into Year 7 of Mirena Use|Overall Study||305||
59964561|NCT02985541|76082188|FG000|Continued Into Year 8 of Mirena Use|Overall Study||243||
59964562|NCT02985541|76082188|FG000|COMPLETED|Overall Study||223||
59964563|NCT02985541|76082188|FG000|NOT COMPLETED|Overall Study||141||
59964564|NCT02461225|76082194|FG000|STARTED|Overall Study||19||
59964565|NCT02461225|76082195|FG001|STARTED|Overall Study||11||
59964566|NCT02461225|76082194|FG000|COMPLETED|Overall Study||19||
59964567|NCT02461225|76082195|FG001|COMPLETED|Overall Study||11||
59964568|NCT02461225|76082194|FG000|NOT COMPLETED|Overall Study||0||
59964569|NCT02461225|76082195|FG001|NOT COMPLETED|Overall Study||0||
59964570|NCT02910037|76082201|FG000|STARTED|Overall Study||214||
59964571|NCT02910037|76082201|FG000|COMPLETED|Overall Study||204||
59964572|NCT02910037|76082201|FG000|NOT COMPLETED|Overall Study||10||
59964573|NCT02356705|76082224|FG000|STARTED|Overall Study||14||
60074262|NCT01604343|76189696|FG000|STARTED|Prior to W52 Administration(Through W52)||556||
60074263|NCT01604343|76189697|FG001|STARTED|Prior to W52 Administration(Through W52)||0||
60074264|NCT01604343|76189698|FG002|STARTED|Prior to W52 Administration(Through W52)||557||
60074265|NCT01604343|76189699|FG003|STARTED|Prior to W52 Administration(Through W52)||0||
60074266|NCT01604343|76189700|FG004|STARTED|Prior to W52 Administration(Through W52)||557||
60074267|NCT01604343|76189696|FG000|Participants Re-randomized at Week 18|Prior to W52 Administration(Through W52)|Out of 187, 95 were re-randomized to sirukumab 50 mg and 92 were re-randomized to 100 mg group.|187||
59809463|NCT00539864|75931612|FG001|NOT COMPLETED|Overall Study||2||
59809464|NCT00673049|75931620|FG000|STARTED|Before Progression on Erlotinib||292||
59809465|NCT00673049|75931621|FG001|STARTED|Before Progression on Erlotinib||290||
59809466|NCT00673049|75931622|FG002|STARTED|Before Progression on Erlotinib||1||
59809467|NCT00673049|75931623|FG003|STARTED|Before Progression on Erlotinib|Participants treated with erlo alone who subsequently received figi upon disease progression.|0||
59809468|NCT00673049|75931620|FG000|Treated|Before Progression on Erlotinib||289||
59809469|NCT00673049|75931621|FG001|Treated|Before Progression on Erlotinib||289||
59809470|NCT00673049|75931622|FG002|Treated|Before Progression on Erlotinib||1||
59809471|NCT00673049|75931623|FG003|Treated|Before Progression on Erlotinib||0||
59809472|NCT00673049|75931620|FG000|COMPLETED|Before Progression on Erlotinib||0||
59809473|NCT00673049|75931621|FG001|COMPLETED|Before Progression on Erlotinib||0||
59809474|NCT00673049|75931622|FG002|COMPLETED|Before Progression on Erlotinib||0||
59809475|NCT00673049|75931623|FG003|COMPLETED|Before Progression on Erlotinib||0||
59809476|NCT00673049|75931620|FG000|NOT COMPLETED|Before Progression on Erlotinib||292||
59809477|NCT00673049|75931621|FG001|NOT COMPLETED|Before Progression on Erlotinib||290||
59809478|NCT00673049|75931622|FG002|NOT COMPLETED|Before Progression on Erlotinib||1||
59809479|NCT00673049|75931623|FG003|NOT COMPLETED|Before Progression on Erlotinib||0||
59809480|NCT00673049|75931620|FG000|STARTED|After Progression on Erlotinib||0||
59809481|NCT00673049|75931621|FG001|STARTED|After Progression on Erlotinib||0||
59809482|NCT00673049|75931622|FG002|STARTED|After Progression on Erlotinib||0||
59809483|NCT00673049|75931623|FG003|STARTED|After Progression on Erlotinib||83||
59809484|NCT00673049|75931620|FG000|COMPLETED|After Progression on Erlotinib||0||
59809485|NCT00673049|75931621|FG001|COMPLETED|After Progression on Erlotinib||0||
59809486|NCT00673049|75931622|FG002|COMPLETED|After Progression on Erlotinib||0||
59809487|NCT00673049|75931623|FG003|COMPLETED|After Progression on Erlotinib||0||
59809488|NCT00673049|75931620|FG000|NOT COMPLETED|After Progression on Erlotinib||0||
59809489|NCT00673049|75931621|FG001|NOT COMPLETED|After Progression on Erlotinib||0||
59809490|NCT00673049|75931622|FG002|NOT COMPLETED|After Progression on Erlotinib||0||
59809491|NCT00673049|75931623|FG003|NOT COMPLETED|After Progression on Erlotinib||83||
59809492|NCT00412750|75931634|FG000|STARTED|Overall Study||50||
59809493|NCT00412750|75931635|FG001|STARTED|Overall Study||55||
59809494|NCT00412750|75931636|FG002|STARTED|Overall Study||54||
59809495|NCT00412750|75931634|FG000|COMPLETED|Overall Study||19||
59809496|NCT00412750|75931635|FG001|COMPLETED|Overall Study||34||
59809497|NCT00412750|75931636|FG002|COMPLETED|Overall Study||31||
59809498|NCT00412750|75931634|FG000|NOT COMPLETED|Overall Study||31||
59809499|NCT00412750|75931635|FG001|NOT COMPLETED|Overall Study||21||
59809500|NCT00412750|75931636|FG002|NOT COMPLETED|Overall Study||23||
59809501|NCT00076999|75931650|FG000|STARTED|Overall Study||25||
59809502|NCT00076999|75931651|FG001|STARTED|Overall Study||31||
59809503|NCT00076999|75931652|FG002|STARTED|Overall Study||19||
59809504|NCT00076999|75931653|FG003|STARTED|Overall Study||6||
59809505|NCT00076999|75931654|FG004|STARTED|Overall Study||34||
59809506|NCT00076999|75931650|FG000|COMPLETED|Overall Study||13||
59809507|NCT00076999|75931651|FG001|COMPLETED|Overall Study||7||
59964574|NCT02356705|76082225|FG001|STARTED|Overall Study||14||
59964575|NCT02356705|76082226|FG002|STARTED|Overall Study||14||
59964576|NCT02356705|76082224|FG000|COMPLETED|Overall Study||14||
59964577|NCT02356705|76082225|FG001|COMPLETED|Overall Study||14||
59964578|NCT02356705|76082226|FG002|COMPLETED|Overall Study||14||
59964579|NCT02356705|76082224|FG000|NOT COMPLETED|Overall Study||0||
59964580|NCT02356705|76082225|FG001|NOT COMPLETED|Overall Study||0||
59964581|NCT02356705|76082226|FG002|NOT COMPLETED|Overall Study||0||
59964582|NCT02511184|76082236|FG000|STARTED|Overall Study||2||
59964583|NCT02511184|76082237|FG001|STARTED|Overall Study||7||
59964584|NCT02511184|76082236|FG000|COMPLETED|Overall Study||0||
59964585|NCT02511184|76082237|FG001|COMPLETED|Overall Study||0||
59964586|NCT02511184|76082236|FG000|NOT COMPLETED|Overall Study||2||
59964587|NCT02511184|76082237|FG001|NOT COMPLETED|Overall Study||7||
59964588|NCT02984995|76082246|FG000|STARTED|Overall Study||34||
59964589|NCT02984995|76082247|FG001|STARTED|Overall Study||3||
59964590|NCT02984995|76082246|FG000|COMPLETED|Overall Study||9||
59964591|NCT02984995|76082247|FG001|COMPLETED|Overall Study||0||
59964592|NCT02984995|76082246|FG000|NOT COMPLETED|Overall Study||25||
59964593|NCT02984995|76082247|FG001|NOT COMPLETED|Overall Study||3||
59964594|NCT02384239|76082261|FG000|STARTED|Overall Study||36||
59964595|NCT02384239|76082262|FG001|STARTED|Overall Study||34||
59964596|NCT02384239|76082261|FG000|COMPLETED|Overall Study||36||
59964597|NCT02384239|76082262|FG001|COMPLETED|Overall Study||34||
59964598|NCT02384239|76082261|FG000|NOT COMPLETED|Overall Study||0||
59964599|NCT02384239|76082262|FG001|NOT COMPLETED|Overall Study||0||
59964600|NCT02984683|76082271|FG000|STARTED|Overall Study||11||
59964601|NCT02984683|76082272|FG001|STARTED|Overall Study||12||
59964602|NCT02984683|76082271|FG000|COMPLETED|Overall Study||0||
59964603|NCT02984683|76082272|FG001|COMPLETED|Overall Study||0||
59964604|NCT02984683|76082271|FG000|NOT COMPLETED|Overall Study||11||
59964605|NCT02984683|76082272|FG001|NOT COMPLETED|Overall Study||12||
59964606|NCT02909101|76082280|FG000|STARTED|Overall Study||29||
59964607|NCT02909101|76082281|FG001|STARTED|Overall Study||29||
59964608|NCT02909101|76082280|FG000|COMPLETED|Overall Study||28||
59964609|NCT02909101|76082281|FG001|COMPLETED|Overall Study||28||
59964610|NCT02909101|76082280|FG000|NOT COMPLETED|Overall Study||1||
59964611|NCT02909101|76082281|FG001|NOT COMPLETED|Overall Study||1||
59964612|NCT03004469|76082290|FG000|STARTED|Overall Study||189||
59964613|NCT03004469|76082291|FG001|STARTED|Overall Study||184||
59964614|NCT03004469|76082292|FG002|STARTED|Overall Study||85||
59964615|NCT03004469|76082290|FG000|COMPLETED|Overall Study||128||
59964616|NCT03004469|76082291|FG001|COMPLETED|Overall Study||135||
59964617|NCT03004469|76082292|FG002|COMPLETED|Overall Study||60||
59964618|NCT03004469|76082290|FG000|NOT COMPLETED|Overall Study||61||
59809508|NCT00076999|75931652|FG002|COMPLETED|Overall Study||2||
59809509|NCT00076999|75931653|FG003|COMPLETED|Overall Study||5||
59809510|NCT00076999|75931654|FG004|COMPLETED|Overall Study||9||
59809511|NCT00076999|75931650|FG000|NOT COMPLETED|Overall Study||12||
59809512|NCT00076999|75931651|FG001|NOT COMPLETED|Overall Study||24||
59809513|NCT00076999|75931652|FG002|NOT COMPLETED|Overall Study||17||
59809514|NCT00076999|75931653|FG003|NOT COMPLETED|Overall Study||1||
59964619|NCT03004469|76082291|FG001|NOT COMPLETED|Overall Study||49||
59964620|NCT03004469|76082292|FG002|NOT COMPLETED|Overall Study||25||
59964621|NCT02910713|76082301|FG000|STARTED|Overall Study||185||
59964622|NCT02910713|76082301|FG000|Safety Population: Entered CAE|Overall Study||171||
59964623|NCT02910713|76082301|FG000|COMPLETED|Overall Study|Completed=Completed both Intranasal and Extranasal applications.|143||
59964624|NCT02910713|76082301|FG000|NOT COMPLETED|Overall Study||42||
59964625|NCT02998541|76082309|FG000|STARTED|Overall Study||86||
59964626|NCT02998541|76082310|FG001|STARTED|Overall Study||90||
59964627|NCT02998541|76082311|FG002|STARTED|Overall Study||43||
59964628|NCT02998541|76082309|FG000|COMPLETED|Overall Study||78||
59964629|NCT02998541|76082310|FG001|COMPLETED|Overall Study||81||
59964630|NCT02998541|76082311|FG002|COMPLETED|Overall Study||37||
59964631|NCT02998541|76082309|FG000|NOT COMPLETED|Overall Study||8||
59964632|NCT02998541|76082310|FG001|NOT COMPLETED|Overall Study||9||
59964633|NCT02998541|76082311|FG002|NOT COMPLETED|Overall Study||6||
59964634|NCT02998151|76082319|FG000|STARTED|Overall Study||29||
59809515|NCT00076999|75931654|FG004|NOT COMPLETED|Overall Study||25||
59809516|NCT03905096|75931669|FG000|STARTED|Period 1 for Trial Part 1 and 2||18||
59809517|NCT03905096|75931670|FG001|STARTED|Period 1 for Trial Part 1 and 2||14||
59809518|NCT03905096|75931669|FG000|COMPLETED|Period 1 for Trial Part 1 and 2||18||
59809519|NCT03905096|75931670|FG001|COMPLETED|Period 1 for Trial Part 1 and 2||14||
59809520|NCT03905096|75931669|FG000|NOT COMPLETED|Period 1 for Trial Part 1 and 2||0||
59809521|NCT03905096|75931670|FG001|NOT COMPLETED|Period 1 for Trial Part 1 and 2||0||
59809522|NCT03905096|75931669|FG000|STARTED|Period 2 for Trial Part 1 and 2||18||
59809523|NCT03905096|75931670|FG001|STARTED|Period 2 for Trial Part 1 and 2||14||
59964635|NCT02998151|76082319|FG000|Placebo|Overall Study|Two participants withdrew from the study before receiving placebo.|27||
59964636|NCT02998151|76082319|FG000|Acamprosate|Overall Study|Every participant received acamprosate prior to acamprosate's discontinuance.|16|Acamprosate was discontinued due to undetectable serum levels after dosage.|
59809524|NCT03905096|75931669|FG000|COMPLETED|Period 2 for Trial Part 1 and 2||17||
59809525|NCT03905096|75931670|FG001|COMPLETED|Period 2 for Trial Part 1 and 2||14||
59809526|NCT03905096|75931669|FG000|NOT COMPLETED|Period 2 for Trial Part 1 and 2||1||
59809527|NCT03905096|75931670|FG001|NOT COMPLETED|Period 2 for Trial Part 1 and 2||0||
59809528|NCT00412360|75931685|FG000|STARTED|Overall Study||113||
59964637|NCT02998151|76082319|FG000|Lovastatin|Overall Study|All participants received lovastatin.|29||
59964638|NCT02998151|76082319|FG000|Minocycline|Overall Study|Two participants withdrew from the study before receiving minocycline.|27||
59964639|NCT02998151|76082319|FG000|Baclofen|Overall Study|All 13 remaining participants received baclofen after acamprosate was discontinued. Five participants were re-enrolled to receive baclofen.|18|Baclofen replaced acamprosate after it was determined acamprosate was undetectable in serum after dosage.|
59964640|NCT02998151|76082319|FG000|COMPLETED|Overall Study|Acamprosate was discontinued mid-study due to undetectable serum levels and replaced with baclofen. Participants who already completed acamprosate were given the option to re-enroll and receive baclofen. Five participants received all 5 interventions; 26 received 4+ interventions.|5|Five participants completed all 5 study arms; however, 26 completed all that were originally asked of them (4 visits, with 5 of those 26 re-enrolling to complete baclofen as well).|
59964641|NCT02998151|76082319|FG000|NOT COMPLETED|Overall Study||24||
59964642|NCT02994290|76082334|FG000|STARTED|Overall Study||491||
59964643|NCT02994290|76082335|FG001|STARTED|Overall Study||296||
59964644|NCT02994290|76082336|FG002|STARTED|Overall Study||30||
60074268|NCT01604343|76189697|FG001|Participants Re-randomized at Week 18|Prior to W52 Administration(Through W52)||0||
59524752|NCT01050647|75619843|FG001|COMPLETED|Overall Study||11||
59524753|NCT01050647|75619842|FG000|NOT COMPLETED|Overall Study||0||
59524754|NCT01050647|75619843|FG001|NOT COMPLETED|Overall Study||0||
59809529|NCT00412360|75931686|FG001|STARTED|Overall Study||111||
59809530|NCT00412360|75931685|FG000|COMPLETED|Overall Study||112||
59964645|NCT02994290|76082334|FG000|COMPLETED|Overall Study||491||
59964646|NCT02994290|76082335|FG001|COMPLETED|Overall Study||296||
59964647|NCT02994290|76082336|FG002|COMPLETED|Overall Study||30||
59964648|NCT02994290|76082334|FG000|NOT COMPLETED|Overall Study||0||
59964649|NCT02994290|76082335|FG001|NOT COMPLETED|Overall Study||0||
59964650|NCT02994290|76082336|FG002|NOT COMPLETED|Overall Study||0||
59964651|NCT01066819|76082350|FG000|STARTED|Overall Study||1006||
59964652|NCT01066819|76082351|FG001|STARTED|Overall Study||348||
59964653|NCT01066819|76082352|FG002|STARTED|Overall Study||257||
59964654|NCT01066819|76082353|FG003|STARTED|Overall Study||25||
59964655|NCT01066819|76082354|FG004|STARTED|Overall Study||7||
60074269|NCT01604343|76189698|FG002|Participants Re-randomized at Week 18|Prior to W52 Administration(Through W52)||0||
60074270|NCT01604343|76189699|FG003|Participants Re-randomized at Week 18|Prior to W52 Administration(Through W52)||0||
60074271|NCT01604343|76189700|FG004|Participants Re-randomized at Week 18|Prior to W52 Administration(Through W52)||0||
60074272|NCT01604343|76189696|FG000|Participants Re-randomized at Week 40|Prior to W52 Administration(Through W52)|Out of 24, 12 were re-randomized to sirukumab 50 mg and 12 were re-randomized to 100 mg group.|24||
60074273|NCT01604343|76189697|FG001|Participants Re-randomized at Week 40|Prior to W52 Administration(Through W52)||0||
60074274|NCT01604343|76189698|FG002|Participants Re-randomized at Week 40|Prior to W52 Administration(Through W52)||0||
60074275|NCT01604343|76189699|FG003|Participants Re-randomized at Week 40|Prior to W52 Administration(Through W52)||0||
60074276|NCT01604343|76189700|FG004|Participants Re-randomized at Week 40|Prior to W52 Administration(Through W52)||0||
60074277|NCT01604343|76189696|FG000|COMPLETED|Prior to W52 Administration(Through W52)||458||
60074278|NCT01604343|76189697|FG001|COMPLETED|Prior to W52 Administration(Through W52)||0||
60074279|NCT01604343|76189698|FG002|COMPLETED|Prior to W52 Administration(Through W52)||481||
60074280|NCT01604343|76189699|FG003|COMPLETED|Prior to W52 Administration(Through W52)||0||
60074281|NCT01604343|76189700|FG004|COMPLETED|Prior to W52 Administration(Through W52)||470||
60074282|NCT01604343|76189696|FG000|NOT COMPLETED|Prior to W52 Administration(Through W52)||98||
60074283|NCT01604343|76189697|FG001|NOT COMPLETED|Prior to W52 Administration(Through W52)||0||
60074284|NCT01604343|76189698|FG002|NOT COMPLETED|Prior to W52 Administration(Through W52)||76||
60074285|NCT01604343|76189699|FG003|NOT COMPLETED|Prior to W52 Administration(Through W52)||0||
60103597|NCT04075734|76221848|FG000|NOT COMPLETED|Overall Study||4||
59524755|NCT01052207|75619851|FG000|STARTED|Overall Study||60||
59524756|NCT01052207|75619852|FG001|STARTED|Overall Study||42||
59524757|NCT01052207|75619851|FG000|COMPLETED|Overall Study||60||
59524758|NCT01052207|75619852|FG001|COMPLETED|Overall Study||42||
59524759|NCT01052207|75619851|FG000|NOT COMPLETED|Overall Study||0||
59524760|NCT01052207|75619852|FG001|NOT COMPLETED|Overall Study||0||
59524761|NCT01670006|75619858|FG000|STARTED|Overall Study||10||
59524762|NCT01670006|75619858|FG000|COMPLETED|Overall Study||10||
59524763|NCT01670006|75619858|FG000|NOT COMPLETED|Overall Study||0||
59524764|NCT01052831|75619864|FG000|STARTED|Overall Study||26||
59524765|NCT01052831|75619865|FG001|STARTED|Overall Study||24||
59524766|NCT01052831|75619864|FG000|COMPLETED|Overall Study||22||
59809531|NCT00412360|75931686|FG001|COMPLETED|Overall Study||108||
59809532|NCT00412360|75931685|FG000|NOT COMPLETED|Overall Study||1||
59809533|NCT00412360|75931686|FG001|NOT COMPLETED|Overall Study||3||
59809534|NCT00571103|75931692|FG000|STARTED|Overall Study||28||
59809535|NCT00571103|75931692|FG000|COMPLETED|Overall Study|Of the 28 participants, 1 subject withdrew and 1 was lost to follow-up after their baseline visit.|26||
59809536|NCT00571103|75931692|FG000|NOT COMPLETED|Overall Study||2||
59964656|NCT01066819|76082355|FG005|STARTED|Overall Study||13||
59964657|NCT01066819|76082350|FG000|COMPLETED|Overall Study||317||
59964658|NCT01066819|76082351|FG001|COMPLETED|Overall Study||177||
59964659|NCT01066819|76082352|FG002|COMPLETED|Overall Study||111||
59964660|NCT01066819|76082353|FG003|COMPLETED|Overall Study||8||
59964661|NCT01066819|76082354|FG004|COMPLETED|Overall Study||3||
59964662|NCT01066819|76082355|FG005|COMPLETED|Overall Study||7||
59964663|NCT01066819|76082350|FG000|NOT COMPLETED|Overall Study||689||
59964664|NCT01066819|76082351|FG001|NOT COMPLETED|Overall Study||171||
59964665|NCT01066819|76082352|FG002|NOT COMPLETED|Overall Study||146||
59964666|NCT01066819|76082353|FG003|NOT COMPLETED|Overall Study||17||
59964667|NCT01066819|76082354|FG004|NOT COMPLETED|Overall Study||4||
59964668|NCT01066819|76082355|FG005|NOT COMPLETED|Overall Study||6||
59964669|NCT04056299|76082369|FG000|STARTED|Overall Study||9||
59964670|NCT04056299|76082370|FG001|STARTED|Overall Study||6||
59964671|NCT04056299|76082369|FG000|COMPLETED|Overall Study||6||
59964672|NCT04056299|76082370|FG001|COMPLETED|Overall Study||3||
59964673|NCT04056299|76082369|FG000|NOT COMPLETED|Overall Study||3||
59964674|NCT04056299|76082370|FG001|NOT COMPLETED|Overall Study||3||
59964675|NCT04057937|76082378|FG000|STARTED|Placebo-controlled Phase||44||
59964676|NCT04057937|76082379|FG001|STARTED|Placebo-controlled Phase||46||
59964677|NCT04057937|76082378|FG000|COMPLETED|Placebo-controlled Phase||41||
59809537|NCT00069277|75931696|FG000|STARTED|Overall Study||21||
59809538|NCT00069277|75931696|FG000|COMPLETED|Overall Study||0||
59809539|NCT00069277|75931696|FG000|NOT COMPLETED|Overall Study||21||
59809540|NCT00418522|75931702|FG000|STARTED|Overall Study||219||
59809541|NCT00418522|75931703|FG001|STARTED|Overall Study||194||
59809542|NCT00418522|75931702|FG000|Received Treatment|Overall Study||212||
59809543|NCT00418522|75931703|FG001|Received Treatment|Overall Study||190||
59809544|NCT00418522|75931702|FG000|COMPLETED|Overall Study||136||
59809545|NCT00418522|75931703|FG001|COMPLETED|Overall Study||152||
59809546|NCT00418522|75931702|FG000|NOT COMPLETED|Overall Study||83||
59964678|NCT04057937|76082379|FG001|COMPLETED|Placebo-controlled Phase||46||
59964679|NCT04057937|76082378|FG000|NOT COMPLETED|Placebo-controlled Phase||3||
59964680|NCT04057937|76082379|FG001|NOT COMPLETED|Placebo-controlled Phase||0||
59964681|NCT04057937|76082378|FG000|STARTED|Active-treatment Phase||41||
59964682|NCT04057937|76082379|FG001|STARTED|Active-treatment Phase||46||
59964683|NCT04057937|76082378|FG000|COMPLETED|Active-treatment Phase||40||
59964684|NCT04057937|76082379|FG001|COMPLETED|Active-treatment Phase||44||
59964685|NCT04057937|76082378|FG000|NOT COMPLETED|Active-treatment Phase||1||
59809547|NCT00418522|75931703|FG001|NOT COMPLETED|Overall Study||42||
59809548|NCT00403546|75931711|FG000|STARTED|Signed Informed Consent/Open-Label||131||
59809549|NCT00403546|75931712|FG001|STARTED|Signed Informed Consent/Open-Label||0||
59809550|NCT00403546|75931713|FG002|STARTED|Signed Informed Consent/Open-Label||0||
59809551|NCT00403546|75931711|FG000|COMPLETED|Signed Informed Consent/Open-Label||103||
59809552|NCT00403546|75931712|FG001|COMPLETED|Signed Informed Consent/Open-Label||0||
59809553|NCT00403546|75931713|FG002|COMPLETED|Signed Informed Consent/Open-Label||0||
59809554|NCT00403546|75931711|FG000|NOT COMPLETED|Signed Informed Consent/Open-Label||28||
59809555|NCT00403546|75931712|FG001|NOT COMPLETED|Signed Informed Consent/Open-Label||0||
59809556|NCT00403546|75931713|FG002|NOT COMPLETED|Signed Informed Consent/Open-Label||0||
59809557|NCT00403546|75931711|FG000|STARTED|Screening Phase||103||
59809558|NCT00403546|75931712|FG001|STARTED|Screening Phase||0||
59809559|NCT00403546|75931713|FG002|STARTED|Screening Phase||0||
59809560|NCT00403546|75931711|FG000|COMPLETED|Screening Phase|All participants who completed Screening were randomized to the High-Dose and Placebo arms.|75||
59809561|NCT00403546|75931712|FG001|COMPLETED|Screening Phase||0||
59809562|NCT00403546|75931713|FG002|COMPLETED|Screening Phase||0||
59809563|NCT00403546|75931711|FG000|NOT COMPLETED|Screening Phase||28||
59809564|NCT00403546|75931712|FG001|NOT COMPLETED|Screening Phase||0||
59809565|NCT00403546|75931713|FG002|NOT COMPLETED|Screening Phase||0||
59809566|NCT00403546|75931711|FG000|STARTED|Randomized Trial|All participants who completed Screening were randomized to the High-Dose and Placebo arms.|0||
59964686|NCT04057937|76082379|FG001|NOT COMPLETED|Active-treatment Phase||2||
59964687|NCT01069523|76082388|FG000|STARTED|Overall Study||13||
59964688|NCT01069523|76082389|FG001|STARTED|Overall Study||16||
59964689|NCT01069523|76082388|FG000|COMPLETED|Overall Study||9||
59964690|NCT01069523|76082389|FG001|COMPLETED|Overall Study||9||
59964691|NCT01069523|76082388|FG000|NOT COMPLETED|Overall Study||4||
59964692|NCT01069523|76082389|FG001|NOT COMPLETED|Overall Study||7||
59964693|NCT01069289|76082399|FG000|STARTED|Overall Study||636||
59809567|NCT00403546|75931712|FG001|STARTED|Randomized Trial||38||
59809568|NCT00403546|75931713|FG002|STARTED|Randomized Trial||37||
59964694|NCT01069289|76082400|FG001|STARTED|Overall Study||657||
59964695|NCT01069289|76082399|FG000|COMPLETED|Overall Study||594||
59964696|NCT01069289|76082400|FG001|COMPLETED|Overall Study||601||
59964697|NCT01069289|76082399|FG000|NOT COMPLETED|Overall Study||42||
60074286|NCT01604343|76189700|FG004|NOT COMPLETED|Prior to W52 Administration(Through W52)||87||
59809569|NCT00403546|75931711|FG000|COMPLETED|Randomized Trial||0||
59809570|NCT00403546|75931712|FG001|COMPLETED|Randomized Trial||21||
59964698|NCT01069289|76082400|FG001|NOT COMPLETED|Overall Study||56||
59964699|NCT03303989|76082408|FG000|STARTED|Overall Study||24||
59964700|NCT03303989|76082409|FG001|STARTED|Overall Study||11||
59809571|NCT00403546|75931713|FG002|COMPLETED|Randomized Trial||21||
59809572|NCT00403546|75931711|FG000|NOT COMPLETED|Randomized Trial||0||
59809573|NCT00403546|75931712|FG001|NOT COMPLETED|Randomized Trial||17||
59964701|NCT03303989|76082408|FG000|COMPLETED|Overall Study||22||
59964702|NCT03303989|76082409|FG001|COMPLETED|Overall Study||10||
59964703|NCT03303989|76082408|FG000|NOT COMPLETED|Overall Study||2||
59964704|NCT03303989|76082409|FG001|NOT COMPLETED|Overall Study||1||
59964705|NCT02510794|76082419|FG000|STARTED|Overall Study||59||
59964706|NCT02510794|76082420|FG001|STARTED|Overall Study||62||
59964707|NCT02510794|76082421|FG002|STARTED|Overall Study||63||
59964708|NCT02510794|76082422|FG003|STARTED|Overall Study||41||
59964709|NCT02510794|76082419|FG000|COMPLETED|Overall Study||51||
59964710|NCT02510794|76082420|FG001|COMPLETED|Overall Study||56||
59964711|NCT02510794|76082421|FG002|COMPLETED|Overall Study||56||
59964712|NCT02510794|76082422|FG003|COMPLETED|Overall Study||36||
59964713|NCT02510794|76082419|FG000|NOT COMPLETED|Overall Study||8||
59964714|NCT02510794|76082420|FG001|NOT COMPLETED|Overall Study||6||
59964715|NCT02510794|76082421|FG002|NOT COMPLETED|Overall Study||7||
59964716|NCT02510794|76082422|FG003|NOT COMPLETED|Overall Study||5||
59964717|NCT03370757|76082436|FG000|STARTED|Overall Study||20||
59964718|NCT03370757|76082437|FG001|STARTED|Overall Study||28||
59964719|NCT03370757|76082436|FG000|COMPLETED|Overall Study||20||
59964720|NCT03370757|76082437|FG001|COMPLETED|Overall Study||26||
59964721|NCT03370757|76082436|FG000|NOT COMPLETED|Overall Study||0||
59964722|NCT03370757|76082437|FG001|NOT COMPLETED|Overall Study||2||
59964723|NCT02510014|76082447|FG000|STARTED|Run-In Period (Days -14 to Day -1)||508|Received at least one dose of SUBOXONE sublingual film.|
59964724|NCT02510014|76082448|FG001|STARTED|Run-In Period (Days -14 to Day -1)||267|Received at least one dose of SUBOXONE sublingual film.|
59964725|NCT02510014|76082447|FG000|COMPLETED|Run-In Period (Days -14 to Day -1)||412||
59964726|NCT02510014|76082448|FG001|COMPLETED|Run-In Period (Days -14 to Day -1)||257||
59964727|NCT02510014|76082447|FG000|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||96||
59964728|NCT02510014|76082448|FG001|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||10||
59964729|NCT02510014|76082447|FG000|STARTED|Treatment Period||412||
59964730|NCT02510014|76082448|FG001|STARTED|Treatment Period||257||
59964731|NCT02510014|76082447|FG000|COMPLETED|Treatment Period||206||
59964732|NCT02510014|76082448|FG001|COMPLETED|Treatment Period||200||
59964733|NCT02510014|76082447|FG000|NOT COMPLETED|Treatment Period||206||
59964734|NCT02510014|76082448|FG001|NOT COMPLETED|Treatment Period||57||
59964735|NCT02509312|76082456|FG000|STARTED|Overall Study||35||
59964736|NCT02509312|76082457|FG001|STARTED|Overall Study||35||
59964737|NCT02509312|76082456|FG000|Intraoperative Checkpoint|Overall Study||28|Checkpoint to confirm patients still meet inclusion and exclusion criteria.|
59964738|NCT02509312|76082457|FG001|Intraoperative Checkpoint|Overall Study||30|Checkpoint to confirm patients still meet inclusion and exclusion criteria.|
59964739|NCT02509312|76082456|FG000|COMPLETED|Overall Study||28||
59964740|NCT02509312|76082457|FG001|COMPLETED|Overall Study||30||
59964741|NCT02509312|76082456|FG000|NOT COMPLETED|Overall Study||7||
59964742|NCT02509312|76082457|FG001|NOT COMPLETED|Overall Study||5||
59964743|NCT02509156|76082467|FG000|STARTED|Open-Label Lead-In Phase||6||
59524767|NCT01052831|75619865|FG001|COMPLETED|Overall Study||23||
59524768|NCT01052831|75619864|FG000|NOT COMPLETED|Overall Study||4||
59809574|NCT00403546|75931713|FG002|NOT COMPLETED|Randomized Trial||16||
59809575|NCT00403390|75931724|FG000|STARTED|Overall Study||16||
59964744|NCT02509156|76082468|FG001|STARTED|Open-Label Lead-In Phase||0||
59964745|NCT02509156|76082467|FG000|COMPLETED|Open-Label Lead-In Phase||6||
59964746|NCT02509156|76082468|FG001|COMPLETED|Open-Label Lead-In Phase||0||
59964747|NCT02509156|76082467|FG000|NOT COMPLETED|Open-Label Lead-In Phase||0||
59964748|NCT02509156|76082468|FG001|NOT COMPLETED|Open-Label Lead-In Phase||0||
59964749|NCT02509156|76082467|FG000|STARTED|Randomized Phase|Includes randomized participants only|14||
59964750|NCT02509156|76082468|FG001|STARTED|Randomized Phase||17||
59809576|NCT00403390|75931725|FG001|STARTED|Overall Study||18||
59809577|NCT00403390|75931724|FG000|COMPLETED|Overall Study||13||
59809578|NCT00403390|75931725|FG001|COMPLETED|Overall Study||18||
59809579|NCT00403390|75931724|FG000|NOT COMPLETED|Overall Study||3||
59809580|NCT00403390|75931725|FG001|NOT COMPLETED|Overall Study||0||
59809581|NCT00403234|75931735|FG000|STARTED|Overall Study||2||
59809582|NCT00403234|75931736|FG001|STARTED|Overall Study||3||
59809583|NCT00403234|75931737|FG002|STARTED|Overall Study||3||
59809584|NCT00403234|75931738|FG003|STARTED|Overall Study||2||
59809585|NCT00403234|75931735|FG000|COMPLETED|Overall Study||1||
59809586|NCT00403234|75931736|FG001|COMPLETED|Overall Study||2||
59964751|NCT02509156|76082467|FG000|COMPLETED|Randomized Phase||12||
59964752|NCT02509156|76082468|FG001|COMPLETED|Randomized Phase||16||
59964753|NCT02509156|76082467|FG000|NOT COMPLETED|Randomized Phase||2||
59964754|NCT02509156|76082468|FG001|NOT COMPLETED|Randomized Phase||1||
59964755|NCT01654666|76082477|FG000|STARTED|Overall Study||63||
59964756|NCT01654666|76082478|FG001|STARTED|Overall Study||63||
59524769|NCT01052831|75619865|FG001|NOT COMPLETED|Overall Study||1||
59809587|NCT00403234|75931737|FG002|COMPLETED|Overall Study||2||
59809588|NCT00403234|75931738|FG003|COMPLETED|Overall Study||2||
59809589|NCT00403234|75931735|FG000|NOT COMPLETED|Overall Study||1||
59809590|NCT00403234|75931736|FG001|NOT COMPLETED|Overall Study||1||
59964757|NCT01654666|76082479|FG002|STARTED|Overall Study||63||
59964758|NCT01654666|76082477|FG000|Primary Analysis|Overall Study||52||
59964759|NCT01654666|76082478|FG001|Primary Analysis|Overall Study||56||
59964760|NCT01654666|76082479|FG002|Primary Analysis|Overall Study||54||
59964761|NCT01654666|76082477|FG000|COMPLETED|Overall Study||48||
59964762|NCT01654666|76082478|FG001|COMPLETED|Overall Study||50||
59964763|NCT01654666|76082479|FG002|COMPLETED|Overall Study||49||
59964764|NCT01654666|76082477|FG000|NOT COMPLETED|Overall Study||15||
59964765|NCT01654666|76082478|FG001|NOT COMPLETED|Overall Study||13||
59964766|NCT01654666|76082479|FG002|NOT COMPLETED|Overall Study||14||
59964767|NCT02519842|76082489|FG000|STARTED|Base Study: Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6.|38||
59964768|NCT02519842|76082490|FG001|STARTED|Base Study: Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6.|37||
59964769|NCT02519842|76082491|FG002|STARTED|Base Study: Cycle 1||0||
59964770|NCT02519842|76082489|FG000|Treated|Base Study: Cycle 1||37||
59964771|NCT02519842|76082490|FG001|Treated|Base Study: Cycle 1||34||
59964772|NCT02519842|76082491|FG002|Treated|Base Study: Cycle 1||0||
59964773|NCT02519842|76082489|FG000|COMPLETED|Base Study: Cycle 1||36||
59964774|NCT02519842|76082490|FG001|COMPLETED|Base Study: Cycle 1||34||
59964775|NCT02519842|76082491|FG002|COMPLETED|Base Study: Cycle 1||0||
59964776|NCT02519842|76082489|FG000|NOT COMPLETED|Base Study: Cycle 1||2||
59964777|NCT02519842|76082490|FG001|NOT COMPLETED|Base Study: Cycle 1||3||
59964778|NCT02519842|76082491|FG002|NOT COMPLETED|Base Study: Cycle 1||0||
59964779|NCT02519842|76082489|FG000|STARTED|Optional Extension: Cycles 2-6|27 participants from this arm in Cycle 1 entered optional Cycles 2-6|0||
59964780|NCT02519842|76082490|FG001|STARTED|Optional Extension: Cycles 2-6|28 participants from this arm in Cycle 1 entered optional Cycles 2-6|0||
59964781|NCT02519842|76082491|FG002|STARTED|Optional Extension: Cycles 2-6|Enrollment in Cycles 2-6 was optional.|55||
59964782|NCT02519842|76082489|FG000|Treated|Optional Extension: Cycles 2-6||0||
59964783|NCT02519842|76082490|FG001|Treated|Optional Extension: Cycles 2-6||0||
59964784|NCT02519842|76082491|FG002|Treated|Optional Extension: Cycles 2-6||55||
59964785|NCT02519842|76082489|FG000|COMPLETED|Optional Extension: Cycles 2-6||0||
59964786|NCT02519842|76082490|FG001|COMPLETED|Optional Extension: Cycles 2-6||0||
59964787|NCT02519842|76082491|FG002|COMPLETED|Optional Extension: Cycles 2-6||26||
59964788|NCT02519842|76082489|FG000|NOT COMPLETED|Optional Extension: Cycles 2-6||0||
59964789|NCT02519842|76082490|FG001|NOT COMPLETED|Optional Extension: Cycles 2-6||0||
59964790|NCT02519842|76082491|FG002|NOT COMPLETED|Optional Extension: Cycles 2-6||29||
59964791|NCT02509078|76082501|FG000|STARTED|Overall Study||502||
59964792|NCT02509078|76082502|FG001|STARTED|Overall Study||506||
59809591|NCT00403234|75931737|FG002|NOT COMPLETED|Overall Study||1||
59809592|NCT00403234|75931738|FG003|NOT COMPLETED|Overall Study||0||
59809593|NCT00402688|75931751|FG000|STARTED|Overall Study||81||
59809594|NCT00402688|75931752|FG001|STARTED|Overall Study||81||
59809595|NCT00402688|75931753|FG002|STARTED|Overall Study||80||
59809596|NCT00402688|75931751|FG000|COMPLETED|Overall Study||60||
59809597|NCT00402688|75931752|FG001|COMPLETED|Overall Study||65||
59809598|NCT00402688|75931753|FG002|COMPLETED|Overall Study||65||
59809599|NCT00402688|75931751|FG000|NOT COMPLETED|Overall Study||21||
59809600|NCT00402688|75931752|FG001|NOT COMPLETED|Overall Study||16||
59809601|NCT00402688|75931753|FG002|NOT COMPLETED|Overall Study||15||
59809602|NCT00671879|75931764|FG000|STARTED|Overall Study||281||
59809603|NCT00671879|75931765|FG001|STARTED|Overall Study||279||
59809604|NCT00671879|75931766|FG002|STARTED|Overall Study||280||
59809605|NCT00671879|75931764|FG000|COMPLETED|Overall Study||281||
59809606|NCT00671879|75931765|FG001|COMPLETED|Overall Study||275||
59809607|NCT00671879|75931766|FG002|COMPLETED|Overall Study||274||
59809608|NCT00671879|75931764|FG000|NOT COMPLETED|Overall Study||0||
59809609|NCT00671879|75931765|FG001|NOT COMPLETED|Overall Study||4||
59809610|NCT00671879|75931766|FG002|NOT COMPLETED|Overall Study||6||
59809611|NCT00401830|75931777|FG000|STARTED|Overall Study||81||
59809612|NCT00401830|75931778|FG001|STARTED|Overall Study||78||
59809613|NCT00401830|75931777|FG000|COMPLETED|Overall Study||50||
59964793|NCT02509078|76082501|FG000|COMPLETED|Overall Study||501||
59964794|NCT02509078|76082502|FG001|COMPLETED|Overall Study||505||
59964795|NCT02509078|76082501|FG000|NOT COMPLETED|Overall Study||1||
59964796|NCT02509078|76082502|FG001|NOT COMPLETED|Overall Study||1||
59964797|NCT02993783|76082512|FG000|STARTED|Overall Study||8||
59964798|NCT02993783|76082513|FG001|STARTED|Overall Study||9||
59964799|NCT02993783|76082512|FG000|COMPLETED|Overall Study||2||
59964800|NCT02993783|76082513|FG001|COMPLETED|Overall Study||0||
59964801|NCT02993783|76082512|FG000|NOT COMPLETED|Overall Study||6||
59964802|NCT02993783|76082513|FG001|NOT COMPLETED|Overall Study||9||
59964803|NCT02993471|76082519|FG000|STARTED|Period 1 (Drug Cocktail)||28||
59964804|NCT02993471|76082519|FG000|Received at Least 1 Dose of Study Drug|Period 1 (Drug Cocktail)||28||
59964805|NCT02993471|76082519|FG000|COMPLETED|Period 1 (Drug Cocktail)||28||
59809614|NCT00401830|75931778|FG001|COMPLETED|Overall Study||46||
59809615|NCT00401830|75931777|FG000|NOT COMPLETED|Overall Study||31||
59809616|NCT00401830|75931778|FG001|NOT COMPLETED|Overall Study||32||
59809617|NCT00401752|75931786|FG000|STARTED|Overall Study||107||
59809618|NCT00401752|75931787|FG001|STARTED|Overall Study||112||
59809619|NCT00401752|75931786|FG000|Number of Patients Received Treatment|Overall Study||107||
59524770|NCT01054079|75619871|FG000|STARTED|Overall Study||20||
59964806|NCT02993471|76082519|FG000|NOT COMPLETED|Period 1 (Drug Cocktail)||0||
59964807|NCT02993471|76082519|FG000|STARTED|Period 2 (Drug Cocktail + Ixekizumab)||28||
59964808|NCT02993471|76082519|FG000|Received at Least 1 Dose of Study Drug|Period 2 (Drug Cocktail + Ixekizumab)||27||
59964809|NCT02993471|76082519|FG000|COMPLETED|Period 2 (Drug Cocktail + Ixekizumab)||26||
59964810|NCT02993471|76082519|FG000|NOT COMPLETED|Period 2 (Drug Cocktail + Ixekizumab)||2||
59964811|NCT02988713|76082541|FG000|STARTED|Overall Study||35||
59964812|NCT02988713|76082541|FG000|COMPLETED|Overall Study||32||
59964813|NCT02988713|76082541|FG000|NOT COMPLETED|Overall Study||3||
59964814|NCT01068743|76082545|FG000|STARTED|Period 1||6||
59964815|NCT01068743|76082546|FG001|STARTED|Period 1||6||
59964816|NCT01068743|76082547|FG002|STARTED|Period 1||6||
59524771|NCT01054079|75619871|FG000|# Recieved Proper PSA Testing|Overall Study||10||
59524772|NCT01054079|75619871|FG000|COMPLETED|Overall Study|while all 20 patients received at least some of the intervention, some did not get proper PSA tests.|20||
59524773|NCT01054079|75619871|FG000|NOT COMPLETED|Overall Study||0||
59524774|NCT01054703|75619875|FG000|STARTED|Overall Study||14||
59524775|NCT01054703|75619875|FG000|COMPLETED|Overall Study||14||
59524776|NCT01054703|75619875|FG000|NOT COMPLETED|Overall Study||0||
59524777|NCT02544750|75619881|FG000|STARTED|Overall Study||124||
59524778|NCT02544750|75619882|FG001|STARTED|Overall Study||75||
59524779|NCT02544750|75619881|FG000|COMPLETED|Overall Study||22||
59524780|NCT02544750|75619882|FG001|COMPLETED|Overall Study||12||
59524781|NCT02544750|75619881|FG000|NOT COMPLETED|Overall Study||102||
59524782|NCT02544750|75619882|FG001|NOT COMPLETED|Overall Study||63||
59524783|NCT02171195|75619897|FG000|STARTED|Overall Study||16||
59524784|NCT02171195|75619898|FG001|STARTED|Overall Study||6||
59524785|NCT02171195|75619899|FG002|STARTED|Overall Study||6||
59524786|NCT02171195|75619900|FG003|STARTED|Overall Study||6||
59524787|NCT02171195|75619901|FG004|STARTED|Overall Study||6||
59524788|NCT02171195|75619902|FG005|STARTED|Overall Study||6||
59524789|NCT02171195|75619903|FG006|STARTED|Overall Study||6||
59524790|NCT02171195|75619904|FG007|STARTED|Overall Study||6||
59524791|NCT02171195|75619905|FG008|STARTED|Overall Study||6||
59524792|NCT02171195|75619897|FG000|COMPLETED|Overall Study||16||
59524793|NCT02171195|75619898|FG001|COMPLETED|Overall Study||6||
59524794|NCT02171195|75619899|FG002|COMPLETED|Overall Study||6||
59524795|NCT02171195|75619900|FG003|COMPLETED|Overall Study||6||
59524796|NCT02171195|75619901|FG004|COMPLETED|Overall Study||6||
59524797|NCT02171195|75619902|FG005|COMPLETED|Overall Study||6||
59524798|NCT02171195|75619903|FG006|COMPLETED|Overall Study||6||
59524799|NCT02171195|75619904|FG007|COMPLETED|Overall Study||6||
59524800|NCT02171195|75619905|FG008|COMPLETED|Overall Study||6||
59524801|NCT02171195|75619897|FG000|NOT COMPLETED|Overall Study||0||
59524802|NCT02171195|75619898|FG001|NOT COMPLETED|Overall Study||0||
59524803|NCT02171195|75619899|FG002|NOT COMPLETED|Overall Study||0||
59524804|NCT02171195|75619900|FG003|NOT COMPLETED|Overall Study||0||
59524805|NCT02171195|75619901|FG004|NOT COMPLETED|Overall Study||0||
59809620|NCT00401752|75931787|FG001|Number of Patients Received Treatment|Overall Study||111||
59809621|NCT00401752|75931786|FG000|Patients Included in ITT Population|Overall Study||106||
59964817|NCT01068743|76082548|FG003|STARTED|Period 1||6||
59524806|NCT02171195|75619902|FG005|NOT COMPLETED|Overall Study||0||
59524807|NCT02171195|75619903|FG006|NOT COMPLETED|Overall Study||0||
59524808|NCT02171195|75619904|FG007|NOT COMPLETED|Overall Study||0||
59524809|NCT02171195|75619905|FG008|NOT COMPLETED|Overall Study||0||
59524810|NCT02540538|75619928|FG000|STARTED|Overall Study||12||
59524811|NCT02540538|75619929|FG001|STARTED|Overall Study||12||
59524812|NCT02540538|75619930|FG002|STARTED|Overall Study||10||
59524813|NCT02540538|75619928|FG000|COMPLETED|Overall Study||12||
59524814|NCT02540538|75619929|FG001|COMPLETED|Overall Study||11||
59809622|NCT00401752|75931787|FG001|Patients Included in ITT Population|Overall Study||111||
59809623|NCT00401752|75931786|FG000|Patients Included in Safety Population|Overall Study||107||
59964818|NCT01068743|76082545|FG000|COMPLETED|Period 1||6||
59964819|NCT01068743|76082546|FG001|COMPLETED|Period 1||6||
59524815|NCT02540538|75619930|FG002|COMPLETED|Overall Study||10||
59524816|NCT02540538|75619928|FG000|NOT COMPLETED|Overall Study||0||
59524817|NCT02540538|75619929|FG001|NOT COMPLETED|Overall Study||1||
59524818|NCT02540538|75619930|FG002|NOT COMPLETED|Overall Study||0||
59524819|NCT02201628|75619938|FG000|STARTED|Overall Study||50||
59524820|NCT02201628|75619938|FG000|COMPLETED|Overall Study||50||
59524821|NCT02201628|75619938|FG000|NOT COMPLETED|Overall Study||0||
59524822|NCT01055171|75619944|FG000|STARTED|Overall Study|Randomized to receive medication.|29||
59524823|NCT01055171|75619945|FG001|STARTED|Overall Study|Randomized to receive placebo.|28||
59524824|NCT01055171|75619944|FG000|Retrieval Completion|Overall Study|Received the medication and completed the retrieval session.|25||
59524825|NCT01055171|75619945|FG001|Retrieval Completion|Overall Study|Received the sugar pill and completed the retrieval session.|24||
59524826|NCT01055171|75619944|FG000|Test Procedure Completion|Overall Study|Received the medication and completed the first test session.|21||
59524827|NCT01055171|75619945|FG001|Test Procedure Completion|Overall Study|Received the placebo and completed the first test session.|23||
59621479|NCT00344682|75733080|FG001|COMPLETED|Overall Study||14||
59809624|NCT00401752|75931787|FG001|Patients Included in Safety Population|Overall Study||110||
59524828|NCT01055171|75619944|FG000|COMPLETED|Overall Study|Received the medication and completed all visits including the one-week follow-up.|18||
59524829|NCT01055171|75619945|FG001|COMPLETED|Overall Study|Received the sugar pill and completed all visits including the one-week follow-up.|21||
59524830|NCT01055171|75619944|FG000|NOT COMPLETED|Overall Study||11||
59524831|NCT01055171|75619945|FG001|NOT COMPLETED|Overall Study||7||
59524832|NCT00888290|75619951|FG000|STARTED|Overall Study||20||
59524833|NCT00888290|75619951|FG000|COMPLETED|Overall Study||20||
59964820|NCT01068743|76082547|FG002|COMPLETED|Period 1||6||
59964821|NCT01068743|76082548|FG003|COMPLETED|Period 1||6||
59524834|NCT00888290|75619951|FG000|NOT COMPLETED|Overall Study||0||
59524835|NCT01057277|75619957|FG000|STARTED|Overall Study||3||
59524836|NCT01057277|75619957|FG000|COMPLETED|Overall Study||3||
59524837|NCT01057277|75619957|FG000|NOT COMPLETED|Overall Study||0||
59809625|NCT00401752|75931786|FG000|Patients Included in Per-Protocol Popula|Overall Study||100||
59809626|NCT00401752|75931787|FG001|Patients Included in Per-Protocol Popula|Overall Study||99||
59809627|NCT00401752|75931786|FG000|COMPLETED|Overall Study||97||
59809628|NCT00401752|75931787|FG001|COMPLETED|Overall Study||94||
59809629|NCT00401752|75931786|FG000|NOT COMPLETED|Overall Study||10||
59809630|NCT00401752|75931787|FG001|NOT COMPLETED|Overall Study||18||
59809631|NCT00539240|75931796|FG000|STARTED|Overall Study||59||
59809632|NCT00539240|75931797|FG001|STARTED|Overall Study||55||
59809633|NCT00539240|75931798|FG002|STARTED|Overall Study||54||
59809634|NCT00539240|75931796|FG000|COMPLETED|Overall Study||53||
59809635|NCT00539240|75931797|FG001|COMPLETED|Overall Study||48||
59809636|NCT00539240|75931798|FG002|COMPLETED|Overall Study||39||
59809637|NCT00539240|75931796|FG000|NOT COMPLETED|Overall Study||6||
59809638|NCT00539240|75931797|FG001|NOT COMPLETED|Overall Study||7||
59809639|NCT00539240|75931798|FG002|NOT COMPLETED|Overall Study||15||
59809640|NCT00417976|75931806|FG000|STARTED|Overall Study||42||
59809641|NCT00417976|75931806|FG000|COMPLETED|Overall Study||39||
59809642|NCT00417976|75931806|FG000|NOT COMPLETED|Overall Study||3||
59809643|NCT00673673|75931811|FG000|STARTED|Overall Study||39||
59809644|NCT00673673|75931811|FG000|COMPLETED|Overall Study||3||
59809645|NCT00673673|75931811|FG000|NOT COMPLETED|Overall Study||36||
59809646|NCT00069121|75931817|FG000|STARTED|Overall Study||942||
59809647|NCT00069121|75931818|FG001|STARTED|Overall Study||944||
59809648|NCT00069121|75931817|FG000|Received Treatment|Overall Study|Safety Population|926||
59809649|NCT00069121|75931818|FG001|Received Treatment|Overall Study|Safety Population|938||
59809650|NCT00069121|75931817|FG000|COMPLETED|Overall Study|total includes Completed and Alive in follow-up|575||
59809651|NCT00069121|75931818|FG001|COMPLETED|Overall Study|total includes Completed and Alive in follow-up|619||
59809652|NCT00069121|75931817|FG000|NOT COMPLETED|Overall Study||367||
59809653|NCT00069121|75931818|FG001|NOT COMPLETED|Overall Study||325||
59809654|NCT00399802|75931830|FG000|STARTED|Overall Study||14||
59809655|NCT00399802|75931831|FG001|STARTED|Overall Study||29||
59809656|NCT00399802|75931830|FG000|COMPLETED|Overall Study||14||
59809657|NCT00399802|75931831|FG001|COMPLETED|Overall Study||26||
59809658|NCT00399802|75931830|FG000|NOT COMPLETED|Overall Study||0||
59809659|NCT00399802|75931831|FG001|NOT COMPLETED|Overall Study||3||
59809660|NCT00399568|75931839|FG000|STARTED|Overall Study||166||
59809661|NCT00399568|75931840|FG001|STARTED|Overall Study||165||
59809662|NCT00399568|75931839|FG000|COMPLETED|Overall Study||154||
59809663|NCT00399568|75931840|FG001|COMPLETED|Overall Study||156||
59809664|NCT00399568|75931839|FG000|NOT COMPLETED|Overall Study||12||
59809665|NCT00399568|75931840|FG001|NOT COMPLETED|Overall Study||9||
59809666|NCT03900728|75931851|FG000|STARTED|Overall Study||40||
59809667|NCT03900728|75931852|FG001|STARTED|Overall Study||57||
59809668|NCT03900728|75931853|FG002|STARTED|Overall Study||39||
59809669|NCT03900728|75931851|FG000|COMPLETED|Overall Study||40||
59809670|NCT03900728|75931852|FG001|COMPLETED|Overall Study||57||
59809671|NCT03900728|75931853|FG002|COMPLETED|Overall Study||35||
59809672|NCT03900728|75931851|FG000|NOT COMPLETED|Overall Study||0||
59809673|NCT03900728|75931852|FG001|NOT COMPLETED|Overall Study||0||
59809674|NCT03900728|75931853|FG002|NOT COMPLETED|Overall Study||4||
59809675|NCT00068419|75931861|FG000|STARTED|Overall Study||70||
59524838|NCT04697056|75619963|FG000|STARTED|Overall Study||4||
59524839|NCT04697056|75619964|FG001|STARTED|Overall Study||1||
59524840|NCT04697056|75619963|FG000|COMPLETED|Overall Study||0||
59524841|NCT04697056|75619964|FG001|COMPLETED|Overall Study||0||
59809676|NCT00068419|75931861|FG000|COMPLETED|Overall Study|Participant flow data reported here are for the period of protocol therapy.|10||
59809677|NCT00068419|75931861|FG000|NOT COMPLETED|Overall Study||60||
59809678|NCT00068107|75931865|FG000|STARTED|Overall Study||12||
59809679|NCT00068107|75931865|FG000|COMPLETED|Overall Study||3||
59809680|NCT00068107|75931865|FG000|NOT COMPLETED|Overall Study||9||
59809681|NCT00394654|75931874|FG000|STARTED|Overall Study||15||
59964822|NCT01068743|76082545|FG000|NOT COMPLETED|Period 1||0||
59964823|NCT01068743|76082546|FG001|NOT COMPLETED|Period 1||0||
59809682|NCT00394654|75931875|FG001|STARTED|Overall Study||15||
59809683|NCT00394654|75931874|FG000|COMPLETED|Overall Study||13||
59809684|NCT00394654|75931875|FG001|COMPLETED|Overall Study||15||
59809685|NCT00394654|75931874|FG000|NOT COMPLETED|Overall Study||2||
59809686|NCT00394654|75931875|FG001|NOT COMPLETED|Overall Study||0||
59809687|NCT03900416|75931883|FG000|STARTED|Baseline||72||
59964824|NCT01068743|76082547|FG002|NOT COMPLETED|Period 1||0||
59964825|NCT01068743|76082548|FG003|NOT COMPLETED|Period 1||0||
59964826|NCT01068743|76082545|FG000|STARTED|Period 2||6||
59964827|NCT01068743|76082546|FG001|STARTED|Period 2||6||
59964828|NCT01068743|76082547|FG002|STARTED|Period 2||6||
59964829|NCT01068743|76082548|FG003|STARTED|Period 2||6||
59964830|NCT01068743|76082545|FG000|COMPLETED|Period 2||6||
59964831|NCT01068743|76082546|FG001|COMPLETED|Period 2||6||
59964832|NCT01068743|76082547|FG002|COMPLETED|Period 2||6||
59964833|NCT01068743|76082548|FG003|COMPLETED|Period 2||6||
59964834|NCT01068743|76082545|FG000|NOT COMPLETED|Period 2||0||
59964835|NCT01068743|76082546|FG001|NOT COMPLETED|Period 2||0||
59964836|NCT01068743|76082547|FG002|NOT COMPLETED|Period 2||0||
59964837|NCT01068743|76082548|FG003|NOT COMPLETED|Period 2||0||
59964838|NCT01068743|76082545|FG000|STARTED|Period 3||6||
59964839|NCT01068743|76082546|FG001|STARTED|Period 3||6||
59964840|NCT01068743|76082547|FG002|STARTED|Period 3||6||
59964841|NCT01068743|76082548|FG003|STARTED|Period 3||6||
59964842|NCT01068743|76082545|FG000|COMPLETED|Period 3||6||
59964843|NCT01068743|76082546|FG001|COMPLETED|Period 3||5||
59964844|NCT01068743|76082547|FG002|COMPLETED|Period 3||6||
59964845|NCT01068743|76082548|FG003|COMPLETED|Period 3||6||
59964846|NCT01068743|76082545|FG000|NOT COMPLETED|Period 3||0||
59964847|NCT01068743|76082546|FG001|NOT COMPLETED|Period 3||1||
59964848|NCT01068743|76082547|FG002|NOT COMPLETED|Period 3||0||
59964849|NCT01068743|76082548|FG003|NOT COMPLETED|Period 3||0||
59964850|NCT01068743|76082545|FG000|STARTED|Period 4||6||
59964851|NCT01068743|76082546|FG001|STARTED|Period 4||5||
59964852|NCT01068743|76082547|FG002|STARTED|Period 4||6||
59964853|NCT01068743|76082548|FG003|STARTED|Period 4||6||
59964854|NCT01068743|76082545|FG000|COMPLETED|Period 4||6||
59964855|NCT01068743|76082546|FG001|COMPLETED|Period 4||5||
59964856|NCT01068743|76082547|FG002|COMPLETED|Period 4||6||
59964857|NCT01068743|76082548|FG003|COMPLETED|Period 4||6||
59964858|NCT01068743|76082545|FG000|NOT COMPLETED|Period 4||0||
59964859|NCT01068743|76082546|FG001|NOT COMPLETED|Period 4||0||
59964860|NCT01068743|76082547|FG002|NOT COMPLETED|Period 4||0||
59964861|NCT01068743|76082548|FG003|NOT COMPLETED|Period 4||0||
59964862|NCT02992691|76082561|FG000|STARTED|Overall Study||56||
59964863|NCT02992691|76082561|FG000|Received Test Product 1|Overall Study||55||
59964864|NCT02992691|76082561|FG000|Received Test Product 2|Overall Study||55||
59964865|NCT02992691|76082561|FG000|Received Test Product 3|Overall Study||52||
59964866|NCT02992691|76082561|FG000|Received Positive Control|Overall Study||55||
59964867|NCT02992691|76082561|FG000|Received Negative Control|Overall Study||55||
59964868|NCT02992691|76082561|FG000|COMPLETED|Overall Study||53||
59964869|NCT02992691|76082561|FG000|NOT COMPLETED|Overall Study||3||
59964870|NCT02921087|76082578|FG000|STARTED|Overall Study||12||
59964871|NCT02921087|76082579|FG001|STARTED|Overall Study||11||
59964872|NCT02921087|76082578|FG000|COMPLETED|Overall Study||12||
59964873|NCT02921087|76082579|FG001|COMPLETED|Overall Study|One subject dropped out prior to 1 week of lens wear while wearing the control lens (lens 1).|10||
59964874|NCT02921087|76082578|FG000|NOT COMPLETED|Overall Study||0||
59964875|NCT02921087|76082579|FG001|NOT COMPLETED|Overall Study||1||
59964876|NCT02907619|76082598|FG000|STARTED|Overall Study||19||
59964877|NCT02907619|76082599|FG001|STARTED|Overall Study||20||
59964878|NCT02907619|76082600|FG002|STARTED|Overall Study||20||
59964879|NCT02907619|76082598|FG000|Received Treatment|Overall Study||19||
59964880|NCT02907619|76082599|FG001|Received Treatment|Overall Study||20||
59964881|NCT02907619|76082600|FG002|Received Treatment|Overall Study||20||
59964882|NCT02907619|76082598|FG000|COMPLETED|Overall Study||0||
59964883|NCT02907619|76082599|FG001|COMPLETED|Overall Study||0||
59964884|NCT02907619|76082600|FG002|COMPLETED|Overall Study||0||
59964885|NCT02907619|76082598|FG000|NOT COMPLETED|Overall Study||19||
59964886|NCT02907619|76082599|FG001|NOT COMPLETED|Overall Study||20||
59964887|NCT02907619|76082600|FG002|NOT COMPLETED|Overall Study||20||
59964888|NCT02986373|76082610|FG000|STARTED|Overall Study||145||
59964889|NCT02986373|76082610|FG000|COMPLETED|Overall Study||106||
59964890|NCT02986373|76082610|FG000|NOT COMPLETED|Overall Study||39||
59964891|NCT02986139|76082616|FG000|STARTED|Overall Study||56||
59964892|NCT02986139|76082617|FG001|STARTED|Overall Study||55||
59964893|NCT02986139|76082616|FG000|Received Etanercept|Overall Study||56||
59964894|NCT02986139|76082617|FG001|Received Etanercept|Overall Study||53||
59964895|NCT02986139|76082616|FG000|COMPLETED|Overall Study||55||
59964896|NCT02986139|76082617|FG001|COMPLETED|Overall Study||51||
59964897|NCT02986139|76082616|FG000|NOT COMPLETED|Overall Study||1||
59964898|NCT02986139|76082617|FG001|NOT COMPLETED|Overall Study||4||
59964899|NCT02989805|76082629|FG000|STARTED|Overall Study||160||
59964900|NCT02989805|76082630|FG001|STARTED|Overall Study||166||
59964901|NCT02989805|76082629|FG000|COMPLETED|Overall Study||154||
59964902|NCT02989805|76082630|FG001|COMPLETED|Overall Study||162||
59964903|NCT02989805|76082629|FG000|NOT COMPLETED|Overall Study||6||
59964904|NCT02989805|76082630|FG001|NOT COMPLETED|Overall Study||4||
59964905|NCT02907463|76082636|FG000|STARTED|Overall Study||280||
59964906|NCT02907463|76082636|FG000|Enrolled Cohort|Overall Study||280||
59964907|NCT02907463|76082636|FG000|Per Protocol Cohort|Overall Study||276||
59964908|NCT02907463|76082636|FG000|COMPLETED|Overall Study||243||
59964909|NCT02907463|76082636|FG000|NOT COMPLETED|Overall Study||37||
59964910|NCT02906917|76082650|FG000|STARTED|Initiation Period (Week 0-26)||267||
59964911|NCT02906917|76082651|FG001|STARTED|Initiation Period (Week 0-26)||265||
59964912|NCT02906917|76082650|FG000|Exposed|Initiation Period (Week 0-26)||265||
59964913|NCT02906917|76082651|FG001|Exposed|Initiation Period (Week 0-26)||263||
59964914|NCT02906917|76082650|FG000|COMPLETED|Initiation Period (Week 0-26)||261||
59964915|NCT02906917|76082651|FG001|COMPLETED|Initiation Period (Week 0-26)||254||
59964916|NCT02906917|76082650|FG000|NOT COMPLETED|Initiation Period (Week 0-26)||6||
59964917|NCT02906917|76082651|FG001|NOT COMPLETED|Initiation Period (Week 0-26)||11||
59964918|NCT02906917|76082650|FG000|STARTED|Intensification Period (Week 26-38)||261||
59964919|NCT02906917|76082651|FG001|STARTED|Intensification Period (Week 26-38)||254||
59964920|NCT02906917|76082650|FG000|COMPLETED|Intensification Period (Week 26-38)||252||
59964921|NCT02906917|76082651|FG001|COMPLETED|Intensification Period (Week 26-38)||247||
59964922|NCT02906917|76082650|FG000|NOT COMPLETED|Intensification Period (Week 26-38)||9||
59964923|NCT02906917|76082651|FG001|NOT COMPLETED|Intensification Period (Week 26-38)||7||
59964924|NCT02982187|76082659|FG000|STARTED|Overall Study||20||
59964925|NCT02982187|76082660|FG001|STARTED|Overall Study||20||
59964926|NCT02982187|76082661|FG002|STARTED|Overall Study||20||
59964927|NCT02982187|76082662|FG003|STARTED|Overall Study||20||
59964928|NCT02982187|76082663|FG004|STARTED|Overall Study||20||
59964929|NCT02982187|76082664|FG005|STARTED|Overall Study||20||
59964930|NCT02982187|76082665|FG006|STARTED|Overall Study||20||
59964931|NCT02982187|76082666|FG007|STARTED|Overall Study||20||
59964932|NCT02982187|76082659|FG000|COMPLETED|Overall Study||20||
59964933|NCT02982187|76082660|FG001|COMPLETED|Overall Study||20||
59964934|NCT02982187|76082661|FG002|COMPLETED|Overall Study||20||
59964935|NCT02982187|76082662|FG003|COMPLETED|Overall Study||20||
59964936|NCT02982187|76082663|FG004|COMPLETED|Overall Study||20||
59964937|NCT02982187|76082664|FG005|COMPLETED|Overall Study||20||
59964938|NCT02982187|76082665|FG006|COMPLETED|Overall Study||19||
59964939|NCT02982187|76082666|FG007|COMPLETED|Overall Study||20||
59964940|NCT02982187|76082659|FG000|NOT COMPLETED|Overall Study||0||
59964941|NCT02982187|76082660|FG001|NOT COMPLETED|Overall Study||0||
59964942|NCT02982187|76082661|FG002|NOT COMPLETED|Overall Study||0||
59964943|NCT02982187|76082662|FG003|NOT COMPLETED|Overall Study||0||
59964944|NCT02982187|76082663|FG004|NOT COMPLETED|Overall Study||0||
59964945|NCT02982187|76082664|FG005|NOT COMPLETED|Overall Study||0||
59964946|NCT02982187|76082665|FG006|NOT COMPLETED|Overall Study||1||
59964947|NCT02982187|76082666|FG007|NOT COMPLETED|Overall Study||0||
60074287|NCT01604343|76189696|FG000|STARTED|Week 52 to Week 104||0||
60074288|NCT01604343|76189697|FG001|STARTED|Week 52 to Week 104|Participants re-randomized at Week 18 (95), 40 (12) and 52 were included|243||
59809688|NCT03900416|75931884|FG001|STARTED|Baseline||80||
59809689|NCT03900416|75931883|FG000|COMPLETED|Baseline||72||
60074289|NCT01604343|76189698|FG002|STARTED|Week 52 to Week 104||481||
60074290|NCT01604343|76189699|FG003|STARTED|Week 52 to Week 104|Participants re-randomized at Week 18 (92), 40 (12) and 52 were included|241||
60074291|NCT01604343|76189700|FG004|STARTED|Week 52 to Week 104||470||
60074292|NCT01604343|76189696|FG000|Treated|Week 52 to Week 104||0||
60074293|NCT01604343|76189697|FG001|Treated|Week 52 to Week 104||242||
59809690|NCT03900416|75931884|FG001|COMPLETED|Baseline||80||
59809691|NCT03900416|75931883|FG000|NOT COMPLETED|Baseline||0||
59809692|NCT03900416|75931884|FG001|NOT COMPLETED|Baseline||0||
59809693|NCT03900416|75931883|FG000|STARTED|Post||72||
59809694|NCT03900416|75931884|FG001|STARTED|Post||80||
59809695|NCT03900416|75931883|FG000|COMPLETED|Post||72||
59809696|NCT03900416|75931884|FG001|COMPLETED|Post||80||
59809697|NCT03900416|75931883|FG000|NOT COMPLETED|Post||0||
59809698|NCT03900416|75931884|FG001|NOT COMPLETED|Post||0||
59809699|NCT03900416|75931883|FG000|STARTED|Six Week Follow-up||72||
59809700|NCT03900416|75931884|FG001|STARTED|Six Week Follow-up||80||
59809701|NCT03900416|75931883|FG000|COMPLETED|Six Week Follow-up||70||
59809702|NCT03900416|75931884|FG001|COMPLETED|Six Week Follow-up||80||
59964948|NCT02981953|76082676|FG000|STARTED|Overall Study||40||
59964949|NCT02981953|76082676|FG000|COMPLETED|Overall Study||29||
59964950|NCT02981953|76082676|FG000|NOT COMPLETED|Overall Study||11||
59964951|NCT02021071|76082682|FG000|STARTED|Overall Study||12||
59964952|NCT02021071|76082683|FG001|STARTED|Overall Study||12||
59964953|NCT02021071|76082682|FG000|COMPLETED|Overall Study||12||
59964954|NCT02021071|76082683|FG001|COMPLETED|Overall Study||12||
59964955|NCT02021071|76082682|FG000|NOT COMPLETED|Overall Study||0||
59964956|NCT02021071|76082683|FG001|NOT COMPLETED|Overall Study||0||
59964957|NCT01066585|76082692|FG000|STARTED|Overall Study||211||
59809703|NCT03900416|75931883|FG000|NOT COMPLETED|Six Week Follow-up||2||
59809704|NCT03900416|75931884|FG001|NOT COMPLETED|Six Week Follow-up||0||
59809705|NCT03900416|75931883|FG000|STARTED|Twelve Week Follow-up||70||
59809706|NCT03900416|75931884|FG001|STARTED|Twelve Week Follow-up||80||
59964958|NCT01066585|76082693|FG001|STARTED|Overall Study||199||
59964959|NCT01066585|76082692|FG000|COMPLETED|Overall Study||210||
59964960|NCT01066585|76082693|FG001|COMPLETED|Overall Study||196||
59964961|NCT01066585|76082692|FG000|NOT COMPLETED|Overall Study||1||
59964962|NCT01066585|76082693|FG001|NOT COMPLETED|Overall Study||3||
59964963|NCT02980783|76082699|FG000|STARTED|Overall Study||53||
59964964|NCT02980783|76082699|FG000|COMPLETED|Overall Study||52||
59964965|NCT02980783|76082699|FG000|NOT COMPLETED|Overall Study||1||
59964966|NCT02980705|76082705|FG000|STARTED|Overall Study||50||
59964967|NCT02980705|76082706|FG001|STARTED|Overall Study||51||
59964968|NCT02980705|76082705|FG000|COMPLETED|Overall Study||42||
59964969|NCT02980705|76082706|FG001|COMPLETED|Overall Study||40||
59964970|NCT02980705|76082705|FG000|NOT COMPLETED|Overall Study||8||
59964971|NCT02980705|76082706|FG001|NOT COMPLETED|Overall Study||11||
59964972|NCT02989649|76082713|FG000|STARTED|Overall Study||593||
59964973|NCT02989649|76082713|FG000|Started But Not Treated|Overall Study||84||
59964974|NCT02989649|76082713|FG000|Eligible to Enter Into Treatment Period|Overall Study||509||
59964975|NCT02989649|76082713|FG000|COMPLETED|Overall Study||173||
59964976|NCT02989649|76082713|FG000|NOT COMPLETED|Overall Study||420||
59964977|NCT02905435|76082717|FG000|STARTED|Overall Study||14||
59964978|NCT02905435|76082717|FG000|COMPLETED|Overall Study||7||
59964979|NCT02905435|76082717|FG000|NOT COMPLETED|Overall Study||7||
59964980|NCT02978833|76082724|FG000|STARTED|Overall Study||1||
59964981|NCT02978833|76082725|FG001|STARTED|Overall Study||1||
59964982|NCT02978833|76082724|FG000|COMPLETED|Overall Study||0||
59964983|NCT02978833|76082725|FG001|COMPLETED|Overall Study||0||
59964984|NCT02978833|76082724|FG000|NOT COMPLETED|Overall Study||1||
59964985|NCT02978833|76082725|FG001|NOT COMPLETED|Overall Study||1||
59964986|NCT01067339|76082734|FG000|STARTED|Overall Study||31||
59964987|NCT01067339|76082735|FG001|STARTED|Overall Study||34||
59964988|NCT01067339|76082734|FG000|COMPLETED|Overall Study||25||
59964989|NCT01067339|76082735|FG001|COMPLETED|Overall Study||29||
59964990|NCT01067339|76082734|FG000|NOT COMPLETED|Overall Study||6||
59964991|NCT01067339|76082735|FG001|NOT COMPLETED|Overall Study||5||
59964992|NCT02573259|76082748|FG000|STARTED|Overall Study||2||
59964993|NCT02573259|76082749|FG001|STARTED|Overall Study||8||
59964994|NCT02573259|76082750|FG002|STARTED|Overall Study||8||
59964995|NCT02573259|76082751|FG003|STARTED|Overall Study||7||
59964996|NCT02573259|76082752|FG004|STARTED|Overall Study||15||
59964997|NCT02573259|76082753|FG005|STARTED|Overall Study||68||
59964998|NCT02573259|76082754|FG006|STARTED|Overall Study||39||
59964999|NCT02573259|76082748|FG000|Treated|Overall Study||2||
59965000|NCT02573259|76082749|FG001|Treated|Overall Study||8||
59965001|NCT02573259|76082750|FG002|Treated|Overall Study||8||
59965002|NCT02573259|76082751|FG003|Treated|Overall Study||7||
59965003|NCT02573259|76082752|FG004|Treated|Overall Study||15||
59965004|NCT02573259|76082753|FG005|Treated|Overall Study||68||
59965005|NCT02573259|76082754|FG006|Treated|Overall Study||38||
59965006|NCT02573259|76082748|FG000|COMPLETED|Overall Study||1||
59965007|NCT02573259|76082749|FG001|COMPLETED|Overall Study||0||
59965008|NCT02573259|76082750|FG002|COMPLETED|Overall Study||2||
59965009|NCT02573259|76082751|FG003|COMPLETED|Overall Study||1||
59965010|NCT02573259|76082752|FG004|COMPLETED|Overall Study||2||
59965011|NCT02573259|76082753|FG005|COMPLETED|Overall Study||10||
59965012|NCT02573259|76082754|FG006|COMPLETED|Overall Study||5||
59965013|NCT02573259|76082748|FG000|NOT COMPLETED|Overall Study||1||
59809707|NCT03900416|75931883|FG000|COMPLETED|Twelve Week Follow-up||69||
59809708|NCT03900416|75931884|FG001|COMPLETED|Twelve Week Follow-up||76||
59809709|NCT03900416|75931883|FG000|NOT COMPLETED|Twelve Week Follow-up||1||
59809710|NCT03900416|75931884|FG001|NOT COMPLETED|Twelve Week Follow-up||4||
59809711|NCT03900416|75931883|FG000|STARTED|Six Month Follow-up||69||
59809712|NCT03900416|75931884|FG001|STARTED|Six Month Follow-up||76||
59809713|NCT03900416|75931883|FG000|COMPLETED|Six Month Follow-up||64||
59809714|NCT03900416|75931884|FG001|COMPLETED|Six Month Follow-up||72||
59809715|NCT03900416|75931883|FG000|NOT COMPLETED|Six Month Follow-up||5||
59809716|NCT03900416|75931884|FG001|NOT COMPLETED|Six Month Follow-up||4||
59809717|NCT00399490|75931890|FG000|STARTED|Overall Study||281||
59809718|NCT00399490|75931890|FG000|COMPLETED|Overall Study||183||
59809719|NCT00399490|75931890|FG000|NOT COMPLETED|Overall Study||98||
59809720|NCT00398866|75931899|FG000|STARTED|Overall Study||66||
59965014|NCT02573259|76082749|FG001|NOT COMPLETED|Overall Study||8||
60074294|NCT01604343|76189698|FG002|Treated|Week 52 to Week 104||481||
59809721|NCT00398866|75931900|FG001|STARTED|Overall Study||68||
59809722|NCT00398866|75931901|FG002|STARTED|Overall Study||66||
59965015|NCT02573259|76082750|FG002|NOT COMPLETED|Overall Study||6||
59809723|NCT00398866|75931899|FG000|COMPLETED|Overall Study||52||
59809724|NCT00398866|75931900|FG001|COMPLETED|Overall Study||60||
59965016|NCT02573259|76082751|FG003|NOT COMPLETED|Overall Study||6||
59965017|NCT02573259|76082752|FG004|NOT COMPLETED|Overall Study||13||
59965018|NCT02573259|76082753|FG005|NOT COMPLETED|Overall Study||58||
60074295|NCT01604343|76189699|FG003|Treated|Week 52 to Week 104||241||
59965019|NCT02573259|76082754|FG006|NOT COMPLETED|Overall Study||34||
59965020|NCT02785991|76082786|FG000|STARTED|Overall Study||1742||
59965021|NCT02785991|76082786|FG000|COMPLETED|Overall Study||1741||
59965022|NCT02785991|76082786|FG000|NOT COMPLETED|Overall Study||1||
59965023|NCT02977507|76082791|FG000|STARTED|Overall Study||8||
59965024|NCT02977507|76082792|FG001|STARTED|Overall Study||10||
59965025|NCT02977507|76082791|FG000|COMPLETED|Overall Study||6||
59965026|NCT02977507|76082792|FG001|COMPLETED|Overall Study||10||
59965027|NCT02977507|76082791|FG000|NOT COMPLETED|Overall Study||2||
59965028|NCT02977507|76082792|FG001|NOT COMPLETED|Overall Study||0||
59965029|NCT02976103|76082801|FG000|STARTED|Overall Study||67||
59809725|NCT00398866|75931901|FG002|COMPLETED|Overall Study||58||
59809726|NCT00398866|75931899|FG000|NOT COMPLETED|Overall Study||14||
59809727|NCT00398866|75931900|FG001|NOT COMPLETED|Overall Study||8||
59809728|NCT00398866|75931901|FG002|NOT COMPLETED|Overall Study||8||
59809729|NCT00398632|75931910|FG000|STARTED|Overall Study||6||
59809730|NCT00398632|75931910|FG000|COMPLETED|Overall Study|2/6 subjects withdrew at end of week 6; 1 for lack of efficacy, 1 because of time constraints.|4||
59809731|NCT00398632|75931910|FG000|NOT COMPLETED|Overall Study||2||
59809732|NCT00673361|75931915|FG000|STARTED|Overall Study||9||
59809733|NCT00673361|75931915|FG000|COMPLETED|Overall Study||7||
59809734|NCT00673361|75931915|FG000|NOT COMPLETED|Overall Study||2||
59965030|NCT02976103|76082802|FG001|STARTED|Overall Study||72||
59965031|NCT02976103|76082801|FG000|COMPLETED|Overall Study|54 participants answered final (T3) questionnaire|54||
59965032|NCT02976103|76082802|FG001|COMPLETED|Overall Study|64 participants answered final (T3 questionnaire)|64||
59965033|NCT02976103|76082801|FG000|NOT COMPLETED|Overall Study||13||
59965034|NCT02976103|76082802|FG001|NOT COMPLETED|Overall Study||8||
59965035|NCT01066039|76082809|FG000|STARTED|Overall Study||202||
59965036|NCT01066039|76082809|FG000|Treated|Overall Study||200||
59965037|NCT01066039|76082809|FG000|COMPLETED|Overall Study||158||
59965038|NCT01066039|76082809|FG000|NOT COMPLETED|Overall Study||44||
59965039|NCT02919995|76082819|FG000|STARTED|Overall Study||1||
59965040|NCT02919995|76082820|FG001|STARTED|Overall Study||2||
59965041|NCT02919995|76082821|FG002|STARTED|Overall Study||2||
59965042|NCT02919995|76082822|FG003|STARTED|Overall Study||2||
59965043|NCT02919995|76082823|FG004|STARTED|Overall Study||1||
59965044|NCT02919995|76082824|FG005|STARTED|Overall Study||2||
59965045|NCT02919995|76082819|FG000|COMPLETED|Overall Study||1||
59965046|NCT02919995|76082820|FG001|COMPLETED|Overall Study||2||
59965047|NCT02919995|76082821|FG002|COMPLETED|Overall Study||2||
59965048|NCT02919995|76082822|FG003|COMPLETED|Overall Study||2||
59965049|NCT02919995|76082823|FG004|COMPLETED|Overall Study||1||
59965050|NCT02919995|76082824|FG005|COMPLETED|Overall Study||1||
59965051|NCT02919995|76082819|FG000|NOT COMPLETED|Overall Study||0||
59965052|NCT02919995|76082820|FG001|NOT COMPLETED|Overall Study||0||
59965053|NCT02919995|76082821|FG002|NOT COMPLETED|Overall Study||0||
59965054|NCT02919995|76082822|FG003|NOT COMPLETED|Overall Study||0||
59965055|NCT02919995|76082823|FG004|NOT COMPLETED|Overall Study||0||
59965056|NCT02919995|76082824|FG005|NOT COMPLETED|Overall Study||1||
59965057|NCT02919761|76082832|FG000|STARTED|Part 1: Open Label||259||
59809735|NCT00393718|75931921|FG000|STARTED|Overall Study||268||
59809736|NCT00393718|75931922|FG001|STARTED|Overall Study||132||
59809737|NCT00393718|75931921|FG000|COMPLETED|Overall Study||225||
59809738|NCT00393718|75931922|FG001|COMPLETED|Overall Study||110||
59809739|NCT00393718|75931921|FG000|NOT COMPLETED|Overall Study||43||
59809740|NCT00393718|75931922|FG001|NOT COMPLETED|Overall Study||22||
59809741|NCT00669071|75931928|FG000|STARTED|Overall Study||56||
59809742|NCT00669071|75931928|FG000|COMPLETED|Overall Study||52||
59809743|NCT00669071|75931928|FG000|NOT COMPLETED|Overall Study||4||
59809744|NCT00398320|75931934|FG000|STARTED|Overall Study||40||
59809745|NCT00398320|75931934|FG000|COMPLETED|Overall Study||34||
59809746|NCT00398320|75931934|FG000|NOT COMPLETED|Overall Study||6||
59809747|NCT00670007|75931938|FG000|STARTED|Overall Study||140||
59809748|NCT00670007|75931938|FG000|COMPLETED|Overall Study||131||
59809749|NCT00670007|75931938|FG000|NOT COMPLETED|Overall Study||9||
59809750|NCT00535496|75931945|FG000|STARTED|Overall Study||15||
59809751|NCT00535496|75931946|FG001|STARTED|Overall Study||15||
59809752|NCT00535496|75931947|FG002|STARTED|Overall Study||30||
59809753|NCT00535496|75931948|FG003|STARTED|Overall Study||31||
59809754|NCT00535496|75931945|FG000|All-Subjects-Treated (AST) Group|Overall Study||15||
59809755|NCT00535496|75931946|FG001|All-Subjects-Treated (AST) Group|Overall Study||14||
59809756|NCT00535496|75931947|FG002|All-Subjects-Treated (AST) Group|Overall Study||30||
59809757|NCT00535496|75931948|FG003|All-Subjects-Treated (AST) Group|Overall Study||31||
59965058|NCT02919761|76082833|FG001|STARTED|Part 1: Open Label|Part 2 Blinded groups were not evaluated as such during Part 1|0||
59965059|NCT02919761|76082834|FG002|STARTED|Part 1: Open Label||0||
59965060|NCT02919761|76082832|FG000|mITT Population|Part 1: Open Label||259|All participants who received study drug and contributed efficacy data.|
59965061|NCT02919761|76082833|FG001|mITT Population|Part 1: Open Label||0|All participants who received study drug and contributed efficacy data.|
59965062|NCT02919761|76082834|FG002|mITT Population|Part 1: Open Label||0|All participants who received study drug and contributed efficacy data.|
59965063|NCT02919761|76082832|FG000|Safety Population|Part 1: Open Label||259|All participants who received study drug.|
59965064|NCT02919761|76082833|FG001|Safety Population|Part 1: Open Label||0|All participants who received study drug.|
59965065|NCT02919761|76082834|FG002|Safety Population|Part 1: Open Label||0|All participants who received study drug.|
59965066|NCT02919761|76082832|FG000|Per Protocol Population|Part 1: Open Label||236|All participants who completed the Part 1 of the study without major protocol deviation.|
59965067|NCT02919761|76082833|FG001|Per Protocol Population|Part 1: Open Label||0|All participants who completed the Part 1 of the study without major protocol deviation.|
59809758|NCT00535496|75931945|FG000|COMPLETED|Overall Study||15||
59809759|NCT00535496|75931946|FG001|COMPLETED|Overall Study||13||
59809760|NCT00535496|75931947|FG002|COMPLETED|Overall Study||30||
59809761|NCT00535496|75931948|FG003|COMPLETED|Overall Study||31||
59965068|NCT02919761|76082834|FG002|Per Protocol Population|Part 1: Open Label||0|All participants who completed the Part 1 of the study without major protocol deviation.|
59965069|NCT02919761|76082832|FG000|COMPLETED|Part 1: Open Label||235||
59965070|NCT02919761|76082833|FG001|COMPLETED|Part 1: Open Label||0||
59965071|NCT02919761|76082834|FG002|COMPLETED|Part 1: Open Label||0||
59965072|NCT02919761|76082832|FG000|NOT COMPLETED|Part 1: Open Label||24||
59965073|NCT02919761|76082833|FG001|NOT COMPLETED|Part 1: Open Label||0||
59965074|NCT02919761|76082834|FG002|NOT COMPLETED|Part 1: Open Label||0||
59621480|NCT00344682|75733079|FG000|NOT COMPLETED|Overall Study||4||
59621481|NCT00344682|75733080|FG001|NOT COMPLETED|Overall Study||1||
59621482|NCT00345384|75733088|FG000|STARTED|Overall Study||19||
59621483|NCT00345384|75733089|FG001|STARTED|Overall Study||19||
59965075|NCT02919761|76082832|FG000|STARTED|Part 2: Double-blind|154 of the original Part 1 participants continued to Part 2, randomized to Acthar or placebo|0||
59965076|NCT02919761|76082833|FG001|STARTED|Part 2: Double-blind|77 participants who completed Part 1 were to receive Acthar for an additional 12 weeks in Part 2|77||
59965077|NCT02919761|76082834|FG002|STARTED|Part 2: Double-blind|77 participants who completed Part 1 were to receive placebo for an additional 12 weeks in Part 2|77||
59965078|NCT02919761|76082832|FG000|Safety Population|Part 2: Double-blind||0||
59965079|NCT02919761|76082833|FG001|Safety Population|Part 2: Double-blind||77||
59965080|NCT02919761|76082834|FG002|Safety Population|Part 2: Double-blind||77||
59965081|NCT02919761|76082832|FG000|mITT Population|Part 2: Double-blind||0||
59965082|NCT02919761|76082833|FG001|mITT Population|Part 2: Double-blind||77||
59965083|NCT02919761|76082834|FG002|mITT Population|Part 2: Double-blind||76||
59965084|NCT02919761|76082832|FG000|Per Protocol Population|Part 2: Double-blind||0||
59965085|NCT02919761|76082833|FG001|Per Protocol Population|Part 2: Double-blind||76||
59965086|NCT02919761|76082834|FG002|Per Protocol Population|Part 2: Double-blind||73||
59965087|NCT02919761|76082832|FG000|COMPLETED|Part 2: Double-blind||0||
59965088|NCT02919761|76082833|FG001|COMPLETED|Part 2: Double-blind||71||
59965089|NCT02919761|76082834|FG002|COMPLETED|Part 2: Double-blind||56||
59965090|NCT02919761|76082832|FG000|NOT COMPLETED|Part 2: Double-blind||0||
59965091|NCT02919761|76082833|FG001|NOT COMPLETED|Part 2: Double-blind||6||
59965092|NCT02919761|76082834|FG002|NOT COMPLETED|Part 2: Double-blind||21||
59965093|NCT02910167|76082845|FG000|STARTED|Overall Study||360||
59965094|NCT02910167|76082845|FG000|COMPLETED|Overall Study||341||
59965095|NCT02910167|76082845|FG000|NOT COMPLETED|Overall Study||19||
59965096|NCT01067105|76082849|FG000|STARTED|Overall Study||824||
59965097|NCT01067105|76082849|FG000|COMPLETED|Overall Study||683||
59965098|NCT01067105|76082849|FG000|NOT COMPLETED|Overall Study||141||
59965099|NCT03924765|76082853|FG000|STARTED|Overall Study||5||
59965100|NCT03924765|76082853|FG000|COMPLETED|Overall Study||5||
59965101|NCT03924765|76082853|FG000|NOT COMPLETED|Overall Study||0||
59965102|NCT02910089|76082859|FG000|STARTED|Overall Study|Patients allocated to intervention|700|1,400 randomized patients|
59965103|NCT02910089|76082860|FG001|STARTED|Overall Study|Patients allocated to control|700|1,400 randomized patients|
59965104|NCT02910089|76082859|FG000|COMPLETED|Overall Study|22 patients ineligible (3.1%)|678|38 patients (2.7%) were excluded from analysis because they lost insurance eligibility.|
59965105|NCT02910089|76082860|FG001|COMPLETED|Overall Study|16 Patients ineligible (2.3%)|684|38 patients (2.7%) were excluded from analysis because they lost insurance eligibility.|
59965106|NCT02910089|76082859|FG000|NOT COMPLETED|Overall Study||22||
59965107|NCT02910089|76082860|FG001|NOT COMPLETED|Overall Study||16||
59965108|NCT02985515|76082868|FG000|STARTED|Olfaction Testing||20|30 day period|
59965109|NCT02985515|76082869|FG001|STARTED|Olfaction Testing||31|30 day period|
59965110|NCT02985515|76082868|FG000|COMPLETED|Olfaction Testing||20||
59965111|NCT02985515|76082869|FG001|COMPLETED|Olfaction Testing||23||
59965112|NCT02985515|76082868|FG000|NOT COMPLETED|Olfaction Testing||0||
59965113|NCT02985515|76082869|FG001|NOT COMPLETED|Olfaction Testing||8||
59965114|NCT02985515|76082868|FG000|STARTED|Smell Training||0||
59965115|NCT02985515|76082869|FG001|STARTED|Smell Training||23||
59965116|NCT02985515|76082868|FG000|COMPLETED|Smell Training||0||
59965117|NCT02985515|76082869|FG001|COMPLETED|Smell Training||23||
59965118|NCT02985515|76082868|FG000|NOT COMPLETED|Smell Training||0||
59965119|NCT02985515|76082869|FG001|NOT COMPLETED|Smell Training||0||
59965120|NCT02696759|76082878|FG000|STARTED|Overall Study||15||
59965121|NCT02696759|76082878|FG000|COMPLETED|Overall Study||15||
59965122|NCT02696759|76082878|FG000|NOT COMPLETED|Overall Study||0||
59965123|NCT02910011|76082882|FG000|STARTED|Overall Study||15||
59965124|NCT02910011|76082882|FG000|COMPLETED|Overall Study||13||
59965125|NCT02910011|76082882|FG000|NOT COMPLETED|Overall Study||2||
59965126|NCT02908841|76082890|FG000|STARTED|Overall Study||10||
59965127|NCT02908841|76082891|FG001|STARTED|Overall Study||12||
59965128|NCT02908841|76082890|FG000|COMPLETED|Overall Study||6||
59965129|NCT02908841|76082891|FG001|COMPLETED|Overall Study||12||
59965130|NCT02908841|76082890|FG000|NOT COMPLETED|Overall Study||4||
59965131|NCT02908841|76082891|FG001|NOT COMPLETED|Overall Study||0||
59965132|NCT02909153|76082902|FG000|STARTED|Overall Study||6||
59965133|NCT02909153|76082903|FG001|STARTED|Overall Study||6||
59965134|NCT02909153|76082904|FG002|STARTED|Overall Study||6||
59965135|NCT02909153|76082905|FG003|STARTED|Overall Study||6||
59965136|NCT02909153|76082906|FG004|STARTED|Overall Study||6||
59621484|NCT00345384|75733088|FG000|COMPLETED|Overall Study||19||
59995305|NCT04529096|76111147|FG001|NOT COMPLETED|Overall Study||6||
59965137|NCT02909153|76082902|FG000|Triferic in Dianeal PD Solution|Overall Study||6|Cohort 1: 5 mg Fe/L Triferic, Cohort 2: 12.5 mg Fe/L Triferic, Cohort 3: 7.5 mg Fe/L Triferic|
59965138|NCT02909153|76082903|FG001|Triferic in Dianeal PD Solution|Overall Study||6|Cohort 1: 5 mg Fe/L Triferic, Cohort 2: 12.5 mg Fe/L Triferic, Cohort 3: 7.5 mg Fe/L Triferic|
59809762|NCT00535496|75931945|FG000|NOT COMPLETED|Overall Study||0||
59809763|NCT00535496|75931946|FG001|NOT COMPLETED|Overall Study||2||
59809764|NCT00535496|75931947|FG002|NOT COMPLETED|Overall Study||0||
59809765|NCT00535496|75931948|FG003|NOT COMPLETED|Overall Study||0||
59809766|NCT00539006|75931959|FG000|STARTED|Pre-treatment||96||
59809767|NCT00539006|75931960|FG001|STARTED|Pre-treatment||95||
59809768|NCT00539006|75931961|FG002|STARTED|Pre-treatment||95||
59809769|NCT00539006|75931962|FG003|STARTED|Pre-treatment||91||
59965139|NCT02909153|76082904|FG002|Triferic in Dianeal PD Solution|Overall Study||6|Cohort 1: 5 mg Fe/L Triferic, Cohort 2: 12.5 mg Fe/L Triferic, Cohort 3: 7.5 mg Fe/L Triferic|
59965140|NCT02909153|76082905|FG003|Triferic in Dianeal PD Solution|Overall Study||0|Cohort 1: 5 mg Fe/L Triferic, Cohort 2: 12.5 mg Fe/L Triferic, Cohort 3: 7.5 mg Fe/L Triferic|
59965141|NCT02909153|76082906|FG004|Triferic in Dianeal PD Solution|Overall Study||0|Cohort 1: 5 mg Fe/L Triferic, Cohort 2: 12.5 mg Fe/L Triferic, Cohort 3: 7.5 mg Fe/L Triferic|
59965142|NCT02909153|76082902|FG000|Triferic 6.6mg Fe Via 4hr IV Infusions|Overall Study||6||
59965143|NCT02909153|76082903|FG001|Triferic 6.6mg Fe Via 4hr IV Infusions|Overall Study||5||
59965144|NCT02909153|76082904|FG002|Triferic 6.6mg Fe Via 4hr IV Infusions|Overall Study||6||
59965145|NCT02909153|76082905|FG003|Triferic 6.6mg Fe Via 4hr IV Infusions|Overall Study||6||
59965146|NCT02909153|76082906|FG004|Triferic 6.6mg Fe Via 4hr IV Infusions|Overall Study||6||
59965147|NCT02909153|76082902|FG000|Triferic in Extraneal PD Solution|Overall Study||0|Cohort 4: dosed Triferic 5 mg Fe/L, Cohort 5: dosed Triferic 2.5 mg Fe/L|
59965148|NCT02909153|76082903|FG001|Triferic in Extraneal PD Solution|Overall Study||0|Cohort 4: dosed Triferic 5 mg Fe/L, Cohort 5: dosed Triferic 2.5 mg Fe/L|
59965149|NCT02909153|76082904|FG002|Triferic in Extraneal PD Solution|Overall Study||0|Cohort 4: dosed Triferic 5 mg Fe/L, Cohort 5: dosed Triferic 2.5 mg Fe/L|
59965150|NCT02909153|76082905|FG003|Triferic in Extraneal PD Solution|Overall Study||6|Cohort 4: dosed Triferic 5 mg Fe/L, Cohort 5: dosed Triferic 2.5 mg Fe/L|
59965151|NCT02909153|76082906|FG004|Triferic in Extraneal PD Solution|Overall Study||6|Cohort 4: dosed Triferic 5 mg Fe/L, Cohort 5: dosed Triferic 2.5 mg Fe/L|
59965152|NCT02909153|76082902|FG000|COMPLETED|Overall Study||6||
59965153|NCT02909153|76082903|FG001|COMPLETED|Overall Study||5||
59965154|NCT02909153|76082904|FG002|COMPLETED|Overall Study||6||
59965155|NCT02909153|76082905|FG003|COMPLETED|Overall Study||6||
59965156|NCT02909153|76082906|FG004|COMPLETED|Overall Study||6||
59965157|NCT02909153|76082902|FG000|NOT COMPLETED|Overall Study||0||
59965158|NCT02909153|76082903|FG001|NOT COMPLETED|Overall Study||1||
59965159|NCT02909153|76082904|FG002|NOT COMPLETED|Overall Study||0||
59965160|NCT02909153|76082905|FG003|NOT COMPLETED|Overall Study||0||
59965161|NCT02909153|76082906|FG004|NOT COMPLETED|Overall Study||0||
59965162|NCT02908529|76082918|FG000|STARTED|Overall Study||10||
59965163|NCT02908529|76082919|FG001|STARTED|Overall Study||12||
59965164|NCT02908529|76082918|FG000|COMPLETED|Overall Study||10||
59965165|NCT02908529|76082919|FG001|COMPLETED|Overall Study||10||
59965166|NCT02908529|76082918|FG000|NOT COMPLETED|Overall Study||0||
59965167|NCT02908529|76082919|FG001|NOT COMPLETED|Overall Study||2||
59965168|NCT02984267|76082929|FG000|STARTED|Overall Study||8||
59965169|NCT02984267|76082930|FG001|STARTED|Overall Study||10||
59965170|NCT02984267|76082929|FG000|COMPLETED|Overall Study||7||
59965171|NCT02984267|76082930|FG001|COMPLETED|Overall Study||9||
59965172|NCT02984267|76082929|FG000|NOT COMPLETED|Overall Study||1||
60074296|NCT01604343|76189700|FG004|Treated|Week 52 to Week 104||470||
59809770|NCT00539006|75931959|FG000|COMPLETED|Pre-treatment||96||
59809771|NCT00539006|75931960|FG001|COMPLETED|Pre-treatment||94||
59809772|NCT00539006|75931961|FG002|COMPLETED|Pre-treatment||95||
59809773|NCT00539006|75931962|FG003|COMPLETED|Pre-treatment||91||
59809774|NCT00539006|75931959|FG000|NOT COMPLETED|Pre-treatment||0||
59809775|NCT00539006|75931960|FG001|NOT COMPLETED|Pre-treatment||1||
59809776|NCT00539006|75931961|FG002|NOT COMPLETED|Pre-treatment||0||
59809777|NCT00539006|75931962|FG003|NOT COMPLETED|Pre-treatment||0||
59809778|NCT00539006|75931959|FG000|STARTED|Treatment Period 1||96||
59809779|NCT00539006|75931960|FG001|STARTED|Treatment Period 1||94||
59809780|NCT00539006|75931961|FG002|STARTED|Treatment Period 1||95||
59809781|NCT00539006|75931962|FG003|STARTED|Treatment Period 1||91||
59809782|NCT00539006|75931959|FG000|COMPLETED|Treatment Period 1||96||
59809783|NCT00539006|75931960|FG001|COMPLETED|Treatment Period 1||94||
59809784|NCT00539006|75931961|FG002|COMPLETED|Treatment Period 1||93||
59809785|NCT00539006|75931962|FG003|COMPLETED|Treatment Period 1||90||
59809786|NCT00539006|75931959|FG000|NOT COMPLETED|Treatment Period 1||0||
59809787|NCT00539006|75931960|FG001|NOT COMPLETED|Treatment Period 1||0||
59809788|NCT00539006|75931961|FG002|NOT COMPLETED|Treatment Period 1||2||
59809789|NCT00539006|75931962|FG003|NOT COMPLETED|Treatment Period 1||1||
59809790|NCT00539006|75931959|FG000|STARTED|Washout||96||
59809791|NCT00539006|75931960|FG001|STARTED|Washout||94||
59809792|NCT00539006|75931961|FG002|STARTED|Washout||93||
59809793|NCT00539006|75931962|FG003|STARTED|Washout||90||
59809794|NCT00539006|75931959|FG000|COMPLETED|Washout||76||
59809795|NCT00539006|75931960|FG001|COMPLETED|Washout||84||
59809796|NCT00539006|75931961|FG002|COMPLETED|Washout||77||
59809797|NCT00539006|75931962|FG003|COMPLETED|Washout||81||
59809798|NCT00539006|75931959|FG000|NOT COMPLETED|Washout||20||
59965173|NCT02984267|76082930|FG001|NOT COMPLETED|Overall Study||1||
59965174|NCT02675751|76082936|FG000|STARTED|Overall Study||167|"Participants 167~Units (eyes) 334"|334
59965175|NCT02675751|76082936|FG000|COMPLETED|Overall Study||151|"Participants 151~Units (eyes) 302"|302
59965176|NCT02675751|76082936|FG000|NOT COMPLETED|Overall Study||16||32
59965177|NCT02643381|76082942|FG000|STARTED|Overall Study||400||
59965178|NCT02643381|76082943|FG001|STARTED|Overall Study||401||
59965179|NCT02643381|76082942|FG000|COMPLETED|Overall Study||396||
59965180|NCT02643381|76082943|FG001|COMPLETED|Overall Study||395||
59965181|NCT02643381|76082942|FG000|NOT COMPLETED|Overall Study||4||
59965182|NCT02643381|76082943|FG001|NOT COMPLETED|Overall Study||6||
59965183|NCT02974855|76082953|FG000|STARTED|Overall Study||7||
59965184|NCT02974855|76082954|FG001|STARTED|Overall Study||6||
59965185|NCT02974855|76082955|FG002|STARTED|Overall Study||6||
59965186|NCT02974855|76082956|FG003|STARTED|Overall Study||7||
59965187|NCT02974855|76082953|FG000|COMPLETED|Overall Study||7||
59965188|NCT02974855|76082954|FG001|COMPLETED|Overall Study||5||
59965189|NCT02974855|76082955|FG002|COMPLETED|Overall Study||6||
59965190|NCT02974855|76082956|FG003|COMPLETED|Overall Study||6||
59965191|NCT02974855|76082953|FG000|NOT COMPLETED|Overall Study||0||
59965192|NCT02974855|76082954|FG001|NOT COMPLETED|Overall Study||1||
59965193|NCT02974855|76082955|FG002|NOT COMPLETED|Overall Study||0||
59965194|NCT02974855|76082956|FG003|NOT COMPLETED|Overall Study||1||
59965195|NCT04328961|76082972|FG000|STARTED|Overall Study||422||
59965196|NCT04328961|76082973|FG001|STARTED|Overall Study||407||
59965197|NCT04328961|76082972|FG000|COMPLETED|Overall Study||336||
59965198|NCT04328961|76082973|FG001|COMPLETED|Overall Study||353||
59965199|NCT04328961|76082972|FG000|NOT COMPLETED|Overall Study||86||
59965200|NCT04328961|76082973|FG001|NOT COMPLETED|Overall Study||54||
59809799|NCT00539006|75931960|FG001|NOT COMPLETED|Washout||10||
59809800|NCT00539006|75931961|FG002|NOT COMPLETED|Washout||16||
59809801|NCT00539006|75931962|FG003|NOT COMPLETED|Washout||9||
59809802|NCT00539006|75931959|FG000|STARTED|Treatment Period 2||76||
59809803|NCT00539006|75931960|FG001|STARTED|Treatment Period 2||84||
59809804|NCT00539006|75931961|FG002|STARTED|Treatment Period 2||77||
59809805|NCT00539006|75931962|FG003|STARTED|Treatment Period 2||81||
59809806|NCT00539006|75931959|FG000|COMPLETED|Treatment Period 2||75||
59965201|NCT00455403|76082981|FG000|STARTED|Overall Study||59||
59965202|NCT00455403|76082982|FG001|STARTED|Overall Study||57||
59965203|NCT00455403|76082981|FG000|COMPLETED|Overall Study||56||
59965204|NCT00455403|76082982|FG001|COMPLETED|Overall Study||51||
59965205|NCT00455403|76082981|FG000|NOT COMPLETED|Overall Study||3||
59965206|NCT00455403|76082982|FG001|NOT COMPLETED|Overall Study||6||
59965207|NCT02979613|76082990|FG000|STARTED|Double-Blind Phase||245||
59965208|NCT02979613|76082991|FG001|STARTED|Double-Blind Phase||245||
59965209|NCT02979613|76082990|FG000|COMPLETED|Double-Blind Phase||235||
59965210|NCT02979613|76082991|FG001|COMPLETED|Double-Blind Phase||237||
59965211|NCT02979613|76082990|FG000|NOT COMPLETED|Double-Blind Phase||10||
59965212|NCT02979613|76082991|FG001|NOT COMPLETED|Double-Blind Phase||8||
59965213|NCT02979613|76082990|FG000|STARTED|Open-Label Extension (OLE) Phase||235||
59965214|NCT02979613|76082991|FG001|STARTED|Open-Label Extension (OLE) Phase||237||
59965215|NCT02979613|76082990|FG000|COMPLETED|Open-Label Extension (OLE) Phase||232||
59965216|NCT02979613|76082991|FG001|COMPLETED|Open-Label Extension (OLE) Phase||231||
59965217|NCT02979613|76082990|FG000|NOT COMPLETED|Open-Label Extension (OLE) Phase||3||
59965218|NCT02979613|76082991|FG001|NOT COMPLETED|Open-Label Extension (OLE) Phase||6||
59965219|NCT01064167|76083001|FG000|STARTED|Overall Study||130||
59965220|NCT01064167|76083002|FG001|STARTED|Overall Study||130||
59965221|NCT01064167|76083001|FG000|COMPLETED|Overall Study||116||
59965222|NCT01064167|76083002|FG001|COMPLETED|Overall Study||115||
59965223|NCT01064167|76083001|FG000|NOT COMPLETED|Overall Study||14||
59965224|NCT01064167|76083002|FG001|NOT COMPLETED|Overall Study||15||
59809807|NCT00539006|75931960|FG001|COMPLETED|Treatment Period 2||83||
59809808|NCT00539006|75931961|FG002|COMPLETED|Treatment Period 2||77||
59965225|NCT02974543|76083010|FG000|STARTED|Overall Study||11||
59809809|NCT00539006|75931962|FG003|COMPLETED|Treatment Period 2||81||
59809810|NCT00539006|75931959|FG000|NOT COMPLETED|Treatment Period 2||1||
59809811|NCT00539006|75931960|FG001|NOT COMPLETED|Treatment Period 2||1||
59809812|NCT00539006|75931961|FG002|NOT COMPLETED|Treatment Period 2||0||
59965226|NCT02974543|76083011|FG001|STARTED|Overall Study||10||
59965227|NCT02974543|76083010|FG000|Began Washout Period|Overall Study||10||
59965228|NCT02974543|76083011|FG001|Began Washout Period|Overall Study||10||
59965229|NCT02974543|76083010|FG000|Began Crossover Assignment|Overall Study||10||
59809813|NCT00539006|75931962|FG003|NOT COMPLETED|Treatment Period 2||0||
59965230|NCT02974543|76083011|FG001|Began Crossover Assignment|Overall Study||10||
59965231|NCT02974543|76083010|FG000|COMPLETED|Overall Study||10||
59965232|NCT02974543|76083011|FG001|COMPLETED|Overall Study||10||
59965233|NCT02974543|76083010|FG000|NOT COMPLETED|Overall Study||1||
59965234|NCT02974543|76083011|FG001|NOT COMPLETED|Overall Study||0||
59965235|NCT01064947|76083025|FG000|STARTED|Overall Study||70||
59965236|NCT01064947|76083025|FG000|COMPLETED|Overall Study||29||
59965237|NCT01064947|76083025|FG000|NOT COMPLETED|Overall Study||41||
59965238|NCT02974153|76083036|FG000|STARTED|Overall Study||374||
59965239|NCT02974153|76083037|FG001|STARTED|Overall Study||372||
59965240|NCT02974153|76083038|FG002|STARTED|Overall Study||375||
59965241|NCT02974153|76083036|FG000|Participants Treated|Overall Study||350||
59965242|NCT02974153|76083037|FG001|Participants Treated|Overall Study||356||
59965243|NCT02974153|76083038|FG002|Participants Treated|Overall Study||366||
59965244|NCT02974153|76083036|FG000|COMPLETED|Overall Study||322||
59965245|NCT02974153|76083037|FG001|COMPLETED|Overall Study||324||
59965246|NCT02974153|76083038|FG002|COMPLETED|Overall Study||325||
59965247|NCT02974153|76083036|FG000|NOT COMPLETED|Overall Study||52||
59965248|NCT02974153|76083037|FG001|NOT COMPLETED|Overall Study||48||
59965249|NCT02974153|76083038|FG002|NOT COMPLETED|Overall Study||50||
59965250|NCT02508532|76083053|FG000|STARTED|Part 1 - Dose Determining Period||6||
59965251|NCT02508532|76083054|FG001|STARTED|Part 1 - Dose Determining Period||6||
59965252|NCT02508532|76083055|FG002|STARTED|Part 1 - Dose Determining Period||6||
59965253|NCT02508532|76083056|FG003|STARTED|Part 1 - Dose Determining Period||6||
59965254|NCT02508532|76083057|FG004|STARTED|Part 1 - Dose Determining Period||6||
59965255|NCT02508532|76083058|FG005|STARTED|Part 1 - Dose Determining Period||6||
59965256|NCT02508532|76083059|FG006|STARTED|Part 1 - Dose Determining Period||7||
59965257|NCT02508532|76083060|FG007|STARTED|Part 1 - Dose Determining Period||3||
59965258|NCT02508532|76083061|FG008|STARTED|Part 1 - Dose Determining Period|This group includes patients enrolled in Part 1 and Part 2 at a starting dose of 300 or 400 mg QD. This group was not used to determine the MTD in Part 1|0||
59965259|NCT02508532|76083053|FG000|Patients From Part 1 Included in the Part 2 Analyses|Part 1 - Dose Determining Period||0||
59965260|NCT02508532|76083054|FG001|Patients From Part 1 Included in the Part 2 Analyses|Part 1 - Dose Determining Period||0||
59965261|NCT02508532|76083055|FG002|Patients From Part 1 Included in the Part 2 Analyses|Part 1 - Dose Determining Period||0||
59965262|NCT02508532|76083056|FG003|Patients From Part 1 Included in the Part 2 Analyses|Part 1 - Dose Determining Period||0||
59965263|NCT02508532|76083057|FG004|Patients From Part 1 Included in the Part 2 Analyses|Part 1 - Dose Determining Period||0||
59965264|NCT02508532|76083058|FG005|Patients From Part 1 Included in the Part 2 Analyses|Part 1 - Dose Determining Period||6||
59965265|NCT02508532|76083059|FG006|Patients From Part 1 Included in the Part 2 Analyses|Part 1 - Dose Determining Period||7||
59965266|NCT02508532|76083060|FG007|Patients From Part 1 Included in the Part 2 Analyses|Part 1 - Dose Determining Period||0||
59965267|NCT02508532|76083061|FG008|Patients From Part 1 Included in the Part 2 Analyses|Part 1 - Dose Determining Period||0||
59965268|NCT02508532|76083053|FG000|COMPLETED|Part 1 - Dose Determining Period||6||
59965269|NCT02508532|76083054|FG001|COMPLETED|Part 1 - Dose Determining Period||6||
59965270|NCT02508532|76083055|FG002|COMPLETED|Part 1 - Dose Determining Period||6||
59965271|NCT02508532|76083056|FG003|COMPLETED|Part 1 - Dose Determining Period||6||
59965272|NCT02508532|76083057|FG004|COMPLETED|Part 1 - Dose Determining Period||6||
59965273|NCT02508532|76083058|FG005|COMPLETED|Part 1 - Dose Determining Period||6||
59965274|NCT02508532|76083059|FG006|COMPLETED|Part 1 - Dose Determining Period||6||
59965275|NCT02508532|76083060|FG007|COMPLETED|Part 1 - Dose Determining Period||2||
59965276|NCT02508532|76083061|FG008|COMPLETED|Part 1 - Dose Determining Period||0||
59965277|NCT02508532|76083053|FG000|NOT COMPLETED|Part 1 - Dose Determining Period||0||
59965278|NCT02508532|76083054|FG001|NOT COMPLETED|Part 1 - Dose Determining Period||0||
59965279|NCT02508532|76083055|FG002|NOT COMPLETED|Part 1 - Dose Determining Period||0||
59965280|NCT02508532|76083056|FG003|NOT COMPLETED|Part 1 - Dose Determining Period||0||
59965281|NCT02508532|76083057|FG004|NOT COMPLETED|Part 1 - Dose Determining Period||0||
59965282|NCT02508532|76083058|FG005|NOT COMPLETED|Part 1 - Dose Determining Period||0||
59965283|NCT02508532|76083059|FG006|NOT COMPLETED|Part 1 - Dose Determining Period||1||
59965284|NCT02508532|76083060|FG007|NOT COMPLETED|Part 1 - Dose Determining Period||1||
59965285|NCT02508532|76083061|FG008|NOT COMPLETED|Part 1 - Dose Determining Period||0||
59965286|NCT02508532|76083053|FG000|STARTED|Part 2 - Treatment|These patients are not included in Part 2 analyses|0||
59965287|NCT02508532|76083054|FG001|STARTED|Part 2 - Treatment|These patients are not included in Part 2 analyses|0||
59965288|NCT02508532|76083055|FG002|STARTED|Part 2 - Treatment|These patients are not included in Part 2 analyses|0||
59965289|NCT02508532|76083056|FG003|STARTED|Part 2 - Treatment|These patients are not included in Part 2 analyses|0||
59965290|NCT02508532|76083057|FG004|STARTED|Part 2 - Treatment|These patients are not included in Part 2 analyses|0||
60074297|NCT01604343|76189696|FG000|COMPLETED|Week 52 to Week 104||0||
60074298|NCT01604343|76189697|FG001|COMPLETED|Week 52 to Week 104||200||
60074299|NCT01604343|76189698|FG002|COMPLETED|Week 52 to Week 104||414||
60074300|NCT01604343|76189699|FG003|COMPLETED|Week 52 to Week 104||195||
60074301|NCT01604343|76189700|FG004|COMPLETED|Week 52 to Week 104||429||
60074302|NCT01604343|76189696|FG000|NOT COMPLETED|Week 52 to Week 104||0||
60074303|NCT01604343|76189697|FG001|NOT COMPLETED|Week 52 to Week 104||43||
60074304|NCT01604343|76189698|FG002|NOT COMPLETED|Week 52 to Week 104||67||
60074305|NCT01604343|76189699|FG003|NOT COMPLETED|Week 52 to Week 104||46||
60074306|NCT01604343|76189700|FG004|NOT COMPLETED|Week 52 to Week 104||41||
60074307|NCT01604343|76189696|FG000|STARTED|Safety Follow-up Period (Week 104-120)||109||
60074308|NCT01604343|76189697|FG001|STARTED|Safety Follow-up Period (Week 104-120)||27||
60074309|NCT01604343|76189698|FG002|STARTED|Safety Follow-up Period (Week 104-120)||105||
59965291|NCT02508532|76083058|FG005|STARTED|Part 2 - Treatment|"Part 1 Only:~6 Patients from this group are included in the 300 or 400 mg QD group."|0||
59965292|NCT02508532|76083059|FG006|STARTED|Part 2 - Treatment|"Part 1 Only:~7 Patients from this group are included in the 300 or 400 mg QD group."|0||
59965293|NCT02508532|76083060|FG007|STARTED|Part 2 - Treatment|These patients are not included in Part 2 analyses|0||
59965294|NCT02508532|76083061|FG008|STARTED|Part 2 - Treatment|Includes 13 patients enrolled in Part 1 at a starting dose of 300 mg (n = 6) or 400 mg (n = 7) QD.|217||
59965295|NCT02508532|76083053|FG000|COMPLETED|Part 2 - Treatment||0||
59965296|NCT02508532|76083054|FG001|COMPLETED|Part 2 - Treatment||0||
59965297|NCT02508532|76083055|FG002|COMPLETED|Part 2 - Treatment||0||
59965298|NCT02508532|76083056|FG003|COMPLETED|Part 2 - Treatment||0||
59965299|NCT02508532|76083057|FG004|COMPLETED|Part 2 - Treatment||0||
59965300|NCT02508532|76083058|FG005|COMPLETED|Part 2 - Treatment||0||
59965301|NCT02508532|76083059|FG006|COMPLETED|Part 2 - Treatment||0||
59965302|NCT02508532|76083060|FG007|COMPLETED|Part 2 - Treatment||0||
59965303|NCT02508532|76083061|FG008|COMPLETED|Part 2 - Treatment||0||
59965304|NCT02508532|76083053|FG000|NOT COMPLETED|Part 2 - Treatment||0||
59965305|NCT02508532|76083054|FG001|NOT COMPLETED|Part 2 - Treatment||0||
59965306|NCT02508532|76083055|FG002|NOT COMPLETED|Part 2 - Treatment||0||
59965307|NCT02508532|76083056|FG003|NOT COMPLETED|Part 2 - Treatment||0||
59965308|NCT02508532|76083057|FG004|NOT COMPLETED|Part 2 - Treatment||0||
59965309|NCT02508532|76083058|FG005|NOT COMPLETED|Part 2 - Treatment||0||
59965310|NCT02508532|76083059|FG006|NOT COMPLETED|Part 2 - Treatment||0||
59965311|NCT02508532|76083060|FG007|NOT COMPLETED|Part 2 - Treatment||0||
59965312|NCT02508532|76083061|FG008|NOT COMPLETED|Part 2 - Treatment||217||
59965313|NCT02508532|76083053|FG000|STARTED|Part 1 and Part 2 End of Study||6||
59965314|NCT02508532|76083054|FG001|STARTED|Part 1 and Part 2 End of Study||6||
59965315|NCT02508532|76083055|FG002|STARTED|Part 1 and Part 2 End of Study||6||
59965316|NCT02508532|76083056|FG003|STARTED|Part 1 and Part 2 End of Study||6||
59965317|NCT02508532|76083057|FG004|STARTED|Part 1 and Part 2 End of Study||6||
59965318|NCT02508532|76083058|FG005|STARTED|Part 1 and Part 2 End of Study|These 6 patients are included in the 300 or 400 mg QD dose group|0||
59965319|NCT02508532|76083059|FG006|STARTED|Part 1 and Part 2 End of Study|These 7 patients are included in the 300 or 400 mg QD dose group|0||
59965320|NCT02508532|76083060|FG007|STARTED|Part 1 and Part 2 End of Study||3||
59965321|NCT02508532|76083061|FG008|STARTED|Part 1 and Part 2 End of Study|Includes 13 patients enrolled in Part 1 at a starting dose of 300 mg (n = 6) or 400 mg (n = 7) QD.|217||
59965322|NCT02508532|76083053|FG000|COMPLETED|Part 1 and Part 2 End of Study||0||
59965323|NCT02508532|76083054|FG001|COMPLETED|Part 1 and Part 2 End of Study||0||
59965324|NCT02508532|76083055|FG002|COMPLETED|Part 1 and Part 2 End of Study||0||
59965325|NCT02508532|76083056|FG003|COMPLETED|Part 1 and Part 2 End of Study||0||
59965326|NCT02508532|76083057|FG004|COMPLETED|Part 1 and Part 2 End of Study||0||
59965327|NCT02508532|76083058|FG005|COMPLETED|Part 1 and Part 2 End of Study||0||
59965328|NCT02508532|76083059|FG006|COMPLETED|Part 1 and Part 2 End of Study||0||
59965329|NCT02508532|76083060|FG007|COMPLETED|Part 1 and Part 2 End of Study||0||
59965330|NCT02508532|76083061|FG008|COMPLETED|Part 1 and Part 2 End of Study||0||
59965331|NCT02508532|76083053|FG000|NOT COMPLETED|Part 1 and Part 2 End of Study||6||
59965332|NCT02508532|76083054|FG001|NOT COMPLETED|Part 1 and Part 2 End of Study||6||
59965333|NCT02508532|76083055|FG002|NOT COMPLETED|Part 1 and Part 2 End of Study||6||
59965334|NCT02508532|76083056|FG003|NOT COMPLETED|Part 1 and Part 2 End of Study||6||
59965335|NCT02508532|76083057|FG004|NOT COMPLETED|Part 1 and Part 2 End of Study||6||
59965336|NCT02508532|76083058|FG005|NOT COMPLETED|Part 1 and Part 2 End of Study||0||
59965337|NCT02508532|76083059|FG006|NOT COMPLETED|Part 1 and Part 2 End of Study||0||
59965338|NCT02508532|76083060|FG007|NOT COMPLETED|Part 1 and Part 2 End of Study||3||
59965339|NCT02508532|76083061|FG008|NOT COMPLETED|Part 1 and Part 2 End of Study||217||
59965340|NCT02918071|76083090|FG000|STARTED|Overall Study||121||
59965341|NCT02918071|76083090|FG000|COMPLETED|Overall Study||118||
59965342|NCT02918071|76083090|FG000|NOT COMPLETED|Overall Study||3||
59965343|NCT02507752|76083094|FG000|STARTED|Overall Study||72||
59965344|NCT02507752|76083094|FG000|COMPLETED|Overall Study||55||
59965345|NCT02507752|76083094|FG000|NOT COMPLETED|Overall Study||17||
59965346|NCT02506816|76083098|FG000|STARTED|Overall Study||36||
59965347|NCT02506816|76083098|FG000|Samples Availability|Overall Study|31 of 36 patients had valid samples for analysis of biomarkers (primary and secondary analysis)|31||
59524842|NCT04697056|75619963|FG000|NOT COMPLETED|Overall Study||4||
59965348|NCT02506816|76083098|FG000|COMPLETED|Overall Study||33||
59965349|NCT02506816|76083098|FG000|NOT COMPLETED|Overall Study||3||
59965350|NCT02506036|76083104|FG000|STARTED|First Intervention (4-6 Weeks)||3||
59965351|NCT02506036|76083105|FG001|STARTED|First Intervention (4-6 Weeks)||3||
59965352|NCT02506036|76083104|FG000|COMPLETED|First Intervention (4-6 Weeks)||2||
59965353|NCT02506036|76083105|FG001|COMPLETED|First Intervention (4-6 Weeks)||1||
59995306|NCT04442503|76111155|FG000|STARTED|Overall Study||101||
59995307|NCT04442503|76111156|FG001|STARTED|Overall Study||99||
59995308|NCT04442503|76111155|FG000|Number of Participants Received Investigational Product (IP)|Overall Study||98||
59995309|NCT04442503|76111156|FG001|Number of Participants Received Investigational Product (IP)|Overall Study||98||
59995310|NCT04442503|76111155|FG000|COMPLETED|Overall Study||86||
59995311|NCT04442503|76111156|FG001|COMPLETED|Overall Study||84||
59995312|NCT04442503|76111155|FG000|NOT COMPLETED|Overall Study||15||
59965354|NCT02506036|76083104|FG000|NOT COMPLETED|First Intervention (4-6 Weeks)||1||
59965355|NCT02506036|76083105|FG001|NOT COMPLETED|First Intervention (4-6 Weeks)||2||
59965356|NCT02506036|76083104|FG000|STARTED|Washout (1-2 Weeks)||2||
59965357|NCT02506036|76083105|FG001|STARTED|Washout (1-2 Weeks)||1||
59965358|NCT02506036|76083104|FG000|COMPLETED|Washout (1-2 Weeks)||2||
59965359|NCT02506036|76083105|FG001|COMPLETED|Washout (1-2 Weeks)||1||
59965360|NCT02506036|76083104|FG000|NOT COMPLETED|Washout (1-2 Weeks)||0||
59965361|NCT02506036|76083105|FG001|NOT COMPLETED|Washout (1-2 Weeks)||0||
59965362|NCT02506036|76083104|FG000|STARTED|Second Intervention (4-6 Weeks)||2||
59965363|NCT02506036|76083105|FG001|STARTED|Second Intervention (4-6 Weeks)||1||
59809814|NCT00539006|75931959|FG000|STARTED|Post-Study||75||
59809815|NCT00539006|75931960|FG001|STARTED|Post-Study||83||
59809816|NCT00539006|75931961|FG002|STARTED|Post-Study||77||
59809817|NCT00539006|75931962|FG003|STARTED|Post-Study||81||
59809818|NCT00539006|75931959|FG000|COMPLETED|Post-Study||75||
59809819|NCT00539006|75931960|FG001|COMPLETED|Post-Study||83||
59809820|NCT00539006|75931961|FG002|COMPLETED|Post-Study||77||
59809821|NCT00539006|75931962|FG003|COMPLETED|Post-Study||81||
59809822|NCT00539006|75931959|FG000|NOT COMPLETED|Post-Study||0||
59965364|NCT02506036|76083104|FG000|COMPLETED|Second Intervention (4-6 Weeks)||2||
59965365|NCT02506036|76083105|FG001|COMPLETED|Second Intervention (4-6 Weeks)||1||
59965366|NCT02506036|76083104|FG000|NOT COMPLETED|Second Intervention (4-6 Weeks)||0||
59965367|NCT02506036|76083105|FG001|NOT COMPLETED|Second Intervention (4-6 Weeks)||0||
59965368|NCT01063855|76083113|FG000|STARTED|Overall Study||245||
59965369|NCT01063855|76083114|FG001|STARTED|Overall Study||250||
59965370|NCT01063855|76083113|FG000|COMPLETED|Overall Study||208||
59965371|NCT01063855|76083114|FG001|COMPLETED|Overall Study||221||
59965372|NCT01063855|76083113|FG000|NOT COMPLETED|Overall Study||37||
59965373|NCT01063855|76083114|FG001|NOT COMPLETED|Overall Study||29||
59965374|NCT01063153|76083126|FG000|STARTED|Overall Study||33||
59965375|NCT01063153|76083127|FG001|STARTED|Overall Study||38||
59965376|NCT01063153|76083126|FG000|COMPLETED|Overall Study||31||
59965377|NCT01063153|76083127|FG001|COMPLETED|Overall Study||26||
59965378|NCT01063153|76083126|FG000|NOT COMPLETED|Overall Study||2||
59965379|NCT01063153|76083127|FG001|NOT COMPLETED|Overall Study||12||
59965380|NCT01062841|76083139|FG000|STARTED|Overall Study||203||
59965381|NCT01062841|76083140|FG001|STARTED|Overall Study||215||
59965382|NCT01062841|76083139|FG000|COMPLETED|Overall Study||154||
59965383|NCT01062841|76083140|FG001|COMPLETED|Overall Study||162||
59965384|NCT01062841|76083139|FG000|NOT COMPLETED|Overall Study||49||
59965385|NCT01062841|76083140|FG001|NOT COMPLETED|Overall Study||53||
59965386|NCT02505334|76083148|FG000|STARTED|Main Treatment Period||233||
59965387|NCT02505334|76083149|FG001|STARTED|Main Treatment Period||233||
59965388|NCT02505334|76083148|FG000|COMPLETED|Main Treatment Period||218||
59965389|NCT02505334|76083149|FG001|COMPLETED|Main Treatment Period||194||
59965390|NCT02505334|76083148|FG000|NOT COMPLETED|Main Treatment Period||15||
59965391|NCT02505334|76083149|FG001|NOT COMPLETED|Main Treatment Period||39||
60074310|NCT01604343|76189699|FG003|STARTED|Safety Follow-up Period (Week 104-120)||36||
59809823|NCT00539006|75931960|FG001|NOT COMPLETED|Post-Study||0||
59809824|NCT00539006|75931961|FG002|NOT COMPLETED|Post-Study||0||
59809825|NCT00539006|75931962|FG003|NOT COMPLETED|Post-Study||0||
59965392|NCT02505334|76083148|FG000|STARTED|Extension Treatment Period|6 subjects withdrew from the trial after the main period and prior to entering the extension period|212||
59965393|NCT02505334|76083149|FG001|STARTED|Extension Treatment Period|This treatment arm is not considered for this period as the subjects were treated for 26 weeks|0||
59965394|NCT02505334|76083148|FG000|COMPLETED|Extension Treatment Period||194||
59965395|NCT02505334|76083149|FG001|COMPLETED|Extension Treatment Period||0||
59965396|NCT02505334|76083148|FG000|NOT COMPLETED|Extension Treatment Period||18||
59965397|NCT02505334|76083149|FG001|NOT COMPLETED|Extension Treatment Period||0||
59965398|NCT01062061|76083155|FG000|STARTED|Overall Study||754||
59965399|NCT01062061|76083155|FG000|COMPLETED|Overall Study||727||
59965400|NCT01062061|76083155|FG000|NOT COMPLETED|Overall Study||27||
59965401|NCT02504320|76083167|FG000|STARTED|Treatment Period 1||19||
59965402|NCT02504320|76083168|FG001|STARTED|Treatment Period 1||19||
59965403|NCT02504320|76083169|FG002|STARTED|Treatment Period 1||20||
59965404|NCT02504320|76083170|FG003|STARTED|Treatment Period 1||20||
59965405|NCT02504320|76083167|FG000|COMPLETED|Treatment Period 1||19||
59965406|NCT02504320|76083168|FG001|COMPLETED|Treatment Period 1||19||
60074311|NCT01604343|76189700|FG004|STARTED|Safety Follow-up Period (Week 104-120)||114||
60074312|NCT01604343|76189696|FG000|Safety Population|Safety Follow-up Period (Week 104-120)||109||
59809826|NCT00537056|75931978|FG000|STARTED|Baseline PET/CT||17||
59809827|NCT00537056|75931978|FG000|COMPLETED|Baseline PET/CT||17||
59809828|NCT00537056|75931978|FG000|NOT COMPLETED|Baseline PET/CT||0||
59809829|NCT00537056|75931978|FG000|STARTED|Interim PET/CT||17||
59809830|NCT00537056|75931978|FG000|COMPLETED|Interim PET/CT||12||
59809831|NCT00537056|75931978|FG000|NOT COMPLETED|Interim PET/CT||5||
59809832|NCT00537056|75931978|FG000|STARTED|12-month Follow-up||17||
59809833|NCT00537056|75931978|FG000|COMPLETED|12-month Follow-up||17||
59809834|NCT00537056|75931978|FG000|NOT COMPLETED|12-month Follow-up||0||
59809835|NCT00535262|75931984|FG000|STARTED|Overall Study|3 patients were enrolled in the study. Data was collected for only two weeks before funding expired.|3||
59965407|NCT02504320|76083169|FG002|COMPLETED|Treatment Period 1||19||
59965408|NCT02504320|76083170|FG003|COMPLETED|Treatment Period 1||20||
59965409|NCT02504320|76083167|FG000|NOT COMPLETED|Treatment Period 1||0||
59965410|NCT02504320|76083168|FG001|NOT COMPLETED|Treatment Period 1||0||
59965411|NCT02504320|76083169|FG002|NOT COMPLETED|Treatment Period 1||1||
59965412|NCT02504320|76083170|FG003|NOT COMPLETED|Treatment Period 1||0||
59965413|NCT02504320|76083167|FG000|STARTED|Treatment Period 2||19||
59965414|NCT02504320|76083168|FG001|STARTED|Treatment Period 2||19||
59965415|NCT02504320|76083169|FG002|STARTED|Treatment Period 2||19||
59965416|NCT02504320|76083170|FG003|STARTED|Treatment Period 2||20||
59965417|NCT02504320|76083167|FG000|COMPLETED|Treatment Period 2||19||
59965418|NCT02504320|76083168|FG001|COMPLETED|Treatment Period 2||18||
59965419|NCT02504320|76083169|FG002|COMPLETED|Treatment Period 2||19||
59965420|NCT02504320|76083170|FG003|COMPLETED|Treatment Period 2||20||
59965421|NCT02504320|76083167|FG000|NOT COMPLETED|Treatment Period 2||0||
59965422|NCT02504320|76083168|FG001|NOT COMPLETED|Treatment Period 2||1||
59965423|NCT02504320|76083169|FG002|NOT COMPLETED|Treatment Period 2||0||
59965424|NCT02504320|76083170|FG003|NOT COMPLETED|Treatment Period 2||0||
59965425|NCT02504320|76083167|FG000|STARTED|Treatment Period 3||19||
59965426|NCT02504320|76083168|FG001|STARTED|Treatment Period 3||18||
59809836|NCT00535262|75931984|FG000|COMPLETED|Overall Study|Pharmaceutical company withdrew supply of EmSam prematurely before protocol was complete.|0||
59809837|NCT00535262|75931984|FG000|NOT COMPLETED|Overall Study||3||
59809838|NCT00074581|75931990|FG000|STARTED|Overall Study|886 HIV-infected index cases and 903 HIV-uninfected partners|1789||
59809839|NCT00074581|75931991|FG001|STARTED|Overall Study|877 HIV-infected index cases and 890 HIV-uninfected partners|1767||
59965427|NCT02504320|76083169|FG002|STARTED|Treatment Period 3||19||
59965428|NCT02504320|76083170|FG003|STARTED|Treatment Period 3||20||
59965429|NCT02504320|76083167|FG000|COMPLETED|Treatment Period 3||19||
59965430|NCT02504320|76083168|FG001|COMPLETED|Treatment Period 3||18||
59965431|NCT02504320|76083169|FG002|COMPLETED|Treatment Period 3||18||
59965432|NCT02504320|76083170|FG003|COMPLETED|Treatment Period 3||19||
59965433|NCT02504320|76083167|FG000|NOT COMPLETED|Treatment Period 3||0||
59965434|NCT02504320|76083168|FG001|NOT COMPLETED|Treatment Period 3||0||
59965435|NCT02504320|76083169|FG002|NOT COMPLETED|Treatment Period 3||1||
59965436|NCT02504320|76083170|FG003|NOT COMPLETED|Treatment Period 3||1||
59965437|NCT02504320|76083167|FG000|STARTED|Treatment Period 4||19||
59965438|NCT02504320|76083168|FG001|STARTED|Treatment Period 4||18||
59965439|NCT02504320|76083169|FG002|STARTED|Treatment Period 4||18||
59965440|NCT02504320|76083170|FG003|STARTED|Treatment Period 4||19||
59965441|NCT02504320|76083167|FG000|COMPLETED|Treatment Period 4||19||
59965442|NCT02504320|76083168|FG001|COMPLETED|Treatment Period 4||18||
59965443|NCT02504320|76083169|FG002|COMPLETED|Treatment Period 4||18||
59965444|NCT02504320|76083170|FG003|COMPLETED|Treatment Period 4||19||
59965445|NCT02504320|76083167|FG000|NOT COMPLETED|Treatment Period 4||0||
59965446|NCT02504320|76083168|FG001|NOT COMPLETED|Treatment Period 4||0||
59965447|NCT02504320|76083169|FG002|NOT COMPLETED|Treatment Period 4||0||
59965448|NCT02504320|76083170|FG003|NOT COMPLETED|Treatment Period 4||0||
59965449|NCT01061671|76083182|FG000|STARTED|Overall Study||433||
59965450|NCT01061671|76083183|FG001|STARTED|Overall Study||452||
59965451|NCT01061671|76083182|FG000|COMPLETED|Overall Study||386||
59965452|NCT01061671|76083183|FG001|COMPLETED|Overall Study||397||
59965453|NCT01061671|76083182|FG000|NOT COMPLETED|Overall Study||47||
59965454|NCT01061671|76083183|FG001|NOT COMPLETED|Overall Study||55||
59965455|NCT00709995|76083191|FG000|STARTED|Overall Study||11||
59965456|NCT00709995|76083192|FG001|STARTED|Overall Study||6||
59965457|NCT00709995|76083191|FG000|Progressive Disease|Overall Study||6||
59965458|NCT00709995|76083192|FG001|Progressive Disease|Overall Study||1||
59965459|NCT00709995|76083191|FG000|COMPLETED|Overall Study||6||
59965460|NCT00709995|76083192|FG001|COMPLETED|Overall Study||1||
59965461|NCT00709995|76083191|FG000|NOT COMPLETED|Overall Study||5||
59965462|NCT00709995|76083192|FG001|NOT COMPLETED|Overall Study||5||
59809840|NCT00074581|75931990|FG000|COMPLETED|Overall Study||1545||
59809841|NCT00074581|75931991|FG001|COMPLETED|Overall Study||1541||
59809842|NCT00074581|75931990|FG000|NOT COMPLETED|Overall Study||244||
59809843|NCT00074581|75931991|FG001|NOT COMPLETED|Overall Study||226||
59965463|NCT02503540|76083201|FG000|STARTED|Overall Study||31||
59965464|NCT02503540|76083201|FG000|COMPLETED|Overall Study||28||
59809844|NCT03895034|75931997|FG000|STARTED|Overall Study||66||111
59965465|NCT02503540|76083201|FG000|NOT COMPLETED|Overall Study||3||
59965466|NCT02502526|76083208|FG000|STARTED|Overall Study||62|All randomized subjects|
59965467|NCT02502526|76083209|FG001|STARTED|Overall Study||59|All randomized subjects|
59965468|NCT02502526|76083210|FG002|STARTED|Overall Study||61|All randomized subjects|
59965469|NCT02502526|76083208|FG000|Intent-to-Treat (ITT)|Overall Study||57|All randomized subjects who completed a procedure|
59965470|NCT02502526|76083209|FG001|Intent-to-Treat (ITT)|Overall Study||57|All randomized subjects who completed a procedure|
59965471|NCT02502526|76083210|FG002|Intent-to-Treat (ITT)|Overall Study||59|All randomized subjects who completed a procedure|
59965472|NCT02502526|76083208|FG000|COMPLETED|Overall Study||56|All subjects who completed the study|
59965473|NCT02502526|76083209|FG001|COMPLETED|Overall Study||55|All subjects who completed the study|
59965474|NCT02502526|76083210|FG002|COMPLETED|Overall Study||55|All subjects who completed the study|
59965475|NCT02502526|76083208|FG000|NOT COMPLETED|Overall Study||6||
59965476|NCT02502526|76083209|FG001|NOT COMPLETED|Overall Study||4||
59965477|NCT02502526|76083210|FG002|NOT COMPLETED|Overall Study||6||
59965478|NCT02972515|76083219|FG000|STARTED|Overall Study||166||
59965479|NCT02972515|76083219|FG000|COMPLETED|Overall Study||88||
59965480|NCT02972515|76083219|FG000|NOT COMPLETED|Overall Study||78||
59965481|NCT02972359|76083223|FG000|STARTED|Overall Study||318||
59965482|NCT02972359|76083223|FG000|COMPLETED|Overall Study||247||
59965483|NCT02972359|76083223|FG000|NOT COMPLETED|Overall Study||71||
59965484|NCT01060111|76083230|FG000|STARTED|Overall Study||81||
59965485|NCT01060111|76083231|FG001|STARTED|Overall Study||84||
59965486|NCT01060111|76083232|FG002|STARTED|Overall Study||80||
59965487|NCT01060111|76083230|FG000|Treated|Overall Study||81||
59965488|NCT01060111|76083231|FG001|Treated|Overall Study||83||
59965489|NCT01060111|76083232|FG002|Treated|Overall Study||79||
59965490|NCT01060111|76083230|FG000|COMPLETED|Overall Study||54||
59965491|NCT01060111|76083231|FG001|COMPLETED|Overall Study||61||
59965492|NCT01060111|76083232|FG002|COMPLETED|Overall Study||45||
59965493|NCT01060111|76083230|FG000|NOT COMPLETED|Overall Study||27||
59809845|NCT03895034|75931997|FG000|COMPLETED|Overall Study||64||109
59809846|NCT03895034|75931997|FG000|NOT COMPLETED|Overall Study||2||2
59809847|NCT00536978|75932001|FG000|STARTED|Overall Study||22||
59809848|NCT00536978|75932001|FG000|COMPLETED|Overall Study||0||
59809849|NCT00536978|75932001|FG000|NOT COMPLETED|Overall Study||22||
59809850|NCT03809611|75932007|FG000|STARTED|Overall Study||62||
59809851|NCT03809611|75932008|FG001|STARTED|Overall Study||62||
59809852|NCT03809611|75932007|FG000|COMPLETED|Overall Study||61||
59809853|NCT03809611|75932008|FG001|COMPLETED|Overall Study||61||
59809854|NCT03809611|75932007|FG000|NOT COMPLETED|Overall Study||1||
59809855|NCT03809611|75932008|FG001|NOT COMPLETED|Overall Study||1||
59809856|NCT03807739|75932019|FG000|STARTED|Overall Study||9||
59809857|NCT03807739|75932020|FG001|STARTED|Overall Study||10||
59965494|NCT01060111|76083231|FG001|NOT COMPLETED|Overall Study||23||
59965495|NCT01060111|76083232|FG002|NOT COMPLETED|Overall Study||35||
59965496|NCT02969863|76083243|FG000|STARTED|Overall Study||4||
59965497|NCT02969863|76083244|FG001|STARTED|Overall Study||4||
59965498|NCT02969863|76083245|FG002|STARTED|Overall Study||4||
59965499|NCT02969863|76083246|FG003|STARTED|Overall Study||4||
59965500|NCT02969863|76083247|FG004|STARTED|Overall Study||4||
59965501|NCT02969863|76083248|FG005|STARTED|Overall Study||4||
59965502|NCT02969863|76083243|FG000|COMPLETED|Overall Study||3||
59965503|NCT02969863|76083244|FG001|COMPLETED|Overall Study||4||
59965504|NCT02969863|76083245|FG002|COMPLETED|Overall Study||4||
59965505|NCT02969863|76083246|FG003|COMPLETED|Overall Study||4||
59965506|NCT02969863|76083247|FG004|COMPLETED|Overall Study||4||
59965507|NCT02969863|76083248|FG005|COMPLETED|Overall Study||4||
59965508|NCT02969863|76083243|FG000|NOT COMPLETED|Overall Study||1||
59965509|NCT02969863|76083244|FG001|NOT COMPLETED|Overall Study||0||
59965510|NCT02969863|76083245|FG002|NOT COMPLETED|Overall Study||0||
59965511|NCT02969863|76083246|FG003|NOT COMPLETED|Overall Study||0||
59965512|NCT02969863|76083247|FG004|NOT COMPLETED|Overall Study||0||
59965513|NCT02969863|76083248|FG005|NOT COMPLETED|Overall Study||0||
59965514|NCT02969707|76083264|FG000|STARTED|Overall Study||49||
59965515|NCT02969707|76083265|FG001|STARTED|Overall Study||52||
59965516|NCT02969707|76083264|FG000|COMPLETED|Overall Study||41||
59965517|NCT02969707|76083265|FG001|COMPLETED|Overall Study||44||
59965518|NCT02969707|76083264|FG000|NOT COMPLETED|Overall Study||8||
59965519|NCT02969707|76083265|FG001|NOT COMPLETED|Overall Study||8||
59965520|NCT02967055|76083276|FG000|STARTED|Overall Study|Assessed for eligibility|54||
59965521|NCT02967055|76083276|FG000|In-person Screening|Overall Study||14|Presented for In-person screening|
59524843|NCT04697056|75619964|FG001|NOT COMPLETED|Overall Study||1||
59524844|NCT00866840|75619972|FG000|STARTED|Overall Study||13||
59524845|NCT00866840|75619972|FG000|COMPLETED|Overall Study||13||
59524846|NCT00866840|75619972|FG000|NOT COMPLETED|Overall Study||0||
59809858|NCT03807739|75932021|FG002|STARTED|Overall Study||9||
59809859|NCT03807739|75932022|FG003|STARTED|Overall Study||10||
59965522|NCT02967055|76083276|FG000|Enrolled|Overall Study|Enrolled|9||
59524847|NCT01057901|75619978|FG000|STARTED|Overall Study||376||
59809860|NCT03807739|75932019|FG000|COMPLETED|Overall Study||7||
59809861|NCT03807739|75932020|FG001|COMPLETED|Overall Study||10||
59809862|NCT03807739|75932021|FG002|COMPLETED|Overall Study||9||
59809863|NCT03807739|75932022|FG003|COMPLETED|Overall Study||10||
59809864|NCT03807739|75932019|FG000|NOT COMPLETED|Overall Study||2||
59809865|NCT03807739|75932020|FG001|NOT COMPLETED|Overall Study||0||
59809866|NCT03807739|75932021|FG002|NOT COMPLETED|Overall Study||0||
59809867|NCT03807739|75932022|FG003|NOT COMPLETED|Overall Study||0||
59809868|NCT00536744|75932034|FG000|STARTED|Overall Study||107||
59524848|NCT01057901|75619979|FG001|STARTED|Overall Study||372||
59965523|NCT02967055|76083276|FG000|Completed 4 Week Follow-up Visit|Overall Study||8||
59965524|NCT02967055|76083276|FG000|COMPLETED|Overall Study||5||
59965525|NCT02967055|76083276|FG000|NOT COMPLETED|Overall Study||49||
59524849|NCT01057901|75619978|FG000|COMPLETED|Overall Study||116||
59524850|NCT01057901|75619979|FG001|COMPLETED|Overall Study||126||
59965526|NCT02904265|76083282|FG000|STARTED|Overall Study|Study closed due to only 3 participants recruited|1||
59965527|NCT02904265|76083283|FG001|STARTED|Overall Study|Study closed due to only 3 participants recruited|2||
59965528|NCT02904265|76083282|FG000|COMPLETED|Overall Study||0||
59965529|NCT02904265|76083283|FG001|COMPLETED|Overall Study||0||
59965530|NCT02904265|76083282|FG000|NOT COMPLETED|Overall Study||1||
59965531|NCT02904265|76083283|FG001|NOT COMPLETED|Overall Study||2||
59965532|NCT03461211|76083291|FG000|STARTED|Overall Study||37||
59965533|NCT03461211|76083292|FG001|STARTED|Overall Study||14||
59965534|NCT03461211|76083291|FG000|Proptosis Non-Responders in OPTIC|Overall Study||36||
59965535|NCT03461211|76083292|FG001|Proptosis Non-Responders in OPTIC|Overall Study||5||
59965536|NCT03461211|76083291|FG000|Relapsed During Follow-Up Period of OPTIC|Overall Study||1||
59965537|NCT03461211|76083292|FG001|Relapsed During Follow-Up Period of OPTIC|Overall Study||9||
59965538|NCT03461211|76083291|FG000|COMPLETED|Overall Study||36||
59965539|NCT03461211|76083292|FG001|COMPLETED|Overall Study||12||
59965540|NCT03461211|76083291|FG000|NOT COMPLETED|Overall Study||1||
59965541|NCT03461211|76083292|FG001|NOT COMPLETED|Overall Study||2||
59965542|NCT02967679|76083300|FG000|STARTED|Overall Study||15||
59965543|NCT02967679|76083300|FG000|COMPLETED|Overall Study||14||
59965544|NCT02967679|76083300|FG000|NOT COMPLETED|Overall Study||1||
59965545|NCT03104205|76083304|FG000|STARTED|Overall Study||53||
59965546|NCT03104205|76083304|FG000|COMPLETED|Overall Study||44||
59965547|NCT03104205|76083304|FG000|NOT COMPLETED|Overall Study||9||
59965548|NCT02966509|76083310|FG000|STARTED|Baseline Satisfaction Survey||105||
59965549|NCT02966509|76083311|FG001|STARTED|Baseline Satisfaction Survey||108||
59965550|NCT02966509|76083310|FG000|COMPLETED|Baseline Satisfaction Survey||101||
59965551|NCT02966509|76083311|FG001|COMPLETED|Baseline Satisfaction Survey||101||
59965552|NCT02966509|76083310|FG000|NOT COMPLETED|Baseline Satisfaction Survey||4||
59965553|NCT02966509|76083311|FG001|NOT COMPLETED|Baseline Satisfaction Survey||7||
59965554|NCT02966509|76083310|FG000|STARTED|6 Month Satisfaction Decision Survey||105||
59965555|NCT02966509|76083311|FG001|STARTED|6 Month Satisfaction Decision Survey||108||
59965556|NCT02966509|76083310|FG000|COMPLETED|6 Month Satisfaction Decision Survey||80||
59965557|NCT02966509|76083311|FG001|COMPLETED|6 Month Satisfaction Decision Survey||77||
59965558|NCT02966509|76083310|FG000|NOT COMPLETED|6 Month Satisfaction Decision Survey||25||
59965559|NCT02966509|76083311|FG001|NOT COMPLETED|6 Month Satisfaction Decision Survey||31||
59965560|NCT02966509|76083310|FG000|STARTED|6 Month Satisfaction Survey||105||
59965561|NCT02966509|76083311|FG001|STARTED|6 Month Satisfaction Survey||108||
59965562|NCT02966509|76083310|FG000|COMPLETED|6 Month Satisfaction Survey||58||
59965563|NCT02966509|76083311|FG001|COMPLETED|6 Month Satisfaction Survey||60||
59965564|NCT02966509|76083310|FG000|NOT COMPLETED|6 Month Satisfaction Survey||47||
59965565|NCT02966509|76083311|FG001|NOT COMPLETED|6 Month Satisfaction Survey||48||
59965566|NCT02966509|76083310|FG000|STARTED|6-Month Utilization and Cost||105||
59965567|NCT02966509|76083311|FG001|STARTED|6-Month Utilization and Cost||108||
59965568|NCT02966509|76083310|FG000|COMPLETED|6-Month Utilization and Cost||105||
59965569|NCT02966509|76083311|FG001|COMPLETED|6-Month Utilization and Cost||108||
59965570|NCT02966509|76083310|FG000|NOT COMPLETED|6-Month Utilization and Cost||0||
59965571|NCT02966509|76083311|FG001|NOT COMPLETED|6-Month Utilization and Cost||0||
59965572|NCT02966509|76083310|FG000|STARTED|15-Month Utilization and Cost||105||
59965573|NCT02966509|76083311|FG001|STARTED|15-Month Utilization and Cost||108||
59965574|NCT02966509|76083310|FG000|COMPLETED|15-Month Utilization and Cost||105||
59965575|NCT02966509|76083311|FG001|COMPLETED|15-Month Utilization and Cost||108||
59965576|NCT02966509|76083310|FG000|NOT COMPLETED|15-Month Utilization and Cost||0||
59965577|NCT02966509|76083311|FG001|NOT COMPLETED|15-Month Utilization and Cost||0||
59965578|NCT02966509|76083310|FG000|STARTED|End of Life Utilization and Cost 6 Month||105||
59965579|NCT02966509|76083311|FG001|STARTED|End of Life Utilization and Cost 6 Month||108||
59965580|NCT02966509|76083310|FG000|COMPLETED|End of Life Utilization and Cost 6 Month||36||
59965581|NCT02966509|76083311|FG001|COMPLETED|End of Life Utilization and Cost 6 Month||33||
59965582|NCT02966509|76083310|FG000|NOT COMPLETED|End of Life Utilization and Cost 6 Month||69||
59965583|NCT02966509|76083311|FG001|NOT COMPLETED|End of Life Utilization and Cost 6 Month||75||
59965584|NCT02966509|76083310|FG000|STARTED|End of Life Utilization and Cost 15month||105||
59965585|NCT02966509|76083311|FG001|STARTED|End of Life Utilization and Cost 15month||108||
59965586|NCT02966509|76083310|FG000|COMPLETED|End of Life Utilization and Cost 15month||60||
59965587|NCT02966509|76083311|FG001|COMPLETED|End of Life Utilization and Cost 15month||60||
59965588|NCT02966509|76083310|FG000|NOT COMPLETED|End of Life Utilization and Cost 15month||45||
59965589|NCT02966509|76083311|FG001|NOT COMPLETED|End of Life Utilization and Cost 15month||48||
59965590|NCT02966353|76083317|FG000|STARTED|Overall Study||51||
59965591|NCT02966353|76083317|FG000|Completed After Data Cutoff|Overall Study||1|One patient completed one week after 30 days follow up for safety|
59965592|NCT02966353|76083317|FG000|COMPLETED|Overall Study||29|Primary reason for discontinuation is presented for reason not completed.|
59965593|NCT02966353|76083317|FG000|NOT COMPLETED|Overall Study||22||
59965594|NCT00389649|76083327|FG000|STARTED|Overall Study||2||
59965595|NCT00389649|76083328|FG001|STARTED|Overall Study||2||
59965596|NCT00389649|76083329|FG002|STARTED|Overall Study||3||
59965597|NCT00389649|76083330|FG003|STARTED|Overall Study||2||
59965598|NCT00389649|76083331|FG004|STARTED|Overall Study||2||
59965599|NCT00389649|76083332|FG005|STARTED|Overall Study||2||
59965600|NCT00389649|76083327|FG000|COMPLETED|Overall Study||2||
59965601|NCT00389649|76083328|FG001|COMPLETED|Overall Study||2||
59965602|NCT00389649|76083329|FG002|COMPLETED|Overall Study||3||
59809869|NCT00536744|75932035|FG001|STARTED|Overall Study||99||
59809870|NCT00536744|75932034|FG000|COMPLETED|Overall Study||78||
59809871|NCT00536744|75932035|FG001|COMPLETED|Overall Study||71||
59965603|NCT00389649|76083330|FG003|COMPLETED|Overall Study||2||
59965604|NCT00389649|76083331|FG004|COMPLETED|Overall Study||2||
59965605|NCT00389649|76083332|FG005|COMPLETED|Overall Study||2||
59965606|NCT00389649|76083327|FG000|NOT COMPLETED|Overall Study||0||
59965607|NCT00389649|76083328|FG001|NOT COMPLETED|Overall Study||0||
59965608|NCT00389649|76083329|FG002|NOT COMPLETED|Overall Study||0||
59965609|NCT00389649|76083330|FG003|NOT COMPLETED|Overall Study||0||
59965610|NCT00389649|76083331|FG004|NOT COMPLETED|Overall Study||0||
59965611|NCT00389649|76083332|FG005|NOT COMPLETED|Overall Study||0||
59965612|NCT03856359|76083340|FG000|STARTED|Overall Study||10||
59965613|NCT03856359|76083340|FG000|COMPLETED|Overall Study||9||
59965614|NCT03856359|76083340|FG000|NOT COMPLETED|Overall Study||1||
59965615|NCT03663855|76083344|FG000|STARTED|Overall Study||10||
59965616|NCT03663855|76083344|FG000|COMPLETED|Overall Study||10||
59965617|NCT03663855|76083344|FG000|NOT COMPLETED|Overall Study||0||
59965618|NCT02965573|76083350|FG000|STARTED|Overall Study||12||
59965619|NCT02965573|76083351|FG001|STARTED|Overall Study||12||
59965620|NCT02965573|76083350|FG000|COMPLETED|Overall Study||11||
59809872|NCT00536744|75932034|FG000|NOT COMPLETED|Overall Study||29||
59809873|NCT00536744|75932035|FG001|NOT COMPLETED|Overall Study||28||
59809874|NCT04076072|75932043|FG000|STARTED|Overall Study||20||
59809875|NCT04076072|75932044|FG001|STARTED|Overall Study||20||
59809876|NCT04076072|75932043|FG000|COMPLETED|Overall Study||20||
59965621|NCT02965573|76083351|FG001|COMPLETED|Overall Study||12||
59965622|NCT02965573|76083350|FG000|NOT COMPLETED|Overall Study||1||
59965623|NCT02965573|76083351|FG001|NOT COMPLETED|Overall Study||0||
59965624|NCT02964325|76083359|FG000|STARTED|Overall Study||164||
59965625|NCT02964325|76083360|FG001|STARTED|Overall Study||166||
59965626|NCT02964325|76083359|FG000|Full Analysis Set|Overall Study||164|The Full Analysis Set (FAS) included all randomized subjects. Subjects were analyzed according to the treatment group to which they were assigned at randomization.|
59965627|NCT02964325|76083360|FG001|Full Analysis Set|Overall Study||166|The Full Analysis Set (FAS) included all randomized subjects. Subjects were analyzed according to the treatment group to which they were assigned at randomization.|
59965628|NCT02964325|76083359|FG000|Modified Intent-to-Treat|Overall Study||145|The Modified Intent-to-Treat (mITT) Set included all randomized subjects who underwent at least 1 study transfusion post randomization according to the treatment group (MIRASOL or CONTROL) to which they were randomized.|
59965629|NCT02964325|76083360|FG001|Modified Intent-to-Treat|Overall Study||152|The Modified Intent-to-Treat (mITT) Set included all randomized subjects who underwent at least 1 study transfusion post randomization according to the treatment group (MIRASOL or CONTROL) to which they were randomized.|
59965630|NCT02964325|76083359|FG000|Safety Set|Overall Study||141|The Safety Set (SS) included all randomized subjects who underwent at least 1 PLT transfusion post randomization, independent of the outcome or successful completion of the procedure. Subjects were analyzed according to the majority treatment (MIR PLTs or REF PLTs) received.|
59965631|NCT02964325|76083360|FG001|Safety Set|Overall Study||161|The Safety Set (SS) included all randomized subjects who underwent at least 1 PLT transfusion post randomization, independent of the outcome or successful completion of the procedure. Subjects were analyzed according to the majority treatment (MIR PLTs or REF PLTs) received.|
59965632|NCT02964325|76083359|FG000|COMPLETED|Overall Study||143||
59965633|NCT02964325|76083360|FG001|COMPLETED|Overall Study||143||
59965634|NCT02964325|76083359|FG000|NOT COMPLETED|Overall Study||21||
59965635|NCT02964325|76083360|FG001|NOT COMPLETED|Overall Study||23||
59965636|NCT02964247|76083368|FG000|STARTED|Overall Study||203||
59965637|NCT02964247|76083369|FG001|STARTED|Overall Study||100||
59965638|NCT02964247|76083368|FG000|Exposed to Trial Product|Overall Study||202||
59965639|NCT02964247|76083369|FG001|Exposed to Trial Product|Overall Study||100||
59965640|NCT02964247|76083368|FG000|COMPLETED|Overall Study||200||
59965641|NCT02964247|76083369|FG001|COMPLETED|Overall Study||98||
59965642|NCT02964247|76083368|FG000|NOT COMPLETED|Overall Study||3||
59965643|NCT02964247|76083369|FG001|NOT COMPLETED|Overall Study||2||
60074313|NCT01604343|76189697|FG001|Safety Population|Safety Follow-up Period (Week 104-120)||26||
59809877|NCT04076072|75932044|FG001|COMPLETED|Overall Study||20||
59809878|NCT04076072|75932043|FG000|NOT COMPLETED|Overall Study||0||
59809879|NCT04076072|75932044|FG001|NOT COMPLETED|Overall Study||0||
59809880|NCT00536510|75932052|FG000|STARTED|Overall Study||322||
59809881|NCT00536510|75932053|FG001|STARTED|Overall Study||324||
59809882|NCT00536510|75932052|FG000|COMPLETED|Overall Study||240||
59809883|NCT00536510|75932053|FG001|COMPLETED|Overall Study||295||
59809884|NCT00536510|75932052|FG000|NOT COMPLETED|Overall Study||82||
59809885|NCT00536510|75932053|FG001|NOT COMPLETED|Overall Study||29||
59809886|NCT00398086|75932062|FG000|STARTED|Overall Study||20||
59809887|NCT00398086|75932063|FG001|STARTED|Overall Study||44||
59809888|NCT00398086|75932064|FG002|STARTED|Overall Study||3||
59809889|NCT00398086|75932062|FG000|Phase 1, Dose Escalation Population|Overall Study||20||
59809890|NCT00398086|75932063|FG001|Phase 1, Dose Escalation Population|Overall Study||7||
59809891|NCT00398086|75932064|FG002|Phase 1, Dose Escalation Population|Overall Study||3||
59809892|NCT00398086|75932062|FG000|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease.|11||
59809893|NCT00398086|75932063|FG001|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease.|21||
59965644|NCT03654729|76083378|FG000|STARTED|Overall Study||97||
59965645|NCT03654729|76083379|FG001|STARTED|Overall Study||96||
59965646|NCT03654729|76083380|FG002|STARTED|Overall Study||98||
59965647|NCT03654729|76083378|FG000|Treated|Overall Study||96||
59965648|NCT03654729|76083379|FG001|Treated|Overall Study||93||
59965649|NCT03654729|76083380|FG002|Treated|Overall Study||96||
59965650|NCT03654729|76083378|FG000|COMPLETED|Overall Study||66||
59965651|NCT03654729|76083379|FG001|COMPLETED|Overall Study||70||
59965652|NCT03654729|76083380|FG002|COMPLETED|Overall Study||69||
59965653|NCT03654729|76083378|FG000|NOT COMPLETED|Overall Study||31||
59809894|NCT00398086|75932064|FG002|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease.|1||
59809895|NCT00398086|75932062|FG000|NOT COMPLETED|Overall Study||9||
59809896|NCT00398086|75932063|FG001|NOT COMPLETED|Overall Study||23||
59809897|NCT00398086|75932064|FG002|NOT COMPLETED|Overall Study||2||
59809898|NCT00536198|75932074|FG000|STARTED|Overall Study||125||
59809899|NCT00536198|75932075|FG001|STARTED|Overall Study||127||
59965654|NCT03654729|76083379|FG001|NOT COMPLETED|Overall Study||26||
59965655|NCT03654729|76083380|FG002|NOT COMPLETED|Overall Study||29||
59965656|NCT01377987|76083388|FG000|STARTED|First Intervention (7 Days)||14||
59965657|NCT01377987|76083389|FG001|STARTED|First Intervention (7 Days)||15||
59965658|NCT01377987|76083388|FG000|COMPLETED|First Intervention (7 Days)||14||
59965659|NCT01377987|76083389|FG001|COMPLETED|First Intervention (7 Days)||15||
59965660|NCT01377987|76083388|FG000|NOT COMPLETED|First Intervention (7 Days)||0||
59965661|NCT01377987|76083389|FG001|NOT COMPLETED|First Intervention (7 Days)||0||
59965662|NCT01377987|76083388|FG000|STARTED|Washout (7 Days)||14||
59965663|NCT01377987|76083389|FG001|STARTED|Washout (7 Days)||15||
59965664|NCT01377987|76083388|FG000|COMPLETED|Washout (7 Days)||13||
59965665|NCT01377987|76083389|FG001|COMPLETED|Washout (7 Days)||14||
59965666|NCT01377987|76083388|FG000|NOT COMPLETED|Washout (7 Days)||1||
59965667|NCT01377987|76083389|FG001|NOT COMPLETED|Washout (7 Days)||1||
59809900|NCT00536198|75932074|FG000|Cycle 1|Overall Study||110||
59809901|NCT00536198|75932075|FG001|Cycle 1|Overall Study||123||
59809902|NCT00536198|75932074|FG000|Cycle 2|Overall Study||104||
59809903|NCT00536198|75932075|FG001|Cycle 2|Overall Study||112||
59809904|NCT00536198|75932074|FG000|Cycle 3|Overall Study||100||
59809905|NCT00536198|75932075|FG001|Cycle 3|Overall Study||101||
59809906|NCT00536198|75932074|FG000|Cycle 4|Overall Study||95||
59809907|NCT00536198|75932075|FG001|Cycle 4|Overall Study||98||
59809908|NCT00536198|75932074|FG000|Cycle 5|Overall Study||88||
59809909|NCT00536198|75932075|FG001|Cycle 5|Overall Study||85||
59809910|NCT00536198|75932074|FG000|Cycle 6|Overall Study||88||
59965668|NCT01377987|76083388|FG000|STARTED|Second Intervention (7 Days)||13||
59965669|NCT01377987|76083389|FG001|STARTED|Second Intervention (7 Days)||14||
59965670|NCT01377987|76083388|FG000|COMPLETED|Second Intervention (7 Days)||13||
59965671|NCT01377987|76083389|FG001|COMPLETED|Second Intervention (7 Days)||14||
59965672|NCT01377987|76083388|FG000|NOT COMPLETED|Second Intervention (7 Days)||0||
59965673|NCT01377987|76083389|FG001|NOT COMPLETED|Second Intervention (7 Days)||0||
59965674|NCT02898259|76083400|FG000|STARTED|Overall Study||3||
59965675|NCT02898259|76083401|FG001|STARTED|Overall Study||3||
59965676|NCT02898259|76083402|FG002|STARTED|Overall Study||6||
59965677|NCT02898259|76083403|FG003|STARTED|Overall Study||7||
59965678|NCT02898259|76083404|FG004|STARTED|Overall Study||0||
59965679|NCT02898259|76083400|FG000|COMPLETED|Overall Study||2||
59965680|NCT02898259|76083401|FG001|COMPLETED|Overall Study||2||
59965681|NCT02898259|76083402|FG002|COMPLETED|Overall Study||1||
59965682|NCT02898259|76083403|FG003|COMPLETED|Overall Study||6||
59965683|NCT02898259|76083404|FG004|COMPLETED|Overall Study||0||
59965684|NCT02898259|76083400|FG000|NOT COMPLETED|Overall Study||1||
59965685|NCT02898259|76083401|FG001|NOT COMPLETED|Overall Study||1||
59965686|NCT02898259|76083402|FG002|NOT COMPLETED|Overall Study||5||
59965687|NCT02898259|76083403|FG003|NOT COMPLETED|Overall Study||1||
59965688|NCT02898259|76083404|FG004|NOT COMPLETED|Overall Study||0||
59965689|NCT02963935|76083419|FG000|STARTED|Overall Study||142||
59965690|NCT02963935|76083420|FG001|STARTED|Overall Study||140||
59965691|NCT02963935|76083419|FG000|COMPLETED|Overall Study||114|Completed without discontinuation of trial product|
59965692|NCT02963935|76083420|FG001|COMPLETED|Overall Study||103|Completed without discontinuation of trial product|
59809911|NCT00536198|75932075|FG001|Cycle 6|Overall Study||88||
59809912|NCT00536198|75932074|FG000|COMPLETED|Overall Study||88||
59809913|NCT00536198|75932075|FG001|COMPLETED|Overall Study||88||
59809914|NCT00536198|75932074|FG000|NOT COMPLETED|Overall Study||37||
59965693|NCT02963935|76083419|FG000|NOT COMPLETED|Overall Study||28||
59965694|NCT02963935|76083420|FG001|NOT COMPLETED|Overall Study||37||
59965695|NCT02963701|76083428|FG000|STARTED|Period 1 (Including Washout) (2 Days)||28||
59965696|NCT02963701|76083429|FG001|STARTED|Period 1 (Including Washout) (2 Days)||28||
59965697|NCT02963701|76083428|FG000|COMPLETED|Period 1 (Including Washout) (2 Days)|One subject withdrawn from the study after period 1|27||
59965698|NCT02963701|76083429|FG001|COMPLETED|Period 1 (Including Washout) (2 Days)||28||
59965699|NCT02963701|76083428|FG000|NOT COMPLETED|Period 1 (Including Washout) (2 Days)||1||
59965700|NCT02963701|76083429|FG001|NOT COMPLETED|Period 1 (Including Washout) (2 Days)||0||
59965701|NCT02963701|76083428|FG000|STARTED|Period 2 (2 Days)||27||
59965702|NCT02963701|76083429|FG001|STARTED|Period 2 (2 Days)||28||
59965703|NCT02963701|76083428|FG000|COMPLETED|Period 2 (2 Days)||27||
59965704|NCT02963701|76083429|FG001|COMPLETED|Period 2 (2 Days)||28||
59965705|NCT02963701|76083428|FG000|NOT COMPLETED|Period 2 (2 Days)||0||
59965706|NCT02963701|76083429|FG001|NOT COMPLETED|Period 2 (2 Days)||0||
59965707|NCT01345591|76083435|FG000|STARTED|Overall Study||20||
59965708|NCT01345591|76083435|FG000|COMPLETED|Overall Study||19||
59965709|NCT01345591|76083435|FG000|NOT COMPLETED|Overall Study||1||
59965710|NCT02961751|76083444|FG000|STARTED|Overall Study||211||
59965711|NCT02961751|76083444|FG000|COMPLETED|Overall Study||196||
59965712|NCT02961751|76083444|FG000|NOT COMPLETED|Overall Study||15||
59809915|NCT00536198|75932075|FG001|NOT COMPLETED|Overall Study||39||
59809916|NCT00393484|75932085|FG000|STARTED|Double-blind Period (Day 1 to Week 96)|Number treated|56||
59809917|NCT00393484|75932086|FG001|STARTED|Double-blind Period (Day 1 to Week 96)|Number treated|64||
59809918|NCT00393484|75932085|FG000|Participants Excluded From Analysis|Double-blind Period (Day 1 to Week 96)||1||
59809919|NCT00393484|75932086|FG001|Participants Excluded From Analysis|Double-blind Period (Day 1 to Week 96)||1||
59809920|NCT00393484|75932085|FG000|COMPLETED|Double-blind Period (Day 1 to Week 96)||54||
59809921|NCT00393484|75932086|FG001|COMPLETED|Double-blind Period (Day 1 to Week 96)||52||
59809922|NCT00393484|75932085|FG000|NOT COMPLETED|Double-blind Period (Day 1 to Week 96)||2||
59809923|NCT00393484|75932086|FG001|NOT COMPLETED|Double-blind Period (Day 1 to Week 96)||12||
59809924|NCT00393484|75932085|FG000|STARTED|Open-label Period (Weeks 96 to 240)||48||
59809925|NCT00393484|75932086|FG001|STARTED|Open-label Period (Weeks 96 to 240)||44||
59809926|NCT00393484|75932085|FG000|Withdrew Consent|Open-label Period (Weeks 96 to 240)|Did not participate in open-label period|6||
59809927|NCT00393484|75932086|FG001|Withdrew Consent|Open-label Period (Weeks 96 to 240)|Did not participate in open-label period|6||
59809928|NCT00393484|75932085|FG000|Lack of Efficacy|Open-label Period (Weeks 96 to 240)|Did not participate in open-label period|0||
59965713|NCT02963311|76083448|FG000|STARTED|Overall Study||9||
59965714|NCT02963311|76083448|FG000|COMPLETED|Overall Study||4||
59965715|NCT02963311|76083448|FG000|NOT COMPLETED|Overall Study||5||
59965716|NCT02962765|76083452|FG000|STARTED|Overall Study||78||
59965717|NCT02962765|76083452|FG000|FAS Population|Overall Study||78||
59965718|NCT02962765|76083452|FG000|SAF Population|Overall Study||78||
59965719|NCT02962765|76083452|FG000|Prophylactic Treatment Group|Overall Study||77||
59965720|NCT02962765|76083452|FG000|On Demand Treatment Group|Overall Study||2||
59965721|NCT02962765|76083452|FG000|SURG Population|Overall Study||4||
59965722|NCT02962765|76083452|FG000|COMPLETED|Overall Study||61||
59965723|NCT02962765|76083452|FG000|NOT COMPLETED|Overall Study||17||
59965724|NCT00965757|76083465|FG000|STARTED|Double-blind Phase||165||
59965725|NCT00965757|76083466|FG001|STARTED|Double-blind Phase||88||
60074314|NCT01604343|76189698|FG002|Safety Population|Safety Follow-up Period (Week 104-120)||105||
60074315|NCT01604343|76189699|FG003|Safety Population|Safety Follow-up Period (Week 104-120)||36||
60074316|NCT01604343|76189700|FG004|Safety Population|Safety Follow-up Period (Week 104-120)||114||
60074317|NCT01604343|76189696|FG000|COMPLETED|Safety Follow-up Period (Week 104-120)||79||
60074318|NCT01604343|76189697|FG001|COMPLETED|Safety Follow-up Period (Week 104-120)||20||
60074319|NCT01604343|76189698|FG002|COMPLETED|Safety Follow-up Period (Week 104-120)||72||
60074320|NCT01604343|76189699|FG003|COMPLETED|Safety Follow-up Period (Week 104-120)||26||
60074321|NCT01604343|76189700|FG004|COMPLETED|Safety Follow-up Period (Week 104-120)||85||
60074322|NCT01604343|76189696|FG000|NOT COMPLETED|Safety Follow-up Period (Week 104-120)||30||
60074323|NCT01604343|76189697|FG001|NOT COMPLETED|Safety Follow-up Period (Week 104-120)||7||
59809929|NCT00393484|75932086|FG001|Lack of Efficacy|Open-label Period (Weeks 96 to 240)|Did not participate in open-label period|2||
59809930|NCT00393484|75932085|FG000|COMPLETED|Open-label Period (Weeks 96 to 240)||40||
59809931|NCT00393484|75932086|FG001|COMPLETED|Open-label Period (Weeks 96 to 240)||21||
59809932|NCT00393484|75932085|FG000|NOT COMPLETED|Open-label Period (Weeks 96 to 240)||8||
59809933|NCT00393484|75932086|FG001|NOT COMPLETED|Open-label Period (Weeks 96 to 240)||23||
59809934|NCT00667823|75932094|FG000|STARTED|Overall Study||550||
60074324|NCT01604343|76189698|FG002|NOT COMPLETED|Safety Follow-up Period (Week 104-120)||33||
59809935|NCT00667823|75932094|FG000|COMPLETED|Overall Study||334||
59809936|NCT00667823|75932094|FG000|NOT COMPLETED|Overall Study||216||
59809937|NCT00397930|75932100|FG000|STARTED|Overall Study||206||
59809938|NCT00397930|75932101|FG001|STARTED|Overall Study||204||
59809939|NCT00397930|75932100|FG000|COMPLETED|Overall Study||168||
59809940|NCT00397930|75932101|FG001|COMPLETED|Overall Study||153||
59809941|NCT00397930|75932100|FG000|NOT COMPLETED|Overall Study||38||
59809942|NCT00397930|75932101|FG001|NOT COMPLETED|Overall Study||51||
59965726|NCT00965757|76083467|FG002|STARTED|Double-blind Phase||0||
59965727|NCT00965757|76083468|FG003|STARTED|Double-blind Phase||0||
59965728|NCT00965757|76083465|FG000|COMPLETED|Double-blind Phase||148||
59965729|NCT00965757|76083466|FG001|COMPLETED|Double-blind Phase||70||
59965730|NCT00965757|76083467|FG002|COMPLETED|Double-blind Phase||0||
59965731|NCT00965757|76083468|FG003|COMPLETED|Double-blind Phase||0||
59965732|NCT00965757|76083465|FG000|NOT COMPLETED|Double-blind Phase||17||
59965733|NCT00965757|76083466|FG001|NOT COMPLETED|Double-blind Phase||18||
59965734|NCT00965757|76083467|FG002|NOT COMPLETED|Double-blind Phase||0||
59965735|NCT00965757|76083468|FG003|NOT COMPLETED|Double-blind Phase||0||
59965736|NCT00965757|76083465|FG000|STARTED|Extension Phase||0||
59965737|NCT00965757|76083466|FG001|STARTED|Extension Phase||0||
59965738|NCT00965757|76083467|FG002|STARTED|Extension Phase||165||
59965739|NCT00965757|76083468|FG003|STARTED|Extension Phase||88||
59965740|NCT00965757|76083465|FG000|COMPLETED|Extension Phase||0||
59965741|NCT00965757|76083466|FG001|COMPLETED|Extension Phase||0||
59965742|NCT00965757|76083467|FG002|COMPLETED|Extension Phase||132||
59965743|NCT00965757|76083468|FG003|COMPLETED|Extension Phase||64||
59965744|NCT00965757|76083465|FG000|NOT COMPLETED|Extension Phase||0||
59965745|NCT00965757|76083466|FG001|NOT COMPLETED|Extension Phase||0||
59965746|NCT00965757|76083467|FG002|NOT COMPLETED|Extension Phase||33||
59965747|NCT00965757|76083468|FG003|NOT COMPLETED|Extension Phase||24||
59965748|NCT03072459|76083476|FG000|STARTED|Overall Study||128||
59965749|NCT03072459|76083476|FG000|COMPLETED|Overall Study||126||
59965750|NCT03072459|76083476|FG000|NOT COMPLETED|Overall Study||2||
59965751|NCT01067521|76083482|FG000|STARTED|Double-Blind Placebo-Controlled Period||943||
59965752|NCT01067521|76083483|FG001|STARTED|Double-Blind Placebo-Controlled Period||461||
59965753|NCT01067521|76083482|FG000|COMPLETED|Double-Blind Placebo-Controlled Period||859||
59965754|NCT01067521|76083483|FG001|COMPLETED|Double-Blind Placebo-Controlled Period||430||
59965755|NCT01067521|76083482|FG000|NOT COMPLETED|Double-Blind Placebo-Controlled Period||84||
59965756|NCT01067521|76083483|FG001|NOT COMPLETED|Double-Blind Placebo-Controlled Period||31||
59965757|NCT01067521|76083482|FG000|STARTED|Open-Label Period|Some participants did not continue into the open-label period.|834||
59965758|NCT01067521|76083483|FG001|STARTED|Open-Label Period|Some participants did not continue into the open-label period.|419||
59965759|NCT01067521|76083482|FG000|COMPLETED|Open-Label Period||580||
59965760|NCT01067521|76083483|FG001|COMPLETED|Open-Label Period||261||
59965761|NCT01067521|76083482|FG000|NOT COMPLETED|Open-Label Period||254||
59965762|NCT01067521|76083483|FG001|NOT COMPLETED|Open-Label Period||158||
59965763|NCT02735577|76083494|FG000|STARTED|Disulfiram Treatment||7||
59965764|NCT02735577|76083494|FG000|COMPLETED|Disulfiram Treatment||6||
59965765|NCT02735577|76083494|FG000|NOT COMPLETED|Disulfiram Treatment||1||
59965766|NCT02735577|76083494|FG000|STARTED|Optional 28 Days of Disulfiram Treatment||6||
59965767|NCT02735577|76083494|FG000|COMPLETED|Optional 28 Days of Disulfiram Treatment||4||
59965768|NCT02735577|76083494|FG000|NOT COMPLETED|Optional 28 Days of Disulfiram Treatment||2||
59965769|NCT01345123|76083501|FG000|STARTED|Overall Study||3323||
59965770|NCT01345123|76083502|FG001|STARTED|Overall Study||3311||
59965771|NCT01345123|76083503|FG002|STARTED|Overall Study||3291||
59965772|NCT01345123|76083501|FG000|COMPLETED|Overall Study|3323 - 79 study participants who were no longer health plan eligible members (zero eligible months)|3244||
59965773|NCT01345123|76083502|FG001|COMPLETED|Overall Study|3311 - 85 study participants who were no longer health plan eligible members (zero eligible months)|3226||
59965774|NCT01345123|76083503|FG002|COMPLETED|Overall Study|3291 - 88 study participants who were no longer health plan eligible members (zero eligible months)|3203||
59965775|NCT01345123|76083501|FG000|NOT COMPLETED|Overall Study||79||
59965776|NCT01345123|76083502|FG001|NOT COMPLETED|Overall Study||85||
59965777|NCT01345123|76083503|FG002|NOT COMPLETED|Overall Study||88||
59965778|NCT02735421|76083512|FG000|STARTED|Part A (Randomized): up to 24 Weeks||67||
59965779|NCT02735421|76083512|FG000|COMPLETED|Part A (Randomized): up to 24 Weeks||54||
59965780|NCT02735421|76083512|FG000|NOT COMPLETED|Part A (Randomized): up to 24 Weeks||13||
59965781|NCT02735421|76083512|FG000|STARTED|Part 2 (Open Label): up to 48 Weeks|Participants who continue treatment with A-BPO Forte gel for up to 24 additional weeks.|45||
59965782|NCT02735421|76083512|FG000|COMPLETED|Part 2 (Open Label): up to 48 Weeks||41||
59965783|NCT02735421|76083512|FG000|NOT COMPLETED|Part 2 (Open Label): up to 48 Weeks||4||
59965784|NCT02983799|76083529|FG000|STARTED|Overall Study||75||
59965785|NCT02983799|76083530|FG001|STARTED|Overall Study||26||
59965786|NCT02983799|76083531|FG002|STARTED|Overall Study||68||
59965787|NCT02983799|76083532|FG003|STARTED|Overall Study||90||
59965788|NCT02983799|76083533|FG004|STARTED|Overall Study||13||
59965789|NCT02983799|76083529|FG000|COMPLETED|Overall Study||25|Patients continuing study at data cut-off|
59965790|NCT02983799|76083530|FG001|COMPLETED|Overall Study||8|Patients continuing study at data cut-off|
59965791|NCT02983799|76083531|FG002|COMPLETED|Overall Study||18|Patients continuing study at data cut-off|
59965792|NCT02983799|76083532|FG003|COMPLETED|Overall Study||14|Patients continuing study at data cut-off|
59524851|NCT01057901|75619978|FG000|NOT COMPLETED|Overall Study||260||
59524852|NCT01057901|75619979|FG001|NOT COMPLETED|Overall Study||246||
59524853|NCT01058993|75619985|FG000|STARTED|Overall Study||6||
59524854|NCT01058993|75619985|FG000|COMPLETED|Overall Study||6||
59524855|NCT01058993|75619985|FG000|NOT COMPLETED|Overall Study||0||
59524856|NCT01059305|75619989|FG000|STARTED|Overall Study||10||
59524857|NCT01059305|75619989|FG000|COMPLETED|Overall Study||10||
59524858|NCT01059305|75619989|FG000|NOT COMPLETED|Overall Study||0||
59524859|NCT03824405|75619995|FG000|STARTED|Overall Study||100||
59524860|NCT03824405|75619996|FG001|STARTED|Overall Study||100||
59524861|NCT03824405|75619995|FG000|COMPLETED|Overall Study||65||
59524862|NCT03824405|75619996|FG001|COMPLETED|Overall Study||55||
59965793|NCT02983799|76083533|FG004|COMPLETED|Overall Study||3|Patients continuing study at data cut-off|
59524863|NCT03824405|75619995|FG000|NOT COMPLETED|Overall Study||35||
59524864|NCT03824405|75619996|FG001|NOT COMPLETED|Overall Study||45||
59524865|NCT02169479|75620006|FG000|STARTED|Overall Study||4||
59524866|NCT02169479|75620007|FG001|STARTED|Overall Study||4||
59524867|NCT02169479|75620008|FG002|STARTED|Overall Study||4||
59524868|NCT02169479|75620009|FG003|STARTED|Overall Study||4||
59524869|NCT02169479|75620006|FG000|25 mg BIA 9-1067|Overall Study||4||
59524870|NCT02169479|75620007|FG001|25 mg BIA 9-1067|Overall Study||3||
59524871|NCT02169479|75620008|FG002|25 mg BIA 9-1067|Overall Study||4||
59524872|NCT02169479|75620009|FG003|25 mg BIA 9-1067|Overall Study||4||
59524873|NCT02169479|75620006|FG000|50 mg BIA 9-1067|Overall Study||4||
59524874|NCT02169479|75620007|FG001|50 mg BIA 9-1067|Overall Study||4||
59524875|NCT02169479|75620008|FG002|50 mg BIA 9-1067|Overall Study||4||
59524876|NCT02169479|75620009|FG003|50 mg BIA 9-1067|Overall Study||4||
59524877|NCT02169479|75620006|FG000|100 mg BIA 9-1067|Overall Study||3||
59524878|NCT02169479|75620007|FG001|100 mg BIA 9-1067|Overall Study||4||
59524879|NCT02169479|75620008|FG002|100 mg BIA 9-1067|Overall Study||4||
59524880|NCT02169479|75620009|FG003|100 mg BIA 9-1067|Overall Study||4||
59524881|NCT02169479|75620006|FG000|Placebo|Overall Study||3||
59524882|NCT02169479|75620007|FG001|Placebo|Overall Study||3||
59524883|NCT02169479|75620008|FG002|Placebo|Overall Study||4||
59524884|NCT02169479|75620009|FG003|Placebo|Overall Study||4||
59524885|NCT02169479|75620006|FG000|COMPLETED|Overall Study||3||
59524886|NCT02169479|75620007|FG001|COMPLETED|Overall Study||3||
59524887|NCT02169479|75620008|FG002|COMPLETED|Overall Study||4||
59524888|NCT02169479|75620009|FG003|COMPLETED|Overall Study||4||
59524889|NCT02169479|75620006|FG000|NOT COMPLETED|Overall Study||1||
59524890|NCT02169479|75620007|FG001|NOT COMPLETED|Overall Study||1||
59524891|NCT02169479|75620008|FG002|NOT COMPLETED|Overall Study||0||
59524892|NCT02169479|75620009|FG003|NOT COMPLETED|Overall Study||0||
59524893|NCT01059851|75620021|FG000|STARTED|Overall Study||8||
59524894|NCT01059851|75620022|FG001|STARTED|Overall Study||8||
59524895|NCT01059851|75620023|FG002|STARTED|Overall Study||0||
59524896|NCT01059851|75620024|FG003|STARTED|Overall Study||0||
59524897|NCT01059851|75620025|FG004|STARTED|Overall Study||0||
59524898|NCT01059851|75620026|FG005|STARTED|Overall Study||0||
59621485|NCT00345384|75733089|FG001|COMPLETED|Overall Study||19||
59965794|NCT02983799|76083529|FG000|NOT COMPLETED|Overall Study||50||
59965795|NCT02983799|76083530|FG001|NOT COMPLETED|Overall Study||18||
59524899|NCT01059851|75620021|FG000|COMPLETED|Overall Study||8||
59524900|NCT01059851|75620022|FG001|COMPLETED|Overall Study||8||
59524901|NCT01059851|75620023|FG002|COMPLETED|Overall Study||0||
59524902|NCT01059851|75620024|FG003|COMPLETED|Overall Study||0||
59524903|NCT01059851|75620025|FG004|COMPLETED|Overall Study||0||
59621486|NCT00345384|75733088|FG000|NOT COMPLETED|Overall Study||0||
59621487|NCT00345384|75733089|FG001|NOT COMPLETED|Overall Study||0||
59621488|NCT00346476|75733097|FG000|STARTED|Overall Study||1250||
59621489|NCT00346476|75733097|FG000|COMPLETED|Overall Study||1250||
59621490|NCT00346476|75733097|FG000|NOT COMPLETED|Overall Study||0||
59621491|NCT00347022|75733103|FG000|STARTED|Overall Study||74||
59621492|NCT00347022|75733104|FG001|STARTED|Overall Study||71||
59621493|NCT00347022|75733103|FG000|COMPLETED|Overall Study||62||
59621494|NCT00347022|75733104|FG001|COMPLETED|Overall Study||66||
59621495|NCT00347022|75733103|FG000|NOT COMPLETED|Overall Study||12||
59621496|NCT00347022|75733104|FG001|NOT COMPLETED|Overall Study||5||
59809943|NCT00397540|75932109|FG000|STARTED|Overall Study||60||
59965796|NCT02983799|76083531|FG002|NOT COMPLETED|Overall Study||50||
59965797|NCT02983799|76083532|FG003|NOT COMPLETED|Overall Study||76||
59524904|NCT01059851|75620026|FG005|COMPLETED|Overall Study||0||
59524905|NCT01059851|75620021|FG000|NOT COMPLETED|Overall Study||0||
59524906|NCT01059851|75620022|FG001|NOT COMPLETED|Overall Study||0||
59524907|NCT01059851|75620023|FG002|NOT COMPLETED|Overall Study||0||
59524908|NCT01059851|75620024|FG003|NOT COMPLETED|Overall Study||0||
59524909|NCT01059851|75620025|FG004|NOT COMPLETED|Overall Study||0||
59524910|NCT01059851|75620026|FG005|NOT COMPLETED|Overall Study||0||
59524911|NCT02169869|75620038|FG000|STARTED|Overall Study||17||
59621497|NCT00350142|75733110|FG000|STARTED|Overall Study||20||
59621498|NCT00350142|75733110|FG000|COMPLETED|Overall Study||20||
59524912|NCT02169869|75620039|FG001|STARTED|Overall Study||16||
59524913|NCT02169869|75620038|FG000|COMPLETED|Overall Study||17||
59524914|NCT02169869|75620039|FG001|COMPLETED|Overall Study||16||
59524915|NCT02169869|75620038|FG000|NOT COMPLETED|Overall Study||0||
59524916|NCT02169869|75620039|FG001|NOT COMPLETED|Overall Study||0||
59524917|NCT01059929|75620047|FG000|STARTED|Overall Study||20||
59524918|NCT01059929|75620048|FG001|STARTED|Overall Study||21||
59524919|NCT01059929|75620047|FG000|COMPLETED|Overall Study||20||
59524920|NCT01059929|75620048|FG001|COMPLETED|Overall Study||21||
59524921|NCT01059929|75620047|FG000|NOT COMPLETED|Overall Study||0||
59524922|NCT01059929|75620048|FG001|NOT COMPLETED|Overall Study||0||
59524923|NCT01062269|75620054|FG000|STARTED|Overall Study||42||
59524924|NCT01062269|75620054|FG000|COMPLETED|Overall Study||42||
59524925|NCT01062269|75620054|FG000|NOT COMPLETED|Overall Study||0||
59524926|NCT01062893|75620064|FG000|STARTED|Overall Study||41||
59524927|NCT01062893|75620065|FG001|STARTED|Overall Study||41||
59524928|NCT01062893|75620064|FG000|COMPLETED|Overall Study||27||
59524929|NCT01062893|75620065|FG001|COMPLETED|Overall Study||28||
59524930|NCT01062893|75620064|FG000|NOT COMPLETED|Overall Study||14||
59524931|NCT01062893|75620065|FG001|NOT COMPLETED|Overall Study||13||
59524932|NCT01063049|75620074|FG000|STARTED|Overall Study||200||
59524933|NCT01063049|75620075|FG001|STARTED|Overall Study||200||
59524934|NCT01063049|75620076|FG002|STARTED|Overall Study||200||
59524935|NCT01063049|75620074|FG000|COMPLETED|Overall Study||200||
59524936|NCT01063049|75620075|FG001|COMPLETED|Overall Study||200||
59524937|NCT01063049|75620076|FG002|COMPLETED|Overall Study||200||
59524938|NCT01063049|75620074|FG000|NOT COMPLETED|Overall Study||0||
59524939|NCT01063049|75620075|FG001|NOT COMPLETED|Overall Study||0||
60074325|NCT01604343|76189699|FG003|NOT COMPLETED|Safety Follow-up Period (Week 104-120)||10||
60074326|NCT01604343|76189700|FG004|NOT COMPLETED|Safety Follow-up Period (Week 104-120)||29||
59524940|NCT01063049|75620076|FG002|NOT COMPLETED|Overall Study||0||
59524941|NCT02991144|75620088|FG000|STARTED|Overall Study||3||
59524942|NCT02991144|75620089|FG001|STARTED|Overall Study||3||
59524943|NCT02991144|75620090|FG002|STARTED|Overall Study||3||
59524944|NCT02991144|75620091|FG003|STARTED|Overall Study||2||
59524945|NCT02991144|75620088|FG000|COMPLETED|Overall Study||3||
59524946|NCT02991144|75620089|FG001|COMPLETED|Overall Study||3||
59524947|NCT02991144|75620090|FG002|COMPLETED|Overall Study||3||
59524948|NCT02991144|75620091|FG003|COMPLETED|Overall Study||2||
59524949|NCT02991144|75620088|FG000|NOT COMPLETED|Overall Study||0||
59524950|NCT02991144|75620089|FG001|NOT COMPLETED|Overall Study||0||
59524951|NCT02991144|75620090|FG002|NOT COMPLETED|Overall Study||0||
59524952|NCT02991144|75620091|FG003|NOT COMPLETED|Overall Study||0||
59524953|NCT02532972|75620102|FG000|STARTED|Overall Study||11||
59524954|NCT02532972|75620102|FG000|COMPLETED|Overall Study||10||
59524955|NCT02532972|75620102|FG000|NOT COMPLETED|Overall Study||1||
59524956|NCT01246063|75620112|FG000|STARTED|Overall Study||3||
59524957|NCT01246063|75620113|FG001|STARTED|Overall Study||4||
59524958|NCT01246063|75620114|FG002|STARTED|Overall Study||4||
59524959|NCT01246063|75620115|FG003|STARTED|Overall Study||5||
59524960|NCT01246063|75620116|FG004|STARTED|Overall Study||7||
59524961|NCT01246063|75620117|FG005|STARTED|Overall Study||17||
59524962|NCT01246063|75620112|FG000|COMPLETED|Overall Study||3||
59524963|NCT01246063|75620113|FG001|COMPLETED|Overall Study||4||
59524964|NCT01246063|75620114|FG002|COMPLETED|Overall Study||4||
59524965|NCT01246063|75620115|FG003|COMPLETED|Overall Study||5||
59524966|NCT01246063|75620116|FG004|COMPLETED|Overall Study||7||
59524967|NCT01246063|75620117|FG005|COMPLETED|Overall Study||17||
59524968|NCT01246063|75620112|FG000|NOT COMPLETED|Overall Study||0||
59524969|NCT01246063|75620113|FG001|NOT COMPLETED|Overall Study||0||
59524970|NCT01246063|75620114|FG002|NOT COMPLETED|Overall Study||0||
59524971|NCT01246063|75620115|FG003|NOT COMPLETED|Overall Study||0||
59524972|NCT01246063|75620116|FG004|NOT COMPLETED|Overall Study||0||
59524973|NCT01246063|75620117|FG005|NOT COMPLETED|Overall Study||0||
59524974|NCT01205503|75620137|FG000|STARTED|First Intervention (1st Cycle)||16||
59524975|NCT01205503|75620138|FG001|STARTED|First Intervention (1st Cycle)||16||
59524976|NCT01205503|75620137|FG000|COMPLETED|First Intervention (1st Cycle)||16||
59524977|NCT01205503|75620138|FG001|COMPLETED|First Intervention (1st Cycle)||16||
59524978|NCT01205503|75620137|FG000|NOT COMPLETED|First Intervention (1st Cycle)||0||
59524979|NCT01205503|75620138|FG001|NOT COMPLETED|First Intervention (1st Cycle)||0||
59524980|NCT01205503|75620137|FG000|STARTED|Second Intervention (2nd Cycle)||16||
59524981|NCT01205503|75620138|FG001|STARTED|Second Intervention (2nd Cycle)||16||
59524982|NCT01205503|75620137|FG000|COMPLETED|Second Intervention (2nd Cycle)||16||
59524983|NCT01205503|75620138|FG001|COMPLETED|Second Intervention (2nd Cycle)||16||
59524984|NCT01205503|75620137|FG000|NOT COMPLETED|Second Intervention (2nd Cycle)||0||
59524985|NCT01205503|75620138|FG001|NOT COMPLETED|Second Intervention (2nd Cycle)||0||
59524986|NCT01158157|75620144|FG000|STARTED|Overall Study|61 subjects screened; 25 subjects were vaccinated; 36 subjects were not eligible.|25||
59524987|NCT01158157|75620144|FG000|COMPLETED|Overall Study||25||
59524988|NCT01158157|75620144|FG000|NOT COMPLETED|Overall Study||0||
59524989|NCT03187834|75620155|FG000|STARTED|Overall Study||62||31
59524990|NCT03187834|75620156|FG001|STARTED|Overall Study||62||31
59524991|NCT03187834|75620157|FG002|STARTED|Overall Study||62||31
59524992|NCT03187834|75620158|FG003|STARTED|Overall Study||62||31
59524993|NCT03187834|75620155|FG000|Receive Antibiotic|Overall Study||31||31
59524994|NCT03187834|75620156|FG001|Receive Antibiotic|Overall Study||31||31
59524995|NCT03187834|75620157|FG002|Receive Antibiotic|Overall Study||31||31
59524996|NCT03187834|75620158|FG003|Receive Antibiotic|Overall Study||31||31
59524997|NCT03187834|75620155|FG000|Receive Placebo|Overall Study||31||31
59524998|NCT03187834|75620156|FG001|Receive Placebo|Overall Study||31||31
59524999|NCT03187834|75620157|FG002|Receive Placebo|Overall Study||31||31
59525000|NCT03187834|75620158|FG003|Receive Placebo|Overall Study||31||31
59525001|NCT03187834|75620155|FG000|COMPLETED|Overall Study||57||30
59525002|NCT03187834|75620156|FG001|COMPLETED|Overall Study||58||31
59525003|NCT03187834|75620157|FG002|COMPLETED|Overall Study||56||31
59525004|NCT03187834|75620158|FG003|COMPLETED|Overall Study||58||31
59525005|NCT03187834|75620155|FG000|NOT COMPLETED|Overall Study||5||1
59525006|NCT03187834|75620156|FG001|NOT COMPLETED|Overall Study||4||0
59525007|NCT03187834|75620157|FG002|NOT COMPLETED|Overall Study||6||0
59809944|NCT00397540|75932110|FG001|STARTED|Overall Study||85||
59965798|NCT02983799|76083533|FG004|NOT COMPLETED|Overall Study||10||
59965799|NCT02186847|76083551|FG000|STARTED|Overall Study||84||
59965800|NCT02186847|76083552|FG001|STARTED|Overall Study||86||
59965801|NCT02186847|76083551|FG000|Eligible Population|Overall Study||81||
59965802|NCT02186847|76083552|FG001|Eligible Population|Overall Study||86||
59965803|NCT02186847|76083551|FG000|Eligible and Started Protocol Treatment|Overall Study||76||
59965804|NCT02186847|76083552|FG001|Eligible and Started Protocol Treatment|Overall Study||82||
59965805|NCT02186847|76083551|FG000|COMPLETED|Overall Study||81|Participants contributing data to results are considered to have completed the study.|
59965806|NCT02186847|76083552|FG001|COMPLETED|Overall Study||86|Participants contributing data to results are considered to have completed the study.|
59965807|NCT02186847|76083551|FG000|NOT COMPLETED|Overall Study||3||
59965808|NCT02186847|76083552|FG001|NOT COMPLETED|Overall Study||0||
59965809|NCT01066871|76083562|FG000|STARTED|Overall Study||20||
59965810|NCT01066871|76083563|FG001|STARTED|Overall Study||18||
59965811|NCT01066871|76083564|FG002|STARTED|Overall Study||18||
59965812|NCT01066871|76083565|FG003|STARTED|Overall Study||18||
59965813|NCT01066871|76083562|FG000|COMPLETED|Overall Study||16||
59965814|NCT01066871|76083563|FG001|COMPLETED|Overall Study||13||
59965815|NCT01066871|76083564|FG002|COMPLETED|Overall Study||12||
59965816|NCT01066871|76083565|FG003|COMPLETED|Overall Study||13||
59965817|NCT01066871|76083562|FG000|NOT COMPLETED|Overall Study||4||
59965818|NCT01066871|76083563|FG001|NOT COMPLETED|Overall Study||5||
59965819|NCT01066871|76083564|FG002|NOT COMPLETED|Overall Study||6||
59965820|NCT01066871|76083565|FG003|NOT COMPLETED|Overall Study||5||
59809945|NCT00397540|75932109|FG000|COMPLETED|Overall Study||59||
59809946|NCT00397540|75932110|FG001|COMPLETED|Overall Study||85||
59809947|NCT00397540|75932109|FG000|NOT COMPLETED|Overall Study||1||
59809948|NCT00397540|75932110|FG001|NOT COMPLETED|Overall Study||0||
59809949|NCT00536120|75932119|FG000|STARTED|Overall Study||30||
59809950|NCT00536120|75932120|FG001|STARTED|Overall Study||30||
59809951|NCT00536120|75932119|FG000|COMPLETED|Overall Study||24||
59809952|NCT00536120|75932120|FG001|COMPLETED|Overall Study||27||
59809953|NCT00536120|75932119|FG000|NOT COMPLETED|Overall Study||6||
59809954|NCT00536120|75932120|FG001|NOT COMPLETED|Overall Study||3||
59809955|NCT00057811|75932128|FG000|STARTED|Overall Study||51||
59809956|NCT00057811|75932129|FG001|STARTED|Overall Study||46||
59809957|NCT00057811|75932128|FG000|COMPLETED|Overall Study||41||
59809958|NCT00057811|75932129|FG001|COMPLETED|Overall Study||34||
59809959|NCT00057811|75932128|FG000|NOT COMPLETED|Overall Study||10||
59809960|NCT00057811|75932129|FG001|NOT COMPLETED|Overall Study||12||
59965821|NCT02982863|76083585|FG000|STARTED|Overall Study||5745||
59965822|NCT02982863|76083586|FG001|STARTED|Overall Study||16745||
59965823|NCT02982863|76083587|FG002|STARTED|Overall Study||13238||
59525008|NCT03187834|75620158|FG003|NOT COMPLETED|Overall Study||4||0
59525009|NCT01206595|75620182|FG000|STARTED|Overall Study||38||
59809961|NCT03502148|75932135|FG000|STARTED|Overall Study||10||
59965824|NCT02982863|76083588|FG003|STARTED|Overall Study||10158||
59965825|NCT02982863|76083589|FG004|STARTED|Overall Study||2760||
59965826|NCT02982863|76083585|FG000|COMPLETED|Overall Study||4936||
59525010|NCT01206595|75620183|FG001|STARTED|Overall Study||20||
59809962|NCT03502148|75932135|FG000|COMPLETED|Overall Study||10||
59809963|NCT03502148|75932135|FG000|NOT COMPLETED|Overall Study||0||
59809964|NCT02866682|75932142|FG000|STARTED|Overall Study||39||
59809965|NCT02866682|75932143|FG001|STARTED|Overall Study||132||
59965827|NCT02982863|76083586|FG001|COMPLETED|Overall Study||12484||
59965828|NCT02982863|76083587|FG002|COMPLETED|Overall Study||11386||
59965829|NCT02982863|76083588|FG003|COMPLETED|Overall Study||8758||
59965830|NCT02982863|76083589|FG004|COMPLETED|Overall Study||2268||
59965831|NCT02982863|76083585|FG000|NOT COMPLETED|Overall Study||809||
59965832|NCT02982863|76083586|FG001|NOT COMPLETED|Overall Study||4261||
59965833|NCT02982863|76083587|FG002|NOT COMPLETED|Overall Study||1852||
59525011|NCT01206595|75620182|FG000|COMPLETED|Overall Study||38||
59809966|NCT02866682|75932142|FG000|COMPLETED|Overall Study||39||
59809967|NCT02866682|75932143|FG001|COMPLETED|Overall Study||120||
59809968|NCT02866682|75932142|FG000|NOT COMPLETED|Overall Study||0||
59809969|NCT02866682|75932143|FG001|NOT COMPLETED|Overall Study||12||
59809970|NCT01976390|75932151|FG000|STARTED|Overall Study||41||
59809971|NCT01976390|75932152|FG001|STARTED|Overall Study||19||
59525012|NCT01206595|75620183|FG001|COMPLETED|Overall Study||20||
59525013|NCT01206595|75620182|FG000|NOT COMPLETED|Overall Study||0||
59809972|NCT01976390|75932151|FG000|COMPLETED|Overall Study||41||
59809973|NCT01976390|75932152|FG001|COMPLETED|Overall Study||19||
59965834|NCT02982863|76083588|FG003|NOT COMPLETED|Overall Study||1400||
59965835|NCT02982863|76083589|FG004|NOT COMPLETED|Overall Study||492||
59965836|NCT02353247|76083610|FG000|STARTED|Overall Study||30||
59965837|NCT02353247|76083611|FG001|STARTED|Overall Study||23||
59965838|NCT02353247|76083612|FG002|STARTED|Overall Study||35||
59525014|NCT01206595|75620183|FG001|NOT COMPLETED|Overall Study||0||
59525015|NCT01158703|75620193|FG000|STARTED|Overall Study||12||
59525016|NCT01158703|75620194|FG001|STARTED|Overall Study||8||
59525017|NCT01158703|75620193|FG000|COMPLETED|Overall Study||12||
59525018|NCT01158703|75620194|FG001|COMPLETED|Overall Study||8||
59525019|NCT01158703|75620193|FG000|NOT COMPLETED|Overall Study||0||
59525020|NCT01158703|75620194|FG001|NOT COMPLETED|Overall Study||0||
59525021|NCT01159015|75620202|FG000|STARTED|Overall Study||357||
59525022|NCT01159015|75620203|FG001|STARTED|Overall Study||177||
59525023|NCT01159015|75620202|FG000|COMPLETED|Overall Study||339||
59809974|NCT01976390|75932151|FG000|NOT COMPLETED|Overall Study||0||
59809975|NCT01976390|75932152|FG001|NOT COMPLETED|Overall Study||0||
59809976|NCT00570713|75932160|FG000|STARTED|Overall Study||78||
59809977|NCT00570713|75932161|FG001|STARTED|Overall Study||77||
59809978|NCT00570713|75932160|FG000|COMPLETED|Overall Study||0||
59809979|NCT00570713|75932161|FG001|COMPLETED|Overall Study||0||
59809980|NCT00570713|75932160|FG000|NOT COMPLETED|Overall Study||78||
59809981|NCT00570713|75932161|FG001|NOT COMPLETED|Overall Study||77||
59965839|NCT02353247|76083610|FG000|COMPLETED|Overall Study||21||
59809982|NCT00556946|75932167|FG000|STARTED|Overall Study||17||
59965840|NCT02353247|76083611|FG001|COMPLETED|Overall Study||18||
59965841|NCT02353247|76083612|FG002|COMPLETED|Overall Study||0||
59965842|NCT02353247|76083610|FG000|NOT COMPLETED|Overall Study||9||
59965843|NCT02353247|76083611|FG001|NOT COMPLETED|Overall Study||5||
59965844|NCT02353247|76083612|FG002|NOT COMPLETED|Overall Study||35||
59965845|NCT03368937|76083626|FG000|STARTED|Overall Study||5||
59965846|NCT03368937|76083626|FG000|COMPLETED|Overall Study||5||
59965847|NCT03368937|76083626|FG000|NOT COMPLETED|Overall Study||0||
59965848|NCT04343651|76083632|FG000|STARTED|Overall Study||29||
59965849|NCT04343651|76083633|FG001|STARTED|Overall Study||57||
59965850|NCT04343651|76083632|FG000|COMPLETED|Overall Study||17||
59965851|NCT04343651|76083633|FG001|COMPLETED|Overall Study||33||
59965852|NCT04343651|76083632|FG000|NOT COMPLETED|Overall Study||12||
59965853|NCT04343651|76083633|FG001|NOT COMPLETED|Overall Study||24||
59965854|NCT02906579|76083641|FG000|STARTED|Overall Study||11||
59965855|NCT02906579|76083641|FG000|Completed Cycle 1 (Placebo)|Overall Study||11||
59965856|NCT02906579|76083641|FG000|Completed Cycle 2 (10 mg IW-1973)|Overall Study||11||
59965857|NCT02906579|76083641|FG000|Completed Cycle 3 (20 mg IW-1973)|Overall Study||11||
59965858|NCT02906579|76083641|FG000|Completed Cycle 4 (30 mg IW-1973)|Overall Study||10||
59965859|NCT02906579|76083641|FG000|Completed Cycle 5 (40 mg IW-1973)|Overall Study||9||
59965860|NCT02906579|76083641|FG000|Completed Cycle 6 (50 mg IW-1973)|Overall Study||9||
59965861|NCT02906579|76083641|FG000|COMPLETED|Overall Study||9||
59965862|NCT02906579|76083641|FG000|NOT COMPLETED|Overall Study||2||
59965863|NCT01328535|76083661|FG000|STARTED|Overall Study||25||
59965864|NCT01328535|76083661|FG000|COMPLETED|Overall Study||24||
59965865|NCT01328535|76083661|FG000|NOT COMPLETED|Overall Study||1||
59965866|NCT02905331|76083669|FG000|STARTED|Placebo Controlled Period(Week[wk] 0-16)||16||
59965867|NCT02905331|76083670|FG001|STARTED|Placebo Controlled Period(Week[wk] 0-16)||62||
59965868|NCT02905331|76083671|FG002|STARTED|Placebo Controlled Period(Week[wk] 0-16)||0||
59965869|NCT02905331|76083669|FG000|COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||13||
59965870|NCT02905331|76083670|FG001|COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||61||
59965871|NCT02905331|76083671|FG002|COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||0||
59965872|NCT02905331|76083669|FG000|NOT COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||3||
59965873|NCT02905331|76083670|FG001|NOT COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||1||
59965874|NCT02905331|76083671|FG002|NOT COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||0||
59525024|NCT01159015|75620203|FG001|COMPLETED|Overall Study||170||
59525025|NCT01159015|75620202|FG000|NOT COMPLETED|Overall Study||18||
59525026|NCT01159015|75620203|FG001|NOT COMPLETED|Overall Study||7||
59525027|NCT01207765|75620209|FG000|STARTED|Overall Study||8||
59525028|NCT01207765|75620209|FG000|COMPLETED|Overall Study||8||
59525029|NCT01207765|75620209|FG000|NOT COMPLETED|Overall Study||0||
59525030|NCT01249027|75620213|FG000|STARTED|1 Year Clinical Follow up||2482||
59525031|NCT01249027|75620213|FG000|COMPLETED|1 Year Clinical Follow up||2391||
59525032|NCT01249027|75620213|FG000|NOT COMPLETED|1 Year Clinical Follow up||91||
59809983|NCT00556946|75932167|FG000|COMPLETED|Overall Study||16||
59965875|NCT02905331|76083669|FG000|STARTED|Active Treatment and Follow up (wk16-40)||0||
59965876|NCT02905331|76083670|FG001|STARTED|Active Treatment and Follow up (wk16-40)||61||
59965877|NCT02905331|76083671|FG002|STARTED|Active Treatment and Follow up (wk16-40)||13||
59965878|NCT02905331|76083669|FG000|COMPLETED|Active Treatment and Follow up (wk16-40)||0||
59965879|NCT02905331|76083670|FG001|COMPLETED|Active Treatment and Follow up (wk16-40)||53||
59965880|NCT02905331|76083671|FG002|COMPLETED|Active Treatment and Follow up (wk16-40)||13||
59965881|NCT02905331|76083669|FG000|NOT COMPLETED|Active Treatment and Follow up (wk16-40)||0||
59995313|NCT04442503|76111156|FG001|NOT COMPLETED|Overall Study||15||
59995314|NCT04140396|76111162|FG000|STARTED|Overall Study||0||
59965882|NCT02905331|76083670|FG001|NOT COMPLETED|Active Treatment and Follow up (wk16-40)||8||
59965883|NCT02905331|76083671|FG002|NOT COMPLETED|Active Treatment and Follow up (wk16-40)||0||
59965884|NCT02979197|76083682|FG000|STARTED|Overall Study||48||
59965885|NCT02979197|76083683|FG001|STARTED|Overall Study||49||
59965886|NCT02979197|76083684|FG002|STARTED|Overall Study||8||
59965887|NCT02979197|76083682|FG000|COMPLETED|Overall Study||44||
59965888|NCT02979197|76083683|FG001|COMPLETED|Overall Study||45||
59965889|NCT02979197|76083684|FG002|COMPLETED|Overall Study||8||
59965890|NCT02979197|76083682|FG000|NOT COMPLETED|Overall Study||4||
59965891|NCT02979197|76083683|FG001|NOT COMPLETED|Overall Study||4||
59965892|NCT02979197|76083684|FG002|NOT COMPLETED|Overall Study||0||
59965893|NCT02982239|76083694|FG000|STARTED|Overall Study||20||
59965894|NCT02982239|76083695|FG001|STARTED|Overall Study||20||
59965895|NCT02982239|76083694|FG000|COMPLETED|Overall Study||17||
59965896|NCT02982239|76083695|FG001|COMPLETED|Overall Study||18||
59965897|NCT02982239|76083694|FG000|NOT COMPLETED|Overall Study||3||
59965898|NCT02982239|76083695|FG001|NOT COMPLETED|Overall Study||2||
59965899|NCT01066793|76083708|FG000|STARTED|Overall Study||1128||
59965900|NCT01066793|76083709|FG001|STARTED|Overall Study||572||
59965901|NCT01066793|76083710|FG002|STARTED|Overall Study||484||
59965902|NCT01066793|76083711|FG003|STARTED|Overall Study||143||
59965903|NCT01066793|76083712|FG004|STARTED|Overall Study||11||
59965904|NCT01066793|76083713|FG005|STARTED|Overall Study||5||
59965905|NCT01066793|76083708|FG000|COMPLETED|Overall Study||754||
59965906|NCT01066793|76083709|FG001|COMPLETED|Overall Study||495||
59965907|NCT01066793|76083710|FG002|COMPLETED|Overall Study||369||
59965908|NCT01066793|76083711|FG003|COMPLETED|Overall Study||94||
59525033|NCT01249027|75620213|FG000|STARTED|2 Years Clinical Follow up||2391||
59525034|NCT01249027|75620213|FG000|COMPLETED|2 Years Clinical Follow up||2254||
59525035|NCT01249027|75620213|FG000|NOT COMPLETED|2 Years Clinical Follow up||137||
59525036|NCT01249027|75620213|FG000|STARTED|3 Years Clinical Follow up||2254||
59525037|NCT01249027|75620213|FG000|COMPLETED|3 Years Clinical Follow up||2223||
59525038|NCT01249027|75620213|FG000|NOT COMPLETED|3 Years Clinical Follow up||31||
59525039|NCT01249027|75620213|FG000|STARTED|4 Years Clinical Follow up||2223||
59965909|NCT01066793|76083712|FG004|COMPLETED|Overall Study||11||
59965910|NCT01066793|76083713|FG005|COMPLETED|Overall Study||4||
59965911|NCT01066793|76083708|FG000|NOT COMPLETED|Overall Study||374||
59965912|NCT01066793|76083709|FG001|NOT COMPLETED|Overall Study||77||
59621499|NCT00350142|75733110|FG000|NOT COMPLETED|Overall Study||0||
59965913|NCT01066793|76083710|FG002|NOT COMPLETED|Overall Study||115||
59965914|NCT01066793|76083711|FG003|NOT COMPLETED|Overall Study||49||
59525040|NCT01249027|75620213|FG000|COMPLETED|4 Years Clinical Follow up||2210||
59525041|NCT01249027|75620213|FG000|NOT COMPLETED|4 Years Clinical Follow up||13||
59525042|NCT01249027|75620213|FG000|STARTED|5 Years Clinical Follow up||2210||
59525043|NCT01249027|75620213|FG000|COMPLETED|5 Years Clinical Follow up||2142||
59525044|NCT01249027|75620213|FG000|NOT COMPLETED|5 Years Clinical Follow up||68||
59525045|NCT01250899|75620219|FG000|STARTED|Overall Study||40||
59525046|NCT01250899|75620220|FG001|STARTED|Overall Study||82||
59621500|NCT00350220|75733117|FG000|STARTED|Overall Study||30||
59621501|NCT00350220|75733118|FG001|STARTED|Overall Study||30||
59621502|NCT00350220|75733117|FG000|COMPLETED|Overall Study||30||
59621503|NCT00350220|75733118|FG001|COMPLETED|Overall Study||30||
59965915|NCT01066793|76083712|FG004|NOT COMPLETED|Overall Study||0||
59965916|NCT01066793|76083713|FG005|NOT COMPLETED|Overall Study||1||
59965917|NCT03985293|76083734|FG000|STARTED|DOUBLE-BLIND TREATMENT||66||
59965918|NCT03985293|76083735|FG001|STARTED|DOUBLE-BLIND TREATMENT||68||
59965919|NCT03985293|76083736|FG002|STARTED|DOUBLE-BLIND TREATMENT||68||
59965920|NCT03985293|76083737|FG003|STARTED|DOUBLE-BLIND TREATMENT||71||
59965921|NCT03985293|76083738|FG004|STARTED|DOUBLE-BLIND TREATMENT||67||
59965922|NCT03985293|76083739|FG005|STARTED|DOUBLE-BLIND TREATMENT||71||
59965923|NCT03985293|76083734|FG000|COMPLETED|DOUBLE-BLIND TREATMENT||57||
59965924|NCT03985293|76083735|FG001|COMPLETED|DOUBLE-BLIND TREATMENT||54||
59965925|NCT03985293|76083736|FG002|COMPLETED|DOUBLE-BLIND TREATMENT||63||
59965926|NCT03985293|76083737|FG003|COMPLETED|DOUBLE-BLIND TREATMENT||57||
59965927|NCT03985293|76083738|FG004|COMPLETED|DOUBLE-BLIND TREATMENT||47||
59965928|NCT03985293|76083739|FG005|COMPLETED|DOUBLE-BLIND TREATMENT||38||
59965929|NCT03985293|76083734|FG000|NOT COMPLETED|DOUBLE-BLIND TREATMENT||9||
59965930|NCT03985293|76083735|FG001|NOT COMPLETED|DOUBLE-BLIND TREATMENT||14||
59965931|NCT03985293|76083736|FG002|NOT COMPLETED|DOUBLE-BLIND TREATMENT||5||
59965932|NCT03985293|76083737|FG003|NOT COMPLETED|DOUBLE-BLIND TREATMENT||14||
59965933|NCT03985293|76083738|FG004|NOT COMPLETED|DOUBLE-BLIND TREATMENT||20||
59965934|NCT03985293|76083739|FG005|NOT COMPLETED|DOUBLE-BLIND TREATMENT||33||
59525047|NCT01250899|75620219|FG000|COMPLETED|Overall Study||40||
59525048|NCT01250899|75620220|FG001|COMPLETED|Overall Study||82||
59965935|NCT03985293|76083734|FG000|STARTED|FOLLOW-UP||57||
59965936|NCT03985293|76083735|FG001|STARTED|FOLLOW-UP||54||
59965937|NCT03985293|76083736|FG002|STARTED|FOLLOW-UP||63||
59965938|NCT03985293|76083737|FG003|STARTED|FOLLOW-UP||57||
59965939|NCT03985293|76083738|FG004|STARTED|FOLLOW-UP||47||
59965940|NCT03985293|76083739|FG005|STARTED|FOLLOW-UP||38||
59965941|NCT03985293|76083734|FG000|COMPLETED|FOLLOW-UP||57||
59965942|NCT03985293|76083735|FG001|COMPLETED|FOLLOW-UP||54||
59965943|NCT03985293|76083736|FG002|COMPLETED|FOLLOW-UP||62||
59965944|NCT03985293|76083737|FG003|COMPLETED|FOLLOW-UP||57||
59965945|NCT03985293|76083738|FG004|COMPLETED|FOLLOW-UP||47||
59965946|NCT03985293|76083739|FG005|COMPLETED|FOLLOW-UP||38||
59965947|NCT03985293|76083734|FG000|NOT COMPLETED|FOLLOW-UP||0||
59965948|NCT03985293|76083735|FG001|NOT COMPLETED|FOLLOW-UP||0||
59965949|NCT03985293|76083736|FG002|NOT COMPLETED|FOLLOW-UP||1||
59965950|NCT03985293|76083737|FG003|NOT COMPLETED|FOLLOW-UP||0||
59965951|NCT03985293|76083738|FG004|NOT COMPLETED|FOLLOW-UP||0||
59965952|NCT03985293|76083739|FG005|NOT COMPLETED|FOLLOW-UP||0||
59965953|NCT03654755|76083756|FG000|STARTED|Overall Study||45||
59965954|NCT03654755|76083757|FG001|STARTED|Overall Study||41||
59965955|NCT03654755|76083758|FG002|STARTED|Overall Study||76||
59965956|NCT03654755|76083756|FG000|New Start of Treatment|Overall Study||9||
59809984|NCT00556946|75932167|FG000|NOT COMPLETED|Overall Study||1||
59809985|NCT00669617|75932171|FG000|STARTED|Period 1||18||
59809986|NCT00669617|75932172|FG001|STARTED|Period 1||17||
59809987|NCT00669617|75932173|FG002|STARTED|Period 1||18||
59809988|NCT00669617|75932174|FG003|STARTED|Period 1||18||
59809989|NCT00669617|75932175|FG004|STARTED|Period 1||18||
59965957|NCT03654755|76083757|FG001|New Start of Treatment|Overall Study||12||
59965958|NCT03654755|76083758|FG002|New Start of Treatment|Overall Study||15||
59965959|NCT03654755|76083756|FG000|Continued Treatment|Overall Study|Includes 11 participants that started at 40 mg and received a dose escalation during the study|36|Continued treatment from parent study|
59965960|NCT03654755|76083757|FG001|Continued Treatment|Overall Study|Includes 6 participants that started at 60 mg and received a dose escalation to 80 mg during the study|29|Continued treatment from parent study|
59965961|NCT03654755|76083758|FG002|Continued Treatment|Overall Study||61|Continued treatment from parent study|
59965962|NCT03654755|76083756|FG000|COMPLETED|Overall Study||0||
59965963|NCT03654755|76083757|FG001|COMPLETED|Overall Study||0||
59965964|NCT03654755|76083758|FG002|COMPLETED|Overall Study||0||
59965965|NCT03654755|76083756|FG000|NOT COMPLETED|Overall Study||45||
59965966|NCT03654755|76083757|FG001|NOT COMPLETED|Overall Study||41||
59965967|NCT03654755|76083758|FG002|NOT COMPLETED|Overall Study||76||
59965968|NCT02980601|76083768|FG000|STARTED|Overall Study||6||
59965969|NCT02980601|76083769|FG001|STARTED|Overall Study||4||
59965970|NCT02980601|76083768|FG000|COMPLETED|Overall Study||1||
59965971|NCT02980601|76083769|FG001|COMPLETED|Overall Study||1||
59965972|NCT02980601|76083768|FG000|NOT COMPLETED|Overall Study||5||
59965973|NCT02980601|76083769|FG001|NOT COMPLETED|Overall Study||3||
59965974|NCT02980523|76083780|FG000|STARTED|Overall Study||30||60
59965975|NCT02980523|76083781|FG001|STARTED|Overall Study||30||60
59965976|NCT02980523|76083782|FG002|STARTED|Overall Study||30||60
59965977|NCT02980523|76083783|FG003|STARTED|Overall Study||30||60
59965978|NCT02980523|76083784|FG004|STARTED|Overall Study||30||60
59965979|NCT02980523|76083780|FG000|COMPLETED|Overall Study||27||54
59965980|NCT02980523|76083781|FG001|COMPLETED|Overall Study||19||38
59965981|NCT02980523|76083782|FG002|COMPLETED|Overall Study||24||48
59965982|NCT02980523|76083783|FG003|COMPLETED|Overall Study||21||42
59965983|NCT02980523|76083784|FG004|COMPLETED|Overall Study||20||40
59809990|NCT00669617|75932171|FG000|COMPLETED|Period 1||18||
59809991|NCT00669617|75932172|FG001|COMPLETED|Period 1||17||
59809992|NCT00669617|75932173|FG002|COMPLETED|Period 1||17||
59809993|NCT00669617|75932174|FG003|COMPLETED|Period 1||18||
59809994|NCT00669617|75932175|FG004|COMPLETED|Period 1||17||
59965984|NCT02980523|76083780|FG000|NOT COMPLETED|Overall Study||3||6
59965985|NCT02980523|76083781|FG001|NOT COMPLETED|Overall Study||11||22
59965986|NCT02980523|76083782|FG002|NOT COMPLETED|Overall Study||6||12
59965987|NCT02980523|76083783|FG003|NOT COMPLETED|Overall Study||9||18
59621504|NCT00350220|75733117|FG000|NOT COMPLETED|Overall Study||0||
59621505|NCT00350220|75733118|FG001|NOT COMPLETED|Overall Study||0||
59621506|NCT03821844|75733126|FG000|STARTED|Overall Study||532||27
59621507|NCT03821844|75733127|FG001|STARTED|Overall Study||541||27
59621508|NCT03821844|75733126|FG000|COMPLETED|Overall Study||483||27
59621509|NCT03821844|75733127|FG001|COMPLETED|Overall Study||493||27
59621510|NCT03821844|75733126|FG000|NOT COMPLETED|Overall Study||49||0
59621511|NCT03821844|75733127|FG001|NOT COMPLETED|Overall Study||48||0
59809995|NCT00669617|75932171|FG000|NOT COMPLETED|Period 1||0||
59621512|NCT00350532|75733135|FG000|STARTED|Overall Study||24||
59809996|NCT00669617|75932172|FG001|NOT COMPLETED|Period 1||0||
59809997|NCT00669617|75932173|FG002|NOT COMPLETED|Period 1||1||
59809998|NCT00669617|75932174|FG003|NOT COMPLETED|Period 1||0||
59809999|NCT00669617|75932175|FG004|NOT COMPLETED|Period 1||1||
59810000|NCT00669617|75932171|FG000|STARTED|Period 2||18||
59810001|NCT00669617|75932172|FG001|STARTED|Period 2||17||
59965988|NCT02980523|76083784|FG004|NOT COMPLETED|Overall Study||10||20
59965989|NCT02980133|76083803|FG000|STARTED|Overall Study||209||
59965990|NCT02980133|76083804|FG001|STARTED|Overall Study||211||
59965991|NCT02980133|76083805|FG002|STARTED|Overall Study||210||
59965992|NCT02980133|76083806|FG003|STARTED|Overall Study||211||
59965993|NCT02980133|76083803|FG000|Received at Least 1 Dose of Study Drug|Overall Study||209|Safety analysis set|
59965994|NCT02980133|76083804|FG001|Received at Least 1 Dose of Study Drug|Overall Study||211|Safety analysis set|
59965995|NCT02980133|76083805|FG002|Received at Least 1 Dose of Study Drug|Overall Study||208|Safety analysis set|
59810002|NCT00669617|75932173|FG002|STARTED|Period 2||17||
59965996|NCT02980133|76083806|FG003|Received at Least 1 Dose of Study Drug|Overall Study||211|Safety analysis set|
59965997|NCT02980133|76083803|FG000|COMPLETED|Overall Study||202||
59965998|NCT02980133|76083804|FG001|COMPLETED|Overall Study||206||
59965999|NCT02980133|76083805|FG002|COMPLETED|Overall Study||203||
59966000|NCT02980133|76083806|FG003|COMPLETED|Overall Study||205||
59966001|NCT02980133|76083803|FG000|NOT COMPLETED|Overall Study||7||
59966002|NCT02980133|76083804|FG001|NOT COMPLETED|Overall Study||5||
59966003|NCT02980133|76083805|FG002|NOT COMPLETED|Overall Study||7||
59966004|NCT02980133|76083806|FG003|NOT COMPLETED|Overall Study||6||
59966005|NCT02979431|76083823|FG000|STARTED|Overall Study||44|Intent-to-treat (ITT) Population: The ITT population consisted of all randomized subjects.|
59966006|NCT02979431|76083824|FG001|STARTED|Overall Study||46|Intent-to-treat (ITT) Population: The ITT population consisted of all randomized subjects.|
59966007|NCT02979431|76083825|FG002|STARTED|Overall Study||45|Intent-to-treat (ITT) Population: The ITT population consisted of all randomized subjects.|
59966008|NCT02979431|76083826|FG003|STARTED|Overall Study||45|Intent-to-treat (ITT) Population: The ITT population consisted of all randomized subjects.|
59966009|NCT02979431|76083823|FG000|Included in the mITT Population|Overall Study||42|modified ITT (mITT): All randomized subjects who received at least 1 study drug administration.|
59966010|NCT02979431|76083824|FG001|Included in the mITT Population|Overall Study||45|modified ITT (mITT): All randomized subjects who received at least 1 study drug administration.|
59966011|NCT02979431|76083825|FG002|Included in the mITT Population|Overall Study||43|modified ITT (mITT): All randomized subjects who received at least 1 study drug administration.|
59966012|NCT02979431|76083826|FG003|Included in the mITT Population|Overall Study||45|modified ITT (mITT): All randomized subjects who received at least 1 study drug administration.|
59966013|NCT02979431|76083823|FG000|Included in the Safety Population|Overall Study||40|Safety: All subjects who received at least 1 study drug administration, as treated.|
59966014|NCT02979431|76083824|FG001|Included in the Safety Population|Overall Study||45|Safety: All subjects who received at least 1 study drug administration, as treated.|
59966015|NCT02979431|76083825|FG002|Included in the Safety Population|Overall Study|Includes a subject that was randomized to placebo but received a dose of ALX-0171 6.0 mg/kg|44|Safety: All subjects who received at least 1 study drug administration, as treated.|
59966016|NCT02979431|76083826|FG003|Included in the Safety Population|Overall Study|Includes a subject that was randomized to placebo but received a dose of ALX-0171 9.0 mg/kg|46|Safety: All subjects who received at least 1 study drug administration, as treated.|
59966017|NCT02979431|76083823|FG000|COMPLETED|Overall Study||40||
59966018|NCT02979431|76083824|FG001|COMPLETED|Overall Study||44||
59966019|NCT02979431|76083825|FG002|COMPLETED|Overall Study||43||
59966020|NCT02979431|76083826|FG003|COMPLETED|Overall Study||44||
59966021|NCT02979431|76083823|FG000|NOT COMPLETED|Overall Study||4||
59966022|NCT02979431|76083824|FG001|NOT COMPLETED|Overall Study||2||
59966023|NCT02979431|76083825|FG002|NOT COMPLETED|Overall Study||2||
59966024|NCT02979431|76083826|FG003|NOT COMPLETED|Overall Study||1||
59966025|NCT02978417|76083838|FG000|STARTED|Overall Study||5||
59966026|NCT02978417|76083839|FG001|STARTED|Overall Study||5||
59966027|NCT02978417|76083838|FG000|COMPLETED|Overall Study||3||
59966028|NCT02978417|76083839|FG001|COMPLETED|Overall Study||3||
59966029|NCT02978417|76083838|FG000|NOT COMPLETED|Overall Study||2||
59966030|NCT02978417|76083839|FG001|NOT COMPLETED|Overall Study||2||
59966031|NCT03440463|76083848|FG000|STARTED|Baseline||201||
59966032|NCT03440463|76083849|FG001|STARTED|Baseline||163||
59966033|NCT03440463|76083850|FG002|STARTED|Baseline||164||
59966034|NCT03440463|76083848|FG000|COMPLETED|Baseline||201||
59966035|NCT03440463|76083849|FG001|COMPLETED|Baseline||163||
59966036|NCT03440463|76083850|FG002|COMPLETED|Baseline||164||
59966037|NCT03440463|76083848|FG000|NOT COMPLETED|Baseline||0||
59966038|NCT03440463|76083849|FG001|NOT COMPLETED|Baseline||0||
59966039|NCT03440463|76083850|FG002|NOT COMPLETED|Baseline||0||
59966040|NCT03440463|76083848|FG000|STARTED|1-month Follow-up||201||
59966041|NCT03440463|76083849|FG001|STARTED|1-month Follow-up||163||
59966042|NCT03440463|76083850|FG002|STARTED|1-month Follow-up||164||
59966043|NCT03440463|76083848|FG000|COMPLETED|1-month Follow-up||134||
59966044|NCT03440463|76083849|FG001|COMPLETED|1-month Follow-up||113||
59966045|NCT03440463|76083850|FG002|COMPLETED|1-month Follow-up||107||
59966046|NCT03440463|76083848|FG000|NOT COMPLETED|1-month Follow-up||67||
59966047|NCT03440463|76083849|FG001|NOT COMPLETED|1-month Follow-up||50||
59966048|NCT03440463|76083850|FG002|NOT COMPLETED|1-month Follow-up||57||
59525049|NCT01250899|75620219|FG000|NOT COMPLETED|Overall Study||0||
59525050|NCT01250899|75620220|FG001|NOT COMPLETED|Overall Study||0||
59525051|NCT01212445|75620227|FG000|STARTED|Overall Study||52||
59525052|NCT01212445|75620228|FG001|STARTED|Overall Study||51||
59525053|NCT01212445|75620229|FG002|STARTED|Overall Study||51||
59525054|NCT01212445|75620227|FG000|COMPLETED|Overall Study||52||
59966049|NCT03440463|76083848|FG000|STARTED|3-month Follow-up||201||
59966050|NCT03440463|76083849|FG001|STARTED|3-month Follow-up||163||
59966051|NCT03440463|76083850|FG002|STARTED|3-month Follow-up||164||
59966052|NCT03440463|76083848|FG000|COMPLETED|3-month Follow-up||117||
59966053|NCT03440463|76083849|FG001|COMPLETED|3-month Follow-up||89||
59966054|NCT03440463|76083850|FG002|COMPLETED|3-month Follow-up||96||
59966055|NCT03440463|76083848|FG000|NOT COMPLETED|3-month Follow-up||84||
59966056|NCT03440463|76083849|FG001|NOT COMPLETED|3-month Follow-up||74||
59966057|NCT03440463|76083850|FG002|NOT COMPLETED|3-month Follow-up||68||
59966058|NCT02733627|76083862|FG000|STARTED|Overall Study||9||
59966059|NCT02733627|76083863|FG001|STARTED|Overall Study||9||
59966060|NCT02733627|76083864|FG002|STARTED|Overall Study||9||
59966061|NCT02733627|76083865|FG003|STARTED|Overall Study||9||
59966062|NCT02733627|76083862|FG000|COMPLETED|Overall Study||9||
59525055|NCT01212445|75620228|FG001|COMPLETED|Overall Study||51||
59525056|NCT01212445|75620229|FG002|COMPLETED|Overall Study||51||
59525057|NCT01212445|75620227|FG000|NOT COMPLETED|Overall Study||0||
59525058|NCT01212445|75620228|FG001|NOT COMPLETED|Overall Study||0||
59525059|NCT01212445|75620229|FG002|NOT COMPLETED|Overall Study||0||
59525060|NCT01250977|75620240|FG000|STARTED|Overall Study||6||
59525061|NCT01250977|75620241|FG001|STARTED|Overall Study||14||
59525062|NCT01250977|75620240|FG000|COMPLETED|Overall Study||6||
59525063|NCT01250977|75620241|FG001|COMPLETED|Overall Study||12||
59525064|NCT01250977|75620240|FG000|NOT COMPLETED|Overall Study||0||
59525065|NCT01250977|75620241|FG001|NOT COMPLETED|Overall Study||2||
59525066|NCT01251757|75620250|FG000|STARTED|Overall Study|Separate analyses were done for statin users and ACEI/ARB users. This is the combined N.|7255||
59525067|NCT01251757|75620251|FG001|STARTED|Overall Study|Separate analyses were done for statin users and ACEI/ARB users. This is the combined N.|7247||
59525068|NCT01251757|75620252|FG002|STARTED|Overall Study|Separate analyses were done for statin users and ACEI/ARB users. This is the combined N.|7250||
59525069|NCT01251757|75620250|FG000|COMPLETED|Overall Study|mean (SD) duration of follow-up was 9.7 (2.3) mos, but we computed an adherence score for everyone.|7255||
59525070|NCT01251757|75620251|FG001|COMPLETED|Overall Study|mean (SD) duration of follow-up was 9.6 (2.4) mos, but we computed an adherence score for everyone.|7247||
59525071|NCT01251757|75620252|FG002|COMPLETED|Overall Study|mean (SD) duration of follow-up was 9.6 (2.5) mos, but we computed an adherence score for everyone.|7250||
59525072|NCT01251757|75620250|FG000|NOT COMPLETED|Overall Study||0||
59525073|NCT01251757|75620251|FG001|NOT COMPLETED|Overall Study||0||
59525074|NCT01251757|75620252|FG002|NOT COMPLETED|Overall Study||0||
59525075|NCT01252147|75620264|FG000|STARTED|Overall Study||68||
59525076|NCT01252147|75620264|FG000|COMPLETED|Overall Study||68||
59525077|NCT01252147|75620264|FG000|NOT COMPLETED|Overall Study||0||
59525078|NCT01161121|75620268|FG000|STARTED|Overall Study||46||
59525079|NCT01161121|75620268|FG000|COMPLETED|Overall Study||46||
59525080|NCT01161121|75620268|FG000|NOT COMPLETED|Overall Study||0||
59525081|NCT01214083|75620279|FG000|STARTED|Overall Study||31||
59525082|NCT01214083|75620280|FG001|STARTED|Overall Study||33||
59525083|NCT01214083|75620281|FG002|STARTED|Overall Study||31||
59525084|NCT01214083|75620279|FG000|COMPLETED|Overall Study||19||
59525085|NCT01214083|75620280|FG001|COMPLETED|Overall Study||23||
59525086|NCT01214083|75620281|FG002|COMPLETED|Overall Study||21||
59525087|NCT01214083|75620279|FG000|NOT COMPLETED|Overall Study||12||
59525088|NCT01214083|75620280|FG001|NOT COMPLETED|Overall Study||10||
59525089|NCT01214083|75620281|FG002|NOT COMPLETED|Overall Study||10||
59525090|NCT01254877|75620292|FG000|STARTED|Overall Study||67||
59525091|NCT01254877|75620293|FG001|STARTED|Overall Study||69||
59525092|NCT01254877|75620294|FG002|STARTED|Overall Study||69||
59525093|NCT01254877|75620292|FG000|COMPLETED|Overall Study||57||
59525094|NCT01254877|75620293|FG001|COMPLETED|Overall Study||58||
59525095|NCT01254877|75620294|FG002|COMPLETED|Overall Study||64||
59525096|NCT01254877|75620292|FG000|NOT COMPLETED|Overall Study||10||
59621513|NCT00350532|75733136|FG001|STARTED|Overall Study||19||
59621514|NCT00350532|75733135|FG000|COMPLETED|Overall Study||24||
59621515|NCT00350532|75733136|FG001|COMPLETED|Overall Study||19||
59621516|NCT00350532|75733135|FG000|NOT COMPLETED|Overall Study||0||
59621517|NCT00350532|75733136|FG001|NOT COMPLETED|Overall Study||0||
59621518|NCT00351000|75733142|FG000|STARTED|Overall Study||24||
59621519|NCT00351000|75733142|FG000|COMPLETED|Overall Study||21||
59810003|NCT00669617|75932174|FG003|STARTED|Period 2||18||
59810004|NCT00669617|75932175|FG004|STARTED|Period 2||17||
59810005|NCT00669617|75932171|FG000|COMPLETED|Period 2||18||
59810006|NCT00669617|75932172|FG001|COMPLETED|Period 2||17||
59810007|NCT00669617|75932173|FG002|COMPLETED|Period 2||17||
59810008|NCT00669617|75932174|FG003|COMPLETED|Period 2||18||
59966063|NCT02733627|76083863|FG001|COMPLETED|Overall Study||8||
59621520|NCT00351000|75733142|FG000|NOT COMPLETED|Overall Study||3||
59621521|NCT00351936|75733149|FG000|STARTED|Overall Study||15||
59621522|NCT00351936|75733149|FG000|COMPLETED|Overall Study||15||
59810009|NCT00669617|75932175|FG004|COMPLETED|Period 2||17||
60074327|NCT01801436|76189710|FG000|STARTED|Overall Study||14||
59525097|NCT01254877|75620293|FG001|NOT COMPLETED|Overall Study||11||
59525098|NCT01254877|75620294|FG002|NOT COMPLETED|Overall Study||5||
59525099|NCT02189317|75620304|FG000|STARTED|Overall Study||16||
59525100|NCT02189317|75620305|FG001|STARTED|Overall Study||16||
59525101|NCT02189317|75620304|FG000|COMPLETED|Overall Study||16||
59525102|NCT02189317|75620305|FG001|COMPLETED|Overall Study||16||
59525103|NCT02189317|75620304|FG000|NOT COMPLETED|Overall Study||0||
59525104|NCT02189317|75620305|FG001|NOT COMPLETED|Overall Study||0||
59525105|NCT03713944|75620311|FG000|STARTED|Study Treatment||30||
59525106|NCT03713944|75620311|FG000|COMPLETED|Study Treatment||0||
59525107|NCT03713944|75620311|FG000|NOT COMPLETED|Study Treatment||30||
59525108|NCT03713944|75620311|FG000|STARTED|Follow up||30|Treatment and Follow up both are at different time period. Therefore, the number of subjects to start follow up is not equal to the number of subjects who have completed treatment.|
59525109|NCT03713944|75620311|FG000|COMPLETED|Follow up||14||
59525110|NCT03713944|75620311|FG000|NOT COMPLETED|Follow up||16||
59621523|NCT00351936|75733149|FG000|NOT COMPLETED|Overall Study||0||
59810010|NCT00669617|75932171|FG000|NOT COMPLETED|Period 2||0||
59966064|NCT02733627|76083864|FG002|COMPLETED|Overall Study||7||
59966065|NCT02733627|76083865|FG003|COMPLETED|Overall Study||9||
59966066|NCT02733627|76083862|FG000|NOT COMPLETED|Overall Study||0||
59966067|NCT02733627|76083863|FG001|NOT COMPLETED|Overall Study||1||
59966068|NCT02733627|76083864|FG002|NOT COMPLETED|Overall Study||2||
59966069|NCT02733627|76083865|FG003|NOT COMPLETED|Overall Study||0||
59810011|NCT00669617|75932172|FG001|NOT COMPLETED|Period 2||0||
59810012|NCT00669617|75932173|FG002|NOT COMPLETED|Period 2||0||
59810013|NCT00669617|75932174|FG003|NOT COMPLETED|Period 2||0||
59810014|NCT00669617|75932175|FG004|NOT COMPLETED|Period 2||0||
59810015|NCT00669617|75932171|FG000|STARTED|Period 3||18||
59810016|NCT00669617|75932172|FG001|STARTED|Period 3||17||
59966070|NCT02958865|76083882|FG000|STARTED|Induction Period (Day 1 to Week 8)||25||
59966071|NCT02958865|76083883|FG001|STARTED|Induction Period (Day 1 to Week 8)||51||
59966072|NCT02958865|76083884|FG002|STARTED|Induction Period (Day 1 to Week 8)||49||
59966073|NCT02958865|76083885|FG003|STARTED|Induction Period (Day 1 to Week 8)||50||
59966074|NCT02958865|76083886|FG004|STARTED|Induction Period (Day 1 to Week 8)||48||
59966075|NCT02958865|76083887|FG005|STARTED|Induction Period (Day 1 to Week 8)||47||
59810017|NCT00669617|75932173|FG002|STARTED|Period 3||17||
59810018|NCT00669617|75932174|FG003|STARTED|Period 3||18||
59810019|NCT00669617|75932175|FG004|STARTED|Period 3||17||
59966076|NCT02958865|76083888|FG006|STARTED|Induction Period (Day 1 to Week 8)||47||
59966077|NCT02958865|76083889|FG007|STARTED|Induction Period (Day 1 to Week 8)||0||
59966078|NCT02958865|76083890|FG008|STARTED|Induction Period (Day 1 to Week 8)||0||
59966079|NCT02958865|76083891|FG009|STARTED|Induction Period (Day 1 to Week 8)||0||
59966080|NCT02958865|76083892|FG010|STARTED|Induction Period (Day 1 to Week 8)||0||
59966081|NCT02958865|76083893|FG011|STARTED|Induction Period (Day 1 to Week 8)||0||
59966082|NCT02958865|76083894|FG012|STARTED|Induction Period (Day 1 to Week 8)||0||
59966083|NCT02958865|76083895|FG013|STARTED|Induction Period (Day 1 to Week 8)||0||
59966084|NCT02958865|76083896|FG014|STARTED|Induction Period (Day 1 to Week 8)||0||
59966085|NCT02958865|76083897|FG015|STARTED|Induction Period (Day 1 to Week 8)||0||
59966086|NCT02958865|76083882|FG000|COMPLETED|Induction Period (Day 1 to Week 8)||21||
59966087|NCT02958865|76083883|FG001|COMPLETED|Induction Period (Day 1 to Week 8)||44||
59966088|NCT02958865|76083884|FG002|COMPLETED|Induction Period (Day 1 to Week 8)||43||
59966089|NCT02958865|76083885|FG003|COMPLETED|Induction Period (Day 1 to Week 8)||41||
59966090|NCT02958865|76083886|FG004|COMPLETED|Induction Period (Day 1 to Week 8)||45||
59966091|NCT02958865|76083887|FG005|COMPLETED|Induction Period (Day 1 to Week 8)||43||
59966092|NCT02958865|76083888|FG006|COMPLETED|Induction Period (Day 1 to Week 8)||44||
59966093|NCT02958865|76083889|FG007|COMPLETED|Induction Period (Day 1 to Week 8)||0||
59966094|NCT02958865|76083890|FG008|COMPLETED|Induction Period (Day 1 to Week 8)||0||
60074328|NCT01801436|76189710|FG000|COMPLETED|Overall Study||5||
59810020|NCT00669617|75932171|FG000|COMPLETED|Period 3||17||
59810021|NCT00669617|75932172|FG001|COMPLETED|Period 3||17||
59810022|NCT00669617|75932173|FG002|COMPLETED|Period 3||17||
59810023|NCT00669617|75932174|FG003|COMPLETED|Period 3||18||
59810024|NCT00669617|75932175|FG004|COMPLETED|Period 3||17||
59810025|NCT00669617|75932171|FG000|NOT COMPLETED|Period 3||1||
59810026|NCT00669617|75932172|FG001|NOT COMPLETED|Period 3||0||
59810027|NCT00669617|75932173|FG002|NOT COMPLETED|Period 3||0||
59810028|NCT00669617|75932174|FG003|NOT COMPLETED|Period 3||0||
59810029|NCT00669617|75932175|FG004|NOT COMPLETED|Period 3||0||
59810030|NCT00669617|75932171|FG000|STARTED|Period 4||17||
59810031|NCT00669617|75932172|FG001|STARTED|Period 4||17||
59810032|NCT00669617|75932173|FG002|STARTED|Period 4||17||
59810033|NCT00669617|75932174|FG003|STARTED|Period 4||18||
59810034|NCT00669617|75932175|FG004|STARTED|Period 4||17||
59810035|NCT00669617|75932171|FG000|COMPLETED|Period 4||17||
59810036|NCT00669617|75932172|FG001|COMPLETED|Period 4||17||
59810037|NCT00669617|75932173|FG002|COMPLETED|Period 4||17||
59810038|NCT00669617|75932174|FG003|COMPLETED|Period 4||18||
59810039|NCT00669617|75932175|FG004|COMPLETED|Period 4||17||
59810040|NCT00669617|75932171|FG000|NOT COMPLETED|Period 4||0||
59810041|NCT00669617|75932172|FG001|NOT COMPLETED|Period 4||0||
59810042|NCT00669617|75932173|FG002|NOT COMPLETED|Period 4||0||
59810043|NCT00669617|75932174|FG003|NOT COMPLETED|Period 4||0||
59810044|NCT00669617|75932175|FG004|NOT COMPLETED|Period 4||0||
59810045|NCT00669617|75932171|FG000|STARTED|Period 5||17||
59810046|NCT00669617|75932172|FG001|STARTED|Period 5||17||
59810047|NCT00669617|75932173|FG002|STARTED|Period 5||17||
59810048|NCT00669617|75932174|FG003|STARTED|Period 5||18||
59810049|NCT00669617|75932175|FG004|STARTED|Period 5||17||
59810050|NCT00669617|75932171|FG000|COMPLETED|Period 5||17||
59810051|NCT00669617|75932172|FG001|COMPLETED|Period 5||17||
59810052|NCT00669617|75932173|FG002|COMPLETED|Period 5||17||
59966095|NCT02958865|76083891|FG009|COMPLETED|Induction Period (Day 1 to Week 8)||0||
59966096|NCT02958865|76083892|FG010|COMPLETED|Induction Period (Day 1 to Week 8)||0||
59966097|NCT02958865|76083893|FG011|COMPLETED|Induction Period (Day 1 to Week 8)||0||
59966098|NCT02958865|76083894|FG012|COMPLETED|Induction Period (Day 1 to Week 8)||0||
59966099|NCT02958865|76083895|FG013|COMPLETED|Induction Period (Day 1 to Week 8)||0||
59966100|NCT02958865|76083896|FG014|COMPLETED|Induction Period (Day 1 to Week 8)||0||
59966101|NCT02958865|76083897|FG015|COMPLETED|Induction Period (Day 1 to Week 8)||0||
59966102|NCT02958865|76083882|FG000|NOT COMPLETED|Induction Period (Day 1 to Week 8)||4||
59966103|NCT02958865|76083883|FG001|NOT COMPLETED|Induction Period (Day 1 to Week 8)||7||
59966104|NCT02958865|76083884|FG002|NOT COMPLETED|Induction Period (Day 1 to Week 8)||6||
59966105|NCT02958865|76083885|FG003|NOT COMPLETED|Induction Period (Day 1 to Week 8)||9||
59966106|NCT02958865|76083886|FG004|NOT COMPLETED|Induction Period (Day 1 to Week 8)||3||
59966107|NCT02958865|76083887|FG005|NOT COMPLETED|Induction Period (Day 1 to Week 8)||4||
59966108|NCT02958865|76083888|FG006|NOT COMPLETED|Induction Period (Day 1 to Week 8)||3||
59966109|NCT02958865|76083889|FG007|NOT COMPLETED|Induction Period (Day 1 to Week 8)||0||
59966110|NCT02958865|76083890|FG008|NOT COMPLETED|Induction Period (Day 1 to Week 8)||0||
59966111|NCT02958865|76083891|FG009|NOT COMPLETED|Induction Period (Day 1 to Week 8)||0||
59966112|NCT02958865|76083892|FG010|NOT COMPLETED|Induction Period (Day 1 to Week 8)||0||
59966113|NCT02958865|76083893|FG011|NOT COMPLETED|Induction Period (Day 1 to Week 8)||0||
59966114|NCT02958865|76083894|FG012|NOT COMPLETED|Induction Period (Day 1 to Week 8)||0||
59966115|NCT02958865|76083895|FG013|NOT COMPLETED|Induction Period (Day 1 to Week 8)||0||
59966116|NCT02958865|76083896|FG014|NOT COMPLETED|Induction Period (Day 1 to Week 8)||0||
59966117|NCT02958865|76083897|FG015|NOT COMPLETED|Induction Period (Day 1 to Week 8)||0||
59966118|NCT02958865|76083882|FG000|STARTED|Chronic Period (Week 8 to Week 32)||0||
59966119|NCT02958865|76083883|FG001|STARTED|Chronic Period (Week 8 to Week 32)||0||
59966120|NCT02958865|76083884|FG002|STARTED|Chronic Period (Week 8 to Week 32)||0||
59966121|NCT02958865|76083885|FG003|STARTED|Chronic Period (Week 8 to Week 32)||0||
59966122|NCT02958865|76083886|FG004|STARTED|Chronic Period (Week 8 to Week 32)||0||
59966123|NCT02958865|76083887|FG005|STARTED|Chronic Period (Week 8 to Week 32)||0||
59966124|NCT02958865|76083888|FG006|STARTED|Chronic Period (Week 8 to Week 32)||0||
59966125|NCT02958865|76083889|FG007|STARTED|Chronic Period (Week 8 to Week 32)||35||
59966126|NCT02958865|76083890|FG008|STARTED|Chronic Period (Week 8 to Week 32)||36||
59966127|NCT02958865|76083891|FG009|STARTED|Chronic Period (Week 8 to Week 32)||39||
59966128|NCT02958865|76083892|FG010|STARTED|Chronic Period (Week 8 to Week 32)||10||
59966129|NCT02958865|76083893|FG011|STARTED|Chronic Period (Week 8 to Week 32)||38||
59966130|NCT02958865|76083894|FG012|STARTED|Chronic Period (Week 8 to Week 32)||37||
59966131|NCT02958865|76083895|FG013|STARTED|Chronic Period (Week 8 to Week 32)||39||
59966132|NCT02958865|76083896|FG014|STARTED|Chronic Period (Week 8 to Week 32)||9||
59966133|NCT02958865|76083897|FG015|STARTED|Chronic Period (Week 8 to Week 32)||37||
59966134|NCT02958865|76083882|FG000|COMPLETED|Chronic Period (Week 8 to Week 32)||0||
59966135|NCT02958865|76083883|FG001|COMPLETED|Chronic Period (Week 8 to Week 32)||0||
59966136|NCT02958865|76083884|FG002|COMPLETED|Chronic Period (Week 8 to Week 32)||0||
59966137|NCT02958865|76083885|FG003|COMPLETED|Chronic Period (Week 8 to Week 32)||0||
59966138|NCT02958865|76083886|FG004|COMPLETED|Chronic Period (Week 8 to Week 32)||0||
59966139|NCT02958865|76083887|FG005|COMPLETED|Chronic Period (Week 8 to Week 32)||0||
59966140|NCT02958865|76083888|FG006|COMPLETED|Chronic Period (Week 8 to Week 32)||0||
59966141|NCT02958865|76083889|FG007|COMPLETED|Chronic Period (Week 8 to Week 32)||33||
59966142|NCT02958865|76083890|FG008|COMPLETED|Chronic Period (Week 8 to Week 32)||33||
59966143|NCT02958865|76083891|FG009|COMPLETED|Chronic Period (Week 8 to Week 32)||33||
59966144|NCT02958865|76083892|FG010|COMPLETED|Chronic Period (Week 8 to Week 32)||10||
59966145|NCT02958865|76083893|FG011|COMPLETED|Chronic Period (Week 8 to Week 32)||31||
59966146|NCT02958865|76083894|FG012|COMPLETED|Chronic Period (Week 8 to Week 32)||26||
59966147|NCT02958865|76083895|FG013|COMPLETED|Chronic Period (Week 8 to Week 32)||31||
59966148|NCT02958865|76083896|FG014|COMPLETED|Chronic Period (Week 8 to Week 32)||5||
59966149|NCT02958865|76083897|FG015|COMPLETED|Chronic Period (Week 8 to Week 32)||20||
59966150|NCT02958865|76083882|FG000|NOT COMPLETED|Chronic Period (Week 8 to Week 32)||0||
59966151|NCT02958865|76083883|FG001|NOT COMPLETED|Chronic Period (Week 8 to Week 32)||0||
59966152|NCT02958865|76083884|FG002|NOT COMPLETED|Chronic Period (Week 8 to Week 32)||0||
59966153|NCT02958865|76083885|FG003|NOT COMPLETED|Chronic Period (Week 8 to Week 32)||0||
59966154|NCT02958865|76083886|FG004|NOT COMPLETED|Chronic Period (Week 8 to Week 32)||0||
59966155|NCT02958865|76083887|FG005|NOT COMPLETED|Chronic Period (Week 8 to Week 32)||0||
59966156|NCT02958865|76083888|FG006|NOT COMPLETED|Chronic Period (Week 8 to Week 32)||0||
59966157|NCT02958865|76083889|FG007|NOT COMPLETED|Chronic Period (Week 8 to Week 32)||2||
59966158|NCT02958865|76083890|FG008|NOT COMPLETED|Chronic Period (Week 8 to Week 32)||3||
59966159|NCT02958865|76083891|FG009|NOT COMPLETED|Chronic Period (Week 8 to Week 32)||6||
59966160|NCT02958865|76083892|FG010|NOT COMPLETED|Chronic Period (Week 8 to Week 32)||0||
59966161|NCT02958865|76083893|FG011|NOT COMPLETED|Chronic Period (Week 8 to Week 32)||7||
59966162|NCT02958865|76083894|FG012|NOT COMPLETED|Chronic Period (Week 8 to Week 32)||11||
59966163|NCT02958865|76083895|FG013|NOT COMPLETED|Chronic Period (Week 8 to Week 32)||8||
59966164|NCT02958865|76083896|FG014|NOT COMPLETED|Chronic Period (Week 8 to Week 32)||4||
59966165|NCT02958865|76083897|FG015|NOT COMPLETED|Chronic Period (Week 8 to Week 32)||17||
59966166|NCT01990209|76083942|FG000|STARTED|Overall Study|One participant was found to be ineligible after starting with study treatment and hence excluded from further analyses|27||
59966167|NCT01990209|76083943|FG001|STARTED|Overall Study||44||
59966168|NCT01990209|76083942|FG000|COMPLETED|Overall Study||0||
59966169|NCT01990209|76083943|FG001|COMPLETED|Overall Study||0||
59966170|NCT01990209|76083942|FG000|NOT COMPLETED|Overall Study||27||
59966171|NCT01990209|76083943|FG001|NOT COMPLETED|Overall Study||44||
59966172|NCT02958553|76083949|FG000|STARTED|Phase I, 1st Visit -Passive Prosthesis||8||
59966173|NCT02958553|76083949|FG000|COMPLETED|Phase I, 1st Visit -Passive Prosthesis||8||
59966174|NCT02958553|76083949|FG000|NOT COMPLETED|Phase I, 1st Visit -Passive Prosthesis||0||
59966175|NCT02958553|76083949|FG000|STARTED|Phase I, 2nd Visit -Fitted With emPOWER||8||
59966176|NCT02958553|76083949|FG000|COMPLETED|Phase I, 2nd Visit -Fitted With emPOWER||8||
59966177|NCT02958553|76083949|FG000|NOT COMPLETED|Phase I, 2nd Visit -Fitted With emPOWER||0||
59966178|NCT02958553|76083949|FG000|STARTED|Phase I, 3rd Visit -2 Week emPOWER FU||8||
59966179|NCT02958553|76083949|FG000|COMPLETED|Phase I, 3rd Visit -2 Week emPOWER FU||7||
59966180|NCT02958553|76083949|FG000|NOT COMPLETED|Phase I, 3rd Visit -2 Week emPOWER FU||1||
59966181|NCT02958553|76083949|FG000|STARTED|Phase II, 4th Visit -3 Month emPOWER FU|Only 4 subjects started Phase II of the study. Phase II was optional per protocol.|7||
59966182|NCT02958553|76083949|FG000|COMPLETED|Phase II, 4th Visit -3 Month emPOWER FU||4||
59966183|NCT02958553|76083949|FG000|NOT COMPLETED|Phase II, 4th Visit -3 Month emPOWER FU||3||
59966184|NCT02958553|76083949|FG000|STARTED|Phase II, 5th Visit -Crossover Visit||4||
59966185|NCT02958553|76083949|FG000|COMPLETED|Phase II, 5th Visit -Crossover Visit||4||
59966186|NCT02958553|76083949|FG000|NOT COMPLETED|Phase II, 5th Visit -Crossover Visit||0||
59966187|NCT02958553|76083949|FG000|STARTED|Phase II, 6th Visit -6 Month emPOWER FU||4||
59966188|NCT02958553|76083949|FG000|COMPLETED|Phase II, 6th Visit -6 Month emPOWER FU||2||
59966189|NCT02958553|76083949|FG000|NOT COMPLETED|Phase II, 6th Visit -6 Month emPOWER FU||2||
59966190|NCT02958553|76083949|FG000|STARTED|Phase II, 7th Visit -12 Month emPOWER FU||2||
59966191|NCT02958553|76083949|FG000|COMPLETED|Phase II, 7th Visit -12 Month emPOWER FU||2||
59966192|NCT02958553|76083949|FG000|NOT COMPLETED|Phase II, 7th Visit -12 Month emPOWER FU||0||
59966193|NCT02501902|76083962|FG000|STARTED|Overall Study||3||
59966194|NCT02501902|76083963|FG001|STARTED|Overall Study||7||
59966195|NCT02501902|76083964|FG002|STARTED|Overall Study||4||
59966196|NCT02501902|76083965|FG003|STARTED|Overall Study||11||
59966197|NCT02501902|76083966|FG004|STARTED|Overall Study||11||
59966198|NCT02501902|76083967|FG005|STARTED|Overall Study||11||
59966199|NCT02501902|76083968|FG006|STARTED|Overall Study||9||
59966200|NCT02501902|76083969|FG007|STARTED|Overall Study||20||
59966201|NCT02501902|76083962|FG000|COMPLETED|Overall Study||0|0|
59966202|NCT02501902|76083963|FG001|COMPLETED|Overall Study||0|0|
59966203|NCT02501902|76083964|FG002|COMPLETED|Overall Study||0|0|
59966204|NCT02501902|76083965|FG003|COMPLETED|Overall Study||0|0|
59966205|NCT02501902|76083966|FG004|COMPLETED|Overall Study||0|0|
59966206|NCT02501902|76083967|FG005|COMPLETED|Overall Study||0|0|
59966207|NCT02501902|76083968|FG006|COMPLETED|Overall Study||0|0|
59966208|NCT02501902|76083969|FG007|COMPLETED|Overall Study||0|0|
59966209|NCT02501902|76083962|FG000|NOT COMPLETED|Overall Study||3||
59966210|NCT02501902|76083963|FG001|NOT COMPLETED|Overall Study||7||
59966211|NCT02501902|76083964|FG002|NOT COMPLETED|Overall Study||4||
59966212|NCT02501902|76083965|FG003|NOT COMPLETED|Overall Study||11||
59966213|NCT02501902|76083966|FG004|NOT COMPLETED|Overall Study||11||
59966214|NCT02501902|76083967|FG005|NOT COMPLETED|Overall Study||11||
59966215|NCT02501902|76083968|FG006|NOT COMPLETED|Overall Study||9||
59966216|NCT02501902|76083969|FG007|NOT COMPLETED|Overall Study||20||
59966217|NCT01955109|76083994|FG000|STARTED|Overall Study||123||
59966218|NCT01955109|76083995|FG001|STARTED|Overall Study||48||
59966219|NCT01955109|76083994|FG000|Completed Study Until Month 12|Overall Study||103||
59621524|NCT00352794|75733154|FG000|STARTED|Overall Study||40||
59966220|NCT01955109|76083995|FG001|Completed Study Until Month 12|Overall Study||46||
59966221|NCT01955109|76083994|FG000|COMPLETED|Overall Study||78|Completed Month 24 (or Month 26 if applicable)|
59966222|NCT01955109|76083995|FG001|COMPLETED|Overall Study||39|Completed Month 24 (or Month 26 if applicable)|
59966223|NCT01955109|76083994|FG000|NOT COMPLETED|Overall Study||45||
59966224|NCT01955109|76083995|FG001|NOT COMPLETED|Overall Study||9||
59966225|NCT02500732|76084003|FG000|STARTED|Overall Study||27||
59966226|NCT02500732|76084004|FG001|STARTED|Overall Study||30||
59966227|NCT02500732|76084003|FG000|COMPLETED|Overall Study||27||
59966228|NCT02500732|76084004|FG001|COMPLETED|Overall Study|Not true event in 1 participant (pseudosyncope)|29||
59966229|NCT02500732|76084003|FG000|NOT COMPLETED|Overall Study||0||
59966230|NCT02500732|76084004|FG001|NOT COMPLETED|Overall Study||1||
59966231|NCT02518048|76084010|FG000|STARTED|Overall Study||35||
59966232|NCT02518048|76084010|FG000|COMPLETED|Overall Study||34||
59966233|NCT02518048|76084010|FG000|NOT COMPLETED|Overall Study||1||
59966234|NCT02499952|76084015|FG000|STARTED|Overall Study||12||
59966235|NCT02499952|76084015|FG000|COMPLETED|Overall Study||2||
59966236|NCT02499952|76084015|FG000|NOT COMPLETED|Overall Study||10||
59966237|NCT02499406|76084019|FG000|STARTED|Overall Study||17||
59966238|NCT02499406|76084019|FG000|COMPLETED|Overall Study||13||
59966239|NCT02499406|76084019|FG000|NOT COMPLETED|Overall Study||4||
59966240|NCT02498392|76084025|FG000|STARTED|Double-blind(DB) Lead-in Period(3 Weeks)||160||
59966241|NCT02498392|76084026|FG001|STARTED|Double-blind(DB) Lead-in Period(3 Weeks)||0||
59966242|NCT02498392|76084025|FG000|Treated|Double-blind(DB) Lead-in Period(3 Weeks)||153||
59966243|NCT02498392|76084026|FG001|Treated|Double-blind(DB) Lead-in Period(3 Weeks)||0||
59966244|NCT02498392|76084025|FG000|COMPLETED|Double-blind(DB) Lead-in Period(3 Weeks)||153||
59966245|NCT02498392|76084026|FG001|COMPLETED|Double-blind(DB) Lead-in Period(3 Weeks)||0||
59966246|NCT02498392|76084025|FG000|NOT COMPLETED|Double-blind(DB) Lead-in Period(3 Weeks)||7||
59966247|NCT02498392|76084026|FG001|NOT COMPLETED|Double-blind(DB) Lead-in Period(3 Weeks)||0||
59966248|NCT02498392|76084025|FG000|STARTED|DB Treatment (6 Weeks)+Withdrawal Period||76||
59966249|NCT02498392|76084026|FG001|STARTED|DB Treatment (6 Weeks)+Withdrawal Period||77||
59966250|NCT02498392|76084025|FG000|COMPLETED|DB Treatment (6 Weeks)+Withdrawal Period||70||
59966251|NCT02498392|76084026|FG001|COMPLETED|DB Treatment (6 Weeks)+Withdrawal Period||67||
59966252|NCT02498392|76084025|FG000|NOT COMPLETED|DB Treatment (6 Weeks)+Withdrawal Period||6||
59966253|NCT02498392|76084026|FG001|NOT COMPLETED|DB Treatment (6 Weeks)+Withdrawal Period||10||
59966254|NCT03205605|76084034|FG000|STARTED|Overall Study||13||
59966255|NCT03205605|76084034|FG000|COMPLETED|Overall Study||12||
59966256|NCT03205605|76084034|FG000|NOT COMPLETED|Overall Study||1||
59966257|NCT02498236|76084052|FG000|STARTED|Overall Study||6||
59966258|NCT02498236|76084053|FG001|STARTED|Overall Study||6||
59966259|NCT02498236|76084054|FG002|STARTED|Overall Study||6||
59966260|NCT02498236|76084055|FG003|STARTED|Overall Study||6||
59966261|NCT02498236|76084056|FG004|STARTED|Overall Study||7||
59966262|NCT02498236|76084057|FG005|STARTED|Overall Study||6||
59966263|NCT02498236|76084058|FG006|STARTED|Overall Study||7||
59966264|NCT02498236|76084059|FG007|STARTED|Overall Study||7||
59966265|NCT02498236|76084052|FG000|Randomized|Overall Study||6||
59966266|NCT02498236|76084053|FG001|Randomized|Overall Study||6||
59966267|NCT02498236|76084054|FG002|Randomized|Overall Study||6||
59966268|NCT02498236|76084055|FG003|Randomized|Overall Study||6||
59966269|NCT02498236|76084056|FG004|Randomized|Overall Study||7||
59966270|NCT02498236|76084057|FG005|Randomized|Overall Study||6||
59966271|NCT02498236|76084058|FG006|Randomized|Overall Study||7||
59966272|NCT02498236|76084059|FG007|Randomized|Overall Study||7||
59966273|NCT02498236|76084052|FG000|COMPLETED|Overall Study||5||
59966274|NCT02498236|76084053|FG001|COMPLETED|Overall Study||6||
59966275|NCT02498236|76084054|FG002|COMPLETED|Overall Study||6||
59966276|NCT02498236|76084055|FG003|COMPLETED|Overall Study||6||
59966277|NCT02498236|76084056|FG004|COMPLETED|Overall Study||6||
59966278|NCT02498236|76084057|FG005|COMPLETED|Overall Study||6||
59966279|NCT02498236|76084058|FG006|COMPLETED|Overall Study||6||
59966280|NCT02498236|76084059|FG007|COMPLETED|Overall Study||6||
59966281|NCT02498236|76084052|FG000|NOT COMPLETED|Overall Study||1||
59966282|NCT02498236|76084053|FG001|NOT COMPLETED|Overall Study||0||
59966283|NCT02498236|76084054|FG002|NOT COMPLETED|Overall Study||0||
59966284|NCT02498236|76084055|FG003|NOT COMPLETED|Overall Study||0||
59966285|NCT02498236|76084056|FG004|NOT COMPLETED|Overall Study||1||
59966286|NCT02498236|76084057|FG005|NOT COMPLETED|Overall Study||0||
59966287|NCT02498236|76084058|FG006|NOT COMPLETED|Overall Study||1||
59966288|NCT02498236|76084059|FG007|NOT COMPLETED|Overall Study||1||
59966289|NCT02496676|76084082|FG000|STARTED|Phase 1 - Period 1||2||
59966290|NCT02496676|76084083|FG001|STARTED|Phase 1 - Period 1||3||
59966291|NCT02496676|76084082|FG000|COMPLETED|Phase 1 - Period 1||2||
59966292|NCT02496676|76084083|FG001|COMPLETED|Phase 1 - Period 1||2||
59966293|NCT02496676|76084082|FG000|NOT COMPLETED|Phase 1 - Period 1||0||
59966294|NCT02496676|76084083|FG001|NOT COMPLETED|Phase 1 - Period 1||1||
59966295|NCT02496676|76084082|FG000|STARTED|Phase 1 - Period 2||2||
59966296|NCT02496676|76084083|FG001|STARTED|Phase 1 - Period 2||2||
59966297|NCT02496676|76084082|FG000|COMPLETED|Phase 1 - Period 2||2||
59966298|NCT02496676|76084083|FG001|COMPLETED|Phase 1 - Period 2||2||
59966299|NCT02496676|76084082|FG000|NOT COMPLETED|Phase 1 - Period 2||0||
59966300|NCT02496676|76084083|FG001|NOT COMPLETED|Phase 1 - Period 2||0||
59966301|NCT02496676|76084082|FG000|STARTED|Washout Period||2||
59966302|NCT02496676|76084083|FG001|STARTED|Washout Period||2||
59966303|NCT02496676|76084082|FG000|COMPLETED|Washout Period||2||
59966304|NCT02496676|76084083|FG001|COMPLETED|Washout Period||2||
59966305|NCT02496676|76084082|FG000|NOT COMPLETED|Washout Period||0||
59966306|NCT02496676|76084083|FG001|NOT COMPLETED|Washout Period||0||
59966307|NCT02496676|76084082|FG000|STARTED|Phase 2 - IV MgSO4||2||
59966308|NCT02496676|76084083|FG001|STARTED|Phase 2 - IV MgSO4||2||
59966309|NCT02496676|76084082|FG000|COMPLETED|Phase 2 - IV MgSO4||2||
59966310|NCT02496676|76084083|FG001|COMPLETED|Phase 2 - IV MgSO4||1||
59966311|NCT02496676|76084082|FG000|NOT COMPLETED|Phase 2 - IV MgSO4||0||
59966312|NCT02496676|76084083|FG001|NOT COMPLETED|Phase 2 - IV MgSO4||1||
59966313|NCT02496676|76084082|FG000|STARTED|Phase 2 - Oral Magnesium||2||
59966314|NCT02496676|76084083|FG001|STARTED|Phase 2 - Oral Magnesium||1||
59966315|NCT02496676|76084082|FG000|COMPLETED|Phase 2 - Oral Magnesium||2||
59966316|NCT02496676|76084083|FG001|COMPLETED|Phase 2 - Oral Magnesium||1||
59966317|NCT02496676|76084082|FG000|NOT COMPLETED|Phase 2 - Oral Magnesium||0||
59966318|NCT02496676|76084083|FG001|NOT COMPLETED|Phase 2 - Oral Magnesium||0||
59966319|NCT02517268|76084099|FG000|STARTED|Overall Study||40||
59966320|NCT02517268|76084100|FG001|STARTED|Overall Study||37||
59966321|NCT02517268|76084099|FG000|COMPLETED|Overall Study||39||
59966322|NCT02517268|76084100|FG001|COMPLETED|Overall Study||37||
59966323|NCT02517268|76084099|FG000|NOT COMPLETED|Overall Study||1||
59966324|NCT02517268|76084100|FG001|NOT COMPLETED|Overall Study||0||
59966325|NCT01160211|76084109|FG000|STARTED|Overall Study||120||
59966326|NCT01160211|76084110|FG001|STARTED|Overall Study||118||
59966327|NCT01160211|76084111|FG002|STARTED|Overall Study||117||
59966328|NCT01160211|76084109|FG000|Ongoing|Overall Study||90||
59966329|NCT01160211|76084110|FG001|Ongoing|Overall Study||75||
59966330|NCT01160211|76084111|FG002|Ongoing|Overall Study||79||
59966331|NCT01160211|76084109|FG000|COMPLETED|Overall Study||21||
59966332|NCT01160211|76084110|FG001|COMPLETED|Overall Study||31||
59966333|NCT01160211|76084111|FG002|COMPLETED|Overall Study||30||
59966334|NCT01160211|76084109|FG000|NOT COMPLETED|Overall Study||99||
59966335|NCT01160211|76084110|FG001|NOT COMPLETED|Overall Study||87||
59966336|NCT01160211|76084111|FG002|NOT COMPLETED|Overall Study||87||
59525111|NCT01256983|75620317|FG000|STARTED|Overall Study||15||
59525112|NCT01256983|75620318|FG001|STARTED|Overall Study||15||
59525113|NCT01256983|75620317|FG000|COMPLETED|Overall Study||14||
59525114|NCT01256983|75620318|FG001|COMPLETED|Overall Study||12||
59525115|NCT01256983|75620317|FG000|NOT COMPLETED|Overall Study||1||
59525116|NCT01256983|75620318|FG001|NOT COMPLETED|Overall Study||3||
59525117|NCT01214161|75620326|FG000|STARTED|Overall Study||100||
59525118|NCT01214161|75620327|FG001|STARTED|Overall Study||100||
59525119|NCT01214161|75620326|FG000|COMPLETED|Overall Study||100||
59525120|NCT01214161|75620327|FG001|COMPLETED|Overall Study||100||
59525121|NCT01214161|75620326|FG000|NOT COMPLETED|Overall Study||0||
59966337|NCT01064687|76084124|FG000|STARTED|Overall Study||279||
59966338|NCT01064687|76084125|FG001|STARTED|Overall Study||280||
59966339|NCT01064687|76084126|FG002|STARTED|Overall Study|Of 278 participants randomized to Exenatide, 2 chose not to take study drug.|278||
59966340|NCT01064687|76084127|FG003|STARTED|Overall Study||141||
59966341|NCT01064687|76084124|FG000|Received at Least 1 Dose of Study Drug|Overall Study||279||
59966342|NCT01064687|76084125|FG001|Received at Least 1 Dose of Study Drug|Overall Study||280||
59966343|NCT01064687|76084126|FG002|Received at Least 1 Dose of Study Drug|Overall Study||276||
59966344|NCT01064687|76084127|FG003|Received at Least 1 Dose of Study Drug|Overall Study||141||
59966345|NCT01064687|76084124|FG000|Completed 26 Weeks|Overall Study||260||
59966346|NCT01064687|76084125|FG001|Completed 26 Weeks|Overall Study||263||
59966347|NCT01064687|76084126|FG002|Completed 26 Weeks|Overall Study||252||
59966348|NCT01064687|76084127|FG003|Completed 26 Weeks|Overall Study||124||
59966349|NCT01064687|76084124|FG000|COMPLETED|Overall Study||245||
59525122|NCT01214161|75620327|FG001|NOT COMPLETED|Overall Study||0||
59525123|NCT01257217|75620337|FG000|STARTED|Overall Study||15||
59525124|NCT01257217|75620338|FG001|STARTED|Overall Study||10||
59525125|NCT01257217|75620337|FG000|COMPLETED|Overall Study||13||
59525126|NCT01257217|75620338|FG001|COMPLETED|Overall Study||10||
59525127|NCT01257217|75620337|FG000|NOT COMPLETED|Overall Study||2||
59525128|NCT01257217|75620338|FG001|NOT COMPLETED|Overall Study||0||
59525129|NCT01214317|75620350|FG000|STARTED|Overall Study||18||
59525130|NCT01214317|75620351|FG001|STARTED|Overall Study||22||
59525131|NCT01214317|75620350|FG000|COMPLETED|Overall Study||18||
59525132|NCT01214317|75620351|FG001|COMPLETED|Overall Study||22||
59525133|NCT01214317|75620350|FG000|NOT COMPLETED|Overall Study||0||
59525134|NCT01214317|75620351|FG001|NOT COMPLETED|Overall Study||0||
59525135|NCT02189629|75620359|FG000|STARTED|Overall Study||453||
59525136|NCT02189629|75620359|FG000|COMPLETED|Overall Study||348||
59525137|NCT02189629|75620359|FG000|NOT COMPLETED|Overall Study||105||
59525138|NCT01281007|75620365|FG000|STARTED|Overall Study||75||
59525139|NCT01281007|75620366|FG001|STARTED|Overall Study||75||
59525140|NCT01281007|75620365|FG000|COMPLETED|Overall Study||71||
59966350|NCT01064687|76084125|FG001|COMPLETED|Overall Study||254||
59525141|NCT01281007|75620366|FG001|COMPLETED|Overall Study||67||
59525142|NCT01281007|75620365|FG000|NOT COMPLETED|Overall Study||4||
59525143|NCT01281007|75620366|FG001|NOT COMPLETED|Overall Study||8||
59525144|NCT01281475|75620374|FG000|STARTED|Overall Study||33||
59525145|NCT01281475|75620375|FG001|STARTED|Overall Study||34||
59525146|NCT01281475|75620374|FG000|COMPLETED|Overall Study||29||
59525147|NCT01281475|75620375|FG001|COMPLETED|Overall Study||26||
59966351|NCT01064687|76084126|FG002|COMPLETED|Overall Study||237||
59966352|NCT01064687|76084127|FG003|COMPLETED|Overall Study||124||
59966353|NCT01064687|76084124|FG000|NOT COMPLETED|Overall Study||34||
59966354|NCT01064687|76084125|FG001|NOT COMPLETED|Overall Study||26||
59966355|NCT01064687|76084126|FG002|NOT COMPLETED|Overall Study||41||
59966356|NCT01064687|76084127|FG003|NOT COMPLETED|Overall Study||17||
59966357|NCT02493946|76084151|FG000|STARTED|DB Period||126||
59966358|NCT02493946|76084152|FG001|STARTED|DB Period||64||
59966359|NCT02493946|76084153|FG002|STARTED|DB Period||0||
59966360|NCT02493946|76084151|FG000|COMPLETED|DB Period||118||
59966361|NCT02493946|76084152|FG001|COMPLETED|DB Period||59||
59966362|NCT02493946|76084153|FG002|COMPLETED|DB Period||0||
59966363|NCT02493946|76084151|FG000|NOT COMPLETED|DB Period||8||
59966364|NCT02493946|76084152|FG001|NOT COMPLETED|DB Period||5||
59966365|NCT02493946|76084153|FG002|NOT COMPLETED|DB Period||0||
59966366|NCT02493946|76084151|FG000|STARTED|Open Label Period|Only the BTX-A-HAC Solution 50 U - LT Analyses arm is applicable for this period.|0||
59966367|NCT02493946|76084152|FG001|STARTED|Open Label Period|Only the BTX-A-HAC Solution 50 U - LT Analyses arm is applicable for this period.|0||
59966368|NCT02493946|76084153|FG002|STARTED|Open Label Period|The previous period relates to DB period only, this period relates to OL treatment only.|595||
59966369|NCT02493946|76084151|FG000|COMPLETED|Open Label Period||0||
59966370|NCT02493946|76084152|FG001|COMPLETED|Open Label Period||0||
59966371|NCT02493946|76084153|FG002|COMPLETED|Open Label Period||509||
59966372|NCT02493946|76084151|FG000|NOT COMPLETED|Open Label Period||0||
59966373|NCT02493946|76084152|FG001|NOT COMPLETED|Open Label Period||0||
59810053|NCT00669617|75932174|FG003|COMPLETED|Period 5||18||
59810054|NCT00669617|75932175|FG004|COMPLETED|Period 5||17||
59810055|NCT00669617|75932171|FG000|NOT COMPLETED|Period 5||0||
59810056|NCT00669617|75932172|FG001|NOT COMPLETED|Period 5||0||
59810057|NCT00669617|75932173|FG002|NOT COMPLETED|Period 5||0||
59810058|NCT00669617|75932174|FG003|NOT COMPLETED|Period 5||0||
59810059|NCT00669617|75932175|FG004|NOT COMPLETED|Period 5||0||
59810060|NCT00535730|75932189|FG000|STARTED|Overall Study||236||
59810061|NCT00535730|75932190|FG001|STARTED|Overall Study|Two subjects were allocated but not vaccinated making the number of subjects vaccinated 235|237||
59810062|NCT00535730|75932189|FG000|COMPLETED|Overall Study||234||
59810063|NCT00535730|75932190|FG001|COMPLETED|Overall Study||230||
59966374|NCT02493946|76084153|FG002|NOT COMPLETED|Open Label Period||86||
59966375|NCT01064531|76084163|FG000|STARTED|Overall Study||21||21
59966376|NCT01064531|76084164|FG001|STARTED|Overall Study||20||20
59966377|NCT01064531|76084163|FG000|COMPLETED|Overall Study||18||18
59966378|NCT01064531|76084164|FG001|COMPLETED|Overall Study||13||13
59966379|NCT01064531|76084163|FG000|NOT COMPLETED|Overall Study||3||3
59966380|NCT01064531|76084164|FG001|NOT COMPLETED|Overall Study||7||7
59966381|NCT02220855|76084170|FG000|STARTED|Overall Study||14||
59966382|NCT02220855|76084170|FG000|COMPLETED|Overall Study||0||
59966383|NCT02220855|76084170|FG000|NOT COMPLETED|Overall Study||14||
59966384|NCT02918279|76084176|FG000|STARTED|Overall Study||125||
59966385|NCT02918279|76084177|FG001|STARTED|Overall Study||126||
59966386|NCT02918279|76084176|FG000|Full Analysis Set|Overall Study||125||
59966387|NCT02918279|76084177|FG001|Full Analysis Set|Overall Study||126||
59966388|NCT02918279|76084176|FG000|Safety Analysis Set|Overall Study||125||
59966389|NCT02918279|76084177|FG001|Safety Analysis Set|Overall Study||126||
59966390|NCT02918279|76084176|FG000|COMPLETED|Overall Study||112||
59966391|NCT02918279|76084177|FG001|COMPLETED|Overall Study||103||
59966392|NCT02918279|76084176|FG000|NOT COMPLETED|Overall Study||13||
59966393|NCT02918279|76084177|FG001|NOT COMPLETED|Overall Study||23||
59966394|NCT04268745|76084185|FG000|STARTED|Overall Study||15||
59966395|NCT04268745|76084186|FG001|STARTED|Overall Study||15||
59966396|NCT04268745|76084185|FG000|COMPLETED|Overall Study||8||
59966397|NCT04268745|76084186|FG001|COMPLETED|Overall Study||10||
59966398|NCT04268745|76084185|FG000|NOT COMPLETED|Overall Study||7||
59966399|NCT04268745|76084186|FG001|NOT COMPLETED|Overall Study||5||
59966400|NCT02956837|76084196|FG000|STARTED|Overall Study||100||
59966401|NCT02956837|76084197|FG001|STARTED|Overall Study||99||
59966402|NCT02956837|76084198|FG002|STARTED|Overall Study||99||
59966403|NCT02956837|76084199|FG003|STARTED|Overall Study||102||
59966404|NCT02956837|76084196|FG000|COMPLETED|Overall Study||100||
59966405|NCT02956837|76084197|FG001|COMPLETED|Overall Study||96||
59810064|NCT00535730|75932189|FG000|NOT COMPLETED|Overall Study||2||
59810065|NCT00535730|75932190|FG001|NOT COMPLETED|Overall Study||7||
59810066|NCT00666965|75932201|FG000|STARTED|Overall Study||58||
59810067|NCT00666965|75932202|FG001|STARTED|Overall Study||57||
59810068|NCT00666965|75932203|FG002|STARTED|Overall Study||58||
59810069|NCT00666965|75932204|FG003|STARTED|Overall Study||57||
59810070|NCT00666965|75932201|FG000|COMPLETED|Overall Study||55||
59810071|NCT00666965|75932202|FG001|COMPLETED|Overall Study||53||
59810072|NCT00666965|75932203|FG002|COMPLETED|Overall Study||56||
59810073|NCT00666965|75932204|FG003|COMPLETED|Overall Study||42||
59966406|NCT02956837|76084198|FG002|COMPLETED|Overall Study||97||
59966407|NCT02956837|76084199|FG003|COMPLETED|Overall Study||99||
59810074|NCT00666965|75932201|FG000|NOT COMPLETED|Overall Study||3||
59810075|NCT00666965|75932202|FG001|NOT COMPLETED|Overall Study||4||
59810076|NCT00666965|75932203|FG002|NOT COMPLETED|Overall Study||2||
59810077|NCT00666965|75932204|FG003|NOT COMPLETED|Overall Study||15||
59810078|NCT03889886|75932218|FG000|STARTED|Overall Study||76||
59966408|NCT02956837|76084196|FG000|NOT COMPLETED|Overall Study||0||
59966409|NCT02956837|76084197|FG001|NOT COMPLETED|Overall Study||3||
59966410|NCT02956837|76084198|FG002|NOT COMPLETED|Overall Study||2||
59966411|NCT02956837|76084199|FG003|NOT COMPLETED|Overall Study||3||
59966412|NCT01063595|76084212|FG000|STARTED|Enrolled in Study and Randomized||32||
59966413|NCT01063595|76084213|FG001|STARTED|Enrolled in Study and Randomized||31||
59966414|NCT01063595|76084212|FG000|Received Treatment|Enrolled in Study and Randomized||31||
59966415|NCT01063595|76084213|FG001|Received Treatment|Enrolled in Study and Randomized||29||
59966416|NCT01063595|76084212|FG000|COMPLETED|Enrolled in Study and Randomized||31||
59966417|NCT01063595|76084213|FG001|COMPLETED|Enrolled in Study and Randomized||29||
59966418|NCT01063595|76084212|FG000|NOT COMPLETED|Enrolled in Study and Randomized||1||
59966419|NCT01063595|76084213|FG001|NOT COMPLETED|Enrolled in Study and Randomized||2||
59966420|NCT01063595|76084212|FG000|STARTED|First Intervention||31||
59966421|NCT01063595|76084213|FG001|STARTED|First Intervention||29||
59966422|NCT01063595|76084212|FG000|COMPLETED|First Intervention||29||
59966423|NCT01063595|76084213|FG001|COMPLETED|First Intervention||24||
59810079|NCT03889886|75932219|FG001|STARTED|Overall Study||77||
59810080|NCT03889886|75932220|FG002|STARTED|Overall Study||76||
59810081|NCT03889886|75932221|FG003|STARTED|Overall Study||76||
59810082|NCT03889886|75932218|FG000|COMPLETED|Overall Study||76||
59810083|NCT03889886|75932219|FG001|COMPLETED|Overall Study||76||
59810084|NCT03889886|75932220|FG002|COMPLETED|Overall Study||75||
59810085|NCT03889886|75932221|FG003|COMPLETED|Overall Study||69||
59810086|NCT03889886|75932218|FG000|NOT COMPLETED|Overall Study||0||
59810087|NCT03889886|75932219|FG001|NOT COMPLETED|Overall Study||1||
59966424|NCT01063595|76084212|FG000|NOT COMPLETED|First Intervention||2||
59966425|NCT01063595|76084213|FG001|NOT COMPLETED|First Intervention||5||
59966426|NCT01063595|76084212|FG000|STARTED|Second Intervention||29||
59966427|NCT01063595|76084213|FG001|STARTED|Second Intervention||24||
59966428|NCT01063595|76084212|FG000|COMPLETED|Second Intervention||29||
59966429|NCT01063595|76084213|FG001|COMPLETED|Second Intervention||24||
59966430|NCT01063595|76084212|FG000|NOT COMPLETED|Second Intervention||0||
59966431|NCT01063595|76084213|FG001|NOT COMPLETED|Second Intervention||0||
59966432|NCT01063283|76084221|FG000|STARTED|Cycle 1||20||
59966433|NCT01063283|76084222|FG001|STARTED|Cycle 1||0||
59966434|NCT01063283|76084223|FG002|STARTED|Cycle 1||0||
59966435|NCT01063283|76084221|FG000|COMPLETED|Cycle 1||17||
59966436|NCT01063283|76084222|FG001|COMPLETED|Cycle 1||0||
59966437|NCT01063283|76084223|FG002|COMPLETED|Cycle 1||0||
59966438|NCT01063283|76084221|FG000|NOT COMPLETED|Cycle 1||3||
59966439|NCT01063283|76084222|FG001|NOT COMPLETED|Cycle 1||0||
59966440|NCT01063283|76084223|FG002|NOT COMPLETED|Cycle 1||0||
59966441|NCT01063283|76084221|FG000|STARTED|Randomized Phase (Cycle 2 and Beyond)||0||
59966442|NCT01063283|76084222|FG001|STARTED|Randomized Phase (Cycle 2 and Beyond)||6||
59966443|NCT01063283|76084223|FG002|STARTED|Randomized Phase (Cycle 2 and Beyond)||11||
59966444|NCT01063283|76084221|FG000|COMPLETED|Randomized Phase (Cycle 2 and Beyond)||0||
59810088|NCT03889886|75932220|FG002|NOT COMPLETED|Overall Study||1||
59810089|NCT03889886|75932221|FG003|NOT COMPLETED|Overall Study||7||
59810090|NCT03888482|75932233|FG000|STARTED|First Wear Period (8 -1/+2 Days)||76||
59966445|NCT01063283|76084222|FG001|COMPLETED|Randomized Phase (Cycle 2 and Beyond)||6||
59810091|NCT03888482|75932234|FG001|STARTED|First Wear Period (8 -1/+2 Days)||75||
59810092|NCT03888482|75932233|FG000|COMPLETED|First Wear Period (8 -1/+2 Days)||76||
59810093|NCT03888482|75932234|FG001|COMPLETED|First Wear Period (8 -1/+2 Days)||75||
59966446|NCT01063283|76084223|FG002|COMPLETED|Randomized Phase (Cycle 2 and Beyond)||11||
59966447|NCT01063283|76084221|FG000|NOT COMPLETED|Randomized Phase (Cycle 2 and Beyond)||0||
59966448|NCT01063283|76084222|FG001|NOT COMPLETED|Randomized Phase (Cycle 2 and Beyond)||0||
59966449|NCT01063283|76084223|FG002|NOT COMPLETED|Randomized Phase (Cycle 2 and Beyond)||0||
59966450|NCT01062971|76084231|FG000|STARTED|Overall Study||60||
59966451|NCT01062971|76084232|FG001|STARTED|Overall Study||63||
59966452|NCT01062971|76084231|FG000|COMPLETED|Overall Study||56||
59966453|NCT01062971|76084232|FG001|COMPLETED|Overall Study||56||
59966454|NCT01062971|76084231|FG000|NOT COMPLETED|Overall Study||4||
59966455|NCT01062971|76084232|FG001|NOT COMPLETED|Overall Study||7||
59966456|NCT01348165|76084245|FG000|STARTED|Overall Study||10||
59966457|NCT01348165|76084246|FG001|STARTED|Overall Study||5||
59966458|NCT01348165|76084247|FG002|STARTED|Overall Study||6||
59966459|NCT01348165|76084248|FG003|STARTED|Overall Study||6||
59966460|NCT01348165|76084249|FG004|STARTED|Overall Study||6||
59966461|NCT01348165|76084250|FG005|STARTED|Overall Study||1||
59966462|NCT01348165|76084251|FG006|STARTED|Overall Study||6||
59966463|NCT01348165|76084245|FG000|COMPLETED|Overall Study||10||
59966464|NCT01348165|76084246|FG001|COMPLETED|Overall Study||5||
59966465|NCT01348165|76084247|FG002|COMPLETED|Overall Study||6||
59966466|NCT01348165|76084248|FG003|COMPLETED|Overall Study||6||
59966467|NCT01348165|76084249|FG004|COMPLETED|Overall Study||6||
59966468|NCT01348165|76084250|FG005|COMPLETED|Overall Study||1||
59966469|NCT01348165|76084251|FG006|COMPLETED|Overall Study||5||
59966470|NCT01348165|76084245|FG000|NOT COMPLETED|Overall Study||0||
59966471|NCT01348165|76084246|FG001|NOT COMPLETED|Overall Study||0||
59810094|NCT03888482|75932233|FG000|NOT COMPLETED|First Wear Period (8 -1/+2 Days)||0||
59810095|NCT03888482|75932234|FG001|NOT COMPLETED|First Wear Period (8 -1/+2 Days)||0||
59810096|NCT03888482|75932233|FG000|STARTED|Second Wear (8 -1/+2 Days)|2 subjects were discontinued between Treatment 1 and Treatment 2.|74||
59810097|NCT03888482|75932234|FG001|STARTED|Second Wear (8 -1/+2 Days)||75||
59810098|NCT03888482|75932233|FG000|COMPLETED|Second Wear (8 -1/+2 Days)||73||
59810099|NCT03888482|75932234|FG001|COMPLETED|Second Wear (8 -1/+2 Days)||74||
59810100|NCT03888482|75932233|FG000|NOT COMPLETED|Second Wear (8 -1/+2 Days)||1||
59810101|NCT03888482|75932234|FG001|NOT COMPLETED|Second Wear (8 -1/+2 Days)||1||
59810102|NCT00667355|75932242|FG000|STARTED|Overall Study||41||
59810103|NCT00667355|75932242|FG000|COMPLETED|Overall Study||30||
59810104|NCT00667355|75932242|FG000|NOT COMPLETED|Overall Study||11||
59810105|NCT00532844|75932248|FG000|STARTED|Treatment Period - Day 1 to Day 14|Only the 48 subjects enrolled in the final protocol are included in the participant flow.|24||
59966472|NCT01348165|76084247|FG002|NOT COMPLETED|Overall Study||0||
59966473|NCT01348165|76084248|FG003|NOT COMPLETED|Overall Study||0||
59966474|NCT01348165|76084249|FG004|NOT COMPLETED|Overall Study||0||
59966475|NCT01348165|76084250|FG005|NOT COMPLETED|Overall Study||0||
59966476|NCT01348165|76084251|FG006|NOT COMPLETED|Overall Study||1||
59966477|NCT02493868|76084271|FG000|STARTED|Induction Phase: DE Participants||437||
59966478|NCT02493868|76084272|FG001|STARTED|Induction Phase: DE Participants||0||
59966479|NCT02493868|76084271|FG000|COMPLETED|Induction Phase: DE Participants|Participants who completed and met predefined response criteria continued to OP phase.|273||
59966480|NCT02493868|76084272|FG001|COMPLETED|Induction Phase: DE Participants||0||
59966481|NCT02493868|76084271|FG000|NOT COMPLETED|Induction Phase: DE Participants||164||
59966482|NCT02493868|76084272|FG001|NOT COMPLETED|Induction Phase: DE Participants||0||
59966483|NCT02493868|76084271|FG000|STARTED|Optimization Phase: DE+TE Participants|Total participants: direct-entry (273) + esketamine-treated transferred-entry participants (182).|455||
59966484|NCT02493868|76084272|FG001|STARTED|Optimization Phase: DE+TE Participants|Placebo treated transferred-entry participant.|86||
59966485|NCT02493868|76084271|FG000|COMPLETED|Optimization Phase: DE+TE Participants|Participants who completed and met predefined remission/response criteria randomized to MA phase|297||
59966486|NCT02493868|76084272|FG001|COMPLETED|Optimization Phase: DE+TE Participants|Participants who completed and met predefined remission/response criteria continued to MA phase.|54||
59966487|NCT02493868|76084271|FG000|NOT COMPLETED|Optimization Phase: DE+TE Participants||158||
59966488|NCT02493868|76084272|FG001|NOT COMPLETED|Optimization Phase: DE+TE Participants||32||
59525148|NCT01281475|75620374|FG000|NOT COMPLETED|Overall Study||4||
59525149|NCT01281475|75620375|FG001|NOT COMPLETED|Overall Study||8||
59810106|NCT00532844|75932249|FG001|STARTED|Treatment Period - Day 1 to Day 14|Only the 48 subjects enrolled in the final protocol are included in the participant flow.|24||
59966489|NCT02493868|76084271|FG000|STARTED|Maintenance Phase: DE+TE Participants|152 participants randomized from intranasal esketamine arm after OP phase: DE (90) + TE (62)|152||
59966490|NCT02493868|76084272|FG001|STARTED|Maintenance Phase: DE+TE Participants|145 participants randomized from intranasal esketamine arm after OP phase+54 continued from OP phase|199||
59966491|NCT02493868|76084271|FG000|Stable Remitters|Maintenance Phase: DE+TE Participants||90||
59966492|NCT02493868|76084272|FG001|Stable Remitters|Maintenance Phase: DE+TE Participants||86||
59966493|NCT02493868|76084271|FG000|Stable Responders|Maintenance Phase: DE+TE Participants||62||
59966494|NCT02493868|76084272|FG001|Stable Responders|Maintenance Phase: DE+TE Participants||59||
59966495|NCT02493868|76084271|FG000|COMPLETED|Maintenance Phase: DE+TE Participants||139||
59966496|NCT02493868|76084272|FG001|COMPLETED|Maintenance Phase: DE+TE Participants||177||
59966497|NCT02493868|76084271|FG000|NOT COMPLETED|Maintenance Phase: DE+TE Participants||13||
59966498|NCT02493868|76084272|FG001|NOT COMPLETED|Maintenance Phase: DE+TE Participants||22||
59966499|NCT02493868|76084271|FG000|STARTED|Follow-up Phase||481||
59966500|NCT02493868|76084272|FG001|STARTED|Follow-up Phase||64||
59966501|NCT02493868|76084271|FG000|COMPLETED|Follow-up Phase||470||
59966502|NCT02493868|76084272|FG001|COMPLETED|Follow-up Phase||62||
59966503|NCT02493868|76084271|FG000|NOT COMPLETED|Follow-up Phase||11||
59966504|NCT02493868|76084272|FG001|NOT COMPLETED|Follow-up Phase||2||
59966505|NCT02516410|76084286|FG000|STARTED|Overall Study||85||
59966506|NCT02516410|76084287|FG001|STARTED|Overall Study||83||
59966507|NCT02516410|76084286|FG000|COMPLETED|Overall Study||85||
59966508|NCT02516410|76084287|FG001|COMPLETED|Overall Study||81||
59810107|NCT00532844|75932248|FG000|COMPLETED|Treatment Period - Day 1 to Day 14||24||
59810108|NCT00532844|75932249|FG001|COMPLETED|Treatment Period - Day 1 to Day 14||23||
59810109|NCT00532844|75932248|FG000|NOT COMPLETED|Treatment Period - Day 1 to Day 14||0||
59810110|NCT00532844|75932249|FG001|NOT COMPLETED|Treatment Period - Day 1 to Day 14||1||
59810111|NCT00532844|75932248|FG000|STARTED|Washout (1 Day)||24||
59810112|NCT00532844|75932249|FG001|STARTED|Washout (1 Day)||23||
59810113|NCT00532844|75932248|FG000|COMPLETED|Washout (1 Day)||24||
59810114|NCT00532844|75932249|FG001|COMPLETED|Washout (1 Day)||23||
59810115|NCT00532844|75932248|FG000|NOT COMPLETED|Washout (1 Day)||0||
59810116|NCT00532844|75932249|FG001|NOT COMPLETED|Washout (1 Day)||0||
59810117|NCT00532844|75932248|FG000|STARTED|Treatment Period - Day 15 to Day 28||24||
59966509|NCT02516410|76084286|FG000|NOT COMPLETED|Overall Study||0||
59525150|NCT01282723|75620383|FG000|STARTED|Overall Study||20||
59810118|NCT00532844|75932249|FG001|STARTED|Treatment Period - Day 15 to Day 28||23||
59810119|NCT00532844|75932248|FG000|COMPLETED|Treatment Period - Day 15 to Day 28||20||
59810120|NCT00532844|75932249|FG001|COMPLETED|Treatment Period - Day 15 to Day 28||23||
59810121|NCT00532844|75932248|FG000|NOT COMPLETED|Treatment Period - Day 15 to Day 28||4||
59966510|NCT02516410|76084287|FG001|NOT COMPLETED|Overall Study||2||
59966511|NCT02493712|76084297|FG000|STARTED|Overall Study||16||
59966512|NCT02493712|76084298|FG001|STARTED|Overall Study||18||
59966513|NCT02493712|76084299|FG002|STARTED|Overall Study||17||
59966514|NCT02493712|76084297|FG000|COMPLETED|Overall Study||14||
59966515|NCT02493712|76084298|FG001|COMPLETED|Overall Study||12||
59966516|NCT02493712|76084299|FG002|COMPLETED|Overall Study||11||
59966517|NCT02493712|76084297|FG000|NOT COMPLETED|Overall Study||2||
59966518|NCT02493712|76084298|FG001|NOT COMPLETED|Overall Study||6||
59966519|NCT02493712|76084299|FG002|NOT COMPLETED|Overall Study||6||
59966520|NCT02516332|76084310|FG000|STARTED|Overall Study||52||
59966521|NCT02516332|76084311|FG001|STARTED|Overall Study||53||
59966522|NCT02516332|76084312|FG002|STARTED|Overall Study||23||
59966523|NCT02516332|76084310|FG000|COMPLETED|Overall Study||50||
59966524|NCT02516332|76084311|FG001|COMPLETED|Overall Study||52||
59966525|NCT02516332|76084312|FG002|COMPLETED|Overall Study||21||
59966526|NCT02516332|76084310|FG000|NOT COMPLETED|Overall Study||2||
59966527|NCT02516332|76084311|FG001|NOT COMPLETED|Overall Study||1||
59966528|NCT02516332|76084312|FG002|NOT COMPLETED|Overall Study||2||
59966529|NCT02483572|76084322|FG000|STARTED|Overall Study||2||
59966530|NCT02483572|76084323|FG001|STARTED|Overall Study||2||
59966531|NCT02483572|76084322|FG000|COMPLETED|Overall Study||0||
59966532|NCT02483572|76084323|FG001|COMPLETED|Overall Study||1||
59966533|NCT02483572|76084322|FG000|NOT COMPLETED|Overall Study||2||
59966534|NCT02483572|76084323|FG001|NOT COMPLETED|Overall Study||1||
59966535|NCT01062425|76084331|FG000|STARTED|Overall Study||55||
59966536|NCT01062425|76084332|FG001|STARTED|Overall Study||103||
59966537|NCT01062425|76084331|FG000|COMPLETED|Overall Study|Randomized eligible subjects are considered to have completed the study.|52||
59966538|NCT01062425|76084332|FG001|COMPLETED|Overall Study|Randomized eligible subjects are considered to have completed the study.|97||
59966539|NCT01062425|76084331|FG000|NOT COMPLETED|Overall Study||3||
59966540|NCT01062425|76084332|FG001|NOT COMPLETED|Overall Study||6||
59966541|NCT01060553|76084338|FG000|STARTED|Overall Study||15||
59966542|NCT01060553|76084339|FG001|STARTED|Overall Study||15||
59966543|NCT01060553|76084338|FG000|COMPLETED|Overall Study|5 subjects completed more than half the sessions and midpoint outcome measures were obtained|6||
59966544|NCT01060553|76084339|FG001|COMPLETED|Overall Study||5||
59966545|NCT01060553|76084338|FG000|NOT COMPLETED|Overall Study||9||
59966546|NCT01060553|76084339|FG001|NOT COMPLETED|Overall Study||10||
59966547|NCT02491684|76084346|FG000|STARTED|Pre-treatment Phase||61||
59966548|NCT02491684|76084347|FG001|STARTED|Pre-treatment Phase||60||
60074329|NCT01801436|76189710|FG000|NOT COMPLETED|Overall Study||9||
60074330|NCT01771250|76189714|FG000|STARTED|Period 1||8||
60074331|NCT01771250|76189715|FG001|STARTED|Period 1||7||
60074332|NCT01771250|76189714|FG000|Received at Least One Dose of Study Drug|Period 1||7||
59621525|NCT00352794|75733154|FG000|COMPLETED|Overall Study||40||
60074333|NCT01771250|76189715|FG001|Received at Least One Dose of Study Drug|Period 1||7||
60074334|NCT01771250|76189714|FG000|COMPLETED|Period 1||7||
59621526|NCT00352794|75733154|FG000|NOT COMPLETED|Overall Study||0||
59621527|NCT00353418|75733160|FG000|STARTED|Overall Study||138||
59621528|NCT00353418|75733161|FG001|STARTED|Overall Study||277||
59621529|NCT00353418|75733160|FG000|COMPLETED|Overall Study||55||
59621530|NCT00353418|75733161|FG001|COMPLETED|Overall Study||119||
59621531|NCT00353418|75733160|FG000|NOT COMPLETED|Overall Study||83||
59966549|NCT02491684|76084346|FG000|COMPLETED|Pre-treatment Phase||61||
59966550|NCT02491684|76084347|FG001|COMPLETED|Pre-treatment Phase||60||
59966551|NCT02491684|76084346|FG000|NOT COMPLETED|Pre-treatment Phase||0||
59966552|NCT02491684|76084347|FG001|NOT COMPLETED|Pre-treatment Phase||0||
59966553|NCT02491684|76084346|FG000|STARTED|Treatment Phase||61||
59966554|NCT02491684|76084347|FG001|STARTED|Treatment Phase||60||
59966555|NCT02491684|76084346|FG000|COMPLETED|Treatment Phase||58||
59966556|NCT02491684|76084347|FG001|COMPLETED|Treatment Phase||57||
59966557|NCT02491684|76084346|FG000|NOT COMPLETED|Treatment Phase||3||
59966558|NCT02491684|76084347|FG001|NOT COMPLETED|Treatment Phase||3||
59966559|NCT01061723|76084359|FG000|STARTED|Overall Study||50||
59966560|NCT01061723|76084360|FG001|STARTED|Overall Study||49||
59966561|NCT01061723|76084361|FG002|STARTED|Overall Study||50||
59966562|NCT01061723|76084362|FG003|STARTED|Overall Study||52||
59966563|NCT01061723|76084363|FG004|STARTED|Overall Study||50||
59966564|NCT01061723|76084364|FG005|STARTED|Overall Study||50||
59966565|NCT01061723|76084359|FG000|Treated|Overall Study||50||
59966566|NCT01061723|76084360|FG001|Treated|Overall Study||49||
59966567|NCT01061723|76084361|FG002|Treated|Overall Study||50||
59966568|NCT01061723|76084362|FG003|Treated|Overall Study||52||
60074335|NCT01771250|76189715|FG001|COMPLETED|Period 1||7||
59621532|NCT00353418|75733161|FG001|NOT COMPLETED|Overall Study||158||
59621533|NCT00353652|75733169|FG000|STARTED|First Intervention - 3 Months||15||
59621534|NCT00353652|75733170|FG001|STARTED|First Intervention - 3 Months||15||
59621535|NCT00353652|75733171|FG002|STARTED|First Intervention - 3 Months||6||
59966569|NCT01061723|76084363|FG004|Treated|Overall Study||50||
59966570|NCT01061723|76084364|FG005|Treated|Overall Study||49||
59966571|NCT01061723|76084359|FG000|COMPLETED|Overall Study||46||
60074336|NCT01771250|76189714|FG000|NOT COMPLETED|Period 1||1||
60074337|NCT01771250|76189715|FG001|NOT COMPLETED|Period 1||0||
59966572|NCT01061723|76084360|FG001|COMPLETED|Overall Study||43||
59810122|NCT00532844|75932249|FG001|NOT COMPLETED|Treatment Period - Day 15 to Day 28||0||
59810123|NCT03190460|75932270|FG000|STARTED|Overall Study||40||
59810124|NCT03190460|75932271|FG001|STARTED|Overall Study||20||
59810125|NCT03190460|75932270|FG000|COMPLETED|Overall Study||3||
59810126|NCT03190460|75932271|FG001|COMPLETED|Overall Study||2||
59966573|NCT01061723|76084361|FG002|COMPLETED|Overall Study||40||
59966574|NCT01061723|76084362|FG003|COMPLETED|Overall Study||44||
59966575|NCT01061723|76084363|FG004|COMPLETED|Overall Study||47||
59966576|NCT01061723|76084364|FG005|COMPLETED|Overall Study||41||
59966577|NCT01061723|76084359|FG000|NOT COMPLETED|Overall Study||4||
59966578|NCT01061723|76084360|FG001|NOT COMPLETED|Overall Study||6||
59966579|NCT01061723|76084361|FG002|NOT COMPLETED|Overall Study||10||
59966580|NCT01061723|76084362|FG003|NOT COMPLETED|Overall Study||8||
59966581|NCT01061723|76084363|FG004|NOT COMPLETED|Overall Study||3||
59966582|NCT01061723|76084364|FG005|NOT COMPLETED|Overall Study||9||
59966583|NCT01061567|76084383|FG000|STARTED|Overall Study||1814||
59966584|NCT01061567|76084383|FG000|COMPLETED|Overall Study||1738||
59966585|NCT01061567|76084383|FG000|NOT COMPLETED|Overall Study||76||
59966586|NCT01061333|76084387|FG000|STARTED|Period 1: Placebo Run-in||8||
59966587|NCT01061333|76084388|FG001|STARTED|Period 1: Placebo Run-in||8||
59966588|NCT01061333|76084387|FG000|COMPLETED|Period 1: Placebo Run-in||8||
59966589|NCT01061333|76084388|FG001|COMPLETED|Period 1: Placebo Run-in||8||
59966590|NCT01061333|76084387|FG000|NOT COMPLETED|Period 1: Placebo Run-in||0||
59966591|NCT01061333|76084388|FG001|NOT COMPLETED|Period 1: Placebo Run-in||0||
59966592|NCT01061333|76084387|FG000|STARTED|Period 2: 20-day Washout||8||
59966593|NCT01061333|76084388|FG001|STARTED|Period 2: 20-day Washout||8||
59966594|NCT01061333|76084387|FG000|COMPLETED|Period 2: 20-day Washout||8||
59966595|NCT01061333|76084388|FG001|COMPLETED|Period 2: 20-day Washout||8||
59966596|NCT01061333|76084387|FG000|NOT COMPLETED|Period 2: 20-day Washout||0||
59966597|NCT01061333|76084388|FG001|NOT COMPLETED|Period 2: 20-day Washout||0||
59966598|NCT01061333|76084387|FG000|STARTED|Period 3: Nedocromil-Montelukast X-over||8||
59966599|NCT01061333|76084388|FG001|STARTED|Period 3: Nedocromil-Montelukast X-over||8||
59966600|NCT01061333|76084387|FG000|COMPLETED|Period 3: Nedocromil-Montelukast X-over||8||
59966601|NCT01061333|76084388|FG001|COMPLETED|Period 3: Nedocromil-Montelukast X-over||8||
59966602|NCT01061333|76084387|FG000|NOT COMPLETED|Period 3: Nedocromil-Montelukast X-over||0||
59966603|NCT01061333|76084388|FG001|NOT COMPLETED|Period 3: Nedocromil-Montelukast X-over||0||
59966604|NCT01061333|76084387|FG000|STARTED|Period 4: 20-day Washout||8||
59966605|NCT01061333|76084388|FG001|STARTED|Period 4: 20-day Washout||8||
59966606|NCT01061333|76084387|FG000|COMPLETED|Period 4: 20-day Washout||8||
59966607|NCT01061333|76084388|FG001|COMPLETED|Period 4: 20-day Washout||7||
59966608|NCT01061333|76084387|FG000|NOT COMPLETED|Period 4: 20-day Washout||0||
59966609|NCT01061333|76084388|FG001|NOT COMPLETED|Period 4: 20-day Washout||1||
59966610|NCT01061333|76084387|FG000|STARTED|Period 5: Nedocromil-Montelukast X-over||8||
59966611|NCT01061333|76084388|FG001|STARTED|Period 5: Nedocromil-Montelukast X-over||7||
59966612|NCT01061333|76084387|FG000|COMPLETED|Period 5: Nedocromil-Montelukast X-over||8||
59966613|NCT01061333|76084388|FG001|COMPLETED|Period 5: Nedocromil-Montelukast X-over||7||
59966614|NCT01061333|76084387|FG000|NOT COMPLETED|Period 5: Nedocromil-Montelukast X-over||0||
59966615|NCT01061333|76084388|FG001|NOT COMPLETED|Period 5: Nedocromil-Montelukast X-over||0||
59966616|NCT01061333|76084387|FG000|STARTED|Period 6: 20-day Washout||8||
59966617|NCT01061333|76084388|FG001|STARTED|Period 6: 20-day Washout||7||
59966618|NCT01061333|76084387|FG000|COMPLETED|Period 6: 20-day Washout||8||
59966619|NCT01061333|76084388|FG001|COMPLETED|Period 6: 20-day Washout||7||
59966620|NCT01061333|76084387|FG000|NOT COMPLETED|Period 6: 20-day Washout||0||
59966621|NCT01061333|76084388|FG001|NOT COMPLETED|Period 6: 20-day Washout||0||
59966622|NCT01061333|76084387|FG000|STARTED|Period 7: Mometasone||8||
59966623|NCT01061333|76084388|FG001|STARTED|Period 7: Mometasone||7||
59966624|NCT01061333|76084387|FG000|COMPLETED|Period 7: Mometasone||8||
59966625|NCT01061333|76084388|FG001|COMPLETED|Period 7: Mometasone||7||
59966626|NCT01061333|76084387|FG000|NOT COMPLETED|Period 7: Mometasone||0||
59966627|NCT01061333|76084388|FG001|NOT COMPLETED|Period 7: Mometasone||0||
59966628|NCT02489968|76084401|FG000|STARTED|Open-label Treatment Period||439||
59966629|NCT02489968|76084402|FG001|STARTED|Open-label Treatment Period|1 subject did not receive treatment and hence excluded. Started represents treated numbers.|440||
59966630|NCT02489968|76084403|FG002|STARTED|Open-label Treatment Period||0||
59966631|NCT02489968|76084404|FG003|STARTED|Open-label Treatment Period||0||
59966632|NCT02489968|76084405|FG004|STARTED|Open-label Treatment Period||0||
59966633|NCT02489968|76084406|FG005|STARTED|Open-label Treatment Period||0||
59966634|NCT02489968|76084401|FG000|COMPLETED|Open-label Treatment Period||215||
59966635|NCT02489968|76084402|FG001|COMPLETED|Open-label Treatment Period||232||
59966636|NCT02489968|76084403|FG002|COMPLETED|Open-label Treatment Period||0||
59966637|NCT02489968|76084404|FG003|COMPLETED|Open-label Treatment Period||0||
59810127|NCT03190460|75932270|FG000|NOT COMPLETED|Overall Study||37||
59966638|NCT02489968|76084405|FG004|COMPLETED|Open-label Treatment Period||0||
59966639|NCT02489968|76084406|FG005|COMPLETED|Open-label Treatment Period||0||
59966640|NCT02489968|76084401|FG000|NOT COMPLETED|Open-label Treatment Period||224||
59810128|NCT03190460|75932271|FG001|NOT COMPLETED|Overall Study||18||
59810129|NCT00666263|75932277|FG000|STARTED|Study Part 1 (Stabilization Phase 1)||22||
59810130|NCT00666263|75932278|FG001|STARTED|Study Part 1 (Stabilization Phase 1)||22||
59966641|NCT02489968|76084402|FG001|NOT COMPLETED|Open-label Treatment Period||208||
59966642|NCT02489968|76084403|FG002|NOT COMPLETED|Open-label Treatment Period||0||
59966643|NCT02489968|76084404|FG003|NOT COMPLETED|Open-label Treatment Period||0||
59966644|NCT02489968|76084405|FG004|NOT COMPLETED|Open-label Treatment Period||0||
59966645|NCT02489968|76084406|FG005|NOT COMPLETED|Open-label Treatment Period||0||
59966646|NCT02489968|76084401|FG000|STARTED|Double-blind Treatment Period||0||
59966647|NCT02489968|76084402|FG001|STARTED|Double-blind Treatment Period||0||
59966648|NCT02489968|76084403|FG002|STARTED|Double-blind Treatment Period||107||
59966649|NCT02489968|76084404|FG003|STARTED|Double-blind Treatment Period||108||
59966650|NCT02489968|76084405|FG004|STARTED|Double-blind Treatment Period||116||
59966651|NCT02489968|76084406|FG005|STARTED|Double-blind Treatment Period||116||
59966652|NCT02489968|76084401|FG000|COMPLETED|Double-blind Treatment Period||0||
59966653|NCT02489968|76084402|FG001|COMPLETED|Double-blind Treatment Period||0||
59966654|NCT02489968|76084403|FG002|COMPLETED|Double-blind Treatment Period||105||
59966655|NCT02489968|76084404|FG003|COMPLETED|Double-blind Treatment Period||100||
59966656|NCT02489968|76084405|FG004|COMPLETED|Double-blind Treatment Period||110||
59966657|NCT02489968|76084406|FG005|COMPLETED|Double-blind Treatment Period||108||
59966658|NCT02489968|76084401|FG000|NOT COMPLETED|Double-blind Treatment Period||0||
59966659|NCT02489968|76084402|FG001|NOT COMPLETED|Double-blind Treatment Period||0||
59966660|NCT02489968|76084403|FG002|NOT COMPLETED|Double-blind Treatment Period||2||
59966661|NCT02489968|76084404|FG003|NOT COMPLETED|Double-blind Treatment Period||8||
59966662|NCT02489968|76084405|FG004|NOT COMPLETED|Double-blind Treatment Period||6||
59966663|NCT02489968|76084406|FG005|NOT COMPLETED|Double-blind Treatment Period||8||
59966664|NCT02483416|76084420|FG000|STARTED|Overall Study||21||
59966665|NCT02483416|76084421|FG001|STARTED|Overall Study||7||
59966666|NCT02483416|76084420|FG000|COMPLETED|Overall Study||18||
59966667|NCT02483416|76084421|FG001|COMPLETED|Overall Study||6||
59966668|NCT02483416|76084420|FG000|NOT COMPLETED|Overall Study||3||
59966669|NCT02483416|76084421|FG001|NOT COMPLETED|Overall Study||1||
59966670|NCT01061177|76084428|FG000|STARTED|Overall Study||1089||
59966671|NCT01061177|76084428|FG000|ITT_MR (b2a2 &/or b3a2 +ve Pts Only)|Overall Study||1056||
59966672|NCT01061177|76084428|FG000|ITT_CyR (Ph+ Patients Only)|Overall Study||983||
59966673|NCT01061177|76084428|FG000|COMPLETED|Overall Study||881||
59966674|NCT01061177|76084428|FG000|NOT COMPLETED|Overall Study||208||
59966675|NCT02481934|76084432|FG000|STARTED|Overall Study||5||
59966676|NCT02481934|76084432|FG000|COMPLETED|Overall Study||3||
59966677|NCT02481934|76084432|FG000|NOT COMPLETED|Overall Study||2||
59966678|NCT02973425|76084438|FG000|STARTED|Overall Study||220||
59966679|NCT02973425|76084439|FG001|STARTED|Overall Study||213||
59966680|NCT02973425|76084438|FG000|COMPLETED|Overall Study||171||
59966681|NCT02973425|76084439|FG001|COMPLETED|Overall Study||160||
59966682|NCT02973425|76084438|FG000|NOT COMPLETED|Overall Study||49||
59966683|NCT02973425|76084439|FG001|NOT COMPLETED|Overall Study||53||
59966684|NCT02489500|76084448|FG000|STARTED|Overall Study||2||
59966685|NCT02489500|76084449|FG001|STARTED|Overall Study||1||
59966686|NCT02489500|76084448|FG000|COMPLETED|Overall Study||1||
59966687|NCT02489500|76084449|FG001|COMPLETED|Overall Study||0||
59966688|NCT02489500|76084448|FG000|NOT COMPLETED|Overall Study||1||
59966689|NCT02489500|76084449|FG001|NOT COMPLETED|Overall Study||1||
59966690|NCT02732847|76084457|FG000|STARTED|Overall Study||75||
59966691|NCT02732847|76084458|FG001|STARTED|Overall Study||74||
59966692|NCT02732847|76084457|FG000|COMPLETED|Overall Study||33||
59966693|NCT02732847|76084458|FG001|COMPLETED|Overall Study||32||
59966694|NCT02732847|76084457|FG000|NOT COMPLETED|Overall Study||42||
59966695|NCT02732847|76084458|FG001|NOT COMPLETED|Overall Study||42||
59966696|NCT02489344|76084464|FG000|STARTED|ACT13739 (Initial Study): 26 Weeks||11|Enrolled and treated.|
59966697|NCT02489344|76084464|FG000|COMPLETED|ACT13739 (Initial Study): 26 Weeks||9||
59966698|NCT02489344|76084464|FG000|NOT COMPLETED|ACT13739 (Initial Study): 26 Weeks||2||
59966699|NCT02489344|76084464|FG000|STARTED|LTS14116 (Extension Study): 31 Months||8|Enrolled and treated.|
59966700|NCT02489344|76084464|FG000|COMPLETED|LTS14116 (Extension Study): 31 Months||5|2 participant completed,not discontinued early,but counted not completed due to no completion record|
59810131|NCT00666263|75932277|FG000|COMPLETED|Study Part 1 (Stabilization Phase 1)||22||
59810132|NCT00666263|75932278|FG001|COMPLETED|Study Part 1 (Stabilization Phase 1)||21||
59966701|NCT02489344|76084464|FG000|NOT COMPLETED|LTS14116 (Extension Study): 31 Months||3||
59966702|NCT02488330|76084468|FG000|STARTED|Overall Study||12||
59966703|NCT02488330|76084468|FG000|COMPLETED|Overall Study||0||
59966704|NCT02488330|76084468|FG000|NOT COMPLETED|Overall Study||12||
59966705|NCT02481310|76084475|FG000|STARTED|Induction Treatment (6 Cycles)||1||
59966706|NCT02481310|76084476|FG001|STARTED|Induction Treatment (6 Cycles)||36||
59810133|NCT00666263|75932277|FG000|NOT COMPLETED|Study Part 1 (Stabilization Phase 1)||0||
59810134|NCT00666263|75932278|FG001|NOT COMPLETED|Study Part 1 (Stabilization Phase 1)||1||
59810135|NCT00666263|75932277|FG000|STARTED|Study Part 2 (Cross-over Period 1)||22||
59810136|NCT00666263|75932278|FG001|STARTED|Study Part 2 (Cross-over Period 1)||21||
59995315|NCT04140396|76111163|FG001|STARTED|Overall Study||1||
59995316|NCT04140396|76111162|FG000|COMPLETED|Overall Study||0||
59995317|NCT04140396|76111163|FG001|COMPLETED|Overall Study||1||
59966707|NCT02481310|76084477|FG002|STARTED|Induction Treatment (6 Cycles)||1||
59966708|NCT02481310|76084475|FG000|Reached First Evaluable Response|Induction Treatment (6 Cycles)||1||
59966709|NCT02481310|76084476|FG001|Reached First Evaluable Response|Induction Treatment (6 Cycles)||34||
59966710|NCT02481310|76084477|FG002|Reached First Evaluable Response|Induction Treatment (6 Cycles)||1||
59966711|NCT02481310|76084475|FG000|Complete 6 Cycles|Induction Treatment (6 Cycles)||1||
59966712|NCT02481310|76084476|FG001|Complete 6 Cycles|Induction Treatment (6 Cycles)||30||
59966713|NCT02481310|76084477|FG002|Complete 6 Cycles|Induction Treatment (6 Cycles)||1||
59966714|NCT02481310|76084475|FG000|COMPLETED|Induction Treatment (6 Cycles)||1||
59966715|NCT02481310|76084476|FG001|COMPLETED|Induction Treatment (6 Cycles)||30||
59966716|NCT02481310|76084477|FG002|COMPLETED|Induction Treatment (6 Cycles)||1||
59966717|NCT02481310|76084475|FG000|NOT COMPLETED|Induction Treatment (6 Cycles)||0||
59966718|NCT02481310|76084476|FG001|NOT COMPLETED|Induction Treatment (6 Cycles)||6||
59966719|NCT02481310|76084477|FG002|NOT COMPLETED|Induction Treatment (6 Cycles)||0||
59966720|NCT02481310|76084475|FG000|STARTED|Maintenance Treatment||1|Maintenance treatment can continue for up to one year or longer for continued clinical benefit if approved.|
59966721|NCT02481310|76084476|FG001|STARTED|Maintenance Treatment|9 patients that competed induction did not start maintenance treatment.|21|Maintenance treatment can continue for up to one year or longer for continued clinical benefit if approved.|
59966722|NCT02481310|76084477|FG002|STARTED|Maintenance Treatment||1|Maintenance treatment can continue for up to one year or longer for continued clinical benefit if approved.|
59966723|NCT02481310|76084475|FG000|Started Maintenance Treatment|Maintenance Treatment||1||
59966724|NCT02481310|76084476|FG001|Started Maintenance Treatment|Maintenance Treatment||21||
59966725|NCT02481310|76084477|FG002|Started Maintenance Treatment|Maintenance Treatment||1||
59966726|NCT02481310|76084475|FG000|COMPLETED|Maintenance Treatment||1||
59966727|NCT02481310|76084476|FG001|COMPLETED|Maintenance Treatment||21||
59966728|NCT02481310|76084477|FG002|COMPLETED|Maintenance Treatment||1||
59966729|NCT02481310|76084475|FG000|NOT COMPLETED|Maintenance Treatment||0||
59966730|NCT02481310|76084476|FG001|NOT COMPLETED|Maintenance Treatment||0||
59966731|NCT02481310|76084477|FG002|NOT COMPLETED|Maintenance Treatment||0||
59966732|NCT02481310|76084475|FG000|STARTED|Follow up||1|All patients that are treated with at least one dose of study drug go into the follow up period.|
59966733|NCT02481310|76084476|FG001|STARTED|Follow up|2 patients died prior to entering follow up, 1 patient withdrew consent and 1 patient currently on treatment.|32|All patients that are treated with at least one dose of study drug go into the follow up period.|
59966734|NCT02481310|76084477|FG002|STARTED|Follow up||1|All patients that are treated with at least one dose of study drug go into the follow up period.|
59966735|NCT02481310|76084475|FG000|COMPLETED|Follow up||1||
59966736|NCT02481310|76084476|FG001|COMPLETED|Follow up||29||
59966737|NCT02481310|76084477|FG002|COMPLETED|Follow up||1||
59966738|NCT02481310|76084475|FG000|NOT COMPLETED|Follow up||0||
59966739|NCT02481310|76084476|FG001|NOT COMPLETED|Follow up||3||
59966740|NCT02481310|76084477|FG002|NOT COMPLETED|Follow up||0||
59966741|NCT02480764|76084484|FG000|STARTED|Overall Study||199||
59966742|NCT02480764|76084485|FG001|STARTED|Overall Study||209||
59810137|NCT00666263|75932277|FG000|COMPLETED|Study Part 2 (Cross-over Period 1)||22||
59810138|NCT00666263|75932278|FG001|COMPLETED|Study Part 2 (Cross-over Period 1)||21||
59810139|NCT00666263|75932277|FG000|NOT COMPLETED|Study Part 2 (Cross-over Period 1)||0||
59810140|NCT00666263|75932278|FG001|NOT COMPLETED|Study Part 2 (Cross-over Period 1)||0||
59810141|NCT00666263|75932277|FG000|STARTED|Study Part 3 (Stabilization Phase 2)||22||
59966743|NCT02480764|76084486|FG002|STARTED|Overall Study||204||
59966744|NCT02480764|76084484|FG000|COMPLETED|Overall Study||189||
59966745|NCT02480764|76084485|FG001|COMPLETED|Overall Study||189||
59966746|NCT02480764|76084486|FG002|COMPLETED|Overall Study||183||
59966747|NCT02480764|76084484|FG000|NOT COMPLETED|Overall Study||10||
59966748|NCT02480764|76084485|FG001|NOT COMPLETED|Overall Study||20||
59966749|NCT02480764|76084486|FG002|NOT COMPLETED|Overall Study||21||
59966750|NCT02487472|76084494|FG000|STARTED|Overall Study||101||
59966751|NCT02487472|76084494|FG000|COMPLETED|Overall Study||90||
59966752|NCT02487472|76084494|FG000|NOT COMPLETED|Overall Study||11||
59966753|NCT02451670|76084502|FG000|STARTED|Overall Study||5264||47
59966754|NCT02451670|76084503|FG001|STARTED|Overall Study||5083||38
59966755|NCT02451670|76084502|FG000|COMPLETED|Overall Study||4550||47
59966756|NCT02451670|76084503|FG001|COMPLETED|Overall Study||4387||38
59966757|NCT02451670|76084502|FG000|NOT COMPLETED|Overall Study||714||0
59966758|NCT02451670|76084503|FG001|NOT COMPLETED|Overall Study||696||0
59966759|NCT02486692|76084511|FG000|STARTED|Overall Study||30||
59966760|NCT02486692|76084512|FG001|STARTED|Overall Study||30||
59966761|NCT02486692|76084511|FG000|COMPLETED|Overall Study||26||
59966762|NCT02486692|76084512|FG001|COMPLETED|Overall Study||23||
59966763|NCT02486692|76084511|FG000|NOT COMPLETED|Overall Study||4||
59810142|NCT00666263|75932278|FG001|STARTED|Study Part 3 (Stabilization Phase 2)||21||
59966764|NCT02486692|76084512|FG001|NOT COMPLETED|Overall Study||7||
59966765|NCT00427193|76084520|FG000|STARTED|Overall Study||143||
59966766|NCT00427193|76084521|FG001|STARTED|Overall Study||75||
59966767|NCT00427193|76084520|FG000|COMPLETED|Overall Study||117||
59966768|NCT00427193|76084521|FG001|COMPLETED|Overall Study||71||
60074338|NCT01771250|76189714|FG000|STARTED|Period 2||7||
59810143|NCT00666263|75932277|FG000|COMPLETED|Study Part 3 (Stabilization Phase 2)||22||
59810144|NCT00666263|75932278|FG001|COMPLETED|Study Part 3 (Stabilization Phase 2)||21||
59810145|NCT00666263|75932277|FG000|NOT COMPLETED|Study Part 3 (Stabilization Phase 2)||0||
59810146|NCT00666263|75932278|FG001|NOT COMPLETED|Study Part 3 (Stabilization Phase 2)||0||
59810147|NCT00666263|75932277|FG000|STARTED|Study Part 4 (Cross-over Period 2)||22||
59810148|NCT00666263|75932278|FG001|STARTED|Study Part 4 (Cross-over Period 2)||21||
59810149|NCT00666263|75932277|FG000|COMPLETED|Study Part 4 (Cross-over Period 2)||21||
59810150|NCT00666263|75932278|FG001|COMPLETED|Study Part 4 (Cross-over Period 2)||21||
59810151|NCT00666263|75932277|FG000|NOT COMPLETED|Study Part 4 (Cross-over Period 2)||1||
59810152|NCT00666263|75932278|FG001|NOT COMPLETED|Study Part 4 (Cross-over Period 2)||0||
59810153|NCT00666263|75932277|FG000|STARTED|Study Part 5 (Stabilization Phase 3)||21||
59810154|NCT00666263|75932278|FG001|STARTED|Study Part 5 (Stabilization Phase 3)||21||
59810155|NCT00666263|75932277|FG000|COMPLETED|Study Part 5 (Stabilization Phase 3)||21||
59810156|NCT00666263|75932278|FG001|COMPLETED|Study Part 5 (Stabilization Phase 3)||20||
59810157|NCT00666263|75932277|FG000|NOT COMPLETED|Study Part 5 (Stabilization Phase 3)||0||
59810158|NCT00666263|75932278|FG001|NOT COMPLETED|Study Part 5 (Stabilization Phase 3)||1||
59810159|NCT00666263|75932277|FG000|STARTED|End of Study Visit|End of Study Visit done on all 22 randomized regardless of participation in Study Parts|22||
59810160|NCT00666263|75932278|FG001|STARTED|End of Study Visit|End of Study Visit done on all 22 randomized regardless of participation in Study Parts|22||
59810161|NCT00666263|75932277|FG000|COMPLETED|End of Study Visit||22||
59810162|NCT00666263|75932278|FG001|COMPLETED|End of Study Visit||22||
59810163|NCT00666263|75932277|FG000|NOT COMPLETED|End of Study Visit||0||
59810164|NCT00666263|75932278|FG001|NOT COMPLETED|End of Study Visit||0||
59810165|NCT00667277|75932323|FG000|STARTED|Overall Study||13||
59810166|NCT00667277|75932323|FG000|COMPLETED|Overall Study||11||
59810167|NCT00667277|75932323|FG000|NOT COMPLETED|Overall Study||2||
59810168|NCT00534638|75932329|FG000|STARTED|Overall Study||14837||
59810169|NCT00534638|75932330|FG001|STARTED|Overall Study||17338||
59810170|NCT00534638|75932329|FG000|COMPLETED|Overall Study||8346||
59810171|NCT00534638|75932330|FG001|COMPLETED|Overall Study||5547||
59810172|NCT00534638|75932329|FG000|NOT COMPLETED|Overall Study||6491||
59810173|NCT00534638|75932330|FG001|NOT COMPLETED|Overall Study||11791||
59810174|NCT00662129|75932341|FG000|STARTED|Overall Study||50||
59810175|NCT00662129|75932341|FG000|COMPLETED|Overall Study||47||
59810176|NCT00662129|75932341|FG000|NOT COMPLETED|Overall Study||3||
59810177|NCT00664859|75932348|FG000|STARTED|Overall Study||51||
59810178|NCT00664859|75932349|FG001|STARTED|Overall Study||45||
59810179|NCT00664859|75932350|FG002|STARTED|Overall Study||44||
59810180|NCT00664859|75932348|FG000|COMPLETED|Overall Study||34||
59810181|NCT00664859|75932349|FG001|COMPLETED|Overall Study||35||
59810182|NCT00664859|75932350|FG002|COMPLETED|Overall Study||23||
59810183|NCT00664859|75932348|FG000|NOT COMPLETED|Overall Study||17||
59810184|NCT00664859|75932349|FG001|NOT COMPLETED|Overall Study||10||
59810185|NCT00664859|75932350|FG002|NOT COMPLETED|Overall Study||21||
59810186|NCT00570401|75932358|FG000|STARTED|Overall Study||21||
59810187|NCT00570401|75932358|FG000|COMPLETED|Overall Study||19||
59810188|NCT00570401|75932358|FG000|NOT COMPLETED|Overall Study||2||
59810189|NCT00532298|75932368|FG000|STARTED|Overall Study||269||
59810190|NCT00532298|75932369|FG001|STARTED|Overall Study||266||
59810191|NCT00532298|75932370|FG002|STARTED|Overall Study||264||
59810192|NCT00532298|75932371|FG003|STARTED|Overall Study||264||
59810193|NCT00532298|75932372|FG004|STARTED|Overall Study||268||
59810194|NCT00532298|75932373|FG005|STARTED|Overall Study||263||
59810195|NCT00532298|75932368|FG000|COMPLETED|Overall Study||267||
59810196|NCT00532298|75932369|FG001|COMPLETED|Overall Study||265||
59810197|NCT00532298|75932370|FG002|COMPLETED|Overall Study||263||
59810198|NCT00532298|75932371|FG003|COMPLETED|Overall Study||264||
59810199|NCT00532298|75932372|FG004|COMPLETED|Overall Study||267||
59810200|NCT00532298|75932373|FG005|COMPLETED|Overall Study||261||
59810201|NCT00532298|75932368|FG000|NOT COMPLETED|Overall Study||2||
59810202|NCT00532298|75932369|FG001|NOT COMPLETED|Overall Study||1||
59810203|NCT00532298|75932370|FG002|NOT COMPLETED|Overall Study||1||
59810204|NCT00532298|75932371|FG003|NOT COMPLETED|Overall Study||0||
59810205|NCT00532298|75932372|FG004|NOT COMPLETED|Overall Study||1||
59810206|NCT00532298|75932373|FG005|NOT COMPLETED|Overall Study||2||
59810207|NCT00410410|75932393|FG000|STARTED|Induction Period (IP)||141||
59810208|NCT00410410|75932394|FG001|STARTED|Induction Period (IP)||139||
59810209|NCT00410410|75932395|FG002|STARTED|Induction Period (IP)||70||
59810210|NCT00410410|75932396|FG003|STARTED|Induction Period (IP)||140||
59810211|NCT00410410|75932397|FG004|STARTED|Induction Period (IP)||51||
59810212|NCT00410410|75932398|FG005|STARTED|Induction Period (IP)||50||
59810213|NCT00410410|75932399|FG006|STARTED|Induction Period (IP)||0||
59966769|NCT00427193|76084520|FG000|NOT COMPLETED|Overall Study||26||
59810214|NCT00410410|75932400|FG007|STARTED|Induction Period (IP)||0||
59810215|NCT00410410|75932401|FG008|STARTED|Induction Period (IP)||0||
59966770|NCT00427193|76084521|FG001|NOT COMPLETED|Overall Study||4||
59810216|NCT00410410|75932393|FG000|COMPLETED|Induction Period (IP)||106||
59810217|NCT00410410|75932394|FG001|COMPLETED|Induction Period (IP)||104||
59810218|NCT00410410|75932395|FG002|COMPLETED|Induction Period (IP)||53||
59810219|NCT00410410|75932396|FG003|COMPLETED|Induction Period (IP)||120||
59810220|NCT00410410|75932397|FG004|COMPLETED|Induction Period (IP)||19||
59966771|NCT01060007|76084529|FG000|STARTED|Overall Study||80||
59810221|NCT00410410|75932398|FG005|COMPLETED|Induction Period (IP)||21||
59810222|NCT00410410|75932399|FG006|COMPLETED|Induction Period (IP)||0||
59810223|NCT00410410|75932400|FG007|COMPLETED|Induction Period (IP)||0||
59966772|NCT01060007|76084529|FG000|COMPLETED|Overall Study||76||
59966773|NCT01060007|76084529|FG000|NOT COMPLETED|Overall Study||4||
59966774|NCT02971163|76084538|FG000|STARTED|Overall Study||24||
59966775|NCT02971163|76084539|FG001|STARTED|Overall Study||26||
59966776|NCT02971163|76084538|FG000|COMPLETED|Overall Study||20||
59966777|NCT02971163|76084539|FG001|COMPLETED|Overall Study||24||
59966778|NCT02971163|76084538|FG000|NOT COMPLETED|Overall Study||4||
59966779|NCT02971163|76084539|FG001|NOT COMPLETED|Overall Study||2||
59966780|NCT02971007|76084548|FG000|STARTED|Overall Study||46||
59966781|NCT02971007|76084549|FG001|STARTED|Overall Study||45||
59966782|NCT02971007|76084550|FG002|STARTED|Overall Study||46||
59966783|NCT02971007|76084548|FG000|COMPLETED|Overall Study||44||
59966784|NCT02971007|76084549|FG001|COMPLETED|Overall Study||42||
59966785|NCT02971007|76084550|FG002|COMPLETED|Overall Study||45||
59966786|NCT02971007|76084548|FG000|NOT COMPLETED|Overall Study||2||
59966787|NCT02971007|76084549|FG001|NOT COMPLETED|Overall Study||3||
59966788|NCT02971007|76084550|FG002|NOT COMPLETED|Overall Study||1||
59966789|NCT03881553|76084561|FG000|STARTED|Overall Study||11||
59966790|NCT03881553|76084562|FG001|STARTED|Overall Study||2||
59966791|NCT03881553|76084563|FG002|STARTED|Overall Study||4||
59966792|NCT03881553|76084561|FG000|COMPLETED|Overall Study||10||
59966793|NCT03881553|76084562|FG001|COMPLETED|Overall Study||1||
59966794|NCT03881553|76084563|FG002|COMPLETED|Overall Study||3||
59966795|NCT03881553|76084561|FG000|NOT COMPLETED|Overall Study||1||
59966796|NCT03881553|76084562|FG001|NOT COMPLETED|Overall Study||1||
59966797|NCT03881553|76084563|FG002|NOT COMPLETED|Overall Study||1||
59966798|NCT02970929|76084571|FG000|STARTED|Overall Study||157||
59966799|NCT02970929|76084571|FG000|Subjects Who Received Study Medication|Overall Study||156||
59810224|NCT00410410|75932401|FG008|COMPLETED|Induction Period (IP)||0||
59810225|NCT00410410|75932393|FG000|NOT COMPLETED|Induction Period (IP)||35||
59810226|NCT00410410|75932394|FG001|NOT COMPLETED|Induction Period (IP)||35||
59810227|NCT00410410|75932395|FG002|NOT COMPLETED|Induction Period (IP)||17||
59810228|NCT00410410|75932396|FG003|NOT COMPLETED|Induction Period (IP)||20||
59966800|NCT02970929|76084571|FG000|COMPLETED|Overall Study||105||
59966801|NCT02970929|76084571|FG000|NOT COMPLETED|Overall Study||52||
59966802|NCT00148733|76084579|FG000|STARTED|Overall Study||1314||
59966803|NCT00148733|76084580|FG001|STARTED|Overall Study||1314||
59966804|NCT00148733|76084579|FG000|COMPLETED|Overall Study||1300||
59966805|NCT00148733|76084580|FG001|COMPLETED|Overall Study||1299||
59966806|NCT00148733|76084579|FG000|NOT COMPLETED|Overall Study||14||
59966807|NCT00148733|76084580|FG001|NOT COMPLETED|Overall Study||15||
59966808|NCT02970305|76084588|FG000|STARTED|Overall Study||201||
59966809|NCT02970305|76084589|FG001|STARTED|Overall Study||202||
59966810|NCT02970305|76084588|FG000|COMPLETED|Overall Study||172||
59966811|NCT02970305|76084589|FG001|COMPLETED|Overall Study||174||
59966812|NCT02970305|76084588|FG000|NOT COMPLETED|Overall Study||29||
59966813|NCT02970305|76084589|FG001|NOT COMPLETED|Overall Study||28||
59966814|NCT03698409|76084597|FG000|STARTED|Overall Study||39||
59966815|NCT03698409|76084598|FG001|STARTED|Overall Study||29||
59966816|NCT03698409|76084597|FG000|COMPLETED|Overall Study||39||
59810229|NCT00410410|75932397|FG004|NOT COMPLETED|Induction Period (IP)||32||
59966817|NCT03698409|76084598|FG001|COMPLETED|Overall Study||29||
59966818|NCT03698409|76084597|FG000|NOT COMPLETED|Overall Study||0||
59966819|NCT03698409|76084598|FG001|NOT COMPLETED|Overall Study||0||
59966820|NCT02732691|76084604|FG000|STARTED|Overall Study||68||
59966821|NCT02732691|76084604|FG000|COMPLETED|Overall Study||68||
60074339|NCT01771250|76189715|FG001|STARTED|Period 2||7||
59810230|NCT00410410|75932398|FG005|NOT COMPLETED|Induction Period (IP)||29||
59810231|NCT00410410|75932399|FG006|NOT COMPLETED|Induction Period (IP)||0||
59810232|NCT00410410|75932400|FG007|NOT COMPLETED|Induction Period (IP)||0||
59810233|NCT00410410|75932401|FG008|NOT COMPLETED|Induction Period (IP)||0||
59810234|NCT00410410|75932393|FG000|STARTED|Maintenance Period (MP)||0||
59810235|NCT00410410|75932394|FG001|STARTED|Maintenance Period (MP)||0||
59810236|NCT00410410|75932395|FG002|STARTED|Maintenance Period (MP)||0||
59810237|NCT00410410|75932396|FG003|STARTED|Maintenance Period (MP)||0||
59966822|NCT02732691|76084604|FG000|NOT COMPLETED|Overall Study||0||
59966823|NCT02022033|76084608|FG000|STARTED|Overall Study||25||
59966824|NCT02022033|76084608|FG000|COMPLETED|Overall Study||24||
59966825|NCT02022033|76084608|FG000|NOT COMPLETED|Overall Study||1||
59966826|NCT03505671|76084614|FG000|STARTED|Overall Study||11||
59966827|NCT03505671|76084615|FG001|STARTED|Overall Study||12||
59966828|NCT03505671|76084614|FG000|COMPLETED|Overall Study||8||
59966829|NCT03505671|76084615|FG001|COMPLETED|Overall Study||11||
59966830|NCT03505671|76084614|FG000|NOT COMPLETED|Overall Study||3||
59966831|NCT03505671|76084615|FG001|NOT COMPLETED|Overall Study||1||
59966832|NCT02747433|76084623|FG000|STARTED|Overall Study||5||
59966833|NCT02747433|76084624|FG001|STARTED|Overall Study||5||
59966834|NCT02747433|76084623|FG000|COMPLETED|Overall Study||5||
59966835|NCT02747433|76084624|FG001|COMPLETED|Overall Study||5||
59966836|NCT02747433|76084623|FG000|NOT COMPLETED|Overall Study||0||
59966837|NCT02747433|76084624|FG001|NOT COMPLETED|Overall Study||0||
59525151|NCT01282723|75620383|FG000|COMPLETED|Overall Study||20||
59525152|NCT01282723|75620383|FG000|NOT COMPLETED|Overall Study||0||
59525153|NCT01572662|75620389|FG000|STARTED|Overall Study||50||
59525154|NCT01572662|75620390|FG001|STARTED|Overall Study||151||
59525155|NCT01572662|75620389|FG000|COMPLETED|Overall Study||49||
59525156|NCT01572662|75620390|FG001|COMPLETED|Overall Study||150||
59525157|NCT01572662|75620389|FG000|NOT COMPLETED|Overall Study||1||
59525158|NCT01572662|75620390|FG001|NOT COMPLETED|Overall Study||1||
59525159|NCT01258153|75620399|FG000|STARTED|Overall Study||40||
59525160|NCT01258153|75620400|FG001|STARTED|Overall Study||38||
59525161|NCT01258153|75620401|FG002|STARTED|Overall Study||37||
59525162|NCT01258153|75620399|FG000|COMPLETED|Overall Study||39||
59525163|NCT01258153|75620400|FG001|COMPLETED|Overall Study||37||
59525164|NCT01258153|75620401|FG002|COMPLETED|Overall Study||36||
59525165|NCT01258153|75620399|FG000|NOT COMPLETED|Overall Study||1||
59525166|NCT01258153|75620400|FG001|NOT COMPLETED|Overall Study||1||
59525167|NCT01258153|75620401|FG002|NOT COMPLETED|Overall Study||1||
59525168|NCT02088788|75620413|FG000|STARTED|Overall Study||135||
59525169|NCT02088788|75620414|FG001|STARTED|Overall Study||130||
59525170|NCT02088788|75620413|FG000|COMPLETED|Overall Study||105||
59525171|NCT02088788|75620414|FG001|COMPLETED|Overall Study||89||
59525172|NCT02088788|75620413|FG000|NOT COMPLETED|Overall Study||30||
59525173|NCT02088788|75620414|FG001|NOT COMPLETED|Overall Study||41||
59810238|NCT00410410|75932397|FG004|STARTED|Maintenance Period (MP)||0||
59810239|NCT00410410|75932398|FG005|STARTED|Maintenance Period (MP)||0||
59810240|NCT00410410|75932399|FG006|STARTED|Maintenance Period (MP)|At end of IP, 65 participants met response criteria and were randomly assigned to abatacept in MP.|65||
59810241|NCT00410410|75932400|FG007|STARTED|Maintenance Period (MP)|At end of IP, 66 participants met response criteria and were randomly assigned to placebo in MP.|66||
59810242|NCT00410410|75932401|FG008|STARTED|Maintenance Period (MP)||0||
59810243|NCT00410410|75932393|FG000|COMPLETED|Maintenance Period (MP)||0||
59525174|NCT02325154|75620420|FG000|STARTED|Overall Study||100||
59525175|NCT02325154|75620420|FG000|COMPLETED|Overall Study||99||
59525176|NCT02325154|75620420|FG000|NOT COMPLETED|Overall Study||1||
59525177|NCT01258387|75620432|FG000|STARTED|Overall Study||6||
59525178|NCT01258387|75620433|FG001|STARTED|Overall Study||6||
59525179|NCT01258387|75620434|FG002|STARTED|Overall Study||6||
59525180|NCT01258387|75620435|FG003|STARTED|Overall Study||6||
59525181|NCT01258387|75620436|FG004|STARTED|Overall Study||6||
59810244|NCT00410410|75932394|FG001|COMPLETED|Maintenance Period (MP)||0||
59810245|NCT00410410|75932395|FG002|COMPLETED|Maintenance Period (MP)||0||
59810246|NCT00410410|75932396|FG003|COMPLETED|Maintenance Period (MP)||0||
59810247|NCT00410410|75932397|FG004|COMPLETED|Maintenance Period (MP)||0||
59810248|NCT00410410|75932398|FG005|COMPLETED|Maintenance Period (MP)||0||
59810249|NCT00410410|75932399|FG006|COMPLETED|Maintenance Period (MP)||15||
59810250|NCT00410410|75932400|FG007|COMPLETED|Maintenance Period (MP)||11||
59810251|NCT00410410|75932401|FG008|COMPLETED|Maintenance Period (MP)||0||
59810252|NCT00410410|75932393|FG000|NOT COMPLETED|Maintenance Period (MP)||0||
59810253|NCT00410410|75932394|FG001|NOT COMPLETED|Maintenance Period (MP)||0||
59810254|NCT00410410|75932395|FG002|NOT COMPLETED|Maintenance Period (MP)||0||
59810255|NCT00410410|75932396|FG003|NOT COMPLETED|Maintenance Period (MP)||0||
59810256|NCT00410410|75932397|FG004|NOT COMPLETED|Maintenance Period (MP)||0||
59810257|NCT00410410|75932398|FG005|NOT COMPLETED|Maintenance Period (MP)||0||
59810258|NCT00410410|75932399|FG006|NOT COMPLETED|Maintenance Period (MP)||50||
59810259|NCT00410410|75932400|FG007|NOT COMPLETED|Maintenance Period (MP)||55||
59810260|NCT00410410|75932401|FG008|NOT COMPLETED|Maintenance Period (MP)||0||
59810261|NCT00410410|75932393|FG000|STARTED|Open-Label Period (OL)||0||
59810262|NCT00410410|75932394|FG001|STARTED|Open-Label Period (OL)||0||
59966838|NCT01103349|76084636|FG000|STARTED|Overall Study||95||
59966839|NCT01103349|76084637|FG001|STARTED|Overall Study||81||
59966840|NCT01103349|76084638|FG002|STARTED|Overall Study||67||
59966841|NCT01103349|76084636|FG000|COMPLETED|Overall Study||84||
59966842|NCT01103349|76084637|FG001|COMPLETED|Overall Study||74||
59966843|NCT01103349|76084638|FG002|COMPLETED|Overall Study||63||
59966844|NCT01103349|76084636|FG000|NOT COMPLETED|Overall Study||11||
59966845|NCT01103349|76084637|FG001|NOT COMPLETED|Overall Study||7||
60074340|NCT01771250|76189714|FG000|COMPLETED|Period 2||7||
59525182|NCT01258387|75620437|FG005|STARTED|Overall Study||6||
59525183|NCT01258387|75620438|FG006|STARTED|Overall Study||4||
59525184|NCT01258387|75620432|FG000|Patients Randomized to GGF2|Overall Study||4||
59525185|NCT01258387|75620433|FG001|Patients Randomized to GGF2|Overall Study||4||
59525186|NCT01258387|75620434|FG002|Patients Randomized to GGF2|Overall Study||4||
59525187|NCT01258387|75620435|FG003|Patients Randomized to GGF2|Overall Study||4||
59525188|NCT01258387|75620436|FG004|Patients Randomized to GGF2|Overall Study||4||
59525189|NCT01258387|75620437|FG005|Patients Randomized to GGF2|Overall Study||4||
59525190|NCT01258387|75620438|FG006|Patients Randomized to GGF2|Overall Study||3||
59525191|NCT01258387|75620432|FG000|Patients Randomized to Placebo|Overall Study||2||
59525192|NCT01258387|75620433|FG001|Patients Randomized to Placebo|Overall Study||2||
59966846|NCT01103349|76084638|FG002|NOT COMPLETED|Overall Study||4||
59966847|NCT02959177|76084649|FG000|STARTED|Double-Blind Treatment Phase||115||
59966848|NCT02959177|76084650|FG001|STARTED|Double-Blind Treatment Phase||114||
59966849|NCT02959177|76084651|FG002|STARTED|Double-Blind Treatment Phase||230||
59966850|NCT02959177|76084649|FG000|Received at Least 1 Dose of Study Drug|Double-Blind Treatment Phase||115||
59966851|NCT02959177|76084650|FG001|Received at Least 1 Dose of Study Drug|Double-Blind Treatment Phase||114||
59966852|NCT02959177|76084651|FG002|Received at Least 1 Dose of Study Drug|Double-Blind Treatment Phase||230||
59966853|NCT02959177|76084649|FG000|COMPLETED|Double-Blind Treatment Phase||104||
59966854|NCT02959177|76084650|FG001|COMPLETED|Double-Blind Treatment Phase||111||
59966855|NCT02959177|76084651|FG002|COMPLETED|Double-Blind Treatment Phase||225||
59966856|NCT02959177|76084649|FG000|NOT COMPLETED|Double-Blind Treatment Phase||11||
59966857|NCT02959177|76084650|FG001|NOT COMPLETED|Double-Blind Treatment Phase||3||
59966858|NCT02959177|76084651|FG002|NOT COMPLETED|Double-Blind Treatment Phase||5||
59966859|NCT02959177|76084649|FG000|STARTED|Follow-up Post Treatment Phase|Not all participants entered Post Treatment Follow-up Phase|52|Entered Post Treatment Phase|
59966860|NCT02959177|76084650|FG001|STARTED|Follow-up Post Treatment Phase|Not all participants entered Post Treatment Follow-up Phase|52|Entered Post Treatment Phase|
59966861|NCT02959177|76084651|FG002|STARTED|Follow-up Post Treatment Phase|Not all participants entered Post Treatment Follow-up Phase|100|Entered Post Treatment Phase|
59966862|NCT02959177|76084649|FG000|COMPLETED|Follow-up Post Treatment Phase||51||
59966863|NCT02959177|76084650|FG001|COMPLETED|Follow-up Post Treatment Phase||51||
59966864|NCT02959177|76084651|FG002|COMPLETED|Follow-up Post Treatment Phase||98||
59966865|NCT02959177|76084649|FG000|NOT COMPLETED|Follow-up Post Treatment Phase||1||
59966866|NCT02959177|76084650|FG001|NOT COMPLETED|Follow-up Post Treatment Phase||1||
59966867|NCT02959177|76084651|FG002|NOT COMPLETED|Follow-up Post Treatment Phase||2||
59966868|NCT04706403|76084668|FG000|STARTED|Overall Study||172||
59966869|NCT04706403|76084669|FG001|STARTED|Overall Study||121||
59966870|NCT04706403|76084670|FG002|STARTED|Overall Study||165||
59966871|NCT04706403|76084671|FG003|STARTED|Overall Study||146||
59966872|NCT04706403|76084672|FG004|STARTED|Overall Study||152||
59966873|NCT04706403|76084668|FG000|COMPLETED|Overall Study||172||
59966874|NCT04706403|76084669|FG001|COMPLETED|Overall Study||121||
59966875|NCT04706403|76084670|FG002|COMPLETED|Overall Study||164||
59966876|NCT04706403|76084671|FG003|COMPLETED|Overall Study||145||
59966877|NCT04706403|76084672|FG004|COMPLETED|Overall Study||150||
59966878|NCT04706403|76084668|FG000|NOT COMPLETED|Overall Study||0||
59966879|NCT04706403|76084669|FG001|NOT COMPLETED|Overall Study||0||
59966880|NCT04706403|76084670|FG002|NOT COMPLETED|Overall Study||1||
59966881|NCT04706403|76084671|FG003|NOT COMPLETED|Overall Study||1||
59966882|NCT04706403|76084672|FG004|NOT COMPLETED|Overall Study||2||
59966883|NCT02983617|76084686|FG000|STARTED|Overall Study||6||
59966884|NCT02983617|76084687|FG001|STARTED|Overall Study||30||
59966885|NCT02983617|76084686|FG000|COMPLETED|Overall Study||6||
59810263|NCT00410410|75932395|FG002|STARTED|Open-Label Period (OL)||0||
59810264|NCT00410410|75932396|FG003|STARTED|Open-Label Period (OL)||0||
59810265|NCT00410410|75932397|FG004|STARTED|Open-Label Period (OL)||0||
59810266|NCT00410410|75932398|FG005|STARTED|Open-Label Period (OL)||0||
59810267|NCT00410410|75932399|FG006|STARTED|Open-Label Period (OL)||0||
59810268|NCT00410410|75932400|FG007|STARTED|Open-Label Period (OL)||0||
59966886|NCT02983617|76084687|FG001|COMPLETED|Overall Study||21||
59966887|NCT02983617|76084686|FG000|NOT COMPLETED|Overall Study||0||
59810269|NCT00410410|75932401|FG008|STARTED|Open-Label Period (OL)|349 entered OL (those who completed IP but failed response criteria, or completed/relapsed on MP).|349||
59810270|NCT00410410|75932393|FG000|COMPLETED|Open-Label Period (OL)||0||
59810271|NCT00410410|75932394|FG001|COMPLETED|Open-Label Period (OL)||0||
59810272|NCT00410410|75932395|FG002|COMPLETED|Open-Label Period (OL)||0||
59810273|NCT00410410|75932396|FG003|COMPLETED|Open-Label Period (OL)||0||
59810274|NCT00410410|75932397|FG004|COMPLETED|Open-Label Period (OL)||0||
59810275|NCT00410410|75932398|FG005|COMPLETED|Open-Label Period (OL)||0||
59810276|NCT00410410|75932399|FG006|COMPLETED|Open-Label Period (OL)||0||
59810277|NCT00410410|75932400|FG007|COMPLETED|Open-Label Period (OL)||0||
59966888|NCT02983617|76084687|FG001|NOT COMPLETED|Overall Study||9||
59966889|NCT02873689|76084695|FG000|STARTED|Overall Study||109||
59966890|NCT02873689|76084696|FG001|STARTED|Overall Study||108||
59810278|NCT00410410|75932401|FG008|COMPLETED|Open-Label Period (OL)||0||
59810279|NCT00410410|75932393|FG000|NOT COMPLETED|Open-Label Period (OL)||0||
59810280|NCT00410410|75932394|FG001|NOT COMPLETED|Open-Label Period (OL)||0||
59810281|NCT00410410|75932395|FG002|NOT COMPLETED|Open-Label Period (OL)||0||
59810282|NCT00410410|75932396|FG003|NOT COMPLETED|Open-Label Period (OL)||0||
59810283|NCT00410410|75932397|FG004|NOT COMPLETED|Open-Label Period (OL)||0||
59810284|NCT00410410|75932398|FG005|NOT COMPLETED|Open-Label Period (OL)||0||
59810285|NCT00410410|75932399|FG006|NOT COMPLETED|Open-Label Period (OL)||0||
59810286|NCT00410410|75932400|FG007|NOT COMPLETED|Open-Label Period (OL)||0||
59810287|NCT00410410|75932401|FG008|NOT COMPLETED|Open-Label Period (OL)||349||
59810288|NCT00534404|75932439|FG000|STARTED|Overall Study||827||
59966891|NCT02873689|76084695|FG000|Treated|Overall Study||108||
59966892|NCT02873689|76084696|FG001|Treated|Overall Study||107||
59966893|NCT02873689|76084695|FG000|COMPLETED|Overall Study||102||
59966894|NCT02873689|76084696|FG001|COMPLETED|Overall Study||103||
59966895|NCT02873689|76084695|FG000|NOT COMPLETED|Overall Study||7||
59966896|NCT02873689|76084696|FG001|NOT COMPLETED|Overall Study||5||
59966897|NCT02901431|76084710|FG000|STARTED|PK Part||12||
59966898|NCT02901431|76084711|FG001|STARTED|PK Part||11||
59966899|NCT02901431|76084712|FG002|STARTED|PK Part||15||
59966900|NCT02901431|76084713|FG003|STARTED|PK Part||0||
59966901|NCT02901431|76084714|FG004|STARTED|PK Part||0||
59966902|NCT02901431|76084715|FG005|STARTED|PK Part||0||
59966903|NCT02901431|76084716|FG006|STARTED|PK Part||0||
59966904|NCT02901431|76084717|FG007|STARTED|PK Part||0||
59966905|NCT02901431|76084718|FG008|STARTED|PK Part||0||
59966906|NCT02901431|76084719|FG009|STARTED|PK Part||0||
59966907|NCT02901431|76084720|FG010|STARTED|PK Part||0||
59966908|NCT02901431|76084721|FG011|STARTED|PK Part||0||
59966909|NCT02901431|76084722|FG012|STARTED|PK Part||0||
59966910|NCT02901431|76084710|FG000|COMPLETED|PK Part||5||
59966911|NCT02901431|76084711|FG001|COMPLETED|PK Part||5||
59966912|NCT02901431|76084712|FG002|COMPLETED|PK Part||6||
59966913|NCT02901431|76084713|FG003|COMPLETED|PK Part||0||
59966914|NCT02901431|76084714|FG004|COMPLETED|PK Part||0||
59966915|NCT02901431|76084715|FG005|COMPLETED|PK Part||0||
59966916|NCT02901431|76084716|FG006|COMPLETED|PK Part||0||
59966917|NCT02901431|76084717|FG007|COMPLETED|PK Part||0||
59966918|NCT02901431|76084718|FG008|COMPLETED|PK Part||0||
59966919|NCT02901431|76084719|FG009|COMPLETED|PK Part||0||
59966920|NCT02901431|76084720|FG010|COMPLETED|PK Part||0||
59966921|NCT02901431|76084721|FG011|COMPLETED|PK Part||0||
59966922|NCT02901431|76084722|FG012|COMPLETED|PK Part||0||
59966923|NCT02901431|76084710|FG000|NOT COMPLETED|PK Part||7||
59966924|NCT02901431|76084711|FG001|NOT COMPLETED|PK Part||6||
59966925|NCT02901431|76084712|FG002|NOT COMPLETED|PK Part||9||
59966926|NCT02901431|76084713|FG003|NOT COMPLETED|PK Part||0||
59966927|NCT02901431|76084714|FG004|NOT COMPLETED|PK Part||0||
59966928|NCT02901431|76084715|FG005|NOT COMPLETED|PK Part||0||
59966929|NCT02901431|76084716|FG006|NOT COMPLETED|PK Part||0||
59966930|NCT02901431|76084717|FG007|NOT COMPLETED|PK Part||0||
59810289|NCT00534404|75932440|FG001|STARTED|Overall Study||830||
59810290|NCT00534404|75932441|FG002|STARTED|Overall Study||828||
59810291|NCT00534404|75932439|FG000|Completed at Least 1 Online Session|Overall Study||781||
59810292|NCT00534404|75932440|FG001|Completed at Least 1 Online Session|Overall Study||813||
59810293|NCT00534404|75932441|FG002|Completed at Least 1 Online Session|Overall Study||658||
59810294|NCT00534404|75932439|FG000|Completed First NRT Order|Overall Study||765||
59810295|NCT00534404|75932440|FG001|Completed First NRT Order|Overall Study|Participants could order NRT without completing a web session|821||
59810296|NCT00534404|75932441|FG002|Completed First NRT Order|Overall Study|NRT was not available for this arm|0||
59810297|NCT00534404|75932439|FG000|Completed Second NRT Order|Overall Study||640||
59810298|NCT00534404|75932440|FG001|Completed Second NRT Order|Overall Study||789||
59810299|NCT00534404|75932441|FG002|Completed Second NRT Order|Overall Study|NRT not available for this arm.|0||
59810300|NCT00534404|75932439|FG000|Completed at Least 1 Counseling Call|Overall Study||813||
59810301|NCT00534404|75932440|FG001|Completed at Least 1 Counseling Call|Overall Study|There was no counseling offered in this arm|0||
59810302|NCT00534404|75932441|FG002|Completed at Least 1 Counseling Call|Overall Study|There was no counseling offered in this arm|0||
59810303|NCT00534404|75932439|FG000|1-month Follow up Completed|Overall Study||742||
59810304|NCT00534404|75932440|FG001|1-month Follow up Completed|Overall Study||781||
59810305|NCT00534404|75932441|FG002|1-month Follow up Completed|Overall Study||626||
59810306|NCT00534404|75932439|FG000|3-month Follow up Completed|Overall Study||682||
59810307|NCT00534404|75932440|FG001|3-month Follow up Completed|Overall Study||731||
59810308|NCT00534404|75932441|FG002|3-month Follow up Completed|Overall Study||593||
59810309|NCT00534404|75932439|FG000|COMPLETED|Overall Study||647||
59810310|NCT00534404|75932440|FG001|COMPLETED|Overall Study||687||
59810311|NCT00534404|75932441|FG002|COMPLETED|Overall Study||586||
59810312|NCT00534404|75932439|FG000|NOT COMPLETED|Overall Study||180||
59810313|NCT00534404|75932440|FG001|NOT COMPLETED|Overall Study||143||
59810314|NCT00534404|75932441|FG002|NOT COMPLETED|Overall Study||242||
59810315|NCT00393094|75932449|FG000|STARTED|Period1Bevacizumab & Irinotecan Patients||31||
59810316|NCT00393094|75932449|FG000|COMPLETED|Period1Bevacizumab & Irinotecan Patients||30||
59810317|NCT00393094|75932449|FG000|NOT COMPLETED|Period1Bevacizumab & Irinotecan Patients||1||
59810318|NCT00393094|75932449|FG000|STARTED|Disease Progression After Trtmt: Onstudy||30||
59810319|NCT00393094|75932449|FG000|COMPLETED|Disease Progression After Trtmt: Onstudy||29||
59810320|NCT00393094|75932449|FG000|NOT COMPLETED|Disease Progression After Trtmt: Onstudy||1||
59810321|NCT00409786|75932455|FG000|STARTED|Overall Study||50||
59810322|NCT00409786|75932455|FG000|COMPLETED|Overall Study||47||
59810323|NCT00409786|75932455|FG000|NOT COMPLETED|Overall Study||3||
59817881|NCT04488770|75940333|FG007|STARTED|Part 1-Cohort 2: Period 1 (Up to 5 Days)||2||
59966931|NCT02901431|76084718|FG008|NOT COMPLETED|PK Part||0||
59966932|NCT02901431|76084719|FG009|NOT COMPLETED|PK Part||0||
59966933|NCT02901431|76084720|FG010|NOT COMPLETED|PK Part||0||
59966934|NCT02901431|76084721|FG011|NOT COMPLETED|PK Part||0||
59966935|NCT02901431|76084722|FG012|NOT COMPLETED|PK Part||0||
59966936|NCT02901431|76084710|FG000|STARTED|Main Treatment Part||0||
59966937|NCT02901431|76084711|FG001|STARTED|Main Treatment Part||0||
59966938|NCT02901431|76084712|FG002|STARTED|Main Treatment Part||0||
59966939|NCT02901431|76084713|FG003|STARTED|Main Treatment Part||112||
59966940|NCT02901431|76084714|FG004|STARTED|Main Treatment Part||57||
59966941|NCT02901431|76084715|FG005|STARTED|Main Treatment Part||66||
59966942|NCT02901431|76084716|FG006|STARTED|Main Treatment Part||66||
59966943|NCT02901431|76084717|FG007|STARTED|Main Treatment Part||7||
59966944|NCT02901431|76084718|FG008|STARTED|Main Treatment Part||0||
59810324|NCT00409708|75932461|FG000|STARTED|Treatment|A total of 142 participants were screened for the study but only 109 were randomized to treatment|53||
59810325|NCT00409708|75932462|FG001|STARTED|Treatment||56||
59810326|NCT00409708|75932461|FG000|COMPLETED|Treatment||38||
59810327|NCT00409708|75932462|FG001|COMPLETED|Treatment||39||
59810328|NCT00409708|75932461|FG000|NOT COMPLETED|Treatment||15||
59810329|NCT00409708|75932462|FG001|NOT COMPLETED|Treatment||17||
59810330|NCT00409708|75932461|FG000|STARTED|Washout||38||
59810331|NCT00409708|75932462|FG001|STARTED|Washout||39||
59810332|NCT00409708|75932461|FG000|COMPLETED|Washout||17||
59810333|NCT00409708|75932462|FG001|COMPLETED|Washout||29||
59810334|NCT00409708|75932461|FG000|NOT COMPLETED|Washout||21||
59810335|NCT00409708|75932462|FG001|NOT COMPLETED|Washout||10||
59810336|NCT00790985|75932470|FG000|STARTED|Overall Study||108||
59966945|NCT02901431|76084719|FG009|STARTED|Main Treatment Part||0||
59966946|NCT02901431|76084720|FG010|STARTED|Main Treatment Part||0||
59966947|NCT02901431|76084721|FG011|STARTED|Main Treatment Part||0||
59966948|NCT02901431|76084722|FG012|STARTED|Main Treatment Part||0||
59966949|NCT02901431|76084710|FG000|COMPLETED|Main Treatment Part||0||
59966950|NCT02901431|76084711|FG001|COMPLETED|Main Treatment Part||0||
59966951|NCT02901431|76084712|FG002|COMPLETED|Main Treatment Part||0||
59966952|NCT02901431|76084713|FG003|COMPLETED|Main Treatment Part||86||
59966953|NCT02901431|76084714|FG004|COMPLETED|Main Treatment Part||50||
59966954|NCT02901431|76084715|FG005|COMPLETED|Main Treatment Part||54||
59966955|NCT02901431|76084716|FG006|COMPLETED|Main Treatment Part||55||
59966956|NCT02901431|76084717|FG007|COMPLETED|Main Treatment Part||7||
59966957|NCT02901431|76084718|FG008|COMPLETED|Main Treatment Part||0||
59966958|NCT02901431|76084719|FG009|COMPLETED|Main Treatment Part||0||
59966959|NCT02901431|76084720|FG010|COMPLETED|Main Treatment Part||0||
59966960|NCT02901431|76084721|FG011|COMPLETED|Main Treatment Part||0||
59966961|NCT02901431|76084722|FG012|COMPLETED|Main Treatment Part||0||
59966962|NCT02901431|76084710|FG000|NOT COMPLETED|Main Treatment Part||0||
59966963|NCT02901431|76084711|FG001|NOT COMPLETED|Main Treatment Part||0||
59966964|NCT02901431|76084712|FG002|NOT COMPLETED|Main Treatment Part||0||
59966965|NCT02901431|76084713|FG003|NOT COMPLETED|Main Treatment Part||26||
59966966|NCT02901431|76084714|FG004|NOT COMPLETED|Main Treatment Part||7||
59966967|NCT02901431|76084715|FG005|NOT COMPLETED|Main Treatment Part||12||
59966968|NCT02901431|76084716|FG006|NOT COMPLETED|Main Treatment Part||11||
59966969|NCT02901431|76084717|FG007|NOT COMPLETED|Main Treatment Part||0||
59966970|NCT02901431|76084718|FG008|NOT COMPLETED|Main Treatment Part||0||
59966971|NCT02901431|76084719|FG009|NOT COMPLETED|Main Treatment Part||0||
59966972|NCT02901431|76084720|FG010|NOT COMPLETED|Main Treatment Part||0||
59966973|NCT02901431|76084721|FG011|NOT COMPLETED|Main Treatment Part||0||
59966974|NCT02901431|76084722|FG012|NOT COMPLETED|Main Treatment Part||0||
59810337|NCT00790985|75932471|FG001|STARTED|Overall Study||115||
59810338|NCT00790985|75932470|FG000|COMPLETED|Overall Study||106||
59810339|NCT00790985|75932471|FG001|COMPLETED|Overall Study||114||
59810340|NCT00790985|75932470|FG000|NOT COMPLETED|Overall Study||2||
59810341|NCT00790985|75932471|FG001|NOT COMPLETED|Overall Study||1||
59966975|NCT02901431|76084710|FG000|STARTED|Open Label Part||0||
59966976|NCT02901431|76084711|FG001|STARTED|Open Label Part||0||
59966977|NCT02901431|76084712|FG002|STARTED|Open Label Part||0||
59966978|NCT02901431|76084713|FG003|STARTED|Open Label Part||0||
59966979|NCT02901431|76084714|FG004|STARTED|Open Label Part||0||
59966980|NCT02901431|76084715|FG005|STARTED|Open Label Part||0||
59966981|NCT02901431|76084716|FG006|STARTED|Open Label Part||0||
59966982|NCT02901431|76084717|FG007|STARTED|Open Label Part||0||
59810342|NCT00391846|75932479|FG000|STARTED|Overall Study|Of the 127 randomised patients 8 were discontinued|127||
59810343|NCT00391846|75932480|FG001|STARTED|Overall Study|Of th 125 randomised patients 7 were discontinued|125||
59810344|NCT00391846|75932479|FG000|COMPLETED|Overall Study|119 completed patients includes 4 CV related deaths|119||
59810345|NCT00391846|75932480|FG001|COMPLETED|Overall Study|118 completed patients includes 5 CV related deaths|118||
59810346|NCT00391846|75932479|FG000|NOT COMPLETED|Overall Study||8||
59810347|NCT00391846|75932480|FG001|NOT COMPLETED|Overall Study||7||
59810348|NCT00448630|75932486|FG000|STARTED|Overall Study||328||
59810349|NCT00448630|75932486|FG000|COMPLETED|Overall Study|Number of patients who remained on same medication to end of study.|301||
59810350|NCT00448630|75932486|FG000|NOT COMPLETED|Overall Study||27||
59810351|NCT00534248|75932505|FG000|STARTED|Overall Study||11211||
59810352|NCT00534248|75932506|FG001|STARTED|Overall Study||11228||
59810353|NCT00534248|75932505|FG000|VACCINATED|Overall Study||11186||
59810354|NCT00534248|75932506|FG001|VACCINATED|Overall Study||11210||
59810355|NCT00534248|75932505|FG000|COMPLETED|Overall Study||10550||
59810356|NCT00534248|75932506|FG001|COMPLETED|Overall Study||10555||
59966983|NCT02901431|76084718|FG008|STARTED|Open Label Part||68||
59966984|NCT02901431|76084719|FG009|STARTED|Open Label Part||35||
59966985|NCT02901431|76084720|FG010|STARTED|Open Label Part||40||
59966986|NCT02901431|76084721|FG011|STARTED|Open Label Part||46||
59966987|NCT02901431|76084722|FG012|STARTED|Open Label Part||5||
59966988|NCT02901431|76084710|FG000|COMPLETED|Open Label Part||0||
59966989|NCT02901431|76084711|FG001|COMPLETED|Open Label Part||0||
59966990|NCT02901431|76084712|FG002|COMPLETED|Open Label Part||0||
59966991|NCT02901431|76084713|FG003|COMPLETED|Open Label Part||0||
59966992|NCT02901431|76084714|FG004|COMPLETED|Open Label Part||0||
59966993|NCT02901431|76084715|FG005|COMPLETED|Open Label Part||0||
59966994|NCT02901431|76084716|FG006|COMPLETED|Open Label Part||0||
59966995|NCT02901431|76084717|FG007|COMPLETED|Open Label Part||0||
59966996|NCT02901431|76084718|FG008|COMPLETED|Open Label Part||20||
59966997|NCT02901431|76084719|FG009|COMPLETED|Open Label Part||11||
59966998|NCT02901431|76084720|FG010|COMPLETED|Open Label Part||11||
59966999|NCT02901431|76084721|FG011|COMPLETED|Open Label Part||7||
59967000|NCT02901431|76084722|FG012|COMPLETED|Open Label Part||2||
59967001|NCT02901431|76084710|FG000|NOT COMPLETED|Open Label Part||0||
59967002|NCT02901431|76084711|FG001|NOT COMPLETED|Open Label Part||0||
59967003|NCT02901431|76084712|FG002|NOT COMPLETED|Open Label Part||0||
59967004|NCT02901431|76084713|FG003|NOT COMPLETED|Open Label Part||0||
59967005|NCT02901431|76084714|FG004|NOT COMPLETED|Open Label Part||0||
59967006|NCT02901431|76084715|FG005|NOT COMPLETED|Open Label Part||0||
59967007|NCT02901431|76084716|FG006|NOT COMPLETED|Open Label Part||0||
59967008|NCT02901431|76084717|FG007|NOT COMPLETED|Open Label Part||0||
59967009|NCT02901431|76084718|FG008|NOT COMPLETED|Open Label Part||48||
59967010|NCT02901431|76084719|FG009|NOT COMPLETED|Open Label Part||24||
59967011|NCT02901431|76084720|FG010|NOT COMPLETED|Open Label Part||29||
59967012|NCT02901431|76084721|FG011|NOT COMPLETED|Open Label Part||39||
59967013|NCT02901431|76084722|FG012|NOT COMPLETED|Open Label Part||3||
59967014|NCT02873377|76084749|FG000|STARTED|Period 1: Enrollment||65||
59967015|NCT02873377|76084750|FG001|STARTED|Period 1: Enrollment||69||
59967016|NCT02873377|76084749|FG000|COMPLETED|Period 1: Enrollment||65||
59967017|NCT02873377|76084750|FG001|COMPLETED|Period 1: Enrollment||69||
59967018|NCT02873377|76084749|FG000|NOT COMPLETED|Period 1: Enrollment||0||
59967019|NCT02873377|76084750|FG001|NOT COMPLETED|Period 1: Enrollment||0||
59967020|NCT02873377|76084749|FG000|STARTED|Period Title 2: 3 Months Follow up||65||
59967021|NCT02873377|76084750|FG001|STARTED|Period Title 2: 3 Months Follow up||69||
59967022|NCT02873377|76084749|FG000|COMPLETED|Period Title 2: 3 Months Follow up||43||
59967023|NCT02873377|76084750|FG001|COMPLETED|Period Title 2: 3 Months Follow up||47||
59967024|NCT02873377|76084749|FG000|NOT COMPLETED|Period Title 2: 3 Months Follow up||22||
59967025|NCT02873377|76084750|FG001|NOT COMPLETED|Period Title 2: 3 Months Follow up||22||
59967026|NCT02873377|76084749|FG000|STARTED|Period Title 3: 6 Months Follow up||65||
59967027|NCT02873377|76084750|FG001|STARTED|Period Title 3: 6 Months Follow up||69||
59967028|NCT02873377|76084749|FG000|COMPLETED|Period Title 3: 6 Months Follow up||50||
59967029|NCT02873377|76084750|FG001|COMPLETED|Period Title 3: 6 Months Follow up||46||
59967030|NCT02873377|76084749|FG000|NOT COMPLETED|Period Title 3: 6 Months Follow up||15||
60074341|NCT01771250|76189715|FG001|COMPLETED|Period 2||7||
59621536|NCT00353652|75733172|FG003|STARTED|First Intervention - 3 Months||7||
59967031|NCT02873377|76084750|FG001|NOT COMPLETED|Period Title 3: 6 Months Follow up||23||
59967032|NCT02966795|76084759|FG000|STARTED|Overall Study||23||
59967033|NCT02966795|76084760|FG001|STARTED|Overall Study||61||
59967034|NCT02966795|76084759|FG000|COMPLETED|Overall Study||23||
59967035|NCT02966795|76084760|FG001|COMPLETED|Overall Study||60||
59967036|NCT02966795|76084759|FG000|NOT COMPLETED|Overall Study||0||
59967037|NCT02966795|76084760|FG001|NOT COMPLETED|Overall Study||1||
59967038|NCT02873221|76084768|FG000|STARTED|Treatment Period||417||
59967039|NCT02873221|76084769|FG001|STARTED|Treatment Period||417||
59967040|NCT02873221|76084770|FG002|STARTED|Treatment Period||420||
59967041|NCT02873221|76084768|FG000|Safety Population: Received Study Drug|Treatment Period||417||
59967042|NCT02873221|76084769|FG001|Safety Population: Received Study Drug|Treatment Period||404||
59967043|NCT02873221|76084770|FG002|Safety Population: Received Study Drug|Treatment Period||409||
59967044|NCT02873221|76084768|FG000|COMPLETED|Treatment Period||329||
59967045|NCT02873221|76084769|FG001|COMPLETED|Treatment Period||291||
59967046|NCT02873221|76084770|FG002|COMPLETED|Treatment Period||315||
59967047|NCT02873221|76084768|FG000|NOT COMPLETED|Treatment Period||88||
59967048|NCT02873221|76084769|FG001|NOT COMPLETED|Treatment Period||126||
59967049|NCT02873221|76084770|FG002|NOT COMPLETED|Treatment Period||105||
59967050|NCT02873221|76084768|FG000|STARTED|Safety Follow-up Period||350||
59967051|NCT02873221|76084769|FG001|STARTED|Safety Follow-up Period||356||
59967052|NCT02873221|76084770|FG002|STARTED|Safety Follow-up Period||364||
59967053|NCT02873221|76084768|FG000|COMPLETED|Safety Follow-up Period||343||
59967054|NCT02873221|76084769|FG001|COMPLETED|Safety Follow-up Period||339||
59967055|NCT02873221|76084770|FG002|COMPLETED|Safety Follow-up Period||350||
59967056|NCT02873221|76084768|FG000|NOT COMPLETED|Safety Follow-up Period||7||
59967057|NCT02873221|76084769|FG001|NOT COMPLETED|Safety Follow-up Period||17||
59967058|NCT02873221|76084770|FG002|NOT COMPLETED|Safety Follow-up Period||14||
59967059|NCT02968979|76084778|FG000|STARTED|Overall Study||539||
59621537|NCT00353652|75733173|FG004|STARTED|First Intervention - 3 Months||3||
59967060|NCT02968979|76084778|FG000|COMPLETED|Overall Study|This cross-sectional study had only 1 visit.|531||
59967061|NCT02968979|76084778|FG000|NOT COMPLETED|Overall Study||8||
59967062|NCT02966015|76084830|FG000|STARTED|Inclusion Visit||95||
59967063|NCT02966015|76084831|FG001|STARTED|Inclusion Visit||58||
59967064|NCT02966015|76084830|FG000|COMPLETED|Inclusion Visit||87||
59967065|NCT02966015|76084831|FG001|COMPLETED|Inclusion Visit||55||
59967066|NCT02966015|76084830|FG000|NOT COMPLETED|Inclusion Visit||8||
59967067|NCT02966015|76084831|FG001|NOT COMPLETED|Inclusion Visit||3||
59967068|NCT02966015|76084830|FG000|STARTED|Test Period||87||
59967069|NCT02966015|76084831|FG001|STARTED|Test Period||55||
59967070|NCT02966015|76084830|FG000|COMPLETED|Test Period||87||
59967071|NCT02966015|76084831|FG001|COMPLETED|Test Period||55||
59967072|NCT02966015|76084830|FG000|NOT COMPLETED|Test Period||0||
59967073|NCT02966015|76084831|FG001|NOT COMPLETED|Test Period||0||
59967074|NCT02968433|76084837|FG000|STARTED|Overall Study||16||
59967075|NCT02968433|76084837|FG000|COMPLETED|Overall Study||15||
59967076|NCT02968433|76084837|FG000|NOT COMPLETED|Overall Study||1||
59967077|NCT02872285|76084849|FG000|STARTED|Overall Study||22||
59967078|NCT02872285|76084850|FG001|STARTED|Overall Study||11||
59967079|NCT02872285|76084849|FG000|COMPLETED|Overall Study||17||
59967080|NCT02872285|76084850|FG001|COMPLETED|Overall Study||9||
59967081|NCT02872285|76084849|FG000|NOT COMPLETED|Overall Study||5||
59967082|NCT02872285|76084850|FG001|NOT COMPLETED|Overall Study||2||
59967083|NCT02871739|76084860|FG000|STARTED|Overall Study||6||
59967084|NCT02871739|76084861|FG001|STARTED|Overall Study||6||
59967085|NCT02871739|76084862|FG002|STARTED|Overall Study||4||
59967086|NCT02871739|76084863|FG003|STARTED|Overall Study||7||
59967087|NCT02871739|76084860|FG000|Completed First SPI|Overall Study||3||
59967088|NCT02871739|76084861|FG001|Completed First SPI|Overall Study||5||
59967089|NCT02871739|76084862|FG002|Completed First SPI|Overall Study||4||
59967090|NCT02871739|76084863|FG003|Completed First SPI|Overall Study||6||
59967091|NCT02871739|76084860|FG000|Completed Second SPI|Overall Study||3||
59967092|NCT02871739|76084861|FG001|Completed Second SPI|Overall Study||4||
59967093|NCT02871739|76084862|FG002|Completed Second SPI|Overall Study||4||
59967094|NCT02871739|76084863|FG003|Completed Second SPI|Overall Study||5||
59967095|NCT02871739|76084860|FG000|Complete Final Survey|Overall Study||3||
59967096|NCT02871739|76084861|FG001|Complete Final Survey|Overall Study||4||
59967097|NCT02871739|76084862|FG002|Complete Final Survey|Overall Study||4||
59967098|NCT02871739|76084863|FG003|Complete Final Survey|Overall Study||5||
59967099|NCT02871739|76084860|FG000|COMPLETED|Overall Study||3||
59967100|NCT02871739|76084861|FG001|COMPLETED|Overall Study||4||
59967101|NCT02871739|76084862|FG002|COMPLETED|Overall Study||4||
59967102|NCT02871739|76084863|FG003|COMPLETED|Overall Study||5||
59967103|NCT02871739|76084860|FG000|NOT COMPLETED|Overall Study||3||
59967104|NCT02871739|76084861|FG001|NOT COMPLETED|Overall Study||2||
59967105|NCT02871739|76084862|FG002|NOT COMPLETED|Overall Study||0||
59967106|NCT02871739|76084863|FG003|NOT COMPLETED|Overall Study||2||
59967107|NCT02896361|76084873|FG000|STARTED|First Intervention (2 Weeks)||9||
59967108|NCT02896361|76084874|FG001|STARTED|First Intervention (2 Weeks)||10||
59967109|NCT02896361|76084875|FG002|STARTED|First Intervention (2 Weeks)||8||
59810357|NCT00534248|75932505|FG000|NOT COMPLETED|Overall Study||661||
59810358|NCT00534248|75932506|FG001|NOT COMPLETED|Overall Study||673||
59810359|NCT00391768|75932519|FG000|STARTED|Overall Study||12||
59810360|NCT00391768|75932520|FG001|STARTED|Overall Study||3||
59810361|NCT00391768|75932521|FG002|STARTED|Overall Study||7||
59810362|NCT00391768|75932522|FG003|STARTED|Overall Study||8||
59810363|NCT00391768|75932523|FG004|STARTED|Overall Study||24||
59810364|NCT00391768|75932524|FG005|STARTED|Overall Study||10||
59810365|NCT00391768|75932525|FG006|STARTED|Overall Study||23||
59810366|NCT00391768|75932519|FG000|COMPLETED|Overall Study||12||
59810367|NCT00391768|75932520|FG001|COMPLETED|Overall Study||3||
59810368|NCT00391768|75932521|FG002|COMPLETED|Overall Study||6||
59810369|NCT00391768|75932522|FG003|COMPLETED|Overall Study||7||
59967110|NCT02896361|76084873|FG000|COMPLETED|First Intervention (2 Weeks)||9||
59967111|NCT02896361|76084874|FG001|COMPLETED|First Intervention (2 Weeks)||10||
59967112|NCT02896361|76084875|FG002|COMPLETED|First Intervention (2 Weeks)||8||
59967113|NCT02896361|76084873|FG000|NOT COMPLETED|First Intervention (2 Weeks)||0||
59967114|NCT02896361|76084874|FG001|NOT COMPLETED|First Intervention (2 Weeks)||0||
59810370|NCT00391768|75932523|FG004|COMPLETED|Overall Study||22||
59810371|NCT00391768|75932524|FG005|COMPLETED|Overall Study||7||
59810372|NCT00391768|75932525|FG006|COMPLETED|Overall Study||19||
59810373|NCT00391768|75932519|FG000|NOT COMPLETED|Overall Study||0||
59810374|NCT00391768|75932520|FG001|NOT COMPLETED|Overall Study||0||
59810375|NCT00391768|75932521|FG002|NOT COMPLETED|Overall Study||1||
59810376|NCT00391768|75932522|FG003|NOT COMPLETED|Overall Study||1||
59810377|NCT00391768|75932523|FG004|NOT COMPLETED|Overall Study||2||
59810378|NCT00391768|75932524|FG005|NOT COMPLETED|Overall Study||3||
59810379|NCT00391768|75932525|FG006|NOT COMPLETED|Overall Study||4||
59967115|NCT02896361|76084875|FG002|NOT COMPLETED|First Intervention (2 Weeks)||0||
59967116|NCT02896361|76084873|FG000|STARTED|Second Intervention (2 Weeks)||9||
59967117|NCT02896361|76084874|FG001|STARTED|Second Intervention (2 Weeks)||10||
59967118|NCT02896361|76084875|FG002|STARTED|Second Intervention (2 Weeks)||8||
59967119|NCT02896361|76084873|FG000|COMPLETED|Second Intervention (2 Weeks)||9||
59967120|NCT02896361|76084874|FG001|COMPLETED|Second Intervention (2 Weeks)||10||
59810380|NCT00391222|75932562|FG000|STARTED|Period II (Open-label Risperidone LAI)||0||
59967121|NCT02896361|76084875|FG002|COMPLETED|Second Intervention (2 Weeks)||8||
59967122|NCT02896361|76084873|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||0||
59967123|NCT02896361|76084874|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||0||
59810381|NCT00391222|75932563|FG001|STARTED|Period II (Open-label Risperidone LAI)||0||
59810382|NCT00391222|75932564|FG002|STARTED|Period II (Open-label Risperidone LAI)||0||
59817882|NCT04488770|75940334|FG008|STARTED|Part 1-Cohort 2: Period 1 (Up to 5 Days)||0||
59967124|NCT02896361|76084875|FG002|NOT COMPLETED|Second Intervention (2 Weeks)||0||
59967125|NCT02896361|76084873|FG000|STARTED|Third Intervention (2 Weeks)||9||
59967126|NCT02896361|76084874|FG001|STARTED|Third Intervention (2 Weeks)||10||
59967127|NCT02896361|76084875|FG002|STARTED|Third Intervention (2 Weeks)||8||
59967128|NCT02896361|76084873|FG000|COMPLETED|Third Intervention (2 Weeks)||8||
59967129|NCT02896361|76084874|FG001|COMPLETED|Third Intervention (2 Weeks)||9||
59967130|NCT02896361|76084875|FG002|COMPLETED|Third Intervention (2 Weeks)||8||
59967131|NCT02896361|76084873|FG000|NOT COMPLETED|Third Intervention (2 Weeks)||1||
59967132|NCT02896361|76084874|FG001|NOT COMPLETED|Third Intervention (2 Weeks)||1||
59967133|NCT02896361|76084875|FG002|NOT COMPLETED|Third Intervention (2 Weeks)||0||
59967134|NCT03703895|76084889|FG000|STARTED|Overall Study||15||
59967135|NCT03703895|76084890|FG001|STARTED|Overall Study||5||
59967136|NCT03703895|76084889|FG000|COMPLETED|Overall Study||15||
59967137|NCT03703895|76084890|FG001|COMPLETED|Overall Study||5||
59967138|NCT03703895|76084889|FG000|NOT COMPLETED|Overall Study||0||
59967139|NCT03703895|76084890|FG001|NOT COMPLETED|Overall Study||0||
59967140|NCT02962739|76084898|FG000|STARTED|Overall Study||6||
59967141|NCT02962739|76084899|FG001|STARTED|Overall Study||7||
59967142|NCT02962739|76084900|FG002|STARTED|Overall Study||7||
59967143|NCT02962739|76084901|FG003|STARTED|Overall Study||6||
59967144|NCT02962739|76084902|FG004|STARTED|Overall Study||6||
59967145|NCT02962739|76084903|FG005|STARTED|Overall Study||6||
59967146|NCT02962739|76084898|FG000|COMPLETED|Overall Study||6||
59967147|NCT02962739|76084899|FG001|COMPLETED|Overall Study||6||
59967148|NCT02962739|76084900|FG002|COMPLETED|Overall Study||6||
59967149|NCT02962739|76084901|FG003|COMPLETED|Overall Study||6||
59967150|NCT02962739|76084902|FG004|COMPLETED|Overall Study||5||
59967151|NCT02962739|76084903|FG005|COMPLETED|Overall Study||6||
59967152|NCT02962739|76084898|FG000|NOT COMPLETED|Overall Study||0||
59967153|NCT02962739|76084899|FG001|NOT COMPLETED|Overall Study||1||
59967154|NCT02962739|76084900|FG002|NOT COMPLETED|Overall Study||1||
59967155|NCT02962739|76084901|FG003|NOT COMPLETED|Overall Study||0||
59967156|NCT02962739|76084902|FG004|NOT COMPLETED|Overall Study||1||
59967157|NCT02962739|76084903|FG005|NOT COMPLETED|Overall Study||0||
59967158|NCT01344629|76084911|FG000|STARTED|Crossover Period 1||32||
59967159|NCT01344629|76084912|FG001|STARTED|Crossover Period 1||32||
59967160|NCT01344629|76084911|FG000|COMPLETED|Crossover Period 1||32||
59967161|NCT01344629|76084912|FG001|COMPLETED|Crossover Period 1||32||
59967162|NCT01344629|76084911|FG000|NOT COMPLETED|Crossover Period 1||0||
59967163|NCT01344629|76084912|FG001|NOT COMPLETED|Crossover Period 1||0||
59967164|NCT01344629|76084911|FG000|STARTED|Crossover Period 2||32||
59967165|NCT01344629|76084912|FG001|STARTED|Crossover Period 2||32||
59967166|NCT01344629|76084911|FG000|COMPLETED|Crossover Period 2||32||
59967167|NCT01344629|76084912|FG001|COMPLETED|Crossover Period 2||31||
59967168|NCT01344629|76084911|FG000|NOT COMPLETED|Crossover Period 2||0||
59967169|NCT01344629|76084912|FG001|NOT COMPLETED|Crossover Period 2||1||
59967170|NCT01344629|76084911|FG000|STARTED|Crossover Period 3||32||
59967171|NCT01344629|76084912|FG001|STARTED|Crossover Period 3||31||
59967172|NCT01344629|76084911|FG000|COMPLETED|Crossover Period 3||32||
59967173|NCT01344629|76084912|FG001|COMPLETED|Crossover Period 3||31||
59967174|NCT01344629|76084911|FG000|NOT COMPLETED|Crossover Period 3||0||
59967175|NCT01344629|76084912|FG001|NOT COMPLETED|Crossover Period 3||0||
59967176|NCT01344629|76084911|FG000|STARTED|Crossover Period 4||32||
59967177|NCT01344629|76084912|FG001|STARTED|Crossover Period 4||31||
59967178|NCT01344629|76084911|FG000|COMPLETED|Crossover Period 4||32||
59967179|NCT01344629|76084912|FG001|COMPLETED|Crossover Period 4||31||
59967180|NCT01344629|76084911|FG000|NOT COMPLETED|Crossover Period 4||0||
59967181|NCT01344629|76084912|FG001|NOT COMPLETED|Crossover Period 4||0||
59525193|NCT01258387|75620434|FG002|Patients Randomized to Placebo|Overall Study||2||
59525194|NCT01258387|75620435|FG003|Patients Randomized to Placebo|Overall Study||2||
59525195|NCT01258387|75620436|FG004|Patients Randomized to Placebo|Overall Study||2||
59967182|NCT01092117|76084918|FG000|STARTED|Index Procedure to 1 Month||161||
59967183|NCT01092117|76084918|FG000|COMPLETED|Index Procedure to 1 Month||160||
59967184|NCT01092117|76084918|FG000|NOT COMPLETED|Index Procedure to 1 Month||1||
59525196|NCT01258387|75620437|FG005|Patients Randomized to Placebo|Overall Study||2||
59525197|NCT01258387|75620438|FG006|Patients Randomized to Placebo|Overall Study||1||
59525198|NCT01258387|75620432|FG000|COMPLETED|Overall Study||6||
59525199|NCT01258387|75620433|FG001|COMPLETED|Overall Study||6||
59525200|NCT01258387|75620434|FG002|COMPLETED|Overall Study||6||
59525201|NCT01258387|75620435|FG003|COMPLETED|Overall Study||6||
59525202|NCT01258387|75620436|FG004|COMPLETED|Overall Study||6||
59967185|NCT01092117|76084918|FG000|STARTED|1 Month||160||
59967186|NCT01092117|76084918|FG000|COMPLETED|1 Month||157||
59967187|NCT01092117|76084918|FG000|NOT COMPLETED|1 Month||3||
59967188|NCT01092117|76084918|FG000|STARTED|6 Months||157||
59967189|NCT01092117|76084918|FG000|COMPLETED|6 Months||152||
59967190|NCT01092117|76084918|FG000|NOT COMPLETED|6 Months||5||
59967191|NCT01092117|76084918|FG000|STARTED|12 Month||152||
59967192|NCT01092117|76084918|FG000|COMPLETED|12 Month||138||
59967193|NCT01092117|76084918|FG000|NOT COMPLETED|12 Month||14||
59967194|NCT01092117|76084918|FG000|STARTED|Year 2||138||
59967195|NCT01092117|76084918|FG000|COMPLETED|Year 2||128||
59967196|NCT01092117|76084918|FG000|NOT COMPLETED|Year 2||10||
59967197|NCT01092117|76084918|FG000|STARTED|Year 3||128||
59967198|NCT01092117|76084918|FG000|COMPLETED|Year 3||109||
59967199|NCT01092117|76084918|FG000|NOT COMPLETED|Year 3||19||
59967200|NCT01092117|76084918|FG000|STARTED|Year 4||109||
59967201|NCT01092117|76084918|FG000|COMPLETED|Year 4||93||
59967202|NCT01092117|76084918|FG000|NOT COMPLETED|Year 4||16||
59967203|NCT01543256|76084924|FG000|STARTED|Overall Study||80||
59967204|NCT01543256|76084925|FG001|STARTED|Overall Study||84||
59967205|NCT01543256|76084924|FG000|COMPLETED|Overall Study||62||
59967206|NCT01543256|76084925|FG001|COMPLETED|Overall Study||70||
59967207|NCT01543256|76084924|FG000|NOT COMPLETED|Overall Study||18||
59967208|NCT01543256|76084925|FG001|NOT COMPLETED|Overall Study||14||
59967209|NCT01065779|76084931|FG000|STARTED|Overall Study||880||
59967210|NCT01065779|76084931|FG000|COMPLETED|Overall Study||798||
59967211|NCT01065779|76084931|FG000|NOT COMPLETED|Overall Study||82||
59967212|NCT02963441|76084935|FG000|STARTED|Overall Study||900||
59967213|NCT02963441|76084935|FG000|COMPLETED|Overall Study||819||
59967214|NCT02963441|76084935|FG000|NOT COMPLETED|Overall Study||81||
59967215|NCT01345253|76084942|FG000|STARTED|Double-blind (DB) Phase (52 Weeks)||226||
59967216|NCT01345253|76084943|FG001|STARTED|Double-blind (DB) Phase (52 Weeks)||451||
59967217|NCT01345253|76084942|FG000|COMPLETED|Double-blind (DB) Phase (52 Weeks)||170||
59967218|NCT01345253|76084943|FG001|COMPLETED|Double-blind (DB) Phase (52 Weeks)||372||
59967219|NCT01345253|76084942|FG000|NOT COMPLETED|Double-blind (DB) Phase (52 Weeks)||56||
59967220|NCT01345253|76084943|FG001|NOT COMPLETED|Double-blind (DB) Phase (52 Weeks)||79||
59967221|NCT01345253|76084942|FG000|STARTED|Open-label Phase (Up to Year 5 Week 44)|Only eligible China par. enrolled in OL phase from MITT + additional 9 China par. from Safety Pop|134||
59967222|NCT01345253|76084943|FG001|STARTED|Open-label Phase (Up to Year 5 Week 44)|Only eligible China par. enrolled in OL phase from MITT + additional 16 China par. from Safety Pop|290||
59967223|NCT01345253|76084942|FG000|COMPLETED|Open-label Phase (Up to Year 5 Week 44)||69||
59967224|NCT01345253|76084943|FG001|COMPLETED|Open-label Phase (Up to Year 5 Week 44)||146||
59967225|NCT01345253|76084942|FG000|NOT COMPLETED|Open-label Phase (Up to Year 5 Week 44)||65||
59967226|NCT01345253|76084943|FG001|NOT COMPLETED|Open-label Phase (Up to Year 5 Week 44)||144||
59967227|NCT02477800|76084954|FG000|STARTED|Placebo-Controlled Period||545||
59967228|NCT02477800|76084955|FG001|STARTED|Placebo-Controlled Period||547||
59967229|NCT02477800|76084956|FG002|STARTED|Placebo-Controlled Period||555||
59967230|NCT02477800|76084957|FG003|STARTED|Placebo-Controlled Period||0||
59967231|NCT02477800|76084958|FG004|STARTED|Placebo-Controlled Period||0||
59967232|NCT02477800|76084959|FG005|STARTED|Placebo-Controlled Period||0||
59967233|NCT02477800|76084960|FG006|STARTED|Placebo-Controlled Period||0||
59967234|NCT02477800|76084954|FG000|COMPLETED|Placebo-Controlled Period||325||
59967235|NCT02477800|76084955|FG001|COMPLETED|Placebo-Controlled Period||325||
59967236|NCT02477800|76084956|FG002|COMPLETED|Placebo-Controlled Period||288||
59967237|NCT02477800|76084957|FG003|COMPLETED|Placebo-Controlled Period||0||
59967238|NCT02477800|76084958|FG004|COMPLETED|Placebo-Controlled Period||0||
59967239|NCT02477800|76084959|FG005|COMPLETED|Placebo-Controlled Period||0||
59967240|NCT02477800|76084960|FG006|COMPLETED|Placebo-Controlled Period||0||
59967241|NCT02477800|76084954|FG000|NOT COMPLETED|Placebo-Controlled Period||220||
59967242|NCT02477800|76084955|FG001|NOT COMPLETED|Placebo-Controlled Period||222||
59967243|NCT02477800|76084956|FG002|NOT COMPLETED|Placebo-Controlled Period||267||
59967244|NCT02477800|76084957|FG003|NOT COMPLETED|Placebo-Controlled Period||0||
59967245|NCT02477800|76084958|FG004|NOT COMPLETED|Placebo-Controlled Period||0||
59967246|NCT02477800|76084959|FG005|NOT COMPLETED|Placebo-Controlled Period||0||
59967247|NCT02477800|76084960|FG006|NOT COMPLETED|Placebo-Controlled Period||0||
59967248|NCT02477800|76084954|FG000|STARTED|Long Term Extension Period||0||
59967249|NCT02477800|76084955|FG001|STARTED|Long Term Extension Period||0||
59967250|NCT02477800|76084956|FG002|STARTED|Long Term Extension Period||0||
59967251|NCT02477800|76084957|FG003|STARTED|Long Term Extension Period|12 PC completers did not enter LTE.|150||
59967252|NCT02477800|76084958|FG004|STARTED|Long Term Extension Period|11 PC completers did not enter LTE.|152||
59967253|NCT02477800|76084959|FG005|STARTED|Long Term Extension Period|26 PC completers did not enter LTE.|299||
59995318|NCT04140396|76111162|FG000|NOT COMPLETED|Overall Study||0||
59967254|NCT02477800|76084960|FG006|STARTED|Long Term Extension Period|37 PC completers did not enter LTE.|251||
59967255|NCT02477800|76084954|FG000|COMPLETED|Long Term Extension Period||0||
59967256|NCT02477800|76084955|FG001|COMPLETED|Long Term Extension Period||0||
59967257|NCT02477800|76084956|FG002|COMPLETED|Long Term Extension Period||0||
59967258|NCT02477800|76084957|FG003|COMPLETED|Long Term Extension Period||0||
59967259|NCT02477800|76084958|FG004|COMPLETED|Long Term Extension Period||0||
59967260|NCT02477800|76084959|FG005|COMPLETED|Long Term Extension Period||0||
59967261|NCT02477800|76084960|FG006|COMPLETED|Long Term Extension Period||0||
59967262|NCT02477800|76084954|FG000|NOT COMPLETED|Long Term Extension Period||0||
59967263|NCT02477800|76084955|FG001|NOT COMPLETED|Long Term Extension Period||0||
59967264|NCT02477800|76084956|FG002|NOT COMPLETED|Long Term Extension Period||0||
59967265|NCT02477800|76084957|FG003|NOT COMPLETED|Long Term Extension Period||150||
59967266|NCT02477800|76084958|FG004|NOT COMPLETED|Long Term Extension Period||152||
59967267|NCT02477800|76084959|FG005|NOT COMPLETED|Long Term Extension Period||299||
59967268|NCT02477800|76084960|FG006|NOT COMPLETED|Long Term Extension Period||251||
59967269|NCT02957747|76084974|FG000|STARTED|Overall Study||76||
59967270|NCT02957747|76084975|FG001|STARTED|Overall Study||77||
59967271|NCT02957747|76084974|FG000|COMPLETED|Overall Study||66||
59967272|NCT02957747|76084975|FG001|COMPLETED|Overall Study||69||
59967273|NCT02957747|76084974|FG000|NOT COMPLETED|Overall Study||10||
59967274|NCT02957747|76084975|FG001|NOT COMPLETED|Overall Study||8||
59967275|NCT01344161|76084984|FG000|STARTED|Overall Study||43||
59967276|NCT01344161|76084985|FG001|STARTED|Overall Study||42||
59810383|NCT00391222|75932565|FG003|STARTED|Period II (Open-label Risperidone LAI)|The 25 patients at the site of Dr. Parikh were excluded from the analysis due to GCP non-compliance|560||
59810384|NCT00391222|75932562|FG000|COMPLETED|Period II (Open-label Risperidone LAI)||0||
59810385|NCT00391222|75932563|FG001|COMPLETED|Period II (Open-label Risperidone LAI)||0||
59810386|NCT00391222|75932564|FG002|COMPLETED|Period II (Open-label Risperidone LAI)||0||
59967277|NCT01344161|76084984|FG000|COMPLETED|Overall Study||38||
59967278|NCT01344161|76084985|FG001|COMPLETED|Overall Study||39||
59967279|NCT01344161|76084984|FG000|NOT COMPLETED|Overall Study||5||
59967280|NCT01344161|76084985|FG001|NOT COMPLETED|Overall Study||3||
59967281|NCT02451358|76084995|FG000|STARTED|Overall Study||100||
59967282|NCT02451358|76084996|FG001|STARTED|Overall Study||100||
59967283|NCT02451358|76084997|FG002|STARTED|Overall Study||100||
59967284|NCT02451358|76084998|FG003|STARTED|Overall Study||100||
59967285|NCT02451358|76084995|FG000|Vaccinated at Day 0|Overall Study||100||
59967286|NCT02451358|76084996|FG001|Vaccinated at Day 0|Overall Study||100||
59967287|NCT02451358|76084997|FG002|Vaccinated at Day 0|Overall Study||100||
59967288|NCT02451358|76084998|FG003|Vaccinated at Day 0|Overall Study||100||
59967289|NCT02451358|76084995|FG000|Vaccinated at Day 28|Overall Study||99||
59967290|NCT02451358|76084996|FG001|Vaccinated at Day 28|Overall Study||98||
59810387|NCT00391222|75932565|FG003|COMPLETED|Period II (Open-label Risperidone LAI)||398||
59810388|NCT00391222|75932562|FG000|NOT COMPLETED|Period II (Open-label Risperidone LAI)||0||
59810389|NCT00391222|75932563|FG001|NOT COMPLETED|Period II (Open-label Risperidone LAI)||0||
59810390|NCT00391222|75932564|FG002|NOT COMPLETED|Period II (Open-label Risperidone LAI)||0||
59810391|NCT00391222|75932565|FG003|NOT COMPLETED|Period II (Open-label Risperidone LAI)||162||
59810392|NCT00391222|75932562|FG000|STARTED|Period III (Double-Blind Treatment)|Patients were randomized to one of 3 arms in Period III, after completing open-label Period II|132||
59810393|NCT00391222|75932563|FG001|STARTED|Period III (Double-Blind Treatment)|Patients were randomized to one of 3 arms in Period III, after completing open-label Period II|135||
59810394|NCT00391222|75932564|FG002|STARTED|Period III (Double-Blind Treatment)|Patients were randomized to one of 3 arms in Period III, after completing open-label Period II|131||
59967291|NCT02451358|76084997|FG002|Vaccinated at Day 28|Overall Study|Participants aged 9 years and older received only 1 dose of Quadrivalent Influenza Vaccine.|0||
59967292|NCT02451358|76084998|FG003|Vaccinated at Day 28|Overall Study|Participants aged 9 years and older received only 1 dose of Quadrivalent Influenza Vaccine.|0||
59967293|NCT02451358|76084995|FG000|COMPLETED|Overall Study||99||
59967294|NCT02451358|76084996|FG001|COMPLETED|Overall Study||98||
59967295|NCT02451358|76084997|FG002|COMPLETED|Overall Study||99||
59967296|NCT02451358|76084998|FG003|COMPLETED|Overall Study||100||
59967297|NCT02451358|76084995|FG000|NOT COMPLETED|Overall Study||1||
59967298|NCT02451358|76084996|FG001|NOT COMPLETED|Overall Study||2||
59967299|NCT02451358|76084997|FG002|NOT COMPLETED|Overall Study||1||
59967300|NCT02451358|76084998|FG003|NOT COMPLETED|Overall Study||0||
59967301|NCT02749721|76085008|FG000|STARTED|Screening||31||
59967302|NCT02749721|76085008|FG000|COMPLETED|Screening||25||
59967303|NCT02749721|76085008|FG000|NOT COMPLETED|Screening||6||
59967304|NCT02749721|76085008|FG000|STARTED|8-week Open-Label Treatment Phase||25||
59967305|NCT02749721|76085008|FG000|COMPLETED|8-week Open-Label Treatment Phase||22||
59967306|NCT02749721|76085008|FG000|NOT COMPLETED|8-week Open-Label Treatment Phase||3||
59967307|NCT01348139|76085014|FG000|STARTED|Period 1||5||
59967308|NCT01348139|76085015|FG001|STARTED|Period 1||4||
59967309|NCT01348139|76085016|FG002|STARTED|Period 1||4||
59967310|NCT01348139|76085017|FG003|STARTED|Period 1||4||
59967311|NCT01348139|76085018|FG004|STARTED|Period 1||5||
59967312|NCT01348139|76085019|FG005|STARTED|Period 1||4||
59967313|NCT01348139|76085014|FG000|COMPLETED|Period 1||4||
59967314|NCT01348139|76085015|FG001|COMPLETED|Period 1||4||
60074342|NCT01771250|76189714|FG000|NOT COMPLETED|Period 2||0||
59967315|NCT01348139|76085016|FG002|COMPLETED|Period 1||4||
59967316|NCT01348139|76085017|FG003|COMPLETED|Period 1||4||
59967317|NCT01348139|76085018|FG004|COMPLETED|Period 1||5||
59967318|NCT01348139|76085019|FG005|COMPLETED|Period 1||4||
59967319|NCT01348139|76085014|FG000|NOT COMPLETED|Period 1||1||
59967320|NCT01348139|76085015|FG001|NOT COMPLETED|Period 1||0||
59967321|NCT01348139|76085016|FG002|NOT COMPLETED|Period 1||0||
59967322|NCT01348139|76085017|FG003|NOT COMPLETED|Period 1||0||
59967323|NCT01348139|76085018|FG004|NOT COMPLETED|Period 1||0||
59967324|NCT01348139|76085019|FG005|NOT COMPLETED|Period 1||0||
59967325|NCT01348139|76085014|FG000|STARTED|Period 2||4||
59967326|NCT01348139|76085015|FG001|STARTED|Period 2||4||
59967327|NCT01348139|76085016|FG002|STARTED|Period 2||4||
59967328|NCT01348139|76085017|FG003|STARTED|Period 2||4||
59967329|NCT01348139|76085018|FG004|STARTED|Period 2||5||
59967330|NCT01348139|76085019|FG005|STARTED|Period 2||4||
59967331|NCT01348139|76085014|FG000|COMPLETED|Period 2||4||
59967332|NCT01348139|76085015|FG001|COMPLETED|Period 2||4||
59967333|NCT01348139|76085016|FG002|COMPLETED|Period 2||4||
59967334|NCT01348139|76085017|FG003|COMPLETED|Period 2||4||
59967335|NCT01348139|76085018|FG004|COMPLETED|Period 2||5||
59967336|NCT01348139|76085019|FG005|COMPLETED|Period 2||4||
59967337|NCT01348139|76085014|FG000|NOT COMPLETED|Period 2||0||
59967338|NCT01348139|76085015|FG001|NOT COMPLETED|Period 2||0||
59967339|NCT01348139|76085016|FG002|NOT COMPLETED|Period 2||0||
59967340|NCT01348139|76085017|FG003|NOT COMPLETED|Period 2||0||
59967341|NCT01348139|76085018|FG004|NOT COMPLETED|Period 2||0||
59967342|NCT01348139|76085019|FG005|NOT COMPLETED|Period 2||0||
59967343|NCT01348139|76085014|FG000|STARTED|Period 3||4||
59967344|NCT01348139|76085015|FG001|STARTED|Period 3||4||
59967345|NCT01348139|76085016|FG002|STARTED|Period 3||4||
59967346|NCT01348139|76085017|FG003|STARTED|Period 3||4||
59967347|NCT01348139|76085018|FG004|STARTED|Period 3||5||
59967348|NCT01348139|76085019|FG005|STARTED|Period 3||4||
59967349|NCT01348139|76085014|FG000|COMPLETED|Period 3||4||
59967350|NCT01348139|76085015|FG001|COMPLETED|Period 3||4||
59967351|NCT01348139|76085016|FG002|COMPLETED|Period 3||4||
59810395|NCT00391222|75932565|FG003|STARTED|Period III (Double-Blind Treatment)||0||
59810396|NCT00391222|75932562|FG000|COMPLETED|Period III (Double-Blind Treatment)||104||
59810397|NCT00391222|75932563|FG001|COMPLETED|Period III (Double-Blind Treatment)||113||
59810398|NCT00391222|75932564|FG002|COMPLETED|Period III (Double-Blind Treatment)||108||
59810399|NCT00391222|75932565|FG003|COMPLETED|Period III (Double-Blind Treatment)||0||
59810400|NCT00391222|75932562|FG000|NOT COMPLETED|Period III (Double-Blind Treatment)||28||
59810401|NCT00391222|75932563|FG001|NOT COMPLETED|Period III (Double-Blind Treatment)||22||
59810402|NCT00391222|75932564|FG002|NOT COMPLETED|Period III (Double-Blind Treatment)||23||
59810403|NCT00391222|75932565|FG003|NOT COMPLETED|Period III (Double-Blind Treatment)||0||
59810404|NCT00409006|75932577|FG000|STARTED|Overall Study||39||
59810405|NCT00409006|75932578|FG001|STARTED|Overall Study||31||
59810406|NCT00409006|75932577|FG000|COMPLETED|Overall Study||19||
59810407|NCT00409006|75932578|FG001|COMPLETED|Overall Study||19||
59810408|NCT00409006|75932577|FG000|NOT COMPLETED|Overall Study||20||
59810409|NCT00409006|75932578|FG001|NOT COMPLETED|Overall Study||12||
59810410|NCT00534092|75932586|FG000|STARTED|Overall Study||55||
59810411|NCT00534092|75932587|FG001|STARTED|Overall Study||14||
59967352|NCT01348139|76085017|FG003|COMPLETED|Period 3||4||
60074343|NCT01771250|76189715|FG001|NOT COMPLETED|Period 2||0||
59810412|NCT00534092|75932586|FG000|COMPLETED|Overall Study||53||
59810413|NCT00534092|75932587|FG001|COMPLETED|Overall Study||14||
59810414|NCT00534092|75932586|FG000|NOT COMPLETED|Overall Study||2||
59810415|NCT00534092|75932587|FG001|NOT COMPLETED|Overall Study||0||
59810416|NCT00408928|75932595|FG000|STARTED|Overall Study||11||
59967353|NCT01348139|76085018|FG004|COMPLETED|Period 3||5||
59967354|NCT01348139|76085019|FG005|COMPLETED|Period 3||4||
59967355|NCT01348139|76085014|FG000|NOT COMPLETED|Period 3||0||
59967356|NCT01348139|76085015|FG001|NOT COMPLETED|Period 3||0||
59967357|NCT01348139|76085016|FG002|NOT COMPLETED|Period 3||0||
59967358|NCT01348139|76085017|FG003|NOT COMPLETED|Period 3||0||
59967359|NCT01348139|76085018|FG004|NOT COMPLETED|Period 3||0||
59967360|NCT01348139|76085019|FG005|NOT COMPLETED|Period 3||0||
59967361|NCT01348139|76085014|FG000|STARTED|Period 4||4||
59967362|NCT01348139|76085015|FG001|STARTED|Period 4||4||
59967363|NCT01348139|76085016|FG002|STARTED|Period 4||4||
59967364|NCT01348139|76085017|FG003|STARTED|Period 4||4||
59967365|NCT01348139|76085018|FG004|STARTED|Period 4||5||
59967366|NCT01348139|76085019|FG005|STARTED|Period 4||4||
59967367|NCT01348139|76085014|FG000|COMPLETED|Period 4||4||
59967368|NCT01348139|76085015|FG001|COMPLETED|Period 4||4||
59967369|NCT01348139|76085016|FG002|COMPLETED|Period 4||4||
59967370|NCT01348139|76085017|FG003|COMPLETED|Period 4||4||
59967371|NCT01348139|76085018|FG004|COMPLETED|Period 4||5||
59967372|NCT01348139|76085019|FG005|COMPLETED|Period 4||4||
60103598|NCT04075734|76221849|FG001|NOT COMPLETED|Overall Study||1||
59967373|NCT01348139|76085014|FG000|NOT COMPLETED|Period 4||0||
59967374|NCT01348139|76085015|FG001|NOT COMPLETED|Period 4||0||
59967375|NCT01348139|76085016|FG002|NOT COMPLETED|Period 4||0||
59967376|NCT01348139|76085017|FG003|NOT COMPLETED|Period 4||0||
59967377|NCT01348139|76085018|FG004|NOT COMPLETED|Period 4||0||
59967378|NCT01348139|76085019|FG005|NOT COMPLETED|Period 4||0||
59967379|NCT01348139|76085014|FG000|STARTED|Period 5||4||
59967380|NCT01348139|76085015|FG001|STARTED|Period 5||4||
59967381|NCT01348139|76085016|FG002|STARTED|Period 5||4||
59967382|NCT01348139|76085017|FG003|STARTED|Period 5||4||
59967383|NCT01348139|76085018|FG004|STARTED|Period 5||5||
59967384|NCT01348139|76085019|FG005|STARTED|Period 5||4||
59967385|NCT01348139|76085014|FG000|COMPLETED|Period 5||4||
59967386|NCT01348139|76085015|FG001|COMPLETED|Period 5||4||
59967387|NCT01348139|76085016|FG002|COMPLETED|Period 5||4||
59967388|NCT01348139|76085017|FG003|COMPLETED|Period 5||4||
59967389|NCT01348139|76085018|FG004|COMPLETED|Period 5||5||
59967390|NCT01348139|76085019|FG005|COMPLETED|Period 5||4||
59967391|NCT01348139|76085014|FG000|NOT COMPLETED|Period 5||0||
59967392|NCT01348139|76085015|FG001|NOT COMPLETED|Period 5||0||
59967393|NCT01348139|76085016|FG002|NOT COMPLETED|Period 5||0||
59967394|NCT01348139|76085017|FG003|NOT COMPLETED|Period 5||0||
59967395|NCT01348139|76085018|FG004|NOT COMPLETED|Period 5||0||
59967396|NCT01348139|76085019|FG005|NOT COMPLETED|Period 5||0||
59967397|NCT01348139|76085014|FG000|STARTED|Period 6||4||
59967398|NCT01348139|76085015|FG001|STARTED|Period 6||4||
59967399|NCT01348139|76085016|FG002|STARTED|Period 6||4||
59967400|NCT01348139|76085017|FG003|STARTED|Period 6||4||
59967401|NCT01348139|76085018|FG004|STARTED|Period 6||5||
59967402|NCT01348139|76085019|FG005|STARTED|Period 6||4||
59967403|NCT01348139|76085014|FG000|COMPLETED|Period 6||4||
59967404|NCT01348139|76085015|FG001|COMPLETED|Period 6||4||
59967405|NCT01348139|76085016|FG002|COMPLETED|Period 6||4||
59967406|NCT01348139|76085017|FG003|COMPLETED|Period 6||4||
59967407|NCT01348139|76085018|FG004|COMPLETED|Period 6||5||
59967408|NCT01348139|76085019|FG005|COMPLETED|Period 6||4||
59967409|NCT01348139|76085014|FG000|NOT COMPLETED|Period 6||0||
59967410|NCT01348139|76085015|FG001|NOT COMPLETED|Period 6||0||
59967411|NCT01348139|76085016|FG002|NOT COMPLETED|Period 6||0||
59967412|NCT01348139|76085017|FG003|NOT COMPLETED|Period 6||0||
59967413|NCT01348139|76085018|FG004|NOT COMPLETED|Period 6||0||
59967414|NCT01348139|76085019|FG005|NOT COMPLETED|Period 6||0||
59967415|NCT02868229|76085037|FG000|STARTED|Overall Study||12||
59967416|NCT02868229|76085038|FG001|STARTED|Overall Study||16||
59967417|NCT02868229|76085039|FG002|STARTED|Overall Study||16||
59967418|NCT02868229|76085040|FG003|STARTED|Overall Study||17||
59967419|NCT02868229|76085037|FG000|Intent to Treat (ITT) Population|Overall Study||12||
59967420|NCT02868229|76085038|FG001|Intent to Treat (ITT) Population|Overall Study||16||
59967421|NCT02868229|76085039|FG002|Intent to Treat (ITT) Population|Overall Study||16||
59967422|NCT02868229|76085040|FG003|Intent to Treat (ITT) Population|Overall Study||17||
59967423|NCT02868229|76085037|FG000|Pharmacodynamic (PD) Population|Overall Study||12||
59967424|NCT02868229|76085038|FG001|Pharmacodynamic (PD) Population|Overall Study||16||
59967425|NCT02868229|76085039|FG002|Pharmacodynamic (PD) Population|Overall Study||13||
59967426|NCT02868229|76085040|FG003|Pharmacodynamic (PD) Population|Overall Study||12||
59967427|NCT02868229|76085037|FG000|Pharmacokinetic (PK) Population|Overall Study||12||
59967428|NCT02868229|76085038|FG001|Pharmacokinetic (PK) Population|Overall Study||16||
59967429|NCT02868229|76085039|FG002|Pharmacokinetic (PK) Population|Overall Study||16||
59967430|NCT02868229|76085040|FG003|Pharmacokinetic (PK) Population|Overall Study||17||
59967431|NCT02868229|76085037|FG000|Safety Analysis Population|Overall Study||12||
59967432|NCT02868229|76085038|FG001|Safety Analysis Population|Overall Study||16||
59967433|NCT02868229|76085039|FG002|Safety Analysis Population|Overall Study||16||
59967434|NCT02868229|76085040|FG003|Safety Analysis Population|Overall Study||17||
59967435|NCT02868229|76085037|FG000|Maximum Tolerated Dose (MTD) Population|Overall Study||12||
59967436|NCT02868229|76085038|FG001|Maximum Tolerated Dose (MTD) Population|Overall Study||16||
59967437|NCT02868229|76085039|FG002|Maximum Tolerated Dose (MTD) Population|Overall Study||16||
59967438|NCT02868229|76085040|FG003|Maximum Tolerated Dose (MTD) Population|Overall Study||16||
59967439|NCT02868229|76085037|FG000|COMPLETED|Overall Study||11||
59967440|NCT02868229|76085038|FG001|COMPLETED|Overall Study||16||
59967441|NCT02868229|76085039|FG002|COMPLETED|Overall Study||15||
59967442|NCT02868229|76085040|FG003|COMPLETED|Overall Study||12||
59967443|NCT02868229|76085037|FG000|NOT COMPLETED|Overall Study||1||
59967444|NCT02868229|76085038|FG001|NOT COMPLETED|Overall Study||0||
59967445|NCT02868229|76085039|FG002|NOT COMPLETED|Overall Study||1||
59967446|NCT02868229|76085040|FG003|NOT COMPLETED|Overall Study||5||
59967447|NCT02956967|76085055|FG000|STARTED|Overall Study||171||
59967448|NCT02956967|76085055|FG000|COMPLETED|Overall Study||123||
59967449|NCT02956967|76085055|FG000|NOT COMPLETED|Overall Study||48||
59967450|NCT00000125|76085061|FG000|STARTED|Overall Study||819||
59967451|NCT00000125|76085062|FG001|STARTED|Overall Study||817||
59967452|NCT00000125|76085061|FG000|Completed OHTS Phase I, June 2002|Overall Study||706||
59967453|NCT00000125|76085062|FG001|Completed OHTS Phase I, June 2002|Overall Study||702||
59967454|NCT00000125|76085061|FG000|COMPLETED|Overall Study|Completed OHTS Phase 2, through March 2009|580||
59967455|NCT00000125|76085062|FG001|COMPLETED|Overall Study|Completed OHTS Phase 2, through March 2009|579||
59967456|NCT00000125|76085061|FG000|NOT COMPLETED|Overall Study||239||
59967457|NCT00000125|76085062|FG001|NOT COMPLETED|Overall Study||238||
59967458|NCT00000371|76085070|FG000|STARTED|Overall Study||27||
59967459|NCT00000371|76085071|FG001|STARTED|Overall Study||28||
59967460|NCT00000371|76085070|FG000|COMPLETED|Overall Study||14||
59967461|NCT00000371|76085071|FG001|COMPLETED|Overall Study||12||
59967462|NCT00000371|76085070|FG000|NOT COMPLETED|Overall Study||13||
59967463|NCT00000371|76085071|FG001|NOT COMPLETED|Overall Study||16||
59967464|NCT02867995|76085079|FG000|STARTED|Overall Study|Total patients consented|9||
59967465|NCT02867995|76085080|FG001|STARTED|Overall Study|Total patients consented|30||
59967466|NCT02867995|76085079|FG000|COMPLETED|Overall Study|Total patients completed|9||
59967467|NCT02867995|76085080|FG001|COMPLETED|Overall Study|Total patients completed|27||
59967468|NCT02867995|76085079|FG000|NOT COMPLETED|Overall Study||0||
59967469|NCT02867995|76085080|FG001|NOT COMPLETED|Overall Study||3||
59967470|NCT03392883|76085093|FG000|STARTED|Overall Study||1264||
59967471|NCT03392883|76085094|FG001|STARTED|Overall Study||45||
59967472|NCT03392883|76085095|FG002|STARTED|Overall Study||39||
59967473|NCT03392883|76085093|FG000|COMPLETED|Overall Study||928||
59967474|NCT03392883|76085094|FG001|COMPLETED|Overall Study||32||
59967475|NCT03392883|76085095|FG002|COMPLETED|Overall Study||30||
59967476|NCT03392883|76085093|FG000|NOT COMPLETED|Overall Study||336||
59967477|NCT03392883|76085094|FG001|NOT COMPLETED|Overall Study||13||
59967478|NCT03392883|76085095|FG002|NOT COMPLETED|Overall Study||9||
59967479|NCT02748863|76085106|FG000|STARTED|Treatment Period 1||72||
59967480|NCT02748863|76085107|FG001|STARTED|Treatment Period 1||71||
59967481|NCT02748863|76085108|FG002|STARTED|Treatment Period 1||71||
59967482|NCT02748863|76085109|FG003|STARTED|Treatment Period 1|Not applicable for this period|0||
59967483|NCT02748863|76085110|FG004|STARTED|Treatment Period 1|Not applicable for this period|0||
59525203|NCT01258387|75620437|FG005|COMPLETED|Overall Study||6||
59525204|NCT01258387|75620438|FG006|COMPLETED|Overall Study||4||
59525205|NCT01258387|75620432|FG000|NOT COMPLETED|Overall Study||0||
59525206|NCT01258387|75620433|FG001|NOT COMPLETED|Overall Study||0||
59525207|NCT01258387|75620434|FG002|NOT COMPLETED|Overall Study||0||
59525208|NCT01258387|75620435|FG003|NOT COMPLETED|Overall Study||0||
59525209|NCT01258387|75620436|FG004|NOT COMPLETED|Overall Study||0||
59525210|NCT01258387|75620437|FG005|NOT COMPLETED|Overall Study||0||
59525211|NCT01258387|75620438|FG006|NOT COMPLETED|Overall Study||0||
59525212|NCT00056498|75620458|FG000|STARTED|Overall Study||30||
59525213|NCT00056498|75620459|FG001|STARTED|Overall Study||35||
59525214|NCT00056498|75620458|FG000|COMPLETED|Overall Study||25||
59525215|NCT00056498|75620459|FG001|COMPLETED|Overall Study||28||
59525216|NCT00056498|75620458|FG000|NOT COMPLETED|Overall Study||5||
59525217|NCT00056498|75620459|FG001|NOT COMPLETED|Overall Study||7||
59525218|NCT00058370|75620465|FG000|STARTED|Overall Study||6||
59525219|NCT00058370|75620465|FG000|COMPLETED|Overall Study||6||
59525220|NCT00058370|75620465|FG000|NOT COMPLETED|Overall Study||0||
59525221|NCT00059228|75620471|FG000|STARTED|Overall Study||6||
59525222|NCT00059228|75620472|FG001|STARTED|Overall Study||6||
59621538|NCT00353652|75733174|FG005|STARTED|First Intervention - 3 Months||0||
59621539|NCT00353652|75733175|FG006|STARTED|First Intervention - 3 Months||1||
59621540|NCT00353652|75733176|FG007|STARTED|First Intervention - 3 Months||0||
59621541|NCT00353652|75733169|FG000|COMPLETED|First Intervention - 3 Months||12||
59621542|NCT00353652|75733170|FG001|COMPLETED|First Intervention - 3 Months||11||
59621543|NCT00353652|75733171|FG002|COMPLETED|First Intervention - 3 Months||6||
59621544|NCT00353652|75733172|FG003|COMPLETED|First Intervention - 3 Months||7||
59621545|NCT00353652|75733173|FG004|COMPLETED|First Intervention - 3 Months||3||
59621546|NCT00353652|75733174|FG005|COMPLETED|First Intervention - 3 Months||0||
59621547|NCT00353652|75733175|FG006|COMPLETED|First Intervention - 3 Months||1||
59621548|NCT00353652|75733176|FG007|COMPLETED|First Intervention - 3 Months||0||
59621549|NCT00353652|75733169|FG000|NOT COMPLETED|First Intervention - 3 Months||3||
59621550|NCT00353652|75733170|FG001|NOT COMPLETED|First Intervention - 3 Months||4||
59967484|NCT02748863|76085106|FG000|COMPLETED|Treatment Period 1||72||
59967485|NCT02748863|76085107|FG001|COMPLETED|Treatment Period 1||69||
59967486|NCT02748863|76085108|FG002|COMPLETED|Treatment Period 1||69||
59967487|NCT02748863|76085109|FG003|COMPLETED|Treatment Period 1||0||
59967488|NCT02748863|76085110|FG004|COMPLETED|Treatment Period 1||0||
59967489|NCT02748863|76085106|FG000|NOT COMPLETED|Treatment Period 1||0||
59967490|NCT02748863|76085107|FG001|NOT COMPLETED|Treatment Period 1||2||
59967491|NCT02748863|76085108|FG002|NOT COMPLETED|Treatment Period 1||2||
59967492|NCT02748863|76085109|FG003|NOT COMPLETED|Treatment Period 1||0||
59967493|NCT02748863|76085110|FG004|NOT COMPLETED|Treatment Period 1||0||
59967494|NCT02748863|76085106|FG000|STARTED|Treatment Period 2||72||
59967495|NCT02748863|76085107|FG001|STARTED|Treatment Period 2||69||
59967496|NCT02748863|76085108|FG002|STARTED|Treatment Period 2||0||
59967497|NCT02748863|76085109|FG003|STARTED|Treatment Period 2||34||
59525223|NCT00059228|75620471|FG000|COMPLETED|Overall Study||6||
59525224|NCT00059228|75620472|FG001|COMPLETED|Overall Study||5||
59525225|NCT00059228|75620471|FG000|NOT COMPLETED|Overall Study||0||
59525226|NCT00059228|75620472|FG001|NOT COMPLETED|Overall Study||1||
59525227|NCT00060008|75620478|FG000|STARTED|Overall Study||18||
59621551|NCT00353652|75733171|FG002|NOT COMPLETED|First Intervention - 3 Months||0||
59621552|NCT00353652|75733172|FG003|NOT COMPLETED|First Intervention - 3 Months||0||
59525228|NCT00060008|75620478|FG000|COMPLETED|Overall Study||18||
59525229|NCT00060008|75620478|FG000|NOT COMPLETED|Overall Study||0||
59967498|NCT02748863|76085110|FG004|STARTED|Treatment Period 2||34||
59967499|NCT02748863|76085106|FG000|COMPLETED|Treatment Period 2||67||
59967500|NCT02748863|76085107|FG001|COMPLETED|Treatment Period 2||66||
59967501|NCT02748863|76085108|FG002|COMPLETED|Treatment Period 2||0||
59967502|NCT02748863|76085109|FG003|COMPLETED|Treatment Period 2||32||
59967503|NCT02748863|76085110|FG004|COMPLETED|Treatment Period 2||33||
59967504|NCT02748863|76085106|FG000|NOT COMPLETED|Treatment Period 2||5||
59967505|NCT02748863|76085107|FG001|NOT COMPLETED|Treatment Period 2||3||
59967506|NCT02748863|76085108|FG002|NOT COMPLETED|Treatment Period 2||0||
59967507|NCT02748863|76085109|FG003|NOT COMPLETED|Treatment Period 2||2||
59967508|NCT02748863|76085110|FG004|NOT COMPLETED|Treatment Period 2||1||
59967509|NCT02244554|76085125|FG000|STARTED|Overall Study||10||20
59967510|NCT02244554|76085125|FG000|Treatment With Picosecond Pulse Duration|Overall Study||10||10
59967511|NCT02244554|76085125|FG000|Treatment With Nanosecond Pulse Duration|Overall Study||10||10
59967512|NCT02244554|76085125|FG000|COMPLETED|Overall Study||10||20
59967513|NCT02244554|76085125|FG000|NOT COMPLETED|Overall Study||0||0
59967514|NCT02865499|76085131|FG000|STARTED|Baseline||8||
59967515|NCT02865499|76085131|FG000|COMPLETED|Baseline||6||
59967516|NCT02865499|76085131|FG000|NOT COMPLETED|Baseline||2||
59967517|NCT02865499|76085131|FG000|STARTED|8 Weeks||6||
59967518|NCT02865499|76085131|FG000|COMPLETED|8 Weeks||6||
59967519|NCT02865499|76085131|FG000|NOT COMPLETED|8 Weeks||0||
59967520|NCT02865499|76085131|FG000|STARTED|12 Weeks||6||
59967521|NCT02865499|76085131|FG000|COMPLETED|12 Weeks||6||
59967522|NCT02865499|76085131|FG000|NOT COMPLETED|12 Weeks||0||
59967523|NCT02870933|76085137|FG000|STARTED|Overall Study||15||
59967524|NCT02870933|76085138|FG001|STARTED|Overall Study||15||
59967525|NCT02870933|76085137|FG000|COMPLETED|Overall Study||13||
59967526|NCT02870933|76085138|FG001|COMPLETED|Overall Study||13||
59967527|NCT02870933|76085137|FG000|NOT COMPLETED|Overall Study||2||
59967528|NCT02870933|76085138|FG001|NOT COMPLETED|Overall Study||2||
59967529|NCT02864407|76085145|FG000|STARTED|Overall Study||3223|Enrolled|
59967530|NCT02864407|76085145|FG000|Effectiveness Analysis Set|Overall Study||2105||
59967531|NCT02864407|76085145|FG000|Long-term Safety Analysis Set|Overall Study||813||
59967532|NCT02864407|76085145|FG000|Long-term Effectiveness Analysis Set|Overall Study||767||
59967533|NCT02864407|76085145|FG000|COMPLETED|Overall Study||3100|Safety analysis set|
59967534|NCT02864407|76085145|FG000|NOT COMPLETED|Overall Study||123||
59967535|NCT02873429|76085151|FG000|STARTED|Baseline||109||
59967536|NCT02873429|76085152|FG001|STARTED|Baseline||100||
59967537|NCT02873429|76085151|FG000|COMPLETED|Baseline||109||
59967538|NCT02873429|76085152|FG001|COMPLETED|Baseline||100||
59967539|NCT02873429|76085151|FG000|NOT COMPLETED|Baseline||0||
59967540|NCT02873429|76085152|FG001|NOT COMPLETED|Baseline||0||
59967541|NCT02873429|76085151|FG000|STARTED|6-8 Weeks|4 CAM participants not eligible to complete follow ups because they did not continue treatment.|105||
59967542|NCT02873429|76085152|FG001|STARTED|6-8 Weeks|2 Con. participants not eligible to complete follow ups because they did not continue treatment.|98||
59967543|NCT02873429|76085151|FG000|COMPLETED|6-8 Weeks||95||
59967544|NCT02873429|76085152|FG001|COMPLETED|6-8 Weeks||97||
59967545|NCT02873429|76085151|FG000|NOT COMPLETED|6-8 Weeks||10||
59967546|NCT02873429|76085152|FG001|NOT COMPLETED|6-8 Weeks||1||
59967547|NCT02873429|76085151|FG000|STARTED|16 Weeks|10 CAM participants Missed 6-8 week but are eligible for 16 week|105||
59967548|NCT02873429|76085152|FG001|STARTED|16 Weeks|1 Conv. participant Missed 6-8 week but was eligible for 16 week|98||
59967549|NCT02873429|76085151|FG000|COMPLETED|16 Weeks||100||
59967550|NCT02873429|76085152|FG001|COMPLETED|16 Weeks||96||
59967551|NCT02873429|76085151|FG000|NOT COMPLETED|16 Weeks||5||
59967552|NCT02873429|76085152|FG001|NOT COMPLETED|16 Weeks||2||
59967553|NCT02486302|76085158|FG000|STARTED|Overall Study||1534||
59967554|NCT02486302|76085158|FG000|Treated|Overall Study||1523||
59967555|NCT02486302|76085158|FG000|COMPLETED|Overall Study||858||
59967556|NCT02486302|76085158|FG000|NOT COMPLETED|Overall Study||676||
59967557|NCT02747875|76085173|FG000|STARTED|Overall Study||12||
59967558|NCT02747875|76085174|FG001|STARTED|Overall Study||14||
59967559|NCT02747875|76085173|FG000|COMPLETED|Overall Study||11||
59967560|NCT02747875|76085174|FG001|COMPLETED|Overall Study||13||
59967561|NCT02747875|76085173|FG000|NOT COMPLETED|Overall Study||1||
59967562|NCT02747875|76085174|FG001|NOT COMPLETED|Overall Study||1||
59967563|NCT03394755|76085183|FG000|STARTED|Overall Study||8||
59967564|NCT03394755|76085184|FG001|STARTED|Overall Study||8||
59967565|NCT03394755|76085185|FG002|STARTED|Overall Study||8||
59967566|NCT03394755|76085183|FG000|COMPLETED|Overall Study||8||
59967567|NCT03394755|76085184|FG001|COMPLETED|Overall Study||8||
59967568|NCT03394755|76085185|FG002|COMPLETED|Overall Study||8||
59967569|NCT03394755|76085183|FG000|NOT COMPLETED|Overall Study||0||
59967570|NCT03394755|76085184|FG001|NOT COMPLETED|Overall Study||0||
59967571|NCT03394755|76085185|FG002|NOT COMPLETED|Overall Study||0||
59967572|NCT02451124|76085200|FG000|STARTED|Overall Study||156||
59967573|NCT02451124|76085200|FG000|COMPLETED|Overall Study||155||
59967574|NCT02451124|76085200|FG000|NOT COMPLETED|Overall Study||1||
59967575|NCT02450578|76085212|FG000|STARTED|Overall Study||6||
59967576|NCT02450578|76085213|FG001|STARTED|Overall Study||6||
59967577|NCT02450578|76085214|FG002|STARTED|Overall Study||6||
59967578|NCT02450578|76085215|FG003|STARTED|Overall Study||4||
59967579|NCT02450578|76085212|FG000|COMPLETED|Overall Study||5||
59967580|NCT02450578|76085213|FG001|COMPLETED|Overall Study||6||
59967581|NCT02450578|76085214|FG002|COMPLETED|Overall Study||6||
59967582|NCT02450578|76085215|FG003|COMPLETED|Overall Study||4||
59967583|NCT02450578|76085212|FG000|NOT COMPLETED|Overall Study||1||
59967584|NCT02450578|76085213|FG001|NOT COMPLETED|Overall Study||0||
59967585|NCT02450578|76085214|FG002|NOT COMPLETED|Overall Study||0||
59967586|NCT02450578|76085215|FG003|NOT COMPLETED|Overall Study||0||
59967587|NCT03980145|76085231|FG000|STARTED|Overall Study||7||
59967588|NCT03980145|76085232|FG001|STARTED|Overall Study||8||
59967589|NCT03980145|76085231|FG000|COMPLETED|Overall Study||7||
59967590|NCT03980145|76085232|FG001|COMPLETED|Overall Study||8||
59967591|NCT03980145|76085231|FG000|NOT COMPLETED|Overall Study||0||
59967592|NCT03980145|76085232|FG001|NOT COMPLETED|Overall Study||0||
59967593|NCT02449018|76085242|FG000|STARTED|Overall Study||64||
59967594|NCT02449018|76085243|FG001|STARTED|Overall Study||28||
59967595|NCT02449018|76085242|FG000|COMPLETED|Overall Study||52||
59967596|NCT02449018|76085243|FG001|COMPLETED|Overall Study||26||
59967597|NCT02449018|76085242|FG000|NOT COMPLETED|Overall Study||12||
59967598|NCT02449018|76085243|FG001|NOT COMPLETED|Overall Study||2||
59967599|NCT02859415|76085251|FG000|STARTED|Overall Study||1||
59967600|NCT02859415|76085252|FG001|STARTED|Overall Study||2||
59967601|NCT02859415|76085251|FG000|COMPLETED|Overall Study||0||
59967602|NCT02859415|76085252|FG001|COMPLETED|Overall Study||1||
59967603|NCT02859415|76085251|FG000|NOT COMPLETED|Overall Study||1||
60074344|NCT01770860|76189721|FG000|STARTED|Overall Study|Forty-six subjects were enrolled but one subject withdrew before randomization.|46||
59810417|NCT00408928|75932595|FG000|COMPLETED|Overall Study||8||
59810418|NCT00408928|75932595|FG000|NOT COMPLETED|Overall Study||3||
59810419|NCT00390910|75932602|FG000|STARTED|Overall Study||50||
59810420|NCT00390910|75932603|FG001|STARTED|Overall Study||87||
59810421|NCT00390910|75932604|FG002|STARTED|Overall Study||149||
59810422|NCT00390910|75932602|FG000|COMPLETED|Overall Study||48||
59810423|NCT00390910|75932603|FG001|COMPLETED|Overall Study||83||
59967604|NCT02859415|76085252|FG001|NOT COMPLETED|Overall Study||1||
59967605|NCT02871791|76085262|FG000|STARTED|Phase 1b||6||
59967606|NCT02871791|76085263|FG001|STARTED|Phase 1b||3||
59967607|NCT02871791|76085262|FG000|COMPLETED|Phase 1b||0||
59967608|NCT02871791|76085263|FG001|COMPLETED|Phase 1b||0||
59967609|NCT02871791|76085262|FG000|NOT COMPLETED|Phase 1b||6||
59967610|NCT02871791|76085263|FG001|NOT COMPLETED|Phase 1b||3||
59967611|NCT02871791|76085262|FG000|STARTED|Phase 2||32||
59967612|NCT02871791|76085263|FG001|STARTED|Phase 2||0||
59967613|NCT02871791|76085262|FG000|COMPLETED|Phase 2||29||
59967614|NCT02871791|76085263|FG001|COMPLETED|Phase 2||0||
59967615|NCT02871791|76085262|FG000|NOT COMPLETED|Phase 2||3||
59967616|NCT02871791|76085263|FG001|NOT COMPLETED|Phase 2||0||
59967617|NCT02871635|76085271|FG000|STARTED|Overall Study||72||
59967618|NCT02871635|76085272|FG001|STARTED|Overall Study||75||
59967619|NCT02871635|76085271|FG000|COMPLETED|Overall Study||54||
59967620|NCT02871635|76085272|FG001|COMPLETED|Overall Study||56||
59967621|NCT02871635|76085271|FG000|NOT COMPLETED|Overall Study||18||
59967622|NCT02871635|76085272|FG001|NOT COMPLETED|Overall Study||19||
59967623|NCT02477332|76085286|FG000|STARTED|Overall Study||43||
59967624|NCT02477332|76085287|FG001|STARTED|Overall Study||84||
59967625|NCT02477332|76085288|FG002|STARTED|Overall Study||85||
59967626|NCT02477332|76085289|FG003|STARTED|Overall Study||85||
59967627|NCT02477332|76085290|FG004|STARTED|Overall Study||43||
59967628|NCT02477332|76085291|FG005|STARTED|Overall Study||42||
59967629|NCT02477332|76085286|FG000|COMPLETED|Overall Study||40||
60074345|NCT01770860|76189721|FG000|Randomization|Overall Study|One participant withdrew before randomization|45||
59810424|NCT00390910|75932604|FG002|COMPLETED|Overall Study||139||
59810425|NCT00390910|75932602|FG000|NOT COMPLETED|Overall Study||2||
59810426|NCT00390910|75932603|FG001|NOT COMPLETED|Overall Study||4||
59810427|NCT00390910|75932604|FG002|NOT COMPLETED|Overall Study||10||
59810428|NCT00533702|75932616|FG000|STARTED|Overall Study||54||
59810429|NCT00533702|75932617|FG001|STARTED|Overall Study||52||
59810430|NCT00533702|75932616|FG000|Received Any Quantity of Study Drug|Overall Study||52||
59810431|NCT00533702|75932617|FG001|Received Any Quantity of Study Drug|Overall Study||50||
59810432|NCT00533702|75932616|FG000|COMPLETED|Overall Study||49||
59810433|NCT00533702|75932617|FG001|COMPLETED|Overall Study||50||
59810434|NCT00533702|75932616|FG000|NOT COMPLETED|Overall Study||5||
59810435|NCT00533702|75932617|FG001|NOT COMPLETED|Overall Study||2||
59810436|NCT00408694|75932623|FG000|STARTED|Overall Study||46||
59810437|NCT00408694|75932623|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|44||
59810438|NCT00408694|75932623|FG000|NOT COMPLETED|Overall Study||2||
59810439|NCT00396136|75932627|FG000|STARTED|Overall Study||221||
59810440|NCT00396136|75932627|FG000|COMPLETED|Overall Study||96||
59967630|NCT02477332|76085287|FG001|COMPLETED|Overall Study||77||
59967631|NCT02477332|76085288|FG002|COMPLETED|Overall Study||73||
59967632|NCT02477332|76085289|FG003|COMPLETED|Overall Study||72||
59967633|NCT02477332|76085290|FG004|COMPLETED|Overall Study||39||
59967634|NCT02477332|76085291|FG005|COMPLETED|Overall Study||37||
59967635|NCT02477332|76085286|FG000|NOT COMPLETED|Overall Study||3||
59967636|NCT02477332|76085287|FG001|NOT COMPLETED|Overall Study||7||
59967637|NCT02477332|76085288|FG002|NOT COMPLETED|Overall Study||12||
59810441|NCT00396136|75932627|FG000|NOT COMPLETED|Overall Study||125||
59967638|NCT02477332|76085289|FG003|NOT COMPLETED|Overall Study||13||
59967639|NCT02477332|76085290|FG004|NOT COMPLETED|Overall Study||4||
59967640|NCT02477332|76085291|FG005|NOT COMPLETED|Overall Study||5||
59967641|NCT02477020|76085309|FG000|STARTED|Overall Study||81||
59967642|NCT02477020|76085310|FG001|STARTED|Overall Study||83||
59967643|NCT02477020|76085309|FG000|COMPLETED|Overall Study|Completed = participants who completed study treatment.|51||
59967644|NCT02477020|76085310|FG001|COMPLETED|Overall Study|Completed = participants who completed study treatment.|55||
59967645|NCT02477020|76085309|FG000|NOT COMPLETED|Overall Study||30||
59967646|NCT02477020|76085310|FG001|NOT COMPLETED|Overall Study||28||
59967647|NCT02862535|76085320|FG000|STARTED|Overall Study||9||
59967648|NCT02862535|76085321|FG001|STARTED|Overall Study||6||
59967649|NCT02862535|76085322|FG002|STARTED|Overall Study||10||
59967650|NCT02862535|76085323|FG003|STARTED|Overall Study||11||
59967651|NCT02862535|76085320|FG000|COMPLETED|Overall Study||0||
59967652|NCT02862535|76085321|FG001|COMPLETED|Overall Study||0||
59967653|NCT02862535|76085322|FG002|COMPLETED|Overall Study||0||
59967654|NCT02862535|76085323|FG003|COMPLETED|Overall Study||0||
59967655|NCT02862535|76085320|FG000|NOT COMPLETED|Overall Study||9||
59967656|NCT02862535|76085321|FG001|NOT COMPLETED|Overall Study||6||
59967657|NCT02862535|76085322|FG002|NOT COMPLETED|Overall Study||10||
59967658|NCT02862535|76085323|FG003|NOT COMPLETED|Overall Study||11||
59967659|NCT02448706|76085333|FG000|STARTED|Overall Study||25||
59967660|NCT02448706|76085334|FG001|STARTED|Overall Study||24||
59967661|NCT02448706|76085333|FG000|Withdrew for Personal Reasons|Overall Study||1||
59967662|NCT02448706|76085334|FG001|Withdrew for Personal Reasons|Overall Study||1||
59967663|NCT02448706|76085333|FG000|Completed Baseline Testing|Overall Study||24||
59967664|NCT02448706|76085334|FG001|Completed Baseline Testing|Overall Study||23||
59967665|NCT02448706|76085333|FG000|COMPLETED|Overall Study||20||
59967666|NCT02448706|76085334|FG001|COMPLETED|Overall Study||20||
59967667|NCT02448706|76085333|FG000|NOT COMPLETED|Overall Study||5||
59967668|NCT02448706|76085334|FG001|NOT COMPLETED|Overall Study||4||
59967669|NCT02868281|76085344|FG000|STARTED|Overall Study||252||
59810442|NCT00530894|75932635|FG000|STARTED|Overall Study||348||
59810443|NCT00530894|75932636|FG001|STARTED|Overall Study||351||
59810444|NCT00530894|75932637|FG002|STARTED|Overall Study||179||
59810445|NCT00530894|75932638|FG003|STARTED|Overall Study||179||
59810446|NCT00530894|75932635|FG000|COMPLETED|Overall Study||260||
59810447|NCT00530894|75932636|FG001|COMPLETED|Overall Study||236||
59810448|NCT00530894|75932637|FG002|COMPLETED|Overall Study||124||
59967670|NCT02868281|76085345|FG001|STARTED|Overall Study||278||
59967671|NCT02868281|76085344|FG000|COMPLETED|Overall Study||209||
59967672|NCT02868281|76085345|FG001|COMPLETED|Overall Study||234||
59967673|NCT02868281|76085344|FG000|NOT COMPLETED|Overall Study||43||
59967674|NCT02868281|76085345|FG001|NOT COMPLETED|Overall Study||44||
59967675|NCT02476006|76085351|FG000|STARTED|Overall Study||998||
59967676|NCT02476006|76085351|FG000|Treated|Overall Study||994||
59967677|NCT02476006|76085351|FG000|COMPLETED|Overall Study||878||
59967678|NCT02476006|76085351|FG000|NOT COMPLETED|Overall Study||120||
59967679|NCT02475850|76085357|FG000|STARTED|Overall Study||2802||
59967680|NCT02475850|76085358|FG001|STARTED|Overall Study||2649||
59967681|NCT02475850|76085357|FG000|COMPLETED|Overall Study||2209||
59967682|NCT02475850|76085358|FG001|COMPLETED|Overall Study||2165||
59967683|NCT02475850|76085357|FG000|NOT COMPLETED|Overall Study||593||
59967684|NCT02475850|76085358|FG001|NOT COMPLETED|Overall Study||484||
59967685|NCT02419612|76085367|FG000|STARTED|Short-term Treatment Period||227||
59967686|NCT02419612|76085368|FG001|STARTED|Short-term Treatment Period||217||
59967687|NCT02419612|76085367|FG000|Recevied Treatment|Short-term Treatment Period||227||
59967688|NCT02419612|76085368|FG001|Recevied Treatment|Short-term Treatment Period||216||
59967689|NCT02419612|76085367|FG000|COMPLETED|Short-term Treatment Period||210||
59967690|NCT02419612|76085368|FG001|COMPLETED|Short-term Treatment Period||194||
59967691|NCT02419612|76085367|FG000|NOT COMPLETED|Short-term Treatment Period||17||
59967692|NCT02419612|76085368|FG001|NOT COMPLETED|Short-term Treatment Period||23||
59967693|NCT02419612|76085367|FG000|STARTED|Long-term Treatment Period|Not all subjects who completed the previous period were eligible to enter the long-term period.|196||
59967694|NCT02419612|76085368|FG001|STARTED|Long-term Treatment Period|Not all subjects who completed the previous period were eligible to enter the long-term period.|186||
59967695|NCT02419612|76085367|FG000|Received Treatment|Long-term Treatment Period||196||
59810449|NCT00530894|75932638|FG003|COMPLETED|Overall Study||85||
59810450|NCT00530894|75932635|FG000|NOT COMPLETED|Overall Study||88||
59810451|NCT00530894|75932636|FG001|NOT COMPLETED|Overall Study||115||
59810452|NCT00530894|75932637|FG002|NOT COMPLETED|Overall Study||55||
59967696|NCT02419612|76085368|FG001|Received Treatment|Long-term Treatment Period||183||
59967697|NCT02419612|76085367|FG000|COMPLETED|Long-term Treatment Period||174||
59967698|NCT02419612|76085368|FG001|COMPLETED|Long-term Treatment Period||164||
59967699|NCT02419612|76085367|FG000|NOT COMPLETED|Long-term Treatment Period||22||
59967700|NCT02419612|76085368|FG001|NOT COMPLETED|Long-term Treatment Period||22||
59967701|NCT02447848|76085374|FG000|STARTED|Overall Study||76||
59810453|NCT00530894|75932638|FG003|NOT COMPLETED|Overall Study||94||
59810454|NCT00056407|75932652|FG000|STARTED|Overall Study||4126||
59810455|NCT00056407|75932653|FG001|STARTED|Overall Study||4105||
59967702|NCT02447848|76085374|FG000|COMPLETED|Overall Study||65||
59967703|NCT02447848|76085374|FG000|NOT COMPLETED|Overall Study||11||
59967704|NCT02418910|76085378|FG000|STARTED|Overall Study||50||
59967705|NCT02418910|76085378|FG000|COMPLETED|Overall Study||43||
59967706|NCT02418910|76085378|FG000|NOT COMPLETED|Overall Study||7||
59967707|NCT03095456|76085384|FG000|STARTED|Overall Study||103||
59967708|NCT03095456|76085385|FG001|STARTED|Overall Study||104||
59967709|NCT03095456|76085384|FG000|COMPLETED|Overall Study||99||
59967710|NCT03095456|76085385|FG001|COMPLETED|Overall Study||96||
59967711|NCT03095456|76085384|FG000|NOT COMPLETED|Overall Study||4||
59967712|NCT03095456|76085385|FG001|NOT COMPLETED|Overall Study||8||
59967713|NCT02418754|76085394|FG000|STARTED|Period 1 (Day 1 to Week 12)||103|Safety Analysis Set (SAF): all initially randomized participants who received any study drug|103
59967714|NCT02418754|76085395|FG001|STARTED|Period 1 (Day 1 to Week 12)||200|Safety Analysis Set (SAF): all initially randomized participants who received any study drug|200
59967715|NCT02418754|76085396|FG002|STARTED|Period 1 (Day 1 to Week 12)||202|Safety Analysis Set (SAF): all initially randomized participants who received any study drug|202
59967716|NCT02418754|76085397|FG003|STARTED|Period 1 (Day 1 to Week 12)||0|Safety Analysis Set (SAF): all initially randomized participants who received any study drug|0
59967717|NCT02418754|76085398|FG004|STARTED|Period 1 (Day 1 to Week 12)||0|Safety Analysis Set (SAF): all initially randomized participants who received any study drug|0
59967718|NCT02418754|76085394|FG000|COMPLETED|Period 1 (Day 1 to Week 12)||101|Completed week 12 in the SAF|101
59967719|NCT02418754|76085395|FG001|COMPLETED|Period 1 (Day 1 to Week 12)||196|Completed week 12 in the SAF|196
59967720|NCT02418754|76085396|FG002|COMPLETED|Period 1 (Day 1 to Week 12)||200|Completed week 12 in the SAF|200
59967721|NCT02418754|76085397|FG003|COMPLETED|Period 1 (Day 1 to Week 12)||0|Completed week 12 in the SAF|0
59967722|NCT02418754|76085398|FG004|COMPLETED|Period 1 (Day 1 to Week 12)||0|Completed week 12 in the SAF|0
59967723|NCT02418754|76085394|FG000|NOT COMPLETED|Period 1 (Day 1 to Week 12)||2||2
59967724|NCT02418754|76085395|FG001|NOT COMPLETED|Period 1 (Day 1 to Week 12)||4||4
59967725|NCT02418754|76085396|FG002|NOT COMPLETED|Period 1 (Day 1 to Week 12)||2||2
59967726|NCT02418754|76085397|FG003|NOT COMPLETED|Period 1 (Day 1 to Week 12)||0||0
59967727|NCT02418754|76085398|FG004|NOT COMPLETED|Period 1 (Day 1 to Week 12)||0||0
59967728|NCT02418754|76085394|FG000|STARTED|Period 2 (Day 1 to Week 52/End of Study)||103|SAF (includes all initially randomized participants who received any study drug)|103
59967729|NCT02418754|76085395|FG001|STARTED|Period 2 (Day 1 to Week 52/End of Study)||106|SAF (includes all initially randomized participants who received any study drug)|106
59967730|NCT02418754|76085396|FG002|STARTED|Period 2 (Day 1 to Week 52/End of Study)||108|SAF (includes all initially randomized participants who received any study drug)|108
59967731|NCT02418754|76085397|FG003|STARTED|Period 2 (Day 1 to Week 52/End of Study)||94|SAF (includes all initially randomized participants who received any study drug)|94
59967732|NCT02418754|76085398|FG004|STARTED|Period 2 (Day 1 to Week 52/End of Study)||94|SAF (includes all initially randomized participants who received any study drug)|94
59967733|NCT02418754|76085394|FG000|COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||70|Completed week 52 in the SAF|70
59967734|NCT02418754|76085395|FG001|COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||64|Completed week 52 in the SAF|64
59967735|NCT02418754|76085396|FG002|COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||71|Completed week 52 in the SAF|71
59967736|NCT02418754|76085397|FG003|COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||67|Completed week 52 in the SAF|67
59967737|NCT02418754|76085398|FG004|COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||67|Completed week 52 in the SAF|67
59967738|NCT02418754|76085394|FG000|NOT COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||33||33
59967739|NCT02418754|76085395|FG001|NOT COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||42||42
59967740|NCT02418754|76085396|FG002|NOT COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||37||37
59967741|NCT02418754|76085397|FG003|NOT COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||27||27
59967742|NCT02418754|76085398|FG004|NOT COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||27||27
59967743|NCT02447458|76085414|FG000|STARTED|Overall Study||5||
59967744|NCT02447458|76085415|FG001|STARTED|Overall Study||6||
59967745|NCT02447458|76085416|FG002|STARTED|Overall Study||6||
59967746|NCT02447458|76085417|FG003|STARTED|Overall Study||6||
59967747|NCT02447458|76085418|FG004|STARTED|Overall Study||6||
59967748|NCT02447458|76085419|FG005|STARTED|Overall Study||10||
59967749|NCT02447458|76085414|FG000|COMPLETED|Overall Study||5||
59967750|NCT02447458|76085415|FG001|COMPLETED|Overall Study||6||
59967751|NCT02447458|76085416|FG002|COMPLETED|Overall Study||5||
59967752|NCT02447458|76085417|FG003|COMPLETED|Overall Study||6||
59967753|NCT02447458|76085418|FG004|COMPLETED|Overall Study||6||
59967754|NCT02447458|76085419|FG005|COMPLETED|Overall Study||10||
59967755|NCT02447458|76085414|FG000|NOT COMPLETED|Overall Study||0||
59967756|NCT02447458|76085415|FG001|NOT COMPLETED|Overall Study||0||
59967757|NCT02447458|76085416|FG002|NOT COMPLETED|Overall Study||1||
59967758|NCT02447458|76085417|FG003|NOT COMPLETED|Overall Study||0||
59967759|NCT02447458|76085418|FG004|NOT COMPLETED|Overall Study||0||
59967760|NCT02447458|76085419|FG005|NOT COMPLETED|Overall Study||0||
59967761|NCT02862457|76085445|FG000|STARTED|Overall Study||3||
59967762|NCT02862457|76085446|FG001|STARTED|Overall Study||3||
59967763|NCT02862457|76085447|FG002|STARTED|Overall Study||3||
59967764|NCT02862457|76085448|FG003|STARTED|Overall Study||6||
59967765|NCT02862457|76085449|FG004|STARTED|Overall Study||7||
59967766|NCT02862457|76085450|FG005|STARTED|Overall Study||6||
59967767|NCT02862457|76085451|FG006|STARTED|Overall Study||6||
59967768|NCT02862457|76085445|FG000|COMPLETED|Overall Study||1||
59967769|NCT02862457|76085446|FG001|COMPLETED|Overall Study||0||
59967770|NCT02862457|76085447|FG002|COMPLETED|Overall Study||0||
59967771|NCT02862457|76085448|FG003|COMPLETED|Overall Study||2||
59967772|NCT02862457|76085449|FG004|COMPLETED|Overall Study||7||
59967773|NCT02862457|76085450|FG005|COMPLETED|Overall Study||3||
59967774|NCT02862457|76085451|FG006|COMPLETED|Overall Study||5||
59967775|NCT02862457|76085445|FG000|NOT COMPLETED|Overall Study||2||
59967776|NCT02862457|76085446|FG001|NOT COMPLETED|Overall Study||3||
59967777|NCT02862457|76085447|FG002|NOT COMPLETED|Overall Study||3||
59967778|NCT02862457|76085448|FG003|NOT COMPLETED|Overall Study||4||
59967779|NCT02862457|76085449|FG004|NOT COMPLETED|Overall Study||0||
59967780|NCT02862457|76085450|FG005|NOT COMPLETED|Overall Study||3||
59967781|NCT02862457|76085451|FG006|NOT COMPLETED|Overall Study||1||
59967782|NCT02447302|76085478|FG000|STARTED|Overall Study||52||
59967783|NCT02447302|76085479|FG001|STARTED|Overall Study||50||
59967784|NCT02447302|76085480|FG002|STARTED|Overall Study||54||
59967785|NCT02447302|76085478|FG000|COMPLETED|Overall Study||47||
59967786|NCT02447302|76085479|FG001|COMPLETED|Overall Study||46||
59967787|NCT02447302|76085480|FG002|COMPLETED|Overall Study||48||
59967788|NCT02447302|76085478|FG000|NOT COMPLETED|Overall Study||5||
59967789|NCT02447302|76085479|FG001|NOT COMPLETED|Overall Study||4||
59967790|NCT02447302|76085480|FG002|NOT COMPLETED|Overall Study||6||
59967791|NCT02454517|76085490|FG000|STARTED|Overall Study||58||
59967792|NCT02454517|76085491|FG001|STARTED|Overall Study||59||
59967793|NCT02454517|76085490|FG000|COMPLETED|Overall Study||50||
59967794|NCT02454517|76085491|FG001|COMPLETED|Overall Study||50||
59967795|NCT02454517|76085490|FG000|NOT COMPLETED|Overall Study||8||
59967796|NCT02454517|76085491|FG001|NOT COMPLETED|Overall Study||9||
59967797|NCT03861039|76085502|FG000|STARTED|Overall Study||148||
59967798|NCT03861039|76085503|FG001|STARTED|Overall Study||147||
59967799|NCT03861039|76085504|FG002|STARTED|Overall Study||148||
59967800|NCT03861039|76085502|FG000|Received at Least One Dose of Study Drug|Overall Study||148||
59967801|NCT03861039|76085503|FG001|Received at Least One Dose of Study Drug|Overall Study||147||
59967802|NCT03861039|76085504|FG002|Received at Least One Dose of Study Drug|Overall Study||148||
59967803|NCT03861039|76085502|FG000|COMPLETED|Overall Study||145||
59967804|NCT03861039|76085503|FG001|COMPLETED|Overall Study||139||
59967805|NCT03861039|76085504|FG002|COMPLETED|Overall Study||133||
59967806|NCT03861039|76085502|FG000|NOT COMPLETED|Overall Study||3||
59967807|NCT03861039|76085503|FG001|NOT COMPLETED|Overall Study||8||
59967808|NCT03861039|76085504|FG002|NOT COMPLETED|Overall Study||15||
59967809|NCT02731755|76085514|FG000|STARTED|First Intervention||8||
59967810|NCT02731755|76085515|FG001|STARTED|First Intervention||10||
59810456|NCT00056407|75932652|FG000|COMPLETED|Overall Study||2915||
59810457|NCT00056407|75932653|FG001|COMPLETED|Overall Study||2912||
59810458|NCT00056407|75932652|FG000|NOT COMPLETED|Overall Study||1211||
59810459|NCT00056407|75932653|FG001|NOT COMPLETED|Overall Study||1193||
59810460|NCT00388726|75932661|FG000|STARTED|Overall Study||508||
59810461|NCT00388726|75932662|FG001|STARTED|Overall Study||254||
59810462|NCT00388726|75932661|FG000|COMPLETED|Overall Study||24||
59810463|NCT00388726|75932662|FG001|COMPLETED|Overall Study||10||
59810464|NCT00388726|75932661|FG000|NOT COMPLETED|Overall Study||484||
59810465|NCT00388726|75932662|FG001|NOT COMPLETED|Overall Study||244||
59967811|NCT02731755|76085514|FG000|COMPLETED|First Intervention||8||
59967812|NCT02731755|76085515|FG001|COMPLETED|First Intervention||8||
59967813|NCT02731755|76085514|FG000|NOT COMPLETED|First Intervention||0||
59967814|NCT02731755|76085515|FG001|NOT COMPLETED|First Intervention||2||
59810466|NCT00387790|75932668|FG000|STARTED|Overall Study||64||
59810467|NCT00387790|75932668|FG000|COMPLETED|Overall Study||50||
59810468|NCT00387790|75932668|FG000|NOT COMPLETED|Overall Study||14||
59967815|NCT02731755|76085514|FG000|STARTED|Second Intervention||8||
59967816|NCT02731755|76085515|FG001|STARTED|Second Intervention||8||
59967817|NCT02731755|76085514|FG000|COMPLETED|Second Intervention||8||
59967818|NCT02731755|76085515|FG001|COMPLETED|Second Intervention||8||
59967819|NCT02731755|76085514|FG000|NOT COMPLETED|Second Intervention||0||
59967820|NCT02731755|76085515|FG001|NOT COMPLETED|Second Intervention||0||
59810469|NCT00073021|75932674|FG000|STARTED|Overall Study|Subjects with Moderate Disease [PGA = 2] at Baseline|139||
59967821|NCT01704404|76085521|FG000|STARTED|Overall Study||11||
59967822|NCT01704404|76085522|FG001|STARTED|Overall Study||10||
59967823|NCT01704404|76085523|FG002|STARTED|Overall Study||10||
59967824|NCT01704404|76085524|FG003|STARTED|Overall Study||11||
59967825|NCT01704404|76085525|FG004|STARTED|Overall Study||11||
59810470|NCT00073021|75932675|FG001|STARTED|Overall Study|Subjects with Moderate Disease [PGA = 2] at Baseline|129||
59810471|NCT00073021|75932674|FG000|COMPLETED|Overall Study||113||
59810472|NCT00073021|75932675|FG001|COMPLETED|Overall Study||113||
59810473|NCT00073021|75932674|FG000|NOT COMPLETED|Overall Study||26||
59967826|NCT01704404|76085526|FG005|STARTED|Overall Study||9||
59967827|NCT01704404|76085521|FG000|COMPLETED|Overall Study||10||
59967828|NCT01704404|76085522|FG001|COMPLETED|Overall Study||9||
59967829|NCT01704404|76085523|FG002|COMPLETED|Overall Study||9||
59967830|NCT01704404|76085524|FG003|COMPLETED|Overall Study||8||
59967831|NCT01704404|76085525|FG004|COMPLETED|Overall Study||10||
59967832|NCT01704404|76085526|FG005|COMPLETED|Overall Study||9||
59967833|NCT01704404|76085521|FG000|NOT COMPLETED|Overall Study||1||
59967834|NCT01704404|76085522|FG001|NOT COMPLETED|Overall Study||1||
59967835|NCT01704404|76085523|FG002|NOT COMPLETED|Overall Study||1||
59967836|NCT01704404|76085524|FG003|NOT COMPLETED|Overall Study||3||
59967837|NCT01704404|76085525|FG004|NOT COMPLETED|Overall Study||1||
59967838|NCT01704404|76085526|FG005|NOT COMPLETED|Overall Study||0||
59967839|NCT02866175|76085544|FG000|STARTED|Overall Study||751||
59967840|NCT02866175|76085545|FG001|STARTED|Overall Study||755||
59967841|NCT02866175|76085544|FG000|COMPLETED|Overall Study||616||
59967842|NCT02866175|76085545|FG001|COMPLETED|Overall Study||580||
59967843|NCT02866175|76085544|FG000|NOT COMPLETED|Overall Study||135||
59967844|NCT02866175|76085545|FG001|NOT COMPLETED|Overall Study||175||
59967845|NCT01592643|76085552|FG000|STARTED|Overall Study||30||45
59967846|NCT01592643|76085552|FG000|COMPLETED|Overall Study||30||45
59967847|NCT01592643|76085552|FG000|NOT COMPLETED|Overall Study||0||0
59967848|NCT01336205|76085558|FG000|STARTED|Overall Study||563||
59967849|NCT01336205|76085559|FG001|STARTED|Overall Study||281||
59967850|NCT01336205|76085558|FG000|COMPLETED|Overall Study||330||
59967851|NCT01336205|76085559|FG001|COMPLETED|Overall Study||192||
59967852|NCT01336205|76085558|FG000|NOT COMPLETED|Overall Study||233||
59967853|NCT01336205|76085559|FG001|NOT COMPLETED|Overall Study||89||
59967854|NCT02865395|76085568|FG000|STARTED|Overall Study||6||
59967855|NCT02865395|76085569|FG001|STARTED|Overall Study||10||
59967856|NCT02865395|76085570|FG002|STARTED|Overall Study||7||
59967857|NCT02865395|76085568|FG000|COMPLETED|Overall Study|Data Not Collected|0||
59967858|NCT02865395|76085569|FG001|COMPLETED|Overall Study|Data Not Collected|0||
59967859|NCT02865395|76085570|FG002|COMPLETED|Overall Study|Data Not Collected|0||
59967860|NCT02865395|76085568|FG000|NOT COMPLETED|Overall Study||6||
59967861|NCT02865395|76085569|FG001|NOT COMPLETED|Overall Study||10||
59967862|NCT02865395|76085570|FG002|NOT COMPLETED|Overall Study||7||
59967863|NCT01123707|76085582|FG000|STARTED|Overall Study||44||
59967864|NCT01123707|76085583|FG001|STARTED|Overall Study||41||
59967865|NCT01123707|76085584|FG002|STARTED|Overall Study||38||
59967866|NCT01123707|76085585|FG003|STARTED|Overall Study||50||
59967867|NCT01123707|76085582|FG000|Safety Sample|Overall Study||44|Participants who received at least one dose of aripiprazole/escitalopram combination therapy.|
59967868|NCT01123707|76085583|FG001|Safety Sample|Overall Study||41|Participants who received at least one dose of aripiprazole/escitalopram combination therapy.|
59967869|NCT01123707|76085584|FG002|Safety Sample|Overall Study||36|Participants who received at least one dose of aripiprazole/escitalopram combination therapy.|
59967870|NCT01123707|76085585|FG003|Safety Sample|Overall Study||49|Participants who received at least one dose of aripiprazole/escitalopram combination therapy.|
59967871|NCT01123707|76085582|FG000|COMPLETED|Overall Study||0||
59967872|NCT01123707|76085583|FG001|COMPLETED|Overall Study||0||
59967873|NCT01123707|76085584|FG002|COMPLETED|Overall Study||0||
59967874|NCT01123707|76085585|FG003|COMPLETED|Overall Study||0||
59967875|NCT01123707|76085582|FG000|NOT COMPLETED|Overall Study||44||
59967876|NCT01123707|76085583|FG001|NOT COMPLETED|Overall Study||41||
59967877|NCT01123707|76085584|FG002|NOT COMPLETED|Overall Study||38||
59967878|NCT01123707|76085585|FG003|NOT COMPLETED|Overall Study||50||
59810474|NCT00073021|75932675|FG001|NOT COMPLETED|Overall Study||16||
59810475|NCT00407758|75932681|FG000|STARTED|Overall Study||28||
59810476|NCT00407758|75932681|FG000|COMPLETED|Overall Study||27|Eligible and treated patients.|
59810477|NCT00407758|75932681|FG000|NOT COMPLETED|Overall Study||1||
59810478|NCT00531752|75932689|FG000|STARTED|First Double-blind Intervention Period||17||
59967879|NCT02755103|76085597|FG000|STARTED|Overall Study||45||
59967880|NCT02755103|76085598|FG001|STARTED|Overall Study||45||
59967881|NCT02755103|76085597|FG000|8 Week Follow-up Completed|Overall Study||32||
59967882|NCT02755103|76085598|FG001|8 Week Follow-up Completed|Overall Study||28||
59967883|NCT02755103|76085597|FG000|3 Month Follow-up Completed|Overall Study||26||
59967884|NCT02755103|76085598|FG001|3 Month Follow-up Completed|Overall Study||27||
59967885|NCT02755103|76085597|FG000|COMPLETED|Overall Study||25|6 Month Follow-up Completed|
59967886|NCT02755103|76085598|FG001|COMPLETED|Overall Study||27|6 Month Follow-up Completed|
59967887|NCT02755103|76085597|FG000|NOT COMPLETED|Overall Study||20||
59967888|NCT02755103|76085598|FG001|NOT COMPLETED|Overall Study||18||
59967889|NCT01258803|76085608|FG000|STARTED|Treatment Period 1 (1 Dose)||15||
59967890|NCT01258803|76085609|FG001|STARTED|Treatment Period 1 (1 Dose)||16||
59995319|NCT04140396|76111163|FG001|NOT COMPLETED|Overall Study||0||
59995320|NCT04109976|76111169|FG000|STARTED|Overall Study||107||
59995321|NCT04109976|76111170|FG001|STARTED|Overall Study||107||
59995322|NCT04109976|76111169|FG000|COMPLETED|Overall Study||106||
59525230|NCT00062738|75620486|FG000|STARTED|Overall Study||17||
59525231|NCT00062738|75620487|FG001|STARTED|Overall Study||18||
59525232|NCT00062738|75620488|FG002|STARTED|Overall Study||17||
59525233|NCT00062738|75620486|FG000|COMPLETED|Overall Study||17||
59525234|NCT00062738|75620487|FG001|COMPLETED|Overall Study||18||
59525235|NCT00062738|75620488|FG002|COMPLETED|Overall Study||17||
59525236|NCT00062738|75620486|FG000|NOT COMPLETED|Overall Study||0||
59525237|NCT00062738|75620487|FG001|NOT COMPLETED|Overall Study||0||
59525238|NCT00062738|75620488|FG002|NOT COMPLETED|Overall Study||0||
59525239|NCT00063362|75620501|FG000|STARTED|Overall Study||23||
59525240|NCT00063362|75620502|FG001|STARTED|Overall Study||26||
59525241|NCT00063362|75620501|FG000|COMPLETED|Overall Study||19||
59525242|NCT00063362|75620502|FG001|COMPLETED|Overall Study||22||
59525243|NCT00063362|75620501|FG000|NOT COMPLETED|Overall Study||4||
59525244|NCT00063362|75620502|FG001|NOT COMPLETED|Overall Study||4||
59525245|NCT00064844|75620510|FG000|STARTED|Overall Study||45||
59525246|NCT00064844|75620511|FG001|STARTED|Overall Study||51||
59525247|NCT00064844|75620510|FG000|2 Week Follow-up|Overall Study||45||
59525248|NCT00064844|75620511|FG001|2 Week Follow-up|Overall Study||51||
59525249|NCT00064844|75620510|FG000|3 Month Follow-up|Overall Study||40||
59525250|NCT00064844|75620511|FG001|3 Month Follow-up|Overall Study||47||
59525251|NCT00064844|75620510|FG000|6 Month Follow-up|Overall Study||39||
59525252|NCT00064844|75620511|FG001|6 Month Follow-up|Overall Study||40||
59525253|NCT00064844|75620510|FG000|12 Month Follow-up|Overall Study||37||
59525254|NCT00064844|75620511|FG001|12 Month Follow-up|Overall Study||32||
59525255|NCT00064844|75620510|FG000|COMPLETED|Overall Study||37||
59525256|NCT00064844|75620511|FG001|COMPLETED|Overall Study||32||
59525257|NCT00064844|75620510|FG000|NOT COMPLETED|Overall Study||8||
59525258|NCT00064844|75620511|FG001|NOT COMPLETED|Overall Study||19||
59525259|NCT00067028|75620520|FG000|STARTED|Overall Study||17||
59525260|NCT00067028|75620521|FG001|STARTED|Overall Study||36||
59525261|NCT00067028|75620522|FG002|STARTED|Overall Study||63||
59525262|NCT00067028|75620520|FG000|COMPLETED|Overall Study||17||
59525263|NCT00067028|75620521|FG001|COMPLETED|Overall Study||36||
59525264|NCT00067028|75620522|FG002|COMPLETED|Overall Study||63||
59525265|NCT00067028|75620520|FG000|NOT COMPLETED|Overall Study||0||
59525266|NCT00067028|75620521|FG001|NOT COMPLETED|Overall Study||0||
59525267|NCT00067028|75620522|FG002|NOT COMPLETED|Overall Study||0||
59525268|NCT00067808|75620535|FG000|STARTED|Overall Study||17||
59525269|NCT00067808|75620536|FG001|STARTED|Overall Study||93||
59525270|NCT00067808|75620537|FG002|STARTED|Overall Study||14||
59525271|NCT00067808|75620535|FG000|COMPLETED|Overall Study||17||
59525272|NCT00067808|75620536|FG001|COMPLETED|Overall Study||93||
59525273|NCT00067808|75620537|FG002|COMPLETED|Overall Study||14||
59967891|NCT01258803|76085610|FG002|STARTED|Treatment Period 1 (1 Dose)||15||
59967892|NCT01258803|76085611|FG003|STARTED|Treatment Period 1 (1 Dose)||15||
59967893|NCT01258803|76085612|FG004|STARTED|Treatment Period 1 (1 Dose)||15||
59967894|NCT01258803|76085613|FG005|STARTED|Treatment Period 1 (1 Dose)||16||
59967895|NCT01258803|76085608|FG000|COMPLETED|Treatment Period 1 (1 Dose)||15||
59967896|NCT01258803|76085609|FG001|COMPLETED|Treatment Period 1 (1 Dose)||16||
59967897|NCT01258803|76085610|FG002|COMPLETED|Treatment Period 1 (1 Dose)||15||
59967898|NCT01258803|76085611|FG003|COMPLETED|Treatment Period 1 (1 Dose)||15||
59967899|NCT01258803|76085612|FG004|COMPLETED|Treatment Period 1 (1 Dose)||15||
60074346|NCT01770860|76189721|FG000|COMPLETED|Overall Study||40||
59525274|NCT00067808|75620535|FG000|NOT COMPLETED|Overall Study||0||
59525275|NCT00067808|75620536|FG001|NOT COMPLETED|Overall Study||0||
59525276|NCT00067808|75620537|FG002|NOT COMPLETED|Overall Study||0||
59525277|NCT00493870|75620547|FG000|STARTED|Overall Study||981||
59525278|NCT00493870|75620548|FG001|STARTED|Overall Study||980||
59525279|NCT00493870|75620547|FG000|COMPLETED|Overall Study||969||
59525280|NCT00493870|75620548|FG001|COMPLETED|Overall Study||965||
59525281|NCT00493870|75620547|FG000|NOT COMPLETED|Overall Study||12||
59525282|NCT00493870|75620548|FG001|NOT COMPLETED|Overall Study||15||
59525283|NCT01063829|75620564|FG000|STARTED|Overall Study||33||
59967900|NCT01258803|76085613|FG005|COMPLETED|Treatment Period 1 (1 Dose)||16||
59967901|NCT01258803|76085608|FG000|NOT COMPLETED|Treatment Period 1 (1 Dose)||0||
59967902|NCT01258803|76085609|FG001|NOT COMPLETED|Treatment Period 1 (1 Dose)||0||
59967903|NCT01258803|76085610|FG002|NOT COMPLETED|Treatment Period 1 (1 Dose)||0||
59967904|NCT01258803|76085611|FG003|NOT COMPLETED|Treatment Period 1 (1 Dose)||0||
59967905|NCT01258803|76085612|FG004|NOT COMPLETED|Treatment Period 1 (1 Dose)||0||
59967906|NCT01258803|76085613|FG005|NOT COMPLETED|Treatment Period 1 (1 Dose)||0||
59525284|NCT01063829|75620565|FG001|STARTED|Overall Study||31||
59525285|NCT01063829|75620566|FG002|STARTED|Overall Study||34||
59967907|NCT01258803|76085608|FG000|STARTED|Treatment Period 2 (1 Dose)||15||
59525286|NCT01063829|75620567|FG003|STARTED|Overall Study||33||
59525287|NCT01063829|75620564|FG000|COMPLETED|Overall Study|Non-completers considered as failure; FAS|17||
59525288|NCT01063829|75620565|FG001|COMPLETED|Overall Study|Non-completers considered as failure; FAS|21||
59525289|NCT01063829|75620566|FG002|COMPLETED|Overall Study|Non-completers considered as failure; FAS|24||
59525290|NCT01063829|75620567|FG003|COMPLETED|Overall Study|Non-completers considered as failure; FAS|12||
59525291|NCT01063829|75620564|FG000|NOT COMPLETED|Overall Study||16||
59525292|NCT01063829|75620565|FG001|NOT COMPLETED|Overall Study||10||
59967908|NCT01258803|76085609|FG001|STARTED|Treatment Period 2 (1 Dose)||16||
59967909|NCT01258803|76085610|FG002|STARTED|Treatment Period 2 (1 Dose)||15||
59967910|NCT01258803|76085611|FG003|STARTED|Treatment Period 2 (1 Dose)||15||
59967911|NCT01258803|76085612|FG004|STARTED|Treatment Period 2 (1 Dose)||15||
59967912|NCT01258803|76085613|FG005|STARTED|Treatment Period 2 (1 Dose)||16||
59967913|NCT01258803|76085608|FG000|COMPLETED|Treatment Period 2 (1 Dose)||14||
59967914|NCT01258803|76085609|FG001|COMPLETED|Treatment Period 2 (1 Dose)||14||
59967915|NCT01258803|76085610|FG002|COMPLETED|Treatment Period 2 (1 Dose)||15||
59967916|NCT01258803|76085611|FG003|COMPLETED|Treatment Period 2 (1 Dose)||15||
59967917|NCT01258803|76085612|FG004|COMPLETED|Treatment Period 2 (1 Dose)||15||
59967918|NCT01258803|76085613|FG005|COMPLETED|Treatment Period 2 (1 Dose)||15||
59967919|NCT01258803|76085608|FG000|NOT COMPLETED|Treatment Period 2 (1 Dose)||1||
59967920|NCT01258803|76085609|FG001|NOT COMPLETED|Treatment Period 2 (1 Dose)||2||
59967921|NCT01258803|76085610|FG002|NOT COMPLETED|Treatment Period 2 (1 Dose)||0||
59967922|NCT01258803|76085611|FG003|NOT COMPLETED|Treatment Period 2 (1 Dose)||0||
59967923|NCT01258803|76085612|FG004|NOT COMPLETED|Treatment Period 2 (1 Dose)||0||
59967924|NCT01258803|76085613|FG005|NOT COMPLETED|Treatment Period 2 (1 Dose)||1||
59967925|NCT01258803|76085608|FG000|STARTED|Treatment Period 3 (1 Dose)||14||
59967926|NCT01258803|76085609|FG001|STARTED|Treatment Period 3 (1 Dose)||14||
59967927|NCT01258803|76085610|FG002|STARTED|Treatment Period 3 (1 Dose)||15||
59967928|NCT01258803|76085611|FG003|STARTED|Treatment Period 3 (1 Dose)||15||
59967929|NCT01258803|76085612|FG004|STARTED|Treatment Period 3 (1 Dose)||15||
59967930|NCT01258803|76085613|FG005|STARTED|Treatment Period 3 (1 Dose)||15||
59967931|NCT01258803|76085608|FG000|COMPLETED|Treatment Period 3 (1 Dose)||14||
59967932|NCT01258803|76085609|FG001|COMPLETED|Treatment Period 3 (1 Dose)||14||
59967933|NCT01258803|76085610|FG002|COMPLETED|Treatment Period 3 (1 Dose)||14||
59967934|NCT01258803|76085611|FG003|COMPLETED|Treatment Period 3 (1 Dose)||15||
59967935|NCT01258803|76085612|FG004|COMPLETED|Treatment Period 3 (1 Dose)||15||
59967936|NCT01258803|76085613|FG005|COMPLETED|Treatment Period 3 (1 Dose)||15||
59967937|NCT01258803|76085608|FG000|NOT COMPLETED|Treatment Period 3 (1 Dose)||0||
59967938|NCT01258803|76085609|FG001|NOT COMPLETED|Treatment Period 3 (1 Dose)||0||
59967939|NCT01258803|76085610|FG002|NOT COMPLETED|Treatment Period 3 (1 Dose)||1||
59967940|NCT01258803|76085611|FG003|NOT COMPLETED|Treatment Period 3 (1 Dose)||0||
59967941|NCT01258803|76085612|FG004|NOT COMPLETED|Treatment Period 3 (1 Dose)||0||
59967942|NCT01258803|76085613|FG005|NOT COMPLETED|Treatment Period 3 (1 Dose)||0||
59967943|NCT01258803|76085608|FG000|STARTED|Treatment Period 4 (1 Dose)||14||
59967944|NCT01258803|76085609|FG001|STARTED|Treatment Period 4 (1 Dose)||14||
59967945|NCT01258803|76085610|FG002|STARTED|Treatment Period 4 (1 Dose)||14||
59967946|NCT01258803|76085611|FG003|STARTED|Treatment Period 4 (1 Dose)||15||
59810479|NCT00531752|75932690|FG001|STARTED|First Double-blind Intervention Period||17||
59810480|NCT00531752|75932691|FG002|STARTED|First Double-blind Intervention Period||16||
59810481|NCT00531752|75932692|FG003|STARTED|First Double-blind Intervention Period||16||
59810482|NCT00531752|75932689|FG000|Treated|First Double-blind Intervention Period||16||
59810483|NCT00531752|75932690|FG001|Treated|First Double-blind Intervention Period||17||
59810484|NCT00531752|75932691|FG002|Treated|First Double-blind Intervention Period||16||
59967947|NCT01258803|76085612|FG004|STARTED|Treatment Period 4 (1 Dose)||15||
59967948|NCT01258803|76085613|FG005|STARTED|Treatment Period 4 (1 Dose)||15||
59810485|NCT00531752|75932692|FG003|Treated|First Double-blind Intervention Period||16||
59967949|NCT01258803|76085608|FG000|COMPLETED|Treatment Period 4 (1 Dose)||14||
59967950|NCT01258803|76085609|FG001|COMPLETED|Treatment Period 4 (1 Dose)||14||
59967951|NCT01258803|76085610|FG002|COMPLETED|Treatment Period 4 (1 Dose)||14||
59967952|NCT01258803|76085611|FG003|COMPLETED|Treatment Period 4 (1 Dose)||15||
59967953|NCT01258803|76085612|FG004|COMPLETED|Treatment Period 4 (1 Dose)||15||
59967954|NCT01258803|76085613|FG005|COMPLETED|Treatment Period 4 (1 Dose)||15||
59967955|NCT01258803|76085608|FG000|NOT COMPLETED|Treatment Period 4 (1 Dose)||0||
59967956|NCT01258803|76085609|FG001|NOT COMPLETED|Treatment Period 4 (1 Dose)||0||
59967957|NCT01258803|76085610|FG002|NOT COMPLETED|Treatment Period 4 (1 Dose)||0||
59967958|NCT01258803|76085611|FG003|NOT COMPLETED|Treatment Period 4 (1 Dose)||0||
59967959|NCT01258803|76085612|FG004|NOT COMPLETED|Treatment Period 4 (1 Dose)||0||
59967960|NCT01258803|76085613|FG005|NOT COMPLETED|Treatment Period 4 (1 Dose)||0||
59967961|NCT02865083|76085629|FG000|STARTED|Overall Study||3||
59967962|NCT02865083|76085630|FG001|STARTED|Overall Study||1||
59967963|NCT02865083|76085629|FG000|COMPLETED|Overall Study||0||
59967964|NCT02865083|76085630|FG001|COMPLETED|Overall Study||0||
59967965|NCT02865083|76085629|FG000|NOT COMPLETED|Overall Study||3||
59967966|NCT02865083|76085630|FG001|NOT COMPLETED|Overall Study||1||
59967967|NCT00862251|76085639|FG000|STARTED|Overall Study||322||
59967968|NCT00862251|76085640|FG001|STARTED|Overall Study||162||
59967969|NCT00862251|76085641|FG002|STARTED|Overall Study||324||
59810486|NCT00531752|75932689|FG000|COMPLETED|First Double-blind Intervention Period||11||
59810487|NCT00531752|75932690|FG001|COMPLETED|First Double-blind Intervention Period||13||
59810488|NCT00531752|75932691|FG002|COMPLETED|First Double-blind Intervention Period||9||
59967970|NCT00862251|76085639|FG000|COMPLETED|Overall Study||303||
59967971|NCT00862251|76085640|FG001|COMPLETED|Overall Study||157||
59967972|NCT00862251|76085641|FG002|COMPLETED|Overall Study||315||
59967973|NCT00862251|76085639|FG000|NOT COMPLETED|Overall Study||19||
59810489|NCT00531752|75932692|FG003|COMPLETED|First Double-blind Intervention Period||13||
59810490|NCT00531752|75932689|FG000|NOT COMPLETED|First Double-blind Intervention Period||6||
59810491|NCT00531752|75932690|FG001|NOT COMPLETED|First Double-blind Intervention Period||4||
59810492|NCT00531752|75932691|FG002|NOT COMPLETED|First Double-blind Intervention Period||7||
59810493|NCT00531752|75932692|FG003|NOT COMPLETED|First Double-blind Intervention Period||3||
59967974|NCT00862251|76085640|FG001|NOT COMPLETED|Overall Study||5||
59967975|NCT00862251|76085641|FG002|NOT COMPLETED|Overall Study||9||
59967976|NCT00038727|76085655|FG000|STARTED|Overall Study|Includes all enrollees from DPPOS 1-3|916||
59967977|NCT00038727|76085656|FG001|STARTED|Overall Study|Includes all enrollees from DPPOS 1-3|927||
59967978|NCT00038727|76085657|FG002|STARTED|Overall Study|Includes all enrollees from DPPOS 1-3|936||
59967979|NCT00038727|76085655|FG000|DPPOS Phase 1 Primary|Overall Study|As reported in the Lancet 2009|910||
59967980|NCT00038727|76085656|FG001|DPPOS Phase 1 Primary|Overall Study|As reported in the Lancet 2009|924||
59967981|NCT00038727|76085657|FG002|DPPOS Phase 1 Primary|Overall Study|As reported in the Lancet 2009|932||
59967982|NCT00038727|76085655|FG000|DPPOS Phase 2 Enrolled|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|915||
59967983|NCT00038727|76085656|FG001|DPPOS Phase 2 Enrolled|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|926||
59967984|NCT00038727|76085657|FG002|DPPOS Phase 2 Enrolled|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|935||
59967985|NCT00038727|76085655|FG000|DPPOS Phase 2 Primary|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|751||
59967986|NCT00038727|76085656|FG001|DPPOS Phase 2 Primary|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|772||
59967987|NCT00038727|76085657|FG002|DPPOS Phase 2 Primary|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|780||
59967988|NCT00038727|76085655|FG000|DPPOS Phase 3 Enrolled|Overall Study||916|As of February 2016|
59967989|NCT00038727|76085656|FG001|DPPOS Phase 3 Enrolled|Overall Study||927|As of February 2016|
59967990|NCT00038727|76085657|FG002|DPPOS Phase 3 Enrolled|Overall Study||936|As of February 2016|
59967991|NCT00038727|76085655|FG000|COMPLETED|Overall Study||916||
59967992|NCT00038727|76085656|FG001|COMPLETED|Overall Study||927||
59967993|NCT00038727|76085657|FG002|COMPLETED|Overall Study||936||
59967994|NCT00038727|76085655|FG000|NOT COMPLETED|Overall Study||0||
59967995|NCT00038727|76085656|FG001|NOT COMPLETED|Overall Study||0||
59967996|NCT00038727|76085657|FG002|NOT COMPLETED|Overall Study||0||
59967997|NCT02864381|76085670|FG000|STARTED|Overall Study||72||
59967998|NCT02864381|76085671|FG001|STARTED|Overall Study||72||
59967999|NCT02864381|76085670|FG000|COMPLETED|Overall Study||0||
59968000|NCT02864381|76085671|FG001|COMPLETED|Overall Study||0||
59968001|NCT02864381|76085670|FG000|NOT COMPLETED|Overall Study||72||
59810494|NCT00531752|75932689|FG000|STARTED|Wash-out Period (at Least 7 Days)||11||
59810495|NCT00531752|75932690|FG001|STARTED|Wash-out Period (at Least 7 Days)||13||
59810496|NCT00531752|75932691|FG002|STARTED|Wash-out Period (at Least 7 Days)||9||
59810497|NCT00531752|75932692|FG003|STARTED|Wash-out Period (at Least 7 Days)||13||
59810498|NCT00531752|75932689|FG000|COMPLETED|Wash-out Period (at Least 7 Days)||11||
59810499|NCT00531752|75932690|FG001|COMPLETED|Wash-out Period (at Least 7 Days)||13||
59968002|NCT02864381|76085671|FG001|NOT COMPLETED|Overall Study||72||
59968003|NCT02860169|76085679|FG000|STARTED|Part A||46|Part A recruited healthy participants for an online survey.|
59968004|NCT02860169|76085679|FG000|Healthy Participants|Part A||46||
59968005|NCT02860169|76085679|FG000|Participants With Cold and Flu|Part A||0||
60074347|NCT01770860|76189721|FG000|NOT COMPLETED|Overall Study||6||
60074348|NCT01603875|76189732|FG000|STARTED|Overall Study||35||
60074349|NCT01603875|76189733|FG001|STARTED|Overall Study||35||
60074350|NCT01603875|76189734|FG002|STARTED|Overall Study||35||
59810500|NCT00531752|75932691|FG002|COMPLETED|Wash-out Period (at Least 7 Days)||9||
59810501|NCT00531752|75932692|FG003|COMPLETED|Wash-out Period (at Least 7 Days)||13||
59810502|NCT00531752|75932689|FG000|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0||
59810503|NCT00531752|75932690|FG001|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0||
59810504|NCT00531752|75932691|FG002|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0||
59810505|NCT00531752|75932692|FG003|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0||
59810506|NCT00531752|75932689|FG000|STARTED|Second Double-blind Intervention Period||11||
59810507|NCT00531752|75932690|FG001|STARTED|Second Double-blind Intervention Period||13||
59810508|NCT00531752|75932691|FG002|STARTED|Second Double-blind Intervention Period||9||
59810509|NCT00531752|75932692|FG003|STARTED|Second Double-blind Intervention Period||13||
59810510|NCT00531752|75932689|FG000|COMPLETED|Second Double-blind Intervention Period||9||
59968006|NCT02860169|76085679|FG000|COMPLETED|Part A||35||
59968007|NCT02860169|76085679|FG000|NOT COMPLETED|Part A||11||
59968008|NCT02860169|76085679|FG000|STARTED|Part B||20|Part B separately recruited healthy (control) and cold and flu participants.|
59968009|NCT02860169|76085679|FG000|Healthy Participants|Part B||10||
59968010|NCT02860169|76085679|FG000|Participants With Cold and Flu|Part B||10||
59968011|NCT02860169|76085679|FG000|COMPLETED|Part B||9||
59968012|NCT02860169|76085679|FG000|NOT COMPLETED|Part B||11||
59968013|NCT02860169|76085679|FG000|STARTED|Part C||48|Part C separately recruited healthy (control) and cold and flu participants.|
60074351|NCT01603875|76189732|FG000|COMPLETED|Overall Study||28||
60074352|NCT01603875|76189733|FG001|COMPLETED|Overall Study||27||
59810511|NCT00531752|75932690|FG001|COMPLETED|Second Double-blind Intervention Period||11||
60074353|NCT01603875|76189734|FG002|COMPLETED|Overall Study||26||
60074354|NCT01603875|76189732|FG000|NOT COMPLETED|Overall Study||7||
59968014|NCT02860169|76085679|FG000|Healthy Participants|Part C||6||
59968015|NCT02860169|76085679|FG000|Participants With Cold and Flu|Part C||42||
59968016|NCT02860169|76085679|FG000|COMPLETED|Part C||47||
59968017|NCT02860169|76085679|FG000|NOT COMPLETED|Part C||1||
59968018|NCT00409773|76085690|FG000|STARTED|Overall Study||229||
59968019|NCT00409773|76085691|FG001|STARTED|Overall Study||229||
59968020|NCT00409773|76085692|FG002|STARTED|Overall Study||229||
59968021|NCT00409773|76085693|FG003|STARTED|Overall Study||228||
59968022|NCT00409773|76085694|FG004|STARTED|Overall Study||228||
59968023|NCT00409773|76085690|FG000|COMPLETED|Overall Study||220||
59968024|NCT00409773|76085691|FG001|COMPLETED|Overall Study||222||
59968025|NCT00409773|76085692|FG002|COMPLETED|Overall Study||220||
59968026|NCT00409773|76085693|FG003|COMPLETED|Overall Study||216||
59968027|NCT00409773|76085694|FG004|COMPLETED|Overall Study||218||
59968028|NCT00409773|76085690|FG000|NOT COMPLETED|Overall Study||9||
59968029|NCT00409773|76085691|FG001|NOT COMPLETED|Overall Study||7||
59968030|NCT00409773|76085692|FG002|NOT COMPLETED|Overall Study||9||
59968031|NCT00409773|76085693|FG003|NOT COMPLETED|Overall Study||12||
59968032|NCT00409773|76085694|FG004|NOT COMPLETED|Overall Study||10||
59968033|NCT02861807|76085708|FG000|STARTED|Overall Study||47||
59968034|NCT02861807|76085709|FG001|STARTED|Overall Study||37||
59968035|NCT02861807|76085708|FG000|Attended Post-treatment Assessment|Overall Study||34||
59968036|NCT02861807|76085709|FG001|Attended Post-treatment Assessment|Overall Study||18||
59968037|NCT02861807|76085708|FG000|Attended 2-month Follow-up|Overall Study||32||
59968038|NCT02861807|76085709|FG001|Attended 2-month Follow-up|Overall Study||20||
59968039|NCT02861807|76085708|FG000|COMPLETED|Overall Study||35||
59968040|NCT02861807|76085709|FG001|COMPLETED|Overall Study||23||
59968041|NCT02861807|76085708|FG000|NOT COMPLETED|Overall Study||12||
59968042|NCT02861807|76085709|FG001|NOT COMPLETED|Overall Study||14||
59968043|NCT02858401|76085722|FG000|STARTED|Overall Study||6||
59968044|NCT02858401|76085723|FG001|STARTED|Overall Study||6||
59968045|NCT02858401|76085724|FG002|STARTED|Overall Study||6||
59968046|NCT02858401|76085725|FG003|STARTED|Overall Study||6||
59968047|NCT02858401|76085726|FG004|STARTED|Overall Study||6||
59968048|NCT02858401|76085727|FG005|STARTED|Overall Study||6||
59968049|NCT02858401|76085728|FG006|STARTED|Overall Study||12||
59968050|NCT02858401|76085722|FG000|COMPLETED|Overall Study||6||
59968051|NCT02858401|76085723|FG001|COMPLETED|Overall Study||5||
59968052|NCT02858401|76085724|FG002|COMPLETED|Overall Study||6||
59968053|NCT02858401|76085725|FG003|COMPLETED|Overall Study||6||
59968054|NCT02858401|76085726|FG004|COMPLETED|Overall Study||6||
59968055|NCT02858401|76085727|FG005|COMPLETED|Overall Study||5||
59968056|NCT02858401|76085728|FG006|COMPLETED|Overall Study||12||
59968057|NCT02858401|76085722|FG000|NOT COMPLETED|Overall Study||0||
59968058|NCT02858401|76085723|FG001|NOT COMPLETED|Overall Study||1||
59968059|NCT02858401|76085724|FG002|NOT COMPLETED|Overall Study||0||
59968060|NCT02858401|76085725|FG003|NOT COMPLETED|Overall Study||0||
59968061|NCT02858401|76085726|FG004|NOT COMPLETED|Overall Study||0||
59968062|NCT02858401|76085727|FG005|NOT COMPLETED|Overall Study||1||
59525293|NCT01063829|75620566|FG002|NOT COMPLETED|Overall Study||10||
59525294|NCT01063829|75620567|FG003|NOT COMPLETED|Overall Study||21||
59968063|NCT02858401|76085728|FG006|NOT COMPLETED|Overall Study||0||
59968064|NCT02857283|76085755|FG000|STARTED|First Exposure||8||
59968065|NCT02857283|76085756|FG001|STARTED|First Exposure||7||
59968066|NCT02857283|76085755|FG000|COMPLETED|First Exposure||7||
59968067|NCT02857283|76085756|FG001|COMPLETED|First Exposure||7||
59968068|NCT02857283|76085755|FG000|NOT COMPLETED|First Exposure||1||
59968069|NCT02857283|76085756|FG001|NOT COMPLETED|First Exposure||0||
59968070|NCT02857283|76085755|FG000|STARTED|Washout (2 Weeks)||7||
59968071|NCT02857283|76085756|FG001|STARTED|Washout (2 Weeks)||7||
59525295|NCT00072566|75620577|FG000|STARTED|Overall Study||70||
59525296|NCT00072566|75620577|FG000|COMPLETED|Overall Study||70||
59525297|NCT00072566|75620577|FG000|NOT COMPLETED|Overall Study||0||
59525298|NCT01258855|75620583|FG000|STARTED|Overall Study||55||
59525299|NCT01258855|75620584|FG001|STARTED|Overall Study||29||
59525300|NCT01258855|75620583|FG000|COMPLETED|Overall Study||55||
59525301|NCT01258855|75620584|FG001|COMPLETED|Overall Study||29||
59525302|NCT01258855|75620583|FG000|NOT COMPLETED|Overall Study||0||
59525303|NCT01258855|75620584|FG001|NOT COMPLETED|Overall Study||0||
59968072|NCT02857283|76085755|FG000|COMPLETED|Washout (2 Weeks)||7||
59968073|NCT02857283|76085756|FG001|COMPLETED|Washout (2 Weeks)||7||
59968074|NCT02857283|76085755|FG000|NOT COMPLETED|Washout (2 Weeks)||0||
59968075|NCT02857283|76085756|FG001|NOT COMPLETED|Washout (2 Weeks)||0||
59968076|NCT02857283|76085755|FG000|STARTED|Second Exposure||7||
59968077|NCT02857283|76085756|FG001|STARTED|Second Exposure||7||
59968078|NCT02857283|76085755|FG000|COMPLETED|Second Exposure||7||
59968079|NCT02857283|76085756|FG001|COMPLETED|Second Exposure||7||
59968080|NCT02857283|76085755|FG000|NOT COMPLETED|Second Exposure||0||
59525304|NCT01259011|75620592|FG000|STARTED|Main Study Period|101 dyads (=202 individuals)|101||
59525305|NCT01259011|75620593|FG001|STARTED|Main Study Period|109 dyads (=218 individuals)|109||
59525306|NCT01259011|75620592|FG000|COMPLETED|Main Study Period||101||
59525307|NCT01259011|75620593|FG001|COMPLETED|Main Study Period||109||
59968081|NCT02857283|76085756|FG001|NOT COMPLETED|Second Exposure||0||
59968082|NCT02734667|76085765|FG000|STARTED|Overall Study||84||
59968083|NCT02734667|76085766|FG001|STARTED|Overall Study||36||
59968084|NCT02734667|76085765|FG000|Youth|Overall Study||42||
59968085|NCT02734667|76085766|FG001|Youth|Overall Study||18||
59968086|NCT02734667|76085765|FG000|Parent|Overall Study||42||
59968087|NCT02734667|76085766|FG001|Parent|Overall Study||18||
59968088|NCT02734667|76085765|FG000|COMPLETED|Overall Study||82||
59968089|NCT02734667|76085766|FG001|COMPLETED|Overall Study||30||
59968090|NCT02734667|76085765|FG000|NOT COMPLETED|Overall Study||2||
59968091|NCT02734667|76085766|FG001|NOT COMPLETED|Overall Study||6||
59968092|NCT02746679|76085774|FG000|STARTED|Overall Study||80||
59968093|NCT02746679|76085775|FG001|STARTED|Overall Study||81||
59968094|NCT02746679|76085774|FG000|COMPLETED|Overall Study||76||
59968095|NCT02746679|76085775|FG001|COMPLETED|Overall Study||75||
59968096|NCT02746679|76085774|FG000|NOT COMPLETED|Overall Study||4||
59968097|NCT02746679|76085775|FG001|NOT COMPLETED|Overall Study||6||
59968098|NCT02731131|76085783|FG000|STARTED|Overall Study||6||
59968099|NCT02731131|76085784|FG001|STARTED|Overall Study||6||
59968100|NCT02731131|76085783|FG000|COMPLETED|Overall Study||6||
59968101|NCT02731131|76085784|FG001|COMPLETED|Overall Study||4||
59968102|NCT02731131|76085783|FG000|NOT COMPLETED|Overall Study||0||
59968103|NCT02731131|76085784|FG001|NOT COMPLETED|Overall Study||2||
59968104|NCT02746705|76085792|FG000|STARTED|Overall Study||17||
59968105|NCT02746705|76085793|FG001|STARTED|Overall Study||14||
59968106|NCT02746705|76085792|FG000|COMPLETED|Overall Study||15||
59968107|NCT02746705|76085793|FG001|COMPLETED|Overall Study||12||
59968108|NCT02746705|76085792|FG000|NOT COMPLETED|Overall Study||2||
59968109|NCT02746705|76085793|FG001|NOT COMPLETED|Overall Study||2||
59968110|NCT02746627|76085802|FG000|STARTED|Overall Study||60||
59968111|NCT02746627|76085803|FG001|STARTED|Overall Study||30||
59968112|NCT02746627|76085804|FG002|STARTED|Overall Study||30||
59810512|NCT00531752|75932691|FG002|COMPLETED|Second Double-blind Intervention Period||9||
59810513|NCT00531752|75932692|FG003|COMPLETED|Second Double-blind Intervention Period||11||
59810514|NCT00531752|75932689|FG000|NOT COMPLETED|Second Double-blind Intervention Period||2||
59810515|NCT00531752|75932690|FG001|NOT COMPLETED|Second Double-blind Intervention Period||2||
59810516|NCT00531752|75932691|FG002|NOT COMPLETED|Second Double-blind Intervention Period||0||
59810517|NCT00531752|75932692|FG003|NOT COMPLETED|Second Double-blind Intervention Period||2||
59810518|NCT00395746|75932703|FG000|STARTED|Overall Study|Exposed to study drug|88||
59810519|NCT00395746|75932704|FG001|STARTED|Overall Study|Exposed to study drug|88||
59810520|NCT00395746|75932705|FG002|STARTED|Overall Study|Exposed to study drug|88||
59810521|NCT00395746|75932703|FG000|COMPLETED|Overall Study|Completed 52 weeks treatment|78||
59810522|NCT00395746|75932704|FG001|COMPLETED|Overall Study|Completed 52 weeks treatment|84||
59810523|NCT00395746|75932705|FG002|COMPLETED|Overall Study|Completed 52 weeks treatment|66||
59810524|NCT00395746|75932703|FG000|NOT COMPLETED|Overall Study||10||
59810525|NCT00395746|75932704|FG001|NOT COMPLETED|Overall Study||4||
59810526|NCT00395746|75932705|FG002|NOT COMPLETED|Overall Study||22||
59810527|NCT00055471|75932716|FG000|STARTED|Period 1: Dose Escalation Period||3||
59810528|NCT00055471|75932717|FG001|STARTED|Period 1: Dose Escalation Period|Dose level given only after lower dose was successfully administered.|10||
59810529|NCT00055471|75932718|FG002|STARTED|Period 1: Dose Escalation Period|Dose level given only after lower dose was successfully administered.|3||
59810530|NCT00055471|75932716|FG000|COMPLETED|Period 1: Dose Escalation Period||3||
59810531|NCT00055471|75932717|FG001|COMPLETED|Period 1: Dose Escalation Period||8||
59810532|NCT00055471|75932718|FG002|COMPLETED|Period 1: Dose Escalation Period||0||
59810533|NCT00055471|75932716|FG000|NOT COMPLETED|Period 1: Dose Escalation Period||0||
59810534|NCT00055471|75932717|FG001|NOT COMPLETED|Period 1: Dose Escalation Period||2||
59810535|NCT00055471|75932718|FG002|NOT COMPLETED|Period 1: Dose Escalation Period||3||
59968113|NCT02746627|76085802|FG000|COMPLETED|Overall Study||59||
59968114|NCT02746627|76085803|FG001|COMPLETED|Overall Study||29||
59968115|NCT02746627|76085804|FG002|COMPLETED|Overall Study||29||
59968116|NCT02746627|76085802|FG000|NOT COMPLETED|Overall Study||1||
59968117|NCT02746627|76085803|FG001|NOT COMPLETED|Overall Study||1||
59968118|NCT02746627|76085804|FG002|NOT COMPLETED|Overall Study||1||
59968119|NCT02856113|76085814|FG000|STARTED|Overall Study||77||
59968120|NCT02856113|76085815|FG001|STARTED|Overall Study||75||
59968121|NCT02856113|76085814|FG000|Safety Population|Overall Study||76|Safety Population included all participants who took at least 1 dose of study medication. One participant was randomized in error and did not receive any study medication.|
59968122|NCT02856113|76085815|FG001|Safety Population|Overall Study||75|Safety Population included all participants who took at least 1 dose of study medication. One participant was randomized in error and did not receive any study medication.|
59968123|NCT02856113|76085814|FG000|COMPLETED|Overall Study||66|Data is reported for participants who completed all study visits.|
60074355|NCT01603875|76189733|FG001|NOT COMPLETED|Overall Study||8||
60074356|NCT01603875|76189734|FG002|NOT COMPLETED|Overall Study||9||
60074357|NCT01770392|76189742|FG000|STARTED|Nintedanib||26||
59968124|NCT02856113|76085815|FG001|COMPLETED|Overall Study||60|Data is reported for participants who completed all study visits.|
59968125|NCT02856113|76085814|FG000|NOT COMPLETED|Overall Study||11||
59968126|NCT02856113|76085815|FG001|NOT COMPLETED|Overall Study||15||
59968127|NCT02855411|76085822|FG000|STARTED|Overall Study||35||
59968128|NCT02855411|76085822|FG000|Assigned to Study Treatment|Overall Study||0||
59968129|NCT02855411|76085822|FG000|COMPLETED|Overall Study||0||
59968130|NCT02855411|76085822|FG000|NOT COMPLETED|Overall Study||35||
59968131|NCT02745145|76085829|FG000|STARTED|Overall Study||10||
59968132|NCT02745145|76085830|FG001|STARTED|Overall Study||5||
59968133|NCT02745145|76085831|FG002|STARTED|Overall Study||9||
59968134|NCT02745145|76085829|FG000|COMPLETED|Overall Study||0||
59810536|NCT00055471|75932716|FG000|STARTED|Period 2: Extension Period|Period 2 - attend Pts who,in the opinion of the Investigator,show benefit from treatment with ZD4054|3||
59810537|NCT00055471|75932717|FG001|STARTED|Period 2: Extension Period|2 pts discontinued after completion of Period1,therefore 9 pts proceeded to participate in Period2|6||
59810538|NCT00055471|75932718|FG002|STARTED|Period 2: Extension Period||0||
59810539|NCT00055471|75932716|FG000|COMPLETED|Period 2: Extension Period||3||
59810540|NCT00055471|75932717|FG001|COMPLETED|Period 2: Extension Period||6||
59810541|NCT00055471|75932718|FG002|COMPLETED|Period 2: Extension Period||0||
59968135|NCT02745145|76085830|FG001|COMPLETED|Overall Study||0||
59968136|NCT02745145|76085831|FG002|COMPLETED|Overall Study||0||
59968137|NCT02745145|76085829|FG000|NOT COMPLETED|Overall Study||10||
59968138|NCT02745145|76085830|FG001|NOT COMPLETED|Overall Study||5||
59968139|NCT02745145|76085831|FG002|NOT COMPLETED|Overall Study||9||
59968140|NCT02976129|76085841|FG000|STARTED|Overall Study||82||
59968141|NCT02976129|76085842|FG001|STARTED|Overall Study||43||
59968142|NCT02976129|76085841|FG000|COMPLETED|Overall Study||77||
59968143|NCT02976129|76085842|FG001|COMPLETED|Overall Study||41||
59968144|NCT02976129|76085841|FG000|NOT COMPLETED|Overall Study||5||
59968145|NCT02976129|76085842|FG001|NOT COMPLETED|Overall Study||2||
59968146|NCT02854631|76085850|FG000|STARTED|Overall Study||52||
59968147|NCT02854631|76085851|FG001|STARTED|Overall Study||52||
59968148|NCT02854631|76085850|FG000|COMPLETED|Overall Study||26||
59968149|NCT02854631|76085851|FG001|COMPLETED|Overall Study||37||
59968150|NCT02854631|76085850|FG000|NOT COMPLETED|Overall Study||26||
59968151|NCT02854631|76085851|FG001|NOT COMPLETED|Overall Study||15||
59968152|NCT02855359|76085859|FG000|STARTED|Overall Study||11||
59968153|NCT02855359|76085860|FG001|STARTED|Overall Study||13||
59968154|NCT02855359|76085861|FG002|STARTED|Overall Study||0||
59968155|NCT02855359|76085862|FG003|STARTED|Overall Study||0||
59968156|NCT02855359|76085859|FG000|COMPLETED|Overall Study||0||
59968157|NCT02855359|76085860|FG001|COMPLETED|Overall Study||0||
59968158|NCT02855359|76085861|FG002|COMPLETED|Overall Study||0||
59968159|NCT02855359|76085862|FG003|COMPLETED|Overall Study||0||
59968160|NCT02855359|76085859|FG000|NOT COMPLETED|Overall Study||11||
59968161|NCT02855359|76085860|FG001|NOT COMPLETED|Overall Study||13||
59968162|NCT02855359|76085861|FG002|NOT COMPLETED|Overall Study||0||
59968163|NCT02855359|76085862|FG003|NOT COMPLETED|Overall Study||0||
59968164|NCT02949297|76085870|FG000|STARTED|1 Month||75||
59968165|NCT02949297|76085870|FG000|COMPLETED|1 Month||75||
59968166|NCT02949297|76085870|FG000|NOT COMPLETED|1 Month||0||
59968167|NCT02949297|76085870|FG000|STARTED|6 Months||75||
59810542|NCT00055471|75932716|FG000|NOT COMPLETED|Period 2: Extension Period||0||
59810543|NCT00055471|75932717|FG001|NOT COMPLETED|Period 2: Extension Period||0||
59810544|NCT00055471|75932718|FG002|NOT COMPLETED|Period 2: Extension Period||0||
59810545|NCT00395512|75932730|FG000|STARTED|Overall Study||164||
59810546|NCT00395512|75932731|FG001|STARTED|Overall Study||163||
59810547|NCT00395512|75932732|FG002|STARTED|Overall Study||164||
59810548|NCT00395512|75932733|FG003|STARTED|Overall Study||164||
59810549|NCT00395512|75932730|FG000|Safety Set|Overall Study||164||
59810550|NCT00395512|75932731|FG001|Safety Set|Overall Study||163||
59810551|NCT00395512|75932732|FG002|Safety Set|Overall Study||164||
59810552|NCT00395512|75932733|FG003|Safety Set|Overall Study|1 participant was lost to follow-up post visit 1. It is unknown if they took any study medication.|163||
59810553|NCT00395512|75932730|FG000|COMPLETED|Overall Study||126||
59810554|NCT00395512|75932731|FG001|COMPLETED|Overall Study||126||
59810555|NCT00395512|75932732|FG002|COMPLETED|Overall Study||136||
59810556|NCT00395512|75932733|FG003|COMPLETED|Overall Study||126||
59810557|NCT00395512|75932730|FG000|NOT COMPLETED|Overall Study||38||
59810558|NCT00395512|75932731|FG001|NOT COMPLETED|Overall Study||37||
59810559|NCT00395512|75932732|FG002|NOT COMPLETED|Overall Study||28||
59810560|NCT00395512|75932733|FG003|NOT COMPLETED|Overall Study||38||
59810561|NCT00054691|75932743|FG000|STARTED|Overall Study||40||
59968168|NCT02949297|76085870|FG000|COMPLETED|6 Months||72||
59968169|NCT02949297|76085870|FG000|NOT COMPLETED|6 Months||3||
59968170|NCT02949297|76085870|FG000|STARTED|12 Months||72||
59968171|NCT02949297|76085870|FG000|COMPLETED|12 Months||67||
59968172|NCT02949297|76085870|FG000|NOT COMPLETED|12 Months||5||
59968173|NCT02853929|76085876|FG000|STARTED|Overall Study||270|Number of subjects enrolled|
59968174|NCT02853929|76085877|FG001|STARTED|Overall Study||281|Number of subjects enrolled|
59968175|NCT02853929|76085876|FG000|Vaccinated|Overall Study||263||
59968176|NCT02853929|76085877|FG001|Vaccinated|Overall Study||277||
59968177|NCT02853929|76085876|FG000|COMPLETED|Overall Study||259||
59968178|NCT02853929|76085877|FG001|COMPLETED|Overall Study||277||
59968179|NCT02853929|76085876|FG000|NOT COMPLETED|Overall Study||11||
59968180|NCT02853929|76085877|FG001|NOT COMPLETED|Overall Study||4||
59968181|NCT02667639|76085885|FG000|STARTED|Overall Study||25||
59968182|NCT02667639|76085886|FG001|STARTED|Overall Study||10||
59968183|NCT02667639|76085885|FG000|COMPLETED|Overall Study||25||
59968184|NCT02667639|76085886|FG001|COMPLETED|Overall Study||10||
59968185|NCT02667639|76085885|FG000|NOT COMPLETED|Overall Study||0||
59968186|NCT02667639|76085886|FG001|NOT COMPLETED|Overall Study||0||
59968187|NCT02067975|76085896|FG000|STARTED|Overall Study||20||
59968188|NCT02067975|76085897|FG001|STARTED|Overall Study||18||
59968189|NCT02067975|76085898|FG002|STARTED|Overall Study||21||
59968190|NCT02067975|76085899|FG003|STARTED|Overall Study||18||
59968191|NCT02067975|76085900|FG004|STARTED|Overall Study||8||
59968192|NCT02067975|76085901|FG005|STARTED|Overall Study||8||
59968193|NCT02067975|76085896|FG000|COMPLETED|Overall Study||16||
59968194|NCT02067975|76085897|FG001|COMPLETED|Overall Study||16||
59968195|NCT02067975|76085898|FG002|COMPLETED|Overall Study||19||
59968196|NCT02067975|76085899|FG003|COMPLETED|Overall Study||14||
59968197|NCT02067975|76085900|FG004|COMPLETED|Overall Study||0||
59968198|NCT02067975|76085901|FG005|COMPLETED|Overall Study||0||
59968199|NCT02067975|76085896|FG000|NOT COMPLETED|Overall Study||4||
59968200|NCT02067975|76085897|FG001|NOT COMPLETED|Overall Study||2||
59968201|NCT02067975|76085898|FG002|NOT COMPLETED|Overall Study||2||
59968202|NCT02067975|76085899|FG003|NOT COMPLETED|Overall Study||4||
59968203|NCT02067975|76085900|FG004|NOT COMPLETED|Overall Study||8||
59968204|NCT02067975|76085901|FG005|NOT COMPLETED|Overall Study||8||
59810562|NCT00054691|75932743|FG000|COMPLETED|Overall Study||37||
59810563|NCT00054691|75932743|FG000|NOT COMPLETED|Overall Study||3||
59810564|NCT00387712|75932749|FG000|STARTED|Overall Study||47||
59968205|NCT02730819|76085913|FG000|STARTED|Overall Study||19||
59968206|NCT02730819|76085913|FG000|Follow-up Week 2|Overall Study||15||
59968207|NCT02730819|76085913|FG000|Follow-up Week 4|Overall Study||16||
59810565|NCT00387712|75932750|FG001|STARTED|Overall Study||52||
59810566|NCT00387712|75932749|FG000|COMPLETED|Overall Study||18||
59810567|NCT00387712|75932750|FG001|COMPLETED|Overall Study||16||
59968208|NCT02730819|76085913|FG000|Follow-up Week 8|Overall Study||14||
59968209|NCT02730819|76085913|FG000|Follow-up Week 12|Overall Study||11||
59968210|NCT02730819|76085913|FG000|Follow-up Week 16|Overall Study||11||
59968211|NCT02730819|76085913|FG000|Follow-up Week 20|Overall Study||10||
59968212|NCT02730819|76085913|FG000|COMPLETED|Overall Study||10||
59968213|NCT02730819|76085913|FG000|NOT COMPLETED|Overall Study||9||
59968214|NCT02038946|76085917|FG000|STARTED|Overall Study||92||
59968215|NCT02038946|76085917|FG000|COMPLETED|Overall Study||80|Completed = Participants continuing in the Follow-up period|
59968216|NCT02038946|76085917|FG000|NOT COMPLETED|Overall Study||12||
59968217|NCT03143829|76085923|FG000|STARTED|Overall Study||38||
59968218|NCT03143829|76085924|FG001|STARTED|Overall Study||42||
59968219|NCT03143829|76085923|FG000|COMPLETED|Overall Study||33||
59968220|NCT03143829|76085924|FG001|COMPLETED|Overall Study||32||
59968221|NCT03143829|76085923|FG000|NOT COMPLETED|Overall Study||5||
59968222|NCT03143829|76085924|FG001|NOT COMPLETED|Overall Study||10||
59968223|NCT02853331|76085932|FG000|STARTED|Overall Study||432||
59968224|NCT02853331|76085933|FG001|STARTED|Overall Study||429||
59968225|NCT02853331|76085932|FG000|Treated|Overall Study||429||
59968226|NCT02853331|76085933|FG001|Treated|Overall Study||425||
59810568|NCT00387712|75932749|FG000|NOT COMPLETED|Overall Study||29||
59810569|NCT00387712|75932750|FG001|NOT COMPLETED|Overall Study||36||
59810570|NCT00072475|75932756|FG000|STARTED|Overall Study||142||
59810571|NCT00072475|75932756|FG000|COMPLETED|Overall Study||45||
59810572|NCT00072475|75932756|FG000|NOT COMPLETED|Overall Study||97||
59810573|NCT00066469|75932760|FG000|STARTED|Overall Study||55||
59810574|NCT00066469|75932760|FG000|COMPLETED|Overall Study||39||
59810575|NCT00066469|75932760|FG000|NOT COMPLETED|Overall Study||16||
59810576|NCT00387088|75932766|FG000|STARTED|Overall Study||1989||
59810577|NCT00387088|75932767|FG001|STARTED|Overall Study||2002||
59810578|NCT00387088|75932766|FG000|COMPLETED|Overall Study||1671||
59810579|NCT00387088|75932767|FG001|COMPLETED|Overall Study||1629||
59968227|NCT02853331|76085932|FG000|COMPLETED|Overall Study||0||
59968228|NCT02853331|76085933|FG001|COMPLETED|Overall Study||0||
59968229|NCT02853331|76085932|FG000|NOT COMPLETED|Overall Study||432||
59968230|NCT02853331|76085933|FG001|NOT COMPLETED|Overall Study||429||
59968231|NCT05896761|76085941|FG000|STARTED|Thigh Injection Phase (Up to Week 16)||54||
59968232|NCT05896761|76085942|FG001|STARTED|Thigh Injection Phase (Up to Week 16)||64||
59968233|NCT05896761|76085941|FG000|COMPLETED|Thigh Injection Phase (Up to Week 16)||51||
59968234|NCT05896761|76085942|FG001|COMPLETED|Thigh Injection Phase (Up to Week 16)||61||
59968235|NCT05896761|76085941|FG000|NOT COMPLETED|Thigh Injection Phase (Up to Week 16)||3||
59968236|NCT05896761|76085942|FG001|NOT COMPLETED|Thigh Injection Phase (Up to Week 16)||3||
59968237|NCT05896761|76085941|FG000|STARTED|Return to Glu Inj Phase (Weeks 16 to 24)||51||
59621553|NCT00353652|75733173|FG004|NOT COMPLETED|First Intervention - 3 Months||0||
59810580|NCT00387088|75932766|FG000|NOT COMPLETED|Overall Study||318||
59968238|NCT05896761|76085942|FG001|STARTED|Return to Glu Inj Phase (Weeks 16 to 24)||61||
59968239|NCT05896761|76085941|FG000|COMPLETED|Return to Glu Inj Phase (Weeks 16 to 24)||51||
59810581|NCT00387088|75932767|FG001|NOT COMPLETED|Overall Study||373||
59810582|NCT00053365|75932773|FG000|STARTED|Overall Study||61||
59810583|NCT00053365|75932773|FG000|COMPLETED|Overall Study||55||
59968240|NCT05896761|76085942|FG001|COMPLETED|Return to Glu Inj Phase (Weeks 16 to 24)||61||
59968241|NCT05896761|76085941|FG000|NOT COMPLETED|Return to Glu Inj Phase (Weeks 16 to 24)||0||
59968242|NCT05896761|76085942|FG001|NOT COMPLETED|Return to Glu Inj Phase (Weeks 16 to 24)||0||
59968243|NCT05097573|76085959|FG000|STARTED|Overall Study||17||
59968244|NCT05097573|76085959|FG000|COMPLETED|Overall Study||15||
59968245|NCT05097573|76085959|FG000|NOT COMPLETED|Overall Study||2||
59968246|NCT05048784|76085967|FG000|STARTED|Period 1||66||
59968247|NCT05048784|76085968|FG001|STARTED|Period 1||66||
59968248|NCT05048784|76085969|FG002|STARTED|Period 1||6||
59968249|NCT05048784|76085970|FG003|STARTED|Period 1||7||
59968250|NCT05048784|76085967|FG000|Administered Treatment A|Period 1||66||
59968251|NCT05048784|76085968|FG001|Administered Treatment A|Period 1||0||
59968252|NCT05048784|76085969|FG002|Administered Treatment A|Period 1||6||
59968253|NCT05048784|76085970|FG003|Administered Treatment A|Period 1||0||
59968254|NCT05048784|76085967|FG000|Administered Treatment B|Period 1||0||
59968255|NCT05048784|76085968|FG001|Administered Treatment B|Period 1||66||
59968256|NCT05048784|76085969|FG002|Administered Treatment B|Period 1||0||
59968257|NCT05048784|76085970|FG003|Administered Treatment B|Period 1||7||
59968258|NCT05048784|76085967|FG000|COMPLETED|Period 1||63||
59968259|NCT05048784|76085968|FG001|COMPLETED|Period 1||65||
59968260|NCT05048784|76085969|FG002|COMPLETED|Period 1||6||
59968261|NCT05048784|76085970|FG003|COMPLETED|Period 1||7||
59621554|NCT00353652|75733174|FG005|NOT COMPLETED|First Intervention - 3 Months||0||
59621555|NCT00353652|75733175|FG006|NOT COMPLETED|First Intervention - 3 Months||0||
59621556|NCT00353652|75733176|FG007|NOT COMPLETED|First Intervention - 3 Months||0||
59621557|NCT00353652|75733169|FG000|STARTED|Second Intervention - 3 Months||12||
59621558|NCT00353652|75733170|FG001|STARTED|Second Intervention - 3 Months||11||
59621559|NCT00353652|75733171|FG002|STARTED|Second Intervention - 3 Months||6||
59621560|NCT00353652|75733172|FG003|STARTED|Second Intervention - 3 Months||7||
59621561|NCT00353652|75733173|FG004|STARTED|Second Intervention - 3 Months||3||
59621562|NCT00353652|75733174|FG005|STARTED|Second Intervention - 3 Months||0||
59621563|NCT00353652|75733175|FG006|STARTED|Second Intervention - 3 Months||1||
59621564|NCT00353652|75733176|FG007|STARTED|Second Intervention - 3 Months||0||
59968262|NCT05048784|76085967|FG000|NOT COMPLETED|Period 1||3||
59968263|NCT05048784|76085968|FG001|NOT COMPLETED|Period 1||1||
59968264|NCT05048784|76085969|FG002|NOT COMPLETED|Period 1||0||
59968265|NCT05048784|76085970|FG003|NOT COMPLETED|Period 1||0||
59968266|NCT05048784|76085967|FG000|STARTED|Period 2||63||
59968267|NCT05048784|76085968|FG001|STARTED|Period 2||65||
59968268|NCT05048784|76085969|FG002|STARTED|Period 2||6||
59968269|NCT05048784|76085970|FG003|STARTED|Period 2||7||
59968270|NCT05048784|76085967|FG000|Administered Treatment A|Period 2||0||
59968271|NCT05048784|76085968|FG001|Administered Treatment A|Period 2||65||
59968272|NCT05048784|76085969|FG002|Administered Treatment A|Period 2||0||
59968273|NCT05048784|76085970|FG003|Administered Treatment A|Period 2||7||
59968274|NCT05048784|76085967|FG000|Administered Treatment B|Period 2||63||
59968275|NCT05048784|76085968|FG001|Administered Treatment B|Period 2||0||
59968276|NCT05048784|76085969|FG002|Administered Treatment B|Period 2||6||
59968277|NCT05048784|76085970|FG003|Administered Treatment B|Period 2||0||
59968278|NCT05048784|76085967|FG000|COMPLETED|Period 2||63||
59968279|NCT05048784|76085968|FG001|COMPLETED|Period 2||64||
59968280|NCT05048784|76085969|FG002|COMPLETED|Period 2||6||
59810584|NCT00053365|75932773|FG000|NOT COMPLETED|Overall Study||6||
59810585|NCT00387010|75932779|FG000|STARTED|Dose Titration Period||218||
59810586|NCT00387010|75932779|FG000|COMPLETED|Dose Titration Period||180||
59810587|NCT00387010|75932779|FG000|NOT COMPLETED|Dose Titration Period||38||
59810588|NCT00387010|75932779|FG000|STARTED|Treatment Period||180||
59968281|NCT05048784|76085970|FG003|COMPLETED|Period 2||7||
59968282|NCT05048784|76085967|FG000|NOT COMPLETED|Period 2||0||
59968283|NCT05048784|76085968|FG001|NOT COMPLETED|Period 2||1||
59968284|NCT05048784|76085969|FG002|NOT COMPLETED|Period 2||0||
59968285|NCT05048784|76085970|FG003|NOT COMPLETED|Period 2||0||
59968286|NCT05048784|76085967|FG000|STARTED|Period 3|Participants assigned to treatment sequence AB did not enter Period 3, as pre-specified.|0||
59968287|NCT05048784|76085968|FG001|STARTED|Period 3|Participants assigned to treatment sequence BA did not enter Period 3, as pre-specified.|0||
59968288|NCT05048784|76085969|FG002|STARTED|Period 3||6||
59968289|NCT05048784|76085970|FG003|STARTED|Period 3||7||
59968290|NCT05048784|76085967|FG000|Administered Treatment C|Period 3||0||
59968291|NCT05048784|76085968|FG001|Administered Treatment C|Period 3||0||
59968292|NCT05048784|76085969|FG002|Administered Treatment C|Period 3||6||
59968293|NCT05048784|76085970|FG003|Administered Treatment C|Period 3||7||
59968294|NCT05048784|76085967|FG000|COMPLETED|Period 3||0||
59968295|NCT05048784|76085968|FG001|COMPLETED|Period 3||0||
59968296|NCT05048784|76085969|FG002|COMPLETED|Period 3||6||
59621565|NCT00353652|75733169|FG000|COMPLETED|Second Intervention - 3 Months||12||
59621566|NCT00353652|75733170|FG001|COMPLETED|Second Intervention - 3 Months||11||
59810589|NCT00387010|75932779|FG000|Full Analysis Set|Treatment Period|FAS: treated patients with at least 1 paired baseline and post baseline efficacy assessment|175||
59968297|NCT05048784|76085970|FG003|COMPLETED|Period 3||7||
59968298|NCT05048784|76085967|FG000|NOT COMPLETED|Period 3||0||
59968299|NCT05048784|76085968|FG001|NOT COMPLETED|Period 3||0||
59968300|NCT05048784|76085969|FG002|NOT COMPLETED|Period 3||0||
59968301|NCT05048784|76085970|FG003|NOT COMPLETED|Period 3||0||
59968302|NCT04985799|76085980|FG000|STARTED|Overall Study||73||
59968303|NCT04985799|76085981|FG001|STARTED|Overall Study||74||
59968304|NCT04985799|76085980|FG000|COMPLETED|Overall Study||73||
59968305|NCT04985799|76085981|FG001|COMPLETED|Overall Study||74||
59968306|NCT04985799|76085980|FG000|NOT COMPLETED|Overall Study||0||
59968307|NCT04985799|76085981|FG001|NOT COMPLETED|Overall Study||0||
59968308|NCT04940221|76085987|FG000|STARTED|Overall Study||80||
59968309|NCT04940221|76085987|FG000|COMPLETED|Overall Study||80||
59968310|NCT04940221|76085987|FG000|NOT COMPLETED|Overall Study||0||
59968311|NCT04849845|76085991|FG000|STARTED|Afrezza Dose 1||20||
59968312|NCT04849845|76085991|FG000|COMPLETED|Afrezza Dose 1||20||
59968313|NCT04849845|76085991|FG000|NOT COMPLETED|Afrezza Dose 1||0||
59968314|NCT04849845|76085991|FG000|STARTED|Afrezza Dose 2||20||
59968315|NCT04849845|76085991|FG000|COMPLETED|Afrezza Dose 2||20||
59968316|NCT04849845|76085991|FG000|NOT COMPLETED|Afrezza Dose 2||0||
59968317|NCT04700280|76085999|FG000|STARTED|Overall Study||20||
59968318|NCT04700280|76086000|FG001|STARTED|Overall Study||11||
59968319|NCT04700280|76085999|FG000|COMPLETED|Overall Study||9||
59968320|NCT04700280|76086000|FG001|COMPLETED|Overall Study||8||
59968321|NCT04700280|76085999|FG000|NOT COMPLETED|Overall Study||11||
59968322|NCT04700280|76086000|FG001|NOT COMPLETED|Overall Study||3||
59968323|NCT04679675|76086010|FG000|STARTED|Overall Study||12709||
59968324|NCT04679675|76086011|FG001|STARTED|Overall Study||9279||
59968325|NCT04679675|76086012|FG002|STARTED|Overall Study||2974||
59968326|NCT04679675|76086013|FG003|STARTED|Overall Study||7809||
59968327|NCT04679675|76086010|FG000|COMPLETED|Overall Study||12142||
59968328|NCT04679675|76086011|FG001|COMPLETED|Overall Study||8854||
59968329|NCT04679675|76086012|FG002|COMPLETED|Overall Study||2897||
59968330|NCT04679675|76086013|FG003|COMPLETED|Overall Study||7462||
59968331|NCT04679675|76086010|FG000|NOT COMPLETED|Overall Study||567||
59968332|NCT04679675|76086011|FG001|NOT COMPLETED|Overall Study||425||
59968333|NCT04679675|76086012|FG002|NOT COMPLETED|Overall Study||77||
59968334|NCT04679675|76086013|FG003|NOT COMPLETED|Overall Study||347||
59968335|NCT04626128|76086027|FG000|STARTED|Overall Study||6||
59968336|NCT04626128|76086028|FG001|STARTED|Overall Study||5||
59968337|NCT04626128|76086029|FG002|STARTED|Overall Study||8||
59968338|NCT04626128|76086030|FG003|STARTED|Overall Study||8||
59968339|NCT04626128|76086027|FG000|Safety Population|Overall Study||6|Defined as all enrolled participants who were administered CLS-AX, and from whom at least one post-Baseline safety measurement was obtained.|
59968340|NCT04626128|76086028|FG001|Safety Population|Overall Study||5|Defined as all enrolled participants who were administered CLS-AX, and from whom at least one post-Baseline safety measurement was obtained.|
59968341|NCT04626128|76086029|FG002|Safety Population|Overall Study||8|Defined as all enrolled participants who were administered CLS-AX, and from whom at least one post-Baseline safety measurement was obtained.|
59968342|NCT04626128|76086030|FG003|Safety Population|Overall Study||8|Defined as all enrolled participants who were administered CLS-AX, and from whom at least one post-Baseline safety measurement was obtained.|
59968343|NCT04626128|76086027|FG000|Pharmacokinetic Population|Overall Study||6|Defined as all participants that provide plasma samples for axitinib concentration analysis.|
59968344|NCT04626128|76086028|FG001|Pharmacokinetic Population|Overall Study||5|Defined as all participants that provide plasma samples for axitinib concentration analysis.|
59968345|NCT04626128|76086029|FG002|Pharmacokinetic Population|Overall Study||8|Defined as all participants that provide plasma samples for axitinib concentration analysis.|
59968346|NCT04626128|76086030|FG003|Pharmacokinetic Population|Overall Study||8|Defined as all participants that provide plasma samples for axitinib concentration analysis.|
59968347|NCT04626128|76086027|FG000|COMPLETED|Overall Study||6||
59968348|NCT04626128|76086028|FG001|COMPLETED|Overall Study||4||
59968349|NCT04626128|76086029|FG002|COMPLETED|Overall Study||8||
59968350|NCT04626128|76086030|FG003|COMPLETED|Overall Study||8||
59968351|NCT04626128|76086027|FG000|NOT COMPLETED|Overall Study||0||
59968352|NCT04626128|76086028|FG001|NOT COMPLETED|Overall Study||1||
59968353|NCT04626128|76086029|FG002|NOT COMPLETED|Overall Study||0||
59968354|NCT04626128|76086030|FG003|NOT COMPLETED|Overall Study||0||
59968355|NCT04581824|76086042|FG000|STARTED|Overall Study||121||
59968356|NCT04581824|76086043|FG001|STARTED|Overall Study||122||
59968357|NCT04581824|76086042|FG000|COMPLETED|Overall Study|42 participants died.|42|Participants who completed follow-up or died due to any reason were considered as completed.|
59968358|NCT04581824|76086043|FG001|COMPLETED|Overall Study|48 participants died.|48|Participants who completed follow-up or died due to any reason were considered as completed.|
59968359|NCT04581824|76086042|FG000|NOT COMPLETED|Overall Study||79||
59968360|NCT04581824|76086043|FG001|NOT COMPLETED|Overall Study||74||
59968361|NCT04523571|76086055|FG000|STARTED|Received 2 Doses||24||
59968362|NCT04523571|76086056|FG001|STARTED|Received 2 Doses||24||
59968363|NCT04523571|76086057|FG002|STARTED|Received 2 Doses||24||
59968364|NCT04523571|76086058|FG003|STARTED|Received 2 Doses||24||
59968365|NCT04523571|76086059|FG004|STARTED|Received 2 Doses||24||
59968366|NCT04523571|76086060|FG005|STARTED|Received 2 Doses||24||
59968367|NCT04523571|76086055|FG000|COMPLETED|Received 2 Doses||24||
59968368|NCT04523571|76086056|FG001|COMPLETED|Received 2 Doses||24||
59968369|NCT04523571|76086057|FG002|COMPLETED|Received 2 Doses||24||
59968370|NCT04523571|76086058|FG003|COMPLETED|Received 2 Doses||23||
59968371|NCT04523571|76086059|FG004|COMPLETED|Received 2 Doses||23||
59968372|NCT04523571|76086060|FG005|COMPLETED|Received 2 Doses||24||
59968373|NCT04523571|76086055|FG000|NOT COMPLETED|Received 2 Doses||0||
60074358|NCT01770392|76189742|FG000|COMPLETED|Nintedanib||26||
59968374|NCT04523571|76086056|FG001|NOT COMPLETED|Received 2 Doses||0||
59968375|NCT04523571|76086057|FG002|NOT COMPLETED|Received 2 Doses||0||
59968376|NCT04523571|76086058|FG003|NOT COMPLETED|Received 2 Doses||1||
59968377|NCT04523571|76086059|FG004|NOT COMPLETED|Received 2 Doses||1||
59968378|NCT04523571|76086060|FG005|NOT COMPLETED|Received 2 Doses||0||
59968379|NCT04523571|76086055|FG000|STARTED|Received 2 Doses and Completed Follow-up||24||
59968380|NCT04523571|76086056|FG001|STARTED|Received 2 Doses and Completed Follow-up||24||
59968381|NCT04523571|76086057|FG002|STARTED|Received 2 Doses and Completed Follow-up||24||
59968382|NCT04523571|76086058|FG003|STARTED|Received 2 Doses and Completed Follow-up||23||
59968383|NCT04523571|76086059|FG004|STARTED|Received 2 Doses and Completed Follow-up||23||
59968384|NCT04523571|76086060|FG005|STARTED|Received 2 Doses and Completed Follow-up||24||
59968385|NCT04523571|76086055|FG000|COMPLETED|Received 2 Doses and Completed Follow-up||23||
59968386|NCT04523571|76086056|FG001|COMPLETED|Received 2 Doses and Completed Follow-up||24||
59968387|NCT04523571|76086057|FG002|COMPLETED|Received 2 Doses and Completed Follow-up||23||
59968388|NCT04523571|76086058|FG003|COMPLETED|Received 2 Doses and Completed Follow-up||22||
60074359|NCT01770392|76189742|FG000|NOT COMPLETED|Nintedanib||0||
60074360|NCT01770392|76189742|FG000|STARTED|Washout Period of at Least 14 Days||26||
59525308|NCT01259011|75620592|FG000|NOT COMPLETED|Main Study Period||0||
59525309|NCT01259011|75620593|FG001|NOT COMPLETED|Main Study Period||0||
59810590|NCT00387010|75932779|FG000|COMPLETED|Treatment Period||169||
59810591|NCT00387010|75932779|FG000|NOT COMPLETED|Treatment Period||11||
59968389|NCT04523571|76086059|FG004|COMPLETED|Received 2 Doses and Completed Follow-up||22||
59968390|NCT04523571|76086060|FG005|COMPLETED|Received 2 Doses and Completed Follow-up||23||
59968391|NCT04523571|76086055|FG000|NOT COMPLETED|Received 2 Doses and Completed Follow-up||1||
59968392|NCT04523571|76086056|FG001|NOT COMPLETED|Received 2 Doses and Completed Follow-up||0||
59968393|NCT04523571|76086057|FG002|NOT COMPLETED|Received 2 Doses and Completed Follow-up||1||
59968394|NCT04523571|76086058|FG003|NOT COMPLETED|Received 2 Doses and Completed Follow-up||1||
59968395|NCT04523571|76086059|FG004|NOT COMPLETED|Received 2 Doses and Completed Follow-up||1||
59968396|NCT04523571|76086060|FG005|NOT COMPLETED|Received 2 Doses and Completed Follow-up||1||
59968397|NCT04361617|76086076|FG000|STARTED|Overall Study||17||
59968398|NCT04361617|76086077|FG001|STARTED|Overall Study||17||
59968399|NCT04361617|76086076|FG000|COMPLETED|Overall Study||17||
59968400|NCT04361617|76086077|FG001|COMPLETED|Overall Study||16||
59968401|NCT04361617|76086076|FG000|NOT COMPLETED|Overall Study||0||
59968402|NCT04361617|76086077|FG001|NOT COMPLETED|Overall Study||1||
59968403|NCT04021914|76086083|FG000|STARTED|Overall Study||6||
59968404|NCT04021914|76086083|FG000|COMPLETED|Overall Study||5||
59968405|NCT04021914|76086083|FG000|NOT COMPLETED|Overall Study||1||
59968406|NCT03909178|76086089|FG000|STARTED|Overall Study||57||
59968407|NCT03909178|76086090|FG001|STARTED|Overall Study||53||
59968408|NCT03909178|76086089|FG000|COMPLETED|Overall Study||54||
59968409|NCT03909178|76086090|FG001|COMPLETED|Overall Study||49||
59968410|NCT03909178|76086089|FG000|NOT COMPLETED|Overall Study||3||
59968411|NCT03909178|76086090|FG001|NOT COMPLETED|Overall Study||4||
59968412|NCT03851588|76086100|FG000|STARTED|Overall Study||53||
59810592|NCT00386776|75932783|FG000|STARTED|Overall Study||40||
59810593|NCT00386776|75932783|FG000|COMPLETED|Overall Study||32||
59810594|NCT00386776|75932783|FG000|NOT COMPLETED|Overall Study||8||
59968413|NCT03851588|76086101|FG001|STARTED|Overall Study||55||
59968414|NCT03851588|76086100|FG000|COMPLETED|Overall Study||51||
59968415|NCT03851588|76086101|FG001|COMPLETED|Overall Study||52||
59968416|NCT03851588|76086100|FG000|NOT COMPLETED|Overall Study||2||
59968417|NCT03851588|76086101|FG001|NOT COMPLETED|Overall Study||3||
59968418|NCT03850444|76086109|FG000|STARTED|Overall Study||128||
59968419|NCT03850444|76086110|FG001|STARTED|Overall Study||134||
59968420|NCT03850444|76086109|FG000|Treated|Overall Study||128||
59968421|NCT03850444|76086110|FG001|Treated|Overall Study||125||
59810595|NCT00065065|75932791|FG000|STARTED|Overall Study||52||
59810596|NCT00065065|75932792|FG001|STARTED|Overall Study||53||
59810597|NCT00065065|75932791|FG000|COMPLETED|Overall Study||42||
59968422|NCT03850444|76086109|FG000|Received Second Course of Pembrolizumab|Overall Study||5||
59968423|NCT03850444|76086110|FG001|Received Second Course of Pembrolizumab|Overall Study||0||
59968424|NCT03850444|76086109|FG000|COMPLETED|Overall Study||0||
59968425|NCT03850444|76086110|FG001|COMPLETED|Overall Study||0||
59968426|NCT03850444|76086109|FG000|NOT COMPLETED|Overall Study||128||
59968427|NCT03850444|76086110|FG001|NOT COMPLETED|Overall Study||134||
59810598|NCT00065065|75932792|FG001|COMPLETED|Overall Study||33||
59810599|NCT00065065|75932791|FG000|NOT COMPLETED|Overall Study||10||
59810600|NCT00065065|75932792|FG001|NOT COMPLETED|Overall Study||20||
59968428|NCT03781804|76086120|FG000|STARTED|Overall Study||111||
59968429|NCT03781804|76086121|FG001|STARTED|Overall Study||109||
59968430|NCT03781804|76086122|FG002|STARTED|Overall Study||112||
59810601|NCT00386308|75932802|FG000|STARTED|Overall Study||123||
59810602|NCT00386308|75932803|FG001|STARTED|Overall Study||73||
59810603|NCT00386308|75932802|FG000|Intent to Treat Population|Overall Study||117||
59968431|NCT03781804|76086120|FG000|COMPLETED|Overall Study||102||
59810604|NCT00386308|75932803|FG001|Intent to Treat Population|Overall Study||72||
59968432|NCT03781804|76086121|FG001|COMPLETED|Overall Study||101||
59968433|NCT03781804|76086122|FG002|COMPLETED|Overall Study||96||
59968434|NCT03781804|76086120|FG000|NOT COMPLETED|Overall Study||9||
59968435|NCT03781804|76086121|FG001|NOT COMPLETED|Overall Study||8||
59968436|NCT03781804|76086122|FG002|NOT COMPLETED|Overall Study||16||
59968437|NCT03623386|76086133|FG000|STARTED|Overall Study||26||
59968438|NCT03623386|76086134|FG001|STARTED|Overall Study||28||
59968439|NCT03623386|76086135|FG002|STARTED|Overall Study||9||
59968440|NCT03623386|76086133|FG000|COMPLETED|Overall Study||22||
59968441|NCT03623386|76086134|FG001|COMPLETED|Overall Study||22||
59968442|NCT03623386|76086135|FG002|COMPLETED|Overall Study||9||
59968443|NCT03623386|76086133|FG000|NOT COMPLETED|Overall Study||4||
59968444|NCT03623386|76086134|FG001|NOT COMPLETED|Overall Study||6||
59968445|NCT03623386|76086135|FG002|NOT COMPLETED|Overall Study||0||
59968446|NCT03581448|76086142|FG000|STARTED|Overall Study||21||
59968447|NCT03581448|76086142|FG000|COMPLETED|Overall Study||21||
59968448|NCT03581448|76086142|FG000|NOT COMPLETED|Overall Study||0||
59968449|NCT03507686|76086146|FG000|STARTED|Treatment Period 1(Day 1 up to Month 12)||60||
59968450|NCT03507686|76086147|FG001|STARTED|Treatment Period 1(Day 1 up to Month 12)||0||
59968451|NCT03507686|76086146|FG000|COMPLETED|Treatment Period 1(Day 1 up to Month 12)||50||
59810605|NCT00386308|75932802|FG000|Modified Intent to Treat Population|Overall Study||115||
59968452|NCT03507686|76086147|FG001|COMPLETED|Treatment Period 1(Day 1 up to Month 12)||0||
59968453|NCT03507686|76086146|FG000|NOT COMPLETED|Treatment Period 1(Day 1 up to Month 12)||10||
59968454|NCT03507686|76086147|FG001|NOT COMPLETED|Treatment Period 1(Day 1 up to Month 12)||0||
59968455|NCT03507686|76086146|FG000|STARTED|Treatment Period 2 (Month13 to Month24)||0||
59968456|NCT03507686|76086147|FG001|STARTED|Treatment Period 2 (Month13 to Month24)|Note: Started population included 50 participants who completed Period 1 and 6 unique participants who were enrolled in period 2.|56||
59968457|NCT03507686|76086146|FG000|COMPLETED|Treatment Period 2 (Month13 to Month24)||0||
59968458|NCT03507686|76086147|FG001|COMPLETED|Treatment Period 2 (Month13 to Month24)||53||
59968459|NCT03507686|76086146|FG000|NOT COMPLETED|Treatment Period 2 (Month13 to Month24)||0||
59968460|NCT03507686|76086147|FG001|NOT COMPLETED|Treatment Period 2 (Month13 to Month24)||3||
59968461|NCT03471507|76086155|FG000|STARTED|Overall Study||81||
59968462|NCT03471507|76086156|FG001|STARTED|Overall Study||83||
59968463|NCT03471507|76086155|FG000|COMPLETED|Overall Study||78||
59968464|NCT03471507|76086156|FG001|COMPLETED|Overall Study||78||
59968465|NCT03471507|76086155|FG000|NOT COMPLETED|Overall Study||3||
59968466|NCT03471507|76086156|FG001|NOT COMPLETED|Overall Study||5||
59968467|NCT03338894|76086162|FG000|STARTED|Overall Study||78||
59968468|NCT03338894|76086162|FG000|COMPLETED|Overall Study||56||
59968469|NCT03338894|76086162|FG000|NOT COMPLETED|Overall Study||22||
59968470|NCT03138564|76086170|FG000|STARTED|Overall Study||462||22
59968471|NCT03138564|76086171|FG001|STARTED|Overall Study||390||17
59968472|NCT03138564|76086170|FG000|Patients Beginning the Study|Overall Study||231||22
59968473|NCT03138564|76086171|FG001|Patients Beginning the Study|Overall Study||195||17
59968474|NCT03138564|76086170|FG000|Surrogates Beginning the Study|Overall Study||231||22
59968475|NCT03138564|76086171|FG001|Surrogates Beginning the Study|Overall Study||195||17
59968476|NCT03138564|76086170|FG000|Patients Completing the Week 2 Assessment|Overall Study||182||22
59968477|NCT03138564|76086171|FG001|Patients Completing the Week 2 Assessment|Overall Study||192||17
59968478|NCT03138564|76086170|FG000|Surrogates Completing the Week 2 Assessment|Overall Study||183||22
59968479|NCT03138564|76086171|FG001|Surrogates Completing the Week 2 Assessment|Overall Study||189||17
59968480|NCT03138564|76086170|FG000|Surrogates Eligible for Post-bereavement Visit|Overall Study||54||22
59968481|NCT03138564|76086171|FG001|Surrogates Eligible for Post-bereavement Visit|Overall Study||35||17
59968482|NCT03138564|76086170|FG000|Surrogates Completing Post-bereavement Visit|Overall Study||46||22
59968483|NCT03138564|76086171|FG001|Surrogates Completing Post-bereavement Visit|Overall Study||31||17
59525310|NCT01259011|75620592|FG000|STARTED|After Patient Death|of 101 patient-surrogate dyads/pairs randomized, 17 surrogates of patients who died|17||
59525311|NCT01259011|75620593|FG001|STARTED|After Patient Death|of 109 patient-surrogate dyads/pairs randomized, 28 surrogates of patients who died|28||
59525312|NCT01259011|75620592|FG000|COMPLETED|After Patient Death||17||
59525313|NCT01259011|75620593|FG001|COMPLETED|After Patient Death||28||
59525314|NCT01259011|75620592|FG000|NOT COMPLETED|After Patient Death||0||
59968484|NCT03138564|76086170|FG000|COMPLETED|Overall Study||365|Completed Week 2 visit|22
59968485|NCT03138564|76086171|FG001|COMPLETED|Overall Study||381|Completed Week 2 visit|17
59968486|NCT03138564|76086170|FG000|NOT COMPLETED|Overall Study||97||0
59968487|NCT03138564|76086171|FG001|NOT COMPLETED|Overall Study||9||0
59525315|NCT01259011|75620593|FG001|NOT COMPLETED|After Patient Death||0||
59525316|NCT02191033|75620603|FG000|STARTED|Overall Study||20||
59525317|NCT02191033|75620604|FG001|STARTED|Overall Study||20||
59525318|NCT02191033|75620603|FG000|COMPLETED|Overall Study||18||
59525319|NCT02191033|75620604|FG001|COMPLETED|Overall Study||19||
59525320|NCT02191033|75620603|FG000|NOT COMPLETED|Overall Study||2||
59525321|NCT02191033|75620604|FG001|NOT COMPLETED|Overall Study||1||
59525322|NCT01260493|75620612|FG000|STARTED|Overall Study||92||
59525323|NCT01260493|75620613|FG001|STARTED|Overall Study||89||
59525324|NCT01260493|75620612|FG000|COMPLETED|Overall Study||76||
59968488|NCT03137407|76086185|FG000|STARTED|Overall Study||30||
59968489|NCT03137407|76086186|FG001|STARTED|Overall Study||29||
59525325|NCT01260493|75620613|FG001|COMPLETED|Overall Study||85||
59525326|NCT01260493|75620612|FG000|NOT COMPLETED|Overall Study||16||
59968490|NCT03137407|76086185|FG000|COMPLETED|Overall Study||26||
59968491|NCT03137407|76086186|FG001|COMPLETED|Overall Study||23||
59525327|NCT01260493|75620613|FG001|NOT COMPLETED|Overall Study||4||
59525328|NCT01260649|75620621|FG000|STARTED|Overall Study||8||
59525329|NCT01260649|75620622|FG001|STARTED|Overall Study||9||
59525330|NCT01260649|75620621|FG000|COMPLETED|Overall Study||6||
59525331|NCT01260649|75620622|FG001|COMPLETED|Overall Study||8||
59525332|NCT01260649|75620621|FG000|NOT COMPLETED|Overall Study||2||
59525333|NCT01260649|75620622|FG001|NOT COMPLETED|Overall Study||1||
59525334|NCT01260883|75620631|FG000|STARTED|Overall Study||22||
59525335|NCT01260883|75620632|FG001|STARTED|Overall Study||11||
59525336|NCT01260883|75620633|FG002|STARTED|Overall Study||18||
59525337|NCT01260883|75620631|FG000|COMPLETED|Overall Study||22||
59525338|NCT01260883|75620632|FG001|COMPLETED|Overall Study||11||
59810606|NCT00386308|75932803|FG001|Modified Intent to Treat Population|Overall Study||72||
59810607|NCT00386308|75932802|FG000|COMPLETED|Overall Study||94||
59810608|NCT00386308|75932803|FG001|COMPLETED|Overall Study||54||
59810609|NCT00386308|75932802|FG000|NOT COMPLETED|Overall Study||29||
59810610|NCT00386308|75932803|FG001|NOT COMPLETED|Overall Study||19||
59810611|NCT00064987|75932811|FG000|STARTED|Overall Study||10||
59810612|NCT00064987|75932812|FG001|STARTED|Overall Study||6||
59525339|NCT01260883|75620633|FG002|COMPLETED|Overall Study||18||
59525340|NCT01260883|75620631|FG000|NOT COMPLETED|Overall Study||0||
59810613|NCT00064987|75932811|FG000|COMPLETED|Overall Study||7||
59810614|NCT00064987|75932812|FG001|COMPLETED|Overall Study||6||
59810615|NCT00064987|75932811|FG000|NOT COMPLETED|Overall Study||3||
59810616|NCT00064987|75932812|FG001|NOT COMPLETED|Overall Study||0||
59810617|NCT00374452|75932820|FG000|STARTED|Overall Study||34|Randomization of the clinic sites.|10
59810618|NCT00374452|75932821|FG001|STARTED|Overall Study||48|Randomization of the clinic sites.|10
59810619|NCT00374452|75932820|FG000|Intervention Started|Overall Study||30||10
59810620|NCT00374452|75932821|FG001|Intervention Started|Overall Study||46||10
59810621|NCT00374452|75932820|FG000|COMPLETED|Overall Study||29||10
59810622|NCT00374452|75932821|FG001|COMPLETED|Overall Study||43||10
59810623|NCT00374452|75932820|FG000|NOT COMPLETED|Overall Study||5||0
59810624|NCT00374452|75932821|FG001|NOT COMPLETED|Overall Study||5||0
59810625|NCT00064753|75932829|FG000|STARTED|Overall Study||2056||
59810626|NCT00064753|75932830|FG001|STARTED|Overall Study||2054||
59810627|NCT00064753|75932829|FG000|COMPLETED|Overall Study||1382||
59810628|NCT00064753|75932830|FG001|COMPLETED|Overall Study||1406||
59810629|NCT00064753|75932829|FG000|NOT COMPLETED|Overall Study||674||
59810630|NCT00064753|75932830|FG001|NOT COMPLETED|Overall Study||648||
59810631|NCT00374140|75932836|FG000|STARTED|Overall Study||40||
59810632|NCT00374140|75932836|FG000|COMPLETED|Overall Study||38||
59810633|NCT00374140|75932836|FG000|NOT COMPLETED|Overall Study||2||
59810634|NCT00665561|75932842|FG000|STARTED|Overall Study||1316||
59810635|NCT00665561|75932843|FG001|STARTED|Overall Study||1130||
59810636|NCT00665561|75932842|FG000|COMPLETED|Overall Study||814||
59810637|NCT00665561|75932843|FG001|COMPLETED|Overall Study||596||
59810638|NCT00665561|75932842|FG000|NOT COMPLETED|Overall Study||502||
59810639|NCT00665561|75932843|FG001|NOT COMPLETED|Overall Study||534||
59810640|NCT00663923|75932849|FG000|STARTED|Overall Study||50||
59968492|NCT03137407|76086185|FG000|NOT COMPLETED|Overall Study||4||
59968493|NCT03137407|76086186|FG001|NOT COMPLETED|Overall Study||6||
59968494|NCT02923180|76086194|FG000|STARTED|Overall Study||32||
59968495|NCT02923180|76086194|FG000|COMPLETED|Overall Study||6||
59968496|NCT02923180|76086194|FG000|NOT COMPLETED|Overall Study||26||
59968497|NCT02836717|76086201|FG000|STARTED|Test Phase||73||
60074361|NCT01770392|76189742|FG000|COMPLETED|Washout Period of at Least 14 Days||25||
59810641|NCT00663923|75932849|FG000|COMPLETED|Overall Study||48||
59810642|NCT00663923|75932849|FG000|NOT COMPLETED|Overall Study||2||
59810643|NCT00386152|75932858|FG000|STARTED|Overall Study|number of subjects treated|75||
59810644|NCT00386152|75932859|FG001|STARTED|Overall Study|number of subjects treated|77||
59810645|NCT00386152|75932860|FG002|STARTED|Overall Study|number of subjects treated|75||
59810646|NCT00386152|75932858|FG000|COMPLETED|Overall Study||31||
59810647|NCT00386152|75932859|FG001|COMPLETED|Overall Study||37||
59810648|NCT00386152|75932860|FG002|COMPLETED|Overall Study||42||
59810649|NCT00386152|75932858|FG000|NOT COMPLETED|Overall Study||44||
59810650|NCT00386152|75932859|FG001|NOT COMPLETED|Overall Study||40||
59810651|NCT00386152|75932860|FG002|NOT COMPLETED|Overall Study||33||
59810652|NCT00385918|75932870|FG000|STARTED|Feasibility & Baseline Measurement Phase||0||
59810653|NCT00385918|75932871|FG001|STARTED|Feasibility & Baseline Measurement Phase||0||
59810654|NCT00385918|75932872|FG002|STARTED|Feasibility & Baseline Measurement Phase|Total # of subjects screened.The screening occurred before randomization.|35||
59810655|NCT00385918|75932870|FG000|Number Eligible|Feasibility & Baseline Measurement Phase||0||
59810656|NCT00385918|75932871|FG001|Number Eligible|Feasibility & Baseline Measurement Phase||0||
59525341|NCT01260883|75620632|FG001|NOT COMPLETED|Overall Study||0||
59525342|NCT01260883|75620633|FG002|NOT COMPLETED|Overall Study||0||
59525343|NCT00076622|75620666|FG000|STARTED|Overall Study||23||
59968498|NCT02836717|76086202|FG001|STARTED|Test Phase||16||
59525344|NCT00076622|75620667|FG001|STARTED|Overall Study||13||
59525345|NCT00076622|75620668|FG002|STARTED|Overall Study||40||
59525346|NCT00076622|75620669|FG003|STARTED|Overall Study||18||
59810657|NCT00385918|75932872|FG002|Number Eligible|Feasibility & Baseline Measurement Phase|8 subjects failed screening.|27||
59810658|NCT00385918|75932870|FG000|Completed Baseline Tests|Feasibility & Baseline Measurement Phase||0||
59810659|NCT00385918|75932871|FG001|Completed Baseline Tests|Feasibility & Baseline Measurement Phase||0||
59810660|NCT00385918|75932872|FG002|Completed Baseline Tests|Feasibility & Baseline Measurement Phase|6 subjects did not complete all baseline tests.|21||
59810661|NCT00385918|75932870|FG000|COMPLETED|Feasibility & Baseline Measurement Phase||0||
59810662|NCT00385918|75932871|FG001|COMPLETED|Feasibility & Baseline Measurement Phase||0||
59968499|NCT02836717|76086203|FG002|STARTED|Test Phase||12||
59968500|NCT02836717|76086201|FG000|COMPLETED|Test Phase||59||
59968501|NCT02836717|76086202|FG001|COMPLETED|Test Phase||8||
59968502|NCT02836717|76086203|FG002|COMPLETED|Test Phase||12||
59968503|NCT02836717|76086201|FG000|NOT COMPLETED|Test Phase||14||
59968504|NCT02836717|76086202|FG001|NOT COMPLETED|Test Phase||8||
59968505|NCT02836717|76086203|FG002|NOT COMPLETED|Test Phase||0||
59968506|NCT02836717|76086201|FG000|STARTED|Study Phase||59||
59968507|NCT02836717|76086202|FG001|STARTED|Study Phase||8||
59968508|NCT02836717|76086203|FG002|STARTED|Study Phase||12||
59968509|NCT02836717|76086201|FG000|COMPLETED|Study Phase||45||
59968510|NCT02836717|76086202|FG001|COMPLETED|Study Phase||1||
59968511|NCT02836717|76086203|FG002|COMPLETED|Study Phase||11||
59968512|NCT02836717|76086201|FG000|NOT COMPLETED|Study Phase||14||
59968513|NCT02836717|76086202|FG001|NOT COMPLETED|Study Phase||7||
59968514|NCT02836717|76086203|FG002|NOT COMPLETED|Study Phase||1||
59968515|NCT02743494|76086214|FG000|STARTED|Pre-treatment Period||532|Started = randomized|
59968516|NCT02743494|76086215|FG001|STARTED|Pre-treatment Period||262|Started = randomized|
59968517|NCT02743494|76086214|FG000|COMPLETED|Pre-treatment Period||532|Completed = Entering the treatment period|
59968518|NCT02743494|76086215|FG001|COMPLETED|Pre-treatment Period||260|Completed = Entering the treatment period|
59968519|NCT02743494|76086214|FG000|NOT COMPLETED|Pre-treatment Period||0||
59968520|NCT02743494|76086215|FG001|NOT COMPLETED|Pre-treatment Period||2||
59968521|NCT02743494|76086214|FG000|STARTED|Treatment Period||532||
59968522|NCT02743494|76086215|FG001|STARTED|Treatment Period||260||
59968523|NCT02743494|76086214|FG000|COMPLETED|Treatment Period||31|Completed = continuing in the treatment|
59968524|NCT02743494|76086215|FG001|COMPLETED|Treatment Period||19|Completed = continuing in the treatment|
59810663|NCT00385918|75932872|FG002|COMPLETED|Feasibility & Baseline Measurement Phase||21||
59810664|NCT00385918|75932870|FG000|NOT COMPLETED|Feasibility & Baseline Measurement Phase||0||
59810665|NCT00385918|75932871|FG001|NOT COMPLETED|Feasibility & Baseline Measurement Phase||0||
59810666|NCT00385918|75932872|FG002|NOT COMPLETED|Feasibility & Baseline Measurement Phase||14||
59810667|NCT00385918|75932870|FG000|STARTED|Intervention Phase After Randomization|Participant successfully completed screening; this is the number in the Lokomat training arm.|15||
59810668|NCT00385918|75932871|FG001|STARTED|Intervention Phase After Randomization|Participants successfully completed screening; this is the number in the home stretching arm.|6||
59810669|NCT00385918|75932872|FG002|STARTED|Intervention Phase After Randomization||0||
59810670|NCT00385918|75932870|FG000|COMPLETED|Intervention Phase After Randomization|Participants completed the 3-month training intervention|12||
59810671|NCT00385918|75932871|FG001|COMPLETED|Intervention Phase After Randomization|Participants completed the 3-month home-base intervention|6||
59810672|NCT00385918|75932872|FG002|COMPLETED|Intervention Phase After Randomization||0||
59968525|NCT02743494|76086214|FG000|NOT COMPLETED|Treatment Period||501||
59968526|NCT02743494|76086215|FG001|NOT COMPLETED|Treatment Period||241||
59968527|NCT02336282|76086221|FG000|STARTED|Overall Study||33||
59968528|NCT02336282|76086221|FG000|COMPLETED|Overall Study||28||
59968529|NCT02336282|76086221|FG000|NOT COMPLETED|Overall Study||5||
59968530|NCT02272842|76086235|FG000|STARTED|Overall Study||300||
59968531|NCT02272842|76086236|FG001|STARTED|Overall Study||300||
59968532|NCT02272842|76086235|FG000|COMPLETED|Overall Study||284||
60074362|NCT01770392|76189742|FG000|NOT COMPLETED|Washout Period of at Least 14 Days||1||
60074363|NCT01770392|76189742|FG000|STARTED|Nintedanib+ Rifampicin||25||
59810673|NCT00385918|75932870|FG000|NOT COMPLETED|Intervention Phase After Randomization||3||
59968533|NCT02272842|76086236|FG001|COMPLETED|Overall Study||290||
59968534|NCT02272842|76086235|FG000|NOT COMPLETED|Overall Study||16||
59968535|NCT02272842|76086236|FG001|NOT COMPLETED|Overall Study||10||
59968536|NCT02258659|76086243|FG000|STARTED|Overall Study||62||
59968537|NCT02258659|76086243|FG000|COMPLETED|Overall Study||61||
59968538|NCT02258659|76086243|FG000|NOT COMPLETED|Overall Study||1||
59968539|NCT01990300|76086247|FG000|STARTED|Overall Study||3281||
59968540|NCT01990300|76086247|FG000|COMPLETED|Overall Study||3139||
59968541|NCT01990300|76086247|FG000|NOT COMPLETED|Overall Study||142||
59968542|NCT01909934|76086251|FG000|STARTED|Overall Study||50||
59968543|NCT01909934|76086251|FG000|COMPLETED|Overall Study||0||
59968544|NCT01909934|76086251|FG000|NOT COMPLETED|Overall Study||50||
59968545|NCT01811303|76086255|FG000|STARTED|First Intervention (1 Day)||4||
59968546|NCT01811303|76086256|FG001|STARTED|First Intervention (1 Day)||4||
59968547|NCT01811303|76086257|FG002|STARTED|First Intervention (1 Day)||4||
59968548|NCT01811303|76086258|FG003|STARTED|First Intervention (1 Day)||2||
59968549|NCT01811303|76086255|FG000|COMPLETED|First Intervention (1 Day)||4||
59968550|NCT01811303|76086256|FG001|COMPLETED|First Intervention (1 Day)||4||
59968551|NCT01811303|76086257|FG002|COMPLETED|First Intervention (1 Day)||4||
59968552|NCT01811303|76086258|FG003|COMPLETED|First Intervention (1 Day)||2||
59968553|NCT01811303|76086255|FG000|NOT COMPLETED|First Intervention (1 Day)||0||
59968554|NCT01811303|76086256|FG001|NOT COMPLETED|First Intervention (1 Day)||0||
59968555|NCT01811303|76086257|FG002|NOT COMPLETED|First Intervention (1 Day)||0||
59968556|NCT01811303|76086258|FG003|NOT COMPLETED|First Intervention (1 Day)||0||
59968557|NCT01811303|76086255|FG000|STARTED|Washout (2 Days or More)||4||
59968558|NCT01811303|76086256|FG001|STARTED|Washout (2 Days or More)||4||
59968559|NCT01811303|76086257|FG002|STARTED|Washout (2 Days or More)||4||
59525347|NCT00076622|75620666|FG000|COMPLETED|Overall Study||23||
59525348|NCT00076622|75620667|FG001|COMPLETED|Overall Study||13||
59525349|NCT00076622|75620668|FG002|COMPLETED|Overall Study||40||
59525350|NCT00076622|75620669|FG003|COMPLETED|Overall Study||18||
59968560|NCT01811303|76086258|FG003|STARTED|Washout (2 Days or More)||2||
59968561|NCT01811303|76086255|FG000|COMPLETED|Washout (2 Days or More)||4||
59968562|NCT01811303|76086256|FG001|COMPLETED|Washout (2 Days or More)||4||
59968563|NCT01811303|76086257|FG002|COMPLETED|Washout (2 Days or More)||4||
59968564|NCT01811303|76086258|FG003|COMPLETED|Washout (2 Days or More)||2||
59968565|NCT01811303|76086255|FG000|NOT COMPLETED|Washout (2 Days or More)||0||
59968566|NCT01811303|76086256|FG001|NOT COMPLETED|Washout (2 Days or More)||0||
59968567|NCT01811303|76086257|FG002|NOT COMPLETED|Washout (2 Days or More)||0||
59968568|NCT01811303|76086258|FG003|NOT COMPLETED|Washout (2 Days or More)||0||
59968569|NCT01811303|76086255|FG000|STARTED|Second Intervention (1 Day)||4||
59968570|NCT01811303|76086256|FG001|STARTED|Second Intervention (1 Day)||4||
59968571|NCT01811303|76086257|FG002|STARTED|Second Intervention (1 Day)||4||
59968572|NCT01811303|76086258|FG003|STARTED|Second Intervention (1 Day)||2||
59968573|NCT01811303|76086255|FG000|COMPLETED|Second Intervention (1 Day)||4||
59968574|NCT01811303|76086256|FG001|COMPLETED|Second Intervention (1 Day)||4||
59968575|NCT01811303|76086257|FG002|COMPLETED|Second Intervention (1 Day)||4||
59968576|NCT01811303|76086258|FG003|COMPLETED|Second Intervention (1 Day)||2||
59968577|NCT01811303|76086255|FG000|NOT COMPLETED|Second Intervention (1 Day)||0||
59968578|NCT01811303|76086256|FG001|NOT COMPLETED|Second Intervention (1 Day)||0||
59968579|NCT01811303|76086257|FG002|NOT COMPLETED|Second Intervention (1 Day)||0||
59968580|NCT01811303|76086258|FG003|NOT COMPLETED|Second Intervention (1 Day)||0||
59968581|NCT01811303|76086255|FG000|STARTED|Washout (2 Days or More)||4||
59968582|NCT01811303|76086256|FG001|STARTED|Washout (2 Days or More)||4||
59968583|NCT01811303|76086257|FG002|STARTED|Washout (2 Days or More)||4||
59968584|NCT01811303|76086258|FG003|STARTED|Washout (2 Days or More)||2||
59968585|NCT01811303|76086255|FG000|COMPLETED|Washout (2 Days or More)||4||
59968586|NCT01811303|76086256|FG001|COMPLETED|Washout (2 Days or More)||4||
59968587|NCT01811303|76086257|FG002|COMPLETED|Washout (2 Days or More)||4||
59968588|NCT01811303|76086258|FG003|COMPLETED|Washout (2 Days or More)||2||
59968589|NCT01811303|76086255|FG000|NOT COMPLETED|Washout (2 Days or More)||0||
59968590|NCT01811303|76086256|FG001|NOT COMPLETED|Washout (2 Days or More)||0||
59968591|NCT01811303|76086257|FG002|NOT COMPLETED|Washout (2 Days or More)||0||
59968592|NCT01811303|76086258|FG003|NOT COMPLETED|Washout (2 Days or More)||0||
59968593|NCT01811303|76086255|FG000|STARTED|Third Intervention (1 Day)||4||
59968594|NCT01811303|76086256|FG001|STARTED|Third Intervention (1 Day)||4||
59968595|NCT01811303|76086257|FG002|STARTED|Third Intervention (1 Day)||4||
59968596|NCT01811303|76086258|FG003|STARTED|Third Intervention (1 Day)||2||
59968597|NCT01811303|76086255|FG000|COMPLETED|Third Intervention (1 Day)||4||
59968598|NCT01811303|76086256|FG001|COMPLETED|Third Intervention (1 Day)||4||
59968599|NCT01811303|76086257|FG002|COMPLETED|Third Intervention (1 Day)||4||
59968600|NCT01811303|76086258|FG003|COMPLETED|Third Intervention (1 Day)||2||
59968601|NCT01811303|76086255|FG000|NOT COMPLETED|Third Intervention (1 Day)||0||
59968602|NCT01811303|76086256|FG001|NOT COMPLETED|Third Intervention (1 Day)||0||
59968603|NCT01811303|76086257|FG002|NOT COMPLETED|Third Intervention (1 Day)||0||
59968604|NCT01811303|76086258|FG003|NOT COMPLETED|Third Intervention (1 Day)||0||
59968605|NCT01811303|76086255|FG000|STARTED|Washout (2 Days or More)||4||
59968606|NCT01811303|76086256|FG001|STARTED|Washout (2 Days or More)||4||
59968607|NCT01811303|76086257|FG002|STARTED|Washout (2 Days or More)||4||
59968608|NCT01811303|76086258|FG003|STARTED|Washout (2 Days or More)||2||
59968609|NCT01811303|76086255|FG000|COMPLETED|Washout (2 Days or More)||4||
59968610|NCT01811303|76086256|FG001|COMPLETED|Washout (2 Days or More)||4||
59968611|NCT01811303|76086257|FG002|COMPLETED|Washout (2 Days or More)||4||
59968612|NCT01811303|76086258|FG003|COMPLETED|Washout (2 Days or More)||2||
59968613|NCT01811303|76086255|FG000|NOT COMPLETED|Washout (2 Days or More)||0||
59968614|NCT01811303|76086256|FG001|NOT COMPLETED|Washout (2 Days or More)||0||
59968615|NCT01811303|76086257|FG002|NOT COMPLETED|Washout (2 Days or More)||0||
59968616|NCT01811303|76086258|FG003|NOT COMPLETED|Washout (2 Days or More)||0||
59968617|NCT01811303|76086255|FG000|STARTED|Fourth Intervention (1 Day)||4||
59968618|NCT01811303|76086256|FG001|STARTED|Fourth Intervention (1 Day)||4||
59968619|NCT01811303|76086257|FG002|STARTED|Fourth Intervention (1 Day)||4||
59968620|NCT01811303|76086258|FG003|STARTED|Fourth Intervention (1 Day)||2||
59968621|NCT01811303|76086255|FG000|COMPLETED|Fourth Intervention (1 Day)||4||
59968622|NCT01811303|76086256|FG001|COMPLETED|Fourth Intervention (1 Day)||4||
59525351|NCT00076622|75620666|FG000|NOT COMPLETED|Overall Study||0||
59525352|NCT00076622|75620667|FG001|NOT COMPLETED|Overall Study||0||
59525353|NCT00076622|75620668|FG002|NOT COMPLETED|Overall Study||0||
59968623|NCT01811303|76086257|FG002|COMPLETED|Fourth Intervention (1 Day)||4||
59968624|NCT01811303|76086258|FG003|COMPLETED|Fourth Intervention (1 Day)||2||
59968625|NCT01811303|76086255|FG000|NOT COMPLETED|Fourth Intervention (1 Day)||0||
59968626|NCT01811303|76086256|FG001|NOT COMPLETED|Fourth Intervention (1 Day)||0||
59621567|NCT00353652|75733171|FG002|COMPLETED|Second Intervention - 3 Months||6||
59621568|NCT00353652|75733172|FG003|COMPLETED|Second Intervention - 3 Months||7||
59621569|NCT00353652|75733173|FG004|COMPLETED|Second Intervention - 3 Months||3||
59621570|NCT00353652|75733174|FG005|COMPLETED|Second Intervention - 3 Months||0||
59621571|NCT00353652|75733175|FG006|COMPLETED|Second Intervention - 3 Months||1||
59621572|NCT00353652|75733176|FG007|COMPLETED|Second Intervention - 3 Months||0||
59621573|NCT00353652|75733169|FG000|NOT COMPLETED|Second Intervention - 3 Months||0||
59621574|NCT00353652|75733170|FG001|NOT COMPLETED|Second Intervention - 3 Months||0||
59621575|NCT00353652|75733171|FG002|NOT COMPLETED|Second Intervention - 3 Months||0||
59621576|NCT00353652|75733172|FG003|NOT COMPLETED|Second Intervention - 3 Months||0||
59621577|NCT00353652|75733173|FG004|NOT COMPLETED|Second Intervention - 3 Months||0||
59621578|NCT00353652|75733174|FG005|NOT COMPLETED|Second Intervention - 3 Months||0||
59621579|NCT00353652|75733175|FG006|NOT COMPLETED|Second Intervention - 3 Months||0||
59621580|NCT00353652|75733176|FG007|NOT COMPLETED|Second Intervention - 3 Months||0||
59621581|NCT00353652|75733169|FG000|STARTED|Third Intervention - 3 Months||0||
59621582|NCT00353652|75733170|FG001|STARTED|Third Intervention - 3 Months||0||
59621583|NCT00353652|75733171|FG002|STARTED|Third Intervention - 3 Months||6||
59621584|NCT00353652|75733172|FG003|STARTED|Third Intervention - 3 Months||7||
59621585|NCT00353652|75733173|FG004|STARTED|Third Intervention - 3 Months||3||
59621586|NCT00353652|75733174|FG005|STARTED|Third Intervention - 3 Months||0||
59621587|NCT00353652|75733175|FG006|STARTED|Third Intervention - 3 Months||1||
59621588|NCT00353652|75733176|FG007|STARTED|Third Intervention - 3 Months||0||
59621589|NCT00353652|75733169|FG000|COMPLETED|Third Intervention - 3 Months||0||
59621590|NCT00353652|75733170|FG001|COMPLETED|Third Intervention - 3 Months||0||
59621591|NCT00353652|75733171|FG002|COMPLETED|Third Intervention - 3 Months||6||
59621592|NCT00353652|75733172|FG003|COMPLETED|Third Intervention - 3 Months||6||
59621593|NCT00353652|75733173|FG004|COMPLETED|Third Intervention - 3 Months||3||
59621594|NCT00353652|75733174|FG005|COMPLETED|Third Intervention - 3 Months||0||
59621595|NCT00353652|75733175|FG006|COMPLETED|Third Intervention - 3 Months||1||
59621596|NCT00353652|75733176|FG007|COMPLETED|Third Intervention - 3 Months||0||
59621597|NCT00353652|75733169|FG000|NOT COMPLETED|Third Intervention - 3 Months||0||
59621598|NCT00353652|75733170|FG001|NOT COMPLETED|Third Intervention - 3 Months||0||
59621599|NCT00353652|75733171|FG002|NOT COMPLETED|Third Intervention - 3 Months||0||
59621600|NCT00353652|75733172|FG003|NOT COMPLETED|Third Intervention - 3 Months||1||
59621601|NCT00353652|75733173|FG004|NOT COMPLETED|Third Intervention - 3 Months||0||
59621602|NCT00353652|75733174|FG005|NOT COMPLETED|Third Intervention - 3 Months||0||
59621603|NCT00353652|75733175|FG006|NOT COMPLETED|Third Intervention - 3 Months||0||
59621604|NCT00353652|75733176|FG007|NOT COMPLETED|Third Intervention - 3 Months||0||
59621605|NCT03921840|75733193|FG000|STARTED|Overall Study|first enrollment|12||
59621606|NCT03921840|75733194|FG001|STARTED|Overall Study||12||
59621607|NCT03921840|75733193|FG000|COMPLETED|Overall Study||11||
59621608|NCT03921840|75733194|FG001|COMPLETED|Overall Study||12||
59621609|NCT03921840|75733193|FG000|NOT COMPLETED|Overall Study||1||
59621610|NCT03921840|75733194|FG001|NOT COMPLETED|Overall Study||0||
59621611|NCT00354978|75733200|FG000|STARTED|Overall Study||43||
59621612|NCT00354978|75733200|FG000|COMPLETED|Overall Study||43||
59621613|NCT00354978|75733200|FG000|NOT COMPLETED|Overall Study||0||
59621614|NCT00355914|75733206|FG000|STARTED|Overall Study||60||
59621615|NCT00355914|75733207|FG001|STARTED|Overall Study||60||
59621616|NCT00355914|75733206|FG000|COMPLETED|Overall Study||60||
59621617|NCT00355914|75733207|FG001|COMPLETED|Overall Study||60||
59621618|NCT00355914|75733206|FG000|NOT COMPLETED|Overall Study||0||
59621619|NCT00355914|75733207|FG001|NOT COMPLETED|Overall Study||0||
59621620|NCT00356304|75733217|FG000|STARTED|Overall Study||26||
59621621|NCT00356304|75733218|FG001|STARTED|Overall Study||24||
59621622|NCT00356304|75733217|FG000|COMPLETED|Overall Study||24||
59621623|NCT00356304|75733218|FG001|COMPLETED|Overall Study||20||
59621624|NCT00356304|75733217|FG000|NOT COMPLETED|Overall Study||2||
59621625|NCT00356304|75733218|FG001|NOT COMPLETED|Overall Study||4||
59621626|NCT03138096|75733229|FG000|STARTED|Overall Study||3||
59621627|NCT03138096|75733230|FG001|STARTED|Overall Study||3||
59621628|NCT03138096|75733231|FG002|STARTED|Overall Study||12||
59621629|NCT03138096|75733232|FG003|STARTED|Overall Study||6||
59621630|NCT03138096|75733233|FG004|STARTED|Overall Study|Phase 2 was not started because of unsufficient effectivity of the Pb(PfCS@UIS4) immunizations as pre-determined in the study protocol.|0||
59621631|NCT03138096|75733229|FG000|COMPLETED|Overall Study||3||
59621632|NCT03138096|75733230|FG001|COMPLETED|Overall Study||3||
59621633|NCT03138096|75733231|FG002|COMPLETED|Overall Study||12||
59621634|NCT03138096|75733232|FG003|COMPLETED|Overall Study||6||
59968627|NCT01811303|76086257|FG002|NOT COMPLETED|Fourth Intervention (1 Day)||0||
60074364|NCT01770392|76189742|FG000|COMPLETED|Nintedanib+ Rifampicin||25||
59621635|NCT03138096|75733233|FG004|COMPLETED|Overall Study||0||
59621636|NCT03138096|75733229|FG000|NOT COMPLETED|Overall Study||0||
59968628|NCT01811303|76086258|FG003|NOT COMPLETED|Fourth Intervention (1 Day)||0||
59621637|NCT03138096|75733230|FG001|NOT COMPLETED|Overall Study||0||
59621638|NCT03138096|75733231|FG002|NOT COMPLETED|Overall Study||0||
59621639|NCT03138096|75733232|FG003|NOT COMPLETED|Overall Study||0||
59621640|NCT03138096|75733233|FG004|NOT COMPLETED|Overall Study||0||
59621641|NCT00357162|75733256|FG000|STARTED|Overall Study||21||
59621642|NCT00357162|75733256|FG000|COMPLETED|Overall Study||21||
59621643|NCT00357162|75733256|FG000|NOT COMPLETED|Overall Study||0||
59621644|NCT00358332|75733264|FG000|STARTED|Overall Study||15||
59621645|NCT00358332|75733265|FG001|STARTED|Overall Study||30||
59621646|NCT00358332|75733266|FG002|STARTED|Overall Study||30||
59621647|NCT00358332|75733267|FG003|STARTED|Overall Study||25||
59621648|NCT00358332|75733264|FG000|COMPLETED|Overall Study||15||
59621649|NCT00358332|75733265|FG001|COMPLETED|Overall Study||27||
59621650|NCT00358332|75733266|FG002|COMPLETED|Overall Study||29||
59621651|NCT00358332|75733267|FG003|COMPLETED|Overall Study||25||
59621652|NCT00358332|75733264|FG000|NOT COMPLETED|Overall Study||0||
59621653|NCT00358332|75733265|FG001|NOT COMPLETED|Overall Study||3||
59621654|NCT00358332|75733266|FG002|NOT COMPLETED|Overall Study||1||
59621655|NCT00358332|75733267|FG003|NOT COMPLETED|Overall Study||0||
59621656|NCT00359736|75733279|FG000|STARTED|Overall Study||14||
59621657|NCT00359736|75733280|FG001|STARTED|Overall Study||15||
59621658|NCT00359736|75733279|FG000|COMPLETED|Overall Study||14||
59621659|NCT00359736|75733280|FG001|COMPLETED|Overall Study||15||
59621660|NCT00359736|75733279|FG000|NOT COMPLETED|Overall Study||0||
59621661|NCT00359736|75733280|FG001|NOT COMPLETED|Overall Study||0||
59621662|NCT00360126|75733288|FG000|STARTED|Overall Study||11||
59621663|NCT00360126|75733288|FG000|COMPLETED|Overall Study||11||
59621664|NCT00360126|75733288|FG000|NOT COMPLETED|Overall Study||0||
59621665|NCT00360360|75733292|FG000|STARTED|Overall Study||60||
59621666|NCT00360360|75733292|FG000|COMPLETED|Overall Study||54||
59621667|NCT00360360|75733292|FG000|NOT COMPLETED|Overall Study||6||
59621668|NCT00360672|75733296|FG000|STARTED|Overall Study||27||
59621669|NCT00360672|75733296|FG000|COMPLETED|Overall Study||27||
59621670|NCT00360672|75733296|FG000|NOT COMPLETED|Overall Study||0||
59621671|NCT00360828|75733300|FG000|STARTED|Overall Study||10||
59621672|NCT00360828|75733300|FG000|COMPLETED|Overall Study||9||
59621673|NCT00360828|75733300|FG000|NOT COMPLETED|Overall Study||1||
59810674|NCT00385918|75932871|FG001|NOT COMPLETED|Intervention Phase After Randomization||0||
59810675|NCT00385918|75932872|FG002|NOT COMPLETED|Intervention Phase After Randomization||0||
59810676|NCT00385840|75932881|FG000|STARTED|Overall Study||133||
59810677|NCT00385840|75932882|FG001|STARTED|Overall Study||545||
59810678|NCT00385840|75932881|FG000|COMPLETED|Overall Study||129||
59810679|NCT00385840|75932882|FG001|COMPLETED|Overall Study||531||
59810680|NCT00385840|75932881|FG000|NOT COMPLETED|Overall Study||4||
59810681|NCT00385840|75932882|FG001|NOT COMPLETED|Overall Study||14||
59810682|NCT00385762|75932888|FG000|STARTED|Overall Study||35||
59810683|NCT00385762|75932888|FG000|COMPLETED|Overall Study||33||
59525354|NCT00076622|75620669|FG003|NOT COMPLETED|Overall Study||0||
59525355|NCT00078728|75620685|FG000|STARTED|Overall Study||20||
59525356|NCT00078728|75620686|FG001|STARTED|Overall Study||20||
59810684|NCT00385762|75932888|FG000|NOT COMPLETED|Overall Study||2||
59810685|NCT00385684|75932892|FG000|STARTED|FIRST INTERVENTION OF PHASE A||6||
59810686|NCT00385684|75932893|FG001|STARTED|FIRST INTERVENTION OF PHASE A||5||
59810687|NCT00385684|75932892|FG000|COMPLETED|FIRST INTERVENTION OF PHASE A||5||
59810688|NCT00385684|75932893|FG001|COMPLETED|FIRST INTERVENTION OF PHASE A||5||
59525357|NCT00078728|75620685|FG000|COMPLETED|Overall Study||16||
59525358|NCT00078728|75620686|FG001|COMPLETED|Overall Study||17||
59525359|NCT00078728|75620685|FG000|NOT COMPLETED|Overall Study||4||
59525360|NCT00078728|75620686|FG001|NOT COMPLETED|Overall Study||3||
59525361|NCT02092610|75620695|FG000|STARTED|Overall Study||25||
59525362|NCT02092610|75620696|FG001|STARTED|Overall Study||52||
59525363|NCT02092610|75620695|FG000|COMPLETED|Overall Study||17||
59810689|NCT00385684|75932892|FG000|NOT COMPLETED|FIRST INTERVENTION OF PHASE A||1||
59810690|NCT00385684|75932893|FG001|NOT COMPLETED|FIRST INTERVENTION OF PHASE A||0||
59810691|NCT00385684|75932892|FG000|STARTED|SECOND INTERVENTION OF PHASE A||5||
59810692|NCT00385684|75932893|FG001|STARTED|SECOND INTERVENTION OF PHASE A||5||
59525364|NCT02092610|75620696|FG001|COMPLETED|Overall Study||40||
59621674|NCT00361140|75733307|FG000|STARTED|Overall Study||40||
59621675|NCT00361140|75733308|FG001|STARTED|Overall Study||29||
59621676|NCT00361140|75733309|FG002|STARTED|Overall Study||3||
59621677|NCT00361140|75733307|FG000|COMPLETED|Overall Study||40||
59621678|NCT00361140|75733308|FG001|COMPLETED|Overall Study||29||
59621679|NCT00361140|75733309|FG002|COMPLETED|Overall Study||3||
59621680|NCT00361140|75733307|FG000|NOT COMPLETED|Overall Study||0||
59621681|NCT00361140|75733308|FG001|NOT COMPLETED|Overall Study||0||
59621682|NCT00361140|75733309|FG002|NOT COMPLETED|Overall Study||0||
59621683|NCT00361374|75733320|FG000|STARTED|Overall Study||66||
59621684|NCT00361374|75733321|FG001|STARTED|Overall Study||65||
59621685|NCT00361374|75733322|FG002|STARTED|Overall Study||65||
59621686|NCT00361374|75733320|FG000|COMPLETED|Overall Study||51||
59621687|NCT00361374|75733321|FG001|COMPLETED|Overall Study||50||
59525365|NCT02092610|75620695|FG000|NOT COMPLETED|Overall Study||8||
59525366|NCT02092610|75620696|FG001|NOT COMPLETED|Overall Study||12||
59525367|NCT02093234|75620705|FG000|STARTED|Overall Study||56||
59621688|NCT00361374|75733322|FG002|COMPLETED|Overall Study||53||
59621689|NCT00361374|75733320|FG000|NOT COMPLETED|Overall Study||15||
59621690|NCT00361374|75733321|FG001|NOT COMPLETED|Overall Study||15||
59621691|NCT00361374|75733322|FG002|NOT COMPLETED|Overall Study||12||
59621692|NCT00362466|75733332|FG000|STARTED|Overall Study||2||
59621693|NCT00362466|75733333|FG001|STARTED|Overall Study||1||
59621694|NCT00362466|75733332|FG000|COMPLETED|Overall Study||2||
59621695|NCT00362466|75733333|FG001|COMPLETED|Overall Study||1||
59621696|NCT00362466|75733332|FG000|NOT COMPLETED|Overall Study||0||
59621697|NCT00362466|75733333|FG001|NOT COMPLETED|Overall Study||0||
59621698|NCT00305682|75733345|FG000|STARTED|Overall Study||98||
59621699|NCT00305682|75733346|FG001|STARTED|Overall Study||71||
59621700|NCT00305682|75733347|FG002|STARTED|Overall Study||7||
59621701|NCT00305682|75733348|FG003|STARTED|Overall Study||34||
59621702|NCT00305682|75733349|FG004|STARTED|Overall Study||39||
59621703|NCT00305682|75733350|FG005|STARTED|Overall Study||35||
59621704|NCT00305682|75733345|FG000|COMPLETED|Overall Study||98||
59621705|NCT00305682|75733346|FG001|COMPLETED|Overall Study||71||
59621706|NCT00305682|75733347|FG002|COMPLETED|Overall Study||7||
59621707|NCT00305682|75733348|FG003|COMPLETED|Overall Study||34||
59621708|NCT00305682|75733349|FG004|COMPLETED|Overall Study||39||
59621709|NCT00305682|75733350|FG005|COMPLETED|Overall Study||35||
59621710|NCT00305682|75733345|FG000|NOT COMPLETED|Overall Study||0||
59621711|NCT00305682|75733346|FG001|NOT COMPLETED|Overall Study||0||
59621712|NCT00305682|75733347|FG002|NOT COMPLETED|Overall Study||0||
59621713|NCT00305682|75733348|FG003|NOT COMPLETED|Overall Study||0||
59621714|NCT00305682|75733349|FG004|NOT COMPLETED|Overall Study||0||
59621715|NCT00305682|75733350|FG005|NOT COMPLETED|Overall Study||0||
59621716|NCT00305760|75733364|FG000|STARTED|Overall Study||60||
59621717|NCT00305760|75733364|FG000|COMPLETED|Overall Study||13||
59621718|NCT00305760|75733364|FG000|NOT COMPLETED|Overall Study||47||
59621719|NCT00309738|75733370|FG000|STARTED|Overall Study||236||
59621720|NCT00309738|75733371|FG001|STARTED|Overall Study||119||
59621721|NCT00309738|75733370|FG000|Safety Population|Overall Study|Subjects who received at least one dose of study medication|233||
59621722|NCT00309738|75733371|FG001|Safety Population|Overall Study|Subjects who received at least one dose of study medication|119||
59621723|NCT00309738|75733370|FG000|COMPLETED|Overall Study||223||
59621724|NCT00309738|75733371|FG001|COMPLETED|Overall Study||107||
59621725|NCT00309738|75733370|FG000|NOT COMPLETED|Overall Study||13||
59621726|NCT00309738|75733371|FG001|NOT COMPLETED|Overall Study||12||
59621727|NCT00310050|75733377|FG000|STARTED|Overall Study||4||
59621728|NCT00310050|75733377|FG000|COMPLETED|Overall Study||3||
59621729|NCT00310050|75733377|FG000|NOT COMPLETED|Overall Study||1||
59621730|NCT00363168|75733383|FG000|STARTED|Overall Study||5||
59621731|NCT00363168|75733384|FG001|STARTED|Overall Study||2||
59621732|NCT00363168|75733383|FG000|COMPLETED|Overall Study||5||
59621733|NCT00363168|75733384|FG001|COMPLETED|Overall Study||2||
59621734|NCT00363168|75733383|FG000|NOT COMPLETED|Overall Study||0||
59621735|NCT00363168|75733384|FG001|NOT COMPLETED|Overall Study||0||
59621736|NCT00365274|75733390|FG000|STARTED|Overall Study||6||
59621737|NCT00365274|75733390|FG000|COMPLETED|Overall Study||6||
59621738|NCT00365274|75733390|FG000|NOT COMPLETED|Overall Study||0||
59621739|NCT00310362|75733397|FG000|STARTED|Overall Study||1199||
59621740|NCT00310362|75733398|FG001|STARTED|Overall Study||1205||
59621741|NCT00310362|75733399|FG002|STARTED|Overall Study||1206||
59621742|NCT00310362|75733397|FG000|COMPLETED|Overall Study||1199||
59621743|NCT00310362|75733398|FG001|COMPLETED|Overall Study||1205||
59621744|NCT00310362|75733399|FG002|COMPLETED|Overall Study||1206||
59621745|NCT00310362|75733397|FG000|NOT COMPLETED|Overall Study||0||
59621746|NCT00310362|75733398|FG001|NOT COMPLETED|Overall Study||0||
59621747|NCT00310362|75733399|FG002|NOT COMPLETED|Overall Study||0||
59621748|NCT00311376|75733416|FG000|STARTED|Treatment Cycle 1||132||
59621749|NCT00311376|75733417|FG001|STARTED|Treatment Cycle 1||135||
59621750|NCT00311376|75733418|FG002|STARTED|Treatment Cycle 1||149||
59621751|NCT00311376|75733416|FG000|COMPLETED|Treatment Cycle 1||105||
59621752|NCT00311376|75733417|FG001|COMPLETED|Treatment Cycle 1||118||
59621753|NCT00311376|75733418|FG002|COMPLETED|Treatment Cycle 1||132||
59621754|NCT00311376|75733416|FG000|NOT COMPLETED|Treatment Cycle 1||27||
59621755|NCT00311376|75733417|FG001|NOT COMPLETED|Treatment Cycle 1||17||
59621756|NCT00311376|75733418|FG002|NOT COMPLETED|Treatment Cycle 1||17||
59621757|NCT00311376|75733416|FG000|STARTED|Treatment Cycle 2|69 from the 300U group + 46 from the Placebo group entered Cycle 2|115||
59621758|NCT00311376|75733417|FG001|STARTED|Treatment Cycle 2|74 from the 200U group + 51 from the Placebo group entered Cycle 2|125||
59621759|NCT00311376|75733418|FG002|STARTED|Treatment Cycle 2|Cycle 1 Placebo pts were randomized to receive 300U or 200U in Cycle 2|0||
59621760|NCT00311376|75733416|FG000|COMPLETED|Treatment Cycle 2||106||
59621761|NCT00311376|75733417|FG001|COMPLETED|Treatment Cycle 2||112||
59621762|NCT00311376|75733418|FG002|COMPLETED|Treatment Cycle 2||0||
59621763|NCT00311376|75733416|FG000|NOT COMPLETED|Treatment Cycle 2||9||
59621764|NCT00311376|75733417|FG001|NOT COMPLETED|Treatment Cycle 2||13||
59621765|NCT00311376|75733418|FG002|NOT COMPLETED|Treatment Cycle 2||0||
59621766|NCT02104830|75733429|FG000|STARTED|Overall Study||42||
59621767|NCT02104830|75733430|FG001|STARTED|Overall Study||43||
59621768|NCT02104830|75733431|FG002|STARTED|Overall Study||43||
59621769|NCT02104830|75733429|FG000|COMPLETED|Overall Study||38||
59621770|NCT02104830|75733430|FG001|COMPLETED|Overall Study||36||
59621771|NCT02104830|75733431|FG002|COMPLETED|Overall Study||36||
59621772|NCT02104830|75733429|FG000|NOT COMPLETED|Overall Study||4||
59621773|NCT02104830|75733430|FG001|NOT COMPLETED|Overall Study||7||
59621774|NCT02104830|75733431|FG002|NOT COMPLETED|Overall Study||7||
59621775|NCT00311766|75733441|FG000|STARTED|Overall Study||8||
59621776|NCT00311766|75733442|FG001|STARTED|Overall Study||22||
59621777|NCT00311766|75733441|FG000|COMPLETED|Overall Study||8||
59621778|NCT00311766|75733442|FG001|COMPLETED|Overall Study||17||
59621779|NCT00311766|75733441|FG000|NOT COMPLETED|Overall Study||0||
59621780|NCT00311766|75733442|FG001|NOT COMPLETED|Overall Study||5||
59621781|NCT00313560|75733448|FG000|STARTED|Overall Study||48||
59621782|NCT00313560|75733448|FG000|COMPLETED|Overall Study||48||
59621783|NCT00313560|75733448|FG000|NOT COMPLETED|Overall Study||0||
59621784|NCT00314106|75733458|FG000|STARTED|Overall Study||18||
59621785|NCT00314106|75733459|FG001|STARTED|Overall Study||8||
59621786|NCT00314106|75733458|FG000|COMPLETED|Overall Study||18||
59621787|NCT00314106|75733459|FG001|COMPLETED|Overall Study||8||
59621788|NCT00314106|75733458|FG000|NOT COMPLETED|Overall Study||0||
59621789|NCT00314106|75733459|FG001|NOT COMPLETED|Overall Study||0||
59621790|NCT00315120|75733469|FG000|STARTED|Overall Study||115||
59621791|NCT00315120|75733470|FG001|STARTED|Overall Study||118||
59621792|NCT00315120|75733471|FG002|STARTED|Overall Study||115||
59621793|NCT00315120|75733472|FG003|STARTED|Overall Study||107||
59621794|NCT00315120|75733469|FG000|COMPLETED|Overall Study||115||
59810693|NCT00385684|75932892|FG000|COMPLETED|SECOND INTERVENTION OF PHASE A||5||
59810694|NCT00385684|75932893|FG001|COMPLETED|SECOND INTERVENTION OF PHASE A||3||
59810695|NCT00385684|75932892|FG000|NOT COMPLETED|SECOND INTERVENTION OF PHASE A||0||
59810696|NCT00385684|75932893|FG001|NOT COMPLETED|SECOND INTERVENTION OF PHASE A||2||
59810697|NCT00385684|75932892|FG000|STARTED|PHASE B||5||
59810698|NCT00385684|75932893|FG001|STARTED|PHASE B||3||
59810699|NCT00385684|75932892|FG000|COMPLETED|PHASE B||5||
59810700|NCT00385684|75932893|FG001|COMPLETED|PHASE B||3||
59621795|NCT00315120|75733470|FG001|COMPLETED|Overall Study||118||
59621796|NCT00315120|75733471|FG002|COMPLETED|Overall Study||115||
59621797|NCT00315120|75733472|FG003|COMPLETED|Overall Study||107||
59621798|NCT00315120|75733469|FG000|NOT COMPLETED|Overall Study||0||
59621799|NCT00315120|75733470|FG001|NOT COMPLETED|Overall Study||0||
59621800|NCT00315120|75733471|FG002|NOT COMPLETED|Overall Study||0||
59621801|NCT00315120|75733472|FG003|NOT COMPLETED|Overall Study||0||
59621802|NCT00315588|75733484|FG000|STARTED|Overall Study||7||
59621803|NCT00315588|75733484|FG000|COMPLETED|Overall Study||7||
59621804|NCT00315588|75733484|FG000|NOT COMPLETED|Overall Study||0||
59621805|NCT00367380|75733493|FG000|STARTED|Overall Study||6||
59621806|NCT00367380|75733494|FG001|STARTED|Overall Study||6||
59621807|NCT00367380|75733495|FG002|STARTED|Overall Study||6||
59621808|NCT00367380|75733493|FG000|COMPLETED|Overall Study||6||
59621809|NCT00367380|75733494|FG001|COMPLETED|Overall Study||6||
59621810|NCT00367380|75733495|FG002|COMPLETED|Overall Study||6||
59810701|NCT00385684|75932892|FG000|NOT COMPLETED|PHASE B||0||
59810702|NCT00385684|75932893|FG001|NOT COMPLETED|PHASE B||0||
59810703|NCT00661661|75932901|FG000|STARTED|Overall Study||382||
59810704|NCT00661661|75932902|FG001|STARTED|Overall Study||105||
59810705|NCT00661661|75932901|FG000|COMPLETED|Overall Study||242||
59810706|NCT00661661|75932902|FG001|COMPLETED|Overall Study||66||
59810707|NCT00661661|75932901|FG000|NOT COMPLETED|Overall Study||140||
59810708|NCT00661661|75932902|FG001|NOT COMPLETED|Overall Study||39||
59810709|NCT00038467|75932912|FG000|STARTED|Overall Study||2352||
59810710|NCT00038467|75932913|FG001|STARTED|Overall Study||2372||
59810711|NCT00038467|75932912|FG000|Treated|Overall Study|8 participants randomized to receive exemestane, received tamoxifen. Reported as per randomization.|2321||
59621811|NCT00367380|75733493|FG000|NOT COMPLETED|Overall Study||0||
59621812|NCT00367380|75733494|FG001|NOT COMPLETED|Overall Study||0||
59621813|NCT00367380|75733495|FG002|NOT COMPLETED|Overall Study||0||
59621814|NCT00368316|75733505|FG000|STARTED|Overall Study||1434||
59621815|NCT00368316|75733506|FG001|STARTED|Overall Study||1365||
59621816|NCT00368316|75733505|FG000|COMPLETED|Overall Study||1392||
59621817|NCT00368316|75733506|FG001|COMPLETED|Overall Study||1319||
59810712|NCT00038467|75932913|FG001|Treated|Overall Study|7 participants randomized to receive tamoxifen, received exemestane. Reported as per randomization.|2337||
59621818|NCT00368316|75733505|FG000|NOT COMPLETED|Overall Study||42||
59621819|NCT00368316|75733506|FG001|NOT COMPLETED|Overall Study||46||
59621820|NCT00368940|75733514|FG000|STARTED|Intention-to-Treat||37||
60103599|NCT04075734|76221850|FG002|NOT COMPLETED|Overall Study||0||
59621821|NCT00368940|75733515|FG001|STARTED|Intention-to-Treat||37||
59621822|NCT00368940|75733514|FG000|COMPLETED|Intention-to-Treat||37||
59621823|NCT00368940|75733515|FG001|COMPLETED|Intention-to-Treat||37||
59621824|NCT00368940|75733514|FG000|NOT COMPLETED|Intention-to-Treat||0||
59621825|NCT00368940|75733515|FG001|NOT COMPLETED|Intention-to-Treat||0||
59621826|NCT00368940|75733514|FG000|STARTED|Completed 12-wk Treatment||37||
59621827|NCT00368940|75733515|FG001|STARTED|Completed 12-wk Treatment||37||
59621828|NCT00368940|75733514|FG000|COMPLETED|Completed 12-wk Treatment||31||
59621829|NCT00368940|75733515|FG001|COMPLETED|Completed 12-wk Treatment||32||
59621830|NCT00368940|75733514|FG000|NOT COMPLETED|Completed 12-wk Treatment||6||
59621831|NCT00368940|75733515|FG001|NOT COMPLETED|Completed 12-wk Treatment||5||
59621832|NCT00369564|75733524|FG000|STARTED|Overall Study||127||
59621833|NCT00369564|75733525|FG001|STARTED|Overall Study||123||
59621834|NCT00369564|75733524|FG000|COMPLETED|Overall Study||84||
59621835|NCT00369564|75733525|FG001|COMPLETED|Overall Study||100||
59621836|NCT00369564|75733524|FG000|NOT COMPLETED|Overall Study||43||
59621837|NCT00369564|75733525|FG001|NOT COMPLETED|Overall Study||23||
59621838|NCT00315822|75733537|FG000|STARTED|Overall Study||198||
59621839|NCT00315822|75733538|FG001|STARTED|Overall Study||202||
59621840|NCT00315822|75733537|FG000|COMPLETED|Overall Study||198||
59621841|NCT00315822|75733538|FG001|COMPLETED|Overall Study||202||
59621842|NCT00315822|75733537|FG000|NOT COMPLETED|Overall Study||0||
59621843|NCT00315822|75733538|FG001|NOT COMPLETED|Overall Study||0||
59810713|NCT00038467|75932912|FG000|COMPLETED|Overall Study||1810||
59810714|NCT00038467|75932913|FG001|COMPLETED|Overall Study||1830||
59810715|NCT00038467|75932912|FG000|NOT COMPLETED|Overall Study||542||
59968629|NCT01318317|76086269|FG000|STARTED|Overall Study||1||
59968630|NCT01318317|76086270|FG001|STARTED|Overall Study||4||
59968631|NCT01318317|76086271|FG002|STARTED|Overall Study||3||
59968632|NCT01318317|76086269|FG000|COMPLETED|Overall Study||1||
59968633|NCT01318317|76086270|FG001|COMPLETED|Overall Study||4||
59968634|NCT01318317|76086271|FG002|COMPLETED|Overall Study||3||
59968635|NCT01318317|76086269|FG000|NOT COMPLETED|Overall Study||0||
59968636|NCT01318317|76086270|FG001|NOT COMPLETED|Overall Study||0||
59968637|NCT01318317|76086271|FG002|NOT COMPLETED|Overall Study||0||
59968638|NCT01076400|76086280|FG000|STARTED|Overall Study||7||
59968639|NCT01076400|76086281|FG001|STARTED|Overall Study|No participants were enrolled in Part 2 of the study.|0||
59968640|NCT01076400|76086282|FG002|STARTED|Overall Study|No participants were enrolled in Part 2 of the study.|0||
59968641|NCT01076400|76086280|FG000|COMPLETED|Overall Study||0||
59621844|NCT00316524|75733548|FG000|STARTED|Overall Study||183|Vaccinated|
59621845|NCT00316524|75733549|FG001|STARTED|Overall Study||181|Vaccinated|
59621846|NCT00316524|75733550|FG002|STARTED|Overall Study||181|Vaccinated|
59621847|NCT00316524|75733551|FG003|STARTED|Overall Study||200|Vaccinated|
59621848|NCT00316524|75733548|FG000|COMPLETED|Overall Study||175|Active Trial Phase|
59621849|NCT00316524|75733549|FG001|COMPLETED|Overall Study||173|Active Trial Phase|
59621850|NCT00316524|75733550|FG002|COMPLETED|Overall Study||175|Active Trial Phase|
59621851|NCT00316524|75733551|FG003|COMPLETED|Overall Study||200|Active Trial Phase|
59621852|NCT00316524|75733548|FG000|NOT COMPLETED|Overall Study||8||
59621853|NCT00316524|75733549|FG001|NOT COMPLETED|Overall Study||8||
59621854|NCT00316524|75733550|FG002|NOT COMPLETED|Overall Study||6||
59621855|NCT00316524|75733551|FG003|NOT COMPLETED|Overall Study||0||
59621856|NCT00317226|75733565|FG000|STARTED|Overall Study||127||
59621857|NCT00317226|75733565|FG000|COMPLETED|Overall Study||104||
59810716|NCT00038467|75932913|FG001|NOT COMPLETED|Overall Study||542||
59810717|NCT00051025|75932921|FG000|STARTED|Overall Study||5||
59810718|NCT00051025|75932922|FG001|STARTED|Overall Study||4||
59810719|NCT00051025|75932921|FG000|COMPLETED|Overall Study||3||
59810720|NCT00051025|75932922|FG001|COMPLETED|Overall Study||0||
59810721|NCT00051025|75932921|FG000|NOT COMPLETED|Overall Study||2||
59810722|NCT00051025|75932922|FG001|NOT COMPLETED|Overall Study||4||
59810723|NCT00660179|75932931|FG000|STARTED|Overall Study||250||
59810724|NCT00660179|75932932|FG001|STARTED|Overall Study||250||
59810725|NCT00660179|75932933|FG002|STARTED|Overall Study||242||
59810726|NCT00660179|75932931|FG000|COMPLETED|Overall Study||194||
59810727|NCT00660179|75932932|FG001|COMPLETED|Overall Study||192||
59810728|NCT00660179|75932933|FG002|COMPLETED|Overall Study||201||
59810729|NCT00660179|75932931|FG000|NOT COMPLETED|Overall Study||56||
59810730|NCT00660179|75932932|FG001|NOT COMPLETED|Overall Study||58||
59810731|NCT00660179|75932933|FG002|NOT COMPLETED|Overall Study||41||
59810732|NCT00050167|75932943|FG000|STARTED|Overall Study||302||
59968642|NCT01076400|76086281|FG001|COMPLETED|Overall Study||0||
59968643|NCT01076400|76086282|FG002|COMPLETED|Overall Study||0||
59968644|NCT01076400|76086280|FG000|NOT COMPLETED|Overall Study||7||
59968645|NCT01076400|76086281|FG001|NOT COMPLETED|Overall Study||0||
59968646|NCT01076400|76086282|FG002|NOT COMPLETED|Overall Study||0||
59968647|NCT01000051|76086288|FG000|STARTED|Overall Study||42||
59968648|NCT01000051|76086289|FG001|STARTED|Overall Study||18||
59968649|NCT01000051|76086288|FG000|COMPLETED|Overall Study||39||
59968650|NCT01000051|76086289|FG001|COMPLETED|Overall Study||17||
59968651|NCT01000051|76086288|FG000|NOT COMPLETED|Overall Study||3||
59968652|NCT01000051|76086289|FG001|NOT COMPLETED|Overall Study||1||
59621858|NCT00317226|75733565|FG000|NOT COMPLETED|Overall Study||23||
59621859|NCT00318708|75733571|FG000|STARTED|Overall Study||47||
59621860|NCT00318708|75733572|FG001|STARTED|Overall Study||45||
59621861|NCT00318708|75733571|FG000|8-week Milestone|Overall Study||42||
59621862|NCT00318708|75733572|FG001|8-week Milestone|Overall Study||42||
59621863|NCT00318708|75733571|FG000|COMPLETED|Overall Study||39||
59810733|NCT00050167|75932944|FG001|STARTED|Overall Study||301||
59810734|NCT00050167|75932943|FG000|COMPLETED|Overall Study||301||
59810735|NCT00050167|75932944|FG001|COMPLETED|Overall Study||300||
59810736|NCT00050167|75932943|FG000|NOT COMPLETED|Overall Study||1||
59810737|NCT00050167|75932944|FG001|NOT COMPLETED|Overall Study||1||
59810738|NCT00660023|75932950|FG000|STARTED|Overall Study||124||
59968653|NCT00953160|76086295|FG000|STARTED|Overall Study||76||
59968654|NCT00953160|76086295|FG000|COMPLETED|Overall Study||49||
59968655|NCT00953160|76086295|FG000|NOT COMPLETED|Overall Study||27||
59968656|NCT00934895|76086306|FG000|STARTED|Overall Study||0||
59968657|NCT00934895|76086307|FG001|STARTED|Overall Study||0||
59968658|NCT00934895|76086308|FG002|STARTED|Overall Study||3||
59968659|NCT00934895|76086309|FG003|STARTED|Overall Study||6||
59968660|NCT00934895|76086310|FG004|STARTED|Overall Study||4||
59968661|NCT00934895|76086311|FG005|STARTED|Overall Study||0||
59968662|NCT00934895|76086312|FG006|STARTED|Overall Study||14||
59968663|NCT00934895|76086306|FG000|COMPLETED|Overall Study||0||
59968664|NCT00934895|76086307|FG001|COMPLETED|Overall Study||0||
59968665|NCT00934895|76086308|FG002|COMPLETED|Overall Study||3||
59968666|NCT00934895|76086309|FG003|COMPLETED|Overall Study||6||
59968667|NCT00934895|76086310|FG004|COMPLETED|Overall Study||4||
59968668|NCT00934895|76086311|FG005|COMPLETED|Overall Study||0||
59968669|NCT00934895|76086312|FG006|COMPLETED|Overall Study||14||
59968670|NCT00934895|76086306|FG000|NOT COMPLETED|Overall Study||0||
59968671|NCT00934895|76086307|FG001|NOT COMPLETED|Overall Study||0||
59968672|NCT00934895|76086308|FG002|NOT COMPLETED|Overall Study||0||
59968673|NCT00934895|76086309|FG003|NOT COMPLETED|Overall Study||0||
59968674|NCT00934895|76086310|FG004|NOT COMPLETED|Overall Study||0||
59968675|NCT00934895|76086311|FG005|NOT COMPLETED|Overall Study||0||
59968676|NCT00934895|76086312|FG006|NOT COMPLETED|Overall Study||0||
59968677|NCT00913497|76086322|FG000|STARTED|Overall Study||16||
59968678|NCT00913497|76086322|FG000|COMPLETED|Overall Study||13||
59968679|NCT00913497|76086322|FG000|NOT COMPLETED|Overall Study||3||
59968680|NCT00874822|76086328|FG000|STARTED|Overall Study||216||
59968681|NCT00874822|76086328|FG000|COMPLETED|Overall Study||208||
59968682|NCT00874822|76086328|FG000|NOT COMPLETED|Overall Study||8||
59968683|NCT00693238|76086334|FG000|STARTED|Overall Study||122||
59968684|NCT00693238|76086335|FG001|STARTED|Overall Study||106||
59968685|NCT00693238|76086334|FG000|COMPLETED|Overall Study||122||
59968686|NCT00693238|76086335|FG001|COMPLETED|Overall Study||106||
59968687|NCT00693238|76086334|FG000|NOT COMPLETED|Overall Study||0||
59968688|NCT00693238|76086335|FG001|NOT COMPLETED|Overall Study||0||
59968689|NCT00556933|76086345|FG000|STARTED|Single vs. Divided-dose rATG Induction||45||
59968690|NCT00556933|76086346|FG001|STARTED|Single vs. Divided-dose rATG Induction||45||
59968691|NCT00556933|76086347|FG002|STARTED|Single vs. Divided-dose rATG Induction||45||
59968692|NCT00556933|76086348|FG003|STARTED|Single vs. Divided-dose rATG Induction||45||
59968693|NCT00556933|76086345|FG000|COMPLETED|Single vs. Divided-dose rATG Induction||43||
59968694|NCT00556933|76086346|FG001|COMPLETED|Single vs. Divided-dose rATG Induction||37||
59968695|NCT00556933|76086347|FG002|COMPLETED|Single vs. Divided-dose rATG Induction||39||
59968696|NCT00556933|76086348|FG003|COMPLETED|Single vs. Divided-dose rATG Induction||43||
59968697|NCT00556933|76086345|FG000|NOT COMPLETED|Single vs. Divided-dose rATG Induction||2||
59968698|NCT00556933|76086346|FG001|NOT COMPLETED|Single vs. Divided-dose rATG Induction||8||
59968699|NCT00556933|76086347|FG002|NOT COMPLETED|Single vs. Divided-dose rATG Induction||6||
59968700|NCT00556933|76086348|FG003|NOT COMPLETED|Single vs. Divided-dose rATG Induction||2||
59968701|NCT00556933|76086345|FG000|STARTED|CNI Withdrawal vs. Minimization||43||
59968702|NCT00556933|76086346|FG001|STARTED|CNI Withdrawal vs. Minimization||37||
59968703|NCT00556933|76086347|FG002|STARTED|CNI Withdrawal vs. Minimization||39||
59968704|NCT00556933|76086348|FG003|STARTED|CNI Withdrawal vs. Minimization||43||
59968705|NCT00556933|76086345|FG000|COMPLETED|CNI Withdrawal vs. Minimization||42||
59968706|NCT00556933|76086346|FG001|COMPLETED|CNI Withdrawal vs. Minimization||33||
59968707|NCT00556933|76086347|FG002|COMPLETED|CNI Withdrawal vs. Minimization||36||
59968708|NCT00556933|76086348|FG003|COMPLETED|CNI Withdrawal vs. Minimization||41||
59968709|NCT00556933|76086345|FG000|NOT COMPLETED|CNI Withdrawal vs. Minimization||1||
59968710|NCT00556933|76086346|FG001|NOT COMPLETED|CNI Withdrawal vs. Minimization||4||
59968711|NCT00556933|76086347|FG002|NOT COMPLETED|CNI Withdrawal vs. Minimization||3||
59968712|NCT00556933|76086348|FG003|NOT COMPLETED|CNI Withdrawal vs. Minimization||2||
59968713|NCT00503880|76086367|FG000|STARTED|Overall Study||2||
59968714|NCT00503880|76086368|FG001|STARTED|Overall Study||0||
59968715|NCT00503880|76086369|FG002|STARTED|Overall Study||0||
59968716|NCT00503880|76086370|FG003|STARTED|Overall Study||0||
59968717|NCT00503880|76086371|FG004|STARTED|Overall Study||0||
59968718|NCT00503880|76086367|FG000|COMPLETED|Overall Study||0||
59968719|NCT00503880|76086368|FG001|COMPLETED|Overall Study||0||
59968720|NCT00503880|76086369|FG002|COMPLETED|Overall Study||0||
59968721|NCT00503880|76086370|FG003|COMPLETED|Overall Study||0||
59968722|NCT00503880|76086371|FG004|COMPLETED|Overall Study||0||
59968723|NCT00503880|76086367|FG000|NOT COMPLETED|Overall Study||2||
59968724|NCT00503880|76086368|FG001|NOT COMPLETED|Overall Study||0||
59968725|NCT00503880|76086369|FG002|NOT COMPLETED|Overall Study||0||
59968726|NCT00503880|76086370|FG003|NOT COMPLETED|Overall Study||0||
59968727|NCT00503880|76086371|FG004|NOT COMPLETED|Overall Study||0||
59968728|NCT00378326|76086377|FG000|STARTED|Overall Study||26||
59968729|NCT00378326|76086377|FG000|COMPLETED|Overall Study||26||
59968730|NCT00378326|76086377|FG000|NOT COMPLETED|Overall Study||0||
59968731|NCT00280917|76086387|FG000|STARTED|Overall Study||65||
59968732|NCT00280917|76086388|FG001|STARTED|Overall Study||63||
59968733|NCT00280917|76086389|FG002|STARTED|Overall Study||63||
59968734|NCT00280917|76086390|FG003|STARTED|Overall Study||63||
59968735|NCT00280917|76086387|FG000|COMPLETED|Overall Study||63||
59968736|NCT00280917|76086388|FG001|COMPLETED|Overall Study||57||
59968737|NCT00280917|76086389|FG002|COMPLETED|Overall Study||57||
59968738|NCT00280917|76086390|FG003|COMPLETED|Overall Study||61||
59968739|NCT00280917|76086387|FG000|NOT COMPLETED|Overall Study||2||
59968740|NCT00280917|76086388|FG001|NOT COMPLETED|Overall Study||6||
59968741|NCT00280917|76086389|FG002|NOT COMPLETED|Overall Study||6||
59968742|NCT00280917|76086390|FG003|NOT COMPLETED|Overall Study||2||
59968743|NCT00271739|76086402|FG000|STARTED|Overall Study||844||
59968744|NCT00271739|76086403|FG001|STARTED|Overall Study||821||
59968745|NCT00271739|76086402|FG000|COMPLETED|Overall Study||729||
59968746|NCT00271739|76086403|FG001|COMPLETED|Overall Study||716||
59968747|NCT00271739|76086402|FG000|NOT COMPLETED|Overall Study||115||
59968748|NCT00271739|76086403|FG001|NOT COMPLETED|Overall Study||105||
59968749|NCT00006478|76086409|FG000|STARTED|Overall Study||19||
59968750|NCT00006478|76086409|FG000|COMPLETED|Overall Study||12||
59968751|NCT00006478|76086409|FG000|NOT COMPLETED|Overall Study||7||
59968752|NCT05718466|76086415|FG000|STARTED|Overall Study||18||
59968753|NCT05718466|76086416|FG001|STARTED|Overall Study||17||
59968754|NCT05718466|76086415|FG000|COMPLETED|Overall Study||17||
59968755|NCT05718466|76086416|FG001|COMPLETED|Overall Study||14||
59968756|NCT05718466|76086415|FG000|NOT COMPLETED|Overall Study||1||
59968757|NCT05718466|76086416|FG001|NOT COMPLETED|Overall Study||3||
59968758|NCT04938453|76086424|FG000|STARTED|Period 1||10||
59968759|NCT04938453|76086425|FG001|STARTED|Period 1||10||
59968760|NCT04938453|76086424|FG000|COMPLETED|Period 1||10||
59968761|NCT04938453|76086425|FG001|COMPLETED|Period 1||10||
59968762|NCT04938453|76086424|FG000|NOT COMPLETED|Period 1||0||
59968763|NCT04938453|76086425|FG001|NOT COMPLETED|Period 1||0||
59968764|NCT04938453|76086424|FG000|STARTED|Washout Period 1||10||
59968765|NCT04938453|76086425|FG001|STARTED|Washout Period 1||10||
59968766|NCT04938453|76086424|FG000|COMPLETED|Washout Period 1||9||
59968767|NCT04938453|76086425|FG001|COMPLETED|Washout Period 1||9||
59968768|NCT04938453|76086424|FG000|NOT COMPLETED|Washout Period 1||1||
59968769|NCT04938453|76086425|FG001|NOT COMPLETED|Washout Period 1||1||
59968770|NCT04938453|76086424|FG000|STARTED|Period 2||9||
59968771|NCT04938453|76086425|FG001|STARTED|Period 2||9||
59968772|NCT04938453|76086424|FG000|COMPLETED|Period 2||9||
59968773|NCT04938453|76086425|FG001|COMPLETED|Period 2||9||
59968774|NCT04938453|76086424|FG000|NOT COMPLETED|Period 2||0||
59968775|NCT04938453|76086425|FG001|NOT COMPLETED|Period 2||0||
59968776|NCT04817111|76086431|FG000|STARTED|Overall Study||7||
59968777|NCT04817111|76086431|FG000|COMPLETED|Overall Study||7||
59968778|NCT04817111|76086431|FG000|NOT COMPLETED|Overall Study||0||
59968779|NCT04679948|76086435|FG000|STARTED|Period 1||16||
59968780|NCT04679948|76086435|FG000|COMPLETED|Period 1||16||
59968781|NCT04679948|76086435|FG000|NOT COMPLETED|Period 1||0||
59968782|NCT04679948|76086435|FG000|STARTED|Period 2||16||
59968783|NCT04679948|76086435|FG000|COMPLETED|Period 2||16||
59968784|NCT04679948|76086435|FG000|NOT COMPLETED|Period 2||0||
59968785|NCT04633291|76086449|FG000|STARTED|Overall Study||11||
59968786|NCT04633291|76086450|FG001|STARTED|Overall Study||11||
59968787|NCT04633291|76086449|FG000|COMPLETED|Overall Study||11||
59968788|NCT04633291|76086450|FG001|COMPLETED|Overall Study||11||
59968789|NCT04633291|76086449|FG000|NOT COMPLETED|Overall Study||0||
59968790|NCT04633291|76086450|FG001|NOT COMPLETED|Overall Study||0||
59968791|NCT04491084|76086458|FG000|STARTED|Overall Study||2||
59968792|NCT04491084|76086459|FG001|STARTED|Overall Study||3||
59968793|NCT04491084|76086458|FG000|COMPLETED|Overall Study||2||
59968794|NCT04491084|76086459|FG001|COMPLETED|Overall Study||3||
59968795|NCT04491084|76086458|FG000|NOT COMPLETED|Overall Study||0||
59968796|NCT04491084|76086459|FG001|NOT COMPLETED|Overall Study||0||
59968797|NCT04147260|76086470|FG000|STARTED|Overall Study||9||
59968798|NCT04147260|76086471|FG001|STARTED|Overall Study||27||
59968799|NCT04147260|76086472|FG002|STARTED|Overall Study||9||
59968800|NCT04147260|76086473|FG003|STARTED|Overall Study||28||
59968801|NCT04147260|76086474|FG004|STARTED|Overall Study||12||
59968802|NCT04147260|76086470|FG000|COMPLETED|Overall Study||8||
59968803|NCT04147260|76086471|FG001|COMPLETED|Overall Study||27||
59968804|NCT04147260|76086472|FG002|COMPLETED|Overall Study||7||
59968805|NCT04147260|76086473|FG003|COMPLETED|Overall Study||25||
59968806|NCT04147260|76086474|FG004|COMPLETED|Overall Study||12||
59968807|NCT04147260|76086470|FG000|NOT COMPLETED|Overall Study||1||
59968808|NCT04147260|76086471|FG001|NOT COMPLETED|Overall Study||0||
59968809|NCT04147260|76086472|FG002|NOT COMPLETED|Overall Study||2||
59968810|NCT04147260|76086473|FG003|NOT COMPLETED|Overall Study||3||
59968811|NCT04147260|76086474|FG004|NOT COMPLETED|Overall Study||0||
59968812|NCT04134728|76086491|FG000|STARTED|Overall Study||156||
59968813|NCT04134728|76086492|FG001|STARTED|Overall Study||158||
59968814|NCT04134728|76086493|FG002|STARTED|Overall Study||156||
59968815|NCT04134728|76086494|FG003|STARTED|Overall Study||26||
59968816|NCT04134728|76086495|FG004|STARTED|Overall Study||26||
59968817|NCT04134728|76086496|FG005|STARTED|Overall Study||27||
59968818|NCT04134728|76086491|FG000|COMPLETED|Overall Study||143||
59968819|NCT04134728|76086492|FG001|COMPLETED|Overall Study||144||
59968820|NCT04134728|76086493|FG002|COMPLETED|Overall Study||133||
59968821|NCT04134728|76086494|FG003|COMPLETED|Overall Study||23||
59968822|NCT04134728|76086495|FG004|COMPLETED|Overall Study||25||
59968823|NCT04134728|76086496|FG005|COMPLETED|Overall Study||26||
59968824|NCT04134728|76086491|FG000|NOT COMPLETED|Overall Study||13||
59968825|NCT04134728|76086492|FG001|NOT COMPLETED|Overall Study||14||
59968826|NCT04134728|76086493|FG002|NOT COMPLETED|Overall Study||23||
59968827|NCT04134728|76086494|FG003|NOT COMPLETED|Overall Study||3||
59968828|NCT04134728|76086495|FG004|NOT COMPLETED|Overall Study||1||
59968829|NCT04134728|76086496|FG005|NOT COMPLETED|Overall Study||1||
59968830|NCT03886272|76086530|FG000|STARTED|Period 1||7||
59968831|NCT03886272|76086531|FG001|STARTED|Period 1||7||
59968832|NCT03886272|76086532|FG002|STARTED|Period 1||7||
59968833|NCT03886272|76086533|FG003|STARTED|Period 1||7||
59968834|NCT03886272|76086534|FG004|STARTED|Period 1||5||
59968835|NCT03886272|76086535|FG005|STARTED|Period 1||5||
59968836|NCT03886272|76086536|FG006|STARTED|Period 1||5||
59968837|NCT03886272|76086530|FG000|COMPLETED|Period 1||7||
59968838|NCT03886272|76086531|FG001|COMPLETED|Period 1||7||
59968839|NCT03886272|76086532|FG002|COMPLETED|Period 1||7||
59968840|NCT03886272|76086533|FG003|COMPLETED|Period 1||7||
59968841|NCT03886272|76086534|FG004|COMPLETED|Period 1||5||
59968842|NCT03886272|76086535|FG005|COMPLETED|Period 1||4||
59968843|NCT03886272|76086536|FG006|COMPLETED|Period 1||5||
59810739|NCT00660023|75932950|FG000|Treated|Overall Study||114||
59810740|NCT00660023|75932950|FG000|COMPLETED|Overall Study||95||
59810741|NCT00660023|75932950|FG000|NOT COMPLETED|Overall Study||29||
59810742|NCT00062647|75932956|FG000|STARTED|Overall Study||30||
59810743|NCT00062647|75932957|FG001|STARTED|Overall Study||30||
59810744|NCT00062647|75932956|FG000|COMPLETED|Overall Study||14||
59810745|NCT00062647|75932957|FG001|COMPLETED|Overall Study||17||
59810746|NCT00062647|75932956|FG000|NOT COMPLETED|Overall Study||16||
59810747|NCT00062647|75932957|FG001|NOT COMPLETED|Overall Study||13||
59810748|NCT00570323|75932965|FG000|STARTED|Started Treatment After Randomization||36||
59810749|NCT00570323|75932966|FG001|STARTED|Started Treatment After Randomization||36||
59810750|NCT00570323|75932965|FG000|COMPLETED|Started Treatment After Randomization||34||
59810751|NCT00570323|75932966|FG001|COMPLETED|Started Treatment After Randomization||35||
59810752|NCT00570323|75932965|FG000|NOT COMPLETED|Started Treatment After Randomization||2||
59810753|NCT00570323|75932966|FG001|NOT COMPLETED|Started Treatment After Randomization||1||
59810754|NCT00570323|75932965|FG000|STARTED|Complete Study After Start||34||
59810755|NCT00570323|75932966|FG001|STARTED|Complete Study After Start||35||
59810756|NCT00570323|75932965|FG000|COMPLETED|Complete Study After Start||31||
59810757|NCT00570323|75932966|FG001|COMPLETED|Complete Study After Start||34||
59810758|NCT00570323|75932965|FG000|NOT COMPLETED|Complete Study After Start||3||
59810759|NCT00570323|75932966|FG001|NOT COMPLETED|Complete Study After Start||1||
59810760|NCT00661505|75932974|FG000|STARTED|Overall Study||132||
59810761|NCT00661505|75932974|FG000|COMPLETED|Overall Study||102||
59810762|NCT00661505|75932974|FG000|NOT COMPLETED|Overall Study||30||
59810763|NCT00662909|75932982|FG000|STARTED|Overall Study||454||
59810764|NCT00662909|75932983|FG001|STARTED|Overall Study||442||
59810765|NCT00662909|75932984|FG002|STARTED|Overall Study||433||
59810766|NCT00662909|75932982|FG000|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|453||
59810767|NCT00662909|75932983|FG001|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|442||
59810768|NCT00662909|75932984|FG002|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|433||
59810769|NCT00662909|75932982|FG000|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|433||
59810770|NCT00662909|75932983|FG001|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|425||
59810771|NCT00662909|75932984|FG002|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|412||
59810772|NCT00662909|75932982|FG000|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|325||
59810773|NCT00662909|75932983|FG001|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|312||
59810774|NCT00662909|75932984|FG002|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|296||
59810775|NCT00662909|75932982|FG000|COMPLETED|Overall Study||385||
59810776|NCT00662909|75932983|FG001|COMPLETED|Overall Study||383||
59810777|NCT00662909|75932984|FG002|COMPLETED|Overall Study||380||
59968844|NCT03886272|76086530|FG000|NOT COMPLETED|Period 1||0||
59968845|NCT03886272|76086531|FG001|NOT COMPLETED|Period 1||0||
59968846|NCT03886272|76086532|FG002|NOT COMPLETED|Period 1||0||
59968847|NCT03886272|76086533|FG003|NOT COMPLETED|Period 1||0||
59968848|NCT03886272|76086534|FG004|NOT COMPLETED|Period 1||0||
59968849|NCT03886272|76086535|FG005|NOT COMPLETED|Period 1||1||
59968850|NCT03886272|76086536|FG006|NOT COMPLETED|Period 1||0||
59968851|NCT03886272|76086530|FG000|STARTED|Period 2||7||
59968852|NCT03886272|76086531|FG001|STARTED|Period 2||7||
59968853|NCT03886272|76086532|FG002|STARTED|Period 2||7||
59968854|NCT03886272|76086533|FG003|STARTED|Period 2||7||
59968855|NCT03886272|76086534|FG004|STARTED|Period 2||5||
59968856|NCT03886272|76086535|FG005|STARTED|Period 2||4||
59968857|NCT03886272|76086536|FG006|STARTED|Period 2||5||
59968858|NCT03886272|76086530|FG000|COMPLETED|Period 2||7||
59968859|NCT03886272|76086531|FG001|COMPLETED|Period 2||7||
59968860|NCT03886272|76086532|FG002|COMPLETED|Period 2||7||
59968861|NCT03886272|76086533|FG003|COMPLETED|Period 2||7||
59968862|NCT03886272|76086534|FG004|COMPLETED|Period 2||5||
59968863|NCT03886272|76086535|FG005|COMPLETED|Period 2||4||
59968864|NCT03886272|76086536|FG006|COMPLETED|Period 2||5||
59968865|NCT03886272|76086530|FG000|NOT COMPLETED|Period 2||0||
59968866|NCT03886272|76086531|FG001|NOT COMPLETED|Period 2||0||
59968867|NCT03886272|76086532|FG002|NOT COMPLETED|Period 2||0||
59968868|NCT03886272|76086533|FG003|NOT COMPLETED|Period 2||0||
59968869|NCT03886272|76086534|FG004|NOT COMPLETED|Period 2||0||
59968870|NCT03886272|76086535|FG005|NOT COMPLETED|Period 2||0||
59968871|NCT03886272|76086536|FG006|NOT COMPLETED|Period 2||0||
59968872|NCT03886272|76086530|FG000|STARTED|Period 3|This study arm is part of two-way cross over design. No third period exists in two way cross over.|0||
59968873|NCT03886272|76086531|FG001|STARTED|Period 3|This study arm is part of two-way cross over design. No third period exists in two way cross over.|0||
59810778|NCT00662909|75932982|FG000|NOT COMPLETED|Overall Study||69||
59810779|NCT00662909|75932983|FG001|NOT COMPLETED|Overall Study||59||
59810780|NCT00662909|75932984|FG002|NOT COMPLETED|Overall Study||53||
59810781|NCT00050011|75932994|FG000|STARTED|Overall Study||301||
59968874|NCT03886272|76086532|FG002|STARTED|Period 3|This study arm is part of two-way cross over design.No third period exists in two way cross over.|0||
59968875|NCT03886272|76086533|FG003|STARTED|Period 3|This study arm is part of two-way cross over design. No third period exists in two way cross over.|0||
59968876|NCT03886272|76086534|FG004|STARTED|Period 3||5||
59968877|NCT03886272|76086535|FG005|STARTED|Period 3||4||
59968878|NCT03886272|76086536|FG006|STARTED|Period 3||5||
59968879|NCT03886272|76086530|FG000|COMPLETED|Period 3||0||
59968880|NCT03886272|76086531|FG001|COMPLETED|Period 3||0||
59968881|NCT03886272|76086532|FG002|COMPLETED|Period 3||0||
59968882|NCT03886272|76086533|FG003|COMPLETED|Period 3||0||
59968883|NCT03886272|76086534|FG004|COMPLETED|Period 3||5||
59968884|NCT03886272|76086535|FG005|COMPLETED|Period 3||4||
59968885|NCT03886272|76086536|FG006|COMPLETED|Period 3||5||
59968886|NCT03886272|76086530|FG000|NOT COMPLETED|Period 3||0||
59968887|NCT03886272|76086531|FG001|NOT COMPLETED|Period 3||0||
59968888|NCT03886272|76086532|FG002|NOT COMPLETED|Period 3||0||
59968889|NCT03886272|76086533|FG003|NOT COMPLETED|Period 3||0||
59968890|NCT03886272|76086534|FG004|NOT COMPLETED|Period 3||0||
59968891|NCT03886272|76086535|FG005|NOT COMPLETED|Period 3||0||
59968892|NCT03886272|76086536|FG006|NOT COMPLETED|Period 3||0||
59968893|NCT03732833|76086555|FG000|STARTED|Overall Study||86||
59968894|NCT03732833|76086556|FG001|STARTED|Overall Study||171||
59968895|NCT03732833|76086557|FG002|STARTED|Overall Study|The number of participants in the Efficacy set = 167; The number of participants in the Safety set = 168|167||
59968896|NCT03732833|76086555|FG000|COMPLETED|Overall Study||68||
59810782|NCT00050011|75932995|FG001|STARTED|Overall Study||301||
59810783|NCT00050011|75932994|FG000|Intent-to-treat Population|Overall Study||300||
59810784|NCT00050011|75932995|FG001|Intent-to-treat Population|Overall Study||300||
59810785|NCT00050011|75932994|FG000|COMPLETED|Overall Study||180||
59810786|NCT00050011|75932995|FG001|COMPLETED|Overall Study||175||
59968897|NCT03732833|76086556|FG001|COMPLETED|Overall Study||138||
59968898|NCT03732833|76086557|FG002|COMPLETED|Overall Study||150||
59968899|NCT03732833|76086555|FG000|NOT COMPLETED|Overall Study||18||
59968900|NCT03732833|76086556|FG001|NOT COMPLETED|Overall Study||33||
59968901|NCT03732833|76086557|FG002|NOT COMPLETED|Overall Study||17||
59968902|NCT03493919|76086574|FG000|STARTED|Overall Study||470||
59968903|NCT03493919|76086575|FG001|STARTED|Overall Study||165||
59968904|NCT03493919|76086576|FG002|STARTED|Overall Study||165||
59968905|NCT03493919|76086577|FG003|STARTED|Overall Study||161||
59968906|NCT03493919|76086574|FG000|COMPLETED|Overall Study||454||
59968907|NCT03493919|76086575|FG001|COMPLETED|Overall Study||161||
59968908|NCT03493919|76086576|FG002|COMPLETED|Overall Study||163||
59968909|NCT03493919|76086577|FG003|COMPLETED|Overall Study||157||
59968910|NCT03493919|76086574|FG000|NOT COMPLETED|Overall Study||16||
59968911|NCT03493919|76086575|FG001|NOT COMPLETED|Overall Study||4||
59968912|NCT03493919|76086576|FG002|NOT COMPLETED|Overall Study||2||
59968913|NCT03493919|76086577|FG003|NOT COMPLETED|Overall Study||4||
59968914|NCT03280628|76086595|FG000|STARTED|Overall Study||20||
59968915|NCT03280628|76086596|FG001|STARTED|Overall Study||17||
59968916|NCT03280628|76086597|FG002|STARTED|Overall Study||18||
59968917|NCT03280628|76086595|FG000|COMPLETED|Overall Study||12||
59968918|NCT03280628|76086596|FG001|COMPLETED|Overall Study||11||
59968919|NCT03280628|76086597|FG002|COMPLETED|Overall Study||7||
59968920|NCT03280628|76086595|FG000|NOT COMPLETED|Overall Study||8||
59810787|NCT00050011|75932994|FG000|NOT COMPLETED|Overall Study||121||
59968921|NCT03280628|76086596|FG001|NOT COMPLETED|Overall Study||6||
59968922|NCT03280628|76086597|FG002|NOT COMPLETED|Overall Study||11||
59994940|NCT03420781|76110740|FG002|NOT COMPLETED|RW Period: 6 Weeks (Week 41 to Week 46)||6||
59994941|NCT03420781|76110741|FG003|NOT COMPLETED|RW Period: 6 Weeks (Week 41 to Week 46)||5||
59994942|NCT03420781|76110742|FG004|NOT COMPLETED|RW Period: 6 Weeks (Week 41 to Week 46)||5||
59968923|NCT03075176|76086609|FG000|STARTED|Overall Study|"In this section, we are not able to enter the correct value in the Total columns to reflect the number of unique participants. 18 participants underwent LASIK (of which 18 eyes received wavefront optimized treatment and 18 eyes received topography-guided treatment). The format provided in CT.gov automatically double-counts the row of Participants via calculation and does not allow us to accurately reflect each person in a split-person study."|18||18
59968924|NCT03075176|76086610|FG001|STARTED|Overall Study|"In this section, we are not able to enter the correct value in the Total columns to reflect the number of unique participants. 20 participants underwent PRK (of which 20 eyes received wavefront optimized treatment and 20 eyes received topography-guided treatment). The format provided in CT.gov automatically double-counts the row of Participants via calculation and does not allow us to accurately reflect each person in a split-person study."|20||20
59968925|NCT03075176|76086611|FG002|STARTED|Overall Study|"In this section, we are not able to enter the correct value in the Total columns to reflect the number of unique participants. 18 participants underwent LASIK (of which 18 eyes received wavefront optimized treatment and 18 eyes received topography-guided treatment). The format provided in CT.gov automatically double-counts the row of Participants via calculation and does not allow us to accurately reflect each person in a split-person study."|18||18
59968926|NCT03075176|76086612|FG003|STARTED|Overall Study|"In this section, we are not able to enter the correct value in the Total columns to reflect the number of unique participants. 20 participants underwent PRK (of which 20 eyes received wavefront optimized treatment and 20 eyes received topography-guided treatment). The format provided in CT.gov automatically double-counts the row of Participants via calculation and does not allow us to accurately reflect each person in a split-person study."|20||20
59968927|NCT03075176|76086609|FG000|COMPLETED|Overall Study||18||18
59968928|NCT03075176|76086610|FG001|COMPLETED|Overall Study||20||20
59968929|NCT03075176|76086611|FG002|COMPLETED|Overall Study||18||18
59968930|NCT03075176|76086612|FG003|COMPLETED|Overall Study||20||20
59968931|NCT03075176|76086609|FG000|NOT COMPLETED|Overall Study||0||0
59968932|NCT03075176|76086610|FG001|NOT COMPLETED|Overall Study||0||0
59968933|NCT03075176|76086611|FG002|NOT COMPLETED|Overall Study||0||0
59968934|NCT03075176|76086612|FG003|NOT COMPLETED|Overall Study||0||0
59968935|NCT03058146|76086624|FG000|STARTED|Overall Study||21||
59968936|NCT03058146|76086625|FG001|STARTED|Overall Study||23||
59968937|NCT03058146|76086624|FG000|COMPLETED|Overall Study||17||
59968938|NCT03058146|76086625|FG001|COMPLETED|Overall Study||21||
59968939|NCT03058146|76086624|FG000|NOT COMPLETED|Overall Study||4||
59968940|NCT03058146|76086625|FG001|NOT COMPLETED|Overall Study||2||
59968941|NCT02851511|76086637|FG000|STARTED|Overall (Phase I + Phase II)||168||
59968942|NCT02851511|76086638|FG001|STARTED|Overall (Phase I + Phase II)||166||
59810788|NCT00050011|75932995|FG001|NOT COMPLETED|Overall Study||126||
59810789|NCT00661427|75933004|FG000|STARTED|Overall Study||35||
59810790|NCT00661427|75933005|FG001|STARTED|Overall Study||26||
59968943|NCT02851511|76086639|FG002|STARTED|Overall (Phase I + Phase II)||23||
59968944|NCT02851511|76086640|FG003|STARTED|Overall (Phase I + Phase II)||22||
59968945|NCT02851511|76086637|FG000|COMPLETED|Overall (Phase I + Phase II)||126||
59968946|NCT02851511|76086638|FG001|COMPLETED|Overall (Phase I + Phase II)||127||
59968947|NCT02851511|76086639|FG002|COMPLETED|Overall (Phase I + Phase II)||23||
59968948|NCT02851511|76086640|FG003|COMPLETED|Overall (Phase I + Phase II)||18||
59968949|NCT02851511|76086637|FG000|NOT COMPLETED|Overall (Phase I + Phase II)||42||
59968950|NCT02851511|76086638|FG001|NOT COMPLETED|Overall (Phase I + Phase II)||39||
59968951|NCT02851511|76086639|FG002|NOT COMPLETED|Overall (Phase I + Phase II)||0||
59968952|NCT02851511|76086640|FG003|NOT COMPLETED|Overall (Phase I + Phase II)||4||
59968953|NCT02851511|76086637|FG000|STARTED|Phase I||21||
59968954|NCT02851511|76086638|FG001|STARTED|Phase I||21||
59968955|NCT02851511|76086639|FG002|STARTED|Phase I||23||
59968956|NCT02851511|76086640|FG003|STARTED|Phase I||22||
59968957|NCT02851511|76086637|FG000|COMPLETED|Phase I||19||
59968958|NCT02851511|76086638|FG001|COMPLETED|Phase I||20||
59968959|NCT02851511|76086639|FG002|COMPLETED|Phase I||23||
59968960|NCT02851511|76086640|FG003|COMPLETED|Phase I||18||
59968961|NCT02851511|76086637|FG000|NOT COMPLETED|Phase I||2||
59968962|NCT02851511|76086638|FG001|NOT COMPLETED|Phase I||1||
59968963|NCT02851511|76086639|FG002|NOT COMPLETED|Phase I||0||
59968964|NCT02851511|76086640|FG003|NOT COMPLETED|Phase I||4||
59968965|NCT02851511|76086637|FG000|STARTED|Phase II||147||
59968966|NCT02851511|76086638|FG001|STARTED|Phase II||145||
59968967|NCT02851511|76086639|FG002|STARTED|Phase II||0||
59968968|NCT02851511|76086640|FG003|STARTED|Phase II||0||
59968969|NCT02851511|76086637|FG000|COMPLETED|Phase II||107||
59968970|NCT02851511|76086638|FG001|COMPLETED|Phase II||107||
59968971|NCT02851511|76086639|FG002|COMPLETED|Phase II||0||
59968972|NCT02851511|76086640|FG003|COMPLETED|Phase II||0||
59810791|NCT00661427|75933004|FG000|COMPLETED|Overall Study||30||
59810792|NCT00661427|75933005|FG001|COMPLETED|Overall Study||19||
59810793|NCT00661427|75933004|FG000|NOT COMPLETED|Overall Study||5||
59810794|NCT00661427|75933005|FG001|NOT COMPLETED|Overall Study||7||
59810795|NCT00049543|75933013|FG000|STARTED|Overall Study||251||
59810796|NCT00049543|75933014|FG001|STARTED|Overall Study||252||
59810797|NCT00049543|75933013|FG000|COMPLETED|Overall Study||249||
59810798|NCT00049543|75933014|FG001|COMPLETED|Overall Study||243||
59810799|NCT00049543|75933013|FG000|NOT COMPLETED|Overall Study||2||
59810800|NCT00049543|75933014|FG001|NOT COMPLETED|Overall Study||9||
59810801|NCT00048997|75933022|FG000|STARTED|Overall Study||176||
59810802|NCT00048997|75933023|FG001|STARTED|Overall Study||180||
59810803|NCT00048997|75933022|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|163||
59810804|NCT00048997|75933023|FG001|COMPLETED|Overall Study||177||
59968973|NCT02851511|76086637|FG000|NOT COMPLETED|Phase II||40||
59968974|NCT02851511|76086638|FG001|NOT COMPLETED|Phase II||38||
59968975|NCT02851511|76086639|FG002|NOT COMPLETED|Phase II||0||
59968976|NCT02851511|76086640|FG003|NOT COMPLETED|Phase II||0||
59968977|NCT02630147|76086652|FG000|STARTED|First Intervention (First Night)||14||
59968978|NCT02630147|76086653|FG001|STARTED|First Intervention (First Night)||13||
59810805|NCT00048997|75933022|FG000|NOT COMPLETED|Overall Study||13||
59810806|NCT00048997|75933023|FG001|NOT COMPLETED|Overall Study||3||
59810807|NCT00035815|75933030|FG000|STARTED|Overall Study|Enrollment began June 2003, accrual was for 2 years, follow-up period was 2 years.|167||
59810808|NCT00035815|75933031|FG001|STARTED|Overall Study|Enrollment began June 2003, accrual was for 2 years, follow-up period was 2 years.|163||
59810809|NCT00035815|75933030|FG000|COMPLETED|Overall Study||150||
59810810|NCT00035815|75933031|FG001|COMPLETED|Overall Study||152||
59968979|NCT02630147|76086652|FG000|COMPLETED|First Intervention (First Night)||14||
59968980|NCT02630147|76086653|FG001|COMPLETED|First Intervention (First Night)||13||
59968981|NCT02630147|76086652|FG000|NOT COMPLETED|First Intervention (First Night)||0||
59968982|NCT02630147|76086653|FG001|NOT COMPLETED|First Intervention (First Night)||0||
59968983|NCT02630147|76086652|FG000|STARTED|Washout, no Intervention (Second Night)||14||
59968984|NCT02630147|76086653|FG001|STARTED|Washout, no Intervention (Second Night)||13||
59968985|NCT02630147|76086652|FG000|COMPLETED|Washout, no Intervention (Second Night)||14||
59968986|NCT02630147|76086653|FG001|COMPLETED|Washout, no Intervention (Second Night)||13||
59968987|NCT02630147|76086652|FG000|NOT COMPLETED|Washout, no Intervention (Second Night)||0||
59968988|NCT02630147|76086653|FG001|NOT COMPLETED|Washout, no Intervention (Second Night)||0||
59968989|NCT02630147|76086652|FG000|STARTED|Second Intervention (Third Night)||14||
59968990|NCT02630147|76086653|FG001|STARTED|Second Intervention (Third Night)||13||
59968991|NCT02630147|76086652|FG000|COMPLETED|Second Intervention (Third Night)||14||
59968992|NCT02630147|76086653|FG001|COMPLETED|Second Intervention (Third Night)||13||
59968993|NCT02630147|76086652|FG000|NOT COMPLETED|Second Intervention (Third Night)||0||
59968994|NCT02630147|76086653|FG001|NOT COMPLETED|Second Intervention (Third Night)||0||
59968995|NCT02478320|76086661|FG000|STARTED|Overall Study||12||
59968996|NCT02478320|76086662|FG001|STARTED|Overall Study||0||
59968997|NCT02478320|76086661|FG000|COMPLETED|Overall Study||0||
59968998|NCT02478320|76086662|FG001|COMPLETED|Overall Study||0||
59968999|NCT02478320|76086661|FG000|NOT COMPLETED|Overall Study||12||
59969000|NCT02478320|76086662|FG001|NOT COMPLETED|Overall Study||0||
59969001|NCT02311998|76086672|FG000|STARTED|Overall Study||3||
59969002|NCT02311998|76086673|FG001|STARTED|Overall Study||6||
59969003|NCT02311998|76086674|FG002|STARTED|Overall Study||9||
59969004|NCT02311998|76086675|FG003|STARTED|Overall Study||4||
59969005|NCT02311998|76086672|FG000|COMPLETED|Overall Study||3||
59969006|NCT02311998|76086673|FG001|COMPLETED|Overall Study||6||
59969007|NCT02311998|76086674|FG002|COMPLETED|Overall Study||9||
59969008|NCT02311998|76086675|FG003|COMPLETED|Overall Study||4||
59525368|NCT02093234|75620706|FG001|STARTED|Overall Study||56||
59525369|NCT02093234|75620707|FG002|STARTED|Overall Study||54||
59525370|NCT02093234|75620705|FG000|COMPLETED|Overall Study||53||
59525371|NCT02093234|75620706|FG001|COMPLETED|Overall Study||52||
59525372|NCT02093234|75620707|FG002|COMPLETED|Overall Study||50||
59525373|NCT02093234|75620705|FG000|NOT COMPLETED|Overall Study||3||
59525374|NCT02093234|75620706|FG001|NOT COMPLETED|Overall Study||4||
59525375|NCT02093234|75620707|FG002|NOT COMPLETED|Overall Study||4||
59525376|NCT00083720|75620715|FG000|STARTED|Overall Study|Patients analyzed for efficacy who met the epidermal growth factor receptor (EGFR) negative criteria|85||
59810811|NCT00035815|75933030|FG000|NOT COMPLETED|Overall Study||17||
59810812|NCT00035815|75933031|FG001|NOT COMPLETED|Overall Study||11||
59969009|NCT02311998|76086672|FG000|NOT COMPLETED|Overall Study||0||
59525377|NCT00083720|75620715|FG000|COMPLETED|Overall Study|Two patients died prior to receiving cetuximab.|85||
59525378|NCT00083720|75620715|FG000|NOT COMPLETED|Overall Study||0||
59525379|NCT00085436|75620719|FG000|STARTED|Overall Study||18||
59810813|NCT00662831|75933039|FG000|STARTED|Overall Study||184||
59810814|NCT00662831|75933040|FG001|STARTED|Overall Study||92||
59810815|NCT00662831|75933039|FG000|COMPLETED|Overall Study||78||
59810816|NCT00662831|75933040|FG001|COMPLETED|Overall Study||33||
59810817|NCT00662831|75933039|FG000|NOT COMPLETED|Overall Study||106||
59969010|NCT02311998|76086673|FG001|NOT COMPLETED|Overall Study||0||
59969011|NCT02311998|76086674|FG002|NOT COMPLETED|Overall Study||0||
59969012|NCT02311998|76086675|FG003|NOT COMPLETED|Overall Study||0||
59969013|NCT02252042|76086687|FG000|STARTED|Overall Study||247||
59969014|NCT02252042|76086688|FG001|STARTED|Overall Study||248||
59969015|NCT02252042|76086687|FG000|Received First Course of Pembrolizumab|Overall Study|1 participant was randomized but did not receive study treatment.|246||
59969016|NCT02252042|76086688|FG001|Received First Course of Pembrolizumab|Overall Study|14 participants were randomized but did not receive study treatment.|234||
59969017|NCT02252042|76086687|FG000|Received Second Course of Pembrolizumab|Overall Study||2||
59969018|NCT02252042|76086688|FG001|Received Second Course of Pembrolizumab|Overall Study||0||
59969019|NCT02252042|76086687|FG000|COMPLETED|Overall Study||0||
59525380|NCT00085436|75620719|FG000|COMPLETED|Overall Study||18||
59969020|NCT02252042|76086688|FG001|COMPLETED|Overall Study||0||
59969021|NCT02252042|76086687|FG000|NOT COMPLETED|Overall Study||247||
59969022|NCT02252042|76086688|FG001|NOT COMPLETED|Overall Study||248||
59969023|NCT01900847|76086697|FG000|STARTED|Overall Study||10||
59969024|NCT01900847|76086698|FG001|STARTED|Overall Study||7||
59969025|NCT01900847|76086697|FG000|COMPLETED|Overall Study||10||
59969026|NCT01900847|76086698|FG001|COMPLETED|Overall Study||7||
59969027|NCT01900847|76086697|FG000|NOT COMPLETED|Overall Study||0||
59969028|NCT01900847|76086698|FG001|NOT COMPLETED|Overall Study||0||
59969029|NCT01710007|76086706|FG000|STARTED|Overall Study||103||
59969030|NCT01710007|76086707|FG001|STARTED|Overall Study||99||
59969031|NCT01710007|76086706|FG000|COMPLETED|Overall Study||87||
59969032|NCT01710007|76086707|FG001|COMPLETED|Overall Study||81||
59969033|NCT01710007|76086706|FG000|NOT COMPLETED|Overall Study||16||
59969034|NCT01710007|76086707|FG001|NOT COMPLETED|Overall Study||18||
59969035|NCT00378482|76086715|FG000|STARTED|Overall Study||37|37|
59969036|NCT00378482|76086715|FG000|COMPLETED|Overall Study||6|6|
59969037|NCT00378482|76086715|FG000|NOT COMPLETED|Overall Study||31||
59969038|NCT05288673|76086722|FG000|STARTED|Overall Study||6||
59969039|NCT05288673|76086723|FG001|STARTED|Overall Study||6||
59969040|NCT05288673|76086724|FG002|STARTED|Overall Study||4||
59969041|NCT05288673|76086722|FG000|Received At Least 1 Dose Of Study Drug|Overall Study||6||
59969042|NCT05288673|76086723|FG001|Received At Least 1 Dose Of Study Drug|Overall Study||6||
59969043|NCT05288673|76086724|FG002|Received At Least 1 Dose Of Study Drug|Overall Study||4||
59969044|NCT05288673|76086722|FG000|COMPLETED|Overall Study||6||
59969045|NCT05288673|76086723|FG001|COMPLETED|Overall Study||6||
59969046|NCT05288673|76086724|FG002|COMPLETED|Overall Study||3||
59969047|NCT05288673|76086722|FG000|NOT COMPLETED|Overall Study||0||
59969048|NCT05288673|76086723|FG001|NOT COMPLETED|Overall Study||0||
59969049|NCT05288673|76086724|FG002|NOT COMPLETED|Overall Study||1||
59969050|NCT05288660|76086735|FG000|STARTED|Overall Study||4||
59969051|NCT05288660|76086736|FG001|STARTED|Overall Study||6||
59969052|NCT05288660|76086737|FG002|STARTED|Overall Study||4||
59969053|NCT05288660|76086735|FG000|Received at Least 1 Dose of Study Drug|Overall Study||4||
59969054|NCT05288660|76086736|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6||
59969055|NCT05288660|76086737|FG002|Received at Least 1 Dose of Study Drug|Overall Study||4||
59969056|NCT05288660|76086735|FG000|COMPLETED|Overall Study||4||
59969057|NCT05288660|76086736|FG001|COMPLETED|Overall Study||6||
59969058|NCT05288660|76086737|FG002|COMPLETED|Overall Study||4||
59969059|NCT05288660|76086735|FG000|NOT COMPLETED|Overall Study||0||
59969060|NCT05288660|76086736|FG001|NOT COMPLETED|Overall Study||0||
59969061|NCT05288660|76086737|FG002|NOT COMPLETED|Overall Study||0||
59969062|NCT04764539|76086747|FG000|STARTED|Overall Study||3||
59969063|NCT04764539|76086748|FG001|STARTED|Overall Study||3||
59969064|NCT04764539|76086747|FG000|COMPLETED|Overall Study||3||
59969065|NCT04764539|76086748|FG001|COMPLETED|Overall Study||3||
59969066|NCT04764539|76086747|FG000|NOT COMPLETED|Overall Study||0||
59969067|NCT04764539|76086748|FG001|NOT COMPLETED|Overall Study||0||
59969068|NCT04626271|76086756|FG000|STARTED|Overall Study||250||546
59969069|NCT04626271|76086756|FG000|COMPLETED|Overall Study||250||546
59969070|NCT04626271|76086756|FG000|NOT COMPLETED|Overall Study||0||0
59969071|NCT04604795|76086770|FG000|STARTED|Part A: Period 1 (Day 1)||3||
59969072|NCT04604795|76086771|FG001|STARTED|Part A: Period 1 (Day 1)||3||
59969073|NCT04604795|76086772|FG002|STARTED|Part A: Period 1 (Day 1)||3||
59969074|NCT04604795|76086773|FG003|STARTED|Part A: Period 1 (Day 1)||3||
59969075|NCT04604795|76086774|FG004|STARTED|Part A: Period 1 (Day 1)||0||
59969076|NCT04604795|76086775|FG005|STARTED|Part A: Period 1 (Day 1)||0||
59969077|NCT04604795|76086776|FG006|STARTED|Part A: Period 1 (Day 1)||0||
59969078|NCT04604795|76086777|FG007|STARTED|Part A: Period 1 (Day 1)||0||
59969079|NCT04604795|76086778|FG008|STARTED|Part A: Period 1 (Day 1)||0||
59969080|NCT04604795|76086779|FG009|STARTED|Part A: Period 1 (Day 1)||0||
59969081|NCT04604795|76086770|FG000|COMPLETED|Part A: Period 1 (Day 1)||3||
59969082|NCT04604795|76086771|FG001|COMPLETED|Part A: Period 1 (Day 1)||3||
59969083|NCT04604795|76086772|FG002|COMPLETED|Part A: Period 1 (Day 1)||3||
59969084|NCT04604795|76086773|FG003|COMPLETED|Part A: Period 1 (Day 1)||3||
59969085|NCT04604795|76086774|FG004|COMPLETED|Part A: Period 1 (Day 1)||0||
59969086|NCT04604795|76086775|FG005|COMPLETED|Part A: Period 1 (Day 1)||0||
59969087|NCT04604795|76086776|FG006|COMPLETED|Part A: Period 1 (Day 1)||0||
59969088|NCT04604795|76086777|FG007|COMPLETED|Part A: Period 1 (Day 1)||0||
59969089|NCT04604795|76086778|FG008|COMPLETED|Part A: Period 1 (Day 1)||0||
59969090|NCT04604795|76086779|FG009|COMPLETED|Part A: Period 1 (Day 1)||0||
59969091|NCT04604795|76086770|FG000|NOT COMPLETED|Part A: Period 1 (Day 1)||0||
59969092|NCT04604795|76086771|FG001|NOT COMPLETED|Part A: Period 1 (Day 1)||0||
59969093|NCT04604795|76086772|FG002|NOT COMPLETED|Part A: Period 1 (Day 1)||0||
59969094|NCT04604795|76086773|FG003|NOT COMPLETED|Part A: Period 1 (Day 1)||0||
59969095|NCT04604795|76086774|FG004|NOT COMPLETED|Part A: Period 1 (Day 1)||0||
59969096|NCT04604795|76086775|FG005|NOT COMPLETED|Part A: Period 1 (Day 1)||0||
59969097|NCT04604795|76086776|FG006|NOT COMPLETED|Part A: Period 1 (Day 1)||0||
59969098|NCT04604795|76086777|FG007|NOT COMPLETED|Part A: Period 1 (Day 1)||0||
59969099|NCT04604795|76086778|FG008|NOT COMPLETED|Part A: Period 1 (Day 1)||0||
59969100|NCT04604795|76086779|FG009|NOT COMPLETED|Part A: Period 1 (Day 1)||0||
59969101|NCT04604795|76086770|FG000|STARTED|Part A: Washout Period 1(Up to Day 20)||3||
59969102|NCT04604795|76086771|FG001|STARTED|Part A: Washout Period 1(Up to Day 20)||3||
59969103|NCT04604795|76086772|FG002|STARTED|Part A: Washout Period 1(Up to Day 20)||3||
59969104|NCT04604795|76086773|FG003|STARTED|Part A: Washout Period 1(Up to Day 20)||3||
59969105|NCT04604795|76086774|FG004|STARTED|Part A: Washout Period 1(Up to Day 20)||0||
59969106|NCT04604795|76086775|FG005|STARTED|Part A: Washout Period 1(Up to Day 20)||0||
59969107|NCT04604795|76086776|FG006|STARTED|Part A: Washout Period 1(Up to Day 20)||0||
59969108|NCT04604795|76086777|FG007|STARTED|Part A: Washout Period 1(Up to Day 20)||0||
59969109|NCT04604795|76086778|FG008|STARTED|Part A: Washout Period 1(Up to Day 20)||0||
59969110|NCT04604795|76086779|FG009|STARTED|Part A: Washout Period 1(Up to Day 20)||0||
59969111|NCT04604795|76086770|FG000|COMPLETED|Part A: Washout Period 1(Up to Day 20)||2||
59969112|NCT04604795|76086771|FG001|COMPLETED|Part A: Washout Period 1(Up to Day 20)||2||
59969113|NCT04604795|76086772|FG002|COMPLETED|Part A: Washout Period 1(Up to Day 20)||3||
59969114|NCT04604795|76086773|FG003|COMPLETED|Part A: Washout Period 1(Up to Day 20)||3||
59969115|NCT04604795|76086774|FG004|COMPLETED|Part A: Washout Period 1(Up to Day 20)||0||
59969116|NCT04604795|76086775|FG005|COMPLETED|Part A: Washout Period 1(Up to Day 20)||0||
59969117|NCT04604795|76086776|FG006|COMPLETED|Part A: Washout Period 1(Up to Day 20)||0||
59969118|NCT04604795|76086777|FG007|COMPLETED|Part A: Washout Period 1(Up to Day 20)||0||
59969119|NCT04604795|76086778|FG008|COMPLETED|Part A: Washout Period 1(Up to Day 20)||0||
59969120|NCT04604795|76086779|FG009|COMPLETED|Part A: Washout Period 1(Up to Day 20)||0||
59969121|NCT04604795|76086770|FG000|NOT COMPLETED|Part A: Washout Period 1(Up to Day 20)||1||
59969122|NCT04604795|76086771|FG001|NOT COMPLETED|Part A: Washout Period 1(Up to Day 20)||1||
59969123|NCT04604795|76086772|FG002|NOT COMPLETED|Part A: Washout Period 1(Up to Day 20)||0||
59969124|NCT04604795|76086773|FG003|NOT COMPLETED|Part A: Washout Period 1(Up to Day 20)||0||
59969125|NCT04604795|76086774|FG004|NOT COMPLETED|Part A: Washout Period 1(Up to Day 20)||0||
59969126|NCT04604795|76086775|FG005|NOT COMPLETED|Part A: Washout Period 1(Up to Day 20)||0||
59969127|NCT04604795|76086776|FG006|NOT COMPLETED|Part A: Washout Period 1(Up to Day 20)||0||
59969128|NCT04604795|76086777|FG007|NOT COMPLETED|Part A: Washout Period 1(Up to Day 20)||0||
59969129|NCT04604795|76086778|FG008|NOT COMPLETED|Part A: Washout Period 1(Up to Day 20)||0||
59969130|NCT04604795|76086779|FG009|NOT COMPLETED|Part A: Washout Period 1(Up to Day 20)||0||
59969131|NCT04604795|76086770|FG000|STARTED|Part A: Period 2 (Day 1)||3||
59969132|NCT04604795|76086771|FG001|STARTED|Part A: Period 2 (Day 1)||3||
59969133|NCT04604795|76086772|FG002|STARTED|Part A: Period 2 (Day 1)||3||
59969134|NCT04604795|76086773|FG003|STARTED|Part A: Period 2 (Day 1)||3||
59969135|NCT04604795|76086774|FG004|STARTED|Part A: Period 2 (Day 1)||0||
59969136|NCT04604795|76086775|FG005|STARTED|Part A: Period 2 (Day 1)||0||
59969137|NCT04604795|76086776|FG006|STARTED|Part A: Period 2 (Day 1)||0||
59969138|NCT04604795|76086777|FG007|STARTED|Part A: Period 2 (Day 1)||0||
59969139|NCT04604795|76086778|FG008|STARTED|Part A: Period 2 (Day 1)||0||
59969140|NCT04604795|76086779|FG009|STARTED|Part A: Period 2 (Day 1)||0||
59969141|NCT04604795|76086770|FG000|New Participant Enrolled and Dosed|Part A: Period 2 (Day 1)||1||
59969142|NCT04604795|76086771|FG001|New Participant Enrolled and Dosed|Part A: Period 2 (Day 1)||1||
59969143|NCT04604795|76086772|FG002|New Participant Enrolled and Dosed|Part A: Period 2 (Day 1)||0||
59969144|NCT04604795|76086773|FG003|New Participant Enrolled and Dosed|Part A: Period 2 (Day 1)||0||
59969145|NCT04604795|76086774|FG004|New Participant Enrolled and Dosed|Part A: Period 2 (Day 1)||0||
59969146|NCT04604795|76086775|FG005|New Participant Enrolled and Dosed|Part A: Period 2 (Day 1)||0||
59969147|NCT04604795|76086776|FG006|New Participant Enrolled and Dosed|Part A: Period 2 (Day 1)||0||
59525381|NCT00085436|75620719|FG000|NOT COMPLETED|Overall Study||0||
60074365|NCT01770392|76189742|FG000|NOT COMPLETED|Nintedanib+ Rifampicin||0||
59525382|NCT00086138|75620726|FG000|STARTED|Overall Study||64||
59969148|NCT04604795|76086777|FG007|New Participant Enrolled and Dosed|Part A: Period 2 (Day 1)||0||
59969149|NCT04604795|76086778|FG008|New Participant Enrolled and Dosed|Part A: Period 2 (Day 1)||0||
59969150|NCT04604795|76086779|FG009|New Participant Enrolled and Dosed|Part A: Period 2 (Day 1)||0||
59969151|NCT04604795|76086770|FG000|COMPLETED|Part A: Period 2 (Day 1)||3||
59969152|NCT04604795|76086771|FG001|COMPLETED|Part A: Period 2 (Day 1)||3||
59969153|NCT04604795|76086772|FG002|COMPLETED|Part A: Period 2 (Day 1)||3||
59969154|NCT04604795|76086773|FG003|COMPLETED|Part A: Period 2 (Day 1)||3||
59969155|NCT04604795|76086774|FG004|COMPLETED|Part A: Period 2 (Day 1)||0||
59969156|NCT04604795|76086775|FG005|COMPLETED|Part A: Period 2 (Day 1)||0||
59969157|NCT04604795|76086776|FG006|COMPLETED|Part A: Period 2 (Day 1)||0||
59969158|NCT04604795|76086777|FG007|COMPLETED|Part A: Period 2 (Day 1)||0||
59969159|NCT04604795|76086778|FG008|COMPLETED|Part A: Period 2 (Day 1)||0||
60074366|NCT01603641|76189752|FG000|STARTED|Overall Study||370||
59525383|NCT00086138|75620727|FG001|STARTED|Overall Study||67||
59969160|NCT04604795|76086779|FG009|COMPLETED|Part A: Period 2 (Day 1)||0||
59969161|NCT04604795|76086770|FG000|NOT COMPLETED|Part A: Period 2 (Day 1)||0||
60074367|NCT01603641|76189752|FG000|Safety Population (Treated)|Overall Study||367||
60074368|NCT01603641|76189752|FG000|Modified Intent-to-treat Population|Overall Study||366||
60074369|NCT01603641|76189752|FG000|COMPLETED|Overall Study||335||
59525384|NCT00086138|75620726|FG000|COMPLETED|Overall Study||60||
59969162|NCT04604795|76086771|FG001|NOT COMPLETED|Part A: Period 2 (Day 1)||0||
59969163|NCT04604795|76086772|FG002|NOT COMPLETED|Part A: Period 2 (Day 1)||0||
59969164|NCT04604795|76086773|FG003|NOT COMPLETED|Part A: Period 2 (Day 1)||0||
59969165|NCT04604795|76086774|FG004|NOT COMPLETED|Part A: Period 2 (Day 1)||0||
59969166|NCT04604795|76086775|FG005|NOT COMPLETED|Part A: Period 2 (Day 1)||0||
59969167|NCT04604795|76086776|FG006|NOT COMPLETED|Part A: Period 2 (Day 1)||0||
59969168|NCT04604795|76086777|FG007|NOT COMPLETED|Part A: Period 2 (Day 1)||0||
59969169|NCT04604795|76086778|FG008|NOT COMPLETED|Part A: Period 2 (Day 1)||0||
59969170|NCT04604795|76086779|FG009|NOT COMPLETED|Part A: Period 2 (Day 1)||0||
59969171|NCT04604795|76086770|FG000|STARTED|Part A: Washout Period 2 (Up to Day 12)||3||
59969172|NCT04604795|76086771|FG001|STARTED|Part A: Washout Period 2 (Up to Day 12)||3||
59969173|NCT04604795|76086772|FG002|STARTED|Part A: Washout Period 2 (Up to Day 12)||3||
59969174|NCT04604795|76086773|FG003|STARTED|Part A: Washout Period 2 (Up to Day 12)||3||
59969175|NCT04604795|76086774|FG004|STARTED|Part A: Washout Period 2 (Up to Day 12)||0||
59969176|NCT04604795|76086775|FG005|STARTED|Part A: Washout Period 2 (Up to Day 12)||0||
60074370|NCT01603641|76189752|FG000|NOT COMPLETED|Overall Study||35||
59810818|NCT00662831|75933040|FG001|NOT COMPLETED|Overall Study||59||
59810819|NCT00662363|75933048|FG000|STARTED|Overall Study||32||
59810820|NCT00662363|75933049|FG001|STARTED|Overall Study||32||
59810821|NCT00662363|75933048|FG000|COMPLETED|Overall Study|1 subject withdrew before taking any study medication|21||
59810822|NCT00662363|75933049|FG001|COMPLETED|Overall Study|one subject died before receiving any study med 2 subjects withdrew before taking any study med|22||
59810823|NCT00662363|75933048|FG000|NOT COMPLETED|Overall Study||11||
59810824|NCT00662363|75933049|FG001|NOT COMPLETED|Overall Study||10||
59810825|NCT00661271|75933059|FG000|STARTED|Overall Study||48||
59810826|NCT00661271|75933060|FG001|STARTED|Overall Study||45||
59810827|NCT00661271|75933059|FG000|COMPLETED|Overall Study||20||
59810828|NCT00661271|75933060|FG001|COMPLETED|Overall Study||20||
59810829|NCT00661271|75933059|FG000|NOT COMPLETED|Overall Study||28||
59810830|NCT00661271|75933060|FG001|NOT COMPLETED|Overall Study||25||
59969177|NCT04604795|76086776|FG006|STARTED|Part A: Washout Period 2 (Up to Day 12)||0||
59969178|NCT04604795|76086777|FG007|STARTED|Part A: Washout Period 2 (Up to Day 12)||0||
59969179|NCT04604795|76086778|FG008|STARTED|Part A: Washout Period 2 (Up to Day 12)||0||
59969180|NCT04604795|76086779|FG009|STARTED|Part A: Washout Period 2 (Up to Day 12)||0||
59969181|NCT04604795|76086770|FG000|COMPLETED|Part A: Washout Period 2 (Up to Day 12)||3||
59969182|NCT04604795|76086771|FG001|COMPLETED|Part A: Washout Period 2 (Up to Day 12)||3||
59969183|NCT04604795|76086772|FG002|COMPLETED|Part A: Washout Period 2 (Up to Day 12)||3||
59969184|NCT04604795|76086773|FG003|COMPLETED|Part A: Washout Period 2 (Up to Day 12)||3||
59969185|NCT04604795|76086774|FG004|COMPLETED|Part A: Washout Period 2 (Up to Day 12)||0||
59969186|NCT04604795|76086775|FG005|COMPLETED|Part A: Washout Period 2 (Up to Day 12)||0||
59969187|NCT04604795|76086776|FG006|COMPLETED|Part A: Washout Period 2 (Up to Day 12)||0||
59969188|NCT04604795|76086777|FG007|COMPLETED|Part A: Washout Period 2 (Up to Day 12)||0||
59969189|NCT04604795|76086778|FG008|COMPLETED|Part A: Washout Period 2 (Up to Day 12)||0||
59969190|NCT04604795|76086779|FG009|COMPLETED|Part A: Washout Period 2 (Up to Day 12)||0||
59969191|NCT04604795|76086770|FG000|NOT COMPLETED|Part A: Washout Period 2 (Up to Day 12)||0||
59969192|NCT04604795|76086771|FG001|NOT COMPLETED|Part A: Washout Period 2 (Up to Day 12)||0||
59969193|NCT04604795|76086772|FG002|NOT COMPLETED|Part A: Washout Period 2 (Up to Day 12)||0||
59969194|NCT04604795|76086773|FG003|NOT COMPLETED|Part A: Washout Period 2 (Up to Day 12)||0||
59969195|NCT04604795|76086774|FG004|NOT COMPLETED|Part A: Washout Period 2 (Up to Day 12)||0||
59969196|NCT04604795|76086775|FG005|NOT COMPLETED|Part A: Washout Period 2 (Up to Day 12)||0||
59969197|NCT04604795|76086776|FG006|NOT COMPLETED|Part A: Washout Period 2 (Up to Day 12)||0||
59969198|NCT04604795|76086777|FG007|NOT COMPLETED|Part A: Washout Period 2 (Up to Day 12)||0||
59969199|NCT04604795|76086778|FG008|NOT COMPLETED|Part A: Washout Period 2 (Up to Day 12)||0||
59969200|NCT04604795|76086779|FG009|NOT COMPLETED|Part A: Washout Period 2 (Up to Day 12)||0||
59969201|NCT04604795|76086770|FG000|STARTED|Part A: Period 3 (Day 1)||3||
59969202|NCT04604795|76086771|FG001|STARTED|Part A: Period 3 (Day 1)||3||
59969203|NCT04604795|76086772|FG002|STARTED|Part A: Period 3 (Day 1)||3||
59969204|NCT04604795|76086773|FG003|STARTED|Part A: Period 3 (Day 1)||3||
59969205|NCT04604795|76086774|FG004|STARTED|Part A: Period 3 (Day 1)||0||
59969206|NCT04604795|76086775|FG005|STARTED|Part A: Period 3 (Day 1)||0||
59969207|NCT04604795|76086776|FG006|STARTED|Part A: Period 3 (Day 1)||0||
59969208|NCT04604795|76086777|FG007|STARTED|Part A: Period 3 (Day 1)||0||
59969209|NCT04604795|76086778|FG008|STARTED|Part A: Period 3 (Day 1)||0||
59969210|NCT04604795|76086779|FG009|STARTED|Part A: Period 3 (Day 1)||0||
59969211|NCT04604795|76086770|FG000|COMPLETED|Part A: Period 3 (Day 1)||3||
59969212|NCT04604795|76086771|FG001|COMPLETED|Part A: Period 3 (Day 1)||3||
59969213|NCT04604795|76086772|FG002|COMPLETED|Part A: Period 3 (Day 1)||3||
59969214|NCT04604795|76086773|FG003|COMPLETED|Part A: Period 3 (Day 1)||3||
59969215|NCT04604795|76086774|FG004|COMPLETED|Part A: Period 3 (Day 1)||0||
59969216|NCT04604795|76086775|FG005|COMPLETED|Part A: Period 3 (Day 1)||0||
59969217|NCT04604795|76086776|FG006|COMPLETED|Part A: Period 3 (Day 1)||0||
59969218|NCT04604795|76086777|FG007|COMPLETED|Part A: Period 3 (Day 1)||0||
59969219|NCT04604795|76086778|FG008|COMPLETED|Part A: Period 3 (Day 1)||0||
59810831|NCT00661193|75933068|FG000|STARTED|Overall Study||33||
59969220|NCT04604795|76086779|FG009|COMPLETED|Part A: Period 3 (Day 1)||0||
59969221|NCT04604795|76086770|FG000|NOT COMPLETED|Part A: Period 3 (Day 1)||0||
59969222|NCT04604795|76086771|FG001|NOT COMPLETED|Part A: Period 3 (Day 1)||0||
59621864|NCT00318708|75733572|FG001|COMPLETED|Overall Study||40||
59969223|NCT04604795|76086772|FG002|NOT COMPLETED|Part A: Period 3 (Day 1)||0||
59969224|NCT04604795|76086773|FG003|NOT COMPLETED|Part A: Period 3 (Day 1)||0||
59969225|NCT04604795|76086774|FG004|NOT COMPLETED|Part A: Period 3 (Day 1)||0||
59969226|NCT04604795|76086775|FG005|NOT COMPLETED|Part A: Period 3 (Day 1)||0||
59969227|NCT04604795|76086776|FG006|NOT COMPLETED|Part A: Period 3 (Day 1)||0||
59969228|NCT04604795|76086777|FG007|NOT COMPLETED|Part A: Period 3 (Day 1)||0||
59969229|NCT04604795|76086778|FG008|NOT COMPLETED|Part A: Period 3 (Day 1)||0||
59969230|NCT04604795|76086779|FG009|NOT COMPLETED|Part A: Period 3 (Day 1)||0||
59969231|NCT04604795|76086770|FG000|STARTED|Part A: Washout Period 3 (Up to Day 20)||3||
59969232|NCT04604795|76086771|FG001|STARTED|Part A: Washout Period 3 (Up to Day 20)||3||
59969233|NCT04604795|76086772|FG002|STARTED|Part A: Washout Period 3 (Up to Day 20)||3||
59969234|NCT04604795|76086773|FG003|STARTED|Part A: Washout Period 3 (Up to Day 20)||3||
59969235|NCT04604795|76086774|FG004|STARTED|Part A: Washout Period 3 (Up to Day 20)||0||
59969236|NCT04604795|76086775|FG005|STARTED|Part A: Washout Period 3 (Up to Day 20)||0||
59969237|NCT04604795|76086776|FG006|STARTED|Part A: Washout Period 3 (Up to Day 20)||0||
59969238|NCT04604795|76086777|FG007|STARTED|Part A: Washout Period 3 (Up to Day 20)||0||
59969239|NCT04604795|76086778|FG008|STARTED|Part A: Washout Period 3 (Up to Day 20)||0||
59969240|NCT04604795|76086779|FG009|STARTED|Part A: Washout Period 3 (Up to Day 20)||0||
59969241|NCT04604795|76086770|FG000|COMPLETED|Part A: Washout Period 3 (Up to Day 20)||3||
59969242|NCT04604795|76086771|FG001|COMPLETED|Part A: Washout Period 3 (Up to Day 20)||3||
59969243|NCT04604795|76086772|FG002|COMPLETED|Part A: Washout Period 3 (Up to Day 20)||3||
59969244|NCT04604795|76086773|FG003|COMPLETED|Part A: Washout Period 3 (Up to Day 20)||3||
59969245|NCT04604795|76086774|FG004|COMPLETED|Part A: Washout Period 3 (Up to Day 20)||0||
59969246|NCT04604795|76086775|FG005|COMPLETED|Part A: Washout Period 3 (Up to Day 20)||0||
59969247|NCT04604795|76086776|FG006|COMPLETED|Part A: Washout Period 3 (Up to Day 20)||0||
59969248|NCT04604795|76086777|FG007|COMPLETED|Part A: Washout Period 3 (Up to Day 20)||0||
59969249|NCT04604795|76086778|FG008|COMPLETED|Part A: Washout Period 3 (Up to Day 20)||0||
59969250|NCT04604795|76086779|FG009|COMPLETED|Part A: Washout Period 3 (Up to Day 20)||0||
59969251|NCT04604795|76086770|FG000|NOT COMPLETED|Part A: Washout Period 3 (Up to Day 20)||0||
59969252|NCT04604795|76086771|FG001|NOT COMPLETED|Part A: Washout Period 3 (Up to Day 20)||0||
59969253|NCT04604795|76086772|FG002|NOT COMPLETED|Part A: Washout Period 3 (Up to Day 20)||0||
59621865|NCT00318708|75733571|FG000|NOT COMPLETED|Overall Study||8||
59621866|NCT00318708|75733572|FG001|NOT COMPLETED|Overall Study||5||
59621867|NCT00319644|75733584|FG000|STARTED|Overall Study||21||
59621868|NCT00319644|75733585|FG001|STARTED|Overall Study||16||
59621869|NCT00319644|75733584|FG000|COMPLETED|Overall Study||21||
59621870|NCT00319644|75733585|FG001|COMPLETED|Overall Study||16||
59621871|NCT00319644|75733584|FG000|NOT COMPLETED|Overall Study||0||
59621872|NCT00319644|75733585|FG001|NOT COMPLETED|Overall Study||0||
59621873|NCT02422446|75733593|FG000|STARTED|Overall Study||1||
59621874|NCT02422446|75733594|FG001|STARTED|Overall Study||1||
59621875|NCT02422446|75733593|FG000|COMPLETED|Overall Study||1||
59621876|NCT02422446|75733594|FG001|COMPLETED|Overall Study||1||
59621877|NCT02422446|75733593|FG000|NOT COMPLETED|Overall Study||0||
59621878|NCT02422446|75733594|FG001|NOT COMPLETED|Overall Study||0||
59621879|NCT00321594|75733602|FG000|STARTED|Phase I, Level 1-4||3||
59621880|NCT00321594|75733603|FG001|STARTED|Phase I, Level 1-4||3||
59621881|NCT00321594|75733604|FG002|STARTED|Phase I, Level 1-4||6||
59621882|NCT00321594|75733605|FG003|STARTED|Phase I, Level 1-4||6||
59621883|NCT00321594|75733606|FG004|STARTED|Phase I, Level 1-4||0||
59621884|NCT00321594|75733602|FG000|COMPLETED|Phase I, Level 1-4||3||
59621885|NCT00321594|75733603|FG001|COMPLETED|Phase I, Level 1-4||3||
59621886|NCT00321594|75733604|FG002|COMPLETED|Phase I, Level 1-4||6||
59621887|NCT00321594|75733605|FG003|COMPLETED|Phase I, Level 1-4||6||
59621888|NCT00321594|75733606|FG004|COMPLETED|Phase I, Level 1-4||0||
59621889|NCT00321594|75733602|FG000|NOT COMPLETED|Phase I, Level 1-4||0||
59621890|NCT00321594|75733603|FG001|NOT COMPLETED|Phase I, Level 1-4||0||
59621891|NCT00321594|75733604|FG002|NOT COMPLETED|Phase I, Level 1-4||0||
59621892|NCT00321594|75733605|FG003|NOT COMPLETED|Phase I, Level 1-4||0||
59621893|NCT00321594|75733606|FG004|NOT COMPLETED|Phase I, Level 1-4||0||
59621894|NCT00321594|75733602|FG000|STARTED|Phase II, MTD Dose|Only last six patients in Phase I, Level 4 include in Phase II MTD Dose|0||
59621895|NCT00321594|75733603|FG001|STARTED|Phase II, MTD Dose|Only last six patients in Phase I, Level 4 include in Phase II MTD Dose|0||
59621896|NCT00321594|75733604|FG002|STARTED|Phase II, MTD Dose|Only last six patients in Phase I, Level 4 include in Phase II MTD Dose|0||
59969254|NCT04604795|76086773|FG003|NOT COMPLETED|Part A: Washout Period 3 (Up to Day 20)||0||
59969255|NCT04604795|76086774|FG004|NOT COMPLETED|Part A: Washout Period 3 (Up to Day 20)||0||
59969256|NCT04604795|76086775|FG005|NOT COMPLETED|Part A: Washout Period 3 (Up to Day 20)||0||
59621897|NCT00321594|75733605|FG003|STARTED|Phase II, MTD Dose|Only last six patients in Phase I, Level 4 include in Phase II MTD Dose|6||
59621898|NCT00321594|75733606|FG004|STARTED|Phase II, MTD Dose|last six patients in Phase I, Level 4 include in Phase II MTD Dose total number = 6 + 36 = 42|36||
59621899|NCT00321594|75733602|FG000|COMPLETED|Phase II, MTD Dose||0||
59810832|NCT00661193|75933069|FG001|STARTED|Overall Study||26||
59810833|NCT00661193|75933068|FG000|COMPLETED|Overall Study||0||
59810834|NCT00661193|75933069|FG001|COMPLETED|Overall Study||0||
59810835|NCT00661193|75933068|FG000|NOT COMPLETED|Overall Study||33||
59810836|NCT00661193|75933069|FG001|NOT COMPLETED|Overall Study||26||
59810837|NCT00658541|75933075|FG000|STARTED|First Intervention||19||
59810838|NCT00658541|75933076|FG001|STARTED|First Intervention||19||
59810839|NCT00658541|75933075|FG000|COMPLETED|First Intervention||19||
59810840|NCT00658541|75933076|FG001|COMPLETED|First Intervention||19||
59969257|NCT04604795|76086776|FG006|NOT COMPLETED|Part A: Washout Period 3 (Up to Day 20)||0||
59969258|NCT04604795|76086777|FG007|NOT COMPLETED|Part A: Washout Period 3 (Up to Day 20)||0||
59969259|NCT04604795|76086778|FG008|NOT COMPLETED|Part A: Washout Period 3 (Up to Day 20)||0||
59969260|NCT04604795|76086779|FG009|NOT COMPLETED|Part A: Washout Period 3 (Up to Day 20)||0||
59969261|NCT04604795|76086770|FG000|STARTED|Part A: Period 4 (Day 1)||3||
59969262|NCT04604795|76086771|FG001|STARTED|Part A: Period 4 (Day 1)||3||
59969263|NCT04604795|76086772|FG002|STARTED|Part A: Period 4 (Day 1)||3||
59969264|NCT04604795|76086773|FG003|STARTED|Part A: Period 4 (Day 1)||3||
59969265|NCT04604795|76086774|FG004|STARTED|Part A: Period 4 (Day 1)||0||
59969266|NCT04604795|76086775|FG005|STARTED|Part A: Period 4 (Day 1)||0||
59969267|NCT04604795|76086776|FG006|STARTED|Part A: Period 4 (Day 1)||0||
59969268|NCT04604795|76086777|FG007|STARTED|Part A: Period 4 (Day 1)||0||
59810841|NCT00658541|75933075|FG000|NOT COMPLETED|First Intervention||0||
59810842|NCT00658541|75933076|FG001|NOT COMPLETED|First Intervention||0||
59810843|NCT00658541|75933075|FG000|STARTED|Washout Period of 7 Days||19||
59810844|NCT00658541|75933076|FG001|STARTED|Washout Period of 7 Days||19||
59810845|NCT00658541|75933075|FG000|COMPLETED|Washout Period of 7 Days||18||
59810846|NCT00658541|75933076|FG001|COMPLETED|Washout Period of 7 Days||17||
59810847|NCT00658541|75933075|FG000|NOT COMPLETED|Washout Period of 7 Days||1||
59810848|NCT00658541|75933076|FG001|NOT COMPLETED|Washout Period of 7 Days||2||
59810849|NCT00658541|75933075|FG000|STARTED|Second Intervention||18||
59810850|NCT00658541|75933076|FG001|STARTED|Second Intervention||17||
59810851|NCT00658541|75933075|FG000|COMPLETED|Second Intervention||18||
59810852|NCT00658541|75933076|FG001|COMPLETED|Second Intervention||17||
59810853|NCT00658541|75933075|FG000|NOT COMPLETED|Second Intervention||0||
59810854|NCT00658541|75933076|FG001|NOT COMPLETED|Second Intervention||0||
59810855|NCT00048061|75933086|FG000|STARTED|Overall Study||400||
59810856|NCT00048061|75933087|FG001|STARTED|Overall Study||401||
59810857|NCT00048061|75933088|FG002|STARTED|Overall Study||400||
59810858|NCT00048061|75933089|FG003|STARTED|Overall Study||401||
59810859|NCT00048061|75933086|FG000|COMPLETED|Overall Study||325||
59810860|NCT00048061|75933087|FG001|COMPLETED|Overall Study||328||
59810861|NCT00048061|75933088|FG002|COMPLETED|Overall Study||316||
59810862|NCT00048061|75933089|FG003|COMPLETED|Overall Study||322||
59810863|NCT00048061|75933086|FG000|NOT COMPLETED|Overall Study||75||
59810864|NCT00048061|75933087|FG001|NOT COMPLETED|Overall Study||73||
59810865|NCT00048061|75933088|FG002|NOT COMPLETED|Overall Study||84||
59810866|NCT00048061|75933089|FG003|NOT COMPLETED|Overall Study||79||
59810867|NCT00656513|75933102|FG000|STARTED|Overall Study||48||
59810868|NCT00656513|75933103|FG001|STARTED|Overall Study||73||
59810869|NCT00656513|75933104|FG002|STARTED|Overall Study||75||
59810870|NCT00656513|75933102|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|44||
59810871|NCT00656513|75933103|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|43||
59810872|NCT00656513|75933104|FG002|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|53||
59810873|NCT00656513|75933102|FG000|NOT COMPLETED|Overall Study||4||
59810874|NCT00656513|75933103|FG001|NOT COMPLETED|Overall Study||30||
59810875|NCT00656513|75933104|FG002|NOT COMPLETED|Overall Study||22||
59810876|NCT00655889|75933112|FG000|STARTED|Overall Study||13||
59810877|NCT00655889|75933112|FG000|COMPLETED|Overall Study||11||
59810878|NCT00655889|75933112|FG000|NOT COMPLETED|Overall Study||2||
59810879|NCT00655733|75933118|FG000|STARTED|Overall Study||51||
59810880|NCT00655733|75933119|FG001|STARTED|Overall Study||50||
59810881|NCT00655733|75933118|FG000|COMPLETED|Overall Study||44||
59810882|NCT00655733|75933119|FG001|COMPLETED|Overall Study||42||
59969269|NCT04604795|76086778|FG008|STARTED|Part A: Period 4 (Day 1)||0||
59969270|NCT04604795|76086779|FG009|STARTED|Part A: Period 4 (Day 1)||0||
59969271|NCT04604795|76086770|FG000|COMPLETED|Part A: Period 4 (Day 1)||3||
59969272|NCT04604795|76086771|FG001|COMPLETED|Part A: Period 4 (Day 1)||3||
59969273|NCT04604795|76086772|FG002|COMPLETED|Part A: Period 4 (Day 1)||3||
59969274|NCT04604795|76086773|FG003|COMPLETED|Part A: Period 4 (Day 1)||3||
59969275|NCT04604795|76086774|FG004|COMPLETED|Part A: Period 4 (Day 1)||0||
59810883|NCT00655733|75933118|FG000|NOT COMPLETED|Overall Study||7||
59810884|NCT00655733|75933119|FG001|NOT COMPLETED|Overall Study||8||
59810885|NCT00657371|75933127|FG000|STARTED|Overall Study||288||
59810886|NCT00657371|75933127|FG000|COMPLETED|Overall Study||249||
59810887|NCT00657371|75933127|FG000|NOT COMPLETED|Overall Study||39||
59810888|NCT00658775|75933133|FG000|STARTED|Overall Study|Treated|537||
59810889|NCT00658775|75933134|FG001|STARTED|Overall Study|Treated|528||
59810890|NCT00658775|75933133|FG000|COMPLETED|Overall Study||495||
59810891|NCT00658775|75933134|FG001|COMPLETED|Overall Study||485||
59969276|NCT04604795|76086775|FG005|COMPLETED|Part A: Period 4 (Day 1)||0||
59969277|NCT04604795|76086776|FG006|COMPLETED|Part A: Period 4 (Day 1)||0||
59969278|NCT04604795|76086777|FG007|COMPLETED|Part A: Period 4 (Day 1)||0||
59969279|NCT04604795|76086778|FG008|COMPLETED|Part A: Period 4 (Day 1)||0||
59969280|NCT04604795|76086779|FG009|COMPLETED|Part A: Period 4 (Day 1)||0||
59969281|NCT04604795|76086770|FG000|NOT COMPLETED|Part A: Period 4 (Day 1)||0||
59969282|NCT04604795|76086771|FG001|NOT COMPLETED|Part A: Period 4 (Day 1)||0||
59969283|NCT04604795|76086772|FG002|NOT COMPLETED|Part A: Period 4 (Day 1)||0||
59969284|NCT04604795|76086773|FG003|NOT COMPLETED|Part A: Period 4 (Day 1)||0||
59969285|NCT04604795|76086774|FG004|NOT COMPLETED|Part A: Period 4 (Day 1)||0||
59969286|NCT04604795|76086775|FG005|NOT COMPLETED|Part A: Period 4 (Day 1)||0||
59969287|NCT04604795|76086776|FG006|NOT COMPLETED|Part A: Period 4 (Day 1)||0||
59969288|NCT04604795|76086777|FG007|NOT COMPLETED|Part A: Period 4 (Day 1)||0||
59969289|NCT04604795|76086778|FG008|NOT COMPLETED|Part A: Period 4 (Day 1)||0||
59969290|NCT04604795|76086779|FG009|NOT COMPLETED|Part A: Period 4 (Day 1)||0||
59969291|NCT04604795|76086770|FG000|STARTED|Part B: Up to Day 14||0||
59969292|NCT04604795|76086771|FG001|STARTED|Part B: Up to Day 14||0||
59969293|NCT04604795|76086772|FG002|STARTED|Part B: Up to Day 14||0||
59969294|NCT04604795|76086773|FG003|STARTED|Part B: Up to Day 14||0||
59969295|NCT04604795|76086774|FG004|STARTED|Part B: Up to Day 14||10||
59969296|NCT04604795|76086775|FG005|STARTED|Part B: Up to Day 14||10||
59969297|NCT04604795|76086776|FG006|STARTED|Part B: Up to Day 14||9||
59969298|NCT04604795|76086777|FG007|STARTED|Part B: Up to Day 14||9||
59969299|NCT04604795|76086778|FG008|STARTED|Part B: Up to Day 14||0||
59969300|NCT04604795|76086779|FG009|STARTED|Part B: Up to Day 14||0||
59969301|NCT04604795|76086770|FG000|COMPLETED|Part B: Up to Day 14||0||
59969302|NCT04604795|76086771|FG001|COMPLETED|Part B: Up to Day 14||0||
59969303|NCT04604795|76086772|FG002|COMPLETED|Part B: Up to Day 14||0||
59969304|NCT04604795|76086773|FG003|COMPLETED|Part B: Up to Day 14||0||
59969305|NCT04604795|76086774|FG004|COMPLETED|Part B: Up to Day 14||8||
59969306|NCT04604795|76086775|FG005|COMPLETED|Part B: Up to Day 14||9||
59969307|NCT04604795|76086776|FG006|COMPLETED|Part B: Up to Day 14||9||
59969308|NCT04604795|76086777|FG007|COMPLETED|Part B: Up to Day 14||9||
59969309|NCT04604795|76086778|FG008|COMPLETED|Part B: Up to Day 14||0||
59969310|NCT04604795|76086779|FG009|COMPLETED|Part B: Up to Day 14||0||
59969311|NCT04604795|76086770|FG000|NOT COMPLETED|Part B: Up to Day 14||0||
59969312|NCT04604795|76086771|FG001|NOT COMPLETED|Part B: Up to Day 14||0||
59969313|NCT04604795|76086772|FG002|NOT COMPLETED|Part B: Up to Day 14||0||
59969314|NCT04604795|76086773|FG003|NOT COMPLETED|Part B: Up to Day 14||0||
59969315|NCT04604795|76086774|FG004|NOT COMPLETED|Part B: Up to Day 14||2||
59969316|NCT04604795|76086775|FG005|NOT COMPLETED|Part B: Up to Day 14||1||
59969317|NCT04604795|76086776|FG006|NOT COMPLETED|Part B: Up to Day 14||0||
59810892|NCT00658775|75933133|FG000|NOT COMPLETED|Overall Study||42||
59810893|NCT00658775|75933134|FG001|NOT COMPLETED|Overall Study||43||
59810894|NCT00488631|75933146|FG000|STARTED|Double Blind Period (Week 0-54)||156||
59810895|NCT00488631|75933147|FG001|STARTED|Double Blind Period (Week 0-54)||154||
59810896|NCT00488631|75933148|FG002|STARTED|Double Blind Period (Week 0-54)||154||
59810897|NCT00488631|75933149|FG003|STARTED|Double Blind Period (Week 0-54)||129||
59810898|NCT00488631|75933150|FG004|STARTED|Double Blind Period (Week 0-54)||230||
59810899|NCT00488631|75933151|FG005|STARTED|Double Blind Period (Week 0-54)||405||
59810900|NCT00488631|75933152|FG006|STARTED|Double Blind Period (Week 0-54)||0||
59969318|NCT04604795|76086777|FG007|NOT COMPLETED|Part B: Up to Day 14||0||
59969319|NCT04604795|76086778|FG008|NOT COMPLETED|Part B: Up to Day 14||0||
59969320|NCT04604795|76086779|FG009|NOT COMPLETED|Part B: Up to Day 14||0||
59969321|NCT04604795|76086770|FG000|STARTED|Part C: Period 1 (Day 1)||0||
59969322|NCT04604795|76086771|FG001|STARTED|Part C: Period 1 (Day 1)||0||
59969323|NCT04604795|76086772|FG002|STARTED|Part C: Period 1 (Day 1)||0||
59969324|NCT04604795|76086773|FG003|STARTED|Part C: Period 1 (Day 1)||0||
59969325|NCT04604795|76086774|FG004|STARTED|Part C: Period 1 (Day 1)||0||
59969326|NCT04604795|76086775|FG005|STARTED|Part C: Period 1 (Day 1)||0||
59969327|NCT04604795|76086776|FG006|STARTED|Part C: Period 1 (Day 1)||0||
59969328|NCT04604795|76086777|FG007|STARTED|Part C: Period 1 (Day 1)||0||
59969329|NCT04604795|76086778|FG008|STARTED|Part C: Period 1 (Day 1)||6||
59969330|NCT04604795|76086779|FG009|STARTED|Part C: Period 1 (Day 1)||6||
59969331|NCT04604795|76086770|FG000|COMPLETED|Part C: Period 1 (Day 1)||0||
59969332|NCT04604795|76086771|FG001|COMPLETED|Part C: Period 1 (Day 1)||0||
59969333|NCT04604795|76086772|FG002|COMPLETED|Part C: Period 1 (Day 1)||0||
59969334|NCT04604795|76086773|FG003|COMPLETED|Part C: Period 1 (Day 1)||0||
59969335|NCT04604795|76086774|FG004|COMPLETED|Part C: Period 1 (Day 1)||0||
59969336|NCT04604795|76086775|FG005|COMPLETED|Part C: Period 1 (Day 1)||0||
59969337|NCT04604795|76086776|FG006|COMPLETED|Part C: Period 1 (Day 1)||0||
59969338|NCT04604795|76086777|FG007|COMPLETED|Part C: Period 1 (Day 1)||0||
59969339|NCT04604795|76086778|FG008|COMPLETED|Part C: Period 1 (Day 1)||6||
59969340|NCT04604795|76086779|FG009|COMPLETED|Part C: Period 1 (Day 1)||6||
59969341|NCT04604795|76086770|FG000|NOT COMPLETED|Part C: Period 1 (Day 1)||0||
59969342|NCT04604795|76086771|FG001|NOT COMPLETED|Part C: Period 1 (Day 1)||0||
59969343|NCT04604795|76086772|FG002|NOT COMPLETED|Part C: Period 1 (Day 1)||0||
59969344|NCT04604795|76086773|FG003|NOT COMPLETED|Part C: Period 1 (Day 1)||0||
59969345|NCT04604795|76086774|FG004|NOT COMPLETED|Part C: Period 1 (Day 1)||0||
59969346|NCT04604795|76086775|FG005|NOT COMPLETED|Part C: Period 1 (Day 1)||0||
59969347|NCT04604795|76086776|FG006|NOT COMPLETED|Part C: Period 1 (Day 1)||0||
59969348|NCT04604795|76086777|FG007|NOT COMPLETED|Part C: Period 1 (Day 1)||0||
59969349|NCT04604795|76086778|FG008|NOT COMPLETED|Part C: Period 1 (Day 1)||0||
59969350|NCT04604795|76086779|FG009|NOT COMPLETED|Part C: Period 1 (Day 1)||0||
59969351|NCT04604795|76086770|FG000|STARTED|Part C: Washout Period 1 (Up to Day 6)||0||
59969352|NCT04604795|76086771|FG001|STARTED|Part C: Washout Period 1 (Up to Day 6)||0||
59969353|NCT04604795|76086772|FG002|STARTED|Part C: Washout Period 1 (Up to Day 6)||0||
59969354|NCT04604795|76086773|FG003|STARTED|Part C: Washout Period 1 (Up to Day 6)||0||
59969355|NCT04604795|76086774|FG004|STARTED|Part C: Washout Period 1 (Up to Day 6)||0||
59969356|NCT04604795|76086775|FG005|STARTED|Part C: Washout Period 1 (Up to Day 6)||0||
59969357|NCT04604795|76086776|FG006|STARTED|Part C: Washout Period 1 (Up to Day 6)||0||
59969358|NCT04604795|76086777|FG007|STARTED|Part C: Washout Period 1 (Up to Day 6)||0||
59969359|NCT04604795|76086778|FG008|STARTED|Part C: Washout Period 1 (Up to Day 6)||6||
59969360|NCT04604795|76086779|FG009|STARTED|Part C: Washout Period 1 (Up to Day 6)||6||
59969361|NCT04604795|76086770|FG000|COMPLETED|Part C: Washout Period 1 (Up to Day 6)||0||
59969362|NCT04604795|76086771|FG001|COMPLETED|Part C: Washout Period 1 (Up to Day 6)||0||
59969363|NCT04604795|76086772|FG002|COMPLETED|Part C: Washout Period 1 (Up to Day 6)||0||
59969364|NCT04604795|76086773|FG003|COMPLETED|Part C: Washout Period 1 (Up to Day 6)||0||
59969365|NCT04604795|76086774|FG004|COMPLETED|Part C: Washout Period 1 (Up to Day 6)||0||
59969366|NCT04604795|76086775|FG005|COMPLETED|Part C: Washout Period 1 (Up to Day 6)||0||
59969367|NCT04604795|76086776|FG006|COMPLETED|Part C: Washout Period 1 (Up to Day 6)||0||
59969368|NCT04604795|76086777|FG007|COMPLETED|Part C: Washout Period 1 (Up to Day 6)||0||
59969369|NCT04604795|76086778|FG008|COMPLETED|Part C: Washout Period 1 (Up to Day 6)||6||
59969370|NCT04604795|76086779|FG009|COMPLETED|Part C: Washout Period 1 (Up to Day 6)||5||
59969371|NCT04604795|76086770|FG000|NOT COMPLETED|Part C: Washout Period 1 (Up to Day 6)||0||
59969372|NCT04604795|76086771|FG001|NOT COMPLETED|Part C: Washout Period 1 (Up to Day 6)||0||
59969373|NCT04604795|76086772|FG002|NOT COMPLETED|Part C: Washout Period 1 (Up to Day 6)||0||
59969374|NCT04604795|76086773|FG003|NOT COMPLETED|Part C: Washout Period 1 (Up to Day 6)||0||
59969375|NCT04604795|76086774|FG004|NOT COMPLETED|Part C: Washout Period 1 (Up to Day 6)||0||
59969376|NCT04604795|76086775|FG005|NOT COMPLETED|Part C: Washout Period 1 (Up to Day 6)||0||
59969377|NCT04604795|76086776|FG006|NOT COMPLETED|Part C: Washout Period 1 (Up to Day 6)||0||
59969378|NCT04604795|76086777|FG007|NOT COMPLETED|Part C: Washout Period 1 (Up to Day 6)||0||
59969379|NCT04604795|76086778|FG008|NOT COMPLETED|Part C: Washout Period 1 (Up to Day 6)||0||
59969380|NCT04604795|76086779|FG009|NOT COMPLETED|Part C: Washout Period 1 (Up to Day 6)||1||
59969381|NCT04604795|76086770|FG000|STARTED|Part C: Period 2 (Day 1)||0||
59969382|NCT04604795|76086771|FG001|STARTED|Part C: Period 2 (Day 1)||0||
59969383|NCT04604795|76086772|FG002|STARTED|Part C: Period 2 (Day 1)||0||
59969384|NCT04604795|76086773|FG003|STARTED|Part C: Period 2 (Day 1)||0||
59969385|NCT04604795|76086774|FG004|STARTED|Part C: Period 2 (Day 1)||0||
59969386|NCT04604795|76086775|FG005|STARTED|Part C: Period 2 (Day 1)||0||
59969387|NCT04604795|76086776|FG006|STARTED|Part C: Period 2 (Day 1)||0||
59969388|NCT04604795|76086777|FG007|STARTED|Part C: Period 2 (Day 1)||0||
59969389|NCT04604795|76086778|FG008|STARTED|Part C: Period 2 (Day 1)||6||
59969390|NCT04604795|76086779|FG009|STARTED|Part C: Period 2 (Day 1)||5||
59810901|NCT00488631|75933153|FG007|STARTED|Double Blind Period (Week 0-54)||0||
59810902|NCT00488631|75933154|FG008|STARTED|Double Blind Period (Week 0-54)||0||
59810903|NCT00488631|75933155|FG009|STARTED|Double Blind Period (Week 0-54)||0||
59810904|NCT00488631|75933146|FG000|COMPLETED|Double Blind Period (Week 0-54)||113||
59810905|NCT00488631|75933147|FG001|COMPLETED|Double Blind Period (Week 0-54)||111||
59810906|NCT00488631|75933148|FG002|COMPLETED|Double Blind Period (Week 0-54)||109||
59810907|NCT00488631|75933149|FG003|COMPLETED|Double Blind Period (Week 0-54)||88||
59810908|NCT00488631|75933150|FG004|COMPLETED|Double Blind Period (Week 0-54)||127||
59810909|NCT00488631|75933151|FG005|COMPLETED|Double Blind Period (Week 0-54)||189||
59810910|NCT00488631|75933152|FG006|COMPLETED|Double Blind Period (Week 0-54)||0||
59810911|NCT00488631|75933153|FG007|COMPLETED|Double Blind Period (Week 0-54)||0||
59969391|NCT04604795|76086770|FG000|COMPLETED|Part C: Period 2 (Day 1)||0||
59969392|NCT04604795|76086771|FG001|COMPLETED|Part C: Period 2 (Day 1)||0||
59969393|NCT04604795|76086772|FG002|COMPLETED|Part C: Period 2 (Day 1)||0||
59969394|NCT04604795|76086773|FG003|COMPLETED|Part C: Period 2 (Day 1)||0||
59969395|NCT04604795|76086774|FG004|COMPLETED|Part C: Period 2 (Day 1)||0||
59969396|NCT04604795|76086775|FG005|COMPLETED|Part C: Period 2 (Day 1)||0||
59969397|NCT04604795|76086776|FG006|COMPLETED|Part C: Period 2 (Day 1)||0||
59969398|NCT04604795|76086777|FG007|COMPLETED|Part C: Period 2 (Day 1)||0||
59969399|NCT04604795|76086778|FG008|COMPLETED|Part C: Period 2 (Day 1)||6||
59969400|NCT04604795|76086779|FG009|COMPLETED|Part C: Period 2 (Day 1)||5||
59969401|NCT04604795|76086770|FG000|NOT COMPLETED|Part C: Period 2 (Day 1)||0||
59969402|NCT04604795|76086771|FG001|NOT COMPLETED|Part C: Period 2 (Day 1)||0||
59810912|NCT00488631|75933154|FG008|COMPLETED|Double Blind Period (Week 0-54)||0||
59810913|NCT00488631|75933155|FG009|COMPLETED|Double Blind Period (Week 0-54)||0||
59810914|NCT00488631|75933146|FG000|NOT COMPLETED|Double Blind Period (Week 0-54)||43||
59810915|NCT00488631|75933147|FG001|NOT COMPLETED|Double Blind Period (Week 0-54)||43||
59969403|NCT04604795|76086772|FG002|NOT COMPLETED|Part C: Period 2 (Day 1)||0||
59969404|NCT04604795|76086773|FG003|NOT COMPLETED|Part C: Period 2 (Day 1)||0||
59969405|NCT04604795|76086774|FG004|NOT COMPLETED|Part C: Period 2 (Day 1)||0||
59969406|NCT04604795|76086775|FG005|NOT COMPLETED|Part C: Period 2 (Day 1)||0||
59810916|NCT00488631|75933148|FG002|NOT COMPLETED|Double Blind Period (Week 0-54)||45||
59810917|NCT00488631|75933149|FG003|NOT COMPLETED|Double Blind Period (Week 0-54)||41||
59810918|NCT00488631|75933150|FG004|NOT COMPLETED|Double Blind Period (Week 0-54)||103||
59810919|NCT00488631|75933151|FG005|NOT COMPLETED|Double Blind Period (Week 0-54)||216||
59810920|NCT00488631|75933152|FG006|NOT COMPLETED|Double Blind Period (Week 0-54)||0||
59810921|NCT00488631|75933153|FG007|NOT COMPLETED|Double Blind Period (Week 0-54)||0||
59810922|NCT00488631|75933154|FG008|NOT COMPLETED|Double Blind Period (Week 0-54)||0||
59810923|NCT00488631|75933155|FG009|NOT COMPLETED|Double Blind Period (Week 0-54)||0||
59810924|NCT00488631|75933146|FG000|STARTED|Open Label Study Extension (Week 54-228)||0||
59810925|NCT00488631|75933147|FG001|STARTED|Open Label Study Extension (Week 54-228)||0||
59810926|NCT00488631|75933148|FG002|STARTED|Open Label Study Extension (Week 54-228)||0||
59810927|NCT00488631|75933149|FG003|STARTED|Open Label Study Extension (Week 54-228)||0||
59810928|NCT00488631|75933150|FG004|STARTED|Open Label Study Extension (Week 54-228)||0||
59810929|NCT00488631|75933151|FG005|STARTED|Open Label Study Extension (Week 54-228)||0||
59810930|NCT00488631|75933152|FG006|STARTED|Open Label Study Extension (Week 54-228)||96||
59969407|NCT04604795|76086776|FG006|NOT COMPLETED|Part C: Period 2 (Day 1)||0||
59969408|NCT04604795|76086777|FG007|NOT COMPLETED|Part C: Period 2 (Day 1)||0||
59969409|NCT04604795|76086778|FG008|NOT COMPLETED|Part C: Period 2 (Day 1)||0||
59969410|NCT04604795|76086779|FG009|NOT COMPLETED|Part C: Period 2 (Day 1)||0||
59969411|NCT04604795|76086770|FG000|STARTED|Part C: Washout Period 2 (Up to Day 24)||0||
59969412|NCT04604795|76086771|FG001|STARTED|Part C: Washout Period 2 (Up to Day 24)||0||
59969413|NCT04604795|76086772|FG002|STARTED|Part C: Washout Period 2 (Up to Day 24)||0||
59969414|NCT04604795|76086773|FG003|STARTED|Part C: Washout Period 2 (Up to Day 24)||0||
59969415|NCT04604795|76086774|FG004|STARTED|Part C: Washout Period 2 (Up to Day 24)||0||
59969416|NCT04604795|76086775|FG005|STARTED|Part C: Washout Period 2 (Up to Day 24)||0||
59969417|NCT04604795|76086776|FG006|STARTED|Part C: Washout Period 2 (Up to Day 24)||0||
60074371|NCT01556763|76189759|FG000|STARTED|Overall Study||4||
59525385|NCT00086138|75620727|FG001|COMPLETED|Overall Study||64||
59810931|NCT00488631|75933153|FG007|STARTED|Open Label Study Extension (Week 54-228)||93||
59810932|NCT00488631|75933154|FG008|STARTED|Open Label Study Extension (Week 54-228)||470||
59810933|NCT00488631|75933155|FG009|STARTED|Open Label Study Extension (Week 54-228)||7||
59810934|NCT00488631|75933146|FG000|COMPLETED|Open Label Study Extension (Week 54-228)||0||
59810935|NCT00488631|75933147|FG001|COMPLETED|Open Label Study Extension (Week 54-228)||0||
59810936|NCT00488631|75933148|FG002|COMPLETED|Open Label Study Extension (Week 54-228)||0||
59810937|NCT00488631|75933149|FG003|COMPLETED|Open Label Study Extension (Week 54-228)||0||
59810938|NCT00488631|75933150|FG004|COMPLETED|Open Label Study Extension (Week 54-228)||0||
59810939|NCT00488631|75933151|FG005|COMPLETED|Open Label Study Extension (Week 54-228)||0||
59810940|NCT00488631|75933152|FG006|COMPLETED|Open Label Study Extension (Week 54-228)||16||
59810941|NCT00488631|75933153|FG007|COMPLETED|Open Label Study Extension (Week 54-228)||66||
59810942|NCT00488631|75933154|FG008|COMPLETED|Open Label Study Extension (Week 54-228)||288||
59810943|NCT00488631|75933155|FG009|COMPLETED|Open Label Study Extension (Week 54-228)||4||
59810944|NCT00488631|75933146|FG000|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0||
59810945|NCT00488631|75933147|FG001|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0||
59969418|NCT04604795|76086777|FG007|STARTED|Part C: Washout Period 2 (Up to Day 24)||0||
59969419|NCT04604795|76086778|FG008|STARTED|Part C: Washout Period 2 (Up to Day 24)||6||
59969420|NCT04604795|76086779|FG009|STARTED|Part C: Washout Period 2 (Up to Day 24)||5||
59969421|NCT04604795|76086770|FG000|COMPLETED|Part C: Washout Period 2 (Up to Day 24)||0||
59969422|NCT04604795|76086771|FG001|COMPLETED|Part C: Washout Period 2 (Up to Day 24)||0||
59969423|NCT04604795|76086772|FG002|COMPLETED|Part C: Washout Period 2 (Up to Day 24)||0||
59969424|NCT04604795|76086773|FG003|COMPLETED|Part C: Washout Period 2 (Up to Day 24)||0||
59969425|NCT04604795|76086774|FG004|COMPLETED|Part C: Washout Period 2 (Up to Day 24)||0||
59969426|NCT04604795|76086775|FG005|COMPLETED|Part C: Washout Period 2 (Up to Day 24)||0||
59969427|NCT04604795|76086776|FG006|COMPLETED|Part C: Washout Period 2 (Up to Day 24)||0||
59969428|NCT04604795|76086777|FG007|COMPLETED|Part C: Washout Period 2 (Up to Day 24)||0||
59969429|NCT04604795|76086778|FG008|COMPLETED|Part C: Washout Period 2 (Up to Day 24)||6||
59969430|NCT04604795|76086779|FG009|COMPLETED|Part C: Washout Period 2 (Up to Day 24)||5||
59969431|NCT04604795|76086770|FG000|NOT COMPLETED|Part C: Washout Period 2 (Up to Day 24)||0||
59969432|NCT04604795|76086771|FG001|NOT COMPLETED|Part C: Washout Period 2 (Up to Day 24)||0||
59969433|NCT04604795|76086772|FG002|NOT COMPLETED|Part C: Washout Period 2 (Up to Day 24)||0||
59969434|NCT04604795|76086773|FG003|NOT COMPLETED|Part C: Washout Period 2 (Up to Day 24)||0||
59969435|NCT04604795|76086774|FG004|NOT COMPLETED|Part C: Washout Period 2 (Up to Day 24)||0||
59969436|NCT04604795|76086775|FG005|NOT COMPLETED|Part C: Washout Period 2 (Up to Day 24)||0||
59969437|NCT04604795|76086776|FG006|NOT COMPLETED|Part C: Washout Period 2 (Up to Day 24)||0||
59969438|NCT04604795|76086777|FG007|NOT COMPLETED|Part C: Washout Period 2 (Up to Day 24)||0||
60074372|NCT01556763|76189760|FG001|STARTED|Overall Study||9||
59969439|NCT04604795|76086778|FG008|NOT COMPLETED|Part C: Washout Period 2 (Up to Day 24)||0||
59969440|NCT04604795|76086779|FG009|NOT COMPLETED|Part C: Washout Period 2 (Up to Day 24)||0||
59969441|NCT04604795|76086770|FG000|STARTED|Part C: Period 3 (Day 1)||0||
59969442|NCT04604795|76086771|FG001|STARTED|Part C: Period 3 (Day 1)||0||
59969443|NCT04604795|76086772|FG002|STARTED|Part C: Period 3 (Day 1)||0||
59969444|NCT04604795|76086773|FG003|STARTED|Part C: Period 3 (Day 1)||0||
59969445|NCT04604795|76086774|FG004|STARTED|Part C: Period 3 (Day 1)||0||
59969446|NCT04604795|76086775|FG005|STARTED|Part C: Period 3 (Day 1)||0||
59969447|NCT04604795|76086776|FG006|STARTED|Part C: Period 3 (Day 1)||0||
59969448|NCT04604795|76086777|FG007|STARTED|Part C: Period 3 (Day 1)||0||
59969449|NCT04604795|76086778|FG008|STARTED|Part C: Period 3 (Day 1)||6||
59969450|NCT04604795|76086779|FG009|STARTED|Part C: Period 3 (Day 1)||6||
59969451|NCT04604795|76086770|FG000|New Participant Enrolled and Dosed|Part C: Period 3 (Day 1)||0||
59969452|NCT04604795|76086771|FG001|New Participant Enrolled and Dosed|Part C: Period 3 (Day 1)||0||
59969453|NCT04604795|76086772|FG002|New Participant Enrolled and Dosed|Part C: Period 3 (Day 1)||0||
59969454|NCT04604795|76086773|FG003|New Participant Enrolled and Dosed|Part C: Period 3 (Day 1)||0||
59969455|NCT04604795|76086774|FG004|New Participant Enrolled and Dosed|Part C: Period 3 (Day 1)||0||
59969456|NCT04604795|76086775|FG005|New Participant Enrolled and Dosed|Part C: Period 3 (Day 1)||0||
59969457|NCT04604795|76086776|FG006|New Participant Enrolled and Dosed|Part C: Period 3 (Day 1)||0||
59969458|NCT04604795|76086777|FG007|New Participant Enrolled and Dosed|Part C: Period 3 (Day 1)||0||
59969459|NCT04604795|76086778|FG008|New Participant Enrolled and Dosed|Part C: Period 3 (Day 1)||0||
59969460|NCT04604795|76086779|FG009|New Participant Enrolled and Dosed|Part C: Period 3 (Day 1)||1||
59969461|NCT04604795|76086770|FG000|COMPLETED|Part C: Period 3 (Day 1)||0||
59969462|NCT04604795|76086771|FG001|COMPLETED|Part C: Period 3 (Day 1)||0||
59969463|NCT04604795|76086772|FG002|COMPLETED|Part C: Period 3 (Day 1)||0||
59969464|NCT04604795|76086773|FG003|COMPLETED|Part C: Period 3 (Day 1)||0||
59969465|NCT04604795|76086774|FG004|COMPLETED|Part C: Period 3 (Day 1)||0||
59969466|NCT04604795|76086775|FG005|COMPLETED|Part C: Period 3 (Day 1)||0||
59969467|NCT04604795|76086776|FG006|COMPLETED|Part C: Period 3 (Day 1)||0||
59969468|NCT04604795|76086777|FG007|COMPLETED|Part C: Period 3 (Day 1)||0||
59969469|NCT04604795|76086778|FG008|COMPLETED|Part C: Period 3 (Day 1)||6||
59969470|NCT04604795|76086779|FG009|COMPLETED|Part C: Period 3 (Day 1)||6||
59969471|NCT04604795|76086770|FG000|NOT COMPLETED|Part C: Period 3 (Day 1)||0||
59969472|NCT04604795|76086771|FG001|NOT COMPLETED|Part C: Period 3 (Day 1)||0||
59969473|NCT04604795|76086772|FG002|NOT COMPLETED|Part C: Period 3 (Day 1)||0||
59969474|NCT04604795|76086773|FG003|NOT COMPLETED|Part C: Period 3 (Day 1)||0||
59969475|NCT04604795|76086774|FG004|NOT COMPLETED|Part C: Period 3 (Day 1)||0||
59969476|NCT04604795|76086775|FG005|NOT COMPLETED|Part C: Period 3 (Day 1)||0||
59969477|NCT04604795|76086776|FG006|NOT COMPLETED|Part C: Period 3 (Day 1)||0||
59810946|NCT00488631|75933148|FG002|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0||
59810947|NCT00488631|75933149|FG003|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0||
59810948|NCT00488631|75933150|FG004|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0||
59810949|NCT00488631|75933151|FG005|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0||
59810950|NCT00488631|75933152|FG006|NOT COMPLETED|Open Label Study Extension (Week 54-228)||80||
59810951|NCT00488631|75933153|FG007|NOT COMPLETED|Open Label Study Extension (Week 54-228)||27||
59810952|NCT00488631|75933154|FG008|NOT COMPLETED|Open Label Study Extension (Week 54-228)||182||
59810953|NCT00488631|75933155|FG009|NOT COMPLETED|Open Label Study Extension (Week 54-228)||3||
59810954|NCT00655499|75933178|FG000|STARTED|Overall Study||69||
59810955|NCT00655499|75933178|FG000|COMPLETED|Overall Study||65||
59810956|NCT00655499|75933178|FG000|NOT COMPLETED|Overall Study||4||
59810957|NCT00654875|75933185|FG000|STARTED|Overall Study||164||
59810958|NCT00654875|75933186|FG001|STARTED|Overall Study||164||
59810959|NCT00654875|75933185|FG000|COMPLETED|Overall Study||147||
59810960|NCT00654875|75933186|FG001|COMPLETED|Overall Study||147||
59810961|NCT00654875|75933185|FG000|NOT COMPLETED|Overall Study||17||
59810962|NCT00654875|75933186|FG001|NOT COMPLETED|Overall Study||17||
59810963|NCT00651755|75933192|FG000|STARTED|Cycle 1 (First 21 Days)||11||
59810964|NCT00651755|75933193|FG001|STARTED|Cycle 1 (First 21 Days)||9||
59810965|NCT00651755|75933192|FG000|COMPLETED|Cycle 1 (First 21 Days)||10||
59810966|NCT00651755|75933193|FG001|COMPLETED|Cycle 1 (First 21 Days)||9||
59810967|NCT00651755|75933192|FG000|NOT COMPLETED|Cycle 1 (First 21 Days)||1||
59810968|NCT00651755|75933193|FG001|NOT COMPLETED|Cycle 1 (First 21 Days)||0||
59810969|NCT00651755|75933192|FG000|STARTED|Cycle 2 (Second 21 Days)||10||
59810970|NCT00651755|75933193|FG001|STARTED|Cycle 2 (Second 21 Days)||9||
59969478|NCT04604795|76086777|FG007|NOT COMPLETED|Part C: Period 3 (Day 1)||0||
59969479|NCT04604795|76086778|FG008|NOT COMPLETED|Part C: Period 3 (Day 1)||0||
59969480|NCT04604795|76086779|FG009|NOT COMPLETED|Part C: Period 3 (Day 1)||0||
59969481|NCT04604795|76086770|FG000|STARTED|Part C: Washout Period 3 (Up to Day10)||0||
59969482|NCT04604795|76086771|FG001|STARTED|Part C: Washout Period 3 (Up to Day10)||0||
59969483|NCT04604795|76086772|FG002|STARTED|Part C: Washout Period 3 (Up to Day10)||0||
59969484|NCT04604795|76086773|FG003|STARTED|Part C: Washout Period 3 (Up to Day10)||0||
59810971|NCT00651755|75933192|FG000|COMPLETED|Cycle 2 (Second 21 Days)||10||
59810972|NCT00651755|75933193|FG001|COMPLETED|Cycle 2 (Second 21 Days)||8||
60074373|NCT01556763|76189761|FG002|STARTED|Overall Study||8||
60074374|NCT01556763|76189759|FG000|COMPLETED|Overall Study||4||
60074375|NCT01556763|76189760|FG001|COMPLETED|Overall Study||8||
60074376|NCT01556763|76189761|FG002|COMPLETED|Overall Study||8||
60074377|NCT01556763|76189759|FG000|NOT COMPLETED|Overall Study||0||
60074378|NCT01556763|76189760|FG001|NOT COMPLETED|Overall Study||1||
59525386|NCT00086138|75620726|FG000|NOT COMPLETED|Overall Study||4||
59525387|NCT00086138|75620727|FG001|NOT COMPLETED|Overall Study||3||
59525388|NCT00088634|75620735|FG000|STARTED|Overall Study||90||
59525389|NCT00088634|75620736|FG001|STARTED|Overall Study||90||
59525390|NCT00088634|75620735|FG000|COMPLETED|Overall Study||52||
59525391|NCT00088634|75620736|FG001|COMPLETED|Overall Study||47||
59525392|NCT00088634|75620735|FG000|NOT COMPLETED|Overall Study||38||
59810973|NCT00651755|75933192|FG000|NOT COMPLETED|Cycle 2 (Second 21 Days)||0||
59810974|NCT00651755|75933193|FG001|NOT COMPLETED|Cycle 2 (Second 21 Days)||1||
59810975|NCT00654641|75933202|FG000|STARTED|Overall Study||28||
59810976|NCT00654641|75933203|FG001|STARTED|Overall Study||26||
59810977|NCT00654641|75933202|FG000|COMPLETED|Overall Study||26||
59810978|NCT00654641|75933203|FG001|COMPLETED|Overall Study||23||
59810979|NCT00654641|75933202|FG000|NOT COMPLETED|Overall Study||2||
59810980|NCT00654641|75933203|FG001|NOT COMPLETED|Overall Study||3||
59810981|NCT00569777|75933211|FG000|STARTED|Overall Study||206||
59810982|NCT00569777|75933212|FG001|STARTED|Overall Study||104||
59810983|NCT00569777|75933211|FG000|COMPLETED|Overall Study||196||
59810984|NCT00569777|75933212|FG001|COMPLETED|Overall Study||101||
59810985|NCT00569777|75933211|FG000|NOT COMPLETED|Overall Study||10||
59810986|NCT00569777|75933212|FG001|NOT COMPLETED|Overall Study||3||
59810987|NCT00569231|75933218|FG000|STARTED|Overall Study||18||
59810988|NCT00569231|75933218|FG000|COMPLETED|Overall Study||11||
59810989|NCT00569231|75933218|FG000|NOT COMPLETED|Overall Study||7||
59810990|NCT00654095|75933222|FG000|STARTED|Overall Study||146||
59810991|NCT00654095|75933222|FG000|COMPLETED|Overall Study||114||
59810992|NCT00654095|75933222|FG000|NOT COMPLETED|Overall Study||32||
59810993|NCT00650585|75933228|FG000|STARTED|Overall Study||4348||
59810994|NCT00650585|75933229|FG001|STARTED|Overall Study||3990||
59810995|NCT00650585|75933228|FG000|COMPLETED|Overall Study|Completed posttest--a self-report survey administered 30 approximately 30 days after treatment|2551||
59810996|NCT00650585|75933229|FG001|COMPLETED|Overall Study|Completed posttest--a self-report survey administered 30 approximately 30 days after treatment|2513||
59810997|NCT00650585|75933228|FG000|NOT COMPLETED|Overall Study||1797||
59810998|NCT00650585|75933229|FG001|NOT COMPLETED|Overall Study||1477||
59810999|NCT00653939|75933237|FG000|STARTED|Overall Study|2 patients randomized did not receive treatment due to brain metastasis or consent withdrawal.|31||
59811000|NCT00653939|75933238|FG001|STARTED|Overall Study|1 patient randomized did not receive treatment due to acute renal failure.|32||
59811001|NCT00653939|75933237|FG000|COMPLETED|Overall Study||19||
59811002|NCT00653939|75933238|FG001|COMPLETED|Overall Study||17||
59811003|NCT00653939|75933237|FG000|NOT COMPLETED|Overall Study||12||
59811004|NCT00653939|75933238|FG001|NOT COMPLETED|Overall Study||15||
59525393|NCT00088634|75620736|FG001|NOT COMPLETED|Overall Study||43||
59525394|NCT00519818|75620742|FG000|STARTED|Overall Study||14||
59525395|NCT00519818|75620742|FG000|COMPLETED|Overall Study||14||
59525396|NCT00519818|75620742|FG000|NOT COMPLETED|Overall Study||0||
59525397|NCT00089102|75620748|FG000|STARTED|Overall Study||9||
59525398|NCT00089102|75620748|FG000|COMPLETED|Overall Study||9||
59811005|NCT00646451|75933246|FG000|STARTED|Overall Study||10||
59811006|NCT00646451|75933247|FG001|STARTED|Overall Study||10||
59811007|NCT00646451|75933246|FG000|COMPLETED|Overall Study||6||
59811008|NCT00646451|75933247|FG001|COMPLETED|Overall Study||10||
59811009|NCT00646451|75933246|FG000|NOT COMPLETED|Overall Study||4||
59811010|NCT00646451|75933247|FG001|NOT COMPLETED|Overall Study||0||
59811011|NCT00642707|75933259|FG000|STARTED|Overall Study||11||
59811012|NCT00642707|75933260|FG001|STARTED|Overall Study||11||
59811013|NCT00642707|75933261|FG002|STARTED|Overall Study||12||
59811014|NCT00642707|75933262|FG003|STARTED|Overall Study||10||
59811015|NCT00642707|75933259|FG000|COMPLETED|Overall Study||10||
59811016|NCT00642707|75933260|FG001|COMPLETED|Overall Study||11||
59811017|NCT00642707|75933261|FG002|COMPLETED|Overall Study||12||
59811018|NCT00642707|75933262|FG003|COMPLETED|Overall Study||8||
59811019|NCT00642707|75933259|FG000|NOT COMPLETED|Overall Study||1||
59811020|NCT00642707|75933260|FG001|NOT COMPLETED|Overall Study||0||
59811021|NCT00642707|75933261|FG002|NOT COMPLETED|Overall Study||0||
59811022|NCT00642707|75933262|FG003|NOT COMPLETED|Overall Study||2||
59525399|NCT00089102|75620748|FG000|NOT COMPLETED|Overall Study||0||
59525400|NCT00086450|75620754|FG000|STARTED|Overall Study||953||
59525401|NCT00086450|75620755|FG001|STARTED|Overall Study||947||
59811023|NCT00568685|75933275|FG000|STARTED|Overall Study||51||
59811024|NCT00568685|75933276|FG001|STARTED|Overall Study||51||
59811025|NCT00568685|75933277|FG002|STARTED|Overall Study||51||
59811026|NCT00568685|75933275|FG000|COMPLETED|Overall Study||41||
59811027|NCT00568685|75933276|FG001|COMPLETED|Overall Study||46||
59811028|NCT00568685|75933277|FG002|COMPLETED|Overall Study||46||
59811029|NCT00568685|75933275|FG000|NOT COMPLETED|Overall Study||10||
59811030|NCT00568685|75933276|FG001|NOT COMPLETED|Overall Study||5||
59811031|NCT00568685|75933277|FG002|NOT COMPLETED|Overall Study||5||
60074379|NCT01556763|76189761|FG002|NOT COMPLETED|Overall Study||0||
59621900|NCT00321594|75733603|FG001|COMPLETED|Phase II, MTD Dose||0||
59621901|NCT00321594|75733604|FG002|COMPLETED|Phase II, MTD Dose||0||
59621902|NCT00321594|75733605|FG003|COMPLETED|Phase II, MTD Dose||6||
59621903|NCT00321594|75733606|FG004|COMPLETED|Phase II, MTD Dose||36||
59621904|NCT00321594|75733602|FG000|NOT COMPLETED|Phase II, MTD Dose||0||
59969485|NCT04604795|76086774|FG004|STARTED|Part C: Washout Period 3 (Up to Day10)||0||
59969486|NCT04604795|76086775|FG005|STARTED|Part C: Washout Period 3 (Up to Day10)||0||
59969487|NCT04604795|76086776|FG006|STARTED|Part C: Washout Period 3 (Up to Day10)||0||
59969488|NCT04604795|76086777|FG007|STARTED|Part C: Washout Period 3 (Up to Day10)||0||
59969489|NCT04604795|76086778|FG008|STARTED|Part C: Washout Period 3 (Up to Day10)||6||
59969490|NCT04604795|76086779|FG009|STARTED|Part C: Washout Period 3 (Up to Day10)||6||
59969491|NCT04604795|76086770|FG000|COMPLETED|Part C: Washout Period 3 (Up to Day10)||0||
59969492|NCT04604795|76086771|FG001|COMPLETED|Part C: Washout Period 3 (Up to Day10)||0||
59969493|NCT04604795|76086772|FG002|COMPLETED|Part C: Washout Period 3 (Up to Day10)||0||
59969494|NCT04604795|76086773|FG003|COMPLETED|Part C: Washout Period 3 (Up to Day10)||0||
59969495|NCT04604795|76086774|FG004|COMPLETED|Part C: Washout Period 3 (Up to Day10)||0||
59969496|NCT04604795|76086775|FG005|COMPLETED|Part C: Washout Period 3 (Up to Day10)||0||
59969497|NCT04604795|76086776|FG006|COMPLETED|Part C: Washout Period 3 (Up to Day10)||0||
59969498|NCT04604795|76086777|FG007|COMPLETED|Part C: Washout Period 3 (Up to Day10)||0||
59969499|NCT04604795|76086778|FG008|COMPLETED|Part C: Washout Period 3 (Up to Day10)||5||
59969500|NCT04604795|76086779|FG009|COMPLETED|Part C: Washout Period 3 (Up to Day10)||6||
59969501|NCT04604795|76086770|FG000|NOT COMPLETED|Part C: Washout Period 3 (Up to Day10)||0||
59969502|NCT04604795|76086771|FG001|NOT COMPLETED|Part C: Washout Period 3 (Up to Day10)||0||
59969503|NCT04604795|76086772|FG002|NOT COMPLETED|Part C: Washout Period 3 (Up to Day10)||0||
59969504|NCT04604795|76086773|FG003|NOT COMPLETED|Part C: Washout Period 3 (Up to Day10)||0||
59969505|NCT04604795|76086774|FG004|NOT COMPLETED|Part C: Washout Period 3 (Up to Day10)||0||
59969506|NCT04604795|76086775|FG005|NOT COMPLETED|Part C: Washout Period 3 (Up to Day10)||0||
59969507|NCT04604795|76086776|FG006|NOT COMPLETED|Part C: Washout Period 3 (Up to Day10)||0||
59969508|NCT04604795|76086777|FG007|NOT COMPLETED|Part C: Washout Period 3 (Up to Day10)||0||
59969509|NCT04604795|76086778|FG008|NOT COMPLETED|Part C: Washout Period 3 (Up to Day10)||1||
59969510|NCT04604795|76086779|FG009|NOT COMPLETED|Part C: Washout Period 3 (Up to Day10)||0||
59969511|NCT04604795|76086770|FG000|STARTED|Part C: Period 4 (Day 1)||0||
59969512|NCT04604795|76086771|FG001|STARTED|Part C: Period 4 (Day 1)||0||
59969513|NCT04604795|76086772|FG002|STARTED|Part C: Period 4 (Day 1)||0||
59969514|NCT04604795|76086773|FG003|STARTED|Part C: Period 4 (Day 1)||0||
59969515|NCT04604795|76086774|FG004|STARTED|Part C: Period 4 (Day 1)||0||
59969516|NCT04604795|76086775|FG005|STARTED|Part C: Period 4 (Day 1)||0||
59969517|NCT04604795|76086776|FG006|STARTED|Part C: Period 4 (Day 1)||0||
59969518|NCT04604795|76086777|FG007|STARTED|Part C: Period 4 (Day 1)||0||
59969519|NCT04604795|76086778|FG008|STARTED|Part C: Period 4 (Day 1)||5||
59969520|NCT04604795|76086779|FG009|STARTED|Part C: Period 4 (Day 1)||6||
59969521|NCT04604795|76086770|FG000|COMPLETED|Part C: Period 4 (Day 1)||0||
59969522|NCT04604795|76086771|FG001|COMPLETED|Part C: Period 4 (Day 1)||0||
59969523|NCT04604795|76086772|FG002|COMPLETED|Part C: Period 4 (Day 1)||0||
59969524|NCT04604795|76086773|FG003|COMPLETED|Part C: Period 4 (Day 1)||0||
59969525|NCT04604795|76086774|FG004|COMPLETED|Part C: Period 4 (Day 1)||0||
59621905|NCT00321594|75733603|FG001|NOT COMPLETED|Phase II, MTD Dose||0||
59621906|NCT00321594|75733604|FG002|NOT COMPLETED|Phase II, MTD Dose||0||
59621907|NCT00321594|75733605|FG003|NOT COMPLETED|Phase II, MTD Dose||0||
59621908|NCT00321594|75733606|FG004|NOT COMPLETED|Phase II, MTD Dose||0||
59621909|NCT00390234|75733618|FG000|STARTED|Overall Study||63||
59811032|NCT00061945|75933291|FG000|STARTED|Registration Through Course 3||119||
59811033|NCT00061945|75933292|FG001|STARTED|Registration Through Course 3||181||
59811034|NCT00061945|75933291|FG000|COMPLETED|Registration Through Course 3||25||
59811035|NCT00061945|75933292|FG001|COMPLETED|Registration Through Course 3||66||
59811036|NCT00061945|75933291|FG000|NOT COMPLETED|Registration Through Course 3||94||
59811037|NCT00061945|75933292|FG001|NOT COMPLETED|Registration Through Course 3||115||
59621910|NCT00390234|75733618|FG000|COMPLETED|Overall Study||63||
59621911|NCT00390234|75733618|FG000|NOT COMPLETED|Overall Study||0||
59621912|NCT00391716|75733626|FG000|STARTED|Overall Study||54||
59621913|NCT00391716|75733627|FG001|STARTED|Overall Study||47||
59621914|NCT00391716|75733628|FG002|STARTED|Overall Study||49||
59621915|NCT00391716|75733626|FG000|COMPLETED|Overall Study||27||
59621916|NCT00391716|75733627|FG001|COMPLETED|Overall Study||28||
59621917|NCT00391716|75733628|FG002|COMPLETED|Overall Study||30||
59621918|NCT00391716|75733626|FG000|NOT COMPLETED|Overall Study||27||
59621919|NCT00391716|75733627|FG001|NOT COMPLETED|Overall Study||19||
59621920|NCT00391716|75733628|FG002|NOT COMPLETED|Overall Study||19||
59811038|NCT00061945|75933291|FG000|STARTED|Course IV: Alemtuzumab||25||
59811039|NCT00061945|75933292|FG001|STARTED|Course IV: Alemtuzumab||66||
59621921|NCT00392496|75733636|FG000|STARTED|Overall Study||19||
59621922|NCT00392496|75733636|FG000|COMPLETED|Overall Study||19||
59621923|NCT00392496|75733636|FG000|NOT COMPLETED|Overall Study||0||
59621924|NCT00393978|75733642|FG000|STARTED|Overall Study||37||
59621925|NCT00393978|75733643|FG001|STARTED|Overall Study||38||
59811040|NCT00061945|75933291|FG000|COMPLETED|Course IV: Alemtuzumab||18||
59969526|NCT04604795|76086775|FG005|COMPLETED|Part C: Period 4 (Day 1)||0||
59969527|NCT04604795|76086776|FG006|COMPLETED|Part C: Period 4 (Day 1)||0||
59969528|NCT04604795|76086777|FG007|COMPLETED|Part C: Period 4 (Day 1)||0||
59969529|NCT04604795|76086778|FG008|COMPLETED|Part C: Period 4 (Day 1)||5||
59969530|NCT04604795|76086779|FG009|COMPLETED|Part C: Period 4 (Day 1)||6||
59969531|NCT04604795|76086770|FG000|NOT COMPLETED|Part C: Period 4 (Day 1)||0||
59969532|NCT04604795|76086771|FG001|NOT COMPLETED|Part C: Period 4 (Day 1)||0||
59969533|NCT04604795|76086772|FG002|NOT COMPLETED|Part C: Period 4 (Day 1)||0||
59969534|NCT04604795|76086773|FG003|NOT COMPLETED|Part C: Period 4 (Day 1)||0||
59969535|NCT04604795|76086774|FG004|NOT COMPLETED|Part C: Period 4 (Day 1)||0||
59969536|NCT04604795|76086775|FG005|NOT COMPLETED|Part C: Period 4 (Day 1)||0||
59969537|NCT04604795|76086776|FG006|NOT COMPLETED|Part C: Period 4 (Day 1)||0||
59969538|NCT04604795|76086777|FG007|NOT COMPLETED|Part C: Period 4 (Day 1)||0||
59969539|NCT04604795|76086778|FG008|NOT COMPLETED|Part C: Period 4 (Day 1)||0||
59969540|NCT04604795|76086779|FG009|NOT COMPLETED|Part C: Period 4 (Day 1)||0||
59969541|NCT04604795|76086770|FG000|STARTED|Part C: Washout Period 4 (Up to Day 13)||0||
59969542|NCT04604795|76086771|FG001|STARTED|Part C: Washout Period 4 (Up to Day 13)||0||
59969543|NCT04604795|76086772|FG002|STARTED|Part C: Washout Period 4 (Up to Day 13)||0||
59969544|NCT04604795|76086773|FG003|STARTED|Part C: Washout Period 4 (Up to Day 13)||0||
59969545|NCT04604795|76086774|FG004|STARTED|Part C: Washout Period 4 (Up to Day 13)||0||
59969546|NCT04604795|76086775|FG005|STARTED|Part C: Washout Period 4 (Up to Day 13)||0||
59969547|NCT04604795|76086776|FG006|STARTED|Part C: Washout Period 4 (Up to Day 13)||0||
59969548|NCT04604795|76086777|FG007|STARTED|Part C: Washout Period 4 (Up to Day 13)||0||
59969549|NCT04604795|76086778|FG008|STARTED|Part C: Washout Period 4 (Up to Day 13)||5||
59621926|NCT00393978|75733642|FG000|COMPLETED|Overall Study||21||
59621927|NCT00393978|75733643|FG001|COMPLETED|Overall Study||18||
59621928|NCT00393978|75733642|FG000|NOT COMPLETED|Overall Study||16||
59621929|NCT00393978|75733643|FG001|NOT COMPLETED|Overall Study||20||
59621930|NCT00396006|75733649|FG000|STARTED|Overall Study||13||
59621931|NCT00396006|75733649|FG000|COMPLETED|Overall Study||13||
59621932|NCT00396006|75733649|FG000|NOT COMPLETED|Overall Study||0||
59969550|NCT04604795|76086779|FG009|STARTED|Part C: Washout Period 4 (Up to Day 13)||6||
59969551|NCT04604795|76086770|FG000|COMPLETED|Part C: Washout Period 4 (Up to Day 13)||0||
59969552|NCT04604795|76086771|FG001|COMPLETED|Part C: Washout Period 4 (Up to Day 13)||0||
59969553|NCT04604795|76086772|FG002|COMPLETED|Part C: Washout Period 4 (Up to Day 13)||0||
59969554|NCT04604795|76086773|FG003|COMPLETED|Part C: Washout Period 4 (Up to Day 13)||0||
59969555|NCT04604795|76086774|FG004|COMPLETED|Part C: Washout Period 4 (Up to Day 13)||0||
59969556|NCT04604795|76086775|FG005|COMPLETED|Part C: Washout Period 4 (Up to Day 13)||0||
59969557|NCT04604795|76086776|FG006|COMPLETED|Part C: Washout Period 4 (Up to Day 13)||0||
59969558|NCT04604795|76086777|FG007|COMPLETED|Part C: Washout Period 4 (Up to Day 13)||0||
59969559|NCT04604795|76086778|FG008|COMPLETED|Part C: Washout Period 4 (Up to Day 13)||4||
59969560|NCT04604795|76086779|FG009|COMPLETED|Part C: Washout Period 4 (Up to Day 13)||6||
59969561|NCT04604795|76086770|FG000|NOT COMPLETED|Part C: Washout Period 4 (Up to Day 13)||0||
59969562|NCT04604795|76086771|FG001|NOT COMPLETED|Part C: Washout Period 4 (Up to Day 13)||0||
59969563|NCT04604795|76086772|FG002|NOT COMPLETED|Part C: Washout Period 4 (Up to Day 13)||0||
59969564|NCT04604795|76086773|FG003|NOT COMPLETED|Part C: Washout Period 4 (Up to Day 13)||0||
59969565|NCT04604795|76086774|FG004|NOT COMPLETED|Part C: Washout Period 4 (Up to Day 13)||0||
59969566|NCT04604795|76086775|FG005|NOT COMPLETED|Part C: Washout Period 4 (Up to Day 13)||0||
59969567|NCT04604795|76086776|FG006|NOT COMPLETED|Part C: Washout Period 4 (Up to Day 13)||0||
59969568|NCT04604795|76086777|FG007|NOT COMPLETED|Part C: Washout Period 4 (Up to Day 13)||0||
59969569|NCT04604795|76086778|FG008|NOT COMPLETED|Part C: Washout Period 4 (Up to Day 13)||1||
59969570|NCT04604795|76086779|FG009|NOT COMPLETED|Part C: Washout Period 4 (Up to Day 13)||0||
59969571|NCT04604795|76086770|FG000|STARTED|Part C: Period 5 (Day 1)||0||
59969572|NCT04604795|76086771|FG001|STARTED|Part C: Period 5 (Day 1)||0||
59969573|NCT04604795|76086772|FG002|STARTED|Part C: Period 5 (Day 1)||0||
59969574|NCT04604795|76086773|FG003|STARTED|Part C: Period 5 (Day 1)||0||
59969575|NCT04604795|76086774|FG004|STARTED|Part C: Period 5 (Day 1)||0||
59969576|NCT04604795|76086775|FG005|STARTED|Part C: Period 5 (Day 1)||0||
59969577|NCT04604795|76086776|FG006|STARTED|Part C: Period 5 (Day 1)||0||
59969578|NCT04604795|76086777|FG007|STARTED|Part C: Period 5 (Day 1)||0||
59969579|NCT04604795|76086778|FG008|STARTED|Part C: Period 5 (Day 1)||4||
59969580|NCT04604795|76086779|FG009|STARTED|Part C: Period 5 (Day 1)||6||
59969581|NCT04604795|76086770|FG000|COMPLETED|Part C: Period 5 (Day 1)||0||
59969582|NCT04604795|76086771|FG001|COMPLETED|Part C: Period 5 (Day 1)||0||
59969583|NCT04604795|76086772|FG002|COMPLETED|Part C: Period 5 (Day 1)||0||
59969584|NCT04604795|76086773|FG003|COMPLETED|Part C: Period 5 (Day 1)||0||
59969585|NCT04604795|76086774|FG004|COMPLETED|Part C: Period 5 (Day 1)||0||
59969586|NCT04604795|76086775|FG005|COMPLETED|Part C: Period 5 (Day 1)||0||
59621933|NCT00397020|75733656|FG000|STARTED|Overall Study||14||
59969587|NCT04604795|76086776|FG006|COMPLETED|Part C: Period 5 (Day 1)||0||
59969588|NCT04604795|76086777|FG007|COMPLETED|Part C: Period 5 (Day 1)||0||
59811041|NCT00061945|75933292|FG001|COMPLETED|Course IV: Alemtuzumab||50||
59811042|NCT00061945|75933291|FG000|NOT COMPLETED|Course IV: Alemtuzumab||7||
59811043|NCT00061945|75933292|FG001|NOT COMPLETED|Course IV: Alemtuzumab||16||
59969589|NCT04604795|76086778|FG008|COMPLETED|Part C: Period 5 (Day 1)||3||
59969590|NCT04604795|76086779|FG009|COMPLETED|Part C: Period 5 (Day 1)||6||
59969591|NCT04604795|76086770|FG000|NOT COMPLETED|Part C: Period 5 (Day 1)||0||
59969592|NCT04604795|76086771|FG001|NOT COMPLETED|Part C: Period 5 (Day 1)||0||
59969593|NCT04604795|76086772|FG002|NOT COMPLETED|Part C: Period 5 (Day 1)||0||
59969594|NCT04604795|76086773|FG003|NOT COMPLETED|Part C: Period 5 (Day 1)||0||
59969595|NCT04604795|76086774|FG004|NOT COMPLETED|Part C: Period 5 (Day 1)||0||
59969596|NCT04604795|76086775|FG005|NOT COMPLETED|Part C: Period 5 (Day 1)||0||
59969597|NCT04604795|76086776|FG006|NOT COMPLETED|Part C: Period 5 (Day 1)||0||
59969598|NCT04604795|76086777|FG007|NOT COMPLETED|Part C: Period 5 (Day 1)||0||
59969599|NCT04604795|76086778|FG008|NOT COMPLETED|Part C: Period 5 (Day 1)||1||
59969600|NCT04604795|76086779|FG009|NOT COMPLETED|Part C: Period 5 (Day 1)||0||
59969601|NCT04560088|76086824|FG000|STARTED|Overall Study||24||
59969602|NCT04560088|76086825|FG001|STARTED|Overall Study||31||
59969603|NCT04560088|76086824|FG000|COMPLETED|Overall Study||19||
59969604|NCT04560088|76086825|FG001|COMPLETED|Overall Study||30||
59969605|NCT04560088|76086824|FG000|NOT COMPLETED|Overall Study||5||
59969606|NCT04560088|76086825|FG001|NOT COMPLETED|Overall Study||1||
59969607|NCT04535141|76086833|FG000|STARTED|Overall Study||46||
59969608|NCT04535141|76086834|FG001|STARTED|Overall Study||45||
59969609|NCT04535141|76086833|FG000|COMPLETED|Overall Study||46||
59969610|NCT04535141|76086834|FG001|COMPLETED|Overall Study||45||
59969611|NCT04535141|76086833|FG000|NOT COMPLETED|Overall Study||0||
59969612|NCT04535141|76086834|FG001|NOT COMPLETED|Overall Study||0||
59969613|NCT04374500|76086850|FG000|STARTED|Overall Study||10|Recruitment and study procedures in all protocols were performed in 2006|
59969614|NCT04374500|76086851|FG001|STARTED|Overall Study||10|Recruitment and study procedures in all protocols were performed in 2006|
59969615|NCT04374500|76086852|FG002|STARTED|Overall Study||83|Recruitment and study procedures in all protocols were performed in 2006|
59969616|NCT04374500|76086850|FG000|COMPLETED|Overall Study|10 men completed the study.|10||
59969617|NCT04374500|76086851|FG001|COMPLETED|Overall Study|10 men completed 20 examinations.|10||
59969618|NCT04374500|76086852|FG002|COMPLETED|Overall Study|83 men and women competed 83 examinations.|83||
59969619|NCT04374500|76086850|FG000|NOT COMPLETED|Overall Study||0||
60074380|NCT01576575|76189771|FG000|STARTED|Buprenorphine Control||21||
59525402|NCT00086450|75620754|FG000|COMPLETED|Overall Study||953||
59811044|NCT00642473|75933303|FG000|STARTED|Overall Study||18||
59811045|NCT00642473|75933304|FG001|STARTED|Overall Study||16||
59811046|NCT00642473|75933303|FG000|COMPLETED|Overall Study||14||
59811047|NCT00642473|75933304|FG001|COMPLETED|Overall Study||5||
59969620|NCT04374500|76086851|FG001|NOT COMPLETED|Overall Study||0||
59969621|NCT04374500|76086852|FG002|NOT COMPLETED|Overall Study||0||
59969622|NCT04314284|76086875|FG000|STARTED|Overall Study||69||
59969623|NCT04314284|76086876|FG001|STARTED|Overall Study||81||
59969624|NCT04314284|76086875|FG000|COMPLETED|Overall Study||65||
59969625|NCT04314284|76086876|FG001|COMPLETED|Overall Study||68||
59969626|NCT04314284|76086875|FG000|NOT COMPLETED|Overall Study||4||
59969627|NCT04314284|76086876|FG001|NOT COMPLETED|Overall Study||13||
59969628|NCT04203823|76086884|FG000|STARTED|Overall Study||54||
59969629|NCT04203823|76086885|FG001|STARTED|Overall Study||72||
59969630|NCT04203823|76086884|FG000|COMPLETED|Overall Study||51||
59969631|NCT04203823|76086885|FG001|COMPLETED|Overall Study||65||
59969632|NCT04203823|76086884|FG000|NOT COMPLETED|Overall Study||3||
59969633|NCT04203823|76086885|FG001|NOT COMPLETED|Overall Study||7||
59969634|NCT04162899|76086894|FG000|STARTED|Overall Study||35||
59969635|NCT04162899|76086895|FG001|STARTED|Overall Study||35||
59969636|NCT04162899|76086896|FG002|STARTED|Overall Study||35||
59969637|NCT04162899|76086894|FG000|COMPLETED|Overall Study||29||
60074381|NCT01576575|76189771|FG000|COMPLETED|Buprenorphine Control||18||
60074382|NCT01576575|76189771|FG000|NOT COMPLETED|Buprenorphine Control||3||
60074383|NCT01576575|76189771|FG000|STARTED|Buprenorphine + Rifampin||18||
59811048|NCT00642473|75933303|FG000|NOT COMPLETED|Overall Study||4||
59811049|NCT00642473|75933304|FG001|NOT COMPLETED|Overall Study||11||
59811050|NCT00645671|75933315|FG000|STARTED|Overall Study||201||
59811051|NCT00645671|75933316|FG001|STARTED|Overall Study||199||
59811052|NCT00645671|75933315|FG000|COMPLETED|Overall Study||200||
59811053|NCT00645671|75933316|FG001|COMPLETED|Overall Study||193||
59969638|NCT04162899|76086895|FG001|COMPLETED|Overall Study||32||
59969639|NCT04162899|76086896|FG002|COMPLETED|Overall Study||23||
59969640|NCT04162899|76086894|FG000|NOT COMPLETED|Overall Study||6||
59969641|NCT04162899|76086895|FG001|NOT COMPLETED|Overall Study||3||
59969642|NCT04162899|76086896|FG002|NOT COMPLETED|Overall Study||12||
60074384|NCT01576575|76189771|FG000|COMPLETED|Buprenorphine + Rifampin||15||
59525403|NCT00086450|75620755|FG001|COMPLETED|Overall Study||947||
59525404|NCT00086450|75620754|FG000|NOT COMPLETED|Overall Study||0||
59525405|NCT00086450|75620755|FG001|NOT COMPLETED|Overall Study||0||
59811054|NCT00645671|75933315|FG000|NOT COMPLETED|Overall Study||1||
59811055|NCT00645671|75933316|FG001|NOT COMPLETED|Overall Study||6||
60103600|NCT01291108|76221863|FG000|STARTED|Month 1 (Monotherapy)||65||
59811056|NCT00366340|75933324|FG000|STARTED|Infant Series||301||
59811057|NCT00366340|75933325|FG001|STARTED|Infant Series||303||
59811058|NCT00366340|75933324|FG000|Vaccinated Dose 1|Infant Series||300||
59525406|NCT00093782|75620761|FG000|STARTED|Overall Study||36||
59525407|NCT00093782|75620761|FG000|COMPLETED|Overall Study||36||
59525408|NCT00093782|75620761|FG000|NOT COMPLETED|Overall Study||0||
59525409|NCT00096122|75620765|FG000|STARTED|Overall Study||95||
59525410|NCT00096122|75620765|FG000|COMPLETED|Overall Study||95||
59525411|NCT00096122|75620765|FG000|NOT COMPLETED|Overall Study||0||
59525412|NCT00014222|75620772|FG000|STARTED|Overall Study||701||
59525413|NCT00014222|75620773|FG001|STARTED|Overall Study||701||
59525414|NCT00014222|75620774|FG002|STARTED|Overall Study||702||
59525415|NCT00014222|75620772|FG000|COMPLETED|Overall Study||680|Only 2043 patients reported toxicity data.|
59525416|NCT00014222|75620773|FG001|COMPLETED|Overall Study||688|Only 2043 patients reported toxicity data.|
59525417|NCT00014222|75620774|FG002|COMPLETED|Overall Study||675|Only 2043 patients reported toxicity data.|
59525418|NCT00014222|75620772|FG000|NOT COMPLETED|Overall Study||21||
59525419|NCT00014222|75620773|FG001|NOT COMPLETED|Overall Study||13||
59525420|NCT00014222|75620774|FG002|NOT COMPLETED|Overall Study||27||
59525421|NCT05245526|75620782|FG000|STARTED|Overall Study||12||
59525422|NCT05245526|75620782|FG000|COMPLETED|Overall Study||12||
59525423|NCT05245526|75620782|FG000|NOT COMPLETED|Overall Study||0||
59525424|NCT04733157|75620790|FG000|STARTED|Overall Study||613||
59525425|NCT04733157|75620791|FG001|STARTED|Overall Study||613||
59525426|NCT04733157|75620790|FG000|COMPLETED|Overall Study||611||
59525427|NCT04733157|75620791|FG001|COMPLETED|Overall Study||613||
59525428|NCT04733157|75620790|FG000|NOT COMPLETED|Overall Study||2||
59525429|NCT04733157|75620791|FG001|NOT COMPLETED|Overall Study||0||
59525430|NCT04591171|75620797|FG000|STARTED|Overall Study||9||
59525431|NCT04591171|75620797|FG000|COMPLETED|Overall Study||9||
59811059|NCT00366340|75933325|FG001|Vaccinated Dose 1|Infant Series||303||
59811060|NCT00366340|75933324|FG000|Vaccinated Dose 2|Infant Series||296||
59811061|NCT00366340|75933325|FG001|Vaccinated Dose 2|Infant Series||297||
59811062|NCT00366340|75933324|FG000|Vaccinated Dose 3|Infant Series||294||
59811063|NCT00366340|75933325|FG001|Vaccinated Dose 3|Infant Series||293||
59811064|NCT00366340|75933324|FG000|COMPLETED|Infant Series||293||
59811065|NCT00366340|75933325|FG001|COMPLETED|Infant Series||293||
59969643|NCT03896633|76086906|FG000|STARTED|Overall Study||321||
59969644|NCT03896633|76086907|FG001|STARTED|Overall Study||316||
59969645|NCT03896633|76086906|FG000|COMPLETED|Overall Study||312||
60074385|NCT01576575|76189771|FG000|NOT COMPLETED|Buprenorphine + Rifampin||3||
59969646|NCT03896633|76086907|FG001|COMPLETED|Overall Study||306||
59969647|NCT03896633|76086906|FG000|NOT COMPLETED|Overall Study||9||
59969648|NCT03896633|76086907|FG001|NOT COMPLETED|Overall Study||10||
59969649|NCT03823131|76086916|FG000|STARTED|Overall Study||14||
59969650|NCT03823131|76086917|FG001|STARTED|Overall Study||0||
59969651|NCT03823131|76086918|FG002|STARTED|Overall Study||0||
59969652|NCT03823131|76086916|FG000|COMPLETED|Overall Study||14||
59969653|NCT03823131|76086917|FG001|COMPLETED|Overall Study||0||
59969654|NCT03823131|76086918|FG002|COMPLETED|Overall Study||0||
59969655|NCT03823131|76086916|FG000|NOT COMPLETED|Overall Study||0||
59969656|NCT03823131|76086917|FG001|NOT COMPLETED|Overall Study||0||
59969657|NCT03823131|76086918|FG002|NOT COMPLETED|Overall Study||0||
59969658|NCT03728504|76086925|FG000|STARTED|Overall Study||33||
60074386|NCT01576575|76189771|FG000|STARTED|Buprenorphine + Grapefruit||15||
60103601|NCT01291108|76221864|FG001|STARTED|Month 1 (Monotherapy)||0||
59525432|NCT04591171|75620797|FG000|NOT COMPLETED|Overall Study||0||
59525433|NCT04396834|75620803|FG000|STARTED|Overall Study||1||
59525434|NCT04396834|75620804|FG001|STARTED|Overall Study||1||
59525435|NCT04396834|75620803|FG000|COMPLETED|Overall Study||1||
59525436|NCT04396834|75620804|FG001|COMPLETED|Overall Study||1||
59525437|NCT04396834|75620803|FG000|NOT COMPLETED|Overall Study||0||
59525438|NCT04396834|75620804|FG001|NOT COMPLETED|Overall Study||0||
59525439|NCT04179968|75620810|FG000|STARTED|Overall Study||20||
59525440|NCT04179968|75620810|FG000|COMPLETED|Overall Study||19||
59525441|NCT04179968|75620810|FG000|NOT COMPLETED|Overall Study||1||
59525442|NCT03951753|75620817|FG000|STARTED|Overall Study||45||
59525443|NCT03951753|75620818|FG001|STARTED|Overall Study||44||
59525444|NCT03951753|75620819|FG002|STARTED|Overall Study||28||
59525445|NCT03951753|75620817|FG000|COMPLETED|Overall Study||41||
59525446|NCT03951753|75620818|FG001|COMPLETED|Overall Study||43||
59525447|NCT03951753|75620819|FG002|COMPLETED|Overall Study||24||
59525448|NCT03951753|75620817|FG000|NOT COMPLETED|Overall Study||4||
59525449|NCT03951753|75620818|FG001|NOT COMPLETED|Overall Study||1||
59525450|NCT03951753|75620819|FG002|NOT COMPLETED|Overall Study||4||
59525451|NCT03941964|75620829|FG000|STARTED|Overall Study||30||
59525452|NCT03941964|75620830|FG001|STARTED|Overall Study||30||
59525453|NCT03941964|75620829|FG000|COMPLETED|Overall Study||7||
59525454|NCT03941964|75620830|FG001|COMPLETED|Overall Study||11||
59525455|NCT03941964|75620829|FG000|NOT COMPLETED|Overall Study||23||
59525456|NCT03941964|75620830|FG001|NOT COMPLETED|Overall Study||19||
59969659|NCT03728504|76086926|FG001|STARTED|Overall Study||32||
59811066|NCT00366340|75933324|FG000|NOT COMPLETED|Infant Series||8||
59811067|NCT00366340|75933325|FG001|NOT COMPLETED|Infant Series||10||
59811068|NCT00366340|75933324|FG000|STARTED|After the Infant Series||293||
59969660|NCT03728504|76086927|FG002|STARTED|Overall Study||32||
59811069|NCT00366340|75933325|FG001|STARTED|After the Infant Series||293||
59811070|NCT00366340|75933324|FG000|COMPLETED|After the Infant Series||290||
59811071|NCT00366340|75933325|FG001|COMPLETED|After the Infant Series||287||
59811072|NCT00366340|75933324|FG000|NOT COMPLETED|After the Infant Series||3||
59811073|NCT00366340|75933325|FG001|NOT COMPLETED|After the Infant Series||6||
59811074|NCT00366340|75933324|FG000|STARTED|Toddler Dose||290||
59969661|NCT03728504|76086925|FG000|COMPLETED|Overall Study||27||
59969662|NCT03728504|76086926|FG001|COMPLETED|Overall Study||19||
59969663|NCT03728504|76086927|FG002|COMPLETED|Overall Study||22||
59969664|NCT03728504|76086925|FG000|NOT COMPLETED|Overall Study||6||
59969665|NCT03728504|76086926|FG001|NOT COMPLETED|Overall Study||13||
59969666|NCT03728504|76086927|FG002|NOT COMPLETED|Overall Study||10||
59969667|NCT03703466|76086938|FG000|STARTED|Overall Study||24||
59811075|NCT00366340|75933325|FG001|STARTED|Toddler Dose||287||
59811076|NCT00366340|75933324|FG000|COMPLETED|Toddler Dose||289||
59811077|NCT00366340|75933325|FG001|COMPLETED|Toddler Dose||286||
59811078|NCT00366340|75933324|FG000|NOT COMPLETED|Toddler Dose||1||
59811079|NCT00366340|75933325|FG001|NOT COMPLETED|Toddler Dose||1||
59811080|NCT00061633|75933357|FG000|STARTED|Overall Study||84||
59811081|NCT00061633|75933358|FG001|STARTED|Overall Study||85||
59811082|NCT00061633|75933357|FG000|COMPLETED|Overall Study||79||
59811083|NCT00061633|75933358|FG001|COMPLETED|Overall Study||74||
59811084|NCT00061633|75933357|FG000|NOT COMPLETED|Overall Study||5||
59811085|NCT00061633|75933358|FG001|NOT COMPLETED|Overall Study||11||
59811086|NCT00645593|75933366|FG000|STARTED|Overall Study||29||
59811087|NCT00645593|75933367|FG001|STARTED|Overall Study||60||
59811088|NCT00645593|75933366|FG000|COMPLETED|Overall Study||28||
59811089|NCT00645593|75933367|FG001|COMPLETED|Overall Study||60||
59811090|NCT00645593|75933366|FG000|NOT COMPLETED|Overall Study||1||
59811091|NCT00645593|75933367|FG001|NOT COMPLETED|Overall Study||0||
59811092|NCT03832738|75933376|FG000|STARTED|Overall Study||51||
59811093|NCT03832738|75933377|FG001|STARTED|Overall Study||50||
59811094|NCT03832738|75933378|FG002|STARTED|Overall Study||51||
59811095|NCT03832738|75933376|FG000|COMPLETED|Overall Study||43||
59811096|NCT03832738|75933377|FG001|COMPLETED|Overall Study||38||
59811097|NCT03832738|75933378|FG002|COMPLETED|Overall Study||32||
59811098|NCT03832738|75933376|FG000|NOT COMPLETED|Overall Study||8||
59811099|NCT03832738|75933377|FG001|NOT COMPLETED|Overall Study||12||
59811100|NCT03832738|75933378|FG002|NOT COMPLETED|Overall Study||19||
59811101|NCT00046891|75933388|FG000|STARTED|Overall Study||113||
59811102|NCT00046891|75933389|FG001|STARTED|Overall Study||113||
59811103|NCT00046891|75933388|FG000|COMPLETED|Overall Study||84||
59811104|NCT00046891|75933389|FG001|COMPLETED|Overall Study||83||
59811105|NCT00046891|75933388|FG000|NOT COMPLETED|Overall Study||29||
59811106|NCT00046891|75933389|FG001|NOT COMPLETED|Overall Study||30||
59811107|NCT00365794|75933403|FG000|STARTED|Overall Study|22 subjects were enrolled since only 20 completed all post treatment measures.|22|All milestones were met 1) target number enrolled and 2) all finished study therapy and measurements|
59811108|NCT00365794|75933403|FG000|COMPLETED|Overall Study||20||
59811109|NCT00365794|75933403|FG000|NOT COMPLETED|Overall Study||2||
59811110|NCT00383500|75933411|FG000|STARTED|Overall Study||27||
59811111|NCT00383500|75933412|FG001|STARTED|Overall Study||24||
59811112|NCT00383500|75933413|FG002|STARTED|Overall Study||24||
59811113|NCT00383500|75933411|FG000|COMPLETED|Overall Study||19||
59811114|NCT00383500|75933412|FG001|COMPLETED|Overall Study||21||
59811115|NCT00383500|75933413|FG002|COMPLETED|Overall Study||22||
59811116|NCT00383500|75933411|FG000|NOT COMPLETED|Overall Study||8||
59811117|NCT00383500|75933412|FG001|NOT COMPLETED|Overall Study||3||
59811118|NCT00383500|75933413|FG002|NOT COMPLETED|Overall Study||2||
59811119|NCT00365716|75933427|FG000|STARTED|Base Study (Day 1 to Month 7)||290||
59811120|NCT00365716|75933428|FG001|STARTED|Base Study (Day 1 to Month 7)||284||
59811121|NCT00365716|75933429|FG002|STARTED|Base Study (Day 1 to Month 7)||292||
59811122|NCT00365716|75933430|FG003|STARTED|Base Study (Day 1 to Month 7)||146||
59811123|NCT00365716|75933431|FG004|STARTED|Base Study (Day 1 to Month 7)||146||
59811124|NCT00365716|75933432|FG005|STARTED|Base Study (Day 1 to Month 7)||0||
59811125|NCT00365716|75933433|FG006|STARTED|Base Study (Day 1 to Month 7)||0||
59811126|NCT00365716|75933427|FG000|COMPLETED|Base Study (Day 1 to Month 7)||269||
59969668|NCT03703466|76086939|FG001|STARTED|Overall Study||24||
59811127|NCT00365716|75933428|FG001|COMPLETED|Base Study (Day 1 to Month 7)||260||
59811128|NCT00365716|75933429|FG002|COMPLETED|Base Study (Day 1 to Month 7)||271||
59811129|NCT00365716|75933430|FG003|COMPLETED|Base Study (Day 1 to Month 7)||136||
59811130|NCT00365716|75933431|FG004|COMPLETED|Base Study (Day 1 to Month 7)||139||
59811131|NCT00365716|75933432|FG005|COMPLETED|Base Study (Day 1 to Month 7)||0||
59969669|NCT03703466|76086940|FG002|STARTED|Overall Study||24||
59969670|NCT03703466|76086938|FG000|Received at Least One Dose of Study Drug|Overall Study||24||
59811132|NCT00365716|75933433|FG006|COMPLETED|Base Study (Day 1 to Month 7)||0||
59811133|NCT00365716|75933427|FG000|NOT COMPLETED|Base Study (Day 1 to Month 7)||21||
59811134|NCT00365716|75933428|FG001|NOT COMPLETED|Base Study (Day 1 to Month 7)||24||
59811135|NCT00365716|75933429|FG002|NOT COMPLETED|Base Study (Day 1 to Month 7)||21||
59811136|NCT00365716|75933430|FG003|NOT COMPLETED|Base Study (Day 1 to Month 7)||10||
59811137|NCT00365716|75933431|FG004|NOT COMPLETED|Base Study (Day 1 to Month 7)||7||
59811138|NCT00365716|75933432|FG005|NOT COMPLETED|Base Study (Day 1 to Month 7)||0||
59811139|NCT00365716|75933433|FG006|NOT COMPLETED|Base Study (Day 1 to Month 7)||0||
59969671|NCT03703466|76086939|FG001|Received at Least One Dose of Study Drug|Overall Study||23||
59969672|NCT03703466|76086940|FG002|Received at Least One Dose of Study Drug|Overall Study||24||
59969673|NCT03703466|76086938|FG000|COMPLETED|Overall Study||20||
59969674|NCT03703466|76086939|FG001|COMPLETED|Overall Study||18||
59969675|NCT03703466|76086940|FG002|COMPLETED|Overall Study||22||
59969676|NCT03703466|76086938|FG000|NOT COMPLETED|Overall Study||4||
59969677|NCT03703466|76086939|FG001|NOT COMPLETED|Overall Study||6||
59969678|NCT03703466|76086940|FG002|NOT COMPLETED|Overall Study||2||
59969679|NCT03677128|76086954|FG000|STARTED|Overall Study||46||
59969680|NCT03677128|76086955|FG001|STARTED|Overall Study||29||
59969681|NCT03677128|76086956|FG002|STARTED|Overall Study||63||
59969682|NCT03677128|76086957|FG003|STARTED|Overall Study||25||
59811140|NCT00365716|75933427|FG000|STARTED|Long Term Follow-up (Month 7 toMonth 36)||269||
59811141|NCT00365716|75933428|FG001|STARTED|Long Term Follow-up (Month 7 toMonth 36)||260||
59811142|NCT00365716|75933429|FG002|STARTED|Long Term Follow-up (Month 7 toMonth 36)||271||
59811143|NCT00365716|75933430|FG003|STARTED|Long Term Follow-up (Month 7 toMonth 36)||136||
59969683|NCT03677128|76086958|FG004|STARTED|Overall Study||4||
59969684|NCT03677128|76086954|FG000|COMPLETED|Overall Study||36||
59969685|NCT03677128|76086955|FG001|COMPLETED|Overall Study||16||
59969686|NCT03677128|76086956|FG002|COMPLETED|Overall Study||63||
59969687|NCT03677128|76086957|FG003|COMPLETED|Overall Study||25||
59969688|NCT03677128|76086958|FG004|COMPLETED|Overall Study||4||
59969689|NCT03677128|76086954|FG000|NOT COMPLETED|Overall Study||10||
59969690|NCT03677128|76086955|FG001|NOT COMPLETED|Overall Study||13||
59969691|NCT03677128|76086956|FG002|NOT COMPLETED|Overall Study||0||
59969692|NCT03677128|76086957|FG003|NOT COMPLETED|Overall Study||0||
59969693|NCT03677128|76086958|FG004|NOT COMPLETED|Overall Study||0||
59969694|NCT03664544|76086973|FG000|STARTED|Overall Study||6||
59969695|NCT03664544|76086974|FG001|STARTED|Overall Study||6||
59969696|NCT03664544|76086973|FG000|COMPLETED|Overall Study||6||
59969697|NCT03664544|76086974|FG001|COMPLETED|Overall Study||6||
59969698|NCT03664544|76086973|FG000|NOT COMPLETED|Overall Study||0||
59969699|NCT03664544|76086974|FG001|NOT COMPLETED|Overall Study||0||
59969700|NCT03385343|76086980|FG000|STARTED|Overall Study||30||
59969701|NCT03385343|76086980|FG000|COMPLETED|Overall Study||22||
59811144|NCT00365716|75933431|FG004|STARTED|Long Term Follow-up (Month 7 toMonth 36)||139||
59811145|NCT00365716|75933432|FG005|STARTED|Long Term Follow-up (Month 7 toMonth 36)||0||
59811146|NCT00365716|75933433|FG006|STARTED|Long Term Follow-up (Month 7 toMonth 36)||0||
59811147|NCT00365716|75933427|FG000|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||137||
59811148|NCT00365716|75933428|FG001|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||245||
59811149|NCT00365716|75933429|FG002|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||251||
59811150|NCT00365716|75933430|FG003|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||57||
59811151|NCT00365716|75933431|FG004|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||57||
59811152|NCT00365716|75933432|FG005|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||0||
59811153|NCT00365716|75933433|FG006|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||0||
59811154|NCT00365716|75933427|FG000|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||132||
59811155|NCT00365716|75933428|FG001|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||15||
59811156|NCT00365716|75933429|FG002|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||20||
59811157|NCT00365716|75933430|FG003|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||79||
59811158|NCT00365716|75933431|FG004|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||82||
59969702|NCT03385343|76086980|FG000|NOT COMPLETED|Overall Study||8||
59969703|NCT03326583|76086985|FG000|STARTED|Pre-Treatment||27||
59969704|NCT03326583|76086985|FG000|COMPLETED|Pre-Treatment||26||
59969705|NCT03326583|76086985|FG000|NOT COMPLETED|Pre-Treatment||1||
59969706|NCT03326583|76086985|FG000|STARTED|Treatment||26||
59969707|NCT03326583|76086985|FG000|COMPLETED|Treatment||24||
59969708|NCT03326583|76086985|FG000|NOT COMPLETED|Treatment||2||
59969709|NCT03326583|76086985|FG000|STARTED|Post-Treatment||24||
59969710|NCT03326583|76086985|FG000|COMPLETED|Post-Treatment||24||
59969711|NCT03326583|76086985|FG000|NOT COMPLETED|Post-Treatment||0||
59969712|NCT03248128|76086999|FG000|STARTED|Overall Study||455||
59969713|NCT03248128|76087000|FG001|STARTED|Overall Study||451||
59811159|NCT00365716|75933432|FG005|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||0||
59811160|NCT00365716|75933433|FG006|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||0||
59811161|NCT00365716|75933427|FG000|STARTED|Extension 1||0||
59811162|NCT00365716|75933428|FG001|STARTED|Extension 1||0||
59969714|NCT03248128|76086999|FG000|ITT Population|Overall Study||454||
59969715|NCT03248128|76087000|FG001|ITT Population|Overall Study||448||
59969716|NCT03248128|76086999|FG000|COMPLETED|Overall Study||433||
59969717|NCT03248128|76087000|FG001|COMPLETED|Overall Study||431||
59969718|NCT03248128|76086999|FG000|NOT COMPLETED|Overall Study||22||
59969719|NCT03248128|76087000|FG001|NOT COMPLETED|Overall Study||20||
59969720|NCT03136328|76087009|FG000|STARTED|Overall Study||11||
59969721|NCT03136328|76087009|FG000|COMPLETED|Overall Study||11||
59969722|NCT03136328|76087009|FG000|NOT COMPLETED|Overall Study||0||
59969723|NCT02925650|76087018|FG000|STARTED|Overall Study||5||
59969724|NCT02925650|76087019|FG001|STARTED|Overall Study||5||
59969725|NCT02925650|76087020|FG002|STARTED|Overall Study||1||
59969726|NCT02925650|76087021|FG003|STARTED|Overall Study||7||
59969727|NCT02925650|76087018|FG000|COMPLETED|Overall Study||4||
59969728|NCT02925650|76087019|FG001|COMPLETED|Overall Study||5||
59969729|NCT02925650|76087020|FG002|COMPLETED|Overall Study||1||
59969730|NCT02925650|76087021|FG003|COMPLETED|Overall Study||5||
59969731|NCT02925650|76087018|FG000|NOT COMPLETED|Overall Study||1||
59969732|NCT02925650|76087019|FG001|NOT COMPLETED|Overall Study||0||
59969733|NCT02925650|76087020|FG002|NOT COMPLETED|Overall Study||0||
59969734|NCT02925650|76087021|FG003|NOT COMPLETED|Overall Study||2||
59969735|NCT02802631|76087043|FG000|STARTED|Overall Study||8||
59969736|NCT02802631|76087044|FG001|STARTED|Overall Study||8||
59969737|NCT02802631|76087045|FG002|STARTED|Overall Study||6||
59969738|NCT02802631|76087046|FG003|STARTED|Overall Study||8||
59969739|NCT02802631|76087047|FG004|STARTED|Overall Study||8||
59969740|NCT02802631|76087048|FG005|STARTED|Overall Study||8||
59969741|NCT02802631|76087049|FG006|STARTED|Overall Study||9||
59969742|NCT02802631|76087050|FG007|STARTED|Overall Study||14||
59969743|NCT02802631|76087043|FG000|COMPLETED|Overall Study||6||
59969744|NCT02802631|76087044|FG001|COMPLETED|Overall Study||6||
59969745|NCT02802631|76087045|FG002|COMPLETED|Overall Study|Due to an error, 180 mg given instead of 300 mg as planned. Cohort 3 was discontinued on Day 5 and replaced by Cohort 3b.|0||
59969746|NCT02802631|76087046|FG003|COMPLETED|Overall Study||7||
59969747|NCT02802631|76087047|FG004|COMPLETED|Overall Study|Cohort 4 was discontinued Day 8 due to dose-limiting toxicity.|0||
59969748|NCT02802631|76087048|FG005|COMPLETED|Overall Study||7||
59969749|NCT02802631|76087049|FG006|COMPLETED|Overall Study||4||
59969750|NCT02802631|76087050|FG007|COMPLETED|Overall Study||10||
59969751|NCT02802631|76087043|FG000|NOT COMPLETED|Overall Study||2||
59969752|NCT02802631|76087044|FG001|NOT COMPLETED|Overall Study||2||
59969753|NCT02802631|76087045|FG002|NOT COMPLETED|Overall Study||6||
59969754|NCT02802631|76087046|FG003|NOT COMPLETED|Overall Study||1||
59969755|NCT02802631|76087047|FG004|NOT COMPLETED|Overall Study||8||
59969756|NCT02802631|76087048|FG005|NOT COMPLETED|Overall Study||1||
59969757|NCT02802631|76087049|FG006|NOT COMPLETED|Overall Study||5||
59969758|NCT02802631|76087050|FG007|NOT COMPLETED|Overall Study||4||
59969759|NCT02757898|76087077|FG000|STARTED|Overall Study||5||
59811163|NCT00365716|75933429|FG002|STARTED|Extension 1||0||
59811164|NCT00365716|75933430|FG003|STARTED|Extension 1||0||
59811165|NCT00365716|75933431|FG004|STARTED|Extension 1||0||
59811166|NCT00365716|75933432|FG005|STARTED|Extension 1||241||
59811167|NCT00365716|75933433|FG006|STARTED|Extension 1||0||
59811168|NCT00365716|75933427|FG000|COMPLETED|Extension 1||0||
59811169|NCT00365716|75933428|FG001|COMPLETED|Extension 1||0||
59811170|NCT00365716|75933429|FG002|COMPLETED|Extension 1||0||
59811171|NCT00365716|75933430|FG003|COMPLETED|Extension 1||0||
59811172|NCT00365716|75933431|FG004|COMPLETED|Extension 1||0||
59811173|NCT00365716|75933432|FG005|COMPLETED|Extension 1||219||
59811174|NCT00365716|75933433|FG006|COMPLETED|Extension 1||0||
59811175|NCT00365716|75933427|FG000|NOT COMPLETED|Extension 1||0||
59811176|NCT00365716|75933428|FG001|NOT COMPLETED|Extension 1||0||
59811177|NCT00365716|75933429|FG002|NOT COMPLETED|Extension 1||0||
59811178|NCT00365716|75933430|FG003|NOT COMPLETED|Extension 1||0||
59811179|NCT00365716|75933431|FG004|NOT COMPLETED|Extension 1||0||
59811180|NCT00365716|75933432|FG005|NOT COMPLETED|Extension 1||22||
59811181|NCT00365716|75933433|FG006|NOT COMPLETED|Extension 1||0||
59969760|NCT02757898|76087077|FG000|COMPLETED|Overall Study||5||
59969761|NCT02757898|76087077|FG000|NOT COMPLETED|Overall Study||0||
59969762|NCT02754479|76087082|FG000|STARTED|Overall Study||4||
59969763|NCT02754479|76087082|FG000|COMPLETED|Overall Study||3||
59969764|NCT02754479|76087082|FG000|NOT COMPLETED|Overall Study||1||
59969765|NCT02730546|76087086|FG000|STARTED|Overall Study||31||
59811182|NCT00365716|75933427|FG000|STARTED|Extension 2||0||
59811183|NCT00365716|75933428|FG001|STARTED|Extension 2||0||
59811184|NCT00365716|75933429|FG002|STARTED|Extension 2||0||
59811185|NCT00365716|75933430|FG003|STARTED|Extension 2||0||
59811186|NCT00365716|75933431|FG004|STARTED|Extension 2||0||
59811187|NCT00365716|75933432|FG005|STARTED|Extension 2||0||
59811188|NCT00365716|75933433|FG006|STARTED|Extension 2|17 Participants continued into Extension 2 from Extension 1|17||
59969766|NCT02730546|76087086|FG000|COMPLETED|Overall Study||31||
59969767|NCT02730546|76087086|FG000|NOT COMPLETED|Overall Study||0||
59969768|NCT02589496|76087090|FG000|STARTED|Overall Study||80||
59969769|NCT02589496|76087090|FG000|COMPLETED|Overall Study||80||
59969770|NCT02589496|76087090|FG000|NOT COMPLETED|Overall Study||0||
59969771|NCT02036476|76087095|FG000|STARTED|Overall Study||8||
59969772|NCT02036476|76087095|FG000|COMPLETED|Overall Study||0||
59969773|NCT02036476|76087095|FG000|NOT COMPLETED|Overall Study||8||
59969774|NCT01722604|76087102|FG000|STARTED|Overall Study||129||
59969775|NCT01722604|76087103|FG001|STARTED|Overall Study||129||
59969776|NCT01722604|76087102|FG000|COMPLETED|Overall Study||123||
59969777|NCT01722604|76087103|FG001|COMPLETED|Overall Study||120||
59811189|NCT00365716|75933427|FG000|COMPLETED|Extension 2||0||
59811190|NCT00365716|75933428|FG001|COMPLETED|Extension 2||0||
59811191|NCT00365716|75933429|FG002|COMPLETED|Extension 2||0||
59969778|NCT01722604|76087102|FG000|NOT COMPLETED|Overall Study||6||
59969779|NCT01722604|76087103|FG001|NOT COMPLETED|Overall Study||9||
59811192|NCT00365716|75933430|FG003|COMPLETED|Extension 2||0||
59811193|NCT00365716|75933431|FG004|COMPLETED|Extension 2||0||
59811194|NCT00365716|75933432|FG005|COMPLETED|Extension 2||0||
59811195|NCT00365716|75933433|FG006|COMPLETED|Extension 2||7||
59811196|NCT00365716|75933427|FG000|NOT COMPLETED|Extension 2||0||
59811197|NCT00365716|75933428|FG001|NOT COMPLETED|Extension 2||0||
59969780|NCT01202994|76087109|FG000|STARTED|Overall Study||27||
59969781|NCT01202994|76087109|FG000|COMPLETED|Overall Study||27||
59969782|NCT01202994|76087109|FG000|NOT COMPLETED|Overall Study||0||
59969783|NCT00930943|76087114|FG000|STARTED|Overall Study||30||
59969784|NCT00930943|76087114|FG000|COMPLETED|Overall Study||30||
59969785|NCT00930943|76087114|FG000|NOT COMPLETED|Overall Study||0||
59969786|NCT00643994|76087120|FG000|STARTED|Overall Study|379 patients signed the informed consent form and were enrolled. Of these 379 patients, 69 did not participate in the study due to not meeting eligibility criteria, insurance did not approve participation in a clinical study, or the patient withdrew from study prior to receiving treatment.|310|Received CyberKnife 36.25 Gy delivered in 5 fractions of 7.25 Gy per fraction|
59969787|NCT00643994|76087120|FG000|10-yr Follow up|Overall Study||69|optional extension per protocol amendment|
59969788|NCT00643994|76087120|FG000|COMPLETED|Overall Study||214|Completed required 5-year follow up|
59969789|NCT00643994|76087120|FG000|NOT COMPLETED|Overall Study||96||
59969790|NCT00643617|76087126|FG000|STARTED|Overall Study||112|Received CyberKnife treatment|
59969791|NCT00643617|76087127|FG001|STARTED|Overall Study||147|Received CyberKnife treatment|
59969792|NCT00643617|76087126|FG000|10-yr Follow up|Overall Study||36|Optional extension per protocol amendment|
59969793|NCT00643617|76087127|FG001|10-yr Follow up|Overall Study||33|Optional extension per protocol amendment|
59969794|NCT00643617|76087126|FG000|COMPLETED|Overall Study||64|Completed required 5-year follow up|
59969795|NCT00643617|76087127|FG001|COMPLETED|Overall Study||87|Completed required 5-year follow up|
59969796|NCT00643617|76087126|FG000|NOT COMPLETED|Overall Study||48||
59969797|NCT00643617|76087127|FG001|NOT COMPLETED|Overall Study||60||
59969798|NCT00620425|76087140|FG000|STARTED|Overall Study||18||
59969799|NCT00620425|76087140|FG000|COMPLETED|Overall Study||18||
59969800|NCT00620425|76087140|FG000|NOT COMPLETED|Overall Study||0||
59969801|NCT00504582|76087154|FG000|STARTED|Overall Study||47||
59969802|NCT00504582|76087155|FG001|STARTED|Overall Study||45||
59969803|NCT00504582|76087156|FG002|STARTED|Overall Study||20||
59969804|NCT00504582|76087154|FG000|COMPLETED|Overall Study||46||
59969805|NCT00504582|76087155|FG001|COMPLETED|Overall Study||45||
59969806|NCT00504582|76087156|FG002|COMPLETED|Overall Study||20||
59969807|NCT00504582|76087154|FG000|NOT COMPLETED|Overall Study||1||
59969808|NCT00504582|76087155|FG001|NOT COMPLETED|Overall Study||0||
59969809|NCT00504582|76087156|FG002|NOT COMPLETED|Overall Study||0||
59969810|NCT00353938|76087166|FG000|STARTED|Stage 1||9||
59969811|NCT00353938|76087167|FG001|STARTED|Stage 1||5||
59969812|NCT00353938|76087168|FG002|STARTED|Stage 1||0||
59969813|NCT00353938|76087169|FG003|STARTED|Stage 1||0||
59811198|NCT00365716|75933429|FG002|NOT COMPLETED|Extension 2||0||
59811199|NCT00365716|75933430|FG003|NOT COMPLETED|Extension 2||0||
59811200|NCT00365716|75933431|FG004|NOT COMPLETED|Extension 2||0||
59811201|NCT00365716|75933432|FG005|NOT COMPLETED|Extension 2||0||
59811202|NCT00365716|75933433|FG006|NOT COMPLETED|Extension 2||10||
59811203|NCT00059839|75933449|FG000|STARTED|Overall Study||65||
59811204|NCT00059839|75933450|FG001|STARTED|Overall Study||64||
59811205|NCT00059839|75933449|FG000|COMPLETED|Overall Study||53||
59811206|NCT00059839|75933450|FG001|COMPLETED|Overall Study||47||
59811207|NCT00059839|75933449|FG000|NOT COMPLETED|Overall Study||12||
59811208|NCT00059839|75933450|FG001|NOT COMPLETED|Overall Study||17||
59811209|NCT00059215|75933460|FG000|STARTED|Overall Study||200||
59811210|NCT00059215|75933461|FG001|STARTED|Overall Study||200||
59811211|NCT00059215|75933462|FG002|STARTED|Overall Study||251||
59811212|NCT00059215|75933463|FG003|STARTED|Overall Study||254||
59811213|NCT00059215|75933460|FG000|COMPLETED|Overall Study|One subject discontinued before receiving treatment and is not included in the evaluable set.|187||
59811214|NCT00059215|75933461|FG001|COMPLETED|Overall Study||186||
59811215|NCT00059215|75933462|FG002|COMPLETED|Overall Study||236||
59811216|NCT00059215|75933463|FG003|COMPLETED|Overall Study||239||
59811217|NCT00059215|75933460|FG000|NOT COMPLETED|Overall Study||13||
59811218|NCT00059215|75933461|FG001|NOT COMPLETED|Overall Study||14||
59811219|NCT00059215|75933462|FG002|NOT COMPLETED|Overall Study||15||
59811220|NCT00059215|75933463|FG003|NOT COMPLETED|Overall Study||15||
59969814|NCT00353938|76087166|FG000|COMPLETED|Stage 1||8||
59969815|NCT00353938|76087167|FG001|COMPLETED|Stage 1||5||
59969816|NCT00353938|76087168|FG002|COMPLETED|Stage 1||0||
59969817|NCT00353938|76087169|FG003|COMPLETED|Stage 1||0||
59969818|NCT00353938|76087166|FG000|NOT COMPLETED|Stage 1||1||
59811221|NCT00058825|75933474|FG000|STARTED|Overall Study||27||
59811222|NCT00058825|75933474|FG000|COMPLETED|Overall Study||5||
59811223|NCT00058825|75933474|FG000|NOT COMPLETED|Overall Study||22||
59969819|NCT00353938|76087167|FG001|NOT COMPLETED|Stage 1||0||
59969820|NCT00353938|76087168|FG002|NOT COMPLETED|Stage 1||0||
59969821|NCT00353938|76087169|FG003|NOT COMPLETED|Stage 1||0||
59969822|NCT00353938|76087166|FG000|STARTED|Stage 2||0||
59811224|NCT00364858|75933482|FG000|STARTED|Overall Study||33||
59811225|NCT00364858|75933483|FG001|STARTED|Overall Study||62||
59811226|NCT00364858|75933482|FG000|COMPLETED|Overall Study||26||
59811227|NCT00364858|75933483|FG001|COMPLETED|Overall Study||40||
59811228|NCT00364858|75933482|FG000|NOT COMPLETED|Overall Study||7||
59969823|NCT00353938|76087167|FG001|STARTED|Stage 2||0||
59969824|NCT00353938|76087168|FG002|STARTED|Stage 2||4||
59969825|NCT00353938|76087169|FG003|STARTED|Stage 2||0||
59969826|NCT00353938|76087166|FG000|COMPLETED|Stage 2||0||
59969827|NCT00353938|76087167|FG001|COMPLETED|Stage 2||0||
59969828|NCT00353938|76087168|FG002|COMPLETED|Stage 2||4||
59969829|NCT00353938|76087169|FG003|COMPLETED|Stage 2||0||
59969830|NCT00353938|76087166|FG000|NOT COMPLETED|Stage 2||0||
59969831|NCT00353938|76087167|FG001|NOT COMPLETED|Stage 2||0||
59969832|NCT00353938|76087168|FG002|NOT COMPLETED|Stage 2||0||
59969833|NCT00353938|76087169|FG003|NOT COMPLETED|Stage 2||0||
59969834|NCT00353938|76087166|FG000|STARTED|Stage 3||0||
59969835|NCT00353938|76087167|FG001|STARTED|Stage 3||0||
59969836|NCT00353938|76087168|FG002|STARTED|Stage 3||0||
59969837|NCT00353938|76087169|FG003|STARTED|Stage 3||3||
59969838|NCT00353938|76087166|FG000|COMPLETED|Stage 3||0||
59969839|NCT00353938|76087167|FG001|COMPLETED|Stage 3||0||
59811229|NCT00364858|75933483|FG001|NOT COMPLETED|Overall Study||22||
59811230|NCT03803059|75933490|FG000|STARTED|Overall Study||35||
59811231|NCT03803059|75933490|FG000|COMPLETED|Overall Study||32||
59811232|NCT03803059|75933490|FG000|NOT COMPLETED|Overall Study||3||
59811233|NCT00372424|75933495|FG000|STARTED|Overall Study||26||
59811234|NCT00372424|75933495|FG000|Treated|Overall Study||25||
59811235|NCT00372424|75933495|FG000|COMPLETED|Overall Study||0||
59811236|NCT00372424|75933495|FG000|NOT COMPLETED|Overall Study||26||
59811237|NCT00372190|75933501|FG000|STARTED|Overall Study|95 were allocated to mesh group, however 2 never underwent any surgery|93||
59811238|NCT00372190|75933502|FG001|STARTED|Overall Study|99 were allocated to conventional arm, however 2 never underwent any surgery|97||
59811239|NCT00372190|75933501|FG000|COMPLETED|Overall Study||90||
59811240|NCT00372190|75933502|FG001|COMPLETED|Overall Study||96||
59811241|NCT00372190|75933501|FG000|NOT COMPLETED|Overall Study||3||
59811242|NCT00372190|75933502|FG001|NOT COMPLETED|Overall Study||1||
59811243|NCT00044083|75933512|FG000|STARTED|First Intervention (One Week)- HV's||74||
59811244|NCT00044083|75933513|FG001|STARTED|First Intervention (One Week)- HV's||73||
59811245|NCT00044083|75933512|FG000|COMPLETED|First Intervention (One Week)- HV's||64||
59811246|NCT00044083|75933513|FG001|COMPLETED|First Intervention (One Week)- HV's||66||
59969840|NCT00353938|76087168|FG002|COMPLETED|Stage 3||0||
59969841|NCT00353938|76087169|FG003|COMPLETED|Stage 3||3||
59969842|NCT00353938|76087166|FG000|NOT COMPLETED|Stage 3||0||
59969843|NCT00353938|76087167|FG001|NOT COMPLETED|Stage 3||0||
59969844|NCT00353938|76087168|FG002|NOT COMPLETED|Stage 3||0||
59969845|NCT00353938|76087169|FG003|NOT COMPLETED|Stage 3||0||
59969846|NCT00314366|76087179|FG000|STARTED|Overall Study||11||
59969847|NCT00314366|76087180|FG001|STARTED|Overall Study||10||
59969848|NCT00314366|76087179|FG000|COMPLETED|Overall Study||10||
59969849|NCT00314366|76087180|FG001|COMPLETED|Overall Study||10||
59969850|NCT00314366|76087179|FG000|NOT COMPLETED|Overall Study||1||
59969851|NCT00314366|76087180|FG001|NOT COMPLETED|Overall Study||0||
59969852|NCT01595061|76087189|FG000|STARTED|Overall Study||57||
59969853|NCT01595061|76087189|FG000|COMPLETED|Overall Study||53||
59969854|NCT01595061|76087189|FG000|NOT COMPLETED|Overall Study||4||
59811247|NCT00044083|75933512|FG000|NOT COMPLETED|First Intervention (One Week)- HV's||10||
59811248|NCT00044083|75933513|FG001|NOT COMPLETED|First Intervention (One Week)- HV's||7||
59811249|NCT00044083|75933512|FG000|STARTED|Second Intervention (One Week) HV's||64||
59811250|NCT00044083|75933513|FG001|STARTED|Second Intervention (One Week) HV's||66||
59811251|NCT00044083|75933512|FG000|COMPLETED|Second Intervention (One Week) HV's||64||
59811252|NCT00044083|75933513|FG001|COMPLETED|Second Intervention (One Week) HV's||66||
59811253|NCT00044083|75933512|FG000|NOT COMPLETED|Second Intervention (One Week) HV's||0||
59811254|NCT00044083|75933513|FG001|NOT COMPLETED|Second Intervention (One Week) HV's||0||
59811255|NCT00044083|75933512|FG000|STARTED|First Intervention (One Week) Patients||31||
59969855|NCT02852005|76087198|FG000|STARTED|Overall Study||4||
60074387|NCT01576575|76189771|FG000|COMPLETED|Buprenorphine + Grapefruit||14||
60074388|NCT01576575|76189771|FG000|NOT COMPLETED|Buprenorphine + Grapefruit||1||
59811256|NCT00044083|75933513|FG001|STARTED|First Intervention (One Week) Patients||32||
59811257|NCT00044083|75933512|FG000|COMPLETED|First Intervention (One Week) Patients||30||
59811258|NCT00044083|75933513|FG001|COMPLETED|First Intervention (One Week) Patients||30||
59811259|NCT00044083|75933512|FG000|NOT COMPLETED|First Intervention (One Week) Patients||1||
59811260|NCT00044083|75933513|FG001|NOT COMPLETED|First Intervention (One Week) Patients||2||
59811261|NCT00044083|75933512|FG000|STARTED|Second Intervention (One Week) Patients||30||
59811262|NCT00044083|75933513|FG001|STARTED|Second Intervention (One Week) Patients||30||
59969856|NCT02852005|76087199|FG001|STARTED|Overall Study||4||
59969857|NCT02852005|76087200|FG002|STARTED|Overall Study||6||
59969858|NCT02852005|76087201|FG003|STARTED|Overall Study||6||
59969859|NCT02852005|76087202|FG004|STARTED|Overall Study||7||
59969860|NCT02852005|76087198|FG000|Month 0.5|Overall Study||3||
59969861|NCT02852005|76087199|FG001|Month 0.5|Overall Study||4||
59969862|NCT02852005|76087200|FG002|Month 0.5|Overall Study||6||
59811263|NCT00044083|75933512|FG000|COMPLETED|Second Intervention (One Week) Patients||30||
59811264|NCT00044083|75933513|FG001|COMPLETED|Second Intervention (One Week) Patients||29||
59969863|NCT02852005|76087201|FG003|Month 0.5|Overall Study||6||
59969864|NCT02852005|76087202|FG004|Month 0.5|Overall Study||7||
59969865|NCT02852005|76087198|FG000|Month 4.5|Overall Study||3||
59969866|NCT02852005|76087199|FG001|Month 4.5|Overall Study||4||
59969867|NCT02852005|76087200|FG002|Month 4.5|Overall Study||6||
59969868|NCT02852005|76087201|FG003|Month 4.5|Overall Study||6||
59969869|NCT02852005|76087202|FG004|Month 4.5|Overall Study||7||
59969870|NCT02852005|76087198|FG000|Month 10|Overall Study||3||
59969871|NCT02852005|76087199|FG001|Month 10|Overall Study||3||
59969872|NCT02852005|76087200|FG002|Month 10|Overall Study||6||
59969873|NCT02852005|76087201|FG003|Month 10|Overall Study||5||
59969874|NCT02852005|76087202|FG004|Month 10|Overall Study||7||
59969875|NCT02852005|76087198|FG000|COMPLETED|Overall Study||3||
59969876|NCT02852005|76087199|FG001|COMPLETED|Overall Study||4||
59969877|NCT02852005|76087200|FG002|COMPLETED|Overall Study||6||
59969878|NCT02852005|76087201|FG003|COMPLETED|Overall Study||6||
59969879|NCT02852005|76087202|FG004|COMPLETED|Overall Study||6||
59969880|NCT02852005|76087198|FG000|NOT COMPLETED|Overall Study||1||
59969881|NCT02852005|76087199|FG001|NOT COMPLETED|Overall Study||0||
59969882|NCT02852005|76087200|FG002|NOT COMPLETED|Overall Study||0||
59969883|NCT02852005|76087201|FG003|NOT COMPLETED|Overall Study||0||
59969884|NCT02852005|76087202|FG004|NOT COMPLETED|Overall Study||1||
59969885|NCT02851615|76087218|FG000|STARTED|Overall Study||27||
59969886|NCT02851615|76087219|FG001|STARTED|Overall Study||31||
59969887|NCT02851615|76087218|FG000|COMPLETED|Overall Study||26||
59969888|NCT02851615|76087219|FG001|COMPLETED|Overall Study||27||
59969889|NCT02851615|76087218|FG000|NOT COMPLETED|Overall Study||1||
59969890|NCT02851615|76087219|FG001|NOT COMPLETED|Overall Study||4||
59969891|NCT02849743|76087228|FG000|STARTED|First Intervention (8 Weeks)||6||
59969892|NCT02849743|76087229|FG001|STARTED|First Intervention (8 Weeks)||7||
59969893|NCT02849743|76087228|FG000|COMPLETED|First Intervention (8 Weeks)||6||
59969894|NCT02849743|76087229|FG001|COMPLETED|First Intervention (8 Weeks)||6||
59969895|NCT02849743|76087228|FG000|NOT COMPLETED|First Intervention (8 Weeks)||0||
59969896|NCT02849743|76087229|FG001|NOT COMPLETED|First Intervention (8 Weeks)||1||
59969897|NCT02849743|76087228|FG000|STARTED|Washout (4 Weeks)||6||
59969898|NCT02849743|76087229|FG001|STARTED|Washout (4 Weeks)||6||
59969899|NCT02849743|76087228|FG000|COMPLETED|Washout (4 Weeks)||6||
59969900|NCT02849743|76087229|FG001|COMPLETED|Washout (4 Weeks)||6||
59969901|NCT02849743|76087228|FG000|NOT COMPLETED|Washout (4 Weeks)||0||
59969902|NCT02849743|76087229|FG001|NOT COMPLETED|Washout (4 Weeks)||0||
59969903|NCT02849743|76087228|FG000|STARTED|Second Intervention (8 Weeks)||6||
59969904|NCT02849743|76087229|FG001|STARTED|Second Intervention (8 Weeks)||6||
59969905|NCT02849743|76087228|FG000|COMPLETED|Second Intervention (8 Weeks)||5||
59969906|NCT02849743|76087229|FG001|COMPLETED|Second Intervention (8 Weeks)||6||
59969907|NCT02849743|76087228|FG000|NOT COMPLETED|Second Intervention (8 Weeks)||1||
59969908|NCT02849743|76087229|FG001|NOT COMPLETED|Second Intervention (8 Weeks)||0||
59969909|NCT02851069|76087264|FG000|STARTED|Overall Study||65|Received at least 1 dose of study drug.|
59969910|NCT02851069|76087264|FG000|COMPLETED|Overall Study||59||
59969911|NCT02851069|76087264|FG000|NOT COMPLETED|Overall Study||6||
59811265|NCT00044083|75933512|FG000|NOT COMPLETED|Second Intervention (One Week) Patients||0||
59811266|NCT00044083|75933513|FG001|NOT COMPLETED|Second Intervention (One Week) Patients||1||
59811267|NCT00058123|75933546|FG000|STARTED|Overall Study||55||
59811268|NCT00058123|75933546|FG000|COMPLETED|Overall Study||45||
59811269|NCT00058123|75933546|FG000|NOT COMPLETED|Overall Study||10||
59811270|NCT00022633|75933553|FG000|STARTED|Overall Study||55||
59811271|NCT00022633|75933554|FG001|STARTED|Overall Study||10||
59811272|NCT00022633|75933553|FG000|Eligible|Overall Study||51||
59969912|NCT02849509|76087272|FG000|STARTED|Overall Study||379||
59969913|NCT02849509|76087273|FG001|STARTED|Overall Study||591||
59969914|NCT02849509|76087274|FG002|STARTED|Overall Study||343||
59811273|NCT00022633|75933554|FG001|Eligible|Overall Study||10||
59811274|NCT00022633|75933553|FG000|COMPLETED|Overall Study||23||
59811275|NCT00022633|75933554|FG001|COMPLETED|Overall Study||5||
59811276|NCT00022633|75933553|FG000|NOT COMPLETED|Overall Study||32||
59811277|NCT00022633|75933554|FG001|NOT COMPLETED|Overall Study||5||
59969915|NCT02849509|76087272|FG000|COMPLETED|Overall Study|Not prematurely discontinued from Pradaxa or VKA|289||
59969916|NCT02849509|76087273|FG001|COMPLETED|Overall Study|Not prematurely discontinued from Pradaxa or VKA|425||
59811278|NCT00021541|75933561|FG000|STARTED|Period 1-First Treatment||31||
59811279|NCT00021541|75933562|FG001|STARTED|Period 1-First Treatment|These are the patients randomized to receive placebo. Two of these patients were deemed ineligible.|31||
59969917|NCT02849509|76087274|FG002|COMPLETED|Overall Study|Not prematurely discontinued from Pradaxa or VKA|258||
59811280|NCT00021541|75933561|FG000|Pts Who Progressed to Second Treatment|Period 1-First Treatment||20||
59811281|NCT00021541|75933562|FG001|Pts Who Progressed to Second Treatment|Period 1-First Treatment||23||
59811282|NCT00021541|75933561|FG000|Ineligible Patients|Period 1-First Treatment||0||
59811283|NCT00021541|75933562|FG001|Ineligible Patients|Period 1-First Treatment||2||
59969918|NCT02849509|76087272|FG000|NOT COMPLETED|Overall Study||90||
59969919|NCT02849509|76087273|FG001|NOT COMPLETED|Overall Study||166||
59969920|NCT02849509|76087274|FG002|NOT COMPLETED|Overall Study||85||
59969921|NCT02848729|76087286|FG000|STARTED|Overall Study||27||
59969922|NCT02848729|76087287|FG001|STARTED|Overall Study||23||
59969923|NCT02848729|76087286|FG000|Per Protocol Population|Overall Study||11||
59969924|NCT02848729|76087287|FG001|Per Protocol Population|Overall Study||11||
59969925|NCT02848729|76087286|FG000|Safety Population|Overall Study||27||
59969926|NCT02848729|76087287|FG001|Safety Population|Overall Study||23||
59969927|NCT02848729|76087286|FG000|COMPLETED|Overall Study||11||
59969928|NCT02848729|76087287|FG001|COMPLETED|Overall Study||12||
59969929|NCT02848729|76087286|FG000|NOT COMPLETED|Overall Study||16||
59969930|NCT02848729|76087287|FG001|NOT COMPLETED|Overall Study||11||
59969931|NCT00158756|76087305|FG000|STARTED|Overall Study||80||
59969932|NCT00158756|76087306|FG001|STARTED|Overall Study||25||
59811284|NCT00021541|75933561|FG000|COMPLETED|Period 1-First Treatment||20||
59811285|NCT00021541|75933562|FG001|COMPLETED|Period 1-First Treatment||23||
59811286|NCT00021541|75933561|FG000|NOT COMPLETED|Period 1-First Treatment||11||
59811287|NCT00021541|75933562|FG001|NOT COMPLETED|Period 1-First Treatment||8||
59811288|NCT00021541|75933561|FG000|STARTED|Period 2-crossover||20||
59811289|NCT00021541|75933562|FG001|STARTED|Period 2-crossover||23||
59969933|NCT00158756|76087307|FG002|STARTED|Overall Study||81||
59969934|NCT00158756|76087308|FG003|STARTED|Overall Study||23||
59969935|NCT00158756|76087309|FG004|STARTED|Overall Study||99||
59969936|NCT00158756|76087305|FG000|COMPLETED|Overall Study||75||
59969937|NCT00158756|76087306|FG001|COMPLETED|Overall Study||25||
59969938|NCT00158756|76087307|FG002|COMPLETED|Overall Study||73||
59969939|NCT00158756|76087308|FG003|COMPLETED|Overall Study||22||
59969940|NCT00158756|76087309|FG004|COMPLETED|Overall Study||96||
59969941|NCT00158756|76087305|FG000|NOT COMPLETED|Overall Study||5||
59969942|NCT00158756|76087306|FG001|NOT COMPLETED|Overall Study||0||
59969943|NCT00158756|76087307|FG002|NOT COMPLETED|Overall Study||8||
59969944|NCT00158756|76087308|FG003|NOT COMPLETED|Overall Study||1||
59969945|NCT00158756|76087309|FG004|NOT COMPLETED|Overall Study||3||
59969946|NCT02730195|76087321|FG000|STARTED|Overall Study||9||
59969947|NCT02730195|76087321|FG000|COMPLETED|Overall Study||8||
59969948|NCT02730195|76087321|FG000|NOT COMPLETED|Overall Study||1||
59969949|NCT03355755|76087325|FG000|STARTED|Overall Study||15||
59969950|NCT03355755|76087325|FG000|COMPLETED|Overall Study||13||
59969951|NCT03355755|76087325|FG000|NOT COMPLETED|Overall Study||2||
59969952|NCT02730351|76087329|FG000|STARTED|Treatment Period 1 (2 Weeks)||37||
59969953|NCT02730351|76087330|FG001|STARTED|Treatment Period 1 (2 Weeks)||37||
59969954|NCT02730351|76087329|FG000|COMPLETED|Treatment Period 1 (2 Weeks)||36||
59969955|NCT02730351|76087330|FG001|COMPLETED|Treatment Period 1 (2 Weeks)||37||
59969956|NCT02730351|76087329|FG000|NOT COMPLETED|Treatment Period 1 (2 Weeks)||1||
59969957|NCT02730351|76087330|FG001|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0||
59969958|NCT02730351|76087329|FG000|STARTED|Wash-out Period (2 Weeks)||36||
59969959|NCT02730351|76087330|FG001|STARTED|Wash-out Period (2 Weeks)||37||
59811290|NCT00021541|75933561|FG000|COMPLETED|Period 2-crossover||10||
59811291|NCT00021541|75933562|FG001|COMPLETED|Period 2-crossover||12||
59969960|NCT02730351|76087329|FG000|COMPLETED|Wash-out Period (2 Weeks)||35||
60074389|NCT01576575|76189771|FG000|STARTED|Buprenorphine + Ketoconazole||14||
60074390|NCT01576575|76189771|FG000|COMPLETED|Buprenorphine + Ketoconazole||14||
59811292|NCT00021541|75933561|FG000|NOT COMPLETED|Period 2-crossover||10||
59811293|NCT00021541|75933562|FG001|NOT COMPLETED|Period 2-crossover||11||
59811294|NCT00021229|75933573|FG000|STARTED|Overall Study||36||
59811295|NCT00021229|75933574|FG001|STARTED|Overall Study||33||
59811296|NCT00021229|75933575|FG002|STARTED|Overall Study||16||
59811297|NCT00021229|75933573|FG000|Enrolled in Phase I|Overall Study||35||
59811298|NCT00021229|75933574|FG001|Enrolled in Phase I|Overall Study||33||
59811299|NCT00021229|75933575|FG002|Enrolled in Phase I|Overall Study||16||
59811300|NCT00021229|75933573|FG000|Maximum Tolerated Dose (MTD) Estimation|Overall Study|12 participants enrolled in the Phase I part did not complete the 8 week MTD estimation period.|23||
59811301|NCT00021229|75933574|FG001|Maximum Tolerated Dose (MTD) Estimation|Overall Study|13 participants enrolled in the Phase I part did not complete the 8 week MTD estimation period.|20||
59811302|NCT00021229|75933575|FG002|Maximum Tolerated Dose (MTD) Estimation|Overall Study|4 participants enrolled in the Phase I part did not complete the 8 week MTD estimation period.|12||
59811303|NCT00021229|75933573|FG000|Enrolled in Phase II|Overall Study|Thirteen participants treated at the MTD in the phase I were also part of the phase II.|14||
59811304|NCT00021229|75933574|FG001|Enrolled in Phase II|Overall Study|Participants from stratum IIA did not participate in the phase II part of the study.|0||
59969961|NCT02730351|76087330|FG001|COMPLETED|Wash-out Period (2 Weeks)||36||
59969962|NCT02730351|76087329|FG000|NOT COMPLETED|Wash-out Period (2 Weeks)||1||
59969963|NCT02730351|76087330|FG001|NOT COMPLETED|Wash-out Period (2 Weeks)||1||
59969964|NCT02730351|76087329|FG000|STARTED|Treatment Period 2 (2 Weeks)||35||
59969965|NCT02730351|76087330|FG001|STARTED|Treatment Period 2 (2 Weeks)||36||
59969966|NCT02730351|76087329|FG000|COMPLETED|Treatment Period 2 (2 Weeks)||33||
59969967|NCT02730351|76087330|FG001|COMPLETED|Treatment Period 2 (2 Weeks)||36||
59969968|NCT02730351|76087329|FG000|NOT COMPLETED|Treatment Period 2 (2 Weeks)||2||
59969969|NCT02730351|76087330|FG001|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0||
59969970|NCT01376349|76087339|FG000|STARTED|Raondomized Treatment||147||
59969971|NCT01376349|76087340|FG001|STARTED|Raondomized Treatment||149||
59969972|NCT01376349|76087341|FG002|STARTED|Raondomized Treatment||147||
59969973|NCT01376349|76087339|FG000|COMPLETED|Raondomized Treatment||123||
60074391|NCT01576575|76189771|FG000|NOT COMPLETED|Buprenorphine + Ketoconazole||0||
59969974|NCT01376349|76087340|FG001|COMPLETED|Raondomized Treatment||114||
59969975|NCT01376349|76087341|FG002|COMPLETED|Raondomized Treatment||118||
59969976|NCT01376349|76087339|FG000|NOT COMPLETED|Raondomized Treatment||24||
59969977|NCT01376349|76087340|FG001|NOT COMPLETED|Raondomized Treatment||35||
59969978|NCT01376349|76087341|FG002|NOT COMPLETED|Raondomized Treatment||29||
59969979|NCT01376349|76087339|FG000|STARTED|Optional Continuation Phase||0||
59969980|NCT01376349|76087340|FG001|STARTED|Optional Continuation Phase||0||
59969981|NCT01376349|76087341|FG002|STARTED|Optional Continuation Phase|Patients completing Arm III Placebo were offered the option of continuing High Dose DHEA|94||
59969982|NCT01376349|76087339|FG000|COMPLETED|Optional Continuation Phase||0||
59969983|NCT01376349|76087340|FG001|COMPLETED|Optional Continuation Phase||0||
59811305|NCT00021229|75933575|FG002|Enrolled in Phase II|Overall Study|Participants from stratum IIB did not participate in the phase II part of the study.|0||
59811306|NCT00021229|75933573|FG000|COMPLETED|Overall Study|1 participant completed 13 courses of therapy|1||
59811307|NCT00021229|75933574|FG001|COMPLETED|Overall Study||0||
59811308|NCT00021229|75933575|FG002|COMPLETED|Overall Study||0||
59811309|NCT00021229|75933573|FG000|NOT COMPLETED|Overall Study||35||
59811310|NCT00021229|75933574|FG001|NOT COMPLETED|Overall Study||33||
59969984|NCT01376349|76087341|FG002|COMPLETED|Optional Continuation Phase||94||
59969985|NCT01376349|76087339|FG000|NOT COMPLETED|Optional Continuation Phase||0||
59969986|NCT01376349|76087340|FG001|NOT COMPLETED|Optional Continuation Phase||0||
59969987|NCT01376349|76087341|FG002|NOT COMPLETED|Optional Continuation Phase||0||
59969988|NCT03030261|76087350|FG000|STARTED|Overall Study||25||
59969989|NCT03030261|76087350|FG000|COMPLETED|Overall Study||20||
59969990|NCT03030261|76087350|FG000|NOT COMPLETED|Overall Study||5||
59969991|NCT02176161|76087359|FG000|STARTED|Overall Study||15||
59969992|NCT02176161|76087360|FG001|STARTED|Overall Study||18||
59969993|NCT02176161|76087361|FG002|STARTED|Overall Study||26||
59969994|NCT02176161|76087359|FG000|COMPLETED|Overall Study||15||
59969995|NCT02176161|76087360|FG001|COMPLETED|Overall Study||18||
59969996|NCT02176161|76087361|FG002|COMPLETED|Overall Study||26||
59969997|NCT02176161|76087359|FG000|NOT COMPLETED|Overall Study||0||
59969998|NCT02176161|76087360|FG001|NOT COMPLETED|Overall Study||0||
59969999|NCT02176161|76087361|FG002|NOT COMPLETED|Overall Study||0||
59970000|NCT01700673|76087372|FG000|STARTED|Overall Study||1||
59970001|NCT01700673|76087373|FG001|STARTED|Overall Study||23||
59970002|NCT01700673|76087374|FG002|STARTED|Overall Study||1||
59970003|NCT01700673|76087372|FG000|COMPLETED|Overall Study||1||
59970004|NCT01700673|76087373|FG001|COMPLETED|Overall Study||17||
59970005|NCT01700673|76087374|FG002|COMPLETED|Overall Study||1||
59970006|NCT01700673|76087372|FG000|NOT COMPLETED|Overall Study||0||
59970007|NCT01700673|76087373|FG001|NOT COMPLETED|Overall Study||6||
59970008|NCT01700673|76087374|FG002|NOT COMPLETED|Overall Study||0||
59970009|NCT00158600|76087385|FG000|STARTED|Overall Study||60||
59970010|NCT00158600|76087386|FG001|STARTED|Overall Study||30||
60074392|NCT01555983|76189781|FG000|STARTED|Overall Study||9||
59811311|NCT00021229|75933575|FG002|NOT COMPLETED|Overall Study||16||
59811312|NCT00372112|75933589|FG000|STARTED|Overall Study||17||
59811313|NCT00372112|75933590|FG001|STARTED|Overall Study||16||
59811314|NCT00372112|75933591|FG002|STARTED|Overall Study||17||
59811315|NCT00372112|75933592|FG003|STARTED|Overall Study||18||
59811316|NCT00372112|75933589|FG000|COMPLETED|Overall Study||16||
59811317|NCT00372112|75933590|FG001|COMPLETED|Overall Study||15||
59811318|NCT00372112|75933591|FG002|COMPLETED|Overall Study||13||
59811319|NCT00372112|75933592|FG003|COMPLETED|Overall Study||14||
59811320|NCT00372112|75933589|FG000|NOT COMPLETED|Overall Study||1||
59811321|NCT00372112|75933590|FG001|NOT COMPLETED|Overall Study||1||
59811322|NCT00372112|75933591|FG002|NOT COMPLETED|Overall Study||4||
59811323|NCT00372112|75933592|FG003|NOT COMPLETED|Overall Study||4||
59811324|NCT00488475|75933605|FG000|STARTED|Overall Study||4945||
59811325|NCT00488475|75933605|FG000|COMPLETED|Overall Study||3191||
59811326|NCT00488475|75933605|FG000|NOT COMPLETED|Overall Study||1754||
59811327|NCT00042991|75933616|FG000|STARTED|Overall Study||6||
59811328|NCT00042991|75933617|FG001|STARTED|Overall Study|These 43 patients form the Phase-II cohort, seven contributing from the Phase-I trial.|43||
59811329|NCT00042991|75933618|FG002|STARTED|Overall Study||7||
59811330|NCT00042991|75933619|FG003|STARTED|Overall Study||2||
59811331|NCT00042991|75933620|FG004|STARTED|Overall Study||3||
59811332|NCT00042991|75933621|FG005|STARTED|Overall Study||5||
59811333|NCT00042991|75933622|FG006|STARTED|Overall Study||3||
59811334|NCT00042991|75933616|FG000|Phase-I Trial|Overall Study||6||
59811335|NCT00042991|75933617|FG001|Phase-I Trial|Overall Study|These seven patients contributed to both Phase-I and Phase-II objectives.|7||
59811336|NCT00042991|75933618|FG002|Phase-I Trial|Overall Study||7||
59970011|NCT00158600|76087385|FG000|COMPLETED|Overall Study||55||
59811337|NCT00042991|75933619|FG003|Phase-I Trial|Overall Study||2||
59970012|NCT00158600|76087386|FG001|COMPLETED|Overall Study||26||
59970013|NCT00158600|76087385|FG000|NOT COMPLETED|Overall Study||5||
59970014|NCT00158600|76087386|FG001|NOT COMPLETED|Overall Study||4||
59970015|NCT01680458|76087393|FG000|STARTED|Overall Study||30||
59811338|NCT00042991|75933620|FG004|Phase-I Trial|Overall Study||3||
59970016|NCT01680458|76087393|FG000|COMPLETED|Overall Study||27||
59970017|NCT01680458|76087393|FG000|NOT COMPLETED|Overall Study||3||
59970018|NCT04543136|76087397|FG000|STARTED|Overall Study||3||
59970019|NCT04543136|76087398|FG001|STARTED|Overall Study||3||
59970020|NCT04543136|76087399|FG002|STARTED|Overall Study||2||
59970021|NCT04543136|76087400|FG003|STARTED|Overall Study||3||
59970022|NCT04543136|76087401|FG004|STARTED|Overall Study||2||
59970023|NCT04543136|76087402|FG005|STARTED|Overall Study||3||
59970024|NCT04543136|76087397|FG000|COMPLETED|Overall Study||3||
59970025|NCT04543136|76087398|FG001|COMPLETED|Overall Study|Participant withdrew after baseline visit and prior to any interventions.|2||
59970026|NCT04543136|76087399|FG002|COMPLETED|Overall Study||2||
59970027|NCT04543136|76087400|FG003|COMPLETED|Overall Study|Participant withdrew after baseline visit and prior to any interventions.|2||
59970028|NCT04543136|76087401|FG004|COMPLETED|Overall Study||2||
59970029|NCT04543136|76087402|FG005|COMPLETED|Overall Study||3||
59970030|NCT04543136|76087397|FG000|NOT COMPLETED|Overall Study||0||
59970031|NCT04543136|76087398|FG001|NOT COMPLETED|Overall Study||1||
59970032|NCT04543136|76087399|FG002|NOT COMPLETED|Overall Study||0||
59970033|NCT04543136|76087400|FG003|NOT COMPLETED|Overall Study||1||
59970034|NCT04543136|76087401|FG004|NOT COMPLETED|Overall Study||0||
59970035|NCT04543136|76087402|FG005|NOT COMPLETED|Overall Study||0||
60074393|NCT01555983|76189782|FG001|STARTED|Overall Study||7||
60074394|NCT01555983|76189783|FG002|STARTED|Overall Study||7||
60074395|NCT01555983|76189784|FG003|STARTED|Overall Study||7||
59811339|NCT00042991|75933621|FG005|Phase-I Trial|Overall Study||5||
59811340|NCT00042991|75933622|FG006|Phase-I Trial|Overall Study||3||
59811341|NCT00042991|75933616|FG000|Phase-II Trial|Overall Study||0||
59811342|NCT00042991|75933617|FG001|Phase-II Trial|Overall Study||36||
59811343|NCT00042991|75933618|FG002|Phase-II Trial|Overall Study||0||
59811344|NCT00042991|75933619|FG003|Phase-II Trial|Overall Study||0||
59811345|NCT00042991|75933620|FG004|Phase-II Trial|Overall Study||0||
59811346|NCT00042991|75933621|FG005|Phase-II Trial|Overall Study||0||
59811347|NCT00042991|75933622|FG006|Phase-II Trial|Overall Study||0||
59811348|NCT00042991|75933616|FG000|COMPLETED|Overall Study||0||
59811349|NCT00042991|75933617|FG001|COMPLETED|Overall Study||3||
59811350|NCT00042991|75933618|FG002|COMPLETED|Overall Study||1||
59811351|NCT00042991|75933619|FG003|COMPLETED|Overall Study||0||
59811352|NCT00042991|75933620|FG004|COMPLETED|Overall Study||0||
59811353|NCT00042991|75933621|FG005|COMPLETED|Overall Study||0||
59811354|NCT00042991|75933622|FG006|COMPLETED|Overall Study||1||
59811355|NCT00042991|75933616|FG000|NOT COMPLETED|Overall Study||6||
59811356|NCT00042991|75933617|FG001|NOT COMPLETED|Overall Study||40||
59811357|NCT00042991|75933618|FG002|NOT COMPLETED|Overall Study||6||
59811358|NCT00042991|75933619|FG003|NOT COMPLETED|Overall Study||2||
59811359|NCT00042991|75933620|FG004|NOT COMPLETED|Overall Study||3||
59811360|NCT00042991|75933621|FG005|NOT COMPLETED|Overall Study||5||
59811361|NCT00042991|75933622|FG006|NOT COMPLETED|Overall Study||2||
59811362|NCT00466167|75933643|FG000|STARTED|Overall Study||165||
59811363|NCT00466167|75933644|FG001|STARTED|Overall Study||175||
59811364|NCT00466167|75933645|FG002|STARTED|Overall Study||178||
59811365|NCT00466167|75933643|FG000|COMPLETED|Overall Study||145||
59811366|NCT00466167|75933644|FG001|COMPLETED|Overall Study||163||
59811367|NCT00466167|75933645|FG002|COMPLETED|Overall Study||157||
59811368|NCT00466167|75933643|FG000|NOT COMPLETED|Overall Study||20||
59811369|NCT00466167|75933644|FG001|NOT COMPLETED|Overall Study||12||
59811370|NCT00466167|75933645|FG002|NOT COMPLETED|Overall Study||21||
59811371|NCT00480441|75933655|FG000|STARTED|Screening||61||
59811372|NCT00480441|75933656|FG001|STARTED|Screening|"Participants did not enter this arm until period 3 randomization"|0||
59811373|NCT00480441|75933657|FG002|STARTED|Screening|"Participants did not enter this arm until period 3 randomization"|0||
59811374|NCT00480441|75933655|FG000|COMPLETED|Screening||24||
59970036|NCT00709761|76087410|FG000|STARTED|Overall Study||60||
59970037|NCT00709761|76087410|FG000|COMPLETED|Overall Study||33||
59970038|NCT00709761|76087410|FG000|NOT COMPLETED|Overall Study||27||
59970039|NCT01789346|76087414|FG000|STARTED|Overall Study||20||40
59970040|NCT01789346|76087414|FG000|Treatment With 532 nm KTP Laser|Overall Study||20||20
59970041|NCT01789346|76087414|FG000|Treatment With 595 nm PDL Laser|Overall Study||20||20
60074396|NCT01555983|76189785|FG004|STARTED|Overall Study||5||
60074397|NCT01555983|76189786|FG005|STARTED|Overall Study||7||
59811375|NCT00480441|75933656|FG001|COMPLETED|Screening|"Participants did not enter this arm until period 3 randomization"|0||
59811376|NCT00480441|75933657|FG002|COMPLETED|Screening|"Participants did not enter this arm until period 3 randomization"|0||
59811377|NCT00480441|75933655|FG000|NOT COMPLETED|Screening||37||
59811378|NCT00480441|75933656|FG001|NOT COMPLETED|Screening||0||
59811379|NCT00480441|75933657|FG002|NOT COMPLETED|Screening||0||
59970042|NCT01789346|76087414|FG000|COMPLETED|Overall Study||18||36
60074398|NCT01555983|76189781|FG000|COMPLETED|Overall Study|One subject only finished the placebo session, then dropped out of study|8||
59811380|NCT00480441|75933655|FG000|STARTED|Baseline Functional MRI|All non-randomized participants who also met specific eligibility for baseline functional MRI|24||
59970043|NCT01789346|76087414|FG000|NOT COMPLETED|Overall Study||2||4
59970044|NCT02848651|76087420|FG000|STARTED|Overall Study||153||
59970045|NCT02848651|76087420|FG000|Received Treatment|Overall Study||152||
59970046|NCT02848651|76087420|FG000|COMPLETED|Overall Study||47||
59970047|NCT02848651|76087420|FG000|NOT COMPLETED|Overall Study||106||
59970048|NCT00709059|76087440|FG000|STARTED|Overall Study||538||
60074399|NCT01555983|76189782|FG001|COMPLETED|Overall Study||7||
59970049|NCT00709059|76087440|FG000|COMPLETED|Overall Study||444||
59970050|NCT00709059|76087440|FG000|NOT COMPLETED|Overall Study||94||
59970051|NCT01678820|76087447|FG000|STARTED|Overall Study||100||
59970052|NCT01678820|76087448|FG001|STARTED|Overall Study||99||
59811381|NCT00480441|75933656|FG001|STARTED|Baseline Functional MRI|"Participants did not enter this arm until period 3 randomization"|0||
59811382|NCT00480441|75933657|FG002|STARTED|Baseline Functional MRI|"Participants did not enter this arm until period 3 randomization"|0||
59811383|NCT00480441|75933655|FG000|COMPLETED|Baseline Functional MRI||12||
59970053|NCT01678820|76087449|FG002|STARTED|Overall Study||100||
59970054|NCT01678820|76087447|FG000|Treated With Double-blind Study Drug|Overall Study||100||
59970055|NCT01678820|76087448|FG001|Treated With Double-blind Study Drug|Overall Study||97||
59970056|NCT01678820|76087449|FG002|Treated With Double-blind Study Drug|Overall Study||98||
59970057|NCT01678820|76087447|FG000|COMPLETED|Overall Study||38||
60074400|NCT01555983|76189783|FG002|COMPLETED|Overall Study||7||
59811384|NCT00480441|75933656|FG001|COMPLETED|Baseline Functional MRI|"Participants did not enter this arm until period 3 randomization"|0||
59811385|NCT00480441|75933657|FG002|COMPLETED|Baseline Functional MRI|"Participants did not enter this arm until period 3 randomization"|0||
59811386|NCT00480441|75933655|FG000|NOT COMPLETED|Baseline Functional MRI||12||
59811387|NCT00480441|75933656|FG001|NOT COMPLETED|Baseline Functional MRI||0||
59811388|NCT00480441|75933657|FG002|NOT COMPLETED|Baseline Functional MRI||0||
59811389|NCT00480441|75933655|FG000|STARTED|Randomization||0||
59811390|NCT00480441|75933656|FG001|STARTED|Randomization||13||
59811391|NCT00480441|75933657|FG002|STARTED|Randomization||11||
59811392|NCT00480441|75933655|FG000|COMPLETED|Randomization||0||
59811393|NCT00480441|75933656|FG001|COMPLETED|Randomization||6||
59811394|NCT00480441|75933657|FG002|COMPLETED|Randomization||9||
59811395|NCT00480441|75933655|FG000|NOT COMPLETED|Randomization||0||
59811396|NCT00480441|75933656|FG001|NOT COMPLETED|Randomization||7||
59811397|NCT00480441|75933657|FG002|NOT COMPLETED|Randomization||2||
59811398|NCT00488319|75933667|FG000|STARTED|Overall Study||39||
59811399|NCT00488319|75933668|FG001|STARTED|Overall Study||118||
59811400|NCT00488319|75933669|FG002|STARTED|Overall Study||243||
59811401|NCT00488319|75933667|FG000|COMPLETED|Overall Study||24||
59811402|NCT00488319|75933668|FG001|COMPLETED|Overall Study||75||
59811403|NCT00488319|75933669|FG002|COMPLETED|Overall Study||121||
59811404|NCT00488319|75933667|FG000|NOT COMPLETED|Overall Study||15||
59811405|NCT00488319|75933668|FG001|NOT COMPLETED|Overall Study||43||
59811406|NCT00488319|75933669|FG002|NOT COMPLETED|Overall Study||122||
59811407|NCT00463047|75933678|FG000|STARTED|Titration Period 1|323 subjects entered study period but 3 discontinued before being randomized to treatment|160||
59811408|NCT00463047|75933679|FG001|STARTED|Titration Period 1||160||
59811409|NCT00463047|75933678|FG000|COMPLETED|Titration Period 1||123||
59811410|NCT00463047|75933679|FG001|COMPLETED|Titration Period 1||121||
59970058|NCT01678820|76087448|FG001|COMPLETED|Overall Study||36||
59970059|NCT01678820|76087449|FG002|COMPLETED|Overall Study||43||
59970060|NCT01678820|76087447|FG000|NOT COMPLETED|Overall Study||62||
59970061|NCT01678820|76087448|FG001|NOT COMPLETED|Overall Study||63||
59970062|NCT01678820|76087449|FG002|NOT COMPLETED|Overall Study||57||
59970063|NCT02660138|76087461|FG000|STARTED|Overall Study||76|Subjects randomised in DBPC cycle|
59970064|NCT02660138|76087462|FG001|STARTED|Overall Study||76|Subjects randomised in DBPC cycle|
59970065|NCT02660138|76087463|FG002|STARTED|Overall Study||75|Subjects randomised in DBPC cycle|
59970066|NCT02660138|76087461|FG000|Subjects Treated in DBPC Cycle|Overall Study||76||
59970067|NCT02660138|76087462|FG001|Subjects Treated in DBPC Cycle|Overall Study||75||
59970068|NCT02660138|76087463|FG002|Subjects Treated in DBPC Cycle|Overall Study||75||
59970069|NCT02660138|76087461|FG000|Subjects Entered in the Dysport Cycles|Overall Study||49||
59970070|NCT02660138|76087462|FG001|Subjects Entered in the Dysport Cycles|Overall Study||75||
59970071|NCT02660138|76087463|FG002|Subjects Entered in the Dysport Cycles|Overall Study||75||
59970072|NCT02660138|76087461|FG000|COMPLETED|Overall Study||6|Subjects completed the study in the Dysport cycles|
59970073|NCT02660138|76087462|FG001|COMPLETED|Overall Study||2|Subjects completed the study in the Dysport cycles|
59970074|NCT02660138|76087463|FG002|COMPLETED|Overall Study||3|Subjects completed the study in the Dysport cycles|
59970075|NCT02660138|76087461|FG000|NOT COMPLETED|Overall Study||70||
59970076|NCT02660138|76087462|FG001|NOT COMPLETED|Overall Study||74||
59970077|NCT02660138|76087463|FG002|NOT COMPLETED|Overall Study||72||
59970078|NCT01603394|76087474|FG000|STARTED|Overall Study||9||
59970079|NCT01603394|76087474|FG000|COMPLETED|Overall Study||8||
59970080|NCT01603394|76087474|FG000|NOT COMPLETED|Overall Study||1||
59970081|NCT02729025|76087480|FG000|STARTED|Overall Study||64||
59970082|NCT02729025|76087481|FG001|STARTED|Overall Study||65||
59970083|NCT02729025|76087480|FG000|COMPLETED|Overall Study||64||
59970084|NCT02729025|76087481|FG001|COMPLETED|Overall Study||64||
59970085|NCT02729025|76087480|FG000|NOT COMPLETED|Overall Study||0||
59970086|NCT02729025|76087481|FG001|NOT COMPLETED|Overall Study||1||
59970087|NCT01603082|76087489|FG000|STARTED|Overall Study|Randomized|51||
59970088|NCT01603082|76087490|FG001|STARTED|Overall Study|Randomized|49||
60074401|NCT01555983|76189784|FG003|COMPLETED|Overall Study||7||
59970089|NCT01603082|76087489|FG000|COMPLETED|Overall Study|Completed the study.|49||
59970090|NCT01603082|76087490|FG001|COMPLETED|Overall Study|Completed the study|48||
59970091|NCT01603082|76087489|FG000|NOT COMPLETED|Overall Study||2||
59970092|NCT01603082|76087490|FG001|NOT COMPLETED|Overall Study||1||
59970093|NCT03780387|76087496|FG000|STARTED|Overall Study||1||
59970094|NCT03780387|76087496|FG000|COMPLETED|Overall Study||1||
59970095|NCT03780387|76087496|FG000|NOT COMPLETED|Overall Study||0||
59970096|NCT02846779|76087503|FG000|STARTED|Overall Study||2000||
59970097|NCT02846779|76087504|FG001|STARTED|Overall Study||2000||
59970098|NCT02846779|76087505|FG002|STARTED|Overall Study||2000||
59970099|NCT02846779|76087503|FG000|COMPLETED|Overall Study||1861||
59970100|NCT02846779|76087504|FG001|COMPLETED|Overall Study||1873||
59970101|NCT02846779|76087505|FG002|COMPLETED|Overall Study||1862||
59970102|NCT02846779|76087503|FG000|NOT COMPLETED|Overall Study||139||
59970103|NCT02846779|76087504|FG001|NOT COMPLETED|Overall Study||127||
59811411|NCT00463047|75933678|FG000|NOT COMPLETED|Titration Period 1||37||
59811412|NCT00463047|75933679|FG001|NOT COMPLETED|Titration Period 1||39||
59811413|NCT00463047|75933678|FG000|STARTED|Titration Period 2||123||
59811414|NCT00463047|75933679|FG001|STARTED|Titration Period 2||121||
59811415|NCT00463047|75933678|FG000|COMPLETED|Titration Period 2||93||
59811416|NCT00463047|75933679|FG001|COMPLETED|Titration Period 2||98||
59811417|NCT00463047|75933678|FG000|NOT COMPLETED|Titration Period 2||30||
59811418|NCT00463047|75933679|FG001|NOT COMPLETED|Titration Period 2||23||
59811419|NCT00463047|75933678|FG000|STARTED|Double-Blind Treatment Period 1|After completion of titration period subjects were re-randomized to these two treatment arms|96||
59811420|NCT00463047|75933679|FG001|STARTED|Double-Blind Treatment Period 1|After completion of titration period subjects were re-randomized to these two treatment arms|94||
59811421|NCT00463047|75933678|FG000|COMPLETED|Double-Blind Treatment Period 1||93||
59811422|NCT00463047|75933679|FG001|COMPLETED|Double-Blind Treatment Period 1||90||
59811423|NCT00463047|75933678|FG000|NOT COMPLETED|Double-Blind Treatment Period 1||3||
59811424|NCT00463047|75933679|FG001|NOT COMPLETED|Double-Blind Treatment Period 1||4||
59811425|NCT00463047|75933678|FG000|STARTED|Double-Blind Treatment Period 2||93||
59811426|NCT00463047|75933679|FG001|STARTED|Double-Blind Treatment Period 2||90||
59811427|NCT00463047|75933678|FG000|COMPLETED|Double-Blind Treatment Period 2||92||
59811428|NCT00463047|75933679|FG001|COMPLETED|Double-Blind Treatment Period 2||88||
59811429|NCT00463047|75933678|FG000|NOT COMPLETED|Double-Blind Treatment Period 2||1||
59811430|NCT00463047|75933679|FG001|NOT COMPLETED|Double-Blind Treatment Period 2||2||
59811431|NCT00487695|75933686|FG000|STARTED|First Procedure||23||
59811432|NCT00487695|75933687|FG001|STARTED|First Procedure||23||
59811433|NCT00487695|75933686|FG000|COMPLETED|First Procedure||20||
59811434|NCT00487695|75933687|FG001|COMPLETED|First Procedure||23||
59811435|NCT00487695|75933686|FG000|NOT COMPLETED|First Procedure||3||
59811436|NCT00487695|75933687|FG001|NOT COMPLETED|First Procedure||0||
59811437|NCT00487695|75933686|FG000|STARTED|Second Procedure||20||
59811438|NCT00487695|75933687|FG001|STARTED|Second Procedure||23||
59811439|NCT00487695|75933686|FG000|COMPLETED|Second Procedure||19||
59811440|NCT00487695|75933687|FG001|COMPLETED|Second Procedure||20||
59811441|NCT00487695|75933686|FG000|NOT COMPLETED|Second Procedure||1||
59811442|NCT00487695|75933687|FG001|NOT COMPLETED|Second Procedure||3||
59811443|NCT00487539|75933697|FG000|STARTED|Overall Study||331||
59811444|NCT00487539|75933698|FG001|STARTED|Overall Study||72||
59811445|NCT00487539|75933699|FG002|STARTED|Overall Study||331||
59811446|NCT00487539|75933700|FG003|STARTED|Overall Study||331||
59811447|NCT00487539|75933697|FG000|COMPLETED|Overall Study||324||
59811448|NCT00487539|75933698|FG001|COMPLETED|Overall Study||69||
59811449|NCT00487539|75933699|FG002|COMPLETED|Overall Study||328||
59811450|NCT00487539|75933700|FG003|COMPLETED|Overall Study||327||
59811451|NCT00487539|75933697|FG000|NOT COMPLETED|Overall Study||7||
59811452|NCT00487539|75933698|FG001|NOT COMPLETED|Overall Study||3||
59811453|NCT00487539|75933699|FG002|NOT COMPLETED|Overall Study||3||
59811454|NCT00487539|75933700|FG003|NOT COMPLETED|Overall Study||4||
59811455|NCT00486837|75933711|FG000|STARTED|Overall Study||37||
59811456|NCT00486837|75933712|FG001|STARTED|Overall Study||35||
59811457|NCT00486837|75933711|FG000|COMPLETED|Overall Study||28||
59811458|NCT00486837|75933712|FG001|COMPLETED|Overall Study||28||
59811459|NCT00486837|75933711|FG000|NOT COMPLETED|Overall Study||9||
59811460|NCT00486837|75933712|FG001|NOT COMPLETED|Overall Study||7||
59811461|NCT00486759|75933722|FG000|STARTED|Treatment||390||
59811462|NCT00486759|75933723|FG001|STARTED|Treatment||397||
59811463|NCT00486759|75933722|FG000|COMPLETED|Treatment||203||
59811464|NCT00486759|75933723|FG001|COMPLETED|Treatment||260||
59811465|NCT00486759|75933722|FG000|NOT COMPLETED|Treatment||187||
59970104|NCT02846779|76087505|FG002|NOT COMPLETED|Overall Study||138||
59970105|NCT00406393|76087515|FG000|STARTED|Overall Study||151||
59970106|NCT00406393|76087516|FG001|STARTED|Overall Study||153||
59811466|NCT00486759|75933723|FG001|NOT COMPLETED|Treatment||137||
59811467|NCT00486759|75933722|FG000|STARTED|Safety Follow-up||203||
59811468|NCT00486759|75933723|FG001|STARTED|Safety Follow-up||260||
59811469|NCT00486759|75933722|FG000|COMPLETED|Safety Follow-up||64||
59811470|NCT00486759|75933723|FG001|COMPLETED|Safety Follow-up||142||
59811471|NCT00486759|75933722|FG000|NOT COMPLETED|Safety Follow-up||139||
59811472|NCT00486759|75933723|FG001|NOT COMPLETED|Safety Follow-up||118||
59811473|NCT00486603|75933731|FG000|STARTED|Overall Study||3||
59811474|NCT00486603|75933732|FG001|STARTED|Overall Study||7||
59811475|NCT00486603|75933733|FG002|STARTED|Overall Study||3||
59970107|NCT00406393|76087515|FG000|COMPLETED|Overall Study||149||
59970108|NCT00406393|76087516|FG001|COMPLETED|Overall Study||152||
59970109|NCT00406393|76087515|FG000|NOT COMPLETED|Overall Study||2||
59970110|NCT00406393|76087516|FG001|NOT COMPLETED|Overall Study||1||
59970111|NCT02845375|76087525|FG000|STARTED|Overall Study||13||
59970112|NCT02845375|76087526|FG001|STARTED|Overall Study||14||
59970113|NCT02845375|76087527|FG002|STARTED|Overall Study||13||
59970114|NCT02845375|76087525|FG000|COMPLETED|Overall Study||12||
59970115|NCT02845375|76087526|FG001|COMPLETED|Overall Study||12||
59811476|NCT00486603|75933734|FG003|STARTED|Overall Study||3||
59811477|NCT00486603|75933735|FG004|STARTED|Overall Study||76||
59811478|NCT00486603|75933731|FG000|COMPLETED|Overall Study||2||
59970116|NCT02845375|76087527|FG002|COMPLETED|Overall Study||12||
60074402|NCT01555983|76189785|FG004|COMPLETED|Overall Study|One subject complete 6.7%THC and placebo sessions, then dropped out|4||
60074403|NCT01555983|76189786|FG005|COMPLETED|Overall Study|One subject completed the 6.7%THC session, then dropped out.|6||
60074404|NCT01555983|76189781|FG000|NOT COMPLETED|Overall Study||1||
60074405|NCT01555983|76189782|FG001|NOT COMPLETED|Overall Study||0||
60074406|NCT01555983|76189783|FG002|NOT COMPLETED|Overall Study||0||
60074407|NCT01555983|76189784|FG003|NOT COMPLETED|Overall Study||0||
60074408|NCT01555983|76189785|FG004|NOT COMPLETED|Overall Study||1||
60074409|NCT01555983|76189786|FG005|NOT COMPLETED|Overall Study||1||
59970117|NCT02845375|76087525|FG000|NOT COMPLETED|Overall Study||1||
59970118|NCT02845375|76087526|FG001|NOT COMPLETED|Overall Study||2||
59970119|NCT02845375|76087527|FG002|NOT COMPLETED|Overall Study||1||
59970120|NCT02658734|76087535|FG000|STARTED|Overall Study||70||
59970121|NCT02658734|76087535|FG000|COMPLETED|Overall Study||13||
59970122|NCT02658734|76087535|FG000|NOT COMPLETED|Overall Study||57||
59525457|NCT03932240|75620839|FG000|STARTED|Overall Study||18||
59811479|NCT00486603|75933732|FG001|COMPLETED|Overall Study||6||
59811480|NCT00486603|75933733|FG002|COMPLETED|Overall Study||3||
59811481|NCT00486603|75933734|FG003|COMPLETED|Overall Study||3||
59811482|NCT00486603|75933735|FG004|COMPLETED|Overall Study||76||
59811483|NCT00486603|75933731|FG000|NOT COMPLETED|Overall Study||1||
59811484|NCT00486603|75933732|FG001|NOT COMPLETED|Overall Study||1||
59811485|NCT00486603|75933733|FG002|NOT COMPLETED|Overall Study||0||
59811486|NCT00486603|75933734|FG003|NOT COMPLETED|Overall Study||0||
59811487|NCT00486603|75933735|FG004|NOT COMPLETED|Overall Study||0||
59811488|NCT00486291|75933752|FG000|STARTED|Overall Study|3 subjects discontinued prior to first dose|105||
59970123|NCT02844439|76087539|FG000|STARTED|Overall Study|"All Subjects with Glioblastoma:~24 subjects with EGFR-gene amplified + 16 subjects without EGFR gene-amplified nor EGFRvIII^pos"|40||
59970124|NCT02844439|76087539|FG000|Subpopulation A (EGFR Gene Amplified Glioblastoma)|Overall Study||24||
59970125|NCT02844439|76087539|FG000|Subpopulation B (EGFRvIII^Pos Glioblastoma)|Overall Study||11||
60074410|NCT01576341|76189794|FG000|STARTED|Overall Study||417||
60074411|NCT01576341|76189794|FG000|COMPLETED|Overall Study||324||
60074412|NCT01576341|76189794|FG000|NOT COMPLETED|Overall Study||93||
60074413|NCT03331978|76189803|FG000|STARTED|Overall Study||122||
59811489|NCT00486291|75933753|FG001|STARTED|Overall Study|1 subject discontinued prior to first dose|105||
59811490|NCT00486291|75933752|FG000|COMPLETED|Overall Study||89||
59811491|NCT00486291|75933753|FG001|COMPLETED|Overall Study||76||
59811492|NCT00486291|75933752|FG000|NOT COMPLETED|Overall Study||16||
59811493|NCT00486291|75933753|FG001|NOT COMPLETED|Overall Study||29||
59811494|NCT00474045|75933761|FG000|STARTED|Overall Study||233||
59811495|NCT00474045|75933762|FG001|STARTED|Overall Study||237||
59811496|NCT00474045|75933761|FG000|Exposed-All Subjects|Overall Study||233||
59970126|NCT02844439|76087539|FG000|COMPLETED|Overall Study||0||
59970127|NCT02844439|76087539|FG000|NOT COMPLETED|Overall Study||40||
59970128|NCT01677182|76087553|FG000|STARTED|Overall Study||184||
60074414|NCT03331978|76189804|FG001|STARTED|Overall Study||123||
60074415|NCT03331978|76189803|FG000|COMPLETED|Overall Study||85||
60074416|NCT03331978|76189804|FG001|COMPLETED|Overall Study||81||
60074417|NCT03331978|76189803|FG000|NOT COMPLETED|Overall Study||37||
60074418|NCT03331978|76189804|FG001|NOT COMPLETED|Overall Study||42||
60074419|NCT01687413|76189812|FG000|STARTED|Overall Study||27||
60074420|NCT01687413|76189813|FG001|STARTED|Overall Study||15||
60074421|NCT01687413|76189812|FG000|COMPLETED|Overall Study||26||
60074422|NCT01687413|76189813|FG001|COMPLETED|Overall Study||11||
60074423|NCT01687413|76189812|FG000|NOT COMPLETED|Overall Study||1||
59525458|NCT03932240|75620840|FG001|STARTED|Overall Study||18||
60074424|NCT01687413|76189813|FG001|NOT COMPLETED|Overall Study||4||
60074425|NCT01555671|76189839|FG000|STARTED|Overall Study||125||
60074426|NCT01555671|76189840|FG001|STARTED|Overall Study||125||
60074427|NCT01555671|76189839|FG000|COMPLETED|Overall Study||105||
59811497|NCT00474045|75933762|FG001|Exposed-All Subjects|Overall Study|5 withdrawn before treatment initiation|232||
59811498|NCT00474045|75933761|FG000|Exposed-Pregnant Subjects|Overall Study||152||
59811499|NCT00474045|75933762|FG001|Exposed-Pregnant Subjects|Overall Study|3 withdrawn before treatment initiation|158||
59811500|NCT00474045|75933761|FG000|Pregnancies (for Exposed-pregnant)|Overall Study||152||
59811501|NCT00474045|75933762|FG001|Pregnancies (for Exposed-pregnant)|Overall Study|2 subjects had spontaneous abortion and became pregnant again|160||
59811502|NCT00474045|75933761|FG000|COMPLETED|Overall Study||127||
59811503|NCT00474045|75933762|FG001|COMPLETED|Overall Study||136||
59811504|NCT00474045|75933761|FG000|NOT COMPLETED|Overall Study||106||
60074428|NCT01555671|76189840|FG001|COMPLETED|Overall Study||100||
59970129|NCT01677182|76087554|FG001|STARTED|Overall Study||169||
59970130|NCT01677182|76087555|FG002|STARTED|Overall Study||182||
59970131|NCT01677182|76087553|FG000|COMPLETED|Overall Study||150||
59970132|NCT01677182|76087554|FG001|COMPLETED|Overall Study||141||
59970133|NCT01677182|76087555|FG002|COMPLETED|Overall Study||143||
59970134|NCT01677182|76087553|FG000|NOT COMPLETED|Overall Study||34||
59970135|NCT01677182|76087554|FG001|NOT COMPLETED|Overall Study||28||
59970136|NCT01677182|76087555|FG002|NOT COMPLETED|Overall Study||39||
59970137|NCT02843659|76087566|FG000|STARTED|Overall Study||5||
59970138|NCT02843659|76087567|FG001|STARTED|Overall Study||6||
59970139|NCT02843659|76087568|FG002|STARTED|Overall Study||7||
59970140|NCT02843659|76087566|FG000|COMPLETED|Overall Study||1||
59970141|NCT02843659|76087567|FG001|COMPLETED|Overall Study||0||
59970142|NCT02843659|76087568|FG002|COMPLETED|Overall Study||2||
59970143|NCT02843659|76087566|FG000|NOT COMPLETED|Overall Study||4||
59970144|NCT02843659|76087567|FG001|NOT COMPLETED|Overall Study||6||
59970145|NCT02843659|76087568|FG002|NOT COMPLETED|Overall Study||5||
59970146|NCT00708435|76087578|FG000|STARTED|Overall Study||107||
59970147|NCT00708435|76087579|FG001|STARTED|Overall Study||109||
59970148|NCT00708435|76087578|FG000|COMPLETED|Overall Study|These data are 'on-study' results collected up to the subject's Day 45 visit.|82||
59970149|NCT00708435|76087579|FG001|COMPLETED|Overall Study|These data are 'on-study' results collected up to the subject's Day 45 visit.|92||
59970150|NCT00708435|76087578|FG000|NOT COMPLETED|Overall Study||25||
59970151|NCT00708435|76087579|FG001|NOT COMPLETED|Overall Study||17||
59970152|NCT02841787|76087590|FG000|STARTED|Overall Study||12||
59970153|NCT02841787|76087591|FG001|STARTED|Overall Study||23||
59970154|NCT02841787|76087592|FG002|STARTED|Overall Study||12||
59970155|NCT02841787|76087590|FG000|COMPLETED|Overall Study||9||
59970156|NCT02841787|76087591|FG001|COMPLETED|Overall Study||19||
59970157|NCT02841787|76087592|FG002|COMPLETED|Overall Study||12||
59970158|NCT02841787|76087590|FG000|NOT COMPLETED|Overall Study||3||
59970159|NCT02841787|76087591|FG001|NOT COMPLETED|Overall Study||4||
59970160|NCT02841787|76087592|FG002|NOT COMPLETED|Overall Study||0||
59970161|NCT01376037|76087602|FG000|STARTED|Overall Study||31||
59970162|NCT01376037|76087603|FG001|STARTED|Overall Study||31||
59970163|NCT01376037|76087602|FG000|COMPLETED|Overall Study||31||
59970164|NCT01376037|76087603|FG001|COMPLETED|Overall Study||29||
59970165|NCT01376037|76087602|FG000|NOT COMPLETED|Overall Study||0||
59970166|NCT01376037|76087603|FG001|NOT COMPLETED|Overall Study||2||
59970167|NCT02657408|76087611|FG000|STARTED|Overall Study||28||
59970168|NCT02657408|76087612|FG001|STARTED|Overall Study||29||
59970169|NCT02657408|76087611|FG000|COMPLETED|Overall Study||25||
59970170|NCT02657408|76087612|FG001|COMPLETED|Overall Study||22||
59970171|NCT02657408|76087611|FG000|NOT COMPLETED|Overall Study||3||
59970172|NCT02657408|76087612|FG001|NOT COMPLETED|Overall Study||7||
59970173|NCT02841709|76087618|FG000|STARTED|1st Intervention||12||
59970174|NCT02841709|76087619|FG001|STARTED|1st Intervention||11||
59970175|NCT02841709|76087620|FG002|STARTED|1st Intervention||12||
59970176|NCT02841709|76087621|FG003|STARTED|1st Intervention||12||
59970177|NCT02841709|76087622|FG004|STARTED|1st Intervention||11||
59970178|NCT02841709|76087618|FG000|COMPLETED|1st Intervention||12||
59970179|NCT02841709|76087619|FG001|COMPLETED|1st Intervention||11||
59970180|NCT02841709|76087620|FG002|COMPLETED|1st Intervention||12||
59970181|NCT02841709|76087621|FG003|COMPLETED|1st Intervention||12||
59970182|NCT02841709|76087622|FG004|COMPLETED|1st Intervention||11||
59970183|NCT02841709|76087618|FG000|NOT COMPLETED|1st Intervention||0||
59970184|NCT02841709|76087619|FG001|NOT COMPLETED|1st Intervention||0||
59970185|NCT02841709|76087620|FG002|NOT COMPLETED|1st Intervention||0||
59970186|NCT02841709|76087621|FG003|NOT COMPLETED|1st Intervention||0||
59970187|NCT02841709|76087622|FG004|NOT COMPLETED|1st Intervention||0||
59970188|NCT02841709|76087618|FG000|STARTED|Washout Period 1||12||
59970189|NCT02841709|76087619|FG001|STARTED|Washout Period 1||11||
59970190|NCT02841709|76087620|FG002|STARTED|Washout Period 1||12||
59970191|NCT02841709|76087621|FG003|STARTED|Washout Period 1||12||
59970192|NCT02841709|76087622|FG004|STARTED|Washout Period 1||11||
59970193|NCT02841709|76087618|FG000|COMPLETED|Washout Period 1||12||
59970194|NCT02841709|76087619|FG001|COMPLETED|Washout Period 1||11||
59970195|NCT02841709|76087620|FG002|COMPLETED|Washout Period 1||12||
59970196|NCT02841709|76087621|FG003|COMPLETED|Washout Period 1||12||
59970197|NCT02841709|76087622|FG004|COMPLETED|Washout Period 1||11||
59970198|NCT02841709|76087618|FG000|NOT COMPLETED|Washout Period 1||0||
59970199|NCT02841709|76087619|FG001|NOT COMPLETED|Washout Period 1||0||
59970200|NCT02841709|76087620|FG002|NOT COMPLETED|Washout Period 1||0||
59970201|NCT02841709|76087621|FG003|NOT COMPLETED|Washout Period 1||0||
59970202|NCT02841709|76087622|FG004|NOT COMPLETED|Washout Period 1||0||
59970203|NCT02841709|76087618|FG000|STARTED|2nd Intervention||12||
59970204|NCT02841709|76087619|FG001|STARTED|2nd Intervention||11||
59970205|NCT02841709|76087620|FG002|STARTED|2nd Intervention||12||
59970206|NCT02841709|76087621|FG003|STARTED|2nd Intervention||12||
59970207|NCT02841709|76087622|FG004|STARTED|2nd Intervention||11||
59970208|NCT02841709|76087618|FG000|COMPLETED|2nd Intervention||12||
59970209|NCT02841709|76087619|FG001|COMPLETED|2nd Intervention||11||
59970210|NCT02841709|76087620|FG002|COMPLETED|2nd Intervention||12||
59970211|NCT02841709|76087621|FG003|COMPLETED|2nd Intervention||12||
59970212|NCT02841709|76087622|FG004|COMPLETED|2nd Intervention||11||
59970213|NCT02841709|76087618|FG000|NOT COMPLETED|2nd Intervention||0||
59970214|NCT02841709|76087619|FG001|NOT COMPLETED|2nd Intervention||0||
59970215|NCT02841709|76087620|FG002|NOT COMPLETED|2nd Intervention||0||
59970216|NCT02841709|76087621|FG003|NOT COMPLETED|2nd Intervention||0||
59970217|NCT02841709|76087622|FG004|NOT COMPLETED|2nd Intervention||0||
59970218|NCT02841709|76087618|FG000|STARTED|Washout Period 2||12||
59970219|NCT02841709|76087619|FG001|STARTED|Washout Period 2||11||
59970220|NCT02841709|76087620|FG002|STARTED|Washout Period 2||12||
59970221|NCT02841709|76087621|FG003|STARTED|Washout Period 2||12||
59970222|NCT02841709|76087622|FG004|STARTED|Washout Period 2||11||
59970223|NCT02841709|76087618|FG000|COMPLETED|Washout Period 2||12||
59970224|NCT02841709|76087619|FG001|COMPLETED|Washout Period 2||11||
59970225|NCT02841709|76087620|FG002|COMPLETED|Washout Period 2||12||
59970226|NCT02841709|76087621|FG003|COMPLETED|Washout Period 2||12||
59970227|NCT02841709|76087622|FG004|COMPLETED|Washout Period 2||11||
59970228|NCT02841709|76087618|FG000|NOT COMPLETED|Washout Period 2||0||
59970229|NCT02841709|76087619|FG001|NOT COMPLETED|Washout Period 2||0||
59970230|NCT02841709|76087620|FG002|NOT COMPLETED|Washout Period 2||0||
59970231|NCT02841709|76087621|FG003|NOT COMPLETED|Washout Period 2||0||
59970232|NCT02841709|76087622|FG004|NOT COMPLETED|Washout Period 2||0||
59970233|NCT02841709|76087618|FG000|STARTED|3rd Intervention||12||
59970234|NCT02841709|76087619|FG001|STARTED|3rd Intervention||11||
59970235|NCT02841709|76087620|FG002|STARTED|3rd Intervention||12||
59970236|NCT02841709|76087621|FG003|STARTED|3rd Intervention||12||
59970237|NCT02841709|76087622|FG004|STARTED|3rd Intervention||11||
59970238|NCT02841709|76087618|FG000|COMPLETED|3rd Intervention||12||
59811505|NCT00474045|75933762|FG001|NOT COMPLETED|Overall Study||101||
59811506|NCT00462501|75933768|FG000|STARTED|Overall Study||35||
59811507|NCT00462501|75933768|FG000|COMPLETED|Overall Study||30||
60074429|NCT01555671|76189839|FG000|NOT COMPLETED|Overall Study||20||
60074430|NCT01555671|76189840|FG001|NOT COMPLETED|Overall Study||25||
60074431|NCT01801358|76189854|FG000|STARTED|Overall Study||6||
60074432|NCT01801358|76189855|FG001|STARTED|Overall Study||6||
59811508|NCT00462501|75933768|FG000|NOT COMPLETED|Overall Study||5||
59970239|NCT02841709|76087619|FG001|COMPLETED|3rd Intervention||11||
59970240|NCT02841709|76087620|FG002|COMPLETED|3rd Intervention||12||
59811509|NCT00383188|75933777|FG000|STARTED|Overall Study||69||
59811510|NCT00383188|75933778|FG001|STARTED|Overall Study||74||
59811511|NCT00383188|75933779|FG002|STARTED|Overall Study||44||
59811512|NCT00383188|75933780|FG003|STARTED|Overall Study||40||
59811513|NCT00383188|75933781|FG004|STARTED|Overall Study||75||
59811514|NCT00383188|75933777|FG000|COMPLETED|Overall Study||52||
59970241|NCT02841709|76087621|FG003|COMPLETED|3rd Intervention||12||
60074433|NCT01801358|76189856|FG002|STARTED|Overall Study||6||
60074434|NCT01801358|76189857|FG003|STARTED|Overall Study||6||
60074435|NCT01801358|76189858|FG004|STARTED|Overall Study||6||
60074436|NCT01801358|76189859|FG005|STARTED|Overall Study||8||
60074437|NCT01801358|76189854|FG000|COMPLETED|Overall Study||0||
60074438|NCT01801358|76189855|FG001|COMPLETED|Overall Study||0||
60074439|NCT01801358|76189856|FG002|COMPLETED|Overall Study||0||
60074440|NCT01801358|76189857|FG003|COMPLETED|Overall Study||0||
60074441|NCT01801358|76189858|FG004|COMPLETED|Overall Study||0||
60074442|NCT01801358|76189859|FG005|COMPLETED|Overall Study||0||
59811515|NCT00383188|75933778|FG001|COMPLETED|Overall Study||63||
59811516|NCT00383188|75933779|FG002|COMPLETED|Overall Study||31||
59811517|NCT00383188|75933780|FG003|COMPLETED|Overall Study||28||
59811518|NCT00383188|75933781|FG004|COMPLETED|Overall Study||52||
59811519|NCT00383188|75933777|FG000|NOT COMPLETED|Overall Study||17||
59811520|NCT00383188|75933778|FG001|NOT COMPLETED|Overall Study||11||
59811521|NCT00383188|75933779|FG002|NOT COMPLETED|Overall Study||13||
59811522|NCT00383188|75933780|FG003|NOT COMPLETED|Overall Study||12||
59811523|NCT00383188|75933781|FG004|NOT COMPLETED|Overall Study||23||
59811524|NCT00462345|75933795|FG000|STARTED|Overall Study||40||
59811525|NCT00462345|75933795|FG000|Completed First Course|Overall Study||38||
59811526|NCT00462345|75933795|FG000|COMPLETED|Overall Study||37||
59970242|NCT02841709|76087622|FG004|COMPLETED|3rd Intervention||11||
59970243|NCT02841709|76087618|FG000|NOT COMPLETED|3rd Intervention||0||
59970244|NCT02841709|76087619|FG001|NOT COMPLETED|3rd Intervention||0||
59970245|NCT02841709|76087620|FG002|NOT COMPLETED|3rd Intervention||0||
59970246|NCT02841709|76087621|FG003|NOT COMPLETED|3rd Intervention||0||
59970247|NCT02841709|76087622|FG004|NOT COMPLETED|3rd Intervention||0||
59970248|NCT02841709|76087618|FG000|STARTED|Washout Period 3||12||
59970249|NCT02841709|76087619|FG001|STARTED|Washout Period 3||11||
59970250|NCT02841709|76087620|FG002|STARTED|Washout Period 3||12||
59970251|NCT02841709|76087621|FG003|STARTED|Washout Period 3||12||
59970252|NCT02841709|76087622|FG004|STARTED|Washout Period 3||11||
59970253|NCT02841709|76087618|FG000|COMPLETED|Washout Period 3||12||
59970254|NCT02841709|76087619|FG001|COMPLETED|Washout Period 3||11||
59970255|NCT02841709|76087620|FG002|COMPLETED|Washout Period 3||12||
59970256|NCT02841709|76087621|FG003|COMPLETED|Washout Period 3||12||
59970257|NCT02841709|76087622|FG004|COMPLETED|Washout Period 3||11||
59811527|NCT00462345|75933795|FG000|NOT COMPLETED|Overall Study||3||
59811528|NCT00453999|75933802|FG000|STARTED|Overall Study||45||
59970258|NCT02841709|76087618|FG000|NOT COMPLETED|Washout Period 3||0||
59970259|NCT02841709|76087619|FG001|NOT COMPLETED|Washout Period 3||0||
59970260|NCT02841709|76087620|FG002|NOT COMPLETED|Washout Period 3||0||
59970261|NCT02841709|76087621|FG003|NOT COMPLETED|Washout Period 3||0||
59970262|NCT02841709|76087622|FG004|NOT COMPLETED|Washout Period 3||0||
59970263|NCT02841709|76087618|FG000|STARTED|4th Intervention||12||
59970264|NCT02841709|76087619|FG001|STARTED|4th Intervention||11||
59970265|NCT02841709|76087620|FG002|STARTED|4th Intervention||12||
59970266|NCT02841709|76087621|FG003|STARTED|4th Intervention||12||
59970267|NCT02841709|76087622|FG004|STARTED|4th Intervention||11||
59970268|NCT02841709|76087618|FG000|COMPLETED|4th Intervention||12||
59970269|NCT02841709|76087619|FG001|COMPLETED|4th Intervention||11||
59970270|NCT02841709|76087620|FG002|COMPLETED|4th Intervention||12||
59970271|NCT02841709|76087621|FG003|COMPLETED|4th Intervention||12||
59970272|NCT02841709|76087622|FG004|COMPLETED|4th Intervention||11||
59970273|NCT02841709|76087618|FG000|NOT COMPLETED|4th Intervention||0||
59970274|NCT02841709|76087619|FG001|NOT COMPLETED|4th Intervention||0||
59970275|NCT02841709|76087620|FG002|NOT COMPLETED|4th Intervention||0||
59970276|NCT02841709|76087621|FG003|NOT COMPLETED|4th Intervention||0||
59970277|NCT02841709|76087622|FG004|NOT COMPLETED|4th Intervention||0||
59970278|NCT02841709|76087618|FG000|STARTED|Washout Period 4||12||
59970279|NCT02841709|76087619|FG001|STARTED|Washout Period 4||11||
59970280|NCT02841709|76087620|FG002|STARTED|Washout Period 4||12||
59970281|NCT02841709|76087621|FG003|STARTED|Washout Period 4||12||
59970282|NCT02841709|76087622|FG004|STARTED|Washout Period 4||11||
59970283|NCT02841709|76087618|FG000|COMPLETED|Washout Period 4||12||
59970284|NCT02841709|76087619|FG001|COMPLETED|Washout Period 4||11||
59970285|NCT02841709|76087620|FG002|COMPLETED|Washout Period 4||12||
59970286|NCT02841709|76087621|FG003|COMPLETED|Washout Period 4||12||
59970287|NCT02841709|76087622|FG004|COMPLETED|Washout Period 4||11||
59970288|NCT02841709|76087618|FG000|NOT COMPLETED|Washout Period 4||0||
59811529|NCT00453999|75933803|FG001|STARTED|Overall Study||46||
59811530|NCT00453999|75933804|FG002|STARTED|Overall Study||46||
59811531|NCT00453999|75933802|FG000|COMPLETED|Overall Study||40||
59811532|NCT00453999|75933803|FG001|COMPLETED|Overall Study||41||
59811533|NCT00453999|75933804|FG002|COMPLETED|Overall Study||43||
59811534|NCT00453999|75933802|FG000|NOT COMPLETED|Overall Study||5||
59970289|NCT02841709|76087619|FG001|NOT COMPLETED|Washout Period 4||0||
59970290|NCT02841709|76087620|FG002|NOT COMPLETED|Washout Period 4||0||
59970291|NCT02841709|76087621|FG003|NOT COMPLETED|Washout Period 4||0||
59970292|NCT02841709|76087622|FG004|NOT COMPLETED|Washout Period 4||0||
59970293|NCT02841709|76087618|FG000|STARTED|5th Intervention||12||
59970294|NCT02841709|76087619|FG001|STARTED|5th Intervention||11||
59970295|NCT02841709|76087620|FG002|STARTED|5th Intervention||12||
59970296|NCT02841709|76087621|FG003|STARTED|5th Intervention||12||
59811535|NCT00453999|75933803|FG001|NOT COMPLETED|Overall Study||5||
59811536|NCT00453999|75933804|FG002|NOT COMPLETED|Overall Study||3||
59970297|NCT02841709|76087622|FG004|STARTED|5th Intervention||11||
59970298|NCT02841709|76087618|FG000|COMPLETED|5th Intervention|Note: In total, 2 subjects did not complete Sequence 1.|10||
59970299|NCT02841709|76087619|FG001|COMPLETED|5th Intervention||11||
59970300|NCT02841709|76087620|FG002|COMPLETED|5th Intervention||12||
59970301|NCT02841709|76087621|FG003|COMPLETED|5th Intervention||12||
59970302|NCT02841709|76087622|FG004|COMPLETED|5th Intervention|Note: In total, 2 subjects did not complete Sequence 5.|9||
59970303|NCT02841709|76087618|FG000|NOT COMPLETED|5th Intervention||2||
59970304|NCT02841709|76087619|FG001|NOT COMPLETED|5th Intervention||0||
59970305|NCT02841709|76087620|FG002|NOT COMPLETED|5th Intervention||0||
59811537|NCT00453921|75933817|FG000|STARTED|Overall Study||19||
59811538|NCT00453921|75933818|FG001|STARTED|Overall Study||18||
59811539|NCT00453921|75933819|FG002|STARTED|Overall Study||20||
59811540|NCT00453921|75933820|FG003|STARTED|Overall Study||19||
59811541|NCT00453921|75933817|FG000|COMPLETED|Overall Study||18||
59811542|NCT00453921|75933818|FG001|COMPLETED|Overall Study||17||
59811543|NCT00453921|75933819|FG002|COMPLETED|Overall Study||18||
59811544|NCT00453921|75933820|FG003|COMPLETED|Overall Study||18||
59970306|NCT02841709|76087621|FG003|NOT COMPLETED|5th Intervention||0||
59970307|NCT02841709|76087622|FG004|NOT COMPLETED|5th Intervention||2||
59970308|NCT01353859|76087635|FG000|STARTED|Overall Study||39||
59970309|NCT01353859|76087635|FG000|COMPLETED|Overall Study||35||
59970310|NCT01353859|76087635|FG000|NOT COMPLETED|Overall Study||4||
59970311|NCT02850965|76087641|FG000|STARTED|Overall Study||159|Randomized|
59970312|NCT02850965|76087642|FG001|STARTED|Overall Study||159|Randomized|
59970313|NCT02850965|76087641|FG000|Treated|Overall Study||159||
59970314|NCT02850965|76087642|FG001|Treated|Overall Study||158||
59970315|NCT02850965|76087641|FG000|COMPLETED|Overall Study||141||
59811545|NCT00453921|75933817|FG000|NOT COMPLETED|Overall Study||1||
59811546|NCT00453921|75933818|FG001|NOT COMPLETED|Overall Study||1||
59811547|NCT00453921|75933819|FG002|NOT COMPLETED|Overall Study||2||
59811548|NCT00453921|75933820|FG003|NOT COMPLETED|Overall Study||1||
59970316|NCT02850965|76087642|FG001|COMPLETED|Overall Study||134||
59970317|NCT02850965|76087641|FG000|NOT COMPLETED|Overall Study||18||
59970318|NCT02850965|76087642|FG001|NOT COMPLETED|Overall Study||25||
59970319|NCT01375959|76087650|FG000|STARTED|First Intervention (6 Weeks)||17||
59970320|NCT01375959|76087651|FG001|STARTED|First Intervention (6 Weeks)||21||
59811549|NCT00382720|75933837|FG000|STARTED|Overall Study||79||
59811550|NCT00382720|75933838|FG001|STARTED|Overall Study||89||
59811551|NCT00382720|75933839|FG002|STARTED|Overall Study||86||
59970321|NCT01375959|76087650|FG000|Received Invertention|First Intervention (6 Weeks)||17||
59970322|NCT01375959|76087651|FG001|Received Invertention|First Intervention (6 Weeks)||21||
59970323|NCT01375959|76087650|FG000|COMPLETED|First Intervention (6 Weeks)|Two participants were withdrawn due to adverse events.|15||
59970324|NCT01375959|76087651|FG001|COMPLETED|First Intervention (6 Weeks)|Three participants were withdrawn due to adverse events.|18||
59970325|NCT01375959|76087650|FG000|NOT COMPLETED|First Intervention (6 Weeks)||2||
59970326|NCT01375959|76087651|FG001|NOT COMPLETED|First Intervention (6 Weeks)||3||
59970327|NCT01375959|76087650|FG000|STARTED|Wash-Out (3 Weeks)||15||
59970328|NCT01375959|76087651|FG001|STARTED|Wash-Out (3 Weeks)||18||
59970329|NCT01375959|76087650|FG000|COMPLETED|Wash-Out (3 Weeks)||15||
59970330|NCT01375959|76087651|FG001|COMPLETED|Wash-Out (3 Weeks)||18||
59970331|NCT01375959|76087650|FG000|NOT COMPLETED|Wash-Out (3 Weeks)||0||
59970332|NCT01375959|76087651|FG001|NOT COMPLETED|Wash-Out (3 Weeks)||0||
59970333|NCT01375959|76087650|FG000|STARTED|Second Intervention (6 Weeks)||15||
59970334|NCT01375959|76087651|FG001|STARTED|Second Intervention (6 Weeks)||18||
59970335|NCT01375959|76087650|FG000|COMPLETED|Second Intervention (6 Weeks)||15||
59970336|NCT01375959|76087651|FG001|COMPLETED|Second Intervention (6 Weeks)||15||
59970337|NCT01375959|76087650|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0||
59970338|NCT01375959|76087651|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||3||
59970339|NCT00708201|76087661|FG000|STARTED|Overall Study||137||
59970340|NCT00708201|76087662|FG001|STARTED|Overall Study||143||
59970341|NCT00708201|76087661|FG000|Received at Least 1 Dose of Study Drug|Overall Study||130||
59970342|NCT00708201|76087662|FG001|Received at Least 1 Dose of Study Drug|Overall Study||137||
59970343|NCT00708201|76087661|FG000|COMPLETED|Overall Study||130||
59970344|NCT00708201|76087662|FG001|COMPLETED|Overall Study||137||
59970345|NCT00708201|76087661|FG000|NOT COMPLETED|Overall Study||7||
59970346|NCT00708201|76087662|FG001|NOT COMPLETED|Overall Study||6||
59970347|NCT02848313|76087670|FG000|STARTED|Overall Study||21||
59970348|NCT02848313|76087671|FG001|STARTED|Overall Study||19||
59970349|NCT02848313|76087670|FG000|COMPLETED|Overall Study||18||
59970350|NCT02848313|76087671|FG001|COMPLETED|Overall Study||15||
59970351|NCT02848313|76087670|FG000|NOT COMPLETED|Overall Study||3||
59970352|NCT02848313|76087671|FG001|NOT COMPLETED|Overall Study||4||
59970353|NCT02728089|76087677|FG000|STARTED|Overall Study||115||
59970354|NCT02728089|76087677|FG000|Treated|Overall Study||114||
59970355|NCT02728089|76087677|FG000|COMPLETED|Overall Study||112||
59970356|NCT02728089|76087677|FG000|NOT COMPLETED|Overall Study||3||
59970357|NCT02840461|76087684|FG000|STARTED|Overall Study||259||
59970358|NCT02840461|76087685|FG001|STARTED|Overall Study||257||
59970359|NCT02840461|76087686|FG002|STARTED|Overall Study||114||
59970360|NCT02840461|76087684|FG000|COMPLETED|Overall Study||236||
59970361|NCT02840461|76087685|FG001|COMPLETED|Overall Study||235||
59970362|NCT02840461|76087686|FG002|COMPLETED|Overall Study||100||
59970363|NCT02840461|76087684|FG000|NOT COMPLETED|Overall Study||23||
59811552|NCT00382720|75933837|FG000|Administered Non-Optimal Dose (Part I)|Overall Study||10||
59970364|NCT02840461|76087685|FG001|NOT COMPLETED|Overall Study||22||
59970365|NCT02840461|76087686|FG002|NOT COMPLETED|Overall Study||14||
59811553|NCT00382720|75933838|FG001|Administered Non-Optimal Dose (Part I)|Overall Study||11||
59811554|NCT00382720|75933839|FG002|Administered Non-Optimal Dose (Part I)|Overall Study||0||
59811555|NCT00382720|75933837|FG000|Administered Optimal Dose (Parts I & II)|Overall Study||78||
59811556|NCT00382720|75933838|FG001|Administered Optimal Dose (Parts I & II)|Overall Study||88||
59811557|NCT00382720|75933839|FG002|Administered Optimal Dose (Parts I & II)|Overall Study||82||
59811558|NCT00382720|75933837|FG000|Full Analysis Population (FAP)|Overall Study|ITT who received at least one dose of study medication|78||
59811559|NCT00382720|75933838|FG001|Full Analysis Population (FAP)|Overall Study|ITT who received at least one dose of study medication|88||
59811560|NCT00382720|75933839|FG002|Full Analysis Population (FAP)|Overall Study|ITT who received at least one dose of study medication|82||
59811561|NCT00382720|75933837|FG000|COMPLETED|Overall Study||0||
59811562|NCT00382720|75933838|FG001|COMPLETED|Overall Study||0||
59811563|NCT00382720|75933839|FG002|COMPLETED|Overall Study||0||
59811564|NCT00382720|75933837|FG000|NOT COMPLETED|Overall Study||79||
59811565|NCT00382720|75933838|FG001|NOT COMPLETED|Overall Study||89||
59811566|NCT00382720|75933839|FG002|NOT COMPLETED|Overall Study||86||
59811567|NCT00453063|75933849|FG000|STARTED|Overall Study||211||
59811568|NCT00453063|75933850|FG001|STARTED|Overall Study||215||
59811569|NCT00453063|75933849|FG000|COMPLETED|Overall Study||208||
59811570|NCT00453063|75933850|FG001|COMPLETED|Overall Study||212||
59970366|NCT02839681|76087695|FG000|STARTED|Overall Study||2||
59970367|NCT02839681|76087695|FG000|COMPLETED|Overall Study||0||
59970368|NCT02839681|76087695|FG000|NOT COMPLETED|Overall Study||2||
59970369|NCT01676012|76087699|FG000|STARTED|Overall Study||32||
59970370|NCT01676012|76087699|FG000|COMPLETED|Overall Study||29||
59970371|NCT01676012|76087699|FG000|NOT COMPLETED|Overall Study||3||
59970372|NCT04760444|76087705|FG000|STARTED|Overall Study||12||
59970373|NCT04760444|76087706|FG001|STARTED|Overall Study||13||
59970374|NCT04760444|76087705|FG000|COMPLETED|Overall Study||11||
59970375|NCT04760444|76087706|FG001|COMPLETED|Overall Study||8||
59970376|NCT04760444|76087705|FG000|NOT COMPLETED|Overall Study||1||
59970377|NCT04760444|76087706|FG001|NOT COMPLETED|Overall Study||5||
59970378|NCT02727777|76087715|FG000|STARTED|Overall Study||4||
59970379|NCT02727777|76087716|FG001|STARTED|Overall Study||0||
59970380|NCT02727777|76087717|FG002|STARTED|Overall Study||0||
59811571|NCT00453063|75933849|FG000|NOT COMPLETED|Overall Study||3||
59811572|NCT00453063|75933850|FG001|NOT COMPLETED|Overall Study||3||
59811573|NCT00371566|75933858|FG000|STARTED|Treatment Phase||36||
59811574|NCT00371566|75933859|FG001|STARTED|Treatment Phase||71||
59811575|NCT00371566|75933858|FG000|COMPLETED|Treatment Phase||36||
59811576|NCT00371566|75933859|FG001|COMPLETED|Treatment Phase|1 screen failure included in the ITT population|68||
59811577|NCT00371566|75933858|FG000|NOT COMPLETED|Treatment Phase||0||
59811578|NCT00371566|75933859|FG001|NOT COMPLETED|Treatment Phase||3||
59970381|NCT02727777|76087715|FG000|COMPLETED|Overall Study||0||
59970382|NCT02727777|76087716|FG001|COMPLETED|Overall Study||0||
59970383|NCT02727777|76087717|FG002|COMPLETED|Overall Study||0||
59970384|NCT02727777|76087715|FG000|NOT COMPLETED|Overall Study||4||
59970385|NCT02727777|76087716|FG001|NOT COMPLETED|Overall Study||0||
59970386|NCT02727777|76087717|FG002|NOT COMPLETED|Overall Study||0||
59970387|NCT00707577|76087727|FG000|STARTED|Overall Study||174||
59970388|NCT00707577|76087728|FG001|STARTED|Overall Study||156||
59970389|NCT00707577|76087727|FG000|COMPLETED|Overall Study||120||
59970390|NCT00707577|76087728|FG001|COMPLETED|Overall Study||118||
59970391|NCT00707577|76087727|FG000|NOT COMPLETED|Overall Study||54||
59970392|NCT00707577|76087728|FG001|NOT COMPLETED|Overall Study||38||
59970393|NCT01675622|76087736|FG000|STARTED|Overall Study||122||
59970394|NCT01675622|76087737|FG001|STARTED|Overall Study||120||
59970395|NCT01675622|76087736|FG000|COMPLETED|Overall Study||96||
59970396|NCT01675622|76087737|FG001|COMPLETED|Overall Study||96||
59970397|NCT01675622|76087736|FG000|NOT COMPLETED|Overall Study||26||
59970398|NCT01675622|76087737|FG001|NOT COMPLETED|Overall Study||24||
59970399|NCT02655224|76087745|FG000|STARTED|Overall Study||33||
59970400|NCT02655224|76087746|FG001|STARTED|Overall Study||32||
59970401|NCT02655224|76087745|FG000|COMPLETED|Overall Study||32|Completed=Completed Treatment|
59970402|NCT02655224|76087746|FG001|COMPLETED|Overall Study||31|Completed=Completed Treatment|
59970403|NCT02655224|76087745|FG000|NOT COMPLETED|Overall Study||1||
59970404|NCT02655224|76087746|FG001|NOT COMPLETED|Overall Study||1||
59970405|NCT01675544|76087752|FG000|STARTED|Overall Study||46||
59970406|NCT01675544|76087752|FG000|COMPLETED|Overall Study||44||
59970407|NCT01675544|76087752|FG000|NOT COMPLETED|Overall Study||2||
59970408|NCT02993107|76087762|FG000|STARTED|Overall Study||113||
59970409|NCT02993107|76087763|FG001|STARTED|Overall Study||120||
59970410|NCT02993107|76087764|FG002|STARTED|Overall Study||50||
59970411|NCT02993107|76087765|FG003|STARTED|Overall Study||35||
59970412|NCT02993107|76087766|FG004|STARTED|Overall Study||34||
59970413|NCT02993107|76087767|FG005|STARTED|Overall Study||36||
59970414|NCT02993107|76087762|FG000|Adverse Event|Overall Study||12||
59970415|NCT02993107|76087763|FG001|Adverse Event|Overall Study||4||
59970416|NCT02993107|76087764|FG002|Adverse Event|Overall Study||1||
59970417|NCT02993107|76087765|FG003|Adverse Event|Overall Study||1||
59970418|NCT02993107|76087766|FG004|Adverse Event|Overall Study||3||
59970419|NCT02993107|76087767|FG005|Adverse Event|Overall Study||5||
59970420|NCT02993107|76087762|FG000|Physician Decision|Overall Study||1||
59811579|NCT00371566|75933858|FG000|STARTED|Chemoradiation Phase||36||
59811580|NCT00371566|75933859|FG001|STARTED|Chemoradiation Phase||68||
59811581|NCT00371566|75933858|FG000|COMPLETED|Chemoradiation Phase||31||
59811582|NCT00371566|75933859|FG001|COMPLETED|Chemoradiation Phase||65||
59811583|NCT00371566|75933858|FG000|NOT COMPLETED|Chemoradiation Phase||5||
59811584|NCT00371566|75933859|FG001|NOT COMPLETED|Chemoradiation Phase||3||
59811585|NCT00371566|75933858|FG000|STARTED|Follow Up Phase||31||
59811586|NCT00371566|75933859|FG001|STARTED|Follow Up Phase||65||
59970421|NCT02993107|76087763|FG001|Physician Decision|Overall Study||0||
59970422|NCT02993107|76087764|FG002|Physician Decision|Overall Study||1||
59970423|NCT02993107|76087765|FG003|Physician Decision|Overall Study||0||
59970424|NCT02993107|76087766|FG004|Physician Decision|Overall Study||0||
59970425|NCT02993107|76087767|FG005|Physician Decision|Overall Study||0||
59970426|NCT02993107|76087762|FG000|Withdrawal by Subject|Overall Study||32||
59970427|NCT02993107|76087763|FG001|Withdrawal by Subject|Overall Study||7||
59970428|NCT02993107|76087764|FG002|Withdrawal by Subject|Overall Study||7||
59970429|NCT02993107|76087765|FG003|Withdrawal by Subject|Overall Study||3||
59970430|NCT02993107|76087766|FG004|Withdrawal by Subject|Overall Study||6||
59970431|NCT02993107|76087767|FG005|Withdrawal by Subject|Overall Study||2||
59811587|NCT00371566|75933858|FG000|COMPLETED|Follow Up Phase||28||
59970432|NCT02993107|76087762|FG000|Lost to Follow-up|Overall Study||0||
59970433|NCT02993107|76087763|FG001|Lost to Follow-up|Overall Study||1||
59970434|NCT02993107|76087764|FG002|Lost to Follow-up|Overall Study||0||
59970435|NCT02993107|76087765|FG003|Lost to Follow-up|Overall Study||0||
59970436|NCT02993107|76087766|FG004|Lost to Follow-up|Overall Study||0||
59970437|NCT02993107|76087767|FG005|Lost to Follow-up|Overall Study||1||
59970438|NCT02993107|76087762|FG000|Sponsor Decision|Overall Study||4||
59970439|NCT02993107|76087763|FG001|Sponsor Decision|Overall Study||0||
59970440|NCT02993107|76087764|FG002|Sponsor Decision|Overall Study||1||
59970441|NCT02993107|76087765|FG003|Sponsor Decision|Overall Study||1||
59970442|NCT02993107|76087766|FG004|Sponsor Decision|Overall Study||0||
59970443|NCT02993107|76087767|FG005|Sponsor Decision|Overall Study||4||
59970444|NCT02993107|76087762|FG000|Protocol Deviation|Overall Study||0||
59970445|NCT02993107|76087763|FG001|Protocol Deviation|Overall Study||0||
59970446|NCT02993107|76087764|FG002|Protocol Deviation|Overall Study||0||
59970447|NCT02993107|76087765|FG003|Protocol Deviation|Overall Study||0||
59970448|NCT02993107|76087766|FG004|Protocol Deviation|Overall Study||1||
59970449|NCT02993107|76087767|FG005|Protocol Deviation|Overall Study||0||
59970450|NCT02993107|76087762|FG000|Other Reasons|Overall Study||2||
59970451|NCT02993107|76087763|FG001|Other Reasons|Overall Study||1||
59970452|NCT02993107|76087764|FG002|Other Reasons|Overall Study||1||
59970453|NCT02993107|76087765|FG003|Other Reasons|Overall Study||1||
59970454|NCT02993107|76087766|FG004|Other Reasons|Overall Study||2||
59970455|NCT02993107|76087767|FG005|Other Reasons|Overall Study||3||
59970456|NCT02993107|76087762|FG000|COMPLETED|Overall Study||62||
59970457|NCT02993107|76087763|FG001|COMPLETED|Overall Study||107||
59970458|NCT02993107|76087764|FG002|COMPLETED|Overall Study||39||
59970459|NCT02993107|76087765|FG003|COMPLETED|Overall Study||29||
59970460|NCT02993107|76087766|FG004|COMPLETED|Overall Study||22||
59970461|NCT02993107|76087767|FG005|COMPLETED|Overall Study||21||
59970462|NCT02993107|76087762|FG000|NOT COMPLETED|Overall Study||51||
59970463|NCT02993107|76087763|FG001|NOT COMPLETED|Overall Study||13||
59970464|NCT02993107|76087764|FG002|NOT COMPLETED|Overall Study||11||
59970465|NCT02993107|76087765|FG003|NOT COMPLETED|Overall Study||6||
59970466|NCT02993107|76087766|FG004|NOT COMPLETED|Overall Study||12||
59970467|NCT02993107|76087767|FG005|NOT COMPLETED|Overall Study||15||
59970468|NCT02838901|76087795|FG000|STARTED|Overall Study||9||
59970469|NCT02838901|76087796|FG001|STARTED|Overall Study||9||
59970470|NCT02838901|76087795|FG000|COMPLETED|Overall Study||7||
59970471|NCT02838901|76087796|FG001|COMPLETED|Overall Study||7||
59970472|NCT02838901|76087795|FG000|NOT COMPLETED|Overall Study||2||
59970473|NCT02838901|76087796|FG001|NOT COMPLETED|Overall Study||2||
59970474|NCT04244084|76087806|FG000|STARTED|Overall Study||118||
59970475|NCT04244084|76087807|FG001|STARTED|Overall Study||122||
59970476|NCT04244084|76087806|FG000|COMPLETED|Overall Study||118||
59970477|NCT04244084|76087807|FG001|COMPLETED|Overall Study||122||
60074443|NCT01801358|76189854|FG000|NOT COMPLETED|Overall Study||6||
60074444|NCT01801358|76189855|FG001|NOT COMPLETED|Overall Study||6||
59970478|NCT04244084|76087806|FG000|NOT COMPLETED|Overall Study||0||
59970479|NCT04244084|76087807|FG001|NOT COMPLETED|Overall Study||0||
59970480|NCT04513652|76087815|FG000|STARTED|Overall Study||60||
59970481|NCT04513652|76087816|FG001|STARTED|Overall Study||60||
59970482|NCT04513652|76087815|FG000|COMPLETED|Overall Study||60||
59970483|NCT04513652|76087816|FG001|COMPLETED|Overall Study||60||
59970484|NCT04513652|76087815|FG000|NOT COMPLETED|Overall Study||0||
59970485|NCT04513652|76087816|FG001|NOT COMPLETED|Overall Study||0||
59970486|NCT00706797|76087824|FG000|STARTED|Overall Study||70||
59970487|NCT00706797|76087825|FG001|STARTED|Overall Study||71||
59970488|NCT00706797|76087824|FG000|Safety Population|Overall Study|Safety population=all randomly assigned subjects who had at least 1 dose of study treatment.|63||
59970489|NCT00706797|76087825|FG001|Safety Population|Overall Study||71||
59970490|NCT00706797|76087824|FG000|COMPLETED|Overall Study||1||
59970491|NCT00706797|76087825|FG001|COMPLETED|Overall Study||0||
59970492|NCT00706797|76087824|FG000|NOT COMPLETED|Overall Study||69||
59970493|NCT00706797|76087825|FG001|NOT COMPLETED|Overall Study||71||
59970494|NCT00706641|76087831|FG000|STARTED|Dasatinib Administration||25||
59970495|NCT00706641|76087831|FG000|Toxicity Evaluation|Dasatinib Administration||24||
59970496|NCT00706641|76087831|FG000|COMPLETED|Dasatinib Administration||23||
59970497|NCT00706641|76087831|FG000|NOT COMPLETED|Dasatinib Administration||2||
59970498|NCT00706641|76087831|FG000|STARTED|Radical Cystectomy||23||
59970499|NCT00706641|76087831|FG000|COMPLETED|Radical Cystectomy||22||
59970500|NCT00706641|76087831|FG000|NOT COMPLETED|Radical Cystectomy||1||
59970501|NCT01362530|76087837|FG000|STARTED|Base Study (Cycle 1)||155||
59970502|NCT01362530|76087838|FG001|STARTED|Base Study (Cycle 1)||152||
59970503|NCT01362530|76087837|FG000|Received Study Treatment|Base Study (Cycle 1)||152||
59970504|NCT01362530|76087838|FG001|Received Study Treatment|Base Study (Cycle 1)||150||
59970505|NCT01362530|76087837|FG000|COMPLETED|Base Study (Cycle 1)||150||
59970506|NCT01362530|76087838|FG001|COMPLETED|Base Study (Cycle 1)||149||
59970507|NCT01362530|76087837|FG000|NOT COMPLETED|Base Study (Cycle 1)||5||
59970508|NCT01362530|76087838|FG001|NOT COMPLETED|Base Study (Cycle 1)||3||
59970509|NCT01362530|76087837|FG000|STARTED|Optional Extension (Cycles 2-6)||171||
59970510|NCT01362530|76087838|FG001|STARTED|Optional Extension (Cycles 2-6)||0||
59970511|NCT01362530|76087837|FG000|COMPLETED|Optional Extension (Cycles 2-6)||46||
59970512|NCT01362530|76087838|FG001|COMPLETED|Optional Extension (Cycles 2-6)||0||
59970513|NCT01362530|76087837|FG000|NOT COMPLETED|Optional Extension (Cycles 2-6)||125||
59970514|NCT01362530|76087838|FG001|NOT COMPLETED|Optional Extension (Cycles 2-6)||0||
59970515|NCT02654054|76087848|FG000|STARTED|Treatment Period||102|randomized|
59970516|NCT02654054|76087849|FG001|STARTED|Treatment Period||104|randomized|
59970517|NCT02654054|76087850|FG002|STARTED|Treatment Period||207|randomized|
59970518|NCT02654054|76087848|FG000|Randomized and Treated|Treatment Period||102||
59970519|NCT02654054|76087849|FG001|Randomized and Treated|Treatment Period||104||
59970520|NCT02654054|76087850|FG002|Randomized and Treated|Treatment Period||206||
59970521|NCT02654054|76087848|FG000|COMPLETED|Treatment Period||83|completed treatment period|
59970522|NCT02654054|76087849|FG001|COMPLETED|Treatment Period||81|completed treatment period|
59970523|NCT02654054|76087850|FG002|COMPLETED|Treatment Period||164|completed treatment period|
59970524|NCT02654054|76087848|FG000|NOT COMPLETED|Treatment Period||19||
59970525|NCT02654054|76087849|FG001|NOT COMPLETED|Treatment Period||23||
59970526|NCT02654054|76087850|FG002|NOT COMPLETED|Treatment Period||43||
59970527|NCT02654054|76087848|FG000|STARTED|Post-Treatment Follow-Up Period||25||
59970528|NCT02654054|76087849|FG001|STARTED|Post-Treatment Follow-Up Period||32||
59970529|NCT02654054|76087850|FG002|STARTED|Post-Treatment Follow-Up Period||59||
59970530|NCT02654054|76087848|FG000|COMPLETED|Post-Treatment Follow-Up Period||17||
59970531|NCT02654054|76087849|FG001|COMPLETED|Post-Treatment Follow-Up Period||24||
59970532|NCT02654054|76087850|FG002|COMPLETED|Post-Treatment Follow-Up Period||29||
59970533|NCT02654054|76087848|FG000|NOT COMPLETED|Post-Treatment Follow-Up Period||8||
59970534|NCT02654054|76087849|FG001|NOT COMPLETED|Post-Treatment Follow-Up Period||8||
59970535|NCT02654054|76087850|FG002|NOT COMPLETED|Post-Treatment Follow-Up Period||30||
59970536|NCT02701556|76087861|FG000|STARTED|Overall Study||198||
59970537|NCT02701556|76087862|FG001|STARTED|Overall Study||198||
59970538|NCT02701556|76087861|FG000|COMPLETED|Overall Study||175||
59970539|NCT02701556|76087862|FG001|COMPLETED|Overall Study||178||
59970540|NCT02701556|76087861|FG000|NOT COMPLETED|Overall Study||23||
59970541|NCT02701556|76087862|FG001|NOT COMPLETED|Overall Study||20||
59970542|NCT02653664|76087871|FG000|STARTED|Post-Treatment||110|Fifteen of the 343 enrolled subjects withdrew or were withdrawn from the trial prior to randomization. As a result, 328 of the 343 enrolled subjects were randomized. All randomized subjects were listed as 'started' for all time periods following randomization given we conducted an Intention-to-Treat (ITT) analysis.|
59970543|NCT02653664|76087872|FG001|STARTED|Post-Treatment||110|Fifteen of the 343 enrolled subjects withdrew or were withdrawn from the trial prior to randomization. As a result, 328 of the 343 enrolled subjects were randomized. All randomized subjects were listed as 'started' for all time periods following randomization given we conducted an Intention-to-Treat (ITT) analysis.|
59970544|NCT02653664|76087873|FG002|STARTED|Post-Treatment||108|Fifteen of the 343 enrolled subjects withdrew or were withdrawn from the trial prior to randomization. As a result, 328 of the 343 enrolled subjects were randomized. All randomized subjects were listed as 'started' for all time periods following randomization given we conducted an Intention-to-Treat (ITT) analysis.|
59970545|NCT02653664|76087871|FG000|Primary and Secondary Data|Post-Treatment||93||
59970546|NCT02653664|76087872|FG001|Primary and Secondary Data|Post-Treatment||104||
59621934|NCT00397020|75733657|FG001|STARTED|Overall Study||16||
59621935|NCT00397020|75733656|FG000|COMPLETED|Overall Study||13||
59621936|NCT00397020|75733657|FG001|COMPLETED|Overall Study||15||
59621937|NCT00397020|75733656|FG000|NOT COMPLETED|Overall Study||1||
59621938|NCT00397020|75733657|FG001|NOT COMPLETED|Overall Study||1||
59994943|NCT03269695|76110760|FG000|STARTED|Overall Study||10||
59621939|NCT00371436|75733665|FG000|STARTED|Overall Study||92||
59621940|NCT00371436|75733666|FG001|STARTED|Overall Study||89||
59621941|NCT00371436|75733665|FG000|COMPLETED|Overall Study||58||
59970547|NCT02653664|76087873|FG002|Primary and Secondary Data|Post-Treatment||91||
59970548|NCT02653664|76087871|FG000|Primary Outcome Data Only|Post-Treatment||3||
59970549|NCT02653664|76087872|FG001|Primary Outcome Data Only|Post-Treatment||0||
59970550|NCT02653664|76087873|FG002|Primary Outcome Data Only|Post-Treatment||3||
59970551|NCT02653664|76087871|FG000|COMPLETED|Post-Treatment||96|Number of subjects who provided average pain intensity data during this assessment period.|
59970552|NCT02653664|76087872|FG001|COMPLETED|Post-Treatment||104|Number of subjects who provided average pain intensity data during this assessment period.|
59970553|NCT02653664|76087873|FG002|COMPLETED|Post-Treatment||94|Number of subjects who provided average pain intensity data during this assessment period.|
59970554|NCT02653664|76087871|FG000|NOT COMPLETED|Post-Treatment||14||
59970555|NCT02653664|76087872|FG001|NOT COMPLETED|Post-Treatment||6||
59970556|NCT02653664|76087873|FG002|NOT COMPLETED|Post-Treatment||14||
59970557|NCT02653664|76087871|FG000|STARTED|3 Month Follow-Up||110|All randomized subjects were listed as 'started' for all time periods following randomization given we conducted an Intention-to-Treat (ITT) analysis.|
59970558|NCT02653664|76087872|FG001|STARTED|3 Month Follow-Up||110|All randomized subjects were listed as 'started' for all time periods following randomization given we conducted an Intention-to-Treat (ITT) analysis.|
59970559|NCT02653664|76087873|FG002|STARTED|3 Month Follow-Up||108|All randomized subjects were listed as 'started' for all time periods following randomization given we conducted an Intention-to-Treat (ITT) analysis.|
59970560|NCT02653664|76087871|FG000|Primary and Secondary Data|3 Month Follow-Up||83||
59970561|NCT02653664|76087872|FG001|Primary and Secondary Data|3 Month Follow-Up||95||
59970562|NCT02653664|76087873|FG002|Primary and Secondary Data|3 Month Follow-Up||82||
59970563|NCT02653664|76087871|FG000|Primary Outcome Data Only|3 Month Follow-Up||6||
59970564|NCT02653664|76087872|FG001|Primary Outcome Data Only|3 Month Follow-Up||0||
59970565|NCT02653664|76087873|FG002|Primary Outcome Data Only|3 Month Follow-Up||1||
59970566|NCT02653664|76087871|FG000|COMPLETED|3 Month Follow-Up||89|Number of subjects who provided average pain intensity data during this assessment period.|
59970567|NCT02653664|76087872|FG001|COMPLETED|3 Month Follow-Up||95|Number of subjects who provided average pain intensity data during this assessment period.|
59970568|NCT02653664|76087873|FG002|COMPLETED|3 Month Follow-Up||83|Number of subjects who provided average pain intensity data during this assessment period.|
59970569|NCT02653664|76087871|FG000|NOT COMPLETED|3 Month Follow-Up||21||
59970570|NCT02653664|76087872|FG001|NOT COMPLETED|3 Month Follow-Up||15||
59970571|NCT02653664|76087873|FG002|NOT COMPLETED|3 Month Follow-Up||25||
59970572|NCT02653664|76087871|FG000|STARTED|6 Month Follow-Up||110|All randomized subjects were listed as 'started' for all time periods following randomization given we conducted an Intention-to-Treat (ITT) analysis.|
59970573|NCT02653664|76087872|FG001|STARTED|6 Month Follow-Up||110|All randomized subjects were listed as 'started' for all time periods following randomization given we conducted an Intention-to-Treat (ITT) analysis.|
59970574|NCT02653664|76087873|FG002|STARTED|6 Month Follow-Up||108|All randomized subjects were listed as 'started' for all time periods following randomization given we conducted an Intention-to-Treat (ITT) analysis.|
59970575|NCT02653664|76087871|FG000|Primary and Secondary Outcome Data|6 Month Follow-Up||85||
59970576|NCT02653664|76087872|FG001|Primary and Secondary Outcome Data|6 Month Follow-Up||87||
59970577|NCT02653664|76087873|FG002|Primary and Secondary Outcome Data|6 Month Follow-Up||83||
59970578|NCT02653664|76087871|FG000|Primary Outcome Data Only|6 Month Follow-Up||2||
59970579|NCT02653664|76087872|FG001|Primary Outcome Data Only|6 Month Follow-Up||2||
59970580|NCT02653664|76087873|FG002|Primary Outcome Data Only|6 Month Follow-Up||2||
59970581|NCT02653664|76087871|FG000|COMPLETED|6 Month Follow-Up||87|Number of subjects who provided average pain intensity data during this assessment period.|
59970582|NCT02653664|76087872|FG001|COMPLETED|6 Month Follow-Up||89|Number of subjects who provided average pain intensity data during this assessment period.|
59970583|NCT02653664|76087873|FG002|COMPLETED|6 Month Follow-Up||85|Number of subjects who provided average pain intensity data during this assessment period.|
59970584|NCT02653664|76087871|FG000|NOT COMPLETED|6 Month Follow-Up||23||
59970585|NCT02653664|76087872|FG001|NOT COMPLETED|6 Month Follow-Up||21||
59970586|NCT02653664|76087873|FG002|NOT COMPLETED|6 Month Follow-Up||23||
59970587|NCT04150562|76087884|FG000|STARTED|Overall Study||2||
59970588|NCT04150562|76087885|FG001|STARTED|Overall Study||0||
59970589|NCT04150562|76087884|FG000|COMPLETED|Overall Study||2||
59970590|NCT04150562|76087885|FG001|COMPLETED|Overall Study||0||
59970591|NCT04150562|76087884|FG000|NOT COMPLETED|Overall Study||0||
59970592|NCT04150562|76087885|FG001|NOT COMPLETED|Overall Study||0||
59970593|NCT02488629|76087891|FG000|STARTED|Overall Study||3||
59970594|NCT02488629|76087892|FG001|STARTED|Overall Study||2||
59970595|NCT02488629|76087893|FG002|STARTED|Overall Study||0||
59970596|NCT02488629|76087894|FG003|STARTED|Overall Study||0||
59970597|NCT02488629|76087891|FG000|COMPLETED|Overall Study|All 5 patients withdrew from the study. The reasons for premature study discontinuation were RECIST disease progression (4 patients [80%]) and voluntary discontinuation (1 [20%]). All 5 patients were enrolled in the Run-in Phase I and no patients were enrolled in Phase II.|0||
59970598|NCT02488629|76087892|FG001|COMPLETED|Overall Study||0||
59970599|NCT02488629|76087893|FG002|COMPLETED|Overall Study||0||
59970600|NCT02488629|76087894|FG003|COMPLETED|Overall Study||0||
59970601|NCT02488629|76087891|FG000|NOT COMPLETED|Overall Study||3||
59970602|NCT02488629|76087892|FG001|NOT COMPLETED|Overall Study||2||
59970603|NCT02488629|76087893|FG002|NOT COMPLETED|Overall Study||0||
59970604|NCT02488629|76087894|FG003|NOT COMPLETED|Overall Study||0||
59970605|NCT04510922|76087899|FG000|STARTED|Overall Study||9||
59970606|NCT04510922|76087899|FG000|COMPLETED|Overall Study||9||
59970607|NCT04510922|76087899|FG000|NOT COMPLETED|Overall Study||0||
59970608|NCT02727699|76087905|FG000|STARTED|Overall Study||91||
59970609|NCT02727699|76087906|FG001|STARTED|Overall Study||94||
59970610|NCT02727699|76087905|FG000|COMPLETED|Overall Study||82||
59970611|NCT02727699|76087906|FG001|COMPLETED|Overall Study||89||
59970612|NCT02727699|76087905|FG000|NOT COMPLETED|Overall Study||9||
59970613|NCT02727699|76087906|FG001|NOT COMPLETED|Overall Study||5||
59970614|NCT03331263|76087912|FG000|STARTED|Period 1||4||
59970615|NCT03331263|76087913|FG001|STARTED|Period 1||4||
59970616|NCT03331263|76087914|FG002|STARTED|Period 1||4||
59970617|NCT03331263|76087912|FG000|COMPLETED|Period 1||4||
59970618|NCT03331263|76087913|FG001|COMPLETED|Period 1||4||
59970619|NCT03331263|76087914|FG002|COMPLETED|Period 1||4||
59970620|NCT03331263|76087912|FG000|NOT COMPLETED|Period 1||0||
59970621|NCT03331263|76087913|FG001|NOT COMPLETED|Period 1||0||
59970622|NCT03331263|76087914|FG002|NOT COMPLETED|Period 1||0||
59970623|NCT03331263|76087912|FG000|STARTED|Period 2||4||
59970624|NCT03331263|76087913|FG001|STARTED|Period 2||3||
59970625|NCT03331263|76087914|FG002|STARTED|Period 2||4||
59970626|NCT03331263|76087912|FG000|COMPLETED|Period 2||4||
59970627|NCT03331263|76087913|FG001|COMPLETED|Period 2||3||
59970628|NCT03331263|76087914|FG002|COMPLETED|Period 2||4||
59970629|NCT03331263|76087912|FG000|NOT COMPLETED|Period 2||0||
59970630|NCT03331263|76087913|FG001|NOT COMPLETED|Period 2||0||
59970631|NCT03331263|76087914|FG002|NOT COMPLETED|Period 2||0||
59970632|NCT03331263|76087912|FG000|STARTED|Period 3||4||
59970633|NCT03331263|76087913|FG001|STARTED|Period 3||3||
59970634|NCT03331263|76087914|FG002|STARTED|Period 3||3||
59970635|NCT03331263|76087912|FG000|COMPLETED|Period 3||4||
59970636|NCT03331263|76087913|FG001|COMPLETED|Period 3||3||
59970637|NCT03331263|76087914|FG002|COMPLETED|Period 3||3||
59970638|NCT03331263|76087912|FG000|NOT COMPLETED|Period 3||0||
59970639|NCT03331263|76087913|FG001|NOT COMPLETED|Period 3||0||
59811588|NCT00371566|75933859|FG001|COMPLETED|Follow Up Phase||58||
59811589|NCT00371566|75933858|FG000|NOT COMPLETED|Follow Up Phase||3||
59811590|NCT00371566|75933859|FG001|NOT COMPLETED|Follow Up Phase||7||
59811591|NCT00382408|75933867|FG000|STARTED|Overall Study||3031||
59811592|NCT00382408|75933868|FG001|STARTED|Overall Study||1009||
59811593|NCT00382408|75933867|FG000|COMPLETED|Overall Study||2887||
59811594|NCT00382408|75933868|FG001|COMPLETED|Overall Study||955||
59811595|NCT00382408|75933867|FG000|NOT COMPLETED|Overall Study||144||
59811596|NCT00382408|75933868|FG001|NOT COMPLETED|Overall Study||54||
59811597|NCT00371254|75933876|FG000|STARTED|Overall Study|Number of participants treated|23||
59811598|NCT00371254|75933877|FG001|STARTED|Overall Study|Number of participants treated|21||
59811599|NCT00371254|75933876|FG000|COMPLETED|Overall Study|Number of participants remained on study till the study drug could be tolerated|0||
59811600|NCT00371254|75933877|FG001|COMPLETED|Overall Study|Number of participants remained on study till the study drug could be tolerated|0||
59811601|NCT00371254|75933876|FG000|NOT COMPLETED|Overall Study||23||
59811602|NCT00371254|75933877|FG001|NOT COMPLETED|Overall Study||21||
59811603|NCT00452673|75933887|FG000|STARTED|Dose Escalation Period||7||
59811604|NCT00452673|75933888|FG001|STARTED|Dose Escalation Period||9||
59811605|NCT00452673|75933889|FG002|STARTED|Dose Escalation Period||6||
59811606|NCT00452673|75933890|FG003|STARTED|Dose Escalation Period||9||
59811607|NCT00452673|75933891|FG004|STARTED|Dose Escalation Period||0||
59811608|NCT00452673|75933887|FG000|COMPLETED|Dose Escalation Period||0||
59811609|NCT00452673|75933888|FG001|COMPLETED|Dose Escalation Period||0||
59811610|NCT00452673|75933889|FG002|COMPLETED|Dose Escalation Period||0||
59811611|NCT00452673|75933890|FG003|COMPLETED|Dose Escalation Period||0||
59811612|NCT00452673|75933891|FG004|COMPLETED|Dose Escalation Period||0||
59811613|NCT00452673|75933887|FG000|NOT COMPLETED|Dose Escalation Period||7||
59811614|NCT00452673|75933888|FG001|NOT COMPLETED|Dose Escalation Period||9||
59811615|NCT00452673|75933889|FG002|NOT COMPLETED|Dose Escalation Period||6||
59970640|NCT03331263|76087914|FG002|NOT COMPLETED|Period 3||0||
59970641|NCT03576716|76087924|FG000|STARTED|Overall Study||10||
59970642|NCT03576716|76087925|FG001|STARTED|Overall Study||9||
59811616|NCT00452673|75933890|FG003|NOT COMPLETED|Dose Escalation Period||9||
59811617|NCT00452673|75933891|FG004|NOT COMPLETED|Dose Escalation Period||0||
59811618|NCT00452673|75933887|FG000|STARTED|Dose Expansion Period||0||
59970643|NCT03576716|76087924|FG000|COMPLETED|Overall Study||10||
59970644|NCT03576716|76087925|FG001|COMPLETED|Overall Study||8||
59970645|NCT03576716|76087924|FG000|NOT COMPLETED|Overall Study||0||
59970646|NCT03576716|76087925|FG001|NOT COMPLETED|Overall Study||1||
59970647|NCT04009850|76087933|FG000|STARTED|Overall Study||3||
59970648|NCT04009850|76087934|FG001|STARTED|Overall Study||0||
59970649|NCT04009850|76087933|FG000|COMPLETED|Overall Study||3||
59811619|NCT00452673|75933888|FG001|STARTED|Dose Expansion Period||0||
59970650|NCT04009850|76087934|FG001|COMPLETED|Overall Study||0||
59970651|NCT04009850|76087933|FG000|NOT COMPLETED|Overall Study||0||
59970652|NCT04009850|76087934|FG001|NOT COMPLETED|Overall Study||0||
59970653|NCT02847637|76087944|FG000|STARTED|Overall Study||18||
59970654|NCT02847637|76087945|FG001|STARTED|Overall Study||36||
59970655|NCT02847637|76087946|FG002|STARTED|Overall Study||35||
59970656|NCT02847637|76087947|FG003|STARTED|Overall Study||63||
59994944|NCT03269695|76110761|FG001|STARTED|Overall Study||10||
59994945|NCT03269695|76110760|FG000|Treated|Overall Study||10||
59621942|NCT00371436|75733666|FG001|COMPLETED|Overall Study||68||
59621943|NCT00371436|75733665|FG000|NOT COMPLETED|Overall Study||34||
59970657|NCT02847637|76087944|FG000|Completed First 24 Weeks of Treatment|Overall Study|A total of 17 participants in Arm C switched from no prophylaxis to receive emicizumab prophylaxis; however, 1 switched to emicizumab prior to completing 24 weeks on no prophylaxis (at 23.5 weeks).|16||
59970658|NCT02847637|76087945|FG001|Completed First 24 Weeks of Treatment|Overall Study||35||
59970659|NCT02847637|76087946|FG002|Completed First 24 Weeks of Treatment|Overall Study||34||
59970660|NCT02847637|76087947|FG003|Completed First 24 Weeks of Treatment|Overall Study||63||
59970661|NCT02847637|76087944|FG000|Emicizumab Dose Was Up-Titrated|Overall Study||0||
59970662|NCT02847637|76087945|FG001|Emicizumab Dose Was Up-Titrated|Overall Study||1||
59970663|NCT02847637|76087946|FG002|Emicizumab Dose Was Up-Titrated|Overall Study||1||
59970664|NCT02847637|76087947|FG003|Emicizumab Dose Was Up-Titrated|Overall Study||7||
59970665|NCT02847637|76087944|FG000|Opted to Change Emicizumab Dosing Regimen|Overall Study||1|Upon Implementation of Protocol Version 4|
59970666|NCT02847637|76087945|FG001|Opted to Change Emicizumab Dosing Regimen|Overall Study||3|Upon Implementation of Protocol Version 4|
59970667|NCT02847637|76087946|FG002|Opted to Change Emicizumab Dosing Regimen|Overall Study||1|Upon Implementation of Protocol Version 4|
59970668|NCT02847637|76087947|FG003|Opted to Change Emicizumab Dosing Regimen|Overall Study||1|Upon Implementation of Protocol Version 4|
59970669|NCT02847637|76087944|FG000|COMPLETED|Overall Study||17||
59970670|NCT02847637|76087945|FG001|COMPLETED|Overall Study||34||
59970671|NCT02847637|76087946|FG002|COMPLETED|Overall Study||34||
59970672|NCT02847637|76087947|FG003|COMPLETED|Overall Study||63||
59970673|NCT02847637|76087944|FG000|NOT COMPLETED|Overall Study||1||
59970674|NCT02847637|76087945|FG001|NOT COMPLETED|Overall Study||2||
59970675|NCT02847637|76087946|FG002|NOT COMPLETED|Overall Study||1||
59970676|NCT02847637|76087947|FG003|NOT COMPLETED|Overall Study||0||
59970677|NCT00706095|76087974|FG000|STARTED|Overall Study||6||
59970678|NCT00706095|76087975|FG001|STARTED|Overall Study||7||
59970679|NCT00706095|76087976|FG002|STARTED|Overall Study||5||
59621944|NCT00371436|75733666|FG001|NOT COMPLETED|Overall Study||21||
59621945|NCT00397878|75733672|FG000|STARTED|Overall Study||10||
59621946|NCT00397878|75733672|FG000|COMPLETED|Overall Study||10||
59621947|NCT00397878|75733672|FG000|NOT COMPLETED|Overall Study||0||
59621948|NCT00400686|75733676|FG000|STARTED|Overall Study||31||
59621949|NCT00400686|75733676|FG000|COMPLETED|Overall Study||31||
59970680|NCT00706095|76087974|FG000|COMPLETED|Overall Study||0||
59970681|NCT00706095|76087975|FG001|COMPLETED|Overall Study||0||
59970682|NCT00706095|76087976|FG002|COMPLETED|Overall Study||0||
59970683|NCT00706095|76087974|FG000|NOT COMPLETED|Overall Study||6||
59970684|NCT00706095|76087975|FG001|NOT COMPLETED|Overall Study||7||
59621950|NCT00400686|75733676|FG000|NOT COMPLETED|Overall Study||0||
59621951|NCT00373386|75733680|FG000|STARTED|Overall Study||9||
59970685|NCT00706095|76087976|FG002|NOT COMPLETED|Overall Study||5||
59970686|NCT02837731|76087986|FG000|STARTED|Allocation||102||
59970687|NCT02837731|76087987|FG001|STARTED|Allocation||48||
59970688|NCT02837731|76087986|FG000|COMPLETED|Allocation||83||
59970689|NCT02837731|76087987|FG001|COMPLETED|Allocation||41||
59970690|NCT02837731|76087986|FG000|NOT COMPLETED|Allocation||19||
59970691|NCT02837731|76087987|FG001|NOT COMPLETED|Allocation||7||
59970692|NCT02837731|76087986|FG000|STARTED|Follow-up||83||
59970693|NCT02837731|76087987|FG001|STARTED|Follow-up||41||
59970694|NCT02837731|76087986|FG000|COMPLETED|Follow-up||83||
59970695|NCT02837731|76087987|FG001|COMPLETED|Follow-up||41||
59970696|NCT02837731|76087986|FG000|NOT COMPLETED|Follow-up||0||
59970697|NCT02837731|76087987|FG001|NOT COMPLETED|Follow-up||0||
59970698|NCT02837731|76087986|FG000|STARTED|Analysis||83||
59970699|NCT02837731|76087987|FG001|STARTED|Analysis||41||
59970700|NCT02837731|76087986|FG000|COMPLETED|Analysis||83||
59970701|NCT02837731|76087987|FG001|COMPLETED|Analysis||41||
59970702|NCT02837731|76087986|FG000|NOT COMPLETED|Analysis||0||
59621952|NCT00373386|75733680|FG000|COMPLETED|Overall Study||9||
59621953|NCT00373386|75733680|FG000|NOT COMPLETED|Overall Study||0||
59970703|NCT02837731|76087987|FG001|NOT COMPLETED|Analysis||0||
59970704|NCT02836873|76087995|FG000|STARTED|Overall Study||157||
59621954|NCT00373698|75733688|FG000|STARTED|Overall Study||96||
59621955|NCT00373698|75733689|FG001|STARTED|Overall Study||99||
59621956|NCT00373698|75733688|FG000|COMPLETED|Overall Study||85||
59621957|NCT00373698|75733689|FG001|COMPLETED|Overall Study||99||
59621958|NCT00373698|75733688|FG000|NOT COMPLETED|Overall Study||11||
59621959|NCT00373698|75733689|FG001|NOT COMPLETED|Overall Study||0||
59621960|NCT00374088|75733699|FG000|STARTED|Overall Study||10||
59970705|NCT02836873|76087996|FG001|STARTED|Overall Study||155||
59970706|NCT02836873|76087995|FG000|COMPLETED|Overall Study||152||
59970707|NCT02836873|76087996|FG001|COMPLETED|Overall Study||144||
59970708|NCT02836873|76087995|FG000|NOT COMPLETED|Overall Study||5||
59970709|NCT02836873|76087996|FG001|NOT COMPLETED|Overall Study||11||
59970710|NCT02724410|76088004|FG000|STARTED|Overall Study||44||
59970711|NCT02724410|76088005|FG001|STARTED|Overall Study||38||
59970712|NCT02724410|76088004|FG000|COMPLETED|Overall Study||44||
59970713|NCT02724410|76088005|FG001|COMPLETED|Overall Study||38||
59970714|NCT02724410|76088004|FG000|NOT COMPLETED|Overall Study||0||
59970715|NCT02724410|76088005|FG001|NOT COMPLETED|Overall Study||0||
59970716|NCT01342081|76088014|FG000|STARTED|Overall Study||161||
59970717|NCT01342081|76088015|FG001|STARTED|Overall Study||164||
59970718|NCT01342081|76088016|FG002|STARTED|Overall Study||164||
59811620|NCT00452673|75933889|FG002|STARTED|Dose Expansion Period||0||
59811621|NCT00452673|75933890|FG003|STARTED|Dose Expansion Period||0||
59811622|NCT00452673|75933891|FG004|STARTED|Dose Expansion Period|The last dose level arm in the escalation period was selected for the dose expansion period.|21||
59811623|NCT00452673|75933887|FG000|COMPLETED|Dose Expansion Period||0||
59811624|NCT00452673|75933888|FG001|COMPLETED|Dose Expansion Period||0||
59811625|NCT00452673|75933889|FG002|COMPLETED|Dose Expansion Period||0||
59970719|NCT01342081|76088014|FG000|COMPLETED|Overall Study||159||
59970720|NCT01342081|76088015|FG001|COMPLETED|Overall Study||162||
59970721|NCT01342081|76088016|FG002|COMPLETED|Overall Study||163||
59970722|NCT01342081|76088014|FG000|NOT COMPLETED|Overall Study||2||
59970723|NCT01342081|76088015|FG001|NOT COMPLETED|Overall Study||2||
59970724|NCT01342081|76088016|FG002|NOT COMPLETED|Overall Study||1||
59970725|NCT01341457|76088026|FG000|STARTED|Overall Study||7||
59970726|NCT01341457|76088027|FG001|STARTED|Overall Study||10||
59970727|NCT01341457|76088026|FG000|Received at Least One Dose of Study Drug|Overall Study||7||
59970728|NCT01341457|76088027|FG001|Received at Least One Dose of Study Drug|Overall Study||10||
59970729|NCT01341457|76088026|FG000|COMPLETED|Overall Study||5||
59970730|NCT01341457|76088027|FG001|COMPLETED|Overall Study||10||
59970731|NCT01341457|76088026|FG000|NOT COMPLETED|Overall Study||2||
59970732|NCT01341457|76088027|FG001|NOT COMPLETED|Overall Study||0||
59970733|NCT02832037|76088039|FG000|STARTED|Overall Study||85|= Randomized and Treated|
59811626|NCT00452673|75933890|FG003|COMPLETED|Dose Expansion Period||0||
59970734|NCT02832037|76088040|FG001|STARTED|Overall Study||84|= Randomized and Treated|
59970735|NCT02832037|76088041|FG002|STARTED|Overall Study||85|= Randomized and Treated|
59970736|NCT02832037|76088042|FG003|STARTED|Overall Study||85|= Randomized and Treated|
59970737|NCT02832037|76088043|FG004|STARTED|Overall Study||170|= Randomized and Treated|
59970738|NCT02832037|76088039|FG000|COMPLETED|Overall Study||66||
59970739|NCT02832037|76088040|FG001|COMPLETED|Overall Study||72||
59970740|NCT02832037|76088041|FG002|COMPLETED|Overall Study||77||
59970741|NCT02832037|76088042|FG003|COMPLETED|Overall Study||78||
59970742|NCT02832037|76088043|FG004|COMPLETED|Overall Study||151||
59970743|NCT02832037|76088039|FG000|NOT COMPLETED|Overall Study||19||
59970744|NCT02832037|76088040|FG001|NOT COMPLETED|Overall Study||12||
59970745|NCT02832037|76088041|FG002|NOT COMPLETED|Overall Study||8||
59970746|NCT02832037|76088042|FG003|NOT COMPLETED|Overall Study||7||
59970747|NCT02832037|76088043|FG004|NOT COMPLETED|Overall Study||19||
59811627|NCT00452673|75933891|FG004|COMPLETED|Dose Expansion Period||0||
59811628|NCT00452673|75933887|FG000|NOT COMPLETED|Dose Expansion Period||0||
59811629|NCT00452673|75933888|FG001|NOT COMPLETED|Dose Expansion Period||0||
59811630|NCT00452673|75933889|FG002|NOT COMPLETED|Dose Expansion Period||0||
59811631|NCT00452673|75933890|FG003|NOT COMPLETED|Dose Expansion Period||0||
59811632|NCT00452673|75933891|FG004|NOT COMPLETED|Dose Expansion Period||21||
59811633|NCT00461253|75933904|FG000|STARTED|Overall Study|Identified cases|10093||
59970748|NCT01675154|76088059|FG000|STARTED|First Intervention Period (4 Weeks)||2||
59970749|NCT01675154|76088060|FG001|STARTED|First Intervention Period (4 Weeks)||1||
59970750|NCT01675154|76088061|FG002|STARTED|First Intervention Period (4 Weeks)||1||
59970751|NCT01675154|76088062|FG003|STARTED|First Intervention Period (4 Weeks)||1||
59970752|NCT01675154|76088059|FG000|COMPLETED|First Intervention Period (4 Weeks)||2||
59970753|NCT01675154|76088060|FG001|COMPLETED|First Intervention Period (4 Weeks)||1||
59970754|NCT01675154|76088061|FG002|COMPLETED|First Intervention Period (4 Weeks)||1||
59970755|NCT01675154|76088062|FG003|COMPLETED|First Intervention Period (4 Weeks)||1||
59970756|NCT01675154|76088059|FG000|NOT COMPLETED|First Intervention Period (4 Weeks)||0||
59970757|NCT01675154|76088060|FG001|NOT COMPLETED|First Intervention Period (4 Weeks)||0||
59811634|NCT00461253|75933905|FG001|STARTED|Overall Study|Identified controls|40250||
59811635|NCT00461253|75933904|FG000|COMPLETED|Overall Study|Analyzed cases|5113||
59811636|NCT00461253|75933905|FG001|COMPLETED|Overall Study|Analyzed controls|20452||
59811637|NCT00461253|75933904|FG000|NOT COMPLETED|Overall Study||4980||
59970758|NCT01675154|76088061|FG002|NOT COMPLETED|First Intervention Period (4 Weeks)||0||
59970759|NCT01675154|76088062|FG003|NOT COMPLETED|First Intervention Period (4 Weeks)||0||
59970760|NCT01675154|76088059|FG000|STARTED|First Washout Period (1 Week)|Subjects were enrolled Regimen 1|2||
59970761|NCT01675154|76088060|FG001|STARTED|First Washout Period (1 Week)||1||
59970762|NCT01675154|76088061|FG002|STARTED|First Washout Period (1 Week)||1||
59970763|NCT01675154|76088062|FG003|STARTED|First Washout Period (1 Week)||1||
59811638|NCT00461253|75933905|FG001|NOT COMPLETED|Overall Study||19798||
59811639|NCT00469833|75933911|FG000|STARTED|Overall Study|17 subjects met inclusion criteria and consented for the study|17||
59811640|NCT00469833|75933911|FG000|COMPLETED|Overall Study||15||
59811641|NCT00469833|75933911|FG000|NOT COMPLETED|Overall Study||2||
59811642|NCT00382174|75933923|FG000|STARTED|Overall Study||18||
59811643|NCT00382174|75933924|FG001|STARTED|Overall Study||54||
59811644|NCT00382174|75933925|FG002|STARTED|Overall Study||72||
59811645|NCT00382174|75933923|FG000|COMPLETED|Overall Study||14||
59811646|NCT00382174|75933924|FG001|COMPLETED|Overall Study||37||
59811647|NCT00382174|75933925|FG002|COMPLETED|Overall Study||51||
59811648|NCT00382174|75933923|FG000|NOT COMPLETED|Overall Study||4||
59811649|NCT00382174|75933924|FG001|NOT COMPLETED|Overall Study||17||
59811650|NCT00382174|75933925|FG002|NOT COMPLETED|Overall Study||21||
59811651|NCT00641537|75933938|FG000|STARTED|96-week Period||98||
59811652|NCT00641537|75933939|FG001|STARTED|96-week Period||92||
59811653|NCT00641537|75933940|FG002|STARTED|96-week Period||186||
59811654|NCT00641537|75933941|FG003|STARTED|96-week Period||186||
59811655|NCT00641537|75933942|FG004|STARTED|96-week Period||244||
59811656|NCT00641537|75933943|FG005|STARTED|96-week Period||22||
59811657|NCT00641537|75933944|FG006|STARTED|96-week Period||17||
59811658|NCT00641537|75933945|FG007|STARTED|96-week Period||22||
59811659|NCT00641537|75933938|FG000|COMPLETED|96-week Period||89||
59811660|NCT00641537|75933939|FG001|COMPLETED|96-week Period||82||
59811661|NCT00641537|75933940|FG002|COMPLETED|96-week Period||166||
59811662|NCT00641537|75933941|FG003|COMPLETED|96-week Period||174||
59811663|NCT00641537|75933942|FG004|COMPLETED|96-week Period||227||
59811664|NCT00641537|75933943|FG005|COMPLETED|96-week Period||15||
59811665|NCT00641537|75933944|FG006|COMPLETED|96-week Period||12||
59811666|NCT00641537|75933945|FG007|COMPLETED|96-week Period||16||
59811667|NCT00641537|75933938|FG000|NOT COMPLETED|96-week Period||9||
59811668|NCT00641537|75933939|FG001|NOT COMPLETED|96-week Period||10||
59811669|NCT00641537|75933940|FG002|NOT COMPLETED|96-week Period||20||
59811670|NCT00641537|75933941|FG003|NOT COMPLETED|96-week Period||12||
59811671|NCT00641537|75933942|FG004|NOT COMPLETED|96-week Period||17||
59811672|NCT00641537|75933943|FG005|NOT COMPLETED|96-week Period||7||
59811673|NCT00641537|75933944|FG006|NOT COMPLETED|96-week Period||5||
59811674|NCT00641537|75933945|FG007|NOT COMPLETED|96-week Period||6||
59811675|NCT00641537|75933938|FG000|STARTED|24-Week Supplemental Follow-up Period||75||
59811676|NCT00641537|75933939|FG001|STARTED|24-Week Supplemental Follow-up Period||69||
59811677|NCT00641537|75933940|FG002|STARTED|24-Week Supplemental Follow-up Period||143||
59811678|NCT00641537|75933941|FG003|STARTED|24-Week Supplemental Follow-up Period||151||
59811679|NCT00641537|75933942|FG004|STARTED|24-Week Supplemental Follow-up Period||198||
59811680|NCT00641537|75933943|FG005|STARTED|24-Week Supplemental Follow-up Period||15||
59811681|NCT00641537|75933944|FG006|STARTED|24-Week Supplemental Follow-up Period||9||
59811682|NCT00641537|75933945|FG007|STARTED|24-Week Supplemental Follow-up Period||11||
59811683|NCT00641537|75933938|FG000|COMPLETED|24-Week Supplemental Follow-up Period||75||
59811684|NCT00641537|75933939|FG001|COMPLETED|24-Week Supplemental Follow-up Period||66||
59811685|NCT00641537|75933940|FG002|COMPLETED|24-Week Supplemental Follow-up Period||140||
59811686|NCT00641537|75933941|FG003|COMPLETED|24-Week Supplemental Follow-up Period||147||
59811687|NCT00641537|75933942|FG004|COMPLETED|24-Week Supplemental Follow-up Period||193||
59811688|NCT00641537|75933943|FG005|COMPLETED|24-Week Supplemental Follow-up Period||14||
59811689|NCT00641537|75933944|FG006|COMPLETED|24-Week Supplemental Follow-up Period||8||
59811690|NCT00641537|75933945|FG007|COMPLETED|24-Week Supplemental Follow-up Period||10||
59811691|NCT00641537|75933938|FG000|NOT COMPLETED|24-Week Supplemental Follow-up Period||0||
59811692|NCT00641537|75933939|FG001|NOT COMPLETED|24-Week Supplemental Follow-up Period||3||
59811693|NCT00641537|75933940|FG002|NOT COMPLETED|24-Week Supplemental Follow-up Period||3||
59811694|NCT00641537|75933941|FG003|NOT COMPLETED|24-Week Supplemental Follow-up Period||4||
59811695|NCT00641537|75933942|FG004|NOT COMPLETED|24-Week Supplemental Follow-up Period||5||
59811696|NCT00641537|75933943|FG005|NOT COMPLETED|24-Week Supplemental Follow-up Period||1||
59811697|NCT00641537|75933944|FG006|NOT COMPLETED|24-Week Supplemental Follow-up Period||1||
59811698|NCT00641537|75933945|FG007|NOT COMPLETED|24-Week Supplemental Follow-up Period||1||
59811699|NCT03840135|75933965|FG000|STARTED|Overall Study||86||
59811700|NCT03840135|75933966|FG001|STARTED|Overall Study||86||
59811701|NCT03840135|75933965|FG000|COMPLETED|Overall Study||79||
59811702|NCT03840135|75933966|FG001|COMPLETED|Overall Study||85||
59811703|NCT03840135|75933965|FG000|NOT COMPLETED|Overall Study||7||
59811704|NCT03840135|75933966|FG001|NOT COMPLETED|Overall Study||1||
59811705|NCT00461175|75933978|FG000|STARTED|Overall Study|859 patients could not be assigned to a cohort and are therefore missing in the participant flow.|43600||
59811706|NCT00461175|75933979|FG001|STARTED|Overall Study|859 patients could not be assigned to a cohort and are therefore missing in the participant flow.|18735||
59811707|NCT00461175|75933978|FG000|COMPLETED|Overall Study||43078||
59811708|NCT00461175|75933979|FG001|COMPLETED|Overall Study||18370||
59811709|NCT00461175|75933978|FG000|NOT COMPLETED|Overall Study||522||
59811710|NCT00461175|75933979|FG001|NOT COMPLETED|Overall Study||365||
59811711|NCT00641147|75933987|FG000|STARTED|Completed 4 Months.||21||
59811712|NCT00641147|75933988|FG001|STARTED|Completed 4 Months.||23||
59811713|NCT00641147|75933987|FG000|COMPLETED|Completed 4 Months.||19||
59811714|NCT00641147|75933988|FG001|COMPLETED|Completed 4 Months.||23||
59970764|NCT01675154|76088059|FG000|COMPLETED|First Washout Period (1 Week)||2||
59970765|NCT01675154|76088060|FG001|COMPLETED|First Washout Period (1 Week)||1||
59970766|NCT01675154|76088061|FG002|COMPLETED|First Washout Period (1 Week)||1||
59970767|NCT01675154|76088062|FG003|COMPLETED|First Washout Period (1 Week)||1||
59970768|NCT01675154|76088059|FG000|NOT COMPLETED|First Washout Period (1 Week)||0||
59970769|NCT01675154|76088060|FG001|NOT COMPLETED|First Washout Period (1 Week)||0||
59970770|NCT01675154|76088061|FG002|NOT COMPLETED|First Washout Period (1 Week)||0||
59970771|NCT01675154|76088062|FG003|NOT COMPLETED|First Washout Period (1 Week)||0||
59970772|NCT01675154|76088059|FG000|STARTED|Second Intervention Period (4 Weeks)||1||
59970773|NCT01675154|76088060|FG001|STARTED|Second Intervention Period (4 Weeks)|Subjects were enrolled in Regimen 2|1||
59970774|NCT01675154|76088061|FG002|STARTED|Second Intervention Period (4 Weeks)||1||
59970775|NCT01675154|76088062|FG003|STARTED|Second Intervention Period (4 Weeks)||2||
59970776|NCT01675154|76088059|FG000|COMPLETED|Second Intervention Period (4 Weeks)||0||
59970777|NCT01675154|76088060|FG001|COMPLETED|Second Intervention Period (4 Weeks)||1||
59970778|NCT01675154|76088061|FG002|COMPLETED|Second Intervention Period (4 Weeks)||1||
59970779|NCT01675154|76088062|FG003|COMPLETED|Second Intervention Period (4 Weeks)||1||
59970780|NCT01675154|76088059|FG000|NOT COMPLETED|Second Intervention Period (4 Weeks)||1||
59970781|NCT01675154|76088060|FG001|NOT COMPLETED|Second Intervention Period (4 Weeks)||0||
59970782|NCT01675154|76088061|FG002|NOT COMPLETED|Second Intervention Period (4 Weeks)||0||
59970783|NCT01675154|76088062|FG003|NOT COMPLETED|Second Intervention Period (4 Weeks)||1||
59970784|NCT01675154|76088059|FG000|STARTED|Second Washout Period (1 Week)||1||
59970785|NCT01675154|76088060|FG001|STARTED|Second Washout Period (1 Week)||1||
59970786|NCT01675154|76088061|FG002|STARTED|Second Washout Period (1 Week)||1||
59970787|NCT01675154|76088062|FG003|STARTED|Second Washout Period (1 Week)||2||
59970788|NCT01675154|76088059|FG000|COMPLETED|Second Washout Period (1 Week)||1||
59970789|NCT01675154|76088060|FG001|COMPLETED|Second Washout Period (1 Week)||1||
59970790|NCT01675154|76088061|FG002|COMPLETED|Second Washout Period (1 Week)||1||
60074445|NCT01801358|76189856|FG002|NOT COMPLETED|Overall Study||6||
60074446|NCT01801358|76189857|FG003|NOT COMPLETED|Overall Study||6||
60074447|NCT01801358|76189858|FG004|NOT COMPLETED|Overall Study||6||
60074448|NCT01801358|76189859|FG005|NOT COMPLETED|Overall Study||8||
60074449|NCT01807598|76189894|FG000|STARTED|Overall Study||10||
60074450|NCT01807598|76189894|FG000|COMPLETED|Overall Study||4||
60074451|NCT01807598|76189894|FG000|NOT COMPLETED|Overall Study||6||
60074452|NCT01801280|76189902|FG000|STARTED|Period 1|Each period lasted 10-14 weeks|5||
60074453|NCT01801280|76189903|FG001|STARTED|Period 1||5||
59811715|NCT00641147|75933987|FG000|NOT COMPLETED|Completed 4 Months.||2||
59811716|NCT00641147|75933988|FG001|NOT COMPLETED|Completed 4 Months.||0||
59811717|NCT00641147|75933987|FG000|STARTED|Completed 8 Months.||19||
59811718|NCT00641147|75933988|FG001|STARTED|Completed 8 Months.||23||
59811719|NCT00641147|75933987|FG000|COMPLETED|Completed 8 Months.||16||
59970791|NCT01675154|76088062|FG003|COMPLETED|Second Washout Period (1 Week)||2||
59970792|NCT01675154|76088059|FG000|NOT COMPLETED|Second Washout Period (1 Week)||0||
60074454|NCT01801280|76189904|FG002|STARTED|Period 1||5||
60074455|NCT01801280|76189905|FG003|STARTED|Period 1||5||
60074456|NCT01801280|76189902|FG000|COMPLETED|Period 1||5||
60074457|NCT01801280|76189903|FG001|COMPLETED|Period 1||4||
60074458|NCT01801280|76189904|FG002|COMPLETED|Period 1||5||
60074459|NCT01801280|76189905|FG003|COMPLETED|Period 1||5||
60074460|NCT01801280|76189902|FG000|NOT COMPLETED|Period 1||0||
59811720|NCT00641147|75933988|FG001|COMPLETED|Completed 8 Months.||21||
59811721|NCT00641147|75933987|FG000|NOT COMPLETED|Completed 8 Months.||3||
59970793|NCT01675154|76088060|FG001|NOT COMPLETED|Second Washout Period (1 Week)||0||
59970794|NCT01675154|76088061|FG002|NOT COMPLETED|Second Washout Period (1 Week)||0||
59970795|NCT01675154|76088062|FG003|NOT COMPLETED|Second Washout Period (1 Week)||0||
59970796|NCT01675154|76088059|FG000|STARTED|Third Intervention Period (4 Weeks)||1|Further participation of two patients was halted after Period 2 due to unavailability of the study medications.|
59970797|NCT01675154|76088060|FG001|STARTED|Third Intervention Period (4 Weeks)||1|Further participation of two patients was halted after Period 2 due to unavailability of the study medications.|
59970798|NCT01675154|76088061|FG002|STARTED|Third Intervention Period (4 Weeks)||1|Further participation of two patients was halted after Period 2 due to unavailability of the study medications.|
59970799|NCT01675154|76088062|FG003|STARTED|Third Intervention Period (4 Weeks)||0|Further participation of two patients was halted after Period 2 due to unavailability of the study medications.|
59970800|NCT01675154|76088059|FG000|COMPLETED|Third Intervention Period (4 Weeks)||1||
60074461|NCT01801280|76189903|FG001|NOT COMPLETED|Period 1||1||
60074462|NCT01801280|76189904|FG002|NOT COMPLETED|Period 1||0||
60074463|NCT01801280|76189905|FG003|NOT COMPLETED|Period 1||0||
60074464|NCT01801280|76189902|FG000|STARTED|Period 2||5||
60074465|NCT01801280|76189903|FG001|STARTED|Period 2||4||
60074466|NCT01801280|76189904|FG002|STARTED|Period 2||5||
60074467|NCT01801280|76189905|FG003|STARTED|Period 2||5||
60074468|NCT01801280|76189902|FG000|COMPLETED|Period 2||4||
59811722|NCT00641147|75933988|FG001|NOT COMPLETED|Completed 8 Months.||2||
59811723|NCT00641147|75933987|FG000|STARTED|Completed 12 Months.||16||
59811724|NCT00641147|75933988|FG001|STARTED|Completed 12 Months.||21||
59811725|NCT00641147|75933987|FG000|COMPLETED|Completed 12 Months.||15||
59811726|NCT00641147|75933988|FG001|COMPLETED|Completed 12 Months.||19||
59970801|NCT01675154|76088060|FG001|COMPLETED|Third Intervention Period (4 Weeks)||0||
59970802|NCT01675154|76088061|FG002|COMPLETED|Third Intervention Period (4 Weeks)||1||
59970803|NCT01675154|76088062|FG003|COMPLETED|Third Intervention Period (4 Weeks)||0||
59970804|NCT01675154|76088059|FG000|NOT COMPLETED|Third Intervention Period (4 Weeks)||0||
59970805|NCT01675154|76088060|FG001|NOT COMPLETED|Third Intervention Period (4 Weeks)||1||
59970806|NCT01675154|76088061|FG002|NOT COMPLETED|Third Intervention Period (4 Weeks)||0||
59970807|NCT01675154|76088062|FG003|NOT COMPLETED|Third Intervention Period (4 Weeks)||0||
59970808|NCT01675154|76088059|FG000|STARTED|Third Washout Period (1 Week)||1||
59970809|NCT01675154|76088060|FG001|STARTED|Third Washout Period (1 Week)||0||
59811727|NCT00641147|75933987|FG000|NOT COMPLETED|Completed 12 Months.||1||
59811728|NCT00641147|75933988|FG001|NOT COMPLETED|Completed 12 Months.||2||
59811729|NCT00641147|75933987|FG000|STARTED|Completed 16 Months.||15||
59811730|NCT00641147|75933988|FG001|STARTED|Completed 16 Months.||19||
59811731|NCT00641147|75933987|FG000|COMPLETED|Completed 16 Months.||13||
59811732|NCT00641147|75933988|FG001|COMPLETED|Completed 16 Months.||19||
59811733|NCT00641147|75933987|FG000|NOT COMPLETED|Completed 16 Months.||2||
59811734|NCT00641147|75933988|FG001|NOT COMPLETED|Completed 16 Months.||0||
59811735|NCT00460239|75933998|FG000|STARTED|Overall Study||0||
59811736|NCT00460239|75933999|FG001|STARTED|Overall Study||3||
59811737|NCT00460239|75934000|FG002|STARTED|Overall Study||1||
59811738|NCT00460239|75934001|FG003|STARTED|Overall Study||0||
59811739|NCT00460239|75934002|FG004|STARTED|Overall Study||1||
59811740|NCT00460239|75934003|FG005|STARTED|Overall Study||4||
59811741|NCT00460239|75934004|FG006|STARTED|Overall Study||1||
59811742|NCT00460239|75934005|FG007|STARTED|Overall Study||1||
59811743|NCT00460239|75934006|FG008|STARTED|Overall Study||1||
59811744|NCT00460239|75933998|FG000|COMPLETED|Overall Study||0||
59970810|NCT01675154|76088061|FG002|STARTED|Third Washout Period (1 Week)||1||
59970811|NCT01675154|76088062|FG003|STARTED|Third Washout Period (1 Week)||0||
59970812|NCT01675154|76088059|FG000|COMPLETED|Third Washout Period (1 Week)||1||
59970813|NCT01675154|76088060|FG001|COMPLETED|Third Washout Period (1 Week)||0||
59970814|NCT01675154|76088061|FG002|COMPLETED|Third Washout Period (1 Week)||1||
59970815|NCT01675154|76088062|FG003|COMPLETED|Third Washout Period (1 Week)||0||
59970816|NCT01675154|76088059|FG000|NOT COMPLETED|Third Washout Period (1 Week)||0||
59970817|NCT01675154|76088060|FG001|NOT COMPLETED|Third Washout Period (1 Week)||0||
59970818|NCT01675154|76088061|FG002|NOT COMPLETED|Third Washout Period (1 Week)||0||
59970819|NCT01675154|76088062|FG003|NOT COMPLETED|Third Washout Period (1 Week)||0||
59970820|NCT01675154|76088059|FG000|STARTED|Fourth Intervention Period (4 Weeks)||1||
59970821|NCT01675154|76088060|FG001|STARTED|Fourth Intervention Period (4 Weeks)||0||
59970822|NCT01675154|76088061|FG002|STARTED|Fourth Intervention Period (4 Weeks)||1||
59970823|NCT01675154|76088062|FG003|STARTED|Fourth Intervention Period (4 Weeks)||0||
59970824|NCT01675154|76088059|FG000|COMPLETED|Fourth Intervention Period (4 Weeks)||1|One patient dropped out during Period 3 due to personal reasons. Therefore, not included in this intervention period.|
59970825|NCT01675154|76088060|FG001|COMPLETED|Fourth Intervention Period (4 Weeks)||0|One patient dropped out during Period 3 due to personal reasons. Therefore, not included in this intervention period.|
59970826|NCT01675154|76088061|FG002|COMPLETED|Fourth Intervention Period (4 Weeks)||1|One patient dropped out during Period 3 due to personal reasons. Therefore, not included in this intervention period.|
59970827|NCT01675154|76088062|FG003|COMPLETED|Fourth Intervention Period (4 Weeks)||0|One patient dropped out during Period 3 due to personal reasons. Therefore, not included in this intervention period.|
59970828|NCT01675154|76088059|FG000|NOT COMPLETED|Fourth Intervention Period (4 Weeks)||0||
59970829|NCT01675154|76088060|FG001|NOT COMPLETED|Fourth Intervention Period (4 Weeks)||0||
59970830|NCT01675154|76088061|FG002|NOT COMPLETED|Fourth Intervention Period (4 Weeks)||0||
59970831|NCT01675154|76088062|FG003|NOT COMPLETED|Fourth Intervention Period (4 Weeks)||0||
59970832|NCT02744755|76088086|FG000|STARTED|Study Period 1||177|randomized|
59970833|NCT02744755|76088087|FG001|STARTED|Study Period 1||176|randomized|
59970834|NCT02744755|76088086|FG000|COMPLETED|Study Period 1||163|completed study period 1|
59970835|NCT02744755|76088087|FG001|COMPLETED|Study Period 1||168|completed study period 1|
59970836|NCT02744755|76088086|FG000|NOT COMPLETED|Study Period 1||14||
59970837|NCT02744755|76088087|FG001|NOT COMPLETED|Study Period 1||8||
59811745|NCT00460239|75933999|FG001|COMPLETED|Overall Study||2||
59811746|NCT00460239|75934000|FG002|COMPLETED|Overall Study||1||
59811747|NCT00460239|75934001|FG003|COMPLETED|Overall Study||0||
59970838|NCT02744755|76088086|FG000|STARTED|Study Period 2||159||
59970839|NCT02744755|76088087|FG001|STARTED|Study Period 2||166||
59970840|NCT02744755|76088086|FG000|COMPLETED|Study Period 2||145||
59811748|NCT00460239|75934002|FG004|COMPLETED|Overall Study||1||
59811749|NCT00460239|75934003|FG005|COMPLETED|Overall Study||1||
59811750|NCT00460239|75934004|FG006|COMPLETED|Overall Study||1||
59811751|NCT00460239|75934005|FG007|COMPLETED|Overall Study||1||
59811752|NCT00460239|75934006|FG008|COMPLETED|Overall Study||1||
59811753|NCT00460239|75933998|FG000|NOT COMPLETED|Overall Study||0||
59811754|NCT00460239|75933999|FG001|NOT COMPLETED|Overall Study||1||
59811755|NCT00460239|75934000|FG002|NOT COMPLETED|Overall Study||0||
59811756|NCT00460239|75934001|FG003|NOT COMPLETED|Overall Study||0||
59811757|NCT00460239|75934002|FG004|NOT COMPLETED|Overall Study||0||
59811758|NCT00460239|75934003|FG005|NOT COMPLETED|Overall Study||3||
59970841|NCT02744755|76088087|FG001|COMPLETED|Study Period 2||158||
59970842|NCT02744755|76088086|FG000|NOT COMPLETED|Study Period 2||14||
59970843|NCT02744755|76088087|FG001|NOT COMPLETED|Study Period 2||8||
59970844|NCT03924752|76088097|FG000|STARTED|Overall Study||10||
59811759|NCT00460239|75934004|FG006|NOT COMPLETED|Overall Study||0||
59811760|NCT00460239|75934005|FG007|NOT COMPLETED|Overall Study||0||
59811761|NCT00460239|75934006|FG008|NOT COMPLETED|Overall Study||0||
59811762|NCT00640835|75934021|FG000|STARTED|Overall Study||194||
59811763|NCT00640835|75934022|FG001|STARTED|Overall Study||188||
59811764|NCT00640835|75934021|FG000|COMPLETED|Overall Study||118||
59970845|NCT03924752|76088097|FG000|COMPLETED|Overall Study||10||
59525459|NCT03932240|75620839|FG000|COMPLETED|Overall Study||17||
59525460|NCT03932240|75620840|FG001|COMPLETED|Overall Study||13||
59525461|NCT03932240|75620839|FG000|NOT COMPLETED|Overall Study||1||
59525462|NCT03932240|75620840|FG001|NOT COMPLETED|Overall Study||5||
59525463|NCT03931746|75620848|FG000|STARTED|Overall Study||8||
59525464|NCT03931746|75620849|FG001|STARTED|Overall Study||6||
59525465|NCT03931746|75620848|FG000|COMPLETED|Overall Study||7||
59970846|NCT03924752|76088097|FG000|NOT COMPLETED|Overall Study||0||
59970847|NCT01356589|76088101|FG000|STARTED|Overall Study||1288||
59970848|NCT01356589|76088101|FG000|Treated|Overall Study||1285||
59970849|NCT01356589|76088101|FG000|COMPLETED|Overall Study||1283||
59970850|NCT01356589|76088101|FG000|NOT COMPLETED|Overall Study||5||
59970851|NCT02830087|76088111|FG000|STARTED|Overall Study||4||
59970852|NCT02830087|76088112|FG001|STARTED|Overall Study||4||
59970853|NCT02830087|76088113|FG002|STARTED|Overall Study||4||
59970854|NCT02830087|76088114|FG003|STARTED|Overall Study||3||
59970855|NCT02830087|76088115|FG004|STARTED|Overall Study||3||
59970856|NCT02830087|76088116|FG005|STARTED|Overall Study||3||
59970857|NCT02830087|76088111|FG000|COMPLETED|Overall Study||0||
59970858|NCT02830087|76088112|FG001|COMPLETED|Overall Study||0||
59970859|NCT02830087|76088113|FG002|COMPLETED|Overall Study||0||
59970860|NCT02830087|76088114|FG003|COMPLETED|Overall Study||0||
59970861|NCT02830087|76088115|FG004|COMPLETED|Overall Study||0||
59970862|NCT02830087|76088116|FG005|COMPLETED|Overall Study||0||
59970863|NCT02830087|76088111|FG000|NOT COMPLETED|Overall Study||4||
59970864|NCT02830087|76088112|FG001|NOT COMPLETED|Overall Study||4||
60074469|NCT01801280|76189903|FG001|COMPLETED|Period 2||4||
60074470|NCT01801280|76189904|FG002|COMPLETED|Period 2||5||
60074471|NCT01801280|76189905|FG003|COMPLETED|Period 2||5||
60074472|NCT01801280|76189902|FG000|NOT COMPLETED|Period 2||1||
60074473|NCT01801280|76189903|FG001|NOT COMPLETED|Period 2||0||
60074474|NCT01801280|76189904|FG002|NOT COMPLETED|Period 2||0||
59525466|NCT03931746|75620849|FG001|COMPLETED|Overall Study||4||
59525467|NCT03931746|75620848|FG000|NOT COMPLETED|Overall Study||1||
59525468|NCT03931746|75620849|FG001|NOT COMPLETED|Overall Study||2||
59525469|NCT03837509|75620860|FG000|STARTED|Phase 1||6||
59525470|NCT03837509|75620861|FG001|STARTED|Phase 1||4||
59525471|NCT03837509|75620862|FG002|STARTED|Phase 1||0||
59525472|NCT03837509|75620863|FG003|STARTED|Phase 1||0||
59525473|NCT03837509|75620864|FG004|STARTED|Phase 1||0||
59525474|NCT03837509|75620860|FG000|COMPLETED|Phase 1||1||
59525475|NCT03837509|75620861|FG001|COMPLETED|Phase 1||2||
59970865|NCT02830087|76088113|FG002|NOT COMPLETED|Overall Study||4||
59970866|NCT02830087|76088114|FG003|NOT COMPLETED|Overall Study||3||
59970867|NCT02830087|76088115|FG004|NOT COMPLETED|Overall Study||3||
59970868|NCT02830087|76088116|FG005|NOT COMPLETED|Overall Study||3||
59970869|NCT02481921|76088132|FG000|STARTED|Overall Study||117||
59970870|NCT02481921|76088133|FG001|STARTED|Overall Study||125||
59970871|NCT02481921|76088132|FG000|COMPLETED|Overall Study||95||
59970872|NCT02481921|76088133|FG001|COMPLETED|Overall Study||103||
59970873|NCT02481921|76088132|FG000|NOT COMPLETED|Overall Study||22||
59970874|NCT02481921|76088133|FG001|NOT COMPLETED|Overall Study||22||
59970875|NCT02829775|76088139|FG000|STARTED|Overall Study||9||
59970876|NCT02829775|76088139|FG000|COMPLETED|Overall Study||4||
59970877|NCT02829775|76088139|FG000|NOT COMPLETED|Overall Study||5||
59970878|NCT03488030|76088146|FG000|STARTED|Overall Study||101||
59970879|NCT03488030|76088147|FG001|STARTED|Overall Study||145||
60074475|NCT01801280|76189905|FG003|NOT COMPLETED|Period 2||0||
60074476|NCT01801280|76189902|FG000|STARTED|Period 3||4||
60074477|NCT01801280|76189903|FG001|STARTED|Period 3||4||
59525476|NCT03837509|75620862|FG002|COMPLETED|Phase 1||0||
59525477|NCT03837509|75620863|FG003|COMPLETED|Phase 1||0||
59525478|NCT03837509|75620864|FG004|COMPLETED|Phase 1||0||
59525479|NCT03837509|75620860|FG000|NOT COMPLETED|Phase 1||5||
59525480|NCT03837509|75620861|FG001|NOT COMPLETED|Phase 1||2||
59525481|NCT03837509|75620862|FG002|NOT COMPLETED|Phase 1||0||
59525482|NCT03837509|75620863|FG003|NOT COMPLETED|Phase 1||0||
59525483|NCT03837509|75620864|FG004|NOT COMPLETED|Phase 1||0||
59525484|NCT03837509|75620860|FG000|STARTED|Phase 2||0||
59525485|NCT03837509|75620861|FG001|STARTED|Phase 2||0||
59811765|NCT00640835|75934022|FG001|COMPLETED|Overall Study||131||
59811766|NCT00640835|75934021|FG000|NOT COMPLETED|Overall Study||76||
59970880|NCT03488030|76088146|FG000|COMPLETED|Overall Study||101|Participants with moderate to severe IBD at Day 1.|
59970881|NCT03488030|76088147|FG001|COMPLETED|Overall Study||145|Participants with moderate to severe IBD at Day 1.|
59970882|NCT03488030|76088146|FG000|NOT COMPLETED|Overall Study||0||
59970883|NCT03488030|76088147|FG001|NOT COMPLETED|Overall Study||0||
59970884|NCT01355497|76088160|FG000|STARTED|Overall Study||165||
59970885|NCT01355497|76088161|FG001|STARTED|Overall Study||165||
59970886|NCT01355497|76088160|FG000|COMPLETED|Overall Study||99||
59970887|NCT01355497|76088161|FG001|COMPLETED|Overall Study||102||
59970888|NCT01355497|76088160|FG000|NOT COMPLETED|Overall Study||66||
59970889|NCT01355497|76088161|FG001|NOT COMPLETED|Overall Study||63||
59970890|NCT01355575|76088167|FG000|STARTED|Overall Study||15||
59970891|NCT01355575|76088167|FG000|COMPLETED|Overall Study||13||
59970892|NCT01355575|76088167|FG000|NOT COMPLETED|Overall Study||2||
59970893|NCT02826421|76088179|FG000|STARTED|Overall Study||22||
59970894|NCT02826421|76088180|FG001|STARTED|Overall Study||29||
59970895|NCT02826421|76088181|FG002|STARTED|Overall Study||28||
59970896|NCT02826421|76088182|FG003|STARTED|Overall Study||30||
59970897|NCT02826421|76088179|FG000|Treated|Overall Study||19||
59970898|NCT02826421|76088180|FG001|Treated|Overall Study||26||
59970899|NCT02826421|76088181|FG002|Treated|Overall Study||26||
59970900|NCT02826421|76088182|FG003|Treated|Overall Study||28||
59970901|NCT02826421|76088179|FG000|COMPLETED|Overall Study||19||
59970902|NCT02826421|76088180|FG001|COMPLETED|Overall Study||26||
59525486|NCT03837509|75620862|FG002|STARTED|Phase 2||2||
59525487|NCT03837509|75620863|FG003|STARTED|Phase 2||1||
59525488|NCT03837509|75620864|FG004|STARTED|Phase 2||2||
59525489|NCT03837509|75620860|FG000|Disease Progression in Part 1|Phase 2||0||
59525490|NCT03837509|75620861|FG001|Disease Progression in Part 1|Phase 2||0||
59525491|NCT03837509|75620862|FG002|Disease Progression in Part 1|Phase 2||0||
59525492|NCT03837509|75620863|FG003|Disease Progression in Part 1|Phase 2||1||
59525493|NCT03837509|75620864|FG004|Disease Progression in Part 1|Phase 2||2||
59525494|NCT03837509|75620860|FG000|COMPLETED|Phase 2||0||
59525495|NCT03837509|75620861|FG001|COMPLETED|Phase 2||0||
59525496|NCT03837509|75620862|FG002|COMPLETED|Phase 2||2||
59525497|NCT03837509|75620863|FG003|COMPLETED|Phase 2||0||
59525498|NCT03837509|75620864|FG004|COMPLETED|Phase 2||1||
59811767|NCT00640835|75934022|FG001|NOT COMPLETED|Overall Study||57||
59811768|NCT03839355|75934030|FG000|STARTED|Overall Study||18||
59811769|NCT03839355|75934031|FG001|STARTED|Overall Study||16||
59811770|NCT03839355|75934030|FG000|COMPLETED|Overall Study||17||
59811771|NCT03839355|75934031|FG001|COMPLETED|Overall Study||16||
59811772|NCT03839355|75934030|FG000|NOT COMPLETED|Overall Study||1||
59811773|NCT03839355|75934031|FG001|NOT COMPLETED|Overall Study||0||
59811774|NCT00382018|75934041|FG000|STARTED|Overall Study||276|Patients in this group were only followed for OS and PFS. Thus, no treatment status data.|
59811775|NCT00382018|75934042|FG001|STARTED|Overall Study||165|Patients in this group were only followed for OS and PFS. Thus, no treatment status data.|
59811776|NCT00382018|75934043|FG002|STARTED|Overall Study||64|Patients in this group were only followed for OS and PFS. Thus, no treatment status data.|
59811777|NCT00382018|75934044|FG003|STARTED|Overall Study||59|Patients in this group were only followed for OS and PFS. Thus, no treatment status data.|
59811778|NCT00382018|75934041|FG000|COMPLETED|Overall Study|This group of patients did not receive protocol treatment.|276||
59811779|NCT00382018|75934042|FG001|COMPLETED|Overall Study||0||
59811780|NCT00382018|75934043|FG002|COMPLETED|Overall Study||0||
59811781|NCT00382018|75934044|FG003|COMPLETED|Overall Study||0||
59811782|NCT00382018|75934041|FG000|NOT COMPLETED|Overall Study||0||
59811783|NCT00382018|75934042|FG001|NOT COMPLETED|Overall Study||165||
59811784|NCT00382018|75934043|FG002|NOT COMPLETED|Overall Study||64||
59811785|NCT00382018|75934044|FG003|NOT COMPLETED|Overall Study||59||
59811786|NCT00640601|75934057|FG000|STARTED|Overall Study|331 patients enrolled and 295 patients started investigational product (IP)|295||
59811787|NCT00640601|75934057|FG000|COMPLETED|Overall Study||183||
59811788|NCT00640601|75934057|FG000|NOT COMPLETED|Overall Study||112||
59970903|NCT02826421|76088181|FG002|COMPLETED|Overall Study||26||
59970904|NCT02826421|76088182|FG003|COMPLETED|Overall Study||28||
59811789|NCT03838731|75934063|FG000|STARTED|Overall Study||27||
59811790|NCT03838731|75934064|FG001|STARTED|Overall Study||29||
59811791|NCT03838731|75934063|FG000|COMPLETED|Overall Study||26||
59811792|NCT03838731|75934064|FG001|COMPLETED|Overall Study||28||
59811793|NCT03838731|75934063|FG000|NOT COMPLETED|Overall Study||1||
59811794|NCT03838731|75934064|FG001|NOT COMPLETED|Overall Study||1||
59811795|NCT00452439|75934072|FG000|STARTED|Overall Study||36||
59811796|NCT00452439|75934073|FG001|STARTED|Overall Study||36||
59811797|NCT00452439|75934072|FG000|COMPLETED|Overall Study||22||
59811798|NCT00452439|75934073|FG001|COMPLETED|Overall Study||29||
59970905|NCT02826421|76088179|FG000|NOT COMPLETED|Overall Study||3||
59525499|NCT03837509|75620860|FG000|NOT COMPLETED|Phase 2||0||
59525500|NCT03837509|75620861|FG001|NOT COMPLETED|Phase 2||0||
59970906|NCT02826421|76088180|FG001|NOT COMPLETED|Overall Study||3||
59970907|NCT02826421|76088181|FG002|NOT COMPLETED|Overall Study||2||
59970908|NCT02826421|76088182|FG003|NOT COMPLETED|Overall Study||2||
59970909|NCT02825251|76088195|FG000|STARTED|Overall Study||236||
59970910|NCT02825251|76088196|FG001|STARTED|Overall Study||236||
59970911|NCT02825251|76088195|FG000|COMPLETED|Overall Study||233||
59970912|NCT02825251|76088196|FG001|COMPLETED|Overall Study||230||
59970913|NCT02825251|76088195|FG000|NOT COMPLETED|Overall Study||3||
59970914|NCT02825251|76088196|FG001|NOT COMPLETED|Overall Study||6||
59970915|NCT04860505|76088202|FG000|STARTED|Overall Study||20||
59970916|NCT04860505|76088202|FG000|Attended 24 Hours Post-dose Visit|Overall Study||20||
59970917|NCT04860505|76088202|FG000|COMPLETED|Overall Study||18|Completed 7 days post-dose visit|
59970918|NCT04860505|76088202|FG000|NOT COMPLETED|Overall Study||2||
59970919|NCT04063865|76088208|FG000|STARTED|Overall Study||6||
59970920|NCT04063865|76088209|FG001|STARTED|Overall Study||8||
59970921|NCT04063865|76088208|FG000|COMPLETED|Overall Study||0||
59970922|NCT04063865|76088209|FG001|COMPLETED|Overall Study||0||
59970923|NCT04063865|76088208|FG000|NOT COMPLETED|Overall Study||6||
59970924|NCT04063865|76088209|FG001|NOT COMPLETED|Overall Study||8||
59970925|NCT03994211|76088217|FG000|STARTED|Core Phase||12||
59970926|NCT03994211|76088218|FG001|STARTED|Core Phase||13||
59970927|NCT03994211|76088219|FG002|STARTED|Core Phase||0||
59970928|NCT03994211|76088217|FG000|COMPLETED|Core Phase||12||
59970929|NCT03994211|76088218|FG001|COMPLETED|Core Phase||12||
59970930|NCT03994211|76088219|FG002|COMPLETED|Core Phase||0||
59970931|NCT03994211|76088217|FG000|NOT COMPLETED|Core Phase||0||
59970932|NCT03994211|76088218|FG001|NOT COMPLETED|Core Phase||1||
59970933|NCT03994211|76088219|FG002|NOT COMPLETED|Core Phase||0||
59970934|NCT03994211|76088217|FG000|STARTED|Extension Phase||0||
59970935|NCT03994211|76088218|FG001|STARTED|Extension Phase||0||
59970936|NCT03994211|76088219|FG002|STARTED|Extension Phase||24||
59970937|NCT03994211|76088217|FG000|COMPLETED|Extension Phase||0||
59970938|NCT03994211|76088218|FG001|COMPLETED|Extension Phase||0||
59970939|NCT03994211|76088219|FG002|COMPLETED|Extension Phase||0||
59970940|NCT03994211|76088217|FG000|NOT COMPLETED|Extension Phase||0||
59970941|NCT03994211|76088218|FG001|NOT COMPLETED|Extension Phase||0||
59970942|NCT03994211|76088219|FG002|NOT COMPLETED|Extension Phase||24||
59970943|NCT03818607|76088234|FG000|STARTED|Period 1 (Week 1 to Week 52)||20||
59970944|NCT03818607|76088235|FG001|STARTED|Period 1 (Week 1 to Week 52)||22||
59970945|NCT03818607|76088234|FG000|Participants Treated|Period 1 (Week 1 to Week 52)||20||
59970946|NCT03818607|76088235|FG001|Participants Treated|Period 1 (Week 1 to Week 52)||22||
59970947|NCT03818607|76088234|FG000|COMPLETED|Period 1 (Week 1 to Week 52)||20||
59970948|NCT03818607|76088235|FG001|COMPLETED|Period 1 (Week 1 to Week 52)||21||
59970949|NCT03818607|76088234|FG000|NOT COMPLETED|Period 1 (Week 1 to Week 52)||0||
59970950|NCT03818607|76088235|FG001|NOT COMPLETED|Period 1 (Week 1 to Week 52)||1||
59970951|NCT03818607|76088234|FG000|STARTED|Period 2 (Week 53 to Week 79)||20||
59970952|NCT03818607|76088235|FG001|STARTED|Period 2 (Week 53 to Week 79)||21||
59970953|NCT03818607|76088234|FG000|Participants Treated|Period 2 (Week 53 to Week 79)||20||
59970954|NCT03818607|76088235|FG001|Participants Treated|Period 2 (Week 53 to Week 79)||21||
59970955|NCT03818607|76088234|FG000|COMPLETED|Period 2 (Week 53 to Week 79)||19||
59970956|NCT03818607|76088235|FG001|COMPLETED|Period 2 (Week 53 to Week 79)||20||
59970957|NCT03818607|76088234|FG000|NOT COMPLETED|Period 2 (Week 53 to Week 79)||1||
59970958|NCT03818607|76088235|FG001|NOT COMPLETED|Period 2 (Week 53 to Week 79)||1||
59970959|NCT03512002|76088252|FG000|STARTED|Overall Study||3||
59970960|NCT03512002|76088253|FG001|STARTED|Overall Study||5||
59970961|NCT03512002|76088252|FG000|COMPLETED|Overall Study||3||
59970962|NCT03512002|76088253|FG001|COMPLETED|Overall Study||5||
59970963|NCT03512002|76088252|FG000|NOT COMPLETED|Overall Study||0||
59970964|NCT03512002|76088253|FG001|NOT COMPLETED|Overall Study||0||
59970965|NCT03387579|76088262|FG000|STARTED|Overall Study||12||
59970966|NCT03387579|76088263|FG001|STARTED|Overall Study||12||
59970967|NCT03387579|76088264|FG002|STARTED|Overall Study||24||
59970968|NCT03387579|76088262|FG000|COMPLETED|Overall Study||12||
59970969|NCT03387579|76088263|FG001|COMPLETED|Overall Study||12||
59970970|NCT03387579|76088264|FG002|COMPLETED|Overall Study||24||
59970971|NCT03387579|76088262|FG000|NOT COMPLETED|Overall Study||0||
59970972|NCT03387579|76088263|FG001|NOT COMPLETED|Overall Study||0||
59970973|NCT03387579|76088264|FG002|NOT COMPLETED|Overall Study||0||
60074478|NCT01801280|76189904|FG002|STARTED|Period 3||5||
59621961|NCT00374088|75733700|FG001|STARTED|Overall Study||11||
59621962|NCT00374088|75733699|FG000|COMPLETED|Overall Study||9||
59970974|NCT02422615|76088275|FG000|STARTED|Treatment Period||484||
59970975|NCT02422615|76088276|FG001|STARTED|Treatment Period||242||
59970976|NCT02422615|76088275|FG000|Untreated|Treatment Period||1||
59970977|NCT02422615|76088276|FG001|Untreated|Treatment Period||1||
59970978|NCT02422615|76088275|FG000|Crossover Cohort|Treatment Period||0|Participants in the placebo+fulvestrant arm who crossed over to the ribociclib+fulvestrant arm and received at least one dose of the study treatment.|
59970979|NCT02422615|76088276|FG001|Crossover Cohort|Treatment Period||3|Participants in the placebo+fulvestrant arm who crossed over to the ribociclib+fulvestrant arm and received at least one dose of the study treatment.|
59970980|NCT02422615|76088275|FG000|COMPLETED|Treatment Period||0|Treatment ongoing at the time of the cut-off 11-Jan-2023|
59970981|NCT02422615|76088276|FG001|COMPLETED|Treatment Period||0|Treatment ongoing at the time of the cut-off 11-Jan-2023|
59970982|NCT02422615|76088275|FG000|NOT COMPLETED|Treatment Period||484||
59970983|NCT02422615|76088276|FG001|NOT COMPLETED|Treatment Period||242||
59970984|NCT02422615|76088275|FG000|STARTED|Post-treatment Efficacy Follow-up||34||
59970985|NCT02422615|76088276|FG001|STARTED|Post-treatment Efficacy Follow-up||9||
59970986|NCT02422615|76088275|FG000|COMPLETED|Post-treatment Efficacy Follow-up||0||
59970987|NCT02422615|76088276|FG001|COMPLETED|Post-treatment Efficacy Follow-up||0||
59970988|NCT02422615|76088275|FG000|NOT COMPLETED|Post-treatment Efficacy Follow-up||34||
59970989|NCT02422615|76088276|FG001|NOT COMPLETED|Post-treatment Efficacy Follow-up||9||
60074479|NCT01801280|76189905|FG003|STARTED|Period 3||5||
59970990|NCT02382406|76088291|FG000|STARTED|Study Treatment||14||
59970991|NCT02382406|76088292|FG001|STARTED|Study Treatment||0||
59970992|NCT02382406|76088293|FG002|STARTED|Study Treatment||32||
59970993|NCT02382406|76088291|FG000|COMPLETED|Study Treatment||0||
59970994|NCT02382406|76088292|FG001|COMPLETED|Study Treatment||0||
59970995|NCT02382406|76088293|FG002|COMPLETED|Study Treatment||2||
59970996|NCT02382406|76088291|FG000|NOT COMPLETED|Study Treatment||14||
59970997|NCT02382406|76088292|FG001|NOT COMPLETED|Study Treatment||0||
59970998|NCT02382406|76088293|FG002|NOT COMPLETED|Study Treatment||30||
59970999|NCT02382406|76088291|FG000|STARTED|Follow up||14|Treatment and Follow up both are at different time period. Therefore, the number of subjects to start follow up is not equal to the number of subjects who have completed treatment.|
59971000|NCT02382406|76088292|FG001|STARTED|Follow up||0|Treatment and Follow up both are at different time period. Therefore, the number of subjects to start follow up is not equal to the number of subjects who have completed treatment.|
59971001|NCT02382406|76088293|FG002|STARTED|Follow up||32|Treatment and Follow up both are at different time period. Therefore, the number of subjects to start follow up is not equal to the number of subjects who have completed treatment.|
59971002|NCT02382406|76088291|FG000|COMPLETED|Follow up||0||
59971003|NCT02382406|76088292|FG001|COMPLETED|Follow up||0||
59971004|NCT02382406|76088293|FG002|COMPLETED|Follow up||2||
59971005|NCT02382406|76088291|FG000|NOT COMPLETED|Follow up||14||
59971006|NCT02382406|76088292|FG001|NOT COMPLETED|Follow up||0||
59971007|NCT02382406|76088293|FG002|NOT COMPLETED|Follow up||30||
59971008|NCT02186587|76088305|FG000|STARTED|Overall Study||28||
59971009|NCT02186587|76088306|FG001|STARTED|Overall Study||0||
59971010|NCT02186587|76088305|FG000|COMPLETED|Overall Study||23||
59971011|NCT02186587|76088306|FG001|COMPLETED|Overall Study||0||
59971012|NCT02186587|76088305|FG000|NOT COMPLETED|Overall Study||5||
59971013|NCT02186587|76088306|FG001|NOT COMPLETED|Overall Study||0||
59971014|NCT02101268|76088313|FG000|STARTED|Randomized Treatment Phase|The MMB group is only applicable to the randomized treatment phase. Participants who complete the randomized phase and continue to receive MMB in the extended treatment phase constitute the MMB to MMB group.|104||
59971015|NCT02101268|76088314|FG001|STARTED|Randomized Treatment Phase|The BAT group is only applicable to the randomized treatment phase. Participants who complete the randomized phase and begin receiving MMB in the extended treatment phase constitute the BAT to MMB group.|52||
59971016|NCT02101268|76088315|FG002|STARTED|Randomized Treatment Phase|The MMB to MMB group is only applicable to the extended treatment phase.|0||
59971017|NCT02101268|76088316|FG003|STARTED|Randomized Treatment Phase|The BAT to MMB group is only applicable to the extended treatment phase.|0||
59971018|NCT02101268|76088313|FG000|COMPLETED|Randomized Treatment Phase||77||
59971019|NCT02101268|76088314|FG001|COMPLETED|Randomized Treatment Phase||41||
59971020|NCT02101268|76088315|FG002|COMPLETED|Randomized Treatment Phase||0||
59971021|NCT02101268|76088316|FG003|COMPLETED|Randomized Treatment Phase||0||
59971022|NCT02101268|76088313|FG000|NOT COMPLETED|Randomized Treatment Phase||27||
59811799|NCT00452439|75934072|FG000|NOT COMPLETED|Overall Study||14||
59811800|NCT00452439|75934073|FG001|NOT COMPLETED|Overall Study||7||
59811801|NCT00381940|75934079|FG000|STARTED|Overall Study||26||
59811802|NCT00381940|75934079|FG000|COMPLETED|Overall Study||21||
59811803|NCT00381940|75934079|FG000|NOT COMPLETED|Overall Study||5||
59811804|NCT00364156|75934085|FG000|STARTED|Overall Study||282||
59811805|NCT00364156|75934086|FG001|STARTED|Overall Study||286||
59811806|NCT00364156|75934085|FG000|COMPLETED|Overall Study||203||
59811807|NCT00364156|75934086|FG001|COMPLETED|Overall Study||205||
59971023|NCT02101268|76088314|FG001|NOT COMPLETED|Randomized Treatment Phase||11||
59971024|NCT02101268|76088315|FG002|NOT COMPLETED|Randomized Treatment Phase||0||
59971025|NCT02101268|76088316|FG003|NOT COMPLETED|Randomized Treatment Phase||0||
59971026|NCT02101268|76088313|FG000|STARTED|Extended Treatment Phase|The MMB group is only applicable to the randomized treatment phase. Participants who complete the randomized phase and continue to receive MMB in the extended treatment phase constitute the MMB to MMB group.|0||
59971027|NCT02101268|76088314|FG001|STARTED|Extended Treatment Phase|The BAT group is only applicable to the randomized treatment phase. Participants who complete the randomized phase and begin receiving MMB in the extended treatment phase constitute the BAT to MMB group.|0||
59971028|NCT02101268|76088315|FG002|STARTED|Extended Treatment Phase|Of 77 participants in the MMB group who completed the randomized treatment phase, 64 entered the extended treatment phase to continue receiving MMB.|64||
59971029|NCT02101268|76088316|FG003|STARTED|Extended Treatment Phase|Of 41 participants in the BAT group who completed the randomized treatment phase, 40 entered the extended treatment phase to begin receiving MMB.|40||
59971030|NCT02101268|76088313|FG000|COMPLETED|Extended Treatment Phase||0||
59971031|NCT02101268|76088314|FG001|COMPLETED|Extended Treatment Phase||0||
59971032|NCT02101268|76088315|FG002|COMPLETED|Extended Treatment Phase||0||
59971033|NCT02101268|76088316|FG003|COMPLETED|Extended Treatment Phase||0||
59971034|NCT02101268|76088313|FG000|NOT COMPLETED|Extended Treatment Phase||0||
59994946|NCT03269695|76110761|FG001|Treated|Overall Study||10||
59994947|NCT03269695|76110760|FG000|COMPLETED|Overall Study||8||
59994948|NCT03269695|76110761|FG001|COMPLETED|Overall Study||7||
59811808|NCT00364156|75934085|FG000|NOT COMPLETED|Overall Study||79||
59811809|NCT00364156|75934086|FG001|NOT COMPLETED|Overall Study||81||
59811810|NCT00452361|75934094|FG000|STARTED|Overall Study||21||
59811811|NCT00452361|75934095|FG001|STARTED|Overall Study||10||
59811812|NCT00452361|75934094|FG000|COMPLETED|Overall Study||0||
59811813|NCT00452361|75934095|FG001|COMPLETED|Overall Study||0||
59811814|NCT00452361|75934094|FG000|NOT COMPLETED|Overall Study||21||
59971035|NCT02101268|76088314|FG001|NOT COMPLETED|Extended Treatment Phase||0||
59971036|NCT02101268|76088315|FG002|NOT COMPLETED|Extended Treatment Phase||64||
59971037|NCT02101268|76088316|FG003|NOT COMPLETED|Extended Treatment Phase||40||
59971038|NCT02045446|76088326|FG000|STARTED|Overall Study||15||
59971039|NCT02045446|76088327|FG001|STARTED|Overall Study||14||
59971040|NCT02045446|76088326|FG000|COMPLETED|Overall Study||15||
59971041|NCT02045446|76088327|FG001|COMPLETED|Overall Study||14||
59971042|NCT02045446|76088326|FG000|NOT COMPLETED|Overall Study||0||
59971043|NCT02045446|76088327|FG001|NOT COMPLETED|Overall Study||0||
59971044|NCT01898650|76088333|FG000|STARTED|Overall Study|12 were enrolled, beginning on 1/30/2013|12||
59971045|NCT01898650|76088333|FG000|Scanned|Overall Study||11||
59971046|NCT01898650|76088333|FG000|COMPLETED|Overall Study|last subject scanned|11||
59971047|NCT01898650|76088333|FG000|NOT COMPLETED|Overall Study||1||
59971048|NCT01880515|76088339|FG000|STARTED|Overall Study||53||
59971049|NCT01880515|76088340|FG001|STARTED|Overall Study||54||
59971050|NCT01880515|76088339|FG000|COMPLETED|Overall Study||45||
59971051|NCT01880515|76088340|FG001|COMPLETED|Overall Study||45||
59971052|NCT01880515|76088339|FG000|NOT COMPLETED|Overall Study||8||
59971053|NCT01880515|76088340|FG001|NOT COMPLETED|Overall Study||9||
59971054|NCT01668719|76088350|FG000|STARTED|Phase I||6||
59971055|NCT01668719|76088351|FG001|STARTED|Phase I||0||
59971056|NCT01668719|76088352|FG002|STARTED|Phase I||0||
59971057|NCT01668719|76088350|FG000|COMPLETED|Phase I||0||
59971058|NCT01668719|76088351|FG001|COMPLETED|Phase I||0||
59971059|NCT01668719|76088352|FG002|COMPLETED|Phase I||0||
59971060|NCT01668719|76088350|FG000|NOT COMPLETED|Phase I||6||
59971061|NCT01668719|76088351|FG001|NOT COMPLETED|Phase I||0||
59971062|NCT01668719|76088352|FG002|NOT COMPLETED|Phase I||0||
59971063|NCT01668719|76088350|FG000|STARTED|Phase II||0||
59971064|NCT01668719|76088351|FG001|STARTED|Phase II||52||
59971065|NCT01668719|76088352|FG002|STARTED|Phase II||48||
59971066|NCT01668719|76088350|FG000|COMPLETED|Phase II||0||
59971067|NCT01668719|76088351|FG001|COMPLETED|Phase II||0||
59971068|NCT01668719|76088352|FG002|COMPLETED|Phase II||0||
59971069|NCT01668719|76088350|FG000|NOT COMPLETED|Phase II||0||
59971070|NCT01668719|76088351|FG001|NOT COMPLETED|Phase II||52||
59971071|NCT01668719|76088352|FG002|NOT COMPLETED|Phase II||48||
59971072|NCT01642901|76088364|FG000|STARTED|Intervention||10||
59971073|NCT01642901|76088365|FG001|STARTED|Intervention||5||
59971074|NCT01642901|76088364|FG000|COMPLETED|Intervention|One participant had knee flexion contractures and spasticity that prevented accurate DXA at the knee.|10||
59971075|NCT01642901|76088365|FG001|COMPLETED|Intervention||5||
59971076|NCT01642901|76088364|FG000|NOT COMPLETED|Intervention||0||
59971077|NCT01642901|76088365|FG001|NOT COMPLETED|Intervention||0||
59971078|NCT01642901|76088364|FG000|STARTED|4-month Follow-up||10||
59811815|NCT00452361|75934095|FG001|NOT COMPLETED|Overall Study||10||
59811816|NCT00640289|75934101|FG000|STARTED|Overall Study||72||
59811817|NCT00640289|75934101|FG000|COMPLETED|Overall Study||59||
59811818|NCT00640289|75934101|FG000|NOT COMPLETED|Overall Study||13||
59811819|NCT00568451|75934109|FG000|STARTED|Overall Study||0||
59971079|NCT01642901|76088365|FG001|STARTED|4-month Follow-up||5||
59971080|NCT01642901|76088364|FG000|COMPLETED|4-month Follow-up||10||
59971081|NCT01642901|76088365|FG001|COMPLETED|4-month Follow-up||5||
59971082|NCT01642901|76088364|FG000|NOT COMPLETED|4-month Follow-up||0||
59971083|NCT01642901|76088365|FG001|NOT COMPLETED|4-month Follow-up||0||
59971084|NCT01642901|76088364|FG000|STARTED|12-month Follow-up||10||
59971085|NCT01642901|76088365|FG001|STARTED|12-month Follow-up||5||
59971086|NCT01642901|76088364|FG000|COMPLETED|12-month Follow-up|One participant had knee flexion contractures and spasticity that prevented accurate DXA at the knee.|9||
59971087|NCT01642901|76088365|FG001|COMPLETED|12-month Follow-up||5||
59971088|NCT01642901|76088364|FG000|NOT COMPLETED|12-month Follow-up||1||
59971089|NCT01642901|76088365|FG001|NOT COMPLETED|12-month Follow-up||0||
59971090|NCT01488045|76088373|FG000|STARTED|Overall Study|Approved by IRB 3/11/11 Enrollment start date|145||
59971091|NCT01488045|76088374|FG001|STARTED|Overall Study|3/11/2011 Approved by IRB and enrollment started.|144||
59971092|NCT01488045|76088373|FG000|COMPLETED|Overall Study|Enrollment target number met on 10/10/14|136||
59971093|NCT01488045|76088374|FG001|COMPLETED|Overall Study|Target number met on 10/10/14|126||
59971094|NCT01488045|76088373|FG000|NOT COMPLETED|Overall Study||9||
59971095|NCT01488045|76088374|FG001|NOT COMPLETED|Overall Study||18||
59971096|NCT01090479|76088382|FG000|STARTED|Overall Study||50||
59971097|NCT01090479|76088383|FG001|STARTED|Overall Study||50||
59971098|NCT01090479|76088382|FG000|COMPLETED|Overall Study||50||
59971099|NCT01090479|76088383|FG001|COMPLETED|Overall Study||50||
59811820|NCT00568451|75934110|FG001|STARTED|Overall Study||0||
59811821|NCT00568451|75934111|FG002|STARTED|Overall Study||2||
59971100|NCT01090479|76088382|FG000|NOT COMPLETED|Overall Study||0||
59971101|NCT01090479|76088383|FG001|NOT COMPLETED|Overall Study||0||
59971102|NCT00946712|76088393|FG000|STARTED|Overall Study||671||
59811822|NCT00568451|75934112|FG003|STARTED|Overall Study||9||
59971103|NCT00946712|76088394|FG001|STARTED|Overall Study||662||
59971104|NCT00946712|76088393|FG000|COMPLETED|Overall Study||124||
59971105|NCT00946712|76088394|FG001|COMPLETED|Overall Study||0||
59971106|NCT00946712|76088393|FG000|NOT COMPLETED|Overall Study||547||
59971107|NCT00946712|76088394|FG001|NOT COMPLETED|Overall Study||662||
59971108|NCT00656669|76088401|FG000|STARTED|Single Agent Sunitinib (Cycle 1)||23||
59971109|NCT00656669|76088401|FG000|COMPLETED|Single Agent Sunitinib (Cycle 1)||23||
59971110|NCT00656669|76088401|FG000|NOT COMPLETED|Single Agent Sunitinib (Cycle 1)||0||
59971111|NCT00656669|76088401|FG000|STARTED|Paclitaxel/Sunitinib (Cycles 2-5)||23||
59971112|NCT00656669|76088401|FG000|COMPLETED|Paclitaxel/Sunitinib (Cycles 2-5)||17||
59971113|NCT00656669|76088401|FG000|NOT COMPLETED|Paclitaxel/Sunitinib (Cycles 2-5)||6||
59971114|NCT00656669|76088401|FG000|STARTED|AC (Cycles 6-9)||17||
59971115|NCT00656669|76088401|FG000|COMPLETED|AC (Cycles 6-9)||15||
59971116|NCT00656669|76088401|FG000|NOT COMPLETED|AC (Cycles 6-9)||2||
59971117|NCT01338493|76088410|FG000|STARTED|Enrolled||139||
59971118|NCT01338493|76088410|FG000|COMPLETED|Enrolled||134||
59971119|NCT01338493|76088410|FG000|NOT COMPLETED|Enrolled||5||
59971120|NCT01338493|76088410|FG000|STARTED|Implant||134||
59971121|NCT01338493|76088410|FG000|COMPLETED|Implant||134||
59971122|NCT01338493|76088410|FG000|NOT COMPLETED|Implant||0||
59971123|NCT01338493|76088410|FG000|STARTED|Discharge||134||
59971124|NCT01338493|76088410|FG000|COMPLETED|Discharge||132||
59971125|NCT01338493|76088410|FG000|NOT COMPLETED|Discharge||2||
59971126|NCT01338493|76088410|FG000|STARTED|6 Months Follow up||132||
59811823|NCT00568451|75934109|FG000|COMPLETED|Overall Study||0||
59811824|NCT00568451|75934110|FG001|COMPLETED|Overall Study||0||
59811825|NCT00568451|75934111|FG002|COMPLETED|Overall Study||0||
59971127|NCT01338493|76088410|FG000|COMPLETED|6 Months Follow up||113||
59971128|NCT01338493|76088410|FG000|NOT COMPLETED|6 Months Follow up||19||
59971129|NCT01338493|76088410|FG000|STARTED|12 Months Follow up||113||
59971130|NCT01338493|76088410|FG000|COMPLETED|12 Months Follow up||104||
59971131|NCT01338493|76088410|FG000|NOT COMPLETED|12 Months Follow up||9||
59971132|NCT01338493|76088410|FG000|STARTED|24 Months Follow up||104||
59971133|NCT01338493|76088410|FG000|COMPLETED|24 Months Follow up||104||
59971134|NCT01338493|76088410|FG000|NOT COMPLETED|24 Months Follow up||0||
59971135|NCT01362296|76088416|FG000|STARTED|Randomized Phase (RP)||87||
59971136|NCT01362296|76088417|FG001|STARTED|Randomized Phase (RP)||43||
59971137|NCT01362296|76088418|FG002|STARTED|Randomized Phase (RP)||0||
59971138|NCT01362296|76088419|FG003|STARTED|Randomized Phase (RP)||0||
59971139|NCT01362296|76088416|FG000|COMPLETED|Randomized Phase (RP)||0||
59971140|NCT01362296|76088417|FG001|COMPLETED|Randomized Phase (RP)||0||
59971141|NCT01362296|76088418|FG002|COMPLETED|Randomized Phase (RP)||0||
59971142|NCT01362296|76088419|FG003|COMPLETED|Randomized Phase (RP)||0||
59971143|NCT01362296|76088416|FG000|NOT COMPLETED|Randomized Phase (RP)||87||
59971144|NCT01362296|76088417|FG001|NOT COMPLETED|Randomized Phase (RP)||43||
59971145|NCT01362296|76088418|FG002|NOT COMPLETED|Randomized Phase (RP)||0||
59971146|NCT01362296|76088419|FG003|NOT COMPLETED|Randomized Phase (RP)||0||
59971147|NCT01362296|76088416|FG000|STARTED|Crossover Phase|These participants elected to enter the Crossover Phase at the time of disease progression.|0||
59971148|NCT01362296|76088417|FG001|STARTED|Crossover Phase|These participants elected to enter the Crossover Phase at the time of disease progression.|0||
59971149|NCT01362296|76088418|FG002|STARTED|Crossover Phase|These participants elected to enter the Crossover Phase at the time of disease progression.|23||
59971150|NCT01362296|76088419|FG003|STARTED|Crossover Phase|These participants elected to enter the Crossover Phase at the time of disease progression.|2||
59971151|NCT01362296|76088416|FG000|COMPLETED|Crossover Phase||0||
59971152|NCT01362296|76088417|FG001|COMPLETED|Crossover Phase||0||
59811826|NCT00568451|75934112|FG003|COMPLETED|Overall Study||2||
59811827|NCT00568451|75934109|FG000|NOT COMPLETED|Overall Study||0||
59811828|NCT00568451|75934110|FG001|NOT COMPLETED|Overall Study||0||
59811829|NCT00568451|75934111|FG002|NOT COMPLETED|Overall Study||2||
59811830|NCT00568451|75934112|FG003|NOT COMPLETED|Overall Study||7||
59811831|NCT00459537|75934125|FG000|STARTED|Overall Study||507||
59811832|NCT00459537|75934126|FG001|STARTED|Overall Study||522||
59811833|NCT00459537|75934125|FG000|Safety Population|Overall Study|Participants who had at least one dose of study drug and one post-baseline safety assessment.|493||
59971153|NCT01362296|76088418|FG002|COMPLETED|Crossover Phase||0||
59971154|NCT01362296|76088419|FG003|COMPLETED|Crossover Phase||0||
59971155|NCT01362296|76088416|FG000|NOT COMPLETED|Crossover Phase||0||
59971156|NCT01362296|76088417|FG001|NOT COMPLETED|Crossover Phase||0||
59971157|NCT01362296|76088418|FG002|NOT COMPLETED|Crossover Phase||23||
59971158|NCT01362296|76088419|FG003|NOT COMPLETED|Crossover Phase||2||
59971159|NCT01338415|76088431|FG000|STARTED|Core + Extension||33||
59971160|NCT01338415|76088432|FG001|STARTED|Core + Extension||31||
59971161|NCT01338415|76088433|FG002|STARTED|Core + Extension||0||
59971162|NCT01338415|76088431|FG000|Enrolled in FUTURE 3 Extension|Core + Extension||31||
59971163|NCT01338415|76088432|FG001|Enrolled in FUTURE 3 Extension|Core + Extension||27||
59971164|NCT01338415|76088433|FG002|Enrolled in FUTURE 3 Extension|Core + Extension||0||
59971165|NCT01338415|76088431|FG000|COMPLETED|Core + Extension||23||
59811834|NCT00459537|75934126|FG001|Safety Population|Overall Study||512||
59811835|NCT00459537|75934125|FG000|COMPLETED|Overall Study||441||
59811836|NCT00459537|75934126|FG001|COMPLETED|Overall Study||446||
59971166|NCT01338415|76088432|FG001|COMPLETED|Core + Extension||22||
59971167|NCT01338415|76088433|FG002|COMPLETED|Core + Extension||0||
59971168|NCT01338415|76088431|FG000|NOT COMPLETED|Core + Extension||10||
59971169|NCT01338415|76088432|FG001|NOT COMPLETED|Core + Extension||9||
59971170|NCT01338415|76088433|FG002|NOT COMPLETED|Core + Extension||0||
59994949|NCT03269695|76110760|FG000|NOT COMPLETED|Overall Study||2||
59971171|NCT01338415|76088431|FG000|STARTED|Exceptional Use Treatment Period||0||
59971172|NCT01338415|76088432|FG001|STARTED|Exceptional Use Treatment Period||0||
59971173|NCT01338415|76088433|FG002|STARTED|Exceptional Use Treatment Period||10||
59971174|NCT01338415|76088431|FG000|COMPLETED|Exceptional Use Treatment Period||0||
59971175|NCT01338415|76088432|FG001|COMPLETED|Exceptional Use Treatment Period||0||
59971176|NCT01338415|76088433|FG002|COMPLETED|Exceptional Use Treatment Period||4||
59971177|NCT01338415|76088431|FG000|NOT COMPLETED|Exceptional Use Treatment Period||0||
59971178|NCT01338415|76088432|FG001|NOT COMPLETED|Exceptional Use Treatment Period||0||
59971179|NCT01338415|76088433|FG002|NOT COMPLETED|Exceptional Use Treatment Period||6||
59971180|NCT05258149|76088443|FG000|STARTED|Period 1||70||
60074480|NCT01801280|76189902|FG000|COMPLETED|Period 3||4||
60074481|NCT01801280|76189903|FG001|COMPLETED|Period 3||4||
59971181|NCT05258149|76088444|FG001|STARTED|Period 1||73||
59971182|NCT05258149|76088443|FG000|COMPLETED|Period 1||69||
59971183|NCT05258149|76088444|FG001|COMPLETED|Period 1||72||
59971184|NCT05258149|76088443|FG000|NOT COMPLETED|Period 1||1||
59971185|NCT05258149|76088444|FG001|NOT COMPLETED|Period 1||1||
59971186|NCT05258149|76088443|FG000|STARTED|Period 2||69||
59971187|NCT05258149|76088444|FG001|STARTED|Period 2||72||
59971188|NCT05258149|76088443|FG000|COMPLETED|Period 2||68||
59971189|NCT05258149|76088444|FG001|COMPLETED|Period 2||71||
59971190|NCT05258149|76088443|FG000|NOT COMPLETED|Period 2||1||
59971191|NCT05258149|76088444|FG001|NOT COMPLETED|Period 2||1||
59971192|NCT05258149|76088443|FG000|STARTED|Period 3||68||
59971193|NCT05258149|76088444|FG001|STARTED|Period 3||71||
59971194|NCT05258149|76088443|FG000|COMPLETED|Period 3||68||
59971195|NCT05258149|76088444|FG001|COMPLETED|Period 3||70||
59971196|NCT05258149|76088443|FG000|NOT COMPLETED|Period 3||0||
59971197|NCT05258149|76088444|FG001|NOT COMPLETED|Period 3||1||
59971198|NCT01371643|76088452|FG000|STARTED|Overall Study||15||
59971199|NCT01371643|76088453|FG001|STARTED|Overall Study||26||
59971200|NCT01371643|76088452|FG000|COMPLETED|Overall Study||12||
59971201|NCT01371643|76088453|FG001|COMPLETED|Overall Study||26||
59971202|NCT01371643|76088452|FG000|NOT COMPLETED|Overall Study||3||
59971203|NCT01371643|76088453|FG001|NOT COMPLETED|Overall Study||0||
59971204|NCT01371565|76088459|FG000|STARTED|Overall Study||4||
59971205|NCT01371565|76088459|FG000|COMPLETED|Overall Study||1||
59971206|NCT01371565|76088459|FG000|NOT COMPLETED|Overall Study||3||
59971207|NCT04093843|76088463|FG000|STARTED|Overall Study||6||
59971208|NCT04093843|76088463|FG000|COMPLETED|Overall Study||6||
59971209|NCT04093843|76088463|FG000|NOT COMPLETED|Overall Study||0||
59971210|NCT02821819|76088467|FG000|STARTED|Overall Study||15||
59971211|NCT02821819|76088467|FG000|COMPLETED|Overall Study||14||
59971212|NCT02821819|76088467|FG000|NOT COMPLETED|Overall Study||1||
59971213|NCT03926611|76088478|FG000|STARTED|Overall Study||44||
59971214|NCT03926611|76088479|FG001|STARTED|Overall Study||44||
59971215|NCT03926611|76088480|FG002|STARTED|Overall Study||47||
59971216|NCT03926611|76088481|FG003|STARTED|Overall Study||44||
59971217|NCT03926611|76088482|FG004|STARTED|Overall Study||44||
59971218|NCT03926611|76088483|FG005|STARTED|Overall Study||45||
59971219|NCT03926611|76088484|FG006|STARTED|Overall Study||43||
59971220|NCT03926611|76088478|FG000|Randomized Set (RAN)|Overall Study||44||
59971221|NCT03926611|76088479|FG001|Randomized Set (RAN)|Overall Study||44||
59971222|NCT03926611|76088480|FG002|Randomized Set (RAN)|Overall Study||47||
59971223|NCT03926611|76088481|FG003|Randomized Set (RAN)|Overall Study||44||
59971224|NCT03926611|76088482|FG004|Randomized Set (RAN)|Overall Study||44||
59971225|NCT03926611|76088483|FG005|Randomized Set (RAN)|Overall Study||45||
59971226|NCT03926611|76088484|FG006|Randomized Set (RAN)|Overall Study||43||
59971227|NCT03926611|76088478|FG000|Full Analysis Set (FAS)|Overall Study||44||
59971228|NCT03926611|76088479|FG001|Full Analysis Set (FAS)|Overall Study||44||
59971229|NCT03926611|76088480|FG002|Full Analysis Set (FAS)|Overall Study||47||
59971230|NCT03926611|76088481|FG003|Full Analysis Set (FAS)|Overall Study||44||
59971231|NCT03926611|76088482|FG004|Full Analysis Set (FAS)|Overall Study||43||
59971232|NCT03926611|76088483|FG005|Full Analysis Set (FAS)|Overall Study||45||
60074482|NCT01801280|76189904|FG002|COMPLETED|Period 3||5||
60074483|NCT01801280|76189905|FG003|COMPLETED|Period 3||5||
59971233|NCT03926611|76088484|FG006|Full Analysis Set (FAS)|Overall Study||42||
59971234|NCT03926611|76088478|FG000|Safety Set (SAF)|Overall Study||44||
59971235|NCT03926611|76088479|FG001|Safety Set (SAF)|Overall Study||44||
59971236|NCT03926611|76088480|FG002|Safety Set (SAF)|Overall Study||47||
59971237|NCT03926611|76088481|FG003|Safety Set (SAF)|Overall Study||44||
59971238|NCT03926611|76088482|FG004|Safety Set (SAF)|Overall Study||43||
59971239|NCT03926611|76088483|FG005|Safety Set (SAF)|Overall Study||45||
59971240|NCT03926611|76088484|FG006|Safety Set (SAF)|Overall Study||42||
59971241|NCT03926611|76088478|FG000|COMPLETED|Overall Study||41||
59971242|NCT03926611|76088479|FG001|COMPLETED|Overall Study||41||
59971243|NCT03926611|76088480|FG002|COMPLETED|Overall Study||45||
59971244|NCT03926611|76088481|FG003|COMPLETED|Overall Study||40||
59971245|NCT03926611|76088482|FG004|COMPLETED|Overall Study||40||
59971246|NCT03926611|76088483|FG005|COMPLETED|Overall Study||36||
60074484|NCT01801280|76189902|FG000|NOT COMPLETED|Period 3||0||
60074485|NCT01801280|76189903|FG001|NOT COMPLETED|Period 3||0||
60074486|NCT01801280|76189904|FG002|NOT COMPLETED|Period 3||0||
59971247|NCT03926611|76088484|FG006|COMPLETED|Overall Study||38||
59811837|NCT00459537|75934125|FG000|NOT COMPLETED|Overall Study||66||
59811838|NCT00459537|75934126|FG001|NOT COMPLETED|Overall Study||76||
59811839|NCT03850509|75934134|FG000|STARTED|Overall Study||2||
59811840|NCT03850509|75934135|FG001|STARTED|Overall Study||1||
59811841|NCT03850509|75934134|FG000|COMPLETED|Overall Study||0||
59811842|NCT03850509|75934135|FG001|COMPLETED|Overall Study||0||
59971248|NCT03926611|76088478|FG000|NOT COMPLETED|Overall Study||3||
59971249|NCT03926611|76088479|FG001|NOT COMPLETED|Overall Study||3||
59971250|NCT03926611|76088480|FG002|NOT COMPLETED|Overall Study||2||
59971251|NCT03926611|76088481|FG003|NOT COMPLETED|Overall Study||4||
59971252|NCT03926611|76088482|FG004|NOT COMPLETED|Overall Study||4||
59971253|NCT03926611|76088483|FG005|NOT COMPLETED|Overall Study||9||
59971254|NCT03926611|76088484|FG006|NOT COMPLETED|Overall Study||5||
59971255|NCT01272999|76088506|FG000|STARTED|Overall Study||357||
59971256|NCT01272999|76088507|FG001|STARTED|Overall Study||34||
59971257|NCT01272999|76088506|FG000|COMPLETED|Overall Study||357||
59971258|NCT01272999|76088507|FG001|COMPLETED|Overall Study||34||
59971259|NCT01272999|76088506|FG000|NOT COMPLETED|Overall Study||0||
59971260|NCT01272999|76088507|FG001|NOT COMPLETED|Overall Study||0||
59971261|NCT02818777|76088513|FG000|STARTED|Overall Study|The number of baseline participants was 13.|13||
59971262|NCT02818777|76088513|FG000|COMPLETED|Overall Study||10||
59971263|NCT02818777|76088513|FG000|NOT COMPLETED|Overall Study||3||
59971264|NCT04160078|76088523|FG000|STARTED|Overall Study||18||
59971265|NCT04160078|76088523|FG000|COMPLETED|Overall Study||18||
59971266|NCT04160078|76088523|FG000|NOT COMPLETED|Overall Study||0||
59971267|NCT02817841|76088527|FG000|STARTED|Overall Study||1864||
59971268|NCT02817841|76088527|FG000|COMPLETED|Overall Study||1016||
59971269|NCT02817841|76088527|FG000|NOT COMPLETED|Overall Study||848||
59971270|NCT02814565|76088537|FG000|STARTED|Overall Study||90||
59971271|NCT02814565|76088538|FG001|STARTED|Overall Study||90||
59971272|NCT02814565|76088537|FG000|COMPLETED|Overall Study||89||
59971273|NCT02814565|76088538|FG001|COMPLETED|Overall Study||88||
59971274|NCT02814565|76088537|FG000|NOT COMPLETED|Overall Study||1||
59971275|NCT02814565|76088538|FG001|NOT COMPLETED|Overall Study||2||
59971276|NCT02650466|76088544|FG000|STARTED|Overall Study||24||
59971277|NCT02650466|76088544|FG000|COMPLETED|Overall Study||17||
59971278|NCT02650466|76088544|FG000|NOT COMPLETED|Overall Study||7||
59971279|NCT02815735|76088550|FG000|STARTED|First Intervention (4 Weeks)||36||
59971280|NCT02815735|76088551|FG001|STARTED|First Intervention (4 Weeks)||38||
59971281|NCT02815735|76088550|FG000|COMPLETED|First Intervention (4 Weeks)||34||
59971282|NCT02815735|76088551|FG001|COMPLETED|First Intervention (4 Weeks)||37||
59971283|NCT02815735|76088550|FG000|NOT COMPLETED|First Intervention (4 Weeks)||2||
59971284|NCT02815735|76088551|FG001|NOT COMPLETED|First Intervention (4 Weeks)||1||
59971285|NCT02815735|76088550|FG000|STARTED|Second Intervention (4 Weeks)||34||
59971286|NCT02815735|76088551|FG001|STARTED|Second Intervention (4 Weeks)||37||
59971287|NCT02815735|76088550|FG000|COMPLETED|Second Intervention (4 Weeks)||33||
59971288|NCT02815735|76088551|FG001|COMPLETED|Second Intervention (4 Weeks)||37||
59971289|NCT02815735|76088550|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||1||
59971290|NCT02815735|76088551|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||0||
59971291|NCT02814643|76088568|FG000|STARTED|Overall Study||51||
59971292|NCT02814643|76088569|FG001|STARTED|Overall Study||52||
59971293|NCT02814643|76088568|FG000|COMPLETED|Overall Study||50||
59971294|NCT02814643|76088569|FG001|COMPLETED|Overall Study||49||
59971295|NCT02814643|76088568|FG000|NOT COMPLETED|Overall Study||1||
59971296|NCT02814643|76088569|FG001|NOT COMPLETED|Overall Study||3||
59811843|NCT03850509|75934134|FG000|NOT COMPLETED|Overall Study||2||
59811844|NCT03850509|75934135|FG001|NOT COMPLETED|Overall Study||1||
59811845|NCT00635999|75934144|FG000|STARTED|Overall Study||27||
59811846|NCT00635999|75934145|FG001|STARTED|Overall Study||25||
59811847|NCT00635999|75934146|FG002|STARTED|Overall Study||24||
59811848|NCT00635999|75934144|FG000|COMPLETED|Overall Study||23||
59811849|NCT00635999|75934145|FG001|COMPLETED|Overall Study||23||
59811850|NCT00635999|75934146|FG002|COMPLETED|Overall Study||23||
59971297|NCT02724111|76088577|FG000|STARTED|Overall Study||45||
59971298|NCT02724111|76088578|FG001|STARTED|Overall Study||45||
59971299|NCT02724111|76088577|FG000|COMPLETED|Overall Study||43||
59971300|NCT02724111|76088578|FG001|COMPLETED|Overall Study||40||
59971301|NCT02724111|76088577|FG000|NOT COMPLETED|Overall Study||2||
59971302|NCT02724111|76088578|FG001|NOT COMPLETED|Overall Study||5||
59971303|NCT02649218|76088584|FG000|STARTED|Overall Study||226||
59971304|NCT02649218|76088584|FG000|COMPLETED|Overall Study||201||
59811851|NCT00635999|75934144|FG000|NOT COMPLETED|Overall Study||4||
59811852|NCT00635999|75934145|FG001|NOT COMPLETED|Overall Study||2||
59811853|NCT00635999|75934146|FG002|NOT COMPLETED|Overall Study||1||
59811854|NCT00469209|75934157|FG000|STARTED|Overall Study||20||
59971305|NCT02649218|76088584|FG000|NOT COMPLETED|Overall Study||25||
59971306|NCT02814175|76088591|FG000|STARTED|Part 1||122||
59971307|NCT02814175|76088592|FG001|STARTED|Part 1||123||
59971308|NCT02814175|76088593|FG002|STARTED|Part 1||0||
59971309|NCT02814175|76088594|FG003|STARTED|Part 1||0||
59971310|NCT02814175|76088595|FG004|STARTED|Part 1||0||
59971311|NCT02814175|76088596|FG005|STARTED|Part 1||0||
59971312|NCT02814175|76088591|FG000|COMPLETED|Part 1||110||
59971313|NCT02814175|76088592|FG001|COMPLETED|Part 1||117||
59971314|NCT02814175|76088593|FG002|COMPLETED|Part 1||0||
59971315|NCT02814175|76088594|FG003|COMPLETED|Part 1||0||
59971316|NCT02814175|76088595|FG004|COMPLETED|Part 1||0||
59971317|NCT02814175|76088596|FG005|COMPLETED|Part 1||0||
59971318|NCT02814175|76088591|FG000|NOT COMPLETED|Part 1||12||
59971319|NCT02814175|76088592|FG001|NOT COMPLETED|Part 1||6||
59971320|NCT02814175|76088593|FG002|NOT COMPLETED|Part 1||0||
59971321|NCT02814175|76088594|FG003|NOT COMPLETED|Part 1||0||
59971322|NCT02814175|76088595|FG004|NOT COMPLETED|Part 1||0||
59525501|NCT03837509|75620862|FG002|NOT COMPLETED|Phase 2||0||
59525502|NCT03837509|75620863|FG003|NOT COMPLETED|Phase 2||1||
59525503|NCT03837509|75620864|FG004|NOT COMPLETED|Phase 2||1||
59525504|NCT03822117|75620884|FG000|STARTED|Overall Study||49||
59525505|NCT03822117|75620885|FG001|STARTED|Overall Study||32||
59525506|NCT03822117|75620886|FG002|STARTED|Overall Study||26||
59971323|NCT02814175|76088596|FG005|NOT COMPLETED|Part 1||0||
59971324|NCT02814175|76088591|FG000|STARTED|Part 2||0||
59971325|NCT02814175|76088592|FG001|STARTED|Part 2||0||
59971326|NCT02814175|76088593|FG002|STARTED|Part 2||15||
59971327|NCT02814175|76088594|FG003|STARTED|Part 2||95||
59971328|NCT02814175|76088595|FG004|STARTED|Part 2||54||
59971329|NCT02814175|76088596|FG005|STARTED|Part 2||63||
59971330|NCT02814175|76088591|FG000|COMPLETED|Part 2||0||
59971331|NCT02814175|76088592|FG001|COMPLETED|Part 2||0||
59971332|NCT02814175|76088593|FG002|COMPLETED|Part 2||15||
59971333|NCT02814175|76088594|FG003|COMPLETED|Part 2||91||
59971334|NCT02814175|76088595|FG004|COMPLETED|Part 2||52||
59971335|NCT02814175|76088596|FG005|COMPLETED|Part 2||57||
59971336|NCT02814175|76088591|FG000|NOT COMPLETED|Part 2||0||
59971337|NCT02814175|76088592|FG001|NOT COMPLETED|Part 2||0||
59971338|NCT02814175|76088593|FG002|NOT COMPLETED|Part 2||0||
59971339|NCT02814175|76088594|FG003|NOT COMPLETED|Part 2||4||
59971340|NCT02814175|76088595|FG004|NOT COMPLETED|Part 2||2||
59971341|NCT02814175|76088596|FG005|NOT COMPLETED|Part 2||6||
59971342|NCT01335997|76088612|FG000|STARTED|Period I and II||577||
59971343|NCT01335997|76088613|FG001|STARTED|Period I and II||562||
59971344|NCT01335997|76088612|FG000|COMPLETED|Period I and II||84||
59971345|NCT01335997|76088613|FG001|COMPLETED|Period I and II||83||
59971346|NCT01335997|76088612|FG000|NOT COMPLETED|Period I and II||493||
59971347|NCT01335997|76088613|FG001|NOT COMPLETED|Period I and II||479||
59971348|NCT01335997|76088612|FG000|STARTED|Period III||84||
59971349|NCT01335997|76088613|FG001|STARTED|Period III||83||
59971350|NCT01335997|76088612|FG000|COMPLETED|Period III||6||
59971351|NCT01335997|76088613|FG001|COMPLETED|Period III||4||
59971352|NCT01335997|76088612|FG000|NOT COMPLETED|Period III||78||
59971353|NCT01335997|76088613|FG001|NOT COMPLETED|Period III||79||
59971354|NCT02725671|76088621|FG000|STARTED|Overall Study||2||
59971355|NCT02725671|76088621|FG000|COMPLETED|Overall Study||1||
59811855|NCT00469209|75934158|FG001|STARTED|Overall Study||20||
59811856|NCT00469209|75934159|FG002|STARTED|Overall Study||20||
59811857|NCT00469209|75934157|FG000|COMPLETED|Overall Study||19||
59971356|NCT02725671|76088621|FG000|NOT COMPLETED|Overall Study||1||
59971357|NCT02446990|76088629|FG000|STARTED|Overall Study||9550||
59971358|NCT02446990|76088630|FG001|STARTED|Overall Study||9552||
59971359|NCT02446990|76088629|FG000|COMPLETED|Overall Study||8830||
59971360|NCT02446990|76088630|FG001|COMPLETED|Overall Study||8894||
59971361|NCT02446990|76088629|FG000|NOT COMPLETED|Overall Study||720||
59971362|NCT02446990|76088630|FG001|NOT COMPLETED|Overall Study||658||
59971363|NCT02725515|76088638|FG000|STARTED|Overall Study||53||
59811858|NCT00469209|75934158|FG001|COMPLETED|Overall Study||20||
59811859|NCT00469209|75934159|FG002|COMPLETED|Overall Study||19||
59811860|NCT00469209|75934157|FG000|NOT COMPLETED|Overall Study||1||
59811861|NCT00469209|75934158|FG001|NOT COMPLETED|Overall Study||0||
59971364|NCT02725515|76088639|FG001|STARTED|Overall Study||52||
59811862|NCT00469209|75934159|FG002|NOT COMPLETED|Overall Study||1||
59811863|NCT00635219|75934172|FG000|STARTED|Overall Study||148||
59971365|NCT02725515|76088638|FG000|COMPLETED|Overall Study||28||
59971366|NCT02725515|76088639|FG001|COMPLETED|Overall Study||17||
59971367|NCT02725515|76088638|FG000|NOT COMPLETED|Overall Study||25||
59971368|NCT02725515|76088639|FG001|NOT COMPLETED|Overall Study||35||
59971369|NCT02416180|76088645|FG000|STARTED|Overall Study||111||
59971370|NCT02416180|76088645|FG000|COMPLETED|Overall Study||110||
59971371|NCT02416180|76088645|FG000|NOT COMPLETED|Overall Study||1||
59971372|NCT02473510|76088651|FG000|STARTED|Overall Study||60||
59811864|NCT00635219|75934173|FG001|STARTED|Overall Study||155||
59811865|NCT00635219|75934174|FG002|STARTED|Overall Study||157||
59811866|NCT00635219|75934175|FG003|STARTED|Overall Study||151||
59811867|NCT00635219|75934176|FG004|STARTED|Overall Study||155||
59971373|NCT02473510|76088652|FG001|STARTED|Overall Study||240||
59971374|NCT02473510|76088651|FG000|COMPLETED|Overall Study||59||
59971375|NCT02473510|76088652|FG001|COMPLETED|Overall Study||238||
59971376|NCT02473510|76088651|FG000|NOT COMPLETED|Overall Study||1||
59971377|NCT02473510|76088652|FG001|NOT COMPLETED|Overall Study||2||
59971378|NCT02445586|76088658|FG000|STARTED|Overall Study||52|Intent-to-Treat (ITT) Population|
59971379|NCT02445586|76088658|FG000|Received at Least One Dose of Study Drug|Overall Study||52|Safety Population|
59971380|NCT02445586|76088658|FG000|COMPLETED|Overall Study||13||
59971381|NCT02445586|76088658|FG000|NOT COMPLETED|Overall Study||39||
59971382|NCT01674062|76088664|FG000|STARTED|Overall Study||66||
59971383|NCT01674062|76088665|FG001|STARTED|Overall Study||29||
59971384|NCT01674062|76088664|FG000|COMPLETED|Overall Study||0||
59971385|NCT01674062|76088665|FG001|COMPLETED|Overall Study||0||
59971386|NCT01674062|76088664|FG000|NOT COMPLETED|Overall Study||66||
59971387|NCT01674062|76088665|FG001|NOT COMPLETED|Overall Study||29||
59971388|NCT02472886|76088674|FG000|STARTED|Overall Study||67||
59971389|NCT02472886|76088675|FG001|STARTED|Overall Study||59||
59971390|NCT02472886|76088676|FG002|STARTED|Overall Study||27||
59971391|NCT02472886|76088674|FG000|COMPLETED|Overall Study||67||
59971392|NCT02472886|76088675|FG001|COMPLETED|Overall Study||57||
59971393|NCT02472886|76088676|FG002|COMPLETED|Overall Study||26||
59971394|NCT02472886|76088674|FG000|NOT COMPLETED|Overall Study||0||
59971395|NCT02472886|76088675|FG001|NOT COMPLETED|Overall Study||2||
59971396|NCT02472886|76088676|FG002|NOT COMPLETED|Overall Study||1||
59971397|NCT02472652|76088689|FG000|STARTED|Overall Study||2||
59971398|NCT02472652|76088689|FG000|COMPLETED|Overall Study||1||
59971399|NCT02472652|76088689|FG000|NOT COMPLETED|Overall Study||1||
59971400|NCT02807857|76088693|FG000|STARTED|Enrolled Set||1415||
59971401|NCT02807857|76088693|FG000|COMPLETED|Enrolled Set||864||
59971402|NCT02807857|76088693|FG000|NOT COMPLETED|Enrolled Set||551||
59971403|NCT02807857|76088693|FG000|STARTED|Follow-Up Set||864||
59971404|NCT02807857|76088693|FG000|COMPLETED|Follow-Up Set||680||
59971405|NCT02807857|76088693|FG000|NOT COMPLETED|Follow-Up Set||184||
59971406|NCT02648438|76088706|FG000|STARTED|Overall Study||12||
59971407|NCT02648438|76088707|FG001|STARTED|Overall Study||12||
59971408|NCT02648438|76088708|FG002|STARTED|Overall Study||6||
59971409|NCT02648438|76088706|FG000|COMPLETED|Overall Study||9||
59971410|NCT02648438|76088707|FG001|COMPLETED|Overall Study||9||
59971411|NCT02648438|76088708|FG002|COMPLETED|Overall Study||6||
59971412|NCT02648438|76088706|FG000|NOT COMPLETED|Overall Study||3||
59971413|NCT02648438|76088707|FG001|NOT COMPLETED|Overall Study||3||
59971414|NCT02648438|76088708|FG002|NOT COMPLETED|Overall Study||0||
59971415|NCT02415556|76088728|FG000|STARTED|Overall Study||57||
59971416|NCT02415556|76088729|FG001|STARTED|Overall Study||58||
59971417|NCT02415556|76088730|FG002|STARTED|Overall Study||65||
59971418|NCT02415556|76088731|FG003|STARTED|Overall Study||64||
59971419|NCT02415556|76088728|FG000|COMPLETED|Overall Study||32||
59971420|NCT02415556|76088729|FG001|COMPLETED|Overall Study||37||
59971421|NCT02415556|76088730|FG002|COMPLETED|Overall Study||43||
59971422|NCT02415556|76088731|FG003|COMPLETED|Overall Study||44||
59971423|NCT02415556|76088728|FG000|NOT COMPLETED|Overall Study||25||
59971424|NCT02415556|76088729|FG001|NOT COMPLETED|Overall Study||21||
59971425|NCT02415556|76088730|FG002|NOT COMPLETED|Overall Study||22||
59971426|NCT02415556|76088731|FG003|NOT COMPLETED|Overall Study||20||
59621963|NCT00374088|75733700|FG001|COMPLETED|Overall Study||10||
59621964|NCT00374088|75733699|FG000|NOT COMPLETED|Overall Study||1||
59621965|NCT00374088|75733700|FG001|NOT COMPLETED|Overall Study||1||
59621966|NCT00401622|75733708|FG000|STARTED|Overall Study||160||
59621967|NCT00401622|75733709|FG001|STARTED|Overall Study||160||
59621968|NCT00401622|75733708|FG000|COMPLETED|Overall Study||126||
59621969|NCT00401622|75733709|FG001|COMPLETED|Overall Study||117||
59621970|NCT00401622|75733708|FG000|NOT COMPLETED|Overall Study||34||
59621971|NCT00401622|75733709|FG001|NOT COMPLETED|Overall Study||43||
59621972|NCT00374244|75733717|FG000|STARTED|Overall Study||14||
59621973|NCT00374244|75733718|FG001|STARTED|Overall Study||14||
59971427|NCT02807623|76088744|FG000|STARTED|Overall Study||98||
59971428|NCT02807623|76088745|FG001|STARTED|Overall Study||100||
59971429|NCT02807623|76088746|FG002|STARTED|Overall Study||102||
59621974|NCT00374244|75733717|FG000|COMPLETED|Overall Study||14||
59621975|NCT00374244|75733718|FG001|COMPLETED|Overall Study||14||
59621976|NCT00374244|75733717|FG000|NOT COMPLETED|Overall Study||0||
59621977|NCT00374244|75733718|FG001|NOT COMPLETED|Overall Study||0||
59621978|NCT00377832|75733726|FG000|STARTED|Overall Study||7||
59621979|NCT00377832|75733727|FG001|STARTED|Overall Study||6||
59621980|NCT00377832|75733726|FG000|COMPLETED|Overall Study||7||
59621981|NCT00377832|75733727|FG001|COMPLETED|Overall Study||6||
59621982|NCT00377832|75733726|FG000|NOT COMPLETED|Overall Study||0||
59621983|NCT00377832|75733727|FG001|NOT COMPLETED|Overall Study||0||
59621984|NCT00401778|75733739|FG000|STARTED|Overall Study||10||
59621985|NCT00401778|75733740|FG001|STARTED|Overall Study||12||
59621986|NCT00401778|75733741|FG002|STARTED|Overall Study||11||
59971430|NCT02807623|76088744|FG000|COMPLETED|Overall Study||75||
59971431|NCT02807623|76088745|FG001|COMPLETED|Overall Study||79||
59971432|NCT02807623|76088746|FG002|COMPLETED|Overall Study||79||
59971433|NCT02807623|76088744|FG000|NOT COMPLETED|Overall Study||23||
59971434|NCT02807623|76088745|FG001|NOT COMPLETED|Overall Study||21||
59971435|NCT02807623|76088746|FG002|NOT COMPLETED|Overall Study||23||
59971436|NCT02805907|76088765|FG000|STARTED|Overall Study||56||
59971437|NCT02805907|76088766|FG001|STARTED|Overall Study||56||
59971438|NCT02805907|76088765|FG000|COMPLETED|Overall Study||53||
59971439|NCT02805907|76088766|FG001|COMPLETED|Overall Study||53||
59971440|NCT02805907|76088765|FG000|NOT COMPLETED|Overall Study||3||
59971441|NCT02805907|76088766|FG001|NOT COMPLETED|Overall Study||3||
59971442|NCT02723175|76088774|FG000|STARTED|Overall Study||8||
59971443|NCT02723175|76088775|FG001|STARTED|Overall Study||7||
59971444|NCT02723175|76088774|FG000|COMPLETED|Overall Study||4||
59971445|NCT02723175|76088775|FG001|COMPLETED|Overall Study||4||
59971446|NCT02723175|76088774|FG000|NOT COMPLETED|Overall Study||4||
59971447|NCT02723175|76088775|FG001|NOT COMPLETED|Overall Study||3||
59971448|NCT02801617|76088783|FG000|STARTED|Overall Study||51||
59971449|NCT02801617|76088784|FG001|STARTED|Overall Study||56||
59971450|NCT02801617|76088783|FG000|COMPLETED|Overall Study||49||
59971451|NCT02801617|76088784|FG001|COMPLETED|Overall Study||50||
59971452|NCT02801617|76088783|FG000|NOT COMPLETED|Overall Study||2||
59971453|NCT02801617|76088784|FG001|NOT COMPLETED|Overall Study||6||
59971454|NCT01334515|76088796|FG000|STARTED|Overall Study||16||
59971455|NCT01334515|76088797|FG001|STARTED|Overall Study||36||
59971456|NCT01334515|76088796|FG000|COMPLETED|Overall Study||4||
59971457|NCT01334515|76088797|FG001|COMPLETED|Overall Study||7||
59971458|NCT01334515|76088796|FG000|NOT COMPLETED|Overall Study||12||
59971459|NCT01334515|76088797|FG001|NOT COMPLETED|Overall Study||29||
59971460|NCT02802319|76088805|FG000|STARTED|Overall Study||22||
59971461|NCT02802319|76088806|FG001|STARTED|Overall Study||22||
59971462|NCT02802319|76088805|FG000|COMPLETED|Overall Study||20||
59971463|NCT02802319|76088806|FG001|COMPLETED|Overall Study||17||
59971464|NCT02802319|76088805|FG000|NOT COMPLETED|Overall Study||2||
59971465|NCT02802319|76088806|FG001|NOT COMPLETED|Overall Study||5||
59971466|NCT02415400|76088816|FG000|STARTED|Overall Study||1153|Started = Randomized|
59971467|NCT02415400|76088817|FG001|STARTED|Overall Study||1153|Started = Randomized|
59971468|NCT02415400|76088818|FG002|STARTED|Overall Study||1154|Started = Randomized|
59971469|NCT02415400|76088819|FG003|STARTED|Overall Study||1154|Started = Randomized|
59971470|NCT02415400|76088816|FG000|COMPLETED|Overall Study||1087|Completed = Completing the period|
59971471|NCT02415400|76088817|FG001|COMPLETED|Overall Study||1091|Completed = Completing the period|
59971472|NCT02415400|76088818|FG002|COMPLETED|Overall Study||1069|Completed = Completing the period|
59971473|NCT02415400|76088819|FG003|COMPLETED|Overall Study||1071|Completed = Completing the period|
59971474|NCT02415400|76088816|FG000|NOT COMPLETED|Overall Study||66||
59971475|NCT02415400|76088817|FG001|NOT COMPLETED|Overall Study||62||
59971476|NCT02415400|76088818|FG002|NOT COMPLETED|Overall Study||85||
59971477|NCT02415400|76088819|FG003|NOT COMPLETED|Overall Study||83||
59971478|NCT04194801|76088836|FG000|STARTED|Part Ib/II End Of Treatment-BLU554||4||
59971479|NCT04194801|76088837|FG001|STARTED|Part Ib/II End Of Treatment-BLU554||7||
59971480|NCT04194801|76088838|FG002|STARTED|Part Ib/II End Of Treatment-BLU554||15||
59971481|NCT04194801|76088836|FG000|COMPLETED|Part Ib/II End Of Treatment-BLU554||0||
59971482|NCT04194801|76088837|FG001|COMPLETED|Part Ib/II End Of Treatment-BLU554||0||
59971483|NCT04194801|76088838|FG002|COMPLETED|Part Ib/II End Of Treatment-BLU554||0||
59971484|NCT04194801|76088836|FG000|NOT COMPLETED|Part Ib/II End Of Treatment-BLU554||4||
59971485|NCT04194801|76088837|FG001|NOT COMPLETED|Part Ib/II End Of Treatment-BLU554||7||
59971486|NCT04194801|76088838|FG002|NOT COMPLETED|Part Ib/II End Of Treatment-BLU554||15||
59971487|NCT04194801|76088836|FG000|STARTED|Part Ib/II End Of Treatment-CS1001||4||
59971488|NCT04194801|76088837|FG001|STARTED|Part Ib/II End Of Treatment-CS1001||7||
59971489|NCT04194801|76088838|FG002|STARTED|Part Ib/II End Of Treatment-CS1001||15||
59971490|NCT04194801|76088836|FG000|COMPLETED|Part Ib/II End Of Treatment-CS1001||0||
59971491|NCT04194801|76088837|FG001|COMPLETED|Part Ib/II End Of Treatment-CS1001||0||
59971492|NCT04194801|76088838|FG002|COMPLETED|Part Ib/II End Of Treatment-CS1001||0||
59971493|NCT04194801|76088836|FG000|NOT COMPLETED|Part Ib/II End Of Treatment-CS1001||4||
59971494|NCT04194801|76088837|FG001|NOT COMPLETED|Part Ib/II End Of Treatment-CS1001||7||
59971495|NCT04194801|76088838|FG002|NOT COMPLETED|Part Ib/II End Of Treatment-CS1001||15||
59971496|NCT04194801|76088836|FG000|STARTED|Part Ib/II End of Study||4||
59971497|NCT04194801|76088837|FG001|STARTED|Part Ib/II End of Study||7||
59971498|NCT04194801|76088838|FG002|STARTED|Part Ib/II End of Study||15||
59971499|NCT04194801|76088836|FG000|COMPLETED|Part Ib/II End of Study||0||
59971500|NCT04194801|76088837|FG001|COMPLETED|Part Ib/II End of Study||0||
59971501|NCT04194801|76088838|FG002|COMPLETED|Part Ib/II End of Study||0||
59971502|NCT04194801|76088836|FG000|NOT COMPLETED|Part Ib/II End of Study||4||
59971503|NCT04194801|76088837|FG001|NOT COMPLETED|Part Ib/II End of Study||7||
59971504|NCT04194801|76088838|FG002|NOT COMPLETED|Part Ib/II End of Study||15||
59971505|NCT02802865|76088862|FG000|STARTED|Overall Study||35||
59971506|NCT02802865|76088863|FG001|STARTED|Overall Study||35||
59971507|NCT02802865|76088862|FG000|COMPLETED|Overall Study||34||
59971508|NCT02802865|76088863|FG001|COMPLETED|Overall Study||33||
59971509|NCT02802865|76088862|FG000|NOT COMPLETED|Overall Study||1||
59971510|NCT02802865|76088863|FG001|NOT COMPLETED|Overall Study||2||
59971511|NCT02414932|76088871|FG000|STARTED|Overall Study||3||
59971512|NCT02414932|76088872|FG001|STARTED|Overall Study||3||
59971513|NCT02414932|76088871|FG000|COMPLETED|Overall Study||0||
59971514|NCT02414932|76088872|FG001|COMPLETED|Overall Study||0||
59971515|NCT02414932|76088871|FG000|NOT COMPLETED|Overall Study||3||
59971516|NCT02414932|76088872|FG001|NOT COMPLETED|Overall Study||3||
59971517|NCT00704535|76088878|FG000|STARTED|Overall Study||4105||
59971518|NCT00704535|76088878|FG000|COMPLETED|Overall Study||3959||
59971519|NCT00704535|76088878|FG000|NOT COMPLETED|Overall Study||146||
59971520|NCT01740687|76088882|FG000|STARTED|Overall Study||211||
59971521|NCT01740687|76088882|FG000|Underwent NovaSure EA Treatment|Overall Study||209||
59971522|NCT01740687|76088882|FG000|COMPLETED|Overall Study||174||
59971523|NCT01740687|76088882|FG000|NOT COMPLETED|Overall Study||37||
59971524|NCT02648204|76088890|FG000|STARTED|Overall Study||301||
59971525|NCT02648204|76088891|FG001|STARTED|Overall Study||300||
59971526|NCT02648204|76088892|FG002|STARTED|Overall Study||300||
59971527|NCT02648204|76088893|FG003|STARTED|Overall Study||300||
59971528|NCT02648204|76088890|FG000|Exposed|Overall Study||301||
59971529|NCT02648204|76088891|FG001|Exposed|Overall Study||300||
59971530|NCT02648204|76088892|FG002|Exposed|Overall Study||299||
59971531|NCT02648204|76088893|FG003|Exposed|Overall Study||299||
59971532|NCT02648204|76088890|FG000|COMPLETED|Overall Study||279||
59971533|NCT02648204|76088891|FG001|COMPLETED|Overall Study||279||
59971534|NCT02648204|76088892|FG002|COMPLETED|Overall Study||287||
59971535|NCT02648204|76088893|FG003|COMPLETED|Overall Study||284||
59971536|NCT02648204|76088890|FG000|NOT COMPLETED|Overall Study||22||
59971537|NCT02648204|76088891|FG001|NOT COMPLETED|Overall Study||21||
59971538|NCT02648204|76088892|FG002|NOT COMPLETED|Overall Study||13||
59971539|NCT02648204|76088893|FG003|NOT COMPLETED|Overall Study||16||
59971540|NCT02799745|76088905|FG000|STARTED|Overall Study||114||
59971541|NCT02799745|76088906|FG001|STARTED|Overall Study||113||
59971542|NCT02799745|76088905|FG000|Treated|Overall Study||112||
59971543|NCT02799745|76088906|FG001|Treated|Overall Study||113||
59971544|NCT02799745|76088905|FG000|COMPLETED|Overall Study||58||
59971545|NCT02799745|76088906|FG001|COMPLETED|Overall Study||42||
59971546|NCT02799745|76088905|FG000|NOT COMPLETED|Overall Study||56||
59971547|NCT02799745|76088906|FG001|NOT COMPLETED|Overall Study||71||
59971548|NCT00705159|76088916|FG000|STARTED|Overall Study||34||
59971549|NCT00705159|76088917|FG001|STARTED|Overall Study||35||
59971550|NCT00705159|76088918|FG002|STARTED|Overall Study||34||
59971551|NCT00705159|76088919|FG003|STARTED|Overall Study||34||
59971552|NCT00705159|76088916|FG000|COMPLETED|Overall Study||34||
59971553|NCT00705159|76088917|FG001|COMPLETED|Overall Study||33||
59971554|NCT00705159|76088918|FG002|COMPLETED|Overall Study||29||
59971555|NCT00705159|76088919|FG003|COMPLETED|Overall Study||30||
59971556|NCT00705159|76088916|FG000|NOT COMPLETED|Overall Study||0||
59971557|NCT00705159|76088917|FG001|NOT COMPLETED|Overall Study||2||
59971558|NCT00705159|76088918|FG002|NOT COMPLETED|Overall Study||5||
59971559|NCT00705159|76088919|FG003|NOT COMPLETED|Overall Study||4||
59971560|NCT01673984|76088931|FG000|STARTED|Overall Study||14||
59971561|NCT01673984|76088932|FG001|STARTED|Overall Study||7||
59971562|NCT01673984|76088931|FG000|COMPLETED|Overall Study||4||
59811868|NCT00635219|75934172|FG000|COMPLETED|Overall Study||123||
59811869|NCT00635219|75934173|FG001|COMPLETED|Overall Study||130||
59811870|NCT00635219|75934174|FG002|COMPLETED|Overall Study||122||
59811871|NCT00635219|75934175|FG003|COMPLETED|Overall Study||117||
59811872|NCT00635219|75934176|FG004|COMPLETED|Overall Study||113||
59811873|NCT00635219|75934172|FG000|NOT COMPLETED|Overall Study||25||
59971563|NCT01673984|76088932|FG001|COMPLETED|Overall Study||1||
59971564|NCT01673984|76088931|FG000|NOT COMPLETED|Overall Study||10||
59971565|NCT01673984|76088932|FG001|NOT COMPLETED|Overall Study||6||
59971566|NCT04233008|76088940|FG000|STARTED|Overall Study||89||
59971567|NCT04233008|76088941|FG001|STARTED|Overall Study||89||
59971568|NCT04233008|76088940|FG000|COMPLETED|Overall Study||89||
59971569|NCT04233008|76088941|FG001|COMPLETED|Overall Study||89||
59971570|NCT04233008|76088940|FG000|NOT COMPLETED|Overall Study||0||
59971571|NCT04233008|76088941|FG001|NOT COMPLETED|Overall Study||0||
59971572|NCT02332928|76088951|FG000|STARTED|Overall Study||40||
59971573|NCT02332928|76088952|FG001|STARTED|Overall Study||40||
59811874|NCT00635219|75934173|FG001|NOT COMPLETED|Overall Study||25||
59971574|NCT02332928|76088951|FG000|COMPLETED|Overall Study||39||
59971575|NCT02332928|76088952|FG001|COMPLETED|Overall Study||38||
59971576|NCT02332928|76088951|FG000|NOT COMPLETED|Overall Study||1||
59971577|NCT02332928|76088952|FG001|NOT COMPLETED|Overall Study||2||
59971578|NCT02647658|76088960|FG000|STARTED|Overall Study||1207||39
59971579|NCT02647658|76088961|FG001|STARTED|Overall Study||1093||37
59811875|NCT00635219|75934174|FG002|NOT COMPLETED|Overall Study||35||
59971580|NCT02647658|76088960|FG000|6 Month Assessment|Overall Study||658||38
59971581|NCT02647658|76088961|FG001|6 Month Assessment|Overall Study||635||35
59971582|NCT02647658|76088960|FG000|COMPLETED|Overall Study||1192||39
59971583|NCT02647658|76088961|FG001|COMPLETED|Overall Study||1069||37
59971584|NCT02647658|76088960|FG000|NOT COMPLETED|Overall Study||15||0
59971585|NCT02647658|76088961|FG001|NOT COMPLETED|Overall Study||24||0
59971586|NCT00703677|76088967|FG000|STARTED|Overall Study||17||
59971587|NCT00703677|76088967|FG000|COMPLETED|Overall Study||14||
59971588|NCT00703677|76088967|FG000|NOT COMPLETED|Overall Study||3||
59811876|NCT00635219|75934175|FG003|NOT COMPLETED|Overall Study||34||
59811877|NCT00635219|75934176|FG004|NOT COMPLETED|Overall Study||42||
59811878|NCT00363766|75934190|FG000|STARTED|Overall Study||32||
59971589|NCT03993938|76088971|FG000|STARTED|Overall Study||30||
59971590|NCT03993938|76088971|FG000|COMPLETED|Overall Study||30||
59971591|NCT03993938|76088971|FG000|NOT COMPLETED|Overall Study||0||
59971592|NCT00703911|76088975|FG000|STARTED|Overall Study||102||
59971593|NCT00703911|76088975|FG000|COMPLETED|Overall Study||92||
59971594|NCT00703911|76088975|FG000|NOT COMPLETED|Overall Study||10||
59971595|NCT02055547|76088979|FG000|STARTED|Overall Study||2||
59971596|NCT02055547|76088980|FG001|STARTED|Overall Study||2||
59971597|NCT02055547|76088981|FG002|STARTED|Overall Study||5||
59971598|NCT02055547|76088982|FG003|STARTED|Overall Study||2||
59971599|NCT02055547|76088983|FG004|STARTED|Overall Study||2||
59971600|NCT02055547|76088984|FG005|STARTED|Overall Study||2||
59971601|NCT02055547|76088985|FG006|STARTED|Overall Study||2||
59971602|NCT02055547|76088986|FG007|STARTED|Overall Study||6||
59971603|NCT02055547|76088987|FG008|STARTED|Overall Study||6||
59971604|NCT02055547|76088988|FG009|STARTED|Overall Study||6||
59971605|NCT02055547|76088989|FG010|STARTED|Overall Study||6||
59971606|NCT02055547|76088990|FG011|STARTED|Overall Study||6||
59971607|NCT02055547|76088991|FG012|STARTED|Overall Study||2||
59971608|NCT02055547|76088992|FG013|STARTED|Overall Study||2||
59971609|NCT02055547|76088993|FG014|STARTED|Overall Study||2||
59971610|NCT02055547|76088994|FG015|STARTED|Overall Study||2||
59971611|NCT02055547|76088995|FG016|STARTED|Overall Study||2||
59971612|NCT02055547|76088996|FG017|STARTED|Overall Study||2||
59971613|NCT02055547|76088997|FG018|STARTED|Overall Study||2||
59971614|NCT02055547|76088979|FG000|COMPLETED|Overall Study||2||
59971615|NCT02055547|76088980|FG001|COMPLETED|Overall Study||1||
59971616|NCT02055547|76088981|FG002|COMPLETED|Overall Study||2||
59971617|NCT02055547|76088982|FG003|COMPLETED|Overall Study||2||
59971618|NCT02055547|76088983|FG004|COMPLETED|Overall Study||1||
59971619|NCT02055547|76088984|FG005|COMPLETED|Overall Study||1||
59971620|NCT02055547|76088985|FG006|COMPLETED|Overall Study||0||
59971621|NCT02055547|76088986|FG007|COMPLETED|Overall Study||6||
59971622|NCT02055547|76088987|FG008|COMPLETED|Overall Study||4||
59971623|NCT02055547|76088988|FG009|COMPLETED|Overall Study||5||
59971624|NCT02055547|76088989|FG010|COMPLETED|Overall Study||5||
59971625|NCT02055547|76088990|FG011|COMPLETED|Overall Study||6||
59971626|NCT02055547|76088991|FG012|COMPLETED|Overall Study||2||
59971627|NCT02055547|76088992|FG013|COMPLETED|Overall Study||1||
59971628|NCT02055547|76088993|FG014|COMPLETED|Overall Study||2||
59971629|NCT02055547|76088994|FG015|COMPLETED|Overall Study||1||
59971630|NCT02055547|76088995|FG016|COMPLETED|Overall Study||2||
59971631|NCT02055547|76088996|FG017|COMPLETED|Overall Study||2||
59971632|NCT02055547|76088997|FG018|COMPLETED|Overall Study||2||
59971633|NCT02055547|76088979|FG000|NOT COMPLETED|Overall Study||0||
59971634|NCT02055547|76088980|FG001|NOT COMPLETED|Overall Study||1||
59971635|NCT02055547|76088981|FG002|NOT COMPLETED|Overall Study||3||
59971636|NCT02055547|76088982|FG003|NOT COMPLETED|Overall Study||0||
59971637|NCT02055547|76088983|FG004|NOT COMPLETED|Overall Study||1||
59971638|NCT02055547|76088984|FG005|NOT COMPLETED|Overall Study||1||
59971639|NCT02055547|76088985|FG006|NOT COMPLETED|Overall Study||2||
59971640|NCT02055547|76088986|FG007|NOT COMPLETED|Overall Study||0||
59971641|NCT02055547|76088987|FG008|NOT COMPLETED|Overall Study||2||
59811879|NCT00363766|75934191|FG001|STARTED|Overall Study||20||
59811880|NCT00363766|75934190|FG000|COMPLETED|Overall Study||0||
59811881|NCT00363766|75934191|FG001|COMPLETED|Overall Study||0||
59971642|NCT02055547|76088988|FG009|NOT COMPLETED|Overall Study||1||
59971643|NCT02055547|76088989|FG010|NOT COMPLETED|Overall Study||1||
59971644|NCT02055547|76088990|FG011|NOT COMPLETED|Overall Study||0||
59971645|NCT02055547|76088991|FG012|NOT COMPLETED|Overall Study||0||
59971646|NCT02055547|76088992|FG013|NOT COMPLETED|Overall Study||1||
59971647|NCT02055547|76088993|FG014|NOT COMPLETED|Overall Study||0||
59971648|NCT02055547|76088994|FG015|NOT COMPLETED|Overall Study||1||
59971649|NCT02055547|76088995|FG016|NOT COMPLETED|Overall Study||0||
59971650|NCT02055547|76088996|FG017|NOT COMPLETED|Overall Study||0||
59971651|NCT02055547|76088997|FG018|NOT COMPLETED|Overall Study||0||
59971652|NCT02414854|76089035|FG000|STARTED|Overall Study||317|Randomized|
59971653|NCT02414854|76089036|FG001|STARTED|Overall Study||631|Randomized|
59971654|NCT02414854|76089037|FG002|STARTED|Overall Study||321|Randomized|
59971655|NCT02414854|76089038|FG003|STARTED|Overall Study||633|Randomized|
59811882|NCT00363766|75934190|FG000|NOT COMPLETED|Overall Study||32||
59971656|NCT02414854|76089035|FG000|Treated|Overall Study|2 got other treatment (1 each dupilumab 200+300) than assigned + were allocated to those in AE table|315|Randomized|
59971657|NCT02414854|76089036|FG001|Treated|Overall Study||629|Randomized|
59971658|NCT02414854|76089037|FG002|Treated|Overall Study||321|Randomized|
59971659|NCT02414854|76089038|FG003|Treated|Overall Study|1 got other treatment (dupilumab 200) than assigned + was allocated to that in AE table|632|Randomized|
59971660|NCT02414854|76089035|FG000|COMPLETED|Overall Study||295||
59971661|NCT02414854|76089036|FG001|COMPLETED|Overall Study||586||
59811883|NCT00363766|75934191|FG001|NOT COMPLETED|Overall Study||20||
59971662|NCT02414854|76089037|FG002|COMPLETED|Overall Study||301||
59811884|NCT00468819|75934201|FG000|STARTED|Overall Study|Enrolled participants|48||
59971663|NCT02414854|76089038|FG003|COMPLETED|Overall Study||582||
59971664|NCT02414854|76089035|FG000|NOT COMPLETED|Overall Study||22||
59971665|NCT02414854|76089036|FG001|NOT COMPLETED|Overall Study||45||
59971666|NCT02414854|76089037|FG002|NOT COMPLETED|Overall Study||20||
59971667|NCT02414854|76089038|FG003|NOT COMPLETED|Overall Study||51||
59971668|NCT03332498|76089051|FG000|STARTED|Overall Study||4||
59971669|NCT03332498|76089052|FG001|STARTED|Overall Study||4||
59971670|NCT03332498|76089053|FG002|STARTED|Overall Study||32||
59971671|NCT03332498|76089051|FG000|COMPLETED|Overall Study||4||
59971672|NCT03332498|76089052|FG001|COMPLETED|Overall Study||4||
59971673|NCT03332498|76089053|FG002|COMPLETED|Overall Study||30||
59971674|NCT03332498|76089051|FG000|NOT COMPLETED|Overall Study||0||
59971675|NCT03332498|76089052|FG001|NOT COMPLETED|Overall Study||0||
59971676|NCT03332498|76089053|FG002|NOT COMPLETED|Overall Study||2||
59971677|NCT01334125|76089062|FG000|STARTED|Overall Study||15||
59971678|NCT01334125|76089063|FG001|STARTED|Overall Study||13||
59971679|NCT01334125|76089062|FG000|COMPLETED|Overall Study|3 subjects move to another city|12||
59971680|NCT01334125|76089063|FG001|COMPLETED|Overall Study|3 subjects left for college and moved out of the area|10||
59971681|NCT01334125|76089062|FG000|NOT COMPLETED|Overall Study||3||
59971682|NCT01334125|76089063|FG001|NOT COMPLETED|Overall Study||3||
59971683|NCT02414152|76089070|FG000|STARTED|Overall Study||2||
59971684|NCT02414152|76089070|FG000|COMPLETED|Overall Study|Both subjects completed 56 days of anakinra but did not complete all visits in observational period|0||
59971685|NCT02414152|76089070|FG000|NOT COMPLETED|Overall Study||2||
59971686|NCT02413996|76089076|FG000|STARTED|Overall Study||44||
59971687|NCT02413996|76089077|FG001|STARTED|Overall Study||41||
59971688|NCT02413996|76089076|FG000|COMPLETED|Overall Study||35||
59971689|NCT02413996|76089077|FG001|COMPLETED|Overall Study||39||
59971690|NCT02413996|76089076|FG000|NOT COMPLETED|Overall Study||9||
59971691|NCT02413996|76089077|FG001|NOT COMPLETED|Overall Study||2||
59971692|NCT01333501|76089085|FG000|STARTED|Overall Study||106||
59971693|NCT01333501|76089086|FG001|STARTED|Overall Study||51||
59971694|NCT01333501|76089085|FG000|Full Analysis Set (FAS)|Overall Study||80||
59971695|NCT01333501|76089086|FG001|Full Analysis Set (FAS)|Overall Study||28||
59971696|NCT01333501|76089085|FG000|Safety Population|Overall Study||104||
59971697|NCT01333501|76089086|FG001|Safety Population|Overall Study||47||
59971698|NCT01333501|76089085|FG000|COMPLETED|Overall Study||97||
59971699|NCT01333501|76089086|FG001|COMPLETED|Overall Study||30||
59971700|NCT01333501|76089085|FG000|NOT COMPLETED|Overall Study||9||
59971701|NCT01333501|76089086|FG001|NOT COMPLETED|Overall Study||21||
59971702|NCT01362140|76089094|FG000|STARTED|Overall Study||49||
59971703|NCT01362140|76089095|FG001|STARTED|Overall Study||98||
59971704|NCT01362140|76089094|FG000|Received Treatment|Overall Study||49||
59971705|NCT01362140|76089095|FG001|Received Treatment|Overall Study||97||
59971706|NCT01362140|76089094|FG000|COMPLETED|Overall Study|Completed treatment in the double-blind treatment period|39||
59971707|NCT01362140|76089095|FG001|COMPLETED|Overall Study|Completed treatment in the double-blind treatment period|87||
59971708|NCT01362140|76089094|FG000|NOT COMPLETED|Overall Study||10||
59971709|NCT01362140|76089095|FG001|NOT COMPLETED|Overall Study||11||
59971710|NCT01333189|76089103|FG000|STARTED|Overall Study||13||
59971711|NCT01333189|76089104|FG001|STARTED|Overall Study||13||
59971712|NCT01333189|76089103|FG000|COMPLETED|Overall Study||11||
59971713|NCT01333189|76089104|FG001|COMPLETED|Overall Study||11||
59971714|NCT01333189|76089103|FG000|NOT COMPLETED|Overall Study||2||
59971715|NCT01333189|76089104|FG001|NOT COMPLETED|Overall Study||2||
59971716|NCT01333111|76089113|FG000|STARTED|Overall Study||30||
59971717|NCT01333111|76089114|FG001|STARTED|Overall Study||29||
59971718|NCT01333111|76089115|FG002|STARTED|Overall Study||15||
59971719|NCT01333111|76089113|FG000|COMPLETED|Overall Study||28||
59971720|NCT01333111|76089114|FG001|COMPLETED|Overall Study||26||
59971721|NCT01333111|76089115|FG002|COMPLETED|Overall Study||13||
59971722|NCT01333111|76089113|FG000|NOT COMPLETED|Overall Study||2||
59971723|NCT01333111|76089114|FG001|NOT COMPLETED|Overall Study||3||
59971724|NCT01333111|76089115|FG002|NOT COMPLETED|Overall Study||2||
59971725|NCT00702507|76089123|FG000|STARTED|Initial Treatment Phase||200||
59971726|NCT00702507|76089123|FG000|COMPLETED|Initial Treatment Phase||159||
59971727|NCT00702507|76089123|FG000|NOT COMPLETED|Initial Treatment Phase||41||
59971728|NCT00702507|76089123|FG000|STARTED|Follow-up Phase||159||
59971729|NCT00702507|76089123|FG000|COMPLETED|Follow-up Phase||132||
59971730|NCT00702507|76089123|FG000|NOT COMPLETED|Follow-up Phase||27||
59971731|NCT00583778|76089130|FG000|STARTED|Overall Study||74||
59971732|NCT00583778|76089131|FG001|STARTED|Overall Study||67||
59971733|NCT00583778|76089130|FG000|COMPLETED|Overall Study||74||
59971734|NCT00583778|76089131|FG001|COMPLETED|Overall Study||67||
59971735|NCT00583778|76089130|FG000|NOT COMPLETED|Overall Study||0||
59971736|NCT00583778|76089131|FG001|NOT COMPLETED|Overall Study||0||
59971737|NCT01673594|76089139|FG000|STARTED|Overall Study||18||
59971738|NCT01673594|76089140|FG001|STARTED|Overall Study||19||
59971739|NCT01673594|76089139|FG000|COMPLETED|Overall Study||12||
59971740|NCT01673594|76089140|FG001|COMPLETED|Overall Study||13||
59971741|NCT01673594|76089139|FG000|NOT COMPLETED|Overall Study||6||
59971742|NCT01673594|76089140|FG001|NOT COMPLETED|Overall Study||6||
59971743|NCT02721147|76089149|FG000|STARTED|Overall Study||40||
59971744|NCT02721147|76089150|FG001|STARTED|Overall Study||18||
59971745|NCT02721147|76089151|FG002|STARTED|Overall Study||31||
59971746|NCT02721147|76089149|FG000|COMPLETED|Overall Study||38||
59971747|NCT02721147|76089150|FG001|COMPLETED|Overall Study||18||
59971748|NCT02721147|76089151|FG002|COMPLETED|Overall Study||31||
59971749|NCT02721147|76089149|FG000|NOT COMPLETED|Overall Study||2||
59971750|NCT02721147|76089150|FG001|NOT COMPLETED|Overall Study||0||
59971751|NCT02721147|76089151|FG002|NOT COMPLETED|Overall Study||0||
59971752|NCT02720757|76089159|FG000|STARTED|Overall Study||132||
59971753|NCT02720757|76089159|FG000|COMPLETED|Overall Study||114||
59971754|NCT02720757|76089159|FG000|NOT COMPLETED|Overall Study||18||
59971755|NCT02786498|76089167|FG000|STARTED|Overall Study||27||
59971756|NCT02786498|76089168|FG001|STARTED|Overall Study||24||
59971757|NCT02786498|76089169|FG002|STARTED|Overall Study||24||
59811885|NCT00468819|75934202|FG001|STARTED|Overall Study|Enrolled participants|44||
59811886|NCT00468819|75934203|FG002|STARTED|Overall Study|Enrolled participants|48||
59811887|NCT00468819|75934201|FG000|Treatment Received/ Safety Follow-up|Overall Study|FAS (Full Analysis Set)|46||
59811888|NCT00468819|75934202|FG001|Treatment Received/ Safety Follow-up|Overall Study|FAS|44||
59811889|NCT00468819|75934203|FG002|Treatment Received/ Safety Follow-up|Overall Study|FAS|48||
59811890|NCT00468819|75934201|FG000|COMPLETED|Overall Study||42||
59811891|NCT00468819|75934202|FG001|COMPLETED|Overall Study||44||
59811892|NCT00468819|75934203|FG002|COMPLETED|Overall Study||46||
59811893|NCT00468819|75934201|FG000|NOT COMPLETED|Overall Study||6||
59811894|NCT00468819|75934202|FG001|NOT COMPLETED|Overall Study||0||
59811895|NCT00468819|75934203|FG002|NOT COMPLETED|Overall Study||2||
59811896|NCT00451191|75934215|FG000|STARTED|Overall Study||68||
59811897|NCT00451191|75934216|FG001|STARTED|Overall Study||66||
59811898|NCT00451191|75934215|FG000|COMPLETED|Overall Study||53||
59811899|NCT00451191|75934216|FG001|COMPLETED|Overall Study||55||
59811900|NCT00451191|75934215|FG000|NOT COMPLETED|Overall Study||15||
59811901|NCT00451191|75934216|FG001|NOT COMPLETED|Overall Study||11||
59811902|NCT00451035|75934222|FG000|STARTED|Overall Study||29||
59811903|NCT00451035|75934222|FG000|COMPLETED|Overall Study||12||
59811904|NCT00451035|75934222|FG000|NOT COMPLETED|Overall Study||17||
59811905|NCT00468585|75934231|FG000|STARTED|Overall Study||4||
59811906|NCT00468585|75934232|FG001|STARTED|Overall Study||3||
59811907|NCT00468585|75934233|FG002|STARTED|Overall Study||50||
59811908|NCT00468585|75934234|FG003|STARTED|Overall Study||6||
59811909|NCT00468585|75934231|FG000|COMPLETED|Overall Study||3||
59811910|NCT00468585|75934232|FG001|COMPLETED|Overall Study||3||
59811911|NCT00468585|75934233|FG002|COMPLETED|Overall Study||45||
59811912|NCT00468585|75934234|FG003|COMPLETED|Overall Study||5||
59811913|NCT00468585|75934231|FG000|NOT COMPLETED|Overall Study||1||
59811914|NCT00468585|75934232|FG001|NOT COMPLETED|Overall Study||0||
59811915|NCT00468585|75934233|FG002|NOT COMPLETED|Overall Study||5||
59811916|NCT00468585|75934234|FG003|NOT COMPLETED|Overall Study||1||
59971758|NCT02786498|76089170|FG003|STARTED|Overall Study||27||
59971759|NCT02786498|76089167|FG000|COMPLETED|Overall Study||25||
59971760|NCT02786498|76089168|FG001|COMPLETED|Overall Study||24||
59971761|NCT02786498|76089169|FG002|COMPLETED|Overall Study||24||
59971762|NCT02786498|76089170|FG003|COMPLETED|Overall Study||26||
59971763|NCT02786498|76089167|FG000|NOT COMPLETED|Overall Study||2||
59971764|NCT02786498|76089168|FG001|NOT COMPLETED|Overall Study||0||
59971765|NCT02786498|76089169|FG002|NOT COMPLETED|Overall Study||0||
59971766|NCT02786498|76089170|FG003|NOT COMPLETED|Overall Study||1||
59971767|NCT04368260|76089180|FG000|STARTED|Overall Study||40||
59971768|NCT04368260|76089180|FG000|COMPLETED|Overall Study||40||
59971769|NCT04368260|76089180|FG000|NOT COMPLETED|Overall Study||0||
59971770|NCT02646566|76089189|FG000|STARTED|Overall Study||237||
59971771|NCT02646566|76089190|FG001|STARTED|Overall Study||230||
59971772|NCT02646566|76089191|FG002|STARTED|Overall Study||235||
59971773|NCT02646566|76089189|FG000|COMPLETED|Overall Study||231||
59971774|NCT02646566|76089190|FG001|COMPLETED|Overall Study||226||
59971775|NCT02646566|76089191|FG002|COMPLETED|Overall Study||230||
59971776|NCT02646566|76089189|FG000|NOT COMPLETED|Overall Study||6||
59971777|NCT02646566|76089190|FG001|NOT COMPLETED|Overall Study||4||
59971778|NCT02646566|76089191|FG002|NOT COMPLETED|Overall Study||5||
59811917|NCT00450801|75934244|FG000|STARTED|Overall Study||22||
59811918|NCT00450801|75934244|FG000|COMPLETED|Overall Study||21||
59971779|NCT01072682|76089199|FG000|STARTED|Overall Study||35||
59971780|NCT01072682|76089199|FG000|COMPLETED|Overall Study||35||
59971781|NCT01072682|76089199|FG000|NOT COMPLETED|Overall Study||0||
59811919|NCT00450801|75934244|FG000|NOT COMPLETED|Overall Study||1||
59811920|NCT00458211|75934253|FG000|STARTED|Overall Study||40||
59811921|NCT00458211|75934253|FG000|COMPLETED|Overall Study|12 early termination 2 protocol violation 2 ( from Rochester) withdrawn from further analysis|24||
59971782|NCT02720523|76089207|FG000|STARTED|Period 1: Placebo-controlled Period||49||
59971783|NCT02720523|76089208|FG001|STARTED|Period 1: Placebo-controlled Period||49||
59971784|NCT02720523|76089209|FG002|STARTED|Period 1: Placebo-controlled Period||49||
59811922|NCT00458211|75934253|FG000|NOT COMPLETED|Overall Study||16||
59811923|NCT00450723|75934261|FG000|STARTED|Overall Study||39||
59811924|NCT00450723|75934261|FG000|COMPLETED|Overall Study||34||
59811925|NCT00450723|75934261|FG000|NOT COMPLETED|Overall Study||5||
59811926|NCT00467961|75934266|FG000|STARTED|Overall Study||31||
59811927|NCT00467961|75934266|FG000|COMPLETED|Overall Study||24||
59971785|NCT02720523|76089210|FG003|STARTED|Period 1: Placebo-controlled Period||50||
59971786|NCT02720523|76089211|FG004|STARTED|Period 1: Placebo-controlled Period||0||
59971787|NCT02720523|76089212|FG005|STARTED|Period 1: Placebo-controlled Period||0||
59811928|NCT00467961|75934266|FG000|NOT COMPLETED|Overall Study||7||
59811929|NCT00457821|75934278|FG000|STARTED|Part 1|Number of subjects randomized|4||
59811930|NCT00457821|75934279|FG001|STARTED|Part 1|Number of subjects randomized|4||
59811931|NCT00457821|75934280|FG002|STARTED|Part 1|Number of subjects randomized|5||
59811932|NCT00457821|75934281|FG003|STARTED|Part 1|Number of subjects randomized|4||
59811933|NCT00457821|75934282|FG004|STARTED|Part 1|Number of subjects randomized|4||
59811934|NCT00457821|75934283|FG005|STARTED|Part 1|Arm in Part 2 only|0||
59811935|NCT00457821|75934284|FG006|STARTED|Part 1|Arm in Part 2 only|0||
59971788|NCT02720523|76089213|FG006|STARTED|Period 1: Placebo-controlled Period||0||
59971789|NCT02720523|76089207|FG000|COMPLETED|Period 1: Placebo-controlled Period||47||
59811936|NCT00457821|75934285|FG007|STARTED|Part 1|Arm in Part 2 only|0||
59811937|NCT00457821|75934278|FG000|COMPLETED|Part 1||4||
59971790|NCT02720523|76089208|FG001|COMPLETED|Period 1: Placebo-controlled Period||49||
59971791|NCT02720523|76089209|FG002|COMPLETED|Period 1: Placebo-controlled Period||47||
59971792|NCT02720523|76089210|FG003|COMPLETED|Period 1: Placebo-controlled Period||44||
59971793|NCT02720523|76089211|FG004|COMPLETED|Period 1: Placebo-controlled Period||0||
59971794|NCT02720523|76089212|FG005|COMPLETED|Period 1: Placebo-controlled Period||0||
59971795|NCT02720523|76089213|FG006|COMPLETED|Period 1: Placebo-controlled Period||0||
59971796|NCT02720523|76089207|FG000|NOT COMPLETED|Period 1: Placebo-controlled Period||2||
59971797|NCT02720523|76089208|FG001|NOT COMPLETED|Period 1: Placebo-controlled Period||0||
59971798|NCT02720523|76089209|FG002|NOT COMPLETED|Period 1: Placebo-controlled Period||2||
59971799|NCT02720523|76089210|FG003|NOT COMPLETED|Period 1: Placebo-controlled Period||6||
59971800|NCT02720523|76089211|FG004|NOT COMPLETED|Period 1: Placebo-controlled Period||0||
59971801|NCT02720523|76089212|FG005|NOT COMPLETED|Period 1: Placebo-controlled Period||0||
59971802|NCT02720523|76089213|FG006|NOT COMPLETED|Period 1: Placebo-controlled Period||0||
59971803|NCT02720523|76089207|FG000|STARTED|Period 2: Long-term Extension Period||0||
59971804|NCT02720523|76089208|FG001|STARTED|Period 2: Long-term Extension Period||0||
59971805|NCT02720523|76089209|FG002|STARTED|Period 2: Long-term Extension Period||0||
59971806|NCT02720523|76089210|FG003|STARTED|Period 2: Long-term Extension Period||0||
59971807|NCT02720523|76089211|FG004|STARTED|Period 2: Long-term Extension Period|Includes participants originally randomized to placebo and upadacitinib 7.5 mg|65||
59971808|NCT02720523|76089212|FG005|STARTED|Period 2: Long-term Extension Period|Includes participants originally randomized to placebo and upadacitinib 15 mg|62||
59971809|NCT02720523|76089213|FG006|STARTED|Period 2: Long-term Extension Period|Includes participants originally randomized to placebo and upadacitinib 30 mg|60||
59971810|NCT02720523|76089207|FG000|COMPLETED|Period 2: Long-term Extension Period||0|Completed study as of the data cutoff date of 12 July 2018|
59971811|NCT02720523|76089208|FG001|COMPLETED|Period 2: Long-term Extension Period||0|Completed study as of the data cutoff date of 12 July 2018|
59971812|NCT02720523|76089209|FG002|COMPLETED|Period 2: Long-term Extension Period||0|Completed study as of the data cutoff date of 12 July 2018|
59971813|NCT02720523|76089210|FG003|COMPLETED|Period 2: Long-term Extension Period||0|Completed study as of the data cutoff date of 12 July 2018|
59971814|NCT02720523|76089211|FG004|COMPLETED|Period 2: Long-term Extension Period||0|Completed study as of the data cutoff date of 12 July 2018|
59971815|NCT02720523|76089212|FG005|COMPLETED|Period 2: Long-term Extension Period||0|Completed study as of the data cutoff date of 12 July 2018|
59971816|NCT02720523|76089213|FG006|COMPLETED|Period 2: Long-term Extension Period||0|Completed study as of the data cutoff date of 12 July 2018|
59971817|NCT02720523|76089207|FG000|NOT COMPLETED|Period 2: Long-term Extension Period||0||
59971818|NCT02720523|76089208|FG001|NOT COMPLETED|Period 2: Long-term Extension Period||0||
59971819|NCT02720523|76089209|FG002|NOT COMPLETED|Period 2: Long-term Extension Period||0||
59971820|NCT02720523|76089210|FG003|NOT COMPLETED|Period 2: Long-term Extension Period||0||
59971821|NCT02720523|76089211|FG004|NOT COMPLETED|Period 2: Long-term Extension Period||65||
59971822|NCT02720523|76089212|FG005|NOT COMPLETED|Period 2: Long-term Extension Period||62||
59971823|NCT02720523|76089213|FG006|NOT COMPLETED|Period 2: Long-term Extension Period||60||
59971824|NCT02646332|76089228|FG000|STARTED|Overall Study||124||
59971825|NCT02646332|76089229|FG001|STARTED|Overall Study||124||
59811938|NCT00457821|75934279|FG001|COMPLETED|Part 1||4||
59811939|NCT00457821|75934280|FG002|COMPLETED|Part 1||4||
59811940|NCT00457821|75934281|FG003|COMPLETED|Part 1||4||
59811941|NCT00457821|75934282|FG004|COMPLETED|Part 1||4||
59811942|NCT00457821|75934283|FG005|COMPLETED|Part 1||0||
59811943|NCT00457821|75934284|FG006|COMPLETED|Part 1||0||
59971826|NCT02646332|76089228|FG000|COMPLETED|Overall Study||124||
59971827|NCT02646332|76089229|FG001|COMPLETED|Overall Study||121||
59971828|NCT02646332|76089228|FG000|NOT COMPLETED|Overall Study||0||
59971829|NCT02646332|76089229|FG001|NOT COMPLETED|Overall Study||3||
59971830|NCT02471716|76089240|FG000|STARTED|Overall Study||3||
59971831|NCT02471716|76089241|FG001|STARTED|Overall Study||3||
59971832|NCT02471716|76089242|FG002|STARTED|Overall Study||3||
59971833|NCT02471716|76089243|FG003|STARTED|Overall Study||33||
59971834|NCT02471716|76089244|FG004|STARTED|Overall Study||24||
59971835|NCT02471716|76089240|FG000|COMPLETED|Overall Study||3||
59971836|NCT02471716|76089241|FG001|COMPLETED|Overall Study||2||
59811944|NCT00457821|75934285|FG007|COMPLETED|Part 1||0||
59811945|NCT00457821|75934278|FG000|NOT COMPLETED|Part 1||0||
59811946|NCT00457821|75934279|FG001|NOT COMPLETED|Part 1||0||
59811947|NCT00457821|75934280|FG002|NOT COMPLETED|Part 1||1||
59811948|NCT00457821|75934281|FG003|NOT COMPLETED|Part 1||0||
59811949|NCT00457821|75934282|FG004|NOT COMPLETED|Part 1||0||
59811950|NCT00457821|75934283|FG005|NOT COMPLETED|Part 1||0||
59811951|NCT00457821|75934284|FG006|NOT COMPLETED|Part 1||0||
59811952|NCT00457821|75934285|FG007|NOT COMPLETED|Part 1||0||
59811953|NCT00457821|75934278|FG000|STARTED|Part 2|Arm in Part 1 only|0||
59811954|NCT00457821|75934279|FG001|STARTED|Part 2|Arm in Part 1 only|0||
59811955|NCT00457821|75934280|FG002|STARTED|Part 2|Arm in Part 1 only|0||
59811956|NCT00457821|75934281|FG003|STARTED|Part 2|Arm in Part 1 only|0||
59811957|NCT00457821|75934282|FG004|STARTED|Part 2|Arm in Part 1 only|0||
59811958|NCT00457821|75934283|FG005|STARTED|Part 2|All subjects who received at least 1 dose of study drug (ivacaftor).|8||
59811959|NCT00457821|75934284|FG006|STARTED|Part 2|All subjects who received at least 1 dose of study drug (ivacaftor).|7||
59811960|NCT00457821|75934285|FG007|STARTED|Part 2|All subjects who received at least 1 dose of study drug (placebo).|5||
59811961|NCT00457821|75934278|FG000|Completed Study Drug Treatment|Part 2||0||
59811962|NCT00457821|75934279|FG001|Completed Study Drug Treatment|Part 2||0||
59811963|NCT00457821|75934280|FG002|Completed Study Drug Treatment|Part 2||0||
59811964|NCT00457821|75934281|FG003|Completed Study Drug Treatment|Part 2||0||
59811965|NCT00457821|75934282|FG004|Completed Study Drug Treatment|Part 2||0||
59811966|NCT00457821|75934283|FG005|Completed Study Drug Treatment|Part 2||8||
59811967|NCT00457821|75934284|FG006|Completed Study Drug Treatment|Part 2|1 subject missed a 250-mg dose of ivacaftor on Day 28 of Part 2.|7||
59811968|NCT00457821|75934285|FG007|Completed Study Drug Treatment|Part 2||4||
59811969|NCT00457821|75934278|FG000|COMPLETED|Part 2||0||
59811970|NCT00457821|75934279|FG001|COMPLETED|Part 2||0||
59811971|NCT00457821|75934280|FG002|COMPLETED|Part 2||0||
59811972|NCT00457821|75934281|FG003|COMPLETED|Part 2||0||
59811973|NCT00457821|75934282|FG004|COMPLETED|Part 2||0||
59811974|NCT00457821|75934283|FG005|COMPLETED|Part 2||8||
59811975|NCT00457821|75934284|FG006|COMPLETED|Part 2||7||
59811976|NCT00457821|75934285|FG007|COMPLETED|Part 2||4||
59811977|NCT00457821|75934278|FG000|NOT COMPLETED|Part 2||0||
59811978|NCT00457821|75934279|FG001|NOT COMPLETED|Part 2||0||
59811979|NCT00457821|75934280|FG002|NOT COMPLETED|Part 2||0||
59811980|NCT00457821|75934281|FG003|NOT COMPLETED|Part 2||0||
59811981|NCT00457821|75934282|FG004|NOT COMPLETED|Part 2||0||
59811982|NCT00457821|75934283|FG005|NOT COMPLETED|Part 2||0||
59811983|NCT00457821|75934284|FG006|NOT COMPLETED|Part 2||0||
59811984|NCT00457821|75934285|FG007|NOT COMPLETED|Part 2||1||
59811985|NCT00633893|75934305|FG000|STARTED|Overall Study||840||
59811986|NCT00633893|75934306|FG001|STARTED|Overall Study|2 participants were randomized to 5 mg study drug but not treated.|813||
59811987|NCT00633893|75934307|FG002|STARTED|Overall Study|3 participants were randomized to placebo but not treated.|829||
59811988|NCT00633893|75934305|FG000|COMPLETED|Overall Study||726||
59811989|NCT00633893|75934306|FG001|COMPLETED|Overall Study||684||
59811990|NCT00633893|75934307|FG002|COMPLETED|Overall Study||641||
59811991|NCT00633893|75934305|FG000|NOT COMPLETED|Overall Study||114||
59811992|NCT00633893|75934306|FG001|NOT COMPLETED|Overall Study||129||
59811993|NCT00633893|75934307|FG002|NOT COMPLETED|Overall Study||188||
59811994|NCT00457743|75934318|FG000|STARTED|Overall Study|Overall study|3||
59811995|NCT00457743|75934319|FG001|STARTED|Overall Study|Overall study|30||
59811996|NCT00457743|75934320|FG002|STARTED|Overall Study|Overall study|3||
59811997|NCT00457743|75934318|FG000|Enrolled in Phase 1|Overall Study||3||
59811998|NCT00457743|75934319|FG001|Enrolled in Phase 1|Overall Study||6||
59811999|NCT00457743|75934320|FG002|Enrolled in Phase 1|Overall Study||3||
59812000|NCT00457743|75934318|FG000|Completed Phase 1|Overall Study||3||
59812001|NCT00457743|75934319|FG001|Completed Phase 1|Overall Study||6||
59812002|NCT00457743|75934320|FG002|Completed Phase 1|Overall Study||3||
59812003|NCT00457743|75934318|FG000|Enrolled in Phase 2|Overall Study|Three subjects who completed Phase 1 entered Phase 2.|3||
59812004|NCT00457743|75934319|FG001|Enrolled in Phase 2|Overall Study|Six subjects who completed Phase 1 entered Phase 2, and 24 subjects were newly enrolled.|30||
59812005|NCT00457743|75934320|FG002|Enrolled in Phase 2|Overall Study|Three subjects who completed Phase 1 entered Phase 2.|3||
59812006|NCT00457743|75934318|FG000|COMPLETED|Overall Study|However, all 3 subjects enrolled were included in analysis (Intent-to treat population).|0||
59812007|NCT00457743|75934319|FG001|COMPLETED|Overall Study|However, all 30 subjects enrolled were included in analysis(Intent-to treat population).|3||
59812008|NCT00457743|75934320|FG002|COMPLETED|Overall Study|However, all 3 subjects enrolled were included in analysis(Intent-to treat population).|0||
59971837|NCT02471716|76089242|FG002|COMPLETED|Overall Study||3||
59812009|NCT00457743|75934318|FG000|NOT COMPLETED|Overall Study||3||
59812010|NCT00457743|75934319|FG001|NOT COMPLETED|Overall Study||27||
59812011|NCT00457743|75934320|FG002|NOT COMPLETED|Overall Study||3||
59812012|NCT00450411|75934329|FG000|STARTED|Overall Study||100||
59812013|NCT00450411|75934329|FG000|Eligible and Started Protocol Treatment|Overall Study||92||
59812014|NCT00450411|75934329|FG000|COMPLETED|Overall Study||92|Subjects contributing data to analysis are considered to have completed the study.|
59812015|NCT00450411|75934329|FG000|NOT COMPLETED|Overall Study||8||
59812016|NCT00644969|75934335|FG000|STARTED|Treatment Phase||85||
59971838|NCT02471716|76089243|FG003|COMPLETED|Overall Study||18||
59971839|NCT02471716|76089244|FG004|COMPLETED|Overall Study||8||
59971840|NCT02471716|76089240|FG000|NOT COMPLETED|Overall Study||0||
59971841|NCT02471716|76089241|FG001|NOT COMPLETED|Overall Study||1||
59971842|NCT02471716|76089242|FG002|NOT COMPLETED|Overall Study||0||
59971843|NCT02471716|76089243|FG003|NOT COMPLETED|Overall Study||15||
59971844|NCT02471716|76089244|FG004|NOT COMPLETED|Overall Study||16||
59971845|NCT01370863|76089260|FG000|STARTED|Overall Study||34||
59971846|NCT01370863|76089261|FG001|STARTED|Overall Study||33||
59971847|NCT01370863|76089260|FG000|COMPLETED|Overall Study||32||
59971848|NCT01370863|76089261|FG001|COMPLETED|Overall Study||30||
59971849|NCT01370863|76089260|FG000|NOT COMPLETED|Overall Study||2||
59971850|NCT01370863|76089261|FG001|NOT COMPLETED|Overall Study||3||
59971851|NCT02444182|76089269|FG000|STARTED|Overall Study||54||
59971852|NCT02444182|76089270|FG001|STARTED|Overall Study||54||
59525507|NCT03822117|75620887|FG003|STARTED|Overall Study||4||
59812017|NCT00644969|75934336|FG001|STARTED|Treatment Phase||43||
59812018|NCT00644969|75934335|FG000|COMPLETED|Treatment Phase||71||
59812019|NCT00644969|75934336|FG001|COMPLETED|Treatment Phase||40||
59812020|NCT00644969|75934335|FG000|NOT COMPLETED|Treatment Phase||14||
59812021|NCT00644969|75934336|FG001|NOT COMPLETED|Treatment Phase||3||
59812022|NCT00644969|75934335|FG000|STARTED|Post Treatment Phase||71||
59812023|NCT00644969|75934336|FG001|STARTED|Post Treatment Phase||40||
59812024|NCT00644969|75934335|FG000|COMPLETED|Post Treatment Phase||61||
59812025|NCT00644969|75934336|FG001|COMPLETED|Post Treatment Phase||37||
59812026|NCT00644969|75934335|FG000|NOT COMPLETED|Post Treatment Phase||10||
59812027|NCT00644969|75934336|FG001|NOT COMPLETED|Post Treatment Phase||3||
59812028|NCT00644423|75934344|FG000|STARTED|Overall Study||6||
59812029|NCT00644423|75934345|FG001|STARTED|Overall Study||5||
59812030|NCT00644423|75934344|FG000|COMPLETED|Overall Study||5||
59812031|NCT00644423|75934345|FG001|COMPLETED|Overall Study||4||
59812032|NCT00644423|75934344|FG000|NOT COMPLETED|Overall Study||1||
59812033|NCT00644423|75934345|FG001|NOT COMPLETED|Overall Study||1||
59812034|NCT00628355|75934353|FG000|STARTED|Overall Study||15||
59812035|NCT00628355|75934354|FG001|STARTED|Overall Study||15||
59812036|NCT00628355|75934353|FG000|COMPLETED|Overall Study||14||
59812037|NCT00628355|75934354|FG001|COMPLETED|Overall Study||14||
59812038|NCT00628355|75934353|FG000|NOT COMPLETED|Overall Study||1||
59812039|NCT00628355|75934354|FG001|NOT COMPLETED|Overall Study||1||
59812040|NCT00627497|75934365|FG000|STARTED|Overall Study||14||
59812041|NCT00627497|75934366|FG001|STARTED|Overall Study||12||
59812042|NCT00627497|75934367|FG002|STARTED|Overall Study||4||
59812043|NCT00627497|75934368|FG003|STARTED|Overall Study||2||
59812044|NCT00627497|75934365|FG000|COMPLETED|Overall Study||13||
59812045|NCT00627497|75934366|FG001|COMPLETED|Overall Study||11||
59812046|NCT00627497|75934367|FG002|COMPLETED|Overall Study||4||
59812047|NCT00627497|75934368|FG003|COMPLETED|Overall Study||2||
59812048|NCT00627497|75934365|FG000|NOT COMPLETED|Overall Study||1||
59812049|NCT00627497|75934366|FG001|NOT COMPLETED|Overall Study||1||
59812050|NCT00627497|75934367|FG002|NOT COMPLETED|Overall Study||0||
59812051|NCT00627497|75934368|FG003|NOT COMPLETED|Overall Study||0||
59525508|NCT03822117|75620884|FG000|COMPLETED|Overall Study||0||
59525509|NCT03822117|75620885|FG001|COMPLETED|Overall Study||0||
59525510|NCT03822117|75620886|FG002|COMPLETED|Overall Study||0||
59812052|NCT00648167|75934378|FG000|STARTED|Overall Study||55||
59812053|NCT00648167|75934378|FG000|Start Dose 4.5 g/Day|Overall Study||34||
59812054|NCT00648167|75934378|FG000|Start Dose 6 g/Day|Overall Study||21||
59812055|NCT00648167|75934378|FG000|COMPLETED|Overall Study||48||
59812056|NCT00648167|75934378|FG000|NOT COMPLETED|Overall Study||7||
59812057|NCT03691623|75934388|FG000|STARTED|Overall Study||39||
59812058|NCT03691623|75934389|FG001|STARTED|Overall Study||38||
59812059|NCT03691623|75934390|FG002|STARTED|Overall Study||38||
59812060|NCT03691623|75934391|FG003|STARTED|Overall Study||21||
59525511|NCT03822117|75620887|FG003|COMPLETED|Overall Study||0||
59525512|NCT03822117|75620884|FG000|NOT COMPLETED|Overall Study||49||
59812061|NCT03691623|75934392|FG004|STARTED|Overall Study||21||
59812062|NCT03691623|75934393|FG005|STARTED|Overall Study||21||
59971853|NCT02444182|76089269|FG000|COMPLETED|Overall Study||52||
59525513|NCT03822117|75620885|FG001|NOT COMPLETED|Overall Study||32||
59525514|NCT03822117|75620886|FG002|NOT COMPLETED|Overall Study||26||
59525515|NCT03822117|75620887|FG003|NOT COMPLETED|Overall Study||4||
59971854|NCT02444182|76089270|FG001|COMPLETED|Overall Study||49||
59812063|NCT03691623|75934388|FG000|Inoculated With Challenge Virus|Overall Study||39||
59812064|NCT03691623|75934389|FG001|Inoculated With Challenge Virus|Overall Study||38||
59812065|NCT03691623|75934390|FG002|Inoculated With Challenge Virus|Overall Study||38||
59812066|NCT03691623|75934391|FG003|Inoculated With Challenge Virus|Overall Study||21||
59812067|NCT03691623|75934392|FG004|Inoculated With Challenge Virus|Overall Study||21||
59812068|NCT03691623|75934393|FG005|Inoculated With Challenge Virus|Overall Study||21||
59812069|NCT03691623|75934388|FG000|Received Treatment|Overall Study||38||
59812070|NCT03691623|75934389|FG001|Received Treatment|Overall Study||38||
59812071|NCT03691623|75934390|FG002|Received Treatment|Overall Study||38||
59812072|NCT03691623|75934391|FG003|Received Treatment|Overall Study||21||
59812073|NCT03691623|75934392|FG004|Received Treatment|Overall Study||21||
59812074|NCT03691623|75934393|FG005|Received Treatment|Overall Study||21||
59812075|NCT03691623|75934388|FG000|COMPLETED|Overall Study||39||
59812076|NCT03691623|75934389|FG001|COMPLETED|Overall Study||38||
59812077|NCT03691623|75934390|FG002|COMPLETED|Overall Study||38||
59812078|NCT03691623|75934391|FG003|COMPLETED|Overall Study||21||
59812079|NCT03691623|75934392|FG004|COMPLETED|Overall Study||21||
59812080|NCT03691623|75934393|FG005|COMPLETED|Overall Study||21||
59812081|NCT03691623|75934388|FG000|NOT COMPLETED|Overall Study||0||
59812082|NCT03691623|75934389|FG001|NOT COMPLETED|Overall Study||0||
59812083|NCT03691623|75934390|FG002|NOT COMPLETED|Overall Study||0||
59812084|NCT03691623|75934391|FG003|NOT COMPLETED|Overall Study||0||
59812085|NCT03691623|75934392|FG004|NOT COMPLETED|Overall Study||0||
59812086|NCT03691623|75934393|FG005|NOT COMPLETED|Overall Study||0||
59812087|NCT00647699|75934412|FG000|STARTED|Overall Study||73||
59812088|NCT00647699|75934413|FG001|STARTED|Overall Study||74||
59812089|NCT00647699|75934412|FG000|COMPLETED|Overall Study||65||
59812090|NCT00647699|75934413|FG001|COMPLETED|Overall Study||62||
59812091|NCT00647699|75934412|FG000|NOT COMPLETED|Overall Study||8||
59812092|NCT00647699|75934413|FG001|NOT COMPLETED|Overall Study||12||
59971855|NCT02444182|76089269|FG000|NOT COMPLETED|Overall Study||2||
59971856|NCT02444182|76089270|FG001|NOT COMPLETED|Overall Study||5||
59971857|NCT02471404|76089279|FG000|STARTED|Overall Study||314||
59971858|NCT02471404|76089280|FG001|STARTED|Overall Study||312||
59971859|NCT02471404|76089281|FG002|STARTED|Overall Study||313||
59971860|NCT02471404|76089279|FG000|COMPLETED|Overall Study||281||
59971861|NCT02471404|76089280|FG001|COMPLETED|Overall Study||298||
59971862|NCT02471404|76089281|FG002|COMPLETED|Overall Study||288||
59971863|NCT02471404|76089279|FG000|NOT COMPLETED|Overall Study||33||
59971864|NCT02471404|76089280|FG001|NOT COMPLETED|Overall Study||14||
59971865|NCT02471404|76089281|FG002|NOT COMPLETED|Overall Study||25||
59971866|NCT02471014|76089291|FG000|STARTED|Overall Study||25||
59971867|NCT02471014|76089292|FG001|STARTED|Overall Study||25||
59971868|NCT02471014|76089291|FG000|COMPLETED|Overall Study||23||
59971869|NCT02471014|76089292|FG001|COMPLETED|Overall Study||23||
59971870|NCT02471014|76089291|FG000|NOT COMPLETED|Overall Study||2||
59971871|NCT02471014|76089292|FG001|NOT COMPLETED|Overall Study||2||
59971872|NCT02413372|76089301|FG000|STARTED|Treatment||25||
59971873|NCT02413372|76089302|FG001|STARTED|Treatment||24||
59971874|NCT02413372|76089303|FG002|STARTED|Treatment||26||
59812093|NCT00467649|75934421|FG000|STARTED|Phase 1 (Randomized Population)|One patient randomized to the SYMLIN group withdrew consent prior to receiving the first dose|57||
59812094|NCT00467649|75934422|FG001|STARTED|Phase 1 (Randomized Population)||56||
59812095|NCT00467649|75934423|FG002|STARTED|Phase 1 (Randomized Population)||0||
59812096|NCT00467649|75934424|FG003|STARTED|Phase 1 (Randomized Population)||0||
59812097|NCT00467649|75934425|FG004|STARTED|Phase 1 (Randomized Population)||0||
59812098|NCT00467649|75934426|FG005|STARTED|Phase 1 (Randomized Population)||0||
59812099|NCT00467649|75934421|FG000|Intent to Treat|Phase 1 (Randomized Population)||56||
59812100|NCT00467649|75934422|FG001|Intent to Treat|Phase 1 (Randomized Population)||56||
59812101|NCT00467649|75934423|FG002|Intent to Treat|Phase 1 (Randomized Population)||0||
59812102|NCT00467649|75934424|FG003|Intent to Treat|Phase 1 (Randomized Population)||0||
59812103|NCT00467649|75934425|FG004|Intent to Treat|Phase 1 (Randomized Population)||0||
59812104|NCT00467649|75934426|FG005|Intent to Treat|Phase 1 (Randomized Population)||0||
59812105|NCT00467649|75934421|FG000|COMPLETED|Phase 1 (Randomized Population)||48||
59812106|NCT00467649|75934422|FG001|COMPLETED|Phase 1 (Randomized Population)||50||
59812107|NCT00467649|75934423|FG002|COMPLETED|Phase 1 (Randomized Population)||0||
59812108|NCT00467649|75934424|FG003|COMPLETED|Phase 1 (Randomized Population)||0||
59812109|NCT00467649|75934425|FG004|COMPLETED|Phase 1 (Randomized Population)||0||
59812110|NCT00467649|75934426|FG005|COMPLETED|Phase 1 (Randomized Population)||0||
59812111|NCT00467649|75934421|FG000|NOT COMPLETED|Phase 1 (Randomized Population)||9||
59812112|NCT00467649|75934422|FG001|NOT COMPLETED|Phase 1 (Randomized Population)||6||
59812113|NCT00467649|75934423|FG002|NOT COMPLETED|Phase 1 (Randomized Population)||0||
59812114|NCT00467649|75934424|FG003|NOT COMPLETED|Phase 1 (Randomized Population)||0||
59812115|NCT00467649|75934425|FG004|NOT COMPLETED|Phase 1 (Randomized Population)||0||
59812116|NCT00467649|75934426|FG005|NOT COMPLETED|Phase 1 (Randomized Population)||0||
59812117|NCT00467649|75934421|FG000|STARTED|Phase 2 (Intent-to-Treat Population)||0||
59812118|NCT00467649|75934422|FG001|STARTED|Phase 2 (Intent-to-Treat Population)||0||
59812119|NCT00467649|75934423|FG002|STARTED|Phase 2 (Intent-to-Treat Population)||17||
59812120|NCT00467649|75934424|FG003|STARTED|Phase 2 (Intent-to-Treat Population)||31||
59812121|NCT00467649|75934425|FG004|STARTED|Phase 2 (Intent-to-Treat Population)||14||
59971875|NCT02413372|76089301|FG000|COMPLETED|Treatment||24||
59812122|NCT00467649|75934426|FG005|STARTED|Phase 2 (Intent-to-Treat Population)||36||
59812123|NCT00467649|75934421|FG000|COMPLETED|Phase 2 (Intent-to-Treat Population)||0||
59812124|NCT00467649|75934422|FG001|COMPLETED|Phase 2 (Intent-to-Treat Population)||0||
59971876|NCT02413372|76089302|FG001|COMPLETED|Treatment||22||
59971877|NCT02413372|76089303|FG002|COMPLETED|Treatment||25||
59971878|NCT02413372|76089301|FG000|NOT COMPLETED|Treatment||1||
59971879|NCT02413372|76089302|FG001|NOT COMPLETED|Treatment||2||
59971880|NCT02413372|76089303|FG002|NOT COMPLETED|Treatment||1||
59971881|NCT02413372|76089301|FG000|STARTED|Follow-up||22||
59971882|NCT02413372|76089302|FG001|STARTED|Follow-up||21||
59812125|NCT00467649|75934423|FG002|COMPLETED|Phase 2 (Intent-to-Treat Population)||17||
59812126|NCT00467649|75934424|FG003|COMPLETED|Phase 2 (Intent-to-Treat Population)||29||
59812127|NCT00467649|75934425|FG004|COMPLETED|Phase 2 (Intent-to-Treat Population)||14||
59812128|NCT00467649|75934426|FG005|COMPLETED|Phase 2 (Intent-to-Treat Population)||35||
59812129|NCT00467649|75934421|FG000|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||0||
59971883|NCT02413372|76089303|FG002|STARTED|Follow-up||25||
59971884|NCT02413372|76089301|FG000|COMPLETED|Follow-up||20||
59971885|NCT02413372|76089302|FG001|COMPLETED|Follow-up||20||
59971886|NCT02413372|76089303|FG002|COMPLETED|Follow-up||23||
59971887|NCT02413372|76089301|FG000|NOT COMPLETED|Follow-up||2||
59971888|NCT02413372|76089302|FG001|NOT COMPLETED|Follow-up||1||
59971889|NCT02413372|76089303|FG002|NOT COMPLETED|Follow-up||2||
59971890|NCT02413294|76089311|FG000|STARTED|Overall Study||12||
59971891|NCT02413294|76089311|FG000|COMPLETED|Overall Study||11||
59971892|NCT02413294|76089311|FG000|NOT COMPLETED|Overall Study||1||
59971893|NCT02739542|76089317|FG000|STARTED|Overall Study||44||
59971894|NCT02739542|76089318|FG001|STARTED|Overall Study||43||
59971895|NCT02739542|76089317|FG000|COMPLETED|Overall Study||30||
59971896|NCT02739542|76089318|FG001|COMPLETED|Overall Study||29||
59971897|NCT02739542|76089317|FG000|NOT COMPLETED|Overall Study||14||
59971898|NCT02739542|76089318|FG001|NOT COMPLETED|Overall Study||14||
59971899|NCT02719353|76089324|FG000|STARTED|First Intervention||7||
59971900|NCT02719353|76089325|FG001|STARTED|First Intervention||7||
59971901|NCT02719353|76089324|FG000|COMPLETED|First Intervention||7||
59971902|NCT02719353|76089325|FG001|COMPLETED|First Intervention||6||
59971903|NCT02719353|76089324|FG000|NOT COMPLETED|First Intervention||0||
59971904|NCT02719353|76089325|FG001|NOT COMPLETED|First Intervention||1||
59971905|NCT02719353|76089324|FG000|STARTED|Second Intervention||7||
59971906|NCT02719353|76089325|FG001|STARTED|Second Intervention||6||
59971907|NCT02719353|76089324|FG000|COMPLETED|Second Intervention||7||
59971908|NCT02719353|76089325|FG001|COMPLETED|Second Intervention||6||
59971909|NCT02719353|76089324|FG000|NOT COMPLETED|Second Intervention||0||
59971910|NCT02719353|76089325|FG001|NOT COMPLETED|Second Intervention||0||
59971911|NCT01362062|76089334|FG000|STARTED|Overall Study||48||
59971912|NCT01362062|76089335|FG001|STARTED|Overall Study||62||
59971913|NCT01362062|76089334|FG000|COMPLETED|Overall Study||22||
59971914|NCT01362062|76089335|FG001|COMPLETED|Overall Study||62||
59971915|NCT01362062|76089334|FG000|NOT COMPLETED|Overall Study||26||
59971916|NCT01362062|76089335|FG001|NOT COMPLETED|Overall Study||0||
59971917|NCT01361594|76089342|FG000|STARTED|Overall Study||152||
59971918|NCT01361594|76089343|FG001|STARTED|Overall Study||153||
59971919|NCT01361594|76089342|FG000|COMPLETED|Overall Study||151||
59971920|NCT01361594|76089343|FG001|COMPLETED|Overall Study||151||
59971921|NCT01361594|76089342|FG000|NOT COMPLETED|Overall Study||1||
59971922|NCT01361594|76089343|FG001|NOT COMPLETED|Overall Study||2||
59971923|NCT02642432|76089349|FG000|STARTED|Overall Study||146||
59971924|NCT02642432|76089349|FG000|COMPLETED|Overall Study||138||
59971925|NCT02642432|76089349|FG000|NOT COMPLETED|Overall Study||8||
59971926|NCT02640482|76089355|FG000|STARTED|Overall Study||202||
60074487|NCT01801280|76189905|FG003|NOT COMPLETED|Period 3||0||
60074488|NCT01801280|76189902|FG000|STARTED|Period 4||4||
59812130|NCT00467649|75934422|FG001|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||0||
59812131|NCT00467649|75934423|FG002|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||0||
59812132|NCT00467649|75934424|FG003|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||2||
59812133|NCT00467649|75934425|FG004|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||0||
59812134|NCT00467649|75934426|FG005|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||1||
59812135|NCT00450333|75934448|FG000|STARTED|Overall Study||98||
59812136|NCT00450333|75934449|FG001|STARTED|Overall Study||107||
59812137|NCT00450333|75934450|FG002|STARTED|Overall Study||100||
59812138|NCT00450333|75934451|FG003|STARTED|Overall Study||102||
59812139|NCT00450333|75934448|FG000|COMPLETED|Overall Study||44||
59812140|NCT00450333|75934449|FG001|COMPLETED|Overall Study||44||
59812141|NCT00450333|75934450|FG002|COMPLETED|Overall Study||75||
59971927|NCT02640482|76089356|FG001|STARTED|Overall Study||100||
59971928|NCT02640482|76089355|FG000|COMPLETED|Overall Study||199||
59971929|NCT02640482|76089356|FG001|COMPLETED|Overall Study||100||
59971930|NCT02640482|76089355|FG000|NOT COMPLETED|Overall Study||3||
59971931|NCT02640482|76089356|FG001|NOT COMPLETED|Overall Study||0||
59971932|NCT02719743|76089367|FG000|STARTED|Overall Study||38||
60074489|NCT01801280|76189903|FG001|STARTED|Period 4||4||
59971933|NCT02719743|76089368|FG001|STARTED|Overall Study||37||
59971934|NCT02719743|76089369|FG002|STARTED|Overall Study||38||
59971935|NCT02719743|76089370|FG003|STARTED|Overall Study||37||
59971936|NCT02719743|76089371|FG004|STARTED|Overall Study||35||
59971937|NCT02719743|76089367|FG000|COMPLETED|Overall Study||37||
59971938|NCT02719743|76089368|FG001|COMPLETED|Overall Study||34||
59971939|NCT02719743|76089369|FG002|COMPLETED|Overall Study||38||
59971940|NCT02719743|76089370|FG003|COMPLETED|Overall Study||36||
59971941|NCT02719743|76089371|FG004|COMPLETED|Overall Study||33||
59971942|NCT02719743|76089367|FG000|NOT COMPLETED|Overall Study||1||
59971943|NCT02719743|76089368|FG001|NOT COMPLETED|Overall Study||3||
59971944|NCT02719743|76089369|FG002|NOT COMPLETED|Overall Study||0||
60074490|NCT01801280|76189904|FG002|STARTED|Period 4||5||
59971945|NCT02719743|76089370|FG003|NOT COMPLETED|Overall Study||1||
59971946|NCT02719743|76089371|FG004|NOT COMPLETED|Overall Study||2||
59971947|NCT02641730|76089386|FG000|STARTED|Placebo Controlled Period (Week 0 - 16)||53||
59971948|NCT02641730|76089387|FG001|STARTED|Placebo Controlled Period (Week 0 - 16)||0||
59971949|NCT02641730|76089388|FG002|STARTED|Placebo Controlled Period (Week 0 - 16)||0||
59971950|NCT02641730|76089389|FG003|STARTED|Placebo Controlled Period (Week 0 - 16)||54||
59971951|NCT02641730|76089390|FG004|STARTED|Placebo Controlled Period (Week 0 - 16)||52||
59971952|NCT02641730|76089386|FG000|COMPLETED|Placebo Controlled Period (Week 0 - 16)||51||
59971953|NCT02641730|76089387|FG001|COMPLETED|Placebo Controlled Period (Week 0 - 16)||0||
59971954|NCT02641730|76089388|FG002|COMPLETED|Placebo Controlled Period (Week 0 - 16)||0||
59971955|NCT02641730|76089389|FG003|COMPLETED|Placebo Controlled Period (Week 0 - 16)||53||
59971956|NCT02641730|76089390|FG004|COMPLETED|Placebo Controlled Period (Week 0 - 16)||50||
59971957|NCT02641730|76089386|FG000|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||2||
59971958|NCT02641730|76089387|FG001|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||0||
59971959|NCT02641730|76089388|FG002|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||0||
59971960|NCT02641730|76089389|FG003|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||1||
59971961|NCT02641730|76089390|FG004|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||2||
59971962|NCT02641730|76089386|FG000|STARTED|After Controlled Period (Week 16 - 52)||0||
59971963|NCT02641730|76089387|FG001|STARTED|After Controlled Period (Week 16 - 52)||25||
59971964|NCT02641730|76089388|FG002|STARTED|After Controlled Period (Week 16 - 52)||26||
59971965|NCT02641730|76089389|FG003|STARTED|After Controlled Period (Week 16 - 52)||53||
59971966|NCT02641730|76089390|FG004|STARTED|After Controlled Period (Week 16 - 52)||50||
59971967|NCT02641730|76089386|FG000|COMPLETED|After Controlled Period (Week 16 - 52)||0||
59971968|NCT02641730|76089387|FG001|COMPLETED|After Controlled Period (Week 16 - 52)||21||
59971969|NCT02641730|76089388|FG002|COMPLETED|After Controlled Period (Week 16 - 52)||24||
59971970|NCT02641730|76089389|FG003|COMPLETED|After Controlled Period (Week 16 - 52)||45||
59971971|NCT02641730|76089390|FG004|COMPLETED|After Controlled Period (Week 16 - 52)||44||
59971972|NCT02641730|76089386|FG000|NOT COMPLETED|After Controlled Period (Week 16 - 52)||0||
59971973|NCT02641730|76089387|FG001|NOT COMPLETED|After Controlled Period (Week 16 - 52)||4||
59971974|NCT02641730|76089388|FG002|NOT COMPLETED|After Controlled Period (Week 16 - 52)||2||
59971975|NCT02641730|76089389|FG003|NOT COMPLETED|After Controlled Period (Week 16 - 52)||8||
59971976|NCT02641730|76089390|FG004|NOT COMPLETED|After Controlled Period (Week 16 - 52)||6||
59971977|NCT02641730|76089386|FG000|STARTED|Observational Period (Week 60 - Week 84)||0||
59971978|NCT02641730|76089387|FG001|STARTED|Observational Period (Week 60 - Week 84)||21||
59971979|NCT02641730|76089388|FG002|STARTED|Observational Period (Week 60 - Week 84)||24||
59971980|NCT02641730|76089389|FG003|STARTED|Observational Period (Week 60 - Week 84)||45||
59971981|NCT02641730|76089390|FG004|STARTED|Observational Period (Week 60 - Week 84)||44||
59812142|NCT00450333|75934451|FG003|COMPLETED|Overall Study||74||
59971982|NCT02641730|76089386|FG000|COMPLETED|Observational Period (Week 60 - Week 84)||0||
59971983|NCT02641730|76089387|FG001|COMPLETED|Observational Period (Week 60 - Week 84)||21||
59971984|NCT02641730|76089388|FG002|COMPLETED|Observational Period (Week 60 - Week 84)||24||
59971985|NCT02641730|76089389|FG003|COMPLETED|Observational Period (Week 60 - Week 84)||45||
59971986|NCT02641730|76089390|FG004|COMPLETED|Observational Period (Week 60 - Week 84)||43||
59971987|NCT02641730|76089386|FG000|NOT COMPLETED|Observational Period (Week 60 - Week 84)||0||
59971988|NCT02641730|76089387|FG001|NOT COMPLETED|Observational Period (Week 60 - Week 84)||0||
59971989|NCT02641730|76089388|FG002|NOT COMPLETED|Observational Period (Week 60 - Week 84)||0||
59971990|NCT02641730|76089389|FG003|NOT COMPLETED|Observational Period (Week 60 - Week 84)||0||
59971991|NCT02641730|76089390|FG004|NOT COMPLETED|Observational Period (Week 60 - Week 84)||1||
59971992|NCT02797171|76089410|FG000|STARTED|Overall Study||23||
59971993|NCT02797171|76089411|FG001|STARTED|Overall Study||23||
59971994|NCT02797171|76089412|FG002|STARTED|Overall Study||7||
59525516|NCT03497897|75620901|FG000|STARTED|Overall Study||26||
59525517|NCT03497897|75620902|FG001|STARTED|Overall Study||11||
59525518|NCT03497897|75620903|FG002|STARTED|Overall Study||29||
59812143|NCT00450333|75934448|FG000|NOT COMPLETED|Overall Study||54||
59971995|NCT02797171|76089413|FG003|STARTED|Overall Study||16||
59971996|NCT02797171|76089414|FG004|STARTED|Overall Study||10||
59971997|NCT02797171|76089415|FG005|STARTED|Overall Study||1||
59971998|NCT02797171|76089410|FG000|Safety Population|Overall Study||23||
59525519|NCT03497897|75620901|FG000|Completed Treatment Period|Overall Study||23||
59525520|NCT03497897|75620902|FG001|Completed Treatment Period|Overall Study||9||
59525521|NCT03497897|75620903|FG002|Completed Treatment Period|Overall Study||24||
59525522|NCT03497897|75620901|FG000|Pharmacodynamic (PD) Analysis Set|Overall Study||24|The PD analysis set included all participants with available PD data who received any study drug and with no protocol deviations with relevant impact on PD data.|
59525523|NCT03497897|75620902|FG001|Pharmacodynamic (PD) Analysis Set|Overall Study||11|The PD analysis set included all participants with available PD data who received any study drug and with no protocol deviations with relevant impact on PD data.|
59525524|NCT03497897|75620903|FG002|Pharmacodynamic (PD) Analysis Set|Overall Study||28|The PD analysis set included all participants with available PD data who received any study drug and with no protocol deviations with relevant impact on PD data.|
59525525|NCT03497897|75620901|FG000|COMPLETED|Overall Study||20|Participants who completed the study|
59525526|NCT03497897|75620902|FG001|COMPLETED|Overall Study||9|Participants who completed the study|
59971999|NCT02797171|76089411|FG001|Safety Population|Overall Study||23||
59972000|NCT02797171|76089412|FG002|Safety Population|Overall Study||7||
59972001|NCT02797171|76089413|FG003|Safety Population|Overall Study||16||
59972002|NCT02797171|76089414|FG004|Safety Population|Overall Study||10||
59972003|NCT02797171|76089415|FG005|Safety Population|Overall Study||1||
59972004|NCT02797171|76089410|FG000|COMPLETED|Overall Study||19||
59972005|NCT02797171|76089411|FG001|COMPLETED|Overall Study||21||
59972006|NCT02797171|76089412|FG002|COMPLETED|Overall Study||5||
59972007|NCT02797171|76089413|FG003|COMPLETED|Overall Study||15||
59972008|NCT02797171|76089414|FG004|COMPLETED|Overall Study||8||
59972009|NCT02797171|76089415|FG005|COMPLETED|Overall Study||0||
59972010|NCT02797171|76089410|FG000|NOT COMPLETED|Overall Study||4||
59972011|NCT02797171|76089411|FG001|NOT COMPLETED|Overall Study||2||
59972012|NCT02797171|76089412|FG002|NOT COMPLETED|Overall Study||2||
59972013|NCT02797171|76089413|FG003|NOT COMPLETED|Overall Study||1||
59972014|NCT02797171|76089414|FG004|NOT COMPLETED|Overall Study||2||
59972015|NCT02797171|76089415|FG005|NOT COMPLETED|Overall Study||1||
59972016|NCT02797951|76089429|FG000|STARTED|Overall Study||165||
59972017|NCT02797951|76089429|FG000|Received at Least One Dose of Study Drug|Overall Study||164||
59972018|NCT02797951|76089429|FG000|COMPLETED|Overall Study||116|Participants who continued until sponsor ended the study following regulatory approval or non-approval of study drug for cluster headache indication in a country/region.|
59972019|NCT02797951|76089429|FG000|NOT COMPLETED|Overall Study||49||
59972020|NCT00701805|76089437|FG000|STARTED|Overall Study||26||
59972021|NCT00701805|76089438|FG001|STARTED|Overall Study||29||
59972022|NCT00701805|76089439|FG002|STARTED|Overall Study||23||
59972023|NCT00701805|76089440|FG003|STARTED|Overall Study||26||
59972024|NCT00701805|76089437|FG000|COMPLETED|Overall Study||23||
59972025|NCT00701805|76089438|FG001|COMPLETED|Overall Study||25||
59972026|NCT00701805|76089439|FG002|COMPLETED|Overall Study||16||
59972027|NCT00701805|76089440|FG003|COMPLETED|Overall Study||22||
59972028|NCT00701805|76089437|FG000|NOT COMPLETED|Overall Study||3||
59972029|NCT00701805|76089438|FG001|NOT COMPLETED|Overall Study||4||
59972030|NCT00701805|76089439|FG002|NOT COMPLETED|Overall Study||7||
59972031|NCT00701805|76089440|FG003|NOT COMPLETED|Overall Study||4||
59972032|NCT02715765|76089453|FG000|STARTED|Overall Study||3||
59972033|NCT02715765|76089454|FG001|STARTED|Overall Study||0||
59972034|NCT02715765|76089455|FG002|STARTED|Overall Study||0||
59972035|NCT02715765|76089453|FG000|COMPLETED|Overall Study||0||
59972036|NCT02715765|76089454|FG001|COMPLETED|Overall Study||0||
59972037|NCT02715765|76089455|FG002|COMPLETED|Overall Study||0||
59972038|NCT02715765|76089453|FG000|NOT COMPLETED|Overall Study||3||
59972039|NCT02715765|76089454|FG001|NOT COMPLETED|Overall Study||0||
59972040|NCT02715765|76089455|FG002|NOT COMPLETED|Overall Study||0||
59972041|NCT04542291|76089463|FG000|STARTED|Overall Study||15||
59972042|NCT04542291|76089463|FG000|COMPLETED|Overall Study||12||
59972043|NCT04542291|76089463|FG000|NOT COMPLETED|Overall Study||3||
59972044|NCT02795767|76089470|FG000|STARTED|Overall Study||68||
59972045|NCT02795767|76089471|FG001|STARTED|Overall Study||10||
59972046|NCT02795767|76089472|FG002|STARTED|Overall Study||10||
59621987|NCT00401778|75733739|FG000|COMPLETED|Overall Study||9||
59621988|NCT00401778|75733740|FG001|COMPLETED|Overall Study||11||
59621989|NCT00401778|75733741|FG002|COMPLETED|Overall Study||10||
59621990|NCT00401778|75733739|FG000|NOT COMPLETED|Overall Study||1||
59621991|NCT00401778|75733740|FG001|NOT COMPLETED|Overall Study||1||
59621992|NCT00401778|75733741|FG002|NOT COMPLETED|Overall Study||1||
59621993|NCT00402714|75733751|FG000|STARTED|Overall Study||3||
59621994|NCT00402714|75733752|FG001|STARTED|Overall Study||11||
59621995|NCT00402714|75733751|FG000|COMPLETED|Overall Study||3||
59972047|NCT02795767|76089470|FG000|Received at Least One Dose of Emicizumab|Overall Study||68||
59972048|NCT02795767|76089471|FG001|Received at Least One Dose of Emicizumab|Overall Study||10||
59972049|NCT02795767|76089472|FG002|Received at Least One Dose of Emicizumab|Overall Study||10||
59972050|NCT02795767|76089470|FG000|Dose Up-Titrated to 3 mg/kg QW|Overall Study||0||
59972051|NCT02795767|76089471|FG001|Dose Up-Titrated to 3 mg/kg QW|Overall Study||0||
59972052|NCT02795767|76089472|FG002|Dose Up-Titrated to 3 mg/kg QW|Overall Study||3||
59972053|NCT02795767|76089470|FG000|Completed 52 Weeks in Study|Overall Study||67||
59621996|NCT00402714|75733752|FG001|COMPLETED|Overall Study||11||
59621997|NCT00402714|75733751|FG000|NOT COMPLETED|Overall Study||0||
59972054|NCT02795767|76089471|FG001|Completed 52 Weeks in Study|Overall Study||10||
59972055|NCT02795767|76089472|FG002|Completed 52 Weeks in Study|Overall Study||9||
59972056|NCT02795767|76089470|FG000|COMPLETED|Overall Study||67||
59972057|NCT02795767|76089471|FG001|COMPLETED|Overall Study||10||
59972058|NCT02795767|76089472|FG002|COMPLETED|Overall Study||10||
59972059|NCT02795767|76089470|FG000|NOT COMPLETED|Overall Study||1||
59972060|NCT02795767|76089471|FG001|NOT COMPLETED|Overall Study||0||
59621998|NCT00402714|75733752|FG001|NOT COMPLETED|Overall Study||0||
59621999|NCT00405288|75733762|FG000|STARTED|Overall Study||204||
59622000|NCT00405288|75733763|FG001|STARTED|Overall Study||204||
59972061|NCT02795767|76089472|FG002|NOT COMPLETED|Overall Study||0||
59972062|NCT03443635|76089486|FG000|STARTED|Overall Study||2616||
59972063|NCT03443635|76089487|FG001|STARTED|Overall Study||4576||
59972064|NCT03443635|76089486|FG000|COMPLETED|Overall Study||2127||
59622001|NCT00405288|75733762|FG000|COMPLETED|Overall Study||204||
59972065|NCT03443635|76089487|FG001|COMPLETED|Overall Study||3720||
59972066|NCT03443635|76089486|FG000|NOT COMPLETED|Overall Study||489||
59972067|NCT03443635|76089487|FG001|NOT COMPLETED|Overall Study||856||
59972068|NCT02796391|76089499|FG000|STARTED|Overall Study||7||
59972069|NCT02796391|76089500|FG001|STARTED|Overall Study||8||
59972070|NCT02796391|76089501|FG002|STARTED|Overall Study||41||
59972071|NCT02796391|76089502|FG003|STARTED|Overall Study||32||
59972072|NCT02796391|76089503|FG004|STARTED|Overall Study||34||
59972073|NCT02796391|76089504|FG005|STARTED|Overall Study||40||
59972074|NCT02796391|76089499|FG000|COMPLETED|Overall Study||4||
59972075|NCT02796391|76089500|FG001|COMPLETED|Overall Study||5||
59972076|NCT02796391|76089501|FG002|COMPLETED|Overall Study||16||
59972077|NCT02796391|76089502|FG003|COMPLETED|Overall Study||14||
59972078|NCT02796391|76089503|FG004|COMPLETED|Overall Study||14||
59972079|NCT02796391|76089504|FG005|COMPLETED|Overall Study||20||
59972080|NCT02796391|76089499|FG000|NOT COMPLETED|Overall Study||3||
59972081|NCT02796391|76089500|FG001|NOT COMPLETED|Overall Study||3||
59972082|NCT02796391|76089501|FG002|NOT COMPLETED|Overall Study||25||
59972083|NCT02796391|76089502|FG003|NOT COMPLETED|Overall Study||18||
59972084|NCT02796391|76089503|FG004|NOT COMPLETED|Overall Study||20||
59972085|NCT02796391|76089504|FG005|NOT COMPLETED|Overall Study||20||
59972086|NCT01370317|76089520|FG000|STARTED|Overall Study||18||
59972087|NCT01370317|76089521|FG001|STARTED|Overall Study||9||
59972088|NCT01370317|76089520|FG000|COMPLETED|Overall Study||17||
59972089|NCT01370317|76089521|FG001|COMPLETED|Overall Study||8||
59972090|NCT01370317|76089520|FG000|NOT COMPLETED|Overall Study||1||
59972091|NCT01370317|76089521|FG001|NOT COMPLETED|Overall Study||1||
59972092|NCT01370083|76089529|FG000|STARTED|Overall Study||7||
59972093|NCT01370083|76089530|FG001|STARTED|Overall Study||7||
59972094|NCT01370083|76089529|FG000|COMPLETED|Overall Study||5||
59972095|NCT01370083|76089530|FG001|COMPLETED|Overall Study||6||
59972096|NCT01370083|76089529|FG000|NOT COMPLETED|Overall Study||2||
59972097|NCT01370083|76089530|FG001|NOT COMPLETED|Overall Study||1||
59972098|NCT03350815|76089536|FG000|STARTED|Period 1||322||
59972099|NCT03350815|76089537|FG001|STARTED|Period 1||0||
59972100|NCT03350815|76089538|FG002|STARTED|Period 1||0||
59972101|NCT03350815|76089539|FG003|STARTED|Period 1||0||
59972102|NCT03350815|76089536|FG000|Non-responders|Period 1||50|"One patient completed Treatment Period 1 and was randomized (secukinumab 150 mg - 300 mg [IR]); however, the patient did not receive any treatment in Treatment Period 2 due to Technical problems."|
59972103|NCT03350815|76089537|FG001|Non-responders|Period 1||0|"One patient completed Treatment Period 1 and was randomized (secukinumab 150 mg - 300 mg [IR]); however, the patient did not receive any treatment in Treatment Period 2 due to Technical problems."|
59972104|NCT03350815|76089538|FG002|Non-responders|Period 1||0|"One patient completed Treatment Period 1 and was randomized (secukinumab 150 mg - 300 mg [IR]); however, the patient did not receive any treatment in Treatment Period 2 due to Technical problems."|
59972105|NCT03350815|76089539|FG003|Non-responders|Period 1||0|"One patient completed Treatment Period 1 and was randomized (secukinumab 150 mg - 300 mg [IR]); however, the patient did not receive any treatment in Treatment Period 2 due to Technical problems."|
59972106|NCT03350815|76089536|FG000|Inadequate Responders|Period 1||207||
59972107|NCT03350815|76089537|FG001|Inadequate Responders|Period 1||0||
59972108|NCT03350815|76089538|FG002|Inadequate Responders|Period 1||0||
59972109|NCT03350815|76089539|FG003|Inadequate Responders|Period 1||0||
59972110|NCT03350815|76089536|FG000|Responders|Period 1||22||
59812144|NCT00450333|75934449|FG001|NOT COMPLETED|Overall Study||63||
59812145|NCT00450333|75934450|FG002|NOT COMPLETED|Overall Study||25||
59812146|NCT00450333|75934451|FG003|NOT COMPLETED|Overall Study||28||
59812147|NCT00643565|75934463|FG000|STARTED|Overall Study||80||
59812148|NCT00643565|75934464|FG001|STARTED|Overall Study||74||
59972111|NCT03350815|76089537|FG001|Responders|Period 1||0||
59972112|NCT03350815|76089538|FG002|Responders|Period 1||0||
59972113|NCT03350815|76089539|FG003|Responders|Period 1||0||
59972114|NCT03350815|76089536|FG000|COMPLETED|Period 1||279||
59972115|NCT03350815|76089537|FG001|COMPLETED|Period 1||0||
59972116|NCT03350815|76089538|FG002|COMPLETED|Period 1||0||
59972117|NCT03350815|76089539|FG003|COMPLETED|Period 1||0||
59972118|NCT03350815|76089536|FG000|NOT COMPLETED|Period 1||43||
59972119|NCT03350815|76089537|FG001|NOT COMPLETED|Period 1||0||
59972120|NCT03350815|76089538|FG002|NOT COMPLETED|Period 1||0||
59972121|NCT03350815|76089539|FG003|NOT COMPLETED|Period 1||0||
59972122|NCT03350815|76089536|FG000|STARTED|Period 2||0||
59972123|NCT03350815|76089537|FG001|STARTED|Period 2||102||
59972124|NCT03350815|76089538|FG002|STARTED|Period 2||105||
59972125|NCT03350815|76089539|FG003|STARTED|Period 2||22||
59972126|NCT03350815|76089536|FG000|COMPLETED|Period 2||0||
59972127|NCT03350815|76089537|FG001|COMPLETED|Period 2||86||
59972128|NCT03350815|76089538|FG002|COMPLETED|Period 2||88||
59972129|NCT03350815|76089539|FG003|COMPLETED|Period 2||22||
59812149|NCT00643565|75934463|FG000|COMPLETED|Overall Study||7||
59972130|NCT03350815|76089536|FG000|NOT COMPLETED|Period 2||0||
59812150|NCT00643565|75934464|FG001|COMPLETED|Overall Study||7||
59812151|NCT00643565|75934463|FG000|NOT COMPLETED|Overall Study||73||
59812152|NCT00643565|75934464|FG001|NOT COMPLETED|Overall Study||67||
59812153|NCT00643487|75934471|FG000|STARTED|Overall Study||8||
59972131|NCT03350815|76089537|FG001|NOT COMPLETED|Period 2||16||
59972132|NCT03350815|76089538|FG002|NOT COMPLETED|Period 2||17||
59972133|NCT03350815|76089539|FG003|NOT COMPLETED|Period 2||0||
59972134|NCT00854295|76089554|FG000|STARTED|Overall Study||106||
59972135|NCT00854295|76089555|FG001|STARTED|Overall Study||14||
59972136|NCT00854295|76089556|FG002|STARTED|Overall Study||77||
59972137|NCT00854295|76089557|FG003|STARTED|Overall Study||69||
59972138|NCT00854295|76089554|FG000|COMPLETED|Overall Study||65||
59972139|NCT00854295|76089555|FG001|COMPLETED|Overall Study||8||
59972140|NCT00854295|76089556|FG002|COMPLETED|Overall Study||54||
59972141|NCT00854295|76089557|FG003|COMPLETED|Overall Study||44||
59972142|NCT00854295|76089554|FG000|NOT COMPLETED|Overall Study||41||
59972143|NCT00854295|76089555|FG001|NOT COMPLETED|Overall Study||6||
59972144|NCT00854295|76089556|FG002|NOT COMPLETED|Overall Study||23||
59972145|NCT00854295|76089557|FG003|NOT COMPLETED|Overall Study||25||
59972146|NCT02792959|76089568|FG000|STARTED|Overall Study||11||
60074491|NCT01801280|76189905|FG003|STARTED|Period 4||5||
59812154|NCT00643487|75934471|FG000|COMPLETED|Overall Study||5||
59812155|NCT00643487|75934471|FG000|NOT COMPLETED|Overall Study||3||
59812156|NCT00450255|75934475|FG000|STARTED|Overall Study||41||
59812157|NCT00450255|75934475|FG000|COMPLETED|Overall Study||40||
59812158|NCT00450255|75934475|FG000|NOT COMPLETED|Overall Study||1||
59812159|NCT00450177|75934482|FG000|STARTED|Overall Study||97||
59812160|NCT00450177|75934483|FG001|STARTED|Overall Study||103||
59812161|NCT00450177|75934482|FG000|COMPLETED|Overall Study||88||
59812162|NCT00450177|75934483|FG001|COMPLETED|Overall Study||92||
59812163|NCT00450177|75934482|FG000|NOT COMPLETED|Overall Study||9||
59812164|NCT00450177|75934483|FG001|NOT COMPLETED|Overall Study||11||
59812165|NCT03848949|75934491|FG000|STARTED|Overall Study||54||
59812166|NCT03848949|75934492|FG001|STARTED|Overall Study||53||
59812167|NCT03848949|75934491|FG000|COMPLETED|Overall Study||49||
59812168|NCT03848949|75934492|FG001|COMPLETED|Overall Study||46||
59812169|NCT03848949|75934491|FG000|NOT COMPLETED|Overall Study||5||
59812170|NCT03848949|75934492|FG001|NOT COMPLETED|Overall Study||7||
59812171|NCT00467259|75934500|FG000|STARTED|Overall Study||251||
59812172|NCT00467259|75934501|FG001|STARTED|Overall Study||1020||
59812173|NCT00467259|75934500|FG000|ITT Population|Overall Study||251||
59812174|NCT00467259|75934501|FG001|ITT Population|Overall Study|One subject did not take any study medication and was excluded from ITT population.|1019||
59812175|NCT00467259|75934500|FG000|COMPLETED|Overall Study||176||
59812176|NCT00467259|75934501|FG001|COMPLETED|Overall Study||778||
59812177|NCT00467259|75934500|FG000|NOT COMPLETED|Overall Study||75||
59812178|NCT00467259|75934501|FG001|NOT COMPLETED|Overall Study||242||
59812179|NCT00449865|75934509|FG000|STARTED|Overall Study||867||
59812180|NCT00449865|75934510|FG001|STARTED|Overall Study||874||
59812181|NCT00449865|75934509|FG000|Completed Year 1|Overall Study|867 Expected at Year 1|802||
59812182|NCT00449865|75934510|FG001|Completed Year 1|Overall Study|874 Expected at Year 1|822||
59812183|NCT00449865|75934509|FG000|Completed Year 2|Overall Study|867 Expected at Year 2|768||
59812184|NCT00449865|75934510|FG001|Completed Year 2|Overall Study|874 Expected at Year 2|766||
59812185|NCT00449865|75934509|FG000|Completed Year 3|Overall Study|867 Expected at Year 3|719||
59812186|NCT00449865|75934510|FG001|Completed Year 3|Overall Study|874 Expected at Year 3|715||
59812187|NCT00449865|75934509|FG000|Completed Year 4|Overall Study|679 Expected at Year 4|521||
59812188|NCT00449865|75934510|FG001|Completed Year 4|Overall Study|686 Expected at Year 4|523||
59812189|NCT00449865|75934509|FG000|COMPLETED|Overall Study|478 Expected at Year 5|345||
59812190|NCT00449865|75934510|FG001|COMPLETED|Overall Study|477 Expected at Year 5|340||
59812191|NCT00449865|75934509|FG000|NOT COMPLETED|Overall Study||522||
59812192|NCT00449865|75934510|FG001|NOT COMPLETED|Overall Study||534||
59812193|NCT00449787|75934518|FG000|STARTED|Overall Study||203||
59812194|NCT00449787|75934519|FG001|STARTED|Overall Study||198||
59812195|NCT00449787|75934518|FG000|COMPLETED|Overall Study||98||
59812196|NCT00449787|75934519|FG001|COMPLETED|Overall Study||98||
59812197|NCT00449787|75934518|FG000|NOT COMPLETED|Overall Study||105||
59972147|NCT02792959|76089568|FG000|COMPLETED|Overall Study||10||
59972148|NCT02792959|76089568|FG000|NOT COMPLETED|Overall Study||1||
60074492|NCT01801280|76189902|FG000|COMPLETED|Period 4||4||
59812198|NCT00449787|75934519|FG001|NOT COMPLETED|Overall Study||100||
59812199|NCT00449163|75934527|FG000|STARTED|Overall Study||25||
59812200|NCT00449163|75934527|FG000|COMPLETED|Overall Study||22||
59812201|NCT00449163|75934527|FG000|NOT COMPLETED|Overall Study||3||
59812202|NCT00448539|75934533|FG000|STARTED|Overall Study||134||
59812203|NCT00448539|75934534|FG001|STARTED|Overall Study||152||
59812204|NCT00448539|75934533|FG000|COMPLETED|Overall Study||0||
59812205|NCT00448539|75934534|FG001|COMPLETED|Overall Study||0||
59812206|NCT00448539|75934533|FG000|NOT COMPLETED|Overall Study||134||
59972149|NCT01652872|76089574|FG000|STARTED|Overall Study||377||
59972150|NCT01652872|76089575|FG001|STARTED|Overall Study||379||
59812207|NCT00448539|75934534|FG001|NOT COMPLETED|Overall Study||152||
59812208|NCT00457665|75934542|FG000|STARTED|12 Months||28||
59812209|NCT00457665|75934543|FG001|STARTED|12 Months||28||
59812210|NCT00457665|75934542|FG000|COMPLETED|12 Months||20||
59972151|NCT01652872|76089574|FG000|Received Investigational Product|Overall Study||377||
59972152|NCT01652872|76089575|FG001|Received Investigational Product|Overall Study||377||
59972153|NCT01652872|76089574|FG000|COMPLETED|Overall Study||232||
59972154|NCT01652872|76089575|FG001|COMPLETED|Overall Study||226||
59972155|NCT01652872|76089574|FG000|NOT COMPLETED|Overall Study||145||
59972156|NCT01652872|76089575|FG001|NOT COMPLETED|Overall Study||153||
59972157|NCT04251273|76089583|FG000|STARTED|Overall Study||1304||
59972158|NCT04251273|76089584|FG001|STARTED|Overall Study||1284||
59972159|NCT04251273|76089583|FG000|COMPLETED|Overall Study||973||
59812211|NCT00457665|75934543|FG001|COMPLETED|12 Months||19||
59812212|NCT00457665|75934542|FG000|NOT COMPLETED|12 Months||8||
59812213|NCT00457665|75934543|FG001|NOT COMPLETED|12 Months||9||
59812214|NCT00457665|75934542|FG000|STARTED|24 Months||20||
59812215|NCT00457665|75934543|FG001|STARTED|24 Months||19||
59812216|NCT00457665|75934542|FG000|COMPLETED|24 Months||15||
59812217|NCT00457665|75934543|FG001|COMPLETED|24 Months||11||
59812218|NCT00457665|75934542|FG000|NOT COMPLETED|24 Months||5||
59812219|NCT00457665|75934543|FG001|NOT COMPLETED|24 Months||8||
59812220|NCT00447603|75934549|FG000|STARTED|Screening||40||
59812221|NCT00447603|75934550|FG001|STARTED|Screening||0||
59812222|NCT00447603|75934551|FG002|STARTED|Screening||0||
59812223|NCT00447603|75934549|FG000|COMPLETED|Screening||19||
59812224|NCT00447603|75934550|FG001|COMPLETED|Screening||0||
59812225|NCT00447603|75934551|FG002|COMPLETED|Screening||0||
59812226|NCT00447603|75934549|FG000|NOT COMPLETED|Screening||21||
59812227|NCT00447603|75934550|FG001|NOT COMPLETED|Screening||0||
59812228|NCT00447603|75934551|FG002|NOT COMPLETED|Screening||0||
59812229|NCT00447603|75934549|FG000|STARTED|Filter Period||0||
59812230|NCT00447603|75934550|FG001|STARTED|Filter Period|The study was discontinued early; no participant entered treatment period|4||
59812231|NCT00447603|75934551|FG002|STARTED|Filter Period|The study was discontinued early; no participant entered treatment period|15||
59812232|NCT00447603|75934549|FG000|COMPLETED|Filter Period||0||
59812233|NCT00447603|75934550|FG001|COMPLETED|Filter Period||0||
59812234|NCT00447603|75934551|FG002|COMPLETED|Filter Period||0||
59812235|NCT00447603|75934549|FG000|NOT COMPLETED|Filter Period||0||
59812236|NCT00447603|75934550|FG001|NOT COMPLETED|Filter Period||4||
59812237|NCT00447603|75934551|FG002|NOT COMPLETED|Filter Period||15||
59812238|NCT00447057|75934563|FG000|STARTED|Overall Study||83||
59812239|NCT00447057|75934564|FG001|STARTED|Overall Study||76||
59812240|NCT00447057|75934565|FG002|STARTED|Overall Study||19||
59812241|NCT00447057|75934566|FG003|STARTED|Overall Study||26||
59812242|NCT00447057|75934563|FG000|COMPLETED|Overall Study||0||
59812243|NCT00447057|75934564|FG001|COMPLETED|Overall Study||3||
59812244|NCT00447057|75934565|FG002|COMPLETED|Overall Study||0||
59812245|NCT00447057|75934566|FG003|COMPLETED|Overall Study||0||
59812246|NCT00447057|75934563|FG000|NOT COMPLETED|Overall Study||83||
59812247|NCT00447057|75934564|FG001|NOT COMPLETED|Overall Study||73||
59812248|NCT00447057|75934565|FG002|NOT COMPLETED|Overall Study||19||
59812249|NCT00447057|75934566|FG003|NOT COMPLETED|Overall Study||26||
59812250|NCT00446511|75934578|FG000|STARTED|Overall Study||21||
59812251|NCT00446511|75934579|FG001|STARTED|Overall Study||17||
59812252|NCT00446511|75934580|FG002|STARTED|Overall Study||103||
59812253|NCT00446511|75934581|FG003|STARTED|Overall Study||109||
59812254|NCT00446511|75934578|FG000|COMPLETED|Overall Study||11||
59812255|NCT00446511|75934579|FG001|COMPLETED|Overall Study||15||
59812256|NCT00446511|75934580|FG002|COMPLETED|Overall Study||96||
59812257|NCT00446511|75934581|FG003|COMPLETED|Overall Study||103||
59812258|NCT00446511|75934578|FG000|NOT COMPLETED|Overall Study||10||
59812259|NCT00446511|75934579|FG001|NOT COMPLETED|Overall Study||2||
59812260|NCT00446511|75934580|FG002|NOT COMPLETED|Overall Study||7||
59812261|NCT00446511|75934581|FG003|NOT COMPLETED|Overall Study||6||
59812262|NCT00446199|75934597|FG000|STARTED|Overall Study||183||
59812263|NCT00446199|75934598|FG001|STARTED|Overall Study||184||
59812264|NCT00446199|75934599|FG002|STARTED|Overall Study||185||
59812265|NCT00446199|75934600|FG003|STARTED|Overall Study||183||
59812266|NCT00446199|75934597|FG000|Participants Received Treatment|Overall Study|SAF=all randomized participants who took at least 1 dose of study medication.|181||
59972160|NCT04251273|76089584|FG001|COMPLETED|Overall Study||994||
59972161|NCT04251273|76089583|FG000|NOT COMPLETED|Overall Study||331||
59972162|NCT04251273|76089584|FG001|NOT COMPLETED|Overall Study||290||
59812267|NCT00446199|75934598|FG001|Participants Received Treatment|Overall Study|SAF=all randomized participants who took at least 1 dose of study medication.|183||
59812268|NCT00446199|75934599|FG002|Participants Received Treatment|Overall Study|SAF=all randomized participants who took at least 1 dose of study medication.|182||
59812269|NCT00446199|75934600|FG003|Participants Received Treatment|Overall Study|SAF=all randomized participants who took at least 1 dose of study medication.|180||
59812270|NCT00446199|75934597|FG000|Baseline and Postdose VMS Data Available|Overall Study|FAS=all randomized participants with Baseline VMS data and at least 1 day VMS data postdose.|178||
59972163|NCT02443402|76089592|FG000|STARTED|Overall Study||36||
59972164|NCT02443402|76089593|FG001|STARTED|Overall Study||31||
59812271|NCT00446199|75934598|FG001|Baseline and Postdose VMS Data Available|Overall Study|FAS=all randomized participants with Baseline VMS data and at least 1 day VMS data postdose.|177||
59812272|NCT00446199|75934599|FG002|Baseline and Postdose VMS Data Available|Overall Study|FAS=all randomized participants with Baseline VMS data and at least 1 day VMS data postdose.|179||
59817883|NCT04488770|75940335|FG009|STARTED|Part 1-Cohort 2: Period 1 (Up to 5 Days)||0||
59972165|NCT02443402|76089592|FG000|COMPLETED|Overall Study||32||
59972166|NCT02443402|76089593|FG001|COMPLETED|Overall Study||28||
59972167|NCT02443402|76089592|FG000|NOT COMPLETED|Overall Study||4||
59972168|NCT02443402|76089593|FG001|NOT COMPLETED|Overall Study||3||
59972169|NCT01370005|76089602|FG000|STARTED|Overall Study||272||
59972170|NCT01370005|76089603|FG001|STARTED|Overall Study||276||
59972171|NCT01370005|76089604|FG002|STARTED|Overall Study||277||
59972172|NCT01370005|76089602|FG000|COMPLETED|Overall Study||256||
59972173|NCT01370005|76089603|FG001|COMPLETED|Overall Study||265||
59972174|NCT01370005|76089604|FG002|COMPLETED|Overall Study||266||
59972175|NCT01370005|76089602|FG000|NOT COMPLETED|Overall Study||16||
59972176|NCT01370005|76089603|FG001|NOT COMPLETED|Overall Study||11||
59972177|NCT01370005|76089604|FG002|NOT COMPLETED|Overall Study||11||
59972178|NCT02442778|76089615|FG000|STARTED|Overall Study||210||
59972179|NCT02442778|76089616|FG001|STARTED|Overall Study||151||
59972180|NCT02442778|76089617|FG002|STARTED|Overall Study||161||
59972181|NCT02442778|76089615|FG000|Safety Population|Overall Study||210|Safety Population included all participants who received at least one dose of study medication. Participants were included in the treatment group based on the actual treatment received.|
59972182|NCT02442778|76089616|FG001|Safety Population|Overall Study||151|Safety Population included all participants who received at least one dose of study medication. Participants were included in the treatment group based on the actual treatment received.|
59972183|NCT02442778|76089617|FG002|Safety Population|Overall Study||160|Safety Population included all participants who received at least one dose of study medication. Participants were included in the treatment group based on the actual treatment received.|
59972184|NCT02442778|76089615|FG000|Modified Intent-to-Treat (mITT) Population|Overall Study||210|mITT Population included all randomized participants who had at least one post-baseline efficacy assessment. Participants were included in the treatment group to which they were randomized regardless of treatment received|
59972185|NCT02442778|76089616|FG001|Modified Intent-to-Treat (mITT) Population|Overall Study||150|mITT Population included all randomized participants who had at least one post-baseline efficacy assessment. Participants were included in the treatment group to which they were randomized regardless of treatment received|
59972186|NCT02442778|76089617|FG002|Modified Intent-to-Treat (mITT) Population|Overall Study||159|mITT Population included all randomized participants who had at least one post-baseline efficacy assessment. Participants were included in the treatment group to which they were randomized regardless of treatment received|
59972187|NCT02442778|76089615|FG000|COMPLETED|Overall Study||192||
59972188|NCT02442778|76089616|FG001|COMPLETED|Overall Study||121||
59972189|NCT02442778|76089617|FG002|COMPLETED|Overall Study||146||
59972190|NCT02442778|76089615|FG000|NOT COMPLETED|Overall Study||18||
59972191|NCT02442778|76089616|FG001|NOT COMPLETED|Overall Study||30||
59972192|NCT02442778|76089617|FG002|NOT COMPLETED|Overall Study||15||
59972193|NCT02412436|76089625|FG000|STARTED|Overall Study||62||
59972194|NCT02412436|76089625|FG000|COMPLETED|Overall Study||44||
59972195|NCT02412436|76089625|FG000|NOT COMPLETED|Overall Study||18||
59972196|NCT01651000|76089631|FG000|STARTED|Overall Study||72||
59972197|NCT01651000|76089632|FG001|STARTED|Overall Study||141||
59972198|NCT01651000|76089631|FG000|Entered Extension Study|Overall Study||50||
59972199|NCT01651000|76089632|FG001|Entered Extension Study|Overall Study||93||
59972200|NCT01651000|76089631|FG000|COMPLETED|Overall Study||62||
59972201|NCT01651000|76089632|FG001|COMPLETED|Overall Study||113||
59972202|NCT01651000|76089631|FG000|NOT COMPLETED|Overall Study||10||
59972203|NCT01651000|76089632|FG001|NOT COMPLETED|Overall Study||28||
59972204|NCT02469610|76089640|FG000|STARTED|Overall Study||34||
59812273|NCT00446199|75934600|FG003|Baseline and Postdose VMS Data Available|Overall Study|FAS=all randomized participants with Baseline VMS data and at least 1 day VMS data postdose.|176||
59812274|NCT00446199|75934597|FG000|COMPLETED|Overall Study||160||
59812275|NCT00446199|75934598|FG001|COMPLETED|Overall Study||164||
59812276|NCT00446199|75934599|FG002|COMPLETED|Overall Study||158||
59812277|NCT00446199|75934600|FG003|COMPLETED|Overall Study||153||
59812278|NCT00446199|75934597|FG000|NOT COMPLETED|Overall Study||23||
59812279|NCT00446199|75934598|FG001|NOT COMPLETED|Overall Study||20||
59812280|NCT00446199|75934599|FG002|NOT COMPLETED|Overall Study||27||
59812281|NCT00446199|75934600|FG003|NOT COMPLETED|Overall Study||30||
59812282|NCT00456495|75934610|FG000|STARTED|Overall Study||5||
59812283|NCT00456495|75934610|FG000|COMPLETED|Overall Study||3||
59812284|NCT00456495|75934610|FG000|NOT COMPLETED|Overall Study||2||
59812285|NCT00445341|75934615|FG000|STARTED|Overall Study||28||
59812286|NCT00445341|75934615|FG000|COMPLETED|Overall Study||26||
59812287|NCT00445341|75934615|FG000|NOT COMPLETED|Overall Study||2||
59812288|NCT03846453|75934621|FG000|STARTED|Placebo Run-in (14 Days)||1108||
59812289|NCT03846453|75934622|FG001|STARTED|Placebo Run-in (14 Days)|Participants in this group were randomized after they completed the placebo run-in period.|0||
59812290|NCT03846453|75934623|FG002|STARTED|Placebo Run-in (14 Days)|Participants in this group were randomized after they completed the placebo run-in period.|0||
59812291|NCT03846453|75934621|FG000|COMPLETED|Placebo Run-in (14 Days)||637||
59812292|NCT03846453|75934622|FG001|COMPLETED|Placebo Run-in (14 Days)||0||
59812293|NCT03846453|75934623|FG002|COMPLETED|Placebo Run-in (14 Days)||0||
59812294|NCT03846453|75934621|FG000|NOT COMPLETED|Placebo Run-in (14 Days)||471||
59812295|NCT03846453|75934622|FG001|NOT COMPLETED|Placebo Run-in (14 Days)||0||
59812296|NCT03846453|75934623|FG002|NOT COMPLETED|Placebo Run-in (14 Days)||0||
59812297|NCT03846453|75934621|FG000|STARTED|Randomized Treatment Period (Days 57±3)|All participants who completed the placebo run-in period and qualified were randomized to either 0.25% HL036 Ophthalmic Solution group or placebo group.|0||
59972205|NCT02469610|76089641|FG001|STARTED|Overall Study||31||
59972206|NCT02469610|76089640|FG000|COMPLETED|Overall Study||30||
59972207|NCT02469610|76089641|FG001|COMPLETED|Overall Study||30||
59972208|NCT02469610|76089640|FG000|NOT COMPLETED|Overall Study||4||
59972209|NCT02469610|76089641|FG001|NOT COMPLETED|Overall Study||1||
59972210|NCT02469298|76089651|FG000|STARTED|Overall Study||15||
59972211|NCT02469298|76089652|FG001|STARTED|Overall Study||7||
59972212|NCT02469298|76089653|FG002|STARTED|Overall Study||16||
59972213|NCT02469298|76089654|FG003|STARTED|Overall Study||7||
59972214|NCT02469298|76089651|FG000|COMPLETED|Overall Study||14||
59972215|NCT02469298|76089652|FG001|COMPLETED|Overall Study||6||
59972216|NCT02469298|76089653|FG002|COMPLETED|Overall Study||14||
59972217|NCT02469298|76089654|FG003|COMPLETED|Overall Study||5||
59972218|NCT02469298|76089651|FG000|NOT COMPLETED|Overall Study||1||
59972219|NCT02469298|76089652|FG001|NOT COMPLETED|Overall Study||1||
59972220|NCT02469298|76089653|FG002|NOT COMPLETED|Overall Study||2||
59972221|NCT02469298|76089654|FG003|NOT COMPLETED|Overall Study||2||
59972222|NCT04163991|76089676|FG000|STARTED|Overall Study||16||
59972223|NCT04163991|76089677|FG001|STARTED|Overall Study||16||
59972224|NCT04163991|76089678|FG002|STARTED|Overall Study||16||
59972225|NCT04163991|76089679|FG003|STARTED|Overall Study||15||
59972226|NCT04163991|76089680|FG004|STARTED|Overall Study||15||
59972227|NCT04163991|76089676|FG000|COMPLETED|Overall Study||15||
59972228|NCT04163991|76089677|FG001|COMPLETED|Overall Study||13||
59972229|NCT04163991|76089678|FG002|COMPLETED|Overall Study||11||
59972230|NCT04163991|76089679|FG003|COMPLETED|Overall Study||12||
59972231|NCT04163991|76089680|FG004|COMPLETED|Overall Study||14||
59972232|NCT04163991|76089676|FG000|NOT COMPLETED|Overall Study||1||
59972233|NCT04163991|76089677|FG001|NOT COMPLETED|Overall Study||3||
59972234|NCT04163991|76089678|FG002|NOT COMPLETED|Overall Study||5||
59972235|NCT04163991|76089679|FG003|NOT COMPLETED|Overall Study||3||
59972236|NCT04163991|76089680|FG004|NOT COMPLETED|Overall Study||1||
59972237|NCT02442622|76089698|FG000|STARTED|Overall Study||15||
59972238|NCT02442622|76089699|FG001|STARTED|Overall Study||17||
59972239|NCT02442622|76089698|FG000|COMPLETED|Overall Study||12||
59972240|NCT02442622|76089699|FG001|COMPLETED|Overall Study||16||
59972241|NCT02442622|76089698|FG000|NOT COMPLETED|Overall Study||3||
59972242|NCT02442622|76089699|FG001|NOT COMPLETED|Overall Study||1||
59972243|NCT02411578|76089707|FG000|STARTED|Crossover Trial Phase||8||
59972244|NCT02411578|76089708|FG001|STARTED|Crossover Trial Phase||12||
59972245|NCT02411578|76089707|FG000|COMPLETED|Crossover Trial Phase||8||
59972246|NCT02411578|76089708|FG001|COMPLETED|Crossover Trial Phase||11||
59972247|NCT02411578|76089707|FG000|NOT COMPLETED|Crossover Trial Phase||0||
59972248|NCT02411578|76089708|FG001|NOT COMPLETED|Crossover Trial Phase||1||
59972249|NCT02411578|76089707|FG000|STARTED|Extension Phase||8||
59622002|NCT00405288|75733763|FG001|COMPLETED|Overall Study||204||
59622003|NCT00405288|75733762|FG000|NOT COMPLETED|Overall Study||0||
59622004|NCT00405288|75733763|FG001|NOT COMPLETED|Overall Study||0||
59622005|NCT00458406|75733771|FG000|STARTED|Month 1||43||
59622006|NCT00458406|75733772|FG001|STARTED|Month 1||13||
59622007|NCT00458406|75733771|FG000|COMPLETED|Month 1||43||
59622008|NCT00458406|75733772|FG001|COMPLETED|Month 1||13||
59622009|NCT00458406|75733771|FG000|NOT COMPLETED|Month 1||0||
59622010|NCT00458406|75733772|FG001|NOT COMPLETED|Month 1||0||
59622011|NCT00458406|75733771|FG000|STARTED|Month 3||43||
59622012|NCT00458406|75733772|FG001|STARTED|Month 3||13||
59622013|NCT00458406|75733771|FG000|COMPLETED|Month 3||43||
59622014|NCT00458406|75733772|FG001|COMPLETED|Month 3||13||
59622015|NCT00458406|75733771|FG000|NOT COMPLETED|Month 3||0||
59622016|NCT00458406|75733772|FG001|NOT COMPLETED|Month 3||0||
60074493|NCT01801280|76189903|FG001|COMPLETED|Period 4||4||
60074494|NCT01801280|76189904|FG002|COMPLETED|Period 4||4||
60074495|NCT01801280|76189905|FG003|COMPLETED|Period 4||5||
60074496|NCT01801280|76189902|FG000|NOT COMPLETED|Period 4||0||
60074497|NCT01801280|76189903|FG001|NOT COMPLETED|Period 4||0||
60074498|NCT01801280|76189904|FG002|NOT COMPLETED|Period 4||1||
60074499|NCT01801280|76189905|FG003|NOT COMPLETED|Period 4||0||
59972250|NCT02411578|76089708|FG001|STARTED|Extension Phase|2 Crossover Trial participants could not continue due to study syringes expiration|9||
59972251|NCT02411578|76089707|FG000|COMPLETED|Extension Phase||8||
59972252|NCT02411578|76089708|FG001|COMPLETED|Extension Phase||9||
60103602|NCT01291108|76221865|FG002|STARTED|Month 1 (Monotherapy)||0||
59622017|NCT00381810|75733785|FG000|STARTED|Treatment and Safety Follow-up||31||
59622018|NCT00381810|75733785|FG000|COMPLETED|Treatment and Safety Follow-up||16||
59622019|NCT00381810|75733785|FG000|NOT COMPLETED|Treatment and Safety Follow-up||15||
59622020|NCT00381810|75733785|FG000|STARTED|B Cell Follow-up|Participants only entered the B cell follow-up period if their peripheral B cells were depleted.|7||
59622021|NCT00381810|75733785|FG000|COMPLETED|B Cell Follow-up||0||
59972253|NCT02411578|76089707|FG000|NOT COMPLETED|Extension Phase||0||
59972254|NCT02411578|76089708|FG001|NOT COMPLETED|Extension Phase||0||
59972255|NCT02442310|76089716|FG000|STARTED|Overall Study||20||
59972256|NCT02442310|76089716|FG000|COMPLETED|Overall Study||17||
59972257|NCT02442310|76089716|FG000|NOT COMPLETED|Overall Study||3||
59972258|NCT02411110|76089728|FG000|STARTED|Treatment Period 1||65||
59972259|NCT02411110|76089729|FG001|STARTED|Treatment Period 1||66||
59972260|NCT02411110|76089728|FG000|COMPLETED|Treatment Period 1||56||
59972261|NCT02411110|76089729|FG001|COMPLETED|Treatment Period 1||59||
59972262|NCT02411110|76089728|FG000|NOT COMPLETED|Treatment Period 1||9||
59972263|NCT02411110|76089729|FG001|NOT COMPLETED|Treatment Period 1||7||
59972264|NCT02411110|76089728|FG000|STARTED|Treatment Period 2|Period 2 was optional.|50||
59972265|NCT02411110|76089729|FG001|STARTED|Treatment Period 2|Period 2 was optional.|48||
59972266|NCT02411110|76089728|FG000|COMPLETED|Treatment Period 2||49||
59972267|NCT02411110|76089729|FG001|COMPLETED|Treatment Period 2||44||
59972268|NCT02411110|76089728|FG000|NOT COMPLETED|Treatment Period 2||1||
59972269|NCT02411110|76089729|FG001|NOT COMPLETED|Treatment Period 2||4||
59972270|NCT01369849|76089740|FG000|STARTED|Overall Study||6||
59972271|NCT01369849|76089741|FG001|STARTED|Overall Study||4||
59972272|NCT01369849|76089742|FG002|STARTED|Overall Study||5||
59972273|NCT01369849|76089740|FG000|COMPLETED|Overall Study||6||
59972274|NCT01369849|76089741|FG001|COMPLETED|Overall Study||3||
59972275|NCT01369849|76089742|FG002|COMPLETED|Overall Study||4||
59972276|NCT01369849|76089740|FG000|NOT COMPLETED|Overall Study||0||
59972277|NCT01369849|76089741|FG001|NOT COMPLETED|Overall Study||1||
59972278|NCT01369849|76089742|FG002|NOT COMPLETED|Overall Study||1||
59972279|NCT02716779|76089755|FG000|STARTED|Monotherapy||14||
59972280|NCT02716779|76089756|FG001|STARTED|Monotherapy||26||
59972281|NCT02716779|76089757|FG002|STARTED|Monotherapy||27||
59972282|NCT02716779|76089755|FG000|COMPLETED|Monotherapy||14||
59972283|NCT02716779|76089756|FG001|COMPLETED|Monotherapy||25||
59972284|NCT02716779|76089757|FG002|COMPLETED|Monotherapy||26||
59972285|NCT02716779|76089755|FG000|NOT COMPLETED|Monotherapy||0||
59972286|NCT02716779|76089756|FG001|NOT COMPLETED|Monotherapy||1||
59972287|NCT02716779|76089757|FG002|NOT COMPLETED|Monotherapy||1||
59972288|NCT02716779|76089755|FG000|STARTED|Combination Therapy||14||
59972289|NCT02716779|76089756|FG001|STARTED|Combination Therapy||25||
59972290|NCT02716779|76089757|FG002|STARTED|Combination Therapy||26||
59972291|NCT02716779|76089755|FG000|COMPLETED|Combination Therapy||14||
59972292|NCT02716779|76089756|FG001|COMPLETED|Combination Therapy||23||
59972293|NCT02716779|76089757|FG002|COMPLETED|Combination Therapy||25||
59972294|NCT02716779|76089755|FG000|NOT COMPLETED|Combination Therapy||0||
59972295|NCT02716779|76089756|FG001|NOT COMPLETED|Combination Therapy||2||
59972296|NCT02716779|76089757|FG002|NOT COMPLETED|Combination Therapy||1||
59972297|NCT01369615|76089773|FG000|STARTED|Overall Study||9||
59972298|NCT01369615|76089774|FG001|STARTED|Overall Study||14||
59972299|NCT01369615|76089773|FG000|COMPLETED|Overall Study||9||
59972300|NCT01369615|76089774|FG001|COMPLETED|Overall Study||12||
59972301|NCT01369615|76089773|FG000|NOT COMPLETED|Overall Study||0||
59972302|NCT01369615|76089774|FG001|NOT COMPLETED|Overall Study||2||
59972303|NCT02811913|76089780|FG000|STARTED|Overall Study||20||
59972304|NCT02811913|76089780|FG000|COMPLETED|Overall Study||16||
59972305|NCT02811913|76089780|FG000|NOT COMPLETED|Overall Study||4||
59972306|NCT02468674|76089798|FG000|STARTED|Overall Study||5|All randomized patients were included in the Full Analysis (FAS) and Safety Set|
59972307|NCT02468674|76089799|FG001|STARTED|Overall Study||5|All randomized patients were included in the Full Analysis (FAS) and Safety Set|
59972308|NCT02468674|76089800|FG002|STARTED|Overall Study||5|All randomized patients were included in the Full Analysis (FAS) and Safety Set|
59972309|NCT02468674|76089801|FG003|STARTED|Overall Study||4|All randomized patients were included in the Full Analysis (FAS) and Safety Set|
59972310|NCT02468674|76089802|FG004|STARTED|Overall Study||7|All randomized patients were included in the Full Analysis (FAS) and Safety Set|
59972311|NCT02468674|76089803|FG005|STARTED|Overall Study||7|All randomized patients were included in the Full Analysis (FAS) and Safety Set|
59972312|NCT02468674|76089804|FG006|STARTED|Overall Study||15|All randomized patients were included in the Full Analysis (FAS) and Safety Set|
59972313|NCT02468674|76089805|FG007|STARTED|Overall Study||69|All randomized patients were included in the Full Analysis (FAS) and Safety Set|
59972314|NCT02468674|76089806|FG008|STARTED|Overall Study||43|All randomized patients were included in the Full Analysis (FAS) and Safety Set|
59972315|NCT02468674|76089798|FG000|COMPLETED|Overall Study||4||
59972316|NCT02468674|76089799|FG001|COMPLETED|Overall Study||5||
59972317|NCT02468674|76089800|FG002|COMPLETED|Overall Study||5||
59972318|NCT02468674|76089801|FG003|COMPLETED|Overall Study||3||
59972319|NCT02468674|76089802|FG004|COMPLETED|Overall Study||6||
59972320|NCT02468674|76089803|FG005|COMPLETED|Overall Study||6||
59972321|NCT02468674|76089804|FG006|COMPLETED|Overall Study||14||
59972322|NCT02468674|76089805|FG007|COMPLETED|Overall Study||65||
59972323|NCT02468674|76089806|FG008|COMPLETED|Overall Study||40||
59972324|NCT02468674|76089798|FG000|NOT COMPLETED|Overall Study||1||
59972325|NCT02468674|76089799|FG001|NOT COMPLETED|Overall Study||0||
59972326|NCT02468674|76089800|FG002|NOT COMPLETED|Overall Study||0||
59972327|NCT02468674|76089801|FG003|NOT COMPLETED|Overall Study||1||
59972328|NCT02468674|76089802|FG004|NOT COMPLETED|Overall Study||1||
59972329|NCT02468674|76089803|FG005|NOT COMPLETED|Overall Study||1||
59972330|NCT02468674|76089804|FG006|NOT COMPLETED|Overall Study||1||
59972331|NCT02468674|76089805|FG007|NOT COMPLETED|Overall Study||4||
59972332|NCT02468674|76089806|FG008|NOT COMPLETED|Overall Study||3||
59972333|NCT02467192|76089826|FG000|STARTED|Overall Study||203||
59972334|NCT02467192|76089826|FG000|COMPLETED|Overall Study||200||
59972335|NCT02467192|76089826|FG000|NOT COMPLETED|Overall Study||3||
59972336|NCT02410954|76089836|FG000|STARTED|Overall Study||14||
59972337|NCT02410954|76089837|FG001|STARTED|Overall Study||0||
59972338|NCT02410954|76089836|FG000|COMPLETED|Overall Study||0||
59812298|NCT03846453|75934622|FG001|STARTED|Randomized Treatment Period (Days 57±3)||318||
59812299|NCT03846453|75934623|FG002|STARTED|Randomized Treatment Period (Days 57±3)||319||
59812300|NCT03846453|75934621|FG000|COMPLETED|Randomized Treatment Period (Days 57±3)||0||
59972339|NCT02410954|76089837|FG001|COMPLETED|Overall Study||0||
59972340|NCT02410954|76089836|FG000|NOT COMPLETED|Overall Study||14||
59972341|NCT02410954|76089837|FG001|NOT COMPLETED|Overall Study||0||
59972342|NCT05488535|76089843|FG000|STARTED|Overall Study||101||
59972343|NCT05488535|76089843|FG000|COMPLETED|Overall Study||96||
59972344|NCT05488535|76089843|FG000|NOT COMPLETED|Overall Study||5||
59972345|NCT05219877|76089849|FG000|STARTED|Overall Study||67||
59972346|NCT05219877|76089850|FG001|STARTED|Overall Study||67||
59972347|NCT05219877|76089849|FG000|COMPLETED|Overall Study||63||
59972348|NCT05219877|76089850|FG001|COMPLETED|Overall Study||63||
59972349|NCT05219877|76089849|FG000|NOT COMPLETED|Overall Study||4||
59972350|NCT05219877|76089850|FG001|NOT COMPLETED|Overall Study||4||
59972351|NCT05153499|76089858|FG000|STARTED|Overall Study||12||
59972352|NCT05153499|76089859|FG001|STARTED|Overall Study||7||
59972353|NCT05153499|76089858|FG000|COMPLETED|Overall Study||4||
59972354|NCT05153499|76089859|FG001|COMPLETED|Overall Study||2||
59972355|NCT05153499|76089858|FG000|NOT COMPLETED|Overall Study||8||
59972356|NCT05153499|76089859|FG001|NOT COMPLETED|Overall Study||5||
59972357|NCT05047770|76089869|FG000|STARTED|Overall Study||272||
59972358|NCT05047770|76089870|FG001|STARTED|Overall Study||267||
59972359|NCT05047770|76089871|FG002|STARTED|Overall Study||497||
59972360|NCT05047770|76089872|FG003|STARTED|Overall Study||498||
59972361|NCT05047770|76089869|FG000|COMPLETED|Overall Study||249||
59972362|NCT05047770|76089870|FG001|COMPLETED|Overall Study||252||
59972363|NCT05047770|76089871|FG002|COMPLETED|Overall Study||478||
59972364|NCT05047770|76089872|FG003|COMPLETED|Overall Study||473||
59972365|NCT05047770|76089869|FG000|NOT COMPLETED|Overall Study||23||
59972366|NCT05047770|76089870|FG001|NOT COMPLETED|Overall Study||15||
59972367|NCT05047770|76089871|FG002|NOT COMPLETED|Overall Study||19||
59972368|NCT05047770|76089872|FG003|NOT COMPLETED|Overall Study||25||
59972369|NCT04977700|76089884|FG000|STARTED|Overall Study||31||
59972370|NCT04977700|76089885|FG001|STARTED|Overall Study||10||
59972371|NCT04977700|76089884|FG000|COMPLETED|Overall Study||31||
59972372|NCT04977700|76089885|FG001|COMPLETED|Overall Study||10||
59972373|NCT04977700|76089884|FG000|NOT COMPLETED|Overall Study||0||
59972374|NCT04977700|76089885|FG001|NOT COMPLETED|Overall Study||0||
59972375|NCT04941703|76089896|FG000|STARTED|Overall Study||8||
59972376|NCT04941703|76089897|FG001|STARTED|Overall Study||10||
59972377|NCT04941703|76089896|FG000|COMPLETED|Overall Study||8||
59972378|NCT04941703|76089897|FG001|COMPLETED|Overall Study||10||
59972379|NCT04941703|76089896|FG000|NOT COMPLETED|Overall Study||0||
59812301|NCT03846453|75934622|FG001|COMPLETED|Randomized Treatment Period (Days 57±3)||291||
59812302|NCT03846453|75934623|FG002|COMPLETED|Randomized Treatment Period (Days 57±3)||294||
59812303|NCT03846453|75934621|FG000|NOT COMPLETED|Randomized Treatment Period (Days 57±3)||0||
59812304|NCT03846453|75934622|FG001|NOT COMPLETED|Randomized Treatment Period (Days 57±3)||27||
59812305|NCT03846453|75934623|FG002|NOT COMPLETED|Randomized Treatment Period (Days 57±3)||25||
59812306|NCT00444951|75934634|FG000|STARTED|Overall Study||145||
59972380|NCT04941703|76089897|FG001|NOT COMPLETED|Overall Study||0||
59972381|NCT04818242|76089905|FG000|STARTED|Overall Study||50||
59972382|NCT04818242|76089906|FG001|STARTED|Overall Study||50||
59972383|NCT04818242|76089905|FG000|COMPLETED|Overall Study||50||
59972384|NCT04818242|76089906|FG001|COMPLETED|Overall Study||47||
59972385|NCT04818242|76089905|FG000|NOT COMPLETED|Overall Study||0||
59972386|NCT04818242|76089906|FG001|NOT COMPLETED|Overall Study||3||
59972387|NCT04740814|76089912|FG000|STARTED|Overall Study||33||
59812307|NCT00444951|75934635|FG001|STARTED|Overall Study||142||
59812308|NCT00444951|75934636|FG002|STARTED|Overall Study||163||
59812309|NCT00444951|75934634|FG000|COMPLETED|Overall Study||140||
59972388|NCT04740814|76089912|FG000|COMPLETED|Overall Study||23||
59972389|NCT04740814|76089912|FG000|NOT COMPLETED|Overall Study||10||
59972390|NCT04683835|76089916|FG000|STARTED|Overall Study||80||
59972391|NCT04683835|76089916|FG000|COMPLETED|Overall Study||80||
59972392|NCT04683835|76089916|FG000|NOT COMPLETED|Overall Study||0||
59972393|NCT04652453|76089923|FG000|STARTED|Overall Study||50||
59972394|NCT04652453|76089924|FG001|STARTED|Overall Study||22||
59972395|NCT04652453|76089925|FG002|STARTED|Overall Study||11||
59972396|NCT04652453|76089923|FG000|COMPLETED|Overall Study||35||
59972397|NCT04652453|76089924|FG001|COMPLETED|Overall Study||15||
59972398|NCT04652453|76089925|FG002|COMPLETED|Overall Study||11||
59972399|NCT04652453|76089923|FG000|NOT COMPLETED|Overall Study||15||
59972400|NCT04652453|76089924|FG001|NOT COMPLETED|Overall Study||7||
59972401|NCT04652453|76089925|FG002|NOT COMPLETED|Overall Study||0||
59972402|NCT04624672|76089933|FG000|STARTED|Overall Study||2||
59972403|NCT04624672|76089934|FG001|STARTED|Overall Study||1||
59972404|NCT04624672|76089933|FG000|COMPLETED|Overall Study||0||
59972405|NCT04624672|76089934|FG001|COMPLETED|Overall Study||0||
59972406|NCT04624672|76089933|FG000|NOT COMPLETED|Overall Study||2||
59972407|NCT04624672|76089934|FG001|NOT COMPLETED|Overall Study||1||
59972408|NCT04565327|76089942|FG000|STARTED|Overall Study||0||
59972409|NCT04565327|76089943|FG001|STARTED|Overall Study||7||
59972410|NCT04565327|76089942|FG000|COMPLETED|Overall Study||0||
59972411|NCT04565327|76089943|FG001|COMPLETED|Overall Study||7||
59972412|NCT04565327|76089942|FG000|NOT COMPLETED|Overall Study||0||
59972413|NCT04565327|76089943|FG001|NOT COMPLETED|Overall Study||0||
59972414|NCT04491955|76089953|FG000|STARTED|Overall Study||12||
59972415|NCT04491955|76089954|FG001|STARTED|Overall Study||8||
59972416|NCT04491955|76089955|FG002|STARTED|Overall Study||6||
59972417|NCT04491955|76089956|FG003|STARTED|Overall Study||6||
59972418|NCT04491955|76089953|FG000|COMPLETED|Overall Study||12||
59972419|NCT04491955|76089954|FG001|COMPLETED|Overall Study||8||
59972420|NCT04491955|76089955|FG002|COMPLETED|Overall Study||6||
59972421|NCT04491955|76089956|FG003|COMPLETED|Overall Study||6||
59972422|NCT04491955|76089953|FG000|NOT COMPLETED|Overall Study||0||
59972423|NCT04491955|76089954|FG001|NOT COMPLETED|Overall Study||0||
59972424|NCT04491955|76089955|FG002|NOT COMPLETED|Overall Study||0||
59972425|NCT04491955|76089956|FG003|NOT COMPLETED|Overall Study||0||
59972426|NCT04476108|76089971|FG000|STARTED|Overall Study||84||
59972427|NCT04476108|76089972|FG001|STARTED|Overall Study||41||
59972428|NCT04476108|76089971|FG000|Received at Least 1 Dose of Study Drug|Overall Study||83||
59972429|NCT04476108|76089972|FG001|Received at Least 1 Dose of Study Drug|Overall Study||41||
59972430|NCT04476108|76089971|FG000|COMPLETED|Overall Study||76||
59972431|NCT04476108|76089972|FG001|COMPLETED|Overall Study||38||
59972432|NCT04476108|76089971|FG000|NOT COMPLETED|Overall Study||8||
59972433|NCT04476108|76089972|FG001|NOT COMPLETED|Overall Study||3||
59972434|NCT04456686|76089980|FG000|STARTED|Overall Study||78||
59972435|NCT04456686|76089981|FG001|STARTED|Overall Study||39||
59972436|NCT04456686|76089980|FG000|Received at Least 1 Dose of Study Drug|Overall Study||77||
59972437|NCT04456686|76089981|FG001|Received at Least 1 Dose of Study Drug|Overall Study||36||
59972438|NCT04456686|76089980|FG000|COMPLETED|Overall Study||63||
59972439|NCT04456686|76089981|FG001|COMPLETED|Overall Study||32||
59972440|NCT04456686|76089980|FG000|NOT COMPLETED|Overall Study||15||
59972441|NCT04456686|76089981|FG001|NOT COMPLETED|Overall Study||7||
59972442|NCT04396496|76089987|FG000|STARTED|Overall Study||2||
59972443|NCT04396496|76089987|FG000|COMPLETED|Overall Study||2||
59972444|NCT04396496|76089987|FG000|NOT COMPLETED|Overall Study||0||
59972445|NCT04365660|76089991|FG000|STARTED|Overall Study||1||
59972446|NCT04365660|76089991|FG000|Received PET/CT Scan|Overall Study||0||
59972447|NCT04365660|76089991|FG000|COMPLETED|Overall Study||0||
59972448|NCT04365660|76089991|FG000|NOT COMPLETED|Overall Study||1||
59972449|NCT04362670|76090000|FG000|STARTED|Overall Study||5||
59972450|NCT04362670|76090001|FG001|STARTED|Overall Study||42||
59972451|NCT04362670|76090002|FG002|STARTED|Overall Study||41||
59972452|NCT04362670|76090003|FG003|STARTED|Overall Study||43||
59972453|NCT04362670|76090004|FG004|STARTED|Overall Study||22||
59972454|NCT04362670|76090000|FG000|COMPLETED|Overall Study||5||
59972455|NCT04362670|76090001|FG001|COMPLETED|Overall Study||39||
59972456|NCT04362670|76090002|FG002|COMPLETED|Overall Study||39||
59972457|NCT04362670|76090003|FG003|COMPLETED|Overall Study||42||
60074500|NCT01769456|76189915|FG000|STARTED|Overall Study|1 subject inadvertently enrolled, discontin'd after baseline, re-enrolled later and completed study|78||
60074501|NCT01769456|76189915|FG000|COMPLETED|Overall Study||41||
59972458|NCT04362670|76090004|FG004|COMPLETED|Overall Study||22||
59972459|NCT04362670|76090000|FG000|NOT COMPLETED|Overall Study||0||
59972460|NCT04362670|76090001|FG001|NOT COMPLETED|Overall Study||3||
59972461|NCT04362670|76090002|FG002|NOT COMPLETED|Overall Study||2||
59972462|NCT04362670|76090003|FG003|NOT COMPLETED|Overall Study||1||
59972463|NCT04362670|76090004|FG004|NOT COMPLETED|Overall Study||0||
59972464|NCT04320069|76090016|FG000|STARTED|Phase 1: Omnipod Horizon™ Without CGM||25||
59972465|NCT04320069|76090016|FG000|COMPLETED|Phase 1: Omnipod Horizon™ Without CGM||25||
59972466|NCT04320069|76090016|FG000|NOT COMPLETED|Phase 1: Omnipod Horizon™ Without CGM||0||
59972467|NCT04320069|76090016|FG000|STARTED|Phase 2: Omnipod Horizon™ With CGM||25||
59972468|NCT04320069|76090016|FG000|COMPLETED|Phase 2: Omnipod Horizon™ With CGM||25||
60074502|NCT01769456|76189915|FG000|NOT COMPLETED|Overall Study||37||
59972469|NCT04320069|76090016|FG000|NOT COMPLETED|Phase 2: Omnipod Horizon™ With CGM||0||
59972470|NCT04269889|76090020|FG000|STARTED|Initial Phase (Day 0 to Month 6)||15||
59972471|NCT04269889|76090020|FG000|COMPLETED|Initial Phase (Day 0 to Month 6)||14||
59972472|NCT04269889|76090020|FG000|NOT COMPLETED|Initial Phase (Day 0 to Month 6)||1||
59972473|NCT04269889|76090020|FG000|STARTED|Extended Phase (6 Months to Year 3)||14||
59972474|NCT04269889|76090020|FG000|COMPLETED|Extended Phase (6 Months to Year 3)||1||
59972475|NCT04269889|76090020|FG000|NOT COMPLETED|Extended Phase (6 Months to Year 3)||13||
59972476|NCT04230941|76090029|FG000|STARTED|Overall Study||4||
59972477|NCT04230941|76090030|FG001|STARTED|Overall Study||1||
59972478|NCT04230941|76090029|FG000|COMPLETED|Overall Study|Enrollment paused for usability testing (2021). Usability testing met pre-established threshold (2021). Usability testing now determined complete (2022).|4||
59972479|NCT04230941|76090030|FG001|COMPLETED|Overall Study||1||
59972480|NCT04230941|76090029|FG000|NOT COMPLETED|Overall Study||0||
59972481|NCT04230941|76090030|FG001|NOT COMPLETED|Overall Study||0||
59972482|NCT04176731|76090036|FG000|STARTED|Overall Study||36||
60074503|NCT01769378|76189922|FG000|STARTED|Overall Study||240||
60074504|NCT01769378|76189923|FG001|STARTED|Overall Study||60||
59972483|NCT04176731|76090036|FG000|COMPLETED|Overall Study||36||
59972484|NCT04176731|76090036|FG000|NOT COMPLETED|Overall Study||0||
59972485|NCT04099251|76090042|FG000|STARTED|Pre-Treatment||526|Started=randomized|
59972486|NCT04099251|76090043|FG001|STARTED|Pre-Treatment||264|Started=randomized|
59972487|NCT04099251|76090042|FG000|COMPLETED|Pre-Treatment||524|Completed=treated|
59972488|NCT04099251|76090043|FG001|COMPLETED|Pre-Treatment||264|Completed=treated|
59972489|NCT04099251|76090042|FG000|NOT COMPLETED|Pre-Treatment||2||
59972490|NCT04099251|76090043|FG001|NOT COMPLETED|Pre-Treatment||0||
59972491|NCT04099251|76090042|FG000|STARTED|Blinded Treatment Phase||524||
59972492|NCT04099251|76090043|FG001|STARTED|Blinded Treatment Phase||264||
59972493|NCT04099251|76090042|FG000|COMPLETED|Blinded Treatment Phase||257||
59972494|NCT04099251|76090043|FG001|COMPLETED|Blinded Treatment Phase||158||
59972495|NCT04099251|76090042|FG000|NOT COMPLETED|Blinded Treatment Phase||267||
59972496|NCT04099251|76090043|FG001|NOT COMPLETED|Blinded Treatment Phase||106||
59972497|NCT04099251|76090042|FG000|STARTED|Optional Open-Label Phase Pre-Treatment||2|"Started=Number of participants enrolled in the open-label phase~Eligible participants received open-label Nivolumab treatment during a follow-up phase."|
59972498|NCT04099251|76090043|FG001|STARTED|Optional Open-Label Phase Pre-Treatment||30|"Started=Number of participants enrolled in the open-label phase~Eligible participants received open-label Nivolumab treatment during a follow-up phase."|
59972499|NCT04099251|76090042|FG000|COMPLETED|Optional Open-Label Phase Pre-Treatment||2|Completed=received treatment|
59972500|NCT04099251|76090043|FG001|COMPLETED|Optional Open-Label Phase Pre-Treatment||28|Completed=received treatment|
59972501|NCT04099251|76090042|FG000|NOT COMPLETED|Optional Open-Label Phase Pre-Treatment||0||
59972502|NCT04099251|76090043|FG001|NOT COMPLETED|Optional Open-Label Phase Pre-Treatment||2||
59972503|NCT04099251|76090042|FG000|STARTED|Optional Open-Label Phase Treatment||2|Started=received optional open-label treatment|
59972504|NCT04099251|76090043|FG001|STARTED|Optional Open-Label Phase Treatment||28|Started=received optional open-label treatment|
59972505|NCT04099251|76090042|FG000|COMPLETED|Optional Open-Label Phase Treatment||0||
59972506|NCT04099251|76090043|FG001|COMPLETED|Optional Open-Label Phase Treatment||3||
59972507|NCT04099251|76090042|FG000|NOT COMPLETED|Optional Open-Label Phase Treatment||2||
59972508|NCT04099251|76090043|FG001|NOT COMPLETED|Optional Open-Label Phase Treatment||25||
59972509|NCT04066491|76090053|FG000|STARTED|Overall Study||12||
59972510|NCT04066491|76090054|FG001|STARTED|Overall Study||149||
59972511|NCT04066491|76090055|FG002|STARTED|Overall Study||148||
59972512|NCT04066491|76090053|FG000|Treated|Overall Study||12||
59972513|NCT04066491|76090054|FG001|Treated|Overall Study||149||
59972514|NCT04066491|76090055|FG002|Treated|Overall Study||146||
59972515|NCT04066491|76090053|FG000|COMPLETED|Overall Study||12||
59972516|NCT04066491|76090054|FG001|COMPLETED|Overall Study||149||
59972517|NCT04066491|76090055|FG002|COMPLETED|Overall Study||146||
59972518|NCT04066491|76090053|FG000|NOT COMPLETED|Overall Study||0||
59972519|NCT04066491|76090054|FG001|NOT COMPLETED|Overall Study||0||
59972520|NCT04066491|76090055|FG002|NOT COMPLETED|Overall Study||2||
59972521|NCT03892642|76090064|FG000|STARTED|Overall Study||18||
59622022|NCT00381810|75733785|FG000|NOT COMPLETED|B Cell Follow-up||7||
59622023|NCT00458952|75733791|FG000|STARTED|Overall Study||7||
59622024|NCT00458952|75733792|FG001|STARTED|Overall Study||14||
59622025|NCT00458952|75733791|FG000|COMPLETED|Overall Study||5||
59622026|NCT00458952|75733792|FG001|COMPLETED|Overall Study||9||
59972522|NCT03892642|76090064|FG000|COMPLETED|Overall Study||18||
59972523|NCT03892642|76090064|FG000|NOT COMPLETED|Overall Study||0||
59972524|NCT03883828|76090070|FG000|STARTED|Overall Study||40||
59972525|NCT03883828|76090071|FG001|STARTED|Overall Study||40||
59972526|NCT03883828|76090070|FG000|COMPLETED|Overall Study||39||
59972527|NCT03883828|76090071|FG001|COMPLETED|Overall Study||38||
59972528|NCT03883828|76090070|FG000|NOT COMPLETED|Overall Study||1||
59972529|NCT03883828|76090071|FG001|NOT COMPLETED|Overall Study||2||
59972530|NCT03844269|76090077|FG000|STARTED|Overall Study||28||
59972531|NCT03844269|76090077|FG000|COMPLETED|Overall Study||25||
59972532|NCT03844269|76090077|FG000|NOT COMPLETED|Overall Study||3||
59972533|NCT03805100|76090085|FG000|STARTED|Overall Study|Number of participants randomized to Xlucane.|292||
59972534|NCT03805100|76090086|FG001|STARTED|Overall Study|Number of participants randomized to Lucentis.|290||
59972535|NCT03805100|76090085|FG000|COMPLETED|Overall Study|Number of participants completing the treatment per protocol.|245||
59972536|NCT03805100|76090086|FG001|COMPLETED|Overall Study|Number of participants completing the treatment per protocol.|241||
59972537|NCT03805100|76090085|FG000|NOT COMPLETED|Overall Study||47||
59972538|NCT03805100|76090086|FG001|NOT COMPLETED|Overall Study||49||
59972539|NCT03777917|76090094|FG000|STARTED|Overall Study||43||
59622027|NCT00458952|75733791|FG000|NOT COMPLETED|Overall Study||2||
59622028|NCT00458952|75733792|FG001|NOT COMPLETED|Overall Study||5||
59972540|NCT03777917|76090095|FG001|STARTED|Overall Study||23||
59972541|NCT03777917|76090094|FG000|Safety Population|Overall Study||43|1 participant randomized into treatment group did not receive any treatment and was excluded from the safety population, and 1 participant randomized into the untreated group received Belotero Balance®.|
59622029|NCT00459732|75733798|FG000|STARTED|Overall Study||23||
59622030|NCT00459732|75733799|FG001|STARTED|Overall Study||17||
59622031|NCT00459732|75733798|FG000|COMPLETED|Overall Study|4 on zn dropped: 1 pregnant and 1 nausea after baseline, 1 lost to followup, 1 exited after 12 month|19||
59622032|NCT00459732|75733799|FG001|COMPLETED|Overall Study|3 on placebo dropped: 1 pregnant after 12 mo, 1 lost to followup, one died after 12 month timepoint|14||
59972542|NCT03777917|76090095|FG001|Safety Population|Overall Study||22|1 participant randomized into treatment group did not receive any treatment and was excluded from the safety population, and 1 participant randomized into the untreated group received Belotero Balance®.|
59972543|NCT03777917|76090094|FG000|COMPLETED|Overall Study||34||
59972544|NCT03777917|76090095|FG001|COMPLETED|Overall Study||21||
59972545|NCT03777917|76090094|FG000|NOT COMPLETED|Overall Study||9||
59972546|NCT03777917|76090095|FG001|NOT COMPLETED|Overall Study||2||
59972547|NCT03594123|76090104|FG000|STARTED|Overall Study||163||
59972548|NCT03594123|76090105|FG001|STARTED|Overall Study||96||
59972549|NCT03594123|76090104|FG000|Efficacy Sample:|Overall Study||159|Efficacy sample comprised of all participants in the safety sample who have a baseline assessment and at least one postbaseline assessment for cohen-mansfield agitation inventory (CMAI) total score.|
59972550|NCT03594123|76090105|FG001|Efficacy Sample:|Overall Study||95|Efficacy sample comprised of all participants in the safety sample who have a baseline assessment and at least one postbaseline assessment for cohen-mansfield agitation inventory (CMAI) total score.|
59972551|NCT03594123|76090104|FG000|COMPLETED|Overall Study||142||
59972552|NCT03594123|76090105|FG001|COMPLETED|Overall Study||87||
59972553|NCT03594123|76090104|FG000|NOT COMPLETED|Overall Study||21||
59972554|NCT03594123|76090105|FG001|NOT COMPLETED|Overall Study||9||
59972555|NCT03583359|76090113|FG000|STARTED|Overall Study||123||
59972556|NCT03583359|76090114|FG001|STARTED|Overall Study||57||
59972557|NCT03583359|76090113|FG000|Treated Participants|Overall Study||122||
59972558|NCT03583359|76090114|FG001|Treated Participants|Overall Study||53||
59972559|NCT03583359|76090113|FG000|COMPLETED|Overall Study||94||
59972560|NCT03583359|76090114|FG001|COMPLETED|Overall Study||45||
59972561|NCT03583359|76090113|FG000|NOT COMPLETED|Overall Study||29||
59972562|NCT03583359|76090114|FG001|NOT COMPLETED|Overall Study||12||
59972563|NCT03537651|76090120|FG000|STARTED|Overall Study||130||
59972564|NCT03537651|76090120|FG000|113B/116 FAS|Overall Study||64|All enrolled participants from parent Study 113B who received at least 1 dose of TEZ/IVA in Study 116 and had an eligible genotype.|
59972565|NCT03537651|76090120|FG000|113B/116 LCI FAS|Overall Study||30|All enrolled participants who participated in the LCI sub study in parent Study 113B and received at least 1 dose of TEZ/IVA in Study 116 and had an eligible genotype.|
59972566|NCT03537651|76090120|FG000|115/116 FAS|Overall Study||66|All enrolled participants who were randomized to either TEZ/IVA, IVA or placebo treatment group in parent Study 115 and received at least 1 dose of TEZ/IVA in Study 116 and had an eligible genotype.|
59972567|NCT03537651|76090120|FG000|115/116 FAS (TEZ/IVA Group)|Overall Study||53|All enrolled participants who were randomized to the TEZ/IVA treatment group in parent Study 115 and received at least 1 dose of TEZ/IVA in Study 116 and had an eligible genotype.|
59972568|NCT03537651|76090120|FG000|COMPLETED|Overall Study||69||
59972569|NCT03537651|76090120|FG000|NOT COMPLETED|Overall Study||61||
59972570|NCT03506438|76090133|FG000|STARTED|Overall Study||55||
59972571|NCT03506438|76090134|FG001|STARTED|Overall Study||56||
59972572|NCT03506438|76090135|FG002|STARTED|Overall Study||55||
59972573|NCT03506438|76090136|FG003|STARTED|Overall Study||56||
59972574|NCT03506438|76090137|FG004|STARTED|Overall Study||19||
59972575|NCT03506438|76090138|FG005|STARTED|Overall Study||18||
59972576|NCT03506438|76090133|FG000|COMPLETED|Overall Study||47||
60074505|NCT01769378|76189922|FG000|Received at Least 1 Dose of Study Drug|Overall Study||239||
59525527|NCT03497897|75620903|FG002|COMPLETED|Overall Study||23|Participants who completed the study|
59525528|NCT03497897|75620901|FG000|NOT COMPLETED|Overall Study||6||
59525529|NCT03497897|75620902|FG001|NOT COMPLETED|Overall Study||2||
59525530|NCT03497897|75620903|FG002|NOT COMPLETED|Overall Study||6||
59525531|NCT03428217|75620914|FG000|STARTED|Overall Study||223||
59525532|NCT03428217|75620915|FG001|STARTED|Overall Study||221||
59525533|NCT03428217|75620914|FG000|Received at Least 1 Dose of Study Drug|Overall Study||221||
59525534|NCT03428217|75620915|FG001|Received at Least 1 Dose of Study Drug|Overall Study||221||
59525535|NCT03428217|75620914|FG000|COMPLETED|Overall Study||0|Participants received study treatment until disease progression or unacceptable toxicity, whichever occurred first.|
59525536|NCT03428217|75620915|FG001|COMPLETED|Overall Study||0|Participants received study treatment until disease progression or unacceptable toxicity, whichever occurred first.|
59525537|NCT03428217|75620914|FG000|NOT COMPLETED|Overall Study||223||
59525538|NCT03428217|75620915|FG001|NOT COMPLETED|Overall Study||221||
59525539|NCT03189719|75620925|FG000|STARTED|Overall Study||373||
59525540|NCT03189719|75620926|FG001|STARTED|Overall Study||376||
59525541|NCT03189719|75620925|FG000|Treated|Overall Study||370||
59622033|NCT00459732|75733798|FG000|NOT COMPLETED|Overall Study||4||
59622034|NCT00459732|75733799|FG001|NOT COMPLETED|Overall Study||3||
59622035|NCT00459810|75733805|FG000|STARTED|Overall Study||21||
59622036|NCT00459810|75733805|FG000|COMPLETED|Overall Study||21||
59622037|NCT00459810|75733805|FG000|NOT COMPLETED|Overall Study||0||
59622038|NCT00405522|75733811|FG000|STARTED|Overall Study||17||
59972577|NCT03506438|76090134|FG001|COMPLETED|Overall Study||49||
59972578|NCT03506438|76090135|FG002|COMPLETED|Overall Study||47||
60103603|NCT01291108|76221866|FG003|STARTED|Month 1 (Monotherapy)||60||
59525542|NCT03189719|75620926|FG001|Treated|Overall Study||370||
59525543|NCT03189719|75620925|FG000|COMPLETED|Overall Study||0||
59525544|NCT03189719|75620926|FG001|COMPLETED|Overall Study||0||
59525545|NCT03189719|75620925|FG000|NOT COMPLETED|Overall Study||373||
59525546|NCT03189719|75620926|FG001|NOT COMPLETED|Overall Study||376||
59525547|NCT02969525|75620937|FG000|STARTED|Double-Blind Period||42||
59812310|NCT00444951|75934635|FG001|COMPLETED|Overall Study||136||
59622039|NCT00405522|75733812|FG001|STARTED|Overall Study||17||
59622040|NCT00405522|75733811|FG000|COMPLETED|Overall Study||17||
59622041|NCT00405522|75733812|FG001|COMPLETED|Overall Study||17||
59972579|NCT03506438|76090136|FG003|COMPLETED|Overall Study||49||
59972580|NCT03506438|76090137|FG004|COMPLETED|Overall Study||19||
59972581|NCT03506438|76090138|FG005|COMPLETED|Overall Study||18||
59972582|NCT03506438|76090133|FG000|NOT COMPLETED|Overall Study||8||
59972583|NCT03506438|76090134|FG001|NOT COMPLETED|Overall Study||7||
59972584|NCT03506438|76090135|FG002|NOT COMPLETED|Overall Study||8||
59972585|NCT03506438|76090136|FG003|NOT COMPLETED|Overall Study||7||
59972586|NCT03506438|76090137|FG004|NOT COMPLETED|Overall Study||0||
59972587|NCT03506438|76090138|FG005|NOT COMPLETED|Overall Study||0||
59972588|NCT03493542|76090151|FG000|STARTED|Overall Study||383||
59972589|NCT03493542|76090152|FG001|STARTED|Overall Study||383||
59972590|NCT03493542|76090151|FG000|Vaccination 1|Overall Study||383||
59972591|NCT03493542|76090152|FG001|Vaccination 1|Overall Study||383||
59972592|NCT03493542|76090151|FG000|Vaccination 2|Overall Study||379||
59972593|NCT03493542|76090152|FG001|Vaccination 2|Overall Study||378||
59972594|NCT03493542|76090151|FG000|Vaccination 3|Overall Study||376||
59972595|NCT03493542|76090152|FG001|Vaccination 3|Overall Study||374||
59972596|NCT03493542|76090151|FG000|COMPLETED|Overall Study||376||
59972597|NCT03493542|76090152|FG001|COMPLETED|Overall Study||374||
59972598|NCT03493542|76090151|FG000|NOT COMPLETED|Overall Study||7||
59972599|NCT03493542|76090152|FG001|NOT COMPLETED|Overall Study||9||
59972600|NCT03476798|76090158|FG000|STARTED|Overall Study||33||
59972601|NCT03476798|76090158|FG000|COMPLETED|Overall Study||28||
59972602|NCT03476798|76090158|FG000|NOT COMPLETED|Overall Study||5||
59972603|NCT03473015|76090165|FG000|STARTED|Overall Study||25||
59972604|NCT03473015|76090166|FG001|STARTED|Overall Study||30||
59972605|NCT03473015|76090167|FG002|STARTED|Overall Study||50||
59972606|NCT03473015|76090165|FG000|Post-stenting IMR|Overall Study||25||
59972607|NCT03473015|76090166|FG001|Post-stenting IMR|Overall Study||30||
59972608|NCT03473015|76090167|FG002|Post-stenting IMR|Overall Study||50||
59972609|NCT03473015|76090165|FG000|IMR Reassessment 24-48 Hours Post-PCI|Overall Study||20||
59972610|NCT03473015|76090166|FG001|IMR Reassessment 24-48 Hours Post-PCI|Overall Study|IMR was not reassessed in this group as the pre-stent IMR was equal or less than 40 units|0||
59972611|NCT03473015|76090167|FG002|IMR Reassessment 24-48 Hours Post-PCI|Overall Study||31||
59972612|NCT03473015|76090165|FG000|Acute Cardiac MRI Within 24 Hours|Overall Study||17||
59972613|NCT03473015|76090166|FG001|Acute Cardiac MRI Within 24 Hours|Overall Study||17||
59972614|NCT03473015|76090167|FG002|Acute Cardiac MRI Within 24 Hours|Overall Study||29||
59972615|NCT03473015|76090165|FG000|Cardiac MRI at 6 Months|Overall Study||14||
59972616|NCT03473015|76090166|FG001|Cardiac MRI at 6 Months|Overall Study||16||
59972617|NCT03473015|76090167|FG002|Cardiac MRI at 6 Months|Overall Study||24||
59972618|NCT03473015|76090165|FG000|COMPLETED|Overall Study||25||
59972619|NCT03473015|76090166|FG001|COMPLETED|Overall Study||30||
59972620|NCT03473015|76090167|FG002|COMPLETED|Overall Study||50||
59972621|NCT03473015|76090165|FG000|NOT COMPLETED|Overall Study||0||
59972622|NCT03473015|76090166|FG001|NOT COMPLETED|Overall Study||0||
59972623|NCT03473015|76090167|FG002|NOT COMPLETED|Overall Study||0||
59972624|NCT03459625|76090178|FG000|STARTED|Overall Study||60||
59972625|NCT03459625|76090179|FG001|STARTED|Overall Study||58||
59972626|NCT03459625|76090178|FG000|COMPLETED|Overall Study||59||
59972627|NCT03459625|76090179|FG001|COMPLETED|Overall Study||58||
59972628|NCT03459625|76090178|FG000|NOT COMPLETED|Overall Study||1||
59972629|NCT03459625|76090179|FG001|NOT COMPLETED|Overall Study||0||
59972630|NCT03366337|76090189|FG000|STARTED|Overall Study||31||
59972631|NCT03366337|76090190|FG001|STARTED|Overall Study||26||
59972632|NCT03366337|76090191|FG002|STARTED|Overall Study||28||
59972633|NCT03366337|76090192|FG003|STARTED|Overall Study||18||
59622042|NCT00405522|75733811|FG000|NOT COMPLETED|Overall Study||0||
59622043|NCT00405522|75733812|FG001|NOT COMPLETED|Overall Study||0||
59622044|NCT00381966|75733818|FG000|STARTED|Overall Study||5||
59622045|NCT00381966|75733818|FG000|COMPLETED|Overall Study||5||
59622046|NCT00381966|75733818|FG000|NOT COMPLETED|Overall Study||0||
59622047|NCT00461292|75733825|FG000|STARTED|Treatment Cycle 1||91||
59622048|NCT00461292|75733826|FG001|STARTED|Treatment Cycle 1||92||
59972634|NCT03366337|76090189|FG000|COMPLETED|Overall Study||28||
59972635|NCT03366337|76090190|FG001|COMPLETED|Overall Study||26||
59972636|NCT03366337|76090191|FG002|COMPLETED|Overall Study||26||
59972637|NCT03366337|76090192|FG003|COMPLETED|Overall Study||17||
59972638|NCT03366337|76090189|FG000|NOT COMPLETED|Overall Study||3||
59972639|NCT03366337|76090190|FG001|NOT COMPLETED|Overall Study||0||
59972640|NCT03366337|76090191|FG002|NOT COMPLETED|Overall Study||2||
59972641|NCT03366337|76090192|FG003|NOT COMPLETED|Overall Study||1||
59972642|NCT03350906|76090204|FG000|STARTED|Overall Study||30||
59972643|NCT03350906|76090205|FG001|STARTED|Overall Study||33||
59972644|NCT03350906|76090204|FG000|COMPLETED|Overall Study||30||
59972645|NCT03350906|76090205|FG001|COMPLETED|Overall Study||33||
59972646|NCT03350906|76090204|FG000|NOT COMPLETED|Overall Study||0||
59622049|NCT00461292|75733827|FG002|STARTED|Treatment Cycle 1||92||
59972647|NCT03350906|76090205|FG001|NOT COMPLETED|Overall Study||0||
59972648|NCT03253744|76090215|FG000|STARTED|SBRT Treatment||6||
59972649|NCT03253744|76090216|FG001|STARTED|SBRT Treatment||2||
59972650|NCT03253744|76090217|FG002|STARTED|SBRT Treatment||3||
59972651|NCT03253744|76090218|FG003|STARTED|SBRT Treatment||6||
59972652|NCT03253744|76090215|FG000|COMPLETED|SBRT Treatment||6||
59972653|NCT03253744|76090216|FG001|COMPLETED|SBRT Treatment||2||
59972654|NCT03253744|76090217|FG002|COMPLETED|SBRT Treatment||3||
59972655|NCT03253744|76090218|FG003|COMPLETED|SBRT Treatment||6||
59972656|NCT03253744|76090215|FG000|NOT COMPLETED|SBRT Treatment||0||
59812311|NCT00444951|75934636|FG002|COMPLETED|Overall Study||160||
59812312|NCT00444951|75934634|FG000|NOT COMPLETED|Overall Study||5||
59812313|NCT00444951|75934635|FG001|NOT COMPLETED|Overall Study||6||
59972657|NCT03253744|76090216|FG001|NOT COMPLETED|SBRT Treatment||0||
59972658|NCT03253744|76090217|FG002|NOT COMPLETED|SBRT Treatment||0||
59972659|NCT03253744|76090218|FG003|NOT COMPLETED|SBRT Treatment||0||
59972660|NCT03253744|76090215|FG000|STARTED|Completed Dose-Limiting Toxicity Assess.||6||
59972661|NCT03253744|76090216|FG001|STARTED|Completed Dose-Limiting Toxicity Assess.||2||
59972662|NCT03253744|76090217|FG002|STARTED|Completed Dose-Limiting Toxicity Assess.||3||
59972663|NCT03253744|76090218|FG003|STARTED|Completed Dose-Limiting Toxicity Assess.||6||
59972664|NCT03253744|76090215|FG000|COMPLETED|Completed Dose-Limiting Toxicity Assess.||6||
59972665|NCT03253744|76090216|FG001|COMPLETED|Completed Dose-Limiting Toxicity Assess.||2||
59972666|NCT03253744|76090217|FG002|COMPLETED|Completed Dose-Limiting Toxicity Assess.||3||
59972667|NCT03253744|76090218|FG003|COMPLETED|Completed Dose-Limiting Toxicity Assess.||6||
59972668|NCT03253744|76090215|FG000|NOT COMPLETED|Completed Dose-Limiting Toxicity Assess.||0||
59972669|NCT03253744|76090216|FG001|NOT COMPLETED|Completed Dose-Limiting Toxicity Assess.||0||
59972670|NCT03253744|76090217|FG002|NOT COMPLETED|Completed Dose-Limiting Toxicity Assess.||0||
59972671|NCT03253744|76090218|FG003|NOT COMPLETED|Completed Dose-Limiting Toxicity Assess.||0||
59972672|NCT03253744|76090215|FG000|STARTED|Completion of Follow-Up||6||
59972673|NCT03253744|76090216|FG001|STARTED|Completion of Follow-Up||2||
59972674|NCT03253744|76090217|FG002|STARTED|Completion of Follow-Up||3||
59972675|NCT03253744|76090218|FG003|STARTED|Completion of Follow-Up||6||
59972676|NCT03253744|76090215|FG000|COMPLETED|Completion of Follow-Up||4||
59972677|NCT03253744|76090216|FG001|COMPLETED|Completion of Follow-Up||2||
59972678|NCT03253744|76090217|FG002|COMPLETED|Completion of Follow-Up||3||
59972679|NCT03253744|76090218|FG003|COMPLETED|Completion of Follow-Up||2||
59972680|NCT03253744|76090215|FG000|NOT COMPLETED|Completion of Follow-Up||2||
59972681|NCT03253744|76090216|FG001|NOT COMPLETED|Completion of Follow-Up||0||
59972682|NCT03253744|76090217|FG002|NOT COMPLETED|Completion of Follow-Up||0||
59972683|NCT03253744|76090218|FG003|NOT COMPLETED|Completion of Follow-Up||4||
59972684|NCT03232736|76090232|FG000|STARTED|Overall Study||9||
59972685|NCT03232736|76090233|FG001|STARTED|Overall Study||13||
59972686|NCT03232736|76090232|FG000|COMPLETED|Overall Study||9||
59972687|NCT03232736|76090233|FG001|COMPLETED|Overall Study||13||
59972688|NCT03232736|76090232|FG000|NOT COMPLETED|Overall Study||0||
59972689|NCT03232736|76090233|FG001|NOT COMPLETED|Overall Study||0||
59972690|NCT03104400|76090247|FG000|STARTED|Overall Study||211||
59812314|NCT00444951|75934636|FG002|NOT COMPLETED|Overall Study||3||
59812315|NCT00444795|75934644|FG000|STARTED|Overall Study||620||
59812316|NCT00444795|75934644|FG000|COMPLETED|Overall Study|Refer to the Safety Analysis Set.|617||
59812317|NCT00444795|75934644|FG000|NOT COMPLETED|Overall Study||3||
59812318|NCT03846219|75934651|FG000|STARTED|Overall Study||72|Patients randomized|
59812319|NCT03846219|75934652|FG001|STARTED|Overall Study||69|Patients randomized|
59812320|NCT03846219|75934653|FG002|STARTED|Overall Study||69|Patients randomized|
59812321|NCT03846219|75934651|FG000|Patients Treated|Overall Study||71||
59812322|NCT03846219|75934652|FG001|Patients Treated|Overall Study||69||
59812323|NCT03846219|75934653|FG002|Patients Treated|Overall Study||69||
59972691|NCT03104400|76090248|FG001|STARTED|Overall Study||212||
59972692|NCT03104400|76090249|FG002|STARTED|Overall Study||429||
59972693|NCT03104400|76090250|FG003|STARTED|Overall Study||430||
59972694|NCT03104400|76090251|FG004|STARTED|Overall Study||423||
59972695|NCT03104400|76090247|FG000|Received Study Drug|Overall Study||211||
59972696|NCT03104400|76090248|FG001|Received Study Drug|Overall Study||212||
59972697|NCT03104400|76090249|FG002|Received Study Drug|Overall Study||429||
59972698|NCT03104400|76090250|FG003|Received Study Drug|Overall Study||429||
59972699|NCT03104400|76090251|FG004|Received Study Drug|Overall Study||423||
59972700|NCT03104400|76090247|FG000|Completed Week 24|Overall Study||190||
59972701|NCT03104400|76090248|FG001|Completed Week 24|Overall Study||193||
59972702|NCT03104400|76090249|FG002|Completed Week 24|Overall Study||404||
59972703|NCT03104400|76090250|FG003|Completed Week 24|Overall Study||408||
59812324|NCT03846219|75934651|FG000|COMPLETED|Overall Study||69||
59972704|NCT03104400|76090251|FG004|Completed Week 24|Overall Study||394||
59972705|NCT03104400|76090247|FG000|COMPLETED|Overall Study||177|Completed Week 56 (Period 1)|
59972706|NCT03104400|76090248|FG001|COMPLETED|Overall Study||178|Completed Week 56 (Period 1)|
59972707|NCT03104400|76090249|FG002|COMPLETED|Overall Study||370|Completed Week 56 (Period 1)|
59812325|NCT03846219|75934652|FG001|COMPLETED|Overall Study||65||
59812326|NCT03846219|75934653|FG002|COMPLETED|Overall Study||64||
59812327|NCT03846219|75934651|FG000|NOT COMPLETED|Overall Study||3||
59994950|NCT03269695|76110761|FG001|NOT COMPLETED|Overall Study||3||
59812328|NCT03846219|75934652|FG001|NOT COMPLETED|Overall Study||4||
59812329|NCT03846219|75934653|FG002|NOT COMPLETED|Overall Study||5||
59812330|NCT00455325|75934669|FG000|STARTED|Cohort 1: Placebo||35||
59972708|NCT03104400|76090250|FG003|COMPLETED|Overall Study||379|Completed Week 56 (Period 1)|
59972709|NCT03104400|76090251|FG004|COMPLETED|Overall Study||366|Completed Week 56 (Period 1)|
59972710|NCT03104400|76090247|FG000|NOT COMPLETED|Overall Study||34||
59972711|NCT03104400|76090248|FG001|NOT COMPLETED|Overall Study||34||
59972712|NCT03104400|76090249|FG002|NOT COMPLETED|Overall Study||59||
59972713|NCT03104400|76090250|FG003|NOT COMPLETED|Overall Study||51||
59972714|NCT03104400|76090251|FG004|NOT COMPLETED|Overall Study||57||
59972715|NCT03053453|76090267|FG000|STARTED|Overall Study||26||
59972716|NCT03053453|76090268|FG001|STARTED|Overall Study||26||
59972717|NCT03053453|76090267|FG000|COMPLETED|Overall Study||26||
59972718|NCT03053453|76090268|FG001|COMPLETED|Overall Study||26||
59972719|NCT03053453|76090267|FG000|NOT COMPLETED|Overall Study||0||
59972720|NCT03053453|76090268|FG001|NOT COMPLETED|Overall Study||0||
59972721|NCT03034044|76090274|FG000|STARTED|Overall Study||106||
59972722|NCT03034044|76090274|FG000|Received Xyntha|Overall Study||105||
59972723|NCT03034044|76090274|FG000|COMPLETED|Overall Study||105||
59972724|NCT03034044|76090274|FG000|NOT COMPLETED|Overall Study||1||
59972725|NCT02878798|76090280|FG000|STARTED|Overall Study||66||
59972726|NCT02878798|76090281|FG001|STARTED|Overall Study||66||
59972727|NCT02878798|76090280|FG000|COMPLETED|Overall Study||59||
59972728|NCT02878798|76090281|FG001|COMPLETED|Overall Study||59||
59972729|NCT02878798|76090280|FG000|NOT COMPLETED|Overall Study||7||
59972730|NCT02878798|76090281|FG001|NOT COMPLETED|Overall Study||7||
59972731|NCT02854436|76090287|FG000|STARTED|Overall Study||289||
59972732|NCT02854436|76090287|FG000|Intent to Treat Participants (Breast Cancer Gene [BRCA] and Non-BRCA Participants)|Overall Study|There were 142 BRCA participants and 81 non-BRCA participants.|223||
59972733|NCT02854436|76090287|FG000|COMPLETED|Overall Study||0||
59972734|NCT02854436|76090287|FG000|NOT COMPLETED|Overall Study||289||
59972735|NCT02741193|76090291|FG000|STARTED|Overall Study||2||
59972736|NCT02741193|76090291|FG000|COMPLETED|Overall Study||0||
59972737|NCT02741193|76090291|FG000|NOT COMPLETED|Overall Study||2||
59972738|NCT02725177|76090295|FG000|STARTED|Overall Study||9||
59972739|NCT02725177|76090295|FG000|COMPLETED|Overall Study||4||
59972740|NCT02725177|76090295|FG000|NOT COMPLETED|Overall Study||5||
59972741|NCT02488759|76090305|FG000|STARTED|Overall Study||113|Started = treated|
59972742|NCT02488759|76090306|FG001|STARTED|Overall Study||195|Started = treated|
59972743|NCT02488759|76090307|FG002|STARTED|Overall Study||133|Started = treated|
60074506|NCT01769378|76189923|FG001|Received at Least 1 Dose of Study Drug|Overall Study||60||
60074507|NCT01769378|76189922|FG000|COMPLETED|Overall Study|Completed the study on study treatment|215||
59812331|NCT00455325|75934670|FG001|STARTED|Cohort 1: Placebo||0||
59812332|NCT00455325|75934671|FG002|STARTED|Cohort 1: Placebo||0||
59812333|NCT00455325|75934672|FG003|STARTED|Cohort 1: Placebo||0||
59812334|NCT00455325|75934669|FG000|COMPLETED|Cohort 1: Placebo||27||
59812335|NCT00455325|75934670|FG001|COMPLETED|Cohort 1: Placebo||0||
59812336|NCT00455325|75934671|FG002|COMPLETED|Cohort 1: Placebo||0||
59812337|NCT00455325|75934672|FG003|COMPLETED|Cohort 1: Placebo||0||
59812338|NCT00455325|75934669|FG000|NOT COMPLETED|Cohort 1: Placebo||8||
59972744|NCT02488759|76090308|FG003|STARTED|Overall Study||8|Started = treated|
59972745|NCT02488759|76090309|FG004|STARTED|Overall Study||6|Started = treated|
59972746|NCT02488759|76090310|FG005|STARTED|Overall Study||123|Started = treated|
59972747|NCT02488759|76090305|FG000|COMPLETED|Overall Study||0|Completed = completed the treatment period|
59972748|NCT02488759|76090306|FG001|COMPLETED|Overall Study||0|Completed = completed the treatment period|
59972749|NCT02488759|76090307|FG002|COMPLETED|Overall Study||0|Completed = completed the treatment period|
59972750|NCT02488759|76090308|FG003|COMPLETED|Overall Study||0|Completed = completed the treatment period|
59972751|NCT02488759|76090309|FG004|COMPLETED|Overall Study||0|Completed = completed the treatment period|
59972752|NCT02488759|76090310|FG005|COMPLETED|Overall Study||116|Completed = completed the treatment period|
59972753|NCT02488759|76090305|FG000|NOT COMPLETED|Overall Study||113||
59972754|NCT02488759|76090306|FG001|NOT COMPLETED|Overall Study||195||
59972755|NCT02488759|76090307|FG002|NOT COMPLETED|Overall Study||133||
59972756|NCT02488759|76090308|FG003|NOT COMPLETED|Overall Study||8||
59972757|NCT02488759|76090309|FG004|NOT COMPLETED|Overall Study||6||
59972758|NCT02488759|76090310|FG005|NOT COMPLETED|Overall Study||7||
59972759|NCT02466685|76090326|FG000|STARTED|Overall Study||30||
59972760|NCT02466685|76090327|FG001|STARTED|Overall Study||30||
59972761|NCT02466685|76090326|FG000|COMPLETED|Overall Study||22||
59972762|NCT02466685|76090327|FG001|COMPLETED|Overall Study||26||
59972763|NCT02466685|76090326|FG000|NOT COMPLETED|Overall Study||8||
59972764|NCT02466685|76090327|FG001|NOT COMPLETED|Overall Study||4||
59972765|NCT02312206|76090338|FG000|STARTED|Overall Study||130||
59972766|NCT02312206|76090339|FG001|STARTED|Overall Study||130||
59972767|NCT02312206|76090338|FG000|Informed Consent Obtained|Overall Study||130||
59972768|NCT02312206|76090339|FG001|Informed Consent Obtained|Overall Study||130||
59812339|NCT00455325|75934670|FG001|NOT COMPLETED|Cohort 1: Placebo||0||
59812340|NCT00455325|75934671|FG002|NOT COMPLETED|Cohort 1: Placebo||0||
59972769|NCT02312206|76090338|FG000|COMPLETED|Overall Study||0||
59972770|NCT02312206|76090339|FG001|COMPLETED|Overall Study||0||
59812341|NCT00455325|75934672|FG003|NOT COMPLETED|Cohort 1: Placebo||0||
59972771|NCT02312206|76090338|FG000|NOT COMPLETED|Overall Study||130||
60074508|NCT01769378|76189923|FG001|COMPLETED|Overall Study|Completed the study on study treatment|56||
59972772|NCT02312206|76090339|FG001|NOT COMPLETED|Overall Study||130||
59972773|NCT02264665|76090350|FG000|STARTED|Overall Study||35||
59972774|NCT02264665|76090351|FG001|STARTED|Overall Study||23||
59972775|NCT02264665|76090352|FG002|STARTED|Overall Study||52||
59972776|NCT02264665|76090353|FG003|STARTED|Overall Study||30||
59972777|NCT02264665|76090354|FG004|STARTED|Overall Study||1||
59972778|NCT02264665|76090355|FG005|STARTED|Overall Study||0||
59972779|NCT02264665|76090356|FG006|STARTED|Overall Study||3||
59972780|NCT02264665|76090350|FG000|Reference Set (Full Analysis Set)|Overall Study||32||
59972781|NCT02264665|76090351|FG001|Reference Set (Full Analysis Set)|Overall Study||23||
59972782|NCT02264665|76090352|FG002|Reference Set (Full Analysis Set)|Overall Study||50||
59972783|NCT02264665|76090353|FG003|Reference Set (Full Analysis Set)|Overall Study||28||
59972784|NCT02264665|76090354|FG004|Reference Set (Full Analysis Set)|Overall Study||1||
59972785|NCT02264665|76090355|FG005|Reference Set (Full Analysis Set)|Overall Study||0||
59972786|NCT02264665|76090356|FG006|Reference Set (Full Analysis Set)|Overall Study||0||
59972787|NCT02264665|76090350|FG000|Safety Set|Overall Study||35||
59972788|NCT02264665|76090351|FG001|Safety Set|Overall Study||23||
59972789|NCT02264665|76090352|FG002|Safety Set|Overall Study||52||
59972790|NCT02264665|76090353|FG003|Safety Set|Overall Study||30||
59972791|NCT02264665|76090354|FG004|Safety Set|Overall Study||1||
59972792|NCT02264665|76090355|FG005|Safety Set|Overall Study||0||
59972793|NCT02264665|76090356|FG006|Safety Set|Overall Study||0||
59972794|NCT02264665|76090350|FG000|COMPLETED|Overall Study||22||
59972795|NCT02264665|76090351|FG001|COMPLETED|Overall Study||15||
59972796|NCT02264665|76090352|FG002|COMPLETED|Overall Study||31||
59972797|NCT02264665|76090353|FG003|COMPLETED|Overall Study||21||
59972798|NCT02264665|76090354|FG004|COMPLETED|Overall Study||1||
59972799|NCT02264665|76090355|FG005|COMPLETED|Overall Study||0||
59812342|NCT00455325|75934669|FG000|STARTED|Cohort 2: 80 mg Chloroquine Weekly||0||
59812343|NCT00455325|75934670|FG001|STARTED|Cohort 2: 80 mg Chloroquine Weekly||27||
59812344|NCT00455325|75934671|FG002|STARTED|Cohort 2: 80 mg Chloroquine Weekly||0||
59812345|NCT00455325|75934672|FG003|STARTED|Cohort 2: 80 mg Chloroquine Weekly||0||
59812346|NCT00455325|75934669|FG000|COMPLETED|Cohort 2: 80 mg Chloroquine Weekly||0|This is a sequential study|
59812347|NCT00455325|75934670|FG001|COMPLETED|Cohort 2: 80 mg Chloroquine Weekly||26|This is a sequential study|
59812348|NCT00455325|75934671|FG002|COMPLETED|Cohort 2: 80 mg Chloroquine Weekly||0|This is a sequential study|
59812349|NCT00455325|75934672|FG003|COMPLETED|Cohort 2: 80 mg Chloroquine Weekly||0|This is a sequential study|
59812350|NCT00455325|75934669|FG000|NOT COMPLETED|Cohort 2: 80 mg Chloroquine Weekly||0||
59812351|NCT00455325|75934670|FG001|NOT COMPLETED|Cohort 2: 80 mg Chloroquine Weekly||1||
59812352|NCT00455325|75934671|FG002|NOT COMPLETED|Cohort 2: 80 mg Chloroquine Weekly||0||
59812353|NCT00455325|75934672|FG003|NOT COMPLETED|Cohort 2: 80 mg Chloroquine Weekly||0||
59812354|NCT00455325|75934669|FG000|STARTED|Cohort 3: 80 mg Chloroquine Daily||0||
59812355|NCT00455325|75934670|FG001|STARTED|Cohort 3: 80 mg Chloroquine Daily||0||
59812356|NCT00455325|75934671|FG002|STARTED|Cohort 3: 80 mg Chloroquine Daily||26||
59812357|NCT00455325|75934672|FG003|STARTED|Cohort 3: 80 mg Chloroquine Daily||0||
59812358|NCT00455325|75934669|FG000|COMPLETED|Cohort 3: 80 mg Chloroquine Daily||0||
59812359|NCT00455325|75934670|FG001|COMPLETED|Cohort 3: 80 mg Chloroquine Daily||0||
59812360|NCT00455325|75934671|FG002|COMPLETED|Cohort 3: 80 mg Chloroquine Daily||25||
59812361|NCT00455325|75934672|FG003|COMPLETED|Cohort 3: 80 mg Chloroquine Daily||0||
59972800|NCT02264665|76090356|FG006|COMPLETED|Overall Study||0||
59972801|NCT02264665|76090350|FG000|NOT COMPLETED|Overall Study||13||
59972802|NCT02264665|76090351|FG001|NOT COMPLETED|Overall Study||8||
59972803|NCT02264665|76090352|FG002|NOT COMPLETED|Overall Study||21||
59972804|NCT02264665|76090353|FG003|NOT COMPLETED|Overall Study||9||
59972805|NCT02264665|76090354|FG004|NOT COMPLETED|Overall Study||0||
59972806|NCT02264665|76090355|FG005|NOT COMPLETED|Overall Study||0||
59972807|NCT02264665|76090356|FG006|NOT COMPLETED|Overall Study||3||
59972808|NCT02155712|76090383|FG000|STARTED|Overall Study||397||
59972809|NCT02155712|76090384|FG001|STARTED|Overall Study||216||
59972810|NCT02155712|76090383|FG000|COMPLETED|Overall Study||0||
59972811|NCT02155712|76090384|FG001|COMPLETED|Overall Study||37||
59972812|NCT02155712|76090383|FG000|NOT COMPLETED|Overall Study||397||
59972813|NCT02155712|76090384|FG001|NOT COMPLETED|Overall Study||179||
59972814|NCT01972217|76090398|FG000|STARTED|Part A: Open-label Safety Run-in Period||3||
59972815|NCT01972217|76090399|FG001|STARTED|Part A: Open-label Safety Run-in Period||13||
59972816|NCT01972217|76090400|FG002|STARTED|Part A: Open-label Safety Run-in Period||0||
59972817|NCT01972217|76090401|FG003|STARTED|Part A: Open-label Safety Run-in Period||0||
59972818|NCT01972217|76090398|FG000|COMPLETED|Part A: Open-label Safety Run-in Period||2||
59972819|NCT01972217|76090399|FG001|COMPLETED|Part A: Open-label Safety Run-in Period||1||
59972820|NCT01972217|76090400|FG002|COMPLETED|Part A: Open-label Safety Run-in Period||0||
59972821|NCT01972217|76090401|FG003|COMPLETED|Part A: Open-label Safety Run-in Period||0||
59972822|NCT01972217|76090398|FG000|NOT COMPLETED|Part A: Open-label Safety Run-in Period||1||
59972823|NCT01972217|76090399|FG001|NOT COMPLETED|Part A: Open-label Safety Run-in Period||12||
59972824|NCT01972217|76090400|FG002|NOT COMPLETED|Part A: Open-label Safety Run-in Period||0||
59972825|NCT01972217|76090401|FG003|NOT COMPLETED|Part A: Open-label Safety Run-in Period||0||
59994951|NCT00462943|76110771|FG000|STARTED|Overall Study||46||
59994952|NCT00462943|76110772|FG001|STARTED|Overall Study||31||
59812362|NCT00455325|75934669|FG000|NOT COMPLETED|Cohort 3: 80 mg Chloroquine Daily||0||
59812363|NCT00455325|75934670|FG001|NOT COMPLETED|Cohort 3: 80 mg Chloroquine Daily||0||
59812364|NCT00455325|75934671|FG002|NOT COMPLETED|Cohort 3: 80 mg Chloroquine Daily||1||
59812365|NCT00455325|75934672|FG003|NOT COMPLETED|Cohort 3: 80 mg Chloroquine Daily||0||
59812366|NCT00455325|75934669|FG000|STARTED|Cohort 4: 250mg Chloroquine Daily||0||
59812367|NCT00455325|75934670|FG001|STARTED|Cohort 4: 250mg Chloroquine Daily||0||
59812368|NCT00455325|75934671|FG002|STARTED|Cohort 4: 250mg Chloroquine Daily||0||
59812369|NCT00455325|75934672|FG003|STARTED|Cohort 4: 250mg Chloroquine Daily||25||
59972826|NCT01972217|76090398|FG000|STARTED|Part B Double-blind, Randomised Period|Patients recruited to Part A did not participate in Part B.|0||
59972827|NCT01972217|76090399|FG001|STARTED|Part B Double-blind, Randomised Period|Patients recruited to Part A did not participate in Part B.|0||
59972828|NCT01972217|76090400|FG002|STARTED|Part B Double-blind, Randomised Period|Patients recruited to Part B did not participate in Part A.|71||
59972829|NCT01972217|76090401|FG003|STARTED|Part B Double-blind, Randomised Period|Patients recruited to Part B did not participate in Part A.|71||
59972830|NCT01972217|76090398|FG000|Received Olaparib/Placebo|Part B Double-blind, Randomised Period||0||
59972831|NCT01972217|76090399|FG001|Received Olaparib/Placebo|Part B Double-blind, Randomised Period||0||
59972832|NCT01972217|76090400|FG002|Received Olaparib/Placebo|Part B Double-blind, Randomised Period||71||
59972833|NCT01972217|76090401|FG003|Received Olaparib/Placebo|Part B Double-blind, Randomised Period||71||
59972834|NCT01972217|76090398|FG000|Received Abiraterone|Part B Double-blind, Randomised Period||0||
59972835|NCT01972217|76090399|FG001|Received Abiraterone|Part B Double-blind, Randomised Period||0||
59972836|NCT01972217|76090400|FG002|Received Abiraterone|Part B Double-blind, Randomised Period||71||
59972837|NCT01972217|76090401|FG003|Received Abiraterone|Part B Double-blind, Randomised Period||71||
59972838|NCT01972217|76090398|FG000|COMPLETED|Part B Double-blind, Randomised Period||0||
59972839|NCT01972217|76090399|FG001|COMPLETED|Part B Double-blind, Randomised Period||0||
59972840|NCT01972217|76090400|FG002|COMPLETED|Part B Double-blind, Randomised Period||25||
59972841|NCT01972217|76090401|FG003|COMPLETED|Part B Double-blind, Randomised Period||24||
59972842|NCT01972217|76090398|FG000|NOT COMPLETED|Part B Double-blind, Randomised Period||0||
60074509|NCT01769378|76189922|FG000|NOT COMPLETED|Overall Study||25||
60074510|NCT01769378|76189923|FG001|NOT COMPLETED|Overall Study||4||
60074511|NCT01807520|76189932|FG000|STARTED|Treatment Period 1 (0-16 Weeks)||67||
60074512|NCT01807520|76189933|FG001|STARTED|Treatment Period 1 (0-16 Weeks)||66||
59525548|NCT02969525|75620938|FG001|STARTED|Double-Blind Period||41||
59525549|NCT02969525|75620939|FG002|STARTED|Double-Blind Period||41||
59525550|NCT02969525|75620940|FG003|STARTED|Double-Blind Period||41||
59525551|NCT02969525|75620941|FG004|STARTED|Double-Blind Period||41||
59525552|NCT02969525|75620942|FG005|STARTED|Double-Blind Period||0||
59525553|NCT02969525|75620943|FG006|STARTED|Double-Blind Period||0||
59525554|NCT02969525|75620944|FG007|STARTED|Double-Blind Period||0||
59525555|NCT02969525|75620945|FG008|STARTED|Double-Blind Period||0||
59525556|NCT02969525|75620946|FG009|STARTED|Double-Blind Period||0||
59525557|NCT02969525|75620947|FG010|STARTED|Double-Blind Period||0||
59525558|NCT02969525|75620948|FG011|STARTED|Double-Blind Period||0||
59525559|NCT02969525|75620937|FG000|Completed Double-Blind Period|Double-Blind Period||42||
59525560|NCT02969525|75620938|FG001|Completed Double-Blind Period|Double-Blind Period||41||
59525561|NCT02969525|75620939|FG002|Completed Double-Blind Period|Double-Blind Period||40||
59812370|NCT00455325|75934669|FG000|COMPLETED|Cohort 4: 250mg Chloroquine Daily||0||
59812371|NCT00455325|75934670|FG001|COMPLETED|Cohort 4: 250mg Chloroquine Daily||0||
59812372|NCT00455325|75934671|FG002|COMPLETED|Cohort 4: 250mg Chloroquine Daily||0||
59812373|NCT00455325|75934672|FG003|COMPLETED|Cohort 4: 250mg Chloroquine Daily||25||
59812374|NCT00455325|75934669|FG000|NOT COMPLETED|Cohort 4: 250mg Chloroquine Daily||0||
59525562|NCT02969525|75620940|FG003|Completed Double-Blind Period|Double-Blind Period||39||
59525563|NCT02969525|75620941|FG004|Completed Double-Blind Period|Double-Blind Period||41||
59525564|NCT02969525|75620942|FG005|Completed Double-Blind Period|Double-Blind Period||0||
59525565|NCT02969525|75620943|FG006|Completed Double-Blind Period|Double-Blind Period||0||
59525566|NCT02969525|75620944|FG007|Completed Double-Blind Period|Double-Blind Period||0||
59812375|NCT00455325|75934670|FG001|NOT COMPLETED|Cohort 4: 250mg Chloroquine Daily||0||
59812376|NCT00455325|75934671|FG002|NOT COMPLETED|Cohort 4: 250mg Chloroquine Daily||0||
59812377|NCT00455325|75934672|FG003|NOT COMPLETED|Cohort 4: 250mg Chloroquine Daily||0||
59812378|NCT00443781|75934683|FG000|STARTED|Overall Study||62||
59812379|NCT00443781|75934683|FG000|COMPLETED|Overall Study||37||
59812380|NCT00443781|75934683|FG000|NOT COMPLETED|Overall Study||25||
59972843|NCT01972217|76090399|FG001|NOT COMPLETED|Part B Double-blind, Randomised Period||0||
59972844|NCT01972217|76090400|FG002|NOT COMPLETED|Part B Double-blind, Randomised Period||46||
59972845|NCT01972217|76090401|FG003|NOT COMPLETED|Part B Double-blind, Randomised Period||47||
59972846|NCT01934452|76090415|FG000|STARTED|Overall Study||35||
59972847|NCT01934452|76090416|FG001|STARTED|Overall Study||42||
59972848|NCT01934452|76090415|FG000|COMPLETED|Overall Study||35||
59972849|NCT01934452|76090416|FG001|COMPLETED|Overall Study||42||
59972850|NCT01934452|76090415|FG000|NOT COMPLETED|Overall Study||0||
59972851|NCT01934452|76090416|FG001|NOT COMPLETED|Overall Study||0||
59972852|NCT01918007|76090424|FG000|STARTED|Overall Study||93||
59972853|NCT01918007|76090425|FG001|STARTED|Overall Study||93||
59972854|NCT01918007|76090424|FG000|COMPLETED|Overall Study||68||
59972855|NCT01918007|76090425|FG001|COMPLETED|Overall Study||72||
59972856|NCT01918007|76090424|FG000|NOT COMPLETED|Overall Study||25||
59972857|NCT01918007|76090425|FG001|NOT COMPLETED|Overall Study||21||
59972858|NCT01863446|76090435|FG000|STARTED|Overall Study||5||
59972859|NCT01863446|76090436|FG001|STARTED|Overall Study||4||
59972860|NCT01863446|76090437|FG002|STARTED|Overall Study||12||
59972861|NCT01863446|76090438|FG003|STARTED|Overall Study||12||
59972862|NCT01863446|76090435|FG000|COMPLETED|Overall Study||4||
59972863|NCT01863446|76090436|FG001|COMPLETED|Overall Study||4||
59972864|NCT01863446|76090437|FG002|COMPLETED|Overall Study||10||
59972865|NCT01863446|76090438|FG003|COMPLETED|Overall Study||10||
59972866|NCT01863446|76090435|FG000|NOT COMPLETED|Overall Study||1||
59972867|NCT01863446|76090436|FG001|NOT COMPLETED|Overall Study||0||
59972868|NCT01863446|76090437|FG002|NOT COMPLETED|Overall Study||2||
59972869|NCT01863446|76090438|FG003|NOT COMPLETED|Overall Study||2||
59972870|NCT01809691|76090450|FG000|STARTED|Overall Study||638||
60074513|NCT01807520|76189934|FG002|STARTED|Treatment Period 1 (0-16 Weeks)||65||
60074514|NCT01807520|76189935|FG003|STARTED|Treatment Period 1 (0-16 Weeks)||0||
60074515|NCT01807520|76189936|FG004|STARTED|Treatment Period 1 (0-16 Weeks)||0||
60074516|NCT01807520|76189937|FG005|STARTED|Treatment Period 1 (0-16 Weeks)||0||
60074517|NCT01807520|76189938|FG006|STARTED|Treatment Period 1 (0-16 Weeks)||0||
60074518|NCT01807520|76189932|FG000|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||67||
60074519|NCT01807520|76189933|FG001|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||66||
60074520|NCT01807520|76189934|FG002|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||65||
59812381|NCT00443703|75934689|FG000|STARTED|Overall Study||177||
59812382|NCT00443703|75934690|FG001|STARTED|Overall Study||175||
59812383|NCT00443703|75934689|FG000|Treated|Overall Study||174||
59812384|NCT00443703|75934690|FG001|Treated|Overall Study||174||
59812385|NCT00443703|75934689|FG000|COMPLETED|Overall Study||149||
59812386|NCT00443703|75934690|FG001|COMPLETED|Overall Study||157||
59812387|NCT00443703|75934689|FG000|NOT COMPLETED|Overall Study||28||
59812388|NCT00443703|75934690|FG001|NOT COMPLETED|Overall Study||18||
59812389|NCT00381706|75934702|FG000|STARTED|Overall Study||82||
59812390|NCT00381706|75934703|FG001|STARTED|Overall Study||83||
59812391|NCT00381706|75934704|FG002|STARTED|Overall Study||80||
59812392|NCT00381706|75934702|FG000|COMPLETED|Overall Study||75||
59812393|NCT00381706|75934703|FG001|COMPLETED|Overall Study||81||
59812394|NCT00381706|75934704|FG002|COMPLETED|Overall Study||79||
59812395|NCT00381706|75934702|FG000|NOT COMPLETED|Overall Study||7||
59812396|NCT00381706|75934703|FG001|NOT COMPLETED|Overall Study||2||
59812397|NCT00381706|75934704|FG002|NOT COMPLETED|Overall Study||1||
59812398|NCT00535236|75934728|FG000|STARTED|Overall Study||40||
59812399|NCT00535236|75934729|FG001|STARTED|Overall Study||10||
59812400|NCT00535236|75934730|FG002|STARTED|Overall Study||41||
59812401|NCT00535236|75934731|FG003|STARTED|Overall Study||10||
59812402|NCT00535236|75934732|FG004|STARTED|Overall Study||59||
59812403|NCT00535236|75934733|FG005|STARTED|Overall Study||20||
59812404|NCT00535236|75934734|FG006|STARTED|Overall Study||62||
59812405|NCT00535236|75934735|FG007|STARTED|Overall Study||19||
59812406|NCT00535236|75934736|FG008|STARTED|Overall Study||60||
59812407|NCT00535236|75934737|FG009|STARTED|Overall Study||20||
59812408|NCT00535236|75934728|FG000|Vaccination 1|Overall Study||40||
59972871|NCT01809691|76090451|FG001|STARTED|Overall Study||641||
59972872|NCT01809691|76090450|FG000|COMPLETED|Overall Study||0||
59972873|NCT01809691|76090451|FG001|COMPLETED|Overall Study||0||
59972874|NCT01809691|76090450|FG000|NOT COMPLETED|Overall Study||638||
59972875|NCT01809691|76090451|FG001|NOT COMPLETED|Overall Study||641||
59972876|NCT01772472|76090459|FG000|STARTED|Overall Study||743||
59972877|NCT01772472|76090460|FG001|STARTED|Overall Study||743||
59972878|NCT01772472|76090459|FG000|COMPLETED|Overall Study||0||
59972879|NCT01772472|76090460|FG001|COMPLETED|Overall Study||0||
59972880|NCT01772472|76090459|FG000|NOT COMPLETED|Overall Study||743||
59972881|NCT01772472|76090460|FG001|NOT COMPLETED|Overall Study||743||
59972882|NCT01619176|76090468|FG000|STARTED|Overall Study||6||
59972883|NCT01619176|76090469|FG001|STARTED|Overall Study||4||
59972884|NCT01619176|76090468|FG000|COMPLETED|Overall Study||6||
59972885|NCT01619176|76090469|FG001|COMPLETED|Overall Study||4||
59972886|NCT01619176|76090468|FG000|NOT COMPLETED|Overall Study||0||
59972887|NCT01619176|76090469|FG001|NOT COMPLETED|Overall Study||0||
60074521|NCT01807520|76189935|FG003|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||0||
60074522|NCT01807520|76189936|FG004|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||0||
60074523|NCT01807520|76189937|FG005|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||0||
59812409|NCT00535236|75934729|FG001|Vaccination 1|Overall Study||10||
59812410|NCT00535236|75934730|FG002|Vaccination 1|Overall Study||40||
59812411|NCT00535236|75934731|FG003|Vaccination 1|Overall Study||10||
59812412|NCT00535236|75934732|FG004|Vaccination 1|Overall Study||58||
59812413|NCT00535236|75934733|FG005|Vaccination 1|Overall Study||19||
59972888|NCT01532388|76090477|FG000|STARTED|3-month Follow-up||101||
59972889|NCT01532388|76090478|FG001|STARTED|3-month Follow-up||101||
59972890|NCT01532388|76090477|FG000|COMPLETED|3-month Follow-up||33||
59972891|NCT01532388|76090478|FG001|COMPLETED|3-month Follow-up||33||
59972892|NCT01532388|76090477|FG000|NOT COMPLETED|3-month Follow-up||68||
59972893|NCT01532388|76090478|FG001|NOT COMPLETED|3-month Follow-up||68||
59972894|NCT01532388|76090477|FG000|STARTED|6-month Follow-up|All participants registered in the trial were contacted for follow-ups at 3, 6 and 12 months.|101||
59972895|NCT01532388|76090478|FG001|STARTED|6-month Follow-up|All participants registered in the trial were contacted for follow-ups at 3, 6 and 12 months.|101||
59972896|NCT01532388|76090477|FG000|COMPLETED|6-month Follow-up||27||
59972897|NCT01532388|76090478|FG001|COMPLETED|6-month Follow-up||35||
59972898|NCT01532388|76090477|FG000|NOT COMPLETED|6-month Follow-up||74||
59972899|NCT01532388|76090478|FG001|NOT COMPLETED|6-month Follow-up||66||
59972900|NCT01532388|76090477|FG000|STARTED|12-month Follow-up|All participants registered in the trial were contacted for follow-ups at 3, 6 and 12 months.|101||
59972901|NCT01532388|76090478|FG001|STARTED|12-month Follow-up|All participants registered in the trial were contacted for follow-ups at 3, 6 and 12 months.|101||
59972902|NCT01532388|76090477|FG000|COMPLETED|12-month Follow-up||32||
59972903|NCT01532388|76090478|FG001|COMPLETED|12-month Follow-up||34||
59972904|NCT01532388|76090477|FG000|NOT COMPLETED|12-month Follow-up||69||
59972905|NCT01532388|76090478|FG001|NOT COMPLETED|12-month Follow-up||67||
59972906|NCT01413516|76090486|FG000|STARTED|Overall Study||8||
59972907|NCT01413516|76090487|FG001|STARTED|Overall Study||9||
59972908|NCT01413516|76090486|FG000|COMPLETED|Overall Study||8||
59972909|NCT01413516|76090487|FG001|COMPLETED|Overall Study||9||
59972910|NCT01413516|76090486|FG000|NOT COMPLETED|Overall Study||0||
59972911|NCT01413516|76090487|FG001|NOT COMPLETED|Overall Study||0||
59972912|NCT01106534|76090493|FG000|STARTED|Overall Study||2997||
59972913|NCT01106534|76090493|FG000|COMPLETED|Overall Study||2960||
59972914|NCT01106534|76090493|FG000|NOT COMPLETED|Overall Study||37||
59972915|NCT00961064|76090498|FG000|STARTED|Initial Treatment (Weeks 1 - 20)||30||
59972916|NCT00961064|76090498|FG000|COMPLETED|Initial Treatment (Weeks 1 - 20)||14||
59972917|NCT00961064|76090498|FG000|NOT COMPLETED|Initial Treatment (Weeks 1 - 20)||16||
59972918|NCT00961064|76090498|FG000|STARTED|Extended Access: Week 20 to Up to Year 5||14||
60074524|NCT01807520|76189938|FG006|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||0||
59622050|NCT00461292|75733825|FG000|COMPLETED|Treatment Cycle 1||76||
59622051|NCT00461292|75733826|FG001|COMPLETED|Treatment Cycle 1||80||
59622052|NCT00461292|75733827|FG002|COMPLETED|Treatment Cycle 1||81||
59622053|NCT00461292|75733825|FG000|NOT COMPLETED|Treatment Cycle 1||15||
59622054|NCT00461292|75733826|FG001|NOT COMPLETED|Treatment Cycle 1||12||
59812414|NCT00535236|75934734|FG006|Vaccination 1|Overall Study||61||
59972919|NCT00961064|76090498|FG000|COMPLETED|Extended Access: Week 20 to Up to Year 5||7||
59972920|NCT00961064|76090498|FG000|NOT COMPLETED|Extended Access: Week 20 to Up to Year 5||7||
59622055|NCT00461292|75733827|FG002|NOT COMPLETED|Treatment Cycle 1||11||
59622056|NCT00461292|75733825|FG000|STARTED|Treatment Cycle 2|32 from the 300U group + 31 from the Placebo group entered Cycle 2|63||
59622057|NCT00461292|75733826|FG001|STARTED|Treatment Cycle 2|42 from the 200U group + 32 from the Placebo group entered Cycle 2|74||
59622058|NCT00461292|75733827|FG002|STARTED|Treatment Cycle 2|Cycle 1 Placebo pts were randomized to receive 300U or 200 U in Cycle 2|0||
59622059|NCT00461292|75733825|FG000|COMPLETED|Treatment Cycle 2||58||
59622060|NCT00461292|75733826|FG001|COMPLETED|Treatment Cycle 2||72||
59622061|NCT00461292|75733827|FG002|COMPLETED|Treatment Cycle 2||0||
59622062|NCT00461292|75733825|FG000|NOT COMPLETED|Treatment Cycle 2||5||
59972921|NCT00513526|76090503|FG000|STARTED|Overall Study||109||
59972922|NCT00513526|76090503|FG000|COMPLETED|Overall Study||92||
59972923|NCT00513526|76090503|FG000|NOT COMPLETED|Overall Study||17||
59622063|NCT00461292|75733826|FG001|NOT COMPLETED|Treatment Cycle 2||2||
59622064|NCT00461292|75733827|FG002|NOT COMPLETED|Treatment Cycle 2||0||
60074525|NCT01807520|76189932|FG000|Safety Set|Treatment Period 1 (0-16 Weeks)||67||
59622065|NCT00382590|75733837|FG000|STARTED|Overall Study||4||
59622066|NCT00382590|75733838|FG001|STARTED|Overall Study||6||
59622067|NCT00382590|75733837|FG000|COMPLETED|Overall Study||4||
59622068|NCT00382590|75733838|FG001|COMPLETED|Overall Study||6||
59622069|NCT00382590|75733837|FG000|NOT COMPLETED|Overall Study||0||
59622070|NCT00382590|75733838|FG001|NOT COMPLETED|Overall Study||0||
59622071|NCT00382824|75733846|FG000|STARTED|Overall Study||32||
59622072|NCT00382824|75733847|FG001|STARTED|Overall Study||29||
59622073|NCT00382824|75733846|FG000|COMPLETED|Overall Study||20||
59622074|NCT00382824|75733847|FG001|COMPLETED|Overall Study||16||
59622075|NCT00382824|75733846|FG000|NOT COMPLETED|Overall Study||12||
59622076|NCT00382824|75733847|FG001|NOT COMPLETED|Overall Study||13||
59622077|NCT00462072|75733856|FG000|STARTED|Baseline (Week 0)||10||
59622078|NCT00462072|75733857|FG001|STARTED|Baseline (Week 0)||12||
59622079|NCT00462072|75733858|FG002|STARTED|Baseline (Week 0)||9||
59622080|NCT00462072|75733856|FG000|COMPLETED|Baseline (Week 0)||10||
59622081|NCT00462072|75733857|FG001|COMPLETED|Baseline (Week 0)||12||
59622082|NCT00462072|75733858|FG002|COMPLETED|Baseline (Week 0)||9||
59622083|NCT00462072|75733856|FG000|NOT COMPLETED|Baseline (Week 0)||0||
59622084|NCT00462072|75733857|FG001|NOT COMPLETED|Baseline (Week 0)||0||
59622085|NCT00462072|75733858|FG002|NOT COMPLETED|Baseline (Week 0)||0||
59622086|NCT00462072|75733856|FG000|STARTED|Week 10||10||
59622087|NCT00462072|75733857|FG001|STARTED|Week 10||12||
59622088|NCT00462072|75733858|FG002|STARTED|Week 10||9||
59622089|NCT00462072|75733856|FG000|COMPLETED|Week 10||10||
59622090|NCT00462072|75733857|FG001|COMPLETED|Week 10||12||
59622091|NCT00462072|75733858|FG002|COMPLETED|Week 10||9||
60074526|NCT01807520|76189933|FG001|Safety Set|Treatment Period 1 (0-16 Weeks)||65||
59525567|NCT02969525|75620945|FG008|Completed Double-Blind Period|Double-Blind Period||0||
59812415|NCT00535236|75934735|FG007|Vaccination 1|Overall Study||19||
59812416|NCT00535236|75934736|FG008|Vaccination 1|Overall Study||60||
59812417|NCT00535236|75934737|FG009|Vaccination 1|Overall Study||20||
59812418|NCT00535236|75934728|FG000|Vaccination 2|Overall Study||35||
59812419|NCT00535236|75934729|FG001|Vaccination 2|Overall Study||10||
59812420|NCT00535236|75934730|FG002|Vaccination 2|Overall Study||37||
59812421|NCT00535236|75934731|FG003|Vaccination 2|Overall Study||8||
59812422|NCT00535236|75934732|FG004|Vaccination 2|Overall Study||52||
59812423|NCT00535236|75934733|FG005|Vaccination 2|Overall Study||19||
59812424|NCT00535236|75934734|FG006|Vaccination 2|Overall Study||58||
59812425|NCT00535236|75934735|FG007|Vaccination 2|Overall Study||19||
59812426|NCT00535236|75934736|FG008|Vaccination 2|Overall Study||57||
59812427|NCT00535236|75934737|FG009|Vaccination 2|Overall Study||19||
59812428|NCT00535236|75934728|FG000|Vaccination 3|Overall Study||34||
59812429|NCT00535236|75934729|FG001|Vaccination 3|Overall Study||10||
59812430|NCT00535236|75934730|FG002|Vaccination 3|Overall Study||35||
59972924|NCT00321555|76090510|FG000|STARTED|Overall Study||15||
59972925|NCT00321555|76090510|FG000|COMPLETED|Overall Study||9||
59972926|NCT00321555|76090510|FG000|NOT COMPLETED|Overall Study||6||
59972927|NCT00131885|76090518|FG000|STARTED|Time 1: First Intervention||9||
59972928|NCT00131885|76090519|FG001|STARTED|Time 1: First Intervention||9||
59972929|NCT00131885|76090520|FG002|STARTED|Time 1: First Intervention||9||
59972930|NCT00131885|76090521|FG003|STARTED|Time 1: First Intervention||9||
59972931|NCT00131885|76090518|FG000|COMPLETED|Time 1: First Intervention||9||
59972932|NCT00131885|76090519|FG001|COMPLETED|Time 1: First Intervention||9||
59972933|NCT00131885|76090520|FG002|COMPLETED|Time 1: First Intervention||9||
59972934|NCT00131885|76090521|FG003|COMPLETED|Time 1: First Intervention||9||
59972935|NCT00131885|76090518|FG000|NOT COMPLETED|Time 1: First Intervention||0||
59972936|NCT00131885|76090519|FG001|NOT COMPLETED|Time 1: First Intervention||0||
59972937|NCT00131885|76090520|FG002|NOT COMPLETED|Time 1: First Intervention||0||
59972938|NCT00131885|76090521|FG003|NOT COMPLETED|Time 1: First Intervention||0||
59972939|NCT00131885|76090518|FG000|STARTED|Time 2: Second Intervention||9||
59972940|NCT00131885|76090519|FG001|STARTED|Time 2: Second Intervention||9||
59972941|NCT00131885|76090520|FG002|STARTED|Time 2: Second Intervention||9||
59972942|NCT00131885|76090521|FG003|STARTED|Time 2: Second Intervention||9||
59972943|NCT00131885|76090518|FG000|COMPLETED|Time 2: Second Intervention||9||
59972944|NCT00131885|76090519|FG001|COMPLETED|Time 2: Second Intervention||9||
59972945|NCT00131885|76090520|FG002|COMPLETED|Time 2: Second Intervention||9||
59972946|NCT00131885|76090521|FG003|COMPLETED|Time 2: Second Intervention||9||
59972947|NCT00131885|76090518|FG000|NOT COMPLETED|Time 2: Second Intervention||0||
59972948|NCT00131885|76090519|FG001|NOT COMPLETED|Time 2: Second Intervention||0||
59972949|NCT00131885|76090520|FG002|NOT COMPLETED|Time 2: Second Intervention||0||
59972950|NCT00131885|76090521|FG003|NOT COMPLETED|Time 2: Second Intervention||0||
59972951|NCT00099437|76090533|FG000|STARTED|Overall Study|randomised patients|374||
59972952|NCT00099437|76090534|FG001|STARTED|Overall Study|randomised patients|362||
59972953|NCT00099437|76090533|FG000|COMPLETED|Overall Study|ongoing study treatment at survival follow-up data cut-off|8||
59972954|NCT00099437|76090534|FG001|COMPLETED|Overall Study|ongoing study treatment at survival follow-up data cut-off|13||
59972955|NCT00099437|76090533|FG000|NOT COMPLETED|Overall Study||366||
59972956|NCT00099437|76090534|FG001|NOT COMPLETED|Overall Study||349||
59972957|NCT00047060|76090540|FG000|STARTED|Overall Study||5||
59812431|NCT00535236|75934731|FG003|Vaccination 3|Overall Study||8||
59812432|NCT00535236|75934732|FG004|Vaccination 3|Overall Study||48||
59812433|NCT00535236|75934733|FG005|Vaccination 3|Overall Study||19||
59812434|NCT00535236|75934734|FG006|Vaccination 3|Overall Study||51||
59972958|NCT00047060|76090540|FG000|COMPLETED|Overall Study||3||
59972959|NCT00047060|76090540|FG000|NOT COMPLETED|Overall Study||2||
59972960|NCT02689453|76090549|FG000|STARTED|Overall Study||3||
59972961|NCT02689453|76090550|FG001|STARTED|Overall Study||4||
59972962|NCT02689453|76090551|FG002|STARTED|Overall Study||4||
59972963|NCT02689453|76090549|FG000|COMPLETED|Overall Study||3||
59972964|NCT02689453|76090550|FG001|COMPLETED|Overall Study||3||
59972965|NCT02689453|76090551|FG002|COMPLETED|Overall Study||3||
59972966|NCT02689453|76090549|FG000|NOT COMPLETED|Overall Study||0||
59972967|NCT02689453|76090550|FG001|NOT COMPLETED|Overall Study||1||
59972968|NCT02689453|76090551|FG002|NOT COMPLETED|Overall Study||1||
59972969|NCT02310919|76090563|FG000|STARTED|Overall Study||54||
59972970|NCT02310919|76090564|FG001|STARTED|Overall Study||51||
59972971|NCT02310919|76090563|FG000|COMPLETED|Overall Study|Four participants receiving the study trigger deviated from protocol. One patient was randomized before her E2 resulted >5,000 pg/ml. Another elected to convert to intrauterine insemination while another underwent oocyte cryopreservation as their male partner was unable to produce a fresh sperm sample for fertilization. The 4th patient inadvertently spilled a portion of the trigger prior to injection. Since her post-trigger hCG was <18 IU/L, she was unblinded and re-triggered with 10,000 IU hCG.|54||
60074527|NCT01807520|76189934|FG002|Safety Set|Treatment Period 1 (0-16 Weeks)||65||
60074528|NCT01807520|76189935|FG003|Safety Set|Treatment Period 1 (0-16 Weeks)||0||
59525568|NCT02969525|75620946|FG009|Completed Double-Blind Period|Double-Blind Period||0||
59972972|NCT02310919|76090564|FG001|COMPLETED|Overall Study|Two participants that received the standard trigger requested exclusionary embryo co-culture to be added post-trigger.|51||
59972973|NCT02310919|76090563|FG000|NOT COMPLETED|Overall Study||0||
59972974|NCT02310919|76090564|FG001|NOT COMPLETED|Overall Study||0||
59972975|NCT02090881|76090571|FG000|STARTED|Overall Study||25||
59972976|NCT02090881|76090571|FG000|COMPLETED|Overall Study||25||
59972977|NCT02090881|76090571|FG000|NOT COMPLETED|Overall Study||0||
59972978|NCT00701103|76090586|FG000|STARTED|Overall Study||5||
59972979|NCT00701103|76090587|FG001|STARTED|Overall Study||3||
59972980|NCT00701103|76090588|FG002|STARTED|Overall Study||8||
59972981|NCT00701103|76090589|FG003|STARTED|Overall Study||6||
59972982|NCT00701103|76090590|FG004|STARTED|Overall Study||6||
59972983|NCT00701103|76090591|FG005|STARTED|Overall Study||6||
59972984|NCT00701103|76090592|FG006|STARTED|Overall Study||8||
59972985|NCT00701103|76090593|FG007|STARTED|Overall Study||7||
59972986|NCT00701103|76090594|FG008|STARTED|Overall Study||9||
59972987|NCT00701103|76090595|FG009|STARTED|Overall Study||11||
59972988|NCT00701103|76090596|FG010|STARTED|Overall Study||11||
59972989|NCT00701103|76090586|FG000|COMPLETED|Overall Study||0||
59972990|NCT00701103|76090587|FG001|COMPLETED|Overall Study||0||
59972991|NCT00701103|76090588|FG002|COMPLETED|Overall Study||0||
59972992|NCT00701103|76090589|FG003|COMPLETED|Overall Study||0||
59972993|NCT00701103|76090590|FG004|COMPLETED|Overall Study||0||
59972994|NCT00701103|76090591|FG005|COMPLETED|Overall Study||0||
59972995|NCT00701103|76090592|FG006|COMPLETED|Overall Study||0||
59972996|NCT00701103|76090593|FG007|COMPLETED|Overall Study||0||
59972997|NCT00701103|76090594|FG008|COMPLETED|Overall Study||0||
59972998|NCT00701103|76090595|FG009|COMPLETED|Overall Study||0||
59972999|NCT00701103|76090596|FG010|COMPLETED|Overall Study||0||
59973000|NCT00701103|76090586|FG000|NOT COMPLETED|Overall Study||5||
59973001|NCT00701103|76090587|FG001|NOT COMPLETED|Overall Study||3||
59973002|NCT00701103|76090588|FG002|NOT COMPLETED|Overall Study||8||
59973003|NCT00701103|76090589|FG003|NOT COMPLETED|Overall Study||6||
59973004|NCT00701103|76090590|FG004|NOT COMPLETED|Overall Study||6||
59973005|NCT00701103|76090591|FG005|NOT COMPLETED|Overall Study||6||
59973006|NCT00701103|76090592|FG006|NOT COMPLETED|Overall Study||8||
59973007|NCT00701103|76090593|FG007|NOT COMPLETED|Overall Study||7||
59973008|NCT00701103|76090594|FG008|NOT COMPLETED|Overall Study||9||
59973009|NCT00701103|76090595|FG009|NOT COMPLETED|Overall Study||11||
59973010|NCT00701103|76090596|FG010|NOT COMPLETED|Overall Study||11||
59973011|NCT01369225|76090630|FG000|STARTED|Overall Study||6||
59973012|NCT01369225|76090631|FG001|STARTED|Overall Study||3||
59973013|NCT01369225|76090632|FG002|STARTED|Overall Study||12||
59973014|NCT01369225|76090633|FG003|STARTED|Overall Study||10||
59973015|NCT01369225|76090634|FG004|STARTED|Overall Study||12||
59973016|NCT01369225|76090635|FG005|STARTED|Overall Study||9||
59973017|NCT01369225|76090630|FG000|COMPLETED|Overall Study||4||
59973018|NCT01369225|76090631|FG001|COMPLETED|Overall Study||3||
59973019|NCT01369225|76090632|FG002|COMPLETED|Overall Study||9||
59973020|NCT01369225|76090633|FG003|COMPLETED|Overall Study||8||
59973021|NCT01369225|76090634|FG004|COMPLETED|Overall Study||10||
59973022|NCT01369225|76090635|FG005|COMPLETED|Overall Study||9||
59973023|NCT01369225|76090630|FG000|NOT COMPLETED|Overall Study||2||
59973024|NCT01369225|76090631|FG001|NOT COMPLETED|Overall Study||0||
59973025|NCT01369225|76090632|FG002|NOT COMPLETED|Overall Study||3||
59973026|NCT01369225|76090633|FG003|NOT COMPLETED|Overall Study||2||
59973027|NCT01369225|76090634|FG004|NOT COMPLETED|Overall Study||2||
59973028|NCT01369225|76090635|FG005|NOT COMPLETED|Overall Study||0||
59973029|NCT02639546|76090657|FG000|STARTED|Overall Study||6||
60074529|NCT01807520|76189936|FG004|Safety Set|Treatment Period 1 (0-16 Weeks)||0||
60074530|NCT01807520|76189937|FG005|Safety Set|Treatment Period 1 (0-16 Weeks)||0||
59973030|NCT02639546|76090658|FG001|STARTED|Overall Study||6||
60074531|NCT01807520|76189938|FG006|Safety Set|Treatment Period 1 (0-16 Weeks)||0||
59973031|NCT02639546|76090659|FG002|STARTED|Overall Study||6||
59973032|NCT02639546|76090660|FG003|STARTED|Overall Study||6||
59973033|NCT02639546|76090661|FG004|STARTED|Overall Study||7||
59973034|NCT02639546|76090662|FG005|STARTED|Overall Study||8||
59973035|NCT02639546|76090663|FG006|STARTED|Overall Study||5||
59973036|NCT02639546|76090664|FG007|STARTED|Overall Study||12||
59973037|NCT02639546|76090657|FG000|Tumor Type - Neuroblastoma|Overall Study||0||
59973038|NCT02639546|76090658|FG001|Tumor Type - Neuroblastoma|Overall Study||0||
59973039|NCT02639546|76090659|FG002|Tumor Type - Neuroblastoma|Overall Study||1||
59973040|NCT02639546|76090660|FG003|Tumor Type - Neuroblastoma|Overall Study||0||
59973041|NCT02639546|76090661|FG004|Tumor Type - Neuroblastoma|Overall Study||0||
60074532|NCT01807520|76189932|FG000|COMPLETED|Treatment Period 1 (0-16 Weeks)||63||
60074533|NCT01807520|76189933|FG001|COMPLETED|Treatment Period 1 (0-16 Weeks)||65||
59973042|NCT02639546|76090662|FG005|Tumor Type - Neuroblastoma|Overall Study||0||
59973043|NCT02639546|76090663|FG006|Tumor Type - Neuroblastoma|Overall Study||0||
59973044|NCT02639546|76090664|FG007|Tumor Type - Neuroblastoma|Overall Study||0||
59973045|NCT02639546|76090657|FG000|Tumor Type - High-Grade Glioma|Overall Study||3||
59973046|NCT02639546|76090658|FG001|Tumor Type - High-Grade Glioma|Overall Study||1||
60074534|NCT01807520|76189934|FG002|COMPLETED|Treatment Period 1 (0-16 Weeks)||58||
59973047|NCT02639546|76090659|FG002|Tumor Type - High-Grade Glioma|Overall Study||0||
59973048|NCT02639546|76090660|FG003|Tumor Type - High-Grade Glioma|Overall Study||0||
59973049|NCT02639546|76090661|FG004|Tumor Type - High-Grade Glioma|Overall Study||1||
59973050|NCT02639546|76090662|FG005|Tumor Type - High-Grade Glioma|Overall Study||0||
59973051|NCT02639546|76090663|FG006|Tumor Type - High-Grade Glioma|Overall Study||0||
59973052|NCT02639546|76090664|FG007|Tumor Type - High-Grade Glioma|Overall Study||0||
59973053|NCT02639546|76090657|FG000|Tumor Type - Low-Grade Glioma|Overall Study||1||
59973054|NCT02639546|76090658|FG001|Tumor Type - Low-Grade Glioma|Overall Study||2||
59973055|NCT02639546|76090659|FG002|Tumor Type - Low-Grade Glioma|Overall Study||4||
59973056|NCT02639546|76090660|FG003|Tumor Type - Low-Grade Glioma|Overall Study||5||
59973057|NCT02639546|76090661|FG004|Tumor Type - Low-Grade Glioma|Overall Study||3||
59973058|NCT02639546|76090662|FG005|Tumor Type - Low-Grade Glioma|Overall Study||2||
59973059|NCT02639546|76090663|FG006|Tumor Type - Low-Grade Glioma|Overall Study||3||
59973060|NCT02639546|76090664|FG007|Tumor Type - Low-Grade Glioma|Overall Study||12||
59973061|NCT02639546|76090657|FG000|Tumor Type - Dnet In Noonan's Syndrome Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0||
59525569|NCT02969525|75620947|FG010|Completed Double-Blind Period|Double-Blind Period||0||
59525570|NCT02969525|75620948|FG011|Completed Double-Blind Period|Double-Blind Period||0||
59525571|NCT02969525|75620937|FG000|Completed Wk12 and Started Dose-Blind|Double-Blind Period||40||
59525572|NCT02969525|75620938|FG001|Completed Wk12 and Started Dose-Blind|Double-Blind Period||41||
59812435|NCT00535236|75934735|FG007|Vaccination 3|Overall Study||18||
59812436|NCT00535236|75934736|FG008|Vaccination 3|Overall Study||53||
59812437|NCT00535236|75934737|FG009|Vaccination 3|Overall Study||18||
59812438|NCT00535236|75934728|FG000|Vaccination 4|Overall Study||34||
59812439|NCT00535236|75934729|FG001|Vaccination 4|Overall Study||10||
59812440|NCT00535236|75934730|FG002|Vaccination 4|Overall Study||32||
59812441|NCT00535236|75934731|FG003|Vaccination 4|Overall Study||6||
59812442|NCT00535236|75934732|FG004|Vaccination 4|Overall Study||47||
59812443|NCT00535236|75934733|FG005|Vaccination 4|Overall Study||19||
59812444|NCT00535236|75934734|FG006|Vaccination 4|Overall Study||51||
59812445|NCT00535236|75934735|FG007|Vaccination 4|Overall Study||18||
59812446|NCT00535236|75934736|FG008|Vaccination 4|Overall Study||50||
59812447|NCT00535236|75934737|FG009|Vaccination 4|Overall Study||17||
59812448|NCT00535236|75934728|FG000|COMPLETED|Overall Study||33||
59812449|NCT00535236|75934729|FG001|COMPLETED|Overall Study||8||
59812450|NCT00535236|75934730|FG002|COMPLETED|Overall Study||29||
59812451|NCT00535236|75934731|FG003|COMPLETED|Overall Study||6||
59812452|NCT00535236|75934732|FG004|COMPLETED|Overall Study||47||
59812453|NCT00535236|75934733|FG005|COMPLETED|Overall Study||19||
59812454|NCT00535236|75934734|FG006|COMPLETED|Overall Study||51||
59812455|NCT00535236|75934735|FG007|COMPLETED|Overall Study||18||
59812456|NCT00535236|75934736|FG008|COMPLETED|Overall Study||47||
59812457|NCT00535236|75934737|FG009|COMPLETED|Overall Study||16||
59812458|NCT00535236|75934728|FG000|NOT COMPLETED|Overall Study||7||
59812459|NCT00535236|75934729|FG001|NOT COMPLETED|Overall Study||2||
59812460|NCT00535236|75934730|FG002|NOT COMPLETED|Overall Study||12||
59812461|NCT00535236|75934731|FG003|NOT COMPLETED|Overall Study||4||
59812462|NCT00535236|75934732|FG004|NOT COMPLETED|Overall Study||12||
59812463|NCT00535236|75934733|FG005|NOT COMPLETED|Overall Study||1||
59812464|NCT00535236|75934734|FG006|NOT COMPLETED|Overall Study||11||
59812465|NCT00535236|75934735|FG007|NOT COMPLETED|Overall Study||1||
59812466|NCT00535236|75934736|FG008|NOT COMPLETED|Overall Study||13||
59812467|NCT00535236|75934737|FG009|NOT COMPLETED|Overall Study||4||
59812468|NCT00370552|75934765|FG000|STARTED|Overall Study|Randomized|46||
59812469|NCT00370552|75934766|FG001|STARTED|Overall Study|Randomized|45||
59812470|NCT00370552|75934767|FG002|STARTED|Overall Study|Randomized|32||
59812471|NCT00370552|75934765|FG000|COMPLETED|Overall Study||0||
59812472|NCT00370552|75934766|FG001|COMPLETED|Overall Study||0||
59812473|NCT00370552|75934767|FG002|COMPLETED|Overall Study||0||
59812474|NCT00370552|75934765|FG000|NOT COMPLETED|Overall Study||46||
59973062|NCT02639546|76090658|FG001|Tumor Type - Dnet In Noonan's Syndrome Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0||
59973063|NCT02639546|76090659|FG002|Tumor Type - Dnet In Noonan's Syndrome Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0||
59973064|NCT02639546|76090660|FG003|Tumor Type - Dnet In Noonan's Syndrome Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0||
59994953|NCT00462943|76110773|FG002|STARTED|Overall Study||23||
59622092|NCT00462072|75733856|FG000|NOT COMPLETED|Week 10||0||
59812475|NCT00370552|75934766|FG001|NOT COMPLETED|Overall Study||45||
59812476|NCT00370552|75934767|FG002|NOT COMPLETED|Overall Study||32||
59812477|NCT00537030|75934775|FG000|STARTED|Overall Study||59||
59812478|NCT00537030|75934775|FG000|COMPLETED|Overall Study||43||
59812479|NCT00537030|75934775|FG000|NOT COMPLETED|Overall Study||16||
59812480|NCT00381238|75934779|FG000|STARTED|Overall Study||33||
59812481|NCT00381238|75934779|FG000|COMPLETED|Overall Study||21||
59812482|NCT00381238|75934779|FG000|NOT COMPLETED|Overall Study||12||
59812483|NCT03896022|75934786|FG000|STARTED|Overall Study||74||
59812484|NCT03896022|75934787|FG001|STARTED|Overall Study||51||
59812485|NCT03896022|75934788|FG002|STARTED|Overall Study||52||
59812486|NCT03896022|75934786|FG000|COMPLETED|Overall Study||70||
59812487|NCT03896022|75934787|FG001|COMPLETED|Overall Study||51||
59812488|NCT03896022|75934788|FG002|COMPLETED|Overall Study||52||
59973065|NCT02639546|76090661|FG004|Tumor Type - Dnet In Noonan's Syndrome Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0||
59973066|NCT02639546|76090662|FG005|Tumor Type - Dnet In Noonan's Syndrome Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0||
59973067|NCT02639546|76090663|FG006|Tumor Type - Dnet In Noonan's Syndrome Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||1||
59973068|NCT02639546|76090664|FG007|Tumor Type - Dnet In Noonan's Syndrome Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0||
59973069|NCT02639546|76090657|FG000|Tumor Type - Malignant Peripheral Nerve Sheath Tumor|Overall Study||0||
59973070|NCT02639546|76090658|FG001|Tumor Type - Malignant Peripheral Nerve Sheath Tumor|Overall Study||0||
59973071|NCT02639546|76090659|FG002|Tumor Type - Malignant Peripheral Nerve Sheath Tumor|Overall Study||0||
59973072|NCT02639546|76090660|FG003|Tumor Type - Malignant Peripheral Nerve Sheath Tumor|Overall Study||0||
59973073|NCT02639546|76090661|FG004|Tumor Type - Malignant Peripheral Nerve Sheath Tumor|Overall Study||1||
59973074|NCT02639546|76090662|FG005|Tumor Type - Malignant Peripheral Nerve Sheath Tumor|Overall Study||1||
59973075|NCT02639546|76090663|FG006|Tumor Type - Malignant Peripheral Nerve Sheath Tumor|Overall Study||0||
59973076|NCT02639546|76090664|FG007|Tumor Type - Malignant Peripheral Nerve Sheath Tumor|Overall Study||0||
59973077|NCT02639546|76090657|FG000|Tumor Type - Metastatic Mediastinal Yolksac Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||1||
59973078|NCT02639546|76090658|FG001|Tumor Type - Metastatic Mediastinal Yolksac Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0||
59973079|NCT02639546|76090659|FG002|Tumor Type - Metastatic Mediastinal Yolksac Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0||
59973080|NCT02639546|76090660|FG003|Tumor Type - Metastatic Mediastinal Yolksac Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0||
59973081|NCT02639546|76090661|FG004|Tumor Type - Metastatic Mediastinal Yolksac Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0||
59973082|NCT02639546|76090662|FG005|Tumor Type - Metastatic Mediastinal Yolksac Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0||
59973083|NCT02639546|76090663|FG006|Tumor Type - Metastatic Mediastinal Yolksac Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0||
59973084|NCT02639546|76090664|FG007|Tumor Type - Metastatic Mediastinal Yolksac Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0||
59973085|NCT02639546|76090657|FG000|Tumor Type - Non-Rhabdomyosarcoma Soft Tissue Sarcoma|Overall Study||0||
59973086|NCT02639546|76090658|FG001|Tumor Type - Non-Rhabdomyosarcoma Soft Tissue Sarcoma|Overall Study||1||
59973087|NCT02639546|76090659|FG002|Tumor Type - Non-Rhabdomyosarcoma Soft Tissue Sarcoma|Overall Study||0||
59973088|NCT02639546|76090660|FG003|Tumor Type - Non-Rhabdomyosarcoma Soft Tissue Sarcoma|Overall Study||0||
59973089|NCT02639546|76090661|FG004|Tumor Type - Non-Rhabdomyosarcoma Soft Tissue Sarcoma|Overall Study||0||
59973090|NCT02639546|76090662|FG005|Tumor Type - Non-Rhabdomyosarcoma Soft Tissue Sarcoma|Overall Study||0||
59973091|NCT02639546|76090663|FG006|Tumor Type - Non-Rhabdomyosarcoma Soft Tissue Sarcoma|Overall Study||0||
59973092|NCT02639546|76090664|FG007|Tumor Type - Non-Rhabdomyosarcoma Soft Tissue Sarcoma|Overall Study||0||
59973093|NCT02639546|76090657|FG000|Tumor Type - Plexiform Neurofibroma|Overall Study||1||
59973094|NCT02639546|76090658|FG001|Tumor Type - Plexiform Neurofibroma|Overall Study||2||
59973095|NCT02639546|76090659|FG002|Tumor Type - Plexiform Neurofibroma|Overall Study||1||
59973096|NCT02639546|76090660|FG003|Tumor Type - Plexiform Neurofibroma|Overall Study||1||
59973097|NCT02639546|76090661|FG004|Tumor Type - Plexiform Neurofibroma|Overall Study||2||
59973098|NCT02639546|76090662|FG005|Tumor Type - Plexiform Neurofibroma|Overall Study||4||
59973099|NCT02639546|76090663|FG006|Tumor Type - Plexiform Neurofibroma|Overall Study||1||
59973100|NCT02639546|76090664|FG007|Tumor Type - Plexiform Neurofibroma|Overall Study||0||
59973101|NCT02639546|76090657|FG000|Tumor Type - Rhabdoid Tumor/ATRT|Overall Study||0||
59973102|NCT02639546|76090658|FG001|Tumor Type - Rhabdoid Tumor/ATRT|Overall Study||0||
59973103|NCT02639546|76090659|FG002|Tumor Type - Rhabdoid Tumor/ATRT|Overall Study||0||
59973104|NCT02639546|76090660|FG003|Tumor Type - Rhabdoid Tumor/ATRT|Overall Study||0||
59973105|NCT02639546|76090661|FG004|Tumor Type - Rhabdoid Tumor/ATRT|Overall Study||0||
59973106|NCT02639546|76090662|FG005|Tumor Type - Rhabdoid Tumor/ATRT|Overall Study||1||
59973107|NCT02639546|76090663|FG006|Tumor Type - Rhabdoid Tumor/ATRT|Overall Study||0||
59973108|NCT02639546|76090664|FG007|Tumor Type - Rhabdoid Tumor/ATRT|Overall Study||0||
59973109|NCT02639546|76090657|FG000|COMPLETED|Overall Study||0||
59973110|NCT02639546|76090658|FG001|COMPLETED|Overall Study||0||
59973111|NCT02639546|76090659|FG002|COMPLETED|Overall Study||0||
59973112|NCT02639546|76090660|FG003|COMPLETED|Overall Study||0||
59973113|NCT02639546|76090661|FG004|COMPLETED|Overall Study||0||
59973114|NCT02639546|76090662|FG005|COMPLETED|Overall Study||0||
59973115|NCT02639546|76090663|FG006|COMPLETED|Overall Study||0||
59973116|NCT02639546|76090664|FG007|COMPLETED|Overall Study||0||
59973117|NCT02639546|76090657|FG000|NOT COMPLETED|Overall Study||6||
59973118|NCT02639546|76090658|FG001|NOT COMPLETED|Overall Study||6||
59973119|NCT02639546|76090659|FG002|NOT COMPLETED|Overall Study||6||
59973120|NCT02639546|76090660|FG003|NOT COMPLETED|Overall Study||6||
59973121|NCT02639546|76090661|FG004|NOT COMPLETED|Overall Study||7||
59973122|NCT02639546|76090662|FG005|NOT COMPLETED|Overall Study||8||
59973123|NCT02639546|76090663|FG006|NOT COMPLETED|Overall Study||5||
59973124|NCT02639546|76090664|FG007|NOT COMPLETED|Overall Study||12||
59973125|NCT02639390|76090698|FG000|STARTED|Overall Study||0||
59973126|NCT02639390|76090699|FG001|STARTED|Overall Study||5||
59973127|NCT02639390|76090698|FG000|COMPLETED|Overall Study||0||
60074535|NCT01807520|76189935|FG003|COMPLETED|Treatment Period 1 (0-16 Weeks)||0||
59973128|NCT02639390|76090699|FG001|COMPLETED|Overall Study||3||
59973129|NCT02639390|76090698|FG000|NOT COMPLETED|Overall Study||0||
59973130|NCT02639390|76090699|FG001|NOT COMPLETED|Overall Study||2||
59973131|NCT02718417|76090708|FG000|STARTED|Chemotherapy Phase (CP)||332||
59973132|NCT02718417|76090709|FG001|STARTED|Chemotherapy Phase (CP)||331||
59973133|NCT02718417|76090710|FG002|STARTED|Chemotherapy Phase (CP)||335||
59973134|NCT02718417|76090708|FG000|Safety Population|Chemotherapy Phase (CP)||328|Participants who had received at least one dose of study drug|
59973135|NCT02718417|76090709|FG001|Safety Population|Chemotherapy Phase (CP)||329|Participants who had received at least one dose of study drug|
59973136|NCT02718417|76090710|FG002|Safety Population|Chemotherapy Phase (CP)||334|Participants who had received at least one dose of study drug|
59973137|NCT02718417|76090708|FG000|COMPLETED|Chemotherapy Phase (CP)||280||
59973138|NCT02718417|76090709|FG001|COMPLETED|Chemotherapy Phase (CP)||294||
59973139|NCT02718417|76090710|FG002|COMPLETED|Chemotherapy Phase (CP)||289||
59973140|NCT02718417|76090708|FG000|NOT COMPLETED|Chemotherapy Phase (CP)||52||
59973141|NCT02718417|76090709|FG001|NOT COMPLETED|Chemotherapy Phase (CP)||37||
59973142|NCT02718417|76090710|FG002|NOT COMPLETED|Chemotherapy Phase (CP)||46||
59973143|NCT02718417|76090708|FG000|STARTED|Maintenance Phase (MP)|Included participants without evidence of disease progression at the end of Chemotherapy phase.|267||
59973144|NCT02718417|76090709|FG001|STARTED|Maintenance Phase (MP)|Included participants without evidence of disease progression at the end of Chemotherapy phase.|288||
59525573|NCT02969525|75620939|FG002|Completed Wk12 and Started Dose-Blind|Double-Blind Period||40||
59525574|NCT02969525|75620940|FG003|Completed Wk12 and Started Dose-Blind|Double-Blind Period||37||
59525575|NCT02969525|75620941|FG004|Completed Wk12 and Started Dose-Blind|Double-Blind Period||41||
59525576|NCT02969525|75620942|FG005|Completed Wk12 and Started Dose-Blind|Double-Blind Period||0||
59525577|NCT02969525|75620943|FG006|Completed Wk12 and Started Dose-Blind|Double-Blind Period||0||
59525578|NCT02969525|75620944|FG007|Completed Wk12 and Started Dose-Blind|Double-Blind Period||0||
59525579|NCT02969525|75620945|FG008|Completed Wk12 and Started Dose-Blind|Double-Blind Period||0||
59525580|NCT02969525|75620946|FG009|Completed Wk12 and Started Dose-Blind|Double-Blind Period||0||
59525581|NCT02969525|75620947|FG010|Completed Wk12 and Started Dose-Blind|Double-Blind Period||0||
59525582|NCT02969525|75620948|FG011|Completed Wk12 and Started Dose-Blind|Double-Blind Period||0||
59525583|NCT02969525|75620937|FG000|COMPLETED|Double-Blind Period||40||
59525584|NCT02969525|75620938|FG001|COMPLETED|Double-Blind Period||41||
59525585|NCT02969525|75620939|FG002|COMPLETED|Double-Blind Period||40||
59525586|NCT02969525|75620940|FG003|COMPLETED|Double-Blind Period||37||
59525587|NCT02969525|75620941|FG004|COMPLETED|Double-Blind Period||41||
59525588|NCT02969525|75620942|FG005|COMPLETED|Double-Blind Period||0||
59525589|NCT02969525|75620943|FG006|COMPLETED|Double-Blind Period||0||
59525590|NCT02969525|75620944|FG007|COMPLETED|Double-Blind Period||0||
59525591|NCT02969525|75620945|FG008|COMPLETED|Double-Blind Period||0||
59525592|NCT02969525|75620946|FG009|COMPLETED|Double-Blind Period||0||
59525593|NCT02969525|75620947|FG010|COMPLETED|Double-Blind Period||0||
59525594|NCT02969525|75620948|FG011|COMPLETED|Double-Blind Period||0||
59525595|NCT02969525|75620937|FG000|NOT COMPLETED|Double-Blind Period||2||
59525596|NCT02969525|75620938|FG001|NOT COMPLETED|Double-Blind Period||0||
59525597|NCT02969525|75620939|FG002|NOT COMPLETED|Double-Blind Period||1||
59525598|NCT02969525|75620940|FG003|NOT COMPLETED|Double-Blind Period||4||
59525599|NCT02969525|75620941|FG004|NOT COMPLETED|Double-Blind Period||0||
59973145|NCT02718417|76090710|FG002|STARTED|Maintenance Phase (MP)|After completing CP, participants moved to observation phase. MP was not applicable for this arm.|0||
59973146|NCT02718417|76090708|FG000|COMPLETED|Maintenance Phase (MP)||1||
59973147|NCT02718417|76090709|FG001|COMPLETED|Maintenance Phase (MP)||1||
59973148|NCT02718417|76090710|FG002|COMPLETED|Maintenance Phase (MP)||0||
59973149|NCT02718417|76090708|FG000|NOT COMPLETED|Maintenance Phase (MP)||266||
59973150|NCT02718417|76090709|FG001|NOT COMPLETED|Maintenance Phase (MP)||287||
59973151|NCT02718417|76090710|FG002|NOT COMPLETED|Maintenance Phase (MP)||0||
59973152|NCT02718417|76090708|FG000|STARTED|Observation Phase (OP)|After completing MP, participants moved to follow-up phase. OP was not applicable.|0||
59994954|NCT00462943|76110771|FG000|COMPLETED|Overall Study||1||
59994955|NCT00462943|76110772|FG001|COMPLETED|Overall Study||1||
59994956|NCT00462943|76110773|FG002|COMPLETED|Overall Study||0||
59994957|NCT00462943|76110771|FG000|NOT COMPLETED|Overall Study||45||
59994958|NCT00462943|76110772|FG001|NOT COMPLETED|Overall Study||30||
59994959|NCT00462943|76110773|FG002|NOT COMPLETED|Overall Study||23||
59525600|NCT02969525|75620942|FG005|NOT COMPLETED|Double-Blind Period||0||
59525601|NCT02969525|75620943|FG006|NOT COMPLETED|Double-Blind Period||0||
59525602|NCT02969525|75620944|FG007|NOT COMPLETED|Double-Blind Period||0||
59525603|NCT02969525|75620945|FG008|NOT COMPLETED|Double-Blind Period||0||
59525604|NCT02969525|75620946|FG009|NOT COMPLETED|Double-Blind Period||0||
59525605|NCT02969525|75620947|FG010|NOT COMPLETED|Double-Blind Period||0||
59525606|NCT02969525|75620948|FG011|NOT COMPLETED|Double-Blind Period||0||
59525607|NCT02969525|75620937|FG000|STARTED|Dose-Blind Period||0||
59525608|NCT02969525|75620938|FG001|STARTED|Dose-Blind Period||0||
59525609|NCT02969525|75620939|FG002|STARTED|Dose-Blind Period||0||
59525610|NCT02969525|75620940|FG003|STARTED|Dose-Blind Period||0||
59525611|NCT02969525|75620941|FG004|STARTED|Dose-Blind Period||0||
59525612|NCT02969525|75620942|FG005|STARTED|Dose-Blind Period||20||
59994960|NCT04409041|76110781|FG000|STARTED|Overall Study||43||
59994961|NCT04409041|76110781|FG000|COMPLETED|Overall Study||26||
59973153|NCT02718417|76090709|FG001|STARTED|Observation Phase (OP)|After completing MP, participants moved to follow-up phase. OP was not applicable.|0||
59973154|NCT02718417|76090710|FG002|STARTED|Observation Phase (OP)|Included participants without evidence of disease progression at the end of Chemotherapy phase.|284||
59973155|NCT02718417|76090708|FG000|COMPLETED|Observation Phase (OP)||0||
59973156|NCT02718417|76090709|FG001|COMPLETED|Observation Phase (OP)||0||
59973157|NCT02718417|76090710|FG002|COMPLETED|Observation Phase (OP)||2||
59973158|NCT02718417|76090708|FG000|NOT COMPLETED|Observation Phase (OP)||0||
59973159|NCT02718417|76090709|FG001|NOT COMPLETED|Observation Phase (OP)||0||
59973160|NCT02718417|76090710|FG002|NOT COMPLETED|Observation Phase (OP)||282||
59973161|NCT02718417|76090708|FG000|STARTED|Follow-up Phase|Participants not completing MP could also start this phase.|238||
59973162|NCT02718417|76090709|FG001|STARTED|Follow-up Phase|Participants not completing MP could also start this phase.|263||
59973163|NCT02718417|76090710|FG002|STARTED|Follow-up Phase|Participants not completing OP could also start this phase.|39||
59973164|NCT02718417|76090708|FG000|COMPLETED|Follow-up Phase||103||
59973165|NCT02718417|76090709|FG001|COMPLETED|Follow-up Phase||91||
59973166|NCT02718417|76090710|FG002|COMPLETED|Follow-up Phase||20||
59973167|NCT02718417|76090708|FG000|NOT COMPLETED|Follow-up Phase||135||
59973168|NCT02718417|76090709|FG001|NOT COMPLETED|Follow-up Phase||172||
59973169|NCT02718417|76090710|FG002|NOT COMPLETED|Follow-up Phase||19||
59973170|NCT02718417|76090708|FG000|STARTED|Long-term Follow-up Phase|Participants not completing follow-up phase could also start this phase.|139||
59973171|NCT02718417|76090709|FG001|STARTED|Long-term Follow-up Phase|Participants not completing follow-up phase could also start this phase.|112||
59973172|NCT02718417|76090710|FG002|STARTED|Long-term Follow-up Phase|Participants not completing follow-up could also start this phase.|135||
59973173|NCT02718417|76090708|FG000|COMPLETED|Long-term Follow-up Phase||0||
59973174|NCT02718417|76090709|FG001|COMPLETED|Long-term Follow-up Phase||0||
59973175|NCT02718417|76090710|FG002|COMPLETED|Long-term Follow-up Phase||0||
59973176|NCT02718417|76090708|FG000|NOT COMPLETED|Long-term Follow-up Phase||139||
59973177|NCT02718417|76090709|FG001|NOT COMPLETED|Long-term Follow-up Phase||112||
59973178|NCT02718417|76090710|FG002|NOT COMPLETED|Long-term Follow-up Phase||135||
59973179|NCT02640404|76090727|FG000|STARTED|Overall Study||112||
59973180|NCT02640404|76090728|FG001|STARTED|Overall Study||112||
59973181|NCT02640404|76090727|FG000|COMPLETED|Overall Study||110||
59973182|NCT02640404|76090728|FG001|COMPLETED|Overall Study||112||
59973183|NCT02640404|76090727|FG000|NOT COMPLETED|Overall Study||2||
59973184|NCT02640404|76090728|FG001|NOT COMPLETED|Overall Study||0||
59973185|NCT00701727|76090734|FG000|STARTED|First Treatment Period||16||
59973186|NCT00701727|76090735|FG001|STARTED|First Treatment Period||15||
59973187|NCT00701727|76090734|FG000|COMPLETED|First Treatment Period||15||
59973188|NCT00701727|76090735|FG001|COMPLETED|First Treatment Period||13||
59973189|NCT00701727|76090734|FG000|NOT COMPLETED|First Treatment Period||1||
59973190|NCT00701727|76090735|FG001|NOT COMPLETED|First Treatment Period||2||
59973191|NCT00701727|76090734|FG000|STARTED|Second Treatment Period||15||
59973192|NCT00701727|76090735|FG001|STARTED|Second Treatment Period||13||
59973193|NCT00701727|76090734|FG000|COMPLETED|Second Treatment Period||13||
59973194|NCT00701727|76090735|FG001|COMPLETED|Second Treatment Period||13||
59973195|NCT00701727|76090734|FG000|NOT COMPLETED|Second Treatment Period||2||
59973196|NCT00701727|76090735|FG001|NOT COMPLETED|Second Treatment Period||0||
59973197|NCT04155008|76090743|FG000|STARTED|Overall Study||0||
59973198|NCT04155008|76090744|FG001|STARTED|Overall Study||1||
59973199|NCT04155008|76090743|FG000|COMPLETED|Overall Study||0||
59973200|NCT04155008|76090744|FG001|COMPLETED|Overall Study||1||
59973201|NCT04155008|76090743|FG000|NOT COMPLETED|Overall Study||0||
59973202|NCT04155008|76090744|FG001|NOT COMPLETED|Overall Study||0||
59973203|NCT01369069|76090752|FG000|STARTED|Overall Study||581||
59973204|NCT01369069|76090753|FG001|STARTED|Overall Study||570||
59973205|NCT01369069|76090752|FG000|COMPLETED|Overall Study||564||
59973206|NCT01369069|76090753|FG001|COMPLETED|Overall Study||554||
59973207|NCT01369069|76090752|FG000|NOT COMPLETED|Overall Study||17||
59973208|NCT01369069|76090753|FG001|NOT COMPLETED|Overall Study||16||
59973209|NCT02441218|76090761|FG000|STARTED|Overall Study||3241||
59973210|NCT02441218|76090762|FG001|STARTED|Overall Study||3264||
60074536|NCT01807520|76189936|FG004|COMPLETED|Treatment Period 1 (0-16 Weeks)||0||
60074537|NCT01807520|76189937|FG005|COMPLETED|Treatment Period 1 (0-16 Weeks)||0||
59973211|NCT02441218|76090761|FG000|COMPLETED|Overall Study||2663||
59973212|NCT02441218|76090762|FG001|COMPLETED|Overall Study||2652||
59973213|NCT02441218|76090761|FG000|NOT COMPLETED|Overall Study||578||
59973214|NCT02441218|76090762|FG001|NOT COMPLETED|Overall Study||612||
59973215|NCT02410252|76090768|FG000|STARTED|Overall Study||25||
59973216|NCT02410252|76090768|FG000|COMPLETED|Overall Study||19||
59973217|NCT02410252|76090768|FG000|NOT COMPLETED|Overall Study||6||
59973218|NCT02440594|76090782|FG000|STARTED|Overall Study||509||
59973219|NCT02440594|76090783|FG001|STARTED|Overall Study||509||
59973220|NCT02440594|76090784|FG002|STARTED|Overall Study||436||
59973221|NCT02440594|76090785|FG003|STARTED|Overall Study||429||
59973222|NCT02440594|76090786|FG004|STARTED|Overall Study||55||
60074538|NCT01807520|76189938|FG006|COMPLETED|Treatment Period 1 (0-16 Weeks)||0||
60074539|NCT01807520|76189932|FG000|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||4||
60074540|NCT01807520|76189933|FG001|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||1||
59973223|NCT02440594|76090787|FG005|STARTED|Overall Study||54||
59973224|NCT02440594|76090788|FG006|STARTED|Overall Study||150||
59973225|NCT02440594|76090789|FG007|STARTED|Overall Study||290||
59973226|NCT02440594|76090782|FG000|COMPLETED|Overall Study||377|Completed numbers reflect number completing 2 or more follow-ups assessments|
59973227|NCT02440594|76090783|FG001|COMPLETED|Overall Study||401|Completed numbers reflect number completing 2 or more follow-ups assessments|
59973228|NCT02440594|76090784|FG002|COMPLETED|Overall Study||319|Completed numbers reflect number completing 2 or more follow-ups assessments|
59973229|NCT02440594|76090785|FG003|COMPLETED|Overall Study||340|Completed numbers reflect number completing 2 or more follow-ups assessments|
59973230|NCT02440594|76090786|FG004|COMPLETED|Overall Study||46|Completed numbers reflect number completing 2 or more follow-ups assessments|
59973231|NCT02440594|76090787|FG005|COMPLETED|Overall Study||47|Completed numbers reflect number completing 2 or more follow-ups assessments|
59973232|NCT02440594|76090788|FG006|COMPLETED|Overall Study||113|Completed numbers reflect number completing 2 or more follow-ups assessments|
59973233|NCT02440594|76090789|FG007|COMPLETED|Overall Study||234|Completed numbers reflect number completing 2 or more follow-ups assessments|
59973234|NCT02440594|76090782|FG000|NOT COMPLETED|Overall Study||132||
59973235|NCT02440594|76090783|FG001|NOT COMPLETED|Overall Study||108||
59973236|NCT02440594|76090784|FG002|NOT COMPLETED|Overall Study||117||
59973237|NCT02440594|76090785|FG003|NOT COMPLETED|Overall Study||89||
59973238|NCT02440594|76090786|FG004|NOT COMPLETED|Overall Study||9||
59973239|NCT02440594|76090787|FG005|NOT COMPLETED|Overall Study||7||
59973240|NCT02440594|76090788|FG006|NOT COMPLETED|Overall Study||37||
59973241|NCT02440594|76090789|FG007|NOT COMPLETED|Overall Study||56||
59973242|NCT03836001|76090816|FG000|STARTED|Blinded Phase (2 Months)||12||
59973243|NCT03836001|76090817|FG001|STARTED|Blinded Phase (2 Months)||12||
59973244|NCT03836001|76090818|FG002|STARTED|Blinded Phase (2 Months)||0||
59973245|NCT03836001|76090816|FG000|COMPLETED|Blinded Phase (2 Months)||12||
59973246|NCT03836001|76090817|FG001|COMPLETED|Blinded Phase (2 Months)||10||
59973247|NCT03836001|76090818|FG002|COMPLETED|Blinded Phase (2 Months)||0||
59973248|NCT03836001|76090816|FG000|NOT COMPLETED|Blinded Phase (2 Months)||0||
59973249|NCT03836001|76090817|FG001|NOT COMPLETED|Blinded Phase (2 Months)||2||
59973250|NCT03836001|76090818|FG002|NOT COMPLETED|Blinded Phase (2 Months)||0||
59973251|NCT03836001|76090816|FG000|STARTED|Washout (1 Month)||12||
59973252|NCT03836001|76090817|FG001|STARTED|Washout (1 Month)||10||
59973253|NCT03836001|76090818|FG002|STARTED|Washout (1 Month)||0||
59973254|NCT03836001|76090816|FG000|COMPLETED|Washout (1 Month)|6 participants continued into the open label extension.|12||
59973255|NCT03836001|76090817|FG001|COMPLETED|Washout (1 Month)|4 participants continued into the open label extension.|10||
59973256|NCT03836001|76090818|FG002|COMPLETED|Washout (1 Month)||0||
59973257|NCT03836001|76090816|FG000|NOT COMPLETED|Washout (1 Month)||0||
59973258|NCT03836001|76090817|FG001|NOT COMPLETED|Washout (1 Month)||0||
59973259|NCT03836001|76090818|FG002|NOT COMPLETED|Washout (1 Month)||0||
59973260|NCT03836001|76090816|FG000|STARTED|Open-label Extension (3 or 12 Months)||0||
59973261|NCT03836001|76090817|FG001|STARTED|Open-label Extension (3 or 12 Months)||0||
59973262|NCT03836001|76090818|FG002|STARTED|Open-label Extension (3 or 12 Months)||10||
59973263|NCT03836001|76090816|FG000|Entered 12-month Follow-up Period|Open-label Extension (3 or 12 Months)||0||
59973264|NCT03836001|76090817|FG001|Entered 12-month Follow-up Period|Open-label Extension (3 or 12 Months)||0||
59973265|NCT03836001|76090818|FG002|Entered 12-month Follow-up Period|Open-label Extension (3 or 12 Months)||2||
59973266|NCT03836001|76090816|FG000|Entered 3-month Follow-up Period|Open-label Extension (3 or 12 Months)||0||
59973267|NCT03836001|76090817|FG001|Entered 3-month Follow-up Period|Open-label Extension (3 or 12 Months)||0||
59973268|NCT03836001|76090818|FG002|Entered 3-month Follow-up Period|Open-label Extension (3 or 12 Months)||8||
59973269|NCT03836001|76090816|FG000|COMPLETED|Open-label Extension (3 or 12 Months)||0||
60074541|NCT01807520|76189934|FG002|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||7||
60074542|NCT01807520|76189935|FG003|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||0||
59622093|NCT00462072|75733857|FG001|NOT COMPLETED|Week 10||0||
59622094|NCT00462072|75733858|FG002|NOT COMPLETED|Week 10||0||
59622095|NCT00462228|75733870|FG000|STARTED|Memantine or Placebo 12 Weeks||11||
59622096|NCT00462228|75733870|FG000|COMPLETED|Memantine or Placebo 12 Weeks||11||
59622097|NCT00462228|75733870|FG000|NOT COMPLETED|Memantine or Placebo 12 Weeks||0||
59622098|NCT00462228|75733870|FG000|STARTED|No Treatment (Washout) 4 Weeks||11||
59622099|NCT00462228|75733870|FG000|COMPLETED|No Treatment (Washout) 4 Weeks||11||
59622100|NCT00462228|75733870|FG000|NOT COMPLETED|No Treatment (Washout) 4 Weeks||0||
59622101|NCT00462228|75733870|FG000|STARTED|Placebo or Memantine 12 Weeks||11||
59622102|NCT00462228|75733870|FG000|COMPLETED|Placebo or Memantine 12 Weeks||11||
59622103|NCT00462228|75733870|FG000|NOT COMPLETED|Placebo or Memantine 12 Weeks||0||
59622104|NCT00462228|75733870|FG000|STARTED|No Treatment (Washout) 4 Weeks||11||
59622105|NCT00462228|75733870|FG000|COMPLETED|No Treatment (Washout) 4 Weeks||11||
59622106|NCT00462228|75733870|FG000|NOT COMPLETED|No Treatment (Washout) 4 Weeks||0||
59622107|NCT00408564|75733877|FG000|STARTED|Overall Study||39||
59622108|NCT00408564|75733877|FG000|COMPLETED|Overall Study||39||
59622109|NCT00408564|75733877|FG000|NOT COMPLETED|Overall Study||0||
59973270|NCT03836001|76090817|FG001|COMPLETED|Open-label Extension (3 or 12 Months)||0||
59973271|NCT03836001|76090818|FG002|COMPLETED|Open-label Extension (3 or 12 Months)||8||
60103604|NCT01291108|76221867|FG004|STARTED|Month 1 (Monotherapy)||0||
59622110|NCT02110758|75733887|FG000|STARTED|Baseline: August 2011-July 2013||0||
59973272|NCT03836001|76090816|FG000|NOT COMPLETED|Open-label Extension (3 or 12 Months)||0||
59973273|NCT03836001|76090817|FG001|NOT COMPLETED|Open-label Extension (3 or 12 Months)||0||
59973274|NCT03836001|76090818|FG002|NOT COMPLETED|Open-label Extension (3 or 12 Months)||2||
59973275|NCT02465866|76090825|FG000|STARTED|Period 1||5||
59973276|NCT02465866|76090826|FG001|STARTED|Period 1||5||
59973277|NCT02465866|76090827|FG002|STARTED|Period 1||5||
59973278|NCT02465866|76090828|FG003|STARTED|Period 1||5||
59973279|NCT02465866|76090825|FG000|COMPLETED|Period 1||5||
59973280|NCT02465866|76090826|FG001|COMPLETED|Period 1||5||
59973281|NCT02465866|76090827|FG002|COMPLETED|Period 1||5||
59973282|NCT02465866|76090828|FG003|COMPLETED|Period 1||5||
59973283|NCT02465866|76090825|FG000|NOT COMPLETED|Period 1||0||
59973284|NCT02465866|76090826|FG001|NOT COMPLETED|Period 1||0||
59973285|NCT02465866|76090827|FG002|NOT COMPLETED|Period 1||0||
59973286|NCT02465866|76090828|FG003|NOT COMPLETED|Period 1||0||
59973287|NCT02465866|76090825|FG000|STARTED|Period 1: Washout (14 Days)||5||
59973288|NCT02465866|76090826|FG001|STARTED|Period 1: Washout (14 Days)||5||
59973289|NCT02465866|76090827|FG002|STARTED|Period 1: Washout (14 Days)||5||
59973290|NCT02465866|76090828|FG003|STARTED|Period 1: Washout (14 Days)||5||
59973291|NCT02465866|76090825|FG000|COMPLETED|Period 1: Washout (14 Days)||5||
59973292|NCT02465866|76090826|FG001|COMPLETED|Period 1: Washout (14 Days)||5||
59973293|NCT02465866|76090827|FG002|COMPLETED|Period 1: Washout (14 Days)||5||
59973294|NCT02465866|76090828|FG003|COMPLETED|Period 1: Washout (14 Days)||5||
59973295|NCT02465866|76090825|FG000|NOT COMPLETED|Period 1: Washout (14 Days)||0||
59973296|NCT02465866|76090826|FG001|NOT COMPLETED|Period 1: Washout (14 Days)||0||
59973297|NCT02465866|76090827|FG002|NOT COMPLETED|Period 1: Washout (14 Days)||0||
59973298|NCT02465866|76090828|FG003|NOT COMPLETED|Period 1: Washout (14 Days)||0||
59973299|NCT02465866|76090825|FG000|STARTED|Period 2||5||
59973300|NCT02465866|76090826|FG001|STARTED|Period 2||5||
59973301|NCT02465866|76090827|FG002|STARTED|Period 2||5||
59973302|NCT02465866|76090828|FG003|STARTED|Period 2||5||
59973303|NCT02465866|76090825|FG000|COMPLETED|Period 2||5||
59973304|NCT02465866|76090826|FG001|COMPLETED|Period 2||5||
59973305|NCT02465866|76090827|FG002|COMPLETED|Period 2||5||
59973306|NCT02465866|76090828|FG003|COMPLETED|Period 2||5||
59973307|NCT02465866|76090825|FG000|NOT COMPLETED|Period 2||0||
59973308|NCT02465866|76090826|FG001|NOT COMPLETED|Period 2||0||
59973309|NCT02465866|76090827|FG002|NOT COMPLETED|Period 2||0||
59973310|NCT02465866|76090828|FG003|NOT COMPLETED|Period 2||0||
59973311|NCT02465866|76090825|FG000|STARTED|Period 2: Washout (14 Days)||5||
59973312|NCT02465866|76090826|FG001|STARTED|Period 2: Washout (14 Days)||5||
59973313|NCT02465866|76090827|FG002|STARTED|Period 2: Washout (14 Days)||5||
59973314|NCT02465866|76090828|FG003|STARTED|Period 2: Washout (14 Days)||5||
59973315|NCT02465866|76090825|FG000|COMPLETED|Period 2: Washout (14 Days)||5||
59973316|NCT02465866|76090826|FG001|COMPLETED|Period 2: Washout (14 Days)||5||
59973317|NCT02465866|76090827|FG002|COMPLETED|Period 2: Washout (14 Days)||5||
59973318|NCT02465866|76090828|FG003|COMPLETED|Period 2: Washout (14 Days)||5||
59973319|NCT02465866|76090825|FG000|NOT COMPLETED|Period 2: Washout (14 Days)||0||
59973320|NCT02465866|76090826|FG001|NOT COMPLETED|Period 2: Washout (14 Days)||0||
59973321|NCT02465866|76090827|FG002|NOT COMPLETED|Period 2: Washout (14 Days)||0||
59973322|NCT02465866|76090828|FG003|NOT COMPLETED|Period 2: Washout (14 Days)||0||
59973323|NCT02465866|76090825|FG000|STARTED|Period 3||5||
59973324|NCT02465866|76090826|FG001|STARTED|Period 3||5||
59973325|NCT02465866|76090827|FG002|STARTED|Period 3||5||
59973326|NCT02465866|76090828|FG003|STARTED|Period 3||5||
59973327|NCT02465866|76090825|FG000|COMPLETED|Period 3||5||
59973328|NCT02465866|76090826|FG001|COMPLETED|Period 3||4||
59973329|NCT02465866|76090827|FG002|COMPLETED|Period 3||5||
59973330|NCT02465866|76090828|FG003|COMPLETED|Period 3||5||
59973331|NCT02465866|76090825|FG000|NOT COMPLETED|Period 3||0||
59973332|NCT02465866|76090826|FG001|NOT COMPLETED|Period 3||1||
59973333|NCT02465866|76090827|FG002|NOT COMPLETED|Period 3||0||
59973334|NCT02465866|76090828|FG003|NOT COMPLETED|Period 3||0||
60074543|NCT01807520|76189936|FG004|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||0||
60074544|NCT01807520|76189937|FG005|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||0||
60074545|NCT01807520|76189938|FG006|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||0||
60074546|NCT01807520|76189932|FG000|STARTED|Treatment Period 2 (16-132 Weeks)||63||
60074547|NCT01807520|76189933|FG001|STARTED|Treatment Period 2 (16-132 Weeks)||65||
59973335|NCT02465866|76090825|FG000|STARTED|Period 3: Washout (14 Days)||5||
59973336|NCT02465866|76090826|FG001|STARTED|Period 3: Washout (14 Days)||4||
59973337|NCT02465866|76090827|FG002|STARTED|Period 3: Washout (14 Days)||5||
59973338|NCT02465866|76090828|FG003|STARTED|Period 3: Washout (14 Days)||5||
59973339|NCT02465866|76090825|FG000|COMPLETED|Period 3: Washout (14 Days)||5||
59973340|NCT02465866|76090826|FG001|COMPLETED|Period 3: Washout (14 Days)||4||
59973341|NCT02465866|76090827|FG002|COMPLETED|Period 3: Washout (14 Days)||5||
59973342|NCT02465866|76090828|FG003|COMPLETED|Period 3: Washout (14 Days)||5||
59973343|NCT02465866|76090825|FG000|NOT COMPLETED|Period 3: Washout (14 Days)||0||
59973344|NCT02465866|76090826|FG001|NOT COMPLETED|Period 3: Washout (14 Days)||0||
59973345|NCT02465866|76090827|FG002|NOT COMPLETED|Period 3: Washout (14 Days)||0||
59973346|NCT02465866|76090828|FG003|NOT COMPLETED|Period 3: Washout (14 Days)||0||
59973347|NCT02465866|76090825|FG000|STARTED|Period 4||5||
59973348|NCT02465866|76090826|FG001|STARTED|Period 4||4||
59973349|NCT02465866|76090827|FG002|STARTED|Period 4||5||
59973350|NCT02465866|76090828|FG003|STARTED|Period 4||5||
59973351|NCT02465866|76090825|FG000|COMPLETED|Period 4||5||
59973352|NCT02465866|76090826|FG001|COMPLETED|Period 4||4||
59973353|NCT02465866|76090827|FG002|COMPLETED|Period 4||5||
59973354|NCT02465866|76090828|FG003|COMPLETED|Period 4||5||
59973355|NCT02465866|76090825|FG000|NOT COMPLETED|Period 4||0||
59973356|NCT02465866|76090826|FG001|NOT COMPLETED|Period 4||0||
59973357|NCT02465866|76090827|FG002|NOT COMPLETED|Period 4||0||
59973358|NCT02465866|76090828|FG003|NOT COMPLETED|Period 4||0||
59973359|NCT02465866|76090825|FG000|STARTED|Period 4: Washout (14 Days)||5||
59973360|NCT02465866|76090826|FG001|STARTED|Period 4: Washout (14 Days)||4||
59973361|NCT02465866|76090827|FG002|STARTED|Period 4: Washout (14 Days)||5||
59973362|NCT02465866|76090828|FG003|STARTED|Period 4: Washout (14 Days)||5||
59973363|NCT02465866|76090825|FG000|COMPLETED|Period 4: Washout (14 Days)||5||
59973364|NCT02465866|76090826|FG001|COMPLETED|Period 4: Washout (14 Days)||4||
59973365|NCT02465866|76090827|FG002|COMPLETED|Period 4: Washout (14 Days)||5||
59973366|NCT02465866|76090828|FG003|COMPLETED|Period 4: Washout (14 Days)||5||
59973367|NCT02465866|76090825|FG000|NOT COMPLETED|Period 4: Washout (14 Days)||0||
59973368|NCT02465866|76090826|FG001|NOT COMPLETED|Period 4: Washout (14 Days)||0||
59973369|NCT02465866|76090827|FG002|NOT COMPLETED|Period 4: Washout (14 Days)||0||
59973370|NCT02465866|76090828|FG003|NOT COMPLETED|Period 4: Washout (14 Days)||0||
59973371|NCT02439970|76090840|FG000|STARTED|Overall Study||2||
59973372|NCT02439970|76090841|FG001|STARTED|Overall Study||3||
59973373|NCT02439970|76090840|FG000|COMPLETED|Overall Study||0||
59973374|NCT02439970|76090841|FG001|COMPLETED|Overall Study||0||
59973375|NCT02439970|76090840|FG000|NOT COMPLETED|Overall Study||2||
59973376|NCT02439970|76090841|FG001|NOT COMPLETED|Overall Study||3||
59973377|NCT02437864|76090849|FG000|STARTED|Overall Study||200||
59973378|NCT02437864|76090850|FG001|STARTED|Overall Study||160||
59973379|NCT02437864|76090849|FG000|COMPLETED|Overall Study||196||
59973380|NCT02437864|76090850|FG001|COMPLETED|Overall Study||160||
59973381|NCT02437864|76090849|FG000|NOT COMPLETED|Overall Study||4||
59973382|NCT02437864|76090850|FG001|NOT COMPLETED|Overall Study||0||
59973383|NCT02408068|76090856|FG000|STARTED|Treatment 1 (1.5 Days)||3||
59973384|NCT02408068|76090857|FG001|STARTED|Treatment 1 (1.5 Days)||3||
59973385|NCT02408068|76090858|FG002|STARTED|Treatment 1 (1.5 Days)||3||
59973386|NCT02408068|76090859|FG003|STARTED|Treatment 1 (1.5 Days)||3||
59973387|NCT02408068|76090860|FG004|STARTED|Treatment 1 (1.5 Days)||3||
59973388|NCT02408068|76090861|FG005|STARTED|Treatment 1 (1.5 Days)||3||
59973389|NCT02408068|76090856|FG000|COMPLETED|Treatment 1 (1.5 Days)||3||
59973390|NCT02408068|76090857|FG001|COMPLETED|Treatment 1 (1.5 Days)||3||
59973391|NCT02408068|76090858|FG002|COMPLETED|Treatment 1 (1.5 Days)||3||
59973392|NCT02408068|76090859|FG003|COMPLETED|Treatment 1 (1.5 Days)||3||
59973393|NCT02408068|76090860|FG004|COMPLETED|Treatment 1 (1.5 Days)||3||
59973394|NCT02408068|76090861|FG005|COMPLETED|Treatment 1 (1.5 Days)||3||
59973395|NCT02408068|76090856|FG000|NOT COMPLETED|Treatment 1 (1.5 Days)||0||
59973396|NCT02408068|76090857|FG001|NOT COMPLETED|Treatment 1 (1.5 Days)||0||
59973397|NCT02408068|76090858|FG002|NOT COMPLETED|Treatment 1 (1.5 Days)||0||
59973398|NCT02408068|76090859|FG003|NOT COMPLETED|Treatment 1 (1.5 Days)||0||
59973399|NCT02408068|76090860|FG004|NOT COMPLETED|Treatment 1 (1.5 Days)||0||
59973400|NCT02408068|76090861|FG005|NOT COMPLETED|Treatment 1 (1.5 Days)||0||
59973401|NCT02408068|76090856|FG000|STARTED|Washout Period 1 (7 Days)||3||
59973402|NCT02408068|76090857|FG001|STARTED|Washout Period 1 (7 Days)||3||
59973403|NCT02408068|76090858|FG002|STARTED|Washout Period 1 (7 Days)||3||
59973404|NCT02408068|76090859|FG003|STARTED|Washout Period 1 (7 Days)||3||
59973405|NCT02408068|76090860|FG004|STARTED|Washout Period 1 (7 Days)||3||
59973406|NCT02408068|76090861|FG005|STARTED|Washout Period 1 (7 Days)||3||
59973407|NCT02408068|76090856|FG000|COMPLETED|Washout Period 1 (7 Days)||3||
59973408|NCT02408068|76090857|FG001|COMPLETED|Washout Period 1 (7 Days)||3||
59973409|NCT02408068|76090858|FG002|COMPLETED|Washout Period 1 (7 Days)||3||
59973410|NCT02408068|76090859|FG003|COMPLETED|Washout Period 1 (7 Days)||3||
59973411|NCT02408068|76090860|FG004|COMPLETED|Washout Period 1 (7 Days)||3||
59973412|NCT02408068|76090861|FG005|COMPLETED|Washout Period 1 (7 Days)||3||
59973413|NCT02408068|76090856|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0||
59973414|NCT02408068|76090857|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0||
59973415|NCT02408068|76090858|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0||
59973416|NCT02408068|76090859|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0||
59973417|NCT02408068|76090860|FG004|NOT COMPLETED|Washout Period 1 (7 Days)||0||
59973418|NCT02408068|76090861|FG005|NOT COMPLETED|Washout Period 1 (7 Days)||0||
59973419|NCT02408068|76090856|FG000|STARTED|Treatment 2 (1.5 Days)||3||
59973420|NCT02408068|76090857|FG001|STARTED|Treatment 2 (1.5 Days)||3||
59973421|NCT02408068|76090858|FG002|STARTED|Treatment 2 (1.5 Days)||3||
59973422|NCT02408068|76090859|FG003|STARTED|Treatment 2 (1.5 Days)||3||
60074548|NCT01807520|76189934|FG002|STARTED|Treatment Period 2 (16-132 Weeks)||0||
59973423|NCT02408068|76090860|FG004|STARTED|Treatment 2 (1.5 Days)||3||
59973424|NCT02408068|76090861|FG005|STARTED|Treatment 2 (1.5 Days)||3||
59973425|NCT02408068|76090856|FG000|COMPLETED|Treatment 2 (1.5 Days)||3||
59973426|NCT02408068|76090857|FG001|COMPLETED|Treatment 2 (1.5 Days)||3||
59973427|NCT02408068|76090858|FG002|COMPLETED|Treatment 2 (1.5 Days)||3||
59973428|NCT02408068|76090859|FG003|COMPLETED|Treatment 2 (1.5 Days)||3||
59973429|NCT02408068|76090860|FG004|COMPLETED|Treatment 2 (1.5 Days)||3||
59973430|NCT02408068|76090861|FG005|COMPLETED|Treatment 2 (1.5 Days)||3||
59973431|NCT02408068|76090856|FG000|NOT COMPLETED|Treatment 2 (1.5 Days)||0||
59973432|NCT02408068|76090857|FG001|NOT COMPLETED|Treatment 2 (1.5 Days)||0||
59973433|NCT02408068|76090858|FG002|NOT COMPLETED|Treatment 2 (1.5 Days)||0||
59973434|NCT02408068|76090859|FG003|NOT COMPLETED|Treatment 2 (1.5 Days)||0||
59973435|NCT02408068|76090860|FG004|NOT COMPLETED|Treatment 2 (1.5 Days)||0||
59973436|NCT02408068|76090861|FG005|NOT COMPLETED|Treatment 2 (1.5 Days)||0||
59622111|NCT02110758|75733888|FG001|STARTED|Baseline: August 2011-July 2013||0||
59973437|NCT02408068|76090856|FG000|STARTED|Washout Period 2 (7 Days)||3||
59973438|NCT02408068|76090857|FG001|STARTED|Washout Period 2 (7 Days)||3||
59973439|NCT02408068|76090858|FG002|STARTED|Washout Period 2 (7 Days)||3||
59973440|NCT02408068|76090859|FG003|STARTED|Washout Period 2 (7 Days)||3||
59973441|NCT02408068|76090860|FG004|STARTED|Washout Period 2 (7 Days)||3||
59973442|NCT02408068|76090861|FG005|STARTED|Washout Period 2 (7 Days)||3||
59973443|NCT02408068|76090856|FG000|COMPLETED|Washout Period 2 (7 Days)||3||
59973444|NCT02408068|76090857|FG001|COMPLETED|Washout Period 2 (7 Days)||3||
59973445|NCT02408068|76090858|FG002|COMPLETED|Washout Period 2 (7 Days)||3||
59973446|NCT02408068|76090859|FG003|COMPLETED|Washout Period 2 (7 Days)||3||
59973447|NCT02408068|76090860|FG004|COMPLETED|Washout Period 2 (7 Days)||3||
59973448|NCT02408068|76090861|FG005|COMPLETED|Washout Period 2 (7 Days)||3||
59973449|NCT02408068|76090856|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0||
59973450|NCT02408068|76090857|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0||
59973451|NCT02408068|76090858|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0||
59973452|NCT02408068|76090859|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0||
59973453|NCT02408068|76090860|FG004|NOT COMPLETED|Washout Period 2 (7 Days)||0||
59973454|NCT02408068|76090861|FG005|NOT COMPLETED|Washout Period 2 (7 Days)||0||
59973455|NCT02408068|76090856|FG000|STARTED|Treatment 3 (1.5 Days)||3||
59973456|NCT02408068|76090857|FG001|STARTED|Treatment 3 (1.5 Days)||3||
59973457|NCT02408068|76090858|FG002|STARTED|Treatment 3 (1.5 Days)||3||
59973458|NCT02408068|76090859|FG003|STARTED|Treatment 3 (1.5 Days)||3||
59973459|NCT02408068|76090860|FG004|STARTED|Treatment 3 (1.5 Days)||3||
59973460|NCT02408068|76090861|FG005|STARTED|Treatment 3 (1.5 Days)||3||
59973461|NCT02408068|76090856|FG000|COMPLETED|Treatment 3 (1.5 Days)||3||
59973462|NCT02408068|76090857|FG001|COMPLETED|Treatment 3 (1.5 Days)||3||
59973463|NCT02408068|76090858|FG002|COMPLETED|Treatment 3 (1.5 Days)||2||
59973464|NCT02408068|76090859|FG003|COMPLETED|Treatment 3 (1.5 Days)||3||
59973465|NCT02408068|76090860|FG004|COMPLETED|Treatment 3 (1.5 Days)||3||
59973466|NCT02408068|76090861|FG005|COMPLETED|Treatment 3 (1.5 Days)||3||
59973467|NCT02408068|76090856|FG000|NOT COMPLETED|Treatment 3 (1.5 Days)||0||
59973468|NCT02408068|76090857|FG001|NOT COMPLETED|Treatment 3 (1.5 Days)||0||
59973469|NCT02408068|76090858|FG002|NOT COMPLETED|Treatment 3 (1.5 Days)||1||
59973470|NCT02408068|76090859|FG003|NOT COMPLETED|Treatment 3 (1.5 Days)||0||
59973471|NCT02408068|76090860|FG004|NOT COMPLETED|Treatment 3 (1.5 Days)||0||
59973472|NCT02408068|76090861|FG005|NOT COMPLETED|Treatment 3 (1.5 Days)||0||
60074549|NCT01807520|76189935|FG003|STARTED|Treatment Period 2 (16-132 Weeks)||29||
60074550|NCT01807520|76189936|FG004|STARTED|Treatment Period 2 (16-132 Weeks)||29||
60074551|NCT01807520|76189937|FG005|STARTED|Treatment Period 2 (16-132 Weeks)||0||
60074552|NCT01807520|76189938|FG006|STARTED|Treatment Period 2 (16-132 Weeks)||0||
60074553|NCT01807520|76189932|FG000|Safety Set|Treatment Period 2 (16-132 Weeks)||63||
59622112|NCT02110758|75733889|FG002|STARTED|Baseline: August 2011-July 2013||9832||
59622113|NCT02110758|75733890|FG003|STARTED|Baseline: August 2011-July 2013||18994||
59622114|NCT02110758|75733891|FG004|STARTED|Baseline: August 2011-July 2013||308||
59622115|NCT02110758|75733887|FG000|COMPLETED|Baseline: August 2011-July 2013||0|This involved cross-sectional samples of patients; we did not follow individuals longitudinally|
59622116|NCT02110758|75733888|FG001|COMPLETED|Baseline: August 2011-July 2013||0|This involved cross-sectional samples of patients; we did not follow individuals longitudinally|
59622117|NCT02110758|75733889|FG002|COMPLETED|Baseline: August 2011-July 2013||9832|This involved cross-sectional samples of patients; we did not follow individuals longitudinally|
59622118|NCT02110758|75733890|FG003|COMPLETED|Baseline: August 2011-July 2013||18994|This involved cross-sectional samples of patients; we did not follow individuals longitudinally|
59709595|NCT01237223|75828361|FG000|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||120||
59709596|NCT01237223|75828362|FG001|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||142||
59709597|NCT01237223|75828363|FG002|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||143||
59709598|NCT01237223|75828364|FG003|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||153||
59709599|NCT01237223|75828365|FG004|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||155||
59709600|NCT01237223|75828366|FG005|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||154||
59709601|NCT01237223|75828361|FG000|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||33||
59709602|NCT01237223|75828362|FG001|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||15||
59709603|NCT01237223|75828363|FG002|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||15||
59709604|NCT01237223|75828364|FG003|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||5||
59709605|NCT01237223|75828365|FG004|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||4||
59709606|NCT01237223|75828366|FG005|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||5||
59973473|NCT01361126|76090874|FG000|STARTED|Overall Study||13||
59973474|NCT01361126|76090875|FG001|STARTED|Overall Study||4||
59973475|NCT01361126|76090874|FG000|COMPLETED|Overall Study||13||
59973476|NCT01361126|76090875|FG001|COMPLETED|Overall Study||2||
59973477|NCT01361126|76090874|FG000|NOT COMPLETED|Overall Study||0||
59973478|NCT01361126|76090875|FG001|NOT COMPLETED|Overall Study||2||
59973479|NCT04428645|76090882|FG000|STARTED|Run in Visit Training (2 Hours)||25||
59973480|NCT04428645|76090882|FG000|COMPLETED|Run in Visit Training (2 Hours)||25||
59973481|NCT04428645|76090882|FG000|NOT COMPLETED|Run in Visit Training (2 Hours)||0||
59973482|NCT04428645|76090882|FG000|STARTED|First at Home Period (~2 Weeks)||25||
59973483|NCT04428645|76090882|FG000|COMPLETED|First at Home Period (~2 Weeks)||25||
59973484|NCT04428645|76090882|FG000|NOT COMPLETED|First at Home Period (~2 Weeks)||0||
59973485|NCT04428645|76090882|FG000|STARTED|DailyDose Training Visit (2 Hours)||25||
59973486|NCT04428645|76090882|FG000|COMPLETED|DailyDose Training Visit (2 Hours)||25||
59973487|NCT04428645|76090882|FG000|NOT COMPLETED|DailyDose Training Visit (2 Hours)||0||
59973488|NCT04428645|76090882|FG000|STARTED|Second at Home Period (8 Weeks)||25||
59973489|NCT04428645|76090882|FG000|COMPLETED|Second at Home Period (8 Weeks)||24||
59973490|NCT04428645|76090882|FG000|NOT COMPLETED|Second at Home Period (8 Weeks)||1||
59973491|NCT04428645|76090882|FG000|STARTED|Study Close-out Visit (30 Minutes)||24||
59973492|NCT04428645|76090882|FG000|COMPLETED|Study Close-out Visit (30 Minutes)||24||
59973493|NCT04428645|76090882|FG000|NOT COMPLETED|Study Close-out Visit (30 Minutes)||0||
59973494|NCT01368835|76090886|FG000|STARTED|Overall Study|103 Subjects Enrolled|103||
59973495|NCT01368835|76090886|FG000|COMPLETED|Overall Study||70||
59973496|NCT01368835|76090886|FG000|NOT COMPLETED|Overall Study||33||
59973497|NCT04371471|76090891|FG000|STARTED|Overall Study||91||
59973498|NCT04371471|76090891|FG000|COMPLETED|Overall Study||81||
59973499|NCT04371471|76090891|FG000|NOT COMPLETED|Overall Study||10||
59973500|NCT02407990|76090905|FG000|STARTED|Overall Study||3||
59973501|NCT02407990|76090906|FG001|STARTED|Overall Study||26||
59973502|NCT02407990|76090907|FG002|STARTED|Overall Study||26||
59973503|NCT02407990|76090908|FG003|STARTED|Overall Study||7||
59973504|NCT02407990|76090909|FG004|STARTED|Overall Study||21||
59973505|NCT02407990|76090910|FG005|STARTED|Overall Study||20||
59973506|NCT02407990|76090911|FG006|STARTED|Overall Study||13||
59973507|NCT02407990|76090912|FG007|STARTED|Overall Study||335||
59622119|NCT02110758|75733891|FG004|COMPLETED|Baseline: August 2011-July 2013||308|This involved cross-sectional samples of patients; we did not follow individuals longitudinally|
59622120|NCT02110758|75733887|FG000|NOT COMPLETED|Baseline: August 2011-July 2013||0||
59622121|NCT02110758|75733888|FG001|NOT COMPLETED|Baseline: August 2011-July 2013||0||
59622122|NCT02110758|75733889|FG002|NOT COMPLETED|Baseline: August 2011-July 2013||0||
59622123|NCT02110758|75733890|FG003|NOT COMPLETED|Baseline: August 2011-July 2013||0||
59622124|NCT02110758|75733891|FG004|NOT COMPLETED|Baseline: August 2011-July 2013||0||
59622125|NCT02110758|75733887|FG000|STARTED|Start-Up: August 2013-June 2014||175||
59622126|NCT02110758|75733888|FG001|STARTED|Start-Up: August 2013-June 2014||431||
59622127|NCT02110758|75733889|FG002|STARTED|Start-Up: August 2013-June 2014||8057||
59812489|NCT03896022|75934786|FG000|NOT COMPLETED|Overall Study||4||
59812490|NCT03896022|75934787|FG001|NOT COMPLETED|Overall Study||0||
59812491|NCT03896022|75934788|FG002|NOT COMPLETED|Overall Study||0||
59812492|NCT03831880|75934800|FG000|STARTED|Period 1 (12 Weeks)||43||
59812493|NCT03831880|75934801|FG001|STARTED|Period 1 (12 Weeks)||44||
59812494|NCT03831880|75934800|FG000|COMPLETED|Period 1 (12 Weeks)||43||
59812495|NCT03831880|75934801|FG001|COMPLETED|Period 1 (12 Weeks)||43||
59812496|NCT03831880|75934800|FG000|NOT COMPLETED|Period 1 (12 Weeks)||0||
59812497|NCT03831880|75934801|FG001|NOT COMPLETED|Period 1 (12 Weeks)||1||
59812498|NCT03831880|75934800|FG000|STARTED|Period 2 (12 Weeks)||43||
59812499|NCT03831880|75934801|FG001|STARTED|Period 2 (12 Weeks)||43||
59622128|NCT02110758|75733890|FG003|STARTED|Start-Up: August 2013-June 2014||12883||
59622129|NCT02110758|75733891|FG004|STARTED|Start-Up: August 2013-June 2014||0||
59622130|NCT02110758|75733887|FG000|COMPLETED|Start-Up: August 2013-June 2014||175|This involved cross-sectional samples of patients; we did not follow individuals longitudinally|
59973508|NCT02407990|76090905|FG000|COMPLETED|Overall Study||0||
59973509|NCT02407990|76090906|FG001|COMPLETED|Overall Study||0||
59973510|NCT02407990|76090907|FG002|COMPLETED|Overall Study||0||
59973511|NCT02407990|76090908|FG003|COMPLETED|Overall Study||0||
59973512|NCT02407990|76090909|FG004|COMPLETED|Overall Study||0||
59973513|NCT02407990|76090910|FG005|COMPLETED|Overall Study||0||
59622131|NCT02110758|75733888|FG001|COMPLETED|Start-Up: August 2013-June 2014||431|This involved cross-sectional samples of patients; we did not follow individuals longitudinally|
59709607|NCT01236755|75828382|FG000|STARTED|Spectacles Wearing Phase||91||
59709608|NCT01236755|75828382|FG000|COMPLETED|Spectacles Wearing Phase||74||
59709609|NCT01236755|75828382|FG000|NOT COMPLETED|Spectacles Wearing Phase||17||
59709610|NCT01236755|75828382|FG000|STARTED|Orthokeratology Wearing Phase||74||
59709611|NCT01236755|75828382|FG000|COMPLETED|Orthokeratology Wearing Phase||66||
59709612|NCT01236755|75828382|FG000|NOT COMPLETED|Orthokeratology Wearing Phase||8||
59709613|NCT01236365|75828389|FG000|STARTED|Overall Study||21||
59709614|NCT01236365|75828390|FG001|STARTED|Overall Study||21||
59709615|NCT01236365|75828389|FG000|COMPLETED|Overall Study||19||
59709616|NCT01236365|75828390|FG001|COMPLETED|Overall Study||19||
59973514|NCT02407990|76090911|FG006|COMPLETED|Overall Study||0||
59973515|NCT02407990|76090912|FG007|COMPLETED|Overall Study||0||
59973516|NCT02407990|76090905|FG000|NOT COMPLETED|Overall Study||3||
59973517|NCT02407990|76090906|FG001|NOT COMPLETED|Overall Study||26||
59973518|NCT02407990|76090907|FG002|NOT COMPLETED|Overall Study||26||
59973519|NCT02407990|76090908|FG003|NOT COMPLETED|Overall Study||7||
59973520|NCT02407990|76090909|FG004|NOT COMPLETED|Overall Study||21||
59973521|NCT02407990|76090910|FG005|NOT COMPLETED|Overall Study||20||
59812500|NCT03831880|75934800|FG000|COMPLETED|Period 2 (12 Weeks)||43||
59812501|NCT03831880|75934801|FG001|COMPLETED|Period 2 (12 Weeks)||42||
59812502|NCT03831880|75934800|FG000|NOT COMPLETED|Period 2 (12 Weeks)||0||
59812503|NCT03831880|75934801|FG001|NOT COMPLETED|Period 2 (12 Weeks)||1||
59812504|NCT03831880|75934800|FG000|STARTED|Follow-up (5 Weeks)||43||
59812505|NCT03831880|75934801|FG001|STARTED|Follow-up (5 Weeks)|1 participant who discontinued from Period 1 completed follow-up visit.|43||
59973522|NCT02407990|76090911|FG006|NOT COMPLETED|Overall Study||13||
59973523|NCT02407990|76090912|FG007|NOT COMPLETED|Overall Study||335||
59973524|NCT03288129|76090936|FG000|STARTED|Overall Study||54||
59973525|NCT03288129|76090936|FG000|COMPLETED|Overall Study||32||
59973526|NCT03288129|76090936|FG000|NOT COMPLETED|Overall Study||22||
59973527|NCT01673282|76090942|FG000|STARTED|Overall Study||153||
59973528|NCT01673282|76090943|FG001|STARTED|Overall Study||158||
59973529|NCT01673282|76090942|FG000|COMPLETED|Overall Study||120||
59973530|NCT01673282|76090943|FG001|COMPLETED|Overall Study||132||
59973531|NCT01673282|76090942|FG000|NOT COMPLETED|Overall Study||33||
59973532|NCT01673282|76090943|FG001|NOT COMPLETED|Overall Study||26||
59973533|NCT04157751|76090951|FG000|STARTED|Overall Study||265|Randomised|
59973534|NCT04157751|76090952|FG001|STARTED|Overall Study||265|Randomised|
59973535|NCT04157751|76090951|FG000|Treated|Overall Study||264||
59973536|NCT04157751|76090952|FG001|Treated|Overall Study||260||
59973537|NCT04157751|76090951|FG000|COMPLETED|Overall Study||202||
59973538|NCT04157751|76090952|FG001|COMPLETED|Overall Study||208||
59973539|NCT04157751|76090951|FG000|NOT COMPLETED|Overall Study||63||
59973540|NCT04157751|76090952|FG001|NOT COMPLETED|Overall Study||57||
59973541|NCT01673126|76090960|FG000|STARTED|Overall Study|First stimulation (20 minutes) Washout (2 days) Second stimulation (20 minutes)|36||
59973542|NCT01673126|76090961|FG001|STARTED|Overall Study|First stimulation (20 minutes) Washout (2days) Second stimulation (20 minutes)|26||
59973543|NCT01673126|76090960|FG000|COMPLETED|Overall Study||32||
59973544|NCT01673126|76090961|FG001|COMPLETED|Overall Study||23||
59973545|NCT01673126|76090960|FG000|NOT COMPLETED|Overall Study||4||
59973546|NCT01673126|76090961|FG001|NOT COMPLETED|Overall Study||3||
59973547|NCT02407054|76090970|FG000|STARTED|Overall Study||13||
59973548|NCT02407054|76090971|FG001|STARTED|Overall Study||65||
59525613|NCT02969525|75620943|FG006|STARTED|Dose-Blind Period||20||
59525614|NCT02969525|75620944|FG007|STARTED|Dose-Blind Period||22||
59525615|NCT02969525|75620945|FG008|STARTED|Dose-Blind Period||19||
59525616|NCT02969525|75620946|FG009|STARTED|Dose-Blind Period||37||
59525617|NCT02969525|75620947|FG010|STARTED|Dose-Blind Period||40||
59525618|NCT02969525|75620948|FG011|STARTED|Dose-Blind Period||41||
59525619|NCT02969525|75620937|FG000|COMPLETED|Dose-Blind Period||0||
59525620|NCT02969525|75620938|FG001|COMPLETED|Dose-Blind Period||0||
59525621|NCT02969525|75620939|FG002|COMPLETED|Dose-Blind Period||0||
59525622|NCT02969525|75620940|FG003|COMPLETED|Dose-Blind Period||0||
59525623|NCT02969525|75620941|FG004|COMPLETED|Dose-Blind Period||0||
59525624|NCT02969525|75620942|FG005|COMPLETED|Dose-Blind Period||20||
59812506|NCT03831880|75934800|FG000|COMPLETED|Follow-up (5 Weeks)||43||
59812507|NCT03831880|75934801|FG001|COMPLETED|Follow-up (5 Weeks)||43||
59812508|NCT03831880|75934800|FG000|NOT COMPLETED|Follow-up (5 Weeks)||0||
59812509|NCT03831880|75934801|FG001|NOT COMPLETED|Follow-up (5 Weeks)||0||
59812510|NCT04257552|75934812|FG000|STARTED|Overall Study||42||
59812511|NCT04257552|75934813|FG001|STARTED|Overall Study||43||
59812512|NCT04257552|75934814|FG002|STARTED|Overall Study||43||
59812513|NCT04257552|75934812|FG000|COMPLETED|Overall Study||42||
59812514|NCT04257552|75934813|FG001|COMPLETED|Overall Study||43||
59812515|NCT04257552|75934814|FG002|COMPLETED|Overall Study||43||
59812516|NCT04257552|75934812|FG000|NOT COMPLETED|Overall Study||0||
59812517|NCT04257552|75934813|FG001|NOT COMPLETED|Overall Study||0||
59812518|NCT04257552|75934814|FG002|NOT COMPLETED|Overall Study||0||
59973549|NCT02407054|76090972|FG002|STARTED|Overall Study||64||
59973550|NCT02407054|76090970|FG000|Received at Least One Dose of Study Drug|Overall Study||13||
59973551|NCT02407054|76090971|FG001|Received at Least One Dose of Study Drug|Overall Study||65||
59973552|NCT02407054|76090972|FG002|Received at Least One Dose of Study Drug|Overall Study||64||
59973553|NCT02407054|76090970|FG000|COMPLETED|Overall Study||6||
59973554|NCT02407054|76090971|FG001|COMPLETED|Overall Study||47||
59973555|NCT02407054|76090972|FG002|COMPLETED|Overall Study||57||
59973556|NCT02407054|76090970|FG000|NOT COMPLETED|Overall Study||7||
59973557|NCT02407054|76090971|FG001|NOT COMPLETED|Overall Study||18||
59973558|NCT02407054|76090972|FG002|NOT COMPLETED|Overall Study||7||
59525625|NCT02969525|75620943|FG006|COMPLETED|Dose-Blind Period||18||
59525626|NCT02969525|75620944|FG007|COMPLETED|Dose-Blind Period||22||
59525627|NCT02969525|75620945|FG008|COMPLETED|Dose-Blind Period||18||
59525628|NCT02969525|75620946|FG009|COMPLETED|Dose-Blind Period||34||
59525629|NCT02969525|75620947|FG010|COMPLETED|Dose-Blind Period||38||
59525630|NCT02969525|75620948|FG011|COMPLETED|Dose-Blind Period||39||
59525631|NCT02969525|75620937|FG000|NOT COMPLETED|Dose-Blind Period||0||
59525632|NCT02969525|75620938|FG001|NOT COMPLETED|Dose-Blind Period||0||
59525633|NCT02969525|75620939|FG002|NOT COMPLETED|Dose-Blind Period||0||
59525634|NCT02969525|75620940|FG003|NOT COMPLETED|Dose-Blind Period||0||
59525635|NCT02969525|75620941|FG004|NOT COMPLETED|Dose-Blind Period||0||
59525636|NCT02969525|75620942|FG005|NOT COMPLETED|Dose-Blind Period||0||
59525637|NCT02969525|75620943|FG006|NOT COMPLETED|Dose-Blind Period||2||
59525638|NCT02969525|75620944|FG007|NOT COMPLETED|Dose-Blind Period||0||
59525639|NCT02969525|75620945|FG008|NOT COMPLETED|Dose-Blind Period||1||
59525640|NCT02969525|75620946|FG009|NOT COMPLETED|Dose-Blind Period||3||
59525641|NCT02969525|75620947|FG010|NOT COMPLETED|Dose-Blind Period||2||
59525642|NCT02969525|75620948|FG011|NOT COMPLETED|Dose-Blind Period||2||
59525643|NCT02856594|75620970|FG000|STARTED|Overall Study||234||
59525644|NCT02856594|75620971|FG001|STARTED|Overall Study||235||
59525645|NCT02856594|75620970|FG000|Analysis Population|Overall Study||188||
59525646|NCT02856594|75620971|FG001|Analysis Population|Overall Study||206||
59525647|NCT02856594|75620970|FG000|COMPLETED|Overall Study||188||
59525648|NCT02856594|75620971|FG001|COMPLETED|Overall Study||206||
59525649|NCT02856594|75620970|FG000|NOT COMPLETED|Overall Study||46||
59525650|NCT02856594|75620971|FG001|NOT COMPLETED|Overall Study||29||
59525651|NCT04232215|75620979|FG000|STARTED|First Intervention (8 Weeks)||28||
59525652|NCT04232215|75620980|FG001|STARTED|First Intervention (8 Weeks)||27||
59525653|NCT04232215|75620979|FG000|COMPLETED|First Intervention (8 Weeks)||28||
59525654|NCT04232215|75620980|FG001|COMPLETED|First Intervention (8 Weeks)||25||
59525655|NCT04232215|75620979|FG000|NOT COMPLETED|First Intervention (8 Weeks)||0||
59525656|NCT04232215|75620980|FG001|NOT COMPLETED|First Intervention (8 Weeks)||2||
59525657|NCT04232215|75620979|FG000|STARTED|Second Intervention (8 Weeks)||28||
59525658|NCT04232215|75620980|FG001|STARTED|Second Intervention (8 Weeks)||25||
59525659|NCT04232215|75620979|FG000|COMPLETED|Second Intervention (8 Weeks)||28||
59525660|NCT04232215|75620980|FG001|COMPLETED|Second Intervention (8 Weeks)||1||
59525661|NCT04232215|75620979|FG000|NOT COMPLETED|Second Intervention (8 Weeks)||0||
59525662|NCT04232215|75620980|FG001|NOT COMPLETED|Second Intervention (8 Weeks)||24||
59525663|NCT02774954|75620988|FG000|STARTED|Baseline||482||
59525664|NCT02774954|75620989|FG001|STARTED|Baseline||497||
59525665|NCT02774954|75620988|FG000|Completed Baseline Interview and Intervention|Baseline||482||
59525666|NCT02774954|75620989|FG001|Completed Baseline Interview and Intervention|Baseline||497||
59525667|NCT02774954|75620988|FG000|COMPLETED|Baseline||482||
59525668|NCT02774954|75620989|FG001|COMPLETED|Baseline||497||
59525669|NCT02774954|75620988|FG000|NOT COMPLETED|Baseline||0||
59525670|NCT02774954|75620989|FG001|NOT COMPLETED|Baseline||0||
59525671|NCT02774954|75620988|FG000|STARTED|6 Month Follow-up||482||
59525672|NCT02774954|75620989|FG001|STARTED|6 Month Follow-up||497||
59525673|NCT02774954|75620988|FG000|COMPLETED|6 Month Follow-up||286||
59525674|NCT02774954|75620989|FG001|COMPLETED|6 Month Follow-up||313||
59525675|NCT02774954|75620988|FG000|NOT COMPLETED|6 Month Follow-up||196||
59525676|NCT02774954|75620989|FG001|NOT COMPLETED|6 Month Follow-up||184||
59525677|NCT02774954|75620988|FG000|STARTED|12 Month Follow-up||286||
59525678|NCT02774954|75620989|FG001|STARTED|12 Month Follow-up||313||
59525679|NCT02774954|75620988|FG000|COMPLETED|12 Month Follow-up||253||
59525680|NCT02774954|75620989|FG001|COMPLETED|12 Month Follow-up||279||
59525681|NCT02774954|75620988|FG000|NOT COMPLETED|12 Month Follow-up||33||
59525682|NCT02774954|75620989|FG001|NOT COMPLETED|12 Month Follow-up||34||
59525683|NCT02399813|75620995|FG000|STARTED|Overall Study||36||
59525684|NCT02399813|75620995|FG000|COMPLETED|Overall Study||0||
59525685|NCT02399813|75620995|FG000|NOT COMPLETED|Overall Study||36||
59525686|NCT02291055|75621004|FG000|STARTED|Overall Study||5||
59525687|NCT02291055|75621005|FG001|STARTED|Overall Study||5||
59525688|NCT02291055|75621006|FG002|STARTED|Overall Study||11||
59525689|NCT02291055|75621007|FG003|STARTED|Overall Study||27||
59525690|NCT02291055|75621008|FG004|STARTED|Overall Study||27||
59525691|NCT02291055|75621004|FG000|COMPLETED|Overall Study||0||
59525692|NCT02291055|75621005|FG001|COMPLETED|Overall Study||0||
59525693|NCT02291055|75621006|FG002|COMPLETED|Overall Study||3||
59525694|NCT02291055|75621007|FG003|COMPLETED|Overall Study||0||
59525695|NCT02291055|75621008|FG004|COMPLETED|Overall Study||0||
59525696|NCT02291055|75621004|FG000|NOT COMPLETED|Overall Study||5||
59525697|NCT02291055|75621005|FG001|NOT COMPLETED|Overall Study||5||
59525698|NCT02291055|75621006|FG002|NOT COMPLETED|Overall Study||8||
59525699|NCT02291055|75621007|FG003|NOT COMPLETED|Overall Study||27||
59525700|NCT02291055|75621008|FG004|NOT COMPLETED|Overall Study||27||
59525701|NCT00723697|75621024|FG000|STARTED|Overall Study||1307||
59525702|NCT00723697|75621024|FG000|COMPLETED|Overall Study||1289||
59525703|NCT00723697|75621024|FG000|NOT COMPLETED|Overall Study||18||
59525704|NCT00684073|75621031|FG000|STARTED|Selection||60||
59525705|NCT00684073|75621031|FG000|COMPLETED|Selection|number of subjects who had a Day 1 visit|53||
59525706|NCT00684073|75621031|FG000|NOT COMPLETED|Selection||7||
59525707|NCT00684073|75621031|FG000|STARTED|Treatment (Days 1 Through 5)|number of subjects who had a Day 1 visit|53||
59525708|NCT00684073|75621031|FG000|COMPLETED|Treatment (Days 1 Through 5)|number of subjects who had a Day 5 visit (and therefore completed study)|52||
59525709|NCT00684073|75621031|FG000|NOT COMPLETED|Treatment (Days 1 Through 5)||1||
59525710|NCT01215643|75621044|FG000|STARTED|Overall Study||83||
59525711|NCT01215643|75621045|FG001|STARTED|Overall Study||84||
59525712|NCT01215643|75621046|FG002|STARTED|Overall Study||94||
59525713|NCT01215643|75621047|FG003|STARTED|Overall Study||39||
59525714|NCT01215643|75621048|FG004|STARTED|Overall Study||40||
59525715|NCT01215643|75621044|FG000|COMPLETED|Overall Study||74||
59525716|NCT01215643|75621045|FG001|COMPLETED|Overall Study||80||
59525717|NCT01215643|75621046|FG002|COMPLETED|Overall Study||82||
59525718|NCT01215643|75621047|FG003|COMPLETED|Overall Study||35||
59525719|NCT01215643|75621048|FG004|COMPLETED|Overall Study||29||
59525720|NCT01215643|75621044|FG000|NOT COMPLETED|Overall Study||9||
59525721|NCT01215643|75621045|FG001|NOT COMPLETED|Overall Study||4||
59525722|NCT01215643|75621046|FG002|NOT COMPLETED|Overall Study||12||
59525723|NCT01215643|75621047|FG003|NOT COMPLETED|Overall Study||4||
59812519|NCT00380692|75934824|FG000|STARTED|Study Period II - Double Blind||48||
59812520|NCT00380692|75934825|FG001|STARTED|Study Period II - Double Blind||49||
59812521|NCT00380692|75934824|FG000|COMPLETED|Study Period II - Double Blind||43||
59812522|NCT00380692|75934825|FG001|COMPLETED|Study Period II - Double Blind||46||
59812523|NCT00380692|75934824|FG000|NOT COMPLETED|Study Period II - Double Blind||5||
59812524|NCT00380692|75934825|FG001|NOT COMPLETED|Study Period II - Double Blind||3||
59812525|NCT00380692|75934824|FG000|STARTED|Study Period III - Open Label|One patient who completed Study Period II did not enter Study Period III.|42||
59812526|NCT00380692|75934825|FG001|STARTED|Study Period III - Open Label||46||
59973559|NCT01652716|76090983|FG000|STARTED|Overall Study||229||
59973560|NCT01652716|76090984|FG001|STARTED|Overall Study|Two subjects in the exenatide BID group withdrew from the study before receiving study drug.|148||
59973561|NCT01652716|76090983|FG000|Completed 28-week|Overall Study||197||
59973562|NCT01652716|76090984|FG001|Completed 28-week|Overall Study||118||
59973563|NCT01652716|76090983|FG000|COMPLETED|Overall Study|* completed study|173||
59973564|NCT01652716|76090984|FG001|COMPLETED|Overall Study|* completed study|102||
59973565|NCT01652716|76090983|FG000|NOT COMPLETED|Overall Study||56||
59973566|NCT01652716|76090984|FG001|NOT COMPLETED|Overall Study||46||
59973567|NCT02790073|76090990|FG000|STARTED|Overall Study||14||
59973568|NCT02790073|76090990|FG000|COMPLETED|Overall Study||11||
59973569|NCT02790073|76090990|FG000|NOT COMPLETED|Overall Study||3||
59973570|NCT02789137|76090994|FG000|STARTED|Overall Study||111||
59973571|NCT02789137|76090994|FG000|COMPLETED|Overall Study||53||
59973572|NCT02789137|76090994|FG000|NOT COMPLETED|Overall Study||58||
59973573|NCT01672970|76090999|FG000|STARTED|Overall Study||291||
59973574|NCT01672970|76090999|FG000|Treated|Overall Study||290||
59973575|NCT01672970|76090999|FG000|COMPLETED|Overall Study||244||
59973576|NCT01672970|76090999|FG000|NOT COMPLETED|Overall Study||47||
59973577|NCT02788747|76091006|FG000|STARTED|Overall Study||23||
59973578|NCT02788747|76091007|FG001|STARTED|Overall Study||24||
59973579|NCT02788747|76091008|FG002|STARTED|Overall Study||24||
59973580|NCT02788747|76091006|FG000|COMPLETED|Overall Study||22||
59973581|NCT02788747|76091007|FG001|COMPLETED|Overall Study||24||
59973582|NCT02788747|76091008|FG002|COMPLETED|Overall Study||24||
59525724|NCT01215643|75621048|FG004|NOT COMPLETED|Overall Study||11||
59525725|NCT01261507|75621065|FG000|STARTED|Overall Study||15||
59525726|NCT01261507|75621065|FG000|COMPLETED|Overall Study||15||
59525727|NCT01261507|75621065|FG000|NOT COMPLETED|Overall Study||0||
59525728|NCT01261819|75621074|FG000|STARTED|Overall Study||33||
59525729|NCT01261819|75621075|FG001|STARTED|Overall Study||33||
59525730|NCT01261819|75621074|FG000|COMPLETED|Overall Study||33||
59525731|NCT01261819|75621075|FG001|COMPLETED|Overall Study||33||
59525732|NCT01261819|75621074|FG000|NOT COMPLETED|Overall Study||0||
59525733|NCT01261819|75621075|FG001|NOT COMPLETED|Overall Study||0||
59973583|NCT02788747|76091006|FG000|NOT COMPLETED|Overall Study||1||
59973584|NCT02788747|76091007|FG001|NOT COMPLETED|Overall Study||0||
59973585|NCT02788747|76091008|FG002|NOT COMPLETED|Overall Study||0||
59973586|NCT02406742|76091022|FG000|STARTED|Overall Study||14||
59973587|NCT02406742|76091023|FG001|STARTED|Overall Study||16||
59973588|NCT02406742|76091024|FG002|STARTED|Overall Study||16||
59973589|NCT02406742|76091022|FG000|Dose Escalation 1|Overall Study||3|CC-122 0.25mg|
59525734|NCT01262131|75621084|FG000|STARTED|Overall Study||5||
59525735|NCT01262131|75621085|FG001|STARTED|Overall Study||4||
59525736|NCT01262131|75621086|FG002|STARTED|Overall Study||4||
59525737|NCT01262131|75621084|FG000|COMPLETED|Overall Study||5||
59525738|NCT01262131|75621085|FG001|COMPLETED|Overall Study||4||
59525739|NCT01262131|75621086|FG002|COMPLETED|Overall Study||4||
59973590|NCT02406742|76091023|FG001|Dose Escalation 1|Overall Study||0|CC-122 0.25mg|
59973591|NCT02406742|76091024|FG002|Dose Escalation 1|Overall Study||0|CC-122 0.25mg|
59973592|NCT02406742|76091022|FG000|Dose Escalation 2|Overall Study||9|CC-122 0.5mg|
59973593|NCT02406742|76091023|FG001|Dose Escalation 2|Overall Study||5|CC-122 0.5mg|
59973594|NCT02406742|76091024|FG002|Dose Escalation 2|Overall Study||3|CC-122 0.5mg|
59973595|NCT02406742|76091022|FG000|Dose Escalation 3|Overall Study||2|CC-122 1.0mg|
59973596|NCT02406742|76091023|FG001|Dose Escalation 3|Overall Study||3|CC-122 1.0mg|
59973597|NCT02406742|76091024|FG002|Dose Escalation 3|Overall Study||3|CC-122 1.0mg|
59973598|NCT02406742|76091022|FG000|Dose Escalation 4|Overall Study||0|CC-122 2.0mg|
59973599|NCT02406742|76091023|FG001|Dose Escalation 4|Overall Study||3|CC-122 2.0mg|
59973600|NCT02406742|76091024|FG002|Dose Escalation 4|Overall Study||3|CC-122 2.0mg|
59973601|NCT02406742|76091022|FG000|Dose Escalation 5|Overall Study||0|CC-122 3.0mg|
59973602|NCT02406742|76091023|FG001|Dose Escalation 5|Overall Study||5|CC-122 3.0mg|
59973603|NCT02406742|76091024|FG002|Dose Escalation 5|Overall Study||5|CC-122 3.0mg|
59973604|NCT02406742|76091022|FG000|COMPLETED|Overall Study||0||
59973605|NCT02406742|76091023|FG001|COMPLETED|Overall Study||0||
59973606|NCT02406742|76091024|FG002|COMPLETED|Overall Study||0||
59973607|NCT02406742|76091022|FG000|NOT COMPLETED|Overall Study||14||
59973608|NCT02406742|76091023|FG001|NOT COMPLETED|Overall Study||16||
59973609|NCT02406742|76091024|FG002|NOT COMPLETED|Overall Study||16||
59973610|NCT02714595|76091034|FG000|STARTED|Overall Study||101||
59973611|NCT02714595|76091035|FG001|STARTED|Overall Study||51||
59973612|NCT02714595|76091034|FG000|Received Treatment|Overall Study||101|Safety population|
59973613|NCT02714595|76091035|FG001|Received Treatment|Overall Study||49|Safety population|
59973614|NCT02714595|76091034|FG000|Carbapenem-resistant Microbiological Intent-to-treat|Overall Study||80|CR Micro-ITT population; See definition in Baseline Characteristics section|
59973615|NCT02714595|76091035|FG001|Carbapenem-resistant Microbiological Intent-to-treat|Overall Study||38|CR Micro-ITT population; See definition in Baseline Characteristics section|
59973616|NCT02714595|76091034|FG000|COMPLETED|Overall Study||69||
59812527|NCT00380692|75934824|FG000|COMPLETED|Study Period III - Open Label||36||
59812528|NCT00380692|75934825|FG001|COMPLETED|Study Period III - Open Label||34||
59812529|NCT00380692|75934824|FG000|NOT COMPLETED|Study Period III - Open Label||6||
59812530|NCT00380692|75934825|FG001|NOT COMPLETED|Study Period III - Open Label||12||
59812531|NCT00536874|75934831|FG000|STARTED|Overall Study||39||
59812532|NCT00536874|75934831|FG000|COMPLETED|Overall Study||35||
59973617|NCT02714595|76091035|FG001|COMPLETED|Overall Study||38||
59973618|NCT02714595|76091034|FG000|NOT COMPLETED|Overall Study||32||
59973619|NCT02714595|76091035|FG001|NOT COMPLETED|Overall Study||13||
59973620|NCT02437162|76091062|FG000|STARTED|Overall Study||116||
59973621|NCT02437162|76091063|FG001|STARTED|Overall Study||116||
59973622|NCT02437162|76091064|FG002|STARTED|Overall Study||115||
59973623|NCT02437162|76091062|FG000|Treated|Overall Study||116||
59973624|NCT02437162|76091063|FG001|Treated|Overall Study||116||
59973625|NCT02437162|76091064|FG002|Treated|Overall Study||114||
59973626|NCT02437162|76091062|FG000|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|26||
59973627|NCT02437162|76091063|FG001|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|21||
59973628|NCT02437162|76091064|FG002|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|14||
59973629|NCT02437162|76091062|FG000|Cross Over at Week 24|Overall Study|Out of 87: crossed over to Ustekinumab 45 mg (n=44) and Ustekinumab 90 mg (n=43)|87||
59973630|NCT02437162|76091063|FG001|Cross Over at Week 24|Overall Study||0||
59812533|NCT00536874|75934831|FG000|NOT COMPLETED|Overall Study||4||
59812534|NCT00380068|75934835|FG000|STARTED|Overall Study||224||
59812535|NCT00380068|75934835|FG000|COMPLETED|Overall Study||155||
59812536|NCT00380068|75934835|FG000|NOT COMPLETED|Overall Study||69||
59812537|NCT00536484|75934841|FG000|STARTED|Overall Study|448 participants randomised; 3 not treated|445||
59812538|NCT00536484|75934842|FG001|STARTED|Overall Study|448 participants randomised; 10 not treated|438||
59812539|NCT00536484|75934841|FG000|COMPLETED|Overall Study|88 completed on matched 4mg dose and 297 on matched 8mg dose|385||
59812540|NCT00536484|75934842|FG001|COMPLETED|Overall Study|134 completed on 4mg dose and 248 on 8mg dose|382||
59812541|NCT00536484|75934841|FG000|NOT COMPLETED|Overall Study||60||
59812542|NCT00536484|75934842|FG001|NOT COMPLETED|Overall Study||56||
59812543|NCT00370396|75934851|FG000|STARTED|Overall Study||737|1112 subjects were vaccinated in current study out of 1200 who received at least 1 dose of Prevenar|
59812544|NCT00370396|75934852|FG001|STARTED|Overall Study||92|1112 subjects were vaccinated in current study out of 1200 who received at least 1 dose of Prevenar|
59812545|NCT00370396|75934853|FG002|STARTED|Overall Study||283|1112 subjects were vaccinated in current study out of 1200 who received at least 1 dose of Prevenar|
59973631|NCT02437162|76091064|FG002|Cross Over at Week 24|Overall Study||0||
59973632|NCT02437162|76091062|FG000|COMPLETED|Overall Study||9||
59973633|NCT02437162|76091063|FG001|COMPLETED|Overall Study||8||
59973634|NCT02437162|76091064|FG002|COMPLETED|Overall Study||6||
59973635|NCT02437162|76091062|FG000|NOT COMPLETED|Overall Study||107||
59973636|NCT02437162|76091063|FG001|NOT COMPLETED|Overall Study||108||
59973637|NCT02437162|76091064|FG002|NOT COMPLETED|Overall Study||109||
59812546|NCT00370396|75934851|FG000|COMPLETED|Overall Study||726||
59812547|NCT00370396|75934852|FG001|COMPLETED|Overall Study||91||
59812548|NCT00370396|75934853|FG002|COMPLETED|Overall Study||282||
59973638|NCT01368211|76091079|FG000|STARTED|First Platelets Transfusion||8||
59973639|NCT01368211|76091080|FG001|STARTED|First Platelets Transfusion||7||
59973640|NCT01368211|76091079|FG000|COMPLETED|First Platelets Transfusion||8||
59973641|NCT01368211|76091080|FG001|COMPLETED|First Platelets Transfusion||7||
59973642|NCT01368211|76091079|FG000|NOT COMPLETED|First Platelets Transfusion||0||
59973643|NCT01368211|76091080|FG001|NOT COMPLETED|First Platelets Transfusion||0||
59973644|NCT01368211|76091079|FG000|STARTED|Second Platelets Transfusion||8||
59973645|NCT01368211|76091080|FG001|STARTED|Second Platelets Transfusion||7||
59973646|NCT01368211|76091079|FG000|COMPLETED|Second Platelets Transfusion||7||
59973647|NCT01368211|76091080|FG001|COMPLETED|Second Platelets Transfusion||5||
59973648|NCT01368211|76091079|FG000|NOT COMPLETED|Second Platelets Transfusion||1||
59973649|NCT01368211|76091080|FG001|NOT COMPLETED|Second Platelets Transfusion||2||
59973650|NCT02437084|76091086|FG000|STARTED|Overall Study||75||
59622132|NCT02110758|75733889|FG002|COMPLETED|Start-Up: August 2013-June 2014||8057|This involved cross-sectional samples of patients; we did not follow individuals longitudinally|
59622133|NCT02110758|75733890|FG003|COMPLETED|Start-Up: August 2013-June 2014||12883|This involved cross-sectional samples of patients; we did not follow individuals longitudinally|
59622134|NCT02110758|75733891|FG004|COMPLETED|Start-Up: August 2013-June 2014||0|This involved cross-sectional samples of patients; we did not follow individuals longitudinally|
59622135|NCT02110758|75733887|FG000|NOT COMPLETED|Start-Up: August 2013-June 2014||0||
59622136|NCT02110758|75733888|FG001|NOT COMPLETED|Start-Up: August 2013-June 2014||0||
59622137|NCT02110758|75733889|FG002|NOT COMPLETED|Start-Up: August 2013-June 2014||0||
59973651|NCT02437084|76091086|FG000|COMPLETED|Overall Study||72||
59973652|NCT02437084|76091086|FG000|NOT COMPLETED|Overall Study||3||
59973653|NCT02406586|76091093|FG000|STARTED|Overall Study||12||
59973654|NCT02406586|76091094|FG001|STARTED|Overall Study||12||
59973655|NCT02406586|76091095|FG002|STARTED|Overall Study||12||
59973656|NCT02406586|76091093|FG000|COMPLETED|Overall Study||11||
59973657|NCT02406586|76091094|FG001|COMPLETED|Overall Study||8||
59973658|NCT02406586|76091095|FG002|COMPLETED|Overall Study||10||
59973659|NCT02406586|76091093|FG000|NOT COMPLETED|Overall Study||1||
59973660|NCT02406586|76091094|FG001|NOT COMPLETED|Overall Study||4||
59973661|NCT02406586|76091095|FG002|NOT COMPLETED|Overall Study||2||
59973662|NCT02460562|76091108|FG000|STARTED|Overall Study||74||
59973663|NCT02460562|76091109|FG001|STARTED|Overall Study||76||
59973664|NCT02460562|76091108|FG000|COMPLETED|Overall Study||59||
59973665|NCT02460562|76091109|FG001|COMPLETED|Overall Study||60||
59973666|NCT02460562|76091108|FG000|NOT COMPLETED|Overall Study||15||
59973667|NCT02460562|76091109|FG001|NOT COMPLETED|Overall Study||16||
59973668|NCT02788357|76091117|FG000|STARTED|Overall Study||6||
59973669|NCT02788357|76091118|FG001|STARTED|Overall Study||6||
59973670|NCT02788357|76091117|FG000|COMPLETED|Overall Study||3||
59973671|NCT02788357|76091118|FG001|COMPLETED|Overall Study||6||
59973672|NCT02788357|76091117|FG000|NOT COMPLETED|Overall Study||3||
59973673|NCT02788357|76091118|FG001|NOT COMPLETED|Overall Study||0||
59973674|NCT02457910|76091130|FG000|STARTED|Overall Study||3||
59973675|NCT02457910|76091131|FG001|STARTED|Overall Study|In dose escalation, two patients receiving the 4 mg dose of taselisib were removed for toxicities|5||
59973676|NCT02457910|76091132|FG002|STARTED|Overall Study||3||
59973677|NCT02457910|76091133|FG003|STARTED|Overall Study||2||
59973678|NCT02457910|76091134|FG004|STARTED|Overall Study|3 participants crossed over to enzalutamide and taselisib|5||
59973679|NCT02457910|76091135|FG005|STARTED|Overall Study||12||
59973680|NCT02457910|76091130|FG000|COMPLETED|Overall Study||0||
59973681|NCT02457910|76091131|FG001|COMPLETED|Overall Study||0||
59973682|NCT02457910|76091132|FG002|COMPLETED|Overall Study||0||
59973683|NCT02457910|76091133|FG003|COMPLETED|Overall Study||0||
59973684|NCT02457910|76091134|FG004|COMPLETED|Overall Study||0||
59973685|NCT02457910|76091135|FG005|COMPLETED|Overall Study||1||
59622138|NCT02110758|75733890|FG003|NOT COMPLETED|Start-Up: August 2013-June 2014||0||
59622139|NCT02110758|75733891|FG004|NOT COMPLETED|Start-Up: August 2013-June 2014||0||
59622140|NCT02110758|75733887|FG000|STARTED|Intervention: July 2014-December 2015||0||
59973686|NCT02457910|76091130|FG000|NOT COMPLETED|Overall Study||3||
59973687|NCT02457910|76091131|FG001|NOT COMPLETED|Overall Study||5||
59973688|NCT02457910|76091132|FG002|NOT COMPLETED|Overall Study||3||
59973689|NCT02457910|76091133|FG003|NOT COMPLETED|Overall Study||2||
59973690|NCT02457910|76091134|FG004|NOT COMPLETED|Overall Study||5||
59973691|NCT02457910|76091135|FG005|NOT COMPLETED|Overall Study||11||
59973692|NCT02405962|76091154|FG000|STARTED|Overall Study||84||
59973693|NCT02405962|76091155|FG001|STARTED|Overall Study||84||
59973694|NCT02405962|76091154|FG000|Post-intervention|Overall Study||80||
59973695|NCT02405962|76091155|FG001|Post-intervention|Overall Study||81||
59973696|NCT02405962|76091154|FG000|3 Months After the Intervention|Overall Study||80||
59973697|NCT02405962|76091155|FG001|3 Months After the Intervention|Overall Study||79||
59973698|NCT02405962|76091154|FG000|COMPLETED|Overall Study||83||
59973699|NCT02405962|76091155|FG001|COMPLETED|Overall Study||79||
59973700|NCT02405962|76091154|FG000|NOT COMPLETED|Overall Study||1||
59973701|NCT02405962|76091155|FG001|NOT COMPLETED|Overall Study||5||
59973702|NCT02436304|76091164|FG000|STARTED|Overall Study||153||
59973703|NCT02436304|76091165|FG001|STARTED|Overall Study||102||
59973704|NCT02436304|76091166|FG002|STARTED|Overall Study||101||
59973705|NCT02436304|76091164|FG000|COMPLETED|Overall Study||153||
59973706|NCT02436304|76091165|FG001|COMPLETED|Overall Study||100||
59973707|NCT02436304|76091166|FG002|COMPLETED|Overall Study||100||
59973708|NCT02436304|76091164|FG000|NOT COMPLETED|Overall Study||0||
59973709|NCT02436304|76091165|FG001|NOT COMPLETED|Overall Study||2||
59973710|NCT02436304|76091166|FG002|NOT COMPLETED|Overall Study||1||
59812549|NCT00370396|75934851|FG000|NOT COMPLETED|Overall Study||11||
59812550|NCT00370396|75934852|FG001|NOT COMPLETED|Overall Study||1||
59812551|NCT00370396|75934853|FG002|NOT COMPLETED|Overall Study||1||
59812552|NCT00455013|75934864|FG000|STARTED|Short Term Period|35 randomized, 33 transplanted and treated.|33||
59812553|NCT00455013|75934865|FG001|STARTED|Short Term Period|27 randomized, 26 transplanted and treated.|26||
59812554|NCT00455013|75934866|FG002|STARTED|Short Term Period|31 randomized, 30 transplanted and treated|30||
59812555|NCT00455013|75934864|FG000|COMPLETED|Short Term Period|5 discontinued belatacept by Month 6 (1 more by Month 12), 2 switched from MMF to sirolimus.|27||
59812556|NCT00455013|75934865|FG001|COMPLETED|Short Term Period|5 discontinued belatacept by Month 6; 10 additional switched from sirolimus to MMF.|21||
59812557|NCT00455013|75934866|FG002|COMPLETED|Short Term Period|1 discontinued tacrolimus by Month 6 and 2 discontinued by Month 12 (1 more by Month 12)|28||
59812558|NCT00455013|75934864|FG000|NOT COMPLETED|Short Term Period||6||
59812559|NCT00455013|75934865|FG001|NOT COMPLETED|Short Term Period||5||
59812560|NCT00455013|75934866|FG002|NOT COMPLETED|Short Term Period||2||
59973711|NCT02402218|76091178|FG000|STARTED|Overall Study||36||
59973712|NCT02402218|76091179|FG001|STARTED|Overall Study||54||
59973713|NCT02402218|76091180|FG002|STARTED|Overall Study||54||
59973714|NCT02402218|76091178|FG000|Initiated Treatment With LDV/SOF|Overall Study||24||
59973715|NCT02402218|76091179|FG001|Initiated Treatment With LDV/SOF|Overall Study||45||
59973716|NCT02402218|76091180|FG002|Initiated Treatment With LDV/SOF|Overall Study||41||
59973717|NCT02402218|76091178|FG000|Completed Treatment With LDV/SOF|Overall Study||23||
59973718|NCT02402218|76091179|FG001|Completed Treatment With LDV/SOF|Overall Study||42||
59973719|NCT02402218|76091180|FG002|Completed Treatment With LDV/SOF|Overall Study||39||
59973720|NCT02402218|76091178|FG000|Achieved Sustained Virologic Response|Overall Study||22||
59973721|NCT02402218|76091179|FG001|Achieved Sustained Virologic Response|Overall Study||41||
59973722|NCT02402218|76091180|FG002|Achieved Sustained Virologic Response|Overall Study||37||
59973723|NCT02402218|76091178|FG000|COMPLETED|Overall Study||22||
59973724|NCT02402218|76091179|FG001|COMPLETED|Overall Study||41||
59973725|NCT02402218|76091180|FG002|COMPLETED|Overall Study||37||
59973726|NCT02402218|76091178|FG000|NOT COMPLETED|Overall Study||14||
59973727|NCT02402218|76091179|FG001|NOT COMPLETED|Overall Study||13||
59973728|NCT02402218|76091180|FG002|NOT COMPLETED|Overall Study||17||
59973729|NCT02457520|76091188|FG000|STARTED|Active Treatment Phase|All subjects received treatment according to the same regimen.|201||
59973730|NCT02457520|76091188|FG000|COMPLETED|Active Treatment Phase||167|Subjects Completing Treatment Phase, n (%)|
59973731|NCT02457520|76091188|FG000|NOT COMPLETED|Active Treatment Phase||34||
59973732|NCT02457520|76091188|FG000|STARTED|Post-treatment Period||167||
59973733|NCT02457520|76091188|FG000|COMPLETED|Post-treatment Period||119||
59973734|NCT02457520|76091188|FG000|NOT COMPLETED|Post-treatment Period||48||
59973735|NCT02788279|76091221|FG000|STARTED|Overall Study||90|Intent to treat (ITT) population|
59973736|NCT02788279|76091222|FG001|STARTED|Overall Study||183|Intent to treat (ITT) population|
59973737|NCT02788279|76091223|FG002|STARTED|Overall Study||90|Intent to treat (ITT) population|
59973738|NCT02788279|76091221|FG000|Received Treatment (Safety Population)|Overall Study||80||
59973739|NCT02788279|76091222|FG001|Received Treatment (Safety Population)|Overall Study||179||
59812561|NCT00455013|75934864|FG000|STARTED|Long Term Extension (LTE)||27||
59812562|NCT00455013|75934865|FG001|STARTED|Long Term Extension (LTE)|2 Participants chose not to enter the LTE.|19||
59812563|NCT00455013|75934866|FG002|STARTED|Long Term Extension (LTE)|1 Participant chose not to enter the LTE.|27||
59812564|NCT00455013|75934864|FG000|COMPLETED|Long Term Extension (LTE)||25||
59812565|NCT00455013|75934865|FG001|COMPLETED|Long Term Extension (LTE)||16||
59812566|NCT00455013|75934866|FG002|COMPLETED|Long Term Extension (LTE)||20||
59812567|NCT00455013|75934864|FG000|NOT COMPLETED|Long Term Extension (LTE)||2||
59812568|NCT00455013|75934865|FG001|NOT COMPLETED|Long Term Extension (LTE)||3||
59812569|NCT00455013|75934866|FG002|NOT COMPLETED|Long Term Extension (LTE)||7||
59812570|NCT00363298|75934876|FG000|STARTED|First Study Week||12||
59973740|NCT02788279|76091223|FG002|Received Treatment (Safety Population)|Overall Study||90||
59973741|NCT02788279|76091221|FG000|Modified ITT Population|Overall Study||57|Patient-reported outcome (PRO)|
59973742|NCT02788279|76091222|FG001|Modified ITT Population|Overall Study||125|Patient-reported outcome (PRO)|
59973743|NCT02788279|76091223|FG002|Modified ITT Population|Overall Study||61|Patient-reported outcome (PRO)|
59973744|NCT02788279|76091221|FG000|COMPLETED|Overall Study||0||
59973745|NCT02788279|76091222|FG001|COMPLETED|Overall Study||0||
59973746|NCT02788279|76091223|FG002|COMPLETED|Overall Study||0||
59973747|NCT02788279|76091221|FG000|NOT COMPLETED|Overall Study||90||
59973748|NCT02788279|76091222|FG001|NOT COMPLETED|Overall Study||183||
59973749|NCT02788279|76091223|FG002|NOT COMPLETED|Overall Study||90||
59973750|NCT02435992|76091239|FG000|STARTED|Overall Study||429||
60074554|NCT01807520|76189933|FG001|Safety Set|Treatment Period 2 (16-132 Weeks)||65||
59525740|NCT01262131|75621084|FG000|NOT COMPLETED|Overall Study||0||
59812571|NCT00363298|75934877|FG001|STARTED|First Study Week||12||
59973751|NCT02435992|76091240|FG001|STARTED|Overall Study||216||
59973752|NCT02435992|76091241|FG002|STARTED|Overall Study||367||
59973753|NCT02435992|76091242|FG003|STARTED|Overall Study||0||
59973754|NCT02435992|76091243|FG004|STARTED|Overall Study||0||
59973755|NCT02435992|76091239|FG000|Transition to Maintenance Period|Overall Study||233|Completed Induction Week 10, continuing into MP|
59973756|NCT02435992|76091240|FG001|Transition to Maintenance Period|Overall Study||69|Completed Induction Week 10, continuing into MP|
59973757|NCT02435992|76091241|FG002|Transition to Maintenance Period|Overall Study||224|Completed Induction Week 10, continuing into MP|
59973758|NCT02435992|76091242|FG003|Transition to Maintenance Period|Overall Study||0|Completed Induction Week 10, continuing into MP|
59973759|NCT02435992|76091243|FG004|Transition to Maintenance Period|Overall Study||0|Completed Induction Week 10, continuing into MP|
59973760|NCT02435992|76091239|FG000|Treated in Maintenance Period|Overall Study||0|Subjects who entered Maintenance Period from Induction period|
59973761|NCT02435992|76091240|FG001|Treated in Maintenance Period|Overall Study||69|Subjects who entered Maintenance Period from Induction period|
59973762|NCT02435992|76091241|FG002|Treated in Maintenance Period|Overall Study||0|Subjects who entered Maintenance Period from Induction period|
59973763|NCT02435992|76091242|FG003|Treated in Maintenance Period|Overall Study|Randomized from cohort 1 and 2 RCP1063 treatment|230|Subjects who entered Maintenance Period from Induction period|
59973764|NCT02435992|76091243|FG004|Treated in Maintenance Period|Overall Study|Randomized from cohort 1 and 2 RCP1063 treatment|227|Subjects who entered Maintenance Period from Induction period|
59973765|NCT02435992|76091239|FG000|COMPLETED|Overall Study||401||
59973766|NCT02435992|76091240|FG001|COMPLETED|Overall Study||192||
59973767|NCT02435992|76091241|FG002|COMPLETED|Overall Study||324||
59973768|NCT02435992|76091242|FG003|COMPLETED|Overall Study||0||
59973769|NCT02435992|76091243|FG004|COMPLETED|Overall Study||0||
59973770|NCT02435992|76091239|FG000|NOT COMPLETED|Overall Study||28||
59973771|NCT02435992|76091240|FG001|NOT COMPLETED|Overall Study||24||
59973772|NCT02435992|76091241|FG002|NOT COMPLETED|Overall Study||43||
59973773|NCT02435992|76091242|FG003|NOT COMPLETED|Overall Study||0||
59973774|NCT02435992|76091243|FG004|NOT COMPLETED|Overall Study||0||
59973775|NCT02788513|76091260|FG000|STARTED|Overall Study||123||
59973776|NCT02788513|76091261|FG001|STARTED|Overall Study||122||
59973777|NCT02788513|76091262|FG002|STARTED|Overall Study||122||
59973778|NCT02788513|76091263|FG003|STARTED|Overall Study||123||
59973779|NCT02788513|76091264|FG004|STARTED|Overall Study||120||
59973780|NCT02788513|76091260|FG000|COMPLETED|Overall Study||114||
59973781|NCT02788513|76091261|FG001|COMPLETED|Overall Study||114||
59525741|NCT01262131|75621085|FG001|NOT COMPLETED|Overall Study||0||
59525742|NCT01262131|75621086|FG002|NOT COMPLETED|Overall Study||0||
59525743|NCT01262599|75621096|FG000|STARTED|Overall Study||16||
59525744|NCT01262599|75621097|FG001|STARTED|Overall Study||16||
59525745|NCT01262599|75621096|FG000|COMPLETED|Overall Study||16||
59525746|NCT01262599|75621097|FG001|COMPLETED|Overall Study||16||
59525747|NCT01262599|75621096|FG000|NOT COMPLETED|Overall Study||0||
59525748|NCT01262599|75621097|FG001|NOT COMPLETED|Overall Study||0||
59525749|NCT01262755|75621105|FG000|STARTED|Overall Study||450||
59525750|NCT01262755|75621105|FG000|COMPLETED|Overall Study||450||
59525751|NCT01262755|75621105|FG000|NOT COMPLETED|Overall Study||0||
59525752|NCT01284517|75621111|FG000|STARTED|Overall Study||180||
59525753|NCT01284517|75621112|FG001|STARTED|Overall Study||176||
59525754|NCT01284517|75621111|FG000|COMPLETED|Overall Study||148||
59525755|NCT01284517|75621112|FG001|COMPLETED|Overall Study||140||
59525756|NCT01284517|75621111|FG000|NOT COMPLETED|Overall Study||32||
59525757|NCT01284517|75621112|FG001|NOT COMPLETED|Overall Study||36||
59525758|NCT01216735|75621120|FG000|STARTED|First Intervention (3 Weeks)||8||
59973782|NCT02788513|76091262|FG002|COMPLETED|Overall Study||114||
59973783|NCT02788513|76091263|FG003|COMPLETED|Overall Study||117||
59973784|NCT02788513|76091264|FG004|COMPLETED|Overall Study||115||
59973785|NCT02788513|76091260|FG000|NOT COMPLETED|Overall Study||9||
59973786|NCT02788513|76091261|FG001|NOT COMPLETED|Overall Study||8||
59973787|NCT02788513|76091262|FG002|NOT COMPLETED|Overall Study||8||
59525759|NCT01216735|75621121|FG001|STARTED|First Intervention (3 Weeks)||7||
59525760|NCT01216735|75621120|FG000|COMPLETED|First Intervention (3 Weeks)||8||
59525761|NCT01216735|75621121|FG001|COMPLETED|First Intervention (3 Weeks)||7||
59525762|NCT01216735|75621120|FG000|NOT COMPLETED|First Intervention (3 Weeks)||0||
59525763|NCT01216735|75621121|FG001|NOT COMPLETED|First Intervention (3 Weeks)||0||
59525764|NCT01216735|75621120|FG000|STARTED|Washout (3 Weeks)||8||
59525765|NCT01216735|75621121|FG001|STARTED|Washout (3 Weeks)||7||
59525766|NCT01216735|75621120|FG000|COMPLETED|Washout (3 Weeks)||8||
59525767|NCT01216735|75621121|FG001|COMPLETED|Washout (3 Weeks)||7||
59525768|NCT01216735|75621120|FG000|NOT COMPLETED|Washout (3 Weeks)||0||
59525769|NCT01216735|75621121|FG001|NOT COMPLETED|Washout (3 Weeks)||0||
59525770|NCT01216735|75621120|FG000|STARTED|Second Intervention (3 Weeks)||8||
59525771|NCT01216735|75621121|FG001|STARTED|Second Intervention (3 Weeks)||7||
59709617|NCT01236365|75828389|FG000|NOT COMPLETED|Overall Study||2||
59709618|NCT01236365|75828390|FG001|NOT COMPLETED|Overall Study||2||
59709619|NCT01235975|75828410|FG000|STARTED|Overall Study||274||
59709620|NCT01235975|75828411|FG001|STARTED|Overall Study||95||
59709621|NCT01235975|75828410|FG000|COMPLETED|Overall Study||257||
59709622|NCT01235975|75828411|FG001|COMPLETED|Overall Study||88||
59709623|NCT01235975|75828410|FG000|NOT COMPLETED|Overall Study||17||
59709624|NCT01235975|75828411|FG001|NOT COMPLETED|Overall Study||7||
59812572|NCT00363298|75934876|FG000|COMPLETED|First Study Week|At end of week 1, 6/12 subjects met Y-BOCS response criterion and began 4-week continuation phase|6||
59812573|NCT00363298|75934877|FG001|COMPLETED|First Study Week|At end of week 1, 7/12 subjects met Y-BOCS response criterion and began 4-week continuation phase|7||
59812574|NCT00363298|75934876|FG000|NOT COMPLETED|First Study Week||6||
59973788|NCT02788513|76091263|FG003|NOT COMPLETED|Overall Study||6||
59973789|NCT02788513|76091264|FG004|NOT COMPLETED|Overall Study||5||
59973790|NCT03077828|76091276|FG000|STARTED|Treatment Cycles||43||
59973791|NCT03077828|76091276|FG000|Cycle 1|Treatment Cycles||42||
59973792|NCT03077828|76091276|FG000|Cycle 2|Treatment Cycles||39||
59973793|NCT03077828|76091276|FG000|Cycle 3|Treatment Cycles||39||
59973794|NCT03077828|76091276|FG000|Optional Cycle 4|Treatment Cycles||5|Cycle #4 is not required on the study protocol. Patients with a Deauville score ≤3 may proceed directly to AHSCT per provider discretion if the procedure can be arranged within 21-35 days after cycle #3. Alternatively, if the patient's FDG-PET/CT has a Deauville score >3, they will come off protocol, receive no further study agent, and be treated per investigator discretion.|
59973795|NCT03077828|76091276|FG000|COMPLETED|Treatment Cycles||39||
59973796|NCT03077828|76091276|FG000|NOT COMPLETED|Treatment Cycles||4||
59973797|NCT03077828|76091276|FG000|STARTED|Autologous Stem Cell Transplant||42|Autologous Stem Cell Transplant will took place 21-42 days after the final study regimen pembrolizumab dose (optional pembro-ICE combination or otherwise, per provider discretion). Transplant visit parameters were obtained on the initial day of induction chemotherapy or within 21-42 days following final study regimen but prior to the autologous stem cell transplant procedure.|
59973798|NCT03077828|76091276|FG000|COMPLETED|Autologous Stem Cell Transplant||38||
59973799|NCT03077828|76091276|FG000|NOT COMPLETED|Autologous Stem Cell Transplant||4||
59973800|NCT03077828|76091276|FG000|STARTED|Follow-up||39||
59973801|NCT03077828|76091276|FG000|COMPLETED|Follow-up||24||
59973802|NCT03077828|76091276|FG000|NOT COMPLETED|Follow-up||15||
59973803|NCT02401672|76091282|FG000|STARTED|Overall Study||22||
59973804|NCT02401672|76091283|FG001|STARTED|Overall Study||20||
59973805|NCT02401672|76091282|FG000|COMPLETED|Overall Study||21||
59973806|NCT02401672|76091283|FG001|COMPLETED|Overall Study||17||
59973807|NCT02401672|76091282|FG000|NOT COMPLETED|Overall Study||1||
59973808|NCT02401672|76091283|FG001|NOT COMPLETED|Overall Study||3||
59973809|NCT02435914|76091293|FG000|STARTED|Overall Study||58||
59973810|NCT02435914|76091294|FG001|STARTED|Overall Study||59||
59973811|NCT02435914|76091295|FG002|STARTED|Overall Study||60||
59812575|NCT00363298|75934877|FG001|NOT COMPLETED|First Study Week||5||
59812576|NCT00363298|75934876|FG000|STARTED|4-week Study Continuation Phase||6||
59812577|NCT00363298|75934877|FG001|STARTED|4-week Study Continuation Phase||7||
59812578|NCT00363298|75934876|FG000|COMPLETED|4-week Study Continuation Phase||5||
59812579|NCT00363298|75934877|FG001|COMPLETED|4-week Study Continuation Phase||7||
59973812|NCT02435914|76091296|FG003|STARTED|Overall Study||59||
59973813|NCT02435914|76091293|FG000|COMPLETED|Overall Study||57||
59973814|NCT02435914|76091294|FG001|COMPLETED|Overall Study||58||
59973815|NCT02435914|76091295|FG002|COMPLETED|Overall Study||59||
59973816|NCT02435914|76091296|FG003|COMPLETED|Overall Study||59||
59973817|NCT02435914|76091293|FG000|NOT COMPLETED|Overall Study||1||
59973818|NCT02435914|76091294|FG001|NOT COMPLETED|Overall Study||1||
59973819|NCT02435914|76091295|FG002|NOT COMPLETED|Overall Study||1||
59973820|NCT02435914|76091296|FG003|NOT COMPLETED|Overall Study||0||
59973821|NCT02786953|76091308|FG000|STARTED|Overall Study||20||
59973822|NCT02786953|76091309|FG001|STARTED|Overall Study||19||
59973823|NCT02786953|76091308|FG000|Baseline Teen Survey Data Completed|Overall Study||20||
59812580|NCT00363298|75934876|FG000|NOT COMPLETED|4-week Study Continuation Phase||1||
59812581|NCT00363298|75934877|FG001|NOT COMPLETED|4-week Study Continuation Phase||0||
59812582|NCT00363142|75934886|FG000|STARTED|Overall Study||140||
59812583|NCT00363142|75934887|FG001|STARTED|Overall Study||69||
59812584|NCT00363142|75934886|FG000|COMPLETED|Overall Study||133||
59812585|NCT00363142|75934887|FG001|COMPLETED|Overall Study||66||
59812586|NCT00363142|75934886|FG000|NOT COMPLETED|Overall Study||7||
59812587|NCT00363142|75934887|FG001|NOT COMPLETED|Overall Study||3||
59812588|NCT00454857|75934896|FG000|STARTED|Overall Study||326||
59812589|NCT00454857|75934896|FG000|Completed Retrospective Chart Review|Overall Study||324||
59812590|NCT00454857|75934896|FG000|Completed ≥1 Observational Study Visit|Overall Study||319||
59812591|NCT00454857|75934896|FG000|COMPLETED|Overall Study||272||
59812592|NCT00454857|75934896|FG000|NOT COMPLETED|Overall Study||54||
59994962|NCT04409041|76110781|FG000|NOT COMPLETED|Overall Study||17||
59994963|NCT02051309|76110788|FG000|STARTED|Overall Study||58||
59994964|NCT02051309|76110789|FG001|STARTED|Overall Study||63||
59994965|NCT02051309|76110788|FG000|COMPLETED|Overall Study||26||
59994966|NCT02051309|76110789|FG001|COMPLETED|Overall Study||35||
59994967|NCT02051309|76110788|FG000|NOT COMPLETED|Overall Study||32||
59709625|NCT00903331|75828419|FG000|STARTED|Overall Study||59||
59709626|NCT00903331|75828420|FG001|STARTED|Overall Study||119||
59709627|NCT00903331|75828419|FG000|COMPLETED|Overall Study||54||
59709628|NCT00903331|75828420|FG001|COMPLETED|Overall Study||101||
59709629|NCT00903331|75828419|FG000|NOT COMPLETED|Overall Study||5||
59709630|NCT00903331|75828420|FG001|NOT COMPLETED|Overall Study||18||
59709631|NCT01235741|75828429|FG000|STARTED|Non-Randomized Low Calorie Diet Lead-In|6 Week LCD period. Those who lost >=2% of body weight were randomized to treatment.|213||
59709632|NCT01235741|75828430|FG001|STARTED|Non-Randomized Low Calorie Diet Lead-In||0||
59973824|NCT02786953|76091309|FG001|Baseline Teen Survey Data Completed|Overall Study|One participant withdrawn and data excluded due to becoming ineligible due to a new diagnosis|18||
59973825|NCT02786953|76091308|FG000|Baseline Parent Survey Completed|Overall Study||20||
59973826|NCT02786953|76091309|FG001|Baseline Parent Survey Completed|Overall Study|One participant withdrawn and data excluded due to becoming ineligible due to a new diagnosis|18||
59973827|NCT02786953|76091308|FG000|Actigraph Data Complete|Overall Study||14||
59973828|NCT02786953|76091309|FG001|Actigraph Data Complete|Overall Study|One participant withdrawn and data excluded due to becoming ineligible due to a new diagnosis|17||
59973829|NCT02786953|76091308|FG000|A1C Data Baseline|Overall Study||20||
59973830|NCT02786953|76091309|FG001|A1C Data Baseline|Overall Study|One participant withdrawn and data excluded due to becoming ineligible due to a new diagnosis|18||
59973831|NCT02786953|76091308|FG000|Session 1 Completed|Overall Study||17||
59973832|NCT02786953|76091309|FG001|Session 1 Completed|Overall Study||0||
59973833|NCT02786953|76091308|FG000|Session 2 Completed|Overall Study||16||
59973834|NCT02786953|76091309|FG001|Session 2 Completed|Overall Study||0||
59973835|NCT02786953|76091308|FG000|Session 3 Completed|Overall Study||16||
59973836|NCT02786953|76091309|FG001|Session 3 Completed|Overall Study||0||
59812593|NCT00379912|75934902|FG000|STARTED|Overall Study||7||
59812594|NCT00379912|75934903|FG001|STARTED|Overall Study||8||
59812595|NCT00379912|75934902|FG000|COMPLETED|Overall Study||6||
59812596|NCT00379912|75934903|FG001|COMPLETED|Overall Study||8||
59812597|NCT00379912|75934902|FG000|NOT COMPLETED|Overall Study||1||
59812598|NCT00379912|75934903|FG001|NOT COMPLETED|Overall Study||0||
59812599|NCT00379834|75934915|FG000|STARTED|Overall Study||10||
59812600|NCT00379834|75934915|FG000|COMPLETED|Overall Study||8||
59812601|NCT00379834|75934915|FG000|NOT COMPLETED|Overall Study||2||
59812602|NCT00379210|75934921|FG000|STARTED|Overall Study||30||
59812603|NCT00379210|75934922|FG001|STARTED|Overall Study||30||
59973837|NCT02786953|76091308|FG000|3 Month Teen Survey Completed|Overall Study||17||
59973838|NCT02786953|76091309|FG001|3 Month Teen Survey Completed|Overall Study||18||
59973839|NCT02786953|76091308|FG000|3 Month Parent Survey Completed|Overall Study||17||
59973840|NCT02786953|76091309|FG001|3 Month Parent Survey Completed|Overall Study||18||
59973841|NCT02786953|76091308|FG000|A1C 3 Month|Overall Study||15||
59973842|NCT02786953|76091309|FG001|A1C 3 Month|Overall Study||17||
59973843|NCT02786953|76091308|FG000|COMPLETED|Overall Study||17||
59973844|NCT02786953|76091309|FG001|COMPLETED|Overall Study||18||
59973845|NCT02786953|76091308|FG000|NOT COMPLETED|Overall Study||3||
59973846|NCT02786953|76091309|FG001|NOT COMPLETED|Overall Study||1||
59973847|NCT02435836|76091315|FG000|STARTED|Overall Study||631||
59973848|NCT02435836|76091315|FG000|COMPLETED|Overall Study||0||
59973849|NCT02435836|76091315|FG000|NOT COMPLETED|Overall Study||631||
59973850|NCT02788201|76091325|FG000|STARTED|Overall Study||1||
59973851|NCT02788201|76091326|FG001|STARTED|Overall Study||1||
59973852|NCT02788201|76091327|FG002|STARTED|Overall Study||1||
59973853|NCT02788201|76091328|FG003|STARTED|Overall Study||1||
59973854|NCT02788201|76091329|FG004|STARTED|Overall Study||1||
59973855|NCT02788201|76091330|FG005|STARTED|Overall Study||3||
59973856|NCT02788201|76091325|FG000|Did Not Start Treatment|Overall Study||0||
59973857|NCT02788201|76091326|FG001|Did Not Start Treatment|Overall Study||0||
59973858|NCT02788201|76091327|FG002|Did Not Start Treatment|Overall Study||0||
59973859|NCT02788201|76091328|FG003|Did Not Start Treatment|Overall Study||0||
59973860|NCT02788201|76091329|FG004|Did Not Start Treatment|Overall Study||0||
59973861|NCT02788201|76091330|FG005|Did Not Start Treatment|Overall Study||3||
60074555|NCT01807520|76189934|FG002|Safety Set|Treatment Period 2 (16-132 Weeks)||0||
59812604|NCT00379210|75934921|FG000|COMPLETED|Overall Study||20||
59812605|NCT00379210|75934922|FG001|COMPLETED|Overall Study||23||
59812606|NCT00379210|75934921|FG000|NOT COMPLETED|Overall Study||10||
59812607|NCT00379210|75934922|FG001|NOT COMPLETED|Overall Study||7||
59812608|NCT00378898|75934930|FG000|STARTED|Overall Study||22||
59812609|NCT00378898|75934931|FG001|STARTED|Overall Study||17||
59812610|NCT00378898|75934930|FG000|COMPLETED|Overall Study||11||
59812611|NCT00378898|75934931|FG001|COMPLETED|Overall Study||11||
59973862|NCT02788201|76091325|FG000|COMPLETED|Overall Study||0||
59973863|NCT02788201|76091326|FG001|COMPLETED|Overall Study||0||
59973864|NCT02788201|76091327|FG002|COMPLETED|Overall Study||0||
59973865|NCT02788201|76091328|FG003|COMPLETED|Overall Study||0||
59973866|NCT02788201|76091329|FG004|COMPLETED|Overall Study||1||
59973867|NCT02788201|76091330|FG005|COMPLETED|Overall Study||0||
59973868|NCT02788201|76091325|FG000|NOT COMPLETED|Overall Study||1||
60074556|NCT01807520|76189935|FG003|Safety Set|Treatment Period 2 (16-132 Weeks)||29||
60074557|NCT01807520|76189936|FG004|Safety Set|Treatment Period 2 (16-132 Weeks)||29||
59812612|NCT00378898|75934930|FG000|NOT COMPLETED|Overall Study||11||
59812613|NCT00378898|75934931|FG001|NOT COMPLETED|Overall Study||6||
59812614|NCT00378508|75934941|FG000|STARTED|Overall Study||29||
59812615|NCT00378508|75934942|FG001|STARTED|Overall Study||34||
59812616|NCT00378508|75934941|FG000|Randomized|Overall Study||29||
59812617|NCT00378508|75934942|FG001|Randomized|Overall Study||34||
59812618|NCT00378508|75934941|FG000|Received Intervention/Placebo|Overall Study||28||
59812619|NCT00378508|75934942|FG001|Received Intervention/Placebo|Overall Study||31||
59812620|NCT00378508|75934941|FG000|COMPLETED|Overall Study||27||
59812621|NCT00378508|75934942|FG001|COMPLETED|Overall Study||31||
59812622|NCT00378508|75934941|FG000|NOT COMPLETED|Overall Study||2||
59973869|NCT02788201|76091326|FG001|NOT COMPLETED|Overall Study||1||
59973870|NCT02788201|76091327|FG002|NOT COMPLETED|Overall Study||1||
59973871|NCT02788201|76091328|FG003|NOT COMPLETED|Overall Study||1||
59973872|NCT02788201|76091329|FG004|NOT COMPLETED|Overall Study||0||
59973873|NCT02788201|76091330|FG005|NOT COMPLETED|Overall Study||3||
59973874|NCT02456740|76091349|FG000|STARTED|Double-blind Treatment Phase (24 Weeks)||319||
59973875|NCT02456740|76091350|FG001|STARTED|Double-blind Treatment Phase (24 Weeks)||317||
59973876|NCT02456740|76091351|FG002|STARTED|Double-blind Treatment Phase (24 Weeks)||319||
59973877|NCT02456740|76091352|FG003|STARTED|Double-blind Treatment Phase (24 Weeks)||0||
59973878|NCT02456740|76091353|FG004|STARTED|Double-blind Treatment Phase (24 Weeks)||0||
59973879|NCT02456740|76091354|FG005|STARTED|Double-blind Treatment Phase (24 Weeks)||0||
59973880|NCT02456740|76091355|FG006|STARTED|Double-blind Treatment Phase (24 Weeks)||0||
59973881|NCT02456740|76091356|FG007|STARTED|Double-blind Treatment Phase (24 Weeks)||0||
59973882|NCT02456740|76091357|FG008|STARTED|Double-blind Treatment Phase (24 Weeks)||0||
59973883|NCT02456740|76091349|FG000|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||319||
59973884|NCT02456740|76091350|FG001|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||314||
59973885|NCT02456740|76091351|FG002|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||319||
59973886|NCT02456740|76091352|FG003|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0||
59973887|NCT02456740|76091353|FG004|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0||
59973888|NCT02456740|76091354|FG005|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0||
59973889|NCT02456740|76091355|FG006|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0||
59973890|NCT02456740|76091356|FG007|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0||
59973891|NCT02456740|76091357|FG008|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0||
59973892|NCT02456740|76091349|FG000|COMPLETED|Double-blind Treatment Phase (24 Weeks)||282||
59973893|NCT02456740|76091350|FG001|COMPLETED|Double-blind Treatment Phase (24 Weeks)||284||
59973894|NCT02456740|76091351|FG002|COMPLETED|Double-blind Treatment Phase (24 Weeks)||292||
59973895|NCT02456740|76091352|FG003|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0||
59973896|NCT02456740|76091353|FG004|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0||
59973897|NCT02456740|76091354|FG005|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0||
59973898|NCT02456740|76091355|FG006|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0||
59973899|NCT02456740|76091356|FG007|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0||
59973900|NCT02456740|76091357|FG008|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0||
59973901|NCT02456740|76091349|FG000|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||37||
59973902|NCT02456740|76091350|FG001|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||33||
59973903|NCT02456740|76091351|FG002|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||27||
59973904|NCT02456740|76091352|FG003|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0||
59973905|NCT02456740|76091353|FG004|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0||
59973906|NCT02456740|76091354|FG005|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0||
59973907|NCT02456740|76091355|FG006|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0||
59973908|NCT02456740|76091356|FG007|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0||
59973909|NCT02456740|76091357|FG008|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0||
59973910|NCT02456740|76091349|FG000|STARTED|Active Treatment Phase (Weeks 24 - 52)||0|Fourteen participants who completed the DBTP did not continue onto the active treatment phase|
59973911|NCT02456740|76091350|FG001|STARTED|Active Treatment Phase (Weeks 24 - 52)||0|Fourteen participants who completed the DBTP did not continue onto the active treatment phase|
59973912|NCT02456740|76091351|FG002|STARTED|Active Treatment Phase (Weeks 24 - 52)||0|Fourteen participants who completed the DBTP did not continue onto the active treatment phase|
59973913|NCT02456740|76091352|FG003|STARTED|Active Treatment Phase (Weeks 24 - 52)||138|Fourteen participants who completed the DBTP did not continue onto the active treatment phase|
59973914|NCT02456740|76091353|FG004|STARTED|Active Treatment Phase (Weeks 24 - 52)||140|Fourteen participants who completed the DBTP did not continue onto the active treatment phase|
59973915|NCT02456740|76091354|FG005|STARTED|Active Treatment Phase (Weeks 24 - 52)||143|Fourteen participants who completed the DBTP did not continue onto the active treatment phase|
59973916|NCT02456740|76091355|FG006|STARTED|Active Treatment Phase (Weeks 24 - 52)||140|Fourteen participants who completed the DBTP did not continue onto the active treatment phase|
59973917|NCT02456740|76091356|FG007|STARTED|Active Treatment Phase (Weeks 24 - 52)||140|Fourteen participants who completed the DBTP did not continue onto the active treatment phase|
59973918|NCT02456740|76091357|FG008|STARTED|Active Treatment Phase (Weeks 24 - 52)||144|Fourteen participants who completed the DBTP did not continue onto the active treatment phase|
59973919|NCT02456740|76091349|FG000|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0||
59973920|NCT02456740|76091350|FG001|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0||
59973921|NCT02456740|76091351|FG002|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0||
59973922|NCT02456740|76091352|FG003|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||124||
59973923|NCT02456740|76091353|FG004|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||123||
59973924|NCT02456740|76091354|FG005|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||130||
59973925|NCT02456740|76091355|FG006|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||131||
59973926|NCT02456740|76091356|FG007|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||128||
59973927|NCT02456740|76091357|FG008|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||126||
59973928|NCT02456740|76091349|FG000|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0||
59973929|NCT02456740|76091350|FG001|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0||
59973930|NCT02456740|76091351|FG002|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0||
59973931|NCT02456740|76091352|FG003|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||14||
59973932|NCT02456740|76091353|FG004|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||17||
59973933|NCT02456740|76091354|FG005|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||13||
59973934|NCT02456740|76091355|FG006|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||9||
59973935|NCT02456740|76091356|FG007|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||12||
59973936|NCT02456740|76091357|FG008|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||18||
59973937|NCT02400580|76091369|FG000|STARTED|Overall Study||91||
59973938|NCT02400580|76091370|FG001|STARTED|Overall Study||92||
59973939|NCT02400580|76091369|FG000|COMPLETED|Overall Study||89||
59973940|NCT02400580|76091370|FG001|COMPLETED|Overall Study||91||
59973941|NCT02400580|76091369|FG000|NOT COMPLETED|Overall Study||2||
59973942|NCT02400580|76091370|FG001|NOT COMPLETED|Overall Study||1||
59973943|NCT01367119|76091378|FG000|STARTED|Overall Study||21||
59973944|NCT01367119|76091379|FG001|STARTED|Overall Study||17||
59973945|NCT01367119|76091378|FG000|COMPLETED|Overall Study||19||
59973946|NCT01367119|76091379|FG001|COMPLETED|Overall Study||16||
59973947|NCT01367119|76091378|FG000|NOT COMPLETED|Overall Study||2||
59973948|NCT01367119|76091379|FG001|NOT COMPLETED|Overall Study||1||
59973949|NCT02635724|76091388|FG000|STARTED|Overall Study||41||
59973950|NCT02635724|76091389|FG001|STARTED|Overall Study||26||
59973951|NCT02635724|76091390|FG002|STARTED|Overall Study||7||
59973952|NCT02635724|76091388|FG000|ITT Population|Overall Study||41|Intent-to-Treat (ITT) population included all enrolled subjects.|
59973953|NCT02635724|76091389|FG001|ITT Population|Overall Study||26|Intent-to-Treat (ITT) population included all enrolled subjects.|
59973954|NCT02635724|76091390|FG002|ITT Population|Overall Study||7|Intent-to-Treat (ITT) population included all enrolled subjects.|
59973955|NCT02635724|76091388|FG000|Safety Population|Overall Study||41|The safety population included all enrolled subjects who received any amount of study drug.|
59973956|NCT02635724|76091389|FG001|Safety Population|Overall Study||25|The safety population included all enrolled subjects who received any amount of study drug.|
59973957|NCT02635724|76091390|FG002|Safety Population|Overall Study||7|The safety population included all enrolled subjects who received any amount of study drug.|
59973958|NCT02635724|76091388|FG000|ITTI Population|Overall Study||28|Intent-to-Treat Infected (ITTI) population included all subjects who were enrolled, treated, and had influenza type A or B confirmed by PCR.|
59973959|NCT02635724|76091389|FG001|ITTI Population|Overall Study||19|Intent-to-Treat Infected (ITTI) population included all subjects who were enrolled, treated, and had influenza type A or B confirmed by PCR.|
59973960|NCT02635724|76091390|FG002|ITTI Population|Overall Study||5|Intent-to-Treat Infected (ITTI) population included all subjects who were enrolled, treated, and had influenza type A or B confirmed by PCR.|
59973961|NCT02635724|76091388|FG000|E-R Population|Overall Study||28|Exposure-Response (E-R) population included all subjects in the ITTI population who had a quantifiable peramivir concentration on Day 1 and had at least one post-baseline effectiveness assessment.|
59973962|NCT02635724|76091389|FG001|E-R Population|Overall Study||19|Exposure-Response (E-R) population included all subjects in the ITTI population who had a quantifiable peramivir concentration on Day 1 and had at least one post-baseline effectiveness assessment.|
59973963|NCT02635724|76091390|FG002|E-R Population|Overall Study||5|Exposure-Response (E-R) population included all subjects in the ITTI population who had a quantifiable peramivir concentration on Day 1 and had at least one post-baseline effectiveness assessment.|
59973964|NCT02635724|76091388|FG000|COMPLETED|Overall Study||41||
59973965|NCT02635724|76091389|FG001|COMPLETED|Overall Study||25||
59973966|NCT02635724|76091390|FG002|COMPLETED|Overall Study||7||
59973967|NCT02635724|76091388|FG000|NOT COMPLETED|Overall Study||0||
59973968|NCT02635724|76091389|FG001|NOT COMPLETED|Overall Study||1||
59973969|NCT02635724|76091390|FG002|NOT COMPLETED|Overall Study||0||
59973970|NCT02635646|76091400|FG000|STARTED|Overall Study||57||
59973971|NCT02635646|76091401|FG001|STARTED|Overall Study||65||
59973972|NCT02635646|76091400|FG000|COMPLETED|Overall Study||32||
59973973|NCT02635646|76091401|FG001|COMPLETED|Overall Study||39||
59973974|NCT02635646|76091400|FG000|NOT COMPLETED|Overall Study||25||
59973975|NCT02635646|76091401|FG001|NOT COMPLETED|Overall Study||26||
59973976|NCT02634788|76091417|FG000|STARTED|Overall Study||79||
59973977|NCT02634788|76091418|FG001|STARTED|Overall Study||81||
59973978|NCT02634788|76091419|FG002|STARTED|Overall Study||80||
59973979|NCT02634788|76091420|FG003|STARTED|Overall Study||82||
59973980|NCT02634788|76091417|FG000|COMPLETED|Overall Study||75||
59973981|NCT02634788|76091418|FG001|COMPLETED|Overall Study||71||
59973982|NCT02634788|76091419|FG002|COMPLETED|Overall Study||75||
59973983|NCT02634788|76091420|FG003|COMPLETED|Overall Study||77||
59973984|NCT02634788|76091417|FG000|NOT COMPLETED|Overall Study||4||
59973985|NCT02634788|76091418|FG001|NOT COMPLETED|Overall Study||10||
59973986|NCT02634788|76091419|FG002|NOT COMPLETED|Overall Study||5||
59973987|NCT02634788|76091420|FG003|NOT COMPLETED|Overall Study||5||
59973988|NCT02785939|76091432|FG000|STARTED|Overall Study||31||
59973989|NCT02785939|76091433|FG001|STARTED|Overall Study||10||
59973990|NCT02785939|76091432|FG000|Participants Re-registered to Palbociclib After Progression on Docetaxel|Overall Study||0||
59973991|NCT02785939|76091433|FG001|Participants Re-registered to Palbociclib After Progression on Docetaxel|Overall Study||1||
59973992|NCT02785939|76091432|FG000|COMPLETED|Overall Study||0|Re-registered participant did not complete palbociclib treatment due to progression|
59973993|NCT02785939|76091433|FG001|COMPLETED|Overall Study||0|Re-registered participant did not complete palbociclib treatment due to progression|
59973994|NCT02785939|76091432|FG000|NOT COMPLETED|Overall Study||31||
59973995|NCT02785939|76091433|FG001|NOT COMPLETED|Overall Study||10||
59973996|NCT04894916|76091439|FG000|STARTED|Overall Study||59||
59973997|NCT04894916|76091439|FG000|COMPLETED|Overall Study||53||
59973998|NCT04894916|76091439|FG000|NOT COMPLETED|Overall Study||6||
59973999|NCT02134717|76091443|FG000|STARTED|Overall Study||3||
59974000|NCT02134717|76091443|FG000|COMPLETED|Overall Study||3||
59974001|NCT02134717|76091443|FG000|NOT COMPLETED|Overall Study||0||
59974002|NCT02634320|76091447|FG000|STARTED|Overall Study||51||
59974003|NCT02634320|76091447|FG000|COMPLETED|Overall Study||35||
59974004|NCT02634320|76091447|FG000|NOT COMPLETED|Overall Study||16||
59974005|NCT02435680|76091454|FG000|STARTED|Overall Study||21||
59974006|NCT02435680|76091455|FG001|STARTED|Overall Study||13||
59974007|NCT02435680|76091456|FG002|STARTED|Overall Study||16||
59974008|NCT02435680|76091454|FG000|COMPLETED|Overall Study||0||
59974009|NCT02435680|76091455|FG001|COMPLETED|Overall Study||0||
59974010|NCT02435680|76091456|FG002|COMPLETED|Overall Study||0||
59974011|NCT02435680|76091454|FG000|NOT COMPLETED|Overall Study||21||
59974012|NCT02435680|76091455|FG001|NOT COMPLETED|Overall Study||13||
59974013|NCT02435680|76091456|FG002|NOT COMPLETED|Overall Study||16||
59974014|NCT03371732|76091470|FG000|STARTED|Overall Study||51||
59974015|NCT03371732|76091471|FG001|STARTED|Overall Study||53||
59974016|NCT03371732|76091470|FG000|COMPLETED|Overall Study||39||
59974017|NCT03371732|76091471|FG001|COMPLETED|Overall Study||46||
59974018|NCT03371732|76091470|FG000|NOT COMPLETED|Overall Study||12||
59974019|NCT03371732|76091471|FG001|NOT COMPLETED|Overall Study||7||
59974020|NCT02745119|76091483|FG000|STARTED|Overall Study||145||
59974021|NCT02745119|76091484|FG001|STARTED|Overall Study||274||
59974022|NCT02745119|76091485|FG002|STARTED|Overall Study||146||
59974023|NCT02745119|76091486|FG003|STARTED|Overall Study||277||
59974024|NCT02745119|76091483|FG000|COMPLETED|Overall Study||0||
59974025|NCT02745119|76091484|FG001|COMPLETED|Overall Study||0||
59974026|NCT02745119|76091485|FG002|COMPLETED|Overall Study||0||
59974027|NCT02745119|76091486|FG003|COMPLETED|Overall Study||0||
59974028|NCT02745119|76091483|FG000|NOT COMPLETED|Overall Study||145||
59974029|NCT02745119|76091484|FG001|NOT COMPLETED|Overall Study||274||
59974030|NCT02745119|76091485|FG002|NOT COMPLETED|Overall Study||146||
59974031|NCT02745119|76091486|FG003|NOT COMPLETED|Overall Study||277||
59974032|NCT01367665|76091500|FG000|STARTED|Overall Study||1119||
59974033|NCT01367665|76091501|FG001|STARTED|Overall Study||96||
59974034|NCT01367665|76091500|FG000|COMPLETED|Overall Study||677||
59974035|NCT01367665|76091501|FG001|COMPLETED|Overall Study||41||
59974036|NCT01367665|76091500|FG000|NOT COMPLETED|Overall Study||442||
59974037|NCT01367665|76091501|FG001|NOT COMPLETED|Overall Study||55||
59974038|NCT02576847|76091508|FG000|STARTED|Overall Study||307||
59974039|NCT02576847|76091508|FG000|COMPLETED|Overall Study||170||
59974040|NCT02576847|76091508|FG000|NOT COMPLETED|Overall Study||137||
59974041|NCT00075803|76091514|FG000|STARTED|Overall Study||295||
59974042|NCT00075803|76091515|FG001|STARTED|Overall Study||305||
59974043|NCT00075803|76091514|FG000|COMPLETED|Overall Study||295||
59974044|NCT00075803|76091515|FG001|COMPLETED|Overall Study||305||
59974045|NCT00075803|76091514|FG000|NOT COMPLETED|Overall Study||0||
59812623|NCT00378508|75934942|FG001|NOT COMPLETED|Overall Study||3||
59812624|NCT00454779|75934951|FG000|STARTED|First-line Treatment Phase||56||
59812625|NCT00454779|75934952|FG001|STARTED|First-line Treatment Phase||57||
59812626|NCT00454779|75934951|FG000|Received Study Medication|First-line Treatment Phase||56||
59812627|NCT00454779|75934952|FG001|Received Study Medication|First-line Treatment Phase||55||
59974046|NCT00075803|76091515|FG001|NOT COMPLETED|Overall Study||0||
59974047|NCT02135029|76091524|FG000|STARTED|Overall Study||73||
59812628|NCT00454779|75934951|FG000|COMPLETED|First-line Treatment Phase|Disease progression (radiographically determined) or death|51||
59812629|NCT00454779|75934952|FG001|COMPLETED|First-line Treatment Phase|Disease progression (radiographically determined) or death|49||
59812630|NCT00454779|75934951|FG000|NOT COMPLETED|First-line Treatment Phase||5||
59812631|NCT00454779|75934952|FG001|NOT COMPLETED|First-line Treatment Phase||8||
59812632|NCT00454779|75934951|FG000|STARTED|Second-line Treatment Phase|Subjects in this arm do not have second-line treatment period|0||
59812633|NCT00454779|75934952|FG001|STARTED|Second-line Treatment Phase|Second-line Panitumumab Monotherapy|30||
59812634|NCT00454779|75934951|FG000|COMPLETED|Second-line Treatment Phase|Disease progression (radiographically determined) or death|0||
59812635|NCT00454779|75934952|FG001|COMPLETED|Second-line Treatment Phase|Disease progression (radiographically determined) or death|27||
59812636|NCT00454779|75934951|FG000|NOT COMPLETED|Second-line Treatment Phase||0||
59812637|NCT00454779|75934952|FG001|NOT COMPLETED|Second-line Treatment Phase||3||
59812638|NCT02416206|75934958|FG000|STARTED|Overall Study||65||
59974048|NCT02135029|76091525|FG001|STARTED|Overall Study||74||
59974049|NCT02135029|76091526|FG002|STARTED|Overall Study||37||
59974050|NCT02135029|76091524|FG000|Treated|Overall Study||73||
59974051|NCT02135029|76091525|FG001|Treated|Overall Study||74||
59974052|NCT02135029|76091526|FG002|Treated|Overall Study||36||
59974053|NCT02135029|76091524|FG000|COMPLETED|Overall Study||69||
59974054|NCT02135029|76091525|FG001|COMPLETED|Overall Study||69||
59974055|NCT02135029|76091526|FG002|COMPLETED|Overall Study||34||
59974056|NCT02135029|76091524|FG000|NOT COMPLETED|Overall Study||4||
59974057|NCT02135029|76091525|FG001|NOT COMPLETED|Overall Study||5||
59812639|NCT02416206|75934958|FG000|COMPLETED|Overall Study||65||
59974058|NCT02135029|76091526|FG002|NOT COMPLETED|Overall Study||3||
59974059|NCT02842151|76091535|FG000|STARTED|Overall Study||150|All subjects with attempted implantation (successful or aborted) (Safety Analysis Set)|
59974060|NCT02842151|76091535|FG000|COMPLETED|Overall Study||148||
59974061|NCT02842151|76091535|FG000|NOT COMPLETED|Overall Study||2||
59974062|NCT02842073|76091541|FG000|STARTED|Overall Study||12||
59974063|NCT02842073|76091541|FG000|COMPLETED|Overall Study||11||
59974064|NCT02842073|76091541|FG000|NOT COMPLETED|Overall Study||1||
59974065|NCT01367275|76091545|FG000|STARTED|Overall Study||8||
59974066|NCT01367275|76091545|FG000|COMPLETED|Overall Study||5||
59974067|NCT01367275|76091545|FG000|NOT COMPLETED|Overall Study||3||
59974068|NCT02842853|76091553|FG000|STARTED|Overall Study||902||
59974069|NCT02842853|76091554|FG001|STARTED|Overall Study||895||
59974070|NCT02842853|76091555|FG002|STARTED|Overall Study||906||
59974071|NCT02842853|76091556|FG003|STARTED|Overall Study||641||
59974072|NCT02842853|76091553|FG000|Vaccinated|Overall Study||895||
59974073|NCT02842853|76091554|FG001|Vaccinated|Overall Study||886||
59974074|NCT02842853|76091555|FG002|Vaccinated|Overall Study||900||
59974075|NCT02842853|76091556|FG003|Vaccinated|Overall Study||636||
59812640|NCT02416206|75934958|FG000|NOT COMPLETED|Overall Study||0||
59812641|NCT00439569|75934962|FG000|STARTED|Cohort 1 (500 mg/kg/Day)||7||
59812642|NCT00439569|75934962|FG000|COMPLETED|Cohort 1 (500 mg/kg/Day)||3||
59812643|NCT00439569|75934962|FG000|NOT COMPLETED|Cohort 1 (500 mg/kg/Day)||4||
59812644|NCT00439569|75934962|FG000|STARTED|Cohort 2 (500 mg/kg/Day)|2 new subjects in Cohort 2 were enrolled into the study after Cohort 1 completed the study.|2||
59812645|NCT00439569|75934962|FG000|COMPLETED|Cohort 2 (500 mg/kg/Day)||1||
59974076|NCT02842853|76091553|FG000|Safety Analysis Set (SafAS)|Overall Study||895|SafAS: participants who received at least 1 dose of study vaccine & had any safety data available.|
59974077|NCT02842853|76091554|FG001|Safety Analysis Set (SafAS)|Overall Study||883|SafAS: participants who received at least 1 dose of study vaccine & had any safety data available.|
59974078|NCT02842853|76091555|FG002|Safety Analysis Set (SafAS)|Overall Study||898|SafAS: participants who received at least 1 dose of study vaccine & had any safety data available.|
59974079|NCT02842853|76091556|FG003|Safety Analysis Set (SafAS)|Overall Study||635|SafAS: participants who received at least 1 dose of study vaccine & had any safety data available.|
59974080|NCT02842853|76091553|FG000|COMPLETED|Overall Study||879||
59974081|NCT02842853|76091554|FG001|COMPLETED|Overall Study||861||
59974082|NCT02842853|76091555|FG002|COMPLETED|Overall Study||885||
59974083|NCT02842853|76091556|FG003|COMPLETED|Overall Study||617||
59812646|NCT00439569|75934962|FG000|NOT COMPLETED|Cohort 2 (500 mg/kg/Day)||1||
59812647|NCT00443079|75934968|FG000|STARTED|Overall Study||3||
59812648|NCT00443079|75934969|FG001|STARTED|Overall Study||3||
59812649|NCT00443079|75934968|FG000|COMPLETED|Overall Study||3||
59812650|NCT00443079|75934969|FG001|COMPLETED|Overall Study||2||
59812651|NCT00443079|75934968|FG000|NOT COMPLETED|Overall Study||0||
59812652|NCT00443079|75934969|FG001|NOT COMPLETED|Overall Study||1||
59812653|NCT02553915|75934981|FG000|STARTED|Overall Study||15||
59812654|NCT02553915|75934982|FG001|STARTED|Overall Study||15||
59812655|NCT02553915|75934983|FG002|STARTED|Overall Study||15||
59812656|NCT02553915|75934984|FG003|STARTED|Overall Study||16||
59812657|NCT02553915|75934981|FG000|COMPLETED|Overall Study||11||
59812658|NCT02553915|75934982|FG001|COMPLETED|Overall Study||14||
59812659|NCT02553915|75934983|FG002|COMPLETED|Overall Study||12||
59812660|NCT02553915|75934984|FG003|COMPLETED|Overall Study||13||
59812661|NCT02553915|75934981|FG000|NOT COMPLETED|Overall Study||4||
59812662|NCT02553915|75934982|FG001|NOT COMPLETED|Overall Study||1||
59812663|NCT02553915|75934983|FG002|NOT COMPLETED|Overall Study||3||
59974084|NCT02842853|76091553|FG000|NOT COMPLETED|Overall Study||23||
59974085|NCT02842853|76091554|FG001|NOT COMPLETED|Overall Study||34||
59974086|NCT02842853|76091555|FG002|NOT COMPLETED|Overall Study||21||
59974087|NCT02842853|76091556|FG003|NOT COMPLETED|Overall Study||24||
59974088|NCT02433340|76091572|FG000|STARTED|Overall Study||42||
59812664|NCT02553915|75934984|FG003|NOT COMPLETED|Overall Study||3||
59812665|NCT03119766|75934996|FG000|STARTED|Overall Study||151||
59812666|NCT03119766|75934997|FG001|STARTED|Overall Study||158||
59812667|NCT03119766|75934996|FG000|COMPLETED|Overall Study||151||
59812668|NCT03119766|75934997|FG001|COMPLETED|Overall Study||158||
59812669|NCT03119766|75934996|FG000|NOT COMPLETED|Overall Study||0||
59812670|NCT03119766|75934997|FG001|NOT COMPLETED|Overall Study||0||
59812671|NCT00427635|75935005|FG000|STARTED|Treatment Phase|Randomised|26||
59812672|NCT00427635|75935006|FG001|STARTED|Treatment Phase|Randomised|26||
59812673|NCT00427635|75935005|FG000|COMPLETED|Treatment Phase|ITT population. One voluntary discontinuation by parent/guardian|25||
59812674|NCT00427635|75935006|FG001|COMPLETED|Treatment Phase|ITT population|26||
59812675|NCT00427635|75935005|FG000|NOT COMPLETED|Treatment Phase||1||
59812676|NCT00427635|75935006|FG001|NOT COMPLETED|Treatment Phase||0||
59812677|NCT00427635|75935005|FG000|STARTED|Study Completion to Safety Follow-up||25||
59812678|NCT00427635|75935006|FG001|STARTED|Study Completion to Safety Follow-up||26||
59812679|NCT00427635|75935005|FG000|COMPLETED|Study Completion to Safety Follow-up||25||
59812680|NCT00427635|75935006|FG001|COMPLETED|Study Completion to Safety Follow-up|One participant lost to follow-up|25||
59812681|NCT00427635|75935005|FG000|NOT COMPLETED|Study Completion to Safety Follow-up||0||
59812682|NCT00427635|75935006|FG001|NOT COMPLETED|Study Completion to Safety Follow-up||1||
59974089|NCT02433340|76091573|FG001|STARTED|Overall Study||37||
59974090|NCT02433340|76091574|FG002|STARTED|Overall Study||39||
59974091|NCT02433340|76091575|FG003|STARTED|Overall Study||40||
59974092|NCT02433340|76091572|FG000|COMPLETED|Overall Study||40||
59974093|NCT02433340|76091573|FG001|COMPLETED|Overall Study||35||
59974094|NCT02433340|76091574|FG002|COMPLETED|Overall Study||37||
59974095|NCT02433340|76091575|FG003|COMPLETED|Overall Study||38||
59974096|NCT02433340|76091572|FG000|NOT COMPLETED|Overall Study||2||
59974097|NCT02433340|76091573|FG001|NOT COMPLETED|Overall Study||2||
59974098|NCT02433340|76091574|FG002|NOT COMPLETED|Overall Study||2||
59974099|NCT02433340|76091575|FG003|NOT COMPLETED|Overall Study||2||
59974100|NCT02400346|76091587|FG000|STARTED|Overall Study||132||
59974101|NCT02400346|76091587|FG000|COMPLETED|Overall Study||88||
59974102|NCT02400346|76091587|FG000|NOT COMPLETED|Overall Study||44||
59974103|NCT02399254|76091591|FG000|STARTED|Overall Study||21||
59974104|NCT02399254|76091591|FG000|COMPLETED|Overall Study||19|Transferring activity data was an issue at all sites despite good support from the manufacturer.|
59974105|NCT02399254|76091591|FG000|NOT COMPLETED|Overall Study||2||
59974106|NCT02456662|76091598|FG000|STARTED|Overall Study||159||
59974107|NCT02456662|76091599|FG001|STARTED|Overall Study||160||
59974108|NCT02456662|76091598|FG000|COMPLETED|Overall Study||157||
59974109|NCT02456662|76091599|FG001|COMPLETED|Overall Study||159||
59974110|NCT02456662|76091598|FG000|NOT COMPLETED|Overall Study||2||
59974111|NCT02456662|76091599|FG001|NOT COMPLETED|Overall Study||1||
59974112|NCT01653262|76091605|FG000|STARTED|Overall Study||29||
59974113|NCT01653262|76091605|FG000|COMPLETED|Overall Study||26||
59974114|NCT01653262|76091605|FG000|NOT COMPLETED|Overall Study||3||
59974115|NCT02455336|76091611|FG000|STARTED|Overall Study||15||
59974116|NCT02455336|76091612|FG001|STARTED|Overall Study||8||
59974117|NCT02455336|76091611|FG000|COMPLETED|Overall Study||10||
59974118|NCT02455336|76091612|FG001|COMPLETED|Overall Study||6||
59974119|NCT02455336|76091611|FG000|NOT COMPLETED|Overall Study||5||
59974120|NCT02455336|76091612|FG001|NOT COMPLETED|Overall Study||2||
59974121|NCT04878731|76091618|FG000|STARTED|Overall Study||6||
59974122|NCT04878731|76091618|FG000|COMPLETED|Overall Study||6||
59974123|NCT04878731|76091618|FG000|NOT COMPLETED|Overall Study||0||
59974124|NCT04826809|76091622|FG000|STARTED|Overall Study||41||
59974125|NCT04826809|76091622|FG000|COMPLETED|Overall Study||41||
59974126|NCT04826809|76091622|FG000|NOT COMPLETED|Overall Study||0||
59974127|NCT04665050|76091629|FG000|STARTED|Overall Study||51||
59974128|NCT04665050|76091630|FG001|STARTED|Overall Study||51||
59974129|NCT04665050|76091629|FG000|COMPLETED|Overall Study||51||
59974130|NCT04665050|76091630|FG001|COMPLETED|Overall Study||51||
59974131|NCT04665050|76091629|FG000|NOT COMPLETED|Overall Study||0||
59974132|NCT04665050|76091630|FG001|NOT COMPLETED|Overall Study||0||
59974133|NCT04525703|76091639|FG000|STARTED|Overall Study||12||
59974134|NCT04525703|76091640|FG001|STARTED|Overall Study||21||
59974135|NCT04525703|76091641|FG002|STARTED|Overall Study||15||
59974136|NCT04525703|76091639|FG000|Completed Baseline Interview|Overall Study||12||
59974137|NCT04525703|76091640|FG001|Completed Baseline Interview|Overall Study||21||
59974138|NCT04525703|76091641|FG002|Completed Baseline Interview|Overall Study||15||
59974139|NCT04525703|76091639|FG000|Attended Any of the P4P Program|Overall Study||9||
59974140|NCT04525703|76091640|FG001|Attended Any of the P4P Program|Overall Study||16||
59974141|NCT04525703|76091641|FG002|Attended Any of the P4P Program|Overall Study||11||
59974142|NCT04525703|76091639|FG000|Completed P4P Program|Overall Study||7||
59974143|NCT04525703|76091640|FG001|Completed P4P Program|Overall Study||12||
59974144|NCT04525703|76091641|FG002|Completed P4P Program|Overall Study||9||
59974145|NCT04525703|76091639|FG000|Completed Post Intervention Survey|Overall Study||7||
59974146|NCT04525703|76091640|FG001|Completed Post Intervention Survey|Overall Study||12||
59974147|NCT04525703|76091641|FG002|Completed Post Intervention Survey|Overall Study||9||
59974148|NCT04525703|76091639|FG000|Completed 3-month Follow up Survey|Overall Study||6||
59974149|NCT04525703|76091640|FG001|Completed 3-month Follow up Survey|Overall Study||6||
59974150|NCT04525703|76091641|FG002|Completed 3-month Follow up Survey|Overall Study||7||
59974151|NCT04525703|76091639|FG000|COMPLETED|Overall Study||6||
59974152|NCT04525703|76091640|FG001|COMPLETED|Overall Study||6||
59974153|NCT04525703|76091641|FG002|COMPLETED|Overall Study||7||
59974154|NCT04525703|76091639|FG000|NOT COMPLETED|Overall Study||6||
59974155|NCT04525703|76091640|FG001|NOT COMPLETED|Overall Study||15||
59974156|NCT04525703|76091641|FG002|NOT COMPLETED|Overall Study||8||
59974157|NCT04509076|76091654|FG000|STARTED|Overall Study||40||
59974158|NCT04509076|76091655|FG001|STARTED|Overall Study||40||
59812683|NCT00427011|75935012|FG000|STARTED|Overall Study||25||
59974159|NCT04509076|76091654|FG000|COMPLETED|Overall Study||38||
59974160|NCT04509076|76091655|FG001|COMPLETED|Overall Study||36||
59974161|NCT04509076|76091654|FG000|NOT COMPLETED|Overall Study||2||
59974162|NCT04509076|76091655|FG001|NOT COMPLETED|Overall Study||4||
59974163|NCT04388774|76091661|FG000|STARTED|Overall Study||10||
59974164|NCT04388774|76091661|FG000|COMPLETED|Overall Study||10||
59974165|NCT04388774|76091661|FG000|NOT COMPLETED|Overall Study||0||
59974166|NCT04267614|76091669|FG000|STARTED|Overall Study||1226|(Medical records retrieved)|
59974167|NCT04267614|76091669|FG000|Included in Analysis|Overall Study||979||
60074558|NCT01807520|76189937|FG005|Safety Set|Treatment Period 2 (16-132 Weeks)||0||
59974168|NCT04267614|76091669|FG000|COMPLETED|Overall Study||979||
59974169|NCT04267614|76091669|FG000|NOT COMPLETED|Overall Study||247||
59974170|NCT03735680|76091680|FG000|STARTED|Overall Study||3||
59974171|NCT03735680|76091681|FG001|STARTED|Overall Study||3||
59974172|NCT03735680|76091682|FG002|STARTED|Overall Study||3||
59974173|NCT03735680|76091683|FG003|STARTED|Overall Study||4||
59974174|NCT03735680|76091684|FG004|STARTED|Overall Study||6||
59974175|NCT03735680|76091685|FG005|STARTED|Overall Study||11||
59974176|NCT03735680|76091680|FG000|COMPLETED|Overall Study||3||
59974177|NCT03735680|76091681|FG001|COMPLETED|Overall Study||2||
59974178|NCT03735680|76091682|FG002|COMPLETED|Overall Study||2||
59974179|NCT03735680|76091683|FG003|COMPLETED|Overall Study||4||
59974180|NCT03735680|76091684|FG004|COMPLETED|Overall Study||6||
59974181|NCT03735680|76091685|FG005|COMPLETED|Overall Study||10||
59974182|NCT03735680|76091680|FG000|NOT COMPLETED|Overall Study||0||
59974183|NCT03735680|76091681|FG001|NOT COMPLETED|Overall Study||1||
59974184|NCT03735680|76091682|FG002|NOT COMPLETED|Overall Study||1||
59974185|NCT03735680|76091683|FG003|NOT COMPLETED|Overall Study||0||
59974186|NCT03735680|76091684|FG004|NOT COMPLETED|Overall Study||0||
59974187|NCT03735680|76091685|FG005|NOT COMPLETED|Overall Study||1||
59974188|NCT03726658|76091721|FG000|STARTED|Overall Study||26||
59974189|NCT03726658|76091722|FG001|STARTED|Overall Study||26||
59974190|NCT03726658|76091723|FG002|STARTED|Overall Study||26||
59974191|NCT03726658|76091724|FG003|STARTED|Overall Study||25||
59974192|NCT03726658|76091725|FG004|STARTED|Overall Study||40||
59974193|NCT03726658|76091726|FG005|STARTED|Overall Study||40||
59974194|NCT03726658|76091727|FG006|STARTED|Overall Study||41||
59974195|NCT03726658|76091721|FG000|COMPLETED|Overall Study||25||
59974196|NCT03726658|76091722|FG001|COMPLETED|Overall Study||26||
59974197|NCT03726658|76091723|FG002|COMPLETED|Overall Study||24||
59974198|NCT03726658|76091724|FG003|COMPLETED|Overall Study||25||
59974199|NCT03726658|76091725|FG004|COMPLETED|Overall Study||34||
59974200|NCT03726658|76091726|FG005|COMPLETED|Overall Study||35||
59974201|NCT03726658|76091727|FG006|COMPLETED|Overall Study||36||
59974202|NCT03726658|76091721|FG000|NOT COMPLETED|Overall Study||1||
59974203|NCT03726658|76091722|FG001|NOT COMPLETED|Overall Study||0||
59974204|NCT03726658|76091723|FG002|NOT COMPLETED|Overall Study||2||
59974205|NCT03726658|76091724|FG003|NOT COMPLETED|Overall Study||0||
59974206|NCT03726658|76091725|FG004|NOT COMPLETED|Overall Study||6||
59974207|NCT03726658|76091726|FG005|NOT COMPLETED|Overall Study||5||
59812684|NCT00427011|75935012|FG000|COMPLETED|Overall Study||0||
59812685|NCT00427011|75935012|FG000|NOT COMPLETED|Overall Study||25||
59812686|NCT03891264|75935017|FG000|STARTED|Overall Study||7||
59812687|NCT03891264|75935017|FG000|Received Intervention|Overall Study||3||
59812688|NCT03891264|75935017|FG000|COMPLETED|Overall Study||2||
59812689|NCT03891264|75935017|FG000|NOT COMPLETED|Overall Study||5||
59812690|NCT00439179|75935025|FG000|STARTED|Overall Study|1 with biliary|3||
59812691|NCT00439179|75935026|FG001|STARTED|Overall Study|2 with biliary|13||
59812692|NCT00439179|75935027|FG002|STARTED|Overall Study|2 with biliary|6||
59812693|NCT00439179|75935028|FG003|STARTED|Overall Study|2 with biliry|5||
59812694|NCT00439179|75935025|FG000|COMPLETED|Overall Study||3||
59812695|NCT00439179|75935026|FG001|COMPLETED|Overall Study||11||
59812696|NCT00439179|75935027|FG002|COMPLETED|Overall Study||6||
59812697|NCT00439179|75935028|FG003|COMPLETED|Overall Study||5||
59812698|NCT00439179|75935025|FG000|NOT COMPLETED|Overall Study||0||
59812699|NCT00439179|75935026|FG001|NOT COMPLETED|Overall Study||2||
59812700|NCT00439179|75935027|FG002|NOT COMPLETED|Overall Study||0||
59812701|NCT00439179|75935028|FG003|NOT COMPLETED|Overall Study||0||
59812702|NCT00438633|75935043|FG000|STARTED|Overall Study||32||
59812703|NCT00438633|75935044|FG001|STARTED|Overall Study||31||
59812704|NCT00438633|75935043|FG000|3-month Follow-up|Overall Study||26||
59974208|NCT03726658|76091727|FG006|NOT COMPLETED|Overall Study||5||
59974209|NCT03719885|76091743|FG000|STARTED|Overall Study||55||
59974210|NCT03719885|76091743|FG000|COMPLETED|Overall Study||35||
59974211|NCT03719885|76091743|FG000|NOT COMPLETED|Overall Study||20||
59974212|NCT03718091|76091753|FG000|STARTED|Overall Study||8||
59974213|NCT03718091|76091754|FG001|STARTED|Overall Study||7||
59974214|NCT03718091|76091755|FG002|STARTED|Overall Study||9||
59812705|NCT00438633|75935044|FG001|3-month Follow-up|Overall Study||24||
59812706|NCT00438633|75935043|FG000|COMPLETED|Overall Study||16||
59812707|NCT00438633|75935044|FG001|COMPLETED|Overall Study||14||
59812708|NCT00438633|75935043|FG000|NOT COMPLETED|Overall Study||16||
59812709|NCT00438633|75935044|FG001|NOT COMPLETED|Overall Study||17||
59812710|NCT00438399|75935053|FG000|STARTED|Overall Study||38||
59812711|NCT00438399|75935054|FG001|STARTED|Overall Study||40||
59974215|NCT03718091|76091756|FG003|STARTED|Overall Study||5||
59974216|NCT03718091|76091753|FG000|COMPLETED|Overall Study||8||
59974217|NCT03718091|76091754|FG001|COMPLETED|Overall Study||7||
59974218|NCT03718091|76091755|FG002|COMPLETED|Overall Study||9||
59974219|NCT03718091|76091756|FG003|COMPLETED|Overall Study||5||
59974220|NCT03718091|76091753|FG000|NOT COMPLETED|Overall Study||0||
59974221|NCT03718091|76091754|FG001|NOT COMPLETED|Overall Study||0||
59974222|NCT03718091|76091755|FG002|NOT COMPLETED|Overall Study||0||
59974223|NCT03718091|76091756|FG003|NOT COMPLETED|Overall Study||0||
59974224|NCT03572049|76091766|FG000|STARTED|Overall Study||42||
59812712|NCT00438399|75935055|FG002|STARTED|Overall Study||35||
59812713|NCT00438399|75935056|FG003|STARTED|Overall Study||36||
59974225|NCT03572049|76091767|FG001|STARTED|Overall Study||46||
59974226|NCT03572049|76091766|FG000|COMPLETED|Overall Study||33||
59974227|NCT03572049|76091767|FG001|COMPLETED|Overall Study||35||
59974228|NCT03572049|76091766|FG000|NOT COMPLETED|Overall Study||9||
59974229|NCT03572049|76091767|FG001|NOT COMPLETED|Overall Study||11||
59974230|NCT03476876|76091775|FG000|STARTED|Overall Study||19||19
59974231|NCT03476876|76091776|FG001|STARTED|Overall Study||15||15
59974232|NCT03476876|76091775|FG000|COMPLETED|Overall Study||9||9
59974233|NCT03476876|76091776|FG001|COMPLETED|Overall Study||7||7
59974234|NCT03476876|76091775|FG000|NOT COMPLETED|Overall Study||10||10
59974235|NCT03476876|76091776|FG001|NOT COMPLETED|Overall Study||8||8
59974236|NCT03063606|76091787|FG000|STARTED|Overall Study||18||
59974237|NCT03063606|76091788|FG001|STARTED|Overall Study||13||
59974238|NCT03063606|76091787|FG000|COMPLETED|Overall Study||16||
59974239|NCT03063606|76091788|FG001|COMPLETED|Overall Study||10||
59974240|NCT03063606|76091787|FG000|NOT COMPLETED|Overall Study||2||
59974241|NCT03063606|76091788|FG001|NOT COMPLETED|Overall Study||3||
59974242|NCT03062358|76091796|FG000|STARTED|Overall Study||300|All randomized participants|
59974243|NCT03062358|76091797|FG001|STARTED|Overall Study||153|All randomized participants|
59974244|NCT03062358|76091796|FG000|Treated|Overall Study||299|First Course Pembrolizumab|
59974245|NCT03062358|76091797|FG001|Treated|Overall Study||153|First Course Pembrolizumab|
59974246|NCT03062358|76091796|FG000|Second Course|Overall Study||6|Second Course Pembrolizumab|
59974247|NCT03062358|76091797|FG001|Second Course|Overall Study||0|Second Course Pembrolizumab|
59974248|NCT03062358|76091796|FG000|COMPLETED|Overall Study||0||
59974249|NCT03062358|76091797|FG001|COMPLETED|Overall Study||0||
59974250|NCT03062358|76091796|FG000|NOT COMPLETED|Overall Study||300||
59974251|NCT03062358|76091797|FG001|NOT COMPLETED|Overall Study||153||
59974252|NCT02706873|76091808|FG000|STARTED|Period 1 (Weeks 1 to 48)||315||
59974253|NCT02706873|76091809|FG001|STARTED|Period 1 (Weeks 1 to 48)||55||
59974254|NCT02706873|76091810|FG002|STARTED|Period 1 (Weeks 1 to 48)||317||
59974255|NCT02706873|76091811|FG003|STARTED|Period 1 (Weeks 1 to 48)||315||
59974256|NCT02706873|76091808|FG000|Received Study Drug|Period 1 (Weeks 1 to 48)||314||
59974257|NCT02706873|76091809|FG001|Received Study Drug|Period 1 (Weeks 1 to 48)||55||
59974258|NCT02706873|76091810|FG002|Received Study Drug|Period 1 (Weeks 1 to 48)||317||
59974259|NCT02706873|76091811|FG003|Received Study Drug|Period 1 (Weeks 1 to 48)||314||
59974260|NCT02706873|76091808|FG000|Global Analysis Population|Period 1 (Weeks 1 to 48)|Includes 28 participants in the Japan sub-study|314|Participants enrolled in the methotrexate, upadacitinib 15 mg and 30 mg treatment groups|
59974261|NCT02706873|76091809|FG001|Global Analysis Population|Period 1 (Weeks 1 to 48)||0|Participants enrolled in the methotrexate, upadacitinib 15 mg and 30 mg treatment groups|
59974262|NCT02706873|76091810|FG002|Global Analysis Population|Period 1 (Weeks 1 to 48)|Includes 27 participants in the Japan sub-study|317|Participants enrolled in the methotrexate, upadacitinib 15 mg and 30 mg treatment groups|
59974263|NCT02706873|76091811|FG003|Global Analysis Population|Period 1 (Weeks 1 to 48)|Includes 28 participants in the Japan sub-study|314|Participants enrolled in the methotrexate, upadacitinib 15 mg and 30 mg treatment groups|
59974264|NCT02706873|76091808|FG000|Japan Sub-study|Period 1 (Weeks 1 to 48)||28|Participants in the methotrexate, upadacitinib 7.5, 15, and 30 mg treatment groups enrolled in Japan|
59974265|NCT02706873|76091809|FG001|Japan Sub-study|Period 1 (Weeks 1 to 48)||55|Participants in the methotrexate, upadacitinib 7.5, 15, and 30 mg treatment groups enrolled in Japan|
59974266|NCT02706873|76091810|FG002|Japan Sub-study|Period 1 (Weeks 1 to 48)||27|Participants in the methotrexate, upadacitinib 7.5, 15, and 30 mg treatment groups enrolled in Japan|
59974267|NCT02706873|76091811|FG003|Japan Sub-study|Period 1 (Weeks 1 to 48)||28|Participants in the methotrexate, upadacitinib 7.5, 15, and 30 mg treatment groups enrolled in Japan|
59974268|NCT02706873|76091808|FG000|Completed Week 24 Study Drug|Period 1 (Weeks 1 to 48)||268||
59974269|NCT02706873|76091809|FG001|Completed Week 24 Study Drug|Period 1 (Weeks 1 to 48)||51||
59974270|NCT02706873|76091810|FG002|Completed Week 24 Study Drug|Period 1 (Weeks 1 to 48)||290||
59974271|NCT02706873|76091811|FG003|Completed Week 24 Study Drug|Period 1 (Weeks 1 to 48)||282||
59812714|NCT00438399|75935057|FG004|STARTED|Overall Study||33||
59812715|NCT00438399|75935058|FG005|STARTED|Overall Study||37||
59812716|NCT00438399|75935053|FG000|TREATED & ANALYZED|Overall Study||30||
59974272|NCT02706873|76091808|FG000|Received Combination Rescue Therapy at Week 26|Period 1 (Weeks 1 to 48)|"Combination therapy includes the addition of upadacitinib to methotrexate. Participants with inadequate response were randomized equally to receive upadacitinib 7.5 mg (Japan only), 15 mg or 30 mg QD in addition to methotrexate.~One participant received upadacitinib 7.5 mg; 18 participants received upadacitinib 15 mg; 18 participants received upadacitinib 30 mg."|37||
59974273|NCT02706873|76091809|FG001|Received Combination Rescue Therapy at Week 26|Period 1 (Weeks 1 to 48)|Combination therapy includes the addition of methotrexate to upadacitinib 7.5 mg.|3||
59974274|NCT02706873|76091810|FG002|Received Combination Rescue Therapy at Week 26|Period 1 (Weeks 1 to 48)|Combination therapy includes the addition of methotrexate to upadacitinib 15 mg.|19||
59974275|NCT02706873|76091811|FG003|Received Combination Rescue Therapy at Week 26|Period 1 (Weeks 1 to 48)|Combination therapy includes the addition of methotrexate to upadacitinib 30 mg.|9||
59994968|NCT02051309|76110789|FG001|NOT COMPLETED|Overall Study||28||
59812717|NCT00438399|75935054|FG001|TREATED & ANALYZED|Overall Study||32||
59812718|NCT00438399|75935055|FG002|TREATED & ANALYZED|Overall Study||28||
59812719|NCT00438399|75935056|FG003|TREATED & ANALYZED|Overall Study||32||
59812720|NCT00438399|75935057|FG004|TREATED & ANALYZED|Overall Study||30||
59974276|NCT02706873|76091808|FG000|COMPLETED|Period 1 (Weeks 1 to 48)||256|Completed Week 48|
59974277|NCT02706873|76091809|FG001|COMPLETED|Period 1 (Weeks 1 to 48)||51|Completed Week 48|
59974278|NCT02706873|76091810|FG002|COMPLETED|Period 1 (Weeks 1 to 48)||277|Completed Week 48|
59974279|NCT02706873|76091811|FG003|COMPLETED|Period 1 (Weeks 1 to 48)||271|Completed Week 48|
59974280|NCT02706873|76091808|FG000|NOT COMPLETED|Period 1 (Weeks 1 to 48)||59||
59974281|NCT02706873|76091809|FG001|NOT COMPLETED|Period 1 (Weeks 1 to 48)||4||
59974282|NCT02706873|76091810|FG002|NOT COMPLETED|Period 1 (Weeks 1 to 48)||40||
59974283|NCT02706873|76091811|FG003|NOT COMPLETED|Period 1 (Weeks 1 to 48)||44||
59974284|NCT02706873|76091808|FG000|STARTED|Period 2 (Weeks 48 to 260)||253|Nine participants who completed Period 1 opted not to enter Period 2.|
59974285|NCT02706873|76091809|FG001|STARTED|Period 2 (Weeks 48 to 260)||50|Nine participants who completed Period 1 opted not to enter Period 2.|
59974286|NCT02706873|76091810|FG002|STARTED|Period 2 (Weeks 48 to 260)||275|Nine participants who completed Period 1 opted not to enter Period 2.|
59974287|NCT02706873|76091811|FG003|STARTED|Period 2 (Weeks 48 to 260)||268|Nine participants who completed Period 1 opted not to enter Period 2.|
59974288|NCT02706873|76091808|FG000|Received Study Drug|Period 2 (Weeks 48 to 260)||242||
59974289|NCT02706873|76091809|FG001|Received Study Drug|Period 2 (Weeks 48 to 260)||48||
59974290|NCT02706873|76091810|FG002|Received Study Drug|Period 2 (Weeks 48 to 260)||273||
59974291|NCT02706873|76091811|FG003|Received Study Drug|Period 2 (Weeks 48 to 260)||260||
59974292|NCT02706873|76091808|FG000|COMPLETED|Period 2 (Weeks 48 to 260)||163||
59974293|NCT02706873|76091809|FG001|COMPLETED|Period 2 (Weeks 48 to 260)||40||
59974294|NCT02706873|76091810|FG002|COMPLETED|Period 2 (Weeks 48 to 260)||217||
59525772|NCT01216735|75621120|FG000|COMPLETED|Second Intervention (3 Weeks)||8||
59812721|NCT00438399|75935058|FG005|TREATED & ANALYZED|Overall Study||31||
59974295|NCT02706873|76091811|FG003|COMPLETED|Period 2 (Weeks 48 to 260)||187||
59974296|NCT02706873|76091808|FG000|NOT COMPLETED|Period 2 (Weeks 48 to 260)||90||
59974297|NCT02706873|76091809|FG001|NOT COMPLETED|Period 2 (Weeks 48 to 260)||10||
59974298|NCT02706873|76091810|FG002|NOT COMPLETED|Period 2 (Weeks 48 to 260)||58||
59974299|NCT02706873|76091811|FG003|NOT COMPLETED|Period 2 (Weeks 48 to 260)||81||
59974300|NCT02584634|76091834|FG000|STARTED|Overall Study||12||
59974301|NCT02584634|76091835|FG001|STARTED|Overall Study||31||
59974302|NCT02584634|76091834|FG000|COMPLETED|Overall Study||0||
59974303|NCT02584634|76091835|FG001|COMPLETED|Overall Study||0||
59974304|NCT02584634|76091834|FG000|NOT COMPLETED|Overall Study||12||
59974305|NCT02584634|76091835|FG001|NOT COMPLETED|Overall Study||31||
59974306|NCT01835964|76091843|FG000|STARTED|Overall Study||30||
59974307|NCT01835964|76091843|FG000|Training|Overall Study||30||
59974308|NCT01835964|76091843|FG000|Observation Period|Overall Study||28||
59525773|NCT01216735|75621121|FG001|COMPLETED|Second Intervention (3 Weeks)||7||
59812722|NCT00438399|75935053|FG000|COMPLETED|Overall Study||30||
59974309|NCT01835964|76091843|FG000|Physiological Test|Overall Study||28||
59974310|NCT01835964|76091843|FG000|COMPLETED|Overall Study||28||
59974311|NCT01835964|76091843|FG000|NOT COMPLETED|Overall Study||2||
59974312|NCT01275729|76091849|FG000|STARTED|Overall Study||96||
59974313|NCT01275729|76091849|FG000|COMPLETED|Overall Study||92||
59974314|NCT01275729|76091849|FG000|NOT COMPLETED|Overall Study||4||
59974315|NCT01107626|76091857|FG000|STARTED|Step 1: Induction Therapy||642||
59974316|NCT01107626|76091858|FG001|STARTED|Step 1: Induction Therapy||287||
59974317|NCT01107626|76091859|FG002|STARTED|Step 1: Induction Therapy||294||
59974318|NCT01107626|76091860|FG003|STARTED|Step 1: Induction Therapy||293||
59974319|NCT01107626|76091857|FG000|COMPLETED|Step 1: Induction Therapy||65||
59974320|NCT01107626|76091858|FG001|COMPLETED|Step 1: Induction Therapy||287||
59974321|NCT01107626|76091859|FG002|COMPLETED|Step 1: Induction Therapy||294||
59974322|NCT01107626|76091860|FG003|COMPLETED|Step 1: Induction Therapy||293||
59974323|NCT01107626|76091857|FG000|NOT COMPLETED|Step 1: Induction Therapy||577||
59974324|NCT01107626|76091858|FG001|NOT COMPLETED|Step 1: Induction Therapy||0||
59974325|NCT01107626|76091859|FG002|NOT COMPLETED|Step 1: Induction Therapy||0||
59974326|NCT01107626|76091860|FG003|NOT COMPLETED|Step 1: Induction Therapy||0||
59974327|NCT01107626|76091857|FG000|STARTED|Step 2: Maintenance Therapy|Patients without complete/partial response or stable disease post induction phase weren't randomized|0||
59974328|NCT01107626|76091858|FG001|STARTED|Step 2: Maintenance Therapy||287||
59974329|NCT01107626|76091859|FG002|STARTED|Step 2: Maintenance Therapy||294||
59974330|NCT01107626|76091860|FG003|STARTED|Step 2: Maintenance Therapy||293||
59812723|NCT00438399|75935054|FG001|COMPLETED|Overall Study||32||
59812724|NCT00438399|75935055|FG002|COMPLETED|Overall Study||28||
59812725|NCT00438399|75935056|FG003|COMPLETED|Overall Study||32||
59812726|NCT00438399|75935057|FG004|COMPLETED|Overall Study||30||
59812727|NCT00438399|75935058|FG005|COMPLETED|Overall Study||31||
59812728|NCT00438399|75935053|FG000|NOT COMPLETED|Overall Study||8||
59812729|NCT00438399|75935054|FG001|NOT COMPLETED|Overall Study||8||
59812730|NCT00438399|75935055|FG002|NOT COMPLETED|Overall Study||7||
59812731|NCT00438399|75935056|FG003|NOT COMPLETED|Overall Study||4||
59812732|NCT00438399|75935057|FG004|NOT COMPLETED|Overall Study||3||
59812733|NCT00438399|75935058|FG005|NOT COMPLETED|Overall Study||6||
59812734|NCT00426231|75935069|FG000|STARTED|Overall Study||36||
59812735|NCT00426231|75935070|FG001|STARTED|Overall Study||37||
59812736|NCT00426231|75935069|FG000|COMPLETED|Overall Study|For the 6 month endpoint|27||
59812737|NCT00426231|75935070|FG001|COMPLETED|Overall Study|For the 6-month endpoint|25||
59812738|NCT00426231|75935069|FG000|NOT COMPLETED|Overall Study||9||
59812739|NCT00426231|75935070|FG001|NOT COMPLETED|Overall Study||12||
59812740|NCT00425607|75935076|FG000|STARTED|Overall Study||29||
59812741|NCT00425607|75935076|FG000|Received Treatment|Overall Study||28||
59812742|NCT00425607|75935076|FG000|COMPLETED|Overall Study||27||
59812743|NCT00425607|75935076|FG000|NOT COMPLETED|Overall Study||2||
59812744|NCT00437073|75935082|FG000|STARTED|Overall Study||13||
59812745|NCT00437073|75935083|FG001|STARTED|Overall Study||9||
59812746|NCT00437073|75935082|FG000|COMPLETED|Overall Study||12||
59812747|NCT00437073|75935083|FG001|COMPLETED|Overall Study||8||
59812748|NCT00437073|75935082|FG000|NOT COMPLETED|Overall Study||1||
59812749|NCT00437073|75935083|FG001|NOT COMPLETED|Overall Study||1||
59974331|NCT01107626|76091857|FG000|COMPLETED|Step 2: Maintenance Therapy|Patients without complete/partial response or stable disease post induction phase weren't randomized|0||
59974332|NCT01107626|76091858|FG001|COMPLETED|Step 2: Maintenance Therapy||1||
59974333|NCT01107626|76091859|FG002|COMPLETED|Step 2: Maintenance Therapy||0||
59974334|NCT01107626|76091860|FG003|COMPLETED|Step 2: Maintenance Therapy||1||
59974335|NCT01107626|76091857|FG000|NOT COMPLETED|Step 2: Maintenance Therapy||0||
59974336|NCT01107626|76091858|FG001|NOT COMPLETED|Step 2: Maintenance Therapy||286||
59974337|NCT01107626|76091859|FG002|NOT COMPLETED|Step 2: Maintenance Therapy||294||
59812750|NCT00425373|75935098|FG000|STARTED|Overall Study||159||
59812751|NCT00425373|75935099|FG001|STARTED|Overall Study||167||
59812752|NCT00425373|75935100|FG002|STARTED|Overall Study||160||
59812753|NCT00425373|75935101|FG003|STARTED|Overall Study||162||
59812754|NCT00425373|75935102|FG004|STARTED|Overall Study||169||
59812755|NCT00425373|75935103|FG005|STARTED|Overall Study||163||
59812756|NCT00425373|75935104|FG006|STARTED|Overall Study||161||
59812757|NCT00425373|75935105|FG007|STARTED|Overall Study||161||
59812758|NCT00425373|75935106|FG008|STARTED|Overall Study||166||
59812759|NCT00425373|75935098|FG000|COMPLETED|Overall Study||154||
59812760|NCT00425373|75935099|FG001|COMPLETED|Overall Study||164||
59812761|NCT00425373|75935100|FG002|COMPLETED|Overall Study||157||
59812762|NCT00425373|75935101|FG003|COMPLETED|Overall Study||160||
59812763|NCT00425373|75935102|FG004|COMPLETED|Overall Study||159||
59812764|NCT00425373|75935103|FG005|COMPLETED|Overall Study||154||
59812765|NCT00425373|75935104|FG006|COMPLETED|Overall Study||154||
59812766|NCT00425373|75935105|FG007|COMPLETED|Overall Study||151||
59812767|NCT00425373|75935106|FG008|COMPLETED|Overall Study||148||
59974338|NCT01107626|76091860|FG003|NOT COMPLETED|Step 2: Maintenance Therapy||292||
59812768|NCT00425373|75935098|FG000|NOT COMPLETED|Overall Study||5||
59812769|NCT00425373|75935099|FG001|NOT COMPLETED|Overall Study||3||
59812770|NCT00425373|75935100|FG002|NOT COMPLETED|Overall Study||3||
59974339|NCT00828009|76091869|FG000|STARTED|Step 1 - Chemo RT/Consolidation Chemo||70||
59812771|NCT00425373|75935101|FG003|NOT COMPLETED|Overall Study||2||
59974340|NCT00828009|76091869|FG000|Started Treatment|Step 1 - Chemo RT/Consolidation Chemo||68||
59974341|NCT00828009|76091869|FG000|COMPLETED|Step 1 - Chemo RT/Consolidation Chemo||39||
59974342|NCT00828009|76091869|FG000|NOT COMPLETED|Step 1 - Chemo RT/Consolidation Chemo||31||
59974343|NCT00828009|76091869|FG000|STARTED|Step 2 - Maintenance Therapy|Among 39 pts with tx completion, 4 did not register to step 2 and 2 had PD at the end of step 1.|33||
59974344|NCT00828009|76091869|FG000|COMPLETED|Step 2 - Maintenance Therapy|Max maintenance therapy was 34 cycles. No patients were off treatment due to completion of 34 cycles|0||
59974345|NCT00828009|76091869|FG000|NOT COMPLETED|Step 2 - Maintenance Therapy||33||
59974346|NCT00578721|76091874|FG000|STARTED|Overall Study||24||
59974347|NCT00578721|76091874|FG000|COMPLETED|Overall Study||20||
59974348|NCT00578721|76091874|FG000|NOT COMPLETED|Overall Study||4||
59974349|NCT00357890|76091880|FG000|STARTED|Overall Study||6||
59974350|NCT00357890|76091881|FG001|STARTED|Overall Study||6||
59974351|NCT00357890|76091880|FG000|COMPLETED|Overall Study||6||
59974352|NCT00357890|76091881|FG001|COMPLETED|Overall Study||6||
59974353|NCT00357890|76091880|FG000|NOT COMPLETED|Overall Study||0||
59974354|NCT00357890|76091881|FG001|NOT COMPLETED|Overall Study||0||
59974355|NCT00068393|76091889|FG000|STARTED|Overall Study||39||
59974356|NCT00068393|76091889|FG000|Eligible and Treated|Overall Study||38||
59974357|NCT00068393|76091889|FG000|COMPLETED|Overall Study||29||
59974358|NCT00068393|76091889|FG000|NOT COMPLETED|Overall Study||10||
59974359|NCT00062010|76091893|FG000|STARTED|Overall Study||37||
59974360|NCT00062010|76091893|FG000|Eligible and Treated|Overall Study||34||
59974361|NCT00062010|76091893|FG000|COMPLETED|Overall Study||34||
59974362|NCT00062010|76091893|FG000|NOT COMPLETED|Overall Study||3||
59974363|NCT00047008|76091899|FG000|STARTED|Overall Study||372||
59974364|NCT00047008|76091900|FG001|STARTED|Overall Study||371||
59974365|NCT00047008|76091899|FG000|COMPLETED|Overall Study||361||
59974366|NCT00047008|76091900|FG001|COMPLETED|Overall Study||360||
59974367|NCT00047008|76091899|FG000|NOT COMPLETED|Overall Study||11||
59974368|NCT00047008|76091900|FG001|NOT COMPLETED|Overall Study||11||
59974369|NCT02397694|76091908|FG000|STARTED|Double-Blinded Phase||65||
59974370|NCT02397694|76091909|FG001|STARTED|Double-Blinded Phase||33||
59974371|NCT02397694|76091908|FG000|COMPLETED|Double-Blinded Phase||62||
59974372|NCT02397694|76091909|FG001|COMPLETED|Double-Blinded Phase||30||
59974373|NCT02397694|76091908|FG000|NOT COMPLETED|Double-Blinded Phase||3||
59812772|NCT00425373|75935102|FG004|NOT COMPLETED|Overall Study||10||
59812773|NCT00425373|75935103|FG005|NOT COMPLETED|Overall Study||9||
59812774|NCT00425373|75935104|FG006|NOT COMPLETED|Overall Study||7||
59812775|NCT00425373|75935105|FG007|NOT COMPLETED|Overall Study||10||
59812776|NCT00425373|75935106|FG008|NOT COMPLETED|Overall Study||18||
59812777|NCT03894540|75935132|FG000|STARTED|Overall Study||1|Received IPN60090 treatment in Part A.|
59812778|NCT03894540|75935133|FG001|STARTED|Overall Study||1|Received IPN60090 treatment in Part A.|
59812779|NCT03894540|75935134|FG002|STARTED|Overall Study||1|Received IPN60090 treatment in Part A.|
59812780|NCT03894540|75935135|FG003|STARTED|Overall Study||4|Received IPN60090 treatment in Part A.|
59812781|NCT03894540|75935136|FG004|STARTED|Overall Study||11|Received IPN60090 treatment in Part A.|
59812782|NCT03894540|75935137|FG005|STARTED|Overall Study||4|Received IPN60090 treatment in Part A.|
59974374|NCT02397694|76091909|FG001|NOT COMPLETED|Double-Blinded Phase||3||
59974375|NCT02397694|76091908|FG000|STARTED|Open Label Extension Phase||62||
59974376|NCT02397694|76091909|FG001|STARTED|Open Label Extension Phase||30||
59974377|NCT02397694|76091908|FG000|COMPLETED|Open Label Extension Phase||54||
59974378|NCT02397694|76091909|FG001|COMPLETED|Open Label Extension Phase||29||
59974379|NCT02397694|76091908|FG000|NOT COMPLETED|Open Label Extension Phase||8||
59812783|NCT03894540|75935132|FG000|COMPLETED|Overall Study||0|Completed IPN60090 treatment in Part A.|
59812784|NCT03894540|75935133|FG001|COMPLETED|Overall Study||0|Completed IPN60090 treatment in Part A.|
59812785|NCT03894540|75935134|FG002|COMPLETED|Overall Study||0|Completed IPN60090 treatment in Part A.|
59812786|NCT03894540|75935135|FG003|COMPLETED|Overall Study||0|Completed IPN60090 treatment in Part A.|
59812787|NCT03894540|75935136|FG004|COMPLETED|Overall Study||0|Completed IPN60090 treatment in Part A.|
59812788|NCT03894540|75935137|FG005|COMPLETED|Overall Study||0|Completed IPN60090 treatment in Part A.|
59812789|NCT03894540|75935132|FG000|NOT COMPLETED|Overall Study||1||
59974380|NCT02397694|76091909|FG001|NOT COMPLETED|Open Label Extension Phase||1||
59974381|NCT02783599|76091919|FG000|STARTED|Overall Study||51||
59974382|NCT02783599|76091919|FG000|Received At Least One Dose of Study Drug|Overall Study||51||
59974383|NCT02783599|76091919|FG000|COMPLETED|Overall Study||11||
59974384|NCT02783599|76091919|FG000|NOT COMPLETED|Overall Study||40||
59974385|NCT02838017|76091932|FG000|STARTED|Overall Study||252||
59974386|NCT02838017|76091933|FG001|STARTED|Overall Study||252||
59974387|NCT02838017|76091932|FG000|COMPLETED|Overall Study||238||
59974388|NCT02838017|76091933|FG001|COMPLETED|Overall Study||241||
59974389|NCT02838017|76091932|FG000|NOT COMPLETED|Overall Study||14||
59974390|NCT02838017|76091933|FG001|NOT COMPLETED|Overall Study||11||
59974391|NCT03188666|76091941|FG000|STARTED|Period 1 (28 Weeks Double-blind)||24||
59974392|NCT03188666|76091942|FG001|STARTED|Period 1 (28 Weeks Double-blind)||20||
59974393|NCT03188666|76091943|FG002|STARTED|Period 1 (28 Weeks Double-blind)||0||
59974394|NCT03188666|76091944|FG003|STARTED|Period 1 (28 Weeks Double-blind)||0||
59974395|NCT03188666|76091941|FG000|COMPLETED|Period 1 (28 Weeks Double-blind)||24||
59974396|NCT03188666|76091942|FG001|COMPLETED|Period 1 (28 Weeks Double-blind)||19||
59974397|NCT03188666|76091943|FG002|COMPLETED|Period 1 (28 Weeks Double-blind)||0||
59974398|NCT03188666|76091944|FG003|COMPLETED|Period 1 (28 Weeks Double-blind)||0||
59974399|NCT03188666|76091941|FG000|NOT COMPLETED|Period 1 (28 Weeks Double-blind)||0||
59974400|NCT03188666|76091942|FG001|NOT COMPLETED|Period 1 (28 Weeks Double-blind)||1||
59974401|NCT03188666|76091943|FG002|NOT COMPLETED|Period 1 (28 Weeks Double-blind)||0||
59974402|NCT03188666|76091944|FG003|NOT COMPLETED|Period 1 (28 Weeks Double-blind)||0||
59974403|NCT03188666|76091941|FG000|STARTED|Period 2 (28 Weeks Open-label)||0||
59974404|NCT03188666|76091942|FG001|STARTED|Period 2 (28 Weeks Open-label)||0||
59974405|NCT03188666|76091943|FG002|STARTED|Period 2 (28 Weeks Open-label)||24||
59974406|NCT03188666|76091944|FG003|STARTED|Period 2 (28 Weeks Open-label)||19||
59974407|NCT03188666|76091941|FG000|COMPLETED|Period 2 (28 Weeks Open-label)||0||
59974408|NCT03188666|76091942|FG001|COMPLETED|Period 2 (28 Weeks Open-label)||0||
59974409|NCT03188666|76091943|FG002|COMPLETED|Period 2 (28 Weeks Open-label)||24||
59974410|NCT03188666|76091944|FG003|COMPLETED|Period 2 (28 Weeks Open-label)||18||
59974411|NCT03188666|76091941|FG000|NOT COMPLETED|Period 2 (28 Weeks Open-label)||0||
59974412|NCT03188666|76091942|FG001|NOT COMPLETED|Period 2 (28 Weeks Open-label)||0||
59974413|NCT03188666|76091943|FG002|NOT COMPLETED|Period 2 (28 Weeks Open-label)||0||
59974414|NCT03188666|76091944|FG003|NOT COMPLETED|Period 2 (28 Weeks Open-label)||1||
59974415|NCT03188666|76091941|FG000|STARTED|Period 3 (20 Weeks Follow-up)||0||
59974416|NCT03188666|76091942|FG001|STARTED|Period 3 (20 Weeks Follow-up)||0||
59974417|NCT03188666|76091943|FG002|STARTED|Period 3 (20 Weeks Follow-up)||24||
59974418|NCT03188666|76091944|FG003|STARTED|Period 3 (20 Weeks Follow-up)||18||
59974419|NCT03188666|76091941|FG000|COMPLETED|Period 3 (20 Weeks Follow-up)||0||
59974420|NCT03188666|76091942|FG001|COMPLETED|Period 3 (20 Weeks Follow-up)||0||
59974421|NCT03188666|76091943|FG002|COMPLETED|Period 3 (20 Weeks Follow-up)||21||
59974422|NCT03188666|76091944|FG003|COMPLETED|Period 3 (20 Weeks Follow-up)||16||
59974423|NCT03188666|76091941|FG000|NOT COMPLETED|Period 3 (20 Weeks Follow-up)||0||
59974424|NCT03188666|76091942|FG001|NOT COMPLETED|Period 3 (20 Weeks Follow-up)||0||
59974425|NCT03188666|76091943|FG002|NOT COMPLETED|Period 3 (20 Weeks Follow-up)||3||
59974426|NCT03188666|76091944|FG003|NOT COMPLETED|Period 3 (20 Weeks Follow-up)||2||
59974427|NCT02836769|76091958|FG000|STARTED|Overall Study||35||
59974428|NCT02836769|76091958|FG000|Received Intervention|Overall Study||30||
59974429|NCT02836769|76091958|FG000|Completed Post-test Assessment|Overall Study||21||
59974430|NCT02836769|76091958|FG000|COMPLETED|Overall Study||20||
59974431|NCT02836769|76091958|FG000|NOT COMPLETED|Overall Study||15||
59812790|NCT03894540|75935133|FG001|NOT COMPLETED|Overall Study||1||
59812791|NCT03894540|75935134|FG002|NOT COMPLETED|Overall Study||1||
59812792|NCT03894540|75935135|FG003|NOT COMPLETED|Overall Study||4||
59974432|NCT02836613|76091964|FG000|STARTED|Overall Study||80||
59974433|NCT02836613|76091965|FG001|STARTED|Overall Study||80||
59974434|NCT02836613|76091964|FG000|COMPLETED|Overall Study||79||
59974435|NCT02836613|76091965|FG001|COMPLETED|Overall Study||77||
59974436|NCT02836613|76091964|FG000|NOT COMPLETED|Overall Study||1||
59974437|NCT02836613|76091965|FG001|NOT COMPLETED|Overall Study||3||
59974438|NCT02397460|76091979|FG000|STARTED|Treatment Period 1||7||
59812793|NCT03894540|75935136|FG004|NOT COMPLETED|Overall Study||11||
59812794|NCT03894540|75935137|FG005|NOT COMPLETED|Overall Study||4||
59812795|NCT00535626|75935155|FG000|STARTED|Overall Study||190||193
59812796|NCT00535626|75935155|FG000|COMPLETED|Overall Study||85||86
59812797|NCT00535626|75935155|FG000|NOT COMPLETED|Overall Study||105||107
59812798|NCT01646814|75935162|FG000|STARTED|Overall Study||121||
59974439|NCT02397460|76091980|FG001|STARTED|Treatment Period 1||7||
59974440|NCT02397460|76091981|FG002|STARTED|Treatment Period 1||6||
59974441|NCT02397460|76091982|FG003|STARTED|Treatment Period 1||6||
59974442|NCT02397460|76091983|FG004|STARTED|Treatment Period 1||6||
59974443|NCT02397460|76091984|FG005|STARTED|Treatment Period 1||6||
59974444|NCT02397460|76091985|FG006|STARTED|Treatment Period 1||6||
59974445|NCT02397460|76091986|FG007|STARTED|Treatment Period 1||6||
59974446|NCT02397460|76091979|FG000|COMPLETED|Treatment Period 1||7||
59974447|NCT02397460|76091980|FG001|COMPLETED|Treatment Period 1||7||
60074559|NCT01807520|76189938|FG006|Safety Set|Treatment Period 2 (16-132 Weeks)||0||
59812799|NCT01646814|75935163|FG001|STARTED|Overall Study||126||
59812800|NCT01646814|75935162|FG000|COMPLETED|Overall Study||110||
59812801|NCT01646814|75935163|FG001|COMPLETED|Overall Study||120||
59812802|NCT01646814|75935162|FG000|NOT COMPLETED|Overall Study||11||
59812803|NCT01646814|75935163|FG001|NOT COMPLETED|Overall Study||6||
59812804|NCT01416636|75935171|FG000|STARTED|Overall Study||53||
59812805|NCT01416636|75935172|FG001|STARTED|Overall Study||52||
59812806|NCT01416636|75935171|FG000|COMPLETED|Overall Study||45||
59812807|NCT01416636|75935172|FG001|COMPLETED|Overall Study||46||
59812808|NCT01416636|75935171|FG000|NOT COMPLETED|Overall Study||8||
59812809|NCT01416636|75935172|FG001|NOT COMPLETED|Overall Study||6||
59974448|NCT02397460|76091981|FG002|COMPLETED|Treatment Period 1||6||
59974449|NCT02397460|76091982|FG003|COMPLETED|Treatment Period 1||6||
59974450|NCT02397460|76091983|FG004|COMPLETED|Treatment Period 1||6||
59974451|NCT02397460|76091984|FG005|COMPLETED|Treatment Period 1||6||
59974452|NCT02397460|76091985|FG006|COMPLETED|Treatment Period 1||6||
59974453|NCT02397460|76091986|FG007|COMPLETED|Treatment Period 1||6||
59974454|NCT02397460|76091979|FG000|NOT COMPLETED|Treatment Period 1||0||
59974455|NCT02397460|76091980|FG001|NOT COMPLETED|Treatment Period 1||0||
59974456|NCT02397460|76091981|FG002|NOT COMPLETED|Treatment Period 1||0||
59974457|NCT02397460|76091982|FG003|NOT COMPLETED|Treatment Period 1||0||
59974458|NCT02397460|76091983|FG004|NOT COMPLETED|Treatment Period 1||0||
59974459|NCT02397460|76091984|FG005|NOT COMPLETED|Treatment Period 1||0||
59974460|NCT02397460|76091985|FG006|NOT COMPLETED|Treatment Period 1||0||
59974461|NCT02397460|76091986|FG007|NOT COMPLETED|Treatment Period 1||0||
59974462|NCT02397460|76091979|FG000|STARTED|Treatment Period 2||7||
59974463|NCT02397460|76091980|FG001|STARTED|Treatment Period 2||7||
59974464|NCT02397460|76091981|FG002|STARTED|Treatment Period 2||6||
59974465|NCT02397460|76091982|FG003|STARTED|Treatment Period 2||6||
59974466|NCT02397460|76091983|FG004|STARTED|Treatment Period 2||6||
59974467|NCT02397460|76091984|FG005|STARTED|Treatment Period 2||6||
59974468|NCT02397460|76091985|FG006|STARTED|Treatment Period 2||6||
59974469|NCT02397460|76091986|FG007|STARTED|Treatment Period 2||6||
59974470|NCT02397460|76091979|FG000|COMPLETED|Treatment Period 2||7||
59974471|NCT02397460|76091980|FG001|COMPLETED|Treatment Period 2||7||
59974472|NCT02397460|76091981|FG002|COMPLETED|Treatment Period 2||6||
59974473|NCT02397460|76091982|FG003|COMPLETED|Treatment Period 2||6||
59974474|NCT02397460|76091983|FG004|COMPLETED|Treatment Period 2||6||
59974475|NCT02397460|76091984|FG005|COMPLETED|Treatment Period 2||6||
59812810|NCT03889704|75935178|FG000|STARTED|Overall Study||2||
59812811|NCT03889704|75935178|FG000|COMPLETED|Overall Study||1||
59812812|NCT03889704|75935178|FG000|NOT COMPLETED|Overall Study||1||
59812813|NCT03887442|75935184|FG000|STARTED|Overall Study||9||
59812814|NCT03887442|75935185|FG001|STARTED|Overall Study||8||
59812815|NCT03887442|75935184|FG000|COMPLETED|Overall Study||8||
59812816|NCT03887442|75935185|FG001|COMPLETED|Overall Study||8||
59812817|NCT03887442|75935184|FG000|NOT COMPLETED|Overall Study||1||
59812818|NCT03887442|75935185|FG001|NOT COMPLETED|Overall Study||0||
59812819|NCT00425061|75935200|FG000|STARTED|Overall Study||16||
59812820|NCT00425061|75935201|FG001|STARTED|Overall Study||17||
59812821|NCT00425061|75935202|FG002|STARTED|Overall Study||16||
59812822|NCT00425061|75935203|FG003|STARTED|Overall Study||16||
59812823|NCT00425061|75935204|FG004|STARTED|Overall Study||45||
59974476|NCT02397460|76091985|FG006|COMPLETED|Treatment Period 2||6||
59974477|NCT02397460|76091986|FG007|COMPLETED|Treatment Period 2||5||
59974478|NCT02397460|76091979|FG000|NOT COMPLETED|Treatment Period 2||0||
59974479|NCT02397460|76091980|FG001|NOT COMPLETED|Treatment Period 2||0||
59974480|NCT02397460|76091981|FG002|NOT COMPLETED|Treatment Period 2||0||
59974481|NCT02397460|76091982|FG003|NOT COMPLETED|Treatment Period 2||0||
59974482|NCT02397460|76091983|FG004|NOT COMPLETED|Treatment Period 2||0||
59974483|NCT02397460|76091984|FG005|NOT COMPLETED|Treatment Period 2||0||
59974484|NCT02397460|76091985|FG006|NOT COMPLETED|Treatment Period 2||0||
59974485|NCT02397460|76091986|FG007|NOT COMPLETED|Treatment Period 2||1||
59974486|NCT02397460|76091979|FG000|STARTED|Treatment Period 3||7||
59974487|NCT02397460|76091980|FG001|STARTED|Treatment Period 3||7||
59974488|NCT02397460|76091981|FG002|STARTED|Treatment Period 3||6||
59974489|NCT02397460|76091982|FG003|STARTED|Treatment Period 3||6||
59974490|NCT02397460|76091983|FG004|STARTED|Treatment Period 3||6||
59974491|NCT02397460|76091984|FG005|STARTED|Treatment Period 3||6||
59974492|NCT02397460|76091985|FG006|STARTED|Treatment Period 3||6||
59974493|NCT02397460|76091986|FG007|STARTED|Treatment Period 3||5||
59974494|NCT02397460|76091979|FG000|COMPLETED|Treatment Period 3||7||
59812824|NCT00425061|75935205|FG005|STARTED|Overall Study||4||
59812825|NCT00425061|75935206|FG006|STARTED|Overall Study||45||
59812826|NCT00425061|75935200|FG000|COMPLETED|Overall Study||14||
59974495|NCT02397460|76091980|FG001|COMPLETED|Treatment Period 3||7||
59974496|NCT02397460|76091981|FG002|COMPLETED|Treatment Period 3||6||
59974497|NCT02397460|76091982|FG003|COMPLETED|Treatment Period 3||6||
59974498|NCT02397460|76091983|FG004|COMPLETED|Treatment Period 3||6||
59974499|NCT02397460|76091984|FG005|COMPLETED|Treatment Period 3||6||
59974500|NCT02397460|76091985|FG006|COMPLETED|Treatment Period 3||6||
59812827|NCT00425061|75935201|FG001|COMPLETED|Overall Study||15||
59812828|NCT00425061|75935202|FG002|COMPLETED|Overall Study||16||
59812829|NCT00425061|75935203|FG003|COMPLETED|Overall Study||14||
59812830|NCT00425061|75935204|FG004|COMPLETED|Overall Study||19||
59812831|NCT00425061|75935205|FG005|COMPLETED|Overall Study||0||
59812832|NCT00425061|75935206|FG006|COMPLETED|Overall Study||26||
59812833|NCT00425061|75935200|FG000|NOT COMPLETED|Overall Study||2||
59812834|NCT00425061|75935201|FG001|NOT COMPLETED|Overall Study||2||
59974501|NCT02397460|76091986|FG007|COMPLETED|Treatment Period 3||5||
59974502|NCT02397460|76091979|FG000|NOT COMPLETED|Treatment Period 3||0||
59974503|NCT02397460|76091980|FG001|NOT COMPLETED|Treatment Period 3||0||
59974504|NCT02397460|76091981|FG002|NOT COMPLETED|Treatment Period 3||0||
59974505|NCT02397460|76091982|FG003|NOT COMPLETED|Treatment Period 3||0||
59812835|NCT00425061|75935202|FG002|NOT COMPLETED|Overall Study||0||
59812836|NCT00425061|75935203|FG003|NOT COMPLETED|Overall Study||2||
59974506|NCT02397460|76091983|FG004|NOT COMPLETED|Treatment Period 3||0||
59974507|NCT02397460|76091984|FG005|NOT COMPLETED|Treatment Period 3||0||
59974508|NCT02397460|76091985|FG006|NOT COMPLETED|Treatment Period 3||0||
59974509|NCT02397460|76091986|FG007|NOT COMPLETED|Treatment Period 3||0||
59974510|NCT02397460|76091979|FG000|STARTED|Treatment Period 4||7||
59974511|NCT02397460|76091980|FG001|STARTED|Treatment Period 4||7||
59974512|NCT02397460|76091981|FG002|STARTED|Treatment Period 4||6||
59974513|NCT02397460|76091982|FG003|STARTED|Treatment Period 4||6||
59974514|NCT02397460|76091983|FG004|STARTED|Treatment Period 4||6||
59974515|NCT02397460|76091984|FG005|STARTED|Treatment Period 4||6||
59974516|NCT02397460|76091985|FG006|STARTED|Treatment Period 4||6||
59974517|NCT02397460|76091986|FG007|STARTED|Treatment Period 4||5||
59974518|NCT02397460|76091979|FG000|COMPLETED|Treatment Period 4||7||
59974519|NCT02397460|76091980|FG001|COMPLETED|Treatment Period 4||6||
59974520|NCT02397460|76091981|FG002|COMPLETED|Treatment Period 4||6||
59974521|NCT02397460|76091982|FG003|COMPLETED|Treatment Period 4||6||
59974522|NCT02397460|76091983|FG004|COMPLETED|Treatment Period 4||5||
59974523|NCT02397460|76091984|FG005|COMPLETED|Treatment Period 4||6||
59974524|NCT02397460|76091985|FG006|COMPLETED|Treatment Period 4||6||
59974525|NCT02397460|76091986|FG007|COMPLETED|Treatment Period 4||5||
59974526|NCT02397460|76091979|FG000|NOT COMPLETED|Treatment Period 4||0||
59974527|NCT02397460|76091980|FG001|NOT COMPLETED|Treatment Period 4||1||
59974528|NCT02397460|76091981|FG002|NOT COMPLETED|Treatment Period 4||0||
59974529|NCT02397460|76091982|FG003|NOT COMPLETED|Treatment Period 4||0||
59974530|NCT02397460|76091983|FG004|NOT COMPLETED|Treatment Period 4||1||
59974531|NCT02397460|76091984|FG005|NOT COMPLETED|Treatment Period 4||0||
59525774|NCT01216735|75621120|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||0||
59525775|NCT01216735|75621121|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0||
59525776|NCT01285843|75621129|FG000|STARTED|Overall Study||20||
59525777|NCT01285843|75621130|FG001|STARTED|Overall Study||20||
59525778|NCT01285843|75621129|FG000|COMPLETED|Overall Study||18||
59525779|NCT01285843|75621130|FG001|COMPLETED|Overall Study||18||
59525780|NCT01285843|75621129|FG000|NOT COMPLETED|Overall Study||2||
59525781|NCT01285843|75621130|FG001|NOT COMPLETED|Overall Study||2||
59525782|NCT01263301|75621138|FG000|STARTED|Overall Study||5||
59525783|NCT01263301|75621139|FG001|STARTED|Overall Study||11||
59525784|NCT01263301|75621138|FG000|COMPLETED|Overall Study||5||
59525785|NCT01263301|75621139|FG001|COMPLETED|Overall Study||11||
59525786|NCT01263301|75621138|FG000|NOT COMPLETED|Overall Study||0||
59525787|NCT01263301|75621139|FG001|NOT COMPLETED|Overall Study||0||
59525788|NCT01264705|75621154|FG000|STARTED|Overall Study||3||
59525789|NCT01264705|75621155|FG001|STARTED|Overall Study||3||
59525790|NCT01264705|75621156|FG002|STARTED|Overall Study||41||
59525791|NCT01264705|75621154|FG000|COMPLETED|Overall Study||3||
59525792|NCT01264705|75621155|FG001|COMPLETED|Overall Study||3||
59974532|NCT02397460|76091985|FG006|NOT COMPLETED|Treatment Period 4||0||
59974533|NCT02397460|76091986|FG007|NOT COMPLETED|Treatment Period 4||0||
59974534|NCT02834819|76092062|FG000|STARTED|Overall Study||9||
59974535|NCT02834819|76092063|FG001|STARTED|Overall Study||9||
59974536|NCT02834819|76092062|FG000|COMPLETED|Overall Study||4||
59974537|NCT02834819|76092063|FG001|COMPLETED|Overall Study||9||
59974538|NCT02834819|76092062|FG000|NOT COMPLETED|Overall Study||5||
59974539|NCT02834819|76092063|FG001|NOT COMPLETED|Overall Study||0||
59974540|NCT02454478|76092069|FG000|STARTED|Overall Study||7||
59974541|NCT02454478|76092069|FG000|COMPLETED|Overall Study||6||
59974542|NCT02454478|76092069|FG000|NOT COMPLETED|Overall Study||1||
59974543|NCT01341587|76092075|FG000|STARTED|Overall Study||4||
59974544|NCT01341587|76092076|FG001|STARTED|Overall Study||10||
59974545|NCT01341587|76092075|FG000|COMPLETED|Overall Study||0||
59525793|NCT01264705|75621156|FG002|COMPLETED|Overall Study||41||
59525794|NCT01264705|75621154|FG000|NOT COMPLETED|Overall Study||0||
59525795|NCT01264705|75621155|FG001|NOT COMPLETED|Overall Study||0||
59525796|NCT01264705|75621156|FG002|NOT COMPLETED|Overall Study||0||
59525797|NCT01217515|75621170|FG000|STARTED|Overall Study||154||
59525798|NCT01217515|75621171|FG001|STARTED|Overall Study||156||
59525799|NCT01217515|75621172|FG002|STARTED|Overall Study||155||
59525800|NCT01217515|75621170|FG000|COMPLETED|Overall Study||147||
59525801|NCT01217515|75621171|FG001|COMPLETED|Overall Study||148||
59974546|NCT01341587|76092076|FG001|COMPLETED|Overall Study||0||
59974547|NCT01341587|76092075|FG000|NOT COMPLETED|Overall Study||4||
59974548|NCT01341587|76092076|FG001|NOT COMPLETED|Overall Study||10||
59974549|NCT01358825|76092084|FG000|STARTED|Overall Study||12||
59974550|NCT01358825|76092085|FG001|STARTED|Overall Study||46||
59974551|NCT01358825|76092084|FG000|COMPLETED|Overall Study||12||
59974552|NCT01358825|76092085|FG001|COMPLETED|Overall Study||45||
59974553|NCT01358825|76092084|FG000|NOT COMPLETED|Overall Study||0||
59974554|NCT01358825|76092085|FG001|NOT COMPLETED|Overall Study||1||
59974555|NCT02453386|76092094|FG000|STARTED|Overall Study||151||
59812837|NCT00425061|75935204|FG004|NOT COMPLETED|Overall Study||26||
59812838|NCT00425061|75935205|FG005|NOT COMPLETED|Overall Study||4||
59812839|NCT00425061|75935206|FG006|NOT COMPLETED|Overall Study||19||
59974556|NCT02453386|76092095|FG001|STARTED|Overall Study||149||
59974557|NCT02453386|76092096|FG002|STARTED|Overall Study||149||
59974558|NCT02453386|76092094|FG000|COMPLETED|Overall Study||102||
59974559|NCT02453386|76092095|FG001|COMPLETED|Overall Study||100||
59974560|NCT02453386|76092096|FG002|COMPLETED|Overall Study||108||
59974561|NCT02453386|76092094|FG000|NOT COMPLETED|Overall Study||49||
59974562|NCT02453386|76092095|FG001|NOT COMPLETED|Overall Study||49||
59974563|NCT02453386|76092096|FG002|NOT COMPLETED|Overall Study||41||
59974564|NCT02431468|76092114|FG000|STARTED|Overall Study||46|Safety Analysis set|
59974565|NCT02431468|76092115|FG001|STARTED|Overall Study||47|Safety Analysis set|
59974566|NCT02431468|76092116|FG002|STARTED|Overall Study||48|Safety Analysis set|
59974567|NCT02431468|76092114|FG000|COMPLETED|Overall Study||38||
59974568|NCT02431468|76092115|FG001|COMPLETED|Overall Study||29||
59974569|NCT02431468|76092116|FG002|COMPLETED|Overall Study||39||
59974570|NCT02431468|76092114|FG000|NOT COMPLETED|Overall Study||8||
59974571|NCT02431468|76092115|FG001|NOT COMPLETED|Overall Study||18||
59974572|NCT02431468|76092116|FG002|NOT COMPLETED|Overall Study||9||
59974573|NCT02452762|76092132|FG000|STARTED|Overall Study||45||
59974574|NCT02452762|76092133|FG001|STARTED|Overall Study||22||
59974575|NCT02452762|76092132|FG000|COMPLETED|Overall Study||40||
59974576|NCT02452762|76092133|FG001|COMPLETED|Overall Study||19||
59974577|NCT02452762|76092132|FG000|NOT COMPLETED|Overall Study||5||
59974578|NCT02452762|76092133|FG001|NOT COMPLETED|Overall Study||3||
59974579|NCT02633306|76092140|FG000|STARTED|Overall Study||9||
59974580|NCT02633306|76092140|FG000|COMPLETED|Overall Study||6||
59974581|NCT02633306|76092140|FG000|NOT COMPLETED|Overall Study||3||
59974582|NCT02396758|76092149|FG000|STARTED|Overall Study||38||
59974583|NCT02396758|76092150|FG001|STARTED|Overall Study||37||
59974584|NCT02396758|76092151|FG002|STARTED|Overall Study||38||
59974585|NCT02396758|76092152|FG003|STARTED|Overall Study||18||
59974586|NCT02396758|76092149|FG000|COMPLETED|Overall Study||26||
59974587|NCT02396758|76092150|FG001|COMPLETED|Overall Study||31||
59974588|NCT02396758|76092151|FG002|COMPLETED|Overall Study||34||
59974589|NCT02396758|76092152|FG003|COMPLETED|Overall Study||13||
59974590|NCT02396758|76092149|FG000|NOT COMPLETED|Overall Study||12||
59974591|NCT02396758|76092150|FG001|NOT COMPLETED|Overall Study||6||
59974592|NCT02396758|76092151|FG002|NOT COMPLETED|Overall Study||4||
59974593|NCT02396758|76092152|FG003|NOT COMPLETED|Overall Study||5||
59974594|NCT02632838|76092164|FG000|STARTED|Overall Study||15||
59974595|NCT02632838|76092165|FG001|STARTED|Overall Study||15||
59974596|NCT02632838|76092164|FG000|COMPLETED|Overall Study||12||
59974597|NCT02632838|76092165|FG001|COMPLETED|Overall Study||13||
59974598|NCT02632838|76092164|FG000|NOT COMPLETED|Overall Study||3||
59974599|NCT02632838|76092165|FG001|NOT COMPLETED|Overall Study||2||
59974600|NCT02396212|76092175|FG000|STARTED|Overall Study||19||
59974601|NCT02396212|76092175|FG000|COMPLETED|Overall Study||16||
59525802|NCT01217515|75621172|FG002|COMPLETED|Overall Study||145||
59812840|NCT00424827|75935224|FG000|STARTED|Overall Study||11||
59812841|NCT00424827|75935224|FG000|COMPLETED|Overall Study||10||
59812842|NCT00424827|75935224|FG000|NOT COMPLETED|Overall Study||1||
59974602|NCT02396212|76092175|FG000|NOT COMPLETED|Overall Study||3||
59974603|NCT02395822|76092179|FG000|STARTED|Overall Study||17||
59974604|NCT02395822|76092179|FG000|COMPLETED|Overall Study||15||
59812843|NCT03885726|75935229|FG000|STARTED|Overall Study||32||
59812844|NCT03885726|75935229|FG000|COMPLETED|Overall Study||28||
59812845|NCT03885726|75935229|FG000|NOT COMPLETED|Overall Study||4||
59812846|NCT00377962|75935239|FG000|STARTED|Core Study: 0-12 Months||140||
59974605|NCT02395822|76092179|FG000|NOT COMPLETED|Overall Study||2||
59974606|NCT01651936|76092185|FG000|STARTED|Base Study||30||
59974607|NCT01651936|76092186|FG001|STARTED|Base Study||26||
59974608|NCT01651936|76092187|FG002|STARTED|Base Study||0||
59974609|NCT01651936|76092185|FG000|COMPLETED|Base Study||3||
59974610|NCT01651936|76092186|FG001|COMPLETED|Base Study||1||
59974611|NCT01651936|76092187|FG002|COMPLETED|Base Study||0||
59974612|NCT01651936|76092185|FG000|NOT COMPLETED|Base Study||27||
59974613|NCT01651936|76092186|FG001|NOT COMPLETED|Base Study||25||
59812847|NCT00377962|75935240|FG001|STARTED|Core Study: 0-12 Months||142||
59812848|NCT00377962|75935239|FG000|COMPLETED|Core Study: 0-12 Months||112||
59812849|NCT00377962|75935240|FG001|COMPLETED|Core Study: 0-12 Months||133||
59812850|NCT00377962|75935239|FG000|NOT COMPLETED|Core Study: 0-12 Months||28||
59812851|NCT00377962|75935240|FG001|NOT COMPLETED|Core Study: 0-12 Months||9||
59974614|NCT01651936|76092187|FG002|NOT COMPLETED|Base Study||0||
59974615|NCT01651936|76092185|FG000|STARTED|Extension Study||0||
59974616|NCT01651936|76092186|FG001|STARTED|Extension Study||0||
59974617|NCT01651936|76092187|FG002|STARTED|Extension Study|Includes completers and early escapees from the Base Study|14||
59974618|NCT01651936|76092185|FG000|COMPLETED|Extension Study||0||
59974619|NCT01651936|76092186|FG001|COMPLETED|Extension Study||0||
59974620|NCT01651936|76092187|FG002|COMPLETED|Extension Study||0||
59974621|NCT01651936|76092185|FG000|NOT COMPLETED|Extension Study||0||
59974622|NCT01651936|76092186|FG001|NOT COMPLETED|Extension Study||0||
59974623|NCT01651936|76092187|FG002|NOT COMPLETED|Extension Study||14||
59974624|NCT02395042|76092197|FG000|STARTED|Treatment 1 Period||12||
59974625|NCT02395042|76092198|FG001|STARTED|Treatment 1 Period||31||
59974626|NCT02395042|76092199|FG002|STARTED|Treatment 1 Period||16||
59974627|NCT02395042|76092197|FG000|COMPLETED|Treatment 1 Period||9||
59974628|NCT02395042|76092198|FG001|COMPLETED|Treatment 1 Period||25||
59974629|NCT02395042|76092199|FG002|COMPLETED|Treatment 1 Period||14||
59974630|NCT02395042|76092197|FG000|NOT COMPLETED|Treatment 1 Period||3||
59974631|NCT02395042|76092198|FG001|NOT COMPLETED|Treatment 1 Period||6||
59974632|NCT02395042|76092199|FG002|NOT COMPLETED|Treatment 1 Period||2||
59974633|NCT02395042|76092197|FG000|STARTED|Treatment 2 Period|Not all participants participated in Treatment 2 Period.|10||
59974634|NCT02395042|76092198|FG001|STARTED|Treatment 2 Period|Not all participants participated in Treatment 2 Period.|24||
59974635|NCT02395042|76092199|FG002|STARTED|Treatment 2 Period|Not all participants participated in Treatment 2 Period.|13||
59974636|NCT02395042|76092197|FG000|COMPLETED|Treatment 2 Period||9||
59974637|NCT02395042|76092198|FG001|COMPLETED|Treatment 2 Period||23||
59974638|NCT02395042|76092199|FG002|COMPLETED|Treatment 2 Period||13||
59974639|NCT02395042|76092197|FG000|NOT COMPLETED|Treatment 2 Period||1||
59974640|NCT02395042|76092198|FG001|NOT COMPLETED|Treatment 2 Period||1||
59974641|NCT02395042|76092199|FG002|NOT COMPLETED|Treatment 2 Period||0||
59974642|NCT02394808|76092210|FG000|STARTED|Period 1||25||
59974643|NCT02394808|76092211|FG001|STARTED|Period 1||29||
59974644|NCT02394808|76092210|FG000|COMPLETED|Period 1||25||
59974645|NCT02394808|76092211|FG001|COMPLETED|Period 1||28||
59974646|NCT02394808|76092210|FG000|NOT COMPLETED|Period 1||0||
59974647|NCT02394808|76092211|FG001|NOT COMPLETED|Period 1||1||
59974648|NCT02394808|76092210|FG000|STARTED|Period 2||25||
59974649|NCT02394808|76092211|FG001|STARTED|Period 2||28||
59974650|NCT02394808|76092210|FG000|COMPLETED|Period 2||24||
59974651|NCT02394808|76092211|FG001|COMPLETED|Period 2||28||
59974652|NCT02394808|76092210|FG000|NOT COMPLETED|Period 2||1||
59974653|NCT02394808|76092211|FG001|NOT COMPLETED|Period 2||0||
59974654|NCT02630966|76092219|FG000|STARTED|Overall Study||16||
59974655|NCT02630966|76092220|FG001|STARTED|Overall Study||18||
59974656|NCT02630966|76092219|FG000|COMPLETED|Overall Study||14|Completed here refers to participants who completed study drug.|
59974657|NCT02630966|76092220|FG001|COMPLETED|Overall Study||10|Completed here refers to participants who completed study drug.|
59974658|NCT02630966|76092219|FG000|NOT COMPLETED|Overall Study||2||
59974659|NCT02630966|76092220|FG001|NOT COMPLETED|Overall Study||8||
59974660|NCT01651780|76092228|FG000|STARTED|Overall Study||405||
59974661|NCT01651780|76092229|FG001|STARTED|Overall Study||398||
59974662|NCT01651780|76092228|FG000|Intent-To-Treat (ITT) Population|Overall Study||404||
59974663|NCT01651780|76092229|FG001|Intent-To-Treat (ITT) Population|Overall Study||398||
59974664|NCT01651780|76092228|FG000|Received at Least 1 Dose of Study Drug|Overall Study|All but 1 participant in the bivalirudin group (withdrew consent) comprised the ITT population.|393||
59974665|NCT01651780|76092229|FG001|Received at Least 1 Dose of Study Drug|Overall Study||394||
59974666|NCT01651780|76092228|FG000|BRAVO 2 Feasibility Cohort|Overall Study|1st 2 participants/site made up the bivalirudin feasibility cohort (BRAVO2) and analyzed separately.|65||
59525803|NCT01217515|75621170|FG000|NOT COMPLETED|Overall Study||7||
59525804|NCT01217515|75621171|FG001|NOT COMPLETED|Overall Study||8||
59812852|NCT00377962|75935239|FG000|STARTED|Extension Study: 12-24 Months||108||
59812853|NCT00377962|75935240|FG001|STARTED|Extension Study: 12-24 Months||127||
59812854|NCT00377962|75935239|FG000|COMPLETED|Extension Study: 12-24 Months||98||
59812855|NCT00377962|75935240|FG001|COMPLETED|Extension Study: 12-24 Months||123||
59974667|NCT01651780|76092229|FG001|BRAVO 2 Feasibility Cohort|Overall Study|1st 2 participants/site made up the bivalirudin feasibility cohort (BRAVO2) and analyzed separately.|0||
59974668|NCT01651780|76092228|FG000|COMPLETED|Overall Study||394||
59974669|NCT01651780|76092229|FG001|COMPLETED|Overall Study||388||
59974670|NCT01651780|76092228|FG000|NOT COMPLETED|Overall Study||11||
59974671|NCT01651780|76092229|FG001|NOT COMPLETED|Overall Study||10||
59974672|NCT02394730|76092241|FG000|STARTED|Overall Study||34||
59812856|NCT00377962|75935239|FG000|NOT COMPLETED|Extension Study: 12-24 Months||10||
59812857|NCT00377962|75935240|FG001|NOT COMPLETED|Extension Study: 12-24 Months||4||
59525805|NCT01217515|75621172|FG002|NOT COMPLETED|Overall Study||10||
59525806|NCT00016718|75621183|FG000|STARTED|Overall Study||6||
59812858|NCT00424749|75935252|FG000|STARTED|Overall Study||4||
59812859|NCT00424749|75935252|FG000|COMPLETED|Overall Study||3||
59812860|NCT00424749|75935252|FG000|NOT COMPLETED|Overall Study||1||
59812861|NCT00424593|75935258|FG000|STARTED|Acute Double-Blind Period||115||
59812862|NCT00424593|75935259|FG001|STARTED|Acute Double-Blind Period||121||
59812863|NCT00424593|75935258|FG000|COMPLETED|Acute Double-Blind Period||84||
59812864|NCT00424593|75935259|FG001|COMPLETED|Acute Double-Blind Period||98||
59812865|NCT00424593|75935258|FG000|NOT COMPLETED|Acute Double-Blind Period||31||
59812866|NCT00424593|75935259|FG001|NOT COMPLETED|Acute Double-Blind Period||23||
59812867|NCT00424593|75935258|FG000|STARTED|Dose-Blind Extension Period|83 duloxetine patients from the acute phase entered the dose-blind period.|181||
59812868|NCT00424593|75935259|FG001|STARTED|Dose-Blind Extension Period|98 placebo patients from acute phase entered dose-blind period and received duloxetine.|0||
59812869|NCT00424593|75935258|FG000|COMPLETED|Dose-Blind Extension Period||117||
59812870|NCT00424593|75935259|FG001|COMPLETED|Dose-Blind Extension Period||0||
59812871|NCT00424593|75935258|FG000|NOT COMPLETED|Dose-Blind Extension Period||64||
59812872|NCT00424593|75935259|FG001|NOT COMPLETED|Dose-Blind Extension Period||0||
59812873|NCT00369382|75935267|FG000|STARTED|Overall Study||59||
59812874|NCT00369382|75935268|FG001|STARTED|Overall Study||57||
59812875|NCT00369382|75935267|FG000|Received Treatment|Overall Study||57||
59812876|NCT00369382|75935268|FG001|Received Treatment|Overall Study||57||
59812877|NCT00369382|75935267|FG000|Completed Assigned Treatment Regimen|Overall Study||48||
59812878|NCT00369382|75935268|FG001|Completed Assigned Treatment Regimen|Overall Study||33||
59812879|NCT00369382|75935267|FG000|COMPLETED|Overall Study||49||
59812880|NCT00369382|75935268|FG001|COMPLETED|Overall Study||54||
59812881|NCT00369382|75935267|FG000|NOT COMPLETED|Overall Study||10||
59812882|NCT00369382|75935268|FG001|NOT COMPLETED|Overall Study||3||
59812883|NCT00424515|75935277|FG000|STARTED|Overall Study||11||
59812884|NCT00424515|75935278|FG001|STARTED|Overall Study||13||
59812885|NCT00424515|75935277|FG000|COMPLETED|Overall Study||0||
59812886|NCT00424515|75935278|FG001|COMPLETED|Overall Study||0||
59812887|NCT00424515|75935277|FG000|NOT COMPLETED|Overall Study||11||
59812888|NCT00424515|75935278|FG001|NOT COMPLETED|Overall Study||13||
59812889|NCT00377260|75935286|FG000|STARTED|Overall Study||144||
59812890|NCT00377260|75935287|FG001|STARTED|Overall Study||147||
59812891|NCT00377260|75935286|FG000|COMPLETED|Overall Study|A child is considered a completer if he/she had at least one visit after the end of therapy.|142||
59812892|NCT00377260|75935287|FG001|COMPLETED|Overall Study|A child is considered a completer if he/she had at least one visit after the end of therapy.|142||
59812893|NCT00377260|75935286|FG000|NOT COMPLETED|Overall Study||2||
59812894|NCT00377260|75935287|FG001|NOT COMPLETED|Overall Study||5||
59812895|NCT00441441|75935295|FG000|STARTED|Overall Study||173||
59812896|NCT00441441|75935296|FG001|STARTED|Overall Study||177||
59812897|NCT00441441|75935295|FG000|COMPLETED|Overall Study||162||
59812898|NCT00441441|75935296|FG001|COMPLETED|Overall Study||163||
59812899|NCT00441441|75935295|FG000|NOT COMPLETED|Overall Study||11||
59812900|NCT00441441|75935296|FG001|NOT COMPLETED|Overall Study||14||
59974673|NCT02394730|76092242|FG001|STARTED|Overall Study||31||
59974674|NCT02394730|76092241|FG000|COMPLETED|Overall Study||33||
59974675|NCT02394730|76092242|FG001|COMPLETED|Overall Study||30||
59974676|NCT02394730|76092241|FG000|NOT COMPLETED|Overall Study||1||
59974677|NCT02394730|76092242|FG001|NOT COMPLETED|Overall Study||1||
59974678|NCT02430532|76092250|FG000|STARTED|Overall Study||30||
59974679|NCT02430532|76092251|FG001|STARTED|Overall Study||28||
59812901|NCT00436917|75935316|FG000|STARTED|Overall Study|7 participants (1 cancellation, 1 major violation, 5 ineligibles) were excluded from all analysis.|53||
59812902|NCT00436917|75935316|FG000|COMPLETED|Overall Study||32||
59812903|NCT00436917|75935316|FG000|NOT COMPLETED|Overall Study||21||
59812904|NCT00436605|75935320|FG000|STARTED|Overall Study||39||
59812905|NCT00436605|75935320|FG000|COMPLETED|Overall Study||36||
59812906|NCT00436605|75935320|FG000|NOT COMPLETED|Overall Study||3||
59812907|NCT00368992|75935324|FG000|STARTED|Overall Study||110||
59812908|NCT00368992|75935324|FG000|COMPLETED|Overall Study||0||
59812909|NCT00368992|75935324|FG000|NOT COMPLETED|Overall Study||110||
59812910|NCT00376246|75935329|FG000|STARTED|First Intervention (2 Weeks)||14||
59812911|NCT00376246|75935330|FG001|STARTED|First Intervention (2 Weeks)||14||
59974680|NCT02430532|76092250|FG000|COMPLETED|Overall Study||0||
59812912|NCT00376246|75935329|FG000|COMPLETED|First Intervention (2 Weeks)||10||
59812913|NCT00376246|75935330|FG001|COMPLETED|First Intervention (2 Weeks)||12||
59812914|NCT00376246|75935329|FG000|NOT COMPLETED|First Intervention (2 Weeks)||4||
59812915|NCT00376246|75935330|FG001|NOT COMPLETED|First Intervention (2 Weeks)||2||
59812916|NCT00376246|75935329|FG000|STARTED|Washout (2 Weeks)||10||
59812917|NCT00376246|75935330|FG001|STARTED|Washout (2 Weeks)||12||
59812918|NCT00376246|75935329|FG000|COMPLETED|Washout (2 Weeks)||10||
59812919|NCT00376246|75935330|FG001|COMPLETED|Washout (2 Weeks)||12||
59812920|NCT00376246|75935329|FG000|NOT COMPLETED|Washout (2 Weeks)||0||
59812921|NCT00376246|75935330|FG001|NOT COMPLETED|Washout (2 Weeks)||0||
59974681|NCT02430532|76092251|FG001|COMPLETED|Overall Study||0||
59974682|NCT02430532|76092250|FG000|NOT COMPLETED|Overall Study||30||
59974683|NCT02430532|76092251|FG001|NOT COMPLETED|Overall Study||28||
59974684|NCT02394340|76092259|FG000|STARTED|Overall Study||20||
59974685|NCT02394340|76092259|FG000|Received at Least 1 Dose of Study Drug|Overall Study||20||
59812922|NCT00376246|75935329|FG000|STARTED|Second Intervention (2 Weeks)||10||
59812923|NCT00376246|75935330|FG001|STARTED|Second Intervention (2 Weeks)||12||
59812924|NCT00376246|75935329|FG000|COMPLETED|Second Intervention (2 Weeks)||10||
59812925|NCT00376246|75935330|FG001|COMPLETED|Second Intervention (2 Weeks)||12||
59974686|NCT02394340|76092259|FG000|COMPLETED|Overall Study||18||
59974687|NCT02394340|76092259|FG000|NOT COMPLETED|Overall Study||2||
59974688|NCT01672736|76092263|FG000|STARTED|Overall Study|Phase I study part stopped early due to manufacturer's decision to stop further drug development.|19||
59974689|NCT01672736|76092263|FG000|COMPLETED|Overall Study|3 patients taken off study due to non-availability of further study (Linsitinib) drug supply.|16|Phase II part of the study not done due to termination of further study drug development.|
59974690|NCT01672736|76092263|FG000|NOT COMPLETED|Overall Study||3||
59974691|NCT01560637|76092267|FG000|STARTED|Overall Study|471 subjects from the parent study (TDE-PH-310) consented to participate in TDE-PH-311. However, one subject withdrew consent prior to receiving oral treprostinil in TDE-PH-311. This subject was not included in the data summary.|470||
59974692|NCT01560637|76092267|FG000|COMPLETED|Overall Study||272||
59974693|NCT01560637|76092267|FG000|NOT COMPLETED|Overall Study||198||
59974694|NCT01353911|76092279|FG000|STARTED|Overall Study||36||
59974695|NCT01353911|76092280|FG001|STARTED|Overall Study||66||
59974696|NCT01353911|76092281|FG002|STARTED|Overall Study||68||
59974697|NCT01353911|76092282|FG003|STARTED|Overall Study||24||
59974698|NCT01353911|76092283|FG004|STARTED|Overall Study||29||
59974699|NCT01353911|76092284|FG005|STARTED|Overall Study||43||
59974700|NCT01353911|76092285|FG006|STARTED|Overall Study||36||
59974701|NCT01353911|76092286|FG007|STARTED|Overall Study||66||
59974702|NCT01353911|76092279|FG000|COMPLETED|Overall Study||28||
59974703|NCT01353911|76092280|FG001|COMPLETED|Overall Study||57||
59974704|NCT01353911|76092281|FG002|COMPLETED|Overall Study||59||
59974705|NCT01353911|76092282|FG003|COMPLETED|Overall Study||22||
59974706|NCT01353911|76092283|FG004|COMPLETED|Overall Study||23||
59812926|NCT00376246|75935329|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||0||
59812927|NCT00376246|75935330|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||0||
59812928|NCT00368836|75935340|FG000|STARTED|Phase II||350||
59812929|NCT00368836|75935340|FG000|COMPLETED|Phase II||329||
59812930|NCT00368836|75935340|FG000|NOT COMPLETED|Phase II||21||
59812931|NCT00368836|75935340|FG000|STARTED|Phase I Pre-op/Post-op|The phases consisted of unique subjects. Those enrolled in Phase I did not carry over to Phase II.|125||
59974707|NCT01353911|76092284|FG005|COMPLETED|Overall Study||36||
59974708|NCT01353911|76092285|FG006|COMPLETED|Overall Study||30||
59974709|NCT01353911|76092286|FG007|COMPLETED|Overall Study||51||
59974710|NCT01353911|76092279|FG000|NOT COMPLETED|Overall Study||8||
59974711|NCT01353911|76092280|FG001|NOT COMPLETED|Overall Study||9||
59974712|NCT01353911|76092281|FG002|NOT COMPLETED|Overall Study||9||
59974713|NCT01353911|76092282|FG003|NOT COMPLETED|Overall Study||2||
59974714|NCT01353911|76092283|FG004|NOT COMPLETED|Overall Study||6||
59974715|NCT01353911|76092284|FG005|NOT COMPLETED|Overall Study||7||
59812932|NCT00368836|75935340|FG000|COMPLETED|Phase I Pre-op/Post-op||104||
59812933|NCT00368836|75935340|FG000|NOT COMPLETED|Phase I Pre-op/Post-op||21||
59812934|NCT00376168|75935349|FG000|STARTED|Overall Study||16||
59812935|NCT00376168|75935350|FG001|STARTED|Overall Study|One patient randomized but not treated|16||
59812936|NCT00376168|75935349|FG000|COMPLETED|Overall Study||14||
59812937|NCT00376168|75935350|FG001|COMPLETED|Overall Study||15||
59812938|NCT00376168|75935349|FG000|NOT COMPLETED|Overall Study||2||
59812939|NCT00376168|75935350|FG001|NOT COMPLETED|Overall Study||1||
59812940|NCT00375934|75935358|FG000|STARTED|Overall Study||99||
59812941|NCT00375934|75935359|FG001|STARTED|Overall Study||101||
59974716|NCT01353911|76092285|FG006|NOT COMPLETED|Overall Study||6||
59974717|NCT01353911|76092286|FG007|NOT COMPLETED|Overall Study||15||
59974718|NCT01671488|76092304|FG000|STARTED|Overall Study||11|This is for patients who signed consent|
59974719|NCT01671488|76092304|FG000|COMPLETED|Overall Study||10||
59974720|NCT01671488|76092304|FG000|NOT COMPLETED|Overall Study||1||
59974721|NCT02783911|76092310|FG000|STARTED|Overall Study||11||12
59974722|NCT02783911|76092311|FG001|STARTED|Overall Study||46||53
59974723|NCT02783911|76092310|FG000|COMPLETED|Overall Study||8||9
59974724|NCT02783911|76092311|FG001|COMPLETED|Overall Study||14||15
59974725|NCT02783911|76092310|FG000|NOT COMPLETED|Overall Study||3||3
59974726|NCT02783911|76092311|FG001|NOT COMPLETED|Overall Study||32||38
59812942|NCT00375934|75935358|FG000|COMPLETED|Overall Study||96||
59812943|NCT00375934|75935359|FG001|COMPLETED|Overall Study||95||
59974727|NCT01358357|76092319|FG000|STARTED|Open Label Phase||0||
59974728|NCT01358357|76092320|FG001|STARTED|Open Label Phase||0||
59974729|NCT01358357|76092321|FG002|STARTED|Open Label Phase||965||
59974730|NCT01358357|76092319|FG000|COMPLETED|Open Label Phase||0||
59974731|NCT01358357|76092320|FG001|COMPLETED|Open Label Phase||0||
59974732|NCT01358357|76092321|FG002|COMPLETED|Open Label Phase||503||
59974733|NCT01358357|76092319|FG000|NOT COMPLETED|Open Label Phase||0||
59974734|NCT01358357|76092320|FG001|NOT COMPLETED|Open Label Phase||0||
59974735|NCT01358357|76092321|FG002|NOT COMPLETED|Open Label Phase||462||
59812944|NCT00375934|75935358|FG000|NOT COMPLETED|Overall Study||3||
59812945|NCT00375934|75935359|FG001|NOT COMPLETED|Overall Study||6||
59812946|NCT00642941|75935377|FG000|STARTED|Overall Study||70||
59812947|NCT00642941|75935378|FG001|STARTED|Overall Study||54||
59812948|NCT00642941|75935379|FG002|STARTED|Overall Study||7||
59974736|NCT01358357|76092319|FG000|STARTED|Double-Blind Phase||246||
59974737|NCT01358357|76092320|FG001|STARTED|Double-Blind Phase||250||
59974738|NCT01358357|76092321|FG002|STARTED|Double-Blind Phase||0||
59974739|NCT01358357|76092319|FG000|COMPLETED|Double-Blind Phase||166||
59974740|NCT01358357|76092320|FG001|COMPLETED|Double-Blind Phase||150||
59974741|NCT01358357|76092321|FG002|COMPLETED|Double-Blind Phase||0||
59974742|NCT01358357|76092319|FG000|NOT COMPLETED|Double-Blind Phase||80||
59974743|NCT01358357|76092320|FG001|NOT COMPLETED|Double-Blind Phase||100||
59974744|NCT01358357|76092321|FG002|NOT COMPLETED|Double-Blind Phase||0||
59974745|NCT02831387|76092330|FG000|STARTED|Overall Study||23||
59974746|NCT02831387|76092331|FG001|STARTED|Overall Study||24||
59974747|NCT02831387|76092330|FG000|COMPLETED|Overall Study||22||
59974748|NCT02831387|76092331|FG001|COMPLETED|Overall Study||22||
59974749|NCT02831387|76092330|FG000|NOT COMPLETED|Overall Study||1||
59974750|NCT02831387|76092331|FG001|NOT COMPLETED|Overall Study||2||
59974751|NCT02831855|76092337|FG000|STARTED|Open Label Phase (24 Weeks)||694||
59974752|NCT02831855|76092338|FG001|STARTED|Open Label Phase (24 Weeks)||0||
59974753|NCT02831855|76092339|FG002|STARTED|Open Label Phase (24 Weeks)||0||
59974754|NCT02831855|76092337|FG000|COMPLETED|Open Label Phase (24 Weeks)||623||
59974755|NCT02831855|76092338|FG001|COMPLETED|Open Label Phase (24 Weeks)||0||
59974756|NCT02831855|76092339|FG002|COMPLETED|Open Label Phase (24 Weeks)||0||
59974757|NCT02831855|76092337|FG000|NOT COMPLETED|Open Label Phase (24 Weeks)||71||
59974758|NCT02831855|76092338|FG001|NOT COMPLETED|Open Label Phase (24 Weeks)||0||
59974759|NCT02831855|76092339|FG002|NOT COMPLETED|Open Label Phase (24 Weeks)||0||
59974760|NCT02831855|76092337|FG000|STARTED|Double Blind Phase (24 Weeks)||0||
59974761|NCT02831855|76092338|FG001|STARTED|Double Blind Phase (24 Weeks)|Only eligible participants from open label phase, were randomized into double blind phase.|267||
59974762|NCT02831855|76092339|FG002|STARTED|Double Blind Phase (24 Weeks)|Only eligible participants from open label phase, were randomized into double blind phase. .|266||
59974763|NCT02831855|76092337|FG000|Treated|Double Blind Phase (24 Weeks)||0||
59974764|NCT02831855|76092338|FG001|Treated|Double Blind Phase (24 Weeks)||264||
59974765|NCT02831855|76092339|FG002|Treated|Double Blind Phase (24 Weeks)||266||
59974766|NCT02831855|76092337|FG000|COMPLETED|Double Blind Phase (24 Weeks)||0||
59974767|NCT02831855|76092338|FG001|COMPLETED|Double Blind Phase (24 Weeks)||238||
59812949|NCT00642941|75935380|FG003|STARTED|Overall Study||40||
59812950|NCT00642941|75935381|FG004|STARTED|Overall Study||25||
59812951|NCT00642941|75935382|FG005|STARTED|Overall Study||41||
59812952|NCT00642941|75935383|FG006|STARTED|Overall Study||23||
59974768|NCT02831855|76092339|FG002|COMPLETED|Double Blind Phase (24 Weeks)||247||
59974769|NCT02831855|76092337|FG000|NOT COMPLETED|Double Blind Phase (24 Weeks)||0||
59974770|NCT02831855|76092338|FG001|NOT COMPLETED|Double Blind Phase (24 Weeks)||29||
59974771|NCT02831855|76092339|FG002|NOT COMPLETED|Double Blind Phase (24 Weeks)||19||
59974772|NCT02628938|76092352|FG000|STARTED|Overall Study||15||
59974773|NCT02628938|76092353|FG001|STARTED|Overall Study||15||
59974774|NCT02628938|76092354|FG002|STARTED|Overall Study||15||
59974775|NCT02628938|76092352|FG000|COMPLETED|Overall Study||10||
59974776|NCT02628938|76092353|FG001|COMPLETED|Overall Study||13||
59974777|NCT02628938|76092354|FG002|COMPLETED|Overall Study||11||
59974778|NCT02628938|76092352|FG000|NOT COMPLETED|Overall Study||5||
59974779|NCT02628938|76092353|FG001|NOT COMPLETED|Overall Study||2||
59974780|NCT02628938|76092354|FG002|NOT COMPLETED|Overall Study||4||
59974781|NCT04904510|76092362|FG000|STARTED|Overall Study||297||
59974782|NCT04904510|76092362|FG000|COMPLETED|Overall Study||297||
59974783|NCT04904510|76092362|FG000|NOT COMPLETED|Overall Study||0||
59974784|NCT01356407|76092368|FG000|STARTED|Overall Study||150||
59974785|NCT01356407|76092369|FG001|STARTED|Overall Study||150||
59974786|NCT01356407|76092368|FG000|COMPLETED|Overall Study||144||
59974787|NCT01356407|76092369|FG001|COMPLETED|Overall Study||146||
59974788|NCT01356407|76092368|FG000|NOT COMPLETED|Overall Study||6||
59974789|NCT01356407|76092369|FG001|NOT COMPLETED|Overall Study||4||
59974790|NCT00109837|76092375|FG000|STARTED|Overall Study||79||
59974791|NCT00109837|76092375|FG000|Eligible|Overall Study||78||
59974792|NCT00109837|76092375|FG000|Eligible and Ph-|Overall Study||61||
59974793|NCT00109837|76092375|FG000|Eligible and Ph- and Treated|Overall Study||60||
59974794|NCT00109837|76092375|FG000|COMPLETED|Overall Study||56||
59974795|NCT00109837|76092375|FG000|NOT COMPLETED|Overall Study||23||
59974796|NCT02828111|76092388|FG000|STARTED|Overall Study||6||
59812953|NCT00642941|75935384|FG007|STARTED|Overall Study||14||
59812954|NCT00642941|75935385|FG008|STARTED|Overall Study||11||
59812955|NCT00642941|75935386|FG009|STARTED|Overall Study||9||
59974797|NCT02828111|76092389|FG001|STARTED|Overall Study||6||
59974798|NCT02828111|76092390|FG002|STARTED|Overall Study||6||
59974799|NCT02828111|76092391|FG003|STARTED|Overall Study||6||
59974800|NCT02828111|76092392|FG004|STARTED|Overall Study||12||
59974801|NCT02828111|76092388|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6||
59974802|NCT02828111|76092389|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6||
59974803|NCT02828111|76092390|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6||
59974804|NCT02828111|76092391|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6||
59974805|NCT02828111|76092392|FG004|Received at Least 1 Dose of Study Drug|Overall Study||12||
59974806|NCT02828111|76092388|FG000|COMPLETED|Overall Study||6||
59974807|NCT02828111|76092389|FG001|COMPLETED|Overall Study||6||
59974808|NCT02828111|76092390|FG002|COMPLETED|Overall Study||4||
59974809|NCT02828111|76092391|FG003|COMPLETED|Overall Study||5||
59974810|NCT02828111|76092392|FG004|COMPLETED|Overall Study||11||
59974811|NCT02828111|76092388|FG000|NOT COMPLETED|Overall Study||0||
59974812|NCT02828111|76092389|FG001|NOT COMPLETED|Overall Study||0||
59974813|NCT02828111|76092390|FG002|NOT COMPLETED|Overall Study||2||
59974814|NCT02828111|76092391|FG003|NOT COMPLETED|Overall Study||1||
59974815|NCT02828111|76092392|FG004|NOT COMPLETED|Overall Study||1||
59974816|NCT01671332|76092415|FG000|STARTED|Overall Study||40||
59974817|NCT01671332|76092416|FG001|STARTED|Overall Study||40||
59974818|NCT01671332|76092415|FG000|Crossed Over to Docetaxel Plus Suramin|Overall Study||0|Participants with disease progression on Docetaxel Arm were allowed to crossover to Suramin.|
59974819|NCT01671332|76092416|FG001|Crossed Over to Docetaxel Plus Suramin|Overall Study|Participants with disease progression on Docetaxel Arm were allowed to crossover to Suramin.|13|Participants with disease progression on Docetaxel Arm were allowed to crossover to Suramin.|
59974820|NCT01671332|76092415|FG000|COMPLETED|Overall Study||39||
59974821|NCT01671332|76092416|FG001|COMPLETED|Overall Study||39||
59812956|NCT00642941|75935387|FG010|STARTED|Overall Study||12||
59812957|NCT00642941|75935388|FG011|STARTED|Overall Study||11||
59812958|NCT00642941|75935377|FG000|COMPLETED|Overall Study||0||
59974822|NCT01671332|76092415|FG000|NOT COMPLETED|Overall Study||1||
59974823|NCT01671332|76092416|FG001|NOT COMPLETED|Overall Study||1||
59974824|NCT01355627|76092424|FG000|STARTED|Overall Study||362||
59974825|NCT01355627|76092425|FG001|STARTED|Overall Study||364||
59974826|NCT01355627|76092424|FG000|Safety Analysis Set|Overall Study||362||
59974827|NCT01355627|76092425|FG001|Safety Analysis Set|Overall Study||364||
59974828|NCT01355627|76092424|FG000|Full Analysis Set|Overall Study|One participant's data for final follow-up is missing, completion status could not be confirmed.|361||
59974829|NCT01355627|76092425|FG001|Full Analysis Set|Overall Study|One participant randomized to Current Practice actually received TachoSil®.|365||
59974830|NCT01355627|76092424|FG000|COMPLETED|Overall Study||329||
59974831|NCT01355627|76092425|FG001|COMPLETED|Overall Study||326||
59974832|NCT01355627|76092424|FG000|NOT COMPLETED|Overall Study||33||
59974833|NCT01355627|76092425|FG001|NOT COMPLETED|Overall Study||38||
59974834|NCT00100802|76092431|FG000|STARTED|Overall Study||118||
59974835|NCT00100802|76092431|FG000|COMPLETED|Overall Study||38||
59974836|NCT00100802|76092431|FG000|NOT COMPLETED|Overall Study||80||
59974837|NCT01355159|76092437|FG000|STARTED|Overall Study||1228||
59974838|NCT01355159|76092438|FG001|STARTED|Overall Study||1236||
59974839|NCT01355159|76092437|FG000|COMPLETED|Overall Study||1144||
59974840|NCT01355159|76092438|FG001|COMPLETED|Overall Study||1157||
59974841|NCT01355159|76092437|FG000|NOT COMPLETED|Overall Study||84||
59974842|NCT01355159|76092438|FG001|NOT COMPLETED|Overall Study||79||
59974843|NCT02630186|76092444|FG000|STARTED|Overall Study||3||
59974844|NCT02630186|76092444|FG000|COMPLETED|Overall Study||2||
59974845|NCT02630186|76092444|FG000|NOT COMPLETED|Overall Study||1||
59974846|NCT01669928|76092450|FG000|STARTED|First Intervention||51||
59974847|NCT01669928|76092451|FG001|STARTED|First Intervention||52||
59812959|NCT00642941|75935378|FG001|COMPLETED|Overall Study||0||
59812960|NCT00642941|75935379|FG002|COMPLETED|Overall Study||0||
59812961|NCT00642941|75935380|FG003|COMPLETED|Overall Study||0||
59812962|NCT00642941|75935381|FG004|COMPLETED|Overall Study||0||
59974848|NCT01669928|76092450|FG000|COMPLETED|First Intervention||48||
59974849|NCT01669928|76092451|FG001|COMPLETED|First Intervention||47||
59974850|NCT01669928|76092450|FG000|NOT COMPLETED|First Intervention||3||
59974851|NCT01669928|76092451|FG001|NOT COMPLETED|First Intervention||5||
59974852|NCT01669928|76092450|FG000|STARTED|Second Intervention||48||
59974853|NCT01669928|76092451|FG001|STARTED|Second Intervention||47||
59974854|NCT01669928|76092450|FG000|COMPLETED|Second Intervention||48||
59974855|NCT01669928|76092451|FG001|COMPLETED|Second Intervention||47||
59974856|NCT01669928|76092450|FG000|NOT COMPLETED|Second Intervention||0||
59974857|NCT01669928|76092451|FG001|NOT COMPLETED|Second Intervention||0||
59974858|NCT01355081|76092462|FG000|STARTED|Overall Study||119||
59974859|NCT01355081|76092463|FG001|STARTED|Overall Study||123||
59974860|NCT01355081|76092464|FG002|STARTED|Overall Study||124||
59974861|NCT01355081|76092462|FG000|COMPLETED|Overall Study||112||
59974862|NCT01355081|76092463|FG001|COMPLETED|Overall Study||113||
59974863|NCT01355081|76092464|FG002|COMPLETED|Overall Study||113||
59974864|NCT01355081|76092462|FG000|NOT COMPLETED|Overall Study||7||
59974865|NCT01355081|76092463|FG001|NOT COMPLETED|Overall Study||10||
59974866|NCT01355081|76092464|FG002|NOT COMPLETED|Overall Study||11||
59812963|NCT00642941|75935382|FG005|COMPLETED|Overall Study||0||
59812964|NCT00642941|75935383|FG006|COMPLETED|Overall Study||0||
59812965|NCT00642941|75935384|FG007|COMPLETED|Overall Study||0||
59812966|NCT00642941|75935385|FG008|COMPLETED|Overall Study||0||
59974867|NCT01354223|76092474|FG000|STARTED|Overall Study||60||
59812967|NCT00642941|75935386|FG009|COMPLETED|Overall Study||0||
59812968|NCT00642941|75935387|FG010|COMPLETED|Overall Study||0||
59812969|NCT00642941|75935388|FG011|COMPLETED|Overall Study||0||
59812970|NCT00642941|75935377|FG000|NOT COMPLETED|Overall Study||70||
59812971|NCT00642941|75935378|FG001|NOT COMPLETED|Overall Study||54||
59812972|NCT00642941|75935379|FG002|NOT COMPLETED|Overall Study||7||
59812973|NCT00642941|75935380|FG003|NOT COMPLETED|Overall Study||40||
59812974|NCT00642941|75935381|FG004|NOT COMPLETED|Overall Study||25||
59812975|NCT00642941|75935382|FG005|NOT COMPLETED|Overall Study||41||
59812976|NCT00642941|75935383|FG006|NOT COMPLETED|Overall Study||23||
59812977|NCT00642941|75935384|FG007|NOT COMPLETED|Overall Study||14||
59812978|NCT00642941|75935385|FG008|NOT COMPLETED|Overall Study||11||
59812979|NCT00642941|75935386|FG009|NOT COMPLETED|Overall Study||9||
59812980|NCT00642941|75935387|FG010|NOT COMPLETED|Overall Study||12||
59812981|NCT00642941|75935388|FG011|NOT COMPLETED|Overall Study||11||
59812982|NCT00531960|75935437|FG000|STARTED|Overall Study||61||
59812983|NCT00531960|75935438|FG001|STARTED|Overall Study||63||
59812984|NCT00531960|75935437|FG000|COMPLETED|Overall Study||0||
59812985|NCT00531960|75935438|FG001|COMPLETED|Overall Study||0||
59812986|NCT00531960|75935437|FG000|NOT COMPLETED|Overall Study||61||
59812987|NCT00531960|75935438|FG001|NOT COMPLETED|Overall Study||63||
59812988|NCT00361504|75935446|FG000|STARTED|Overall Study|Number of participants who received at least 1 dose of study medication|894||
59812989|NCT00361504|75935447|FG001|STARTED|Overall Study|Number of participants who received at least 1 dose of study medication|223||
59812990|NCT00361504|75935446|FG000|COMPLETED|Overall Study||413||
59812991|NCT00361504|75935447|FG001|COMPLETED|Overall Study||78||
59812992|NCT00361504|75935446|FG000|NOT COMPLETED|Overall Study||481||
59812993|NCT00361504|75935447|FG001|NOT COMPLETED|Overall Study||145||
59812994|NCT00361270|75935457|FG000|STARTED|Overall Study||49||
59812995|NCT00361270|75935458|FG001|STARTED|Overall Study||39||
59812996|NCT00361270|75935459|FG002|STARTED|Overall Study||35||
59812997|NCT00361270|75935460|FG003|STARTED|Overall Study||38||
59812998|NCT00361270|75935457|FG000|COMPLETED|Overall Study||25||
59812999|NCT00361270|75935458|FG001|COMPLETED|Overall Study||25||
59813000|NCT00361270|75935459|FG002|COMPLETED|Overall Study||25||
59813001|NCT00361270|75935460|FG003|COMPLETED|Overall Study||25||
59813002|NCT00361270|75935457|FG000|NOT COMPLETED|Overall Study||24||
59813003|NCT00361270|75935458|FG001|NOT COMPLETED|Overall Study||14||
59813004|NCT00361270|75935459|FG002|NOT COMPLETED|Overall Study||10||
59813005|NCT00361270|75935460|FG003|NOT COMPLETED|Overall Study||13||
59813006|NCT00367744|75935479|FG000|STARTED|Overall Study||34||
59813007|NCT00367744|75935480|FG001|STARTED|Overall Study||37||
59813008|NCT00367744|75935479|FG000|COMPLETED|Overall Study||30||
59813009|NCT00367744|75935480|FG001|COMPLETED|Overall Study||32||
59813010|NCT00367744|75935479|FG000|NOT COMPLETED|Overall Study||4||
59813011|NCT00367744|75935480|FG001|NOT COMPLETED|Overall Study||5||
59813012|NCT03883386|75935489|FG000|STARTED|First Assignment||2||
59813013|NCT03883386|75935490|FG001|STARTED|First Assignment||1||
59813014|NCT03883386|75935489|FG000|Surveys Begun|First Assignment||1||
59974868|NCT01354223|76092475|FG001|STARTED|Overall Study||30||
59974869|NCT01354223|76092474|FG000|COMPLETED|Overall Study||57||
59974870|NCT01354223|76092475|FG001|COMPLETED|Overall Study||29||
59974871|NCT01354223|76092474|FG000|NOT COMPLETED|Overall Study||3||
59813015|NCT03883386|75935490|FG001|Surveys Begun|First Assignment||1||
59813016|NCT03883386|75935489|FG000|COMPLETED|First Assignment||0||
59813017|NCT03883386|75935490|FG001|COMPLETED|First Assignment||0||
59813018|NCT03883386|75935489|FG000|NOT COMPLETED|First Assignment||2||
59813019|NCT03883386|75935490|FG001|NOT COMPLETED|First Assignment||1||
59813020|NCT03883386|75935489|FG000|STARTED|Washout and Second Assignment||0||
59813021|NCT03883386|75935490|FG001|STARTED|Washout and Second Assignment||0||
59813022|NCT03883386|75935489|FG000|COMPLETED|Washout and Second Assignment||0||
59813023|NCT03883386|75935490|FG001|COMPLETED|Washout and Second Assignment||0||
59813024|NCT03883386|75935489|FG000|NOT COMPLETED|Washout and Second Assignment||0||
59813025|NCT03883386|75935490|FG001|NOT COMPLETED|Washout and Second Assignment||0||
59813026|NCT00530946|75935500|FG000|STARTED|Overall Study||43||
59813027|NCT00530946|75935501|FG001|STARTED|Overall Study||41||
59813028|NCT00530946|75935502|FG002|STARTED|Overall Study||41||
59813029|NCT00530946|75935503|FG003|STARTED|Overall Study||40||
59813030|NCT00530946|75935500|FG000|COMPLETED|Overall Study||41||
59974872|NCT01354223|76092475|FG001|NOT COMPLETED|Overall Study||1||
59974873|NCT04043455|76092485|FG000|STARTED|Main Study Double-Blind Treatment Period||67||
59974874|NCT04043455|76092486|FG001|STARTED|Main Study Double-Blind Treatment Period||67||
59974875|NCT04043455|76092487|FG002|STARTED|Main Study Double-Blind Treatment Period||69||
59974876|NCT04043455|76092488|FG003|STARTED|Main Study Double-Blind Treatment Period||70||
59813031|NCT00530946|75935501|FG001|COMPLETED|Overall Study||39||
59813032|NCT00530946|75935502|FG002|COMPLETED|Overall Study||40||
59813033|NCT00530946|75935503|FG003|COMPLETED|Overall Study||38||
59813034|NCT00530946|75935500|FG000|NOT COMPLETED|Overall Study||2||
59813035|NCT00530946|75935501|FG001|NOT COMPLETED|Overall Study||2||
59974877|NCT04043455|76092489|FG004|STARTED|Main Study Double-Blind Treatment Period||0||
59974878|NCT04043455|76092490|FG005|STARTED|Main Study Double-Blind Treatment Period||0||
59974879|NCT04043455|76092485|FG000|Received Treatment|Main Study Double-Blind Treatment Period||67||
59974880|NCT04043455|76092486|FG001|Received Treatment|Main Study Double-Blind Treatment Period||66||
59974881|NCT04043455|76092487|FG002|Received Treatment|Main Study Double-Blind Treatment Period||69||
59974882|NCT04043455|76092488|FG003|Received Treatment|Main Study Double-Blind Treatment Period||70||
59974883|NCT04043455|76092489|FG004|Received Treatment|Main Study Double-Blind Treatment Period||0||
59974884|NCT04043455|76092490|FG005|Received Treatment|Main Study Double-Blind Treatment Period||0||
59974885|NCT04043455|76092485|FG000|COMPLETED|Main Study Double-Blind Treatment Period||59||
59974886|NCT04043455|76092486|FG001|COMPLETED|Main Study Double-Blind Treatment Period||53||
59974887|NCT04043455|76092487|FG002|COMPLETED|Main Study Double-Blind Treatment Period||61||
59974888|NCT04043455|76092488|FG003|COMPLETED|Main Study Double-Blind Treatment Period||58||
59974889|NCT04043455|76092489|FG004|COMPLETED|Main Study Double-Blind Treatment Period||0||
59974890|NCT04043455|76092490|FG005|COMPLETED|Main Study Double-Blind Treatment Period||0||
59974891|NCT04043455|76092485|FG000|NOT COMPLETED|Main Study Double-Blind Treatment Period||8||
59974892|NCT04043455|76092486|FG001|NOT COMPLETED|Main Study Double-Blind Treatment Period||14||
59974893|NCT04043455|76092487|FG002|NOT COMPLETED|Main Study Double-Blind Treatment Period||8||
59974894|NCT04043455|76092488|FG003|NOT COMPLETED|Main Study Double-Blind Treatment Period||12||
59974895|NCT04043455|76092489|FG004|NOT COMPLETED|Main Study Double-Blind Treatment Period||0||
59974896|NCT04043455|76092490|FG005|NOT COMPLETED|Main Study Double-Blind Treatment Period||0||
59974897|NCT04043455|76092485|FG000|STARTED|Double-Blind LTE Treatment Period||0||
59974898|NCT04043455|76092486|FG001|STARTED|Double-Blind LTE Treatment Period||0||
59974899|NCT04043455|76092487|FG002|STARTED|Double-Blind LTE Treatment Period||0||
59974900|NCT04043455|76092488|FG003|STARTED|Double-Blind LTE Treatment Period||0||
59974901|NCT04043455|76092489|FG004|STARTED|Double-Blind LTE Treatment Period||53||
59974902|NCT04043455|76092490|FG005|STARTED|Double-Blind LTE Treatment Period||52||
59974903|NCT04043455|76092485|FG000|Received Treatment|Double-Blind LTE Treatment Period||0||
59974904|NCT04043455|76092486|FG001|Received Treatment|Double-Blind LTE Treatment Period||0||
59974905|NCT04043455|76092487|FG002|Received Treatment|Double-Blind LTE Treatment Period||0||
59974906|NCT04043455|76092488|FG003|Received Treatment|Double-Blind LTE Treatment Period||0||
59974907|NCT04043455|76092489|FG004|Received Treatment|Double-Blind LTE Treatment Period||53||
59974908|NCT04043455|76092490|FG005|Received Treatment|Double-Blind LTE Treatment Period||51||
59974909|NCT04043455|76092485|FG000|COMPLETED|Double-Blind LTE Treatment Period||0||
59974910|NCT04043455|76092486|FG001|COMPLETED|Double-Blind LTE Treatment Period||0||
59974911|NCT04043455|76092487|FG002|COMPLETED|Double-Blind LTE Treatment Period||0||
59974912|NCT04043455|76092488|FG003|COMPLETED|Double-Blind LTE Treatment Period||0||
59974913|NCT04043455|76092489|FG004|COMPLETED|Double-Blind LTE Treatment Period||0||
59974914|NCT04043455|76092490|FG005|COMPLETED|Double-Blind LTE Treatment Period||0||
59974915|NCT04043455|76092485|FG000|NOT COMPLETED|Double-Blind LTE Treatment Period||0||
59974916|NCT04043455|76092486|FG001|NOT COMPLETED|Double-Blind LTE Treatment Period||0||
59974917|NCT04043455|76092487|FG002|NOT COMPLETED|Double-Blind LTE Treatment Period||0||
59974918|NCT04043455|76092488|FG003|NOT COMPLETED|Double-Blind LTE Treatment Period||0||
59974919|NCT04043455|76092489|FG004|NOT COMPLETED|Double-Blind LTE Treatment Period||53||
59974920|NCT04043455|76092490|FG005|NOT COMPLETED|Double-Blind LTE Treatment Period||52||
59974921|NCT02627144|76092508|FG000|STARTED|Overall Study||365||
59974922|NCT02627144|76092508|FG000|Treated|Overall Study||359||
59974923|NCT02627144|76092508|FG000|COMPLETED|Overall Study||0||
59974924|NCT02627144|76092508|FG000|NOT COMPLETED|Overall Study||365||
59974925|NCT02626520|76092514|FG000|STARTED|Overall Study||1||
59974926|NCT02626520|76092515|FG001|STARTED|Overall Study||10||
59974927|NCT02626520|76092514|FG000|COMPLETED|Overall Study||0||
59974928|NCT02626520|76092515|FG001|COMPLETED|Overall Study||0||
59974929|NCT02626520|76092514|FG000|NOT COMPLETED|Overall Study||1||
59974930|NCT02626520|76092515|FG001|NOT COMPLETED|Overall Study||10||
59974931|NCT04522141|76092523|FG000|STARTED|Overall Study||42||
59974932|NCT04522141|76092524|FG001|STARTED|Overall Study||39||
59974933|NCT04522141|76092523|FG000|COMPLETED|Overall Study||41||
59974934|NCT04522141|76092524|FG001|COMPLETED|Overall Study||39||
59974935|NCT04522141|76092523|FG000|NOT COMPLETED|Overall Study||1||
59974936|NCT04522141|76092524|FG001|NOT COMPLETED|Overall Study||0||
59974937|NCT03359161|76092530|FG000|STARTED|Overall Study||9||
59974938|NCT03359161|76092530|FG000|Pilot Phase|Overall Study||9|Pilot Phase|
60074560|NCT01807520|76189932|FG000|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||67||
59974939|NCT03359161|76092530|FG000|COMPLETED|Overall Study|Prematurely terminated after 9 patients.|9||
59974940|NCT03359161|76092530|FG000|NOT COMPLETED|Overall Study||0||
60074561|NCT01807520|76189933|FG001|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||66||
59974941|NCT03232801|76092536|FG000|STARTED|Overall Study||31||
59974942|NCT03232801|76092537|FG001|STARTED|Overall Study||30||
59974943|NCT03232801|76092536|FG000|Completed Baseline Survey|Overall Study||28||
59974944|NCT03232801|76092537|FG001|Completed Baseline Survey|Overall Study||27||
60074562|NCT01807520|76189934|FG002|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||0||
59974945|NCT03232801|76092536|FG000|Attended at Least One Session|Overall Study||18||
59974946|NCT03232801|76092537|FG001|Attended at Least One Session|Overall Study||23||
59974947|NCT03232801|76092536|FG000|Completed Week 7 Follow-up|Overall Study||15||
59974948|NCT03232801|76092537|FG001|Completed Week 7 Follow-up|Overall Study||22||
59974949|NCT03232801|76092536|FG000|Completed Week 12 Follow-up|Overall Study||15||
59974950|NCT03232801|76092537|FG001|Completed Week 12 Follow-up|Overall Study||18||
59974951|NCT03232801|76092536|FG000|COMPLETED|Overall Study||15||
59974952|NCT03232801|76092537|FG001|COMPLETED|Overall Study||18||
59974953|NCT03232801|76092536|FG000|NOT COMPLETED|Overall Study||16||
59974954|NCT03232801|76092537|FG001|NOT COMPLETED|Overall Study||12||
59974955|NCT01329029|76092547|FG000|STARTED|Overall Study||973||
59974956|NCT01329029|76092548|FG001|STARTED|Overall Study||972||
59974957|NCT01329029|76092547|FG000|Full Analysis Set (FAS)|Overall Study||969||
59974958|NCT01329029|76092548|FG001|Full Analysis Set (FAS)|Overall Study||966||
59974959|NCT01329029|76092547|FG000|Safety Population|Overall Study||968||
59974960|NCT01329029|76092548|FG001|Safety Population|Overall Study||967||
59974961|NCT01329029|76092547|FG000|COMPLETED|Overall Study||704||
59974962|NCT01329029|76092548|FG001|COMPLETED|Overall Study||780||
59974963|NCT01329029|76092547|FG000|NOT COMPLETED|Overall Study||269||
59974964|NCT01329029|76092548|FG001|NOT COMPLETED|Overall Study||192||
59974965|NCT01372085|76092564|FG000|STARTED|First Intervention (Period 1)||8||
59974966|NCT01372085|76092565|FG001|STARTED|First Intervention (Period 1)||2||
59974967|NCT01372085|76092566|FG002|STARTED|First Intervention (Period 1)||2||
59974968|NCT01372085|76092567|FG003|STARTED|First Intervention (Period 1)||1||
59974969|NCT01372085|76092568|FG004|STARTED|First Intervention (Period 1)|Replacement participant repeated Periods 1, 2 to fulfill treatment arm comparison requirements.|3||
59974970|NCT01372085|76092569|FG005|STARTED|First Intervention (Period 1)||5||
59974971|NCT01372085|76092570|FG006|STARTED|First Intervention (Period 1)||3||
59974972|NCT01372085|76092571|FG007|STARTED|First Intervention (Period 1)||1||
59974973|NCT01372085|76092572|FG008|STARTED|First Intervention (Period 1)||1||
59974974|NCT01372085|76092573|FG009|STARTED|First Intervention (Period 1)||0||
59974975|NCT01372085|76092564|FG000|COMPLETED|First Intervention (Period 1)||8||
59974976|NCT01372085|76092565|FG001|COMPLETED|First Intervention (Period 1)||2||
59974977|NCT01372085|76092566|FG002|COMPLETED|First Intervention (Period 1)||2||
59974978|NCT01372085|76092567|FG003|COMPLETED|First Intervention (Period 1)||1||
59974979|NCT01372085|76092568|FG004|COMPLETED|First Intervention (Period 1)||3||
59974980|NCT01372085|76092569|FG005|COMPLETED|First Intervention (Period 1)||5||
59974981|NCT01372085|76092570|FG006|COMPLETED|First Intervention (Period 1)||3||
59974982|NCT01372085|76092571|FG007|COMPLETED|First Intervention (Period 1)||1||
59813036|NCT00530946|75935502|FG002|NOT COMPLETED|Overall Study||1||
59813037|NCT00530946|75935503|FG003|NOT COMPLETED|Overall Study||2||
59813038|NCT00424047|75935515|FG000|STARTED|Blinded Treatment (Up to 03 Aug 2005)||176||
59813039|NCT00424047|75935516|FG001|STARTED|Blinded Treatment (Up to 03 Aug 2005)||175||
59813040|NCT00424047|75935515|FG000|Safety Population|Blinded Treatment (Up to 03 Aug 2005)|Includes those who took at least one dose of study medication regimen|176||
59813041|NCT00424047|75935516|FG001|Safety Population|Blinded Treatment (Up to 03 Aug 2005)|Includes those who took at least one dose of study medication regimen|175||
59813042|NCT00424047|75935515|FG000|Evaluable Population|Blinded Treatment (Up to 03 Aug 2005)|1 participant excluded because they had no baseline M-protein assessment|175||
59813043|NCT00424047|75935516|FG001|Evaluable Population|Blinded Treatment (Up to 03 Aug 2005)|4 participants excluded because they had no baseline M-protein assessment|171||
59813044|NCT00424047|75935515|FG000|COMPLETED|Blinded Treatment (Up to 03 Aug 2005)|54 participants ongoing and continuing on lenalidomide/dexamethasone treatment|54||
59813045|NCT00424047|75935516|FG001|COMPLETED|Blinded Treatment (Up to 03 Aug 2005)|Ongoing and includes 15 participants who crossed over to lenalidomide/dexamethasone after unblinding|19||
59813046|NCT00424047|75935515|FG000|NOT COMPLETED|Blinded Treatment (Up to 03 Aug 2005)||122||
59813047|NCT00424047|75935516|FG001|NOT COMPLETED|Blinded Treatment (Up to 03 Aug 2005)||156||
59813048|NCT00424047|75935515|FG000|STARTED|On Study at Time of Unblinding|Refers to original treatment group assignment in the study.|176||
59813049|NCT00424047|75935516|FG001|STARTED|On Study at Time of Unblinding||175||
59813050|NCT00424047|75935515|FG000|COMPLETED|On Study at Time of Unblinding|Participants completed = those continuing on long term Lenalidomide and dexamethasone|21||
59813051|NCT00424047|75935516|FG001|COMPLETED|On Study at Time of Unblinding|Participants completed = those continuing on long term dexamethasone|8||
59813052|NCT00424047|75935515|FG000|NOT COMPLETED|On Study at Time of Unblinding||155||
59813053|NCT00424047|75935516|FG001|NOT COMPLETED|On Study at Time of Unblinding||167||
59813054|NCT00424047|75935515|FG000|STARTED|Long Term Extension (Up to 25 Jun 2013)||21||
59813055|NCT00424047|75935516|FG001|STARTED|Long Term Extension (Up to 25 Jun 2013)|2 participants opted to receive dex alone, 3 crossed over to Len/Dex and 3 added Len at a later date|8||
59813056|NCT00424047|75935515|FG000|COMPLETED|Long Term Extension (Up to 25 Jun 2013)||0||
59813057|NCT00424047|75935516|FG001|COMPLETED|Long Term Extension (Up to 25 Jun 2013)||0||
59974983|NCT01372085|76092572|FG008|COMPLETED|First Intervention (Period 1)||1||
59974984|NCT01372085|76092573|FG009|COMPLETED|First Intervention (Period 1)||0||
59974985|NCT01372085|76092564|FG000|NOT COMPLETED|First Intervention (Period 1)||0||
59974986|NCT01372085|76092565|FG001|NOT COMPLETED|First Intervention (Period 1)||0||
59974987|NCT01372085|76092566|FG002|NOT COMPLETED|First Intervention (Period 1)||0||
59974988|NCT01372085|76092567|FG003|NOT COMPLETED|First Intervention (Period 1)||0||
59974989|NCT01372085|76092568|FG004|NOT COMPLETED|First Intervention (Period 1)||0||
59974990|NCT01372085|76092569|FG005|NOT COMPLETED|First Intervention (Period 1)||0||
59974991|NCT01372085|76092570|FG006|NOT COMPLETED|First Intervention (Period 1)||0||
59974992|NCT01372085|76092571|FG007|NOT COMPLETED|First Intervention (Period 1)||0||
59974993|NCT01372085|76092572|FG008|NOT COMPLETED|First Intervention (Period 1)||0||
59974994|NCT01372085|76092573|FG009|NOT COMPLETED|First Intervention (Period 1)||0||
59974995|NCT01372085|76092564|FG000|STARTED|Washout Period 1|Pts completed one period and did not enter washout for Part A.|0||
59974996|NCT01372085|76092565|FG001|STARTED|Washout Period 1|Pts completed one period and did not enter washout for Part A.|0||
59974997|NCT01372085|76092566|FG002|STARTED|Washout Period 1||2||
59974998|NCT01372085|76092567|FG003|STARTED|Washout Period 1||1||
59974999|NCT01372085|76092568|FG004|STARTED|Washout Period 1||3||
59975000|NCT01372085|76092569|FG005|STARTED|Washout Period 1||5||
59975001|NCT01372085|76092570|FG006|STARTED|Washout Period 1||3||
59975002|NCT01372085|76092571|FG007|STARTED|Washout Period 1||1||
59975003|NCT01372085|76092572|FG008|STARTED|Washout Period 1||1||
59975004|NCT01372085|76092573|FG009|STARTED|Washout Period 1||0||
59975005|NCT01372085|76092564|FG000|COMPLETED|Washout Period 1||0||
59975006|NCT01372085|76092565|FG001|COMPLETED|Washout Period 1||0||
59975007|NCT01372085|76092566|FG002|COMPLETED|Washout Period 1||2||
59975008|NCT01372085|76092567|FG003|COMPLETED|Washout Period 1||1||
59975009|NCT01372085|76092568|FG004|COMPLETED|Washout Period 1||3||
59975010|NCT01372085|76092569|FG005|COMPLETED|Washout Period 1||5||
59975011|NCT01372085|76092570|FG006|COMPLETED|Washout Period 1||3||
59975012|NCT01372085|76092571|FG007|COMPLETED|Washout Period 1||1||
59975013|NCT01372085|76092572|FG008|COMPLETED|Washout Period 1||1||
59975014|NCT01372085|76092573|FG009|COMPLETED|Washout Period 1||0||
59975015|NCT01372085|76092564|FG000|NOT COMPLETED|Washout Period 1||0||
59975016|NCT01372085|76092565|FG001|NOT COMPLETED|Washout Period 1||0||
59975017|NCT01372085|76092566|FG002|NOT COMPLETED|Washout Period 1||0||
59975018|NCT01372085|76092567|FG003|NOT COMPLETED|Washout Period 1||0||
59975019|NCT01372085|76092568|FG004|NOT COMPLETED|Washout Period 1||0||
59975020|NCT01372085|76092569|FG005|NOT COMPLETED|Washout Period 1||0||
59975021|NCT01372085|76092570|FG006|NOT COMPLETED|Washout Period 1||0||
59975022|NCT01372085|76092571|FG007|NOT COMPLETED|Washout Period 1||0||
59975023|NCT01372085|76092572|FG008|NOT COMPLETED|Washout Period 1||0||
59975024|NCT01372085|76092573|FG009|NOT COMPLETED|Washout Period 1||0||
59975025|NCT01372085|76092564|FG000|STARTED|Second Intervention (Period 2)||0||
59975026|NCT01372085|76092565|FG001|STARTED|Second Intervention (Period 2)||0||
59975027|NCT01372085|76092566|FG002|STARTED|Second Intervention (Period 2)||2||
59975028|NCT01372085|76092567|FG003|STARTED|Second Intervention (Period 2)||1||
59975029|NCT01372085|76092568|FG004|STARTED|Second Intervention (Period 2)||3||
59975030|NCT01372085|76092569|FG005|STARTED|Second Intervention (Period 2)||5||
59975031|NCT01372085|76092570|FG006|STARTED|Second Intervention (Period 2)||3||
59975032|NCT01372085|76092571|FG007|STARTED|Second Intervention (Period 2)||1||
59975033|NCT01372085|76092572|FG008|STARTED|Second Intervention (Period 2)||1||
59975034|NCT01372085|76092573|FG009|STARTED|Second Intervention (Period 2)||0||
59975035|NCT01372085|76092564|FG000|COMPLETED|Second Intervention (Period 2)||0||
59975036|NCT01372085|76092565|FG001|COMPLETED|Second Intervention (Period 2)||0||
59975037|NCT01372085|76092566|FG002|COMPLETED|Second Intervention (Period 2)||2||
59975038|NCT01372085|76092567|FG003|COMPLETED|Second Intervention (Period 2)||1||
59975039|NCT01372085|76092568|FG004|COMPLETED|Second Intervention (Period 2)||3||
59975040|NCT01372085|76092569|FG005|COMPLETED|Second Intervention (Period 2)||5||
59975041|NCT01372085|76092570|FG006|COMPLETED|Second Intervention (Period 2)||3||
59975042|NCT01372085|76092571|FG007|COMPLETED|Second Intervention (Period 2)||1||
59975043|NCT01372085|76092572|FG008|COMPLETED|Second Intervention (Period 2)||1||
60074563|NCT01807520|76189935|FG003|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||29||
60074564|NCT01807520|76189936|FG004|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||29||
59975044|NCT01372085|76092573|FG009|COMPLETED|Second Intervention (Period 2)||0||
59975045|NCT01372085|76092564|FG000|NOT COMPLETED|Second Intervention (Period 2)||0||
59975046|NCT01372085|76092565|FG001|NOT COMPLETED|Second Intervention (Period 2)||0||
59975047|NCT01372085|76092566|FG002|NOT COMPLETED|Second Intervention (Period 2)||0||
59975048|NCT01372085|76092567|FG003|NOT COMPLETED|Second Intervention (Period 2)||0||
59975049|NCT01372085|76092568|FG004|NOT COMPLETED|Second Intervention (Period 2)||0||
59975050|NCT01372085|76092569|FG005|NOT COMPLETED|Second Intervention (Period 2)||0||
59975051|NCT01372085|76092570|FG006|NOT COMPLETED|Second Intervention (Period 2)||0||
59975052|NCT01372085|76092571|FG007|NOT COMPLETED|Second Intervention (Period 2)||0||
59975053|NCT01372085|76092572|FG008|NOT COMPLETED|Second Intervention (Period 2)||0||
59975054|NCT01372085|76092573|FG009|NOT COMPLETED|Second Intervention (Period 2)||0||
59975055|NCT01372085|76092564|FG000|STARTED|Washout Period 2||0||
59975056|NCT01372085|76092565|FG001|STARTED|Washout Period 2||0||
59975057|NCT01372085|76092566|FG002|STARTED|Washout Period 2||2||
59975058|NCT01372085|76092567|FG003|STARTED|Washout Period 2||1||
59975059|NCT01372085|76092568|FG004|STARTED|Washout Period 2||3||
59975060|NCT01372085|76092569|FG005|STARTED|Washout Period 2||5||
59975061|NCT01372085|76092570|FG006|STARTED|Washout Period 2||3||
59975062|NCT01372085|76092571|FG007|STARTED|Washout Period 2||1||
59975063|NCT01372085|76092572|FG008|STARTED|Washout Period 2||1||
59975064|NCT01372085|76092573|FG009|STARTED|Washout Period 2||0||
59975065|NCT01372085|76092564|FG000|COMPLETED|Washout Period 2||0||
59975066|NCT01372085|76092565|FG001|COMPLETED|Washout Period 2||0||
59975067|NCT01372085|76092566|FG002|COMPLETED|Washout Period 2||2||
59975068|NCT01372085|76092567|FG003|COMPLETED|Washout Period 2||1||
59975069|NCT01372085|76092568|FG004|COMPLETED|Washout Period 2|One participant discontinued Washout Period 2 and was replaced in Period 1.|2||
59975070|NCT01372085|76092569|FG005|COMPLETED|Washout Period 2||5||
59975071|NCT01372085|76092570|FG006|COMPLETED|Washout Period 2||3||
59975072|NCT01372085|76092571|FG007|COMPLETED|Washout Period 2||1||
59975073|NCT01372085|76092572|FG008|COMPLETED|Washout Period 2||1||
59975074|NCT01372085|76092573|FG009|COMPLETED|Washout Period 2||0||
59975075|NCT01372085|76092564|FG000|NOT COMPLETED|Washout Period 2||0||
59975076|NCT01372085|76092565|FG001|NOT COMPLETED|Washout Period 2||0||
59975077|NCT01372085|76092566|FG002|NOT COMPLETED|Washout Period 2||0||
59975078|NCT01372085|76092567|FG003|NOT COMPLETED|Washout Period 2||0||
59975079|NCT01372085|76092568|FG004|NOT COMPLETED|Washout Period 2||1||
59975080|NCT01372085|76092569|FG005|NOT COMPLETED|Washout Period 2||0||
59975081|NCT01372085|76092570|FG006|NOT COMPLETED|Washout Period 2||0||
59975082|NCT01372085|76092571|FG007|NOT COMPLETED|Washout Period 2||0||
59975083|NCT01372085|76092572|FG008|NOT COMPLETED|Washout Period 2||0||
59975084|NCT01372085|76092573|FG009|NOT COMPLETED|Washout Period 2||0||
59975085|NCT01372085|76092564|FG000|STARTED|Third Intervention (Period 3)||0||
59975086|NCT01372085|76092565|FG001|STARTED|Third Intervention (Period 3)||0||
59975087|NCT01372085|76092566|FG002|STARTED|Third Intervention (Period 3)||2||
59975088|NCT01372085|76092567|FG003|STARTED|Third Intervention (Period 3)||1||
59813058|NCT00424047|75935515|FG000|NOT COMPLETED|Long Term Extension (Up to 25 Jun 2013)||21||
59813059|NCT00424047|75935516|FG001|NOT COMPLETED|Long Term Extension (Up to 25 Jun 2013)||8||
59813060|NCT00530790|75935527|FG000|STARTED|Overall Study||35||
59813061|NCT00530790|75935527|FG000|COMPLETED|Overall Study||30||
59813062|NCT00530790|75935527|FG000|NOT COMPLETED|Overall Study||5||
59813063|NCT00530088|75935531|FG000|STARTED|Overall Study||30||
59975089|NCT01372085|76092568|FG004|STARTED|Third Intervention (Period 3)||2||
59975090|NCT01372085|76092569|FG005|STARTED|Third Intervention (Period 3)|Replacement pts repeated Period (P) 3 to fulfill requirement for P3 versus P4a comparison.|7||
59975091|NCT01372085|76092570|FG006|STARTED|Third Intervention (Period 3)||3||
59975092|NCT01372085|76092571|FG007|STARTED|Third Intervention (Period 3)||1||
59975093|NCT01372085|76092572|FG008|STARTED|Third Intervention (Period 3)||1||
59975094|NCT01372085|76092573|FG009|STARTED|Third Intervention (Period 3)||0||
59975095|NCT01372085|76092564|FG000|COMPLETED|Third Intervention (Period 3)||0||
59975096|NCT01372085|76092565|FG001|COMPLETED|Third Intervention (Period 3)||0||
59975097|NCT01372085|76092566|FG002|COMPLETED|Third Intervention (Period 3)||2||
59975098|NCT01372085|76092567|FG003|COMPLETED|Third Intervention (Period 3)||1||
59975099|NCT01372085|76092568|FG004|COMPLETED|Third Intervention (Period 3)||2||
59975100|NCT01372085|76092569|FG005|COMPLETED|Third Intervention (Period 3)||7||
59975101|NCT01372085|76092570|FG006|COMPLETED|Third Intervention (Period 3)||3||
59975102|NCT01372085|76092571|FG007|COMPLETED|Third Intervention (Period 3)||1||
59975103|NCT01372085|76092572|FG008|COMPLETED|Third Intervention (Period 3)||1||
59975104|NCT01372085|76092573|FG009|COMPLETED|Third Intervention (Period 3)||0||
59975105|NCT01372085|76092564|FG000|NOT COMPLETED|Third Intervention (Period 3)||0||
59975106|NCT01372085|76092565|FG001|NOT COMPLETED|Third Intervention (Period 3)||0||
59975107|NCT01372085|76092566|FG002|NOT COMPLETED|Third Intervention (Period 3)||0||
59975108|NCT01372085|76092567|FG003|NOT COMPLETED|Third Intervention (Period 3)||0||
59975109|NCT01372085|76092568|FG004|NOT COMPLETED|Third Intervention (Period 3)||0||
59975110|NCT01372085|76092569|FG005|NOT COMPLETED|Third Intervention (Period 3)||0||
59975111|NCT01372085|76092570|FG006|NOT COMPLETED|Third Intervention (Period 3)||0||
59975112|NCT01372085|76092571|FG007|NOT COMPLETED|Third Intervention (Period 3)||0||
59975113|NCT01372085|76092572|FG008|NOT COMPLETED|Third Intervention (Period 3)||0||
59975114|NCT01372085|76092573|FG009|NOT COMPLETED|Third Intervention (Period 3)||0||
59975115|NCT01372085|76092564|FG000|STARTED|Washout Period 3||0||
59975116|NCT01372085|76092565|FG001|STARTED|Washout Period 3||0||
59975117|NCT01372085|76092566|FG002|STARTED|Washout Period 3||2||
59813064|NCT00530088|75935531|FG000|COMPLETED|Overall Study||20||
59813065|NCT00530088|75935531|FG000|NOT COMPLETED|Overall Study||10||
59813066|NCT00360568|75935537|FG000|STARTED|Overall Study||33||
59813067|NCT00360568|75935538|FG001|STARTED|Overall Study||29||
59813068|NCT00360568|75935537|FG000|COMPLETED|Overall Study||31||
59813069|NCT00360568|75935538|FG001|COMPLETED|Overall Study||24||
59813070|NCT00360568|75935537|FG000|NOT COMPLETED|Overall Study||2||
59813071|NCT00360568|75935538|FG001|NOT COMPLETED|Overall Study||5||
59975118|NCT01372085|76092567|FG003|STARTED|Washout Period 3||1||
59975119|NCT01372085|76092568|FG004|STARTED|Washout Period 3||2||
59975120|NCT01372085|76092569|FG005|STARTED|Washout Period 3||7||
59975121|NCT01372085|76092570|FG006|STARTED|Washout Period 3||3||
59975122|NCT01372085|76092571|FG007|STARTED|Washout Period 3||1||
59813072|NCT00436215|75935546|FG000|STARTED|Overall Study||55||
59813073|NCT00436215|75935546|FG000|COMPLETED|Overall Study||51||
59813074|NCT00436215|75935546|FG000|NOT COMPLETED|Overall Study||4||
59813075|NCT00441363|75935552|FG000|STARTED|Overall Study||32||
59975123|NCT01372085|76092572|FG008|STARTED|Washout Period 3||1||
59975124|NCT01372085|76092573|FG009|STARTED|Washout Period 3||0||
59975125|NCT01372085|76092564|FG000|COMPLETED|Washout Period 3||0||
59975126|NCT01372085|76092565|FG001|COMPLETED|Washout Period 3||0||
59975127|NCT01372085|76092566|FG002|COMPLETED|Washout Period 3||2||
59975128|NCT01372085|76092567|FG003|COMPLETED|Washout Period 3||1||
59975129|NCT01372085|76092568|FG004|COMPLETED|Washout Period 3||2||
59975130|NCT01372085|76092569|FG005|COMPLETED|Washout Period 3|Two participants (pts) discontinued Washout P3 and were replaced in P3.|5||
59975131|NCT01372085|76092570|FG006|COMPLETED|Washout Period 3||3||
59975132|NCT01372085|76092571|FG007|COMPLETED|Washout Period 3||1||
59975133|NCT01372085|76092572|FG008|COMPLETED|Washout Period 3||1||
59975134|NCT01372085|76092573|FG009|COMPLETED|Washout Period 3||0||
59975135|NCT01372085|76092564|FG000|NOT COMPLETED|Washout Period 3||0||
59975136|NCT01372085|76092565|FG001|NOT COMPLETED|Washout Period 3||0||
59975137|NCT01372085|76092566|FG002|NOT COMPLETED|Washout Period 3||0||
59975138|NCT01372085|76092567|FG003|NOT COMPLETED|Washout Period 3||0||
59975139|NCT01372085|76092568|FG004|NOT COMPLETED|Washout Period 3||0||
59975140|NCT01372085|76092569|FG005|NOT COMPLETED|Washout Period 3||2||
59975141|NCT01372085|76092570|FG006|NOT COMPLETED|Washout Period 3||0||
59975142|NCT01372085|76092571|FG007|NOT COMPLETED|Washout Period 3||0||
59975143|NCT01372085|76092572|FG008|NOT COMPLETED|Washout Period 3||0||
59975144|NCT01372085|76092573|FG009|NOT COMPLETED|Washout Period 3||0||
59975145|NCT01372085|76092564|FG000|STARTED|Forth Intervention (Period 4a/4b)||0||
59975146|NCT01372085|76092565|FG001|STARTED|Forth Intervention (Period 4a/4b)||0||
59975147|NCT01372085|76092566|FG002|STARTED|Forth Intervention (Period 4a/4b)||2||
59975148|NCT01372085|76092567|FG003|STARTED|Forth Intervention (Period 4a/4b)||1||
59975149|NCT01372085|76092568|FG004|STARTED|Forth Intervention (Period 4a/4b)||2||
59975150|NCT01372085|76092569|FG005|STARTED|Forth Intervention (Period 4a/4b)||5||
59975151|NCT01372085|76092570|FG006|STARTED|Forth Intervention (Period 4a/4b)||3||
59975152|NCT01372085|76092571|FG007|STARTED|Forth Intervention (Period 4a/4b)||1||
59975153|NCT01372085|76092572|FG008|STARTED|Forth Intervention (Period 4a/4b)||1||
59813076|NCT00441363|75935553|FG001|STARTED|Overall Study||34||
59813077|NCT00441363|75935552|FG000|COMPLETED|Overall Study|no subject withdrew early since the trial was terminated|15||
59813078|NCT00441363|75935553|FG001|COMPLETED|Overall Study||19||
59813079|NCT00441363|75935552|FG000|NOT COMPLETED|Overall Study||17||
59813080|NCT00441363|75935553|FG001|NOT COMPLETED|Overall Study||15||
59813081|NCT00530712|75935559|FG000|STARTED|Enrollment|Total Enrolled Subjects|287||
59813082|NCT00530712|75935559|FG000|COMPLETED|Enrollment|Subjects Available at Discharge|287||
59813083|NCT00530712|75935559|FG000|NOT COMPLETED|Enrollment||0||
59813084|NCT00530712|75935559|FG000|STARTED|30 Day Follow-up Visit|Subjects Expected for 30-Day Visit|287||
59813085|NCT00530712|75935559|FG000|COMPLETED|30 Day Follow-up Visit|Subjects that Completed 30-Day Follow-up Visit|280||
59813086|NCT00530712|75935559|FG000|NOT COMPLETED|30 Day Follow-up Visit||7||
59813087|NCT00530712|75935559|FG000|STARTED|6 Month Follow-up Visit|Subjects Expected for 6-Month Visit|287||
59813088|NCT00530712|75935559|FG000|COMPLETED|6 Month Follow-up Visit|Subjects that Completed 6-Month Follow-up Visit|275||
59813089|NCT00530712|75935559|FG000|NOT COMPLETED|6 Month Follow-up Visit||12||
59813090|NCT00530712|75935559|FG000|STARTED|12 Month Follow-up Visit|Subjects Expected for 12 Month Visit|287||
59813091|NCT00530712|75935559|FG000|COMPLETED|12 Month Follow-up Visit|Subjects that Completed 12-Month Follow-up Visit|263||
59813092|NCT00530712|75935559|FG000|NOT COMPLETED|12 Month Follow-up Visit||24||
59813093|NCT00626795|75935567|FG000|STARTED|Open-label TD1414 Cream TID Treatment||0||
59813094|NCT00626795|75935568|FG001|STARTED|Open-label TD1414 Cream TID Treatment||65||
59813095|NCT00626795|75935569|FG002|STARTED|Open-label TD1414 Cream TID Treatment||0||
59813096|NCT00626795|75935567|FG000|COMPLETED|Open-label TD1414 Cream TID Treatment||0||
59813097|NCT00626795|75935568|FG001|COMPLETED|Open-label TD1414 Cream TID Treatment||64||
59813098|NCT00626795|75935569|FG002|COMPLETED|Open-label TD1414 Cream TID Treatment||0||
59813099|NCT00626795|75935567|FG000|NOT COMPLETED|Open-label TD1414 Cream TID Treatment||0||
59813100|NCT00626795|75935568|FG001|NOT COMPLETED|Open-label TD1414 Cream TID Treatment||1||
59813101|NCT00626795|75935569|FG002|NOT COMPLETED|Open-label TD1414 Cream TID Treatment||0||
59975154|NCT01372085|76092573|FG009|STARTED|Forth Intervention (Period 4a/4b)|One pt was enrolled directly into P4b to fulfill requirement for safety and tolerability assessment.|1||
59975155|NCT01372085|76092564|FG000|COMPLETED|Forth Intervention (Period 4a/4b)||0||
59975156|NCT01372085|76092565|FG001|COMPLETED|Forth Intervention (Period 4a/4b)||0||
59975157|NCT01372085|76092566|FG002|COMPLETED|Forth Intervention (Period 4a/4b)||2||
59975158|NCT01372085|76092567|FG003|COMPLETED|Forth Intervention (Period 4a/4b)||1||
59813102|NCT00626795|75935567|FG000|STARTED|Blinded Treatment||204||
59813103|NCT00626795|75935568|FG001|STARTED|Blinded Treatment||205||
59813104|NCT00626795|75935569|FG002|STARTED|Blinded Treatment||205||
59813105|NCT00626795|75935567|FG000|COMPLETED|Blinded Treatment||194||
59975159|NCT01372085|76092568|FG004|COMPLETED|Forth Intervention (Period 4a/4b)||2||
59813106|NCT00626795|75935568|FG001|COMPLETED|Blinded Treatment||200||
59813107|NCT00626795|75935569|FG002|COMPLETED|Blinded Treatment||196||
59813108|NCT00626795|75935567|FG000|NOT COMPLETED|Blinded Treatment||10||
59975160|NCT01372085|76092569|FG005|COMPLETED|Forth Intervention (Period 4a/4b)||5||
59975161|NCT01372085|76092570|FG006|COMPLETED|Forth Intervention (Period 4a/4b)||3||
59975162|NCT01372085|76092571|FG007|COMPLETED|Forth Intervention (Period 4a/4b)||1||
59975163|NCT01372085|76092572|FG008|COMPLETED|Forth Intervention (Period 4a/4b)||1||
59975164|NCT01372085|76092573|FG009|COMPLETED|Forth Intervention (Period 4a/4b)||1||
59975165|NCT01372085|76092564|FG000|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0||
59975166|NCT01372085|76092565|FG001|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0||
59975167|NCT01372085|76092566|FG002|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0||
59975168|NCT01372085|76092567|FG003|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0||
59975169|NCT01372085|76092568|FG004|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0||
59975170|NCT01372085|76092569|FG005|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0||
59975171|NCT01372085|76092570|FG006|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0||
59975172|NCT01372085|76092571|FG007|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0||
59525807|NCT00016718|75621184|FG001|STARTED|Overall Study||21||
59525808|NCT00016718|75621185|FG002|STARTED|Overall Study||16||
59525809|NCT00016718|75621183|FG000|COMPLETED|Overall Study||6||
59525810|NCT00016718|75621184|FG001|COMPLETED|Overall Study||21||
59975173|NCT01372085|76092572|FG008|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0||
59975174|NCT01372085|76092573|FG009|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0||
59975175|NCT04012853|76092599|FG000|STARTED|Overall Study||13||
59975176|NCT04012853|76092600|FG001|STARTED|Overall Study||13||
59975177|NCT04012853|76092599|FG000|COMPLETED|Overall Study||10||
59975178|NCT04012853|76092600|FG001|COMPLETED|Overall Study||12||
59975179|NCT04012853|76092599|FG000|NOT COMPLETED|Overall Study||3||
59975180|NCT04012853|76092600|FG001|NOT COMPLETED|Overall Study||1||
59525811|NCT00016718|75621185|FG002|COMPLETED|Overall Study||16||
59525812|NCT00016718|75621183|FG000|NOT COMPLETED|Overall Study||0||
59525813|NCT00016718|75621184|FG001|NOT COMPLETED|Overall Study||0||
59525814|NCT00016718|75621185|FG002|NOT COMPLETED|Overall Study||0||
59525815|NCT00019682|75621195|FG000|STARTED|Overall Study||94||
59525816|NCT00019682|75621196|FG001|STARTED|Overall Study||91||
60074565|NCT01807520|76189937|FG005|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||0||
60074566|NCT01807520|76189938|FG006|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||0||
60074567|NCT01807520|76189932|FG000|COMPLETED|Treatment Period 2 (16-132 Weeks)||38||
60074568|NCT01807520|76189933|FG001|COMPLETED|Treatment Period 2 (16-132 Weeks)||47||
60074569|NCT01807520|76189934|FG002|COMPLETED|Treatment Period 2 (16-132 Weeks)||0||
60074570|NCT01807520|76189935|FG003|COMPLETED|Treatment Period 2 (16-132 Weeks)||22||
60074571|NCT01807520|76189936|FG004|COMPLETED|Treatment Period 2 (16-132 Weeks)||24||
60074572|NCT01807520|76189937|FG005|COMPLETED|Treatment Period 2 (16-132 Weeks)||0||
60074573|NCT01807520|76189938|FG006|COMPLETED|Treatment Period 2 (16-132 Weeks)||0||
60074574|NCT01807520|76189932|FG000|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||25||
60074575|NCT01807520|76189933|FG001|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||18||
60074576|NCT01807520|76189934|FG002|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||0||
60074577|NCT01807520|76189935|FG003|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||7||
60074578|NCT01807520|76189936|FG004|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||5||
60074579|NCT01807520|76189937|FG005|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||0||
60074580|NCT01807520|76189938|FG006|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||0||
60074581|NCT01807520|76189932|FG000|STARTED|Follow-up Period (132-140 Weeks)||0||
60074582|NCT01807520|76189933|FG001|STARTED|Follow-up Period (132-140 Weeks)||0||
60074583|NCT01807520|76189934|FG002|STARTED|Follow-up Period (132-140 Weeks)|These participants discontinued from Treatment Period 1.|2||
60074584|NCT01807520|76189935|FG003|STARTED|Follow-up Period (132-140 Weeks)||0||
60074585|NCT01807520|76189936|FG004|STARTED|Follow-up Period (132-140 Weeks)||0||
60074586|NCT01807520|76189937|FG005|STARTED|Follow-up Period (132-140 Weeks)|These participants received AIN457150mg during treatment period 1 and/or treatment period 2.|81||
60074587|NCT01807520|76189938|FG006|STARTED|Follow-up Period (132-140 Weeks)|These participants received AIN457 300mg during treatment period 1 and/or treatment period 2.|76||
60074588|NCT01807520|76189932|FG000|COMPLETED|Follow-up Period (132-140 Weeks)||0||
60074589|NCT01807520|76189933|FG001|COMPLETED|Follow-up Period (132-140 Weeks)||0||
60074590|NCT01807520|76189934|FG002|COMPLETED|Follow-up Period (132-140 Weeks)||2||
60074591|NCT01807520|76189935|FG003|COMPLETED|Follow-up Period (132-140 Weeks)||0||
60074592|NCT01807520|76189936|FG004|COMPLETED|Follow-up Period (132-140 Weeks)||0||
60074593|NCT01807520|76189937|FG005|COMPLETED|Follow-up Period (132-140 Weeks)||77||
60074594|NCT01807520|76189938|FG006|COMPLETED|Follow-up Period (132-140 Weeks)||75||
60074595|NCT01807520|76189932|FG000|NOT COMPLETED|Follow-up Period (132-140 Weeks)||0||
60074596|NCT01807520|76189933|FG001|NOT COMPLETED|Follow-up Period (132-140 Weeks)||0||
60074597|NCT01807520|76189934|FG002|NOT COMPLETED|Follow-up Period (132-140 Weeks)||0||
60074598|NCT01807520|76189935|FG003|NOT COMPLETED|Follow-up Period (132-140 Weeks)||0||
60074599|NCT01807520|76189936|FG004|NOT COMPLETED|Follow-up Period (132-140 Weeks)||0||
60074600|NCT01807520|76189937|FG005|NOT COMPLETED|Follow-up Period (132-140 Weeks)||4||
60074601|NCT01807520|76189938|FG006|NOT COMPLETED|Follow-up Period (132-140 Weeks)||1||
60074602|NCT01806896|76189951|FG000|STARTED|Overall Study||20||
60074603|NCT01806896|76189952|FG001|STARTED|Overall Study||17||
60074604|NCT01806896|76189951|FG000|Received Treatment|Overall Study||19||
60074605|NCT01806896|76189952|FG001|Received Treatment|Overall Study||17||
60074606|NCT01806896|76189951|FG000|COMPLETED|Overall Study||17||
60074607|NCT01806896|76189952|FG001|COMPLETED|Overall Study||17||
59622141|NCT02110758|75733888|FG001|STARTED|Intervention: July 2014-December 2015||0||
59622142|NCT02110758|75733889|FG002|STARTED|Intervention: July 2014-December 2015||10106||
59622143|NCT02110758|75733890|FG003|STARTED|Intervention: July 2014-December 2015||33012||
59622144|NCT02110758|75733891|FG004|STARTED|Intervention: July 2014-December 2015||0||
59622145|NCT02110758|75733887|FG000|COMPLETED|Intervention: July 2014-December 2015||0|This involved cross-sectional samples of patients; we did not follow individuals longitudinally|
59622146|NCT02110758|75733888|FG001|COMPLETED|Intervention: July 2014-December 2015||0|This involved cross-sectional samples of patients; we did not follow individuals longitudinally|
59813109|NCT00626795|75935568|FG001|NOT COMPLETED|Blinded Treatment||5||
59813110|NCT00626795|75935569|FG002|NOT COMPLETED|Blinded Treatment||9||
59813111|NCT00626639|75935583|FG000|STARTED|Overall Study||2||
59975181|NCT02941549|76092609|FG000|STARTED|Overall Study||31||
59975182|NCT02941549|76092610|FG001|STARTED|Overall Study||32||
59975183|NCT02941549|76092611|FG002|STARTED|Overall Study||33||
59975184|NCT02941549|76092609|FG000|COMPLETED|Overall Study||28||
59975185|NCT02941549|76092610|FG001|COMPLETED|Overall Study||31||
59975186|NCT02941549|76092611|FG002|COMPLETED|Overall Study||31||
59975187|NCT02941549|76092609|FG000|NOT COMPLETED|Overall Study||3||
59975188|NCT02941549|76092610|FG001|NOT COMPLETED|Overall Study||1||
59975189|NCT02941549|76092611|FG002|NOT COMPLETED|Overall Study||2||
59975190|NCT02394028|76092633|FG000|STARTED|Induction Phase||59||
59975191|NCT02394028|76092634|FG001|STARTED|Induction Phase||120||
59975192|NCT02394028|76092635|FG002|STARTED|Induction Phase||121||
59975193|NCT02394028|76092636|FG003|STARTED|Induction Phase||176||
59975194|NCT02394028|76092637|FG004|STARTED|Induction Phase||174||
59975195|NCT02394028|76092638|FG005|STARTED|Induction Phase||97||
59975196|NCT02394028|76092639|FG006|STARTED|Induction Phase||143||
59975197|NCT02394028|76092640|FG007|STARTED|Induction Phase||145||
60074608|NCT01806896|76189951|FG000|NOT COMPLETED|Overall Study||3||
59975198|NCT02394028|76092641|FG008|STARTED|Induction Phase||0||
59975199|NCT02394028|76092642|FG009|STARTED|Induction Phase||0||
59975200|NCT02394028|76092643|FG010|STARTED|Induction Phase||0||
59975201|NCT02394028|76092633|FG000|COMPLETED|Induction Phase||52||
59975202|NCT02394028|76092634|FG001|COMPLETED|Induction Phase||104||
59975203|NCT02394028|76092635|FG002|COMPLETED|Induction Phase||108||
59975204|NCT02394028|76092636|FG003|COMPLETED|Induction Phase||141||
59975205|NCT02394028|76092637|FG004|COMPLETED|Induction Phase||145||
60074609|NCT01806896|76189952|FG001|NOT COMPLETED|Overall Study||0||
60074610|NCT01768676|76189960|FG000|STARTED|Overall Study||90||
59622147|NCT02110758|75733889|FG002|COMPLETED|Intervention: July 2014-December 2015||10106|This involved cross-sectional samples of patients; we did not follow individuals longitudinally|
59622148|NCT02110758|75733890|FG003|COMPLETED|Intervention: July 2014-December 2015||33012|This involved cross-sectional samples of patients; we did not follow individuals longitudinally|
59622149|NCT02110758|75733891|FG004|COMPLETED|Intervention: July 2014-December 2015||0|This involved cross-sectional samples of patients; we did not follow individuals longitudinally|
59622150|NCT02110758|75733887|FG000|NOT COMPLETED|Intervention: July 2014-December 2015||0||
59622151|NCT02110758|75733888|FG001|NOT COMPLETED|Intervention: July 2014-December 2015||0||
59622152|NCT02110758|75733889|FG002|NOT COMPLETED|Intervention: July 2014-December 2015||0||
59622153|NCT02110758|75733890|FG003|NOT COMPLETED|Intervention: July 2014-December 2015||0||
59622154|NCT02110758|75733891|FG004|NOT COMPLETED|Intervention: July 2014-December 2015||0||
59622155|NCT02110758|75733887|FG000|STARTED|Follow-Up: January-July 2016||81||
59622156|NCT02110758|75733888|FG001|STARTED|Follow-Up: January-July 2016||179||
59622157|NCT02110758|75733889|FG002|STARTED|Follow-Up: January-July 2016||6451||
59622158|NCT02110758|75733890|FG003|STARTED|Follow-Up: January-July 2016||24392||
59622159|NCT02110758|75733891|FG004|STARTED|Follow-Up: January-July 2016||349||
59622160|NCT02110758|75733887|FG000|COMPLETED|Follow-Up: January-July 2016||81|This involved cross-sectional samples of patients; we did not follow individuals longitudinally|
59622161|NCT02110758|75733888|FG001|COMPLETED|Follow-Up: January-July 2016||179|This involved cross-sectional samples of patients; we did not follow individuals longitudinally|
59622162|NCT02110758|75733889|FG002|COMPLETED|Follow-Up: January-July 2016||6451|This involved cross-sectional samples of patients; we did not follow individuals longitudinally|
59622163|NCT02110758|75733890|FG003|COMPLETED|Follow-Up: January-July 2016||24392|This involved cross-sectional samples of patients; we did not follow individuals longitudinally|
59813112|NCT00626639|75935584|FG001|STARTED|Overall Study||3||
59813113|NCT00626639|75935583|FG000|COMPLETED|Overall Study|Participants who received all 8 doses of investigational product.|0||
59813114|NCT00626639|75935584|FG001|COMPLETED|Overall Study|Participants who received all 8 doses of investigational product.|1||
59813115|NCT00626639|75935583|FG000|NOT COMPLETED|Overall Study||2||
59813116|NCT00626639|75935584|FG001|NOT COMPLETED|Overall Study||2||
59622164|NCT02110758|75733891|FG004|COMPLETED|Follow-Up: January-July 2016||349|This involved cross-sectional samples of patients; we did not follow individuals longitudinally|
59975206|NCT02394028|76092638|FG005|COMPLETED|Induction Phase||80||
59975207|NCT02394028|76092639|FG006|COMPLETED|Induction Phase||118||
59975208|NCT02394028|76092640|FG007|COMPLETED|Induction Phase||114||
59975209|NCT02394028|76092641|FG008|COMPLETED|Induction Phase||0||
59975210|NCT02394028|76092642|FG009|COMPLETED|Induction Phase||0||
59975211|NCT02394028|76092643|FG010|COMPLETED|Induction Phase||0||
60074611|NCT01768676|76189961|FG001|STARTED|Overall Study||91||
60074612|NCT01768676|76189960|FG000|COMPLETED|Overall Study||66||
60074613|NCT01768676|76189961|FG001|COMPLETED|Overall Study||60||
60074614|NCT01768676|76189960|FG000|NOT COMPLETED|Overall Study||24||
59975212|NCT02394028|76092633|FG000|NOT COMPLETED|Induction Phase||7||
59975213|NCT02394028|76092634|FG001|NOT COMPLETED|Induction Phase||16||
59975214|NCT02394028|76092635|FG002|NOT COMPLETED|Induction Phase||13||
59975215|NCT02394028|76092636|FG003|NOT COMPLETED|Induction Phase||35||
59975216|NCT02394028|76092637|FG004|NOT COMPLETED|Induction Phase||29||
59975217|NCT02394028|76092638|FG005|NOT COMPLETED|Induction Phase||17||
59975218|NCT02394028|76092639|FG006|NOT COMPLETED|Induction Phase||25||
59975219|NCT02394028|76092640|FG007|NOT COMPLETED|Induction Phase||31||
59975220|NCT02394028|76092641|FG008|NOT COMPLETED|Induction Phase||0||
59975221|NCT02394028|76092642|FG009|NOT COMPLETED|Induction Phase||0||
59975222|NCT02394028|76092643|FG010|NOT COMPLETED|Induction Phase||0||
59975223|NCT02394028|76092633|FG000|STARTED|Maintenance Phase|Participants from the induction phase who had achieved a CDAI-70 response without the use of rescue therapy were enrolled in the maintenance phase to receive either placebo or etrolizumab 105 mg.|0||
59975224|NCT02394028|76092634|FG001|STARTED|Maintenance Phase|Participants from the induction phase who had achieved a CDAI-70 response without the use of rescue therapy were enrolled in the maintenance phase to receive either placebo or etrolizumab 105 mg.|0||
59975225|NCT02394028|76092635|FG002|STARTED|Maintenance Phase|Participants from the induction phase who had achieved a CDAI-70 response without the use of rescue therapy were enrolled in the maintenance phase to receive either placebo or etrolizumab 105 mg.|0||
59975226|NCT02394028|76092636|FG003|STARTED|Maintenance Phase|Participants from the induction phase who had achieved a CDAI-70 response without the use of rescue therapy were enrolled in the maintenance phase to receive either placebo or etrolizumab 105 mg.|0||
59975227|NCT02394028|76092637|FG004|STARTED|Maintenance Phase|Participants from the induction phase who had achieved a CDAI-70 response without the use of rescue therapy were enrolled in the maintenance phase to receive either placebo or etrolizumab 105 mg.|0||
59975228|NCT02394028|76092638|FG005|STARTED|Maintenance Phase|Participants from the induction phase who had achieved a CDAI-70 response without the use of rescue therapy were enrolled in the maintenance phase to receive either placebo or etrolizumab 105 mg.|0||
59975229|NCT02394028|76092639|FG006|STARTED|Maintenance Phase|Participants from the induction phase who had achieved a CDAI-70 response without the use of rescue therapy were enrolled in the maintenance phase to receive either placebo or etrolizumab 105 mg.|0||
59975230|NCT02394028|76092640|FG007|STARTED|Maintenance Phase|Participants from the induction phase who had achieved a CDAI-70 response without the use of rescue therapy were enrolled in the maintenance phase to receive either placebo or etrolizumab 105 mg.|0||
59975231|NCT02394028|76092641|FG008|STARTED|Maintenance Phase|Participants from the induction phase who had achieved a CDAI-70 response without the use of rescue therapy were enrolled in the maintenance phase to receive placebo.|53||
59975232|NCT02394028|76092642|FG009|STARTED|Maintenance Phase|Participants from the induction phase who had achieved a CDAI-70 response without the use of rescue therapy were enrolled in the maintenance phase to receive placebo.|217||
59975233|NCT02394028|76092643|FG010|STARTED|Maintenance Phase|Participants from the induction phase who had achieved a CDAI-70 response without the use of rescue therapy were enrolled in the maintenance phase to receive etrolizumab 105 mg.|217||
59975234|NCT02394028|76092633|FG000|COMPLETED|Maintenance Phase||0||
59975235|NCT02394028|76092634|FG001|COMPLETED|Maintenance Phase||0||
59975236|NCT02394028|76092635|FG002|COMPLETED|Maintenance Phase||0||
59975237|NCT02394028|76092636|FG003|COMPLETED|Maintenance Phase||0||
59975238|NCT02394028|76092637|FG004|COMPLETED|Maintenance Phase||0||
59975239|NCT02394028|76092638|FG005|COMPLETED|Maintenance Phase||0||
59975240|NCT02394028|76092639|FG006|COMPLETED|Maintenance Phase||0||
59975241|NCT02394028|76092640|FG007|COMPLETED|Maintenance Phase||0||
59975242|NCT02394028|76092641|FG008|COMPLETED|Maintenance Phase||41||
59975243|NCT02394028|76092642|FG009|COMPLETED|Maintenance Phase||175||
59975244|NCT02394028|76092643|FG010|COMPLETED|Maintenance Phase||165||
59975245|NCT02394028|76092633|FG000|NOT COMPLETED|Maintenance Phase||0||
59975246|NCT02394028|76092634|FG001|NOT COMPLETED|Maintenance Phase||0||
59975247|NCT02394028|76092635|FG002|NOT COMPLETED|Maintenance Phase||0||
59975248|NCT02394028|76092636|FG003|NOT COMPLETED|Maintenance Phase||0||
59975249|NCT02394028|76092637|FG004|NOT COMPLETED|Maintenance Phase||0||
59975250|NCT02394028|76092638|FG005|NOT COMPLETED|Maintenance Phase||0||
59975251|NCT02394028|76092639|FG006|NOT COMPLETED|Maintenance Phase||0||
59975252|NCT02394028|76092640|FG007|NOT COMPLETED|Maintenance Phase||0||
59525817|NCT00019682|75621195|FG000|COMPLETED|Overall Study||93||
59525818|NCT00019682|75621196|FG001|COMPLETED|Overall Study||85||
59525819|NCT00019682|75621195|FG000|NOT COMPLETED|Overall Study||1||
59525820|NCT00019682|75621196|FG001|NOT COMPLETED|Overall Study||6||
59813117|NCT00626561|75935592|FG000|STARTED|Overall Study||4||
59813118|NCT00626561|75935592|FG000|COMPLETED|Overall Study||0||
59813119|NCT00626561|75935592|FG000|NOT COMPLETED|Overall Study||4||
59813120|NCT03880266|75935604|FG000|STARTED|Overall Study||12||
59813121|NCT03880266|75935605|FG001|STARTED|Overall Study||6||
59813122|NCT03880266|75935606|FG002|STARTED|Overall Study||12||
59813123|NCT03880266|75935607|FG003|STARTED|Overall Study||4||
59813124|NCT03880266|75935608|FG004|STARTED|Overall Study||12||
59813125|NCT03880266|75935609|FG005|STARTED|Overall Study||6||
59813126|NCT03880266|75935610|FG006|STARTED|Overall Study||13||
59525821|NCT00022490|75621202|FG000|STARTED|Overall Study||24||
59525822|NCT00022490|75621202|FG000|COMPLETED|Overall Study||24||
59813127|NCT03880266|75935611|FG007|STARTED|Overall Study||7||
59813128|NCT03880266|75935604|FG000|COMPLETED|Overall Study||12||
59813129|NCT03880266|75935605|FG001|COMPLETED|Overall Study||5||
59813130|NCT03880266|75935606|FG002|COMPLETED|Overall Study||11||
59975253|NCT02394028|76092641|FG008|NOT COMPLETED|Maintenance Phase||12||
59975254|NCT02394028|76092642|FG009|NOT COMPLETED|Maintenance Phase||42||
59975255|NCT02394028|76092643|FG010|NOT COMPLETED|Maintenance Phase||52||
59975256|NCT01371539|76092697|FG000|STARTED|Period One: One Week||53||
59975257|NCT01371539|76092698|FG001|STARTED|Period One: One Week||51||
59975258|NCT01371539|76092697|FG000|COMPLETED|Period One: One Week||53||
59975259|NCT01371539|76092698|FG001|COMPLETED|Period One: One Week||50||
59975260|NCT01371539|76092697|FG000|NOT COMPLETED|Period One: One Week||0||
59975261|NCT01371539|76092698|FG001|NOT COMPLETED|Period One: One Week||1||
59975262|NCT01371539|76092697|FG000|STARTED|Period Two: One Week||53||
59975263|NCT01371539|76092698|FG001|STARTED|Period Two: One Week||50||
59975264|NCT01371539|76092697|FG000|COMPLETED|Period Two: One Week||53||
59975265|NCT01371539|76092698|FG001|COMPLETED|Period Two: One Week||47||
59975266|NCT01371539|76092697|FG000|NOT COMPLETED|Period Two: One Week||0||
59975267|NCT01371539|76092698|FG001|NOT COMPLETED|Period Two: One Week||3||
59975268|NCT02819297|76092706|FG000|STARTED|Overall Study||299||
59975269|NCT02819297|76092707|FG001|STARTED|Overall Study||304||
59975270|NCT02819297|76092706|FG000|COMPLETED|Overall Study||239||
59975271|NCT02819297|76092707|FG001|COMPLETED|Overall Study||252||
59975272|NCT02819297|76092706|FG000|NOT COMPLETED|Overall Study||60||
59975273|NCT02819297|76092707|FG001|NOT COMPLETED|Overall Study||52||
59975274|NCT02429830|76092713|FG000|STARTED|Overall Study||30||
59975275|NCT02429830|76092713|FG000|COMPLETED|Overall Study||27||
59975276|NCT02429830|76092713|FG000|NOT COMPLETED|Overall Study||3||
59975277|NCT02821715|76092717|FG000|STARTED|Overall Study||8||
59975278|NCT02821715|76092718|FG001|STARTED|Overall Study||8||
59975279|NCT02821715|76092719|FG002|STARTED|Overall Study||8||
59975280|NCT02821715|76092720|FG003|STARTED|Overall Study||9||
59975281|NCT02821715|76092721|FG004|STARTED|Overall Study||6||
59975282|NCT02821715|76092722|FG005|STARTED|Overall Study||9||
59975283|NCT02821715|76092717|FG000|COMPLETED|Overall Study||7||
59975284|NCT02821715|76092718|FG001|COMPLETED|Overall Study||8||
59975285|NCT02821715|76092719|FG002|COMPLETED|Overall Study||8||
59975286|NCT02821715|76092720|FG003|COMPLETED|Overall Study||9||
59975287|NCT02821715|76092721|FG004|COMPLETED|Overall Study||6||
59975288|NCT02821715|76092722|FG005|COMPLETED|Overall Study||9||
59975289|NCT02821715|76092717|FG000|NOT COMPLETED|Overall Study||1||
59975290|NCT02821715|76092718|FG001|NOT COMPLETED|Overall Study||0||
59975291|NCT02821715|76092719|FG002|NOT COMPLETED|Overall Study||0||
59975292|NCT02821715|76092720|FG003|NOT COMPLETED|Overall Study||0||
59975293|NCT02821715|76092721|FG004|NOT COMPLETED|Overall Study||0||
59975294|NCT02821715|76092722|FG005|NOT COMPLETED|Overall Study||0||
59975295|NCT02813681|76092733|FG000|STARTED|Overall Study||27||
59975296|NCT02813681|76092734|FG001|STARTED|Overall Study||34||
59975297|NCT02813681|76092735|FG002|STARTED|Overall Study||19||
59975298|NCT02813681|76092733|FG000|COMPLETED|Overall Study||22||
59975299|NCT02813681|76092734|FG001|COMPLETED|Overall Study||28||
59975300|NCT02813681|76092735|FG002|COMPLETED|Overall Study||19||
59975301|NCT02813681|76092733|FG000|NOT COMPLETED|Overall Study||5||
59975302|NCT02813681|76092734|FG001|NOT COMPLETED|Overall Study||6||
59975303|NCT02813681|76092735|FG002|NOT COMPLETED|Overall Study||0||
59975304|NCT02393950|76092747|FG000|STARTED|Overall Study||9||
59975305|NCT02393950|76092748|FG001|STARTED|Overall Study||9||
59975306|NCT02393950|76092747|FG000|Period 1|Overall Study|6 subjects ODM-106 Capsule B 2 mg and 2 subjects on placebo|8||
59975307|NCT02393950|76092748|FG001|Period 1|Overall Study|6 subjects ODM-106 Capsule B 100 mg (1 x 100mg) and 2 subjects on placebo|8||
59975308|NCT02393950|76092747|FG000|Period 2|Overall Study|6 subjects ODM-106 Capsule B 10 mg and 2 subjects on placebo|8||
59975309|NCT02393950|76092748|FG001|Period 2|Overall Study|6 subjects ODM-106 Capsule B 100 mg (10 x 10mg) and 2 subjects on placebo|8||
59975310|NCT02393950|76092747|FG000|Period 3|Overall Study|6 subjects ODM-106 Capsule B 25 mg and 2 subjects on placebo|8||
59975311|NCT02393950|76092748|FG001|Period 3|Overall Study|6 subjects ODM-106 Capsule B 200 mg (20 x 10mg) and 2 subjects on placebo|8||
59975312|NCT02393950|76092747|FG000|Period 4|Overall Study|6 subjects ODM-106 Capsule B 50 mg and 2 subjects on placebo|8||
59975313|NCT02393950|76092748|FG001|Period 4|Overall Study|6 subjects ODM-106 Capsule A 100 mg (10 x 10mg) and 2 subjects on placebo|8||
59975314|NCT02393950|76092747|FG000|COMPLETED|Overall Study||8||
59975315|NCT02393950|76092748|FG001|COMPLETED|Overall Study||8||
59975316|NCT02393950|76092747|FG000|NOT COMPLETED|Overall Study||1||
59975317|NCT02393950|76092748|FG001|NOT COMPLETED|Overall Study||1||
59975318|NCT02815397|76092783|FG000|STARTED|Overall Study||2||
59975319|NCT02815397|76092783|FG000|COMPLETED|Overall Study||0||
59975320|NCT02815397|76092783|FG000|NOT COMPLETED|Overall Study||2||
59975321|NCT02427958|76092787|FG000|STARTED|Overall Study||307||
59975322|NCT02427958|76092787|FG000|COMPLETED|Overall Study||283||
59975323|NCT02427958|76092787|FG000|NOT COMPLETED|Overall Study||24||
59975324|NCT02392624|76092794|FG000|STARTED|Overall Study||71||
59975325|NCT02392624|76092795|FG001|STARTED|Overall Study||81||
59975326|NCT02392624|76092796|FG002|STARTED|Overall Study||53||
59975327|NCT02392624|76092794|FG000|COMPLETED|Overall Study||0||
59975328|NCT02392624|76092795|FG001|COMPLETED|Overall Study||66||
59975329|NCT02392624|76092796|FG002|COMPLETED|Overall Study||40||
59975330|NCT02392624|76092794|FG000|NOT COMPLETED|Overall Study||71||
59975331|NCT02392624|76092795|FG001|NOT COMPLETED|Overall Study||15||
59975332|NCT02392624|76092796|FG002|NOT COMPLETED|Overall Study||13||
59975333|NCT02387164|76092806|FG000|STARTED|Overall Study||13||
59975334|NCT02387164|76092807|FG001|STARTED|Overall Study||13||
59975335|NCT02387164|76092806|FG000|COMPLETED|Overall Study||10||
59975336|NCT02387164|76092807|FG001|COMPLETED|Overall Study||11||
59975337|NCT02387164|76092806|FG000|NOT COMPLETED|Overall Study||3||
59975338|NCT02387164|76092807|FG001|NOT COMPLETED|Overall Study||2||
59975339|NCT03813719|76092813|FG000|STARTED|Overall Study||250||
59975340|NCT03813719|76092813|FG000|COMPLETED|Overall Study||250||
59975341|NCT03813719|76092813|FG000|NOT COMPLETED|Overall Study||0||
59813131|NCT03880266|75935607|FG003|COMPLETED|Overall Study||4||
59813132|NCT03880266|75935608|FG004|COMPLETED|Overall Study||12||
59813133|NCT03880266|75935609|FG005|COMPLETED|Overall Study||6||
59813134|NCT03880266|75935610|FG006|COMPLETED|Overall Study||13||
59813135|NCT03880266|75935611|FG007|COMPLETED|Overall Study||7||
59813136|NCT03880266|75935604|FG000|NOT COMPLETED|Overall Study||0||
59813137|NCT03880266|75935605|FG001|NOT COMPLETED|Overall Study||1||
59813138|NCT03880266|75935606|FG002|NOT COMPLETED|Overall Study||1||
59813139|NCT03880266|75935607|FG003|NOT COMPLETED|Overall Study||0||
59813140|NCT03880266|75935608|FG004|NOT COMPLETED|Overall Study||0||
59813141|NCT03880266|75935609|FG005|NOT COMPLETED|Overall Study||0||
59975342|NCT02392234|76092825|FG000|STARTED|Treatment Period 1 (8 Weeks)||41||
59975343|NCT02392234|76092826|FG001|STARTED|Treatment Period 1 (8 Weeks)||43||
59975344|NCT02392234|76092827|FG002|STARTED|Treatment Period 1 (8 Weeks)||40||
59975345|NCT02392234|76092828|FG003|STARTED|Treatment Period 1 (8 Weeks)||42||
59975346|NCT02392234|76092829|FG004|STARTED|Treatment Period 1 (8 Weeks)||41||
59975347|NCT02392234|76092830|FG005|STARTED|Treatment Period 1 (8 Weeks)||41||
59975348|NCT02392234|76092825|FG000|Treated|Treatment Period 1 (8 Weeks)||41||
59975349|NCT02392234|76092826|FG001|Treated|Treatment Period 1 (8 Weeks)||43||
59975350|NCT02392234|76092827|FG002|Treated|Treatment Period 1 (8 Weeks)||39||
59975351|NCT02392234|76092828|FG003|Treated|Treatment Period 1 (8 Weeks)||42||
59975352|NCT02392234|76092829|FG004|Treated|Treatment Period 1 (8 Weeks)||40||
59975353|NCT02392234|76092830|FG005|Treated|Treatment Period 1 (8 Weeks)||41||
59975354|NCT02392234|76092825|FG000|COMPLETED|Treatment Period 1 (8 Weeks)||38||
59975355|NCT02392234|76092826|FG001|COMPLETED|Treatment Period 1 (8 Weeks)||43||
59975356|NCT02392234|76092827|FG002|COMPLETED|Treatment Period 1 (8 Weeks)||38||
59813142|NCT03880266|75935610|FG006|NOT COMPLETED|Overall Study||0||
59813143|NCT03880266|75935611|FG007|NOT COMPLETED|Overall Study||0||
59813144|NCT00423891|75935632|FG000|STARTED|Enrolled||35||
59813145|NCT00423891|75935633|FG001|STARTED|Enrolled||21||
59975357|NCT02392234|76092828|FG003|COMPLETED|Treatment Period 1 (8 Weeks)||41||
59813146|NCT00423891|75935634|FG002|STARTED|Enrolled||8||
59813147|NCT00423891|75935632|FG000|COMPLETED|Enrolled||24||
59813148|NCT00423891|75935633|FG001|COMPLETED|Enrolled||19||
59813149|NCT00423891|75935634|FG002|COMPLETED|Enrolled||5||
59813150|NCT00423891|75935632|FG000|NOT COMPLETED|Enrolled||11||
59813151|NCT00423891|75935633|FG001|NOT COMPLETED|Enrolled||2||
59813152|NCT00423891|75935634|FG002|NOT COMPLETED|Enrolled||3||
59813153|NCT00423891|75935632|FG000|STARTED|Treatment||24||
59813154|NCT00423891|75935633|FG001|STARTED|Treatment||19||
59813155|NCT00423891|75935634|FG002|STARTED|Treatment||5||
59813156|NCT00423891|75935632|FG000|COMPLETED|Treatment||22||
59813157|NCT00423891|75935633|FG001|COMPLETED|Treatment||19||
59813158|NCT00423891|75935634|FG002|COMPLETED|Treatment||5||
59813159|NCT00423891|75935632|FG000|NOT COMPLETED|Treatment||2||
59813160|NCT00423891|75935633|FG001|NOT COMPLETED|Treatment||0||
59813161|NCT00423891|75935634|FG002|NOT COMPLETED|Treatment||0||
59813162|NCT00423891|75935632|FG000|STARTED|Post-Dosing Follow Up||22||
59813163|NCT00423891|75935633|FG001|STARTED|Post-Dosing Follow Up||18||
59813164|NCT00423891|75935634|FG002|STARTED|Post-Dosing Follow Up||5||
59813165|NCT00423891|75935632|FG000|COMPLETED|Post-Dosing Follow Up||20||
59813166|NCT00423891|75935633|FG001|COMPLETED|Post-Dosing Follow Up||15||
59813167|NCT00423891|75935634|FG002|COMPLETED|Post-Dosing Follow Up||3||
59813168|NCT00423891|75935632|FG000|NOT COMPLETED|Post-Dosing Follow Up||2||
59813169|NCT00423891|75935633|FG001|NOT COMPLETED|Post-Dosing Follow Up||3||
59813170|NCT00423891|75935634|FG002|NOT COMPLETED|Post-Dosing Follow Up||2||
59813171|NCT00423813|75935647|FG000|STARTED|Overall Study||188||
59813172|NCT00423813|75935648|FG001|STARTED|Overall Study||195||
59813173|NCT00423813|75935649|FG002|STARTED|Overall Study||190||
59813174|NCT00423813|75935647|FG000|Treated|Overall Study||188||
59813175|NCT00423813|75935648|FG001|Treated|Overall Study||194||
59813176|NCT00423813|75935649|FG002|Treated|Overall Study||189||
59975358|NCT02392234|76092829|FG004|COMPLETED|Treatment Period 1 (8 Weeks)||37||
59975359|NCT02392234|76092830|FG005|COMPLETED|Treatment Period 1 (8 Weeks)||38||
60074615|NCT01768676|76189961|FG001|NOT COMPLETED|Overall Study||31||
59813177|NCT00423813|75935647|FG000|COMPLETED|Overall Study||131||
59813178|NCT00423813|75935648|FG001|COMPLETED|Overall Study||129||
59813179|NCT00423813|75935649|FG002|COMPLETED|Overall Study||116||
59813180|NCT00423813|75935647|FG000|NOT COMPLETED|Overall Study||57||
59813181|NCT00423813|75935648|FG001|NOT COMPLETED|Overall Study||66||
59813182|NCT00423813|75935649|FG002|NOT COMPLETED|Overall Study||74||
59813183|NCT03687372|75935659|FG000|STARTED|Overall Study||254||
59813184|NCT03687372|75935660|FG001|STARTED|Overall Study||249||
59813185|NCT03687372|75935659|FG000|COMPLETED|Overall Study||237||
59813186|NCT03687372|75935660|FG001|COMPLETED|Overall Study||210||
59813187|NCT03687372|75935659|FG000|NOT COMPLETED|Overall Study||17||
59813188|NCT03687372|75935660|FG001|NOT COMPLETED|Overall Study||39||
59813189|NCT00626405|75935670|FG000|STARTED|Overall Study||43||
59813190|NCT00626405|75935671|FG001|STARTED|Overall Study||52||
59813191|NCT00626405|75935670|FG000|COMPLETED|Overall Study||42||
59813192|NCT00626405|75935671|FG001|COMPLETED|Overall Study||51||
59813193|NCT00626405|75935670|FG000|NOT COMPLETED|Overall Study||1||
59813194|NCT00626405|75935671|FG001|NOT COMPLETED|Overall Study||1||
59813195|NCT00358150|75935677|FG000|STARTED|Overall Study||26||
59813196|NCT00358150|75935677|FG000|COMPLETED|Overall Study||19||
59813197|NCT00358150|75935677|FG000|NOT COMPLETED|Overall Study||7||
59813198|NCT05723822|75935684|FG000|STARTED|Overall Study||12||
59813199|NCT05723822|75935684|FG000|COMPLETED|Overall Study||12||
59813200|NCT05723822|75935684|FG000|NOT COMPLETED|Overall Study||0||
59813201|NCT05327777|75935692|FG000|STARTED|Overall Study||58||
59813202|NCT05327777|75935693|FG001|STARTED|Overall Study||42||
59813203|NCT05327777|75935694|FG002|STARTED|Overall Study||29||
59813204|NCT05327777|75935692|FG000|COMPLETED|Overall Study||58||
59813205|NCT05327777|75935693|FG001|COMPLETED|Overall Study||42||
59813206|NCT05327777|75935694|FG002|COMPLETED|Overall Study||29||
59813207|NCT05327777|75935692|FG000|NOT COMPLETED|Overall Study||0||
59813208|NCT05327777|75935693|FG001|NOT COMPLETED|Overall Study||0||
59813209|NCT05327777|75935694|FG002|NOT COMPLETED|Overall Study||0||
59813210|NCT05061966|75935704|FG000|STARTED|Overall Study||135||
59813211|NCT05061966|75935705|FG001|STARTED|Overall Study||135||
59813212|NCT05061966|75935704|FG000|COMPLETED|Overall Study||122||
59813213|NCT05061966|75935705|FG001|COMPLETED|Overall Study||122||
59813214|NCT05061966|75935704|FG000|NOT COMPLETED|Overall Study||13||
59813215|NCT05061966|75935705|FG001|NOT COMPLETED|Overall Study||13||
59813216|NCT05027815|75935713|FG000|STARTED|Overall Study||3||
59813217|NCT05027815|75935714|FG001|STARTED|Overall Study||1||
59813218|NCT05027815|75935713|FG000|COMPLETED|Overall Study||1||
59813219|NCT05027815|75935714|FG001|COMPLETED|Overall Study||0||
59813220|NCT05027815|75935713|FG000|NOT COMPLETED|Overall Study||2||
59622165|NCT02110758|75733887|FG000|NOT COMPLETED|Follow-Up: January-July 2016||0||
59622166|NCT02110758|75733888|FG001|NOT COMPLETED|Follow-Up: January-July 2016||0||
59622167|NCT02110758|75733889|FG002|NOT COMPLETED|Follow-Up: January-July 2016||0||
59622168|NCT02110758|75733890|FG003|NOT COMPLETED|Follow-Up: January-July 2016||0||
59622169|NCT02110758|75733891|FG004|NOT COMPLETED|Follow-Up: January-July 2016||0||
59622170|NCT02111772|75733905|FG000|STARTED|Overall Study||12||
59622171|NCT02111772|75733906|FG001|STARTED|Overall Study||14||
59622172|NCT02111772|75733905|FG000|COMPLETED|Overall Study||12||
59622173|NCT02111772|75733906|FG001|COMPLETED|Overall Study||14||
59622174|NCT02111772|75733905|FG000|NOT COMPLETED|Overall Study||0||
59813221|NCT05027815|75935714|FG001|NOT COMPLETED|Overall Study||1||
59813222|NCT04827134|75935724|FG000|STARTED|Treatment Period 1 (1 Day)||8||
59813223|NCT04827134|75935725|FG001|STARTED|Treatment Period 1 (1 Day)||8||
59975360|NCT02392234|76092825|FG000|NOT COMPLETED|Treatment Period 1 (8 Weeks)||3||
59975361|NCT02392234|76092826|FG001|NOT COMPLETED|Treatment Period 1 (8 Weeks)||0||
59975362|NCT02392234|76092827|FG002|NOT COMPLETED|Treatment Period 1 (8 Weeks)||2||
59975363|NCT02392234|76092828|FG003|NOT COMPLETED|Treatment Period 1 (8 Weeks)||1||
59975364|NCT02392234|76092829|FG004|NOT COMPLETED|Treatment Period 1 (8 Weeks)||4||
59975365|NCT02392234|76092830|FG005|NOT COMPLETED|Treatment Period 1 (8 Weeks)||3||
59975366|NCT02392234|76092825|FG000|STARTED|Treatment Period 2 (8 Weeks)||38||
59975367|NCT02392234|76092826|FG001|STARTED|Treatment Period 2 (8 Weeks)||43||
59622175|NCT02111772|75733906|FG001|NOT COMPLETED|Overall Study||0||
59622176|NCT00383448|75733912|FG000|STARTED|Overall Study||38||
59622177|NCT00383448|75733912|FG000|COMPLETED|Overall Study||38||
59622178|NCT00383448|75733912|FG000|NOT COMPLETED|Overall Study||0||
59622179|NCT00383760|75733917|FG000|STARTED|Overall Study||15||
59622180|NCT00383760|75733917|FG000|COMPLETED|Overall Study||15||
59622181|NCT00383760|75733917|FG000|NOT COMPLETED|Overall Study||0||
59622182|NCT00384774|75733929|FG000|STARTED|Overall Study||42||
59622183|NCT00384774|75733930|FG001|STARTED|Overall Study||4||
59622184|NCT00384774|75733931|FG002|STARTED|Overall Study||12||
59622185|NCT00384774|75733932|FG003|STARTED|Overall Study||24||
59622186|NCT00384774|75733933|FG004|STARTED|Overall Study||28||
59813224|NCT04827134|75935726|FG002|STARTED|Treatment Period 1 (1 Day)||8||
59622187|NCT00384774|75733934|FG005|STARTED|Overall Study||16||
59622188|NCT00384774|75733935|FG006|STARTED|Overall Study||4||
59622189|NCT00384774|75733929|FG000|Received at Least 1 Dose of Study Drug|Overall Study||42||
59622190|NCT00384774|75733930|FG001|Received at Least 1 Dose of Study Drug|Overall Study||4||
59622191|NCT00384774|75733931|FG002|Received at Least 1 Dose of Study Drug|Overall Study||12||
59622192|NCT00384774|75733932|FG003|Received at Least 1 Dose of Study Drug|Overall Study||24||
59622193|NCT00384774|75733933|FG004|Received at Least 1 Dose of Study Drug|Overall Study||28||
59622194|NCT00384774|75733934|FG005|Received at Least 1 Dose of Study Drug|Overall Study||16||
59813225|NCT04827134|75935727|FG003|STARTED|Treatment Period 1 (1 Day)||9||
59813226|NCT04827134|75935724|FG000|COMPLETED|Treatment Period 1 (1 Day)||8||
59975368|NCT02392234|76092827|FG002|STARTED|Treatment Period 2 (8 Weeks)||38||
59975369|NCT02392234|76092828|FG003|STARTED|Treatment Period 2 (8 Weeks)||41||
59975370|NCT02392234|76092829|FG004|STARTED|Treatment Period 2 (8 Weeks)||37||
59975371|NCT02392234|76092830|FG005|STARTED|Treatment Period 2 (8 Weeks)||38||
59975372|NCT02392234|76092825|FG000|COMPLETED|Treatment Period 2 (8 Weeks)||37||
59975373|NCT02392234|76092826|FG001|COMPLETED|Treatment Period 2 (8 Weeks)||43||
59975374|NCT02392234|76092827|FG002|COMPLETED|Treatment Period 2 (8 Weeks)||38||
59975375|NCT02392234|76092828|FG003|COMPLETED|Treatment Period 2 (8 Weeks)||41||
59975376|NCT02392234|76092829|FG004|COMPLETED|Treatment Period 2 (8 Weeks)||37||
59975377|NCT02392234|76092830|FG005|COMPLETED|Treatment Period 2 (8 Weeks)||38||
59975378|NCT02392234|76092825|FG000|NOT COMPLETED|Treatment Period 2 (8 Weeks)||1||
59975379|NCT02392234|76092826|FG001|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0||
59975380|NCT02392234|76092827|FG002|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0||
59813227|NCT04827134|75935725|FG001|COMPLETED|Treatment Period 1 (1 Day)||8||
59813228|NCT04827134|75935726|FG002|COMPLETED|Treatment Period 1 (1 Day)||7||
59813229|NCT04827134|75935727|FG003|COMPLETED|Treatment Period 1 (1 Day)||9||
59813230|NCT04827134|75935724|FG000|NOT COMPLETED|Treatment Period 1 (1 Day)||0||
59813231|NCT04827134|75935725|FG001|NOT COMPLETED|Treatment Period 1 (1 Day)||0||
59813232|NCT04827134|75935726|FG002|NOT COMPLETED|Treatment Period 1 (1 Day)||1||
59813233|NCT04827134|75935727|FG003|NOT COMPLETED|Treatment Period 1 (1 Day)||0||
59525823|NCT00022490|75621202|FG000|NOT COMPLETED|Overall Study||0||
59525824|NCT00097448|75621208|FG000|STARTED|Overall Study||125||
59525825|NCT00097448|75621209|FG001|STARTED|Overall Study||130||
59525826|NCT00097448|75621208|FG000|COMPLETED|Overall Study||121||
59525827|NCT00097448|75621209|FG001|COMPLETED|Overall Study||129||
59525828|NCT00097448|75621208|FG000|NOT COMPLETED|Overall Study||4||
59525829|NCT00097448|75621209|FG001|NOT COMPLETED|Overall Study||1||
59525830|NCT00028262|75621215|FG000|STARTED|Overall Study||10||
59525831|NCT00028262|75621215|FG000|COMPLETED|Overall Study||9||
59525832|NCT00028262|75621215|FG000|NOT COMPLETED|Overall Study||1||
59525833|NCT00101036|75621221|FG000|STARTED|Overall Study||17||
59525834|NCT00101036|75621222|FG001|STARTED|Overall Study||40||
59525835|NCT00101036|75621221|FG000|COMPLETED|Overall Study||17||
59525836|NCT00101036|75621222|FG001|COMPLETED|Overall Study||40||
59525837|NCT00101036|75621221|FG000|NOT COMPLETED|Overall Study||0||
59525838|NCT00101036|75621222|FG001|NOT COMPLETED|Overall Study||0||
59525839|NCT00030992|75621228|FG000|STARTED|Overall Study||102||
59525840|NCT00030992|75621228|FG000|COMPLETED|Overall Study||102||
59525841|NCT00030992|75621228|FG000|NOT COMPLETED|Overall Study||0||
59525842|NCT00032630|75621234|FG000|STARTED|Overall Study||1099||
59525843|NCT00032630|75621235|FG001|STARTED|Overall Study||1104||
59525844|NCT00032630|75621234|FG000|COMPLETED|Overall Study||1050||
59525845|NCT00032630|75621235|FG001|COMPLETED|Overall Study||1061||
59525846|NCT00032630|75621234|FG000|NOT COMPLETED|Overall Study||49||
59525847|NCT00032630|75621235|FG001|NOT COMPLETED|Overall Study||43||
59525848|NCT01217749|75621244|FG000|STARTED|Overall Study||27||
59525849|NCT01217749|75621245|FG001|STARTED|Overall Study||20||
59525850|NCT01217749|75621246|FG002|STARTED|Overall Study||24||
59525851|NCT01217749|75621244|FG000|COMPLETED|Overall Study||24||
59525852|NCT01217749|75621245|FG001|COMPLETED|Overall Study||17||
59525853|NCT01217749|75621246|FG002|COMPLETED|Overall Study||22||
59525854|NCT01217749|75621244|FG000|NOT COMPLETED|Overall Study||3||
59813234|NCT04827134|75935724|FG000|STARTED|Washout Period (up to 7 Days)||8||
59813235|NCT04827134|75935725|FG001|STARTED|Washout Period (up to 7 Days)||8||
59813236|NCT04827134|75935726|FG002|STARTED|Washout Period (up to 7 Days)||7||
59813237|NCT04827134|75935727|FG003|STARTED|Washout Period (up to 7 Days)||9||
59813238|NCT04827134|75935724|FG000|COMPLETED|Washout Period (up to 7 Days)||8||
59813239|NCT04827134|75935725|FG001|COMPLETED|Washout Period (up to 7 Days)||8||
59813240|NCT04827134|75935726|FG002|COMPLETED|Washout Period (up to 7 Days)||7||
59813241|NCT04827134|75935727|FG003|COMPLETED|Washout Period (up to 7 Days)||9||
59813242|NCT04827134|75935724|FG000|NOT COMPLETED|Washout Period (up to 7 Days)||0||
59813243|NCT04827134|75935725|FG001|NOT COMPLETED|Washout Period (up to 7 Days)||0||
59525855|NCT01217749|75621245|FG001|NOT COMPLETED|Overall Study||3||
59525856|NCT01217749|75621246|FG002|NOT COMPLETED|Overall Study||2||
59525857|NCT01217827|75621258|FG000|STARTED|Overall Study||46||
59525858|NCT01217827|75621259|FG001|STARTED|Overall Study||43||
59525859|NCT01217827|75621258|FG000|COMPLETED|Overall Study||46||
59525860|NCT01217827|75621259|FG001|COMPLETED|Overall Study||43||
59525861|NCT01217827|75621258|FG000|NOT COMPLETED|Overall Study||0||
59525862|NCT01217827|75621259|FG001|NOT COMPLETED|Overall Study||0||
59525863|NCT02197273|75621267|FG000|STARTED|Overall Study||107||
59525864|NCT02197273|75621268|FG001|STARTED|Overall Study||104||
59975381|NCT02392234|76092828|FG003|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0||
59975382|NCT02392234|76092829|FG004|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0||
59975383|NCT02392234|76092830|FG005|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0||
59975384|NCT02963090|76092844|FG000|STARTED|Non-cross Over Phase||3||
59975385|NCT02963090|76092845|FG001|STARTED|Non-cross Over Phase||6||
59975386|NCT02963090|76092844|FG000|COMPLETED|Non-cross Over Phase||2||
59975387|NCT02963090|76092845|FG001|COMPLETED|Non-cross Over Phase||6||
59975388|NCT02963090|76092844|FG000|NOT COMPLETED|Non-cross Over Phase||1||
59975389|NCT02963090|76092845|FG001|NOT COMPLETED|Non-cross Over Phase||0||
59813244|NCT04827134|75935726|FG002|NOT COMPLETED|Washout Period (up to 7 Days)||0||
59813245|NCT04827134|75935727|FG003|NOT COMPLETED|Washout Period (up to 7 Days)||0||
59813246|NCT04827134|75935724|FG000|STARTED|Treatment Period 2 (1 Day)||8||
59813247|NCT04827134|75935725|FG001|STARTED|Treatment Period 2 (1 Day)||8||
59975390|NCT02963090|76092844|FG000|STARTED|Cross Over Phase||2||
59975391|NCT02963090|76092845|FG001|STARTED|Cross Over Phase||0||
59975392|NCT02963090|76092844|FG000|COMPLETED|Cross Over Phase||2||
59975393|NCT02963090|76092845|FG001|COMPLETED|Cross Over Phase||0||
59975394|NCT02963090|76092844|FG000|NOT COMPLETED|Cross Over Phase||0||
59975395|NCT02963090|76092845|FG001|NOT COMPLETED|Cross Over Phase||0||
59975396|NCT02427802|76092857|FG000|STARTED|Overall Study||305||
59975397|NCT02427802|76092858|FG001|STARTED|Overall Study||154||
59975398|NCT02427802|76092859|FG002|STARTED|Overall Study||153||
59975399|NCT02427802|76092857|FG000|COMPLETED|Overall Study||246||
59975400|NCT02427802|76092858|FG001|COMPLETED|Overall Study||120||
59975401|NCT02427802|76092859|FG002|COMPLETED|Overall Study||110||
59975402|NCT02427802|76092857|FG000|NOT COMPLETED|Overall Study||59||
59975403|NCT02427802|76092858|FG001|NOT COMPLETED|Overall Study||34||
59975404|NCT02427802|76092859|FG002|NOT COMPLETED|Overall Study||43||
59975405|NCT02427646|76092869|FG000|STARTED|Overall Study||24||
59975406|NCT02427646|76092870|FG001|STARTED|Overall Study||28||
59975407|NCT02427646|76092869|FG000|COMPLETED|Overall Study||16||
59975408|NCT02427646|76092870|FG001|COMPLETED|Overall Study||14||
59975409|NCT02427646|76092869|FG000|NOT COMPLETED|Overall Study||8||
59975410|NCT02427646|76092870|FG001|NOT COMPLETED|Overall Study||14||
59975411|NCT02392000|76092878|FG000|STARTED|Overall Study||38||
59975412|NCT02392000|76092878|FG000|COMPLETED|Overall Study||11||
59975413|NCT02392000|76092878|FG000|NOT COMPLETED|Overall Study||27||
59975414|NCT02385526|76092886|FG000|STARTED|Overall Study||22||
59975415|NCT02385526|76092887|FG001|STARTED|Overall Study||20||
59975416|NCT02385526|76092888|FG002|STARTED|Overall Study||20||
59975417|NCT02385526|76092886|FG000|COMPLETED|Overall Study||20||
59975418|NCT02385526|76092887|FG001|COMPLETED|Overall Study||17||
59975419|NCT02385526|76092888|FG002|COMPLETED|Overall Study||20||
59975420|NCT02385526|76092886|FG000|NOT COMPLETED|Overall Study||2||
59975421|NCT02385526|76092887|FG001|NOT COMPLETED|Overall Study||3||
59975422|NCT02385526|76092888|FG002|NOT COMPLETED|Overall Study||0||
59975423|NCT02808143|76092898|FG000|STARTED|Pre-Induction Period||3||
59813248|NCT04827134|75935726|FG002|STARTED|Treatment Period 2 (1 Day)||7||
59813249|NCT04827134|75935727|FG003|STARTED|Treatment Period 2 (1 Day)||9||
59813250|NCT04827134|75935724|FG000|COMPLETED|Treatment Period 2 (1 Day)||8||
59813251|NCT04827134|75935725|FG001|COMPLETED|Treatment Period 2 (1 Day)||8||
59813252|NCT04827134|75935726|FG002|COMPLETED|Treatment Period 2 (1 Day)||7||
59813253|NCT04827134|75935727|FG003|COMPLETED|Treatment Period 2 (1 Day)||9||
59813254|NCT04827134|75935724|FG000|NOT COMPLETED|Treatment Period 2 (1 Day)||0||
59813255|NCT04827134|75935725|FG001|NOT COMPLETED|Treatment Period 2 (1 Day)||0||
59813256|NCT04827134|75935726|FG002|NOT COMPLETED|Treatment Period 2 (1 Day)||0||
59813257|NCT04827134|75935727|FG003|NOT COMPLETED|Treatment Period 2 (1 Day)||0||
59975424|NCT02808143|76092899|FG001|STARTED|Pre-Induction Period||6||
59975425|NCT02808143|76092898|FG000|COMPLETED|Pre-Induction Period||3||
59975426|NCT02808143|76092899|FG001|COMPLETED|Pre-Induction Period||6||
59975427|NCT02808143|76092898|FG000|NOT COMPLETED|Pre-Induction Period||0||
59975428|NCT02808143|76092899|FG001|NOT COMPLETED|Pre-Induction Period||0||
59975429|NCT02808143|76092898|FG000|STARTED|Induction Period||3||
59975430|NCT02808143|76092899|FG001|STARTED|Induction Period||6||
59975431|NCT02808143|76092898|FG000|COMPLETED|Induction Period||3||
59975432|NCT02808143|76092899|FG001|COMPLETED|Induction Period||6||
59975433|NCT02808143|76092898|FG000|NOT COMPLETED|Induction Period||0||
59975434|NCT02808143|76092899|FG001|NOT COMPLETED|Induction Period||0||
59975435|NCT02808143|76092898|FG000|STARTED|Maintenance Phase||3||
59975436|NCT02808143|76092899|FG001|STARTED|Maintenance Phase||6||
59975437|NCT02808143|76092898|FG000|COMPLETED|Maintenance Phase||1||
59975438|NCT02808143|76092899|FG001|COMPLETED|Maintenance Phase||1||
59975439|NCT02808143|76092898|FG000|NOT COMPLETED|Maintenance Phase||2||
59975440|NCT02808143|76092899|FG001|NOT COMPLETED|Maintenance Phase||5||
59975441|NCT02808143|76092898|FG000|STARTED|Survival Follow-Up||3|Once off treatment, patients were followed clinically for disease recurrence and survival according to protocol schedule until death, withdrawal, or end of study (whichever occurs first).|
59975442|NCT02808143|76092899|FG001|STARTED|Survival Follow-Up||6|Once off treatment, patients were followed clinically for disease recurrence and survival according to protocol schedule until death, withdrawal, or end of study (whichever occurs first).|
59975443|NCT02808143|76092898|FG000|COMPLETED|Survival Follow-Up||0||
59975444|NCT02808143|76092899|FG001|COMPLETED|Survival Follow-Up||0||
59975445|NCT02808143|76092898|FG000|NOT COMPLETED|Survival Follow-Up||3||
59975446|NCT02808143|76092899|FG001|NOT COMPLETED|Survival Follow-Up||6||
59975447|NCT02427100|76092909|FG000|STARTED|Overall Study||15||
59975448|NCT02427100|76092910|FG001|STARTED|Overall Study||17||
59975449|NCT02427100|76092909|FG000|COMPLETED|Overall Study||15||
59975450|NCT02427100|76092910|FG001|COMPLETED|Overall Study||15||
59975451|NCT02427100|76092909|FG000|NOT COMPLETED|Overall Study||0||
59813258|NCT04818593|75935741|FG000|STARTED|Overall Study||54||231
59813259|NCT04818593|75935742|FG001|STARTED|Overall Study||54||225
59813260|NCT04818593|75935741|FG000|COMPLETED|Overall Study||34|Oocyte units were assigned to density gradient and/or ZyMot microfluidics insemination techniques depending on how they met study criteria. Sperm samples that were insufficient for ZyMot processing were not processed and the corresponding participant dyad was withdrawn from the study. The number of oocyte units that started the study for each arm is equal to the number completed, as the unit number (oocytes) is not known for the cycles that were withdrawn from the study and cannot be calculated.|231
59817884|NCT04488770|75940336|FG010|STARTED|Part 1-Cohort 2: Period 1 (Up to 5 Days)||0||
59817885|NCT04488770|75940337|FG011|STARTED|Part 1-Cohort 2: Period 1 (Up to 5 Days)||0||
59817886|NCT04488770|75940338|FG012|STARTED|Part 1-Cohort 2: Period 1 (Up to 5 Days)||0||
59975452|NCT02427100|76092910|FG001|NOT COMPLETED|Overall Study||2||
59975453|NCT02806973|76092916|FG000|STARTED|Period 1||8||
59975454|NCT02806973|76092917|FG001|STARTED|Period 1||8||
59975455|NCT02806973|76092918|FG002|STARTED|Period 1||8||
59975456|NCT02806973|76092919|FG003|STARTED|Period 1||8||
59975457|NCT02806973|76092916|FG000|COMPLETED|Period 1||8||
59975458|NCT02806973|76092917|FG001|COMPLETED|Period 1||6||
59975459|NCT02806973|76092918|FG002|COMPLETED|Period 1||7||
59975460|NCT02806973|76092919|FG003|COMPLETED|Period 1||6||
59975461|NCT02806973|76092916|FG000|NOT COMPLETED|Period 1||0||
59975462|NCT02806973|76092917|FG001|NOT COMPLETED|Period 1||2||
59975463|NCT02806973|76092918|FG002|NOT COMPLETED|Period 1||1||
59975464|NCT02806973|76092919|FG003|NOT COMPLETED|Period 1||2||
59975465|NCT02806973|76092916|FG000|STARTED|Period 2||8||
59975466|NCT02806973|76092917|FG001|STARTED|Period 2||6||
59975467|NCT02806973|76092918|FG002|STARTED|Period 2||7||
59975468|NCT02806973|76092919|FG003|STARTED|Period 2||6||
59975469|NCT02806973|76092916|FG000|COMPLETED|Period 2||8||
59975470|NCT02806973|76092917|FG001|COMPLETED|Period 2||6||
59975471|NCT02806973|76092918|FG002|COMPLETED|Period 2||7||
59975472|NCT02806973|76092919|FG003|COMPLETED|Period 2||6||
59975473|NCT02806973|76092916|FG000|NOT COMPLETED|Period 2||0||
59975474|NCT02806973|76092917|FG001|NOT COMPLETED|Period 2||0||
59975475|NCT02806973|76092918|FG002|NOT COMPLETED|Period 2||0||
59975476|NCT02806973|76092919|FG003|NOT COMPLETED|Period 2||0||
59975477|NCT02806973|76092916|FG000|STARTED|Period 3||8||
59975478|NCT02806973|76092917|FG001|STARTED|Period 3||6||
59975479|NCT02806973|76092918|FG002|STARTED|Period 3||7||
59975480|NCT02806973|76092919|FG003|STARTED|Period 3||6||
59975481|NCT02806973|76092916|FG000|COMPLETED|Period 3||8||
59975482|NCT02806973|76092917|FG001|COMPLETED|Period 3||6||
59975483|NCT02806973|76092918|FG002|COMPLETED|Period 3||6||
59975484|NCT02806973|76092919|FG003|COMPLETED|Period 3||3||
59975485|NCT02806973|76092916|FG000|NOT COMPLETED|Period 3||0||
59975486|NCT02806973|76092917|FG001|NOT COMPLETED|Period 3||0||
59975487|NCT02806973|76092918|FG002|NOT COMPLETED|Period 3||1||
59975488|NCT02806973|76092919|FG003|NOT COMPLETED|Period 3||3||
59975489|NCT02806973|76092916|FG000|STARTED|Period 4||8||
59975490|NCT02806973|76092917|FG001|STARTED|Period 4||6||
59975491|NCT02806973|76092918|FG002|STARTED|Period 4||6||
59975492|NCT02806973|76092919|FG003|STARTED|Period 4||3||
59975493|NCT02806973|76092916|FG000|COMPLETED|Period 4||8||
59817887|NCT04488770|75940326|FG000|COMPLETED|Part 1-Cohort 2: Period 1 (Up to 5 Days)||0||
59975494|NCT02806973|76092917|FG001|COMPLETED|Period 4||6||
59975495|NCT02806973|76092918|FG002|COMPLETED|Period 4||6||
59975496|NCT02806973|76092919|FG003|COMPLETED|Period 4||3||
59975497|NCT02806973|76092916|FG000|NOT COMPLETED|Period 4||0||
59975498|NCT02806973|76092917|FG001|NOT COMPLETED|Period 4||0||
59975499|NCT02806973|76092918|FG002|NOT COMPLETED|Period 4||0||
59975500|NCT02806973|76092919|FG003|NOT COMPLETED|Period 4||0||
59975501|NCT02806505|76092931|FG000|STARTED|Overall Study||38||
59975502|NCT02806505|76092932|FG001|STARTED|Overall Study||43||
59975503|NCT02806505|76092931|FG000|COMPLETED|Overall Study||28||
59975504|NCT02806505|76092932|FG001|COMPLETED|Overall Study||32||
59975505|NCT02806505|76092931|FG000|NOT COMPLETED|Overall Study||10||
59975506|NCT02806505|76092932|FG001|NOT COMPLETED|Overall Study||11||
59975507|NCT02807363|76092942|FG000|STARTED|Dosing Period||9||
59975508|NCT02807363|76092943|FG001|STARTED|Dosing Period||9||
59975509|NCT02807363|76092944|FG002|STARTED|Dosing Period||5||
59975510|NCT02807363|76092945|FG003|STARTED|Dosing Period||12||
59975511|NCT02807363|76092942|FG000|COMPLETED|Dosing Period||9||
59975512|NCT02807363|76092943|FG001|COMPLETED|Dosing Period||8||
59975513|NCT02807363|76092944|FG002|COMPLETED|Dosing Period||5||
59975514|NCT02807363|76092945|FG003|COMPLETED|Dosing Period||12||
59975515|NCT02807363|76092942|FG000|NOT COMPLETED|Dosing Period||0||
59975516|NCT02807363|76092943|FG001|NOT COMPLETED|Dosing Period||1||
59975517|NCT02807363|76092944|FG002|NOT COMPLETED|Dosing Period||0||
59975518|NCT02807363|76092945|FG003|NOT COMPLETED|Dosing Period||0||
59975519|NCT02807363|76092942|FG000|STARTED|Post- Dosing Period||9||
59975520|NCT02807363|76092943|FG001|STARTED|Post- Dosing Period||8||
59975521|NCT02807363|76092944|FG002|STARTED|Post- Dosing Period||5||
59975522|NCT02807363|76092945|FG003|STARTED|Post- Dosing Period||12||
59975523|NCT02807363|76092942|FG000|COMPLETED|Post- Dosing Period||9||
59975524|NCT02807363|76092943|FG001|COMPLETED|Post- Dosing Period||8||
59975525|NCT02807363|76092944|FG002|COMPLETED|Post- Dosing Period||5||
59975526|NCT02807363|76092945|FG003|COMPLETED|Post- Dosing Period||12||
59975527|NCT02807363|76092942|FG000|NOT COMPLETED|Post- Dosing Period||0||
59975528|NCT02807363|76092943|FG001|NOT COMPLETED|Post- Dosing Period||0||
59975529|NCT02807363|76092944|FG002|NOT COMPLETED|Post- Dosing Period||0||
59975530|NCT02807363|76092945|FG003|NOT COMPLETED|Post- Dosing Period||0||
59975531|NCT02383966|76092959|FG000|STARTED|Overall Study||164||
59975532|NCT02383966|76092960|FG001|STARTED|Overall Study||79||
59975533|NCT02383966|76092959|FG000|COMPLETED|Overall Study||138||
59975534|NCT02383966|76092960|FG001|COMPLETED|Overall Study||72||
59975535|NCT02383966|76092959|FG000|NOT COMPLETED|Overall Study||26||
59975536|NCT02383966|76092960|FG001|NOT COMPLETED|Overall Study||7||
59975537|NCT02383576|76092968|FG000|STARTED|Overall Study||94||
59975538|NCT02383576|76092969|FG001|STARTED|Overall Study||91||
59975539|NCT02383576|76092968|FG000|COMPLETED|Overall Study||31||
59975540|NCT02383576|76092969|FG001|COMPLETED|Overall Study||46||
59975541|NCT02383576|76092968|FG000|NOT COMPLETED|Overall Study||63||
59975542|NCT02383576|76092969|FG001|NOT COMPLETED|Overall Study||45||
59975543|NCT02748317|76092975|FG000|STARTED|Overall Study||96||
59975544|NCT02748317|76092975|FG000|COMPLETED|Overall Study||73||
59975545|NCT02748317|76092975|FG000|NOT COMPLETED|Overall Study||23||
59975546|NCT02426086|76092981|FG000|STARTED|Overall Study||48||
59975547|NCT02426086|76092982|FG001|STARTED|Overall Study||59||
59975548|NCT02426086|76092981|FG000|Treated|Overall Study||48||
59975549|NCT02426086|76092982|FG001|Treated|Overall Study||59||
59975550|NCT02426086|76092981|FG000|COMPLETED|Overall Study||0|Disposition data is reported until the end of study.|
59975551|NCT02426086|76092982|FG001|COMPLETED|Overall Study||0|Disposition data is reported until the end of study.|
59813261|NCT04818593|75935742|FG001|COMPLETED|Overall Study||34|Oocyte units were assigned to density gradient and/or ZyMot microfluidics insemination techniques depending on how they met study criteria. Sperm samples that were insufficient for ZyMot processing were not processed and the corresponding participant dyad was withdrawn from the study. The number of oocyte units that started the study for each arm is equal to the number completed, as the unit number (oocytes) is not known for the cycles that were withdrawn from the study and cannot be calculated.|225
59813262|NCT04818593|75935741|FG000|NOT COMPLETED|Overall Study||20||0
59813263|NCT04818593|75935742|FG001|NOT COMPLETED|Overall Study||20||0
59813264|NCT04680975|75935748|FG000|STARTED|Overall Study||10||
59813265|NCT04680975|75935748|FG000|COMPLETED|Overall Study||4||
59813266|NCT04680975|75935748|FG000|NOT COMPLETED|Overall Study||6||
59813267|NCT04673786|75935754|FG000|STARTED|Treatment Period I (Weeks 0 to 16)||256||
59813268|NCT04673786|75935755|FG001|STARTED|Treatment Period I (Weeks 0 to 16)||253||
59813269|NCT04673786|75935756|FG002|STARTED|Treatment Period I (Weeks 0 to 16)||0||
59813270|NCT04673786|75935754|FG000|COMPLETED|Treatment Period I (Weeks 0 to 16)||253||
59975552|NCT02426086|76092981|FG000|NOT COMPLETED|Overall Study||48||
59975553|NCT02426086|76092982|FG001|NOT COMPLETED|Overall Study||59||
59975554|NCT02422264|76092995|FG000|STARTED|Overall Study||296||
59622195|NCT00384774|75733935|FG006|Received at Least 1 Dose of Study Drug|Overall Study||4||
59622196|NCT00384774|75733929|FG000|COMPLETED|Overall Study||42||
59622197|NCT00384774|75733930|FG001|COMPLETED|Overall Study||4||
59622198|NCT00384774|75733931|FG002|COMPLETED|Overall Study||12||
59622199|NCT00384774|75733932|FG003|COMPLETED|Overall Study||24||
59622200|NCT00384774|75733933|FG004|COMPLETED|Overall Study||28||
59622201|NCT00384774|75733934|FG005|COMPLETED|Overall Study||16||
59975555|NCT02422264|76092996|FG001|STARTED|Overall Study||305||
59975556|NCT02422264|76092995|FG000|COMPLETED|Overall Study||291||
59975557|NCT02422264|76092996|FG001|COMPLETED|Overall Study||301||
59975558|NCT02422264|76092995|FG000|NOT COMPLETED|Overall Study||5||
59975559|NCT02422264|76092996|FG001|NOT COMPLETED|Overall Study||4||
59975560|NCT02390362|76093004|FG000|STARTED|Overall Study|1 subject enrolled in this arm. completed 2 doses of Rituximab.|1||
59975561|NCT02390362|76093005|FG001|STARTED|Overall Study||2||
59975562|NCT02390362|76093004|FG000|COMPLETED|Overall Study||1||
59975563|NCT02390362|76093005|FG001|COMPLETED|Overall Study||1||
59975564|NCT02390362|76093004|FG000|NOT COMPLETED|Overall Study||0||
59975565|NCT02390362|76093005|FG001|NOT COMPLETED|Overall Study||1||
59975566|NCT02389894|76093014|FG000|STARTED|Overall Study||133||
59975567|NCT02389894|76093015|FG001|STARTED|Overall Study||118||
59975568|NCT02389894|76093016|FG002|STARTED|Overall Study||132||
59975569|NCT02389894|76093014|FG000|COMPLETED|Overall Study||125||
59975570|NCT02389894|76093015|FG001|COMPLETED|Overall Study||108||
59975571|NCT02389894|76093016|FG002|COMPLETED|Overall Study||123||
59975572|NCT02389894|76093014|FG000|NOT COMPLETED|Overall Study||8||
59975573|NCT02389894|76093015|FG001|NOT COMPLETED|Overall Study||10||
59975574|NCT02389894|76093016|FG002|NOT COMPLETED|Overall Study||9||
59975575|NCT02389816|76093027|FG000|STARTED|Overall Study||164||
59975576|NCT02389816|76093028|FG001|STARTED|Overall Study||165||
59975577|NCT02389816|76093029|FG002|STARTED|Overall Study||164||
59975578|NCT02389816|76093027|FG000|COMPLETED|Overall Study||149||
59975579|NCT02389816|76093028|FG001|COMPLETED|Overall Study||152||
59975580|NCT02389816|76093029|FG002|COMPLETED|Overall Study||152||
59975581|NCT02389816|76093027|FG000|NOT COMPLETED|Overall Study||15||
59975582|NCT02389816|76093028|FG001|NOT COMPLETED|Overall Study||13||
59975583|NCT02389816|76093029|FG002|NOT COMPLETED|Overall Study||12||
59975584|NCT02388724|76093039|FG000|STARTED|Overall Study||244||
59975585|NCT02388724|76093040|FG001|STARTED|Overall Study||237||
59975586|NCT02388724|76093039|FG000|Safety Set: Randomized But Not Treated|Overall Study||0||
59975587|NCT02388724|76093040|FG001|Safety Set: Randomized But Not Treated|Overall Study||2||
59975588|NCT02388724|76093039|FG000|COMPLETED|Overall Study||232|Completed=Completed Treatment|
59975589|NCT02388724|76093040|FG001|COMPLETED|Overall Study||224|Completed=Completed Treatment|
59975590|NCT02388724|76093039|FG000|NOT COMPLETED|Overall Study||12||
59975591|NCT02388724|76093040|FG001|NOT COMPLETED|Overall Study||13||
59975592|NCT02382796|76093046|FG000|STARTED|Overall Study||7||
59975593|NCT02382796|76093046|FG000|COMPLETED|Overall Study||0||
59975594|NCT02382796|76093046|FG000|NOT COMPLETED|Overall Study||7||
59975595|NCT02382640|76093054|FG000|STARTED|Intervention Period 1 (3 Days)||9||
59975596|NCT02382640|76093055|FG001|STARTED|Intervention Period 1 (3 Days)||9||
59975597|NCT02382640|76093056|FG002|STARTED|Intervention Period 1 (3 Days)||9||
59975598|NCT02382640|76093057|FG003|STARTED|Intervention Period 1 (3 Days)||9||
59975599|NCT02382640|76093054|FG000|COMPLETED|Intervention Period 1 (3 Days)||9||
59975600|NCT02382640|76093055|FG001|COMPLETED|Intervention Period 1 (3 Days)||9||
59975601|NCT02382640|76093056|FG002|COMPLETED|Intervention Period 1 (3 Days)||9||
59975602|NCT02382640|76093057|FG003|COMPLETED|Intervention Period 1 (3 Days)||9||
59975603|NCT02382640|76093054|FG000|NOT COMPLETED|Intervention Period 1 (3 Days)||0||
59975604|NCT02382640|76093055|FG001|NOT COMPLETED|Intervention Period 1 (3 Days)||0||
59975605|NCT02382640|76093056|FG002|NOT COMPLETED|Intervention Period 1 (3 Days)||0||
59975606|NCT02382640|76093057|FG003|NOT COMPLETED|Intervention Period 1 (3 Days)||0||
59975607|NCT02382640|76093054|FG000|STARTED|Washout Period 1 (7 Days)||9||
59975608|NCT02382640|76093055|FG001|STARTED|Washout Period 1 (7 Days)||9||
59975609|NCT02382640|76093056|FG002|STARTED|Washout Period 1 (7 Days)||9||
59975610|NCT02382640|76093057|FG003|STARTED|Washout Period 1 (7 Days)||9||
59975611|NCT02382640|76093054|FG000|COMPLETED|Washout Period 1 (7 Days)||9||
59975612|NCT02382640|76093055|FG001|COMPLETED|Washout Period 1 (7 Days)||9||
59975613|NCT02382640|76093056|FG002|COMPLETED|Washout Period 1 (7 Days)||9||
59975614|NCT02382640|76093057|FG003|COMPLETED|Washout Period 1 (7 Days)||9||
59975615|NCT02382640|76093054|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0||
59975616|NCT02382640|76093055|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0||
59975617|NCT02382640|76093056|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0||
59975618|NCT02382640|76093057|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0||
59975619|NCT02382640|76093054|FG000|STARTED|Intervention Period 2 (3 Days)||9||
59975620|NCT02382640|76093055|FG001|STARTED|Intervention Period 2 (3 Days)||9||
59975621|NCT02382640|76093056|FG002|STARTED|Intervention Period 2 (3 Days)||9||
59975622|NCT02382640|76093057|FG003|STARTED|Intervention Period 2 (3 Days)||9||
59975623|NCT02382640|76093054|FG000|COMPLETED|Intervention Period 2 (3 Days)||9||
59975624|NCT02382640|76093055|FG001|COMPLETED|Intervention Period 2 (3 Days)||9||
59975625|NCT02382640|76093056|FG002|COMPLETED|Intervention Period 2 (3 Days)||9||
59975626|NCT02382640|76093057|FG003|COMPLETED|Intervention Period 2 (3 Days)||9||
59975627|NCT02382640|76093054|FG000|NOT COMPLETED|Intervention Period 2 (3 Days)||0||
59975628|NCT02382640|76093055|FG001|NOT COMPLETED|Intervention Period 2 (3 Days)||0||
59975629|NCT02382640|76093056|FG002|NOT COMPLETED|Intervention Period 2 (3 Days)||0||
59975630|NCT02382640|76093057|FG003|NOT COMPLETED|Intervention Period 2 (3 Days)||0||
59975631|NCT02382640|76093054|FG000|STARTED|Washout Period 2 (7 Days)||9||
59975632|NCT02382640|76093055|FG001|STARTED|Washout Period 2 (7 Days)||9||
59975633|NCT02382640|76093056|FG002|STARTED|Washout Period 2 (7 Days)||9||
59975634|NCT02382640|76093057|FG003|STARTED|Washout Period 2 (7 Days)||9||
59975635|NCT02382640|76093054|FG000|COMPLETED|Washout Period 2 (7 Days)||9||
59975636|NCT02382640|76093055|FG001|COMPLETED|Washout Period 2 (7 Days)||9||
59975637|NCT02382640|76093056|FG002|COMPLETED|Washout Period 2 (7 Days)||9||
59975638|NCT02382640|76093057|FG003|COMPLETED|Washout Period 2 (7 Days)||9||
59975639|NCT02382640|76093054|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0||
59975640|NCT02382640|76093055|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0||
59975641|NCT02382640|76093056|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0||
59975642|NCT02382640|76093057|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0||
59975643|NCT02382640|76093054|FG000|STARTED|Intervention Period 3 (3 Days)||9||
59975644|NCT02382640|76093055|FG001|STARTED|Intervention Period 3 (3 Days)||9||
59525865|NCT02197273|75621267|FG000|COMPLETED|Overall Study||107||
59975645|NCT02382640|76093056|FG002|STARTED|Intervention Period 3 (3 Days)||9||
59975646|NCT02382640|76093057|FG003|STARTED|Intervention Period 3 (3 Days)||9||
59975647|NCT02382640|76093054|FG000|COMPLETED|Intervention Period 3 (3 Days)||9||
59975648|NCT02382640|76093055|FG001|COMPLETED|Intervention Period 3 (3 Days)||9||
59975649|NCT02382640|76093056|FG002|COMPLETED|Intervention Period 3 (3 Days)||9||
59975650|NCT02382640|76093057|FG003|COMPLETED|Intervention Period 3 (3 Days)||9||
59975651|NCT02382640|76093054|FG000|NOT COMPLETED|Intervention Period 3 (3 Days)||0||
59975652|NCT02382640|76093055|FG001|NOT COMPLETED|Intervention Period 3 (3 Days)||0||
59975653|NCT02382640|76093056|FG002|NOT COMPLETED|Intervention Period 3 (3 Days)||0||
59975654|NCT02382640|76093057|FG003|NOT COMPLETED|Intervention Period 3 (3 Days)||0||
59975655|NCT02382640|76093054|FG000|STARTED|Washout Period 3 (7 Days)||9||
59975656|NCT02382640|76093055|FG001|STARTED|Washout Period 3 (7 Days)||9||
59975657|NCT02382640|76093056|FG002|STARTED|Washout Period 3 (7 Days)||9||
59975658|NCT02382640|76093057|FG003|STARTED|Washout Period 3 (7 Days)||9||
59975659|NCT02382640|76093054|FG000|COMPLETED|Washout Period 3 (7 Days)||9||
59975660|NCT02382640|76093055|FG001|COMPLETED|Washout Period 3 (7 Days)||9||
59975661|NCT02382640|76093056|FG002|COMPLETED|Washout Period 3 (7 Days)||9||
59975662|NCT02382640|76093057|FG003|COMPLETED|Washout Period 3 (7 Days)||9||
59975663|NCT02382640|76093054|FG000|NOT COMPLETED|Washout Period 3 (7 Days)||0||
59975664|NCT02382640|76093055|FG001|NOT COMPLETED|Washout Period 3 (7 Days)||0||
59975665|NCT02382640|76093056|FG002|NOT COMPLETED|Washout Period 3 (7 Days)||0||
59975666|NCT02382640|76093057|FG003|NOT COMPLETED|Washout Period 3 (7 Days)||0||
59975667|NCT02382640|76093054|FG000|STARTED|Intervention Period 4 (3 Days)||9||
59975668|NCT02382640|76093055|FG001|STARTED|Intervention Period 4 (3 Days)||9||
59975669|NCT02382640|76093056|FG002|STARTED|Intervention Period 4 (3 Days)||9||
59975670|NCT02382640|76093057|FG003|STARTED|Intervention Period 4 (3 Days)||9||
59975671|NCT02382640|76093054|FG000|COMPLETED|Intervention Period 4 (3 Days)||8||
59975672|NCT02382640|76093055|FG001|COMPLETED|Intervention Period 4 (3 Days)||9||
59975673|NCT02382640|76093056|FG002|COMPLETED|Intervention Period 4 (3 Days)||9||
59975674|NCT02382640|76093057|FG003|COMPLETED|Intervention Period 4 (3 Days)||9||
59975675|NCT02382640|76093054|FG000|NOT COMPLETED|Intervention Period 4 (3 Days)||1||
59975676|NCT02382640|76093055|FG001|NOT COMPLETED|Intervention Period 4 (3 Days)||0||
59975677|NCT02382640|76093056|FG002|NOT COMPLETED|Intervention Period 4 (3 Days)||0||
59975678|NCT02382640|76093057|FG003|NOT COMPLETED|Intervention Period 4 (3 Days)||0||
59975679|NCT02801669|76093069|FG000|STARTED|Overall Study||492||
59975680|NCT02801669|76093070|FG001|STARTED|Overall Study||492||
59975681|NCT02801669|76093069|FG000|Received at Least 1 Dose of Study Drug|Overall Study||492||
59975682|NCT02801669|76093070|FG001|Received at Least 1 Dose of Study Drug|Overall Study||490||
59975683|NCT02801669|76093069|FG000|COMPLETED|Overall Study||341||
59975684|NCT02801669|76093070|FG001|COMPLETED|Overall Study||340||
59975685|NCT02801669|76093069|FG000|NOT COMPLETED|Overall Study||151||
59975686|NCT02801669|76093070|FG001|NOT COMPLETED|Overall Study||152||
59975687|NCT02804399|76093076|FG000|STARTED|Period 1||12||
59975688|NCT02804399|76093077|FG001|STARTED|Period 1||0||
59975689|NCT02804399|76093076|FG000|COMPLETED|Period 1||12||
59975690|NCT02804399|76093077|FG001|COMPLETED|Period 1||0||
59975691|NCT02804399|76093076|FG000|NOT COMPLETED|Period 1||0||
59975692|NCT02804399|76093077|FG001|NOT COMPLETED|Period 1||0||
59975693|NCT02804399|76093076|FG000|STARTED|Washout Period at Least 10 Days||12||
59975694|NCT02804399|76093077|FG001|STARTED|Washout Period at Least 10 Days||0||
59975695|NCT02804399|76093076|FG000|COMPLETED|Washout Period at Least 10 Days||12||
59975696|NCT02804399|76093077|FG001|COMPLETED|Washout Period at Least 10 Days||0||
59975697|NCT02804399|76093076|FG000|NOT COMPLETED|Washout Period at Least 10 Days||0||
59975698|NCT02804399|76093077|FG001|NOT COMPLETED|Washout Period at Least 10 Days||0||
59975699|NCT02804399|76093076|FG000|STARTED|Period 2||0||
59975700|NCT02804399|76093077|FG001|STARTED|Period 2||12||
59975701|NCT02804399|76093076|FG000|COMPLETED|Period 2||0||
59975702|NCT02804399|76093077|FG001|COMPLETED|Period 2||11||
59975703|NCT02804399|76093076|FG000|NOT COMPLETED|Period 2||0||
59975704|NCT02804399|76093077|FG001|NOT COMPLETED|Period 2||1||
59813271|NCT04673786|75935755|FG001|COMPLETED|Treatment Period I (Weeks 0 to 16)||249||
59813272|NCT04673786|75935756|FG002|COMPLETED|Treatment Period I (Weeks 0 to 16)||0||
59813273|NCT04673786|75935754|FG000|NOT COMPLETED|Treatment Period I (Weeks 0 to 16)||3||
59813274|NCT04673786|75935755|FG001|NOT COMPLETED|Treatment Period I (Weeks 0 to 16)||4||
59813275|NCT04673786|75935756|FG002|NOT COMPLETED|Treatment Period I (Weeks 0 to 16)||0||
59813276|NCT04673786|75935754|FG000|STARTED|Treatment Period II (Weeks 16 to 52)||253||
59813277|NCT04673786|75935755|FG001|STARTED|Treatment Period II (Weeks 16 to 52)|Patients who had administrated EU-Stelara during Treatment Period I were re-randomized in a ratio of 1:1 to continue EU-Stelara or switch to CT-P43.|125||
59813278|NCT04673786|75935756|FG002|STARTED|Treatment Period II (Weeks 16 to 52)|Patients who had administrated EU-Stelara during Treatment Period I were re-randomized in a ratio of 1:1 to continue EU-Stelara or switch to CT-P43.|124||
59813279|NCT04673786|75935754|FG000|COMPLETED|Treatment Period II (Weeks 16 to 52)||239||
59813280|NCT04673786|75935755|FG001|COMPLETED|Treatment Period II (Weeks 16 to 52)||122||
59813281|NCT04673786|75935756|FG002|COMPLETED|Treatment Period II (Weeks 16 to 52)||122||
59975705|NCT01333943|76093088|FG000|STARTED|Overall Study||47||
59975706|NCT01333943|76093089|FG001|STARTED|Overall Study||47||
59975707|NCT01333943|76093088|FG000|COMPLETED|Overall Study||46||
59975708|NCT01333943|76093089|FG001|COMPLETED|Overall Study||47||
59975709|NCT01333943|76093088|FG000|NOT COMPLETED|Overall Study||1||
59975710|NCT01333943|76093089|FG001|NOT COMPLETED|Overall Study||0||
59975711|NCT01333865|76093095|FG000|STARTED|Overall Study|25 participants signed consent, but only 19 completed screening and were analyzed at baseline.|19||
59975712|NCT01333865|76093095|FG000|COMPLETED|Overall Study|2 participants were withdrawn. One was still analyzed, but one was withdrawn too early for analysis|17||
59975713|NCT01333865|76093095|FG000|NOT COMPLETED|Overall Study||2||
59975714|NCT01333475|76093101|FG000|STARTED|Overall Study||12||
59975715|NCT01333475|76093102|FG001|STARTED|Overall Study||9||
59975716|NCT01333475|76093101|FG000|COMPLETED|Overall Study||10||
59975717|NCT01333475|76093102|FG001|COMPLETED|Overall Study||6||
59975718|NCT01333475|76093101|FG000|NOT COMPLETED|Overall Study||2||
59975719|NCT01333475|76093102|FG001|NOT COMPLETED|Overall Study||3||
59525866|NCT02197273|75621268|FG001|COMPLETED|Overall Study||104||
59525867|NCT02197273|75621267|FG000|NOT COMPLETED|Overall Study||0||
59525868|NCT02197273|75621268|FG001|NOT COMPLETED|Overall Study||0||
59525869|NCT01288027|75621274|FG000|STARTED|Overall Study||16||
59525870|NCT01288027|75621274|FG000|Full Analysis Set (FAS)|Overall Study|All participants who received at least 1 complete infusion of alglucosidase alfa.|16||
59525871|NCT01288027|75621274|FG000|COMPLETED|Overall Study||16||
59525872|NCT01288027|75621274|FG000|NOT COMPLETED|Overall Study||0||
59525873|NCT01288807|75621278|FG000|STARTED|Overall Study||8||
59525874|NCT01288807|75621278|FG000|COMPLETED|Overall Study||8||
59525875|NCT01288807|75621278|FG000|NOT COMPLETED|Overall Study||0||
59525876|NCT01289275|75621286|FG000|STARTED|Overall Study||317||
59525877|NCT01289275|75621287|FG001|STARTED|Overall Study||320||
59525878|NCT01289275|75621288|FG002|STARTED|Overall Study||317||
59525879|NCT01289275|75621289|FG003|STARTED|Overall Study||316||
59525880|NCT01289275|75621286|FG000|COMPLETED|Overall Study||317||
59525881|NCT01289275|75621287|FG001|COMPLETED|Overall Study||320||
59525882|NCT01289275|75621288|FG002|COMPLETED|Overall Study||317||
59525883|NCT01289275|75621289|FG003|COMPLETED|Overall Study||316||
59525884|NCT01289275|75621286|FG000|NOT COMPLETED|Overall Study||0||
59525885|NCT01289275|75621287|FG001|NOT COMPLETED|Overall Study||0||
59525886|NCT01289275|75621288|FG002|NOT COMPLETED|Overall Study||0||
59525887|NCT01289275|75621289|FG003|NOT COMPLETED|Overall Study||0||
59525888|NCT01289431|75621310|FG000|STARTED|Overall Study||34||
59525889|NCT01289431|75621311|FG001|STARTED|Overall Study||34||
59525890|NCT01289431|75621312|FG002|STARTED|Overall Study||34||
59525891|NCT01289431|75621313|FG003|STARTED|Overall Study||33||
59525892|NCT01289431|75621314|FG004|STARTED|Overall Study||34||
59525893|NCT01289431|75621315|FG005|STARTED|Overall Study||33||
59525894|NCT01289431|75621316|FG006|STARTED|Overall Study||34||
59525895|NCT01289431|75621310|FG000|COMPLETED|Overall Study||29||
59525896|NCT01289431|75621311|FG001|COMPLETED|Overall Study||32||
59525897|NCT01289431|75621312|FG002|COMPLETED|Overall Study||30||
59525898|NCT01289431|75621313|FG003|COMPLETED|Overall Study||28||
59525899|NCT01289431|75621314|FG004|COMPLETED|Overall Study||32||
59525900|NCT01289431|75621315|FG005|COMPLETED|Overall Study||31||
59525901|NCT01289431|75621316|FG006|COMPLETED|Overall Study||33||
59525902|NCT01289431|75621310|FG000|NOT COMPLETED|Overall Study||5||
59525903|NCT01289431|75621311|FG001|NOT COMPLETED|Overall Study||2||
59525904|NCT01289431|75621312|FG002|NOT COMPLETED|Overall Study||4||
59525905|NCT01289431|75621313|FG003|NOT COMPLETED|Overall Study||5||
59525906|NCT01289431|75621314|FG004|NOT COMPLETED|Overall Study||2||
59525907|NCT01289431|75621315|FG005|NOT COMPLETED|Overall Study||2||
59525908|NCT01289431|75621316|FG006|NOT COMPLETED|Overall Study||1||
59975720|NCT01333397|76093114|FG000|STARTED|Overall Study||35||
59975721|NCT01333397|76093115|FG001|STARTED|Overall Study||36||
59975722|NCT01333397|76093116|FG002|STARTED|Overall Study||35||
59975723|NCT01333397|76093117|FG003|STARTED|Overall Study||35||
59975724|NCT01333397|76093118|FG004|STARTED|Overall Study||35||
59975725|NCT01333397|76093114|FG000|COMPLETED|Overall Study||34||
59525909|NCT01289665|75621334|FG000|STARTED|Overall Study||60||
59525910|NCT01289665|75621335|FG001|STARTED|Overall Study||60||
59525911|NCT01289665|75621334|FG000|COMPLETED|Overall Study||59||
59525912|NCT01289665|75621335|FG001|COMPLETED|Overall Study||60||
59525913|NCT01289665|75621334|FG000|NOT COMPLETED|Overall Study||1||
59525914|NCT01289665|75621335|FG001|NOT COMPLETED|Overall Study||0||
59525915|NCT01290913|75621341|FG000|STARTED|Overall Study||13||
59525916|NCT01290913|75621341|FG000|COMPLETED|Overall Study||12||
59525917|NCT01290913|75621341|FG000|NOT COMPLETED|Overall Study||1||
59525918|NCT01267045|75621347|FG000|STARTED|2-month Outcomes||26||
59525919|NCT01267045|75621348|FG001|STARTED|2-month Outcomes||29||
59525920|NCT01267045|75621347|FG000|COMPLETED|2-month Outcomes||22||
59525921|NCT01267045|75621348|FG001|COMPLETED|2-month Outcomes||26||
59525922|NCT01267045|75621347|FG000|NOT COMPLETED|2-month Outcomes||4||
59525923|NCT01267045|75621348|FG001|NOT COMPLETED|2-month Outcomes||3||
59525924|NCT01267045|75621347|FG000|STARTED|6-month Outcome||22||
59525925|NCT01267045|75621348|FG001|STARTED|6-month Outcome||26||
59525926|NCT01267045|75621347|FG000|COMPLETED|6-month Outcome||22||
59525927|NCT01267045|75621348|FG001|COMPLETED|6-month Outcome||23||
59525928|NCT01267045|75621347|FG000|NOT COMPLETED|6-month Outcome||0||
59525929|NCT01267045|75621348|FG001|NOT COMPLETED|6-month Outcome||3||
59525930|NCT00101660|75621357|FG000|STARTED|Overall Study||99||
59525931|NCT00101660|75621358|FG001|STARTED|Overall Study||288||
59975726|NCT01333397|76093115|FG001|COMPLETED|Overall Study||36||
59975727|NCT01333397|76093116|FG002|COMPLETED|Overall Study||35||
59525932|NCT00101660|75621357|FG000|COMPLETED|Overall Study||99||
59525933|NCT00101660|75621358|FG001|COMPLETED|Overall Study||288||
59525934|NCT00101660|75621357|FG000|NOT COMPLETED|Overall Study||0||
59525935|NCT00101660|75621358|FG001|NOT COMPLETED|Overall Study||0||
59525936|NCT01267279|75621372|FG000|STARTED|Overall Study||24||
59525937|NCT01267279|75621373|FG001|STARTED|Overall Study||27||
59525938|NCT01267279|75621372|FG000|COMPLETED|Overall Study||22||
59525939|NCT01267279|75621373|FG001|COMPLETED|Overall Study||21||
59813282|NCT04673786|75935754|FG000|NOT COMPLETED|Treatment Period II (Weeks 16 to 52)||14||
59813283|NCT04673786|75935755|FG001|NOT COMPLETED|Treatment Period II (Weeks 16 to 52)||3||
59813284|NCT04673786|75935756|FG002|NOT COMPLETED|Treatment Period II (Weeks 16 to 52)||2||
59813285|NCT04672798|75935771|FG000|STARTED|Overall Study||68||
59813286|NCT04672798|75935772|FG001|STARTED|Overall Study||33||
59813287|NCT04672798|75935771|FG000|COMPLETED|Overall Study||59||
59975728|NCT01333397|76093117|FG003|COMPLETED|Overall Study||34||
59975729|NCT01333397|76093118|FG004|COMPLETED|Overall Study||35||
59975730|NCT01333397|76093114|FG000|NOT COMPLETED|Overall Study||1||
59975731|NCT01333397|76093115|FG001|NOT COMPLETED|Overall Study||0||
59975732|NCT01333397|76093116|FG002|NOT COMPLETED|Overall Study||0||
59975733|NCT01333397|76093117|FG003|NOT COMPLETED|Overall Study||1||
59975734|NCT01333397|76093118|FG004|NOT COMPLETED|Overall Study||0||
59975735|NCT02798861|76093139|FG000|STARTED|Overall Study||160||
59975736|NCT02798861|76093139|FG000|COMPLETED|Overall Study||137||
59975737|NCT02798861|76093139|FG000|NOT COMPLETED|Overall Study||23||
59975738|NCT02798315|76093143|FG000|STARTED|Overall Study||40||
59975739|NCT02798315|76093143|FG000|COMPLETED|Overall Study||39||
59975740|NCT02798315|76093143|FG000|NOT COMPLETED|Overall Study||1||
59975741|NCT02796755|76093149|FG000|STARTED|Overall Study||15||
59975742|NCT02796755|76093150|FG001|STARTED|Overall Study||15||
59975743|NCT02796755|76093149|FG000|COMPLETED|Overall Study||13||
59975744|NCT02796755|76093150|FG001|COMPLETED|Overall Study||15||
59975745|NCT02796755|76093149|FG000|NOT COMPLETED|Overall Study||2||
59975746|NCT02796755|76093150|FG001|NOT COMPLETED|Overall Study||0||
59975747|NCT02382016|76093158|FG000|STARTED|Double-blind (DB) Treatment Period||43||
59975748|NCT02382016|76093159|FG001|STARTED|Double-blind (DB) Treatment Period||42||
59975749|NCT02382016|76093158|FG000|COMPLETED|Double-blind (DB) Treatment Period||39||
59975750|NCT02382016|76093159|FG001|COMPLETED|Double-blind (DB) Treatment Period||41||
59975751|NCT02382016|76093158|FG000|NOT COMPLETED|Double-blind (DB) Treatment Period||4||
59975752|NCT02382016|76093159|FG001|NOT COMPLETED|Double-blind (DB) Treatment Period||1||
59975753|NCT02382016|76093158|FG000|STARTED|Open-label (OL) Treatment Period||80||
59975754|NCT02382016|76093159|FG001|STARTED|Open-label (OL) Treatment Period||0||
59975755|NCT02382016|76093158|FG000|COMPLETED|Open-label (OL) Treatment Period||71||
59975756|NCT02382016|76093159|FG001|COMPLETED|Open-label (OL) Treatment Period||0||
59975757|NCT02382016|76093158|FG000|NOT COMPLETED|Open-label (OL) Treatment Period||9||
59975758|NCT02382016|76093159|FG001|NOT COMPLETED|Open-label (OL) Treatment Period||0||
59975759|NCT02382016|76093158|FG000|STARTED|OL Extension Period|Participants(French site) who completed DB,OL periods, consented receiving macitentan in OLE period.|33||
59975760|NCT02382016|76093159|FG001|STARTED|OL Extension Period||0||
59975761|NCT02382016|76093158|FG000|COMPLETED|OL Extension Period||27||
59975762|NCT02382016|76093159|FG001|COMPLETED|OL Extension Period||0||
59975763|NCT02382016|76093158|FG000|NOT COMPLETED|OL Extension Period||6||
59975764|NCT02382016|76093159|FG001|NOT COMPLETED|OL Extension Period||0||
60074616|NCT01555125|76189970|FG000|STARTED|Induction Period||59||
59813288|NCT04672798|75935772|FG001|COMPLETED|Overall Study||31||
59813289|NCT04672798|75935771|FG000|NOT COMPLETED|Overall Study||9||
59813290|NCT04672798|75935772|FG001|NOT COMPLETED|Overall Study||2||
59813291|NCT04583969|75935780|FG000|STARTED|Overall Study||272||
59813292|NCT04583969|75935781|FG001|STARTED|Overall Study||255||
59813293|NCT04583969|75935780|FG000|COMPLETED|Overall Study||215||
59813294|NCT04583969|75935781|FG001|COMPLETED|Overall Study||196||
59813295|NCT04583969|75935780|FG000|NOT COMPLETED|Overall Study||57||
59975765|NCT02422186|76093169|FG000|STARTED|Double-blind Induction Phase (4 Weeks)||72||
59975766|NCT02422186|76093170|FG001|STARTED|Double-blind Induction Phase (4 Weeks)||66||
59813296|NCT04583969|75935781|FG001|NOT COMPLETED|Overall Study||59||
59813297|NCT04561115|75935787|FG000|STARTED|GC Run-in Phase (Up to 4.5 Months)|Participants not on stable GC treatment entered the GC Run-in Phase to receive GC treatment to achieve an approximate steady-state condition prior to entering the GC PK Phase.|22||
59813298|NCT04561115|75935788|FG001|STARTED|GC Run-in Phase (Up to 4.5 Months)||0||
59813299|NCT04561115|75935787|FG000|COMPLETED|GC Run-in Phase (Up to 4.5 Months)||22||
59813300|NCT04561115|75935788|FG001|COMPLETED|GC Run-in Phase (Up to 4.5 Months)||0||
59975767|NCT02422186|76093169|FG000|Full Analysis Set (FAS)|Double-blind Induction Phase (4 Weeks)||72||
59975768|NCT02422186|76093170|FG001|Full Analysis Set (FAS)|Double-blind Induction Phase (4 Weeks)||65||
59975769|NCT02422186|76093169|FG000|Safety Analysis Set|Double-blind Induction Phase (4 Weeks)||72||
59975770|NCT02422186|76093170|FG001|Safety Analysis Set|Double-blind Induction Phase (4 Weeks)||65||
59975771|NCT02422186|76093169|FG000|COMPLETED|Double-blind Induction Phase (4 Weeks)||62||
59975772|NCT02422186|76093170|FG001|COMPLETED|Double-blind Induction Phase (4 Weeks)||60||
59975773|NCT02422186|76093169|FG000|NOT COMPLETED|Double-blind Induction Phase (4 Weeks)||10||
59975774|NCT02422186|76093170|FG001|NOT COMPLETED|Double-blind Induction Phase (4 Weeks)||6||
59975775|NCT02422186|76093169|FG000|STARTED|Follow-up Phase (2 Weeks)||12||
59975776|NCT02422186|76093170|FG001|STARTED|Follow-up Phase (2 Weeks)||3||
59975777|NCT02422186|76093169|FG000|COMPLETED|Follow-up Phase (2 Weeks)||8||
59975778|NCT02422186|76093170|FG001|COMPLETED|Follow-up Phase (2 Weeks)||3||
59975779|NCT02422186|76093169|FG000|NOT COMPLETED|Follow-up Phase (2 Weeks)||4||
59975780|NCT02422186|76093170|FG001|NOT COMPLETED|Follow-up Phase (2 Weeks)||0||
59975781|NCT02421952|76093178|FG000|STARTED|Overall Study||208||
59975782|NCT02421952|76093178|FG000|Excluded From PACU and Post-Analysis|Overall Study||16|Reasons itemized below|
59975783|NCT02421952|76093178|FG000|Included in PACU Analysis|Overall Study||192||
59975784|NCT02421952|76093178|FG000|COMPLETED|Overall Study||99|Diary returned|
59975785|NCT02421952|76093178|FG000|NOT COMPLETED|Overall Study||109||
59975786|NCT02796677|76093189|FG000|STARTED|Overall Study||317|All participants in the screened population who were randomized to a treatment group in the study.|
59975787|NCT02796677|76093190|FG001|STARTED|Overall Study||478|All participants in the screened population who were randomized to a treatment group in the study.|
59975788|NCT02796677|76093191|FG002|STARTED|Overall Study||320|All participants in the screened population who were randomized to a treatment group in the study.|
59975789|NCT02796677|76093192|FG003|STARTED|Overall Study||479|All participants in the screened population who were randomized to a treatment group in the study.|
59975790|NCT02796677|76093189|FG000|Completed Treatment and Follow-up|Overall Study||279|Participants who completed the study treatment and the study, and attend to the follow-up contact|
59975791|NCT02796677|76093190|FG001|Completed Treatment and Follow-up|Overall Study||405|Participants who completed the study treatment and the study, and attend to the follow-up contact|
59975792|NCT02796677|76093191|FG002|Completed Treatment and Follow-up|Overall Study||267|Participants who completed the study treatment and the study, and attend to the follow-up contact|
59975793|NCT02796677|76093192|FG003|Completed Treatment and Follow-up|Overall Study||403|Participants who completed the study treatment and the study, and attend to the follow-up contact|
59975794|NCT02796677|76093189|FG000|COMPLETED|Overall Study||279|Participants who completed the study treatment and the study|
59975795|NCT02796677|76093190|FG001|COMPLETED|Overall Study||405|Participants who completed the study treatment and the study|
59975796|NCT02796677|76093191|FG002|COMPLETED|Overall Study||267|Participants who completed the study treatment and the study|
59975797|NCT02796677|76093192|FG003|COMPLETED|Overall Study||405|Participants who completed the study treatment and the study|
59975798|NCT02796677|76093189|FG000|NOT COMPLETED|Overall Study||38||
59975799|NCT02796677|76093190|FG001|NOT COMPLETED|Overall Study||73||
59975800|NCT02796677|76093191|FG002|NOT COMPLETED|Overall Study||53||
59975801|NCT02796677|76093192|FG003|NOT COMPLETED|Overall Study||74||
59975802|NCT02421172|76093206|FG000|STARTED|Period 1||33||
59975803|NCT02421172|76093207|FG001|STARTED|Period 1||33||
59975804|NCT02421172|76093208|FG002|STARTED|Period 1||0||
59975805|NCT02421172|76093209|FG003|STARTED|Period 1||0||
59975806|NCT02421172|76093210|FG004|STARTED|Period 1||0||
59975807|NCT02421172|76093206|FG000|PD Analysis Set Period 1|Period 1||31||
59975808|NCT02421172|76093207|FG001|PD Analysis Set Period 1|Period 1||33||
59975809|NCT02421172|76093208|FG002|PD Analysis Set Period 1|Period 1||0||
59975810|NCT02421172|76093209|FG003|PD Analysis Set Period 1|Period 1||0||
59975811|NCT02421172|76093210|FG004|PD Analysis Set Period 1|Period 1||0||
59975812|NCT02421172|76093206|FG000|PK Analysis Set Period 1|Period 1||33||
59975813|NCT02421172|76093207|FG001|PK Analysis Set Period 1|Period 1||0||
59975814|NCT02421172|76093208|FG002|PK Analysis Set Period 1|Period 1||0||
59975815|NCT02421172|76093209|FG003|PK Analysis Set Period 1|Period 1||0||
59975816|NCT02421172|76093210|FG004|PK Analysis Set Period 1|Period 1||0||
59813301|NCT04561115|75935787|FG000|NOT COMPLETED|GC Run-in Phase (Up to 4.5 Months)||0||
59813302|NCT04561115|75935788|FG001|NOT COMPLETED|GC Run-in Phase (Up to 4.5 Months)||0||
59813303|NCT04561115|75935787|FG000|STARTED|GC Run-In + PK Phase (Up to 6 Months)|11 participants directly entered GC PK Phase.|33||
59813304|NCT04561115|75935788|FG001|STARTED|GC Run-In + PK Phase (Up to 6 Months)||0||
59813305|NCT04561115|75935787|FG000|COMPLETED|GC Run-In + PK Phase (Up to 6 Months)||32||
59813306|NCT04561115|75935788|FG001|COMPLETED|GC Run-In + PK Phase (Up to 6 Months)||0||
59813307|NCT04561115|75935787|FG000|NOT COMPLETED|GC Run-In + PK Phase (Up to 6 Months)||1||
59813308|NCT04561115|75935788|FG001|NOT COMPLETED|GC Run-In + PK Phase (Up to 6 Months)||0||
59813309|NCT04561115|75935787|FG000|STARTED|IVIG-PEG Treatment (Up to 4.5 Months)||0||
59813310|NCT04561115|75935788|FG001|STARTED|IVIG-PEG Treatment (Up to 4.5 Months)||32||
59813311|NCT04561115|75935787|FG000|COMPLETED|IVIG-PEG Treatment (Up to 4.5 Months)||0||
59813312|NCT04561115|75935788|FG001|COMPLETED|IVIG-PEG Treatment (Up to 4.5 Months)||31||
59813313|NCT04561115|75935787|FG000|NOT COMPLETED|IVIG-PEG Treatment (Up to 4.5 Months)||0||
59813314|NCT04561115|75935788|FG001|NOT COMPLETED|IVIG-PEG Treatment (Up to 4.5 Months)||1||
59813315|NCT04561115|75935787|FG000|STARTED|IVIG-PEG + PK Phase (Up to 6 Months)||0||
59813316|NCT04561115|75935788|FG001|STARTED|IVIG-PEG + PK Phase (Up to 6 Months)||32||
59813317|NCT04561115|75935787|FG000|COMPLETED|IVIG-PEG + PK Phase (Up to 6 Months)||0||
59813318|NCT04561115|75935788|FG001|COMPLETED|IVIG-PEG + PK Phase (Up to 6 Months)||31||
59813319|NCT04561115|75935787|FG000|NOT COMPLETED|IVIG-PEG + PK Phase (Up to 6 Months)||0||
59813320|NCT04561115|75935788|FG001|NOT COMPLETED|IVIG-PEG + PK Phase (Up to 6 Months)||1||
59813321|NCT04366258|75935794|FG000|STARTED|Baseline Assessments||55||
59975817|NCT02421172|76093206|FG000|COMPLETED|Period 1||29||
60074617|NCT01555125|76189971|FG001|STARTED|Induction Period||59||
60074618|NCT01555125|76189972|FG002|STARTED|Induction Period||0||
60074619|NCT01555125|76189973|FG003|STARTED|Induction Period||0||
59813322|NCT04366258|75935794|FG000|COMPLETED|Baseline Assessments||31||
59813323|NCT04366258|75935794|FG000|NOT COMPLETED|Baseline Assessments||24||
59813324|NCT04366258|75935794|FG000|STARTED|Randomized Cross-Over||31||
59813325|NCT04366258|75935794|FG000|Received t-PBM at High Irradiance|Randomized Cross-Over||27||
59975818|NCT02421172|76093207|FG001|COMPLETED|Period 1||31||
59813326|NCT04366258|75935794|FG000|Received t-PBM at Medium Irradiance|Randomized Cross-Over||29||
59813327|NCT04366258|75935794|FG000|Received t-PBM at Low Irradiance|Randomized Cross-Over||29||
59813328|NCT04366258|75935794|FG000|Received t-PBM at Sham Irradiance|Randomized Cross-Over||29||
59975819|NCT02421172|76093208|FG002|COMPLETED|Period 1||0||
59975820|NCT02421172|76093209|FG003|COMPLETED|Period 1||0||
59975821|NCT02421172|76093210|FG004|COMPLETED|Period 1||0||
59975822|NCT02421172|76093206|FG000|NOT COMPLETED|Period 1||4||
59975823|NCT02421172|76093207|FG001|NOT COMPLETED|Period 1||2||
59975824|NCT02421172|76093208|FG002|NOT COMPLETED|Period 1||0||
59975825|NCT02421172|76093209|FG003|NOT COMPLETED|Period 1||0||
59975826|NCT02421172|76093210|FG004|NOT COMPLETED|Period 1||0||
59975827|NCT02421172|76093206|FG000|STARTED|Period 2||0||
59975828|NCT02421172|76093207|FG001|STARTED|Period 2||0||
59975829|NCT02421172|76093208|FG002|STARTED|Period 2||29||
59975830|NCT02421172|76093209|FG003|STARTED|Period 2||16||
59975831|NCT02421172|76093210|FG004|STARTED|Period 2||15||
60074620|NCT01555125|76189974|FG004|STARTED|Induction Period||59||
59813329|NCT04366258|75935794|FG000|COMPLETED|Randomized Cross-Over||31||
59813330|NCT04366258|75935794|FG000|NOT COMPLETED|Randomized Cross-Over||0||
59813331|NCT04333420|75935809|FG000|STARTED|Overall Study||15||
59813332|NCT04333420|75935810|FG001|STARTED|Overall Study||15||
59813333|NCT04333420|75935811|FG002|STARTED|Overall Study||178||
59813334|NCT04333420|75935812|FG003|STARTED|Overall Study||191||
59813335|NCT04333420|75935809|FG000|Contributed to Full Analysis Set (FAS)|Overall Study||15||
59813336|NCT04333420|75935810|FG001|Contributed to Full Analysis Set (FAS)|Overall Study||15||
59813337|NCT04333420|75935811|FG002|Contributed to Full Analysis Set (FAS)|Overall Study|One patient was randomized in error and was excluded from Full Analysis Set.|177||
59813338|NCT04333420|75935812|FG003|Contributed to Full Analysis Set (FAS)|Overall Study||191||
59813339|NCT04333420|75935809|FG000|Contributed to Safety Analysis Set (SAF)|Overall Study||15||
59813340|NCT04333420|75935810|FG001|Contributed to Safety Analysis Set (SAF)|Overall Study||15||
59813341|NCT04333420|75935811|FG002|Contributed to Safety Analysis Set (SAF)|Overall Study||175||
59813342|NCT04333420|75935812|FG003|Contributed to Safety Analysis Set (SAF)|Overall Study||189||
59813343|NCT04333420|75935809|FG000|COMPLETED|Overall Study||13||
59813344|NCT04333420|75935810|FG001|COMPLETED|Overall Study||11||
59813345|NCT04333420|75935811|FG002|COMPLETED|Overall Study||103||
59813346|NCT04333420|75935812|FG003|COMPLETED|Overall Study||93||
59813347|NCT04333420|75935809|FG000|NOT COMPLETED|Overall Study||2||
59813348|NCT04333420|75935810|FG001|NOT COMPLETED|Overall Study||4||
59813349|NCT04333420|75935811|FG002|NOT COMPLETED|Overall Study||75||
59813350|NCT04333420|75935812|FG003|NOT COMPLETED|Overall Study||98||
59813351|NCT04177693|75935826|FG000|STARTED|Overall Study||16||
59813352|NCT04177693|75935827|FG001|STARTED|Overall Study||11||
59975832|NCT02421172|76093206|FG000|COMPLETED|Period 2||0||
60074621|NCT01555125|76189970|FG000|COMPLETED|Induction Period||58||
59813353|NCT04177693|75935828|FG002|STARTED|Overall Study||12||
59813354|NCT04177693|75935826|FG000|COMPLETED|Overall Study||14||
59813355|NCT04177693|75935827|FG001|COMPLETED|Overall Study||11||
59813356|NCT04177693|75935828|FG002|COMPLETED|Overall Study||11||
59813357|NCT04177693|75935826|FG000|NOT COMPLETED|Overall Study||2||
59813358|NCT04177693|75935827|FG001|NOT COMPLETED|Overall Study||0||
59813359|NCT04177693|75935828|FG002|NOT COMPLETED|Overall Study||1||
59813360|NCT04101331|75935842|FG000|STARTED|Overall Study||108||
59813361|NCT04101331|75935842|FG000|COMPLETED|Overall Study||8|'Completed' are subjects still on treatment at the time of interim analysis.|
59813362|NCT04101331|75935842|FG000|NOT COMPLETED|Overall Study||100||
59813363|NCT04082884|75935846|FG000|STARTED|Overall Study||6||
59813364|NCT04082884|75935846|FG000|Completed Standard Diet|Overall Study||5||
59813365|NCT04082884|75935846|FG000|1 Week Transition to Low Carbohydrate Diet Completed|Overall Study||5||
59975833|NCT02421172|76093207|FG001|COMPLETED|Period 2||0||
59975834|NCT02421172|76093208|FG002|COMPLETED|Period 2||22||
59975835|NCT02421172|76093209|FG003|COMPLETED|Period 2||13||
59975836|NCT02421172|76093210|FG004|COMPLETED|Period 2||14||
59813366|NCT04082884|75935846|FG000|High Protein Low Carbohydrate Completed|Overall Study||5||
59813367|NCT04082884|75935846|FG000|High Fat Low Carbohydrate Completed|Overall Study||4||
59813368|NCT04082884|75935846|FG000|COMPLETED|Overall Study||5||
59813369|NCT04082884|75935846|FG000|NOT COMPLETED|Overall Study||1||
59813370|NCT03891667|75935852|FG000|STARTED|Overall Study||6|Started means that participants signed consent and were randomized to study medication.|
59813371|NCT03891667|75935853|FG001|STARTED|Overall Study||5|Started means that participants signed consent and were randomized to study medication.|
59813372|NCT03891667|75935852|FG000|Start of the Medication|Overall Study||5||
59813373|NCT03891667|75935853|FG001|Start of the Medication|Overall Study||5||
59813374|NCT03891667|75935852|FG000|Completed All 8 Weeks of Drug Treatment|Overall Study||1||
59975837|NCT02421172|76093206|FG000|NOT COMPLETED|Period 2||0||
59975838|NCT02421172|76093207|FG001|NOT COMPLETED|Period 2||0||
59975839|NCT02421172|76093208|FG002|NOT COMPLETED|Period 2||7||
59975840|NCT02421172|76093209|FG003|NOT COMPLETED|Period 2||3||
60074622|NCT01555125|76189971|FG001|COMPLETED|Induction Period||56||
60074623|NCT01555125|76189972|FG002|COMPLETED|Induction Period||0||
59975841|NCT02421172|76093210|FG004|NOT COMPLETED|Period 2||1||
60074624|NCT01555125|76189973|FG003|COMPLETED|Induction Period||0||
59813375|NCT03891667|75935853|FG001|Completed All 8 Weeks of Drug Treatment|Overall Study||2||
59813376|NCT03891667|75935852|FG000|Completed All 10 Weeks of Assessments|Overall Study||4||
59813377|NCT03891667|75935853|FG001|Completed All 10 Weeks of Assessments|Overall Study||2||
59813378|NCT03891667|75935852|FG000|COMPLETED|Overall Study||4||
59813379|NCT03891667|75935853|FG001|COMPLETED|Overall Study||2||
59813380|NCT03891667|75935852|FG000|NOT COMPLETED|Overall Study||2||
59813381|NCT03891667|75935853|FG001|NOT COMPLETED|Overall Study||3||
59813382|NCT03859869|75935862|FG000|STARTED|Overall Study||0||
59813383|NCT03859869|75935863|FG001|STARTED|Overall Study||1||
59813384|NCT03859869|75935864|FG002|STARTED|Overall Study||0||
59813385|NCT03859869|75935862|FG000|COMPLETED|Overall Study||0||
59813386|NCT03859869|75935863|FG001|COMPLETED|Overall Study||1||
59813387|NCT03859869|75935864|FG002|COMPLETED|Overall Study||0||
59813388|NCT03859869|75935862|FG000|NOT COMPLETED|Overall Study||0||
59813389|NCT03859869|75935863|FG001|NOT COMPLETED|Overall Study||0||
59813390|NCT03859869|75935864|FG002|NOT COMPLETED|Overall Study||0||
59813391|NCT03717402|75935871|FG000|STARTED|Overall Study||20||
59813392|NCT03717402|75935871|FG000|COMPLETED|Overall Study||20||
59813393|NCT03717402|75935871|FG000|NOT COMPLETED|Overall Study||0||
59813394|NCT03715153|75935877|FG000|STARTED|Double-blind Period (From W0 to W26)||107||
59813395|NCT03715153|75935878|FG001|STARTED|Double-blind Period (From W0 to W26)||104||
59813396|NCT03715153|75935877|FG000|COMPLETED|Double-blind Period (From W0 to W26)||90||
59813397|NCT03715153|75935878|FG001|COMPLETED|Double-blind Period (From W0 to W26)||95||
59813398|NCT03715153|75935877|FG000|NOT COMPLETED|Double-blind Period (From W0 to W26)||17||
59813399|NCT03715153|75935878|FG001|NOT COMPLETED|Double-blind Period (From W0 to W26)||9||
59975842|NCT02379052|76093223|FG000|STARTED|Overall Study||24||
59975843|NCT02379052|76093224|FG001|STARTED|Overall Study||23||
59975844|NCT02379052|76093223|FG000|COMPLETED|Overall Study||18||
59975845|NCT02379052|76093224|FG001|COMPLETED|Overall Study||18||
59975846|NCT02379052|76093223|FG000|NOT COMPLETED|Overall Study||6||
59975847|NCT02379052|76093224|FG001|NOT COMPLETED|Overall Study||5||
59975848|NCT02378662|76093232|FG000|STARTED|Overall Study||2||
59975849|NCT02378662|76093233|FG001|STARTED|Overall Study||0||
59975850|NCT02378662|76093232|FG000|Harvesting|Overall Study||2||
59975851|NCT02378662|76093233|FG001|Harvesting|Overall Study||0||
59622202|NCT00384774|75733935|FG006|COMPLETED|Overall Study||4||
59622203|NCT00384774|75733929|FG000|NOT COMPLETED|Overall Study||0||
59813400|NCT03715153|75935877|FG000|STARTED|Open-label Period (From W26 to W52)|Not all participants who completed the double-blind phase chose to continue into the open-label period.|86||
59813401|NCT03715153|75935878|FG001|STARTED|Open-label Period (From W26 to W52)|Not all participants who completed the double-blind phase chose to continue into the open-label period.|92||
59813402|NCT03715153|75935877|FG000|COMPLETED|Open-label Period (From W26 to W52)||46||
59813403|NCT03715153|75935878|FG001|COMPLETED|Open-label Period (From W26 to W52)||50||
59813404|NCT03715153|75935877|FG000|NOT COMPLETED|Open-label Period (From W26 to W52)||40||
59975852|NCT02378662|76093232|FG000|Implantation|Overall Study||2||
59975853|NCT02378662|76093233|FG001|Implantation|Overall Study||0||
59975854|NCT02378662|76093232|FG000|COMPLETED|Overall Study||0||
59975855|NCT02378662|76093233|FG001|COMPLETED|Overall Study||0||
59975856|NCT02378662|76093232|FG000|NOT COMPLETED|Overall Study||2||
59975857|NCT02378662|76093233|FG001|NOT COMPLETED|Overall Study||0||
59975858|NCT02378506|76093239|FG000|STARTED|Overall Study||188||
59975859|NCT02378506|76093239|FG000|Treated|Overall Study||187||
59525940|NCT01267279|75621372|FG000|NOT COMPLETED|Overall Study||2||
59525941|NCT01267279|75621373|FG001|NOT COMPLETED|Overall Study||6||
59525942|NCT01268527|75621381|FG000|STARTED|Overall Study||15||
59525943|NCT01268527|75621382|FG001|STARTED|Overall Study||15||
59525944|NCT01268527|75621381|FG000|COMPLETED|Overall Study||15||
59525945|NCT01268527|75621382|FG001|COMPLETED|Overall Study||15||
59525946|NCT01268527|75621381|FG000|NOT COMPLETED|Overall Study||0||
59525947|NCT01268527|75621382|FG001|NOT COMPLETED|Overall Study||0||
59525948|NCT01270555|75621401|FG000|STARTED|Overall Study||32||
59525949|NCT01270555|75621401|FG000|COMPLETED|Overall Study||19||
59525950|NCT01270555|75621401|FG000|NOT COMPLETED|Overall Study||13||
59525951|NCT01270711|75621413|FG000|STARTED|Part 1: Compliance||7537||
59525952|NCT01270711|75621414|FG001|STARTED|Part 1: Compliance||6580||
59525953|NCT01270711|75621415|FG002|STARTED|Part 1: Compliance||326||
59525954|NCT01270711|75621416|FG003|STARTED|Part 1: Compliance||5486||
59525955|NCT01270711|75621417|FG004|STARTED|Part 1: Compliance||2024||
59525956|NCT01270711|75621418|FG005|STARTED|Part 1: Compliance||0||
59525957|NCT01270711|75621419|FG006|STARTED|Part 1: Compliance||0||
59525958|NCT01270711|75621420|FG007|STARTED|Part 1: Compliance||0||
59813405|NCT03715153|75935878|FG001|NOT COMPLETED|Open-label Period (From W26 to W52)||42||
59813406|NCT03660683|75935891|FG000|STARTED|Overall Study||4||
59813407|NCT03660683|75935892|FG001|STARTED|Overall Study||5||
59813408|NCT03660683|75935893|FG002|STARTED|Overall Study||6||
59813409|NCT03660683|75935891|FG000|COMPLETED|Overall Study||4||
59813410|NCT03660683|75935892|FG001|COMPLETED|Overall Study||5||
59813411|NCT03660683|75935893|FG002|COMPLETED|Overall Study||6||
59813412|NCT03660683|75935891|FG000|NOT COMPLETED|Overall Study||0||
59813413|NCT03660683|75935892|FG001|NOT COMPLETED|Overall Study||0||
59813414|NCT03660683|75935893|FG002|NOT COMPLETED|Overall Study||0||
59975860|NCT02378506|76093239|FG000|COMPLETED|Overall Study||163||
59975861|NCT02378506|76093239|FG000|NOT COMPLETED|Overall Study||25||
59975862|NCT02347774|76093246|FG000|STARTED|Study Participation||214||
59975863|NCT02347774|76093247|FG001|STARTED|Study Participation||214||
59975864|NCT02347774|76093248|FG002|STARTED|Study Participation|One subject randomized in error to the placebo arm was never dosed .|213||
59975865|NCT02347774|76093246|FG000|COMPLETED|Study Participation||199||
59975866|NCT02347774|76093247|FG001|COMPLETED|Study Participation||193||
59975867|NCT02347774|76093248|FG002|COMPLETED|Study Participation||188||
59975868|NCT02347774|76093246|FG000|NOT COMPLETED|Study Participation||15||
59975869|NCT02347774|76093247|FG001|NOT COMPLETED|Study Participation||21||
59975870|NCT02347774|76093248|FG002|NOT COMPLETED|Study Participation||25||
59975871|NCT02347774|76093246|FG000|STARTED|On Study Treatment||214||
59975872|NCT02347774|76093247|FG001|STARTED|On Study Treatment||214||
59975873|NCT02347774|76093248|FG002|STARTED|On Study Treatment|One subject randomized in error to the placebo arm was never dosed .|213||
59975874|NCT02347774|76093246|FG000|COMPLETED|On Study Treatment||190||
59975875|NCT02347774|76093247|FG001|COMPLETED|On Study Treatment||183||
59975876|NCT02347774|76093248|FG002|COMPLETED|On Study Treatment||177||
59975877|NCT02347774|76093246|FG000|NOT COMPLETED|On Study Treatment||24||
59975878|NCT02347774|76093247|FG001|NOT COMPLETED|On Study Treatment||31||
59975879|NCT02347774|76093248|FG002|NOT COMPLETED|On Study Treatment||36||
59975880|NCT02794883|76093259|FG000|STARTED|Pre-Surgical Treatment||12||
59975881|NCT02794883|76093260|FG001|STARTED|Pre-Surgical Treatment||12||
59975882|NCT02794883|76093261|FG002|STARTED|Pre-Surgical Treatment||12||
59975883|NCT02794883|76093259|FG000|Registered for Study|Pre-Surgical Treatment||12||
59975884|NCT02794883|76093260|FG001|Registered for Study|Pre-Surgical Treatment||12||
59525959|NCT01270711|75621413|FG000|COMPLETED|Part 1: Compliance||7537||
59525960|NCT01270711|75621414|FG001|COMPLETED|Part 1: Compliance||6580||
59525961|NCT01270711|75621415|FG002|COMPLETED|Part 1: Compliance||326||
59525962|NCT01270711|75621416|FG003|COMPLETED|Part 1: Compliance||5486||
59975885|NCT02794883|76093261|FG002|Registered for Study|Pre-Surgical Treatment||12||
59975886|NCT02794883|76093259|FG000|Received First Dose (Pre-surgical Dose) of Study Drug|Pre-Surgical Treatment||12||
59975887|NCT02794883|76093260|FG001|Received First Dose (Pre-surgical Dose) of Study Drug|Pre-Surgical Treatment||11||
59975888|NCT02794883|76093261|FG002|Received First Dose (Pre-surgical Dose) of Study Drug|Pre-Surgical Treatment||11||
59975889|NCT02794883|76093259|FG000|COMPLETED|Pre-Surgical Treatment||12||
59975890|NCT02794883|76093260|FG001|COMPLETED|Pre-Surgical Treatment||11||
59975891|NCT02794883|76093261|FG002|COMPLETED|Pre-Surgical Treatment||11||
59975892|NCT02794883|76093259|FG000|NOT COMPLETED|Pre-Surgical Treatment||0||
59975893|NCT02794883|76093260|FG001|NOT COMPLETED|Pre-Surgical Treatment||1||
59975894|NCT02794883|76093261|FG002|NOT COMPLETED|Pre-Surgical Treatment||1||
59975895|NCT02794883|76093259|FG000|STARTED|Post-Surgery Treatment (Adjuvant)||12||
59975896|NCT02794883|76093260|FG001|STARTED|Post-Surgery Treatment (Adjuvant)||11||
59975897|NCT02794883|76093261|FG002|STARTED|Post-Surgery Treatment (Adjuvant)||11||
59975898|NCT02794883|76093259|FG000|Started Cycle 1|Post-Surgery Treatment (Adjuvant)||11||
59975899|NCT02794883|76093260|FG001|Started Cycle 1|Post-Surgery Treatment (Adjuvant)||8||
59975900|NCT02794883|76093261|FG002|Started Cycle 1|Post-Surgery Treatment (Adjuvant)||11||
59975901|NCT02794883|76093259|FG000|Started Cycle 2|Post-Surgery Treatment (Adjuvant)||7||
59975902|NCT02794883|76093260|FG001|Started Cycle 2|Post-Surgery Treatment (Adjuvant)||8||
59975903|NCT02794883|76093261|FG002|Started Cycle 2|Post-Surgery Treatment (Adjuvant)||11||
59975904|NCT02794883|76093259|FG000|Started Cycle 3|Post-Surgery Treatment (Adjuvant)||3||
59975905|NCT02794883|76093260|FG001|Started Cycle 3|Post-Surgery Treatment (Adjuvant)||7||
59975906|NCT02794883|76093261|FG002|Started Cycle 3|Post-Surgery Treatment (Adjuvant)||4||
59975907|NCT02794883|76093259|FG000|Started Cycle 4|Post-Surgery Treatment (Adjuvant)||2||
59975908|NCT02794883|76093260|FG001|Started Cycle 4|Post-Surgery Treatment (Adjuvant)||5||
59975909|NCT02794883|76093261|FG002|Started Cycle 4|Post-Surgery Treatment (Adjuvant)||2||
59975910|NCT02794883|76093259|FG000|Started Cycle 5|Post-Surgery Treatment (Adjuvant)||2||
59975911|NCT02794883|76093260|FG001|Started Cycle 5|Post-Surgery Treatment (Adjuvant)||3||
59975912|NCT02794883|76093261|FG002|Started Cycle 5|Post-Surgery Treatment (Adjuvant)||2||
59975913|NCT02794883|76093259|FG000|Started Cycle 6|Post-Surgery Treatment (Adjuvant)||0||
59975914|NCT02794883|76093260|FG001|Started Cycle 6|Post-Surgery Treatment (Adjuvant)||3||
59975915|NCT02794883|76093261|FG002|Started Cycle 6|Post-Surgery Treatment (Adjuvant)||2||
59975916|NCT02794883|76093259|FG000|Started Cycle 7|Post-Surgery Treatment (Adjuvant)||0||
59975917|NCT02794883|76093260|FG001|Started Cycle 7|Post-Surgery Treatment (Adjuvant)||3||
59975918|NCT02794883|76093261|FG002|Started Cycle 7|Post-Surgery Treatment (Adjuvant)||1||
59975919|NCT02794883|76093259|FG000|Started Cycle 8|Post-Surgery Treatment (Adjuvant)||0||
59975920|NCT02794883|76093260|FG001|Started Cycle 8|Post-Surgery Treatment (Adjuvant)||3||
59975921|NCT02794883|76093261|FG002|Started Cycle 8|Post-Surgery Treatment (Adjuvant)||1||
59975922|NCT02794883|76093259|FG000|Started Cycle 9|Post-Surgery Treatment (Adjuvant)||0||
59975923|NCT02794883|76093260|FG001|Started Cycle 9|Post-Surgery Treatment (Adjuvant)||3||
59975924|NCT02794883|76093261|FG002|Started Cycle 9|Post-Surgery Treatment (Adjuvant)||1||
59975925|NCT02794883|76093259|FG000|Started Cycle 10|Post-Surgery Treatment (Adjuvant)||0||
59975926|NCT02794883|76093260|FG001|Started Cycle 10|Post-Surgery Treatment (Adjuvant)||2||
59994969|NCT02730793|76110797|FG000|STARTED|Overall Study||2||
59525963|NCT01270711|75621417|FG004|COMPLETED|Part 1: Compliance||2024||
59975927|NCT02794883|76093261|FG002|Started Cycle 10|Post-Surgery Treatment (Adjuvant)||1||
59975928|NCT02794883|76093259|FG000|Started Cycle 11|Post-Surgery Treatment (Adjuvant)||0||
59975929|NCT02794883|76093260|FG001|Started Cycle 11|Post-Surgery Treatment (Adjuvant)||2||
59975930|NCT02794883|76093261|FG002|Started Cycle 11|Post-Surgery Treatment (Adjuvant)||1||
59975931|NCT02794883|76093259|FG000|Started Cycle 12|Post-Surgery Treatment (Adjuvant)||0||
59975932|NCT02794883|76093260|FG001|Started Cycle 12|Post-Surgery Treatment (Adjuvant)||1||
59975933|NCT02794883|76093261|FG002|Started Cycle 12|Post-Surgery Treatment (Adjuvant)||1||
59975934|NCT02794883|76093259|FG000|Started Cycle 13|Post-Surgery Treatment (Adjuvant)||0||
59975935|NCT02794883|76093260|FG001|Started Cycle 13|Post-Surgery Treatment (Adjuvant)||1||
59975936|NCT02794883|76093261|FG002|Started Cycle 13|Post-Surgery Treatment (Adjuvant)||1||
59975937|NCT02794883|76093259|FG000|Started Cycle 14|Post-Surgery Treatment (Adjuvant)||0||
59975938|NCT02794883|76093260|FG001|Started Cycle 14|Post-Surgery Treatment (Adjuvant)||1||
59975939|NCT02794883|76093261|FG002|Started Cycle 14|Post-Surgery Treatment (Adjuvant)||1||
59975940|NCT02794883|76093259|FG000|Started Cycle 15|Post-Surgery Treatment (Adjuvant)||0||
59975941|NCT02794883|76093260|FG001|Started Cycle 15|Post-Surgery Treatment (Adjuvant)||0||
59975942|NCT02794883|76093261|FG002|Started Cycle 15|Post-Surgery Treatment (Adjuvant)||1||
59975943|NCT02794883|76093259|FG000|Started Cycle 16|Post-Surgery Treatment (Adjuvant)||0||
59975944|NCT02794883|76093260|FG001|Started Cycle 16|Post-Surgery Treatment (Adjuvant)||0||
59975945|NCT02794883|76093261|FG002|Started Cycle 16|Post-Surgery Treatment (Adjuvant)||1||
59975946|NCT02794883|76093259|FG000|Started Cycle 17|Post-Surgery Treatment (Adjuvant)||0||
59975947|NCT02794883|76093260|FG001|Started Cycle 17|Post-Surgery Treatment (Adjuvant)||0||
59975948|NCT02794883|76093261|FG002|Started Cycle 17|Post-Surgery Treatment (Adjuvant)||0||
59975949|NCT02794883|76093259|FG000|COMPLETED|Post-Surgery Treatment (Adjuvant)||0||
59975950|NCT02794883|76093260|FG001|COMPLETED|Post-Surgery Treatment (Adjuvant)||0||
59975951|NCT02794883|76093261|FG002|COMPLETED|Post-Surgery Treatment (Adjuvant)||0||
59975952|NCT02794883|76093259|FG000|NOT COMPLETED|Post-Surgery Treatment (Adjuvant)||12||
59975953|NCT02794883|76093260|FG001|NOT COMPLETED|Post-Surgery Treatment (Adjuvant)||11||
59975954|NCT02794883|76093261|FG002|NOT COMPLETED|Post-Surgery Treatment (Adjuvant)||11||
59975955|NCT02794883|76093259|FG000|STARTED|Follow-up Period (up to 2 Years)||12|All patients who receive at least 1 dose of study drug go into follow-up.|
59975956|NCT02794883|76093260|FG001|STARTED|Follow-up Period (up to 2 Years)||11|All patients who receive at least 1 dose of study drug go into follow-up.|
59975957|NCT02794883|76093261|FG002|STARTED|Follow-up Period (up to 2 Years)||11|All patients who receive at least 1 dose of study drug go into follow-up.|
59975958|NCT02794883|76093259|FG000|COMPLETED|Follow-up Period (up to 2 Years)||0||
59975959|NCT02794883|76093260|FG001|COMPLETED|Follow-up Period (up to 2 Years)||1||
59975960|NCT02794883|76093261|FG002|COMPLETED|Follow-up Period (up to 2 Years)||1||
59975961|NCT02794883|76093259|FG000|NOT COMPLETED|Follow-up Period (up to 2 Years)||12||
59975962|NCT02794883|76093260|FG001|NOT COMPLETED|Follow-up Period (up to 2 Years)||10||
59975963|NCT02794883|76093261|FG002|NOT COMPLETED|Follow-up Period (up to 2 Years)||10||
59975964|NCT01370603|76093271|FG000|STARTED|Period 1||164||
59975965|NCT01370603|76093272|FG001|STARTED|Period 1||164||
59975966|NCT01370603|76093271|FG000|COMPLETED|Period 1||150||
59975967|NCT01370603|76093272|FG001|COMPLETED|Period 1||154||
59975968|NCT01370603|76093271|FG000|NOT COMPLETED|Period 1||14||
59975969|NCT01370603|76093272|FG001|NOT COMPLETED|Period 1||10||
59975970|NCT01370603|76093271|FG000|STARTED|Crossover Washout||150||
59975971|NCT01370603|76093272|FG001|STARTED|Crossover Washout||154||
59975972|NCT01370603|76093271|FG000|COMPLETED|Crossover Washout||141||
59975973|NCT01370603|76093272|FG001|COMPLETED|Crossover Washout||150||
59975974|NCT01370603|76093271|FG000|NOT COMPLETED|Crossover Washout||9||
59975975|NCT01370603|76093272|FG001|NOT COMPLETED|Crossover Washout||4||
59975976|NCT01370603|76093271|FG000|STARTED|Period 2||141||
59975977|NCT01370603|76093272|FG001|STARTED|Period 2||150||
59975978|NCT01370603|76093271|FG000|COMPLETED|Period 2||138||
59975979|NCT01370603|76093272|FG001|COMPLETED|Period 2||146||
59975980|NCT01370603|76093271|FG000|NOT COMPLETED|Period 2||3||
59975981|NCT01370603|76093272|FG001|NOT COMPLETED|Period 2||4||
59975982|NCT02347072|76093278|FG000|STARTED|Overall Study||80||
59975983|NCT02347072|76093278|FG000|GFF MDI 14.4/9.6 µg|Overall Study||75||
59813415|NCT03569293|75935907|FG000|STARTED|Overall Study||241|Randomized into study|
59813416|NCT03569293|75935908|FG001|STARTED|Overall Study||239|Randomized into study|
59813417|NCT03569293|75935909|FG002|STARTED|Overall Study||243|Randomized into study|
59813418|NCT03569293|75935910|FG003|STARTED|Overall Study||61|Randomized into study|
59813419|NCT03569293|75935911|FG004|STARTED|Overall Study||64|Randomized into study|
59975984|NCT02347072|76093278|FG000|Placebo MDI|Overall Study||72||
59975985|NCT02347072|76093278|FG000|Spiriva Respimat 5 µg|Overall Study||73||
59975986|NCT02347072|76093278|FG000|COMPLETED|Overall Study||62||
59975987|NCT02347072|76093278|FG000|NOT COMPLETED|Overall Study||18||
59975988|NCT02794103|76093286|FG000|STARTED|Overall Study||18||
59975989|NCT02794103|76093286|FG000|COMPLETED|Overall Study||15||
59975990|NCT02794103|76093286|FG000|NOT COMPLETED|Overall Study||3||
59975991|NCT02346370|76093293|FG000|STARTED|Overall Study||8||
59975992|NCT02346370|76093294|FG001|STARTED|Overall Study||4||
59975993|NCT02346370|76093295|FG002|STARTED|Overall Study||4||
59975994|NCT02346370|76093293|FG000|COMPLETED|Overall Study||0||
59975995|NCT02346370|76093294|FG001|COMPLETED|Overall Study||0||
59975996|NCT02346370|76093295|FG002|COMPLETED|Overall Study||0||
59975997|NCT02346370|76093293|FG000|NOT COMPLETED|Overall Study||8||
59975998|NCT02346370|76093294|FG001|NOT COMPLETED|Overall Study||4||
59975999|NCT02346370|76093295|FG002|NOT COMPLETED|Overall Study||4||
59976000|NCT02346136|76093307|FG000|STARTED|Overall Study||93||
59976001|NCT02346136|76093308|FG001|STARTED|Overall Study||87||
59976002|NCT02346136|76093307|FG000|COMPLETED|Overall Study||71||
59976003|NCT02346136|76093308|FG001|COMPLETED|Overall Study||64||
59976004|NCT02346136|76093307|FG000|NOT COMPLETED|Overall Study||22||
59976005|NCT02346136|76093308|FG001|NOT COMPLETED|Overall Study||23||
59976006|NCT02793947|76093316|FG000|STARTED|Overall Study||47||
59976007|NCT02793947|76093317|FG001|STARTED|Overall Study||55||
59976008|NCT02793947|76093316|FG000|COMPLETED|Overall Study||45||
59976009|NCT02793947|76093317|FG001|COMPLETED|Overall Study||50||
59976010|NCT02793947|76093316|FG000|NOT COMPLETED|Overall Study||2||
59976011|NCT02793947|76093317|FG001|NOT COMPLETED|Overall Study||5||
59976012|NCT02345512|76093323|FG000|STARTED|Overall Study||11||
59976013|NCT02345512|76093323|FG000|COMPLETED|Overall Study||9||
59976014|NCT02345512|76093323|FG000|NOT COMPLETED|Overall Study||2||
59976015|NCT02345434|76093334|FG000|STARTED|Overall Study||763||
59976016|NCT02345434|76093335|FG001|STARTED|Overall Study||762||
59976017|NCT02345434|76093334|FG000|COMPLETED|Overall Study||758||
59976018|NCT02345434|76093335|FG001|COMPLETED|Overall Study||760||
59976019|NCT02345434|76093334|FG000|NOT COMPLETED|Overall Study||5||
59976020|NCT02345434|76093335|FG001|NOT COMPLETED|Overall Study||2||
59976021|NCT01370213|76093344|FG000|STARTED|Overall Study||7||
59976022|NCT01370213|76093345|FG001|STARTED|Overall Study||17||
59976023|NCT01370213|76093346|FG002|STARTED|Overall Study||1||
59976024|NCT01370213|76093344|FG000|COMPLETED|Overall Study||6||
59976025|NCT01370213|76093345|FG001|COMPLETED|Overall Study||15||
59976026|NCT01370213|76093346|FG002|COMPLETED|Overall Study||1||
59976027|NCT01370213|76093344|FG000|NOT COMPLETED|Overall Study||1||
59976028|NCT01370213|76093345|FG001|NOT COMPLETED|Overall Study||2||
59813420|NCT03569293|75935912|FG005|STARTED|Overall Study||64|Randomized into study|
59813421|NCT03569293|75935907|FG000|Received Study Drug|Overall Study||241||
59813422|NCT03569293|75935908|FG001|Received Study Drug|Overall Study||239||
59813423|NCT03569293|75935909|FG002|Received Study Drug|Overall Study||243||
59813424|NCT03569293|75935910|FG003|Received Study Drug|Overall Study||61||
59813425|NCT03569293|75935911|FG004|Received Study Drug|Overall Study||64||
59976029|NCT01370213|76093346|FG002|NOT COMPLETED|Overall Study||0||
59976030|NCT01370525|76093355|FG000|STARTED|Overall Study||171||
59976031|NCT01370525|76093356|FG001|STARTED|Overall Study||169||
59976032|NCT01370525|76093355|FG000|Patients Who Received Treatment|Overall Study||168||
59976033|NCT01370525|76093356|FG001|Patients Who Received Treatment|Overall Study||163||
59976034|NCT01370525|76093355|FG000|Patients Who Completed Treatment|Overall Study||163||
59976035|NCT01370525|76093356|FG001|Patients Who Completed Treatment|Overall Study||158||
59976036|NCT01370525|76093355|FG000|COMPLETED|Overall Study||163||
59976037|NCT01370525|76093356|FG001|COMPLETED|Overall Study||158||
59976038|NCT01370525|76093355|FG000|NOT COMPLETED|Overall Study||8||
59976039|NCT01370525|76093356|FG001|NOT COMPLETED|Overall Study||11||
59976040|NCT02792777|76093364|FG000|STARTED|Overall Study||96||
59976041|NCT02792777|76093365|FG001|STARTED|Overall Study||52||
59813426|NCT03569293|75935912|FG005|Received Study Drug|Overall Study||64||
59813427|NCT03569293|75935907|FG000|COMPLETED|Overall Study||204|Completed Week 16|
59813428|NCT03569293|75935908|FG001|COMPLETED|Overall Study||230|Completed Week 16|
59976042|NCT02792777|76093364|FG000|COMPLETED|Overall Study||89||
59976043|NCT02792777|76093365|FG001|COMPLETED|Overall Study||52||
59976044|NCT02792777|76093364|FG000|NOT COMPLETED|Overall Study||7||
59976045|NCT02792777|76093365|FG001|NOT COMPLETED|Overall Study||0||
59976046|NCT02625974|76093374|FG000|STARTED|Overall Study||219||
59976047|NCT02625974|76093375|FG001|STARTED|Overall Study||111||
59976048|NCT02625974|76093374|FG000|Received Treatment|Overall Study||219||
59976049|NCT02625974|76093375|FG001|Received Treatment|Overall Study||111||
59976050|NCT02625974|76093374|FG000|COMPLETED|Overall Study||203|Completed treatment|
59976051|NCT02625974|76093375|FG001|COMPLETED|Overall Study||105|Completed treatment|
59976052|NCT02625974|76093374|FG000|NOT COMPLETED|Overall Study||16||
59976053|NCT02625974|76093375|FG001|NOT COMPLETED|Overall Study||6||
59976054|NCT02792699|76093420|FG000|STARTED|Overall Study||104||
59976055|NCT02792699|76093421|FG001|STARTED|Overall Study||104||
59976056|NCT02792699|76093422|FG002|STARTED|Overall Study||103||
59976057|NCT02792699|76093420|FG000|Received First Infusion of First Dose|Overall Study||104|Day 1|
59976058|NCT02792699|76093421|FG001|Received First Infusion of First Dose|Overall Study||104|Day 1|
59976059|NCT02792699|76093422|FG002|Received First Infusion of First Dose|Overall Study||103|Day 1|
59976060|NCT02792699|76093420|FG000|Received Second Infusion of First Dose|Overall Study||102|Day 15 (week 2)|
59976061|NCT02792699|76093421|FG001|Received Second Infusion of First Dose|Overall Study||103|Day 15 (week 2)|
59976062|NCT02792699|76093422|FG002|Received Second Infusion of First Dose|Overall Study||99|Day 15 (week 2)|
59976063|NCT02792699|76093420|FG000|Received First Infusion of Second Dose|Overall Study||97|Week 24|
59976064|NCT02792699|76093421|FG001|Received First Infusion of Second Dose|Overall Study||99|Week 24|
59976065|NCT02792699|76093422|FG002|Received First Infusion of Second Dose|Overall Study||95|Week 24|
59976066|NCT02792699|76093420|FG000|Received Second Infusion of Second Dose|Overall Study||97|Week 26|
59976067|NCT02792699|76093421|FG001|Received Second Infusion of Second Dose|Overall Study||99|Week 26|
59976068|NCT02792699|76093422|FG002|Received Second Infusion of Second Dose|Overall Study||93|Week 26|
59976069|NCT02792699|76093420|FG000|COMPLETED|Overall Study||95||
59976070|NCT02792699|76093421|FG001|COMPLETED|Overall Study||94||
59976071|NCT02792699|76093422|FG002|COMPLETED|Overall Study||93||
59976072|NCT02792699|76093420|FG000|NOT COMPLETED|Overall Study||9||
59976073|NCT02792699|76093421|FG001|NOT COMPLETED|Overall Study||10||
59976074|NCT02792699|76093422|FG002|NOT COMPLETED|Overall Study||10||
59976075|NCT03010319|76093439|FG000|STARTED|Overall Study||110||
59976076|NCT03010319|76093440|FG001|STARTED|Overall Study||116||
59976077|NCT03010319|76093439|FG000|COMPLETED|Overall Study||84||
59976078|NCT03010319|76093440|FG001|COMPLETED|Overall Study||87||
59976079|NCT03010319|76093439|FG000|NOT COMPLETED|Overall Study||26||
59976080|NCT03010319|76093440|FG001|NOT COMPLETED|Overall Study||29||
59976081|NCT01369511|76093450|FG000|STARTED|Overall Study||98||
59976082|NCT01369511|76093451|FG001|STARTED|Overall Study||104||
59976083|NCT01369511|76093452|FG002|STARTED|Overall Study||98||
59976084|NCT01369511|76093453|FG003|STARTED|Overall Study||100||
59976085|NCT01369511|76093450|FG000|Received at Least 1 Dose of Study Drug|Overall Study||98||
59976086|NCT01369511|76093451|FG001|Received at Least 1 Dose of Study Drug|Overall Study|One participant was a screen failure and inadvertently randomized but did not receive study drug.|103||
59976087|NCT01369511|76093452|FG002|Received at Least 1 Dose of Study Drug|Overall Study||98||
59976088|NCT01369511|76093453|FG003|Received at Least 1 Dose of Study Drug|Overall Study||100||
59976089|NCT01369511|76093450|FG000|COMPLETED|Overall Study||85||
59976090|NCT01369511|76093451|FG001|COMPLETED|Overall Study||91||
59976091|NCT01369511|76093452|FG002|COMPLETED|Overall Study||87||
59976092|NCT01369511|76093453|FG003|COMPLETED|Overall Study||89||
59976093|NCT01369511|76093450|FG000|NOT COMPLETED|Overall Study||13||
59976094|NCT01369511|76093451|FG001|NOT COMPLETED|Overall Study||13||
59976095|NCT01369511|76093452|FG002|NOT COMPLETED|Overall Study||11||
59976096|NCT01369511|76093453|FG003|NOT COMPLETED|Overall Study||11||
59976097|NCT01369433|76093465|FG000|STARTED|Overall Study||209||
59976098|NCT01369433|76093466|FG001|STARTED|Overall Study||16||
59976099|NCT01369433|76093465|FG000|COMPLETED|Overall Study||0||
59976100|NCT01369433|76093466|FG001|COMPLETED|Overall Study||0||
59976101|NCT01369433|76093465|FG000|NOT COMPLETED|Overall Study||209||
59976102|NCT01369433|76093466|FG001|NOT COMPLETED|Overall Study||16||
59976103|NCT02624492|76093475|FG000|STARTED|Overall Study||5||
59976104|NCT02624492|76093476|FG001|STARTED|Overall Study||8||
59976105|NCT02624492|76093477|FG002|STARTED|Overall Study||8||
59976106|NCT02624492|76093475|FG000|COMPLETED|Overall Study||3||
59976107|NCT02624492|76093476|FG001|COMPLETED|Overall Study||4||
59976108|NCT02624492|76093477|FG002|COMPLETED|Overall Study||3||
59976109|NCT02624492|76093475|FG000|NOT COMPLETED|Overall Study||2||
60074625|NCT01555125|76189974|FG004|COMPLETED|Induction Period||56||
59976110|NCT02624492|76093476|FG001|NOT COMPLETED|Overall Study||4||
59976111|NCT02624492|76093477|FG002|NOT COMPLETED|Overall Study||5||
59976112|NCT01975831|76093494|FG000|STARTED|Overall Study||3||
59976113|NCT01975831|76093495|FG001|STARTED|Overall Study||11||
59976114|NCT01975831|76093496|FG002|STARTED|Overall Study||4||
59976115|NCT01975831|76093497|FG003|STARTED|Overall Study||4||
59976116|NCT01975831|76093498|FG004|STARTED|Overall Study||19||
59976117|NCT01975831|76093499|FG005|STARTED|Overall Study||16||
59976118|NCT01975831|76093500|FG006|STARTED|Overall Study||16||
59976119|NCT01975831|76093501|FG007|STARTED|Overall Study||16||
59976120|NCT01975831|76093502|FG008|STARTED|Overall Study||15||
59976121|NCT01975831|76093494|FG000|COMPLETED|Overall Study||0||
59976122|NCT01975831|76093495|FG001|COMPLETED|Overall Study||2||
59976123|NCT01975831|76093496|FG002|COMPLETED|Overall Study||0||
59976124|NCT01975831|76093497|FG003|COMPLETED|Overall Study||0||
59976125|NCT01975831|76093498|FG004|COMPLETED|Overall Study||1||
59976126|NCT01975831|76093499|FG005|COMPLETED|Overall Study||2||
59976127|NCT01975831|76093500|FG006|COMPLETED|Overall Study||0||
60074626|NCT01555125|76189970|FG000|NOT COMPLETED|Induction Period||1||
60074627|NCT01555125|76189971|FG001|NOT COMPLETED|Induction Period||3||
59976128|NCT01975831|76093501|FG007|COMPLETED|Overall Study||1||
59976129|NCT01975831|76093502|FG008|COMPLETED|Overall Study||3||
59976130|NCT01975831|76093494|FG000|NOT COMPLETED|Overall Study||3||
59976131|NCT01975831|76093495|FG001|NOT COMPLETED|Overall Study||9||
59976132|NCT01975831|76093496|FG002|NOT COMPLETED|Overall Study||4||
59976133|NCT01975831|76093497|FG003|NOT COMPLETED|Overall Study||4||
59976134|NCT01975831|76093498|FG004|NOT COMPLETED|Overall Study||18||
59976135|NCT01975831|76093499|FG005|NOT COMPLETED|Overall Study||14||
59976136|NCT01975831|76093500|FG006|NOT COMPLETED|Overall Study||16||
59976137|NCT01975831|76093501|FG007|NOT COMPLETED|Overall Study||15||
59976138|NCT01975831|76093502|FG008|NOT COMPLETED|Overall Study||12||
59976139|NCT00700713|76093525|FG000|STARTED|Overall Study||48||
59976140|NCT00700713|76093526|FG001|STARTED|Overall Study||66||
59976141|NCT00700713|76093527|FG002|STARTED|Overall Study||67||
59525964|NCT01270711|75621418|FG005|COMPLETED|Part 1: Compliance||0||
59813429|NCT03569293|75935909|FG002|COMPLETED|Overall Study||229|Completed Week 16|
59813430|NCT03569293|75935910|FG003|COMPLETED|Overall Study||57|Completed Week 16|
59813431|NCT03569293|75935911|FG004|COMPLETED|Overall Study||64|Completed Week 16|
59813432|NCT03569293|75935912|FG005|COMPLETED|Overall Study||64|Completed Week 16|
59813433|NCT03569293|75935907|FG000|NOT COMPLETED|Overall Study||37||
59813434|NCT03569293|75935908|FG001|NOT COMPLETED|Overall Study||9||
59813435|NCT03569293|75935909|FG002|NOT COMPLETED|Overall Study||14||
59813436|NCT03569293|75935910|FG003|NOT COMPLETED|Overall Study||4||
59813437|NCT03569293|75935911|FG004|NOT COMPLETED|Overall Study||0||
59813438|NCT03569293|75935912|FG005|NOT COMPLETED|Overall Study||0||
59813439|NCT03464136|75935928|FG000|STARTED|Overall Study||195||
59813440|NCT03464136|75935929|FG001|STARTED|Overall Study||191||
59813441|NCT03464136|75935928|FG000|COMPLETED|Overall Study||165||
59813442|NCT03464136|75935929|FG001|COMPLETED|Overall Study||166||
59813443|NCT03464136|75935928|FG000|NOT COMPLETED|Overall Study||30||
59813444|NCT03464136|75935929|FG001|NOT COMPLETED|Overall Study||25||
59813445|NCT03325972|75935937|FG000|STARTED|Overall Study||33||
59813446|NCT03325972|75935938|FG001|STARTED|Overall Study||31||
59813447|NCT03325972|75935937|FG000|COMPLETED|Overall Study||18||
59813448|NCT03325972|75935938|FG001|COMPLETED|Overall Study||13||
59525965|NCT01270711|75621419|FG006|COMPLETED|Part 1: Compliance||0||
59525966|NCT01270711|75621420|FG007|COMPLETED|Part 1: Compliance||0||
59525967|NCT01270711|75621413|FG000|NOT COMPLETED|Part 1: Compliance||0||
59525968|NCT01270711|75621414|FG001|NOT COMPLETED|Part 1: Compliance||0||
59525969|NCT01270711|75621415|FG002|NOT COMPLETED|Part 1: Compliance||0||
59525970|NCT01270711|75621416|FG003|NOT COMPLETED|Part 1: Compliance||0||
59813449|NCT03325972|75935937|FG000|NOT COMPLETED|Overall Study||15||
59813450|NCT03325972|75935938|FG001|NOT COMPLETED|Overall Study||18||
59813451|NCT03026790|75935946|FG000|STARTED|Overall Study||411||
59813452|NCT03026790|75935947|FG001|STARTED|Overall Study||409||
59976142|NCT00700713|76093525|FG000|COMPLETED|Overall Study||47||
59976143|NCT00700713|76093526|FG001|COMPLETED|Overall Study||66||
59976144|NCT00700713|76093527|FG002|COMPLETED|Overall Study||65||
59976145|NCT00700713|76093525|FG000|NOT COMPLETED|Overall Study||1||
59976146|NCT00700713|76093526|FG001|NOT COMPLETED|Overall Study||0||
59976147|NCT00700713|76093527|FG002|NOT COMPLETED|Overall Study||2||
59976148|NCT02622386|76093535|FG000|STARTED|First Assignment||12||
59976149|NCT02622386|76093536|FG001|STARTED|First Assignment||11||
59525971|NCT01270711|75621417|FG004|NOT COMPLETED|Part 1: Compliance||0||
59525972|NCT01270711|75621418|FG005|NOT COMPLETED|Part 1: Compliance||0||
59525973|NCT01270711|75621419|FG006|NOT COMPLETED|Part 1: Compliance||0||
59525974|NCT01270711|75621420|FG007|NOT COMPLETED|Part 1: Compliance||0||
59525975|NCT01270711|75621413|FG000|STARTED|Part 2: Effectiveness||0||
59525976|NCT01270711|75621414|FG001|STARTED|Part 2: Effectiveness||0||
59525977|NCT01270711|75621415|FG002|STARTED|Part 2: Effectiveness||0||
59813453|NCT03026790|75935946|FG000|COMPLETED|Overall Study||358||
59813454|NCT03026790|75935947|FG001|COMPLETED|Overall Study||363||
59813455|NCT03026790|75935946|FG000|NOT COMPLETED|Overall Study||53||
59813456|NCT03026790|75935947|FG001|NOT COMPLETED|Overall Study||46||
59813457|NCT03020823|75935953|FG000|STARTED|Overall Study||10||
59813458|NCT03020823|75935953|FG000|12 mg/m² Only|Overall Study||3||
59813459|NCT03020823|75935953|FG000|12 & 18 mg/m²|Overall Study||4||
59813460|NCT03020823|75935953|FG000|12, 18 & 24 mg/m²|Overall Study||3||
59813461|NCT03020823|75935953|FG000|COMPLETED|Overall Study|4 subjects discontinued from the study owing to disease progression based on clinical judgement, 4 subjects discontinued because of diagnosed PD based on RECIST, and 2 subjects discontinued because of intolerable adverse event(s) or failure to tolerate the study treatment.|0||
59813462|NCT03020823|75935953|FG000|NOT COMPLETED|Overall Study||10||
59813463|NCT02969369|75935961|FG000|STARTED|Study||14||
59813464|NCT02969369|75935962|FG001|STARTED|Study||25||
59813465|NCT02969369|75935961|FG000|Modified Intent-to-Treat Population|Study||14||
59813466|NCT02969369|75935962|FG001|Modified Intent-to-Treat Population|Study||24||
59813467|NCT02969369|75935961|FG000|COMPLETED|Study||10||
59813468|NCT02969369|75935962|FG001|COMPLETED|Study||11||
59813469|NCT02969369|75935961|FG000|NOT COMPLETED|Study||4||
59813470|NCT02969369|75935962|FG001|NOT COMPLETED|Study||14||
59817888|NCT04488770|75940327|FG001|COMPLETED|Part 1-Cohort 2: Period 1 (Up to 5 Days)||0||
59976150|NCT02622386|76093535|FG000|COMPLETED|First Assignment||9||
59813471|NCT02969369|75935961|FG000|STARTED|Double-blind Period|Not all subjects who completed the Double Blind period, enrolled in the Open Label period.|14||
59813472|NCT02969369|75935962|FG001|STARTED|Double-blind Period|Not all subjects who completed the Double Blind period, enrolled in the Open Label period.|25||
59813473|NCT02969369|75935961|FG000|Modified Intent-to-Treat Population|Double-blind Period||14||
59813474|NCT02969369|75935962|FG001|Modified Intent-to-Treat Population|Double-blind Period||24||
59813475|NCT02969369|75935961|FG000|COMPLETED|Double-blind Period||11||
59813476|NCT02969369|75935962|FG001|COMPLETED|Double-blind Period||15||
59813477|NCT02969369|75935961|FG000|NOT COMPLETED|Double-blind Period||3||
59813478|NCT02969369|75935962|FG001|NOT COMPLETED|Double-blind Period||10||
59813479|NCT02969369|75935961|FG000|STARTED|Open-label SEP-363856 Period|Not all subjects who completed the Double Blind period, enrolled in the Open Label period.|7||
59813480|NCT02969369|75935962|FG001|STARTED|Open-label SEP-363856 Period|Not all subjects who completed the Double Blind period, enrolled in the Open Label period.|9||
59813481|NCT02969369|75935961|FG000|COMPLETED|Open-label SEP-363856 Period||6||
59813482|NCT02969369|75935962|FG001|COMPLETED|Open-label SEP-363856 Period||5||
59813483|NCT02969369|75935961|FG000|NOT COMPLETED|Open-label SEP-363856 Period||1||
59813484|NCT02969369|75935962|FG001|NOT COMPLETED|Open-label SEP-363856 Period||4||
59813485|NCT02664610|75935970|FG000|STARTED|Overall Study||46||
59813486|NCT02664610|75935971|FG001|STARTED|Overall Study||48||
59813487|NCT02664610|75935970|FG000|COMPLETED|Overall Study||32||
59813488|NCT02664610|75935971|FG001|COMPLETED|Overall Study||41||
59813489|NCT02664610|75935970|FG000|NOT COMPLETED|Overall Study||14||
59976151|NCT02622386|76093536|FG001|COMPLETED|First Assignment||9||
59976152|NCT02622386|76093535|FG000|NOT COMPLETED|First Assignment||3||
59976153|NCT02622386|76093536|FG001|NOT COMPLETED|First Assignment||2||
59976154|NCT02622386|76093535|FG000|STARTED|Washout||9||
59976155|NCT02622386|76093536|FG001|STARTED|Washout||9||
59976156|NCT02622386|76093535|FG000|COMPLETED|Washout||5||
59976157|NCT02622386|76093536|FG001|COMPLETED|Washout||5||
59976158|NCT02622386|76093535|FG000|NOT COMPLETED|Washout||4||
59976159|NCT02622386|76093536|FG001|NOT COMPLETED|Washout||4||
59976160|NCT02622386|76093535|FG000|STARTED|Second Assignment||5||
59976161|NCT02622386|76093536|FG001|STARTED|Second Assignment||5||
59976162|NCT02622386|76093535|FG000|COMPLETED|Second Assignment||5||
59976163|NCT02622386|76093536|FG001|COMPLETED|Second Assignment||3||
59976164|NCT02622386|76093535|FG000|NOT COMPLETED|Second Assignment||0||
59976165|NCT02622386|76093536|FG001|NOT COMPLETED|Second Assignment||2||
59976166|NCT02792231|76093544|FG000|STARTED|Overall Study||481||
59976167|NCT02792231|76093545|FG001|STARTED|Overall Study||474||
59976168|NCT02792231|76093544|FG000|COMPLETED|Overall Study||399||
59976169|NCT02792231|76093545|FG001|COMPLETED|Overall Study||390||
59976170|NCT02792231|76093544|FG000|NOT COMPLETED|Overall Study||82||
59976171|NCT02792231|76093545|FG001|NOT COMPLETED|Overall Study||84||
59976172|NCT00700401|76093551|FG000|STARTED|Overall Study||262||
59976173|NCT00700401|76093551|FG000|COMPLETED|Overall Study||168||
59976174|NCT00700401|76093551|FG000|NOT COMPLETED|Overall Study||94||
59813490|NCT02664610|75935971|FG001|NOT COMPLETED|Overall Study||7||
59813491|NCT02583269|75935982|FG000|STARTED|Overall Study||3||
59813492|NCT02583269|75935983|FG001|STARTED|Overall Study||7||
59813493|NCT02583269|75935984|FG002|STARTED|Overall Study||3||
59813494|NCT02583269|75935985|FG003|STARTED|Overall Study||5||
59813495|NCT02583269|75935986|FG004|STARTED|Overall Study||6||
59813496|NCT02583269|75935982|FG000|COMPLETED|Overall Study||2||
59813497|NCT02583269|75935983|FG001|COMPLETED|Overall Study||7||
59813498|NCT02583269|75935984|FG002|COMPLETED|Overall Study||3||
59813499|NCT02583269|75935985|FG003|COMPLETED|Overall Study||5||
59813500|NCT02583269|75935986|FG004|COMPLETED|Overall Study||6||
59813501|NCT02583269|75935982|FG000|NOT COMPLETED|Overall Study||1||
59813502|NCT02583269|75935983|FG001|NOT COMPLETED|Overall Study||0||
59813503|NCT02583269|75935984|FG002|NOT COMPLETED|Overall Study||0||
59813504|NCT02583269|75935985|FG003|NOT COMPLETED|Overall Study||0||
59813505|NCT02583269|75935986|FG004|NOT COMPLETED|Overall Study||0||
59813506|NCT02546921|75936006|FG000|STARTED|Overall Study||2||
59976175|NCT02621606|76093558|FG000|STARTED|Overall Study||3||
59976176|NCT02621606|76093559|FG001|STARTED|Overall Study||7||
59813507|NCT02546921|75936007|FG001|STARTED|Overall Study||8||
59813508|NCT02546921|75936008|FG002|STARTED|Overall Study||6||
59813509|NCT02546921|75936009|FG003|STARTED|Overall Study||3||
59813510|NCT02546921|75936010|FG004|STARTED|Overall Study||3||
59813511|NCT02546921|75936011|FG005|STARTED|Overall Study||3||
59813512|NCT02546921|75936012|FG006|STARTED|Overall Study||1||
59813513|NCT02546921|75936006|FG000|COMPLETED|Overall Study||1||
59813514|NCT02546921|75936007|FG001|COMPLETED|Overall Study||2||
59976177|NCT02621606|76093560|FG002|STARTED|Overall Study||10||
59976178|NCT02621606|76093558|FG000|Treated|Overall Study||3||
59976179|NCT02621606|76093559|FG001|Treated|Overall Study||7||
59976180|NCT02621606|76093560|FG002|Treated|Overall Study||10||
59976181|NCT02621606|76093558|FG000|COMPLETED|Overall Study||3||
59976182|NCT02621606|76093559|FG001|COMPLETED|Overall Study||6||
59976183|NCT02621606|76093560|FG002|COMPLETED|Overall Study||10||
59976184|NCT02621606|76093558|FG000|NOT COMPLETED|Overall Study||0||
59976185|NCT02621606|76093559|FG001|NOT COMPLETED|Overall Study||1||
59976186|NCT02621606|76093560|FG002|NOT COMPLETED|Overall Study||0||
59813515|NCT02546921|75936008|FG002|COMPLETED|Overall Study||4||
59813516|NCT02546921|75936009|FG003|COMPLETED|Overall Study||3||
59813517|NCT02546921|75936010|FG004|COMPLETED|Overall Study||2||
59813518|NCT02546921|75936011|FG005|COMPLETED|Overall Study||2||
59813519|NCT02546921|75936012|FG006|COMPLETED|Overall Study||1||
59813520|NCT02546921|75936006|FG000|NOT COMPLETED|Overall Study||1||
59813521|NCT02546921|75936007|FG001|NOT COMPLETED|Overall Study||6||
59813522|NCT02546921|75936008|FG002|NOT COMPLETED|Overall Study||2||
59813523|NCT02546921|75936009|FG003|NOT COMPLETED|Overall Study||0||
59813524|NCT02546921|75936010|FG004|NOT COMPLETED|Overall Study||1||
59813525|NCT02546921|75936011|FG005|NOT COMPLETED|Overall Study||1||
59813526|NCT02546921|75936012|FG006|NOT COMPLETED|Overall Study||0||
59813527|NCT02527681|75936031|FG000|STARTED|Overall Study||15||
59813528|NCT02527681|75936031|FG000|COMPLETED|Overall Study||15||
59813529|NCT02527681|75936031|FG000|NOT COMPLETED|Overall Study||0||
59813530|NCT02516696|75936037|FG000|STARTED|Overall Study||7||
59813531|NCT02516696|75936038|FG001|STARTED|Overall Study||5||
59813532|NCT02516696|75936037|FG000|COMPLETED|Overall Study||7||
59813533|NCT02516696|75936038|FG001|COMPLETED|Overall Study||5||
59813534|NCT02516696|75936037|FG000|NOT COMPLETED|Overall Study||0||
59813535|NCT02516696|75936038|FG001|NOT COMPLETED|Overall Study||0||
59813536|NCT02513329|75936046|FG000|STARTED|Overall Study||20||
59813537|NCT02513329|75936047|FG001|STARTED|Overall Study||17||
59813538|NCT02513329|75936046|FG000|COMPLETED|Overall Study||15|6 months after intervention follow up period|
59813539|NCT02513329|75936047|FG001|COMPLETED|Overall Study||15|6 months after intervention follow up period|
59813540|NCT02513329|75936046|FG000|NOT COMPLETED|Overall Study||5||
59813541|NCT02513329|75936047|FG001|NOT COMPLETED|Overall Study||2||
59813542|NCT02425826|75936057|FG000|STARTED|Placebo-controlled Phase (Week 0 - 16)||148||
59813543|NCT02425826|75936058|FG001|STARTED|Placebo-controlled Phase (Week 0 - 16)||73||
59813544|NCT02425826|75936059|FG002|STARTED|Placebo-controlled Phase (Week 0 - 16)||0||
59813545|NCT02425826|75936057|FG000|Intent to Treat|Placebo-controlled Phase (Week 0 - 16)|ITT = includes participants who received at least one dose of study drug.|147||
59813546|NCT02425826|75936058|FG001|Intent to Treat|Placebo-controlled Phase (Week 0 - 16)|ITT = includes participants who received at least one dose of study drug.|73||
59813547|NCT02425826|75936059|FG002|Intent to Treat|Placebo-controlled Phase (Week 0 - 16)||0||
59813548|NCT02425826|75936057|FG000|COMPLETED|Placebo-controlled Phase (Week 0 - 16)|Completed = participants who completed Week 16|121||
59813549|NCT02425826|75936058|FG001|COMPLETED|Placebo-controlled Phase (Week 0 - 16)|Completed = participants who completed Week 16|64||
59813550|NCT02425826|75936059|FG002|COMPLETED|Placebo-controlled Phase (Week 0 - 16)||0||
59813551|NCT02425826|75936057|FG000|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 16)||27||
59976187|NCT02871401|76093570|FG000|STARTED|Overall Study||20||
59976188|NCT02871401|76093571|FG001|STARTED|Overall Study||11||
59976189|NCT02871401|76093570|FG000|COMPLETED|Overall Study||19||
59976190|NCT02871401|76093571|FG001|COMPLETED|Overall Study||11||
59976191|NCT02871401|76093570|FG000|NOT COMPLETED|Overall Study||1||
59976192|NCT02871401|76093571|FG001|NOT COMPLETED|Overall Study||0||
59813552|NCT02425826|75936058|FG001|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 16)||9||
59813553|NCT02425826|75936059|FG002|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 16)||0||
59813554|NCT02425826|75936057|FG000|STARTED|Apremilast Extension Phase (Weeks 16-52)||121||
59813555|NCT02425826|75936058|FG001|STARTED|Apremilast Extension Phase (Weeks 16-52)||0||
59813556|NCT02425826|75936059|FG002|STARTED|Apremilast Extension Phase (Weeks 16-52)||64||
59813557|NCT02425826|75936057|FG000|Received Treatment|Apremilast Extension Phase (Weeks 16-52)||121||
59813558|NCT02425826|75936058|FG001|Received Treatment|Apremilast Extension Phase (Weeks 16-52)||0||
59976193|NCT02619812|76093581|FG000|STARTED|Overall Study||0||
59976194|NCT02619812|76093582|FG001|STARTED|Overall Study||0||
59976195|NCT02619812|76093583|FG002|STARTED|Overall Study||1||
59813559|NCT02425826|75936059|FG002|Received Treatment|Apremilast Extension Phase (Weeks 16-52)||64||
59813560|NCT02425826|75936057|FG000|COMPLETED|Apremilast Extension Phase (Weeks 16-52)||86||
59813561|NCT02425826|75936058|FG001|COMPLETED|Apremilast Extension Phase (Weeks 16-52)||0||
59813562|NCT02425826|75936059|FG002|COMPLETED|Apremilast Extension Phase (Weeks 16-52)||50||
59813563|NCT02425826|75936057|FG000|NOT COMPLETED|Apremilast Extension Phase (Weeks 16-52)||35||
59813564|NCT02425826|75936058|FG001|NOT COMPLETED|Apremilast Extension Phase (Weeks 16-52)||0||
59813565|NCT02425826|75936059|FG002|NOT COMPLETED|Apremilast Extension Phase (Weeks 16-52)||14||
59813566|NCT02425826|75936057|FG000|STARTED|Post-Treatment Observational Follow-Up||81||
59813567|NCT02425826|75936058|FG001|STARTED|Post-Treatment Observational Follow-Up||0||
59813568|NCT02425826|75936059|FG002|STARTED|Post-Treatment Observational Follow-Up||49||
59813569|NCT02425826|75936057|FG000|COMPLETED|Post-Treatment Observational Follow-Up||80||
59813570|NCT02425826|75936058|FG001|COMPLETED|Post-Treatment Observational Follow-Up||0||
59813571|NCT02425826|75936059|FG002|COMPLETED|Post-Treatment Observational Follow-Up||49||
59813572|NCT02425826|75936057|FG000|NOT COMPLETED|Post-Treatment Observational Follow-Up||1||
59976196|NCT02619812|76093584|FG003|STARTED|Overall Study||2||
59976197|NCT02619812|76093581|FG000|COMPLETED|Overall Study||0||
59976198|NCT02619812|76093582|FG001|COMPLETED|Overall Study||0||
59976199|NCT02619812|76093583|FG002|COMPLETED|Overall Study||0||
59976200|NCT02619812|76093584|FG003|COMPLETED|Overall Study||0||
59976201|NCT02619812|76093581|FG000|NOT COMPLETED|Overall Study||0||
59976202|NCT02619812|76093582|FG001|NOT COMPLETED|Overall Study||0||
59976203|NCT02619812|76093583|FG002|NOT COMPLETED|Overall Study||1||
59976204|NCT02619812|76093584|FG003|NOT COMPLETED|Overall Study||2||
59976205|NCT02623322|76093597|FG000|STARTED|Overall Study||43||
59976206|NCT02623322|76093598|FG001|STARTED|Overall Study||41||
59976207|NCT02623322|76093599|FG002|STARTED|Overall Study||40||
59976208|NCT02623322|76093597|FG000|COMPLETED|Overall Study||41||
59976209|NCT02623322|76093598|FG001|COMPLETED|Overall Study||40||
59976210|NCT02623322|76093599|FG002|COMPLETED|Overall Study||40||
59976211|NCT02623322|76093597|FG000|NOT COMPLETED|Overall Study||2||
59813573|NCT02425826|75936058|FG001|NOT COMPLETED|Post-Treatment Observational Follow-Up||0||
59813574|NCT02425826|75936059|FG002|NOT COMPLETED|Post-Treatment Observational Follow-Up||0||
59813575|NCT02406027|75936072|FG000|STARTED|Double-blind Treatment Phase (Period 1)||35||
59813576|NCT02406027|75936073|FG001|STARTED|Double-blind Treatment Phase (Period 1)||29||
59813577|NCT02406027|75936074|FG002|STARTED|Double-blind Treatment Phase (Period 1)||26||
59813578|NCT02406027|75936075|FG003|STARTED|Double-blind Treatment Phase (Period 1)||0||
59813579|NCT02406027|75936076|FG004|STARTED|Double-blind Treatment Phase (Period 1)||0||
59813580|NCT02406027|75936077|FG005|STARTED|Double-blind Treatment Phase (Period 1)||0||
59813581|NCT02406027|75936078|FG006|STARTED|Double-blind Treatment Phase (Period 1)||0||
59813582|NCT02406027|75936072|FG000|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||6||
59976212|NCT02623322|76093598|FG001|NOT COMPLETED|Overall Study||1||
59976213|NCT02623322|76093599|FG002|NOT COMPLETED|Overall Study||0||
59976214|NCT00105157|76093613|FG000|STARTED|Double-Blind (DB)||44||
59976215|NCT00105157|76093614|FG001|STARTED|Double-Blind (DB)||45||
59976216|NCT00105157|76093615|FG002|STARTED|Double-Blind (DB)||45||
59976217|NCT00105157|76093616|FG003|STARTED|Double-Blind (DB)||45||
59976218|NCT00105157|76093613|FG000|Treated|Double-Blind (DB)||43||
59976219|NCT00105157|76093614|FG001|Treated|Double-Blind (DB)||45||
59976220|NCT00105157|76093615|FG002|Treated|Double-Blind (DB)||45||
59976221|NCT00105157|76093616|FG003|Treated|Double-Blind (DB)||45||
59976222|NCT00105157|76093613|FG000|COMPLETED|Double-Blind (DB)||30||
59976223|NCT00105157|76093614|FG001|COMPLETED|Double-Blind (DB)||31||
59976224|NCT00105157|76093615|FG002|COMPLETED|Double-Blind (DB)||33||
59976225|NCT00105157|76093616|FG003|COMPLETED|Double-Blind (DB)||6||
59976226|NCT00105157|76093613|FG000|NOT COMPLETED|Double-Blind (DB)||14||
59976227|NCT00105157|76093614|FG001|NOT COMPLETED|Double-Blind (DB)||14||
59976228|NCT00105157|76093615|FG002|NOT COMPLETED|Double-Blind (DB)||12||
59976229|NCT00105157|76093616|FG003|NOT COMPLETED|Double-Blind (DB)||39||
59976230|NCT00105157|76093613|FG000|STARTED|Open-Label Continuation of DB||30||
59976231|NCT00105157|76093614|FG001|STARTED|Open-Label Continuation of DB||31||
59976232|NCT00105157|76093615|FG002|STARTED|Open-Label Continuation of DB||33||
59976233|NCT00105157|76093616|FG003|STARTED|Open-Label Continuation of DB||6||
59976234|NCT00105157|76093613|FG000|COMPLETED|Open-Label Continuation of DB||23||
59976235|NCT00105157|76093614|FG001|COMPLETED|Open-Label Continuation of DB||21||
59976236|NCT00105157|76093615|FG002|COMPLETED|Open-Label Continuation of DB||24||
59976237|NCT00105157|76093616|FG003|COMPLETED|Open-Label Continuation of DB||5||
59525978|NCT01270711|75621416|FG003|STARTED|Part 2: Effectiveness||0||
59525979|NCT01270711|75621417|FG004|STARTED|Part 2: Effectiveness||0||
59525980|NCT01270711|75621418|FG005|STARTED|Part 2: Effectiveness||11||
59525981|NCT01270711|75621419|FG006|STARTED|Part 2: Effectiveness||2||
59525982|NCT01270711|75621420|FG007|STARTED|Part 2: Effectiveness||48||
59525983|NCT01270711|75621413|FG000|COMPLETED|Part 2: Effectiveness||0||
59525984|NCT01270711|75621414|FG001|COMPLETED|Part 2: Effectiveness||0||
59525985|NCT01270711|75621415|FG002|COMPLETED|Part 2: Effectiveness||0||
59813583|NCT02406027|75936073|FG001|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||8||
59813584|NCT02406027|75936074|FG002|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||6||
59813585|NCT02406027|75936075|FG003|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||0||
59976238|NCT00105157|76093613|FG000|NOT COMPLETED|Open-Label Continuation of DB||7||
59976239|NCT00105157|76093614|FG001|NOT COMPLETED|Open-Label Continuation of DB||10||
59976240|NCT00105157|76093615|FG002|NOT COMPLETED|Open-Label Continuation of DB||9||
59976241|NCT00105157|76093616|FG003|NOT COMPLETED|Open-Label Continuation of DB||1||
59976242|NCT00105157|76093613|FG000|STARTED|Open-Label Post Virologic Failure(OLPVF)|Number of Patients appropriate for and who consented to enter the OLPVF|11||
59976243|NCT00105157|76093614|FG001|STARTED|Open-Label Post Virologic Failure(OLPVF)|Number of Patients appropriate for and who consented to enter the OLPVF|13||
59976244|NCT00105157|76093615|FG002|STARTED|Open-Label Post Virologic Failure(OLPVF)|Number of Patients appropriate for and who consented to enter the OLPVF|11||
59976245|NCT00105157|76093616|FG003|STARTED|Open-Label Post Virologic Failure(OLPVF)|Number of Patients appropriate for and who consented to enter the OLPVF|37||
59976246|NCT00105157|76093613|FG000|COMPLETED|Open-Label Post Virologic Failure(OLPVF)||2||
59976247|NCT00105157|76093614|FG001|COMPLETED|Open-Label Post Virologic Failure(OLPVF)||7||
59976248|NCT00105157|76093615|FG002|COMPLETED|Open-Label Post Virologic Failure(OLPVF)||5||
59976249|NCT00105157|76093616|FG003|COMPLETED|Open-Label Post Virologic Failure(OLPVF)||19||
59976250|NCT00105157|76093613|FG000|NOT COMPLETED|Open-Label Post Virologic Failure(OLPVF)||9||
59976251|NCT00105157|76093614|FG001|NOT COMPLETED|Open-Label Post Virologic Failure(OLPVF)||6||
59976252|NCT00105157|76093615|FG002|NOT COMPLETED|Open-Label Post Virologic Failure(OLPVF)||6||
59976253|NCT00105157|76093616|FG003|NOT COMPLETED|Open-Label Post Virologic Failure(OLPVF)||18||
59976254|NCT04912700|76093627|FG000|STARTED|Overall Study||10880||
59976255|NCT04912700|76093628|FG001|STARTED|Overall Study||825||
59525986|NCT01270711|75621416|FG003|COMPLETED|Part 2: Effectiveness||0||
59525987|NCT01270711|75621417|FG004|COMPLETED|Part 2: Effectiveness||0||
59813586|NCT02406027|75936076|FG004|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||0||
59813587|NCT02406027|75936077|FG005|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||0||
59813588|NCT02406027|75936078|FG006|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||0||
59525988|NCT01270711|75621418|FG005|COMPLETED|Part 2: Effectiveness||11||
59525989|NCT01270711|75621419|FG006|COMPLETED|Part 2: Effectiveness||2||
59525990|NCT01270711|75621420|FG007|COMPLETED|Part 2: Effectiveness||48||
59525991|NCT01270711|75621413|FG000|NOT COMPLETED|Part 2: Effectiveness||0||
59525992|NCT01270711|75621414|FG001|NOT COMPLETED|Part 2: Effectiveness||0||
59813589|NCT02406027|75936072|FG000|Prodromal|Double-blind Treatment Phase (Period 1)||29||
59813590|NCT02406027|75936073|FG001|Prodromal|Double-blind Treatment Phase (Period 1)||21||
59813591|NCT02406027|75936074|FG002|Prodromal|Double-blind Treatment Phase (Period 1)||20||
59813592|NCT02406027|75936075|FG003|Prodromal|Double-blind Treatment Phase (Period 1)||0||
59813593|NCT02406027|75936076|FG004|Prodromal|Double-blind Treatment Phase (Period 1)||0||
59813594|NCT02406027|75936077|FG005|Prodromal|Double-blind Treatment Phase (Period 1)||0||
59813595|NCT02406027|75936078|FG006|Prodromal|Double-blind Treatment Phase (Period 1)||0||
59813596|NCT02406027|75936072|FG000|COMPLETED|Double-blind Treatment Phase (Period 1)||29||
59813597|NCT02406027|75936073|FG001|COMPLETED|Double-blind Treatment Phase (Period 1)||26||
59813598|NCT02406027|75936074|FG002|COMPLETED|Double-blind Treatment Phase (Period 1)||22||
59813599|NCT02406027|75936075|FG003|COMPLETED|Double-blind Treatment Phase (Period 1)||0||
59813600|NCT02406027|75936076|FG004|COMPLETED|Double-blind Treatment Phase (Period 1)||0||
59813601|NCT02406027|75936077|FG005|COMPLETED|Double-blind Treatment Phase (Period 1)||0||
59813602|NCT02406027|75936078|FG006|COMPLETED|Double-blind Treatment Phase (Period 1)||0||
59813603|NCT02406027|75936072|FG000|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||6||
59813604|NCT02406027|75936073|FG001|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||3||
59813605|NCT02406027|75936074|FG002|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||4||
59813606|NCT02406027|75936075|FG003|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||0||
59813607|NCT02406027|75936076|FG004|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||0||
59813608|NCT02406027|75936077|FG005|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||0||
59813609|NCT02406027|75936078|FG006|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||0||
59813610|NCT02406027|75936072|FG000|STARTED|Open-label Phase (Period 2)||0||
59813611|NCT02406027|75936073|FG001|STARTED|Open-label Phase (Period 2)||0||
59813612|NCT02406027|75936074|FG002|STARTED|Open-label Phase (Period 2)||0||
59813613|NCT02406027|75936075|FG003|STARTED|Open-label Phase (Period 2)||15||
59813614|NCT02406027|75936076|FG004|STARTED|Open-label Phase (Period 2)||14||
59813615|NCT02406027|75936077|FG005|STARTED|Open-label Phase (Period 2)||26||
59813616|NCT02406027|75936078|FG006|STARTED|Open-label Phase (Period 2)||22||
59813617|NCT02406027|75936072|FG000|COMPLETED|Open-label Phase (Period 2)||0||
59813618|NCT02406027|75936073|FG001|COMPLETED|Open-label Phase (Period 2)||0||
59813619|NCT02406027|75936074|FG002|COMPLETED|Open-label Phase (Period 2)||0||
59813620|NCT02406027|75936075|FG003|COMPLETED|Open-label Phase (Period 2)||0||
59813621|NCT02406027|75936076|FG004|COMPLETED|Open-label Phase (Period 2)||0||
59813622|NCT02406027|75936077|FG005|COMPLETED|Open-label Phase (Period 2)||0||
59813623|NCT02406027|75936078|FG006|COMPLETED|Open-label Phase (Period 2)||0||
59813624|NCT02406027|75936072|FG000|NOT COMPLETED|Open-label Phase (Period 2)||0||
59813625|NCT02406027|75936073|FG001|NOT COMPLETED|Open-label Phase (Period 2)||0||
59813626|NCT02406027|75936074|FG002|NOT COMPLETED|Open-label Phase (Period 2)||0||
59813627|NCT02406027|75936075|FG003|NOT COMPLETED|Open-label Phase (Period 2)||15||
59813628|NCT02406027|75936076|FG004|NOT COMPLETED|Open-label Phase (Period 2)||14||
59813629|NCT02406027|75936077|FG005|NOT COMPLETED|Open-label Phase (Period 2)||26||
59813630|NCT02406027|75936078|FG006|NOT COMPLETED|Open-label Phase (Period 2)||22||
59813631|NCT02278120|75936096|FG000|STARTED|Overall Study||335||
59813632|NCT02278120|75936097|FG001|STARTED|Overall Study||337||
59817889|NCT04488770|75940328|FG002|COMPLETED|Part 1-Cohort 2: Period 1 (Up to 5 Days)||0||
59976256|NCT04912700|76093629|FG002|STARTED|Overall Study||129||
59976257|NCT04912700|76093627|FG000|COMPLETED|Overall Study||10880||
59976258|NCT04912700|76093628|FG001|COMPLETED|Overall Study||825||
59976259|NCT04912700|76093629|FG002|COMPLETED|Overall Study||129||
59976260|NCT04912700|76093627|FG000|NOT COMPLETED|Overall Study||0||
59976261|NCT04912700|76093628|FG001|NOT COMPLETED|Overall Study||0||
59976262|NCT04912700|76093629|FG002|NOT COMPLETED|Overall Study||0||
59976263|NCT02148133|76093637|FG000|STARTED|Overall Study||21|Full Analysis Set (FAS)|
59976264|NCT02148133|76093637|FG000|Safety Set (SS)|Overall Study||21|All patients who were treated with eltrombopag at least once|
59976265|NCT02148133|76093637|FG000|Pharmacokinetic Analysis Set (PAS)|Overall Study||21|All patients who provided Pharmacokinetics (PK) serum samples|
59976266|NCT02148133|76093637|FG000|COMPLETED|Overall Study||16||
59976267|NCT02148133|76093637|FG000|NOT COMPLETED|Overall Study||5||
59976268|NCT00803569|76093641|FG000|STARTED|Overall Study||13||
59976269|NCT00803569|76093641|FG000|COMPLETED|Overall Study||9||
59976270|NCT00803569|76093641|FG000|NOT COMPLETED|Overall Study||4||
59976271|NCT00112957|76093645|FG000|STARTED|Overall Study||23||
59976272|NCT00112957|76093645|FG000|COMPLETED|Overall Study||4|Completed through the 12-month follow-up|
59976273|NCT00112957|76093645|FG000|NOT COMPLETED|Overall Study||19||
59976274|NCT02376790|76093652|FG000|STARTED|Overall Study||284||
59976275|NCT02376790|76093653|FG001|STARTED|Overall Study||284||
59976276|NCT02376790|76093654|FG002|STARTED|Overall Study||283||
59976277|NCT02376790|76093652|FG000|Received Treatment|Overall Study||282||
59976278|NCT02376790|76093653|FG001|Received Treatment|Overall Study||284||
59525993|NCT01270711|75621415|FG002|NOT COMPLETED|Part 2: Effectiveness||0||
59525994|NCT01270711|75621416|FG003|NOT COMPLETED|Part 2: Effectiveness||0||
59525995|NCT01270711|75621417|FG004|NOT COMPLETED|Part 2: Effectiveness||0||
59525996|NCT01270711|75621418|FG005|NOT COMPLETED|Part 2: Effectiveness||0||
59525997|NCT01270711|75621419|FG006|NOT COMPLETED|Part 2: Effectiveness||0||
59525998|NCT01270711|75621420|FG007|NOT COMPLETED|Part 2: Effectiveness||0||
59525999|NCT01340053|75621443|FG000|STARTED|Overall Study||47||
59526000|NCT01340053|75621444|FG001|STARTED|Overall Study||46||
59526001|NCT01340053|75621445|FG002|STARTED|Overall Study||47||
59526002|NCT01340053|75621446|FG003|STARTED|Overall Study||46||
59526003|NCT01340053|75621443|FG000|COMPLETED|Overall Study||43||
59526004|NCT01340053|75621444|FG001|COMPLETED|Overall Study||44||
59526005|NCT01340053|75621445|FG002|COMPLETED|Overall Study||43||
59526006|NCT01340053|75621446|FG003|COMPLETED|Overall Study||43||
59976279|NCT02376790|76093654|FG002|Received Treatment|Overall Study||282||
59976280|NCT02376790|76093652|FG000|COMPLETED|Overall Study||224||
59976281|NCT02376790|76093653|FG001|COMPLETED|Overall Study||237||
59976282|NCT02376790|76093654|FG002|COMPLETED|Overall Study||230||
59976283|NCT02376790|76093652|FG000|NOT COMPLETED|Overall Study||60||
59976284|NCT02376790|76093653|FG001|NOT COMPLETED|Overall Study||47||
59976285|NCT02376790|76093654|FG002|NOT COMPLETED|Overall Study||53||
59976286|NCT02376166|76093662|FG000|STARTED|Overall Study||15||
59976287|NCT02376166|76093662|FG000|COMPLETED|Overall Study||12||
59976288|NCT02376166|76093662|FG000|NOT COMPLETED|Overall Study||3||
59976289|NCT02311894|76093666|FG000|STARTED|Overall Study||82||
59976290|NCT02311894|76093666|FG000|Modified ITT Population|Overall Study||81|Participants who took at least one dose of study drug and had at least one post-baseline assessment.|
59976291|NCT02311894|76093666|FG000|COMPLETED|Overall Study||78||
59976292|NCT02311894|76093666|FG000|NOT COMPLETED|Overall Study||4||
59976293|NCT02310646|76093672|FG000|STARTED|First Intervention (Day 1 - Day 7)||109||
59976294|NCT02310646|76093673|FG001|STARTED|First Intervention (Day 1 - Day 7)||104||
59976295|NCT02310646|76093672|FG000|COMPLETED|First Intervention (Day 1 - Day 7)||107||
59976296|NCT02310646|76093673|FG001|COMPLETED|First Intervention (Day 1 - Day 7)||104||
59976297|NCT02310646|76093672|FG000|NOT COMPLETED|First Intervention (Day 1 - Day 7)||2||
59526007|NCT01340053|75621443|FG000|NOT COMPLETED|Overall Study||4||
59526008|NCT01340053|75621444|FG001|NOT COMPLETED|Overall Study||2||
59526009|NCT01340053|75621445|FG002|NOT COMPLETED|Overall Study||4||
59526010|NCT01340053|75621446|FG003|NOT COMPLETED|Overall Study||3||
59526011|NCT01270867|75621458|FG000|STARTED|Overall Study||90||
59526012|NCT01270867|75621459|FG001|STARTED|Overall Study||88||
59526013|NCT01270867|75621458|FG000|COMPLETED|Overall Study||89||
59976298|NCT02310646|76093673|FG001|NOT COMPLETED|First Intervention (Day 1 - Day 7)||0||
59976299|NCT02310646|76093672|FG000|STARTED|Second Intervention (Day 8 - Day 14)||107||
59976300|NCT02310646|76093673|FG001|STARTED|Second Intervention (Day 8 - Day 14)||104||
59976301|NCT02310646|76093672|FG000|COMPLETED|Second Intervention (Day 8 - Day 14)||107||
59976302|NCT02310646|76093673|FG001|COMPLETED|Second Intervention (Day 8 - Day 14)||104||
59976303|NCT02310646|76093672|FG000|NOT COMPLETED|Second Intervention (Day 8 - Day 14)||0||
59976304|NCT02310646|76093673|FG001|NOT COMPLETED|Second Intervention (Day 8 - Day 14)||0||
59526014|NCT01270867|75621459|FG001|COMPLETED|Overall Study||88||
59526015|NCT01270867|75621458|FG000|NOT COMPLETED|Overall Study||1||
59526016|NCT01270867|75621459|FG001|NOT COMPLETED|Overall Study||0||
59813633|NCT02278120|75936096|FG000|COMPLETED|Overall Study||174|Completed = Treatment ongoing at time of data cut-off, 20-Aug-2017|
59813634|NCT02278120|75936097|FG001|COMPLETED|Overall Study||121|Completed = Treatment ongoing at time of data cut-off, 20-Aug-2017|
59813635|NCT02278120|75936096|FG000|NOT COMPLETED|Overall Study||161||
59813636|NCT02278120|75936097|FG001|NOT COMPLETED|Overall Study||216||
59813637|NCT02255357|75936105|FG000|STARTED|Overall Study||14||
59813638|NCT02255357|75936106|FG001|STARTED|Overall Study||29||
59813639|NCT02255357|75936105|FG000|COMPLETED|Overall Study||4||
59526017|NCT01271413|75621467|FG000|STARTED|Overall Study||37||
59526018|NCT01271413|75621468|FG001|STARTED|Overall Study||36||
59526019|NCT01271413|75621467|FG000|COMPLETED|Overall Study||28||
59526020|NCT01271413|75621468|FG001|COMPLETED|Overall Study||28||
59526021|NCT01271413|75621467|FG000|NOT COMPLETED|Overall Study||9||
59526022|NCT01271413|75621468|FG001|NOT COMPLETED|Overall Study||8||
59526023|NCT01292005|75621476|FG000|STARTED|Overall Study||14||
59526024|NCT01292005|75621477|FG001|STARTED|Overall Study||14||
59526025|NCT01292005|75621476|FG000|COMPLETED|Overall Study||14||
59526026|NCT01292005|75621477|FG001|COMPLETED|Overall Study||14||
59526027|NCT01292005|75621476|FG000|NOT COMPLETED|Overall Study||0||
59526028|NCT01292005|75621477|FG001|NOT COMPLETED|Overall Study||0||
59526029|NCT01341067|75621483|FG000|STARTED|Overall Study||30||
59526030|NCT01341067|75621483|FG000|COMPLETED|Overall Study||26||
59526031|NCT01341067|75621483|FG000|NOT COMPLETED|Overall Study||4||
59526032|NCT01292629|75621487|FG000|STARTED|Overall Study||125||
59526033|NCT01292629|75621487|FG000|COMPLETED|Overall Study||125||
59526034|NCT01292629|75621487|FG000|NOT COMPLETED|Overall Study||0||
59526035|NCT01272583|75621494|FG000|STARTED|Overall Study||8||
59526036|NCT01272583|75621495|FG001|STARTED|Overall Study||8||
59526037|NCT01272583|75621494|FG000|COMPLETED|Overall Study||8||
59526038|NCT01272583|75621495|FG001|COMPLETED|Overall Study||8||
59526039|NCT01272583|75621494|FG000|NOT COMPLETED|Overall Study||0||
59526040|NCT01272583|75621495|FG001|NOT COMPLETED|Overall Study||0||
59526041|NCT01341301|75621503|FG000|STARTED|Overall Study||25||
59526042|NCT01341301|75621503|FG000|COMPLETED|Overall Study||25||
59526043|NCT01341301|75621503|FG000|NOT COMPLETED|Overall Study||0||
59526044|NCT01342471|75621511|FG000|STARTED|Overall Study||29||
59526045|NCT01342471|75621512|FG001|STARTED|Overall Study||29||
59526046|NCT01342471|75621511|FG000|COMPLETED|Overall Study||24||
59526047|NCT01342471|75621512|FG001|COMPLETED|Overall Study||23||
59526048|NCT01342471|75621511|FG000|NOT COMPLETED|Overall Study||5||
59526049|NCT01342471|75621512|FG001|NOT COMPLETED|Overall Study||6||
59526050|NCT01273207|75621518|FG000|STARTED|Overall Study||7||
59526051|NCT01273207|75621518|FG000|COMPLETED|Overall Study||2||
59526052|NCT01273207|75621518|FG000|NOT COMPLETED|Overall Study||5||
59526053|NCT02195713|75621524|FG000|STARTED|Overall Study||10||
59813640|NCT02255357|75936106|FG001|COMPLETED|Overall Study||5||
59813641|NCT02255357|75936105|FG000|NOT COMPLETED|Overall Study||10||
59976305|NCT02375698|76093697|FG000|STARTED|Overall Study||16||
59976306|NCT02375698|76093698|FG001|STARTED|Overall Study||6||
59526054|NCT02195713|75621525|FG001|STARTED|Overall Study||10||
59526055|NCT02195713|75621524|FG000|COMPLETED|Overall Study||10||
59526056|NCT02195713|75621525|FG001|COMPLETED|Overall Study||10||
59976307|NCT02375698|76093697|FG000|COMPLETED|Overall Study||14||
59976308|NCT02375698|76093698|FG001|COMPLETED|Overall Study||4||
59976309|NCT02375698|76093697|FG000|NOT COMPLETED|Overall Study||2||
59976310|NCT02375698|76093698|FG001|NOT COMPLETED|Overall Study||2||
59976311|NCT02374918|76093708|FG000|STARTED|Overall Study||17||
59976312|NCT02374918|76093709|FG001|STARTED|Overall Study||18||
59976313|NCT02374918|76093710|FG002|STARTED|Overall Study||22||
59526057|NCT02195713|75621524|FG000|NOT COMPLETED|Overall Study||0||
59526058|NCT02195713|75621525|FG001|NOT COMPLETED|Overall Study||0||
59526059|NCT01342549|75621533|FG000|STARTED|Overall Study||31||
59526060|NCT01342549|75621534|FG001|STARTED|Overall Study||31||
59526061|NCT01342549|75621533|FG000|COMPLETED|Overall Study||31||
59526062|NCT01342549|75621534|FG001|COMPLETED|Overall Study||31||
59526063|NCT01342549|75621533|FG000|NOT COMPLETED|Overall Study||0||
59976314|NCT02374918|76093711|FG003|STARTED|Overall Study||20||
59813642|NCT02255357|75936106|FG001|NOT COMPLETED|Overall Study||24||
59976315|NCT02374918|76093708|FG000|COMPLETED|Overall Study||14||
59976316|NCT02374918|76093709|FG001|COMPLETED|Overall Study||17||
59976317|NCT02374918|76093710|FG002|COMPLETED|Overall Study||18||
59976318|NCT02374918|76093711|FG003|COMPLETED|Overall Study||18||
59976319|NCT02374918|76093708|FG000|NOT COMPLETED|Overall Study||3||
59976320|NCT02374918|76093709|FG001|NOT COMPLETED|Overall Study||1||
59976321|NCT02374918|76093710|FG002|NOT COMPLETED|Overall Study||4||
59976322|NCT02374918|76093711|FG003|NOT COMPLETED|Overall Study||2||
59976323|NCT02344576|76093723|FG000|STARTED|Enrollment|Includes 7 patients who agreed to medical record review only and were excluded from further analysis|142||
59976324|NCT02344576|76093724|FG001|STARTED|Enrollment|Includes 8 patients who agreed to medical record review only and were excluded from further analysis|121||
59976325|NCT02344576|76093725|FG002|STARTED|Enrollment||111||
59976326|NCT02344576|76093726|FG003|STARTED|Enrollment||71||
59976327|NCT02344576|76093723|FG000|Agreed to Survey Data Collection|Enrollment||135||
59976328|NCT02344576|76093724|FG001|Agreed to Survey Data Collection|Enrollment||113||
59976329|NCT02344576|76093725|FG002|Agreed to Survey Data Collection|Enrollment||111||
59976330|NCT02344576|76093726|FG003|Agreed to Survey Data Collection|Enrollment||71||
59976331|NCT02344576|76093723|FG000|COMPLETED|Enrollment||135||
59976332|NCT02344576|76093724|FG001|COMPLETED|Enrollment||113||
59976333|NCT02344576|76093725|FG002|COMPLETED|Enrollment||111||
59976334|NCT02344576|76093726|FG003|COMPLETED|Enrollment||71||
59976335|NCT02344576|76093723|FG000|NOT COMPLETED|Enrollment||7||
59976336|NCT02344576|76093724|FG001|NOT COMPLETED|Enrollment||8||
59976337|NCT02344576|76093725|FG002|NOT COMPLETED|Enrollment||0||
59976338|NCT02344576|76093726|FG003|NOT COMPLETED|Enrollment||0||
59976339|NCT02344576|76093723|FG000|STARTED|1-Month Follow-Up||135||
59976340|NCT02344576|76093724|FG001|STARTED|1-Month Follow-Up||113||
59976341|NCT02344576|76093725|FG002|STARTED|1-Month Follow-Up||111||
59976342|NCT02344576|76093726|FG003|STARTED|1-Month Follow-Up||71||
59976343|NCT02344576|76093723|FG000|Completed 1-Month Survey|1-Month Follow-Up||104||
59976344|NCT02344576|76093724|FG001|Completed 1-Month Survey|1-Month Follow-Up||79||
59976345|NCT02344576|76093725|FG002|Completed 1-Month Survey|1-Month Follow-Up||89||
59976346|NCT02344576|76093726|FG003|Completed 1-Month Survey|1-Month Follow-Up||53||
59976347|NCT02344576|76093723|FG000|COMPLETED|1-Month Follow-Up|Includes 13 patients who were still enrolled at 1-month but did not complete the 1-month survey.|117||
59976348|NCT02344576|76093724|FG001|COMPLETED|1-Month Follow-Up|Includes 7 patients who were still enrolled at 1-month but did not complete the 1-month survey.|86||
59976349|NCT02344576|76093725|FG002|COMPLETED|1-Month Follow-Up|Includes 3 caregivers who were still enrolled at 1-month but did not complete the 1-month survey.|92||
59976350|NCT02344576|76093726|FG003|COMPLETED|1-Month Follow-Up|Includes 5 caregivers who were still enrolled at 1-month but did not complete the 1-month survey.|58||
59976351|NCT02344576|76093723|FG000|NOT COMPLETED|1-Month Follow-Up||18||
59976352|NCT02344576|76093724|FG001|NOT COMPLETED|1-Month Follow-Up||27||
59976353|NCT02344576|76093725|FG002|NOT COMPLETED|1-Month Follow-Up||19||
59976354|NCT02344576|76093726|FG003|NOT COMPLETED|1-Month Follow-Up||13||
59976355|NCT02344576|76093723|FG000|STARTED|6-Month Follow-Up||117||
59976356|NCT02344576|76093724|FG001|STARTED|6-Month Follow-Up||86||
59976357|NCT02344576|76093725|FG002|STARTED|6-Month Follow-Up||92||
59976358|NCT02344576|76093726|FG003|STARTED|6-Month Follow-Up||58||
59976359|NCT02344576|76093723|FG000|Completed 6-Month Survey|6-Month Follow-Up||98||
59976360|NCT02344576|76093724|FG001|Completed 6-Month Survey|6-Month Follow-Up||67||
59976361|NCT02344576|76093725|FG002|Completed 6-Month Survey|6-Month Follow-Up||78||
59976362|NCT02344576|76093726|FG003|Completed 6-Month Survey|6-Month Follow-Up||50||
59976363|NCT02344576|76093723|FG000|COMPLETED|6-Month Follow-Up||98||
59976364|NCT02344576|76093724|FG001|COMPLETED|6-Month Follow-Up||67||
59976365|NCT02344576|76093725|FG002|COMPLETED|6-Month Follow-Up||78||
59976366|NCT02344576|76093726|FG003|COMPLETED|6-Month Follow-Up||50||
59976367|NCT02344576|76093723|FG000|NOT COMPLETED|6-Month Follow-Up||19||
59976368|NCT02344576|76093724|FG001|NOT COMPLETED|6-Month Follow-Up||19||
59976369|NCT02344576|76093725|FG002|NOT COMPLETED|6-Month Follow-Up||14||
59976370|NCT02344576|76093726|FG003|NOT COMPLETED|6-Month Follow-Up||8||
59976371|NCT02344576|76093723|FG000|STARTED|12-Month Medical Record Follow-Up||98|12-month period applicable to patient participants only.|
59976372|NCT02344576|76093724|FG001|STARTED|12-Month Medical Record Follow-Up||67|12-month period applicable to patient participants only.|
59976373|NCT02344576|76093725|FG002|STARTED|12-Month Medical Record Follow-Up|This period not applicable to caregivers, as medical record review was completed for patients only.|78|12-month period applicable to patient participants only.|
59976374|NCT02344576|76093726|FG003|STARTED|12-Month Medical Record Follow-Up|This period not applicable to caregivers, as medical record review was completed for patients only.|50|12-month period applicable to patient participants only.|
59976375|NCT02344576|76093723|FG000|COMPLETED|12-Month Medical Record Follow-Up||98|12-month period applicable to patient participants only.|
59976376|NCT02344576|76093724|FG001|COMPLETED|12-Month Medical Record Follow-Up||67|12-month period applicable to patient participants only.|
59976377|NCT02344576|76093725|FG002|COMPLETED|12-Month Medical Record Follow-Up|This period not applicable to caregivers, as medical record review was completed for patients only.|78|12-month period applicable to patient participants only.|
59976378|NCT02344576|76093726|FG003|COMPLETED|12-Month Medical Record Follow-Up|This period not applicable to caregivers, as medical record review was completed for patients only.|50|12-month period applicable to patient participants only.|
59976379|NCT02344576|76093723|FG000|NOT COMPLETED|12-Month Medical Record Follow-Up||0||
59976380|NCT02344576|76093724|FG001|NOT COMPLETED|12-Month Medical Record Follow-Up||0||
59976381|NCT02344576|76093725|FG002|NOT COMPLETED|12-Month Medical Record Follow-Up||0||
59976382|NCT02344576|76093726|FG003|NOT COMPLETED|12-Month Medical Record Follow-Up||0||
59976383|NCT02344342|76093742|FG000|STARTED|Overall Study||13||
59976384|NCT02344342|76093743|FG001|STARTED|Overall Study||11||
59976385|NCT02344342|76093744|FG002|STARTED|Overall Study||14||
59976386|NCT02344342|76093745|FG003|STARTED|Overall Study||13||
59976387|NCT02344342|76093742|FG000|COMPLETED|Overall Study||2||
59976388|NCT02344342|76093743|FG001|COMPLETED|Overall Study||2||
59976389|NCT02344342|76093744|FG002|COMPLETED|Overall Study||0||
59976390|NCT02344342|76093745|FG003|COMPLETED|Overall Study||3||
59976391|NCT02344342|76093742|FG000|NOT COMPLETED|Overall Study||11||
59976392|NCT02344342|76093743|FG001|NOT COMPLETED|Overall Study||9||
59976393|NCT02344342|76093744|FG002|NOT COMPLETED|Overall Study||14||
59976394|NCT02344342|76093745|FG003|NOT COMPLETED|Overall Study||10||
59976395|NCT02310568|76093764|FG000|STARTED|Stage 1 ( 4 Weeks)||15||
59976396|NCT02310568|76093765|FG001|STARTED|Stage 1 ( 4 Weeks)||15||
59976397|NCT02310568|76093766|FG002|STARTED|Stage 1 ( 4 Weeks)||15||
59976398|NCT02310568|76093767|FG003|STARTED|Stage 1 ( 4 Weeks)||24||
59976399|NCT02310568|76093768|FG004|STARTED|Stage 1 ( 4 Weeks)||21||
59976400|NCT02310568|76093764|FG000|COMPLETED|Stage 1 ( 4 Weeks)||12||
59976401|NCT02310568|76093765|FG001|COMPLETED|Stage 1 ( 4 Weeks)||13||
59976402|NCT02310568|76093766|FG002|COMPLETED|Stage 1 ( 4 Weeks)||14||
59976403|NCT02310568|76093767|FG003|COMPLETED|Stage 1 ( 4 Weeks)||22||
59976404|NCT02310568|76093768|FG004|COMPLETED|Stage 1 ( 4 Weeks)||20||
59976405|NCT02310568|76093764|FG000|NOT COMPLETED|Stage 1 ( 4 Weeks)||3||
59976406|NCT02310568|76093765|FG001|NOT COMPLETED|Stage 1 ( 4 Weeks)||2||
59622204|NCT00384774|75733930|FG001|NOT COMPLETED|Overall Study||0||
59622205|NCT00384774|75733931|FG002|NOT COMPLETED|Overall Study||0||
59622206|NCT00384774|75733932|FG003|NOT COMPLETED|Overall Study||0||
59622207|NCT00384774|75733933|FG004|NOT COMPLETED|Overall Study||0||
59622208|NCT00384774|75733934|FG005|NOT COMPLETED|Overall Study||0||
59622209|NCT00384774|75733935|FG006|NOT COMPLETED|Overall Study||0||
59622210|NCT00410280|75733953|FG000|STARTED|Overall Study||14||
59622211|NCT00410280|75733954|FG001|STARTED|Overall Study||13||
59622212|NCT00410280|75733953|FG000|COMPLETED|Overall Study||14||
59622213|NCT00410280|75733954|FG001|COMPLETED|Overall Study||13||
59622214|NCT00410280|75733953|FG000|NOT COMPLETED|Overall Study||0||
59622215|NCT00410280|75733954|FG001|NOT COMPLETED|Overall Study||0||
59622216|NCT00410826|75733962|FG000|STARTED|Overall Study||105||
59976407|NCT02310568|76093766|FG002|NOT COMPLETED|Stage 1 ( 4 Weeks)||1||
59976408|NCT02310568|76093767|FG003|NOT COMPLETED|Stage 1 ( 4 Weeks)||2||
59976409|NCT02310568|76093768|FG004|NOT COMPLETED|Stage 1 ( 4 Weeks)||1||
59976410|NCT02310568|76093764|FG000|STARTED|Stage 2 (4 Weeks)||12||
59976411|NCT02310568|76093765|FG001|STARTED|Stage 2 (4 Weeks)||13||
59976412|NCT02310568|76093766|FG002|STARTED|Stage 2 (4 Weeks)||14||
59976413|NCT02310568|76093767|FG003|STARTED|Stage 2 (4 Weeks)||22||
59976414|NCT02310568|76093768|FG004|STARTED|Stage 2 (4 Weeks)||20||
59976415|NCT02310568|76093764|FG000|COMPLETED|Stage 2 (4 Weeks)||11||
59622217|NCT00410826|75733963|FG001|STARTED|Overall Study||99||
59622218|NCT00410826|75733962|FG000|COMPLETED|Overall Study||96||
59622219|NCT00410826|75733963|FG001|COMPLETED|Overall Study||95||
59622220|NCT00410826|75733962|FG000|NOT COMPLETED|Overall Study||9||
59622221|NCT00410826|75733963|FG001|NOT COMPLETED|Overall Study||4||
59622222|NCT00464646|75733971|FG000|STARTED|Overall Study||76||
59622223|NCT00464646|75733972|FG001|STARTED|Overall Study||29||
59976416|NCT02310568|76093765|FG001|COMPLETED|Stage 2 (4 Weeks)||12||
59976417|NCT02310568|76093766|FG002|COMPLETED|Stage 2 (4 Weeks)||13||
59976418|NCT02310568|76093767|FG003|COMPLETED|Stage 2 (4 Weeks)||17||
59976419|NCT02310568|76093768|FG004|COMPLETED|Stage 2 (4 Weeks)||19||
59976420|NCT02310568|76093764|FG000|NOT COMPLETED|Stage 2 (4 Weeks)||1||
59622224|NCT00464646|75733971|FG000|COMPLETED|Overall Study||76||
59976421|NCT02310568|76093765|FG001|NOT COMPLETED|Stage 2 (4 Weeks)||1||
59976422|NCT02310568|76093766|FG002|NOT COMPLETED|Stage 2 (4 Weeks)||1||
59976423|NCT02310568|76093767|FG003|NOT COMPLETED|Stage 2 (4 Weeks)||5||
59976424|NCT02310568|76093768|FG004|NOT COMPLETED|Stage 2 (4 Weeks)||1||
59994970|NCT02730793|76110798|FG001|STARTED|Overall Study||3||
59622225|NCT00464646|75733972|FG001|COMPLETED|Overall Study||29||
59622226|NCT00464646|75733971|FG000|NOT COMPLETED|Overall Study||0||
59622227|NCT00464646|75733972|FG001|NOT COMPLETED|Overall Study||0||
59813643|NCT02211131|75936114|FG000|STARTED|Overall Study||74||
59813644|NCT02211131|75936115|FG001|STARTED|Overall Study||76||
59813645|NCT02211131|75936114|FG000|COMPLETED|Overall Study||40||
59813646|NCT02211131|75936115|FG001|COMPLETED|Overall Study||48||
59813647|NCT02211131|75936114|FG000|NOT COMPLETED|Overall Study||34||
59813648|NCT02211131|75936115|FG001|NOT COMPLETED|Overall Study||28||
59813649|NCT02155647|75936130|FG000|STARTED|Overall Study||88||
59813650|NCT02155647|75936131|FG001|STARTED|Overall Study||116||
59813651|NCT02155647|75936130|FG000|COMPLETED|Overall Study||47||
59813652|NCT02155647|75936131|FG001|COMPLETED|Overall Study||64||
59813653|NCT02155647|75936130|FG000|NOT COMPLETED|Overall Study||41||
59813654|NCT02155647|75936131|FG001|NOT COMPLETED|Overall Study||52||
59813655|NCT02136810|75936137|FG000|STARTED|Overall Study||200|A convenience sample of 200 participants were enrolled.|
59813656|NCT02136810|75936137|FG000|COMPLETED|Overall Study||200||
59813657|NCT02136810|75936137|FG000|NOT COMPLETED|Overall Study||0||
59813658|NCT02134587|75936141|FG000|STARTED|Overall Study||203||
59976425|NCT02310100|76093786|FG000|STARTED|Overall Study|First enrollment|178|FDA approval|
59976426|NCT02310100|76093786|FG000|COMPLETED|Overall Study||160||
59976427|NCT02310100|76093786|FG000|NOT COMPLETED|Overall Study||18||
59976428|NCT02780167|76093796|FG000|STARTED|Overall Study||56||
59976429|NCT02780167|76093797|FG001|STARTED|Overall Study||49||
59976430|NCT02780167|76093798|FG002|STARTED|Overall Study||51||
59976431|NCT02780167|76093799|FG003|STARTED|Overall Study||56||
59976432|NCT02780167|76093800|FG004|STARTED|Overall Study||55||
59976433|NCT02780167|76093796|FG000|COMPLETED|Overall Study||28||
59976434|NCT02780167|76093797|FG001|COMPLETED|Overall Study||27||
59976435|NCT02780167|76093798|FG002|COMPLETED|Overall Study||27||
59976436|NCT02780167|76093799|FG003|COMPLETED|Overall Study||37||
59976437|NCT02780167|76093800|FG004|COMPLETED|Overall Study||38||
59976438|NCT02780167|76093796|FG000|NOT COMPLETED|Overall Study||28||
59976439|NCT02780167|76093797|FG001|NOT COMPLETED|Overall Study||22||
59976440|NCT02780167|76093798|FG002|NOT COMPLETED|Overall Study||24||
59976441|NCT02780167|76093799|FG003|NOT COMPLETED|Overall Study||19||
59976442|NCT02780167|76093800|FG004|NOT COMPLETED|Overall Study||17||
59976443|NCT02779075|76093812|FG000|STARTED|Overall Study||16||
59976444|NCT02779075|76093813|FG001|STARTED|Overall Study||13||
59976445|NCT02779075|76093812|FG000|COMPLETED|Overall Study||14||
59976446|NCT02779075|76093813|FG001|COMPLETED|Overall Study||10||
59976447|NCT02779075|76093812|FG000|NOT COMPLETED|Overall Study||2||
59976448|NCT02779075|76093813|FG001|NOT COMPLETED|Overall Study||3||
59976449|NCT02150551|76093819|FG000|STARTED|Overall Study||1||
59976450|NCT02150551|76093819|FG000|COMPLETED|Overall Study||1||
59976451|NCT02150551|76093819|FG000|NOT COMPLETED|Overall Study||0||
59976452|NCT00105079|76093825|FG000|STARTED|Overall Study||167||
59976453|NCT00105079|76093826|FG001|STARTED|Overall Study||170||
59976454|NCT00105079|76093825|FG000|Safety Population|Overall Study||163||
59976455|NCT00105079|76093826|FG001|Safety Population|Overall Study||168||
59976456|NCT00105079|76093825|FG000|COMPLETED|Overall Study||128||
59976457|NCT00105079|76093826|FG001|COMPLETED|Overall Study||135||
59976458|NCT00105079|76093825|FG000|NOT COMPLETED|Overall Study||39||
59976459|NCT00105079|76093826|FG001|NOT COMPLETED|Overall Study||35||
59976460|NCT02777827|76093832|FG000|STARTED|Treatment Period 1||5||
59813659|NCT02134587|75936141|FG000|COMPLETED|Overall Study||173||
59813660|NCT02134587|75936141|FG000|NOT COMPLETED|Overall Study||30||
59813661|NCT01752920|75936154|FG000|STARTED|Overall Study||29||
59813662|NCT01752920|75936155|FG001|STARTED|Overall Study||13||
59813663|NCT01752920|75936156|FG002|STARTED|Overall Study||19||
59813664|NCT01752920|75936157|FG003|STARTED|Overall Study||58||
59813665|NCT01752920|75936154|FG000|COMPLETED|Overall Study||0||
59813666|NCT01752920|75936155|FG001|COMPLETED|Overall Study||0||
59813667|NCT01752920|75936156|FG002|COMPLETED|Overall Study||0||
59976461|NCT02777827|76093833|FG001|STARTED|Treatment Period 1||5||
59976462|NCT02777827|76093834|FG002|STARTED|Treatment Period 1||5||
59976463|NCT02777827|76093835|FG003|STARTED|Treatment Period 1||5||
59976464|NCT02777827|76093836|FG004|STARTED|Treatment Period 1||4||
59976465|NCT02777827|76093837|FG005|STARTED|Treatment Period 1||6||
60074628|NCT01555125|76189972|FG002|NOT COMPLETED|Induction Period||0||
59813668|NCT01752920|75936157|FG003|COMPLETED|Overall Study||0||
59813669|NCT01752920|75936154|FG000|NOT COMPLETED|Overall Study||29||
59813670|NCT01752920|75936155|FG001|NOT COMPLETED|Overall Study||13||
59813671|NCT01752920|75936156|FG002|NOT COMPLETED|Overall Study||19||
59813672|NCT01752920|75936157|FG003|NOT COMPLETED|Overall Study||58||
59813673|NCT00976963|75936171|FG000|STARTED|Overall Study||150||
59813674|NCT00976963|75936172|FG001|STARTED|Overall Study||150||
59976466|NCT02777827|76093832|FG000|COMPLETED|Treatment Period 1||5||
59976467|NCT02777827|76093833|FG001|COMPLETED|Treatment Period 1||5||
59976468|NCT02777827|76093834|FG002|COMPLETED|Treatment Period 1||5||
59976469|NCT02777827|76093835|FG003|COMPLETED|Treatment Period 1||5||
59976470|NCT02777827|76093836|FG004|COMPLETED|Treatment Period 1||4||
59976471|NCT02777827|76093837|FG005|COMPLETED|Treatment Period 1||6||
59976472|NCT02777827|76093832|FG000|NOT COMPLETED|Treatment Period 1||0||
59976473|NCT02777827|76093833|FG001|NOT COMPLETED|Treatment Period 1||0||
59976474|NCT02777827|76093834|FG002|NOT COMPLETED|Treatment Period 1||0||
59976475|NCT02777827|76093835|FG003|NOT COMPLETED|Treatment Period 1||0||
59976476|NCT02777827|76093836|FG004|NOT COMPLETED|Treatment Period 1||0||
59976477|NCT02777827|76093837|FG005|NOT COMPLETED|Treatment Period 1||0||
59976478|NCT02777827|76093832|FG000|STARTED|Washout Between Periods 1 and 2||5||
59976479|NCT02777827|76093833|FG001|STARTED|Washout Between Periods 1 and 2||5||
59976480|NCT02777827|76093834|FG002|STARTED|Washout Between Periods 1 and 2||5||
59976481|NCT02777827|76093835|FG003|STARTED|Washout Between Periods 1 and 2||5||
59976482|NCT02777827|76093836|FG004|STARTED|Washout Between Periods 1 and 2||4||
59976483|NCT02777827|76093837|FG005|STARTED|Washout Between Periods 1 and 2||6||
59976484|NCT02777827|76093832|FG000|COMPLETED|Washout Between Periods 1 and 2||5||
59976485|NCT02777827|76093833|FG001|COMPLETED|Washout Between Periods 1 and 2||5||
59976486|NCT02777827|76093834|FG002|COMPLETED|Washout Between Periods 1 and 2||5||
59976487|NCT02777827|76093835|FG003|COMPLETED|Washout Between Periods 1 and 2||5||
59976488|NCT02777827|76093836|FG004|COMPLETED|Washout Between Periods 1 and 2||4||
59976489|NCT02777827|76093837|FG005|COMPLETED|Washout Between Periods 1 and 2||6||
59976490|NCT02777827|76093832|FG000|NOT COMPLETED|Washout Between Periods 1 and 2||0||
59976491|NCT02777827|76093833|FG001|NOT COMPLETED|Washout Between Periods 1 and 2||0||
59813675|NCT00976963|75936171|FG000|Treated With Assigned Intervention|Overall Study|"Participants who were not treated with the assigned randomization therapy were excluded from the main efficacy analyses, Cure."|146||
59813676|NCT00976963|75936172|FG001|Treated With Assigned Intervention|Overall Study||150||
59813677|NCT00976963|75936171|FG000|COMPLETED|Overall Study||146||
59813678|NCT00976963|75936172|FG001|COMPLETED|Overall Study||150||
59813679|NCT00976963|75936171|FG000|NOT COMPLETED|Overall Study||4||
59813680|NCT00976963|75936172|FG001|NOT COMPLETED|Overall Study||0||
59813681|NCT00074269|75936178|FG000|STARTED|Overall Study||5||
59813682|NCT00074269|75936178|FG000|COMPLETED|Overall Study||5||
59813683|NCT00074269|75936178|FG000|NOT COMPLETED|Overall Study||0||
59813684|NCT00423735|75936189|FG000|STARTED|Overall Study||29||
59813685|NCT00423735|75936190|FG001|STARTED|Overall Study||35||
59813686|NCT00423735|75936191|FG002|STARTED|Overall Study||0||
59813687|NCT00423735|75936189|FG000|COMPLETED|Overall Study||21||
59813688|NCT00423735|75936190|FG001|COMPLETED|Overall Study||29||
59813689|NCT00423735|75936191|FG002|COMPLETED|Overall Study||0||
59813690|NCT00423735|75936189|FG000|NOT COMPLETED|Overall Study||8||
59813691|NCT00423735|75936190|FG001|NOT COMPLETED|Overall Study||6||
59813692|NCT00423735|75936191|FG002|NOT COMPLETED|Overall Study||0||
59813693|NCT00626327|75936204|FG000|STARTED|Overall Study||504||
59976492|NCT02777827|76093834|FG002|NOT COMPLETED|Washout Between Periods 1 and 2||0||
59976493|NCT02777827|76093835|FG003|NOT COMPLETED|Washout Between Periods 1 and 2||0||
59976494|NCT02777827|76093836|FG004|NOT COMPLETED|Washout Between Periods 1 and 2||0||
59976495|NCT02777827|76093837|FG005|NOT COMPLETED|Washout Between Periods 1 and 2||0||
59976496|NCT02777827|76093832|FG000|STARTED|Treatment Period 2||5||
59976497|NCT02777827|76093833|FG001|STARTED|Treatment Period 2||5||
59976498|NCT02777827|76093834|FG002|STARTED|Treatment Period 2||5||
59976499|NCT02777827|76093835|FG003|STARTED|Treatment Period 2||5||
59976500|NCT02777827|76093836|FG004|STARTED|Treatment Period 2||4||
59976501|NCT02777827|76093837|FG005|STARTED|Treatment Period 2||6||
59976502|NCT02777827|76093832|FG000|COMPLETED|Treatment Period 2||5||
59976503|NCT02777827|76093833|FG001|COMPLETED|Treatment Period 2||5||
59976504|NCT02777827|76093834|FG002|COMPLETED|Treatment Period 2||5||
59976505|NCT02777827|76093835|FG003|COMPLETED|Treatment Period 2||5||
59976506|NCT02777827|76093836|FG004|COMPLETED|Treatment Period 2||4||
59976507|NCT02777827|76093837|FG005|COMPLETED|Treatment Period 2||6||
59976508|NCT02777827|76093832|FG000|NOT COMPLETED|Treatment Period 2||0||
59976509|NCT02777827|76093833|FG001|NOT COMPLETED|Treatment Period 2||0||
59976510|NCT02777827|76093834|FG002|NOT COMPLETED|Treatment Period 2||0||
60074629|NCT01555125|76189973|FG003|NOT COMPLETED|Induction Period||0||
60074630|NCT01555125|76189974|FG004|NOT COMPLETED|Induction Period||3||
60074631|NCT01555125|76189970|FG000|STARTED|Maintenance Period||58||
60074632|NCT01555125|76189971|FG001|STARTED|Maintenance Period||56||
60074633|NCT01555125|76189972|FG002|STARTED|Maintenance Period||29||
60074634|NCT01555125|76189973|FG003|STARTED|Maintenance Period||27||
59976511|NCT02777827|76093835|FG003|NOT COMPLETED|Treatment Period 2||0||
59976512|NCT02777827|76093836|FG004|NOT COMPLETED|Treatment Period 2||0||
59976513|NCT02777827|76093837|FG005|NOT COMPLETED|Treatment Period 2||0||
59976514|NCT02777827|76093832|FG000|STARTED|Washout Between Periods 2 and 3||5||
59976515|NCT02777827|76093833|FG001|STARTED|Washout Between Periods 2 and 3||5||
59976516|NCT02777827|76093834|FG002|STARTED|Washout Between Periods 2 and 3||5||
59813694|NCT00626327|75936205|FG001|STARTED|Overall Study||616||
60074635|NCT01555125|76189974|FG004|STARTED|Maintenance Period||0||
60074636|NCT01555125|76189970|FG000|COMPLETED|Maintenance Period||48||
60074637|NCT01555125|76189971|FG001|COMPLETED|Maintenance Period||52||
60074638|NCT01555125|76189972|FG002|COMPLETED|Maintenance Period||25||
59813695|NCT00626327|75936206|FG002|STARTED|Overall Study||510||
59813696|NCT00626327|75936204|FG000|COMPLETED|Overall Study||426||
59813697|NCT00626327|75936205|FG001|COMPLETED|Overall Study||557||
59813698|NCT00626327|75936206|FG002|COMPLETED|Overall Study||422||
59813699|NCT00626327|75936204|FG000|NOT COMPLETED|Overall Study||78||
59813700|NCT00626327|75936205|FG001|NOT COMPLETED|Overall Study||59||
59813701|NCT00626327|75936206|FG002|NOT COMPLETED|Overall Study||88||
59976517|NCT02777827|76093835|FG003|STARTED|Washout Between Periods 2 and 3||5||
59976518|NCT02777827|76093836|FG004|STARTED|Washout Between Periods 2 and 3||4||
59976519|NCT02777827|76093837|FG005|STARTED|Washout Between Periods 2 and 3||6||
59976520|NCT02777827|76093832|FG000|COMPLETED|Washout Between Periods 2 and 3||5||
59976521|NCT02777827|76093833|FG001|COMPLETED|Washout Between Periods 2 and 3||5||
59976522|NCT02777827|76093834|FG002|COMPLETED|Washout Between Periods 2 and 3||5||
59976523|NCT02777827|76093835|FG003|COMPLETED|Washout Between Periods 2 and 3||5||
59976524|NCT02777827|76093836|FG004|COMPLETED|Washout Between Periods 2 and 3||4||
59976525|NCT02777827|76093837|FG005|COMPLETED|Washout Between Periods 2 and 3||6||
59976526|NCT02777827|76093832|FG000|NOT COMPLETED|Washout Between Periods 2 and 3||0||
59976527|NCT02777827|76093833|FG001|NOT COMPLETED|Washout Between Periods 2 and 3||0||
59976528|NCT02777827|76093834|FG002|NOT COMPLETED|Washout Between Periods 2 and 3||0||
59976529|NCT02777827|76093835|FG003|NOT COMPLETED|Washout Between Periods 2 and 3||0||
59976530|NCT02777827|76093836|FG004|NOT COMPLETED|Washout Between Periods 2 and 3||0||
59976531|NCT02777827|76093837|FG005|NOT COMPLETED|Washout Between Periods 2 and 3||0||
59976532|NCT02777827|76093832|FG000|STARTED|Treatment Period 3||5||
59976533|NCT02777827|76093833|FG001|STARTED|Treatment Period 3||5||
59976534|NCT02777827|76093834|FG002|STARTED|Treatment Period 3||5||
59976535|NCT02777827|76093835|FG003|STARTED|Treatment Period 3||5||
59976536|NCT02777827|76093836|FG004|STARTED|Treatment Period 3||4||
59976537|NCT02777827|76093837|FG005|STARTED|Treatment Period 3||6||
59976538|NCT02777827|76093832|FG000|COMPLETED|Treatment Period 3||5||
59976539|NCT02777827|76093833|FG001|COMPLETED|Treatment Period 3||5||
59976540|NCT02777827|76093834|FG002|COMPLETED|Treatment Period 3||5||
59976541|NCT02777827|76093835|FG003|COMPLETED|Treatment Period 3||5||
59976542|NCT02777827|76093836|FG004|COMPLETED|Treatment Period 3||4||
59976543|NCT02777827|76093837|FG005|COMPLETED|Treatment Period 3||6||
59976544|NCT02777827|76093832|FG000|NOT COMPLETED|Treatment Period 3||0||
59976545|NCT02777827|76093833|FG001|NOT COMPLETED|Treatment Period 3||0||
59976546|NCT02777827|76093834|FG002|NOT COMPLETED|Treatment Period 3||0||
59976547|NCT02777827|76093835|FG003|NOT COMPLETED|Treatment Period 3||0||
59976548|NCT02777827|76093836|FG004|NOT COMPLETED|Treatment Period 3||0||
59976549|NCT02777827|76093837|FG005|NOT COMPLETED|Treatment Period 3||0||
59976550|NCT02777827|76093832|FG000|STARTED|Washout Between Periods 3 and 4||5||
59976551|NCT02777827|76093833|FG001|STARTED|Washout Between Periods 3 and 4||5||
59976552|NCT02777827|76093834|FG002|STARTED|Washout Between Periods 3 and 4||5||
59976553|NCT02777827|76093835|FG003|STARTED|Washout Between Periods 3 and 4||5||
59976554|NCT02777827|76093836|FG004|STARTED|Washout Between Periods 3 and 4||4||
59976555|NCT02777827|76093837|FG005|STARTED|Washout Between Periods 3 and 4||6||
59813702|NCT00357994|75936224|FG000|STARTED|Overall Study||37||
59813703|NCT00357994|75936225|FG001|STARTED|Overall Study||34||
59813704|NCT00357994|75936224|FG000|COMPLETED|Overall Study||35||
59813705|NCT00357994|75936225|FG001|COMPLETED|Overall Study||31||
59976556|NCT02777827|76093832|FG000|COMPLETED|Washout Between Periods 3 and 4||5||
59976557|NCT02777827|76093833|FG001|COMPLETED|Washout Between Periods 3 and 4||5||
59976558|NCT02777827|76093834|FG002|COMPLETED|Washout Between Periods 3 and 4||4||
59976559|NCT02777827|76093835|FG003|COMPLETED|Washout Between Periods 3 and 4||5||
59976560|NCT02777827|76093836|FG004|COMPLETED|Washout Between Periods 3 and 4||4||
59976561|NCT02777827|76093837|FG005|COMPLETED|Washout Between Periods 3 and 4||6||
59976562|NCT02777827|76093832|FG000|NOT COMPLETED|Washout Between Periods 3 and 4||0||
59976563|NCT02777827|76093833|FG001|NOT COMPLETED|Washout Between Periods 3 and 4||0||
59976564|NCT02777827|76093834|FG002|NOT COMPLETED|Washout Between Periods 3 and 4||1||
59976565|NCT02777827|76093835|FG003|NOT COMPLETED|Washout Between Periods 3 and 4||0||
59976566|NCT02777827|76093836|FG004|NOT COMPLETED|Washout Between Periods 3 and 4||0||
59976567|NCT02777827|76093837|FG005|NOT COMPLETED|Washout Between Periods 3 and 4||0||
59976568|NCT02777827|76093832|FG000|STARTED|Treatment Period 4||5||
60074639|NCT01555125|76189973|FG003|COMPLETED|Maintenance Period||25||
59813706|NCT00357994|75936224|FG000|NOT COMPLETED|Overall Study||2||
59813707|NCT00357994|75936225|FG001|NOT COMPLETED|Overall Study||3||
59976569|NCT02777827|76093833|FG001|STARTED|Treatment Period 4||5||
59976570|NCT02777827|76093834|FG002|STARTED|Treatment Period 4||4||
59976571|NCT02777827|76093835|FG003|STARTED|Treatment Period 4||5||
59976572|NCT02777827|76093836|FG004|STARTED|Treatment Period 4||4||
59976573|NCT02777827|76093837|FG005|STARTED|Treatment Period 4||6||
59976574|NCT02777827|76093832|FG000|COMPLETED|Treatment Period 4||5||
59976575|NCT02777827|76093833|FG001|COMPLETED|Treatment Period 4||5||
60074640|NCT01555125|76189974|FG004|COMPLETED|Maintenance Period||0||
60074641|NCT01555125|76189970|FG000|NOT COMPLETED|Maintenance Period||10||
60074642|NCT01555125|76189971|FG001|NOT COMPLETED|Maintenance Period||4||
59976576|NCT02777827|76093834|FG002|COMPLETED|Treatment Period 4||4||
59976577|NCT02777827|76093835|FG003|COMPLETED|Treatment Period 4||5||
59976578|NCT02777827|76093836|FG004|COMPLETED|Treatment Period 4||4||
59976579|NCT02777827|76093837|FG005|COMPLETED|Treatment Period 4||6||
60074643|NCT01555125|76189972|FG002|NOT COMPLETED|Maintenance Period||4||
59813708|NCT00423657|75936233|FG000|STARTED|Overall Study||342||
59813709|NCT00423657|75936234|FG001|STARTED|Overall Study||338||
59813710|NCT00423657|75936233|FG000|COMPLETED|Overall Study||316||
59813711|NCT00423657|75936234|FG001|COMPLETED|Overall Study||313||
59976580|NCT02777827|76093832|FG000|NOT COMPLETED|Treatment Period 4||0||
59976581|NCT02777827|76093833|FG001|NOT COMPLETED|Treatment Period 4||0||
59976582|NCT02777827|76093834|FG002|NOT COMPLETED|Treatment Period 4||0||
59976583|NCT02777827|76093835|FG003|NOT COMPLETED|Treatment Period 4||0||
59976584|NCT02777827|76093836|FG004|NOT COMPLETED|Treatment Period 4||0||
59976585|NCT02777827|76093837|FG005|NOT COMPLETED|Treatment Period 4||0||
59976586|NCT02777827|76093832|FG000|STARTED|Washout Between Periods 4 and 5||5||
59976587|NCT02777827|76093833|FG001|STARTED|Washout Between Periods 4 and 5||5||
59976588|NCT02777827|76093834|FG002|STARTED|Washout Between Periods 4 and 5||4||
59976589|NCT02777827|76093835|FG003|STARTED|Washout Between Periods 4 and 5||5||
59976590|NCT02777827|76093836|FG004|STARTED|Washout Between Periods 4 and 5||4||
59976591|NCT02777827|76093837|FG005|STARTED|Washout Between Periods 4 and 5||6||
59976592|NCT02777827|76093832|FG000|COMPLETED|Washout Between Periods 4 and 5||5||
59976593|NCT02777827|76093833|FG001|COMPLETED|Washout Between Periods 4 and 5||5||
59976594|NCT02777827|76093834|FG002|COMPLETED|Washout Between Periods 4 and 5||4||
59813712|NCT00423657|75936233|FG000|NOT COMPLETED|Overall Study||26||
59813713|NCT00423657|75936234|FG001|NOT COMPLETED|Overall Study||25||
59813714|NCT00367432|75936240|FG000|STARTED|First Period (16 Weeks)|Eligible subjects from preceding study N01221 [NCT00280696] entered the First Period of N01222|313||
59813715|NCT00367432|75936241|FG001|STARTED|First Period (16 Weeks)||0||
59813716|NCT00367432|75936240|FG000|COMPLETED|First Period (16 Weeks)||275||
59813717|NCT00367432|75936241|FG001|COMPLETED|First Period (16 Weeks)||0||
59813718|NCT00367432|75936240|FG000|NOT COMPLETED|First Period (16 Weeks)||38||
59813719|NCT00367432|75936241|FG001|NOT COMPLETED|First Period (16 Weeks)||0||
59813720|NCT00367432|75936240|FG000|STARTED|Second Period (up to 54 Months)|275 subjects from N01221 [NCT00280696] completed First Period and entered Second Period of N01222|275||
59976595|NCT02777827|76093835|FG003|COMPLETED|Washout Between Periods 4 and 5||5||
59976596|NCT02777827|76093836|FG004|COMPLETED|Washout Between Periods 4 and 5||4||
59976597|NCT02777827|76093837|FG005|COMPLETED|Washout Between Periods 4 and 5||6||
59813721|NCT00367432|75936241|FG001|STARTED|Second Period (up to 54 Months)|85 subjects from N01020 [NCT00160615] entered Second Period of N01222|85||
59813722|NCT00367432|75936240|FG000|COMPLETED|Second Period (up to 54 Months)||188||
59976598|NCT02777827|76093832|FG000|NOT COMPLETED|Washout Between Periods 4 and 5||0||
59976599|NCT02777827|76093833|FG001|NOT COMPLETED|Washout Between Periods 4 and 5||0||
59976600|NCT02777827|76093834|FG002|NOT COMPLETED|Washout Between Periods 4 and 5||0||
59976601|NCT02777827|76093835|FG003|NOT COMPLETED|Washout Between Periods 4 and 5||0||
59976602|NCT02777827|76093836|FG004|NOT COMPLETED|Washout Between Periods 4 and 5||0||
59976603|NCT02777827|76093837|FG005|NOT COMPLETED|Washout Between Periods 4 and 5||0||
59976604|NCT02777827|76093832|FG000|STARTED|Treatment Period 5||5||
59976605|NCT02777827|76093833|FG001|STARTED|Treatment Period 5||5||
59976606|NCT02777827|76093834|FG002|STARTED|Treatment Period 5||4||
59976607|NCT02777827|76093835|FG003|STARTED|Treatment Period 5||5||
59976608|NCT02777827|76093836|FG004|STARTED|Treatment Period 5||4||
59976609|NCT02777827|76093837|FG005|STARTED|Treatment Period 5||6||
59976610|NCT02777827|76093832|FG000|COMPLETED|Treatment Period 5||5||
59976611|NCT02777827|76093833|FG001|COMPLETED|Treatment Period 5||5||
59976612|NCT02777827|76093834|FG002|COMPLETED|Treatment Period 5||4||
59976613|NCT02777827|76093835|FG003|COMPLETED|Treatment Period 5||5||
59976614|NCT02777827|76093836|FG004|COMPLETED|Treatment Period 5||4||
59976615|NCT02777827|76093837|FG005|COMPLETED|Treatment Period 5||6||
59976616|NCT02777827|76093832|FG000|NOT COMPLETED|Treatment Period 5||0||
59976617|NCT02777827|76093833|FG001|NOT COMPLETED|Treatment Period 5||0||
59976618|NCT02777827|76093834|FG002|NOT COMPLETED|Treatment Period 5||0||
59976619|NCT02777827|76093835|FG003|NOT COMPLETED|Treatment Period 5||0||
59976620|NCT02777827|76093836|FG004|NOT COMPLETED|Treatment Period 5||0||
59976621|NCT02777827|76093837|FG005|NOT COMPLETED|Treatment Period 5||0||
59813723|NCT00367432|75936241|FG001|COMPLETED|Second Period (up to 54 Months)||69||
59976622|NCT02777827|76093832|FG000|STARTED|Washout Between Periods 5 and 6||5||
59813724|NCT00367432|75936240|FG000|NOT COMPLETED|Second Period (up to 54 Months)||87||
59813725|NCT00367432|75936241|FG001|NOT COMPLETED|Second Period (up to 54 Months)||16||
59813726|NCT00623363|75936247|FG000|STARTED|Overall Study||7||
59813727|NCT00623363|75936248|FG001|STARTED|Overall Study||20||
59813728|NCT00623363|75936247|FG000|COMPLETED|Overall Study||5||
59813729|NCT00623363|75936248|FG001|COMPLETED|Overall Study||18||
59813730|NCT00623363|75936247|FG000|NOT COMPLETED|Overall Study||2||
59976623|NCT02777827|76093833|FG001|STARTED|Washout Between Periods 5 and 6||5||
59976624|NCT02777827|76093834|FG002|STARTED|Washout Between Periods 5 and 6||4||
59976625|NCT02777827|76093835|FG003|STARTED|Washout Between Periods 5 and 6||5||
59976626|NCT02777827|76093836|FG004|STARTED|Washout Between Periods 5 and 6||4||
59976627|NCT02777827|76093837|FG005|STARTED|Washout Between Periods 5 and 6||6||
59976628|NCT02777827|76093832|FG000|COMPLETED|Washout Between Periods 5 and 6||5||
59976629|NCT02777827|76093833|FG001|COMPLETED|Washout Between Periods 5 and 6||5||
59976630|NCT02777827|76093834|FG002|COMPLETED|Washout Between Periods 5 and 6||4||
59976631|NCT02777827|76093835|FG003|COMPLETED|Washout Between Periods 5 and 6||5||
59976632|NCT02777827|76093836|FG004|COMPLETED|Washout Between Periods 5 and 6||4||
59976633|NCT02777827|76093837|FG005|COMPLETED|Washout Between Periods 5 and 6||6||
59976634|NCT02777827|76093832|FG000|NOT COMPLETED|Washout Between Periods 5 and 6||0||
59976635|NCT02777827|76093833|FG001|NOT COMPLETED|Washout Between Periods 5 and 6||0||
59976636|NCT02777827|76093834|FG002|NOT COMPLETED|Washout Between Periods 5 and 6||0||
59976637|NCT02777827|76093835|FG003|NOT COMPLETED|Washout Between Periods 5 and 6||0||
59976638|NCT02777827|76093836|FG004|NOT COMPLETED|Washout Between Periods 5 and 6||0||
59976639|NCT02777827|76093837|FG005|NOT COMPLETED|Washout Between Periods 5 and 6||0||
59976640|NCT02777827|76093832|FG000|STARTED|Treatment Period 6||5||
59976641|NCT02777827|76093833|FG001|STARTED|Treatment Period 6||5||
59976642|NCT02777827|76093834|FG002|STARTED|Treatment Period 6||4||
59976643|NCT02777827|76093835|FG003|STARTED|Treatment Period 6||5||
59976644|NCT02777827|76093836|FG004|STARTED|Treatment Period 6||4||
59976645|NCT02777827|76093837|FG005|STARTED|Treatment Period 6||6||
59976646|NCT02777827|76093832|FG000|COMPLETED|Treatment Period 6||5||
59976647|NCT02777827|76093833|FG001|COMPLETED|Treatment Period 6||5||
59976648|NCT02777827|76093834|FG002|COMPLETED|Treatment Period 6||4||
59976649|NCT02777827|76093835|FG003|COMPLETED|Treatment Period 6||5||
59622228|NCT00385008|75733981|FG000|STARTED|Overall Study||10||
59622229|NCT00385008|75733982|FG001|STARTED|Overall Study||10||
59622230|NCT00385008|75733981|FG000|In Absence of Migraine|Overall Study||10||
59622231|NCT00385008|75733982|FG001|In Absence of Migraine|Overall Study||10||
59622232|NCT00385008|75733981|FG000|In Presence of Migraine|Overall Study||5|5 participants out of 10 in each arm were re-dosed in presence of migraine.|
59622233|NCT00385008|75733982|FG001|In Presence of Migraine|Overall Study||5|5 participants out of 10 in each arm were re-dosed in presence of migraine.|
59622234|NCT00385008|75733981|FG000|COMPLETED|Overall Study||10||
59622235|NCT00385008|75733982|FG001|COMPLETED|Overall Study||10||
59622236|NCT00385008|75733981|FG000|NOT COMPLETED|Overall Study||0||
59622237|NCT00385008|75733982|FG001|NOT COMPLETED|Overall Study||0||
59622238|NCT00466206|75733989|FG000|STARTED|Overall Study||10||
59622239|NCT00466206|75733989|FG000|COMPLETED|Overall Study|One of 10 patients withdrawn from study but completed treatment under Compassionate Use Designation|10||
59622240|NCT00466206|75733989|FG000|NOT COMPLETED|Overall Study||0||
59622241|NCT00410904|75733998|FG000|STARTED|Overall Study||40||
59622242|NCT00410904|75733999|FG001|STARTED|Overall Study||20||
59622243|NCT00410904|75733998|FG000|COMPLETED|Overall Study||40||
59622244|NCT00410904|75733999|FG001|COMPLETED|Overall Study||20||
59622245|NCT00410904|75733998|FG000|NOT COMPLETED|Overall Study||0||
59622246|NCT00410904|75733999|FG001|NOT COMPLETED|Overall Study||0||
59622247|NCT00385788|75734008|FG000|STARTED|Overall Study||12||
59813731|NCT00623363|75936248|FG001|NOT COMPLETED|Overall Study||2||
59813732|NCT00423267|75936257|FG000|STARTED|Period A||9||
59813733|NCT00423267|75936258|FG001|STARTED|Period A||7||
59813734|NCT00423267|75936257|FG000|COMPLETED|Period A||7||
59813735|NCT00423267|75936258|FG001|COMPLETED|Period A||6||
59813736|NCT00423267|75936257|FG000|NOT COMPLETED|Period A||2||
59813737|NCT00423267|75936258|FG001|NOT COMPLETED|Period A||1||
59813738|NCT00423267|75936257|FG000|STARTED|Period B||12||
59813739|NCT00423267|75936258|FG001|STARTED|Period B||0||
59813740|NCT00423267|75936257|FG000|COMPLETED|Period B||12||
59813741|NCT00423267|75936258|FG001|COMPLETED|Period B||0||
59813742|NCT00423267|75936257|FG000|NOT COMPLETED|Period B||0||
59622248|NCT00385788|75734009|FG001|STARTED|Overall Study||40||
59622249|NCT00385788|75734008|FG000|COMPLETED|Overall Study||12||
59622250|NCT00385788|75734009|FG001|COMPLETED|Overall Study||40||
59622251|NCT00385788|75734008|FG000|NOT COMPLETED|Overall Study||0||
59622252|NCT00385788|75734009|FG001|NOT COMPLETED|Overall Study||0||
59622253|NCT00411684|75734015|FG000|STARTED|Overall Study||1533||
59622254|NCT00411684|75734015|FG000|COMPLETED|Overall Study||1241||
59622255|NCT00411684|75734015|FG000|NOT COMPLETED|Overall Study||292||
59622256|NCT00386256|75734023|FG000|STARTED|Overall Study||16||
59976650|NCT02777827|76093836|FG004|COMPLETED|Treatment Period 6||4||
59976651|NCT02777827|76093837|FG005|COMPLETED|Treatment Period 6||6||
59976652|NCT02777827|76093832|FG000|NOT COMPLETED|Treatment Period 6||0||
59976653|NCT02777827|76093833|FG001|NOT COMPLETED|Treatment Period 6||0||
59976654|NCT02777827|76093834|FG002|NOT COMPLETED|Treatment Period 6||0||
59976655|NCT02777827|76093835|FG003|NOT COMPLETED|Treatment Period 6||0||
59976656|NCT02777827|76093836|FG004|NOT COMPLETED|Treatment Period 6||0||
59976657|NCT02777827|76093837|FG005|NOT COMPLETED|Treatment Period 6||0||
59622257|NCT00386256|75734024|FG001|STARTED|Overall Study||15||
59622258|NCT00386256|75734025|FG002|STARTED|Overall Study||4||
59622259|NCT00386256|75734026|FG003|STARTED|Overall Study||3||
59813743|NCT00423267|75936258|FG001|NOT COMPLETED|Period B||0||
59813744|NCT00626093|75936266|FG000|STARTED|Overall Study||77||
59813745|NCT00626093|75936266|FG000|COMPLETED|Overall Study||54||
59813746|NCT00626093|75936266|FG000|NOT COMPLETED|Overall Study||23||
59622260|NCT00386256|75734023|FG000|COMPLETED|Overall Study||16||
59622261|NCT00386256|75734024|FG001|COMPLETED|Overall Study||15||
59622262|NCT00386256|75734025|FG002|COMPLETED|Overall Study||4||
59813747|NCT00357760|75936272|FG000|STARTED|Overall Study||59||
59813748|NCT00357760|75936273|FG001|STARTED|Overall Study||35||
59976658|NCT02712333|76093853|FG000|STARTED|First Period||34||
59976659|NCT02712333|76093854|FG001|STARTED|First Period||26||
59976660|NCT02712333|76093853|FG000|COMPLETED|First Period||31||
59976661|NCT02712333|76093854|FG001|COMPLETED|First Period||24||
59976662|NCT02712333|76093853|FG000|NOT COMPLETED|First Period||3||
59976663|NCT02712333|76093854|FG001|NOT COMPLETED|First Period||2||
59976664|NCT02712333|76093853|FG000|STARTED|Second Period||31||
59976665|NCT02712333|76093854|FG001|STARTED|Second Period||24||
59976666|NCT02712333|76093853|FG000|COMPLETED|Second Period||31||
59976667|NCT02712333|76093854|FG001|COMPLETED|Second Period||24||
59976668|NCT02712333|76093853|FG000|NOT COMPLETED|Second Period||0||
59976669|NCT02712333|76093854|FG001|NOT COMPLETED|Second Period||0||
59976670|NCT02343406|76093870|FG000|STARTED|Overall Study||88||
59976671|NCT02343406|76093871|FG001|STARTED|Overall Study||86||
59976672|NCT02343406|76093872|FG002|STARTED|Overall Study||60||
59976673|NCT02343406|76093873|FG003|STARTED|Overall Study||26||
59976674|NCT02343406|76093874|FG004|STARTED|Overall Study||6||
59976675|NCT02343406|76093870|FG000|COMPLETED|Overall Study||0||
59976676|NCT02343406|76093871|FG001|COMPLETED|Overall Study||0||
59976677|NCT02343406|76093872|FG002|COMPLETED|Overall Study||2||
59976678|NCT02343406|76093873|FG003|COMPLETED|Overall Study||0||
59976679|NCT02343406|76093874|FG004|COMPLETED|Overall Study||1||
59976680|NCT02343406|76093870|FG000|NOT COMPLETED|Overall Study||88||
59976681|NCT02343406|76093871|FG001|NOT COMPLETED|Overall Study||86||
59976682|NCT02343406|76093872|FG002|NOT COMPLETED|Overall Study||58||
59976683|NCT02343406|76093873|FG003|NOT COMPLETED|Overall Study||26||
59976684|NCT02343406|76093874|FG004|NOT COMPLETED|Overall Study||5||
59976685|NCT02710071|76093887|FG000|STARTED|Placebo (2 Weeks).||21||
59976686|NCT02710071|76093888|FG001|STARTED|Placebo (2 Weeks).||20||
59976687|NCT02710071|76093887|FG000|COMPLETED|Placebo (2 Weeks).||21||
59976688|NCT02710071|76093888|FG001|COMPLETED|Placebo (2 Weeks).||20||
59976689|NCT02710071|76093887|FG000|NOT COMPLETED|Placebo (2 Weeks).||0||
59976690|NCT02710071|76093888|FG001|NOT COMPLETED|Placebo (2 Weeks).||0||
59976691|NCT02710071|76093887|FG000|STARTED|First Intervention (6 Weeks).||21||
59976692|NCT02710071|76093888|FG001|STARTED|First Intervention (6 Weeks).||20||
59976693|NCT02710071|76093887|FG000|COMPLETED|First Intervention (6 Weeks).||18||
59976694|NCT02710071|76093888|FG001|COMPLETED|First Intervention (6 Weeks).||16||
59976695|NCT02710071|76093887|FG000|NOT COMPLETED|First Intervention (6 Weeks).||3||
59976696|NCT02710071|76093888|FG001|NOT COMPLETED|First Intervention (6 Weeks).||4||
59976697|NCT02710071|76093887|FG000|STARTED|Second Intervention (6 Weeks).||18||
59976698|NCT02710071|76093888|FG001|STARTED|Second Intervention (6 Weeks).||16||
59976699|NCT02710071|76093887|FG000|COMPLETED|Second Intervention (6 Weeks).||17||
59976700|NCT02710071|76093888|FG001|COMPLETED|Second Intervention (6 Weeks).||14||
59976701|NCT02710071|76093887|FG000|NOT COMPLETED|Second Intervention (6 Weeks).||1||
59976702|NCT02710071|76093888|FG001|NOT COMPLETED|Second Intervention (6 Weeks).||2||
59976703|NCT02373202|76093899|FG000|STARTED|Overall Study||15||
59976704|NCT02373202|76093900|FG001|STARTED|Overall Study||15||
59976705|NCT02373202|76093901|FG002|STARTED|Overall Study||30||
59976706|NCT02373202|76093902|FG003|STARTED|Overall Study||31||
59976707|NCT02373202|76093899|FG000|COMPLETED|Overall Study||13||
59976708|NCT02373202|76093900|FG001|COMPLETED|Overall Study||9||
59976709|NCT02373202|76093901|FG002|COMPLETED|Overall Study||27||
59976710|NCT02373202|76093902|FG003|COMPLETED|Overall Study||30||
59976711|NCT02373202|76093899|FG000|NOT COMPLETED|Overall Study||2||
59976712|NCT02373202|76093900|FG001|NOT COMPLETED|Overall Study||6||
59976713|NCT02373202|76093901|FG002|NOT COMPLETED|Overall Study||3||
59976714|NCT02373202|76093902|FG003|NOT COMPLETED|Overall Study||1||
59976715|NCT02622074|76093918|FG000|STARTED|Overall Study||10||
59976716|NCT02622074|76093919|FG001|STARTED|Overall Study||10||
59976717|NCT02622074|76093920|FG002|STARTED|Overall Study||10||
59976718|NCT02622074|76093921|FG003|STARTED|Overall Study||10||
59976719|NCT02622074|76093922|FG004|STARTED|Overall Study||10||
59976720|NCT02622074|76093923|FG005|STARTED|Overall Study||10||
59622263|NCT00386256|75734026|FG003|COMPLETED|Overall Study||3||
59622264|NCT00386256|75734023|FG000|NOT COMPLETED|Overall Study||0||
59622265|NCT00386256|75734024|FG001|NOT COMPLETED|Overall Study||0||
59976721|NCT02622074|76093918|FG000|COMPLETED|Overall Study||6||
59976722|NCT02622074|76093919|FG001|COMPLETED|Overall Study||9||
59622266|NCT00386256|75734025|FG002|NOT COMPLETED|Overall Study||0||
59622267|NCT00386256|75734026|FG003|NOT COMPLETED|Overall Study||0||
59976723|NCT02622074|76093920|FG002|COMPLETED|Overall Study||10||
59976724|NCT02622074|76093921|FG003|COMPLETED|Overall Study||9||
59976725|NCT02622074|76093922|FG004|COMPLETED|Overall Study||9||
59622268|NCT00412074|75734039|FG000|STARTED|Overall Study||199||
59622269|NCT00412074|75734040|FG001|STARTED|Overall Study||66||
59622270|NCT00412074|75734041|FG002|STARTED|Overall Study||195||
59976726|NCT02622074|76093923|FG005|COMPLETED|Overall Study||10||
59813749|NCT00357760|75936272|FG000|Patients Who Started Treatment|Overall Study||57||
59813750|NCT00357760|75936273|FG001|Patients Who Started Treatment|Overall Study||34||
59813751|NCT00357760|75936272|FG000|Eligible and Treated Patients|Overall Study||57||
59813752|NCT00357760|75936273|FG001|Eligible and Treated Patients|Overall Study||32||
59813753|NCT00357760|75936272|FG000|Patients Who Undergo Dose Escalation|Overall Study|Only patients who progressed on the low dose (Arm B) had the opportunity to undergo dose escalation.|0||
59813754|NCT00357760|75936273|FG001|Patients Who Undergo Dose Escalation|Overall Study||16||
59813755|NCT00357760|75936272|FG000|COMPLETED|Overall Study|Patients continued receiving protocol treatment until progressive disease or unacceptable toxicity.|0||
59813756|NCT00357760|75936273|FG001|COMPLETED|Overall Study|Patients continued receiving protocol treatment until progressive disease or unacceptable toxicity.|0||
59813757|NCT00357760|75936272|FG000|NOT COMPLETED|Overall Study||59||
59976727|NCT02622074|76093918|FG000|NOT COMPLETED|Overall Study||4||
59976728|NCT02622074|76093919|FG001|NOT COMPLETED|Overall Study||1||
59976729|NCT02622074|76093920|FG002|NOT COMPLETED|Overall Study||0||
59976730|NCT02622074|76093921|FG003|NOT COMPLETED|Overall Study||1||
59976731|NCT02622074|76093922|FG004|NOT COMPLETED|Overall Study||1||
59976732|NCT02622074|76093923|FG005|NOT COMPLETED|Overall Study||0||
59976733|NCT02308696|76093939|FG000|STARTED|Overall Study||222||
59976734|NCT02308696|76093940|FG001|STARTED|Overall Study||234||
59976735|NCT02308696|76093939|FG000|COMPLETED|Overall Study||169||
59976736|NCT02308696|76093940|FG001|COMPLETED|Overall Study||203||
59976737|NCT02308696|76093939|FG000|NOT COMPLETED|Overall Study||53||
59976738|NCT02308696|76093940|FG001|NOT COMPLETED|Overall Study||31||
59976739|NCT02342704|76093948|FG000|STARTED|Overall Study|Safety Population: randomized participants who received at least 1 dose of study treatment.|54||
59976740|NCT02342704|76093949|FG001|STARTED|Overall Study|Safety Population: randomized participants who received at least 1 dose of study treatment.|54||
59976741|NCT02342704|76093948|FG000|COMPLETED|Overall Study||1||
59976742|NCT02342704|76093949|FG001|COMPLETED|Overall Study||3||
59976743|NCT02342704|76093948|FG000|NOT COMPLETED|Overall Study||53||
59976744|NCT02342704|76093949|FG001|NOT COMPLETED|Overall Study||51||
59976745|NCT02342548|76093958|FG000|STARTED|Overall Study||51||
59976746|NCT02342548|76093959|FG001|STARTED|Overall Study||71||
59976747|NCT02342548|76093960|FG002|STARTED|Overall Study||66||
59976748|NCT02342548|76093958|FG000|COMPLETED|Overall Study||17||
59976749|NCT02342548|76093959|FG001|COMPLETED|Overall Study||9||
59976750|NCT02342548|76093960|FG002|COMPLETED|Overall Study||23||
59976751|NCT02342548|76093958|FG000|NOT COMPLETED|Overall Study||34||
59976752|NCT02342548|76093959|FG001|NOT COMPLETED|Overall Study||62||
59976753|NCT02342548|76093960|FG002|NOT COMPLETED|Overall Study||43||
59976754|NCT03142191|76093973|FG000|STARTED|Placebo Controlled Period||39||
59976755|NCT03142191|76093974|FG001|STARTED|Placebo Controlled Period||37||
59976756|NCT03142191|76093975|FG002|STARTED|Placebo Controlled Period||36||
59976757|NCT03142191|76093976|FG003|STARTED|Placebo Controlled Period||15||
59976758|NCT03142191|76093977|FG004|STARTED|Placebo Controlled Period||8||
59976759|NCT03142191|76093973|FG000|COMPLETED|Placebo Controlled Period||32||
59976760|NCT03142191|76093974|FG001|COMPLETED|Placebo Controlled Period||28||
59976761|NCT03142191|76093975|FG002|COMPLETED|Placebo Controlled Period||31||
59976762|NCT03142191|76093976|FG003|COMPLETED|Placebo Controlled Period||15||
59976763|NCT03142191|76093977|FG004|COMPLETED|Placebo Controlled Period||7||
59976764|NCT03142191|76093973|FG000|NOT COMPLETED|Placebo Controlled Period||7||
59976765|NCT03142191|76093974|FG001|NOT COMPLETED|Placebo Controlled Period||9||
59976766|NCT03142191|76093975|FG002|NOT COMPLETED|Placebo Controlled Period||5||
59976767|NCT03142191|76093976|FG003|NOT COMPLETED|Placebo Controlled Period||0||
59976768|NCT03142191|76093977|FG004|NOT COMPLETED|Placebo Controlled Period||1||
59976769|NCT03142191|76093973|FG000|STARTED|Active Treatment Extension Period||31||
59976770|NCT03142191|76093974|FG001|STARTED|Active Treatment Extension Period||27||
59976771|NCT03142191|76093975|FG002|STARTED|Active Treatment Extension Period||30||
59976772|NCT03142191|76093976|FG003|STARTED|Active Treatment Extension Period||15||
59976773|NCT03142191|76093977|FG004|STARTED|Active Treatment Extension Period||6||
59976774|NCT03142191|76093973|FG000|CC-90001 200mg|Active Treatment Extension Period||0|Participants who were in the placebo arm during treatment period and are now taking CC-90001 200mg|
59976775|NCT03142191|76093974|FG001|CC-90001 200mg|Active Treatment Extension Period||0|Participants who were in the placebo arm during treatment period and are now taking CC-90001 200mg|
59976776|NCT03142191|76093975|FG002|CC-90001 200mg|Active Treatment Extension Period||15|Participants who were in the placebo arm during treatment period and are now taking CC-90001 200mg|
59976777|NCT03142191|76093976|FG003|CC-90001 200mg|Active Treatment Extension Period||0|Participants who were in the placebo arm during treatment period and are now taking CC-90001 200mg|
59976778|NCT03142191|76093977|FG004|CC-90001 200mg|Active Treatment Extension Period||3|Participants who were in the placebo arm during treatment period and are now taking CC-90001 200mg|
59976779|NCT03142191|76093973|FG000|CC-90001 400mg|Active Treatment Extension Period||0|Participants who were in the placebo arm during treatment period and are now taking CC-90001 400mg|
59976780|NCT03142191|76093974|FG001|CC-90001 400mg|Active Treatment Extension Period||0|Participants who were in the placebo arm during treatment period and are now taking CC-90001 400mg|
59976781|NCT03142191|76093975|FG002|CC-90001 400mg|Active Treatment Extension Period||15|Participants who were in the placebo arm during treatment period and are now taking CC-90001 400mg|
59976782|NCT03142191|76093976|FG003|CC-90001 400mg|Active Treatment Extension Period||0|Participants who were in the placebo arm during treatment period and are now taking CC-90001 400mg|
59994971|NCT02730793|76110797|FG000|COMPLETED|Overall Study||2||
59976783|NCT03142191|76093977|FG004|CC-90001 400mg|Active Treatment Extension Period||3|Participants who were in the placebo arm during treatment period and are now taking CC-90001 400mg|
59976784|NCT03142191|76093973|FG000|COMPLETED|Active Treatment Extension Period||5||
59976785|NCT03142191|76093974|FG001|COMPLETED|Active Treatment Extension Period||13||
59976786|NCT03142191|76093975|FG002|COMPLETED|Active Treatment Extension Period||15||
59976787|NCT03142191|76093976|FG003|COMPLETED|Active Treatment Extension Period||3||
59976788|NCT03142191|76093977|FG004|COMPLETED|Active Treatment Extension Period||0||
59976789|NCT03142191|76093973|FG000|NOT COMPLETED|Active Treatment Extension Period||26||
59976790|NCT03142191|76093974|FG001|NOT COMPLETED|Active Treatment Extension Period||14||
59976791|NCT03142191|76093975|FG002|NOT COMPLETED|Active Treatment Extension Period||15||
59976792|NCT03142191|76093976|FG003|NOT COMPLETED|Active Treatment Extension Period||12||
59976793|NCT03142191|76093977|FG004|NOT COMPLETED|Active Treatment Extension Period||6||
59976794|NCT02617628|76094006|FG000|STARTED|Overall Study||74||
59976795|NCT02617628|76094007|FG001|STARTED|Overall Study||72||
59976796|NCT02617628|76094006|FG000|COMPLETED|Overall Study||12||
59976797|NCT02617628|76094007|FG001|COMPLETED|Overall Study||11||
59976798|NCT02617628|76094006|FG000|NOT COMPLETED|Overall Study||62||
59976799|NCT02617628|76094007|FG001|NOT COMPLETED|Overall Study||61||
59976800|NCT02308540|76094023|FG000|STARTED|Overall Study||17||
59976801|NCT02308540|76094024|FG001|STARTED|Overall Study||17||
59976802|NCT02308540|76094025|FG002|STARTED|Overall Study||56||
59976803|NCT02308540|76094026|FG003|STARTED|Overall Study||56||
59976804|NCT02308540|76094027|FG004|STARTED|Overall Study||100||
59976805|NCT02308540|76094028|FG005|STARTED|Overall Study||100||
59976806|NCT02308540|76094023|FG000|Randomized|Overall Study||17||
59976807|NCT02308540|76094024|FG001|Randomized|Overall Study||17||
59976808|NCT02308540|76094025|FG002|Randomized|Overall Study||56||
59976809|NCT02308540|76094026|FG003|Randomized|Overall Study||56||
59976810|NCT02308540|76094027|FG004|Randomized|Overall Study||100||
59976811|NCT02308540|76094028|FG005|Randomized|Overall Study||100||
59976812|NCT02308540|76094023|FG000|Vaccinated|Overall Study||17||
59976813|NCT02308540|76094024|FG001|Vaccinated|Overall Study||17||
59976814|NCT02308540|76094025|FG002|Vaccinated|Overall Study||56||
59976815|NCT02308540|76094026|FG003|Vaccinated|Overall Study||56||
59976816|NCT02308540|76094027|FG004|Vaccinated|Overall Study||100||
59976817|NCT02308540|76094028|FG005|Vaccinated|Overall Study||100||
59976818|NCT02308540|76094023|FG000|COMPLETED|Overall Study||17||
59976819|NCT02308540|76094024|FG001|COMPLETED|Overall Study||17||
59976820|NCT02308540|76094025|FG002|COMPLETED|Overall Study||56||
59976821|NCT02308540|76094026|FG003|COMPLETED|Overall Study||56||
59976822|NCT02308540|76094027|FG004|COMPLETED|Overall Study||100||
59976823|NCT02308540|76094028|FG005|COMPLETED|Overall Study||99||
59976824|NCT02308540|76094023|FG000|NOT COMPLETED|Overall Study||0||
59976825|NCT02308540|76094024|FG001|NOT COMPLETED|Overall Study||0||
59976826|NCT02308540|76094025|FG002|NOT COMPLETED|Overall Study||0||
59976827|NCT02308540|76094026|FG003|NOT COMPLETED|Overall Study||0||
59976828|NCT02308540|76094027|FG004|NOT COMPLETED|Overall Study||0||
59976829|NCT02308540|76094028|FG005|NOT COMPLETED|Overall Study||1||
59976830|NCT02308228|76094079|FG000|STARTED|Overall Study||54||
59976831|NCT02308228|76094080|FG001|STARTED|Overall Study||55||
59976832|NCT02308228|76094079|FG000|COMPLETED|Overall Study||46||
59976833|NCT02308228|76094080|FG001|COMPLETED|Overall Study||48||
59976834|NCT02308228|76094079|FG000|NOT COMPLETED|Overall Study||8||
59526064|NCT01342549|75621534|FG001|NOT COMPLETED|Overall Study||0||
59976835|NCT02308228|76094080|FG001|NOT COMPLETED|Overall Study||7||
59976836|NCT04891874|76094088|FG000|STARTED|Overall Study|Participants in this period were recruited from August 1, 2015 to December 31, 2016.|38||
59976837|NCT04891874|76094089|FG001|STARTED|Overall Study||38||
59976838|NCT04891874|76094088|FG000|COMPLETED|Overall Study||38||
59976839|NCT04891874|76094089|FG001|COMPLETED|Overall Study||38||
59976840|NCT04891874|76094088|FG000|NOT COMPLETED|Overall Study||0||
59976841|NCT04891874|76094089|FG001|NOT COMPLETED|Overall Study||0||
59976842|NCT02616614|76094098|FG000|STARTED|Overall Study||347||
59976843|NCT02616614|76094099|FG001|STARTED|Overall Study||345||
59526065|NCT01343095|75621543|FG000|STARTED|Overall Study||2||
59526066|NCT01343095|75621544|FG001|STARTED|Overall Study||3||
59526067|NCT01343095|75621545|FG002|STARTED|Overall Study||3||
59526068|NCT01343095|75621543|FG000|COMPLETED|Overall Study||2||
59976844|NCT02616614|76094100|FG002|STARTED|Overall Study||170||
59976845|NCT02616614|76094098|FG000|Safety Population|Overall Study||329|Randomized participants who received the study drug|
59526069|NCT01343095|75621544|FG001|COMPLETED|Overall Study||3||
59526070|NCT01343095|75621545|FG002|COMPLETED|Overall Study||3||
59976846|NCT02616614|76094099|FG001|Safety Population|Overall Study||328|Randomized participants who received the study drug|
59976847|NCT02616614|76094100|FG002|Safety Population|Overall Study||161|Randomized participants who received the study drug|
59976848|NCT02616614|76094098|FG000|mITT Population|Overall Study||325|Randomized participants, received at least 1 dose of study drug and at least 1 post-baseline visit|
59976849|NCT02616614|76094099|FG001|mITT Population|Overall Study||325|Randomized participants, received at least 1 dose of study drug and at least 1 post-baseline visit|
59976850|NCT02616614|76094100|FG002|mITT Population|Overall Study||160|Randomized participants, received at least 1 dose of study drug and at least 1 post-baseline visit|
59976851|NCT02616614|76094098|FG000|PP Population|Overall Study||253|Randomized subjects, compliant with study drug, completed study|
59976852|NCT02616614|76094099|FG001|PP Population|Overall Study||255|Randomized subjects, compliant with study drug, completed study|
59976853|NCT02616614|76094100|FG002|PP Population|Overall Study||122|Randomized subjects, compliant with study drug, completed study|
59976854|NCT02616614|76094098|FG000|COMPLETED|Overall Study||282||
59976855|NCT02616614|76094099|FG001|COMPLETED|Overall Study||285||
59976856|NCT02616614|76094100|FG002|COMPLETED|Overall Study||141||
59976857|NCT02616614|76094098|FG000|NOT COMPLETED|Overall Study||65||
59976858|NCT02616614|76094099|FG001|NOT COMPLETED|Overall Study||60||
59976859|NCT02616614|76094100|FG002|NOT COMPLETED|Overall Study||29||
59976860|NCT04408040|76094113|FG000|STARTED|Overall Study||0||
59976861|NCT04408040|76094114|FG001|STARTED|Overall Study||1||
59976862|NCT04408040|76094115|FG002|STARTED|Overall Study||6||
59976863|NCT04408040|76094116|FG003|STARTED|Overall Study||1||
59976864|NCT04408040|76094113|FG000|COMPLETED|Overall Study||0||
59976865|NCT04408040|76094114|FG001|COMPLETED|Overall Study||1||
59976866|NCT04408040|76094115|FG002|COMPLETED|Overall Study||6||
59976867|NCT04408040|76094116|FG003|COMPLETED|Overall Study||1||
59976868|NCT04408040|76094113|FG000|NOT COMPLETED|Overall Study||0||
59976869|NCT04408040|76094114|FG001|NOT COMPLETED|Overall Study||0||
59976870|NCT04408040|76094115|FG002|NOT COMPLETED|Overall Study||0||
59976871|NCT04408040|76094116|FG003|NOT COMPLETED|Overall Study||0||
59976872|NCT02616380|76094126|FG000|STARTED|Overall Study||100||
59976873|NCT02616380|76094126|FG000|COMPLETED|Overall Study||97||
59976874|NCT02616380|76094126|FG000|NOT COMPLETED|Overall Study||3||
59976875|NCT04881968|76094130|FG000|STARTED|Overall Study||1261||
59976876|NCT04881968|76094130|FG000|COMPLETED|Overall Study||1261||
59976877|NCT04881968|76094130|FG000|NOT COMPLETED|Overall Study||0||
59976878|NCT04436822|76094136|FG000|STARTED|Overall Study||172||
59976879|NCT04436822|76094137|FG001|STARTED|Overall Study||138||
59976880|NCT04436822|76094136|FG000|COMPLETED|Overall Study||160||
59976881|NCT04436822|76094137|FG001|COMPLETED|Overall Study||132||
59976882|NCT04436822|76094136|FG000|NOT COMPLETED|Overall Study||12||
59976883|NCT04436822|76094137|FG001|NOT COMPLETED|Overall Study||6||
59976884|NCT01596062|76094147|FG000|STARTED|Overall Study||3||
59976885|NCT01596062|76094148|FG001|STARTED|Overall Study||6||
59976886|NCT01596062|76094149|FG002|STARTED|Overall Study||7||
59976887|NCT01596062|76094147|FG000|COMPLETED|Overall Study||2||
59976888|NCT01596062|76094148|FG001|COMPLETED|Overall Study||6||
59976889|NCT01596062|76094149|FG002|COMPLETED|Overall Study||4||
59976890|NCT01596062|76094147|FG000|NOT COMPLETED|Overall Study||1||
59976891|NCT01596062|76094148|FG001|NOT COMPLETED|Overall Study||0||
59976892|NCT01596062|76094149|FG002|NOT COMPLETED|Overall Study||3||
59976893|NCT04090658|76094159|FG000|STARTED|Overall Study||20||
59976894|NCT04090658|76094160|FG001|STARTED|Overall Study||20||
59976895|NCT04090658|76094159|FG000|COMPLETED|Overall Study||20||
59976896|NCT04090658|76094160|FG001|COMPLETED|Overall Study||20||
59976897|NCT04090658|76094159|FG000|NOT COMPLETED|Overall Study||0||
59976898|NCT04090658|76094160|FG001|NOT COMPLETED|Overall Study||0||
59976899|NCT02614898|76094168|FG000|STARTED|Overall Study||15||
59976900|NCT02614898|76094169|FG001|STARTED|Overall Study||52||
59976901|NCT02614898|76094168|FG000|Safety Population|Overall Study||15||
59976902|NCT02614898|76094169|FG001|Safety Population|Overall Study||52||
59976903|NCT02614898|76094168|FG000|COMPLETED|Overall Study||0||
59976904|NCT02614898|76094169|FG001|COMPLETED|Overall Study||1||
59976905|NCT02614898|76094168|FG000|NOT COMPLETED|Overall Study||15||
59976906|NCT02614898|76094169|FG001|NOT COMPLETED|Overall Study||51||
59976907|NCT03811028|76094178|FG000|STARTED|Overall Study||3||
59976908|NCT03811028|76094179|FG001|STARTED|Overall Study||3||
60074644|NCT01555125|76189973|FG003|NOT COMPLETED|Maintenance Period||2||
60074645|NCT01555125|76189974|FG004|NOT COMPLETED|Maintenance Period||0||
60074646|NCT01555125|76189970|FG000|STARTED|Extension||46||
60074647|NCT01555125|76189971|FG001|STARTED|Extension||51||
59976909|NCT03811028|76094178|FG000|COMPLETED|Overall Study||3||
59976910|NCT03811028|76094179|FG001|COMPLETED|Overall Study||3||
59976911|NCT03811028|76094178|FG000|NOT COMPLETED|Overall Study||0||
59976912|NCT03811028|76094179|FG001|NOT COMPLETED|Overall Study||0||
59976913|NCT02776033|76094189|FG000|STARTED|Overall Study||18||
59976914|NCT02776033|76094190|FG001|STARTED|Overall Study||23||
59976915|NCT02776033|76094191|FG002|STARTED|Overall Study||24||
59976916|NCT02776033|76094189|FG000|COMPLETED|Overall Study||14||
59976917|NCT02776033|76094190|FG001|COMPLETED|Overall Study||21||
59976918|NCT02776033|76094191|FG002|COMPLETED|Overall Study||22||
59976919|NCT02776033|76094189|FG000|NOT COMPLETED|Overall Study||4||
59976920|NCT02776033|76094190|FG001|NOT COMPLETED|Overall Study||2||
59976921|NCT02776033|76094191|FG002|NOT COMPLETED|Overall Study||2||
59976922|NCT02777125|76094207|FG000|STARTED|Overall Study||488||
59976923|NCT02777125|76094208|FG001|STARTED|Overall Study||492||
59976924|NCT02777125|76094207|FG000|COMPLETED|Overall Study||445||
59976925|NCT02777125|76094208|FG001|COMPLETED|Overall Study||445||
59976926|NCT02777125|76094207|FG000|NOT COMPLETED|Overall Study||43||
59976927|NCT02777125|76094208|FG001|NOT COMPLETED|Overall Study||47||
59976928|NCT00806390|76094217|FG000|STARTED|Overall Study||7||
59976929|NCT00806390|76094218|FG001|STARTED|Overall Study||8||
60074648|NCT01555125|76189972|FG002|STARTED|Extension||23||
59976930|NCT00806390|76094217|FG000|COMPLETED|Overall Study||7||
59976931|NCT00806390|76094218|FG001|COMPLETED|Overall Study||8||
59526071|NCT01343095|75621543|FG000|NOT COMPLETED|Overall Study||0||
59526072|NCT01343095|75621544|FG001|NOT COMPLETED|Overall Study||0||
59526073|NCT01343095|75621545|FG002|NOT COMPLETED|Overall Study||0||
59526074|NCT01343251|75621557|FG000|STARTED|Overall Study||16||
59526075|NCT01343251|75621558|FG001|STARTED|Overall Study||17||
59526076|NCT01343251|75621557|FG000|COMPLETED|Overall Study||16||
59526077|NCT01343251|75621558|FG001|COMPLETED|Overall Study||17||
59526078|NCT01343251|75621557|FG000|NOT COMPLETED|Overall Study||0||
59526079|NCT01343251|75621558|FG001|NOT COMPLETED|Overall Study||0||
59526080|NCT01343485|75621569|FG000|STARTED|Overall Study||185||
59526081|NCT01343485|75621570|FG001|STARTED|Overall Study||180||
59526082|NCT01343485|75621569|FG000|COMPLETED|Overall Study||36||
59526083|NCT01343485|75621570|FG001|COMPLETED|Overall Study||46||
59526084|NCT01343485|75621569|FG000|NOT COMPLETED|Overall Study||149||
59526085|NCT01343485|75621570|FG001|NOT COMPLETED|Overall Study||134||
59526086|NCT01345513|75621576|FG000|STARTED|Overall Study||50||
59526087|NCT01345513|75621576|FG000|COMPLETED|Overall Study||50||
59526088|NCT01345513|75621576|FG000|NOT COMPLETED|Overall Study||0||
59526089|NCT01294267|75621580|FG000|STARTED|Overall Study||20||
59526090|NCT01294267|75621580|FG000|COMPLETED|Overall Study||20||
59526091|NCT01294267|75621580|FG000|NOT COMPLETED|Overall Study||0||
59526092|NCT01276171|75621587|FG000|STARTED|Overall Study||249||
59526093|NCT01276171|75621588|FG001|STARTED|Overall Study||244||
59526094|NCT01276171|75621589|FG002|STARTED|Overall Study||256||
59526095|NCT01276171|75621587|FG000|COMPLETED|Overall Study||249||
59526096|NCT01276171|75621588|FG001|COMPLETED|Overall Study||244||
59526097|NCT01276171|75621589|FG002|COMPLETED|Overall Study||256||
59526098|NCT01276171|75621587|FG000|NOT COMPLETED|Overall Study||0||
59526099|NCT01276171|75621588|FG001|NOT COMPLETED|Overall Study||0||
59526100|NCT01276171|75621589|FG002|NOT COMPLETED|Overall Study||0||
59526101|NCT01346683|75621597|FG000|STARTED|Overall Study||45||107
59526102|NCT01346683|75621597|FG000|COMPLETED|Overall Study||45||107
59526103|NCT01346683|75621597|FG000|NOT COMPLETED|Overall Study||0||0
59526104|NCT01295515|75621601|FG000|STARTED|Overall Study||7||
59526105|NCT01295515|75621601|FG000|COMPLETED|Overall Study||7||
59526106|NCT01295515|75621601|FG000|NOT COMPLETED|Overall Study||0||
59526107|NCT01277341|75621609|FG000|STARTED|Overall Study||150||
59526108|NCT01277341|75621610|FG001|STARTED|Overall Study||150||
59526109|NCT01277341|75621611|FG002|STARTED|Overall Study||149||
59526110|NCT01277341|75621612|FG003|STARTED|Overall Study||152||
59526111|NCT01277341|75621609|FG000|COMPLETED|Overall Study||146||
59526112|NCT01277341|75621610|FG001|COMPLETED|Overall Study||145||
59526113|NCT01277341|75621611|FG002|COMPLETED|Overall Study||145||
59526114|NCT01277341|75621612|FG003|COMPLETED|Overall Study||146||
59526115|NCT01277341|75621609|FG000|NOT COMPLETED|Overall Study||4||
59526116|NCT01277341|75621610|FG001|NOT COMPLETED|Overall Study||5||
59526117|NCT01277341|75621611|FG002|NOT COMPLETED|Overall Study||4||
59526118|NCT01277341|75621612|FG003|NOT COMPLETED|Overall Study||6||
59526119|NCT01346839|75621624|FG000|STARTED|Overall Study||683||
59526120|NCT01346839|75621625|FG001|STARTED|Overall Study||573||
59526121|NCT01346839|75621624|FG000|COMPLETED|Overall Study||369||
59526122|NCT01346839|75621625|FG001|COMPLETED|Overall Study|All triggers were applied retrospectively on 7/19/2012.|364||
59526123|NCT01346839|75621624|FG000|NOT COMPLETED|Overall Study||314||
59526124|NCT01346839|75621625|FG001|NOT COMPLETED|Overall Study||209||
59526125|NCT00101816|75621633|FG000|STARTED|Overall Study||10||
59526126|NCT00101816|75621634|FG001|STARTED|Overall Study||99||
59526127|NCT00101816|75621633|FG000|COMPLETED|Overall Study||10||
59526128|NCT00101816|75621634|FG001|COMPLETED|Overall Study||99||
59526129|NCT00101816|75621633|FG000|NOT COMPLETED|Overall Study||0||
59526130|NCT00101816|75621634|FG001|NOT COMPLETED|Overall Study||0||
59526131|NCT00102518|75621648|FG000|STARTED|Overall Study||325||
59526132|NCT00102518|75621648|FG000|COMPLETED|Overall Study||238||
59526133|NCT00102518|75621648|FG000|NOT COMPLETED|Overall Study||87||
59526134|NCT02090894|75621652|FG000|STARTED|Overall Study||11||
59526135|NCT02090894|75621652|FG000|COMPLETED|Overall Study||11||
59526136|NCT02090894|75621652|FG000|NOT COMPLETED|Overall Study||0||
59526137|NCT00103376|75621659|FG000|STARTED|Overall Study||8||
59526138|NCT00103376|75621660|FG001|STARTED|Overall Study||7||
59526139|NCT00103376|75621661|FG002|STARTED|Overall Study||8||
59526140|NCT00103376|75621659|FG000|COMPLETED|Overall Study||8||
59526141|NCT00103376|75621660|FG001|COMPLETED|Overall Study||7||
59526142|NCT00103376|75621661|FG002|COMPLETED|Overall Study||8||
59526143|NCT00103376|75621659|FG000|NOT COMPLETED|Overall Study||0||
59526144|NCT00103376|75621660|FG001|NOT COMPLETED|Overall Study||0||
59526145|NCT00103376|75621661|FG002|NOT COMPLETED|Overall Study||0||
59976932|NCT00806390|76094217|FG000|NOT COMPLETED|Overall Study||0||
59976933|NCT00806390|76094218|FG001|NOT COMPLETED|Overall Study||0||
59976934|NCT00566618|76094224|FG000|STARTED|Overall Study||1||
59526146|NCT00042224|75621677|FG000|STARTED|Overall Study||20||
59526147|NCT00042224|75621678|FG001|STARTED|Overall Study||19||
59526148|NCT00042224|75621677|FG000|COMPLETED|Overall Study||17||
59526149|NCT00042224|75621678|FG001|COMPLETED|Overall Study||16||
59976935|NCT00566618|76094225|FG001|STARTED|Overall Study||6||
59976936|NCT00566618|76094226|FG002|STARTED|Overall Study||18||
59976937|NCT00566618|76094224|FG000|COMPLETED|Overall Study||0||
59976938|NCT00566618|76094225|FG001|COMPLETED|Overall Study||0||
59976939|NCT00566618|76094226|FG002|COMPLETED|Overall Study||0||
59976940|NCT00566618|76094224|FG000|NOT COMPLETED|Overall Study||1||
59976941|NCT00566618|76094225|FG001|NOT COMPLETED|Overall Study||6||
59976942|NCT00566618|76094226|FG002|NOT COMPLETED|Overall Study||18||
59976943|NCT02769481|76094233|FG000|STARTED|Overall Study||213||
59976944|NCT02769481|76094234|FG001|STARTED|Overall Study||213||
59976945|NCT02769481|76094233|FG000|Study Complete at Week 60|Overall Study||193||
59976946|NCT02769481|76094234|FG001|Study Complete at Week 60|Overall Study||192||
59976947|NCT02769481|76094233|FG000|COMPLETED|Overall Study||180||
59976948|NCT02769481|76094234|FG001|COMPLETED|Overall Study||177||
59976949|NCT02769481|76094233|FG000|NOT COMPLETED|Overall Study||33||
59976950|NCT02769481|76094234|FG001|NOT COMPLETED|Overall Study||36||
59976951|NCT02769247|76094244|FG000|STARTED|Overall Study||40||
59976952|NCT02769247|76094245|FG001|STARTED|Overall Study||40||
59976953|NCT02769247|76094246|FG002|STARTED|Overall Study||40||
59976954|NCT02769247|76094247|FG003|STARTED|Overall Study||40||
59976955|NCT02769247|76094244|FG000|COMPLETED|Overall Study|unable to insert IUD in one patient; 1 pt decided against study participation after enrollment|38||
59976956|NCT02769247|76094245|FG001|COMPLETED|Overall Study||40||
59976957|NCT02769247|76094246|FG002|COMPLETED|Overall Study|1 took non-study med after enrollment/randomization, before IUD insertion (excluded from study)|39||
59976958|NCT02769247|76094247|FG003|COMPLETED|Overall Study|1 patient decided against study participation after enrollment/randomization|39||
59976959|NCT02769247|76094244|FG000|NOT COMPLETED|Overall Study||2||
59976960|NCT02769247|76094245|FG001|NOT COMPLETED|Overall Study||0||
59976961|NCT02769247|76094246|FG002|NOT COMPLETED|Overall Study||1||
59976962|NCT02769247|76094247|FG003|NOT COMPLETED|Overall Study||1||
59976963|NCT02773537|76094264|FG000|STARTED|Overall Study||25||
59976964|NCT02773537|76094265|FG001|STARTED|Overall Study||25||
59976965|NCT02773537|76094266|FG002|STARTED|Overall Study||25||
59976966|NCT02773537|76094264|FG000|COMPLETED|Overall Study||25||
59976967|NCT02773537|76094265|FG001|COMPLETED|Overall Study||24||
59976968|NCT02773537|76094266|FG002|COMPLETED|Overall Study||21||
59976969|NCT02773537|76094264|FG000|NOT COMPLETED|Overall Study||0||
59976970|NCT02773537|76094265|FG001|NOT COMPLETED|Overall Study||1||
59813758|NCT00357760|75936273|FG001|NOT COMPLETED|Overall Study||35||
59813759|NCT00622739|75936281|FG000|STARTED|Overall Study||13||
59813760|NCT00622739|75936282|FG001|STARTED|Overall Study||15||
59813761|NCT00622739|75936281|FG000|COMPLETED|Overall Study||11||
59813762|NCT00622739|75936282|FG001|COMPLETED|Overall Study||9||
59976971|NCT02773537|76094266|FG002|NOT COMPLETED|Overall Study||4||
59976972|NCT02780713|76094274|FG000|STARTED|Period 1: Variant A (100mg)|After washout period participants entered Treatment Period 2.|14|Participants received AZD9496 in 5-sequential treatment periods.|
59976973|NCT02780713|76094275|FG001|STARTED|Period 1: Variant A (100mg)|After washout period participants entered Treatment Period 3.|0|Participants received AZD9496 in 5-sequential treatment periods.|
59976974|NCT02780713|76094276|FG002|STARTED|Period 1: Variant A (100mg)|After washout period participants entered Treatment Period 4.|0|Participants received AZD9496 in 5-sequential treatment periods.|
59976975|NCT02780713|76094277|FG003|STARTED|Period 1: Variant A (100mg)|After washout period participants entered Treatment Period 5.|0|Participants received AZD9496 in 5-sequential treatment periods.|
59976976|NCT02780713|76094278|FG004|STARTED|Period 1: Variant A (100mg)||0|Participants received AZD9496 in 5-sequential treatment periods.|
59976977|NCT02780713|76094274|FG000|COMPLETED|Period 1: Variant A (100mg)||14|12 participants received and completed treatment and 2 participants withdrew from the study|
59976978|NCT02780713|76094275|FG001|COMPLETED|Period 1: Variant A (100mg)||0|12 participants received and completed treatment and 2 participants withdrew from the study|
59976979|NCT02780713|76094276|FG002|COMPLETED|Period 1: Variant A (100mg)||0|12 participants received and completed treatment and 2 participants withdrew from the study|
59976980|NCT02780713|76094277|FG003|COMPLETED|Period 1: Variant A (100mg)||0|12 participants received and completed treatment and 2 participants withdrew from the study|
59622271|NCT00412074|75734039|FG000|COMPLETED|Overall Study||122||
59622272|NCT00412074|75734040|FG001|COMPLETED|Overall Study||44||
59813763|NCT00622739|75936281|FG000|NOT COMPLETED|Overall Study||2||
59813764|NCT00622739|75936282|FG001|NOT COMPLETED|Overall Study||6||
59813765|NCT00435825|75936294|FG000|STARTED|Overall Study||141||
59526150|NCT00042224|75621677|FG000|NOT COMPLETED|Overall Study||3||
59526151|NCT00042224|75621678|FG001|NOT COMPLETED|Overall Study||3||
59526152|NCT01296763|75621687|FG000|STARTED|Overall Study||7||
59526153|NCT01296763|75621688|FG001|STARTED|Overall Study||5||
59526154|NCT01296763|75621689|FG002|STARTED|Overall Study||6||
59526155|NCT01296763|75621687|FG000|COMPLETED|Overall Study||7||
59526156|NCT01296763|75621688|FG001|COMPLETED|Overall Study||5||
59813766|NCT00435825|75936295|FG001|STARTED|Overall Study||136||
59813767|NCT00435825|75936296|FG002|STARTED|Overall Study||138||
59813768|NCT00435825|75936297|FG003|STARTED|Overall Study||136||
59813769|NCT00435825|75936294|FG000|Received Study Drug|Overall Study||140||
59813770|NCT00435825|75936295|FG001|Received Study Drug|Overall Study||136||
59813771|NCT00435825|75936296|FG002|Received Study Drug|Overall Study||136||
59813772|NCT00435825|75936297|FG003|Received Study Drug|Overall Study||136||
59813773|NCT00435825|75936294|FG000|Entered Follow-up|Overall Study||140||
59813774|NCT00435825|75936295|FG001|Entered Follow-up|Overall Study||132||
59813775|NCT00435825|75936296|FG002|Entered Follow-up|Overall Study||135||
59813776|NCT00435825|75936297|FG003|Entered Follow-up|Overall Study||133||
59813777|NCT00435825|75936294|FG000|Completed 24 Weeks Treatment|Overall Study||128||
59813778|NCT00435825|75936295|FG001|Completed 24 Weeks Treatment|Overall Study||126||
59813779|NCT00435825|75936296|FG002|Completed 24 Weeks Treatment|Overall Study||134||
59976981|NCT02780713|76094278|FG004|COMPLETED|Period 1: Variant A (100mg)||0|12 participants received and completed treatment and 2 participants withdrew from the study|
59976982|NCT02780713|76094274|FG000|NOT COMPLETED|Period 1: Variant A (100mg)||0||
59976983|NCT02780713|76094275|FG001|NOT COMPLETED|Period 1: Variant A (100mg)||0||
59976984|NCT02780713|76094276|FG002|NOT COMPLETED|Period 1: Variant A (100mg)||0||
59976985|NCT02780713|76094277|FG003|NOT COMPLETED|Period 1: Variant A (100mg)||0||
59976986|NCT02780713|76094278|FG004|NOT COMPLETED|Period 1: Variant A (100mg)||0||
59976987|NCT02780713|76094274|FG000|STARTED|Period 2: Reference (100mg)||0||
59976988|NCT02780713|76094275|FG001|STARTED|Period 2: Reference (100mg)||14||
59976989|NCT02780713|76094276|FG002|STARTED|Period 2: Reference (100mg)||0||
59976990|NCT02780713|76094277|FG003|STARTED|Period 2: Reference (100mg)||0||
59976991|NCT02780713|76094278|FG004|STARTED|Period 2: Reference (100mg)||0||
59976992|NCT02780713|76094274|FG000|COMPLETED|Period 2: Reference (100mg)||0|12 participants received and completed treatment and 2 participants withdrew from the study|
59976993|NCT02780713|76094275|FG001|COMPLETED|Period 2: Reference (100mg)||14|12 participants received and completed treatment and 2 participants withdrew from the study|
59976994|NCT02780713|76094276|FG002|COMPLETED|Period 2: Reference (100mg)||0|12 participants received and completed treatment and 2 participants withdrew from the study|
59976995|NCT02780713|76094277|FG003|COMPLETED|Period 2: Reference (100mg)||0|12 participants received and completed treatment and 2 participants withdrew from the study|
59976996|NCT02780713|76094278|FG004|COMPLETED|Period 2: Reference (100mg)||0|12 participants received and completed treatment and 2 participants withdrew from the study|
59976997|NCT02780713|76094274|FG000|NOT COMPLETED|Period 2: Reference (100mg)||0||
59976998|NCT02780713|76094275|FG001|NOT COMPLETED|Period 2: Reference (100mg)||0||
59976999|NCT02780713|76094276|FG002|NOT COMPLETED|Period 2: Reference (100mg)||0||
59977000|NCT02780713|76094277|FG003|NOT COMPLETED|Period 2: Reference (100mg)||0||
59977001|NCT02780713|76094278|FG004|NOT COMPLETED|Period 2: Reference (100mg)||0||
59977002|NCT02780713|76094274|FG000|STARTED|Period 3: Variant B (100mg)||0||
59977003|NCT02780713|76094275|FG001|STARTED|Period 3: Variant B (100mg)||0||
59977004|NCT02780713|76094276|FG002|STARTED|Period 3: Variant B (100mg)||14||
59977005|NCT02780713|76094277|FG003|STARTED|Period 3: Variant B (100mg)||0||
59977006|NCT02780713|76094278|FG004|STARTED|Period 3: Variant B (100mg)||0||
59977007|NCT02780713|76094274|FG000|COMPLETED|Period 3: Variant B (100mg)||0|12 participants received and completed treatment and 2 participants withdrew from the study|
59977008|NCT02780713|76094275|FG001|COMPLETED|Period 3: Variant B (100mg)||0|12 participants received and completed treatment and 2 participants withdrew from the study|
59813780|NCT00435825|75936297|FG003|Completed 24 Weeks Treatment|Overall Study||131||
59813781|NCT00435825|75936294|FG000|Completed 48 Weeks Treatment|Overall Study||0||
59813782|NCT00435825|75936295|FG001|Completed 48 Weeks Treatment|Overall Study||0||
59813783|NCT00435825|75936296|FG002|Completed 48 Weeks Treatment|Overall Study||124||
59813784|NCT00435825|75936297|FG003|Completed 48 Weeks Treatment|Overall Study||117||
59813785|NCT00435825|75936294|FG000|COMPLETED|Overall Study|Completed is the number of participants who received study treatment and completed follow-up.|123||
59813786|NCT00435825|75936295|FG001|COMPLETED|Overall Study||124||
59813787|NCT00435825|75936296|FG002|COMPLETED|Overall Study||127||
59813788|NCT00435825|75936297|FG003|COMPLETED|Overall Study||120||
59813789|NCT00435825|75936294|FG000|NOT COMPLETED|Overall Study||18||
59813790|NCT00435825|75936295|FG001|NOT COMPLETED|Overall Study||12||
59977009|NCT02780713|76094276|FG002|COMPLETED|Period 3: Variant B (100mg)||12|12 participants received and completed treatment and 2 participants withdrew from the study|
59977010|NCT02780713|76094277|FG003|COMPLETED|Period 3: Variant B (100mg)||0|12 participants received and completed treatment and 2 participants withdrew from the study|
59977011|NCT02780713|76094278|FG004|COMPLETED|Period 3: Variant B (100mg)||0|12 participants received and completed treatment and 2 participants withdrew from the study|
59977012|NCT02780713|76094274|FG000|NOT COMPLETED|Period 3: Variant B (100mg)||0||
59977013|NCT02780713|76094275|FG001|NOT COMPLETED|Period 3: Variant B (100mg)||0||
59977014|NCT02780713|76094276|FG002|NOT COMPLETED|Period 3: Variant B (100mg)||2||
59977015|NCT02780713|76094277|FG003|NOT COMPLETED|Period 3: Variant B (100mg)||0||
59813791|NCT00435825|75936296|FG002|NOT COMPLETED|Overall Study||11||
59813792|NCT00435825|75936297|FG003|NOT COMPLETED|Overall Study||16||
59813793|NCT00574145|75936309|FG000|STARTED|Overall Study||22||
59813794|NCT00574145|75936310|FG001|STARTED|Overall Study||22||
59813795|NCT00574145|75936309|FG000|COMPLETED|Overall Study||20||
59813796|NCT00574145|75936310|FG001|COMPLETED|Overall Study||21||
59813797|NCT00574145|75936309|FG000|NOT COMPLETED|Overall Study||2||
59977016|NCT02780713|76094278|FG004|NOT COMPLETED|Period 3: Variant B (100mg)||0||
59977017|NCT02780713|76094274|FG000|STARTED|Period 4: Variant C (100mg)||0||
59977018|NCT02780713|76094275|FG001|STARTED|Period 4: Variant C (100mg)||0||
59977019|NCT02780713|76094276|FG002|STARTED|Period 4: Variant C (100mg)||0||
59977020|NCT02780713|76094277|FG003|STARTED|Period 4: Variant C (100mg)||12||
59977021|NCT02780713|76094278|FG004|STARTED|Period 4: Variant C (100mg)||0||
59977022|NCT02780713|76094274|FG000|COMPLETED|Period 4: Variant C (100mg)||0|12 participants received and completed treatment and 2 participants withdrew from the study|
59977023|NCT02780713|76094275|FG001|COMPLETED|Period 4: Variant C (100mg)||0|12 participants received and completed treatment and 2 participants withdrew from the study|
59977024|NCT02780713|76094276|FG002|COMPLETED|Period 4: Variant C (100mg)||0|12 participants received and completed treatment and 2 participants withdrew from the study|
59977025|NCT02780713|76094277|FG003|COMPLETED|Period 4: Variant C (100mg)||12|12 participants received and completed treatment and 2 participants withdrew from the study|
59977026|NCT02780713|76094278|FG004|COMPLETED|Period 4: Variant C (100mg)||0|12 participants received and completed treatment and 2 participants withdrew from the study|
59977027|NCT02780713|76094274|FG000|NOT COMPLETED|Period 4: Variant C (100mg)||0||
59977028|NCT02780713|76094275|FG001|NOT COMPLETED|Period 4: Variant C (100mg)||0||
59977029|NCT02780713|76094276|FG002|NOT COMPLETED|Period 4: Variant C (100mg)||0||
59977030|NCT02780713|76094277|FG003|NOT COMPLETED|Period 4: Variant C (100mg)||0||
59977031|NCT02780713|76094278|FG004|NOT COMPLETED|Period 4: Variant C (100mg)||0||
59977032|NCT02780713|76094274|FG000|STARTED|Period 5: Variant B (300mg)||0||
59977033|NCT02780713|76094275|FG001|STARTED|Period 5: Variant B (300mg)||0||
59977034|NCT02780713|76094276|FG002|STARTED|Period 5: Variant B (300mg)||0||
59977035|NCT02780713|76094277|FG003|STARTED|Period 5: Variant B (300mg)||0||
59977036|NCT02780713|76094278|FG004|STARTED|Period 5: Variant B (300mg)||12||
59977037|NCT02780713|76094274|FG000|COMPLETED|Period 5: Variant B (300mg)||0|12 participants received and completed treatment and 2 participants withdrew from the study|
59977038|NCT02780713|76094275|FG001|COMPLETED|Period 5: Variant B (300mg)||0|12 participants received and completed treatment and 2 participants withdrew from the study|
59977039|NCT02780713|76094276|FG002|COMPLETED|Period 5: Variant B (300mg)||0|12 participants received and completed treatment and 2 participants withdrew from the study|
59977040|NCT02780713|76094277|FG003|COMPLETED|Period 5: Variant B (300mg)||0|12 participants received and completed treatment and 2 participants withdrew from the study|
59977041|NCT02780713|76094278|FG004|COMPLETED|Period 5: Variant B (300mg)||12|12 participants received and completed treatment and 2 participants withdrew from the study|
59977042|NCT02780713|76094274|FG000|NOT COMPLETED|Period 5: Variant B (300mg)||0||
59977043|NCT02780713|76094275|FG001|NOT COMPLETED|Period 5: Variant B (300mg)||0||
59977044|NCT02780713|76094276|FG002|NOT COMPLETED|Period 5: Variant B (300mg)||0||
59977045|NCT02780713|76094277|FG003|NOT COMPLETED|Period 5: Variant B (300mg)||0||
59977046|NCT02780713|76094278|FG004|NOT COMPLETED|Period 5: Variant B (300mg)||0||
59977047|NCT02767765|76094297|FG000|STARTED|Overall Study||61||
59977048|NCT02767765|76094297|FG000|COMPLETED|Overall Study||50||
59977049|NCT02767765|76094297|FG000|NOT COMPLETED|Overall Study||11||
59977050|NCT02772757|76094304|FG000|STARTED|Overall Study||22||
59977051|NCT02772757|76094305|FG001|STARTED|Overall Study||24||
59977052|NCT02772757|76094306|FG002|STARTED|Overall Study||26||
59977053|NCT02772757|76094304|FG000|COMPLETED|Overall Study||21||
59977054|NCT02772757|76094305|FG001|COMPLETED|Overall Study||21||
59977055|NCT02772757|76094306|FG002|COMPLETED|Overall Study||21||
59977056|NCT02772757|76094304|FG000|NOT COMPLETED|Overall Study||1||
59977057|NCT02772757|76094305|FG001|NOT COMPLETED|Overall Study||3||
59977058|NCT02772757|76094306|FG002|NOT COMPLETED|Overall Study||5||
59977059|NCT00103207|76094315|FG000|STARTED|Overall Study||72||
59977060|NCT00103207|76094315|FG000|Eligible Patients w/ Confirmed Diagnosis|Overall Study||41||
59977061|NCT00103207|76094315|FG000|Eligible Patients w/ Smoking Status Data|Overall Study||37||
59977062|NCT00103207|76094315|FG000|COMPLETED|Overall Study||34||
59977063|NCT00103207|76094315|FG000|NOT COMPLETED|Overall Study||38||
59977064|NCT01369355|76094327|FG000|STARTED|Week 0 - Week 44 (Maintenance)||133||
59977065|NCT01369355|76094328|FG001|STARTED|Week 0 - Week 44 (Maintenance)||132||
59977066|NCT01369355|76094329|FG002|STARTED|Week 0 - Week 44 (Maintenance)||132||
59977067|NCT01369355|76094330|FG003|STARTED|Week 0 - Week 44 (Maintenance)||123||
59977068|NCT01369355|76094331|FG004|STARTED|Week 0 - Week 44 (Maintenance)||285||
59977069|NCT01369355|76094332|FG005|STARTED|Week 0 - Week 44 (Maintenance)||476||
59977070|NCT01369355|76094333|FG006|STARTED|Week 0 - Week 44 (Maintenance)||0||
59977071|NCT01369355|76094334|FG007|STARTED|Week 0 - Week 44 (Maintenance)||0||
59977072|NCT01369355|76094335|FG008|STARTED|Week 0 - Week 44 (Maintenance)||0||
59977073|NCT01369355|76094327|FG000|COMPLETED|Week 0 - Week 44 (Maintenance)||102||
59977074|NCT01369355|76094328|FG001|COMPLETED|Week 0 - Week 44 (Maintenance)||103||
59977075|NCT01369355|76094329|FG002|COMPLETED|Week 0 - Week 44 (Maintenance)||101||
60074649|NCT01555125|76189973|FG003|STARTED|Extension||23||
59977076|NCT01369355|76094330|FG003|COMPLETED|Week 0 - Week 44 (Maintenance)||93||
59977077|NCT01369355|76094331|FG004|COMPLETED|Week 0 - Week 44 (Maintenance)||131||
59977078|NCT01369355|76094332|FG005|COMPLETED|Week 0 - Week 44 (Maintenance)||204||
59977079|NCT01369355|76094333|FG006|COMPLETED|Week 0 - Week 44 (Maintenance)||0||
59977080|NCT01369355|76094334|FG007|COMPLETED|Week 0 - Week 44 (Maintenance)||0||
59977081|NCT01369355|76094335|FG008|COMPLETED|Week 0 - Week 44 (Maintenance)||0||
59977082|NCT01369355|76094327|FG000|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||31||
60074650|NCT01555125|76189974|FG004|STARTED|Extension||0||
59977083|NCT01369355|76094328|FG001|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||29||
59977084|NCT01369355|76094329|FG002|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||31||
59977085|NCT01369355|76094330|FG003|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||30||
59977086|NCT01369355|76094331|FG004|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||154||
59977087|NCT01369355|76094332|FG005|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||272||
59977088|NCT01369355|76094333|FG006|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||0||
59977089|NCT01369355|76094334|FG007|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||0||
59977090|NCT01369355|76094335|FG008|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||0||
59977091|NCT01369355|76094327|FG000|STARTED|Long-term Extension (Week 44-272)||0||
59977092|NCT01369355|76094328|FG001|STARTED|Long-term Extension (Week 44-272)||0||
59977093|NCT01369355|76094329|FG002|STARTED|Long-term Extension (Week 44-272)||0||
59977094|NCT01369355|76094330|FG003|STARTED|Long-term Extension (Week 44-272)||0||
59977095|NCT01369355|76094331|FG004|STARTED|Long-term Extension (Week 44-272)||0||
59977096|NCT01369355|76094332|FG005|STARTED|Long-term Extension (Week 44-272)||0||
59977097|NCT01369355|76094333|FG006|STARTED|Long-term Extension (Week 44-272)||151||
59977098|NCT01369355|76094334|FG007|STARTED|Long-term Extension (Week 44-272)||213||
59977099|NCT01369355|76094335|FG008|STARTED|Long-term Extension (Week 44-272)||354||
59977100|NCT01369355|76094327|FG000|COMPLETED|Long-term Extension (Week 44-272)||0||
59977101|NCT01369355|76094328|FG001|COMPLETED|Long-term Extension (Week 44-272)||0||
59977102|NCT01369355|76094329|FG002|COMPLETED|Long-term Extension (Week 44-272)||0||
59977103|NCT01369355|76094330|FG003|COMPLETED|Long-term Extension (Week 44-272)||0||
59977104|NCT01369355|76094331|FG004|COMPLETED|Long-term Extension (Week 44-272)||0||
59977105|NCT01369355|76094332|FG005|COMPLETED|Long-term Extension (Week 44-272)||0||
59977106|NCT01369355|76094333|FG006|COMPLETED|Long-term Extension (Week 44-272)||0||
59977107|NCT01369355|76094334|FG007|COMPLETED|Long-term Extension (Week 44-272)||107||
59977108|NCT01369355|76094335|FG008|COMPLETED|Long-term Extension (Week 44-272)||183||
59977109|NCT01369355|76094327|FG000|NOT COMPLETED|Long-term Extension (Week 44-272)||0||
59977110|NCT01369355|76094328|FG001|NOT COMPLETED|Long-term Extension (Week 44-272)||0||
59977111|NCT01369355|76094329|FG002|NOT COMPLETED|Long-term Extension (Week 44-272)||0||
59977112|NCT01369355|76094330|FG003|NOT COMPLETED|Long-term Extension (Week 44-272)||0||
59977113|NCT01369355|76094331|FG004|NOT COMPLETED|Long-term Extension (Week 44-272)||0||
59977114|NCT01369355|76094332|FG005|NOT COMPLETED|Long-term Extension (Week 44-272)||0||
59977115|NCT01369355|76094333|FG006|NOT COMPLETED|Long-term Extension (Week 44-272)||151||
59977116|NCT01369355|76094334|FG007|NOT COMPLETED|Long-term Extension (Week 44-272)||106||
59977117|NCT01369355|76094335|FG008|NOT COMPLETED|Long-term Extension (Week 44-272)||171||
59977118|NCT02614196|76094358|FG000|STARTED|Double Blind Treatment Phase||463||
59977119|NCT02614196|76094359|FG001|STARTED|Double Blind Treatment Phase||233||
59977120|NCT02614196|76094360|FG002|STARTED|Double Blind Treatment Phase||226||
59977121|NCT02614196|76094361|FG003|STARTED|Double Blind Treatment Phase||30||
59977122|NCT02614196|76094362|FG004|STARTED|Double Blind Treatment Phase||15||
59977123|NCT02614196|76094363|FG005|STARTED|Double Blind Treatment Phase||19||
59977124|NCT02614196|76094358|FG000|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||461||
59977125|NCT02614196|76094359|FG001|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||231||
59977126|NCT02614196|76094360|FG002|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||223||
59977127|NCT02614196|76094361|FG003|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||30||
59526157|NCT01296763|75621689|FG002|COMPLETED|Overall Study||6||
59977128|NCT02614196|76094362|FG004|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||14||
59977129|NCT02614196|76094363|FG005|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||19||
59977130|NCT02614196|76094358|FG000|COMPLETED|Double Blind Treatment Phase||387||
59977131|NCT02614196|76094359|FG001|COMPLETED|Double Blind Treatment Phase||203||
59977132|NCT02614196|76094360|FG002|COMPLETED|Double Blind Treatment Phase||195||
59977133|NCT02614196|76094361|FG003|COMPLETED|Double Blind Treatment Phase||26||
59977134|NCT02614196|76094362|FG004|COMPLETED|Double Blind Treatment Phase||14||
59977135|NCT02614196|76094363|FG005|COMPLETED|Double Blind Treatment Phase||19||
59977136|NCT02614196|76094358|FG000|NOT COMPLETED|Double Blind Treatment Phase||76||
59977137|NCT02614196|76094359|FG001|NOT COMPLETED|Double Blind Treatment Phase||30||
59977138|NCT02614196|76094360|FG002|NOT COMPLETED|Double Blind Treatment Phase||31||
59977139|NCT02614196|76094361|FG003|NOT COMPLETED|Double Blind Treatment Phase||4||
59977140|NCT02614196|76094362|FG004|NOT COMPLETED|Double Blind Treatment Phase||1||
59977141|NCT02614196|76094363|FG005|NOT COMPLETED|Double Blind Treatment Phase||0||
59977142|NCT02614196|76094358|FG000|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post treatment phase|410||
59977143|NCT02614196|76094359|FG001|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post treatment phase|213||
59977144|NCT02614196|76094360|FG002|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post treatment phase|207||
59994972|NCT02730793|76110798|FG001|COMPLETED|Overall Study||1||
59977145|NCT02614196|76094361|FG003|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post treatment phase|25||
59977146|NCT02614196|76094362|FG004|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post treatment phase|15||
59977147|NCT02614196|76094363|FG005|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post treatment phase|19||
59977148|NCT02614196|76094358|FG000|COMPLETED|Post Treatment Follow-up Phase||390||
59977149|NCT02614196|76094359|FG001|COMPLETED|Post Treatment Follow-up Phase||208||
59977150|NCT02614196|76094360|FG002|COMPLETED|Post Treatment Follow-up Phase||199||
59977151|NCT02614196|76094361|FG003|COMPLETED|Post Treatment Follow-up Phase||24||
59977152|NCT02614196|76094362|FG004|COMPLETED|Post Treatment Follow-up Phase||13||
59977153|NCT02614196|76094363|FG005|COMPLETED|Post Treatment Follow-up Phase||19||
59977154|NCT02614196|76094358|FG000|NOT COMPLETED|Post Treatment Follow-up Phase||20||
59977155|NCT02614196|76094359|FG001|NOT COMPLETED|Post Treatment Follow-up Phase||5||
59977156|NCT02614196|76094360|FG002|NOT COMPLETED|Post Treatment Follow-up Phase||8||
59977157|NCT02614196|76094361|FG003|NOT COMPLETED|Post Treatment Follow-up Phase||1||
59813798|NCT00574145|75936310|FG001|NOT COMPLETED|Overall Study||1||
59813799|NCT00423189|75936319|FG000|STARTED|Overall Study||2||
59813800|NCT00423189|75936320|FG001|STARTED|Overall Study||3||
59813801|NCT00423189|75936321|FG002|STARTED|Overall Study||2||
59813802|NCT00423189|75936319|FG000|COMPLETED|Overall Study||2||
59813803|NCT00423189|75936320|FG001|COMPLETED|Overall Study||2||
59813804|NCT00423189|75936321|FG002|COMPLETED|Overall Study||2||
59813805|NCT00423189|75936319|FG000|NOT COMPLETED|Overall Study||0||
59813806|NCT00423189|75936320|FG001|NOT COMPLETED|Overall Study||1||
59977158|NCT02614196|76094362|FG004|NOT COMPLETED|Post Treatment Follow-up Phase||2||
59977159|NCT02614196|76094363|FG005|NOT COMPLETED|Post Treatment Follow-up Phase||0||
59977160|NCT02765035|76094393|FG000|STARTED|First Intervention (90 Days)||5||
59977161|NCT02765035|76094394|FG001|STARTED|First Intervention (90 Days)||8||
59977162|NCT02765035|76094393|FG000|COMPLETED|First Intervention (90 Days)||4||
59977163|NCT02765035|76094394|FG001|COMPLETED|First Intervention (90 Days)||7||
59977164|NCT02765035|76094393|FG000|NOT COMPLETED|First Intervention (90 Days)||1||
59977165|NCT02765035|76094394|FG001|NOT COMPLETED|First Intervention (90 Days)||1||
59977166|NCT02765035|76094393|FG000|STARTED|Second Intervention (30 Days)||4||
59813807|NCT00423189|75936321|FG002|NOT COMPLETED|Overall Study||0||
59813808|NCT00422799|75936334|FG000|STARTED|Overall Study||63||
59813809|NCT00422799|75936334|FG000|COMPLETED|Overall Study||50||
59813810|NCT00422799|75936334|FG000|NOT COMPLETED|Overall Study||13||
59813811|NCT00435045|75936340|FG000|STARTED|Weeks 1-8 / 10 mg Dose Level||123||
59813812|NCT00435045|75936341|FG001|STARTED|Weeks 1-8 / 10 mg Dose Level||122||
59813813|NCT00435045|75936340|FG000|COMPLETED|Weeks 1-8 / 10 mg Dose Level||118||
59977167|NCT02765035|76094394|FG001|STARTED|Second Intervention (30 Days)||7||
59977168|NCT02765035|76094393|FG000|COMPLETED|Second Intervention (30 Days)||2||
59977169|NCT02765035|76094394|FG001|COMPLETED|Second Intervention (30 Days)||5||
59977170|NCT02765035|76094393|FG000|NOT COMPLETED|Second Intervention (30 Days)||2||
59977171|NCT02765035|76094394|FG001|NOT COMPLETED|Second Intervention (30 Days)||2||
59977172|NCT02307682|76094404|FG000|STARTED|Overall Study||360|All randomized subjects|
59977173|NCT02307682|76094405|FG001|STARTED|Overall Study||361|All randomized subjects|
59977174|NCT02307682|76094406|FG002|STARTED|Overall Study||361|All randomized subjects|
59977175|NCT02307682|76094404|FG000|Randomized and Treated|Overall Study||358||
59977176|NCT02307682|76094405|FG001|Randomized and Treated|Overall Study||360||
59977177|NCT02307682|76094406|FG002|Randomized and Treated|Overall Study||360||
59977178|NCT02307682|76094404|FG000|COMPLETED|Overall Study||310||
59977179|NCT02307682|76094405|FG001|COMPLETED|Overall Study||304||
59977180|NCT02307682|76094406|FG002|COMPLETED|Overall Study||297||
59977181|NCT02307682|76094404|FG000|NOT COMPLETED|Overall Study||50||
59977182|NCT02307682|76094405|FG001|NOT COMPLETED|Overall Study||57||
59977183|NCT02307682|76094406|FG002|NOT COMPLETED|Overall Study||64||
59977184|NCT02615990|76094416|FG000|STARTED|Overall Study||1||
59977185|NCT02615990|76094417|FG001|STARTED|Overall Study||1||
59977186|NCT02615990|76094416|FG000|COMPLETED|Overall Study||0||
59977187|NCT02615990|76094417|FG001|COMPLETED|Overall Study||0||
59977188|NCT02615990|76094416|FG000|NOT COMPLETED|Overall Study||1||
59977189|NCT02615990|76094417|FG001|NOT COMPLETED|Overall Study||1||
59977190|NCT02613884|76094423|FG000|STARTED|Overall Study||26||
59977191|NCT02613884|76094423|FG000|Safety Endpoint 1|Overall Study||26|Serum Calcium Level 1-week after dose|
59977192|NCT02613884|76094423|FG000|Feasibility Questionnaire|Overall Study||26|Phone survey|
59977193|NCT02613884|76094423|FG000|Safety Endpoint 2|Overall Study||26|Serum Calcium Level at 3-month after dose|
59813814|NCT00435045|75936341|FG001|COMPLETED|Weeks 1-8 / 10 mg Dose Level||118||
59813815|NCT00435045|75936340|FG000|NOT COMPLETED|Weeks 1-8 / 10 mg Dose Level||5||
59813816|NCT00435045|75936341|FG001|NOT COMPLETED|Weeks 1-8 / 10 mg Dose Level||4||
59813817|NCT00435045|75936340|FG000|STARTED|Weeks 9-12 / 20mg Dose Level||118||
59813818|NCT00435045|75936341|FG001|STARTED|Weeks 9-12 / 20mg Dose Level||118||
59813819|NCT00435045|75936340|FG000|COMPLETED|Weeks 9-12 / 20mg Dose Level||113||
59813820|NCT00435045|75936341|FG001|COMPLETED|Weeks 9-12 / 20mg Dose Level||113||
59977194|NCT02613884|76094423|FG000|Efficacy Endpoint 1|Overall Study||25|25OHD level at 3 Months|
59994973|NCT02730793|76110797|FG000|NOT COMPLETED|Overall Study||0||
59977195|NCT02613884|76094423|FG000|Efficacy Timepoint 2|Overall Study||25|25OHD3 level at 6 months|
59977196|NCT02613884|76094423|FG000|Efficacy Timepoint 3|Overall Study||24|25OHD3 level at 12 months|
59813821|NCT00435045|75936340|FG000|NOT COMPLETED|Weeks 9-12 / 20mg Dose Level||5||
59813822|NCT00435045|75936341|FG001|NOT COMPLETED|Weeks 9-12 / 20mg Dose Level||5||
59813823|NCT00435045|75936340|FG000|STARTED|Weeks 13-16 / 40mg Dose Level||113||
59813824|NCT00435045|75936341|FG001|STARTED|Weeks 13-16 / 40mg Dose Level||113||
59813825|NCT00435045|75936340|FG000|COMPLETED|Weeks 13-16 / 40mg Dose Level||108||
59813826|NCT00435045|75936341|FG001|COMPLETED|Weeks 13-16 / 40mg Dose Level||111||
59813827|NCT00435045|75936340|FG000|NOT COMPLETED|Weeks 13-16 / 40mg Dose Level||5||
59813828|NCT00435045|75936341|FG001|NOT COMPLETED|Weeks 13-16 / 40mg Dose Level||2||
59813829|NCT00441129|75936349|FG000|STARTED|Overall Study||60||
59813830|NCT00441129|75936350|FG001|STARTED|Overall Study||55||
59813831|NCT00441129|75936349|FG000|COMPLETED|Overall Study||54||
59813832|NCT00441129|75936350|FG001|COMPLETED|Overall Study||41||
59813833|NCT00441129|75936349|FG000|NOT COMPLETED|Overall Study||6||
59813834|NCT00441129|75936350|FG001|NOT COMPLETED|Overall Study||14||
59813835|NCT00622505|75936358|FG000|STARTED|Overall Study||79||
59813836|NCT00622505|75936359|FG001|STARTED|Overall Study||42||
59813837|NCT00622505|75936358|FG000|COMPLETED|Overall Study||50||
59813838|NCT00622505|75936359|FG001|COMPLETED|Overall Study||19||
59813839|NCT00622505|75936358|FG000|NOT COMPLETED|Overall Study||29||
59813840|NCT00622505|75936359|FG001|NOT COMPLETED|Overall Study||23||
59813841|NCT00357370|75936368|FG000|STARTED|Cohort 1||4||
59813842|NCT00357370|75936369|FG001|STARTED|Cohort 1||0||
59813843|NCT00357370|75936370|FG002|STARTED|Cohort 1||0||
59977197|NCT02613884|76094423|FG000|COMPLETED|Overall Study||24||
59977198|NCT02613884|76094423|FG000|NOT COMPLETED|Overall Study||2||
59977199|NCT02791763|76094431|FG000|STARTED|Overall Study||149||
59977200|NCT02791763|76094432|FG001|STARTED|Overall Study||150||
59977201|NCT02791763|76094433|FG002|STARTED|Overall Study||56||
59977202|NCT02791763|76094431|FG000|COMPLETED|Overall Study||111||
59977203|NCT02791763|76094432|FG001|COMPLETED|Overall Study||113||
59977204|NCT02791763|76094433|FG002|COMPLETED|Overall Study||43||
59977205|NCT02791763|76094431|FG000|NOT COMPLETED|Overall Study||38||
59977206|NCT02791763|76094432|FG001|NOT COMPLETED|Overall Study||37||
59977207|NCT02791763|76094433|FG002|NOT COMPLETED|Overall Study||13||
59977208|NCT02613572|76094453|FG000|STARTED|Phase I: Tolerability, 600, 800, 1200 mg||15||
59977209|NCT02613572|76094454|FG001|STARTED|Phase I: Tolerability, 600, 800, 1200 mg||0||
59977210|NCT02613572|76094455|FG002|STARTED|Phase I: Tolerability, 600, 800, 1200 mg||0||
59977211|NCT02613572|76094453|FG000|600 mg|Phase I: Tolerability, 600, 800, 1200 mg||15||
59977212|NCT02613572|76094454|FG001|600 mg|Phase I: Tolerability, 600, 800, 1200 mg||0||
59977213|NCT02613572|76094455|FG002|600 mg|Phase I: Tolerability, 600, 800, 1200 mg||0||
59977214|NCT02613572|76094453|FG000|800 mg|Phase I: Tolerability, 600, 800, 1200 mg||15||
59977215|NCT02613572|76094454|FG001|800 mg|Phase I: Tolerability, 600, 800, 1200 mg||0||
59977216|NCT02613572|76094455|FG002|800 mg|Phase I: Tolerability, 600, 800, 1200 mg||0||
59977217|NCT02613572|76094453|FG000|1200 mg|Phase I: Tolerability, 600, 800, 1200 mg||14||
59977218|NCT02613572|76094454|FG001|1200 mg|Phase I: Tolerability, 600, 800, 1200 mg||0||
59977219|NCT02613572|76094455|FG002|1200 mg|Phase I: Tolerability, 600, 800, 1200 mg||0||
59813844|NCT00357370|75936368|FG000|COMPLETED|Cohort 1||4||
59813845|NCT00357370|75936369|FG001|COMPLETED|Cohort 1||0||
59813846|NCT00357370|75936370|FG002|COMPLETED|Cohort 1||0||
59813847|NCT00357370|75936368|FG000|NOT COMPLETED|Cohort 1||0||
59813848|NCT00357370|75936369|FG001|NOT COMPLETED|Cohort 1||0||
59813849|NCT00357370|75936370|FG002|NOT COMPLETED|Cohort 1||0||
59813850|NCT00357370|75936368|FG000|STARTED|Cohort 2||24||
59813851|NCT00357370|75936369|FG001|STARTED|Cohort 2||23||
59813852|NCT00357370|75936370|FG002|STARTED|Cohort 2||24||
59813853|NCT00357370|75936368|FG000|COMPLETED|Cohort 2||22||
59813854|NCT00357370|75936369|FG001|COMPLETED|Cohort 2||16||
59813855|NCT00357370|75936370|FG002|COMPLETED|Cohort 2||22||
59813856|NCT00357370|75936368|FG000|NOT COMPLETED|Cohort 2||2||
59813857|NCT00357370|75936369|FG001|NOT COMPLETED|Cohort 2||7||
59813858|NCT00357370|75936370|FG002|NOT COMPLETED|Cohort 2||2||
59813859|NCT00574847|75936380|FG000|STARTED|Overall Study||64||
59813860|NCT00574847|75936381|FG001|STARTED|Overall Study||63||
59977220|NCT02613572|76094453|FG000|COMPLETED|Phase I: Tolerability, 600, 800, 1200 mg||14||
59977221|NCT02613572|76094454|FG001|COMPLETED|Phase I: Tolerability, 600, 800, 1200 mg||0||
59977222|NCT02613572|76094455|FG002|COMPLETED|Phase I: Tolerability, 600, 800, 1200 mg||0||
59994974|NCT02730793|76110798|FG001|NOT COMPLETED|Overall Study||2||
59994975|NCT02855125|76110806|FG000|STARTED|Overall Study||64||
59994976|NCT02855125|76110807|FG001|STARTED|Overall Study||64||
59994977|NCT02855125|76110806|FG000|Treated|Overall Study||64||
59994978|NCT02855125|76110807|FG001|Treated|Overall Study||63||
59994979|NCT02855125|76110806|FG000|COMPLETED|Overall Study||0||
59994980|NCT02855125|76110807|FG001|COMPLETED|Overall Study||0||
59994981|NCT02855125|76110806|FG000|NOT COMPLETED|Overall Study||64||
59994982|NCT02855125|76110807|FG001|NOT COMPLETED|Overall Study||64||
59994983|NCT03367429|76110816|FG000|STARTED|Overall Study||0||
59994984|NCT03367429|76110817|FG001|STARTED|Overall Study||1||
59994985|NCT03367429|76110818|FG002|STARTED|Overall Study||2||
59977223|NCT02613572|76094453|FG000|NOT COMPLETED|Phase I: Tolerability, 600, 800, 1200 mg||1||
59977224|NCT02613572|76094454|FG001|NOT COMPLETED|Phase I: Tolerability, 600, 800, 1200 mg||0||
59977225|NCT02613572|76094455|FG002|NOT COMPLETED|Phase I: Tolerability, 600, 800, 1200 mg||0||
59977226|NCT02613572|76094453|FG000|STARTED|Phase II: Double-Blind Rand Plac Control||0||
59977227|NCT02613572|76094454|FG001|STARTED|Phase II: Double-Blind Rand Plac Control||27||
59977228|NCT02613572|76094455|FG002|STARTED|Phase II: Double-Blind Rand Plac Control||26||
59977229|NCT02613572|76094453|FG000|COMPLETED|Phase II: Double-Blind Rand Plac Control||0||
59977230|NCT02613572|76094454|FG001|COMPLETED|Phase II: Double-Blind Rand Plac Control||26||
59813861|NCT00574847|75936380|FG000|COMPLETED|Overall Study||56||
59813862|NCT00574847|75936381|FG001|COMPLETED|Overall Study||56||
59813863|NCT00574847|75936380|FG000|NOT COMPLETED|Overall Study||8||
59813864|NCT00574847|75936381|FG001|NOT COMPLETED|Overall Study||7||
59813865|NCT00348790|75936387|FG000|STARTED|Began Treatment||25||
59813866|NCT00348790|75936387|FG000|COMPLETED|Began Treatment||25||
59977231|NCT02613572|76094455|FG002|COMPLETED|Phase II: Double-Blind Rand Plac Control||26||
59977232|NCT02613572|76094453|FG000|NOT COMPLETED|Phase II: Double-Blind Rand Plac Control||0||
59977233|NCT02613572|76094454|FG001|NOT COMPLETED|Phase II: Double-Blind Rand Plac Control||1||
59977234|NCT02613572|76094455|FG002|NOT COMPLETED|Phase II: Double-Blind Rand Plac Control||0||
59977235|NCT02087189|76094467|FG000|STARTED|Overall Study||30||
59977236|NCT02087189|76094467|FG000|COMPLETED|Overall Study||28||
59977237|NCT02087189|76094467|FG000|NOT COMPLETED|Overall Study||2||
59977238|NCT02341456|76094474|FG000|STARTED|Overall Study||7||
59977239|NCT02341456|76094475|FG001|STARTED|Overall Study||6||
59977240|NCT02341456|76094476|FG002|STARTED|Overall Study||6||
59977241|NCT02341456|76094474|FG000|COMPLETED|Overall Study||3||
59977242|NCT02341456|76094475|FG001|COMPLETED|Overall Study||0||
59977243|NCT02341456|76094476|FG002|COMPLETED|Overall Study||2||
59977244|NCT02341456|76094474|FG000|NOT COMPLETED|Overall Study||4||
59977245|NCT02341456|76094475|FG001|NOT COMPLETED|Overall Study||6||
59977246|NCT02341456|76094476|FG002|NOT COMPLETED|Overall Study||4||
59977247|NCT02370784|76094486|FG000|STARTED|Overall Study||10||
59977248|NCT02370784|76094487|FG001|STARTED|Overall Study||14||
59977249|NCT02370784|76094486|FG000|COMPLETED|Overall Study||10||
59977250|NCT02370784|76094487|FG001|COMPLETED|Overall Study||13||
59977251|NCT02370784|76094486|FG000|NOT COMPLETED|Overall Study||0||
59977252|NCT02370784|76094487|FG001|NOT COMPLETED|Overall Study||1||
59977253|NCT02307370|76094495|FG000|STARTED|Overall Study||44||
59977254|NCT02307370|76094495|FG000|30 Day Follow-up|Overall Study||40||
59977255|NCT02307370|76094495|FG000|180 Day Patient Telephone Contact|Overall Study||25||
59977256|NCT02307370|76094495|FG000|COMPLETED|Overall Study||25||
59977257|NCT02307370|76094495|FG000|NOT COMPLETED|Overall Study||19||
59977258|NCT02370394|76094503|FG000|STARTED|Overall Study||28||
59977259|NCT02370394|76094504|FG001|STARTED|Overall Study||25||
59977260|NCT02370394|76094503|FG000|COMPLETED|Overall Study||26||
59977261|NCT02370394|76094504|FG001|COMPLETED|Overall Study||23||
59977262|NCT02370394|76094503|FG000|NOT COMPLETED|Overall Study||2||
59977263|NCT02370394|76094504|FG001|NOT COMPLETED|Overall Study||2||
59977264|NCT01595438|76094513|FG000|STARTED|Overall Study||516||
59977265|NCT01595438|76094514|FG001|STARTED|Overall Study||517||
59977266|NCT01595438|76094513|FG000|COMPLETED|Overall Study||473||
59977267|NCT01595438|76094514|FG001|COMPLETED|Overall Study||476||
59977268|NCT01595438|76094513|FG000|NOT COMPLETED|Overall Study||43||
59977269|NCT01595438|76094514|FG001|NOT COMPLETED|Overall Study||41||
59977270|NCT02340520|76094520|FG000|STARTED|Overall Study||11||
60074651|NCT01555125|76189970|FG000|COMPLETED|Extension||1||
60074652|NCT01555125|76189971|FG001|COMPLETED|Extension||0||
60074653|NCT01555125|76189972|FG002|COMPLETED|Extension||0||
59813867|NCT00348790|75936387|FG000|NOT COMPLETED|Began Treatment||0||
59813868|NCT00348790|75936387|FG000|STARTED|Completed Treatment||25||
59977271|NCT02340520|76094520|FG000|COMPLETED|Overall Study||8||
59977272|NCT02340520|76094520|FG000|NOT COMPLETED|Overall Study||3||
59977273|NCT02339584|76094526|FG000|STARTED|Overall Study||188||
59977274|NCT02339584|76094527|FG001|STARTED|Overall Study||191||
59977275|NCT02339584|76094526|FG000|COMPLETED|Overall Study||173||
59977276|NCT02339584|76094527|FG001|COMPLETED|Overall Study||176||
59977277|NCT02339584|76094526|FG000|NOT COMPLETED|Overall Study||15||
59977278|NCT02339584|76094527|FG001|NOT COMPLETED|Overall Study||15||
59813869|NCT00348790|75936387|FG000|COMPLETED|Completed Treatment||0||
59813870|NCT00348790|75936387|FG000|NOT COMPLETED|Completed Treatment||25||
59813871|NCT00360490|75936394|FG000|STARTED|Overall Study||82||
59813872|NCT00360490|75936395|FG001|STARTED|Overall Study||83||
59813873|NCT00360490|75936394|FG000|COMPLETED|Overall Study||73||
59813874|NCT00360490|75936395|FG001|COMPLETED|Overall Study||72||
59813875|NCT00360490|75936394|FG000|NOT COMPLETED|Overall Study||9||
59977279|NCT02339506|76094533|FG000|STARTED|Period 1 (Placebo or Cosyntropin)||12||
59977280|NCT02339506|76094534|FG001|STARTED|Period 1 (Placebo or Cosyntropin)||11||
59977281|NCT02339506|76094533|FG000|COMPLETED|Period 1 (Placebo or Cosyntropin)||12||
59977282|NCT02339506|76094534|FG001|COMPLETED|Period 1 (Placebo or Cosyntropin)||10||
59977283|NCT02339506|76094533|FG000|NOT COMPLETED|Period 1 (Placebo or Cosyntropin)||0||
59977284|NCT02339506|76094534|FG001|NOT COMPLETED|Period 1 (Placebo or Cosyntropin)||1||
60074654|NCT01555125|76189973|FG003|COMPLETED|Extension||1||
59977285|NCT02339506|76094533|FG000|STARTED|Washout (Period 2)||12||
59977286|NCT02339506|76094534|FG001|STARTED|Washout (Period 2)||10||
59977287|NCT02339506|76094533|FG000|COMPLETED|Washout (Period 2)||10||
59977288|NCT02339506|76094534|FG001|COMPLETED|Washout (Period 2)||10||
59977289|NCT02339506|76094533|FG000|NOT COMPLETED|Washout (Period 2)||2||
59977290|NCT02339506|76094534|FG001|NOT COMPLETED|Washout (Period 2)||0||
59977291|NCT02339506|76094533|FG000|STARTED|Period 3 (Placebo or Cosyntropin)||10||
59977292|NCT02339506|76094534|FG001|STARTED|Period 3 (Placebo or Cosyntropin)||10||
59977293|NCT02339506|76094533|FG000|COMPLETED|Period 3 (Placebo or Cosyntropin)||10||
59977294|NCT02339506|76094534|FG001|COMPLETED|Period 3 (Placebo or Cosyntropin)||10||
59977295|NCT02339506|76094533|FG000|NOT COMPLETED|Period 3 (Placebo or Cosyntropin)||0||
59977296|NCT02339506|76094534|FG001|NOT COMPLETED|Period 3 (Placebo or Cosyntropin)||0||
59977297|NCT02305888|76094543|FG000|STARTED|Overall Study||63||
59977298|NCT02305888|76094544|FG001|STARTED|Overall Study||63||
59977299|NCT02305888|76094545|FG002|STARTED|Overall Study||63||
59977300|NCT02305888|76094543|FG000|COMPLETED|Overall Study||63||
59977301|NCT02305888|76094544|FG001|COMPLETED|Overall Study||62||
59977302|NCT02305888|76094545|FG002|COMPLETED|Overall Study||62||
59977303|NCT02305888|76094543|FG000|NOT COMPLETED|Overall Study||0||
59977304|NCT02305888|76094544|FG001|NOT COMPLETED|Overall Study||1||
59977305|NCT02305888|76094545|FG002|NOT COMPLETED|Overall Study||1||
59977306|NCT02338882|76094555|FG000|STARTED|Overall Study||50||
59977307|NCT02338882|76094556|FG001|STARTED|Overall Study||50||
59526158|NCT01296763|75621687|FG000|NOT COMPLETED|Overall Study||0||
59526159|NCT01296763|75621688|FG001|NOT COMPLETED|Overall Study||0||
59526160|NCT01296763|75621689|FG002|NOT COMPLETED|Overall Study||0||
59526161|NCT01347541|75621699|FG000|STARTED|Overall Study||3||
59813876|NCT00360490|75936395|FG001|NOT COMPLETED|Overall Study||11||
59813877|NCT00624377|75936401|FG000|STARTED|Overall Study||2031||
59813878|NCT00624377|75936401|FG000|COMPLETED|Overall Study||1387||
59813879|NCT00624377|75936401|FG000|NOT COMPLETED|Overall Study||644||
59813880|NCT00624065|75936407|FG000|STARTED|Overall Study||216||
59813881|NCT00624065|75936408|FG001|STARTED|Overall Study||216||
59813882|NCT00624065|75936407|FG000|COMPLETED|Overall Study||197||
59813883|NCT00624065|75936408|FG001|COMPLETED|Overall Study||192||
59813884|NCT00624065|75936407|FG000|NOT COMPLETED|Overall Study||19||
59813885|NCT00624065|75936408|FG001|NOT COMPLETED|Overall Study||24||
59813886|NCT00360412|75936416|FG000|STARTED|Overall Study||333||
59813887|NCT00360412|75936417|FG001|STARTED|Overall Study||664||
59813888|NCT00360412|75936416|FG000|COMPLETED|Overall Study||0||
59813889|NCT00360412|75936417|FG001|COMPLETED|Overall Study||2||
59813890|NCT00360412|75936416|FG000|NOT COMPLETED|Overall Study||333||
59977308|NCT02338882|76094555|FG000|COMPLETED|Overall Study||43||
59977309|NCT02338882|76094556|FG001|COMPLETED|Overall Study||47||
59977310|NCT02338882|76094555|FG000|NOT COMPLETED|Overall Study||7||
59977311|NCT02338882|76094556|FG001|NOT COMPLETED|Overall Study||3||
59977312|NCT01594970|76094568|FG000|STARTED|Overall Study||295||
59977313|NCT01594970|76094569|FG001|STARTED|Overall Study||248||
59977314|NCT01594970|76094570|FG002|STARTED|Overall Study||257||
59977315|NCT01594970|76094568|FG000|COMPLETED|Overall Study||220||
59977316|NCT01594970|76094569|FG001|COMPLETED|Overall Study||166||
59977317|NCT01594970|76094570|FG002|COMPLETED|Overall Study||191||
59977318|NCT01594970|76094568|FG000|NOT COMPLETED|Overall Study||75||
59977319|NCT01594970|76094569|FG001|NOT COMPLETED|Overall Study||82||
59977320|NCT01594970|76094570|FG002|NOT COMPLETED|Overall Study||66||
59977321|NCT02338492|76094578|FG000|STARTED|Overall Study||81||
59977322|NCT02338492|76094578|FG000|Enrolled|Overall Study||81||
59977323|NCT02338492|76094578|FG000|Device Implanted|Overall Study||79||
59977324|NCT02338492|76094578|FG000|Treatment Failure|Overall Study||2||
59526162|NCT01347541|75621700|FG001|STARTED|Overall Study||1||
59526163|NCT01347541|75621699|FG000|COMPLETED|Overall Study||3||
59526164|NCT01347541|75621700|FG001|COMPLETED|Overall Study||1||
59813891|NCT00360412|75936417|FG001|NOT COMPLETED|Overall Study||662||
59813892|NCT00623831|75936425|FG000|STARTED|Overall Study||13||
59813893|NCT00623831|75936426|FG001|STARTED|Overall Study||4||
59813894|NCT00623831|75936425|FG000|COMPLETED|Overall Study||12||
59813895|NCT00623831|75936426|FG001|COMPLETED|Overall Study||3||
59813896|NCT00623831|75936425|FG000|NOT COMPLETED|Overall Study||1||
59813897|NCT00623831|75936426|FG001|NOT COMPLETED|Overall Study||1||
59813898|NCT00360334|75936437|FG000|STARTED|Overall Study||118||
59813899|NCT00360334|75936438|FG001|STARTED|Overall Study||117||
59813900|NCT00360334|75936437|FG000|Full Analysis Set (FAS)|Overall Study|FAS = received ≥ 1 dose of study drug|118||
59813901|NCT00360334|75936438|FG001|Full Analysis Set (FAS)|Overall Study|FAS = received ≥ 1 dose of study drug|116||
59813902|NCT00360334|75936437|FG000|COMPLETED|Overall Study||99||
59813903|NCT00360334|75936438|FG001|COMPLETED|Overall Study||104||
59813904|NCT00360334|75936437|FG000|NOT COMPLETED|Overall Study||19||
59813905|NCT00360334|75936438|FG001|NOT COMPLETED|Overall Study||13||
59977325|NCT02338492|76094578|FG000|COMPLETED|Overall Study||36||
59977326|NCT02338492|76094578|FG000|NOT COMPLETED|Overall Study||45||
59526165|NCT01347541|75621699|FG000|NOT COMPLETED|Overall Study||0||
59813906|NCT00422097|75936450|FG000|STARTED|Dose Level 1||3||
59977327|NCT02337946|76094582|FG000|STARTED|Protocol Treatment 1 Period||164||
59977328|NCT02337946|76094583|FG001|STARTED|Protocol Treatment 1 Period||0||
59977329|NCT02337946|76094584|FG002|STARTED|Protocol Treatment 1 Period||0||
59977330|NCT02337946|76094582|FG000|COMPLETED|Protocol Treatment 1 Period||114||
59977331|NCT02337946|76094583|FG001|COMPLETED|Protocol Treatment 1 Period||0||
59977332|NCT02337946|76094584|FG002|COMPLETED|Protocol Treatment 1 Period||0||
59977333|NCT02337946|76094582|FG000|NOT COMPLETED|Protocol Treatment 1 Period||50||
59977334|NCT02337946|76094583|FG001|NOT COMPLETED|Protocol Treatment 1 Period||0||
59977335|NCT02337946|76094584|FG002|NOT COMPLETED|Protocol Treatment 1 Period||0||
59977336|NCT02337946|76094582|FG000|STARTED|In-between Period||114||
59977337|NCT02337946|76094583|FG001|STARTED|In-between Period||0||
59977338|NCT02337946|76094584|FG002|STARTED|In-between Period||0||
59813907|NCT00422097|75936451|FG001|STARTED|Dose Level 1||0||
59813908|NCT00422097|75936452|FG002|STARTED|Dose Level 1||0||
59813909|NCT00422097|75936453|FG003|STARTED|Dose Level 1||0||
59813910|NCT00422097|75936454|FG004|STARTED|Dose Level 1||0||
59813911|NCT00422097|75936455|FG005|STARTED|Dose Level 1||0||
59813912|NCT00422097|75936456|FG006|STARTED|Dose Level 1||0||
59977339|NCT02337946|76094582|FG000|COMPLETED|In-between Period||113||
59977340|NCT02337946|76094583|FG001|COMPLETED|In-between Period||0||
59977341|NCT02337946|76094584|FG002|COMPLETED|In-between Period||0||
59977342|NCT02337946|76094582|FG000|NOT COMPLETED|In-between Period||1||
59977343|NCT02337946|76094583|FG001|NOT COMPLETED|In-between Period||0||
59977344|NCT02337946|76094584|FG002|NOT COMPLETED|In-between Period||0||
59813913|NCT00422097|75936457|FG007|STARTED|Dose Level 1||0||
59813914|NCT00422097|75936450|FG000|COMPLETED|Dose Level 1||3||
59977345|NCT02337946|76094582|FG000|STARTED|Protocol Treatment 2 Period||0||
59977346|NCT02337946|76094583|FG001|STARTED|Protocol Treatment 2 Period||56||
59977347|NCT02337946|76094584|FG002|STARTED|Protocol Treatment 2 Period||57||
59977348|NCT02337946|76094582|FG000|Safety Population|Protocol Treatment 2 Period||0||
59977349|NCT02337946|76094583|FG001|Safety Population|Protocol Treatment 2 Period||56||
59977350|NCT02337946|76094584|FG002|Safety Population|Protocol Treatment 2 Period||54||
59977351|NCT02337946|76094582|FG000|COMPLETED|Protocol Treatment 2 Period||0||
59977352|NCT02337946|76094583|FG001|COMPLETED|Protocol Treatment 2 Period||5||
59977353|NCT02337946|76094584|FG002|COMPLETED|Protocol Treatment 2 Period||7||
59977354|NCT02337946|76094582|FG000|NOT COMPLETED|Protocol Treatment 2 Period||0||
59977355|NCT02337946|76094583|FG001|NOT COMPLETED|Protocol Treatment 2 Period||51||
59977356|NCT02337946|76094584|FG002|NOT COMPLETED|Protocol Treatment 2 Period||50||
59977357|NCT01369199|76094590|FG000|STARTED|Overall Study||28||
59977358|NCT01369199|76094590|FG000|End of Treatment (EOT)|Overall Study|1 withdrew consent before treatment,1 missed end of treatment (EOT) visit but completed follow-up.|26||
59977359|NCT01369199|76094590|FG000|COMPLETED|Overall Study||25|End of follow-up|
60074655|NCT01555125|76189974|FG004|COMPLETED|Extension||0||
59526166|NCT01347541|75621700|FG001|NOT COMPLETED|Overall Study||0||
59526167|NCT01296841|75621708|FG000|STARTED|Overall Study||19||
59813915|NCT00422097|75936451|FG001|COMPLETED|Dose Level 1||0||
59977360|NCT01369199|76094590|FG000|NOT COMPLETED|Overall Study||3||
59977361|NCT01368965|76094594|FG000|STARTED|Overall Study|Two subjects withdrew consent prior to study treatment. Data analyses are based on 52 subjects.|52||
59977362|NCT01368965|76094594|FG000|Subject Withdrawal Prior to Treatment|Overall Study||2||
59977363|NCT01368965|76094594|FG000|COMPLETED|Overall Study||40||
59977364|NCT01368965|76094594|FG000|NOT COMPLETED|Overall Study||12||
59977365|NCT02610140|76094602|FG000|STARTED|Randomization and Treatment Period||166|Randomized|
59977366|NCT02610140|76094603|FG001|STARTED|Randomization and Treatment Period||82|Randomized|
59977367|NCT02610140|76094602|FG000|Participants Received Treatment|Randomization and Treatment Period|Safety analysis set|163||
59977368|NCT02610140|76094603|FG001|Participants Received Treatment|Randomization and Treatment Period|Safety analysis set|72||
59977369|NCT02610140|76094602|FG000|COMPLETED|Randomization and Treatment Period||0||
59977370|NCT02610140|76094603|FG001|COMPLETED|Randomization and Treatment Period||0||
59977371|NCT02610140|76094602|FG000|NOT COMPLETED|Randomization and Treatment Period||166||
59977372|NCT02610140|76094603|FG001|NOT COMPLETED|Randomization and Treatment Period||82||
59977373|NCT02610140|76094602|FG000|STARTED|Safety Follow-up||102|Safety follow-up performed|
59977374|NCT02610140|76094603|FG001|STARTED|Safety Follow-up||45|Safety follow-up performed|
59977375|NCT02610140|76094602|FG000|COMPLETED|Safety Follow-up||57||
59977376|NCT02610140|76094603|FG001|COMPLETED|Safety Follow-up||21||
59977377|NCT02610140|76094602|FG000|NOT COMPLETED|Safety Follow-up||45||
59977378|NCT02610140|76094603|FG001|NOT COMPLETED|Safety Follow-up||24||
59977379|NCT02610140|76094602|FG000|STARTED|Active Follow-up||48||
59813916|NCT00422097|75936452|FG002|COMPLETED|Dose Level 1||0||
59813917|NCT00422097|75936453|FG003|COMPLETED|Dose Level 1||0||
59813918|NCT00422097|75936454|FG004|COMPLETED|Dose Level 1||0||
59813919|NCT00422097|75936455|FG005|COMPLETED|Dose Level 1||0||
59813920|NCT00422097|75936456|FG006|COMPLETED|Dose Level 1||0||
59977380|NCT02610140|76094603|FG001|STARTED|Active Follow-up||26||
59977381|NCT02610140|76094602|FG000|COMPLETED|Active Follow-up||0||
60074656|NCT01555125|76189970|FG000|NOT COMPLETED|Extension||45||
59526168|NCT01296841|75621709|FG001|STARTED|Overall Study||15||
59526169|NCT01296841|75621708|FG000|COMPLETED|Overall Study||19||
59813921|NCT00422097|75936457|FG007|COMPLETED|Dose Level 1||0||
59813922|NCT00422097|75936450|FG000|NOT COMPLETED|Dose Level 1||0||
59813923|NCT00422097|75936451|FG001|NOT COMPLETED|Dose Level 1||0||
59813924|NCT00422097|75936452|FG002|NOT COMPLETED|Dose Level 1||0||
59977382|NCT02610140|76094603|FG001|COMPLETED|Active Follow-up||0||
59977383|NCT02610140|76094602|FG000|NOT COMPLETED|Active Follow-up||48||
59977384|NCT02610140|76094603|FG001|NOT COMPLETED|Active Follow-up||26||
59977385|NCT02610140|76094602|FG000|STARTED|Long-term Follow-up||123||
59977386|NCT02610140|76094603|FG001|STARTED|Long-term Follow-up||66||
59813925|NCT00422097|75936453|FG003|NOT COMPLETED|Dose Level 1||0||
59813926|NCT00422097|75936454|FG004|NOT COMPLETED|Dose Level 1||0||
59813927|NCT00422097|75936455|FG005|NOT COMPLETED|Dose Level 1||0||
59813928|NCT00422097|75936456|FG006|NOT COMPLETED|Dose Level 1||0||
59813929|NCT00422097|75936457|FG007|NOT COMPLETED|Dose Level 1||0||
59977387|NCT02610140|76094602|FG000|COMPLETED|Long-term Follow-up||0||
59977388|NCT02610140|76094603|FG001|COMPLETED|Long-term Follow-up||0||
59977389|NCT02610140|76094602|FG000|NOT COMPLETED|Long-term Follow-up||123||
59813930|NCT00422097|75936450|FG000|STARTED|Dose Level 2||0||
59813931|NCT00422097|75936451|FG001|STARTED|Dose Level 2||6||
59813932|NCT00422097|75936452|FG002|STARTED|Dose Level 2||0||
59813933|NCT00422097|75936453|FG003|STARTED|Dose Level 2||0||
59813934|NCT00422097|75936454|FG004|STARTED|Dose Level 2||0||
59813935|NCT00422097|75936455|FG005|STARTED|Dose Level 2||0||
59813936|NCT00422097|75936456|FG006|STARTED|Dose Level 2||0||
59813937|NCT00422097|75936457|FG007|STARTED|Dose Level 2||0||
59813938|NCT00422097|75936450|FG000|COMPLETED|Dose Level 2||0||
59813939|NCT00422097|75936451|FG001|COMPLETED|Dose Level 2||5||
59813940|NCT00422097|75936452|FG002|COMPLETED|Dose Level 2||0||
59813941|NCT00422097|75936453|FG003|COMPLETED|Dose Level 2||0||
59813942|NCT00422097|75936454|FG004|COMPLETED|Dose Level 2||0||
59813943|NCT00422097|75936455|FG005|COMPLETED|Dose Level 2||0||
59813944|NCT00422097|75936456|FG006|COMPLETED|Dose Level 2||0||
59813945|NCT00422097|75936457|FG007|COMPLETED|Dose Level 2||0||
59813946|NCT00422097|75936450|FG000|NOT COMPLETED|Dose Level 2||0||
59813947|NCT00422097|75936451|FG001|NOT COMPLETED|Dose Level 2||1||
59813948|NCT00422097|75936452|FG002|NOT COMPLETED|Dose Level 2||0||
59813949|NCT00422097|75936453|FG003|NOT COMPLETED|Dose Level 2||0||
59813950|NCT00422097|75936454|FG004|NOT COMPLETED|Dose Level 2||0||
59813951|NCT00422097|75936455|FG005|NOT COMPLETED|Dose Level 2||0||
59813952|NCT00422097|75936456|FG006|NOT COMPLETED|Dose Level 2||0||
59813953|NCT00422097|75936457|FG007|NOT COMPLETED|Dose Level 2||0||
59977390|NCT02610140|76094603|FG001|NOT COMPLETED|Long-term Follow-up||66||
59977391|NCT02789657|76094613|FG000|STARTED|Overall Study||27||
59977392|NCT02789657|76094614|FG001|STARTED|Overall Study||3||
59977393|NCT02789657|76094615|FG002|STARTED|Overall Study||0||
59977394|NCT02789657|76094616|FG003|STARTED|Overall Study||2||
59977395|NCT02789657|76094613|FG000|COMPLETED|Overall Study||25||
59813954|NCT00422097|75936450|FG000|STARTED|Dose Level 3||0||
59813955|NCT00422097|75936451|FG001|STARTED|Dose Level 3||0||
59813956|NCT00422097|75936452|FG002|STARTED|Dose Level 3||3||
59813957|NCT00422097|75936453|FG003|STARTED|Dose Level 3||0||
59813958|NCT00422097|75936454|FG004|STARTED|Dose Level 3||0||
59813959|NCT00422097|75936455|FG005|STARTED|Dose Level 3||0||
59813960|NCT00422097|75936456|FG006|STARTED|Dose Level 3||0||
59813961|NCT00422097|75936457|FG007|STARTED|Dose Level 3||0||
59813962|NCT00422097|75936450|FG000|COMPLETED|Dose Level 3||0||
59813963|NCT00422097|75936451|FG001|COMPLETED|Dose Level 3||0||
59813964|NCT00422097|75936452|FG002|COMPLETED|Dose Level 3||3||
59813965|NCT00422097|75936453|FG003|COMPLETED|Dose Level 3||0||
59813966|NCT00422097|75936454|FG004|COMPLETED|Dose Level 3||0||
59813967|NCT00422097|75936455|FG005|COMPLETED|Dose Level 3||0||
59813968|NCT00422097|75936456|FG006|COMPLETED|Dose Level 3||0||
59813969|NCT00422097|75936457|FG007|COMPLETED|Dose Level 3||0||
59813970|NCT00422097|75936450|FG000|NOT COMPLETED|Dose Level 3||0||
59526170|NCT01296841|75621709|FG001|COMPLETED|Overall Study||15||
59526171|NCT01296841|75621708|FG000|NOT COMPLETED|Overall Study||0||
59813971|NCT00422097|75936451|FG001|NOT COMPLETED|Dose Level 3||0||
59813972|NCT00422097|75936452|FG002|NOT COMPLETED|Dose Level 3||0||
59813973|NCT00422097|75936453|FG003|NOT COMPLETED|Dose Level 3||0||
59813974|NCT00422097|75936454|FG004|NOT COMPLETED|Dose Level 3||0||
59813975|NCT00422097|75936455|FG005|NOT COMPLETED|Dose Level 3||0||
59813976|NCT00422097|75936456|FG006|NOT COMPLETED|Dose Level 3||0||
59813977|NCT00422097|75936457|FG007|NOT COMPLETED|Dose Level 3||0||
59813978|NCT00422097|75936450|FG000|STARTED|Dose Level 4||0||
59813979|NCT00422097|75936451|FG001|STARTED|Dose Level 4||0||
59813980|NCT00422097|75936452|FG002|STARTED|Dose Level 4||0||
59813981|NCT00422097|75936453|FG003|STARTED|Dose Level 4||3||
59977396|NCT02789657|76094614|FG001|COMPLETED|Overall Study||3||
59977397|NCT02789657|76094615|FG002|COMPLETED|Overall Study||0||
59977398|NCT02789657|76094616|FG003|COMPLETED|Overall Study||2||
59977399|NCT02789657|76094613|FG000|NOT COMPLETED|Overall Study||2||
59977400|NCT02789657|76094614|FG001|NOT COMPLETED|Overall Study||0||
59977401|NCT02789657|76094615|FG002|NOT COMPLETED|Overall Study||0||
59977402|NCT02789657|76094616|FG003|NOT COMPLETED|Overall Study||0||
59977403|NCT02609984|76094627|FG000|STARTED|Overall Study||45||
59977404|NCT02609984|76094628|FG001|STARTED|Overall Study||44||
59977405|NCT02609984|76094627|FG000|Treated|Overall Study||45||
59977406|NCT02609984|76094628|FG001|Treated|Overall Study||43||
59977407|NCT02609984|76094627|FG000|COMPLETED|Overall Study||1||
59977408|NCT02609984|76094628|FG001|COMPLETED|Overall Study||5||
59977409|NCT02609984|76094627|FG000|NOT COMPLETED|Overall Study||44||
59977410|NCT02609984|76094628|FG001|NOT COMPLETED|Overall Study||39||
59977411|NCT02609672|76094636|FG000|STARTED|Overall Study||12||
59977412|NCT02609672|76094637|FG001|STARTED|Overall Study||12||
59977413|NCT02609672|76094636|FG000|COMPLETED|Overall Study||9||
59977414|NCT02609672|76094637|FG001|COMPLETED|Overall Study||11||
59977415|NCT02609672|76094636|FG000|NOT COMPLETED|Overall Study||3||
59977416|NCT02609672|76094637|FG001|NOT COMPLETED|Overall Study||1||
59977417|NCT02611778|76094645|FG000|STARTED|Overall Study||238||
59977418|NCT02611778|76094646|FG001|STARTED|Overall Study||239||
59977419|NCT02611778|76094645|FG000|COMPLETED|Overall Study||226||
59977420|NCT02611778|76094646|FG001|COMPLETED|Overall Study||226||
59977421|NCT02611778|76094645|FG000|NOT COMPLETED|Overall Study||12||
59977422|NCT02611778|76094646|FG001|NOT COMPLETED|Overall Study||13||
59977423|NCT02709369|76094653|FG000|STARTED|Overall Study||300||
59977424|NCT02709369|76094653|FG000|COMPLETED|Overall Study||273||
59977425|NCT02709369|76094653|FG000|NOT COMPLETED|Overall Study||27||
59977426|NCT02613182|76094657|FG000|STARTED|Overall Study||34||
59977427|NCT02613182|76094657|FG000|Number of Patients Dosed|Overall Study||34||
59977428|NCT02613182|76094657|FG000|COMPLETED|Overall Study||0||
59977429|NCT02613182|76094657|FG000|NOT COMPLETED|Overall Study||34||
59977430|NCT05325853|76094663|FG000|STARTED|Overall Study||30||
59977431|NCT05325853|76094664|FG001|STARTED|Overall Study||30||
59977432|NCT05325853|76094663|FG000|COMPLETED|Overall Study||30||
59977433|NCT05325853|76094664|FG001|COMPLETED|Overall Study||30||
59977434|NCT05325853|76094663|FG000|NOT COMPLETED|Overall Study||0||
59977435|NCT05325853|76094664|FG001|NOT COMPLETED|Overall Study||0||
59977436|NCT05036642|76094672|FG000|STARTED|Pilot Phase||1||
59977437|NCT05036642|76094673|FG001|STARTED|Pilot Phase||0||
59977438|NCT05036642|76094672|FG000|COMPLETED|Pilot Phase||1||
59526172|NCT01296841|75621709|FG001|NOT COMPLETED|Overall Study||0||
59526173|NCT01349491|75621719|FG000|STARTED|Overall Study||5||
59813982|NCT00422097|75936454|FG004|STARTED|Dose Level 4||0||
59813983|NCT00422097|75936455|FG005|STARTED|Dose Level 4||0||
59813984|NCT00422097|75936456|FG006|STARTED|Dose Level 4||0||
59813985|NCT00422097|75936457|FG007|STARTED|Dose Level 4||0||
59813986|NCT00422097|75936450|FG000|COMPLETED|Dose Level 4||0||
59813987|NCT00422097|75936451|FG001|COMPLETED|Dose Level 4||0||
59813988|NCT00422097|75936452|FG002|COMPLETED|Dose Level 4||0||
59813989|NCT00422097|75936453|FG003|COMPLETED|Dose Level 4||3||
59977439|NCT05036642|76094673|FG001|COMPLETED|Pilot Phase||0||
59977440|NCT05036642|76094672|FG000|NOT COMPLETED|Pilot Phase||0||
59977441|NCT05036642|76094673|FG001|NOT COMPLETED|Pilot Phase||0||
59977442|NCT05036642|76094672|FG000|STARTED|Evaluation Phase||0||
59977443|NCT05036642|76094673|FG001|STARTED|Evaluation Phase||11||
59977444|NCT05036642|76094672|FG000|COMPLETED|Evaluation Phase||0||
59977445|NCT05036642|76094673|FG001|COMPLETED|Evaluation Phase||11||
59977446|NCT05036642|76094672|FG000|NOT COMPLETED|Evaluation Phase||0||
59977447|NCT05036642|76094673|FG001|NOT COMPLETED|Evaluation Phase||0||
59977448|NCT04843579|76094683|FG000|STARTED|Overall Study||4||
59977449|NCT04843579|76094683|FG000|COMPLETED|Overall Study||2||
59977450|NCT04843579|76094683|FG000|NOT COMPLETED|Overall Study||2||
59977451|NCT04649359|76094689|FG000|STARTED|Overall Study||123||
59977452|NCT04649359|76094690|FG001|STARTED|Overall Study||64||
59977453|NCT04649359|76094689|FG000|COMPLETED|Overall Study||0||
59977454|NCT04649359|76094690|FG001|COMPLETED|Overall Study||0||
59526174|NCT01349491|75621720|FG001|STARTED|Overall Study||5||
59526175|NCT01349491|75621719|FG000|COMPLETED|Overall Study||5||
59813990|NCT00422097|75936454|FG004|COMPLETED|Dose Level 4||0||
59813991|NCT00422097|75936455|FG005|COMPLETED|Dose Level 4||0||
59813992|NCT00422097|75936456|FG006|COMPLETED|Dose Level 4||0||
59813993|NCT00422097|75936457|FG007|COMPLETED|Dose Level 4||0||
59813994|NCT00422097|75936450|FG000|NOT COMPLETED|Dose Level 4||0||
59977455|NCT04649359|76094689|FG000|NOT COMPLETED|Overall Study||123||
59977456|NCT04649359|76094690|FG001|NOT COMPLETED|Overall Study||64||
59977457|NCT04632030|76094699|FG000|STARTED|Overall Study||96||
59977458|NCT04632030|76094700|FG001|STARTED|Overall Study||86||
59977459|NCT04632030|76094701|FG002|STARTED|Overall Study||93||
59977460|NCT04632030|76094699|FG000|COMPLETED|Overall Study||96||
59977461|NCT04632030|76094700|FG001|COMPLETED|Overall Study||86||
59977462|NCT04632030|76094701|FG002|COMPLETED|Overall Study||93||
59977463|NCT04632030|76094699|FG000|NOT COMPLETED|Overall Study||0||
59977464|NCT04632030|76094700|FG001|NOT COMPLETED|Overall Study||0||
59977465|NCT04632030|76094701|FG002|NOT COMPLETED|Overall Study||0||
59977466|NCT04567693|76094712|FG000|STARTED|Overall Study||32||
59977467|NCT04567693|76094713|FG001|STARTED|Overall Study||31||
59977468|NCT04567693|76094714|FG002|STARTED|Overall Study||30||
59977469|NCT04567693|76094712|FG000|COMPLETED|Overall Study||30||
59977470|NCT04567693|76094713|FG001|COMPLETED|Overall Study||31||
59977471|NCT04567693|76094714|FG002|COMPLETED|Overall Study||24||
59977472|NCT04567693|76094712|FG000|NOT COMPLETED|Overall Study||2||
59977473|NCT04567693|76094713|FG001|NOT COMPLETED|Overall Study||0||
59977474|NCT04567693|76094714|FG002|NOT COMPLETED|Overall Study||6||
59977475|NCT04238663|76094725|FG000|STARTED|Overall Study||38||
59977476|NCT04238663|76094726|FG001|STARTED|Overall Study||38||
59977477|NCT04238663|76094727|FG002|STARTED|Overall Study||38||
59977478|NCT04238663|76094725|FG000|COMPLETED|Overall Study||38||
59977479|NCT04238663|76094726|FG001|COMPLETED|Overall Study||37||
59977480|NCT04238663|76094727|FG002|COMPLETED|Overall Study||38||
59977481|NCT04238663|76094725|FG000|NOT COMPLETED|Overall Study||0||
59977482|NCT04238663|76094726|FG001|NOT COMPLETED|Overall Study||1||
59977483|NCT04238663|76094727|FG002|NOT COMPLETED|Overall Study||0||
59977484|NCT04235660|76094737|FG000|STARTED|Overall Study||1||
59977485|NCT04235660|76094738|FG001|STARTED|Overall Study||1||
59977486|NCT04235660|76094737|FG000|COMPLETED|Overall Study||0||
59977487|NCT04235660|76094738|FG001|COMPLETED|Overall Study||0||
59977488|NCT04235660|76094737|FG000|NOT COMPLETED|Overall Study||1||
59977489|NCT04235660|76094738|FG001|NOT COMPLETED|Overall Study||1||
59977490|NCT04139642|76094747|FG000|STARTED|Historical Control Period (12 Months)||20||8
59977491|NCT04139642|76094748|FG001|STARTED|Historical Control Period (12 Months)||22||8
59977492|NCT04139642|76094747|FG000|COMPLETED|Historical Control Period (12 Months)||20||8
59977493|NCT04139642|76094748|FG001|COMPLETED|Historical Control Period (12 Months)||22||8
59977494|NCT04139642|76094747|FG000|NOT COMPLETED|Historical Control Period (12 Months)||0||0
59977495|NCT04139642|76094748|FG001|NOT COMPLETED|Historical Control Period (12 Months)||0||0
59977496|NCT04139642|76094747|FG000|STARTED|First Intervention (9 Months)||20||8
59977497|NCT04139642|76094748|FG001|STARTED|First Intervention (9 Months)||22||8
59977498|NCT04139642|76094747|FG000|COMPLETED|First Intervention (9 Months)||20||8
59977499|NCT04139642|76094748|FG001|COMPLETED|First Intervention (9 Months)||21||7
59977500|NCT04139642|76094747|FG000|NOT COMPLETED|First Intervention (9 Months)||0||0
59977501|NCT04139642|76094748|FG001|NOT COMPLETED|First Intervention (9 Months)||1||1
59977502|NCT04139642|76094747|FG000|STARTED|Second Intervention (9 Months)||20||8
59977503|NCT04139642|76094748|FG001|STARTED|Second Intervention (9 Months)||21||7
59813995|NCT00422097|75936451|FG001|NOT COMPLETED|Dose Level 4||0||
59813996|NCT00422097|75936452|FG002|NOT COMPLETED|Dose Level 4||0||
59813997|NCT00422097|75936453|FG003|NOT COMPLETED|Dose Level 4||0||
59813998|NCT00422097|75936454|FG004|NOT COMPLETED|Dose Level 4||0||
59813999|NCT00422097|75936455|FG005|NOT COMPLETED|Dose Level 4||0||
59814000|NCT00422097|75936456|FG006|NOT COMPLETED|Dose Level 4||0||
59814001|NCT00422097|75936457|FG007|NOT COMPLETED|Dose Level 4||0||
59814002|NCT00422097|75936450|FG000|STARTED|Dose Level 5||0||
59814003|NCT00422097|75936451|FG001|STARTED|Dose Level 5||0||
59814004|NCT00422097|75936452|FG002|STARTED|Dose Level 5||0||
59814005|NCT00422097|75936453|FG003|STARTED|Dose Level 5||0||
59814006|NCT00422097|75936454|FG004|STARTED|Dose Level 5||23||
59814007|NCT00422097|75936455|FG005|STARTED|Dose Level 5||0||
59814008|NCT00422097|75936456|FG006|STARTED|Dose Level 5||0||
59814009|NCT00422097|75936457|FG007|STARTED|Dose Level 5||0||
59814010|NCT00422097|75936450|FG000|COMPLETED|Dose Level 5||0||
59814011|NCT00422097|75936451|FG001|COMPLETED|Dose Level 5||0||
59977504|NCT04139642|76094747|FG000|COMPLETED|Second Intervention (9 Months)||20||8
59814012|NCT00422097|75936452|FG002|COMPLETED|Dose Level 5||0||
59814013|NCT00422097|75936453|FG003|COMPLETED|Dose Level 5||0||
59814014|NCT00422097|75936454|FG004|COMPLETED|Dose Level 5||23||
59814015|NCT00422097|75936455|FG005|COMPLETED|Dose Level 5||0||
59814016|NCT00422097|75936456|FG006|COMPLETED|Dose Level 5||0||
59977505|NCT04139642|76094748|FG001|COMPLETED|Second Intervention (9 Months)||21||7
59977506|NCT04139642|76094747|FG000|NOT COMPLETED|Second Intervention (9 Months)||0||0
59977507|NCT04139642|76094748|FG001|NOT COMPLETED|Second Intervention (9 Months)||0||0
59977508|NCT04052698|76094757|FG000|STARTED|Overall Study||43||
59977509|NCT04052698|76094757|FG000|Safety Analysis Set (SAF)|Overall Study|The safety set (SAF) included all patients who received at least 1 dose of IMP.|43||
59814017|NCT00422097|75936457|FG007|COMPLETED|Dose Level 5||0||
59977510|NCT04052698|76094757|FG000|Modified Full Analysis Set (mFAS)|Overall Study|The modified full analysis set (mFAS) included all enrolled patients who received at least one dose of IMP after the baseline IVR visit in adults or the baseline PK visit in children, and excluded all patients for whom laboratory results did not confirm the patient's VWD status|33||
59977511|NCT04052698|76094757|FG000|COMPLETED|Overall Study||30||
59814018|NCT00422097|75936450|FG000|NOT COMPLETED|Dose Level 5||0||
59814019|NCT00422097|75936451|FG001|NOT COMPLETED|Dose Level 5||0||
59814020|NCT00422097|75936452|FG002|NOT COMPLETED|Dose Level 5||0||
59814021|NCT00422097|75936453|FG003|NOT COMPLETED|Dose Level 5||0||
59814022|NCT00422097|75936454|FG004|NOT COMPLETED|Dose Level 5||0||
59977512|NCT04052698|76094757|FG000|NOT COMPLETED|Overall Study||13||
59977513|NCT03980483|76094791|FG000|STARTED|Overall Study||513||
59977514|NCT03980483|76094792|FG001|STARTED|Overall Study||510||
59977515|NCT03980483|76094793|FG002|STARTED|Overall Study||258||
59977516|NCT03980483|76094794|FG003|STARTED|Overall Study||85||
59977517|NCT03980483|76094795|FG004|STARTED|Overall Study||86||
59977518|NCT03980483|76094796|FG005|STARTED|Overall Study||85||
59622273|NCT00412074|75734041|FG002|COMPLETED|Overall Study||128||
59622274|NCT00412074|75734039|FG000|NOT COMPLETED|Overall Study||77||
59622275|NCT00412074|75734040|FG001|NOT COMPLETED|Overall Study||22||
59622276|NCT00412074|75734041|FG002|NOT COMPLETED|Overall Study||67||
59622277|NCT00412464|75734052|FG000|STARTED|Overall Study|Age Groups: 1-5 Years (10); 6-12 Years (7); 13-18 years (7)|24||
59622278|NCT00412464|75734052|FG000|COMPLETED|Overall Study|Age Groups: 1-5 Years (10); 6-12 Years (7); 13-18 years (7)|24||
59622279|NCT00412464|75734052|FG000|NOT COMPLETED|Overall Study||0||
59622280|NCT00466752|75734058|FG000|STARTED|Overall Study||5||
59622281|NCT00466752|75734059|FG001|STARTED|Overall Study||0||
59622282|NCT00466752|75734058|FG000|COMPLETED|Overall Study||5||
59622283|NCT00466752|75734059|FG001|COMPLETED|Overall Study||0||
59622284|NCT00466752|75734058|FG000|NOT COMPLETED|Overall Study||0||
59622285|NCT00466752|75734059|FG001|NOT COMPLETED|Overall Study||0||
59622286|NCT02115750|75734067|FG000|STARTED|Part 1||323||
59622287|NCT02115750|75734068|FG001|STARTED|Part 1||324||
59622288|NCT02115750|75734067|FG000|COMPLETED|Part 1||301||
59622289|NCT02115750|75734068|FG001|COMPLETED|Part 1||312||
59814023|NCT00422097|75936455|FG005|NOT COMPLETED|Dose Level 5||0||
59977519|NCT03980483|76094791|FG000|Safety Set|Overall Study||513|All randomized participants who received at least one dose of study treatment.|
59977520|NCT03980483|76094792|FG001|Safety Set|Overall Study||510|All randomized participants who received at least one dose of study treatment.|
59977521|NCT03980483|76094793|FG002|Safety Set|Overall Study||273|All randomized participants who received at least one dose of study treatment.|
59977522|NCT03980483|76094794|FG003|Safety Set|Overall Study||0|All randomized participants who received at least one dose of study treatment.|
59977523|NCT03980483|76094795|FG004|Safety Set|Overall Study||0|All randomized participants who received at least one dose of study treatment.|
59977524|NCT03980483|76094796|FG005|Safety Set|Overall Study||0|All randomized participants who received at least one dose of study treatment.|
59977525|NCT03980483|76094791|FG000|Safety Set-Placebo Switch|Overall Study||0|All participants randomized to a placebo switch treatment arm (i.e. Placebo to GSK3196165 90mg, Placebo to GSK3196165 150mg or Placebo to Tofacitinib 5mg) who received at least one dose of study treatment.|
59977526|NCT03980483|76094792|FG001|Safety Set-Placebo Switch|Overall Study||0|All participants randomized to a placebo switch treatment arm (i.e. Placebo to GSK3196165 90mg, Placebo to GSK3196165 150mg or Placebo to Tofacitinib 5mg) who received at least one dose of study treatment.|
59977527|NCT03980483|76094793|FG002|Safety Set-Placebo Switch|Overall Study||0|All participants randomized to a placebo switch treatment arm (i.e. Placebo to GSK3196165 90mg, Placebo to GSK3196165 150mg or Placebo to Tofacitinib 5mg) who received at least one dose of study treatment.|
59977528|NCT03980483|76094794|FG003|Safety Set-Placebo Switch|Overall Study||80|All participants randomized to a placebo switch treatment arm (i.e. Placebo to GSK3196165 90mg, Placebo to GSK3196165 150mg or Placebo to Tofacitinib 5mg) who received at least one dose of study treatment.|
59977529|NCT03980483|76094795|FG004|Safety Set-Placebo Switch|Overall Study||82|All participants randomized to a placebo switch treatment arm (i.e. Placebo to GSK3196165 90mg, Placebo to GSK3196165 150mg or Placebo to Tofacitinib 5mg) who received at least one dose of study treatment.|
59814024|NCT00422097|75936456|FG006|NOT COMPLETED|Dose Level 5||0||
59814025|NCT00422097|75936457|FG007|NOT COMPLETED|Dose Level 5||0||
59814026|NCT00422097|75936450|FG000|STARTED|Dose Level 6||0||
59814027|NCT00422097|75936451|FG001|STARTED|Dose Level 6||0||
59814028|NCT00422097|75936452|FG002|STARTED|Dose Level 6||0||
60074657|NCT01555125|76189971|FG001|NOT COMPLETED|Extension||51||
59977530|NCT03980483|76094796|FG005|Safety Set-Placebo Switch|Overall Study||68|All participants randomized to a placebo switch treatment arm (i.e. Placebo to GSK3196165 90mg, Placebo to GSK3196165 150mg or Placebo to Tofacitinib 5mg) who received at least one dose of study treatment.|
59977531|NCT03980483|76094791|FG000|COMPLETED|Overall Study||431||
59977532|NCT03980483|76094792|FG001|COMPLETED|Overall Study||436||
59977533|NCT03980483|76094793|FG002|COMPLETED|Overall Study||221||
59977534|NCT03980483|76094794|FG003|COMPLETED|Overall Study||69||
59977535|NCT03980483|76094795|FG004|COMPLETED|Overall Study||73||
59977536|NCT03980483|76094796|FG005|COMPLETED|Overall Study||75||
59977537|NCT03980483|76094791|FG000|NOT COMPLETED|Overall Study||82||
59977538|NCT03980483|76094792|FG001|NOT COMPLETED|Overall Study||74||
59977539|NCT03980483|76094793|FG002|NOT COMPLETED|Overall Study||37||
59977540|NCT03980483|76094794|FG003|NOT COMPLETED|Overall Study||16||
59977541|NCT03980483|76094795|FG004|NOT COMPLETED|Overall Study||13||
59977542|NCT03980483|76094796|FG005|NOT COMPLETED|Overall Study||10||
59977543|NCT03833661|76094815|FG000|STARTED|Overall Study||159||
59977544|NCT03833661|76094815|FG000|COMPLETED|Overall Study||159||
59977545|NCT03833661|76094815|FG000|NOT COMPLETED|Overall Study||0||
59977546|NCT03824808|76094821|FG000|STARTED|Overall Study||11||
59977547|NCT03824808|76094822|FG001|STARTED|Overall Study||10||
59977548|NCT03824808|76094821|FG000|COMPLETED|Overall Study||11||
59977549|NCT03824808|76094822|FG001|COMPLETED|Overall Study||10||
59977550|NCT03824808|76094821|FG000|NOT COMPLETED|Overall Study||0||
59977551|NCT03824808|76094822|FG001|NOT COMPLETED|Overall Study||0||
59977552|NCT03769116|76094830|FG000|STARTED|Overall Study||20||
59977553|NCT03769116|76094831|FG001|STARTED|Overall Study||21||
59977554|NCT03769116|76094830|FG000|Received At Least 1 Dose Of Study Drug|Overall Study||20|Intent-to-Treat (ITT) Population|
59977555|NCT03769116|76094831|FG001|Received At Least 1 Dose Of Study Drug|Overall Study||21|Intent-to-Treat (ITT) Population|
59977556|NCT03769116|76094830|FG000|COMPLETED|Overall Study||20|Participants completing Part 1; study ongoing.|
59977557|NCT03769116|76094831|FG001|COMPLETED|Overall Study||21|Participants completing Part 1; study ongoing.|
59977558|NCT03769116|76094830|FG000|NOT COMPLETED|Overall Study||0||
59977559|NCT03769116|76094831|FG001|NOT COMPLETED|Overall Study||0||
59977560|NCT03510468|76094837|FG000|STARTED|Overall Study||28||
59977561|NCT03510468|76094837|FG000|COMPLETED|Overall Study||18||
59977562|NCT03510468|76094837|FG000|NOT COMPLETED|Overall Study||10||
59977563|NCT03374202|76094844|FG000|STARTED|One Year Follow Up||3||
59977564|NCT03374202|76094845|FG001|STARTED|One Year Follow Up||3||
59977565|NCT03374202|76094846|FG002|STARTED|One Year Follow Up||4||
59977566|NCT03374202|76094844|FG000|Received Study Product|One Year Follow Up||3||
59977567|NCT03374202|76094845|FG001|Received Study Product|One Year Follow Up||3||
59977568|NCT03374202|76094846|FG002|Received Study Product|One Year Follow Up||4||
59977569|NCT03374202|76094844|FG000|COMPLETED|One Year Follow Up||3|Participants who completed one year of study visits.|
60074658|NCT01555125|76189972|FG002|NOT COMPLETED|Extension||23||
60074659|NCT01555125|76189973|FG003|NOT COMPLETED|Extension||22||
60074660|NCT01555125|76189974|FG004|NOT COMPLETED|Extension||0||
60074661|NCT01555125|76189970|FG000|STARTED|Follow-Up Period||36||
60074662|NCT01555125|76189971|FG001|STARTED|Follow-Up Period||31||
60074663|NCT01555125|76189972|FG002|STARTED|Follow-Up Period||19||
60074664|NCT01555125|76189973|FG003|STARTED|Follow-Up Period||18||
59814029|NCT00422097|75936453|FG003|STARTED|Dose Level 6||0||
59814030|NCT00422097|75936454|FG004|STARTED|Dose Level 6||0||
59814031|NCT00422097|75936455|FG005|STARTED|Dose Level 6||6||
59814032|NCT00422097|75936456|FG006|STARTED|Dose Level 6||0||
59977570|NCT03374202|76094845|FG001|COMPLETED|One Year Follow Up||3|Participants who completed one year of study visits.|
59977571|NCT03374202|76094846|FG002|COMPLETED|One Year Follow Up||4|Participants who completed one year of study visits.|
59977572|NCT03374202|76094844|FG000|NOT COMPLETED|One Year Follow Up||0||
59977573|NCT03374202|76094845|FG001|NOT COMPLETED|One Year Follow Up||0||
59977574|NCT03374202|76094846|FG002|NOT COMPLETED|One Year Follow Up||0||
59977575|NCT03374202|76094844|FG000|STARTED|Five Year Long Term Follow Up||3||
59977576|NCT03374202|76094845|FG001|STARTED|Five Year Long Term Follow Up||3||
59977577|NCT03374202|76094846|FG002|STARTED|Five Year Long Term Follow Up||4||
59977578|NCT03374202|76094844|FG000|COMPLETED|Five Year Long Term Follow Up||2|Participants who completed 5 years of the study per protocol as of May 2023|
59977579|NCT03374202|76094845|FG001|COMPLETED|Five Year Long Term Follow Up||0|Participants who completed 5 years of the study per protocol as of May 2023|
59977580|NCT03374202|76094846|FG002|COMPLETED|Five Year Long Term Follow Up||0|Participants who completed 5 years of the study per protocol as of May 2023|
59977581|NCT03374202|76094844|FG000|NOT COMPLETED|Five Year Long Term Follow Up||1||
59977582|NCT03374202|76094845|FG001|NOT COMPLETED|Five Year Long Term Follow Up||3||
59977583|NCT03374202|76094846|FG002|NOT COMPLETED|Five Year Long Term Follow Up||4||
59977584|NCT03248739|76094856|FG000|STARTED|Overall Study||17||
59977585|NCT03248739|76094857|FG001|STARTED|Overall Study||16||
59977586|NCT03248739|76094856|FG000|COMPLETED|Overall Study||17||
59977587|NCT03248739|76094857|FG001|COMPLETED|Overall Study||16||
59977588|NCT03248739|76094856|FG000|NOT COMPLETED|Overall Study||0||
59977589|NCT03248739|76094857|FG001|NOT COMPLETED|Overall Study||0||
59977590|NCT03218826|76094868|FG000|STARTED|Overall Study||6||
59977591|NCT03218826|76094869|FG001|STARTED|Overall Study||1||
59977592|NCT03218826|76094870|FG002|STARTED|Overall Study||5||
59977593|NCT03218826|76094871|FG003|STARTED|Overall Study||4||
59977594|NCT03218826|76094872|FG004|STARTED|Overall Study||7||
59977595|NCT03218826|76094868|FG000|COMPLETED|Overall Study||5||
59977596|NCT03218826|76094869|FG001|COMPLETED|Overall Study||1||
59977597|NCT03218826|76094870|FG002|COMPLETED|Overall Study||3||
59977598|NCT03218826|76094871|FG003|COMPLETED|Overall Study||3||
59977599|NCT03218826|76094872|FG004|COMPLETED|Overall Study||6||
59977600|NCT03218826|76094868|FG000|NOT COMPLETED|Overall Study||1||
59977601|NCT03218826|76094869|FG001|NOT COMPLETED|Overall Study||0||
59977602|NCT03218826|76094870|FG002|NOT COMPLETED|Overall Study||2||
59977603|NCT03218826|76094871|FG003|NOT COMPLETED|Overall Study||1||
59977604|NCT03218826|76094872|FG004|NOT COMPLETED|Overall Study||1||
59977605|NCT03075215|76094884|FG000|STARTED|12-Month Primary Endpoint||2005||
59977606|NCT03075215|76094884|FG000|COMPLETED|12-Month Primary Endpoint||1586||
59977607|NCT03075215|76094884|FG000|NOT COMPLETED|12-Month Primary Endpoint||419||
59977608|NCT03075215|76094884|FG000|STARTED|Post Market Clinical Follow-Up ONLY||103||
59977609|NCT03075215|76094884|FG000|COMPLETED|Post Market Clinical Follow-Up ONLY||63||
59977610|NCT03075215|76094884|FG000|NOT COMPLETED|Post Market Clinical Follow-Up ONLY||40||
59977611|NCT03063632|76094890|FG000|STARTED|Overall Study||16||
59977612|NCT03063632|76094891|FG001|STARTED|Overall Study||12||
59977613|NCT03063632|76094890|FG000|COMPLETED|Overall Study||9||
59977614|NCT03063632|76094891|FG001|COMPLETED|Overall Study||2||
59977615|NCT03063632|76094890|FG000|NOT COMPLETED|Overall Study||7||
59977616|NCT03063632|76094891|FG001|NOT COMPLETED|Overall Study||10||
59977617|NCT02891603|76094902|FG000|STARTED|Overall Study||10||
59977618|NCT02891603|76094903|FG001|STARTED|Overall Study||8||
59977619|NCT02891603|76094904|FG002|STARTED|Overall Study||22||
59977620|NCT02891603|76094902|FG000|COMPLETED|Overall Study||10||
59977621|NCT02891603|76094903|FG001|COMPLETED|Overall Study||8||
59977622|NCT02891603|76094904|FG002|COMPLETED|Overall Study||22||
59814033|NCT00422097|75936457|FG007|STARTED|Dose Level 6||0||
59814034|NCT00422097|75936450|FG000|COMPLETED|Dose Level 6||0||
59977623|NCT02891603|76094902|FG000|NOT COMPLETED|Overall Study||0||
59977624|NCT02891603|76094903|FG001|NOT COMPLETED|Overall Study||0||
59977625|NCT02891603|76094904|FG002|NOT COMPLETED|Overall Study||0||
59977626|NCT02759731|76094911|FG000|STARTED|Overall Study||24||
59977627|NCT02759731|76094911|FG000|COMPLETED|Overall Study||16||
59814035|NCT00422097|75936451|FG001|COMPLETED|Dose Level 6||0||
59977628|NCT02759731|76094911|FG000|NOT COMPLETED|Overall Study||8||
59977629|NCT02665117|76094919|FG000|STARTED|Overall Study||30||
59977630|NCT02665117|76094920|FG001|STARTED|Overall Study||31||
59977631|NCT02665117|76094919|FG000|COMPLETED|Overall Study||29||
59977632|NCT02665117|76094920|FG001|COMPLETED|Overall Study||31||
59977633|NCT02665117|76094919|FG000|NOT COMPLETED|Overall Study||1||
59977634|NCT02665117|76094920|FG001|NOT COMPLETED|Overall Study||0||
59977635|NCT02617485|76094928|FG000|STARTED|Treatment and Observation Period||100||
59977636|NCT02617485|76094929|FG001|STARTED|Treatment and Observation Period||40||
59814036|NCT00422097|75936452|FG002|COMPLETED|Dose Level 6||0||
59977637|NCT02617485|76094928|FG000|COMPLETED|Treatment and Observation Period||85||
59977638|NCT02617485|76094929|FG001|COMPLETED|Treatment and Observation Period||35||
59977639|NCT02617485|76094928|FG000|NOT COMPLETED|Treatment and Observation Period||15||
59977640|NCT02617485|76094929|FG001|NOT COMPLETED|Treatment and Observation Period||5||
59977641|NCT02617485|76094928|FG000|STARTED|Follow-up Period||85||
59977642|NCT02617485|76094929|FG001|STARTED|Follow-up Period||35||
59977643|NCT02617485|76094928|FG000|COMPLETED|Follow-up Period||70||
59977644|NCT02617485|76094929|FG001|COMPLETED|Follow-up Period||29||
59977645|NCT02617485|76094928|FG000|NOT COMPLETED|Follow-up Period||15||
59977646|NCT02617485|76094929|FG001|NOT COMPLETED|Follow-up Period||6||
59977647|NCT02589522|76094938|FG000|STARTED|Overall Study||11||
59977648|NCT02589522|76094939|FG001|STARTED|Overall Study||4||
59977649|NCT02589522|76094940|FG002|STARTED|Overall Study||0||
59977650|NCT02589522|76094938|FG000|COMPLETED|Overall Study||9||
59977651|NCT02589522|76094939|FG001|COMPLETED|Overall Study||2||
59977652|NCT02589522|76094940|FG002|COMPLETED|Overall Study||0||
59977653|NCT02589522|76094938|FG000|NOT COMPLETED|Overall Study||2||
59977654|NCT02589522|76094939|FG001|NOT COMPLETED|Overall Study||2||
59977655|NCT02589522|76094940|FG002|NOT COMPLETED|Overall Study||0||
59977656|NCT02485860|76094950|FG000|STARTED|Overall Study||50||
59977657|NCT02485860|76094951|FG001|STARTED|Overall Study||50||
59977658|NCT02485860|76094950|FG000|COMPLETED|Overall Study||44||
59977659|NCT02485860|76094951|FG001|COMPLETED|Overall Study||47||
59977660|NCT02485860|76094950|FG000|NOT COMPLETED|Overall Study||6||
59977661|NCT02485860|76094951|FG001|NOT COMPLETED|Overall Study||3||
59977662|NCT02385123|76094957|FG000|STARTED|Overall Study||60||
59977663|NCT02385123|76094957|FG000|COMPLETED|Overall Study||45||
59977664|NCT02385123|76094957|FG000|NOT COMPLETED|Overall Study||15||
59977665|NCT02337686|76094961|FG000|STARTED|Overall Study||15||
59977666|NCT02337686|76094961|FG000|COMPLETED|Overall Study||14||
59977667|NCT02337686|76094961|FG000|NOT COMPLETED|Overall Study||1||
59977668|NCT02097420|76094965|FG000|STARTED|Overall Study||23||
59977669|NCT02097420|76094965|FG000|COMPLETED|Overall Study||3||
59977670|NCT02097420|76094965|FG000|NOT COMPLETED|Overall Study||20||
59977671|NCT02000115|76094972|FG000|STARTED|Overall Study||381||
59977672|NCT02000115|76094973|FG001|STARTED|Overall Study||369||
59977673|NCT02000115|76094974|FG002|STARTED|Overall Study||100||
59977674|NCT02000115|76094975|FG003|STARTED|Overall Study||53||
59977675|NCT02000115|76094972|FG000|COMPLETED|Overall Study|6 subjects missed the One-year follow-up visit|302||
59977676|NCT02000115|76094973|FG001|COMPLETED|Overall Study|8 subjects missed the One-year follow-up visit|301||
59526176|NCT01349491|75621720|FG001|COMPLETED|Overall Study||5||
59526177|NCT01349491|75621719|FG000|NOT COMPLETED|Overall Study||0||
59526178|NCT01349491|75621720|FG001|NOT COMPLETED|Overall Study||0||
59526179|NCT01298167|75621728|FG000|STARTED|Overall Study||6||
59526180|NCT01298167|75621729|FG001|STARTED|Overall Study||8||
59977677|NCT02000115|76094974|FG002|COMPLETED|Overall Study|1 subject missed the 30 day follow-up visit|99||
59977678|NCT02000115|76094975|FG003|COMPLETED|Overall Study||0||
59977679|NCT02000115|76094972|FG000|NOT COMPLETED|Overall Study||79||
59977680|NCT02000115|76094973|FG001|NOT COMPLETED|Overall Study||68||
59977681|NCT02000115|76094974|FG002|NOT COMPLETED|Overall Study||1||
59977682|NCT02000115|76094975|FG003|NOT COMPLETED|Overall Study||53||
59977683|NCT01861028|76094984|FG000|STARTED|Overall Study||44||
59977684|NCT01861028|76094984|FG000|COMPLETED|Overall Study||44||
59977685|NCT01861028|76094984|FG000|NOT COMPLETED|Overall Study||0||
59526181|NCT01298167|75621728|FG000|COMPLETED|Overall Study||5||
59814037|NCT00422097|75936453|FG003|COMPLETED|Dose Level 6||0||
59814038|NCT00422097|75936454|FG004|COMPLETED|Dose Level 6||0||
59814039|NCT00422097|75936455|FG005|COMPLETED|Dose Level 6||6||
59814040|NCT00422097|75936456|FG006|COMPLETED|Dose Level 6||0||
59814041|NCT00422097|75936457|FG007|COMPLETED|Dose Level 6||0||
59814042|NCT00422097|75936450|FG000|NOT COMPLETED|Dose Level 6||0||
59814043|NCT00422097|75936451|FG001|NOT COMPLETED|Dose Level 6||0||
59977686|NCT01717001|76094991|FG000|STARTED|Overall Study||38||
59977687|NCT01717001|76094992|FG001|STARTED|Overall Study||28||
59977688|NCT01717001|76094991|FG000|COMPLETED|Overall Study||32||
59977689|NCT01717001|76094992|FG001|COMPLETED|Overall Study||24||
59977690|NCT01717001|76094991|FG000|NOT COMPLETED|Overall Study||6||
59977691|NCT01717001|76094992|FG001|NOT COMPLETED|Overall Study||4||
59977692|NCT01564654|76094998|FG000|STARTED|Overall Study|106 knees (bilateral)|89||
59977693|NCT01564654|76094998|FG000|COMPLETED|Overall Study|106 knees (bilateral)|89||
59977694|NCT01564654|76094998|FG000|NOT COMPLETED|Overall Study||0||
59977695|NCT00893516|76095004|FG000|STARTED|Overall Study||0||
59977696|NCT00893516|76095005|FG001|STARTED|Overall Study||0||
59977697|NCT00893516|76095004|FG000|COMPLETED|Overall Study||0||
59977698|NCT00893516|76095005|FG001|COMPLETED|Overall Study||0||
59977699|NCT00893516|76095004|FG000|NOT COMPLETED|Overall Study||0||
59977700|NCT00893516|76095005|FG001|NOT COMPLETED|Overall Study||0||
59977701|NCT00113360|76095011|FG000|STARTED|Overall Study|67 participants were enrolled for screening.|67||
59977702|NCT00113360|76095011|FG000|COMPLETED|Overall Study||60||
59526182|NCT01298167|75621729|FG001|COMPLETED|Overall Study||8||
59526183|NCT01298167|75621728|FG000|NOT COMPLETED|Overall Study||1||
59814044|NCT00422097|75936452|FG002|NOT COMPLETED|Dose Level 6||0||
59814045|NCT00422097|75936453|FG003|NOT COMPLETED|Dose Level 6||0||
59814046|NCT00422097|75936454|FG004|NOT COMPLETED|Dose Level 6||0||
59977703|NCT00113360|76095011|FG000|NOT COMPLETED|Overall Study||7||
59977704|NCT00087685|76095015|FG000|STARTED|Overall Study||35||
59977705|NCT00087685|76095015|FG000|COMPLETED|Overall Study||21||
59977706|NCT00087685|76095015|FG000|NOT COMPLETED|Overall Study||14||
59977707|NCT02610842|76095019|FG000|STARTED|Overall Study||27||
59977708|NCT02610842|76095019|FG000|COMPLETED|Overall Study||22||
59977709|NCT02610842|76095019|FG000|NOT COMPLETED|Overall Study||5||
59977710|NCT01648582|76095028|FG000|STARTED|Overall Study||258||
59977711|NCT01648582|76095029|FG001|STARTED|Overall Study||257||
59977712|NCT01648582|76095030|FG002|STARTED|Overall Study||259||
59977713|NCT01648582|76095028|FG000|Received at Least One Dose of Study Drug|Overall Study||258||
59977714|NCT01648582|76095029|FG001|Received at Least One Dose of Study Drug|Overall Study||257||
59977715|NCT01648582|76095030|FG002|Received at Least One Dose of Study Drug|Overall Study||259||
59977716|NCT01648582|76095028|FG000|Modified Intent-to-Treat Population|Overall Study||253||
59977717|NCT01648582|76095029|FG001|Modified Intent-to-Treat Population|Overall Study||252||
59977718|NCT01648582|76095030|FG002|Modified Intent-to-Treat Population|Overall Study||250||
59977719|NCT01648582|76095028|FG000|COMPLETED|Overall Study||226||
59977720|NCT01648582|76095029|FG001|COMPLETED|Overall Study||219||
59977721|NCT01648582|76095030|FG002|COMPLETED|Overall Study||227||
59977722|NCT01648582|76095028|FG000|NOT COMPLETED|Overall Study||32||
59977723|NCT01648582|76095029|FG001|NOT COMPLETED|Overall Study||38||
59977724|NCT01648582|76095030|FG002|NOT COMPLETED|Overall Study||32||
59977725|NCT02607800|76095043|FG000|STARTED|Overall Study||502||
59977726|NCT02607800|76095044|FG001|STARTED|Overall Study||441||
59977727|NCT02607800|76095043|FG000|COMPLETED|Overall Study||492||
59977728|NCT02607800|76095044|FG001|COMPLETED|Overall Study||430||
59977729|NCT02607800|76095043|FG000|NOT COMPLETED|Overall Study||10||
59977730|NCT02607800|76095044|FG001|NOT COMPLETED|Overall Study||11||
59977731|NCT02304484|76095051|FG000|STARTED|Overall Study||770||
59977732|NCT02304484|76095051|FG000|COMPLETED|Overall Study||745||
59977733|NCT02304484|76095051|FG000|NOT COMPLETED|Overall Study||25||
59977734|NCT02708355|76095058|FG000|STARTED|Overall Study||21||
59977735|NCT02708355|76095059|FG001|STARTED|Overall Study||22||
59977736|NCT02708355|76095060|FG002|STARTED|Overall Study||12||
59977737|NCT02708355|76095058|FG000|COMPLETED|Overall Study||20||
59977738|NCT02708355|76095059|FG001|COMPLETED|Overall Study||22||
59977739|NCT02708355|76095060|FG002|COMPLETED|Overall Study||12||
59977740|NCT02708355|76095058|FG000|NOT COMPLETED|Overall Study||1||
59977741|NCT02708355|76095059|FG001|NOT COMPLETED|Overall Study||0||
59977742|NCT02708355|76095060|FG002|NOT COMPLETED|Overall Study||0||
59977743|NCT02708277|76095070|FG000|STARTED|Overall Study||50||
59977744|NCT02708277|76095071|FG001|STARTED|Overall Study||43||
59977745|NCT02708277|76095070|FG000|COMPLETED|Overall Study||43||
59977746|NCT02708277|76095071|FG001|COMPLETED|Overall Study||39||
59977747|NCT02708277|76095070|FG000|NOT COMPLETED|Overall Study||7||
59977748|NCT02708277|76095071|FG001|NOT COMPLETED|Overall Study||4||
59977749|NCT02337478|76095077|FG000|STARTED|Overall Study||5||
59977750|NCT02337478|76095077|FG000|COMPLETED|Overall Study||0||
59977751|NCT02337478|76095077|FG000|NOT COMPLETED|Overall Study||5||
59977752|NCT02303704|76095083|FG000|STARTED|Overall Study||220||
59977753|NCT02303704|76095084|FG001|STARTED|Overall Study||228||
59977754|NCT02303704|76095083|FG000|COMPLETED|Overall Study||215||
59977755|NCT02303704|76095084|FG001|COMPLETED|Overall Study||219||
59977756|NCT02303704|76095083|FG000|NOT COMPLETED|Overall Study||5||
59977757|NCT02303704|76095084|FG001|NOT COMPLETED|Overall Study||9||
59977758|NCT02608892|76095092|FG000|STARTED|Overall Study||51||
59977759|NCT02608892|76095093|FG001|STARTED|Overall Study||49||
59977760|NCT02608892|76095092|FG000|COMPLETED|Overall Study||50||
59977761|NCT02608892|76095093|FG001|COMPLETED|Overall Study||49||
59977762|NCT02608892|76095092|FG000|NOT COMPLETED|Overall Study||1||
59977763|NCT02608892|76095093|FG001|NOT COMPLETED|Overall Study||0||
59977773|NCT02708121|76095115|FG000|STARTED|Overall Study||35||
59977774|NCT02708121|76095116|FG001|STARTED|Overall Study||31||
59977775|NCT02708121|76095115|FG000|Provided Acceptability Data|Overall Study||20|No. of participants who completed the post mobilization tool acceptability survey.|
59977776|NCT02708121|76095116|FG001|Provided Acceptability Data|Overall Study|This condition did not participate in acceptability survey|0|No. of participants who completed the post mobilization tool acceptability survey.|
59977777|NCT02708121|76095115|FG000|Treatment Program Use Data Available|Overall Study||34|No. of participants in which the treatment program provided initiation data|
59977778|NCT02708121|76095116|FG001|Treatment Program Use Data Available|Overall Study||24|No. of participants in which the treatment program provided initiation data|
59977779|NCT02708121|76095115|FG000|6 Month In-Person Follow Up Data|Overall Study||22|No. of participants who attended the six month assessment follow up|
59977780|NCT02708121|76095116|FG001|6 Month In-Person Follow Up Data|Overall Study||19|No. of participants who attended the six month assessment follow up|
59977781|NCT02708121|76095115|FG000|6 Month Weight Data Via EHR|Overall Study||14|No. of participants in which their weight data at 6 month follow up was available via health record|
59977782|NCT02708121|76095116|FG001|6 Month Weight Data Via EHR|Overall Study||13|No. of participants in which their weight data at 6 month follow up was available via health record|
59977783|NCT02708121|76095115|FG000|COMPLETED|Overall Study||34|No. of participants who received allocated intervention|
59977784|NCT02708121|76095116|FG001|COMPLETED|Overall Study||26|No. of participants who received allocated intervention|
59977785|NCT02708121|76095115|FG000|NOT COMPLETED|Overall Study||1||
59977786|NCT02708121|76095116|FG001|NOT COMPLETED|Overall Study||5||
59977787|NCT02707965|76095131|FG000|STARTED|Overall Study||3||
59977788|NCT02707965|76095132|FG001|STARTED|Overall Study||2||
59977789|NCT02707965|76095133|FG002|STARTED|Overall Study||4||
59977790|NCT02707965|76095134|FG003|STARTED|Overall Study||0||
59977791|NCT02707965|76095135|FG004|STARTED|Overall Study||2||
59977792|NCT02707965|76095136|FG005|STARTED|Overall Study||1||
59977793|NCT02707965|76095137|FG006|STARTED|Overall Study||0||
59977794|NCT02707965|76095138|FG007|STARTED|Overall Study||3||
59977795|NCT02707965|76095139|FG008|STARTED|Overall Study||1||
59977796|NCT02707965|76095140|FG009|STARTED|Overall Study||0||
59977797|NCT02707965|76095141|FG010|STARTED|Overall Study||1||
59977798|NCT02707965|76095142|FG011|STARTED|Overall Study||0||
59977799|NCT02707965|76095143|FG012|STARTED|Overall Study||0||
59977800|NCT02707965|76095144|FG013|STARTED|Overall Study||2||
59977801|NCT02707965|76095145|FG014|STARTED|Overall Study||2||
59977802|NCT02707965|76095146|FG015|STARTED|Overall Study||0||
59977803|NCT02707965|76095131|FG000|COMPLETED|Overall Study||2||
59977804|NCT02707965|76095132|FG001|COMPLETED|Overall Study||1||
59977805|NCT02707965|76095133|FG002|COMPLETED|Overall Study||3||
59977806|NCT02707965|76095134|FG003|COMPLETED|Overall Study||0||
59977807|NCT02707965|76095135|FG004|COMPLETED|Overall Study||2||
59977808|NCT02707965|76095136|FG005|COMPLETED|Overall Study||1||
59977809|NCT02707965|76095137|FG006|COMPLETED|Overall Study||0||
59977810|NCT02707965|76095138|FG007|COMPLETED|Overall Study||0||
59977811|NCT02707965|76095139|FG008|COMPLETED|Overall Study||1||
59977812|NCT02707965|76095140|FG009|COMPLETED|Overall Study||0||
59977813|NCT02707965|76095141|FG010|COMPLETED|Overall Study||1||
59977814|NCT02707965|76095142|FG011|COMPLETED|Overall Study||0||
59977815|NCT02707965|76095143|FG012|COMPLETED|Overall Study||0||
59977816|NCT02707965|76095144|FG013|COMPLETED|Overall Study||2||
59977817|NCT02707965|76095145|FG014|COMPLETED|Overall Study||0||
59977818|NCT02707965|76095146|FG015|COMPLETED|Overall Study||0||
59977819|NCT02707965|76095131|FG000|NOT COMPLETED|Overall Study||1||
59977820|NCT02707965|76095132|FG001|NOT COMPLETED|Overall Study||1||
59977821|NCT02707965|76095133|FG002|NOT COMPLETED|Overall Study||1||
59977822|NCT02707965|76095134|FG003|NOT COMPLETED|Overall Study||0||
59977823|NCT02707965|76095135|FG004|NOT COMPLETED|Overall Study||0||
59977824|NCT02707965|76095136|FG005|NOT COMPLETED|Overall Study||0||
59977825|NCT02707965|76095137|FG006|NOT COMPLETED|Overall Study||0||
59977826|NCT02707965|76095138|FG007|NOT COMPLETED|Overall Study||3||
59977827|NCT02707965|76095139|FG008|NOT COMPLETED|Overall Study||0||
59977828|NCT02707965|76095140|FG009|NOT COMPLETED|Overall Study||0||
59977829|NCT02707965|76095141|FG010|NOT COMPLETED|Overall Study||0||
59977830|NCT02707965|76095142|FG011|NOT COMPLETED|Overall Study||0||
59977831|NCT02707965|76095143|FG012|NOT COMPLETED|Overall Study||0||
59977832|NCT02707965|76095144|FG013|NOT COMPLETED|Overall Study||0||
59977833|NCT02707965|76095145|FG014|NOT COMPLETED|Overall Study||2||
59977834|NCT02707965|76095146|FG015|NOT COMPLETED|Overall Study||0||
59977835|NCT01667900|76095184|FG000|STARTED|Part A, Period 1||1||
59977836|NCT01667900|76095185|FG001|STARTED|Part A, Period 1||1||
59977837|NCT01667900|76095186|FG002|STARTED|Part A, Period 1||1||
59977838|NCT01667900|76095187|FG003|STARTED|Part A, Period 1||1||
59526184|NCT01298167|75621729|FG001|NOT COMPLETED|Overall Study||0||
59977839|NCT01667900|76095188|FG004|STARTED|Part A, Period 1||1||
59977840|NCT01667900|76095189|FG005|STARTED|Part A, Period 1||1||
59977841|NCT01667900|76095190|FG006|STARTED|Part A, Period 1||1||
59977842|NCT01667900|76095191|FG007|STARTED|Part A, Period 1||1||
59977843|NCT01667900|76095192|FG008|STARTED|Part A, Period 1||1||
59977844|NCT01667900|76095193|FG009|STARTED|Part A, Period 1||1||
59977845|NCT01667900|76095194|FG010|STARTED|Part A, Period 1||1||
59977846|NCT01667900|76095195|FG011|STARTED|Part A, Period 1||1||
59977847|NCT01667900|76095196|FG012|STARTED|Part A, Period 1||1||
59977848|NCT01667900|76095197|FG013|STARTED|Part A, Period 1||1||
59977849|NCT01667900|76095198|FG014|STARTED|Part A, Period 1||1||
59977850|NCT01667900|76095199|FG015|STARTED|Part A, Period 1||1||
59977851|NCT01667900|76095200|FG016|STARTED|Part A, Period 1|Part B participants did not participate in Part A.|0||
59977852|NCT01667900|76095201|FG017|STARTED|Part A, Period 1|Part B participants did not participate in Part A.|0||
59977853|NCT01667900|76095202|FG018|STARTED|Part A, Period 1|Part B participants did not participate in Part A.|0||
59977854|NCT01667900|76095203|FG019|STARTED|Part A, Period 1|Part B participants did not participate in Part A.|0||
59977855|NCT01667900|76095184|FG000|COMPLETED|Part A, Period 1||1||
59977856|NCT01667900|76095185|FG001|COMPLETED|Part A, Period 1||1||
59977857|NCT01667900|76095186|FG002|COMPLETED|Part A, Period 1||1||
59977858|NCT01667900|76095187|FG003|COMPLETED|Part A, Period 1||1||
59977859|NCT01667900|76095188|FG004|COMPLETED|Part A, Period 1||1||
59977860|NCT01667900|76095189|FG005|COMPLETED|Part A, Period 1||1||
59977861|NCT01667900|76095190|FG006|COMPLETED|Part A, Period 1||1||
59977862|NCT01667900|76095191|FG007|COMPLETED|Part A, Period 1||1||
59977863|NCT01667900|76095192|FG008|COMPLETED|Part A, Period 1||1||
59977864|NCT01667900|76095193|FG009|COMPLETED|Part A, Period 1||1||
59977865|NCT01667900|76095194|FG010|COMPLETED|Part A, Period 1||1||
59977866|NCT01667900|76095195|FG011|COMPLETED|Part A, Period 1||1||
59977867|NCT01667900|76095196|FG012|COMPLETED|Part A, Period 1||1||
59977868|NCT01667900|76095197|FG013|COMPLETED|Part A, Period 1||1||
59977869|NCT01667900|76095198|FG014|COMPLETED|Part A, Period 1||1||
59977870|NCT01667900|76095199|FG015|COMPLETED|Part A, Period 1||1||
59977871|NCT01667900|76095200|FG016|COMPLETED|Part A, Period 1||0||
59977872|NCT01667900|76095201|FG017|COMPLETED|Part A, Period 1||0||
59977873|NCT01667900|76095202|FG018|COMPLETED|Part A, Period 1||0||
59977874|NCT01667900|76095203|FG019|COMPLETED|Part A, Period 1||0||
59622290|NCT02115750|75734067|FG000|NOT COMPLETED|Part 1||22||
59622291|NCT02115750|75734068|FG001|NOT COMPLETED|Part 1||12||
59622292|NCT02115750|75734067|FG000|STARTED|Part 2: All Subjects Receive CHS-0214||280||
59622293|NCT02115750|75734068|FG001|STARTED|Part 2: All Subjects Receive CHS-0214||284||
59814047|NCT00422097|75936455|FG005|NOT COMPLETED|Dose Level 6||0||
59977875|NCT01667900|76095184|FG000|NOT COMPLETED|Part A, Period 1||0||
59977876|NCT01667900|76095185|FG001|NOT COMPLETED|Part A, Period 1||0||
59977877|NCT01667900|76095186|FG002|NOT COMPLETED|Part A, Period 1||0||
59977878|NCT01667900|76095187|FG003|NOT COMPLETED|Part A, Period 1||0||
59977879|NCT01667900|76095188|FG004|NOT COMPLETED|Part A, Period 1||0||
59977880|NCT01667900|76095189|FG005|NOT COMPLETED|Part A, Period 1||0||
59977881|NCT01667900|76095190|FG006|NOT COMPLETED|Part A, Period 1||0||
59977882|NCT01667900|76095191|FG007|NOT COMPLETED|Part A, Period 1||0||
59977883|NCT01667900|76095192|FG008|NOT COMPLETED|Part A, Period 1||0||
59977884|NCT01667900|76095193|FG009|NOT COMPLETED|Part A, Period 1||0||
59977885|NCT01667900|76095194|FG010|NOT COMPLETED|Part A, Period 1||0||
59977886|NCT01667900|76095195|FG011|NOT COMPLETED|Part A, Period 1||0||
59977887|NCT01667900|76095196|FG012|NOT COMPLETED|Part A, Period 1||0||
59977888|NCT01667900|76095197|FG013|NOT COMPLETED|Part A, Period 1||0||
59977889|NCT01667900|76095198|FG014|NOT COMPLETED|Part A, Period 1||0||
59977890|NCT01667900|76095199|FG015|NOT COMPLETED|Part A, Period 1||0||
59977891|NCT01667900|76095200|FG016|NOT COMPLETED|Part A, Period 1||0||
59977892|NCT01667900|76095201|FG017|NOT COMPLETED|Part A, Period 1||0||
59977893|NCT01667900|76095202|FG018|NOT COMPLETED|Part A, Period 1||0||
59977894|NCT01667900|76095203|FG019|NOT COMPLETED|Part A, Period 1||0||
59977895|NCT01667900|76095184|FG000|STARTED|Part A, Washout 1||1||
59977896|NCT01667900|76095185|FG001|STARTED|Part A, Washout 1||1||
59977897|NCT01667900|76095186|FG002|STARTED|Part A, Washout 1||1||
59977898|NCT01667900|76095187|FG003|STARTED|Part A, Washout 1||1||
60074665|NCT01555125|76189974|FG004|STARTED|Follow-Up Period||0||
60074666|NCT01555125|76189970|FG000|COMPLETED|Follow-Up Period||32||
60074667|NCT01555125|76189971|FG001|COMPLETED|Follow-Up Period||30||
60074668|NCT01555125|76189972|FG002|COMPLETED|Follow-Up Period||18||
60074669|NCT01555125|76189973|FG003|COMPLETED|Follow-Up Period||17||
60074670|NCT01555125|76189974|FG004|COMPLETED|Follow-Up Period||0||
60074671|NCT01555125|76189970|FG000|NOT COMPLETED|Follow-Up Period||4||
60074672|NCT01555125|76189971|FG001|NOT COMPLETED|Follow-Up Period||1||
59622294|NCT02115750|75734067|FG000|COMPLETED|Part 2: All Subjects Receive CHS-0214||269||
59622295|NCT02115750|75734068|FG001|COMPLETED|Part 2: All Subjects Receive CHS-0214||272||
59622296|NCT02115750|75734067|FG000|NOT COMPLETED|Part 2: All Subjects Receive CHS-0214||11||
59622297|NCT02115750|75734068|FG001|NOT COMPLETED|Part 2: All Subjects Receive CHS-0214||12||
59622298|NCT02115828|75734076|FG000|STARTED|Overall Study||9||
59977899|NCT01667900|76095188|FG004|STARTED|Part A, Washout 1||1||
59977900|NCT01667900|76095189|FG005|STARTED|Part A, Washout 1||1||
59977901|NCT01667900|76095190|FG006|STARTED|Part A, Washout 1||1||
59977902|NCT01667900|76095191|FG007|STARTED|Part A, Washout 1||1||
59977903|NCT01667900|76095192|FG008|STARTED|Part A, Washout 1||1||
59977904|NCT01667900|76095193|FG009|STARTED|Part A, Washout 1||1||
59977905|NCT01667900|76095194|FG010|STARTED|Part A, Washout 1||1||
59977906|NCT01667900|76095195|FG011|STARTED|Part A, Washout 1||1||
59977907|NCT01667900|76095196|FG012|STARTED|Part A, Washout 1||1||
59977908|NCT01667900|76095197|FG013|STARTED|Part A, Washout 1||1||
60074673|NCT01555125|76189972|FG002|NOT COMPLETED|Follow-Up Period||1||
60074674|NCT01555125|76189973|FG003|NOT COMPLETED|Follow-Up Period||1||
59977909|NCT01667900|76095198|FG014|STARTED|Part A, Washout 1||1||
59977910|NCT01667900|76095199|FG015|STARTED|Part A, Washout 1||1||
59977911|NCT01667900|76095200|FG016|STARTED|Part A, Washout 1||0||
59977912|NCT01667900|76095201|FG017|STARTED|Part A, Washout 1||0||
59977913|NCT01667900|76095202|FG018|STARTED|Part A, Washout 1||0||
59977914|NCT01667900|76095203|FG019|STARTED|Part A, Washout 1||0||
59977915|NCT01667900|76095184|FG000|COMPLETED|Part A, Washout 1||1||
59977916|NCT01667900|76095185|FG001|COMPLETED|Part A, Washout 1||1||
59977917|NCT01667900|76095186|FG002|COMPLETED|Part A, Washout 1||1||
59977918|NCT01667900|76095187|FG003|COMPLETED|Part A, Washout 1||1||
59977919|NCT01667900|76095188|FG004|COMPLETED|Part A, Washout 1||1||
59977920|NCT01667900|76095189|FG005|COMPLETED|Part A, Washout 1||1||
59977921|NCT01667900|76095190|FG006|COMPLETED|Part A, Washout 1||1||
59977922|NCT01667900|76095191|FG007|COMPLETED|Part A, Washout 1||1||
59977923|NCT01667900|76095192|FG008|COMPLETED|Part A, Washout 1||1||
59977924|NCT01667900|76095193|FG009|COMPLETED|Part A, Washout 1||1||
59977925|NCT01667900|76095194|FG010|COMPLETED|Part A, Washout 1||1||
59977926|NCT01667900|76095195|FG011|COMPLETED|Part A, Washout 1||1||
59977927|NCT01667900|76095196|FG012|COMPLETED|Part A, Washout 1||1||
59977928|NCT01667900|76095197|FG013|COMPLETED|Part A, Washout 1||1||
59977929|NCT01667900|76095198|FG014|COMPLETED|Part A, Washout 1||1||
59977930|NCT01667900|76095199|FG015|COMPLETED|Part A, Washout 1||1||
59977931|NCT01667900|76095200|FG016|COMPLETED|Part A, Washout 1||0||
59977932|NCT01667900|76095201|FG017|COMPLETED|Part A, Washout 1||0||
59977933|NCT01667900|76095202|FG018|COMPLETED|Part A, Washout 1||0||
59977934|NCT01667900|76095203|FG019|COMPLETED|Part A, Washout 1||0||
59977935|NCT01667900|76095184|FG000|NOT COMPLETED|Part A, Washout 1||0||
59977936|NCT01667900|76095185|FG001|NOT COMPLETED|Part A, Washout 1||0||
59977937|NCT01667900|76095186|FG002|NOT COMPLETED|Part A, Washout 1||0||
59977938|NCT01667900|76095187|FG003|NOT COMPLETED|Part A, Washout 1||0||
59977939|NCT01667900|76095188|FG004|NOT COMPLETED|Part A, Washout 1||0||
59977940|NCT01667900|76095189|FG005|NOT COMPLETED|Part A, Washout 1||0||
59977941|NCT01667900|76095190|FG006|NOT COMPLETED|Part A, Washout 1||0||
59977942|NCT01667900|76095191|FG007|NOT COMPLETED|Part A, Washout 1||0||
59977943|NCT01667900|76095192|FG008|NOT COMPLETED|Part A, Washout 1||0||
59977944|NCT01667900|76095193|FG009|NOT COMPLETED|Part A, Washout 1||0||
59977945|NCT01667900|76095194|FG010|NOT COMPLETED|Part A, Washout 1||0||
59977946|NCT01667900|76095195|FG011|NOT COMPLETED|Part A, Washout 1||0||
59977947|NCT01667900|76095196|FG012|NOT COMPLETED|Part A, Washout 1||0||
59977948|NCT01667900|76095197|FG013|NOT COMPLETED|Part A, Washout 1||0||
59977949|NCT01667900|76095198|FG014|NOT COMPLETED|Part A, Washout 1||0||
59977950|NCT01667900|76095199|FG015|NOT COMPLETED|Part A, Washout 1||0||
59977951|NCT01667900|76095200|FG016|NOT COMPLETED|Part A, Washout 1||0||
59977952|NCT01667900|76095201|FG017|NOT COMPLETED|Part A, Washout 1||0||
59977953|NCT01667900|76095202|FG018|NOT COMPLETED|Part A, Washout 1||0||
59977954|NCT01667900|76095203|FG019|NOT COMPLETED|Part A, Washout 1||0||
59977955|NCT01667900|76095184|FG000|STARTED|Part A, Period 2||1||
59977956|NCT01667900|76095185|FG001|STARTED|Part A, Period 2||1||
59977957|NCT01667900|76095186|FG002|STARTED|Part A, Period 2||1||
59977958|NCT01667900|76095187|FG003|STARTED|Part A, Period 2||1||
59977959|NCT01667900|76095188|FG004|STARTED|Part A, Period 2||1||
59977960|NCT01667900|76095189|FG005|STARTED|Part A, Period 2||1||
59977961|NCT01667900|76095190|FG006|STARTED|Part A, Period 2||1||
59977962|NCT01667900|76095191|FG007|STARTED|Part A, Period 2||1||
59977963|NCT01667900|76095192|FG008|STARTED|Part A, Period 2||1||
59977964|NCT01667900|76095193|FG009|STARTED|Part A, Period 2||1||
59977965|NCT01667900|76095194|FG010|STARTED|Part A, Period 2||1||
59977966|NCT01667900|76095195|FG011|STARTED|Part A, Period 2||1||
59977967|NCT01667900|76095196|FG012|STARTED|Part A, Period 2||1||
59977968|NCT01667900|76095197|FG013|STARTED|Part A, Period 2||1||
59977969|NCT01667900|76095198|FG014|STARTED|Part A, Period 2||1||
59977970|NCT01667900|76095199|FG015|STARTED|Part A, Period 2||1||
59977971|NCT01667900|76095200|FG016|STARTED|Part A, Period 2||0||
59977972|NCT01667900|76095201|FG017|STARTED|Part A, Period 2||0||
59977973|NCT01667900|76095202|FG018|STARTED|Part A, Period 2||0||
59977974|NCT01667900|76095203|FG019|STARTED|Part A, Period 2||0||
59977975|NCT01667900|76095184|FG000|COMPLETED|Part A, Period 2||1||
59977976|NCT01667900|76095185|FG001|COMPLETED|Part A, Period 2||1||
59977977|NCT01667900|76095186|FG002|COMPLETED|Part A, Period 2||1||
59977978|NCT01667900|76095187|FG003|COMPLETED|Part A, Period 2||1||
59977979|NCT01667900|76095188|FG004|COMPLETED|Part A, Period 2||1||
59977980|NCT01667900|76095189|FG005|COMPLETED|Part A, Period 2||1||
59977981|NCT01667900|76095190|FG006|COMPLETED|Part A, Period 2||1||
59977982|NCT01667900|76095191|FG007|COMPLETED|Part A, Period 2||1||
59977983|NCT01667900|76095192|FG008|COMPLETED|Part A, Period 2||1||
59977984|NCT01667900|76095193|FG009|COMPLETED|Part A, Period 2||1||
59977985|NCT01667900|76095194|FG010|COMPLETED|Part A, Period 2||1||
59977986|NCT01667900|76095195|FG011|COMPLETED|Part A, Period 2||1||
59977987|NCT01667900|76095196|FG012|COMPLETED|Part A, Period 2||1||
59977988|NCT01667900|76095197|FG013|COMPLETED|Part A, Period 2||1||
59977989|NCT01667900|76095198|FG014|COMPLETED|Part A, Period 2||1||
59977990|NCT01667900|76095199|FG015|COMPLETED|Part A, Period 2||1||
59977991|NCT01667900|76095200|FG016|COMPLETED|Part A, Period 2||0||
59977992|NCT01667900|76095201|FG017|COMPLETED|Part A, Period 2||0||
59977993|NCT01667900|76095202|FG018|COMPLETED|Part A, Period 2||0||
59977994|NCT01667900|76095203|FG019|COMPLETED|Part A, Period 2||0||
59977995|NCT01667900|76095184|FG000|NOT COMPLETED|Part A, Period 2||0||
59977996|NCT01667900|76095185|FG001|NOT COMPLETED|Part A, Period 2||0||
59977997|NCT01667900|76095186|FG002|NOT COMPLETED|Part A, Period 2||0||
59977998|NCT01667900|76095187|FG003|NOT COMPLETED|Part A, Period 2||0||
59977999|NCT01667900|76095188|FG004|NOT COMPLETED|Part A, Period 2||0||
59978000|NCT01667900|76095189|FG005|NOT COMPLETED|Part A, Period 2||0||
59978001|NCT01667900|76095190|FG006|NOT COMPLETED|Part A, Period 2||0||
59978002|NCT01667900|76095191|FG007|NOT COMPLETED|Part A, Period 2||0||
59978003|NCT01667900|76095192|FG008|NOT COMPLETED|Part A, Period 2||0||
59978004|NCT01667900|76095193|FG009|NOT COMPLETED|Part A, Period 2||0||
59978005|NCT01667900|76095194|FG010|NOT COMPLETED|Part A, Period 2||0||
59978006|NCT01667900|76095195|FG011|NOT COMPLETED|Part A, Period 2||0||
59978007|NCT01667900|76095196|FG012|NOT COMPLETED|Part A, Period 2||0||
59978008|NCT01667900|76095197|FG013|NOT COMPLETED|Part A, Period 2||0||
59978009|NCT01667900|76095198|FG014|NOT COMPLETED|Part A, Period 2||0||
59978010|NCT01667900|76095199|FG015|NOT COMPLETED|Part A, Period 2||0||
59978011|NCT01667900|76095200|FG016|NOT COMPLETED|Part A, Period 2||0||
59978012|NCT01667900|76095201|FG017|NOT COMPLETED|Part A, Period 2||0||
59978013|NCT01667900|76095202|FG018|NOT COMPLETED|Part A, Period 2||0||
59978014|NCT01667900|76095203|FG019|NOT COMPLETED|Part A, Period 2||0||
59978015|NCT01667900|76095184|FG000|STARTED|Part A, Washout 2||1||
59978016|NCT01667900|76095185|FG001|STARTED|Part A, Washout 2||1||
59978017|NCT01667900|76095186|FG002|STARTED|Part A, Washout 2||1||
59978018|NCT01667900|76095187|FG003|STARTED|Part A, Washout 2||1||
59978019|NCT01667900|76095188|FG004|STARTED|Part A, Washout 2||1||
59978020|NCT01667900|76095189|FG005|STARTED|Part A, Washout 2||1||
59978021|NCT01667900|76095190|FG006|STARTED|Part A, Washout 2||1||
59978022|NCT01667900|76095191|FG007|STARTED|Part A, Washout 2||1||
59978023|NCT01667900|76095192|FG008|STARTED|Part A, Washout 2||1||
59978024|NCT01667900|76095193|FG009|STARTED|Part A, Washout 2||1||
59978025|NCT01667900|76095194|FG010|STARTED|Part A, Washout 2||1||
59978026|NCT01667900|76095195|FG011|STARTED|Part A, Washout 2||1||
59978027|NCT01667900|76095196|FG012|STARTED|Part A, Washout 2||1||
59978028|NCT01667900|76095197|FG013|STARTED|Part A, Washout 2||1||
59978029|NCT01667900|76095198|FG014|STARTED|Part A, Washout 2||1||
59978030|NCT01667900|76095199|FG015|STARTED|Part A, Washout 2||1||
59978031|NCT01667900|76095200|FG016|STARTED|Part A, Washout 2||0||
59978032|NCT01667900|76095201|FG017|STARTED|Part A, Washout 2||0||
59978033|NCT01667900|76095202|FG018|STARTED|Part A, Washout 2||0||
59978034|NCT01667900|76095203|FG019|STARTED|Part A, Washout 2||0||
59978035|NCT01667900|76095184|FG000|COMPLETED|Part A, Washout 2||1||
59978036|NCT01667900|76095185|FG001|COMPLETED|Part A, Washout 2||1||
59978037|NCT01667900|76095186|FG002|COMPLETED|Part A, Washout 2||1||
59978038|NCT01667900|76095187|FG003|COMPLETED|Part A, Washout 2||1||
59978039|NCT01667900|76095188|FG004|COMPLETED|Part A, Washout 2||1||
59978040|NCT01667900|76095189|FG005|COMPLETED|Part A, Washout 2||1||
59978041|NCT01667900|76095190|FG006|COMPLETED|Part A, Washout 2||1||
59978042|NCT01667900|76095191|FG007|COMPLETED|Part A, Washout 2||1||
59978043|NCT01667900|76095192|FG008|COMPLETED|Part A, Washout 2||1||
59978044|NCT01667900|76095193|FG009|COMPLETED|Part A, Washout 2||1||
59978045|NCT01667900|76095194|FG010|COMPLETED|Part A, Washout 2||1||
59978046|NCT01667900|76095195|FG011|COMPLETED|Part A, Washout 2||1||
59978047|NCT01667900|76095196|FG012|COMPLETED|Part A, Washout 2||1||
59978048|NCT01667900|76095197|FG013|COMPLETED|Part A, Washout 2||1||
59978049|NCT01667900|76095198|FG014|COMPLETED|Part A, Washout 2||1||
59978050|NCT01667900|76095199|FG015|COMPLETED|Part A, Washout 2||1||
59978051|NCT01667900|76095200|FG016|COMPLETED|Part A, Washout 2||0||
59978052|NCT01667900|76095201|FG017|COMPLETED|Part A, Washout 2||0||
59978053|NCT01667900|76095202|FG018|COMPLETED|Part A, Washout 2||0||
59978054|NCT01667900|76095203|FG019|COMPLETED|Part A, Washout 2||0||
59978055|NCT01667900|76095184|FG000|NOT COMPLETED|Part A, Washout 2||0||
59978056|NCT01667900|76095185|FG001|NOT COMPLETED|Part A, Washout 2||0||
59978057|NCT01667900|76095186|FG002|NOT COMPLETED|Part A, Washout 2||0||
59978058|NCT01667900|76095187|FG003|NOT COMPLETED|Part A, Washout 2||0||
59978059|NCT01667900|76095188|FG004|NOT COMPLETED|Part A, Washout 2||0||
59978060|NCT01667900|76095189|FG005|NOT COMPLETED|Part A, Washout 2||0||
59978061|NCT01667900|76095190|FG006|NOT COMPLETED|Part A, Washout 2||0||
59978062|NCT01667900|76095191|FG007|NOT COMPLETED|Part A, Washout 2||0||
59978063|NCT01667900|76095192|FG008|NOT COMPLETED|Part A, Washout 2||0||
59978064|NCT01667900|76095193|FG009|NOT COMPLETED|Part A, Washout 2||0||
59978065|NCT01667900|76095194|FG010|NOT COMPLETED|Part A, Washout 2||0||
59978066|NCT01667900|76095195|FG011|NOT COMPLETED|Part A, Washout 2||0||
59978067|NCT01667900|76095196|FG012|NOT COMPLETED|Part A, Washout 2||0||
59978068|NCT01667900|76095197|FG013|NOT COMPLETED|Part A, Washout 2||0||
59978069|NCT01667900|76095198|FG014|NOT COMPLETED|Part A, Washout 2||0||
59978070|NCT01667900|76095199|FG015|NOT COMPLETED|Part A, Washout 2||0||
59978071|NCT01667900|76095200|FG016|NOT COMPLETED|Part A, Washout 2||0||
59978072|NCT01667900|76095201|FG017|NOT COMPLETED|Part A, Washout 2||0||
59978073|NCT01667900|76095202|FG018|NOT COMPLETED|Part A, Washout 2||0||
59978074|NCT01667900|76095203|FG019|NOT COMPLETED|Part A, Washout 2||0||
59978075|NCT01667900|76095184|FG000|STARTED|Part A, Period 3||1||
59978076|NCT01667900|76095185|FG001|STARTED|Part A, Period 3||1||
59978077|NCT01667900|76095186|FG002|STARTED|Part A, Period 3||1||
59978078|NCT01667900|76095187|FG003|STARTED|Part A, Period 3||1||
59978079|NCT01667900|76095188|FG004|STARTED|Part A, Period 3||1||
59978080|NCT01667900|76095189|FG005|STARTED|Part A, Period 3||1||
59978081|NCT01667900|76095190|FG006|STARTED|Part A, Period 3||1||
59978082|NCT01667900|76095191|FG007|STARTED|Part A, Period 3||1||
59978083|NCT01667900|76095192|FG008|STARTED|Part A, Period 3||1||
59978084|NCT01667900|76095193|FG009|STARTED|Part A, Period 3||1||
59978085|NCT01667900|76095194|FG010|STARTED|Part A, Period 3||1||
59978086|NCT01667900|76095195|FG011|STARTED|Part A, Period 3||1||
59978087|NCT01667900|76095196|FG012|STARTED|Part A, Period 3||1||
59978088|NCT01667900|76095197|FG013|STARTED|Part A, Period 3||1||
59978089|NCT01667900|76095198|FG014|STARTED|Part A, Period 3||1||
59978090|NCT01667900|76095199|FG015|STARTED|Part A, Period 3||1||
59978091|NCT01667900|76095200|FG016|STARTED|Part A, Period 3||0||
59978092|NCT01667900|76095201|FG017|STARTED|Part A, Period 3||0||
59978093|NCT01667900|76095202|FG018|STARTED|Part A, Period 3||0||
59978094|NCT01667900|76095203|FG019|STARTED|Part A, Period 3||0||
59978095|NCT01667900|76095184|FG000|COMPLETED|Part A, Period 3||1||
59978096|NCT01667900|76095185|FG001|COMPLETED|Part A, Period 3||1||
59978097|NCT01667900|76095186|FG002|COMPLETED|Part A, Period 3||1||
59978098|NCT01667900|76095187|FG003|COMPLETED|Part A, Period 3||1||
59978099|NCT01667900|76095188|FG004|COMPLETED|Part A, Period 3||1||
59978100|NCT01667900|76095189|FG005|COMPLETED|Part A, Period 3||1||
59978101|NCT01667900|76095190|FG006|COMPLETED|Part A, Period 3||1||
59978102|NCT01667900|76095191|FG007|COMPLETED|Part A, Period 3||1||
59978103|NCT01667900|76095192|FG008|COMPLETED|Part A, Period 3||1||
59978104|NCT01667900|76095193|FG009|COMPLETED|Part A, Period 3||1||
59978105|NCT01667900|76095194|FG010|COMPLETED|Part A, Period 3||1||
59978106|NCT01667900|76095195|FG011|COMPLETED|Part A, Period 3||1||
59978107|NCT01667900|76095196|FG012|COMPLETED|Part A, Period 3||1||
59978108|NCT01667900|76095197|FG013|COMPLETED|Part A, Period 3||1||
59978109|NCT01667900|76095198|FG014|COMPLETED|Part A, Period 3||1||
59978110|NCT01667900|76095199|FG015|COMPLETED|Part A, Period 3||1||
59978111|NCT01667900|76095200|FG016|COMPLETED|Part A, Period 3||0||
59978112|NCT01667900|76095201|FG017|COMPLETED|Part A, Period 3||0||
59978113|NCT01667900|76095202|FG018|COMPLETED|Part A, Period 3||0||
59978114|NCT01667900|76095203|FG019|COMPLETED|Part A, Period 3||0||
59978115|NCT01667900|76095184|FG000|NOT COMPLETED|Part A, Period 3||0||
59978116|NCT01667900|76095185|FG001|NOT COMPLETED|Part A, Period 3||0||
59978117|NCT01667900|76095186|FG002|NOT COMPLETED|Part A, Period 3||0||
59978118|NCT01667900|76095187|FG003|NOT COMPLETED|Part A, Period 3||0||
59978119|NCT01667900|76095188|FG004|NOT COMPLETED|Part A, Period 3||0||
59978120|NCT01667900|76095189|FG005|NOT COMPLETED|Part A, Period 3||0||
59978121|NCT01667900|76095190|FG006|NOT COMPLETED|Part A, Period 3||0||
59978122|NCT01667900|76095191|FG007|NOT COMPLETED|Part A, Period 3||0||
59978123|NCT01667900|76095192|FG008|NOT COMPLETED|Part A, Period 3||0||
59978124|NCT01667900|76095193|FG009|NOT COMPLETED|Part A, Period 3||0||
59978125|NCT01667900|76095194|FG010|NOT COMPLETED|Part A, Period 3||0||
59978126|NCT01667900|76095195|FG011|NOT COMPLETED|Part A, Period 3||0||
59978127|NCT01667900|76095196|FG012|NOT COMPLETED|Part A, Period 3||0||
59978128|NCT01667900|76095197|FG013|NOT COMPLETED|Part A, Period 3||0||
59978129|NCT01667900|76095198|FG014|NOT COMPLETED|Part A, Period 3||0||
59978130|NCT01667900|76095199|FG015|NOT COMPLETED|Part A, Period 3||0||
59978131|NCT01667900|76095200|FG016|NOT COMPLETED|Part A, Period 3||0||
59978132|NCT01667900|76095201|FG017|NOT COMPLETED|Part A, Period 3||0||
59978133|NCT01667900|76095202|FG018|NOT COMPLETED|Part A, Period 3||0||
59978134|NCT01667900|76095203|FG019|NOT COMPLETED|Part A, Period 3||0||
59978135|NCT01667900|76095184|FG000|STARTED|Part B|Part A participants did not participate in Part B.|0||
59978136|NCT01667900|76095185|FG001|STARTED|Part B|Part A participants did not participate in Part B.|0||
59978137|NCT01667900|76095186|FG002|STARTED|Part B|Part A participants did not participate in Part B.|0||
59978138|NCT01667900|76095187|FG003|STARTED|Part B|Part A participants did not participate in Part B.|0||
59978139|NCT01667900|76095188|FG004|STARTED|Part B|Part A participants did not participate in Part B.|0||
59978140|NCT01667900|76095189|FG005|STARTED|Part B|Part A participants did not participate in Part B.|0||
59978141|NCT01667900|76095190|FG006|STARTED|Part B|Part A participants did not participate in Part B.|0||
59978142|NCT01667900|76095191|FG007|STARTED|Part B|Part A participants did not participate in Part B.|0||
59978143|NCT01667900|76095192|FG008|STARTED|Part B|Part A participants did not participate in Part B.|0||
59978144|NCT01667900|76095193|FG009|STARTED|Part B|Part A participants did not participate in Part B.|0||
59978145|NCT01667900|76095194|FG010|STARTED|Part B|Part A participants did not participate in Part B.|0||
59978146|NCT01667900|76095195|FG011|STARTED|Part B|Part A participants did not participate in Part B.|0||
59978147|NCT01667900|76095196|FG012|STARTED|Part B|Part A participants did not participate in Part B.|0||
59978148|NCT01667900|76095197|FG013|STARTED|Part B|Part A participants did not participate in Part B.|0||
59978149|NCT01667900|76095198|FG014|STARTED|Part B|Part A participants did not participate in Part B.|0||
59978150|NCT01667900|76095199|FG015|STARTED|Part B|Part A participants did not participate in Part B.|0||
59978151|NCT01667900|76095200|FG016|STARTED|Part B||11||
59978152|NCT01667900|76095201|FG017|STARTED|Part B||11||
59978153|NCT01667900|76095202|FG018|STARTED|Part B||10||
59978154|NCT01667900|76095203|FG019|STARTED|Part B||10||
59526185|NCT01280695|75621740|FG000|STARTED|Overall Study||26||
59978155|NCT01667900|76095184|FG000|COMPLETED|Part B||0||
59978156|NCT01667900|76095185|FG001|COMPLETED|Part B||0||
59526186|NCT01280695|75621741|FG001|STARTED|Overall Study||25||
59978157|NCT01667900|76095186|FG002|COMPLETED|Part B||0||
59978158|NCT01667900|76095187|FG003|COMPLETED|Part B||0||
59978159|NCT01667900|76095188|FG004|COMPLETED|Part B||0||
59978160|NCT01667900|76095189|FG005|COMPLETED|Part B||0||
59978161|NCT01667900|76095190|FG006|COMPLETED|Part B||0||
59978162|NCT01667900|76095191|FG007|COMPLETED|Part B||0||
59978163|NCT01667900|76095192|FG008|COMPLETED|Part B||0||
59978164|NCT01667900|76095193|FG009|COMPLETED|Part B||0||
59978165|NCT01667900|76095194|FG010|COMPLETED|Part B||0||
59978166|NCT01667900|76095195|FG011|COMPLETED|Part B||0||
59978167|NCT01667900|76095196|FG012|COMPLETED|Part B||0||
59978168|NCT01667900|76095197|FG013|COMPLETED|Part B||0||
59978169|NCT01667900|76095198|FG014|COMPLETED|Part B||0||
59978170|NCT01667900|76095199|FG015|COMPLETED|Part B||0||
59978171|NCT01667900|76095200|FG016|COMPLETED|Part B||10||
59978172|NCT01667900|76095201|FG017|COMPLETED|Part B||11||
59978173|NCT01667900|76095202|FG018|COMPLETED|Part B||10||
59978174|NCT01667900|76095203|FG019|COMPLETED|Part B||10||
59978175|NCT01667900|76095184|FG000|NOT COMPLETED|Part B||0||
59978176|NCT01667900|76095185|FG001|NOT COMPLETED|Part B||0||
59978177|NCT01667900|76095186|FG002|NOT COMPLETED|Part B||0||
59978178|NCT01667900|76095187|FG003|NOT COMPLETED|Part B||0||
59978179|NCT01667900|76095188|FG004|NOT COMPLETED|Part B||0||
59978180|NCT01667900|76095189|FG005|NOT COMPLETED|Part B||0||
59978181|NCT01667900|76095190|FG006|NOT COMPLETED|Part B||0||
59978182|NCT01667900|76095191|FG007|NOT COMPLETED|Part B||0||
59978183|NCT01667900|76095192|FG008|NOT COMPLETED|Part B||0||
59978184|NCT01667900|76095193|FG009|NOT COMPLETED|Part B||0||
59978185|NCT01667900|76095194|FG010|NOT COMPLETED|Part B||0||
59978186|NCT01667900|76095195|FG011|NOT COMPLETED|Part B||0||
59978187|NCT01667900|76095196|FG012|NOT COMPLETED|Part B||0||
59978188|NCT01667900|76095197|FG013|NOT COMPLETED|Part B||0||
59978189|NCT01667900|76095198|FG014|NOT COMPLETED|Part B||0||
59978190|NCT01667900|76095199|FG015|NOT COMPLETED|Part B||0||
59978191|NCT01667900|76095200|FG016|NOT COMPLETED|Part B||1||
59978192|NCT01667900|76095201|FG017|NOT COMPLETED|Part B||0||
59978193|NCT01667900|76095202|FG018|NOT COMPLETED|Part B||0||
59978194|NCT01667900|76095203|FG019|NOT COMPLETED|Part B||0||
59978195|NCT00702273|76095225|FG000|STARTED|Base Study P05787 (NCT00696800)|Participants randomized to the base study P05787 (NCT00696800)|757||
59978196|NCT00702273|76095226|FG001|STARTED|Base Study P05787 (NCT00696800)|Participants randomized to the base study P05787 (NCT00696800)|752||
59978197|NCT00702273|76095225|FG000|Treated|Base Study P05787 (NCT00696800)|Participants from the Intent to Treat group (ITT) from the base study P05787 (NCT00696800)|756||
59978198|NCT00702273|76095226|FG001|Treated|Base Study P05787 (NCT00696800)|Participants from the Intent to Treat group (ITT) from the base study P05787 (NCT00696800)|750||
59978199|NCT00702273|76095225|FG000|COMPLETED|Base Study P05787 (NCT00696800)|To complete study, participants from the base study P05787 (NCT00696800) had embryos transferred|672||
59978200|NCT00702273|76095226|FG001|COMPLETED|Base Study P05787 (NCT00696800)|To complete study, participants from the base study P05787 (NCT00696800) had embryos transferred|704||
59978201|NCT00702273|76095225|FG000|NOT COMPLETED|Base Study P05787 (NCT00696800)||85||
59978202|NCT00702273|76095226|FG001|NOT COMPLETED|Base Study P05787 (NCT00696800)||48||
59978203|NCT00702273|76095225|FG000|STARTED|Follow Up Study P05716 (NCT00702273)|Participants from base study,who had at least one embryo thawed for a FTET cycle.|168||
59978204|NCT00702273|76095226|FG001|STARTED|Follow Up Study P05716 (NCT00702273)|Participants from base study, who had at least one embryo thawed for a FTET cycle|176||
59978205|NCT00702273|76095225|FG000|COMPLETED|Follow Up Study P05716 (NCT00702273)|Participants with embryo transfer in any FTET cycle|148||
59978206|NCT00702273|76095226|FG001|COMPLETED|Follow Up Study P05716 (NCT00702273)|Participants with embryo transfer in any FTET cycle|147||
59978207|NCT00702273|76095225|FG000|NOT COMPLETED|Follow Up Study P05716 (NCT00702273)||20||
59978208|NCT00702273|76095226|FG001|NOT COMPLETED|Follow Up Study P05716 (NCT00702273)||29||
60074675|NCT01555125|76189974|FG004|NOT COMPLETED|Follow-Up Period||0||
59978209|NCT02605928|76095232|FG000|STARTED|Overall Study||79||132
59978210|NCT02605928|76095232|FG000|Pivotal Phase, Statistical Phase|Overall Study||51|First punctures utilized for model tuning. Performance of the device was evaluated after tuning.|80
59978211|NCT02605928|76095232|FG000|COMPLETED|Overall Study||46|Included to statistical analysis|72
59978212|NCT02605928|76095232|FG000|NOT COMPLETED|Overall Study||33||60
59978213|NCT02706717|76095238|FG000|STARTED|Overall Study||47||
59978214|NCT02706717|76095239|FG001|STARTED|Overall Study|3 placebo participants never initiated study treatment.|46||
59978215|NCT02706717|76095238|FG000|COMPLETED|Overall Study||46||
60074676|NCT01768286|76189993|FG000|STARTED|Overall Study||109||
60074677|NCT01768286|76189994|FG001|STARTED|Overall Study||111||
60074678|NCT01768286|76189995|FG002|STARTED|Overall Study||110||
60074679|NCT01768286|76189996|FG003|STARTED|Overall Study||111||
60074680|NCT01768286|76189993|FG000|COMPLETED|Overall Study||102||
60074681|NCT01768286|76189994|FG001|COMPLETED|Overall Study||107||
60074682|NCT01768286|76189995|FG002|COMPLETED|Overall Study||108||
60074683|NCT01768286|76189996|FG003|COMPLETED|Overall Study||110||
59526187|NCT01280695|75621742|FG002|STARTED|Overall Study||26||
59978216|NCT02706717|76095239|FG001|COMPLETED|Overall Study||35||
59978217|NCT02706717|76095238|FG000|NOT COMPLETED|Overall Study||1||
59978218|NCT02706717|76095239|FG001|NOT COMPLETED|Overall Study||11||
60074684|NCT01768286|76189993|FG000|NOT COMPLETED|Overall Study||7||
60074685|NCT01768286|76189994|FG001|NOT COMPLETED|Overall Study||4||
60074686|NCT01768286|76189995|FG002|NOT COMPLETED|Overall Study||2||
59978219|NCT01331837|76095247|FG000|STARTED|Overall Study||1538||
59978220|NCT01331837|76095248|FG001|STARTED|Overall Study||1542||
59978221|NCT01331837|76095247|FG000|COMPLETED|Overall Study||1482||
59978222|NCT01331837|76095248|FG001|COMPLETED|Overall Study||1475||
59978223|NCT01331837|76095247|FG000|NOT COMPLETED|Overall Study||56||
59978224|NCT01331837|76095248|FG001|NOT COMPLETED|Overall Study||67||
59978225|NCT02706483|76095254|FG000|STARTED|Overall Study||2272||
59978226|NCT02706483|76095254|FG000|COMPLETED|Overall Study||1842||
59978227|NCT02706483|76095254|FG000|NOT COMPLETED|Overall Study||430||
59978228|NCT01648348|76095261|FG000|STARTED|Overall Study||5||
59978229|NCT01648348|76095262|FG001|STARTED|Overall Study||3||
59978230|NCT01648348|76095263|FG002|STARTED|Overall Study||4||
59978231|NCT01648348|76095264|FG003|STARTED|Overall Study||3||
59978232|NCT01648348|76095265|FG004|STARTED|Overall Study||52||
59978233|NCT01648348|76095266|FG005|STARTED|Overall Study||49||
59978234|NCT01648348|76095261|FG000|COMPLETED|Overall Study||3||
59978235|NCT01648348|76095262|FG001|COMPLETED|Overall Study||3||
59978236|NCT01648348|76095263|FG002|COMPLETED|Overall Study||3||
59978237|NCT01648348|76095264|FG003|COMPLETED|Overall Study||3||
59978238|NCT01648348|76095265|FG004|COMPLETED|Overall Study||49||
59978239|NCT01648348|76095266|FG005|COMPLETED|Overall Study||43||
59978240|NCT01648348|76095261|FG000|NOT COMPLETED|Overall Study||2||
59978241|NCT01648348|76095262|FG001|NOT COMPLETED|Overall Study||0||
59978242|NCT01648348|76095263|FG002|NOT COMPLETED|Overall Study||1||
59978243|NCT01648348|76095264|FG003|NOT COMPLETED|Overall Study||0||
59978244|NCT01648348|76095265|FG004|NOT COMPLETED|Overall Study||3||
59978245|NCT01648348|76095266|FG005|NOT COMPLETED|Overall Study||6||
59978246|NCT01648270|76095279|FG000|STARTED|Intravenous Buprenorphine||25||
59978247|NCT01648270|76095279|FG000|COMPLETED|Intravenous Buprenorphine||13||
59978248|NCT01648270|76095279|FG000|NOT COMPLETED|Intravenous Buprenorphine||12||
59978249|NCT01648270|76095279|FG000|STARTED|Sublingual Buprenorphine||13||
59978250|NCT01648270|76095279|FG000|COMPLETED|Sublingual Buprenorphine||13||
59978251|NCT01648270|76095279|FG000|NOT COMPLETED|Sublingual Buprenorphine||0||
59978252|NCT01648270|76095279|FG000|STARTED|Cyclosporine Plus IV Buprenorphine||13||
59978253|NCT01648270|76095279|FG000|COMPLETED|Cyclosporine Plus IV Buprenorphine||13||
59978254|NCT01648270|76095279|FG000|NOT COMPLETED|Cyclosporine Plus IV Buprenorphine||0||
59622299|NCT02115828|75734076|FG000|COMPLETED|Overall Study||9||
59622300|NCT02115828|75734076|FG000|NOT COMPLETED|Overall Study||0||
59622301|NCT02115984|75734082|FG000|STARTED|Overall Study||57||
59622302|NCT02115984|75734083|FG001|STARTED|Overall Study||23||
59622303|NCT02115984|75734082|FG000|COMPLETED|Overall Study||51||
59622304|NCT02115984|75734083|FG001|COMPLETED|Overall Study||16||
59622305|NCT02115984|75734082|FG000|NOT COMPLETED|Overall Study||6||
59622306|NCT02115984|75734083|FG001|NOT COMPLETED|Overall Study||7||
59978255|NCT01648270|76095279|FG000|STARTED|Cyclosporine + Sublingual Buprenorphine||13||
59978256|NCT01648270|76095279|FG000|COMPLETED|Cyclosporine + Sublingual Buprenorphine||13||
59978257|NCT01648270|76095279|FG000|NOT COMPLETED|Cyclosporine + Sublingual Buprenorphine||0||
59978258|NCT02302846|76095289|FG000|STARTED|Overall Study||5||
59978259|NCT02302846|76095289|FG000|COMPLETED|Overall Study||4||
59978260|NCT02302846|76095289|FG000|NOT COMPLETED|Overall Study||1||
59978261|NCT02336230|76095293|FG000|STARTED|Overall Study||55||
59978262|NCT02336230|76095293|FG000|Full Analysis Set (FAS)|Overall Study||55|The FAS included all participants who provided informed consent, were screened, and were found eligible to enter the study.|
59978263|NCT02336230|76095293|FG000|Safety Analysis Population|Overall Study||54|The Safety Analysis Population included all participants who signed the informed consent form and received at least 1 dose of remestemcel-L.|
59978264|NCT02336230|76095293|FG000|COMPLETED|Overall Study||42||
59978265|NCT02336230|76095293|FG000|NOT COMPLETED|Overall Study||13||
59978266|NCT02302222|76095299|FG000|STARTED|Overall Study||34||
59978267|NCT02302222|76095300|FG001|STARTED|Overall Study||37||
59978268|NCT02302222|76095299|FG000|COMPLETED|Overall Study||33||
59978269|NCT02302222|76095300|FG001|COMPLETED|Overall Study||31||
59978270|NCT02302222|76095299|FG000|NOT COMPLETED|Overall Study||1||
59978271|NCT02302222|76095300|FG001|NOT COMPLETED|Overall Study||6||
59978272|NCT02335450|76095306|FG000|STARTED|Overall Study||5||
59978273|NCT02335450|76095306|FG000|COMPLETED|Overall Study||4||
59978274|NCT02335450|76095306|FG000|NOT COMPLETED|Overall Study||1||
59622307|NCT00413166|75734092|FG000|STARTED|Overall Study||57||
59622308|NCT00413166|75734093|FG001|STARTED|Overall Study||5||
59622309|NCT00413166|75734094|FG002|STARTED|Overall Study||16||
59978275|NCT02302066|76095320|FG000|STARTED|Overall Study||201||
59978276|NCT02302066|76095321|FG001|STARTED|Overall Study||398||
59978277|NCT02302066|76095322|FG002|STARTED|Overall Study||1002||
59978278|NCT02302066|76095323|FG003|STARTED|Overall Study||199||
59978279|NCT02302066|76095320|FG000|Safety Analysis Set|Overall Study||200||
59978280|NCT02302066|76095321|FG001|Safety Analysis Set|Overall Study||398||
59622310|NCT00413166|75734092|FG000|COMPLETED|Overall Study||57||
59622311|NCT00413166|75734093|FG001|COMPLETED|Overall Study||5||
59622312|NCT00413166|75734094|FG002|COMPLETED|Overall Study||16||
59622313|NCT00413166|75734092|FG000|NOT COMPLETED|Overall Study||0||
59622314|NCT00413166|75734093|FG001|NOT COMPLETED|Overall Study||0||
59622315|NCT00413166|75734094|FG002|NOT COMPLETED|Overall Study||0||
59622316|NCT00386880|75734102|FG000|STARTED|Overall Study||30||
59622317|NCT00386880|75734103|FG001|STARTED|Overall Study||8||
59978281|NCT02302066|76095322|FG002|Safety Analysis Set|Overall Study||998||
59978282|NCT02302066|76095323|FG003|Safety Analysis Set|Overall Study||198||
59978283|NCT02302066|76095320|FG000|Immunogenicity Subset|Overall Study||92||
59978284|NCT02302066|76095321|FG001|Immunogenicity Subset|Overall Study||187||
59978285|NCT02302066|76095322|FG002|Immunogenicity Subset|Overall Study||192||
59978286|NCT02302066|76095323|FG003|Immunogenicity Subset|Overall Study||94||
59978287|NCT02302066|76095320|FG000|Per-Protocol Set (PPS)|Overall Study||83||
59978288|NCT02302066|76095321|FG001|Per-Protocol Set (PPS)|Overall Study||171||
59978289|NCT02302066|76095322|FG002|Per-Protocol Set (PPS)|Overall Study||174||
59978290|NCT02302066|76095323|FG003|Per-Protocol Set (PPS)|Overall Study||81||
59978291|NCT02302066|76095320|FG000|COMPLETED|Overall Study||168||
59978292|NCT02302066|76095321|FG001|COMPLETED|Overall Study||323||
59978293|NCT02302066|76095322|FG002|COMPLETED|Overall Study||830||
59978294|NCT02302066|76095323|FG003|COMPLETED|Overall Study||158||
59978295|NCT02302066|76095320|FG000|NOT COMPLETED|Overall Study||33||
59978296|NCT02302066|76095321|FG001|NOT COMPLETED|Overall Study||75||
59978297|NCT02302066|76095322|FG002|NOT COMPLETED|Overall Study||172||
59978298|NCT02302066|76095323|FG003|NOT COMPLETED|Overall Study||41||
59978299|NCT02301988|76095345|FG000|STARTED|Overall Study||76||
59978300|NCT02301988|76095346|FG001|STARTED|Overall Study||75||
59978301|NCT02301988|76095345|FG000|COMPLETED|Overall Study||66||
59978302|NCT02301988|76095346|FG001|COMPLETED|Overall Study||66||
59978303|NCT02301988|76095345|FG000|NOT COMPLETED|Overall Study||10||
59978304|NCT02301988|76095346|FG001|NOT COMPLETED|Overall Study||9||
59978305|NCT04326920|76095354|FG000|STARTED|Overall Study||40||
59978306|NCT04326920|76095355|FG001|STARTED|Overall Study||41||
59978307|NCT04326920|76095354|FG000|COMPLETED|Overall Study||40||
59978308|NCT04326920|76095355|FG001|COMPLETED|Overall Study||39||
59978309|NCT04326920|76095354|FG000|NOT COMPLETED|Overall Study||0||
59814048|NCT00422097|75936456|FG006|NOT COMPLETED|Dose Level 6||0||
59978310|NCT04326920|76095355|FG001|NOT COMPLETED|Overall Study||2||
59978311|NCT02334748|76095361|FG000|STARTED|Overall Study||31|31|
59978312|NCT02334748|76095361|FG000|COMPLETED|Overall Study||23|23|
59978313|NCT02334748|76095361|FG000|NOT COMPLETED|Overall Study||8||
59978314|NCT02332876|76095367|FG000|STARTED|Overall Study||43||
59978315|NCT02332876|76095368|FG001|STARTED|Overall Study||44||
59978316|NCT02332876|76095367|FG000|COMPLETED|Overall Study||42||
59978317|NCT02332876|76095368|FG001|COMPLETED|Overall Study||43||
59978318|NCT02332876|76095367|FG000|NOT COMPLETED|Overall Study||1||
59978319|NCT02332876|76095368|FG001|NOT COMPLETED|Overall Study||1||
59978320|NCT02332798|76095377|FG000|STARTED|Overall Study||13||
59978321|NCT02332798|76095378|FG001|STARTED|Overall Study||14||
59978322|NCT02332798|76095379|FG002|STARTED|Overall Study||12||
59978323|NCT02332798|76095377|FG000|COMPLETED|Overall Study||12||
59978324|NCT02332798|76095378|FG001|COMPLETED|Overall Study||12||
59978325|NCT02332798|76095379|FG002|COMPLETED|Overall Study||11||
59814049|NCT00422097|75936457|FG007|NOT COMPLETED|Dose Level 6||0||
59814050|NCT00422097|75936450|FG000|STARTED|Ixabepilone With Famotidine or Food||0||
59814051|NCT00422097|75936451|FG001|STARTED|Ixabepilone With Famotidine or Food||0||
59814052|NCT00422097|75936452|FG002|STARTED|Ixabepilone With Famotidine or Food||0||
59814053|NCT00422097|75936453|FG003|STARTED|Ixabepilone With Famotidine or Food||0||
59814054|NCT00422097|75936454|FG004|STARTED|Ixabepilone With Famotidine or Food||0||
59814055|NCT00422097|75936455|FG005|STARTED|Ixabepilone With Famotidine or Food||0||
59814056|NCT00422097|75936456|FG006|STARTED|Ixabepilone With Famotidine or Food||8||
59814057|NCT00422097|75936457|FG007|STARTED|Ixabepilone With Famotidine or Food||7||
59814058|NCT00422097|75936450|FG000|COMPLETED|Ixabepilone With Famotidine or Food||0||
59978326|NCT02332798|76095377|FG000|NOT COMPLETED|Overall Study||1||
59978327|NCT02332798|76095378|FG001|NOT COMPLETED|Overall Study||2||
59978328|NCT02332798|76095379|FG002|NOT COMPLETED|Overall Study||1||
59978329|NCT02790437|76095389|FG000|STARTED|Overall Study||16||
59978330|NCT02790437|76095390|FG001|STARTED|Overall Study||3||
59978331|NCT02790437|76095389|FG000|COMPLETED|Overall Study||13||
59978332|NCT02790437|76095390|FG001|COMPLETED|Overall Study||3||
59978333|NCT02790437|76095389|FG000|NOT COMPLETED|Overall Study||3||
59978334|NCT02790437|76095390|FG001|NOT COMPLETED|Overall Study||0||
59978335|NCT02604212|76095407|FG000|STARTED|Overall Study||6||
59978336|NCT02604212|76095408|FG001|STARTED|Overall Study||5||
59978337|NCT02604212|76095409|FG002|STARTED|Overall Study||10||
59978338|NCT02604212|76095410|FG003|STARTED|Overall Study||11||
59978339|NCT02604212|76095407|FG000|COMPLETED|Overall Study||4||
59978340|NCT02604212|76095408|FG001|COMPLETED|Overall Study||4||
59978341|NCT02604212|76095409|FG002|COMPLETED|Overall Study||6||
59978342|NCT02604212|76095410|FG003|COMPLETED|Overall Study||8||
59978343|NCT02604212|76095407|FG000|NOT COMPLETED|Overall Study||2||
59978344|NCT02604212|76095408|FG001|NOT COMPLETED|Overall Study||1||
59978345|NCT02604212|76095409|FG002|NOT COMPLETED|Overall Study||4||
59978346|NCT02604212|76095410|FG003|NOT COMPLETED|Overall Study||3||
59978347|NCT02789111|76095427|FG000|STARTED|Overall Study||24||
59978348|NCT02789111|76095428|FG001|STARTED|Overall Study||25||
59978349|NCT02789111|76095427|FG000|COMPLETED|Overall Study||23||
59978350|NCT02789111|76095428|FG001|COMPLETED|Overall Study||21||
59978351|NCT02789111|76095427|FG000|NOT COMPLETED|Overall Study||1||
59978352|NCT02789111|76095428|FG001|NOT COMPLETED|Overall Study||4||
59978353|NCT01359644|76095446|FG000|STARTED|Treatment Period||15||
59978354|NCT01359644|76095447|FG001|STARTED|Treatment Period||16||
59978355|NCT01359644|76095448|FG002|STARTED|Treatment Period||14||
59978356|NCT01359644|76095449|FG003|STARTED|Treatment Period||14||
59978357|NCT01359644|76095450|FG004|STARTED|Treatment Period||15||
59978358|NCT01359644|76095451|FG005|STARTED|Treatment Period||14||
59978359|NCT01359644|76095452|FG006|STARTED|Treatment Period||41||
59978360|NCT01359644|76095453|FG007|STARTED|Treatment Period||41||
59978361|NCT01359644|76095454|FG008|STARTED|Treatment Period||21||
59978362|NCT01359644|76095455|FG009|STARTED|Treatment Period||20||
59978363|NCT01359644|76095446|FG000|COMPLETED|Treatment Period||15||
59978364|NCT01359644|76095447|FG001|COMPLETED|Treatment Period||15||
59978365|NCT01359644|76095448|FG002|COMPLETED|Treatment Period||13||
59978366|NCT01359644|76095449|FG003|COMPLETED|Treatment Period||14||
59978367|NCT01359644|76095450|FG004|COMPLETED|Treatment Period||15||
59978368|NCT01359644|76095451|FG005|COMPLETED|Treatment Period||12||
59978369|NCT01359644|76095452|FG006|COMPLETED|Treatment Period||41||
59978370|NCT01359644|76095453|FG007|COMPLETED|Treatment Period||41||
59978371|NCT01359644|76095454|FG008|COMPLETED|Treatment Period||21||
59978372|NCT01359644|76095455|FG009|COMPLETED|Treatment Period||20||
59978373|NCT01359644|76095446|FG000|NOT COMPLETED|Treatment Period||0||
59978374|NCT01359644|76095447|FG001|NOT COMPLETED|Treatment Period||1||
59978375|NCT01359644|76095448|FG002|NOT COMPLETED|Treatment Period||1||
59978376|NCT01359644|76095449|FG003|NOT COMPLETED|Treatment Period||0||
59978377|NCT01359644|76095450|FG004|NOT COMPLETED|Treatment Period||0||
59978378|NCT01359644|76095451|FG005|NOT COMPLETED|Treatment Period||2||
59978379|NCT01359644|76095452|FG006|NOT COMPLETED|Treatment Period||0||
59978380|NCT01359644|76095453|FG007|NOT COMPLETED|Treatment Period||0||
59978381|NCT01359644|76095454|FG008|NOT COMPLETED|Treatment Period||0||
59978382|NCT01359644|76095455|FG009|NOT COMPLETED|Treatment Period||0||
59978383|NCT01359644|76095446|FG000|STARTED|Follow-up Period||15||
59978384|NCT01359644|76095447|FG001|STARTED|Follow-up Period||16||
59978385|NCT01359644|76095448|FG002|STARTED|Follow-up Period||14||
59978386|NCT01359644|76095449|FG003|STARTED|Follow-up Period||14||
59978387|NCT01359644|76095450|FG004|STARTED|Follow-up Period||15||
59978388|NCT01359644|76095451|FG005|STARTED|Follow-up Period||13||
59978389|NCT01359644|76095452|FG006|STARTED|Follow-up Period||41||
59978390|NCT01359644|76095453|FG007|STARTED|Follow-up Period||41||
59978391|NCT01359644|76095454|FG008|STARTED|Follow-up Period||21||
59978392|NCT01359644|76095455|FG009|STARTED|Follow-up Period||20||
59978393|NCT01359644|76095446|FG000|COMPLETED|Follow-up Period||15||
59978394|NCT01359644|76095447|FG001|COMPLETED|Follow-up Period||16||
59978395|NCT01359644|76095448|FG002|COMPLETED|Follow-up Period||14||
59978396|NCT01359644|76095449|FG003|COMPLETED|Follow-up Period||14||
59978397|NCT01359644|76095450|FG004|COMPLETED|Follow-up Period||15||
59978398|NCT01359644|76095451|FG005|COMPLETED|Follow-up Period||12||
59978399|NCT01359644|76095452|FG006|COMPLETED|Follow-up Period||40||
59978400|NCT01359644|76095453|FG007|COMPLETED|Follow-up Period||39||
59978401|NCT01359644|76095454|FG008|COMPLETED|Follow-up Period||21||
59978402|NCT01359644|76095455|FG009|COMPLETED|Follow-up Period||20||
59978403|NCT01359644|76095446|FG000|NOT COMPLETED|Follow-up Period||0||
59978404|NCT01359644|76095447|FG001|NOT COMPLETED|Follow-up Period||0||
59978405|NCT01359644|76095448|FG002|NOT COMPLETED|Follow-up Period||0||
59978406|NCT01359644|76095449|FG003|NOT COMPLETED|Follow-up Period||0||
59978407|NCT01359644|76095450|FG004|NOT COMPLETED|Follow-up Period||0||
59978408|NCT01359644|76095451|FG005|NOT COMPLETED|Follow-up Period||1||
59978409|NCT01359644|76095452|FG006|NOT COMPLETED|Follow-up Period||1||
59978410|NCT01359644|76095453|FG007|NOT COMPLETED|Follow-up Period||2||
59978411|NCT01359644|76095454|FG008|NOT COMPLETED|Follow-up Period||0||
59978412|NCT01359644|76095455|FG009|NOT COMPLETED|Follow-up Period||0||
59978413|NCT02603120|76095490|FG000|STARTED|Double-Blind Treatment Phase||284||
59978414|NCT02603120|76095491|FG001|STARTED|Double-Blind Treatment Phase||283||
59978415|NCT02603120|76095490|FG000|COMPLETED|Double-Blind Treatment Phase||265||
59978416|NCT02603120|76095491|FG001|COMPLETED|Double-Blind Treatment Phase||267||
59978417|NCT02603120|76095490|FG000|NOT COMPLETED|Double-Blind Treatment Phase||19||
59978418|NCT02603120|76095491|FG001|NOT COMPLETED|Double-Blind Treatment Phase||16||
59978419|NCT02603120|76095490|FG000|STARTED|OL Extension B/F/TAF Treatment Phase||259||
59978420|NCT02603120|76095491|FG001|STARTED|OL Extension B/F/TAF Treatment Phase||265||
59978421|NCT02603120|76095490|FG000|COMPLETED|OL Extension B/F/TAF Treatment Phase||254||
59978422|NCT02603120|76095491|FG001|COMPLETED|OL Extension B/F/TAF Treatment Phase||254||
59978423|NCT02603120|76095490|FG000|NOT COMPLETED|OL Extension B/F/TAF Treatment Phase||5||
59978424|NCT02603120|76095491|FG001|NOT COMPLETED|OL Extension B/F/TAF Treatment Phase||11||
59978425|NCT02599688|76095499|FG000|STARTED|Overall Study||18||
59526188|NCT01280695|75621743|FG003|STARTED|Overall Study||26||
59526189|NCT01280695|75621744|FG004|STARTED|Overall Study||26||
59526190|NCT01280695|75621740|FG000|COMPLETED|Overall Study||26||
59526191|NCT01280695|75621741|FG001|COMPLETED|Overall Study||24||
59526192|NCT01280695|75621742|FG002|COMPLETED|Overall Study||21||
59526193|NCT01280695|75621743|FG003|COMPLETED|Overall Study||22||
59526194|NCT01280695|75621744|FG004|COMPLETED|Overall Study||24||
59526195|NCT01280695|75621740|FG000|NOT COMPLETED|Overall Study||0||
59526196|NCT01280695|75621741|FG001|NOT COMPLETED|Overall Study||1||
59526197|NCT01280695|75621742|FG002|NOT COMPLETED|Overall Study||5||
59526198|NCT01280695|75621743|FG003|NOT COMPLETED|Overall Study||4||
59526199|NCT01280695|75621744|FG004|NOT COMPLETED|Overall Study||2||
59526200|NCT00103844|75621758|FG000|STARTED|Overall Study||101||
59526201|NCT00103844|75621759|FG001|STARTED|Overall Study||49||
59526202|NCT00103844|75621758|FG000|Crossed Over|Overall Study|22 participants from the dasatinib arm crossed over to imatinib|22||
59526203|NCT00103844|75621759|FG001|Crossed Over|Overall Study|40 participants from the imatinib arm crossed over the dasatinib|40||
59526204|NCT00103844|75621758|FG000|COMPLETED|Overall Study|Completed=no longer on treatment.Treatment continued until disease progression/intolerable toxicity.|101||
59526205|NCT00103844|75621759|FG001|COMPLETED|Overall Study|Completed=no longer on treatment.Treatment continued until disease progression/intolerable toxicity.|49||
59526206|NCT00103844|75621758|FG000|NOT COMPLETED|Overall Study||0||
59526207|NCT00103844|75621759|FG001|NOT COMPLETED|Overall Study||0||
59526208|NCT01402141|75621767|FG000|STARTED|Overall Study||30||
59526209|NCT01402141|75621768|FG001|STARTED|Overall Study||30||
59526210|NCT01402141|75621767|FG000|COMPLETED|Overall Study||29||
59526211|NCT01402141|75621768|FG001|COMPLETED|Overall Study||28||
59526212|NCT01402141|75621767|FG000|NOT COMPLETED|Overall Study||1||
59526213|NCT01402141|75621768|FG001|NOT COMPLETED|Overall Study||2||
59526214|NCT01402375|75621781|FG000|STARTED|Overall Study||120||
59526215|NCT01402375|75621782|FG001|STARTED|Overall Study||120||
59526216|NCT01402375|75621783|FG002|STARTED|Overall Study||120||
59526217|NCT01402375|75621784|FG003|STARTED|Overall Study||120||
59526218|NCT01402375|75621785|FG004|STARTED|Overall Study||120||
59526219|NCT01402375|75621786|FG005|STARTED|Overall Study||120||
59526220|NCT01402375|75621781|FG000|COMPLETED|Overall Study||120||
59526221|NCT01402375|75621782|FG001|COMPLETED|Overall Study||120||
59526222|NCT01402375|75621783|FG002|COMPLETED|Overall Study||120||
59526223|NCT01402375|75621784|FG003|COMPLETED|Overall Study||120||
59526224|NCT01402375|75621785|FG004|COMPLETED|Overall Study||120||
59526225|NCT01402375|75621786|FG005|COMPLETED|Overall Study||120||
59526226|NCT01402375|75621781|FG000|NOT COMPLETED|Overall Study||0||
59526227|NCT01402375|75621782|FG001|NOT COMPLETED|Overall Study||0||
59526228|NCT01402375|75621783|FG002|NOT COMPLETED|Overall Study||0||
59526229|NCT01402375|75621784|FG003|NOT COMPLETED|Overall Study||0||
59978426|NCT02599688|76095499|FG000|COMPLETED|Overall Study||14||
59978427|NCT02599688|76095499|FG000|NOT COMPLETED|Overall Study||4||
59978428|NCT01331291|76095505|FG000|STARTED|Overall Study||2||
59978429|NCT01331291|76095506|FG001|STARTED|Overall Study||9||
60074687|NCT01768286|76189996|FG003|NOT COMPLETED|Overall Study||1||
60074688|NCT01800968|76190008|FG000|STARTED|Overall Study||154||
59526230|NCT01402375|75621785|FG004|NOT COMPLETED|Overall Study||0||
59526231|NCT01402375|75621786|FG005|NOT COMPLETED|Overall Study||0||
59526232|NCT01299103|75621803|FG000|STARTED|Overall Study||15||
59526233|NCT01299103|75621804|FG001|STARTED|Overall Study||15||
59526234|NCT01299103|75621805|FG002|STARTED|Overall Study||10||
59526235|NCT01299103|75621803|FG000|COMPLETED|Overall Study||15||
59526236|NCT01299103|75621804|FG001|COMPLETED|Overall Study||13||
59526237|NCT01299103|75621805|FG002|COMPLETED|Overall Study||8||
59526238|NCT01299103|75621803|FG000|NOT COMPLETED|Overall Study||0||
59526239|NCT01299103|75621804|FG001|NOT COMPLETED|Overall Study||2||
59526240|NCT01299103|75621805|FG002|NOT COMPLETED|Overall Study||2||
59526241|NCT01302379|75621817|FG000|STARTED|Overall Study||83||
59526242|NCT01302379|75621818|FG001|STARTED|Overall Study||83||
59526243|NCT01302379|75621819|FG002|STARTED|Overall Study||84||
59526244|NCT01302379|75621820|FG003|STARTED|Overall Study||83||
59526245|NCT01302379|75621817|FG000|COMPLETED|Overall Study||76||
59526246|NCT01302379|75621818|FG001|COMPLETED|Overall Study||78||
59978430|NCT01331291|76095505|FG000|COMPLETED|Overall Study||0||
60074689|NCT01800968|76190009|FG001|STARTED|Overall Study||146||
60074690|NCT01800968|76190008|FG000|COMPLETED|Overall Study||118||
59978431|NCT01331291|76095506|FG001|COMPLETED|Overall Study||0||
59978432|NCT01331291|76095505|FG000|NOT COMPLETED|Overall Study||2||
59978433|NCT01331291|76095506|FG001|NOT COMPLETED|Overall Study||9||
59978434|NCT02601560|76095519|FG000|STARTED|Overall Study||8||
59978435|NCT02601560|76095520|FG001|STARTED|Overall Study||6||
59978436|NCT02601560|76095521|FG002|STARTED|Overall Study||6||
59978437|NCT02601560|76095522|FG003|STARTED|Overall Study||6||
59978438|NCT02601560|76095523|FG004|STARTED|Overall Study||6||
59978439|NCT02601560|76095524|FG005|STARTED|Overall Study||4||
59978440|NCT02601560|76095525|FG006|STARTED|Overall Study||6||
59978441|NCT02601560|76095526|FG007|STARTED|Overall Study||6||
59978442|NCT02601560|76095519|FG000|COMPLETED|Overall Study||8||
59978443|NCT02601560|76095520|FG001|COMPLETED|Overall Study||6||
59978444|NCT02601560|76095521|FG002|COMPLETED|Overall Study||6||
59978445|NCT02601560|76095522|FG003|COMPLETED|Overall Study||6||
59978446|NCT02601560|76095523|FG004|COMPLETED|Overall Study||6||
59978447|NCT02601560|76095524|FG005|COMPLETED|Overall Study||4||
59978448|NCT02601560|76095525|FG006|COMPLETED|Overall Study||5||
59978449|NCT02601560|76095526|FG007|COMPLETED|Overall Study||6||
59978450|NCT02601560|76095519|FG000|NOT COMPLETED|Overall Study||0||
59978451|NCT02601560|76095520|FG001|NOT COMPLETED|Overall Study||0||
59978452|NCT02601560|76095521|FG002|NOT COMPLETED|Overall Study||0||
59978453|NCT02601560|76095522|FG003|NOT COMPLETED|Overall Study||0||
59978454|NCT02601560|76095523|FG004|NOT COMPLETED|Overall Study||0||
59978455|NCT02601560|76095524|FG005|NOT COMPLETED|Overall Study||0||
59978456|NCT02601560|76095525|FG006|NOT COMPLETED|Overall Study||1||
59978457|NCT02601560|76095526|FG007|NOT COMPLETED|Overall Study||0||
59978458|NCT04350008|76095551|FG000|STARTED|Overall Study||110||
59978459|NCT04350008|76095551|FG000|COMPLETED|Overall Study||110||
59978460|NCT04350008|76095551|FG000|NOT COMPLETED|Overall Study||0||
59978461|NCT02595398|76095557|FG000|STARTED|Overall Study||96||
59978462|NCT02595398|76095558|FG001|STARTED|Overall Study||64||
59978463|NCT02595398|76095557|FG000|Intention-to-Treat (ITT) Population|Overall Study||96|Defined as all randomized subjects who received at least one study treatment. Subjects analyzed as originally allocated after randomization.|
59978464|NCT02595398|76095558|FG001|Intention-to-Treat (ITT) Population|Overall Study||64|Defined as all randomized subjects who received at least one study treatment. Subjects analyzed as originally allocated after randomization.|
59978465|NCT02595398|76095557|FG000|Safety Population|Overall Study||96|Defined as all randomized subjects who were administered at least one dose of study drug.|
59978466|NCT02595398|76095558|FG001|Safety Population|Overall Study||64|Defined as all randomized subjects who were administered at least one dose of study drug.|
59978467|NCT02595398|76095557|FG000|COMPLETED|Overall Study||92||
59978468|NCT02595398|76095558|FG001|COMPLETED|Overall Study||63||
59978469|NCT02595398|76095557|FG000|NOT COMPLETED|Overall Study||4||
59978470|NCT02595398|76095558|FG001|NOT COMPLETED|Overall Study||1||
59978471|NCT01368497|76095564|FG000|STARTED|Overall Study||60||
59978472|NCT01368497|76095564|FG000|End of Treatment|Overall Study|Five discontinued study drugs early and completed the follow-up period per protocol.|60||
60074691|NCT01800968|76190009|FG001|COMPLETED|Overall Study||114||
60074692|NCT01800968|76190008|FG000|NOT COMPLETED|Overall Study||36||
60074693|NCT01800968|76190009|FG001|NOT COMPLETED|Overall Study||32||
60074694|NCT01799720|76190018|FG000|STARTED|Overall Study||20||
60074695|NCT01799720|76190019|FG001|STARTED|Overall Study||18||
60074696|NCT01799720|76190020|FG002|STARTED|Overall Study||19||
60074697|NCT01799720|76190018|FG000|Began the Treatment|Overall Study||20||
60074698|NCT01799720|76190019|FG001|Began the Treatment|Overall Study||18||
60074699|NCT01799720|76190020|FG002|Began the Treatment|Overall Study||19||
60074700|NCT01799720|76190018|FG000|Began the Treatment and Finished it|Overall Study||17||
60074701|NCT01799720|76190019|FG001|Began the Treatment and Finished it|Overall Study||17||
60074702|NCT01799720|76190020|FG002|Began the Treatment and Finished it|Overall Study||18||
60074703|NCT01799720|76190018|FG000|COMPLETED|Overall Study||17||
60074704|NCT01799720|76190019|FG001|COMPLETED|Overall Study||17||
60074705|NCT01799720|76190020|FG002|COMPLETED|Overall Study||18||
60074706|NCT01799720|76190018|FG000|NOT COMPLETED|Overall Study||3||
60074707|NCT01799720|76190019|FG001|NOT COMPLETED|Overall Study||1||
60074708|NCT01799720|76190020|FG002|NOT COMPLETED|Overall Study||1||
59978473|NCT01368497|76095564|FG000|COMPLETED|Overall Study||58||
60074709|NCT01687257|76190030|FG000|STARTED|Overall Study||25||
60074710|NCT01687257|76190031|FG001|STARTED|Overall Study||4||
60074711|NCT01687257|76190032|FG002|STARTED|Overall Study||21||
60074712|NCT01687257|76190030|FG000|COMPLETED|Overall Study||17||
60074713|NCT01687257|76190031|FG001|COMPLETED|Overall Study||0||
60074714|NCT01687257|76190032|FG002|COMPLETED|Overall Study||15||
60074715|NCT01687257|76190030|FG000|NOT COMPLETED|Overall Study||8||
59978474|NCT01368497|76095564|FG000|NOT COMPLETED|Overall Study||2||
59978475|NCT02595008|76095570|FG000|STARTED|Overall Study||20||
59978476|NCT02595008|76095571|FG001|STARTED|Overall Study||4||
59978477|NCT02595008|76095570|FG000|COMPLETED|Overall Study||19||
60074716|NCT01687257|76190031|FG001|NOT COMPLETED|Overall Study||4||
60074717|NCT01687257|76190032|FG002|NOT COMPLETED|Overall Study||6||
60074718|NCT01806740|76190046|FG000|STARTED|Overall Study||37||
60074719|NCT01806740|76190046|FG000|COMPLETED|Overall Study||31||
60074720|NCT01806740|76190046|FG000|NOT COMPLETED|Overall Study||6||
60074721|NCT01687101|76190053|FG000|STARTED|Overall Study||32||
59978478|NCT02595008|76095571|FG001|COMPLETED|Overall Study||4||
59978479|NCT02595008|76095570|FG000|NOT COMPLETED|Overall Study||1||
59978480|NCT02595008|76095571|FG001|NOT COMPLETED|Overall Study||0||
59978481|NCT02598128|76095577|FG000|STARTED|Period A: Days -7 to -1||34||
59978482|NCT02598128|76095578|FG001|STARTED|Period A: Days -7 to -1||0||
59978483|NCT02598128|76095579|FG002|STARTED|Period A: Days -7 to -1||0||
59978484|NCT02598128|76095580|FG003|STARTED|Period A: Days -7 to -1||0||
59978485|NCT02598128|76095577|FG000|COMPLETED|Period A: Days -7 to -1||33||
59978486|NCT02598128|76095578|FG001|COMPLETED|Period A: Days -7 to -1||0||
59978487|NCT02598128|76095579|FG002|COMPLETED|Period A: Days -7 to -1||0||
59978488|NCT02598128|76095580|FG003|COMPLETED|Period A: Days -7 to -1||0||
59978489|NCT02598128|76095577|FG000|NOT COMPLETED|Period A: Days -7 to -1||1||
59978490|NCT02598128|76095578|FG001|NOT COMPLETED|Period A: Days -7 to -1||0||
59978491|NCT02598128|76095579|FG002|NOT COMPLETED|Period A: Days -7 to -1||0||
59978492|NCT02598128|76095580|FG003|NOT COMPLETED|Period A: Days -7 to -1||0||
59978493|NCT02598128|76095577|FG000|STARTED|Period B: Days 1 to 11||0||
59978494|NCT02598128|76095578|FG001|STARTED|Period B: Days 1 to 11||17||
59978495|NCT02598128|76095579|FG002|STARTED|Period B: Days 1 to 11||16||
59978496|NCT02598128|76095580|FG003|STARTED|Period B: Days 1 to 11||0||
59978497|NCT02598128|76095577|FG000|COMPLETED|Period B: Days 1 to 11||0||
59978498|NCT02598128|76095578|FG001|COMPLETED|Period B: Days 1 to 11||17||
59978499|NCT02598128|76095579|FG002|COMPLETED|Period B: Days 1 to 11||16||
59978500|NCT02598128|76095580|FG003|COMPLETED|Period B: Days 1 to 11||0||
59978501|NCT02598128|76095577|FG000|NOT COMPLETED|Period B: Days 1 to 11||0||
59978502|NCT02598128|76095578|FG001|NOT COMPLETED|Period B: Days 1 to 11||0||
59978503|NCT02598128|76095579|FG002|NOT COMPLETED|Period B: Days 1 to 11||0||
59978504|NCT02598128|76095580|FG003|NOT COMPLETED|Period B: Days 1 to 11||0||
59978505|NCT02598128|76095577|FG000|STARTED|Period C: Days 12 to 20||0||
59978506|NCT02598128|76095578|FG001|STARTED|Period C: Days 12 to 20||0||
59978507|NCT02598128|76095579|FG002|STARTED|Period C: Days 12 to 20||0||
59978508|NCT02598128|76095580|FG003|STARTED|Period C: Days 12 to 20||33||
59978509|NCT02598128|76095577|FG000|COMPLETED|Period C: Days 12 to 20||0||
59978510|NCT02598128|76095578|FG001|COMPLETED|Period C: Days 12 to 20||0||
59978511|NCT02598128|76095579|FG002|COMPLETED|Period C: Days 12 to 20||0||
59978512|NCT02598128|76095580|FG003|COMPLETED|Period C: Days 12 to 20||33||
59978513|NCT02598128|76095577|FG000|NOT COMPLETED|Period C: Days 12 to 20||0||
59978514|NCT02598128|76095578|FG001|NOT COMPLETED|Period C: Days 12 to 20||0||
59978515|NCT02598128|76095579|FG002|NOT COMPLETED|Period C: Days 12 to 20||0||
59978516|NCT02598128|76095580|FG003|NOT COMPLETED|Period C: Days 12 to 20||0||
59978517|NCT05137730|76095598|FG000|STARTED|Part I: Treatment Period 1 (1 Day)||42||
59978518|NCT05137730|76095599|FG001|STARTED|Part I: Treatment Period 1 (1 Day)||42||
59978519|NCT05137730|76095600|FG002|STARTED|Part I: Treatment Period 1 (1 Day)||0||
59978520|NCT05137730|76095601|FG003|STARTED|Part I: Treatment Period 1 (1 Day)||0||
59978521|NCT05137730|76095602|FG004|STARTED|Part I: Treatment Period 1 (1 Day)||0||
59978522|NCT05137730|76095603|FG005|STARTED|Part I: Treatment Period 1 (1 Day)||0||
59978523|NCT05137730|76095598|FG000|COMPLETED|Part I: Treatment Period 1 (1 Day)||42||
59978524|NCT05137730|76095599|FG001|COMPLETED|Part I: Treatment Period 1 (1 Day)||42||
59978525|NCT05137730|76095600|FG002|COMPLETED|Part I: Treatment Period 1 (1 Day)||0||
59978526|NCT05137730|76095601|FG003|COMPLETED|Part I: Treatment Period 1 (1 Day)||0||
59978527|NCT05137730|76095602|FG004|COMPLETED|Part I: Treatment Period 1 (1 Day)||0||
59978528|NCT05137730|76095603|FG005|COMPLETED|Part I: Treatment Period 1 (1 Day)||0||
59978529|NCT05137730|76095598|FG000|NOT COMPLETED|Part I: Treatment Period 1 (1 Day)||0||
59978530|NCT05137730|76095599|FG001|NOT COMPLETED|Part I: Treatment Period 1 (1 Day)||0||
59978531|NCT05137730|76095600|FG002|NOT COMPLETED|Part I: Treatment Period 1 (1 Day)||0||
59978532|NCT05137730|76095601|FG003|NOT COMPLETED|Part I: Treatment Period 1 (1 Day)||0||
59978533|NCT05137730|76095602|FG004|NOT COMPLETED|Part I: Treatment Period 1 (1 Day)||0||
59978534|NCT05137730|76095603|FG005|NOT COMPLETED|Part I: Treatment Period 1 (1 Day)||0||
59978535|NCT05137730|76095598|FG000|STARTED|Part I: Washout Period 1 (96 Hours)||42||
59978536|NCT05137730|76095599|FG001|STARTED|Part I: Washout Period 1 (96 Hours)||42||
59978537|NCT05137730|76095600|FG002|STARTED|Part I: Washout Period 1 (96 Hours)||0||
59978538|NCT05137730|76095601|FG003|STARTED|Part I: Washout Period 1 (96 Hours)||0||
59978539|NCT05137730|76095602|FG004|STARTED|Part I: Washout Period 1 (96 Hours)||0||
59978540|NCT05137730|76095603|FG005|STARTED|Part I: Washout Period 1 (96 Hours)||0||
59978541|NCT05137730|76095598|FG000|COMPLETED|Part I: Washout Period 1 (96 Hours)||42||
59978542|NCT05137730|76095599|FG001|COMPLETED|Part I: Washout Period 1 (96 Hours)||42||
59978543|NCT05137730|76095600|FG002|COMPLETED|Part I: Washout Period 1 (96 Hours)||0||
59978544|NCT05137730|76095601|FG003|COMPLETED|Part I: Washout Period 1 (96 Hours)||0||
59994986|NCT03367429|76110816|FG000|COMPLETED|Overall Study||0||
59978545|NCT05137730|76095602|FG004|COMPLETED|Part I: Washout Period 1 (96 Hours)||0||
59978546|NCT05137730|76095603|FG005|COMPLETED|Part I: Washout Period 1 (96 Hours)||0||
59978547|NCT05137730|76095598|FG000|NOT COMPLETED|Part I: Washout Period 1 (96 Hours)||0||
59978548|NCT05137730|76095599|FG001|NOT COMPLETED|Part I: Washout Period 1 (96 Hours)||0||
59978549|NCT05137730|76095600|FG002|NOT COMPLETED|Part I: Washout Period 1 (96 Hours)||0||
59978550|NCT05137730|76095601|FG003|NOT COMPLETED|Part I: Washout Period 1 (96 Hours)||0||
59978551|NCT05137730|76095602|FG004|NOT COMPLETED|Part I: Washout Period 1 (96 Hours)||0||
59978552|NCT05137730|76095603|FG005|NOT COMPLETED|Part I: Washout Period 1 (96 Hours)||0||
59978553|NCT05137730|76095598|FG000|STARTED|Part I: Treatment Period 2 (1 Day)||42||
59978554|NCT05137730|76095599|FG001|STARTED|Part I: Treatment Period 2 (1 Day)||42||
59978555|NCT05137730|76095600|FG002|STARTED|Part I: Treatment Period 2 (1 Day)||0||
59978556|NCT05137730|76095601|FG003|STARTED|Part I: Treatment Period 2 (1 Day)||0||
59978557|NCT05137730|76095602|FG004|STARTED|Part I: Treatment Period 2 (1 Day)||0||
59978558|NCT05137730|76095603|FG005|STARTED|Part I: Treatment Period 2 (1 Day)||0||
59978559|NCT05137730|76095598|FG000|COMPLETED|Part I: Treatment Period 2 (1 Day)||42||
59978560|NCT05137730|76095599|FG001|COMPLETED|Part I: Treatment Period 2 (1 Day)||42||
59978561|NCT05137730|76095600|FG002|COMPLETED|Part I: Treatment Period 2 (1 Day)||0||
59978562|NCT05137730|76095601|FG003|COMPLETED|Part I: Treatment Period 2 (1 Day)||0||
59978563|NCT05137730|76095602|FG004|COMPLETED|Part I: Treatment Period 2 (1 Day)||0||
59978564|NCT05137730|76095603|FG005|COMPLETED|Part I: Treatment Period 2 (1 Day)||0||
59978565|NCT05137730|76095598|FG000|NOT COMPLETED|Part I: Treatment Period 2 (1 Day)||0||
59978566|NCT05137730|76095599|FG001|NOT COMPLETED|Part I: Treatment Period 2 (1 Day)||0||
59978567|NCT05137730|76095600|FG002|NOT COMPLETED|Part I: Treatment Period 2 (1 Day)||0||
59978568|NCT05137730|76095601|FG003|NOT COMPLETED|Part I: Treatment Period 2 (1 Day)||0||
59978569|NCT05137730|76095602|FG004|NOT COMPLETED|Part I: Treatment Period 2 (1 Day)||0||
59978570|NCT05137730|76095603|FG005|NOT COMPLETED|Part I: Treatment Period 2 (1 Day)||0||
59978571|NCT05137730|76095598|FG000|STARTED|Part II: Treatment Period 1 (1 Day)||0||
59978572|NCT05137730|76095599|FG001|STARTED|Part II: Treatment Period 1 (1 Day)||0||
59978573|NCT05137730|76095600|FG002|STARTED|Part II: Treatment Period 1 (1 Day)||3||
59978574|NCT05137730|76095601|FG003|STARTED|Part II: Treatment Period 1 (1 Day)||3||
59978575|NCT05137730|76095602|FG004|STARTED|Part II: Treatment Period 1 (1 Day)||3||
59978576|NCT05137730|76095603|FG005|STARTED|Part II: Treatment Period 1 (1 Day)||3||
59978577|NCT05137730|76095598|FG000|COMPLETED|Part II: Treatment Period 1 (1 Day)||0||
59978578|NCT05137730|76095599|FG001|COMPLETED|Part II: Treatment Period 1 (1 Day)||0||
59978579|NCT05137730|76095600|FG002|COMPLETED|Part II: Treatment Period 1 (1 Day)||3||
59978580|NCT05137730|76095601|FG003|COMPLETED|Part II: Treatment Period 1 (1 Day)||3||
59978581|NCT05137730|76095602|FG004|COMPLETED|Part II: Treatment Period 1 (1 Day)||3||
59978582|NCT05137730|76095603|FG005|COMPLETED|Part II: Treatment Period 1 (1 Day)||3||
59978583|NCT05137730|76095598|FG000|NOT COMPLETED|Part II: Treatment Period 1 (1 Day)||0||
59978584|NCT05137730|76095599|FG001|NOT COMPLETED|Part II: Treatment Period 1 (1 Day)||0||
59978585|NCT05137730|76095600|FG002|NOT COMPLETED|Part II: Treatment Period 1 (1 Day)||0||
59978586|NCT05137730|76095601|FG003|NOT COMPLETED|Part II: Treatment Period 1 (1 Day)||0||
59978587|NCT05137730|76095602|FG004|NOT COMPLETED|Part II: Treatment Period 1 (1 Day)||0||
59978588|NCT05137730|76095603|FG005|NOT COMPLETED|Part II: Treatment Period 1 (1 Day)||0||
59978589|NCT05137730|76095598|FG000|STARTED|Part II: Washout Period 1 (48 Hours)||0||
59978590|NCT05137730|76095599|FG001|STARTED|Part II: Washout Period 1 (48 Hours)||0||
59978591|NCT05137730|76095600|FG002|STARTED|Part II: Washout Period 1 (48 Hours)||3||
59978592|NCT05137730|76095601|FG003|STARTED|Part II: Washout Period 1 (48 Hours)||3||
59978593|NCT05137730|76095602|FG004|STARTED|Part II: Washout Period 1 (48 Hours)||3||
59978594|NCT05137730|76095603|FG005|STARTED|Part II: Washout Period 1 (48 Hours)||3||
59978595|NCT05137730|76095598|FG000|COMPLETED|Part II: Washout Period 1 (48 Hours)||0||
59978596|NCT05137730|76095599|FG001|COMPLETED|Part II: Washout Period 1 (48 Hours)||0||
59978597|NCT05137730|76095600|FG002|COMPLETED|Part II: Washout Period 1 (48 Hours)||3||
59978598|NCT05137730|76095601|FG003|COMPLETED|Part II: Washout Period 1 (48 Hours)||3||
59978599|NCT05137730|76095602|FG004|COMPLETED|Part II: Washout Period 1 (48 Hours)||3||
59978600|NCT05137730|76095603|FG005|COMPLETED|Part II: Washout Period 1 (48 Hours)||3||
59978601|NCT05137730|76095598|FG000|NOT COMPLETED|Part II: Washout Period 1 (48 Hours)||0||
59978602|NCT05137730|76095599|FG001|NOT COMPLETED|Part II: Washout Period 1 (48 Hours)||0||
59978603|NCT05137730|76095600|FG002|NOT COMPLETED|Part II: Washout Period 1 (48 Hours)||0||
59978604|NCT05137730|76095601|FG003|NOT COMPLETED|Part II: Washout Period 1 (48 Hours)||0||
59978605|NCT05137730|76095602|FG004|NOT COMPLETED|Part II: Washout Period 1 (48 Hours)||0||
59526247|NCT01302379|75621819|FG002|COMPLETED|Overall Study||80||
59622318|NCT00386880|75734102|FG000|COMPLETED|Overall Study||30||
59978606|NCT05137730|76095603|FG005|NOT COMPLETED|Part II: Washout Period 1 (48 Hours)||0||
59994987|NCT03367429|76110817|FG001|COMPLETED|Overall Study||1||
59526248|NCT01302379|75621820|FG003|COMPLETED|Overall Study||79||
59526249|NCT01302379|75621817|FG000|NOT COMPLETED|Overall Study||7||
59526250|NCT01302379|75621818|FG001|NOT COMPLETED|Overall Study||5||
59526251|NCT01302379|75621819|FG002|NOT COMPLETED|Overall Study||4||
59526252|NCT01302379|75621820|FG003|NOT COMPLETED|Overall Study||4||
59526253|NCT01404559|75621830|FG000|STARTED|Overall Study||5||
59622319|NCT00386880|75734103|FG001|COMPLETED|Overall Study||8||
59622320|NCT00386880|75734102|FG000|NOT COMPLETED|Overall Study||0||
59622321|NCT00386880|75734103|FG001|NOT COMPLETED|Overall Study||0||
59622322|NCT00413400|75734110|FG000|STARTED|Overall Study||24||
59622323|NCT00413400|75734111|FG001|STARTED|Overall Study||16||
59622324|NCT00413400|75734110|FG000|3 Month Visit|Overall Study||22||
59622325|NCT00413400|75734111|FG001|3 Month Visit|Overall Study||12||
59622326|NCT00413400|75734110|FG000|COMPLETED|Overall Study||22||
59622327|NCT00413400|75734111|FG001|COMPLETED|Overall Study||12||
59622328|NCT00413400|75734110|FG000|NOT COMPLETED|Overall Study||2||
59622329|NCT00413400|75734111|FG001|NOT COMPLETED|Overall Study||4||
59622330|NCT00413478|75734117|FG000|STARTED|Overall Study||9||
59622331|NCT00413478|75734117|FG000|COMPLETED|Overall Study||9||
59622332|NCT00413478|75734117|FG000|NOT COMPLETED|Overall Study||0||
59622333|NCT00413634|75734123|FG000|STARTED|Overall Study||12||
59622334|NCT00413634|75734124|FG001|STARTED|Overall Study||12||
59622335|NCT00413634|75734123|FG000|COMPLETED|Overall Study||12||
59622336|NCT00413634|75734124|FG001|COMPLETED|Overall Study||12||
59622337|NCT00413634|75734123|FG000|NOT COMPLETED|Overall Study||0||
59622338|NCT00413634|75734124|FG001|NOT COMPLETED|Overall Study||0||
59622339|NCT00467298|75734134|FG000|STARTED|Overall Study||46||
59622340|NCT00467298|75734135|FG001|STARTED|Overall Study||44||
59622341|NCT00467298|75734134|FG000|COMPLETED|Overall Study||42||
59622342|NCT00467298|75734135|FG001|COMPLETED|Overall Study||38||
59622343|NCT00467298|75734134|FG000|NOT COMPLETED|Overall Study||4||
59622344|NCT00467298|75734135|FG001|NOT COMPLETED|Overall Study||6||
59622345|NCT00467844|75734144|FG000|STARTED|Overall Study||53||
59622346|NCT00467844|75734145|FG001|STARTED|Overall Study||54||
59622347|NCT00467844|75734146|FG002|STARTED|Overall Study||52||
59622348|NCT00467844|75734144|FG000|COMPLETED|Overall Study||34||
59622349|NCT00467844|75734145|FG001|COMPLETED|Overall Study||34||
59622350|NCT00467844|75734146|FG002|COMPLETED|Overall Study||38||
59622351|NCT00467844|75734144|FG000|NOT COMPLETED|Overall Study||19||
59622352|NCT00467844|75734145|FG001|NOT COMPLETED|Overall Study||20||
59622353|NCT00467844|75734146|FG002|NOT COMPLETED|Overall Study||14||
59622354|NCT00387036|75734157|FG000|STARTED|2-Week First Intervention||6||
59622355|NCT00387036|75734158|FG001|STARTED|2-Week First Intervention||6||
59622356|NCT00387036|75734157|FG000|COMPLETED|2-Week First Intervention||6||
59622357|NCT00387036|75734158|FG001|COMPLETED|2-Week First Intervention||6||
59622358|NCT00387036|75734157|FG000|NOT COMPLETED|2-Week First Intervention||0||
59622359|NCT00387036|75734158|FG001|NOT COMPLETED|2-Week First Intervention||0||
59622360|NCT00387036|75734157|FG000|STARTED|2-Week Placebo Washout||6||
59622361|NCT00387036|75734158|FG001|STARTED|2-Week Placebo Washout||6||
59622362|NCT00387036|75734157|FG000|COMPLETED|2-Week Placebo Washout||6||
59622363|NCT00387036|75734158|FG001|COMPLETED|2-Week Placebo Washout||6||
59622364|NCT00387036|75734157|FG000|NOT COMPLETED|2-Week Placebo Washout||0||
59622365|NCT00387036|75734158|FG001|NOT COMPLETED|2-Week Placebo Washout||0||
59622366|NCT00387036|75734157|FG000|STARTED|2-Week Crossover Second Intervention||6||
59622367|NCT00387036|75734158|FG001|STARTED|2-Week Crossover Second Intervention||6||
59622368|NCT00387036|75734157|FG000|COMPLETED|2-Week Crossover Second Intervention||6||
59622369|NCT00387036|75734158|FG001|COMPLETED|2-Week Crossover Second Intervention||6||
59622370|NCT00387036|75734157|FG000|NOT COMPLETED|2-Week Crossover Second Intervention||0||
59622371|NCT00387036|75734158|FG001|NOT COMPLETED|2-Week Crossover Second Intervention||0||
59622372|NCT00470106|75734168|FG000|STARTED|Overall Study||19||
59622373|NCT00470106|75734169|FG001|STARTED|Overall Study||24||
59622374|NCT00470106|75734170|FG002|STARTED|Overall Study||21||
59622375|NCT00470106|75734171|FG003|STARTED|Overall Study||21||
59622376|NCT00470106|75734168|FG000|COMPLETED|Overall Study||16||
59622377|NCT00470106|75734169|FG001|COMPLETED|Overall Study||19||
59622378|NCT00470106|75734170|FG002|COMPLETED|Overall Study||14||
59622379|NCT00470106|75734171|FG003|COMPLETED|Overall Study||19||
59622380|NCT00470106|75734168|FG000|NOT COMPLETED|Overall Study||3||
59622381|NCT00470106|75734169|FG001|NOT COMPLETED|Overall Study||5||
59622382|NCT00470106|75734170|FG002|NOT COMPLETED|Overall Study||7||
59622383|NCT00470106|75734171|FG003|NOT COMPLETED|Overall Study||2||
59622384|NCT00387660|75734187|FG000|STARTED|Overall Study||40||
59622385|NCT00387660|75734188|FG001|STARTED|Overall Study||40||
59622386|NCT00387660|75734187|FG000|COMPLETED|Overall Study||40||
59622387|NCT00387660|75734188|FG001|COMPLETED|Overall Study||40||
59622388|NCT00387660|75734187|FG000|NOT COMPLETED|Overall Study||0||
59622389|NCT00387660|75734188|FG001|NOT COMPLETED|Overall Study||0||
59622390|NCT00472056|75734198|FG000|STARTED|Overall Study||25||
59622391|NCT00472056|75734199|FG001|STARTED|Overall Study||19||
59622392|NCT00472056|75734200|FG002|STARTED|Overall Study||32||
59622393|NCT00472056|75734201|FG003|STARTED|Overall Study||17||
59622394|NCT00472056|75734198|FG000|COMPLETED|Overall Study||25||
59622395|NCT00472056|75734199|FG001|COMPLETED|Overall Study||19||
59622396|NCT00472056|75734200|FG002|COMPLETED|Overall Study||32||
59622397|NCT00472056|75734201|FG003|COMPLETED|Overall Study||17||
59622398|NCT00472056|75734198|FG000|NOT COMPLETED|Overall Study||0||
59622399|NCT00472056|75734199|FG001|NOT COMPLETED|Overall Study||0||
59622400|NCT00472056|75734200|FG002|NOT COMPLETED|Overall Study||0||
59622401|NCT00472056|75734201|FG003|NOT COMPLETED|Overall Study||0||
59622402|NCT00415506|75734211|FG000|STARTED|Overall Study||12||
59622403|NCT00415506|75734212|FG001|STARTED|Overall Study||10||
59622404|NCT00415506|75734211|FG000|COMPLETED|Overall Study||9||
59622405|NCT00415506|75734212|FG001|COMPLETED|Overall Study||9||
59622406|NCT00415506|75734211|FG000|NOT COMPLETED|Overall Study||3||
59622407|NCT00415506|75734212|FG001|NOT COMPLETED|Overall Study||1||
59622408|NCT00389532|75734220|FG000|STARTED|Overall Study||60||
59622409|NCT00389532|75734221|FG001|STARTED|Overall Study||56||
59622410|NCT00389532|75734220|FG000|COMPLETED|Overall Study|3 of the participants did not have valid post-vaccination serological results|60||
59622411|NCT00389532|75734221|FG001|COMPLETED|Overall Study||56||
59622412|NCT00389532|75734220|FG000|NOT COMPLETED|Overall Study||0||
59622413|NCT00389532|75734221|FG001|NOT COMPLETED|Overall Study||0||
59622414|NCT00475878|75734229|FG000|STARTED|Overall Study||75||
59622415|NCT00475878|75734230|FG001|STARTED|Overall Study||72||
59622416|NCT00475878|75734229|FG000|COMPLETED|Overall Study||75||
59622417|NCT00475878|75734230|FG001|COMPLETED|Overall Study||72||
59622418|NCT00475878|75734229|FG000|NOT COMPLETED|Overall Study||0||
59622419|NCT00475878|75734230|FG001|NOT COMPLETED|Overall Study||0||
59622420|NCT00477204|75734240|FG000|STARTED|Overall Study||4||
59814059|NCT00422097|75936451|FG001|COMPLETED|Ixabepilone With Famotidine or Food||0||
59622421|NCT00477204|75734241|FG001|STARTED|Overall Study||5||
59622422|NCT00477204|75734240|FG000|COMPLETED|Overall Study||4||
59622423|NCT00477204|75734241|FG001|COMPLETED|Overall Study||5||
59622424|NCT00477204|75734240|FG000|NOT COMPLETED|Overall Study||0||
59622425|NCT00477204|75734241|FG001|NOT COMPLETED|Overall Study||0||
59622426|NCT00528450|75734247|FG000|STARTED|Overall Study||1||
59622427|NCT00528450|75734247|FG000|COMPLETED|Overall Study||1||
59622428|NCT00528450|75734247|FG000|NOT COMPLETED|Overall Study||0||
59622429|NCT00478218|75734253|FG000|STARTED|Overall Study||34||
59622430|NCT00478218|75734254|FG001|STARTED|Overall Study||19||
59622431|NCT00478218|75734253|FG000|COMPLETED|Overall Study||34||
59622432|NCT00478218|75734254|FG001|COMPLETED|Overall Study||19||
59622433|NCT00478218|75734253|FG000|NOT COMPLETED|Overall Study||0||
59622434|NCT00478218|75734254|FG001|NOT COMPLETED|Overall Study||0||
59622435|NCT00479154|75734262|FG000|STARTED|Overall Study||3||
59622436|NCT00479154|75734263|FG001|STARTED|Overall Study||3||
59622437|NCT00479154|75734262|FG000|COMPLETED|Overall Study||3||
59622438|NCT00479154|75734263|FG001|COMPLETED|Overall Study||3||
59622439|NCT00479154|75734262|FG000|NOT COMPLETED|Overall Study||0||
59622440|NCT00479154|75734263|FG001|NOT COMPLETED|Overall Study||0||
59622441|NCT00422448|75734269|FG000|STARTED|Overall Study|22 prospectively enrolled during study period and 21 retrospectively enrolled|43||
59622442|NCT00422448|75734269|FG000|COMPLETED|Overall Study||43||
59622443|NCT00422448|75734269|FG000|NOT COMPLETED|Overall Study||0||
59978607|NCT05137730|76095598|FG000|STARTED|Part II: Treatment Period 2 (1 Day)||0||
59978608|NCT05137730|76095599|FG001|STARTED|Part II: Treatment Period 2 (1 Day)||0||
59978609|NCT05137730|76095600|FG002|STARTED|Part II: Treatment Period 2 (1 Day)||3||
59978610|NCT05137730|76095601|FG003|STARTED|Part II: Treatment Period 2 (1 Day)||3||
59978611|NCT05137730|76095602|FG004|STARTED|Part II: Treatment Period 2 (1 Day)||3||
59978612|NCT05137730|76095603|FG005|STARTED|Part II: Treatment Period 2 (1 Day)||3||
59978613|NCT05137730|76095598|FG000|COMPLETED|Part II: Treatment Period 2 (1 Day)||0||
59978614|NCT05137730|76095599|FG001|COMPLETED|Part II: Treatment Period 2 (1 Day)||0||
59978615|NCT05137730|76095600|FG002|COMPLETED|Part II: Treatment Period 2 (1 Day)||3||
59978616|NCT05137730|76095601|FG003|COMPLETED|Part II: Treatment Period 2 (1 Day)||3||
59978617|NCT05137730|76095602|FG004|COMPLETED|Part II: Treatment Period 2 (1 Day)||3||
59978618|NCT05137730|76095603|FG005|COMPLETED|Part II: Treatment Period 2 (1 Day)||3||
59978619|NCT05137730|76095598|FG000|NOT COMPLETED|Part II: Treatment Period 2 (1 Day)||0||
59978620|NCT05137730|76095599|FG001|NOT COMPLETED|Part II: Treatment Period 2 (1 Day)||0||
59978621|NCT05137730|76095600|FG002|NOT COMPLETED|Part II: Treatment Period 2 (1 Day)||0||
59978622|NCT05137730|76095601|FG003|NOT COMPLETED|Part II: Treatment Period 2 (1 Day)||0||
59978623|NCT05137730|76095602|FG004|NOT COMPLETED|Part II: Treatment Period 2 (1 Day)||0||
59978624|NCT05137730|76095603|FG005|NOT COMPLETED|Part II: Treatment Period 2 (1 Day)||0||
59622444|NCT00424554|75734275|FG000|STARTED|Overall Study||34||
59622445|NCT00424554|75734276|FG001|STARTED|Overall Study||6||
59622446|NCT00424554|75734275|FG000|COMPLETED|Overall Study||34||
59622447|NCT00424554|75734276|FG001|COMPLETED|Overall Study||6||
59622448|NCT00424554|75734275|FG000|NOT COMPLETED|Overall Study||0||
59622449|NCT00424554|75734276|FG001|NOT COMPLETED|Overall Study||0||
59978625|NCT05137730|76095598|FG000|STARTED|Part II: Washout Period 2 (48 Hours)||0||
59978626|NCT05137730|76095599|FG001|STARTED|Part II: Washout Period 2 (48 Hours)||0||
59978627|NCT05137730|76095600|FG002|STARTED|Part II: Washout Period 2 (48 Hours)||3||
59978628|NCT05137730|76095601|FG003|STARTED|Part II: Washout Period 2 (48 Hours)||3||
59978629|NCT05137730|76095602|FG004|STARTED|Part II: Washout Period 2 (48 Hours)||3||
59978630|NCT05137730|76095603|FG005|STARTED|Part II: Washout Period 2 (48 Hours)||3||
59978631|NCT05137730|76095598|FG000|COMPLETED|Part II: Washout Period 2 (48 Hours)||0||
59978632|NCT05137730|76095599|FG001|COMPLETED|Part II: Washout Period 2 (48 Hours)||0||
59978633|NCT05137730|76095600|FG002|COMPLETED|Part II: Washout Period 2 (48 Hours)||3||
59978634|NCT05137730|76095601|FG003|COMPLETED|Part II: Washout Period 2 (48 Hours)||3||
59978635|NCT05137730|76095602|FG004|COMPLETED|Part II: Washout Period 2 (48 Hours)||3||
59978636|NCT05137730|76095603|FG005|COMPLETED|Part II: Washout Period 2 (48 Hours)||3||
59978637|NCT05137730|76095598|FG000|NOT COMPLETED|Part II: Washout Period 2 (48 Hours)||0||
59978638|NCT05137730|76095599|FG001|NOT COMPLETED|Part II: Washout Period 2 (48 Hours)||0||
59978639|NCT05137730|76095600|FG002|NOT COMPLETED|Part II: Washout Period 2 (48 Hours)||0||
59978640|NCT05137730|76095601|FG003|NOT COMPLETED|Part II: Washout Period 2 (48 Hours)||0||
59978641|NCT05137730|76095602|FG004|NOT COMPLETED|Part II: Washout Period 2 (48 Hours)||0||
59978642|NCT05137730|76095603|FG005|NOT COMPLETED|Part II: Washout Period 2 (48 Hours)||0||
59978643|NCT05137730|76095598|FG000|STARTED|Part II: Treatment Period 3 (1 Day)||0||
59978644|NCT05137730|76095599|FG001|STARTED|Part II: Treatment Period 3 (1 Day)||0||
59978645|NCT05137730|76095600|FG002|STARTED|Part II: Treatment Period 3 (1 Day)||3||
59978646|NCT05137730|76095601|FG003|STARTED|Part II: Treatment Period 3 (1 Day)||3||
59978647|NCT05137730|76095602|FG004|STARTED|Part II: Treatment Period 3 (1 Day)||3||
59978648|NCT05137730|76095603|FG005|STARTED|Part II: Treatment Period 3 (1 Day)||3||
59978649|NCT05137730|76095598|FG000|COMPLETED|Part II: Treatment Period 3 (1 Day)||0||
59978650|NCT05137730|76095599|FG001|COMPLETED|Part II: Treatment Period 3 (1 Day)||0||
59978651|NCT05137730|76095600|FG002|COMPLETED|Part II: Treatment Period 3 (1 Day)||3||
59978652|NCT05137730|76095601|FG003|COMPLETED|Part II: Treatment Period 3 (1 Day)||3||
59978653|NCT05137730|76095602|FG004|COMPLETED|Part II: Treatment Period 3 (1 Day)||3||
59978654|NCT05137730|76095603|FG005|COMPLETED|Part II: Treatment Period 3 (1 Day)||3||
59978655|NCT05137730|76095598|FG000|NOT COMPLETED|Part II: Treatment Period 3 (1 Day)||0||
59978656|NCT05137730|76095599|FG001|NOT COMPLETED|Part II: Treatment Period 3 (1 Day)||0||
59978657|NCT05137730|76095600|FG002|NOT COMPLETED|Part II: Treatment Period 3 (1 Day)||0||
59978658|NCT05137730|76095601|FG003|NOT COMPLETED|Part II: Treatment Period 3 (1 Day)||0||
59978659|NCT05137730|76095602|FG004|NOT COMPLETED|Part II: Treatment Period 3 (1 Day)||0||
59978660|NCT05137730|76095603|FG005|NOT COMPLETED|Part II: Treatment Period 3 (1 Day)||0||
59978661|NCT05137730|76095598|FG000|STARTED|Part II: Washout Period 3 (48 Hours)||0||
59978662|NCT05137730|76095599|FG001|STARTED|Part II: Washout Period 3 (48 Hours)||0||
59978663|NCT05137730|76095600|FG002|STARTED|Part II: Washout Period 3 (48 Hours)||3||
59978664|NCT05137730|76095601|FG003|STARTED|Part II: Washout Period 3 (48 Hours)||3||
59978665|NCT05137730|76095602|FG004|STARTED|Part II: Washout Period 3 (48 Hours)||3||
59978666|NCT05137730|76095603|FG005|STARTED|Part II: Washout Period 3 (48 Hours)||3||
59978667|NCT05137730|76095598|FG000|COMPLETED|Part II: Washout Period 3 (48 Hours)||0||
59978668|NCT05137730|76095599|FG001|COMPLETED|Part II: Washout Period 3 (48 Hours)||0||
60074722|NCT01687101|76190053|FG000|COMPLETED|Overall Study||25||
60074723|NCT01687101|76190053|FG000|NOT COMPLETED|Overall Study||7||
60074724|NCT01968967|76190059|FG000|STARTED|Treatment Period||1071||
60074725|NCT01968967|76190060|FG001|STARTED|Treatment Period||1068||
60074726|NCT01968967|76190061|FG002|STARTED|Treatment Period||0||
60074727|NCT01968967|76190062|FG003|STARTED|Treatment Period||0||
60074728|NCT01968967|76190063|FG004|STARTED|Treatment Period||0||
60074729|NCT01968967|76190059|FG000|Treated|Treatment Period||1065||
60074730|NCT01968967|76190060|FG001|Treated|Treatment Period||1063||
60074731|NCT01968967|76190061|FG002|Treated|Treatment Period||0||
60074732|NCT01968967|76190062|FG003|Treated|Treatment Period||0||
60074733|NCT01968967|76190063|FG004|Treated|Treatment Period||0||
60074734|NCT01968967|76190059|FG000|COMPLETED|Treatment Period||925||
60074735|NCT01968967|76190060|FG001|COMPLETED|Treatment Period||934||
60074736|NCT01968967|76190061|FG002|COMPLETED|Treatment Period||0||
60074737|NCT01968967|76190062|FG003|COMPLETED|Treatment Period||0||
59978669|NCT05137730|76095600|FG002|COMPLETED|Part II: Washout Period 3 (48 Hours)||3||
59978670|NCT05137730|76095601|FG003|COMPLETED|Part II: Washout Period 3 (48 Hours)||3||
59978671|NCT05137730|76095602|FG004|COMPLETED|Part II: Washout Period 3 (48 Hours)||3||
59978672|NCT05137730|76095603|FG005|COMPLETED|Part II: Washout Period 3 (48 Hours)||3||
59978673|NCT05137730|76095598|FG000|NOT COMPLETED|Part II: Washout Period 3 (48 Hours)||0||
59978674|NCT05137730|76095599|FG001|NOT COMPLETED|Part II: Washout Period 3 (48 Hours)||0||
59978675|NCT05137730|76095600|FG002|NOT COMPLETED|Part II: Washout Period 3 (48 Hours)||0||
60074738|NCT01968967|76190063|FG004|COMPLETED|Treatment Period||0||
60074739|NCT01968967|76190059|FG000|NOT COMPLETED|Treatment Period||146||
60074740|NCT01968967|76190060|FG001|NOT COMPLETED|Treatment Period||134||
60074741|NCT01968967|76190061|FG002|NOT COMPLETED|Treatment Period||0||
60074742|NCT01968967|76190062|FG003|NOT COMPLETED|Treatment Period||0||
60074743|NCT01968967|76190063|FG004|NOT COMPLETED|Treatment Period||0||
59978676|NCT05137730|76095601|FG003|NOT COMPLETED|Part II: Washout Period 3 (48 Hours)||0||
59978677|NCT05137730|76095602|FG004|NOT COMPLETED|Part II: Washout Period 3 (48 Hours)||0||
59978678|NCT05137730|76095603|FG005|NOT COMPLETED|Part II: Washout Period 3 (48 Hours)||0||
59978679|NCT05137730|76095598|FG000|STARTED|Part II: Treatment Period 4 (1 Day)||0||
59978680|NCT05137730|76095599|FG001|STARTED|Part II: Treatment Period 4 (1 Day)||0||
59978681|NCT05137730|76095600|FG002|STARTED|Part II: Treatment Period 4 (1 Day)||3||
59978682|NCT05137730|76095601|FG003|STARTED|Part II: Treatment Period 4 (1 Day)||3||
59978683|NCT05137730|76095602|FG004|STARTED|Part II: Treatment Period 4 (1 Day)||3||
59978684|NCT05137730|76095603|FG005|STARTED|Part II: Treatment Period 4 (1 Day)||3||
59978685|NCT05137730|76095598|FG000|COMPLETED|Part II: Treatment Period 4 (1 Day)||0||
59978686|NCT05137730|76095599|FG001|COMPLETED|Part II: Treatment Period 4 (1 Day)||0||
59978687|NCT05137730|76095600|FG002|COMPLETED|Part II: Treatment Period 4 (1 Day)||3||
59978688|NCT05137730|76095601|FG003|COMPLETED|Part II: Treatment Period 4 (1 Day)||3||
59978689|NCT05137730|76095602|FG004|COMPLETED|Part II: Treatment Period 4 (1 Day)||3||
59978690|NCT05137730|76095603|FG005|COMPLETED|Part II: Treatment Period 4 (1 Day)||3||
59978691|NCT05137730|76095598|FG000|NOT COMPLETED|Part II: Treatment Period 4 (1 Day)||0||
59978692|NCT05137730|76095599|FG001|NOT COMPLETED|Part II: Treatment Period 4 (1 Day)||0||
59978693|NCT05137730|76095600|FG002|NOT COMPLETED|Part II: Treatment Period 4 (1 Day)||0||
59978694|NCT05137730|76095601|FG003|NOT COMPLETED|Part II: Treatment Period 4 (1 Day)||0||
59978695|NCT05137730|76095602|FG004|NOT COMPLETED|Part II: Treatment Period 4 (1 Day)||0||
59978696|NCT05137730|76095603|FG005|NOT COMPLETED|Part II: Treatment Period 4 (1 Day)||0||
59978697|NCT05041439|76095624|FG000|STARTED|Overall Study||25||
59978698|NCT05041439|76095625|FG001|STARTED|Overall Study||25||
59978699|NCT05041439|76095624|FG000|COMPLETED|Overall Study||23||
59978700|NCT05041439|76095625|FG001|COMPLETED|Overall Study||24||
59978701|NCT05041439|76095624|FG000|NOT COMPLETED|Overall Study||2||
59978702|NCT05041439|76095625|FG001|NOT COMPLETED|Overall Study||1||
59978703|NCT05037409|76095634|FG000|STARTED|Blinded Treatment (1 Day)||5||
59978704|NCT05037409|76095635|FG001|STARTED|Blinded Treatment (1 Day)||6||
59814060|NCT00422097|75936452|FG002|COMPLETED|Ixabepilone With Famotidine or Food||0||
59814061|NCT00422097|75936453|FG003|COMPLETED|Ixabepilone With Famotidine or Food||0||
59814062|NCT00422097|75936454|FG004|COMPLETED|Ixabepilone With Famotidine or Food||0||
59814063|NCT00422097|75936455|FG005|COMPLETED|Ixabepilone With Famotidine or Food||0||
59814064|NCT00422097|75936456|FG006|COMPLETED|Ixabepilone With Famotidine or Food||8||
59814065|NCT00422097|75936457|FG007|COMPLETED|Ixabepilone With Famotidine or Food||7||
59814066|NCT00422097|75936450|FG000|NOT COMPLETED|Ixabepilone With Famotidine or Food||0||
59814067|NCT00422097|75936451|FG001|NOT COMPLETED|Ixabepilone With Famotidine or Food||0||
59814068|NCT00422097|75936452|FG002|NOT COMPLETED|Ixabepilone With Famotidine or Food||0||
59814069|NCT00422097|75936453|FG003|NOT COMPLETED|Ixabepilone With Famotidine or Food||0||
59978705|NCT05037409|76095636|FG002|STARTED|Blinded Treatment (1 Day)||2||
59814070|NCT00422097|75936454|FG004|NOT COMPLETED|Ixabepilone With Famotidine or Food||0||
59814071|NCT00422097|75936455|FG005|NOT COMPLETED|Ixabepilone With Famotidine or Food||0||
59814072|NCT00422097|75936456|FG006|NOT COMPLETED|Ixabepilone With Famotidine or Food||0||
59978706|NCT05037409|76095634|FG000|Treated|Blinded Treatment (1 Day)||5||
59978707|NCT05037409|76095635|FG001|Treated|Blinded Treatment (1 Day)||5||
59978708|NCT05037409|76095636|FG002|Treated|Blinded Treatment (1 Day)||2||
59978709|NCT05037409|76095634|FG000|COMPLETED|Blinded Treatment (1 Day)||5||
59978710|NCT05037409|76095635|FG001|COMPLETED|Blinded Treatment (1 Day)||5||
59978711|NCT05037409|76095636|FG002|COMPLETED|Blinded Treatment (1 Day)||2||
59978712|NCT05037409|76095634|FG000|NOT COMPLETED|Blinded Treatment (1 Day)||0||
59978713|NCT05037409|76095635|FG001|NOT COMPLETED|Blinded Treatment (1 Day)||1||
59978714|NCT05037409|76095636|FG002|NOT COMPLETED|Blinded Treatment (1 Day)||0||
59978715|NCT05037409|76095634|FG000|STARTED|Follow-up ( Up to Day 157)||5||
59978716|NCT05037409|76095635|FG001|STARTED|Follow-up ( Up to Day 157)||5||
59978717|NCT05037409|76095636|FG002|STARTED|Follow-up ( Up to Day 157)||2||
59978718|NCT05037409|76095634|FG000|COMPLETED|Follow-up ( Up to Day 157)||5||
59978719|NCT05037409|76095635|FG001|COMPLETED|Follow-up ( Up to Day 157)||5||
59978720|NCT05037409|76095636|FG002|COMPLETED|Follow-up ( Up to Day 157)||2||
59978721|NCT05037409|76095634|FG000|NOT COMPLETED|Follow-up ( Up to Day 157)||0||
59978722|NCT05037409|76095635|FG001|NOT COMPLETED|Follow-up ( Up to Day 157)||0||
59978723|NCT05037409|76095636|FG002|NOT COMPLETED|Follow-up ( Up to Day 157)||0||
59978724|NCT04999111|76095650|FG000|STARTED|Overall Study||331|Enrolled Participants|
59978725|NCT04999111|76095651|FG001|STARTED|Overall Study||328|Enrolled Participants|
59978726|NCT04999111|76095652|FG002|STARTED|Overall Study||116|Enrolled Participants|
59978727|NCT04999111|76095653|FG003|STARTED|Overall Study||329|Enrolled Participants|
59978728|NCT04999111|76095654|FG004|STARTED|Overall Study||331|Enrolled Participants|
59978729|NCT04999111|76095655|FG005|STARTED|Overall Study||106|Enrolled Participants|
59978730|NCT04999111|76095650|FG000|Randomized and Vaccinated|Overall Study||330||
59978731|NCT04999111|76095651|FG001|Randomized and Vaccinated|Overall Study||326||
59978732|NCT04999111|76095652|FG002|Randomized and Vaccinated|Overall Study||116||
59978733|NCT04999111|76095653|FG003|Randomized and Vaccinated|Overall Study||326||
59978734|NCT04999111|76095654|FG004|Randomized and Vaccinated|Overall Study||328||
59978735|NCT04999111|76095655|FG005|Randomized and Vaccinated|Overall Study||106||
59978736|NCT04999111|76095650|FG000|COMPLETED|Overall Study||277||
59978737|NCT04999111|76095651|FG001|COMPLETED|Overall Study||271||
59978738|NCT04999111|76095652|FG002|COMPLETED|Overall Study||96||
59978739|NCT04999111|76095653|FG003|COMPLETED|Overall Study||260||
59978740|NCT04999111|76095654|FG004|COMPLETED|Overall Study||251||
59978741|NCT04999111|76095655|FG005|COMPLETED|Overall Study||84||
59978742|NCT04999111|76095650|FG000|NOT COMPLETED|Overall Study||54||
59978743|NCT04999111|76095651|FG001|NOT COMPLETED|Overall Study||57||
59978744|NCT04999111|76095652|FG002|NOT COMPLETED|Overall Study||20||
59978745|NCT04999111|76095653|FG003|NOT COMPLETED|Overall Study||69||
59978746|NCT04999111|76095654|FG004|NOT COMPLETED|Overall Study||80||
59978747|NCT04999111|76095655|FG005|NOT COMPLETED|Overall Study||22||
59978748|NCT04964557|76095675|FG000|STARTED|Overall Study||206||
59978749|NCT04964557|76095676|FG001|STARTED|Overall Study||205||
59978750|NCT04964557|76095675|FG000|COMPLETED|Overall Study||196||
59978751|NCT04964557|76095676|FG001|COMPLETED|Overall Study||201||
59978752|NCT04964557|76095675|FG000|NOT COMPLETED|Overall Study||10||
59978753|NCT04964557|76095676|FG001|NOT COMPLETED|Overall Study||4||
59978754|NCT04798027|76095689|FG000|STARTED|Overall Study||10||
59978755|NCT04798027|76095690|FG001|STARTED|Overall Study||25||
59978756|NCT04798027|76095691|FG002|STARTED|Overall Study||10||
59978757|NCT04798027|76095692|FG003|STARTED|Overall Study||27||
59978758|NCT04798027|76095693|FG004|STARTED|Overall Study||26||
59978759|NCT04798027|76095694|FG005|STARTED|Overall Study||13||
59978760|NCT04798027|76095695|FG006|STARTED|Overall Study||28||
59978761|NCT04798027|76095696|FG007|STARTED|Overall Study||29||
59978762|NCT04798027|76095697|FG008|STARTED|Overall Study||14||
59978763|NCT04798027|76095689|FG000|Vaccinated on Day 1|Overall Study||10||
59978764|NCT04798027|76095690|FG001|Vaccinated on Day 1|Overall Study||25||
59978765|NCT04798027|76095691|FG002|Vaccinated on Day 1|Overall Study||10||
59978766|NCT04798027|76095692|FG003|Vaccinated on Day 1|Overall Study||27||
59978767|NCT04798027|76095693|FG004|Vaccinated on Day 1|Overall Study||25||
59978768|NCT04798027|76095694|FG005|Vaccinated on Day 1|Overall Study||13||
59978769|NCT04798027|76095695|FG006|Vaccinated on Day 1|Overall Study||28||
59978770|NCT04798027|76095696|FG007|Vaccinated on Day 1|Overall Study||28||
59978771|NCT04798027|76095697|FG008|Vaccinated on Day 1|Overall Study||14||
59978772|NCT04798027|76095689|FG000|Vaccinated on Day 22|Overall Study||10||
59978773|NCT04798027|76095690|FG001|Vaccinated on Day 22|Overall Study||24||
59978774|NCT04798027|76095691|FG002|Vaccinated on Day 22|Overall Study||10||
59978775|NCT04798027|76095692|FG003|Vaccinated on Day 22|Overall Study|Only FEC Cohort 2 participants received second dose of study vaccine at Day 22.|0||
59978776|NCT04798027|76095693|FG004|Vaccinated on Day 22|Overall Study|Only FEC Cohort 2 participants received second dose of study vaccine at Day 22.|0||
59978777|NCT04798027|76095694|FG005|Vaccinated on Day 22|Overall Study|Only FEC Cohort 2 participants received second dose of study vaccine at Day 22.|0||
59978778|NCT04798027|76095695|FG006|Vaccinated on Day 22|Overall Study||19||
59978779|NCT04798027|76095696|FG007|Vaccinated on Day 22|Overall Study||19||
59978780|NCT04798027|76095697|FG008|Vaccinated on Day 22|Overall Study||9||
59978781|NCT04798027|76095689|FG000|Safety Analysis Set (SafAS)|Overall Study|8 participants of 'Sentinel Cohort: SARS-CoV-2 Vaccine low dose' received ultra-low dose and were included in arm 'Sentinel Cohort: SARS-CoV-2 Vaccine ultra-low dose' for safety analysis.|18|Participants who had received at least one injection of study intervention and were analyzed according to the study intervention they actually received.|
59978782|NCT04798027|76095690|FG001|Safety Analysis Set (SafAS)|Overall Study||17|Participants who had received at least one injection of study intervention and were analyzed according to the study intervention they actually received.|
59994988|NCT03367429|76110818|FG002|COMPLETED|Overall Study||2||
59994989|NCT03367429|76110816|FG000|NOT COMPLETED|Overall Study||0||
59978783|NCT04798027|76095691|FG002|Safety Analysis Set (SafAS)|Overall Study||10|Participants who had received at least one injection of study intervention and were analyzed according to the study intervention they actually received.|
59978784|NCT04798027|76095692|FG003|Safety Analysis Set (SafAS)|Overall Study|9 participants of 'FEC Cohort 2: SARS-CoV-2 Vaccine ultra-low dose' received ultra-low dose in arm 'FEC Cohort 1: SARS-CoV-2 Vaccine ultra-low dose' and were included in that arm for safety analysis.|36|Participants who had received at least one injection of study intervention and were analyzed according to the study intervention they actually received.|
59978785|NCT04798027|76095693|FG004|Safety Analysis Set (SafAS)|Overall Study|9 participants of 'FEC Cohort 2: SARS-CoV-2 Vaccine low dose' received low dose in arm 'FEC Cohort 1: SARS-CoV-2 Vaccine low dose' and were included in that arm for safety analysis.|34|Participants who had received at least one injection of study intervention and were analyzed according to the study intervention they actually received.|
59978786|NCT04798027|76095694|FG005|Safety Analysis Set (SafAS)|Overall Study|5 participants of 'FEC Cohort 2: Placebo' received dose in FEC Cohort 1: Placebo and were included in that arm for safety analysis.|18|Participants who had received at least one injection of study intervention and were analyzed according to the study intervention they actually received.|
59978787|NCT04798027|76095695|FG006|Safety Analysis Set (SafAS)|Overall Study||19|Participants who had received at least one injection of study intervention and were analyzed according to the study intervention they actually received.|
59978788|NCT04798027|76095696|FG007|Safety Analysis Set (SafAS)|Overall Study||19|Participants who had received at least one injection of study intervention and were analyzed according to the study intervention they actually received.|
59978789|NCT04798027|76095697|FG008|Safety Analysis Set (SafAS)|Overall Study||9|Participants who had received at least one injection of study intervention and were analyzed according to the study intervention they actually received.|
59978790|NCT04798027|76095689|FG000|COMPLETED|Overall Study||0||
59978791|NCT04798027|76095690|FG001|COMPLETED|Overall Study||0||
59978792|NCT04798027|76095691|FG002|COMPLETED|Overall Study||0||
59978793|NCT04798027|76095692|FG003|COMPLETED|Overall Study||0||
59978794|NCT04798027|76095693|FG004|COMPLETED|Overall Study||0||
59978795|NCT04798027|76095694|FG005|COMPLETED|Overall Study||0||
59978796|NCT04798027|76095695|FG006|COMPLETED|Overall Study||0||
59814073|NCT00422097|75936457|FG007|NOT COMPLETED|Ixabepilone With Famotidine or Food||0||
59814074|NCT00348556|75936481|FG000|STARTED|Overall Study||4||
59814075|NCT00348556|75936481|FG000|COMPLETED|Overall Study||3||
59814076|NCT00348556|75936481|FG000|NOT COMPLETED|Overall Study||1||
59814077|NCT00434967|75936489|FG000|STARTED|Overall Study||97||
59814078|NCT00434967|75936490|FG001|STARTED|Overall Study||465||
59978797|NCT04798027|76095696|FG007|COMPLETED|Overall Study||0||
59978798|NCT04798027|76095697|FG008|COMPLETED|Overall Study||0||
59978799|NCT04798027|76095689|FG000|NOT COMPLETED|Overall Study||10||
59978800|NCT04798027|76095690|FG001|NOT COMPLETED|Overall Study||25||
59978801|NCT04798027|76095691|FG002|NOT COMPLETED|Overall Study||10||
59978802|NCT04798027|76095692|FG003|NOT COMPLETED|Overall Study||27||
59978803|NCT04798027|76095693|FG004|NOT COMPLETED|Overall Study||26||
59978804|NCT04798027|76095694|FG005|NOT COMPLETED|Overall Study||13||
59978805|NCT04798027|76095695|FG006|NOT COMPLETED|Overall Study||28||
59978806|NCT04798027|76095696|FG007|NOT COMPLETED|Overall Study||29||
59978807|NCT04798027|76095697|FG008|NOT COMPLETED|Overall Study||14||
59978808|NCT04682405|76095724|FG000|STARTED|Overall Study||26||
59978809|NCT04682405|76095725|FG001|STARTED|Overall Study||25||
59978810|NCT04682405|76095724|FG000|COMPLETED|Overall Study||26||
59978811|NCT04682405|76095725|FG001|COMPLETED|Overall Study||24||
59978812|NCT04682405|76095724|FG000|NOT COMPLETED|Overall Study||0||
59978813|NCT04682405|76095725|FG001|NOT COMPLETED|Overall Study||1||
59978814|NCT04655313|76095731|FG000|STARTED|Overall Study||20||
59978815|NCT04655313|76095731|FG000|COMPLETED|Overall Study||20|Seven of the 20 participants who completed the study are continuing in study ARQ-151-306.|
59978816|NCT04655313|76095731|FG000|NOT COMPLETED|Overall Study||0||
59978817|NCT04607980|76095737|FG000|STARTED|Overall Study||281||
59978818|NCT04607980|76095738|FG001|STARTED|Overall Study||282||
59978819|NCT04607980|76095737|FG000|Treated|Overall Study||280||
59978820|NCT04607980|76095738|FG001|Treated|Overall Study||282||
59978821|NCT04607980|76095737|FG000|Re-randomized to ABP 654 at Week 28|Overall Study||247||
59978822|NCT04607980|76095738|FG001|Re-randomized to ABP 654 at Week 28|Overall Study||117||
59978823|NCT04607980|76095737|FG000|Re-randomized to Ustekinumab at Week 28|Overall Study||0||
59978824|NCT04607980|76095738|FG001|Re-randomized to Ustekinumab at Week 28|Overall Study||116||
59978825|NCT04607980|76095737|FG000|Not Re-randomized at Week 28 and Dose Intensified|Overall Study||25||
59814079|NCT00434967|75936491|FG002|STARTED|Overall Study||470||
59814080|NCT00434967|75936492|FG003|STARTED|Overall Study||492||
59814081|NCT00434967|75936489|FG000|COMPLETED|Overall Study||90||
59814082|NCT00434967|75936490|FG001|COMPLETED|Overall Study||457||
59814083|NCT00434967|75936491|FG002|COMPLETED|Overall Study||461||
59814084|NCT00434967|75936492|FG003|COMPLETED|Overall Study||478||
59814085|NCT00434967|75936489|FG000|NOT COMPLETED|Overall Study||7||
59814086|NCT00434967|75936490|FG001|NOT COMPLETED|Overall Study||8||
59814087|NCT00434967|75936491|FG002|NOT COMPLETED|Overall Study||9||
59814088|NCT00434967|75936492|FG003|NOT COMPLETED|Overall Study||14||
59814089|NCT00356590|75936502|FG000|STARTED|Overall Study||468||
59814090|NCT00356590|75936502|FG000|COMPLETED|Overall Study||194||
59814091|NCT00356590|75936502|FG000|NOT COMPLETED|Overall Study||274||
59814092|NCT00356278|75936509|FG000|STARTED|Overall Study||53||
59814093|NCT00356278|75936510|FG001|STARTED|Overall Study||50||
59978826|NCT04607980|76095738|FG001|Not Re-randomized at Week 28 and Dose Intensified|Overall Study||34||
59978827|NCT04607980|76095737|FG000|COMPLETED|Overall Study||269||
59978828|NCT04607980|76095738|FG001|COMPLETED|Overall Study||261||
59978829|NCT04607980|76095737|FG000|NOT COMPLETED|Overall Study||12||
59978830|NCT04607980|76095738|FG001|NOT COMPLETED|Overall Study||21||
59978831|NCT04543279|76095758|FG000|STARTED|Overall Study||3||
59978832|NCT04543279|76095759|FG001|STARTED|Overall Study||0||
59978833|NCT04543279|76095758|FG000|COMPLETED|Overall Study||0||
59978834|NCT04543279|76095759|FG001|COMPLETED|Overall Study||0||
59978835|NCT04543279|76095758|FG000|NOT COMPLETED|Overall Study||3||
59978836|NCT04543279|76095759|FG001|NOT COMPLETED|Overall Study||0||
59978837|NCT04540913|76095767|FG000|STARTED|Overall Study||153||
59978838|NCT04540913|76095768|FG001|STARTED|Overall Study||49||
59978839|NCT04540913|76095767|FG000|ITT Population|Overall Study||148||
59978840|NCT04540913|76095768|FG001|ITT Population|Overall Study||48||
59978841|NCT04540913|76095767|FG000|mITT Population|Overall Study||137||
59978842|NCT04540913|76095768|FG001|mITT Population|Overall Study||44||
59978843|NCT04540913|76095767|FG000|PP Population|Overall Study||127||
59978844|NCT04540913|76095768|FG001|PP Population|Overall Study||42||
59978845|NCT04540913|76095767|FG000|COMPLETED|Overall Study||139||
59978846|NCT04540913|76095768|FG001|COMPLETED|Overall Study||46||
59978847|NCT04540913|76095767|FG000|NOT COMPLETED|Overall Study||14||
59814094|NCT00356278|75936511|FG002|STARTED|Overall Study||53||
59622450|NCT02117310|75734282|FG000|STARTED|Overall Study||5||
59622451|NCT02117310|75734282|FG000|COMPLETED|Overall Study||5||
59622452|NCT02117310|75734282|FG000|NOT COMPLETED|Overall Study||0||
59622453|NCT00425802|75734286|FG000|STARTED|Overall Study||61||
59622454|NCT00425802|75734286|FG000|COMPLETED|Overall Study||61||
59814095|NCT00356278|75936509|FG000|COMPLETED|Overall Study||28||
59814096|NCT00356278|75936510|FG001|COMPLETED|Overall Study||35||
59814097|NCT00356278|75936511|FG002|COMPLETED|Overall Study||34||
59814098|NCT00356278|75936509|FG000|NOT COMPLETED|Overall Study||25||
59814099|NCT00356278|75936510|FG001|NOT COMPLETED|Overall Study||15||
59814100|NCT00356278|75936511|FG002|NOT COMPLETED|Overall Study||19||
59978848|NCT04540913|76095768|FG001|NOT COMPLETED|Overall Study||3||
59978849|NCT04540133|76095779|FG000|STARTED|Overall Study||15||
59978850|NCT04540133|76095780|FG001|STARTED|Overall Study||14||
59978851|NCT04540133|76095779|FG000|COMPLETED|Overall Study||14||
59978852|NCT04540133|76095780|FG001|COMPLETED|Overall Study||14||
59978853|NCT04540133|76095779|FG000|NOT COMPLETED|Overall Study||1||
59978854|NCT04540133|76095780|FG001|NOT COMPLETED|Overall Study||0||
59978855|NCT04494633|76095788|FG000|STARTED|Overall Study||35||
59978856|NCT04494633|76095789|FG001|STARTED|Overall Study||38||
59978857|NCT04494633|76095788|FG000|COMPLETED|Overall Study||29||
59978858|NCT04494633|76095789|FG001|COMPLETED|Overall Study||34||
59978859|NCT04494633|76095788|FG000|NOT COMPLETED|Overall Study||6||
59978860|NCT04494633|76095789|FG001|NOT COMPLETED|Overall Study||4||
59978861|NCT04233801|76095799|FG000|STARTED|Overall Study||73||
59978862|NCT04233801|76095800|FG001|STARTED|Overall Study||73||
59978863|NCT04233801|76095801|FG002|STARTED|Overall Study||73||
59978864|NCT04233801|76095799|FG000|COMPLETED|Overall Study||73||
59978865|NCT04233801|76095800|FG001|COMPLETED|Overall Study||71||
59978866|NCT04233801|76095801|FG002|COMPLETED|Overall Study||69||
59978867|NCT04233801|76095799|FG000|NOT COMPLETED|Overall Study||0||
59978868|NCT04233801|76095800|FG001|NOT COMPLETED|Overall Study||2||
59978869|NCT04233801|76095801|FG002|NOT COMPLETED|Overall Study||4||
59978870|NCT04225039|76095814|FG000|STARTED|Overall Study||18||
59978871|NCT04225039|76095815|FG001|STARTED|Overall Study||8||
59978872|NCT04225039|76095816|FG002|STARTED|Overall Study||8||
59978873|NCT04225039|76095817|FG003|STARTED|Overall Study||5||
59978874|NCT04225039|76095814|FG000|COMPLETED|Overall Study||15||
59978875|NCT04225039|76095815|FG001|COMPLETED|Overall Study||7||
59978876|NCT04225039|76095816|FG002|COMPLETED|Overall Study||8||
59978877|NCT04225039|76095817|FG003|COMPLETED|Overall Study||0||
59978878|NCT04225039|76095814|FG000|NOT COMPLETED|Overall Study||3||
59814101|NCT00356200|75936521|FG000|STARTED|Cohort 1: 10 ug/ml||5||
59622455|NCT00425802|75734286|FG000|NOT COMPLETED|Overall Study||0||
59622456|NCT00530634|75734290|FG000|STARTED|Overall Study||3||
59814102|NCT00356200|75936522|FG001|STARTED|Cohort 1: 10 ug/ml||0||
59814103|NCT00356200|75936521|FG000|COMPLETED|Cohort 1: 10 ug/ml||4||
59814104|NCT00356200|75936522|FG001|COMPLETED|Cohort 1: 10 ug/ml||0||
59814105|NCT00356200|75936521|FG000|NOT COMPLETED|Cohort 1: 10 ug/ml||1||
59814106|NCT00356200|75936522|FG001|NOT COMPLETED|Cohort 1: 10 ug/ml||0||
59814107|NCT00356200|75936521|FG000|STARTED|Cohort 2: 100 ug/ml (New Patients)||0||
59978879|NCT04225039|76095815|FG001|NOT COMPLETED|Overall Study||1||
59978880|NCT04225039|76095816|FG002|NOT COMPLETED|Overall Study||0||
59978881|NCT04225039|76095817|FG003|NOT COMPLETED|Overall Study||5||
59978882|NCT04059484|76095826|FG000|STARTED|Overall Study||147||
59978883|NCT04059484|76095827|FG001|STARTED|Overall Study||143||
59978884|NCT04059484|76095826|FG000|COMPLETED|Overall Study||0||
59978885|NCT04059484|76095827|FG001|COMPLETED|Overall Study||0||
59978886|NCT04059484|76095826|FG000|NOT COMPLETED|Overall Study||147||
59978887|NCT04059484|76095827|FG001|NOT COMPLETED|Overall Study||143||
59978888|NCT04059042|76095838|FG000|STARTED|Overall Study||5||
59978889|NCT04059042|76095839|FG001|STARTED|Overall Study||5||
59978890|NCT04059042|76095838|FG000|COMPLETED|Overall Study||4||
59978891|NCT04059042|76095839|FG001|COMPLETED|Overall Study||5||
59978892|NCT04059042|76095838|FG000|NOT COMPLETED|Overall Study||1||
59978893|NCT04059042|76095839|FG001|NOT COMPLETED|Overall Study||0||
59978894|NCT04033003|76095847|FG000|STARTED|T0 Baseline||877||
59978895|NCT04033003|76095848|FG001|STARTED|T0 Baseline||884||
59978896|NCT04033003|76095847|FG000|COMPLETED|T0 Baseline||877||
59978897|NCT04033003|76095848|FG001|COMPLETED|T0 Baseline||884||
59978898|NCT04033003|76095847|FG000|NOT COMPLETED|T0 Baseline||0||
59978899|NCT04033003|76095848|FG001|NOT COMPLETED|T0 Baseline||0||
59978900|NCT04033003|76095847|FG000|STARTED|T1 3rd Trimester||877||
59978901|NCT04033003|76095848|FG001|STARTED|T1 3rd Trimester||884||
59978902|NCT04033003|76095847|FG000|COMPLETED|T1 3rd Trimester||617||
59978903|NCT04033003|76095848|FG001|COMPLETED|T1 3rd Trimester||668||
59978904|NCT04033003|76095847|FG000|NOT COMPLETED|T1 3rd Trimester||260||
59978905|NCT04033003|76095848|FG001|NOT COMPLETED|T1 3rd Trimester||216||
59978906|NCT04033003|76095847|FG000|STARTED|T2 Post Delivery|The participants lost-to-follow up in T1 (third trimester) are eligible to participate in T2 (post-delivery) survey, which is why the number of participants started in T2 does not equal those who completed T1. The number started T2 is the sum of T1 completed + T1 lost-to-follow-up.|730||
59978907|NCT04033003|76095848|FG001|STARTED|T2 Post Delivery|The participants lost-to-follow up in T1 (third trimester) are eligible to participate in T2 (post-delivery) survey, which is why the number of participants started in T2 does not equal those who completed T1. The number started T2 is the sum of T1 completed + T1 lost-to-follow-up.|858||
59978908|NCT04033003|76095847|FG000|COMPLETED|T2 Post Delivery||585||
59978909|NCT04033003|76095848|FG001|COMPLETED|T2 Post Delivery||596||
59978910|NCT04033003|76095847|FG000|NOT COMPLETED|T2 Post Delivery||145||
59978911|NCT04033003|76095848|FG001|NOT COMPLETED|T2 Post Delivery||262||
59978912|NCT03872128|76095857|FG000|STARTED|Overall Study||30|Participants randomized|
59978913|NCT03872128|76095858|FG001|STARTED|Overall Study||30|Participants randomized|
59978914|NCT03872128|76095859|FG002|STARTED|Overall Study||31|Participants randomized|
59978915|NCT03872128|76095857|FG000|Began Treatment|Overall Study||29||
59978916|NCT03872128|76095858|FG001|Began Treatment|Overall Study||30||
59978917|NCT03872128|76095859|FG002|Began Treatment|Overall Study||27||
59978918|NCT03872128|76095857|FG000|COMPLETED|Overall Study||27||
59978919|NCT03872128|76095858|FG001|COMPLETED|Overall Study||25||
59978920|NCT03872128|76095859|FG002|COMPLETED|Overall Study||19||
59978921|NCT03872128|76095857|FG000|NOT COMPLETED|Overall Study||3||
59978922|NCT03872128|76095858|FG001|NOT COMPLETED|Overall Study||5||
59978923|NCT03872128|76095859|FG002|NOT COMPLETED|Overall Study||12||
59978924|NCT03597620|76095869|FG000|STARTED|Overall Study||6||
59978925|NCT03597620|76095870|FG001|STARTED|Overall Study||5||
59978926|NCT03597620|76095869|FG000|COMPLETED|Overall Study||4||
59978927|NCT03597620|76095870|FG001|COMPLETED|Overall Study||5||
59978928|NCT03597620|76095869|FG000|NOT COMPLETED|Overall Study||2||
59978929|NCT03597620|76095870|FG001|NOT COMPLETED|Overall Study||0||
59978930|NCT03397966|76095879|FG000|STARTED|Study Visit 1||3||
59978931|NCT03397966|76095880|FG001|STARTED|Study Visit 1||2||
59978932|NCT03397966|76095879|FG000|COMPLETED|Study Visit 1||3||
59978933|NCT03397966|76095880|FG001|COMPLETED|Study Visit 1||2||
59978934|NCT03397966|76095879|FG000|NOT COMPLETED|Study Visit 1||0||
59978935|NCT03397966|76095880|FG001|NOT COMPLETED|Study Visit 1||0||
59978936|NCT03397966|76095879|FG000|STARTED|Washout Period (2+ Weeks)||3||
59978937|NCT03397966|76095880|FG001|STARTED|Washout Period (2+ Weeks)||2||
59978938|NCT03397966|76095879|FG000|COMPLETED|Washout Period (2+ Weeks)||3||
59978939|NCT03397966|76095880|FG001|COMPLETED|Washout Period (2+ Weeks)||2||
59978940|NCT03397966|76095879|FG000|NOT COMPLETED|Washout Period (2+ Weeks)||0||
59978941|NCT03397966|76095880|FG001|NOT COMPLETED|Washout Period (2+ Weeks)||0||
59978942|NCT03397966|76095879|FG000|STARTED|Study Visit 2||3||
59978943|NCT03397966|76095880|FG001|STARTED|Study Visit 2||2||
59978944|NCT03397966|76095879|FG000|COMPLETED|Study Visit 2||3||
59978945|NCT03397966|76095880|FG001|COMPLETED|Study Visit 2||2||
59978946|NCT03397966|76095879|FG000|NOT COMPLETED|Study Visit 2||0||
59978947|NCT03397966|76095880|FG001|NOT COMPLETED|Study Visit 2||0||
59978948|NCT03221257|76095888|FG000|STARTED|Overall Study||24||
59526254|NCT01404559|75621831|FG001|STARTED|Overall Study||5||
59526255|NCT01404559|75621832|FG002|STARTED|Overall Study||4||
59526256|NCT01404559|75621833|FG003|STARTED|Overall Study||14||
59526257|NCT01404559|75621830|FG000|COMPLETED|Overall Study||5||
59978949|NCT03221257|76095889|FG001|STARTED|Overall Study||27||
59978950|NCT03221257|76095888|FG000|COMPLETED|Overall Study||23||
59978951|NCT03221257|76095889|FG001|COMPLETED|Overall Study||25||
59978952|NCT03221257|76095888|FG000|NOT COMPLETED|Overall Study||1||
59978953|NCT03221257|76095889|FG001|NOT COMPLETED|Overall Study||2||
59978954|NCT02978326|76095898|FG000|STARTED|Part A (Up to 75 Days)||1||
59526258|NCT01404559|75621831|FG001|COMPLETED|Overall Study||5||
59978955|NCT02978326|76095899|FG001|STARTED|Part A (Up to 75 Days)||0||
59978956|NCT02978326|76095900|FG002|STARTED|Part A (Up to 75 Days)||0||
59978957|NCT02978326|76095898|FG000|COMPLETED|Part A (Up to 75 Days)||1|Completed = Number of participants who completed Part A of the study.|
59994990|NCT03367429|76110817|FG001|NOT COMPLETED|Overall Study||0||
59526259|NCT01404559|75621832|FG002|COMPLETED|Overall Study||4||
59978958|NCT02978326|76095899|FG001|COMPLETED|Part A (Up to 75 Days)||0|Completed = Number of participants who completed Part A of the study.|
59978959|NCT02978326|76095900|FG002|COMPLETED|Part A (Up to 75 Days)||0|Completed = Number of participants who completed Part A of the study.|
59978960|NCT02978326|76095898|FG000|NOT COMPLETED|Part A (Up to 75 Days)||0||
59978961|NCT02978326|76095899|FG001|NOT COMPLETED|Part A (Up to 75 Days)||0||
59978962|NCT02978326|76095900|FG002|NOT COMPLETED|Part A (Up to 75 Days)||0||
59994991|NCT03367429|76110818|FG002|NOT COMPLETED|Overall Study||0||
59622457|NCT00530634|75734290|FG000|COMPLETED|Overall Study||3||
59622458|NCT00530634|75734290|FG000|NOT COMPLETED|Overall Study||0||
59814108|NCT00356200|75936522|FG001|STARTED|Cohort 2: 100 ug/ml (New Patients)||5||
59814109|NCT00356200|75936521|FG000|COMPLETED|Cohort 2: 100 ug/ml (New Patients)||0||
59814110|NCT00356200|75936522|FG001|COMPLETED|Cohort 2: 100 ug/ml (New Patients)||3||
59814111|NCT00356200|75936521|FG000|NOT COMPLETED|Cohort 2: 100 ug/ml (New Patients)||0||
59814112|NCT00356200|75936522|FG001|NOT COMPLETED|Cohort 2: 100 ug/ml (New Patients)||2||
59814113|NCT00356122|75936534|FG000|STARTED|TREATMENT||53||
59814114|NCT00356122|75936534|FG000|COMPLETED|TREATMENT||8||
59814115|NCT00356122|75936534|FG000|NOT COMPLETED|TREATMENT||45||
59814116|NCT00356122|75936534|FG000|STARTED|FOLLOW-UP||53||
59814117|NCT00356122|75936534|FG000|COMPLETED|FOLLOW-UP||12||
59814118|NCT00356122|75936534|FG000|NOT COMPLETED|FOLLOW-UP||41||
59814119|NCT00347932|75936540|FG000|STARTED|Overall Study|As Randomized population - received at least one dose of study medication|475||
59814120|NCT00347932|75936541|FG001|STARTED|Overall Study|As Randomized Population - received at least one dose of study medication|482||
59814121|NCT00347932|75936540|FG000|COMPLETED|Overall Study||444||
59814122|NCT00347932|75936541|FG001|COMPLETED|Overall Study||430||
59814123|NCT00347932|75936540|FG000|NOT COMPLETED|Overall Study||31||
59814124|NCT00347932|75936541|FG001|NOT COMPLETED|Overall Study||52||
59814125|NCT00528996|75936552|FG000|STARTED|Overall Study||429||
59814126|NCT00528996|75936553|FG001|STARTED|Overall Study||419||
59814127|NCT00528996|75936554|FG002|STARTED|Overall Study||415||
59814128|NCT00528996|75936555|FG003|STARTED|Overall Study||390||
59814129|NCT00528996|75936556|FG004|STARTED|Overall Study||427||
59814130|NCT00528996|75936552|FG000|COMPLETED|Overall Study||365||
59814131|NCT00528996|75936553|FG001|COMPLETED|Overall Study||395||
59814132|NCT00528996|75936554|FG002|COMPLETED|Overall Study||372||
59814133|NCT00528996|75936555|FG003|COMPLETED|Overall Study||340||
59814134|NCT00528996|75936556|FG004|COMPLETED|Overall Study||390||
59814135|NCT00528996|75936552|FG000|NOT COMPLETED|Overall Study||64||
59814136|NCT00528996|75936553|FG001|NOT COMPLETED|Overall Study||24||
59814137|NCT00528996|75936554|FG002|NOT COMPLETED|Overall Study||43||
59814138|NCT00528996|75936555|FG003|NOT COMPLETED|Overall Study||50||
59814139|NCT00528996|75936556|FG004|NOT COMPLETED|Overall Study||37||
59814140|NCT00359788|75936573|FG000|STARTED|Overall Study||173||
59814141|NCT00359788|75936574|FG001|STARTED|Overall Study||176||
59814142|NCT00359788|75936573|FG000|COMPLETED|Overall Study||150||
59814143|NCT00359788|75936574|FG001|COMPLETED|Overall Study||159||
59814144|NCT00359788|75936573|FG000|NOT COMPLETED|Overall Study||23||
59814145|NCT00359788|75936574|FG001|NOT COMPLETED|Overall Study||17||
59814146|NCT03878160|75936583|FG000|STARTED|Overall Study||7||
59814147|NCT03878160|75936584|FG001|STARTED|Overall Study||9||
59814148|NCT03878160|75936585|FG002|STARTED|Overall Study||11||
59814149|NCT03878160|75936583|FG000|COMPLETED|Overall Study||5||
59814150|NCT03878160|75936584|FG001|COMPLETED|Overall Study||8||
59814151|NCT03878160|75936585|FG002|COMPLETED|Overall Study||10||
59814152|NCT03878160|75936583|FG000|NOT COMPLETED|Overall Study||2||
59814153|NCT03878160|75936584|FG001|NOT COMPLETED|Overall Study||1||
59814154|NCT03878160|75936585|FG002|NOT COMPLETED|Overall Study||1||
59814155|NCT00623597|75936595|FG000|STARTED|Overall Study||5||
59814156|NCT00623597|75936596|FG001|STARTED|Overall Study||13||
59814157|NCT00623597|75936595|FG000|COMPLETED|Overall Study||4||
59814158|NCT00623597|75936596|FG001|COMPLETED|Overall Study||13||
59814159|NCT00623597|75936595|FG000|NOT COMPLETED|Overall Study||1||
59814160|NCT00623597|75936596|FG001|NOT COMPLETED|Overall Study||0||
59814161|NCT00347776|75936607|FG000|STARTED|1.5 Month Follow-up||484||
59814162|NCT00347776|75936608|FG001|STARTED|1.5 Month Follow-up||483||
59814163|NCT00347776|75936609|FG002|STARTED|1.5 Month Follow-up||485||
59814164|NCT00347776|75936607|FG000|COMPLETED|1.5 Month Follow-up||470||
59814165|NCT00347776|75936608|FG001|COMPLETED|1.5 Month Follow-up|473 had no recurrence.2 were lost to follow-up but were still eligible for follow-up at next visits|475||
59814166|NCT00347776|75936609|FG002|COMPLETED|1.5 Month Follow-up|472 had no recurrence.1 was lost to follow-up but was still eligible for follow-up at next visits|473||
59814167|NCT00347776|75936607|FG000|NOT COMPLETED|1.5 Month Follow-up||14||
59814168|NCT00347776|75936608|FG001|NOT COMPLETED|1.5 Month Follow-up||8||
59814169|NCT00347776|75936609|FG002|NOT COMPLETED|1.5 Month Follow-up||12||
59814170|NCT00347776|75936607|FG000|STARTED|6 Month Follow-up||470||
59814171|NCT00347776|75936608|FG001|STARTED|6 Month Follow-up||475||
59622459|NCT02113410|75734296|FG000|STARTED|Overall Study||65||
59622460|NCT02113410|75734297|FG001|STARTED|Overall Study||66||
59814172|NCT00347776|75936609|FG002|STARTED|6 Month Follow-up||473||
59814173|NCT00347776|75936607|FG000|COMPLETED|6 Month Follow-up|440 had no recurrence.8 were lost to follow-up but were still eligible for follow-up at next visits|448||
59814174|NCT00347776|75936608|FG001|COMPLETED|6 Month Follow-up|459 had no recurrence.3 were lost to follow-up but were still eligible for follow-up at next visits|462||
59978963|NCT02978326|76095898|FG000|STARTED|Part B (Up to 45 Days)||0|Started = Number of participants who were randomized to receive study drug in Part B of the study.|
59978964|NCT02978326|76095899|FG001|STARTED|Part B (Up to 45 Days)||76|Started = Number of participants who were randomized to receive study drug in Part B of the study.|
59978965|NCT02978326|76095900|FG002|STARTED|Part B (Up to 45 Days)||77|Started = Number of participants who were randomized to receive study drug in Part B of the study.|
59526260|NCT01404559|75621833|FG003|COMPLETED|Overall Study||14||
59526261|NCT01404559|75621830|FG000|NOT COMPLETED|Overall Study||0||
59526262|NCT01404559|75621831|FG001|NOT COMPLETED|Overall Study||0||
59526263|NCT01404559|75621832|FG002|NOT COMPLETED|Overall Study||0||
59526264|NCT01404559|75621833|FG003|NOT COMPLETED|Overall Study||0||
59526265|NCT01351753|75621846|FG000|STARTED|Overall Study||22||
59978966|NCT02978326|76095898|FG000|Received Study Drug|Part B (Up to 45 Days)||0|Two participants were randomized but did not receive study drug (1 in each treatment group).|
59526266|NCT01351753|75621847|FG001|STARTED|Overall Study||20||
59526267|NCT01351753|75621848|FG002|STARTED|Overall Study||21||
59526268|NCT01351753|75621849|FG003|STARTED|Overall Study||21||
59526269|NCT01351753|75621850|FG004|STARTED|Overall Study||21||
59526270|NCT01351753|75621851|FG005|STARTED|Overall Study||23||
59526271|NCT01351753|75621846|FG000|COMPLETED|Overall Study||15||
59526272|NCT01351753|75621847|FG001|COMPLETED|Overall Study||13||
59526273|NCT01351753|75621848|FG002|COMPLETED|Overall Study||14||
59526274|NCT01351753|75621849|FG003|COMPLETED|Overall Study||21||
59526275|NCT01351753|75621850|FG004|COMPLETED|Overall Study||14||
59526276|NCT01351753|75621851|FG005|COMPLETED|Overall Study||22||
59526277|NCT01351753|75621846|FG000|NOT COMPLETED|Overall Study||7||
59526278|NCT01351753|75621847|FG001|NOT COMPLETED|Overall Study||7||
59978967|NCT02978326|76095899|FG001|Received Study Drug|Part B (Up to 45 Days)||73|Two participants were randomized but did not receive study drug (1 in each treatment group).|
59995323|NCT04109976|76111170|FG001|COMPLETED|Overall Study||107||
59995324|NCT04109976|76111169|FG000|NOT COMPLETED|Overall Study||1||
59995325|NCT04109976|76111170|FG001|NOT COMPLETED|Overall Study||0||
59995326|NCT04068519|76111176|FG000|STARTED|Dose Verification||20||
59995327|NCT04068519|76111176|FG000|COMPLETED|Dose Verification||4||
59995328|NCT04068519|76111176|FG000|NOT COMPLETED|Dose Verification||16||
59995329|NCT04068519|76111176|FG000|STARTED|Pharmacokinetic Sub-study||57||
59995330|NCT04068519|76111176|FG000|COMPLETED|Pharmacokinetic Sub-study||16||
59995331|NCT04068519|76111176|FG000|NOT COMPLETED|Pharmacokinetic Sub-study||41||
59995332|NCT04068519|76111176|FG000|STARTED|Indication Expansion||223||
59995333|NCT04068519|76111176|FG000|COMPLETED|Indication Expansion||54||
59995334|NCT04068519|76111176|FG000|NOT COMPLETED|Indication Expansion||169||
59995335|NCT04036799|76111185|FG000|STARTED|Overall Study||572||
59995336|NCT04036799|76111185|FG000|COMPLETED|Overall Study||572||
59995337|NCT04036799|76111185|FG000|NOT COMPLETED|Overall Study||0||
59995338|NCT03864133|76111189|FG000|STARTED|Overall Study||94||
59995339|NCT03864133|76111189|FG000|COMPLETED|Overall Study||94||
59995340|NCT03864133|76111189|FG000|NOT COMPLETED|Overall Study||0||
59995341|NCT03819660|76111193|FG000|STARTED|Overall Study||13||
59995342|NCT03819660|76111193|FG000|COMPLETED|Overall Study||13||
59995343|NCT03819660|76111193|FG000|NOT COMPLETED|Overall Study||0||
59995344|NCT03818672|76111197|FG000|STARTED|Overall Study||5||
59995345|NCT03818672|76111197|FG000|COMPLETED|Overall Study||5||
59995346|NCT03818672|76111197|FG000|NOT COMPLETED|Overall Study||0||
59995347|NCT03810365|76111203|FG000|STARTED|Overall Study||66||
59995348|NCT03810365|76111204|FG001|STARTED|Overall Study||66||
59995349|NCT03810365|76111203|FG000|COMPLETED|Overall Study||60||
59995350|NCT03810365|76111204|FG001|COMPLETED|Overall Study||59||
59995351|NCT03810365|76111203|FG000|NOT COMPLETED|Overall Study||6||
59995352|NCT03810365|76111204|FG001|NOT COMPLETED|Overall Study||7||
59995353|NCT03632135|76111212|FG000|STARTED|Overall Study||35||
59995354|NCT03632135|76111213|FG001|STARTED|Overall Study||43||
59995355|NCT03632135|76111212|FG000|COMPLETED|Overall Study||35||
59995356|NCT03632135|76111213|FG001|COMPLETED|Overall Study||43||
59995357|NCT03632135|76111212|FG000|NOT COMPLETED|Overall Study||0||
59995358|NCT03632135|76111213|FG001|NOT COMPLETED|Overall Study||0||
59995359|NCT03605758|76111221|FG000|STARTED|Overall Study||22||
59995360|NCT03605758|76111222|FG001|STARTED|Overall Study||26||
59995361|NCT03605758|76111221|FG000|COMPLETED|Overall Study||0||
59995362|NCT03605758|76111222|FG001|COMPLETED|Overall Study||2||
59995363|NCT03605758|76111221|FG000|NOT COMPLETED|Overall Study||22||
59995364|NCT03605758|76111222|FG001|NOT COMPLETED|Overall Study||24||
59995365|NCT03222128|76111229|FG000|STARTED|Overall Study||1074||
59995366|NCT03222128|76111229|FG000|Valve-Implanted|Overall Study||1069||
59995367|NCT03222128|76111229|FG000|COMPLETED|Overall Study||968|One year follow-up|
59995368|NCT03222128|76111229|FG000|NOT COMPLETED|Overall Study||106||
59995369|NCT03016975|76111236|FG000|STARTED|At 30 Days Follow-up||12||
59995370|NCT03016975|76111237|FG001|STARTED|At 30 Days Follow-up||0||
59995371|NCT03016975|76111238|FG002|STARTED|At 30 Days Follow-up||0||
59995372|NCT03016975|76111236|FG000|COMPLETED|At 30 Days Follow-up||11||
59995373|NCT03016975|76111237|FG001|COMPLETED|At 30 Days Follow-up||0||
59995374|NCT03016975|76111238|FG002|COMPLETED|At 30 Days Follow-up||0||
59995375|NCT03016975|76111236|FG000|NOT COMPLETED|At 30 Days Follow-up||1||
59978968|NCT02978326|76095900|FG002|Received Study Drug|Part B (Up to 45 Days)|Two participants were randomized to placebo but received at least 1 dose of SAGE-217 in error and were included in the SAGE-217 group for 'Received Study Drug' and for 'Safety Analysis'.|78|Two participants were randomized but did not receive study drug (1 in each treatment group).|
59978969|NCT02978326|76095898|FG000|Safety Set (Part B)|Part B (Up to 45 Days)||0|Safety Set (Part B) included all participants who were administered study drug in Part B and summarized by actual treatment received.|
59978970|NCT02978326|76095899|FG001|Safety Set (Part B)|Part B (Up to 45 Days)||73|Safety Set (Part B) included all participants who were administered study drug in Part B and summarized by actual treatment received.|
59978971|NCT02978326|76095900|FG002|Safety Set (Part B)|Part B (Up to 45 Days)||78|Safety Set (Part B) included all participants who were administered study drug in Part B and summarized by actual treatment received.|
59978972|NCT02978326|76095898|FG000|Efficacy Set (Part B)|Part B (Up to 45 Days)||0|Efficacy Set (Part B) included all participants who were administered study drug, had a valid Baseline and at least 1 post-baseline efficacy assessment.|
59978973|NCT02978326|76095899|FG001|Efficacy Set (Part B)|Part B (Up to 45 Days)||74|Efficacy Set (Part B) included all participants who were administered study drug, had a valid Baseline and at least 1 post-baseline efficacy assessment.|
59978974|NCT02978326|76095900|FG002|Efficacy Set (Part B)|Part B (Up to 45 Days)||76|Efficacy Set (Part B) included all participants who were administered study drug, had a valid Baseline and at least 1 post-baseline efficacy assessment.|
59978975|NCT02978326|76095898|FG000|COMPLETED|Part B (Up to 45 Days)||0||
59978976|NCT02978326|76095899|FG001|COMPLETED|Part B (Up to 45 Days)||69||
59978977|NCT02978326|76095900|FG002|COMPLETED|Part B (Up to 45 Days)||73||
59978978|NCT02978326|76095898|FG000|NOT COMPLETED|Part B (Up to 45 Days)||0||
59978979|NCT02978326|76095899|FG001|NOT COMPLETED|Part B (Up to 45 Days)||7||
59814175|NCT00347776|75936609|FG002|COMPLETED|6 Month Follow-up|452 had no recurrence.3 were lost to follow-up but were still eligible for follow-up at next visits|455||
59814176|NCT00347776|75936607|FG000|NOT COMPLETED|6 Month Follow-up||22||
59814177|NCT00347776|75936608|FG001|NOT COMPLETED|6 Month Follow-up||13||
59814178|NCT00347776|75936609|FG002|NOT COMPLETED|6 Month Follow-up||18||
59814179|NCT00347776|75936607|FG000|STARTED|12 Month Follow-up||448||
59814180|NCT00347776|75936608|FG001|STARTED|12 Month Follow-up||462||
59814181|NCT00347776|75936609|FG002|STARTED|12 Month Follow-up||455||
59814182|NCT00347776|75936607|FG000|COMPLETED|12 Month Follow-up||425||
59814183|NCT00347776|75936608|FG001|COMPLETED|12 Month Follow-up||446||
59814184|NCT00347776|75936609|FG002|COMPLETED|12 Month Follow-up||436||
59814185|NCT00347776|75936607|FG000|NOT COMPLETED|12 Month Follow-up||23||
59814186|NCT00347776|75936608|FG001|NOT COMPLETED|12 Month Follow-up||16||
59978980|NCT02978326|76095900|FG002|NOT COMPLETED|Part B (Up to 45 Days)||4||
59978981|NCT02967172|76095912|FG000|STARTED|Overall Study||49||
59978982|NCT02967172|76095913|FG001|STARTED|Overall Study||51||
59978983|NCT02967172|76095912|FG000|COMPLETED|Overall Study||49||
59978984|NCT02967172|76095913|FG001|COMPLETED|Overall Study||51||
59978985|NCT02967172|76095912|FG000|NOT COMPLETED|Overall Study||0||
59978986|NCT02967172|76095913|FG001|NOT COMPLETED|Overall Study||0||
59978987|NCT02834403|76095926|FG000|STARTED|Overall Study||2||
59978988|NCT02834403|76095927|FG001|STARTED|Overall Study||2||
59978989|NCT02834403|76095928|FG002|STARTED|Overall Study||2||
59978990|NCT02834403|76095929|FG003|STARTED|Overall Study||2||
59978991|NCT02834403|76095930|FG004|STARTED|Overall Study||3||
59978992|NCT02834403|76095931|FG005|STARTED|Overall Study||4||
59978993|NCT02834403|76095932|FG006|STARTED|Overall Study||22||
59978994|NCT02834403|76095926|FG000|Evaluable Patients|Overall Study||2||
59978995|NCT02834403|76095927|FG001|Evaluable Patients|Overall Study||2||
59978996|NCT02834403|76095928|FG002|Evaluable Patients|Overall Study||2||
59978997|NCT02834403|76095929|FG003|Evaluable Patients|Overall Study||2||
59978998|NCT02834403|76095930|FG004|Evaluable Patients|Overall Study||3||
59978999|NCT02834403|76095931|FG005|Evaluable Patients|Overall Study||4||
59979000|NCT02834403|76095932|FG006|Evaluable Patients|Overall Study||20||
59979001|NCT02834403|76095926|FG000|COMPLETED|Overall Study||0||
59979002|NCT02834403|76095927|FG001|COMPLETED|Overall Study||0||
59979003|NCT02834403|76095928|FG002|COMPLETED|Overall Study||0||
59979004|NCT02834403|76095929|FG003|COMPLETED|Overall Study||1||
59979005|NCT02834403|76095930|FG004|COMPLETED|Overall Study||0||
59979006|NCT02834403|76095931|FG005|COMPLETED|Overall Study||1||
59979007|NCT02834403|76095932|FG006|COMPLETED|Overall Study||4||
59979008|NCT02834403|76095926|FG000|NOT COMPLETED|Overall Study||2||
59979009|NCT02834403|76095927|FG001|NOT COMPLETED|Overall Study||2||
59979010|NCT02834403|76095928|FG002|NOT COMPLETED|Overall Study||2||
59979011|NCT02834403|76095929|FG003|NOT COMPLETED|Overall Study||1||
59979012|NCT02834403|76095930|FG004|NOT COMPLETED|Overall Study||3||
59979013|NCT02834403|76095931|FG005|NOT COMPLETED|Overall Study||3||
60074744|NCT01968967|76190059|FG000|STARTED|Extension Period||0||
60074745|NCT01968967|76190060|FG001|STARTED|Extension Period||0||
60074746|NCT01968967|76190061|FG002|STARTED|Extension Period||47||
59814187|NCT00347776|75936609|FG002|NOT COMPLETED|12 Month Follow-up||19||
59814188|NCT03829228|75936617|FG000|STARTED|Overall Study||30||
59814189|NCT03829228|75936617|FG000|COMPLETED|Overall Study||29||
59814190|NCT03829228|75936617|FG000|NOT COMPLETED|Overall Study||1||
59814191|NCT00529542|75936623|FG000|STARTED|Overall Study||9||
59814192|NCT00529542|75936624|FG001|STARTED|Overall Study||11||
59814193|NCT00529542|75936623|FG000|COMPLETED|Overall Study||8||
59814194|NCT00529542|75936624|FG001|COMPLETED|Overall Study||10||
59814195|NCT00529542|75936623|FG000|NOT COMPLETED|Overall Study||1||
59979014|NCT02834403|76095932|FG006|NOT COMPLETED|Overall Study||18||
59814196|NCT00529542|75936624|FG001|NOT COMPLETED|Overall Study||1||
59814197|NCT00621959|75936632|FG000|STARTED|Overall Study|In all 791 subjects have been screened and 596 have been randomized|295||
59814198|NCT00621959|75936633|FG001|STARTED|Overall Study||301||
59814199|NCT00621959|75936632|FG000|COMPLETED|Overall Study||288||
59814200|NCT00621959|75936633|FG001|COMPLETED|Overall Study||292||
59814201|NCT00621959|75936632|FG000|NOT COMPLETED|Overall Study||7||
59814202|NCT00621959|75936633|FG001|NOT COMPLETED|Overall Study||9||
59814203|NCT03877224|75936641|FG000|STARTED|Overall Study||253||
59814204|NCT03877224|75936642|FG001|STARTED|Overall Study||251||
59814205|NCT03877224|75936641|FG000|Treated|Overall Study||252||
59814206|NCT03877224|75936642|FG001|Treated|Overall Study||249||
59814207|NCT03877224|75936641|FG000|COMPLETED|Overall Study||248||
59814208|NCT03877224|75936642|FG001|COMPLETED|Overall Study||243||
59814209|NCT03877224|75936641|FG000|NOT COMPLETED|Overall Study||5||
59814210|NCT03877224|75936642|FG001|NOT COMPLETED|Overall Study||8||
59814211|NCT00528606|75936650|FG000|STARTED|Overall Study||204||
59814212|NCT00528606|75936651|FG001|STARTED|Overall Study||104||
59814213|NCT00528606|75936650|FG000|COMPLETED|Overall Study||191||
59814214|NCT00528606|75936651|FG001|COMPLETED|Overall Study||100||
59814215|NCT00528606|75936650|FG000|NOT COMPLETED|Overall Study||13||
59814216|NCT00528606|75936651|FG001|NOT COMPLETED|Overall Study||4||
59814217|NCT00621257|75936662|FG000|STARTED|Overall Study||24||
59814218|NCT00621257|75936663|FG001|STARTED|Overall Study||24||
59814219|NCT00621257|75936664|FG002|STARTED|Overall Study||23||
59814220|NCT00621257|75936665|FG003|STARTED|Overall Study||32||
59814221|NCT00621257|75936666|FG004|STARTED|Overall Study||31||
59814222|NCT00621257|75936662|FG000|COMPLETED|Overall Study||20||
59814223|NCT00621257|75936663|FG001|COMPLETED|Overall Study||21||
59814224|NCT00621257|75936664|FG002|COMPLETED|Overall Study||20||
59814225|NCT00621257|75936665|FG003|COMPLETED|Overall Study||26||
59814226|NCT00621257|75936666|FG004|COMPLETED|Overall Study||22||
59814227|NCT00621257|75936662|FG000|NOT COMPLETED|Overall Study||4||
59814228|NCT00621257|75936663|FG001|NOT COMPLETED|Overall Study||3||
59814229|NCT00621257|75936664|FG002|NOT COMPLETED|Overall Study||3||
59814230|NCT00621257|75936665|FG003|NOT COMPLETED|Overall Study||6||
59814231|NCT00621257|75936666|FG004|NOT COMPLETED|Overall Study||9||
59814232|NCT00528840|75936678|FG000|STARTED|Overall Study||201||
59814233|NCT00528840|75936678|FG000|COMPLETED|Overall Study||168||
59814234|NCT00528840|75936678|FG000|NOT COMPLETED|Overall Study||33||
59814235|NCT00528528|75936686|FG000|STARTED|Overall Study||40||
59814236|NCT00528528|75936687|FG001|STARTED|Overall Study||42||
59814237|NCT00528528|75936688|FG002|STARTED|Overall Study||40||
59814238|NCT00528528|75936689|FG003|STARTED|Overall Study||39||
59814239|NCT00528528|75936686|FG000|Ongoing at Time of Cut-off|Overall Study||0||
59814240|NCT00528528|75936687|FG001|Ongoing at Time of Cut-off|Overall Study||0||
59622461|NCT02113410|75734296|FG000|COMPLETED|Overall Study||49||
59814241|NCT00528528|75936688|FG002|Ongoing at Time of Cut-off|Overall Study||1||
59814242|NCT00528528|75936689|FG003|Ongoing at Time of Cut-off|Overall Study||0||
59814243|NCT00528528|75936686|FG000|COMPLETED|Overall Study||37||
59814244|NCT00528528|75936687|FG001|COMPLETED|Overall Study||39||
59814245|NCT00528528|75936688|FG002|COMPLETED|Overall Study||37||
60074747|NCT01968967|76190062|FG003|STARTED|Extension Period||19||
59814246|NCT00528528|75936689|FG003|COMPLETED|Overall Study||36||
59814247|NCT00528528|75936686|FG000|NOT COMPLETED|Overall Study||3||
59814248|NCT00528528|75936687|FG001|NOT COMPLETED|Overall Study||3||
59814249|NCT00528528|75936688|FG002|NOT COMPLETED|Overall Study||3||
59814250|NCT00528528|75936689|FG003|NOT COMPLETED|Overall Study||3||
59814251|NCT00620555|75936701|FG000|STARTED|Overall Study||65||
59979033|NCT01966731|76095970|FG000|STARTED|Overall Study||635||
59979034|NCT01966731|76095970|FG000|Initiated Hydroxyurea|Overall Study||606||
59979035|NCT01966731|76095970|FG000|Completed 3 Months of Treatment|Overall Study||600||
59979036|NCT01966731|76095970|FG000|Completed Study|Overall Study||0||
59979037|NCT01966731|76095970|FG000|COMPLETED|Overall Study||0||
59979038|NCT01966731|76095970|FG000|NOT COMPLETED|Overall Study||635||
59979039|NCT01397851|76095976|FG000|STARTED|Overall Study||41634||
59979040|NCT01397851|76095977|FG001|STARTED|Overall Study||39963||
59979041|NCT01397851|76095976|FG000|COMPLETED|Overall Study||41555||
59979042|NCT01397851|76095977|FG001|COMPLETED|Overall Study||39917||
59979043|NCT01397851|76095976|FG000|NOT COMPLETED|Overall Study||79||
59979044|NCT01397851|76095977|FG001|NOT COMPLETED|Overall Study||46||
59979045|NCT02788175|76095983|FG000|STARTED|Overall Study||26|Screened|
59979046|NCT02788175|76095983|FG000|Received Study Agent|Overall Study||20||
59979047|NCT02788175|76095983|FG000|COMPLETED|Overall Study||13||
59979048|NCT02788175|76095983|FG000|NOT COMPLETED|Overall Study||13||
59979049|NCT02787083|76095989|FG000|STARTED|Overall Study||4||
59979050|NCT02787083|76095990|FG001|STARTED|Overall Study||5||
59979051|NCT02787083|76095989|FG000|COMPLETED|Overall Study||1||
59979052|NCT02787083|76095990|FG001|COMPLETED|Overall Study||3||
59979053|NCT02787083|76095989|FG000|NOT COMPLETED|Overall Study||3||
59979054|NCT02787083|76095990|FG001|NOT COMPLETED|Overall Study||2||
59979055|NCT02787863|76096004|FG000|STARTED|Overall Study||33||
59979056|NCT02787863|76096005|FG001|STARTED|Overall Study||34||
59979057|NCT02787863|76096006|FG002|STARTED|Overall Study||25||
59979058|NCT02787863|76096007|FG003|STARTED|Overall Study||25||
59979059|NCT02787863|76096008|FG004|STARTED|Overall Study||32||
59979060|NCT02787863|76096009|FG005|STARTED|Overall Study||18||
59979061|NCT02787863|76096010|FG006|STARTED|Overall Study||25||
59979062|NCT02787863|76096011|FG007|STARTED|Overall Study||27||
59979063|NCT02787863|76096004|FG000|1 Year After Vaccination|Overall Study||32||
59979064|NCT02787863|76096005|FG001|1 Year After Vaccination|Overall Study||33||
59979065|NCT02787863|76096006|FG002|1 Year After Vaccination|Overall Study||23||
59979066|NCT02787863|76096007|FG003|1 Year After Vaccination|Overall Study||25||
59979067|NCT02787863|76096008|FG004|1 Year After Vaccination|Overall Study||32||
59979068|NCT02787863|76096009|FG005|1 Year After Vaccination|Overall Study||18||
59979069|NCT02787863|76096010|FG006|1 Year After Vaccination|Overall Study||25||
59979070|NCT02787863|76096011|FG007|1 Year After Vaccination|Overall Study||27||
59979071|NCT02787863|76096004|FG000|4 Years After Vaccination|Overall Study||32||
59979072|NCT02787863|76096005|FG001|4 Years After Vaccination|Overall Study||33||
59979073|NCT02787863|76096006|FG002|4 Years After Vaccination|Overall Study||23||
59979074|NCT02787863|76096007|FG003|4 Years After Vaccination|Overall Study||25||
59979075|NCT02787863|76096008|FG004|4 Years After Vaccination|Overall Study||32||
59979076|NCT02787863|76096009|FG005|4 Years After Vaccination|Overall Study||18||
59979077|NCT02787863|76096010|FG006|4 Years After Vaccination|Overall Study||25||
59979078|NCT02787863|76096011|FG007|4 Years After Vaccination|Overall Study||27||
59979079|NCT02787863|76096004|FG000|COMPLETED|Overall Study||32||
59979080|NCT02787863|76096005|FG001|COMPLETED|Overall Study||33||
59979081|NCT02787863|76096006|FG002|COMPLETED|Overall Study||23||
60074748|NCT01968967|76190063|FG004|STARTED|Extension Period||39||
60074749|NCT01968967|76190059|FG000|COMPLETED|Extension Period||0||
59526279|NCT01351753|75621848|FG002|NOT COMPLETED|Overall Study||7||
59979082|NCT02787863|76096007|FG003|COMPLETED|Overall Study||25||
59979083|NCT02787863|76096008|FG004|COMPLETED|Overall Study||32||
59979084|NCT02787863|76096009|FG005|COMPLETED|Overall Study||18||
59979085|NCT02787863|76096010|FG006|COMPLETED|Overall Study||25||
59979086|NCT02787863|76096011|FG007|COMPLETED|Overall Study||27||
59979087|NCT02787863|76096004|FG000|NOT COMPLETED|Overall Study||1||
59979088|NCT02787863|76096005|FG001|NOT COMPLETED|Overall Study||1||
60074750|NCT01968967|76190060|FG001|COMPLETED|Extension Period||0||
60074751|NCT01968967|76190061|FG002|COMPLETED|Extension Period||45||
59979089|NCT02787863|76096006|FG002|NOT COMPLETED|Overall Study||2||
59979090|NCT02787863|76096007|FG003|NOT COMPLETED|Overall Study||0||
59979091|NCT02787863|76096008|FG004|NOT COMPLETED|Overall Study||0||
59979092|NCT02787863|76096009|FG005|NOT COMPLETED|Overall Study||0||
59979093|NCT02787863|76096010|FG006|NOT COMPLETED|Overall Study||0||
59979094|NCT02787863|76096011|FG007|NOT COMPLETED|Overall Study||0||
59979095|NCT02596958|76096052|FG000|STARTED|Overall Study||996||
59979096|NCT02596958|76096052|FG000|COMPLETED|Overall Study||0||
59979097|NCT02596958|76096052|FG000|NOT COMPLETED|Overall Study||996||
59979098|NCT01367249|76096058|FG000|STARTED|Overall Study||222||
59979099|NCT01367249|76096059|FG001|STARTED|Overall Study||218||
59979100|NCT01367249|76096058|FG000|COMPLETED|Overall Study||213||
59979101|NCT01367249|76096059|FG001|COMPLETED|Overall Study||202||
59979102|NCT01367249|76096058|FG000|NOT COMPLETED|Overall Study||9||
59979103|NCT01367249|76096059|FG001|NOT COMPLETED|Overall Study||16||
59979104|NCT02786927|76096065|FG000|STARTED|Overall Study||212||
59979105|NCT02786927|76096065|FG000|COMPLETED|Overall Study||207||
59979106|NCT02786927|76096065|FG000|NOT COMPLETED|Overall Study||5||
59979107|NCT02592434|76096070|FG000|STARTED|Open-Label Phase (18 Weeks)||225||
59979108|NCT02592434|76096071|FG001|STARTED|Open-Label Phase (18 Weeks)||0||
59979109|NCT02592434|76096072|FG002|STARTED|Open-Label Phase (18 Weeks)||0||
59979110|NCT02592434|76096070|FG000|Treated|Open-Label Phase (18 Weeks)||225||
59979111|NCT02592434|76096071|FG001|Treated|Open-Label Phase (18 Weeks)||0||
59979112|NCT02592434|76096072|FG002|Treated|Open-Label Phase (18 Weeks)||0||
59979113|NCT02592434|76096070|FG000|COMPLETED|Open-Label Phase (18 Weeks)||185||
59979114|NCT02592434|76096071|FG001|COMPLETED|Open-Label Phase (18 Weeks)||0||
59979115|NCT02592434|76096072|FG002|COMPLETED|Open-Label Phase (18 Weeks)||0||
59979116|NCT02592434|76096070|FG000|NOT COMPLETED|Open-Label Phase (18 Weeks)||40||
59979117|NCT02592434|76096071|FG001|NOT COMPLETED|Open-Label Phase (18 Weeks)||0||
59979118|NCT02592434|76096072|FG002|NOT COMPLETED|Open-Label Phase (18 Weeks)||0||
59979119|NCT02592434|76096070|FG000|STARTED|Double Blind Phase (26 Weeks)||0||
59979120|NCT02592434|76096071|FG001|STARTED|Double Blind Phase (26 Weeks)|Only those participants who completed OL phase, achieved at least a JIA ACR 30 response in OL phase.|88||
59979121|NCT02592434|76096072|FG002|STARTED|Double Blind Phase (26 Weeks)|Only those participants who completed OL phase,achieved at least a JIA ACR 30 response in OL phase.|85||
59979122|NCT02592434|76096070|FG000|Treated|Double Blind Phase (26 Weeks)||0||
59979123|NCT02592434|76096071|FG001|Treated|Double Blind Phase (26 Weeks)||88||
59979124|NCT02592434|76096072|FG002|Treated|Double Blind Phase (26 Weeks)||85||
59979125|NCT02592434|76096070|FG000|COMPLETED|Double Blind Phase (26 Weeks)||0||
59979126|NCT02592434|76096071|FG001|COMPLETED|Double Blind Phase (26 Weeks)||61||
59979127|NCT02592434|76096072|FG002|COMPLETED|Double Blind Phase (26 Weeks)||38||
59979128|NCT02592434|76096070|FG000|NOT COMPLETED|Double Blind Phase (26 Weeks)||0||
59979129|NCT02592434|76096071|FG001|NOT COMPLETED|Double Blind Phase (26 Weeks)||27||
59979130|NCT02592434|76096072|FG002|NOT COMPLETED|Double Blind Phase (26 Weeks)||47||
59979131|NCT02785913|76096080|FG000|STARTED|Overall Study||26||
59979132|NCT02785913|76096080|FG000|COMPLETED|Overall Study||0||
59979133|NCT02785913|76096080|FG000|NOT COMPLETED|Overall Study||26||
59979134|NCT03596918|76096085|FG000|STARTED|Overall Study||10||
59979135|NCT03596918|76096085|FG000|COMPLETED|Overall Study||10||
59979136|NCT03596918|76096085|FG000|NOT COMPLETED|Overall Study||0||
59979137|NCT02590562|76096089|FG000|STARTED|Overall Study||808||
59979138|NCT02590562|76096089|FG000|COMPLETED|Overall Study||802||
59979139|NCT02590562|76096089|FG000|NOT COMPLETED|Overall Study||6||
59979140|NCT04090190|76096099|FG000|STARTED|Overall Study||20||
59622462|NCT02113410|75734297|FG001|COMPLETED|Overall Study||63||
59814252|NCT00620555|75936701|FG000|COMPLETED|Overall Study||44||
59979141|NCT04090190|76096099|FG000|COMPLETED|Overall Study||20||
59979142|NCT04090190|76096099|FG000|NOT COMPLETED|Overall Study||0||
59979143|NCT03283982|76096105|FG000|STARTED|Overall Study||39||
59979144|NCT03283982|76096106|FG001|STARTED|Overall Study||36||
59979145|NCT03283982|76096105|FG000|COMPLETED|Overall Study||39||
59979146|NCT03283982|76096106|FG001|COMPLETED|Overall Study||36||
59979147|NCT03283982|76096105|FG000|NOT COMPLETED|Overall Study||0||
59979148|NCT03283982|76096106|FG001|NOT COMPLETED|Overall Study||0||
59979149|NCT02783729|76096116|FG000|STARTED|Overall Study||208||
59979150|NCT02783729|76096117|FG001|STARTED|Overall Study||263||
59979151|NCT02783729|76096118|FG002|STARTED|Overall Study||266||
59979152|NCT02783729|76096119|FG003|STARTED|Overall Study||269||
59979153|NCT02783729|76096116|FG000|COMPLETED|Overall Study||198||
59979154|NCT02783729|76096117|FG001|COMPLETED|Overall Study||246||
59979155|NCT02783729|76096118|FG002|COMPLETED|Overall Study||258||
59979156|NCT02783729|76096119|FG003|COMPLETED|Overall Study||260||
59979157|NCT02783729|76096116|FG000|NOT COMPLETED|Overall Study||10||
59979158|NCT02783729|76096117|FG001|NOT COMPLETED|Overall Study||17||
59979159|NCT02783729|76096118|FG002|NOT COMPLETED|Overall Study||8||
59979160|NCT02783729|76096119|FG003|NOT COMPLETED|Overall Study||9||
59979161|NCT02324504|76096134|FG000|STARTED|Overall Study||60||
59979162|NCT02324504|76096134|FG000|COMPLETED|Overall Study||60||
59622463|NCT02113410|75734296|FG000|NOT COMPLETED|Overall Study||16||
59979163|NCT02324504|76096134|FG000|NOT COMPLETED|Overall Study||0||
59979164|NCT00988364|76096145|FG000|STARTED|Overall Study||6||
59979165|NCT00988364|76096146|FG001|STARTED|Overall Study||6||
59979166|NCT00988364|76096147|FG002|STARTED|Overall Study||6||
59979167|NCT00988364|76096148|FG003|STARTED|Overall Study||6||
59979168|NCT00988364|76096145|FG000|COMPLETED|Overall Study||6||
59979169|NCT00988364|76096146|FG001|COMPLETED|Overall Study||6||
59979170|NCT00988364|76096147|FG002|COMPLETED|Overall Study||6||
59979171|NCT00988364|76096148|FG003|COMPLETED|Overall Study||6||
59979172|NCT00988364|76096145|FG000|NOT COMPLETED|Overall Study||0||
59979173|NCT00988364|76096146|FG001|NOT COMPLETED|Overall Study||0||
59979174|NCT00988364|76096147|FG002|NOT COMPLETED|Overall Study||0||
59979175|NCT00988364|76096148|FG003|NOT COMPLETED|Overall Study||0||
59979176|NCT02784431|76096158|FG000|STARTED|Overall Study||20||
59979177|NCT02784431|76096158|FG000|COMPLETED|Overall Study||0||
59979178|NCT02784431|76096158|FG000|NOT COMPLETED|Overall Study||20||
59979179|NCT02590406|76096164|FG000|STARTED|Overall Study||25||
59979180|NCT02590406|76096165|FG001|STARTED|Overall Study||25||
59979181|NCT02590406|76096164|FG000|COMPLETED|Overall Study||24||
59979182|NCT02590406|76096165|FG001|COMPLETED|Overall Study||24||
59979183|NCT02590406|76096164|FG000|NOT COMPLETED|Overall Study||1||
59979184|NCT02590406|76096165|FG001|NOT COMPLETED|Overall Study||1||
59979185|NCT01359254|76096173|FG000|STARTED|Overall Study||1||
59979186|NCT01359254|76096174|FG001|STARTED|Overall Study||0||
59979187|NCT01359254|76096173|FG000|COMPLETED|Overall Study||0||
59979188|NCT01359254|76096174|FG001|COMPLETED|Overall Study||0||
59979189|NCT01359254|76096173|FG000|NOT COMPLETED|Overall Study||1||
59979190|NCT01359254|76096174|FG001|NOT COMPLETED|Overall Study||0||
59979191|NCT01667432|76096180|FG000|STARTED|Overall Study||141||
59979192|NCT01667432|76096180|FG000|COMPLETED|Overall Study||84||
59979193|NCT01667432|76096180|FG000|NOT COMPLETED|Overall Study||57||
59979194|NCT01563107|76096188|FG000|STARTED|Overall Study|12 Healthy Controls were randomized to receive LS diet followed by HS diet|12||
59979195|NCT01563107|76096189|FG001|STARTED|Overall Study|5 Healthy Controls were randomized to receive HS diet followed by LS diet|5||
59979196|NCT01563107|76096190|FG002|STARTED|Overall Study|10 POTS patients were randomized to receive LS diet followed by HS diet|10||
59979197|NCT01563107|76096191|FG003|STARTED|Overall Study|11 POTS patients were randomized to receive HS diet followed by LS diet|11||
59979198|NCT01563107|76096188|FG000|Phase 1 Baseline Labs|Overall Study||12||
59979199|NCT01563107|76096189|FG001|Phase 1 Baseline Labs|Overall Study|1 healthy control was unable to find time to schedule study|4||
59979200|NCT01563107|76096190|FG002|Phase 1 Baseline Labs|Overall Study|2 patients with POTS did not discontinue medication that was prohibited by protocol.|8||
59979201|NCT01563107|76096191|FG003|Phase 1 Baseline Labs|Overall Study|1 patient with POTS did not discontinue medication that was prohibited by protocol, 1 patient was unable to find time to schedule the study, 1 was noted to be too old to participate, and 1 became pregnant between enrollment and the start of phase 1.|7||
59979202|NCT01563107|76096188|FG000|Phase 1-150 mEq Sodium/Day|Overall Study||12||
59979203|NCT01563107|76096189|FG001|Phase 1-150 mEq Sodium/Day|Overall Study||4||
59979204|NCT01563107|76096190|FG002|Phase 1-150 mEq Sodium/Day|Overall Study||8||
59979205|NCT01563107|76096191|FG003|Phase 1-150 mEq Sodium/Day|Overall Study||7||
59979206|NCT01563107|76096188|FG000|Phase 1-start Low Sodium or High Sodium Diet|Overall Study||12||
59979207|NCT01563107|76096189|FG001|Phase 1-start Low Sodium or High Sodium Diet|Overall Study||4||
59979208|NCT01563107|76096190|FG002|Phase 1-start Low Sodium or High Sodium Diet|Overall Study||8||
59979209|NCT01563107|76096191|FG003|Phase 1-start Low Sodium or High Sodium Diet|Overall Study||7||
59979210|NCT01563107|76096188|FG000|Phase 1-finish|Overall Study|1 healthy control withdrew with migraines during phase 1 (low Na+).|11||
59979211|NCT01563107|76096189|FG001|Phase 1-finish|Overall Study|2 healthy controls withdrew during phase 1 (high Na+): 1 unable to tolerate study diet and another with difficulty cooperating with investigators.|2||
59979212|NCT01563107|76096190|FG002|Phase 1-finish|Overall Study||8||
59979213|NCT01563107|76096191|FG003|Phase 1-finish|Overall Study|1 patient with POTS withdrew during phase 1 due to a family illness.|6||
59979214|NCT01563107|76096188|FG000|Phase 2-150 mEq Sodium/Day|Overall Study||11||
59979215|NCT01563107|76096189|FG001|Phase 2-150 mEq Sodium/Day|Overall Study||2||
59979216|NCT01563107|76096190|FG002|Phase 2-150 mEq Sodium/Day|Overall Study||8||
59979217|NCT01563107|76096191|FG003|Phase 2-150 mEq Sodium/Day|Overall Study||6||
59979218|NCT01563107|76096188|FG000|Phase 2-start Low Sodium or High Sodium Diet|Overall Study||11||
59979219|NCT01563107|76096189|FG001|Phase 2-start Low Sodium or High Sodium Diet|Overall Study||2||
59979220|NCT01563107|76096190|FG002|Phase 2-start Low Sodium or High Sodium Diet|Overall Study||8||
59979221|NCT01563107|76096191|FG003|Phase 2-start Low Sodium or High Sodium Diet|Overall Study||6||
59979222|NCT01563107|76096188|FG000|Phase 2-finish|Overall Study||11||
59979223|NCT01563107|76096189|FG001|Phase 2-finish|Overall Study||2||
59979224|NCT01563107|76096190|FG002|Phase 2-finish|Overall Study||8||
59979225|NCT01563107|76096191|FG003|Phase 2-finish|Overall Study||6||
59979226|NCT01563107|76096188|FG000|COMPLETED|Overall Study||11||
59979227|NCT01563107|76096189|FG001|COMPLETED|Overall Study||2||
59979228|NCT01563107|76096190|FG002|COMPLETED|Overall Study||8||
59979229|NCT01563107|76096191|FG003|COMPLETED|Overall Study||6||
59979230|NCT01563107|76096188|FG000|NOT COMPLETED|Overall Study||1||
59979231|NCT01563107|76096189|FG001|NOT COMPLETED|Overall Study||3||
60074752|NCT01968967|76190062|FG003|COMPLETED|Extension Period||19||
60074753|NCT01968967|76190063|FG004|COMPLETED|Extension Period||34||
60074754|NCT01968967|76190059|FG000|NOT COMPLETED|Extension Period||0||
60074755|NCT01968967|76190060|FG001|NOT COMPLETED|Extension Period||0||
59979232|NCT01563107|76096190|FG002|NOT COMPLETED|Overall Study||2||
59979233|NCT01563107|76096191|FG003|NOT COMPLETED|Overall Study||5||
59979234|NCT02589626|76096253|FG000|STARTED|Overall Study|Entered are treated patients|32||
59979235|NCT02589626|76096254|FG001|STARTED|Overall Study|Entered are treated patients|33||
59979236|NCT02589626|76096253|FG000|COMPLETED|Overall Study||29||
59979237|NCT02589626|76096254|FG001|COMPLETED|Overall Study||31||
59979238|NCT02589626|76096253|FG000|NOT COMPLETED|Overall Study||3||
59979239|NCT02589626|76096254|FG001|NOT COMPLETED|Overall Study||2||
59979240|NCT04753034|76096262|FG000|STARTED|Overall Study||31||
59979241|NCT04753034|76096263|FG001|STARTED|Overall Study||32||
59979242|NCT04753034|76096262|FG000|COMPLETED|Overall Study||29||
59979243|NCT04753034|76096263|FG001|COMPLETED|Overall Study||31||
59979244|NCT04753034|76096262|FG000|NOT COMPLETED|Overall Study||2||
59979245|NCT04753034|76096263|FG001|NOT COMPLETED|Overall Study||1||
59979246|NCT01666730|76096269|FG000|STARTED|Overall Study||50||
59979247|NCT01666730|76096269|FG000|COMPLETED|Overall Study||0||
59979248|NCT01666730|76096269|FG000|NOT COMPLETED|Overall Study||50||
59979249|NCT04434560|76096275|FG000|STARTED|Overall Study||1||
59979250|NCT04434560|76096276|FG001|STARTED|Overall Study||0||
59979251|NCT04434560|76096275|FG000|COMPLETED|Overall Study||1||
59979252|NCT04434560|76096276|FG001|COMPLETED|Overall Study||0||
59979253|NCT04434560|76096275|FG000|NOT COMPLETED|Overall Study||0||
59979254|NCT04434560|76096276|FG001|NOT COMPLETED|Overall Study||0||
59979255|NCT00103285|76096282|FG000|STARTED|Induction||5377||
59979256|NCT00103285|76096283|FG001|STARTED|Induction||0||
59979257|NCT00103285|76096284|FG002|STARTED|Induction||0||
59979258|NCT00103285|76096285|FG003|STARTED|Induction||0||
59979259|NCT00103285|76096286|FG004|STARTED|Induction||0||
59979260|NCT00103285|76096287|FG005|STARTED|Induction||0||
59979261|NCT00103285|76096288|FG006|STARTED|Induction||0||
59979262|NCT00103285|76096289|FG007|STARTED|Induction||0||
59979263|NCT00103285|76096282|FG000|COMPLETED|Induction||4028||
59979264|NCT00103285|76096283|FG001|COMPLETED|Induction||0||
59979265|NCT00103285|76096284|FG002|COMPLETED|Induction||0||
59979266|NCT00103285|76096285|FG003|COMPLETED|Induction||0||
59979267|NCT00103285|76096286|FG004|COMPLETED|Induction||0||
59979268|NCT00103285|76096287|FG005|COMPLETED|Induction||0||
59979269|NCT00103285|76096288|FG006|COMPLETED|Induction||0||
59979270|NCT00103285|76096289|FG007|COMPLETED|Induction||0||
59979271|NCT00103285|76096282|FG000|NOT COMPLETED|Induction||1349||
59979272|NCT00103285|76096283|FG001|NOT COMPLETED|Induction||0||
59979273|NCT00103285|76096284|FG002|NOT COMPLETED|Induction||0||
59979274|NCT00103285|76096285|FG003|NOT COMPLETED|Induction||0||
59979275|NCT00103285|76096286|FG004|NOT COMPLETED|Induction||0||
59979276|NCT00103285|76096287|FG005|NOT COMPLETED|Induction||0||
59979277|NCT00103285|76096288|FG006|NOT COMPLETED|Induction||0||
59979278|NCT00103285|76096289|FG007|NOT COMPLETED|Induction||0||
59979279|NCT00103285|76096282|FG000|STARTED|Response Assignment||0||
59979280|NCT00103285|76096283|FG001|STARTED|Response Assignment||939||
59979281|NCT00103285|76096284|FG002|STARTED|Response Assignment||937||
59979282|NCT00103285|76096285|FG003|STARTED|Response Assignment||503||
59979283|NCT00103285|76096286|FG004|STARTED|Response Assignment||509||
59979284|NCT00103285|76096287|FG005|STARTED|Response Assignment||249||
59979285|NCT00103285|76096288|FG006|STARTED|Response Assignment||248||
59979286|NCT00103285|76096289|FG007|STARTED|Response Assignment||643||
59979287|NCT00103285|76096282|FG000|COMPLETED|Response Assignment||0||
59979288|NCT00103285|76096283|FG001|COMPLETED|Response Assignment||807||
59979289|NCT00103285|76096284|FG002|COMPLETED|Response Assignment||853||
59979290|NCT00103285|76096285|FG003|COMPLETED|Response Assignment||441||
59979291|NCT00103285|76096286|FG004|COMPLETED|Response Assignment||425||
59979292|NCT00103285|76096287|FG005|COMPLETED|Response Assignment||201||
59979293|NCT00103285|76096288|FG006|COMPLETED|Response Assignment||199||
59979294|NCT00103285|76096289|FG007|COMPLETED|Response Assignment||523||
59979295|NCT00103285|76096282|FG000|NOT COMPLETED|Response Assignment||0||
59979296|NCT00103285|76096283|FG001|NOT COMPLETED|Response Assignment||132||
59979297|NCT00103285|76096284|FG002|NOT COMPLETED|Response Assignment||84||
59979298|NCT00103285|76096285|FG003|NOT COMPLETED|Response Assignment||62||
59979299|NCT00103285|76096286|FG004|NOT COMPLETED|Response Assignment||84||
59979300|NCT00103285|76096287|FG005|NOT COMPLETED|Response Assignment||48||
59979301|NCT00103285|76096288|FG006|NOT COMPLETED|Response Assignment||49||
59979302|NCT00103285|76096289|FG007|NOT COMPLETED|Response Assignment||120||
59979303|NCT02783573|76096317|FG000|STARTED|Placebo-Controlled Treatment Period||562||
59979304|NCT02783573|76096318|FG001|STARTED|Placebo-Controlled Treatment Period||590||
59979305|NCT02783573|76096319|FG002|STARTED|Placebo-Controlled Treatment Period||570||
59979306|NCT02783573|76096317|FG000|Received at Least 1 Dose of Study Drug|Placebo-Controlled Treatment Period||558||
59979307|NCT02783573|76096318|FG001|Received at Least 1 Dose of Study Drug|Placebo-Controlled Treatment Period||588||
59979308|NCT02783573|76096319|FG002|Received at Least 1 Dose of Study Drug|Placebo-Controlled Treatment Period||568||
59979309|NCT02783573|76096317|FG000|COMPLETED|Placebo-Controlled Treatment Period||26||
59979310|NCT02783573|76096318|FG001|COMPLETED|Placebo-Controlled Treatment Period||28||
59979311|NCT02783573|76096319|FG002|COMPLETED|Placebo-Controlled Treatment Period||22||
59979312|NCT02783573|76096317|FG000|NOT COMPLETED|Placebo-Controlled Treatment Period||536||
59979313|NCT02783573|76096318|FG001|NOT COMPLETED|Placebo-Controlled Treatment Period||562||
59979314|NCT02783573|76096319|FG002|NOT COMPLETED|Placebo-Controlled Treatment Period||548||
59979315|NCT02783573|76096317|FG000|STARTED|Delayed-Start Period|Participants from placebo group were randomized to Lanabecestat 20 mg and 50 mg.|0||
59979316|NCT02783573|76096318|FG001|STARTED|Delayed-Start Period|Participants completed period 1 may not have entered period 2 due to early termination of the study.|17||
59979317|NCT02783573|76096319|FG002|STARTED|Delayed-Start Period|Participants completed period 1 may not have entered period 2 due to early termination of the study.|12||
59979318|NCT02783573|76096317|FG000|Received at Least 1 Dose of Study Drug|Delayed-Start Period||0||
59979319|NCT02783573|76096318|FG001|Received at Least 1 Dose of Study Drug|Delayed-Start Period||14||
59979320|NCT02783573|76096319|FG002|Received at Least 1 Dose of Study Drug|Delayed-Start Period||12||
59979321|NCT02783573|76096317|FG000|COMPLETED|Delayed-Start Period||0||
59979322|NCT02783573|76096318|FG001|COMPLETED|Delayed-Start Period||0||
59979323|NCT02783573|76096319|FG002|COMPLETED|Delayed-Start Period||0||
59979324|NCT02783573|76096317|FG000|NOT COMPLETED|Delayed-Start Period||0||
59979325|NCT02783573|76096318|FG001|NOT COMPLETED|Delayed-Start Period||17||
59979326|NCT02783573|76096319|FG002|NOT COMPLETED|Delayed-Start Period||12||
59979327|NCT01666652|76096335|FG000|STARTED|Overall Study||20||
59979328|NCT01666652|76096336|FG001|STARTED|Overall Study||20||
59979329|NCT01666652|76096337|FG002|STARTED|Overall Study||20||
59979330|NCT01666652|76096338|FG003|STARTED|Overall Study||20||
59979331|NCT01666652|76096339|FG004|STARTED|Overall Study||20||
59979332|NCT01666652|76096335|FG000|COMPLETED|Overall Study||18||
59979333|NCT01666652|76096336|FG001|COMPLETED|Overall Study||19||
59979334|NCT01666652|76096337|FG002|COMPLETED|Overall Study||19||
59979335|NCT01666652|76096338|FG003|COMPLETED|Overall Study||16||
59979336|NCT01666652|76096339|FG004|COMPLETED|Overall Study||19||
59979337|NCT01666652|76096335|FG000|NOT COMPLETED|Overall Study||2||
59979338|NCT01666652|76096336|FG001|NOT COMPLETED|Overall Study||1||
59979339|NCT01666652|76096337|FG002|NOT COMPLETED|Overall Study||1||
59979340|NCT01666652|76096338|FG003|NOT COMPLETED|Overall Study||4||
59979341|NCT01666652|76096339|FG004|NOT COMPLETED|Overall Study||1||
59979342|NCT00109733|76096353|FG000|STARTED|Overall Study||15||
59979343|NCT00109733|76096354|FG001|STARTED|Overall Study||16||
59979344|NCT00109733|76096353|FG000|COMPLETED|Overall Study||13||
59979345|NCT00109733|76096354|FG001|COMPLETED|Overall Study||12||
59979346|NCT00109733|76096353|FG000|NOT COMPLETED|Overall Study||2||
59979347|NCT00109733|76096354|FG001|NOT COMPLETED|Overall Study||4||
59979348|NCT02706405|76096368|FG000|STARTED|Overall Study||5||
59979349|NCT02706405|76096369|FG001|STARTED|Overall Study||3||
59979350|NCT02706405|76096370|FG002|STARTED|Overall Study||3||
59979351|NCT02706405|76096371|FG003|STARTED|Overall Study||1||
59979352|NCT02706405|76096372|FG004|STARTED|Overall Study||1||
59979353|NCT02706405|76096373|FG005|STARTED|Overall Study||3||
59979354|NCT02706405|76096374|FG006|STARTED|Overall Study||6||
59979355|NCT02706405|76096375|FG007|STARTED|Overall Study||7||
59979356|NCT02706405|76096368|FG000|COMPLETED|Overall Study||1||
59979357|NCT02706405|76096369|FG001|COMPLETED|Overall Study||1||
59979358|NCT02706405|76096370|FG002|COMPLETED|Overall Study||3||
59979359|NCT02706405|76096371|FG003|COMPLETED|Overall Study||0||
59979360|NCT02706405|76096372|FG004|COMPLETED|Overall Study||1||
59979361|NCT02706405|76096373|FG005|COMPLETED|Overall Study||2||
59979362|NCT02706405|76096374|FG006|COMPLETED|Overall Study||3||
59979363|NCT02706405|76096375|FG007|COMPLETED|Overall Study||1||
59979364|NCT02706405|76096368|FG000|NOT COMPLETED|Overall Study||4||
59979365|NCT02706405|76096369|FG001|NOT COMPLETED|Overall Study||2||
59979366|NCT02706405|76096370|FG002|NOT COMPLETED|Overall Study||0||
59979367|NCT02706405|76096371|FG003|NOT COMPLETED|Overall Study||1||
59979368|NCT02706405|76096372|FG004|NOT COMPLETED|Overall Study||0||
59979369|NCT02706405|76096373|FG005|NOT COMPLETED|Overall Study||1||
59979370|NCT02706405|76096374|FG006|NOT COMPLETED|Overall Study||3||
59979371|NCT02706405|76096375|FG007|NOT COMPLETED|Overall Study||6||
59979372|NCT02761993|76096404|FG000|STARTED|Overall Study||52||
59979373|NCT02761993|76096405|FG001|STARTED|Overall Study||49||
59979374|NCT02761993|76096406|FG002|STARTED|Overall Study||50||
59979375|NCT02761993|76096404|FG000|COMPLETED|Overall Study||50||
59979376|NCT02761993|76096405|FG001|COMPLETED|Overall Study||43||
59979377|NCT02761993|76096406|FG002|COMPLETED|Overall Study||46||
59979378|NCT02761993|76096404|FG000|NOT COMPLETED|Overall Study||2||
59979379|NCT02761993|76096405|FG001|NOT COMPLETED|Overall Study||6||
59979380|NCT02761993|76096406|FG002|NOT COMPLETED|Overall Study||4||
59979381|NCT02766283|76096414|FG000|STARTED|Overall Study||843||
59979382|NCT02766283|76096414|FG000|COMPLETED|Overall Study||816||
59979383|NCT02766283|76096414|FG000|NOT COMPLETED|Overall Study||27||
59979384|NCT02421315|76096424|FG000|STARTED|Overall Study||28||
59979385|NCT02421315|76096425|FG001|STARTED|Overall Study||27||
59979386|NCT02421315|76096424|FG000|COMPLETED|Overall Study||23||
59979387|NCT02421315|76096425|FG001|COMPLETED|Overall Study||15||
59979388|NCT02421315|76096424|FG000|NOT COMPLETED|Overall Study||5||
59979389|NCT02421315|76096425|FG001|NOT COMPLETED|Overall Study||12||
59979390|NCT03660488|76096435|FG000|STARTED|Overall Study||31||
59979391|NCT03660488|76096436|FG001|STARTED|Overall Study||27||
59979392|NCT03660488|76096435|FG000|COMPLETED|Overall Study||31||
59979393|NCT03660488|76096436|FG001|COMPLETED|Overall Study||27||
59979394|NCT03660488|76096435|FG000|NOT COMPLETED|Overall Study||0||
59979395|NCT03660488|76096436|FG001|NOT COMPLETED|Overall Study||0||
59979396|NCT02761915|76096448|FG000|STARTED|Overall Study||4||
59979397|NCT02761915|76096449|FG001|STARTED|Overall Study||1||
59979398|NCT02761915|76096450|FG002|STARTED|Overall Study||1||
59979399|NCT02761915|76096451|FG003|STARTED|Overall Study||3||
59979400|NCT02761915|76096452|FG004|STARTED|Overall Study||3||
59979401|NCT02761915|76096453|FG005|STARTED|Overall Study||5||
59979402|NCT02761915|76096448|FG000|Underwent Leukapheresis|Overall Study||4||
59979403|NCT02761915|76096449|FG001|Underwent Leukapheresis|Overall Study||1||
59979404|NCT02761915|76096450|FG002|Underwent Leukapheresis|Overall Study||1||
59979405|NCT02761915|76096451|FG003|Underwent Leukapheresis|Overall Study||3||
59979406|NCT02761915|76096452|FG004|Underwent Leukapheresis|Overall Study||3||
59979407|NCT02761915|76096453|FG005|Underwent Leukapheresis|Overall Study||5||
59979408|NCT02761915|76096448|FG000|Received Investigational Medicinal Product|Overall Study||4||
59979409|NCT02761915|76096449|FG001|Received Investigational Medicinal Product|Overall Study||1||
59979410|NCT02761915|76096450|FG002|Received Investigational Medicinal Product|Overall Study||1||
59979411|NCT02761915|76096451|FG003|Received Investigational Medicinal Product|Overall Study||3||
59979412|NCT02761915|76096452|FG004|Received Investigational Medicinal Product|Overall Study||3||
59979413|NCT02761915|76096453|FG005|Received Investigational Medicinal Product|Overall Study||0||
59979414|NCT02761915|76096448|FG000|COMPLETED|Overall Study||0||
59979415|NCT02761915|76096449|FG001|COMPLETED|Overall Study||0||
59979416|NCT02761915|76096450|FG002|COMPLETED|Overall Study||0||
59979417|NCT02761915|76096451|FG003|COMPLETED|Overall Study||0||
59979418|NCT02761915|76096452|FG004|COMPLETED|Overall Study||0||
59979419|NCT02761915|76096453|FG005|COMPLETED|Overall Study||0||
59979420|NCT02761915|76096448|FG000|NOT COMPLETED|Overall Study||4||
59979421|NCT02761915|76096449|FG001|NOT COMPLETED|Overall Study||1||
59979422|NCT02761915|76096450|FG002|NOT COMPLETED|Overall Study||1||
59979423|NCT02761915|76096451|FG003|NOT COMPLETED|Overall Study||3||
59979424|NCT02761915|76096452|FG004|NOT COMPLETED|Overall Study||3||
59979425|NCT02761915|76096453|FG005|NOT COMPLETED|Overall Study||5||
59979426|NCT02706327|76096474|FG000|STARTED|Overall Study||22||
59979427|NCT02706327|76096475|FG001|STARTED|Overall Study||22||
59979428|NCT02706327|76096476|FG002|STARTED|Overall Study||23||
59979429|NCT02706327|76096474|FG000|COMPLETED|Overall Study||21||
59979430|NCT02706327|76096475|FG001|COMPLETED|Overall Study||21||
59979431|NCT02706327|76096476|FG002|COMPLETED|Overall Study||21||
59814253|NCT00620555|75936701|FG000|NOT COMPLETED|Overall Study||21||
59814254|NCT00529386|75936705|FG000|STARTED|Overall Study|Study has been discontinued|7||
59814255|NCT00529386|75936705|FG000|COMPLETED|Overall Study|Study discontinued after 7 patients enrolled and analyzed|6||
59814256|NCT00529386|75936705|FG000|NOT COMPLETED|Overall Study||1||
59814257|NCT03875118|75936711|FG000|STARTED|Overall Study||34||
59814258|NCT03875118|75936712|FG001|STARTED|Overall Study||34||
59814259|NCT03875118|75936711|FG000|COMPLETED|Overall Study||30||
59814260|NCT03875118|75936712|FG001|COMPLETED|Overall Study||30||
59814261|NCT03875118|75936711|FG000|NOT COMPLETED|Overall Study||4||
59814262|NCT03875118|75936712|FG001|NOT COMPLETED|Overall Study||4||
59814263|NCT00529308|75936720|FG000|STARTED|Overall Study||9||
59814264|NCT00529308|75936721|FG001|STARTED|Overall Study||11||
59814265|NCT00529308|75936720|FG000|COMPLETED|Overall Study||8||
59814266|NCT00529308|75936721|FG001|COMPLETED|Overall Study||10||
59814267|NCT00529308|75936720|FG000|NOT COMPLETED|Overall Study||1||
59814268|NCT00529308|75936721|FG001|NOT COMPLETED|Overall Study||1||
59814269|NCT03875508|75936727|FG000|STARTED|Overall Study||108||
59814270|NCT03875508|75936727|FG000|COMPLETED|Overall Study||96||
59814271|NCT03875508|75936727|FG000|NOT COMPLETED|Overall Study||12||
59814272|NCT00620321|75936733|FG000|STARTED|Overall Study||8||
59979432|NCT02706327|76096474|FG000|NOT COMPLETED|Overall Study||1||
59814273|NCT00620321|75936734|FG001|STARTED|Overall Study||16||
59979433|NCT02706327|76096475|FG001|NOT COMPLETED|Overall Study||1||
59979434|NCT02706327|76096476|FG002|NOT COMPLETED|Overall Study||2||
59979435|NCT02764333|76096484|FG000|STARTED|Overall Study||29||
59979436|NCT02764333|76096484|FG000|COMPLETED|Overall Study||28||
59979437|NCT02764333|76096484|FG000|NOT COMPLETED|Overall Study||1||
59979438|NCT02705625|76096491|FG000|STARTED|Overall Study||82||
59979439|NCT02705625|76096492|FG001|STARTED|Overall Study||82||
59814274|NCT00620321|75936733|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8||
59814275|NCT00620321|75936734|FG001|Received at Least 1 Dose of Study Drug|Overall Study||16||
59814276|NCT00620321|75936733|FG000|COMPLETED|Overall Study||0||
59814277|NCT00620321|75936734|FG001|COMPLETED|Overall Study||0||
59814278|NCT00620321|75936733|FG000|NOT COMPLETED|Overall Study||8||
59814279|NCT00620321|75936734|FG001|NOT COMPLETED|Overall Study||16||
59814280|NCT00621023|75936740|FG000|STARTED|Overall Study||6||
59979440|NCT02705625|76096493|FG002|STARTED|Overall Study||80||
59979441|NCT02705625|76096491|FG000|COMPLETED|Overall Study||74||
59979442|NCT02705625|76096492|FG001|COMPLETED|Overall Study||72||
59979443|NCT02705625|76096493|FG002|COMPLETED|Overall Study||69||
59979444|NCT02705625|76096491|FG000|NOT COMPLETED|Overall Study||8||
59814281|NCT00621023|75936740|FG000|COMPLETED|Overall Study|Completed is defined as 5 years of follow up.|0||
59814282|NCT00621023|75936740|FG000|NOT COMPLETED|Overall Study||6||
59814283|NCT00528372|75936753|FG000|STARTED|Short-term (ST) Period (Day 1-Week 24)||75||
59814284|NCT00528372|75936754|FG001|STARTED|Short-term (ST) Period (Day 1-Week 24)||65||
59814285|NCT00528372|75936755|FG002|STARTED|Short-term (ST) Period (Day 1-Week 24)||64||
59814286|NCT00528372|75936756|FG003|STARTED|Short-term (ST) Period (Day 1-Week 24)||70||
59814287|NCT00528372|75936757|FG004|STARTED|Short-term (ST) Period (Day 1-Week 24)||67||
59814288|NCT00528372|75936758|FG005|STARTED|Short-term (ST) Period (Day 1-Week 24)||68||
59814289|NCT00528372|75936759|FG006|STARTED|Short-term (ST) Period (Day 1-Week 24)||76||
59814290|NCT00528372|75936760|FG007|STARTED|Short-term (ST) Period (Day 1-Week 24)||34||
59814291|NCT00528372|75936761|FG008|STARTED|Short-term (ST) Period (Day 1-Week 24)||39||
59814292|NCT00528372|75936753|FG000|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||63||
59814293|NCT00528372|75936754|FG001|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||60||
59814294|NCT00528372|75936755|FG002|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||52||
59814295|NCT00528372|75936756|FG003|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||57||
59814296|NCT00528372|75936757|FG004|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||58||
59814297|NCT00528372|75936758|FG005|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||57||
59814298|NCT00528372|75936759|FG006|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||65||
59814299|NCT00528372|75936760|FG007|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||28||
59814300|NCT00528372|75936761|FG008|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||34||
59814301|NCT00528372|75936753|FG000|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||12||
59814302|NCT00528372|75936754|FG001|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||5||
59814303|NCT00528372|75936755|FG002|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||12||
59814304|NCT00528372|75936756|FG003|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||13||
59979445|NCT02705625|76096492|FG001|NOT COMPLETED|Overall Study||10||
59979446|NCT02705625|76096493|FG002|NOT COMPLETED|Overall Study||11||
59979447|NCT02588612|76096501|FG000|STARTED|Overall Study||10||
59979448|NCT02588612|76096501|FG000|Received T-cell Infusion|Overall Study||5||
59979449|NCT02588612|76096501|FG000|COMPLETED|Overall Study||5||
59979450|NCT02588612|76096501|FG000|NOT COMPLETED|Overall Study||5||
59979451|NCT02946788|76096507|FG000|STARTED|Overall Study||8||
59979452|NCT02946788|76096508|FG001|STARTED|Overall Study||10||
59979453|NCT02946788|76096507|FG000|COMPLETED|Overall Study|October 2017|8||
59814305|NCT00528372|75936757|FG004|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||9||
59814306|NCT00528372|75936758|FG005|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||11||
59814307|NCT00528372|75936759|FG006|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||11||
59814308|NCT00528372|75936760|FG007|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||6||
59979454|NCT02946788|76096508|FG001|COMPLETED|Overall Study|October 2017|9||
59979455|NCT02946788|76096507|FG000|NOT COMPLETED|Overall Study||0||
59979456|NCT02946788|76096508|FG001|NOT COMPLETED|Overall Study||1||
59979457|NCT02704689|76096514|FG000|STARTED|Overall Study||9||
59979458|NCT02704689|76096514|FG000|COMPLETED|Overall Study||6||
59979459|NCT02704689|76096514|FG000|NOT COMPLETED|Overall Study||3||
59814309|NCT00528372|75936761|FG008|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||5||
59814310|NCT00528372|75936753|FG000|STARTED|Long-term (LT) Period (Weeks 24-102)||62||
59814311|NCT00528372|75936754|FG001|STARTED|Long-term (LT) Period (Weeks 24-102)||59||
59814312|NCT00528372|75936755|FG002|STARTED|Long-term (LT) Period (Weeks 24-102)||51||
59814313|NCT00528372|75936756|FG003|STARTED|Long-term (LT) Period (Weeks 24-102)||56||
59814314|NCT00528372|75936757|FG004|STARTED|Long-term (LT) Period (Weeks 24-102)||58||
59814315|NCT00528372|75936758|FG005|STARTED|Long-term (LT) Period (Weeks 24-102)||57||
59814316|NCT00528372|75936759|FG006|STARTED|Long-term (LT) Period (Weeks 24-102)||65||
59814317|NCT00528372|75936760|FG007|STARTED|Long-term (LT) Period (Weeks 24-102)||28||
59814318|NCT00528372|75936761|FG008|STARTED|Long-term (LT) Period (Weeks 24-102)|1 patient completed ST phase but withdrew for sponsor administrative reason before start of LT phase|33||
59814319|NCT00528372|75936753|FG000|COMPLETED|Long-term (LT) Period (Weeks 24-102)||42||
59814320|NCT00528372|75936754|FG001|COMPLETED|Long-term (LT) Period (Weeks 24-102)||40||
59814321|NCT00528372|75936755|FG002|COMPLETED|Long-term (LT) Period (Weeks 24-102)||43||
59814322|NCT00528372|75936756|FG003|COMPLETED|Long-term (LT) Period (Weeks 24-102)||42||
59814323|NCT00528372|75936757|FG004|COMPLETED|Long-term (LT) Period (Weeks 24-102)||37||
59979460|NCT02704143|76096518|FG000|STARTED|Overall Study||63||
59814324|NCT00528372|75936758|FG005|COMPLETED|Long-term (LT) Period (Weeks 24-102)||42||
59979461|NCT02704143|76096518|FG000|COMPLETED|Overall Study||53||
59979462|NCT02704143|76096518|FG000|NOT COMPLETED|Overall Study||10||
59979463|NCT02586506|76096522|FG000|STARTED|Overall Study||259||
59979464|NCT02586506|76096522|FG000|COMPLETED|Overall Study||250||
59979465|NCT02586506|76096522|FG000|NOT COMPLETED|Overall Study||9||
59979466|NCT00109031|76096530|FG000|STARTED|Overall Study||11||
59979467|NCT00109031|76096531|FG001|STARTED|Overall Study||10||
59979468|NCT00109031|76096532|FG002|STARTED|Overall Study||14||
59979469|NCT00109031|76096533|FG003|STARTED|Overall Study||12||
59979470|NCT00109031|76096530|FG000|COMPLETED|Overall Study||11||
59979471|NCT00109031|76096531|FG001|COMPLETED|Overall Study||8||
59979472|NCT00109031|76096532|FG002|COMPLETED|Overall Study||12||
59979473|NCT00109031|76096533|FG003|COMPLETED|Overall Study||12||
59979474|NCT00109031|76096530|FG000|NOT COMPLETED|Overall Study||0||
59979475|NCT00109031|76096531|FG001|NOT COMPLETED|Overall Study||2||
59979476|NCT00109031|76096532|FG002|NOT COMPLETED|Overall Study||2||
59979477|NCT00109031|76096533|FG003|NOT COMPLETED|Overall Study||0||
59979478|NCT01664624|76096547|FG000|STARTED|Overall Study||10||
59979479|NCT01664624|76096548|FG001|STARTED|Overall Study||11||
59979480|NCT01664624|76096549|FG002|STARTED|Overall Study||10||
59979481|NCT01664624|76096550|FG003|STARTED|Overall Study||9||
59979482|NCT01664624|76096547|FG000|COMPLETED|Overall Study||10||
59979483|NCT01664624|76096548|FG001|COMPLETED|Overall Study||10||
59979484|NCT01664624|76096549|FG002|COMPLETED|Overall Study||10||
59979485|NCT01664624|76096550|FG003|COMPLETED|Overall Study||9||
59979486|NCT01664624|76096547|FG000|NOT COMPLETED|Overall Study||0||
59979487|NCT01664624|76096548|FG001|NOT COMPLETED|Overall Study||1||
59622464|NCT02113410|75734297|FG001|NOT COMPLETED|Overall Study||3||
59814325|NCT00528372|75936759|FG006|COMPLETED|Long-term (LT) Period (Weeks 24-102)||48||
59814326|NCT00528372|75936760|FG007|COMPLETED|Long-term (LT) Period (Weeks 24-102)||22||
59814327|NCT00528372|75936761|FG008|COMPLETED|Long-term (LT) Period (Weeks 24-102)||27||
59814328|NCT00528372|75936753|FG000|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||20||
59814329|NCT00528372|75936754|FG001|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||19||
59814330|NCT00528372|75936755|FG002|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||8||
59814331|NCT00528372|75936756|FG003|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||14||
59814332|NCT00528372|75936757|FG004|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||21||
59814333|NCT00528372|75936758|FG005|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||15||
59814334|NCT00528372|75936759|FG006|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||17||
59814335|NCT00528372|75936760|FG007|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||6||
59814336|NCT00528372|75936761|FG008|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||6||
59814337|NCT00527982|75936809|FG000|STARTED|Overall Study||1||
59814338|NCT00527982|75936810|FG001|STARTED|Overall Study||0||
59814339|NCT00527982|75936809|FG000|COMPLETED|Overall Study||0||
59814340|NCT00527982|75936810|FG001|COMPLETED|Overall Study||0||
59814341|NCT00527982|75936809|FG000|NOT COMPLETED|Overall Study||1||
59814342|NCT00527982|75936810|FG001|NOT COMPLETED|Overall Study||0||
59814343|NCT00527904|75936816|FG000|STARTED|Overall Study||239||
59814344|NCT00527904|75936816|FG000|COMPLETED|Overall Study||143||
59814345|NCT00527904|75936816|FG000|NOT COMPLETED|Overall Study||96||
59814346|NCT00619619|75936828|FG000|STARTED|Overall Study||6||
59814347|NCT00619619|75936829|FG001|STARTED|Overall Study||7||
59814348|NCT00619619|75936830|FG002|STARTED|Overall Study||9||
59814349|NCT00619619|75936831|FG003|STARTED|Overall Study||7||
59814350|NCT00619619|75936832|FG004|STARTED|Overall Study||7||
59814351|NCT00619619|75936833|FG005|STARTED|Overall Study||7||
59814352|NCT00619619|75936834|FG006|STARTED|Overall Study||8||
59814353|NCT00619619|75936835|FG007|STARTED|Overall Study||8||
59814354|NCT00619619|75936828|FG000|Entered the Extension Study|Overall Study|Extension study: 3151A6-2001 (NCT00669110)|6||
59814355|NCT00619619|75936829|FG001|Entered the Extension Study|Overall Study||5||
59814356|NCT00619619|75936830|FG002|Entered the Extension Study|Overall Study||8||
59814357|NCT00619619|75936831|FG003|Entered the Extension Study|Overall Study||3||
59814358|NCT00619619|75936832|FG004|Entered the Extension Study|Overall Study||7||
59814359|NCT00619619|75936833|FG005|Entered the Extension Study|Overall Study||6||
59814360|NCT00619619|75936834|FG006|Entered the Extension Study|Overall Study||6||
59622465|NCT00531882|75734308|FG000|STARTED|Overall Study||10||
59622466|NCT00531882|75734309|FG001|STARTED|Overall Study||10||
59622467|NCT00531882|75734310|FG002|STARTED|Overall Study||5||
59622468|NCT00531882|75734308|FG000|COMPLETED|Overall Study||10||
59622469|NCT00531882|75734309|FG001|COMPLETED|Overall Study||10||
59622470|NCT00531882|75734310|FG002|COMPLETED|Overall Study||5||
59622471|NCT00531882|75734308|FG000|NOT COMPLETED|Overall Study||0||
59622472|NCT00531882|75734309|FG001|NOT COMPLETED|Overall Study||0||
59622473|NCT00531882|75734310|FG002|NOT COMPLETED|Overall Study||0||
59622474|NCT00428298|75734320|FG000|STARTED|Overall Study||30||
59622475|NCT00428298|75734321|FG001|STARTED|Overall Study||30||
59622476|NCT00428298|75734320|FG000|Second RBANS at Study Exit|Overall Study||3||
59622477|NCT00428298|75734321|FG001|Second RBANS at Study Exit|Overall Study||3||
59814361|NCT00619619|75936835|FG007|Entered the Extension Study|Overall Study||7||
59814362|NCT00619619|75936828|FG000|COMPLETED|Overall Study|Completed=conclusion of Test Article (treatment) phase for all treatment groups in 3151A6-2000.|6||
59814363|NCT00619619|75936829|FG001|COMPLETED|Overall Study||7||
59814364|NCT00619619|75936830|FG002|COMPLETED|Overall Study||8||
59814365|NCT00619619|75936831|FG003|COMPLETED|Overall Study||6||
59814366|NCT00619619|75936832|FG004|COMPLETED|Overall Study||5||
59814367|NCT00619619|75936833|FG005|COMPLETED|Overall Study||7||
59814368|NCT00619619|75936834|FG006|COMPLETED|Overall Study||7||
59814369|NCT00619619|75936835|FG007|COMPLETED|Overall Study||5||
59814370|NCT00619619|75936828|FG000|NOT COMPLETED|Overall Study||0||
59979488|NCT01664624|76096549|FG002|NOT COMPLETED|Overall Study||0||
59979489|NCT01664624|76096550|FG003|NOT COMPLETED|Overall Study||0||
59979490|NCT02702193|76096562|FG000|STARTED|Baseline Assessment/Randomization||86||
59979491|NCT02702193|76096563|FG001|STARTED|Baseline Assessment/Randomization||87||
59979492|NCT02702193|76096562|FG000|COMPLETED|Baseline Assessment/Randomization||85||
59622478|NCT00428298|75734320|FG000|COMPLETED|Overall Study||16||
59979493|NCT02702193|76096563|FG001|COMPLETED|Baseline Assessment/Randomization||87||
59979494|NCT02702193|76096562|FG000|NOT COMPLETED|Baseline Assessment/Randomization||1||
59979495|NCT02702193|76096563|FG001|NOT COMPLETED|Baseline Assessment/Randomization||0||
59979496|NCT02702193|76096562|FG000|STARTED|4 Month Follow up||86||
59979497|NCT02702193|76096563|FG001|STARTED|4 Month Follow up||87||
59979498|NCT02702193|76096562|FG000|COMPLETED|4 Month Follow up||68||
59979499|NCT02702193|76096563|FG001|COMPLETED|4 Month Follow up||69||
59979500|NCT02702193|76096562|FG000|NOT COMPLETED|4 Month Follow up||18||
59979501|NCT02702193|76096563|FG001|NOT COMPLETED|4 Month Follow up||18||
59979502|NCT02702193|76096562|FG000|STARTED|8 Month Follow up||86||
59979503|NCT02702193|76096563|FG001|STARTED|8 Month Follow up||87||
59979504|NCT02702193|76096562|FG000|COMPLETED|8 Month Follow up||71||
59979505|NCT02702193|76096563|FG001|COMPLETED|8 Month Follow up||69||
59979506|NCT02702193|76096562|FG000|NOT COMPLETED|8 Month Follow up||15||
59979507|NCT02702193|76096563|FG001|NOT COMPLETED|8 Month Follow up||18||
59979508|NCT02702193|76096562|FG000|STARTED|12 Month Follow up||86||
59979509|NCT02702193|76096563|FG001|STARTED|12 Month Follow up||87||
59979510|NCT02702193|76096562|FG000|COMPLETED|12 Month Follow up||69||
59979511|NCT02702193|76096563|FG001|COMPLETED|12 Month Follow up||69||
59979512|NCT02702193|76096562|FG000|NOT COMPLETED|12 Month Follow up||17||
59979513|NCT02702193|76096563|FG001|NOT COMPLETED|12 Month Follow up||18||
59979514|NCT02761057|76096573|FG000|STARTED|Overall Study||46||
59979515|NCT02761057|76096574|FG001|STARTED|Overall Study||44||
59979516|NCT02761057|76096575|FG002|STARTED|Overall Study||28||
59979517|NCT02761057|76096576|FG003|STARTED|Overall Study||29||
59979518|NCT02761057|76096573|FG000|Received Protocol Treatment|Overall Study||45||
59979519|NCT02761057|76096574|FG001|Received Protocol Treatment|Overall Study||43||
59979520|NCT02761057|76096575|FG002|Received Protocol Treatment|Overall Study||27||
59979521|NCT02761057|76096576|FG003|Received Protocol Treatment|Overall Study||28||
59979522|NCT02761057|76096573|FG000|COMPLETED|Overall Study||0||
59979523|NCT02761057|76096574|FG001|COMPLETED|Overall Study||0||
59979524|NCT02761057|76096575|FG002|COMPLETED|Overall Study||0||
59979525|NCT02761057|76096576|FG003|COMPLETED|Overall Study||0||
59979526|NCT02761057|76096573|FG000|NOT COMPLETED|Overall Study||46||
59979527|NCT02761057|76096574|FG001|NOT COMPLETED|Overall Study||44||
59979528|NCT02761057|76096575|FG002|NOT COMPLETED|Overall Study||28||
59979529|NCT02761057|76096576|FG003|NOT COMPLETED|Overall Study||29||
59979530|NCT05085730|76096586|FG000|STARTED|Overall Study||13||
59979531|NCT05085730|76096586|FG000|COMPLETED|Overall Study||8||
59979532|NCT05085730|76096586|FG000|NOT COMPLETED|Overall Study||5||
59979533|NCT04886596|76096598|FG000|STARTED|Overall Study||12467||
59979534|NCT04886596|76096599|FG001|STARTED|Overall Study||12499||
59979535|NCT04886596|76096598|FG000|COMPLETED|Overall Study||0||
59814371|NCT00619619|75936829|FG001|NOT COMPLETED|Overall Study||0||
59814372|NCT00619619|75936830|FG002|NOT COMPLETED|Overall Study||1||
59814373|NCT00619619|75936831|FG003|NOT COMPLETED|Overall Study||1||
59814374|NCT00619619|75936832|FG004|NOT COMPLETED|Overall Study||2||
59814375|NCT00619619|75936833|FG005|NOT COMPLETED|Overall Study||0||
59814376|NCT00619619|75936834|FG006|NOT COMPLETED|Overall Study||1||
59814377|NCT00619619|75936835|FG007|NOT COMPLETED|Overall Study||3||
59814378|NCT00527826|75936858|FG000|STARTED|Overall Study|All Patients Population was used for Participant Flow section.|108||
59814379|NCT00527826|75936859|FG001|STARTED|Overall Study||106||
59814380|NCT00527826|75936858|FG000|COMPLETED|Overall Study||87||
59814381|NCT00527826|75936859|FG001|COMPLETED|Overall Study||80||
59814382|NCT00527826|75936858|FG000|NOT COMPLETED|Overall Study||21||
59979536|NCT04886596|76096599|FG001|COMPLETED|Overall Study||0||
59814383|NCT00527826|75936859|FG001|NOT COMPLETED|Overall Study||26||
59814384|NCT00527748|75936868|FG000|STARTED|Overall Study||26||
59814385|NCT00527748|75936868|FG000|COMPLETED|Overall Study||23||
59814386|NCT00527748|75936868|FG000|NOT COMPLETED|Overall Study||3||
59814387|NCT00619385|75936875|FG000|STARTED|Overall Study||7||
59979537|NCT04886596|76096598|FG000|NOT COMPLETED|Overall Study||12467||
59979538|NCT04886596|76096599|FG001|NOT COMPLETED|Overall Study||12499||
59979539|NCT04839380|76096605|FG000|STARTED|Overall Study|Safety Population: all enrolled participants who received at least 1 application of ruxolitinib 1.5% cream|49||
59979540|NCT04839380|76096605|FG000|Intent-to-Treat Population|Overall Study|Participants who completed the Run-in Period and met all entry criteria.|46||
59814388|NCT00619385|75936876|FG001|STARTED|Overall Study||8||
59814389|NCT00619385|75936877|FG002|STARTED|Overall Study||10||
59814390|NCT00619385|75936875|FG000|COMPLETED|Overall Study||6||
59814391|NCT00619385|75936876|FG001|COMPLETED|Overall Study||6||
59979541|NCT04839380|76096605|FG000|COMPLETED|Overall Study||44||
59979542|NCT04839380|76096605|FG000|NOT COMPLETED|Overall Study||5||
59979543|NCT04788147|76096611|FG000|STARTED|Overall Study||11||
59979544|NCT04788147|76096612|FG001|STARTED|Overall Study||19||
59979545|NCT04788147|76096611|FG000|Enrolled (Received FDG Injection)|Overall Study||8||
59979546|NCT04788147|76096612|FG001|Enrolled (Received FDG Injection)|Overall Study||9||
59979547|NCT04788147|76096611|FG000|COMPLETED|Overall Study||6||
59979548|NCT04788147|76096612|FG001|COMPLETED|Overall Study||9||
59979549|NCT04788147|76096611|FG000|NOT COMPLETED|Overall Study||5||
59814392|NCT00619385|75936877|FG002|COMPLETED|Overall Study||6||
59814393|NCT00619385|75936875|FG000|NOT COMPLETED|Overall Study||1||
59814394|NCT00619385|75936876|FG001|NOT COMPLETED|Overall Study||2||
59814395|NCT00619385|75936877|FG002|NOT COMPLETED|Overall Study||4||
59814396|NCT00619307|75936890|FG000|STARTED|Overall Study||60||
59814397|NCT00619307|75936891|FG001|STARTED|Overall Study||57||
59814398|NCT00619307|75936890|FG000|COMPLETED|Overall Study||56||
59814399|NCT00619307|75936891|FG001|COMPLETED|Overall Study||53||
59814400|NCT00619307|75936890|FG000|NOT COMPLETED|Overall Study||4||
59979550|NCT04788147|76096612|FG001|NOT COMPLETED|Overall Study||10||
59979551|NCT04770155|76096633|FG000|STARTED|Overall Study||1|The only data collected were baseline measurements and no participants were ever given either intervention; the investigator was never able to obtain the treatments to use for the planned intervention arm of the study, resulting in its termination.|
59979552|NCT04770155|76096634|FG001|STARTED|Overall Study||1|The only data collected were baseline measurements and no participants were ever given either intervention; the investigator was never able to obtain the treatments to use for the planned intervention arm of the study, resulting in its termination.|
59979553|NCT04770155|76096635|FG002|STARTED|Overall Study||1|The only data collected were baseline measurements and no participants were ever given either intervention; the investigator was never able to obtain the treatments to use for the planned intervention arm of the study, resulting in its termination.|
59979554|NCT04770155|76096636|FG003|STARTED|Overall Study||1|The only data collected were baseline measurements and no participants were ever given either intervention; the investigator was never able to obtain the treatments to use for the planned intervention arm of the study, resulting in its termination.|
59979555|NCT04770155|76096637|FG004|STARTED|Overall Study||1|The only data collected were baseline measurements and no participants were ever given either intervention; the investigator was never able to obtain the treatments to use for the planned intervention arm of the study, resulting in its termination.|
59979556|NCT04770155|76096638|FG005|STARTED|Overall Study||1|The only data collected were baseline measurements and no participants were ever given either intervention; the investigator was never able to obtain the treatments to use for the planned intervention arm of the study, resulting in its termination.|
59979557|NCT04770155|76096639|FG006|STARTED|Overall Study||1|The only data collected were baseline measurements and no participants were ever given either intervention; the investigator was never able to obtain the treatments to use for the planned intervention arm of the study, resulting in its termination.|
59979558|NCT04770155|76096640|FG007|STARTED|Overall Study||1|The only data collected were baseline measurements and no participants were ever given either intervention; the investigator was never able to obtain the treatments to use for the planned intervention arm of the study, resulting in its termination.|
59979559|NCT04770155|76096633|FG000|COMPLETED|Overall Study||0|The only data collected were baseline measurements and no participants were ever given either intervention; the investigator was never able to obtain the treatments to use for the planned intervention arm of the study, resulting in its termination.|
59979560|NCT04770155|76096634|FG001|COMPLETED|Overall Study||0|The only data collected were baseline measurements and no participants were ever given either intervention; the investigator was never able to obtain the treatments to use for the planned intervention arm of the study, resulting in its termination.|
59979561|NCT04770155|76096635|FG002|COMPLETED|Overall Study||0|The only data collected were baseline measurements and no participants were ever given either intervention; the investigator was never able to obtain the treatments to use for the planned intervention arm of the study, resulting in its termination.|
59979562|NCT04770155|76096636|FG003|COMPLETED|Overall Study||0|The only data collected were baseline measurements and no participants were ever given either intervention; the investigator was never able to obtain the treatments to use for the planned intervention arm of the study, resulting in its termination.|
60074756|NCT01968967|76190061|FG002|NOT COMPLETED|Extension Period||2||
60074757|NCT01968967|76190062|FG003|NOT COMPLETED|Extension Period||0||
60074758|NCT01968967|76190063|FG004|NOT COMPLETED|Extension Period||5||
60074759|NCT01554579|76190079|FG000|STARTED|Overall Study||86||
60074760|NCT01554579|76190080|FG001|STARTED|Overall Study||85||
59814401|NCT00619307|75936891|FG001|NOT COMPLETED|Overall Study||4||
59814402|NCT00619229|75936899|FG000|STARTED|Overall Study||18||
59814403|NCT00619229|75936900|FG001|STARTED|Overall Study||18||
59814404|NCT00619229|75936899|FG000|Full Analysis Set (FAS)|Overall Study||16||
59814405|NCT00619229|75936900|FG001|Full Analysis Set (FAS)|Overall Study||17||
60074761|NCT01554579|76190079|FG000|COMPLETED|Overall Study||76||
59814406|NCT00619229|75936899|FG000|COMPLETED|Overall Study||14||
59814407|NCT00619229|75936900|FG001|COMPLETED|Overall Study||16||
59814408|NCT00619229|75936899|FG000|NOT COMPLETED|Overall Study||4||
59814409|NCT00619229|75936900|FG001|NOT COMPLETED|Overall Study||2||
59814410|NCT00619151|75936908|FG000|STARTED|Overall Study||2||
59814411|NCT00619151|75936909|FG001|STARTED|Overall Study||0||
59814412|NCT00619151|75936908|FG000|COMPLETED|Overall Study||1||
59814413|NCT00619151|75936909|FG001|COMPLETED|Overall Study||0||
59814414|NCT00619151|75936908|FG000|NOT COMPLETED|Overall Study||1||
59814415|NCT00619151|75936909|FG001|NOT COMPLETED|Overall Study||0||
59814416|NCT00618995|75936915|FG000|STARTED|Period 1||6||
59814417|NCT00618995|75936916|FG001|STARTED|Period 1||7||
59814418|NCT00618995|75936917|FG002|STARTED|Period 1||7||
59814419|NCT00618995|75936918|FG003|STARTED|Period 1||6||
59814420|NCT00618995|75936915|FG000|COMPLETED|Period 1||6||
59814421|NCT00618995|75936916|FG001|COMPLETED|Period 1||6||
59814422|NCT00618995|75936917|FG002|COMPLETED|Period 1||5||
59814423|NCT00618995|75936918|FG003|COMPLETED|Period 1||6||
59814424|NCT00618995|75936915|FG000|NOT COMPLETED|Period 1||0||
59814425|NCT00618995|75936916|FG001|NOT COMPLETED|Period 1||1||
59814426|NCT00618995|75936917|FG002|NOT COMPLETED|Period 1||2||
59814427|NCT00618995|75936918|FG003|NOT COMPLETED|Period 1||0||
59814428|NCT00618995|75936915|FG000|STARTED|Period 2||6||
59979563|NCT04770155|76096637|FG004|COMPLETED|Overall Study||0|The only data collected were baseline measurements and no participants were ever given either intervention; the investigator was never able to obtain the treatments to use for the planned intervention arm of the study, resulting in its termination.|
59979564|NCT04770155|76096638|FG005|COMPLETED|Overall Study||0|The only data collected were baseline measurements and no participants were ever given either intervention; the investigator was never able to obtain the treatments to use for the planned intervention arm of the study, resulting in its termination.|
59979565|NCT04770155|76096639|FG006|COMPLETED|Overall Study||0|The only data collected were baseline measurements and no participants were ever given either intervention; the investigator was never able to obtain the treatments to use for the planned intervention arm of the study, resulting in its termination.|
59979566|NCT04770155|76096640|FG007|COMPLETED|Overall Study||0|The only data collected were baseline measurements and no participants were ever given either intervention; the investigator was never able to obtain the treatments to use for the planned intervention arm of the study, resulting in its termination.|
59979567|NCT04770155|76096633|FG000|NOT COMPLETED|Overall Study||1||
59979568|NCT04770155|76096634|FG001|NOT COMPLETED|Overall Study||1||
59979569|NCT04770155|76096635|FG002|NOT COMPLETED|Overall Study||1||
59979570|NCT04770155|76096636|FG003|NOT COMPLETED|Overall Study||1||
59979571|NCT04770155|76096637|FG004|NOT COMPLETED|Overall Study||1||
59979572|NCT04770155|76096638|FG005|NOT COMPLETED|Overall Study||1||
59979573|NCT04770155|76096639|FG006|NOT COMPLETED|Overall Study||1||
59979574|NCT04770155|76096640|FG007|NOT COMPLETED|Overall Study||1||
59979575|NCT04576988|76096660|FG000|STARTED|Double Blind Placebo Controlled (DBPC)||163||
59979576|NCT04576988|76096661|FG001|STARTED|Double Blind Placebo Controlled (DBPC)||160||
59979577|NCT04576988|76096660|FG000|Treated|Double Blind Placebo Controlled (DBPC)||163||
59979578|NCT04576988|76096661|FG001|Treated|Double Blind Placebo Controlled (DBPC)||160||
59979579|NCT04576988|76096660|FG000|COMPLETED|Double Blind Placebo Controlled (DBPC)||159||
59979580|NCT04576988|76096661|FG001|COMPLETED|Double Blind Placebo Controlled (DBPC)||148||
59979581|NCT04576988|76096660|FG000|NOT COMPLETED|Double Blind Placebo Controlled (DBPC)||4||
59979582|NCT04576988|76096661|FG001|NOT COMPLETED|Double Blind Placebo Controlled (DBPC)||12||
59814429|NCT00618995|75936916|FG001|STARTED|Period 2||6||
59814430|NCT00618995|75936917|FG002|STARTED|Period 2||5||
59814431|NCT00618995|75936918|FG003|STARTED|Period 2||6||
59814432|NCT00618995|75936915|FG000|COMPLETED|Period 2||6||
59814433|NCT00618995|75936916|FG001|COMPLETED|Period 2||6||
59814434|NCT00618995|75936917|FG002|COMPLETED|Period 2||4||
59979583|NCT04576988|76096660|FG000|STARTED|Long Term Double Blind (LTDB)||159||
59979584|NCT04576988|76096661|FG001|STARTED|Long Term Double Blind (LTDB)|Not all participants from placebo plus background PAH arm in the DBPC period entered the LTDB period due to clinical worsening or consent withdrawal after DBPC period.|142||
59979585|NCT04576988|76096660|FG000|Treated|Long Term Double Blind (LTDB)||158||
59979586|NCT04576988|76096661|FG001|Treated|Long Term Double Blind (LTDB)||142||
59979587|NCT04576988|76096660|FG000|COMPLETED|Long Term Double Blind (LTDB)||155||
59979588|NCT04576988|76096661|FG001|COMPLETED|Long Term Double Blind (LTDB)||136||
59979589|NCT04576988|76096660|FG000|NOT COMPLETED|Long Term Double Blind (LTDB)||4||
59979590|NCT04576988|76096661|FG001|NOT COMPLETED|Long Term Double Blind (LTDB)||6||
59979591|NCT04471207|76096675|FG000|STARTED|Overall Study||29||
59979592|NCT04471207|76096676|FG001|STARTED|Overall Study||11||
59979593|NCT04471207|76096675|FG000|COMPLETED|Overall Study||18||
59979594|NCT04471207|76096676|FG001|COMPLETED|Overall Study||5||
59979595|NCT04471207|76096675|FG000|NOT COMPLETED|Overall Study||11||
59979596|NCT04471207|76096676|FG001|NOT COMPLETED|Overall Study||6||
59979597|NCT04451707|76096682|FG000|STARTED|Overall Study||67||
59979598|NCT04451707|76096682|FG000|COMPLETED|Overall Study||67||
59979599|NCT04451707|76096682|FG000|NOT COMPLETED|Overall Study||0||
59979600|NCT04356040|76096688|FG000|STARTED|Overall Study||305||
59979601|NCT04356040|76096689|FG001|STARTED|Overall Study||50||
59979602|NCT04356040|76096688|FG000|Device Inserted and RF Energy Delivered|Overall Study||284||
59979603|NCT04356040|76096689|FG001|Device Inserted and RF Energy Delivered|Overall Study||50||
59979604|NCT04356040|76096688|FG000|7-Day Visit|Overall Study||280||
59979605|NCT04356040|76096689|FG001|7-Day Visit|Overall Study||50||
59979606|NCT04356040|76096688|FG000|5-Week Visit|Overall Study||279||
59979607|NCT04356040|76096689|FG001|5-Week Visit|Overall Study||50||
59979608|NCT04356040|76096688|FG000|3-Month Visit|Overall Study||272||
59979609|NCT04356040|76096689|FG001|3-Month Visit|Overall Study||50||
59979610|NCT04356040|76096688|FG000|6-Month Visit|Overall Study||267||
59979611|NCT04356040|76096689|FG001|6-Month Visit|Overall Study||49||
59979612|NCT04356040|76096688|FG000|12-Month Visit|Overall Study||264||
59814435|NCT00618995|75936918|FG003|COMPLETED|Period 2||6||
59814436|NCT00618995|75936915|FG000|NOT COMPLETED|Period 2||0||
59814437|NCT00618995|75936916|FG001|NOT COMPLETED|Period 2||0||
59979613|NCT04356040|76096689|FG001|12-Month Visit|Overall Study||48||
59979614|NCT04356040|76096688|FG000|COMPLETED|Overall Study||268||
59814438|NCT00618995|75936917|FG002|NOT COMPLETED|Period 2||1||
59814439|NCT00618995|75936918|FG003|NOT COMPLETED|Period 2||0||
59814440|NCT00618995|75936915|FG000|STARTED|Period 3||6||
59814441|NCT00618995|75936916|FG001|STARTED|Period 3||6||
59814442|NCT00618995|75936917|FG002|STARTED|Period 3||4||
59814443|NCT00618995|75936918|FG003|STARTED|Period 3||6||
59814444|NCT00618995|75936915|FG000|COMPLETED|Period 3||6||
59814445|NCT00618995|75936916|FG001|COMPLETED|Period 3||6||
59814446|NCT00618995|75936917|FG002|COMPLETED|Period 3||4||
59979615|NCT04356040|76096689|FG001|COMPLETED|Overall Study||48||
59979616|NCT04356040|76096688|FG000|NOT COMPLETED|Overall Study||37||
59979617|NCT04356040|76096689|FG001|NOT COMPLETED|Overall Study||2||
59526280|NCT01351753|75621849|FG003|NOT COMPLETED|Overall Study||0||
59526281|NCT01351753|75621850|FG004|NOT COMPLETED|Overall Study||7||
59526282|NCT01351753|75621851|FG005|NOT COMPLETED|Overall Study||1||
59526283|NCT01353079|75621869|FG000|STARTED|Overall Study||218||
59526284|NCT01353079|75621870|FG001|STARTED|Overall Study||211||
59526285|NCT01353079|75621869|FG000|COMPLETED|Overall Study||191||
59526286|NCT01353079|75621870|FG001|COMPLETED|Overall Study||190||
59526287|NCT01353079|75621869|FG000|NOT COMPLETED|Overall Study||27||
59526288|NCT01353079|75621870|FG001|NOT COMPLETED|Overall Study||21||
59526289|NCT00104234|75621880|FG000|STARTED|Overall Study||19||
59526290|NCT00104234|75621881|FG001|STARTED|Overall Study||20||
59526291|NCT00104234|75621880|FG000|COMPLETED|Overall Study||19||
59526292|NCT00104234|75621881|FG001|COMPLETED|Overall Study||19||
59526293|NCT00104234|75621880|FG000|NOT COMPLETED|Overall Study||0||
59526294|NCT00104234|75621881|FG001|NOT COMPLETED|Overall Study||1||
59526295|NCT01303939|75621889|FG000|STARTED|Overall Study||22||
59526296|NCT01303939|75621890|FG001|STARTED|Overall Study||15||
59526297|NCT01303939|75621889|FG000|COMPLETED|Overall Study|Matched controls not found for comparisons. Only best matched glaucoma patients were included.|15||
59526298|NCT01303939|75621890|FG001|COMPLETED|Overall Study||15||
59526299|NCT01303939|75621889|FG000|NOT COMPLETED|Overall Study||7||
59526300|NCT01303939|75621890|FG001|NOT COMPLETED|Overall Study||0||
59526301|NCT00104858|75621898|FG000|STARTED|Overall Study||52||
59526302|NCT00104858|75621898|FG000|COMPLETED|Overall Study||52||
59526303|NCT00104858|75621898|FG000|NOT COMPLETED|Overall Study||0||
59526304|NCT01354015|75621906|FG000|STARTED|Overall Study||50||
59526305|NCT01354015|75621907|FG001|STARTED|Overall Study||48||
59526306|NCT01354015|75621906|FG000|COMPLETED|Overall Study||44||
59526307|NCT01354015|75621907|FG001|COMPLETED|Overall Study||43||
59526308|NCT01354015|75621906|FG000|NOT COMPLETED|Overall Study||6||
59526309|NCT01354015|75621907|FG001|NOT COMPLETED|Overall Study||5||
59526310|NCT01407523|75621913|FG000|STARTED|Overall Study||16||
59526311|NCT01407523|75621913|FG000|COMPLETED|Overall Study||16||
59526312|NCT01407523|75621913|FG000|NOT COMPLETED|Overall Study||0||
59526313|NCT01304407|75621917|FG000|STARTED|Overall Study||29||
59526314|NCT01304407|75621917|FG000|COMPLETED|Overall Study||29||
59526315|NCT01304407|75621917|FG000|NOT COMPLETED|Overall Study||0||
59526316|NCT01355419|75621921|FG000|STARTED|Overall Study||150||
59526317|NCT01355419|75621921|FG000|COMPLETED|Overall Study||142||
59526318|NCT01355419|75621921|FG000|NOT COMPLETED|Overall Study||8||
59526319|NCT00106106|75621927|FG000|STARTED|Overall Study||26||
59526320|NCT00106106|75621928|FG001|STARTED|Overall Study||23||
59526321|NCT00106106|75621927|FG000|Completed Both MRS Scans|Overall Study||18||
59526322|NCT00106106|75621928|FG001|Completed Both MRS Scans|Overall Study||15||
59526323|NCT00106106|75621927|FG000|COMPLETED|Overall Study|Although 22 subjects completed all other assessments for the study, only 18 completed both MRS scans|22||
59526324|NCT00106106|75621928|FG001|COMPLETED|Overall Study|Although 19 subjects completed all other assessments for the study, only 15 completed both MRS scans|19||
59526325|NCT00106106|75621927|FG000|NOT COMPLETED|Overall Study||4||
59526326|NCT00106106|75621928|FG001|NOT COMPLETED|Overall Study||4||
59526327|NCT01304641|75621936|FG000|STARTED|Overall Study||11470||
59526328|NCT01304641|75621937|FG001|STARTED|Overall Study||20132||
59979618|NCT04349631|76096695|FG000|STARTED|Overall Study||51||
59979619|NCT04349631|76096695|FG000|COMPLETED|Overall Study||41||
59979620|NCT04349631|76096695|FG000|NOT COMPLETED|Overall Study||10||
59979621|NCT03961204|76096699|FG000|STARTED|Overall Study||662||
59526329|NCT01304641|75621936|FG000|COMPLETED|Overall Study||11470||
59526330|NCT01304641|75621937|FG001|COMPLETED|Overall Study||20132||
59526331|NCT01304641|75621936|FG000|NOT COMPLETED|Overall Study||0||
59979622|NCT03961204|76096699|FG000|COMPLETED|Overall Study||655||
59526332|NCT01304641|75621937|FG001|NOT COMPLETED|Overall Study||0||
59526333|NCT01305265|75621945|FG000|STARTED|Overall Study||71||
59526334|NCT01305265|75621946|FG001|STARTED|Overall Study||70||
59526335|NCT01305265|75621945|FG000|COMPLETED|Overall Study||69||
59526336|NCT01305265|75621946|FG001|COMPLETED|Overall Study||64||
59526337|NCT01305265|75621945|FG000|NOT COMPLETED|Overall Study||2||
59526338|NCT01305265|75621946|FG001|NOT COMPLETED|Overall Study||6||
59526339|NCT01305655|75621952|FG000|STARTED|Overall Study|July 2008|47||
59526340|NCT01305655|75621952|FG000|COMPLETED|Overall Study|December 31, 2014|47||
59526341|NCT01305655|75621952|FG000|NOT COMPLETED|Overall Study||0||
59526342|NCT01305811|75621958|FG000|STARTED|Overall Study||52||
59526343|NCT01305811|75621959|FG001|STARTED|Overall Study||52||
59526344|NCT01305811|75621958|FG000|COMPLETED|Overall Study||44||
59526345|NCT01305811|75621959|FG001|COMPLETED|Overall Study||41||
59526346|NCT01305811|75621958|FG000|NOT COMPLETED|Overall Study||8||
59526347|NCT01305811|75621959|FG001|NOT COMPLETED|Overall Study||11||
59526348|NCT01409239|75621969|FG000|STARTED|Overall Study||16||
59526349|NCT01409239|75621970|FG001|STARTED|Overall Study||17||
59526350|NCT01409239|75621969|FG000|COMPLETED|Overall Study||16||
59979623|NCT03961204|76096699|FG000|NOT COMPLETED|Overall Study||7||
59526351|NCT01409239|75621970|FG001|COMPLETED|Overall Study||17||
59979624|NCT03898180|76096705|FG000|STARTED|Overall Study||245||
59814447|NCT00618995|75936918|FG003|COMPLETED|Period 3||6||
59814448|NCT00618995|75936915|FG000|NOT COMPLETED|Period 3||0||
59814449|NCT00618995|75936916|FG001|NOT COMPLETED|Period 3||0||
59814450|NCT00618995|75936917|FG002|NOT COMPLETED|Period 3||0||
59814451|NCT00618995|75936918|FG003|NOT COMPLETED|Period 3||0||
59814452|NCT00618995|75936915|FG000|STARTED|Period 4||6||
59814453|NCT00618995|75936916|FG001|STARTED|Period 4||6||
59814454|NCT00618995|75936917|FG002|STARTED|Period 4||4||
59814455|NCT00618995|75936918|FG003|STARTED|Period 4||6||
59814456|NCT00618995|75936915|FG000|COMPLETED|Period 4||5||
59814457|NCT00618995|75936916|FG001|COMPLETED|Period 4||6||
59814458|NCT00618995|75936917|FG002|COMPLETED|Period 4||4||
59814459|NCT00618995|75936918|FG003|COMPLETED|Period 4||6||
59814460|NCT00618995|75936915|FG000|NOT COMPLETED|Period 4||1||
59814461|NCT00618995|75936916|FG001|NOT COMPLETED|Period 4||0||
59814462|NCT00618995|75936917|FG002|NOT COMPLETED|Period 4||0||
59814463|NCT00618995|75936918|FG003|NOT COMPLETED|Period 4||0||
59814464|NCT03685344|75936932|FG000|STARTED|Overall Study||3||
59814465|NCT03685344|75936933|FG001|STARTED|Overall Study||3||
59814466|NCT03685344|75936934|FG002|STARTED|Overall Study||7||
59814467|NCT03685344|75936935|FG003|STARTED|Overall Study||0||
59814468|NCT03685344|75936932|FG000|Received Treatment|Overall Study||3||
59814469|NCT03685344|75936933|FG001|Received Treatment|Overall Study||3||
59814470|NCT03685344|75936934|FG002|Received Treatment|Overall Study||7||
59814471|NCT03685344|75936935|FG003|Received Treatment|Overall Study||0||
59814472|NCT03685344|75936932|FG000|COMPLETED|Overall Study||0||
59814473|NCT03685344|75936933|FG001|COMPLETED|Overall Study||0||
59814474|NCT03685344|75936934|FG002|COMPLETED|Overall Study||0||
59814475|NCT03685344|75936935|FG003|COMPLETED|Overall Study||0||
59814476|NCT03685344|75936932|FG000|NOT COMPLETED|Overall Study||3||
59814477|NCT03685344|75936933|FG001|NOT COMPLETED|Overall Study||3||
59814478|NCT03685344|75936934|FG002|NOT COMPLETED|Overall Study||7||
59814479|NCT03685344|75936935|FG003|NOT COMPLETED|Overall Study||0||
59814480|NCT00520572|75936951|FG000|STARTED|Overall Study|Participants randomised. One of these participants did not subsequently receive treatment.|64||
59814481|NCT00520572|75936952|FG001|STARTED|Overall Study|Participants randomised.|64||
59814482|NCT00520572|75936953|FG002|STARTED|Overall Study|Participants randomised. One of these participants did not subsequently receive treatment.|64||
59814483|NCT00520572|75936954|FG003|STARTED|Overall Study|Participants randomised.|64||
59814484|NCT00520572|75936955|FG004|STARTED|Overall Study|Participants randomised.|65||
59814485|NCT00520572|75936956|FG005|STARTED|Overall Study|Participants randomised.|64||
59814486|NCT00520572|75936951|FG000|COMPLETED|Overall Study|Participants completed the study.|52||
59814487|NCT00520572|75936952|FG001|COMPLETED|Overall Study|Participants completed the study.|50||
59814488|NCT00520572|75936953|FG002|COMPLETED|Overall Study|Participants completed the study.|49||
59814489|NCT00520572|75936954|FG003|COMPLETED|Overall Study|Participants completed the study.|50||
59814490|NCT00520572|75936955|FG004|COMPLETED|Overall Study|Participants completed the study.|53||
59814491|NCT00520572|75936956|FG005|COMPLETED|Overall Study|Participants completed the study.|62||
59814492|NCT00520572|75936951|FG000|NOT COMPLETED|Overall Study||12||
59814493|NCT00520572|75936952|FG001|NOT COMPLETED|Overall Study||14||
59814494|NCT00520572|75936953|FG002|NOT COMPLETED|Overall Study||15||
59814495|NCT00520572|75936954|FG003|NOT COMPLETED|Overall Study||14||
59814496|NCT00520572|75936955|FG004|NOT COMPLETED|Overall Study||12||
59814497|NCT00520572|75936956|FG005|NOT COMPLETED|Overall Study||2||
59814498|NCT00573833|75936970|FG000|STARTED|Overall Study||23||
59814499|NCT00573833|75936970|FG000|COMPLETED|Overall Study||21||
59814500|NCT00573833|75936970|FG000|NOT COMPLETED|Overall Study||2||
59814501|NCT00520494|75936974|FG000|STARTED|Overall Study||18||
59814502|NCT00520494|75936974|FG000|COMPLETED|Overall Study||17||
59814503|NCT00520494|75936974|FG000|NOT COMPLETED|Overall Study||1||
59814504|NCT00527514|75936978|FG000|STARTED|Weeks 1-3: Amlodipine (Aml) 5mg||185||
59814505|NCT00527514|75936978|FG000|COMPLETED|Weeks 1-3: Amlodipine (Aml) 5mg|1 participant dropped out. 2 participants were subsequently mis-titrated to the third regimen.|184||
59814506|NCT00527514|75936978|FG000|NOT COMPLETED|Weeks 1-3: Amlodipine (Aml) 5mg||1||
59814507|NCT00527514|75936978|FG000|STARTED|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|184 -2 who were mis-titrated -2 who met blood pressure goal = 180|180||
59814508|NCT00527514|75936978|FG000|COMPLETED|Weeks 4-6: Aml 5mg+Olmesartan 20 mg||178||
59814509|NCT00527514|75936978|FG000|NOT COMPLETED|Weeks 4-6: Aml 5mg+Olmesartan 20 mg||2||
59814510|NCT00527514|75936978|FG000|STARTED|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|178 -19 who met blood pressure goal + 2 who were mis-titrated = 161|161||
59814511|NCT00527514|75936978|FG000|COMPLETED|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg||158||
59814512|NCT00527514|75936978|FG000|NOT COMPLETED|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg||3||
59814513|NCT00527514|75936978|FG000|STARTED|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|158 -24 who met blood pressure goal = 134|134||
59814514|NCT00527514|75936978|FG000|COMPLETED|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg||132||
59814515|NCT00527514|75936978|FG000|NOT COMPLETED|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg||2||
59814516|NCT00618449|75936991|FG000|STARTED|Overall Study||679||
59814517|NCT00618449|75936992|FG001|STARTED|Overall Study||668||
59814518|NCT00618449|75936991|FG000|1-month, Post-treatment|Overall Study||666||
59814519|NCT00618449|75936992|FG001|1-month, Post-treatment|Overall Study||656||
59814520|NCT00618449|75936991|FG000|1-year, Post-treatment|Overall Study||581||
59526352|NCT01409239|75621969|FG000|NOT COMPLETED|Overall Study||0||
59526353|NCT01409239|75621970|FG001|NOT COMPLETED|Overall Study||0||
59979625|NCT03898180|76096706|FG001|STARTED|Overall Study||242||
59979626|NCT03898180|76096705|FG000|Treated|Overall Study||241||
59979627|NCT03898180|76096706|FG001|Treated|Overall Study||242||
59979628|NCT03898180|76096705|FG000|COMPLETED|Overall Study||0||
59979629|NCT03898180|76096706|FG001|COMPLETED|Overall Study||0||
59979630|NCT03898180|76096705|FG000|NOT COMPLETED|Overall Study||245||
59979631|NCT03898180|76096706|FG001|NOT COMPLETED|Overall Study||242||
59979632|NCT03816007|76096714|FG000|STARTED|End of 12-week Intervention||16||
59979633|NCT03816007|76096715|FG001|STARTED|End of 12-week Intervention||16||
59979634|NCT03816007|76096714|FG000|COMPLETED|End of 12-week Intervention||13||
59979635|NCT03816007|76096715|FG001|COMPLETED|End of 12-week Intervention||10||
59979636|NCT03816007|76096714|FG000|NOT COMPLETED|End of 12-week Intervention||3||
59979637|NCT03816007|76096715|FG001|NOT COMPLETED|End of 12-week Intervention||6||
59979638|NCT03816007|76096714|FG000|STARTED|Final Assessment at 18 Weeks.||16||
59979639|NCT03816007|76096715|FG001|STARTED|Final Assessment at 18 Weeks.||14||
59979640|NCT03816007|76096714|FG000|COMPLETED|Final Assessment at 18 Weeks.||12||
59979641|NCT03816007|76096715|FG001|COMPLETED|Final Assessment at 18 Weeks.||10||
59979642|NCT03816007|76096714|FG000|NOT COMPLETED|Final Assessment at 18 Weeks.||4||
59979643|NCT03816007|76096715|FG001|NOT COMPLETED|Final Assessment at 18 Weeks.||4||
59979644|NCT03712449|76096723|FG000|STARTED|Overall Study||13||
59979645|NCT03712449|76096724|FG001|STARTED|Overall Study||46||
59979646|NCT03712449|76096723|FG000|Full Analysis Population|Overall Study||13|Full Analysis Population included all participants who had met all eligibility criteria at the screening visit and received any product used as treatment in this study.|
59979647|NCT03712449|76096724|FG001|Full Analysis Population|Overall Study||45|Full Analysis Population included all participants who had met all eligibility criteria at the screening visit and received any product used as treatment in this study.|
59979648|NCT03712449|76096723|FG000|COMPLETED|Overall Study||13||
59979649|NCT03712449|76096724|FG001|COMPLETED|Overall Study||45||
59979650|NCT03712449|76096723|FG000|NOT COMPLETED|Overall Study||0||
59526354|NCT00108524|75621978|FG000|STARTED|Overall Study||81||
59526355|NCT00108524|75621979|FG001|STARTED|Overall Study||79||
59526356|NCT00108524|75621978|FG000|COMPLETED|Overall Study||52||
59526357|NCT00108524|75621979|FG001|COMPLETED|Overall Study||61||
59979651|NCT03712449|76096724|FG001|NOT COMPLETED|Overall Study||1||
59979652|NCT03530124|76096732|FG000|STARTED|Overall Study||107||
59979653|NCT03530124|76096733|FG001|STARTED|Overall Study||116||
59979654|NCT03530124|76096732|FG000|COMPLETED|Overall Study||105||
59979655|NCT03530124|76096733|FG001|COMPLETED|Overall Study||115||
59979656|NCT03530124|76096732|FG000|NOT COMPLETED|Overall Study||2||
59979657|NCT03530124|76096733|FG001|NOT COMPLETED|Overall Study||1||
59979658|NCT03343483|76096741|FG000|STARTED|Overall Study||146||
59979659|NCT03343483|76096742|FG001|STARTED|Overall Study||145||
59979660|NCT03343483|76096741|FG000|COMPLETED|Overall Study||129||
59979661|NCT03343483|76096742|FG001|COMPLETED|Overall Study||112||
59979662|NCT03343483|76096741|FG000|NOT COMPLETED|Overall Study||17||
59979663|NCT03343483|76096742|FG001|NOT COMPLETED|Overall Study||33||
59979664|NCT03035409|76096748|FG000|STARTED|Overall Study||45||
59979665|NCT03035409|76096748|FG000|Day 15|Overall Study||28||
59979666|NCT03035409|76096748|FG000|Day 29|Overall Study||28||
59526358|NCT00108524|75621978|FG000|NOT COMPLETED|Overall Study||29||
59526359|NCT00108524|75621979|FG001|NOT COMPLETED|Overall Study||18||
59526360|NCT01410097|75621987|FG000|STARTED|Overall Study||556||
59526361|NCT01410097|75621988|FG001|STARTED|Overall Study||533||
59526362|NCT01410097|75621987|FG000|COMPLETED|Overall Study||551||
59526363|NCT01410097|75621988|FG001|COMPLETED|Overall Study||530||
59526364|NCT01410097|75621987|FG000|NOT COMPLETED|Overall Study||5||
59526365|NCT01410097|75621988|FG001|NOT COMPLETED|Overall Study||3||
59526366|NCT02093702|75621996|FG000|STARTED|Overall Study||2||
59526367|NCT02093702|75621997|FG001|STARTED|Overall Study||3||
59526368|NCT02093702|75621996|FG000|COMPLETED|Overall Study||2||
59526369|NCT02093702|75621997|FG001|COMPLETED|Overall Study||3||
59526370|NCT02093702|75621996|FG000|NOT COMPLETED|Overall Study||0||
59526371|NCT02093702|75621997|FG001|NOT COMPLETED|Overall Study||0||
59526372|NCT00052442|75622009|FG000|STARTED|Overall Study||16||
59526373|NCT00052442|75622010|FG001|STARTED|Overall Study||3||
59526374|NCT00052442|75622011|FG002|STARTED|Overall Study||27||
59526375|NCT00052442|75622012|FG003|STARTED|Overall Study||11||
59526376|NCT00052442|75622013|FG004|STARTED|Overall Study||15||
59526377|NCT00052442|75622009|FG000|COMPLETED|Overall Study||16||
59526378|NCT00052442|75622010|FG001|COMPLETED|Overall Study||3||
59526379|NCT00052442|75622011|FG002|COMPLETED|Overall Study||27||
59526380|NCT00052442|75622012|FG003|COMPLETED|Overall Study||11||
59526381|NCT00052442|75622013|FG004|COMPLETED|Overall Study||15||
59526382|NCT00052442|75622009|FG000|NOT COMPLETED|Overall Study||0||
59526383|NCT00052442|75622010|FG001|NOT COMPLETED|Overall Study||0||
59526384|NCT00052442|75622011|FG002|NOT COMPLETED|Overall Study||0||
59526385|NCT00052442|75622012|FG003|NOT COMPLETED|Overall Study||0||
59526386|NCT00052442|75622013|FG004|NOT COMPLETED|Overall Study||0||
59526387|NCT01410409|75622027|FG000|STARTED|Overall Study||50||
59979667|NCT03035409|76096748|FG000|Day 43|Overall Study||28||
59979668|NCT03035409|76096748|FG000|COMPLETED|Overall Study||28||
59526388|NCT01410409|75622028|FG001|STARTED|Overall Study||50||
59526389|NCT01410409|75622027|FG000|COMPLETED|Overall Study||49||
59526390|NCT01410409|75622028|FG001|COMPLETED|Overall Study||46||
59526391|NCT01410409|75622027|FG000|NOT COMPLETED|Overall Study||1||
59526392|NCT01410409|75622028|FG001|NOT COMPLETED|Overall Study||4||
59526393|NCT01356277|75622036|FG000|STARTED|Run-in||81|Run-in|
59526394|NCT01356277|75622037|FG001|STARTED|Run-in||88|Run-in|
59526395|NCT01356277|75622036|FG000|COMPLETED|Run-in||76|run-in|
59526396|NCT01356277|75622037|FG001|COMPLETED|Run-in||88|run-in|
59526397|NCT01356277|75622036|FG000|NOT COMPLETED|Run-in||5||
59526398|NCT01356277|75622037|FG001|NOT COMPLETED|Run-in||0||
59526399|NCT01356277|75622036|FG000|STARTED|Intervention Interval||76||
59526400|NCT01356277|75622037|FG001|STARTED|Intervention Interval||88||
59526401|NCT01356277|75622036|FG000|COMPLETED|Intervention Interval||66||
59526402|NCT01356277|75622037|FG001|COMPLETED|Intervention Interval||81||
59526403|NCT01356277|75622036|FG000|NOT COMPLETED|Intervention Interval||10||
59526404|NCT01356277|75622037|FG001|NOT COMPLETED|Intervention Interval||7||
59526405|NCT01410565|75622047|FG000|STARTED|Open Label Phase Apaziquone||0||
59526406|NCT01410565|75622048|FG001|STARTED|Open Label Phase Apaziquone||0||
59526407|NCT01410565|75622049|FG002|STARTED|Open Label Phase Apaziquone||66||
59526408|NCT01410565|75622047|FG000|COMPLETED|Open Label Phase Apaziquone||0||
59526409|NCT01410565|75622048|FG001|COMPLETED|Open Label Phase Apaziquone||0||
59526410|NCT01410565|75622049|FG002|COMPLETED|Open Label Phase Apaziquone||58||
59526411|NCT01410565|75622047|FG000|NOT COMPLETED|Open Label Phase Apaziquone||0||
59526412|NCT01410565|75622048|FG001|NOT COMPLETED|Open Label Phase Apaziquone||0||
59526413|NCT01410565|75622049|FG002|NOT COMPLETED|Open Label Phase Apaziquone||8||
59526414|NCT01410565|75622047|FG000|STARTED|Double Blind Phase|All 66 patients received one dose of Apaziquone in the open label phase.|13||
59814521|NCT00618449|75936992|FG001|1-year, Post-treatment|Overall Study||558||
59814522|NCT00618449|75936991|FG000|COMPLETED|Overall Study||581||
59814523|NCT00618449|75936992|FG001|COMPLETED|Overall Study||558||
59814524|NCT00618449|75936991|FG000|NOT COMPLETED|Overall Study||98||
59814525|NCT00618449|75936992|FG001|NOT COMPLETED|Overall Study||110||
59814526|NCT03684642|75937001|FG000|STARTED|Overall Study||303||
59814527|NCT03684642|75937002|FG001|STARTED|Overall Study||302||
59526415|NCT01410565|75622048|FG001|STARTED|Double Blind Phase||15||
59526416|NCT01410565|75622049|FG002|STARTED|Double Blind Phase||0||
59526417|NCT01410565|75622047|FG000|COMPLETED|Double Blind Phase||0||
59526418|NCT01410565|75622048|FG001|COMPLETED|Double Blind Phase||0||
59526419|NCT01410565|75622049|FG002|COMPLETED|Double Blind Phase||0||
59526420|NCT01410565|75622047|FG000|NOT COMPLETED|Double Blind Phase||13||
59526421|NCT01410565|75622048|FG001|NOT COMPLETED|Double Blind Phase||15||
59526422|NCT01410565|75622049|FG002|NOT COMPLETED|Double Blind Phase||0||
59526423|NCT01357135|75622058|FG000|STARTED|Overall Study||1874||
59526424|NCT01357135|75622059|FG001|STARTED|Overall Study||733||
59526425|NCT01357135|75622060|FG002|STARTED|Overall Study||846||
59526426|NCT01357135|75622058|FG000|COMPLETED|Overall Study||1276||
59526427|NCT01357135|75622059|FG001|COMPLETED|Overall Study||510||
59526428|NCT01357135|75622060|FG002|COMPLETED|Overall Study||583||
59526429|NCT01357135|75622058|FG000|NOT COMPLETED|Overall Study||598||
59526430|NCT01357135|75622059|FG001|NOT COMPLETED|Overall Study||223||
59526431|NCT01357135|75622060|FG002|NOT COMPLETED|Overall Study||263||
59526432|NCT02324335|75622069|FG000|STARTED|Overall Study||30||
59526433|NCT02324335|75622070|FG001|STARTED|Overall Study||29||
59526434|NCT02324335|75622069|FG000|COMPLETED|Overall Study||21||
59526435|NCT02324335|75622070|FG001|COMPLETED|Overall Study||20||
59526436|NCT02324335|75622069|FG000|NOT COMPLETED|Overall Study||9||
59526437|NCT02324335|75622070|FG001|NOT COMPLETED|Overall Study||9||
59526438|NCT01411501|75622080|FG000|STARTED|Overall Study||168||
59979669|NCT03035409|76096748|FG000|NOT COMPLETED|Overall Study||17||
59979670|NCT02948088|76096752|FG000|STARTED|Overall Study||183|Baseline Analysis Set and All Documented Patient Set|
59979671|NCT02948088|76096752|FG000|Full Analysis Set|Overall Study||176||
59979672|NCT02948088|76096752|FG000|COMPLETED|Overall Study||168||
59979673|NCT02948088|76096752|FG000|NOT COMPLETED|Overall Study||15||
59979674|NCT02943915|76096791|FG000|STARTED|Overall Study||14||
59979675|NCT02943915|76096792|FG001|STARTED|Overall Study||13||
60074762|NCT01554579|76190080|FG001|COMPLETED|Overall Study||58||
59814528|NCT03684642|75937003|FG002|STARTED|Overall Study||303||
59979676|NCT02943915|76096793|FG002|STARTED|Overall Study||6||
59979677|NCT02943915|76096794|FG003|STARTED|Overall Study||12||
59979678|NCT02943915|76096791|FG000|COMPLETED|Overall Study||9||
59979679|NCT02943915|76096792|FG001|COMPLETED|Overall Study||10||
59979680|NCT02943915|76096793|FG002|COMPLETED|Overall Study||6||
59979681|NCT02943915|76096794|FG003|COMPLETED|Overall Study||12||
59979682|NCT02943915|76096791|FG000|NOT COMPLETED|Overall Study||5||
59526439|NCT01411501|75622081|FG001|STARTED|Overall Study||172||
59526440|NCT01411501|75622082|FG002|STARTED|Overall Study||165||
59814529|NCT03684642|75937001|FG000|Treated|Overall Study||303||
59814530|NCT03684642|75937002|FG001|Treated|Overall Study||302||
59814531|NCT03684642|75937003|FG002|Treated|Overall Study||302||
59979683|NCT02943915|76096792|FG001|NOT COMPLETED|Overall Study||3||
59979684|NCT02943915|76096793|FG002|NOT COMPLETED|Overall Study||0||
59979685|NCT02943915|76096794|FG003|NOT COMPLETED|Overall Study||0||
59814532|NCT03684642|75937001|FG000|Safety Population|Overall Study|For safety analysis participants are included in the treatment group that they are exposed for longer duration. 10 participants randomized to Efpeglenatide 6 mg received 4 mg dose for longer duration, and considered in the Efpeglenatide 4 mg group for safety analysis.|313|Participants who received at least 1 dose or part of a dose of the Investigational Medicinal Product (IMP), analyzed according to the treatment actually received.|
59814533|NCT03684642|75937002|FG001|Safety Population|Overall Study||292|Participants who received at least 1 dose or part of a dose of the Investigational Medicinal Product (IMP), analyzed according to the treatment actually received.|
59814534|NCT03684642|75937003|FG002|Safety Population|Overall Study||302|Participants who received at least 1 dose or part of a dose of the Investigational Medicinal Product (IMP), analyzed according to the treatment actually received.|
59814535|NCT03684642|75937001|FG000|COMPLETED|Overall Study||200||
59814536|NCT03684642|75937002|FG001|COMPLETED|Overall Study||169||
59814537|NCT03684642|75937003|FG002|COMPLETED|Overall Study||197||
59814538|NCT03684642|75937001|FG000|NOT COMPLETED|Overall Study||103||
59814539|NCT03684642|75937002|FG001|NOT COMPLETED|Overall Study||133||
59814540|NCT03684642|75937003|FG002|NOT COMPLETED|Overall Study||106||
59814541|NCT00519636|75937015|FG000|STARTED|Treatment Period 1||91||
59814542|NCT00519636|75937016|FG001|STARTED|Treatment Period 1||86||
59814543|NCT00519636|75937017|FG002|STARTED|Treatment Period 1||90||
59814544|NCT00519636|75937018|FG003|STARTED|Treatment Period 1||93||
59814545|NCT00519636|75937015|FG000|COMPLETED|Treatment Period 1||89||
59814546|NCT00519636|75937016|FG001|COMPLETED|Treatment Period 1||86||
59814547|NCT00519636|75937017|FG002|COMPLETED|Treatment Period 1||89||
59814548|NCT00519636|75937018|FG003|COMPLETED|Treatment Period 1||93||
59814549|NCT00519636|75937015|FG000|NOT COMPLETED|Treatment Period 1||2||
59814550|NCT00519636|75937016|FG001|NOT COMPLETED|Treatment Period 1||0||
59814551|NCT00519636|75937017|FG002|NOT COMPLETED|Treatment Period 1||1||
59814552|NCT00519636|75937018|FG003|NOT COMPLETED|Treatment Period 1||0||
59814553|NCT00519636|75937015|FG000|STARTED|Washout Period||89||
59814554|NCT00519636|75937016|FG001|STARTED|Washout Period||86||
59814555|NCT00519636|75937017|FG002|STARTED|Washout Period||89||
59814556|NCT00519636|75937018|FG003|STARTED|Washout Period||93||
59814557|NCT00519636|75937015|FG000|COMPLETED|Washout Period||69||
59814558|NCT00519636|75937016|FG001|COMPLETED|Washout Period||72||
59814559|NCT00519636|75937017|FG002|COMPLETED|Washout Period||75||
59814560|NCT00519636|75937018|FG003|COMPLETED|Washout Period||88||
59814561|NCT00519636|75937015|FG000|NOT COMPLETED|Washout Period||20||
59814562|NCT00519636|75937016|FG001|NOT COMPLETED|Washout Period||14||
59814563|NCT00519636|75937017|FG002|NOT COMPLETED|Washout Period||14||
59814564|NCT00519636|75937018|FG003|NOT COMPLETED|Washout Period||5||
59814565|NCT00519636|75937015|FG000|STARTED|Treatment Period 2||69||
59814566|NCT00519636|75937016|FG001|STARTED|Treatment Period 2||72||
59814567|NCT00519636|75937017|FG002|STARTED|Treatment Period 2||75||
59814568|NCT00519636|75937018|FG003|STARTED|Treatment Period 2||88||
59814569|NCT00519636|75937015|FG000|COMPLETED|Treatment Period 2||69||
59814570|NCT00519636|75937016|FG001|COMPLETED|Treatment Period 2||71||
59814571|NCT00519636|75937017|FG002|COMPLETED|Treatment Period 2||74||
59814572|NCT00519636|75937018|FG003|COMPLETED|Treatment Period 2||86||
59814573|NCT00519636|75937015|FG000|NOT COMPLETED|Treatment Period 2||0||
59814574|NCT00519636|75937016|FG001|NOT COMPLETED|Treatment Period 2||1||
59814575|NCT00519636|75937017|FG002|NOT COMPLETED|Treatment Period 2||1||
59814576|NCT00519636|75937018|FG003|NOT COMPLETED|Treatment Period 2||2||
59814577|NCT00519636|75937015|FG000|STARTED|Post Study Period||69||
59814578|NCT00519636|75937016|FG001|STARTED|Post Study Period||71||
59979686|NCT02763384|76096803|FG000|STARTED|Overall Study||12||
59979687|NCT02763384|76096803|FG000|COMPLETED|Overall Study||10||
59979688|NCT02763384|76096803|FG000|NOT COMPLETED|Overall Study||2||
59979689|NCT02649855|76096810|FG000|STARTED|Overall Study||23||
59979690|NCT02649855|76096811|FG001|STARTED|Overall Study||23||
59979691|NCT02649855|76096812|FG002|STARTED|Overall Study||28||
59979692|NCT02649855|76096810|FG000|COMPLETED|Overall Study||19||
59979693|NCT02649855|76096811|FG001|COMPLETED|Overall Study||19||
59979694|NCT02649855|76096812|FG002|COMPLETED|Overall Study||25||
59979695|NCT02649855|76096810|FG000|NOT COMPLETED|Overall Study||4||
59979696|NCT02649855|76096811|FG001|NOT COMPLETED|Overall Study||4||
59979697|NCT02649855|76096812|FG002|NOT COMPLETED|Overall Study||3||
59814579|NCT00519636|75937017|FG002|STARTED|Post Study Period||74||
59814580|NCT00519636|75937018|FG003|STARTED|Post Study Period||86||
59979698|NCT02619682|76096820|FG000|STARTED|Overall Study||30||
59979699|NCT02619682|76096820|FG000|COMPLETED|Overall Study||16||
59979700|NCT02619682|76096820|FG000|NOT COMPLETED|Overall Study||14||
59979701|NCT02613507|76096827|FG000|STARTED|Overall Study||338|(Subjects Randomized)|
59979702|NCT02613507|76096828|FG001|STARTED|Overall Study||166|(Subjects Randomized)|
59979703|NCT02613507|76096827|FG000|COMPLETED|Overall Study||50|(Subjects Continuing in the Treatment Period)|
59814581|NCT00519636|75937015|FG000|COMPLETED|Post Study Period||69||
59814582|NCT00519636|75937016|FG001|COMPLETED|Post Study Period||71||
59814583|NCT00519636|75937017|FG002|COMPLETED|Post Study Period||74||
59814584|NCT00519636|75937018|FG003|COMPLETED|Post Study Period||85||
59814585|NCT00519636|75937015|FG000|NOT COMPLETED|Post Study Period||0||
59814586|NCT00519636|75937016|FG001|NOT COMPLETED|Post Study Period||0||
59814587|NCT00519636|75937017|FG002|NOT COMPLETED|Post Study Period||0||
59814588|NCT00519636|75937018|FG003|NOT COMPLETED|Post Study Period||1||
59979704|NCT02613507|76096828|FG001|COMPLETED|Overall Study||2|(Subjects Continuing in the Treatment Period)|
59979705|NCT02613507|76096827|FG000|NOT COMPLETED|Overall Study||288||
59979706|NCT02613507|76096828|FG001|NOT COMPLETED|Overall Study||164||
59979707|NCT02538510|76096836|FG000|STARTED|Overall Study||25||
59979708|NCT02538510|76096837|FG001|STARTED|Overall Study||25||
59979709|NCT02538510|76096836|FG000|COMPLETED|Overall Study||25||
59979710|NCT02538510|76096837|FG001|COMPLETED|Overall Study||25||
59979711|NCT02538510|76096836|FG000|NOT COMPLETED|Overall Study||0||
59979712|NCT02538510|76096837|FG001|NOT COMPLETED|Overall Study||0||
59979713|NCT02521285|76096849|FG000|STARTED|Overall Study||10||
59979714|NCT02521285|76096850|FG001|STARTED|Overall Study||11||
59979715|NCT02521285|76096849|FG000|COMPLETED|Overall Study||8||
59979716|NCT02521285|76096850|FG001|COMPLETED|Overall Study||8||
59979717|NCT02521285|76096849|FG000|NOT COMPLETED|Overall Study||2||
59979718|NCT02521285|76096850|FG001|NOT COMPLETED|Overall Study||3||
59979719|NCT02407171|76096862|FG000|STARTED|Phase 1 Dose Escalation||10||
59979720|NCT02407171|76096863|FG001|STARTED|Phase 1 Dose Escalation||3||
59979721|NCT02407171|76096864|FG002|STARTED|Phase 1 Dose Escalation||5||
59979722|NCT02407171|76096865|FG003|STARTED|Phase 1 Dose Escalation||6||
59979723|NCT02407171|76096866|FG004|STARTED|Phase 1 Dose Escalation|Phase 2 ONLY patients|0||
59979724|NCT02407171|76096867|FG005|STARTED|Phase 1 Dose Escalation|Phase 2 ONLY patients|0||
59979725|NCT02407171|76096862|FG000|Dose Escalation 30 GY3|Phase 1 Dose Escalation||3||
59979726|NCT02407171|76096863|FG001|Dose Escalation 30 GY3|Phase 1 Dose Escalation||3||
59979727|NCT02407171|76096864|FG002|Dose Escalation 30 GY3|Phase 1 Dose Escalation||4||
59979728|NCT02407171|76096865|FG003|Dose Escalation 30 GY3|Phase 1 Dose Escalation||3||
59979729|NCT02407171|76096866|FG004|Dose Escalation 30 GY3|Phase 1 Dose Escalation||0||
59979730|NCT02407171|76096867|FG005|Dose Escalation 30 GY3|Phase 1 Dose Escalation||0||
59979731|NCT02407171|76096862|FG000|Dose Escalation 30 GY5|Phase 1 Dose Escalation||7||
59979732|NCT02407171|76096863|FG001|Dose Escalation 30 GY5|Phase 1 Dose Escalation||0||
59979733|NCT02407171|76096864|FG002|Dose Escalation 30 GY5|Phase 1 Dose Escalation||1||
59979734|NCT02407171|76096865|FG003|Dose Escalation 30 GY5|Phase 1 Dose Escalation||3||
59814589|NCT00618371|75937032|FG000|STARTED|Overall Study||12||
59814590|NCT00618371|75937032|FG000|COMPLETED|Overall Study||10||
59814591|NCT00618371|75937032|FG000|NOT COMPLETED|Overall Study||2||
59814592|NCT00526890|75937037|FG000|STARTED|Overall Study||16||
59814593|NCT00526890|75937037|FG000|COMPLETED|Overall Study||14||
59814594|NCT00526890|75937037|FG000|NOT COMPLETED|Overall Study||2||
59814595|NCT03864900|75937043|FG000|STARTED|Overall Study||36||
59814596|NCT03864900|75937044|FG001|STARTED|Overall Study||36||
59979735|NCT02407171|76096866|FG004|Dose Escalation 30 GY5|Phase 1 Dose Escalation||0||
59979736|NCT02407171|76096867|FG005|Dose Escalation 30 GY5|Phase 1 Dose Escalation||0||
59979737|NCT02407171|76096862|FG000|COMPLETED|Phase 1 Dose Escalation||10||
59979738|NCT02407171|76096863|FG001|COMPLETED|Phase 1 Dose Escalation||3||
59979739|NCT02407171|76096864|FG002|COMPLETED|Phase 1 Dose Escalation||5||
59979740|NCT02407171|76096865|FG003|COMPLETED|Phase 1 Dose Escalation||6||
59979741|NCT02407171|76096866|FG004|COMPLETED|Phase 1 Dose Escalation||0||
59979742|NCT02407171|76096867|FG005|COMPLETED|Phase 1 Dose Escalation||0||
59979743|NCT02407171|76096862|FG000|NOT COMPLETED|Phase 1 Dose Escalation||0||
59979744|NCT02407171|76096863|FG001|NOT COMPLETED|Phase 1 Dose Escalation||0||
59979745|NCT02407171|76096864|FG002|NOT COMPLETED|Phase 1 Dose Escalation||0||
59979746|NCT02407171|76096865|FG003|NOT COMPLETED|Phase 1 Dose Escalation||0||
59979747|NCT02407171|76096866|FG004|NOT COMPLETED|Phase 1 Dose Escalation||0||
59979748|NCT02407171|76096867|FG005|NOT COMPLETED|Phase 1 Dose Escalation||0||
59979749|NCT02407171|76096862|FG000|STARTED|Phase 2 Treatment||10||
59979750|NCT02407171|76096863|FG001|STARTED|Phase 2 Treatment||3||
59979751|NCT02407171|76096864|FG002|STARTED|Phase 2 Treatment||5||
59979752|NCT02407171|76096865|FG003|STARTED|Phase 2 Treatment||6||
59979753|NCT02407171|76096866|FG004|STARTED|Phase 2 Treatment||35||
59979754|NCT02407171|76096867|FG005|STARTED|Phase 2 Treatment||2||
59814597|NCT03864900|75937043|FG000|COMPLETED|Overall Study||33||
59814598|NCT03864900|75937044|FG001|COMPLETED|Overall Study||30||
59814599|NCT03864900|75937043|FG000|NOT COMPLETED|Overall Study||3||
59814600|NCT03864900|75937044|FG001|NOT COMPLETED|Overall Study||6||
59814601|NCT00526656|75937050|FG000|STARTED|Overall Study||9||
59814602|NCT00526656|75937050|FG000|COMPLETED|Overall Study||7||
59814603|NCT00526656|75937050|FG000|NOT COMPLETED|Overall Study||2||
59814604|NCT00617903|75937057|FG000|STARTED|Overall Study||41||
59814605|NCT00617903|75937058|FG001|STARTED|Overall Study||42||
59814606|NCT00617903|75937057|FG000|COMPLETED|Overall Study||38||
59979755|NCT02407171|76096862|FG000|Received SBRT|Phase 2 Treatment||10||
59814607|NCT00617903|75937058|FG001|COMPLETED|Overall Study||35||
59814608|NCT00617903|75937057|FG000|NOT COMPLETED|Overall Study||3||
59814609|NCT00617903|75937058|FG001|NOT COMPLETED|Overall Study||7||
59814610|NCT00526110|75937066|FG000|STARTED|Overall Study||53||
59814611|NCT00526110|75937067|FG001|STARTED|Overall Study||45||
59979756|NCT02407171|76096863|FG001|Received SBRT|Phase 2 Treatment||3||
59979757|NCT02407171|76096864|FG002|Received SBRT|Phase 2 Treatment||5||
59979758|NCT02407171|76096865|FG003|Received SBRT|Phase 2 Treatment||6||
59979759|NCT02407171|76096866|FG004|Received SBRT|Phase 2 Treatment||0||
59979760|NCT02407171|76096867|FG005|Received SBRT|Phase 2 Treatment||2||
59979761|NCT02407171|76096862|FG000|COMPLETED|Phase 2 Treatment||10||
59979762|NCT02407171|76096863|FG001|COMPLETED|Phase 2 Treatment||3||
59979763|NCT02407171|76096864|FG002|COMPLETED|Phase 2 Treatment||5||
59979764|NCT02407171|76096865|FG003|COMPLETED|Phase 2 Treatment||6||
59979765|NCT02407171|76096866|FG004|COMPLETED|Phase 2 Treatment||35||
59979766|NCT02407171|76096867|FG005|COMPLETED|Phase 2 Treatment||2||
59979767|NCT02407171|76096862|FG000|NOT COMPLETED|Phase 2 Treatment||0||
59979768|NCT02407171|76096863|FG001|NOT COMPLETED|Phase 2 Treatment||0||
59979769|NCT02407171|76096864|FG002|NOT COMPLETED|Phase 2 Treatment||0||
59979770|NCT02407171|76096865|FG003|NOT COMPLETED|Phase 2 Treatment||0||
59979771|NCT02407171|76096866|FG004|NOT COMPLETED|Phase 2 Treatment||0||
59979772|NCT02407171|76096867|FG005|NOT COMPLETED|Phase 2 Treatment||0||
59979773|NCT02331134|76096883|FG000|STARTED|Overall Study||9||
59979774|NCT02331134|76096883|FG000|COMPLETED|Overall Study||8||
59979775|NCT02331134|76096883|FG000|NOT COMPLETED|Overall Study||1||
59979776|NCT02243605|76096889|FG000|STARTED|Stage 1 - Interim Analysis Population||23||
59979777|NCT02243605|76096890|FG001|STARTED|Stage 1 - Interim Analysis Population||22||
59979778|NCT02243605|76096889|FG000|COMPLETED|Stage 1 - Interim Analysis Population||21|Eligible and who received at least one complete cycle or two incomplete cycles of treatment.|
59979779|NCT02243605|76096890|FG001|COMPLETED|Stage 1 - Interim Analysis Population||21|Eligible and who received at least one complete cycle or two incomplete cycles of treatment.|
59979780|NCT02243605|76096889|FG000|NOT COMPLETED|Stage 1 - Interim Analysis Population||2||
59979781|NCT02243605|76096890|FG001|NOT COMPLETED|Stage 1 - Interim Analysis Population||1||
59979782|NCT02243605|76096889|FG000|STARTED|Stage 2 - Final Analysis Population||45||
59979783|NCT02243605|76096890|FG001|STARTED|Stage 2 - Final Analysis Population||45||
59979784|NCT02243605|76096889|FG000|COMPLETED|Stage 2 - Final Analysis Population||39|Eligible and who received at least one complete cycle or two incomplete cycles of treatment.|
59979785|NCT02243605|76096890|FG001|COMPLETED|Stage 2 - Final Analysis Population||42|Eligible and who received at least one complete cycle or two incomplete cycles of treatment.|
59979786|NCT02243605|76096889|FG000|NOT COMPLETED|Stage 2 - Final Analysis Population||6||
59979787|NCT02243605|76096890|FG001|NOT COMPLETED|Stage 2 - Final Analysis Population||3||
59979788|NCT01693601|76096900|FG000|STARTED|Cohort 1||3||
59979789|NCT01693601|76096901|FG001|STARTED|Cohort 1||0||
59979790|NCT01693601|76096902|FG002|STARTED|Cohort 1||0||
59979791|NCT01693601|76096903|FG003|STARTED|Cohort 1||0||
59979792|NCT01693601|76096900|FG000|COMPLETED|Cohort 1||3||
60074763|NCT01554579|76190079|FG000|NOT COMPLETED|Overall Study||10||
60074764|NCT01554579|76190080|FG001|NOT COMPLETED|Overall Study||27||
60074765|NCT01806662|76190087|FG000|STARTED|First Intervention (Weeks 0-16)||16||
60074766|NCT01806662|76190088|FG001|STARTED|First Intervention (Weeks 0-16)||16||
60074767|NCT01806662|76190087|FG000|Received Intervention|First Intervention (Weeks 0-16)||12||
60074768|NCT01806662|76190088|FG001|Received Intervention|First Intervention (Weeks 0-16)||15||
60074769|NCT01806662|76190087|FG000|COMPLETED|First Intervention (Weeks 0-16)||12||
60074770|NCT01806662|76190088|FG001|COMPLETED|First Intervention (Weeks 0-16)||15||
60074771|NCT01806662|76190087|FG000|NOT COMPLETED|First Intervention (Weeks 0-16)||4||
60074772|NCT01806662|76190088|FG001|NOT COMPLETED|First Intervention (Weeks 0-16)||1||
60074773|NCT01806662|76190087|FG000|STARTED|Second Intervention (Weeks 16-32)||12||
60074774|NCT01806662|76190088|FG001|STARTED|Second Intervention (Weeks 16-32)||15||
60074775|NCT01806662|76190087|FG000|COMPLETED|Second Intervention (Weeks 16-32)||10||
60074776|NCT01806662|76190088|FG001|COMPLETED|Second Intervention (Weeks 16-32)||11||
60074777|NCT01806662|76190087|FG000|NOT COMPLETED|Second Intervention (Weeks 16-32)||2||
60074778|NCT01806662|76190088|FG001|NOT COMPLETED|Second Intervention (Weeks 16-32)||4||
60074779|NCT01930123|76190096|FG000|STARTED|Overall Study||81||
60074780|NCT01930123|76190097|FG001|STARTED|Overall Study||37||
60074781|NCT01930123|76190096|FG000|COMPLETED|Overall Study||58||
60074782|NCT01930123|76190097|FG001|COMPLETED|Overall Study||29||
60074783|NCT01930123|76190096|FG000|NOT COMPLETED|Overall Study||23||
59526441|NCT01411501|75622083|FG003|STARTED|Overall Study||170||
59526442|NCT01411501|75622080|FG000|COMPLETED|Overall Study||158||
59526443|NCT01411501|75622081|FG001|COMPLETED|Overall Study||166||
59526444|NCT01411501|75622082|FG002|COMPLETED|Overall Study||159||
59526445|NCT01411501|75622083|FG003|COMPLETED|Overall Study||163||
59526446|NCT01411501|75622080|FG000|NOT COMPLETED|Overall Study||10||
59526447|NCT01411501|75622081|FG001|NOT COMPLETED|Overall Study||6||
59526448|NCT01411501|75622082|FG002|NOT COMPLETED|Overall Study||6||
59979793|NCT01693601|76096901|FG001|COMPLETED|Cohort 1||0||
59979794|NCT01693601|76096902|FG002|COMPLETED|Cohort 1||0||
59979795|NCT01693601|76096903|FG003|COMPLETED|Cohort 1||0||
59979796|NCT01693601|76096900|FG000|NOT COMPLETED|Cohort 1||0||
59979797|NCT01693601|76096901|FG001|NOT COMPLETED|Cohort 1||0||
59979798|NCT01693601|76096902|FG002|NOT COMPLETED|Cohort 1||0||
59979799|NCT01693601|76096903|FG003|NOT COMPLETED|Cohort 1||0||
59979800|NCT01693601|76096900|FG000|STARTED|Cohort 2||0||
59979801|NCT01693601|76096901|FG001|STARTED|Cohort 2||6||
59979802|NCT01693601|76096902|FG002|STARTED|Cohort 2||0||
59979803|NCT01693601|76096903|FG003|STARTED|Cohort 2||0||
59979804|NCT01693601|76096900|FG000|COMPLETED|Cohort 2||0||
60074784|NCT01930123|76190097|FG001|NOT COMPLETED|Overall Study||8||
60074785|NCT01930045|76190103|FG000|STARTED|Part 1 - Period 1||3||
60074786|NCT01930045|76190104|FG001|STARTED|Part 1 - Period 1||3||
59979805|NCT01693601|76096901|FG001|COMPLETED|Cohort 2||6||
59979806|NCT01693601|76096902|FG002|COMPLETED|Cohort 2||0||
59979807|NCT01693601|76096903|FG003|COMPLETED|Cohort 2||0||
59979808|NCT01693601|76096900|FG000|NOT COMPLETED|Cohort 2||0||
59979809|NCT01693601|76096901|FG001|NOT COMPLETED|Cohort 2||0||
59979810|NCT01693601|76096902|FG002|NOT COMPLETED|Cohort 2||0||
59979811|NCT01693601|76096903|FG003|NOT COMPLETED|Cohort 2||0||
59979812|NCT01693601|76096900|FG000|STARTED|Cohort 3||0||
59979813|NCT01693601|76096901|FG001|STARTED|Cohort 3||0||
59979814|NCT01693601|76096902|FG002|STARTED|Cohort 3||3||
59979815|NCT01693601|76096903|FG003|STARTED|Cohort 3||0||
59979816|NCT01693601|76096900|FG000|COMPLETED|Cohort 3||0||
59979817|NCT01693601|76096901|FG001|COMPLETED|Cohort 3||0||
59979818|NCT01693601|76096902|FG002|COMPLETED|Cohort 3||3||
59979819|NCT01693601|76096903|FG003|COMPLETED|Cohort 3||0||
59979820|NCT01693601|76096900|FG000|NOT COMPLETED|Cohort 3||0||
59979821|NCT01693601|76096901|FG001|NOT COMPLETED|Cohort 3||0||
59979822|NCT01693601|76096902|FG002|NOT COMPLETED|Cohort 3||0||
59814612|NCT00526110|75937066|FG000|COMPLETED|Overall Study||51||
59814613|NCT00526110|75937067|FG001|COMPLETED|Overall Study||4||
59814614|NCT00526110|75937066|FG000|NOT COMPLETED|Overall Study||2||
59814615|NCT00526110|75937067|FG001|NOT COMPLETED|Overall Study||41||
59814616|NCT00512148|75937073|FG000|STARTED|Primay Study Period||7||
59814617|NCT00512148|75937073|FG000|COMPLETED|Primay Study Period||6||
59979823|NCT01693601|76096903|FG003|NOT COMPLETED|Cohort 3||0||
59979824|NCT01693601|76096900|FG000|STARTED|Cohort 4||0||
59979825|NCT01693601|76096901|FG001|STARTED|Cohort 4||0||
59979826|NCT01693601|76096902|FG002|STARTED|Cohort 4||0||
59979827|NCT01693601|76096903|FG003|STARTED|Cohort 4||3||
59979828|NCT01693601|76096900|FG000|COMPLETED|Cohort 4||0||
59979829|NCT01693601|76096901|FG001|COMPLETED|Cohort 4||0||
59979830|NCT01693601|76096902|FG002|COMPLETED|Cohort 4||0||
59979831|NCT01693601|76096903|FG003|COMPLETED|Cohort 4||3||
59979832|NCT01693601|76096900|FG000|NOT COMPLETED|Cohort 4||0||
59979833|NCT01693601|76096901|FG001|NOT COMPLETED|Cohort 4||0||
59979834|NCT01693601|76096902|FG002|NOT COMPLETED|Cohort 4||0||
59979835|NCT01693601|76096903|FG003|NOT COMPLETED|Cohort 4||0||
59979836|NCT01284348|76096917|FG000|STARTED|Overall Study||14||
59979837|NCT01284348|76096918|FG001|STARTED|Overall Study||12||
59979838|NCT01284348|76096917|FG000|Treated|Overall Study||14||
59979839|NCT01284348|76096918|FG001|Treated|Overall Study||11||
59979840|NCT01284348|76096917|FG000|COMPLETED|Overall Study||4||
59979841|NCT01284348|76096918|FG001|COMPLETED|Overall Study||0||
59979842|NCT01284348|76096917|FG000|NOT COMPLETED|Overall Study||10||
59979843|NCT01284348|76096918|FG001|NOT COMPLETED|Overall Study||12||
59979844|NCT00727025|76096924|FG000|STARTED|Overall Study||74||
59979845|NCT00727025|76096924|FG000|COMPLETED|Overall Study||51||
59979846|NCT00727025|76096924|FG000|NOT COMPLETED|Overall Study||23||
59979847|NCT02701413|76096934|FG000|STARTED|Overall Study||33||
59979848|NCT02701413|76096935|FG001|STARTED|Overall Study||33||
59979849|NCT02701413|76096934|FG000|COMPLETED|Overall Study||26||
59979850|NCT02701413|76096935|FG001|COMPLETED|Overall Study||22||
59979851|NCT02701413|76096934|FG000|NOT COMPLETED|Overall Study||7||
59979852|NCT02701413|76096935|FG001|NOT COMPLETED|Overall Study||11||
59979853|NCT02582684|76096941|FG000|STARTED|Overall Study||122||
59979854|NCT02582684|76096941|FG000|COMPLETED|Overall Study||105||
59979855|NCT02582684|76096941|FG000|NOT COMPLETED|Overall Study||17||
59979856|NCT02585960|76096948|FG000|STARTED|PK/Safety Assessment Period||57||
59979857|NCT02585960|76096949|FG001|STARTED|PK/Safety Assessment Period||58||
60074787|NCT01930045|76190105|FG002|STARTED|Part 1 - Period 1||3||
59814618|NCT00512148|75937073|FG000|NOT COMPLETED|Primay Study Period||1||
59814619|NCT00512148|75937073|FG000|STARTED|Long Term Follow Up Period||6||
59814620|NCT00512148|75937073|FG000|COMPLETED|Long Term Follow Up Period|6 patients are being followed in long term follow up|0||
59814621|NCT00512148|75937073|FG000|NOT COMPLETED|Long Term Follow Up Period||6||
59814622|NCT00511836|75937081|FG000|STARTED|Double-blind Period||16||
59814623|NCT00511836|75937082|FG001|STARTED|Double-blind Period||15||
59814624|NCT00511836|75937081|FG000|COMPLETED|Double-blind Period||15||
59814625|NCT00511836|75937082|FG001|COMPLETED|Double-blind Period||15||
59979858|NCT02585960|76096950|FG002|STARTED|PK/Safety Assessment Period||6||
59979859|NCT02585960|76096948|FG000|Completed 1st 6 Month Period|PK/Safety Assessment Period||57||
59979860|NCT02585960|76096949|FG001|Completed 1st 6 Month Period|PK/Safety Assessment Period||53||
59979861|NCT02585960|76096950|FG002|Completed 1st 6 Month Period|PK/Safety Assessment Period||0||
59979862|NCT02585960|76096948|FG000|Completed 2nd 6 Month Period|PK/Safety Assessment Period||52||
59979863|NCT02585960|76096949|FG001|Completed 2nd 6 Month Period|PK/Safety Assessment Period||48||
59979864|NCT02585960|76096950|FG002|Completed 2nd 6 Month Period|PK/Safety Assessment Period||0||
59979865|NCT02585960|76096948|FG000|COMPLETED|PK/Safety Assessment Period||52||
59979866|NCT02585960|76096949|FG001|COMPLETED|PK/Safety Assessment Period||48||
59979867|NCT02585960|76096950|FG002|COMPLETED|PK/Safety Assessment Period||0||
59979868|NCT02585960|76096948|FG000|NOT COMPLETED|PK/Safety Assessment Period||5||
59979869|NCT02585960|76096949|FG001|NOT COMPLETED|PK/Safety Assessment Period||10||
59979870|NCT02585960|76096950|FG002|NOT COMPLETED|PK/Safety Assessment Period||6||
59979871|NCT02585960|76096948|FG000|STARTED|Prophylactic Treatment Period||52||
60074788|NCT01930045|76190106|FG003|STARTED|Part 1 - Period 1||3||
59979872|NCT02585960|76096949|FG001|STARTED|Prophylactic Treatment Period||48||
59979873|NCT02585960|76096950|FG002|STARTED|Prophylactic Treatment Period||0||
59979874|NCT02585960|76096948|FG000|COMPLETED|Prophylactic Treatment Period||52||
59979875|NCT02585960|76096949|FG001|COMPLETED|Prophylactic Treatment Period||43||
59979876|NCT02585960|76096950|FG002|COMPLETED|Prophylactic Treatment Period||0||
59979877|NCT02585960|76096948|FG000|NOT COMPLETED|Prophylactic Treatment Period||0||
59979878|NCT02585960|76096949|FG001|NOT COMPLETED|Prophylactic Treatment Period||5||
59979879|NCT02585960|76096950|FG002|NOT COMPLETED|Prophylactic Treatment Period||0||
59979880|NCT02699463|76096963|FG000|STARTED|Overall Study||115||
59979881|NCT02699463|76096964|FG001|STARTED|Overall Study||118||
59979882|NCT02699463|76096963|FG000|COMPLETED|Overall Study||100||
59979883|NCT02699463|76096964|FG001|COMPLETED|Overall Study||109||
59979884|NCT02699463|76096963|FG000|NOT COMPLETED|Overall Study||15||
59979885|NCT02699463|76096964|FG001|NOT COMPLETED|Overall Study||9||
59979886|NCT00100789|76096970|FG000|STARTED|Overall Study||67||
59979887|NCT00100789|76096970|FG000|Eligible|Overall Study||64||
59979888|NCT00100789|76096970|FG000|Eligible and Began Protocol Therapy|Overall Study||63||
59979889|NCT00100789|76096970|FG000|COMPLETED|Overall Study||3||
59979890|NCT00100789|76096970|FG000|NOT COMPLETED|Overall Study||64||
59979891|NCT00708123|76096975|FG000|STARTED|Period 1||12||
59979892|NCT00708123|76096976|FG001|STARTED|Period 1||12||
59979893|NCT00708123|76096977|FG002|STARTED|Period 1||12||
59979894|NCT00708123|76096978|FG003|STARTED|Period 1||12||
59979895|NCT00708123|76096979|FG004|STARTED|Period 1||12||
59979896|NCT00708123|76096975|FG000|COMPLETED|Period 1||12||
59979897|NCT00708123|76096976|FG001|COMPLETED|Period 1||11||
59979898|NCT00708123|76096977|FG002|COMPLETED|Period 1||11||
59979899|NCT00708123|76096978|FG003|COMPLETED|Period 1||11||
59979900|NCT00708123|76096979|FG004|COMPLETED|Period 1||12||
59979901|NCT00708123|76096975|FG000|NOT COMPLETED|Period 1||0||
59979902|NCT00708123|76096976|FG001|NOT COMPLETED|Period 1||1||
59979903|NCT00708123|76096977|FG002|NOT COMPLETED|Period 1||1||
59979904|NCT00708123|76096978|FG003|NOT COMPLETED|Period 1||1||
59979905|NCT00708123|76096979|FG004|NOT COMPLETED|Period 1||0||
59979906|NCT00708123|76096975|FG000|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|11||
59979907|NCT00708123|76096976|FG001|STARTED|Period 2|Due to crossover design,different set of participants received this treatment compared to Period 1|12||
59979908|NCT00708123|76096977|FG002|STARTED|Period 2|Due to crossover design,different set of participants received this treatment compared to Period 1|12||
59979909|NCT00708123|76096978|FG003|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|11||
59979910|NCT00708123|76096979|FG004|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|11||
59979911|NCT00708123|76096975|FG000|COMPLETED|Period 2||10||
59979912|NCT00708123|76096976|FG001|COMPLETED|Period 2||12||
59979913|NCT00708123|76096977|FG002|COMPLETED|Period 2||12||
59979914|NCT00708123|76096978|FG003|COMPLETED|Period 2||10||
59979915|NCT00708123|76096979|FG004|COMPLETED|Period 2||11||
59979916|NCT00708123|76096975|FG000|NOT COMPLETED|Period 2||1||
59979917|NCT00708123|76096976|FG001|NOT COMPLETED|Period 2||0||
59979918|NCT00708123|76096977|FG002|NOT COMPLETED|Period 2||0||
59979919|NCT00708123|76096978|FG003|NOT COMPLETED|Period 2||1||
59979920|NCT00708123|76096979|FG004|NOT COMPLETED|Period 2||0||
59979921|NCT00708123|76096975|FG000|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|12||
59979922|NCT00708123|76096976|FG001|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|10||
59979923|NCT00708123|76096977|FG002|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|11||
59979924|NCT00708123|76096978|FG003|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|12||
59979925|NCT00708123|76096979|FG004|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|10||
59979926|NCT00708123|76096975|FG000|COMPLETED|Period 3||12||
59979927|NCT00708123|76096976|FG001|COMPLETED|Period 3||10||
59979928|NCT00708123|76096977|FG002|COMPLETED|Period 3||10||
59979929|NCT00708123|76096978|FG003|COMPLETED|Period 3||11||
59979930|NCT00708123|76096979|FG004|COMPLETED|Period 3||10||
59979931|NCT00708123|76096975|FG000|NOT COMPLETED|Period 3||0||
59979932|NCT00708123|76096976|FG001|NOT COMPLETED|Period 3||0||
59979933|NCT00708123|76096977|FG002|NOT COMPLETED|Period 3||1||
59979934|NCT00708123|76096978|FG003|NOT COMPLETED|Period 3||1||
59979935|NCT00708123|76096979|FG004|NOT COMPLETED|Period 3||0||
59979936|NCT00708123|76096975|FG000|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|10||
59979937|NCT00708123|76096976|FG001|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|12||
59979938|NCT00708123|76096977|FG002|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|10||
59979939|NCT00708123|76096978|FG003|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|10||
59979940|NCT00708123|76096979|FG004|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|11||
59979941|NCT00708123|76096975|FG000|COMPLETED|Period 4||10||
59979942|NCT00708123|76096976|FG001|COMPLETED|Period 4||11||
59979943|NCT00708123|76096977|FG002|COMPLETED|Period 4||10||
59979944|NCT00708123|76096978|FG003|COMPLETED|Period 4||10||
59979945|NCT00708123|76096979|FG004|COMPLETED|Period 4||11||
59979946|NCT00708123|76096975|FG000|NOT COMPLETED|Period 4||0||
59979947|NCT00708123|76096976|FG001|NOT COMPLETED|Period 4||1||
59979948|NCT00708123|76096977|FG002|NOT COMPLETED|Period 4||0||
59979949|NCT00708123|76096978|FG003|NOT COMPLETED|Period 4||0||
59979950|NCT00708123|76096979|FG004|NOT COMPLETED|Period 4||0||
59979951|NCT00708123|76096975|FG000|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|10||
59979952|NCT00708123|76096976|FG001|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|10||
59979953|NCT00708123|76096977|FG002|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|11||
59979954|NCT00708123|76096978|FG003|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|11||
59979955|NCT00708123|76096979|FG004|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|10||
59979956|NCT00708123|76096975|FG000|COMPLETED|Period 5||10||
59979957|NCT00708123|76096976|FG001|COMPLETED|Period 5||10||
59979958|NCT00708123|76096977|FG002|COMPLETED|Period 5||11||
59979959|NCT00708123|76096978|FG003|COMPLETED|Period 5||11||
59979960|NCT00708123|76096979|FG004|COMPLETED|Period 5||10||
59979961|NCT00708123|76096975|FG000|NOT COMPLETED|Period 5||0||
59979962|NCT00708123|76096976|FG001|NOT COMPLETED|Period 5||0||
59979963|NCT00708123|76096977|FG002|NOT COMPLETED|Period 5||0||
59979964|NCT00708123|76096978|FG003|NOT COMPLETED|Period 5||0||
59979965|NCT00708123|76096979|FG004|NOT COMPLETED|Period 5||0||
59979966|NCT02165215|76096998|FG000|STARTED|Induction Phase||359||
59979967|NCT02165215|76096999|FG001|STARTED|Induction Phase||0||
59979968|NCT02165215|76097000|FG002|STARTED|Induction Phase||0||
59979969|NCT02165215|76096998|FG000|Dosed|Induction Phase||358||
59979970|NCT02165215|76096999|FG001|Dosed|Induction Phase||0||
59979971|NCT02165215|76097000|FG002|Dosed|Induction Phase||0||
59979972|NCT02165215|76096998|FG000|COMPLETED|Induction Phase||336||
59979973|NCT02165215|76096999|FG001|COMPLETED|Induction Phase||0||
59979974|NCT02165215|76097000|FG002|COMPLETED|Induction Phase||0||
59979975|NCT02165215|76096998|FG000|NOT COMPLETED|Induction Phase||23||
59979976|NCT02165215|76096999|FG001|NOT COMPLETED|Induction Phase||0||
59979977|NCT02165215|76097000|FG002|NOT COMPLETED|Induction Phase||0||
59979978|NCT02165215|76096998|FG000|STARTED|Maintenance Phase||0||
59979979|NCT02165215|76096999|FG001|STARTED|Maintenance Phase||108||
59979980|NCT02165215|76097000|FG002|STARTED|Maintenance Phase||106||
59814626|NCT00511836|75937081|FG000|NOT COMPLETED|Double-blind Period||1||
59814627|NCT00511836|75937082|FG001|NOT COMPLETED|Double-blind Period||0||
59814628|NCT00511836|75937081|FG000|STARTED|Optional Open-label VIVITROL (2 Months)|Subjects who received placebo during Month 1 switched to VIVITROL for the optional extension phase.|22||
59814629|NCT00511836|75937082|FG001|STARTED|Optional Open-label VIVITROL (2 Months)|Not all subjects from the double-blind phase entered the optional open-label extension.|0||
59814630|NCT00511836|75937081|FG000|COMPLETED|Optional Open-label VIVITROL (2 Months)||6||
59814631|NCT00511836|75937082|FG001|COMPLETED|Optional Open-label VIVITROL (2 Months)||0||
59814632|NCT00511836|75937081|FG000|NOT COMPLETED|Optional Open-label VIVITROL (2 Months)||16||
59814633|NCT00511836|75937082|FG001|NOT COMPLETED|Optional Open-label VIVITROL (2 Months)||0||
59814634|NCT03998436|75937092|FG000|STARTED|Overall Study||76||
59814635|NCT03998436|75937093|FG001|STARTED|Overall Study||76||
59814636|NCT03998436|75937094|FG002|STARTED|Overall Study||24||
59814637|NCT03998436|75937092|FG000|COMPLETED|Overall Study||68||
59814638|NCT03998436|75937093|FG001|COMPLETED|Overall Study||72||
59814639|NCT03998436|75937094|FG002|COMPLETED|Overall Study||23||
59814640|NCT03998436|75937092|FG000|NOT COMPLETED|Overall Study||8||
59814641|NCT03998436|75937093|FG001|NOT COMPLETED|Overall Study||4||
59814642|NCT03998436|75937094|FG002|NOT COMPLETED|Overall Study||1||
59814643|NCT00573755|75937104|FG000|STARTED|Overall Study||2||
59814644|NCT00573755|75937105|FG001|STARTED|Overall Study||2||
59814645|NCT00573755|75937104|FG000|COMPLETED|Overall Study||1||
59814646|NCT00573755|75937105|FG001|COMPLETED|Overall Study||2||
59814647|NCT00573755|75937104|FG000|NOT COMPLETED|Overall Study||1||
59814648|NCT00573755|75937105|FG001|NOT COMPLETED|Overall Study||0||
59814649|NCT00524316|75937111|FG000|STARTED|Overall Study||16||
59814650|NCT00524316|75937111|FG000|COMPLETED|Overall Study||0||
59814651|NCT00524316|75937111|FG000|NOT COMPLETED|Overall Study||16||
59979981|NCT02165215|76096998|FG000|Dosed|Maintenance Phase||0||
59979982|NCT02165215|76096999|FG001|Dosed|Maintenance Phase||108||
59979983|NCT02165215|76097000|FG002|Dosed|Maintenance Phase||102||
59979984|NCT02165215|76096998|FG000|COMPLETED|Maintenance Phase||0||
59979985|NCT02165215|76096999|FG001|COMPLETED|Maintenance Phase||96||
59979986|NCT02165215|76097000|FG002|COMPLETED|Maintenance Phase||101||
59979987|NCT02165215|76096998|FG000|NOT COMPLETED|Maintenance Phase||0||
59814652|NCT01320072|75937117|FG000|STARTED|Overall Study||16||
59979988|NCT02165215|76096999|FG001|NOT COMPLETED|Maintenance Phase||12||
59979989|NCT02165215|76097000|FG002|NOT COMPLETED|Maintenance Phase||5||
59979990|NCT02757625|76097015|FG000|STARTED|Overall Study||14||
59979991|NCT02757625|76097016|FG001|STARTED|Overall Study||18||
59979992|NCT02757625|76097017|FG002|STARTED|Overall Study||19||
59814653|NCT01320072|75937118|FG001|STARTED|Overall Study||13||
59814654|NCT01320072|75937117|FG000|COMPLETED|Overall Study||16||
59814655|NCT01320072|75937118|FG001|COMPLETED|Overall Study||13||
59814656|NCT01320072|75937117|FG000|NOT COMPLETED|Overall Study||0||
59814657|NCT01320072|75937118|FG001|NOT COMPLETED|Overall Study||0||
59814658|NCT03861936|75937128|FG000|STARTED|Overall Study||48||
59814659|NCT03861936|75937129|FG001|STARTED|Overall Study||53||
59814660|NCT03861936|75937130|FG002|STARTED|Overall Study||49||
59814661|NCT03861936|75937128|FG000|COMPLETED|Overall Study||34||
59814662|NCT03861936|75937129|FG001|COMPLETED|Overall Study||43||
59814663|NCT03861936|75937130|FG002|COMPLETED|Overall Study||39||
59814664|NCT03861936|75937128|FG000|NOT COMPLETED|Overall Study||14||
59814665|NCT03861936|75937129|FG001|NOT COMPLETED|Overall Study||10||
59814666|NCT03861936|75937130|FG002|NOT COMPLETED|Overall Study||10||
59814667|NCT00434577|75937143|FG000|STARTED|Months 0-3||164||
59814668|NCT00434577|75937144|FG001|STARTED|Months 0-3||166||
59814669|NCT00434577|75937145|FG002|STARTED|Months 0-3||165||
59814670|NCT00434577|75937146|FG003|STARTED|Months 0-3||165||
59814671|NCT00434577|75937147|FG004|STARTED|Months 0-3||54||
59814672|NCT00434577|75937143|FG000|COMPLETED|Months 0-3||161||
59814673|NCT00434577|75937144|FG001|COMPLETED|Months 0-3||164||
59979993|NCT02757625|76097018|FG003|STARTED|Overall Study||12||
59979994|NCT02757625|76097015|FG000|COMPLETED|Overall Study||14||
59979995|NCT02757625|76097016|FG001|COMPLETED|Overall Study||18||
59979996|NCT02757625|76097017|FG002|COMPLETED|Overall Study||17||
59979997|NCT02757625|76097018|FG003|COMPLETED|Overall Study||12||
59979998|NCT02757625|76097015|FG000|NOT COMPLETED|Overall Study||0||
59979999|NCT02757625|76097016|FG001|NOT COMPLETED|Overall Study||0||
59980000|NCT02757625|76097017|FG002|NOT COMPLETED|Overall Study||2||
59980001|NCT02757625|76097018|FG003|NOT COMPLETED|Overall Study||0||
59980002|NCT02581202|76097030|FG000|STARTED|Overall Study||216||
59980003|NCT02581202|76097030|FG000|COMPLETED|Overall Study||202||
59980004|NCT02581202|76097030|FG000|NOT COMPLETED|Overall Study||14||
59980005|NCT02758171|76097037|FG000|STARTED|Treatment Period 1||28||
59980006|NCT02758171|76097038|FG001|STARTED|Treatment Period 1||28||
59980007|NCT02758171|76097037|FG000|COMPLETED|Treatment Period 1||28||
59980008|NCT02758171|76097038|FG001|COMPLETED|Treatment Period 1||28||
59980009|NCT02758171|76097037|FG000|NOT COMPLETED|Treatment Period 1||0||
59980010|NCT02758171|76097038|FG001|NOT COMPLETED|Treatment Period 1||0||
59980011|NCT02758171|76097037|FG000|STARTED|Wash-out||28||
59980012|NCT02758171|76097038|FG001|STARTED|Wash-out||28||
59980013|NCT02758171|76097037|FG000|COMPLETED|Wash-out||26||
59980014|NCT02758171|76097038|FG001|COMPLETED|Wash-out||28||
59980015|NCT02758171|76097037|FG000|NOT COMPLETED|Wash-out||2||
59980016|NCT02758171|76097038|FG001|NOT COMPLETED|Wash-out||0||
59980017|NCT02758171|76097037|FG000|STARTED|Treatment Period 2||26||
59980018|NCT02758171|76097038|FG001|STARTED|Treatment Period 2||28||
59980019|NCT02758171|76097037|FG000|COMPLETED|Treatment Period 2||26||
59980020|NCT02758171|76097038|FG001|COMPLETED|Treatment Period 2||28||
59980021|NCT02758171|76097037|FG000|NOT COMPLETED|Treatment Period 2||0||
59980022|NCT02758171|76097038|FG001|NOT COMPLETED|Treatment Period 2||0||
59980023|NCT04154150|76097046|FG000|STARTED|Overall Study||7||
59980024|NCT04154150|76097047|FG001|STARTED|Overall Study||9||
59980025|NCT04154150|76097046|FG000|COMPLETED|Overall Study||7||
59980026|NCT04154150|76097047|FG001|COMPLETED|Overall Study||9||
59980027|NCT04154150|76097046|FG000|NOT COMPLETED|Overall Study||0||
59980028|NCT04154150|76097047|FG001|NOT COMPLETED|Overall Study||0||
59814674|NCT00434577|75937145|FG002|COMPLETED|Months 0-3||161||
59814675|NCT00434577|75937146|FG003|COMPLETED|Months 0-3||164||
59814676|NCT00434577|75937147|FG004|COMPLETED|Months 0-3||51||
59814677|NCT00434577|75937143|FG000|NOT COMPLETED|Months 0-3||3||
59814678|NCT00434577|75937144|FG001|NOT COMPLETED|Months 0-3||2||
59814679|NCT00434577|75937145|FG002|NOT COMPLETED|Months 0-3||4||
59980029|NCT01664078|76097053|FG000|STARTED|Overall Study||190||
59980030|NCT01664078|76097053|FG000|COMPLETED|Overall Study||121||
59980031|NCT01664078|76097053|FG000|NOT COMPLETED|Overall Study||69||
59980032|NCT03367403|76097106|FG000|STARTED|Overall Study||131||
59980033|NCT03367403|76097107|FG001|STARTED|Overall Study||126||
59980034|NCT03367403|76097108|FG002|STARTED|Overall Study||15||
59980035|NCT03367403|76097106|FG000|Received at Least One Dose of Study Drug|Overall Study||131||
59980036|NCT03367403|76097107|FG001|Received at Least One Dose of Study Drug|Overall Study||125||
59980037|NCT03367403|76097108|FG002|Received at Least One Dose of Study Drug|Overall Study||15||
59980038|NCT03367403|76097106|FG000|COMPLETED|Overall Study||94||
59980039|NCT03367403|76097107|FG001|COMPLETED|Overall Study||93||
59980040|NCT03367403|76097108|FG002|COMPLETED|Overall Study||12||
59980041|NCT03367403|76097106|FG000|NOT COMPLETED|Overall Study||37||
59980042|NCT03367403|76097107|FG001|NOT COMPLETED|Overall Study||33||
59980043|NCT03367403|76097108|FG002|NOT COMPLETED|Overall Study||3||
59980044|NCT02577146|76097116|FG000|STARTED|Overall Study||74||
59814680|NCT00434577|75937146|FG003|NOT COMPLETED|Months 0-3||1||
59814681|NCT00434577|75937147|FG004|NOT COMPLETED|Months 0-3||3||
59814682|NCT00434577|75937143|FG000|STARTED|Month 12||156||
59814683|NCT00434577|75937144|FG001|STARTED|Month 12||159||
59814684|NCT00434577|75937145|FG002|STARTED|Month 12||159||
59980045|NCT02577146|76097116|FG000|COMPLETED|Overall Study||46||
59980046|NCT02577146|76097116|FG000|NOT COMPLETED|Overall Study||28||
59980047|NCT00109967|76097122|FG000|STARTED|Overall Study||50||
59980048|NCT00109967|76097123|FG001|STARTED|Overall Study||21||
59980049|NCT00109967|76097122|FG000|COMPLETED|Overall Study||30||
59980050|NCT00109967|76097123|FG001|COMPLETED|Overall Study||15||
59980051|NCT00109967|76097122|FG000|NOT COMPLETED|Overall Study||20||
59980052|NCT00109967|76097123|FG001|NOT COMPLETED|Overall Study||6||
59980053|NCT02579096|76097131|FG000|STARTED|Phase 1, Weeks 0 - 24||468||
59980054|NCT02579096|76097132|FG001|STARTED|Phase 1, Weeks 0 - 24||472||
59980055|NCT02579096|76097131|FG000|COMPLETED|Phase 1, Weeks 0 - 24||411||
59980056|NCT02579096|76097132|FG001|COMPLETED|Phase 1, Weeks 0 - 24||422||
59980057|NCT02579096|76097131|FG000|NOT COMPLETED|Phase 1, Weeks 0 - 24||57||
59980058|NCT02579096|76097132|FG001|NOT COMPLETED|Phase 1, Weeks 0 - 24||50||
59980059|NCT02579096|76097131|FG000|STARTED|Phase 2, Weeks 25 - 48||411||
59980060|NCT02579096|76097132|FG001|STARTED|Phase 2, Weeks 25 - 48||422||
59980061|NCT02579096|76097131|FG000|COMPLETED|Phase 2, Weeks 25 - 48||389||
59980062|NCT02579096|76097132|FG001|COMPLETED|Phase 2, Weeks 25 - 48||391||
59980063|NCT02579096|76097131|FG000|NOT COMPLETED|Phase 2, Weeks 25 - 48||22||
59980064|NCT02579096|76097132|FG001|NOT COMPLETED|Phase 2, Weeks 25 - 48||31||
59980065|NCT02579096|76097131|FG000|STARTED|Phase 3, Weeks 49 - 72||389||
59980066|NCT02579096|76097132|FG001|STARTED|Phase 3, Weeks 49 - 72||391||
59980067|NCT02579096|76097131|FG000|COMPLETED|Phase 3, Weeks 49 - 72||367||
59980068|NCT02579096|76097132|FG001|COMPLETED|Phase 3, Weeks 49 - 72||373||
59980069|NCT02579096|76097131|FG000|NOT COMPLETED|Phase 3, Weeks 49 - 72||22||
59980070|NCT02579096|76097132|FG001|NOT COMPLETED|Phase 3, Weeks 49 - 72||18||
59980071|NCT02578940|76097138|FG000|STARTED|Overall Study||109||
59980072|NCT02578940|76097138|FG000|Received 18F-fluciclovine|Overall Study||104||
59980073|NCT02578940|76097138|FG000|COMPLETED|Overall Study||103||
59980074|NCT02578940|76097138|FG000|NOT COMPLETED|Overall Study||6||
59980075|NCT02578862|76097146|FG000|STARTED|Overall Study||37||
59814685|NCT00434577|75937146|FG003|STARTED|Month 12||161||
59814686|NCT00434577|75937147|FG004|STARTED|Month 12||50||
59814687|NCT00434577|75937143|FG000|COMPLETED|Month 12||156||
59980076|NCT02578862|76097147|FG001|STARTED|Overall Study||35||
59980077|NCT02578862|76097146|FG000|COMPLETED|Overall Study||37||
59980078|NCT02578862|76097147|FG001|COMPLETED|Overall Study||33||
59980079|NCT02578862|76097146|FG000|NOT COMPLETED|Overall Study||0||
59980080|NCT02578862|76097147|FG001|NOT COMPLETED|Overall Study||2||
59980081|NCT02578706|76097156|FG000|STARTED|Overall Study||9||
59980082|NCT02578706|76097157|FG001|STARTED|Overall Study||10||
59980083|NCT02578706|76097158|FG002|STARTED|Overall Study||8||
59980084|NCT02578706|76097156|FG000|COMPLETED|Overall Study||8||
59622479|NCT00428298|75734321|FG001|COMPLETED|Overall Study||19||
59622480|NCT00428298|75734320|FG000|NOT COMPLETED|Overall Study||14||
59622481|NCT00428298|75734321|FG001|NOT COMPLETED|Overall Study||11||
59622482|NCT00486018|75734332|FG000|STARTED|Overall Study||132||
59622483|NCT00486018|75734333|FG001|STARTED|Overall Study||134||
59622484|NCT00486018|75734334|FG002|STARTED|Overall Study||131||
59622485|NCT00486018|75734332|FG000|Received Drug (Safety Population)|Overall Study||131||
59622486|NCT00486018|75734333|FG001|Received Drug (Safety Population)|Overall Study||134||
59622487|NCT00486018|75734334|FG002|Received Drug (Safety Population)|Overall Study||130||
59622488|NCT00486018|75734332|FG000|COMPLETED|Overall Study||123||
59622489|NCT00486018|75734333|FG001|COMPLETED|Overall Study||128||
59622490|NCT00486018|75734334|FG002|COMPLETED|Overall Study||125||
59622491|NCT00486018|75734332|FG000|NOT COMPLETED|Overall Study||9||
59622492|NCT00486018|75734333|FG001|NOT COMPLETED|Overall Study||6||
59622493|NCT00486018|75734334|FG002|NOT COMPLETED|Overall Study||6||
59622494|NCT00486642|75734344|FG000|STARTED|Overall Study||10||
59622495|NCT00486642|75734345|FG001|STARTED|Overall Study||13||
59622496|NCT00486642|75734344|FG000|COMPLETED|Overall Study||10||
59622497|NCT00486642|75734345|FG001|COMPLETED|Overall Study||13||
59980085|NCT02578706|76097157|FG001|COMPLETED|Overall Study||5||
59980086|NCT02578706|76097158|FG002|COMPLETED|Overall Study||8||
59980087|NCT02578706|76097156|FG000|NOT COMPLETED|Overall Study||1||
59980088|NCT02578706|76097157|FG001|NOT COMPLETED|Overall Study||5||
59980089|NCT02578706|76097158|FG002|NOT COMPLETED|Overall Study||0||
59980090|NCT00108953|76097168|FG000|STARTED|Treatment Period|ITT population|47||
59980091|NCT00108953|76097169|FG001|STARTED|Treatment Period|ITT population|49||
59980092|NCT00108953|76097168|FG000|COMPLETED|Treatment Period|No patient under study medication anymore|47||
59980093|NCT00108953|76097169|FG001|COMPLETED|Treatment Period|No patient under study medication anymore|49||
59980094|NCT00108953|76097168|FG000|NOT COMPLETED|Treatment Period||0||
59980095|NCT00108953|76097169|FG001|NOT COMPLETED|Treatment Period||0||
59980096|NCT00108953|76097168|FG000|STARTED|Follow-up|40 out of 47 patients were followed after end of double blind treatment|40||
59980097|NCT00108953|76097169|FG001|STARTED|Follow-up|45 out of 49 patients were followed after end of double blind treatment|45||
59980098|NCT00108953|76097168|FG000|COMPLETED|Follow-up||11||
59622498|NCT00486642|75734344|FG000|NOT COMPLETED|Overall Study||0||
59814688|NCT00434577|75937144|FG001|COMPLETED|Month 12||159||
59814689|NCT00434577|75937145|FG002|COMPLETED|Month 12||159||
59980099|NCT00108953|76097169|FG001|COMPLETED|Follow-up||12||
59980100|NCT00108953|76097168|FG000|NOT COMPLETED|Follow-up||29||
59980101|NCT00108953|76097169|FG001|NOT COMPLETED|Follow-up||33||
59980102|NCT02578316|76097177|FG000|STARTED|Study Phase||6||
59980103|NCT02578316|76097177|FG000|COMPLETED|Study Phase||6||
59980104|NCT02578316|76097177|FG000|NOT COMPLETED|Study Phase||0||
59980105|NCT02578316|76097177|FG000|STARTED|Extension Phase||6||
59980106|NCT02578316|76097177|FG000|COMPLETED|Extension Phase||0||
59980107|NCT02578316|76097177|FG000|NOT COMPLETED|Extension Phase||6||
59980108|NCT02576678|76097188|FG000|STARTED|Overall Study||13||
59980109|NCT02576678|76097189|FG001|STARTED|Overall Study||8||
59980110|NCT02576678|76097190|FG002|STARTED|Overall Study||21||
59980111|NCT02576678|76097188|FG000|Pharmacokinetic (PK) Population|Overall Study||12|PK participants had at least 1 dose of drug and had evaluable PK data|
59980112|NCT02576678|76097189|FG001|Pharmacokinetic (PK) Population|Overall Study||8|PK participants had at least 1 dose of drug and had evaluable PK data|
59980113|NCT02576678|76097190|FG002|Pharmacokinetic (PK) Population|Overall Study||18|PK participants had at least 1 dose of drug and had evaluable PK data|
59980114|NCT02576678|76097188|FG000|COMPLETED|Overall Study||8|Completed = participants who completed week 50.|
59980115|NCT02576678|76097189|FG001|COMPLETED|Overall Study||7|Completed = participants who completed week 50.|
59980116|NCT02576678|76097190|FG002|COMPLETED|Overall Study||16|Completed = participants who completed week 50.|
59980117|NCT02576678|76097188|FG000|NOT COMPLETED|Overall Study||5||
59980118|NCT02576678|76097189|FG001|NOT COMPLETED|Overall Study||1||
59980119|NCT02576678|76097190|FG002|NOT COMPLETED|Overall Study||5||
59980120|NCT00108745|76097201|FG000|STARTED|Overall Study||387||
59980121|NCT00108745|76097202|FG001|STARTED|Overall Study||384||
59980122|NCT00108745|76097203|FG002|STARTED|Overall Study||386||
59980123|NCT00108745|76097201|FG000|COMPLETED|Overall Study||353||
59980124|NCT00108745|76097202|FG001|COMPLETED|Overall Study||349||
59980125|NCT00108745|76097203|FG002|COMPLETED|Overall Study||349||
59980126|NCT00108745|76097201|FG000|NOT COMPLETED|Overall Study||34||
59980127|NCT00108745|76097202|FG001|NOT COMPLETED|Overall Study||35||
59980128|NCT00108745|76097203|FG002|NOT COMPLETED|Overall Study||37||
59980129|NCT02098343|76097216|FG000|STARTED|Overall Study||9||
59980130|NCT02098343|76097217|FG001|STARTED|Overall Study||6||
59980131|NCT02098343|76097218|FG002|STARTED|Overall Study||21||
59980132|NCT02098343|76097219|FG003|STARTED|Overall Study||105||
59980133|NCT02098343|76097220|FG004|STARTED|Overall Study||106||
59980134|NCT02098343|76097216|FG000|COMPLETED|Overall Study||9||
59980135|NCT02098343|76097217|FG001|COMPLETED|Overall Study||6||
59980136|NCT02098343|76097218|FG002|COMPLETED|Overall Study||20||
59980137|NCT02098343|76097219|FG003|COMPLETED|Overall Study||105||
59980138|NCT02098343|76097220|FG004|COMPLETED|Overall Study||106||
59980139|NCT02098343|76097216|FG000|NOT COMPLETED|Overall Study||0||
59980140|NCT02098343|76097217|FG001|NOT COMPLETED|Overall Study||0||
59980141|NCT02098343|76097218|FG002|NOT COMPLETED|Overall Study||1||
59980142|NCT02098343|76097219|FG003|NOT COMPLETED|Overall Study||0||
59980143|NCT02098343|76097220|FG004|NOT COMPLETED|Overall Study||0||
59526449|NCT01411501|75622083|FG003|NOT COMPLETED|Overall Study||7||
59526450|NCT01309867|75622093|FG000|STARTED|Overall Study||151||
59980144|NCT02716805|76097233|FG000|STARTED|Overall Study||6||
59980145|NCT02716805|76097234|FG001|STARTED|Overall Study||0||
59980146|NCT02716805|76097235|FG002|STARTED|Overall Study||0||
59980147|NCT02716805|76097236|FG003|STARTED|Overall Study||0||
59980148|NCT02716805|76097233|FG000|COMPLETED|Overall Study||4||
59980149|NCT02716805|76097234|FG001|COMPLETED|Overall Study||0||
59980150|NCT02716805|76097235|FG002|COMPLETED|Overall Study||0||
59980151|NCT02716805|76097236|FG003|COMPLETED|Overall Study||0||
59526451|NCT01309867|75622094|FG001|STARTED|Overall Study||151||
59526452|NCT01309867|75622093|FG000|COMPLETED|Overall Study||148||
59526453|NCT01309867|75622094|FG001|COMPLETED|Overall Study||139||
59526454|NCT01309867|75622093|FG000|NOT COMPLETED|Overall Study||3||
59526455|NCT01309867|75622094|FG001|NOT COMPLETED|Overall Study||12||
59980152|NCT02716805|76097233|FG000|NOT COMPLETED|Overall Study||2||
59980153|NCT02716805|76097234|FG001|NOT COMPLETED|Overall Study||0||
59980154|NCT02716805|76097235|FG002|NOT COMPLETED|Overall Study||0||
59980155|NCT02716805|76097236|FG003|NOT COMPLETED|Overall Study||0||
59980156|NCT02581982|76097240|FG000|STARTED|Overall Study||27||
59980157|NCT02581982|76097240|FG000|COMPLETED|Overall Study||11||
59980158|NCT02581982|76097240|FG000|NOT COMPLETED|Overall Study||16||
59980159|NCT05853185|76097246|FG000|STARTED|Overall Study||32||
59980160|NCT05853185|76097247|FG001|STARTED|Overall Study||32||
59980161|NCT05853185|76097246|FG000|COMPLETED|Overall Study||32||
59980162|NCT05853185|76097247|FG001|COMPLETED|Overall Study||32||
59980163|NCT05853185|76097246|FG000|NOT COMPLETED|Overall Study||0||
59980164|NCT05853185|76097247|FG001|NOT COMPLETED|Overall Study||0||
59980165|NCT05607147|76097253|FG000|STARTED|Overall Study||10||
59980166|NCT05607147|76097253|FG000|COMPLETED|Overall Study||10||
59980167|NCT05607147|76097253|FG000|NOT COMPLETED|Overall Study||0||
59980168|NCT04830514|76097261|FG000|STARTED|Overall Study||18||
59980169|NCT04830514|76097262|FG001|STARTED|Overall Study||14||
59980170|NCT04830514|76097263|FG002|STARTED|Overall Study||12||
59526456|NCT01357525|75622100|FG000|STARTED|Overall Study||50||
59526457|NCT01357525|75622100|FG000|COMPLETED|Overall Study||49|Participant underwent surgery but did not receive SBRT.|
59980171|NCT04830514|76097261|FG000|COMPLETED|Overall Study||10||
59980172|NCT04830514|76097262|FG001|COMPLETED|Overall Study||11||
59980173|NCT04830514|76097263|FG002|COMPLETED|Overall Study||9||
59980174|NCT04830514|76097261|FG000|NOT COMPLETED|Overall Study||8||
59980175|NCT04830514|76097262|FG001|NOT COMPLETED|Overall Study||3||
59980176|NCT04830514|76097263|FG002|NOT COMPLETED|Overall Study||3||
59980177|NCT04784182|76097273|FG000|STARTED|Overall Study||1||
59980178|NCT04784182|76097274|FG001|STARTED|Overall Study||2||
59980179|NCT04784182|76097273|FG000|COMPLETED|Overall Study||1||
59980180|NCT04784182|76097274|FG001|COMPLETED|Overall Study||2||
59980181|NCT04784182|76097273|FG000|NOT COMPLETED|Overall Study||0||
59980182|NCT04784182|76097274|FG001|NOT COMPLETED|Overall Study||0||
59980183|NCT04362111|76097282|FG000|STARTED|Overall Study||15||
59980184|NCT04362111|76097283|FG001|STARTED|Overall Study|Two patients randomized to the placebo group withdrew within 48 hours of enrollment/randomization. An additional two subjects were enrolled and assigned to the placebo group to balance the treatment groups with regard to participants completing the study. The investigators were blinded as to which group(s) the two subjects withdrawing consent had been randomized to.|17||
59980185|NCT04362111|76097282|FG000|COMPLETED|Overall Study||15||
59980186|NCT04362111|76097283|FG001|COMPLETED|Overall Study||15||
59980187|NCT04362111|76097282|FG000|NOT COMPLETED|Overall Study||0||
59980188|NCT04362111|76097283|FG001|NOT COMPLETED|Overall Study||2||
59980189|NCT04318132|76097294|FG000|STARTED|Overall Study||45||45
59980190|NCT04318132|76097295|FG001|STARTED|Overall Study||47||47
59980191|NCT04318132|76097296|FG002|STARTED|Overall Study||46||46
59980192|NCT04318132|76097297|FG003|STARTED|Overall Study||32||32
59980193|NCT04318132|76097294|FG000|COMPLETED|Overall Study||45||45
59980194|NCT04318132|76097295|FG001|COMPLETED|Overall Study||47||47
59980195|NCT04318132|76097296|FG002|COMPLETED|Overall Study||43||43
59980196|NCT04318132|76097297|FG003|COMPLETED|Overall Study||32||32
59980197|NCT04318132|76097294|FG000|NOT COMPLETED|Overall Study||0||0
59980198|NCT04318132|76097295|FG001|NOT COMPLETED|Overall Study||0||0
59980199|NCT04318132|76097296|FG002|NOT COMPLETED|Overall Study||3||3
59980200|NCT04318132|76097297|FG003|NOT COMPLETED|Overall Study||0||0
59980201|NCT04271254|76097313|FG000|STARTED|Overall Study||5||
59980202|NCT04271254|76097313|FG000|COMPLETED|Overall Study||2||
59980203|NCT04271254|76097313|FG000|NOT COMPLETED|Overall Study||3||
59980204|NCT04146935|76097317|FG000|STARTED|Overall Study||10||
59980205|NCT04146935|76097317|FG000|COMPLETED|Overall Study||10||
59980206|NCT04146935|76097317|FG000|NOT COMPLETED|Overall Study||0||
59980207|NCT03970837|76097333|FG000|STARTED|Overall Study||545|All randomized participants who received at least one dose of study treatment. This population will be based on the treatment the participant was randomized to.|
59980208|NCT03970837|76097334|FG001|STARTED|Overall Study||539|All randomized participants who received at least one dose of study treatment. This population will be based on the treatment the participant was randomized to.|
59980209|NCT03970837|76097335|FG002|STARTED|Overall Study||271|All randomized participants who received at least one dose of study treatment. This population will be based on the treatment the participant was randomized to.|
59980210|NCT03970837|76097336|FG003|STARTED|Overall Study||91|All randomized participants who received at least one dose of study treatment. This population will be based on the treatment the participant was randomized to.|
59980211|NCT03970837|76097337|FG004|STARTED|Overall Study||89|All randomized participants who received at least one dose of study treatment. This population will be based on the treatment the participant was randomized to.|
59980212|NCT03970837|76097338|FG005|STARTED|Overall Study||90|All randomized participants who received at least one dose of study treatment. This population will be based on the treatment the participant was randomized to.|
59980213|NCT03970837|76097339|FG006|STARTED|Overall Study||47|All randomized participants who received at least one dose of study treatment. This population will be based on the treatment the participant was randomized to.|
59980214|NCT03970837|76097340|FG007|STARTED|Overall Study||49|All randomized participants who received at least one dose of study treatment. This population will be based on the treatment the participant was randomized to.|
59980215|NCT03970837|76097341|FG008|STARTED|Overall Study||19|All randomized participants who received at least one dose of study treatment. This population will be based on the treatment the participant was randomized to.|
59980216|NCT03970837|76097342|FG009|STARTED|Overall Study||6|All randomized participants who received at least one dose of study treatment. This population will be based on the treatment the participant was randomized to.|
59980217|NCT03970837|76097343|FG010|STARTED|Overall Study||8|All randomized participants who received at least one dose of study treatment. This population will be based on the treatment the participant was randomized to.|
59980218|NCT03970837|76097344|FG011|STARTED|Overall Study||9|All randomized participants who received at least one dose of study treatment. This population will be based on the treatment the participant was randomized to.|
59980219|NCT03970837|76097333|FG000|Safety Set|Overall Study||545|All randomized participants who received at least one dose of study treatment. This population will be based on the treatment the participants actually received.|
59980220|NCT03970837|76097334|FG001|Safety Set|Overall Study||539|All randomized participants who received at least one dose of study treatment. This population will be based on the treatment the participants actually received.|
59994992|NCT02730871|76110830|FG000|STARTED|Overall Study||67|All randomized subjects|
59994993|NCT02730871|76110831|FG001|STARTED|Overall Study||67|All randomized subjects|
59994994|NCT02730871|76110830|FG000|Full Analysis Set (FAS)|Overall Study||67|Randomized subjects with a baseline assessment who completed at least 1 scheduled on-therapy visit|
59994995|NCT02730871|76110831|FG001|Full Analysis Set (FAS)|Overall Study||67|Randomized subjects with a baseline assessment who completed at least 1 scheduled on-therapy visit|
60074789|NCT01930045|76190107|FG004|STARTED|Part 1 - Period 1||3||
59980221|NCT03970837|76097335|FG002|Safety Set|Overall Study||286|All randomized participants who received at least one dose of study treatment. This population will be based on the treatment the participants actually received.|
59980222|NCT03970837|76097336|FG003|Safety Set|Overall Study||0|All randomized participants who received at least one dose of study treatment. This population will be based on the treatment the participants actually received.|
59980223|NCT03970837|76097337|FG004|Safety Set|Overall Study||0|All randomized participants who received at least one dose of study treatment. This population will be based on the treatment the participants actually received.|
59980224|NCT03970837|76097338|FG005|Safety Set|Overall Study||0|All randomized participants who received at least one dose of study treatment. This population will be based on the treatment the participants actually received.|
59980225|NCT03970837|76097339|FG006|Safety Set|Overall Study||47|All randomized participants who received at least one dose of study treatment. This population will be based on the treatment the participants actually received.|
59980226|NCT03970837|76097340|FG007|Safety Set|Overall Study||49|All randomized participants who received at least one dose of study treatment. This population will be based on the treatment the participants actually received.|
59980227|NCT03970837|76097341|FG008|Safety Set|Overall Study||19|All randomized participants who received at least one dose of study treatment. This population will be based on the treatment the participants actually received.|
59980228|NCT03970837|76097342|FG009|Safety Set|Overall Study||0|All randomized participants who received at least one dose of study treatment. This population will be based on the treatment the participants actually received.|
59980229|NCT03970837|76097343|FG010|Safety Set|Overall Study||0|All randomized participants who received at least one dose of study treatment. This population will be based on the treatment the participants actually received.|
59814690|NCT00434577|75937146|FG003|COMPLETED|Month 12||161||
59814691|NCT00434577|75937147|FG004|COMPLETED|Month 12||50||
59814692|NCT00434577|75937143|FG000|NOT COMPLETED|Month 12||0||
59814693|NCT00434577|75937144|FG001|NOT COMPLETED|Month 12||0||
59814694|NCT00434577|75937145|FG002|NOT COMPLETED|Month 12||0||
59814695|NCT00434577|75937146|FG003|NOT COMPLETED|Month 12||0||
59814696|NCT00434577|75937147|FG004|NOT COMPLETED|Month 12||0||
59980230|NCT03970837|76097344|FG011|Safety Set|Overall Study||0|All randomized participants who received at least one dose of study treatment. This population will be based on the treatment the participants actually received.|
59980231|NCT03970837|76097333|FG000|Safety Set-Placebo Switch|Overall Study||0|All participants randomized to a placebo switch treatment arm (i.e. Placebo to GSK3196165 90mg, Placebo to GSK3196165 150mg or Placebo to Tofacitinib 5mg) who received at least one dose of study treatment after Week 12.|
59980232|NCT03970837|76097334|FG001|Safety Set-Placebo Switch|Overall Study||0|All participants randomized to a placebo switch treatment arm (i.e. Placebo to GSK3196165 90mg, Placebo to GSK3196165 150mg or Placebo to Tofacitinib 5mg) who received at least one dose of study treatment after Week 12.|
59980233|NCT03970837|76097335|FG002|Safety Set-Placebo Switch|Overall Study||0|All participants randomized to a placebo switch treatment arm (i.e. Placebo to GSK3196165 90mg, Placebo to GSK3196165 150mg or Placebo to Tofacitinib 5mg) who received at least one dose of study treatment after Week 12.|
59980234|NCT03970837|76097336|FG003|Safety Set-Placebo Switch|Overall Study||85|All participants randomized to a placebo switch treatment arm (i.e. Placebo to GSK3196165 90mg, Placebo to GSK3196165 150mg or Placebo to Tofacitinib 5mg) who received at least one dose of study treatment after Week 12.|
59980235|NCT03970837|76097337|FG004|Safety Set-Placebo Switch|Overall Study||80|All participants randomized to a placebo switch treatment arm (i.e. Placebo to GSK3196165 90mg, Placebo to GSK3196165 150mg or Placebo to Tofacitinib 5mg) who received at least one dose of study treatment after Week 12.|
59980236|NCT03970837|76097338|FG005|Safety Set-Placebo Switch|Overall Study||67|All participants randomized to a placebo switch treatment arm (i.e. Placebo to GSK3196165 90mg, Placebo to GSK3196165 150mg or Placebo to Tofacitinib 5mg) who received at least one dose of study treatment after Week 12.|
59980237|NCT03970837|76097339|FG006|Safety Set-Placebo Switch|Overall Study||0|All participants randomized to a placebo switch treatment arm (i.e. Placebo to GSK3196165 90mg, Placebo to GSK3196165 150mg or Placebo to Tofacitinib 5mg) who received at least one dose of study treatment after Week 12.|
59980238|NCT03970837|76097340|FG007|Safety Set-Placebo Switch|Overall Study||0|All participants randomized to a placebo switch treatment arm (i.e. Placebo to GSK3196165 90mg, Placebo to GSK3196165 150mg or Placebo to Tofacitinib 5mg) who received at least one dose of study treatment after Week 12.|
59994996|NCT02730871|76110830|FG000|Safety Analysis Set|Overall Study||67|All subjects who received a dose of masked investigational product|
60074790|NCT01930045|76190108|FG005|STARTED|Part 1 - Period 1||3||
59814697|NCT00434577|75937143|FG000|STARTED|Month 24||150||
59814698|NCT00434577|75937144|FG001|STARTED|Month 24||155||
59814699|NCT00434577|75937145|FG002|STARTED|Month 24||154||
59814700|NCT00434577|75937146|FG003|STARTED|Month 24||157||
59814701|NCT00434577|75937147|FG004|STARTED|Month 24||49||
59814702|NCT00434577|75937143|FG000|COMPLETED|Month 24||150||
59814703|NCT00434577|75937144|FG001|COMPLETED|Month 24||155||
59814704|NCT00434577|75937145|FG002|COMPLETED|Month 24||154||
59814705|NCT00434577|75937146|FG003|COMPLETED|Month 24||157||
59814706|NCT00434577|75937147|FG004|COMPLETED|Month 24||49||
59814707|NCT00434577|75937143|FG000|NOT COMPLETED|Month 24||0||
59814708|NCT00434577|75937144|FG001|NOT COMPLETED|Month 24||0||
59814709|NCT00434577|75937145|FG002|NOT COMPLETED|Month 24||0||
59814710|NCT00434577|75937146|FG003|NOT COMPLETED|Month 24||0||
59814711|NCT00434577|75937147|FG004|NOT COMPLETED|Month 24||0||
59814712|NCT00434577|75937143|FG000|STARTED|Month 36||147||
59814713|NCT00434577|75937144|FG001|STARTED|Month 36||147||
59814714|NCT00434577|75937145|FG002|STARTED|Month 36||150||
59814715|NCT00434577|75937146|FG003|STARTED|Month 36||155||
59814716|NCT00434577|75937147|FG004|STARTED|Month 36||47||
59814717|NCT00434577|75937143|FG000|COMPLETED|Month 36||147||
59980239|NCT03970837|76097341|FG008|Safety Set-Placebo Switch|Overall Study||0|All participants randomized to a placebo switch treatment arm (i.e. Placebo to GSK3196165 90mg, Placebo to GSK3196165 150mg or Placebo to Tofacitinib 5mg) who received at least one dose of study treatment after Week 12.|
59980240|NCT03970837|76097342|FG009|Safety Set-Placebo Switch|Overall Study||6|All participants randomized to a placebo switch treatment arm (i.e. Placebo to GSK3196165 90mg, Placebo to GSK3196165 150mg or Placebo to Tofacitinib 5mg) who received at least one dose of study treatment after Week 12.|
59980241|NCT03970837|76097343|FG010|Safety Set-Placebo Switch|Overall Study||8|All participants randomized to a placebo switch treatment arm (i.e. Placebo to GSK3196165 90mg, Placebo to GSK3196165 150mg or Placebo to Tofacitinib 5mg) who received at least one dose of study treatment after Week 12.|
59980242|NCT03970837|76097344|FG011|Safety Set-Placebo Switch|Overall Study||8|All participants randomized to a placebo switch treatment arm (i.e. Placebo to GSK3196165 90mg, Placebo to GSK3196165 150mg or Placebo to Tofacitinib 5mg) who received at least one dose of study treatment after Week 12.|
59980243|NCT03970837|76097333|FG000|COMPLETED|Overall Study||461||
59980244|NCT03970837|76097334|FG001|COMPLETED|Overall Study||447||
59980245|NCT03970837|76097335|FG002|COMPLETED|Overall Study||231||
59980246|NCT03970837|76097336|FG003|COMPLETED|Overall Study||73||
59980247|NCT03970837|76097337|FG004|COMPLETED|Overall Study||69||
59980248|NCT03970837|76097338|FG005|COMPLETED|Overall Study||68||
59980249|NCT03970837|76097339|FG006|COMPLETED|Overall Study||25||
59980250|NCT03970837|76097340|FG007|COMPLETED|Overall Study||23||
59980251|NCT03970837|76097341|FG008|COMPLETED|Overall Study||15||
59980252|NCT03970837|76097342|FG009|COMPLETED|Overall Study||4||
59980253|NCT03970837|76097343|FG010|COMPLETED|Overall Study||5||
59980254|NCT03970837|76097344|FG011|COMPLETED|Overall Study||4||
59980255|NCT03970837|76097333|FG000|NOT COMPLETED|Overall Study||84||
59980256|NCT03970837|76097334|FG001|NOT COMPLETED|Overall Study||92||
59980257|NCT03970837|76097335|FG002|NOT COMPLETED|Overall Study||40||
59980258|NCT03970837|76097336|FG003|NOT COMPLETED|Overall Study||18||
59980259|NCT03970837|76097337|FG004|NOT COMPLETED|Overall Study||20||
59980260|NCT03970837|76097338|FG005|NOT COMPLETED|Overall Study||22||
59980261|NCT03970837|76097339|FG006|NOT COMPLETED|Overall Study||22||
59980262|NCT03970837|76097340|FG007|NOT COMPLETED|Overall Study||26||
59980263|NCT03970837|76097341|FG008|NOT COMPLETED|Overall Study||4||
59980264|NCT03970837|76097342|FG009|NOT COMPLETED|Overall Study||2||
59980265|NCT03970837|76097343|FG010|NOT COMPLETED|Overall Study||3||
59980266|NCT03970837|76097344|FG011|NOT COMPLETED|Overall Study||5||
59980267|NCT03945357|76097389|FG000|STARTED|Overall Study||124||
59980268|NCT03945357|76097390|FG001|STARTED|Overall Study||126||
59980269|NCT03945357|76097389|FG000|COMPLETED|Overall Study||121||
59980270|NCT03945357|76097390|FG001|COMPLETED|Overall Study||120||
59980271|NCT03945357|76097389|FG000|NOT COMPLETED|Overall Study||3||
59980272|NCT03945357|76097390|FG001|NOT COMPLETED|Overall Study||6||
59980273|NCT03938636|76097399|FG000|STARTED|Overall Study||44||
59980274|NCT03938636|76097400|FG001|STARTED|Overall Study||41||
59980275|NCT03938636|76097401|FG002|STARTED|Overall Study||31||
59980276|NCT03938636|76097399|FG000|COMPLETED|Overall Study|15 Arm 1 subjects were deemed non-evaluable due to image acquisition and image quality deviations.|44||
59980277|NCT03938636|76097400|FG001|COMPLETED|Overall Study||38||
59980278|NCT03938636|76097401|FG002|COMPLETED|Overall Study||28||
59980279|NCT03938636|76097399|FG000|NOT COMPLETED|Overall Study||0||
59980280|NCT03938636|76097400|FG001|NOT COMPLETED|Overall Study||3||
59980281|NCT03938636|76097401|FG002|NOT COMPLETED|Overall Study||3||
59980282|NCT03896009|76097415|FG000|STARTED|Overall Study||456||
59980283|NCT03896009|76097416|FG001|STARTED|Overall Study||455||
59980284|NCT03896009|76097417|FG002|STARTED|Overall Study||456||
59980285|NCT03896009|76097418|FG003|STARTED|Overall Study||227||
59980286|NCT03896009|76097415|FG000|COMPLETED|Overall Study||441||
59980287|NCT03896009|76097416|FG001|COMPLETED|Overall Study||433||
59980288|NCT03896009|76097417|FG002|COMPLETED|Overall Study||434||
59980289|NCT03896009|76097418|FG003|COMPLETED|Overall Study||218||
59526458|NCT01357525|75622100|FG000|NOT COMPLETED|Overall Study||1||
59526459|NCT01310179|75622104|FG000|STARTED|Overall Study||12||
59526460|NCT01310179|75622104|FG000|COMPLETED|Overall Study||12||
59526461|NCT01310179|75622104|FG000|NOT COMPLETED|Overall Study||0||
59526462|NCT01412281|75622112|FG000|STARTED|Overall Study||110||
59526463|NCT01412281|75622113|FG001|STARTED|Overall Study||110||
59526464|NCT01412281|75622114|FG002|STARTED|Overall Study||110||
59526465|NCT01412281|75622115|FG003|STARTED|Overall Study||110||
59526466|NCT01412281|75622112|FG000|COMPLETED|Overall Study||110||
59526467|NCT01412281|75622113|FG001|COMPLETED|Overall Study||110||
59526468|NCT01412281|75622114|FG002|COMPLETED|Overall Study||110||
59980290|NCT03896009|76097415|FG000|NOT COMPLETED|Overall Study||15||
59980291|NCT03896009|76097416|FG001|NOT COMPLETED|Overall Study||22||
59980292|NCT03896009|76097417|FG002|NOT COMPLETED|Overall Study||22||
59980293|NCT03896009|76097418|FG003|NOT COMPLETED|Overall Study||9||
59980294|NCT03836716|76097426|FG000|STARTED|Overall Study||120||
59980295|NCT03836716|76097426|FG000|COMPLETED|Overall Study||0||
60074791|NCT01930045|76190103|FG000|COMPLETED|Part 1 - Period 1||3||
59526469|NCT01412281|75622115|FG003|COMPLETED|Overall Study||110||
59526470|NCT01412281|75622112|FG000|NOT COMPLETED|Overall Study||0||
59526471|NCT01412281|75622113|FG001|NOT COMPLETED|Overall Study||0||
59526472|NCT01412281|75622114|FG002|NOT COMPLETED|Overall Study||0||
59526473|NCT01412281|75622115|FG003|NOT COMPLETED|Overall Study||0||
59980296|NCT03836716|76097426|FG000|NOT COMPLETED|Overall Study||120||
59980297|NCT03686215|76097433|FG000|STARTED|Overall Study||357||
59980298|NCT03686215|76097434|FG001|STARTED|Overall Study||35||
59980299|NCT03686215|76097435|FG002|STARTED|Overall Study||14||
59980300|NCT03686215|76097433|FG000|COMPLETED|Overall Study||356||
59980301|NCT03686215|76097434|FG001|COMPLETED|Overall Study||35||
59980302|NCT03686215|76097435|FG002|COMPLETED|Overall Study||0||
59980303|NCT03686215|76097433|FG000|NOT COMPLETED|Overall Study||1||
59980304|NCT03686215|76097434|FG001|NOT COMPLETED|Overall Study||0||
59980305|NCT03686215|76097435|FG002|NOT COMPLETED|Overall Study||14||
59980306|NCT03665077|76097443|FG000|STARTED|Overall Study||28||
59980307|NCT03665077|76097443|FG000|3 Months Blood Draw|Overall Study||22||
59980308|NCT03665077|76097443|FG000|6 Months Blood Draw|Overall Study||24||
59980309|NCT03665077|76097443|FG000|COMPLETED|Overall Study||24||
59980310|NCT03665077|76097443|FG000|NOT COMPLETED|Overall Study||4||
59980311|NCT03606174|76097458|FG000|STARTED|Overall Study||49||
59980312|NCT03606174|76097459|FG001|STARTED|Overall Study||23||
59980313|NCT03606174|76097460|FG002|STARTED|Overall Study||18||
59980314|NCT03606174|76097461|FG003|STARTED|Overall Study||9||
59980315|NCT03606174|76097462|FG004|STARTED|Overall Study||53||
59980316|NCT03606174|76097463|FG005|STARTED|Overall Study||27||
59980317|NCT03606174|76097464|FG006|STARTED|Overall Study||56||
59980318|NCT03606174|76097465|FG007|STARTED|Overall Study||9||
59980319|NCT03606174|76097466|FG008|STARTED|Overall Study||8||
59980320|NCT03606174|76097467|FG009|STARTED|Overall Study||4||
59980321|NCT03606174|76097468|FG010|STARTED|Overall Study||4||
59980322|NCT03606174|76097458|FG000|Started Cohort 9 Lead-in Dose-escalation Part|Overall Study|N/A for Cohorts 1-8|0||
59980323|NCT03606174|76097459|FG001|Started Cohort 9 Lead-in Dose-escalation Part|Overall Study|N/A for Cohorts 1-8|0||
59980324|NCT03606174|76097460|FG002|Started Cohort 9 Lead-in Dose-escalation Part|Overall Study|N/A for Cohorts 1-8|0||
59980325|NCT03606174|76097461|FG003|Started Cohort 9 Lead-in Dose-escalation Part|Overall Study|N/A for Cohorts 1-8|0||
59980326|NCT03606174|76097462|FG004|Started Cohort 9 Lead-in Dose-escalation Part|Overall Study|N/A for Cohorts 1-8|0||
59980327|NCT03606174|76097463|FG005|Started Cohort 9 Lead-in Dose-escalation Part|Overall Study|N/A for Cohorts 1-8|0||
59980328|NCT03606174|76097464|FG006|Started Cohort 9 Lead-in Dose-escalation Part|Overall Study|N/A for Cohorts 1-8|0||
59980329|NCT03606174|76097465|FG007|Started Cohort 9 Lead-in Dose-escalation Part|Overall Study|N/A for Cohorts 1-8|0||
59980330|NCT03606174|76097466|FG008|Started Cohort 9 Lead-in Dose-escalation Part|Overall Study||8||
59980331|NCT03606174|76097467|FG009|Started Cohort 9 Lead-in Dose-escalation Part|Overall Study||4||
59980332|NCT03606174|76097468|FG010|Started Cohort 9 Lead-in Dose-escalation Part|Overall Study||4||
59980333|NCT03606174|76097458|FG000|Started Cohort 9 Dose-expansion Part|Overall Study|N/A for Cohorts 1-8|0||
59980334|NCT03606174|76097459|FG001|Started Cohort 9 Dose-expansion Part|Overall Study|N/A for Cohorts 1-8|0||
59980335|NCT03606174|76097460|FG002|Started Cohort 9 Dose-expansion Part|Overall Study|N/A for Cohorts 1-8|0||
59980336|NCT03606174|76097461|FG003|Started Cohort 9 Dose-expansion Part|Overall Study|N/A for Cohorts 1-8|0||
59980337|NCT03606174|76097462|FG004|Started Cohort 9 Dose-expansion Part|Overall Study|N/A for Cohorts 1-8|0||
59980338|NCT03606174|76097463|FG005|Started Cohort 9 Dose-expansion Part|Overall Study|N/A for Cohorts 1-8|0||
59980339|NCT03606174|76097464|FG006|Started Cohort 9 Dose-expansion Part|Overall Study|N/A for Cohorts 1-8|0||
59980340|NCT03606174|76097465|FG007|Started Cohort 9 Dose-expansion Part|Overall Study|N/A for Cohorts 1-8|0||
59980341|NCT03606174|76097466|FG008|Started Cohort 9 Dose-expansion Part|Overall Study||0||
59980342|NCT03606174|76097467|FG009|Started Cohort 9 Dose-expansion Part|Overall Study||0||
59980343|NCT03606174|76097468|FG010|Started Cohort 9 Dose-expansion Part|Overall Study||0||
59980344|NCT03606174|76097458|FG000|COMPLETED|Overall Study||0||
59980345|NCT03606174|76097459|FG001|COMPLETED|Overall Study||0||
59980346|NCT03606174|76097460|FG002|COMPLETED|Overall Study||0||
59980347|NCT03606174|76097461|FG003|COMPLETED|Overall Study||0||
59980348|NCT03606174|76097462|FG004|COMPLETED|Overall Study||0||
59980349|NCT03606174|76097463|FG005|COMPLETED|Overall Study||0||
59980350|NCT03606174|76097464|FG006|COMPLETED|Overall Study||0||
59980351|NCT03606174|76097465|FG007|COMPLETED|Overall Study||0||
59980352|NCT03606174|76097466|FG008|COMPLETED|Overall Study||0||
59980353|NCT03606174|76097467|FG009|COMPLETED|Overall Study||0||
59980354|NCT03606174|76097468|FG010|COMPLETED|Overall Study||0||
59980355|NCT03606174|76097458|FG000|NOT COMPLETED|Overall Study||49||
59980356|NCT03606174|76097459|FG001|NOT COMPLETED|Overall Study||23||
59622499|NCT00486642|75734345|FG001|NOT COMPLETED|Overall Study||0||
59980357|NCT03606174|76097460|FG002|NOT COMPLETED|Overall Study||18||
59980358|NCT03606174|76097461|FG003|NOT COMPLETED|Overall Study||9||
59980359|NCT03606174|76097462|FG004|NOT COMPLETED|Overall Study||53||
59980360|NCT03606174|76097463|FG005|NOT COMPLETED|Overall Study||27||
59980361|NCT03606174|76097464|FG006|NOT COMPLETED|Overall Study||56||
60074792|NCT01930045|76190104|FG001|COMPLETED|Part 1 - Period 1||3||
59622500|NCT00428922|75734353|FG000|STARTED|Overall Study||26||
59622501|NCT00428922|75734353|FG000|COMPLETED|Overall Study||26||
59622502|NCT00428922|75734353|FG000|NOT COMPLETED|Overall Study||0||
59622503|NCT00533442|75734359|FG000|STARTED|Allocation and Intent to Treat Analysis||86||
59622504|NCT00533442|75734360|FG001|STARTED|Allocation and Intent to Treat Analysis||84||
59622505|NCT00533442|75734359|FG000|COMPLETED|Allocation and Intent to Treat Analysis||86||
60074793|NCT01930045|76190105|FG002|COMPLETED|Part 1 - Period 1||3||
59814718|NCT00434577|75937144|FG001|COMPLETED|Month 36||147||
59814719|NCT00434577|75937145|FG002|COMPLETED|Month 36||150||
59814720|NCT00434577|75937146|FG003|COMPLETED|Month 36||155||
59814721|NCT00434577|75937147|FG004|COMPLETED|Month 36||47||
59814722|NCT00434577|75937143|FG000|NOT COMPLETED|Month 36||0||
59814723|NCT00434577|75937144|FG001|NOT COMPLETED|Month 36||0||
59814724|NCT00434577|75937145|FG002|NOT COMPLETED|Month 36||0||
59814725|NCT00434577|75937146|FG003|NOT COMPLETED|Month 36||0||
59814726|NCT00434577|75937147|FG004|NOT COMPLETED|Month 36||0||
59814727|NCT00434421|75937159|FG000|STARTED|Overall Study||28||
59814728|NCT00434421|75937159|FG000|COMPLETED|Overall Study||26||
59814729|NCT00434421|75937159|FG000|NOT COMPLETED|Overall Study||2||
59814730|NCT00421707|75937165|FG000|STARTED|Period 1: Treatment Period 1||67||
59814731|NCT00421707|75937166|FG001|STARTED|Period 1: Treatment Period 1||65||
59814732|NCT00421707|75937165|FG000|COMPLETED|Period 1: Treatment Period 1||56||
59814733|NCT00421707|75937166|FG001|COMPLETED|Period 1: Treatment Period 1||56||
59814734|NCT00421707|75937165|FG000|NOT COMPLETED|Period 1: Treatment Period 1||11||
59814735|NCT00421707|75937166|FG001|NOT COMPLETED|Period 1: Treatment Period 1||9||
59814736|NCT00421707|75937165|FG000|STARTED|Period 2: Washout||56||
59814737|NCT00421707|75937166|FG001|STARTED|Period 2: Washout||56||
59814738|NCT00421707|75937165|FG000|COMPLETED|Period 2: Washout||55||
59814739|NCT00421707|75937166|FG001|COMPLETED|Period 2: Washout||52||
59814740|NCT00421707|75937165|FG000|NOT COMPLETED|Period 2: Washout||1||
59814741|NCT00421707|75937166|FG001|NOT COMPLETED|Period 2: Washout||4||
59814742|NCT00421707|75937165|FG000|STARTED|Period 3:Treatment Period 2||55||
59814743|NCT00421707|75937166|FG001|STARTED|Period 3:Treatment Period 2||52||
59814744|NCT00421707|75937165|FG000|COMPLETED|Period 3:Treatment Period 2||53||
59814745|NCT00421707|75937166|FG001|COMPLETED|Period 3:Treatment Period 2||49||
59814746|NCT00421707|75937165|FG000|NOT COMPLETED|Period 3:Treatment Period 2||2||
59814747|NCT00421707|75937166|FG001|NOT COMPLETED|Period 3:Treatment Period 2||3||
59980362|NCT03606174|76097465|FG007|NOT COMPLETED|Overall Study||9||
59980363|NCT03606174|76097466|FG008|NOT COMPLETED|Overall Study||8||
59980364|NCT03606174|76097467|FG009|NOT COMPLETED|Overall Study||4||
59980365|NCT03606174|76097468|FG010|NOT COMPLETED|Overall Study||4||
59980366|NCT03450707|76097498|FG000|STARTED|Overall Study||47|"93 is the total number of patients who were randomized to either thiamine or placebo:47 randomized to thiamine, 46 randomized to placebo.~But 7/47 randomized to thiamine did not receive the intervention, and 10/46 randomized to placebo did not receive the placebo, resulting in final numbers of 40 patients who received thiamine and 36 patients who received placebo.~A granular breakdown of the reasons for not having received the intervention is given in the reason not completed field."|
59980367|NCT03450707|76097499|FG001|STARTED|Overall Study||46|"93 is the total number of patients who were randomized to either thiamine or placebo:47 randomized to thiamine, 46 randomized to placebo.~But 7/47 randomized to thiamine did not receive the intervention, and 10/46 randomized to placebo did not receive the placebo, resulting in final numbers of 40 patients who received thiamine and 36 patients who received placebo.~A granular breakdown of the reasons for not having received the intervention is given in the reason not completed field."|
59980368|NCT03450707|76097498|FG000|COMPLETED|Overall Study||40||
59980369|NCT03450707|76097499|FG001|COMPLETED|Overall Study||36||
59980370|NCT03450707|76097498|FG000|NOT COMPLETED|Overall Study||7||
59980371|NCT03450707|76097499|FG001|NOT COMPLETED|Overall Study||10||
59980372|NCT03296527|76097507|FG000|STARTED|Overall Study||500|Randomized (2 randomized participants were not exposed to the IMP)|
59980373|NCT03296527|76097508|FG001|STARTED|Overall Study||511|Randomized (2 randomized participants were not exposed to the IMP)|
59980374|NCT03296527|76097507|FG000|Full Analysis Set|Overall Study||499||
59980375|NCT03296527|76097508|FG001|Full Analysis Set|Overall Study||510||
59980376|NCT03296527|76097507|FG000|COMPLETED|Overall Study||465||
59980377|NCT03296527|76097508|FG001|COMPLETED|Overall Study||458||
59980378|NCT03296527|76097507|FG000|NOT COMPLETED|Overall Study||35||
59980379|NCT03296527|76097508|FG001|NOT COMPLETED|Overall Study||53||
59980380|NCT03228680|76097517|FG000|STARTED|Overall Study||170||
59980381|NCT03228680|76097518|FG001|STARTED|Overall Study||178||
59980382|NCT03228680|76097517|FG000|COMPLETED|Overall Study||147||
59980383|NCT03228680|76097518|FG001|COMPLETED|Overall Study||143||
59980384|NCT03228680|76097517|FG000|NOT COMPLETED|Overall Study||23||
59814748|NCT00796068|75937177|FG000|STARTED|Overall Study||66||
59814749|NCT00796068|75937178|FG001|STARTED|Overall Study||64||
59814750|NCT00796068|75937177|FG000|COMPLETED|Overall Study||66||
59814751|NCT00796068|75937178|FG001|COMPLETED|Overall Study||64||
59814752|NCT00796068|75937177|FG000|NOT COMPLETED|Overall Study||0||
59814753|NCT00796068|75937178|FG001|NOT COMPLETED|Overall Study||0||
59814754|NCT00518622|75937192|FG000|STARTED|Overall Study||3||
59814755|NCT00518622|75937193|FG001|STARTED|Overall Study||6||
59814756|NCT00518622|75937194|FG002|STARTED|Overall Study||6||
59814757|NCT00518622|75937195|FG003|STARTED|Overall Study||5||
59814758|NCT00518622|75937196|FG004|STARTED|Overall Study||6||
59814759|NCT00518622|75937197|FG005|STARTED|Overall Study||5||
59814760|NCT00518622|75937198|FG006|STARTED|Overall Study||4||
59814761|NCT00518622|75937199|FG007|STARTED|Overall Study||5||
59814762|NCT00518622|75937192|FG000|Completed Therapy|Overall Study|Completed therapy defined if participant has taken 8 days of study medication per the protocol.|3||
59814763|NCT00518622|75937193|FG001|Completed Therapy|Overall Study||5||
59814764|NCT00518622|75937194|FG002|Completed Therapy|Overall Study||6||
59814765|NCT00518622|75937195|FG003|Completed Therapy|Overall Study||5||
59980385|NCT03228680|76097518|FG001|NOT COMPLETED|Overall Study||35||
59980386|NCT03194542|76097529|FG000|STARTED|Overall Study||22||
59980387|NCT03194542|76097530|FG001|STARTED|Overall Study||21||
59980388|NCT03194542|76097531|FG002|STARTED|Overall Study||14||
59980389|NCT03194542|76097532|FG003|STARTED|Overall Study||38||
59980390|NCT03194542|76097529|FG000|COMPLETED|Overall Study||0|Treatment ongoing|
59980391|NCT03194542|76097530|FG001|COMPLETED|Overall Study||0|Treatment ongoing|
59980392|NCT03194542|76097531|FG002|COMPLETED|Overall Study||0|Treatment ongoing|
59980393|NCT03194542|76097532|FG003|COMPLETED|Overall Study||0|Treatment ongoing|
59980394|NCT03194542|76097529|FG000|NOT COMPLETED|Overall Study||22||
59980395|NCT03194542|76097530|FG001|NOT COMPLETED|Overall Study||21||
59980396|NCT03194542|76097531|FG002|NOT COMPLETED|Overall Study||14||
59980397|NCT03194542|76097532|FG003|NOT COMPLETED|Overall Study||38||
59980398|NCT03083808|76097545|FG000|STARTED|Overall Study||35||
59980399|NCT03083808|76097545|FG000|COMPLETED|Overall Study||35||
59980400|NCT03083808|76097545|FG000|NOT COMPLETED|Overall Study||0||
59980401|NCT02362035|76097549|FG000|STARTED|Overall Study||161||
59980402|NCT02362035|76097549|FG000|COMPLETED|Overall Study||0||
59980403|NCT02362035|76097549|FG000|NOT COMPLETED|Overall Study||161||
59980404|NCT02328014|76097557|FG000|STARTED|Overall Study||6||
59980405|NCT02328014|76097558|FG001|STARTED|Overall Study||6||
59980406|NCT02328014|76097559|FG002|STARTED|Overall Study||6||
59980407|NCT02328014|76097560|FG003|STARTED|Overall Study||22||
59980408|NCT02328014|76097557|FG000|COMPLETED|Overall Study||0||
59980409|NCT02328014|76097558|FG001|COMPLETED|Overall Study||0||
59980410|NCT02328014|76097559|FG002|COMPLETED|Overall Study||0||
59980411|NCT02328014|76097560|FG003|COMPLETED|Overall Study||0||
59980412|NCT02328014|76097557|FG000|NOT COMPLETED|Overall Study||6||
59980413|NCT02328014|76097558|FG001|NOT COMPLETED|Overall Study||6||
59980414|NCT02328014|76097559|FG002|NOT COMPLETED|Overall Study||6||
59980415|NCT02328014|76097560|FG003|NOT COMPLETED|Overall Study||22||
59980416|NCT02213926|76097570|FG000|STARTED|Overall Study||124||
59980417|NCT02213926|76097570|FG000|COMPLETED|Overall Study||0||
59622506|NCT00533442|75734360|FG001|COMPLETED|Allocation and Intent to Treat Analysis||84||
59622507|NCT00533442|75734359|FG000|NOT COMPLETED|Allocation and Intent to Treat Analysis||0||
59622508|NCT00533442|75734360|FG001|NOT COMPLETED|Allocation and Intent to Treat Analysis||0||
59622509|NCT00533442|75734359|FG000|STARTED|Follow-up|Ongoing Follow-up at 13-123 months (N=77); Lost to Follow-up (N=9, at 5-100 months).|86||
59622510|NCT00533442|75734360|FG001|STARTED|Follow-up|Ongoing Follow-up at 17-124 months (N=74); Lost to Follow-up (N=10, at 5-67 months).|84||
59622511|NCT00533442|75734359|FG000|COMPLETED|Follow-up||77||
59622512|NCT00533442|75734360|FG001|COMPLETED|Follow-up||74||
59622513|NCT00533442|75734359|FG000|NOT COMPLETED|Follow-up||9||
59622514|NCT00533442|75734360|FG001|NOT COMPLETED|Follow-up||10||
59622515|NCT00533910|75734370|FG000|STARTED|Overall Study||21||
59814766|NCT00518622|75937196|FG004|Completed Therapy|Overall Study||6||
59814767|NCT00518622|75937197|FG005|Completed Therapy|Overall Study||5||
59814768|NCT00518622|75937198|FG006|Completed Therapy|Overall Study||4||
59814769|NCT00518622|75937199|FG007|Completed Therapy|Overall Study||5||
59814770|NCT00518622|75937192|FG000|Discontinued Therapy|Overall Study|Discontinued therapy defined if participant has not taken 8 days of medication per the protocol.|0||
59814771|NCT00518622|75937193|FG001|Discontinued Therapy|Overall Study||1||
59814772|NCT00518622|75937194|FG002|Discontinued Therapy|Overall Study||0||
59814773|NCT00518622|75937195|FG003|Discontinued Therapy|Overall Study||0||
59814774|NCT00518622|75937196|FG004|Discontinued Therapy|Overall Study||0||
59814775|NCT00518622|75937197|FG005|Discontinued Therapy|Overall Study||0||
59814776|NCT00518622|75937198|FG006|Discontinued Therapy|Overall Study||0||
59814777|NCT00518622|75937199|FG007|Discontinued Therapy|Overall Study||0||
59814778|NCT00518622|75937192|FG000|COMPLETED|Overall Study||3||
59814779|NCT00518622|75937193|FG001|COMPLETED|Overall Study||5||
59814780|NCT00518622|75937194|FG002|COMPLETED|Overall Study||5||
59814781|NCT00518622|75937195|FG003|COMPLETED|Overall Study||5||
59814782|NCT00518622|75937196|FG004|COMPLETED|Overall Study||6||
59980418|NCT02213926|76097570|FG000|NOT COMPLETED|Overall Study||124||
59980419|NCT01892085|76097577|FG000|STARTED|Overall Study||58||
59980420|NCT01892085|76097578|FG001|STARTED|Overall Study||62||
60074794|NCT01930045|76190106|FG003|COMPLETED|Part 1 - Period 1||3||
59622516|NCT00533910|75734371|FG001|STARTED|Overall Study||21||
59622517|NCT00533910|75734370|FG000|COMPLETED|Overall Study||21||
59622518|NCT00533910|75734371|FG001|COMPLETED|Overall Study||21||
59622519|NCT00533910|75734370|FG000|NOT COMPLETED|Overall Study||0||
59814783|NCT00518622|75937197|FG005|COMPLETED|Overall Study||5||
59814784|NCT00518622|75937198|FG006|COMPLETED|Overall Study||4||
59622520|NCT00533910|75734371|FG001|NOT COMPLETED|Overall Study||0||
59622521|NCT00535002|75734385|FG000|STARTED|Overall Study||19||
59622522|NCT00535002|75734386|FG001|STARTED|Overall Study||12||
59980421|NCT01892085|76097579|FG002|STARTED|Overall Study||60||
59980422|NCT01892085|76097577|FG000|COMPLETED|Overall Study||52||
59980423|NCT01892085|76097578|FG001|COMPLETED|Overall Study||61||
59980424|NCT01892085|76097579|FG002|COMPLETED|Overall Study||55||
59980425|NCT01892085|76097577|FG000|NOT COMPLETED|Overall Study||6||
59980426|NCT01892085|76097578|FG001|NOT COMPLETED|Overall Study||1||
59980427|NCT01892085|76097579|FG002|NOT COMPLETED|Overall Study||5||
59980428|NCT00815880|76097587|FG000|STARTED|Overall Study||21|The first implantation was on April 15, 2009. The last implantation was on December 21, 2010.|
59980429|NCT00815880|76097587|FG000|COMPLETED|Overall Study|3 subjects completed the 5-year follow-up visit.|3||
59980430|NCT00815880|76097587|FG000|NOT COMPLETED|Overall Study||18||
59980431|NCT00390325|76097594|FG000|STARTED|Overall Study||5||
59980432|NCT00390325|76097595|FG001|STARTED|Overall Study||16||
59980433|NCT00390325|76097594|FG000|COMPLETED|Overall Study||5||
59980434|NCT00390325|76097595|FG001|COMPLETED|Overall Study||16||
59980435|NCT00390325|76097594|FG000|NOT COMPLETED|Overall Study||0||
59980436|NCT00390325|76097595|FG001|NOT COMPLETED|Overall Study||0||
59526474|NCT01359007|75622125|FG000|STARTED|Overall Study||5||
59526475|NCT01359007|75622125|FG000|COMPLETED|Overall Study||3||
59526476|NCT01359007|75622125|FG000|NOT COMPLETED|Overall Study||2||
59526477|NCT01361113|75622130|FG000|STARTED|Overall Study||21||
59526478|NCT01361113|75622130|FG000|COMPLETED|Overall Study||21||
59526479|NCT01361113|75622130|FG000|NOT COMPLETED|Overall Study||0||
59526480|NCT01414153|75622140|FG000|STARTED|Overall Study||38||
59526481|NCT01414153|75622141|FG001|STARTED|Overall Study||40||
59526482|NCT01414153|75622142|FG002|STARTED|Overall Study||39||
59526483|NCT01414153|75622143|FG003|STARTED|Overall Study||41||
59622523|NCT00535002|75734387|FG002|STARTED|Overall Study||13||
59622524|NCT00535002|75734388|FG003|STARTED|Overall Study||14||
59980437|NCT00265798|76097605|FG000|STARTED|Overall Study||38||
59980438|NCT00265798|76097605|FG000|COMPLETED|Overall Study||38||
59980439|NCT00265798|76097605|FG000|NOT COMPLETED|Overall Study||0||
59980440|NCT04510285|76097609|FG000|STARTED|Overall Study||1||
59980441|NCT04510285|76097609|FG000|COMPLETED|Overall Study||0||
59980442|NCT04510285|76097609|FG000|NOT COMPLETED|Overall Study||1||
59980443|NCT02576054|76097613|FG000|STARTED|Overall Study||101||
59980444|NCT02576054|76097613|FG000|Vaccination 1|Overall Study||100||
59980445|NCT02576054|76097613|FG000|Vaccination 2|Overall Study||100||
59980446|NCT02576054|76097613|FG000|Vaccination 3|Overall Study||100||
59980447|NCT02576054|76097613|FG000|COMPLETED|Overall Study||100||
59980448|NCT02576054|76097613|FG000|NOT COMPLETED|Overall Study||1||
59980449|NCT01606202|76097621|FG000|STARTED|Overall Study||56||
59980450|NCT01606202|76097622|FG001|STARTED|Overall Study||60||
59980451|NCT01606202|76097621|FG000|COMPLETED|Overall Study||49||
59980452|NCT01606202|76097622|FG001|COMPLETED|Overall Study||57||
59814785|NCT00518622|75937199|FG007|COMPLETED|Overall Study||5||
59980453|NCT01606202|76097621|FG000|NOT COMPLETED|Overall Study||7||
59980454|NCT01606202|76097622|FG001|NOT COMPLETED|Overall Study||3||
59980455|NCT01493960|76097630|FG000|STARTED|Overall Study||87||
59980456|NCT01493960|76097631|FG001|STARTED|Overall Study||44||
59980457|NCT01493960|76097630|FG000|Received Study Drug|Overall Study||87||
59980458|NCT01493960|76097631|FG001|Received Study Drug|Overall Study||43||
59980459|NCT01493960|76097630|FG000|COMPLETED|Overall Study||55||
59980460|NCT01493960|76097631|FG001|COMPLETED|Overall Study||26||
59980461|NCT01493960|76097630|FG000|NOT COMPLETED|Overall Study||32||
59980462|NCT01493960|76097631|FG001|NOT COMPLETED|Overall Study||18||
59980463|NCT02630459|76097641|FG000|STARTED|Double-Blind Treatment Phase (DBTP)||136||
59980464|NCT02630459|76097642|FG001|STARTED|Double-Blind Treatment Phase (DBTP)||67||
59980465|NCT02630459|76097643|FG002|STARTED|Double-Blind Treatment Phase (DBTP)||135||
59980466|NCT02630459|76097644|FG003|STARTED|Double-Blind Treatment Phase (DBTP)||137||
59622525|NCT00535002|75734389|FG004|STARTED|Overall Study||9||
59980467|NCT02630459|76097645|FG004|STARTED|Double-Blind Treatment Phase (DBTP)||0||
59980468|NCT02630459|76097646|FG005|STARTED|Double-Blind Treatment Phase (DBTP)||0||
59526484|NCT01414153|75622140|FG000|COMPLETED|Overall Study||30||
59526485|NCT01414153|75622141|FG001|COMPLETED|Overall Study||38||
59526486|NCT01414153|75622142|FG002|COMPLETED|Overall Study||35||
59526487|NCT01414153|75622143|FG003|COMPLETED|Overall Study||37||
59526488|NCT01414153|75622140|FG000|NOT COMPLETED|Overall Study||8||
59622526|NCT00535002|75734390|FG005|STARTED|Overall Study||17||
59622527|NCT00535002|75734391|FG006|STARTED|Overall Study||12||
59622528|NCT00535002|75734392|FG007|STARTED|Overall Study||16||
59622529|NCT00535002|75734385|FG000|COMPLETED|Overall Study||19||
59622530|NCT00535002|75734386|FG001|COMPLETED|Overall Study||12||
59622531|NCT00535002|75734387|FG002|COMPLETED|Overall Study||13||
59622532|NCT00535002|75734388|FG003|COMPLETED|Overall Study||14||
59622533|NCT00535002|75734389|FG004|COMPLETED|Overall Study||9||
59622534|NCT00535002|75734390|FG005|COMPLETED|Overall Study||17||
59526489|NCT01414153|75622141|FG001|NOT COMPLETED|Overall Study||2||
59622535|NCT00535002|75734391|FG006|COMPLETED|Overall Study||12||
59622536|NCT00535002|75734392|FG007|COMPLETED|Overall Study||16||
59622537|NCT00535002|75734385|FG000|NOT COMPLETED|Overall Study||0||
59622538|NCT00535002|75734386|FG001|NOT COMPLETED|Overall Study||0||
59622539|NCT00535002|75734387|FG002|NOT COMPLETED|Overall Study||0||
59980469|NCT02630459|76097647|FG006|STARTED|Double-Blind Treatment Phase (DBTP)||0||
59980470|NCT02630459|76097648|FG007|STARTED|Double-Blind Treatment Phase (DBTP)||0||
59980471|NCT02630459|76097641|FG000|Received Investigational Product (IP)|Double-Blind Treatment Phase (DBTP)||136||
59980472|NCT02630459|76097642|FG001|Received Investigational Product (IP)|Double-Blind Treatment Phase (DBTP)||66||
59980473|NCT02630459|76097643|FG002|Received Investigational Product (IP)|Double-Blind Treatment Phase (DBTP)||135||
59980474|NCT02630459|76097644|FG003|Received Investigational Product (IP)|Double-Blind Treatment Phase (DBTP)||137||
59980475|NCT02630459|76097645|FG004|Received Investigational Product (IP)|Double-Blind Treatment Phase (DBTP)||0||
59980476|NCT02630459|76097646|FG005|Received Investigational Product (IP)|Double-Blind Treatment Phase (DBTP)||0||
59980477|NCT02630459|76097647|FG006|Received Investigational Product (IP)|Double-Blind Treatment Phase (DBTP)||0||
59980478|NCT02630459|76097648|FG007|Received Investigational Product (IP)|Double-Blind Treatment Phase (DBTP)||0||
59980479|NCT02630459|76097641|FG000|COMPLETED|Double-Blind Treatment Phase (DBTP)||133|Completed week 24 assessment of double-blind treatment phase|
59980480|NCT02630459|76097642|FG001|COMPLETED|Double-Blind Treatment Phase (DBTP)||65|Completed week 24 assessment of double-blind treatment phase|
59980481|NCT02630459|76097643|FG002|COMPLETED|Double-Blind Treatment Phase (DBTP)||130|Completed week 24 assessment of double-blind treatment phase|
59980482|NCT02630459|76097644|FG003|COMPLETED|Double-Blind Treatment Phase (DBTP)||134|Completed week 24 assessment of double-blind treatment phase|
59980483|NCT02630459|76097645|FG004|COMPLETED|Double-Blind Treatment Phase (DBTP)||0|Completed week 24 assessment of double-blind treatment phase|
59980484|NCT02630459|76097646|FG005|COMPLETED|Double-Blind Treatment Phase (DBTP)||0|Completed week 24 assessment of double-blind treatment phase|
59980485|NCT02630459|76097647|FG006|COMPLETED|Double-Blind Treatment Phase (DBTP)||0|Completed week 24 assessment of double-blind treatment phase|
59980486|NCT02630459|76097648|FG007|COMPLETED|Double-Blind Treatment Phase (DBTP)||0|Completed week 24 assessment of double-blind treatment phase|
59980487|NCT02630459|76097641|FG000|NOT COMPLETED|Double-Blind Treatment Phase (DBTP)||3||
59980488|NCT02630459|76097642|FG001|NOT COMPLETED|Double-Blind Treatment Phase (DBTP)||2||
59980489|NCT02630459|76097643|FG002|NOT COMPLETED|Double-Blind Treatment Phase (DBTP)||5||
59980490|NCT02630459|76097644|FG003|NOT COMPLETED|Double-Blind Treatment Phase (DBTP)||3||
59980491|NCT02630459|76097645|FG004|NOT COMPLETED|Double-Blind Treatment Phase (DBTP)||0||
59980492|NCT02630459|76097646|FG005|NOT COMPLETED|Double-Blind Treatment Phase (DBTP)||0||
59980493|NCT02630459|76097647|FG006|NOT COMPLETED|Double-Blind Treatment Phase (DBTP)||0||
59980494|NCT02630459|76097648|FG007|NOT COMPLETED|Double-Blind Treatment Phase (DBTP)||0||
59980495|NCT02630459|76097641|FG000|STARTED|Open-Label Treatment Phase (OLTP)||0||
59980496|NCT02630459|76097642|FG001|STARTED|Open-Label Treatment Phase (OLTP)||0||
59980497|NCT02630459|76097643|FG002|STARTED|Open-Label Treatment Phase (OLTP)||0||
59980498|NCT02630459|76097644|FG003|STARTED|Open-Label Treatment Phase (OLTP)||0||
59980499|NCT02630459|76097645|FG004|STARTED|Open-Label Treatment Phase (OLTP)||386||
59980500|NCT02630459|76097646|FG005|STARTED|Open-Label Treatment Phase (OLTP)||73||
59980501|NCT02630459|76097647|FG006|STARTED|Open-Label Treatment Phase (OLTP)||0||
59980502|NCT02630459|76097648|FG007|STARTED|Open-Label Treatment Phase (OLTP)||0||
59980503|NCT02630459|76097641|FG000|Received Only 70 mg in OLTP|Open-Label Treatment Phase (OLTP)||0||
59980504|NCT02630459|76097642|FG001|Received Only 70 mg in OLTP|Open-Label Treatment Phase (OLTP)||0||
59980505|NCT02630459|76097643|FG002|Received Only 70 mg in OLTP|Open-Label Treatment Phase (OLTP)||0||
59980506|NCT02630459|76097644|FG003|Received Only 70 mg in OLTP|Open-Label Treatment Phase (OLTP)||0||
59980507|NCT02630459|76097645|FG004|Received Only 70 mg in OLTP|Open-Label Treatment Phase (OLTP)||270||
59980508|NCT02630459|76097646|FG005|Received Only 70 mg in OLTP|Open-Label Treatment Phase (OLTP)||0||
59980509|NCT02630459|76097647|FG006|Received Only 70 mg in OLTP|Open-Label Treatment Phase (OLTP)||0||
59980510|NCT02630459|76097648|FG007|Received Only 70 mg in OLTP|Open-Label Treatment Phase (OLTP)||0||
59980511|NCT02630459|76097641|FG000|Received Only 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0||
59980512|NCT02630459|76097642|FG001|Received Only 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0||
59980513|NCT02630459|76097643|FG002|Received Only 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0||
59980514|NCT02630459|76097644|FG003|Received Only 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0||
59980515|NCT02630459|76097645|FG004|Received Only 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0||
59622540|NCT00535002|75734388|FG003|NOT COMPLETED|Overall Study||0||
59622541|NCT00535002|75734389|FG004|NOT COMPLETED|Overall Study||0||
59622542|NCT00535002|75734390|FG005|NOT COMPLETED|Overall Study||0||
59622543|NCT00535002|75734391|FG006|NOT COMPLETED|Overall Study||0||
59622544|NCT00535002|75734392|FG007|NOT COMPLETED|Overall Study||0||
59622545|NCT02117934|75734408|FG000|STARTED|Overall Study||5592||
59622546|NCT02117934|75734409|FG001|STARTED|Overall Study||2782||
59622547|NCT02117934|75734408|FG000|COMPLETED|Overall Study||5092||
59622548|NCT02117934|75734409|FG001|COMPLETED|Overall Study||2567||
59622549|NCT02117934|75734408|FG000|NOT COMPLETED|Overall Study||500||
59622550|NCT02117934|75734409|FG001|NOT COMPLETED|Overall Study||215||
59622551|NCT00429702|75734417|FG000|STARTED|Overall Study||3||
59622552|NCT00429702|75734418|FG001|STARTED|Overall Study||4||
59622553|NCT00429702|75734417|FG000|COMPLETED|Overall Study||3||
59622554|NCT00429702|75734418|FG001|COMPLETED|Overall Study||4||
59622555|NCT00429702|75734417|FG000|NOT COMPLETED|Overall Study||0||
59622556|NCT00429702|75734418|FG001|NOT COMPLETED|Overall Study||0||
59622557|NCT00535392|75734424|FG000|STARTED|Overall Study||33||
59622558|NCT00535392|75734424|FG000|COMPLETED|Overall Study||33||
59622559|NCT00535392|75734424|FG000|NOT COMPLETED|Overall Study||0||
59622560|NCT00535782|75734430|FG000|STARTED|Part 1: 24-Week Double-blind Period||69||
59622561|NCT00535782|75734431|FG001|STARTED|Part 1: 24-Week Double-blind Period||63||
59980516|NCT02630459|76097646|FG005|Received Only 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||73||
59622562|NCT00535782|75734432|FG002|STARTED|Part 1: 24-Week Double-blind Period||0||
59622563|NCT00535782|75734430|FG000|Treated With TCZ + MTX|Part 1: 24-Week Double-blind Period||69||
59709633|NCT01235741|75828431|FG002|STARTED|Non-Randomized Low Calorie Diet Lead-In||0||
59980517|NCT02630459|76097647|FG006|Received Only 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0||
59980518|NCT02630459|76097648|FG007|Received Only 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0||
59980519|NCT02630459|76097641|FG000|Received Both 70 mg and 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0||
59980520|NCT02630459|76097642|FG001|Received Both 70 mg and 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0||
59980521|NCT02630459|76097643|FG002|Received Both 70 mg and 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0||
59980522|NCT02630459|76097644|FG003|Received Both 70 mg and 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0||
59980523|NCT02630459|76097645|FG004|Received Both 70 mg and 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||116||
59980524|NCT02630459|76097646|FG005|Received Both 70 mg and 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0||
59980525|NCT02630459|76097647|FG006|Received Both 70 mg and 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0||
59980526|NCT02630459|76097648|FG007|Received Both 70 mg and 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0||
59980527|NCT02630459|76097641|FG000|COMPLETED|Open-Label Treatment Phase (OLTP)||0||
59980528|NCT02630459|76097642|FG001|COMPLETED|Open-Label Treatment Phase (OLTP)||0||
59980529|NCT02630459|76097643|FG002|COMPLETED|Open-Label Treatment Phase (OLTP)||0||
59980530|NCT02630459|76097644|FG003|COMPLETED|Open-Label Treatment Phase (OLTP)||0||
59980531|NCT02630459|76097645|FG004|COMPLETED|Open-Label Treatment Phase (OLTP)||357||
59980532|NCT02630459|76097646|FG005|COMPLETED|Open-Label Treatment Phase (OLTP)||69||
59980533|NCT02630459|76097647|FG006|COMPLETED|Open-Label Treatment Phase (OLTP)||0||
59980534|NCT02630459|76097648|FG007|COMPLETED|Open-Label Treatment Phase (OLTP)||0||
59980535|NCT02630459|76097641|FG000|NOT COMPLETED|Open-Label Treatment Phase (OLTP)||0||
59980536|NCT02630459|76097642|FG001|NOT COMPLETED|Open-Label Treatment Phase (OLTP)||0||
59980537|NCT02630459|76097643|FG002|NOT COMPLETED|Open-Label Treatment Phase (OLTP)||0||
59980538|NCT02630459|76097644|FG003|NOT COMPLETED|Open-Label Treatment Phase (OLTP)||0||
59980539|NCT02630459|76097645|FG004|NOT COMPLETED|Open-Label Treatment Phase (OLTP)||29||
59980540|NCT02630459|76097646|FG005|NOT COMPLETED|Open-Label Treatment Phase (OLTP)||4||
59980541|NCT02630459|76097647|FG006|NOT COMPLETED|Open-Label Treatment Phase (OLTP)||0||
59980542|NCT02630459|76097648|FG007|NOT COMPLETED|Open-Label Treatment Phase (OLTP)||0||
59980543|NCT02630459|76097641|FG000|STARTED|Optional CHU Sub-Study (During OLTP)||0||
59980544|NCT02630459|76097642|FG001|STARTED|Optional CHU Sub-Study (During OLTP)||0||
59980545|NCT02630459|76097643|FG002|STARTED|Optional CHU Sub-Study (During OLTP)||0||
59980546|NCT02630459|76097644|FG003|STARTED|Optional CHU Sub-Study (During OLTP)||0||
59980547|NCT02630459|76097645|FG004|STARTED|Optional CHU Sub-Study (During OLTP)||0||
59980548|NCT02630459|76097646|FG005|STARTED|Optional CHU Sub-Study (During OLTP)||0||
59980549|NCT02630459|76097647|FG006|STARTED|Optional CHU Sub-Study (During OLTP)||24||
59980550|NCT02630459|76097648|FG007|STARTED|Optional CHU Sub-Study (During OLTP)||25||
59980551|NCT02630459|76097641|FG000|COMPLETED|Optional CHU Sub-Study (During OLTP)||0|Completed week 12 sub-study visit (day 85)|
59980552|NCT02630459|76097642|FG001|COMPLETED|Optional CHU Sub-Study (During OLTP)||0|Completed week 12 sub-study visit (day 85)|
59980553|NCT02630459|76097643|FG002|COMPLETED|Optional CHU Sub-Study (During OLTP)||0|Completed week 12 sub-study visit (day 85)|
59980554|NCT02630459|76097644|FG003|COMPLETED|Optional CHU Sub-Study (During OLTP)||0|Completed week 12 sub-study visit (day 85)|
59980555|NCT02630459|76097645|FG004|COMPLETED|Optional CHU Sub-Study (During OLTP)||0|Completed week 12 sub-study visit (day 85)|
59980556|NCT02630459|76097646|FG005|COMPLETED|Optional CHU Sub-Study (During OLTP)||0|Completed week 12 sub-study visit (day 85)|
59980557|NCT02630459|76097647|FG006|COMPLETED|Optional CHU Sub-Study (During OLTP)||24|Completed week 12 sub-study visit (day 85)|
59980558|NCT02630459|76097648|FG007|COMPLETED|Optional CHU Sub-Study (During OLTP)||25|Completed week 12 sub-study visit (day 85)|
59980559|NCT02630459|76097641|FG000|NOT COMPLETED|Optional CHU Sub-Study (During OLTP)||0||
59980560|NCT02630459|76097642|FG001|NOT COMPLETED|Optional CHU Sub-Study (During OLTP)||0||
59980561|NCT02630459|76097643|FG002|NOT COMPLETED|Optional CHU Sub-Study (During OLTP)||0||
59980562|NCT02630459|76097644|FG003|NOT COMPLETED|Optional CHU Sub-Study (During OLTP)||0||
59980563|NCT02630459|76097645|FG004|NOT COMPLETED|Optional CHU Sub-Study (During OLTP)||0||
59980564|NCT02630459|76097646|FG005|NOT COMPLETED|Optional CHU Sub-Study (During OLTP)||0||
59980565|NCT02630459|76097647|FG006|NOT COMPLETED|Optional CHU Sub-Study (During OLTP)||0||
59980566|NCT02630459|76097648|FG007|NOT COMPLETED|Optional CHU Sub-Study (During OLTP)||0||
59980567|NCT02573948|76097673|FG000|STARTED|RDS||603||
60074795|NCT01930045|76190107|FG004|COMPLETED|Part 1 - Period 1||3||
60074796|NCT01930045|76190108|FG005|COMPLETED|Part 1 - Period 1||3||
60074797|NCT01930045|76190103|FG000|NOT COMPLETED|Part 1 - Period 1||0||
59980568|NCT02573948|76097673|FG000|COMPLETED|RDS||603||
59980569|NCT02573948|76097673|FG000|NOT COMPLETED|RDS||0||
59980570|NCT02573948|76097673|FG000|STARTED|Longitudinal Cohort|Not on ART a/o MMT. MSM and FSW were prioritized for enrolling,|250|Among 603 RDS participants, 250 PWID were selected for the longitudinal follow-up.|
59980571|NCT02573948|76097673|FG000|COMPLETED|Longitudinal Cohort||194||
59980572|NCT02573948|76097673|FG000|NOT COMPLETED|Longitudinal Cohort||56||
59980573|NCT01464593|76097680|FG000|STARTED|Overall Study||1||
59980574|NCT01464593|76097680|FG000|COMPLETED|Overall Study||0||
59980575|NCT01464593|76097680|FG000|NOT COMPLETED|Overall Study||1||
59980576|NCT05279131|76097684|FG000|STARTED|Overall Study||105||
59980577|NCT05279131|76097684|FG000|COMPLETED|Overall Study||102||
60074798|NCT01930045|76190104|FG001|NOT COMPLETED|Part 1 - Period 1||0||
60074799|NCT01930045|76190105|FG002|NOT COMPLETED|Part 1 - Period 1||0||
59980578|NCT05279131|76097684|FG000|NOT COMPLETED|Overall Study||3||
59980579|NCT05241288|76097688|FG000|STARTED|Overall Study||54||
59980580|NCT05241288|76097688|FG000|COMPLETED|Overall Study||40||
59980581|NCT05241288|76097688|FG000|NOT COMPLETED|Overall Study||14||
59980582|NCT05028517|76097695|FG000|STARTED|Overall Study||43||
59980583|NCT05028517|76097696|FG001|STARTED|Overall Study||43||
59980584|NCT05028517|76097697|FG002|STARTED|Overall Study||43||
59980585|NCT05028517|76097695|FG000|Completed Baseline Surveys|Overall Study||41||
59980586|NCT05028517|76097696|FG001|Completed Baseline Surveys|Overall Study||39||
59980587|NCT05028517|76097697|FG002|Completed Baseline Surveys|Overall Study||39||
59980588|NCT05028517|76097695|FG000|Completed 6-week Follow-up Surveys|Overall Study||30||
59980589|NCT05028517|76097696|FG001|Completed 6-week Follow-up Surveys|Overall Study||28||
59980590|NCT05028517|76097697|FG002|Completed 6-week Follow-up Surveys|Overall Study||32||
59980591|NCT05028517|76097695|FG000|COMPLETED|Overall Study||30|12-week Follow-up Surveys|
59980592|NCT05028517|76097696|FG001|COMPLETED|Overall Study||23|12-week Follow-up Surveys|
59980593|NCT05028517|76097697|FG002|COMPLETED|Overall Study||30|12-week Follow-up Surveys|
59980594|NCT05028517|76097695|FG000|NOT COMPLETED|Overall Study||13||
59980595|NCT05028517|76097696|FG001|NOT COMPLETED|Overall Study||20||
59980596|NCT05028517|76097697|FG002|NOT COMPLETED|Overall Study||13||
59980597|NCT05012683|76097705|FG000|STARTED|No Prosthesis (Day 0)||11||
59980598|NCT05012683|76097705|FG000|COMPLETED|No Prosthesis (Day 0)||11||
59980599|NCT05012683|76097705|FG000|NOT COMPLETED|No Prosthesis (Day 0)||0||
59980600|NCT05012683|76097705|FG000|STARTED|Prosthesis (Day 0)||11||
59980601|NCT05012683|76097705|FG000|COMPLETED|Prosthesis (Day 0)||11||
59980602|NCT05012683|76097705|FG000|NOT COMPLETED|Prosthesis (Day 0)||0||
59980603|NCT05012683|76097705|FG000|STARTED|Prosthesis (Day 30)||11||
59980604|NCT05012683|76097705|FG000|COMPLETED|Prosthesis (Day 30)||11||
59980605|NCT05012683|76097705|FG000|NOT COMPLETED|Prosthesis (Day 30)||0||
59980606|NCT05012683|76097705|FG000|STARTED|Prosthesis (Day 60)||11||
59980607|NCT05012683|76097705|FG000|COMPLETED|Prosthesis (Day 60)||11||
59980608|NCT05012683|76097705|FG000|NOT COMPLETED|Prosthesis (Day 60)||0||
59980609|NCT04638400|76097711|FG000|STARTED|Overall Study||5||
59980610|NCT04638400|76097712|FG001|STARTED|Overall Study||5||
59980611|NCT04638400|76097711|FG000|COMPLETED|Overall Study||5||
59980612|NCT04638400|76097712|FG001|COMPLETED|Overall Study||5||
59980613|NCT04638400|76097711|FG000|NOT COMPLETED|Overall Study||0||
59980614|NCT04638400|76097712|FG001|NOT COMPLETED|Overall Study||0||
59980615|NCT04390243|76097718|FG000|STARTED|Overall Study||6||
59980616|NCT04390243|76097718|FG000|COMPLETED|Overall Study||0||
59980617|NCT04390243|76097718|FG000|NOT COMPLETED|Overall Study||6||
59980618|NCT04363944|76097724|FG000|STARTED|Overall Study||18||
59980619|NCT04363944|76097725|FG001|STARTED|Overall Study||1||
59980620|NCT04363944|76097724|FG000|COMPLETED|Overall Study||16||
59980621|NCT04363944|76097725|FG001|COMPLETED|Overall Study||1||
59980622|NCT04363944|76097724|FG000|NOT COMPLETED|Overall Study||2||
59980623|NCT04363944|76097725|FG001|NOT COMPLETED|Overall Study||0||
59980624|NCT04335110|76097738|FG000|STARTED|Overall Study||14|Care partners were enrolled in Spring of 2021, completing in Spring 2023|
59980625|NCT04335110|76097739|FG001|STARTED|Overall Study||14|Care partners were enrolled in Spring of 2021, completing in Spring 2023|
59980626|NCT04335110|76097738|FG000|COMPLETED|Overall Study||13||
59980627|NCT04335110|76097739|FG001|COMPLETED|Overall Study||12||
59980628|NCT04335110|76097738|FG000|NOT COMPLETED|Overall Study||1||
59980629|NCT04335110|76097739|FG001|NOT COMPLETED|Overall Study||2||
59980630|NCT04156620|76097755|FG000|STARTED|Overall Study||264||
59980631|NCT04156620|76097756|FG001|STARTED|Overall Study||262||
59980632|NCT04156620|76097755|FG000|Completed Period 1|Overall Study||255|Baseline up to Week 16|
59980633|NCT04156620|76097756|FG001|Completed Period 1|Overall Study||253|Baseline up to Week 16|
59980634|NCT04156620|76097755|FG000|Started Period 2|Overall Study||255|Week 16 up Week 52|
59980635|NCT04156620|76097756|FG001|Started Period 2|Overall Study|2 patients completed Period 1 but discontinued prior to Period 2|251|Week 16 up Week 52|
59980636|NCT04156620|76097755|FG000|Completed Period 2|Overall Study||233||
59980637|NCT04156620|76097756|FG001|Completed Period 2|Overall Study||235||
59980638|NCT04156620|76097755|FG000|COMPLETED|Overall Study||227|Completed up to Week 60 (follow-up)|
59980639|NCT04156620|76097756|FG001|COMPLETED|Overall Study||233|Completed up to Week 60 (follow-up)|
59980640|NCT04156620|76097755|FG000|NOT COMPLETED|Overall Study||37||
59980641|NCT04156620|76097756|FG001|NOT COMPLETED|Overall Study||29||
59980642|NCT03834688|76097762|FG000|STARTED|Overall Study||33||
59980643|NCT03834688|76097762|FG000|COMPLETED|Overall Study||33||
59980644|NCT03834688|76097762|FG000|NOT COMPLETED|Overall Study||0||
59980645|NCT03816332|76097766|FG000|STARTED|Nivolumab, Tacrolimus, and Prednisone||12||
59980646|NCT03816332|76097766|FG000|COMPLETED|Nivolumab, Tacrolimus, and Prednisone||8||
59980647|NCT03816332|76097766|FG000|NOT COMPLETED|Nivolumab, Tacrolimus, and Prednisone||4||
59980648|NCT03816332|76097766|FG000|STARTED|Nivolumab, Ipilimumab, Tacrolimus, Pred||6||
59980649|NCT03816332|76097766|FG000|COMPLETED|Nivolumab, Ipilimumab, Tacrolimus, Pred||6||
59980650|NCT03816332|76097766|FG000|NOT COMPLETED|Nivolumab, Ipilimumab, Tacrolimus, Pred||0||
59980651|NCT03765736|76097772|FG000|STARTED|Overall Study||197||
59980652|NCT03765736|76097772|FG000|COMPLETED|Overall Study||197||
59980653|NCT03765736|76097772|FG000|NOT COMPLETED|Overall Study||0||
59980654|NCT03740724|76097776|FG000|STARTED|Overall Study||1||
59980655|NCT03740724|76097776|FG000|COMPLETED|Overall Study||0||
59980656|NCT03740724|76097776|FG000|NOT COMPLETED|Overall Study||1||
59980657|NCT03621189|76097783|FG000|STARTED|Overall Study||40||
59980658|NCT03621189|76097784|FG001|STARTED|Overall Study||40||
59980659|NCT03621189|76097783|FG000|COMPLETED|Overall Study||40||
59980660|NCT03621189|76097784|FG001|COMPLETED|Overall Study||35||
59980661|NCT03621189|76097783|FG000|NOT COMPLETED|Overall Study||0||
59980662|NCT03621189|76097784|FG001|NOT COMPLETED|Overall Study||5||
59980663|NCT03486834|76097794|FG000|STARTED|Overall Study||733||
59980664|NCT03486834|76097795|FG001|STARTED|Overall Study||733||
59980665|NCT03486834|76097796|FG002|STARTED|Overall Study||734||
59980666|NCT03486834|76097794|FG000|Treatment 1|Overall Study||729||
59980667|NCT03486834|76097795|FG001|Treatment 1|Overall Study||729||
59980668|NCT03486834|76097796|FG002|Treatment 1|Overall Study||733||
59980669|NCT03486834|76097794|FG000|Treatment 2|Overall Study||680||
59980670|NCT03486834|76097795|FG001|Treatment 2|Overall Study||680||
59980671|NCT03486834|76097796|FG002|Treatment 2|Overall Study||679||
59980672|NCT03486834|76097794|FG000|Treatment 3|Overall Study||614||
59980673|NCT03486834|76097795|FG001|Treatment 3|Overall Study||631||
59980674|NCT03486834|76097796|FG002|Treatment 3|Overall Study||622||
59980675|NCT03486834|76097794|FG000|COMPLETED|Overall Study||614||
59980676|NCT03486834|76097795|FG001|COMPLETED|Overall Study||631||
59980677|NCT03486834|76097796|FG002|COMPLETED|Overall Study||622||
59980678|NCT03486834|76097794|FG000|NOT COMPLETED|Overall Study||119||
59980679|NCT03486834|76097795|FG001|NOT COMPLETED|Overall Study||102||
59980680|NCT03486834|76097796|FG002|NOT COMPLETED|Overall Study||112||
59980681|NCT03445793|76097806|FG000|STARTED|Overall Study||5||
59980682|NCT03445793|76097806|FG000|COMPLETED|Overall Study||5||
59980683|NCT03445793|76097806|FG000|NOT COMPLETED|Overall Study||0||
59980684|NCT03356145|76097812|FG000|STARTED|Overall Study||48||
59980685|NCT03356145|76097813|FG001|STARTED|Overall Study||48||
59980686|NCT03356145|76097812|FG000|Received Allocated Intervention|Overall Study||45||
59980687|NCT03356145|76097813|FG001|Received Allocated Intervention|Overall Study||47||
59980688|NCT03356145|76097812|FG000|COMPLETED|Overall Study||45||
59980689|NCT03356145|76097813|FG001|COMPLETED|Overall Study||47||
59980690|NCT03356145|76097812|FG000|NOT COMPLETED|Overall Study||3||
59980691|NCT03356145|76097813|FG001|NOT COMPLETED|Overall Study||1||
59980692|NCT03312738|76097821|FG000|STARTED|Overall Study||80||
59980693|NCT03312738|76097822|FG001|STARTED|Overall Study||79||
59980694|NCT03312738|76097821|FG000|COMPLETED|Overall Study||0||
59980695|NCT03312738|76097822|FG001|COMPLETED|Overall Study||0||
59980696|NCT03312738|76097821|FG000|NOT COMPLETED|Overall Study||80||
59980697|NCT03312738|76097822|FG001|NOT COMPLETED|Overall Study||79||
59980698|NCT03268954|76097832|FG000|STARTED|Overall Study||227||
59980699|NCT03268954|76097833|FG001|STARTED|Overall Study||227||
59980700|NCT03268954|76097832|FG000|Safety Population|Overall Study||220|Safety Population included all enrolled participants who received at least 1 dose of azacitidine alone or pevonedistat + azacitidine.|
59980701|NCT03268954|76097833|FG001|Safety Population|Overall Study||223|Safety Population included all enrolled participants who received at least 1 dose of azacitidine alone or pevonedistat + azacitidine.|
59980702|NCT03268954|76097832|FG000|COMPLETED|Overall Study||0||
59980703|NCT03268954|76097833|FG001|COMPLETED|Overall Study||0||
59980704|NCT03268954|76097832|FG000|NOT COMPLETED|Overall Study||227||
59980705|NCT03268954|76097833|FG001|NOT COMPLETED|Overall Study||227||
59980706|NCT03196232|76097839|FG000|STARTED|Overall Study||3||
59980707|NCT03196232|76097839|FG000|COMPLETED|Overall Study||3||
59980708|NCT03196232|76097839|FG000|NOT COMPLETED|Overall Study||0||
59980709|NCT03194646|76097847|FG000|STARTED|Overall Study||363|Randomized|
59980710|NCT03194646|76097848|FG001|STARTED|Overall Study||361|Randomized|
59980711|NCT03194646|76097849|FG002|STARTED|Overall Study||183|Randomized|
59980712|NCT03194646|76097850|FG003|STARTED|Overall Study||365|Randomized|
59980713|NCT03194646|76097847|FG000|Treated|Overall Study||349|Treated (with study drug or study drug administration status unknown or randomized to Standard of Care)|
59980714|NCT03194646|76097848|FG001|Treated|Overall Study||347|Treated (with study drug or study drug administration status unknown or randomized to Standard of Care)|
59980715|NCT03194646|76097849|FG002|Treated|Overall Study||177|Treated (with study drug or study drug administration status unknown or randomized to Standard of Care)|
59980716|NCT03194646|76097850|FG003|Treated|Overall Study||365|Treated (with study drug or study drug administration status unknown or randomized to Standard of Care)|
59980717|NCT03194646|76097847|FG000|COMPLETED|Overall Study||59||
59980718|NCT03194646|76097848|FG001|COMPLETED|Overall Study||93||
59980719|NCT03194646|76097849|FG002|COMPLETED|Overall Study||44||
59980720|NCT03194646|76097850|FG003|COMPLETED|Overall Study||85||
59980721|NCT03194646|76097847|FG000|NOT COMPLETED|Overall Study||304||
59980722|NCT03194646|76097848|FG001|NOT COMPLETED|Overall Study||268||
59980723|NCT03194646|76097849|FG002|NOT COMPLETED|Overall Study||139||
59980724|NCT03194646|76097850|FG003|NOT COMPLETED|Overall Study||280||
59980725|NCT03094663|76097867|FG000|STARTED|Overall Study||43||
59980726|NCT03094663|76097868|FG001|STARTED|Overall Study||43||
59980727|NCT03094663|76097867|FG000|COMPLETED|Overall Study||43||
59980728|NCT03094663|76097868|FG001|COMPLETED|Overall Study||43||
59980729|NCT03094663|76097867|FG000|NOT COMPLETED|Overall Study||0||
59980730|NCT03094663|76097868|FG001|NOT COMPLETED|Overall Study||0||
59980731|NCT03022032|76097880|FG000|STARTED|Overall Study||10||
59980732|NCT03022032|76097881|FG001|STARTED|Overall Study||23||
59980733|NCT03022032|76097882|FG002|STARTED|Overall Study||21||
59980734|NCT03022032|76097883|FG003|STARTED|Overall Study||22||
59980735|NCT03022032|76097884|FG004|STARTED|Overall Study||22||
59980736|NCT03022032|76097885|FG005|STARTED|Overall Study||4||
59980737|NCT03022032|76097880|FG000|COMPLETED|Overall Study||10||
59980738|NCT03022032|76097881|FG001|COMPLETED|Overall Study||23||
59980739|NCT03022032|76097882|FG002|COMPLETED|Overall Study||21||
59980740|NCT03022032|76097883|FG003|COMPLETED|Overall Study||22||
59980741|NCT03022032|76097884|FG004|COMPLETED|Overall Study||22||
59980742|NCT03022032|76097885|FG005|COMPLETED|Overall Study||4||
59980743|NCT03022032|76097880|FG000|NOT COMPLETED|Overall Study||0||
59980744|NCT03022032|76097881|FG001|NOT COMPLETED|Overall Study||0||
59980745|NCT03022032|76097882|FG002|NOT COMPLETED|Overall Study||0||
59980746|NCT03022032|76097883|FG003|NOT COMPLETED|Overall Study||0||
59980747|NCT03022032|76097884|FG004|NOT COMPLETED|Overall Study||0||
59980748|NCT03022032|76097885|FG005|NOT COMPLETED|Overall Study||0||
59980749|NCT02979522|76097898|FG000|STARTED|Overall Study||8||
59980750|NCT02979522|76097899|FG001|STARTED|Overall Study||51||
59980751|NCT02979522|76097898|FG000|COMPLETED|Overall Study||0||
59980752|NCT02979522|76097899|FG001|COMPLETED|Overall Study||0||
59980753|NCT02979522|76097898|FG000|NOT COMPLETED|Overall Study||8||
59980754|NCT02979522|76097899|FG001|NOT COMPLETED|Overall Study||51||
59980755|NCT02927262|76097913|FG000|STARTED|Overall Study||63||
59980756|NCT02927262|76097914|FG001|STARTED|Overall Study||35||
59980757|NCT02927262|76097913|FG000|COMPLETED|Overall Study||20||
59980758|NCT02927262|76097914|FG001|COMPLETED|Overall Study||12||
59980759|NCT02927262|76097913|FG000|NOT COMPLETED|Overall Study||43||
59980760|NCT02927262|76097914|FG001|NOT COMPLETED|Overall Study||23||
59980761|NCT02663622|76097924|FG000|STARTED|Overall Study||6||
59980762|NCT02663622|76097925|FG001|STARTED|Overall Study||6||
59980763|NCT02663622|76097926|FG002|STARTED|Overall Study||6||
59980764|NCT02663622|76097927|FG003|STARTED|Overall Study||26||
59980765|NCT02663622|76097924|FG000|COMPLETED|Overall Study||3||
59980766|NCT02663622|76097925|FG001|COMPLETED|Overall Study||5||
59980767|NCT02663622|76097926|FG002|COMPLETED|Overall Study||5||
59980768|NCT02663622|76097927|FG003|COMPLETED|Overall Study||17||
59980769|NCT02663622|76097924|FG000|NOT COMPLETED|Overall Study||3||
59980770|NCT02663622|76097925|FG001|NOT COMPLETED|Overall Study||1||
59980771|NCT02663622|76097926|FG002|NOT COMPLETED|Overall Study||1||
59980772|NCT02663622|76097927|FG003|NOT COMPLETED|Overall Study||9||
59980773|NCT02637713|76097938|FG000|STARTED|Overall Study||5||
59980774|NCT02637713|76097938|FG000|COMPLETED|Overall Study||3||
59980775|NCT02637713|76097938|FG000|NOT COMPLETED|Overall Study||2||
59980776|NCT02553473|76097944|FG000|STARTED|Overall Study||61||
59980777|NCT02553473|76097945|FG001|STARTED|Overall Study||60||
59980778|NCT02553473|76097944|FG000|COMPLETED|Overall Study||54||
59980779|NCT02553473|76097945|FG001|COMPLETED|Overall Study||55||
59980780|NCT02553473|76097944|FG000|NOT COMPLETED|Overall Study||7||
59980781|NCT02553473|76097945|FG001|NOT COMPLETED|Overall Study||5||
59980782|NCT02421939|76097953|FG000|STARTED|Overall Study||247||
59980783|NCT02421939|76097954|FG001|STARTED|Overall Study||124||
59980784|NCT02421939|76097953|FG000|Treated|Overall Study||246||
59980785|NCT02421939|76097954|FG001|Treated|Overall Study||109||
59980786|NCT02421939|76097953|FG000|COMPLETED|Overall Study||38|Participants still on treatment. Last assessment of remission status at the end of treatment visit.|
59980787|NCT02421939|76097954|FG001|COMPLETED|Overall Study||0|Participants still on treatment. Last assessment of remission status at the end of treatment visit.|
59980788|NCT02421939|76097953|FG000|NOT COMPLETED|Overall Study||209||
59980789|NCT02421939|76097954|FG001|NOT COMPLETED|Overall Study||124||
59980790|NCT02294461|76097962|FG000|STARTED|Double-blind Period (up to 29.4 Months)||202||
59980791|NCT02294461|76097963|FG001|STARTED|Double-blind Period (up to 29.4 Months)||193||
59980792|NCT02294461|76097962|FG000|Treated/Received Study Drug|Double-blind Period (up to 29.4 Months)||202||
59980793|NCT02294461|76097963|FG001|Treated/Received Study Drug|Double-blind Period (up to 29.4 Months)||193||
59980794|NCT02294461|76097962|FG000|COMPLETED|Double-blind Period (up to 29.4 Months)||84||
59980795|NCT02294461|76097963|FG001|COMPLETED|Double-blind Period (up to 29.4 Months)||1||
59980796|NCT02294461|76097962|FG000|NOT COMPLETED|Double-blind Period (up to 29.4 Months)||118||
59980797|NCT02294461|76097963|FG001|NOT COMPLETED|Double-blind Period (up to 29.4 Months)||192||
59980798|NCT02294461|76097962|FG000|STARTED|Open-label Period (up to 54.3 Months)|Eligible participants who provided consent took part in open-label period.|85||
59980799|NCT02294461|76097963|FG001|STARTED|Open-label Period (up to 54.3 Months)|Eligible participants who provided consent took part in open-label period.|51||
59980800|NCT02294461|76097962|FG000|COMPLETED|Open-label Period (up to 54.3 Months)||0||
59980801|NCT02294461|76097963|FG001|COMPLETED|Open-label Period (up to 54.3 Months)||0||
59980802|NCT02294461|76097962|FG000|NOT COMPLETED|Open-label Period (up to 54.3 Months)||85||
59980803|NCT02294461|76097963|FG001|NOT COMPLETED|Open-label Period (up to 54.3 Months)||51||
60074800|NCT01930045|76190106|FG003|NOT COMPLETED|Part 1 - Period 1||0||
59980804|NCT01722240|76097983|FG000|STARTED|Overall Study||35||
59980805|NCT01722240|76097984|FG001|STARTED|Overall Study||34||
59980806|NCT01722240|76097983|FG000|COMPLETED|Overall Study||26||
59980807|NCT01722240|76097984|FG001|COMPLETED|Overall Study||20||
59980808|NCT01722240|76097983|FG000|NOT COMPLETED|Overall Study||9||
59980809|NCT01722240|76097984|FG001|NOT COMPLETED|Overall Study||14||
59980810|NCT01697397|76097992|FG000|STARTED|Overall Study||88||
59980811|NCT01697397|76097992|FG000|COMPLETED|Overall Study||88||
59980812|NCT01697397|76097992|FG000|NOT COMPLETED|Overall Study||0||
59980813|NCT01651208|76098005|FG000|STARTED|Overall Study||227||
59980814|NCT01651208|76098006|FG001|STARTED|Overall Study||225||
59980815|NCT01651208|76098005|FG000|COMPLETED|Overall Study|14 patients had no pharmacy claims data to analyze primary outcome|213||
59980816|NCT01651208|76098006|FG001|COMPLETED|Overall Study|16 subjects had no pharmacy claims data to analyze primary outcome|209||
59980817|NCT01651208|76098005|FG000|NOT COMPLETED|Overall Study||14||
59980818|NCT01651208|76098006|FG001|NOT COMPLETED|Overall Study||16||
59980819|NCT01361711|76098013|FG000|STARTED|Trial Entry (Registration)||53||
59980820|NCT01361711|76098013|FG000|Received Dose of Study Drug|Trial Entry (Registration)||52||
59980821|NCT01361711|76098013|FG000|COMPLETED|Trial Entry (Registration)||52||
59980822|NCT01361711|76098013|FG000|NOT COMPLETED|Trial Entry (Registration)||1||
59980823|NCT01361711|76098013|FG000|STARTED|Week 9 Bone Marrow Response Assessment||52||
59980824|NCT01361711|76098013|FG000|COMPLETED|Week 9 Bone Marrow Response Assessment||51|As soon as a patient is determined to have achieved Minimal Residual Disease negative Complete Remission or Complete remission with incomplete marrow recovery (per iwCLL2008 criteria), both alemtuzumab and ofatumumab will be stopped.|
59980825|NCT01361711|76098013|FG000|NOT COMPLETED|Week 9 Bone Marrow Response Assessment||1||
59980826|NCT01361711|76098013|FG000|STARTED|Continued Treatment After 9 Weeks||51||
59980827|NCT01361711|76098013|FG000|COMPLETED|Continued Treatment After 9 Weeks||44|As soon as a patient is determined to have achieved Minimal Residual Disease negative Complete Remission or Complete remission with incomplete marrow recovery (per iwCLL2008 criteria), both alemtuzumab and ofatumumab will be stopped.|
59980828|NCT01361711|76098013|FG000|NOT COMPLETED|Continued Treatment After 9 Weeks||7||
59980829|NCT01361711|76098013|FG000|STARTED|Continued Treatment After 12 Weeks||44|A bone marrow biopsy will be performed during week 9 to assess response. If biopsy results show residual CLL with minimal involvement (< 10% involvement), an additional bone marrow biopsy is recommended after week 12 of treatment.|
59995376|NCT03016975|76111237|FG001|NOT COMPLETED|At 30 Days Follow-up||0||
59995377|NCT03016975|76111238|FG002|NOT COMPLETED|At 30 Days Follow-up||0||
59995378|NCT03016975|76111236|FG000|STARTED|At 6 Months Follow-up||11||
59995379|NCT03016975|76111237|FG001|STARTED|At 6 Months Follow-up||0||
59995380|NCT03016975|76111238|FG002|STARTED|At 6 Months Follow-up||0||
59814786|NCT00518622|75937192|FG000|NOT COMPLETED|Overall Study||0||
59814787|NCT00518622|75937193|FG001|NOT COMPLETED|Overall Study||1||
59814788|NCT00518622|75937194|FG002|NOT COMPLETED|Overall Study||1||
59814789|NCT00518622|75937195|FG003|NOT COMPLETED|Overall Study||0||
59814790|NCT00518622|75937196|FG004|NOT COMPLETED|Overall Study||0||
59814791|NCT00518622|75937197|FG005|NOT COMPLETED|Overall Study||0||
59814792|NCT00518622|75937198|FG006|NOT COMPLETED|Overall Study||0||
59814793|NCT00518622|75937199|FG007|NOT COMPLETED|Overall Study||0||
59814794|NCT00517296|75937219|FG000|STARTED|Overall Study||10||
59814795|NCT00517296|75937220|FG001|STARTED|Overall Study||11||
59814796|NCT00517296|75937219|FG000|COMPLETED|Overall Study||9||
59814797|NCT00517296|75937220|FG001|COMPLETED|Overall Study||11||
59814798|NCT00517296|75937219|FG000|NOT COMPLETED|Overall Study||1||
59814799|NCT00517296|75937220|FG001|NOT COMPLETED|Overall Study||0||
59814800|NCT00516906|75937228|FG000|STARTED|Overall Study||36||
59814801|NCT00516906|75937229|FG001|STARTED|Overall Study|33 patients were randomized but one patient was discharged prior to treatment.|32||
59814802|NCT00516906|75937228|FG000|COMPLETED|Overall Study|Thirty patients were required to complete. Patients not completing were replaced.|30||
59814803|NCT00516906|75937229|FG001|COMPLETED|Overall Study|Thirty patients were required to complete. Patients not completing were replaced.|30||
59814804|NCT00516906|75937228|FG000|NOT COMPLETED|Overall Study||6||
59814805|NCT00516906|75937229|FG001|NOT COMPLETED|Overall Study||2||
59814806|NCT00523848|75937235|FG000|STARTED|Overall Study||46||
59814807|NCT00523848|75937235|FG000|Treated With Study Therapy|Overall Study||44||
59814808|NCT00523848|75937235|FG000|COMPLETED|Overall Study||22||
59814809|NCT00523848|75937235|FG000|NOT COMPLETED|Overall Study||24||
59814810|NCT00617669|75937241|FG000|STARTED|Overall Study||524||
59814811|NCT00617669|75937242|FG001|STARTED|Overall Study||528||
59814812|NCT00617669|75937241|FG000|Patients Who Received IP|Overall Study||522||
59814813|NCT00617669|75937242|FG001|Patients Who Received IP|Overall Study||525||
59814814|NCT00617669|75937241|FG000|COMPLETED|Overall Study|Patients receiving ZD4054 10 mg at data cut-off|94||
59814815|NCT00617669|75937242|FG001|COMPLETED|Overall Study|Patients receiving placebo at data cut-off|77||
59814816|NCT00617669|75937241|FG000|NOT COMPLETED|Overall Study||430||
59814817|NCT00617669|75937242|FG001|NOT COMPLETED|Overall Study||451||
59995381|NCT03016975|76111236|FG000|COMPLETED|At 6 Months Follow-up||6||
59995382|NCT03016975|76111237|FG001|COMPLETED|At 6 Months Follow-up||0||
59814818|NCT03682848|75937248|FG000|STARTED|Overall Study||32||
59814819|NCT03682848|75937248|FG000|COMPLETED|Overall Study||23||
59814820|NCT03682848|75937248|FG000|NOT COMPLETED|Overall Study||9||
59814821|NCT00510510|75937255|FG000|STARTED|Overall Study||92||
59814822|NCT00510510|75937256|FG001|STARTED|Overall Study||98||
59814823|NCT00510510|75937257|FG002|STARTED|Overall Study||91||
59814824|NCT00510510|75937255|FG000|COMPLETED|Overall Study||87||
59814825|NCT00510510|75937256|FG001|COMPLETED|Overall Study||89||
59814826|NCT00510510|75937257|FG002|COMPLETED|Overall Study||74||
59814827|NCT00510510|75937255|FG000|NOT COMPLETED|Overall Study||5||
59814828|NCT00510510|75937256|FG001|NOT COMPLETED|Overall Study||9||
59814829|NCT00510510|75937257|FG002|NOT COMPLETED|Overall Study||17||
59814830|NCT00617591|75937265|FG000|STARTED|Overall Study||57||
59814831|NCT00617591|75937265|FG000|COMPLETED|Overall Study||47||
59814832|NCT00617591|75937265|FG000|NOT COMPLETED|Overall Study||10||
59814833|NCT00510276|75937272|FG000|STARTED|Acute Double-Blind Phase||220||
59814834|NCT00510276|75937273|FG001|STARTED|Acute Double-Blind Phase||225||
59814835|NCT00510276|75937272|FG000|COMPLETED|Acute Double-Blind Phase||115||
59814836|NCT00510276|75937273|FG001|COMPLETED|Acute Double-Blind Phase||130||
59814837|NCT00510276|75937272|FG000|NOT COMPLETED|Acute Double-Blind Phase||105||
59814838|NCT00510276|75937273|FG001|NOT COMPLETED|Acute Double-Blind Phase||95||
59814839|NCT00510276|75937272|FG000|STARTED|Extension Open-Label Phase|4 patients who completed acute phase did not participate in the optional atomoxetine extension phase|111||
59814840|NCT00510276|75937273|FG001|STARTED|Extension Open-Label Phase|1 patient who completed acute phase did not participate in the optional atometine extension phase|129||
59814841|NCT00510276|75937272|FG000|COMPLETED|Extension Open-Label Phase||78||
59814842|NCT00510276|75937273|FG001|COMPLETED|Extension Open-Label Phase||81||
59814843|NCT00510276|75937272|FG000|NOT COMPLETED|Extension Open-Label Phase||33||
59814844|NCT00510276|75937273|FG001|NOT COMPLETED|Extension Open-Label Phase||48||
59814845|NCT00616655|75937289|FG000|STARTED|Overall Study||152||
59995383|NCT03016975|76111238|FG002|COMPLETED|At 6 Months Follow-up||0||
59814846|NCT00616655|75937290|FG001|STARTED|Overall Study||153||
59814847|NCT00616655|75937291|FG002|STARTED|Overall Study||151||
59814848|NCT00616655|75937289|FG000|COMPLETED|Overall Study||117||
59814849|NCT00616655|75937290|FG001|COMPLETED|Overall Study||112||
59814850|NCT00616655|75937291|FG002|COMPLETED|Overall Study||103||
59814851|NCT00616655|75937289|FG000|NOT COMPLETED|Overall Study||35||
59814852|NCT00616655|75937290|FG001|NOT COMPLETED|Overall Study||41||
59995384|NCT03016975|76111236|FG000|NOT COMPLETED|At 6 Months Follow-up||5||
59995385|NCT03016975|76111237|FG001|NOT COMPLETED|At 6 Months Follow-up||0||
59995386|NCT03016975|76111238|FG002|NOT COMPLETED|At 6 Months Follow-up||0||
59995387|NCT03016975|76111236|FG000|STARTED|At 1 Year Follow-up||6||
59995388|NCT03016975|76111237|FG001|STARTED|At 1 Year Follow-up||0||
59995389|NCT03016975|76111238|FG002|STARTED|At 1 Year Follow-up||0||
59995390|NCT03016975|76111236|FG000|COMPLETED|At 1 Year Follow-up||6||
59995391|NCT03016975|76111237|FG001|COMPLETED|At 1 Year Follow-up||0||
59995392|NCT03016975|76111238|FG002|COMPLETED|At 1 Year Follow-up||0||
59995393|NCT03016975|76111236|FG000|NOT COMPLETED|At 1 Year Follow-up||0||
59995394|NCT03016975|76111237|FG001|NOT COMPLETED|At 1 Year Follow-up||0||
59995395|NCT03016975|76111238|FG002|NOT COMPLETED|At 1 Year Follow-up||0||
59995396|NCT03016975|76111236|FG000|STARTED|At 2 Year Follow-up||6||
59995397|NCT03016975|76111237|FG001|STARTED|At 2 Year Follow-up||0||
60074801|NCT01930045|76190107|FG004|NOT COMPLETED|Part 1 - Period 1||0||
60074802|NCT01930045|76190108|FG005|NOT COMPLETED|Part 1 - Period 1||0||
60074803|NCT01930045|76190103|FG000|STARTED|Part 1 - Period 2||3||
60074804|NCT01930045|76190104|FG001|STARTED|Part 1 - Period 2||3||
60074805|NCT01930045|76190105|FG002|STARTED|Part 1 - Period 2||3||
60074806|NCT01930045|76190106|FG003|STARTED|Part 1 - Period 2||3||
60074807|NCT01930045|76190107|FG004|STARTED|Part 1 - Period 2||3||
60074808|NCT01930045|76190108|FG005|STARTED|Part 1 - Period 2||3||
60074809|NCT01930045|76190103|FG000|COMPLETED|Part 1 - Period 2||3||
59980830|NCT01361711|76098013|FG000|COMPLETED|Continued Treatment After 12 Weeks||41|As soon as a patient is determined to have achieved Minimal Residual Disease negative Complete Remission or Complete remission with incomplete marrow recovery (per iwCLL2008 criteria), both alemtuzumab and ofatumumab will be stopped.|
59980831|NCT01361711|76098013|FG000|NOT COMPLETED|Continued Treatment After 12 Weeks||3||
59980832|NCT01361711|76098013|FG000|STARTED|Completed Week 18 of Treatment||41||
59980833|NCT01361711|76098013|FG000|COMPLETED|Completed Week 18 of Treatment||30|As soon as a patient is determined to have achieved Minimal Residual Disease negative Complete Remission or Complete remission with incomplete marrow recovery (per iwCLL2008 criteria), both alemtuzumab and ofatumumab will be stopped.|
59980834|NCT01361711|76098013|FG000|NOT COMPLETED|Completed Week 18 of Treatment||11||
59980835|NCT01361711|76098013|FG000|STARTED|10 Year Follow-up|All patients who receive at least one dose of study drug go into follow-up.|52||
59980836|NCT01361711|76098013|FG000|COMPLETED|10 Year Follow-up||2||
59980837|NCT01361711|76098013|FG000|NOT COMPLETED|10 Year Follow-up||50||
59980838|NCT02572388|76098021|FG000|STARTED|Overall Study||11||
59980839|NCT02572388|76098022|FG001|STARTED|Overall Study||4||
59980840|NCT02572388|76098023|FG002|STARTED|Overall Study||10||
59980841|NCT02572388|76098024|FG003|STARTED|Overall Study||6||
59980842|NCT02572388|76098021|FG000|COMPLETED|Overall Study||10||
59980843|NCT02572388|76098022|FG001|COMPLETED|Overall Study||3||
59980844|NCT02572388|76098023|FG002|COMPLETED|Overall Study||8||
59980845|NCT02572388|76098024|FG003|COMPLETED|Overall Study||4||
59980846|NCT02572388|76098021|FG000|NOT COMPLETED|Overall Study||1||
59980847|NCT02572388|76098022|FG001|NOT COMPLETED|Overall Study||1||
59980848|NCT02572388|76098023|FG002|NOT COMPLETED|Overall Study||2||
59980849|NCT02572388|76098024|FG003|NOT COMPLETED|Overall Study||2||
59980850|NCT02573870|76098036|FG000|STARTED|Overall Study||20||
59980851|NCT02573870|76098037|FG001|STARTED|Overall Study||42||
59980852|NCT02573870|76098036|FG000|COMPLETED|Overall Study||20||
59980853|NCT02573870|76098037|FG001|COMPLETED|Overall Study||35||
59980854|NCT02573870|76098036|FG000|NOT COMPLETED|Overall Study||0||
59980855|NCT02573870|76098037|FG001|NOT COMPLETED|Overall Study||7||
59980856|NCT02572076|76098043|FG000|STARTED|Overall Study||10||
59980857|NCT02572076|76098043|FG000|COMPLETED|Overall Study||9||
59980858|NCT02572076|76098043|FG000|NOT COMPLETED|Overall Study||1||
59980859|NCT02571452|76098049|FG000|STARTED|Overall Study Treatment||47|Randomized to Treatment Arm|
59980860|NCT02571452|76098050|FG001|STARTED|Overall Study Treatment||46|Randomized to Treatment Arm|
59980861|NCT02571452|76098049|FG000|COMPLETED|Overall Study Treatment||47|Completed Treatment|
59980862|NCT02571452|76098050|FG001|COMPLETED|Overall Study Treatment||45|Completed Treatment|
59980863|NCT02571452|76098049|FG000|NOT COMPLETED|Overall Study Treatment||0||
59980864|NCT02571452|76098050|FG001|NOT COMPLETED|Overall Study Treatment||1||
59980865|NCT02571452|76098049|FG000|STARTED|Overall Study 6-Month Follow-up||47|Scheduled for 6-Month Follow-up Assessment|
59980866|NCT02571452|76098050|FG001|STARTED|Overall Study 6-Month Follow-up|Participants in the PMRT arm were not invited to complete 6-Month Follow-up.|0|Scheduled for 6-Month Follow-up Assessment|
59980867|NCT02571452|76098049|FG000|COMPLETED|Overall Study 6-Month Follow-up||42||
59980868|NCT02571452|76098050|FG001|COMPLETED|Overall Study 6-Month Follow-up||0||
59980869|NCT02571452|76098049|FG000|NOT COMPLETED|Overall Study 6-Month Follow-up||5||
59980870|NCT02571452|76098050|FG001|NOT COMPLETED|Overall Study 6-Month Follow-up||0||
59980871|NCT02574260|76098056|FG000|STARTED|Overall Study||3||
59980872|NCT02574260|76098056|FG000|COMPLETED|Overall Study||2||
59980873|NCT02574260|76098056|FG000|NOT COMPLETED|Overall Study||1||
59980874|NCT02570126|76098062|FG000|STARTED|Overall Study||615||
59980875|NCT02570126|76098063|FG001|STARTED|Overall Study||616||
59980876|NCT02570126|76098062|FG000|COMPLETED|Overall Study||609||
59980877|NCT02570126|76098063|FG001|COMPLETED|Overall Study||607||
59814853|NCT00616655|75937291|FG002|NOT COMPLETED|Overall Study||48||
59814854|NCT00510198|75937301|FG000|STARTED|Overall Study||59|3 subjects were exited prior to randomization for not meeting the inclusion /exclusion criteria.|
59814855|NCT00510198|75937302|FG001|STARTED|Overall Study||58|3 subjects were exited prior to randomization for not meeting the inclusion /exclusion criteria.|
59980878|NCT02570126|76098062|FG000|NOT COMPLETED|Overall Study||6||
59980879|NCT02570126|76098063|FG001|NOT COMPLETED|Overall Study||9||
59980880|NCT02755831|76098071|FG000|STARTED|Overall Study||100||
59980881|NCT02755831|76098072|FG001|STARTED|Overall Study||93||
59980882|NCT02755831|76098071|FG000|COMPLETED|Overall Study||97||
59980883|NCT02755831|76098072|FG001|COMPLETED|Overall Study||90||
59980884|NCT02755831|76098071|FG000|NOT COMPLETED|Overall Study||3||
59980885|NCT02755831|76098072|FG001|NOT COMPLETED|Overall Study||3||
59980886|NCT02573246|76098083|FG000|STARTED|Overall Study||14||
59980887|NCT02573246|76098084|FG001|STARTED|Overall Study||15||
59980888|NCT02573246|76098085|FG002|STARTED|Overall Study||18||
59980889|NCT02573246|76098086|FG003|STARTED|Overall Study||16||
59980890|NCT02573246|76098087|FG004|STARTED|Overall Study||15||
59980891|NCT02573246|76098083|FG000|COMPLETED|Overall Study||11||
59814856|NCT00510198|75937301|FG000|COMPLETED|Overall Study||54||
59814857|NCT00510198|75937302|FG001|COMPLETED|Overall Study||54||
59814858|NCT00510198|75937301|FG000|NOT COMPLETED|Overall Study||5||
59814859|NCT00510198|75937302|FG001|NOT COMPLETED|Overall Study||4||
59814860|NCT00516048|75937312|FG000|STARTED|Overall Study||15||
59814861|NCT00516048|75937313|FG001|STARTED|Overall Study||42||
59814862|NCT00516048|75937314|FG002|STARTED|Overall Study||1||
59980892|NCT02573246|76098084|FG001|COMPLETED|Overall Study||14||
59980893|NCT02573246|76098085|FG002|COMPLETED|Overall Study||15||
59980894|NCT02573246|76098086|FG003|COMPLETED|Overall Study||14||
59980895|NCT02573246|76098087|FG004|COMPLETED|Overall Study||11||
59980896|NCT02573246|76098083|FG000|NOT COMPLETED|Overall Study||3||
59980897|NCT02573246|76098084|FG001|NOT COMPLETED|Overall Study||1||
59980898|NCT02573246|76098085|FG002|NOT COMPLETED|Overall Study||3||
59980899|NCT02573246|76098086|FG003|NOT COMPLETED|Overall Study||2||
59980900|NCT02573246|76098087|FG004|NOT COMPLETED|Overall Study||4||
59980901|NCT02570750|76098106|FG000|STARTED|Overall Study||110||
59980902|NCT02570750|76098107|FG001|STARTED|Overall Study||73||
59980903|NCT02570750|76098106|FG000|COMPLETED|Overall Study||96||
59980904|NCT02570750|76098107|FG001|COMPLETED|Overall Study||68||
59980905|NCT02570750|76098106|FG000|NOT COMPLETED|Overall Study||14||
59980906|NCT02570750|76098107|FG001|NOT COMPLETED|Overall Study||5||
59980907|NCT02573012|76098115|FG000|STARTED|Overall Study||131||
59980908|NCT02573012|76098116|FG001|STARTED|Overall Study||128||
59980909|NCT02573012|76098115|FG000|COMPLETED|Overall Study||116||
59980910|NCT02573012|76098116|FG001|COMPLETED|Overall Study||113||
59980911|NCT02573012|76098115|FG000|NOT COMPLETED|Overall Study||15||
59980912|NCT02573012|76098116|FG001|NOT COMPLETED|Overall Study||15||
59980913|NCT02752633|76098122|FG000|STARTED|Overall Study||9||
59980914|NCT02752633|76098122|FG000|COMPLETED|Overall Study||8||
59980915|NCT02752633|76098122|FG000|NOT COMPLETED|Overall Study||1||
59980916|NCT02752087|76098126|FG000|STARTED|Study Period 1||12||
59980917|NCT02752087|76098127|FG001|STARTED|Study Period 1||12||
59980918|NCT02752087|76098126|FG000|Received Study Drug|Study Period 1||12||
59980919|NCT02752087|76098127|FG001|Received Study Drug|Study Period 1||12||
59980920|NCT02752087|76098126|FG000|COMPLETED|Study Period 1||12||
59980921|NCT02752087|76098127|FG001|COMPLETED|Study Period 1||12||
59980922|NCT02752087|76098126|FG000|NOT COMPLETED|Study Period 1||0||
59980923|NCT02752087|76098127|FG001|NOT COMPLETED|Study Period 1||0||
59980924|NCT02752087|76098126|FG000|STARTED|Washout||12||
59980925|NCT02752087|76098127|FG001|STARTED|Washout||12||
59980926|NCT02752087|76098126|FG000|COMPLETED|Washout||11||
59980927|NCT02752087|76098127|FG001|COMPLETED|Washout||12||
59980928|NCT02752087|76098126|FG000|NOT COMPLETED|Washout||1||
59980929|NCT02752087|76098127|FG001|NOT COMPLETED|Washout||0||
59980930|NCT02752087|76098126|FG000|STARTED|Study Period 2||11||
59814863|NCT00516048|75937312|FG000|COMPLETED|Overall Study||15||
59980931|NCT02752087|76098127|FG001|STARTED|Study Period 2||12||
59980932|NCT02752087|76098126|FG000|Received Study Drug|Study Period 2||11||
59980933|NCT02752087|76098127|FG001|Received Study Drug|Study Period 2||12||
59980934|NCT02752087|76098126|FG000|COMPLETED|Study Period 2||11||
59980935|NCT02752087|76098127|FG001|COMPLETED|Study Period 2||12||
59980936|NCT02752087|76098126|FG000|NOT COMPLETED|Study Period 2||0||
59980937|NCT02752087|76098127|FG001|NOT COMPLETED|Study Period 2||0||
59980938|NCT02752087|76098126|FG000|STARTED|Washout||11||
59980939|NCT02752087|76098127|FG001|STARTED|Washout||12||
59980940|NCT02752087|76098126|FG000|COMPLETED|Washout||11||
59980941|NCT02752087|76098127|FG001|COMPLETED|Washout||12||
59980942|NCT02752087|76098126|FG000|NOT COMPLETED|Washout||0||
59980943|NCT02752087|76098127|FG001|NOT COMPLETED|Washout||0||
59980944|NCT02752087|76098126|FG000|STARTED|Study Period 3||11||
59980945|NCT02752087|76098127|FG001|STARTED|Study Period 3||12||
59980946|NCT02752087|76098126|FG000|Received Study Drug|Study Period 3||11||
59980947|NCT02752087|76098127|FG001|Received Study Drug|Study Period 3||12||
59980948|NCT02752087|76098126|FG000|COMPLETED|Study Period 3||11||
59980949|NCT02752087|76098127|FG001|COMPLETED|Study Period 3||12||
59980950|NCT02752087|76098126|FG000|NOT COMPLETED|Study Period 3||0||
59980951|NCT02752087|76098127|FG001|NOT COMPLETED|Study Period 3||0||
59980952|NCT02752087|76098126|FG000|STARTED|Washout||11||
59980953|NCT02752087|76098127|FG001|STARTED|Washout||12||
59980954|NCT02752087|76098126|FG000|COMPLETED|Washout||11||
59980955|NCT02752087|76098127|FG001|COMPLETED|Washout||12||
59980956|NCT02752087|76098126|FG000|NOT COMPLETED|Washout||0||
59980957|NCT02752087|76098127|FG001|NOT COMPLETED|Washout||0||
59980958|NCT02752087|76098126|FG000|STARTED|Study Period 4||11||
59980959|NCT02752087|76098127|FG001|STARTED|Study Period 4||12||
59980960|NCT02752087|76098126|FG000|Received Study Drug|Study Period 4||11||
59980961|NCT02752087|76098127|FG001|Received Study Drug|Study Period 4||12||
59980962|NCT02752087|76098126|FG000|COMPLETED|Study Period 4||11||
59980963|NCT02752087|76098127|FG001|COMPLETED|Study Period 4||12||
59980964|NCT02752087|76098126|FG000|NOT COMPLETED|Study Period 4||0||
59980965|NCT02752087|76098127|FG001|NOT COMPLETED|Study Period 4||0||
59980966|NCT02752087|76098126|FG000|STARTED|Follow-up||11||
59980967|NCT02752087|76098127|FG001|STARTED|Follow-up||12||
59980968|NCT02752087|76098126|FG000|COMPLETED|Follow-up||11||
59980969|NCT02752087|76098127|FG001|COMPLETED|Follow-up||12||
59980970|NCT02752087|76098126|FG000|NOT COMPLETED|Follow-up||0||
59980971|NCT02752087|76098127|FG001|NOT COMPLETED|Follow-up||0||
59980972|NCT04766996|76098136|FG000|STARTED|Overall Study||7||
59980973|NCT04766996|76098137|FG001|STARTED|Overall Study||0||
59980974|NCT04766996|76098138|FG002|STARTED|Overall Study||50||
59980975|NCT04766996|76098136|FG000|COMPLETED|Overall Study||6||
59980976|NCT04766996|76098137|FG001|COMPLETED|Overall Study||0||
59980977|NCT04766996|76098138|FG002|COMPLETED|Overall Study||37||
59980978|NCT04766996|76098136|FG000|NOT COMPLETED|Overall Study||1||
59980979|NCT04766996|76098137|FG001|NOT COMPLETED|Overall Study||0||
59980980|NCT04766996|76098138|FG002|NOT COMPLETED|Overall Study||13||
59980981|NCT02563028|76098144|FG000|STARTED|Overall Study||20||
59980982|NCT02563028|76098144|FG000|COMPLETED|Overall Study||18||
59980983|NCT02563028|76098144|FG000|NOT COMPLETED|Overall Study||2||
59980984|NCT02192827|76098150|FG000|STARTED|Overall Study||154||
59980985|NCT02192827|76098151|FG001|STARTED|Overall Study||154||
59980986|NCT02192827|76098150|FG000|COMPLETED|Overall Study||116||
59980987|NCT02192827|76098151|FG001|COMPLETED|Overall Study||116||
59980988|NCT02192827|76098150|FG000|NOT COMPLETED|Overall Study||38||
59980989|NCT02192827|76098151|FG001|NOT COMPLETED|Overall Study||38||
59980990|NCT02562482|76098159|FG000|STARTED|Overall Study||201||
59980991|NCT02562482|76098160|FG001|STARTED|Overall Study||199||
59980992|NCT02562482|76098159|FG000|Received 1st Injection|Overall Study||197||
59980993|NCT02562482|76098160|FG001|Received 1st Injection|Overall Study||199||
59980994|NCT02562482|76098159|FG000|Received 2nd Injection|Overall Study||192||
59980995|NCT02562482|76098160|FG001|Received 2nd Injection|Overall Study||192||
59980996|NCT02562482|76098159|FG000|COMPLETED|Overall Study||180||
59980997|NCT02562482|76098160|FG001|COMPLETED|Overall Study||183||
59980998|NCT02562482|76098159|FG000|NOT COMPLETED|Overall Study||21||
59980999|NCT02562482|76098160|FG001|NOT COMPLETED|Overall Study||16||
59981000|NCT02933671|76098168|FG000|STARTED|Overall Study||5||
59981001|NCT02933671|76098169|FG001|STARTED|Overall Study||5||
59981002|NCT02933671|76098168|FG000|COMPLETED|Overall Study||5||
59981003|NCT02933671|76098169|FG001|COMPLETED|Overall Study||5||
59981004|NCT02933671|76098168|FG000|NOT COMPLETED|Overall Study||0||
59981005|NCT02933671|76098169|FG001|NOT COMPLETED|Overall Study||0||
59981006|NCT02568254|76098175|FG000|STARTED|Period 1||13||
59981007|NCT02568254|76098176|FG001|STARTED|Period 1||12||
59981008|NCT02568254|76098177|FG002|STARTED|Period 1||13||
59981009|NCT02568254|76098178|FG003|STARTED|Period 1||12||
59981010|NCT02568254|76098179|FG004|STARTED|Period 1||12||
59981011|NCT02568254|76098180|FG005|STARTED|Period 1||12||
59981012|NCT02568254|76098175|FG000|COMPLETED|Period 1||13||
59981013|NCT02568254|76098176|FG001|COMPLETED|Period 1||12||
59981014|NCT02568254|76098177|FG002|COMPLETED|Period 1||13||
59981015|NCT02568254|76098178|FG003|COMPLETED|Period 1||12||
59981016|NCT02568254|76098179|FG004|COMPLETED|Period 1||12||
59981017|NCT02568254|76098180|FG005|COMPLETED|Period 1||12||
59981018|NCT02568254|76098175|FG000|NOT COMPLETED|Period 1||0||
59981019|NCT02568254|76098176|FG001|NOT COMPLETED|Period 1||0||
59981020|NCT02568254|76098177|FG002|NOT COMPLETED|Period 1||0||
59981021|NCT02568254|76098178|FG003|NOT COMPLETED|Period 1||0||
59981022|NCT02568254|76098179|FG004|NOT COMPLETED|Period 1||0||
59981023|NCT02568254|76098180|FG005|NOT COMPLETED|Period 1||0||
59981024|NCT02568254|76098175|FG000|STARTED|Period 2||13||
59981025|NCT02568254|76098176|FG001|STARTED|Period 2||12||
59981026|NCT02568254|76098177|FG002|STARTED|Period 2||13||
59981027|NCT02568254|76098178|FG003|STARTED|Period 2||12||
59981028|NCT02568254|76098179|FG004|STARTED|Period 2||12||
59981029|NCT02568254|76098180|FG005|STARTED|Period 2||12||
59981030|NCT02568254|76098175|FG000|COMPLETED|Period 2||13||
59981031|NCT02568254|76098176|FG001|COMPLETED|Period 2||12||
59981032|NCT02568254|76098177|FG002|COMPLETED|Period 2||12||
59981033|NCT02568254|76098178|FG003|COMPLETED|Period 2||12||
59981034|NCT02568254|76098179|FG004|COMPLETED|Period 2||12||
59981035|NCT02568254|76098180|FG005|COMPLETED|Period 2||12||
59981036|NCT02568254|76098175|FG000|NOT COMPLETED|Period 2||0||
59981037|NCT02568254|76098176|FG001|NOT COMPLETED|Period 2||0||
59981038|NCT02568254|76098177|FG002|NOT COMPLETED|Period 2||1||
59981039|NCT02568254|76098178|FG003|NOT COMPLETED|Period 2||0||
59981040|NCT02568254|76098179|FG004|NOT COMPLETED|Period 2||0||
59981041|NCT02568254|76098180|FG005|NOT COMPLETED|Period 2||0||
59981042|NCT02568254|76098175|FG000|STARTED|Period 3||13||
59981043|NCT02568254|76098176|FG001|STARTED|Period 3||12||
59981044|NCT02568254|76098177|FG002|STARTED|Period 3||12||
59981045|NCT02568254|76098178|FG003|STARTED|Period 3||12||
59981046|NCT02568254|76098179|FG004|STARTED|Period 3||12||
59981047|NCT02568254|76098180|FG005|STARTED|Period 3||12||
59981048|NCT02568254|76098175|FG000|COMPLETED|Period 3||13||
59981049|NCT02568254|76098176|FG001|COMPLETED|Period 3||12||
59981050|NCT02568254|76098177|FG002|COMPLETED|Period 3||12||
59981051|NCT02568254|76098178|FG003|COMPLETED|Period 3||12||
59981052|NCT02568254|76098179|FG004|COMPLETED|Period 3||11||
59981053|NCT02568254|76098180|FG005|COMPLETED|Period 3||12||
59981054|NCT02568254|76098175|FG000|NOT COMPLETED|Period 3||0||
59981055|NCT02568254|76098176|FG001|NOT COMPLETED|Period 3||0||
59981056|NCT02568254|76098177|FG002|NOT COMPLETED|Period 3||0||
59981057|NCT02568254|76098178|FG003|NOT COMPLETED|Period 3||0||
59981058|NCT02568254|76098179|FG004|NOT COMPLETED|Period 3||1||
59981059|NCT02568254|76098180|FG005|NOT COMPLETED|Period 3||0||
59981060|NCT02567708|76098188|FG000|STARTED|Treatment Period 1 (Up to 4 Weeks)||24||
59981061|NCT02567708|76098189|FG001|STARTED|Treatment Period 1 (Up to 4 Weeks)||26||
59981062|NCT02567708|76098188|FG000|COMPLETED|Treatment Period 1 (Up to 4 Weeks)||22||
59981063|NCT02567708|76098189|FG001|COMPLETED|Treatment Period 1 (Up to 4 Weeks)||23||
59981064|NCT02567708|76098188|FG000|NOT COMPLETED|Treatment Period 1 (Up to 4 Weeks)||2||
59981065|NCT02567708|76098189|FG001|NOT COMPLETED|Treatment Period 1 (Up to 4 Weeks)||3||
59981066|NCT02567708|76098188|FG000|STARTED|Washout Period (Up to 4 Weeks)||22||
59981067|NCT02567708|76098189|FG001|STARTED|Washout Period (Up to 4 Weeks)||23||
59981068|NCT02567708|76098188|FG000|COMPLETED|Washout Period (Up to 4 Weeks)||22||
59981069|NCT02567708|76098189|FG001|COMPLETED|Washout Period (Up to 4 Weeks)||23||
59981070|NCT02567708|76098188|FG000|NOT COMPLETED|Washout Period (Up to 4 Weeks)||0||
59981071|NCT02567708|76098189|FG001|NOT COMPLETED|Washout Period (Up to 4 Weeks)||0||
59981072|NCT02567708|76098188|FG000|STARTED|Treatment Period 2 (Up to 4 Weeks)||22||
59981073|NCT02567708|76098189|FG001|STARTED|Treatment Period 2 (Up to 4 Weeks)||23||
59981074|NCT02567708|76098188|FG000|COMPLETED|Treatment Period 2 (Up to 4 Weeks)||22||
59981075|NCT02567708|76098189|FG001|COMPLETED|Treatment Period 2 (Up to 4 Weeks)||20||
59981076|NCT02567708|76098188|FG000|NOT COMPLETED|Treatment Period 2 (Up to 4 Weeks)||0||
59981077|NCT02567708|76098189|FG001|NOT COMPLETED|Treatment Period 2 (Up to 4 Weeks)||3||
59981078|NCT02562716|76098198|FG000|STARTED|Overall Study||55||
59981079|NCT02562716|76098199|FG001|STARTED|Overall Study||47||
59981080|NCT02562716|76098198|FG000|Participants Assessed for AEs|Overall Study||53||
59981081|NCT02562716|76098199|FG001|Participants Assessed for AEs|Overall Study||45||
59981082|NCT02562716|76098198|FG000|COMPLETED|Overall Study||27||
59981083|NCT02562716|76098199|FG001|COMPLETED|Overall Study||19||
59981084|NCT02562716|76098198|FG000|NOT COMPLETED|Overall Study||28||
59981085|NCT02562716|76098199|FG001|NOT COMPLETED|Overall Study||28||
59981086|NCT02751931|76098209|FG000|STARTED|Overall Study||56||
59981087|NCT02751931|76098210|FG001|STARTED|Overall Study||35||
59981088|NCT02751931|76098209|FG000|Treated|Overall Study||55||
59981089|NCT02751931|76098210|FG001|Treated|Overall Study||31||
59981090|NCT02751931|76098209|FG000|COMPLETED|Overall Study||43||
59981091|NCT02751931|76098210|FG001|COMPLETED|Overall Study||27||
59981092|NCT02751931|76098209|FG000|NOT COMPLETED|Overall Study||13||
59981093|NCT02751931|76098210|FG001|NOT COMPLETED|Overall Study||8||
59981094|NCT02561156|76098235|FG000|STARTED|Part 1||12||
59981095|NCT02561156|76098236|FG001|STARTED|Part 1||6||
59981096|NCT02561156|76098237|FG002|STARTED|Part 1||6||
59981097|NCT02561156|76098238|FG003|STARTED|Part 1||6||
59981098|NCT02561156|76098239|FG004|STARTED|Part 1||6||
59981099|NCT02561156|76098240|FG005|STARTED|Part 1||6||
59981100|NCT02561156|76098241|FG006|STARTED|Part 1||6||
59981101|NCT02561156|76098242|FG007|STARTED|Part 1||0||
59981102|NCT02561156|76098243|FG008|STARTED|Part 1||0||
59981103|NCT02561156|76098244|FG009|STARTED|Part 1||0||
59981104|NCT02561156|76098245|FG010|STARTED|Part 1||0||
59981105|NCT02561156|76098246|FG011|STARTED|Part 1||0||
59981106|NCT02561156|76098247|FG012|STARTED|Part 1||0||
59981107|NCT02561156|76098235|FG000|COMPLETED|Part 1||12||
59981108|NCT02561156|76098236|FG001|COMPLETED|Part 1||6||
59981109|NCT02561156|76098237|FG002|COMPLETED|Part 1||6||
59981110|NCT02561156|76098238|FG003|COMPLETED|Part 1||6||
59981111|NCT02561156|76098239|FG004|COMPLETED|Part 1||6||
59981112|NCT02561156|76098240|FG005|COMPLETED|Part 1||6||
59981113|NCT02561156|76098241|FG006|COMPLETED|Part 1||6||
59981114|NCT02561156|76098242|FG007|COMPLETED|Part 1||0||
59981115|NCT02561156|76098243|FG008|COMPLETED|Part 1||0||
59981116|NCT02561156|76098244|FG009|COMPLETED|Part 1||0||
59981117|NCT02561156|76098245|FG010|COMPLETED|Part 1||0||
59981118|NCT02561156|76098246|FG011|COMPLETED|Part 1||0||
59981119|NCT02561156|76098247|FG012|COMPLETED|Part 1||0||
59981120|NCT02561156|76098235|FG000|NOT COMPLETED|Part 1||0||
59981121|NCT02561156|76098236|FG001|NOT COMPLETED|Part 1||0||
59981122|NCT02561156|76098237|FG002|NOT COMPLETED|Part 1||0||
59981123|NCT02561156|76098238|FG003|NOT COMPLETED|Part 1||0||
59981124|NCT02561156|76098239|FG004|NOT COMPLETED|Part 1||0||
59981125|NCT02561156|76098240|FG005|NOT COMPLETED|Part 1||0||
59981126|NCT02561156|76098241|FG006|NOT COMPLETED|Part 1||0||
59981127|NCT02561156|76098242|FG007|NOT COMPLETED|Part 1||0||
59981128|NCT02561156|76098243|FG008|NOT COMPLETED|Part 1||0||
59981129|NCT02561156|76098244|FG009|NOT COMPLETED|Part 1||0||
59981130|NCT02561156|76098245|FG010|NOT COMPLETED|Part 1||0||
59981131|NCT02561156|76098246|FG011|NOT COMPLETED|Part 1||0||
59981132|NCT02561156|76098247|FG012|NOT COMPLETED|Part 1||0||
59981133|NCT02561156|76098235|FG000|STARTED|Part 2||0||
59981134|NCT02561156|76098236|FG001|STARTED|Part 2||0||
59981135|NCT02561156|76098237|FG002|STARTED|Part 2||0||
59981136|NCT02561156|76098238|FG003|STARTED|Part 2||0||
59981137|NCT02561156|76098239|FG004|STARTED|Part 2||0||
59981138|NCT02561156|76098240|FG005|STARTED|Part 2||0||
59981139|NCT02561156|76098241|FG006|STARTED|Part 2||0||
59981140|NCT02561156|76098242|FG007|STARTED|Part 2||10||
59981141|NCT02561156|76098243|FG008|STARTED|Part 2||6||
59981142|NCT02561156|76098244|FG009|STARTED|Part 2||6||
59981143|NCT02561156|76098245|FG010|STARTED|Part 2||6||
59981144|NCT02561156|76098246|FG011|STARTED|Part 2||6||
59981145|NCT02561156|76098247|FG012|STARTED|Part 2||6||
59981146|NCT02561156|76098235|FG000|COMPLETED|Part 2||0||
59981147|NCT02561156|76098236|FG001|COMPLETED|Part 2||0||
59981148|NCT02561156|76098237|FG002|COMPLETED|Part 2||0||
59981149|NCT02561156|76098238|FG003|COMPLETED|Part 2||0||
59981150|NCT02561156|76098239|FG004|COMPLETED|Part 2||0||
59981151|NCT02561156|76098240|FG005|COMPLETED|Part 2||0||
59981152|NCT02561156|76098241|FG006|COMPLETED|Part 2||0||
59981153|NCT02561156|76098242|FG007|COMPLETED|Part 2||10||
59981154|NCT02561156|76098243|FG008|COMPLETED|Part 2||6||
59981155|NCT02561156|76098244|FG009|COMPLETED|Part 2||6||
59981156|NCT02561156|76098245|FG010|COMPLETED|Part 2||6||
59981157|NCT02561156|76098246|FG011|COMPLETED|Part 2||5||
59981158|NCT02561156|76098247|FG012|COMPLETED|Part 2||6||
59981159|NCT02561156|76098235|FG000|NOT COMPLETED|Part 2||0||
59981160|NCT02561156|76098236|FG001|NOT COMPLETED|Part 2||0||
59981161|NCT02561156|76098237|FG002|NOT COMPLETED|Part 2||0||
59981162|NCT02561156|76098238|FG003|NOT COMPLETED|Part 2||0||
59981163|NCT02561156|76098239|FG004|NOT COMPLETED|Part 2||0||
59981164|NCT02561156|76098240|FG005|NOT COMPLETED|Part 2||0||
59981165|NCT02561156|76098241|FG006|NOT COMPLETED|Part 2||0||
59981166|NCT02561156|76098242|FG007|NOT COMPLETED|Part 2||0||
59981167|NCT02561156|76098243|FG008|NOT COMPLETED|Part 2||0||
59981168|NCT02561156|76098244|FG009|NOT COMPLETED|Part 2||0||
59981169|NCT02561156|76098245|FG010|NOT COMPLETED|Part 2||0||
59981170|NCT02561156|76098246|FG011|NOT COMPLETED|Part 2||1||
59981171|NCT02561156|76098247|FG012|NOT COMPLETED|Part 2||0||
59981172|NCT02561078|76098293|FG000|STARTED|Overall Study||209||
59981173|NCT02561078|76098294|FG001|STARTED|Overall Study||211||
59981174|NCT02561078|76098293|FG000|Received at Least 1 Dose of Study Drug|Overall Study||208||
59981175|NCT02561078|76098294|FG001|Received at Least 1 Dose of Study Drug|Overall Study||210||
59981176|NCT02561078|76098293|FG000|COMPLETED|Overall Study||179||
59981177|NCT02561078|76098294|FG001|COMPLETED|Overall Study||186||
59981178|NCT02561078|76098293|FG000|NOT COMPLETED|Overall Study||30||
59981179|NCT02561078|76098294|FG001|NOT COMPLETED|Overall Study||25||
59981180|NCT04907227|76098302|FG000|STARTED|Overall Study||41||
59981181|NCT04907227|76098303|FG001|STARTED|Overall Study||40||
59981182|NCT04907227|76098302|FG000|Treated|Overall Study||41||
59981183|NCT04907227|76098303|FG001|Treated|Overall Study||40||
59981184|NCT04907227|76098302|FG000|COMPLETED|Overall Study||0||
59981185|NCT04907227|76098303|FG001|COMPLETED|Overall Study||0||
59981186|NCT04907227|76098302|FG000|NOT COMPLETED|Overall Study||41||
59981187|NCT04907227|76098303|FG001|NOT COMPLETED|Overall Study||40||
59981188|NCT04881448|76098309|FG000|STARTED|Overall Study||223||
59981189|NCT04881448|76098309|FG000|COMPLETED|Overall Study||0||
59981190|NCT04881448|76098309|FG000|NOT COMPLETED|Overall Study||223||
59981191|NCT04756141|76098315|FG000|STARTED|Overall Study||20||
59981192|NCT04756141|76098315|FG000|COMPLETED|Overall Study||20||
59981193|NCT04756141|76098315|FG000|NOT COMPLETED|Overall Study||0||
59981194|NCT04721145|76098319|FG000|STARTED|Overall Study||26||
59981195|NCT04721145|76098319|FG000|COMPLETED|Overall Study||26||
59981196|NCT04721145|76098319|FG000|NOT COMPLETED|Overall Study||0||
59981197|NCT04684576|76098325|FG000|STARTED|Overall Study||12||
59981198|NCT04684576|76098326|FG001|STARTED|Overall Study||12||
59981199|NCT04684576|76098325|FG000|COMPLETED|Overall Study||12||
59981200|NCT04684576|76098326|FG001|COMPLETED|Overall Study||12||
59981201|NCT04684576|76098325|FG000|NOT COMPLETED|Overall Study||0||
59981202|NCT04684576|76098326|FG001|NOT COMPLETED|Overall Study||0||
59981203|NCT04492566|76098334|FG000|STARTED|Overall Study||10||
59981204|NCT04492566|76098334|FG000|COMPLETED|Overall Study||10||
59981205|NCT04492566|76098334|FG000|NOT COMPLETED|Overall Study||0||
59981206|NCT04275310|76098340|FG000|STARTED|Overall Study||4||
59981207|NCT04275310|76098341|FG001|STARTED|Overall Study||0||
59981208|NCT04275310|76098340|FG000|COMPLETED|Overall Study||0||
59981209|NCT04275310|76098341|FG001|COMPLETED|Overall Study||0||
59981210|NCT04275310|76098340|FG000|NOT COMPLETED|Overall Study||4||
59981211|NCT04275310|76098341|FG001|NOT COMPLETED|Overall Study||0||
59981212|NCT04157088|76098347|FG000|STARTED|Overall Study||30||
59981213|NCT04157088|76098347|FG000|Received Treatment|Overall Study||30||
59981214|NCT04157088|76098347|FG000|Participants Off-Study|Overall Study||30||
59981215|NCT04157088|76098347|FG000|COMPLETED|Overall Study||0||
59981216|NCT04157088|76098347|FG000|NOT COMPLETED|Overall Study||30||
59981217|NCT04140266|76098355|FG000|STARTED|Overall Study||296|Mothers and infants are added as two milestones.|
59981218|NCT04140266|76098356|FG001|STARTED|Overall Study||98|Mothers and infants are added as two milestones.|
59981219|NCT04140266|76098355|FG000|Mothers|Overall Study||148||
59981220|NCT04140266|76098356|FG001|Mothers|Overall Study||49||
59981221|NCT04140266|76098355|FG000|Infants|Overall Study||148||
59981222|NCT04140266|76098356|FG001|Infants|Overall Study||49||
59981223|NCT04140266|76098355|FG000|COMPLETED|Overall Study||290||
59981224|NCT04140266|76098356|FG001|COMPLETED|Overall Study||96||
59981225|NCT04140266|76098355|FG000|NOT COMPLETED|Overall Study||6||
59981226|NCT04140266|76098356|FG001|NOT COMPLETED|Overall Study||2||
59981227|NCT03926143|76098379|FG000|STARTED|Overall Study||9||
59981228|NCT03926143|76098379|FG000|COMPLETED|Overall Study||0||
59981229|NCT03926143|76098379|FG000|NOT COMPLETED|Overall Study||9||
59981230|NCT03821324|76098383|FG000|STARTED|6 Weeks After Treatment||14||28
59981231|NCT03821324|76098383|FG000|COMPLETED|6 Weeks After Treatment||9||18
59981232|NCT03821324|76098383|FG000|NOT COMPLETED|6 Weeks After Treatment||5||10
59981233|NCT03821324|76098383|FG000|STARTED|12 Weeks After Treatment||9||18
59981234|NCT03821324|76098383|FG000|COMPLETED|12 Weeks After Treatment||9||18
59981235|NCT03821324|76098383|FG000|NOT COMPLETED|12 Weeks After Treatment||0||0
59981236|NCT03421652|76098390|FG000|STARTED|Overall Study||20||
59981237|NCT03421652|76098390|FG000|COMPLETED|Overall Study||20||
59981238|NCT03421652|76098390|FG000|NOT COMPLETED|Overall Study||0||
59981239|NCT03018080|76098396|FG000|STARTED|Overall Study||21||
59981240|NCT03018080|76098397|FG001|STARTED|Overall Study||19||
59981241|NCT03018080|76098396|FG000|COMPLETED|Overall Study||9||
59981242|NCT03018080|76098397|FG001|COMPLETED|Overall Study||0||
59981243|NCT03018080|76098396|FG000|NOT COMPLETED|Overall Study||12||
59981244|NCT03018080|76098397|FG001|NOT COMPLETED|Overall Study||19||
59981245|NCT02781090|76098405|FG000|STARTED|3-Month Follow-Up||255||
59981246|NCT02781090|76098406|FG001|STARTED|3-Month Follow-Up||251||
59981247|NCT02781090|76098405|FG000|COMPLETED|3-Month Follow-Up||190||
59981248|NCT02781090|76098406|FG001|COMPLETED|3-Month Follow-Up||194||
59981249|NCT02781090|76098405|FG000|NOT COMPLETED|3-Month Follow-Up||65||
59981250|NCT02781090|76098406|FG001|NOT COMPLETED|3-Month Follow-Up||57||
59981251|NCT02781090|76098405|FG000|STARTED|6-Month Follow-Up||190||
59981252|NCT02781090|76098406|FG001|STARTED|6-Month Follow-Up||194||
59981253|NCT02781090|76098405|FG000|COMPLETED|6-Month Follow-Up||169||
59981254|NCT02781090|76098406|FG001|COMPLETED|6-Month Follow-Up||169||
59981255|NCT02781090|76098405|FG000|NOT COMPLETED|6-Month Follow-Up||21||
59981256|NCT02781090|76098406|FG001|NOT COMPLETED|6-Month Follow-Up||25||
59981257|NCT02774291|76098414|FG000|STARTED|Overall Study||3||
59981258|NCT02774291|76098414|FG000|COMPLETED|Overall Study||2||
59981259|NCT02774291|76098414|FG000|NOT COMPLETED|Overall Study||1||
59981260|NCT01897571|76098430|FG000|STARTED|Overall Study||6||
59981261|NCT01897571|76098431|FG001|STARTED|Overall Study||3||
59981262|NCT01897571|76098432|FG002|STARTED|Overall Study||3||
59981263|NCT01897571|76098433|FG003|STARTED|Overall Study||14||
59981264|NCT01897571|76098434|FG004|STARTED|Overall Study||12||
59981265|NCT01897571|76098435|FG005|STARTED|Overall Study||13||
59981266|NCT01897571|76098436|FG006|STARTED|Overall Study||13||
59981267|NCT01897571|76098437|FG007|STARTED|Overall Study||48||
59981268|NCT01897571|76098438|FG008|STARTED|Overall Study||54||
59981269|NCT01897571|76098439|FG009|STARTED|Overall Study||163||
59981270|NCT01897571|76098440|FG010|STARTED|Overall Study||71||
59981271|NCT01897571|76098430|FG000|COMPLETED|Overall Study||0||
59981272|NCT01897571|76098431|FG001|COMPLETED|Overall Study||1||
59981273|NCT01897571|76098432|FG002|COMPLETED|Overall Study||0||
59981274|NCT01897571|76098433|FG003|COMPLETED|Overall Study||5||
59981275|NCT01897571|76098434|FG004|COMPLETED|Overall Study||0||
59981276|NCT01897571|76098435|FG005|COMPLETED|Overall Study||0||
59981277|NCT01897571|76098436|FG006|COMPLETED|Overall Study||1||
59981278|NCT01897571|76098437|FG007|COMPLETED|Overall Study||16||
59981279|NCT01897571|76098438|FG008|COMPLETED|Overall Study||19||
59981280|NCT01897571|76098439|FG009|COMPLETED|Overall Study||20||
59981281|NCT01897571|76098440|FG010|COMPLETED|Overall Study||6||
59981282|NCT01897571|76098430|FG000|NOT COMPLETED|Overall Study||6||
59981283|NCT01897571|76098431|FG001|NOT COMPLETED|Overall Study||2||
59981284|NCT01897571|76098432|FG002|NOT COMPLETED|Overall Study||3||
59981285|NCT01897571|76098433|FG003|NOT COMPLETED|Overall Study||9||
59981286|NCT01897571|76098434|FG004|NOT COMPLETED|Overall Study||12||
59981287|NCT01897571|76098435|FG005|NOT COMPLETED|Overall Study||13||
59981288|NCT01897571|76098436|FG006|NOT COMPLETED|Overall Study||12||
59981289|NCT01897571|76098437|FG007|NOT COMPLETED|Overall Study||32||
59981290|NCT01897571|76098438|FG008|NOT COMPLETED|Overall Study||35||
59981291|NCT01897571|76098439|FG009|NOT COMPLETED|Overall Study||143||
59981292|NCT01897571|76098440|FG010|NOT COMPLETED|Overall Study||65||
59981293|NCT01207778|76098462|FG000|STARTED|Overall Study||39||
59981294|NCT01207778|76098463|FG001|STARTED|Overall Study||24||
59981295|NCT01207778|76098464|FG002|STARTED|Overall Study||14||
59981296|NCT01207778|76098462|FG000|COMPLETED|Overall Study||39||
59981297|NCT01207778|76098463|FG001|COMPLETED|Overall Study|3 subjects in this arm were not seen at the second visit.|21||
59981298|NCT01207778|76098464|FG002|COMPLETED|Overall Study|3 subjects in this arm were not seen at the second visit|11||
59981299|NCT01207778|76098462|FG000|NOT COMPLETED|Overall Study||0||
59981300|NCT01207778|76098463|FG001|NOT COMPLETED|Overall Study||3||
59981301|NCT01207778|76098464|FG002|NOT COMPLETED|Overall Study||3||
59981302|NCT02567552|76098474|FG000|STARTED|Overall Study||12||
59981303|NCT02567552|76098475|FG001|STARTED|Overall Study||12||
59981304|NCT02567552|76098474|FG000|COMPLETED|Overall Study||12||
59981305|NCT02567552|76098475|FG001|COMPLETED|Overall Study|dropout by pain in the puncture site|11||
59981306|NCT02567552|76098474|FG000|NOT COMPLETED|Overall Study||0||
59981307|NCT02567552|76098475|FG001|NOT COMPLETED|Overall Study||1||
59981308|NCT03803605|76098481|FG000|STARTED|Overall Study||15||
59981309|NCT03803605|76098481|FG000|Step 1: Participants With an RCI Measurement > 0.30 Per Million Cells|Overall Study||8||
59981310|NCT03803605|76098481|FG000|Steps 2-4: Participants Receiving Study Intervention|Overall Study||8||
59981311|NCT03803605|76098481|FG000|COMPLETED|Overall Study||8||
59981312|NCT03803605|76098481|FG000|NOT COMPLETED|Overall Study||7||
59981313|NCT02561000|76098489|FG000|STARTED|Overall Study||34|Randomization|
59981314|NCT02561000|76098490|FG001|STARTED|Overall Study||35|Randomization|
59981315|NCT02561000|76098491|FG002|STARTED|Overall Study||31|Randomization|
59995398|NCT03016975|76111238|FG002|STARTED|At 2 Year Follow-up||0||
59995399|NCT03016975|76111236|FG000|COMPLETED|At 2 Year Follow-up||5||
59995400|NCT03016975|76111237|FG001|COMPLETED|At 2 Year Follow-up||0||
59981316|NCT02561000|76098489|FG000|Safety Population|Overall Study|Includes 1 additional patient who was assigned PZ-128 0.3 mg/kg but received placebo in error (evaluated as placebo for primary safety outcome and adverse events).|35|The Safety population included randomized participants who received any amount of the study drug dose of the double-blind IP infusion (summarized and analyzed as treated).|
59981317|NCT02561000|76098490|FG001|Safety Population|Overall Study|Excludes 4 patients who did not receive the study drug as allocated: 1 patient received placebo in error and was evaluated as placebo for primary safety outcome and adverse events; 2 patients withdrew full consent immediately after randomization prior to receiving any study drug; and 1 patient had an adverse event shortly after randomization prior to receiving any study drug.|31|The Safety population included randomized participants who received any amount of the study drug dose of the double-blind IP infusion (summarized and analyzed as treated).|
59981318|NCT02561000|76098491|FG002|Safety Population|Overall Study||31|The Safety population included randomized participants who received any amount of the study drug dose of the double-blind IP infusion (summarized and analyzed as treated).|
59981319|NCT02561000|76098489|FG000|Intent-to-Treat (ITT) Population at 30 Days|Overall Study||34|The Intent-to-treat (ITT) population included all randomized participants, regardless of study drug intake, who underwent at least 1 follow-up assessment within 30 days after study drug dosing.|
59981320|NCT02561000|76098490|FG001|Intent-to-Treat (ITT) Population at 30 Days|Overall Study|Excludes 2 patients who withdrew full consent immediately after randomization.|33|The Intent-to-treat (ITT) population included all randomized participants, regardless of study drug intake, who underwent at least 1 follow-up assessment within 30 days after study drug dosing.|
59981321|NCT02561000|76098491|FG002|Intent-to-Treat (ITT) Population at 30 Days|Overall Study||31|The Intent-to-treat (ITT) population included all randomized participants, regardless of study drug intake, who underwent at least 1 follow-up assessment within 30 days after study drug dosing.|
59981322|NCT02561000|76098489|FG000|Intent-to-Treat (ITT) Population at 90 Days|Overall Study|Excludes 1 patient who withdrew consent for follow-up 21 days after study drug dosing.|33|The Intent-to-treat (ITT) population included all randomized participants, regardless of study drug intake, who underwent at least 1 follow-up assessment after 30 days up until 90 days after study drug dosing.|
59981323|NCT02561000|76098490|FG001|Intent-to-Treat (ITT) Population at 90 Days|Overall Study|Excludes 4 patients: 2 patients withdrew full consent immediately after randomization; 1 patient followed only for 30 day ITT outcome (did not receive any study drug due to adverse event post randomization); and 1 patient withdrew consent for follow-up 7 days after study drug dosing.|31|The Intent-to-treat (ITT) population included all randomized participants, regardless of study drug intake, who underwent at least 1 follow-up assessment after 30 days up until 90 days after study drug dosing.|
59981324|NCT02561000|76098491|FG002|Intent-to-Treat (ITT) Population at 90 Days|Overall Study||31|The Intent-to-treat (ITT) population included all randomized participants, regardless of study drug intake, who underwent at least 1 follow-up assessment after 30 days up until 90 days after study drug dosing.|
59981325|NCT02561000|76098489|FG000|COMPLETED|Overall Study||32|Completion of the 90-day follow-up time point after study drug dosing.|
59981326|NCT02561000|76098490|FG001|COMPLETED|Overall Study||31|Completion of the 90-day follow-up time point after study drug dosing.|
59981327|NCT02561000|76098491|FG002|COMPLETED|Overall Study||31|Completion of the 90-day follow-up time point after study drug dosing.|
59981328|NCT02561000|76098489|FG000|NOT COMPLETED|Overall Study||2||
59981329|NCT02561000|76098490|FG001|NOT COMPLETED|Overall Study||4||
59981330|NCT02561000|76098491|FG002|NOT COMPLETED|Overall Study||0||
59981331|NCT01663532|76098501|FG000|STARTED|Overall Study||168||
59981332|NCT01663532|76098502|FG001|STARTED|Overall Study||172||
59981333|NCT01663532|76098501|FG000|COMPLETED|Overall Study||94||
59981334|NCT01663532|76098502|FG001|COMPLETED|Overall Study||65||
59981335|NCT01663532|76098501|FG000|NOT COMPLETED|Overall Study||74||
59981336|NCT01663532|76098502|FG001|NOT COMPLETED|Overall Study||107||
59981337|NCT02525939|76098510|FG000|STARTED|Overall Study||3071||
59981338|NCT02525939|76098511|FG001|STARTED|Overall Study||3076||
59981339|NCT02525939|76098510|FG000|Took Study Medication|Overall Study||3064||
59981340|NCT02525939|76098511|FG001|Took Study Medication|Overall Study||3064||
59981341|NCT02525939|76098510|FG000|COMPLETED|Overall Study||2840||
59981342|NCT02525939|76098511|FG001|COMPLETED|Overall Study||2833||
59981343|NCT02525939|76098510|FG000|NOT COMPLETED|Overall Study||231||
59981344|NCT02525939|76098511|FG001|NOT COMPLETED|Overall Study||243||
59981345|NCT01351805|76098521|FG000|STARTED|Overall Study||6463||
59981346|NCT01351805|76098522|FG001|STARTED|Overall Study||6464||
59981347|NCT01351805|76098523|FG002|STARTED|Overall Study||6470||
59981348|NCT01351805|76098524|FG003|STARTED|Overall Study||6474||
59981349|NCT01351805|76098521|FG000|COMPLETED|Overall Study||6463||
59981350|NCT01351805|76098522|FG001|COMPLETED|Overall Study||6464||
59981351|NCT01351805|76098523|FG002|COMPLETED|Overall Study||6470||
59981352|NCT01351805|76098524|FG003|COMPLETED|Overall Study||6474||
59981353|NCT01351805|76098521|FG000|NOT COMPLETED|Overall Study||0||
59981354|NCT01351805|76098522|FG001|NOT COMPLETED|Overall Study||0||
59981355|NCT01351805|76098523|FG002|NOT COMPLETED|Overall Study||0||
59981356|NCT01351805|76098524|FG003|NOT COMPLETED|Overall Study||0||
59981357|NCT02697591|76098548|FG000|STARTED|Overall Study||4||
59981358|NCT02697591|76098549|FG001|STARTED|Overall Study||4||
59981359|NCT02697591|76098550|FG002|STARTED|Overall Study||4||
59981360|NCT02697591|76098551|FG003|STARTED|Overall Study||3||
59981361|NCT02697591|76098552|FG004|STARTED|Overall Study||15||
59981362|NCT02697591|76098553|FG005|STARTED|Overall Study||18||
59981363|NCT02697591|76098554|FG006|STARTED|Overall Study||16||
59981364|NCT02697591|76098555|FG007|STARTED|Overall Study||4||
59981365|NCT02697591|76098556|FG008|STARTED|Overall Study||10||
59981366|NCT02697591|76098557|FG009|STARTED|Overall Study||22||
59981367|NCT02697591|76098548|FG000|COMPLETED|Overall Study||0||
59981368|NCT02697591|76098549|FG001|COMPLETED|Overall Study||0||
59981369|NCT02697591|76098550|FG002|COMPLETED|Overall Study||1||
59981370|NCT02697591|76098551|FG003|COMPLETED|Overall Study||0||
59981371|NCT02697591|76098552|FG004|COMPLETED|Overall Study||2||
59981372|NCT02697591|76098553|FG005|COMPLETED|Overall Study||2||
59981373|NCT02697591|76098554|FG006|COMPLETED|Overall Study||0||
59981374|NCT02697591|76098555|FG007|COMPLETED|Overall Study||1||
59981375|NCT02697591|76098556|FG008|COMPLETED|Overall Study||1||
59981376|NCT02697591|76098557|FG009|COMPLETED|Overall Study||2||
59981377|NCT02697591|76098548|FG000|NOT COMPLETED|Overall Study||4||
59981378|NCT02697591|76098549|FG001|NOT COMPLETED|Overall Study||4||
59981379|NCT02697591|76098550|FG002|NOT COMPLETED|Overall Study||3||
59981380|NCT02697591|76098551|FG003|NOT COMPLETED|Overall Study||3||
59981381|NCT02697591|76098552|FG004|NOT COMPLETED|Overall Study||13||
59981382|NCT02697591|76098553|FG005|NOT COMPLETED|Overall Study||16||
59981383|NCT02697591|76098554|FG006|NOT COMPLETED|Overall Study||16||
59981384|NCT02697591|76098555|FG007|NOT COMPLETED|Overall Study||3||
59981385|NCT02697591|76098556|FG008|NOT COMPLETED|Overall Study||9||
59981386|NCT02697591|76098557|FG009|NOT COMPLETED|Overall Study||20||
59981387|NCT02697435|76098582|FG000|STARTED|Overall Study||25||
59981388|NCT02697435|76098583|FG001|STARTED|Overall Study||30||
59981389|NCT02697435|76098582|FG000|COMPLETED|Overall Study||24||
59981390|NCT02697435|76098583|FG001|COMPLETED|Overall Study||26||
59981391|NCT02697435|76098582|FG000|NOT COMPLETED|Overall Study||1||
59981392|NCT02697435|76098583|FG001|NOT COMPLETED|Overall Study||4||
59981393|NCT02174861|76098590|FG000|STARTED|Overall Study||609||
59981394|NCT02174861|76098590|FG000|Enrolled in CHU Substudy|Overall Study||53||
59981395|NCT02174861|76098590|FG000|COMPLETED|Overall Study||451||
59981396|NCT02174861|76098590|FG000|NOT COMPLETED|Overall Study||158||
59981397|NCT00140855|76098596|FG000|STARTED|Overall Study||6||
59981398|NCT00140855|76098596|FG000|COMPLETED|Overall Study||4||
59981399|NCT00140855|76098596|FG000|NOT COMPLETED|Overall Study||2||
59981400|NCT00700635|76098603|FG000|STARTED|Overall Study||111||
59981401|NCT00700635|76098604|FG001|STARTED|Overall Study||111||
59981402|NCT00700635|76098605|FG002|STARTED|Overall Study||111||
59981403|NCT00700635|76098603|FG000|COMPLETED|Overall Study||100||
59981404|NCT00700635|76098604|FG001|COMPLETED|Overall Study||103||
59981405|NCT00700635|76098605|FG002|COMPLETED|Overall Study||110||
59981406|NCT00700635|76098603|FG000|NOT COMPLETED|Overall Study||11||
59981407|NCT00700635|76098604|FG001|NOT COMPLETED|Overall Study||8||
59981408|NCT00700635|76098605|FG002|NOT COMPLETED|Overall Study||1||
59981409|NCT02780687|76098615|FG000|STARTED|Overall Study||34||
59981410|NCT02780687|76098616|FG001|STARTED|Overall Study||8||
59981411|NCT02780687|76098615|FG000|COMPLETED|Overall Study||0||
59981412|NCT02780687|76098616|FG001|COMPLETED|Overall Study||0||
59981413|NCT02780687|76098615|FG000|NOT COMPLETED|Overall Study||34||
59981414|NCT02780687|76098616|FG001|NOT COMPLETED|Overall Study||8||
59981415|NCT02698371|76098621|FG000|STARTED|All Participants Flow||38|Baseline|210
59981416|NCT02698371|76098621|FG000|COMPLETED|All Participants Flow||35|Two years recall|193
59981417|NCT02698371|76098621|FG000|NOT COMPLETED|All Participants Flow||3||17
59981418|NCT02698371|76098621|FG000|STARTED|FBDC-SE (G1; Control) Arm/Group Flow|Each participant received one NCCLs restoration with FBDC-SE (G1control Arm/Group).|35|Baseline|35
59981419|NCT02698371|76098621|FG000|COMPLETED|FBDC-SE (G1; Control) Arm/Group Flow||32|Two years recall|32
59981420|NCT02698371|76098621|FG000|NOT COMPLETED|FBDC-SE (G1; Control) Arm/Group Flow||3||3
59981421|NCT02698371|76098621|FG000|STARTED|FBDC-SE-EE (G2; Control ) Arm/Group Flow|Each participant received one NCCLs restoration with FBDC-SE-EE (G2 control Arm/group)|35|Baseline|35
59981422|NCT02698371|76098621|FG000|COMPLETED|FBDC-SE-EE (G2; Control ) Arm/Group Flow||32|Two years recall|32
59981423|NCT02698371|76098621|FG000|NOT COMPLETED|FBDC-SE-EE (G2; Control ) Arm/Group Flow||3||3
59814864|NCT00516048|75937313|FG001|COMPLETED|Overall Study||40||
59814865|NCT00516048|75937314|FG002|COMPLETED|Overall Study||0||
59814866|NCT00516048|75937312|FG000|NOT COMPLETED|Overall Study||0||
59814867|NCT00516048|75937313|FG001|NOT COMPLETED|Overall Study||2||
59981424|NCT02698371|76098621|FG000|STARTED|FBU-ER (G3) Arm/Group Flow|Each participant received one NCCLs restoration with FBU-ER (G3 Arm/group)|35|Baseline|35
59981425|NCT02698371|76098621|FG000|COMPLETED|FBU-ER (G3) Arm/Group Flow||32|Two years recall|32
59981426|NCT02698371|76098621|FG000|NOT COMPLETED|FBU-ER (G3) Arm/Group Flow||3||3
59981427|NCT02698371|76098621|FG000|STARTED|FBU-SE (G4) Arm/Group Flow|Each participant received one NCCLs restoration with FBU-SE (G4 Arm/group)|35|Baseline|35
59981428|NCT02698371|76098621|FG000|COMPLETED|FBU-SE (G4) Arm/Group Flow||32|Two years recall|32
59981429|NCT02698371|76098621|FG000|NOT COMPLETED|FBU-SE (G4) Arm/Group Flow||3||3
59814868|NCT00516048|75937314|FG002|NOT COMPLETED|Overall Study||1||
59814869|NCT00617357|75937322|FG000|STARTED|Overall Study|83 subjects enrolled, 80 subjects received Strattice reinforcement of hernia repair|83||
59981430|NCT02698371|76098621|FG000|STARTED|ADU-ER (G5) Arm/Group Flow|Each participant received one NCCLs restoration with ADU-ER (G5 Arm/group)|35|Baseline|35
59981431|NCT02698371|76098621|FG000|COMPLETED|ADU-ER (G5) Arm/Group Flow||32|Two years recall|32
59981432|NCT02698371|76098621|FG000|NOT COMPLETED|ADU-ER (G5) Arm/Group Flow||3||3
59981433|NCT02698371|76098621|FG000|STARTED|ADU-SE (G6) Arm/Group Flow|Each participant received one NCCLs restoration with ADU-SE (G6 Arm/group)|35|Baseline|35
59981434|NCT02698371|76098621|FG000|COMPLETED|ADU-SE (G6) Arm/Group Flow||33|Two years recall|33
59981435|NCT02698371|76098621|FG000|NOT COMPLETED|ADU-SE (G6) Arm/Group Flow||2||2
59981436|NCT02781311|76098640|FG000|STARTED|Overall Study||74||
59981437|NCT02781311|76098641|FG001|STARTED|Overall Study||83||
59981438|NCT02781311|76098642|FG002|STARTED|Overall Study||12||
59981439|NCT02781311|76098640|FG000|Safety Population (Treated)|Overall Study||73||
59981440|NCT02781311|76098641|FG001|Safety Population (Treated)|Overall Study||81||
59981441|NCT02781311|76098642|FG002|Safety Population (Treated)|Overall Study||12||
59981442|NCT02781311|76098640|FG000|mITT Population|Overall Study||70||
59981443|NCT02781311|76098641|FG001|mITT Population|Overall Study||78||
59981444|NCT02781311|76098642|FG002|mITT Population|Overall Study||11||
59981445|NCT02781311|76098640|FG000|COMPLETED|Overall Study||48||
59981446|NCT02781311|76098641|FG001|COMPLETED|Overall Study||57||
59981447|NCT02781311|76098642|FG002|COMPLETED|Overall Study||8||
59981448|NCT02781311|76098640|FG000|NOT COMPLETED|Overall Study||26||
59981449|NCT02781311|76098641|FG001|NOT COMPLETED|Overall Study||26||
59981450|NCT02781311|76098642|FG002|NOT COMPLETED|Overall Study||4||
59981451|NCT02564198|76098652|FG000|STARTED|Overall Study||8||
59981452|NCT02564198|76098653|FG001|STARTED|Overall Study||15||
59981453|NCT02564198|76098654|FG002|STARTED|Overall Study||6||
59981454|NCT02564198|76098652|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8||
59981455|NCT02564198|76098653|FG001|Received at Least 1 Dose of Study Drug|Overall Study||15||
59981456|NCT02564198|76098654|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6||
59981457|NCT02564198|76098652|FG000|COMPLETED|Overall Study||6||
59981458|NCT02564198|76098653|FG001|COMPLETED|Overall Study||10||
59981459|NCT02564198|76098654|FG002|COMPLETED|Overall Study||6||
59981460|NCT02564198|76098652|FG000|NOT COMPLETED|Overall Study||2||
59981461|NCT02564198|76098653|FG001|NOT COMPLETED|Overall Study||5||
59981462|NCT02564198|76098654|FG002|NOT COMPLETED|Overall Study||0||
59981463|NCT02564120|76098669|FG000|STARTED|Overall Study||1556||
59981464|NCT02564120|76098669|FG000|COMPLETED|Overall Study||1110||
59981465|NCT02564120|76098669|FG000|NOT COMPLETED|Overall Study||446||
59981466|NCT00705783|76098685|FG000|STARTED|Conversion Phase||633||
59981467|NCT00705783|76098686|FG001|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0||
59981468|NCT00705783|76098687|FG002|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0||
59981469|NCT00705783|76098685|FG000|Received Study Medication|Conversion Phase||632||
59981470|NCT00705783|76098686|FG001|Received Study Medication|Conversion Phase||0||
59981471|NCT00705783|76098687|FG002|Received Study Medication|Conversion Phase||0||
59981472|NCT00705783|76098685|FG000|COMPLETED|Conversion Phase||500||
59981473|NCT00705783|76098686|FG001|COMPLETED|Conversion Phase||0||
59981474|NCT00705783|76098687|FG002|COMPLETED|Conversion Phase||0||
59981475|NCT00705783|76098685|FG000|NOT COMPLETED|Conversion Phase||133||
59981476|NCT00705783|76098686|FG001|NOT COMPLETED|Conversion Phase||0||
59981477|NCT00705783|76098687|FG002|NOT COMPLETED|Conversion Phase||0||
59981478|NCT00705783|76098685|FG000|STARTED|Oral Stabilization Phase|210 of the 710 patients who started this phase enrolled in this study directly into this phase.|710||
59981479|NCT00705783|76098686|FG001|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0||
59981480|NCT00705783|76098687|FG002|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0||
59981481|NCT00705783|76098685|FG000|Received Study Medication|Oral Stabilization Phase||709||
59981482|NCT00705783|76098686|FG001|Received Study Medication|Oral Stabilization Phase||0||
59981483|NCT00705783|76098687|FG002|Received Study Medication|Oral Stabilization Phase||0||
59981484|NCT00705783|76098685|FG000|COMPLETED|Oral Stabilization Phase||576||
59526490|NCT01414153|75622142|FG002|NOT COMPLETED|Overall Study||4||
59526491|NCT01414153|75622143|FG003|NOT COMPLETED|Overall Study||4||
59526492|NCT01311895|75622155|FG000|STARTED|Overall Study||175||
59981485|NCT00705783|76098686|FG001|COMPLETED|Oral Stabilization Phase||0||
59981486|NCT00705783|76098687|FG002|COMPLETED|Oral Stabilization Phase||0||
59981487|NCT00705783|76098685|FG000|NOT COMPLETED|Oral Stabilization Phase||134||
59981488|NCT00705783|76098686|FG001|NOT COMPLETED|Oral Stabilization Phase||0||
59981489|NCT00705783|76098687|FG002|NOT COMPLETED|Oral Stabilization Phase||0||
59981490|NCT00705783|76098685|FG000|STARTED|Depot Stabilization Phase||576||
59981491|NCT00705783|76098686|FG001|STARTED|Depot Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0||
59981492|NCT00705783|76098687|FG002|STARTED|Depot Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0||
59981493|NCT00705783|76098685|FG000|COMPLETED|Depot Stabilization Phase||403||
59981494|NCT00705783|76098686|FG001|COMPLETED|Depot Stabilization Phase||0||
59981495|NCT00705783|76098687|FG002|COMPLETED|Depot Stabilization Phase||0||
59981496|NCT00705783|76098685|FG000|NOT COMPLETED|Depot Stabilization Phase||173||
59981497|NCT00705783|76098686|FG001|NOT COMPLETED|Depot Stabilization Phase||0||
59981498|NCT00705783|76098687|FG002|NOT COMPLETED|Depot Stabilization Phase||0||
59981499|NCT00705783|76098685|FG000|STARTED|Depot Maintenance Phase|Patients were randomized into the aripiprazole and placebo depot groups in this phase of the study.|0||
59981500|NCT00705783|76098686|FG001|STARTED|Depot Maintenance Phase||269||
59981501|NCT00705783|76098687|FG002|STARTED|Depot Maintenance Phase||134||
59981502|NCT00705783|76098685|FG000|COMPLETED|Depot Maintenance Phase||0||
59981503|NCT00705783|76098686|FG001|COMPLETED|Depot Maintenance Phase||23||
59981504|NCT00705783|76098687|FG002|COMPLETED|Depot Maintenance Phase||3||
59981505|NCT00705783|76098685|FG000|NOT COMPLETED|Depot Maintenance Phase||0||
59981506|NCT00705783|76098686|FG001|NOT COMPLETED|Depot Maintenance Phase||246||
59981507|NCT00705783|76098687|FG002|NOT COMPLETED|Depot Maintenance Phase||131||
59981508|NCT02694549|76098696|FG000|STARTED|Overall Study||12||
59981509|NCT02694549|76098696|FG000|COMPLETED|Overall Study||10||
59981510|NCT02694549|76098696|FG000|NOT COMPLETED|Overall Study||2||
59981511|NCT02782325|76098702|FG000|STARTED|Blinded FMT Treatment (up to 24 Weeks)||4||
59981512|NCT02782325|76098703|FG001|STARTED|Blinded FMT Treatment (up to 24 Weeks)||2||
59981513|NCT02782325|76098704|FG002|STARTED|Blinded FMT Treatment (up to 24 Weeks)||0||
59981514|NCT02782325|76098702|FG000|COMPLETED|Blinded FMT Treatment (up to 24 Weeks)||0||
59981515|NCT02782325|76098703|FG001|COMPLETED|Blinded FMT Treatment (up to 24 Weeks)||0||
59981516|NCT02782325|76098704|FG002|COMPLETED|Blinded FMT Treatment (up to 24 Weeks)||0||
59981517|NCT02782325|76098702|FG000|NOT COMPLETED|Blinded FMT Treatment (up to 24 Weeks)||4||
59981518|NCT02782325|76098703|FG001|NOT COMPLETED|Blinded FMT Treatment (up to 24 Weeks)||2||
59981519|NCT02782325|76098704|FG002|NOT COMPLETED|Blinded FMT Treatment (up to 24 Weeks)||0||
59981520|NCT02782325|76098702|FG000|STARTED|Open Label FMT Period (up to 24 Weeks)||0|One patient declined participation in the open label extension arm|
59981521|NCT02782325|76098703|FG001|STARTED|Open Label FMT Period (up to 24 Weeks)||0|One patient declined participation in the open label extension arm|
59981522|NCT02782325|76098704|FG002|STARTED|Open Label FMT Period (up to 24 Weeks)|1 participant decided to not participate in the open label period|5|One patient declined participation in the open label extension arm|
59981523|NCT02782325|76098702|FG000|COMPLETED|Open Label FMT Period (up to 24 Weeks)||0||
59981524|NCT02782325|76098703|FG001|COMPLETED|Open Label FMT Period (up to 24 Weeks)||0||
59981525|NCT02782325|76098704|FG002|COMPLETED|Open Label FMT Period (up to 24 Weeks)||1||
59981526|NCT02782325|76098702|FG000|NOT COMPLETED|Open Label FMT Period (up to 24 Weeks)||0||
59981527|NCT02782325|76098703|FG001|NOT COMPLETED|Open Label FMT Period (up to 24 Weeks)||0||
59981528|NCT02782325|76098704|FG002|NOT COMPLETED|Open Label FMT Period (up to 24 Weeks)||4||
59981529|NCT02693691|76098712|FG000|STARTED|Primary Endpoint Analysis (First 12M)||234||
59981530|NCT02693691|76098712|FG000|COMPLETED|Primary Endpoint Analysis (First 12M)||184||
59981531|NCT02693691|76098712|FG000|NOT COMPLETED|Primary Endpoint Analysis (First 12M)||50||
59981532|NCT02693691|76098712|FG000|STARTED|Extended Follow-Up (Until Last pt 12M)||184||
59981533|NCT02693691|76098712|FG000|COMPLETED|Extended Follow-Up (Until Last pt 12M)||160||
59981534|NCT02693691|76098712|FG000|NOT COMPLETED|Extended Follow-Up (Until Last pt 12M)||24||
59981535|NCT04203667|76098716|FG000|STARTED|Overall Study||66|Intent to Treat Population|
59981536|NCT04203667|76098716|FG000|Per Protocol Population|Overall Study||45||
59981537|NCT04203667|76098716|FG000|COMPLETED|Overall Study||62||
59981538|NCT04203667|76098716|FG000|NOT COMPLETED|Overall Study||4||
59981539|NCT02782169|76098723|FG000|STARTED|Overall Study||56||
59981540|NCT02782169|76098724|FG001|STARTED|Overall Study||54||
59981541|NCT02782169|76098723|FG000|COMPLETED|Overall Study||55||
59981542|NCT02782169|76098724|FG001|COMPLETED|Overall Study||52||
59981543|NCT02782169|76098723|FG000|NOT COMPLETED|Overall Study||1||
59981544|NCT02782169|76098724|FG001|NOT COMPLETED|Overall Study||2||
59981545|NCT02564042|76098736|FG000|STARTED|Overall Study||38||
59981546|NCT02564042|76098737|FG001|STARTED|Overall Study||38||
59981547|NCT02564042|76098738|FG002|STARTED|Overall Study||38||
59981548|NCT02564042|76098739|FG003|STARTED|Overall Study||38||
59981549|NCT02564042|76098740|FG004|STARTED|Overall Study||37||
59981550|NCT02564042|76098741|FG005|STARTED|Overall Study||38||
59981551|NCT02564042|76098736|FG000|COMPLETED|Overall Study||27||
59981552|NCT02564042|76098737|FG001|COMPLETED|Overall Study||30||
59981553|NCT02564042|76098738|FG002|COMPLETED|Overall Study||32||
59981554|NCT02564042|76098739|FG003|COMPLETED|Overall Study||35||
59981555|NCT02564042|76098740|FG004|COMPLETED|Overall Study||26||
59981556|NCT02564042|76098741|FG005|COMPLETED|Overall Study||24||
59981557|NCT02564042|76098736|FG000|NOT COMPLETED|Overall Study||11||
59981558|NCT02564042|76098737|FG001|NOT COMPLETED|Overall Study||8||
59981559|NCT02564042|76098738|FG002|NOT COMPLETED|Overall Study||6||
59981560|NCT02564042|76098739|FG003|NOT COMPLETED|Overall Study||3||
59981561|NCT02564042|76098740|FG004|NOT COMPLETED|Overall Study||11||
59981562|NCT02564042|76098741|FG005|NOT COMPLETED|Overall Study||14||
59981563|NCT02151383|76098758|FG000|STARTED|Overall Study||8||
59981564|NCT02151383|76098759|FG001|STARTED|Overall Study||3||
59981565|NCT02151383|76098760|FG002|STARTED|Overall Study||1||
59622564|NCT00535782|75734431|FG001|Treated With TCZ + MTX|Part 1: 24-Week Double-blind Period|1 misrandomized patient received the TCZ in error, and 1 patient received TCZ as rescue therapy.|2||
59981566|NCT02151383|76098758|FG000|Low-dose|Overall Study||2||
59981567|NCT02151383|76098759|FG001|Low-dose|Overall Study||3||
59622565|NCT00535782|75734432|FG002|Treated With TCZ + MTX|Part 1: 24-Week Double-blind Period||0||
59981568|NCT02151383|76098760|FG002|Low-dose|Overall Study||1||
59981569|NCT02151383|76098758|FG000|High-dose|Overall Study||6||
59981570|NCT02151383|76098759|FG001|High-dose|Overall Study||0||
59981571|NCT02151383|76098760|FG002|High-dose|Overall Study||0||
59981572|NCT02151383|76098758|FG000|COMPLETED|Overall Study||8||
59981573|NCT02151383|76098759|FG001|COMPLETED|Overall Study||3||
59981574|NCT02151383|76098760|FG002|COMPLETED|Overall Study||1||
59981575|NCT02151383|76098758|FG000|NOT COMPLETED|Overall Study||0||
59981576|NCT02151383|76098759|FG001|NOT COMPLETED|Overall Study||0||
59981577|NCT02151383|76098760|FG002|NOT COMPLETED|Overall Study||0||
59981578|NCT03698864|76098768|FG000|STARTED|Overall Study||12||
59981579|NCT03698864|76098768|FG000|COMPLETED|Overall Study||10||
59981580|NCT03698864|76098768|FG000|NOT COMPLETED|Overall Study||2||
59981581|NCT02695719|76098774|FG000|STARTED|Overall Study||74||
59981582|NCT02695719|76098775|FG001|STARTED|Overall Study||82||
59981583|NCT02695719|76098774|FG000|COMPLETED|Overall Study||71||
59981584|NCT02695719|76098775|FG001|COMPLETED|Overall Study||72||
59981585|NCT02695719|76098774|FG000|NOT COMPLETED|Overall Study||3||
59981586|NCT02695719|76098775|FG001|NOT COMPLETED|Overall Study||10||
59981587|NCT03652454|76098783|FG000|STARTED|Overall Study||14||
59981588|NCT03652454|76098784|FG001|STARTED|Overall Study||14||
59981589|NCT03652454|76098783|FG000|COMPLETED|Overall Study||14||
59981590|NCT03652454|76098784|FG001|COMPLETED|Overall Study||14||
59981591|NCT03652454|76098783|FG000|NOT COMPLETED|Overall Study||0||
59981592|NCT03652454|76098784|FG001|NOT COMPLETED|Overall Study||0||
59981593|NCT02563106|76098792|FG000|STARTED|Overall Study||206||
59981594|NCT02563106|76098793|FG001|STARTED|Overall Study||207||
59981595|NCT02563106|76098792|FG000|COMPLETED|Overall Study||172||
59981596|NCT02563106|76098793|FG001|COMPLETED|Overall Study||178||
59981597|NCT02563106|76098792|FG000|NOT COMPLETED|Overall Study||34||
59981598|NCT02563106|76098793|FG001|NOT COMPLETED|Overall Study||29||
59981599|NCT02691741|76098801|FG000|STARTED|Overall Study||94|Randomized subjects|
59981600|NCT02691741|76098802|FG001|STARTED|Overall Study||94|Randomized subjects|
59981601|NCT02691741|76098801|FG000|All-Implanted Analysis Set|Overall Study||93|All subjects with successful test or control article bilateral implantation|
59981602|NCT02691741|76098802|FG001|All-Implanted Analysis Set|Overall Study||89|All subjects with successful test or control article bilateral implantation|
59981603|NCT02691741|76098801|FG000|Best-Case Analysis Set|Overall Study||86|All subjects successfully implanted, at least 1 post-op visit, no mac. degen., no major deviations|
59981604|NCT02691741|76098802|FG001|Best-Case Analysis Set|Overall Study||85|All subjects successfully implanted, at least 1 post-op visit, no mac. degen., no major deviations|
59981605|NCT02691741|76098801|FG000|Safety Analysis Set|Overall Study||93|All subjects with attempted implantation (successful or aborted after contact with the eye)|
59981606|NCT02691741|76098802|FG001|Safety Analysis Set|Overall Study||89|All subjects with attempted implantation (successful or aborted after contact with the eye)|
59981607|NCT02691741|76098801|FG000|COMPLETED|Overall Study||93||
59981608|NCT02691741|76098802|FG001|COMPLETED|Overall Study||87||
59981609|NCT02691741|76098801|FG000|NOT COMPLETED|Overall Study||1||
59981610|NCT02691741|76098802|FG001|NOT COMPLETED|Overall Study||7||
59981611|NCT02691507|76098815|FG000|STARTED|Overall Study||40||
59981612|NCT02691507|76098816|FG001|STARTED|Overall Study||13||
59981613|NCT02691507|76098815|FG000|COMPLETED|Overall Study||40||
59981614|NCT02691507|76098816|FG001|COMPLETED|Overall Study||12||
59981615|NCT02691507|76098815|FG000|NOT COMPLETED|Overall Study||0||
59981616|NCT02691507|76098816|FG001|NOT COMPLETED|Overall Study||1||
59981617|NCT04579393|76098824|FG000|STARTED|Overall Study||30||
59981618|NCT04579393|76098825|FG001|STARTED|Overall Study||29||
59981619|NCT04579393|76098824|FG000|COMPLETED|Overall Study||27||
59981620|NCT04579393|76098825|FG001|COMPLETED|Overall Study||24||
59981621|NCT04579393|76098824|FG000|NOT COMPLETED|Overall Study||3||
59981622|NCT04579393|76098825|FG001|NOT COMPLETED|Overall Study||5||
59981623|NCT02776553|76098834|FG000|STARTED|Overall Study|One subject was eliminated for repeated hospitalizations.|9||
59981624|NCT02776553|76098835|FG001|STARTED|Overall Study|Two subjects were eliminated for repeated hospitalizations.|8||
59981625|NCT02776553|76098834|FG000|COMPLETED|Overall Study||6||
59981626|NCT02776553|76098835|FG001|COMPLETED|Overall Study||5||
59981627|NCT02776553|76098834|FG000|NOT COMPLETED|Overall Study||3||
59981628|NCT02776553|76098835|FG001|NOT COMPLETED|Overall Study||3||
59981629|NCT02690727|76098841|FG000|STARTED|Overall Study||9||
59526493|NCT01311895|75622156|FG001|STARTED|Overall Study||175||
59526494|NCT01311895|75622155|FG000|COMPLETED|Overall Study||175||
59981630|NCT02690727|76098842|FG001|STARTED|Overall Study||9||
60074810|NCT01930045|76190104|FG001|COMPLETED|Part 1 - Period 2||3||
60074811|NCT01930045|76190105|FG002|COMPLETED|Part 1 - Period 2||3||
59981631|NCT02690727|76098841|FG000|COMPLETED|Overall Study||7||
59981632|NCT02690727|76098842|FG001|COMPLETED|Overall Study||7||
59981633|NCT02690727|76098841|FG000|NOT COMPLETED|Overall Study||2||
60074812|NCT01930045|76190106|FG003|COMPLETED|Part 1 - Period 2||3||
59526495|NCT01311895|75622156|FG001|COMPLETED|Overall Study||175||
59526496|NCT01311895|75622155|FG000|NOT COMPLETED|Overall Study||0||
59526497|NCT01311895|75622156|FG001|NOT COMPLETED|Overall Study||0||
59981634|NCT02690727|76098842|FG001|NOT COMPLETED|Overall Study||2||
59981635|NCT02777333|76098852|FG000|STARTED|Overall Study||15||
59981636|NCT02777333|76098853|FG001|STARTED|Overall Study||15||
59981637|NCT02777333|76098852|FG000|COMPLETED|Overall Study||15||
59981638|NCT02777333|76098853|FG001|COMPLETED|Overall Study||13||
59981639|NCT02777333|76098852|FG000|NOT COMPLETED|Overall Study||0||
59981640|NCT02777333|76098853|FG001|NOT COMPLETED|Overall Study||2||
59981641|NCT02695329|76098861|FG000|STARTED|Overall Study||50||
59981642|NCT02695329|76098862|FG001|STARTED|Overall Study||50||
59981643|NCT02695329|76098861|FG000|COMPLETED|Overall Study||45||
59981644|NCT02695329|76098862|FG001|COMPLETED|Overall Study||45||
59981645|NCT02695329|76098861|FG000|NOT COMPLETED|Overall Study||5||
59981646|NCT02695329|76098862|FG001|NOT COMPLETED|Overall Study||5||
59981647|NCT02690649|76098870|FG000|STARTED|Overall Study||80||
59981648|NCT02690649|76098871|FG001|STARTED|Overall Study||80||
59981649|NCT02690649|76098870|FG000|COMPLETED|Overall Study||79||
59981650|NCT02690649|76098871|FG001|COMPLETED|Overall Study||76||
59981651|NCT02690649|76098870|FG000|NOT COMPLETED|Overall Study||1||
59981652|NCT02690649|76098871|FG001|NOT COMPLETED|Overall Study||4||
59981653|NCT01358864|76098887|FG000|STARTED|Overall Study||49||
59981654|NCT01358864|76098888|FG001|STARTED|Overall Study||99||
59981655|NCT01358864|76098889|FG002|STARTED|Overall Study||103||
59981656|NCT01358864|76098890|FG003|STARTED|Overall Study||29||
59981657|NCT01358864|76098891|FG004|STARTED|Overall Study||57||
59981658|NCT01358864|76098892|FG005|STARTED|Overall Study||55||
59981659|NCT01358864|76098893|FG006|STARTED|Overall Study||146||
59981660|NCT01358864|76098894|FG007|STARTED|Overall Study||140||
59981661|NCT01358864|76098887|FG000|COMPLETED|Overall Study||18||
59981662|NCT01358864|76098888|FG001|COMPLETED|Overall Study||86||
59981663|NCT01358864|76098889|FG002|COMPLETED|Overall Study||87||
59981664|NCT01358864|76098890|FG003|COMPLETED|Overall Study||10||
59981665|NCT01358864|76098891|FG004|COMPLETED|Overall Study||46||
59981666|NCT01358864|76098892|FG005|COMPLETED|Overall Study||42||
59981667|NCT01358864|76098893|FG006|COMPLETED|Overall Study||81||
59981668|NCT01358864|76098894|FG007|COMPLETED|Overall Study||85||
59981669|NCT01358864|76098887|FG000|NOT COMPLETED|Overall Study||31||
59981670|NCT01358864|76098888|FG001|NOT COMPLETED|Overall Study||13||
59981671|NCT01358864|76098889|FG002|NOT COMPLETED|Overall Study||16||
59981672|NCT01358864|76098890|FG003|NOT COMPLETED|Overall Study||19||
59981673|NCT01358864|76098891|FG004|NOT COMPLETED|Overall Study||11||
59981674|NCT01358864|76098892|FG005|NOT COMPLETED|Overall Study||13||
59981675|NCT01358864|76098893|FG006|NOT COMPLETED|Overall Study||65||
59981676|NCT01358864|76098894|FG007|NOT COMPLETED|Overall Study||55||
59981677|NCT02750761|76098920|FG000|STARTED|Overall Study||5||
59981678|NCT02750761|76098921|FG001|STARTED|Overall Study||5||
59981679|NCT02750761|76098922|FG002|STARTED|Overall Study||5||
59981680|NCT02750761|76098923|FG003|STARTED|Overall Study||5||
59981681|NCT02750761|76098924|FG004|STARTED|Overall Study||6||
59981682|NCT02750761|76098925|FG005|STARTED|Overall Study||6||
59981683|NCT02750761|76098920|FG000|COMPLETED|Overall Study||5||
59981684|NCT02750761|76098921|FG001|COMPLETED|Overall Study||5||
59981685|NCT02750761|76098922|FG002|COMPLETED|Overall Study||4||
59981686|NCT02750761|76098923|FG003|COMPLETED|Overall Study||5||
59981687|NCT02750761|76098924|FG004|COMPLETED|Overall Study||6||
59981688|NCT02750761|76098925|FG005|COMPLETED|Overall Study||6||
59981689|NCT02750761|76098920|FG000|NOT COMPLETED|Overall Study||0||
59981690|NCT02750761|76098921|FG001|NOT COMPLETED|Overall Study||0||
59981691|NCT02750761|76098922|FG002|NOT COMPLETED|Overall Study||1||
59981692|NCT02750761|76098923|FG003|NOT COMPLETED|Overall Study||0||
59981693|NCT02750761|76098924|FG004|NOT COMPLETED|Overall Study||0||
59981694|NCT02750761|76098925|FG005|NOT COMPLETED|Overall Study||0||
59981695|NCT04601870|76098946|FG000|STARTED|Overall Study||38||
59981696|NCT04601870|76098947|FG001|STARTED|Overall Study||30||
59981697|NCT04601870|76098948|FG002|STARTED|Overall Study||30||
59981698|NCT04601870|76098946|FG000|COMPLETED|Overall Study||38||
59981699|NCT04601870|76098947|FG001|COMPLETED|Overall Study||30||
59981700|NCT04601870|76098948|FG002|COMPLETED|Overall Study||30||
59981701|NCT04601870|76098946|FG000|NOT COMPLETED|Overall Study||0||
59981702|NCT04601870|76098947|FG001|NOT COMPLETED|Overall Study||0||
59981703|NCT04601870|76098948|FG002|NOT COMPLETED|Overall Study||0||
59981704|NCT01131169|76098958|FG000|STARTED|Overall Study||47||
59981705|NCT01131169|76098959|FG001|STARTED|Overall Study||19||
60074813|NCT01930045|76190107|FG004|COMPLETED|Part 1 - Period 2||3||
59981706|NCT01131169|76098958|FG000|COMPLETED|Overall Study||47||
59981707|NCT01131169|76098959|FG001|COMPLETED|Overall Study||19||
59981708|NCT01131169|76098958|FG000|NOT COMPLETED|Overall Study||0||
59981709|NCT01131169|76098959|FG001|NOT COMPLETED|Overall Study||0||
59981710|NCT02688933|76098968|FG000|STARTED|Overall Study||320||
59981711|NCT02688933|76098969|FG001|STARTED|Overall Study||318||
59981712|NCT02688933|76098968|FG000|COMPLETED|Overall Study||291||
59981713|NCT02688933|76098969|FG001|COMPLETED|Overall Study||281||
59981714|NCT02688933|76098968|FG000|NOT COMPLETED|Overall Study||29||
59981715|NCT02688933|76098969|FG001|NOT COMPLETED|Overall Study||37||
59981716|NCT04372628|76098978|FG000|STARTED|Overall Study||4||
59981717|NCT04372628|76098979|FG001|STARTED|Overall Study||221||
59981718|NCT04372628|76098980|FG002|STARTED|Overall Study||227||
59981719|NCT04372628|76098978|FG000|COMPLETED|Overall Study||3||
59981720|NCT04372628|76098979|FG001|COMPLETED|Overall Study||216||
59981721|NCT04372628|76098980|FG002|COMPLETED|Overall Study||221||
59981722|NCT04372628|76098978|FG000|NOT COMPLETED|Overall Study||1||
59981723|NCT04372628|76098979|FG001|NOT COMPLETED|Overall Study||5||
59981724|NCT04372628|76098980|FG002|NOT COMPLETED|Overall Study||6||
59981725|NCT02688621|76098989|FG000|STARTED|Overall Study||212||
59981726|NCT02688621|76098990|FG001|STARTED|Overall Study||206||
59981727|NCT02688621|76098989|FG000|COMPLETED|Overall Study||172||
59981728|NCT02688621|76098990|FG001|COMPLETED|Overall Study||188||
59981729|NCT02688621|76098989|FG000|NOT COMPLETED|Overall Study||40||
59981730|NCT02688621|76098990|FG001|NOT COMPLETED|Overall Study||18||
59981731|NCT04227704|76099002|FG000|STARTED|Overall Study||8||
59981732|NCT04227704|76099003|FG001|STARTED|Overall Study||9||
59981733|NCT04227704|76099004|FG002|STARTED|Overall Study||8||
59981734|NCT04227704|76099002|FG000|COMPLETED|Overall Study||7||
59981735|NCT04227704|76099003|FG001|COMPLETED|Overall Study||8||
59981736|NCT04227704|76099004|FG002|COMPLETED|Overall Study||8||
59981737|NCT04227704|76099002|FG000|NOT COMPLETED|Overall Study||1||
59981738|NCT04227704|76099003|FG001|NOT COMPLETED|Overall Study||1||
59981739|NCT04227704|76099004|FG002|NOT COMPLETED|Overall Study||0||
59981740|NCT02709512|76099014|FG000|STARTED|Phase 2||87||
59981741|NCT02709512|76099015|FG001|STARTED|Phase 2||89||
59981742|NCT02709512|76099014|FG000|COMPLETED|Phase 2||87||
59981743|NCT02709512|76099015|FG001|COMPLETED|Phase 2||89||
59981744|NCT02709512|76099014|FG000|NOT COMPLETED|Phase 2||0||
59981745|NCT02709512|76099015|FG001|NOT COMPLETED|Phase 2||0||
59981746|NCT02709512|76099014|FG000|STARTED|Phase 3||125||
59981747|NCT02709512|76099015|FG001|STARTED|Phase 3||124||
59981748|NCT02709512|76099014|FG000|COMPLETED|Phase 3|For Phase 3 the total number of subjects enrolled included 87 subjects from Phase 2 that counted towards 125 enrolled subjects on this arm.|125||
59981749|NCT02709512|76099015|FG001|COMPLETED|Phase 3|For Phase 3 the total number of subjects enrolled included 89 subjects from Phase 2 that counted towards 124 enrolled subjects on this arm.|124||
59981750|NCT02709512|76099014|FG000|NOT COMPLETED|Phase 3||0||
59981751|NCT02709512|76099015|FG001|NOT COMPLETED|Phase 3||0||
59981752|NCT03530293|76099025|FG000|STARTED|Pre-randomization||81||
59981753|NCT03530293|76099026|FG001|STARTED|Pre-randomization||0||
59981754|NCT03530293|76099027|FG002|STARTED|Pre-randomization||0||
59981755|NCT03530293|76099025|FG000|Safety Analysis Set|Pre-randomization||80|The safety analysis set includes all enrolled subjects who received at least one dose of study drug and had any safety data collected after the first dose of study drug.|
59981756|NCT03530293|76099026|FG001|Safety Analysis Set|Pre-randomization||0|The safety analysis set includes all enrolled subjects who received at least one dose of study drug and had any safety data collected after the first dose of study drug.|
59981757|NCT03530293|76099027|FG002|Safety Analysis Set|Pre-randomization||0|The safety analysis set includes all enrolled subjects who received at least one dose of study drug and had any safety data collected after the first dose of study drug.|
59981758|NCT03530293|76099025|FG000|COMPLETED|Pre-randomization||57||
59981759|NCT03530293|76099026|FG001|COMPLETED|Pre-randomization||0||
59981760|NCT03530293|76099027|FG002|COMPLETED|Pre-randomization||0||
59981761|NCT03530293|76099025|FG000|NOT COMPLETED|Pre-randomization||24||
59981762|NCT03530293|76099026|FG001|NOT COMPLETED|Pre-randomization||0||
59981763|NCT03530293|76099027|FG002|NOT COMPLETED|Pre-randomization||0||
59981764|NCT03530293|76099025|FG000|STARTED|Randomized Withdrawal Period / Follow-up||0|5 subjects completed the pre-randomization period but were ineligible for randomization due to lack of response.|
59981765|NCT03530293|76099026|FG001|STARTED|Randomized Withdrawal Period / Follow-up||26|5 subjects completed the pre-randomization period but were ineligible for randomization due to lack of response.|
59981766|NCT03530293|76099027|FG002|STARTED|Randomized Withdrawal Period / Follow-up||26|5 subjects completed the pre-randomization period but were ineligible for randomization due to lack of response.|
59981767|NCT03530293|76099025|FG000|COMPLETED|Randomized Withdrawal Period / Follow-up||0||
59981768|NCT03530293|76099026|FG001|COMPLETED|Randomized Withdrawal Period / Follow-up||9||
59981769|NCT03530293|76099027|FG002|COMPLETED|Randomized Withdrawal Period / Follow-up||9||
59981770|NCT03530293|76099025|FG000|NOT COMPLETED|Randomized Withdrawal Period / Follow-up||0||
59981771|NCT03530293|76099026|FG001|NOT COMPLETED|Randomized Withdrawal Period / Follow-up||17||
59981772|NCT03530293|76099027|FG002|NOT COMPLETED|Randomized Withdrawal Period / Follow-up||17||
59981773|NCT02310464|76099038|FG000|STARTED|Overall Study||4||
59981774|NCT02310464|76099039|FG001|STARTED|Overall Study||3||
59981775|NCT02310464|76099040|FG002|STARTED|Overall Study||4||
59981776|NCT02310464|76099041|FG003|STARTED|Overall Study||14||
59981777|NCT02310464|76099038|FG000|COMPLETED|Overall Study||0||
59981778|NCT02310464|76099039|FG001|COMPLETED|Overall Study||0||
59981779|NCT02310464|76099040|FG002|COMPLETED|Overall Study||0||
59981780|NCT02310464|76099041|FG003|COMPLETED|Overall Study||1||
59981781|NCT02310464|76099038|FG000|NOT COMPLETED|Overall Study||4||
59981782|NCT02310464|76099039|FG001|NOT COMPLETED|Overall Study||3||
59981783|NCT02310464|76099040|FG002|NOT COMPLETED|Overall Study||4||
59981784|NCT02310464|76099041|FG003|NOT COMPLETED|Overall Study||13||
59981785|NCT03335371|76099056|FG000|STARTED|Overall Study||5||
59981786|NCT03335371|76099057|FG001|STARTED|Overall Study||9||
59981787|NCT03335371|76099058|FG002|STARTED|Overall Study||11||
59981788|NCT03335371|76099059|FG003|STARTED|Overall Study||40||
59981789|NCT03335371|76099060|FG004|STARTED|Overall Study||45||
59981790|NCT03335371|76099056|FG000|COMPLETED|Overall Study||5||
59981791|NCT03335371|76099057|FG001|COMPLETED|Overall Study||9||
59981792|NCT03335371|76099058|FG002|COMPLETED|Overall Study||10||
59981793|NCT03335371|76099059|FG003|COMPLETED|Overall Study||40||
59981794|NCT03335371|76099060|FG004|COMPLETED|Overall Study||43||
59981795|NCT03335371|76099056|FG000|NOT COMPLETED|Overall Study||0||
59526498|NCT01362127|75622164|FG000|STARTED|Overall Study||90||
59526499|NCT01362127|75622165|FG001|STARTED|Overall Study||91||
59526500|NCT01362127|75622164|FG000|COMPLETED|Overall Study||90||
59526501|NCT01362127|75622165|FG001|COMPLETED|Overall Study||91||
59526502|NCT01362127|75622164|FG000|NOT COMPLETED|Overall Study||0||
59526503|NCT01362127|75622165|FG001|NOT COMPLETED|Overall Study||0||
59526504|NCT01312519|75622173|FG000|STARTED|Overall Study||26||
59526505|NCT01312519|75622174|FG001|STARTED|Overall Study||24||
59526506|NCT01312519|75622173|FG000|COMPLETED|Overall Study||26||
59526507|NCT01312519|75622174|FG001|COMPLETED|Overall Study||24||
59526508|NCT01312519|75622173|FG000|NOT COMPLETED|Overall Study||0||
59526509|NCT01312519|75622174|FG001|NOT COMPLETED|Overall Study||0||
59526510|NCT01312675|75622182|FG000|STARTED|Overall Study||9||
59526511|NCT01312675|75622183|FG001|STARTED|Overall Study||7||
59526512|NCT01312675|75622182|FG000|COMPLETED|Overall Study||9||
59526513|NCT01312675|75622183|FG001|COMPLETED|Overall Study||7||
59526514|NCT01312675|75622182|FG000|NOT COMPLETED|Overall Study||0||
59526515|NCT01312675|75622183|FG001|NOT COMPLETED|Overall Study||0||
59526516|NCT01362205|75622191|FG000|STARTED|Overall Study||22||
59526517|NCT01362205|75622192|FG001|STARTED|Overall Study||27||
59526518|NCT01362205|75622191|FG000|COMPLETED|Overall Study||22||
59526519|NCT01362205|75622192|FG001|COMPLETED|Overall Study||27||
59526520|NCT01362205|75622191|FG000|NOT COMPLETED|Overall Study||0||
59526521|NCT01362205|75622192|FG001|NOT COMPLETED|Overall Study||0||
59526522|NCT01362907|75622198|FG000|STARTED|Period 1, One Week||20||
59526523|NCT01362907|75622199|FG001|STARTED|Period 1, One Week||20||
59526524|NCT01362907|75622198|FG000|COMPLETED|Period 1, One Week||20||
59526525|NCT01362907|75622199|FG001|COMPLETED|Period 1, One Week||20||
59526526|NCT01362907|75622198|FG000|NOT COMPLETED|Period 1, One Week||0||
59526527|NCT01362907|75622199|FG001|NOT COMPLETED|Period 1, One Week||0||
59526528|NCT01362907|75622198|FG000|STARTED|Period 2, One Week||20||
59526529|NCT01362907|75622199|FG001|STARTED|Period 2, One Week||20||
59526530|NCT01362907|75622198|FG000|COMPLETED|Period 2, One Week||20||
59526531|NCT01362907|75622199|FG001|COMPLETED|Period 2, One Week||20||
59526532|NCT01362907|75622198|FG000|NOT COMPLETED|Period 2, One Week||0||
59526533|NCT01362907|75622199|FG001|NOT COMPLETED|Period 2, One Week||0||
59526534|NCT00052910|75622207|FG000|STARTED|Overall Study||280||
59526535|NCT00052910|75622208|FG001|STARTED|Overall Study||266||
59526536|NCT00052910|75622207|FG000|COMPLETED|Overall Study||280||
59526537|NCT00052910|75622208|FG001|COMPLETED|Overall Study||266||
59526538|NCT00052910|75622207|FG000|NOT COMPLETED|Overall Study||0||
59526539|NCT00052910|75622208|FG001|NOT COMPLETED|Overall Study||0||
59526540|NCT01416025|75622216|FG000|STARTED|Overall Study||14||
59526541|NCT01416025|75622217|FG001|STARTED|Overall Study||15||
59526542|NCT01416025|75622216|FG000|COMPLETED|Overall Study||14||
59526543|NCT01416025|75622217|FG001|COMPLETED|Overall Study||15||
59526544|NCT01416025|75622216|FG000|NOT COMPLETED|Overall Study||0||
59526545|NCT01416025|75622217|FG001|NOT COMPLETED|Overall Study||0||
59526546|NCT01363843|75622223|FG000|STARTED|Overall Study||39||
59526547|NCT01363843|75622223|FG000|COMPLETED|Overall Study|39 enrolled, 36 completed 8 cycles of mFOLFOX6, 35 completed chemo-radiation, 38 underwent surgery.|38||
59526548|NCT01363843|75622223|FG000|NOT COMPLETED|Overall Study||1||
59526549|NCT01417741|75622230|FG000|STARTED|Overall Study||75||
59526550|NCT01417741|75622231|FG001|STARTED|Overall Study||86||
59526551|NCT01417741|75622230|FG000|COMPLETED|Overall Study||75|Of the children who received the standard therapy, only 69 recived the post op day one phone call.|
59526552|NCT01417741|75622231|FG001|COMPLETED|Overall Study|only 73 received the post op day phone phone call|86|Of the children who received the standard therapy, only 69 recived the post op day one phone call.|
59526553|NCT01417741|75622230|FG000|NOT COMPLETED|Overall Study||0||
59526554|NCT01417741|75622231|FG001|NOT COMPLETED|Overall Study||0||
59981796|NCT03335371|76099057|FG001|NOT COMPLETED|Overall Study||0||
59981797|NCT03335371|76099058|FG002|NOT COMPLETED|Overall Study||1||
59981798|NCT03335371|76099059|FG003|NOT COMPLETED|Overall Study||0||
59981799|NCT03335371|76099060|FG004|NOT COMPLETED|Overall Study||2||
59526555|NCT02094326|75622237|FG000|STARTED|Overall Study||301||
59526556|NCT02094326|75622237|FG000|COMPLETED|Overall Study||301||
59526557|NCT02094326|75622237|FG000|NOT COMPLETED|Overall Study||0||
59526558|NCT00112112|75622244|FG000|STARTED|Overall Study||10||
59526559|NCT00112112|75622245|FG001|STARTED|Overall Study||10||
59981800|NCT03311269|76099079|FG000|STARTED|Overall Study||10||
59526560|NCT00112112|75622244|FG000|COMPLETED|Overall Study||10||
59526561|NCT00112112|75622245|FG001|COMPLETED|Overall Study||10||
59526562|NCT00112112|75622244|FG000|NOT COMPLETED|Overall Study||0||
59526563|NCT00112112|75622245|FG001|NOT COMPLETED|Overall Study||0||
59526564|NCT02092298|75622251|FG000|STARTED|Overall Study||19||
59526565|NCT02092298|75622251|FG000|COMPLETED|Overall Study||19||
59526566|NCT02092298|75622251|FG000|NOT COMPLETED|Overall Study||0||
59526567|NCT00115076|75622255|FG000|STARTED|Overall Study||30||
59526568|NCT00115076|75622255|FG000|COMPLETED|Overall Study||30||
59526569|NCT00115076|75622255|FG000|NOT COMPLETED|Overall Study||0||
59526570|NCT00254072|75622261|FG000|STARTED|Overall Study||180||
59526571|NCT00254072|75622262|FG001|STARTED|Overall Study||175||
59981801|NCT03311269|76099080|FG001|STARTED|Overall Study||9||
59981802|NCT03311269|76099079|FG000|COMPLETED|Overall Study||10||
59981803|NCT03311269|76099080|FG001|COMPLETED|Overall Study||9||
59981804|NCT03311269|76099079|FG000|NOT COMPLETED|Overall Study||0||
59981805|NCT03311269|76099080|FG001|NOT COMPLETED|Overall Study||0||
59981806|NCT02762929|76099092|FG000|STARTED|Overall Study||32||
59981807|NCT02762929|76099093|FG001|STARTED|Overall Study||175||
59981808|NCT02762929|76099094|FG002|STARTED|Overall Study||25||
59981809|NCT02762929|76099095|FG003|STARTED|Overall Study||104||
59981810|NCT02762929|76099096|FG004|STARTED|Overall Study||64||
59981811|NCT02762929|76099097|FG005|STARTED|Overall Study||30||
59981812|NCT02762929|76099092|FG000|COMPLETED|Overall Study||31||
59981813|NCT02762929|76099093|FG001|COMPLETED|Overall Study||172||
59981814|NCT02762929|76099094|FG002|COMPLETED|Overall Study||25||
59981815|NCT02762929|76099095|FG003|COMPLETED|Overall Study||101||
59981816|NCT02762929|76099096|FG004|COMPLETED|Overall Study||64||
59981817|NCT02762929|76099097|FG005|COMPLETED|Overall Study||30||
59981818|NCT02762929|76099092|FG000|NOT COMPLETED|Overall Study||1||
59981819|NCT02762929|76099093|FG001|NOT COMPLETED|Overall Study||3||
59981820|NCT02762929|76099094|FG002|NOT COMPLETED|Overall Study||0||
59981821|NCT02762929|76099095|FG003|NOT COMPLETED|Overall Study||3||
59981822|NCT02762929|76099096|FG004|NOT COMPLETED|Overall Study||0||
59981823|NCT02762929|76099097|FG005|NOT COMPLETED|Overall Study||0||
59981824|NCT03301051|76099118|FG000|STARTED|Overall Study||5077||
59981825|NCT03301051|76099119|FG001|STARTED|Overall Study||5083||
59981826|NCT03301051|76099118|FG000|Safety Analysis Set|Overall Study||5064||
59981827|NCT03301051|76099119|FG001|Safety Analysis Set|Overall Study||5072||
59981828|NCT03301051|76099118|FG000|Vaccinated|Overall Study|1 participant randomized to placebo fraudulently received doses at 2 different sites. Placebo (first site) and vaccine (second site).|5065||
59981829|NCT03301051|76099119|FG001|Vaccinated|Overall Study||5072||
59981830|NCT03301051|76099118|FG000|COMPLETED|Overall Study||4731||
59981831|NCT03301051|76099119|FG001|COMPLETED|Overall Study||4711||
59981832|NCT03301051|76099118|FG000|NOT COMPLETED|Overall Study||346||
59981833|NCT03301051|76099119|FG001|NOT COMPLETED|Overall Study||372||
59981834|NCT01662986|76099127|FG000|STARTED|Overall Study||40||
59981835|NCT01662986|76099128|FG001|STARTED|Overall Study||39||
59981836|NCT01662986|76099127|FG000|COMPLETED|Overall Study||22||
59981837|NCT01662986|76099128|FG001|COMPLETED|Overall Study||26||
59981838|NCT01662986|76099127|FG000|NOT COMPLETED|Overall Study||18||
59981839|NCT01662986|76099128|FG001|NOT COMPLETED|Overall Study||13||
59981840|NCT01337167|76099136|FG000|STARTED|Infant Series||986||
59981841|NCT01337167|76099137|FG001|STARTED|Infant Series||487||
59981842|NCT01337167|76099136|FG000|COMPLETED|Infant Series||924||
59981843|NCT01337167|76099137|FG001|COMPLETED|Infant Series||460||
59981844|NCT01337167|76099136|FG000|NOT COMPLETED|Infant Series||62||
59981845|NCT01337167|76099137|FG001|NOT COMPLETED|Infant Series||27||
59981846|NCT01337167|76099136|FG000|STARTED|Interim Period||924||
59981847|NCT01337167|76099137|FG001|STARTED|Interim Period||460||
59981848|NCT01337167|76099136|FG000|COMPLETED|Interim Period||843||
59981849|NCT01337167|76099137|FG001|COMPLETED|Interim Period||420||
59981850|NCT01337167|76099136|FG000|NOT COMPLETED|Interim Period||81||
59981851|NCT01337167|76099137|FG001|NOT COMPLETED|Interim Period||40||
59981852|NCT01337167|76099136|FG000|STARTED|Toddler Vaccinations||843||
59981853|NCT01337167|76099137|FG001|STARTED|Toddler Vaccinations||420||
59981854|NCT01337167|76099136|FG000|COMPLETED|Toddler Vaccinations||829||
59981855|NCT01337167|76099137|FG001|COMPLETED|Toddler Vaccinations||407||
59981856|NCT01337167|76099136|FG000|NOT COMPLETED|Toddler Vaccinations||14||
59981857|NCT01337167|76099137|FG001|NOT COMPLETED|Toddler Vaccinations||13||
59981858|NCT01338025|76099145|FG000|STARTED|Overall Study||16||
59981859|NCT01338025|76099146|FG001|STARTED|Overall Study||17||
59981860|NCT01338025|76099145|FG000|COMPLETED|Overall Study||5||
59981861|NCT01338025|76099146|FG001|COMPLETED|Overall Study||6||
59981862|NCT01338025|76099145|FG000|NOT COMPLETED|Overall Study||11||
59981863|NCT01338025|76099146|FG001|NOT COMPLETED|Overall Study||11||
59981864|NCT04314362|76099154|FG000|STARTED|Overall Study|3 patients were randomized, but did not receive treatment (2 in active 1 in vehicle).|21|The results with and without Hylo-Forte were to be combined if Hylo-Forte did not significantly impact safety or efficacy results. The groups were combined for presentation of the results as Hylo-Forte did not significantly impact the observed safety or efficacy results.|
59981865|NCT04314362|76099155|FG001|STARTED|Overall Study||11|The results with and without Hylo-Forte were to be combined if Hylo-Forte did not significantly impact safety or efficacy results. The groups were combined for presentation of the results as Hylo-Forte did not significantly impact the observed safety or efficacy results.|
59981866|NCT04314362|76099154|FG000|COMPLETED|Overall Study||12||
59981867|NCT04314362|76099155|FG001|COMPLETED|Overall Study||10||
59981868|NCT04314362|76099154|FG000|NOT COMPLETED|Overall Study||9||
59981869|NCT04314362|76099155|FG001|NOT COMPLETED|Overall Study||1||
59981870|NCT00457951|76099164|FG000|STARTED|Overall Study||13|In the double-blind phase, 145 subjects consented and 138 met criteria and were randomized.|
59981871|NCT00457951|76099165|FG001|STARTED|Overall Study||66|In the double-blind phase, 145 subjects consented and 138 met criteria and were randomized.|
59981872|NCT00457951|76099166|FG002|STARTED|Overall Study||72|In the double-blind phase, 145 subjects consented and 138 met criteria and were randomized.|
59981873|NCT00457951|76099164|FG000|COMPLETED|Overall Study||13||
59981874|NCT00457951|76099165|FG001|COMPLETED|Overall Study||50||
59981875|NCT00457951|76099166|FG002|COMPLETED|Overall Study||60||
59981876|NCT00457951|76099164|FG000|NOT COMPLETED|Overall Study||0||
59981877|NCT00457951|76099165|FG001|NOT COMPLETED|Overall Study||16||
59981878|NCT00457951|76099166|FG002|NOT COMPLETED|Overall Study||12||
59981879|NCT00345943|76099175|FG000|STARTED|Overall Study||38||
59981880|NCT00345943|76099176|FG001|STARTED|Overall Study||33||
59981881|NCT00345943|76099175|FG000|COMPLETED|Overall Study||33||
59981882|NCT00345943|76099176|FG001|COMPLETED|Overall Study||28||
59981883|NCT00345943|76099175|FG000|NOT COMPLETED|Overall Study||5||
59981884|NCT00345943|76099176|FG001|NOT COMPLETED|Overall Study||5||
59981885|NCT02559206|76099190|FG000|STARTED|Overall Study||66|Randomized|
59981886|NCT02559206|76099191|FG001|STARTED|Overall Study||66|Randomized|
59981887|NCT02559206|76099192|FG002|STARTED|Overall Study||67|Randomized|
59981888|NCT02559206|76099193|FG003|STARTED|Overall Study||67|Randomized|
59981889|NCT02559206|76099194|FG004|STARTED|Overall Study||67|Randomized|
59981890|NCT02559206|76099195|FG005|STARTED|Overall Study||67|Randomized|
59981891|NCT02559206|76099196|FG006|STARTED|Overall Study||66|Randomized|
59981892|NCT02559206|76099197|FG007|STARTED|Overall Study||66|Randomized|
59981893|NCT02559206|76099190|FG000|COMPLETED|Overall Study||58||
59981894|NCT02559206|76099191|FG001|COMPLETED|Overall Study||54||
59981895|NCT02559206|76099192|FG002|COMPLETED|Overall Study||58||
59981896|NCT02559206|76099193|FG003|COMPLETED|Overall Study||53||
59981897|NCT02559206|76099194|FG004|COMPLETED|Overall Study||55||
59981898|NCT02559206|76099195|FG005|COMPLETED|Overall Study||53||
59981899|NCT02559206|76099196|FG006|COMPLETED|Overall Study||60||
59981900|NCT02559206|76099197|FG007|COMPLETED|Overall Study||57||
59981901|NCT02559206|76099190|FG000|NOT COMPLETED|Overall Study||8||
59981902|NCT02559206|76099191|FG001|NOT COMPLETED|Overall Study||12||
59981903|NCT02559206|76099192|FG002|NOT COMPLETED|Overall Study||9||
59981904|NCT02559206|76099193|FG003|NOT COMPLETED|Overall Study||14||
59981905|NCT02559206|76099194|FG004|NOT COMPLETED|Overall Study||12||
59981906|NCT02559206|76099195|FG005|NOT COMPLETED|Overall Study||14||
59981907|NCT02559206|76099196|FG006|NOT COMPLETED|Overall Study||6||
59981908|NCT02559206|76099197|FG007|NOT COMPLETED|Overall Study||9||
59981909|NCT02558894|76099217|FG000|STARTED|Overall Study||32||
59981910|NCT02558894|76099218|FG001|STARTED|Overall Study||33||
59981911|NCT02558894|76099217|FG000|Patients Who Received IP|Overall Study||32||
59981912|NCT02558894|76099218|FG001|Patients Who Received IP|Overall Study||32||
59981913|NCT02558894|76099217|FG000|COMPLETED|Overall Study||0||
59981914|NCT02558894|76099218|FG001|COMPLETED|Overall Study||0||
59981915|NCT02558894|76099217|FG000|NOT COMPLETED|Overall Study||32||
59981916|NCT02558894|76099218|FG001|NOT COMPLETED|Overall Study||33||
59981917|NCT02688387|76099228|FG000|STARTED|Part 1, Period 1 (up to 6 Days)||3||
59981918|NCT02688387|76099229|FG001|STARTED|Part 1, Period 1 (up to 6 Days)||3||
59981919|NCT02688387|76099230|FG002|STARTED|Part 1, Period 1 (up to 6 Days)||4||
59981920|NCT02688387|76099231|FG003|STARTED|Part 1, Period 1 (up to 6 Days)||3||
59981921|NCT02688387|76099232|FG004|STARTED|Part 1, Period 1 (up to 6 Days)||3||
59981922|NCT02688387|76099233|FG005|STARTED|Part 1, Period 1 (up to 6 Days)||2||
59981923|NCT02688387|76099234|FG006|STARTED|Part 1, Period 1 (up to 6 Days)||2||
59981924|NCT02688387|76099235|FG007|STARTED|Part 1, Period 1 (up to 6 Days)||2||
59981925|NCT02688387|76099236|FG008|STARTED|Part 1, Period 1 (up to 6 Days)||2||
59981926|NCT02688387|76099237|FG009|STARTED|Part 1, Period 1 (up to 6 Days)||2||
59981927|NCT02688387|76099238|FG010|STARTED|Part 1, Period 1 (up to 6 Days)||0||
59981928|NCT02688387|76099239|FG011|STARTED|Part 1, Period 1 (up to 6 Days)||0||
59981929|NCT02688387|76099240|FG012|STARTED|Part 1, Period 1 (up to 6 Days)||0||
59981930|NCT02688387|76099241|FG013|STARTED|Part 1, Period 1 (up to 6 Days)||0||
59981931|NCT02688387|76099242|FG014|STARTED|Part 1, Period 1 (up to 6 Days)||0||
60074814|NCT01930045|76190108|FG005|COMPLETED|Part 1 - Period 2||3||
60074815|NCT01930045|76190103|FG000|NOT COMPLETED|Part 1 - Period 2||0||
59981932|NCT02688387|76099243|FG015|STARTED|Part 1, Period 1 (up to 6 Days)||0||
59981933|NCT02688387|76099244|FG016|STARTED|Part 1, Period 1 (up to 6 Days)||0||
59981934|NCT02688387|76099245|FG017|STARTED|Part 1, Period 1 (up to 6 Days)||0||
59981935|NCT02688387|76099246|FG018|STARTED|Part 1, Period 1 (up to 6 Days)||0||
59981936|NCT02688387|76099247|FG019|STARTED|Part 1, Period 1 (up to 6 Days)||0||
59981937|NCT02688387|76099248|FG020|STARTED|Part 1, Period 1 (up to 6 Days)||0||
59981938|NCT02688387|76099249|FG021|STARTED|Part 1, Period 1 (up to 6 Days)||0||
59981939|NCT02688387|76099228|FG000|COMPLETED|Part 1, Period 1 (up to 6 Days)||3||
59981940|NCT02688387|76099229|FG001|COMPLETED|Part 1, Period 1 (up to 6 Days)||3||
59981941|NCT02688387|76099230|FG002|COMPLETED|Part 1, Period 1 (up to 6 Days)||3||
59981942|NCT02688387|76099231|FG003|COMPLETED|Part 1, Period 1 (up to 6 Days)||2||
59981943|NCT02688387|76099232|FG004|COMPLETED|Part 1, Period 1 (up to 6 Days)||3||
59981944|NCT02688387|76099233|FG005|COMPLETED|Part 1, Period 1 (up to 6 Days)||2||
59981945|NCT02688387|76099234|FG006|COMPLETED|Part 1, Period 1 (up to 6 Days)||2||
59981946|NCT02688387|76099235|FG007|COMPLETED|Part 1, Period 1 (up to 6 Days)||2||
59981947|NCT02688387|76099236|FG008|COMPLETED|Part 1, Period 1 (up to 6 Days)||2||
59981948|NCT02688387|76099237|FG009|COMPLETED|Part 1, Period 1 (up to 6 Days)||2||
59981949|NCT02688387|76099238|FG010|COMPLETED|Part 1, Period 1 (up to 6 Days)||0||
59981950|NCT02688387|76099239|FG011|COMPLETED|Part 1, Period 1 (up to 6 Days)||0||
59981951|NCT02688387|76099240|FG012|COMPLETED|Part 1, Period 1 (up to 6 Days)||0||
59981952|NCT02688387|76099241|FG013|COMPLETED|Part 1, Period 1 (up to 6 Days)||0||
59981953|NCT02688387|76099242|FG014|COMPLETED|Part 1, Period 1 (up to 6 Days)||0||
59981954|NCT02688387|76099243|FG015|COMPLETED|Part 1, Period 1 (up to 6 Days)||0||
59981955|NCT02688387|76099244|FG016|COMPLETED|Part 1, Period 1 (up to 6 Days)||0||
59981956|NCT02688387|76099245|FG017|COMPLETED|Part 1, Period 1 (up to 6 Days)||0||
59981957|NCT02688387|76099246|FG018|COMPLETED|Part 1, Period 1 (up to 6 Days)||0||
59981958|NCT02688387|76099247|FG019|COMPLETED|Part 1, Period 1 (up to 6 Days)||0||
59981959|NCT02688387|76099248|FG020|COMPLETED|Part 1, Period 1 (up to 6 Days)||0||
59981960|NCT02688387|76099249|FG021|COMPLETED|Part 1, Period 1 (up to 6 Days)||0||
59981961|NCT02688387|76099228|FG000|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0||
59981962|NCT02688387|76099229|FG001|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0||
59981963|NCT02688387|76099230|FG002|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||1||
59981964|NCT02688387|76099231|FG003|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||1||
59981965|NCT02688387|76099232|FG004|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0||
59981966|NCT02688387|76099233|FG005|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0||
59981967|NCT02688387|76099234|FG006|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0||
59981968|NCT02688387|76099235|FG007|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0||
59981969|NCT02688387|76099236|FG008|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0||
59981970|NCT02688387|76099237|FG009|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0||
59981971|NCT02688387|76099238|FG010|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0||
59981972|NCT02688387|76099239|FG011|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0||
59981973|NCT02688387|76099240|FG012|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0||
59981974|NCT02688387|76099241|FG013|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0||
59981975|NCT02688387|76099242|FG014|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0||
59981976|NCT02688387|76099243|FG015|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0||
59981977|NCT02688387|76099244|FG016|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0||
59981978|NCT02688387|76099245|FG017|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0||
59981979|NCT02688387|76099246|FG018|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0||
59981980|NCT02688387|76099247|FG019|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0||
59981981|NCT02688387|76099248|FG020|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0||
59981982|NCT02688387|76099249|FG021|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0||
59981983|NCT02688387|76099228|FG000|STARTED|Part 1, Washout Period 1 (7 Days)||3||
59981984|NCT02688387|76099229|FG001|STARTED|Part 1, Washout Period 1 (7 Days)||3||
59981985|NCT02688387|76099230|FG002|STARTED|Part 1, Washout Period 1 (7 Days)||3||
59981986|NCT02688387|76099231|FG003|STARTED|Part 1, Washout Period 1 (7 Days)||2||
59981987|NCT02688387|76099232|FG004|STARTED|Part 1, Washout Period 1 (7 Days)||3||
59981988|NCT02688387|76099233|FG005|STARTED|Part 1, Washout Period 1 (7 Days)||2||
59981989|NCT02688387|76099234|FG006|STARTED|Part 1, Washout Period 1 (7 Days)||2||
59981990|NCT02688387|76099235|FG007|STARTED|Part 1, Washout Period 1 (7 Days)||2||
59981991|NCT02688387|76099236|FG008|STARTED|Part 1, Washout Period 1 (7 Days)||2||
59981992|NCT02688387|76099237|FG009|STARTED|Part 1, Washout Period 1 (7 Days)||2||
59981993|NCT02688387|76099238|FG010|STARTED|Part 1, Washout Period 1 (7 Days)||0||
59981994|NCT02688387|76099239|FG011|STARTED|Part 1, Washout Period 1 (7 Days)||0||
59981995|NCT02688387|76099240|FG012|STARTED|Part 1, Washout Period 1 (7 Days)||0||
59981996|NCT02688387|76099241|FG013|STARTED|Part 1, Washout Period 1 (7 Days)||0||
59981997|NCT02688387|76099242|FG014|STARTED|Part 1, Washout Period 1 (7 Days)||0||
59981998|NCT02688387|76099243|FG015|STARTED|Part 1, Washout Period 1 (7 Days)||0||
59981999|NCT02688387|76099244|FG016|STARTED|Part 1, Washout Period 1 (7 Days)||0||
59982000|NCT02688387|76099245|FG017|STARTED|Part 1, Washout Period 1 (7 Days)||0||
59982001|NCT02688387|76099246|FG018|STARTED|Part 1, Washout Period 1 (7 Days)||0||
59982002|NCT02688387|76099247|FG019|STARTED|Part 1, Washout Period 1 (7 Days)||0||
59982003|NCT02688387|76099248|FG020|STARTED|Part 1, Washout Period 1 (7 Days)||0||
59982004|NCT02688387|76099249|FG021|STARTED|Part 1, Washout Period 1 (7 Days)||0||
59982005|NCT02688387|76099228|FG000|COMPLETED|Part 1, Washout Period 1 (7 Days)||3||
59982006|NCT02688387|76099229|FG001|COMPLETED|Part 1, Washout Period 1 (7 Days)||2||
59982007|NCT02688387|76099230|FG002|COMPLETED|Part 1, Washout Period 1 (7 Days)||3||
59982008|NCT02688387|76099231|FG003|COMPLETED|Part 1, Washout Period 1 (7 Days)||2||
59982009|NCT02688387|76099232|FG004|COMPLETED|Part 1, Washout Period 1 (7 Days)||3||
59982010|NCT02688387|76099233|FG005|COMPLETED|Part 1, Washout Period 1 (7 Days)||2||
59982011|NCT02688387|76099234|FG006|COMPLETED|Part 1, Washout Period 1 (7 Days)||2||
59982012|NCT02688387|76099235|FG007|COMPLETED|Part 1, Washout Period 1 (7 Days)||2||
59982013|NCT02688387|76099236|FG008|COMPLETED|Part 1, Washout Period 1 (7 Days)||2||
59982014|NCT02688387|76099237|FG009|COMPLETED|Part 1, Washout Period 1 (7 Days)||2||
59982015|NCT02688387|76099238|FG010|COMPLETED|Part 1, Washout Period 1 (7 Days)||0||
59982016|NCT02688387|76099239|FG011|COMPLETED|Part 1, Washout Period 1 (7 Days)||0||
60074816|NCT01930045|76190104|FG001|NOT COMPLETED|Part 1 - Period 2||0||
59982017|NCT02688387|76099240|FG012|COMPLETED|Part 1, Washout Period 1 (7 Days)||0||
59982018|NCT02688387|76099241|FG013|COMPLETED|Part 1, Washout Period 1 (7 Days)||0||
59982019|NCT02688387|76099242|FG014|COMPLETED|Part 1, Washout Period 1 (7 Days)||0||
59982020|NCT02688387|76099243|FG015|COMPLETED|Part 1, Washout Period 1 (7 Days)||0||
59982021|NCT02688387|76099244|FG016|COMPLETED|Part 1, Washout Period 1 (7 Days)||0||
59982022|NCT02688387|76099245|FG017|COMPLETED|Part 1, Washout Period 1 (7 Days)||0||
59982023|NCT02688387|76099246|FG018|COMPLETED|Part 1, Washout Period 1 (7 Days)||0||
59982024|NCT02688387|76099247|FG019|COMPLETED|Part 1, Washout Period 1 (7 Days)||0||
59982025|NCT02688387|76099248|FG020|COMPLETED|Part 1, Washout Period 1 (7 Days)||0||
59982026|NCT02688387|76099249|FG021|COMPLETED|Part 1, Washout Period 1 (7 Days)||0||
59982027|NCT02688387|76099228|FG000|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0||
59982028|NCT02688387|76099229|FG001|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||1||
59982029|NCT02688387|76099230|FG002|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0||
59982030|NCT02688387|76099231|FG003|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0||
59982031|NCT02688387|76099232|FG004|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0||
59982032|NCT02688387|76099233|FG005|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0||
59982033|NCT02688387|76099234|FG006|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0||
59982034|NCT02688387|76099235|FG007|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0||
59982035|NCT02688387|76099236|FG008|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0||
59982036|NCT02688387|76099237|FG009|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0||
59982037|NCT02688387|76099238|FG010|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0||
59982038|NCT02688387|76099239|FG011|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0||
59982039|NCT02688387|76099240|FG012|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0||
59982040|NCT02688387|76099241|FG013|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0||
59982041|NCT02688387|76099242|FG014|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0||
59982042|NCT02688387|76099243|FG015|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0||
59982043|NCT02688387|76099244|FG016|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0||
59982044|NCT02688387|76099245|FG017|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0||
59982045|NCT02688387|76099246|FG018|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0||
59982046|NCT02688387|76099247|FG019|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0||
59982047|NCT02688387|76099248|FG020|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0||
59982048|NCT02688387|76099249|FG021|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0||
59982049|NCT02688387|76099228|FG000|STARTED|Part 1, Period 2 (up to 6 Days)||3||
59982050|NCT02688387|76099229|FG001|STARTED|Part 1, Period 2 (up to 6 Days)||2||
59982051|NCT02688387|76099230|FG002|STARTED|Part 1, Period 2 (up to 6 Days)||3||
59982052|NCT02688387|76099231|FG003|STARTED|Part 1, Period 2 (up to 6 Days)||2||
59982053|NCT02688387|76099232|FG004|STARTED|Part 1, Period 2 (up to 6 Days)||3||
59982054|NCT02688387|76099233|FG005|STARTED|Part 1, Period 2 (up to 6 Days)||2||
59982055|NCT02688387|76099234|FG006|STARTED|Part 1, Period 2 (up to 6 Days)||2||
59982056|NCT02688387|76099235|FG007|STARTED|Part 1, Period 2 (up to 6 Days)||2||
59982057|NCT02688387|76099236|FG008|STARTED|Part 1, Period 2 (up to 6 Days)||2||
59982058|NCT02688387|76099237|FG009|STARTED|Part 1, Period 2 (up to 6 Days)||2||
59982059|NCT02688387|76099238|FG010|STARTED|Part 1, Period 2 (up to 6 Days)||0||
59982060|NCT02688387|76099239|FG011|STARTED|Part 1, Period 2 (up to 6 Days)||0||
59982061|NCT02688387|76099240|FG012|STARTED|Part 1, Period 2 (up to 6 Days)||0||
59982062|NCT02688387|76099241|FG013|STARTED|Part 1, Period 2 (up to 6 Days)||0||
59982063|NCT02688387|76099242|FG014|STARTED|Part 1, Period 2 (up to 6 Days)||0||
59982064|NCT02688387|76099243|FG015|STARTED|Part 1, Period 2 (up to 6 Days)||0||
59982065|NCT02688387|76099244|FG016|STARTED|Part 1, Period 2 (up to 6 Days)||0||
59982066|NCT02688387|76099245|FG017|STARTED|Part 1, Period 2 (up to 6 Days)||0||
59982067|NCT02688387|76099246|FG018|STARTED|Part 1, Period 2 (up to 6 Days)||0||
59982068|NCT02688387|76099247|FG019|STARTED|Part 1, Period 2 (up to 6 Days)||0||
59982069|NCT02688387|76099248|FG020|STARTED|Part 1, Period 2 (up to 6 Days)||0||
59982070|NCT02688387|76099249|FG021|STARTED|Part 1, Period 2 (up to 6 Days)||0||
59982071|NCT02688387|76099228|FG000|COMPLETED|Part 1, Period 2 (up to 6 Days)||3||
59982072|NCT02688387|76099229|FG001|COMPLETED|Part 1, Period 2 (up to 6 Days)||2||
59982073|NCT02688387|76099230|FG002|COMPLETED|Part 1, Period 2 (up to 6 Days)||2||
59982074|NCT02688387|76099231|FG003|COMPLETED|Part 1, Period 2 (up to 6 Days)||2||
59982075|NCT02688387|76099232|FG004|COMPLETED|Part 1, Period 2 (up to 6 Days)||2||
59982076|NCT02688387|76099233|FG005|COMPLETED|Part 1, Period 2 (up to 6 Days)||2||
59982077|NCT02688387|76099234|FG006|COMPLETED|Part 1, Period 2 (up to 6 Days)||2||
59982078|NCT02688387|76099235|FG007|COMPLETED|Part 1, Period 2 (up to 6 Days)||2||
59982079|NCT02688387|76099236|FG008|COMPLETED|Part 1, Period 2 (up to 6 Days)||2||
59982080|NCT02688387|76099237|FG009|COMPLETED|Part 1, Period 2 (up to 6 Days)||2||
59982081|NCT02688387|76099238|FG010|COMPLETED|Part 1, Period 2 (up to 6 Days)||0||
59982082|NCT02688387|76099239|FG011|COMPLETED|Part 1, Period 2 (up to 6 Days)||0||
59982083|NCT02688387|76099240|FG012|COMPLETED|Part 1, Period 2 (up to 6 Days)||0||
59982084|NCT02688387|76099241|FG013|COMPLETED|Part 1, Period 2 (up to 6 Days)||0||
59982085|NCT02688387|76099242|FG014|COMPLETED|Part 1, Period 2 (up to 6 Days)||0||
59982086|NCT02688387|76099243|FG015|COMPLETED|Part 1, Period 2 (up to 6 Days)||0||
59982087|NCT02688387|76099244|FG016|COMPLETED|Part 1, Period 2 (up to 6 Days)||0||
59982088|NCT02688387|76099245|FG017|COMPLETED|Part 1, Period 2 (up to 6 Days)||0||
59982089|NCT02688387|76099246|FG018|COMPLETED|Part 1, Period 2 (up to 6 Days)||0||
59982090|NCT02688387|76099247|FG019|COMPLETED|Part 1, Period 2 (up to 6 Days)||0||
59982091|NCT02688387|76099248|FG020|COMPLETED|Part 1, Period 2 (up to 6 Days)||0||
59982092|NCT02688387|76099249|FG021|COMPLETED|Part 1, Period 2 (up to 6 Days)||0||
59982093|NCT02688387|76099228|FG000|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0||
59982094|NCT02688387|76099229|FG001|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0||
59982095|NCT02688387|76099230|FG002|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||1||
59982096|NCT02688387|76099231|FG003|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0||
59982097|NCT02688387|76099232|FG004|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||1||
59982098|NCT02688387|76099233|FG005|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0||
59982099|NCT02688387|76099234|FG006|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0||
59982100|NCT02688387|76099235|FG007|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0||
59982101|NCT02688387|76099236|FG008|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0||
59982102|NCT02688387|76099237|FG009|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0||
59982103|NCT02688387|76099238|FG010|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0||
59982104|NCT02688387|76099239|FG011|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0||
59982105|NCT02688387|76099240|FG012|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0||
59982106|NCT02688387|76099241|FG013|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0||
59982107|NCT02688387|76099242|FG014|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0||
59982108|NCT02688387|76099243|FG015|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0||
59982109|NCT02688387|76099244|FG016|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0||
59982110|NCT02688387|76099245|FG017|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0||
59982111|NCT02688387|76099246|FG018|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0||
59982112|NCT02688387|76099247|FG019|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0||
59982113|NCT02688387|76099248|FG020|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0||
59982114|NCT02688387|76099249|FG021|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0||
59982115|NCT02688387|76099228|FG000|STARTED|Part 1, Washout Period 2 (7 Days)||3||
59982116|NCT02688387|76099229|FG001|STARTED|Part 1, Washout Period 2 (7 Days)||2||
59982117|NCT02688387|76099230|FG002|STARTED|Part 1, Washout Period 2 (7 Days)||2||
59982118|NCT02688387|76099231|FG003|STARTED|Part 1, Washout Period 2 (7 Days)||2||
59982119|NCT02688387|76099232|FG004|STARTED|Part 1, Washout Period 2 (7 Days)||2||
59982120|NCT02688387|76099233|FG005|STARTED|Part 1, Washout Period 2 (7 Days)||2||
59982121|NCT02688387|76099234|FG006|STARTED|Part 1, Washout Period 2 (7 Days)||2||
59982122|NCT02688387|76099235|FG007|STARTED|Part 1, Washout Period 2 (7 Days)||2||
59982123|NCT02688387|76099236|FG008|STARTED|Part 1, Washout Period 2 (7 Days)||2||
59982124|NCT02688387|76099237|FG009|STARTED|Part 1, Washout Period 2 (7 Days)||2||
59982125|NCT02688387|76099238|FG010|STARTED|Part 1, Washout Period 2 (7 Days)||0||
59982126|NCT02688387|76099239|FG011|STARTED|Part 1, Washout Period 2 (7 Days)||0||
59982127|NCT02688387|76099240|FG012|STARTED|Part 1, Washout Period 2 (7 Days)||0||
59982128|NCT02688387|76099241|FG013|STARTED|Part 1, Washout Period 2 (7 Days)||0||
59982129|NCT02688387|76099242|FG014|STARTED|Part 1, Washout Period 2 (7 Days)||0||
59982130|NCT02688387|76099243|FG015|STARTED|Part 1, Washout Period 2 (7 Days)||0||
59982131|NCT02688387|76099244|FG016|STARTED|Part 1, Washout Period 2 (7 Days)||0||
59814870|NCT00617357|75937322|FG000|COMPLETED|Overall Study|67 subjects completed study; 7 completed early, 60 completed 24 month visit|67||
59814871|NCT00617357|75937322|FG000|NOT COMPLETED|Overall Study||16||
59814872|NCT00420927|75937334|FG000|STARTED|Period 1||515||
59814873|NCT00420927|75937335|FG001|STARTED|Period 1||517||
59814874|NCT00420927|75937336|FG002|STARTED|Period 1|This treatment group is not relevant to Period 1.|0||
59814875|NCT00420927|75937337|FG003|STARTED|Period 1|This treatment group is not relevant to Period 1.|0||
59814876|NCT00420927|75937338|FG004|STARTED|Period 1|This treatment group is not relevant to Period 1.|0||
59814877|NCT00420927|75937339|FG005|STARTED|Period 1|This treatment group is not relevant to Period 1.|0||
59814878|NCT00420927|75937340|FG006|STARTED|Period 1|This treatment group is not relevant to Period 1.|0||
59814879|NCT00420927|75937334|FG000|COMPLETED|Period 1||466||
59814880|NCT00420927|75937335|FG001|COMPLETED|Period 1||460||
59814881|NCT00420927|75937336|FG002|COMPLETED|Period 1||0||
59814882|NCT00420927|75937337|FG003|COMPLETED|Period 1||0||
59814883|NCT00420927|75937338|FG004|COMPLETED|Period 1||0||
59982132|NCT02688387|76099245|FG017|STARTED|Part 1, Washout Period 2 (7 Days)||0||
59982133|NCT02688387|76099246|FG018|STARTED|Part 1, Washout Period 2 (7 Days)||0||
59982134|NCT02688387|76099247|FG019|STARTED|Part 1, Washout Period 2 (7 Days)||0||
59982135|NCT02688387|76099248|FG020|STARTED|Part 1, Washout Period 2 (7 Days)||0||
59982136|NCT02688387|76099249|FG021|STARTED|Part 1, Washout Period 2 (7 Days)||0||
59982137|NCT02688387|76099228|FG000|COMPLETED|Part 1, Washout Period 2 (7 Days)||3||
59982138|NCT02688387|76099229|FG001|COMPLETED|Part 1, Washout Period 2 (7 Days)||2||
59982139|NCT02688387|76099230|FG002|COMPLETED|Part 1, Washout Period 2 (7 Days)||2||
59982140|NCT02688387|76099231|FG003|COMPLETED|Part 1, Washout Period 2 (7 Days)||2||
59982141|NCT02688387|76099232|FG004|COMPLETED|Part 1, Washout Period 2 (7 Days)||2||
59982142|NCT02688387|76099233|FG005|COMPLETED|Part 1, Washout Period 2 (7 Days)||2||
59982143|NCT02688387|76099234|FG006|COMPLETED|Part 1, Washout Period 2 (7 Days)||2||
59982144|NCT02688387|76099235|FG007|COMPLETED|Part 1, Washout Period 2 (7 Days)||2||
59982145|NCT02688387|76099236|FG008|COMPLETED|Part 1, Washout Period 2 (7 Days)||2||
59814884|NCT00420927|75937339|FG005|COMPLETED|Period 1||0||
59814885|NCT00420927|75937340|FG006|COMPLETED|Period 1||0||
59814886|NCT00420927|75937334|FG000|NOT COMPLETED|Period 1||49||
59814887|NCT00420927|75937335|FG001|NOT COMPLETED|Period 1||57||
59814888|NCT00420927|75937336|FG002|NOT COMPLETED|Period 1||0||
59814889|NCT00420927|75937337|FG003|NOT COMPLETED|Period 1||0||
59814890|NCT00420927|75937338|FG004|NOT COMPLETED|Period 1||0||
59814891|NCT00420927|75937339|FG005|NOT COMPLETED|Period 1||0||
59814892|NCT00420927|75937340|FG006|NOT COMPLETED|Period 1||0||
59982146|NCT02688387|76099237|FG009|COMPLETED|Part 1, Washout Period 2 (7 Days)||2||
59982147|NCT02688387|76099238|FG010|COMPLETED|Part 1, Washout Period 2 (7 Days)||0||
59982148|NCT02688387|76099239|FG011|COMPLETED|Part 1, Washout Period 2 (7 Days)||0||
59982149|NCT02688387|76099240|FG012|COMPLETED|Part 1, Washout Period 2 (7 Days)||0||
59982150|NCT02688387|76099241|FG013|COMPLETED|Part 1, Washout Period 2 (7 Days)||0||
59982151|NCT02688387|76099242|FG014|COMPLETED|Part 1, Washout Period 2 (7 Days)||0||
59982152|NCT02688387|76099243|FG015|COMPLETED|Part 1, Washout Period 2 (7 Days)||0||
59982153|NCT02688387|76099244|FG016|COMPLETED|Part 1, Washout Period 2 (7 Days)||0||
59982154|NCT02688387|76099245|FG017|COMPLETED|Part 1, Washout Period 2 (7 Days)||0||
59982155|NCT02688387|76099246|FG018|COMPLETED|Part 1, Washout Period 2 (7 Days)||0||
59982156|NCT02688387|76099247|FG019|COMPLETED|Part 1, Washout Period 2 (7 Days)||0||
59982157|NCT02688387|76099248|FG020|COMPLETED|Part 1, Washout Period 2 (7 Days)||0||
59982158|NCT02688387|76099249|FG021|COMPLETED|Part 1, Washout Period 2 (7 Days)||0||
59982159|NCT02688387|76099228|FG000|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0||
59982160|NCT02688387|76099229|FG001|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0||
59982161|NCT02688387|76099230|FG002|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0||
59982162|NCT02688387|76099231|FG003|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0||
59982163|NCT02688387|76099232|FG004|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0||
59982164|NCT02688387|76099233|FG005|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0||
59982165|NCT02688387|76099234|FG006|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0||
59982166|NCT02688387|76099235|FG007|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0||
59982167|NCT02688387|76099236|FG008|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0||
59982168|NCT02688387|76099237|FG009|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0||
59982169|NCT02688387|76099238|FG010|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0||
59982170|NCT02688387|76099239|FG011|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0||
59982171|NCT02688387|76099240|FG012|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0||
59982172|NCT02688387|76099241|FG013|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0||
59982173|NCT02688387|76099242|FG014|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0||
59982174|NCT02688387|76099243|FG015|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0||
59982175|NCT02688387|76099244|FG016|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0||
59982176|NCT02688387|76099245|FG017|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0||
59982177|NCT02688387|76099246|FG018|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0||
59982178|NCT02688387|76099247|FG019|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0||
59982179|NCT02688387|76099248|FG020|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0||
59982180|NCT02688387|76099249|FG021|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0||
59982181|NCT02688387|76099228|FG000|STARTED|Part 1, Period 3 (up to 6 Days)||3||
59982182|NCT02688387|76099229|FG001|STARTED|Part 1, Period 3 (up to 6 Days)||2||
59982183|NCT02688387|76099230|FG002|STARTED|Part 1, Period 3 (up to 6 Days)||2||
59982184|NCT02688387|76099231|FG003|STARTED|Part 1, Period 3 (up to 6 Days)||2||
59982185|NCT02688387|76099232|FG004|STARTED|Part 1, Period 3 (up to 6 Days)||2||
59982186|NCT02688387|76099233|FG005|STARTED|Part 1, Period 3 (up to 6 Days)||2||
59982187|NCT02688387|76099234|FG006|STARTED|Part 1, Period 3 (up to 6 Days)||2||
59982188|NCT02688387|76099235|FG007|STARTED|Part 1, Period 3 (up to 6 Days)||2||
59982189|NCT02688387|76099236|FG008|STARTED|Part 1, Period 3 (up to 6 Days)||2||
59982190|NCT02688387|76099237|FG009|STARTED|Part 1, Period 3 (up to 6 Days)||2||
59982191|NCT02688387|76099238|FG010|STARTED|Part 1, Period 3 (up to 6 Days)||0||
59982192|NCT02688387|76099239|FG011|STARTED|Part 1, Period 3 (up to 6 Days)||0||
59982193|NCT02688387|76099240|FG012|STARTED|Part 1, Period 3 (up to 6 Days)||0||
59982194|NCT02688387|76099241|FG013|STARTED|Part 1, Period 3 (up to 6 Days)||0||
59982195|NCT02688387|76099242|FG014|STARTED|Part 1, Period 3 (up to 6 Days)||0||
59982196|NCT02688387|76099243|FG015|STARTED|Part 1, Period 3 (up to 6 Days)||0||
59982197|NCT02688387|76099244|FG016|STARTED|Part 1, Period 3 (up to 6 Days)||0||
59982198|NCT02688387|76099245|FG017|STARTED|Part 1, Period 3 (up to 6 Days)||0||
59982199|NCT02688387|76099246|FG018|STARTED|Part 1, Period 3 (up to 6 Days)||0||
59982200|NCT02688387|76099247|FG019|STARTED|Part 1, Period 3 (up to 6 Days)||0||
59982201|NCT02688387|76099248|FG020|STARTED|Part 1, Period 3 (up to 6 Days)||0||
59982202|NCT02688387|76099249|FG021|STARTED|Part 1, Period 3 (up to 6 Days)||0||
59982203|NCT02688387|76099228|FG000|COMPLETED|Part 1, Period 3 (up to 6 Days)||3||
59982204|NCT02688387|76099229|FG001|COMPLETED|Part 1, Period 3 (up to 6 Days)||2||
59982205|NCT02688387|76099230|FG002|COMPLETED|Part 1, Period 3 (up to 6 Days)||2||
59982206|NCT02688387|76099231|FG003|COMPLETED|Part 1, Period 3 (up to 6 Days)||2||
59982207|NCT02688387|76099232|FG004|COMPLETED|Part 1, Period 3 (up to 6 Days)||2||
59982208|NCT02688387|76099233|FG005|COMPLETED|Part 1, Period 3 (up to 6 Days)||2||
59982209|NCT02688387|76099234|FG006|COMPLETED|Part 1, Period 3 (up to 6 Days)||2||
59982210|NCT02688387|76099235|FG007|COMPLETED|Part 1, Period 3 (up to 6 Days)||2||
59982211|NCT02688387|76099236|FG008|COMPLETED|Part 1, Period 3 (up to 6 Days)||2||
59982212|NCT02688387|76099237|FG009|COMPLETED|Part 1, Period 3 (up to 6 Days)||2||
59982213|NCT02688387|76099238|FG010|COMPLETED|Part 1, Period 3 (up to 6 Days)||0||
59982214|NCT02688387|76099239|FG011|COMPLETED|Part 1, Period 3 (up to 6 Days)||0||
59982215|NCT02688387|76099240|FG012|COMPLETED|Part 1, Period 3 (up to 6 Days)||0||
59982216|NCT02688387|76099241|FG013|COMPLETED|Part 1, Period 3 (up to 6 Days)||0||
59995401|NCT03016975|76111238|FG002|COMPLETED|At 2 Year Follow-up||0||
59995402|NCT03016975|76111236|FG000|NOT COMPLETED|At 2 Year Follow-up||1||
59982217|NCT02688387|76099242|FG014|COMPLETED|Part 1, Period 3 (up to 6 Days)||0||
59982218|NCT02688387|76099243|FG015|COMPLETED|Part 1, Period 3 (up to 6 Days)||0||
59982219|NCT02688387|76099244|FG016|COMPLETED|Part 1, Period 3 (up to 6 Days)||0||
59982220|NCT02688387|76099245|FG017|COMPLETED|Part 1, Period 3 (up to 6 Days)||0||
59982221|NCT02688387|76099246|FG018|COMPLETED|Part 1, Period 3 (up to 6 Days)||0||
59982222|NCT02688387|76099247|FG019|COMPLETED|Part 1, Period 3 (up to 6 Days)||0||
59982223|NCT02688387|76099248|FG020|COMPLETED|Part 1, Period 3 (up to 6 Days)||0||
59982224|NCT02688387|76099249|FG021|COMPLETED|Part 1, Period 3 (up to 6 Days)||0||
59982225|NCT02688387|76099228|FG000|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0||
59982226|NCT02688387|76099229|FG001|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0||
59982227|NCT02688387|76099230|FG002|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0||
59982228|NCT02688387|76099231|FG003|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0||
59982229|NCT02688387|76099232|FG004|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0||
59982230|NCT02688387|76099233|FG005|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0||
59982231|NCT02688387|76099234|FG006|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0||
59982232|NCT02688387|76099235|FG007|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0||
59982233|NCT02688387|76099236|FG008|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0||
59982234|NCT02688387|76099237|FG009|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0||
59982235|NCT02688387|76099238|FG010|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0||
59982236|NCT02688387|76099239|FG011|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0||
59982237|NCT02688387|76099240|FG012|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0||
59982238|NCT02688387|76099241|FG013|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0||
59982239|NCT02688387|76099242|FG014|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0||
59982240|NCT02688387|76099243|FG015|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0||
59982241|NCT02688387|76099244|FG016|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0||
59982242|NCT02688387|76099245|FG017|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0||
59982243|NCT02688387|76099246|FG018|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0||
59982244|NCT02688387|76099247|FG019|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0||
59982245|NCT02688387|76099248|FG020|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0||
59982246|NCT02688387|76099249|FG021|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0||
59982247|NCT02688387|76099228|FG000|STARTED|Part 1, Washout Period 3 (7 Days)||3||
59982248|NCT02688387|76099229|FG001|STARTED|Part 1, Washout Period 3 (7 Days)||2||
59982249|NCT02688387|76099230|FG002|STARTED|Part 1, Washout Period 3 (7 Days)||2||
59982250|NCT02688387|76099231|FG003|STARTED|Part 1, Washout Period 3 (7 Days)||2||
59982251|NCT02688387|76099232|FG004|STARTED|Part 1, Washout Period 3 (7 Days)||2||
59982252|NCT02688387|76099233|FG005|STARTED|Part 1, Washout Period 3 (7 Days)||2||
59982253|NCT02688387|76099234|FG006|STARTED|Part 1, Washout Period 3 (7 Days)||2||
59982254|NCT02688387|76099235|FG007|STARTED|Part 1, Washout Period 3 (7 Days)||2||
59982255|NCT02688387|76099236|FG008|STARTED|Part 1, Washout Period 3 (7 Days)||2||
59982256|NCT02688387|76099237|FG009|STARTED|Part 1, Washout Period 3 (7 Days)||2||
59982257|NCT02688387|76099238|FG010|STARTED|Part 1, Washout Period 3 (7 Days)||0||
59982258|NCT02688387|76099239|FG011|STARTED|Part 1, Washout Period 3 (7 Days)||0||
59982259|NCT02688387|76099240|FG012|STARTED|Part 1, Washout Period 3 (7 Days)||0||
59982260|NCT02688387|76099241|FG013|STARTED|Part 1, Washout Period 3 (7 Days)||0||
59982261|NCT02688387|76099242|FG014|STARTED|Part 1, Washout Period 3 (7 Days)||0||
59982262|NCT02688387|76099243|FG015|STARTED|Part 1, Washout Period 3 (7 Days)||0||
59982263|NCT02688387|76099244|FG016|STARTED|Part 1, Washout Period 3 (7 Days)||0||
59982264|NCT02688387|76099245|FG017|STARTED|Part 1, Washout Period 3 (7 Days)||0||
59982265|NCT02688387|76099246|FG018|STARTED|Part 1, Washout Period 3 (7 Days)||0||
59982266|NCT02688387|76099247|FG019|STARTED|Part 1, Washout Period 3 (7 Days)||0||
59982267|NCT02688387|76099248|FG020|STARTED|Part 1, Washout Period 3 (7 Days)||0||
59982268|NCT02688387|76099249|FG021|STARTED|Part 1, Washout Period 3 (7 Days)||0||
59982269|NCT02688387|76099228|FG000|COMPLETED|Part 1, Washout Period 3 (7 Days)||2||
59982270|NCT02688387|76099229|FG001|COMPLETED|Part 1, Washout Period 3 (7 Days)||2||
59982271|NCT02688387|76099230|FG002|COMPLETED|Part 1, Washout Period 3 (7 Days)||2||
59982272|NCT02688387|76099231|FG003|COMPLETED|Part 1, Washout Period 3 (7 Days)||2||
59982273|NCT02688387|76099232|FG004|COMPLETED|Part 1, Washout Period 3 (7 Days)||2||
59982274|NCT02688387|76099233|FG005|COMPLETED|Part 1, Washout Period 3 (7 Days)||2||
59982275|NCT02688387|76099234|FG006|COMPLETED|Part 1, Washout Period 3 (7 Days)||2||
59982276|NCT02688387|76099235|FG007|COMPLETED|Part 1, Washout Period 3 (7 Days)||2||
59982277|NCT02688387|76099236|FG008|COMPLETED|Part 1, Washout Period 3 (7 Days)||2||
59982278|NCT02688387|76099237|FG009|COMPLETED|Part 1, Washout Period 3 (7 Days)||2||
60074817|NCT01930045|76190105|FG002|NOT COMPLETED|Part 1 - Period 2||0||
60074818|NCT01930045|76190106|FG003|NOT COMPLETED|Part 1 - Period 2||0||
59982279|NCT02688387|76099238|FG010|COMPLETED|Part 1, Washout Period 3 (7 Days)||0||
59982280|NCT02688387|76099239|FG011|COMPLETED|Part 1, Washout Period 3 (7 Days)||0||
59982281|NCT02688387|76099240|FG012|COMPLETED|Part 1, Washout Period 3 (7 Days)||0||
60074819|NCT01930045|76190107|FG004|NOT COMPLETED|Part 1 - Period 2||0||
60074820|NCT01930045|76190108|FG005|NOT COMPLETED|Part 1 - Period 2||0||
60074821|NCT01930045|76190103|FG000|STARTED|Part 1 - Period 3||3||
60074822|NCT01930045|76190104|FG001|STARTED|Part 1 - Period 3||3||
60074823|NCT01930045|76190105|FG002|STARTED|Part 1 - Period 3|One participant missed treatment during Period 3 only.|2||
60074824|NCT01930045|76190106|FG003|STARTED|Part 1 - Period 3||3||
59982282|NCT02688387|76099241|FG013|COMPLETED|Part 1, Washout Period 3 (7 Days)||0||
59982283|NCT02688387|76099242|FG014|COMPLETED|Part 1, Washout Period 3 (7 Days)||0||
59982284|NCT02688387|76099243|FG015|COMPLETED|Part 1, Washout Period 3 (7 Days)||0||
59982285|NCT02688387|76099244|FG016|COMPLETED|Part 1, Washout Period 3 (7 Days)||0||
59982286|NCT02688387|76099245|FG017|COMPLETED|Part 1, Washout Period 3 (7 Days)||0||
59982287|NCT02688387|76099246|FG018|COMPLETED|Part 1, Washout Period 3 (7 Days)||0||
59982288|NCT02688387|76099247|FG019|COMPLETED|Part 1, Washout Period 3 (7 Days)||0||
59982289|NCT02688387|76099248|FG020|COMPLETED|Part 1, Washout Period 3 (7 Days)||0||
59982290|NCT02688387|76099249|FG021|COMPLETED|Part 1, Washout Period 3 (7 Days)||0||
59982291|NCT02688387|76099228|FG000|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||1||
59982292|NCT02688387|76099229|FG001|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0||
59982293|NCT02688387|76099230|FG002|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0||
59982294|NCT02688387|76099231|FG003|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0||
59982295|NCT02688387|76099232|FG004|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0||
59982296|NCT02688387|76099233|FG005|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0||
59982297|NCT02688387|76099234|FG006|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0||
59982298|NCT02688387|76099235|FG007|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0||
59982299|NCT02688387|76099236|FG008|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0||
59982300|NCT02688387|76099237|FG009|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0||
59982301|NCT02688387|76099238|FG010|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0||
59982302|NCT02688387|76099239|FG011|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0||
59982303|NCT02688387|76099240|FG012|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0||
59982304|NCT02688387|76099241|FG013|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0||
59982305|NCT02688387|76099242|FG014|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0||
59982306|NCT02688387|76099243|FG015|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0||
59982307|NCT02688387|76099244|FG016|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0||
59982308|NCT02688387|76099245|FG017|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0||
59982309|NCT02688387|76099246|FG018|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0||
59982310|NCT02688387|76099247|FG019|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0||
59982311|NCT02688387|76099248|FG020|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0||
59982312|NCT02688387|76099249|FG021|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0||
59982313|NCT02688387|76099228|FG000|STARTED|Part 1, Period 4 (up to 6 Days)||2||
59982314|NCT02688387|76099229|FG001|STARTED|Part 1, Period 4 (up to 6 Days)||2||
59982315|NCT02688387|76099230|FG002|STARTED|Part 1, Period 4 (up to 6 Days)||2||
59982316|NCT02688387|76099231|FG003|STARTED|Part 1, Period 4 (up to 6 Days)||2||
59982317|NCT02688387|76099232|FG004|STARTED|Part 1, Period 4 (up to 6 Days)||2||
59982318|NCT02688387|76099233|FG005|STARTED|Part 1, Period 4 (up to 6 Days)||2||
59982319|NCT02688387|76099234|FG006|STARTED|Part 1, Period 4 (up to 6 Days)||2||
59982320|NCT02688387|76099235|FG007|STARTED|Part 1, Period 4 (up to 6 Days)||2||
59982321|NCT02688387|76099236|FG008|STARTED|Part 1, Period 4 (up to 6 Days)||2||
59982322|NCT02688387|76099237|FG009|STARTED|Part 1, Period 4 (up to 6 Days)||2||
59982323|NCT02688387|76099238|FG010|STARTED|Part 1, Period 4 (up to 6 Days)||0||
59982324|NCT02688387|76099239|FG011|STARTED|Part 1, Period 4 (up to 6 Days)||0||
59982325|NCT02688387|76099240|FG012|STARTED|Part 1, Period 4 (up to 6 Days)||0||
59982326|NCT02688387|76099241|FG013|STARTED|Part 1, Period 4 (up to 6 Days)||0||
59982327|NCT02688387|76099242|FG014|STARTED|Part 1, Period 4 (up to 6 Days)||0||
59982328|NCT02688387|76099243|FG015|STARTED|Part 1, Period 4 (up to 6 Days)||0||
59982329|NCT02688387|76099244|FG016|STARTED|Part 1, Period 4 (up to 6 Days)||0||
59982330|NCT02688387|76099245|FG017|STARTED|Part 1, Period 4 (up to 6 Days)||0||
59982331|NCT02688387|76099246|FG018|STARTED|Part 1, Period 4 (up to 6 Days)||0||
59982332|NCT02688387|76099247|FG019|STARTED|Part 1, Period 4 (up to 6 Days)||0||
59982333|NCT02688387|76099248|FG020|STARTED|Part 1, Period 4 (up to 6 Days)||0||
59982334|NCT02688387|76099249|FG021|STARTED|Part 1, Period 4 (up to 6 Days)||0||
59982335|NCT02688387|76099228|FG000|COMPLETED|Part 1, Period 4 (up to 6 Days)||2||
59982336|NCT02688387|76099229|FG001|COMPLETED|Part 1, Period 4 (up to 6 Days)||2||
59982337|NCT02688387|76099230|FG002|COMPLETED|Part 1, Period 4 (up to 6 Days)||2||
59982338|NCT02688387|76099231|FG003|COMPLETED|Part 1, Period 4 (up to 6 Days)||2||
59982339|NCT02688387|76099232|FG004|COMPLETED|Part 1, Period 4 (up to 6 Days)||2||
59982340|NCT02688387|76099233|FG005|COMPLETED|Part 1, Period 4 (up to 6 Days)||2||
59982341|NCT02688387|76099234|FG006|COMPLETED|Part 1, Period 4 (up to 6 Days)||2||
59982342|NCT02688387|76099235|FG007|COMPLETED|Part 1, Period 4 (up to 6 Days)||2||
59982343|NCT02688387|76099236|FG008|COMPLETED|Part 1, Period 4 (up to 6 Days)||2||
59982344|NCT02688387|76099237|FG009|COMPLETED|Part 1, Period 4 (up to 6 Days)||2||
59982345|NCT02688387|76099238|FG010|COMPLETED|Part 1, Period 4 (up to 6 Days)||0||
59982346|NCT02688387|76099239|FG011|COMPLETED|Part 1, Period 4 (up to 6 Days)||0||
59982347|NCT02688387|76099240|FG012|COMPLETED|Part 1, Period 4 (up to 6 Days)||0||
59982348|NCT02688387|76099241|FG013|COMPLETED|Part 1, Period 4 (up to 6 Days)||0||
59982349|NCT02688387|76099242|FG014|COMPLETED|Part 1, Period 4 (up to 6 Days)||0||
59995403|NCT03016975|76111237|FG001|NOT COMPLETED|At 2 Year Follow-up||0||
59995404|NCT03016975|76111238|FG002|NOT COMPLETED|At 2 Year Follow-up||0||
59995405|NCT03016975|76111236|FG000|STARTED|At 3 Year Follow-up||5||
59995406|NCT03016975|76111237|FG001|STARTED|At 3 Year Follow-up||0||
59995407|NCT03016975|76111238|FG002|STARTED|At 3 Year Follow-up||0||
59982350|NCT02688387|76099243|FG015|COMPLETED|Part 1, Period 4 (up to 6 Days)||0||
59982351|NCT02688387|76099244|FG016|COMPLETED|Part 1, Period 4 (up to 6 Days)||0||
59982352|NCT02688387|76099245|FG017|COMPLETED|Part 1, Period 4 (up to 6 Days)||0||
59982353|NCT02688387|76099246|FG018|COMPLETED|Part 1, Period 4 (up to 6 Days)||0||
59982354|NCT02688387|76099247|FG019|COMPLETED|Part 1, Period 4 (up to 6 Days)||0||
59982355|NCT02688387|76099248|FG020|COMPLETED|Part 1, Period 4 (up to 6 Days)||0||
59982356|NCT02688387|76099249|FG021|COMPLETED|Part 1, Period 4 (up to 6 Days)||0||
59982357|NCT02688387|76099228|FG000|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0||
59982358|NCT02688387|76099229|FG001|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0||
59982359|NCT02688387|76099230|FG002|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0||
59982360|NCT02688387|76099231|FG003|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0||
59982361|NCT02688387|76099232|FG004|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0||
59982362|NCT02688387|76099233|FG005|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0||
59982363|NCT02688387|76099234|FG006|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0||
59982364|NCT02688387|76099235|FG007|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0||
59982365|NCT02688387|76099236|FG008|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0||
59982366|NCT02688387|76099237|FG009|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0||
59982367|NCT02688387|76099238|FG010|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0||
59982368|NCT02688387|76099239|FG011|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0||
59982369|NCT02688387|76099240|FG012|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0||
59982370|NCT02688387|76099241|FG013|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0||
59982371|NCT02688387|76099242|FG014|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0||
59982372|NCT02688387|76099243|FG015|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0||
59982373|NCT02688387|76099244|FG016|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0||
59982374|NCT02688387|76099245|FG017|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0||
59982375|NCT02688387|76099246|FG018|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0||
59982376|NCT02688387|76099247|FG019|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0||
59982377|NCT02688387|76099248|FG020|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0||
59982378|NCT02688387|76099249|FG021|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0||
59982379|NCT02688387|76099228|FG000|STARTED|Part 1, Washout Period 4 (7 Days)||2||
59982380|NCT02688387|76099229|FG001|STARTED|Part 1, Washout Period 4 (7 Days)||2||
59982381|NCT02688387|76099230|FG002|STARTED|Part 1, Washout Period 4 (7 Days)||2||
59982382|NCT02688387|76099231|FG003|STARTED|Part 1, Washout Period 4 (7 Days)||2||
59982383|NCT02688387|76099232|FG004|STARTED|Part 1, Washout Period 4 (7 Days)||2||
59982384|NCT02688387|76099233|FG005|STARTED|Part 1, Washout Period 4 (7 Days)||2||
59982385|NCT02688387|76099234|FG006|STARTED|Part 1, Washout Period 4 (7 Days)||2||
59982386|NCT02688387|76099235|FG007|STARTED|Part 1, Washout Period 4 (7 Days)||2||
59982387|NCT02688387|76099236|FG008|STARTED|Part 1, Washout Period 4 (7 Days)||2||
59982388|NCT02688387|76099237|FG009|STARTED|Part 1, Washout Period 4 (7 Days)||2||
59982389|NCT02688387|76099238|FG010|STARTED|Part 1, Washout Period 4 (7 Days)||0||
59982390|NCT02688387|76099239|FG011|STARTED|Part 1, Washout Period 4 (7 Days)||0||
59982391|NCT02688387|76099240|FG012|STARTED|Part 1, Washout Period 4 (7 Days)||0||
59982392|NCT02688387|76099241|FG013|STARTED|Part 1, Washout Period 4 (7 Days)||0||
59982393|NCT02688387|76099242|FG014|STARTED|Part 1, Washout Period 4 (7 Days)||0||
59982394|NCT02688387|76099243|FG015|STARTED|Part 1, Washout Period 4 (7 Days)||0||
59982395|NCT02688387|76099244|FG016|STARTED|Part 1, Washout Period 4 (7 Days)||0||
59982396|NCT02688387|76099245|FG017|STARTED|Part 1, Washout Period 4 (7 Days)||0||
59982397|NCT02688387|76099246|FG018|STARTED|Part 1, Washout Period 4 (7 Days)||0||
59982398|NCT02688387|76099247|FG019|STARTED|Part 1, Washout Period 4 (7 Days)||0||
59982399|NCT02688387|76099248|FG020|STARTED|Part 1, Washout Period 4 (7 Days)||0||
59982400|NCT02688387|76099249|FG021|STARTED|Part 1, Washout Period 4 (7 Days)||0||
59982401|NCT02688387|76099228|FG000|COMPLETED|Part 1, Washout Period 4 (7 Days)||2||
59982402|NCT02688387|76099229|FG001|COMPLETED|Part 1, Washout Period 4 (7 Days)||2||
59982403|NCT02688387|76099230|FG002|COMPLETED|Part 1, Washout Period 4 (7 Days)||2||
59982404|NCT02688387|76099231|FG003|COMPLETED|Part 1, Washout Period 4 (7 Days)||2||
59982405|NCT02688387|76099232|FG004|COMPLETED|Part 1, Washout Period 4 (7 Days)||2||
59982406|NCT02688387|76099233|FG005|COMPLETED|Part 1, Washout Period 4 (7 Days)||2||
59982407|NCT02688387|76099234|FG006|COMPLETED|Part 1, Washout Period 4 (7 Days)||2||
59982408|NCT02688387|76099235|FG007|COMPLETED|Part 1, Washout Period 4 (7 Days)||2||
59982409|NCT02688387|76099236|FG008|COMPLETED|Part 1, Washout Period 4 (7 Days)||2||
59982410|NCT02688387|76099237|FG009|COMPLETED|Part 1, Washout Period 4 (7 Days)||2||
59982411|NCT02688387|76099238|FG010|COMPLETED|Part 1, Washout Period 4 (7 Days)||0||
59982412|NCT02688387|76099239|FG011|COMPLETED|Part 1, Washout Period 4 (7 Days)||0||
59982413|NCT02688387|76099240|FG012|COMPLETED|Part 1, Washout Period 4 (7 Days)||0||
59982414|NCT02688387|76099241|FG013|COMPLETED|Part 1, Washout Period 4 (7 Days)||0||
59982415|NCT02688387|76099242|FG014|COMPLETED|Part 1, Washout Period 4 (7 Days)||0||
59982416|NCT02688387|76099243|FG015|COMPLETED|Part 1, Washout Period 4 (7 Days)||0||
59982417|NCT02688387|76099244|FG016|COMPLETED|Part 1, Washout Period 4 (7 Days)||0||
59982418|NCT02688387|76099245|FG017|COMPLETED|Part 1, Washout Period 4 (7 Days)||0||
59995408|NCT03016975|76111236|FG000|COMPLETED|At 3 Year Follow-up||3||
59526572|NCT00254072|75622261|FG000|COMPLETED|Overall Study||180||
59526573|NCT00254072|75622262|FG001|COMPLETED|Overall Study||175||
59982419|NCT02688387|76099246|FG018|COMPLETED|Part 1, Washout Period 4 (7 Days)||0||
59982420|NCT02688387|76099247|FG019|COMPLETED|Part 1, Washout Period 4 (7 Days)||0||
59982421|NCT02688387|76099248|FG020|COMPLETED|Part 1, Washout Period 4 (7 Days)||0||
59982422|NCT02688387|76099249|FG021|COMPLETED|Part 1, Washout Period 4 (7 Days)||0||
59982423|NCT02688387|76099228|FG000|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0||
59982424|NCT02688387|76099229|FG001|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0||
59982425|NCT02688387|76099230|FG002|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0||
59982426|NCT02688387|76099231|FG003|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0||
59982427|NCT02688387|76099232|FG004|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0||
59982428|NCT02688387|76099233|FG005|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0||
59982429|NCT02688387|76099234|FG006|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0||
59982430|NCT02688387|76099235|FG007|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0||
59982431|NCT02688387|76099236|FG008|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0||
59982432|NCT02688387|76099237|FG009|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0||
59982433|NCT02688387|76099238|FG010|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0||
59982434|NCT02688387|76099239|FG011|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0||
59982435|NCT02688387|76099240|FG012|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0||
59982436|NCT02688387|76099241|FG013|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0||
59982437|NCT02688387|76099242|FG014|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0||
59982438|NCT02688387|76099243|FG015|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0||
59982439|NCT02688387|76099244|FG016|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0||
59982440|NCT02688387|76099245|FG017|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0||
59982441|NCT02688387|76099246|FG018|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0||
59982442|NCT02688387|76099247|FG019|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0||
59982443|NCT02688387|76099248|FG020|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0||
59982444|NCT02688387|76099249|FG021|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0||
59982445|NCT02688387|76099228|FG000|STARTED|Part 1, Period 5 (up to 6 Days)||2||
59982446|NCT02688387|76099229|FG001|STARTED|Part 1, Period 5 (up to 6 Days)||2||
59982447|NCT02688387|76099230|FG002|STARTED|Part 1, Period 5 (up to 6 Days)||2||
59982448|NCT02688387|76099231|FG003|STARTED|Part 1, Period 5 (up to 6 Days)||2||
59982449|NCT02688387|76099232|FG004|STARTED|Part 1, Period 5 (up to 6 Days)||2||
59982450|NCT02688387|76099233|FG005|STARTED|Part 1, Period 5 (up to 6 Days)||2||
59982451|NCT02688387|76099234|FG006|STARTED|Part 1, Period 5 (up to 6 Days)||2||
59982452|NCT02688387|76099235|FG007|STARTED|Part 1, Period 5 (up to 6 Days)||2||
59982453|NCT02688387|76099236|FG008|STARTED|Part 1, Period 5 (up to 6 Days)||2||
59982454|NCT02688387|76099237|FG009|STARTED|Part 1, Period 5 (up to 6 Days)||2||
59982455|NCT02688387|76099238|FG010|STARTED|Part 1, Period 5 (up to 6 Days)||0||
59982456|NCT02688387|76099239|FG011|STARTED|Part 1, Period 5 (up to 6 Days)||0||
59982457|NCT02688387|76099240|FG012|STARTED|Part 1, Period 5 (up to 6 Days)||0||
59982458|NCT02688387|76099241|FG013|STARTED|Part 1, Period 5 (up to 6 Days)||0||
59982459|NCT02688387|76099242|FG014|STARTED|Part 1, Period 5 (up to 6 Days)||0||
59982460|NCT02688387|76099243|FG015|STARTED|Part 1, Period 5 (up to 6 Days)||0||
59982461|NCT02688387|76099244|FG016|STARTED|Part 1, Period 5 (up to 6 Days)||0||
59982462|NCT02688387|76099245|FG017|STARTED|Part 1, Period 5 (up to 6 Days)||0||
59982463|NCT02688387|76099246|FG018|STARTED|Part 1, Period 5 (up to 6 Days)||0||
59982464|NCT02688387|76099247|FG019|STARTED|Part 1, Period 5 (up to 6 Days)||0||
59982465|NCT02688387|76099248|FG020|STARTED|Part 1, Period 5 (up to 6 Days)||0||
59982466|NCT02688387|76099249|FG021|STARTED|Part 1, Period 5 (up to 6 Days)||0||
59982467|NCT02688387|76099228|FG000|COMPLETED|Part 1, Period 5 (up to 6 Days)||2||
59982468|NCT02688387|76099229|FG001|COMPLETED|Part 1, Period 5 (up to 6 Days)||2||
59982469|NCT02688387|76099230|FG002|COMPLETED|Part 1, Period 5 (up to 6 Days)||2||
59982470|NCT02688387|76099231|FG003|COMPLETED|Part 1, Period 5 (up to 6 Days)||2||
59982471|NCT02688387|76099232|FG004|COMPLETED|Part 1, Period 5 (up to 6 Days)||2||
59982472|NCT02688387|76099233|FG005|COMPLETED|Part 1, Period 5 (up to 6 Days)||2||
59982473|NCT02688387|76099234|FG006|COMPLETED|Part 1, Period 5 (up to 6 Days)||2||
59982474|NCT02688387|76099235|FG007|COMPLETED|Part 1, Period 5 (up to 6 Days)||2||
59982475|NCT02688387|76099236|FG008|COMPLETED|Part 1, Period 5 (up to 6 Days)||2||
59982476|NCT02688387|76099237|FG009|COMPLETED|Part 1, Period 5 (up to 6 Days)||2||
59982477|NCT02688387|76099238|FG010|COMPLETED|Part 1, Period 5 (up to 6 Days)||0||
59982478|NCT02688387|76099239|FG011|COMPLETED|Part 1, Period 5 (up to 6 Days)||0||
59982479|NCT02688387|76099240|FG012|COMPLETED|Part 1, Period 5 (up to 6 Days)||0||
59982480|NCT02688387|76099241|FG013|COMPLETED|Part 1, Period 5 (up to 6 Days)||0||
59982481|NCT02688387|76099242|FG014|COMPLETED|Part 1, Period 5 (up to 6 Days)||0||
59982482|NCT02688387|76099243|FG015|COMPLETED|Part 1, Period 5 (up to 6 Days)||0||
59982483|NCT02688387|76099244|FG016|COMPLETED|Part 1, Period 5 (up to 6 Days)||0||
59982484|NCT02688387|76099245|FG017|COMPLETED|Part 1, Period 5 (up to 6 Days)||0||
59982485|NCT02688387|76099246|FG018|COMPLETED|Part 1, Period 5 (up to 6 Days)||0||
59982486|NCT02688387|76099247|FG019|COMPLETED|Part 1, Period 5 (up to 6 Days)||0||
59982487|NCT02688387|76099248|FG020|COMPLETED|Part 1, Period 5 (up to 6 Days)||0||
59982488|NCT02688387|76099249|FG021|COMPLETED|Part 1, Period 5 (up to 6 Days)||0||
59982489|NCT02688387|76099228|FG000|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0||
59982490|NCT02688387|76099229|FG001|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0||
59982491|NCT02688387|76099230|FG002|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0||
59982492|NCT02688387|76099231|FG003|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0||
59982493|NCT02688387|76099232|FG004|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0||
59982494|NCT02688387|76099233|FG005|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0||
59982495|NCT02688387|76099234|FG006|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0||
59982496|NCT02688387|76099235|FG007|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0||
59982497|NCT02688387|76099236|FG008|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0||
59982498|NCT02688387|76099237|FG009|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0||
59982499|NCT02688387|76099238|FG010|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0||
59982500|NCT02688387|76099239|FG011|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0||
59982501|NCT02688387|76099240|FG012|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0||
59982502|NCT02688387|76099241|FG013|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0||
59982503|NCT02688387|76099242|FG014|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0||
59982504|NCT02688387|76099243|FG015|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0||
59982505|NCT02688387|76099244|FG016|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0||
59982506|NCT02688387|76099245|FG017|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0||
59982507|NCT02688387|76099246|FG018|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0||
59982508|NCT02688387|76099247|FG019|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0||
59982509|NCT02688387|76099248|FG020|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0||
59982510|NCT02688387|76099249|FG021|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0||
59982511|NCT02688387|76099228|FG000|STARTED|Part 2, Period 1 (up to 6 Days)||0||
59982512|NCT02688387|76099229|FG001|STARTED|Part 2, Period 1 (up to 6 Days)||0||
59982513|NCT02688387|76099230|FG002|STARTED|Part 2, Period 1 (up to 6 Days)||0||
59982514|NCT02688387|76099231|FG003|STARTED|Part 2, Period 1 (up to 6 Days)||0||
59982515|NCT02688387|76099232|FG004|STARTED|Part 2, Period 1 (up to 6 Days)||0||
59982516|NCT02688387|76099233|FG005|STARTED|Part 2, Period 1 (up to 6 Days)||0||
59982517|NCT02688387|76099234|FG006|STARTED|Part 2, Period 1 (up to 6 Days)||0||
59982518|NCT02688387|76099235|FG007|STARTED|Part 2, Period 1 (up to 6 Days)||0||
59982519|NCT02688387|76099236|FG008|STARTED|Part 2, Period 1 (up to 6 Days)||0||
59982520|NCT02688387|76099237|FG009|STARTED|Part 2, Period 1 (up to 6 Days)||0||
59982521|NCT02688387|76099238|FG010|STARTED|Part 2, Period 1 (up to 6 Days)||6||
59982522|NCT02688387|76099239|FG011|STARTED|Part 2, Period 1 (up to 6 Days)||5||
59982523|NCT02688387|76099240|FG012|STARTED|Part 2, Period 1 (up to 6 Days)||5||
59982524|NCT02688387|76099241|FG013|STARTED|Part 2, Period 1 (up to 6 Days)||5||
59982525|NCT02688387|76099242|FG014|STARTED|Part 2, Period 1 (up to 6 Days)||0||
59982526|NCT02688387|76099243|FG015|STARTED|Part 2, Period 1 (up to 6 Days)||0||
59982527|NCT02688387|76099244|FG016|STARTED|Part 2, Period 1 (up to 6 Days)||0||
59982528|NCT02688387|76099245|FG017|STARTED|Part 2, Period 1 (up to 6 Days)||0||
59982529|NCT02688387|76099246|FG018|STARTED|Part 2, Period 1 (up to 6 Days)||0||
59982530|NCT02688387|76099247|FG019|STARTED|Part 2, Period 1 (up to 6 Days)||0||
59982531|NCT02688387|76099248|FG020|STARTED|Part 2, Period 1 (up to 6 Days)||0||
59982532|NCT02688387|76099249|FG021|STARTED|Part 2, Period 1 (up to 6 Days)||0||
59982533|NCT02688387|76099228|FG000|COMPLETED|Part 2, Period 1 (up to 6 Days)||0||
59982534|NCT02688387|76099229|FG001|COMPLETED|Part 2, Period 1 (up to 6 Days)||0||
59982535|NCT02688387|76099230|FG002|COMPLETED|Part 2, Period 1 (up to 6 Days)||0||
59982536|NCT02688387|76099231|FG003|COMPLETED|Part 2, Period 1 (up to 6 Days)||0||
59982537|NCT02688387|76099232|FG004|COMPLETED|Part 2, Period 1 (up to 6 Days)||0||
59982538|NCT02688387|76099233|FG005|COMPLETED|Part 2, Period 1 (up to 6 Days)||0||
59982539|NCT02688387|76099234|FG006|COMPLETED|Part 2, Period 1 (up to 6 Days)||0||
59982540|NCT02688387|76099235|FG007|COMPLETED|Part 2, Period 1 (up to 6 Days)||0||
59982541|NCT02688387|76099236|FG008|COMPLETED|Part 2, Period 1 (up to 6 Days)||0||
59982542|NCT02688387|76099237|FG009|COMPLETED|Part 2, Period 1 (up to 6 Days)||0||
59982543|NCT02688387|76099238|FG010|COMPLETED|Part 2, Period 1 (up to 6 Days)||5||
59982544|NCT02688387|76099239|FG011|COMPLETED|Part 2, Period 1 (up to 6 Days)||5||
59982545|NCT02688387|76099240|FG012|COMPLETED|Part 2, Period 1 (up to 6 Days)||5||
59982546|NCT02688387|76099241|FG013|COMPLETED|Part 2, Period 1 (up to 6 Days)||5||
59982547|NCT02688387|76099242|FG014|COMPLETED|Part 2, Period 1 (up to 6 Days)||0||
59982548|NCT02688387|76099243|FG015|COMPLETED|Part 2, Period 1 (up to 6 Days)||0||
59982549|NCT02688387|76099244|FG016|COMPLETED|Part 2, Period 1 (up to 6 Days)||0||
59982550|NCT02688387|76099245|FG017|COMPLETED|Part 2, Period 1 (up to 6 Days)||0||
59982551|NCT02688387|76099246|FG018|COMPLETED|Part 2, Period 1 (up to 6 Days)||0||
59982552|NCT02688387|76099247|FG019|COMPLETED|Part 2, Period 1 (up to 6 Days)||0||
59982553|NCT02688387|76099248|FG020|COMPLETED|Part 2, Period 1 (up to 6 Days)||0||
59982554|NCT02688387|76099249|FG021|COMPLETED|Part 2, Period 1 (up to 6 Days)||0||
59982555|NCT02688387|76099228|FG000|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0||
59982556|NCT02688387|76099229|FG001|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0||
59982557|NCT02688387|76099230|FG002|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0||
59982558|NCT02688387|76099231|FG003|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0||
59982559|NCT02688387|76099232|FG004|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0||
59982560|NCT02688387|76099233|FG005|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0||
59982561|NCT02688387|76099234|FG006|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0||
59982562|NCT02688387|76099235|FG007|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0||
59982563|NCT02688387|76099236|FG008|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0||
59982564|NCT02688387|76099237|FG009|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0||
59982565|NCT02688387|76099238|FG010|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||1||
59982566|NCT02688387|76099239|FG011|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0||
59982567|NCT02688387|76099240|FG012|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0||
59982568|NCT02688387|76099241|FG013|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0||
59982569|NCT02688387|76099242|FG014|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0||
59982570|NCT02688387|76099243|FG015|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0||
59982571|NCT02688387|76099244|FG016|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0||
59982572|NCT02688387|76099245|FG017|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0||
59982573|NCT02688387|76099246|FG018|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0||
59982574|NCT02688387|76099247|FG019|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0||
59982575|NCT02688387|76099248|FG020|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0||
59982576|NCT02688387|76099249|FG021|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0||
59982577|NCT02688387|76099228|FG000|STARTED|Part 2, Washout Period 1 (10 Days)||0||
59982578|NCT02688387|76099229|FG001|STARTED|Part 2, Washout Period 1 (10 Days)||0||
59982579|NCT02688387|76099230|FG002|STARTED|Part 2, Washout Period 1 (10 Days)||0||
59982580|NCT02688387|76099231|FG003|STARTED|Part 2, Washout Period 1 (10 Days)||0||
59982581|NCT02688387|76099232|FG004|STARTED|Part 2, Washout Period 1 (10 Days)||0||
59982582|NCT02688387|76099233|FG005|STARTED|Part 2, Washout Period 1 (10 Days)||0||
59982583|NCT02688387|76099234|FG006|STARTED|Part 2, Washout Period 1 (10 Days)||0||
59982584|NCT02688387|76099235|FG007|STARTED|Part 2, Washout Period 1 (10 Days)||0||
59982585|NCT02688387|76099236|FG008|STARTED|Part 2, Washout Period 1 (10 Days)||0||
59982586|NCT02688387|76099237|FG009|STARTED|Part 2, Washout Period 1 (10 Days)||0||
59982587|NCT02688387|76099238|FG010|STARTED|Part 2, Washout Period 1 (10 Days)||5||
59982588|NCT02688387|76099239|FG011|STARTED|Part 2, Washout Period 1 (10 Days)||5||
59982589|NCT02688387|76099240|FG012|STARTED|Part 2, Washout Period 1 (10 Days)||5||
59982590|NCT02688387|76099241|FG013|STARTED|Part 2, Washout Period 1 (10 Days)||5||
59982591|NCT02688387|76099242|FG014|STARTED|Part 2, Washout Period 1 (10 Days)||0||
59982592|NCT02688387|76099243|FG015|STARTED|Part 2, Washout Period 1 (10 Days)||0||
59982593|NCT02688387|76099244|FG016|STARTED|Part 2, Washout Period 1 (10 Days)||0||
59982594|NCT02688387|76099245|FG017|STARTED|Part 2, Washout Period 1 (10 Days)||0||
59982595|NCT02688387|76099246|FG018|STARTED|Part 2, Washout Period 1 (10 Days)||0||
59982596|NCT02688387|76099247|FG019|STARTED|Part 2, Washout Period 1 (10 Days)||0||
59982597|NCT02688387|76099248|FG020|STARTED|Part 2, Washout Period 1 (10 Days)||0||
59982598|NCT02688387|76099249|FG021|STARTED|Part 2, Washout Period 1 (10 Days)||0||
59982599|NCT02688387|76099228|FG000|COMPLETED|Part 2, Washout Period 1 (10 Days)||0||
59982600|NCT02688387|76099229|FG001|COMPLETED|Part 2, Washout Period 1 (10 Days)||0||
59982601|NCT02688387|76099230|FG002|COMPLETED|Part 2, Washout Period 1 (10 Days)||0||
59982602|NCT02688387|76099231|FG003|COMPLETED|Part 2, Washout Period 1 (10 Days)||0||
59982603|NCT02688387|76099232|FG004|COMPLETED|Part 2, Washout Period 1 (10 Days)||0||
59982604|NCT02688387|76099233|FG005|COMPLETED|Part 2, Washout Period 1 (10 Days)||0||
59982605|NCT02688387|76099234|FG006|COMPLETED|Part 2, Washout Period 1 (10 Days)||0||
59982606|NCT02688387|76099235|FG007|COMPLETED|Part 2, Washout Period 1 (10 Days)||0||
59982607|NCT02688387|76099236|FG008|COMPLETED|Part 2, Washout Period 1 (10 Days)||0||
59982608|NCT02688387|76099237|FG009|COMPLETED|Part 2, Washout Period 1 (10 Days)||0||
59982609|NCT02688387|76099238|FG010|COMPLETED|Part 2, Washout Period 1 (10 Days)||5||
59982610|NCT02688387|76099239|FG011|COMPLETED|Part 2, Washout Period 1 (10 Days)||5||
59982611|NCT02688387|76099240|FG012|COMPLETED|Part 2, Washout Period 1 (10 Days)||5||
59982612|NCT02688387|76099241|FG013|COMPLETED|Part 2, Washout Period 1 (10 Days)||5||
59982613|NCT02688387|76099242|FG014|COMPLETED|Part 2, Washout Period 1 (10 Days)||0||
59982614|NCT02688387|76099243|FG015|COMPLETED|Part 2, Washout Period 1 (10 Days)||0||
59982615|NCT02688387|76099244|FG016|COMPLETED|Part 2, Washout Period 1 (10 Days)||0||
59982616|NCT02688387|76099245|FG017|COMPLETED|Part 2, Washout Period 1 (10 Days)||0||
59982617|NCT02688387|76099246|FG018|COMPLETED|Part 2, Washout Period 1 (10 Days)||0||
60074825|NCT01930045|76190107|FG004|STARTED|Part 1 - Period 3||3||
60074826|NCT01930045|76190108|FG005|STARTED|Part 1 - Period 3||3||
60074827|NCT01930045|76190103|FG000|COMPLETED|Part 1 - Period 3||3||
60074828|NCT01930045|76190104|FG001|COMPLETED|Part 1 - Period 3||3||
60074829|NCT01930045|76190105|FG002|COMPLETED|Part 1 - Period 3||2||
60074830|NCT01930045|76190106|FG003|COMPLETED|Part 1 - Period 3||3||
59982618|NCT02688387|76099247|FG019|COMPLETED|Part 2, Washout Period 1 (10 Days)||0||
59982619|NCT02688387|76099248|FG020|COMPLETED|Part 2, Washout Period 1 (10 Days)||0||
59982620|NCT02688387|76099249|FG021|COMPLETED|Part 2, Washout Period 1 (10 Days)||0||
59982621|NCT02688387|76099228|FG000|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0||
59982622|NCT02688387|76099229|FG001|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0||
59982623|NCT02688387|76099230|FG002|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0||
59982624|NCT02688387|76099231|FG003|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0||
59982625|NCT02688387|76099232|FG004|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0||
59982626|NCT02688387|76099233|FG005|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0||
59982627|NCT02688387|76099234|FG006|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0||
60074831|NCT01930045|76190107|FG004|COMPLETED|Part 1 - Period 3||3||
60074832|NCT01930045|76190108|FG005|COMPLETED|Part 1 - Period 3||3||
59982628|NCT02688387|76099235|FG007|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0||
59982629|NCT02688387|76099236|FG008|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0||
59982630|NCT02688387|76099237|FG009|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0||
59982631|NCT02688387|76099238|FG010|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0||
59982632|NCT02688387|76099239|FG011|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0||
59982633|NCT02688387|76099240|FG012|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0||
59982634|NCT02688387|76099241|FG013|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0||
59982635|NCT02688387|76099242|FG014|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0||
59982636|NCT02688387|76099243|FG015|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0||
59982637|NCT02688387|76099244|FG016|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0||
59982638|NCT02688387|76099245|FG017|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0||
59982639|NCT02688387|76099246|FG018|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0||
59982640|NCT02688387|76099247|FG019|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0||
59982641|NCT02688387|76099248|FG020|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0||
59982642|NCT02688387|76099249|FG021|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0||
59982643|NCT02688387|76099228|FG000|STARTED|Part 2, Period 2 (up to 6 Days)||0||
59982644|NCT02688387|76099229|FG001|STARTED|Part 2, Period 2 (up to 6 Days)||0||
59982645|NCT02688387|76099230|FG002|STARTED|Part 2, Period 2 (up to 6 Days)||0||
59982646|NCT02688387|76099231|FG003|STARTED|Part 2, Period 2 (up to 6 Days)||0||
59982647|NCT02688387|76099232|FG004|STARTED|Part 2, Period 2 (up to 6 Days)||0||
59982648|NCT02688387|76099233|FG005|STARTED|Part 2, Period 2 (up to 6 Days)||0||
59982649|NCT02688387|76099234|FG006|STARTED|Part 2, Period 2 (up to 6 Days)||0||
59982650|NCT02688387|76099235|FG007|STARTED|Part 2, Period 2 (up to 6 Days)||0||
59982651|NCT02688387|76099236|FG008|STARTED|Part 2, Period 2 (up to 6 Days)||0||
59982652|NCT02688387|76099237|FG009|STARTED|Part 2, Period 2 (up to 6 Days)||0||
59982653|NCT02688387|76099238|FG010|STARTED|Part 2, Period 2 (up to 6 Days)||5||
59982654|NCT02688387|76099239|FG011|STARTED|Part 2, Period 2 (up to 6 Days)||5||
59982655|NCT02688387|76099240|FG012|STARTED|Part 2, Period 2 (up to 6 Days)||5||
59982656|NCT02688387|76099241|FG013|STARTED|Part 2, Period 2 (up to 6 Days)||5||
59982657|NCT02688387|76099242|FG014|STARTED|Part 2, Period 2 (up to 6 Days)||0||
59982658|NCT02688387|76099243|FG015|STARTED|Part 2, Period 2 (up to 6 Days)||0||
59982659|NCT02688387|76099244|FG016|STARTED|Part 2, Period 2 (up to 6 Days)||0||
59982660|NCT02688387|76099245|FG017|STARTED|Part 2, Period 2 (up to 6 Days)||0||
59982661|NCT02688387|76099246|FG018|STARTED|Part 2, Period 2 (up to 6 Days)||0||
59982662|NCT02688387|76099247|FG019|STARTED|Part 2, Period 2 (up to 6 Days)||0||
59982663|NCT02688387|76099248|FG020|STARTED|Part 2, Period 2 (up to 6 Days)||0||
59982664|NCT02688387|76099249|FG021|STARTED|Part 2, Period 2 (up to 6 Days)||0||
59982665|NCT02688387|76099228|FG000|COMPLETED|Part 2, Period 2 (up to 6 Days)||0||
59982666|NCT02688387|76099229|FG001|COMPLETED|Part 2, Period 2 (up to 6 Days)||0||
59982667|NCT02688387|76099230|FG002|COMPLETED|Part 2, Period 2 (up to 6 Days)||0||
59982668|NCT02688387|76099231|FG003|COMPLETED|Part 2, Period 2 (up to 6 Days)||0||
59526574|NCT00254072|75622261|FG000|NOT COMPLETED|Overall Study||0||
59526575|NCT00254072|75622262|FG001|NOT COMPLETED|Overall Study||0||
59526576|NCT00151814|75622271|FG000|STARTED|Overall Study||4||
59526577|NCT00151814|75622272|FG001|STARTED|Overall Study||10||
59526578|NCT00151814|75622273|FG002|STARTED|Overall Study||10||
59526579|NCT00151814|75622271|FG000|COMPLETED|Overall Study||4||
59526580|NCT00151814|75622272|FG001|COMPLETED|Overall Study||10||
59526581|NCT00151814|75622273|FG002|COMPLETED|Overall Study||10||
59526582|NCT00151814|75622271|FG000|NOT COMPLETED|Overall Study||0||
59526583|NCT00151814|75622272|FG001|NOT COMPLETED|Overall Study||0||
59982669|NCT02688387|76099232|FG004|COMPLETED|Part 2, Period 2 (up to 6 Days)||0||
59982670|NCT02688387|76099233|FG005|COMPLETED|Part 2, Period 2 (up to 6 Days)||0||
59982671|NCT02688387|76099234|FG006|COMPLETED|Part 2, Period 2 (up to 6 Days)||0||
59982672|NCT02688387|76099235|FG007|COMPLETED|Part 2, Period 2 (up to 6 Days)||0||
59982673|NCT02688387|76099236|FG008|COMPLETED|Part 2, Period 2 (up to 6 Days)||0||
59982674|NCT02688387|76099237|FG009|COMPLETED|Part 2, Period 2 (up to 6 Days)||0||
59982675|NCT02688387|76099238|FG010|COMPLETED|Part 2, Period 2 (up to 6 Days)||5||
59982676|NCT02688387|76099239|FG011|COMPLETED|Part 2, Period 2 (up to 6 Days)||5||
59982677|NCT02688387|76099240|FG012|COMPLETED|Part 2, Period 2 (up to 6 Days)||5||
59982678|NCT02688387|76099241|FG013|COMPLETED|Part 2, Period 2 (up to 6 Days)||5||
59982679|NCT02688387|76099242|FG014|COMPLETED|Part 2, Period 2 (up to 6 Days)||0||
59982680|NCT02688387|76099243|FG015|COMPLETED|Part 2, Period 2 (up to 6 Days)||0||
59982681|NCT02688387|76099244|FG016|COMPLETED|Part 2, Period 2 (up to 6 Days)||0||
59982682|NCT02688387|76099245|FG017|COMPLETED|Part 2, Period 2 (up to 6 Days)||0||
59982683|NCT02688387|76099246|FG018|COMPLETED|Part 2, Period 2 (up to 6 Days)||0||
59982684|NCT02688387|76099247|FG019|COMPLETED|Part 2, Period 2 (up to 6 Days)||0||
59982685|NCT02688387|76099248|FG020|COMPLETED|Part 2, Period 2 (up to 6 Days)||0||
59982686|NCT02688387|76099249|FG021|COMPLETED|Part 2, Period 2 (up to 6 Days)||0||
59982687|NCT02688387|76099228|FG000|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0||
59982688|NCT02688387|76099229|FG001|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0||
59982689|NCT02688387|76099230|FG002|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0||
59982690|NCT02688387|76099231|FG003|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0||
59526584|NCT00151814|75622273|FG002|NOT COMPLETED|Overall Study||0||
59526585|NCT00153842|75622282|FG000|STARTED|Overall Study||26||
59982691|NCT02688387|76099232|FG004|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0||
59982692|NCT02688387|76099233|FG005|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0||
59982693|NCT02688387|76099234|FG006|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0||
59982694|NCT02688387|76099235|FG007|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0||
59982695|NCT02688387|76099236|FG008|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0||
59982696|NCT02688387|76099237|FG009|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0||
59982697|NCT02688387|76099238|FG010|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0||
59982698|NCT02688387|76099239|FG011|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0||
59982699|NCT02688387|76099240|FG012|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0||
59982700|NCT02688387|76099241|FG013|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0||
59982701|NCT02688387|76099242|FG014|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0||
59982702|NCT02688387|76099243|FG015|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0||
59982703|NCT02688387|76099244|FG016|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0||
59982704|NCT02688387|76099245|FG017|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0||
59982705|NCT02688387|76099246|FG018|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0||
59982706|NCT02688387|76099247|FG019|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0||
59982707|NCT02688387|76099248|FG020|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0||
59982708|NCT02688387|76099249|FG021|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0||
59982709|NCT02688387|76099228|FG000|STARTED|Part 2, Washout Period 2 (10 Days)||0||
59982710|NCT02688387|76099229|FG001|STARTED|Part 2, Washout Period 2 (10 Days)||0||
59982711|NCT02688387|76099230|FG002|STARTED|Part 2, Washout Period 2 (10 Days)||0||
59982712|NCT02688387|76099231|FG003|STARTED|Part 2, Washout Period 2 (10 Days)||0||
59982713|NCT02688387|76099232|FG004|STARTED|Part 2, Washout Period 2 (10 Days)||0||
59982714|NCT02688387|76099233|FG005|STARTED|Part 2, Washout Period 2 (10 Days)||0||
59982715|NCT02688387|76099234|FG006|STARTED|Part 2, Washout Period 2 (10 Days)||0||
59982716|NCT02688387|76099235|FG007|STARTED|Part 2, Washout Period 2 (10 Days)||0||
59982717|NCT02688387|76099236|FG008|STARTED|Part 2, Washout Period 2 (10 Days)||0||
59982718|NCT02688387|76099237|FG009|STARTED|Part 2, Washout Period 2 (10 Days)||0||
59982719|NCT02688387|76099238|FG010|STARTED|Part 2, Washout Period 2 (10 Days)||5||
59982720|NCT02688387|76099239|FG011|STARTED|Part 2, Washout Period 2 (10 Days)||5||
59982721|NCT02688387|76099240|FG012|STARTED|Part 2, Washout Period 2 (10 Days)||5||
59982722|NCT02688387|76099241|FG013|STARTED|Part 2, Washout Period 2 (10 Days)||5||
59982723|NCT02688387|76099242|FG014|STARTED|Part 2, Washout Period 2 (10 Days)||0||
59982724|NCT02688387|76099243|FG015|STARTED|Part 2, Washout Period 2 (10 Days)||0||
59982725|NCT02688387|76099244|FG016|STARTED|Part 2, Washout Period 2 (10 Days)||0||
59982726|NCT02688387|76099245|FG017|STARTED|Part 2, Washout Period 2 (10 Days)||0||
59982727|NCT02688387|76099246|FG018|STARTED|Part 2, Washout Period 2 (10 Days)||0||
59982728|NCT02688387|76099247|FG019|STARTED|Part 2, Washout Period 2 (10 Days)||0||
59982729|NCT02688387|76099248|FG020|STARTED|Part 2, Washout Period 2 (10 Days)||0||
59982730|NCT02688387|76099249|FG021|STARTED|Part 2, Washout Period 2 (10 Days)||0||
59982731|NCT02688387|76099228|FG000|COMPLETED|Part 2, Washout Period 2 (10 Days)||0||
59982732|NCT02688387|76099229|FG001|COMPLETED|Part 2, Washout Period 2 (10 Days)||0||
59982733|NCT02688387|76099230|FG002|COMPLETED|Part 2, Washout Period 2 (10 Days)||0||
59982734|NCT02688387|76099231|FG003|COMPLETED|Part 2, Washout Period 2 (10 Days)||0||
59982735|NCT02688387|76099232|FG004|COMPLETED|Part 2, Washout Period 2 (10 Days)||0||
59982736|NCT02688387|76099233|FG005|COMPLETED|Part 2, Washout Period 2 (10 Days)||0||
59982737|NCT02688387|76099234|FG006|COMPLETED|Part 2, Washout Period 2 (10 Days)||0||
59982738|NCT02688387|76099235|FG007|COMPLETED|Part 2, Washout Period 2 (10 Days)||0||
59982739|NCT02688387|76099236|FG008|COMPLETED|Part 2, Washout Period 2 (10 Days)||0||
59982740|NCT02688387|76099237|FG009|COMPLETED|Part 2, Washout Period 2 (10 Days)||0||
59982741|NCT02688387|76099238|FG010|COMPLETED|Part 2, Washout Period 2 (10 Days)||5||
59982742|NCT02688387|76099239|FG011|COMPLETED|Part 2, Washout Period 2 (10 Days)||5||
59982743|NCT02688387|76099240|FG012|COMPLETED|Part 2, Washout Period 2 (10 Days)||5||
60074833|NCT01930045|76190103|FG000|NOT COMPLETED|Part 1 - Period 3||0||
59526586|NCT00153842|75622283|FG001|STARTED|Overall Study||7||
59526587|NCT00153842|75622282|FG000|COMPLETED|Overall Study||26||
59982744|NCT02688387|76099241|FG013|COMPLETED|Part 2, Washout Period 2 (10 Days)||5||
59982745|NCT02688387|76099242|FG014|COMPLETED|Part 2, Washout Period 2 (10 Days)||0||
59982746|NCT02688387|76099243|FG015|COMPLETED|Part 2, Washout Period 2 (10 Days)||0||
59982747|NCT02688387|76099244|FG016|COMPLETED|Part 2, Washout Period 2 (10 Days)||0||
59982748|NCT02688387|76099245|FG017|COMPLETED|Part 2, Washout Period 2 (10 Days)||0||
59982749|NCT02688387|76099246|FG018|COMPLETED|Part 2, Washout Period 2 (10 Days)||0||
60074834|NCT01930045|76190104|FG001|NOT COMPLETED|Part 1 - Period 3||0||
60074835|NCT01930045|76190105|FG002|NOT COMPLETED|Part 1 - Period 3||0||
60074836|NCT01930045|76190106|FG003|NOT COMPLETED|Part 1 - Period 3||0||
59982750|NCT02688387|76099247|FG019|COMPLETED|Part 2, Washout Period 2 (10 Days)||0||
59982751|NCT02688387|76099248|FG020|COMPLETED|Part 2, Washout Period 2 (10 Days)||0||
59982752|NCT02688387|76099249|FG021|COMPLETED|Part 2, Washout Period 2 (10 Days)||0||
59526588|NCT00153842|75622283|FG001|COMPLETED|Overall Study||7||
59526589|NCT00153842|75622282|FG000|NOT COMPLETED|Overall Study||0||
59526590|NCT00153842|75622283|FG001|NOT COMPLETED|Overall Study||0||
59982753|NCT02688387|76099228|FG000|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0||
59982754|NCT02688387|76099229|FG001|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0||
59982755|NCT02688387|76099230|FG002|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0||
59982756|NCT02688387|76099231|FG003|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0||
59982757|NCT02688387|76099232|FG004|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0||
59982758|NCT02688387|76099233|FG005|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0||
59982759|NCT02688387|76099234|FG006|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0||
59814893|NCT00420927|75937334|FG000|STARTED|Period 2|This treatment group is not relevant to Period 2.|0||
59814894|NCT00420927|75937335|FG001|STARTED|Period 2|This treatment group is not relevant to Period 2.|0||
59814895|NCT00420927|75937336|FG002|STARTED|Period 2||102||
59814896|NCT00420927|75937337|FG003|STARTED|Period 2||105||
59814897|NCT00420927|75937338|FG004|STARTED|Period 2||259||
59814898|NCT00420927|75937339|FG005|STARTED|Period 2||112||
59814899|NCT00420927|75937340|FG006|STARTED|Period 2||348||
59814900|NCT00420927|75937334|FG000|COMPLETED|Period 2||0||
59814901|NCT00420927|75937335|FG001|COMPLETED|Period 2||0||
59814902|NCT00420927|75937336|FG002|COMPLETED|Period 2||89||
59814903|NCT00420927|75937337|FG003|COMPLETED|Period 2||95||
59814904|NCT00420927|75937338|FG004|COMPLETED|Period 2||216||
59814905|NCT00420927|75937339|FG005|COMPLETED|Period 2||97||
59814906|NCT00420927|75937340|FG006|COMPLETED|Period 2||295||
59814907|NCT00420927|75937334|FG000|NOT COMPLETED|Period 2||0||
59814908|NCT00420927|75937335|FG001|NOT COMPLETED|Period 2||0||
59814909|NCT00420927|75937336|FG002|NOT COMPLETED|Period 2||13||
59814910|NCT00420927|75937337|FG003|NOT COMPLETED|Period 2||10||
59814911|NCT00420927|75937338|FG004|NOT COMPLETED|Period 2||43||
59814912|NCT00420927|75937339|FG005|NOT COMPLETED|Period 2||15||
59814913|NCT00420927|75937340|FG006|NOT COMPLETED|Period 2||53||
59814914|NCT00573443|75937357|FG000|STARTED|Double-Blind Phase||110||
59814915|NCT00573443|75937358|FG001|STARTED|Double-Blind Phase||107||
59814916|NCT00573443|75937359|FG002|STARTED|Double-Blind Phase||109||
59814917|NCT00573443|75937357|FG000|Subjects With PBA Secondary to ALS|Double-Blind Phase||65||
59814918|NCT00573443|75937358|FG001|Subjects With PBA Secondary to ALS|Double-Blind Phase||68||
59814919|NCT00573443|75937359|FG002|Subjects With PBA Secondary to ALS|Double-Blind Phase||64||
59814920|NCT00573443|75937357|FG000|Subjects With PBA Secondary to MS|Double-Blind Phase||45||
59814921|NCT00573443|75937358|FG001|Subjects With PBA Secondary to MS|Double-Blind Phase||39||
59814922|NCT00573443|75937359|FG002|Subjects With PBA Secondary to MS|Double-Blind Phase||45||
59982760|NCT02688387|76099235|FG007|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0||
59814923|NCT00573443|75937357|FG000|COMPLETED|Double-Blind Phase||101||
59814924|NCT00573443|75937358|FG001|COMPLETED|Double-Blind Phase||88||
59814925|NCT00573443|75937359|FG002|COMPLETED|Double-Blind Phase||94||
59814926|NCT00573443|75937357|FG000|NOT COMPLETED|Double-Blind Phase||9||
59814927|NCT00573443|75937358|FG001|NOT COMPLETED|Double-Blind Phase||19||
59814928|NCT00573443|75937359|FG002|NOT COMPLETED|Double-Blind Phase||15||
59814929|NCT00573443|75937357|FG000|STARTED|Open-Label Extension Phase|Subjects who completed any of the arms in the DB phase had the option to enroll in this OLE phase|253||
59814930|NCT00573443|75937358|FG001|STARTED|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0||
59814931|NCT00573443|75937359|FG002|STARTED|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0||
59814932|NCT00573443|75937357|FG000|Subjects With PBA Secondary to ALS|Open-Label Extension Phase||146||
59814933|NCT00573443|75937358|FG001|Subjects With PBA Secondary to ALS|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0||
59814934|NCT00573443|75937359|FG002|Subjects With PBA Secondary to ALS|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0||
59814935|NCT00573443|75937357|FG000|Subjects With PBA Secondary to MS|Open-Label Extension Phase||107||
59814936|NCT00573443|75937358|FG001|Subjects With PBA Secondary to MS|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0||
59814937|NCT00573443|75937359|FG002|Subjects With PBA Secondary to MS|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0||
59982761|NCT02688387|76099236|FG008|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0||
59982762|NCT02688387|76099237|FG009|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0||
59982763|NCT02688387|76099238|FG010|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0||
59982764|NCT02688387|76099239|FG011|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0||
59982765|NCT02688387|76099240|FG012|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0||
59982766|NCT02688387|76099241|FG013|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0||
59982767|NCT02688387|76099242|FG014|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0||
59982768|NCT02688387|76099243|FG015|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0||
59982769|NCT02688387|76099244|FG016|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0||
59982770|NCT02688387|76099245|FG017|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0||
59982771|NCT02688387|76099246|FG018|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0||
59982772|NCT02688387|76099247|FG019|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0||
59982773|NCT02688387|76099248|FG020|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0||
59982774|NCT02688387|76099249|FG021|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0||
59982775|NCT02688387|76099228|FG000|STARTED|Part 2, Period 3 (up to 6 Days)||0||
59982776|NCT02688387|76099229|FG001|STARTED|Part 2, Period 3 (up to 6 Days)||0||
59982777|NCT02688387|76099230|FG002|STARTED|Part 2, Period 3 (up to 6 Days)||0||
59982778|NCT02688387|76099231|FG003|STARTED|Part 2, Period 3 (up to 6 Days)||0||
59982779|NCT02688387|76099232|FG004|STARTED|Part 2, Period 3 (up to 6 Days)||0||
59982780|NCT02688387|76099233|FG005|STARTED|Part 2, Period 3 (up to 6 Days)||0||
59982781|NCT02688387|76099234|FG006|STARTED|Part 2, Period 3 (up to 6 Days)||0||
59982782|NCT02688387|76099235|FG007|STARTED|Part 2, Period 3 (up to 6 Days)||0||
59982783|NCT02688387|76099236|FG008|STARTED|Part 2, Period 3 (up to 6 Days)||0||
59982784|NCT02688387|76099237|FG009|STARTED|Part 2, Period 3 (up to 6 Days)||0||
59982785|NCT02688387|76099238|FG010|STARTED|Part 2, Period 3 (up to 6 Days)||5||
59982786|NCT02688387|76099239|FG011|STARTED|Part 2, Period 3 (up to 6 Days)||5||
59982787|NCT02688387|76099240|FG012|STARTED|Part 2, Period 3 (up to 6 Days)||5||
59982788|NCT02688387|76099241|FG013|STARTED|Part 2, Period 3 (up to 6 Days)||5||
59982789|NCT02688387|76099242|FG014|STARTED|Part 2, Period 3 (up to 6 Days)||0||
59982790|NCT02688387|76099243|FG015|STARTED|Part 2, Period 3 (up to 6 Days)||0||
59982791|NCT02688387|76099244|FG016|STARTED|Part 2, Period 3 (up to 6 Days)||0||
59982792|NCT02688387|76099245|FG017|STARTED|Part 2, Period 3 (up to 6 Days)||0||
59982793|NCT02688387|76099246|FG018|STARTED|Part 2, Period 3 (up to 6 Days)||0||
59982794|NCT02688387|76099247|FG019|STARTED|Part 2, Period 3 (up to 6 Days)||0||
59982795|NCT02688387|76099248|FG020|STARTED|Part 2, Period 3 (up to 6 Days)||0||
59982796|NCT02688387|76099249|FG021|STARTED|Part 2, Period 3 (up to 6 Days)||0||
59982797|NCT02688387|76099228|FG000|COMPLETED|Part 2, Period 3 (up to 6 Days)||0||
59982798|NCT02688387|76099229|FG001|COMPLETED|Part 2, Period 3 (up to 6 Days)||0||
59982799|NCT02688387|76099230|FG002|COMPLETED|Part 2, Period 3 (up to 6 Days)||0||
59982800|NCT02688387|76099231|FG003|COMPLETED|Part 2, Period 3 (up to 6 Days)||0||
59982801|NCT02688387|76099232|FG004|COMPLETED|Part 2, Period 3 (up to 6 Days)||0||
59982802|NCT02688387|76099233|FG005|COMPLETED|Part 2, Period 3 (up to 6 Days)||0||
59982803|NCT02688387|76099234|FG006|COMPLETED|Part 2, Period 3 (up to 6 Days)||0||
59982804|NCT02688387|76099235|FG007|COMPLETED|Part 2, Period 3 (up to 6 Days)||0||
59982805|NCT02688387|76099236|FG008|COMPLETED|Part 2, Period 3 (up to 6 Days)||0||
59982806|NCT02688387|76099237|FG009|COMPLETED|Part 2, Period 3 (up to 6 Days)||0||
59982807|NCT02688387|76099238|FG010|COMPLETED|Part 2, Period 3 (up to 6 Days)||5||
59982808|NCT02688387|76099239|FG011|COMPLETED|Part 2, Period 3 (up to 6 Days)||5||
59982809|NCT02688387|76099240|FG012|COMPLETED|Part 2, Period 3 (up to 6 Days)||5||
59982810|NCT02688387|76099241|FG013|COMPLETED|Part 2, Period 3 (up to 6 Days)||5||
59982811|NCT02688387|76099242|FG014|COMPLETED|Part 2, Period 3 (up to 6 Days)||0||
59982812|NCT02688387|76099243|FG015|COMPLETED|Part 2, Period 3 (up to 6 Days)||0||
59982813|NCT02688387|76099244|FG016|COMPLETED|Part 2, Period 3 (up to 6 Days)||0||
60074837|NCT01930045|76190107|FG004|NOT COMPLETED|Part 1 - Period 3||0||
59982814|NCT02688387|76099245|FG017|COMPLETED|Part 2, Period 3 (up to 6 Days)||0||
59982815|NCT02688387|76099246|FG018|COMPLETED|Part 2, Period 3 (up to 6 Days)||0||
59982816|NCT02688387|76099247|FG019|COMPLETED|Part 2, Period 3 (up to 6 Days)||0||
59982817|NCT02688387|76099248|FG020|COMPLETED|Part 2, Period 3 (up to 6 Days)||0||
59982818|NCT02688387|76099249|FG021|COMPLETED|Part 2, Period 3 (up to 6 Days)||0||
59982819|NCT02688387|76099228|FG000|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0||
59982820|NCT02688387|76099229|FG001|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0||
59982821|NCT02688387|76099230|FG002|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0||
59982822|NCT02688387|76099231|FG003|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0||
59982823|NCT02688387|76099232|FG004|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0||
59982824|NCT02688387|76099233|FG005|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0||
59982825|NCT02688387|76099234|FG006|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0||
59982826|NCT02688387|76099235|FG007|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0||
59982827|NCT02688387|76099236|FG008|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0||
59982828|NCT02688387|76099237|FG009|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0||
59982829|NCT02688387|76099238|FG010|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0||
59982830|NCT02688387|76099239|FG011|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0||
59982831|NCT02688387|76099240|FG012|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0||
59982832|NCT02688387|76099241|FG013|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0||
59982833|NCT02688387|76099242|FG014|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0||
59982834|NCT02688387|76099243|FG015|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0||
59982835|NCT02688387|76099244|FG016|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0||
59982836|NCT02688387|76099245|FG017|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0||
59982837|NCT02688387|76099246|FG018|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0||
59982838|NCT02688387|76099247|FG019|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0||
59982839|NCT02688387|76099248|FG020|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0||
59982840|NCT02688387|76099249|FG021|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0||
59982841|NCT02688387|76099228|FG000|STARTED|Part 2, Washout Period 3 (10 Days)||0||
59982842|NCT02688387|76099229|FG001|STARTED|Part 2, Washout Period 3 (10 Days)||0||
59982843|NCT02688387|76099230|FG002|STARTED|Part 2, Washout Period 3 (10 Days)||0||
59982844|NCT02688387|76099231|FG003|STARTED|Part 2, Washout Period 3 (10 Days)||0||
59982845|NCT02688387|76099232|FG004|STARTED|Part 2, Washout Period 3 (10 Days)||0||
59982846|NCT02688387|76099233|FG005|STARTED|Part 2, Washout Period 3 (10 Days)||0||
59982847|NCT02688387|76099234|FG006|STARTED|Part 2, Washout Period 3 (10 Days)||0||
59982848|NCT02688387|76099235|FG007|STARTED|Part 2, Washout Period 3 (10 Days)||0||
59982849|NCT02688387|76099236|FG008|STARTED|Part 2, Washout Period 3 (10 Days)||0||
59982850|NCT02688387|76099237|FG009|STARTED|Part 2, Washout Period 3 (10 Days)||0||
59982851|NCT02688387|76099238|FG010|STARTED|Part 2, Washout Period 3 (10 Days)||5||
59982852|NCT02688387|76099239|FG011|STARTED|Part 2, Washout Period 3 (10 Days)||5||
59982853|NCT02688387|76099240|FG012|STARTED|Part 2, Washout Period 3 (10 Days)||5||
59982854|NCT02688387|76099241|FG013|STARTED|Part 2, Washout Period 3 (10 Days)||5||
59982855|NCT02688387|76099242|FG014|STARTED|Part 2, Washout Period 3 (10 Days)||0||
59982856|NCT02688387|76099243|FG015|STARTED|Part 2, Washout Period 3 (10 Days)||0||
59982857|NCT02688387|76099244|FG016|STARTED|Part 2, Washout Period 3 (10 Days)||0||
59982858|NCT02688387|76099245|FG017|STARTED|Part 2, Washout Period 3 (10 Days)||0||
59982859|NCT02688387|76099246|FG018|STARTED|Part 2, Washout Period 3 (10 Days)||0||
59982860|NCT02688387|76099247|FG019|STARTED|Part 2, Washout Period 3 (10 Days)||0||
59982861|NCT02688387|76099248|FG020|STARTED|Part 2, Washout Period 3 (10 Days)||0||
59982862|NCT02688387|76099249|FG021|STARTED|Part 2, Washout Period 3 (10 Days)||0||
59982863|NCT02688387|76099228|FG000|COMPLETED|Part 2, Washout Period 3 (10 Days)||0||
59982864|NCT02688387|76099229|FG001|COMPLETED|Part 2, Washout Period 3 (10 Days)||0||
59982865|NCT02688387|76099230|FG002|COMPLETED|Part 2, Washout Period 3 (10 Days)||0||
59982866|NCT02688387|76099231|FG003|COMPLETED|Part 2, Washout Period 3 (10 Days)||0||
59982867|NCT02688387|76099232|FG004|COMPLETED|Part 2, Washout Period 3 (10 Days)||0||
59982868|NCT02688387|76099233|FG005|COMPLETED|Part 2, Washout Period 3 (10 Days)||0||
59982869|NCT02688387|76099234|FG006|COMPLETED|Part 2, Washout Period 3 (10 Days)||0||
59982870|NCT02688387|76099235|FG007|COMPLETED|Part 2, Washout Period 3 (10 Days)||0||
59982871|NCT02688387|76099236|FG008|COMPLETED|Part 2, Washout Period 3 (10 Days)||0||
59982872|NCT02688387|76099237|FG009|COMPLETED|Part 2, Washout Period 3 (10 Days)||0||
59982873|NCT02688387|76099238|FG010|COMPLETED|Part 2, Washout Period 3 (10 Days)||5||
59982874|NCT02688387|76099239|FG011|COMPLETED|Part 2, Washout Period 3 (10 Days)||5||
59982875|NCT02688387|76099240|FG012|COMPLETED|Part 2, Washout Period 3 (10 Days)||5||
59982876|NCT02688387|76099241|FG013|COMPLETED|Part 2, Washout Period 3 (10 Days)||5||
59982877|NCT02688387|76099242|FG014|COMPLETED|Part 2, Washout Period 3 (10 Days)||0||
59982878|NCT02688387|76099243|FG015|COMPLETED|Part 2, Washout Period 3 (10 Days)||0||
59982879|NCT02688387|76099244|FG016|COMPLETED|Part 2, Washout Period 3 (10 Days)||0||
59982880|NCT02688387|76099245|FG017|COMPLETED|Part 2, Washout Period 3 (10 Days)||0||
59982881|NCT02688387|76099246|FG018|COMPLETED|Part 2, Washout Period 3 (10 Days)||0||
59982882|NCT02688387|76099247|FG019|COMPLETED|Part 2, Washout Period 3 (10 Days)||0||
59982883|NCT02688387|76099248|FG020|COMPLETED|Part 2, Washout Period 3 (10 Days)||0||
59982884|NCT02688387|76099249|FG021|COMPLETED|Part 2, Washout Period 3 (10 Days)||0||
59982885|NCT02688387|76099228|FG000|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0||
59982886|NCT02688387|76099229|FG001|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0||
59982887|NCT02688387|76099230|FG002|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0||
59982888|NCT02688387|76099231|FG003|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0||
59982889|NCT02688387|76099232|FG004|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0||
59982890|NCT02688387|76099233|FG005|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0||
59982891|NCT02688387|76099234|FG006|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0||
59982892|NCT02688387|76099235|FG007|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0||
59982893|NCT02688387|76099236|FG008|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0||
59982894|NCT02688387|76099237|FG009|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0||
59982895|NCT02688387|76099238|FG010|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0||
59982896|NCT02688387|76099239|FG011|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0||
59982897|NCT02688387|76099240|FG012|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0||
59982898|NCT02688387|76099241|FG013|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0||
59982899|NCT02688387|76099242|FG014|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0||
59982900|NCT02688387|76099243|FG015|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0||
59982901|NCT02688387|76099244|FG016|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0||
59982902|NCT02688387|76099245|FG017|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0||
59982903|NCT02688387|76099246|FG018|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0||
59982904|NCT02688387|76099247|FG019|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0||
59982905|NCT02688387|76099248|FG020|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0||
59982906|NCT02688387|76099249|FG021|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0||
59982907|NCT02688387|76099228|FG000|STARTED|Part 2, Period 4 (up to 6 Days)||0||
59982908|NCT02688387|76099229|FG001|STARTED|Part 2, Period 4 (up to 6 Days)||0||
59982909|NCT02688387|76099230|FG002|STARTED|Part 2, Period 4 (up to 6 Days)||0||
59982910|NCT02688387|76099231|FG003|STARTED|Part 2, Period 4 (up to 6 Days)||0||
59982911|NCT02688387|76099232|FG004|STARTED|Part 2, Period 4 (up to 6 Days)||0||
59982912|NCT02688387|76099233|FG005|STARTED|Part 2, Period 4 (up to 6 Days)||0||
59982913|NCT02688387|76099234|FG006|STARTED|Part 2, Period 4 (up to 6 Days)||0||
59982914|NCT02688387|76099235|FG007|STARTED|Part 2, Period 4 (up to 6 Days)||0||
59982915|NCT02688387|76099236|FG008|STARTED|Part 2, Period 4 (up to 6 Days)||0||
59982916|NCT02688387|76099237|FG009|STARTED|Part 2, Period 4 (up to 6 Days)||0||
59982917|NCT02688387|76099238|FG010|STARTED|Part 2, Period 4 (up to 6 Days)||5||
59982918|NCT02688387|76099239|FG011|STARTED|Part 2, Period 4 (up to 6 Days)||5||
59982919|NCT02688387|76099240|FG012|STARTED|Part 2, Period 4 (up to 6 Days)||5||
59982920|NCT02688387|76099241|FG013|STARTED|Part 2, Period 4 (up to 6 Days)||5||
59982921|NCT02688387|76099242|FG014|STARTED|Part 2, Period 4 (up to 6 Days)||0||
59982922|NCT02688387|76099243|FG015|STARTED|Part 2, Period 4 (up to 6 Days)||0||
59982923|NCT02688387|76099244|FG016|STARTED|Part 2, Period 4 (up to 6 Days)||0||
59982924|NCT02688387|76099245|FG017|STARTED|Part 2, Period 4 (up to 6 Days)||0||
59982925|NCT02688387|76099246|FG018|STARTED|Part 2, Period 4 (up to 6 Days)||0||
59982926|NCT02688387|76099247|FG019|STARTED|Part 2, Period 4 (up to 6 Days)||0||
59982927|NCT02688387|76099248|FG020|STARTED|Part 2, Period 4 (up to 6 Days)||0||
59982928|NCT02688387|76099249|FG021|STARTED|Part 2, Period 4 (up to 6 Days)||0||
59982929|NCT02688387|76099228|FG000|COMPLETED|Part 2, Period 4 (up to 6 Days)||0||
59982930|NCT02688387|76099229|FG001|COMPLETED|Part 2, Period 4 (up to 6 Days)||0||
59982931|NCT02688387|76099230|FG002|COMPLETED|Part 2, Period 4 (up to 6 Days)||0||
59982932|NCT02688387|76099231|FG003|COMPLETED|Part 2, Period 4 (up to 6 Days)||0||
59982933|NCT02688387|76099232|FG004|COMPLETED|Part 2, Period 4 (up to 6 Days)||0||
59982934|NCT02688387|76099233|FG005|COMPLETED|Part 2, Period 4 (up to 6 Days)||0||
59982935|NCT02688387|76099234|FG006|COMPLETED|Part 2, Period 4 (up to 6 Days)||0||
59982936|NCT02688387|76099235|FG007|COMPLETED|Part 2, Period 4 (up to 6 Days)||0||
59982937|NCT02688387|76099236|FG008|COMPLETED|Part 2, Period 4 (up to 6 Days)||0||
59982938|NCT02688387|76099237|FG009|COMPLETED|Part 2, Period 4 (up to 6 Days)||0||
59982939|NCT02688387|76099238|FG010|COMPLETED|Part 2, Period 4 (up to 6 Days)||5||
59982940|NCT02688387|76099239|FG011|COMPLETED|Part 2, Period 4 (up to 6 Days)||5||
59982941|NCT02688387|76099240|FG012|COMPLETED|Part 2, Period 4 (up to 6 Days)||5||
59982942|NCT02688387|76099241|FG013|COMPLETED|Part 2, Period 4 (up to 6 Days)||5||
59982943|NCT02688387|76099242|FG014|COMPLETED|Part 2, Period 4 (up to 6 Days)||0||
59982944|NCT02688387|76099243|FG015|COMPLETED|Part 2, Period 4 (up to 6 Days)||0||
59982945|NCT02688387|76099244|FG016|COMPLETED|Part 2, Period 4 (up to 6 Days)||0||
59982946|NCT02688387|76099245|FG017|COMPLETED|Part 2, Period 4 (up to 6 Days)||0||
59982947|NCT02688387|76099246|FG018|COMPLETED|Part 2, Period 4 (up to 6 Days)||0||
59982948|NCT02688387|76099247|FG019|COMPLETED|Part 2, Period 4 (up to 6 Days)||0||
59982949|NCT02688387|76099248|FG020|COMPLETED|Part 2, Period 4 (up to 6 Days)||0||
59982950|NCT02688387|76099249|FG021|COMPLETED|Part 2, Period 4 (up to 6 Days)||0||
59982951|NCT02688387|76099228|FG000|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0||
59982952|NCT02688387|76099229|FG001|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0||
59982953|NCT02688387|76099230|FG002|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0||
59982954|NCT02688387|76099231|FG003|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0||
60074838|NCT01930045|76190108|FG005|NOT COMPLETED|Part 1 - Period 3||0||
60074839|NCT01930045|76190103|FG000|STARTED|Pause (up to 37 Days)||3||
60074840|NCT01930045|76190104|FG001|STARTED|Pause (up to 37 Days)||3||
60103605|NCT01291108|76221868|FG005|STARTED|Month 1 (Monotherapy)||0||
59982955|NCT02688387|76099232|FG004|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0||
59982956|NCT02688387|76099233|FG005|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0||
59982957|NCT02688387|76099234|FG006|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0||
59982958|NCT02688387|76099235|FG007|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0||
59982959|NCT02688387|76099236|FG008|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0||
59982960|NCT02688387|76099237|FG009|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0||
59982961|NCT02688387|76099238|FG010|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0||
59982962|NCT02688387|76099239|FG011|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0||
59982963|NCT02688387|76099240|FG012|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0||
59982964|NCT02688387|76099241|FG013|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0||
59982965|NCT02688387|76099242|FG014|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0||
59982966|NCT02688387|76099243|FG015|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0||
59982967|NCT02688387|76099244|FG016|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0||
59982968|NCT02688387|76099245|FG017|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0||
59982969|NCT02688387|76099246|FG018|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0||
59982970|NCT02688387|76099247|FG019|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0||
59982971|NCT02688387|76099248|FG020|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0||
59982972|NCT02688387|76099249|FG021|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0||
59982973|NCT02688387|76099228|FG000|STARTED|Part 3A, Period 1 (up to 6 Days)||0||
59982974|NCT02688387|76099229|FG001|STARTED|Part 3A, Period 1 (up to 6 Days)||0||
59982975|NCT02688387|76099230|FG002|STARTED|Part 3A, Period 1 (up to 6 Days)||0||
59982976|NCT02688387|76099231|FG003|STARTED|Part 3A, Period 1 (up to 6 Days)||0||
59982977|NCT02688387|76099232|FG004|STARTED|Part 3A, Period 1 (up to 6 Days)||0||
59982978|NCT02688387|76099233|FG005|STARTED|Part 3A, Period 1 (up to 6 Days)||0||
59982979|NCT02688387|76099234|FG006|STARTED|Part 3A, Period 1 (up to 6 Days)||0||
59982980|NCT02688387|76099235|FG007|STARTED|Part 3A, Period 1 (up to 6 Days)||0||
59982981|NCT02688387|76099236|FG008|STARTED|Part 3A, Period 1 (up to 6 Days)||0||
59982982|NCT02688387|76099237|FG009|STARTED|Part 3A, Period 1 (up to 6 Days)||0||
59982983|NCT02688387|76099238|FG010|STARTED|Part 3A, Period 1 (up to 6 Days)||0||
59982984|NCT02688387|76099239|FG011|STARTED|Part 3A, Period 1 (up to 6 Days)||0||
59982985|NCT02688387|76099240|FG012|STARTED|Part 3A, Period 1 (up to 6 Days)||0||
59982986|NCT02688387|76099241|FG013|STARTED|Part 3A, Period 1 (up to 6 Days)||0||
59982987|NCT02688387|76099242|FG014|STARTED|Part 3A, Period 1 (up to 6 Days)||9||
59982988|NCT02688387|76099243|FG015|STARTED|Part 3A, Period 1 (up to 6 Days)||8||
59982989|NCT02688387|76099244|FG016|STARTED|Part 3A, Period 1 (up to 6 Days)||8||
59982990|NCT02688387|76099245|FG017|STARTED|Part 3A, Period 1 (up to 6 Days)||8||
59982991|NCT02688387|76099246|FG018|STARTED|Part 3A, Period 1 (up to 6 Days)||0||
59982992|NCT02688387|76099247|FG019|STARTED|Part 3A, Period 1 (up to 6 Days)||0||
59982993|NCT02688387|76099248|FG020|STARTED|Part 3A, Period 1 (up to 6 Days)||0||
59982994|NCT02688387|76099249|FG021|STARTED|Part 3A, Period 1 (up to 6 Days)||0||
59982995|NCT02688387|76099228|FG000|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0||
59982996|NCT02688387|76099229|FG001|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0||
59982997|NCT02688387|76099230|FG002|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0||
59982998|NCT02688387|76099231|FG003|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0||
59982999|NCT02688387|76099232|FG004|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0||
59983000|NCT02688387|76099233|FG005|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0||
59983001|NCT02688387|76099234|FG006|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0||
59983002|NCT02688387|76099235|FG007|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0||
59983003|NCT02688387|76099236|FG008|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0||
59983004|NCT02688387|76099237|FG009|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0||
59983005|NCT02688387|76099238|FG010|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0||
59983006|NCT02688387|76099239|FG011|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0||
59983007|NCT02688387|76099240|FG012|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0||
59983008|NCT02688387|76099241|FG013|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0||
59983009|NCT02688387|76099242|FG014|COMPLETED|Part 3A, Period 1 (up to 6 Days)||8||
59983010|NCT02688387|76099243|FG015|COMPLETED|Part 3A, Period 1 (up to 6 Days)||8||
59983011|NCT02688387|76099244|FG016|COMPLETED|Part 3A, Period 1 (up to 6 Days)||8||
59983012|NCT02688387|76099245|FG017|COMPLETED|Part 3A, Period 1 (up to 6 Days)||8||
59983013|NCT02688387|76099246|FG018|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0||
59983014|NCT02688387|76099247|FG019|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0||
59983015|NCT02688387|76099248|FG020|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0||
59983016|NCT02688387|76099249|FG021|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0||
59983017|NCT02688387|76099228|FG000|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0||
59983018|NCT02688387|76099229|FG001|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0||
59983019|NCT02688387|76099230|FG002|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0||
59983020|NCT02688387|76099231|FG003|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0||
59983021|NCT02688387|76099232|FG004|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0||
59983022|NCT02688387|76099233|FG005|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0||
59983023|NCT02688387|76099234|FG006|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0||
60074841|NCT01930045|76190105|FG002|STARTED|Pause (up to 37 Days)|The participant who missed treatment in Period 3, resumed the study|3||
60074842|NCT01930045|76190106|FG003|STARTED|Pause (up to 37 Days)||3||
59983024|NCT02688387|76099235|FG007|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0||
59983025|NCT02688387|76099236|FG008|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0||
59983026|NCT02688387|76099237|FG009|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0||
59983027|NCT02688387|76099238|FG010|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0||
59983028|NCT02688387|76099239|FG011|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0||
59983029|NCT02688387|76099240|FG012|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0||
59983030|NCT02688387|76099241|FG013|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0||
59983031|NCT02688387|76099242|FG014|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||1||
59983032|NCT02688387|76099243|FG015|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0||
59983033|NCT02688387|76099244|FG016|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0||
59983034|NCT02688387|76099245|FG017|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0||
59983035|NCT02688387|76099246|FG018|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0||
59983036|NCT02688387|76099247|FG019|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0||
59983037|NCT02688387|76099248|FG020|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0||
59983038|NCT02688387|76099249|FG021|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0||
59983039|NCT02688387|76099228|FG000|STARTED|Part 3A, Washout Period 1 (10 Days)||0||
59983040|NCT02688387|76099229|FG001|STARTED|Part 3A, Washout Period 1 (10 Days)||0||
59983041|NCT02688387|76099230|FG002|STARTED|Part 3A, Washout Period 1 (10 Days)||0||
59983042|NCT02688387|76099231|FG003|STARTED|Part 3A, Washout Period 1 (10 Days)||0||
59983043|NCT02688387|76099232|FG004|STARTED|Part 3A, Washout Period 1 (10 Days)||0||
59983044|NCT02688387|76099233|FG005|STARTED|Part 3A, Washout Period 1 (10 Days)||0||
59983045|NCT02688387|76099234|FG006|STARTED|Part 3A, Washout Period 1 (10 Days)||0||
59983046|NCT02688387|76099235|FG007|STARTED|Part 3A, Washout Period 1 (10 Days)||0||
59983047|NCT02688387|76099236|FG008|STARTED|Part 3A, Washout Period 1 (10 Days)||0||
59983048|NCT02688387|76099237|FG009|STARTED|Part 3A, Washout Period 1 (10 Days)||0||
59983049|NCT02688387|76099238|FG010|STARTED|Part 3A, Washout Period 1 (10 Days)||0||
59983050|NCT02688387|76099239|FG011|STARTED|Part 3A, Washout Period 1 (10 Days)||0||
59983051|NCT02688387|76099240|FG012|STARTED|Part 3A, Washout Period 1 (10 Days)||0||
59983052|NCT02688387|76099241|FG013|STARTED|Part 3A, Washout Period 1 (10 Days)||0||
59983053|NCT02688387|76099242|FG014|STARTED|Part 3A, Washout Period 1 (10 Days)||8||
59983054|NCT02688387|76099243|FG015|STARTED|Part 3A, Washout Period 1 (10 Days)||8||
59983055|NCT02688387|76099244|FG016|STARTED|Part 3A, Washout Period 1 (10 Days)||8||
59983056|NCT02688387|76099245|FG017|STARTED|Part 3A, Washout Period 1 (10 Days)||8||
59983057|NCT02688387|76099246|FG018|STARTED|Part 3A, Washout Period 1 (10 Days)||0||
59983058|NCT02688387|76099247|FG019|STARTED|Part 3A, Washout Period 1 (10 Days)||0||
59983059|NCT02688387|76099248|FG020|STARTED|Part 3A, Washout Period 1 (10 Days)||0||
59983060|NCT02688387|76099249|FG021|STARTED|Part 3A, Washout Period 1 (10 Days)||0||
59983061|NCT02688387|76099228|FG000|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0||
59983062|NCT02688387|76099229|FG001|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0||
59983063|NCT02688387|76099230|FG002|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0||
59983064|NCT02688387|76099231|FG003|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0||
59983065|NCT02688387|76099232|FG004|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0||
59983066|NCT02688387|76099233|FG005|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0||
59983067|NCT02688387|76099234|FG006|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0||
59983068|NCT02688387|76099235|FG007|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0||
59983069|NCT02688387|76099236|FG008|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0||
59983070|NCT02688387|76099237|FG009|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0||
59983071|NCT02688387|76099238|FG010|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0||
59983072|NCT02688387|76099239|FG011|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0||
59983073|NCT02688387|76099240|FG012|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0||
59983074|NCT02688387|76099241|FG013|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0||
59983075|NCT02688387|76099242|FG014|COMPLETED|Part 3A, Washout Period 1 (10 Days)||8||
59983076|NCT02688387|76099243|FG015|COMPLETED|Part 3A, Washout Period 1 (10 Days)||8||
59983077|NCT02688387|76099244|FG016|COMPLETED|Part 3A, Washout Period 1 (10 Days)||8||
59983078|NCT02688387|76099245|FG017|COMPLETED|Part 3A, Washout Period 1 (10 Days)||8||
59983079|NCT02688387|76099246|FG018|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0||
59983080|NCT02688387|76099247|FG019|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0||
59983081|NCT02688387|76099248|FG020|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0||
59983082|NCT02688387|76099249|FG021|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0||
59983083|NCT02688387|76099228|FG000|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0||
59983084|NCT02688387|76099229|FG001|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0||
59983085|NCT02688387|76099230|FG002|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0||
59983086|NCT02688387|76099231|FG003|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0||
59983087|NCT02688387|76099232|FG004|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0||
59983088|NCT02688387|76099233|FG005|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0||
59983089|NCT02688387|76099234|FG006|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0||
59983090|NCT02688387|76099235|FG007|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0||
59983091|NCT02688387|76099236|FG008|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0||
59983092|NCT02688387|76099237|FG009|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0||
59983093|NCT02688387|76099238|FG010|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0||
59983094|NCT02688387|76099239|FG011|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0||
59983095|NCT02688387|76099240|FG012|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0||
59983096|NCT02688387|76099241|FG013|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0||
59983097|NCT02688387|76099242|FG014|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0||
59983098|NCT02688387|76099243|FG015|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0||
59983099|NCT02688387|76099244|FG016|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0||
59983100|NCT02688387|76099245|FG017|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0||
59983101|NCT02688387|76099246|FG018|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0||
59983102|NCT02688387|76099247|FG019|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0||
59983103|NCT02688387|76099248|FG020|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0||
59983104|NCT02688387|76099249|FG021|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0||
59983105|NCT02688387|76099228|FG000|STARTED|Part 3A, Period 2 (up to 6 Days)||0||
59983106|NCT02688387|76099229|FG001|STARTED|Part 3A, Period 2 (up to 6 Days)||0||
59983107|NCT02688387|76099230|FG002|STARTED|Part 3A, Period 2 (up to 6 Days)||0||
59983108|NCT02688387|76099231|FG003|STARTED|Part 3A, Period 2 (up to 6 Days)||0||
59983109|NCT02688387|76099232|FG004|STARTED|Part 3A, Period 2 (up to 6 Days)||0||
59983110|NCT02688387|76099233|FG005|STARTED|Part 3A, Period 2 (up to 6 Days)||0||
59983111|NCT02688387|76099234|FG006|STARTED|Part 3A, Period 2 (up to 6 Days)||0||
59983112|NCT02688387|76099235|FG007|STARTED|Part 3A, Period 2 (up to 6 Days)||0||
59983113|NCT02688387|76099236|FG008|STARTED|Part 3A, Period 2 (up to 6 Days)||0||
59983114|NCT02688387|76099237|FG009|STARTED|Part 3A, Period 2 (up to 6 Days)||0||
59983115|NCT02688387|76099238|FG010|STARTED|Part 3A, Period 2 (up to 6 Days)||0||
59983116|NCT02688387|76099239|FG011|STARTED|Part 3A, Period 2 (up to 6 Days)||0||
59983117|NCT02688387|76099240|FG012|STARTED|Part 3A, Period 2 (up to 6 Days)||0||
59983118|NCT02688387|76099241|FG013|STARTED|Part 3A, Period 2 (up to 6 Days)||0||
59983119|NCT02688387|76099242|FG014|STARTED|Part 3A, Period 2 (up to 6 Days)||8||
59983120|NCT02688387|76099243|FG015|STARTED|Part 3A, Period 2 (up to 6 Days)||8||
59983121|NCT02688387|76099244|FG016|STARTED|Part 3A, Period 2 (up to 6 Days)||8||
59983122|NCT02688387|76099245|FG017|STARTED|Part 3A, Period 2 (up to 6 Days)||8||
59983123|NCT02688387|76099246|FG018|STARTED|Part 3A, Period 2 (up to 6 Days)||0||
59983124|NCT02688387|76099247|FG019|STARTED|Part 3A, Period 2 (up to 6 Days)||0||
59983125|NCT02688387|76099248|FG020|STARTED|Part 3A, Period 2 (up to 6 Days)||0||
59983126|NCT02688387|76099249|FG021|STARTED|Part 3A, Period 2 (up to 6 Days)||0||
59983127|NCT02688387|76099228|FG000|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0||
59983128|NCT02688387|76099229|FG001|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0||
59983129|NCT02688387|76099230|FG002|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0||
59983130|NCT02688387|76099231|FG003|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0||
59983131|NCT02688387|76099232|FG004|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0||
59983132|NCT02688387|76099233|FG005|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0||
59983133|NCT02688387|76099234|FG006|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0||
59983134|NCT02688387|76099235|FG007|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0||
59983135|NCT02688387|76099236|FG008|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0||
59983136|NCT02688387|76099237|FG009|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0||
59983137|NCT02688387|76099238|FG010|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0||
59983138|NCT02688387|76099239|FG011|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0||
59983139|NCT02688387|76099240|FG012|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0||
59983140|NCT02688387|76099241|FG013|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0||
59983141|NCT02688387|76099242|FG014|COMPLETED|Part 3A, Period 2 (up to 6 Days)||8||
59983142|NCT02688387|76099243|FG015|COMPLETED|Part 3A, Period 2 (up to 6 Days)||8||
59983143|NCT02688387|76099244|FG016|COMPLETED|Part 3A, Period 2 (up to 6 Days)||8||
59983144|NCT02688387|76099245|FG017|COMPLETED|Part 3A, Period 2 (up to 6 Days)||8||
59983145|NCT02688387|76099246|FG018|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0||
59983146|NCT02688387|76099247|FG019|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0||
59983147|NCT02688387|76099248|FG020|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0||
59983148|NCT02688387|76099249|FG021|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0||
59983149|NCT02688387|76099228|FG000|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0||
59983150|NCT02688387|76099229|FG001|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0||
59983151|NCT02688387|76099230|FG002|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0||
59983152|NCT02688387|76099231|FG003|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0||
59983153|NCT02688387|76099232|FG004|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0||
59983154|NCT02688387|76099233|FG005|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0||
59983155|NCT02688387|76099234|FG006|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0||
59983156|NCT02688387|76099235|FG007|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0||
59983157|NCT02688387|76099236|FG008|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0||
59983158|NCT02688387|76099237|FG009|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0||
59983159|NCT02688387|76099238|FG010|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0||
59983160|NCT02688387|76099239|FG011|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0||
59983161|NCT02688387|76099240|FG012|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0||
59983162|NCT02688387|76099241|FG013|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0||
59983163|NCT02688387|76099242|FG014|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0||
59983164|NCT02688387|76099243|FG015|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0||
59995409|NCT03016975|76111237|FG001|COMPLETED|At 3 Year Follow-up||0||
59983165|NCT02688387|76099244|FG016|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0||
59983166|NCT02688387|76099245|FG017|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0||
59983167|NCT02688387|76099246|FG018|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0||
59983168|NCT02688387|76099247|FG019|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0||
59983169|NCT02688387|76099248|FG020|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0||
59983170|NCT02688387|76099249|FG021|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0||
59983171|NCT02688387|76099228|FG000|STARTED|Part 3A, Washout Period 2 (10 Days)||0||
59983172|NCT02688387|76099229|FG001|STARTED|Part 3A, Washout Period 2 (10 Days)||0||
59983173|NCT02688387|76099230|FG002|STARTED|Part 3A, Washout Period 2 (10 Days)||0||
59983174|NCT02688387|76099231|FG003|STARTED|Part 3A, Washout Period 2 (10 Days)||0||
59983175|NCT02688387|76099232|FG004|STARTED|Part 3A, Washout Period 2 (10 Days)||0||
59983176|NCT02688387|76099233|FG005|STARTED|Part 3A, Washout Period 2 (10 Days)||0||
59983177|NCT02688387|76099234|FG006|STARTED|Part 3A, Washout Period 2 (10 Days)||0||
59983178|NCT02688387|76099235|FG007|STARTED|Part 3A, Washout Period 2 (10 Days)||0||
59983179|NCT02688387|76099236|FG008|STARTED|Part 3A, Washout Period 2 (10 Days)||0||
59622566|NCT00535782|75734430|FG000|Treated With Placebo + MTX|Part 1: 24-Week Double-blind Period||0||
59622567|NCT00535782|75734431|FG001|Treated With Placebo + MTX|Part 1: 24-Week Double-blind Period||62||
59622568|NCT00535782|75734432|FG002|Treated With Placebo + MTX|Part 1: 24-Week Double-blind Period||0||
59622569|NCT00535782|75734430|FG000|COMPLETED|Part 1: 24-Week Double-blind Period||65||
59622570|NCT00535782|75734431|FG001|COMPLETED|Part 1: 24-Week Double-blind Period||59||
59622571|NCT00535782|75734432|FG002|COMPLETED|Part 1: 24-Week Double-blind Period||0||
59622572|NCT00535782|75734430|FG000|NOT COMPLETED|Part 1: 24-Week Double-blind Period||4||
59622573|NCT00535782|75734431|FG001|NOT COMPLETED|Part 1: 24-Week Double-blind Period||4||
59622574|NCT00535782|75734432|FG002|NOT COMPLETED|Part 1: 24-Week Double-blind Period||0||
59622575|NCT00535782|75734430|FG000|STARTED|Part 2: 80-Week Open-label Period||0||
59622576|NCT00535782|75734431|FG001|STARTED|Part 2: 80-Week Open-label Period||0||
59622577|NCT00535782|75734432|FG002|STARTED|Part 2: 80-Week Open-label Period||124||
59622578|NCT00535782|75734430|FG000|COMPLETED|Part 2: 80-Week Open-label Period||0||
59622579|NCT00535782|75734431|FG001|COMPLETED|Part 2: 80-Week Open-label Period||0||
59622580|NCT00535782|75734432|FG002|COMPLETED|Part 2: 80-Week Open-label Period||98||
59622581|NCT00535782|75734430|FG000|NOT COMPLETED|Part 2: 80-Week Open-label Period||0||
59622582|NCT00535782|75734431|FG001|NOT COMPLETED|Part 2: 80-Week Open-label Period||0||
59622583|NCT00535782|75734432|FG002|NOT COMPLETED|Part 2: 80-Week Open-label Period||26||
59622584|NCT00431184|75734441|FG000|STARTED|1st Intervention (Day 1)||10||
59622585|NCT00431184|75734442|FG001|STARTED|1st Intervention (Day 1)||9||
59622586|NCT00431184|75734441|FG000|COMPLETED|1st Intervention (Day 1)||10||
59622587|NCT00431184|75734442|FG001|COMPLETED|1st Intervention (Day 1)||9||
59622588|NCT00431184|75734441|FG000|NOT COMPLETED|1st Intervention (Day 1)||0||
59622589|NCT00431184|75734442|FG001|NOT COMPLETED|1st Intervention (Day 1)||0||
59622590|NCT00431184|75734441|FG000|STARTED|Second Intervention (Day 2)||10||
59622591|NCT00431184|75734442|FG001|STARTED|Second Intervention (Day 2)||9||
59814938|NCT00573443|75937357|FG000|COMPLETED|Open-Label Extension Phase||235||
59983180|NCT02688387|76099237|FG009|STARTED|Part 3A, Washout Period 2 (10 Days)||0||
59983181|NCT02688387|76099238|FG010|STARTED|Part 3A, Washout Period 2 (10 Days)||0||
59983182|NCT02688387|76099239|FG011|STARTED|Part 3A, Washout Period 2 (10 Days)||0||
59983183|NCT02688387|76099240|FG012|STARTED|Part 3A, Washout Period 2 (10 Days)||0||
59983184|NCT02688387|76099241|FG013|STARTED|Part 3A, Washout Period 2 (10 Days)||0||
59983185|NCT02688387|76099242|FG014|STARTED|Part 3A, Washout Period 2 (10 Days)||8||
59983186|NCT02688387|76099243|FG015|STARTED|Part 3A, Washout Period 2 (10 Days)||8||
59983187|NCT02688387|76099244|FG016|STARTED|Part 3A, Washout Period 2 (10 Days)||8||
59983188|NCT02688387|76099245|FG017|STARTED|Part 3A, Washout Period 2 (10 Days)||8||
59983189|NCT02688387|76099246|FG018|STARTED|Part 3A, Washout Period 2 (10 Days)||0||
59983190|NCT02688387|76099247|FG019|STARTED|Part 3A, Washout Period 2 (10 Days)||0||
59983191|NCT02688387|76099248|FG020|STARTED|Part 3A, Washout Period 2 (10 Days)||0||
59983192|NCT02688387|76099249|FG021|STARTED|Part 3A, Washout Period 2 (10 Days)||0||
59983193|NCT02688387|76099228|FG000|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0||
59983194|NCT02688387|76099229|FG001|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0||
59983195|NCT02688387|76099230|FG002|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0||
59983196|NCT02688387|76099231|FG003|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0||
59983197|NCT02688387|76099232|FG004|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0||
59983198|NCT02688387|76099233|FG005|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0||
59983199|NCT02688387|76099234|FG006|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0||
59983200|NCT02688387|76099235|FG007|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0||
59983201|NCT02688387|76099236|FG008|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0||
59983202|NCT02688387|76099237|FG009|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0||
59983203|NCT02688387|76099238|FG010|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0||
59983204|NCT02688387|76099239|FG011|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0||
59983205|NCT02688387|76099240|FG012|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0||
59983206|NCT02688387|76099241|FG013|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0||
59983207|NCT02688387|76099242|FG014|COMPLETED|Part 3A, Washout Period 2 (10 Days)||8||
59995410|NCT03016975|76111238|FG002|COMPLETED|At 3 Year Follow-up||0||
59983208|NCT02688387|76099243|FG015|COMPLETED|Part 3A, Washout Period 2 (10 Days)||8||
59983209|NCT02688387|76099244|FG016|COMPLETED|Part 3A, Washout Period 2 (10 Days)||8||
59983210|NCT02688387|76099245|FG017|COMPLETED|Part 3A, Washout Period 2 (10 Days)||8||
59983211|NCT02688387|76099246|FG018|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0||
59983212|NCT02688387|76099247|FG019|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0||
59622592|NCT00431184|75734441|FG000|COMPLETED|Second Intervention (Day 2)||10||
59622593|NCT00431184|75734442|FG001|COMPLETED|Second Intervention (Day 2)||9||
59622594|NCT00431184|75734441|FG000|NOT COMPLETED|Second Intervention (Day 2)||0||
59622595|NCT00431184|75734442|FG001|NOT COMPLETED|Second Intervention (Day 2)||0||
59622596|NCT00433992|75734452|FG000|STARTED|Overall Study||28||
59622597|NCT00433992|75734453|FG001|STARTED|Overall Study||28||
59983213|NCT02688387|76099248|FG020|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0||
59983214|NCT02688387|76099249|FG021|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0||
59983215|NCT02688387|76099228|FG000|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0||
59983216|NCT02688387|76099229|FG001|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0||
59983217|NCT02688387|76099230|FG002|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0||
59983218|NCT02688387|76099231|FG003|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0||
59983219|NCT02688387|76099232|FG004|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0||
59983220|NCT02688387|76099233|FG005|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0||
59983221|NCT02688387|76099234|FG006|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0||
59983222|NCT02688387|76099235|FG007|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0||
59983223|NCT02688387|76099236|FG008|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0||
59983224|NCT02688387|76099237|FG009|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0||
59983225|NCT02688387|76099238|FG010|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0||
59983226|NCT02688387|76099239|FG011|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0||
59983227|NCT02688387|76099240|FG012|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0||
59983228|NCT02688387|76099241|FG013|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0||
59983229|NCT02688387|76099242|FG014|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0||
59983230|NCT02688387|76099243|FG015|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0||
59983231|NCT02688387|76099244|FG016|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0||
59983232|NCT02688387|76099245|FG017|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0||
59983233|NCT02688387|76099246|FG018|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0||
59983234|NCT02688387|76099247|FG019|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0||
59983235|NCT02688387|76099248|FG020|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0||
59983236|NCT02688387|76099249|FG021|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0||
59983237|NCT02688387|76099228|FG000|STARTED|Part 3A, Period 3 (up to 6 Days)||0||
59983238|NCT02688387|76099229|FG001|STARTED|Part 3A, Period 3 (up to 6 Days)||0||
59983239|NCT02688387|76099230|FG002|STARTED|Part 3A, Period 3 (up to 6 Days)||0||
59983240|NCT02688387|76099231|FG003|STARTED|Part 3A, Period 3 (up to 6 Days)||0||
59983241|NCT02688387|76099232|FG004|STARTED|Part 3A, Period 3 (up to 6 Days)||0||
59983242|NCT02688387|76099233|FG005|STARTED|Part 3A, Period 3 (up to 6 Days)||0||
59983243|NCT02688387|76099234|FG006|STARTED|Part 3A, Period 3 (up to 6 Days)||0||
59983244|NCT02688387|76099235|FG007|STARTED|Part 3A, Period 3 (up to 6 Days)||0||
59983245|NCT02688387|76099236|FG008|STARTED|Part 3A, Period 3 (up to 6 Days)||0||
59983246|NCT02688387|76099237|FG009|STARTED|Part 3A, Period 3 (up to 6 Days)||0||
59983247|NCT02688387|76099238|FG010|STARTED|Part 3A, Period 3 (up to 6 Days)||0||
59983248|NCT02688387|76099239|FG011|STARTED|Part 3A, Period 3 (up to 6 Days)||0||
59983249|NCT02688387|76099240|FG012|STARTED|Part 3A, Period 3 (up to 6 Days)||0||
59983250|NCT02688387|76099241|FG013|STARTED|Part 3A, Period 3 (up to 6 Days)||0||
59983251|NCT02688387|76099242|FG014|STARTED|Part 3A, Period 3 (up to 6 Days)||8||
59983252|NCT02688387|76099243|FG015|STARTED|Part 3A, Period 3 (up to 6 Days)||8||
59983253|NCT02688387|76099244|FG016|STARTED|Part 3A, Period 3 (up to 6 Days)||8||
59983254|NCT02688387|76099245|FG017|STARTED|Part 3A, Period 3 (up to 6 Days)||8||
59983255|NCT02688387|76099246|FG018|STARTED|Part 3A, Period 3 (up to 6 Days)||0||
59983256|NCT02688387|76099247|FG019|STARTED|Part 3A, Period 3 (up to 6 Days)||0||
59983257|NCT02688387|76099248|FG020|STARTED|Part 3A, Period 3 (up to 6 Days)||0||
59983258|NCT02688387|76099249|FG021|STARTED|Part 3A, Period 3 (up to 6 Days)||0||
59983259|NCT02688387|76099228|FG000|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0||
59983260|NCT02688387|76099229|FG001|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0||
59983261|NCT02688387|76099230|FG002|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0||
59983262|NCT02688387|76099231|FG003|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0||
59983263|NCT02688387|76099232|FG004|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0||
59983264|NCT02688387|76099233|FG005|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0||
59983265|NCT02688387|76099234|FG006|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0||
59983266|NCT02688387|76099235|FG007|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0||
59983267|NCT02688387|76099236|FG008|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0||
59983268|NCT02688387|76099237|FG009|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0||
59983269|NCT02688387|76099238|FG010|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0||
59983270|NCT02688387|76099239|FG011|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0||
59622598|NCT00433992|75734452|FG000|COMPLETED|Overall Study||19||
59817890|NCT04488770|75940329|FG003|COMPLETED|Part 1-Cohort 2: Period 1 (Up to 5 Days)||0||
59622599|NCT00433992|75734453|FG001|COMPLETED|Overall Study||20||
59983271|NCT02688387|76099240|FG012|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0||
59983272|NCT02688387|76099241|FG013|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0||
59983273|NCT02688387|76099242|FG014|COMPLETED|Part 3A, Period 3 (up to 6 Days)||8||
59983274|NCT02688387|76099243|FG015|COMPLETED|Part 3A, Period 3 (up to 6 Days)||8||
59983275|NCT02688387|76099244|FG016|COMPLETED|Part 3A, Period 3 (up to 6 Days)||8||
59983276|NCT02688387|76099245|FG017|COMPLETED|Part 3A, Period 3 (up to 6 Days)||8||
59983277|NCT02688387|76099246|FG018|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0||
59983278|NCT02688387|76099247|FG019|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0||
59983279|NCT02688387|76099248|FG020|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0||
59983280|NCT02688387|76099249|FG021|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0||
59983281|NCT02688387|76099228|FG000|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0||
59983282|NCT02688387|76099229|FG001|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0||
59983283|NCT02688387|76099230|FG002|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0||
59983284|NCT02688387|76099231|FG003|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0||
59983285|NCT02688387|76099232|FG004|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0||
59983286|NCT02688387|76099233|FG005|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0||
59983287|NCT02688387|76099234|FG006|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0||
59983288|NCT02688387|76099235|FG007|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0||
59983289|NCT02688387|76099236|FG008|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0||
59983290|NCT02688387|76099237|FG009|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0||
59983291|NCT02688387|76099238|FG010|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0||
59983292|NCT02688387|76099239|FG011|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0||
59983293|NCT02688387|76099240|FG012|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0||
59983294|NCT02688387|76099241|FG013|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0||
59983295|NCT02688387|76099242|FG014|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0||
59983296|NCT02688387|76099243|FG015|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0||
59983297|NCT02688387|76099244|FG016|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0||
59983298|NCT02688387|76099245|FG017|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0||
59983299|NCT02688387|76099246|FG018|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0||
59983300|NCT02688387|76099247|FG019|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0||
59983301|NCT02688387|76099248|FG020|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0||
59983302|NCT02688387|76099249|FG021|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0||
59983303|NCT02688387|76099228|FG000|STARTED|Part 3A, Washout Period 3 (10 Days)||0||
59983304|NCT02688387|76099229|FG001|STARTED|Part 3A, Washout Period 3 (10 Days)||0||
59983305|NCT02688387|76099230|FG002|STARTED|Part 3A, Washout Period 3 (10 Days)||0||
59983306|NCT02688387|76099231|FG003|STARTED|Part 3A, Washout Period 3 (10 Days)||0||
59983307|NCT02688387|76099232|FG004|STARTED|Part 3A, Washout Period 3 (10 Days)||0||
59983308|NCT02688387|76099233|FG005|STARTED|Part 3A, Washout Period 3 (10 Days)||0||
59983309|NCT02688387|76099234|FG006|STARTED|Part 3A, Washout Period 3 (10 Days)||0||
59983310|NCT02688387|76099235|FG007|STARTED|Part 3A, Washout Period 3 (10 Days)||0||
59983311|NCT02688387|76099236|FG008|STARTED|Part 3A, Washout Period 3 (10 Days)||0||
59983312|NCT02688387|76099237|FG009|STARTED|Part 3A, Washout Period 3 (10 Days)||0||
59983313|NCT02688387|76099238|FG010|STARTED|Part 3A, Washout Period 3 (10 Days)||0||
59983314|NCT02688387|76099239|FG011|STARTED|Part 3A, Washout Period 3 (10 Days)||0||
59983315|NCT02688387|76099240|FG012|STARTED|Part 3A, Washout Period 3 (10 Days)||0||
59983316|NCT02688387|76099241|FG013|STARTED|Part 3A, Washout Period 3 (10 Days)||0||
59983317|NCT02688387|76099242|FG014|STARTED|Part 3A, Washout Period 3 (10 Days)||8||
59983318|NCT02688387|76099243|FG015|STARTED|Part 3A, Washout Period 3 (10 Days)||8||
59983319|NCT02688387|76099244|FG016|STARTED|Part 3A, Washout Period 3 (10 Days)||8||
59983320|NCT02688387|76099245|FG017|STARTED|Part 3A, Washout Period 3 (10 Days)||8||
59983321|NCT02688387|76099246|FG018|STARTED|Part 3A, Washout Period 3 (10 Days)||0||
59983322|NCT02688387|76099247|FG019|STARTED|Part 3A, Washout Period 3 (10 Days)||0||
59983323|NCT02688387|76099248|FG020|STARTED|Part 3A, Washout Period 3 (10 Days)||0||
59983324|NCT02688387|76099249|FG021|STARTED|Part 3A, Washout Period 3 (10 Days)||0||
59983325|NCT02688387|76099228|FG000|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0||
59983326|NCT02688387|76099229|FG001|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0||
59983327|NCT02688387|76099230|FG002|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0||
59983328|NCT02688387|76099231|FG003|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0||
59983329|NCT02688387|76099232|FG004|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0||
59983330|NCT02688387|76099233|FG005|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0||
59983331|NCT02688387|76099234|FG006|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0||
59983332|NCT02688387|76099235|FG007|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0||
59983333|NCT02688387|76099236|FG008|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0||
59983334|NCT02688387|76099237|FG009|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0||
59983335|NCT02688387|76099238|FG010|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0||
59983336|NCT02688387|76099239|FG011|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0||
59983337|NCT02688387|76099240|FG012|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0||
59983338|NCT02688387|76099241|FG013|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0||
59983339|NCT02688387|76099242|FG014|COMPLETED|Part 3A, Washout Period 3 (10 Days)||8||
59983340|NCT02688387|76099243|FG015|COMPLETED|Part 3A, Washout Period 3 (10 Days)||8||
59983341|NCT02688387|76099244|FG016|COMPLETED|Part 3A, Washout Period 3 (10 Days)||8||
59983342|NCT02688387|76099245|FG017|COMPLETED|Part 3A, Washout Period 3 (10 Days)||8||
59983343|NCT02688387|76099246|FG018|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0||
59983344|NCT02688387|76099247|FG019|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0||
59983345|NCT02688387|76099248|FG020|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0||
59983346|NCT02688387|76099249|FG021|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0||
59983347|NCT02688387|76099228|FG000|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0||
59983348|NCT02688387|76099229|FG001|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0||
59983349|NCT02688387|76099230|FG002|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0||
59983350|NCT02688387|76099231|FG003|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0||
59983351|NCT02688387|76099232|FG004|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0||
59983352|NCT02688387|76099233|FG005|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0||
59983353|NCT02688387|76099234|FG006|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0||
59983354|NCT02688387|76099235|FG007|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0||
59983355|NCT02688387|76099236|FG008|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0||
59983356|NCT02688387|76099237|FG009|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0||
59983357|NCT02688387|76099238|FG010|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0||
59983358|NCT02688387|76099239|FG011|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0||
59983359|NCT02688387|76099240|FG012|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0||
59983360|NCT02688387|76099241|FG013|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0||
59983361|NCT02688387|76099242|FG014|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0||
59983362|NCT02688387|76099243|FG015|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0||
59983363|NCT02688387|76099244|FG016|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0||
59983364|NCT02688387|76099245|FG017|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0||
59983365|NCT02688387|76099246|FG018|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0||
59983366|NCT02688387|76099247|FG019|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0||
59983367|NCT02688387|76099248|FG020|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0||
59983368|NCT02688387|76099249|FG021|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0||
59983369|NCT02688387|76099228|FG000|STARTED|Part 3A, Period 4 (up to 6 Days)||0||
59983370|NCT02688387|76099229|FG001|STARTED|Part 3A, Period 4 (up to 6 Days)||0||
59983371|NCT02688387|76099230|FG002|STARTED|Part 3A, Period 4 (up to 6 Days)||0||
59983372|NCT02688387|76099231|FG003|STARTED|Part 3A, Period 4 (up to 6 Days)||0||
59983373|NCT02688387|76099232|FG004|STARTED|Part 3A, Period 4 (up to 6 Days)||0||
59983374|NCT02688387|76099233|FG005|STARTED|Part 3A, Period 4 (up to 6 Days)||0||
59983375|NCT02688387|76099234|FG006|STARTED|Part 3A, Period 4 (up to 6 Days)||0||
59983376|NCT02688387|76099235|FG007|STARTED|Part 3A, Period 4 (up to 6 Days)||0||
59983377|NCT02688387|76099236|FG008|STARTED|Part 3A, Period 4 (up to 6 Days)||0||
59983378|NCT02688387|76099237|FG009|STARTED|Part 3A, Period 4 (up to 6 Days)||0||
59983379|NCT02688387|76099238|FG010|STARTED|Part 3A, Period 4 (up to 6 Days)||0||
59983380|NCT02688387|76099239|FG011|STARTED|Part 3A, Period 4 (up to 6 Days)||0||
59983381|NCT02688387|76099240|FG012|STARTED|Part 3A, Period 4 (up to 6 Days)||0||
59983382|NCT02688387|76099241|FG013|STARTED|Part 3A, Period 4 (up to 6 Days)||0||
59983383|NCT02688387|76099242|FG014|STARTED|Part 3A, Period 4 (up to 6 Days)||8||
59983384|NCT02688387|76099243|FG015|STARTED|Part 3A, Period 4 (up to 6 Days)||8||
59983385|NCT02688387|76099244|FG016|STARTED|Part 3A, Period 4 (up to 6 Days)||8||
59983386|NCT02688387|76099245|FG017|STARTED|Part 3A, Period 4 (up to 6 Days)||8||
59983387|NCT02688387|76099246|FG018|STARTED|Part 3A, Period 4 (up to 6 Days)||0||
59983388|NCT02688387|76099247|FG019|STARTED|Part 3A, Period 4 (up to 6 Days)||0||
59983389|NCT02688387|76099248|FG020|STARTED|Part 3A, Period 4 (up to 6 Days)||0||
59983390|NCT02688387|76099249|FG021|STARTED|Part 3A, Period 4 (up to 6 Days)||0||
59983391|NCT02688387|76099228|FG000|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0||
59983392|NCT02688387|76099229|FG001|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0||
59983393|NCT02688387|76099230|FG002|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0||
59983394|NCT02688387|76099231|FG003|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0||
59983395|NCT02688387|76099232|FG004|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0||
59526591|NCT01314001|75622297|FG000|STARTED|Overall Study||215||
59526592|NCT01314001|75622298|FG001|STARTED|Overall Study||193||
59983396|NCT02688387|76099233|FG005|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0||
59983397|NCT02688387|76099234|FG006|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0||
59983398|NCT02688387|76099235|FG007|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0||
59983399|NCT02688387|76099236|FG008|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0||
59983400|NCT02688387|76099237|FG009|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0||
59983401|NCT02688387|76099238|FG010|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0||
59983402|NCT02688387|76099239|FG011|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0||
59983403|NCT02688387|76099240|FG012|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0||
59983404|NCT02688387|76099241|FG013|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0||
59983405|NCT02688387|76099242|FG014|COMPLETED|Part 3A, Period 4 (up to 6 Days)||8||
59983406|NCT02688387|76099243|FG015|COMPLETED|Part 3A, Period 4 (up to 6 Days)||8||
59983407|NCT02688387|76099244|FG016|COMPLETED|Part 3A, Period 4 (up to 6 Days)||8||
59983408|NCT02688387|76099245|FG017|COMPLETED|Part 3A, Period 4 (up to 6 Days)||8||
59983409|NCT02688387|76099246|FG018|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0||
59983410|NCT02688387|76099247|FG019|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0||
59526593|NCT01314001|75622299|FG002|STARTED|Overall Study||227||
59526594|NCT01314001|75622300|FG003|STARTED|Overall Study||191||
59526595|NCT01314001|75622301|FG004|STARTED|Overall Study||220||
59526596|NCT01314001|75622302|FG005|STARTED|Overall Study||200||
59526597|NCT01314001|75622297|FG000|End-of-Treatment Visit|Overall Study||156||
59983411|NCT02688387|76099248|FG020|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0||
59983412|NCT02688387|76099249|FG021|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0||
59983413|NCT02688387|76099228|FG000|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0||
59983414|NCT02688387|76099229|FG001|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0||
59983415|NCT02688387|76099230|FG002|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0||
59983416|NCT02688387|76099231|FG003|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0||
59983417|NCT02688387|76099232|FG004|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0||
59983418|NCT02688387|76099233|FG005|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0||
59983419|NCT02688387|76099234|FG006|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0||
59983420|NCT02688387|76099235|FG007|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0||
59983421|NCT02688387|76099236|FG008|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0||
59983422|NCT02688387|76099237|FG009|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0||
59983423|NCT02688387|76099238|FG010|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0||
59983424|NCT02688387|76099239|FG011|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0||
59983425|NCT02688387|76099240|FG012|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0||
59983426|NCT02688387|76099241|FG013|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0||
59983427|NCT02688387|76099242|FG014|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0||
59983428|NCT02688387|76099243|FG015|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0||
59983429|NCT02688387|76099244|FG016|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0||
59983430|NCT02688387|76099245|FG017|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0||
59983431|NCT02688387|76099246|FG018|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0||
59983432|NCT02688387|76099247|FG019|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0||
59983433|NCT02688387|76099248|FG020|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0||
59983434|NCT02688387|76099249|FG021|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0||
59983435|NCT02688387|76099228|FG000|STARTED|Part 3B, Period 1 (up to 6 Days)||0||
59983436|NCT02688387|76099229|FG001|STARTED|Part 3B, Period 1 (up to 6 Days)||0||
59983437|NCT02688387|76099230|FG002|STARTED|Part 3B, Period 1 (up to 6 Days)||0||
59983438|NCT02688387|76099231|FG003|STARTED|Part 3B, Period 1 (up to 6 Days)||0||
59983439|NCT02688387|76099232|FG004|STARTED|Part 3B, Period 1 (up to 6 Days)||0||
59983440|NCT02688387|76099233|FG005|STARTED|Part 3B, Period 1 (up to 6 Days)||0||
59526598|NCT01314001|75622298|FG001|End-of-Treatment Visit|Overall Study||141||
59983441|NCT02688387|76099234|FG006|STARTED|Part 3B, Period 1 (up to 6 Days)||0||
59983442|NCT02688387|76099235|FG007|STARTED|Part 3B, Period 1 (up to 6 Days)||0||
59983443|NCT02688387|76099236|FG008|STARTED|Part 3B, Period 1 (up to 6 Days)||0||
59983444|NCT02688387|76099237|FG009|STARTED|Part 3B, Period 1 (up to 6 Days)||0||
59983445|NCT02688387|76099238|FG010|STARTED|Part 3B, Period 1 (up to 6 Days)||0||
59983446|NCT02688387|76099239|FG011|STARTED|Part 3B, Period 1 (up to 6 Days)||0||
59983447|NCT02688387|76099240|FG012|STARTED|Part 3B, Period 1 (up to 6 Days)||0||
59983448|NCT02688387|76099241|FG013|STARTED|Part 3B, Period 1 (up to 6 Days)||0||
59983449|NCT02688387|76099242|FG014|STARTED|Part 3B, Period 1 (up to 6 Days)||0||
59983450|NCT02688387|76099243|FG015|STARTED|Part 3B, Period 1 (up to 6 Days)||0||
59983451|NCT02688387|76099244|FG016|STARTED|Part 3B, Period 1 (up to 6 Days)||0||
59983452|NCT02688387|76099245|FG017|STARTED|Part 3B, Period 1 (up to 6 Days)||0||
59983453|NCT02688387|76099246|FG018|STARTED|Part 3B, Period 1 (up to 6 Days)||8||
59983454|NCT02688387|76099247|FG019|STARTED|Part 3B, Period 1 (up to 6 Days)||8||
59983455|NCT02688387|76099248|FG020|STARTED|Part 3B, Period 1 (up to 6 Days)||8||
59983456|NCT02688387|76099249|FG021|STARTED|Part 3B, Period 1 (up to 6 Days)||8||
59983457|NCT02688387|76099228|FG000|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0||
59983458|NCT02688387|76099229|FG001|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0||
59983459|NCT02688387|76099230|FG002|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0||
59983460|NCT02688387|76099231|FG003|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0||
59983461|NCT02688387|76099232|FG004|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0||
59983462|NCT02688387|76099233|FG005|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0||
59983463|NCT02688387|76099234|FG006|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0||
59983464|NCT02688387|76099235|FG007|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0||
59983465|NCT02688387|76099236|FG008|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0||
59983466|NCT02688387|76099237|FG009|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0||
59983467|NCT02688387|76099238|FG010|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0||
59983468|NCT02688387|76099239|FG011|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0||
59983469|NCT02688387|76099240|FG012|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0||
59983470|NCT02688387|76099241|FG013|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0||
59983471|NCT02688387|76099242|FG014|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0||
59983472|NCT02688387|76099243|FG015|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0||
59983473|NCT02688387|76099244|FG016|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0||
59983474|NCT02688387|76099245|FG017|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0||
59526599|NCT01314001|75622299|FG002|End-of-Treatment Visit|Overall Study||179||
59526600|NCT01314001|75622300|FG003|End-of-Treatment Visit|Overall Study||146||
59983475|NCT02688387|76099246|FG018|COMPLETED|Part 3B, Period 1 (up to 6 Days)||8||
59983476|NCT02688387|76099247|FG019|COMPLETED|Part 3B, Period 1 (up to 6 Days)||8||
59983477|NCT02688387|76099248|FG020|COMPLETED|Part 3B, Period 1 (up to 6 Days)||8||
59983478|NCT02688387|76099249|FG021|COMPLETED|Part 3B, Period 1 (up to 6 Days)||8||
59983479|NCT02688387|76099228|FG000|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0||
59983480|NCT02688387|76099229|FG001|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0||
59983481|NCT02688387|76099230|FG002|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0||
59983482|NCT02688387|76099231|FG003|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0||
59983483|NCT02688387|76099232|FG004|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0||
59983484|NCT02688387|76099233|FG005|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0||
59983485|NCT02688387|76099234|FG006|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0||
59983486|NCT02688387|76099235|FG007|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0||
59983487|NCT02688387|76099236|FG008|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0||
59983488|NCT02688387|76099237|FG009|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0||
59983489|NCT02688387|76099238|FG010|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0||
59983490|NCT02688387|76099239|FG011|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0||
59983491|NCT02688387|76099240|FG012|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0||
59983492|NCT02688387|76099241|FG013|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0||
59983493|NCT02688387|76099242|FG014|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0||
59983494|NCT02688387|76099243|FG015|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0||
59983495|NCT02688387|76099244|FG016|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0||
59983496|NCT02688387|76099245|FG017|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0||
59983497|NCT02688387|76099246|FG018|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0||
59983498|NCT02688387|76099247|FG019|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0||
59983499|NCT02688387|76099248|FG020|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0||
59983500|NCT02688387|76099249|FG021|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0||
59983501|NCT02688387|76099228|FG000|STARTED|Part 3B, Washout Period 1 (10 Days)||0||
59983502|NCT02688387|76099229|FG001|STARTED|Part 3B, Washout Period 1 (10 Days)||0||
59983503|NCT02688387|76099230|FG002|STARTED|Part 3B, Washout Period 1 (10 Days)||0||
59983504|NCT02688387|76099231|FG003|STARTED|Part 3B, Washout Period 1 (10 Days)||0||
59983505|NCT02688387|76099232|FG004|STARTED|Part 3B, Washout Period 1 (10 Days)||0||
59983506|NCT02688387|76099233|FG005|STARTED|Part 3B, Washout Period 1 (10 Days)||0||
59983507|NCT02688387|76099234|FG006|STARTED|Part 3B, Washout Period 1 (10 Days)||0||
59983508|NCT02688387|76099235|FG007|STARTED|Part 3B, Washout Period 1 (10 Days)||0||
59983509|NCT02688387|76099236|FG008|STARTED|Part 3B, Washout Period 1 (10 Days)||0||
59983510|NCT02688387|76099237|FG009|STARTED|Part 3B, Washout Period 1 (10 Days)||0||
59983511|NCT02688387|76099238|FG010|STARTED|Part 3B, Washout Period 1 (10 Days)||0||
59983512|NCT02688387|76099239|FG011|STARTED|Part 3B, Washout Period 1 (10 Days)||0||
59983513|NCT02688387|76099240|FG012|STARTED|Part 3B, Washout Period 1 (10 Days)||0||
59983514|NCT02688387|76099241|FG013|STARTED|Part 3B, Washout Period 1 (10 Days)||0||
59983515|NCT02688387|76099242|FG014|STARTED|Part 3B, Washout Period 1 (10 Days)||0||
59983516|NCT02688387|76099243|FG015|STARTED|Part 3B, Washout Period 1 (10 Days)||0||
59983517|NCT02688387|76099244|FG016|STARTED|Part 3B, Washout Period 1 (10 Days)||0||
59983518|NCT02688387|76099245|FG017|STARTED|Part 3B, Washout Period 1 (10 Days)||0||
59983519|NCT02688387|76099246|FG018|STARTED|Part 3B, Washout Period 1 (10 Days)||8||
59983520|NCT02688387|76099247|FG019|STARTED|Part 3B, Washout Period 1 (10 Days)||8||
59983521|NCT02688387|76099248|FG020|STARTED|Part 3B, Washout Period 1 (10 Days)||8||
59983522|NCT02688387|76099249|FG021|STARTED|Part 3B, Washout Period 1 (10 Days)||8||
59983523|NCT02688387|76099228|FG000|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0||
59983524|NCT02688387|76099229|FG001|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0||
59983525|NCT02688387|76099230|FG002|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0||
59983526|NCT02688387|76099231|FG003|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0||
59983527|NCT02688387|76099232|FG004|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0||
59983528|NCT02688387|76099233|FG005|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0||
59983529|NCT02688387|76099234|FG006|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0||
59983530|NCT02688387|76099235|FG007|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0||
59983531|NCT02688387|76099236|FG008|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0||
59983532|NCT02688387|76099237|FG009|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0||
59983533|NCT02688387|76099238|FG010|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0||
59983534|NCT02688387|76099239|FG011|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0||
59983535|NCT02688387|76099240|FG012|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0||
59983536|NCT02688387|76099241|FG013|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0||
60074843|NCT01930045|76190107|FG004|STARTED|Pause (up to 37 Days)||3||
59983537|NCT02688387|76099242|FG014|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0||
59983538|NCT02688387|76099243|FG015|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0||
59983539|NCT02688387|76099244|FG016|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0||
59983540|NCT02688387|76099245|FG017|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0||
60074844|NCT01930045|76190108|FG005|STARTED|Pause (up to 37 Days)||3||
60074845|NCT01930045|76190103|FG000|COMPLETED|Pause (up to 37 Days)||3||
60074846|NCT01930045|76190104|FG001|COMPLETED|Pause (up to 37 Days)||3||
60074847|NCT01930045|76190105|FG002|COMPLETED|Pause (up to 37 Days)||3||
59983541|NCT02688387|76099246|FG018|COMPLETED|Part 3B, Washout Period 1 (10 Days)||8||
59983542|NCT02688387|76099247|FG019|COMPLETED|Part 3B, Washout Period 1 (10 Days)||8||
59983543|NCT02688387|76099248|FG020|COMPLETED|Part 3B, Washout Period 1 (10 Days)||8||
59983544|NCT02688387|76099249|FG021|COMPLETED|Part 3B, Washout Period 1 (10 Days)||8||
59983545|NCT02688387|76099228|FG000|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0||
59983546|NCT02688387|76099229|FG001|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0||
59983547|NCT02688387|76099230|FG002|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0||
59983548|NCT02688387|76099231|FG003|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0||
59983549|NCT02688387|76099232|FG004|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0||
59983550|NCT02688387|76099233|FG005|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0||
59983551|NCT02688387|76099234|FG006|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0||
59983552|NCT02688387|76099235|FG007|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0||
59983553|NCT02688387|76099236|FG008|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0||
59983554|NCT02688387|76099237|FG009|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0||
59983555|NCT02688387|76099238|FG010|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0||
59983556|NCT02688387|76099239|FG011|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0||
59983557|NCT02688387|76099240|FG012|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0||
59983558|NCT02688387|76099241|FG013|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0||
59983559|NCT02688387|76099242|FG014|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0||
59983560|NCT02688387|76099243|FG015|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0||
59983561|NCT02688387|76099244|FG016|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0||
59983562|NCT02688387|76099245|FG017|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0||
59983563|NCT02688387|76099246|FG018|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0||
59983564|NCT02688387|76099247|FG019|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0||
59983565|NCT02688387|76099248|FG020|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0||
59983566|NCT02688387|76099249|FG021|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0||
59983567|NCT02688387|76099228|FG000|STARTED|Part 3B, Period 2 (up to 6 Days)||0||
59983568|NCT02688387|76099229|FG001|STARTED|Part 3B, Period 2 (up to 6 Days)||0||
59983569|NCT02688387|76099230|FG002|STARTED|Part 3B, Period 2 (up to 6 Days)||0||
59983570|NCT02688387|76099231|FG003|STARTED|Part 3B, Period 2 (up to 6 Days)||0||
59983571|NCT02688387|76099232|FG004|STARTED|Part 3B, Period 2 (up to 6 Days)||0||
59983572|NCT02688387|76099233|FG005|STARTED|Part 3B, Period 2 (up to 6 Days)||0||
59983573|NCT02688387|76099234|FG006|STARTED|Part 3B, Period 2 (up to 6 Days)||0||
59983574|NCT02688387|76099235|FG007|STARTED|Part 3B, Period 2 (up to 6 Days)||0||
59983575|NCT02688387|76099236|FG008|STARTED|Part 3B, Period 2 (up to 6 Days)||0||
59983576|NCT02688387|76099237|FG009|STARTED|Part 3B, Period 2 (up to 6 Days)||0||
59983577|NCT02688387|76099238|FG010|STARTED|Part 3B, Period 2 (up to 6 Days)||0||
59983578|NCT02688387|76099239|FG011|STARTED|Part 3B, Period 2 (up to 6 Days)||0||
59983579|NCT02688387|76099240|FG012|STARTED|Part 3B, Period 2 (up to 6 Days)||0||
59983580|NCT02688387|76099241|FG013|STARTED|Part 3B, Period 2 (up to 6 Days)||0||
59983581|NCT02688387|76099242|FG014|STARTED|Part 3B, Period 2 (up to 6 Days)||0||
59983582|NCT02688387|76099243|FG015|STARTED|Part 3B, Period 2 (up to 6 Days)||0||
59983583|NCT02688387|76099244|FG016|STARTED|Part 3B, Period 2 (up to 6 Days)||0||
59983584|NCT02688387|76099245|FG017|STARTED|Part 3B, Period 2 (up to 6 Days)||0||
59983585|NCT02688387|76099246|FG018|STARTED|Part 3B, Period 2 (up to 6 Days)||8||
59983586|NCT02688387|76099247|FG019|STARTED|Part 3B, Period 2 (up to 6 Days)||8||
59983587|NCT02688387|76099248|FG020|STARTED|Part 3B, Period 2 (up to 6 Days)||8||
59983588|NCT02688387|76099249|FG021|STARTED|Part 3B, Period 2 (up to 6 Days)||8||
59983589|NCT02688387|76099228|FG000|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0||
59983590|NCT02688387|76099229|FG001|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0||
59983591|NCT02688387|76099230|FG002|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0||
59983592|NCT02688387|76099231|FG003|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0||
59983593|NCT02688387|76099232|FG004|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0||
59983594|NCT02688387|76099233|FG005|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0||
59983595|NCT02688387|76099234|FG006|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0||
59983596|NCT02688387|76099235|FG007|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0||
59983597|NCT02688387|76099236|FG008|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0||
59983598|NCT02688387|76099237|FG009|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0||
59983599|NCT02688387|76099238|FG010|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0||
59983600|NCT02688387|76099239|FG011|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0||
59983601|NCT02688387|76099240|FG012|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0||
59983602|NCT02688387|76099241|FG013|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0||
60074848|NCT01930045|76190106|FG003|COMPLETED|Pause (up to 37 Days)||3||
59983603|NCT02688387|76099242|FG014|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0||
59983604|NCT02688387|76099243|FG015|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0||
59983605|NCT02688387|76099244|FG016|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0||
59983606|NCT02688387|76099245|FG017|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0||
59983607|NCT02688387|76099246|FG018|COMPLETED|Part 3B, Period 2 (up to 6 Days)||8||
59983608|NCT02688387|76099247|FG019|COMPLETED|Part 3B, Period 2 (up to 6 Days)||8||
60074849|NCT01930045|76190107|FG004|COMPLETED|Pause (up to 37 Days)||3||
60074850|NCT01930045|76190108|FG005|COMPLETED|Pause (up to 37 Days)||1||
60074851|NCT01930045|76190103|FG000|NOT COMPLETED|Pause (up to 37 Days)||0||
59983609|NCT02688387|76099248|FG020|COMPLETED|Part 3B, Period 2 (up to 6 Days)||8||
59983610|NCT02688387|76099249|FG021|COMPLETED|Part 3B, Period 2 (up to 6 Days)||8||
59983611|NCT02688387|76099228|FG000|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0||
59983612|NCT02688387|76099229|FG001|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0||
59983613|NCT02688387|76099230|FG002|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0||
59983614|NCT02688387|76099231|FG003|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0||
59983615|NCT02688387|76099232|FG004|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0||
59983616|NCT02688387|76099233|FG005|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0||
59983617|NCT02688387|76099234|FG006|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0||
59983618|NCT02688387|76099235|FG007|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0||
59983619|NCT02688387|76099236|FG008|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0||
59983620|NCT02688387|76099237|FG009|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0||
59983621|NCT02688387|76099238|FG010|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0||
59983622|NCT02688387|76099239|FG011|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0||
59983623|NCT02688387|76099240|FG012|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0||
59983624|NCT02688387|76099241|FG013|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0||
59983625|NCT02688387|76099242|FG014|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0||
59983626|NCT02688387|76099243|FG015|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0||
59983627|NCT02688387|76099244|FG016|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0||
59983628|NCT02688387|76099245|FG017|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0||
59983629|NCT02688387|76099246|FG018|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0||
59983630|NCT02688387|76099247|FG019|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0||
59983631|NCT02688387|76099248|FG020|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0||
59983632|NCT02688387|76099249|FG021|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0||
59983633|NCT02688387|76099228|FG000|STARTED|Part 3B, Washout Period 2 (10 Days)||0||
59983634|NCT02688387|76099229|FG001|STARTED|Part 3B, Washout Period 2 (10 Days)||0||
59983635|NCT02688387|76099230|FG002|STARTED|Part 3B, Washout Period 2 (10 Days)||0||
59983636|NCT02688387|76099231|FG003|STARTED|Part 3B, Washout Period 2 (10 Days)||0||
59983637|NCT02688387|76099232|FG004|STARTED|Part 3B, Washout Period 2 (10 Days)||0||
59983638|NCT02688387|76099233|FG005|STARTED|Part 3B, Washout Period 2 (10 Days)||0||
59983639|NCT02688387|76099234|FG006|STARTED|Part 3B, Washout Period 2 (10 Days)||0||
59983640|NCT02688387|76099235|FG007|STARTED|Part 3B, Washout Period 2 (10 Days)||0||
59983641|NCT02688387|76099236|FG008|STARTED|Part 3B, Washout Period 2 (10 Days)||0||
59983642|NCT02688387|76099237|FG009|STARTED|Part 3B, Washout Period 2 (10 Days)||0||
59983643|NCT02688387|76099238|FG010|STARTED|Part 3B, Washout Period 2 (10 Days)||0||
59983644|NCT02688387|76099239|FG011|STARTED|Part 3B, Washout Period 2 (10 Days)||0||
59983645|NCT02688387|76099240|FG012|STARTED|Part 3B, Washout Period 2 (10 Days)||0||
59983646|NCT02688387|76099241|FG013|STARTED|Part 3B, Washout Period 2 (10 Days)||0||
59983647|NCT02688387|76099242|FG014|STARTED|Part 3B, Washout Period 2 (10 Days)||0||
59983648|NCT02688387|76099243|FG015|STARTED|Part 3B, Washout Period 2 (10 Days)||0||
59983649|NCT02688387|76099244|FG016|STARTED|Part 3B, Washout Period 2 (10 Days)||0||
59983650|NCT02688387|76099245|FG017|STARTED|Part 3B, Washout Period 2 (10 Days)||0||
59983651|NCT02688387|76099246|FG018|STARTED|Part 3B, Washout Period 2 (10 Days)||8||
59983652|NCT02688387|76099247|FG019|STARTED|Part 3B, Washout Period 2 (10 Days)||8||
59983653|NCT02688387|76099248|FG020|STARTED|Part 3B, Washout Period 2 (10 Days)||8||
59983654|NCT02688387|76099249|FG021|STARTED|Part 3B, Washout Period 2 (10 Days)||8||
59983655|NCT02688387|76099228|FG000|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0||
59983656|NCT02688387|76099229|FG001|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0||
59983657|NCT02688387|76099230|FG002|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0||
59983658|NCT02688387|76099231|FG003|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0||
59983659|NCT02688387|76099232|FG004|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0||
59983660|NCT02688387|76099233|FG005|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0||
59983661|NCT02688387|76099234|FG006|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0||
59983662|NCT02688387|76099235|FG007|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0||
59983663|NCT02688387|76099236|FG008|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0||
59983664|NCT02688387|76099237|FG009|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0||
59983665|NCT02688387|76099238|FG010|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0||
59983666|NCT02688387|76099239|FG011|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0||
59983667|NCT02688387|76099240|FG012|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0||
59983668|NCT02688387|76099241|FG013|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0||
59983669|NCT02688387|76099242|FG014|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0||
59983670|NCT02688387|76099243|FG015|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0||
59983671|NCT02688387|76099244|FG016|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0||
59983672|NCT02688387|76099245|FG017|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0||
59983673|NCT02688387|76099246|FG018|COMPLETED|Part 3B, Washout Period 2 (10 Days)||8||
59983674|NCT02688387|76099247|FG019|COMPLETED|Part 3B, Washout Period 2 (10 Days)||8||
59983675|NCT02688387|76099248|FG020|COMPLETED|Part 3B, Washout Period 2 (10 Days)||8||
59983676|NCT02688387|76099249|FG021|COMPLETED|Part 3B, Washout Period 2 (10 Days)||8||
59983677|NCT02688387|76099228|FG000|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0||
59983678|NCT02688387|76099229|FG001|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0||
59983679|NCT02688387|76099230|FG002|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0||
59983680|NCT02688387|76099231|FG003|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0||
59983681|NCT02688387|76099232|FG004|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0||
59983682|NCT02688387|76099233|FG005|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0||
59983683|NCT02688387|76099234|FG006|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0||
59983684|NCT02688387|76099235|FG007|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0||
59983685|NCT02688387|76099236|FG008|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0||
59983686|NCT02688387|76099237|FG009|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0||
59983687|NCT02688387|76099238|FG010|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0||
59983688|NCT02688387|76099239|FG011|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0||
59983689|NCT02688387|76099240|FG012|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0||
59983690|NCT02688387|76099241|FG013|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0||
59983691|NCT02688387|76099242|FG014|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0||
59983692|NCT02688387|76099243|FG015|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0||
59983693|NCT02688387|76099244|FG016|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0||
59983694|NCT02688387|76099245|FG017|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0||
59983695|NCT02688387|76099246|FG018|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0||
59983696|NCT02688387|76099247|FG019|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0||
59983697|NCT02688387|76099248|FG020|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0||
59983698|NCT02688387|76099249|FG021|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0||
59983699|NCT02688387|76099228|FG000|STARTED|Part 3B, Period 3 (up to 6 Days)||0||
59983700|NCT02688387|76099229|FG001|STARTED|Part 3B, Period 3 (up to 6 Days)||0||
59983701|NCT02688387|76099230|FG002|STARTED|Part 3B, Period 3 (up to 6 Days)||0||
59983702|NCT02688387|76099231|FG003|STARTED|Part 3B, Period 3 (up to 6 Days)||0||
59983703|NCT02688387|76099232|FG004|STARTED|Part 3B, Period 3 (up to 6 Days)||0||
59983704|NCT02688387|76099233|FG005|STARTED|Part 3B, Period 3 (up to 6 Days)||0||
59983705|NCT02688387|76099234|FG006|STARTED|Part 3B, Period 3 (up to 6 Days)||0||
59983706|NCT02688387|76099235|FG007|STARTED|Part 3B, Period 3 (up to 6 Days)||0||
59983707|NCT02688387|76099236|FG008|STARTED|Part 3B, Period 3 (up to 6 Days)||0||
59983708|NCT02688387|76099237|FG009|STARTED|Part 3B, Period 3 (up to 6 Days)||0||
59983709|NCT02688387|76099238|FG010|STARTED|Part 3B, Period 3 (up to 6 Days)||0||
59983710|NCT02688387|76099239|FG011|STARTED|Part 3B, Period 3 (up to 6 Days)||0||
59983711|NCT02688387|76099240|FG012|STARTED|Part 3B, Period 3 (up to 6 Days)||0||
59983712|NCT02688387|76099241|FG013|STARTED|Part 3B, Period 3 (up to 6 Days)||0||
59983713|NCT02688387|76099242|FG014|STARTED|Part 3B, Period 3 (up to 6 Days)||0||
59983714|NCT02688387|76099243|FG015|STARTED|Part 3B, Period 3 (up to 6 Days)||0||
59983715|NCT02688387|76099244|FG016|STARTED|Part 3B, Period 3 (up to 6 Days)||0||
59983716|NCT02688387|76099245|FG017|STARTED|Part 3B, Period 3 (up to 6 Days)||0||
59983717|NCT02688387|76099246|FG018|STARTED|Part 3B, Period 3 (up to 6 Days)||8||
59983718|NCT02688387|76099247|FG019|STARTED|Part 3B, Period 3 (up to 6 Days)||8||
59983719|NCT02688387|76099248|FG020|STARTED|Part 3B, Period 3 (up to 6 Days)||8||
59983720|NCT02688387|76099249|FG021|STARTED|Part 3B, Period 3 (up to 6 Days)||8||
59983721|NCT02688387|76099228|FG000|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0||
59983722|NCT02688387|76099229|FG001|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0||
59983723|NCT02688387|76099230|FG002|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0||
59983724|NCT02688387|76099231|FG003|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0||
59983725|NCT02688387|76099232|FG004|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0||
59983726|NCT02688387|76099233|FG005|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0||
59983727|NCT02688387|76099234|FG006|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0||
59983728|NCT02688387|76099235|FG007|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0||
59983729|NCT02688387|76099236|FG008|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0||
59983730|NCT02688387|76099237|FG009|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0||
59983731|NCT02688387|76099238|FG010|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0||
59983732|NCT02688387|76099239|FG011|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0||
59983733|NCT02688387|76099240|FG012|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0||
59983734|NCT02688387|76099241|FG013|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0||
59983735|NCT02688387|76099242|FG014|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0||
59983736|NCT02688387|76099243|FG015|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0||
59983737|NCT02688387|76099244|FG016|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0||
59983738|NCT02688387|76099245|FG017|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0||
59983739|NCT02688387|76099246|FG018|COMPLETED|Part 3B, Period 3 (up to 6 Days)||8||
59983740|NCT02688387|76099247|FG019|COMPLETED|Part 3B, Period 3 (up to 6 Days)||8||
59983741|NCT02688387|76099248|FG020|COMPLETED|Part 3B, Period 3 (up to 6 Days)||7||
59983742|NCT02688387|76099249|FG021|COMPLETED|Part 3B, Period 3 (up to 6 Days)||8||
59983743|NCT02688387|76099228|FG000|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0||
59983744|NCT02688387|76099229|FG001|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0||
59983745|NCT02688387|76099230|FG002|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0||
59983746|NCT02688387|76099231|FG003|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0||
59983747|NCT02688387|76099232|FG004|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0||
59983748|NCT02688387|76099233|FG005|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0||
59983749|NCT02688387|76099234|FG006|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0||
59995411|NCT03016975|76111236|FG000|NOT COMPLETED|At 3 Year Follow-up||2||
59983750|NCT02688387|76099235|FG007|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0||
59983751|NCT02688387|76099236|FG008|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0||
59983752|NCT02688387|76099237|FG009|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0||
59983753|NCT02688387|76099238|FG010|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0||
59983754|NCT02688387|76099239|FG011|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0||
59983755|NCT02688387|76099240|FG012|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0||
59983756|NCT02688387|76099241|FG013|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0||
59983757|NCT02688387|76099242|FG014|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0||
59983758|NCT02688387|76099243|FG015|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0||
59983759|NCT02688387|76099244|FG016|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0||
59983760|NCT02688387|76099245|FG017|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0||
59983761|NCT02688387|76099246|FG018|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0||
59983762|NCT02688387|76099247|FG019|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0||
59983763|NCT02688387|76099248|FG020|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||1||
59983764|NCT02688387|76099249|FG021|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0||
59983765|NCT02688387|76099228|FG000|STARTED|Part 3B, Washout Period 3 (10 Days)||0||
59983766|NCT02688387|76099229|FG001|STARTED|Part 3B, Washout Period 3 (10 Days)||0||
59983767|NCT02688387|76099230|FG002|STARTED|Part 3B, Washout Period 3 (10 Days)||0||
59983768|NCT02688387|76099231|FG003|STARTED|Part 3B, Washout Period 3 (10 Days)||0||
59983769|NCT02688387|76099232|FG004|STARTED|Part 3B, Washout Period 3 (10 Days)||0||
59983770|NCT02688387|76099233|FG005|STARTED|Part 3B, Washout Period 3 (10 Days)||0||
59983771|NCT02688387|76099234|FG006|STARTED|Part 3B, Washout Period 3 (10 Days)||0||
59983772|NCT02688387|76099235|FG007|STARTED|Part 3B, Washout Period 3 (10 Days)||0||
59983773|NCT02688387|76099236|FG008|STARTED|Part 3B, Washout Period 3 (10 Days)||0||
59983774|NCT02688387|76099237|FG009|STARTED|Part 3B, Washout Period 3 (10 Days)||0||
59983775|NCT02688387|76099238|FG010|STARTED|Part 3B, Washout Period 3 (10 Days)||0||
59983776|NCT02688387|76099239|FG011|STARTED|Part 3B, Washout Period 3 (10 Days)||0||
59983777|NCT02688387|76099240|FG012|STARTED|Part 3B, Washout Period 3 (10 Days)||0||
59983778|NCT02688387|76099241|FG013|STARTED|Part 3B, Washout Period 3 (10 Days)||0||
59983779|NCT02688387|76099242|FG014|STARTED|Part 3B, Washout Period 3 (10 Days)||0||
59983780|NCT02688387|76099243|FG015|STARTED|Part 3B, Washout Period 3 (10 Days)||0||
59983781|NCT02688387|76099244|FG016|STARTED|Part 3B, Washout Period 3 (10 Days)||0||
59983782|NCT02688387|76099245|FG017|STARTED|Part 3B, Washout Period 3 (10 Days)||0||
59983783|NCT02688387|76099246|FG018|STARTED|Part 3B, Washout Period 3 (10 Days)||8||
59983784|NCT02688387|76099247|FG019|STARTED|Part 3B, Washout Period 3 (10 Days)||8||
59983785|NCT02688387|76099248|FG020|STARTED|Part 3B, Washout Period 3 (10 Days)||7||
59983786|NCT02688387|76099249|FG021|STARTED|Part 3B, Washout Period 3 (10 Days)||8||
59983787|NCT02688387|76099228|FG000|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0||
59983788|NCT02688387|76099229|FG001|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0||
59983789|NCT02688387|76099230|FG002|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0||
59983790|NCT02688387|76099231|FG003|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0||
59983791|NCT02688387|76099232|FG004|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0||
59983792|NCT02688387|76099233|FG005|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0||
59983793|NCT02688387|76099234|FG006|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0||
59983794|NCT02688387|76099235|FG007|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0||
59983795|NCT02688387|76099236|FG008|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0||
59983796|NCT02688387|76099237|FG009|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0||
59983797|NCT02688387|76099238|FG010|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0||
59983798|NCT02688387|76099239|FG011|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0||
59983799|NCT02688387|76099240|FG012|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0||
59983800|NCT02688387|76099241|FG013|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0||
59983801|NCT02688387|76099242|FG014|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0||
59983802|NCT02688387|76099243|FG015|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0||
59983803|NCT02688387|76099244|FG016|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0||
59983804|NCT02688387|76099245|FG017|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0||
59983805|NCT02688387|76099246|FG018|COMPLETED|Part 3B, Washout Period 3 (10 Days)||7||
59983806|NCT02688387|76099247|FG019|COMPLETED|Part 3B, Washout Period 3 (10 Days)||7||
59983807|NCT02688387|76099248|FG020|COMPLETED|Part 3B, Washout Period 3 (10 Days)||6||
59983808|NCT02688387|76099249|FG021|COMPLETED|Part 3B, Washout Period 3 (10 Days)||8||
59983809|NCT02688387|76099228|FG000|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0||
59983810|NCT02688387|76099229|FG001|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0||
59995412|NCT03016975|76111237|FG001|NOT COMPLETED|At 3 Year Follow-up||0||
59995413|NCT03016975|76111238|FG002|NOT COMPLETED|At 3 Year Follow-up||0||
59995414|NCT03016975|76111236|FG000|STARTED|At 4-year Follow-up||3||
59995415|NCT03016975|76111237|FG001|STARTED|At 4-year Follow-up||0||
59995416|NCT03016975|76111238|FG002|STARTED|At 4-year Follow-up||0||
59995417|NCT03016975|76111236|FG000|COMPLETED|At 4-year Follow-up||2||
59995418|NCT03016975|76111237|FG001|COMPLETED|At 4-year Follow-up||0||
59995419|NCT03016975|76111238|FG002|COMPLETED|At 4-year Follow-up||0||
59995420|NCT03016975|76111236|FG000|NOT COMPLETED|At 4-year Follow-up||1||
59995421|NCT03016975|76111237|FG001|NOT COMPLETED|At 4-year Follow-up||0||
59983811|NCT02688387|76099230|FG002|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0||
59983812|NCT02688387|76099231|FG003|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0||
59983813|NCT02688387|76099232|FG004|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0||
59983814|NCT02688387|76099233|FG005|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0||
59983815|NCT02688387|76099234|FG006|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0||
59983816|NCT02688387|76099235|FG007|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0||
59983817|NCT02688387|76099236|FG008|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0||
59983818|NCT02688387|76099237|FG009|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0||
59983819|NCT02688387|76099238|FG010|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0||
59983820|NCT02688387|76099239|FG011|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0||
59983821|NCT02688387|76099240|FG012|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0||
59983822|NCT02688387|76099241|FG013|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0||
59983823|NCT02688387|76099242|FG014|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0||
59983824|NCT02688387|76099243|FG015|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0||
59983825|NCT02688387|76099244|FG016|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0||
59983826|NCT02688387|76099245|FG017|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0||
59983827|NCT02688387|76099246|FG018|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||1||
59983828|NCT02688387|76099247|FG019|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||1||
59983829|NCT02688387|76099248|FG020|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||1||
59983830|NCT02688387|76099249|FG021|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0||
59983831|NCT02688387|76099228|FG000|STARTED|Part 3B, Period 4 (up to 6 Days)||0||
59983832|NCT02688387|76099229|FG001|STARTED|Part 3B, Period 4 (up to 6 Days)||0||
59983833|NCT02688387|76099230|FG002|STARTED|Part 3B, Period 4 (up to 6 Days)||0||
59983834|NCT02688387|76099231|FG003|STARTED|Part 3B, Period 4 (up to 6 Days)||0||
59983835|NCT02688387|76099232|FG004|STARTED|Part 3B, Period 4 (up to 6 Days)||0||
59983836|NCT02688387|76099233|FG005|STARTED|Part 3B, Period 4 (up to 6 Days)||0||
59983837|NCT02688387|76099234|FG006|STARTED|Part 3B, Period 4 (up to 6 Days)||0||
59983838|NCT02688387|76099235|FG007|STARTED|Part 3B, Period 4 (up to 6 Days)||0||
59983839|NCT02688387|76099236|FG008|STARTED|Part 3B, Period 4 (up to 6 Days)||0||
59983840|NCT02688387|76099237|FG009|STARTED|Part 3B, Period 4 (up to 6 Days)||0||
59983841|NCT02688387|76099238|FG010|STARTED|Part 3B, Period 4 (up to 6 Days)||0||
59983842|NCT02688387|76099239|FG011|STARTED|Part 3B, Period 4 (up to 6 Days)||0||
59983843|NCT02688387|76099240|FG012|STARTED|Part 3B, Period 4 (up to 6 Days)||0||
59983844|NCT02688387|76099241|FG013|STARTED|Part 3B, Period 4 (up to 6 Days)||0||
59983845|NCT02688387|76099242|FG014|STARTED|Part 3B, Period 4 (up to 6 Days)||0||
59983846|NCT02688387|76099243|FG015|STARTED|Part 3B, Period 4 (up to 6 Days)||0||
59983847|NCT02688387|76099244|FG016|STARTED|Part 3B, Period 4 (up to 6 Days)||0||
59983848|NCT02688387|76099245|FG017|STARTED|Part 3B, Period 4 (up to 6 Days)||0||
59983849|NCT02688387|76099246|FG018|STARTED|Part 3B, Period 4 (up to 6 Days)||7||
59983850|NCT02688387|76099247|FG019|STARTED|Part 3B, Period 4 (up to 6 Days)||7||
59983851|NCT02688387|76099248|FG020|STARTED|Part 3B, Period 4 (up to 6 Days)||6||
59983852|NCT02688387|76099249|FG021|STARTED|Part 3B, Period 4 (up to 6 Days)||8||
59983853|NCT02688387|76099228|FG000|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0||
59983854|NCT02688387|76099229|FG001|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0||
59983855|NCT02688387|76099230|FG002|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0||
59983856|NCT02688387|76099231|FG003|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0||
59983857|NCT02688387|76099232|FG004|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0||
59983858|NCT02688387|76099233|FG005|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0||
59983859|NCT02688387|76099234|FG006|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0||
59983860|NCT02688387|76099235|FG007|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0||
59983861|NCT02688387|76099236|FG008|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0||
59983862|NCT02688387|76099237|FG009|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0||
59983863|NCT02688387|76099238|FG010|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0||
59983864|NCT02688387|76099239|FG011|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0||
59983865|NCT02688387|76099240|FG012|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0||
59983866|NCT02688387|76099241|FG013|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0||
59983867|NCT02688387|76099242|FG014|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0||
59983868|NCT02688387|76099243|FG015|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0||
59983869|NCT02688387|76099244|FG016|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0||
59983870|NCT02688387|76099245|FG017|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0||
59983871|NCT02688387|76099246|FG018|COMPLETED|Part 3B, Period 4 (up to 6 Days)||7||
59983872|NCT02688387|76099247|FG019|COMPLETED|Part 3B, Period 4 (up to 6 Days)||7||
59983873|NCT02688387|76099248|FG020|COMPLETED|Part 3B, Period 4 (up to 6 Days)||6||
59983874|NCT02688387|76099249|FG021|COMPLETED|Part 3B, Period 4 (up to 6 Days)||8||
59983875|NCT02688387|76099228|FG000|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0||
59983876|NCT02688387|76099229|FG001|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0||
59983877|NCT02688387|76099230|FG002|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0||
59983878|NCT02688387|76099231|FG003|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0||
59983879|NCT02688387|76099232|FG004|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0||
59983880|NCT02688387|76099233|FG005|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0||
59983881|NCT02688387|76099234|FG006|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0||
59983882|NCT02688387|76099235|FG007|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0||
59983883|NCT02688387|76099236|FG008|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0||
59983884|NCT02688387|76099237|FG009|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0||
59983885|NCT02688387|76099238|FG010|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0||
59983886|NCT02688387|76099239|FG011|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0||
59983887|NCT02688387|76099240|FG012|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0||
59983888|NCT02688387|76099241|FG013|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0||
59983889|NCT02688387|76099242|FG014|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0||
59983890|NCT02688387|76099243|FG015|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0||
59983891|NCT02688387|76099244|FG016|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0||
59983892|NCT02688387|76099245|FG017|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0||
59983893|NCT02688387|76099246|FG018|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0||
59983894|NCT02688387|76099247|FG019|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0||
59983895|NCT02688387|76099248|FG020|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0||
59983896|NCT02688387|76099249|FG021|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0||
59983897|NCT02476201|76099295|FG000|STARTED|Overall Study||105||
59983898|NCT02476201|76099295|FG000|Implant Attempts|Overall Study||103||
59983899|NCT02476201|76099295|FG000|Sucessful Implants|Overall Study||102||
59983900|NCT02476201|76099295|FG000|6 Months Visit|Overall Study||82||
59983901|NCT02476201|76099295|FG000|COMPLETED|Overall Study||79||
59983902|NCT02476201|76099295|FG000|NOT COMPLETED|Overall Study||26||
59983903|NCT02688153|76099302|FG000|STARTED|Overall Study||62||
59983904|NCT02688153|76099303|FG001|STARTED|Overall Study||58||
59983905|NCT02688153|76099302|FG000|Final Randomized Arm/Group|Overall Study||59||
59983906|NCT02688153|76099303|FG001|Final Randomized Arm/Group|Overall Study||61||
59983907|NCT02688153|76099302|FG000|COMPLETED|Overall Study||47||
59983908|NCT02688153|76099303|FG001|COMPLETED|Overall Study||51||
59983909|NCT02688153|76099302|FG000|NOT COMPLETED|Overall Study||15||
59983910|NCT02688153|76099303|FG001|NOT COMPLETED|Overall Study||7||
59983911|NCT02687919|76099312|FG000|STARTED|Overall Study||16||
59983912|NCT02687919|76099313|FG001|STARTED|Overall Study||15||
59983913|NCT02687919|76099312|FG000|COMPLETED|Overall Study||8||
59983914|NCT02687919|76099313|FG001|COMPLETED|Overall Study||9||
59983915|NCT02687919|76099312|FG000|NOT COMPLETED|Overall Study||8||
59983916|NCT02687919|76099313|FG001|NOT COMPLETED|Overall Study||6||
59983917|NCT02687451|76099325|FG000|STARTED|Overall Study||6||
59983918|NCT02687451|76099326|FG001|STARTED|Overall Study||5||
59983919|NCT02687451|76099327|FG002|STARTED|Overall Study||5||
59983920|NCT02687451|76099328|FG003|STARTED|Overall Study||5||
59983921|NCT02687451|76099329|FG004|STARTED|Overall Study||4||
59983922|NCT02687451|76099330|FG005|STARTED|Overall Study||3||
59983923|NCT02687451|76099325|FG000|COMPLETED|Overall Study||5||
59983924|NCT02687451|76099326|FG001|COMPLETED|Overall Study||5||
59983925|NCT02687451|76099327|FG002|COMPLETED|Overall Study||5||
59983926|NCT02687451|76099328|FG003|COMPLETED|Overall Study||5||
59983927|NCT02687451|76099329|FG004|COMPLETED|Overall Study||4||
59983928|NCT02687451|76099330|FG005|COMPLETED|Overall Study||2||
59983929|NCT02687451|76099325|FG000|NOT COMPLETED|Overall Study||1||
59983930|NCT02687451|76099326|FG001|NOT COMPLETED|Overall Study||0||
59983931|NCT02687451|76099327|FG002|NOT COMPLETED|Overall Study||0||
59983932|NCT02687451|76099328|FG003|NOT COMPLETED|Overall Study||0||
60074852|NCT01930045|76190104|FG001|NOT COMPLETED|Pause (up to 37 Days)||0||
60074853|NCT01930045|76190105|FG002|NOT COMPLETED|Pause (up to 37 Days)||0||
60074854|NCT01930045|76190106|FG003|NOT COMPLETED|Pause (up to 37 Days)||0||
60074855|NCT01930045|76190107|FG004|NOT COMPLETED|Pause (up to 37 Days)||0||
60074856|NCT01930045|76190108|FG005|NOT COMPLETED|Pause (up to 37 Days)||2||
60074857|NCT01930045|76190103|FG000|STARTED|Part 2 - Period 4||3||
60074858|NCT01930045|76190104|FG001|STARTED|Part 2 - Period 4||3||
60074859|NCT01930045|76190105|FG002|STARTED|Part 2 - Period 4||3||
60074860|NCT01930045|76190106|FG003|STARTED|Part 2 - Period 4||3||
59983933|NCT02687451|76099329|FG004|NOT COMPLETED|Overall Study||0||
59983934|NCT02687451|76099330|FG005|NOT COMPLETED|Overall Study||1||
59983935|NCT02557646|76099346|FG000|STARTED|Overall Study||693||
59983936|NCT02557646|76099346|FG000|COMPLETED|Overall Study||417||
59983937|NCT02557646|76099346|FG000|NOT COMPLETED|Overall Study||276||
59983938|NCT02679573|76099352|FG000|STARTED|Overall Study||431||
59983939|NCT02679573|76099353|FG001|STARTED|Overall Study||428||
59983940|NCT02679573|76099352|FG000|COMPLETED|Overall Study||394||
59983941|NCT02679573|76099353|FG001|COMPLETED|Overall Study||389||
59983942|NCT02679573|76099352|FG000|NOT COMPLETED|Overall Study||37||
59983943|NCT02679573|76099353|FG001|NOT COMPLETED|Overall Study||39||
59983944|NCT02685033|76099361|FG000|STARTED|Overall Study||70||
59983945|NCT02685033|76099362|FG001|STARTED|Overall Study||10||
59983946|NCT02685033|76099361|FG000|COMPLETED|Overall Study||67||
59983947|NCT02685033|76099362|FG001|COMPLETED|Overall Study||8||
59983948|NCT02685033|76099361|FG000|NOT COMPLETED|Overall Study||3||
59983949|NCT02685033|76099362|FG001|NOT COMPLETED|Overall Study||2||
59983950|NCT02684097|76099370|FG000|STARTED|Overall Study||15||
59983951|NCT02684097|76099371|FG001|STARTED|Overall Study||7||
59983952|NCT02684097|76099370|FG000|COMPLETED|Overall Study||2||
59983953|NCT02684097|76099371|FG001|COMPLETED|Overall Study||1||
59983954|NCT02684097|76099370|FG000|NOT COMPLETED|Overall Study||13||
59983955|NCT02684097|76099371|FG001|NOT COMPLETED|Overall Study||6||
59983956|NCT02555618|76099379|FG000|STARTED|Overall Study||200||
59983957|NCT02555618|76099380|FG001|STARTED|Overall Study||200||
59983958|NCT02555618|76099379|FG000|COMPLETED|Overall Study||199||
59983959|NCT02555618|76099380|FG001|COMPLETED|Overall Study||200||
59983960|NCT02555618|76099379|FG000|NOT COMPLETED|Overall Study||1||
59983961|NCT02555618|76099380|FG001|NOT COMPLETED|Overall Study||0||
59983962|NCT00258427|76099390|FG000|STARTED|Overall Study||3||
59983963|NCT00258427|76099391|FG001|STARTED|Overall Study||8||
59983964|NCT00258427|76099392|FG002|STARTED|Overall Study||2||
59983965|NCT00258427|76099393|FG003|STARTED|Overall Study||1||
59983966|NCT00258427|76099390|FG000|COMPLETED|Overall Study||3||
59983967|NCT00258427|76099391|FG001|COMPLETED|Overall Study||8||
59983968|NCT00258427|76099392|FG002|COMPLETED|Overall Study||2||
59983969|NCT00258427|76099393|FG003|COMPLETED|Overall Study||1||
59983970|NCT00258427|76099390|FG000|NOT COMPLETED|Overall Study||0||
59983971|NCT00258427|76099391|FG001|NOT COMPLETED|Overall Study||0||
59983972|NCT00258427|76099392|FG002|NOT COMPLETED|Overall Study||0||
59983973|NCT00258427|76099393|FG003|NOT COMPLETED|Overall Study||0||
59983974|NCT02557100|76099406|FG000|STARTED|Single Blind Treatment Period||40|= treated|
59983975|NCT02557100|76099407|FG001|STARTED|Single Blind Treatment Period||40|= treated|
59983976|NCT02557100|76099408|FG002|STARTED|Single Blind Treatment Period||0|= treated|
59983977|NCT02557100|76099406|FG000|COMPLETED|Single Blind Treatment Period||40|= completed treatment|
59983978|NCT02557100|76099407|FG001|COMPLETED|Single Blind Treatment Period||36|= completed treatment|
59983979|NCT02557100|76099408|FG002|COMPLETED|Single Blind Treatment Period||0|= completed treatment|
59983980|NCT02557100|76099406|FG000|NOT COMPLETED|Single Blind Treatment Period||0||
59983981|NCT02557100|76099407|FG001|NOT COMPLETED|Single Blind Treatment Period||4||
59983982|NCT02557100|76099408|FG002|NOT COMPLETED|Single Blind Treatment Period||0||
59983983|NCT02557100|76099406|FG000|STARTED|Transition to Open Label||40||
59983984|NCT02557100|76099407|FG001|STARTED|Transition to Open Label||36||
59983985|NCT02557100|76099408|FG002|STARTED|Transition to Open Label||0||
59983986|NCT02557100|76099406|FG000|COMPLETED|Transition to Open Label||0||
59983987|NCT02557100|76099407|FG001|COMPLETED|Transition to Open Label||0||
59983988|NCT02557100|76099408|FG002|COMPLETED|Transition to Open Label||0||
59983989|NCT02557100|76099406|FG000|NOT COMPLETED|Transition to Open Label||40||
59983990|NCT02557100|76099407|FG001|NOT COMPLETED|Transition to Open Label||36||
59983991|NCT02557100|76099408|FG002|NOT COMPLETED|Transition to Open Label||0||
59983992|NCT02557100|76099406|FG000|STARTED|Cumulative Abatacept Period||0||
59983993|NCT02557100|76099407|FG001|STARTED|Cumulative Abatacept Period||0||
59983994|NCT02557100|76099408|FG002|STARTED|Cumulative Abatacept Period||76||
59983995|NCT02557100|76099406|FG000|COMPLETED|Cumulative Abatacept Period||0||
59983996|NCT02557100|76099407|FG001|COMPLETED|Cumulative Abatacept Period||0||
59983997|NCT02557100|76099408|FG002|COMPLETED|Cumulative Abatacept Period||72||
59983998|NCT02557100|76099406|FG000|NOT COMPLETED|Cumulative Abatacept Period||0||
59983999|NCT02557100|76099407|FG001|NOT COMPLETED|Cumulative Abatacept Period||0||
59984000|NCT02557100|76099408|FG002|NOT COMPLETED|Cumulative Abatacept Period||4||
59984001|NCT01337635|76099418|FG000|STARTED|Overall Study||3||
59984002|NCT01337635|76099419|FG001|STARTED|Overall Study||4||
59984003|NCT01337635|76099418|FG000|COMPLETED|Overall Study||3||
59984004|NCT01337635|76099419|FG001|COMPLETED|Overall Study||3||
59984005|NCT01337635|76099418|FG000|NOT COMPLETED|Overall Study||0||
59984006|NCT01337635|76099419|FG001|NOT COMPLETED|Overall Study||1||
59984007|NCT02556710|76099427|FG000|STARTED|Overall Study||237||
59984008|NCT02556710|76099428|FG001|STARTED|Overall Study||243||
59984009|NCT02556710|76099427|FG000|COMPLETED|Overall Study||226||
59984010|NCT02556710|76099428|FG001|COMPLETED|Overall Study||237||
59984011|NCT02556710|76099427|FG000|NOT COMPLETED|Overall Study||11||
59984012|NCT02556710|76099428|FG001|NOT COMPLETED|Overall Study||6||
59622600|NCT00433992|75734452|FG000|NOT COMPLETED|Overall Study||9||
59984013|NCT02556632|76099439|FG000|STARTED|Overall Study||64||
59984014|NCT02556632|76099440|FG001|STARTED|Overall Study||65||
59984015|NCT02556632|76099441|FG002|STARTED|Overall Study||62||
59984016|NCT02556632|76099439|FG000|COMPLETED|Overall Study||59||
59984017|NCT02556632|76099440|FG001|COMPLETED|Overall Study||59||
59984018|NCT02556632|76099441|FG002|COMPLETED|Overall Study||53||
59984019|NCT02556632|76099439|FG000|NOT COMPLETED|Overall Study||5||
59984020|NCT02556632|76099440|FG001|NOT COMPLETED|Overall Study||6||
59984021|NCT02556632|76099441|FG002|NOT COMPLETED|Overall Study||9||
59984022|NCT01662440|76099453|FG000|STARTED|Overall Study||167||
59984023|NCT01662440|76099454|FG001|STARTED|Overall Study||217||
59984024|NCT01662440|76099455|FG002|STARTED|Overall Study||221||
59984025|NCT01662440|76099456|FG003|STARTED|Overall Study||56||
59984026|NCT01662440|76099453|FG000|COMPLETED|Overall Study||158||
59984027|NCT01662440|76099454|FG001|COMPLETED|Overall Study||211||
59984028|NCT01662440|76099455|FG002|COMPLETED|Overall Study||215||
59984029|NCT01662440|76099456|FG003|COMPLETED|Overall Study||52||
59984030|NCT01662440|76099453|FG000|NOT COMPLETED|Overall Study||9||
59984031|NCT01662440|76099454|FG001|NOT COMPLETED|Overall Study||6||
59984032|NCT01662440|76099455|FG002|NOT COMPLETED|Overall Study||6||
59984033|NCT01662440|76099456|FG003|NOT COMPLETED|Overall Study||4||
59984034|NCT01662362|76099476|FG000|STARTED|Overall Study||63||
59984035|NCT01662362|76099476|FG000|COMPLETED|Overall Study||25||
59984036|NCT01662362|76099476|FG000|NOT COMPLETED|Overall Study||38||
59984037|NCT02554682|76099491|FG000|STARTED|Overall Study||40||
59984038|NCT02554682|76099492|FG001|STARTED|Overall Study||40||
59984039|NCT02554682|76099493|FG002|STARTED|Overall Study||40||
59984040|NCT02554682|76099494|FG003|STARTED|Overall Study||40||
59984041|NCT02554682|76099495|FG004|STARTED|Overall Study||40||
59984042|NCT02554682|76099496|FG005|STARTED|Overall Study||40||
59984043|NCT02554682|76099497|FG006|STARTED|Overall Study||28||
59984044|NCT02554682|76099498|FG007|STARTED|Overall Study||28||
59984045|NCT02554682|76099499|FG008|STARTED|Overall Study||26||
59984046|NCT02554682|76099500|FG009|STARTED|Overall Study||26||
59984047|NCT02554682|76099491|FG000|COMPLETED|Overall Study||25||
59984048|NCT02554682|76099492|FG001|COMPLETED|Overall Study||28||
59984049|NCT02554682|76099493|FG002|COMPLETED|Overall Study||36||
59984050|NCT02554682|76099494|FG003|COMPLETED|Overall Study||37||
59984051|NCT02554682|76099495|FG004|COMPLETED|Overall Study||38||
59984052|NCT02554682|76099496|FG005|COMPLETED|Overall Study||39||
59984053|NCT02554682|76099497|FG006|COMPLETED|Overall Study||22||
59984054|NCT02554682|76099498|FG007|COMPLETED|Overall Study||22||
59984055|NCT02554682|76099499|FG008|COMPLETED|Overall Study||24||
59984056|NCT02554682|76099500|FG009|COMPLETED|Overall Study||24||
59984057|NCT02554682|76099491|FG000|NOT COMPLETED|Overall Study||15||
59984058|NCT02554682|76099492|FG001|NOT COMPLETED|Overall Study||12||
59526601|NCT01314001|75622301|FG004|End-of-Treatment Visit|Overall Study||174||
59526602|NCT01314001|75622302|FG005|End-of-Treatment Visit|Overall Study||160||
59526603|NCT01314001|75622297|FG000|6-Month Follow Up Survey|Overall Study||146||
59526604|NCT01314001|75622298|FG001|6-Month Follow Up Survey|Overall Study||137||
59526605|NCT01314001|75622299|FG002|6-Month Follow Up Survey|Overall Study||165||
59526606|NCT01314001|75622300|FG003|6-Month Follow Up Survey|Overall Study||135||
59526607|NCT01314001|75622301|FG004|6-Month Follow Up Survey|Overall Study||157||
59526608|NCT01314001|75622302|FG005|6-Month Follow Up Survey|Overall Study||139||
59526609|NCT01314001|75622297|FG000|COMPLETED|Overall Study||140||
59526610|NCT01314001|75622298|FG001|COMPLETED|Overall Study||124||
59526611|NCT01314001|75622299|FG002|COMPLETED|Overall Study||158||
59526612|NCT01314001|75622300|FG003|COMPLETED|Overall Study||122||
59526613|NCT01314001|75622301|FG004|COMPLETED|Overall Study||148||
59526614|NCT01314001|75622302|FG005|COMPLETED|Overall Study||129||
59526615|NCT01314001|75622297|FG000|NOT COMPLETED|Overall Study||75||
59526616|NCT01314001|75622298|FG001|NOT COMPLETED|Overall Study||69||
59526617|NCT01314001|75622299|FG002|NOT COMPLETED|Overall Study||69||
59526618|NCT01314001|75622300|FG003|NOT COMPLETED|Overall Study||69||
59526619|NCT01314001|75622301|FG004|NOT COMPLETED|Overall Study||72||
59526620|NCT01314001|75622302|FG005|NOT COMPLETED|Overall Study||71||
59526621|NCT00154466|75622319|FG000|STARTED|Overall Study||20||
59526622|NCT00154466|75622320|FG001|STARTED|Overall Study||19||
59526623|NCT00154466|75622321|FG002|STARTED|Overall Study|Healthy controls underwent the test of myocardial perfusion only at baseline.|19||
59526624|NCT00154466|75622319|FG000|COMPLETED|Overall Study||20||
59526625|NCT00154466|75622320|FG001|COMPLETED|Overall Study||19||
59526626|NCT00154466|75622321|FG002|COMPLETED|Overall Study||19||
59526627|NCT00154466|75622319|FG000|NOT COMPLETED|Overall Study||0||
59526628|NCT00154466|75622320|FG001|NOT COMPLETED|Overall Study||0||
59526629|NCT00154466|75622321|FG002|NOT COMPLETED|Overall Study||0||
59526630|NCT00117806|75622333|FG000|STARTED|Overall Study||81||
59526631|NCT00117806|75622334|FG001|STARTED|Overall Study||76||
59526632|NCT00117806|75622333|FG000|COMPLETED|Overall Study||43||
59526633|NCT00117806|75622334|FG001|COMPLETED|Overall Study||60||
59526634|NCT00117806|75622333|FG000|NOT COMPLETED|Overall Study||38||
59526635|NCT00117806|75622334|FG001|NOT COMPLETED|Overall Study||16||
59526636|NCT01363999|75622343|FG000|STARTED|A: RO5317116/F01 Bilayer Tablet||24||
59526637|NCT01363999|75622343|FG000|COMPLETED|A: RO5317116/F01 Bilayer Tablet||24||
59526638|NCT01363999|75622343|FG000|NOT COMPLETED|A: RO5317116/F01 Bilayer Tablet||0||
59526639|NCT01363999|75622343|FG000|STARTED|B: RO5317116/F03 Bilayer Tablet||24||
59526640|NCT01363999|75622343|FG000|COMPLETED|B: RO5317116/F03 Bilayer Tablet||24||
59526641|NCT01363999|75622343|FG000|NOT COMPLETED|B: RO5317116/F03 Bilayer Tablet||0||
59526642|NCT01363999|75622343|FG000|STARTED|C: RO5317116/ F04 Active-coated Tablet||24||
59526643|NCT01363999|75622343|FG000|COMPLETED|C: RO5317116/ F04 Active-coated Tablet||24||
59622601|NCT00433992|75734453|FG001|NOT COMPLETED|Overall Study||8||
59984059|NCT02554682|76099493|FG002|NOT COMPLETED|Overall Study||4||
59984060|NCT02554682|76099494|FG003|NOT COMPLETED|Overall Study||3||
59984061|NCT02554682|76099495|FG004|NOT COMPLETED|Overall Study||2||
59984062|NCT02554682|76099496|FG005|NOT COMPLETED|Overall Study||1||
59984063|NCT02554682|76099497|FG006|NOT COMPLETED|Overall Study||6||
59984064|NCT02554682|76099498|FG007|NOT COMPLETED|Overall Study||6||
59984065|NCT02554682|76099499|FG008|NOT COMPLETED|Overall Study||2||
59984066|NCT02554682|76099500|FG009|NOT COMPLETED|Overall Study||2||
59984067|NCT03782402|76099527|FG000|STARTED|Overall Study||6||
59984068|NCT03782402|76099528|FG001|STARTED|Overall Study||6||
59984069|NCT03782402|76099527|FG000|COMPLETED|Overall Study||6||
59984070|NCT03782402|76099528|FG001|COMPLETED|Overall Study||6||
59984071|NCT03782402|76099527|FG000|NOT COMPLETED|Overall Study||0||
59984072|NCT03782402|76099528|FG001|NOT COMPLETED|Overall Study||0||
59984073|NCT00154063|76099536|FG000|STARTED|Overall Study||104||
59984074|NCT00154063|76099537|FG001|STARTED|Overall Study||102||
59984075|NCT00154063|76099536|FG000|COMPLETED|Overall Study||92||
59984076|NCT00154063|76099537|FG001|COMPLETED|Overall Study||80||
59984077|NCT00154063|76099536|FG000|NOT COMPLETED|Overall Study||12||
59984078|NCT00154063|76099537|FG001|NOT COMPLETED|Overall Study||22||
59984079|NCT02683941|76099549|FG000|STARTED|Double-blind Phase||51||
59984080|NCT02683941|76099550|FG001|STARTED|Double-blind Phase||26||
59984081|NCT02683941|76099549|FG000|COMPLETED|Double-blind Phase||41|Completers are subjects who complete the double-blind phase of the study or die.|
59984082|NCT02683941|76099550|FG001|COMPLETED|Double-blind Phase||21|Completers are subjects who complete the double-blind phase of the study or die.|
59984083|NCT02683941|76099549|FG000|NOT COMPLETED|Double-blind Phase||10||
59984084|NCT02683941|76099550|FG001|NOT COMPLETED|Double-blind Phase||5||
59984085|NCT02683941|76099549|FG000|STARTED|Open-label Treatment Phase||21|"Prior to protocol amendment #5, subjects qualified for the option to continue into the open-label treatment phase if they met the following additional inclusion criteria:~Subjects have central review confirmed/documented disease progression;~There was a request from the subject to receive open-label lanreotide plus BSC;~Subjects were randomized in the placebo plus BSC arm.~Following protocol amendment #5, the open-label treatment phase remained optional for all subjects."|
59984086|NCT02683941|76099550|FG001|STARTED|Open-label Treatment Phase||19|"Prior to protocol amendment #5, subjects qualified for the option to continue into the open-label treatment phase if they met the following additional inclusion criteria:~Subjects have central review confirmed/documented disease progression;~There was a request from the subject to receive open-label lanreotide plus BSC;~Subjects were randomized in the placebo plus BSC arm.~Following protocol amendment #5, the open-label treatment phase remained optional for all subjects."|
59984087|NCT02683941|76099549|FG000|COMPLETED|Open-label Treatment Phase||1|Completers are subjects who complete the open-label treatment phase of the study or die.|
59984088|NCT02683941|76099550|FG001|COMPLETED|Open-label Treatment Phase||6|Completers are subjects who complete the open-label treatment phase of the study or die.|
59984089|NCT02683941|76099549|FG000|NOT COMPLETED|Open-label Treatment Phase||20||
59984090|NCT02683941|76099550|FG001|NOT COMPLETED|Open-label Treatment Phase||13||
59984091|NCT02683941|76099549|FG000|STARTED|Open-label Follow-up Phase||18|Inclusive of subjects who progressed during the double-blind phase or open-label treatment phase.|
59984092|NCT02683941|76099550|FG001|STARTED|Open-label Follow-up Phase||8|Inclusive of subjects who progressed during the double-blind phase or open-label treatment phase.|
59984093|NCT02683941|76099549|FG000|COMPLETED|Open-label Follow-up Phase||0||
59984094|NCT02683941|76099550|FG001|COMPLETED|Open-label Follow-up Phase||0||
59984095|NCT02683941|76099549|FG000|NOT COMPLETED|Open-label Follow-up Phase||18||
59984096|NCT02683941|76099550|FG001|NOT COMPLETED|Open-label Follow-up Phase||8||
59984097|NCT02678247|76099562|FG000|STARTED|First Intervention (7 Weeks)||15||
59984098|NCT02678247|76099563|FG001|STARTED|First Intervention (7 Weeks)||15||
59995422|NCT03016975|76111238|FG002|NOT COMPLETED|At 4-year Follow-up||0||
59814939|NCT00573443|75937358|FG001|COMPLETED|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0||
59814940|NCT00573443|75937359|FG002|COMPLETED|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0||
59814941|NCT00573443|75937357|FG000|NOT COMPLETED|Open-Label Extension Phase||18||
59814942|NCT00573443|75937358|FG001|NOT COMPLETED|Open-Label Extension Phase||0||
59814943|NCT00573443|75937359|FG002|NOT COMPLETED|Open-Label Extension Phase||0||
59814944|NCT00420849|75937368|FG000|STARTED|Overall Study||587||
59814945|NCT00420849|75937368|FG000|COMPLETED|Overall Study|Participants completed the study upon commercial availability of lenalidomide|256||
59814946|NCT00420849|75937368|FG000|NOT COMPLETED|Overall Study||331||
59814947|NCT00617279|75937377|FG000|STARTED|Overall Study||14||
59814948|NCT00617279|75937378|FG001|STARTED|Overall Study||17||
59814949|NCT00617279|75937377|FG000|COMPLETED|Overall Study||0||
59814950|NCT00617279|75937378|FG001|COMPLETED|Overall Study||0||
59814951|NCT00617279|75937377|FG000|NOT COMPLETED|Overall Study||14||
59814952|NCT00617279|75937378|FG001|NOT COMPLETED|Overall Study||17||
59814953|NCT00420381|75937384|FG000|STARTED|Overall Study||28||
59814954|NCT00420381|75937384|FG000|Received at Least One Dose of Study Drug|Overall Study||27||
59814955|NCT00420381|75937384|FG000|COMPLETED|Overall Study||27||
59814956|NCT00420381|75937384|FG000|NOT COMPLETED|Overall Study||1||
59814957|NCT00617201|75937390|FG000|STARTED|Overall Study||25||
59814958|NCT00617201|75937391|FG001|STARTED|Overall Study||25||
59814959|NCT00617201|75937390|FG000|COMPLETED|Overall Study||16||
59814960|NCT00617201|75937391|FG001|COMPLETED|Overall Study||12||
59814961|NCT00617201|75937390|FG000|NOT COMPLETED|Overall Study||9||
59814962|NCT00617201|75937391|FG001|NOT COMPLETED|Overall Study||13||
59814963|NCT00420303|75937401|FG000|STARTED|Overall Study||12||
59814964|NCT00420303|75937402|FG001|STARTED|Overall Study||12||
59814965|NCT00420303|75937401|FG000|COMPLETED|Overall Study||11||
59814966|NCT00420303|75937402|FG001|COMPLETED|Overall Study||8||
59814967|NCT00420303|75937401|FG000|NOT COMPLETED|Overall Study||1||
59814968|NCT00420303|75937402|FG001|NOT COMPLETED|Overall Study||4||
59814969|NCT00617123|75937410|FG000|STARTED|Referral Screening Period||137||
59814970|NCT00617123|75937411|FG001|STARTED|Referral Screening Period||121||
59814971|NCT00617123|75937410|FG000|COMPLETED|Referral Screening Period||98||
59814972|NCT00617123|75937411|FG001|COMPLETED|Referral Screening Period||95||
59814973|NCT00617123|75937410|FG000|NOT COMPLETED|Referral Screening Period||39||
59814974|NCT00617123|75937411|FG001|NOT COMPLETED|Referral Screening Period||26||
59814975|NCT00617123|75937410|FG000|STARTED|Study Treatment Period||98||
59814976|NCT00617123|75937411|FG001|STARTED|Study Treatment Period||95||
59984099|NCT02678247|76099562|FG000|COMPLETED|First Intervention (7 Weeks)||13||
59984100|NCT02678247|76099563|FG001|COMPLETED|First Intervention (7 Weeks)||11||
59984101|NCT02678247|76099562|FG000|NOT COMPLETED|First Intervention (7 Weeks)||2||
59984102|NCT02678247|76099563|FG001|NOT COMPLETED|First Intervention (7 Weeks)||4||
59984103|NCT02678247|76099562|FG000|STARTED|Second Intervention (7 Weeks)|One subject crossed over despite not completing all data collection time points for the preceding socket.|14||
59984104|NCT02678247|76099563|FG001|STARTED|Second Intervention (7 Weeks)||11||
59984105|NCT02678247|76099562|FG000|COMPLETED|Second Intervention (7 Weeks)||10||
59984106|NCT02678247|76099563|FG001|COMPLETED|Second Intervention (7 Weeks)||9||
59984107|NCT02678247|76099562|FG000|NOT COMPLETED|Second Intervention (7 Weeks)||4||
59984108|NCT02678247|76099563|FG001|NOT COMPLETED|Second Intervention (7 Weeks)||2||
59984109|NCT02683785|76099576|FG000|STARTED|Overall Study||22||
59984110|NCT02683785|76099577|FG001|STARTED|Overall Study||22||
59984111|NCT02683785|76099576|FG000|COMPLETED|Overall Study||21||
59984112|NCT02683785|76099577|FG001|COMPLETED|Overall Study||18||
59984113|NCT02683785|76099576|FG000|NOT COMPLETED|Overall Study||1||
59984114|NCT02683785|76099577|FG001|NOT COMPLETED|Overall Study||4||
59984115|NCT02543294|76099585|FG000|STARTED|Overall Study||20||
59984116|NCT02543294|76099585|FG000|COMPLETED|Overall Study||8||
59984117|NCT02543294|76099585|FG000|NOT COMPLETED|Overall Study||12||
59984118|NCT02551874|76099592|FG000|STARTED|Overall Study||324||
59984119|NCT02551874|76099593|FG001|STARTED|Overall Study||326||
59984120|NCT02551874|76099592|FG000|Received Treatment in Short-term Study|Overall Study||324||
59984121|NCT02551874|76099593|FG001|Received Treatment in Short-term Study|Overall Study||319||
59984122|NCT02551874|76099592|FG000|Entered Long-term Study|Overall Study||306||
59984123|NCT02551874|76099593|FG001|Entered Long-term Study|Overall Study||294||
59984124|NCT02551874|76099592|FG000|Received Treatment in Long-term Study|Overall Study||295||
59984125|NCT02551874|76099593|FG001|Received Treatment in Long-term Study|Overall Study||284||
59984126|NCT02551874|76099592|FG000|COMPLETED|Overall Study||296||
59984127|NCT02551874|76099593|FG001|COMPLETED|Overall Study||287||
59984128|NCT02551874|76099592|FG000|NOT COMPLETED|Overall Study||28||
59984129|NCT02551874|76099593|FG001|NOT COMPLETED|Overall Study||39||
59984130|NCT02706626|76099602|FG000|STARTED|Overall Study||27||
59984131|NCT02706626|76099603|FG001|STARTED|Overall Study||4||
59984132|NCT02706626|76099604|FG002|STARTED|Overall Study|3 subjects from cohort A transitioned to cohort C, total unique subjects = 32|1||
59984133|NCT02706626|76099602|FG000|COMPLETED|Overall Study||27||
59984134|NCT02706626|76099603|FG001|COMPLETED|Overall Study||4||
59984135|NCT02706626|76099604|FG002|COMPLETED|Overall Study||1||
59814977|NCT00617123|75937410|FG000|Treated|Study Treatment Period|1 participant was not treated|97||
59814978|NCT00617123|75937411|FG001|Treated|Study Treatment Period||95||
59814979|NCT00617123|75937410|FG000|COMPLETED|Study Treatment Period||81||
59814980|NCT00617123|75937411|FG001|COMPLETED|Study Treatment Period||79||
59814981|NCT00617123|75937410|FG000|NOT COMPLETED|Study Treatment Period||17||
59814982|NCT00617123|75937411|FG001|NOT COMPLETED|Study Treatment Period||16||
59814983|NCT00419757|75937419|FG000|STARTED|Overall Study|Randomized patients|127||
59814984|NCT00419757|75937420|FG001|STARTED|Overall Study|Randomized patients|123||
59814985|NCT00419757|75937419|FG000|COMPLETED|Overall Study|Randomized patients|109||
59814986|NCT00419757|75937420|FG001|COMPLETED|Overall Study|Randomized patients|102||
59814987|NCT00419757|75937419|FG000|NOT COMPLETED|Overall Study||18||
59814988|NCT00419757|75937420|FG001|NOT COMPLETED|Overall Study||21||
59814989|NCT00434109|75937428|FG000|STARTED|Overall Study||39||
59814990|NCT00434109|75937428|FG000|COMPLETED|Overall Study|Patients completing the maximum eight cycles of sunitinib.|21||
59814991|NCT00434109|75937428|FG000|NOT COMPLETED|Overall Study||18||
59814992|NCT00433329|75937432|FG000|STARTED|Overall Study||100||
59814993|NCT00433329|75937432|FG000|COMPLETED|Overall Study||79||
59814994|NCT00433329|75937432|FG000|NOT COMPLETED|Overall Study||21||
59814995|NCT00616421|75937439|FG000|STARTED|Overall Study||359||
59814996|NCT00616421|75937440|FG001|STARTED|Overall Study||1278||
59984136|NCT02706626|76099602|FG000|NOT COMPLETED|Overall Study||0||
59984137|NCT02706626|76099603|FG001|NOT COMPLETED|Overall Study||0||
59984138|NCT02706626|76099604|FG002|NOT COMPLETED|Overall Study||0||
59984139|NCT02550938|76099616|FG000|STARTED|Overall Study||44||
59984140|NCT02550938|76099617|FG001|STARTED|Overall Study||85||
59814997|NCT00616421|75937441|FG002|STARTED|Overall Study||1270||
59814998|NCT00616421|75937439|FG000|COMPLETED|Overall Study||333||
59814999|NCT00616421|75937440|FG001|COMPLETED|Overall Study||1240||
59815000|NCT00616421|75937441|FG002|COMPLETED|Overall Study||1229||
59815001|NCT00616421|75937439|FG000|NOT COMPLETED|Overall Study||26||
59984141|NCT02550938|76099618|FG002|STARTED|Overall Study||43||
59984142|NCT02550938|76099619|FG003|STARTED|Overall Study||81||
59984143|NCT02550938|76099616|FG000|COMPLETED|Overall Study||36||
59984144|NCT02550938|76099617|FG001|COMPLETED|Overall Study||78||
59984145|NCT02550938|76099618|FG002|COMPLETED|Overall Study||31||
59622602|NCT00535938|75734465|FG000|STARTED|Overall Study||506||
59815002|NCT00616421|75937440|FG001|NOT COMPLETED|Overall Study||38||
59815003|NCT00616421|75937441|FG002|NOT COMPLETED|Overall Study||41||
59815004|NCT00433017|75937465|FG000|STARTED|Overall Study||122||
59815005|NCT00433017|75937466|FG001|STARTED|Overall Study||133||
59815006|NCT00433017|75937465|FG000|Completed 12 Month Phase|Overall Study||114||
59815007|NCT00433017|75937466|FG001|Completed 12 Month Phase|Overall Study||126||
59815008|NCT00433017|75937465|FG000|COMPLETED|Overall Study||26||
59815009|NCT00433017|75937466|FG001|COMPLETED|Overall Study||32||
59815010|NCT00433017|75937465|FG000|NOT COMPLETED|Overall Study||96||
59815011|NCT00433017|75937466|FG001|NOT COMPLETED|Overall Study||101||
59815012|NCT03726671|75937472|FG000|STARTED|First Intervention (2 Weeks)||27||
59815013|NCT03726671|75937473|FG001|STARTED|First Intervention (2 Weeks)||14||
59815014|NCT03726671|75937474|FG002|STARTED|First Intervention (2 Weeks)||14||
59815015|NCT03726671|75937475|FG003|STARTED|First Intervention (2 Weeks)||13||
59815016|NCT03726671|75937476|FG004|STARTED|First Intervention (2 Weeks)||24||
59815017|NCT03726671|75937477|FG005|STARTED|First Intervention (2 Weeks)||9||
59815018|NCT03726671|75937472|FG000|COMPLETED|First Intervention (2 Weeks)||20||
59815019|NCT03726671|75937473|FG001|COMPLETED|First Intervention (2 Weeks)||12||
59815020|NCT03726671|75937474|FG002|COMPLETED|First Intervention (2 Weeks)||12||
59815021|NCT03726671|75937475|FG003|COMPLETED|First Intervention (2 Weeks)||12||
59815022|NCT03726671|75937476|FG004|COMPLETED|First Intervention (2 Weeks)||19||
59815023|NCT03726671|75937477|FG005|COMPLETED|First Intervention (2 Weeks)||8||
59815024|NCT03726671|75937472|FG000|NOT COMPLETED|First Intervention (2 Weeks)||7||
59815025|NCT03726671|75937473|FG001|NOT COMPLETED|First Intervention (2 Weeks)||2||
59815026|NCT03726671|75937474|FG002|NOT COMPLETED|First Intervention (2 Weeks)||2||
59815027|NCT03726671|75937475|FG003|NOT COMPLETED|First Intervention (2 Weeks)||1||
59815028|NCT03726671|75937476|FG004|NOT COMPLETED|First Intervention (2 Weeks)||5||
59815029|NCT03726671|75937477|FG005|NOT COMPLETED|First Intervention (2 Weeks)||1||
59815030|NCT03726671|75937472|FG000|STARTED|Washout (>/= 2 Weeks)||20||
59815031|NCT03726671|75937473|FG001|STARTED|Washout (>/= 2 Weeks)||12||
59815032|NCT03726671|75937474|FG002|STARTED|Washout (>/= 2 Weeks)||12||
59815033|NCT03726671|75937475|FG003|STARTED|Washout (>/= 2 Weeks)||12||
59815034|NCT03726671|75937476|FG004|STARTED|Washout (>/= 2 Weeks)||19||
59815035|NCT03726671|75937477|FG005|STARTED|Washout (>/= 2 Weeks)||8||
59815036|NCT03726671|75937472|FG000|COMPLETED|Washout (>/= 2 Weeks)||20||
59815037|NCT03726671|75937473|FG001|COMPLETED|Washout (>/= 2 Weeks)||12||
59815038|NCT03726671|75937474|FG002|COMPLETED|Washout (>/= 2 Weeks)||12||
59815039|NCT03726671|75937475|FG003|COMPLETED|Washout (>/= 2 Weeks)||12||
59815040|NCT03726671|75937476|FG004|COMPLETED|Washout (>/= 2 Weeks)||19||
59815041|NCT03726671|75937477|FG005|COMPLETED|Washout (>/= 2 Weeks)||8||
59815042|NCT03726671|75937472|FG000|NOT COMPLETED|Washout (>/= 2 Weeks)||0||
59815043|NCT03726671|75937473|FG001|NOT COMPLETED|Washout (>/= 2 Weeks)||0||
59815044|NCT03726671|75937474|FG002|NOT COMPLETED|Washout (>/= 2 Weeks)||0||
59815045|NCT03726671|75937475|FG003|NOT COMPLETED|Washout (>/= 2 Weeks)||0||
59815046|NCT03726671|75937476|FG004|NOT COMPLETED|Washout (>/= 2 Weeks)||0||
59815047|NCT03726671|75937477|FG005|NOT COMPLETED|Washout (>/= 2 Weeks)||0||
59815048|NCT03726671|75937472|FG000|STARTED|Second Intervention (2 Weeks)||20||
59815049|NCT03726671|75937473|FG001|STARTED|Second Intervention (2 Weeks)||12||
59815050|NCT03726671|75937474|FG002|STARTED|Second Intervention (2 Weeks)||12||
59815051|NCT03726671|75937475|FG003|STARTED|Second Intervention (2 Weeks)||12||
59815052|NCT03726671|75937476|FG004|STARTED|Second Intervention (2 Weeks)||19||
59622603|NCT00535938|75734466|FG001|STARTED|Overall Study||866||
59815053|NCT03726671|75937477|FG005|STARTED|Second Intervention (2 Weeks)||8||
59815054|NCT03726671|75937472|FG000|COMPLETED|Second Intervention (2 Weeks)||17||
59815055|NCT03726671|75937473|FG001|COMPLETED|Second Intervention (2 Weeks)||12||
59815056|NCT03726671|75937474|FG002|COMPLETED|Second Intervention (2 Weeks)||12||
59815057|NCT03726671|75937475|FG003|COMPLETED|Second Intervention (2 Weeks)||11||
59984146|NCT02550938|76099619|FG003|COMPLETED|Overall Study||70||
59984147|NCT02550938|76099616|FG000|NOT COMPLETED|Overall Study||8||
59984148|NCT02550938|76099617|FG001|NOT COMPLETED|Overall Study||7||
59815058|NCT03726671|75937476|FG004|COMPLETED|Second Intervention (2 Weeks)||18||
59815059|NCT03726671|75937477|FG005|COMPLETED|Second Intervention (2 Weeks)||8||
59815060|NCT03726671|75937472|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||3||
59815061|NCT03726671|75937473|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||0||
59815062|NCT03726671|75937474|FG002|NOT COMPLETED|Second Intervention (2 Weeks)||0||
59984149|NCT02550938|76099618|FG002|NOT COMPLETED|Overall Study||12||
59984150|NCT02550938|76099619|FG003|NOT COMPLETED|Overall Study||11||
59984151|NCT02769065|76099659|FG000|STARTED|Overall Study||17||
59622604|NCT00535938|75734465|FG000|COMPLETED|Overall Study||115||
59984152|NCT02769065|76099660|FG001|STARTED|Overall Study||6||
59984153|NCT02769065|76099661|FG002|STARTED|Overall Study||6||
59984154|NCT02769065|76099662|FG003|STARTED|Overall Study||6||
59984155|NCT02769065|76099663|FG004|STARTED|Overall Study||6||
59984156|NCT02769065|76099664|FG005|STARTED|Overall Study||6||
59984157|NCT02769065|76099665|FG006|STARTED|Overall Study||7||
59984158|NCT02769065|76099666|FG007|STARTED|Overall Study||6||
59984159|NCT02769065|76099667|FG008|STARTED|Overall Study||6||
59984160|NCT02769065|76099668|FG009|STARTED|Overall Study||6||
59984161|NCT02769065|76099669|FG010|STARTED|Overall Study||6||
59984162|NCT02769065|76099670|FG011|STARTED|Overall Study||6||
59984163|NCT02769065|76099671|FG012|STARTED|Overall Study||6||
59984164|NCT02769065|76099672|FG013|STARTED|Overall Study||6||
59984165|NCT02769065|76099673|FG014|STARTED|Overall Study||6||
59984166|NCT02769065|76099674|FG015|STARTED|Overall Study||3||
59984167|NCT02769065|76099675|FG016|STARTED|Overall Study||5||
59984168|NCT02769065|76099676|FG017|STARTED|Overall Study||5||
59984169|NCT02769065|76099677|FG018|STARTED|Overall Study||5||
59984170|NCT02769065|76099678|FG019|STARTED|Overall Study||0||
59984171|NCT02769065|76099679|FG020|STARTED|Overall Study||4||
59984172|NCT02769065|76099680|FG021|STARTED|Overall Study||4||
59984173|NCT02769065|76099681|FG022|STARTED|Overall Study||4||
59984174|NCT02769065|76099682|FG023|STARTED|Overall Study||6||
59984175|NCT02769065|76099683|FG024|STARTED|Overall Study||6||
59984176|NCT02769065|76099684|FG025|STARTED|Overall Study||9||
59984177|NCT02769065|76099685|FG026|STARTED|Overall Study||9||
59984178|NCT02769065|76099686|FG027|STARTED|Overall Study||5||
59984179|NCT02769065|76099687|FG028|STARTED|Overall Study||6||
59984180|NCT02769065|76099688|FG029|STARTED|Overall Study||6||
59984181|NCT02769065|76099659|FG000|COMPLETED|Overall Study||16||
59984182|NCT02769065|76099660|FG001|COMPLETED|Overall Study||6||
59984183|NCT02769065|76099661|FG002|COMPLETED|Overall Study||6||
59984184|NCT02769065|76099662|FG003|COMPLETED|Overall Study||6||
59984185|NCT02769065|76099663|FG004|COMPLETED|Overall Study||6||
59984186|NCT02769065|76099664|FG005|COMPLETED|Overall Study||6||
59984187|NCT02769065|76099665|FG006|COMPLETED|Overall Study||6||
59984188|NCT02769065|76099666|FG007|COMPLETED|Overall Study||6||
59984189|NCT02769065|76099667|FG008|COMPLETED|Overall Study||6||
59984190|NCT02769065|76099668|FG009|COMPLETED|Overall Study||6||
59984191|NCT02769065|76099669|FG010|COMPLETED|Overall Study||5||
59984192|NCT02769065|76099670|FG011|COMPLETED|Overall Study||6||
59984193|NCT02769065|76099671|FG012|COMPLETED|Overall Study||6||
59984194|NCT02769065|76099672|FG013|COMPLETED|Overall Study||6||
59984195|NCT02769065|76099673|FG014|COMPLETED|Overall Study||6||
59984196|NCT02769065|76099674|FG015|COMPLETED|Overall Study||3||
59984197|NCT02769065|76099675|FG016|COMPLETED|Overall Study||5||
59984198|NCT02769065|76099676|FG017|COMPLETED|Overall Study||5||
59984199|NCT02769065|76099677|FG018|COMPLETED|Overall Study||5||
59984200|NCT02769065|76099678|FG019|COMPLETED|Overall Study||0||
59984201|NCT02769065|76099679|FG020|COMPLETED|Overall Study||4||
59984202|NCT02769065|76099680|FG021|COMPLETED|Overall Study||4||
59984203|NCT02769065|76099681|FG022|COMPLETED|Overall Study||4||
59984204|NCT02769065|76099682|FG023|COMPLETED|Overall Study||6||
59984205|NCT02769065|76099683|FG024|COMPLETED|Overall Study||6||
59984206|NCT02769065|76099684|FG025|COMPLETED|Overall Study||9||
59984207|NCT02769065|76099685|FG026|COMPLETED|Overall Study||9||
59984208|NCT02769065|76099686|FG027|COMPLETED|Overall Study||5||
59984209|NCT02769065|76099687|FG028|COMPLETED|Overall Study||6||
59984210|NCT02769065|76099688|FG029|COMPLETED|Overall Study||6||
59984211|NCT02769065|76099659|FG000|NOT COMPLETED|Overall Study||1||
59984212|NCT02769065|76099660|FG001|NOT COMPLETED|Overall Study||0||
59984213|NCT02769065|76099661|FG002|NOT COMPLETED|Overall Study||0||
60074861|NCT01930045|76190107|FG004|STARTED|Part 2 - Period 4||3||
60074862|NCT01930045|76190108|FG005|STARTED|Part 2 - Period 4||1||
60074863|NCT01930045|76190103|FG000|COMPLETED|Part 2 - Period 4||3||
60074864|NCT01930045|76190104|FG001|COMPLETED|Part 2 - Period 4||3||
60074865|NCT01930045|76190105|FG002|COMPLETED|Part 2 - Period 4||3||
59815063|NCT03726671|75937475|FG003|NOT COMPLETED|Second Intervention (2 Weeks)||1||
59984214|NCT02769065|76099662|FG003|NOT COMPLETED|Overall Study||0||
59984215|NCT02769065|76099663|FG004|NOT COMPLETED|Overall Study||0||
59984216|NCT02769065|76099664|FG005|NOT COMPLETED|Overall Study||0||
59984217|NCT02769065|76099665|FG006|NOT COMPLETED|Overall Study||1||
59984218|NCT02769065|76099666|FG007|NOT COMPLETED|Overall Study||0||
59984219|NCT02769065|76099667|FG008|NOT COMPLETED|Overall Study||0||
59984220|NCT02769065|76099668|FG009|NOT COMPLETED|Overall Study||0||
59984221|NCT02769065|76099669|FG010|NOT COMPLETED|Overall Study||1||
59984222|NCT02769065|76099670|FG011|NOT COMPLETED|Overall Study||0||
59984223|NCT02769065|76099671|FG012|NOT COMPLETED|Overall Study||0||
59984224|NCT02769065|76099672|FG013|NOT COMPLETED|Overall Study||0||
59984225|NCT02769065|76099673|FG014|NOT COMPLETED|Overall Study||0||
59984226|NCT02769065|76099674|FG015|NOT COMPLETED|Overall Study||0||
59984227|NCT02769065|76099675|FG016|NOT COMPLETED|Overall Study||0||
59984228|NCT02769065|76099676|FG017|NOT COMPLETED|Overall Study||0||
60074866|NCT01930045|76190106|FG003|COMPLETED|Part 2 - Period 4||3||
59984229|NCT02769065|76099677|FG018|NOT COMPLETED|Overall Study||0||
59984230|NCT02769065|76099678|FG019|NOT COMPLETED|Overall Study||0||
59984231|NCT02769065|76099679|FG020|NOT COMPLETED|Overall Study||0||
59984232|NCT02769065|76099680|FG021|NOT COMPLETED|Overall Study||0||
59984233|NCT02769065|76099681|FG022|NOT COMPLETED|Overall Study||0||
59984234|NCT02769065|76099682|FG023|NOT COMPLETED|Overall Study||0||
59984235|NCT02769065|76099683|FG024|NOT COMPLETED|Overall Study||0||
59984236|NCT02769065|76099684|FG025|NOT COMPLETED|Overall Study||0||
59984237|NCT02769065|76099685|FG026|NOT COMPLETED|Overall Study||0||
59984238|NCT02769065|76099686|FG027|NOT COMPLETED|Overall Study||0||
59984239|NCT02769065|76099687|FG028|NOT COMPLETED|Overall Study||0||
59984240|NCT02769065|76099688|FG029|NOT COMPLETED|Overall Study||0||
59984241|NCT02681523|76099781|FG000|STARTED|Overall Study||8||
59984242|NCT02681523|76099781|FG000|COMPLETED|Overall Study||6||
59984243|NCT02681523|76099781|FG000|NOT COMPLETED|Overall Study||2||
59984244|NCT02540954|76099787|FG000|STARTED|Overall Study||168|Randomized|
59984245|NCT02540954|76099788|FG001|STARTED|Overall Study||168|Randomized|
59984246|NCT02540954|76099787|FG000|Treated|Overall Study||167||
59984247|NCT02540954|76099788|FG001|Treated|Overall Study||168||
59984248|NCT02540954|76099787|FG000|Post-baseline BCVA Assessment|Overall Study|FAS|165||
59984249|NCT02540954|76099788|FG001|Post-baseline BCVA Assessment|Overall Study|FAS|167||
59984250|NCT02540954|76099787|FG000|COMPLETED|Overall Study|Completed treatment|149||
59984251|NCT02540954|76099788|FG001|COMPLETED|Overall Study|Completed treatment|154||
59984252|NCT02540954|76099787|FG000|NOT COMPLETED|Overall Study||19||
59984253|NCT02540954|76099788|FG001|NOT COMPLETED|Overall Study||14||
59984254|NCT02658812|76099794|FG000|STARTED|Overall Study||9||
59984255|NCT02658812|76099794|FG000|COMPLETED|Overall Study||0||
59984256|NCT02658812|76099794|FG000|NOT COMPLETED|Overall Study||9||
59984257|NCT02680665|76099798|FG000|STARTED|Overall Study||120||
59984258|NCT02680665|76099798|FG000|COMPLETED|Overall Study||115||
59984259|NCT02680665|76099798|FG000|NOT COMPLETED|Overall Study||5||
59984260|NCT00154375|76099804|FG000|STARTED|Overall Study||120||
59984261|NCT00154375|76099805|FG001|STARTED|Overall Study||120||
59984262|NCT00154375|76099804|FG000|Discontinued Study Treatment|Overall Study||111||
59984263|NCT00154375|76099805|FG001|Discontinued Study Treatment|Overall Study||104||
59984264|NCT00154375|76099804|FG000|Not Exposed to Study Treatment|Overall Study|4 randomized patients didn't receive study treatment were excluded from the safety analyses.|2||
59984265|NCT00154375|76099805|FG001|Not Exposed to Study Treatment|Overall Study||2||
59984266|NCT00154375|76099804|FG000|COMPLETED|Overall Study||7||
59984267|NCT00154375|76099805|FG001|COMPLETED|Overall Study||14||
59984268|NCT00154375|76099804|FG000|NOT COMPLETED|Overall Study||113||
59984269|NCT00154375|76099805|FG001|NOT COMPLETED|Overall Study||106||
59984270|NCT02765399|76099814|FG000|STARTED|Overall Study||16||
59984271|NCT02765399|76099815|FG001|STARTED|Overall Study||7||
59984272|NCT02765399|76099814|FG000|COMPLETED|Overall Study||15||
59984273|NCT02765399|76099815|FG001|COMPLETED|Overall Study||7||
59984274|NCT02765399|76099814|FG000|NOT COMPLETED|Overall Study||1||
59984275|NCT02765399|76099815|FG001|NOT COMPLETED|Overall Study||0||
59984276|NCT02676765|76099823|FG000|STARTED|Overall Study||10||
59984277|NCT02676765|76099824|FG001|STARTED|Overall Study||10||
59984278|NCT02676765|76099823|FG000|COMPLETED|Overall Study||10||
59984279|NCT02676765|76099824|FG001|COMPLETED|Overall Study||9||
59984280|NCT02676765|76099823|FG000|NOT COMPLETED|Overall Study||0||
59984281|NCT02676765|76099824|FG001|NOT COMPLETED|Overall Study||1||
59984282|NCT02680041|76099830|FG000|STARTED|Overall Study||221||
59984283|NCT02680041|76099830|FG000|Received 18F-fluciclovine|Overall Study||213||
59984284|NCT02680041|76099830|FG000|COMPLETED|Overall Study||211||
59984285|NCT02680041|76099830|FG000|NOT COMPLETED|Overall Study||10||
59984286|NCT02547974|76099839|FG000|STARTED|Overall Study||15||
59984287|NCT02547974|76099840|FG001|STARTED|Overall Study||31||
59984288|NCT02547974|76099841|FG002|STARTED|Overall Study||30||
59984289|NCT02547974|76099842|FG003|STARTED|Overall Study||44||
59984290|NCT02547974|76099839|FG000|COMPLETED|Overall Study||14||
59984291|NCT02547974|76099840|FG001|COMPLETED|Overall Study||31||
59984292|NCT02547974|76099841|FG002|COMPLETED|Overall Study||30||
59984293|NCT02547974|76099842|FG003|COMPLETED|Overall Study||44||
59984294|NCT02547974|76099839|FG000|NOT COMPLETED|Overall Study||1||
59984295|NCT02547974|76099840|FG001|NOT COMPLETED|Overall Study||0||
59984296|NCT02547974|76099841|FG002|NOT COMPLETED|Overall Study||0||
59984297|NCT02547974|76099842|FG003|NOT COMPLETED|Overall Study||0||
59984298|NCT00154297|76099857|FG000|STARTED|Overall Study|Randomized population.|65||
59984299|NCT00154297|76099858|FG001|STARTED|Overall Study|Randomized population.|74||
59984300|NCT00154297|76099857|FG000|COMPLETED|Overall Study|Completed study by 12 month.|57||
59984301|NCT00154297|76099858|FG001|COMPLETED|Overall Study|Completed study by 12 month.|67||
59984302|NCT00154297|76099857|FG000|NOT COMPLETED|Overall Study||8||
59984303|NCT00154297|76099858|FG001|NOT COMPLETED|Overall Study||7||
59984304|NCT02679729|76099873|FG000|STARTED|Overall Study||6||
59984305|NCT02679729|76099874|FG001|STARTED|Overall Study||7||
59984306|NCT02679729|76099875|FG002|STARTED|Overall Study||6||
59984307|NCT02679729|76099876|FG003|STARTED|Overall Study||6||
59984308|NCT02679729|76099877|FG004|STARTED|Overall Study||6||
59984309|NCT02679729|76099878|FG005|STARTED|Overall Study||6||
59984310|NCT02679729|76099879|FG006|STARTED|Overall Study||6||
59984311|NCT02679729|76099880|FG007|STARTED|Overall Study||14||
59984312|NCT02679729|76099881|FG008|STARTED|Overall Study||6||
59984313|NCT02679729|76099873|FG000|COMPLETED|Overall Study||6||
59984314|NCT02679729|76099874|FG001|COMPLETED|Overall Study||5||
59984315|NCT02679729|76099875|FG002|COMPLETED|Overall Study||6||
59984316|NCT02679729|76099876|FG003|COMPLETED|Overall Study||6||
59984317|NCT02679729|76099877|FG004|COMPLETED|Overall Study||5||
59984318|NCT02679729|76099878|FG005|COMPLETED|Overall Study||6||
59984319|NCT02679729|76099879|FG006|COMPLETED|Overall Study||5||
59984320|NCT02679729|76099880|FG007|COMPLETED|Overall Study||14||
59984321|NCT02679729|76099881|FG008|COMPLETED|Overall Study||6||
59984322|NCT02679729|76099873|FG000|NOT COMPLETED|Overall Study||0||
59984323|NCT02679729|76099874|FG001|NOT COMPLETED|Overall Study||2||
59984324|NCT02679729|76099875|FG002|NOT COMPLETED|Overall Study||0||
59984325|NCT02679729|76099876|FG003|NOT COMPLETED|Overall Study||0||
59984326|NCT02679729|76099877|FG004|NOT COMPLETED|Overall Study||1||
59984327|NCT02679729|76099878|FG005|NOT COMPLETED|Overall Study||0||
59984328|NCT02679729|76099879|FG006|NOT COMPLETED|Overall Study||1||
59984329|NCT02679729|76099880|FG007|NOT COMPLETED|Overall Study||0||
59984330|NCT02679729|76099881|FG008|NOT COMPLETED|Overall Study||0||
59984331|NCT02765165|76099920|FG000|STARTED|Treatment Period||3||
59984332|NCT02765165|76099921|FG001|STARTED|Treatment Period||4||
59984333|NCT02765165|76099922|FG002|STARTED|Treatment Period||3||
59984334|NCT02765165|76099923|FG003|STARTED|Treatment Period||3||
59984335|NCT02765165|76099924|FG004|STARTED|Treatment Period||6||
59984336|NCT02765165|76099925|FG005|STARTED|Treatment Period||3||
59984337|NCT02765165|76099926|FG006|STARTED|Treatment Period||4||
59984338|NCT02765165|76099920|FG000|COMPLETED|Treatment Period|Open-ended design for participation until progression or other reason for withdrawal|0||
59984339|NCT02765165|76099921|FG001|COMPLETED|Treatment Period|Open-ended design for participation until progression or other reason for withdrawal|0||
59984340|NCT02765165|76099922|FG002|COMPLETED|Treatment Period|Open-ended design for participation until progression or other reason for withdrawal|0||
59984341|NCT02765165|76099923|FG003|COMPLETED|Treatment Period|Open-ended design for participation until progression or other reason for withdrawal|0||
59984342|NCT02765165|76099924|FG004|COMPLETED|Treatment Period|Open-ended design for participation until progression or other reason for withdrawal|0||
59984343|NCT02765165|76099925|FG005|COMPLETED|Treatment Period|Open-ended design for participation until progression or other reason for withdrawal|0||
59984344|NCT02765165|76099926|FG006|COMPLETED|Treatment Period|Open-ended design for participation until progression or other reason for withdrawal|0||
59984345|NCT02765165|76099920|FG000|NOT COMPLETED|Treatment Period||3||
59984346|NCT02765165|76099921|FG001|NOT COMPLETED|Treatment Period||4||
59984347|NCT02765165|76099922|FG002|NOT COMPLETED|Treatment Period||3||
59984348|NCT02765165|76099923|FG003|NOT COMPLETED|Treatment Period||3||
59984349|NCT02765165|76099924|FG004|NOT COMPLETED|Treatment Period||6||
59984350|NCT02765165|76099925|FG005|NOT COMPLETED|Treatment Period||3||
59984351|NCT02765165|76099926|FG006|NOT COMPLETED|Treatment Period||4||
59984352|NCT02765165|76099920|FG000|STARTED|Post-treatment Follow-up|Subjects who chose to enter follow-up, including long term follow-up for survival, after discontinuing treatment. Subjects were not required to enter follow-up.|1||
59984353|NCT02765165|76099921|FG001|STARTED|Post-treatment Follow-up|Subjects who chose to enter follow-up, including long term follow-up for survival, after discontinuing treatment. Subjects were not required to enter follow-up.|3||
59984354|NCT02765165|76099922|FG002|STARTED|Post-treatment Follow-up|Subjects who chose to enter follow-up, including long term follow-up for survival, after discontinuing treatment. Subjects were not required to enter follow-up.|3||
59984355|NCT02765165|76099923|FG003|STARTED|Post-treatment Follow-up|Subjects who chose to enter follow-up, including long term follow-up for survival, after discontinuing treatment. Subjects were not required to enter follow-up.|3||
59984356|NCT02765165|76099924|FG004|STARTED|Post-treatment Follow-up|Subjects who chose to enter follow-up, including long term follow-up for survival, after discontinuing treatment. Subjects were not required to enter follow-up.|3||
59984357|NCT02765165|76099925|FG005|STARTED|Post-treatment Follow-up|Subjects who chose to enter follow-up, including long term follow-up for survival, after discontinuing treatment. Subjects were not required to enter follow-up.|3||
59984358|NCT02765165|76099926|FG006|STARTED|Post-treatment Follow-up|Subjects who chose to enter follow-up, including long term follow-up for survival, after discontinuing treatment. Subjects were not required to enter follow-up.|1||
59984359|NCT02765165|76099920|FG000|COMPLETED|Post-treatment Follow-up|Open-ended follow-up|0||
59984360|NCT02765165|76099921|FG001|COMPLETED|Post-treatment Follow-up||0||
59984361|NCT02765165|76099922|FG002|COMPLETED|Post-treatment Follow-up||0||
59984362|NCT02765165|76099923|FG003|COMPLETED|Post-treatment Follow-up||0||
59984363|NCT02765165|76099924|FG004|COMPLETED|Post-treatment Follow-up|Open-ended follow-up|0||
59984364|NCT02765165|76099925|FG005|COMPLETED|Post-treatment Follow-up||0||
59984365|NCT02765165|76099926|FG006|COMPLETED|Post-treatment Follow-up||0||
59984366|NCT02765165|76099920|FG000|NOT COMPLETED|Post-treatment Follow-up||1||
59984367|NCT02765165|76099921|FG001|NOT COMPLETED|Post-treatment Follow-up||3||
59984368|NCT02765165|76099922|FG002|NOT COMPLETED|Post-treatment Follow-up||3||
59984369|NCT02765165|76099923|FG003|NOT COMPLETED|Post-treatment Follow-up||3||
59984370|NCT02765165|76099924|FG004|NOT COMPLETED|Post-treatment Follow-up||3||
59984371|NCT02765165|76099925|FG005|NOT COMPLETED|Post-treatment Follow-up||3||
59984372|NCT02765165|76099926|FG006|NOT COMPLETED|Post-treatment Follow-up||1||
59984373|NCT02675907|76099948|FG000|STARTED|Treatment Phase (48 Hours Post-Dose 1)||100||
59984374|NCT02675907|76099949|FG001|STARTED|Treatment Phase (48 Hours Post-Dose 1)||101||
59984375|NCT02675907|76099948|FG000|COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||95||
59984376|NCT02675907|76099949|FG001|COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||96||
59984377|NCT02675907|76099948|FG000|NOT COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||5||
59984378|NCT02675907|76099949|FG001|NOT COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||5||
59984379|NCT02675907|76099948|FG000|STARTED|Study Overall||100||
59984380|NCT02675907|76099949|FG001|STARTED|Study Overall||101||
59984381|NCT02675907|76099948|FG000|COMPLETED|Study Overall||97||
59984382|NCT02675907|76099949|FG001|COMPLETED|Study Overall||97||
59984383|NCT02675907|76099948|FG000|NOT COMPLETED|Study Overall||3||
59984384|NCT02675907|76099949|FG001|NOT COMPLETED|Study Overall||4||
59984385|NCT02675517|76099955|FG000|STARTED|Overall Study||1737||
59984386|NCT02675517|76099955|FG000|COMPLETED|Overall Study||1578||
59984387|NCT02675517|76099955|FG000|NOT COMPLETED|Overall Study||159||
59984388|NCT02764775|76099959|FG000|STARTED|Overall Study|All 14 participants were assigned to the Headpod utilization group.|14||
59984389|NCT02764775|76099959|FG000|COMPLETED|Overall Study||8||
59984390|NCT02764775|76099959|FG000|NOT COMPLETED|Overall Study||6||
59984391|NCT02774681|76099963|FG000|STARTED|Treatment on Study||12||
59984392|NCT02774681|76099963|FG000|Reached 1st Response/2 Cycles|Treatment on Study||10||
59984393|NCT02774681|76099963|FG000|Went on to Start Cycle 3|Treatment on Study||5||
59984394|NCT02774681|76099963|FG000|COMPLETED|Treatment on Study||5||
59984395|NCT02774681|76099963|FG000|NOT COMPLETED|Treatment on Study||7||
59984396|NCT02774681|76099963|FG000|STARTED|Follow-Up for 3 Years||12||
59984397|NCT02774681|76099963|FG000|COMPLETED|Follow-Up for 3 Years||0||
59984398|NCT02774681|76099963|FG000|NOT COMPLETED|Follow-Up for 3 Years||12||
59984399|NCT02547428|76099969|FG000|STARTED|Period 1- Treatment Sequence 1 (3 Weeks)||42||
59984400|NCT02547428|76099970|FG001|STARTED|Period 1- Treatment Sequence 1 (3 Weeks)||43||
59984401|NCT02547428|76099969|FG000|Received at Least 1 Dose of Study Drug|Period 1- Treatment Sequence 1 (3 Weeks)||42||
60074867|NCT01930045|76190107|FG004|COMPLETED|Part 2 - Period 4||3||
60074868|NCT01930045|76190108|FG005|COMPLETED|Part 2 - Period 4||1||
60074869|NCT01930045|76190103|FG000|NOT COMPLETED|Part 2 - Period 4||0||
60074870|NCT01930045|76190104|FG001|NOT COMPLETED|Part 2 - Period 4||0||
59984402|NCT02547428|76099970|FG001|Received at Least 1 Dose of Study Drug|Period 1- Treatment Sequence 1 (3 Weeks)||43||
59984403|NCT02547428|76099969|FG000|COMPLETED|Period 1- Treatment Sequence 1 (3 Weeks)||31||
59984404|NCT02547428|76099970|FG001|COMPLETED|Period 1- Treatment Sequence 1 (3 Weeks)||37||
59984405|NCT02547428|76099969|FG000|NOT COMPLETED|Period 1- Treatment Sequence 1 (3 Weeks)||11||
59984406|NCT02547428|76099970|FG001|NOT COMPLETED|Period 1- Treatment Sequence 1 (3 Weeks)||6||
59984407|NCT02547428|76099969|FG000|STARTED|Period 2- Treatment Sequence 2 (3 Weeks)||31||
59984408|NCT02547428|76099970|FG001|STARTED|Period 2- Treatment Sequence 2 (3 Weeks)||37||
59984409|NCT02547428|76099969|FG000|COMPLETED|Period 2- Treatment Sequence 2 (3 Weeks)||30||
59984410|NCT02547428|76099970|FG001|COMPLETED|Period 2- Treatment Sequence 2 (3 Weeks)||30||
59984411|NCT02547428|76099969|FG000|NOT COMPLETED|Period 2- Treatment Sequence 2 (3 Weeks)||1||
59984412|NCT02547428|76099970|FG001|NOT COMPLETED|Period 2- Treatment Sequence 2 (3 Weeks)||7||
59984413|NCT01374087|76099985|FG000|STARTED|Overall Study||16|Subjects treated|
59984414|NCT01374087|76099986|FG001|STARTED|Overall Study||15|Subjects treated|
59984415|NCT01374087|76099985|FG000|COMPLETED|Overall Study||0||
59984416|NCT01374087|76099986|FG001|COMPLETED|Overall Study||0||
59984417|NCT01374087|76099985|FG000|NOT COMPLETED|Overall Study||16||
59984418|NCT01374087|76099986|FG001|NOT COMPLETED|Overall Study||15||
59984419|NCT00152971|76099995|FG000|STARTED|Overall Study||857||
59984420|NCT00152971|76099996|FG001|STARTED|Overall Study||871||
59984421|NCT00152971|76099997|FG002|STARTED|Overall Study||868||
59984422|NCT00152971|76099995|FG000|COMPLETED|Overall Study|Non-completers in 'overall study' table may have completed treatment but not study, and vice versa|806||
59984423|NCT00152971|76099996|FG001|COMPLETED|Overall Study|Non-completers in 'overall study' table may have completed treatment but not study, and vice versa|823||
59984424|NCT00152971|76099997|FG002|COMPLETED|Overall Study|Non-completers in 'overall study' table may have completed treatment but not study, and vice versa|819||
59984425|NCT00152971|76099995|FG000|NOT COMPLETED|Overall Study||51||
59984426|NCT00152971|76099996|FG001|NOT COMPLETED|Overall Study||48||
59984427|NCT00152971|76099997|FG002|NOT COMPLETED|Overall Study||49||
59984428|NCT00152971|76099995|FG000|STARTED|Treatment||857||
60074871|NCT01930045|76190105|FG002|NOT COMPLETED|Part 2 - Period 4||0||
59984429|NCT00152971|76099996|FG001|STARTED|Treatment||871||
59984430|NCT00152971|76099997|FG002|STARTED|Treatment||868||
59984431|NCT00152971|76099995|FG000|COMPLETED|Treatment|Non-completers in 'treatment' table may have completed study but not treatment, and vice versa|786||
59984432|NCT00152971|76099996|FG001|COMPLETED|Treatment|Non-completers in 'treatment' table may have completed study but not treatment, and vice versa|808||
59984433|NCT00152971|76099997|FG002|COMPLETED|Treatment|Non-completers in 'treatment' table may have completed study but not treatment, and vice versa|788||
59984434|NCT00152971|76099995|FG000|NOT COMPLETED|Treatment||71||
59984435|NCT00152971|76099996|FG001|NOT COMPLETED|Treatment||63||
59984436|NCT00152971|76099997|FG002|NOT COMPLETED|Treatment||80||
59984437|NCT02538614|76100005|FG000|STARTED|Overall Study||2||
59984438|NCT02538614|76100005|FG000|COMPLETED|Overall Study||0||
59984439|NCT02538614|76100005|FG000|NOT COMPLETED|Overall Study||2||
59984440|NCT04620135|76100013|FG000|STARTED|Intent-to-Treat (ITT) Population||122||
59984441|NCT04620135|76100014|FG001|STARTED|Intent-to-Treat (ITT) Population||123||
59984442|NCT04620135|76100013|FG000|COMPLETED|Intent-to-Treat (ITT) Population||118||
59984443|NCT04620135|76100014|FG001|COMPLETED|Intent-to-Treat (ITT) Population||120||
59984444|NCT04620135|76100013|FG000|NOT COMPLETED|Intent-to-Treat (ITT) Population||4||
59984445|NCT04620135|76100014|FG001|NOT COMPLETED|Intent-to-Treat (ITT) Population||3||
59984446|NCT04620135|76100013|FG000|STARTED|Per-Protocol (PP) Population||121||
59984447|NCT04620135|76100014|FG001|STARTED|Per-Protocol (PP) Population||122||
59984448|NCT04620135|76100013|FG000|COMPLETED|Per-Protocol (PP) Population||117||
59984449|NCT04620135|76100014|FG001|COMPLETED|Per-Protocol (PP) Population||119||
59984450|NCT04620135|76100013|FG000|NOT COMPLETED|Per-Protocol (PP) Population||4||
59984451|NCT04620135|76100014|FG001|NOT COMPLETED|Per-Protocol (PP) Population||3||
59984452|NCT04620135|76100013|FG000|STARTED|Safety Population||122||
59984453|NCT04620135|76100014|FG001|STARTED|Safety Population||123||
59984454|NCT04620135|76100013|FG000|COMPLETED|Safety Population||118||
59984455|NCT04620135|76100014|FG001|COMPLETED|Safety Population||120||
59984456|NCT04620135|76100013|FG000|NOT COMPLETED|Safety Population||4||
59984457|NCT04620135|76100014|FG001|NOT COMPLETED|Safety Population||3||
59984458|NCT04620135|76100013|FG000|STARTED|Study Completion||122||
59984459|NCT04620135|76100014|FG001|STARTED|Study Completion||123||
59984460|NCT04620135|76100013|FG000|COMPLETED|Study Completion||118||
59984461|NCT04620135|76100014|FG001|COMPLETED|Study Completion||120||
59984462|NCT04620135|76100013|FG000|NOT COMPLETED|Study Completion||4||
59984463|NCT04620135|76100014|FG001|NOT COMPLETED|Study Completion||3||
59984464|NCT02552966|76100020|FG000|STARTED|Overall Study||20||
59984465|NCT02552966|76100020|FG000|COMPLETED|Overall Study||15||
59984466|NCT02552966|76100020|FG000|NOT COMPLETED|Overall Study||5||
59984467|NCT02552888|76100026|FG000|STARTED|Overall Study|35 participants were enrolled.|35||
59984468|NCT02552888|76100027|FG001|STARTED|Overall Study|35 participants were enrolled.|35||
59984469|NCT02552888|76100026|FG000|COMPLETED|Overall Study|34 participants completed the study.|34||
59622605|NCT00535938|75734466|FG001|COMPLETED|Overall Study||404||
59984470|NCT02552888|76100027|FG001|COMPLETED|Overall Study|34 participants completed the study|34||
59984471|NCT02552888|76100026|FG000|NOT COMPLETED|Overall Study||1||
59984472|NCT02552888|76100027|FG001|NOT COMPLETED|Overall Study||1||
59984473|NCT02441660|76100037|FG000|STARTED|Sequence 1 (12 Weeks)||5||
59984474|NCT02441660|76100038|FG001|STARTED|Sequence 1 (12 Weeks)||6||
59984475|NCT02441660|76100037|FG000|COMPLETED|Sequence 1 (12 Weeks)||5||
59984476|NCT02441660|76100038|FG001|COMPLETED|Sequence 1 (12 Weeks)||6||
59984477|NCT02441660|76100037|FG000|NOT COMPLETED|Sequence 1 (12 Weeks)||0||
59984478|NCT02441660|76100038|FG001|NOT COMPLETED|Sequence 1 (12 Weeks)||0||
59984479|NCT02441660|76100037|FG000|STARTED|Sequence 2 (12 Weeks)||5||
59984480|NCT02441660|76100038|FG001|STARTED|Sequence 2 (12 Weeks)||6||
59984481|NCT02441660|76100037|FG000|COMPLETED|Sequence 2 (12 Weeks)||5||
59984482|NCT02441660|76100038|FG001|COMPLETED|Sequence 2 (12 Weeks)||6||
59984483|NCT02441660|76100037|FG000|NOT COMPLETED|Sequence 2 (12 Weeks)||0||
59815064|NCT03726671|75937476|FG004|NOT COMPLETED|Second Intervention (2 Weeks)||1||
59984484|NCT02441660|76100038|FG001|NOT COMPLETED|Sequence 2 (12 Weeks)||0||
59984485|NCT01373931|76100046|FG000|STARTED|Lead-in Period||10||
59984486|NCT01373931|76100047|FG001|STARTED|Lead-in Period||10||
59984487|NCT01373931|76100046|FG000|Received at Least 1 Dose of Study Drug|Lead-in Period||8||
59984488|NCT01373931|76100047|FG001|Received at Least 1 Dose of Study Drug|Lead-in Period||10||
59984489|NCT01373931|76100046|FG000|COMPLETED|Lead-in Period||8||
59984490|NCT01373931|76100047|FG001|COMPLETED|Lead-in Period||10||
59984491|NCT01373931|76100046|FG000|NOT COMPLETED|Lead-in Period||2||
59984492|NCT01373931|76100047|FG001|NOT COMPLETED|Lead-in Period||0||
59984493|NCT01373931|76100046|FG000|STARTED|Period 1||8||
59984494|NCT01373931|76100047|FG001|STARTED|Period 1||10||
59984495|NCT01373931|76100046|FG000|COMPLETED|Period 1||6||
59984496|NCT01373931|76100047|FG001|COMPLETED|Period 1||8||
59984497|NCT01373931|76100046|FG000|NOT COMPLETED|Period 1||2||
59984498|NCT01373931|76100047|FG001|NOT COMPLETED|Period 1||2||
59984499|NCT01373931|76100046|FG000|STARTED|Period 2||6||
59984500|NCT01373931|76100047|FG001|STARTED|Period 2||8||
59984501|NCT01373931|76100046|FG000|COMPLETED|Period 2||6||
59984502|NCT01373931|76100047|FG001|COMPLETED|Period 2||8||
59984503|NCT01373931|76100046|FG000|NOT COMPLETED|Period 2||0||
59984504|NCT01373931|76100047|FG001|NOT COMPLETED|Period 2||0||
59984505|NCT02552732|76100054|FG000|STARTED|Overall Study||29||
59984506|NCT02552732|76100054|FG000|Used Device|Overall Study||23||
59984507|NCT02552732|76100054|FG000|Completed Week 1|Overall Study||21||
59984508|NCT02552732|76100054|FG000|Completed Week 2|Overall Study||20||
59984509|NCT02552732|76100054|FG000|Completed Week 3|Overall Study||19||
59984510|NCT02552732|76100054|FG000|Completed Week 4|Overall Study||19||
59984511|NCT02552732|76100054|FG000|Completed Day 1 and Day 31 Spirometry|Overall Study||12||
59984512|NCT02552732|76100054|FG000|COMPLETED|Overall Study||19||
59984513|NCT02552732|76100054|FG000|NOT COMPLETED|Overall Study||10||
59984514|NCT02547038|76100061|FG000|STARTED|Overall Study||176||
59984515|NCT02547038|76100062|FG001|STARTED|Overall Study||176||
59984516|NCT02547038|76100061|FG000|COMPLETED|Overall Study||173||
59984517|NCT02547038|76100062|FG001|COMPLETED|Overall Study||174||
59984518|NCT02547038|76100061|FG000|NOT COMPLETED|Overall Study||3||
59984519|NCT02547038|76100062|FG001|NOT COMPLETED|Overall Study||2||
59984520|NCT02764697|76100068|FG000|STARTED|Overall Study||5||
59984521|NCT02764697|76100068|FG000|COMPLETED|Overall Study||2||
59984522|NCT02764697|76100068|FG000|NOT COMPLETED|Overall Study||3||
59984523|NCT02673489|76100074|FG000|STARTED|Treatment Period||54||
59984524|NCT02673489|76100075|FG001|STARTED|Treatment Period||24||
59984525|NCT02673489|76100074|FG000|COMPLETED|Treatment Period||49||
59984526|NCT02673489|76100075|FG001|COMPLETED|Treatment Period||21||
59984527|NCT02673489|76100074|FG000|NOT COMPLETED|Treatment Period||5||
59984528|NCT02673489|76100075|FG001|NOT COMPLETED|Treatment Period||3||
59984529|NCT02673489|76100074|FG000|STARTED|Follow Up Period||50||
59984530|NCT02673489|76100075|FG001|STARTED|Follow Up Period||23||
59984531|NCT02673489|76100074|FG000|COMPLETED|Follow Up Period||50|Completed Follow-Up Period|
59984532|NCT02673489|76100075|FG001|COMPLETED|Follow Up Period||21|Completed Follow-Up Period|
59984533|NCT02673489|76100074|FG000|NOT COMPLETED|Follow Up Period||0||
59984534|NCT02673489|76100075|FG001|NOT COMPLETED|Follow Up Period||2||
59984535|NCT02772809|76100082|FG000|STARTED|Overall Study||23||
59984536|NCT02772809|76100082|FG000|COMPLETED|Overall Study||17||
59984537|NCT02772809|76100082|FG000|NOT COMPLETED|Overall Study||6||
59984538|NCT02537678|76100093|FG000|STARTED|Baseline to Post-treatment|91 parents/guardians and 91 children started.|91||
59984539|NCT02537678|76100094|FG001|STARTED|Baseline to Post-treatment|92 parents/guardians and 92 children started.|92||
59984540|NCT02537678|76100093|FG000|Completed Post-treatment|Baseline to Post-treatment|61 parents/guardians and 61 children completed post-treatment.|61||
59984541|NCT02537678|76100094|FG001|Completed Post-treatment|Baseline to Post-treatment|71 parents/guardians and 71 children completed post-treatment.|71||
59984542|NCT02537678|76100093|FG000|COMPLETED|Baseline to Post-treatment|61 parent/guardian-child dyads completed.|61||
59984543|NCT02537678|76100094|FG001|COMPLETED|Baseline to Post-treatment|71 parent/guardian-child dyads completed.|71||
59984544|NCT02537678|76100093|FG000|NOT COMPLETED|Baseline to Post-treatment||30||
59984545|NCT02537678|76100094|FG001|NOT COMPLETED|Baseline to Post-treatment||21||
59984546|NCT02537678|76100093|FG000|STARTED|Post-treatment to 6 Month Assessment|61 parents/guardians and 61 children started.|61||
59984547|NCT02537678|76100094|FG001|STARTED|Post-treatment to 6 Month Assessment|71 parents/guardians and 71 children started.|71||
59984548|NCT02537678|76100093|FG000|COMPLETED|Post-treatment to 6 Month Assessment|53 parents/guardians and 53 children completed.|53||
59984549|NCT02537678|76100094|FG001|COMPLETED|Post-treatment to 6 Month Assessment|64 parents/guardians and 64 children completed.|64||
59984550|NCT02537678|76100093|FG000|NOT COMPLETED|Post-treatment to 6 Month Assessment||8||
59984551|NCT02537678|76100094|FG001|NOT COMPLETED|Post-treatment to 6 Month Assessment||7||
59984552|NCT02537678|76100093|FG000|STARTED|6 Month to 12 Month Assessment|53 parent/guardians and 53 children started.|53||
59984553|NCT02537678|76100094|FG001|STARTED|6 Month to 12 Month Assessment|64 parent/guardians and 64 children started.|64||
59984554|NCT02537678|76100093|FG000|COMPLETED|6 Month to 12 Month Assessment|53 parent/guardians and 53 children completed.|53||
59984555|NCT02537678|76100094|FG001|COMPLETED|6 Month to 12 Month Assessment|63 parent/guardians and 63 children completed.|63||
59984556|NCT02537678|76100093|FG000|NOT COMPLETED|6 Month to 12 Month Assessment||0||
59984557|NCT02537678|76100094|FG001|NOT COMPLETED|6 Month to 12 Month Assessment||1||
59984558|NCT02766023|76100106|FG000|STARTED|Overall Study||152||
59984559|NCT02766023|76100107|FG001|STARTED|Overall Study||76||
59984560|NCT02766023|76100106|FG000|COMPLETED|Overall Study||122||
59984561|NCT02766023|76100107|FG001|COMPLETED|Overall Study||59||
60074872|NCT01930045|76190106|FG003|NOT COMPLETED|Part 2 - Period 4||0||
59984562|NCT02766023|76100106|FG000|NOT COMPLETED|Overall Study||30||
59984563|NCT02766023|76100107|FG001|NOT COMPLETED|Overall Study||17||
59984564|NCT02764229|76100113|FG000|STARTED|Overall Study||112||
59984565|NCT02764229|76100113|FG000|COMPLETED|Overall Study||10||
59984566|NCT02764229|76100113|FG000|NOT COMPLETED|Overall Study||102||
59984567|NCT02537522|76100117|FG000|STARTED|Phase I - Contralateral||34||
59984568|NCT02537522|76100118|FG001|STARTED|Phase I - Contralateral||37||
59984569|NCT02537522|76100119|FG002|STARTED|Phase I - Contralateral||0||
59984570|NCT02537522|76100120|FG003|STARTED|Phase I - Contralateral||0||
59984571|NCT02537522|76100117|FG000|COMPLETED|Phase I - Contralateral||19||
59984572|NCT02537522|76100118|FG001|COMPLETED|Phase I - Contralateral||27||
59984573|NCT02537522|76100119|FG002|COMPLETED|Phase I - Contralateral||0||
59984574|NCT02537522|76100120|FG003|COMPLETED|Phase I - Contralateral||0||
59984575|NCT02537522|76100117|FG000|NOT COMPLETED|Phase I - Contralateral||15||
59984576|NCT02537522|76100118|FG001|NOT COMPLETED|Phase I - Contralateral||10||
59984577|NCT02537522|76100119|FG002|NOT COMPLETED|Phase I - Contralateral||0||
59984578|NCT02537522|76100120|FG003|NOT COMPLETED|Phase I - Contralateral||0||
59984579|NCT02537522|76100117|FG000|STARTED|Phase II - Period 1 Bilateral||0||
59984580|NCT02537522|76100118|FG001|STARTED|Phase II - Period 1 Bilateral||0||
59984581|NCT02537522|76100119|FG002|STARTED|Phase II - Period 1 Bilateral||23||
59984582|NCT02537522|76100120|FG003|STARTED|Phase II - Period 1 Bilateral||23||
59984583|NCT02537522|76100117|FG000|COMPLETED|Phase II - Period 1 Bilateral||0||
59984584|NCT02537522|76100118|FG001|COMPLETED|Phase II - Period 1 Bilateral||0||
59984585|NCT02537522|76100119|FG002|COMPLETED|Phase II - Period 1 Bilateral||23||
59984586|NCT02537522|76100120|FG003|COMPLETED|Phase II - Period 1 Bilateral||22||
59984587|NCT02537522|76100117|FG000|NOT COMPLETED|Phase II - Period 1 Bilateral||0||
59984588|NCT02537522|76100118|FG001|NOT COMPLETED|Phase II - Period 1 Bilateral||0||
59984589|NCT02537522|76100119|FG002|NOT COMPLETED|Phase II - Period 1 Bilateral||0||
59984590|NCT02537522|76100120|FG003|NOT COMPLETED|Phase II - Period 1 Bilateral||1||
59984591|NCT02537522|76100117|FG000|STARTED|Phase II - Period 2 Bilateral||0||
59984592|NCT02537522|76100118|FG001|STARTED|Phase II - Period 2 Bilateral||0||
59984593|NCT02537522|76100119|FG002|STARTED|Phase II - Period 2 Bilateral||23||
59984594|NCT02537522|76100120|FG003|STARTED|Phase II - Period 2 Bilateral||22||
59984595|NCT02537522|76100117|FG000|COMPLETED|Phase II - Period 2 Bilateral||0||
59984596|NCT02537522|76100118|FG001|COMPLETED|Phase II - Period 2 Bilateral||0||
59984597|NCT02537522|76100119|FG002|COMPLETED|Phase II - Period 2 Bilateral||23||
59984598|NCT02537522|76100120|FG003|COMPLETED|Phase II - Period 2 Bilateral||22||
59984599|NCT02537522|76100117|FG000|NOT COMPLETED|Phase II - Period 2 Bilateral||0||
59984600|NCT02537522|76100118|FG001|NOT COMPLETED|Phase II - Period 2 Bilateral||0||
59984601|NCT02537522|76100119|FG002|NOT COMPLETED|Phase II - Period 2 Bilateral||0||
59984602|NCT02537522|76100120|FG003|NOT COMPLETED|Phase II - Period 2 Bilateral||0||
59984603|NCT02536976|76100128|FG000|STARTED|Overall Study|2 weeks single blind placebo run-in|3||
59984604|NCT02536976|76100129|FG001|STARTED|Overall Study|2 weeks single blind placebo run-in. 1 participant terminated due to unrelated failing health|2||
59984605|NCT02536976|76100128|FG000|Randomization|Overall Study|2 weeks double blind mirabegron|3||
59984606|NCT02536976|76100129|FG001|Randomization|Overall Study|2 weeks double blind placebo matching mirabegron|1||
59984607|NCT02536976|76100128|FG000|Dose Escalation and Maintenance|Overall Study|10 weeks double blind mirabegron|3||
59984608|NCT02536976|76100129|FG001|Dose Escalation and Maintenance|Overall Study|10 weeks double blind placebo matching mirabegron|1||
59984609|NCT02536976|76100128|FG000|Washout|Overall Study||3||
59984610|NCT02536976|76100129|FG001|Washout|Overall Study||1||
59984611|NCT02536976|76100128|FG000|COMPLETED|Overall Study||3||
59984612|NCT02536976|76100129|FG001|COMPLETED|Overall Study||1||
59984613|NCT02536976|76100128|FG000|NOT COMPLETED|Overall Study||0||
59984614|NCT02536976|76100129|FG001|NOT COMPLETED|Overall Study||1||
59984615|NCT02672553|76100139|FG000|STARTED|Overall Study||51||
59984616|NCT02672553|76100140|FG001|STARTED|Overall Study||49||
59984617|NCT02672553|76100139|FG000|Intent To Treated (ITT) Randomized Arm|Overall Study|Two (2) subjects randomized to Edwards INTUITY were intraoperative screen failures|49|Intent to treat (ITT) is defined as the initial treatment assignment.|
59984618|NCT02672553|76100140|FG001|Intent To Treated (ITT) Randomized Arm|Overall Study|One (1) subject randomized to Control arm/group withdrew prior to study procedure|48|Intent to treat (ITT) is defined as the initial treatment assignment.|
59984619|NCT02672553|76100139|FG000|As Treated (AT) Randomized Arm/Group|Overall Study||46||
59984620|NCT02672553|76100140|FG001|As Treated (AT) Randomized Arm/Group|Overall Study||51||
59622606|NCT00535938|75734465|FG000|NOT COMPLETED|Overall Study||391||
59622607|NCT00535938|75734466|FG001|NOT COMPLETED|Overall Study||462||
59622608|NCT00537576|75734478|FG000|STARTED|Overall Study||3||
59984621|NCT02672553|76100139|FG000|As Intended (AI) Randomized Arm/Group|Overall Study||46|As intended (AI) excluded the three INTUITY subjects converted to control group from analysis.|
59984622|NCT02672553|76100140|FG001|As Intended (AI) Randomized Arm/Group|Overall Study||48|As intended (AI) excluded the three INTUITY subjects converted to control group from analysis.|
59984623|NCT02672553|76100139|FG000|COMPLETED|Overall Study||39||
59984624|NCT02672553|76100140|FG001|COMPLETED|Overall Study||41||
59984625|NCT02672553|76100139|FG000|NOT COMPLETED|Overall Study||12||
59984626|NCT02672553|76100140|FG001|NOT COMPLETED|Overall Study||8||
59984627|NCT01373229|76100147|FG000|STARTED|Overall Study||15||
59984628|NCT01373229|76100147|FG000|COMPLETED|Overall Study||9||
59984629|NCT01373229|76100147|FG000|NOT COMPLETED|Overall Study||6||
59984630|NCT02671461|76100154|FG000|STARTED|Treatment||3||
59984631|NCT02671461|76100155|FG001|STARTED|Treatment||5||
59984632|NCT02671461|76100156|FG002|STARTED|Treatment||7||
59984633|NCT02671461|76100154|FG000|COMPLETED|Treatment||1||
59984634|NCT02671461|76100155|FG001|COMPLETED|Treatment||2||
59984635|NCT02671461|76100156|FG002|COMPLETED|Treatment||2||
59984636|NCT02671461|76100154|FG000|NOT COMPLETED|Treatment||2||
59984637|NCT02671461|76100155|FG001|NOT COMPLETED|Treatment||3||
59984638|NCT02671461|76100156|FG002|NOT COMPLETED|Treatment||5||
59984639|NCT02671461|76100154|FG000|STARTED|Follow-up||2||
59984640|NCT02671461|76100155|FG001|STARTED|Follow-up||5||
59984641|NCT02671461|76100156|FG002|STARTED|Follow-up||7||
59984642|NCT02671461|76100154|FG000|COMPLETED|Follow-up||1||
59984643|NCT02671461|76100155|FG001|COMPLETED|Follow-up||4||
59984644|NCT02671461|76100156|FG002|COMPLETED|Follow-up||6||
59984645|NCT02671461|76100154|FG000|NOT COMPLETED|Follow-up||1||
59984646|NCT02671461|76100155|FG001|NOT COMPLETED|Follow-up||1||
59984647|NCT02671461|76100156|FG002|NOT COMPLETED|Follow-up||1||
59984648|NCT02535416|76100173|FG000|STARTED|Overall Study||4||
59984649|NCT02535416|76100174|FG001|STARTED|Overall Study||2||
59984650|NCT02535416|76100175|FG002|STARTED|Overall Study||4||
59984651|NCT02535416|76100176|FG003|STARTED|Overall Study||4||
59984652|NCT02535416|76100177|FG004|STARTED|Overall Study||4||
59984653|NCT02535416|76100178|FG005|STARTED|Overall Study||4||
59984654|NCT02535416|76100179|FG006|STARTED|Overall Study||6||
59984655|NCT02535416|76100180|FG007|STARTED|Overall Study||6||
59984656|NCT02535416|76100181|FG008|STARTED|Overall Study||6||
59984657|NCT02535416|76100173|FG000|COMPLETED|Overall Study||3||
59984658|NCT02535416|76100174|FG001|COMPLETED|Overall Study||2||
59984659|NCT02535416|76100175|FG002|COMPLETED|Overall Study||4||
59984660|NCT02535416|76100176|FG003|COMPLETED|Overall Study||4||
59984661|NCT02535416|76100177|FG004|COMPLETED|Overall Study||4||
59984662|NCT02535416|76100178|FG005|COMPLETED|Overall Study||4||
59984663|NCT02535416|76100179|FG006|COMPLETED|Overall Study||6||
59984664|NCT02535416|76100180|FG007|COMPLETED|Overall Study||6||
59984665|NCT02535416|76100181|FG008|COMPLETED|Overall Study||6||
59984666|NCT02535416|76100173|FG000|NOT COMPLETED|Overall Study||1||
59984667|NCT02535416|76100174|FG001|NOT COMPLETED|Overall Study||0||
59984668|NCT02535416|76100175|FG002|NOT COMPLETED|Overall Study||0||
59984669|NCT02535416|76100176|FG003|NOT COMPLETED|Overall Study||0||
59984670|NCT02535416|76100177|FG004|NOT COMPLETED|Overall Study||0||
59984671|NCT02535416|76100178|FG005|NOT COMPLETED|Overall Study||0||
59984672|NCT02535416|76100179|FG006|NOT COMPLETED|Overall Study||0||
59984673|NCT02535416|76100180|FG007|NOT COMPLETED|Overall Study||0||
59984674|NCT02535416|76100181|FG008|NOT COMPLETED|Overall Study||0||
59984675|NCT00911443|76100210|FG000|STARTED|Overall Study||97||
59984676|NCT00911443|76100211|FG001|STARTED|Overall Study||97||
59984677|NCT00911443|76100212|FG002|STARTED|Overall Study||98||
59984678|NCT00911443|76100213|FG003|STARTED|Overall Study||99||
59984679|NCT00911443|76100214|FG004|STARTED|Overall Study||97||
59984680|NCT00911443|76100210|FG000|COMPLETED|Overall Study||97||
59984681|NCT00911443|76100211|FG001|COMPLETED|Overall Study||97||
59984682|NCT00911443|76100212|FG002|COMPLETED|Overall Study||98||
59984683|NCT00911443|76100213|FG003|COMPLETED|Overall Study||99||
59984684|NCT00911443|76100214|FG004|COMPLETED|Overall Study||97||
59984685|NCT00911443|76100210|FG000|NOT COMPLETED|Overall Study||0||
59984686|NCT00911443|76100211|FG001|NOT COMPLETED|Overall Study||0||
59984687|NCT00911443|76100212|FG002|NOT COMPLETED|Overall Study||0||
59984688|NCT00911443|76100213|FG003|NOT COMPLETED|Overall Study||0||
59984689|NCT00911443|76100214|FG004|NOT COMPLETED|Overall Study||0||
59984690|NCT00909649|76100223|FG000|STARTED|Overall Study||25||
59984691|NCT00909649|76100224|FG001|STARTED|Overall Study||25||
59984692|NCT00909649|76100223|FG000|COMPLETED|Overall Study||25||
59984693|NCT00909649|76100224|FG001|COMPLETED|Overall Study||25||
59984694|NCT00909649|76100223|FG000|NOT COMPLETED|Overall Study||0||
59984695|NCT00909649|76100224|FG001|NOT COMPLETED|Overall Study||0||
59984696|NCT02670915|76100231|FG000|STARTED|Overall Study||260||
59984697|NCT02670915|76100232|FG001|STARTED|Overall Study||259||
59984698|NCT02670915|76100233|FG002|STARTED|Overall Study||258||
59984699|NCT02670915|76100231|FG000|COMPLETED|Overall Study||256||
59984700|NCT02670915|76100232|FG001|COMPLETED|Overall Study||251||
59984701|NCT02670915|76100233|FG002|COMPLETED|Overall Study||253||
59984702|NCT02670915|76100231|FG000|NOT COMPLETED|Overall Study||4||
59984703|NCT02670915|76100232|FG001|NOT COMPLETED|Overall Study||8||
59984704|NCT02670915|76100233|FG002|NOT COMPLETED|Overall Study||5||
59984705|NCT02545868|76100244|FG000|STARTED|Immunization Study Period (ISP)||33||
59984706|NCT02545868|76100245|FG001|STARTED|Immunization Study Period (ISP)||35||
59984707|NCT02545868|76100246|FG002|STARTED|Immunization Study Period (ISP)||34||
59984708|NCT02545868|76100244|FG000|COMPLETED|Immunization Study Period (ISP)||33||
59984709|NCT02545868|76100245|FG001|COMPLETED|Immunization Study Period (ISP)||35||
59984710|NCT02545868|76100246|FG002|COMPLETED|Immunization Study Period (ISP)||34||
59984711|NCT02545868|76100244|FG000|NOT COMPLETED|Immunization Study Period (ISP)||0||
59984712|NCT02545868|76100245|FG001|NOT COMPLETED|Immunization Study Period (ISP)||0||
59984713|NCT02545868|76100246|FG002|NOT COMPLETED|Immunization Study Period (ISP)||0||
59984714|NCT02545868|76100244|FG000|STARTED|Optional Ocrelizumab Ext (OOE) Period||33||
59984715|NCT02545868|76100245|FG001|STARTED|Optional Ocrelizumab Ext (OOE) Period||35||
59984716|NCT02545868|76100246|FG002|STARTED|Optional Ocrelizumab Ext (OOE) Period||34||
59984717|NCT02545868|76100244|FG000|COMPLETED|Optional Ocrelizumab Ext (OOE) Period||0||
59984718|NCT02545868|76100245|FG001|COMPLETED|Optional Ocrelizumab Ext (OOE) Period||0||
59984719|NCT02545868|76100246|FG002|COMPLETED|Optional Ocrelizumab Ext (OOE) Period||0||
59984720|NCT02545868|76100244|FG000|NOT COMPLETED|Optional Ocrelizumab Ext (OOE) Period||33||
59984721|NCT02545868|76100245|FG001|NOT COMPLETED|Optional Ocrelizumab Ext (OOE) Period||35||
59984722|NCT02545868|76100246|FG002|NOT COMPLETED|Optional Ocrelizumab Ext (OOE) Period||34||
59984723|NCT02764151|76100263|FG000|STARTED|Overall Study||2||
59984724|NCT02764151|76100264|FG001|STARTED|Overall Study||4||
59984725|NCT02764151|76100265|FG002|STARTED|Overall Study||3||
59984726|NCT02764151|76100266|FG003|STARTED|Overall Study||8||
59984727|NCT02764151|76100263|FG000|COMPLETED|Overall Study||2||
59984728|NCT02764151|76100264|FG001|COMPLETED|Overall Study||4||
59984729|NCT02764151|76100265|FG002|COMPLETED|Overall Study||3||
59984730|NCT02764151|76100266|FG003|COMPLETED|Overall Study||5||
59984731|NCT02764151|76100263|FG000|NOT COMPLETED|Overall Study||0||
59984732|NCT02764151|76100264|FG001|NOT COMPLETED|Overall Study||0||
59984733|NCT02764151|76100265|FG002|NOT COMPLETED|Overall Study||0||
59984734|NCT02764151|76100266|FG003|NOT COMPLETED|Overall Study||3||
59984735|NCT02545322|76100276|FG000|STARTED|Overall Study||18||
59984736|NCT02545322|76100276|FG000|COMPLETED|Overall Study||15||
59984737|NCT02545322|76100276|FG000|NOT COMPLETED|Overall Study||3||
59984738|NCT02763215|76100280|FG000|STARTED|Overall Study||64||
59984739|NCT02763215|76100280|FG000|COMPLETED|Overall Study||57||
60074873|NCT01930045|76190107|FG004|NOT COMPLETED|Part 2 - Period 4||0||
60074874|NCT01930045|76190108|FG005|NOT COMPLETED|Part 2 - Period 4||0||
60074875|NCT01930045|76190103|FG000|STARTED|Part 2 - Period 5||3||
60074876|NCT01930045|76190104|FG001|STARTED|Part 2 - Period 5||3||
60074877|NCT01930045|76190105|FG002|STARTED|Part 2 - Period 5||3||
60074878|NCT01930045|76190106|FG003|STARTED|Part 2 - Period 5||3||
60074879|NCT01930045|76190107|FG004|STARTED|Part 2 - Period 5||3||
60074880|NCT01930045|76190108|FG005|STARTED|Part 2 - Period 5||1||
60074881|NCT01930045|76190103|FG000|COMPLETED|Part 2 - Period 5||3||
60074882|NCT01930045|76190104|FG001|COMPLETED|Part 2 - Period 5||3||
60074883|NCT01930045|76190105|FG002|COMPLETED|Part 2 - Period 5||3||
60074884|NCT01930045|76190106|FG003|COMPLETED|Part 2 - Period 5||3||
60074885|NCT01930045|76190107|FG004|COMPLETED|Part 2 - Period 5||3||
60074886|NCT01930045|76190108|FG005|COMPLETED|Part 2 - Period 5||1||
60074887|NCT01930045|76190103|FG000|NOT COMPLETED|Part 2 - Period 5||0||
60074888|NCT01930045|76190104|FG001|NOT COMPLETED|Part 2 - Period 5||0||
59984740|NCT02763215|76100280|FG000|NOT COMPLETED|Overall Study||7||
59984741|NCT00803413|76100288|FG000|STARTED|Overall Period||28||
59984742|NCT00803413|76100289|FG001|STARTED|Overall Period||32||
59984743|NCT00803413|76100290|FG002|STARTED|Overall Period||29||
59984744|NCT00803413|76100291|FG003|STARTED|Overall Period||30||
59984745|NCT00803413|76100288|FG000|COMPLETED|Overall Period||28||
59984746|NCT00803413|76100289|FG001|COMPLETED|Overall Period||32||
59984747|NCT00803413|76100290|FG002|COMPLETED|Overall Period||29||
59984748|NCT00803413|76100291|FG003|COMPLETED|Overall Period||30||
59984749|NCT00803413|76100288|FG000|NOT COMPLETED|Overall Period||0||
59984750|NCT00803413|76100289|FG001|NOT COMPLETED|Overall Period||0||
59984751|NCT00803413|76100290|FG002|NOT COMPLETED|Overall Period||0||
59984752|NCT00803413|76100291|FG003|NOT COMPLETED|Overall Period||0||
59984753|NCT02770547|76100299|FG000|STARTED|Overall Study||16||
59984754|NCT02770547|76100300|FG001|STARTED|Overall Study||16||
59984755|NCT02770547|76100299|FG000|COMPLETED|Overall Study||15||
59984756|NCT02770547|76100300|FG001|COMPLETED|Overall Study||15||
59984757|NCT02770547|76100299|FG000|NOT COMPLETED|Overall Study||1||
59984758|NCT02770547|76100300|FG001|NOT COMPLETED|Overall Study||1||
59984759|NCT01661972|76100308|FG000|STARTED|Overall Study||13||
59984760|NCT01661972|76100309|FG001|STARTED|Overall Study||50||
59984761|NCT01661972|76100308|FG000|COMPLETED|Overall Study||11||
60074889|NCT01930045|76190105|FG002|NOT COMPLETED|Part 2 - Period 5||0||
60074890|NCT01930045|76190106|FG003|NOT COMPLETED|Part 2 - Period 5||0||
60074891|NCT01930045|76190107|FG004|NOT COMPLETED|Part 2 - Period 5||0||
59984762|NCT01661972|76100309|FG001|COMPLETED|Overall Study||46||
59984763|NCT01661972|76100308|FG000|NOT COMPLETED|Overall Study||2||
59984764|NCT01661972|76100309|FG001|NOT COMPLETED|Overall Study||4||
59984765|NCT00888355|76100321|FG000|STARTED|Overall Study||108||
59984766|NCT00888355|76100322|FG001|STARTED|Overall Study||108||
59984767|NCT00888355|76100323|FG002|STARTED|Overall Study||106||
59984768|NCT00888355|76100324|FG003|STARTED|Overall Study||106||
59984769|NCT00888355|76100321|FG000|COMPLETED|Overall Study||86||
59984770|NCT00888355|76100322|FG001|COMPLETED|Overall Study||99||
59984771|NCT00888355|76100323|FG002|COMPLETED|Overall Study||94||
59984772|NCT00888355|76100324|FG003|COMPLETED|Overall Study||96||
59984773|NCT00888355|76100321|FG000|NOT COMPLETED|Overall Study||22||
59984774|NCT00888355|76100322|FG001|NOT COMPLETED|Overall Study||9||
59984775|NCT00888355|76100323|FG002|NOT COMPLETED|Overall Study||12||
59984776|NCT00888355|76100324|FG003|NOT COMPLETED|Overall Study||10||
59984777|NCT00794677|76100332|FG000|STARTED|First Intervention||13||
59984778|NCT00794677|76100333|FG001|STARTED|First Intervention||13||
59984779|NCT00794677|76100332|FG000|COMPLETED|First Intervention||11||
59984780|NCT00794677|76100333|FG001|COMPLETED|First Intervention||13||
59984781|NCT00794677|76100332|FG000|NOT COMPLETED|First Intervention||2||
59984782|NCT00794677|76100333|FG001|NOT COMPLETED|First Intervention||0||
59984783|NCT00794677|76100332|FG000|STARTED|Second Intervention||11||
59984784|NCT00794677|76100333|FG001|STARTED|Second Intervention||13||
59984785|NCT00794677|76100332|FG000|COMPLETED|Second Intervention||11||
59984786|NCT00794677|76100333|FG001|COMPLETED|Second Intervention||13||
59984787|NCT00794677|76100332|FG000|NOT COMPLETED|Second Intervention||0||
59984788|NCT00794677|76100333|FG001|NOT COMPLETED|Second Intervention||0||
59984789|NCT02770391|76100337|FG000|STARTED|Overall Study||54||
59984790|NCT02770391|76100337|FG000|COMPLETED|Overall Study||48||
59984791|NCT02770391|76100337|FG000|NOT COMPLETED|Overall Study||6||
59984792|NCT02536508|76100344|FG000|STARTED|Overall Study||194|Safety population|
59984793|NCT02536508|76100345|FG001|STARTED|Overall Study||174|Safety population|
59984794|NCT02536508|76100346|FG002|STARTED|Overall Study||88|Safety population|
59984795|NCT02536508|76100344|FG000|COMPLETED|Overall Study||142||
59984796|NCT02536508|76100345|FG001|COMPLETED|Overall Study||130||
59984797|NCT02536508|76100346|FG002|COMPLETED|Overall Study||65||
59984798|NCT02536508|76100344|FG000|NOT COMPLETED|Overall Study||52||
59984799|NCT02536508|76100345|FG001|NOT COMPLETED|Overall Study||44||
59984800|NCT02536508|76100346|FG002|NOT COMPLETED|Overall Study||23||
60074892|NCT01930045|76190108|FG005|NOT COMPLETED|Part 2 - Period 5||0||
60074893|NCT01929343|76190123|FG000|STARTED|Overall Study||12||
60074894|NCT01929343|76190124|FG001|STARTED|Overall Study||9||
60074895|NCT01929343|76190125|FG002|STARTED|Overall Study||12||
59984801|NCT00934921|76100356|FG000|STARTED|First Intervention||12||
59984802|NCT00934921|76100357|FG001|STARTED|First Intervention||12||
59984803|NCT00934921|76100356|FG000|COMPLETED|First Intervention||12||
59984804|NCT00934921|76100357|FG001|COMPLETED|First Intervention||12||
59984805|NCT00934921|76100356|FG000|NOT COMPLETED|First Intervention||0||
59984806|NCT00934921|76100357|FG001|NOT COMPLETED|First Intervention||0||
59984807|NCT00934921|76100356|FG000|STARTED|Second Intervention||12||
59984808|NCT00934921|76100357|FG001|STARTED|Second Intervention||12||
59984809|NCT00934921|76100356|FG000|COMPLETED|Second Intervention||12||
59984810|NCT00934921|76100357|FG001|COMPLETED|Second Intervention||12||
59984811|NCT00934921|76100356|FG000|NOT COMPLETED|Second Intervention||0||
59984812|NCT00934921|76100357|FG001|NOT COMPLETED|Second Intervention||0||
59984813|NCT00103259|76100363|FG000|STARTED|Overall Study||27||
59984814|NCT00103259|76100364|FG001|STARTED|Overall Study||44||
59984815|NCT00103259|76100363|FG000|Eligible|Overall Study||27||
59984816|NCT00103259|76100364|FG001|Eligible|Overall Study||41||
59984817|NCT00103259|76100363|FG000|Treated|Overall Study||23||
59984818|NCT00103259|76100364|FG001|Treated|Overall Study||41||
59984819|NCT00103259|76100363|FG000|Eligible and Treated|Overall Study||23||
59984820|NCT00103259|76100364|FG001|Eligible and Treated|Overall Study||38||
59984821|NCT00103259|76100363|FG000|Cross Over to the Other Arm|Overall Study||0||
59984822|NCT00103259|76100364|FG001|Cross Over to the Other Arm|Overall Study|11 patients who progressed on bortezomib crossed over to Arm I. 10 of them were eligible|11||
59984823|NCT00103259|76100363|FG000|Eligible Patients Who Cross Over|Overall Study||0||
59984824|NCT00103259|76100364|FG001|Eligible Patients Who Cross Over|Overall Study||10||
59984825|NCT00103259|76100363|FG000|COMPLETED|Overall Study|Treatment continued until disease progression or intolerable toxicity.|15||
59984826|NCT00103259|76100364|FG001|COMPLETED|Overall Study|Treatment continued until disease progression or intolerable toxicity.This number is for stage I.|32||
59984827|NCT00103259|76100363|FG000|NOT COMPLETED|Overall Study||12||
59984828|NCT00103259|76100364|FG001|NOT COMPLETED|Overall Study||12||
59984829|NCT02544152|76100374|FG000|STARTED|Overall Study||34||
59984830|NCT02544152|76100375|FG001|STARTED|Overall Study||37||
60074896|NCT01929343|76190123|FG000|COMPLETED|Overall Study||11||
59984831|NCT02544152|76100374|FG000|Modified Intent to Treat (mITT)|Overall Study||34||
59984832|NCT02544152|76100375|FG001|Modified Intent to Treat (mITT)|Overall Study||37||
59984833|NCT02544152|76100374|FG000|Safety Analysis Set (SAS)|Overall Study||34||
59984834|NCT02544152|76100375|FG001|Safety Analysis Set (SAS)|Overall Study||37||
59984835|NCT02544152|76100374|FG000|COMPLETED|Overall Study||33||
60074897|NCT01929343|76190124|FG001|COMPLETED|Overall Study||7||
59984836|NCT02544152|76100375|FG001|COMPLETED|Overall Study||30||
59984837|NCT02544152|76100374|FG000|NOT COMPLETED|Overall Study||1||
59984838|NCT02544152|76100375|FG001|NOT COMPLETED|Overall Study||7||
59984839|NCT02534324|76100383|FG000|STARTED|Overall Study||98||
59984840|NCT02534324|76100384|FG001|STARTED|Overall Study||48||
59984841|NCT02534324|76100383|FG000|COMPLETED|Overall Study||73||
59984842|NCT02534324|76100384|FG001|COMPLETED|Overall Study||40||
59984843|NCT02534324|76100383|FG000|NOT COMPLETED|Overall Study||25||
59984844|NCT02534324|76100384|FG001|NOT COMPLETED|Overall Study||8||
59984845|NCT02761733|76100394|FG000|STARTED|Overall Study||60||
59984846|NCT02761733|76100395|FG001|STARTED|Overall Study||60||
59984847|NCT02761733|76100396|FG002|STARTED|Overall Study||60||
59984848|NCT02761733|76100397|FG003|STARTED|Overall Study||60||
59984849|NCT02761733|76100394|FG000|9/30/2014|Overall Study||53|Completion of the 2nd Wave of Data Collection|
59984850|NCT02761733|76100395|FG001|9/30/2014|Overall Study||56|Completion of the 2nd Wave of Data Collection|
59984851|NCT02761733|76100396|FG002|9/30/2014|Overall Study||48|Completion of the 2nd Wave of Data Collection|
59984852|NCT02761733|76100397|FG003|9/30/2014|Overall Study||55|Completion of the 2nd Wave of Data Collection|
59984853|NCT02761733|76100394|FG000|3/31/2015|Overall Study||48|Completion of the 3rd Wave of Data Collection|
59984854|NCT02761733|76100395|FG001|3/31/2015|Overall Study||47|Completion of the 3rd Wave of Data Collection|
59984855|NCT02761733|76100396|FG002|3/31/2015|Overall Study||43|Completion of the 3rd Wave of Data Collection|
59984856|NCT02761733|76100397|FG003|3/31/2015|Overall Study||50|Completion of the 3rd Wave of Data Collection|
59984857|NCT02761733|76100394|FG000|9/30/2015|Overall Study||40|Completion of the 4th Wave of Data Collection|
59984858|NCT02761733|76100395|FG001|9/30/2015|Overall Study||44|Completion of the 4th Wave of Data Collection|
59984859|NCT02761733|76100396|FG002|9/30/2015|Overall Study||33|Completion of the 4th Wave of Data Collection|
59984860|NCT02761733|76100397|FG003|9/30/2015|Overall Study||50|Completion of the 4th Wave of Data Collection|
59984861|NCT02761733|76100394|FG000|COMPLETED|Overall Study||30||
59984862|NCT02761733|76100395|FG001|COMPLETED|Overall Study||39||
59984863|NCT02761733|76100396|FG002|COMPLETED|Overall Study||33||
59984864|NCT02761733|76100397|FG003|COMPLETED|Overall Study||45||
59984865|NCT02761733|76100394|FG000|NOT COMPLETED|Overall Study||30||
59984866|NCT02761733|76100395|FG001|NOT COMPLETED|Overall Study||21||
59984867|NCT02761733|76100396|FG002|NOT COMPLETED|Overall Study||27||
59984868|NCT02761733|76100397|FG003|NOT COMPLETED|Overall Study||15||
59984869|NCT03715465|76100409|FG000|STARTED|Overall Study||20||
59984870|NCT03715465|76100410|FG001|STARTED|Overall Study||20||
59984871|NCT03715465|76100409|FG000|COMPLETED|Overall Study||19||
59984872|NCT03715465|76100410|FG001|COMPLETED|Overall Study||18||
59984873|NCT03715465|76100409|FG000|NOT COMPLETED|Overall Study||1||
59984874|NCT03715465|76100410|FG001|NOT COMPLETED|Overall Study||2||
59984875|NCT00840073|76100418|FG000|STARTED|First Intervention||25||
59984876|NCT00840073|76100419|FG001|STARTED|First Intervention||25||
59984877|NCT00840073|76100418|FG000|COMPLETED|First Intervention||25||
59984878|NCT00840073|76100419|FG001|COMPLETED|First Intervention||25||
59984879|NCT00840073|76100418|FG000|NOT COMPLETED|First Intervention||0||
59984880|NCT00840073|76100419|FG001|NOT COMPLETED|First Intervention||0||
59984881|NCT00840073|76100418|FG000|STARTED|Second Intervention||25||
59984882|NCT00840073|76100419|FG001|STARTED|Second Intervention||25||
59984883|NCT00840073|76100418|FG000|COMPLETED|Second Intervention||24||
59984884|NCT00840073|76100419|FG001|COMPLETED|Second Intervention||24||
59984885|NCT00840073|76100418|FG000|NOT COMPLETED|Second Intervention||1||
59984886|NCT00840073|76100419|FG001|NOT COMPLETED|Second Intervention||1||
59984887|NCT00838279|76100425|FG000|STARTED|First Intervention||16||
59984888|NCT00838279|76100426|FG001|STARTED|First Intervention||16||
59984889|NCT00838279|76100425|FG000|COMPLETED|First Intervention||16||
59984890|NCT00838279|76100426|FG001|COMPLETED|First Intervention||16||
59984891|NCT00838279|76100425|FG000|NOT COMPLETED|First Intervention||0||
59984892|NCT00838279|76100426|FG001|NOT COMPLETED|First Intervention||0||
59984893|NCT00838279|76100425|FG000|STARTED|Washout||16||
59984894|NCT00838279|76100426|FG001|STARTED|Washout||16||
59984895|NCT00838279|76100425|FG000|COMPLETED|Washout||15||
59984896|NCT00838279|76100426|FG001|COMPLETED|Washout||15||
59984897|NCT00838279|76100425|FG000|NOT COMPLETED|Washout||1||
59984898|NCT00838279|76100426|FG001|NOT COMPLETED|Washout||1||
59984899|NCT00838279|76100425|FG000|STARTED|Second Intervention||15||
59984900|NCT00838279|76100426|FG001|STARTED|Second Intervention||15||
59984901|NCT00838279|76100425|FG000|COMPLETED|Second Intervention||15||
59984902|NCT00838279|76100426|FG001|COMPLETED|Second Intervention||15||
59984903|NCT00838279|76100425|FG000|NOT COMPLETED|Second Intervention||0||
59984904|NCT00838279|76100426|FG001|NOT COMPLETED|Second Intervention||0||
59984905|NCT02759939|76100434|FG000|STARTED|Overall Study||1256|Represents participants who consented to the study and were eligible.|
59984906|NCT02759939|76100435|FG001|STARTED|Overall Study||1143|Represents participants who consented to the study and were eligible.|
59984907|NCT02759939|76100436|FG002|STARTED|Overall Study||1393|Represents participants who consented to the study and were eligible.|
59984908|NCT02759939|76100437|FG003|STARTED|Overall Study||1246|Represents participants who consented to the study and were eligible.|
59995423|NCT03016975|76111236|FG000|STARTED|At 5-year Follow-up||2||
59995424|NCT03016975|76111237|FG001|STARTED|At 5-year Follow-up||0||
59995425|NCT03016975|76111238|FG002|STARTED|At 5-year Follow-up||0||
59984909|NCT02759939|76100434|FG000|Analyzed at T1|Overall Study||1245|Participants with valid data on the item assessing occurrence of a conversation about contraception.|
59984910|NCT02759939|76100435|FG001|Analyzed at T1|Overall Study||1141|Participants with valid data on the item assessing occurrence of a conversation about contraception.|
59984911|NCT02759939|76100436|FG002|Analyzed at T1|Overall Study||1388|Participants with valid data on the item assessing occurrence of a conversation about contraception.|
59984912|NCT02759939|76100437|FG003|Analyzed at T1|Overall Study||1244|Participants with valid data on the item assessing occurrence of a conversation about contraception.|
59984913|NCT02759939|76100434|FG000|Eligible for T2 and T3|Overall Study||935|We imposed additional eligibility criteria for the T2 and T3 surveys to minimize participant burden.|
59984914|NCT02759939|76100435|FG001|Eligible for T2 and T3|Overall Study||962|We imposed additional eligibility criteria for the T2 and T3 surveys to minimize participant burden.|
59984915|NCT02759939|76100436|FG002|Eligible for T2 and T3|Overall Study||1022|We imposed additional eligibility criteria for the T2 and T3 surveys to minimize participant burden.|
59984916|NCT02759939|76100437|FG003|Eligible for T2 and T3|Overall Study||853|We imposed additional eligibility criteria for the T2 and T3 surveys to minimize participant burden.|
59984917|NCT02759939|76100434|FG000|Analyzed at T2 and/or T3|Overall Study||303|Participants were not required to have completed the T2 survey to be eligible for the T3 survey.|
59984918|NCT02759939|76100435|FG001|Analyzed at T2 and/or T3|Overall Study||278|Participants were not required to have completed the T2 survey to be eligible for the T3 survey.|
59984919|NCT02759939|76100436|FG002|Analyzed at T2 and/or T3|Overall Study||373|Participants were not required to have completed the T2 survey to be eligible for the T3 survey.|
59984920|NCT02759939|76100437|FG003|Analyzed at T2 and/or T3|Overall Study||304|Participants were not required to have completed the T2 survey to be eligible for the T3 survey.|
59984921|NCT02759939|76100434|FG000|Consented to T2 and T3|Overall Study||579||
59984922|NCT02759939|76100435|FG001|Consented to T2 and T3|Overall Study||626||
59984923|NCT02759939|76100436|FG002|Consented to T2 and T3|Overall Study||702||
59984924|NCT02759939|76100437|FG003|Consented to T2 and T3|Overall Study||564||
59984925|NCT02759939|76100434|FG000|COMPLETED|Overall Study||200||
59984926|NCT02759939|76100435|FG001|COMPLETED|Overall Study||171||
59984927|NCT02759939|76100436|FG002|COMPLETED|Overall Study||239||
59984928|NCT02759939|76100437|FG003|COMPLETED|Overall Study||203||
59984929|NCT02759939|76100434|FG000|NOT COMPLETED|Overall Study||1056||
59984930|NCT02759939|76100435|FG001|NOT COMPLETED|Overall Study||972||
59984931|NCT02759939|76100436|FG002|NOT COMPLETED|Overall Study||1154||
59984932|NCT02759939|76100437|FG003|NOT COMPLETED|Overall Study||1043||
59984933|NCT00758563|76100449|FG000|STARTED|Overall Study||7||
59984934|NCT00758563|76100450|FG001|STARTED|Overall Study||8||
59984935|NCT00758563|76100449|FG000|COMPLETED|Overall Study||7||
59984936|NCT00758563|76100450|FG001|COMPLETED|Overall Study||8||
59984937|NCT00758563|76100449|FG000|NOT COMPLETED|Overall Study||0||
59984938|NCT00758563|76100450|FG001|NOT COMPLETED|Overall Study||0||
59984939|NCT00835705|76100456|FG000|STARTED|First Intervention||24||
59984940|NCT00835705|76100457|FG001|STARTED|First Intervention||28||
59984941|NCT00835705|76100456|FG000|COMPLETED|First Intervention||23||
59984942|NCT00835705|76100457|FG001|COMPLETED|First Intervention||28||
59984943|NCT00835705|76100456|FG000|NOT COMPLETED|First Intervention||1||
59984944|NCT00835705|76100457|FG001|NOT COMPLETED|First Intervention||0||
59984945|NCT00835705|76100456|FG000|STARTED|Second Intervention||23||
59984946|NCT00835705|76100457|FG001|STARTED|Second Intervention||28||
59984947|NCT00835705|76100456|FG000|COMPLETED|Second Intervention||22||
59984948|NCT00835705|76100457|FG001|COMPLETED|Second Intervention||28||
59984949|NCT00835705|76100456|FG000|NOT COMPLETED|Second Intervention||1||
59984950|NCT00835705|76100457|FG001|NOT COMPLETED|Second Intervention||0||
59984951|NCT02759471|76100461|FG000|STARTED|Overall Study||54||
59984952|NCT02759471|76100461|FG000|COMPLETED|Overall Study||52||
59984953|NCT02759471|76100461|FG000|NOT COMPLETED|Overall Study||2||
59984954|NCT00835549|76100469|FG000|STARTED|First Intervention||16||
59984955|NCT00835549|76100470|FG001|STARTED|First Intervention||16||
59984956|NCT00835549|76100469|FG000|COMPLETED|First Intervention||16||
59984957|NCT00835549|76100470|FG001|COMPLETED|First Intervention||16||
59984958|NCT00835549|76100469|FG000|NOT COMPLETED|First Intervention||0||
59984959|NCT00835549|76100470|FG001|NOT COMPLETED|First Intervention||0||
59984960|NCT00835549|76100469|FG000|STARTED|Washout of 7 Days||16||
59984961|NCT00835549|76100470|FG001|STARTED|Washout of 7 Days||16||
59984962|NCT00835549|76100469|FG000|COMPLETED|Washout of 7 Days||14||
59984963|NCT00835549|76100470|FG001|COMPLETED|Washout of 7 Days||16||
59984964|NCT00835549|76100469|FG000|NOT COMPLETED|Washout of 7 Days||2||
59984965|NCT00835549|76100470|FG001|NOT COMPLETED|Washout of 7 Days||0||
59984966|NCT00835549|76100469|FG000|STARTED|Second Intervention||14||
59984967|NCT00835549|76100470|FG001|STARTED|Second Intervention||16||
59984968|NCT00835549|76100469|FG000|COMPLETED|Second Intervention||14||
59984969|NCT00835549|76100470|FG001|COMPLETED|Second Intervention||16||
59984970|NCT00835549|76100469|FG000|NOT COMPLETED|Second Intervention||0||
60074898|NCT01929343|76190125|FG002|COMPLETED|Overall Study||12||
59984971|NCT00835549|76100470|FG001|NOT COMPLETED|Second Intervention||0||
59984972|NCT03945825|76100480|FG000|STARTED|Overall Study||41||
59984973|NCT03945825|76100481|FG001|STARTED|Overall Study||37||
59984974|NCT03945825|76100482|FG002|STARTED|Overall Study||40||
59984975|NCT03945825|76100483|FG003|STARTED|Overall Study||41||
59984976|NCT03945825|76100484|FG004|STARTED|Overall Study||39||
59984977|NCT03945825|76100485|FG005|STARTED|Overall Study||43||
59984978|NCT03945825|76100480|FG000|COMPLETED|Overall Study||39||
59984979|NCT03945825|76100481|FG001|COMPLETED|Overall Study||32||
59984980|NCT03945825|76100482|FG002|COMPLETED|Overall Study||39||
59984981|NCT03945825|76100483|FG003|COMPLETED|Overall Study||39||
59984982|NCT03945825|76100484|FG004|COMPLETED|Overall Study||36||
59984983|NCT03945825|76100485|FG005|COMPLETED|Overall Study||40||
59984984|NCT03945825|76100480|FG000|NOT COMPLETED|Overall Study||2||
59984985|NCT03945825|76100481|FG001|NOT COMPLETED|Overall Study||5||
59984986|NCT03945825|76100482|FG002|NOT COMPLETED|Overall Study||1||
59984987|NCT03945825|76100483|FG003|NOT COMPLETED|Overall Study||2||
59984988|NCT03945825|76100484|FG004|NOT COMPLETED|Overall Study||3||
59984989|NCT03945825|76100485|FG005|NOT COMPLETED|Overall Study||3||
59984990|NCT02759315|76100513|FG000|STARTED|Overall Study||69||
59984991|NCT02759315|76100514|FG001|STARTED|Overall Study||29||
59984992|NCT02759315|76100515|FG002|STARTED|Overall Study||39||
59984993|NCT02759315|76100516|FG003|STARTED|Overall Study||20||
59526644|NCT01363999|75622343|FG000|NOT COMPLETED|C: RO5317116/ F04 Active-coated Tablet||0||
59526645|NCT01363999|75622343|FG000|STARTED|D: RO4607381/ F49 Tablet||24||
59526646|NCT01363999|75622343|FG000|COMPLETED|D: RO4607381/ F49 Tablet||24||
59526647|NCT01363999|75622343|FG000|NOT COMPLETED|D: RO4607381/ F49 Tablet||0||
59526648|NCT00257894|75622352|FG000|STARTED|Overall Study||21||
59526649|NCT00257894|75622353|FG001|STARTED|Overall Study||20||
59526650|NCT00257894|75622352|FG000|COMPLETED|Overall Study||17||
59526651|NCT00257894|75622353|FG001|COMPLETED|Overall Study||15||
59526652|NCT00257894|75622352|FG000|NOT COMPLETED|Overall Study||4||
59526653|NCT00257894|75622353|FG001|NOT COMPLETED|Overall Study||5||
59526654|NCT00258128|75622361|FG000|STARTED|Overall Study||8||
59526655|NCT00258128|75622362|FG001|STARTED|Overall Study||9||
59526656|NCT00258128|75622361|FG000|COMPLETED|Overall Study||8||
59526657|NCT00258128|75622362|FG001|COMPLETED|Overall Study||9||
59526658|NCT00258128|75622361|FG000|NOT COMPLETED|Overall Study||0||
59526659|NCT00258128|75622362|FG001|NOT COMPLETED|Overall Study||0||
59526660|NCT01364623|75622373|FG000|STARTED|Single Dose||8||
59526661|NCT01364623|75622374|FG001|STARTED|Single Dose||8||
59526662|NCT01364623|75622375|FG002|STARTED|Single Dose||8||
59526663|NCT01364623|75622376|FG003|STARTED|Single Dose||0||
59526664|NCT01364623|75622373|FG000|COMPLETED|Single Dose||8||
59526665|NCT01364623|75622374|FG001|COMPLETED|Single Dose||8||
59526666|NCT01364623|75622375|FG002|COMPLETED|Single Dose||8||
59526667|NCT01364623|75622376|FG003|COMPLETED|Single Dose||0||
59984994|NCT02759315|76100517|FG004|STARTED|Overall Study||3||
59984995|NCT02759315|76100513|FG000|COMPLETED|Overall Study||65||
59984996|NCT02759315|76100514|FG001|COMPLETED|Overall Study||28||
59984997|NCT02759315|76100515|FG002|COMPLETED|Overall Study||29||
59984998|NCT02759315|76100516|FG003|COMPLETED|Overall Study||19||
59526668|NCT01364623|75622373|FG000|NOT COMPLETED|Single Dose||0||
59526669|NCT01364623|75622374|FG001|NOT COMPLETED|Single Dose||0||
59526670|NCT01364623|75622375|FG002|NOT COMPLETED|Single Dose||0||
59526671|NCT01364623|75622376|FG003|NOT COMPLETED|Single Dose||0||
59526672|NCT01364623|75622373|FG000|STARTED|Multiple Dose||0||
59526673|NCT01364623|75622374|FG001|STARTED|Multiple Dose||0||
59526674|NCT01364623|75622375|FG002|STARTED|Multiple Dose||0||
59526675|NCT01364623|75622376|FG003|STARTED|Multiple Dose||8||
59622609|NCT00537576|75734479|FG001|STARTED|Overall Study||3||
59622610|NCT00537576|75734480|FG002|STARTED|Overall Study||3||
59984999|NCT02759315|76100517|FG004|COMPLETED|Overall Study||2||
59985000|NCT02759315|76100513|FG000|NOT COMPLETED|Overall Study||4||
59985001|NCT02759315|76100514|FG001|NOT COMPLETED|Overall Study||1||
59985002|NCT02759315|76100515|FG002|NOT COMPLETED|Overall Study||10||
59985003|NCT02759315|76100516|FG003|NOT COMPLETED|Overall Study||1||
59985004|NCT02759315|76100517|FG004|NOT COMPLETED|Overall Study||1||
59985005|NCT00835081|76100533|FG000|STARTED|First Intervention||13||
59985006|NCT00835081|76100534|FG001|STARTED|First Intervention||13||
59985007|NCT00835081|76100533|FG000|COMPLETED|First Intervention||13||
59985008|NCT00835081|76100534|FG001|COMPLETED|First Intervention||13||
59526676|NCT01364623|75622373|FG000|COMPLETED|Multiple Dose||0||
59526677|NCT01364623|75622374|FG001|COMPLETED|Multiple Dose||0||
59526678|NCT01364623|75622375|FG002|COMPLETED|Multiple Dose||0||
59526679|NCT01364623|75622376|FG003|COMPLETED|Multiple Dose||8||
59526680|NCT01364623|75622373|FG000|NOT COMPLETED|Multiple Dose||0||
59526681|NCT01364623|75622374|FG001|NOT COMPLETED|Multiple Dose||0||
59526682|NCT01364623|75622375|FG002|NOT COMPLETED|Multiple Dose||0||
59622611|NCT00537576|75734481|FG003|STARTED|Overall Study||1||
59622612|NCT00537576|75734482|FG004|STARTED|Overall Study||1||
59526683|NCT01364623|75622376|FG003|NOT COMPLETED|Multiple Dose||0||
59526684|NCT00258206|75622391|FG000|STARTED|Overall Study||21||
59985009|NCT00835081|76100533|FG000|NOT COMPLETED|First Intervention||0||
59985010|NCT00835081|76100534|FG001|NOT COMPLETED|First Intervention||0||
59985011|NCT00835081|76100533|FG000|STARTED|Washout of 7 Days||13||
59985012|NCT00835081|76100534|FG001|STARTED|Washout of 7 Days||13||
59985013|NCT00835081|76100533|FG000|COMPLETED|Washout of 7 Days||12||
59985014|NCT00835081|76100534|FG001|COMPLETED|Washout of 7 Days||13||
59985015|NCT00835081|76100533|FG000|NOT COMPLETED|Washout of 7 Days||1||
59985016|NCT00835081|76100534|FG001|NOT COMPLETED|Washout of 7 Days||0||
59985017|NCT00835081|76100533|FG000|STARTED|Second Intervention||12||
59985018|NCT00835081|76100534|FG001|STARTED|Second Intervention||13||
59985019|NCT00835081|76100533|FG000|COMPLETED|Second Intervention||12||
59985020|NCT00835081|76100534|FG001|COMPLETED|Second Intervention||13||
59985021|NCT00835081|76100533|FG000|NOT COMPLETED|Second Intervention||0||
59985022|NCT00835081|76100534|FG001|NOT COMPLETED|Second Intervention||0||
59985023|NCT02543918|76100540|FG000|STARTED|Overall Study||41||
59985024|NCT02543918|76100541|FG001|STARTED|Overall Study||43||
59985025|NCT02543918|76100540|FG000|Received at Least 1 Dose of Study Drug|Overall Study||41||
59985026|NCT02543918|76100541|FG001|Received at Least 1 Dose of Study Drug|Overall Study||42||
59985027|NCT02543918|76100540|FG000|COMPLETED|Overall Study||38||
59985028|NCT02543918|76100541|FG001|COMPLETED|Overall Study||39||
59985029|NCT02543918|76100540|FG000|NOT COMPLETED|Overall Study||3||
59985030|NCT02543918|76100541|FG001|NOT COMPLETED|Overall Study||4||
59985031|NCT01372995|76100550|FG000|STARTED|Overall Study||10||
59985032|NCT01372995|76100551|FG001|STARTED|Overall Study||10||
59985033|NCT01372995|76100552|FG002|STARTED|Overall Study|One participant was transferred to comfort care prior to completing the intervention.|11||
59985034|NCT01372995|76100550|FG000|COMPLETED|Overall Study||10||
59985035|NCT01372995|76100551|FG001|COMPLETED|Overall Study||9||
59985036|NCT01372995|76100552|FG002|COMPLETED|Overall Study|The transferred participant was included in the intent to treat analyses.|10||
59985037|NCT01372995|76100550|FG000|NOT COMPLETED|Overall Study||0||
59985038|NCT01372995|76100551|FG001|NOT COMPLETED|Overall Study||1||
59985039|NCT01372995|76100552|FG002|NOT COMPLETED|Overall Study||1||
59985040|NCT02757521|76100562|FG000|STARTED|Overall Study||1||
59985041|NCT02757521|76100563|FG001|STARTED|Overall Study||0||
59985042|NCT02757521|76100562|FG000|COMPLETED|Overall Study||0||
59985043|NCT02757521|76100563|FG001|COMPLETED|Overall Study||0||
59985044|NCT02757521|76100562|FG000|NOT COMPLETED|Overall Study||1||
59985045|NCT02757521|76100563|FG001|NOT COMPLETED|Overall Study||0||
59985046|NCT00834613|76100571|FG000|STARTED|First Intervention||16||
59985047|NCT00834613|76100572|FG001|STARTED|First Intervention||16||
59985048|NCT00834613|76100571|FG000|COMPLETED|First Intervention||15||
59985049|NCT00834613|76100572|FG001|COMPLETED|First Intervention||16||
59985050|NCT00834613|76100571|FG000|NOT COMPLETED|First Intervention||1||
59985051|NCT00834613|76100572|FG001|NOT COMPLETED|First Intervention||0||
59985052|NCT00834613|76100571|FG000|STARTED|Washout of 7 Days||15||
59985053|NCT00834613|76100572|FG001|STARTED|Washout of 7 Days||16||
59985054|NCT00834613|76100571|FG000|COMPLETED|Washout of 7 Days||15||
59985055|NCT00834613|76100572|FG001|COMPLETED|Washout of 7 Days||16||
59985056|NCT00834613|76100571|FG000|NOT COMPLETED|Washout of 7 Days||0||
59985057|NCT00834613|76100572|FG001|NOT COMPLETED|Washout of 7 Days||0||
59985058|NCT00834613|76100571|FG000|STARTED|Second Intervention||15||
59985059|NCT00834613|76100572|FG001|STARTED|Second Intervention||16||
59985060|NCT00834613|76100571|FG000|COMPLETED|Second Intervention||15||
59985061|NCT00834613|76100572|FG001|COMPLETED|Second Intervention||16||
59985062|NCT00834613|76100571|FG000|NOT COMPLETED|Second Intervention||0||
59985063|NCT00834613|76100572|FG001|NOT COMPLETED|Second Intervention||0||
59985064|NCT00834535|76100578|FG000|STARTED|First Intervention||16||
59985065|NCT00834535|76100579|FG001|STARTED|First Intervention||16||
59985066|NCT00834535|76100578|FG000|COMPLETED|First Intervention||16||
59985067|NCT00834535|76100579|FG001|COMPLETED|First Intervention||16||
60074899|NCT01929343|76190123|FG000|NOT COMPLETED|Overall Study||1||
60074900|NCT01929343|76190124|FG001|NOT COMPLETED|Overall Study||2||
59985068|NCT00834535|76100578|FG000|NOT COMPLETED|First Intervention||0||
59985069|NCT00834535|76100579|FG001|NOT COMPLETED|First Intervention||0||
59985070|NCT00834535|76100578|FG000|STARTED|Washout of 7 Days||16||
59985071|NCT00834535|76100579|FG001|STARTED|Washout of 7 Days||16||
59985072|NCT00834535|76100578|FG000|COMPLETED|Washout of 7 Days||16||
59985073|NCT00834535|76100579|FG001|COMPLETED|Washout of 7 Days||16||
59985074|NCT00834535|76100578|FG000|NOT COMPLETED|Washout of 7 Days||0||
59985075|NCT00834535|76100579|FG001|NOT COMPLETED|Washout of 7 Days||0||
59985076|NCT00834535|76100578|FG000|STARTED|Second Intervention||16||
59985077|NCT00834535|76100579|FG001|STARTED|Second Intervention||16||
59985078|NCT00834535|76100578|FG000|COMPLETED|Second Intervention||16||
59985079|NCT00834535|76100579|FG001|COMPLETED|Second Intervention||16||
59985080|NCT00834535|76100578|FG000|NOT COMPLETED|Second Intervention||0||
59985081|NCT00834535|76100579|FG001|NOT COMPLETED|Second Intervention||0||
59985082|NCT03727373|76100583|FG000|STARTED|Overall Study||8||
59985083|NCT03727373|76100583|FG000|COMPLETED|Overall Study||8||
59985084|NCT03727373|76100583|FG000|NOT COMPLETED|Overall Study||0||
59985085|NCT00834067|76100589|FG000|STARTED|First Intervention||30||
60074901|NCT01929343|76190125|FG002|NOT COMPLETED|Overall Study||0||
60074902|NCT01968811|76190133|FG000|STARTED|Overall Study||10||
59985086|NCT00834067|76100590|FG001|STARTED|First Intervention||30||
59985087|NCT00834067|76100589|FG000|COMPLETED|First Intervention||30||
59985088|NCT00834067|76100590|FG001|COMPLETED|First Intervention||30||
59985089|NCT00834067|76100589|FG000|NOT COMPLETED|First Intervention||0||
59985090|NCT00834067|76100590|FG001|NOT COMPLETED|First Intervention||0||
59985091|NCT00834067|76100589|FG000|STARTED|Washout of 21 Days||30||
59985092|NCT00834067|76100590|FG001|STARTED|Washout of 21 Days||30||
60074903|NCT01968811|76190133|FG000|COMPLETED|Overall Study||5||
59985093|NCT00834067|76100589|FG000|COMPLETED|Washout of 21 Days||30||
59985094|NCT00834067|76100590|FG001|COMPLETED|Washout of 21 Days||29||
59985095|NCT00834067|76100589|FG000|NOT COMPLETED|Washout of 21 Days||0||
59985096|NCT00834067|76100590|FG001|NOT COMPLETED|Washout of 21 Days||1||
59985097|NCT00834067|76100589|FG000|STARTED|Second Intervention||30||
59985098|NCT00834067|76100590|FG001|STARTED|Second Intervention||29||
59985099|NCT00834067|76100589|FG000|COMPLETED|Second Intervention||30||
59985100|NCT00834067|76100590|FG001|COMPLETED|Second Intervention||29||
59985101|NCT00834067|76100589|FG000|NOT COMPLETED|Second Intervention||0||
59985102|NCT00834067|76100590|FG001|NOT COMPLETED|Second Intervention||0||
59985103|NCT02758613|76100598|FG000|STARTED|Treatment||8||
59985104|NCT02758613|76100599|FG001|STARTED|Treatment||8||
59985105|NCT02758613|76100600|FG002|STARTED|Treatment||9||
59985106|NCT02758613|76100601|FG003|STARTED|Treatment||8||
59985107|NCT02758613|76100598|FG000|Received at Least One Dose of Study Drug|Treatment||8||
59985108|NCT02758613|76100599|FG001|Received at Least One Dose of Study Drug|Treatment||8||
59985109|NCT02758613|76100600|FG002|Received at Least One Dose of Study Drug|Treatment||9||
59985110|NCT02758613|76100601|FG003|Received at Least One Dose of Study Drug|Treatment||8||
59985111|NCT02758613|76100598|FG000|COMPLETED|Treatment||6||
59985112|NCT02758613|76100599|FG001|COMPLETED|Treatment||8||
59985113|NCT02758613|76100600|FG002|COMPLETED|Treatment||8||
59985114|NCT02758613|76100601|FG003|COMPLETED|Treatment||8||
59985115|NCT02758613|76100598|FG000|NOT COMPLETED|Treatment||2||
59985116|NCT02758613|76100599|FG001|NOT COMPLETED|Treatment||0||
59985117|NCT02758613|76100600|FG002|NOT COMPLETED|Treatment||1||
59985118|NCT02758613|76100601|FG003|NOT COMPLETED|Treatment||0||
59985119|NCT02758613|76100598|FG000|STARTED|Follow-up||6||
59985120|NCT02758613|76100599|FG001|STARTED|Follow-up||8||
59985121|NCT02758613|76100600|FG002|STARTED|Follow-up||8||
59985122|NCT02758613|76100601|FG003|STARTED|Follow-up||8||
59985123|NCT02758613|76100598|FG000|COMPLETED|Follow-up||6||
59985124|NCT02758613|76100599|FG001|COMPLETED|Follow-up||8||
59985125|NCT02758613|76100600|FG002|COMPLETED|Follow-up||8||
59985126|NCT02758613|76100601|FG003|COMPLETED|Follow-up||8||
59985127|NCT02758613|76100598|FG000|NOT COMPLETED|Follow-up||0||
59985128|NCT02758613|76100599|FG001|NOT COMPLETED|Follow-up||0||
59985129|NCT02758613|76100600|FG002|NOT COMPLETED|Follow-up||0||
59985130|NCT02758613|76100601|FG003|NOT COMPLETED|Follow-up||0||
59985131|NCT02758301|76100616|FG000|STARTED|Overall Study||104||
59985132|NCT02758301|76100617|FG001|STARTED|Overall Study||8||
59622613|NCT00537576|75734483|FG005|STARTED|Overall Study||1||
59622614|NCT00537576|75734478|FG000|COMPLETED|Overall Study||3||
59622615|NCT00537576|75734479|FG001|COMPLETED|Overall Study||3||
59622616|NCT00537576|75734480|FG002|COMPLETED|Overall Study||3||
59622617|NCT00537576|75734481|FG003|COMPLETED|Overall Study||1||
59622618|NCT00537576|75734482|FG004|COMPLETED|Overall Study||1||
59622619|NCT00537576|75734483|FG005|COMPLETED|Overall Study||1||
59622620|NCT00537576|75734478|FG000|NOT COMPLETED|Overall Study||0||
59622621|NCT00537576|75734479|FG001|NOT COMPLETED|Overall Study||0||
59622622|NCT00537576|75734480|FG002|NOT COMPLETED|Overall Study||0||
59622623|NCT00537576|75734481|FG003|NOT COMPLETED|Overall Study||0||
59622624|NCT00537576|75734482|FG004|NOT COMPLETED|Overall Study||0||
59622625|NCT00537576|75734483|FG005|NOT COMPLETED|Overall Study||0||
59622626|NCT00491244|75734499|FG000|STARTED|Overall Study||189||
59622627|NCT00491244|75734500|FG001|STARTED|Overall Study||188||
59985133|NCT02758301|76100616|FG000|COMPLETED|Overall Study||70||
59985134|NCT02758301|76100617|FG001|COMPLETED|Overall Study||0||
59985135|NCT02758301|76100616|FG000|NOT COMPLETED|Overall Study||34||
59985136|NCT02758301|76100617|FG001|NOT COMPLETED|Overall Study||8||
59985137|NCT00833521|76100625|FG000|STARTED|First Intervention||19||
59985138|NCT00833521|76100626|FG001|STARTED|First Intervention||19||
59985139|NCT00833521|76100625|FG000|COMPLETED|First Intervention||19||
59985140|NCT00833521|76100626|FG001|COMPLETED|First Intervention||19||
59985141|NCT00833521|76100625|FG000|NOT COMPLETED|First Intervention||0||
59985142|NCT00833521|76100626|FG001|NOT COMPLETED|First Intervention||0||
59985143|NCT00833521|76100625|FG000|STARTED|Second Intervention||19||
59985144|NCT00833521|76100626|FG001|STARTED|Second Intervention||19||
59622628|NCT00491244|75734499|FG000|COMPLETED|Overall Study||162||
59622629|NCT00491244|75734500|FG001|COMPLETED|Overall Study||168||
59622630|NCT00491244|75734499|FG000|NOT COMPLETED|Overall Study||27||
59985145|NCT00833521|76100625|FG000|COMPLETED|Second Intervention||19||
59985146|NCT00833521|76100626|FG001|COMPLETED|Second Intervention||19||
59985147|NCT00833521|76100625|FG000|NOT COMPLETED|Second Intervention||0||
59985148|NCT00833521|76100626|FG001|NOT COMPLETED|Second Intervention||0||
59985149|NCT02669667|76100637|FG000|STARTED|Overall Study||12||
59985150|NCT02669667|76100638|FG001|STARTED|Overall Study||4||
59985151|NCT02669667|76100639|FG002|STARTED|Overall Study||4||
59985152|NCT02669667|76100640|FG003|STARTED|Overall Study||6||
59985153|NCT02669667|76100641|FG004|STARTED|Overall Study||6||
59622631|NCT00491244|75734500|FG001|NOT COMPLETED|Overall Study||20||
59985154|NCT02669667|76100642|FG005|STARTED|Overall Study||6||
59985155|NCT02669667|76100643|FG006|STARTED|Overall Study||6||
59985156|NCT02669667|76100637|FG000|COMPLETED|Overall Study||12||
59985157|NCT02669667|76100638|FG001|COMPLETED|Overall Study||4||
59985158|NCT02669667|76100639|FG002|COMPLETED|Overall Study||4||
59985159|NCT02669667|76100640|FG003|COMPLETED|Overall Study||6||
59985160|NCT02669667|76100641|FG004|COMPLETED|Overall Study||6||
59985161|NCT02669667|76100642|FG005|COMPLETED|Overall Study||5||
59985162|NCT02669667|76100643|FG006|COMPLETED|Overall Study||6||
59985163|NCT02669667|76100637|FG000|NOT COMPLETED|Overall Study||0||
59985164|NCT02669667|76100638|FG001|NOT COMPLETED|Overall Study||0||
59985165|NCT02669667|76100639|FG002|NOT COMPLETED|Overall Study||0||
59985166|NCT02669667|76100640|FG003|NOT COMPLETED|Overall Study||0||
59985167|NCT02669667|76100641|FG004|NOT COMPLETED|Overall Study||0||
59985168|NCT02669667|76100642|FG005|NOT COMPLETED|Overall Study||1||
59985169|NCT02669667|76100643|FG006|NOT COMPLETED|Overall Study||0||
59985170|NCT02669433|76100668|FG000|STARTED|Overall Study||91||
59985171|NCT02669433|76100669|FG001|STARTED|Overall Study||89||
59985172|NCT02669433|76100670|FG002|STARTED|Overall Study||89||
59985173|NCT02669433|76100668|FG000|Safety Population|Overall Study||91|The Safety population included subjects who took at least 1 dose of double-blind study drug|
59985174|NCT02669433|76100669|FG001|Safety Population|Overall Study||89|The Safety population included subjects who took at least 1 dose of double-blind study drug|
59985175|NCT02669433|76100670|FG002|Safety Population|Overall Study||88|The Safety population included subjects who took at least 1 dose of double-blind study drug|
59985176|NCT02669433|76100668|FG000|Intent to Treat (ITT) Population|Overall Study||89|Subjects took at least 1 dose of double-blind study drug and had at least 1 post-baseline assessment|
59985177|NCT02669433|76100669|FG001|Intent to Treat (ITT) Population|Overall Study||89|Subjects took at least 1 dose of double-blind study drug and had at least 1 post-baseline assessment|
60074904|NCT01968811|76190133|FG000|NOT COMPLETED|Overall Study||5||
60074905|NCT01806584|76190139|FG000|STARTED|Overall Study||14||
60074906|NCT01806584|76190140|FG001|STARTED|Overall Study||18||
60074907|NCT01806584|76190139|FG000|COMPLETED|Overall Study||0||
60074908|NCT01806584|76190140|FG001|COMPLETED|Overall Study||0||
60074909|NCT01806584|76190139|FG000|NOT COMPLETED|Overall Study||14||
60074910|NCT01806584|76190140|FG001|NOT COMPLETED|Overall Study||18||
60074911|NCT01798706|76190148|FG000|STARTED|Overall Study||176||
60074912|NCT01798706|76190149|FG001|STARTED|Overall Study||174||
60074913|NCT01798706|76190148|FG000|COMPLETED|Overall Study||155||
60074914|NCT01798706|76190149|FG001|COMPLETED|Overall Study||153||
59985178|NCT02669433|76100670|FG002|Intent to Treat (ITT) Population|Overall Study||87|Subjects took at least 1 dose of double-blind study drug and had at least 1 post-baseline assessment|
59985179|NCT02669433|76100668|FG000|Per-Protocol Population|Overall Study||78|Subjects in the ITT population who had no major protocol violations|
59526685|NCT00258206|75622391|FG000|COMPLETED|Overall Study||21||
59526686|NCT00258206|75622391|FG000|NOT COMPLETED|Overall Study||0||
59985180|NCT02669433|76100669|FG001|Per-Protocol Population|Overall Study||79|Subjects in the ITT population who had no major protocol violations|
59985181|NCT02669433|76100670|FG002|Per-Protocol Population|Overall Study||82|Subjects in the ITT population who had no major protocol violations|
59985182|NCT02669433|76100668|FG000|Completers Population|Overall Study||73|Subjects in the ITT population who completed the study|
59985183|NCT02669433|76100669|FG001|Completers Population|Overall Study||72|Subjects in the ITT population who completed the study|
59985184|NCT02669433|76100670|FG002|Completers Population|Overall Study||69|Subjects in the ITT population who completed the study|
59985185|NCT02669433|76100668|FG000|UPDRS Primary Population|Overall Study||87||
59985186|NCT02669433|76100669|FG001|UPDRS Primary Population|Overall Study||87||
59985187|NCT02669433|76100670|FG002|UPDRS Primary Population|Overall Study||84||
59985188|NCT02669433|76100668|FG000|COMPLETED|Overall Study||76|Subjects who completed every visit per protocol|
59985189|NCT02669433|76100669|FG001|COMPLETED|Overall Study||75|Subjects who completed every visit per protocol|
59985190|NCT02669433|76100670|FG002|COMPLETED|Overall Study||74|Subjects who completed every visit per protocol|
59985191|NCT02669433|76100668|FG000|NOT COMPLETED|Overall Study||15||
59985192|NCT02669433|76100669|FG001|NOT COMPLETED|Overall Study||14||
59985193|NCT02669433|76100670|FG002|NOT COMPLETED|Overall Study||15||
59985194|NCT02756819|76100678|FG000|STARTED|Overall Study||1945||
59985195|NCT02756819|76100678|FG000|Per-protocol Set (PPS)|Overall Study|Participants who were enrolled, received Edarbi® therapy and did not have major protocol deviations.|1724||
59985196|NCT02756819|76100678|FG000|Safety Analysis Set (SAS)|Overall Study|Participants who received at least one dose of Edarbi® therapy and had any follow-up data.|1934||
59985197|NCT02756819|76100678|FG000|COMPLETED|Overall Study||1893||
59985198|NCT02756819|76100678|FG000|NOT COMPLETED|Overall Study||52||
59985199|NCT00829309|76100684|FG000|STARTED|First Intervention||8||
59985200|NCT00829309|76100685|FG001|STARTED|First Intervention||8||
59985201|NCT00829309|76100684|FG000|COMPLETED|First Intervention||8||
59985202|NCT00829309|76100685|FG001|COMPLETED|First Intervention||8||
59985203|NCT00829309|76100684|FG000|NOT COMPLETED|First Intervention||0||
59985204|NCT00829309|76100685|FG001|NOT COMPLETED|First Intervention||0||
59985205|NCT00829309|76100684|FG000|STARTED|Washout: 7 Days||8||
59985206|NCT00829309|76100685|FG001|STARTED|Washout: 7 Days||8||
59985207|NCT00829309|76100684|FG000|COMPLETED|Washout: 7 Days||7||
59985208|NCT00829309|76100685|FG001|COMPLETED|Washout: 7 Days||8||
59985209|NCT00829309|76100684|FG000|NOT COMPLETED|Washout: 7 Days||1||
59985210|NCT00829309|76100685|FG001|NOT COMPLETED|Washout: 7 Days||0||
59985211|NCT00829309|76100684|FG000|STARTED|Second Intervention||7||
59985212|NCT00829309|76100685|FG001|STARTED|Second Intervention||8||
59985213|NCT00829309|76100684|FG000|COMPLETED|Second Intervention||7||
59985214|NCT00829309|76100685|FG001|COMPLETED|Second Intervention||8||
59985215|NCT00829309|76100684|FG000|NOT COMPLETED|Second Intervention||0||
59985216|NCT00829309|76100685|FG001|NOT COMPLETED|Second Intervention||0||
59985217|NCT02669121|76100691|FG000|STARTED|Overall Study||2377||
59985218|NCT02669121|76100692|FG001|STARTED|Overall Study||2371||
59985219|NCT02669121|76100691|FG000|Treated (Safety Analysis Set)|Overall Study||2357|All participants who received trial vaccination (NoV or placebo).|
59985220|NCT02669121|76100692|FG001|Treated (Safety Analysis Set)|Overall Study||2355|All participants who received trial vaccination (NoV or placebo).|
59985221|NCT02669121|76100691|FG000|COMPLETED|Overall Study||2087||
59985222|NCT02669121|76100692|FG001|COMPLETED|Overall Study||2089||
59985223|NCT02669121|76100691|FG000|NOT COMPLETED|Overall Study||290||
59985224|NCT02669121|76100692|FG001|NOT COMPLETED|Overall Study||282||
59985225|NCT02743117|76100700|FG000|STARTED|Overall Study||60||
59985226|NCT02743117|76100701|FG001|STARTED|Overall Study||241||
59985227|NCT02743117|76100700|FG000|Treated|Overall Study||59||
59985228|NCT02743117|76100701|FG001|Treated|Overall Study||241||
59985229|NCT02743117|76100700|FG000|COMPLETED|Overall Study||59||
59985230|NCT02743117|76100701|FG001|COMPLETED|Overall Study||240||
59985231|NCT02743117|76100700|FG000|NOT COMPLETED|Overall Study||1||
59985232|NCT02743117|76100701|FG001|NOT COMPLETED|Overall Study||1||
59985233|NCT03607539|76100709|FG000|STARTED|Overall Study||266||
59985234|NCT03607539|76100710|FG001|STARTED|Overall Study||131||
59985235|NCT03607539|76100709|FG000|COMPLETED|Overall Study||0||
59985236|NCT03607539|76100710|FG001|COMPLETED|Overall Study||0||
59985237|NCT03607539|76100709|FG000|NOT COMPLETED|Overall Study||266||
59985238|NCT03607539|76100710|FG001|NOT COMPLETED|Overall Study||131||
59985239|NCT02669043|76100716|FG000|STARTED|Overall Study||8||
59985240|NCT02669043|76100716|FG000|COMPLETED|Overall Study||4||
59985241|NCT02669043|76100716|FG000|NOT COMPLETED|Overall Study||4||
59985242|NCT00805129|76100720|FG000|STARTED|Overall Study||46||
59526687|NCT01063907|75622395|FG000|STARTED|Overall Study||15||
59526688|NCT01063907|75622396|FG001|STARTED|Overall Study||80||
59985243|NCT00805129|76100720|FG000|COMPLETED|Overall Study||45||
59985244|NCT00805129|76100720|FG000|NOT COMPLETED|Overall Study||1||
59985245|NCT02668185|76100724|FG000|STARTED|Baseline Period (2 Weeks)||20||
59526689|NCT01063907|75622395|FG000|COMPLETED|Overall Study||15||
59526690|NCT01063907|75622396|FG001|COMPLETED|Overall Study||80||
59526691|NCT01063907|75622395|FG000|NOT COMPLETED|Overall Study||0||
59526692|NCT01063907|75622396|FG001|NOT COMPLETED|Overall Study||0||
59526693|NCT01316263|75622420|FG000|STARTED|Overall Study||7||
59526694|NCT01316263|75622421|FG001|STARTED|Overall Study||14||
59526695|NCT01316263|75622420|FG000|Received Any Study Drug|Overall Study||7||
59815065|NCT03726671|75937477|FG005|NOT COMPLETED|Second Intervention (2 Weeks)||0||
59815066|NCT03726671|75937472|FG000|STARTED|Washout (>/= 2 Weeks)||17||
59815067|NCT03726671|75937473|FG001|STARTED|Washout (>/= 2 Weeks)||12||
59526696|NCT01316263|75622421|FG001|Received Any Study Drug|Overall Study||14||
59526697|NCT01316263|75622420|FG000|COMPLETED|Overall Study||7||
59526698|NCT01316263|75622421|FG001|COMPLETED|Overall Study||14||
59815068|NCT03726671|75937474|FG002|STARTED|Washout (>/= 2 Weeks)||12||
59815069|NCT03726671|75937475|FG003|STARTED|Washout (>/= 2 Weeks)||11||
59815070|NCT03726671|75937476|FG004|STARTED|Washout (>/= 2 Weeks)||18||
59815071|NCT03726671|75937477|FG005|STARTED|Washout (>/= 2 Weeks)||8||
59815072|NCT03726671|75937472|FG000|COMPLETED|Washout (>/= 2 Weeks)||17||
59815073|NCT03726671|75937473|FG001|COMPLETED|Washout (>/= 2 Weeks)||12||
59815074|NCT03726671|75937474|FG002|COMPLETED|Washout (>/= 2 Weeks)||12||
59815075|NCT03726671|75937475|FG003|COMPLETED|Washout (>/= 2 Weeks)||11||
59526699|NCT01316263|75622420|FG000|NOT COMPLETED|Overall Study||0||
59526700|NCT01316263|75622421|FG001|NOT COMPLETED|Overall Study||0||
59526701|NCT01068821|75622431|FG000|STARTED|Overall Study||31||
59526702|NCT01068821|75622432|FG001|STARTED|Overall Study||29||
59526703|NCT01068821|75622431|FG000|COMPLETED|Overall Study|1 patient had slide measured, but her patient ID not listed; couldn't do postoperative followup.|30||
59526704|NCT01068821|75622432|FG001|COMPLETED|Overall Study||29||
59526705|NCT01068821|75622431|FG000|NOT COMPLETED|Overall Study||1||
59526706|NCT01068821|75622432|FG001|NOT COMPLETED|Overall Study||0||
59526707|NCT01070693|75622440|FG000|STARTED|Overall Study||150||
59526708|NCT01070693|75622441|FG001|STARTED|Overall Study||149||
59526709|NCT01070693|75622440|FG000|COMPLETED|Overall Study||122||
59526710|NCT01070693|75622441|FG001|COMPLETED|Overall Study||110||
59526711|NCT01070693|75622440|FG000|NOT COMPLETED|Overall Study||28||
59526712|NCT01070693|75622441|FG001|NOT COMPLETED|Overall Study||39||
59526713|NCT02171819|75622450|FG000|STARTED|Overall Study||31||
59526714|NCT02171819|75622451|FG001|STARTED|Overall Study||32||
59526715|NCT02171819|75622452|FG002|STARTED|Overall Study||12||
59526716|NCT02171819|75622450|FG000|COMPLETED|Overall Study||31||
59526717|NCT02171819|75622451|FG001|COMPLETED|Overall Study||32||
59526718|NCT02171819|75622452|FG002|COMPLETED|Overall Study||12||
59526719|NCT02171819|75622450|FG000|NOT COMPLETED|Overall Study||0||
59526720|NCT02171819|75622451|FG001|NOT COMPLETED|Overall Study||0||
59526721|NCT02171819|75622452|FG002|NOT COMPLETED|Overall Study||0||
59526722|NCT02172755|75622466|FG000|STARTED|Overall Study||14||
59526723|NCT02172755|75622467|FG001|STARTED|Overall Study||16||
59526724|NCT02172755|75622466|FG000|COMPLETED|Overall Study||12||
59526725|NCT02172755|75622467|FG001|COMPLETED|Overall Study||12||
59815076|NCT03726671|75937476|FG004|COMPLETED|Washout (>/= 2 Weeks)||17||
59526726|NCT02172755|75622466|FG000|NOT COMPLETED|Overall Study||2||
59526727|NCT02172755|75622467|FG001|NOT COMPLETED|Overall Study||4||
59526728|NCT02173535|75622493|FG000|STARTED|Period 1||12||
59526729|NCT02173535|75622494|FG001|STARTED|Period 1||12||
59526730|NCT02173535|75622495|FG002|STARTED|Period 1||12||
59526731|NCT02173535|75622496|FG003|STARTED|Period 1||12||
59526732|NCT02173535|75622497|FG004|STARTED|Period 1||12||
59526733|NCT02173535|75622498|FG005|STARTED|Period 1||12||
59526734|NCT02173535|75622499|FG006|STARTED|Period 1||12||
59526735|NCT02173535|75622500|FG007|STARTED|Period 1||12||
59526736|NCT02173535|75622501|FG008|STARTED|Period 1||12||
59526737|NCT02173535|75622502|FG009|STARTED|Period 1||12||
59526738|NCT02173535|75622503|FG010|STARTED|Period 1||12||
59526739|NCT02173535|75622504|FG011|STARTED|Period 1||12||
59526740|NCT02173535|75622505|FG012|STARTED|Period 1||12||
59815077|NCT03726671|75937477|FG005|COMPLETED|Washout (>/= 2 Weeks)||8||
59815078|NCT03726671|75937472|FG000|NOT COMPLETED|Washout (>/= 2 Weeks)||0||
59815079|NCT03726671|75937473|FG001|NOT COMPLETED|Washout (>/= 2 Weeks)||0||
59815080|NCT03726671|75937474|FG002|NOT COMPLETED|Washout (>/= 2 Weeks)||0||
59985246|NCT02668185|76100725|FG001|STARTED|Baseline Period (2 Weeks)||17||
59985247|NCT02668185|76100724|FG000|COMPLETED|Baseline Period (2 Weeks)||20||
59985248|NCT02668185|76100725|FG001|COMPLETED|Baseline Period (2 Weeks)||17||
59526741|NCT02173535|75622506|FG013|STARTED|Period 1||12||
59526742|NCT02173535|75622507|FG014|STARTED|Period 1||12||
59526743|NCT02173535|75622508|FG015|STARTED|Period 1||12||
59526744|NCT02173535|75622509|FG016|STARTED|Period 1||12||
59526745|NCT02173535|75622510|FG017|STARTED|Period 1||12||
59526746|NCT02173535|75622511|FG018|STARTED|Period 1||12||
59526747|NCT02173535|75622512|FG019|STARTED|Period 1||12||
59526748|NCT02173535|75622493|FG000|COMPLETED|Period 1||12||
59526749|NCT02173535|75622494|FG001|COMPLETED|Period 1||12||
59526750|NCT02173535|75622495|FG002|COMPLETED|Period 1||12||
59526751|NCT02173535|75622496|FG003|COMPLETED|Period 1||12||
59526752|NCT02173535|75622497|FG004|COMPLETED|Period 1||12||
59815081|NCT03726671|75937475|FG003|NOT COMPLETED|Washout (>/= 2 Weeks)||0||
59815082|NCT03726671|75937476|FG004|NOT COMPLETED|Washout (>/= 2 Weeks)||1||
59815083|NCT03726671|75937477|FG005|NOT COMPLETED|Washout (>/= 2 Weeks)||0||
59985249|NCT02668185|76100724|FG000|NOT COMPLETED|Baseline Period (2 Weeks)||0||
59985250|NCT02668185|76100725|FG001|NOT COMPLETED|Baseline Period (2 Weeks)||0||
59985251|NCT02668185|76100724|FG000|STARTED|First Intervention (4 Weeks)||20||
59985252|NCT02668185|76100725|FG001|STARTED|First Intervention (4 Weeks)||17||
59985253|NCT02668185|76100724|FG000|COMPLETED|First Intervention (4 Weeks)||18||
59985254|NCT02668185|76100725|FG001|COMPLETED|First Intervention (4 Weeks)||17||
59985255|NCT02668185|76100724|FG000|NOT COMPLETED|First Intervention (4 Weeks)||2||
59985256|NCT02668185|76100725|FG001|NOT COMPLETED|First Intervention (4 Weeks)||0||
59985257|NCT02668185|76100724|FG000|STARTED|Washout Period (2 Weeks)||18||
59985258|NCT02668185|76100725|FG001|STARTED|Washout Period (2 Weeks)||17||
59985259|NCT02668185|76100724|FG000|COMPLETED|Washout Period (2 Weeks)||17||
59985260|NCT02668185|76100725|FG001|COMPLETED|Washout Period (2 Weeks)||15||
59985261|NCT02668185|76100724|FG000|NOT COMPLETED|Washout Period (2 Weeks)||1||
59985262|NCT02668185|76100725|FG001|NOT COMPLETED|Washout Period (2 Weeks)||2||
59985263|NCT02668185|76100724|FG000|STARTED|Second Intervention (4 Weeks)||17||
59985264|NCT02668185|76100725|FG001|STARTED|Second Intervention (4 Weeks)||15||
59985265|NCT02668185|76100724|FG000|COMPLETED|Second Intervention (4 Weeks)||16||
59985266|NCT02668185|76100725|FG001|COMPLETED|Second Intervention (4 Weeks)||12||
59985267|NCT02668185|76100724|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||1||
59985268|NCT02668185|76100725|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||3||
59985269|NCT02668185|76100724|FG000|STARTED|Moitoring Period (2 Weeks)||16||
59985270|NCT02668185|76100725|FG001|STARTED|Moitoring Period (2 Weeks)||12||
59985271|NCT02668185|76100724|FG000|COMPLETED|Moitoring Period (2 Weeks)||16||
59985272|NCT02668185|76100725|FG001|COMPLETED|Moitoring Period (2 Weeks)||12||
59985273|NCT02668185|76100724|FG000|NOT COMPLETED|Moitoring Period (2 Weeks)||0||
59985274|NCT02668185|76100725|FG001|NOT COMPLETED|Moitoring Period (2 Weeks)||0||
59985275|NCT00662389|76100731|FG000|STARTED|Overall Study||4||
59985276|NCT00662389|76100731|FG000|COMPLETED|Overall Study||4||
59985277|NCT00662389|76100731|FG000|NOT COMPLETED|Overall Study||0||
59985278|NCT02742181|76100736|FG000|STARTED|Overall Study||6||
59985279|NCT02742181|76100737|FG001|STARTED|Overall Study||8||
59985280|NCT02742181|76100736|FG000|COMPLETED|Overall Study||5||
59985281|NCT02742181|76100737|FG001|COMPLETED|Overall Study||8||
59985282|NCT02742181|76100736|FG000|NOT COMPLETED|Overall Study||1||
59985283|NCT02742181|76100737|FG001|NOT COMPLETED|Overall Study||0||
59985284|NCT02742103|76100745|FG000|STARTED|Overall Study||55||
59985285|NCT02742103|76100746|FG001|STARTED|Overall Study||28||
59985286|NCT02742103|76100745|FG000|COMPLETED|Overall Study||46||
59985287|NCT02742103|76100746|FG001|COMPLETED|Overall Study||23||
59985288|NCT02742103|76100745|FG000|NOT COMPLETED|Overall Study||9||
59985289|NCT02742103|76100746|FG001|NOT COMPLETED|Overall Study||5||
59985290|NCT02741713|76100754|FG000|STARTED|Overall Study||20||
59985291|NCT02741713|76100755|FG001|STARTED|Overall Study||20||
59985292|NCT02741713|76100754|FG000|COMPLETED|Overall Study||18||
59985293|NCT02741713|76100755|FG001|COMPLETED|Overall Study||19||
59985294|NCT02741713|76100754|FG000|NOT COMPLETED|Overall Study||2||
59985295|NCT02741713|76100755|FG001|NOT COMPLETED|Overall Study||1||
59985296|NCT02663271|76100762|FG000|STARTED|Overall Study||9||
59985297|NCT02663271|76100762|FG000|COMPLETED|Overall Study||3||
59985298|NCT02663271|76100762|FG000|NOT COMPLETED|Overall Study||6||
59985299|NCT02742649|76100769|FG000|STARTED|Pre-Randomization Washout Period||55||
59985300|NCT02742649|76100770|FG001|STARTED|Pre-Randomization Washout Period||0||
59985301|NCT02742649|76100771|FG002|STARTED|Pre-Randomization Washout Period||0||
59985302|NCT02742649|76100772|FG003|STARTED|Pre-Randomization Washout Period||0||
59985303|NCT02742649|76100773|FG004|STARTED|Pre-Randomization Washout Period||0||
59985304|NCT02742649|76100769|FG000|COMPLETED|Pre-Randomization Washout Period||50||
59985305|NCT02742649|76100770|FG001|COMPLETED|Pre-Randomization Washout Period||0||
59985306|NCT02742649|76100771|FG002|COMPLETED|Pre-Randomization Washout Period||0||
59985307|NCT02742649|76100772|FG003|COMPLETED|Pre-Randomization Washout Period||0||
59985308|NCT02742649|76100773|FG004|COMPLETED|Pre-Randomization Washout Period||0||
59985309|NCT02742649|76100769|FG000|NOT COMPLETED|Pre-Randomization Washout Period||5||
59985310|NCT02742649|76100770|FG001|NOT COMPLETED|Pre-Randomization Washout Period||0||
59985311|NCT02742649|76100771|FG002|NOT COMPLETED|Pre-Randomization Washout Period||0||
59985312|NCT02742649|76100772|FG003|NOT COMPLETED|Pre-Randomization Washout Period||0||
59985313|NCT02742649|76100773|FG004|NOT COMPLETED|Pre-Randomization Washout Period||0||
59985314|NCT02742649|76100769|FG000|STARTED|Double-Blind Treatment Period||0||
59985315|NCT02742649|76100770|FG001|STARTED|Double-Blind Treatment Period||17||
59985316|NCT02742649|76100771|FG002|STARTED|Double-Blind Treatment Period||17||
59985317|NCT02742649|76100772|FG003|STARTED|Double-Blind Treatment Period||16||
59985318|NCT02742649|76100773|FG004|STARTED|Double-Blind Treatment Period||0||
59985319|NCT02742649|76100769|FG000|COMPLETED|Double-Blind Treatment Period||0||
59985320|NCT02742649|76100770|FG001|COMPLETED|Double-Blind Treatment Period||16||
59985321|NCT02742649|76100771|FG002|COMPLETED|Double-Blind Treatment Period||17||
59985322|NCT02742649|76100772|FG003|COMPLETED|Double-Blind Treatment Period||16||
59985323|NCT02742649|76100773|FG004|COMPLETED|Double-Blind Treatment Period||0||
59985324|NCT02742649|76100769|FG000|NOT COMPLETED|Double-Blind Treatment Period||0||
59985325|NCT02742649|76100770|FG001|NOT COMPLETED|Double-Blind Treatment Period||1||
59985326|NCT02742649|76100771|FG002|NOT COMPLETED|Double-Blind Treatment Period||0||
59985327|NCT02742649|76100772|FG003|NOT COMPLETED|Double-Blind Treatment Period||0||
59985328|NCT02742649|76100773|FG004|NOT COMPLETED|Double-Blind Treatment Period||0||
59985329|NCT02742649|76100769|FG000|STARTED|Open-Label Period||0||
59985330|NCT02742649|76100770|FG001|STARTED|Open-Label Period||0||
59985331|NCT02742649|76100771|FG002|STARTED|Open-Label Period||0||
59985332|NCT02742649|76100772|FG003|STARTED|Open-Label Period||0||
59985333|NCT02742649|76100773|FG004|STARTED|Open-Label Period||49||
59985334|NCT02742649|76100769|FG000|COMPLETED|Open-Label Period||0||
59985335|NCT02742649|76100770|FG001|COMPLETED|Open-Label Period||0||
59985336|NCT02742649|76100771|FG002|COMPLETED|Open-Label Period||0||
59985337|NCT02742649|76100772|FG003|COMPLETED|Open-Label Period||0||
59985338|NCT02742649|76100773|FG004|COMPLETED|Open-Label Period||48||
59985339|NCT02742649|76100769|FG000|NOT COMPLETED|Open-Label Period||0||
59985340|NCT02742649|76100770|FG001|NOT COMPLETED|Open-Label Period||0||
59985341|NCT02742649|76100771|FG002|NOT COMPLETED|Open-Label Period||0||
59985342|NCT02742649|76100772|FG003|NOT COMPLETED|Open-Label Period||0||
59985343|NCT02742649|76100773|FG004|NOT COMPLETED|Open-Label Period||1||
59985344|NCT02665689|76100786|FG000|STARTED|Overall Study||2||
59985345|NCT02665689|76100787|FG001|STARTED|Overall Study||2||
59985346|NCT02665689|76100786|FG000|COMPLETED|Overall Study||0||
59985347|NCT02665689|76100787|FG001|COMPLETED|Overall Study||0||
59985348|NCT02665689|76100786|FG000|NOT COMPLETED|Overall Study||2||
59985349|NCT02665689|76100787|FG001|NOT COMPLETED|Overall Study||2||
59985350|NCT02665455|76100793|FG000|STARTED|Overall Study||83||
59985351|NCT02665455|76100793|FG000|COMPLETED|Overall Study||74||
59985352|NCT02665455|76100793|FG000|NOT COMPLETED|Overall Study||9||
59985353|NCT02755805|76100799|FG000|STARTED|Overall Study||15||
59985354|NCT02755805|76100800|FG001|STARTED|Overall Study||15||
59985355|NCT02755805|76100799|FG000|COMPLETED|Overall Study||13||
59985356|NCT02755805|76100800|FG001|COMPLETED|Overall Study||11||
59985357|NCT02755805|76100799|FG000|NOT COMPLETED|Overall Study||2||
59985358|NCT02755805|76100800|FG001|NOT COMPLETED|Overall Study||4||
59985359|NCT02755649|76100809|FG000|STARTED|Overall Study||108||
59985360|NCT02755649|76100810|FG001|STARTED|Overall Study||107||
59985361|NCT02755649|76100811|FG002|STARTED|Overall Study||110||
59985362|NCT02755649|76100809|FG000|Completed Treatment (Week 16)|Overall Study||107||
59985363|NCT02755649|76100810|FG001|Completed Treatment (Week 16)|Overall Study||106||
59985364|NCT02755649|76100811|FG002|Completed Treatment (Week 16)|Overall Study||109||
59985365|NCT02755649|76100809|FG000|Completed Study (Week 28)|Overall Study||7||
59985366|NCT02755649|76100810|FG001|Completed Study (Week 28)|Overall Study||8||
59985367|NCT02755649|76100811|FG002|Completed Study (Week 28)|Overall Study||8||
59985368|NCT02755649|76100809|FG000|COMPLETED|Overall Study||7||
59985369|NCT02755649|76100810|FG001|COMPLETED|Overall Study||8||
59985370|NCT02755649|76100811|FG002|COMPLETED|Overall Study||8||
59985371|NCT02755649|76100809|FG000|NOT COMPLETED|Overall Study||101||
59985372|NCT02755649|76100810|FG001|NOT COMPLETED|Overall Study||99||
59985373|NCT02755649|76100811|FG002|NOT COMPLETED|Overall Study||102||
59985374|NCT00151411|76100821|FG000|STARTED|Overall Study||55||
59985375|NCT00151411|76100822|FG001|STARTED|Overall Study||59||
59985376|NCT00151411|76100821|FG000|COMPLETED|Overall Study||22||
59985377|NCT00151411|76100822|FG001|COMPLETED|Overall Study||16||
59985378|NCT00151411|76100821|FG000|NOT COMPLETED|Overall Study||33||
59985379|NCT00151411|76100822|FG001|NOT COMPLETED|Overall Study||43||
59985380|NCT02662569|76100832|FG000|STARTED|Overall Study||166||
59985381|NCT02662569|76100833|FG001|STARTED|Overall Study||161||
59985382|NCT02662569|76100834|FG002|STARTED|Overall Study||327||
59985383|NCT02662569|76100835|FG003|STARTED|Overall Study||332||
59985384|NCT02662569|76100832|FG000|Received Study Drug|Overall Study||164|Study drug defined as subcutaneous evolocumab or placebo to evolocumab|
59985385|NCT02662569|76100833|FG001|Received Study Drug|Overall Study||160|Study drug defined as subcutaneous evolocumab or placebo to evolocumab|
59985386|NCT02662569|76100834|FG002|Received Study Drug|Overall Study||325|Study drug defined as subcutaneous evolocumab or placebo to evolocumab|
59985387|NCT02662569|76100835|FG003|Received Study Drug|Overall Study||332|Study drug defined as subcutaneous evolocumab or placebo to evolocumab|
59985388|NCT02662569|76100832|FG000|COMPLETED|Overall Study||159||
59985389|NCT02662569|76100833|FG001|COMPLETED|Overall Study||160||
59985390|NCT02662569|76100834|FG002|COMPLETED|Overall Study||321||
59985391|NCT02662569|76100835|FG003|COMPLETED|Overall Study||328||
59985392|NCT02662569|76100832|FG000|NOT COMPLETED|Overall Study||7||
59985393|NCT02662569|76100833|FG001|NOT COMPLETED|Overall Study||1||
59985394|NCT02662569|76100834|FG002|NOT COMPLETED|Overall Study||6||
59526753|NCT02173535|75622498|FG005|COMPLETED|Period 1||12||
59985395|NCT02662569|76100835|FG003|NOT COMPLETED|Overall Study||4||
59985396|NCT02741635|76100845|FG000|STARTED|Overall Study||15||
59985397|NCT02741635|76100845|FG000|COMPLETED|Overall Study||14||
59985398|NCT02741635|76100845|FG000|NOT COMPLETED|Overall Study||1||
59985399|NCT02753075|76100853|FG000|STARTED|Overall Study||79||
59985400|NCT02753075|76100854|FG001|STARTED|Overall Study||80||
59985401|NCT02753075|76100855|FG002|STARTED|Overall Study||81||
59985402|NCT02753075|76100853|FG000|COMPLETED|Overall Study||71||
59985403|NCT02753075|76100854|FG001|COMPLETED|Overall Study||77||
59985404|NCT02753075|76100855|FG002|COMPLETED|Overall Study||78||
59985405|NCT02753075|76100853|FG000|NOT COMPLETED|Overall Study||8||
59985406|NCT02753075|76100854|FG001|NOT COMPLETED|Overall Study||3||
59985407|NCT02753075|76100855|FG002|NOT COMPLETED|Overall Study||3||
59985408|NCT02332720|76100887|FG000|STARTED|Part A and Part B||21||
59985409|NCT02332720|76100888|FG001|STARTED|Part A and Part B||21||
59985410|NCT02332720|76100889|FG002|STARTED|Part A and Part B||22||
59985411|NCT02332720|76100890|FG003|STARTED|Part A and Part B||22||
59985412|NCT02332720|76100891|FG004|STARTED|Part A and Part B||16||
59985413|NCT02332720|76100892|FG005|STARTED|Part A and Part B||36||
59985414|NCT02332720|76100893|FG006|STARTED|Part A and Part B||37||
59985415|NCT02332720|76100894|FG007|STARTED|Part A and Part B||35||
59985416|NCT02332720|76100895|FG008|STARTED|Part A and Part B||15||
59985417|NCT02332720|76100896|FG009|STARTED|Part A and Part B||14||
59985418|NCT02332720|76100897|FG010|STARTED|Part A and Part B||14||
59985419|NCT02332720|76100898|FG011|STARTED|Part A and Part B||15||
59985420|NCT02332720|76100899|FG012|STARTED|Part A and Part B||16||
59985421|NCT02332720|76100900|FG013|STARTED|Part A and Part B||13||
59985422|NCT02332720|76100901|FG014|STARTED|Part A and Part B||16||
59985423|NCT02332720|76100902|FG015|STARTED|Part A and Part B||14||
59985424|NCT02332720|76100903|FG016|STARTED|Part A and Part B||15||
59985425|NCT02332720|76100904|FG017|STARTED|Part A and Part B||14||
59985426|NCT02332720|76100905|FG018|STARTED|Part A and Part B||21||
59985427|NCT02332720|76100906|FG019|STARTED|Part A and Part B||25||
59985428|NCT02332720|76100907|FG020|STARTED|Part A and Part B||7||
59985429|NCT02332720|76100908|FG021|STARTED|Part A and Part B||0||
59985430|NCT02332720|76100909|FG022|STARTED|Part A and Part B||4||
59985431|NCT02332720|76100887|FG000|Treated|Part A and Part B||21||
59985432|NCT02332720|76100888|FG001|Treated|Part A and Part B||21||
59985433|NCT02332720|76100889|FG002|Treated|Part A and Part B||22||
59985434|NCT02332720|76100890|FG003|Treated|Part A and Part B||22||
59985435|NCT02332720|76100891|FG004|Treated|Part A and Part B||16||
59985436|NCT02332720|76100892|FG005|Treated|Part A and Part B||36||
59985437|NCT02332720|76100893|FG006|Treated|Part A and Part B||37||
59985438|NCT02332720|76100894|FG007|Treated|Part A and Part B||35||
59985439|NCT02332720|76100895|FG008|Treated|Part A and Part B||15||
59985440|NCT02332720|76100896|FG009|Treated|Part A and Part B||14||
59985441|NCT02332720|76100897|FG010|Treated|Part A and Part B||14||
59985442|NCT02332720|76100898|FG011|Treated|Part A and Part B||15||
59985443|NCT02332720|76100899|FG012|Treated|Part A and Part B||16||
59985444|NCT02332720|76100900|FG013|Treated|Part A and Part B||13||
60074915|NCT01798706|76190148|FG000|NOT COMPLETED|Overall Study||21||
60074916|NCT01798706|76190149|FG001|NOT COMPLETED|Overall Study||21||
60074917|NCT01767194|76190157|FG000|STARTED|Overall Study||19||
60074918|NCT01767194|76190158|FG001|STARTED|Overall Study||54||
60074919|NCT01767194|76190157|FG000|COMPLETED|Overall Study||1||
60074920|NCT01767194|76190158|FG001|COMPLETED|Overall Study||11||
60074921|NCT01767194|76190157|FG000|NOT COMPLETED|Overall Study||18||
60074922|NCT01767194|76190158|FG001|NOT COMPLETED|Overall Study||43||
60074923|NCT01575873|76190169|FG000|STARTED|Overall Study||145||
60074924|NCT01575873|76190170|FG001|STARTED|Overall Study||145||
60074925|NCT01575873|76190171|FG002|STARTED|Overall Study||252||
59526754|NCT02173535|75622499|FG006|COMPLETED|Period 1||12||
59526755|NCT02173535|75622500|FG007|COMPLETED|Period 1||12||
59526756|NCT02173535|75622501|FG008|COMPLETED|Period 1||12||
59985445|NCT02332720|76100901|FG014|Treated|Part A and Part B||16||
59985446|NCT02332720|76100902|FG015|Treated|Part A and Part B||14||
59985447|NCT02332720|76100903|FG016|Treated|Part A and Part B||15||
59985448|NCT02332720|76100904|FG017|Treated|Part A and Part B||14||
59985449|NCT02332720|76100905|FG018|Treated|Part A and Part B||20||
59985450|NCT02332720|76100906|FG019|Treated|Part A and Part B||25||
59985451|NCT02332720|76100907|FG020|Treated|Part A and Part B||7||
59985452|NCT02332720|76100908|FG021|Treated|Part A and Part B||0||
59985453|NCT02332720|76100909|FG022|Treated|Part A and Part B||4||
59985454|NCT02332720|76100887|FG000|COMPLETED|Part A and Part B||20||
59985455|NCT02332720|76100888|FG001|COMPLETED|Part A and Part B||21||
59985456|NCT02332720|76100889|FG002|COMPLETED|Part A and Part B||22||
59985457|NCT02332720|76100890|FG003|COMPLETED|Part A and Part B||22||
59985458|NCT02332720|76100891|FG004|COMPLETED|Part A and Part B||16||
59985459|NCT02332720|76100892|FG005|COMPLETED|Part A and Part B||33||
59985460|NCT02332720|76100893|FG006|COMPLETED|Part A and Part B||36||
59985461|NCT02332720|76100894|FG007|COMPLETED|Part A and Part B||34||
59985462|NCT02332720|76100895|FG008|COMPLETED|Part A and Part B||15||
59985463|NCT02332720|76100896|FG009|COMPLETED|Part A and Part B||14||
59985464|NCT02332720|76100897|FG010|COMPLETED|Part A and Part B||14||
59985465|NCT02332720|76100898|FG011|COMPLETED|Part A and Part B||15||
59985466|NCT02332720|76100899|FG012|COMPLETED|Part A and Part B||16||
59985467|NCT02332720|76100900|FG013|COMPLETED|Part A and Part B||13||
59985468|NCT02332720|76100901|FG014|COMPLETED|Part A and Part B||16||
59985469|NCT02332720|76100902|FG015|COMPLETED|Part A and Part B||13||
59985470|NCT02332720|76100903|FG016|COMPLETED|Part A and Part B||15||
59985471|NCT02332720|76100904|FG017|COMPLETED|Part A and Part B||13||
59985472|NCT02332720|76100905|FG018|COMPLETED|Part A and Part B||20||
59985473|NCT02332720|76100906|FG019|COMPLETED|Part A and Part B||24||
59985474|NCT02332720|76100907|FG020|COMPLETED|Part A and Part B||7||
59985475|NCT02332720|76100908|FG021|COMPLETED|Part A and Part B||0||
59985476|NCT02332720|76100909|FG022|COMPLETED|Part A and Part B||4||
59985477|NCT02332720|76100887|FG000|NOT COMPLETED|Part A and Part B||1||
59985478|NCT02332720|76100888|FG001|NOT COMPLETED|Part A and Part B||0||
59985479|NCT02332720|76100889|FG002|NOT COMPLETED|Part A and Part B||0||
59985480|NCT02332720|76100890|FG003|NOT COMPLETED|Part A and Part B||0||
59985481|NCT02332720|76100891|FG004|NOT COMPLETED|Part A and Part B||0||
59985482|NCT02332720|76100892|FG005|NOT COMPLETED|Part A and Part B||3||
59985483|NCT02332720|76100893|FG006|NOT COMPLETED|Part A and Part B||1||
59985484|NCT02332720|76100894|FG007|NOT COMPLETED|Part A and Part B||1||
59985485|NCT02332720|76100895|FG008|NOT COMPLETED|Part A and Part B||0||
59985486|NCT02332720|76100896|FG009|NOT COMPLETED|Part A and Part B||0||
59985487|NCT02332720|76100897|FG010|NOT COMPLETED|Part A and Part B||0||
59985488|NCT02332720|76100898|FG011|NOT COMPLETED|Part A and Part B||0||
59985489|NCT02332720|76100899|FG012|NOT COMPLETED|Part A and Part B||0||
59985490|NCT02332720|76100900|FG013|NOT COMPLETED|Part A and Part B||0||
59985491|NCT02332720|76100901|FG014|NOT COMPLETED|Part A and Part B||0||
59985492|NCT02332720|76100902|FG015|NOT COMPLETED|Part A and Part B||1||
59985493|NCT02332720|76100903|FG016|NOT COMPLETED|Part A and Part B||0||
59985494|NCT02332720|76100904|FG017|NOT COMPLETED|Part A and Part B||1||
59985495|NCT02332720|76100905|FG018|NOT COMPLETED|Part A and Part B||1||
59985496|NCT02332720|76100906|FG019|NOT COMPLETED|Part A and Part B||1||
59985497|NCT02332720|76100907|FG020|NOT COMPLETED|Part A and Part B||0||
60074926|NCT01575873|76190172|FG003|STARTED|Overall Study||253||
60074927|NCT01575873|76190169|FG000|Received Study Drug|Overall Study|Participants who received oral risedronate|140||
60074928|NCT01575873|76190170|FG001|Received Study Drug|Overall Study|Participants who received subcutaneous denosumab|142||
60074929|NCT01575873|76190171|FG002|Received Study Drug|Overall Study|Participants who received oral risedronate|246||
60074930|NCT01575873|76190172|FG003|Received Study Drug|Overall Study|Participants who received subcutaneous denosumab|251||
60074931|NCT01575873|76190169|FG000|COMPLETED|Overall Study||117||
59985498|NCT02332720|76100908|FG021|NOT COMPLETED|Part A and Part B||0||
59985499|NCT02332720|76100909|FG022|NOT COMPLETED|Part A and Part B||0||
59985500|NCT02332720|76100887|FG000|STARTED|Part C|Part A participants who had relapsed were offered the option of retreatment in Part C.|2||
59985501|NCT02332720|76100888|FG001|STARTED|Part C|Part A participants who had relapsed were offered the option of retreatment in Part C.|1||
59985502|NCT02332720|76100889|FG002|STARTED|Part C|Part A participants who had relapsed were offered the option of retreatment in Part C.|3||
59985503|NCT02332720|76100890|FG003|STARTED|Part C|Part A participants who had relapsed were offered the option of retreatment in Part C.|2||
59985504|NCT02332720|76100891|FG004|STARTED|Part C|Part B participants were not included in Part C.|0||
59985505|NCT02332720|76100892|FG005|STARTED|Part C|Part B participants were not included in Part C.|0||
59985506|NCT02332720|76100893|FG006|STARTED|Part C|Part B participants were not included in Part C.|0||
59985507|NCT02332720|76100894|FG007|STARTED|Part C|Part B participants were not included in Part C.|0||
59985508|NCT02332720|76100895|FG008|STARTED|Part C|Part B participants were not included in Part C.|0||
59985509|NCT02332720|76100896|FG009|STARTED|Part C|Part B participants were not included in Part C.|0||
59985510|NCT02332720|76100897|FG010|STARTED|Part C|Part B participants were not included in Part C.|0||
59985511|NCT02332720|76100898|FG011|STARTED|Part C|Part B participants were not included in Part C.|0||
59985512|NCT02332720|76100899|FG012|STARTED|Part C|Part B participants were not included in Part C.|0||
59985513|NCT02332720|76100900|FG013|STARTED|Part C|Part B participants were not included in Part C.|0||
59985514|NCT02332720|76100901|FG014|STARTED|Part C|Part B participants were not included in Part C.|0||
59985515|NCT02332720|76100902|FG015|STARTED|Part C|Part B participants were not included in Part C.|0||
59985516|NCT02332720|76100903|FG016|STARTED|Part C|Part B participants were not included in Part C.|0||
59985517|NCT02332720|76100904|FG017|STARTED|Part C|Part B participants were not included in Part C.|0||
59985518|NCT02332720|76100905|FG018|STARTED|Part C|Part B participants were not included in Part C.|0||
60074932|NCT01575873|76190170|FG001|COMPLETED|Overall Study||109||
60074933|NCT01575873|76190171|FG002|COMPLETED|Overall Study||178||
59985519|NCT02332720|76100906|FG019|STARTED|Part C|Part B participants were not included in Part C.|0||
59985520|NCT02332720|76100907|FG020|STARTED|Part C|Part B participants were not included in Part C.|0||
59985521|NCT02332720|76100908|FG021|STARTED|Part C||0||
59985522|NCT02332720|76100909|FG022|STARTED|Part C|Part B participants were not included in Part C.|0||
59622632|NCT00492336|75734508|FG000|STARTED|Overall Study||28||
59622633|NCT00492336|75734509|FG001|STARTED|Overall Study||29||
59622634|NCT00492336|75734508|FG000|COMPLETED|Overall Study||26||
59622635|NCT00492336|75734509|FG001|COMPLETED|Overall Study||23||
59622636|NCT00492336|75734508|FG000|NOT COMPLETED|Overall Study||2||
59622637|NCT00492336|75734509|FG001|NOT COMPLETED|Overall Study||6||
59622638|NCT00538434|75734519|FG000|STARTED|Overall Study||56||
59622639|NCT00538434|75734520|FG001|STARTED|Overall Study||57||
59622640|NCT00538434|75734521|FG002|STARTED|Overall Study||57||
59985523|NCT02332720|76100887|FG000|COMPLETED|Part C||2||
59985524|NCT02332720|76100888|FG001|COMPLETED|Part C||1||
59985525|NCT02332720|76100889|FG002|COMPLETED|Part C||3||
59985526|NCT02332720|76100890|FG003|COMPLETED|Part C||2||
59985527|NCT02332720|76100891|FG004|COMPLETED|Part C||0||
59985528|NCT02332720|76100892|FG005|COMPLETED|Part C||0||
59985529|NCT02332720|76100893|FG006|COMPLETED|Part C||0||
59985530|NCT02332720|76100894|FG007|COMPLETED|Part C||0||
59622641|NCT00538434|75734522|FG003|STARTED|Overall Study||57||
59709841|NCT01072149|75828535|FG015|STARTED|Treatment Period 2 (28 Days)||3||
59985531|NCT02332720|76100895|FG008|COMPLETED|Part C||0||
59526757|NCT02173535|75622502|FG009|COMPLETED|Period 1||12||
59526758|NCT02173535|75622503|FG010|COMPLETED|Period 1||12||
59526759|NCT02173535|75622504|FG011|COMPLETED|Period 1||12||
59526760|NCT02173535|75622505|FG012|COMPLETED|Period 1||12||
59526761|NCT02173535|75622506|FG013|COMPLETED|Period 1||12||
59526762|NCT02173535|75622507|FG014|COMPLETED|Period 1||12||
59526763|NCT02173535|75622508|FG015|COMPLETED|Period 1||12||
59526764|NCT02173535|75622509|FG016|COMPLETED|Period 1||12||
59985532|NCT02332720|76100896|FG009|COMPLETED|Part C||0||
59985533|NCT02332720|76100897|FG010|COMPLETED|Part C||0||
59985534|NCT02332720|76100898|FG011|COMPLETED|Part C||0||
59985535|NCT02332720|76100899|FG012|COMPLETED|Part C||0||
59985536|NCT02332720|76100900|FG013|COMPLETED|Part C||0||
59985537|NCT02332720|76100901|FG014|COMPLETED|Part C||0||
59985538|NCT02332720|76100902|FG015|COMPLETED|Part C||0||
59985539|NCT02332720|76100903|FG016|COMPLETED|Part C||0||
59985540|NCT02332720|76100904|FG017|COMPLETED|Part C||0||
59985541|NCT02332720|76100905|FG018|COMPLETED|Part C||0||
59985542|NCT02332720|76100906|FG019|COMPLETED|Part C||0||
59985543|NCT02332720|76100907|FG020|COMPLETED|Part C||0||
59985544|NCT02332720|76100908|FG021|COMPLETED|Part C||0||
59985545|NCT02332720|76100909|FG022|COMPLETED|Part C||0||
59985546|NCT02332720|76100887|FG000|NOT COMPLETED|Part C||0||
59985547|NCT02332720|76100888|FG001|NOT COMPLETED|Part C||0||
59985548|NCT02332720|76100889|FG002|NOT COMPLETED|Part C||0||
59985549|NCT02332720|76100890|FG003|NOT COMPLETED|Part C||0||
59985550|NCT02332720|76100891|FG004|NOT COMPLETED|Part C||0||
59985551|NCT02332720|76100892|FG005|NOT COMPLETED|Part C||0||
59985552|NCT02332720|76100893|FG006|NOT COMPLETED|Part C||0||
59985553|NCT02332720|76100894|FG007|NOT COMPLETED|Part C||0||
59985554|NCT02332720|76100895|FG008|NOT COMPLETED|Part C||0||
59985555|NCT02332720|76100896|FG009|NOT COMPLETED|Part C||0||
59985556|NCT02332720|76100897|FG010|NOT COMPLETED|Part C||0||
59985557|NCT02332720|76100898|FG011|NOT COMPLETED|Part C||0||
59985558|NCT02332720|76100899|FG012|NOT COMPLETED|Part C||0||
59985559|NCT02332720|76100900|FG013|NOT COMPLETED|Part C||0||
59985560|NCT02332720|76100901|FG014|NOT COMPLETED|Part C||0||
59985561|NCT02332720|76100902|FG015|NOT COMPLETED|Part C||0||
59985562|NCT02332720|76100903|FG016|NOT COMPLETED|Part C||0||
59985563|NCT02332720|76100904|FG017|NOT COMPLETED|Part C||0||
59985564|NCT02332720|76100905|FG018|NOT COMPLETED|Part C||0||
59985565|NCT02332720|76100906|FG019|NOT COMPLETED|Part C||0||
59985566|NCT02332720|76100907|FG020|NOT COMPLETED|Part C||0||
59985567|NCT02332720|76100908|FG021|NOT COMPLETED|Part C||0||
59985568|NCT02332720|76100909|FG022|NOT COMPLETED|Part C||0||
59985569|NCT00362401|76100974|FG000|STARTED|Overall Study||15||
59985570|NCT00362401|76100975|FG001|STARTED|Overall Study||29||
59985571|NCT00362401|76100976|FG002|STARTED|Overall Study||40||
59985572|NCT00362401|76100974|FG000|COMPLETED|Overall Study||15||
59985573|NCT00362401|76100975|FG001|COMPLETED|Overall Study||29||
59985574|NCT00362401|76100976|FG002|COMPLETED|Overall Study||40||
59985575|NCT00362401|76100974|FG000|NOT COMPLETED|Overall Study||0||
59985576|NCT00362401|76100975|FG001|NOT COMPLETED|Overall Study||0||
59985577|NCT00362401|76100976|FG002|NOT COMPLETED|Overall Study||0||
59985578|NCT02331394|76100981|FG000|STARTED|Overall Study||15|In the absence of prior data to guide formal power calculations, a sample size of 15 was chosen.|
59985579|NCT02331394|76100981|FG000|COMPLETED|Overall Study|14 patients, 1 dropped out|14||
59985580|NCT02331394|76100981|FG000|NOT COMPLETED|Overall Study||1||
59985581|NCT01645930|76100992|FG000|STARTED|Overall Study||43||
59985582|NCT01645930|76100992|FG000|COMPLETED|Overall Study||0||
59526765|NCT02173535|75622510|FG017|COMPLETED|Period 1||12||
59526766|NCT02173535|75622511|FG018|COMPLETED|Period 1||12||
59526767|NCT02173535|75622512|FG019|COMPLETED|Period 1||12||
59526768|NCT02173535|75622493|FG000|NOT COMPLETED|Period 1||0||
59526769|NCT02173535|75622494|FG001|NOT COMPLETED|Period 1||0||
59526770|NCT02173535|75622495|FG002|NOT COMPLETED|Period 1||0||
59985583|NCT01645930|76100992|FG000|NOT COMPLETED|Overall Study||43||
59985584|NCT02299336|76100996|FG000|STARTED|Overall Study||60||
59985585|NCT02299336|76100996|FG000|COMPLETED|Overall Study||46||
59985586|NCT02299336|76100996|FG000|NOT COMPLETED|Overall Study||14||
59526771|NCT02173535|75622496|FG003|NOT COMPLETED|Period 1||0||
59526772|NCT02173535|75622497|FG004|NOT COMPLETED|Period 1||0||
59526773|NCT02173535|75622498|FG005|NOT COMPLETED|Period 1||0||
59985587|NCT02664441|76101002|FG000|STARTED|Randomization||23||
59985588|NCT02664441|76101003|FG001|STARTED|Randomization||19||
59985589|NCT02664441|76101002|FG000|COMPLETED|Randomization||23||
59985590|NCT02664441|76101003|FG001|COMPLETED|Randomization||18||
59985591|NCT02664441|76101002|FG000|NOT COMPLETED|Randomization||0||
59985592|NCT02664441|76101003|FG001|NOT COMPLETED|Randomization||1||
59985593|NCT02664441|76101002|FG000|STARTED|36-week Randomized Trial||23||
59985594|NCT02664441|76101003|FG001|STARTED|36-week Randomized Trial||18||
59985595|NCT02664441|76101002|FG000|COMPLETED|36-week Randomized Trial||20||
59985596|NCT02664441|76101003|FG001|COMPLETED|36-week Randomized Trial||15||
59985597|NCT02664441|76101002|FG000|NOT COMPLETED|36-week Randomized Trial||3||
59985598|NCT02664441|76101003|FG001|NOT COMPLETED|36-week Randomized Trial||3||
59985599|NCT02664441|76101002|FG000|STARTED|18-week Open Label Extension||20||
59985600|NCT02664441|76101003|FG001|STARTED|18-week Open Label Extension||15||
59985601|NCT02664441|76101002|FG000|COMPLETED|18-week Open Label Extension||17||
59985602|NCT02664441|76101003|FG001|COMPLETED|18-week Open Label Extension||14||
59985603|NCT02664441|76101002|FG000|NOT COMPLETED|18-week Open Label Extension||3||
59985604|NCT02664441|76101003|FG001|NOT COMPLETED|18-week Open Label Extension||1||
59985605|NCT02298946|76101012|FG000|STARTED|Overall Study||8||
59985606|NCT02298946|76101013|FG001|STARTED|Overall Study||9||
59985607|NCT02298946|76101012|FG000|COMPLETED|Overall Study||4||
59985608|NCT02298946|76101013|FG001|COMPLETED|Overall Study||8||
59985609|NCT02298946|76101012|FG000|NOT COMPLETED|Overall Study||4||
59985610|NCT02298946|76101013|FG001|NOT COMPLETED|Overall Study||1||
59985611|NCT02328040|76101020|FG000|STARTED|First Intervention (2 Days)||8||
59985612|NCT02328040|76101021|FG001|STARTED|First Intervention (2 Days)||9||
59985613|NCT02328040|76101020|FG000|COMPLETED|First Intervention (2 Days)||7||
59985614|NCT02328040|76101021|FG001|COMPLETED|First Intervention (2 Days)||8||
59985615|NCT02328040|76101020|FG000|NOT COMPLETED|First Intervention (2 Days)||1||
59985616|NCT02328040|76101021|FG001|NOT COMPLETED|First Intervention (2 Days)||1||
59985617|NCT02328040|76101020|FG000|STARTED|Second Intervention (2 Days)||7||
59985618|NCT02328040|76101021|FG001|STARTED|Second Intervention (2 Days)||8||
59985619|NCT02328040|76101020|FG000|COMPLETED|Second Intervention (2 Days)||7||
59985620|NCT02328040|76101021|FG001|COMPLETED|Second Intervention (2 Days)||8||
59985621|NCT02328040|76101020|FG000|NOT COMPLETED|Second Intervention (2 Days)||0||
59985622|NCT02328040|76101021|FG001|NOT COMPLETED|Second Intervention (2 Days)||0||
59985623|NCT01647958|76101029|FG000|STARTED|Initial Study||41||
59985624|NCT01647958|76101030|FG001|STARTED|Initial Study||24||
59985625|NCT01647958|76101029|FG000|COMPLETED|Initial Study||39||
59985626|NCT01647958|76101030|FG001|COMPLETED|Initial Study||21||
59985627|NCT01647958|76101029|FG000|NOT COMPLETED|Initial Study||2||
59985628|NCT01647958|76101030|FG001|NOT COMPLETED|Initial Study||3||
59985629|NCT01647958|76101029|FG000|STARTED|Continuation Phase||39||
59985630|NCT01647958|76101030|FG001|STARTED|Continuation Phase||21||
59985631|NCT01647958|76101029|FG000|COMPLETED|Continuation Phase|Treatment-arm patients received TIF procedure during Initial Study phase|0||
59985632|NCT01647958|76101030|FG001|COMPLETED|Continuation Phase|21 Control patients received TIF crossover procedure following 6-month follow-up visit.|21||
59985633|NCT01647958|76101029|FG000|NOT COMPLETED|Continuation Phase||39||
59985634|NCT01647958|76101030|FG001|NOT COMPLETED|Continuation Phase||0||
59985635|NCT01647958|76101029|FG000|STARTED|Extended Follow-up Phase|Treatment and Control/Crossover patients were combined into 1 cohort for this follow up. 39+21=60|60||
59985636|NCT01647958|76101030|FG001|STARTED|Extended Follow-up Phase|Treatment and Control/Crossover patients combined into 1 cohort for this period=60, 0 under Control|0||
59985637|NCT01647958|76101029|FG000|COMPLETED|Extended Follow-up Phase|The 8 lost to follow up patients are of the combined Treatment and Control cohort of 52 patients|52||
59985638|NCT01647958|76101030|FG001|COMPLETED|Extended Follow-up Phase||0||
59985639|NCT01647958|76101029|FG000|NOT COMPLETED|Extended Follow-up Phase||8||
59985640|NCT01647958|76101030|FG001|NOT COMPLETED|Extended Follow-up Phase||0||
59526774|NCT02173535|75622499|FG006|NOT COMPLETED|Period 1||0||
59526775|NCT02173535|75622500|FG007|NOT COMPLETED|Period 1||0||
59526776|NCT02173535|75622501|FG008|NOT COMPLETED|Period 1||0||
59526777|NCT02173535|75622502|FG009|NOT COMPLETED|Period 1||0||
59526778|NCT02173535|75622503|FG010|NOT COMPLETED|Period 1||0||
59526779|NCT02173535|75622504|FG011|NOT COMPLETED|Period 1||0||
59526780|NCT02173535|75622505|FG012|NOT COMPLETED|Period 1||0||
59526781|NCT02173535|75622506|FG013|NOT COMPLETED|Period 1||0||
59526782|NCT02173535|75622507|FG014|NOT COMPLETED|Period 1||0||
59526783|NCT02173535|75622508|FG015|NOT COMPLETED|Period 1||0||
59526784|NCT02173535|75622509|FG016|NOT COMPLETED|Period 1||0||
59526785|NCT02173535|75622510|FG017|NOT COMPLETED|Period 1||0||
59526786|NCT02173535|75622511|FG018|NOT COMPLETED|Period 1||0||
59985641|NCT02298868|76101045|FG000|STARTED|Overall Study||10||
59985642|NCT02298868|76101045|FG000|COMPLETED|Overall Study||7||
59985643|NCT02298868|76101045|FG000|NOT COMPLETED|Overall Study||3||
59985644|NCT02327260|76101052|FG000|STARTED|Overall Study||20||
59985645|NCT02327260|76101053|FG001|STARTED|Overall Study||24||
59985646|NCT02327260|76101054|FG002|STARTED|Overall Study||17||
59985647|NCT02327260|76101052|FG000|COMPLETED|Overall Study||14||
59985648|NCT02327260|76101053|FG001|COMPLETED|Overall Study||20||
59985649|NCT02327260|76101054|FG002|COMPLETED|Overall Study||15||
59985650|NCT02327260|76101052|FG000|NOT COMPLETED|Overall Study||6||
59985651|NCT02327260|76101053|FG001|NOT COMPLETED|Overall Study||4||
59985652|NCT02327260|76101054|FG002|NOT COMPLETED|Overall Study||2||
59526787|NCT02173535|75622512|FG019|NOT COMPLETED|Period 1||0||
59526788|NCT02173535|75622493|FG000|STARTED|Period 2||12||
59526789|NCT02173535|75622494|FG001|STARTED|Period 2||12||
59985653|NCT02296840|76101065|FG000|STARTED|Overall Study||18||
59985654|NCT02296840|76101066|FG001|STARTED|Overall Study||27||
59526790|NCT02173535|75622495|FG002|STARTED|Period 2||12||
59526791|NCT02173535|75622496|FG003|STARTED|Period 2||12||
59526792|NCT02173535|75622497|FG004|STARTED|Period 2||12||
59526793|NCT02173535|75622498|FG005|STARTED|Period 2||12||
59985655|NCT02296840|76101065|FG000|COMPLETED|Overall Study||9||
59985656|NCT02296840|76101066|FG001|COMPLETED|Overall Study||8||
59985657|NCT02296840|76101065|FG000|NOT COMPLETED|Overall Study||9||
59985658|NCT02296840|76101066|FG001|NOT COMPLETED|Overall Study||19||
59985659|NCT00336973|76101072|FG000|STARTED|Overall Study||66||
59985660|NCT00336973|76101072|FG000|COMPLETED|Overall Study||33||
59985661|NCT00336973|76101072|FG000|NOT COMPLETED|Overall Study||33||
59985662|NCT02663895|76101075|FG000|STARTED|Overall Study||12||
59985663|NCT02663895|76101075|FG000|COMPLETED|Overall Study||5||
59985664|NCT02663895|76101075|FG000|NOT COMPLETED|Overall Study||7||
59815084|NCT03726671|75937472|FG000|STARTED|Third Intervention (2 Weeks)||17||
59815085|NCT03726671|75937473|FG001|STARTED|Third Intervention (2 Weeks)||12||
59815086|NCT03726671|75937474|FG002|STARTED|Third Intervention (2 Weeks)||12||
59815087|NCT03726671|75937475|FG003|STARTED|Third Intervention (2 Weeks)||11||
59526794|NCT02173535|75622499|FG006|STARTED|Period 2||12||
59526795|NCT02173535|75622500|FG007|STARTED|Period 2||12||
59985665|NCT02663817|76101080|FG000|STARTED|Overall Study||52||
59985666|NCT02663817|76101080|FG000|COMPLETED|Overall Study||50||
59985667|NCT02663817|76101080|FG000|NOT COMPLETED|Overall Study||2||
59985668|NCT01372605|76101088|FG000|STARTED|Overall Study||149||
59985669|NCT01372605|76101089|FG001|STARTED|Overall Study||155||
59985670|NCT01372605|76101088|FG000|COMPLETED|Overall Study||137||
59526796|NCT02173535|75622501|FG008|STARTED|Period 2||12||
59526797|NCT02173535|75622502|FG009|STARTED|Period 2||12||
59526798|NCT02173535|75622503|FG010|STARTED|Period 2||12||
59985671|NCT01372605|76101089|FG001|COMPLETED|Overall Study||145||
59985672|NCT01372605|76101088|FG000|NOT COMPLETED|Overall Study||12||
59985673|NCT01372605|76101089|FG001|NOT COMPLETED|Overall Study||10||
59985674|NCT02751983|76101097|FG000|STARTED|Baseline and Randomization||35||
59985675|NCT02751983|76101098|FG001|STARTED|Baseline and Randomization||35||
59985676|NCT02751983|76101097|FG000|COMPLETED|Baseline and Randomization||35||
59985677|NCT02751983|76101098|FG001|COMPLETED|Baseline and Randomization||35||
59985678|NCT02751983|76101097|FG000|NOT COMPLETED|Baseline and Randomization||0||
59985679|NCT02751983|76101098|FG001|NOT COMPLETED|Baseline and Randomization||0||
59985680|NCT02751983|76101097|FG000|STARTED|Treatment||35||
59985681|NCT02751983|76101098|FG001|STARTED|Treatment||35||
59985682|NCT02751983|76101097|FG000|COMPLETED|Treatment||31||
59526799|NCT02173535|75622504|FG011|STARTED|Period 2||12||
59526800|NCT02173535|75622505|FG012|STARTED|Period 2||12||
59815088|NCT03726671|75937476|FG004|STARTED|Third Intervention (2 Weeks)||17||
59815089|NCT03726671|75937477|FG005|STARTED|Third Intervention (2 Weeks)||8||
59815090|NCT03726671|75937472|FG000|COMPLETED|Third Intervention (2 Weeks)||17||
59815091|NCT03726671|75937473|FG001|COMPLETED|Third Intervention (2 Weeks)||11||
59815092|NCT03726671|75937474|FG002|COMPLETED|Third Intervention (2 Weeks)||12||
59815093|NCT03726671|75937475|FG003|COMPLETED|Third Intervention (2 Weeks)||11||
59815094|NCT03726671|75937476|FG004|COMPLETED|Third Intervention (2 Weeks)||17||
59815095|NCT03726671|75937477|FG005|COMPLETED|Third Intervention (2 Weeks)||8||
59815096|NCT03726671|75937472|FG000|NOT COMPLETED|Third Intervention (2 Weeks)||0||
59815097|NCT03726671|75937473|FG001|NOT COMPLETED|Third Intervention (2 Weeks)||1||
59815098|NCT03726671|75937474|FG002|NOT COMPLETED|Third Intervention (2 Weeks)||0||
59815099|NCT03726671|75937475|FG003|NOT COMPLETED|Third Intervention (2 Weeks)||0||
59815100|NCT03726671|75937476|FG004|NOT COMPLETED|Third Intervention (2 Weeks)||0||
59526801|NCT02173535|75622506|FG013|STARTED|Period 2||12||
59526802|NCT02173535|75622507|FG014|STARTED|Period 2||12||
59526803|NCT02173535|75622508|FG015|STARTED|Period 2||12||
59815101|NCT03726671|75937477|FG005|NOT COMPLETED|Third Intervention (2 Weeks)||0||
59815102|NCT00615719|75937498|FG000|STARTED|Overall Study||35||
59815103|NCT00615719|75937498|FG000|COMPLETED|Overall Study||30||
59815104|NCT00615719|75937498|FG000|NOT COMPLETED|Overall Study||5||
59815105|NCT00418665|75937505|FG000|STARTED|Treatment Period||12||
59815106|NCT00418665|75937506|FG001|STARTED|Treatment Period||14||
59985683|NCT02751983|76101098|FG001|COMPLETED|Treatment||35||
59985684|NCT02751983|76101097|FG000|NOT COMPLETED|Treatment||4||
59985685|NCT02751983|76101098|FG001|NOT COMPLETED|Treatment||0||
59985686|NCT02751983|76101097|FG000|STARTED|Post-Treatment Assessment||35||
59985687|NCT02751983|76101098|FG001|STARTED|Post-Treatment Assessment||0||
59985688|NCT02751983|76101097|FG000|COMPLETED|Post-Treatment Assessment||30||
59985689|NCT02751983|76101098|FG001|COMPLETED|Post-Treatment Assessment||0||
59985690|NCT02751983|76101097|FG000|NOT COMPLETED|Post-Treatment Assessment||5||
59985691|NCT02751983|76101098|FG001|NOT COMPLETED|Post-Treatment Assessment||0||
59985692|NCT02751983|76101097|FG000|STARTED|One-Month Follow-Up Assessments||35||
59985693|NCT02751983|76101098|FG001|STARTED|One-Month Follow-Up Assessments||35||
59985694|NCT02751983|76101097|FG000|COMPLETED|One-Month Follow-Up Assessments||21||
59985695|NCT02751983|76101098|FG001|COMPLETED|One-Month Follow-Up Assessments||23||
59985696|NCT02751983|76101097|FG000|NOT COMPLETED|One-Month Follow-Up Assessments||14||
59526804|NCT02173535|75622509|FG016|STARTED|Period 2||12||
59526805|NCT02173535|75622510|FG017|STARTED|Period 2||12||
59985697|NCT02751983|76101098|FG001|NOT COMPLETED|One-Month Follow-Up Assessments||12||
59985698|NCT02751983|76101097|FG000|STARTED|Three-Month Follow-Up Assessments||35||
59985699|NCT02751983|76101098|FG001|STARTED|Three-Month Follow-Up Assessments||35||
59985700|NCT02751983|76101097|FG000|COMPLETED|Three-Month Follow-Up Assessments||23||
59815107|NCT00418665|75937507|FG002|STARTED|Treatment Period||13||
59815108|NCT00418665|75937505|FG000|Received Study Medication|Treatment Period||11||
59526806|NCT02173535|75622511|FG018|STARTED|Period 2||12||
59526807|NCT02173535|75622512|FG019|STARTED|Period 2||12||
59526808|NCT02173535|75622493|FG000|COMPLETED|Period 2||12||
59526809|NCT02173535|75622494|FG001|COMPLETED|Period 2||12||
59526810|NCT02173535|75622495|FG002|COMPLETED|Period 2||12||
59526811|NCT02173535|75622496|FG003|COMPLETED|Period 2||12||
59526812|NCT02173535|75622497|FG004|COMPLETED|Period 2||12||
59526813|NCT02173535|75622498|FG005|COMPLETED|Period 2||12||
59526814|NCT02173535|75622499|FG006|COMPLETED|Period 2||12||
59526815|NCT02173535|75622500|FG007|COMPLETED|Period 2||12||
59526816|NCT02173535|75622501|FG008|COMPLETED|Period 2||12||
59526817|NCT02173535|75622502|FG009|COMPLETED|Period 2||12||
59526818|NCT02173535|75622503|FG010|COMPLETED|Period 2||12||
59526819|NCT02173535|75622504|FG011|COMPLETED|Period 2||12||
59526820|NCT02173535|75622505|FG012|COMPLETED|Period 2||12||
59526821|NCT02173535|75622506|FG013|COMPLETED|Period 2||12||
59526822|NCT02173535|75622507|FG014|COMPLETED|Period 2||12||
59526823|NCT02173535|75622508|FG015|COMPLETED|Period 2||12||
59526824|NCT02173535|75622509|FG016|COMPLETED|Period 2||12||
59526825|NCT02173535|75622510|FG017|COMPLETED|Period 2||12||
59526826|NCT02173535|75622511|FG018|COMPLETED|Period 2||12||
59526827|NCT02173535|75622512|FG019|COMPLETED|Period 2||12||
59526828|NCT02173535|75622493|FG000|NOT COMPLETED|Period 2||0||
59526829|NCT02173535|75622494|FG001|NOT COMPLETED|Period 2||0||
59526830|NCT02173535|75622495|FG002|NOT COMPLETED|Period 2||0||
59526831|NCT02173535|75622496|FG003|NOT COMPLETED|Period 2||0||
59526832|NCT02173535|75622497|FG004|NOT COMPLETED|Period 2||0||
59526833|NCT02173535|75622498|FG005|NOT COMPLETED|Period 2||0||
59526834|NCT02173535|75622499|FG006|NOT COMPLETED|Period 2||0||
59526835|NCT02173535|75622500|FG007|NOT COMPLETED|Period 2||0||
59526836|NCT02173535|75622501|FG008|NOT COMPLETED|Period 2||0||
59526837|NCT02173535|75622502|FG009|NOT COMPLETED|Period 2||0||
59526838|NCT02173535|75622503|FG010|NOT COMPLETED|Period 2||0||
59526839|NCT02173535|75622504|FG011|NOT COMPLETED|Period 2||0||
59526840|NCT02173535|75622505|FG012|NOT COMPLETED|Period 2||0||
59526841|NCT02173535|75622506|FG013|NOT COMPLETED|Period 2||0||
59526842|NCT02173535|75622507|FG014|NOT COMPLETED|Period 2||0||
59526843|NCT02173535|75622508|FG015|NOT COMPLETED|Period 2||0||
59526844|NCT02173535|75622509|FG016|NOT COMPLETED|Period 2||0||
59526845|NCT02173535|75622510|FG017|NOT COMPLETED|Period 2||0||
59526846|NCT02173535|75622511|FG018|NOT COMPLETED|Period 2||0||
59526847|NCT02173535|75622512|FG019|NOT COMPLETED|Period 2||0||
59526848|NCT02173535|75622493|FG000|STARTED|Period 3||12||
59526849|NCT02173535|75622494|FG001|STARTED|Period 3||12||
59526850|NCT02173535|75622495|FG002|STARTED|Period 3||12||
59526851|NCT02173535|75622496|FG003|STARTED|Period 3||12||
59526852|NCT02173535|75622497|FG004|STARTED|Period 3||12||
59526853|NCT02173535|75622498|FG005|STARTED|Period 3||12||
59526854|NCT02173535|75622499|FG006|STARTED|Period 3||12||
59526855|NCT02173535|75622500|FG007|STARTED|Period 3||12||
59526856|NCT02173535|75622501|FG008|STARTED|Period 3||12||
59526857|NCT02173535|75622502|FG009|STARTED|Period 3||12||
59526858|NCT02173535|75622503|FG010|STARTED|Period 3||12||
59526859|NCT02173535|75622504|FG011|STARTED|Period 3||12||
59526860|NCT02173535|75622505|FG012|STARTED|Period 3||12||
59526861|NCT02173535|75622506|FG013|STARTED|Period 3||12||
59526862|NCT02173535|75622507|FG014|STARTED|Period 3||12||
59526863|NCT02173535|75622508|FG015|STARTED|Period 3||12||
59526864|NCT02173535|75622509|FG016|STARTED|Period 3||12||
59526865|NCT02173535|75622510|FG017|STARTED|Period 3||12||
59526866|NCT02173535|75622511|FG018|STARTED|Period 3||12||
59526867|NCT02173535|75622512|FG019|STARTED|Period 3||12||
59526868|NCT02173535|75622493|FG000|COMPLETED|Period 3||12||
59526869|NCT02173535|75622494|FG001|COMPLETED|Period 3||12||
59526870|NCT02173535|75622495|FG002|COMPLETED|Period 3||12||
59526871|NCT02173535|75622496|FG003|COMPLETED|Period 3||12||
59526872|NCT02173535|75622497|FG004|COMPLETED|Period 3||12||
59526873|NCT02173535|75622498|FG005|COMPLETED|Period 3||12||
59526874|NCT02173535|75622499|FG006|COMPLETED|Period 3||12||
59526875|NCT02173535|75622500|FG007|COMPLETED|Period 3||12||
59526876|NCT02173535|75622501|FG008|COMPLETED|Period 3||12||
59526877|NCT02173535|75622502|FG009|COMPLETED|Period 3||12||
59526878|NCT02173535|75622503|FG010|COMPLETED|Period 3||12||
59526879|NCT02173535|75622504|FG011|COMPLETED|Period 3||12||
59526880|NCT02173535|75622505|FG012|COMPLETED|Period 3||12||
59526881|NCT02173535|75622506|FG013|COMPLETED|Period 3||12||
59526882|NCT02173535|75622507|FG014|COMPLETED|Period 3||12||
59526883|NCT02173535|75622508|FG015|COMPLETED|Period 3||12||
59526884|NCT02173535|75622509|FG016|COMPLETED|Period 3||12||
59526885|NCT02173535|75622510|FG017|COMPLETED|Period 3||12||
59526886|NCT02173535|75622511|FG018|COMPLETED|Period 3||12||
59526887|NCT02173535|75622512|FG019|COMPLETED|Period 3||12||
59526888|NCT02173535|75622493|FG000|NOT COMPLETED|Period 3||0||
59526889|NCT02173535|75622494|FG001|NOT COMPLETED|Period 3||0||
59526890|NCT02173535|75622495|FG002|NOT COMPLETED|Period 3||0||
59526891|NCT02173535|75622496|FG003|NOT COMPLETED|Period 3||0||
59526892|NCT02173535|75622497|FG004|NOT COMPLETED|Period 3||0||
59526893|NCT02173535|75622498|FG005|NOT COMPLETED|Period 3||0||
59526894|NCT02173535|75622499|FG006|NOT COMPLETED|Period 3||0||
59526895|NCT02173535|75622500|FG007|NOT COMPLETED|Period 3||0||
59526896|NCT02173535|75622501|FG008|NOT COMPLETED|Period 3||0||
59526897|NCT02173535|75622502|FG009|NOT COMPLETED|Period 3||0||
59985701|NCT02751983|76101098|FG001|COMPLETED|Three-Month Follow-Up Assessments||19||
59985702|NCT02751983|76101097|FG000|NOT COMPLETED|Three-Month Follow-Up Assessments||12||
59985703|NCT02751983|76101098|FG001|NOT COMPLETED|Three-Month Follow-Up Assessments||16||
59985704|NCT04347941|76101106|FG000|STARTED|Overall Study||12||
59985705|NCT04347941|76101107|FG001|STARTED|Overall Study||12||
59985706|NCT04347941|76101106|FG000|COMPLETED|Overall Study||12||
59985707|NCT04347941|76101107|FG001|COMPLETED|Overall Study||12||
59985708|NCT04347941|76101106|FG000|NOT COMPLETED|Overall Study||0||
59985709|NCT04347941|76101107|FG001|NOT COMPLETED|Overall Study||0||
59985710|NCT00232141|76101118|FG000|STARTED|Overall Study||151||
59985711|NCT00232141|76101119|FG001|STARTED|Overall Study||151||
59985712|NCT00232141|76101118|FG000|COMPLETED|Overall Study||120||
59985713|NCT00232141|76101119|FG001|COMPLETED|Overall Study||125||
59985714|NCT00232141|76101118|FG000|NOT COMPLETED|Overall Study||31||
59985715|NCT00232141|76101119|FG001|NOT COMPLETED|Overall Study||26||
59985716|NCT04374149|76101125|FG000|STARTED|Overall Study||10||
59985717|NCT04374149|76101126|FG001|STARTED|Overall Study||10||
59985718|NCT04374149|76101125|FG000|COMPLETED|Overall Study||10||
59985719|NCT04374149|76101126|FG001|COMPLETED|Overall Study||10||
59985720|NCT04374149|76101125|FG000|NOT COMPLETED|Overall Study||0||
59985721|NCT04374149|76101126|FG001|NOT COMPLETED|Overall Study||0||
59985722|NCT00147277|76101134|FG000|STARTED|Overall Study||475||
59985723|NCT00147277|76101135|FG001|STARTED|Overall Study||450||
59985724|NCT00147277|76101134|FG000|COMPLETED|Overall Study||475||
59985725|NCT00147277|76101135|FG001|COMPLETED|Overall Study||450||
59526898|NCT02173535|75622503|FG010|NOT COMPLETED|Period 3||0||
59526899|NCT02173535|75622504|FG011|NOT COMPLETED|Period 3||0||
59526900|NCT02173535|75622505|FG012|NOT COMPLETED|Period 3||0||
59526901|NCT02173535|75622506|FG013|NOT COMPLETED|Period 3||0||
59526902|NCT02173535|75622507|FG014|NOT COMPLETED|Period 3||0||
59526903|NCT02173535|75622508|FG015|NOT COMPLETED|Period 3||0||
59526904|NCT02173535|75622509|FG016|NOT COMPLETED|Period 3||0||
59526905|NCT02173535|75622510|FG017|NOT COMPLETED|Period 3||0||
59526906|NCT02173535|75622511|FG018|NOT COMPLETED|Period 3||0||
59526907|NCT02173535|75622512|FG019|NOT COMPLETED|Period 3||0||
59985726|NCT00147277|76101134|FG000|NOT COMPLETED|Overall Study||0||
59985727|NCT00147277|76101135|FG001|NOT COMPLETED|Overall Study||0||
59985728|NCT02191917|76101139|FG000|STARTED|Overall Study||8||
59985729|NCT02191917|76101139|FG000|COMPLETED|Overall Study||7||
59985730|NCT02191917|76101139|FG000|NOT COMPLETED|Overall Study||1||
59985731|NCT02741245|76101148|FG000|STARTED|Overall Study||35||
59985732|NCT02741245|76101149|FG001|STARTED|Overall Study||72||
59985733|NCT02741245|76101150|FG002|STARTED|Overall Study||71||
59985734|NCT02741245|76101151|FG003|STARTED|Overall Study||71||
59985735|NCT02741245|76101152|FG004|STARTED|Overall Study||72||
59985736|NCT02741245|76101148|FG000|COMPLETED|Overall Study||35||
60074934|NCT01575873|76190172|FG003|COMPLETED|Overall Study||186||
60074935|NCT01575873|76190169|FG000|NOT COMPLETED|Overall Study||28||
60074936|NCT01575873|76190170|FG001|NOT COMPLETED|Overall Study||36||
60074937|NCT01575873|76190171|FG002|NOT COMPLETED|Overall Study||74||
60074938|NCT01575873|76190172|FG003|NOT COMPLETED|Overall Study||67||
59526908|NCT02173535|75622493|FG000|STARTED|Period 4||12||
59985737|NCT02741245|76101149|FG001|COMPLETED|Overall Study||71||
59985738|NCT02741245|76101150|FG002|COMPLETED|Overall Study||71||
59985739|NCT02741245|76101151|FG003|COMPLETED|Overall Study||67||
59985740|NCT02741245|76101152|FG004|COMPLETED|Overall Study||70||
59985741|NCT02741245|76101148|FG000|NOT COMPLETED|Overall Study||0||
59985742|NCT02741245|76101149|FG001|NOT COMPLETED|Overall Study||1||
59985743|NCT02741245|76101150|FG002|NOT COMPLETED|Overall Study||0||
59985744|NCT02741245|76101151|FG003|NOT COMPLETED|Overall Study||4||
59985745|NCT02741245|76101152|FG004|NOT COMPLETED|Overall Study||2||
59985746|NCT02751827|76101167|FG000|STARTED|Overall Study||41||
59985747|NCT02751827|76101168|FG001|STARTED|Overall Study||171||
59985748|NCT02751827|76101169|FG002|STARTED|Overall Study||100||
60074939|NCT01575561|76190180|FG000|STARTED|Overall Study||377||
60074940|NCT01575561|76190180|FG000|COMPLETED|Overall Study||338||
60074941|NCT01575561|76190180|FG000|NOT COMPLETED|Overall Study||39||
60074942|NCT01609790|76190187|FG000|STARTED|Overall Study||7||
59526909|NCT02173535|75622494|FG001|STARTED|Period 4||12||
59526910|NCT02173535|75622495|FG002|STARTED|Period 4||12||
59526911|NCT02173535|75622496|FG003|STARTED|Period 4||12||
59526912|NCT02173535|75622497|FG004|STARTED|Period 4||12||
59985749|NCT02751827|76101167|FG000|COMPLETED|Overall Study||41|Eligible and assessable population : All eligible patients who have received at least one TKI administration were included in analysis.|
59985750|NCT02751827|76101168|FG001|COMPLETED|Overall Study||171|Eligible and assessable population : All eligible patients who have received at least one TKI administration were included in analysis.|
59985751|NCT02751827|76101169|FG002|COMPLETED|Overall Study||99|Eligible and assessable population : All eligible patients who have received at least one TKI administration were included in analysis.|
59985752|NCT02751827|76101167|FG000|NOT COMPLETED|Overall Study||0||
59985753|NCT02751827|76101168|FG001|NOT COMPLETED|Overall Study||0||
59985754|NCT02751827|76101169|FG002|NOT COMPLETED|Overall Study||1||
59985755|NCT04896593|76101177|FG000|STARTED|Overall Study||22||
59985756|NCT04896593|76101177|FG000|COMPLETED|Overall Study||17||
59985757|NCT04896593|76101177|FG000|NOT COMPLETED|Overall Study||5||
59985758|NCT04601272|76101184|FG000|STARTED|Overall Study||73||
59985759|NCT04601272|76101185|FG001|STARTED|Overall Study||89||
59985760|NCT04601272|76101186|FG002|STARTED|Overall Study||78||
59985761|NCT04601272|76101184|FG000|COMPLETED|Overall Study||71||
59985762|NCT04601272|76101185|FG001|COMPLETED|Overall Study||86||
59985763|NCT04601272|76101186|FG002|COMPLETED|Overall Study||76||
59985764|NCT04601272|76101184|FG000|NOT COMPLETED|Overall Study||2||
59985765|NCT04601272|76101185|FG001|NOT COMPLETED|Overall Study||3||
59985766|NCT04601272|76101186|FG002|NOT COMPLETED|Overall Study||2||
59985767|NCT03965091|76101197|FG000|STARTED|Overall Study||64||
59985768|NCT03965091|76101198|FG001|STARTED|Overall Study||62||
59985769|NCT03965091|76101199|FG002|STARTED|Overall Study||63||
59985770|NCT03965091|76101197|FG000|Received at Least 1 Dose of Study Drug|Overall Study||64||
59985771|NCT03965091|76101198|FG001|Received at Least 1 Dose of Study Drug|Overall Study||62||
59985772|NCT03965091|76101199|FG002|Received at Least 1 Dose of Study Drug|Overall Study||63||
59985773|NCT03965091|76101197|FG000|COMPLETED|Overall Study||41||
59985774|NCT03965091|76101198|FG001|COMPLETED|Overall Study||45||
59985775|NCT03965091|76101199|FG002|COMPLETED|Overall Study||45||
59985776|NCT03965091|76101197|FG000|NOT COMPLETED|Overall Study||23||
59526913|NCT02173535|75622498|FG005|STARTED|Period 4||12||
59526914|NCT02173535|75622499|FG006|STARTED|Period 4||12||
59526915|NCT02173535|75622500|FG007|STARTED|Period 4||12||
59526916|NCT02173535|75622501|FG008|STARTED|Period 4||12||
59526917|NCT02173535|75622502|FG009|STARTED|Period 4||12||
59526918|NCT02173535|75622503|FG010|STARTED|Period 4||12||
59526919|NCT02173535|75622504|FG011|STARTED|Period 4||12||
59526920|NCT02173535|75622505|FG012|STARTED|Period 4||12||
59526921|NCT02173535|75622506|FG013|STARTED|Period 4||12||
59526922|NCT02173535|75622507|FG014|STARTED|Period 4||12||
59526923|NCT02173535|75622508|FG015|STARTED|Period 4||12||
59526924|NCT02173535|75622509|FG016|STARTED|Period 4||12||
59526925|NCT02173535|75622510|FG017|STARTED|Period 4||12||
59622642|NCT00538434|75734519|FG000|Intent-to-treat (ITT) Population|Overall Study|1 participant was randomized but not treated|55||
59985777|NCT03965091|76101198|FG001|NOT COMPLETED|Overall Study||17||
59985778|NCT03965091|76101199|FG002|NOT COMPLETED|Overall Study||18||
59985779|NCT03956030|76101209|FG000|STARTED|Overall Study||4||
59985780|NCT03956030|76101210|FG001|STARTED|Overall Study||4||
59985781|NCT03956030|76101209|FG000|COMPLETED|Overall Study||1||
59985782|NCT03956030|76101210|FG001|COMPLETED|Overall Study||1||
59985783|NCT03956030|76101209|FG000|NOT COMPLETED|Overall Study||3||
59985784|NCT03956030|76101210|FG001|NOT COMPLETED|Overall Study||3||
59985785|NCT03927508|76101216|FG000|STARTED|Overall Study||9||
59985786|NCT03927508|76101216|FG000|COMPLETED|Overall Study||9||
59985787|NCT03927508|76101216|FG000|NOT COMPLETED|Overall Study||0||
59985788|NCT03406715|76101220|FG000|STARTED|Overall Study||14||
59985789|NCT03406715|76101220|FG000|COMPLETED|Overall Study||14||
59985790|NCT03406715|76101220|FG000|NOT COMPLETED|Overall Study||0||
59985791|NCT03359096|76101226|FG000|STARTED|HGNS Washout (1 Week)||31||
59985792|NCT03359096|76101227|FG001|STARTED|HGNS Washout (1 Week)||32||
59985793|NCT03359096|76101226|FG000|COMPLETED|HGNS Washout (1 Week)||31||
59985794|NCT03359096|76101227|FG001|COMPLETED|HGNS Washout (1 Week)||31||
59985795|NCT03359096|76101226|FG000|NOT COMPLETED|HGNS Washout (1 Week)||0||
59985796|NCT03359096|76101227|FG001|NOT COMPLETED|HGNS Washout (1 Week)||1||
59985797|NCT03359096|76101226|FG000|STARTED|First Intervention (4 Weeks)||31||
59985798|NCT03359096|76101227|FG001|STARTED|First Intervention (4 Weeks)||31||
59985799|NCT03359096|76101226|FG000|COMPLETED|First Intervention (4 Weeks)||29||
59985800|NCT03359096|76101227|FG001|COMPLETED|First Intervention (4 Weeks)||31||
59985801|NCT03359096|76101226|FG000|NOT COMPLETED|First Intervention (4 Weeks)||2||
59985802|NCT03359096|76101227|FG001|NOT COMPLETED|First Intervention (4 Weeks)||0||
59985803|NCT03359096|76101226|FG000|STARTED|HGNS Washout (1 Week)||29||
59985804|NCT03359096|76101227|FG001|STARTED|HGNS Washout (1 Week)||31||
59985805|NCT03359096|76101226|FG000|COMPLETED|HGNS Washout (1 Week)||29||
59985806|NCT03359096|76101227|FG001|COMPLETED|HGNS Washout (1 Week)||31||
59985807|NCT03359096|76101226|FG000|NOT COMPLETED|HGNS Washout (1 Week)||0||
59985808|NCT03359096|76101227|FG001|NOT COMPLETED|HGNS Washout (1 Week)||0||
59985809|NCT03359096|76101226|FG000|STARTED|Second Intervention (4 Weeks)||29||
59526926|NCT02173535|75622511|FG018|STARTED|Period 4||12||
59526927|NCT02173535|75622512|FG019|STARTED|Period 4||12||
59526928|NCT02173535|75622493|FG000|COMPLETED|Period 4||12||
59526929|NCT02173535|75622494|FG001|COMPLETED|Period 4||12||
59526930|NCT02173535|75622495|FG002|COMPLETED|Period 4||12||
59526931|NCT02173535|75622496|FG003|COMPLETED|Period 4||12||
59526932|NCT02173535|75622497|FG004|COMPLETED|Period 4||12||
59526933|NCT02173535|75622498|FG005|COMPLETED|Period 4||12||
59526934|NCT02173535|75622499|FG006|COMPLETED|Period 4||12||
59526935|NCT02173535|75622500|FG007|COMPLETED|Period 4||12||
59985810|NCT03359096|76101227|FG001|STARTED|Second Intervention (4 Weeks)||31||
59985811|NCT03359096|76101226|FG000|COMPLETED|Second Intervention (4 Weeks)||29||
59985812|NCT03359096|76101227|FG001|COMPLETED|Second Intervention (4 Weeks)||31||
59985813|NCT03359096|76101226|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0||
59985814|NCT03359096|76101227|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||0||
59985815|NCT03182751|76101235|FG000|STARTED|Overall Study||64||
59985816|NCT03182751|76101236|FG001|STARTED|Overall Study||64||
59985817|NCT03182751|76101235|FG000|COMPLETED|Overall Study||64||
59985818|NCT03182751|76101236|FG001|COMPLETED|Overall Study||64||
59985819|NCT03182751|76101235|FG000|NOT COMPLETED|Overall Study||0||
59985820|NCT03182751|76101236|FG001|NOT COMPLETED|Overall Study||0||
59985821|NCT03019588|76101244|FG000|STARTED|Overall Study||47||
59985822|NCT03019588|76101245|FG001|STARTED|Overall Study||47||
59985823|NCT03019588|76101244|FG000|Treated|Overall Study||47||
59985824|NCT03019588|76101245|FG001|Treated|Overall Study||44||
59985825|NCT03019588|76101244|FG000|COMPLETED|Overall Study||0||
60074943|NCT01609790|76190188|FG001|STARTED|Overall Study||65||
60074944|NCT01609790|76190189|FG002|STARTED|Overall Study||65||
60074945|NCT01609790|76190187|FG000|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|6||
60074946|NCT01609790|76190188|FG001|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|58||
60074947|NCT01609790|76190189|FG002|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|57||
60074948|NCT01609790|76190187|FG000|NOT COMPLETED|Overall Study||1||
60074949|NCT01609790|76190188|FG001|NOT COMPLETED|Overall Study||7||
60074950|NCT01609790|76190189|FG002|NOT COMPLETED|Overall Study||8||
60074951|NCT01767116|76190199|FG000|STARTED|Overall Study||210||
60074952|NCT01767116|76190200|FG001|STARTED|Overall Study||209||
60074953|NCT01767116|76190199|FG000|COMPLETED|Overall Study||208||
60074954|NCT01767116|76190200|FG001|COMPLETED|Overall Study||207||
60074955|NCT01767116|76190199|FG000|NOT COMPLETED|Overall Study||2||
60074956|NCT01767116|76190200|FG001|NOT COMPLETED|Overall Study||2||
60074957|NCT01574703|76190210|FG000|STARTED|Overall Study||1192||
60074958|NCT01574703|76190211|FG001|STARTED|Overall Study||1166||
60074959|NCT01574703|76190212|FG002|STARTED|Overall Study||1116||
60074960|NCT01574703|76190213|FG003|STARTED|Overall Study||1121||
60074961|NCT01574703|76190210|FG000|COMPLETED|Overall Study||1067||
59622643|NCT00538434|75734520|FG001|Intent-to-treat (ITT) Population|Overall Study||57||
59622644|NCT00538434|75734521|FG002|Intent-to-treat (ITT) Population|Overall Study||57||
59622645|NCT00538434|75734522|FG003|Intent-to-treat (ITT) Population|Overall Study||57||
59622646|NCT00538434|75734519|FG000|COMPLETED|Overall Study|Completed all scheduled study visits|47||
59622647|NCT00538434|75734520|FG001|COMPLETED|Overall Study|Completed all scheduled study visits|46||
59622648|NCT00538434|75734521|FG002|COMPLETED|Overall Study|Completed all scheduled study visits|50||
59622649|NCT00538434|75734522|FG003|COMPLETED|Overall Study|Completed all scheduled study visits|51||
59622650|NCT00538434|75734519|FG000|NOT COMPLETED|Overall Study||9||
59622651|NCT00538434|75734520|FG001|NOT COMPLETED|Overall Study||11||
59622652|NCT00538434|75734521|FG002|NOT COMPLETED|Overall Study||7||
59622653|NCT00538434|75734522|FG003|NOT COMPLETED|Overall Study||6||
59985826|NCT03019588|76101245|FG001|COMPLETED|Overall Study||0||
60074962|NCT01574703|76190211|FG001|COMPLETED|Overall Study||1054||
60074963|NCT01574703|76190212|FG002|COMPLETED|Overall Study||1011||
60074964|NCT01574703|76190213|FG003|COMPLETED|Overall Study||1007||
60074965|NCT01574703|76190210|FG000|NOT COMPLETED|Overall Study||125||
60074966|NCT01574703|76190211|FG001|NOT COMPLETED|Overall Study||112||
60074967|NCT01574703|76190212|FG002|NOT COMPLETED|Overall Study||105||
60074968|NCT01574703|76190213|FG003|NOT COMPLETED|Overall Study||114||
59622654|NCT00538512|75734536|FG000|STARTED|Overall Study||814||
59622655|NCT00538512|75734537|FG001|STARTED|Overall Study||813||
59622656|NCT00538512|75734538|FG002|STARTED|Overall Study||325||
59622657|NCT00538512|75734536|FG000|COMPLETED|Overall Study||787||
59985827|NCT03019588|76101244|FG000|NOT COMPLETED|Overall Study||47||
59985828|NCT03019588|76101245|FG001|NOT COMPLETED|Overall Study||47||
59985829|NCT02959944|76101253|FG000|STARTED|Overall Study||95||
59985830|NCT02959944|76101254|FG001|STARTED|Overall Study||98||
59985831|NCT02959944|76101253|FG000|Received at Least 1 Dose of Study Drug|Overall Study||94||
59985832|NCT02959944|76101254|FG001|Received at Least 1 Dose of Study Drug|Overall Study||96||
59985833|NCT02959944|76101253|FG000|COMPLETED|Overall Study||95||
59985834|NCT02959944|76101254|FG001|COMPLETED|Overall Study||98||
59985835|NCT02959944|76101253|FG000|NOT COMPLETED|Overall Study||0||
59985836|NCT02959944|76101254|FG001|NOT COMPLETED|Overall Study||0||
59985837|NCT02774668|76101262|FG000|STARTED|Overall Study||10||
59985838|NCT02774668|76101263|FG001|STARTED|Overall Study||10||
59985839|NCT02774668|76101262|FG000|COMPLETED|Overall Study||10||
59985840|NCT02774668|76101263|FG001|COMPLETED|Overall Study||10||
59985841|NCT02774668|76101262|FG000|NOT COMPLETED|Overall Study||0||
59985842|NCT02774668|76101263|FG001|NOT COMPLETED|Overall Study||0||
59985843|NCT02559180|76101269|FG000|STARTED|Overall Study||20||
60074969|NCT01686633|76190226|FG000|STARTED|Overall Study||347||
59985844|NCT02559180|76101269|FG000|COMPLETED|Overall Study||16||
60074970|NCT01686633|76190227|FG001|STARTED|Overall Study||346||
59985845|NCT02559180|76101269|FG000|NOT COMPLETED|Overall Study||4||
59985846|NCT02455557|76101273|FG000|STARTED|Overall Study||66||
59985847|NCT02455557|76101273|FG000|COMPLETED|Overall Study||64||
59985848|NCT02455557|76101273|FG000|NOT COMPLETED|Overall Study||2||
59985849|NCT02270450|76101281|FG000|STARTED|Overall Study||24||
59985850|NCT02270450|76101282|FG001|STARTED|Overall Study||25||
59985851|NCT02270450|76101283|FG002|STARTED|Overall Study||58||
59985852|NCT02270450|76101284|FG003|STARTED|Overall Study||92||
59985853|NCT02270450|76101281|FG000|COMPLETED|Overall Study||1||
59985854|NCT02270450|76101282|FG001|COMPLETED|Overall Study||3||
59526936|NCT02173535|75622501|FG008|COMPLETED|Period 4||12||
59526937|NCT02173535|75622502|FG009|COMPLETED|Period 4||12||
59526938|NCT02173535|75622503|FG010|COMPLETED|Period 4||12||
59526939|NCT02173535|75622504|FG011|COMPLETED|Period 4||12||
59526940|NCT02173535|75622505|FG012|COMPLETED|Period 4||12||
59526941|NCT02173535|75622506|FG013|COMPLETED|Period 4||12||
59526942|NCT02173535|75622507|FG014|COMPLETED|Period 4||12||
59526943|NCT02173535|75622508|FG015|COMPLETED|Period 4||12||
59526944|NCT02173535|75622509|FG016|COMPLETED|Period 4||12||
59526945|NCT02173535|75622510|FG017|COMPLETED|Period 4||12||
59526946|NCT02173535|75622511|FG018|COMPLETED|Period 4||12||
59526947|NCT02173535|75622512|FG019|COMPLETED|Period 4||12||
59526948|NCT02173535|75622493|FG000|NOT COMPLETED|Period 4||0||
59526949|NCT02173535|75622494|FG001|NOT COMPLETED|Period 4||0||
59526950|NCT02173535|75622495|FG002|NOT COMPLETED|Period 4||0||
59526951|NCT02173535|75622496|FG003|NOT COMPLETED|Period 4||0||
59985855|NCT02270450|76101283|FG002|COMPLETED|Overall Study||18||
59985856|NCT02270450|76101284|FG003|COMPLETED|Overall Study||10||
59985857|NCT02270450|76101281|FG000|NOT COMPLETED|Overall Study||23||
59985858|NCT02270450|76101282|FG001|NOT COMPLETED|Overall Study||22||
59985859|NCT02270450|76101283|FG002|NOT COMPLETED|Overall Study||40||
59985860|NCT02270450|76101284|FG003|NOT COMPLETED|Overall Study||82||
59985861|NCT02195895|76101294|FG000|STARTED|Overall Study||17||
59985862|NCT02195895|76101294|FG000|COMPLETED|Overall Study||17||
59985863|NCT02195895|76101294|FG000|NOT COMPLETED|Overall Study||0||
59985864|NCT01709136|76101298|FG000|STARTED|Overall Study||3||
59985865|NCT01709136|76101298|FG000|COMPLETED|Overall Study||3||
59985866|NCT01709136|76101298|FG000|NOT COMPLETED|Overall Study||0||
59985867|NCT01565499|76101305|FG000|STARTED|Overall Study||83||
59985868|NCT01565499|76101305|FG000|COMPLETED|Overall Study||75||
59985869|NCT01565499|76101305|FG000|NOT COMPLETED|Overall Study||8||
59985870|NCT01036087|76101309|FG000|STARTED|Overall Study||40||
59985871|NCT01036087|76101309|FG000|COMPLETED|Overall Study||37||
59985872|NCT01036087|76101309|FG000|NOT COMPLETED|Overall Study||3||
59985873|NCT00783367|76101315|FG000|STARTED|Overall Study||27||
59985874|NCT00783367|76101316|FG001|STARTED|Overall Study||23||
59985875|NCT00783367|76101315|FG000|COMPLETED|Overall Study||27||
59985876|NCT00783367|76101316|FG001|COMPLETED|Overall Study||23||
59985877|NCT00783367|76101315|FG000|NOT COMPLETED|Overall Study||0||
59985878|NCT00783367|76101316|FG001|NOT COMPLETED|Overall Study||0||
59985879|NCT00572156|76101326|FG000|STARTED|Overall Study||26||
59985880|NCT00572156|76101327|FG001|STARTED|Overall Study||27||
59985881|NCT00572156|76101328|FG002|STARTED|Overall Study||27||
59985882|NCT00572156|76101329|FG003|STARTED|Overall Study||26||
59985883|NCT00572156|76101326|FG000|COMPLETED|Overall Study||0||
59985884|NCT00572156|76101327|FG001|COMPLETED|Overall Study||1||
59985885|NCT00572156|76101328|FG002|COMPLETED|Overall Study||0||
59985886|NCT00572156|76101329|FG003|COMPLETED|Overall Study||1||
59526952|NCT02173535|75622497|FG004|NOT COMPLETED|Period 4||0||
59526953|NCT02173535|75622498|FG005|NOT COMPLETED|Period 4||0||
59985887|NCT00572156|76101326|FG000|NOT COMPLETED|Overall Study||26||
59985888|NCT00572156|76101327|FG001|NOT COMPLETED|Overall Study||26||
59985889|NCT00572156|76101328|FG002|NOT COMPLETED|Overall Study||27||
59985890|NCT00572156|76101329|FG003|NOT COMPLETED|Overall Study||25||
59985891|NCT00447772|76101339|FG000|STARTED|Overall Study||516||
59985892|NCT00447772|76101339|FG000|COMPLETED|Overall Study||489||
59985893|NCT00447772|76101339|FG000|NOT COMPLETED|Overall Study||27||
59985894|NCT02296138|76101348|FG000|STARTED|Overall Study||3952||
59985895|NCT02296138|76101349|FG001|STARTED|Overall Study||3951||
59985896|NCT02296138|76101348|FG000|Treated|Overall Study||3941||
59985897|NCT02296138|76101349|FG001|Treated|Overall Study||3939||
59985898|NCT02296138|76101348|FG000|COMPLETED|Overall Study||3291||
59526954|NCT02173535|75622499|FG006|NOT COMPLETED|Period 4||0||
59985899|NCT02296138|76101349|FG001|COMPLETED|Overall Study||3451||
59985900|NCT02296138|76101348|FG000|NOT COMPLETED|Overall Study||661||
59985901|NCT02296138|76101349|FG001|NOT COMPLETED|Overall Study||500||
59526955|NCT02173535|75622500|FG007|NOT COMPLETED|Period 4||0||
59985902|NCT01306942|76101358|FG000|STARTED|Phase I||6||
59985903|NCT01306942|76101359|FG001|STARTED|Phase I||4||
59985904|NCT01306942|76101360|FG002|STARTED|Phase I||0||
59526956|NCT02173535|75622501|FG008|NOT COMPLETED|Period 4||0||
59526957|NCT02173535|75622502|FG009|NOT COMPLETED|Period 4||0||
59526958|NCT02173535|75622503|FG010|NOT COMPLETED|Period 4||0||
59526959|NCT02173535|75622504|FG011|NOT COMPLETED|Period 4||0||
59985905|NCT01306942|76101361|FG003|STARTED|Phase I||0||
59985906|NCT01306942|76101358|FG000|COMPLETED|Phase I||1||
59985907|NCT01306942|76101359|FG001|COMPLETED|Phase I||1||
59985908|NCT01306942|76101360|FG002|COMPLETED|Phase I||0||
59985909|NCT01306942|76101361|FG003|COMPLETED|Phase I||0||
59985910|NCT01306942|76101358|FG000|NOT COMPLETED|Phase I||5||
59985911|NCT01306942|76101359|FG001|NOT COMPLETED|Phase I||3||
59985912|NCT01306942|76101360|FG002|NOT COMPLETED|Phase I||0||
59985913|NCT01306942|76101361|FG003|NOT COMPLETED|Phase I||0||
59526960|NCT02173535|75622505|FG012|NOT COMPLETED|Period 4||0||
59526961|NCT02173535|75622506|FG013|NOT COMPLETED|Period 4||0||
59526962|NCT02173535|75622507|FG014|NOT COMPLETED|Period 4||0||
59526963|NCT02173535|75622508|FG015|NOT COMPLETED|Period 4||0||
59526964|NCT02173535|75622509|FG016|NOT COMPLETED|Period 4||0||
59526965|NCT02173535|75622510|FG017|NOT COMPLETED|Period 4||0||
59526966|NCT02173535|75622511|FG018|NOT COMPLETED|Period 4||0||
59526967|NCT02173535|75622512|FG019|NOT COMPLETED|Period 4||0||
59526968|NCT02173535|75622493|FG000|STARTED|Period 5||12||
59526969|NCT02173535|75622494|FG001|STARTED|Period 5||12||
59526970|NCT02173535|75622495|FG002|STARTED|Period 5||12||
59526971|NCT02173535|75622496|FG003|STARTED|Period 5||12||
59526972|NCT02173535|75622497|FG004|STARTED|Period 5||12||
59526973|NCT02173535|75622498|FG005|STARTED|Period 5||12||
59526974|NCT02173535|75622499|FG006|STARTED|Period 5||12||
59526975|NCT02173535|75622500|FG007|STARTED|Period 5||12||
59526976|NCT02173535|75622501|FG008|STARTED|Period 5||12||
59526977|NCT02173535|75622502|FG009|STARTED|Period 5||12||
59526978|NCT02173535|75622503|FG010|STARTED|Period 5||12||
59526979|NCT02173535|75622504|FG011|STARTED|Period 5||12||
59526980|NCT02173535|75622505|FG012|STARTED|Period 5||12||
59526981|NCT02173535|75622506|FG013|STARTED|Period 5||12||
59526982|NCT02173535|75622507|FG014|STARTED|Period 5||12||
59526983|NCT02173535|75622508|FG015|STARTED|Period 5||12||
59526984|NCT02173535|75622509|FG016|STARTED|Period 5||12||
59526985|NCT02173535|75622510|FG017|STARTED|Period 5||12||
59526986|NCT02173535|75622511|FG018|STARTED|Period 5||12||
59526987|NCT02173535|75622512|FG019|STARTED|Period 5||12||
59526988|NCT02173535|75622493|FG000|COMPLETED|Period 5||12||
59526989|NCT02173535|75622494|FG001|COMPLETED|Period 5||12||
59526990|NCT02173535|75622495|FG002|COMPLETED|Period 5||12||
59526991|NCT02173535|75622496|FG003|COMPLETED|Period 5||12||
59526992|NCT02173535|75622497|FG004|COMPLETED|Period 5||12||
59526993|NCT02173535|75622498|FG005|COMPLETED|Period 5||12||
59526994|NCT02173535|75622499|FG006|COMPLETED|Period 5||12||
59526995|NCT02173535|75622500|FG007|COMPLETED|Period 5||12||
59526996|NCT02173535|75622501|FG008|COMPLETED|Period 5||12||
59526997|NCT02173535|75622502|FG009|COMPLETED|Period 5||12||
59526998|NCT02173535|75622503|FG010|COMPLETED|Period 5||12||
59526999|NCT02173535|75622504|FG011|COMPLETED|Period 5||12||
59527000|NCT02173535|75622505|FG012|COMPLETED|Period 5||12||
59527001|NCT02173535|75622506|FG013|COMPLETED|Period 5||12||
59527002|NCT02173535|75622507|FG014|COMPLETED|Period 5||12||
59527003|NCT02173535|75622508|FG015|COMPLETED|Period 5||12||
59527004|NCT02173535|75622509|FG016|COMPLETED|Period 5||12||
59527005|NCT02173535|75622510|FG017|COMPLETED|Period 5||12||
59527006|NCT02173535|75622511|FG018|COMPLETED|Period 5||12||
59527007|NCT02173535|75622512|FG019|COMPLETED|Period 5||12||
59527008|NCT02173535|75622493|FG000|NOT COMPLETED|Period 5||0||
59527009|NCT02173535|75622494|FG001|NOT COMPLETED|Period 5||0||
59527010|NCT02173535|75622495|FG002|NOT COMPLETED|Period 5||0||
59527011|NCT02173535|75622496|FG003|NOT COMPLETED|Period 5||0||
59527012|NCT02173535|75622497|FG004|NOT COMPLETED|Period 5||0||
59985914|NCT01306942|76101358|FG000|STARTED|Phase II|Two patients from phase I with measurable disease and RP2D were included in the phase II analyses.|2||
59985915|NCT01306942|76101359|FG001|STARTED|Phase II|Dasatinib 140mg was not the RP2D, so these patients were not included in the phase II analyses.|0||
59985916|NCT01306942|76101360|FG002|STARTED|Phase II||0||
59985917|NCT01306942|76101361|FG003|STARTED|Phase II||27||
59527013|NCT02173535|75622498|FG005|NOT COMPLETED|Period 5||0||
59527014|NCT02173535|75622499|FG006|NOT COMPLETED|Period 5||0||
59527015|NCT02173535|75622500|FG007|NOT COMPLETED|Period 5||0||
59527016|NCT02173535|75622501|FG008|NOT COMPLETED|Period 5||0||
59527017|NCT02173535|75622502|FG009|NOT COMPLETED|Period 5||0||
59527018|NCT02173535|75622503|FG010|NOT COMPLETED|Period 5||0||
59527019|NCT02173535|75622504|FG011|NOT COMPLETED|Period 5||0||
59985918|NCT01306942|76101358|FG000|COMPLETED|Phase II||0||
59985919|NCT01306942|76101359|FG001|COMPLETED|Phase II||0||
59527020|NCT02173535|75622505|FG012|NOT COMPLETED|Period 5||0||
59527021|NCT02173535|75622506|FG013|NOT COMPLETED|Period 5||0||
59527022|NCT02173535|75622507|FG014|NOT COMPLETED|Period 5||0||
59527023|NCT02173535|75622508|FG015|NOT COMPLETED|Period 5||0||
59985920|NCT01306942|76101360|FG002|COMPLETED|Phase II||0||
59985921|NCT01306942|76101361|FG003|COMPLETED|Phase II||11||
59527024|NCT02173535|75622509|FG016|NOT COMPLETED|Period 5||0||
59527025|NCT02173535|75622510|FG017|NOT COMPLETED|Period 5||0||
59527026|NCT02173535|75622511|FG018|NOT COMPLETED|Period 5||0||
59527027|NCT02173535|75622512|FG019|NOT COMPLETED|Period 5||0||
59527028|NCT01072331|75622542|FG000|STARTED|Overall Study||34||
59527029|NCT01072331|75622543|FG001|STARTED|Overall Study||33||
59527030|NCT01072331|75622544|FG002|STARTED|Overall Study||32||
59527031|NCT01072331|75622542|FG000|COMPLETED|Overall Study||34||
59527032|NCT01072331|75622543|FG001|COMPLETED|Overall Study||33||
59527033|NCT01072331|75622544|FG002|COMPLETED|Overall Study||32||
59985922|NCT01306942|76101358|FG000|NOT COMPLETED|Phase II||2||
59985923|NCT01306942|76101359|FG001|NOT COMPLETED|Phase II||0||
59985924|NCT01306942|76101360|FG002|NOT COMPLETED|Phase II||0||
59985925|NCT01306942|76101361|FG003|NOT COMPLETED|Phase II||16||
59985926|NCT02324842|76101376|FG000|STARTED|Overall Study||15||
59985927|NCT02324842|76101377|FG001|STARTED|Overall Study||15||
59985928|NCT02324842|76101378|FG002|STARTED|Overall Study||15||
59985929|NCT02324842|76101376|FG000|COMPLETED|Overall Study||14||
59985930|NCT02324842|76101377|FG001|COMPLETED|Overall Study||14||
59985931|NCT02324842|76101378|FG002|COMPLETED|Overall Study||13||
59985932|NCT02324842|76101376|FG000|NOT COMPLETED|Overall Study||1||
59985933|NCT02324842|76101377|FG001|NOT COMPLETED|Overall Study||1||
59985934|NCT02324842|76101378|FG002|NOT COMPLETED|Overall Study||2||
59985935|NCT02295280|76101388|FG000|STARTED|Overall Study||35||
59985936|NCT02295280|76101389|FG001|STARTED|Overall Study||35||
59985937|NCT02295280|76101388|FG000|COMPLETED|Overall Study||35||
59985938|NCT02295280|76101389|FG001|COMPLETED|Overall Study||34||
59985939|NCT02295280|76101388|FG000|NOT COMPLETED|Overall Study||0||
59985940|NCT02295280|76101389|FG001|NOT COMPLETED|Overall Study||1||
59985941|NCT05263505|76101397|FG000|STARTED|Overall Study||1||
59985942|NCT05263505|76101398|FG001|STARTED|Overall Study||1||
59985943|NCT05263505|76101397|FG000|COMPLETED|Overall Study||1||
59985944|NCT05263505|76101398|FG001|COMPLETED|Overall Study||0||
59985945|NCT05263505|76101397|FG000|NOT COMPLETED|Overall Study||0||
59985946|NCT05263505|76101398|FG001|NOT COMPLETED|Overall Study||1||
59985947|NCT02294734|76101406|FG000|STARTED|Overall Study||63||
59985948|NCT02294734|76101407|FG001|STARTED|Overall Study||63||
59985949|NCT02294734|76101406|FG000|COMPLETED|Overall Study||49||
59985950|NCT02294734|76101407|FG001|COMPLETED|Overall Study||55||
59985951|NCT02294734|76101406|FG000|NOT COMPLETED|Overall Study||14||
59985952|NCT02294734|76101407|FG001|NOT COMPLETED|Overall Study||8||
59985953|NCT04172623|76101417|FG000|STARTED|Overall Study||29||
59985954|NCT04172623|76101418|FG001|STARTED|Overall Study||29||
59985955|NCT04172623|76101417|FG000|COMPLETED|Overall Study||29||
59985956|NCT04172623|76101418|FG001|COMPLETED|Overall Study||29||
59985957|NCT04172623|76101417|FG000|NOT COMPLETED|Overall Study||0||
59985958|NCT04172623|76101418|FG001|NOT COMPLETED|Overall Study||0||
59985959|NCT02323204|76101428|FG000|STARTED|Baseline Survey Completion||155||
59985960|NCT02323204|76101429|FG001|STARTED|Baseline Survey Completion||155||
59985961|NCT02323204|76101430|FG002|STARTED|Baseline Survey Completion||159||
59985962|NCT02323204|76101431|FG003|STARTED|Baseline Survey Completion||159||
59985963|NCT02323204|76101428|FG000|COMPLETED|Baseline Survey Completion||145||
59985964|NCT02323204|76101429|FG001|COMPLETED|Baseline Survey Completion||146||
59985965|NCT02323204|76101430|FG002|COMPLETED|Baseline Survey Completion||154||
59985966|NCT02323204|76101431|FG003|COMPLETED|Baseline Survey Completion||156||
59985967|NCT02323204|76101428|FG000|NOT COMPLETED|Baseline Survey Completion||10||
59985968|NCT02323204|76101429|FG001|NOT COMPLETED|Baseline Survey Completion||9||
59985969|NCT02323204|76101430|FG002|NOT COMPLETED|Baseline Survey Completion||5||
59985970|NCT02323204|76101431|FG003|NOT COMPLETED|Baseline Survey Completion||3||
59985971|NCT02323204|76101428|FG000|STARTED|6-week Follow-up Survey Completion||145||
59985972|NCT02323204|76101429|FG001|STARTED|6-week Follow-up Survey Completion||146||
59985973|NCT02323204|76101430|FG002|STARTED|6-week Follow-up Survey Completion||154||
59985974|NCT02323204|76101431|FG003|STARTED|6-week Follow-up Survey Completion||156||
59985975|NCT02323204|76101428|FG000|COMPLETED|6-week Follow-up Survey Completion||104||
59985976|NCT02323204|76101429|FG001|COMPLETED|6-week Follow-up Survey Completion||110||
59985977|NCT02323204|76101430|FG002|COMPLETED|6-week Follow-up Survey Completion||112||
60074971|NCT01686633|76190228|FG002|STARTED|Overall Study||346||
59985978|NCT02323204|76101431|FG003|COMPLETED|6-week Follow-up Survey Completion||119||
59985979|NCT02323204|76101428|FG000|NOT COMPLETED|6-week Follow-up Survey Completion||41||
59985980|NCT02323204|76101429|FG001|NOT COMPLETED|6-week Follow-up Survey Completion||36||
59985981|NCT02323204|76101430|FG002|NOT COMPLETED|6-week Follow-up Survey Completion||42||
59985982|NCT02323204|76101431|FG003|NOT COMPLETED|6-week Follow-up Survey Completion||37||
59985983|NCT02323204|76101428|FG000|STARTED|6-week Follow-up Intervention Booster|Child participants did not receive intervention booster training.|0||
59985984|NCT02323204|76101429|FG001|STARTED|6-week Follow-up Intervention Booster|Received intervention-specific booster training via phone between 6-weeks and 1 year post-enrollment|146||
59985985|NCT02323204|76101430|FG002|STARTED|6-week Follow-up Intervention Booster|Child participants did not receive intervention booster training.|0||
59985986|NCT02323204|76101431|FG003|STARTED|6-week Follow-up Intervention Booster|Received intervention-specific booster training via phone between 6-weeks and 1 year post-enrollment|156||
59985987|NCT02323204|76101428|FG000|COMPLETED|6-week Follow-up Intervention Booster||0||
59985988|NCT02323204|76101429|FG001|COMPLETED|6-week Follow-up Intervention Booster||103||
59985989|NCT02323204|76101430|FG002|COMPLETED|6-week Follow-up Intervention Booster||0||
59985990|NCT02323204|76101431|FG003|COMPLETED|6-week Follow-up Intervention Booster||120||
59985991|NCT02323204|76101428|FG000|NOT COMPLETED|6-week Follow-up Intervention Booster||0||
59985992|NCT02323204|76101429|FG001|NOT COMPLETED|6-week Follow-up Intervention Booster||43||
59985993|NCT02323204|76101430|FG002|NOT COMPLETED|6-week Follow-up Intervention Booster||0||
60074972|NCT01686633|76190226|FG000|COMPLETED|Overall Study||296||
59985994|NCT02323204|76101431|FG003|NOT COMPLETED|6-week Follow-up Intervention Booster||36||
59985995|NCT02323204|76101428|FG000|STARTED|3-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|145||
59985996|NCT02323204|76101429|FG001|STARTED|3-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|146||
59985997|NCT02323204|76101430|FG002|STARTED|3-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|154||
59985998|NCT02323204|76101431|FG003|STARTED|3-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|156||
59985999|NCT02323204|76101428|FG000|COMPLETED|3-month Follow-up Survey Completion||91||
59986000|NCT02323204|76101429|FG001|COMPLETED|3-month Follow-up Survey Completion||99||
59986001|NCT02323204|76101430|FG002|COMPLETED|3-month Follow-up Survey Completion||113||
59986002|NCT02323204|76101431|FG003|COMPLETED|3-month Follow-up Survey Completion||112||
59986003|NCT02323204|76101428|FG000|NOT COMPLETED|3-month Follow-up Survey Completion||54||
59986004|NCT02323204|76101429|FG001|NOT COMPLETED|3-month Follow-up Survey Completion||47||
59986005|NCT02323204|76101430|FG002|NOT COMPLETED|3-month Follow-up Survey Completion||41||
59986006|NCT02323204|76101431|FG003|NOT COMPLETED|3-month Follow-up Survey Completion||44||
59527034|NCT01072331|75622542|FG000|NOT COMPLETED|Overall Study||0||
59527035|NCT01072331|75622543|FG001|NOT COMPLETED|Overall Study||0||
59527036|NCT01072331|75622544|FG002|NOT COMPLETED|Overall Study||0||
59527037|NCT01072409|75622552|FG000|STARTED|Overall Study||45||
59527038|NCT01072409|75622552|FG000|COMPLETED|Overall Study||38||
59527039|NCT01072409|75622552|FG000|NOT COMPLETED|Overall Study||7||
59527040|NCT01072643|75622556|FG000|STARTED|Overall Study||4||
59527041|NCT01072643|75622556|FG000|COMPLETED|Overall Study||4||
59527042|NCT01072643|75622556|FG000|NOT COMPLETED|Overall Study||0||
59986007|NCT02323204|76101428|FG000|STARTED|6-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|145||
59986008|NCT02323204|76101429|FG001|STARTED|6-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|146||
59986009|NCT02323204|76101430|FG002|STARTED|6-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|154||
59986010|NCT02323204|76101431|FG003|STARTED|6-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|156||
59986011|NCT02323204|76101428|FG000|COMPLETED|6-month Follow-up Survey Completion||96||
59986012|NCT02323204|76101429|FG001|COMPLETED|6-month Follow-up Survey Completion||96||
59986013|NCT02323204|76101430|FG002|COMPLETED|6-month Follow-up Survey Completion||113||
59986014|NCT02323204|76101431|FG003|COMPLETED|6-month Follow-up Survey Completion||112||
59986015|NCT02323204|76101428|FG000|NOT COMPLETED|6-month Follow-up Survey Completion||49||
59986016|NCT02323204|76101429|FG001|NOT COMPLETED|6-month Follow-up Survey Completion||50||
59986017|NCT02323204|76101430|FG002|NOT COMPLETED|6-month Follow-up Survey Completion||41||
59986018|NCT02323204|76101431|FG003|NOT COMPLETED|6-month Follow-up Survey Completion||44||
59986019|NCT02322892|76101443|FG000|STARTED|Overall Study|Number randomized|35||
59986020|NCT02322892|76101444|FG001|STARTED|Overall Study|Number randomized|34||
59986021|NCT02322892|76101443|FG000|COMPLETED|Overall Study|Received placebo|33||
59986022|NCT02322892|76101444|FG001|COMPLETED|Overall Study|Received thiamine|31||
59986023|NCT02322892|76101443|FG000|NOT COMPLETED|Overall Study||2||
59986024|NCT02322892|76101444|FG001|NOT COMPLETED|Overall Study||3||
59986025|NCT03916081|76101453|FG000|STARTED|Overall Study||46||
59986026|NCT03916081|76101454|FG001|STARTED|Overall Study||45||
59986027|NCT03916081|76101455|FG002|STARTED|Overall Study||45||
59986028|NCT03916081|76101453|FG000|COMPLETED|Overall Study||42||
59986029|NCT03916081|76101454|FG001|COMPLETED|Overall Study||44||
59986030|NCT03916081|76101455|FG002|COMPLETED|Overall Study||42||
59986031|NCT03916081|76101453|FG000|NOT COMPLETED|Overall Study||4||
59986032|NCT03916081|76101454|FG001|NOT COMPLETED|Overall Study||1||
59986033|NCT03916081|76101455|FG002|NOT COMPLETED|Overall Study||3||
59986034|NCT03116113|76101472|FG000|STARTED|Part 1 (Day 0 up to Month 24)||3||
59986035|NCT03116113|76101473|FG001|STARTED|Part 1 (Day 0 up to Month 24)||3||
59986036|NCT03116113|76101474|FG002|STARTED|Part 1 (Day 0 up to Month 24)||3||
60074973|NCT01686633|76190227|FG001|COMPLETED|Overall Study||314||
59527043|NCT01073657|75622581|FG000|STARTED|Overall Study||17||
59527044|NCT01073657|75622582|FG001|STARTED|Overall Study||16||
59986037|NCT03116113|76101475|FG003|STARTED|Part 1 (Day 0 up to Month 24)||3||
59986038|NCT03116113|76101476|FG004|STARTED|Part 1 (Day 0 up to Month 24)||3||
59986039|NCT03116113|76101477|FG005|STARTED|Part 1 (Day 0 up to Month 24)||3||
59986040|NCT03116113|76101478|FG006|STARTED|Part 1 (Day 0 up to Month 24)||0||
59986041|NCT03116113|76101479|FG007|STARTED|Part 1 (Day 0 up to Month 24)||0||
59986042|NCT03116113|76101480|FG008|STARTED|Part 1 (Day 0 up to Month 24)||0||
59986043|NCT03116113|76101472|FG000|COMPLETED|Part 1 (Day 0 up to Month 24)||3||
59986044|NCT03116113|76101473|FG001|COMPLETED|Part 1 (Day 0 up to Month 24)||3||
59986045|NCT03116113|76101474|FG002|COMPLETED|Part 1 (Day 0 up to Month 24)||3||
60074974|NCT01686633|76190228|FG002|COMPLETED|Overall Study||321||
60074975|NCT01686633|76190226|FG000|NOT COMPLETED|Overall Study||51||
60074976|NCT01686633|76190227|FG001|NOT COMPLETED|Overall Study||32||
59527045|NCT01073657|75622581|FG000|COMPLETED|Overall Study||17||
59527046|NCT01073657|75622582|FG001|COMPLETED|Overall Study||16||
59527047|NCT01073657|75622581|FG000|NOT COMPLETED|Overall Study||0||
59527048|NCT01073657|75622582|FG001|NOT COMPLETED|Overall Study||0||
59527049|NCT01074125|75622591|FG000|STARTED|Overall Study||51||
59527050|NCT01074125|75622592|FG001|STARTED|Overall Study||52||
59527051|NCT01074125|75622593|FG002|STARTED|Overall Study||48||
59527052|NCT01074125|75622591|FG000|COMPLETED|Overall Study||39||
59986046|NCT03116113|76101475|FG003|COMPLETED|Part 1 (Day 0 up to Month 24)||3||
59986047|NCT03116113|76101476|FG004|COMPLETED|Part 1 (Day 0 up to Month 24)||3||
59986048|NCT03116113|76101477|FG005|COMPLETED|Part 1 (Day 0 up to Month 24)||3||
59986049|NCT03116113|76101478|FG006|COMPLETED|Part 1 (Day 0 up to Month 24)||0||
59986050|NCT03116113|76101479|FG007|COMPLETED|Part 1 (Day 0 up to Month 24)||0||
59986051|NCT03116113|76101480|FG008|COMPLETED|Part 1 (Day 0 up to Month 24)||0||
59986052|NCT03116113|76101472|FG000|NOT COMPLETED|Part 1 (Day 0 up to Month 24)||0||
59986053|NCT03116113|76101473|FG001|NOT COMPLETED|Part 1 (Day 0 up to Month 24)||0||
59986054|NCT03116113|76101474|FG002|NOT COMPLETED|Part 1 (Day 0 up to Month 24)||0||
59986055|NCT03116113|76101475|FG003|NOT COMPLETED|Part 1 (Day 0 up to Month 24)||0||
59986056|NCT03116113|76101476|FG004|NOT COMPLETED|Part 1 (Day 0 up to Month 24)||0||
59986057|NCT03116113|76101477|FG005|NOT COMPLETED|Part 1 (Day 0 up to Month 24)||0||
59986058|NCT03116113|76101478|FG006|NOT COMPLETED|Part 1 (Day 0 up to Month 24)||0||
59986059|NCT03116113|76101479|FG007|NOT COMPLETED|Part 1 (Day 0 up to Month 24)||0||
59986060|NCT03116113|76101480|FG008|NOT COMPLETED|Part 1 (Day 0 up to Month 24)||0||
59986061|NCT03116113|76101472|FG000|STARTED|Part 2 (Month 25 up to Month 36)||0||
59986062|NCT03116113|76101473|FG001|STARTED|Part 2 (Month 25 up to Month 36)||0||
59986063|NCT03116113|76101474|FG002|STARTED|Part 2 (Month 25 up to Month 36)||0||
59527053|NCT01074125|75622592|FG001|COMPLETED|Overall Study||47||
59527054|NCT01074125|75622593|FG002|COMPLETED|Overall Study||36||
59527055|NCT01074125|75622591|FG000|NOT COMPLETED|Overall Study||12||
59986064|NCT03116113|76101475|FG003|STARTED|Part 2 (Month 25 up to Month 36)||0||
59986065|NCT03116113|76101476|FG004|STARTED|Part 2 (Month 25 up to Month 36)||0||
59986066|NCT03116113|76101477|FG005|STARTED|Part 2 (Month 25 up to Month 36)||0||
59986067|NCT03116113|76101478|FG006|STARTED|Part 2 (Month 25 up to Month 36)||9||
59986068|NCT03116113|76101479|FG007|STARTED|Part 2 (Month 25 up to Month 36)||11||
59527056|NCT01074125|75622592|FG001|NOT COMPLETED|Overall Study||5||
59527057|NCT01074125|75622593|FG002|NOT COMPLETED|Overall Study||12||
59527058|NCT01108835|75622606|FG000|STARTED|Overall Study||90||
59527059|NCT01108835|75622607|FG001|STARTED|Overall Study||90||
59527060|NCT01108835|75622606|FG000|COMPLETED|Overall Study||73||
59986069|NCT03116113|76101480|FG008|STARTED|Part 2 (Month 25 up to Month 36)||12||
59986070|NCT03116113|76101472|FG000|COMPLETED|Part 2 (Month 25 up to Month 36)||0||
59986071|NCT03116113|76101473|FG001|COMPLETED|Part 2 (Month 25 up to Month 36)||0||
59986072|NCT03116113|76101474|FG002|COMPLETED|Part 2 (Month 25 up to Month 36)||0||
59986073|NCT03116113|76101475|FG003|COMPLETED|Part 2 (Month 25 up to Month 36)||0||
59986074|NCT03116113|76101476|FG004|COMPLETED|Part 2 (Month 25 up to Month 36)||0||
59986075|NCT03116113|76101477|FG005|COMPLETED|Part 2 (Month 25 up to Month 36)||0||
59986076|NCT03116113|76101478|FG006|COMPLETED|Part 2 (Month 25 up to Month 36)||9||
59986077|NCT03116113|76101479|FG007|COMPLETED|Part 2 (Month 25 up to Month 36)||10||
59986078|NCT03116113|76101480|FG008|COMPLETED|Part 2 (Month 25 up to Month 36)||10||
59986079|NCT03116113|76101472|FG000|NOT COMPLETED|Part 2 (Month 25 up to Month 36)||0||
59986080|NCT03116113|76101473|FG001|NOT COMPLETED|Part 2 (Month 25 up to Month 36)||0||
59986081|NCT03116113|76101474|FG002|NOT COMPLETED|Part 2 (Month 25 up to Month 36)||0||
59527061|NCT01108835|75622607|FG001|COMPLETED|Overall Study||69||
59527062|NCT01108835|75622606|FG000|NOT COMPLETED|Overall Study||17||
59527063|NCT01108835|75622607|FG001|NOT COMPLETED|Overall Study||21||
59527064|NCT01076231|75622614|FG000|STARTED|Overall Study||34||
59986082|NCT03116113|76101475|FG003|NOT COMPLETED|Part 2 (Month 25 up to Month 36)||0||
59986083|NCT03116113|76101476|FG004|NOT COMPLETED|Part 2 (Month 25 up to Month 36)||0||
59986084|NCT03116113|76101477|FG005|NOT COMPLETED|Part 2 (Month 25 up to Month 36)||0||
59986085|NCT03116113|76101478|FG006|NOT COMPLETED|Part 2 (Month 25 up to Month 36)||0||
59986086|NCT03116113|76101479|FG007|NOT COMPLETED|Part 2 (Month 25 up to Month 36)||1||
59986087|NCT03116113|76101480|FG008|NOT COMPLETED|Part 2 (Month 25 up to Month 36)||2||
59986088|NCT02739997|76101505|FG000|STARTED|Overall Study||100||
59986089|NCT02739997|76101505|FG000|COMPLETED|Overall Study||98||
59986090|NCT02739997|76101505|FG000|NOT COMPLETED|Overall Study||2||
59986091|NCT02221037|76101513|FG000|STARTED|Overall Study||5||
59986092|NCT02221037|76101514|FG001|STARTED|Overall Study||11||
59986093|NCT02221037|76101515|FG002|STARTED|Overall Study||8||
59986094|NCT02221037|76101516|FG003|STARTED|Overall Study||9||
59986095|NCT02221037|76101513|FG000|COMPLETED|Overall Study||5||
59986096|NCT02221037|76101514|FG001|COMPLETED|Overall Study||11||
59986097|NCT02221037|76101515|FG002|COMPLETED|Overall Study||7||
59986098|NCT02221037|76101516|FG003|COMPLETED|Overall Study||9||
59986099|NCT02221037|76101513|FG000|NOT COMPLETED|Overall Study||0||
59986100|NCT02221037|76101514|FG001|NOT COMPLETED|Overall Study||0||
59986101|NCT02221037|76101515|FG002|NOT COMPLETED|Overall Study||1||
59986102|NCT02221037|76101516|FG003|NOT COMPLETED|Overall Study||0||
59986103|NCT02704429|76101532|FG000|STARTED|Part A: 24 Weeks||27||
59527065|NCT01076231|75622614|FG000|COMPLETED|Overall Study||0||
59527066|NCT01076231|75622614|FG000|NOT COMPLETED|Overall Study||34||
59986104|NCT02704429|76101533|FG001|STARTED|Part A: 24 Weeks||0||
59986105|NCT02704429|76101532|FG000|COMPLETED|Part A: 24 Weeks||24||
59986106|NCT02704429|76101533|FG001|COMPLETED|Part A: 24 Weeks||0||
59986107|NCT02704429|76101532|FG000|NOT COMPLETED|Part A: 24 Weeks||3||
59986108|NCT02704429|76101533|FG001|NOT COMPLETED|Part A: 24 Weeks||0||
59986109|NCT02704429|76101532|FG000|STARTED|Part B: 28 Weeks||0||
59986110|NCT02704429|76101533|FG001|STARTED|Part B: 28 Weeks|One patient who completed Part A and later relapsed was enrolled in Part B.|15||
59986111|NCT02704429|76101532|FG000|COMPLETED|Part B: 28 Weeks||0||
59986112|NCT02704429|76101533|FG001|COMPLETED|Part B: 28 Weeks||14||
59986113|NCT02704429|76101532|FG000|NOT COMPLETED|Part B: 28 Weeks||0||
59986114|NCT02704429|76101533|FG001|NOT COMPLETED|Part B: 28 Weeks||1||
59986115|NCT02751359|76101540|FG000|STARTED|Overall Study||18||
59986116|NCT02751359|76101540|FG000|COMPLETED|Overall Study||17||
59986117|NCT02751359|76101540|FG000|NOT COMPLETED|Overall Study||1||
59986118|NCT02358993|76101552|FG000|STARTED|Overall Study||105||
59986119|NCT02358993|76101553|FG001|STARTED|Overall Study||96||
59986120|NCT02358993|76101552|FG000|COMPLETED|Overall Study||103||
59986121|NCT02358993|76101553|FG001|COMPLETED|Overall Study||94||
59986122|NCT02358993|76101552|FG000|NOT COMPLETED|Overall Study||2||
59986123|NCT02358993|76101553|FG001|NOT COMPLETED|Overall Study||2||
59986124|NCT02750813|76101559|FG000|STARTED|Period 1, First 14 Days of Wear||125||
59986125|NCT02750813|76101560|FG001|STARTED|Period 1, First 14 Days of Wear||121||
59986126|NCT02750813|76101559|FG000|COMPLETED|Period 1, First 14 Days of Wear||124||
59986127|NCT02750813|76101560|FG001|COMPLETED|Period 1, First 14 Days of Wear||120||
59986128|NCT02750813|76101559|FG000|NOT COMPLETED|Period 1, First 14 Days of Wear||1||
59986129|NCT02750813|76101560|FG001|NOT COMPLETED|Period 1, First 14 Days of Wear||1||
59527067|NCT00117962|75622620|FG000|STARTED|Overall Study||48||
59527068|NCT00117962|75622621|FG001|STARTED|Overall Study||53||
59527069|NCT00117962|75622620|FG000|COMPLETED|Overall Study||26||
59527070|NCT00117962|75622621|FG001|COMPLETED|Overall Study||28||
59527071|NCT00117962|75622620|FG000|NOT COMPLETED|Overall Study||22||
59527072|NCT00117962|75622621|FG001|NOT COMPLETED|Overall Study||25||
59527073|NCT01109069|75622627|FG000|STARTED|Overall Study||199||
59527074|NCT01109069|75622627|FG000|COMPLETED|Overall Study||106||
59527075|NCT01109069|75622627|FG000|NOT COMPLETED|Overall Study||93||
59527076|NCT00118274|75622636|FG000|STARTED|Overall Study||41||
59527077|NCT00118274|75622637|FG001|STARTED|Overall Study||43||
59527078|NCT00118274|75622638|FG002|STARTED|Overall Study||42||
59527079|NCT00118274|75622639|FG003|STARTED|Overall Study||44||
59527080|NCT00118274|75622636|FG000|COMPLETED|Overall Study||21||
59527081|NCT00118274|75622637|FG001|COMPLETED|Overall Study||21||
59527082|NCT00118274|75622638|FG002|COMPLETED|Overall Study||25||
59527083|NCT00118274|75622639|FG003|COMPLETED|Overall Study||29||
59527084|NCT00118274|75622636|FG000|NOT COMPLETED|Overall Study||20||
59527085|NCT00118274|75622637|FG001|NOT COMPLETED|Overall Study||22||
59527086|NCT00118274|75622638|FG002|NOT COMPLETED|Overall Study||17||
59527087|NCT00118274|75622639|FG003|NOT COMPLETED|Overall Study||15||
59527088|NCT01109147|75622652|FG000|STARTED|Overall Study||17||
59527089|NCT01109147|75622653|FG001|STARTED|Overall Study||14||
59527090|NCT01109147|75622654|FG002|STARTED|Overall Study||36||
59986130|NCT02750813|76101559|FG000|STARTED|Period 2, Second 14 Days of Wear||124||
59986131|NCT02750813|76101560|FG001|STARTED|Period 2, Second 14 Days of Wear||120||
59986132|NCT02750813|76101559|FG000|COMPLETED|Period 2, Second 14 Days of Wear||124||
59986133|NCT02750813|76101560|FG001|COMPLETED|Period 2, Second 14 Days of Wear||120||
59527091|NCT01109147|75622652|FG000|COMPLETED|Overall Study|2 have been excluded of the results|15||
59527092|NCT01109147|75622653|FG001|COMPLETED|Overall Study|3 have been excluded of the results|11||
59527093|NCT01109147|75622654|FG002|COMPLETED|Overall Study|10 have been excluded of the results|26||
59527094|NCT01109147|75622652|FG000|NOT COMPLETED|Overall Study||2||
59527095|NCT01109147|75622653|FG001|NOT COMPLETED|Overall Study||3||
59527096|NCT01109147|75622654|FG002|NOT COMPLETED|Overall Study||10||
59527097|NCT01109381|75622662|FG000|STARTED|Overall Study||33||
59986134|NCT02750813|76101559|FG000|NOT COMPLETED|Period 2, Second 14 Days of Wear||0||
59986135|NCT02750813|76101560|FG001|NOT COMPLETED|Period 2, Second 14 Days of Wear||0||
59986136|NCT02401347|76101569|FG000|STARTED|Overall Study||1||
59986137|NCT02401347|76101570|FG001|STARTED|Overall Study||20||
59986138|NCT02401347|76101569|FG000|COMPLETED|Overall Study||1||
59527098|NCT01109381|75622662|FG000|COMPLETED|Overall Study||31||
59527099|NCT01109381|75622662|FG000|NOT COMPLETED|Overall Study||2||
59527100|NCT01110395|75622668|FG000|STARTED|Overall Study||15||
59527101|NCT01110395|75622668|FG000|COMPLETED|Overall Study||15||
59527102|NCT01110395|75622668|FG000|NOT COMPLETED|Overall Study||0||
59986139|NCT02401347|76101570|FG001|COMPLETED|Overall Study||20||
59986140|NCT02401347|76101569|FG000|NOT COMPLETED|Overall Study||0||
59986141|NCT02401347|76101570|FG001|NOT COMPLETED|Overall Study||0||
59986142|NCT00503035|76101576|FG000|STARTED|Overall Study||47||
59986143|NCT00503035|76101576|FG000|COMPLETED|Overall Study||27||
59986144|NCT00503035|76101576|FG000|NOT COMPLETED|Overall Study||20||
59986145|NCT03137381|76101585|FG000|STARTED|Overall Study||44||
59986146|NCT03137381|76101586|FG001|STARTED|Overall Study||30||
59986147|NCT03137381|76101587|FG002|STARTED|Overall Study||38||
60074977|NCT01686633|76190228|FG002|NOT COMPLETED|Overall Study||25||
59986148|NCT03137381|76101588|FG003|STARTED|Overall Study||37||
59986149|NCT03137381|76101585|FG000|Safety Population|Overall Study||44|Safety Population included all participants who received study drug during the treatment period. Participants were analyzed according to the actual treatment received during the study.|
59986150|NCT03137381|76101586|FG001|Safety Population|Overall Study||29|Safety Population included all participants who received study drug during the treatment period. Participants were analyzed according to the actual treatment received during the study.|
59986151|NCT03137381|76101587|FG002|Safety Population|Overall Study||38|Safety Population included all participants who received study drug during the treatment period. Participants were analyzed according to the actual treatment received during the study.|
59986152|NCT03137381|76101588|FG003|Safety Population|Overall Study||36|Safety Population included all participants who received study drug during the treatment period. Participants were analyzed according to the actual treatment received during the study.|
59986153|NCT03137381|76101585|FG000|COMPLETED|Overall Study||35||
59986154|NCT03137381|76101586|FG001|COMPLETED|Overall Study||23||
59986155|NCT03137381|76101587|FG002|COMPLETED|Overall Study||30||
59986156|NCT03137381|76101588|FG003|COMPLETED|Overall Study||36||
59986157|NCT03137381|76101585|FG000|NOT COMPLETED|Overall Study||9||
59986158|NCT03137381|76101586|FG001|NOT COMPLETED|Overall Study||7||
59986159|NCT03137381|76101587|FG002|NOT COMPLETED|Overall Study||8||
59986160|NCT03137381|76101588|FG003|NOT COMPLETED|Overall Study||1||
59986161|NCT03926117|76101602|FG000|STARTED|Overall Study||66||
59986162|NCT03926117|76101603|FG001|STARTED|Overall Study||66||
59986163|NCT03926117|76101604|FG002|STARTED|Overall Study||66||
59986164|NCT03926117|76101605|FG003|STARTED|Overall Study||66||
59986165|NCT03926117|76101602|FG000|Intent-to-treat Analysis Population|Overall Study||66||
59986166|NCT03926117|76101603|FG001|Intent-to-treat Analysis Population|Overall Study||66||
59986167|NCT03926117|76101604|FG002|Intent-to-treat Analysis Population|Overall Study||66||
59986168|NCT03926117|76101605|FG003|Intent-to-treat Analysis Population|Overall Study||66||
59986169|NCT03926117|76101602|FG000|Safety Analysis Population|Overall Study||65||
59986170|NCT03926117|76101603|FG001|Safety Analysis Population|Overall Study||65||
59986171|NCT03926117|76101604|FG002|Safety Analysis Population|Overall Study||66||
59986172|NCT03926117|76101605|FG003|Safety Analysis Population|Overall Study||65||
59986173|NCT03926117|76101602|FG000|Treated|Overall Study||65||
59986174|NCT03926117|76101603|FG001|Treated|Overall Study||65||
59986175|NCT03926117|76101604|FG002|Treated|Overall Study||66||
59986176|NCT03926117|76101605|FG003|Treated|Overall Study||65||
59986177|NCT03926117|76101602|FG000|COMPLETED|Overall Study||60||
59986178|NCT03926117|76101603|FG001|COMPLETED|Overall Study||57||
59986179|NCT03926117|76101604|FG002|COMPLETED|Overall Study||60||
59986180|NCT03926117|76101605|FG003|COMPLETED|Overall Study||59||
59986181|NCT03926117|76101602|FG000|NOT COMPLETED|Overall Study||6||
59986182|NCT03926117|76101603|FG001|NOT COMPLETED|Overall Study||9||
59986183|NCT03926117|76101604|FG002|NOT COMPLETED|Overall Study||6||
59986184|NCT03926117|76101605|FG003|NOT COMPLETED|Overall Study||7||
59986185|NCT03885011|76101618|FG000|STARTED|Overall Study||53||
59986186|NCT03885011|76101619|FG001|STARTED|Overall Study||55||
59986187|NCT03885011|76101620|FG002|STARTED|Overall Study||58||
59986188|NCT03885011|76101618|FG000|COMPLETED|Overall Study||52||
59986189|NCT03885011|76101619|FG001|COMPLETED|Overall Study||52||
59986190|NCT03885011|76101620|FG002|COMPLETED|Overall Study||57||
59986191|NCT03885011|76101618|FG000|NOT COMPLETED|Overall Study||1||
59986192|NCT03885011|76101619|FG001|NOT COMPLETED|Overall Study||3||
59986193|NCT03885011|76101620|FG002|NOT COMPLETED|Overall Study||1||
59986194|NCT03796637|76101628|FG000|STARTED|Overall Study||6||
59986195|NCT03796637|76101628|FG000|COMPLETED|Overall Study||6||
59986196|NCT03796637|76101628|FG000|NOT COMPLETED|Overall Study||0||
59986197|NCT02750501|76101632|FG000|STARTED|Overall Study||44||
59986198|NCT02750501|76101632|FG000|Enrolled|Overall Study||44||
59986199|NCT02750501|76101632|FG000|Treated|Overall Study||39||
59986200|NCT02750501|76101632|FG000|COMPLETED|Overall Study||36||
59986201|NCT02750501|76101632|FG000|NOT COMPLETED|Overall Study||8||
59986202|NCT03676751|76101642|FG000|STARTED|Overall Study||230||
59986203|NCT03676751|76101643|FG001|STARTED|Overall Study||220||
59986204|NCT03676751|76101642|FG000|Received Allocated Treatment|Overall Study||227||
59986205|NCT03676751|76101643|FG001|Received Allocated Treatment|Overall Study||214||
59986206|NCT03676751|76101642|FG000|Week 14 Follow up|Overall Study||218||
59986207|NCT03676751|76101643|FG001|Week 14 Follow up|Overall Study||203||
59986208|NCT03676751|76101642|FG000|COMPLETED|Overall Study||200|Month 6|
60074978|NCT01685697|76190238|FG000|STARTED|Overall Study||31||
60074979|NCT01685697|76190239|FG001|STARTED|Overall Study||31||
59986209|NCT03676751|76101643|FG001|COMPLETED|Overall Study||189|Month 6|
59986210|NCT03676751|76101642|FG000|NOT COMPLETED|Overall Study||30||
59986211|NCT03676751|76101643|FG001|NOT COMPLETED|Overall Study||31||
59986212|NCT03648827|76101649|FG000|STARTED|Overall Study||20||
59986213|NCT03648827|76101649|FG000|Received at Least 1 Dose of Study Drug|Overall Study||20||
59986214|NCT03648827|76101649|FG000|COMPLETED|Overall Study||20||
59986215|NCT03648827|76101649|FG000|NOT COMPLETED|Overall Study||0||
59986216|NCT01337297|76101655|FG000|STARTED|Overall Study||11||
59986217|NCT01337297|76101656|FG001|STARTED|Overall Study||9||
59986218|NCT01337297|76101655|FG000|COMPLETED|Overall Study||6||
59986219|NCT01337297|76101656|FG001|COMPLETED|Overall Study||3||
59986220|NCT01337297|76101655|FG000|NOT COMPLETED|Overall Study||5||
59986221|NCT01337297|76101656|FG001|NOT COMPLETED|Overall Study||6||
59986222|NCT02302963|76101664|FG000|STARTED|Overall Study||25||
59986223|NCT02302963|76101665|FG001|STARTED|Overall Study||24||
59986224|NCT02302963|76101664|FG000|COMPLETED|Overall Study||22||
59986225|NCT02302963|76101665|FG001|COMPLETED|Overall Study||22||
59986226|NCT02302963|76101664|FG000|NOT COMPLETED|Overall Study||3||
59986227|NCT02302963|76101665|FG001|NOT COMPLETED|Overall Study||2||
59986228|NCT04616573|76101674|FG000|STARTED|Overall Study||1||
59986229|NCT04616573|76101675|FG001|STARTED|Overall Study||0||
59986230|NCT04616573|76101676|FG002|STARTED|Overall Study||0||
59986231|NCT04616573|76101674|FG000|COMPLETED|Overall Study||0||
59986232|NCT04616573|76101675|FG001|COMPLETED|Overall Study||0||
59986233|NCT04616573|76101676|FG002|COMPLETED|Overall Study||0||
59986234|NCT04616573|76101674|FG000|NOT COMPLETED|Overall Study||1||
59986235|NCT04616573|76101675|FG001|NOT COMPLETED|Overall Study||0||
59986236|NCT04616573|76101676|FG002|NOT COMPLETED|Overall Study||0||
59986237|NCT03507439|76101686|FG000|STARTED|Overall Study||14||
59986238|NCT03507439|76101687|FG001|STARTED|Overall Study||13||
59986239|NCT03507439|76101686|FG000|COMPLETED|Overall Study||10||
59986240|NCT03507439|76101687|FG001|COMPLETED|Overall Study||11||
59986241|NCT03507439|76101686|FG000|NOT COMPLETED|Overall Study||4||
59986242|NCT03507439|76101687|FG001|NOT COMPLETED|Overall Study||2||
59986243|NCT03507127|76101695|FG000|STARTED|Overall Study||3||
59986244|NCT03507127|76101696|FG001|STARTED|Overall Study||2||
59986245|NCT03507127|76101695|FG000|COMPLETED|Overall Study||1||
59986246|NCT03507127|76101696|FG001|COMPLETED|Overall Study||1||
59986247|NCT03507127|76101695|FG000|NOT COMPLETED|Overall Study||2||
59986248|NCT03507127|76101696|FG001|NOT COMPLETED|Overall Study||1||
59986249|NCT03064113|76101706|FG000|STARTED|Intervention 1 (2 Days)||8||
59986250|NCT03064113|76101707|FG001|STARTED|Intervention 1 (2 Days)||8||
59986251|NCT03064113|76101708|FG002|STARTED|Intervention 1 (2 Days)||8||
59986252|NCT03064113|76101709|FG003|STARTED|Intervention 1 (2 Days)||8||
59986253|NCT03064113|76101706|FG000|COMPLETED|Intervention 1 (2 Days)||8||
59986254|NCT03064113|76101707|FG001|COMPLETED|Intervention 1 (2 Days)||8||
59986255|NCT03064113|76101708|FG002|COMPLETED|Intervention 1 (2 Days)||8||
59986256|NCT03064113|76101709|FG003|COMPLETED|Intervention 1 (2 Days)||8||
59986257|NCT03064113|76101706|FG000|NOT COMPLETED|Intervention 1 (2 Days)||0||
59986258|NCT03064113|76101707|FG001|NOT COMPLETED|Intervention 1 (2 Days)||0||
59986259|NCT03064113|76101708|FG002|NOT COMPLETED|Intervention 1 (2 Days)||0||
59986260|NCT03064113|76101709|FG003|NOT COMPLETED|Intervention 1 (2 Days)||0||
59986261|NCT03064113|76101706|FG000|STARTED|Washout (7 Days)||8||
59986262|NCT03064113|76101707|FG001|STARTED|Washout (7 Days)||8||
59986263|NCT03064113|76101708|FG002|STARTED|Washout (7 Days)||8||
59986264|NCT03064113|76101709|FG003|STARTED|Washout (7 Days)||8||
59986265|NCT03064113|76101706|FG000|COMPLETED|Washout (7 Days)||8||
59986266|NCT03064113|76101707|FG001|COMPLETED|Washout (7 Days)||8||
59986267|NCT03064113|76101708|FG002|COMPLETED|Washout (7 Days)||8||
59986268|NCT03064113|76101709|FG003|COMPLETED|Washout (7 Days)||8||
59986269|NCT03064113|76101706|FG000|NOT COMPLETED|Washout (7 Days)||0||
59986270|NCT03064113|76101707|FG001|NOT COMPLETED|Washout (7 Days)||0||
59986271|NCT03064113|76101708|FG002|NOT COMPLETED|Washout (7 Days)||0||
59986272|NCT03064113|76101709|FG003|NOT COMPLETED|Washout (7 Days)||0||
59986273|NCT03064113|76101706|FG000|STARTED|Intervention 2 (2 Days)||8||
59986274|NCT03064113|76101707|FG001|STARTED|Intervention 2 (2 Days)||8||
59986275|NCT03064113|76101708|FG002|STARTED|Intervention 2 (2 Days)||8||
59986276|NCT03064113|76101709|FG003|STARTED|Intervention 2 (2 Days)||8||
59986277|NCT03064113|76101706|FG000|COMPLETED|Intervention 2 (2 Days)||8||
59986278|NCT03064113|76101707|FG001|COMPLETED|Intervention 2 (2 Days)||8||
59986279|NCT03064113|76101708|FG002|COMPLETED|Intervention 2 (2 Days)||8||
59986280|NCT03064113|76101709|FG003|COMPLETED|Intervention 2 (2 Days)||8||
59986281|NCT03064113|76101706|FG000|NOT COMPLETED|Intervention 2 (2 Days)||0||
59986282|NCT03064113|76101707|FG001|NOT COMPLETED|Intervention 2 (2 Days)||0||
59986283|NCT03064113|76101708|FG002|NOT COMPLETED|Intervention 2 (2 Days)||0||
59986284|NCT03064113|76101709|FG003|NOT COMPLETED|Intervention 2 (2 Days)||0||
59986285|NCT03064113|76101706|FG000|STARTED|Washout (7 Days)||8||
59986286|NCT03064113|76101707|FG001|STARTED|Washout (7 Days)||8||
59986287|NCT03064113|76101708|FG002|STARTED|Washout (7 Days)||8||
59986288|NCT03064113|76101709|FG003|STARTED|Washout (7 Days)||8||
59986289|NCT03064113|76101706|FG000|COMPLETED|Washout (7 Days)||8||
59986290|NCT03064113|76101707|FG001|COMPLETED|Washout (7 Days)||8||
59986291|NCT03064113|76101708|FG002|COMPLETED|Washout (7 Days)||8||
59986292|NCT03064113|76101709|FG003|COMPLETED|Washout (7 Days)||8||
59986293|NCT03064113|76101706|FG000|NOT COMPLETED|Washout (7 Days)||0||
59986294|NCT03064113|76101707|FG001|NOT COMPLETED|Washout (7 Days)||0||
59986295|NCT03064113|76101708|FG002|NOT COMPLETED|Washout (7 Days)||0||
59986296|NCT03064113|76101709|FG003|NOT COMPLETED|Washout (7 Days)||0||
59986297|NCT03064113|76101706|FG000|STARTED|Intervention 3 (2 Days)||8||
59986298|NCT03064113|76101707|FG001|STARTED|Intervention 3 (2 Days)||8||
59986299|NCT03064113|76101708|FG002|STARTED|Intervention 3 (2 Days)||8||
59986300|NCT03064113|76101709|FG003|STARTED|Intervention 3 (2 Days)||8||
59986301|NCT03064113|76101706|FG000|COMPLETED|Intervention 3 (2 Days)||8||
59986302|NCT03064113|76101707|FG001|COMPLETED|Intervention 3 (2 Days)||8||
59986303|NCT03064113|76101708|FG002|COMPLETED|Intervention 3 (2 Days)||8||
59986304|NCT03064113|76101709|FG003|COMPLETED|Intervention 3 (2 Days)||8||
59986305|NCT03064113|76101706|FG000|NOT COMPLETED|Intervention 3 (2 Days)||0||
59986306|NCT03064113|76101707|FG001|NOT COMPLETED|Intervention 3 (2 Days)||0||
59986307|NCT03064113|76101708|FG002|NOT COMPLETED|Intervention 3 (2 Days)||0||
59986308|NCT03064113|76101709|FG003|NOT COMPLETED|Intervention 3 (2 Days)||0||
59986309|NCT03064113|76101706|FG000|STARTED|Washout (7 Days)||8||
59986310|NCT03064113|76101707|FG001|STARTED|Washout (7 Days)||8||
59986311|NCT03064113|76101708|FG002|STARTED|Washout (7 Days)||8||
59986312|NCT03064113|76101709|FG003|STARTED|Washout (7 Days)||8||
59986313|NCT03064113|76101706|FG000|COMPLETED|Washout (7 Days)||8||
59986314|NCT03064113|76101707|FG001|COMPLETED|Washout (7 Days)||8||
59986315|NCT03064113|76101708|FG002|COMPLETED|Washout (7 Days)||8||
59986316|NCT03064113|76101709|FG003|COMPLETED|Washout (7 Days)||8||
59986317|NCT03064113|76101706|FG000|NOT COMPLETED|Washout (7 Days)||0||
59986318|NCT03064113|76101707|FG001|NOT COMPLETED|Washout (7 Days)||0||
59986319|NCT03064113|76101708|FG002|NOT COMPLETED|Washout (7 Days)||0||
59986320|NCT03064113|76101709|FG003|NOT COMPLETED|Washout (7 Days)||0||
59986321|NCT03064113|76101706|FG000|STARTED|Intervention 4 (2 Days)||8||
59986322|NCT03064113|76101707|FG001|STARTED|Intervention 4 (2 Days)||8||
59986323|NCT03064113|76101708|FG002|STARTED|Intervention 4 (2 Days)||8||
59986324|NCT03064113|76101709|FG003|STARTED|Intervention 4 (2 Days)||8||
59986325|NCT03064113|76101706|FG000|COMPLETED|Intervention 4 (2 Days)||8||
59986326|NCT03064113|76101707|FG001|COMPLETED|Intervention 4 (2 Days)||8||
59986327|NCT03064113|76101708|FG002|COMPLETED|Intervention 4 (2 Days)||8||
59986328|NCT03064113|76101709|FG003|COMPLETED|Intervention 4 (2 Days)||8||
59986329|NCT03064113|76101706|FG000|NOT COMPLETED|Intervention 4 (2 Days)||0||
59986330|NCT03064113|76101707|FG001|NOT COMPLETED|Intervention 4 (2 Days)||0||
59986331|NCT03064113|76101708|FG002|NOT COMPLETED|Intervention 4 (2 Days)||0||
59986332|NCT03064113|76101709|FG003|NOT COMPLETED|Intervention 4 (2 Days)||0||
59986333|NCT03064113|76101706|FG000|STARTED|Washout (7 Days)||8||
59986334|NCT03064113|76101707|FG001|STARTED|Washout (7 Days)||8||
59986335|NCT03064113|76101708|FG002|STARTED|Washout (7 Days)||8||
59986336|NCT03064113|76101709|FG003|STARTED|Washout (7 Days)||8||
59986337|NCT03064113|76101706|FG000|COMPLETED|Washout (7 Days)||8||
59986338|NCT03064113|76101707|FG001|COMPLETED|Washout (7 Days)||8||
59986339|NCT03064113|76101708|FG002|COMPLETED|Washout (7 Days)||8||
59986340|NCT03064113|76101709|FG003|COMPLETED|Washout (7 Days)||8||
59986341|NCT03064113|76101706|FG000|NOT COMPLETED|Washout (7 Days)||0||
59986342|NCT03064113|76101707|FG001|NOT COMPLETED|Washout (7 Days)||0||
59986343|NCT03064113|76101708|FG002|NOT COMPLETED|Washout (7 Days)||0||
59986344|NCT03064113|76101709|FG003|NOT COMPLETED|Washout (7 Days)||0||
59986345|NCT02322190|76101719|FG000|STARTED|Overall Study||5||
59986346|NCT02322190|76101720|FG001|STARTED|Overall Study||0||
59986347|NCT02322190|76101719|FG000|COMPLETED|Overall Study||4||
59815109|NCT00418665|75937506|FG001|Received Study Medication|Treatment Period||13||
59815110|NCT00418665|75937507|FG002|Received Study Medication|Treatment Period||13||
59815111|NCT00418665|75937505|FG000|COMPLETED|Treatment Period||7||
59815112|NCT00418665|75937506|FG001|COMPLETED|Treatment Period||8||
59815113|NCT00418665|75937507|FG002|COMPLETED|Treatment Period||9||
59815114|NCT00418665|75937505|FG000|NOT COMPLETED|Treatment Period||5||
59815115|NCT00418665|75937506|FG001|NOT COMPLETED|Treatment Period||6||
59815116|NCT00418665|75937507|FG002|NOT COMPLETED|Treatment Period||4||
59815117|NCT00418665|75937505|FG000|STARTED|Treatment Extension||7||
59815118|NCT00418665|75937506|FG001|STARTED|Treatment Extension||8||
59815119|NCT00418665|75937507|FG002|STARTED|Treatment Extension||9||
59815120|NCT00418665|75937505|FG000|COMPLETED|Treatment Extension||1||
59815121|NCT00418665|75937506|FG001|COMPLETED|Treatment Extension||4||
59815122|NCT00418665|75937507|FG002|COMPLETED|Treatment Extension||7||
59815123|NCT00418665|75937505|FG000|NOT COMPLETED|Treatment Extension||6||
59815124|NCT00418665|75937506|FG001|NOT COMPLETED|Treatment Extension||4||
59815125|NCT00418665|75937507|FG002|NOT COMPLETED|Treatment Extension||2||
59815126|NCT00432237|75937519|FG000|STARTED|Overall Study|1 patient in the MK0974 50 mg group was treated but withdrew consent.|244||
59986348|NCT02322190|76101720|FG001|COMPLETED|Overall Study||0||
59986349|NCT02322190|76101719|FG000|NOT COMPLETED|Overall Study||1||
59986350|NCT02322190|76101720|FG001|NOT COMPLETED|Overall Study||0||
59986351|NCT03790683|76101727|FG000|STARTED|Overall Study||14||
59986352|NCT03790683|76101728|FG001|STARTED|Overall Study||14||
59986353|NCT03790683|76101727|FG000|COMPLETED|Overall Study||14||
59815127|NCT00432237|75937520|FG001|STARTED|Overall Study||485||
59815128|NCT00432237|75937521|FG002|STARTED|Overall Study|1 patient in the MK0974 300 mg group was treated but withdrew consent.|484||
59815129|NCT00432237|75937522|FG003|STARTED|Overall Study||490||
59986354|NCT03790683|76101728|FG001|COMPLETED|Overall Study||14||
59986355|NCT03790683|76101727|FG000|NOT COMPLETED|Overall Study||0||
59986356|NCT03790683|76101728|FG001|NOT COMPLETED|Overall Study||0||
59986357|NCT02321800|76101736|FG000|STARTED|Overall Study||303||
59986358|NCT02321800|76101737|FG001|STARTED|Overall Study||149||
59986359|NCT02321800|76101736|FG000|Received Study Drug|Overall Study||300||
59986360|NCT02321800|76101737|FG001|Received Study Drug|Overall Study||148||
59986361|NCT02321800|76101736|FG000|COMPLETED|Overall Study||283||
59986362|NCT02321800|76101737|FG001|COMPLETED|Overall Study||138||
59815130|NCT00432237|75937519|FG000|Completed--With Data|Overall Study||176||
59986363|NCT02321800|76101736|FG000|NOT COMPLETED|Overall Study||20||
59986364|NCT02321800|76101737|FG001|NOT COMPLETED|Overall Study||11||
59986365|NCT04097223|76101743|FG000|STARTED|Overall Study||17464||
59986366|NCT04097223|76101743|FG000|COMPLETED|Overall Study||17464||
59986367|NCT04097223|76101743|FG000|NOT COMPLETED|Overall Study||0||
59986368|NCT02292784|76101783|FG000|STARTED|Overall Study||5||
59986369|NCT02292784|76101784|FG001|STARTED|Overall Study||44||
59986370|NCT02292784|76101785|FG002|STARTED|Overall Study||49||
59986371|NCT02292784|76101783|FG000|COMPLETED|Overall Study||4||
59986372|NCT02292784|76101784|FG001|COMPLETED|Overall Study||24||
59986373|NCT02292784|76101785|FG002|COMPLETED|Overall Study||28||
59986374|NCT02292784|76101783|FG000|NOT COMPLETED|Overall Study||1||
59986375|NCT02292784|76101784|FG001|NOT COMPLETED|Overall Study||20||
59986376|NCT02292784|76101785|FG002|NOT COMPLETED|Overall Study||21||
59986377|NCT02320396|76101795|FG000|STARTED|Overall Study||224||
59986378|NCT02320396|76101796|FG001|STARTED|Overall Study||225||
59986379|NCT02320396|76101795|FG000|Treated (Full Analysis Set)|Overall Study||223||
59986380|NCT02320396|76101796|FG001|Treated (Full Analysis Set)|Overall Study||225||
59986381|NCT02320396|76101795|FG000|COMPLETED|Overall Study||220||
59986382|NCT02320396|76101796|FG001|COMPLETED|Overall Study||221||
59986383|NCT02320396|76101795|FG000|NOT COMPLETED|Overall Study||4||
59986384|NCT02320396|76101796|FG001|NOT COMPLETED|Overall Study||4||
59986385|NCT02292238|76101804|FG000|STARTED|Overall Study||34||
59986386|NCT02292238|76101805|FG001|STARTED|Overall Study||37||
59986387|NCT02292238|76101804|FG000|COMPLETED|Overall Study||30||
59986388|NCT02292238|76101805|FG001|COMPLETED|Overall Study||33||
59986389|NCT02292238|76101804|FG000|NOT COMPLETED|Overall Study||4||
59986390|NCT02292238|76101805|FG001|NOT COMPLETED|Overall Study||4||
59986391|NCT04344535|76101814|FG000|STARTED|Overall Study||59||
59986392|NCT04344535|76101815|FG001|STARTED|Overall Study||15||
59986393|NCT04344535|76101814|FG000|COMPLETED|Overall Study||59||
59986394|NCT04344535|76101815|FG001|COMPLETED|Overall Study||15||
59986395|NCT04344535|76101814|FG000|NOT COMPLETED|Overall Study||0||
59986396|NCT04344535|76101815|FG001|NOT COMPLETED|Overall Study||0||
59986397|NCT02922985|76101823|FG000|STARTED|Overall Study||60||
59986398|NCT02922985|76101824|FG001|STARTED|Overall Study||60||
59986399|NCT02922985|76101823|FG000|COMPLETED|Overall Study||60||
59986400|NCT02922985|76101824|FG001|COMPLETED|Overall Study||60||
59986401|NCT02922985|76101823|FG000|NOT COMPLETED|Overall Study||0||
59986402|NCT02922985|76101824|FG001|NOT COMPLETED|Overall Study||0||
59986403|NCT02234843|76101842|FG000|STARTED|Overall Study||184||
59986404|NCT02234843|76101843|FG001|STARTED|Overall Study||67||
59986405|NCT02234843|76101844|FG002|STARTED|Overall Study||47||
59986406|NCT02234843|76101845|FG003|STARTED|Overall Study||21||
59986407|NCT02234843|76101846|FG004|STARTED|Overall Study||16||
59986408|NCT02234843|76101847|FG005|STARTED|Overall Study||92||
59986409|NCT02234843|76101848|FG006|STARTED|Overall Study||34||
59986410|NCT02234843|76101849|FG007|STARTED|Overall Study||22||
59986411|NCT02234843|76101850|FG008|STARTED|Overall Study||9||
59986412|NCT02234843|76101851|FG009|STARTED|Overall Study||8||
59986413|NCT02234843|76101842|FG000|COMPLETED|Overall Study||162||
59986414|NCT02234843|76101843|FG001|COMPLETED|Overall Study||61||
59986415|NCT02234843|76101844|FG002|COMPLETED|Overall Study||44||
59986416|NCT02234843|76101845|FG003|COMPLETED|Overall Study||16||
59986417|NCT02234843|76101846|FG004|COMPLETED|Overall Study||14||
59986418|NCT02234843|76101847|FG005|COMPLETED|Overall Study||79||
59986419|NCT02234843|76101848|FG006|COMPLETED|Overall Study||32||
59986420|NCT02234843|76101849|FG007|COMPLETED|Overall Study||20||
59986421|NCT02234843|76101850|FG008|COMPLETED|Overall Study||8||
59986422|NCT02234843|76101851|FG009|COMPLETED|Overall Study||8||
59986423|NCT02234843|76101842|FG000|NOT COMPLETED|Overall Study||22||
59986424|NCT02234843|76101843|FG001|NOT COMPLETED|Overall Study||6||
59986425|NCT02234843|76101844|FG002|NOT COMPLETED|Overall Study||3||
59986426|NCT02234843|76101845|FG003|NOT COMPLETED|Overall Study||5||
59986427|NCT02234843|76101846|FG004|NOT COMPLETED|Overall Study||2||
59986428|NCT02234843|76101847|FG005|NOT COMPLETED|Overall Study||13||
59986429|NCT02234843|76101848|FG006|NOT COMPLETED|Overall Study||2||
59986430|NCT02234843|76101849|FG007|NOT COMPLETED|Overall Study||2||
59986431|NCT02234843|76101850|FG008|NOT COMPLETED|Overall Study||1||
59986432|NCT02234843|76101851|FG009|NOT COMPLETED|Overall Study||0||
59986433|NCT02740231|76101888|FG000|STARTED|Overall Study||41||
59986434|NCT02740231|76101889|FG001|STARTED|Overall Study||41||
59986435|NCT02740231|76101890|FG002|STARTED|Overall Study||41||
59986436|NCT02740231|76101891|FG003|STARTED|Overall Study||41||
59986437|NCT02740231|76101888|FG000|COMPLETED|Overall Study||39||
59986438|NCT02740231|76101889|FG001|COMPLETED|Overall Study||35||
59986439|NCT02740231|76101890|FG002|COMPLETED|Overall Study||40||
59986440|NCT02740231|76101891|FG003|COMPLETED|Overall Study||33||
59986441|NCT02740231|76101888|FG000|NOT COMPLETED|Overall Study||2||
59986442|NCT02740231|76101889|FG001|NOT COMPLETED|Overall Study||6||
59986443|NCT02740231|76101890|FG002|NOT COMPLETED|Overall Study||1||
59986444|NCT02740231|76101891|FG003|NOT COMPLETED|Overall Study||8||
59986445|NCT02750345|76101901|FG000|STARTED|Intervention 1||4||
59986446|NCT02750345|76101902|FG001|STARTED|Intervention 1||4||
59986447|NCT02750345|76101903|FG002|STARTED|Intervention 1||4||
59986448|NCT02750345|76101904|FG003|STARTED|Intervention 1||4||
59986449|NCT02750345|76101905|FG004|STARTED|Intervention 1||4||
59986450|NCT02750345|76101906|FG005|STARTED|Intervention 1||4||
59986451|NCT02750345|76101901|FG000|COMPLETED|Intervention 1||4||
59986452|NCT02750345|76101902|FG001|COMPLETED|Intervention 1||4||
59986453|NCT02750345|76101903|FG002|COMPLETED|Intervention 1||4||
59986454|NCT02750345|76101904|FG003|COMPLETED|Intervention 1||4||
59986455|NCT02750345|76101905|FG004|COMPLETED|Intervention 1||3||
59986456|NCT02750345|76101906|FG005|COMPLETED|Intervention 1||4||
59986457|NCT02750345|76101901|FG000|NOT COMPLETED|Intervention 1||0||
59986458|NCT02750345|76101902|FG001|NOT COMPLETED|Intervention 1||0||
59986459|NCT02750345|76101903|FG002|NOT COMPLETED|Intervention 1||0||
59986460|NCT02750345|76101904|FG003|NOT COMPLETED|Intervention 1||0||
59986461|NCT02750345|76101905|FG004|NOT COMPLETED|Intervention 1||1||
59986462|NCT02750345|76101906|FG005|NOT COMPLETED|Intervention 1||0||
59986463|NCT02750345|76101901|FG000|STARTED|Intervention 2||4||
59986464|NCT02750345|76101902|FG001|STARTED|Intervention 2||4||
59986465|NCT02750345|76101903|FG002|STARTED|Intervention 2||4||
59986466|NCT02750345|76101904|FG003|STARTED|Intervention 2||4||
59986467|NCT02750345|76101905|FG004|STARTED|Intervention 2||3||
59986468|NCT02750345|76101906|FG005|STARTED|Intervention 2||4||
59986469|NCT02750345|76101901|FG000|COMPLETED|Intervention 2||4||
59986470|NCT02750345|76101902|FG001|COMPLETED|Intervention 2||4||
59986471|NCT02750345|76101903|FG002|COMPLETED|Intervention 2||4||
59986472|NCT02750345|76101904|FG003|COMPLETED|Intervention 2||4||
59986473|NCT02750345|76101905|FG004|COMPLETED|Intervention 2||3||
59986474|NCT02750345|76101906|FG005|COMPLETED|Intervention 2||4||
59986475|NCT02750345|76101901|FG000|NOT COMPLETED|Intervention 2||0||
59986476|NCT02750345|76101902|FG001|NOT COMPLETED|Intervention 2||0||
59986477|NCT02750345|76101903|FG002|NOT COMPLETED|Intervention 2||0||
59986478|NCT02750345|76101904|FG003|NOT COMPLETED|Intervention 2||0||
59986479|NCT02750345|76101905|FG004|NOT COMPLETED|Intervention 2||0||
59986480|NCT02750345|76101906|FG005|NOT COMPLETED|Intervention 2||0||
59986481|NCT02750345|76101901|FG000|STARTED|Intervention 3||4||
59986482|NCT02750345|76101902|FG001|STARTED|Intervention 3||4||
59986483|NCT02750345|76101903|FG002|STARTED|Intervention 3||4||
59986484|NCT02750345|76101904|FG003|STARTED|Intervention 3||4||
59986485|NCT02750345|76101905|FG004|STARTED|Intervention 3||3||
59986486|NCT02750345|76101906|FG005|STARTED|Intervention 3||4||
59986487|NCT02750345|76101901|FG000|COMPLETED|Intervention 3||4||
59986488|NCT02750345|76101902|FG001|COMPLETED|Intervention 3||4||
59986489|NCT02750345|76101903|FG002|COMPLETED|Intervention 3||4||
59986490|NCT02750345|76101904|FG003|COMPLETED|Intervention 3||4||
59986491|NCT02750345|76101905|FG004|COMPLETED|Intervention 3||3||
59986492|NCT02750345|76101906|FG005|COMPLETED|Intervention 3||4||
59986493|NCT02750345|76101901|FG000|NOT COMPLETED|Intervention 3||0||
59986494|NCT02750345|76101902|FG001|NOT COMPLETED|Intervention 3||0||
59986495|NCT02750345|76101903|FG002|NOT COMPLETED|Intervention 3||0||
59527103|NCT00166166|75622674|FG000|STARTED|Overall Study||103||
59527104|NCT00166166|75622675|FG001|STARTED|Overall Study||71||
59527105|NCT00166166|75622674|FG000|COMPLETED|Overall Study||103||
59527106|NCT00166166|75622675|FG001|COMPLETED|Overall Study||71||
59527107|NCT00166166|75622674|FG000|NOT COMPLETED|Overall Study||0||
59527108|NCT00166166|75622675|FG001|NOT COMPLETED|Overall Study||0||
59986496|NCT02750345|76101904|FG003|NOT COMPLETED|Intervention 3||0||
59986497|NCT02750345|76101905|FG004|NOT COMPLETED|Intervention 3||0||
59527109|NCT00118352|75622697|FG000|STARTED|Overall Study||12||
59527110|NCT00118352|75622698|FG001|STARTED|Overall Study||0||
59986498|NCT02750345|76101906|FG005|NOT COMPLETED|Intervention 3||0||
59986499|NCT02640625|76101916|FG000|STARTED|Overall Study||20||
59986500|NCT02640625|76101916|FG000|COMPLETED|Overall Study||19||
59527111|NCT00118352|75622699|FG002|STARTED|Overall Study||0||
59527112|NCT00118352|75622697|FG000|COMPLETED|Overall Study||12||
59986501|NCT02640625|76101916|FG000|NOT COMPLETED|Overall Study||1||
59986502|NCT01329263|76101923|FG000|STARTED|Overall Study||15||
59986503|NCT01329263|76101924|FG001|STARTED|Overall Study||45||
59986504|NCT01329263|76101923|FG000|Completed Period 1 Own Menthol|Overall Study||15||
59986505|NCT01329263|76101924|FG001|Completed Period 1 Own Menthol|Overall Study||45||
59986506|NCT01329263|76101923|FG000|Completed Period 2 Own or CCrush Menthol|Overall Study||10||
59986507|NCT01329263|76101924|FG001|Completed Period 2 Own or CCrush Menthol|Overall Study||30||
59986508|NCT01329263|76101923|FG000|CompletedPer 3 Own or CCrush Non-menthol|Overall Study||10||
59986509|NCT01329263|76101924|FG001|CompletedPer 3 Own or CCrush Non-menthol|Overall Study||22||
59986510|NCT01329263|76101923|FG000|COMPLETED|Overall Study||10||
59986511|NCT01329263|76101924|FG001|COMPLETED|Overall Study||22||
59986512|NCT01329263|76101923|FG000|NOT COMPLETED|Overall Study||5||
59986513|NCT01329263|76101924|FG001|NOT COMPLETED|Overall Study||23||
59527113|NCT00118352|75622698|FG001|COMPLETED|Overall Study||0||
59527114|NCT00118352|75622699|FG002|COMPLETED|Overall Study||0||
59527115|NCT00118352|75622697|FG000|NOT COMPLETED|Overall Study||0||
59986514|NCT02474329|76101932|FG000|STARTED|Overall Study|Participants (People with Parkinson's Disease) who signed a consent form.|304||
59986515|NCT02474329|76101932|FG000|COMPLETED|Overall Study|Participants (People with Parkinson's Disease) who contributed data for 13 weeks.|291||
59986516|NCT02474329|76101932|FG000|NOT COMPLETED|Overall Study||13||
59986517|NCT01388491|76101939|FG000|STARTED|Overall Study|number randomized|150||
59986518|NCT01388491|76101940|FG001|STARTED|Overall Study||143||
59986519|NCT01388491|76101939|FG000|Safety Population|Overall Study|Safety: all randomized participants who took 1 or more doses of study drug|145||
59986520|NCT01388491|76101940|FG001|Safety Population|Overall Study||142||
59986521|NCT01388491|76101939|FG000|Intent-to-Treat (ITT) Population|Overall Study|ITT:participants in safety population with baseline (BL) + ≥1 post-BL prothrombin fragment 1+2 value|140||
59986522|NCT01388491|76101940|FG001|Intent-to-Treat (ITT) Population|Overall Study||136||
59986523|NCT01388491|76101939|FG000|Per Protocol (PP) Population|Overall Study|PP: all data from ITT participants obtained prior to any major protocol violations|125||
59986524|NCT01388491|76101940|FG001|Per Protocol (PP) Population|Overall Study||121||
59986525|NCT01388491|76101939|FG000|COMPLETED|Overall Study||116||
59986526|NCT01388491|76101940|FG001|COMPLETED|Overall Study||114||
59986527|NCT01388491|76101939|FG000|NOT COMPLETED|Overall Study||34||
59986528|NCT01388491|76101940|FG001|NOT COMPLETED|Overall Study||29||
59986529|NCT02749799|76101946|FG000|STARTED|Overall Study||45||
59986530|NCT02749799|76101946|FG000|COMPLETED|Overall Study||37||
59986531|NCT02749799|76101946|FG000|NOT COMPLETED|Overall Study||8||
59986532|NCT03253393|76101953|FG000|STARTED|First Intervention||12||
59986533|NCT03253393|76101954|FG001|STARTED|First Intervention||13||
59986534|NCT03253393|76101955|FG002|STARTED|First Intervention||0||
59986535|NCT03253393|76101953|FG000|COMPLETED|First Intervention||12||
59986536|NCT03253393|76101954|FG001|COMPLETED|First Intervention||13||
59986537|NCT03253393|76101955|FG002|COMPLETED|First Intervention||0||
59986538|NCT03253393|76101953|FG000|NOT COMPLETED|First Intervention||0||
59986539|NCT03253393|76101954|FG001|NOT COMPLETED|First Intervention||0||
59986540|NCT03253393|76101955|FG002|NOT COMPLETED|First Intervention||0||
59986541|NCT03253393|76101953|FG000|STARTED|Washout (Minimum 48 Hours)||12||
59986542|NCT03253393|76101954|FG001|STARTED|Washout (Minimum 48 Hours)||13||
59986543|NCT03253393|76101955|FG002|STARTED|Washout (Minimum 48 Hours)|Participants in this group were only assigned to one visit/intervention|0||
59986544|NCT03253393|76101953|FG000|COMPLETED|Washout (Minimum 48 Hours)||12||
59986545|NCT03253393|76101954|FG001|COMPLETED|Washout (Minimum 48 Hours)||13||
59986546|NCT03253393|76101955|FG002|COMPLETED|Washout (Minimum 48 Hours)|Participants in this group were only assigned to one visit/intervention|0||
59986547|NCT03253393|76101953|FG000|NOT COMPLETED|Washout (Minimum 48 Hours)||0||
59986548|NCT03253393|76101954|FG001|NOT COMPLETED|Washout (Minimum 48 Hours)||0||
59986549|NCT03253393|76101955|FG002|NOT COMPLETED|Washout (Minimum 48 Hours)||0||
59986550|NCT03253393|76101953|FG000|STARTED|Second Intervention||12||
59986551|NCT03253393|76101954|FG001|STARTED|Second Intervention||13||
59986552|NCT03253393|76101955|FG002|STARTED|Second Intervention|Participants in this group were only assigned to one visit/intervention|0||
59986553|NCT03253393|76101953|FG000|COMPLETED|Second Intervention||12||
59986554|NCT03253393|76101954|FG001|COMPLETED|Second Intervention||13||
59986555|NCT03253393|76101955|FG002|COMPLETED|Second Intervention|Participants in this group were only assigned to one visit/intervention|0||
59986556|NCT03253393|76101953|FG000|NOT COMPLETED|Second Intervention||0||
59986557|NCT03253393|76101954|FG001|NOT COMPLETED|Second Intervention||0||
59986558|NCT03253393|76101955|FG002|NOT COMPLETED|Second Intervention||0||
59986559|NCT03253393|76101953|FG000|STARTED|Washout (Minimum 48 Hours)||12||
59986560|NCT03253393|76101954|FG001|STARTED|Washout (Minimum 48 Hours)||13||
59986561|NCT03253393|76101955|FG002|STARTED|Washout (Minimum 48 Hours)|Participants in this group were only assigned to one visit/intervention|0||
59986562|NCT03253393|76101953|FG000|COMPLETED|Washout (Minimum 48 Hours)||6||
59986563|NCT03253393|76101954|FG001|COMPLETED|Washout (Minimum 48 Hours)||6||
59995426|NCT03016975|76111236|FG000|COMPLETED|At 5-year Follow-up||2||
59995427|NCT03016975|76111237|FG001|COMPLETED|At 5-year Follow-up||0||
59995428|NCT03016975|76111238|FG002|COMPLETED|At 5-year Follow-up||0||
59995429|NCT03016975|76111236|FG000|NOT COMPLETED|At 5-year Follow-up||0||
59995430|NCT03016975|76111237|FG001|NOT COMPLETED|At 5-year Follow-up||0||
59995431|NCT03016975|76111238|FG002|NOT COMPLETED|At 5-year Follow-up||0||
59995432|NCT02994355|76111250|FG000|STARTED|Overall Study|"Data was collected at the clinic level.~Data was collected at the clinic level."|||12
59995433|NCT02994355|76111251|FG001|STARTED|Overall Study|"Data was collected at the clinic level.~Data was collected at the clinic level."|||12
59995434|NCT02994355|76111250|FG000|COMPLETED|Overall Study|"Data was collected at the clinic level.~Data was collected at the clinic level."|||11
59995435|NCT02994355|76111251|FG001|COMPLETED|Overall Study|"Data was collected at the clinic level.~Data was collected at the clinic level."|||11
59986564|NCT03253393|76101955|FG002|COMPLETED|Washout (Minimum 48 Hours)|Participants in this group were only assigned to one visit/intervention|0||
59986565|NCT03253393|76101953|FG000|NOT COMPLETED|Washout (Minimum 48 Hours)||6||
59986566|NCT03253393|76101954|FG001|NOT COMPLETED|Washout (Minimum 48 Hours)||7||
59986567|NCT03253393|76101955|FG002|NOT COMPLETED|Washout (Minimum 48 Hours)||0||
59986568|NCT03253393|76101953|FG000|STARTED|Third Intervention||6||
59986569|NCT03253393|76101954|FG001|STARTED|Third Intervention||6||
59986570|NCT03253393|76101955|FG002|STARTED|Third Intervention|Participants in this group were only assigned to one visit/intervention|13||
59986571|NCT03253393|76101953|FG000|COMPLETED|Third Intervention||6||
59986572|NCT03253393|76101954|FG001|COMPLETED|Third Intervention||6||
59986573|NCT03253393|76101955|FG002|COMPLETED|Third Intervention|Participants in this group were only assigned to one visit/intervention|13||
59986574|NCT03253393|76101953|FG000|NOT COMPLETED|Third Intervention||0||
59986575|NCT03253393|76101954|FG001|NOT COMPLETED|Third Intervention||0||
59986576|NCT03253393|76101955|FG002|NOT COMPLETED|Third Intervention||0||
59986577|NCT03128671|76101971|FG000|STARTED|Enrollment||89||
59986578|NCT03128671|76101972|FG001|STARTED|Enrollment||89||
59986579|NCT03128671|76101971|FG000|COMPLETED|Enrollment||89||
59986580|NCT03128671|76101972|FG001|COMPLETED|Enrollment||89||
59986581|NCT03128671|76101971|FG000|NOT COMPLETED|Enrollment||0||
59986582|NCT03128671|76101972|FG001|NOT COMPLETED|Enrollment||0||
59986583|NCT03128671|76101971|FG000|STARTED|Allocation||89||
59986584|NCT03128671|76101972|FG001|STARTED|Allocation||89||
59986585|NCT03128671|76101971|FG000|COMPLETED|Allocation||80||
59986586|NCT03128671|76101972|FG001|COMPLETED|Allocation||89||
59986587|NCT03128671|76101971|FG000|NOT COMPLETED|Allocation||9||
59986588|NCT03128671|76101972|FG001|NOT COMPLETED|Allocation||0||
59986589|NCT03128671|76101971|FG000|STARTED|Intervention||80||
59986590|NCT03128671|76101972|FG001|STARTED|Intervention||89||
59986591|NCT03128671|76101971|FG000|COMPLETED|Intervention||44||
59986592|NCT03128671|76101972|FG001|COMPLETED|Intervention||55||
59986593|NCT03128671|76101971|FG000|NOT COMPLETED|Intervention||36||
59986594|NCT03128671|76101972|FG001|NOT COMPLETED|Intervention||34||
59986595|NCT02925338|76101983|FG000|STARTED|Overall Study||547||
59986596|NCT02925338|76101984|FG001|STARTED|Overall Study||230||
59986597|NCT02925338|76101985|FG002|STARTED|Overall Study||142||
59986598|NCT02925338|76101986|FG003|STARTED|Overall Study||411||
59986599|NCT02925338|76101987|FG004|STARTED|Overall Study||96||
59986600|NCT02925338|76101983|FG000|Adult Population|Overall Study||530||
59986601|NCT02925338|76101984|FG001|Adult Population|Overall Study||221||
59986602|NCT02925338|76101985|FG002|Adult Population|Overall Study||142||
59986603|NCT02925338|76101986|FG003|Adult Population|Overall Study||411||
59986604|NCT02925338|76101987|FG004|Adult Population|Overall Study||96||
59986605|NCT02925338|76101983|FG000|Pediatric Population|Overall Study||17||
59986606|NCT02925338|76101984|FG001|Pediatric Population|Overall Study||9||
59986607|NCT02925338|76101985|FG002|Pediatric Population|Overall Study||0||
59986608|NCT02925338|76101986|FG003|Pediatric Population|Overall Study||0||
59986609|NCT02925338|76101987|FG004|Pediatric Population|Overall Study||0||
60074980|NCT01685697|76190238|FG000|COMPLETED|Overall Study||28||
60074981|NCT01685697|76190239|FG001|COMPLETED|Overall Study||28||
59986610|NCT02925338|76101983|FG000|COMPLETED|Overall Study||321||
59986611|NCT02925338|76101984|FG001|COMPLETED|Overall Study||119||
59986612|NCT02925338|76101985|FG002|COMPLETED|Overall Study||78||
59986613|NCT02925338|76101986|FG003|COMPLETED|Overall Study||251||
59986614|NCT02925338|76101987|FG004|COMPLETED|Overall Study||66||
59986615|NCT02925338|76101983|FG000|NOT COMPLETED|Overall Study||226||
59986616|NCT02925338|76101984|FG001|NOT COMPLETED|Overall Study||111||
59986617|NCT02925338|76101985|FG002|NOT COMPLETED|Overall Study||64||
59986618|NCT02925338|76101986|FG003|NOT COMPLETED|Overall Study||160||
59986619|NCT02925338|76101987|FG004|NOT COMPLETED|Overall Study||30||
59986620|NCT02543528|76102005|FG000|STARTED|Adaptation Period||0|168|
59986621|NCT02543528|76102006|FG001|STARTED|Adaptation Period||0|168|
60074982|NCT01685697|76190238|FG000|NOT COMPLETED|Overall Study||3||
59986622|NCT02543528|76102007|FG002|STARTED|Adaptation Period||0|168|
59986623|NCT02543528|76102008|FG003|STARTED|Adaptation Period||0|168|
59986624|NCT02543528|76102009|FG004|STARTED|Adaptation Period||168|168|
59986625|NCT02543528|76102005|FG000|COMPLETED|Adaptation Period||0|142|
59986626|NCT02543528|76102006|FG001|COMPLETED|Adaptation Period||0|142|
59986627|NCT02543528|76102007|FG002|COMPLETED|Adaptation Period||0|142|
59986628|NCT02543528|76102008|FG003|COMPLETED|Adaptation Period||0|142|
59986629|NCT02543528|76102009|FG004|COMPLETED|Adaptation Period||142|142|
59986630|NCT02543528|76102005|FG000|NOT COMPLETED|Adaptation Period||0||
60074983|NCT01685697|76190239|FG001|NOT COMPLETED|Overall Study||3||
59986631|NCT02543528|76102006|FG001|NOT COMPLETED|Adaptation Period||0||
59986632|NCT02543528|76102007|FG002|NOT COMPLETED|Adaptation Period||0||
59986633|NCT02543528|76102008|FG003|NOT COMPLETED|Adaptation Period||0||
59986634|NCT02543528|76102009|FG004|NOT COMPLETED|Adaptation Period||26||
59986635|NCT02543528|76102005|FG000|STARTED|Extended Wear Period||36||
59986636|NCT02543528|76102006|FG001|STARTED|Extended Wear Period||35||
59986637|NCT02543528|76102007|FG002|STARTED|Extended Wear Period||36||
59986638|NCT02543528|76102008|FG003|STARTED|Extended Wear Period||35||
59986639|NCT02543528|76102009|FG004|STARTED|Extended Wear Period||0||
59986640|NCT02543528|76102005|FG000|COMPLETED|Extended Wear Period||8||
59986641|NCT02543528|76102006|FG001|COMPLETED|Extended Wear Period||14||
59986642|NCT02543528|76102007|FG002|COMPLETED|Extended Wear Period||13||
59986643|NCT02543528|76102008|FG003|COMPLETED|Extended Wear Period||23||
59986644|NCT02543528|76102009|FG004|COMPLETED|Extended Wear Period||0||
59986645|NCT02543528|76102005|FG000|NOT COMPLETED|Extended Wear Period||28||
59986646|NCT02543528|76102006|FG001|NOT COMPLETED|Extended Wear Period||21||
59986647|NCT02543528|76102007|FG002|NOT COMPLETED|Extended Wear Period||23||
59986648|NCT02543528|76102008|FG003|NOT COMPLETED|Extended Wear Period||12||
59986649|NCT02543528|76102009|FG004|NOT COMPLETED|Extended Wear Period||0||
59986650|NCT00156533|76102027|FG000|STARTED|Overall Study||5||
59986651|NCT00156533|76102028|FG001|STARTED|Overall Study||5||
59986652|NCT00156533|76102029|FG002|STARTED|Overall Study||5||
59986653|NCT00156533|76102030|FG003|STARTED|Overall Study||5||
59986654|NCT00156533|76102027|FG000|COMPLETED|Overall Study||3||
59986655|NCT00156533|76102028|FG001|COMPLETED|Overall Study||3||
59986656|NCT00156533|76102029|FG002|COMPLETED|Overall Study||3||
59986657|NCT00156533|76102030|FG003|COMPLETED|Overall Study||3||
59622658|NCT00538512|75734537|FG001|COMPLETED|Overall Study||783||
59622659|NCT00538512|75734538|FG002|COMPLETED|Overall Study||312||
59986658|NCT00156533|76102027|FG000|NOT COMPLETED|Overall Study||2||
59986659|NCT00156533|76102028|FG001|NOT COMPLETED|Overall Study||2||
59986660|NCT00156533|76102029|FG002|NOT COMPLETED|Overall Study||2||
59986661|NCT00156533|76102030|FG003|NOT COMPLETED|Overall Study||2||
59986662|NCT01660022|76102048|FG000|STARTED|First Sequence (7 Days)||8||
59986663|NCT01660022|76102049|FG001|STARTED|First Sequence (7 Days)||8||
59986664|NCT01660022|76102050|FG002|STARTED|First Sequence (7 Days)||8||
59986665|NCT01660022|76102051|FG003|STARTED|First Sequence (7 Days)||8||
59986666|NCT01660022|76102052|FG004|STARTED|First Sequence (7 Days)||7||
59986667|NCT01660022|76102053|FG005|STARTED|First Sequence (7 Days)||20||
59986668|NCT01660022|76102048|FG000|COMPLETED|First Sequence (7 Days)||8||
59986669|NCT01660022|76102049|FG001|COMPLETED|First Sequence (7 Days)||7||
59986670|NCT01660022|76102050|FG002|COMPLETED|First Sequence (7 Days)||8||
59986671|NCT01660022|76102051|FG003|COMPLETED|First Sequence (7 Days)||7||
59986672|NCT01660022|76102052|FG004|COMPLETED|First Sequence (7 Days)||6||
59986673|NCT01660022|76102053|FG005|COMPLETED|First Sequence (7 Days)||16||
59986674|NCT01660022|76102048|FG000|NOT COMPLETED|First Sequence (7 Days)||0||
59986675|NCT01660022|76102049|FG001|NOT COMPLETED|First Sequence (7 Days)||1||
59986676|NCT01660022|76102050|FG002|NOT COMPLETED|First Sequence (7 Days)||0||
59986677|NCT01660022|76102051|FG003|NOT COMPLETED|First Sequence (7 Days)||1||
59986678|NCT01660022|76102052|FG004|NOT COMPLETED|First Sequence (7 Days)||1||
59986679|NCT01660022|76102053|FG005|NOT COMPLETED|First Sequence (7 Days)||4||
59986680|NCT01660022|76102048|FG000|STARTED|Second Sequence (42 Days)||8||
59986681|NCT01660022|76102049|FG001|STARTED|Second Sequence (42 Days)||7||
59986682|NCT01660022|76102050|FG002|STARTED|Second Sequence (42 Days)||8||
59986683|NCT01660022|76102051|FG003|STARTED|Second Sequence (42 Days)||7||
59986684|NCT01660022|76102052|FG004|STARTED|Second Sequence (42 Days)||6||
59986685|NCT01660022|76102053|FG005|STARTED|Second Sequence (42 Days)||16||
59986686|NCT01660022|76102048|FG000|COMPLETED|Second Sequence (42 Days)||8||
59527116|NCT00118352|75622698|FG001|NOT COMPLETED|Overall Study||0||
59527117|NCT00118352|75622699|FG002|NOT COMPLETED|Overall Study||0||
59527118|NCT01111331|75622707|FG000|STARTED|Overall Study||9||
59527119|NCT01111331|75622708|FG001|STARTED|Overall Study||9||
59527120|NCT01111331|75622707|FG000|COMPLETED|Overall Study||9||
59527121|NCT01111331|75622708|FG001|COMPLETED|Overall Study||9||
59527122|NCT01111331|75622707|FG000|NOT COMPLETED|Overall Study||0||
59622660|NCT00538512|75734536|FG000|NOT COMPLETED|Overall Study||27||
59986687|NCT01660022|76102049|FG001|COMPLETED|Second Sequence (42 Days)||7||
59986688|NCT01660022|76102050|FG002|COMPLETED|Second Sequence (42 Days)||8||
59986689|NCT01660022|76102051|FG003|COMPLETED|Second Sequence (42 Days)||7||
59986690|NCT01660022|76102052|FG004|COMPLETED|Second Sequence (42 Days)||6||
59622661|NCT00538512|75734537|FG001|NOT COMPLETED|Overall Study||30||
59986691|NCT01660022|76102053|FG005|COMPLETED|Second Sequence (42 Days)||16||
59986692|NCT01660022|76102048|FG000|NOT COMPLETED|Second Sequence (42 Days)||0||
59986693|NCT01660022|76102049|FG001|NOT COMPLETED|Second Sequence (42 Days)||0||
59986694|NCT01660022|76102050|FG002|NOT COMPLETED|Second Sequence (42 Days)||0||
59527123|NCT01111331|75622708|FG001|NOT COMPLETED|Overall Study||0||
59622662|NCT00538512|75734538|FG002|NOT COMPLETED|Overall Study||13||
59986695|NCT01660022|76102051|FG003|NOT COMPLETED|Second Sequence (42 Days)||0||
59986696|NCT01660022|76102052|FG004|NOT COMPLETED|Second Sequence (42 Days)||0||
59986697|NCT01660022|76102053|FG005|NOT COMPLETED|Second Sequence (42 Days)||0||
59527124|NCT00167102|75622720|FG000|STARTED|Overall Study||23||
59622663|NCT00538824|75734546|FG000|STARTED|Overall Study||5||
59986698|NCT00156065|76102082|FG000|STARTED|Overall Study||51||
59986699|NCT00156065|76102083|FG001|STARTED|Overall Study||93||
59986700|NCT00156065|76102084|FG002|STARTED|Overall Study||43||
59986701|NCT00156065|76102082|FG000|COMPLETED|Overall Study||20||
59986702|NCT00156065|76102083|FG001|COMPLETED|Overall Study||30||
59986703|NCT00156065|76102084|FG002|COMPLETED|Overall Study||16||
59986704|NCT00156065|76102082|FG000|NOT COMPLETED|Overall Study||31||
59986705|NCT00156065|76102083|FG001|NOT COMPLETED|Overall Study||63||
59986706|NCT00156065|76102084|FG002|NOT COMPLETED|Overall Study||27||
59986707|NCT01554956|76102095|FG000|STARTED|Part 1 (Segment 1 and Segment 2)|4 Symptomatic eyes (safety & efficacy evaluation) + 4 non symptomatic eyes (safety evaluation only)|4||8
59986708|NCT01554956|76102096|FG001|STARTED|Part 1 (Segment 1 and Segment 2)|11 Symptomatic eyes (safety & efficacy evaluation) +3 non symptomatic eyes (safety evaluation only)|7||14
59986709|NCT01554956|76102097|FG002|STARTED|Part 1 (Segment 1 and Segment 2)||0||0
59986710|NCT01554956|76102095|FG000|COMPLETED|Part 1 (Segment 1 and Segment 2)|4 Symptomatic eyes (safety & efficacy evaluation) + 4 non symptomatic eyes (safety evaluation only)|4||8
59986711|NCT01554956|76102096|FG001|COMPLETED|Part 1 (Segment 1 and Segment 2)|9 Symptomatic eyes (safety & efficacy evaluation) +3 non symptomatic eyes (safety evaluation only)|6||12
59986712|NCT01554956|76102097|FG002|COMPLETED|Part 1 (Segment 1 and Segment 2)||0||0
59986713|NCT01554956|76102095|FG000|NOT COMPLETED|Part 1 (Segment 1 and Segment 2)||0||0
59986714|NCT01554956|76102096|FG001|NOT COMPLETED|Part 1 (Segment 1 and Segment 2)||1||2
59986715|NCT01554956|76102097|FG002|NOT COMPLETED|Part 1 (Segment 1 and Segment 2)||0||0
59986716|NCT01554956|76102095|FG000|STARTED|Part 2 (Continuation Segment)||4||8
59986717|NCT01554956|76102096|FG001|STARTED|Part 2 (Continuation Segment)||6||12
59986718|NCT01554956|76102097|FG002|STARTED|Part 2 (Continuation Segment)|The total number of subjects enrolled in the trial was 12. According to study design 11 subjects were enrolled in the study Part 1. One subject dropped out and a total of 10 subjects completed the Part 1. All these 10 subjects entered in the study Part 2 and one additional subject was enrolled directly in this segment. Therefore a total of 11 subjects have been treated in the study Part 2.|1||2
59986719|NCT01554956|76102095|FG000|COMPLETED|Part 2 (Continuation Segment)||2||4
59527125|NCT00167102|75622721|FG001|STARTED|Overall Study||22||
59527126|NCT00167102|75622720|FG000|COMPLETED|Overall Study||23||
59527127|NCT00167102|75622721|FG001|COMPLETED|Overall Study||22||
59527128|NCT00167102|75622720|FG000|NOT COMPLETED|Overall Study||0||
59527129|NCT00167102|75622721|FG001|NOT COMPLETED|Overall Study||0||
59527130|NCT02176031|75622729|FG000|STARTED|Overall Study||21||
59527131|NCT02176031|75622729|FG000|COMPLETED|Overall Study||9||
59527132|NCT02176031|75622729|FG000|NOT COMPLETED|Overall Study||12||
59527133|NCT02176343|75622734|FG000|STARTED|Overall Study||31||
59527134|NCT02176343|75622734|FG000|COMPLETED|Overall Study||31||
59527135|NCT02176343|75622734|FG000|NOT COMPLETED|Overall Study||0||
59527136|NCT02177201|75622740|FG000|STARTED|Overall Study||80||
59527137|NCT02177201|75622741|FG001|STARTED|Overall Study||80||
59527138|NCT02177201|75622740|FG000|COMPLETED|Overall Study||77||
59622664|NCT00538824|75734546|FG000|Progression of Disease|Overall Study||2||
59622665|NCT00538824|75734546|FG000|COMPLETED|Overall Study||5||
59622666|NCT00538824|75734546|FG000|NOT COMPLETED|Overall Study||0||
59622667|NCT00539526|75734553|FG000|STARTED|Overall Study||35||
59622668|NCT00539526|75734554|FG001|STARTED|Overall Study||33||
59622669|NCT00539526|75734555|FG002|STARTED|Overall Study||38||
59815131|NCT00432237|75937520|FG001|Completed--With Data|Overall Study||381||
59815132|NCT00432237|75937521|FG002|Completed--With Data|Overall Study||370||
59815133|NCT00432237|75937522|FG003|Completed--With Data|Overall Study||365||
59815134|NCT00432237|75937519|FG000|Completed--No Data|Overall Study|For patients in this category, diaries were collected but lost prior to data entry.|1||
59815135|NCT00432237|75937520|FG001|Completed--No Data|Overall Study|For patients in this category, diaries were collected but lost prior to data entry.|3||
59815136|NCT00432237|75937521|FG002|Completed--No Data|Overall Study|For patients in this category, diaries were collected but lost prior to data entry.|5||
59815137|NCT00432237|75937522|FG003|Completed--No Data|Overall Study|For patients in this category, diaries were collected but lost prior to data entry.|1||
59815138|NCT00432237|75937519|FG000|COMPLETED|Overall Study||177||
59815139|NCT00432237|75937520|FG001|COMPLETED|Overall Study||384||
59815140|NCT00432237|75937521|FG002|COMPLETED|Overall Study||375||
59815141|NCT00432237|75937522|FG003|COMPLETED|Overall Study||366||
59815142|NCT00432237|75937519|FG000|NOT COMPLETED|Overall Study||67||
59815143|NCT00432237|75937520|FG001|NOT COMPLETED|Overall Study||101||
59815144|NCT00432237|75937521|FG002|NOT COMPLETED|Overall Study||109||
59815145|NCT00432237|75937522|FG003|NOT COMPLETED|Overall Study||124||
59815146|NCT00531284|75937549|FG000|STARTED|Overall Study||3||
59527139|NCT02177201|75622741|FG001|COMPLETED|Overall Study||77||
59527140|NCT02177201|75622740|FG000|NOT COMPLETED|Overall Study||3||
59527141|NCT02177201|75622741|FG001|NOT COMPLETED|Overall Study||3||
59622670|NCT00539526|75734553|FG000|COMPLETED|Overall Study||32||
59622671|NCT00539526|75734554|FG001|COMPLETED|Overall Study||31||
59622672|NCT00539526|75734555|FG002|COMPLETED|Overall Study||36||
59622673|NCT00539526|75734553|FG000|NOT COMPLETED|Overall Study||3||
59622674|NCT00539526|75734554|FG001|NOT COMPLETED|Overall Study||2||
59622675|NCT00539526|75734555|FG002|NOT COMPLETED|Overall Study||2||
59622676|NCT00496860|75734566|FG000|STARTED|Overall Study||4||
59622677|NCT00496860|75734567|FG001|STARTED|Overall Study||16||
59622678|NCT00496860|75734568|FG002|STARTED|Overall Study||6||
59622679|NCT00496860|75734566|FG000|COMPLETED|Overall Study||3||
59527142|NCT01365793|75622751|FG000|STARTED|Overall Study||344||
59622680|NCT00496860|75734567|FG001|COMPLETED|Overall Study||15||
59986720|NCT01554956|76102096|FG001|COMPLETED|Part 2 (Continuation Segment)||1||2
59986721|NCT01554956|76102097|FG002|COMPLETED|Part 2 (Continuation Segment)||0||0
59622681|NCT00496860|75734568|FG002|COMPLETED|Overall Study||6||
59527143|NCT01365793|75622752|FG001|STARTED|Overall Study||351||
59986722|NCT01554956|76102095|FG000|NOT COMPLETED|Part 2 (Continuation Segment)||2||4
59986723|NCT01554956|76102096|FG001|NOT COMPLETED|Part 2 (Continuation Segment)||5||10
59986724|NCT01554956|76102097|FG002|NOT COMPLETED|Part 2 (Continuation Segment)||1||2
59986725|NCT02138786|76102118|FG000|STARTED|Overall Study||3||
59986726|NCT02138786|76102119|FG001|STARTED|Overall Study||15||
59986727|NCT02138786|76102120|FG002|STARTED|Overall Study||8||
59986728|NCT02138786|76102118|FG000|COMPLETED|Overall Study||0||
59986729|NCT02138786|76102119|FG001|COMPLETED|Overall Study||0||
59986730|NCT02138786|76102120|FG002|COMPLETED|Overall Study||0||
59986731|NCT02138786|76102118|FG000|NOT COMPLETED|Overall Study||3||
59986732|NCT02138786|76102119|FG001|NOT COMPLETED|Overall Study||15||
59986733|NCT02138786|76102120|FG002|NOT COMPLETED|Overall Study||8||
59986734|NCT02529488|76102126|FG000|STARTED|Overall Study||149||
59986735|NCT02529488|76102126|FG000|COMPLETED|Overall Study||145||
59986736|NCT02529488|76102126|FG000|NOT COMPLETED|Overall Study||4||
59986737|NCT01329419|76102134|FG000|STARTED|Overall Study||4393||
59986738|NCT01329419|76102134|FG000|COMPLETED|Overall Study||4158||
59986739|NCT01329419|76102134|FG000|NOT COMPLETED|Overall Study||235||
59986740|NCT01329341|76102139|FG000|STARTED|Overall Study||60||
59986741|NCT01329341|76102139|FG000|COMPLETED|Overall Study||16||
59986742|NCT01329341|76102139|FG000|NOT COMPLETED|Overall Study||44||
59986743|NCT02532764|76102153|FG000|STARTED|Single Ascending Dose (SAD) Cohorts||6||
59986744|NCT02532764|76102154|FG001|STARTED|Single Ascending Dose (SAD) Cohorts||6||
59986745|NCT02532764|76102155|FG002|STARTED|Single Ascending Dose (SAD) Cohorts||9||
59986746|NCT02532764|76102156|FG003|STARTED|Single Ascending Dose (SAD) Cohorts||6||
59986747|NCT02532764|76102157|FG004|STARTED|Single Ascending Dose (SAD) Cohorts||9||
59986748|NCT02532764|76102158|FG005|STARTED|Single Ascending Dose (SAD) Cohorts||0||
59986749|NCT02532764|76102159|FG006|STARTED|Single Ascending Dose (SAD) Cohorts||0||
59986750|NCT02532764|76102160|FG007|STARTED|Single Ascending Dose (SAD) Cohorts||0||
59986751|NCT02532764|76102161|FG008|STARTED|Single Ascending Dose (SAD) Cohorts||0||
59986752|NCT02532764|76102162|FG009|STARTED|Single Ascending Dose (SAD) Cohorts||0||
59986753|NCT02532764|76102153|FG000|COMPLETED|Single Ascending Dose (SAD) Cohorts||6||
59986754|NCT02532764|76102154|FG001|COMPLETED|Single Ascending Dose (SAD) Cohorts||6||
59986755|NCT02532764|76102155|FG002|COMPLETED|Single Ascending Dose (SAD) Cohorts||9||
59986756|NCT02532764|76102156|FG003|COMPLETED|Single Ascending Dose (SAD) Cohorts||6||
59986757|NCT02532764|76102157|FG004|COMPLETED|Single Ascending Dose (SAD) Cohorts||9||
59986758|NCT02532764|76102158|FG005|COMPLETED|Single Ascending Dose (SAD) Cohorts||0||
59986759|NCT02532764|76102159|FG006|COMPLETED|Single Ascending Dose (SAD) Cohorts||0||
59986760|NCT02532764|76102160|FG007|COMPLETED|Single Ascending Dose (SAD) Cohorts||0||
59986761|NCT02532764|76102161|FG008|COMPLETED|Single Ascending Dose (SAD) Cohorts||0||
59986762|NCT02532764|76102162|FG009|COMPLETED|Single Ascending Dose (SAD) Cohorts||0||
59986763|NCT02532764|76102153|FG000|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0||
59986764|NCT02532764|76102154|FG001|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0||
59986765|NCT02532764|76102155|FG002|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0||
59986766|NCT02532764|76102156|FG003|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0||
59986767|NCT02532764|76102157|FG004|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0||
59986768|NCT02532764|76102158|FG005|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0||
59986769|NCT02532764|76102159|FG006|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0||
59986770|NCT02532764|76102160|FG007|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0||
59986771|NCT02532764|76102161|FG008|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0||
59986772|NCT02532764|76102162|FG009|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0||
59986773|NCT02532764|76102153|FG000|STARTED|Multiple Ascending Dose (MAD) Cohorst||0||
59986774|NCT02532764|76102154|FG001|STARTED|Multiple Ascending Dose (MAD) Cohorst||0||
59986775|NCT02532764|76102155|FG002|STARTED|Multiple Ascending Dose (MAD) Cohorst||0||
59986776|NCT02532764|76102156|FG003|STARTED|Multiple Ascending Dose (MAD) Cohorst||0||
59986777|NCT02532764|76102157|FG004|STARTED|Multiple Ascending Dose (MAD) Cohorst||0||
59986778|NCT02532764|76102158|FG005|STARTED|Multiple Ascending Dose (MAD) Cohorst||6||
59986779|NCT02532764|76102159|FG006|STARTED|Multiple Ascending Dose (MAD) Cohorst||6||
59986780|NCT02532764|76102160|FG007|STARTED|Multiple Ascending Dose (MAD) Cohorst||7||
59986781|NCT02532764|76102161|FG008|STARTED|Multiple Ascending Dose (MAD) Cohorst||6||
60074984|NCT02395120|76190250|FG000|STARTED|Overall Study|Caregivers and Children|400|Caregivers and Children|
59986782|NCT02532764|76102162|FG009|STARTED|Multiple Ascending Dose (MAD) Cohorst||9||
60074985|NCT02395120|76190251|FG001|STARTED|Overall Study|Caregivers and Children|398|Caregivers and Children|
60074986|NCT02395120|76190252|FG002|STARTED|Overall Study|Caregivers and Children|43|Caregivers and Children|
60074987|NCT02395120|76190253|FG003|STARTED|Overall Study|Caregivers and Children|63|Caregivers and Children|
59986783|NCT02532764|76102153|FG000|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0||
59986784|NCT02532764|76102154|FG001|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0||
59986785|NCT02532764|76102155|FG002|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0||
59986786|NCT02532764|76102156|FG003|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0||
59986787|NCT02532764|76102157|FG004|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0||
60074988|NCT02395120|76190254|FG004|STARTED|Overall Study|Caregivers and Children|401|Caregivers and Children|
60074989|NCT02395120|76190250|FG000|Started-Caregivers|Overall Study||188|Caregivers (primary caregiver of family)|
59986788|NCT02532764|76102158|FG005|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||6||
59986789|NCT02532764|76102159|FG006|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||6||
59986790|NCT02532764|76102160|FG007|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||6||
59986791|NCT02532764|76102161|FG008|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||5||
59986792|NCT02532764|76102162|FG009|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||8||
59986793|NCT02532764|76102153|FG000|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0||
59986794|NCT02532764|76102154|FG001|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0||
59986795|NCT02532764|76102155|FG002|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0||
59986796|NCT02532764|76102156|FG003|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0||
59986797|NCT02532764|76102157|FG004|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0||
59986798|NCT02532764|76102158|FG005|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0||
59986799|NCT02532764|76102159|FG006|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0||
59986800|NCT02532764|76102160|FG007|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||1||
59986801|NCT02532764|76102161|FG008|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||1||
59986802|NCT02532764|76102162|FG009|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||1||
59986803|NCT02528942|76102189|FG000|STARTED|Overall Study||101||
59986804|NCT02528942|76102189|FG000|COMPLETED|Overall Study||67||
59986805|NCT02528942|76102189|FG000|NOT COMPLETED|Overall Study||34||
59986806|NCT02527148|76102195|FG000|STARTED|Overall Study||50||
59986807|NCT02527148|76102196|FG001|STARTED|Overall Study||50||
59986808|NCT02527148|76102195|FG000|COMPLETED|Overall Study||49||
59986809|NCT02527148|76102196|FG001|COMPLETED|Overall Study||50||
59986810|NCT02527148|76102195|FG000|NOT COMPLETED|Overall Study||1||
59986811|NCT02527148|76102196|FG001|NOT COMPLETED|Overall Study||0||
59986812|NCT02291614|76102215|FG000|STARTED|Overall Study||3||
59986813|NCT02291614|76102216|FG001|STARTED|Overall Study||3||
59986814|NCT02291614|76102217|FG002|STARTED|Overall Study||3||
59986815|NCT02291614|76102218|FG003|STARTED|Overall Study||5||
59986816|NCT02291614|76102219|FG004|STARTED|Overall Study||3||
59986817|NCT02291614|76102220|FG005|STARTED|Overall Study||3||
59986818|NCT02291614|76102221|FG006|STARTED|Overall Study||6||
59986819|NCT02291614|76102222|FG007|STARTED|Overall Study||3||
59986820|NCT02291614|76102223|FG008|STARTED|Overall Study||3||
59986821|NCT02291614|76102224|FG009|STARTED|Overall Study||11||
59986822|NCT02291614|76102225|FG010|STARTED|Overall Study||2||
59986823|NCT02291614|76102215|FG000|Received AMG 211|Overall Study||3||
59986824|NCT02291614|76102216|FG001|Received AMG 211|Overall Study||3||
59986825|NCT02291614|76102217|FG002|Received AMG 211|Overall Study||3||
59986826|NCT02291614|76102218|FG003|Received AMG 211|Overall Study||5||
59527144|NCT01365793|75622753|FG002|STARTED|Overall Study||345||
59986827|NCT02291614|76102219|FG004|Received AMG 211|Overall Study||3||
59986828|NCT02291614|76102220|FG005|Received AMG 211|Overall Study||3||
59986829|NCT02291614|76102221|FG006|Received AMG 211|Overall Study||6||
59986830|NCT02291614|76102222|FG007|Received AMG 211|Overall Study||3||
59986831|NCT02291614|76102223|FG008|Received AMG 211|Overall Study||3||
59986832|NCT02291614|76102224|FG009|Received AMG 211|Overall Study||10||
59986833|NCT02291614|76102225|FG010|Received AMG 211|Overall Study||2||
59986834|NCT02291614|76102215|FG000|COMPLETED|Overall Study||3||
59986835|NCT02291614|76102216|FG001|COMPLETED|Overall Study||2||
59986836|NCT02291614|76102217|FG002|COMPLETED|Overall Study||2||
59986837|NCT02291614|76102218|FG003|COMPLETED|Overall Study||4||
59986838|NCT02291614|76102219|FG004|COMPLETED|Overall Study||2||
59986839|NCT02291614|76102220|FG005|COMPLETED|Overall Study||2||
59986840|NCT02291614|76102221|FG006|COMPLETED|Overall Study||5||
59986841|NCT02291614|76102222|FG007|COMPLETED|Overall Study||2||
59986842|NCT02291614|76102223|FG008|COMPLETED|Overall Study||3||
59986843|NCT02291614|76102224|FG009|COMPLETED|Overall Study||9||
59527145|NCT01365793|75622754|FG003|STARTED|Overall Study||349||
59986844|NCT02291614|76102225|FG010|COMPLETED|Overall Study||0||
59986845|NCT02291614|76102215|FG000|NOT COMPLETED|Overall Study||0||
59986846|NCT02291614|76102216|FG001|NOT COMPLETED|Overall Study||1||
59986847|NCT02291614|76102217|FG002|NOT COMPLETED|Overall Study||1||
59986848|NCT02291614|76102218|FG003|NOT COMPLETED|Overall Study||1||
59986849|NCT02291614|76102219|FG004|NOT COMPLETED|Overall Study||1||
59986850|NCT02291614|76102220|FG005|NOT COMPLETED|Overall Study||1||
59986851|NCT02291614|76102221|FG006|NOT COMPLETED|Overall Study||1||
59527146|NCT01365793|75622751|FG000|COMPLETED|Overall Study||342||
59527147|NCT01365793|75622752|FG001|COMPLETED|Overall Study||344||
59527148|NCT01365793|75622753|FG002|COMPLETED|Overall Study||338||
59527149|NCT01365793|75622754|FG003|COMPLETED|Overall Study||347||
59527150|NCT01365793|75622751|FG000|NOT COMPLETED|Overall Study||2||
59527151|NCT01365793|75622752|FG001|NOT COMPLETED|Overall Study||7||
59527152|NCT01365793|75622753|FG002|NOT COMPLETED|Overall Study||7||
59986852|NCT02291614|76102222|FG007|NOT COMPLETED|Overall Study||1||
59986853|NCT02291614|76102223|FG008|NOT COMPLETED|Overall Study||0||
59986854|NCT02291614|76102224|FG009|NOT COMPLETED|Overall Study||2||
59986855|NCT02291614|76102225|FG010|NOT COMPLETED|Overall Study||2||
59986856|NCT02526524|76102261|FG000|STARTED|Overall Study||94||
59986857|NCT02526524|76102262|FG001|STARTED|Overall Study||95||
59986858|NCT02526524|76102263|FG002|STARTED|Overall Study||96||
59986859|NCT02526524|76102264|FG003|STARTED|Overall Study||96||
59986860|NCT02526524|76102265|FG004|STARTED|Overall Study||96||
59986861|NCT02526524|76102266|FG005|STARTED|Overall Study||94||
59986862|NCT02526524|76102261|FG000|COMPLETED|Overall Study||82||
59986863|NCT02526524|76102262|FG001|COMPLETED|Overall Study||86||
59986864|NCT02526524|76102263|FG002|COMPLETED|Overall Study||70||
59986865|NCT02526524|76102264|FG003|COMPLETED|Overall Study||89||
59986866|NCT02526524|76102265|FG004|COMPLETED|Overall Study||72||
59986867|NCT02526524|76102266|FG005|COMPLETED|Overall Study||73||
59986868|NCT02526524|76102261|FG000|NOT COMPLETED|Overall Study||12||
59986869|NCT02526524|76102262|FG001|NOT COMPLETED|Overall Study||9||
59986870|NCT02526524|76102263|FG002|NOT COMPLETED|Overall Study||26||
59986871|NCT02526524|76102264|FG003|NOT COMPLETED|Overall Study||7||
59986872|NCT02526524|76102265|FG004|NOT COMPLETED|Overall Study||24||
59986873|NCT02526524|76102266|FG005|NOT COMPLETED|Overall Study||21||
59986874|NCT02526290|76102280|FG000|STARTED|Overall Study||97||
59986875|NCT02526290|76102280|FG000|COMPLETED|Overall Study||89||
59986876|NCT02526290|76102280|FG000|NOT COMPLETED|Overall Study||8||
59986877|NCT02319148|76102287|FG000|STARTED|First Intervention Period||22||
59986878|NCT02319148|76102288|FG001|STARTED|First Intervention Period||0||
59986879|NCT02319148|76102289|FG002|STARTED|First Intervention Period||0||
59986880|NCT02319148|76102290|FG003|STARTED|First Intervention Period||0||
59986881|NCT02319148|76102287|FG000|COMPLETED|First Intervention Period||22||
59986882|NCT02319148|76102288|FG001|COMPLETED|First Intervention Period||0||
59986883|NCT02319148|76102289|FG002|COMPLETED|First Intervention Period||0||
59986884|NCT02319148|76102290|FG003|COMPLETED|First Intervention Period||0||
59986885|NCT02319148|76102287|FG000|NOT COMPLETED|First Intervention Period||0||
59986886|NCT02319148|76102288|FG001|NOT COMPLETED|First Intervention Period||0||
59986887|NCT02319148|76102289|FG002|NOT COMPLETED|First Intervention Period||0||
59986888|NCT02319148|76102290|FG003|NOT COMPLETED|First Intervention Period||0||
59986889|NCT02319148|76102287|FG000|STARTED|Washout Period 4 Days||22||
59986890|NCT02319148|76102288|FG001|STARTED|Washout Period 4 Days||0||
59986891|NCT02319148|76102289|FG002|STARTED|Washout Period 4 Days||0||
59986892|NCT02319148|76102290|FG003|STARTED|Washout Period 4 Days||0||
59986893|NCT02319148|76102287|FG000|COMPLETED|Washout Period 4 Days||22||
59986894|NCT02319148|76102288|FG001|COMPLETED|Washout Period 4 Days||0||
59986895|NCT02319148|76102289|FG002|COMPLETED|Washout Period 4 Days||0||
59986896|NCT02319148|76102290|FG003|COMPLETED|Washout Period 4 Days||0||
59986897|NCT02319148|76102287|FG000|NOT COMPLETED|Washout Period 4 Days||0||
59986898|NCT02319148|76102288|FG001|NOT COMPLETED|Washout Period 4 Days||0||
59986899|NCT02319148|76102289|FG002|NOT COMPLETED|Washout Period 4 Days||0||
59986900|NCT02319148|76102290|FG003|NOT COMPLETED|Washout Period 4 Days||0||
59986901|NCT02319148|76102287|FG000|STARTED|Second Intervention Period||0||
59986902|NCT02319148|76102288|FG001|STARTED|Second Intervention Period||7||
59986903|NCT02319148|76102289|FG002|STARTED|Second Intervention Period||7||
59986904|NCT02319148|76102290|FG003|STARTED|Second Intervention Period||8||
59986905|NCT02319148|76102287|FG000|COMPLETED|Second Intervention Period||0||
59986906|NCT02319148|76102288|FG001|COMPLETED|Second Intervention Period||6||
59986907|NCT02319148|76102289|FG002|COMPLETED|Second Intervention Period||6||
59986908|NCT02319148|76102290|FG003|COMPLETED|Second Intervention Period||6||
59986909|NCT02319148|76102287|FG000|NOT COMPLETED|Second Intervention Period||0||
59986910|NCT02319148|76102288|FG001|NOT COMPLETED|Second Intervention Period||1||
59986911|NCT02319148|76102289|FG002|NOT COMPLETED|Second Intervention Period||1||
59986912|NCT02319148|76102290|FG003|NOT COMPLETED|Second Intervention Period||2||
59986913|NCT02526212|76102311|FG000|STARTED|Overall Study||10||
59986914|NCT02526212|76102312|FG001|STARTED|Overall Study||8||
59986915|NCT02526212|76102311|FG000|COMPLETED|Overall Study||8||
59986916|NCT02526212|76102312|FG001|COMPLETED|Overall Study||7||
59986917|NCT02526212|76102311|FG000|NOT COMPLETED|Overall Study||2||
59986918|NCT02526212|76102312|FG001|NOT COMPLETED|Overall Study||1||
59994997|NCT02730871|76110831|FG001|Safety Analysis Set|Overall Study||67|All subjects who received a dose of masked investigational product|
59994998|NCT02730871|76110830|FG000|COMPLETED|Overall Study||61|All subjects who completed the treatment phase whether on study treatment or not|
59994999|NCT02730871|76110831|FG001|COMPLETED|Overall Study||67|All subjects who completed the treatment phase whether on study treatment or not|
59995000|NCT02730871|76110830|FG000|NOT COMPLETED|Overall Study||6||
59995001|NCT02730871|76110831|FG001|NOT COMPLETED|Overall Study||0||
59995002|NCT03376789|76110839|FG000|STARTED|Overall Study||108||
59995003|NCT03376789|76110840|FG001|STARTED|Overall Study||111||
59995004|NCT03376789|76110839|FG000|COMPLETED|Overall Study||103||
59995005|NCT03376789|76110840|FG001|COMPLETED|Overall Study||102||
60074990|NCT02395120|76190251|FG001|Started-Caregivers|Overall Study||188|Caregivers (primary caregiver of family)|
59995006|NCT03376789|76110839|FG000|NOT COMPLETED|Overall Study||5||
59995007|NCT03376789|76110840|FG001|NOT COMPLETED|Overall Study||9||
59995008|NCT04032093|76110856|FG000|STARTED|Overall Study||116||
59995009|NCT04032093|76110857|FG001|STARTED|Overall Study||117||
59995010|NCT04032093|76110858|FG002|STARTED|Overall Study||116||
59995011|NCT04032093|76110859|FG003|STARTED|Overall Study||115||
59995012|NCT04032093|76110860|FG004|STARTED|Overall Study||117||
59995013|NCT04032093|76110861|FG005|STARTED|Overall Study||114||
59995014|NCT04032093|76110862|FG006|STARTED|Overall Study||117||
59986919|NCT02532374|76102318|FG000|STARTED|Overall Study||16||
59986920|NCT02532374|76102318|FG000|Nicorette Inhalator (Visit 3)|Overall Study||15||
59986921|NCT02532374|76102318|FG000|P3L 50 μg/Puff (Visit 4)|Overall Study||15||
59986922|NCT02532374|76102318|FG000|P3L 80 μg/Puff (Visit 5)|Overall Study||14||
59986923|NCT02532374|76102318|FG000|P3L150 μg/Puff (Visit 6)|Overall Study||14||
59986924|NCT02532374|76102318|FG000|COMPLETED|Overall Study||14||
59527153|NCT01365793|75622754|FG003|NOT COMPLETED|Overall Study||2||
59527154|NCT01077401|75622766|FG000|STARTED|Overall Study||77||
59527155|NCT01077401|75622767|FG001|STARTED|Overall Study||75||
59527156|NCT01077401|75622766|FG000|COMPLETED|Overall Study||59||
59527157|NCT01077401|75622767|FG001|COMPLETED|Overall Study||54||
59527158|NCT01077401|75622766|FG000|NOT COMPLETED|Overall Study||18||
59527159|NCT01077401|75622767|FG001|NOT COMPLETED|Overall Study||21||
59527160|NCT01316341|75622776|FG000|STARTED|Overall Study||6||
59527161|NCT01316341|75622777|FG001|STARTED|Overall Study||9||
59527162|NCT01316341|75622778|FG002|STARTED|Overall Study||9||
59527163|NCT01316341|75622776|FG000|COMPLETED|Overall Study||6||
59527164|NCT01316341|75622777|FG001|COMPLETED|Overall Study||9||
59527165|NCT01316341|75622778|FG002|COMPLETED|Overall Study||9||
59527166|NCT01316341|75622776|FG000|NOT COMPLETED|Overall Study||0||
59527167|NCT01316341|75622777|FG001|NOT COMPLETED|Overall Study||0||
59527168|NCT01316341|75622778|FG002|NOT COMPLETED|Overall Study||0||
59527169|NCT01112735|75622797|FG000|STARTED|Overall Study||20||
59815147|NCT00531284|75937550|FG001|STARTED|Overall Study||4||
59815148|NCT00531284|75937551|FG002|STARTED|Overall Study||7||
59815149|NCT00531284|75937552|FG003|STARTED|Overall Study||65||
59815150|NCT00531284|75937553|FG004|STARTED|Overall Study||6||
59815151|NCT00531284|75937554|FG005|STARTED|Overall Study||7||
59815152|NCT00531284|75937555|FG006|STARTED|Overall Study||6||
59815153|NCT00531284|75937556|FG007|STARTED|Overall Study||10||
59815154|NCT00531284|75937557|FG008|STARTED|Overall Study||11||
59815155|NCT00531284|75937558|FG009|STARTED|Overall Study||4||
59815156|NCT00531284|75937559|FG010|STARTED|Overall Study||3||
59815157|NCT00531284|75937560|FG011|STARTED|Overall Study||24||
59815158|NCT00531284|75937561|FG012|STARTED|Overall Study||2||
59815159|NCT00531284|75937562|FG013|STARTED|Overall Study||3||
59815160|NCT00531284|75937563|FG014|STARTED|Overall Study||7||
59815161|NCT00531284|75937564|FG015|STARTED|Overall Study||14||
59815162|NCT00531284|75937565|FG016|STARTED|Overall Study||8||
59815163|NCT00531284|75937549|FG000|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of study drug|0||
59815164|NCT00531284|75937550|FG001|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of study drug|0||
59815165|NCT00531284|75937551|FG002|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of study drug|1||
59815166|NCT00531284|75937552|FG003|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of study drug|2||
59815167|NCT00531284|75937553|FG004|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0||
59815168|NCT00531284|75937554|FG005|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0||
59815169|NCT00531284|75937555|FG006|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0||
59815170|NCT00531284|75937556|FG007|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0||
59815171|NCT00531284|75937557|FG008|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0||
59815172|NCT00531284|75937558|FG009|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0||
59815173|NCT00531284|75937559|FG010|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0||
59815174|NCT00531284|75937560|FG011|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0||
59817891|NCT04488770|75940330|FG004|COMPLETED|Part 1-Cohort 2: Period 1 (Up to 5 Days)||2||
59986925|NCT02532374|76102318|FG000|NOT COMPLETED|Overall Study||2||
59986926|NCT02525744|76102330|FG000|STARTED|Period 1||6||
59986927|NCT02525744|76102331|FG001|STARTED|Period 1||6||
59986928|NCT02525744|76102332|FG002|STARTED|Period 1||6||
59986929|NCT02525744|76102333|FG003|STARTED|Period 1||6||
59986930|NCT02525744|76102330|FG000|Received at Least 1 Dose of Study Drug|Period 1||6||
59986931|NCT02525744|76102331|FG001|Received at Least 1 Dose of Study Drug|Period 1||6||
59527170|NCT01112735|75622798|FG001|STARTED|Overall Study||20||
59527171|NCT01112735|75622797|FG000|COMPLETED|Overall Study||20||
59527172|NCT01112735|75622798|FG001|COMPLETED|Overall Study||20||
59527173|NCT01112735|75622797|FG000|NOT COMPLETED|Overall Study||0||
59527174|NCT01112735|75622798|FG001|NOT COMPLETED|Overall Study||0||
59527175|NCT01113983|75622806|FG000|STARTED|Overall Study||37||
59527176|NCT01113983|75622807|FG001|STARTED|Overall Study||27||
59527177|NCT01113983|75622806|FG000|COMPLETED|Overall Study||12||
59527178|NCT01113983|75622807|FG001|COMPLETED|Overall Study||10||
59527179|NCT01113983|75622806|FG000|NOT COMPLETED|Overall Study||25||
59527180|NCT01113983|75622807|FG001|NOT COMPLETED|Overall Study||17||
59527181|NCT01034111|75622813|FG000|STARTED|Overall Study||30||
59527182|NCT01034111|75622813|FG000|COMPLETED|Overall Study||30||
59527183|NCT01034111|75622813|FG000|NOT COMPLETED|Overall Study||0||
59527184|NCT01114997|75622820|FG000|STARTED|Overall Study||11||
59527185|NCT01114997|75622821|FG001|STARTED|Overall Study||10||
59986932|NCT02525744|76102332|FG002|Received at Least 1 Dose of Study Drug|Period 1||5||
59986933|NCT02525744|76102333|FG003|Received at Least 1 Dose of Study Drug|Period 1||6||
59986934|NCT02525744|76102330|FG000|COMPLETED|Period 1||6||
59986935|NCT02525744|76102331|FG001|COMPLETED|Period 1||6||
59986936|NCT02525744|76102332|FG002|COMPLETED|Period 1||5||
59986937|NCT02525744|76102333|FG003|COMPLETED|Period 1||6||
59986938|NCT02525744|76102330|FG000|NOT COMPLETED|Period 1||0||
59986939|NCT02525744|76102331|FG001|NOT COMPLETED|Period 1||0||
59986940|NCT02525744|76102332|FG002|NOT COMPLETED|Period 1||1||
59986941|NCT02525744|76102333|FG003|NOT COMPLETED|Period 1||0||
59986942|NCT02525744|76102330|FG000|STARTED|Period 2||6||
59986943|NCT02525744|76102331|FG001|STARTED|Period 2||6||
59986944|NCT02525744|76102332|FG002|STARTED|Period 2||5||
59986945|NCT02525744|76102333|FG003|STARTED|Period 2||6||
59986946|NCT02525744|76102330|FG000|Received at Least 1 Dose of Study Drug|Period 2||6||
59986947|NCT02525744|76102331|FG001|Received at Least 1 Dose of Study Drug|Period 2||6||
59986948|NCT02525744|76102332|FG002|Received at Least 1 Dose of Study Drug|Period 2||5||
59986949|NCT02525744|76102333|FG003|Received at Least 1 Dose of Study Drug|Period 2||6||
59986950|NCT02525744|76102330|FG000|COMPLETED|Period 2||6||
59986951|NCT02525744|76102331|FG001|COMPLETED|Period 2||6||
59986952|NCT02525744|76102332|FG002|COMPLETED|Period 2||5||
59986953|NCT02525744|76102333|FG003|COMPLETED|Period 2||6||
59986954|NCT02525744|76102330|FG000|NOT COMPLETED|Period 2||0||
59986955|NCT02525744|76102331|FG001|NOT COMPLETED|Period 2||0||
59986956|NCT02525744|76102332|FG002|NOT COMPLETED|Period 2||0||
59986957|NCT02525744|76102333|FG003|NOT COMPLETED|Period 2||0||
59986958|NCT02525744|76102330|FG000|STARTED|Period 3||6||
59986959|NCT02525744|76102331|FG001|STARTED|Period 3||6||
59986960|NCT02525744|76102332|FG002|STARTED|Period 3||5||
59986961|NCT02525744|76102333|FG003|STARTED|Period 3||6||
59986962|NCT02525744|76102330|FG000|Received at Least 1 Dose of Study Drug|Period 3||6||
59986963|NCT02525744|76102331|FG001|Received at Least 1 Dose of Study Drug|Period 3||6||
59986964|NCT02525744|76102332|FG002|Received at Least 1 Dose of Study Drug|Period 3||5||
59986965|NCT02525744|76102333|FG003|Received at Least 1 Dose of Study Drug|Period 3||6||
59986966|NCT02525744|76102330|FG000|COMPLETED|Period 3||6||
59986967|NCT02525744|76102331|FG001|COMPLETED|Period 3||5||
59986968|NCT02525744|76102332|FG002|COMPLETED|Period 3||5||
59986969|NCT02525744|76102333|FG003|COMPLETED|Period 3||6||
59986970|NCT02525744|76102330|FG000|NOT COMPLETED|Period 3||0||
59986971|NCT02525744|76102331|FG001|NOT COMPLETED|Period 3||1||
59986972|NCT02525744|76102332|FG002|NOT COMPLETED|Period 3||0||
59986973|NCT02525744|76102333|FG003|NOT COMPLETED|Period 3||0||
59986974|NCT02525744|76102330|FG000|STARTED|Period 4||6||
59986975|NCT02525744|76102331|FG001|STARTED|Period 4||5||
59986976|NCT02525744|76102332|FG002|STARTED|Period 4||5||
59986977|NCT02525744|76102333|FG003|STARTED|Period 4||6||
59986978|NCT02525744|76102330|FG000|Received at Least 1 Dose of Study Drug|Period 4||6||
59986979|NCT02525744|76102331|FG001|Received at Least 1 Dose of Study Drug|Period 4||5||
59986980|NCT02525744|76102332|FG002|Received at Least 1 Dose of Study Drug|Period 4||5||
59986981|NCT02525744|76102333|FG003|Received at Least 1 Dose of Study Drug|Period 4||6||
59986982|NCT02525744|76102330|FG000|COMPLETED|Period 4||5||
59986983|NCT02525744|76102331|FG001|COMPLETED|Period 4||5||
59986984|NCT02525744|76102332|FG002|COMPLETED|Period 4||5||
59986985|NCT02525744|76102333|FG003|COMPLETED|Period 4||6||
59986986|NCT02525744|76102330|FG000|NOT COMPLETED|Period 4||1||
59986987|NCT02525744|76102331|FG001|NOT COMPLETED|Period 4||0||
59986988|NCT02525744|76102332|FG002|NOT COMPLETED|Period 4||0||
59986989|NCT02525744|76102333|FG003|NOT COMPLETED|Period 4||0||
59986990|NCT02525744|76102330|FG000|STARTED|Period 5||5||
59986991|NCT02525744|76102331|FG001|STARTED|Period 5||5||
59986992|NCT02525744|76102332|FG002|STARTED|Period 5||5||
59986993|NCT02525744|76102333|FG003|STARTED|Period 5||6||
59986994|NCT02525744|76102330|FG000|Received at Least 1 Dose of Study Drug|Period 5||4||
59986995|NCT02525744|76102331|FG001|Received at Least 1 Dose of Study Drug|Period 5||5||
59986996|NCT02525744|76102332|FG002|Received at Least 1 Dose of Study Drug|Period 5||5||
59986997|NCT02525744|76102333|FG003|Received at Least 1 Dose of Study Drug|Period 5||6||
59986998|NCT02525744|76102330|FG000|COMPLETED|Period 5||4||
59986999|NCT02525744|76102331|FG001|COMPLETED|Period 5||5||
59987000|NCT02525744|76102332|FG002|COMPLETED|Period 5||5||
59987001|NCT02525744|76102333|FG003|COMPLETED|Period 5||6||
59987002|NCT02525744|76102330|FG000|NOT COMPLETED|Period 5||1||
59987003|NCT02525744|76102331|FG001|NOT COMPLETED|Period 5||0||
59987004|NCT02525744|76102332|FG002|NOT COMPLETED|Period 5||0||
59987005|NCT02525744|76102333|FG003|NOT COMPLETED|Period 5||0||
59987006|NCT00152477|76102346|FG000|STARTED|Chemotherapy Period||50||
59987007|NCT00152477|76102347|FG001|STARTED|Chemotherapy Period||56||
59987008|NCT00152477|76102348|FG002|STARTED|Chemotherapy Period||59||
59987009|NCT00152477|76102346|FG000|Part II|Chemotherapy Period||50||
59987010|NCT00152477|76102347|FG001|Part II|Chemotherapy Period||53||
59987011|NCT00152477|76102348|FG002|Part II|Chemotherapy Period||53||
59987012|NCT00152477|76102346|FG000|COMPLETED|Chemotherapy Period||22||
59987013|NCT00152477|76102347|FG001|COMPLETED|Chemotherapy Period||34||
59987014|NCT00152477|76102348|FG002|COMPLETED|Chemotherapy Period||39||
59987015|NCT00152477|76102346|FG000|NOT COMPLETED|Chemotherapy Period||28||
59987016|NCT00152477|76102347|FG001|NOT COMPLETED|Chemotherapy Period||22||
59987017|NCT00152477|76102348|FG002|NOT COMPLETED|Chemotherapy Period||20||
59987018|NCT00152477|76102346|FG000|STARTED|Monotherapy Period|7 subjects completed the Chemotherapy period but did not enter the Monotherapy period.|15||
59987019|NCT00152477|76102347|FG001|STARTED|Monotherapy Period|5 subjects completed the Chemotherapy period but did not enter the Monotherapy period.|29||
59987020|NCT00152477|76102348|FG002|STARTED|Monotherapy Period|5 subjects completed the Chemotherapy period but did not enter the Monotherapy period.|34||
59987021|NCT00152477|76102346|FG000|Part II|Monotherapy Period||13||
59987022|NCT00152477|76102347|FG001|Part II|Monotherapy Period||26||
59987023|NCT00152477|76102348|FG002|Part II|Monotherapy Period||29||
59987024|NCT00152477|76102346|FG000|COMPLETED|Monotherapy Period||0||
59987025|NCT00152477|76102347|FG001|COMPLETED|Monotherapy Period||0||
59987026|NCT00152477|76102348|FG002|COMPLETED|Monotherapy Period||0||
59987027|NCT00152477|76102346|FG000|NOT COMPLETED|Monotherapy Period||15||
59987028|NCT00152477|76102347|FG001|NOT COMPLETED|Monotherapy Period||29||
59987029|NCT00152477|76102348|FG002|NOT COMPLETED|Monotherapy Period||34||
59987030|NCT02525588|76102361|FG000|STARTED|Overall Study||48||
59987031|NCT02525588|76102362|FG001|STARTED|Overall Study||48||
59987032|NCT02525588|76102361|FG000|COMPLETED|Overall Study||42||
59987033|NCT02525588|76102362|FG001|COMPLETED|Overall Study||45||
59987034|NCT02525588|76102361|FG000|NOT COMPLETED|Overall Study||6||
59987035|NCT02525588|76102362|FG001|NOT COMPLETED|Overall Study||3||
59987036|NCT00153179|76102370|FG000|STARTED|Study Visit Day 1||10||
59987037|NCT00153179|76102371|FG001|STARTED|Study Visit Day 1||8||
59987038|NCT00153179|76102372|FG002|STARTED|Study Visit Day 1||13||
59987039|NCT00153179|76102373|FG003|STARTED|Study Visit Day 1||9||
59987040|NCT00153179|76102370|FG000|COMPLETED|Study Visit Day 1||10||
59987041|NCT00153179|76102371|FG001|COMPLETED|Study Visit Day 1||8||
59987042|NCT00153179|76102372|FG002|COMPLETED|Study Visit Day 1||13||
59987043|NCT00153179|76102373|FG003|COMPLETED|Study Visit Day 1||9||
59987044|NCT00153179|76102370|FG000|NOT COMPLETED|Study Visit Day 1||0||
59987045|NCT00153179|76102371|FG001|NOT COMPLETED|Study Visit Day 1||0||
59987046|NCT00153179|76102372|FG002|NOT COMPLETED|Study Visit Day 1||0||
59987047|NCT00153179|76102373|FG003|NOT COMPLETED|Study Visit Day 1||0||
59987048|NCT00153179|76102370|FG000|STARTED|Study Visit Day 2||10||
59987049|NCT00153179|76102371|FG001|STARTED|Study Visit Day 2||8||
59987050|NCT00153179|76102372|FG002|STARTED|Study Visit Day 2||13||
59987051|NCT00153179|76102373|FG003|STARTED|Study Visit Day 2||9||
59987052|NCT00153179|76102370|FG000|COMPLETED|Study Visit Day 2||9||
59987053|NCT00153179|76102371|FG001|COMPLETED|Study Visit Day 2||8||
59987054|NCT00153179|76102372|FG002|COMPLETED|Study Visit Day 2||11||
59987055|NCT00153179|76102373|FG003|COMPLETED|Study Visit Day 2||7||
59987056|NCT00153179|76102370|FG000|NOT COMPLETED|Study Visit Day 2||1||
59987057|NCT00153179|76102371|FG001|NOT COMPLETED|Study Visit Day 2||0||
59987058|NCT00153179|76102372|FG002|NOT COMPLETED|Study Visit Day 2||2||
59987059|NCT00153179|76102373|FG003|NOT COMPLETED|Study Visit Day 2||2||
59987060|NCT02743949|76102384|FG000|STARTED|Overall Study||86||
59987061|NCT02743949|76102385|FG001|STARTED|Overall Study||85||
59987062|NCT02743949|76102386|FG002|STARTED|Overall Study||85||
59987063|NCT02743949|76102384|FG000|COMPLETED|Overall Study||82||
59987064|NCT02743949|76102385|FG001|COMPLETED|Overall Study||84||
59987065|NCT02743949|76102386|FG002|COMPLETED|Overall Study||82||
59987066|NCT02743949|76102384|FG000|NOT COMPLETED|Overall Study||4||
59987067|NCT02743949|76102385|FG001|NOT COMPLETED|Overall Study||1||
59987068|NCT02743949|76102386|FG002|NOT COMPLETED|Overall Study||3||
59987069|NCT02531438|76102396|FG000|STARTED|Overall Study||386||
59987070|NCT02531438|76102397|FG001|STARTED|Overall Study||388||
59987071|NCT02531438|76102396|FG000|COMPLETED|Overall Study||356||
59987072|NCT02531438|76102397|FG001|COMPLETED|Overall Study||362||
59987073|NCT02531438|76102396|FG000|NOT COMPLETED|Overall Study||30||
59987074|NCT02531438|76102397|FG001|NOT COMPLETED|Overall Study||26||
59987075|NCT02289898|76102406|FG000|STARTED|Overall Study||68||
59987076|NCT02289898|76102407|FG001|STARTED|Overall Study||71||
59987077|NCT02289898|76102408|FG002|STARTED|Overall Study||65||
59987078|NCT02289898|76102406|FG000|COMPLETED|Overall Study||16||
59987079|NCT02289898|76102407|FG001|COMPLETED|Overall Study||18||
59987080|NCT02289898|76102408|FG002|COMPLETED|Overall Study||9||
59987081|NCT02289898|76102406|FG000|NOT COMPLETED|Overall Study||52||
59987082|NCT02289898|76102407|FG001|NOT COMPLETED|Overall Study||53||
59987083|NCT02289898|76102408|FG002|NOT COMPLETED|Overall Study||56||
59987084|NCT01660412|76102415|FG000|STARTED|Overall Study||29||
59987085|NCT01660412|76102416|FG001|STARTED|Overall Study||31||
59987086|NCT01660412|76102415|FG000|Head|Overall Study||1||
59987087|NCT01660412|76102416|FG001|Head|Overall Study||4||
59987088|NCT01660412|76102415|FG000|Thorax|Overall Study||9|Including neck and buttocks|
59987089|NCT01660412|76102416|FG001|Thorax|Overall Study||9|Including neck and buttocks|
59987090|NCT01660412|76102415|FG000|Appendicular Structures|Overall Study||17|including shoulder to wrist, back of hand, and hip to ankle|
59995015|NCT04032093|76110863|FG007|STARTED|Overall Study||113||
59995016|NCT04032093|76110864|FG008|STARTED|Overall Study||112||
59995017|NCT04032093|76110865|FG009|STARTED|Overall Study||116||
59995018|NCT04032093|76110856|FG000|Safety Set|Overall Study|1 maternal participant randomized to this arm but not vaccinated. Hence excluded from safety set.|115||
59995019|NCT04032093|76110857|FG001|Safety Set|Overall Study||117||
59622682|NCT00496860|75734566|FG000|NOT COMPLETED|Overall Study||1||
59622683|NCT00496860|75734567|FG001|NOT COMPLETED|Overall Study||1||
59622684|NCT00496860|75734568|FG002|NOT COMPLETED|Overall Study||0||
59622685|NCT01796106|75734578|FG000|STARTED|Overall Study||5||5
59622686|NCT01796106|75734579|FG001|STARTED|Overall Study||7||7
59622687|NCT01796106|75734578|FG000|12 Months Follow up|Overall Study||0||0
59622688|NCT01796106|75734579|FG001|12 Months Follow up|Overall Study||0||0
59622689|NCT01796106|75734578|FG000|COMPLETED|Overall Study||0|24 month follow up was expected for completion.|0
59987091|NCT01660412|76102416|FG001|Appendicular Structures|Overall Study||11|including shoulder to wrist, back of hand, and hip to ankle|
59987092|NCT01660412|76102415|FG000|Other|Overall Study||2|Remainder of the hand and feet|
59987093|NCT01660412|76102416|FG001|Other|Overall Study||4|Remainder of the hand and feet|
59987094|NCT01660412|76102415|FG000|Injection 1|Overall Study||29||
59987095|NCT01660412|76102416|FG001|Injection 1|Overall Study||31||
59987096|NCT01660412|76102415|FG000|Injection 2|Overall Study||29||
59987097|NCT01660412|76102416|FG001|Injection 2|Overall Study||31||
59987098|NCT01660412|76102415|FG000|Injection 3|Overall Study||29||
59987099|NCT01660412|76102416|FG001|Injection 3|Overall Study||31||
59987100|NCT01660412|76102415|FG000|Injection 4|Overall Study||29||
59987101|NCT01660412|76102416|FG001|Injection 4|Overall Study||31||
59987102|NCT01660412|76102415|FG000|COMPLETED|Overall Study||29||
59987103|NCT01660412|76102416|FG001|COMPLETED|Overall Study||28||
59987104|NCT01660412|76102415|FG000|NOT COMPLETED|Overall Study||0||
59987105|NCT01660412|76102416|FG001|NOT COMPLETED|Overall Study||3||
59987106|NCT01659554|76102422|FG000|STARTED|Overall Study|4 subjects enrolled; 4 subjects treated and 4 did not complete protocol schema|4||
59987107|NCT01659554|76102422|FG000|COMPLETED|Overall Study||0||
59987108|NCT01659554|76102422|FG000|NOT COMPLETED|Overall Study||4||
59987109|NCT01659320|76102426|FG000|STARTED|Overall Study||16||
59987110|NCT01659320|76102426|FG000|COMPLETED|Overall Study||13||
59987111|NCT01659320|76102426|FG000|NOT COMPLETED|Overall Study||3||
59987112|NCT01660334|76102430|FG000|STARTED|Overall Study||13||
59987113|NCT01660334|76102430|FG000|COMPLETED|Overall Study||12||
59987114|NCT01660334|76102430|FG000|NOT COMPLETED|Overall Study||1||
59987115|NCT01660256|76102437|FG000|STARTED|Overall Study||84||
59987116|NCT01660256|76102438|FG001|STARTED|Overall Study||83||
59987117|NCT01660256|76102439|FG002|STARTED|Overall Study||42||
59987118|NCT01660256|76102437|FG000|COMPLETED|Overall Study||79||
59987119|NCT01660256|76102438|FG001|COMPLETED|Overall Study||83||
59987120|NCT01660256|76102439|FG002|COMPLETED|Overall Study||38||
59987121|NCT01660256|76102437|FG000|NOT COMPLETED|Overall Study||5||
59987122|NCT01660256|76102438|FG001|NOT COMPLETED|Overall Study||0||
59987123|NCT01660256|76102439|FG002|NOT COMPLETED|Overall Study||4||
59987124|NCT02034123|76102465|FG000|STARTED|Part1(Median of 7.286 Weeks of Exposure)||1||
59987125|NCT02034123|76102466|FG001|STARTED|Part1(Median of 7.286 Weeks of Exposure)||1||
59987126|NCT02034123|76102467|FG002|STARTED|Part1(Median of 7.286 Weeks of Exposure)||5||
59987127|NCT02034123|76102468|FG003|STARTED|Part1(Median of 7.286 Weeks of Exposure)||3||
59987128|NCT02034123|76102469|FG004|STARTED|Part1(Median of 7.286 Weeks of Exposure)||7||
59987129|NCT02034123|76102470|FG005|STARTED|Part1(Median of 7.286 Weeks of Exposure)||3||
59987130|NCT02034123|76102471|FG006|STARTED|Part1(Median of 7.286 Weeks of Exposure)||2||
59987131|NCT02034123|76102472|FG007|STARTED|Part1(Median of 7.286 Weeks of Exposure)||5||
59987132|NCT02034123|76102473|FG008|STARTED|Part1(Median of 7.286 Weeks of Exposure)||2||
59987133|NCT02034123|76102474|FG009|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0||
59987134|NCT02034123|76102475|FG010|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0||
59987135|NCT02034123|76102476|FG011|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0||
59987136|NCT02034123|76102477|FG012|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0||
59987137|NCT02034123|76102478|FG013|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0||
59987138|NCT02034123|76102479|FG014|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0||
59987139|NCT02034123|76102480|FG015|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0||
59987140|NCT02034123|76102481|FG016|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0||
59987141|NCT02034123|76102482|FG017|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0||
59622690|NCT01796106|75734579|FG001|COMPLETED|Overall Study||0|24 month follow up was expected for completion.|0
59622691|NCT01796106|75734578|FG000|NOT COMPLETED|Overall Study||5||5
59622692|NCT01796106|75734579|FG001|NOT COMPLETED|Overall Study||7||7
59622693|NCT00541242|75734587|FG000|STARTED|Treatment Period 1||0||
59622694|NCT00541242|75734588|FG001|STARTED|Treatment Period 1|586 patients were enrolled and received open-label latanoprost for 6 weeks|586||
59622695|NCT00541242|75734587|FG000|COMPLETED|Treatment Period 1||0||
59622696|NCT00541242|75734588|FG001|COMPLETED|Treatment Period 1|43 of the 586 patients did not enter Treatment Period 2 (Randomized at Week 6)|586||
59987142|NCT02034123|76102465|FG000|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||1||
59987143|NCT02034123|76102466|FG001|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||1||
59987144|NCT02034123|76102467|FG002|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||5||
59817892|NCT04488770|75940331|FG005|COMPLETED|Part 1-Cohort 2: Period 1 (Up to 5 Days)||1||
59987145|NCT02034123|76102468|FG003|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||1||
59987146|NCT02034123|76102469|FG004|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||5||
59987147|NCT02034123|76102470|FG005|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||3||
59987148|NCT02034123|76102471|FG006|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||2||
59987149|NCT02034123|76102472|FG007|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||4||
59987150|NCT02034123|76102473|FG008|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0||
59987151|NCT02034123|76102474|FG009|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0||
59987152|NCT02034123|76102475|FG010|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0||
59987153|NCT02034123|76102476|FG011|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0||
59987154|NCT02034123|76102477|FG012|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0||
59987155|NCT02034123|76102478|FG013|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0||
59987156|NCT02034123|76102479|FG014|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0||
59987157|NCT02034123|76102480|FG015|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0||
59987158|NCT02034123|76102481|FG016|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0||
59987159|NCT02034123|76102482|FG017|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0||
59987160|NCT02034123|76102465|FG000|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0||
59987161|NCT02034123|76102466|FG001|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0||
59987162|NCT02034123|76102467|FG002|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0||
59987163|NCT02034123|76102468|FG003|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||2||
59987164|NCT02034123|76102469|FG004|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||2||
59987165|NCT02034123|76102470|FG005|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0||
59987166|NCT02034123|76102471|FG006|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0||
59987167|NCT02034123|76102472|FG007|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||1||
59987168|NCT02034123|76102473|FG008|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||2||
59987169|NCT02034123|76102474|FG009|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0||
59987170|NCT02034123|76102475|FG010|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0||
59987171|NCT02034123|76102476|FG011|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0||
59987172|NCT02034123|76102477|FG012|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0||
59987173|NCT02034123|76102478|FG013|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0||
59987174|NCT02034123|76102479|FG014|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0||
59987175|NCT02034123|76102480|FG015|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0||
59987176|NCT02034123|76102481|FG016|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0||
59987177|NCT02034123|76102482|FG017|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0||
59987178|NCT02034123|76102465|FG000|STARTED|Part2(Up to 2 Years)||0||
59987179|NCT02034123|76102466|FG001|STARTED|Part2(Up to 2 Years)||0||
59987180|NCT02034123|76102467|FG002|STARTED|Part2(Up to 2 Years)||0||
59987181|NCT02034123|76102468|FG003|STARTED|Part2(Up to 2 Years)||0||
59987182|NCT02034123|76102469|FG004|STARTED|Part2(Up to 2 Years)||0||
59987183|NCT02034123|76102470|FG005|STARTED|Part2(Up to 2 Years)||0||
59987184|NCT02034123|76102471|FG006|STARTED|Part2(Up to 2 Years)||0||
59987185|NCT02034123|76102472|FG007|STARTED|Part2(Up to 2 Years)||0||
59987186|NCT02034123|76102473|FG008|STARTED|Part2(Up to 2 Years)||0||
59987187|NCT02034123|76102474|FG009|STARTED|Part2(Up to 2 Years)||0||
59987188|NCT02034123|76102475|FG010|STARTED|Part2(Up to 2 Years)||0||
59987189|NCT02034123|76102476|FG011|STARTED|Part2(Up to 2 Years)||0||
59987190|NCT02034123|76102477|FG012|STARTED|Part2(Up to 2 Years)||0||
59987191|NCT02034123|76102478|FG013|STARTED|Part2(Up to 2 Years)||0||
59987192|NCT02034123|76102479|FG014|STARTED|Part2(Up to 2 Years)||0||
59987193|NCT02034123|76102480|FG015|STARTED|Part2(Up to 2 Years)||0||
59987194|NCT02034123|76102481|FG016|STARTED|Part2(Up to 2 Years)||0||
59987195|NCT02034123|76102482|FG017|STARTED|Part2(Up to 2 Years)||0||
59987196|NCT02034123|76102465|FG000|COMPLETED|Part2(Up to 2 Years)||0||
59987197|NCT02034123|76102466|FG001|COMPLETED|Part2(Up to 2 Years)||0||
59987198|NCT02034123|76102467|FG002|COMPLETED|Part2(Up to 2 Years)||0||
59987199|NCT02034123|76102468|FG003|COMPLETED|Part2(Up to 2 Years)||0||
59987200|NCT02034123|76102469|FG004|COMPLETED|Part2(Up to 2 Years)||0||
59987201|NCT02034123|76102470|FG005|COMPLETED|Part2(Up to 2 Years)||0||
59987202|NCT02034123|76102471|FG006|COMPLETED|Part2(Up to 2 Years)||0||
59987203|NCT02034123|76102472|FG007|COMPLETED|Part2(Up to 2 Years)||0||
59987204|NCT02034123|76102473|FG008|COMPLETED|Part2(Up to 2 Years)||0||
59987205|NCT02034123|76102474|FG009|COMPLETED|Part2(Up to 2 Years)||0||
59987206|NCT02034123|76102475|FG010|COMPLETED|Part2(Up to 2 Years)||0||
59987207|NCT02034123|76102476|FG011|COMPLETED|Part2(Up to 2 Years)||0||
59987208|NCT02034123|76102477|FG012|COMPLETED|Part2(Up to 2 Years)||0||
59987209|NCT02034123|76102478|FG013|COMPLETED|Part2(Up to 2 Years)||0||
59987210|NCT02034123|76102479|FG014|COMPLETED|Part2(Up to 2 Years)||0||
59987211|NCT02034123|76102480|FG015|COMPLETED|Part2(Up to 2 Years)||0||
59987212|NCT02034123|76102481|FG016|COMPLETED|Part2(Up to 2 Years)||0||
59987213|NCT02034123|76102482|FG017|COMPLETED|Part2(Up to 2 Years)||0||
59987214|NCT02034123|76102465|FG000|NOT COMPLETED|Part2(Up to 2 Years)||0||
59987215|NCT02034123|76102466|FG001|NOT COMPLETED|Part2(Up to 2 Years)||0||
59987216|NCT02034123|76102467|FG002|NOT COMPLETED|Part2(Up to 2 Years)||0||
59987217|NCT02034123|76102468|FG003|NOT COMPLETED|Part2(Up to 2 Years)||0||
59987218|NCT02034123|76102469|FG004|NOT COMPLETED|Part2(Up to 2 Years)||0||
59987219|NCT02034123|76102470|FG005|NOT COMPLETED|Part2(Up to 2 Years)||0||
59987220|NCT02034123|76102471|FG006|NOT COMPLETED|Part2(Up to 2 Years)||0||
60074991|NCT02395120|76190252|FG002|Started-Caregivers|Overall Study||20|Caregivers (primary caregiver of family)|
59987221|NCT02034123|76102472|FG007|NOT COMPLETED|Part2(Up to 2 Years)||0||
59987222|NCT02034123|76102473|FG008|NOT COMPLETED|Part2(Up to 2 Years)||0||
59987223|NCT02034123|76102474|FG009|NOT COMPLETED|Part2(Up to 2 Years)||0||
59987224|NCT02034123|76102475|FG010|NOT COMPLETED|Part2(Up to 2 Years)||0||
59987225|NCT02034123|76102476|FG011|NOT COMPLETED|Part2(Up to 2 Years)||0||
59987226|NCT02034123|76102477|FG012|NOT COMPLETED|Part2(Up to 2 Years)||0||
59987227|NCT02034123|76102478|FG013|NOT COMPLETED|Part2(Up to 2 Years)||0||
59987228|NCT02034123|76102479|FG014|NOT COMPLETED|Part2(Up to 2 Years)||0||
59987229|NCT02034123|76102480|FG015|NOT COMPLETED|Part2(Up to 2 Years)||0||
59987230|NCT02034123|76102481|FG016|NOT COMPLETED|Part2(Up to 2 Years)||0||
59987231|NCT02034123|76102482|FG017|NOT COMPLETED|Part2(Up to 2 Years)||0||
59987232|NCT02318602|76102528|FG000|STARTED|Overall Study||9||
59987233|NCT02318602|76102529|FG001|STARTED|Overall Study||26||
59987234|NCT02318602|76102530|FG002|STARTED|Overall Study||17||
59987235|NCT02318602|76102528|FG000|COMPLETED|Overall Study||8||
59987236|NCT02318602|76102529|FG001|COMPLETED|Overall Study||22||
59987237|NCT02318602|76102530|FG002|COMPLETED|Overall Study||15||
59987238|NCT02318602|76102528|FG000|NOT COMPLETED|Overall Study||1||
59987239|NCT02318602|76102529|FG001|NOT COMPLETED|Overall Study||4||
59987240|NCT02318602|76102530|FG002|NOT COMPLETED|Overall Study||2||
59987241|NCT02318368|76102546|FG000|STARTED|Overall Study||7||
59987242|NCT02318368|76102547|FG001|STARTED|Overall Study||3||
59987243|NCT02318368|76102546|FG000|COMPLETED|Overall Study||0||
59987244|NCT02318368|76102547|FG001|COMPLETED|Overall Study||0||
59987245|NCT02318368|76102546|FG000|NOT COMPLETED|Overall Study||7||
59987246|NCT02318368|76102547|FG001|NOT COMPLETED|Overall Study||3||
59987247|NCT02318134|76102555|FG000|STARTED|Overall Study||30||
59987248|NCT02318134|76102556|FG001|STARTED|Overall Study||30||
59987249|NCT02318134|76102555|FG000|COMPLETED|Overall Study||28||
59987250|NCT02318134|76102556|FG001|COMPLETED|Overall Study||29||
59987251|NCT02318134|76102555|FG000|NOT COMPLETED|Overall Study||2||
59987252|NCT02318134|76102556|FG001|NOT COMPLETED|Overall Study||1||
59987253|NCT02317510|76102566|FG000|STARTED|Overall Study||25||
59987254|NCT02317510|76102567|FG001|STARTED|Overall Study||25||
59987255|NCT02317510|76102566|FG000|COMPLETED|Overall Study||25||
59987256|NCT02317510|76102567|FG001|COMPLETED|Overall Study||24||
59987257|NCT02317510|76102566|FG000|NOT COMPLETED|Overall Study||0||
59987258|NCT02317510|76102567|FG001|NOT COMPLETED|Overall Study||1||
59987259|NCT02317432|76102578|FG000|STARTED|Overall Study||153||
59987260|NCT02317432|76102579|FG001|STARTED|Overall Study||154||
59987261|NCT02317432|76102578|FG000|Completed CBT|Overall Study||118|Completed 50% or more (5 or more) Positive Minds CBT sessions, which is considered the appropriate threshold for populations not recognizing the need for services and not actively seeking treatment.|
59987262|NCT02317432|76102579|FG001|Completed CBT|Overall Study|Participants in Enhanced Usual Care did not receive CBT sessions.|0|Completed 50% or more (5 or more) Positive Minds CBT sessions, which is considered the appropriate threshold for populations not recognizing the need for services and not actively seeking treatment.|
59987263|NCT02317432|76102578|FG000|Completed InVEST|Overall Study||63|Completed 50% or more (18 or more) Strong Minds InVEST sessions, which is considered the appropriate threshold for populations not recognizing the need for services and not actively seeking treatment.|
59987264|NCT02317432|76102579|FG001|Completed InVEST|Overall Study|Participants in Enhanced Usual Care did not receive InVEST sessions.|0|Completed 50% or more (18 or more) Strong Minds InVEST sessions, which is considered the appropriate threshold for populations not recognizing the need for services and not actively seeking treatment.|
59995020|NCT04032093|76110858|FG002|Safety Set|Overall Study||116||
59995021|NCT04032093|76110859|FG003|Safety Set|Overall Study|1 maternal participant randomized to this arm but not vaccinated. Hence excluded from safety set.|114||
59995022|NCT04032093|76110860|FG004|Safety Set|Overall Study||117||
59995023|NCT04032093|76110861|FG005|Safety Set|Overall Study||114||
59995024|NCT04032093|76110862|FG006|Safety Set|Overall Study||117||
59995025|NCT04032093|76110863|FG007|Safety Set|Overall Study||113||
59995026|NCT04032093|76110864|FG008|Safety Set|Overall Study||112||
59995027|NCT04032093|76110865|FG009|Safety Set|Overall Study||116||
59995028|NCT04032093|76110856|FG000|COMPLETED|Overall Study||107||
59995029|NCT04032093|76110857|FG001|COMPLETED|Overall Study||107||
59995030|NCT04032093|76110858|FG002|COMPLETED|Overall Study||108||
59995031|NCT04032093|76110859|FG003|COMPLETED|Overall Study||100||
59995032|NCT04032093|76110860|FG004|COMPLETED|Overall Study||99||
59995033|NCT04032093|76110861|FG005|COMPLETED|Overall Study||106||
59995034|NCT04032093|76110862|FG006|COMPLETED|Overall Study||107||
59995035|NCT04032093|76110863|FG007|COMPLETED|Overall Study||108||
59995036|NCT04032093|76110864|FG008|COMPLETED|Overall Study||100||
59995037|NCT04032093|76110865|FG009|COMPLETED|Overall Study||98||
59995038|NCT04032093|76110856|FG000|NOT COMPLETED|Overall Study||9||
59995039|NCT04032093|76110857|FG001|NOT COMPLETED|Overall Study||10||
59995040|NCT04032093|76110858|FG002|NOT COMPLETED|Overall Study||8||
59995041|NCT04032093|76110859|FG003|NOT COMPLETED|Overall Study||15||
60074992|NCT02395120|76190253|FG003|Started-Caregivers|Overall Study||28|Caregivers (primary caregiver of family)|
60074993|NCT02395120|76190254|FG004|Started-Caregivers|Overall Study||187|Caregivers (primary caregiver of family)|
60074994|NCT02395120|76190250|FG000|Started-Children|Overall Study||212|Children (can be multiple children of caregiver)|
60074995|NCT02395120|76190251|FG001|Started-Children|Overall Study||210|Children (can be multiple children of caregiver)|
60074996|NCT02395120|76190252|FG002|Started-Children|Overall Study||23|Children (can be multiple children of caregiver)|
60074997|NCT02395120|76190253|FG003|Started-Children|Overall Study||35|Children (can be multiple children of caregiver)|
60074998|NCT02395120|76190254|FG004|Started-Children|Overall Study||214|Children (can be multiple children of caregiver)|
60074999|NCT02395120|76190250|FG000|Completed-Caregivers|Overall Study||161|Caregivers (primary caregiver of family)|
59987265|NCT02317432|76102578|FG000|Completed CBT + InVEST Exercise|Overall Study||122|Completed either 50% or more Positive Minds CBT sessions or 50% or more Strong Minds InVEST sessions.|
59987266|NCT02317432|76102579|FG001|Completed CBT + InVEST Exercise|Overall Study|Participants in Enhanced Usual Care did not receive either CBT or InVEST sessions.|0|Completed either 50% or more Positive Minds CBT sessions or 50% or more Strong Minds InVEST sessions.|
59987267|NCT02317432|76102578|FG000|Completed Enhanced Usual Care|Overall Study|Participants in CBT + InVEST exercise did not receive Enhanced Usual Care.|0||
59987268|NCT02317432|76102579|FG001|Completed Enhanced Usual Care|Overall Study||148||
59987269|NCT02317432|76102578|FG000|COMPLETED|Overall Study||122||
59987270|NCT02317432|76102579|FG001|COMPLETED|Overall Study||148||
59987271|NCT02317432|76102578|FG000|NOT COMPLETED|Overall Study||31||
59987272|NCT02317432|76102579|FG001|NOT COMPLETED|Overall Study||6||
59987273|NCT02289820|76102592|FG000|STARTED|Overall Study||39||
59987274|NCT02289820|76102593|FG001|STARTED|Overall Study||20||
59987275|NCT02289820|76102594|FG002|STARTED|Overall Study||44||
59987276|NCT02289820|76102595|FG003|STARTED|Overall Study||39||
59987277|NCT02289820|76102596|FG004|STARTED|Overall Study||40||
59987278|NCT02289820|76102597|FG005|STARTED|Overall Study||40||
59987279|NCT02289820|76102598|FG006|STARTED|Overall Study||39||
59987280|NCT02289820|76102592|FG000|COMPLETED|Overall Study||37||
59987281|NCT02289820|76102593|FG001|COMPLETED|Overall Study||18||
59987282|NCT02289820|76102594|FG002|COMPLETED|Overall Study||38||
59987283|NCT02289820|76102595|FG003|COMPLETED|Overall Study||37||
59987284|NCT02289820|76102596|FG004|COMPLETED|Overall Study||40||
59987285|NCT02289820|76102597|FG005|COMPLETED|Overall Study||39||
60075000|NCT02395120|76190251|FG001|Completed-Caregivers|Overall Study||159|Caregivers (primary caregiver of family)|
60075001|NCT02395120|76190252|FG002|Completed-Caregivers|Overall Study||17|Caregivers (primary caregiver of family)|
60075002|NCT02395120|76190253|FG003|Completed-Caregivers|Overall Study||25|Caregivers (primary caregiver of family)|
60075003|NCT02395120|76190254|FG004|Completed-Caregivers|Overall Study||164|Caregivers (primary caregiver of family)|
60075004|NCT02395120|76190250|FG000|Completed-Children|Overall Study||182|Children (can be multiple children of caregiver)|
60075005|NCT02395120|76190251|FG001|Completed-Children|Overall Study||177|Children (can be multiple children of caregiver)|
60075006|NCT02395120|76190252|FG002|Completed-Children|Overall Study||20|Children (can be multiple children of caregiver)|
60075007|NCT02395120|76190253|FG003|Completed-Children|Overall Study||32|Children (can be multiple children of caregiver)|
59987286|NCT02289820|76102598|FG006|COMPLETED|Overall Study||37||
59987287|NCT02289820|76102592|FG000|NOT COMPLETED|Overall Study||2||
59987288|NCT02289820|76102593|FG001|NOT COMPLETED|Overall Study||2||
59987289|NCT02289820|76102594|FG002|NOT COMPLETED|Overall Study||6||
59987290|NCT02289820|76102595|FG003|NOT COMPLETED|Overall Study||2||
59987291|NCT02289820|76102596|FG004|NOT COMPLETED|Overall Study||0||
59987292|NCT02289820|76102597|FG005|NOT COMPLETED|Overall Study||1||
60075008|NCT02395120|76190254|FG004|Completed-Children|Overall Study||186|Children (can be multiple children of caregiver)|
60075009|NCT02395120|76190250|FG000|COMPLETED|Overall Study|Caregivers and Children|343|Caregivers and Children|
60075010|NCT02395120|76190251|FG001|COMPLETED|Overall Study|Caregivers and Children|336|Caregivers and Children|
60075011|NCT02395120|76190252|FG002|COMPLETED|Overall Study|Caregivers and Children|37|Caregivers and Children|
60075012|NCT02395120|76190253|FG003|COMPLETED|Overall Study|Caregivers and Children|57|Caregivers and Children|
60075013|NCT02395120|76190254|FG004|COMPLETED|Overall Study|Caregivers and Children|350|Caregivers and Children|
59987293|NCT02289820|76102598|FG006|NOT COMPLETED|Overall Study||2||
59987294|NCT02289742|76102620|FG000|STARTED|First Wear Period||11||
59987295|NCT02289742|76102621|FG001|STARTED|First Wear Period||12||
59987296|NCT02289742|76102622|FG002|STARTED|First Wear Period||12||
59987297|NCT02289742|76102623|FG003|STARTED|First Wear Period||10||
59987298|NCT02289742|76102620|FG000|Treated|First Wear Period||11||
59987299|NCT02289742|76102621|FG001|Treated|First Wear Period||11||
59987300|NCT02289742|76102622|FG002|Treated|First Wear Period||12||
59987301|NCT02289742|76102623|FG003|Treated|First Wear Period||9||
59987302|NCT02289742|76102620|FG000|COMPLETED|First Wear Period||11||
59987303|NCT02289742|76102621|FG001|COMPLETED|First Wear Period||11||
59987304|NCT02289742|76102622|FG002|COMPLETED|First Wear Period||11||
59987305|NCT02289742|76102623|FG003|COMPLETED|First Wear Period||9||
59987306|NCT02289742|76102620|FG000|NOT COMPLETED|First Wear Period||0||
59987307|NCT02289742|76102621|FG001|NOT COMPLETED|First Wear Period||1||
59987308|NCT02289742|76102622|FG002|NOT COMPLETED|First Wear Period||1||
59987309|NCT02289742|76102623|FG003|NOT COMPLETED|First Wear Period||1||
59987310|NCT02289742|76102620|FG000|STARTED|Second Wear Period||11||
59987311|NCT02289742|76102621|FG001|STARTED|Second Wear Period||11||
59987312|NCT02289742|76102622|FG002|STARTED|Second Wear Period||11||
59987313|NCT02289742|76102623|FG003|STARTED|Second Wear Period||9||
59987314|NCT02289742|76102620|FG000|COMPLETED|Second Wear Period||11||
59987315|NCT02289742|76102621|FG001|COMPLETED|Second Wear Period||11||
60075014|NCT02395120|76190250|FG000|NOT COMPLETED|Overall Study||57||
59987316|NCT02289742|76102622|FG002|COMPLETED|Second Wear Period||11||
59987317|NCT02289742|76102623|FG003|COMPLETED|Second Wear Period||9||
59987318|NCT02289742|76102620|FG000|NOT COMPLETED|Second Wear Period||0||
59987319|NCT02289742|76102621|FG001|NOT COMPLETED|Second Wear Period||0||
60075015|NCT02395120|76190251|FG001|NOT COMPLETED|Overall Study||62||
59987320|NCT02289742|76102622|FG002|NOT COMPLETED|Second Wear Period||0||
59987321|NCT02289742|76102623|FG003|NOT COMPLETED|Second Wear Period||0||
59987322|NCT02289742|76102620|FG000|STARTED|Third Wear Period||11||
59987323|NCT02289742|76102621|FG001|STARTED|Third Wear Period||11||
60075016|NCT02395120|76190252|FG002|NOT COMPLETED|Overall Study||6||
60075017|NCT02395120|76190253|FG003|NOT COMPLETED|Overall Study||6||
60075018|NCT02395120|76190254|FG004|NOT COMPLETED|Overall Study||51||
60075019|NCT01685229|76190268|FG000|STARTED|Overall Study||146||
60075020|NCT01685229|76190269|FG001|STARTED|Overall Study||52||
60075021|NCT01685229|76190268|FG000|COMPLETED|Overall Study||120||
60075022|NCT01685229|76190269|FG001|COMPLETED|Overall Study||36||
60075023|NCT01685229|76190268|FG000|NOT COMPLETED|Overall Study||26||
60075024|NCT01685229|76190269|FG001|NOT COMPLETED|Overall Study||16||
60075025|NCT01551693|76190280|FG000|STARTED|Overall Study||1||
60075026|NCT01551693|76190281|FG001|STARTED|Overall Study||2||
60075027|NCT01551693|76190280|FG000|COMPLETED|Overall Study||0||
60075028|NCT01551693|76190281|FG001|COMPLETED|Overall Study||0||
60075029|NCT01551693|76190280|FG000|NOT COMPLETED|Overall Study||1||
60075030|NCT01551693|76190281|FG001|NOT COMPLETED|Overall Study||2||
60075031|NCT01574157|76190289|FG000|STARTED|Overall Study||35||
60075032|NCT01574157|76190290|FG001|STARTED|Overall Study||39||
60075033|NCT01574157|76190289|FG000|Month 3|Overall Study||31||
60075034|NCT01574157|76190290|FG001|Month 3|Overall Study||33||
60075035|NCT01574157|76190289|FG000|COMPLETED|Overall Study||31|Month 6|
60075036|NCT01574157|76190290|FG001|COMPLETED|Overall Study||31|Month 6|
60075037|NCT01574157|76190289|FG000|NOT COMPLETED|Overall Study||4||
60075038|NCT01574157|76190290|FG001|NOT COMPLETED|Overall Study||8||
60075039|NCT01574079|76190302|FG000|STARTED|Overall Study||18||
60075040|NCT01574079|76190303|FG001|STARTED|Overall Study||15||
60075041|NCT01574079|76190302|FG000|COMPLETED|Overall Study||17||
60075042|NCT01574079|76190303|FG001|COMPLETED|Overall Study||13||
60075043|NCT01574079|76190302|FG000|NOT COMPLETED|Overall Study||1||
60075044|NCT01574079|76190303|FG001|NOT COMPLETED|Overall Study||2||
60075045|NCT01573767|76190313|FG000|STARTED|Overall Study||115||
60075046|NCT01573767|76190314|FG001|STARTED|Overall Study||114||
60075047|NCT01573767|76190315|FG002|STARTED|Overall Study||113||
60075048|NCT01573767|76190316|FG003|STARTED|Overall Study||114||
60075049|NCT01573767|76190313|FG000|COMPLETED|Overall Study||93||
60075050|NCT01573767|76190314|FG001|COMPLETED|Overall Study||93||
60075051|NCT01573767|76190315|FG002|COMPLETED|Overall Study||99||
59527186|NCT01114997|75622822|FG002|STARTED|Overall Study||11||
59987324|NCT02289742|76102622|FG002|STARTED|Third Wear Period||11||
59987325|NCT02289742|76102623|FG003|STARTED|Third Wear Period||9||
60075052|NCT01573767|76190316|FG003|COMPLETED|Overall Study||90||
60075053|NCT01573767|76190313|FG000|NOT COMPLETED|Overall Study||22||
60075054|NCT01573767|76190314|FG001|NOT COMPLETED|Overall Study||21||
60075055|NCT01573767|76190315|FG002|NOT COMPLETED|Overall Study||14||
60075056|NCT01573767|76190316|FG003|NOT COMPLETED|Overall Study||24||
60075057|NCT01551303|76190328|FG000|STARTED|Overall Study||25||
60075058|NCT01551303|76190329|FG001|STARTED|Overall Study||22||
60075059|NCT01551303|76190328|FG000|COMPLETED|Overall Study||21||
59527187|NCT01114997|75622820|FG000|COMPLETED|Overall Study||11||
59527188|NCT01114997|75622821|FG001|COMPLETED|Overall Study||10||
59527189|NCT01114997|75622822|FG002|COMPLETED|Overall Study||11||
59527190|NCT01114997|75622820|FG000|NOT COMPLETED|Overall Study||0||
59527191|NCT01114997|75622821|FG001|NOT COMPLETED|Overall Study||0||
59987326|NCT02289742|76102620|FG000|COMPLETED|Third Wear Period||11||
59987327|NCT02289742|76102621|FG001|COMPLETED|Third Wear Period||10||
59987328|NCT02289742|76102622|FG002|COMPLETED|Third Wear Period||11||
60075060|NCT01551303|76190329|FG001|COMPLETED|Overall Study||15||
60075061|NCT01551303|76190328|FG000|NOT COMPLETED|Overall Study||4||
60075062|NCT01551303|76190329|FG001|NOT COMPLETED|Overall Study||7||
60075063|NCT00638404|76190337|FG000|STARTED|Overall Study||200||
60075064|NCT00638404|76190338|FG001|STARTED|Overall Study||100||
60075065|NCT00638404|76190337|FG000|COMPLETED|Overall Study||192||
60075066|NCT00638404|76190338|FG001|COMPLETED|Overall Study||100||
59987329|NCT02289742|76102623|FG003|COMPLETED|Third Wear Period||8||
59987330|NCT02289742|76102620|FG000|NOT COMPLETED|Third Wear Period||0||
59987331|NCT02289742|76102621|FG001|NOT COMPLETED|Third Wear Period||1||
59987332|NCT02289742|76102622|FG002|NOT COMPLETED|Third Wear Period||0||
59987333|NCT02289742|76102623|FG003|NOT COMPLETED|Third Wear Period||1||
59987334|NCT02289352|76102640|FG000|STARTED|Overall Study||199||
59987335|NCT02289352|76102641|FG001|STARTED|Overall Study||199||
59987336|NCT02289352|76102642|FG002|STARTED|Overall Study||64||
59987337|NCT02289352|76102640|FG000|Safety Population|Overall Study||199|Randomized participants who received the study drug.|
59987338|NCT02289352|76102641|FG001|Safety Population|Overall Study||199|Randomized participants who received the study drug.|
59987339|NCT02289352|76102642|FG002|Safety Population|Overall Study||64|Randomized participants who received the study drug.|
59987340|NCT02289352|76102640|FG000|mITT Population|Overall Study||191|Randomized participants, at least one dose, pre and post assessments during at least one visit (2/3)|
59987341|NCT02289352|76102641|FG001|mITT Population|Overall Study||193|Randomized participants, at least one dose, pre and post assessments during at least one visit (2/3)|
59987342|NCT02289352|76102642|FG002|mITT Population|Overall Study||58|Randomized participants, at least one dose, pre and post assessments during at least one visit (2/3)|
59987343|NCT02289352|76102640|FG000|PP Population|Overall Study||173|Participants completed all visits and assessments, dose compliance, and followed restrictions.|
59995042|NCT04032093|76110860|FG004|NOT COMPLETED|Overall Study||18||
59995043|NCT04032093|76110861|FG005|NOT COMPLETED|Overall Study||8||
59995044|NCT04032093|76110862|FG006|NOT COMPLETED|Overall Study||10||
59995045|NCT04032093|76110863|FG007|NOT COMPLETED|Overall Study||5||
59995046|NCT04032093|76110864|FG008|NOT COMPLETED|Overall Study||12||
59995047|NCT04032093|76110865|FG009|NOT COMPLETED|Overall Study||18||
59995048|NCT01675167|76110889|FG000|STARTED|Open-label Titration Phase||815||
59995049|NCT01675167|76110890|FG001|STARTED|Open-label Titration Phase||0||
59995050|NCT01675167|76110891|FG002|STARTED|Open-label Titration Phase||0||
59995051|NCT01675167|76110889|FG000|COMPLETED|Open-label Titration Phase||511||
59995052|NCT01675167|76110890|FG001|COMPLETED|Open-label Titration Phase||0||
59995053|NCT01675167|76110891|FG002|COMPLETED|Open-label Titration Phase||0||
59995054|NCT01675167|76110889|FG000|NOT COMPLETED|Open-label Titration Phase||304||
59995055|NCT01675167|76110890|FG001|NOT COMPLETED|Open-label Titration Phase||0||
59995056|NCT01675167|76110891|FG002|NOT COMPLETED|Open-label Titration Phase||0||
59995057|NCT01675167|76110889|FG000|STARTED|Double-blind Treatment Phase|All subjects completing OL titration in the previous period were randomized to a DB treatment.|0||
59995058|NCT01675167|76110890|FG001|STARTED|Double-blind Treatment Phase|Subjects were randomized to DB treatment after completing OL titration in the previous period.|254||
60075067|NCT00638404|76190337|FG000|NOT COMPLETED|Overall Study||8||
60075068|NCT00638404|76190338|FG001|NOT COMPLETED|Overall Study||0||
60075069|NCT01550757|76190352|FG000|STARTED|Overall Study||56||
59987344|NCT02289352|76102641|FG001|PP Population|Overall Study||173|Participants completed all visits and assessments, dose compliance, and followed restrictions.|
59987345|NCT02289352|76102642|FG002|PP Population|Overall Study||54|Participants completed all visits and assessments, dose compliance, and followed restrictions.|
59987346|NCT02289352|76102640|FG000|COMPLETED|Overall Study||198||
59987347|NCT02289352|76102641|FG001|COMPLETED|Overall Study||198||
59987348|NCT02289352|76102642|FG002|COMPLETED|Overall Study||64||
59987349|NCT02289352|76102640|FG000|NOT COMPLETED|Overall Study||1||
59987350|NCT02289352|76102641|FG001|NOT COMPLETED|Overall Study||1||
59987351|NCT02289352|76102642|FG002|NOT COMPLETED|Overall Study||0||
59987352|NCT02315560|76102651|FG000|STARTED|Overall Study||25||
59987353|NCT02315560|76102651|FG000|COMPLETED|Overall Study||22||
59987354|NCT02315560|76102651|FG000|NOT COMPLETED|Overall Study||3||
59987355|NCT02522624|76102657|FG000|STARTED|Overall Study||165||
59987356|NCT02522624|76102658|FG001|STARTED|Overall Study||163||
59987357|NCT02522624|76102657|FG000|COMPLETED|Overall Study|Discontinued intervention due to technical failure (n=1)|164||
59987358|NCT02522624|76102658|FG001|COMPLETED|Overall Study||163||
59987359|NCT02522624|76102657|FG000|NOT COMPLETED|Overall Study||1||
59987360|NCT02522624|76102658|FG001|NOT COMPLETED|Overall Study||0||
59987361|NCT02287402|76102664|FG000|STARTED|Treatment Period||197||
60075070|NCT01550757|76190353|FG001|STARTED|Overall Study||52||
60075071|NCT01550757|76190354|FG002|STARTED|Overall Study||130||
60075072|NCT01550757|76190355|FG003|STARTED|Overall Study||144||
60075073|NCT01550757|76190352|FG000|COMPLETED|Overall Study||33||
60075074|NCT01550757|76190353|FG001|COMPLETED|Overall Study||38||
60075075|NCT01550757|76190354|FG002|COMPLETED|Overall Study||85||
60075076|NCT01550757|76190355|FG003|COMPLETED|Overall Study||90||
60075077|NCT01550757|76190352|FG000|NOT COMPLETED|Overall Study||23||
60075078|NCT01550757|76190353|FG001|NOT COMPLETED|Overall Study||14||
60075079|NCT01550757|76190354|FG002|NOT COMPLETED|Overall Study||45||
60075080|NCT01550757|76190355|FG003|NOT COMPLETED|Overall Study||54||
60075081|NCT01685073|76190367|FG000|STARTED|Overall Study|Randomized|62||
59987362|NCT02287402|76102664|FG000|COMPLETED|Treatment Period||170||
59987363|NCT02287402|76102664|FG000|NOT COMPLETED|Treatment Period||27||
59987364|NCT02287402|76102664|FG000|STARTED|Follow-up|64 participants who completed the Treatment Period did not continue to Follow-up.|106||
59987365|NCT02287402|76102664|FG000|COMPLETED|Follow-up||103||
59987366|NCT02287402|76102664|FG000|NOT COMPLETED|Follow-up||3||
59987367|NCT02314780|76102671|FG000|STARTED|Overall Study||9||
59987368|NCT02314780|76102672|FG001|STARTED|Overall Study||10||
59987369|NCT02314780|76102673|FG002|STARTED|Overall Study||8||
59987370|NCT02314780|76102671|FG000|COMPLETED|Overall Study||9||
59987371|NCT02314780|76102672|FG001|COMPLETED|Overall Study||7||
59987372|NCT02314780|76102673|FG002|COMPLETED|Overall Study||8||
59987373|NCT02314780|76102671|FG000|NOT COMPLETED|Overall Study||0||
59987374|NCT02314780|76102672|FG001|NOT COMPLETED|Overall Study||3||
59987375|NCT02314780|76102673|FG002|NOT COMPLETED|Overall Study||0||
59987376|NCT02288182|76102683|FG000|STARTED|Overall Study||25||
59987377|NCT02288182|76102684|FG001|STARTED|Overall Study||27||
59987378|NCT02288182|76102683|FG000|COMPLETED|Overall Study||25||
59987379|NCT02288182|76102684|FG001|COMPLETED|Overall Study||25||
59987380|NCT02288182|76102683|FG000|NOT COMPLETED|Overall Study||0||
59987381|NCT02288182|76102684|FG001|NOT COMPLETED|Overall Study||2||
59987382|NCT02286466|76102694|FG000|STARTED|Overall Study||72||
59987383|NCT02286466|76102695|FG001|STARTED|Overall Study||73||
59987384|NCT02286466|76102694|FG000|Baseline Clinician Assessment|Overall Study||72||
59987385|NCT02286466|76102695|FG001|Baseline Clinician Assessment|Overall Study||72||
59987386|NCT02286466|76102694|FG000|Post Self-report|Overall Study||67||
59987387|NCT02286466|76102695|FG001|Post Self-report|Overall Study||68||
59987388|NCT02286466|76102694|FG000|COMPLETED|Overall Study||65|Post clinician assessment is collected after completing post self-report survey.|
60075082|NCT01685073|76190368|FG001|STARTED|Overall Study|Randomized|65||
60075083|NCT01685073|76190367|FG000|COMPLETED|Overall Study|Retained in treatment through 12 weeks|32||
59815175|NCT00531284|75937561|FG012|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0||
59815176|NCT00531284|75937562|FG013|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0||
59815177|NCT00531284|75937563|FG014|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|3||
59987389|NCT02286466|76102695|FG001|COMPLETED|Overall Study||63|Post clinician assessment is collected after completing post self-report survey.|
60075084|NCT01685073|76190368|FG001|COMPLETED|Overall Study|Retained in treatment through 12 weeks|33||
59987390|NCT02286466|76102694|FG000|NOT COMPLETED|Overall Study||7||
59987391|NCT02286466|76102695|FG001|NOT COMPLETED|Overall Study||10||
59987392|NCT02313766|76102704|FG000|STARTED|Overall Study||50||
59987393|NCT02313766|76102705|FG001|STARTED|Overall Study||50||
59987394|NCT02313766|76102706|FG002|STARTED|Overall Study||50||
60075085|NCT01685073|76190367|FG000|NOT COMPLETED|Overall Study||30||
60075086|NCT01685073|76190368|FG001|NOT COMPLETED|Overall Study||32||
60075087|NCT01572909|76190376|FG000|STARTED|Overall Study||152||
59987395|NCT02313766|76102704|FG000|COMPLETED|Overall Study||49||
59987396|NCT02313766|76102705|FG001|COMPLETED|Overall Study||47||
59987397|NCT02313766|76102706|FG002|COMPLETED|Overall Study||50||
59987398|NCT02313766|76102704|FG000|NOT COMPLETED|Overall Study||1||
59987399|NCT02313766|76102705|FG001|NOT COMPLETED|Overall Study||3||
59987400|NCT02313766|76102706|FG002|NOT COMPLETED|Overall Study||0||
59987401|NCT01646398|76102716|FG000|STARTED|Overall Study||382||
59815178|NCT00531284|75937564|FG015|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|2||
59987402|NCT01646398|76102717|FG001|STARTED|Overall Study||382||
59987403|NCT01646398|76102716|FG000|COMPLETED|Overall Study||381||
60075088|NCT01572909|76190377|FG001|STARTED|Overall Study||148||
60075089|NCT01572909|76190376|FG000|COMPLETED|Overall Study||120||
60075090|NCT01572909|76190377|FG001|COMPLETED|Overall Study||123||
60075091|NCT01572909|76190376|FG000|NOT COMPLETED|Overall Study||32||
60075092|NCT01572909|76190377|FG001|NOT COMPLETED|Overall Study||25||
60075093|NCT01572675|76190387|FG000|STARTED|Overall Study||268||
60075094|NCT01572675|76190388|FG001|STARTED|Overall Study||279||
60075095|NCT01572675|76190387|FG000|COMPLETED|Overall Study||31||
60075096|NCT01572675|76190388|FG001|COMPLETED|Overall Study||56||
60075097|NCT01572675|76190387|FG000|NOT COMPLETED|Overall Study||237||
60075098|NCT01572675|76190388|FG001|NOT COMPLETED|Overall Study||223||
60075099|NCT05065983|76190407|FG000|STARTED|Overall Study||25||
60075100|NCT05065983|76190407|FG000|Exposed|Overall Study||25|Screened participants who received study vaccination.|
60075101|NCT05065983|76190407|FG000|Safety|Overall Study||25|Participants who received study vaccination and provided safety assessment data.|
60075102|NCT05065983|76190407|FG000|mITT|Overall Study||25|Modified Intent-to-treat Population = All participants who were vaccinated and had at least one post injection anti-CHIKV SNA NT80 result.|
60075103|NCT05065983|76190407|FG000|COMPLETED|Overall Study||23||
60075104|NCT05065983|76190407|FG000|NOT COMPLETED|Overall Study||2||
60075105|NCT04797650|76190414|FG000|STARTED|Overall Study||130||
59987404|NCT01646398|76102717|FG001|COMPLETED|Overall Study||382||
59987405|NCT01646398|76102716|FG000|NOT COMPLETED|Overall Study||1||
59987406|NCT01646398|76102717|FG001|NOT COMPLETED|Overall Study||0||
59987407|NCT01646320|76102725|FG000|STARTED|Short-term Period (Day 1 to Week 24)||160||
59987408|NCT01646320|76102726|FG001|STARTED|Short-term Period (Day 1 to Week 24)||160||
59987409|NCT01646320|76102725|FG000|COMPLETED|Short-term Period (Day 1 to Week 24)||148||
60075106|NCT04797650|76190415|FG001|STARTED|Overall Study||258||
60075107|NCT04797650|76190416|FG002|STARTED|Overall Study||129||
60075108|NCT04797650|76190414|FG000|Efficacy Population|Overall Study||127|Efficacy population included all participants who were randomized in the study and dispensed study drug during the treatment period.|
60075109|NCT04797650|76190415|FG001|Efficacy Population|Overall Study||249|Efficacy population included all participants who were randomized in the study and dispensed study drug during the treatment period.|
60075110|NCT04797650|76190416|FG002|Efficacy Population|Overall Study||127|Efficacy population included all participants who were randomized in the study and dispensed study drug during the treatment period.|
60075111|NCT04797650|76190414|FG000|Safety Population|Overall Study||130|Safety population included all participants who received study drug during the treatment period|
60075112|NCT04797650|76190415|FG001|Safety Population|Overall Study||256|Safety population included all participants who received study drug during the treatment period|
60075113|NCT04797650|76190416|FG002|Safety Population|Overall Study||129|Safety population included all participants who received study drug during the treatment period|
60075114|NCT04797650|76190414|FG000|COMPLETED|Overall Study||119||
60075115|NCT04797650|76190415|FG001|COMPLETED|Overall Study||233||
60075116|NCT04797650|76190416|FG002|COMPLETED|Overall Study||120||
60075117|NCT04797650|76190414|FG000|NOT COMPLETED|Overall Study||11||
60075118|NCT04797650|76190415|FG001|NOT COMPLETED|Overall Study||25||
60075119|NCT04797650|76190416|FG002|NOT COMPLETED|Overall Study||9||
59987410|NCT01646320|76102726|FG001|COMPLETED|Short-term Period (Day 1 to Week 24)||153||
59987411|NCT01646320|76102725|FG000|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||12||
60075120|NCT04705597|76190428|FG000|STARTED|Overall Study||96||
60075121|NCT04705597|76190429|FG001|STARTED|Overall Study||98||
60075122|NCT04705597|76190428|FG000|COMPLETED|Overall Study||78||
60075123|NCT04705597|76190429|FG001|COMPLETED|Overall Study||87||
60075124|NCT04705597|76190428|FG000|NOT COMPLETED|Overall Study||18||
60075125|NCT04705597|76190429|FG001|NOT COMPLETED|Overall Study||11||
60075126|NCT04534114|76190439|FG000|STARTED|Main Treatment Period||77||
60075127|NCT04534114|76190440|FG001|STARTED|Main Treatment Period||79||
60075128|NCT04534114|76190441|FG002|STARTED|Main Treatment Period||76||
60075129|NCT04534114|76190442|FG003|STARTED|Main Treatment Period||75||
59815179|NCT00531284|75937565|FG016|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0||
59815180|NCT00531284|75937549|FG000|NOT COMPLETED|Overall Study||3||
59815181|NCT00531284|75937550|FG001|NOT COMPLETED|Overall Study||4||
59815182|NCT00531284|75937551|FG002|NOT COMPLETED|Overall Study||6||
59815183|NCT00531284|75937552|FG003|NOT COMPLETED|Overall Study||63||
59815184|NCT00531284|75937553|FG004|NOT COMPLETED|Overall Study||6||
59815185|NCT00531284|75937554|FG005|NOT COMPLETED|Overall Study||7||
59815186|NCT00531284|75937555|FG006|NOT COMPLETED|Overall Study||6||
59815187|NCT00531284|75937556|FG007|NOT COMPLETED|Overall Study||10||
59987412|NCT01646320|76102726|FG001|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||7||
59987413|NCT01646320|76102725|FG000|STARTED|Long-term Period (Weeks 24 to 52)||147||
59987414|NCT01646320|76102726|FG001|STARTED|Long-term Period (Weeks 24 to 52)||147||
59987415|NCT01646320|76102725|FG000|COMPLETED|Long-term Period (Weeks 24 to 52)||141||
59987416|NCT01646320|76102726|FG001|COMPLETED|Long-term Period (Weeks 24 to 52)||140||
59987417|NCT01646320|76102725|FG000|NOT COMPLETED|Long-term Period (Weeks 24 to 52)||6||
59987418|NCT01646320|76102726|FG001|NOT COMPLETED|Long-term Period (Weeks 24 to 52)||7||
59987419|NCT02524730|76102732|FG000|STARTED|Overall Study||205||
59987420|NCT02524730|76102732|FG000|COMPLETED|Overall Study||159||
59987421|NCT02524730|76102732|FG000|NOT COMPLETED|Overall Study||46||
59987422|NCT01658150|76102736|FG000|STARTED|Overall Study||11||
59987423|NCT01658150|76102736|FG000|COMPLETED|Overall Study||10||
59987424|NCT01658150|76102736|FG000|NOT COMPLETED|Overall Study||1||
59987425|NCT02285998|76102743|FG000|STARTED|Overall Study||4474||
59987426|NCT02285998|76102744|FG001|STARTED|Overall Study||4489||
59987427|NCT02285998|76102743|FG000|COMPLETED|Overall Study||4228||
59987428|NCT02285998|76102744|FG001|COMPLETED|Overall Study||4236||
59987429|NCT02285998|76102743|FG000|NOT COMPLETED|Overall Study||246||
59987430|NCT02285998|76102744|FG001|NOT COMPLETED|Overall Study||253||
59987431|NCT01658072|76102752|FG000|STARTED|Overall Study||45||
59987432|NCT01658072|76102753|FG001|STARTED|Overall Study||45||
59987433|NCT01658072|76102752|FG000|COMPLETED|Overall Study||41||
59987434|NCT01658072|76102753|FG001|COMPLETED|Overall Study||43||
59987435|NCT01658072|76102752|FG000|NOT COMPLETED|Overall Study||4||
59987436|NCT01658072|76102753|FG001|NOT COMPLETED|Overall Study||2||
59987437|NCT02285920|76102763|FG000|STARTED|Overall Study||51||
59987438|NCT02285920|76102764|FG001|STARTED|Overall Study||27||
59987439|NCT02285920|76102765|FG002|STARTED|Overall Study||26||
59987440|NCT02285920|76102766|FG003|STARTED|Overall Study||25||
59987441|NCT02285920|76102763|FG000|COMPLETED|Overall Study||47||
59987442|NCT02285920|76102764|FG001|COMPLETED|Overall Study||23||
59987443|NCT02285920|76102765|FG002|COMPLETED|Overall Study||21||
59987444|NCT02285920|76102766|FG003|COMPLETED|Overall Study||24||
59987445|NCT02285920|76102763|FG000|NOT COMPLETED|Overall Study||4||
59987446|NCT02285920|76102764|FG001|NOT COMPLETED|Overall Study||4||
59987447|NCT02285920|76102765|FG002|NOT COMPLETED|Overall Study||5||
59987448|NCT02285920|76102766|FG003|NOT COMPLETED|Overall Study||1||
59987449|NCT02035137|76102779|FG000|STARTED|Overall Study||38||
59987450|NCT02035137|76102780|FG001|STARTED|Overall Study||37||
59987451|NCT02035137|76102781|FG002|STARTED|Overall Study||39||
59987452|NCT02035137|76102779|FG000|COMPLETED|Overall Study||36||
59987453|NCT02035137|76102780|FG001|COMPLETED|Overall Study||35||
59987454|NCT02035137|76102781|FG002|COMPLETED|Overall Study||34||
59987455|NCT02035137|76102779|FG000|NOT COMPLETED|Overall Study||2||
59527192|NCT01114997|75622822|FG002|NOT COMPLETED|Overall Study||0||
59815188|NCT00531284|75937557|FG008|NOT COMPLETED|Overall Study||11||
59815189|NCT00531284|75937558|FG009|NOT COMPLETED|Overall Study||4||
59815190|NCT00531284|75937559|FG010|NOT COMPLETED|Overall Study||3||
59815191|NCT00531284|75937560|FG011|NOT COMPLETED|Overall Study||24||
59815192|NCT00531284|75937561|FG012|NOT COMPLETED|Overall Study||2||
59815193|NCT00531284|75937562|FG013|NOT COMPLETED|Overall Study||3||
59815194|NCT00531284|75937563|FG014|NOT COMPLETED|Overall Study||4||
59815195|NCT00531284|75937564|FG015|NOT COMPLETED|Overall Study||12||
59815196|NCT00531284|75937565|FG016|NOT COMPLETED|Overall Study||8||
59815197|NCT00531206|75937621|FG000|STARTED|Overall Study||65||
59815198|NCT00531206|75937621|FG000|COMPLETED|Overall Study||45||
59815199|NCT00531206|75937621|FG000|NOT COMPLETED|Overall Study||20||
59815200|NCT00530816|75937628|FG000|STARTED|Overall Study||35||
59815201|NCT00530816|75937629|FG001|STARTED|Overall Study||59||
59815202|NCT00530816|75937630|FG002|STARTED|Overall Study||70||
59815203|NCT00530816|75937628|FG000|COMPLETED|Overall Study||9||
59815204|NCT00530816|75937629|FG001|COMPLETED|Overall Study||17||
59815205|NCT00530816|75937630|FG002|COMPLETED|Overall Study||29||
59815206|NCT00530816|75937628|FG000|NOT COMPLETED|Overall Study||26||
59815207|NCT00530816|75937629|FG001|NOT COMPLETED|Overall Study||42||
59815208|NCT00530816|75937630|FG002|NOT COMPLETED|Overall Study||41||
59815209|NCT00615017|75937644|FG000|STARTED|Overall Study|Patients received treatment|8||
59815210|NCT00615017|75937645|FG001|STARTED|Overall Study|Patients received treatment|9||
59815211|NCT00615017|75937646|FG002|STARTED|Overall Study|Patients received treatment|12||
59987456|NCT02035137|76102780|FG001|NOT COMPLETED|Overall Study||2||
59987457|NCT02035137|76102781|FG002|NOT COMPLETED|Overall Study||5||
59987458|NCT02522780|76102791|FG000|STARTED|Overall Study||138||
59987459|NCT02522780|76102792|FG001|STARTED|Overall Study||138||
59987460|NCT02522780|76102791|FG000|Treated|Overall Study||137||
59987461|NCT02522780|76102792|FG001|Treated|Overall Study||135||
59987462|NCT02522780|76102791|FG000|Intention-to-treat (ITT) Population|Overall Study||136||
59987463|NCT02522780|76102792|FG001|Intention-to-treat (ITT) Population|Overall Study||136||
59987464|NCT02522780|76102791|FG000|COMPLETED|Overall Study||121||
59987465|NCT02522780|76102792|FG001|COMPLETED|Overall Study||111||
59987466|NCT02522780|76102791|FG000|NOT COMPLETED|Overall Study||17||
59987467|NCT02522780|76102792|FG001|NOT COMPLETED|Overall Study||27||
59987468|NCT03566199|76102799|FG000|STARTED|Overall Study||1||
59987469|NCT03566199|76102800|FG001|STARTED|Overall Study||0||
59987470|NCT03566199|76102801|FG002|STARTED|Overall Study||1||
59815212|NCT00615017|75937647|FG003|STARTED|Overall Study|Patients received treatment|10||
59815213|NCT00615017|75937648|FG004|STARTED|Overall Study|Patients received treatment|8||
59815214|NCT00615017|75937649|FG005|STARTED|Overall Study|Patients received treatment|23||
59815215|NCT00615017|75937644|FG000|COMPLETED|Overall Study|Patient completed the study drug|8||
59815216|NCT00615017|75937645|FG001|COMPLETED|Overall Study|Patient completed the study drug|8||
59815217|NCT00615017|75937646|FG002|COMPLETED|Overall Study|Patient completed the study drug|7||
59815218|NCT00615017|75937647|FG003|COMPLETED|Overall Study|Patient completed the study drug|9||
59987471|NCT03566199|76102802|FG003|STARTED|Overall Study||0||
59987472|NCT03566199|76102803|FG004|STARTED|Overall Study||1||
59987473|NCT03566199|76102804|FG005|STARTED|Overall Study||0||
59987474|NCT03566199|76102805|FG006|STARTED|Overall Study||4||
59987475|NCT03566199|76102806|FG007|STARTED|Overall Study||0||
59987476|NCT03566199|76102799|FG000|COMPLETED|Overall Study||1||
59987477|NCT03566199|76102800|FG001|COMPLETED|Overall Study||0||
59987478|NCT03566199|76102801|FG002|COMPLETED|Overall Study||1||
59987479|NCT03566199|76102802|FG003|COMPLETED|Overall Study||0||
59987480|NCT03566199|76102803|FG004|COMPLETED|Overall Study||1||
59987481|NCT03566199|76102804|FG005|COMPLETED|Overall Study||0||
59987482|NCT03566199|76102805|FG006|COMPLETED|Overall Study||4||
60075130|NCT04534114|76190439|FG000|COMPLETED|Main Treatment Period||67||
60075131|NCT04534114|76190440|FG001|COMPLETED|Main Treatment Period||66||
60075132|NCT04534114|76190441|FG002|COMPLETED|Main Treatment Period||64||
60075133|NCT04534114|76190442|FG003|COMPLETED|Main Treatment Period||61||
60075134|NCT04534114|76190439|FG000|NOT COMPLETED|Main Treatment Period||10||
60075135|NCT04534114|76190440|FG001|NOT COMPLETED|Main Treatment Period||13||
60075136|NCT04534114|76190441|FG002|NOT COMPLETED|Main Treatment Period||12||
60075137|NCT04534114|76190442|FG003|NOT COMPLETED|Main Treatment Period||14||
60075138|NCT04534114|76190439|FG000|STARTED|Extension Treatment Period||62||
60075139|NCT04534114|76190440|FG001|STARTED|Extension Treatment Period||61||
60075140|NCT04534114|76190441|FG002|STARTED|Extension Treatment Period||63||
60075141|NCT04534114|76190442|FG003|STARTED|Extension Treatment Period||58||
59987483|NCT03566199|76102806|FG007|COMPLETED|Overall Study||0||
59987484|NCT03566199|76102799|FG000|NOT COMPLETED|Overall Study||0||
59987485|NCT03566199|76102800|FG001|NOT COMPLETED|Overall Study||0||
59987486|NCT03566199|76102801|FG002|NOT COMPLETED|Overall Study||0||
59987487|NCT03566199|76102802|FG003|NOT COMPLETED|Overall Study||0||
59987488|NCT03566199|76102803|FG004|NOT COMPLETED|Overall Study||0||
60075142|NCT04534114|76190439|FG000|COMPLETED|Extension Treatment Period||59||
60075143|NCT04534114|76190440|FG001|COMPLETED|Extension Treatment Period||57||
60075144|NCT04534114|76190441|FG002|COMPLETED|Extension Treatment Period||62||
60075145|NCT04534114|76190442|FG003|COMPLETED|Extension Treatment Period||53||
60075146|NCT04534114|76190439|FG000|NOT COMPLETED|Extension Treatment Period||3||
60075147|NCT04534114|76190440|FG001|NOT COMPLETED|Extension Treatment Period||4||
60075148|NCT04534114|76190441|FG002|NOT COMPLETED|Extension Treatment Period||1||
60075149|NCT04534114|76190442|FG003|NOT COMPLETED|Extension Treatment Period||5||
60075150|NCT04515641|76190454|FG000|STARTED|Overall Study||6||
60075151|NCT04515641|76190455|FG001|STARTED|Overall Study||6||
60075152|NCT04515641|76190454|FG000|COMPLETED|Overall Study||6||
60075153|NCT04515641|76190455|FG001|COMPLETED|Overall Study||6||
60075154|NCT04515641|76190454|FG000|NOT COMPLETED|Overall Study||0||
60075155|NCT04515641|76190455|FG001|NOT COMPLETED|Overall Study||0||
60075156|NCT04474366|76190463|FG000|STARTED|Overall Study||23||
60075157|NCT04474366|76190464|FG001|STARTED|Overall Study||27||
60075158|NCT04474366|76190463|FG000|COMPLETED|Overall Study||21||
60075159|NCT04474366|76190464|FG001|COMPLETED|Overall Study||22||
60075160|NCT04474366|76190463|FG000|NOT COMPLETED|Overall Study||2||
60075161|NCT04474366|76190464|FG001|NOT COMPLETED|Overall Study||5||
59527193|NCT00118742|75622833|FG000|STARTED|Overall Study||145||
59815219|NCT00615017|75937648|FG004|COMPLETED|Overall Study|Patient completed the study drug|7||
59815220|NCT00615017|75937649|FG005|COMPLETED|Overall Study|Patient completed the study drug|20||
59987489|NCT03566199|76102804|FG005|NOT COMPLETED|Overall Study||0||
59987490|NCT03566199|76102805|FG006|NOT COMPLETED|Overall Study||0||
59815221|NCT00615017|75937644|FG000|NOT COMPLETED|Overall Study||0||
59815222|NCT00615017|75937645|FG001|NOT COMPLETED|Overall Study||1||
59987491|NCT03566199|76102806|FG007|NOT COMPLETED|Overall Study||0||
59987492|NCT02285062|76102812|FG000|STARTED|Pre-Treatment Period||285|Started = Randomized|
60075162|NCT04422431|76190470|FG000|STARTED|Treatment Period (48 Weeks)||31||
60075163|NCT04422431|76190470|FG000|Received at Least 1 Dose of Study Drug|Treatment Period (48 Weeks)||31||
60075164|NCT04422431|76190470|FG000|COMPLETED|Treatment Period (48 Weeks)||26||
60075165|NCT04422431|76190470|FG000|NOT COMPLETED|Treatment Period (48 Weeks)||5||
60075166|NCT04422431|76190470|FG000|STARTED|Extension Period (48 Weeks)|1 participant completed treatment period but did not enter the extension period.|25||
60075167|NCT04422431|76190470|FG000|COMPLETED|Extension Period (48 Weeks)||0||
59987493|NCT02285062|76102813|FG001|STARTED|Pre-Treatment Period||285|Started = Randomized|
59987494|NCT02285062|76102812|FG000|COMPLETED|Pre-Treatment Period||284|Completed = Received StudyTreatment|
59987495|NCT02285062|76102813|FG001|COMPLETED|Pre-Treatment Period||283|Completed = Received StudyTreatment|
59987496|NCT02285062|76102812|FG000|NOT COMPLETED|Pre-Treatment Period||1||
59987497|NCT02285062|76102813|FG001|NOT COMPLETED|Pre-Treatment Period||2||
60075168|NCT04422431|76190470|FG000|NOT COMPLETED|Extension Period (48 Weeks)||25||
60075169|NCT04406649|76190475|FG000|STARTED|Overall Study||482||
60075170|NCT04406649|76190475|FG000|COMPLETED|Overall Study||205||
60075171|NCT04406649|76190475|FG000|NOT COMPLETED|Overall Study||277||
60075172|NCT04115488|76190481|FG000|STARTED|Overall Study||131||
60075173|NCT04115488|76190482|FG001|STARTED|Overall Study||133||
60075174|NCT04115488|76190481|FG000|Patients Re-randomized and Switched From Tysabri to PB006 at Week 24.|Overall Study||0||
60075175|NCT04115488|76190482|FG001|Patients Re-randomized and Switched From Tysabri to PB006 at Week 24.|Overall Study||30||
60075176|NCT04115488|76190481|FG000|Patients Continuing on Tysabri Following the Re-randomization at Week 24.|Overall Study||0||
59987498|NCT02285062|76102812|FG000|STARTED|Treatment Period|1 participant was initially randomized in the Placebo plus R-CHOP Arm, but received lenalidomide, and thus, was reassigned to the R2-CHOP Arm.|283||
59987499|NCT02285062|76102813|FG001|STARTED|Treatment Period|2 participants were initially randomized in the R2-CHOP Arm, they never received a dose of lenalidomide, and thus, were reassigned to the Placebo-R-CHOP Arm.|284||
59987500|NCT02285062|76102812|FG000|COMPLETED|Treatment Period||211|Completed = six full cycles of both len/pbo and R-CHOP|
59987501|NCT02285062|76102813|FG001|COMPLETED|Treatment Period||240|Completed = six full cycles of both len/pbo and R-CHOP|
59987502|NCT02285062|76102812|FG000|NOT COMPLETED|Treatment Period||72||
59987503|NCT02285062|76102813|FG001|NOT COMPLETED|Treatment Period||44||
59987504|NCT01352741|76102819|FG000|STARTED|Open-label Tapentadol Titration Period|All participants started with 2 x 50 mg tapentadol PR and titrated upwards in steps of 100 mg/day.|445||
59987505|NCT01352741|76102820|FG001|STARTED|Open-label Tapentadol Titration Period||0||
59987506|NCT01352741|76102819|FG000|Switched to Open-label Continuation Arm|Open-label Tapentadol Titration Period||59||
60075177|NCT04115488|76190482|FG001|Patients Continuing on Tysabri Following the Re-randomization at Week 24.|Overall Study||95||
59987507|NCT01352741|76102820|FG001|Switched to Open-label Continuation Arm|Open-label Tapentadol Titration Period||0||
59987508|NCT01352741|76102819|FG000|Full Analysis Set|Open-label Tapentadol Titration Period||436||
59987509|NCT01352741|76102820|FG001|Full Analysis Set|Open-label Tapentadol Titration Period||0||
59987510|NCT01352741|76102819|FG000|COMPLETED|Open-label Tapentadol Titration Period|59 of 73 participants not completing the titration period entered the open-label continuation arm.|372||
59987511|NCT01352741|76102820|FG001|COMPLETED|Open-label Tapentadol Titration Period||0||
59987512|NCT01352741|76102819|FG000|NOT COMPLETED|Open-label Tapentadol Titration Period||73||
59987513|NCT01352741|76102820|FG001|NOT COMPLETED|Open-label Tapentadol Titration Period||0||
59987514|NCT01352741|76102819|FG000|STARTED|Double-blind Comparative Period|Of the 313 participants that qualified for randomization 154 were randomized to tapentadol.|154||
59987515|NCT01352741|76102820|FG001|STARTED|Double-blind Comparative Period|159 of the 313 participants that qualified were randomized to tapentadol and pregabalin treatment.|159||
59987516|NCT01352741|76102819|FG000|Switched to Open-label Pick-up Arm|Double-blind Comparative Period||19||
59987517|NCT01352741|76102820|FG001|Switched to Open-label Pick-up Arm|Double-blind Comparative Period||18||
59987518|NCT01352741|76102819|FG000|No Pain Assessments Available|Double-blind Comparative Period||2||
59987519|NCT01352741|76102820|FG001|No Pain Assessments Available|Double-blind Comparative Period||2||
59987520|NCT01352741|76102819|FG000|Full Analysis Set|Double-blind Comparative Period||152||
59987521|NCT01352741|76102820|FG001|Full Analysis Set|Double-blind Comparative Period||157||
59987522|NCT01352741|76102819|FG000|Major Protocol Deviations|Double-blind Comparative Period||13||
59987523|NCT01352741|76102820|FG001|Major Protocol Deviations|Double-blind Comparative Period||8||
59987524|NCT01352741|76102819|FG000|Per Protocol Set|Double-blind Comparative Period||139||
59987525|NCT01352741|76102820|FG001|Per Protocol Set|Double-blind Comparative Period||149||
59987526|NCT01352741|76102819|FG000|painDetect Per Protocol Set|Double-blind Comparative Period||109||
59987527|NCT01352741|76102820|FG001|painDetect Per Protocol Set|Double-blind Comparative Period||127||
59987528|NCT01352741|76102819|FG000|SF-12 Per Protocol Set|Double-blind Comparative Period||131||
59987529|NCT01352741|76102820|FG001|SF-12 Per Protocol Set|Double-blind Comparative Period||143||
59987530|NCT01352741|76102819|FG000|EQ-5D Per Protocol Set|Double-blind Comparative Period||131||
59987531|NCT01352741|76102820|FG001|EQ-5D Per Protocol Set|Double-blind Comparative Period||143||
60075178|NCT04115488|76190481|FG000|COMPLETED|Overall Study||117||
60075179|NCT04115488|76190482|FG001|COMPLETED|Overall Study||122||
60075180|NCT04115488|76190481|FG000|NOT COMPLETED|Overall Study||14||
60075181|NCT04115488|76190482|FG001|NOT COMPLETED|Overall Study||11||
60075182|NCT04080752|76190506|FG000|STARTED|Overall Study||112||
60075183|NCT04080752|76190507|FG001|STARTED|Overall Study||110||
60075184|NCT04080752|76190506|FG000|COMPLETED|Overall Study||99||
60075185|NCT04080752|76190507|FG001|COMPLETED|Overall Study||104||
60075186|NCT04080752|76190506|FG000|NOT COMPLETED|Overall Study||13||
60075187|NCT04080752|76190507|FG001|NOT COMPLETED|Overall Study||6||
60075188|NCT03968419|76190517|FG000|STARTED|Treatment Period||35||
60075189|NCT03968419|76190518|FG001|STARTED|Treatment Period||35||
60075190|NCT03968419|76190519|FG002|STARTED|Treatment Period||18||
60075191|NCT03968419|76190517|FG000|COMPLETED|Treatment Period||35||
60075192|NCT03968419|76190518|FG001|COMPLETED|Treatment Period||35||
60075193|NCT03968419|76190519|FG002|COMPLETED|Treatment Period||17||
59987532|NCT01352741|76102819|FG000|HADS Per Protocol Set (PPS)|Double-blind Comparative Period||123||
59987533|NCT01352741|76102820|FG001|HADS Per Protocol Set (PPS)|Double-blind Comparative Period||137||
59987534|NCT01352741|76102819|FG000|Sleep Evaluation (Latency) PPS|Double-blind Comparative Period||123||
59987535|NCT01352741|76102820|FG001|Sleep Evaluation (Latency) PPS|Double-blind Comparative Period||137||
60075194|NCT03968419|76190517|FG000|NOT COMPLETED|Treatment Period||0||
60075195|NCT03968419|76190518|FG001|NOT COMPLETED|Treatment Period||0||
60075196|NCT03968419|76190519|FG002|NOT COMPLETED|Treatment Period||1||
60075197|NCT03968419|76190517|FG000|STARTED|Safety Follow-up Period||35||
60075198|NCT03968419|76190518|FG001|STARTED|Safety Follow-up Period||35||
60075199|NCT03968419|76190519|FG002|STARTED|Safety Follow-up Period||18||
59987536|NCT01352741|76102819|FG000|Sleep Evaluations (Awakenings) PPS|Double-blind Comparative Period||123||
59987537|NCT01352741|76102820|FG001|Sleep Evaluations (Awakenings) PPS|Double-blind Comparative Period||137||
59527194|NCT00118742|75622834|FG001|STARTED|Overall Study||148||
59527195|NCT00118742|75622833|FG000|COMPLETED|Overall Study||96||
59527196|NCT00118742|75622834|FG001|COMPLETED|Overall Study||82||
59987538|NCT01352741|76102819|FG000|Sleep Evaluations (Hours Slept) PPS|Double-blind Comparative Period||123||
59987539|NCT01352741|76102820|FG001|Sleep Evaluations (Hours Slept) PPS|Double-blind Comparative Period||137||
59987540|NCT01352741|76102819|FG000|COMPLETED|Double-blind Comparative Period||126||
59987541|NCT01352741|76102820|FG001|COMPLETED|Double-blind Comparative Period||133||
59987542|NCT01352741|76102819|FG000|NOT COMPLETED|Double-blind Comparative Period||28||
59987543|NCT01352741|76102820|FG001|NOT COMPLETED|Double-blind Comparative Period||26||
59987544|NCT01352741|76102819|FG000|STARTED|Open-Label Tapentadol Continuation Arm|59 of the 73 participants that did not qualify for the comparative period entered this arm.|59||
59987545|NCT01352741|76102820|FG001|STARTED|Open-Label Tapentadol Continuation Arm|In this period no tapentadol PR and pregabalin treatment was planned by the protocol.|0||
59987546|NCT01352741|76102819|FG000|Major Protocol Deviation|Open-Label Tapentadol Continuation Arm||2||
59987547|NCT01352741|76102820|FG001|Major Protocol Deviation|Open-Label Tapentadol Continuation Arm||0||
59987548|NCT01352741|76102819|FG000|Full Analysis Set|Open-Label Tapentadol Continuation Arm||57||
59987549|NCT01352741|76102820|FG001|Full Analysis Set|Open-Label Tapentadol Continuation Arm||0||
59987550|NCT01352741|76102819|FG000|COMPLETED|Open-Label Tapentadol Continuation Arm||51||
59987551|NCT01352741|76102820|FG001|COMPLETED|Open-Label Tapentadol Continuation Arm||0||
59987552|NCT01352741|76102819|FG000|NOT COMPLETED|Open-Label Tapentadol Continuation Arm||8||
59987553|NCT01352741|76102820|FG001|NOT COMPLETED|Open-Label Tapentadol Continuation Arm||0||
59987554|NCT01352741|76102819|FG000|STARTED|Open-Label Tapentadol Pick-Up Arm|19 from tapentadol in the comparative phase and 18 from tapentadol & pregabalin entered this arm.|37||
59987555|NCT01352741|76102820|FG001|STARTED|Open-Label Tapentadol Pick-Up Arm|Participants did not continue treatment. They were switched to tapentadol PR or discontinued.|0||
59987556|NCT01352741|76102819|FG000|COMPLETED|Open-Label Tapentadol Pick-Up Arm||37||
59987557|NCT01352741|76102820|FG001|COMPLETED|Open-Label Tapentadol Pick-Up Arm||0||
59987558|NCT01352741|76102819|FG000|NOT COMPLETED|Open-Label Tapentadol Pick-Up Arm||0||
59987559|NCT01352741|76102820|FG001|NOT COMPLETED|Open-Label Tapentadol Pick-Up Arm||0||
59987560|NCT01657292|76102840|FG000|STARTED|Overall Study||61||
59987561|NCT01657292|76102840|FG000|COMPLETED|Overall Study||51||
59987562|NCT01657292|76102840|FG000|NOT COMPLETED|Overall Study||10||
59987563|NCT00907907|76102849|FG000|STARTED|Period 1||20||
59987564|NCT00907907|76102850|FG001|STARTED|Period 1||20||
59987565|NCT00907907|76102849|FG000|COMPLETED|Period 1||20||
59987566|NCT00907907|76102850|FG001|COMPLETED|Period 1||20||
59987567|NCT00907907|76102849|FG000|NOT COMPLETED|Period 1||0||
59987568|NCT00907907|76102850|FG001|NOT COMPLETED|Period 1||0||
59987569|NCT00907907|76102849|FG000|STARTED|Period 2||20||
59987570|NCT00907907|76102850|FG001|STARTED|Period 2||20||
59987571|NCT00907907|76102849|FG000|COMPLETED|Period 2||20||
59987572|NCT00907907|76102850|FG001|COMPLETED|Period 2||20||
59987573|NCT00907907|76102849|FG000|NOT COMPLETED|Period 2||0||
59987574|NCT00907907|76102850|FG001|NOT COMPLETED|Period 2||0||
59987575|NCT00907907|76102849|FG000|STARTED|Period 3||20||
59987576|NCT00907907|76102850|FG001|STARTED|Period 3||20||
59987577|NCT00907907|76102849|FG000|COMPLETED|Period 3||20||
59987578|NCT00907907|76102850|FG001|COMPLETED|Period 3||20||
59987579|NCT00907907|76102849|FG000|NOT COMPLETED|Period 3||0||
60075200|NCT03968419|76190517|FG000|COMPLETED|Safety Follow-up Period||30||
60075201|NCT03968419|76190518|FG001|COMPLETED|Safety Follow-up Period||32||
59527197|NCT00118742|75622833|FG000|NOT COMPLETED|Overall Study||49||
59527198|NCT00118742|75622834|FG001|NOT COMPLETED|Overall Study||66||
59527199|NCT01034579|75622842|FG000|STARTED|Overall Study||158||
59527200|NCT01034579|75622843|FG001|STARTED|Overall Study||166||
59527201|NCT01034579|75622842|FG000|COMPLETED|Overall Study||158||
59527202|NCT01034579|75622843|FG001|COMPLETED|Overall Study||166||
59527203|NCT01034579|75622842|FG000|NOT COMPLETED|Overall Study||0||
59527204|NCT01034579|75622843|FG001|NOT COMPLETED|Overall Study||0||
59527205|NCT01317667|75622852|FG000|STARTED|Overall Study||10||
59527206|NCT01317667|75622853|FG001|STARTED|Overall Study||10||
59527207|NCT01317667|75622854|FG002|STARTED|Overall Study||10||
59527208|NCT01317667|75622852|FG000|COMPLETED|Overall Study||10||
60075202|NCT03968419|76190519|FG002|COMPLETED|Safety Follow-up Period||17||
60075203|NCT03968419|76190517|FG000|NOT COMPLETED|Safety Follow-up Period||5||
59527209|NCT01317667|75622853|FG001|COMPLETED|Overall Study||10||
60075204|NCT03968419|76190518|FG001|NOT COMPLETED|Safety Follow-up Period||3||
60075205|NCT03968419|76190519|FG002|NOT COMPLETED|Safety Follow-up Period||1||
60075206|NCT03784846|76190533|FG000|STARTED|Pre-COVID Study||17||
60075207|NCT03784846|76190534|FG001|STARTED|Pre-COVID Study||14||
60075208|NCT03784846|76190535|FG002|STARTED|Pre-COVID Study||5||
60075209|NCT03784846|76190533|FG000|COMPLETED|Pre-COVID Study||6||
60075210|NCT03784846|76190534|FG001|COMPLETED|Pre-COVID Study||3||
60075211|NCT03784846|76190535|FG002|COMPLETED|Pre-COVID Study||0||
60075212|NCT03784846|76190533|FG000|NOT COMPLETED|Pre-COVID Study||11||
60075213|NCT03784846|76190534|FG001|NOT COMPLETED|Pre-COVID Study||11||
60075214|NCT03784846|76190535|FG002|NOT COMPLETED|Pre-COVID Study||5||
60075215|NCT03784846|76190533|FG000|STARTED|Post-COVID Study||33||
60075216|NCT03784846|76190534|FG001|STARTED|Post-COVID Study||24||
60075217|NCT03784846|76190535|FG002|STARTED|Post-COVID Study||16||
60075218|NCT03784846|76190533|FG000|COMPLETED|Post-COVID Study||29||
60075219|NCT03784846|76190534|FG001|COMPLETED|Post-COVID Study||17||
59987580|NCT00907907|76102850|FG001|NOT COMPLETED|Period 3||0||
59987581|NCT00907907|76102849|FG000|STARTED|Period 4|one subject withdrew prior to Period 4 dosing|19||
59987582|NCT00907907|76102850|FG001|STARTED|Period 4|two subjects were withdrawn prior to Period 4 dosing|18||
59987583|NCT00907907|76102849|FG000|COMPLETED|Period 4||19||
59987584|NCT00907907|76102850|FG001|COMPLETED|Period 4||18||
59987585|NCT00907907|76102849|FG000|NOT COMPLETED|Period 4||0||
60075220|NCT03784846|76190535|FG002|COMPLETED|Post-COVID Study||15||
60075221|NCT03784846|76190533|FG000|NOT COMPLETED|Post-COVID Study||4||
60075222|NCT03784846|76190534|FG001|NOT COMPLETED|Post-COVID Study||7||
60075223|NCT03784846|76190535|FG002|NOT COMPLETED|Post-COVID Study||1||
60075224|NCT03756350|76190543|FG000|STARTED|Overall Study||30||
60075225|NCT03756350|76190543|FG000|COMPLETED|Overall Study||29||
60075226|NCT03756350|76190543|FG000|NOT COMPLETED|Overall Study||1||
60075227|NCT03684512|76190551|FG000|STARTED|Overall Study|57 adolescents with intellectual disabilities and 55 parents of adolescents with intellectual disabilities were enrolled. 2 parents had multiple children who enrolled in the intervention together.|57||
60075228|NCT03684512|76190552|FG001|STARTED|Overall Study|59 adolescents with intellectual disabilities and 57 parents of adolescents with intellectual disabilities were enrolled. 2 parents had multiple children who enrolled in the intervention together.|59||
59987586|NCT00907907|76102850|FG001|NOT COMPLETED|Period 4||0||
59987587|NCT00905567|76102856|FG000|STARTED|Period 1||12||
59987588|NCT00905567|76102857|FG001|STARTED|Period 1||12||
59987589|NCT00905567|76102856|FG000|COMPLETED|Period 1||12||
59987590|NCT00905567|76102857|FG001|COMPLETED|Period 1||12||
59987591|NCT00905567|76102856|FG000|NOT COMPLETED|Period 1||0||
60075229|NCT03684512|76190551|FG000|Completed 6 Months|Overall Study|47 adolescents with intellectual disabilities and 45 parents of adolescents with intellectual disabilities completed the 6 month intervention. 2 parents had multiple children who enrolled in the intervention together and remained in the study at 6 months.|47||
60075230|NCT03684512|76190552|FG001|Completed 6 Months|Overall Study|54 adolescents with intellectual disabilities and 52 parents of adolescents with intellectual disabilities completed the 6 month intervention. 2 parents had multiple children who enrolled in the intervention together and remained in the study at 6 months.|54||
60075231|NCT03684512|76190551|FG000|Completed 12 Month Active Intervention|Overall Study|40 adolescents with intellectual disabilities and 38 parents of adolescents with intellectual disabilities completed the12 month intervention. 2 parents had multiple children who enrolled in the intervention together and completed the 12 month intervention.|40||
60075232|NCT03684512|76190552|FG001|Completed 12 Month Active Intervention|Overall Study|48 adolescents with intellectual disabilities and 46 parents of adolescents with intellectual disabilities completed the12 month intervention. 2 parents had multiple children who enrolled in the intervention together and completed the 12 month intervention.|48||
60075233|NCT03684512|76190551|FG000|COMPLETED|Overall Study|37 adolescents with intellectual disabilities and 35 parents of adolescents with intellectual disabilities completed the 18 month intervention. 2 parents had multiple children who enrolled in the intervention together and remained in the study until completion.|37||
59987592|NCT00905567|76102857|FG001|NOT COMPLETED|Period 1||0||
59987593|NCT00905567|76102856|FG000|STARTED|Washout||12||
59987594|NCT00905567|76102857|FG001|STARTED|Washout||12||
59987595|NCT00905567|76102856|FG000|COMPLETED|Washout||12||
59987596|NCT00905567|76102857|FG001|COMPLETED|Washout||11||
59987597|NCT00905567|76102856|FG000|NOT COMPLETED|Washout||0||
60075234|NCT03684512|76190552|FG001|COMPLETED|Overall Study|45 adolescents with intellectual disabilities and 43 parents of adolescents with intellectual disabilities completed the 18 month intervention. 2 parents had multiple children who enrolled in the intervention together and remained in the study until completion.|45||
59987598|NCT00905567|76102857|FG001|NOT COMPLETED|Washout||1||
59987599|NCT00905567|76102856|FG000|STARTED|Period 2||12||
59987600|NCT00905567|76102857|FG001|STARTED|Period 2||11||
59987601|NCT00905567|76102856|FG000|COMPLETED|Period 2||12||
59987602|NCT00905567|76102857|FG001|COMPLETED|Period 2||11||
59987603|NCT00905567|76102856|FG000|NOT COMPLETED|Period 2||0||
59987604|NCT00905567|76102857|FG001|NOT COMPLETED|Period 2||0||
59987605|NCT02282020|76102863|FG000|STARTED|Overall Study||178||
59987606|NCT02282020|76102864|FG001|STARTED|Overall Study||88||
59987607|NCT02282020|76102863|FG000|Received Treatment|Overall Study||178||
59987608|NCT02282020|76102864|FG001|Received Treatment|Overall Study||76||
59987609|NCT02282020|76102863|FG000|COMPLETED|Overall Study||19|Ongoing study treatment at time of analysis DCO: 16 April 2021|
59987610|NCT02282020|76102864|FG001|COMPLETED|Overall Study||0|Ongoing study treatment at time of analysis DCO: 16 April 2021|
59987611|NCT02282020|76102863|FG000|NOT COMPLETED|Overall Study||159||
59987612|NCT02282020|76102864|FG001|NOT COMPLETED|Overall Study||88||
59987613|NCT00904943|76102873|FG000|STARTED|Period 1||9||
59987614|NCT00904943|76102874|FG001|STARTED|Period 1||9||
59987615|NCT00904943|76102873|FG000|COMPLETED|Period 1||9||
59987616|NCT00904943|76102874|FG001|COMPLETED|Period 1||9||
59987617|NCT00904943|76102873|FG000|NOT COMPLETED|Period 1||0||
59987618|NCT00904943|76102874|FG001|NOT COMPLETED|Period 1||0||
59987619|NCT00904943|76102873|FG000|STARTED|Period 2||9||
59987620|NCT00904943|76102874|FG001|STARTED|Period 2|one subject was withdrawn prior to Pd. 2 dosing|8||
59987621|NCT00904943|76102873|FG000|COMPLETED|Period 2||9||
60075235|NCT03684512|76190551|FG000|NOT COMPLETED|Overall Study||20||
60075236|NCT03684512|76190552|FG001|NOT COMPLETED|Overall Study||14||
60075237|NCT03653741|76190558|FG000|STARTED|Overall Study||12||
60075238|NCT03653741|76190558|FG000|COMPLETED|Overall Study||12||
60075239|NCT03653741|76190558|FG000|NOT COMPLETED|Overall Study||0||
60075240|NCT03648996|76190565|FG000|STARTED|Overall Study||9||
60075241|NCT03648996|76190566|FG001|STARTED|Overall Study||7||
60075242|NCT03648996|76190567|FG002|STARTED|Overall Study||18||
60075243|NCT03648996|76190565|FG000|COMPLETED|Overall Study||7||
60075244|NCT03648996|76190566|FG001|COMPLETED|Overall Study||5||
60075245|NCT03648996|76190567|FG002|COMPLETED|Overall Study||16||
60075246|NCT03648996|76190565|FG000|NOT COMPLETED|Overall Study||2||
60075247|NCT03648996|76190566|FG001|NOT COMPLETED|Overall Study||2||
60075248|NCT03648996|76190567|FG002|NOT COMPLETED|Overall Study||2||
60075249|NCT03586050|76190578|FG000|STARTED|Overall Study||33||
60075250|NCT03586050|76190578|FG000|COMPLETED|Overall Study||33|This completion is specific to the primary endpoint|
60075251|NCT03586050|76190578|FG000|NOT COMPLETED|Overall Study||0||
60075252|NCT03483961|76190592|FG000|STARTED|Overall Study||53||
60075253|NCT03483961|76190593|FG001|STARTED|Overall Study||52||
60075254|NCT03483961|76190594|FG002|STARTED|Overall Study||51||
60075255|NCT03483961|76190595|FG003|STARTED|Overall Study||50||
60075256|NCT03483961|76190596|FG004|STARTED|Overall Study||53||
60075257|NCT03483961|76190597|FG005|STARTED|Overall Study||53||
60075258|NCT03483961|76190598|FG006|STARTED|Overall Study||51||
60075259|NCT03483961|76190599|FG007|STARTED|Overall Study||52||
60075260|NCT03483961|76190600|FG008|STARTED|Overall Study||20||
60075261|NCT03483961|76190601|FG009|STARTED|Overall Study||10||
60075262|NCT03483961|76190592|FG000|Exposed / Safety|Overall Study||53||
60075263|NCT03483961|76190593|FG001|Exposed / Safety|Overall Study||52||
60075264|NCT03483961|76190594|FG002|Exposed / Safety|Overall Study|One subject was randomized to Group 3 but treated in Group 4 due to a dispensing error.|50||
60075265|NCT03483961|76190595|FG003|Exposed / Safety|Overall Study|One subject was randomized to Group 3 but treated in Group 4 due to a dispensing error.|51||
60075266|NCT03483961|76190596|FG004|Exposed / Safety|Overall Study|One subject did not receive PXVX0317 but is in the Exposed / Safety population because of receipt of placebo.|53||
60075267|NCT03483961|76190597|FG005|Exposed / Safety|Overall Study||53||
60075268|NCT03483961|76190598|FG006|Exposed / Safety|Overall Study|One subject did not receive PXVX0317 but is in the Exposed / Safety population because of receipt of placebo.|51||
60075269|NCT03483961|76190599|FG007|Exposed / Safety|Overall Study|Two subjects did not receive PXVX0317 but are in the Exposed / Safety population because of receipt of placebo.|52||
60075270|NCT03483961|76190600|FG008|Exposed / Safety|Overall Study||20||
60075271|NCT03483961|76190601|FG009|Exposed / Safety|Overall Study||10||
60075272|NCT03483961|76190592|FG000|Immunogenicity-evaluable|Overall Study||47||
60075273|NCT03483961|76190593|FG001|Immunogenicity-evaluable|Overall Study||44||
60075274|NCT03483961|76190594|FG002|Immunogenicity-evaluable|Overall Study||44||
60075275|NCT03483961|76190595|FG003|Immunogenicity-evaluable|Overall Study||45||
60075276|NCT03483961|76190596|FG004|Immunogenicity-evaluable|Overall Study||48||
60075277|NCT03483961|76190597|FG005|Immunogenicity-evaluable|Overall Study||48||
60075278|NCT03483961|76190598|FG006|Immunogenicity-evaluable|Overall Study||47||
60075279|NCT03483961|76190599|FG007|Immunogenicity-evaluable|Overall Study||50||
60075280|NCT03483961|76190600|FG008|Immunogenicity-evaluable|Overall Study||20||
60075281|NCT03483961|76190601|FG009|Immunogenicity-evaluable|Overall Study||10||
60075282|NCT03483961|76190592|FG000|COMPLETED|Overall Study||42||
60075283|NCT03483961|76190593|FG001|COMPLETED|Overall Study||42||
60075284|NCT03483961|76190594|FG002|COMPLETED|Overall Study||39||
60075285|NCT03483961|76190595|FG003|COMPLETED|Overall Study||41||
60075286|NCT03483961|76190596|FG004|COMPLETED|Overall Study||43||
60075287|NCT03483961|76190597|FG005|COMPLETED|Overall Study||47||
60075288|NCT03483961|76190598|FG006|COMPLETED|Overall Study||46||
60075289|NCT03483961|76190599|FG007|COMPLETED|Overall Study||39||
60075290|NCT03483961|76190600|FG008|COMPLETED|Overall Study||18||
59987622|NCT00904943|76102874|FG001|COMPLETED|Period 2||8||
59987623|NCT00904943|76102873|FG000|NOT COMPLETED|Period 2||0||
59987624|NCT00904943|76102874|FG001|NOT COMPLETED|Period 2||0||
59987625|NCT02281552|76102880|FG000|STARTED|Overall Study||104||
59987626|NCT02281552|76102881|FG001|STARTED|Overall Study||105||
59987627|NCT02281552|76102880|FG000|COMPLETED|Overall Study||100||
59987628|NCT02281552|76102881|FG001|COMPLETED|Overall Study||95||
59987629|NCT02281552|76102880|FG000|NOT COMPLETED|Overall Study||4||
59987630|NCT02281552|76102881|FG001|NOT COMPLETED|Overall Study||10||
59987631|NCT00890591|76102887|FG000|STARTED|Overall Study||144||
59987632|NCT00890591|76102887|FG000|COMPLETED|Overall Study||124||
60075291|NCT03483961|76190601|FG009|COMPLETED|Overall Study||10||
59527210|NCT01317667|75622854|FG002|COMPLETED|Overall Study|The original trial design was modified to limit the number of vaccinations in Group 3 to 1 dose.|10||
59527211|NCT01317667|75622852|FG000|NOT COMPLETED|Overall Study||0||
59527212|NCT01317667|75622853|FG001|NOT COMPLETED|Overall Study||0||
59527213|NCT01317667|75622854|FG002|NOT COMPLETED|Overall Study||0||
59527214|NCT00167180|75622864|FG000|STARTED|Overall Study||0||
59527215|NCT00167180|75622865|FG001|STARTED|Overall Study||57||
59527216|NCT00167180|75622864|FG000|COMPLETED|Overall Study||0||
59527217|NCT00167180|75622865|FG001|COMPLETED|Overall Study||57||
59527218|NCT00167180|75622864|FG000|NOT COMPLETED|Overall Study||0||
59527219|NCT00167180|75622865|FG001|NOT COMPLETED|Overall Study||0||
59987633|NCT00890591|76102887|FG000|NOT COMPLETED|Overall Study||20||
59987634|NCT02284906|76102896|FG000|STARTED|Overall Study||3||
59987635|NCT02284906|76102897|FG001|STARTED|Overall Study||18||
59987636|NCT02284906|76102898|FG002|STARTED|Overall Study||19||
59987637|NCT02284906|76102896|FG000|COMPLETED|Overall Study||0||
59987638|NCT02284906|76102897|FG001|COMPLETED|Overall Study||0||
59987639|NCT02284906|76102898|FG002|COMPLETED|Overall Study||0||
59987640|NCT02284906|76102896|FG000|NOT COMPLETED|Overall Study||3||
59987641|NCT02284906|76102897|FG001|NOT COMPLETED|Overall Study||18||
59987642|NCT02284906|76102898|FG002|NOT COMPLETED|Overall Study||19||
59987643|NCT02879305|76102908|FG000|STARTED|Overall Study||1487||
59987644|NCT02879305|76102909|FG001|STARTED|Overall Study||1477||
59987645|NCT02879305|76102908|FG000|COMPLETED|Overall Study||1370||
59987646|NCT02879305|76102909|FG001|COMPLETED|Overall Study||1366||
59987647|NCT02879305|76102908|FG000|NOT COMPLETED|Overall Study||117||
59987648|NCT02879305|76102909|FG001|NOT COMPLETED|Overall Study||111||
59987649|NCT02281318|76102917|FG000|STARTED|Overall Study||277||
59987650|NCT02281318|76102918|FG001|STARTED|Overall Study||274||
59987651|NCT02281318|76102917|FG000|COMPLETED|Overall Study||263||
59987652|NCT02281318|76102918|FG001|COMPLETED|Overall Study||269||
59987653|NCT02281318|76102917|FG000|NOT COMPLETED|Overall Study||14||
59987654|NCT02281318|76102918|FG001|NOT COMPLETED|Overall Study||5||
60075292|NCT03483961|76190592|FG000|NOT COMPLETED|Overall Study||11||
60075293|NCT03483961|76190593|FG001|NOT COMPLETED|Overall Study||10||
60075294|NCT03483961|76190594|FG002|NOT COMPLETED|Overall Study||12||
60075295|NCT03483961|76190595|FG003|NOT COMPLETED|Overall Study||9||
60075296|NCT03483961|76190596|FG004|NOT COMPLETED|Overall Study||10||
60075297|NCT03483961|76190597|FG005|NOT COMPLETED|Overall Study||6||
60075298|NCT03483961|76190598|FG006|NOT COMPLETED|Overall Study||5||
60075299|NCT03483961|76190599|FG007|NOT COMPLETED|Overall Study||13||
60075300|NCT03483961|76190600|FG008|NOT COMPLETED|Overall Study||2||
59527220|NCT01035047|75622873|FG000|STARTED|Overall Study||52||
59527221|NCT01035047|75622874|FG001|STARTED|Overall Study||53||
59527222|NCT01035047|75622873|FG000|COMPLETED|Overall Study||52||
59527223|NCT01035047|75622874|FG001|COMPLETED|Overall Study||53||
59527224|NCT01035047|75622873|FG000|NOT COMPLETED|Overall Study||0||
59527225|NCT01035047|75622874|FG001|NOT COMPLETED|Overall Study||0||
59527226|NCT01317901|75622882|FG000|STARTED|Overall Study||6||
59527227|NCT01317901|75622883|FG001|STARTED|Overall Study||6||
59527228|NCT01317901|75622882|FG000|COMPLETED|Overall Study||6||
59527229|NCT01317901|75622883|FG001|COMPLETED|Overall Study||6||
59527230|NCT01317901|75622882|FG000|NOT COMPLETED|Overall Study||0||
59527231|NCT01317901|75622883|FG001|NOT COMPLETED|Overall Study||0||
59527232|NCT01366495|75622893|FG000|STARTED|Testing Study||0||
59527233|NCT01366495|75622894|FG001|STARTED|Testing Study||0||
59527234|NCT01366495|75622895|FG002|STARTED|Testing Study||349||
59527235|NCT01366495|75622896|FG003|STARTED|Testing Study||348||
59527236|NCT01366495|75622893|FG000|COMPLETED|Testing Study||0||
59527237|NCT01366495|75622894|FG001|COMPLETED|Testing Study||0||
59527238|NCT01366495|75622895|FG002|COMPLETED|Testing Study||349||
59527239|NCT01366495|75622896|FG003|COMPLETED|Testing Study||348||
59527240|NCT01366495|75622893|FG000|NOT COMPLETED|Testing Study||0||
59527241|NCT01366495|75622894|FG001|NOT COMPLETED|Testing Study||0||
59527242|NCT01366495|75622895|FG002|NOT COMPLETED|Testing Study||0||
59527243|NCT01366495|75622896|FG003|NOT COMPLETED|Testing Study||0||
59527244|NCT01366495|75622893|FG000|STARTED|HIV Study||50||
59527245|NCT01366495|75622894|FG001|STARTED|HIV Study||50||
59527246|NCT01366495|75622895|FG002|STARTED|HIV Study||0||
59527247|NCT01366495|75622896|FG003|STARTED|HIV Study||0||
59527248|NCT01366495|75622893|FG000|COMPLETED|HIV Study||49||
59527249|NCT01366495|75622894|FG001|COMPLETED|HIV Study||50||
59987655|NCT01657760|76102926|FG000|STARTED|Overall Study||5||
59987656|NCT01657760|76102927|FG001|STARTED|Overall Study||7||
59987657|NCT01657760|76102928|FG002|STARTED|Overall Study||7||
59987658|NCT01657760|76102929|FG003|STARTED|Overall Study||7||
59987659|NCT01657760|76102926|FG000|COMPLETED|Overall Study||4||
59987660|NCT01657760|76102927|FG001|COMPLETED|Overall Study||6||
59987661|NCT01657760|76102928|FG002|COMPLETED|Overall Study||6||
59987662|NCT01657760|76102929|FG003|COMPLETED|Overall Study||4||
59987663|NCT01657760|76102926|FG000|NOT COMPLETED|Overall Study||1||
59987664|NCT01657760|76102927|FG001|NOT COMPLETED|Overall Study||1||
59987665|NCT01657760|76102928|FG002|NOT COMPLETED|Overall Study||1||
59987666|NCT01657760|76102929|FG003|NOT COMPLETED|Overall Study||3||
59987667|NCT00966953|76102945|FG000|STARTED|1st Intervention||6||
59987668|NCT00966953|76102946|FG001|STARTED|1st Intervention||6||
59987669|NCT00966953|76102947|FG002|STARTED|1st Intervention||6||
59987670|NCT00966953|76102948|FG003|STARTED|1st Intervention||7||
59987671|NCT00966953|76102945|FG000|COMPLETED|1st Intervention||6||
60075301|NCT03483961|76190601|FG009|NOT COMPLETED|Overall Study||0||
60075302|NCT03459807|76190624|FG000|STARTED|Overall Study||25||
60075303|NCT03459807|76190625|FG001|STARTED|Overall Study||25||
60075304|NCT03459807|76190624|FG000|COMPLETED|Overall Study||25||
60075305|NCT03459807|76190625|FG001|COMPLETED|Overall Study||24||
60075306|NCT03459807|76190624|FG000|NOT COMPLETED|Overall Study||0||
60075307|NCT03459807|76190625|FG001|NOT COMPLETED|Overall Study||1||
60075308|NCT03441477|76190632|FG000|STARTED|Overall Study||225||
60075309|NCT03441477|76190632|FG000|COMPLETED|Overall Study||224||
60075310|NCT03441477|76190632|FG000|NOT COMPLETED|Overall Study||1||
59987672|NCT00966953|76102946|FG001|COMPLETED|1st Intervention||6||
59987673|NCT00966953|76102947|FG002|COMPLETED|1st Intervention||6||
59987674|NCT00966953|76102948|FG003|COMPLETED|1st Intervention||7||
59987675|NCT00966953|76102945|FG000|NOT COMPLETED|1st Intervention||0||
59987676|NCT00966953|76102946|FG001|NOT COMPLETED|1st Intervention||0||
60075311|NCT03439293|76190638|FG000|STARTED|Overall Study||61||
60075312|NCT03439293|76190638|FG000|Response-evaluable Population|Overall Study||59|Response-evaluable population was defined as participants who received at least 1 dose of ixazomib, had measurable disease either during screening or before the first dose of study drug, and had a baseline and at least 1 postbaseline disease assessment.|
60075313|NCT03439293|76190638|FG000|COMPLETED|Overall Study||0||
59987677|NCT00966953|76102947|FG002|NOT COMPLETED|1st Intervention||0||
59987678|NCT00966953|76102948|FG003|NOT COMPLETED|1st Intervention||0||
59527250|NCT01366495|75622895|FG002|COMPLETED|HIV Study||0||
59527251|NCT01366495|75622896|FG003|COMPLETED|HIV Study||0||
59527252|NCT01366495|75622893|FG000|NOT COMPLETED|HIV Study||1||
59527253|NCT01366495|75622894|FG001|NOT COMPLETED|HIV Study||0||
59527254|NCT01366495|75622895|FG002|NOT COMPLETED|HIV Study||0||
59527255|NCT01366495|75622896|FG003|NOT COMPLETED|HIV Study||0||
59527256|NCT01366885|75622906|FG000|STARTED|Overall Study|We started recruiting in February 2008 and recruited 20 mothers.|20||
59527257|NCT01366885|75622906|FG000|COMPLETED|Overall Study|We completed our study when the last child born had reached 36 months of age.|19||
59527258|NCT01366885|75622906|FG000|NOT COMPLETED|Overall Study||1||
59527259|NCT01424215|75622912|FG000|STARTED|Overall Study||50||
59527260|NCT01424215|75622913|FG001|STARTED|Overall Study||50||
59527261|NCT01424215|75622912|FG000|COMPLETED|Overall Study||50||
59527262|NCT01424215|75622913|FG001|COMPLETED|Overall Study||50||
59527263|NCT01424215|75622912|FG000|NOT COMPLETED|Overall Study||0||
59527264|NCT01424215|75622913|FG001|NOT COMPLETED|Overall Study||0||
59527265|NCT01370629|75622919|FG000|STARTED|Overall Study||2015||
59527266|NCT01370629|75622919|FG000|COMPLETED|Overall Study||2009||
59527267|NCT01370629|75622919|FG000|NOT COMPLETED|Overall Study||6||
59527268|NCT02094872|75622923|FG000|STARTED|Overall Study||49||
59527269|NCT02094872|75622923|FG000|Received Biopsy|Overall Study||37||
59527270|NCT02094872|75622923|FG000|Received Tumor-board Recommendation|Overall Study|1 individual withdrew consent after biopsy.|36||
59527271|NCT02094872|75622923|FG000|Received Targeted Therapy|Overall Study||20||
59527272|NCT02094872|75622923|FG000|Received Standard of Care|Overall Study|7 standard-of-care patients crossed-over and received targeted therapy.|9||
59527273|NCT02094872|75622923|FG000|Patients Treated With MEK162|Overall Study||20|Total patients treated with MEK162 for final primary endpoint (following study redesign)|
59527274|NCT02094872|75622923|FG000|COMPLETED|Overall Study||20||
59527275|NCT02094872|75622923|FG000|NOT COMPLETED|Overall Study||29||
59527276|NCT01424293|75622927|FG000|STARTED|Overall Study||7||
59527277|NCT01424293|75622927|FG000|COMPLETED|Overall Study||7||
59527278|NCT01424293|75622927|FG000|NOT COMPLETED|Overall Study||0||
59527279|NCT01425229|75622931|FG000|STARTED|Bosentan Single Dose||16||
59527280|NCT01425229|75622931|FG000|COMPLETED|Bosentan Single Dose||16||
59527281|NCT01425229|75622931|FG000|NOT COMPLETED|Bosentan Single Dose||0||
59527282|NCT01425229|75622931|FG000|STARTED|Bosentan Steady-state||16||
59527283|NCT01425229|75622931|FG000|COMPLETED|Bosentan Steady-state||16||
59527284|NCT01425229|75622931|FG000|NOT COMPLETED|Bosentan Steady-state||0||
59527285|NCT01425229|75622931|FG000|STARTED|Bosentan During Clarithromycin||16||
59527286|NCT01425229|75622931|FG000|COMPLETED|Bosentan During Clarithromycin||16||
59527287|NCT01425229|75622931|FG000|NOT COMPLETED|Bosentan During Clarithromycin||0||
59527288|NCT00258362|75622939|FG000|STARTED|Overall Study||41||
59527289|NCT00258362|75622939|FG000|COMPLETED|Overall Study||41||
59527290|NCT00258362|75622939|FG000|NOT COMPLETED|Overall Study||0||
59527291|NCT00258830|75622946|FG000|STARTED|Overall Study||60||
59527292|NCT00258830|75622947|FG001|STARTED|Overall Study||60||
59527293|NCT00258830|75622946|FG000|COMPLETED|Overall Study||60||
59527294|NCT00258830|75622947|FG001|COMPLETED|Overall Study||60||
59527295|NCT00258830|75622946|FG000|NOT COMPLETED|Overall Study||0||
59527296|NCT00258830|75622947|FG001|NOT COMPLETED|Overall Study||0||
59527297|NCT02095340|75622956|FG000|STARTED|Overall Study|Mother (not the child) received the training.|51||
59527298|NCT02095340|75622957|FG001|STARTED|Overall Study|Mother (not the child) received the training.|54||
59527299|NCT02095340|75622958|FG002|STARTED|Overall Study||105||
59527300|NCT02095340|75622956|FG000|COMPLETED|Overall Study||51||
59527301|NCT02095340|75622957|FG001|COMPLETED|Overall Study||54||
59527302|NCT02095340|75622958|FG002|COMPLETED|Overall Study||105||
59527303|NCT02095340|75622956|FG000|NOT COMPLETED|Overall Study||0||
59527304|NCT02095340|75622957|FG001|NOT COMPLETED|Overall Study||0||
59527305|NCT02095340|75622958|FG002|NOT COMPLETED|Overall Study||0||
59527306|NCT02539368|75622972|FG000|STARTED|Overall Study||1522||
59527307|NCT02539368|75622973|FG001|STARTED|Overall Study||494||
59527308|NCT02539368|75622974|FG002|STARTED|Overall Study||358||
59527309|NCT02539368|75622975|FG003|STARTED|Overall Study||67||
59527310|NCT02539368|75622976|FG004|STARTED|Overall Study||102||
59527311|NCT02539368|75622972|FG000|COMPLETED|Overall Study||1117||
59527312|NCT02539368|75622973|FG001|COMPLETED|Overall Study||393||
59527313|NCT02539368|75622974|FG002|COMPLETED|Overall Study||291||
59527314|NCT02539368|75622975|FG003|COMPLETED|Overall Study||60||
59527315|NCT02539368|75622976|FG004|COMPLETED|Overall Study||88||
59527316|NCT02539368|75622972|FG000|NOT COMPLETED|Overall Study||405||
59527317|NCT02539368|75622973|FG001|NOT COMPLETED|Overall Study||101||
59527318|NCT02539368|75622974|FG002|NOT COMPLETED|Overall Study||67||
59527319|NCT02539368|75622975|FG003|NOT COMPLETED|Overall Study||7||
59527320|NCT02539368|75622976|FG004|NOT COMPLETED|Overall Study||14||
59527321|NCT01425307|75622993|FG000|STARTED|Overall Study|Randomized Sample: 61; Intention-to Treat Sample:61|61||
59527322|NCT01425307|75622994|FG001|STARTED|Overall Study|Randomized Sample: 60; Intention-to Treat Sample:60|60||
59527323|NCT01425307|75622993|FG000|COMPLETED|Overall Study|Treatment Phase: 42; 6-Month Follow up: 58|42||
59527324|NCT01425307|75622994|FG001|COMPLETED|Overall Study|Treatment Phase: 41; 6-Month Follow-up:59|41||
59527325|NCT01425307|75622993|FG000|NOT COMPLETED|Overall Study||19||
59527326|NCT01425307|75622994|FG001|NOT COMPLETED|Overall Study||19||
59527327|NCT01035749|75623006|FG000|STARTED|Overall Study||66||
59527328|NCT01035749|75623007|FG001|STARTED|Overall Study||66||
59527329|NCT01035749|75623008|FG002|STARTED|Overall Study||68||
59527330|NCT01035749|75623009|FG003|STARTED|Overall Study||110||
59527331|NCT01035749|75623006|FG000|COMPLETED|Overall Study||66||
59527332|NCT01035749|75623007|FG001|COMPLETED|Overall Study||66||
59527333|NCT01035749|75623008|FG002|COMPLETED|Overall Study||68||
59527334|NCT01035749|75623009|FG003|COMPLETED|Overall Study||110||
59527335|NCT01035749|75623006|FG000|NOT COMPLETED|Overall Study||0||
59527336|NCT01035749|75623007|FG001|NOT COMPLETED|Overall Study||0||
59527337|NCT01035749|75623008|FG002|NOT COMPLETED|Overall Study||0||
59527338|NCT01035749|75623009|FG003|NOT COMPLETED|Overall Study||0||
59527339|NCT00123110|75623022|FG000|STARTED|Overall Study||12||
59527340|NCT00123110|75623023|FG001|STARTED|Overall Study||12||
59527341|NCT00123110|75623024|FG002|STARTED|Overall Study||11||
59527342|NCT00123110|75623022|FG000|COMPLETED|Overall Study||12||
59527343|NCT00123110|75623023|FG001|COMPLETED|Overall Study||12||
59527344|NCT00123110|75623024|FG002|COMPLETED|Overall Study||11||
59527345|NCT00123110|75623022|FG000|NOT COMPLETED|Overall Study||0||
59527346|NCT00123110|75623023|FG001|NOT COMPLETED|Overall Study||0||
59527347|NCT00123110|75623024|FG002|NOT COMPLETED|Overall Study||0||
59527348|NCT02096276|75623034|FG000|STARTED|Overall Study||250||
59527349|NCT02096276|75623035|FG001|STARTED|Overall Study||55||
59527350|NCT02096276|75623034|FG000|COMPLETED|Overall Study||250||
59527351|NCT02096276|75623035|FG001|COMPLETED|Overall Study||55||
59527352|NCT02096276|75623034|FG000|NOT COMPLETED|Overall Study||0||
59527353|NCT02096276|75623035|FG001|NOT COMPLETED|Overall Study||0||
59527354|NCT01425853|75623043|FG000|STARTED|Overall Study||304||
59527355|NCT01425853|75623044|FG001|STARTED|Overall Study||302||
59527356|NCT01425853|75623043|FG000|Safety Population|Overall Study||304||
59527357|NCT01425853|75623044|FG001|Safety Population|Overall Study||299||
59527358|NCT01425853|75623043|FG000|Per Protocol (PP)|Overall Study||264||
59527359|NCT01425853|75623044|FG001|Per Protocol (PP)|Overall Study||258||
59527360|NCT01425853|75623043|FG000|COMPLETED|Overall Study||240||
59527361|NCT01425853|75623044|FG001|COMPLETED|Overall Study||225||
59527362|NCT01425853|75623043|FG000|NOT COMPLETED|Overall Study||64||
59527363|NCT01425853|75623044|FG001|NOT COMPLETED|Overall Study||77||
59527364|NCT01426867|75623054|FG000|STARTED|Overall Study||33||
59987679|NCT00966953|76102945|FG000|STARTED|1 Week Washout After 1st Intervention||6||
59987680|NCT00966953|76102946|FG001|STARTED|1 Week Washout After 1st Intervention||6||
59987681|NCT00966953|76102947|FG002|STARTED|1 Week Washout After 1st Intervention||6||
59987682|NCT00966953|76102948|FG003|STARTED|1 Week Washout After 1st Intervention||7||
59987683|NCT00966953|76102945|FG000|COMPLETED|1 Week Washout After 1st Intervention||6||
59987684|NCT00966953|76102946|FG001|COMPLETED|1 Week Washout After 1st Intervention||6||
59527365|NCT01426867|75623055|FG001|STARTED|Overall Study||34||
59527366|NCT01426867|75623056|FG002|STARTED|Overall Study||34||
59527367|NCT01426867|75623054|FG000|COMPLETED|Overall Study||33||
59527368|NCT01426867|75623055|FG001|COMPLETED|Overall Study||34||
59527369|NCT01426867|75623056|FG002|COMPLETED|Overall Study||34||
59527370|NCT01426867|75623054|FG000|NOT COMPLETED|Overall Study||0||
59527371|NCT01426867|75623055|FG001|NOT COMPLETED|Overall Study||0||
59527372|NCT01426867|75623056|FG002|NOT COMPLETED|Overall Study||0||
59527373|NCT02203747|75623066|FG000|STARTED|Overall Study||45||
59527374|NCT02203747|75623067|FG001|STARTED|Overall Study||34||
59527375|NCT02203747|75623066|FG000|COMPLETED|Overall Study||45||
59527376|NCT02203747|75623067|FG001|COMPLETED|Overall Study||34||
59527377|NCT02203747|75623066|FG000|NOT COMPLETED|Overall Study||0||
59527378|NCT02203747|75623067|FG001|NOT COMPLETED|Overall Study||0||
59527379|NCT00168428|75623075|FG000|STARTED|Double-Blind Phase (DB)||347||
59527380|NCT00168428|75623076|FG001|STARTED|Double-Blind Phase (DB)||358||
59527381|NCT00168428|75623075|FG000|COMPLETED|Double-Blind Phase (DB)|Completed Week 24|311||
59527382|NCT00168428|75623076|FG001|COMPLETED|Double-Blind Phase (DB)|Completed Week 24|334||
59527383|NCT00168428|75623075|FG000|NOT COMPLETED|Double-Blind Phase (DB)||36||
59527384|NCT00168428|75623076|FG001|NOT COMPLETED|Double-Blind Phase (DB)||24||
59527385|NCT00168428|75623075|FG000|STARTED|Open-Label Phase (OL)|Number of DB Botulinum toxin type A patients who rolled into OL phase|305||
59527386|NCT00168428|75623076|FG001|STARTED|Open-Label Phase (OL)|Number of DB Placebo patients who rolled into OL phase|329||
59527387|NCT00168428|75623075|FG000|COMPLETED|Open-Label Phase (OL)||261||
59527388|NCT00168428|75623076|FG001|COMPLETED|Open-Label Phase (OL)||261||
59527389|NCT00168428|75623075|FG000|NOT COMPLETED|Open-Label Phase (OL)||44||
59527390|NCT00168428|75623076|FG001|NOT COMPLETED|Open-Label Phase (OL)||68||
59987685|NCT00966953|76102947|FG002|COMPLETED|1 Week Washout After 1st Intervention||6||
59987686|NCT00966953|76102948|FG003|COMPLETED|1 Week Washout After 1st Intervention||7||
59987687|NCT00966953|76102945|FG000|NOT COMPLETED|1 Week Washout After 1st Intervention||0||
59527391|NCT01427881|75623082|FG000|STARTED|Overall Study||43||
59527392|NCT01427881|75623082|FG000|COMPLETED|Overall Study||43||
59527393|NCT01427881|75623082|FG000|NOT COMPLETED|Overall Study||0||
59527394|NCT00258908|75623086|FG000|STARTED|Overall Study|3 participants were not vaccinated and were not included in the final analysis and in this report.|112||
59527395|NCT00258908|75623086|FG000|COMPLETED|Overall Study||112||
59527396|NCT00258908|75623086|FG000|NOT COMPLETED|Overall Study||0||
59527397|NCT01319539|75623090|FG000|STARTED|Overall Study||12||
59527398|NCT01319539|75623090|FG000|COMPLETED|Overall Study||12||
59527399|NCT01319539|75623090|FG000|NOT COMPLETED|Overall Study||0||
59527400|NCT01319617|75623096|FG000|STARTED|Overall Study||41||
59527401|NCT01319617|75623096|FG000|COMPLETED|Overall Study||40||
59527402|NCT01319617|75623096|FG000|NOT COMPLETED|Overall Study||1||
59527403|NCT01319773|75623105|FG000|STARTED|Overall Study||10||
59527404|NCT01319773|75623106|FG001|STARTED|Overall Study||10||
59527405|NCT01319773|75623107|FG002|STARTED|Overall Study||8||
59527406|NCT01319773|75623108|FG003|STARTED|Overall Study||8||
59527407|NCT01319773|75623109|FG004|STARTED|Overall Study||8||
59527408|NCT01319773|75623105|FG000|COMPLETED|Overall Study||10||
59527409|NCT01319773|75623106|FG001|COMPLETED|Overall Study||10||
59527410|NCT01319773|75623107|FG002|COMPLETED|Overall Study||8||
59527411|NCT01319773|75623108|FG003|COMPLETED|Overall Study||8||
59527412|NCT01319773|75623109|FG004|COMPLETED|Overall Study||8||
59527413|NCT01319773|75623105|FG000|NOT COMPLETED|Overall Study||0||
59527414|NCT01319773|75623106|FG001|NOT COMPLETED|Overall Study||0||
59527415|NCT01319773|75623107|FG002|NOT COMPLETED|Overall Study||0||
59527416|NCT01319773|75623108|FG003|NOT COMPLETED|Overall Study||0||
59527417|NCT01319773|75623109|FG004|NOT COMPLETED|Overall Study||0||
59527418|NCT01319851|75623119|FG000|STARTED|Overall Study||3||
59527419|NCT01319851|75623119|FG000|COMPLETED|Overall Study||3||
59527420|NCT01319851|75623119|FG000|NOT COMPLETED|Overall Study||0||
59527421|NCT02539134|75623129|FG000|STARTED|Overall Study||10||
59527422|NCT02539134|75623130|FG001|STARTED|Overall Study||6||
59527423|NCT02539134|75623131|FG002|STARTED|Overall Study||6||
59527424|NCT02539134|75623132|FG003|STARTED|Overall Study||6||
59527425|NCT02539134|75623133|FG004|STARTED|Overall Study||6||
59527426|NCT02539134|75623134|FG005|STARTED|Overall Study||6||
59527427|NCT02539134|75623129|FG000|COMPLETED|Overall Study||9||
59527428|NCT02539134|75623130|FG001|COMPLETED|Overall Study||6||
59527429|NCT02539134|75623131|FG002|COMPLETED|Overall Study||6||
59527430|NCT02539134|75623132|FG003|COMPLETED|Overall Study||6||
59527431|NCT02539134|75623133|FG004|COMPLETED|Overall Study||6||
59527432|NCT02539134|75623134|FG005|COMPLETED|Overall Study||6||
59527433|NCT02539134|75623129|FG000|NOT COMPLETED|Overall Study||1||
59527434|NCT02539134|75623130|FG001|NOT COMPLETED|Overall Study||0||
59527435|NCT02539134|75623131|FG002|NOT COMPLETED|Overall Study||0||
59527436|NCT02539134|75623132|FG003|NOT COMPLETED|Overall Study||0||
59527437|NCT02539134|75623133|FG004|NOT COMPLETED|Overall Study||0||
59527438|NCT02539134|75623134|FG005|NOT COMPLETED|Overall Study||0||
59527439|NCT00262730|75623153|FG000|STARTED|Overall Study||97||
59527440|NCT00262730|75623153|FG000|COMPLETED|Overall Study||97||
59527441|NCT00262730|75623153|FG000|NOT COMPLETED|Overall Study||0||
59527442|NCT01320553|75623161|FG000|STARTED|Overall Study||31||
59527443|NCT01320553|75623162|FG001|STARTED|Overall Study||30||
59527444|NCT01320553|75623163|FG002|STARTED|Overall Study||31||
59527445|NCT01320553|75623164|FG003|STARTED|Overall Study||30||
59527446|NCT01320553|75623161|FG000|COMPLETED|Overall Study||30||
59527447|NCT01320553|75623162|FG001|COMPLETED|Overall Study||26||
59527448|NCT01320553|75623163|FG002|COMPLETED|Overall Study||29||
59527449|NCT01320553|75623164|FG003|COMPLETED|Overall Study||29||
59527450|NCT01320553|75623161|FG000|NOT COMPLETED|Overall Study||1||
59527451|NCT01320553|75623162|FG001|NOT COMPLETED|Overall Study||4||
59527452|NCT01320553|75623163|FG002|NOT COMPLETED|Overall Study||2||
59527453|NCT01320553|75623164|FG003|NOT COMPLETED|Overall Study||1||
59527454|NCT00262964|75623176|FG000|STARTED|Overall Study||11||
59527455|NCT00262964|75623177|FG001|STARTED|Overall Study||11||
59527456|NCT00262964|75623178|FG002|STARTED|Overall Study||17||
59527457|NCT00262964|75623179|FG003|STARTED|Overall Study||12||
59527458|NCT00262964|75623176|FG000|COMPLETED|Overall Study||11||
59527459|NCT00262964|75623177|FG001|COMPLETED|Overall Study||11||
59527460|NCT00262964|75623178|FG002|COMPLETED|Overall Study||17||
59527461|NCT00262964|75623179|FG003|COMPLETED|Overall Study||12||
59527462|NCT00262964|75623176|FG000|NOT COMPLETED|Overall Study||0||
59527463|NCT00262964|75623177|FG001|NOT COMPLETED|Overall Study||0||
59527464|NCT00262964|75623178|FG002|NOT COMPLETED|Overall Study||0||
59527465|NCT00262964|75623179|FG003|NOT COMPLETED|Overall Study||0||
59527466|NCT01321177|75623203|FG000|STARTED|Overall Study||223||
59527467|NCT01321177|75623204|FG001|STARTED|Overall Study||181||
59527468|NCT01321177|75623203|FG000|COMPLETED|Overall Study||147||
59527469|NCT01321177|75623204|FG001|COMPLETED|Overall Study||84||
59527470|NCT01321177|75623203|FG000|NOT COMPLETED|Overall Study||76||
59527471|NCT01321177|75623204|FG001|NOT COMPLETED|Overall Study||97||
59527472|NCT01372813|75623210|FG000|STARTED|Overall Study||3||
59527473|NCT01372813|75623210|FG000|COMPLETED|Overall Study||3||
59527474|NCT01372813|75623210|FG000|NOT COMPLETED|Overall Study||0||
59527475|NCT00124514|75623219|FG000|STARTED|Overall Study||6||
59527476|NCT00124514|75623220|FG001|STARTED|Overall Study||9||
59527477|NCT00124514|75623221|FG002|STARTED|Overall Study||8||
59527478|NCT00124514|75623222|FG003|STARTED|Overall Study||6||
59527479|NCT00124514|75623223|FG004|STARTED|Overall Study||2||
59527480|NCT00124514|75623219|FG000|COMPLETED|Overall Study||2||
59527481|NCT00124514|75623220|FG001|COMPLETED|Overall Study||7||
59527482|NCT00124514|75623221|FG002|COMPLETED|Overall Study||7||
59527483|NCT00124514|75623222|FG003|COMPLETED|Overall Study||5||
59527484|NCT00124514|75623223|FG004|COMPLETED|Overall Study||1||
59527485|NCT00124514|75623219|FG000|NOT COMPLETED|Overall Study||4||
59527486|NCT00124514|75623220|FG001|NOT COMPLETED|Overall Study||2||
59527487|NCT00124514|75623221|FG002|NOT COMPLETED|Overall Study||1||
59527488|NCT00124514|75623222|FG003|NOT COMPLETED|Overall Study||1||
59527489|NCT00124514|75623223|FG004|NOT COMPLETED|Overall Study||1||
59527490|NCT01373671|75623230|FG000|STARTED|Overall Study||764||
59527491|NCT01373671|75623230|FG000|COMPLETED|Overall Study||672||
59527492|NCT01373671|75623230|FG000|NOT COMPLETED|Overall Study||92||
59527493|NCT02538900|75623238|FG000|STARTED|Overall Study||116||
59527494|NCT02538900|75623239|FG001|STARTED|Overall Study||124||
59527495|NCT02538900|75623240|FG002|STARTED|Overall Study||65||
59527496|NCT02538900|75623238|FG000|COMPLETED|Overall Study||96||
59527497|NCT02538900|75623239|FG001|COMPLETED|Overall Study||106||
59527498|NCT02538900|75623240|FG002|COMPLETED|Overall Study||48||
59527499|NCT02538900|75623238|FG000|NOT COMPLETED|Overall Study||20||
59527500|NCT02538900|75623239|FG001|NOT COMPLETED|Overall Study||18||
59527501|NCT02538900|75623240|FG002|NOT COMPLETED|Overall Study||17||
59527502|NCT01322815|75623250|FG000|STARTED|Overall Study||7||
59527503|NCT01322815|75623251|FG001|STARTED|Overall Study||4||
59527504|NCT01322815|75623250|FG000|COMPLETED|Overall Study||7||
59527505|NCT01322815|75623251|FG001|COMPLETED|Overall Study||4||
59527506|NCT01322815|75623250|FG000|NOT COMPLETED|Overall Study||0||
59527507|NCT01322815|75623251|FG001|NOT COMPLETED|Overall Study||0||
59527508|NCT00265538|75623259|FG000|STARTED|Overall Study||196||
59527509|NCT00265538|75623260|FG001|STARTED|Overall Study||170||
59527510|NCT00265538|75623261|FG002|STARTED|Overall Study||182||
59527511|NCT00265538|75623262|FG003|STARTED|Overall Study||286||
59527512|NCT00265538|75623259|FG000|COMPLETED|Overall Study||186||
59527513|NCT00265538|75623260|FG001|COMPLETED|Overall Study||161||
59527514|NCT00265538|75623261|FG002|COMPLETED|Overall Study||171||
59527515|NCT00265538|75623262|FG003|COMPLETED|Overall Study||267||
59527516|NCT00265538|75623259|FG000|NOT COMPLETED|Overall Study||10||
59527517|NCT00265538|75623260|FG001|NOT COMPLETED|Overall Study||9||
59527518|NCT00265538|75623261|FG002|NOT COMPLETED|Overall Study||11||
59527519|NCT00265538|75623262|FG003|NOT COMPLETED|Overall Study||19||
59527520|NCT00176228|75623274|FG000|STARTED|Overall Study|When study began|48||
59527521|NCT00176228|75623274|FG000|COMPLETED|Overall Study|Study ended|46||
59527522|NCT00176228|75623274|FG000|NOT COMPLETED|Overall Study||2||
59527523|NCT00176306|75623279|FG000|STARTED|Overall Study||15||
59527524|NCT00176306|75623279|FG000|COMPLETED|Overall Study||15||
59527525|NCT00176306|75623279|FG000|NOT COMPLETED|Overall Study||0||
59527526|NCT01429987|75623287|FG000|STARTED|Overall Study||238||
59527527|NCT01429987|75623288|FG001|STARTED|Overall Study||238||
59527528|NCT01429987|75623289|FG002|STARTED|Overall Study||238||
59527529|NCT01429987|75623290|FG003|STARTED|Overall Study||237||
59527530|NCT01429987|75623287|FG000|COMPLETED|Overall Study||189||
59527531|NCT01429987|75623288|FG001|COMPLETED|Overall Study||176||
59527532|NCT01429987|75623289|FG002|COMPLETED|Overall Study||202||
59527533|NCT01429987|75623290|FG003|COMPLETED|Overall Study||171||
59527534|NCT01429987|75623287|FG000|NOT COMPLETED|Overall Study||49||
59527535|NCT01429987|75623288|FG001|NOT COMPLETED|Overall Study||62||
59527536|NCT01429987|75623289|FG002|NOT COMPLETED|Overall Study||36||
59527537|NCT01429987|75623290|FG003|NOT COMPLETED|Overall Study||66||
59527538|NCT00265616|75623302|FG000|STARTED|Overall Study||14||
59815223|NCT00615017|75937646|FG002|NOT COMPLETED|Overall Study||5||
59527539|NCT00265616|75623303|FG001|STARTED|Overall Study||9||
59527540|NCT00265616|75623302|FG000|COMPLETED|Overall Study||14||
59527541|NCT00265616|75623303|FG001|COMPLETED|Overall Study||9||
59527542|NCT00265616|75623302|FG000|NOT COMPLETED|Overall Study||0||
59527543|NCT00265616|75623303|FG001|NOT COMPLETED|Overall Study||0||
59527544|NCT01430299|75623311|FG000|STARTED|Overall Study||20||
59527545|NCT01430299|75623312|FG001|STARTED|Overall Study||23||
59527546|NCT01430299|75623311|FG000|COMPLETED|Overall Study||16||
59527547|NCT01430299|75623312|FG001|COMPLETED|Overall Study||21||
59527548|NCT01430299|75623311|FG000|NOT COMPLETED|Overall Study||4||
59527549|NCT01430299|75623312|FG001|NOT COMPLETED|Overall Study||2||
59527550|NCT01431313|75623321|FG000|STARTED|Overall Study||20||
59527551|NCT01431313|75623322|FG001|STARTED|Overall Study||20||
59527552|NCT01431313|75623323|FG002|STARTED|Overall Study||8||
59527553|NCT01431313|75623321|FG000|COMPLETED|Overall Study||20||
59527554|NCT01431313|75623322|FG001|COMPLETED|Overall Study||20||
59527555|NCT01431313|75623323|FG002|COMPLETED|Overall Study||8||
59527556|NCT01431313|75623321|FG000|NOT COMPLETED|Overall Study||0||
59527557|NCT01431313|75623322|FG001|NOT COMPLETED|Overall Study||0||
59527558|NCT01431313|75623323|FG002|NOT COMPLETED|Overall Study||0||
59527559|NCT00176852|75623335|FG000|STARTED|Overall Study||3||
59527560|NCT00176852|75623336|FG001|STARTED|Overall Study||5||
59527561|NCT00176852|75623337|FG002|STARTED|Overall Study||14||
59527562|NCT00176852|75623335|FG000|COMPLETED|Overall Study||3||
59527563|NCT00176852|75623336|FG001|COMPLETED|Overall Study||5||
59527564|NCT00176852|75623337|FG002|COMPLETED|Overall Study||14||
59527565|NCT00176852|75623335|FG000|NOT COMPLETED|Overall Study||0||
59527566|NCT00176852|75623336|FG001|NOT COMPLETED|Overall Study||0||
59527567|NCT00176852|75623337|FG002|NOT COMPLETED|Overall Study||0||
59527568|NCT01323517|75623345|FG000|STARTED|Overall Study||26||
60075314|NCT03439293|76190638|FG000|NOT COMPLETED|Overall Study||61||
60075315|NCT03423979|76190643|FG000|STARTED|Overall Study||80||
60075316|NCT03423979|76190643|FG000|COMPLETED|Overall Study||79||
60075317|NCT03423979|76190643|FG000|NOT COMPLETED|Overall Study||1||
60075318|NCT03239210|76190649|FG000|STARTED|Overall Study||33||
60075319|NCT03239210|76190650|FG001|STARTED|Overall Study||29||
60075320|NCT03239210|76190649|FG000|COMPLETED|Overall Study||27||
60075321|NCT03239210|76190650|FG001|COMPLETED|Overall Study||24||
60075322|NCT03239210|76190649|FG000|NOT COMPLETED|Overall Study||6||
60075323|NCT03239210|76190650|FG001|NOT COMPLETED|Overall Study||5||
60075324|NCT03227224|76190660|FG000|STARTED|Double-blind Treatment Period (6 Weeks)||138||
60075325|NCT03227224|76190661|FG001|STARTED|Double-blind Treatment Period (6 Weeks)||33||
60075326|NCT03227224|76190662|FG002|STARTED|Double-blind Treatment Period (6 Weeks)||63||
60075327|NCT03227224|76190663|FG003|STARTED|Double-blind Treatment Period (6 Weeks)||53||
60075328|NCT03227224|76190660|FG000|Treated|Double-blind Treatment Period (6 Weeks)||137||
60075329|NCT03227224|76190661|FG001|Treated|Double-blind Treatment Period (6 Weeks)||33||
60075330|NCT03227224|76190662|FG002|Treated|Double-blind Treatment Period (6 Weeks)||61||
60075331|NCT03227224|76190663|FG003|Treated|Double-blind Treatment Period (6 Weeks)||52||
60075332|NCT03227224|76190660|FG000|COMPLETED|Double-blind Treatment Period (6 Weeks)||123||
60075333|NCT03227224|76190661|FG001|COMPLETED|Double-blind Treatment Period (6 Weeks)||27||
60075334|NCT03227224|76190662|FG002|COMPLETED|Double-blind Treatment Period (6 Weeks)||55||
60075335|NCT03227224|76190663|FG003|COMPLETED|Double-blind Treatment Period (6 Weeks)||46||
60075336|NCT03227224|76190660|FG000|NOT COMPLETED|Double-blind Treatment Period (6 Weeks)||15||
60075337|NCT03227224|76190661|FG001|NOT COMPLETED|Double-blind Treatment Period (6 Weeks)||6||
60075338|NCT03227224|76190662|FG002|NOT COMPLETED|Double-blind Treatment Period (6 Weeks)||8||
60075339|NCT03227224|76190663|FG003|NOT COMPLETED|Double-blind Treatment Period (6 Weeks)||7||
60075340|NCT03227224|76190660|FG000|STARTED|Follow-up Phase (2 Weeks)|All participants that started the double-blind period were followed-up for follow-up phase.|138||
60075341|NCT03227224|76190661|FG001|STARTED|Follow-up Phase (2 Weeks)|All participants that started the double-blind period were followed-up for follow-up phase.|33||
60075342|NCT03227224|76190662|FG002|STARTED|Follow-up Phase (2 Weeks)|All participants that started the double-blind period were followed-up for follow-up phase.|63||
60075343|NCT03227224|76190663|FG003|STARTED|Follow-up Phase (2 Weeks)|All participants that started the double-blind period were followed-up for follow-up phase.|53||
60075344|NCT03227224|76190660|FG000|COMPLETED|Follow-up Phase (2 Weeks)||134||
60075345|NCT03227224|76190661|FG001|COMPLETED|Follow-up Phase (2 Weeks)||29||
60075346|NCT03227224|76190662|FG002|COMPLETED|Follow-up Phase (2 Weeks)||57||
60075347|NCT03227224|76190663|FG003|COMPLETED|Follow-up Phase (2 Weeks)||50||
60075348|NCT03227224|76190660|FG000|NOT COMPLETED|Follow-up Phase (2 Weeks)||4||
60075349|NCT03227224|76190661|FG001|NOT COMPLETED|Follow-up Phase (2 Weeks)||4||
60075350|NCT03227224|76190662|FG002|NOT COMPLETED|Follow-up Phase (2 Weeks)||6||
59527569|NCT01323517|75623345|FG000|COMPLETED|Overall Study||26||
59527570|NCT01323517|75623345|FG000|NOT COMPLETED|Overall Study||0||
59527571|NCT01323595|75623351|FG000|STARTED|Overall Study||39||
59527572|NCT01323595|75623352|FG001|STARTED|Overall Study||39||
59527573|NCT01323595|75623351|FG000|COMPLETED|Overall Study|Remaining subjects did not return questionnaire|16||
59527574|NCT01323595|75623352|FG001|COMPLETED|Overall Study|Remaining subjects did not return questionaire|18||
59527575|NCT01323595|75623351|FG000|NOT COMPLETED|Overall Study||23||
59527576|NCT01323595|75623352|FG001|NOT COMPLETED|Overall Study||21||
59527577|NCT01324453|75623362|FG000|STARTED|Overall Study||54||
59527578|NCT01324453|75623363|FG001|STARTED|Overall Study||49||
59527579|NCT01324453|75623362|FG000|COMPLETED|Overall Study||54||
59527580|NCT01324453|75623363|FG001|COMPLETED|Overall Study||49||
59527581|NCT01324453|75623362|FG000|NOT COMPLETED|Overall Study||0||
59527582|NCT01324453|75623363|FG001|NOT COMPLETED|Overall Study||0||
59527583|NCT01376557|75623374|FG000|STARTED|Overall Study||59||
59527584|NCT01376557|75623375|FG001|STARTED|Overall Study||60||
59527585|NCT01376557|75623376|FG002|STARTED|Overall Study||60||
59527586|NCT01376557|75623377|FG003|STARTED|Overall Study||60||
59527587|NCT01376557|75623378|FG004|STARTED|Overall Study||60||
59527588|NCT01376557|75623374|FG000|COMPLETED|Overall Study||51||
59527589|NCT01376557|75623375|FG001|COMPLETED|Overall Study||54||
59527590|NCT01376557|75623376|FG002|COMPLETED|Overall Study||55||
59527591|NCT01376557|75623377|FG003|COMPLETED|Overall Study||54||
59527592|NCT01376557|75623378|FG004|COMPLETED|Overall Study||53||
59527593|NCT01376557|75623374|FG000|NOT COMPLETED|Overall Study||8||
59527594|NCT01376557|75623375|FG001|NOT COMPLETED|Overall Study||6||
59527595|NCT01376557|75623376|FG002|NOT COMPLETED|Overall Study||5||
59527596|NCT01376557|75623377|FG003|NOT COMPLETED|Overall Study||6||
59527597|NCT01376557|75623378|FG004|NOT COMPLETED|Overall Study||7||
59527598|NCT01324687|75623392|FG000|STARTED|Overall Study||1058||
59527599|NCT01324687|75623393|FG001|STARTED|Overall Study||494||
59527600|NCT01324687|75623392|FG000|COMPLETED|Overall Study||1058||
59527601|NCT01324687|75623393|FG001|COMPLETED|Overall Study||479||
59527602|NCT01324687|75623392|FG000|NOT COMPLETED|Overall Study||0||
59527603|NCT01324687|75623393|FG001|NOT COMPLETED|Overall Study||15||
59527604|NCT01431391|75623401|FG000|STARTED|Overall Study||34||
59527605|NCT01431391|75623402|FG001|STARTED|Overall Study||34||
59527606|NCT01431391|75623401|FG000|Received ≥1 Leaukapheresis|Overall Study||34||
59527607|NCT01431391|75623402|FG001|Received ≥1 Leaukapheresis|Overall Study||34||
59527608|NCT01431391|75623401|FG000|COMPLETED|Overall Study||26||
59527609|NCT01431391|75623402|FG001|COMPLETED|Overall Study||30||
59527610|NCT01431391|75623401|FG000|NOT COMPLETED|Overall Study||8||
59527611|NCT01431391|75623402|FG001|NOT COMPLETED|Overall Study||4||
59527612|NCT01431703|75623409|FG000|STARTED|Overall Study||326||
59527613|NCT01431703|75623409|FG000|COMPLETED|Overall Study||326||
59527614|NCT01431703|75623409|FG000|NOT COMPLETED|Overall Study||0||
59527615|NCT01325311|75623415|FG000|STARTED|Overall Study||8||
59527616|NCT01325311|75623416|FG001|STARTED|Overall Study||7||
59527617|NCT01325311|75623415|FG000|COMPLETED|Overall Study||8||
59527618|NCT01325311|75623416|FG001|COMPLETED|Overall Study||7||
59527619|NCT01325311|75623415|FG000|NOT COMPLETED|Overall Study||0||
59527620|NCT01325311|75623416|FG001|NOT COMPLETED|Overall Study||0||
59527621|NCT01432015|75623424|FG000|STARTED|Overall Study||10||
59527622|NCT01432015|75623425|FG001|STARTED|Overall Study||10||
59527623|NCT01432015|75623424|FG000|COMPLETED|Overall Study||10||
59527624|NCT01432015|75623425|FG001|COMPLETED|Overall Study||10||
59527625|NCT01432015|75623424|FG000|NOT COMPLETED|Overall Study||0||
59527626|NCT01432015|75623425|FG001|NOT COMPLETED|Overall Study||0||
59527627|NCT01080209|75623438|FG000|STARTED|Overall Study||28||
59527628|NCT01080209|75623439|FG001|STARTED|Overall Study||53||
59527629|NCT01080209|75623440|FG002|STARTED|Overall Study||33||
59527630|NCT01080209|75623441|FG003|STARTED|Overall Study||42||
59527631|NCT01080209|75623442|FG004|STARTED|Overall Study||6||
59527632|NCT01080209|75623443|FG005|STARTED|Overall Study||2||
59527633|NCT01080209|75623444|FG006|STARTED|Overall Study||51||
59527634|NCT01080209|75623438|FG000|COMPLETED|Overall Study||22||
59527635|NCT01080209|75623439|FG001|COMPLETED|Overall Study||42||
59527636|NCT01080209|75623440|FG002|COMPLETED|Overall Study||28||
59527637|NCT01080209|75623441|FG003|COMPLETED|Overall Study||37||
59527638|NCT01080209|75623442|FG004|COMPLETED|Overall Study||6||
59527639|NCT01080209|75623443|FG005|COMPLETED|Overall Study||2||
59527640|NCT01080209|75623444|FG006|COMPLETED|Overall Study||44||
59527641|NCT01080209|75623438|FG000|NOT COMPLETED|Overall Study||6||
59527642|NCT01080209|75623439|FG001|NOT COMPLETED|Overall Study||11||
59527643|NCT01080209|75623440|FG002|NOT COMPLETED|Overall Study||5||
59527644|NCT01080209|75623441|FG003|NOT COMPLETED|Overall Study||5||
59527645|NCT01080209|75623442|FG004|NOT COMPLETED|Overall Study||0||
59527646|NCT01080209|75623443|FG005|NOT COMPLETED|Overall Study||0||
59527647|NCT01080209|75623444|FG006|NOT COMPLETED|Overall Study||7||
59527648|NCT01080677|75623463|FG000|STARTED|Overall Study||20||
59527649|NCT01080677|75623464|FG001|STARTED|Overall Study||20||
59527650|NCT01080677|75623465|FG002|STARTED|Overall Study||20||
59527651|NCT01080677|75623463|FG000|COMPLETED|Overall Study||20||
59527652|NCT01080677|75623464|FG001|COMPLETED|Overall Study||20||
59527653|NCT01080677|75623465|FG002|COMPLETED|Overall Study||20||
59527654|NCT01080677|75623463|FG000|NOT COMPLETED|Overall Study||0||
59527655|NCT01080677|75623464|FG001|NOT COMPLETED|Overall Study||0||
59527656|NCT01080677|75623465|FG002|NOT COMPLETED|Overall Study||0||
59527657|NCT01378273|75623475|FG000|STARTED|Overall Study||464||
60075351|NCT03227224|76190663|FG003|NOT COMPLETED|Follow-up Phase (2 Weeks)||3||
60075352|NCT03086343|76190682|FG000|STARTED|Overall Study||309||
60075353|NCT03086343|76190683|FG001|STARTED|Overall Study||303||
60075354|NCT03086343|76190682|FG000|COMPLETED|Overall Study||277||
60075355|NCT03086343|76190683|FG001|COMPLETED|Overall Study||278||
60075356|NCT03086343|76190682|FG000|NOT COMPLETED|Overall Study||32||
60075357|NCT03086343|76190683|FG001|NOT COMPLETED|Overall Study||25||
60075358|NCT03074734|76190689|FG000|STARTED|Overall Study|Recruitment of 60 participants started in April 2018.|60||
60075359|NCT03074734|76190689|FG000|Recruitment|Overall Study|The 60 participants were to be recruited before conclusion of the TackSHS project in October 2019.|60||
59527658|NCT01378273|75623476|FG001|STARTED|Overall Study||477||
59527659|NCT01378273|75623475|FG000|COMPLETED|Overall Study||460||
59527660|NCT01378273|75623476|FG001|COMPLETED|Overall Study||476||
59527661|NCT01378273|75623475|FG000|NOT COMPLETED|Overall Study||4||
59527662|NCT01378273|75623476|FG001|NOT COMPLETED|Overall Study||1||
59527663|NCT01115231|75623488|FG000|STARTED|Overall Study||133||
59527664|NCT01115231|75623489|FG001|STARTED|Overall Study||90||
59527665|NCT01115231|75623488|FG000|COMPLETED|Overall Study||133||
59527666|NCT01115231|75623489|FG001|COMPLETED|Overall Study||90||
59527667|NCT01115231|75623488|FG000|NOT COMPLETED|Overall Study||0||
59527668|NCT01115231|75623489|FG001|NOT COMPLETED|Overall Study||0||
59527669|NCT01432405|75623498|FG000|STARTED|Overall Study||12||
59527670|NCT01432405|75623499|FG001|STARTED|Overall Study||12||
59527671|NCT01432405|75623498|FG000|COMPLETED|Overall Study||11||
59527672|NCT01432405|75623499|FG001|COMPLETED|Overall Study||10||
59527673|NCT01432405|75623498|FG000|NOT COMPLETED|Overall Study||1||
59527674|NCT01432405|75623499|FG001|NOT COMPLETED|Overall Study||2||
59527675|NCT01082159|75623505|FG000|STARTED|Overall Study||55||
59527676|NCT01082159|75623505|FG000|COMPLETED|Overall Study||46||
59527677|NCT01082159|75623505|FG000|NOT COMPLETED|Overall Study||9||
59527678|NCT01432561|75623510|FG000|STARTED|Overall Study||8||
59527679|NCT01432561|75623510|FG000|COMPLETED|Overall Study||8||
59527680|NCT01432561|75623510|FG000|NOT COMPLETED|Overall Study||0||
59527681|NCT01116401|75623514|FG000|STARTED|Overall Study||29||
59527682|NCT01116401|75623514|FG000|COMPLETED|Overall Study||29||
59527683|NCT01116401|75623514|FG000|NOT COMPLETED|Overall Study||0||
59527684|NCT01433107|75623520|FG000|STARTED|Overall Study||145||
59527685|NCT01433107|75623521|FG001|STARTED|Overall Study||145||
59527686|NCT01433107|75623520|FG000|COMPLETED|Overall Study||118||
59527687|NCT01433107|75623521|FG001|COMPLETED|Overall Study||128||
59527688|NCT01433107|75623520|FG000|NOT COMPLETED|Overall Study||27||
59527689|NCT01433107|75623521|FG001|NOT COMPLETED|Overall Study||17||
60075360|NCT03074734|76190689|FG000|COMPLETED|Overall Study|60 participants recruited by April 2019.|60||
60075361|NCT03074734|76190689|FG000|NOT COMPLETED|Overall Study||0||
60075362|NCT02904226|76190701|FG000|STARTED|Overall Study||40||
60075363|NCT02904226|76190702|FG001|STARTED|Overall Study||31||
60075364|NCT02904226|76190703|FG002|STARTED|Overall Study||30||
60075365|NCT02904226|76190704|FG003|STARTED|Overall Study||100||
60075366|NCT02904226|76190705|FG004|STARTED|Overall Study||11||
59527690|NCT01082939|75623527|FG000|STARTED|Overall Study||80||
59527691|NCT01082939|75623527|FG000|COMPLETED|Overall Study||80||
60075367|NCT02904226|76190706|FG005|STARTED|Overall Study||0||
60075368|NCT02904226|76190707|FG006|STARTED|Overall Study||6||
60075369|NCT02904226|76190708|FG007|STARTED|Overall Study||0||
60075370|NCT02904226|76190701|FG000|COMPLETED|Overall Study||0||
60075371|NCT02904226|76190702|FG001|COMPLETED|Overall Study||2||
60075372|NCT02904226|76190703|FG002|COMPLETED|Overall Study||0||
60075373|NCT02904226|76190704|FG003|COMPLETED|Overall Study||4||
59527692|NCT01082939|75623527|FG000|NOT COMPLETED|Overall Study||0||
59527693|NCT01327963|75623531|FG000|STARTED|Overall Study||110||
59527694|NCT01327963|75623531|FG000|COMPLETED|Overall Study|110 participants signed informed consent to be included in the study.|110||
59527695|NCT01327963|75623531|FG000|NOT COMPLETED|Overall Study||0||
59527696|NCT01381471|75623537|FG000|STARTED|Overall Study||11060||
59527697|NCT01381471|75623537|FG000|COMPLETED|Overall Study||11060||
59527698|NCT01381471|75623537|FG000|NOT COMPLETED|Overall Study||0||
59527699|NCT01328743|75623543|FG000|STARTED|Overall Study||91||
60075374|NCT02904226|76190705|FG004|COMPLETED|Overall Study||0||
59527700|NCT01328743|75623544|FG001|STARTED|Overall Study||89||
59527701|NCT01328743|75623543|FG000|COMPLETED|Overall Study||82||
59527702|NCT01328743|75623544|FG001|COMPLETED|Overall Study||79||
59527703|NCT01328743|75623543|FG000|NOT COMPLETED|Overall Study||9||
59527704|NCT01328743|75623544|FG001|NOT COMPLETED|Overall Study||10||
59527705|NCT01329679|75623550|FG000|STARTED|Overall Study||13||
59527706|NCT01329679|75623551|FG001|STARTED|Overall Study||13||
59527707|NCT01329679|75623550|FG000|COMPLETED|Overall Study||13||
59527708|NCT01329679|75623551|FG001|COMPLETED|Overall Study||13||
59527709|NCT01329679|75623550|FG000|NOT COMPLETED|Overall Study||0||
59527710|NCT01329679|75623551|FG001|NOT COMPLETED|Overall Study||0||
60075375|NCT02904226|76190706|FG005|COMPLETED|Overall Study||0||
59527711|NCT01433731|75623563|FG000|STARTED|Overall Study||3||
59527712|NCT01433731|75623564|FG001|STARTED|Overall Study||5||
59527713|NCT01433731|75623565|FG002|STARTED|Overall Study||5||
59527714|NCT01433731|75623566|FG003|STARTED|Overall Study||5||
59527715|NCT01433731|75623563|FG000|COMPLETED|Overall Study||3||
59527716|NCT01433731|75623564|FG001|COMPLETED|Overall Study||5||
60075376|NCT02904226|76190707|FG006|COMPLETED|Overall Study||0||
60075377|NCT02904226|76190708|FG007|COMPLETED|Overall Study||0||
60075378|NCT02904226|76190701|FG000|NOT COMPLETED|Overall Study||40||
60075379|NCT02904226|76190702|FG001|NOT COMPLETED|Overall Study||29||
60075380|NCT02904226|76190703|FG002|NOT COMPLETED|Overall Study||30||
59527717|NCT01433731|75623565|FG002|COMPLETED|Overall Study||5||
59527718|NCT01433731|75623566|FG003|COMPLETED|Overall Study||5||
59527719|NCT01433731|75623563|FG000|NOT COMPLETED|Overall Study||0||
59527720|NCT01433731|75623564|FG001|NOT COMPLETED|Overall Study||0||
59527721|NCT01433731|75623565|FG002|NOT COMPLETED|Overall Study||0||
59527722|NCT01433731|75623566|FG003|NOT COMPLETED|Overall Study||0||
59527723|NCT01434121|75623577|FG000|STARTED|Overall Study||8||
59527724|NCT01434121|75623578|FG001|STARTED|Overall Study||8||
59527725|NCT01434121|75623579|FG002|STARTED|Overall Study||8||
59527726|NCT01434121|75623577|FG000|COMPLETED|Overall Study||8||
59527727|NCT01434121|75623578|FG001|COMPLETED|Overall Study||8||
59527728|NCT01434121|75623579|FG002|COMPLETED|Overall Study||8||
59527729|NCT01434121|75623577|FG000|NOT COMPLETED|Overall Study||0||
59527730|NCT01434121|75623578|FG001|NOT COMPLETED|Overall Study||0||
59527731|NCT01434121|75623579|FG002|NOT COMPLETED|Overall Study||0||
59527732|NCT01435603|75623592|FG000|STARTED|Overall Study||167||
59527733|NCT01435603|75623593|FG001|STARTED|Overall Study||164||
59527734|NCT01435603|75623592|FG000|COMPLETED|Overall Study||128||
59527735|NCT01435603|75623593|FG001|COMPLETED|Overall Study||129||
59527736|NCT01435603|75623592|FG000|NOT COMPLETED|Overall Study||39||
59527737|NCT01435603|75623593|FG001|NOT COMPLETED|Overall Study||35||
59527738|NCT01381861|75623599|FG000|STARTED|Overall Study||23||
59527739|NCT01381861|75623599|FG000|COMPLETED|Overall Study||23||
59527740|NCT01381861|75623599|FG000|NOT COMPLETED|Overall Study||0||
59527741|NCT01382719|75623607|FG000|STARTED|Overall Study||98||
59527742|NCT01382719|75623608|FG001|STARTED|Overall Study||100||
59527743|NCT01382719|75623609|FG002|STARTED|Overall Study||100||
59527744|NCT01382719|75623610|FG003|STARTED|Overall Study||99||
59527745|NCT01382719|75623607|FG000|Subjects Not Dosed|Overall Study||1||
59527746|NCT01382719|75623608|FG001|Subjects Not Dosed|Overall Study||0||
59527747|NCT01382719|75623609|FG002|Subjects Not Dosed|Overall Study||1||
59527748|NCT01382719|75623610|FG003|Subjects Not Dosed|Overall Study||1||
59527749|NCT01382719|75623607|FG000|COMPLETED|Overall Study||80||
59527750|NCT01382719|75623608|FG001|COMPLETED|Overall Study||81||
59527751|NCT01382719|75623609|FG002|COMPLETED|Overall Study||66||
60075381|NCT02904226|76190704|FG003|NOT COMPLETED|Overall Study||96||
60075382|NCT02904226|76190705|FG004|NOT COMPLETED|Overall Study||11||
60075383|NCT02904226|76190706|FG005|NOT COMPLETED|Overall Study||0||
60075384|NCT02904226|76190707|FG006|NOT COMPLETED|Overall Study||6||
60075385|NCT02904226|76190708|FG007|NOT COMPLETED|Overall Study||0||
60075386|NCT02788045|76190727|FG000|STARTED|Main Study (Up to Week 72)||110||
60075387|NCT02788045|76190728|FG001|STARTED|Main Study (Up to Week 72)||55||
60075388|NCT02788045|76190729|FG002|STARTED|Main Study (Up to Week 72)||33||
60075389|NCT02788045|76190727|FG000|COMPLETED|Main Study (Up to Week 72)||94||
60075390|NCT02788045|76190728|FG001|COMPLETED|Main Study (Up to Week 72)||45||
60075391|NCT02788045|76190729|FG002|COMPLETED|Main Study (Up to Week 72)||28||
60075392|NCT02788045|76190727|FG000|NOT COMPLETED|Main Study (Up to Week 72)||16||
60075393|NCT02788045|76190728|FG001|NOT COMPLETED|Main Study (Up to Week 72)||10||
60075394|NCT02788045|76190729|FG002|NOT COMPLETED|Main Study (Up to Week 72)||5||
60075395|NCT02788045|76190727|FG000|STARTED|Long Term Extension (From Wk 72 to 264)|Only eligible participants entered LTE phase.|77||
60075396|NCT02788045|76190728|FG001|STARTED|Long Term Extension (From Wk 72 to 264)||0||
60075397|NCT02788045|76190729|FG002|STARTED|Long Term Extension (From Wk 72 to 264)||0||
60075398|NCT02788045|76190727|FG000|COMPLETED|Long Term Extension (From Wk 72 to 264)||60||
59527752|NCT01382719|75623610|FG003|COMPLETED|Overall Study||66||
59527753|NCT01382719|75623607|FG000|NOT COMPLETED|Overall Study||18||
59527754|NCT01382719|75623608|FG001|NOT COMPLETED|Overall Study||19||
59527755|NCT01382719|75623609|FG002|NOT COMPLETED|Overall Study||34||
59527756|NCT01382719|75623610|FG003|NOT COMPLETED|Overall Study||33||
59527757|NCT01037309|75623626|FG000|STARTED|Subcutaneous Cohort 1 - 6||3||
59527758|NCT01037309|75623627|FG001|STARTED|Subcutaneous Cohort 1 - 6||3||
59527759|NCT01037309|75623628|FG002|STARTED|Subcutaneous Cohort 1 - 6||3||
59527760|NCT01037309|75623629|FG003|STARTED|Subcutaneous Cohort 1 - 6||3||
59527761|NCT01037309|75623630|FG004|STARTED|Subcutaneous Cohort 1 - 6||3||
59527762|NCT01037309|75623631|FG005|STARTED|Subcutaneous Cohort 1 - 6||3||
59527763|NCT01037309|75623632|FG006|STARTED|Subcutaneous Cohort 1 - 6||0||
59527764|NCT01037309|75623633|FG007|STARTED|Subcutaneous Cohort 1 - 6||0||
59527765|NCT01037309|75623634|FG008|STARTED|Subcutaneous Cohort 1 - 6||0||
59527766|NCT01037309|75623626|FG000|COMPLETED|Subcutaneous Cohort 1 - 6||3||
59527767|NCT01037309|75623627|FG001|COMPLETED|Subcutaneous Cohort 1 - 6||3||
59527768|NCT01037309|75623628|FG002|COMPLETED|Subcutaneous Cohort 1 - 6||3||
59527769|NCT01037309|75623629|FG003|COMPLETED|Subcutaneous Cohort 1 - 6||3||
59527770|NCT01037309|75623630|FG004|COMPLETED|Subcutaneous Cohort 1 - 6||3||
59527771|NCT01037309|75623631|FG005|COMPLETED|Subcutaneous Cohort 1 - 6||3||
59527772|NCT01037309|75623632|FG006|COMPLETED|Subcutaneous Cohort 1 - 6||0||
59527773|NCT01037309|75623633|FG007|COMPLETED|Subcutaneous Cohort 1 - 6||0||
59527774|NCT01037309|75623634|FG008|COMPLETED|Subcutaneous Cohort 1 - 6||0||
59527775|NCT01037309|75623626|FG000|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0||
59527776|NCT01037309|75623627|FG001|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0||
59527777|NCT01037309|75623628|FG002|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0||
59527778|NCT01037309|75623629|FG003|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0||
59527779|NCT01037309|75623630|FG004|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0||
59527780|NCT01037309|75623631|FG005|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0||
59527781|NCT01037309|75623632|FG006|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0||
59527782|NCT01037309|75623633|FG007|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0||
59527783|NCT01037309|75623634|FG008|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0||
59527784|NCT01037309|75623626|FG000|STARTED|Intravenous Period 7 - 9||0||
59527785|NCT01037309|75623627|FG001|STARTED|Intravenous Period 7 - 9||0||
59527786|NCT01037309|75623628|FG002|STARTED|Intravenous Period 7 - 9||0||
59527787|NCT01037309|75623629|FG003|STARTED|Intravenous Period 7 - 9||0||
59527788|NCT01037309|75623630|FG004|STARTED|Intravenous Period 7 - 9||0||
59527789|NCT01037309|75623631|FG005|STARTED|Intravenous Period 7 - 9||0||
59527790|NCT01037309|75623632|FG006|STARTED|Intravenous Period 7 - 9||3||
59527791|NCT01037309|75623633|FG007|STARTED|Intravenous Period 7 - 9||3||
59527792|NCT01037309|75623634|FG008|STARTED|Intravenous Period 7 - 9||3||
59527793|NCT01037309|75623626|FG000|COMPLETED|Intravenous Period 7 - 9||0||
59527794|NCT01037309|75623627|FG001|COMPLETED|Intravenous Period 7 - 9||0||
59527795|NCT01037309|75623628|FG002|COMPLETED|Intravenous Period 7 - 9||0||
59527796|NCT01037309|75623629|FG003|COMPLETED|Intravenous Period 7 - 9||0||
59527797|NCT01037309|75623630|FG004|COMPLETED|Intravenous Period 7 - 9||0||
59527798|NCT01037309|75623631|FG005|COMPLETED|Intravenous Period 7 - 9||0||
59527799|NCT01037309|75623632|FG006|COMPLETED|Intravenous Period 7 - 9||3||
59527800|NCT01037309|75623633|FG007|COMPLETED|Intravenous Period 7 - 9||3||
59527801|NCT01037309|75623634|FG008|COMPLETED|Intravenous Period 7 - 9||3||
59527802|NCT01037309|75623626|FG000|NOT COMPLETED|Intravenous Period 7 - 9||0||
59527803|NCT01037309|75623627|FG001|NOT COMPLETED|Intravenous Period 7 - 9||0||
59527804|NCT01037309|75623628|FG002|NOT COMPLETED|Intravenous Period 7 - 9||0||
59527805|NCT01037309|75623629|FG003|NOT COMPLETED|Intravenous Period 7 - 9||0||
59527806|NCT01037309|75623630|FG004|NOT COMPLETED|Intravenous Period 7 - 9||0||
59527807|NCT01037309|75623631|FG005|NOT COMPLETED|Intravenous Period 7 - 9||0||
59527808|NCT01037309|75623632|FG006|NOT COMPLETED|Intravenous Period 7 - 9||0||
59527809|NCT01037309|75623633|FG007|NOT COMPLETED|Intravenous Period 7 - 9||0||
59527810|NCT01037309|75623634|FG008|NOT COMPLETED|Intravenous Period 7 - 9||0||
59527811|NCT01038557|75623660|FG000|STARTED|Overall Study||82||
59527812|NCT01038557|75623661|FG001|STARTED|Overall Study||86||
59527813|NCT01038557|75623662|FG002|STARTED|Overall Study||86||
59527814|NCT01038557|75623660|FG000|COMPLETED|Overall Study||82||
59527815|NCT01038557|75623661|FG001|COMPLETED|Overall Study||86||
59527816|NCT01038557|75623662|FG002|COMPLETED|Overall Study||86||
59527817|NCT01038557|75623660|FG000|NOT COMPLETED|Overall Study||0||
59527818|NCT01038557|75623661|FG001|NOT COMPLETED|Overall Study||0||
59527819|NCT01038557|75623662|FG002|NOT COMPLETED|Overall Study||0||
59527820|NCT01117727|75623670|FG000|STARTED|Overall Study||1||
59527821|NCT01117727|75623670|FG000|COMPLETED|Overall Study||1||
59527822|NCT01117727|75623670|FG000|NOT COMPLETED|Overall Study||0||
59527823|NCT01040819|75623677|FG000|STARTED|Overall Study||13||
59527824|NCT01040819|75623678|FG001|STARTED|Overall Study||12||
59527825|NCT01040819|75623677|FG000|COMPLETED|Overall Study||13||
59527826|NCT01040819|75623678|FG001|COMPLETED|Overall Study||12||
59527827|NCT01040819|75623677|FG000|NOT COMPLETED|Overall Study||0||
59527828|NCT01040819|75623678|FG001|NOT COMPLETED|Overall Study||0||
59527829|NCT01041209|75623686|FG000|STARTED|Overall Study||60||
59527830|NCT01041209|75623687|FG001|STARTED|Overall Study||60||
59527831|NCT01041209|75623686|FG000|COMPLETED|Overall Study||60||
59527832|NCT01041209|75623687|FG001|COMPLETED|Overall Study||60||
59527833|NCT01041209|75623686|FG000|NOT COMPLETED|Overall Study||0||
59527834|NCT01041209|75623687|FG001|NOT COMPLETED|Overall Study||0||
59527835|NCT01084265|75623694|FG000|STARTED|Overall Study||31||
59527836|NCT01084265|75623694|FG000|COMPLETED|Overall Study||31||
59527837|NCT01084265|75623694|FG000|NOT COMPLETED|Overall Study||0||
59527838|NCT01084499|75623700|FG000|STARTED|Overall Study|First Intervention (Sequence 1) : Femara (1 Day)|13||
59527839|NCT01084499|75623701|FG001|STARTED|Overall Study|First Intervention (Sequence 2) : Peratra (1 Day)|13||
59527840|NCT01084499|75623700|FG000|Washout (5 Weeks)|Overall Study||13||
59527841|NCT01084499|75623701|FG001|Washout (5 Weeks)|Overall Study||13||
59527842|NCT01084499|75623700|FG000|COMPLETED|Overall Study|Second Intervention (Sequence 1) : Peratra (1 Day)|13||
59527843|NCT01084499|75623701|FG001|COMPLETED|Overall Study|Second Intervention (Sequence 2) : Femara (1 Day)|13||
59527844|NCT01084499|75623700|FG000|NOT COMPLETED|Overall Study||0||
59527845|NCT01084499|75623701|FG001|NOT COMPLETED|Overall Study||0||
59527846|NCT01085513|75623709|FG000|STARTED|Phase I - Development Phase||54||
59527847|NCT01085513|75623710|FG001|STARTED|Phase I - Development Phase||52||
59527848|NCT01085513|75623709|FG000|COMPLETED|Phase I - Development Phase|recruitment was premature terminated|54||
59527849|NCT01085513|75623710|FG001|COMPLETED|Phase I - Development Phase||52||
59527850|NCT01085513|75623709|FG000|NOT COMPLETED|Phase I - Development Phase||0||
59527851|NCT01085513|75623710|FG001|NOT COMPLETED|Phase I - Development Phase||0||
59527852|NCT01085513|75623709|FG000|STARTED|Phase II - Validation Phase||21||
59527853|NCT01085513|75623710|FG001|STARTED|Phase II - Validation Phase||16||
59527854|NCT01085513|75623709|FG000|COMPLETED|Phase II - Validation Phase||21||
59527855|NCT01085513|75623710|FG001|COMPLETED|Phase II - Validation Phase||16||
59527856|NCT01085513|75623709|FG000|NOT COMPLETED|Phase II - Validation Phase||0||
59527857|NCT01085513|75623710|FG001|NOT COMPLETED|Phase II - Validation Phase||0||
59527858|NCT01986348|75623720|FG000|STARTED|Overall Study||8||
59527859|NCT01986348|75623721|FG001|STARTED|Overall Study||24||
59527860|NCT01986348|75623722|FG002|STARTED|Overall Study||14||
59527861|NCT01986348|75623723|FG003|STARTED|Overall Study||30||
59527862|NCT01986348|75623720|FG000|COMPLETED|Overall Study||0||
59527863|NCT01986348|75623721|FG001|COMPLETED|Overall Study||0||
59527864|NCT01986348|75623722|FG002|COMPLETED|Overall Study||0||
59527865|NCT01986348|75623723|FG003|COMPLETED|Overall Study||0||
59527866|NCT01986348|75623720|FG000|NOT COMPLETED|Overall Study||8||
59527867|NCT01986348|75623721|FG001|NOT COMPLETED|Overall Study||24||
59527868|NCT01986348|75623722|FG002|NOT COMPLETED|Overall Study||14||
59527869|NCT01986348|75623723|FG003|NOT COMPLETED|Overall Study||30||
59527870|NCT01118273|75623742|FG000|STARTED|Overall Study||27||
59527871|NCT01118273|75623743|FG001|STARTED|Overall Study||27||
59527872|NCT01118273|75623744|FG002|STARTED|Overall Study||27||
59527873|NCT01118273|75623745|FG003|STARTED|Overall Study||27||
59527874|NCT01118273|75623746|FG004|STARTED|Overall Study||27||
59527875|NCT01118273|75623747|FG005|STARTED|Overall Study||27||
59527876|NCT01118273|75623742|FG000|COMPLETED|Overall Study||27||
59527877|NCT01118273|75623743|FG001|COMPLETED|Overall Study||27||
59527878|NCT01118273|75623744|FG002|COMPLETED|Overall Study||27||
59527879|NCT01118273|75623745|FG003|COMPLETED|Overall Study||27||
59527880|NCT01118273|75623746|FG004|COMPLETED|Overall Study||27||
59527881|NCT01118273|75623747|FG005|COMPLETED|Overall Study||27||
59527882|NCT01118273|75623742|FG000|NOT COMPLETED|Overall Study||0||
59527883|NCT01118273|75623743|FG001|NOT COMPLETED|Overall Study||0||
59527884|NCT01118273|75623744|FG002|NOT COMPLETED|Overall Study||0||
59527885|NCT01118273|75623745|FG003|NOT COMPLETED|Overall Study||0||
59527886|NCT01118273|75623746|FG004|NOT COMPLETED|Overall Study||0||
59527887|NCT01118273|75623747|FG005|NOT COMPLETED|Overall Study||0||
59527888|NCT01383421|75623761|FG000|STARTED|Overall Study|ITT population: all enrolled participants who received at least 1 dose of study drug.|1025||
59527889|NCT01383421|75623761|FG000|COMPLETED|Overall Study||679||
59527890|NCT01383421|75623761|FG000|NOT COMPLETED|Overall Study||346||
59622697|NCT00541242|75734587|FG000|NOT COMPLETED|Treatment Period 1||0||
59527891|NCT01085825|75623771|FG000|STARTED|Overall Study|1st participant enrolled|252||
59527892|NCT01085825|75623772|FG001|STARTED|Overall Study||248||
59527893|NCT01085825|75623771|FG000|COMPLETED|Overall Study||251||
59527894|NCT01085825|75623772|FG001|COMPLETED|Overall Study||247||
59527895|NCT01085825|75623771|FG000|NOT COMPLETED|Overall Study||1||
59527896|NCT01085825|75623772|FG001|NOT COMPLETED|Overall Study||1||
59527897|NCT01085903|75623780|FG000|STARTED|Overall Study||21||
59527898|NCT01085903|75623781|FG001|STARTED|Overall Study||4||
59527899|NCT01085903|75623782|FG002|STARTED|Overall Study||3||
59622698|NCT00541242|75734588|FG001|NOT COMPLETED|Treatment Period 1||0||
59622699|NCT00541242|75734587|FG000|STARTED|Treatment Period 2||270||
59622700|NCT00541242|75734588|FG001|STARTED|Treatment Period 2||273||
59622701|NCT00541242|75734587|FG000|COMPLETED|Treatment Period 2||261||
59527900|NCT01085903|75623780|FG000|COMPLETED|Overall Study||21||
59527901|NCT01085903|75623781|FG001|COMPLETED|Overall Study||4||
59527902|NCT01085903|75623782|FG002|COMPLETED|Overall Study||3||
59527903|NCT01085903|75623780|FG000|NOT COMPLETED|Overall Study||0||
59527904|NCT01085903|75623781|FG001|NOT COMPLETED|Overall Study||0||
59527905|NCT01085903|75623782|FG002|NOT COMPLETED|Overall Study||0||
59527906|NCT01439035|75623801|FG000|STARTED|Overall Study||6||
59527907|NCT01439035|75623801|FG000|COMPLETED|Overall Study||6||
59527908|NCT01439035|75623801|FG000|NOT COMPLETED|Overall Study||0||
59527909|NCT01118741|75623807|FG000|STARTED|Overall Study||9||
59527910|NCT01118741|75623808|FG001|STARTED|Overall Study||10||
59527911|NCT01118741|75623807|FG000|COMPLETED|Overall Study||9||
59622702|NCT00541242|75734588|FG001|COMPLETED|Treatment Period 2||266||
59527912|NCT01118741|75623808|FG001|COMPLETED|Overall Study||10||
59527913|NCT01118741|75623807|FG000|NOT COMPLETED|Overall Study||0||
59527914|NCT01118741|75623808|FG001|NOT COMPLETED|Overall Study||0||
59527915|NCT01439581|75623818|FG000|STARTED|Overall Study||216||
59527916|NCT01439581|75623819|FG001|STARTED|Overall Study||212||
59527917|NCT01439581|75623818|FG000|COMPLETED|Overall Study||216||
59527918|NCT01439581|75623819|FG001|COMPLETED|Overall Study||212||
59527919|NCT01439581|75623818|FG000|NOT COMPLETED|Overall Study||0||
59527920|NCT01439581|75623819|FG001|NOT COMPLETED|Overall Study||0||
59527921|NCT01439815|75623827|FG000|STARTED|Overall Study||11||
59527922|NCT01439815|75623828|FG001|STARTED|Overall Study||11||
59527923|NCT01439815|75623827|FG000|All Randomized Participant Population|Overall Study||11||
59527924|NCT01439815|75623828|FG001|All Randomized Participant Population|Overall Study||11||
59527925|NCT01439815|75623827|FG000|COMPLETED|Overall Study||11||
59527926|NCT01439815|75623828|FG001|COMPLETED|Overall Study||9||
59527927|NCT01439815|75623827|FG000|NOT COMPLETED|Overall Study||0||
59527928|NCT01439815|75623828|FG001|NOT COMPLETED|Overall Study||2||
59527929|NCT01332253|75623836|FG000|STARTED|Overall Study||82||
59527930|NCT01332253|75623837|FG001|STARTED|Overall Study||79||
59527931|NCT01332253|75623836|FG000|COMPLETED|Overall Study||82||
59527932|NCT01332253|75623837|FG001|COMPLETED|Overall Study||79||
59527933|NCT01332253|75623836|FG000|NOT COMPLETED|Overall Study||0||
59527934|NCT01332253|75623837|FG001|NOT COMPLETED|Overall Study||0||
59527935|NCT01332487|75623845|FG000|STARTED|Overall Study||5554||
59527936|NCT01332487|75623846|FG001|STARTED|Overall Study||3063||
59527937|NCT01332487|75623845|FG000|COMPLETED|Overall Study||5554||
59527938|NCT01332487|75623846|FG001|COMPLETED|Overall Study||3063||
59527939|NCT01332487|75623845|FG000|NOT COMPLETED|Overall Study||0||
59527940|NCT01332487|75623846|FG001|NOT COMPLETED|Overall Study||0||
59527941|NCT01332721|75623852|FG000|STARTED|Overall Study||38||
59527942|NCT01332721|75623852|FG000|COMPLETED|Overall Study||38||
59527943|NCT01332721|75623852|FG000|NOT COMPLETED|Overall Study||0||
59527944|NCT01384591|75623859|FG000|STARTED|Overall Study||2||
59527945|NCT01384591|75623860|FG001|STARTED|Overall Study||2||
59527946|NCT01384591|75623861|FG002|STARTED|Overall Study||2||
59527947|NCT01384591|75623859|FG000|COMPLETED|Overall Study||2||
59527948|NCT01384591|75623860|FG001|COMPLETED|Overall Study||2||
59527949|NCT01384591|75623861|FG002|COMPLETED|Overall Study||2||
59527950|NCT01384591|75623859|FG000|NOT COMPLETED|Overall Study||0||
59527951|NCT01384591|75623860|FG001|NOT COMPLETED|Overall Study||0||
59527952|NCT01384591|75623861|FG002|NOT COMPLETED|Overall Study||0||
59527953|NCT01086605|75623871|FG000|STARTED|Overall Study||24||
59527954|NCT01086605|75623872|FG001|STARTED|Overall Study||22||
59527955|NCT01086605|75623871|FG000|COMPLETED|Overall Study||24||
59527956|NCT01086605|75623872|FG001|COMPLETED|Overall Study||22||
59527957|NCT01086605|75623871|FG000|NOT COMPLETED|Overall Study||0||
59527958|NCT01086605|75623872|FG001|NOT COMPLETED|Overall Study||0||
59527959|NCT00265850|75623882|FG000|STARTED|Overall Study||899||
59527960|NCT00265850|75623883|FG001|STARTED|Overall Study||902||
59527961|NCT00265850|75623884|FG002|STARTED|Overall Study||533||
59527962|NCT00265850|75623882|FG000|COMPLETED|Overall Study||899||
59527963|NCT00265850|75623883|FG001|COMPLETED|Overall Study||902||
59527964|NCT00265850|75623884|FG002|COMPLETED|Overall Study||533||
59527965|NCT00265850|75623882|FG000|NOT COMPLETED|Overall Study||0||
59527966|NCT00265850|75623883|FG001|NOT COMPLETED|Overall Study||0||
59527967|NCT00265850|75623884|FG002|NOT COMPLETED|Overall Study||0||
59527968|NCT01385137|75623893|FG000|STARTED|Evaluable at Baseline||131|9 patients on arm 1 and 4 patients on arm 2 found ineligible after registration|
59527969|NCT01385137|75623894|FG001|STARTED|Evaluable at Baseline||131|9 patients on arm 1 and 4 patients on arm 2 found ineligible after registration|
59527970|NCT01385137|75623893|FG000|COMPLETED|Evaluable at Baseline||122||
59527971|NCT01385137|75623894|FG001|COMPLETED|Evaluable at Baseline||127||
59527972|NCT01385137|75623893|FG000|NOT COMPLETED|Evaluable at Baseline||9||
59527973|NCT01385137|75623894|FG001|NOT COMPLETED|Evaluable at Baseline||4||
59527974|NCT01385137|75623893|FG000|STARTED|Evaluable for Primary Endpoint||131||
59527975|NCT01385137|75623894|FG001|STARTED|Evaluable for Primary Endpoint||131||
59527976|NCT01385137|75623893|FG000|COMPLETED|Evaluable for Primary Endpoint||102||
59527977|NCT01385137|75623894|FG001|COMPLETED|Evaluable for Primary Endpoint||107||
59527978|NCT01385137|75623893|FG000|NOT COMPLETED|Evaluable for Primary Endpoint||29||
59527979|NCT01385137|75623894|FG001|NOT COMPLETED|Evaluable for Primary Endpoint||24||
59527980|NCT01086761|75623905|FG000|STARTED|Overall Study||9||
59527981|NCT01086761|75623906|FG001|STARTED|Overall Study||7||
59527982|NCT01086761|75623907|FG002|STARTED|Overall Study||6||
59527983|NCT01086761|75623908|FG003|STARTED|Overall Study||6||
59527984|NCT01086761|75623909|FG004|STARTED|Overall Study||4||
59527985|NCT01086761|75623910|FG005|STARTED|Overall Study||0||
59527986|NCT01086761|75623905|FG000|COMPLETED|Overall Study||9||
59527987|NCT01086761|75623906|FG001|COMPLETED|Overall Study||7||
59527988|NCT01086761|75623907|FG002|COMPLETED|Overall Study||6||
59527989|NCT01086761|75623908|FG003|COMPLETED|Overall Study||6||
59527990|NCT01086761|75623909|FG004|COMPLETED|Overall Study||4||
59527991|NCT01086761|75623910|FG005|COMPLETED|Overall Study||0||
59527992|NCT01086761|75623905|FG000|NOT COMPLETED|Overall Study||0||
59527993|NCT01086761|75623906|FG001|NOT COMPLETED|Overall Study||0||
59527994|NCT01086761|75623907|FG002|NOT COMPLETED|Overall Study||0||
59527995|NCT01086761|75623908|FG003|NOT COMPLETED|Overall Study||0||
59527996|NCT01086761|75623909|FG004|NOT COMPLETED|Overall Study||0||
59527997|NCT01086761|75623910|FG005|NOT COMPLETED|Overall Study||0||
59527998|NCT00125372|75623923|FG000|STARTED|Overall Study||12||
59527999|NCT00125372|75623923|FG000|COMPLETED|Overall Study||10||
59528000|NCT00125372|75623923|FG000|NOT COMPLETED|Overall Study||2||
59528001|NCT01087541|75623929|FG000|STARTED|Overall Study||3307||
59528002|NCT01087541|75623930|FG001|STARTED|Overall Study||3523||
59528003|NCT01087541|75623929|FG000|COMPLETED|Overall Study||3307||
59528004|NCT01087541|75623930|FG001|COMPLETED|Overall Study||3523||
59528005|NCT01087541|75623929|FG000|NOT COMPLETED|Overall Study||0||
59528006|NCT01087541|75623930|FG001|NOT COMPLETED|Overall Study||0||
59528007|NCT01385293|75623936|FG000|STARTED|Overall Study||30||
59528008|NCT01385293|75623936|FG000|COMPLETED|Overall Study||30||
59528009|NCT01385293|75623936|FG000|NOT COMPLETED|Overall Study||0||
59528010|NCT00125528|75623942|FG000|STARTED|Overall Study||20||
59528011|NCT00125528|75623943|FG001|STARTED|Overall Study||21||
59528012|NCT00125528|75623942|FG000|COMPLETED|Overall Study||18||
59528013|NCT00125528|75623943|FG001|COMPLETED|Overall Study||20||
59528014|NCT00125528|75623942|FG000|NOT COMPLETED|Overall Study||2||
59528015|NCT00125528|75623943|FG001|NOT COMPLETED|Overall Study||1||
59528016|NCT00125762|75623949|FG000|STARTED|Overall Study||907||
59528017|NCT00125762|75623949|FG000|COMPLETED|Overall Study||748||
59528018|NCT00125762|75623949|FG000|NOT COMPLETED|Overall Study||159||
59528019|NCT01333813|75623953|FG000|STARTED|Overall Study||297||
59528020|NCT01333813|75623953|FG000|COMPLETED|Overall Study||297||
59528021|NCT01333813|75623953|FG000|NOT COMPLETED|Overall Study||0||
59528022|NCT01390909|75623963|FG000|STARTED|Overall Study||3454||
59528023|NCT01390909|75623964|FG001|STARTED|Overall Study||3552||
59987688|NCT00966953|76102946|FG001|NOT COMPLETED|1 Week Washout After 1st Intervention||0||
59987689|NCT00966953|76102947|FG002|NOT COMPLETED|1 Week Washout After 1st Intervention||0||
59987690|NCT00966953|76102948|FG003|NOT COMPLETED|1 Week Washout After 1st Intervention||0||
59528024|NCT01390909|75623965|FG002|STARTED|Overall Study||3552||
59528025|NCT01390909|75623966|FG003|STARTED|Overall Study||602||
59528026|NCT01390909|75623967|FG004|STARTED|Overall Study||613||
59528027|NCT01390909|75623968|FG005|STARTED|Overall Study||613||
59528028|NCT01390909|75623963|FG000|Participants in Subgroup|Overall Study||0||
59528029|NCT01390909|75623964|FG001|Participants in Subgroup|Overall Study||3454||
59528030|NCT01390909|75623965|FG002|Participants in Subgroup|Overall Study||0||
59528031|NCT01390909|75623966|FG003|Participants in Subgroup|Overall Study||0||
59528032|NCT01390909|75623967|FG004|Participants in Subgroup|Overall Study||602||
59528033|NCT01390909|75623968|FG005|Participants in Subgroup|Overall Study||0||
59528034|NCT01390909|75623963|FG000|COMPLETED|Overall Study||3454||
59528035|NCT01390909|75623964|FG001|COMPLETED|Overall Study||3552||
59528036|NCT01390909|75623965|FG002|COMPLETED|Overall Study||3552||
59528037|NCT01390909|75623966|FG003|COMPLETED|Overall Study||602||
59528038|NCT01390909|75623967|FG004|COMPLETED|Overall Study||613||
59528039|NCT01390909|75623968|FG005|COMPLETED|Overall Study||613||
59528040|NCT01390909|75623963|FG000|NOT COMPLETED|Overall Study||0||
59528041|NCT01390909|75623964|FG001|NOT COMPLETED|Overall Study||0||
59528042|NCT01390909|75623965|FG002|NOT COMPLETED|Overall Study||0||
59528043|NCT01390909|75623966|FG003|NOT COMPLETED|Overall Study||0||
59528044|NCT01390909|75623967|FG004|NOT COMPLETED|Overall Study||0||
59528045|NCT01390909|75623968|FG005|NOT COMPLETED|Overall Study||0||
59528046|NCT01041521|75623988|FG000|STARTED|Overall Study||61||
59528047|NCT01041521|75623989|FG001|STARTED|Overall Study||56||
59528048|NCT01041521|75623988|FG000|COMPLETED|Overall Study||44||
59528049|NCT01041521|75623989|FG001|COMPLETED|Overall Study||40||
59528050|NCT01041521|75623988|FG000|NOT COMPLETED|Overall Study||17||
59528051|NCT01041521|75623989|FG001|NOT COMPLETED|Overall Study||16||
59528052|NCT01042145|75623997|FG000|STARTED|Overall Study||41||
59528053|NCT01042145|75623998|FG001|STARTED|Overall Study||46||
59528054|NCT01042145|75623997|FG000|COMPLETED|Overall Study||40||
59528055|NCT01042145|75623998|FG001|COMPLETED|Overall Study||45||
59528056|NCT01042145|75623997|FG000|NOT COMPLETED|Overall Study||1||
59528057|NCT01042145|75623998|FG001|NOT COMPLETED|Overall Study||1||
59528058|NCT01334827|75624006|FG000|STARTED|Overall Study||48||
59528059|NCT01334827|75624006|FG000|COMPLETED|Overall Study||48||
59528060|NCT01334827|75624006|FG000|NOT COMPLETED|Overall Study||0||
59528061|NCT01042613|75624014|FG000|STARTED|Overall Study||72||
59528062|NCT01042613|75624015|FG001|STARTED|Overall Study||74||
59528063|NCT01042613|75624014|FG000|COMPLETED|Overall Study||72||
59987691|NCT00966953|76102945|FG000|STARTED|2nd Intervention||6||
59987692|NCT00966953|76102946|FG001|STARTED|2nd Intervention||6||
59528064|NCT01042613|75624015|FG001|COMPLETED|Overall Study||74||
59528065|NCT01042613|75624014|FG000|NOT COMPLETED|Overall Study||0||
59528066|NCT01042613|75624015|FG001|NOT COMPLETED|Overall Study||0||
59528067|NCT01043393|75624023|FG000|STARTED|Overall Study||12||
59528068|NCT01043393|75624024|FG001|STARTED|Overall Study||12||
59528069|NCT01043393|75624023|FG000|COMPLETED|Overall Study||12||
59528070|NCT01043393|75624024|FG001|COMPLETED|Overall Study||12||
59528071|NCT01043393|75624023|FG000|NOT COMPLETED|Overall Study||0||
59528072|NCT01043393|75624024|FG001|NOT COMPLETED|Overall Study||0||
59528073|NCT01335061|75624030|FG000|STARTED|Overall Study||25||
59528074|NCT01335061|75624030|FG000|COMPLETED|Overall Study||25||
59528075|NCT01335061|75624030|FG000|NOT COMPLETED|Overall Study||0||
59528076|NCT01087931|75624043|FG000|STARTED|Overall Study||20||
59528077|NCT01087931|75624044|FG001|STARTED|Overall Study||20||
59528078|NCT01087931|75624043|FG000|1st Follow up|Overall Study||20||
59528079|NCT01087931|75624044|FG001|1st Follow up|Overall Study||19||
59528080|NCT01087931|75624043|FG000|Final Follow up|Overall Study||19||
59528081|NCT01087931|75624044|FG001|Final Follow up|Overall Study||17||
59528082|NCT01087931|75624043|FG000|COMPLETED|Overall Study||20|all participants completed either the 1st follow-up evaluation or the final evaluation|
59528083|NCT01087931|75624044|FG001|COMPLETED|Overall Study||20|all participants completed either the 1st follow-up evaluation or the final evaluation|
59528084|NCT01087931|75624043|FG000|NOT COMPLETED|Overall Study||0||
59528085|NCT01087931|75624044|FG001|NOT COMPLETED|Overall Study||0||
59528086|NCT01119755|75624050|FG000|STARTED|Overall Study||80||
59528087|NCT01119755|75624050|FG000|COMPLETED|Overall Study||80||
59528088|NCT01119755|75624050|FG000|NOT COMPLETED|Overall Study||0||
59528089|NCT00176930|75624062|FG000|STARTED|Overall Study||12||
59528090|NCT00176930|75624063|FG001|STARTED|Overall Study||13||
59528091|NCT00176930|75624064|FG002|STARTED|Overall Study||1||
59528092|NCT00176930|75624065|FG003|STARTED|Overall Study||1||
59528093|NCT00176930|75624066|FG004|STARTED|Overall Study||213||
59528094|NCT00176930|75624067|FG005|STARTED|Overall Study||85||
59528095|NCT00176930|75624068|FG006|STARTED|Overall Study||2||
59528096|NCT00176930|75624069|FG007|STARTED|Overall Study||2||
59528097|NCT00176930|75624062|FG000|COMPLETED|Overall Study||12||
59528098|NCT00176930|75624063|FG001|COMPLETED|Overall Study||13||
59528099|NCT00176930|75624064|FG002|COMPLETED|Overall Study||1||
59528100|NCT00176930|75624065|FG003|COMPLETED|Overall Study||1||
59528101|NCT00176930|75624066|FG004|COMPLETED|Overall Study||213||
59528102|NCT00176930|75624067|FG005|COMPLETED|Overall Study||85||
59528103|NCT00176930|75624068|FG006|COMPLETED|Overall Study||2||
59528104|NCT00176930|75624069|FG007|COMPLETED|Overall Study||2||
59528105|NCT00176930|75624062|FG000|NOT COMPLETED|Overall Study||0||
59528106|NCT00176930|75624063|FG001|NOT COMPLETED|Overall Study||0||
59528107|NCT00176930|75624064|FG002|NOT COMPLETED|Overall Study||0||
59528108|NCT00176930|75624065|FG003|NOT COMPLETED|Overall Study||0||
59528109|NCT00176930|75624066|FG004|NOT COMPLETED|Overall Study||0||
59528110|NCT00176930|75624067|FG005|NOT COMPLETED|Overall Study||0||
59528111|NCT00176930|75624068|FG006|NOT COMPLETED|Overall Study||0||
59528112|NCT00176930|75624069|FG007|NOT COMPLETED|Overall Study||0||
59528113|NCT01473745|75624089|FG000|STARTED|Overall Study||24||
59528114|NCT01473745|75624090|FG001|STARTED|Overall Study||24||
59528115|NCT01473745|75624089|FG000|COMPLETED|Overall Study||24||
59528116|NCT01473745|75624090|FG001|COMPLETED|Overall Study||24||
59528117|NCT01473745|75624089|FG000|NOT COMPLETED|Overall Study||0||
59528118|NCT01473745|75624090|FG001|NOT COMPLETED|Overall Study||0||
59528119|NCT01088711|75624100|FG000|STARTED|Overall Study||18||
59528120|NCT01088711|75624101|FG001|STARTED|Overall Study||6||
59528121|NCT01088711|75624102|FG002|STARTED|Overall Study||6||
59528122|NCT01088711|75624103|FG003|STARTED|Overall Study||2||
59528123|NCT01088711|75624100|FG000|COMPLETED|Overall Study||18||
59528124|NCT01088711|75624101|FG001|COMPLETED|Overall Study||6||
59528125|NCT01088711|75624102|FG002|COMPLETED|Overall Study||6||
59528126|NCT01088711|75624103|FG003|COMPLETED|Overall Study||2||
59528127|NCT01088711|75624100|FG000|NOT COMPLETED|Overall Study||0||
59528128|NCT01088711|75624101|FG001|NOT COMPLETED|Overall Study||0||
59528129|NCT01088711|75624102|FG002|NOT COMPLETED|Overall Study||0||
59528130|NCT01088711|75624103|FG003|NOT COMPLETED|Overall Study||0||
59622703|NCT00541242|75734587|FG000|NOT COMPLETED|Treatment Period 2||9||
59528131|NCT00127790|75624119|FG000|STARTED|Pre-Treatment|7 enrolled subjects were withdrawn prior to randomization; 21 of 28 enrolled were randomized.|6||
59528132|NCT00127790|75624120|FG001|STARTED|Pre-Treatment||5||
59528133|NCT00127790|75624121|FG002|STARTED|Pre-Treatment||6||
59528134|NCT00127790|75624122|FG003|STARTED|Pre-Treatment||4||
59528135|NCT00127790|75624119|FG000|COMPLETED|Pre-Treatment||6||
59528136|NCT00127790|75624120|FG001|COMPLETED|Pre-Treatment||5||
59528137|NCT00127790|75624121|FG002|COMPLETED|Pre-Treatment||6||
59528138|NCT00127790|75624122|FG003|COMPLETED|Pre-Treatment||4||
59528139|NCT00127790|75624119|FG000|NOT COMPLETED|Pre-Treatment||0||
59528140|NCT00127790|75624120|FG001|NOT COMPLETED|Pre-Treatment||0||
59528141|NCT00127790|75624121|FG002|NOT COMPLETED|Pre-Treatment||0||
59528142|NCT00127790|75624122|FG003|NOT COMPLETED|Pre-Treatment||0||
59528143|NCT00127790|75624119|FG000|STARTED|Post-Treatment||6||
59528144|NCT00127790|75624120|FG001|STARTED|Post-Treatment||5||
59528145|NCT00127790|75624121|FG002|STARTED|Post-Treatment||6||
59528146|NCT00127790|75624122|FG003|STARTED|Post-Treatment||4||
59528147|NCT00127790|75624119|FG000|COMPLETED|Post-Treatment||6||
59528148|NCT00127790|75624120|FG001|COMPLETED|Post-Treatment||5||
59528149|NCT00127790|75624121|FG002|COMPLETED|Post-Treatment||6||
59528150|NCT00127790|75624122|FG003|COMPLETED|Post-Treatment||4||
59528151|NCT00127790|75624119|FG000|NOT COMPLETED|Post-Treatment||0||
59528152|NCT00127790|75624120|FG001|NOT COMPLETED|Post-Treatment||0||
59528153|NCT00127790|75624121|FG002|NOT COMPLETED|Post-Treatment||0||
59528154|NCT00127790|75624122|FG003|NOT COMPLETED|Post-Treatment||0||
59528155|NCT01120223|75624132|FG000|STARTED|Overall Study||78||
59528156|NCT01120223|75624132|FG000|COMPLETED|Overall Study||74||
59528157|NCT01120223|75624132|FG000|NOT COMPLETED|Overall Study||4||
59528158|NCT00178178|75624140|FG000|STARTED|Overall Study||24||
59528159|NCT00178178|75624141|FG001|STARTED|Overall Study||24||
59528160|NCT00178178|75624142|FG002|STARTED|Overall Study||24||
59528161|NCT00178178|75624143|FG003|STARTED|Overall Study||24||
59528162|NCT00178178|75624140|FG000|COMPLETED|Overall Study||24||
59528163|NCT00178178|75624141|FG001|COMPLETED|Overall Study||24||
59528164|NCT00178178|75624142|FG002|COMPLETED|Overall Study||24||
59528165|NCT00178178|75624143|FG003|COMPLETED|Overall Study||24||
59528166|NCT00178178|75624140|FG000|NOT COMPLETED|Overall Study||0||
59528167|NCT00178178|75624141|FG001|NOT COMPLETED|Overall Study||0||
59528168|NCT00178178|75624142|FG002|NOT COMPLETED|Overall Study||0||
59528169|NCT00178178|75624143|FG003|NOT COMPLETED|Overall Study||0||
59528170|NCT01441843|75624155|FG000|STARTED|Overall Study||200||
59528171|NCT01441843|75624156|FG001|STARTED|Overall Study||200||
59528172|NCT01441843|75624155|FG000|COMPLETED|Overall Study||188||
59528173|NCT01441843|75624156|FG001|COMPLETED|Overall Study||195||
59528174|NCT01441843|75624155|FG000|NOT COMPLETED|Overall Study||12||
59528175|NCT01441843|75624156|FG001|NOT COMPLETED|Overall Study||5||
59528176|NCT00178646|75624165|FG000|STARTED|Overall Study||12||
59528177|NCT00178646|75624166|FG001|STARTED|Overall Study||9||
59528178|NCT00178646|75624167|FG002|STARTED|Overall Study||11||
59528179|NCT00178646|75624165|FG000|COMPLETED|Overall Study||12||
59528180|NCT00178646|75624166|FG001|COMPLETED|Overall Study||8||
59528181|NCT00178646|75624167|FG002|COMPLETED|Overall Study||10||
59528182|NCT00178646|75624165|FG000|NOT COMPLETED|Overall Study||0||
59528183|NCT00178646|75624166|FG001|NOT COMPLETED|Overall Study||1||
59528184|NCT00178646|75624167|FG002|NOT COMPLETED|Overall Study||1||
59528185|NCT02204761|75624178|FG000|STARTED|Overall Study||6||
59528186|NCT02204761|75624178|FG000|COMPLETED|Overall Study||6||
59528187|NCT02204761|75624178|FG000|NOT COMPLETED|Overall Study||0||
59528188|NCT01089569|75624185|FG000|STARTED|Overall Study||20||
59528189|NCT01089569|75624186|FG001|STARTED|Overall Study||20||
59528190|NCT01089569|75624187|FG002|STARTED|Overall Study||20||
59528191|NCT01089569|75624185|FG000|COMPLETED|Overall Study||16||
59528192|NCT01089569|75624186|FG001|COMPLETED|Overall Study||17||
59528193|NCT01089569|75624187|FG002|COMPLETED|Overall Study||16||
59528194|NCT01089569|75624185|FG000|NOT COMPLETED|Overall Study||4||
59528195|NCT01089569|75624186|FG001|NOT COMPLETED|Overall Study||3||
59528196|NCT01089569|75624187|FG002|NOT COMPLETED|Overall Study||4||
59528197|NCT01043939|75624195|FG000|STARTED|First Intervention||12||
59528198|NCT01043939|75624196|FG001|STARTED|First Intervention||12||
59528199|NCT01043939|75624195|FG000|COMPLETED|First Intervention||12||
59528200|NCT01043939|75624196|FG001|COMPLETED|First Intervention||12||
59528201|NCT01043939|75624195|FG000|NOT COMPLETED|First Intervention||0||
59528202|NCT01043939|75624196|FG001|NOT COMPLETED|First Intervention||0||
59528203|NCT01043939|75624195|FG000|STARTED|Washout Period||12||
59528204|NCT01043939|75624196|FG001|STARTED|Washout Period||12||
59528205|NCT01043939|75624195|FG000|COMPLETED|Washout Period||12||
59528206|NCT01043939|75624196|FG001|COMPLETED|Washout Period||12||
59528207|NCT01043939|75624195|FG000|NOT COMPLETED|Washout Period||0||
59528208|NCT01043939|75624196|FG001|NOT COMPLETED|Washout Period||0||
59528209|NCT01043939|75624195|FG000|STARTED|Second Intervention||12||
59528210|NCT01043939|75624196|FG001|STARTED|Second Intervention||12||
59528211|NCT01043939|75624195|FG000|COMPLETED|Second Intervention||12||
59528212|NCT01043939|75624196|FG001|COMPLETED|Second Intervention||12||
59528213|NCT01043939|75624195|FG000|NOT COMPLETED|Second Intervention||0||
59528214|NCT01043939|75624196|FG001|NOT COMPLETED|Second Intervention||0||
59528215|NCT00128180|75624205|FG000|STARTED|Overall Study||32||
59528216|NCT00128180|75624206|FG001|STARTED|Overall Study||34||
59528217|NCT00128180|75624205|FG000|COMPLETED|Overall Study||32||
59528218|NCT00128180|75624206|FG001|COMPLETED|Overall Study||34||
59528219|NCT00128180|75624205|FG000|NOT COMPLETED|Overall Study||0||
59528220|NCT00128180|75624206|FG001|NOT COMPLETED|Overall Study||0||
59528221|NCT01121939|75624212|FG000|STARTED|Overall Study||43||
59528222|NCT01121939|75624212|FG000|COMPLETED|Overall Study|Patients remained on-study until disease progression or unacceptable toxicity occurred.|0||
59528223|NCT01121939|75624212|FG000|NOT COMPLETED|Overall Study||43||
59528224|NCT00181610|75624222|FG000|STARTED|Overall Study||4||
59528225|NCT00181610|75624223|FG001|STARTED|Overall Study||4||
59528226|NCT00181610|75624224|FG002|STARTED|Overall Study||3||
59528227|NCT00181610|75624222|FG000|COMPLETED|Overall Study||4||
59528228|NCT00181610|75624223|FG001|COMPLETED|Overall Study||3||
59528229|NCT00181610|75624224|FG002|COMPLETED|Overall Study||3||
59528230|NCT00181610|75624222|FG000|NOT COMPLETED|Overall Study||0||
59528231|NCT00181610|75624223|FG001|NOT COMPLETED|Overall Study||1||
59528232|NCT00181610|75624224|FG002|NOT COMPLETED|Overall Study||0||
59528233|NCT02205307|75624235|FG000|STARTED|Overall Study||178||
59528234|NCT02205307|75624236|FG001|STARTED|Overall Study||169||
59528235|NCT02205307|75624235|FG000|COMPLETED|Overall Study||161||
59528236|NCT02205307|75624236|FG001|COMPLETED|Overall Study||163||
59528237|NCT02205307|75624235|FG000|NOT COMPLETED|Overall Study||17||
59528238|NCT02205307|75624236|FG001|NOT COMPLETED|Overall Study||6||
59528239|NCT01045031|75624245|FG000|STARTED|Overall Study||58||
59528240|NCT01045031|75624246|FG001|STARTED|Overall Study||56||
59528241|NCT01045031|75624245|FG000|COMPLETED|Overall Study||49||
59528242|NCT01045031|75624246|FG001|COMPLETED|Overall Study||50||
59528243|NCT01045031|75624245|FG000|NOT COMPLETED|Overall Study||9||
59528244|NCT01045031|75624246|FG001|NOT COMPLETED|Overall Study||6||
59528245|NCT00131378|75624260|FG000|STARTED|Overall Study||40||
59528246|NCT00131378|75624261|FG001|STARTED|Overall Study||40||
59528247|NCT00131378|75624262|FG002|STARTED|Overall Study||32||
59528248|NCT00131378|75624263|FG003|STARTED|Overall Study||30||
59528249|NCT00131378|75624260|FG000|COMPLETED|Overall Study||29||
59528250|NCT00131378|75624261|FG001|COMPLETED|Overall Study||22||
59528251|NCT00131378|75624262|FG002|COMPLETED|Overall Study||22||
59528252|NCT00131378|75624263|FG003|COMPLETED|Overall Study||21||
59528253|NCT00131378|75624260|FG000|NOT COMPLETED|Overall Study||11||
59528254|NCT00131378|75624261|FG001|NOT COMPLETED|Overall Study||18||
59528255|NCT00131378|75624262|FG002|NOT COMPLETED|Overall Study||10||
59528256|NCT00131378|75624263|FG003|NOT COMPLETED|Overall Study||9||
59528257|NCT01445821|75624277|FG000|STARTED|Overall Study||22||
59528258|NCT01445821|75624278|FG001|STARTED|Overall Study||22||
59528259|NCT01445821|75624277|FG000|COMPLETED|Overall Study||22||
59528260|NCT01445821|75624278|FG001|COMPLETED|Overall Study||22||
59528261|NCT01445821|75624277|FG000|NOT COMPLETED|Overall Study||0||
59528262|NCT01445821|75624278|FG001|NOT COMPLETED|Overall Study||0||
59528263|NCT01092767|75624284|FG000|STARTED|Overall Study||50||
59528264|NCT01092767|75624284|FG000|COMPLETED|Overall Study||45||
59528265|NCT01092767|75624284|FG000|NOT COMPLETED|Overall Study||5||
59528266|NCT02543892|75624296|FG000|STARTED|Received Vaccination 1||12||
59528267|NCT02543892|75624297|FG001|STARTED|Received Vaccination 1||12||
59528268|NCT02543892|75624298|FG002|STARTED|Received Vaccination 1||12||
59528269|NCT02543892|75624299|FG003|STARTED|Received Vaccination 1||12||
59528270|NCT02543892|75624300|FG004|STARTED|Received Vaccination 1||50||
59528271|NCT02543892|75624301|FG005|STARTED|Received Vaccination 1||50||
59528272|NCT02543892|75624302|FG006|STARTED|Received Vaccination 1||50||
59528273|NCT02543892|75624303|FG007|STARTED|Received Vaccination 1||50||
59528274|NCT02543892|75624296|FG000|COMPLETED|Received Vaccination 1||12||
59528275|NCT02543892|75624297|FG001|COMPLETED|Received Vaccination 1||12||
59528276|NCT02543892|75624298|FG002|COMPLETED|Received Vaccination 1||12||
59528277|NCT02543892|75624299|FG003|COMPLETED|Received Vaccination 1||12||
59528278|NCT02543892|75624300|FG004|COMPLETED|Received Vaccination 1||50||
59528279|NCT02543892|75624301|FG005|COMPLETED|Received Vaccination 1||50||
59528280|NCT02543892|75624302|FG006|COMPLETED|Received Vaccination 1||50||
59528281|NCT02543892|75624303|FG007|COMPLETED|Received Vaccination 1||50||
59528282|NCT02543892|75624296|FG000|NOT COMPLETED|Received Vaccination 1||0||
59528283|NCT02543892|75624297|FG001|NOT COMPLETED|Received Vaccination 1||0||
59528284|NCT02543892|75624298|FG002|NOT COMPLETED|Received Vaccination 1||0||
59528285|NCT02543892|75624299|FG003|NOT COMPLETED|Received Vaccination 1||0||
59528286|NCT02543892|75624300|FG004|NOT COMPLETED|Received Vaccination 1||0||
59528287|NCT02543892|75624301|FG005|NOT COMPLETED|Received Vaccination 1||0||
59528288|NCT02543892|75624302|FG006|NOT COMPLETED|Received Vaccination 1||0||
59528289|NCT02543892|75624303|FG007|NOT COMPLETED|Received Vaccination 1||0||
59528290|NCT02543892|75624296|FG000|STARTED|Received Vaccination 2||12||
59528291|NCT02543892|75624297|FG001|STARTED|Received Vaccination 2||12||
59528292|NCT02543892|75624298|FG002|STARTED|Received Vaccination 2||12||
59528293|NCT02543892|75624299|FG003|STARTED|Received Vaccination 2||12||
59528294|NCT02543892|75624300|FG004|STARTED|Received Vaccination 2||50||
59528295|NCT02543892|75624301|FG005|STARTED|Received Vaccination 2||50||
59528296|NCT02543892|75624302|FG006|STARTED|Received Vaccination 2||50||
59528297|NCT02543892|75624303|FG007|STARTED|Received Vaccination 2||50||
59528298|NCT02543892|75624296|FG000|COMPLETED|Received Vaccination 2||11||
59528299|NCT02543892|75624297|FG001|COMPLETED|Received Vaccination 2||11||
59528300|NCT02543892|75624298|FG002|COMPLETED|Received Vaccination 2||12||
59528301|NCT02543892|75624299|FG003|COMPLETED|Received Vaccination 2||12||
59528302|NCT02543892|75624300|FG004|COMPLETED|Received Vaccination 2||50||
59528303|NCT02543892|75624301|FG005|COMPLETED|Received Vaccination 2||49||
59528304|NCT02543892|75624302|FG006|COMPLETED|Received Vaccination 2||50||
59528305|NCT02543892|75624303|FG007|COMPLETED|Received Vaccination 2||49||
59528306|NCT02543892|75624296|FG000|NOT COMPLETED|Received Vaccination 2||1||
59528307|NCT02543892|75624297|FG001|NOT COMPLETED|Received Vaccination 2||1||
59528308|NCT02543892|75624298|FG002|NOT COMPLETED|Received Vaccination 2||0||
59528309|NCT02543892|75624299|FG003|NOT COMPLETED|Received Vaccination 2||0||
59528310|NCT02543892|75624300|FG004|NOT COMPLETED|Received Vaccination 2||0||
59528311|NCT02543892|75624301|FG005|NOT COMPLETED|Received Vaccination 2||1||
59528312|NCT02543892|75624302|FG006|NOT COMPLETED|Received Vaccination 2||0||
59528313|NCT02543892|75624303|FG007|NOT COMPLETED|Received Vaccination 2||1||
59528314|NCT02543892|75624296|FG000|STARTED|Had Immunology Data||11||
59528315|NCT02543892|75624297|FG001|STARTED|Had Immunology Data||11||
59528316|NCT02543892|75624298|FG002|STARTED|Had Immunology Data||12||
59528317|NCT02543892|75624299|FG003|STARTED|Had Immunology Data||12||
59528318|NCT02543892|75624300|FG004|STARTED|Had Immunology Data||50||
59528319|NCT02543892|75624301|FG005|STARTED|Had Immunology Data||49||
59528320|NCT02543892|75624302|FG006|STARTED|Had Immunology Data||50||
59528321|NCT02543892|75624303|FG007|STARTED|Had Immunology Data||49||
59528322|NCT02543892|75624296|FG000|COMPLETED|Had Immunology Data||11||
59528323|NCT02543892|75624297|FG001|COMPLETED|Had Immunology Data||11||
59528324|NCT02543892|75624298|FG002|COMPLETED|Had Immunology Data||12||
59528325|NCT02543892|75624299|FG003|COMPLETED|Had Immunology Data||12||
59528326|NCT02543892|75624300|FG004|COMPLETED|Had Immunology Data||50||
59528327|NCT02543892|75624301|FG005|COMPLETED|Had Immunology Data||49||
59528328|NCT02543892|75624302|FG006|COMPLETED|Had Immunology Data|Subject received both vaccinations and attended last visit, but withdrew consent afterwards.|49||
59528329|NCT02543892|75624303|FG007|COMPLETED|Had Immunology Data||49||
59528330|NCT02543892|75624296|FG000|NOT COMPLETED|Had Immunology Data||0||
59528331|NCT02543892|75624297|FG001|NOT COMPLETED|Had Immunology Data||0||
59528332|NCT02543892|75624298|FG002|NOT COMPLETED|Had Immunology Data||0||
59528333|NCT02543892|75624299|FG003|NOT COMPLETED|Had Immunology Data||0||
59528334|NCT02543892|75624300|FG004|NOT COMPLETED|Had Immunology Data||0||
59528335|NCT02543892|75624301|FG005|NOT COMPLETED|Had Immunology Data||0||
59528336|NCT02543892|75624302|FG006|NOT COMPLETED|Had Immunology Data||1||
59528337|NCT02543892|75624303|FG007|NOT COMPLETED|Had Immunology Data||0||
59528338|NCT00182000|75624328|FG000|STARTED|Overall Study||14||
59528339|NCT00182000|75624329|FG001|STARTED|Overall Study||15||
59528340|NCT00182000|75624328|FG000|COMPLETED|Overall Study||9||
59528341|NCT00182000|75624329|FG001|COMPLETED|Overall Study||13||
59528342|NCT00182000|75624328|FG000|NOT COMPLETED|Overall Study||5||
59528343|NCT00182000|75624329|FG001|NOT COMPLETED|Overall Study||2||
59528344|NCT01092923|75624337|FG000|STARTED|Overall Study||10||
59528345|NCT01092923|75624338|FG001|STARTED|Overall Study||10||
59528346|NCT01092923|75624337|FG000|COMPLETED|Overall Study||10||
59528347|NCT01092923|75624338|FG001|COMPLETED|Overall Study||10||
59528348|NCT01092923|75624337|FG000|NOT COMPLETED|Overall Study||0||
59528349|NCT01092923|75624338|FG001|NOT COMPLETED|Overall Study||0||
59528350|NCT00267644|75624347|FG000|STARTED|Overall Study||13||
59528351|NCT00267644|75624348|FG001|STARTED|Overall Study||63||
59528352|NCT00267644|75624347|FG000|COMPLETED|Overall Study||13||
59528353|NCT00267644|75624348|FG001|COMPLETED|Overall Study||63||
59528354|NCT00267644|75624347|FG000|NOT COMPLETED|Overall Study||0||
59528355|NCT00267644|75624348|FG001|NOT COMPLETED|Overall Study||0||
59528356|NCT00131456|75624358|FG000|STARTED|Overall Study||52||
59528357|NCT00131456|75624359|FG001|STARTED|Overall Study||51||
59528358|NCT00131456|75624358|FG000|COMPLETED|Overall Study||33||
59528359|NCT00131456|75624359|FG001|COMPLETED|Overall Study||31||
59528360|NCT00131456|75624358|FG000|NOT COMPLETED|Overall Study||19||
59528361|NCT00131456|75624359|FG001|NOT COMPLETED|Overall Study||20||
59528362|NCT01093469|75624368|FG000|STARTED|Overall Study||13||
59528363|NCT01093469|75624369|FG001|STARTED|Overall Study||13||
59528364|NCT01093469|75624370|FG002|STARTED|Overall Study||13||
59528365|NCT01093469|75624368|FG000|COMPLETED|Overall Study||13||
59528366|NCT01093469|75624369|FG001|COMPLETED|Overall Study||13||
59528367|NCT01093469|75624370|FG002|COMPLETED|Overall Study||12||
59528368|NCT01093469|75624368|FG000|NOT COMPLETED|Overall Study||0||
59528369|NCT01093469|75624369|FG001|NOT COMPLETED|Overall Study||0||
59528370|NCT01093469|75624370|FG002|NOT COMPLETED|Overall Study||1||
59528371|NCT01045187|75624378|FG000|STARTED|Overall Study||15||
59528372|NCT01045187|75624378|FG000|COMPLETED|Overall Study||15||
59528373|NCT01045187|75624378|FG000|NOT COMPLETED|Overall Study||0||
59528374|NCT02543658|75624384|FG000|STARTED|Overall Study||40||
59528375|NCT02543658|75624385|FG001|STARTED|Overall Study||40||
59528376|NCT02543658|75624384|FG000|COMPLETED|Overall Study||40||
59528377|NCT02543658|75624385|FG001|COMPLETED|Overall Study||36||
59528378|NCT02543658|75624384|FG000|NOT COMPLETED|Overall Study||0||
59528379|NCT02543658|75624385|FG001|NOT COMPLETED|Overall Study||4||
59528380|NCT01045265|75624392|FG000|STARTED|Overall Study||16||
59528381|NCT01045265|75624392|FG000|COMPLETED|Overall Study||16||
59528382|NCT01045265|75624392|FG000|NOT COMPLETED|Overall Study||0||
59528383|NCT00183092|75624398|FG000|STARTED|Double-blind (Baseline - Month 2)||23||
59528384|NCT00183092|75624399|FG001|STARTED|Double-blind (Baseline - Month 2)||28||
59528385|NCT00183092|75624400|FG002|STARTED|Double-blind (Baseline - Month 2)||0||
59528386|NCT00183092|75624401|FG003|STARTED|Double-blind (Baseline - Month 2)||0||
59528387|NCT00183092|75624398|FG000|Alive at Month 2|Double-blind (Baseline - Month 2)||13||
59528388|NCT00183092|75624399|FG001|Alive at Month 2|Double-blind (Baseline - Month 2)||19||
59528389|NCT00183092|75624400|FG002|Alive at Month 2|Double-blind (Baseline - Month 2)||0||
59528390|NCT00183092|75624401|FG003|Alive at Month 2|Double-blind (Baseline - Month 2)||0||
59528391|NCT00183092|75624398|FG000|Came in for Month 2 Visit|Double-blind (Baseline - Month 2)||10||
59528392|NCT00183092|75624399|FG001|Came in for Month 2 Visit|Double-blind (Baseline - Month 2)||16||
59528393|NCT00183092|75624400|FG002|Came in for Month 2 Visit|Double-blind (Baseline - Month 2)||0||
59528394|NCT00183092|75624401|FG003|Came in for Month 2 Visit|Double-blind (Baseline - Month 2)||0||
59528395|NCT00183092|75624398|FG000|COMPLETED|Double-blind (Baseline - Month 2)||11||
59528396|NCT00183092|75624399|FG001|COMPLETED|Double-blind (Baseline - Month 2)||16||
59528397|NCT00183092|75624400|FG002|COMPLETED|Double-blind (Baseline - Month 2)||0||
59528398|NCT00183092|75624401|FG003|COMPLETED|Double-blind (Baseline - Month 2)||0||
59528399|NCT00183092|75624398|FG000|NOT COMPLETED|Double-blind (Baseline - Month 2)||12||
59528400|NCT00183092|75624399|FG001|NOT COMPLETED|Double-blind (Baseline - Month 2)||12||
59528401|NCT00183092|75624400|FG002|NOT COMPLETED|Double-blind (Baseline - Month 2)||0||
59528402|NCT00183092|75624401|FG003|NOT COMPLETED|Double-blind (Baseline - Month 2)||0||
59528403|NCT00183092|75624398|FG000|STARTED|Open-label Period (Month 2 Until Death)|Participants initially assigned to Quinacrine opted to begin open-label Quinacrine at Month 2|10||
59528404|NCT00183092|75624399|FG001|STARTED|Open-label Period (Month 2 Until Death)|Participants initially assigned to Placebo opted to begin open-label Quinacrine at Month 2|14||
59528405|NCT00183092|75624400|FG002|STARTED|Open-label Period (Month 2 Until Death)|Participants assigned to Quinacrine opted to continue assigned drug during open-label period|1||
59528406|NCT00183092|75624401|FG003|STARTED|Open-label Period (Month 2 Until Death)|Participants assigned to Placebo opted to continue assigned drug during open-label period|1||
59528407|NCT00183092|75624398|FG000|COMPLETED|Open-label Period (Month 2 Until Death)||0||
59528408|NCT00183092|75624399|FG001|COMPLETED|Open-label Period (Month 2 Until Death)||0||
59622704|NCT00541242|75734588|FG001|NOT COMPLETED|Treatment Period 2||7||
59987693|NCT00966953|76102947|FG002|STARTED|2nd Intervention||6||
59987694|NCT00966953|76102948|FG003|STARTED|2nd Intervention||7||
59987695|NCT00966953|76102945|FG000|COMPLETED|2nd Intervention||6||
59528409|NCT00183092|75624400|FG002|COMPLETED|Open-label Period (Month 2 Until Death)||0||
59528410|NCT00183092|75624401|FG003|COMPLETED|Open-label Period (Month 2 Until Death)||0||
59528411|NCT00183092|75624398|FG000|NOT COMPLETED|Open-label Period (Month 2 Until Death)||10||
59528412|NCT00183092|75624399|FG001|NOT COMPLETED|Open-label Period (Month 2 Until Death)||14||
59528413|NCT00183092|75624400|FG002|NOT COMPLETED|Open-label Period (Month 2 Until Death)||1||
59528414|NCT00183092|75624401|FG003|NOT COMPLETED|Open-label Period (Month 2 Until Death)||1||
59528415|NCT01045499|75624408|FG000|STARTED|Overall Study||137||
59815224|NCT00615017|75937647|FG003|NOT COMPLETED|Overall Study||1||
59815225|NCT00615017|75937648|FG004|NOT COMPLETED|Overall Study||1||
59987696|NCT00966953|76102946|FG001|COMPLETED|2nd Intervention||6||
59987697|NCT00966953|76102947|FG002|COMPLETED|2nd Intervention||6||
59987698|NCT00966953|76102948|FG003|COMPLETED|2nd Intervention||7||
59987699|NCT00966953|76102945|FG000|NOT COMPLETED|2nd Intervention||0||
59528416|NCT01045499|75624408|FG000|COMPLETED|Overall Study||127||
59528417|NCT01045499|75624408|FG000|NOT COMPLETED|Overall Study||10||
59528418|NCT00132002|75624412|FG000|STARTED|Overall Study||14||
59528419|NCT00132002|75624412|FG000|COMPLETED|Overall Study||14||
59528420|NCT00132002|75624412|FG000|NOT COMPLETED|Overall Study||0||
59528421|NCT00183794|75624416|FG000|STARTED|Overall Study||20||
59528422|NCT00183794|75624416|FG000|COMPLETED|Overall Study||20||
59528423|NCT00183794|75624416|FG000|NOT COMPLETED|Overall Study||0||
59528424|NCT00270296|75624423|FG000|STARTED|Overall Study||285||
59528425|NCT00270296|75624424|FG001|STARTED|Overall Study||275||
59528426|NCT00270296|75624425|FG002|STARTED|Overall Study||170||
59528427|NCT00270296|75624423|FG000|COMPLETED|Overall Study||186||
59528428|NCT00270296|75624424|FG001|COMPLETED|Overall Study||185||
59528429|NCT00270296|75624425|FG002|COMPLETED|Overall Study||109||
59528430|NCT00270296|75624423|FG000|NOT COMPLETED|Overall Study||99||
59528431|NCT00270296|75624424|FG001|NOT COMPLETED|Overall Study||90||
59528432|NCT00270296|75624425|FG002|NOT COMPLETED|Overall Study||61||
59528433|NCT00270842|75624436|FG000|STARTED|Overall Study||33||
59528434|NCT00270842|75624437|FG001|STARTED|Overall Study||34||
59528435|NCT00270842|75624438|FG002|STARTED|Overall Study||34||
59528436|NCT00270842|75624436|FG000|COMPLETED|Overall Study||18||
59528437|NCT00270842|75624437|FG001|COMPLETED|Overall Study||18||
59528438|NCT00270842|75624438|FG002|COMPLETED|Overall Study||18||
59528439|NCT00270842|75624436|FG000|NOT COMPLETED|Overall Study||15||
59528440|NCT00270842|75624437|FG001|NOT COMPLETED|Overall Study||16||
59528441|NCT00270842|75624438|FG002|NOT COMPLETED|Overall Study||16||
59528442|NCT01046669|75624448|FG000|STARTED|Overall Study||226||
59528443|NCT01046669|75624449|FG001|STARTED|Overall Study||224||
59528444|NCT01046669|75624448|FG000|COMPLETED|Overall Study||226||
59528445|NCT01046669|75624449|FG001|COMPLETED|Overall Study||223||
59528446|NCT01046669|75624448|FG000|NOT COMPLETED|Overall Study||0||
59528447|NCT01046669|75624449|FG001|NOT COMPLETED|Overall Study||1||
59528448|NCT01047527|75624458|FG000|STARTED|Overall Study||180||
59528449|NCT01047527|75624459|FG001|STARTED|Overall Study||173||
59528450|NCT01047527|75624460|FG002|STARTED|Overall Study||172||
59528451|NCT01047527|75624458|FG000|8 Weeks|Overall Study||148||
59815226|NCT00615017|75937649|FG005|NOT COMPLETED|Overall Study||3||
59815227|NCT00614939|75937665|FG000|STARTED|Overall Study|Randomized and treated|85||
59987700|NCT00966953|76102946|FG001|NOT COMPLETED|2nd Intervention||0||
59987701|NCT00966953|76102947|FG002|NOT COMPLETED|2nd Intervention||0||
59987702|NCT00966953|76102948|FG003|NOT COMPLETED|2nd Intervention||0||
59987703|NCT00966953|76102945|FG000|STARTED|1 Week Washout After 2nd Intervention||6||
59987704|NCT00966953|76102946|FG001|STARTED|1 Week Washout After 2nd Intervention||6||
59528452|NCT01047527|75624459|FG001|8 Weeks|Overall Study||142||
59528453|NCT01047527|75624460|FG002|8 Weeks|Overall Study||138||
59528454|NCT01047527|75624458|FG000|24 Weeks|Overall Study||111||
59528455|NCT01047527|75624459|FG001|24 Weeks|Overall Study||123||
59528456|NCT01047527|75624460|FG002|24 Weeks|Overall Study||119||
59528457|NCT01047527|75624458|FG000|COMPLETED|Overall Study||95||
59528458|NCT01047527|75624459|FG001|COMPLETED|Overall Study||112||
59528459|NCT01047527|75624460|FG002|COMPLETED|Overall Study||107||
59528460|NCT01047527|75624458|FG000|NOT COMPLETED|Overall Study||85||
59528461|NCT01047527|75624459|FG001|NOT COMPLETED|Overall Study||61||
59528462|NCT01047527|75624460|FG002|NOT COMPLETED|Overall Study||65||
59528463|NCT01047839|75624472|FG000|STARTED|Overall Study||12||
59528464|NCT01047839|75624473|FG001|STARTED|Overall Study||29||
59528465|NCT01047839|75624474|FG002|STARTED|Overall Study||59||
59528466|NCT01047839|75624472|FG000|COMPLETED|Overall Study||10||
59528467|NCT01047839|75624473|FG001|COMPLETED|Overall Study||29||
59528468|NCT01047839|75624474|FG002|COMPLETED|Overall Study||53||
59987705|NCT00966953|76102947|FG002|STARTED|1 Week Washout After 2nd Intervention||6||
59528469|NCT01047839|75624472|FG000|NOT COMPLETED|Overall Study||2||
59528470|NCT01047839|75624473|FG001|NOT COMPLETED|Overall Study||0||
59528471|NCT01047839|75624474|FG002|NOT COMPLETED|Overall Study||6||
59987706|NCT00966953|76102948|FG003|STARTED|1 Week Washout After 2nd Intervention||7||
59528472|NCT01048697|75624489|FG000|STARTED|Overall Study||18||
59528473|NCT01048697|75624489|FG000|COMPLETED|Overall Study||18||
59528474|NCT01048697|75624489|FG000|NOT COMPLETED|Overall Study||0||
59528475|NCT01049243|75624493|FG000|STARTED|Overall Study||20||
59528476|NCT01049243|75624493|FG000|COMPLETED|Overall Study||18||
59528477|NCT01049243|75624493|FG000|NOT COMPLETED|Overall Study||2||
59528478|NCT01094717|75624500|FG000|STARTED|Overall Study||3||
59528479|NCT01094717|75624501|FG001|STARTED|Overall Study||10||
59528480|NCT01094717|75624500|FG000|COMPLETED|Overall Study||3||
59528481|NCT01094717|75624501|FG001|COMPLETED|Overall Study||10||
59528482|NCT01094717|75624500|FG000|NOT COMPLETED|Overall Study||0||
59528483|NCT01094717|75624501|FG001|NOT COMPLETED|Overall Study||0||
59528484|NCT01095497|75624519|FG000|STARTED|Intravenous CINRYZE||14||
59528485|NCT01095497|75624520|FG001|STARTED|Intravenous CINRYZE||12||
59528486|NCT01095497|75624519|FG000|COMPLETED|Intravenous CINRYZE||13||
59528487|NCT01095497|75624520|FG001|COMPLETED|Intravenous CINRYZE||12||
59528488|NCT01095497|75624519|FG000|NOT COMPLETED|Intravenous CINRYZE||1||
59528489|NCT01095497|75624520|FG001|NOT COMPLETED|Intravenous CINRYZE||0||
59528490|NCT01095497|75624519|FG000|STARTED|Subcutaneous CINRYZE||13||
59528491|NCT01095497|75624520|FG001|STARTED|Subcutaneous CINRYZE||12||
59528492|NCT01095497|75624519|FG000|COMPLETED|Subcutaneous CINRYZE||12||
59528493|NCT01095497|75624520|FG001|COMPLETED|Subcutaneous CINRYZE||12||
59528494|NCT01095497|75624519|FG000|NOT COMPLETED|Subcutaneous CINRYZE||1||
59528495|NCT01095497|75624520|FG001|NOT COMPLETED|Subcutaneous CINRYZE||0||
59528496|NCT01095887|75624531|FG000|STARTED|Overall Study||6||
59528497|NCT01095887|75624531|FG000|COMPLETED|Overall Study||6||
59528498|NCT01095887|75624531|FG000|NOT COMPLETED|Overall Study||0||
59528499|NCT01096823|75624537|FG000|STARTED|Overall Study||14||
59528500|NCT01096823|75624538|FG001|STARTED|Overall Study||16||
59528501|NCT01096823|75624537|FG000|COMPLETED|Overall Study||11||
59528502|NCT01096823|75624538|FG001|COMPLETED|Overall Study||15||
59528503|NCT01096823|75624537|FG000|NOT COMPLETED|Overall Study||3||
59528504|NCT01096823|75624538|FG001|NOT COMPLETED|Overall Study||1||
59528505|NCT01097915|75624547|FG000|STARTED|Overall Study||50||
59528506|NCT01097915|75624548|FG001|STARTED|Overall Study||70||
59528507|NCT01097915|75624549|FG002|STARTED|Overall Study||50||
59528508|NCT01097915|75624547|FG000|COMPLETED|Overall Study||27||
59528509|NCT01097915|75624548|FG001|COMPLETED|Overall Study||28||
59528510|NCT01097915|75624549|FG002|COMPLETED|Overall Study||20||
59528511|NCT01097915|75624547|FG000|NOT COMPLETED|Overall Study||23||
59528512|NCT01097915|75624548|FG001|NOT COMPLETED|Overall Study||42||
59528513|NCT01097915|75624549|FG002|NOT COMPLETED|Overall Study||30||
59528514|NCT01099475|75624566|FG000|STARTED|Overall Study||10||
59528515|NCT01099475|75624567|FG001|STARTED|Overall Study||10||
59528516|NCT01099475|75624566|FG000|COMPLETED|Overall Study||10||
59528517|NCT01099475|75624567|FG001|COMPLETED|Overall Study||10||
59528518|NCT01099475|75624566|FG000|NOT COMPLETED|Overall Study||0||
59528519|NCT01099475|75624567|FG001|NOT COMPLETED|Overall Study||0||
59528520|NCT01099631|75624579|FG000|STARTED|Overall Study||6||
59528521|NCT01099631|75624580|FG001|STARTED|Overall Study||3||
59528522|NCT01099631|75624581|FG002|STARTED|Overall Study||3||
59528523|NCT01099631|75624582|FG003|STARTED|Overall Study||3||
59528524|NCT01099631|75624583|FG004|STARTED|Overall Study||3||
59528525|NCT01099631|75624584|FG005|STARTED|Overall Study||4||
59528526|NCT01099631|75624579|FG000|COMPLETED|Overall Study||6||
59528527|NCT01099631|75624580|FG001|COMPLETED|Overall Study||3||
59528528|NCT01099631|75624581|FG002|COMPLETED|Overall Study||3||
59528529|NCT01099631|75624582|FG003|COMPLETED|Overall Study||3||
59528530|NCT01099631|75624583|FG004|COMPLETED|Overall Study||3||
59528531|NCT01099631|75624584|FG005|COMPLETED|Overall Study||4||
59528532|NCT01099631|75624579|FG000|NOT COMPLETED|Overall Study||0||
59528533|NCT01099631|75624580|FG001|NOT COMPLETED|Overall Study||0||
59528534|NCT01099631|75624581|FG002|NOT COMPLETED|Overall Study||0||
59528535|NCT01099631|75624582|FG003|NOT COMPLETED|Overall Study||0||
59528536|NCT01099631|75624583|FG004|NOT COMPLETED|Overall Study||0||
59528537|NCT01099631|75624584|FG005|NOT COMPLETED|Overall Study||0||
59528538|NCT01100255|75624606|FG000|STARTED|Overall Study||8||
59528539|NCT01100255|75624607|FG001|STARTED|Overall Study||7||
59528540|NCT01100255|75624606|FG000|COMPLETED|Overall Study||8||
59528541|NCT01100255|75624607|FG001|COMPLETED|Overall Study||7||
59528542|NCT01100255|75624606|FG000|NOT COMPLETED|Overall Study||0||
59528543|NCT01100255|75624607|FG001|NOT COMPLETED|Overall Study||0||
59528544|NCT01100723|75624613|FG000|STARTED|Overall Study||92||
59528545|NCT01100723|75624613|FG000|6 Month Analysis|Overall Study|85 subjects had laboratory data at the 6 month analysis and were compared to their baseline data.|85||
59528546|NCT01100723|75624613|FG000|COMPLETED|Overall Study|78 subjects had laboratory data at the 12 month analysis and were compared to their baseline data.|78||
59528547|NCT01100723|75624613|FG000|NOT COMPLETED|Overall Study||14||
59528548|NCT01101971|75624618|FG000|STARTED|Overall Study||45||
59528549|NCT01101971|75624618|FG000|COMPLETED|Overall Study||45||
59528550|NCT01101971|75624618|FG000|NOT COMPLETED|Overall Study||0||
59528551|NCT01125605|75624622|FG000|STARTED|Overall Study|started = had baseline values|325||
59528552|NCT01125605|75624622|FG000|Safety|Overall Study|1 patient was only analysed for safety|326||
59528553|NCT01125605|75624622|FG000|COMPLETED|Overall Study||325||
59528554|NCT01125605|75624622|FG000|NOT COMPLETED|Overall Study||0||
59528555|NCT01127087|75624641|FG000|STARTED|Overall Study||8||
59528556|NCT01127087|75624642|FG001|STARTED|Overall Study||2||
59528557|NCT01127087|75624641|FG000|COMPLETED|Overall Study||8||
59528558|NCT01127087|75624642|FG001|COMPLETED|Overall Study||2||
59528559|NCT01127087|75624641|FG000|NOT COMPLETED|Overall Study||0||
59528560|NCT01127087|75624642|FG001|NOT COMPLETED|Overall Study||0||
59528561|NCT00271154|75624652|FG000|STARTED|Overall Study||191||
59528562|NCT00271154|75624653|FG001|STARTED|Overall Study||419||
59528563|NCT00271154|75624652|FG000|COMPLETED|Overall Study||191||
59528564|NCT00271154|75624653|FG001|COMPLETED|Overall Study||419||
59528565|NCT00271154|75624652|FG000|NOT COMPLETED|Overall Study||0||
59528566|NCT00271154|75624653|FG001|NOT COMPLETED|Overall Study||0||
59528567|NCT00136214|75624662|FG000|STARTED|Overall Study||15||
59528568|NCT00136214|75624663|FG001|STARTED|Overall Study||7||
59528569|NCT00136214|75624662|FG000|COMPLETED|Overall Study||15||
59528570|NCT00136214|75624663|FG001|COMPLETED|Overall Study||7||
59528571|NCT00136214|75624662|FG000|NOT COMPLETED|Overall Study||0||
59528572|NCT00136214|75624663|FG001|NOT COMPLETED|Overall Study||0||
59528573|NCT01127321|75624676|FG000|STARTED|Overall Study||3||
59528574|NCT01127321|75624677|FG001|STARTED|Overall Study||1||
59528575|NCT01127321|75624678|FG002|STARTED|Overall Study||1||
59528576|NCT01127321|75624679|FG003|STARTED|Overall Study||7||
59528577|NCT01127321|75624680|FG004|STARTED|Overall Study||5||
59528578|NCT01127321|75624676|FG000|COMPLETED|Overall Study||3||
59528579|NCT01127321|75624677|FG001|COMPLETED|Overall Study||1||
59528580|NCT01127321|75624678|FG002|COMPLETED|Overall Study||1||
59528581|NCT01127321|75624679|FG003|COMPLETED|Overall Study||7||
59528582|NCT01127321|75624680|FG004|COMPLETED|Overall Study||5||
59528583|NCT01127321|75624676|FG000|NOT COMPLETED|Overall Study||0||
59528584|NCT01127321|75624677|FG001|NOT COMPLETED|Overall Study||0||
59528585|NCT01127321|75624678|FG002|NOT COMPLETED|Overall Study||0||
59528586|NCT01127321|75624679|FG003|NOT COMPLETED|Overall Study||0||
59528587|NCT01127321|75624680|FG004|NOT COMPLETED|Overall Study||0||
59528588|NCT00272168|75624694|FG000|STARTED|Overall Study||47||
59528589|NCT00272168|75624695|FG001|STARTED|Overall Study||41||
59528590|NCT00272168|75624694|FG000|COMPLETED|Overall Study||37||
59528591|NCT00272168|75624695|FG001|COMPLETED|Overall Study||31||
59528592|NCT00272168|75624694|FG000|NOT COMPLETED|Overall Study||10||
59528593|NCT00272168|75624695|FG001|NOT COMPLETED|Overall Study||10||
59528594|NCT00185900|75624703|FG000|STARTED|Overall Study||92||
59528595|NCT00185900|75624704|FG001|STARTED|Overall Study||100||
59528596|NCT00185900|75624703|FG000|COMPLETED|Overall Study||92||
59528597|NCT00185900|75624704|FG001|COMPLETED|Overall Study||100||
59528598|NCT00185900|75624703|FG000|NOT COMPLETED|Overall Study||0||
59528599|NCT00185900|75624704|FG001|NOT COMPLETED|Overall Study||0||
59528600|NCT00186056|75624712|FG000|STARTED|Overall Study||14||
59528601|NCT00186056|75624713|FG001|STARTED|Overall Study||17||
59528602|NCT00186056|75624712|FG000|COMPLETED|Overall Study||12||
59528603|NCT00186056|75624713|FG001|COMPLETED|Overall Study||16||
59528604|NCT00186056|75624712|FG000|NOT COMPLETED|Overall Study||2||
59528605|NCT00186056|75624713|FG001|NOT COMPLETED|Overall Study||1||
59528606|NCT00186446|75624719|FG000|STARTED|Overall Study||20||
59528607|NCT00186446|75624719|FG000|COMPLETED|Overall Study||11||
59528608|NCT00186446|75624719|FG000|NOT COMPLETED|Overall Study||9||
59528609|NCT00136760|75624729|FG000|STARTED|Overall Study||12||
59528610|NCT00136760|75624730|FG001|STARTED|Overall Study||16||
59528611|NCT00136760|75624731|FG002|STARTED|Overall Study||11||
59528612|NCT00136760|75624732|FG003|STARTED|Overall Study||13||
59528613|NCT00136760|75624729|FG000|COMPLETED|Overall Study||12||
59528614|NCT00136760|75624730|FG001|COMPLETED|Overall Study||16||
59528615|NCT00136760|75624731|FG002|COMPLETED|Overall Study||11||
59528616|NCT00136760|75624732|FG003|COMPLETED|Overall Study||13||
59528617|NCT00136760|75624729|FG000|NOT COMPLETED|Overall Study||0||
59528618|NCT00136760|75624730|FG001|NOT COMPLETED|Overall Study||0||
59528619|NCT00136760|75624731|FG002|NOT COMPLETED|Overall Study||0||
59528620|NCT00136760|75624732|FG003|NOT COMPLETED|Overall Study||0||
59528621|NCT00136838|75624742|FG000|STARTED|First Intervention ( 5 Days)||6||
59528622|NCT00136838|75624743|FG001|STARTED|First Intervention ( 5 Days)||6||
59528623|NCT00136838|75624742|FG000|COMPLETED|First Intervention ( 5 Days)||6||
59528624|NCT00136838|75624743|FG001|COMPLETED|First Intervention ( 5 Days)||6||
59528625|NCT00136838|75624742|FG000|NOT COMPLETED|First Intervention ( 5 Days)||0||
59528626|NCT00136838|75624743|FG001|NOT COMPLETED|First Intervention ( 5 Days)||0||
59528627|NCT00136838|75624742|FG000|STARTED|Second Intervention ( 5 Days)||6||
59528628|NCT00136838|75624743|FG001|STARTED|Second Intervention ( 5 Days)||6||
59528629|NCT00136838|75624742|FG000|COMPLETED|Second Intervention ( 5 Days)||6||
59528630|NCT00136838|75624743|FG001|COMPLETED|Second Intervention ( 5 Days)||6||
59528631|NCT00136838|75624742|FG000|NOT COMPLETED|Second Intervention ( 5 Days)||0||
59528632|NCT00136838|75624743|FG001|NOT COMPLETED|Second Intervention ( 5 Days)||0||
59528633|NCT00189098|75624753|FG000|STARTED|Overall Study||51||
59528634|NCT00189098|75624754|FG001|STARTED|Overall Study||50||
59528635|NCT00189098|75624753|FG000|COMPLETED|Overall Study||46||
59528636|NCT00189098|75624754|FG001|COMPLETED|Overall Study||44||
59528637|NCT00189098|75624753|FG000|NOT COMPLETED|Overall Study||5||
59528638|NCT00189098|75624754|FG001|NOT COMPLETED|Overall Study||6||
59528639|NCT00145418|75624762|FG000|STARTED|Overall Study||15||
59528640|NCT00145418|75624762|FG000|COMPLETED|Overall Study||15||
59528641|NCT00145418|75624762|FG000|NOT COMPLETED|Overall Study||0||
59528642|NCT01105247|75624768|FG000|STARTED|Overall Study||116||
59528643|NCT01105247|75624769|FG001|STARTED|Overall Study||16||
59528644|NCT01105247|75624768|FG000|COMPLETED|Overall Study||79||
59528645|NCT01105247|75624769|FG001|COMPLETED|Overall Study||16||
59528646|NCT01105247|75624768|FG000|NOT COMPLETED|Overall Study||37||
59528647|NCT01105247|75624769|FG001|NOT COMPLETED|Overall Study||0||
59528648|NCT01107665|75624780|FG000|STARTED|Overall Study||60||
59528649|NCT01107665|75624780|FG000|COMPLETED|Overall Study||11|Subjects who completed protocol-defined follow-up period.|
59528650|NCT01107665|75624780|FG000|NOT COMPLETED|Overall Study||49||
59528651|NCT01447225|75624790|FG000|STARTED|Overall Study||3||
59528652|NCT01447225|75624791|FG001|STARTED|Overall Study||8||
59528653|NCT01447225|75624792|FG002|STARTED|Overall Study||5||
59528654|NCT01447225|75624793|FG003|STARTED|Overall Study||3||
59528655|NCT01447225|75624794|FG004|STARTED|Overall Study||3||
59528656|NCT01447225|75624795|FG005|STARTED|Overall Study||3||
59528657|NCT01447225|75624796|FG006|STARTED|Overall Study||7||
59528658|NCT01447225|75624797|FG007|STARTED|Overall Study||4||
59528659|NCT01447225|75624798|FG008|STARTED|Overall Study||3||
59528660|NCT01447225|75624799|FG009|STARTED|Overall Study||4||
59528661|NCT01447225|75624790|FG000|COMPLETED|Overall Study||3||
59528662|NCT01447225|75624791|FG001|COMPLETED|Overall Study||8||
59528663|NCT01447225|75624792|FG002|COMPLETED|Overall Study||5||
59528664|NCT01447225|75624793|FG003|COMPLETED|Overall Study||3||
59528665|NCT01447225|75624794|FG004|COMPLETED|Overall Study||3||
59528666|NCT01447225|75624795|FG005|COMPLETED|Overall Study||3||
59528667|NCT01447225|75624796|FG006|COMPLETED|Overall Study||7||
59528668|NCT01447225|75624797|FG007|COMPLETED|Overall Study||4||
59528669|NCT01447225|75624798|FG008|COMPLETED|Overall Study||3||
59528670|NCT01447225|75624799|FG009|COMPLETED|Overall Study||4||
59528671|NCT01447225|75624790|FG000|NOT COMPLETED|Overall Study||0||
59528672|NCT01447225|75624791|FG001|NOT COMPLETED|Overall Study||0||
59528673|NCT01447225|75624792|FG002|NOT COMPLETED|Overall Study||0||
59528674|NCT01447225|75624793|FG003|NOT COMPLETED|Overall Study||0||
59528675|NCT01447225|75624794|FG004|NOT COMPLETED|Overall Study||0||
59528676|NCT01447225|75624795|FG005|NOT COMPLETED|Overall Study||0||
59528677|NCT01447225|75624796|FG006|NOT COMPLETED|Overall Study||0||
59528678|NCT01447225|75624797|FG007|NOT COMPLETED|Overall Study||0||
59528679|NCT01447225|75624798|FG008|NOT COMPLETED|Overall Study||0||
59528680|NCT01447225|75624799|FG009|NOT COMPLETED|Overall Study||0||
59528681|NCT01447849|75624835|FG000|STARTED|First Intervention||10||
59528682|NCT01447849|75624836|FG001|STARTED|First Intervention||10||
59528683|NCT01447849|75624837|FG002|STARTED|First Intervention||10||
59528684|NCT01447849|75624838|FG003|STARTED|First Intervention||10||
59528685|NCT01447849|75624835|FG000|COMPLETED|First Intervention||10||
59528686|NCT01447849|75624836|FG001|COMPLETED|First Intervention||10||
59528687|NCT01447849|75624837|FG002|COMPLETED|First Intervention||10||
59528688|NCT01447849|75624838|FG003|COMPLETED|First Intervention||10||
59528689|NCT01447849|75624835|FG000|NOT COMPLETED|First Intervention||0||
59528690|NCT01447849|75624836|FG001|NOT COMPLETED|First Intervention||0||
59528691|NCT01447849|75624837|FG002|NOT COMPLETED|First Intervention||0||
59528692|NCT01447849|75624838|FG003|NOT COMPLETED|First Intervention||0||
59528693|NCT01447849|75624835|FG000|STARTED|Washout Period for 1 Week||10||
59528694|NCT01447849|75624836|FG001|STARTED|Washout Period for 1 Week||10||
59528695|NCT01447849|75624837|FG002|STARTED|Washout Period for 1 Week||10||
59528696|NCT01447849|75624838|FG003|STARTED|Washout Period for 1 Week||10||
59528697|NCT01447849|75624835|FG000|COMPLETED|Washout Period for 1 Week||10||
59528698|NCT01447849|75624836|FG001|COMPLETED|Washout Period for 1 Week||10||
59528699|NCT01447849|75624837|FG002|COMPLETED|Washout Period for 1 Week||10||
59528700|NCT01447849|75624838|FG003|COMPLETED|Washout Period for 1 Week||10||
59528701|NCT01447849|75624835|FG000|NOT COMPLETED|Washout Period for 1 Week||0||
59528702|NCT01447849|75624836|FG001|NOT COMPLETED|Washout Period for 1 Week||0||
59528703|NCT01447849|75624837|FG002|NOT COMPLETED|Washout Period for 1 Week||0||
59528704|NCT01447849|75624838|FG003|NOT COMPLETED|Washout Period for 1 Week||0||
59528705|NCT01447849|75624835|FG000|STARTED|Second Intervention||10||
59528706|NCT01447849|75624836|FG001|STARTED|Second Intervention||10||
59528707|NCT01447849|75624837|FG002|STARTED|Second Intervention||10||
59528708|NCT01447849|75624838|FG003|STARTED|Second Intervention||10||
59528709|NCT01447849|75624835|FG000|COMPLETED|Second Intervention||10||
59528710|NCT01447849|75624836|FG001|COMPLETED|Second Intervention||10||
59528711|NCT01447849|75624837|FG002|COMPLETED|Second Intervention||10||
59528712|NCT01447849|75624838|FG003|COMPLETED|Second Intervention||10||
59528713|NCT01447849|75624835|FG000|NOT COMPLETED|Second Intervention||0||
59528714|NCT01447849|75624836|FG001|NOT COMPLETED|Second Intervention||0||
59528715|NCT01447849|75624837|FG002|NOT COMPLETED|Second Intervention||0||
59528716|NCT01447849|75624838|FG003|NOT COMPLETED|Second Intervention||0||
59528717|NCT00277394|75624850|FG000|STARTED|Overall Study||269||
59528718|NCT00277394|75624851|FG001|STARTED|Overall Study||270||
59528719|NCT00277394|75624850|FG000|COMPLETED|Overall Study||232||
59528720|NCT00277394|75624851|FG001|COMPLETED|Overall Study||246||
59528721|NCT00277394|75624850|FG000|NOT COMPLETED|Overall Study||37||
59528722|NCT00277394|75624851|FG001|NOT COMPLETED|Overall Study||24||
59528723|NCT01450189|75624860|FG000|STARTED|Overall Study||9||
59528724|NCT01450189|75624861|FG001|STARTED|Overall Study||18||
59528725|NCT01450189|75624862|FG002|STARTED|Overall Study||19||
59528726|NCT01450189|75624860|FG000|COMPLETED|Overall Study||9||
59528727|NCT01450189|75624861|FG001|COMPLETED|Overall Study||18||
59528728|NCT01450189|75624862|FG002|COMPLETED|Overall Study||19||
59528729|NCT01450189|75624860|FG000|NOT COMPLETED|Overall Study||0||
59528730|NCT01450189|75624861|FG001|NOT COMPLETED|Overall Study||0||
59528731|NCT01450189|75624862|FG002|NOT COMPLETED|Overall Study||0||
59528732|NCT00278876|75624877|FG000|STARTED|Overall Study||47||
59528733|NCT00278876|75624877|FG000|COMPLETED|Overall Study||38||
59528734|NCT00278876|75624877|FG000|NOT COMPLETED|Overall Study||9||
59528735|NCT01474213|75624883|FG000|STARTED|Overall Study||20||
59528736|NCT01474213|75624884|FG001|STARTED|Overall Study||20||
59528737|NCT01474213|75624883|FG000|COMPLETED|Overall Study||20||
59528738|NCT01474213|75624884|FG001|COMPLETED|Overall Study||20||
59528739|NCT01474213|75624883|FG000|NOT COMPLETED|Overall Study||0||
59528740|NCT01474213|75624884|FG001|NOT COMPLETED|Overall Study||0||
59528741|NCT00147212|75624894|FG000|STARTED|Overall Study||50||
59528742|NCT00147212|75624894|FG000|COMPLETED|Overall Study||50||
59528743|NCT00147212|75624894|FG000|NOT COMPLETED|Overall Study||0||
59528744|NCT01474915|75624900|FG000|STARTED|Overall Study||60||
59528745|NCT01474915|75624901|FG001|STARTED|Overall Study||61||
59528746|NCT01474915|75624900|FG000|COMPLETED|Overall Study||50||
59528747|NCT01474915|75624901|FG001|COMPLETED|Overall Study||51||
59528748|NCT01474915|75624900|FG000|NOT COMPLETED|Overall Study||10||
59528749|NCT01474915|75624901|FG001|NOT COMPLETED|Overall Study||10||
59528750|NCT00280826|75624908|FG000|STARTED|Overall Study||6||
59528751|NCT00280826|75624908|FG000|COMPLETED|Overall Study||6||
59528752|NCT00280826|75624908|FG000|NOT COMPLETED|Overall Study||0||
59528753|NCT00147446|75624914|FG000|STARTED|Overall Study||60||
59528754|NCT00147446|75624915|FG001|STARTED|Overall Study||61||
59528755|NCT00147446|75624914|FG000|COMPLETED|Overall Study||60||
59528756|NCT00147446|75624915|FG001|COMPLETED|Overall Study||61||
59528757|NCT00147446|75624914|FG000|NOT COMPLETED|Overall Study||0||
59528758|NCT00147446|75624915|FG001|NOT COMPLETED|Overall Study||0||
59528759|NCT01475305|75624925|FG000|STARTED|Overall Study||4||
59528760|NCT01475305|75624926|FG001|STARTED|Overall Study||3||
59528761|NCT01475305|75624925|FG000|End of Quarantine, Day 15|Overall Study||4||
59528762|NCT01475305|75624926|FG001|End of Quarantine, Day 15|Overall Study||3||
59528763|NCT01475305|75624925|FG000|COMPLETED|Overall Study||4||
59528764|NCT01475305|75624926|FG001|COMPLETED|Overall Study||3||
59528765|NCT01475305|75624925|FG000|NOT COMPLETED|Overall Study||0||
59528766|NCT01475305|75624926|FG001|NOT COMPLETED|Overall Study||0||
59528767|NCT00280904|75624933|FG000|STARTED|Overall Study||433||
59528768|NCT00280904|75624933|FG000|COMPLETED|Overall Study||433||
59528769|NCT00280904|75624933|FG000|NOT COMPLETED|Overall Study||0||
59528770|NCT02103218|75624942|FG000|STARTED|Overall Study||51||
59528771|NCT02103218|75624943|FG001|STARTED|Overall Study||59||
59528772|NCT02103218|75624944|FG002|STARTED|Overall Study||48||
59528773|NCT02103218|75624945|FG003|STARTED|Overall Study||54||
59528774|NCT02103218|75624942|FG000|COMPLETED|Overall Study||46||
59528775|NCT02103218|75624943|FG001|COMPLETED|Overall Study||51||
59528776|NCT02103218|75624944|FG002|COMPLETED|Overall Study||44||
59528777|NCT02103218|75624945|FG003|COMPLETED|Overall Study||47||
59528778|NCT02103218|75624942|FG000|NOT COMPLETED|Overall Study||5||
59528779|NCT02103218|75624943|FG001|NOT COMPLETED|Overall Study||8||
59528780|NCT02103218|75624944|FG002|NOT COMPLETED|Overall Study||4||
59528781|NCT02103218|75624945|FG003|NOT COMPLETED|Overall Study||7||
59528782|NCT01451983|75624957|FG000|STARTED|Overall Study||26||
59528783|NCT01451983|75624958|FG001|STARTED|Overall Study||27||
59528784|NCT01451983|75624959|FG002|STARTED|Overall Study||61||
59528785|NCT01451983|75624960|FG003|STARTED|Overall Study||24||
59528786|NCT01451983|75624957|FG000|COMPLETED|Overall Study||26||
59528787|NCT01451983|75624958|FG001|COMPLETED|Overall Study||27||
59528788|NCT01451983|75624959|FG002|COMPLETED|Overall Study||61||
59528789|NCT01451983|75624960|FG003|COMPLETED|Overall Study||24||
59528790|NCT01451983|75624957|FG000|NOT COMPLETED|Overall Study||0||
59528791|NCT01451983|75624958|FG001|NOT COMPLETED|Overall Study||0||
59528792|NCT01451983|75624959|FG002|NOT COMPLETED|Overall Study||0||
59528793|NCT01451983|75624960|FG003|NOT COMPLETED|Overall Study||0||
59528794|NCT01391299|75624973|FG000|STARTED|Overall Study||57||
59528795|NCT01391299|75624974|FG001|STARTED|Overall Study||60||
59528796|NCT01391299|75624975|FG002|STARTED|Overall Study||58||
59528797|NCT01391299|75624973|FG000|COMPLETED|Overall Study||57||
59528798|NCT01391299|75624974|FG001|COMPLETED|Overall Study||59||
59528799|NCT01391299|75624975|FG002|COMPLETED|Overall Study||56||
59528800|NCT01391299|75624973|FG000|NOT COMPLETED|Overall Study||0||
59528801|NCT01391299|75624974|FG001|NOT COMPLETED|Overall Study||1||
59528802|NCT01391299|75624975|FG002|NOT COMPLETED|Overall Study||2||
59528803|NCT02099084|75624983|FG000|STARTED|First Intervention||4||
59528804|NCT02099084|75624984|FG001|STARTED|First Intervention||4||
59528805|NCT02099084|75624983|FG000|COMPLETED|First Intervention||4||
59528806|NCT02099084|75624984|FG001|COMPLETED|First Intervention||4||
59528807|NCT02099084|75624983|FG000|NOT COMPLETED|First Intervention||0||
59528808|NCT02099084|75624984|FG001|NOT COMPLETED|First Intervention||0||
59528809|NCT02099084|75624983|FG000|STARTED|Washout Period of 14 Days||4||
59528810|NCT02099084|75624984|FG001|STARTED|Washout Period of 14 Days||4||
59528811|NCT02099084|75624983|FG000|COMPLETED|Washout Period of 14 Days||4||
59528812|NCT02099084|75624984|FG001|COMPLETED|Washout Period of 14 Days||4||
59528813|NCT02099084|75624983|FG000|NOT COMPLETED|Washout Period of 14 Days||0||
59528814|NCT02099084|75624984|FG001|NOT COMPLETED|Washout Period of 14 Days||0||
59528815|NCT02099084|75624983|FG000|STARTED|Second Intervention||4||
59528816|NCT02099084|75624984|FG001|STARTED|Second Intervention||4||
59528817|NCT02099084|75624983|FG000|COMPLETED|Second Intervention||4||
59528818|NCT02099084|75624984|FG001|COMPLETED|Second Intervention||4||
59528819|NCT02099084|75624983|FG000|NOT COMPLETED|Second Intervention||0||
59528820|NCT02099084|75624984|FG001|NOT COMPLETED|Second Intervention||0||
59528821|NCT02099786|75624992|FG000|STARTED|Overall Study||24||
59528822|NCT02099786|75624993|FG001|STARTED|Overall Study||23||
59528823|NCT02099786|75624992|FG000|Program Eval 1|Overall Study|Baseline (prior to randomization and first cisplatin dose)|24||
59528824|NCT02099786|75624993|FG001|Program Eval 1|Overall Study|Baseline (prior to randomization and first cisplatin dose)|23||
59528825|NCT02099786|75624992|FG000|Program Eval 2|Overall Study|One month post randomization|23||
59528826|NCT02099786|75624993|FG001|Program Eval 2|Overall Study|One month post randomization|19||
59528827|NCT02099786|75624992|FG000|Program Eval 3|Overall Study|One year post randomization|21||
59528828|NCT02099786|75624993|FG001|Program Eval 3|Overall Study|One year post randomization|15||
59528829|NCT02099786|75624992|FG000|COMPLETED|Overall Study||21||
59528830|NCT02099786|75624993|FG001|COMPLETED|Overall Study||15||
59528831|NCT02099786|75624992|FG000|NOT COMPLETED|Overall Study||3||
59528832|NCT02099786|75624993|FG001|NOT COMPLETED|Overall Study||8||
59528833|NCT02100410|75625000|FG000|STARTED|Exposure Pair 1, 30 Minutes||8||
59528834|NCT02100410|75625001|FG001|STARTED|Exposure Pair 1, 30 Minutes||8||
59528835|NCT02100410|75625002|FG002|STARTED|Exposure Pair 1, 30 Minutes||8||
59528836|NCT02100410|75625003|FG003|STARTED|Exposure Pair 1, 30 Minutes||8||
59528837|NCT02100410|75625004|FG004|STARTED|Exposure Pair 1, 30 Minutes||8||
59528838|NCT02100410|75625005|FG005|STARTED|Exposure Pair 1, 30 Minutes||9||
59528839|NCT02100410|75625000|FG000|COMPLETED|Exposure Pair 1, 30 Minutes||8||
59528840|NCT02100410|75625001|FG001|COMPLETED|Exposure Pair 1, 30 Minutes||8||
59528841|NCT02100410|75625002|FG002|COMPLETED|Exposure Pair 1, 30 Minutes||8||
59528842|NCT02100410|75625003|FG003|COMPLETED|Exposure Pair 1, 30 Minutes||8||
59528843|NCT02100410|75625004|FG004|COMPLETED|Exposure Pair 1, 30 Minutes||8||
59528844|NCT02100410|75625005|FG005|COMPLETED|Exposure Pair 1, 30 Minutes||9||
59528845|NCT02100410|75625000|FG000|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0||
59528846|NCT02100410|75625001|FG001|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0||
59528847|NCT02100410|75625002|FG002|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0||
59528848|NCT02100410|75625003|FG003|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0||
59528849|NCT02100410|75625004|FG004|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0||
59528850|NCT02100410|75625005|FG005|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0||
59528851|NCT02100410|75625000|FG000|STARTED|Exposure Pair 2, 30 Minutes||8||
59528852|NCT02100410|75625001|FG001|STARTED|Exposure Pair 2, 30 Minutes||8||
59528853|NCT02100410|75625002|FG002|STARTED|Exposure Pair 2, 30 Minutes||8||
59528854|NCT02100410|75625003|FG003|STARTED|Exposure Pair 2, 30 Minutes||8||
59528855|NCT02100410|75625004|FG004|STARTED|Exposure Pair 2, 30 Minutes||8||
59528856|NCT02100410|75625005|FG005|STARTED|Exposure Pair 2, 30 Minutes||9||
59528857|NCT02100410|75625000|FG000|COMPLETED|Exposure Pair 2, 30 Minutes||8||
59528858|NCT02100410|75625001|FG001|COMPLETED|Exposure Pair 2, 30 Minutes||8||
59528859|NCT02100410|75625002|FG002|COMPLETED|Exposure Pair 2, 30 Minutes||8||
59528860|NCT02100410|75625003|FG003|COMPLETED|Exposure Pair 2, 30 Minutes||8||
59528861|NCT02100410|75625004|FG004|COMPLETED|Exposure Pair 2, 30 Minutes||8||
59528862|NCT02100410|75625005|FG005|COMPLETED|Exposure Pair 2, 30 Minutes||9||
59528863|NCT02100410|75625000|FG000|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0||
59528864|NCT02100410|75625001|FG001|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0||
59528865|NCT02100410|75625002|FG002|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0||
59528866|NCT02100410|75625003|FG003|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0||
59528867|NCT02100410|75625004|FG004|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0||
59528868|NCT02100410|75625005|FG005|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0||
59528869|NCT02100410|75625000|FG000|STARTED|Exposure Pair 3, 30 Minutes||8||
59528870|NCT02100410|75625001|FG001|STARTED|Exposure Pair 3, 30 Minutes||8||
59528871|NCT02100410|75625002|FG002|STARTED|Exposure Pair 3, 30 Minutes||8||
59528872|NCT02100410|75625003|FG003|STARTED|Exposure Pair 3, 30 Minutes||8||
59528873|NCT02100410|75625004|FG004|STARTED|Exposure Pair 3, 30 Minutes||8||
59528874|NCT02100410|75625005|FG005|STARTED|Exposure Pair 3, 30 Minutes||9||
59528875|NCT02100410|75625000|FG000|COMPLETED|Exposure Pair 3, 30 Minutes||8||
59528876|NCT02100410|75625001|FG001|COMPLETED|Exposure Pair 3, 30 Minutes||8||
59528877|NCT02100410|75625002|FG002|COMPLETED|Exposure Pair 3, 30 Minutes||8||
59528878|NCT02100410|75625003|FG003|COMPLETED|Exposure Pair 3, 30 Minutes||8||
59528879|NCT02100410|75625004|FG004|COMPLETED|Exposure Pair 3, 30 Minutes||8||
59528880|NCT02100410|75625005|FG005|COMPLETED|Exposure Pair 3, 30 Minutes||9||
59528881|NCT02100410|75625000|FG000|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0||
59528882|NCT02100410|75625001|FG001|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0||
59528883|NCT02100410|75625002|FG002|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0||
59528884|NCT02100410|75625003|FG003|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0||
59528885|NCT02100410|75625004|FG004|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0||
59528886|NCT02100410|75625005|FG005|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0||
59528887|NCT01477567|75625024|FG000|STARTED|Overall Study||5||
59528888|NCT01477567|75625025|FG001|STARTED|Overall Study||6||
59528889|NCT01477567|75625026|FG002|STARTED|Overall Study||6||
59528890|NCT01477567|75625027|FG003|STARTED|Overall Study||6||
59528891|NCT01477567|75625028|FG004|STARTED|Overall Study||6||
59528892|NCT01477567|75625029|FG005|STARTED|Overall Study||5||
59528893|NCT01477567|75625030|FG006|STARTED|Overall Study||6||
59528894|NCT01477567|75625024|FG000|Received at Least 1 Dose of Study Drug|Overall Study||5||
59528895|NCT01477567|75625025|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6||
59528896|NCT01477567|75625026|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6||
59528897|NCT01477567|75625027|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6||
59528898|NCT01477567|75625028|FG004|Received at Least 1 Dose of Study Drug|Overall Study||6||
59528899|NCT01477567|75625029|FG005|Received at Least 1 Dose of Study Drug|Overall Study||5||
59528900|NCT01477567|75625030|FG006|Received at Least 1 Dose of Study Drug|Overall Study||6||
59528901|NCT01477567|75625024|FG000|COMPLETED|Overall Study||5||
59528902|NCT01477567|75625025|FG001|COMPLETED|Overall Study||6||
59528903|NCT01477567|75625026|FG002|COMPLETED|Overall Study||6||
59528904|NCT01477567|75625027|FG003|COMPLETED|Overall Study||6||
59528905|NCT01477567|75625028|FG004|COMPLETED|Overall Study||6||
59528906|NCT01477567|75625029|FG005|COMPLETED|Overall Study||5||
59528907|NCT01477567|75625030|FG006|COMPLETED|Overall Study||6||
59528908|NCT01477567|75625024|FG000|NOT COMPLETED|Overall Study||0||
59528909|NCT01477567|75625025|FG001|NOT COMPLETED|Overall Study||0||
59528910|NCT01477567|75625026|FG002|NOT COMPLETED|Overall Study||0||
59528911|NCT01477567|75625027|FG003|NOT COMPLETED|Overall Study||0||
59528912|NCT01477567|75625028|FG004|NOT COMPLETED|Overall Study||0||
59528913|NCT01477567|75625029|FG005|NOT COMPLETED|Overall Study||0||
59528914|NCT01477567|75625030|FG006|NOT COMPLETED|Overall Study||0||
59528915|NCT01391611|75625051|FG000|STARTED|Overall Study||25||
59528916|NCT01391611|75625051|FG000|COMPLETED|Overall Study||3||
59528917|NCT01391611|75625051|FG000|NOT COMPLETED|Overall Study||22||
59528918|NCT00281918|75625057|FG000|STARTED|Overall Study|Informed consent unavailable for 2 patients at time of analysis; intent-to-treat population was 407.|409||
59528919|NCT00281918|75625058|FG001|STARTED|Overall Study|Informed consent unavailable for 5 patients at time of analysis; intent-to-treat population was 403.|408||
59528920|NCT00281918|75625057|FG000|Safety Population; Received Study Drug|Overall Study||398||
59528921|NCT00281918|75625058|FG001|Safety Population; Received Study Drug|Overall Study||402||
59528922|NCT00281918|75625057|FG000|COMPLETED|Overall Study|Completed all 6 cycles of study medication.|267||
59528923|NCT00281918|75625058|FG001|COMPLETED|Overall Study|Completed all 6 cycles of study medication.|300||
59528924|NCT00281918|75625057|FG000|NOT COMPLETED|Overall Study||142||
59528925|NCT00281918|75625058|FG001|NOT COMPLETED|Overall Study||108||
59528926|NCT00201734|75625066|FG000|STARTED|Overall Study||32||
59528927|NCT00201734|75625067|FG001|STARTED|Overall Study||25||
59528928|NCT00201734|75625066|FG000|Patients Not Evaluable|Overall Study||3||
59528929|NCT00201734|75625067|FG001|Patients Not Evaluable|Overall Study||0||
59528930|NCT00201734|75625066|FG000|COMPLETED|Overall Study||29||
59528931|NCT00201734|75625067|FG001|COMPLETED|Overall Study||25||
59528932|NCT00201734|75625066|FG000|NOT COMPLETED|Overall Study||3||
59528933|NCT00201734|75625067|FG001|NOT COMPLETED|Overall Study||0||
59528934|NCT00203216|75625074|FG000|STARTED|Overall Study||31||
59528935|NCT00203216|75625074|FG000|COMPLETED|Overall Study||27||
59528936|NCT00203216|75625074|FG000|NOT COMPLETED|Overall Study||4||
59528937|NCT00204932|75625080|FG000|STARTED|Overall Study||24||
59528938|NCT00204932|75625081|FG001|STARTED|Overall Study||24||
59528939|NCT00204932|75625080|FG000|COMPLETED|Overall Study||22||
59528940|NCT00204932|75625081|FG001|COMPLETED|Overall Study||18||
59528941|NCT00204932|75625080|FG000|NOT COMPLETED|Overall Study||2||
59528942|NCT00204932|75625081|FG001|NOT COMPLETED|Overall Study||6||
59528943|NCT00206336|75625087|FG000|STARTED|Overall Study||20||
59528944|NCT00206336|75625087|FG000|COMPLETED|Overall Study||20||
59528945|NCT00206336|75625087|FG000|NOT COMPLETED|Overall Study||0||
59528946|NCT00210470|75625091|FG000|STARTED|Overall Study||27||
59528947|NCT00210470|75625091|FG000|COMPLETED|Overall Study||27||
59528948|NCT00210470|75625091|FG000|NOT COMPLETED|Overall Study||0||
59528949|NCT00212264|75625101|FG000|STARTED|Overall Study||70||
59528950|NCT00212264|75625102|FG001|STARTED|Overall Study||70||
59528951|NCT00212264|75625103|FG002|STARTED|Overall Study||68||
59528952|NCT00212264|75625101|FG000|COMPLETED|Overall Study||58||
59528953|NCT00212264|75625102|FG001|COMPLETED|Overall Study||54||
59528954|NCT00212264|75625103|FG002|COMPLETED|Overall Study||64||
59528955|NCT00212264|75625101|FG000|NOT COMPLETED|Overall Study||12||
59528956|NCT00212264|75625102|FG001|NOT COMPLETED|Overall Study||16||
59528957|NCT00212264|75625103|FG002|NOT COMPLETED|Overall Study||4||
59528958|NCT01108445|75625113|FG000|STARTED|Overall Study||57||
59528959|NCT01108445|75625114|FG001|STARTED|Overall Study||51||
59528960|NCT01108445|75625113|FG000|COMPLETED|Overall Study||1||
59528961|NCT01108445|75625114|FG001|COMPLETED|Overall Study||2||
59528962|NCT01108445|75625113|FG000|NOT COMPLETED|Overall Study||56||
59528963|NCT01108445|75625114|FG001|NOT COMPLETED|Overall Study||49||
59528964|NCT00212888|75625123|FG000|STARTED|Overall Study||19||
59528965|NCT00212888|75625124|FG001|STARTED|Overall Study||18||
59528966|NCT00212888|75625125|FG002|STARTED|Overall Study||15||
59528967|NCT00212888|75625123|FG000|COMPLETED|Overall Study||16||
59528968|NCT00212888|75625124|FG001|COMPLETED|Overall Study||18||
59528969|NCT00212888|75625125|FG002|COMPLETED|Overall Study||14||
59528970|NCT00212888|75625123|FG000|NOT COMPLETED|Overall Study||3||
59528971|NCT00212888|75625124|FG001|NOT COMPLETED|Overall Study||0||
59528972|NCT00212888|75625125|FG002|NOT COMPLETED|Overall Study||1||
59528973|NCT01607892|75625140|FG000|STARTED|Overall Study||58||
59528974|NCT01607892|75625141|FG001|STARTED|Overall Study||27||
59528975|NCT01607892|75625142|FG002|STARTED|Overall Study||81||
59528976|NCT01607892|75625143|FG003|STARTED|Overall Study||95||
59528977|NCT01607892|75625144|FG004|STARTED|Overall Study||24||
59528978|NCT01607892|75625140|FG000|COMPLETED|Overall Study||0||
59528979|NCT01607892|75625141|FG001|COMPLETED|Overall Study||0||
59528980|NCT01607892|75625142|FG002|COMPLETED|Overall Study||0||
59528981|NCT01607892|75625143|FG003|COMPLETED|Overall Study||0||
59528982|NCT01607892|75625144|FG004|COMPLETED|Overall Study||0||
59528983|NCT01607892|75625140|FG000|NOT COMPLETED|Overall Study||58||
59528984|NCT01607892|75625141|FG001|NOT COMPLETED|Overall Study||27||
59528985|NCT01607892|75625142|FG002|NOT COMPLETED|Overall Study||81||
59528986|NCT01607892|75625143|FG003|NOT COMPLETED|Overall Study||95||
59528987|NCT01607892|75625144|FG004|NOT COMPLETED|Overall Study||24||
59528988|NCT01108757|75625172|FG000|STARTED|Overall Study||26||
59528989|NCT01108757|75625173|FG001|STARTED|Overall Study||26||
59528990|NCT01108757|75625172|FG000|COMPLETED|Overall Study||26||
59528991|NCT01108757|75625173|FG001|COMPLETED|Overall Study||26||
59528992|NCT01108757|75625172|FG000|NOT COMPLETED|Overall Study||0||
59528993|NCT01108757|75625173|FG001|NOT COMPLETED|Overall Study||0||
59528994|NCT01162733|75625181|FG000|STARTED|Overall Study||49||
59528995|NCT01162733|75625182|FG001|STARTED|Overall Study||50||
59528996|NCT01162733|75625181|FG000|COMPLETED|Overall Study||22||
59528997|NCT01162733|75625182|FG001|COMPLETED|Overall Study||25||
59528998|NCT01162733|75625181|FG000|NOT COMPLETED|Overall Study||27||
59528999|NCT01162733|75625182|FG001|NOT COMPLETED|Overall Study||25||
59529000|NCT02530242|75625190|FG000|STARTED|Overall Study||16||
59529001|NCT02530242|75625191|FG001|STARTED|Overall Study||16||
59529002|NCT02530242|75625190|FG000|COMPLETED|Overall Study||16||
59529003|NCT02530242|75625191|FG001|COMPLETED|Overall Study||15||
59529004|NCT02530242|75625190|FG000|NOT COMPLETED|Overall Study||0||
59529005|NCT02530242|75625191|FG001|NOT COMPLETED|Overall Study||1||
59529006|NCT01131065|75625197|FG000|STARTED|Overall Study||15||
59529007|NCT01131065|75625197|FG000|COMPLETED|Overall Study||15||
59529008|NCT01131065|75625197|FG000|NOT COMPLETED|Overall Study||0||
59529009|NCT00214526|75625203|FG000|STARTED|Randomized||56||
59529010|NCT00214526|75625204|FG001|STARTED|Randomized||56||
59529011|NCT00214526|75625203|FG000|COMPLETED|Randomized||55||
59529012|NCT00214526|75625204|FG001|COMPLETED|Randomized||54||
59529013|NCT00214526|75625203|FG000|NOT COMPLETED|Randomized||1||
59529014|NCT00214526|75625204|FG001|NOT COMPLETED|Randomized||2||
59529015|NCT00214526|75625203|FG000|STARTED|Treatment Period||55||
59529016|NCT00214526|75625204|FG001|STARTED|Treatment Period||54||
59529017|NCT00214526|75625203|FG000|COMPLETED|Treatment Period||53||
59529018|NCT00214526|75625204|FG001|COMPLETED|Treatment Period||49||
59529019|NCT00214526|75625203|FG000|NOT COMPLETED|Treatment Period||2||
59529020|NCT00214526|75625204|FG001|NOT COMPLETED|Treatment Period||5||
59529021|NCT00214526|75625203|FG000|STARTED|Post-Treatment Period||53||
59529022|NCT00214526|75625204|FG001|STARTED|Post-Treatment Period||49||
59529023|NCT00214526|75625203|FG000|COMPLETED|Post-Treatment Period||52||
59529024|NCT00214526|75625204|FG001|COMPLETED|Post-Treatment Period||49||
59529025|NCT00214526|75625203|FG000|NOT COMPLETED|Post-Treatment Period||1||
59815228|NCT00614939|75937666|FG001|STARTED|Overall Study|Randomized and treated|85||
59529026|NCT00214526|75625204|FG001|NOT COMPLETED|Post-Treatment Period||0||
59529027|NCT02537574|75625215|FG000|STARTED|Overall Study||126||
59529028|NCT02537574|75625216|FG001|STARTED|Overall Study||126||
59529029|NCT02537574|75625217|FG002|STARTED|Overall Study||126||
59529030|NCT02537574|75625215|FG000|COMPLETED|Overall Study||27||
59529031|NCT02537574|75625216|FG001|COMPLETED|Overall Study||23||
59529032|NCT02537574|75625217|FG002|COMPLETED|Overall Study||18||
59529033|NCT02537574|75625215|FG000|NOT COMPLETED|Overall Study||99||
59529034|NCT02537574|75625216|FG001|NOT COMPLETED|Overall Study||103||
59529035|NCT02537574|75625217|FG002|NOT COMPLETED|Overall Study||108||
59529036|NCT01164137|75625227|FG000|STARTED|Overall Study||80||
59529037|NCT01164137|75625228|FG001|STARTED|Overall Study||76||
59529038|NCT01164137|75625227|FG000|COMPLETED|Overall Study||77||
59529039|NCT01164137|75625228|FG001|COMPLETED|Overall Study||76||
59529040|NCT01164137|75625227|FG000|NOT COMPLETED|Overall Study||3||
59529041|NCT01164137|75625228|FG001|NOT COMPLETED|Overall Study||0||
59529042|NCT01165541|75625234|FG000|STARTED|Quetiapine XR Monotherapy||20||
59529043|NCT01165541|75625234|FG000|COMPLETED|Quetiapine XR Monotherapy||16||
59529044|NCT01165541|75625234|FG000|NOT COMPLETED|Quetiapine XR Monotherapy||4||
59529045|NCT01165541|75625234|FG000|STARTED|Quetiapine XR and Mirtazepine||16||
59529046|NCT01165541|75625234|FG000|COMPLETED|Quetiapine XR and Mirtazepine||11||
59529047|NCT01165541|75625234|FG000|NOT COMPLETED|Quetiapine XR and Mirtazepine||5||
59529048|NCT00284180|75625242|FG000|STARTED|Overall Study||11||
59529049|NCT00284180|75625243|FG001|STARTED|Overall Study||21||
59529050|NCT00284180|75625242|FG000|COMPLETED|Overall Study||11||
59529051|NCT00284180|75625243|FG001|COMPLETED|Overall Study||17||
59529052|NCT00284180|75625242|FG000|NOT COMPLETED|Overall Study||0||
59529053|NCT00284180|75625243|FG001|NOT COMPLETED|Overall Study||4||
59529054|NCT01165775|75625249|FG000|STARTED|Overall Study||17||
59529055|NCT01165775|75625249|FG000|COMPLETED|Overall Study||15||
59529056|NCT01165775|75625249|FG000|NOT COMPLETED|Overall Study||2||
59529057|NCT00216320|75625260|FG000|STARTED|Phase 1 (Weeks 0 - 6)||43||
59529058|NCT00216320|75625261|FG001|STARTED|Phase 1 (Weeks 0 - 6)||39||
59529059|NCT00216320|75625262|FG002|STARTED|Phase 1 (Weeks 0 - 6)||30||
59529060|NCT00216320|75625260|FG000|COMPLETED|Phase 1 (Weeks 0 - 6)||43||
59529061|NCT00216320|75625261|FG001|COMPLETED|Phase 1 (Weeks 0 - 6)||35||
59529062|NCT00216320|75625262|FG002|COMPLETED|Phase 1 (Weeks 0 - 6)||25||
59529063|NCT00216320|75625260|FG000|NOT COMPLETED|Phase 1 (Weeks 0 - 6)||0||
59529064|NCT00216320|75625261|FG001|NOT COMPLETED|Phase 1 (Weeks 0 - 6)||4||
59529065|NCT00216320|75625262|FG002|NOT COMPLETED|Phase 1 (Weeks 0 - 6)||5||
59529066|NCT00216320|75625260|FG000|STARTED|Phase 2 (Weeks 6 -12)||43||
59529067|NCT00216320|75625261|FG001|STARTED|Phase 2 (Weeks 6 -12)||35||
59529068|NCT00216320|75625262|FG002|STARTED|Phase 2 (Weeks 6 -12)||25||
59529069|NCT00216320|75625260|FG000|COMPLETED|Phase 2 (Weeks 6 -12)||38||
59529070|NCT00216320|75625261|FG001|COMPLETED|Phase 2 (Weeks 6 -12)||31||
59529071|NCT00216320|75625262|FG002|COMPLETED|Phase 2 (Weeks 6 -12)||24||
59529072|NCT00216320|75625260|FG000|NOT COMPLETED|Phase 2 (Weeks 6 -12)||5||
59529073|NCT00216320|75625261|FG001|NOT COMPLETED|Phase 2 (Weeks 6 -12)||4||
59529074|NCT00216320|75625262|FG002|NOT COMPLETED|Phase 2 (Weeks 6 -12)||1||
59529075|NCT00217490|75625275|FG000|STARTED|Overall Study||154||
59529076|NCT00217490|75625276|FG001|STARTED|Overall Study||153||
59529077|NCT00217490|75625277|FG002|STARTED|Overall Study||155||
59529078|NCT00217490|75625278|FG003|STARTED|Overall Study||153||
59529079|NCT00217490|75625275|FG000|COMPLETED|Overall Study||137||
59529080|NCT00217490|75625276|FG001|COMPLETED|Overall Study||128||
59529081|NCT00217490|75625277|FG002|COMPLETED|Overall Study||131||
59529082|NCT00217490|75625278|FG003|COMPLETED|Overall Study||130||
59529083|NCT00217490|75625275|FG000|NOT COMPLETED|Overall Study||17||
59529084|NCT00217490|75625276|FG001|NOT COMPLETED|Overall Study||25||
59529085|NCT00217490|75625277|FG002|NOT COMPLETED|Overall Study||24||
59529086|NCT00217490|75625278|FG003|NOT COMPLETED|Overall Study||23||
59529087|NCT00217724|75625292|FG000|STARTED|Course 1, (Glutamine/Placebo Arms)||8||
59529088|NCT00217724|75625293|FG001|STARTED|Course 1, (Glutamine/Placebo Arms)||10||
59529089|NCT00217724|75625292|FG000|COMPLETED|Course 1, (Glutamine/Placebo Arms)||5||
59529090|NCT00217724|75625293|FG001|COMPLETED|Course 1, (Glutamine/Placebo Arms)||9||
59529091|NCT00217724|75625292|FG000|NOT COMPLETED|Course 1, (Glutamine/Placebo Arms)||3||
59529092|NCT00217724|75625293|FG001|NOT COMPLETED|Course 1, (Glutamine/Placebo Arms)||1||
59529093|NCT00217724|75625292|FG000|STARTED|Course 2, (Glutamine/Placebo Crossover)||9||
59529094|NCT00217724|75625293|FG001|STARTED|Course 2, (Glutamine/Placebo Crossover)||5||
59529095|NCT00217724|75625292|FG000|COMPLETED|Course 2, (Glutamine/Placebo Crossover)||8||
59529096|NCT00217724|75625293|FG001|COMPLETED|Course 2, (Glutamine/Placebo Crossover)||5||
59529097|NCT00217724|75625292|FG000|NOT COMPLETED|Course 2, (Glutamine/Placebo Crossover)||1||
59529098|NCT00217724|75625293|FG001|NOT COMPLETED|Course 2, (Glutamine/Placebo Crossover)||0||
59529099|NCT00287222|75625299|FG000|STARTED|Overall Study||21||
59529100|NCT00287222|75625299|FG000|COMPLETED|Overall Study||21||
59529101|NCT00287222|75625299|FG000|NOT COMPLETED|Overall Study||0||
59529102|NCT00218426|75625306|FG000|STARTED|Overall Study||102||
59529103|NCT00218426|75625307|FG001|STARTED|Overall Study||102||
59529104|NCT00218426|75625308|FG002|STARTED|Overall Study||102||
59529105|NCT00218426|75625306|FG000|COMPLETED|Overall Study||54||
59529106|NCT00218426|75625307|FG001|COMPLETED|Overall Study||16||
59529107|NCT00218426|75625308|FG002|COMPLETED|Overall Study||11||
59529108|NCT00218426|75625306|FG000|NOT COMPLETED|Overall Study||48||
59529109|NCT00218426|75625307|FG001|NOT COMPLETED|Overall Study||86||
59529110|NCT00218426|75625308|FG002|NOT COMPLETED|Overall Study||91||
59529111|NCT01134575|75625322|FG000|STARTED|Overall Study||3||
59529112|NCT01134575|75625323|FG001|STARTED|Overall Study||45||
59529113|NCT01134575|75625324|FG002|STARTED|Overall Study||42||
59529114|NCT01134575|75625322|FG000|COMPLETED|Overall Study||3||
59529115|NCT01134575|75625323|FG001|COMPLETED|Overall Study||45||
59529116|NCT01134575|75625324|FG002|COMPLETED|Overall Study||42||
59529117|NCT01134575|75625322|FG000|NOT COMPLETED|Overall Study||0||
59529118|NCT01134575|75625323|FG001|NOT COMPLETED|Overall Study||0||
59529119|NCT01134575|75625324|FG002|NOT COMPLETED|Overall Study||0||
59529120|NCT01134887|75625336|FG000|STARTED|Overall Study||9||
59529121|NCT01134887|75625337|FG001|STARTED|Overall Study||11||
59529122|NCT01134887|75625338|FG002|STARTED|Overall Study||5||
59529123|NCT01134887|75625339|FG003|STARTED|Overall Study||5||
59529124|NCT01134887|75625336|FG000|COMPLETED|Overall Study||9||
59529125|NCT01134887|75625337|FG001|COMPLETED|Overall Study|Four patients in the Veteran-Control arm did not have two clinic visits videotaped and left study.|7||
59529126|NCT01134887|75625338|FG002|COMPLETED|Overall Study||5||
59529127|NCT01134887|75625339|FG003|COMPLETED|Overall Study||5||
59529128|NCT01134887|75625336|FG000|NOT COMPLETED|Overall Study||0||
59529129|NCT01134887|75625337|FG001|NOT COMPLETED|Overall Study||4||
59529130|NCT01134887|75625338|FG002|NOT COMPLETED|Overall Study||0||
59529131|NCT01134887|75625339|FG003|NOT COMPLETED|Overall Study||0||
59529132|NCT00223262|75625349|FG000|STARTED|Overall Study||16||
59529133|NCT00223262|75625350|FG001|STARTED|Overall Study||12||
59529134|NCT00223262|75625349|FG000|COMPLETED|Overall Study||8||
59529135|NCT00223262|75625350|FG001|COMPLETED|Overall Study||11||
59529136|NCT00223262|75625349|FG000|NOT COMPLETED|Overall Study||8||
59529137|NCT00223262|75625350|FG001|NOT COMPLETED|Overall Study||1||
59529138|NCT00223652|75625358|FG000|STARTED|T-CBT 12 Weeks, TAU 20 Weeks||41||
59529139|NCT00223652|75625359|FG001|STARTED|T-CBT 12 Weeks, TAU 20 Weeks||44||
59529140|NCT00223652|75625358|FG000|COMPLETED|T-CBT 12 Weeks, TAU 20 Weeks||40||
59529141|NCT00223652|75625359|FG001|COMPLETED|T-CBT 12 Weeks, TAU 20 Weeks||41||
59529142|NCT00223652|75625358|FG000|NOT COMPLETED|T-CBT 12 Weeks, TAU 20 Weeks||1||
59529143|NCT00223652|75625359|FG001|NOT COMPLETED|T-CBT 12 Weeks, TAU 20 Weeks||3||
59529144|NCT00223652|75625358|FG000|STARTED|T-CBT 20 Weeks, TAU 20 Weeks||40||
59529145|NCT00223652|75625359|FG001|STARTED|T-CBT 20 Weeks, TAU 20 Weeks||41||
59529146|NCT00223652|75625358|FG000|COMPLETED|T-CBT 20 Weeks, TAU 20 Weeks||40||
59529147|NCT00223652|75625359|FG001|COMPLETED|T-CBT 20 Weeks, TAU 20 Weeks||41||
59529148|NCT00223652|75625358|FG000|NOT COMPLETED|T-CBT 20 Weeks, TAU 20 Weeks||0||
59529149|NCT00223652|75625359|FG001|NOT COMPLETED|T-CBT 20 Weeks, TAU 20 Weeks||0||
59529150|NCT00223652|75625358|FG000|STARTED|T-CBT and TAU 6 Month Follow-up||40||
59529151|NCT00223652|75625359|FG001|STARTED|T-CBT and TAU 6 Month Follow-up||41||
59529152|NCT00223652|75625358|FG000|COMPLETED|T-CBT and TAU 6 Month Follow-up||39||
59529153|NCT00223652|75625359|FG001|COMPLETED|T-CBT and TAU 6 Month Follow-up||37||
59529154|NCT00223652|75625358|FG000|NOT COMPLETED|T-CBT and TAU 6 Month Follow-up||1||
59529155|NCT00223652|75625359|FG001|NOT COMPLETED|T-CBT and TAU 6 Month Follow-up||4||
59529156|NCT00289718|75625366|FG000|STARTED|Overall Study||51||
59529157|NCT00289718|75625366|FG000|COMPLETED|Overall Study||51||
59529158|NCT00289718|75625366|FG000|NOT COMPLETED|Overall Study||0||
59529159|NCT00290654|75625375|FG000|STARTED|Overall Study||41||
59529160|NCT00290654|75625375|FG000|COMPLETED|Overall Study||41||
59529161|NCT00290654|75625375|FG000|NOT COMPLETED|Overall Study||0||
59529162|NCT00290810|75625379|FG000|STARTED|Overall Study||12||
59529163|NCT00290810|75625379|FG000|COMPLETED|Overall Study||12||
59529164|NCT00290810|75625379|FG000|NOT COMPLETED|Overall Study||0||
59529165|NCT01137539|75625383|FG000|STARTED|Overall Study||50||
59529166|NCT01137539|75625383|FG000|COMPLETED|Overall Study||50||
59529167|NCT01137539|75625383|FG000|NOT COMPLETED|Overall Study||0||
59529168|NCT01138475|75625390|FG000|STARTED|Overall Study||16||
59529169|NCT01138475|75625391|FG001|STARTED|Overall Study||16||
59529170|NCT01138475|75625392|FG002|STARTED|Overall Study||17||
59529171|NCT01138475|75625390|FG000|COMPLETED|Overall Study||16||
59529172|NCT01138475|75625391|FG001|COMPLETED|Overall Study||16||
59529173|NCT01138475|75625392|FG002|COMPLETED|Overall Study||17||
59529174|NCT01138475|75625390|FG000|NOT COMPLETED|Overall Study||0||
59529175|NCT01138475|75625391|FG001|NOT COMPLETED|Overall Study||0||
59529176|NCT01138475|75625392|FG002|NOT COMPLETED|Overall Study||0||
59529177|NCT00293540|75625408|FG000|STARTED|Overall Study||122||
59529178|NCT00293540|75625409|FG001|STARTED|Overall Study||127||
59529179|NCT00293540|75625408|FG000|COMPLETED|Overall Study||115||
59529180|NCT00293540|75625409|FG001|COMPLETED|Overall Study||119||
59529181|NCT00293540|75625408|FG000|NOT COMPLETED|Overall Study||7||
59529182|NCT00293540|75625409|FG001|NOT COMPLETED|Overall Study||8||
59529183|NCT01139411|75625417|FG000|STARTED|Overall Study||26||
59529184|NCT01139411|75625418|FG001|STARTED|Overall Study||23||
59529185|NCT01139411|75625417|FG000|COMPLETED|Overall Study||24||
59529186|NCT01139411|75625418|FG001|COMPLETED|Overall Study||19||
59529187|NCT01139411|75625417|FG000|NOT COMPLETED|Overall Study||2||
59529188|NCT01139411|75625418|FG001|NOT COMPLETED|Overall Study||4||
59529189|NCT01139801|75625428|FG000|STARTED|Overall Study||25||
59529190|NCT01139801|75625429|FG001|STARTED|Overall Study||25||
59529191|NCT01139801|75625428|FG000|COMPLETED|Overall Study||25||
59529192|NCT01139801|75625429|FG001|COMPLETED|Overall Study||25||
59529193|NCT01139801|75625428|FG000|NOT COMPLETED|Overall Study||0||
59529194|NCT01139801|75625429|FG001|NOT COMPLETED|Overall Study||0||
59529195|NCT01139879|75625435|FG000|STARTED|Overall Study||10||
59529196|NCT01139879|75625435|FG000|COMPLETED|Overall Study||10||
59529197|NCT01139879|75625435|FG000|NOT COMPLETED|Overall Study||0||
59529198|NCT00294632|75625443|FG000|STARTED|Phase I Dose Escalation Period||14||
59529199|NCT00294632|75625444|FG001|STARTED|Phase I Dose Escalation Period||0||
59529200|NCT00294632|75625443|FG000|Cohort 1: 10 mg|Phase I Dose Escalation Period||3||
59529201|NCT00294632|75625444|FG001|Cohort 1: 10 mg|Phase I Dose Escalation Period||0||
59529202|NCT00294632|75625443|FG000|Cohort 2: 15 mg|Phase I Dose Escalation Period||3||
59529203|NCT00294632|75625444|FG001|Cohort 2: 15 mg|Phase I Dose Escalation Period||0||
59529204|NCT00294632|75625443|FG000|Cohort 3: 20 mg|Phase I Dose Escalation Period||6||
59529205|NCT00294632|75625444|FG001|Cohort 3: 20 mg|Phase I Dose Escalation Period||0||
59529206|NCT00294632|75625443|FG000|Cohort 4: 25 mg|Phase I Dose Escalation Period||2||
59529207|NCT00294632|75625444|FG001|Cohort 4: 25 mg|Phase I Dose Escalation Period||0||
59529208|NCT00294632|75625443|FG000|COMPLETED|Phase I Dose Escalation Period||14||
59529209|NCT00294632|75625444|FG001|COMPLETED|Phase I Dose Escalation Period||0||
59529210|NCT00294632|75625443|FG000|NOT COMPLETED|Phase I Dose Escalation Period||0||
59529211|NCT00294632|75625444|FG001|NOT COMPLETED|Phase I Dose Escalation Period||0||
59529212|NCT00294632|75625443|FG000|STARTED|Phase II: 20 mg Lenalidomide||6||
59529213|NCT00294632|75625444|FG001|STARTED|Phase II: 20 mg Lenalidomide||38||
59529214|NCT00294632|75625443|FG000|COMPLETED|Phase II: 20 mg Lenalidomide||6||
59529215|NCT00294632|75625444|FG001|COMPLETED|Phase II: 20 mg Lenalidomide||38||
59529216|NCT00294632|75625443|FG000|NOT COMPLETED|Phase II: 20 mg Lenalidomide||0||
59529217|NCT00294632|75625444|FG001|NOT COMPLETED|Phase II: 20 mg Lenalidomide||0||
59529218|NCT01140191|75625451|FG000|STARTED|Overall Study||1||
59529219|NCT01140191|75625451|FG000|COMPLETED|Overall Study||1||
59529220|NCT01140191|75625451|FG000|NOT COMPLETED|Overall Study||0||
59529221|NCT01140815|75625457|FG000|STARTED|Overall Study||25||
59529222|NCT01140815|75625458|FG001|STARTED|Overall Study||25||
59529223|NCT01140815|75625457|FG000|COMPLETED|Overall Study||25||
59529224|NCT01140815|75625458|FG001|COMPLETED|Overall Study||25||
59529225|NCT01140815|75625457|FG000|NOT COMPLETED|Overall Study||0||
59529226|NCT01140815|75625458|FG001|NOT COMPLETED|Overall Study||0||
59815229|NCT00614939|75937665|FG000|COMPLETED|Overall Study|Completed 52 weeks of treatment|50||
59815230|NCT00614939|75937666|FG001|COMPLETED|Overall Study|Completed 52 weeks of treatment|42||
59815231|NCT00614939|75937665|FG000|NOT COMPLETED|Overall Study||35||
59529227|NCT01141049|75625468|FG000|STARTED|Overall Study||19||
59529228|NCT01141049|75625469|FG001|STARTED|Overall Study||21||
59529229|NCT01141049|75625468|FG000|COMPLETED|Overall Study||14||
59529230|NCT01141049|75625469|FG001|COMPLETED|Overall Study||13||
59529231|NCT01141049|75625468|FG000|NOT COMPLETED|Overall Study||5||
59529232|NCT01141049|75625469|FG001|NOT COMPLETED|Overall Study||8||
59529233|NCT01141595|75625475|FG000|STARTED|Overall Study||10||
59529234|NCT01141595|75625475|FG000|COMPLETED|Overall Study||8||
59529235|NCT01141595|75625475|FG000|NOT COMPLETED|Overall Study||2||
59529236|NCT01141907|75625481|FG000|STARTED|Overall Study||6||
59529237|NCT01141907|75625482|FG001|STARTED|Overall Study||5||
59529238|NCT01141907|75625481|FG000|COMPLETED|Overall Study||6||
59529239|NCT01141907|75625482|FG001|COMPLETED|Overall Study||5||
59529240|NCT01141907|75625481|FG000|NOT COMPLETED|Overall Study||0||
59529241|NCT01141907|75625482|FG001|NOT COMPLETED|Overall Study||0||
59529242|NCT01142297|75625488|FG000|STARTED|Overall Study||24||
59529243|NCT01142297|75625488|FG000|COMPLETED|Overall Study||18||
59529244|NCT01142297|75625488|FG000|NOT COMPLETED|Overall Study||6||
59529245|NCT01143701|75625497|FG000|STARTED|Overall Study||258||
59529246|NCT01143701|75625498|FG001|STARTED|Overall Study||319||
59815232|NCT00614939|75937666|FG001|NOT COMPLETED|Overall Study||43||
60075399|NCT02788045|76190728|FG001|COMPLETED|Long Term Extension (From Wk 72 to 264)||0||
60075400|NCT02788045|76190729|FG002|COMPLETED|Long Term Extension (From Wk 72 to 264)||0||
60075401|NCT02788045|76190727|FG000|NOT COMPLETED|Long Term Extension (From Wk 72 to 264)||17||
60075402|NCT02788045|76190728|FG001|NOT COMPLETED|Long Term Extension (From Wk 72 to 264)||0||
60075403|NCT02788045|76190729|FG002|NOT COMPLETED|Long Term Extension (From Wk 72 to 264)||0||
60075404|NCT02775695|76190737|FG000|STARTED|Overall Study||12||
60075405|NCT02775695|76190737|FG000|COMPLETED|Overall Study||12||
60075406|NCT02775695|76190737|FG000|NOT COMPLETED|Overall Study||0||
60075407|NCT02663232|76190741|FG000|STARTED|Overall Study||264||
60075408|NCT02663232|76190741|FG000|COMPLETED|Overall Study||264||
60075409|NCT02663232|76190741|FG000|NOT COMPLETED|Overall Study||0||
60075410|NCT02505919|76190747|FG000|STARTED|Treatment||116||
60075411|NCT02505919|76190748|FG001|STARTED|Treatment||65||
60075412|NCT02505919|76190747|FG000|COMPLETED|Treatment||116||
60075413|NCT02505919|76190748|FG001|COMPLETED|Treatment||65||
60075414|NCT02505919|76190747|FG000|NOT COMPLETED|Treatment||0||
60075415|NCT02505919|76190748|FG001|NOT COMPLETED|Treatment||0||
60075416|NCT02505919|76190747|FG000|STARTED|1 Week Follow-Up||116||
60075417|NCT02505919|76190748|FG001|STARTED|1 Week Follow-Up||65||
59529247|NCT01143701|75625497|FG000|COMPLETED|Overall Study|Number of patients for whom at least one set of post-baseline parent-ratings were collected|235||
59529248|NCT01143701|75625498|FG001|COMPLETED|Overall Study|Number of patients for whom at least one set of post-baseline parent-ratings were collected|287||
59529249|NCT01143701|75625497|FG000|NOT COMPLETED|Overall Study||23||
59529250|NCT01143701|75625498|FG001|NOT COMPLETED|Overall Study||32||
60075418|NCT02505919|76190747|FG000|COMPLETED|1 Week Follow-Up||116||
60075419|NCT02505919|76190748|FG001|COMPLETED|1 Week Follow-Up||65||
59529251|NCT01167569|75625506|FG000|STARTED|Overall Study||28||
59529252|NCT01167569|75625507|FG001|STARTED|Overall Study||29||
59529253|NCT01167569|75625506|FG000|COMPLETED|Overall Study||27||
59529254|NCT01167569|75625507|FG001|COMPLETED|Overall Study||27||
59529255|NCT01167569|75625506|FG000|NOT COMPLETED|Overall Study||1||
59529256|NCT01167569|75625507|FG001|NOT COMPLETED|Overall Study||2||
59529257|NCT00296192|75625520|FG000|STARTED|Overall Study||17||
59529258|NCT00296192|75625521|FG001|STARTED|Overall Study||16||
59529259|NCT00296192|75625522|FG002|STARTED|Overall Study||16||
59529260|NCT00296192|75625523|FG003|STARTED|Overall Study||17||
59529261|NCT00296192|75625524|FG004|STARTED|Overall Study||16||
59529262|NCT00296192|75625520|FG000|COMPLETED|Overall Study||17||
59529263|NCT00296192|75625521|FG001|COMPLETED|Overall Study||16||
59529264|NCT00296192|75625522|FG002|COMPLETED|Overall Study||16||
59529265|NCT00296192|75625523|FG003|COMPLETED|Overall Study||17||
59529266|NCT00296192|75625524|FG004|COMPLETED|Overall Study||16||
59529267|NCT00296192|75625520|FG000|NOT COMPLETED|Overall Study||0||
59529268|NCT00296192|75625521|FG001|NOT COMPLETED|Overall Study||0||
59529269|NCT00296192|75625522|FG002|NOT COMPLETED|Overall Study||0||
59529270|NCT00296192|75625523|FG003|NOT COMPLETED|Overall Study||0||
59529271|NCT00296192|75625524|FG004|NOT COMPLETED|Overall Study||0||
59529272|NCT00297596|75625536|FG000|STARTED|Overall Study||25||
59529273|NCT00297596|75625536|FG000|COMPLETED|Overall Study||25||
59529274|NCT00297596|75625536|FG000|NOT COMPLETED|Overall Study||0||
59529275|NCT01144637|75625544|FG000|STARTED|Overall Study||999||
59529276|NCT01144637|75625545|FG001|STARTED|Overall Study||1005||
59529277|NCT01144637|75625546|FG002|STARTED|Overall Study||999||
59529278|NCT01144637|75625547|FG003|STARTED|Overall Study||1002||
59529279|NCT01144637|75625544|FG000|COMPLETED|Overall Study||925|active trial phase|
59529280|NCT01144637|75625545|FG001|COMPLETED|Overall Study||929|active trial phase|
60075420|NCT02505919|76190747|FG000|NOT COMPLETED|1 Week Follow-Up||0||
60075421|NCT02505919|76190748|FG001|NOT COMPLETED|1 Week Follow-Up||0||
59529281|NCT01144637|75625546|FG002|COMPLETED|Overall Study||939|active trial phase|
59529282|NCT01144637|75625547|FG003|COMPLETED|Overall Study||946|active trial phase|
59529283|NCT01144637|75625544|FG000|NOT COMPLETED|Overall Study||74||
59529284|NCT01144637|75625545|FG001|NOT COMPLETED|Overall Study||76||
59529285|NCT01144637|75625546|FG002|NOT COMPLETED|Overall Study||60||
59529286|NCT01144637|75625547|FG003|NOT COMPLETED|Overall Study||56||
59529287|NCT00298610|75625557|FG000|STARTED|Overall Study||30||
59529288|NCT00298610|75625557|FG000|COMPLETED|Overall Study||30||
59529289|NCT00298610|75625557|FG000|NOT COMPLETED|Overall Study||0||
59529290|NCT00299000|75625563|FG000|STARTED|Overall Study||2||
59529291|NCT00299000|75625564|FG001|STARTED|Overall Study||2||
59529292|NCT00299000|75625563|FG000|COMPLETED|Overall Study||2||
59529293|NCT00299000|75625564|FG001|COMPLETED|Overall Study||2||
59529294|NCT00299000|75625563|FG000|NOT COMPLETED|Overall Study||0||
59529295|NCT00299000|75625564|FG001|NOT COMPLETED|Overall Study||0||
59529296|NCT01144949|75625572|FG000|STARTED|Overall Study||119||
59529297|NCT01144949|75625573|FG001|STARTED|Overall Study||120||
59529298|NCT01144949|75625572|FG000|COMPLETED|Overall Study||108||
59529299|NCT01144949|75625573|FG001|COMPLETED|Overall Study||106||
59529300|NCT01144949|75625572|FG000|NOT COMPLETED|Overall Study||11||
59529301|NCT01144949|75625573|FG001|NOT COMPLETED|Overall Study||14||
59622705|NCT00438204|75734594|FG000|STARTED|Overall Study||39||
59622706|NCT00438204|75734594|FG000|COMPLETED|Overall Study||39||
59529302|NCT00215930|75625579|FG000|STARTED|Overall Study||53||
59529303|NCT00215930|75625579|FG000|COMPLETED|Overall Study||53||
59529304|NCT00215930|75625579|FG000|NOT COMPLETED|Overall Study||0||
59529305|NCT01145183|75625588|FG000|STARTED|Overall Study||21||
59529306|NCT01145183|75625589|FG001|STARTED|Overall Study||26||
59529307|NCT01145183|75625590|FG002|STARTED|Overall Study||19||
59529308|NCT01145183|75625591|FG003|STARTED|Overall Study||10||
59529309|NCT01145183|75625588|FG000|COMPLETED|Overall Study||21||
59529310|NCT01145183|75625589|FG001|COMPLETED|Overall Study||26||
59529311|NCT01145183|75625590|FG002|COMPLETED|Overall Study||19||
59529312|NCT01145183|75625591|FG003|COMPLETED|Overall Study||10||
59529313|NCT01145183|75625588|FG000|NOT COMPLETED|Overall Study||0||
59815233|NCT00530504|75937672|FG000|STARTED|Overall Study||1500||
59815234|NCT00530504|75937672|FG000|COMPLETED|Overall Study||1348||
59815235|NCT00530504|75937672|FG000|NOT COMPLETED|Overall Study||152||
59529314|NCT01145183|75625589|FG001|NOT COMPLETED|Overall Study||0||
59529315|NCT01145183|75625590|FG002|NOT COMPLETED|Overall Study||0||
59529316|NCT01145183|75625591|FG003|NOT COMPLETED|Overall Study||0||
59529317|NCT00230126|75625603|FG000|STARTED|Overall Study||30||
59529318|NCT00230126|75625604|FG001|STARTED|Overall Study||28||
59529319|NCT00230126|75625603|FG000|COMPLETED|Overall Study||28||
59529320|NCT00230126|75625604|FG001|COMPLETED|Overall Study||27||
59529321|NCT00230126|75625603|FG000|NOT COMPLETED|Overall Study||2||
59529322|NCT00230126|75625604|FG001|NOT COMPLETED|Overall Study||1||
59529323|NCT01169519|75625612|FG000|STARTED|Overall Study|This was a pre-post study, All patients receiving a baseline assessment, also received sildenafil.|21||
59529324|NCT01169519|75625612|FG000|COMPLETED|Overall Study||21||
59529325|NCT01169519|75625612|FG000|NOT COMPLETED|Overall Study||0||
59529326|NCT02103608|75625624|FG000|STARTED|Overall Study||17||
59529327|NCT02103608|75625624|FG000|COMPLETED|Overall Study||15||
59529328|NCT02103608|75625624|FG000|NOT COMPLETED|Overall Study||2||
59529329|NCT02101190|75625630|FG000|STARTED|Overall Study||8||
59529330|NCT02101190|75625631|FG001|STARTED|Overall Study||8||
59529331|NCT02101190|75625630|FG000|COMPLETED|Overall Study||8||
59529332|NCT02101190|75625631|FG001|COMPLETED|Overall Study||8||
59529333|NCT02101190|75625630|FG000|NOT COMPLETED|Overall Study||0||
59529334|NCT02101190|75625631|FG001|NOT COMPLETED|Overall Study||0||
59529335|NCT01170533|75625637|FG000|STARTED|Omeprazole Cross-over||20||
59529336|NCT01170533|75625638|FG001|STARTED|Omeprazole Cross-over||0||
59529337|NCT01170533|75625637|FG000|COMPLETED|Omeprazole Cross-over||20||
59529338|NCT01170533|75625638|FG001|COMPLETED|Omeprazole Cross-over||0||
59529339|NCT01170533|75625637|FG000|NOT COMPLETED|Omeprazole Cross-over||0||
59529340|NCT01170533|75625638|FG001|NOT COMPLETED|Omeprazole Cross-over||0||
59529341|NCT01170533|75625637|FG000|STARTED|Pantoprazole Cross-over||0||
59529342|NCT01170533|75625638|FG001|STARTED|Pantoprazole Cross-over|15 participants continued from omeprazole cross-over; the remaining 5 were new participants|20||
59529343|NCT01170533|75625637|FG000|COMPLETED|Pantoprazole Cross-over||0||
59529344|NCT01170533|75625638|FG001|COMPLETED|Pantoprazole Cross-over||20||
59529345|NCT01170533|75625637|FG000|NOT COMPLETED|Pantoprazole Cross-over||0||
59529346|NCT01170533|75625638|FG001|NOT COMPLETED|Pantoprazole Cross-over||0||
59529347|NCT02186795|75625650|FG000|STARTED|Overall Study||24||
59529348|NCT02186795|75625651|FG001|STARTED|Overall Study||24||
59529349|NCT02186795|75625650|FG000|COMPLETED|Overall Study||24||
59529350|NCT02186795|75625651|FG001|COMPLETED|Overall Study||24||
59529351|NCT02186795|75625650|FG000|NOT COMPLETED|Overall Study||0||
59529352|NCT02186795|75625651|FG001|NOT COMPLETED|Overall Study||0||
59529353|NCT01147601|75625659|FG000|STARTED|Overall Study||5||
59529354|NCT01147601|75625660|FG001|STARTED|Overall Study||1||
59529355|NCT01147601|75625659|FG000|COMPLETED|Overall Study||2||
59529356|NCT01147601|75625660|FG001|COMPLETED|Overall Study||1||
59529357|NCT01147601|75625659|FG000|NOT COMPLETED|Overall Study||3||
59529358|NCT01147601|75625660|FG001|NOT COMPLETED|Overall Study||0||
59529359|NCT01149785|75625666|FG000|STARTED|First Intervention||15||
59529360|NCT01149785|75625667|FG001|STARTED|First Intervention||0||
59529361|NCT01149785|75625666|FG000|COMPLETED|First Intervention||15||
59529362|NCT01149785|75625667|FG001|COMPLETED|First Intervention||0||
59529363|NCT01149785|75625666|FG000|NOT COMPLETED|First Intervention||0||
59529364|NCT01149785|75625667|FG001|NOT COMPLETED|First Intervention||0||
59529365|NCT01149785|75625666|FG000|STARTED|Washout Period of at Least 14 Days||15||
60075422|NCT02505919|76190747|FG000|STARTED|1 Month Follow-Up||116||
60075423|NCT02505919|76190748|FG001|STARTED|1 Month Follow-Up||65||
60075424|NCT02505919|76190747|FG000|COMPLETED|1 Month Follow-Up||116||
60075425|NCT02505919|76190748|FG001|COMPLETED|1 Month Follow-Up||65||
60075426|NCT02505919|76190747|FG000|NOT COMPLETED|1 Month Follow-Up||0||
59529366|NCT01149785|75625667|FG001|STARTED|Washout Period of at Least 14 Days||0||
59529367|NCT01149785|75625666|FG000|COMPLETED|Washout Period of at Least 14 Days||15||
59529368|NCT01149785|75625667|FG001|COMPLETED|Washout Period of at Least 14 Days||0||
59529369|NCT01149785|75625666|FG000|NOT COMPLETED|Washout Period of at Least 14 Days||0||
59529370|NCT01149785|75625667|FG001|NOT COMPLETED|Washout Period of at Least 14 Days||0||
59529371|NCT01149785|75625666|FG000|STARTED|Second Intervention||0||
59529372|NCT01149785|75625667|FG001|STARTED|Second Intervention||15||
59529373|NCT01149785|75625666|FG000|COMPLETED|Second Intervention||0||
59529374|NCT01149785|75625667|FG001|COMPLETED|Second Intervention||15||
59529375|NCT01149785|75625666|FG000|NOT COMPLETED|Second Intervention||0||
59529376|NCT01149785|75625667|FG001|NOT COMPLETED|Second Intervention||0||
59529377|NCT02182115|75625675|FG000|STARTED|Overall Study||53||
59529378|NCT02182115|75625676|FG001|STARTED|Overall Study||57||
59529379|NCT02182115|75625675|FG000|COMPLETED|Overall Study||53||
59529380|NCT02182115|75625676|FG001|COMPLETED|Overall Study||57||
59529381|NCT02182115|75625675|FG000|NOT COMPLETED|Overall Study||0||
59529382|NCT02182115|75625676|FG001|NOT COMPLETED|Overall Study||0||
59529383|NCT01151189|75625684|FG000|STARTED|Overall Study||326||
59529384|NCT01151189|75625685|FG001|STARTED|Overall Study||324||
59529385|NCT01151189|75625684|FG000|Received Vaccine|Overall Study||325||
59529386|NCT01151189|75625685|FG001|Received Vaccine|Overall Study||324||
59529387|NCT01151189|75625684|FG000|COMPLETED|Overall Study||311||
59529388|NCT01151189|75625685|FG001|COMPLETED|Overall Study||314||
59529389|NCT01151189|75625684|FG000|NOT COMPLETED|Overall Study||15||
59529390|NCT01151189|75625685|FG001|NOT COMPLETED|Overall Study||10||
60075427|NCT02505919|76190748|FG001|NOT COMPLETED|1 Month Follow-Up||0||
60075428|NCT02505919|76190747|FG000|STARTED|3 Months Follow-Up||116||
59529391|NCT01173029|75625693|FG000|STARTED|Overall Study||61||
59529392|NCT01173029|75625694|FG001|STARTED|Overall Study||31||
59529393|NCT01173029|75625693|FG000|COMPLETED|Overall Study||61||
59529394|NCT01173029|75625694|FG001|COMPLETED|Overall Study||31||
59529395|NCT01173029|75625693|FG000|NOT COMPLETED|Overall Study||0||
59529396|NCT01173029|75625694|FG001|NOT COMPLETED|Overall Study||0||
59529397|NCT01174823|75625711|FG000|STARTED|Overall Study||122||
59529398|NCT01174823|75625712|FG001|STARTED|Overall Study||123||
59529399|NCT01174823|75625711|FG000|COMPLETED|Overall Study||115||
59529400|NCT01174823|75625712|FG001|COMPLETED|Overall Study||119||
59529401|NCT01174823|75625711|FG000|NOT COMPLETED|Overall Study||7||
59529402|NCT01174823|75625712|FG001|NOT COMPLETED|Overall Study||4||
59529403|NCT01151813|75625718|FG000|STARTED|Period 1||8||
59529404|NCT01151813|75625719|FG001|STARTED|Period 1||7||
59529405|NCT01151813|75625718|FG000|COMPLETED|Period 1||8||
59529406|NCT01151813|75625719|FG001|COMPLETED|Period 1||7||
59529407|NCT01151813|75625718|FG000|NOT COMPLETED|Period 1||0||
59529408|NCT01151813|75625719|FG001|NOT COMPLETED|Period 1||0||
59529409|NCT01151813|75625718|FG000|STARTED|Period 2||8||
59529410|NCT01151813|75625719|FG001|STARTED|Period 2||7||
59529411|NCT01151813|75625718|FG000|COMPLETED|Period 2||8||
59529412|NCT01151813|75625719|FG001|COMPLETED|Period 2||7||
59529413|NCT01151813|75625718|FG000|NOT COMPLETED|Period 2||0||
59529414|NCT01151813|75625719|FG001|NOT COMPLETED|Period 2||0||
59529415|NCT01175369|75625728|FG000|STARTED|Overall Study||265||
59529416|NCT01175369|75625729|FG001|STARTED|Overall Study||265||
59529417|NCT01175369|75625728|FG000|COMPLETED|Overall Study||263||
59529418|NCT01175369|75625729|FG001|COMPLETED|Overall Study||260||
59529419|NCT01175369|75625728|FG000|NOT COMPLETED|Overall Study||2||
59529420|NCT01175369|75625729|FG001|NOT COMPLETED|Overall Study||5||
59529421|NCT01176617|75625737|FG000|STARTED|1 - 6 Months (Ron-randomized)||0||
59529422|NCT01176617|75625738|FG001|STARTED|1 - 6 Months (Ron-randomized)||0||
59529423|NCT01176617|75625739|FG002|STARTED|1 - 6 Months (Ron-randomized)||38||
59529424|NCT01176617|75625737|FG000|COMPLETED|1 - 6 Months (Ron-randomized)||0||
59529425|NCT01176617|75625738|FG001|COMPLETED|1 - 6 Months (Ron-randomized)||0||
59529426|NCT01176617|75625739|FG002|COMPLETED|1 - 6 Months (Ron-randomized)||38||
59529427|NCT01176617|75625737|FG000|NOT COMPLETED|1 - 6 Months (Ron-randomized)||0||
59529428|NCT01176617|75625738|FG001|NOT COMPLETED|1 - 6 Months (Ron-randomized)||0||
59529429|NCT01176617|75625739|FG002|NOT COMPLETED|1 - 6 Months (Ron-randomized)||0||
59529430|NCT01176617|75625737|FG000|STARTED|6 - 12 Months (Randomized)||18||
59529431|NCT01176617|75625738|FG001|STARTED|6 - 12 Months (Randomized)||20||
59529432|NCT01176617|75625739|FG002|STARTED|6 - 12 Months (Randomized)||0||
59529433|NCT01176617|75625737|FG000|COMPLETED|6 - 12 Months (Randomized)||13||
59529434|NCT01176617|75625738|FG001|COMPLETED|6 - 12 Months (Randomized)||20||
59529435|NCT01176617|75625739|FG002|COMPLETED|6 - 12 Months (Randomized)||0||
59529436|NCT01176617|75625737|FG000|NOT COMPLETED|6 - 12 Months (Randomized)||5||
59529437|NCT01176617|75625738|FG001|NOT COMPLETED|6 - 12 Months (Randomized)||0||
59529438|NCT01176617|75625739|FG002|NOT COMPLETED|6 - 12 Months (Randomized)||0||
59529439|NCT01177709|75625747|FG000|STARTED|Overall Study||12||
59529440|NCT01177709|75625747|FG000|COMPLETED|Overall Study||12||
59529441|NCT01177709|75625747|FG000|NOT COMPLETED|Overall Study||0||
59529442|NCT01178333|75625754|FG000|STARTED|Overall Study||71||
59529443|NCT01178333|75625755|FG001|STARTED|Overall Study||284||
59529444|NCT01178333|75625756|FG002|STARTED|Overall Study||87||
59529445|NCT01178333|75625754|FG000|COMPLETED|Overall Study||71||
59529446|NCT01178333|75625755|FG001|COMPLETED|Overall Study||284||
59529447|NCT01178333|75625756|FG002|COMPLETED|Overall Study||87||
59529448|NCT01178333|75625754|FG000|NOT COMPLETED|Overall Study||0||
59529449|NCT01178333|75625755|FG001|NOT COMPLETED|Overall Study||0||
59529450|NCT01178333|75625756|FG002|NOT COMPLETED|Overall Study||0||
59529451|NCT01179113|75625768|FG000|STARTED|Overall Study||17||
59529452|NCT01179113|75625769|FG001|STARTED|Overall Study||16||
59529453|NCT01179113|75625768|FG000|COMPLETED|Overall Study||17||
59529454|NCT01179113|75625769|FG001|COMPLETED|Overall Study||16||
59529455|NCT01179113|75625768|FG000|NOT COMPLETED|Overall Study||0||
59529456|NCT01179113|75625769|FG001|NOT COMPLETED|Overall Study||0||
59529457|NCT01152359|75625777|FG000|STARTED|Overall Study||105||
59529458|NCT01152359|75625778|FG001|STARTED|Overall Study||102||
59529459|NCT01152359|75625777|FG000|COMPLETED|Overall Study||81||
59529460|NCT01152359|75625778|FG001|COMPLETED|Overall Study||80||
59529461|NCT01152359|75625777|FG000|NOT COMPLETED|Overall Study||24||
59529462|NCT01152359|75625778|FG001|NOT COMPLETED|Overall Study||22||
59529463|NCT01152515|75625786|FG000|STARTED|Overall Study||25||
59529464|NCT01152515|75625787|FG001|STARTED|Overall Study||25||
59529465|NCT01152515|75625786|FG000|COMPLETED|Overall Study||25||
59529466|NCT01152515|75625787|FG001|COMPLETED|Overall Study||25||
59529467|NCT01152515|75625786|FG000|NOT COMPLETED|Overall Study||0||
59529468|NCT01152515|75625787|FG001|NOT COMPLETED|Overall Study||0||
59529469|NCT01153685|75625795|FG000|STARTED|Overall Study||50||
59529470|NCT01153685|75625796|FG001|STARTED|Overall Study||70||
59529471|NCT01153685|75625795|FG000|COMPLETED|Overall Study||50||
59529472|NCT01153685|75625796|FG001|COMPLETED|Overall Study||70||
59529473|NCT01153685|75625795|FG000|NOT COMPLETED|Overall Study||0||
59529474|NCT01153685|75625796|FG001|NOT COMPLETED|Overall Study||0||
59529475|NCT01154699|75625804|FG000|STARTED|First Intervention (4 Weeks)||13||
59529476|NCT01154699|75625805|FG001|STARTED|First Intervention (4 Weeks)||8||
59529477|NCT01154699|75625804|FG000|Subjects With Asthma Only|First Intervention (4 Weeks)||7|The number of subjects who had asthma but NOT OSA in each arm|
59529478|NCT01154699|75625805|FG001|Subjects With Asthma Only|First Intervention (4 Weeks)||6|The number of subjects who had asthma but NOT OSA in each arm|
59529479|NCT01154699|75625804|FG000|Subjects With Asthma + OSA|First Intervention (4 Weeks)||6|The number of subjects who had asthma and OSA in each arm|
59529480|NCT01154699|75625805|FG001|Subjects With Asthma + OSA|First Intervention (4 Weeks)||2|The number of subjects who had asthma and OSA in each arm|
59529481|NCT01154699|75625804|FG000|COMPLETED|First Intervention (4 Weeks)||13||
59529482|NCT01154699|75625805|FG001|COMPLETED|First Intervention (4 Weeks)||8||
59529483|NCT01154699|75625804|FG000|NOT COMPLETED|First Intervention (4 Weeks)||0||
59529484|NCT01154699|75625805|FG001|NOT COMPLETED|First Intervention (4 Weeks)||0||
59529485|NCT01154699|75625804|FG000|STARTED|Washout Period (4 Weeks)||13||
59529486|NCT01154699|75625805|FG001|STARTED|Washout Period (4 Weeks)||8||
59529487|NCT01154699|75625804|FG000|Subjects With Asthma Only|Washout Period (4 Weeks)||7||
59529488|NCT01154699|75625805|FG001|Subjects With Asthma Only|Washout Period (4 Weeks)||6||
59529489|NCT01154699|75625804|FG000|Subjects With Asthma + OSA|Washout Period (4 Weeks)||6||
59529490|NCT01154699|75625805|FG001|Subjects With Asthma + OSA|Washout Period (4 Weeks)||2||
59529491|NCT01154699|75625804|FG000|COMPLETED|Washout Period (4 Weeks)||13||
59529492|NCT01154699|75625805|FG001|COMPLETED|Washout Period (4 Weeks)||8||
59529493|NCT01154699|75625804|FG000|NOT COMPLETED|Washout Period (4 Weeks)||0||
59529494|NCT01154699|75625805|FG001|NOT COMPLETED|Washout Period (4 Weeks)||0||
59529495|NCT01154699|75625804|FG000|STARTED|Second Intervention||13||
59529496|NCT01154699|75625805|FG001|STARTED|Second Intervention||8||
59529497|NCT01154699|75625804|FG000|Subjects With Asthma Only|Second Intervention||7||
59529498|NCT01154699|75625805|FG001|Subjects With Asthma Only|Second Intervention||6||
59529499|NCT01154699|75625804|FG000|Subjects With Asthma + OSA|Second Intervention||6||
59529500|NCT01154699|75625805|FG001|Subjects With Asthma + OSA|Second Intervention||2||
59529501|NCT01154699|75625804|FG000|COMPLETED|Second Intervention||13||
59529502|NCT01154699|75625805|FG001|COMPLETED|Second Intervention||8||
59529503|NCT01154699|75625804|FG000|NOT COMPLETED|Second Intervention||0||
59529504|NCT01154699|75625805|FG001|NOT COMPLETED|Second Intervention||0||
59529505|NCT01180127|75625817|FG000|STARTED|Overall Study||10||
59529506|NCT01180127|75625818|FG001|STARTED|Overall Study||11||
59529507|NCT01180127|75625819|FG002|STARTED|Overall Study||10||
59529508|NCT01180127|75625820|FG003|STARTED|Overall Study||10||
59529509|NCT01180127|75625817|FG000|COMPLETED|Overall Study||8||
59529510|NCT01180127|75625818|FG001|COMPLETED|Overall Study||11||
59529511|NCT01180127|75625819|FG002|COMPLETED|Overall Study||9||
59529512|NCT01180127|75625820|FG003|COMPLETED|Overall Study||9||
59529513|NCT01180127|75625817|FG000|NOT COMPLETED|Overall Study||2||
59529514|NCT01180127|75625818|FG001|NOT COMPLETED|Overall Study||0||
59529515|NCT01180127|75625819|FG002|NOT COMPLETED|Overall Study||1||
59529516|NCT01180127|75625820|FG003|NOT COMPLETED|Overall Study||1||
59529517|NCT01156571|75625836|FG000|STARTED|Overall Study|ITT: defined as all patients randomized.|5581||
59529518|NCT01156571|75625837|FG001|STARTED|Overall Study|ITT: defined as all patients randomized.|5564||
59529519|NCT01156571|75625836|FG000|COMPLETED|Overall Study|Completed = ITT patients who completed scheduled visits or developed a primary endpoint event|5564||
59529520|NCT01156571|75625837|FG001|COMPLETED|Overall Study|Completed = ITT patients who completed scheduled visits or developed a primary endpoint event|5545||
59529521|NCT01156571|75625836|FG000|NOT COMPLETED|Overall Study||17||
59529522|NCT01156571|75625837|FG001|NOT COMPLETED|Overall Study||19||
59529523|NCT01220687|75625845|FG000|STARTED|Overall Study||16||
59529524|NCT01220687|75625846|FG001|STARTED|Overall Study||15||
59529525|NCT01220687|75625845|FG000|COMPLETED|Overall Study||14||
59529526|NCT01220687|75625846|FG001|COMPLETED|Overall Study||14||
59529527|NCT01220687|75625845|FG000|NOT COMPLETED|Overall Study||2||
59529528|NCT01220687|75625846|FG001|NOT COMPLETED|Overall Study||1||
59529529|NCT01156805|75625854|FG000|STARTED|Overall Study||237||
59529530|NCT01156805|75625855|FG001|STARTED|Overall Study||272||
59529531|NCT01156805|75625854|FG000|COMPLETED|Overall Study||181||
59529532|NCT01156805|75625855|FG001|COMPLETED|Overall Study||216||
59529533|NCT01156805|75625854|FG000|NOT COMPLETED|Overall Study||56||
59529534|NCT01156805|75625855|FG001|NOT COMPLETED|Overall Study||56||
59529535|NCT02531802|75625882|FG000|STARTED|Received Vaccination 1||15||
59529536|NCT02531802|75625883|FG001|STARTED|Received Vaccination 1||15||
59529537|NCT02531802|75625884|FG002|STARTED|Received Vaccination 1||15||
59529538|NCT02531802|75625885|FG003|STARTED|Received Vaccination 1||15||
59529539|NCT02531802|75625886|FG004|STARTED|Received Vaccination 1||15||
59529540|NCT02531802|75625887|FG005|STARTED|Received Vaccination 1||3||
59529541|NCT02531802|75625888|FG006|STARTED|Received Vaccination 1||15||
59529542|NCT02531802|75625889|FG007|STARTED|Received Vaccination 1||15||
59529543|NCT02531802|75625890|FG008|STARTED|Received Vaccination 1||15||
59529544|NCT02531802|75625891|FG009|STARTED|Received Vaccination 1||52||
59529545|NCT02531802|75625892|FG010|STARTED|Received Vaccination 1||15||
59529546|NCT02531802|75625893|FG011|STARTED|Received Vaccination 1||15||
59529547|NCT02531802|75625894|FG012|STARTED|Received Vaccination 1||15||
59529548|NCT02531802|75625895|FG013|STARTED|Received Vaccination 1||15||
59529549|NCT02531802|75625896|FG014|STARTED|Received Vaccination 1||40||
59529550|NCT02531802|75625897|FG015|STARTED|Received Vaccination 1||30||
59529551|NCT02531802|75625898|FG016|STARTED|Received Vaccination 1||30||
59529552|NCT02531802|75625899|FG017|STARTED|Received Vaccination 1||30||
59529553|NCT02531802|75625900|FG018|STARTED|Received Vaccination 1||30||
59529554|NCT02531802|75625901|FG019|STARTED|Received Vaccination 1||30||
59529555|NCT02531802|75625902|FG020|STARTED|Received Vaccination 1||50||
59529556|NCT02531802|75625882|FG000|COMPLETED|Received Vaccination 1||15||
59529557|NCT02531802|75625883|FG001|COMPLETED|Received Vaccination 1||15||
59529558|NCT02531802|75625884|FG002|COMPLETED|Received Vaccination 1||15||
59529559|NCT02531802|75625885|FG003|COMPLETED|Received Vaccination 1||15||
59529560|NCT02531802|75625886|FG004|COMPLETED|Received Vaccination 1||15||
59529561|NCT02531802|75625887|FG005|COMPLETED|Received Vaccination 1||3||
59529562|NCT02531802|75625888|FG006|COMPLETED|Received Vaccination 1||15||
59529563|NCT02531802|75625889|FG007|COMPLETED|Received Vaccination 1||15||
59529564|NCT02531802|75625890|FG008|COMPLETED|Received Vaccination 1||15||
59529565|NCT02531802|75625891|FG009|COMPLETED|Received Vaccination 1||52||
59529566|NCT02531802|75625892|FG010|COMPLETED|Received Vaccination 1||15||
59529567|NCT02531802|75625893|FG011|COMPLETED|Received Vaccination 1||15||
59529568|NCT02531802|75625894|FG012|COMPLETED|Received Vaccination 1||15||
59529569|NCT02531802|75625895|FG013|COMPLETED|Received Vaccination 1||15||
59529570|NCT02531802|75625896|FG014|COMPLETED|Received Vaccination 1||40||
59529571|NCT02531802|75625897|FG015|COMPLETED|Received Vaccination 1||30||
59529572|NCT02531802|75625898|FG016|COMPLETED|Received Vaccination 1||30||
59529573|NCT02531802|75625899|FG017|COMPLETED|Received Vaccination 1||30||
59529574|NCT02531802|75625900|FG018|COMPLETED|Received Vaccination 1||30||
59529575|NCT02531802|75625901|FG019|COMPLETED|Received Vaccination 1||30||
59529576|NCT02531802|75625902|FG020|COMPLETED|Received Vaccination 1||50||
59529577|NCT02531802|75625882|FG000|NOT COMPLETED|Received Vaccination 1||0||
59529578|NCT02531802|75625883|FG001|NOT COMPLETED|Received Vaccination 1||0||
59529579|NCT02531802|75625884|FG002|NOT COMPLETED|Received Vaccination 1||0||
59529580|NCT02531802|75625885|FG003|NOT COMPLETED|Received Vaccination 1||0||
59529581|NCT02531802|75625886|FG004|NOT COMPLETED|Received Vaccination 1||0||
59529582|NCT02531802|75625887|FG005|NOT COMPLETED|Received Vaccination 1||0||
59529583|NCT02531802|75625888|FG006|NOT COMPLETED|Received Vaccination 1||0||
59529584|NCT02531802|75625889|FG007|NOT COMPLETED|Received Vaccination 1||0||
59529585|NCT02531802|75625890|FG008|NOT COMPLETED|Received Vaccination 1||0||
59529586|NCT02531802|75625891|FG009|NOT COMPLETED|Received Vaccination 1||0||
59529587|NCT02531802|75625892|FG010|NOT COMPLETED|Received Vaccination 1||0||
59529588|NCT02531802|75625893|FG011|NOT COMPLETED|Received Vaccination 1||0||
59529589|NCT02531802|75625894|FG012|NOT COMPLETED|Received Vaccination 1||0||
59529590|NCT02531802|75625895|FG013|NOT COMPLETED|Received Vaccination 1||0||
59529591|NCT02531802|75625896|FG014|NOT COMPLETED|Received Vaccination 1||0||
59529592|NCT02531802|75625897|FG015|NOT COMPLETED|Received Vaccination 1||0||
59529593|NCT02531802|75625898|FG016|NOT COMPLETED|Received Vaccination 1||0||
59529594|NCT02531802|75625899|FG017|NOT COMPLETED|Received Vaccination 1||0||
59529595|NCT02531802|75625900|FG018|NOT COMPLETED|Received Vaccination 1||0||
59529596|NCT02531802|75625901|FG019|NOT COMPLETED|Received Vaccination 1||0||
59529597|NCT02531802|75625902|FG020|NOT COMPLETED|Received Vaccination 1||0||
59529598|NCT02531802|75625882|FG000|STARTED|Received Vaccination 2||15||
59529599|NCT02531802|75625883|FG001|STARTED|Received Vaccination 2||15||
59529600|NCT02531802|75625884|FG002|STARTED|Received Vaccination 2||15||
59529601|NCT02531802|75625885|FG003|STARTED|Received Vaccination 2||15||
59529602|NCT02531802|75625886|FG004|STARTED|Received Vaccination 2||15||
59529603|NCT02531802|75625887|FG005|STARTED|Received Vaccination 2||3||
59529604|NCT02531802|75625888|FG006|STARTED|Received Vaccination 2||15||
59529605|NCT02531802|75625889|FG007|STARTED|Received Vaccination 2||15||
59529606|NCT02531802|75625890|FG008|STARTED|Received Vaccination 2||15||
59529607|NCT02531802|75625891|FG009|STARTED|Received Vaccination 2||52||
59529608|NCT02531802|75625892|FG010|STARTED|Received Vaccination 2||15||
59529609|NCT02531802|75625893|FG011|STARTED|Received Vaccination 2||15||
59529610|NCT02531802|75625894|FG012|STARTED|Received Vaccination 2||15||
59529611|NCT02531802|75625895|FG013|STARTED|Received Vaccination 2||15||
59529612|NCT02531802|75625896|FG014|STARTED|Received Vaccination 2||40||
59529613|NCT02531802|75625897|FG015|STARTED|Received Vaccination 2||30||
59529614|NCT02531802|75625898|FG016|STARTED|Received Vaccination 2||30||
59529615|NCT02531802|75625899|FG017|STARTED|Received Vaccination 2||30||
59529616|NCT02531802|75625900|FG018|STARTED|Received Vaccination 2||30||
59529617|NCT02531802|75625901|FG019|STARTED|Received Vaccination 2||30||
59529618|NCT02531802|75625902|FG020|STARTED|Received Vaccination 2||50||
59529619|NCT02531802|75625882|FG000|COMPLETED|Received Vaccination 2||15||
59529620|NCT02531802|75625883|FG001|COMPLETED|Received Vaccination 2||15||
59529621|NCT02531802|75625884|FG002|COMPLETED|Received Vaccination 2||14||
59529622|NCT02531802|75625885|FG003|COMPLETED|Received Vaccination 2||15||
59529623|NCT02531802|75625886|FG004|COMPLETED|Received Vaccination 2||15||
59529624|NCT02531802|75625887|FG005|COMPLETED|Received Vaccination 2||0||
59529625|NCT02531802|75625888|FG006|COMPLETED|Received Vaccination 2||15||
59529626|NCT02531802|75625889|FG007|COMPLETED|Received Vaccination 2||15||
59529627|NCT02531802|75625890|FG008|COMPLETED|Received Vaccination 2||15||
59529628|NCT02531802|75625891|FG009|COMPLETED|Received Vaccination 2||49||
59529629|NCT02531802|75625892|FG010|COMPLETED|Received Vaccination 2||13||
59529630|NCT02531802|75625893|FG011|COMPLETED|Received Vaccination 2||15||
59529631|NCT02531802|75625894|FG012|COMPLETED|Received Vaccination 2||13||
59529632|NCT02531802|75625895|FG013|COMPLETED|Received Vaccination 2||13||
59529633|NCT02531802|75625896|FG014|COMPLETED|Received Vaccination 2||39||
59529634|NCT02531802|75625897|FG015|COMPLETED|Received Vaccination 2||30||
59529635|NCT02531802|75625898|FG016|COMPLETED|Received Vaccination 2||30||
59529636|NCT02531802|75625899|FG017|COMPLETED|Received Vaccination 2||26||
59529637|NCT02531802|75625900|FG018|COMPLETED|Received Vaccination 2||27||
59529638|NCT02531802|75625901|FG019|COMPLETED|Received Vaccination 2||29||
59529639|NCT02531802|75625902|FG020|COMPLETED|Received Vaccination 2||49||
59529640|NCT02531802|75625882|FG000|NOT COMPLETED|Received Vaccination 2||0||
59529641|NCT02531802|75625883|FG001|NOT COMPLETED|Received Vaccination 2||0||
59529642|NCT02531802|75625884|FG002|NOT COMPLETED|Received Vaccination 2||1||
59529643|NCT02531802|75625885|FG003|NOT COMPLETED|Received Vaccination 2||0||
59529644|NCT02531802|75625886|FG004|NOT COMPLETED|Received Vaccination 2||0||
59529645|NCT02531802|75625887|FG005|NOT COMPLETED|Received Vaccination 2||3||
59529646|NCT02531802|75625888|FG006|NOT COMPLETED|Received Vaccination 2||0||
59529647|NCT02531802|75625889|FG007|NOT COMPLETED|Received Vaccination 2||0||
59529648|NCT02531802|75625890|FG008|NOT COMPLETED|Received Vaccination 2||0||
59529649|NCT02531802|75625891|FG009|NOT COMPLETED|Received Vaccination 2||3||
59529650|NCT02531802|75625892|FG010|NOT COMPLETED|Received Vaccination 2||2||
59529651|NCT02531802|75625893|FG011|NOT COMPLETED|Received Vaccination 2||0||
59529652|NCT02531802|75625894|FG012|NOT COMPLETED|Received Vaccination 2||2||
59529653|NCT02531802|75625895|FG013|NOT COMPLETED|Received Vaccination 2||2||
59529654|NCT02531802|75625896|FG014|NOT COMPLETED|Received Vaccination 2||1||
59529655|NCT02531802|75625897|FG015|NOT COMPLETED|Received Vaccination 2||0||
59529656|NCT02531802|75625898|FG016|NOT COMPLETED|Received Vaccination 2||0||
59529657|NCT02531802|75625899|FG017|NOT COMPLETED|Received Vaccination 2||4||
59529658|NCT02531802|75625900|FG018|NOT COMPLETED|Received Vaccination 2||3||
59529659|NCT02531802|75625901|FG019|NOT COMPLETED|Received Vaccination 2||1||
59529660|NCT02531802|75625902|FG020|NOT COMPLETED|Received Vaccination 2||1||
59529661|NCT01157429|75625977|FG000|STARTED|Overall Study||12||
59529662|NCT01157429|75625978|FG001|STARTED|Overall Study||12||
59529663|NCT01157429|75625977|FG000|COMPLETED|Overall Study||8||
59529664|NCT01157429|75625978|FG001|COMPLETED|Overall Study||8||
59529665|NCT01157429|75625977|FG000|NOT COMPLETED|Overall Study||4||
59529666|NCT01157429|75625978|FG001|NOT COMPLETED|Overall Study||4||
59529667|NCT01158521|75625984|FG000|STARTED|Overall Study||25||
59529668|NCT01158521|75625984|FG000|COMPLETED|Overall Study||25||
59529669|NCT01158521|75625984|FG000|NOT COMPLETED|Overall Study||0||
59529670|NCT01221311|75625992|FG000|STARTED|Overall Study||57||
59529671|NCT01221311|75625993|FG001|STARTED|Overall Study||55||
59529672|NCT01221311|75625992|FG000|COMPLETED|Overall Study||57||
59529673|NCT01221311|75625993|FG001|COMPLETED|Overall Study||55||
59529674|NCT01221311|75625992|FG000|NOT COMPLETED|Overall Study||0||
59529675|NCT01221311|75625993|FG001|NOT COMPLETED|Overall Study||0||
59529676|NCT00234884|75625999|FG000|STARTED|Overall Study||3435||
59529677|NCT00234884|75625999|FG000|COMPLETED|Overall Study||1805||
59529678|NCT00234884|75625999|FG000|NOT COMPLETED|Overall Study||1630||
59529679|NCT01602666|75626005|FG000|STARTED|Induction Chemotherapy||107||
59529680|NCT01602666|75626006|FG001|STARTED|Induction Chemotherapy||137||
59529681|NCT01602666|75626005|FG000|COMPLETED|Induction Chemotherapy||70||
59529682|NCT01602666|75626006|FG001|COMPLETED|Induction Chemotherapy||113||
59529683|NCT01602666|75626005|FG000|NOT COMPLETED|Induction Chemotherapy||37||
59529684|NCT01602666|75626006|FG001|NOT COMPLETED|Induction Chemotherapy||24||
59529685|NCT01602666|75626005|FG000|STARTED|Radiation Therapy on Protocol||70||
59529686|NCT01602666|75626006|FG001|STARTED|Radiation Therapy on Protocol||113||
59529687|NCT01602666|75626005|FG000|Evaluable for Reduced Dose (30Gy)|Radiation Therapy on Protocol||66||
59529688|NCT01602666|75626006|FG001|Evaluable for Reduced Dose (30Gy)|Radiation Therapy on Protocol||0||
59529689|NCT01602666|75626005|FG000|Evaluable for Reduced Dose (18 Gy)|Radiation Therapy on Protocol||0||
59529690|NCT01602666|75626006|FG001|Evaluable for Reduced Dose (18 Gy)|Radiation Therapy on Protocol||74||
59529691|NCT01602666|75626005|FG000|Evaluable for RT Dose (24Gy)|Radiation Therapy on Protocol||0||
59529692|NCT01602666|75626006|FG001|Evaluable for RT Dose (24Gy)|Radiation Therapy on Protocol||16||
59529693|NCT01602666|75626005|FG000|COMPLETED|Radiation Therapy on Protocol||60||
59529694|NCT01602666|75626006|FG001|COMPLETED|Radiation Therapy on Protocol||82||
59529695|NCT01602666|75626005|FG000|NOT COMPLETED|Radiation Therapy on Protocol||10||
59529696|NCT01602666|75626006|FG001|NOT COMPLETED|Radiation Therapy on Protocol||31||
59529697|NCT02531646|75626017|FG000|STARTED|Overall Study||37||
59529698|NCT02531646|75626018|FG001|STARTED|Overall Study||18||
59529699|NCT02531646|75626019|FG002|STARTED|Overall Study||11||
59529700|NCT02531646|75626017|FG000|COMPLETED|Overall Study||32||
59529701|NCT02531646|75626018|FG001|COMPLETED|Overall Study||17||
59529702|NCT02531646|75626019|FG002|COMPLETED|Overall Study||11||
59529703|NCT02531646|75626017|FG000|NOT COMPLETED|Overall Study||5||
59529704|NCT02531646|75626018|FG001|NOT COMPLETED|Overall Study||1||
59529705|NCT02531646|75626019|FG002|NOT COMPLETED|Overall Study||0||
59529706|NCT00300482|75626033|FG000|STARTED|Overall Study|"For all arms, started means treated."|261||
59529707|NCT00300482|75626034|FG001|STARTED|Overall Study||261||
59529708|NCT00300482|75626035|FG002|STARTED|Overall Study||259||
59529709|NCT00300482|75626036|FG003|STARTED|Overall Study||261||
59529710|NCT00300482|75626037|FG004|STARTED|Overall Study||266||
59529711|NCT00300482|75626038|FG005|STARTED|Overall Study||131||
59529712|NCT00300482|75626033|FG000|COMPLETED|Overall Study||220||
59529713|NCT00300482|75626034|FG001|COMPLETED|Overall Study||220||
59529714|NCT00300482|75626035|FG002|COMPLETED|Overall Study||208||
59529715|NCT00300482|75626036|FG003|COMPLETED|Overall Study||237||
59529716|NCT00300482|75626037|FG004|COMPLETED|Overall Study||243||
59529717|NCT00300482|75626038|FG005|COMPLETED|Overall Study||115||
59529718|NCT00300482|75626033|FG000|NOT COMPLETED|Overall Study||41||
59529719|NCT00300482|75626034|FG001|NOT COMPLETED|Overall Study||41||
59529720|NCT00300482|75626035|FG002|NOT COMPLETED|Overall Study||51||
59529721|NCT00300482|75626036|FG003|NOT COMPLETED|Overall Study||24||
59529722|NCT00300482|75626037|FG004|NOT COMPLETED|Overall Study||23||
59529723|NCT00300482|75626038|FG005|NOT COMPLETED|Overall Study||16||
59529724|NCT00301028|75626052|FG000|STARTED|Overall Study||47||
59529725|NCT00301028|75626052|FG000|COMPLETED|Overall Study||47||
59529726|NCT00301028|75626052|FG000|NOT COMPLETED|Overall Study||0||
59529727|NCT00301418|75626056|FG000|STARTED|Overall Study||11||
59529728|NCT00301418|75626056|FG000|COMPLETED|Overall Study||11||
59529729|NCT00301418|75626056|FG000|NOT COMPLETED|Overall Study||0||
59529730|NCT00302042|75626062|FG000|STARTED|Overall Study||46||
59529731|NCT00302042|75626063|FG001|STARTED|Overall Study||46||
59529732|NCT00302042|75626062|FG000|COMPLETED|Overall Study||39||
59529733|NCT00302042|75626063|FG001|COMPLETED|Overall Study||38||
59529734|NCT00302042|75626062|FG000|NOT COMPLETED|Overall Study||7||
59529735|NCT00302042|75626063|FG001|NOT COMPLETED|Overall Study||8||
59529736|NCT00237770|75626071|FG000|STARTED|Overall Study||9||
59529737|NCT00237770|75626072|FG001|STARTED|Overall Study||7||
59529738|NCT00237770|75626071|FG000|COMPLETED|Overall Study||9||
59529739|NCT00237770|75626072|FG001|COMPLETED|Overall Study||7||
59529740|NCT00237770|75626071|FG000|NOT COMPLETED|Overall Study||0||
59529741|NCT00237770|75626072|FG001|NOT COMPLETED|Overall Study||0||
59529742|NCT02536404|75626084|FG000|STARTED|Overall Study||112||
59529743|NCT02536404|75626085|FG001|STARTED|Overall Study||6||
59529744|NCT02536404|75626084|FG000|COMPLETED|Overall Study||92||
59529745|NCT02536404|75626085|FG001|COMPLETED|Overall Study||5||
59529746|NCT02536404|75626084|FG000|NOT COMPLETED|Overall Study||20||
59529747|NCT02536404|75626085|FG001|NOT COMPLETED|Overall Study||1||
59529748|NCT01478581|75626095|FG000|STARTED|Overall Study||13||
59529749|NCT01478581|75626096|FG001|STARTED|Overall Study||18||
59529750|NCT01478581|75626097|FG002|STARTED|Overall Study||18||
59529751|NCT01478581|75626098|FG003|STARTED|Overall Study|Simon 2-stage design - cohort 4 expansion per stage 1 data (≥3 Clinical Benefit Responders observed|43||
59529752|NCT01478581|75626095|FG000|COMPLETED|Overall Study||13||
59529753|NCT01478581|75626096|FG001|COMPLETED|Overall Study||18||
59529754|NCT01478581|75626097|FG002|COMPLETED|Overall Study||18||
59529755|NCT01478581|75626098|FG003|COMPLETED|Overall Study||43||
59529756|NCT01478581|75626095|FG000|NOT COMPLETED|Overall Study||0||
59529757|NCT01478581|75626096|FG001|NOT COMPLETED|Overall Study||0||
59529758|NCT01478581|75626097|FG002|NOT COMPLETED|Overall Study||0||
59529759|NCT01478581|75626098|FG003|NOT COMPLETED|Overall Study||0||
59529760|NCT00239642|75626115|FG000|STARTED|Overall Study||49||
59529761|NCT00239642|75626116|FG001|STARTED|Overall Study||47||
59529762|NCT00239642|75626117|FG002|STARTED|Overall Study||49||
59529763|NCT00239642|75626115|FG000|COMPLETED|Overall Study||47||
59529764|NCT00239642|75626116|FG001|COMPLETED|Overall Study||47||
59529765|NCT00239642|75626117|FG002|COMPLETED|Overall Study||47||
59529766|NCT00239642|75626115|FG000|NOT COMPLETED|Overall Study||2||
59529767|NCT00239642|75626116|FG001|NOT COMPLETED|Overall Study||0||
59529768|NCT00239642|75626117|FG002|NOT COMPLETED|Overall Study||2||
59529769|NCT00241904|75626127|FG000|STARTED|Overall Study||261||
59529770|NCT00241904|75626128|FG001|STARTED|Overall Study||264||
59529771|NCT00241904|75626127|FG000|COMPLETED|Overall Study||227||
59529772|NCT00241904|75626128|FG001|COMPLETED|Overall Study||240||
59529773|NCT00241904|75626127|FG000|NOT COMPLETED|Overall Study||34||
59529774|NCT00241904|75626128|FG001|NOT COMPLETED|Overall Study||24||
59529775|NCT01479127|75626135|FG000|STARTED|Overall Study|started oral study drug (full safety sample)|8||
59529776|NCT01479127|75626135|FG000|Started LCIG|Overall Study||6||
59529777|NCT01479127|75626135|FG000|COMPLETED|Overall Study||5||
59529778|NCT01479127|75626135|FG000|NOT COMPLETED|Overall Study||3||
59529779|NCT00242684|75626143|FG000|STARTED|Overall Study||446||
59529780|NCT00242684|75626143|FG000|COMPLETED|Overall Study||446||
59622707|NCT00438204|75734594|FG000|NOT COMPLETED|Overall Study||0||
59529781|NCT00242684|75626143|FG000|NOT COMPLETED|Overall Study||0||
59622708|NCT00438750|75734601|FG000|STARTED|Overall Study||48||
59622709|NCT00438750|75734602|FG001|STARTED|Overall Study||46||
59815236|NCT05080179|75937680|FG000|STARTED|Overall Study||4232||
59529782|NCT00243152|75626147|FG000|STARTED|Overall Study||3||
59529783|NCT00243152|75626148|FG001|STARTED|Overall Study||3||
59529784|NCT00243152|75626147|FG000|Scan 1: Drug or Placebo|Overall Study||3||
59529785|NCT00243152|75626148|FG001|Scan 1: Drug or Placebo|Overall Study||3||
59529786|NCT00243152|75626147|FG000|Scan 2: Placebo or Drug|Overall Study||3||
59529787|NCT00243152|75626148|FG001|Scan 2: Placebo or Drug|Overall Study||3||
59529788|NCT00243152|75626147|FG000|COMPLETED|Overall Study||3||
59529789|NCT00243152|75626148|FG001|COMPLETED|Overall Study||3||
59529790|NCT00243152|75626147|FG000|NOT COMPLETED|Overall Study||0||
59529791|NCT00243152|75626148|FG001|NOT COMPLETED|Overall Study||0||
59529792|NCT01453075|75626157|FG000|STARTED|Overall Study||16||
59529793|NCT01453075|75626158|FG001|STARTED|Overall Study||15||
59529794|NCT01453075|75626157|FG000|COMPLETED|Overall Study||11||
59529795|NCT01453075|75626158|FG001|COMPLETED|Overall Study||14||
59529796|NCT01453075|75626157|FG000|NOT COMPLETED|Overall Study||5||
59529797|NCT01453075|75626158|FG001|NOT COMPLETED|Overall Study||1||
59529798|NCT00248534|75626164|FG000|STARTED|Overall Study||16||
59529799|NCT00248534|75626164|FG000|COMPLETED|Overall Study||16||
59529800|NCT00248534|75626164|FG000|NOT COMPLETED|Overall Study||0||
59529801|NCT00248612|75626172|FG000|STARTED|Overall Study||24||
59529802|NCT00248612|75626173|FG001|STARTED|Overall Study||21||
59529803|NCT00248612|75626174|FG002|STARTED|Overall Study||14||
59529804|NCT00248612|75626175|FG003|STARTED|Overall Study||22||
59529805|NCT00248612|75626172|FG000|COMPLETED|Overall Study||24||
59529806|NCT00248612|75626173|FG001|COMPLETED|Overall Study||21||
59529807|NCT00248612|75626174|FG002|COMPLETED|Overall Study||14||
59529808|NCT00248612|75626175|FG003|COMPLETED|Overall Study||22||
59529809|NCT00248612|75626172|FG000|NOT COMPLETED|Overall Study||0||
59529810|NCT00248612|75626173|FG001|NOT COMPLETED|Overall Study||0||
59529811|NCT00248612|75626174|FG002|NOT COMPLETED|Overall Study||0||
59529812|NCT00248612|75626175|FG003|NOT COMPLETED|Overall Study||0||
59529813|NCT00249470|75626189|FG000|STARTED|Overall Study||28||
59529814|NCT00249470|75626190|FG001|STARTED|Overall Study||28||
59529815|NCT00249470|75626189|FG000|COMPLETED|Overall Study||28||
59529816|NCT00249470|75626190|FG001|COMPLETED|Overall Study||28||
59529817|NCT00249470|75626189|FG000|NOT COMPLETED|Overall Study||0||
59529818|NCT00249470|75626190|FG001|NOT COMPLETED|Overall Study||0||
59529819|NCT00250484|75626198|FG000|STARTED|Overall Study||9||
59529820|NCT00250484|75626199|FG001|STARTED|Overall Study||8||
59529821|NCT00250484|75626198|FG000|COMPLETED|Overall Study||9||
59529822|NCT00250484|75626199|FG001|COMPLETED|Overall Study||8||
59529823|NCT00250484|75626198|FG000|NOT COMPLETED|Overall Study||0||
59529824|NCT00250484|75626199|FG001|NOT COMPLETED|Overall Study||0||
59529825|NCT00252512|75626207|FG000|STARTED|Intervention||165||
59529826|NCT00252512|75626208|FG001|STARTED|Intervention||165||
59529827|NCT00252512|75626207|FG000|COMPLETED|Intervention||136||
59529828|NCT00252512|75626208|FG001|COMPLETED|Intervention||134||
59529829|NCT00252512|75626207|FG000|NOT COMPLETED|Intervention||29||
59529830|NCT00252512|75626208|FG001|NOT COMPLETED|Intervention||31||
59529831|NCT00252512|75626207|FG000|STARTED|Six Month Follow up||136||
59529832|NCT00252512|75626208|FG001|STARTED|Six Month Follow up||134||
59529833|NCT00252512|75626207|FG000|COMPLETED|Six Month Follow up||132||
59529834|NCT00252512|75626208|FG001|COMPLETED|Six Month Follow up||122||
59529835|NCT00252512|75626207|FG000|NOT COMPLETED|Six Month Follow up||4||
59529836|NCT00252512|75626208|FG001|NOT COMPLETED|Six Month Follow up||12||
59529837|NCT00252512|75626207|FG000|STARTED|12 Month Follow up||132||
59529838|NCT00252512|75626208|FG001|STARTED|12 Month Follow up||122||
59529839|NCT00252512|75626207|FG000|COMPLETED|12 Month Follow up||123||
59529840|NCT00252512|75626208|FG001|COMPLETED|12 Month Follow up||121||
59529841|NCT00252512|75626207|FG000|NOT COMPLETED|12 Month Follow up||9||
59529842|NCT00252512|75626208|FG001|NOT COMPLETED|12 Month Follow up||1||
59529843|NCT00252590|75626217|FG000|STARTED|Overall Study||35||
59529844|NCT00252590|75626218|FG001|STARTED|Overall Study||30||
59529845|NCT00252590|75626219|FG002|STARTED|Overall Study||34||
59529846|NCT00252590|75626217|FG000|COMPLETED|Overall Study||33||
59529847|NCT00252590|75626218|FG001|COMPLETED|Overall Study||28||
59529848|NCT00252590|75626219|FG002|COMPLETED|Overall Study||31||
59529849|NCT00252590|75626217|FG000|NOT COMPLETED|Overall Study||2||
59529850|NCT00252590|75626218|FG001|NOT COMPLETED|Overall Study||2||
59529851|NCT00252590|75626219|FG002|NOT COMPLETED|Overall Study||3||
59529852|NCT01453387|75626229|FG000|STARTED|Overall Study||21||
59529853|NCT01453387|75626230|FG001|STARTED|Overall Study||7||
59529854|NCT01453387|75626229|FG000|COMPLETED|Overall Study||21||
59529855|NCT01453387|75626230|FG001|COMPLETED|Overall Study||7||
59529856|NCT01453387|75626229|FG000|NOT COMPLETED|Overall Study||0||
59529857|NCT01453387|75626230|FG001|NOT COMPLETED|Overall Study||0||
59529858|NCT02097992|75626257|FG000|STARTED|Treatment 1 (1 Day)||2||
59529859|NCT02097992|75626258|FG001|STARTED|Treatment 1 (1 Day)||3||
59529860|NCT02097992|75626259|FG002|STARTED|Treatment 1 (1 Day)||4||
59529861|NCT02097992|75626260|FG003|STARTED|Treatment 1 (1 Day)||2||
59529862|NCT02097992|75626257|FG000|COMPLETED|Treatment 1 (1 Day)||2||
59529863|NCT02097992|75626258|FG001|COMPLETED|Treatment 1 (1 Day)||3||
59529864|NCT02097992|75626259|FG002|COMPLETED|Treatment 1 (1 Day)||4||
59529865|NCT02097992|75626260|FG003|COMPLETED|Treatment 1 (1 Day)||2||
59529866|NCT02097992|75626257|FG000|NOT COMPLETED|Treatment 1 (1 Day)||0||
59529867|NCT02097992|75626258|FG001|NOT COMPLETED|Treatment 1 (1 Day)||0||
59529868|NCT02097992|75626259|FG002|NOT COMPLETED|Treatment 1 (1 Day)||0||
59529869|NCT02097992|75626260|FG003|NOT COMPLETED|Treatment 1 (1 Day)||0||
59529870|NCT02097992|75626257|FG000|STARTED|Treatment 2 (4 Weeks)||2||
59529871|NCT02097992|75626258|FG001|STARTED|Treatment 2 (4 Weeks)||3||
59529872|NCT02097992|75626259|FG002|STARTED|Treatment 2 (4 Weeks)||4||
59529873|NCT02097992|75626260|FG003|STARTED|Treatment 2 (4 Weeks)||2||
59529874|NCT02097992|75626257|FG000|COMPLETED|Treatment 2 (4 Weeks)||2||
59529875|NCT02097992|75626258|FG001|COMPLETED|Treatment 2 (4 Weeks)||3||
59529876|NCT02097992|75626259|FG002|COMPLETED|Treatment 2 (4 Weeks)||4||
59529877|NCT02097992|75626260|FG003|COMPLETED|Treatment 2 (4 Weeks)||2||
59529878|NCT02097992|75626257|FG000|NOT COMPLETED|Treatment 2 (4 Weeks)||0||
59529879|NCT02097992|75626258|FG001|NOT COMPLETED|Treatment 2 (4 Weeks)||0||
59529880|NCT02097992|75626259|FG002|NOT COMPLETED|Treatment 2 (4 Weeks)||0||
59529881|NCT02097992|75626260|FG003|NOT COMPLETED|Treatment 2 (4 Weeks)||0||
59529882|NCT02097992|75626257|FG000|STARTED|Washout (4 Weeks)||2||
59529883|NCT02097992|75626258|FG001|STARTED|Washout (4 Weeks)||3||
59529884|NCT02097992|75626259|FG002|STARTED|Washout (4 Weeks)||4||
59529885|NCT02097992|75626260|FG003|STARTED|Washout (4 Weeks)||2||
59529886|NCT02097992|75626257|FG000|COMPLETED|Washout (4 Weeks)||2||
59529887|NCT02097992|75626258|FG001|COMPLETED|Washout (4 Weeks)||3||
59529888|NCT02097992|75626259|FG002|COMPLETED|Washout (4 Weeks)||4||
59529889|NCT02097992|75626260|FG003|COMPLETED|Washout (4 Weeks)||2||
59529890|NCT02097992|75626257|FG000|NOT COMPLETED|Washout (4 Weeks)||0||
59529891|NCT02097992|75626258|FG001|NOT COMPLETED|Washout (4 Weeks)||0||
59529892|NCT02097992|75626259|FG002|NOT COMPLETED|Washout (4 Weeks)||0||
59529893|NCT02097992|75626260|FG003|NOT COMPLETED|Washout (4 Weeks)||0||
59529894|NCT02097992|75626257|FG000|STARTED|Treatment 3 (4 Weeks)||2||
59529895|NCT02097992|75626258|FG001|STARTED|Treatment 3 (4 Weeks)||3||
59529896|NCT02097992|75626259|FG002|STARTED|Treatment 3 (4 Weeks)||4||
59529897|NCT02097992|75626260|FG003|STARTED|Treatment 3 (4 Weeks)||2||
59529898|NCT02097992|75626257|FG000|COMPLETED|Treatment 3 (4 Weeks)||2||
59529899|NCT02097992|75626258|FG001|COMPLETED|Treatment 3 (4 Weeks)||3||
59529900|NCT02097992|75626259|FG002|COMPLETED|Treatment 3 (4 Weeks)||4||
59529901|NCT02097992|75626260|FG003|COMPLETED|Treatment 3 (4 Weeks)||2||
59529902|NCT02097992|75626257|FG000|NOT COMPLETED|Treatment 3 (4 Weeks)||0||
60075429|NCT02505919|76190748|FG001|STARTED|3 Months Follow-Up||65||
60075430|NCT02505919|76190747|FG000|COMPLETED|3 Months Follow-Up||116||
60075431|NCT02505919|76190748|FG001|COMPLETED|3 Months Follow-Up||65||
60075432|NCT02505919|76190747|FG000|NOT COMPLETED|3 Months Follow-Up||0||
60075433|NCT02505919|76190748|FG001|NOT COMPLETED|3 Months Follow-Up||0||
59529903|NCT02097992|75626258|FG001|NOT COMPLETED|Treatment 3 (4 Weeks)||0||
59529904|NCT02097992|75626259|FG002|NOT COMPLETED|Treatment 3 (4 Weeks)||0||
59529905|NCT02097992|75626260|FG003|NOT COMPLETED|Treatment 3 (4 Weeks)||0||
59529906|NCT02098304|75626268|FG000|STARTED|Overall Study||42||
59529907|NCT02098304|75626268|FG000|COMPLETED|Overall Study||42||
59529908|NCT02098304|75626268|FG000|NOT COMPLETED|Overall Study||0||
59529909|NCT01392625|75626276|FG000|STARTED|Overall Study||18||
59529910|NCT01392625|75626277|FG001|STARTED|Overall Study||19||
59529911|NCT01392625|75626276|FG000|COMPLETED|Overall Study||16||
59529912|NCT01392625|75626277|FG001|COMPLETED|Overall Study||18||
59529913|NCT01392625|75626276|FG000|NOT COMPLETED|Overall Study||2||
59529914|NCT01392625|75626277|FG001|NOT COMPLETED|Overall Study||1||
59529915|NCT01454791|75626285|FG000|STARTED|Overall Study||20||
59529916|NCT01454791|75626286|FG001|STARTED|Overall Study||20||
59529917|NCT01454791|75626285|FG000|COMPLETED|Overall Study|20 subjects started with Diclofenac, then switched to placebo|20||
59529918|NCT01454791|75626286|FG001|COMPLETED|Overall Study|20 subjects started with placebo, then switched to Diclofenac|20||
59529919|NCT01454791|75626285|FG000|NOT COMPLETED|Overall Study||0||
59529920|NCT01454791|75626286|FG001|NOT COMPLETED|Overall Study||0||
59529921|NCT02099006|75626294|FG000|STARTED|Overall Study||9||
59529922|NCT02099006|75626294|FG000|Received Placebo|Overall Study||9||
59815237|NCT05080179|75937681|FG001|STARTED|Overall Study||4246||
60075434|NCT02505919|76190747|FG000|STARTED|6 Months Follow-Up||116||
60075435|NCT02505919|76190748|FG001|STARTED|6 Months Follow-Up||65||
60075436|NCT02505919|76190747|FG000|COMPLETED|6 Months Follow-Up||116||
60075437|NCT02505919|76190748|FG001|COMPLETED|6 Months Follow-Up||63||
60075438|NCT02505919|76190747|FG000|NOT COMPLETED|6 Months Follow-Up||0||
60075439|NCT02505919|76190748|FG001|NOT COMPLETED|6 Months Follow-Up||2||
60075440|NCT02505919|76190747|FG000|STARTED|12 Months Follow-Up||116||
60075441|NCT02505919|76190748|FG001|STARTED|12 Months Follow-Up||63||
60075442|NCT02505919|76190747|FG000|COMPLETED|12 Months Follow-Up||115||
60075443|NCT02505919|76190748|FG001|COMPLETED|12 Months Follow-Up||61||
60075444|NCT02505919|76190747|FG000|NOT COMPLETED|12 Months Follow-Up||1||
60075445|NCT02505919|76190748|FG001|NOT COMPLETED|12 Months Follow-Up||2||
60075446|NCT02505919|76190747|FG000|STARTED|24 Months Follow-Up||115||
60075447|NCT02505919|76190748|FG001|STARTED|24 Months Follow-Up||61||
59529923|NCT02099006|75626294|FG000|Received Amitriptyline/ Baclofen|Overall Study||7||
59529924|NCT02099006|75626294|FG000|Received Ketoprofen|Overall Study||3||
59529925|NCT02099006|75626294|FG000|Received Loperamide|Overall Study||7||
59529926|NCT02099006|75626294|FG000|Received Ketamine|Overall Study||6||
59529927|NCT02099006|75626294|FG000|Received Gabapentin|Overall Study||8||
59529928|NCT02099006|75626294|FG000|COMPLETED|Overall Study||8||
59529929|NCT02099006|75626294|FG000|NOT COMPLETED|Overall Study||1||
59529930|NCT01454947|75626308|FG000|STARTED|Overall Study||27||
59529931|NCT01454947|75626309|FG001|STARTED|Overall Study||42||
59529932|NCT01454947|75626310|FG002|STARTED|Overall Study||35||
59529933|NCT01454947|75626311|FG003|STARTED|Overall Study||20||
59529934|NCT01454947|75626312|FG004|STARTED|Overall Study||34||
59529935|NCT01454947|75626313|FG005|STARTED|Overall Study||35||
59529936|NCT01454947|75626314|FG006|STARTED|Overall Study||27||
59529937|NCT01454947|75626315|FG007|STARTED|Overall Study||28||
59529938|NCT01454947|75626308|FG000|COMPLETED|Overall Study||24||
59529939|NCT01454947|75626309|FG001|COMPLETED|Overall Study||38||
59529940|NCT01454947|75626310|FG002|COMPLETED|Overall Study||32||
59529941|NCT01454947|75626311|FG003|COMPLETED|Overall Study||19||
59529942|NCT01454947|75626312|FG004|COMPLETED|Overall Study||33||
59529943|NCT01454947|75626313|FG005|COMPLETED|Overall Study||32||
59529944|NCT01454947|75626314|FG006|COMPLETED|Overall Study||26||
59529945|NCT01454947|75626315|FG007|COMPLETED|Overall Study||23||
59529946|NCT01454947|75626308|FG000|NOT COMPLETED|Overall Study||3||
59529947|NCT01454947|75626309|FG001|NOT COMPLETED|Overall Study||4||
59529948|NCT01454947|75626310|FG002|NOT COMPLETED|Overall Study||3||
59529949|NCT01454947|75626311|FG003|NOT COMPLETED|Overall Study||1||
59529950|NCT01454947|75626312|FG004|NOT COMPLETED|Overall Study||1||
59529951|NCT01454947|75626313|FG005|NOT COMPLETED|Overall Study||3||
59529952|NCT01454947|75626314|FG006|NOT COMPLETED|Overall Study||1||
59529953|NCT01454947|75626315|FG007|NOT COMPLETED|Overall Study||5||
59529954|NCT01455181|75626333|FG000|STARTED|Overall Study||24||
59529955|NCT01455181|75626333|FG000|COMPLETED|Overall Study||24||
59529956|NCT01455181|75626333|FG000|NOT COMPLETED|Overall Study||0||
59529957|NCT00324896|75626339|FG000|STARTED|Overall Study||15||
59529958|NCT00324896|75626340|FG001|STARTED|Overall Study||15||
59529959|NCT00324896|75626339|FG000|COMPLETED|Overall Study||12||
59529960|NCT00324896|75626340|FG001|COMPLETED|Overall Study||7||
59529961|NCT00324896|75626339|FG000|NOT COMPLETED|Overall Study||3||
59529962|NCT00324896|75626340|FG001|NOT COMPLETED|Overall Study||8||
59529963|NCT01479517|75626349|FG000|STARTED|Overall Study||10||
59529964|NCT01479517|75626350|FG001|STARTED|Overall Study||10||
59529965|NCT01479517|75626351|FG002|STARTED|Overall Study||10||
59529966|NCT01479517|75626349|FG000|COMPLETED|Overall Study||10||
59529967|NCT01479517|75626350|FG001|COMPLETED|Overall Study||10||
59529968|NCT01479517|75626351|FG002|COMPLETED|Overall Study||10||
59529969|NCT01479517|75626349|FG000|NOT COMPLETED|Overall Study||0||
59529970|NCT01479517|75626350|FG001|NOT COMPLETED|Overall Study||0||
59529971|NCT01479517|75626351|FG002|NOT COMPLETED|Overall Study||0||
59529972|NCT01480219|75626361|FG000|STARTED|Overall Study||325||
59529973|NCT01480219|75626362|FG001|STARTED|Overall Study||142||
59529974|NCT01480219|75626361|FG000|COMPLETED|Overall Study||325||
59529975|NCT01480219|75626362|FG001|COMPLETED|Overall Study||142||
59529976|NCT01480219|75626361|FG000|NOT COMPLETED|Overall Study||0||
59529977|NCT01480219|75626362|FG001|NOT COMPLETED|Overall Study||0||
59529978|NCT01480297|75626368|FG000|STARTED|Overall Study||8||
59529979|NCT01480297|75626368|FG000|COMPLETED|Overall Study||8||
59529980|NCT01480297|75626368|FG000|NOT COMPLETED|Overall Study||0||
59529981|NCT01480843|75626372|FG000|STARTED|Overall Study||65||
59529982|NCT01480843|75626372|FG000|COMPLETED|Overall Study||60||
59529983|NCT01480843|75626372|FG000|NOT COMPLETED|Overall Study||5||
59529984|NCT01392703|75626376|FG000|STARTED|Day 1||26||
59529985|NCT01392703|75626377|FG001|STARTED|Day 1||26||
59529986|NCT01392703|75626378|FG002|STARTED|Day 1||26||
59529987|NCT01392703|75626376|FG000|COMPLETED|Day 1||26||
59529988|NCT01392703|75626377|FG001|COMPLETED|Day 1||26||
59529989|NCT01392703|75626378|FG002|COMPLETED|Day 1||26||
59529990|NCT01392703|75626376|FG000|NOT COMPLETED|Day 1||0||
59529991|NCT01392703|75626377|FG001|NOT COMPLETED|Day 1||0||
59529992|NCT01392703|75626378|FG002|NOT COMPLETED|Day 1||0||
59529993|NCT01392703|75626376|FG000|STARTED|Day 5||26||
59529994|NCT01392703|75626377|FG001|STARTED|Day 5|1 participant no longer met dosing criteria and dropped out during washout period prior to Day 5.|25||
59529995|NCT01392703|75626378|FG002|STARTED|Day 5||26||
59529996|NCT01392703|75626376|FG000|COMPLETED|Day 5||26||
59529997|NCT01392703|75626377|FG001|COMPLETED|Day 5||25||
59529998|NCT01392703|75626378|FG002|COMPLETED|Day 5||26||
59529999|NCT01392703|75626376|FG000|NOT COMPLETED|Day 5||0||
59530000|NCT01392703|75626377|FG001|NOT COMPLETED|Day 5||0||
59530001|NCT01392703|75626378|FG002|NOT COMPLETED|Day 5||0||
59530002|NCT01392703|75626376|FG000|STARTED|Day 9||26||
59530003|NCT01392703|75626377|FG001|STARTED|Day 9||26||
59530004|NCT01392703|75626378|FG002|STARTED|Day 9||25||
59530005|NCT01392703|75626376|FG000|COMPLETED|Day 9||26||
59530006|NCT01392703|75626377|FG001|COMPLETED|Day 9||26||
59530007|NCT01392703|75626378|FG002|COMPLETED|Day 9||25||
59530008|NCT01392703|75626376|FG000|NOT COMPLETED|Day 9||0||
59530009|NCT01392703|75626377|FG001|NOT COMPLETED|Day 9||0||
59530010|NCT01392703|75626378|FG002|NOT COMPLETED|Day 9||0||
59530011|NCT01392859|75626388|FG000|STARTED|Overall Study||15||
59530012|NCT01392859|75626389|FG001|STARTED|Overall Study||13||
59530013|NCT01392859|75626390|FG002|STARTED|Overall Study||183||
59530014|NCT01392859|75626388|FG000|Wash Out 3-7 Days|Overall Study||15||
59530015|NCT01392859|75626389|FG001|Wash Out 3-7 Days|Overall Study||13||
59530016|NCT01392859|75626390|FG002|Wash Out 3-7 Days|Overall Study||0||
59530017|NCT01392859|75626388|FG000|COMPLETED|Overall Study||13||
59530018|NCT01392859|75626389|FG001|COMPLETED|Overall Study||13||
59530019|NCT01392859|75626390|FG002|COMPLETED|Overall Study||183||
59530020|NCT01392859|75626388|FG000|NOT COMPLETED|Overall Study||2||
59530021|NCT01392859|75626389|FG001|NOT COMPLETED|Overall Study||0||
59530022|NCT01392859|75626390|FG002|NOT COMPLETED|Overall Study||0||
59530023|NCT01457521|75626398|FG000|STARTED|Overall Study||123||
59530024|NCT01457521|75626399|FG001|STARTED|Overall Study||127||
59530025|NCT01457521|75626398|FG000|COMPLETED|Overall Study||111||
59530026|NCT01457521|75626399|FG001|COMPLETED|Overall Study||117||
59530027|NCT01457521|75626398|FG000|NOT COMPLETED|Overall Study||12||
59530028|NCT01457521|75626399|FG001|NOT COMPLETED|Overall Study||10||
59530029|NCT00325442|75626407|FG000|STARTED|Overall Study||176||
59530030|NCT00325442|75626408|FG001|STARTED|Overall Study||174||
59530031|NCT00325442|75626407|FG000|COMPLETED|Overall Study||167||
59530032|NCT00325442|75626408|FG001|COMPLETED|Overall Study||153||
59530033|NCT00325442|75626407|FG000|NOT COMPLETED|Overall Study||9||
59530034|NCT00325442|75626408|FG001|NOT COMPLETED|Overall Study||21||
59530035|NCT01393717|75626417|FG000|STARTED|Overall Study||37||
59530036|NCT01393717|75626418|FG001|STARTED|Overall Study||20||
59530037|NCT01393717|75626417|FG000|COMPLETED|Overall Study||37||
59530038|NCT01393717|75626418|FG001|COMPLETED|Overall Study||20||
59530039|NCT01393717|75626417|FG000|NOT COMPLETED|Overall Study||0||
59530040|NCT01393717|75626418|FG001|NOT COMPLETED|Overall Study||0||
59530041|NCT01459705|75626431|FG000|STARTED|Overall Study||54||
59530042|NCT01459705|75626432|FG001|STARTED|Overall Study||54||
59530043|NCT01459705|75626433|FG002|STARTED|Overall Study||54||
59530044|NCT01459705|75626431|FG000|COMPLETED|Overall Study||32||
59530045|NCT01459705|75626432|FG001|COMPLETED|Overall Study||30||
59530046|NCT01459705|75626433|FG002|COMPLETED|Overall Study||47||
59530047|NCT01459705|75626431|FG000|NOT COMPLETED|Overall Study||22||
59530048|NCT01459705|75626432|FG001|NOT COMPLETED|Overall Study||24||
59530049|NCT01459705|75626433|FG002|NOT COMPLETED|Overall Study||7||
59530050|NCT01460875|75626441|FG000|STARTED|Overall Study||34||
59530051|NCT01460875|75626441|FG000|COMPLETED|Overall Study||34||
59530052|NCT01460875|75626441|FG000|NOT COMPLETED|Overall Study||0||
59530053|NCT01481545|75626447|FG000|STARTED|Overall Study||16||
59530054|NCT01481545|75626448|FG001|STARTED|Overall Study||46||
59530055|NCT01481545|75626447|FG000|COMPLETED|Overall Study||11||
59530056|NCT01481545|75626448|FG001|COMPLETED|Overall Study||40||
59530057|NCT01481545|75626447|FG000|NOT COMPLETED|Overall Study||5||
59530058|NCT01481545|75626448|FG001|NOT COMPLETED|Overall Study||6||
59530059|NCT01482091|75626458|FG000|STARTED|Overall Study||25||
59530060|NCT01482091|75626459|FG001|STARTED|Overall Study||24||
59530061|NCT01482091|75626458|FG000|COMPLETED|Overall Study||25||
59530062|NCT01482091|75626459|FG001|COMPLETED|Overall Study||24||
59530063|NCT01482091|75626458|FG000|NOT COMPLETED|Overall Study||0||
59530064|NCT01482091|75626459|FG001|NOT COMPLETED|Overall Study||0||
59530065|NCT00325598|75626467|FG000|STARTED|Overall Study||50||
59530066|NCT00325598|75626468|FG001|STARTED|Overall Study||50||
59530067|NCT00325598|75626467|FG000|COMPLETED|Overall Study||50||
59530068|NCT00325598|75626468|FG001|COMPLETED|Overall Study||50||
59530069|NCT00325598|75626467|FG000|NOT COMPLETED|Overall Study||0||
59530070|NCT00325598|75626468|FG001|NOT COMPLETED|Overall Study||0||
59530071|NCT00326924|75626478|FG000|STARTED|Overall Study||188||
59530072|NCT00326924|75626479|FG001|STARTED|Overall Study||189||
59530073|NCT00326924|75626478|FG000|COMPLETED|Overall Study||187||
59530074|NCT00326924|75626479|FG001|COMPLETED|Overall Study||188||
59530075|NCT00326924|75626478|FG000|NOT COMPLETED|Overall Study||1||
59530076|NCT00326924|75626479|FG001|NOT COMPLETED|Overall Study||1||
59530077|NCT00327392|75626485|FG000|STARTED|Overall Study||123||
59530078|NCT00327392|75626485|FG000|COMPLETED|Overall Study||123||
59530079|NCT00327392|75626485|FG000|NOT COMPLETED|Overall Study||0||
59530080|NCT00328016|75626491|FG000|STARTED|Overall Study||23||
59530081|NCT00328016|75626492|FG001|STARTED|Overall Study||21||
59530082|NCT00328016|75626491|FG000|COMPLETED|Overall Study||23||
59530083|NCT00328016|75626492|FG001|COMPLETED|Overall Study||21||
59530084|NCT00328016|75626491|FG000|NOT COMPLETED|Overall Study||0||
59530085|NCT00328016|75626492|FG001|NOT COMPLETED|Overall Study||0||
59530086|NCT02108288|75626502|FG000|STARTED|Overall Study||10||
59530087|NCT02108288|75626503|FG001|STARTED|Overall Study||10||
59530088|NCT02108288|75626504|FG002|STARTED|Overall Study||10||
59530089|NCT02108288|75626502|FG000|COMPLETED|Overall Study||10||
59530090|NCT02108288|75626503|FG001|COMPLETED|Overall Study||10||
59530091|NCT02108288|75626504|FG002|COMPLETED|Overall Study||10||
59530092|NCT02108288|75626502|FG000|NOT COMPLETED|Overall Study||0||
59530093|NCT02108288|75626503|FG001|NOT COMPLETED|Overall Study||0||
59530094|NCT02108288|75626504|FG002|NOT COMPLETED|Overall Study||0||
59530095|NCT02108522|75626512|FG000|STARTED|Screening Period||82||
59530096|NCT02108522|75626512|FG000|COMPLETED|Screening Period||58||
59530097|NCT02108522|75626512|FG000|NOT COMPLETED|Screening Period||24||
59530098|NCT02108522|75626512|FG000|STARTED|Period 1: Initial Cohort||50||
59530099|NCT02108522|75626512|FG000|COMPLETED|Period 1: Initial Cohort||28||
59530100|NCT02108522|75626512|FG000|NOT COMPLETED|Period 1: Initial Cohort||22||
59530101|NCT02108522|75626512|FG000|STARTED|Period 2: Expansion Cohort||8||
59530102|NCT02108522|75626512|FG000|COMPLETED|Period 2: Expansion Cohort||2||
59530103|NCT02108522|75626512|FG000|NOT COMPLETED|Period 2: Expansion Cohort||6||
59530104|NCT02106494|75626518|FG000|STARTED|Overall Study||471||
59530105|NCT02106494|75626519|FG001|STARTED|Overall Study||471||
59530106|NCT02106494|75626518|FG000|Safety Population|Overall Study||456||
59530107|NCT02106494|75626519|FG001|Safety Population|Overall Study||459||
59530108|NCT02106494|75626518|FG000|Efficacy Population|Overall Study||450||
59530109|NCT02106494|75626519|FG001|Efficacy Population|Overall Study||452||
59530110|NCT02106494|75626518|FG000|COMPLETED|Overall Study||445||
59530111|NCT02106494|75626519|FG001|COMPLETED|Overall Study||446||
59530112|NCT02106494|75626518|FG000|NOT COMPLETED|Overall Study||26||
59530113|NCT02106494|75626519|FG001|NOT COMPLETED|Overall Study||25||
59530114|NCT00333710|75626530|FG000|STARTED|Overall Study||19||
59530115|NCT00333710|75626531|FG001|STARTED|Overall Study||18||
59530116|NCT00333710|75626532|FG002|STARTED|Overall Study||16||
59530117|NCT00333710|75626530|FG000|COMPLETED|Overall Study||8||
59530118|NCT00333710|75626531|FG001|COMPLETED|Overall Study||14||
59530119|NCT00333710|75626532|FG002|COMPLETED|Overall Study||15||
59530120|NCT00333710|75626530|FG000|NOT COMPLETED|Overall Study||11||
59530121|NCT00333710|75626531|FG001|NOT COMPLETED|Overall Study||4||
59530122|NCT00333710|75626532|FG002|NOT COMPLETED|Overall Study||1||
59530123|NCT00335504|75626544|FG000|STARTED|Overall Study||22||
59530124|NCT00335504|75626545|FG001|STARTED|Overall Study||21||
59530125|NCT00335504|75626546|FG002|STARTED|Overall Study||20||
59530126|NCT00335504|75626547|FG003|STARTED|Overall Study||22||
59530127|NCT00335504|75626544|FG000|COMPLETED|Overall Study||22||
59530128|NCT00335504|75626545|FG001|COMPLETED|Overall Study||21||
59530129|NCT00335504|75626546|FG002|COMPLETED|Overall Study||20||
59530130|NCT00335504|75626547|FG003|COMPLETED|Overall Study||22||
59530131|NCT00335504|75626544|FG000|NOT COMPLETED|Overall Study||0||
59530132|NCT00335504|75626545|FG001|NOT COMPLETED|Overall Study||0||
59530133|NCT00335504|75626546|FG002|NOT COMPLETED|Overall Study||0||
59530134|NCT00335504|75626547|FG003|NOT COMPLETED|Overall Study||0||
59530135|NCT01183169|75626561|FG000|STARTED|Main Phase||121||
59530136|NCT01183169|75626562|FG001|STARTED|Main Phase||115||
59530137|NCT01183169|75626563|FG002|STARTED|Main Phase||59||
59530138|NCT01183169|75626564|FG003|STARTED|Main Phase||55||
59530139|NCT01183169|75626565|FG004|STARTED|Main Phase||109||
59530140|NCT01183169|75626566|FG005|STARTED|Main Phase||0||
59530141|NCT01183169|75626567|FG006|STARTED|Main Phase||0||
59530142|NCT01183169|75626561|FG000|Completed Treatment|Main Phase||72||
59530143|NCT01183169|75626562|FG001|Completed Treatment|Main Phase||78||
59530144|NCT01183169|75626563|FG002|Completed Treatment|Main Phase||17||
59530145|NCT01183169|75626564|FG003|Completed Treatment|Main Phase||17||
59530146|NCT01183169|75626565|FG004|Completed Treatment|Main Phase||77||
59530147|NCT01183169|75626566|FG005|Completed Treatment|Main Phase||0||
59530148|NCT01183169|75626567|FG006|Completed Treatment|Main Phase||0||
59530149|NCT01183169|75626561|FG000|Switched to ALV|Main Phase||0||
59530150|NCT01183169|75626562|FG001|Switched to ALV|Main Phase||0||
59530151|NCT01183169|75626563|FG002|Switched to ALV|Main Phase||35||
59530152|NCT01183169|75626564|FG003|Switched to ALV|Main Phase||30||
59530153|NCT01183169|75626565|FG004|Switched to ALV|Main Phase||0||
59530154|NCT01183169|75626566|FG005|Switched to ALV|Main Phase||0||
59530155|NCT01183169|75626567|FG006|Switched to ALV|Main Phase||0||
59530156|NCT01183169|75626561|FG000|COMPLETED|Main Phase||94||
59530157|NCT01183169|75626562|FG001|COMPLETED|Main Phase||93||
59530158|NCT01183169|75626563|FG002|COMPLETED|Main Phase||18||
59530159|NCT01183169|75626564|FG003|COMPLETED|Main Phase||18||
59530160|NCT01183169|75626565|FG004|COMPLETED|Main Phase||83||
59530161|NCT01183169|75626566|FG005|COMPLETED|Main Phase||0||
59530162|NCT01183169|75626567|FG006|COMPLETED|Main Phase||0||
59530163|NCT01183169|75626561|FG000|NOT COMPLETED|Main Phase||27||
59530164|NCT01183169|75626562|FG001|NOT COMPLETED|Main Phase||22||
59530165|NCT01183169|75626563|FG002|NOT COMPLETED|Main Phase||41||
59530166|NCT01183169|75626564|FG003|NOT COMPLETED|Main Phase||37||
59530167|NCT01183169|75626565|FG004|NOT COMPLETED|Main Phase||26||
59530168|NCT01183169|75626566|FG005|NOT COMPLETED|Main Phase||0||
59530169|NCT01183169|75626567|FG006|NOT COMPLETED|Main Phase||0||
59530170|NCT01183169|75626561|FG000|STARTED|Post-switch Phase|Not a post-switch group|0||
59530171|NCT01183169|75626562|FG001|STARTED|Post-switch Phase|Not a post-switch group|0||
59530172|NCT01183169|75626563|FG002|STARTED|Post-switch Phase|Not a post-switch group|0||
59530173|NCT01183169|75626564|FG003|STARTED|Post-switch Phase|Not a post-switch group|0||
59530174|NCT01183169|75626565|FG004|STARTED|Post-switch Phase|Not a post-switch group|0||
59530175|NCT01183169|75626566|FG005|STARTED|Post-switch Phase|Participants in Treatment C1 who switched to active ALV|35||
59530176|NCT01183169|75626567|FG006|STARTED|Post-switch Phase|Participants in Treatment C2 who switched to active ALV|30||
59530177|NCT01183169|75626561|FG000|Completed Treatment|Post-switch Phase||0||
59530178|NCT01183169|75626562|FG001|Completed Treatment|Post-switch Phase||0||
59530179|NCT01183169|75626563|FG002|Completed Treatment|Post-switch Phase||0||
59530180|NCT01183169|75626564|FG003|Completed Treatment|Post-switch Phase||0||
59530181|NCT01183169|75626565|FG004|Completed Treatment|Post-switch Phase||0||
59530182|NCT01183169|75626566|FG005|Completed Treatment|Post-switch Phase||12||
59530183|NCT01183169|75626567|FG006|Completed Treatment|Post-switch Phase||13||
59530184|NCT01183169|75626561|FG000|COMPLETED|Post-switch Phase||0||
59530185|NCT01183169|75626562|FG001|COMPLETED|Post-switch Phase||0||
59530186|NCT01183169|75626563|FG002|COMPLETED|Post-switch Phase||0||
59530187|NCT01183169|75626564|FG003|COMPLETED|Post-switch Phase||0||
59530188|NCT01183169|75626565|FG004|COMPLETED|Post-switch Phase||0||
59530189|NCT01183169|75626566|FG005|COMPLETED|Post-switch Phase||21||
59530190|NCT01183169|75626567|FG006|COMPLETED|Post-switch Phase||21||
59530191|NCT01183169|75626561|FG000|NOT COMPLETED|Post-switch Phase||0||
59530192|NCT01183169|75626562|FG001|NOT COMPLETED|Post-switch Phase||0||
59530193|NCT01183169|75626563|FG002|NOT COMPLETED|Post-switch Phase||0||
59530194|NCT01183169|75626564|FG003|NOT COMPLETED|Post-switch Phase||0||
59530195|NCT01183169|75626565|FG004|NOT COMPLETED|Post-switch Phase||0||
59530196|NCT01183169|75626566|FG005|NOT COMPLETED|Post-switch Phase||14||
59530197|NCT01183169|75626567|FG006|NOT COMPLETED|Post-switch Phase||9||
59530198|NCT01183481|75626585|FG000|STARTED|Overall Study||19||
59530199|NCT01183481|75626585|FG000|COMPLETED|Overall Study||19||
59530200|NCT01183481|75626585|FG000|NOT COMPLETED|Overall Study||0||
59530201|NCT01183559|75626590|FG000|STARTED|Overall Study||9||
59530202|NCT01183559|75626590|FG000|COMPLETED|Overall Study||9||
59530203|NCT01183559|75626590|FG000|NOT COMPLETED|Overall Study||0||
59530204|NCT01184417|75626597|FG000|STARTED|Overall Study||51||
59530205|NCT01184417|75626598|FG001|STARTED|Overall Study||51||
59530206|NCT01184417|75626597|FG000|COMPLETED|Overall Study||51||
59530207|NCT01184417|75626598|FG001|COMPLETED|Overall Study||51||
59530208|NCT01184417|75626597|FG000|NOT COMPLETED|Overall Study||0||
59530209|NCT01184417|75626598|FG001|NOT COMPLETED|Overall Study||0||
59530210|NCT01159067|75626604|FG000|STARTED|Overall Study||1||
59530211|NCT01159067|75626604|FG000|COMPLETED|Overall Study||1||
59530212|NCT01159067|75626604|FG000|NOT COMPLETED|Overall Study||0||
59530213|NCT01221857|75626608|FG000|STARTED|Overall Study||12||
59530214|NCT01221857|75626608|FG000|COMPLETED|Overall Study||12|1 patient received unmanipulated cord only.|
59530215|NCT01221857|75626608|FG000|NOT COMPLETED|Overall Study||0||
59530216|NCT01159535|75626619|FG000|STARTED|Overall Study||103||
59530217|NCT01159535|75626620|FG001|STARTED|Overall Study||88||
59530218|NCT01159535|75626621|FG002|STARTED|Overall Study||95||
59530219|NCT01159535|75626619|FG000|COMPLETED|Overall Study||79||
59530220|NCT01159535|75626620|FG001|COMPLETED|Overall Study||64||
59530221|NCT01159535|75626621|FG002|COMPLETED|Overall Study||64||
59530222|NCT01159535|75626619|FG000|NOT COMPLETED|Overall Study||24||
59530223|NCT01159535|75626620|FG001|NOT COMPLETED|Overall Study||24||
59530224|NCT01159535|75626621|FG002|NOT COMPLETED|Overall Study||31||
59530225|NCT01222091|75626629|FG000|STARTED|Overall Study||5||
59530226|NCT01222091|75626630|FG001|STARTED|Overall Study||5||
59530227|NCT01222091|75626629|FG000|COMPLETED|Overall Study||5||
59530228|NCT01222091|75626630|FG001|COMPLETED|Overall Study||5||
59530229|NCT01222091|75626629|FG000|NOT COMPLETED|Overall Study||0||
59530230|NCT01222091|75626630|FG001|NOT COMPLETED|Overall Study||0||
59530231|NCT01225055|75626639|FG000|STARTED|Overall Study||20||
59530232|NCT01225055|75626640|FG001|STARTED|Overall Study||20||
59530233|NCT01225055|75626641|FG002|STARTED|Overall Study||21||
59530234|NCT01225055|75626639|FG000|COMPLETED|Overall Study||20||
59530235|NCT01225055|75626640|FG001|COMPLETED|Overall Study||18||
59530236|NCT01225055|75626641|FG002|COMPLETED|Overall Study||18||
59530237|NCT01225055|75626639|FG000|NOT COMPLETED|Overall Study||0||
59530238|NCT01225055|75626640|FG001|NOT COMPLETED|Overall Study||2||
59530239|NCT01225055|75626641|FG002|NOT COMPLETED|Overall Study||3||
59530240|NCT01160237|75626652|FG000|STARTED|Overall Study||4||
59530241|NCT01160237|75626653|FG001|STARTED|Overall Study||3||
59530242|NCT01160237|75626654|FG002|STARTED|Overall Study||0||
59530243|NCT01160237|75626652|FG000|COMPLETED|Overall Study||4||
59530244|NCT01160237|75626653|FG001|COMPLETED|Overall Study||3||
59530245|NCT01160237|75626654|FG002|COMPLETED|Overall Study||0||
59530246|NCT01160237|75626652|FG000|NOT COMPLETED|Overall Study||0||
59530247|NCT01160237|75626653|FG001|NOT COMPLETED|Overall Study||0||
59530248|NCT01160237|75626654|FG002|NOT COMPLETED|Overall Study||0||
59530249|NCT01336140|75626664|FG000|STARTED|Overall Study||150||
59530250|NCT01336140|75626665|FG001|STARTED|Overall Study||150||
59530251|NCT01336140|75626664|FG000|COMPLETED|Overall Study||150||
59530252|NCT01336140|75626665|FG001|COMPLETED|Overall Study||150||
59530253|NCT01336140|75626664|FG000|NOT COMPLETED|Overall Study||0||
59530254|NCT01336140|75626665|FG001|NOT COMPLETED|Overall Study||0||
59530255|NCT01184885|75626671|FG000|STARTED|Overall Study||7||
59530256|NCT01184885|75626671|FG000|COMPLETED|Overall Study||7||
59530257|NCT01184885|75626671|FG000|NOT COMPLETED|Overall Study||0||
59530258|NCT02187887|75626678|FG000|STARTED|Overall Study||393||
59530259|NCT02187887|75626679|FG001|STARTED|Overall Study||400||
59530260|NCT02187887|75626678|FG000|COMPLETED|Overall Study||388||
59530261|NCT02187887|75626679|FG001|COMPLETED|Overall Study||396||
59530262|NCT02187887|75626678|FG000|NOT COMPLETED|Overall Study||5||
59530263|NCT02187887|75626679|FG001|NOT COMPLETED|Overall Study||4||
59530264|NCT01187381|75626685|FG000|STARTED|Overall Study||250||
59530265|NCT01187381|75626685|FG000|COMPLETED|Overall Study|A participant completed study when the trastuzumab treatment was discontinued.|250||
59530266|NCT01187381|75626685|FG000|NOT COMPLETED|Overall Study||0||
59530267|NCT01187771|75626691|FG000|STARTED|Overall Study||28||
59530268|NCT01187771|75626692|FG001|STARTED|Overall Study||21||
59530269|NCT01187771|75626691|FG000|COMPLETED|Overall Study||25||
59530270|NCT01187771|75626692|FG001|COMPLETED|Overall Study||18||
59530271|NCT01187771|75626691|FG000|NOT COMPLETED|Overall Study||3||
59530272|NCT01187771|75626692|FG001|NOT COMPLETED|Overall Study||3||
59530273|NCT01225289|75626702|FG000|STARTED|Overall Study||18||
59530274|NCT01225289|75626703|FG001|STARTED|Overall Study||18||
59530275|NCT01225289|75626702|FG000|COMPLETED|Overall Study||18||
59530276|NCT01225289|75626703|FG001|COMPLETED|Overall Study||17||
59530277|NCT01225289|75626702|FG000|NOT COMPLETED|Overall Study||0||
59530278|NCT01225289|75626703|FG001|NOT COMPLETED|Overall Study||1||
59530279|NCT01161329|75626711|FG000|STARTED|Overall Study||33||
59530280|NCT01161329|75626712|FG001|STARTED|Overall Study||34||
59530281|NCT01161329|75626711|FG000|COMPLETED|Overall Study||29||
59530282|NCT01161329|75626712|FG001|COMPLETED|Overall Study||24||
59530283|NCT01161329|75626711|FG000|NOT COMPLETED|Overall Study||4||
59530284|NCT01161329|75626712|FG001|NOT COMPLETED|Overall Study||10||
59530285|NCT01227005|75626721|FG000|STARTED|Overall Study||55||
59530286|NCT01227005|75626722|FG001|STARTED|Overall Study||52||
59530287|NCT01227005|75626721|FG000|COMPLETED|Overall Study||50||
59530288|NCT01227005|75626722|FG001|COMPLETED|Overall Study||51||
59530289|NCT01227005|75626721|FG000|NOT COMPLETED|Overall Study||5||
59530290|NCT01227005|75626722|FG001|NOT COMPLETED|Overall Study||1||
59530291|NCT01161563|75626730|FG000|STARTED|Overall Study||63||
59530292|NCT01161563|75626731|FG001|STARTED|Overall Study||55||
59530293|NCT01161563|75626730|FG000|COMPLETED|Overall Study||58||
59530294|NCT01161563|75626731|FG001|COMPLETED|Overall Study||49||
59530295|NCT01161563|75626730|FG000|NOT COMPLETED|Overall Study||5||
59530296|NCT01161563|75626731|FG001|NOT COMPLETED|Overall Study||6||
59530297|NCT01189409|75626739|FG000|STARTED|First 3 Weeks||37||
59530298|NCT01189409|75626740|FG001|STARTED|First 3 Weeks||33||
59530299|NCT01189409|75626739|FG000|COMPLETED|First 3 Weeks||19||
59530300|NCT01189409|75626740|FG001|COMPLETED|First 3 Weeks||23||
59530301|NCT01189409|75626739|FG000|NOT COMPLETED|First 3 Weeks||18||
59530302|NCT01189409|75626740|FG001|NOT COMPLETED|First 3 Weeks||10||
59530303|NCT01189409|75626739|FG000|STARTED|Second 3 Weeks (Switch to 2nd Treatment)||19||
59530304|NCT01189409|75626740|FG001|STARTED|Second 3 Weeks (Switch to 2nd Treatment)||23||
59530305|NCT01189409|75626739|FG000|COMPLETED|Second 3 Weeks (Switch to 2nd Treatment)||13||
59530306|NCT01189409|75626740|FG001|COMPLETED|Second 3 Weeks (Switch to 2nd Treatment)||15||
59530307|NCT01189409|75626739|FG000|NOT COMPLETED|Second 3 Weeks (Switch to 2nd Treatment)||6||
59530308|NCT01189409|75626740|FG001|NOT COMPLETED|Second 3 Weeks (Switch to 2nd Treatment)||8||
59530309|NCT01227551|75626753|FG000|STARTED|Overall Study||57||
59530310|NCT01227551|75626753|FG000|COMPLETED|Overall Study||23||
59530311|NCT01227551|75626753|FG000|NOT COMPLETED|Overall Study||34||
59530312|NCT01227785|75626757|FG000|STARTED|Overall Study||120||
59530313|NCT01227785|75626757|FG000|COMPLETED|Overall Study||108||
59530314|NCT01227785|75626757|FG000|NOT COMPLETED|Overall Study||12||
59530315|NCT02191865|75626771|FG000|STARTED|Overall Study||8||
59530316|NCT02191865|75626772|FG001|STARTED|Overall Study||8||
59530317|NCT02191865|75626773|FG002|STARTED|Overall Study||17||
59530318|NCT02191865|75626771|FG000|COMPLETED|Overall Study||8||
59530319|NCT02191865|75626772|FG001|COMPLETED|Overall Study||8||
59530320|NCT02191865|75626773|FG002|COMPLETED|Overall Study||17||
59530321|NCT02191865|75626771|FG000|NOT COMPLETED|Overall Study||0||
59530322|NCT02191865|75626772|FG001|NOT COMPLETED|Overall Study||0||
59530323|NCT02191865|75626773|FG002|NOT COMPLETED|Overall Study||0||
59530324|NCT01191749|75626784|FG000|STARTED|Overall Study||7||
59530325|NCT01191749|75626784|FG000|COMPLETED|Overall Study||7||
59530326|NCT01191749|75626784|FG000|NOT COMPLETED|Overall Study||0||
59530327|NCT01191827|75626790|FG000|STARTED|Overall Study||20||
59530328|NCT01191827|75626791|FG001|STARTED|Overall Study||20||
59530329|NCT01191827|75626790|FG000|COMPLETED|Overall Study||20||
59530330|NCT01191827|75626791|FG001|COMPLETED|Overall Study||20||
59530331|NCT01191827|75626790|FG000|NOT COMPLETED|Overall Study||0||
59530332|NCT01191827|75626791|FG001|NOT COMPLETED|Overall Study||0||
59530333|NCT01192139|75626797|FG000|STARTED|Period 1||5||
59530334|NCT01192139|75626798|FG001|STARTED|Period 1||5||
59530335|NCT01192139|75626799|FG002|STARTED|Period 1||5||
59530336|NCT01192139|75626800|FG003|STARTED|Period 1||5||
59622710|NCT00438750|75734601|FG000|COMPLETED|Overall Study||39||
59622711|NCT00438750|75734602|FG001|COMPLETED|Overall Study||37||
59530337|NCT01192139|75626801|FG004|STARTED|Period 1||5||
59530338|NCT01192139|75626802|FG005|STARTED|Period 1||5||
59530339|NCT01192139|75626797|FG000|COMPLETED|Period 1||5||
59530340|NCT01192139|75626798|FG001|COMPLETED|Period 1||5||
59530341|NCT01192139|75626799|FG002|COMPLETED|Period 1||5||
59530342|NCT01192139|75626800|FG003|COMPLETED|Period 1||5||
59530343|NCT01192139|75626801|FG004|COMPLETED|Period 1||5||
59530344|NCT01192139|75626802|FG005|COMPLETED|Period 1||5||
59530345|NCT01192139|75626797|FG000|NOT COMPLETED|Period 1||0||
59530346|NCT01192139|75626798|FG001|NOT COMPLETED|Period 1||0||
59530347|NCT01192139|75626799|FG002|NOT COMPLETED|Period 1||0||
59530348|NCT01192139|75626800|FG003|NOT COMPLETED|Period 1||0||
59530349|NCT01192139|75626801|FG004|NOT COMPLETED|Period 1||0||
59530350|NCT01192139|75626802|FG005|NOT COMPLETED|Period 1||0||
59530351|NCT01192139|75626797|FG000|STARTED|Period 2||5||
59530352|NCT01192139|75626798|FG001|STARTED|Period 2||5||
60075448|NCT02505919|76190747|FG000|COMPLETED|24 Months Follow-Up||112||
60075449|NCT02505919|76190748|FG001|COMPLETED|24 Months Follow-Up||60||
59530353|NCT01192139|75626799|FG002|STARTED|Period 2||5||
59530354|NCT01192139|75626800|FG003|STARTED|Period 2||5||
59530355|NCT01192139|75626801|FG004|STARTED|Period 2||5||
59530356|NCT01192139|75626802|FG005|STARTED|Period 2||5||
59530357|NCT01192139|75626797|FG000|COMPLETED|Period 2||5||
59530358|NCT01192139|75626798|FG001|COMPLETED|Period 2||5||
59530359|NCT01192139|75626799|FG002|COMPLETED|Period 2||5||
59530360|NCT01192139|75626800|FG003|COMPLETED|Period 2||5||
59530361|NCT01192139|75626801|FG004|COMPLETED|Period 2||5||
59530362|NCT01192139|75626802|FG005|COMPLETED|Period 2||5||
59530363|NCT01192139|75626797|FG000|NOT COMPLETED|Period 2||0||
59530364|NCT01192139|75626798|FG001|NOT COMPLETED|Period 2||0||
59530365|NCT01192139|75626799|FG002|NOT COMPLETED|Period 2||0||
59530366|NCT01192139|75626800|FG003|NOT COMPLETED|Period 2||0||
59530367|NCT01192139|75626801|FG004|NOT COMPLETED|Period 2||0||
59530368|NCT01192139|75626802|FG005|NOT COMPLETED|Period 2||0||
59530369|NCT01192139|75626797|FG000|STARTED|Period 3||5||
59530370|NCT01192139|75626798|FG001|STARTED|Period 3||5||
59530371|NCT01192139|75626799|FG002|STARTED|Period 3||5||
59530372|NCT01192139|75626800|FG003|STARTED|Period 3||5||
59530373|NCT01192139|75626801|FG004|STARTED|Period 3||5||
59530374|NCT01192139|75626802|FG005|STARTED|Period 3||5||
59530375|NCT01192139|75626797|FG000|COMPLETED|Period 3||5||
59530376|NCT01192139|75626798|FG001|COMPLETED|Period 3||5||
59530377|NCT01192139|75626799|FG002|COMPLETED|Period 3||5||
59530378|NCT01192139|75626800|FG003|COMPLETED|Period 3||5||
59530379|NCT01192139|75626801|FG004|COMPLETED|Period 3||5||
59530380|NCT01192139|75626802|FG005|COMPLETED|Period 3||5||
59530381|NCT01192139|75626797|FG000|NOT COMPLETED|Period 3||0||
59530382|NCT01192139|75626798|FG001|NOT COMPLETED|Period 3||0||
59530383|NCT01192139|75626799|FG002|NOT COMPLETED|Period 3||0||
59530384|NCT01192139|75626800|FG003|NOT COMPLETED|Period 3||0||
59530385|NCT01192139|75626801|FG004|NOT COMPLETED|Period 3||0||
59530386|NCT01192139|75626802|FG005|NOT COMPLETED|Period 3||0||
59530387|NCT01229423|75626810|FG000|STARTED|Overall Study||62||
59530388|NCT01229423|75626810|FG000|COMPLETED|Overall Study||47||
59530389|NCT01229423|75626810|FG000|NOT COMPLETED|Overall Study||15||
59530390|NCT01283321|75626816|FG000|STARTED|Overall Study||10||
59530391|NCT01283321|75626817|FG001|STARTED|Overall Study||10||
59530392|NCT01283321|75626816|FG000|COMPLETED|Overall Study||10||
59530393|NCT01283321|75626817|FG001|COMPLETED|Overall Study||10||
59530394|NCT01283321|75626816|FG000|NOT COMPLETED|Overall Study||0||
59530395|NCT01283321|75626817|FG001|NOT COMPLETED|Overall Study||0||
59530396|NCT01229891|75626828|FG000|STARTED|Overall Study||30||
59530397|NCT01229891|75626829|FG001|STARTED|Overall Study||30||
59530398|NCT01229891|75626830|FG002|STARTED|Overall Study||30||
60075450|NCT02505919|76190747|FG000|NOT COMPLETED|24 Months Follow-Up||3||
60075451|NCT02505919|76190748|FG001|NOT COMPLETED|24 Months Follow-Up||1||
59530399|NCT01229891|75626828|FG000|COMPLETED|Overall Study||30||
59530400|NCT01229891|75626829|FG001|COMPLETED|Overall Study||30||
59530401|NCT01229891|75626830|FG002|COMPLETED|Overall Study||30||
59530402|NCT01229891|75626828|FG000|NOT COMPLETED|Overall Study||0||
59530403|NCT01229891|75626829|FG001|NOT COMPLETED|Overall Study||0||
59530404|NCT01229891|75626830|FG002|NOT COMPLETED|Overall Study||0||
59622712|NCT00438750|75734601|FG000|NOT COMPLETED|Overall Study||9||
59622713|NCT00438750|75734602|FG001|NOT COMPLETED|Overall Study||9||
59622714|NCT00439296|75734610|FG000|STARTED|Overall Study||5||
59622715|NCT00439296|75734611|FG001|STARTED|Overall Study||4||
59622716|NCT00439296|75734610|FG000|Treatment Course 1|Overall Study||5||
59622717|NCT00439296|75734611|FG001|Treatment Course 1|Overall Study||3||
59622718|NCT00439296|75734610|FG000|Treatment Course 2|Overall Study||1||
59622719|NCT00439296|75734611|FG001|Treatment Course 2|Overall Study||1||
60075452|NCT02505919|76190747|FG000|STARTED|36 Months Follow-Up||112||
59530405|NCT01283555|75626838|FG000|STARTED|First Intervention||13||
59530406|NCT01283555|75626839|FG001|STARTED|First Intervention||12||
59530407|NCT01283555|75626838|FG000|COMPLETED|First Intervention||13||
59530408|NCT01283555|75626839|FG001|COMPLETED|First Intervention||12||
59530409|NCT01283555|75626838|FG000|NOT COMPLETED|First Intervention||0||
59530410|NCT01283555|75626839|FG001|NOT COMPLETED|First Intervention||0||
59530411|NCT01283555|75626838|FG000|STARTED|Washout Period of at Least 21 Days||13||
59530412|NCT01283555|75626839|FG001|STARTED|Washout Period of at Least 21 Days||12||
59530413|NCT01283555|75626838|FG000|COMPLETED|Washout Period of at Least 21 Days||13||
59530414|NCT01283555|75626839|FG001|COMPLETED|Washout Period of at Least 21 Days||12||
59530415|NCT01283555|75626838|FG000|NOT COMPLETED|Washout Period of at Least 21 Days||0||
59530416|NCT01283555|75626839|FG001|NOT COMPLETED|Washout Period of at Least 21 Days||0||
59530417|NCT01283555|75626838|FG000|STARTED|Second Intervention||13||
59530418|NCT01283555|75626839|FG001|STARTED|Second Intervention||12||
59530419|NCT01283555|75626838|FG000|COMPLETED|Second Intervention||13||
59530420|NCT01283555|75626839|FG001|COMPLETED|Second Intervention||12||
59530421|NCT01283555|75626838|FG000|NOT COMPLETED|Second Intervention||0||
59622720|NCT00439296|75734610|FG000|COMPLETED|Overall Study||5||
59622721|NCT00439296|75734611|FG001|COMPLETED|Overall Study||4||
59530422|NCT01283555|75626839|FG001|NOT COMPLETED|Second Intervention||0||
59530423|NCT00345176|75626853|FG000|STARTED|Overall Study||1012||
59530424|NCT00345176|75626854|FG001|STARTED|Overall Study||1044||
59530425|NCT00345176|75626855|FG002|STARTED|Overall Study||1068||
59530426|NCT00345176|75626856|FG003|STARTED|Overall Study||1079||
59530427|NCT00345176|75626853|FG000|COMPLETED|Overall Study||1007||
59530428|NCT00345176|75626854|FG001|COMPLETED|Overall Study||1038||
59530429|NCT00345176|75626855|FG002|COMPLETED|Overall Study||1062||
59530430|NCT00345176|75626856|FG003|COMPLETED|Overall Study||1069||
59530431|NCT00345176|75626853|FG000|NOT COMPLETED|Overall Study||5||
59530432|NCT00345176|75626854|FG001|NOT COMPLETED|Overall Study||6||
59530433|NCT00345176|75626855|FG002|NOT COMPLETED|Overall Study||6||
59530434|NCT00345176|75626856|FG003|NOT COMPLETED|Overall Study||10||
59530435|NCT01194089|75626870|FG000|STARTED|Overall Study||42||
59530436|NCT01194089|75626871|FG001|STARTED|Overall Study||47||
59530437|NCT01194089|75626870|FG000|COMPLETED|Overall Study||42||
59530438|NCT01194089|75626871|FG001|COMPLETED|Overall Study||47||
59530439|NCT01194089|75626870|FG000|NOT COMPLETED|Overall Study||0||
59530440|NCT01194089|75626871|FG001|NOT COMPLETED|Overall Study||0||
59530441|NCT00345254|75626879|FG000|STARTED|Overall Study||30||
59530442|NCT00345254|75626880|FG001|STARTED|Overall Study||30||
59530443|NCT00345254|75626879|FG000|COMPLETED|Overall Study||30||
59530444|NCT00345254|75626880|FG001|COMPLETED|Overall Study||30||
59530445|NCT00345254|75626879|FG000|NOT COMPLETED|Overall Study||0||
59530446|NCT00345254|75626880|FG001|NOT COMPLETED|Overall Study||0||
59530447|NCT00345332|75626888|FG000|STARTED|Overall Study||11||
59530448|NCT00345332|75626889|FG001|STARTED|Overall Study||20||
59530449|NCT00345332|75626888|FG000|COMPLETED|Overall Study||11||
59530450|NCT00345332|75626889|FG001|COMPLETED|Overall Study||20||
59530451|NCT00345332|75626888|FG000|NOT COMPLETED|Overall Study||0||
59530452|NCT00345332|75626889|FG001|NOT COMPLETED|Overall Study||0||
59530453|NCT01650350|75626895|FG000|STARTED|Overall Study||7||
59530454|NCT01650350|75626895|FG000|COMPLETED|Overall Study||7||
59530455|NCT01650350|75626895|FG000|NOT COMPLETED|Overall Study||0||
59530456|NCT00349388|75626903|FG000|STARTED|Overall Study|no patients enrolled|0||
59530457|NCT00349388|75626904|FG001|STARTED|Overall Study||1||
59530458|NCT00349388|75626903|FG000|COMPLETED|Overall Study|no patients enrolled , therefore no patients completed|0||
59530459|NCT00349388|75626904|FG001|COMPLETED|Overall Study||1||
59530460|NCT00349388|75626903|FG000|NOT COMPLETED|Overall Study||0||
59530461|NCT00349388|75626904|FG001|NOT COMPLETED|Overall Study||0||
59530462|NCT00349778|75626910|FG000|STARTED|Overall Study||102||
59530463|NCT00349778|75626910|FG000|COMPLETED|Overall Study||102||
59530464|NCT00349778|75626910|FG000|NOT COMPLETED|Overall Study||0||
59530465|NCT00305084|75626919|FG000|STARTED|Overall Study||3||
59530466|NCT00305084|75626920|FG001|STARTED|Overall Study||3||
59530467|NCT00305084|75626921|FG002|STARTED|Overall Study||3||
59530468|NCT00305084|75626922|FG003|STARTED|Overall Study||3||
59530469|NCT00305084|75626923|FG004|STARTED|Overall Study||3||
59530470|NCT00305084|75626919|FG000|COMPLETED|Overall Study||3||
59530471|NCT00305084|75626920|FG001|COMPLETED|Overall Study||3||
59530472|NCT00305084|75626921|FG002|COMPLETED|Overall Study||3||
59530473|NCT00305084|75626922|FG003|COMPLETED|Overall Study||3||
59530474|NCT00305084|75626923|FG004|COMPLETED|Overall Study||3||
59530475|NCT00305084|75626919|FG000|NOT COMPLETED|Overall Study||0||
59530476|NCT00305084|75626920|FG001|NOT COMPLETED|Overall Study||0||
59530477|NCT00305084|75626921|FG002|NOT COMPLETED|Overall Study||0||
59530478|NCT00305084|75626922|FG003|NOT COMPLETED|Overall Study||0||
59530479|NCT00305084|75626923|FG004|NOT COMPLETED|Overall Study||0||
59530480|NCT00305162|75626965|FG000|STARTED|48 Hour Follow-up Period||4435||
59530481|NCT00305162|75626966|FG001|STARTED|48 Hour Follow-up Period||4447||
59530482|NCT00305162|75626965|FG000|Intent-to-treat (ITT): SA/UA/NSTEMI|48 Hour Follow-up Period|Patients who completed through 48 hours|3933||
59530483|NCT00305162|75626966|FG001|Intent-to-treat (ITT): SA/UA/NSTEMI|48 Hour Follow-up Period|Patients who completed through 48 hours|3924||
59530484|NCT00305162|75626965|FG000|Intent-to-treat (ITT): STEMI|48 Hour Follow-up Period|Patients who completed through 48 hours|482||
59530485|NCT00305162|75626966|FG001|Intent-to-treat (ITT): STEMI|48 Hour Follow-up Period|Patients who completed through 48 hours|507||
59530486|NCT00305162|75626965|FG000|Modified ITT (mITT): SA/UA/NSTEMI|48 Hour Follow-up Period|Completed through 48 hours; Excludes those who did not receive study drug or undergo index PCI.|3889||
59530487|NCT00305162|75626966|FG001|Modified ITT (mITT): SA/UA/NSTEMI|48 Hour Follow-up Period|Completed through 48 hours; Excludes those who did not receive study drug or undergo index PCI.|3865||
59530488|NCT00305162|75626965|FG000|Modified ITT (mITT): STEMI|48 Hour Follow-up Period|Completed through 48 hours; Excludes those who did not receive study drug or undergo index PCI.|446||
59530489|NCT00305162|75626966|FG001|Modified ITT (mITT): STEMI|48 Hour Follow-up Period|Completed through 48 hours; Excludes those who did not receive study drug or undergo index PCI.|447||
59530490|NCT00305162|75626965|FG000|Safety Population|48 Hour Follow-up Period|Patients who received at least 1 dose of study drug, according to the actual treatment received.|4374||
59530491|NCT00305162|75626966|FG001|Safety Population|48 Hour Follow-up Period|Patients who received at least 1 dose of study drug, according to the actual treatment received.|4365||
59530492|NCT00305162|75626965|FG000|COMPLETED|48 Hour Follow-up Period|intent-to-treat (ITT) completers at 48 hour follow-up|4415||
59530493|NCT00305162|75626966|FG001|COMPLETED|48 Hour Follow-up Period|intent-to-treat (ITT) completers at 48 hour follow-up|4431||
59622722|NCT00439296|75734610|FG000|NOT COMPLETED|Overall Study||0||
59530494|NCT00305162|75626965|FG000|NOT COMPLETED|48 Hour Follow-up Period||20||
59530495|NCT00305162|75626966|FG001|NOT COMPLETED|48 Hour Follow-up Period||16||
59530496|NCT00305162|75626965|FG000|STARTED|30-day Follow-up Period||4435||
59530497|NCT00305162|75626966|FG001|STARTED|30-day Follow-up Period||4447||
59530498|NCT00305162|75626965|FG000|Intent-to-treat (ITT): SA/UA/NSTEMI|30-day Follow-up Period|Completed through 30-days|3902||
59530499|NCT00305162|75626966|FG001|Intent-to-treat (ITT): SA/UA/NSTEMI|30-day Follow-up Period|Completed through 30-days|3883||
59530500|NCT00305162|75626965|FG000|Intent-to-treat (ITT): STEMI|30-day Follow-up Period|Completed through 30-days|471||
59530501|NCT00305162|75626966|FG001|Intent-to-treat (ITT): STEMI|30-day Follow-up Period|Completed through 30-days|501||
59530502|NCT00305162|75626965|FG000|Modified ITT (mITT): SA/UA/NSTEMI|30-day Follow-up Period|Completed through 30-days; Excludes those who did not receive study drug or undergo index PCI.|3860||
59530503|NCT00305162|75626966|FG001|Modified ITT (mITT): SA/UA/NSTEMI|30-day Follow-up Period|Completed through 30-days; Excludes those who did not receive study drug or undergo index PCI.|3827||
59530504|NCT00305162|75626965|FG000|Modified ITT (mITT): STEMI|30-day Follow-up Period|Completed through 30-days; Excludes those who did not receive study drug or undergo index PCI.|438||
59530505|NCT00305162|75626966|FG001|Modified ITT (mITT): STEMI|30-day Follow-up Period|Completed through 30-days; Excludes those who did not receive study drug or undergo index PCI.|444||
59530506|NCT00305162|75626965|FG000|COMPLETED|30-day Follow-up Period|intent-to-treat (ITT) completers at 30-day follow-up|4373||
59530507|NCT00305162|75626966|FG001|COMPLETED|30-day Follow-up Period|intent-to-treat (ITT) completers at 30-day follow-up|4384||
59530508|NCT00305162|75626965|FG000|NOT COMPLETED|30-day Follow-up Period||62||
59530509|NCT00305162|75626966|FG001|NOT COMPLETED|30-day Follow-up Period||63||
59530510|NCT00305162|75626965|FG000|STARTED|1 Year Follow-up Period||4435||
59530511|NCT00305162|75626966|FG001|STARTED|1 Year Follow-up Period||4447||
59530512|NCT00305162|75626965|FG000|Intent-to-treat (ITT): SA/UA/NSTEMI|1 Year Follow-up Period|Completed through 1 year|3900||
59530513|NCT00305162|75626966|FG001|Intent-to-treat (ITT): SA/UA/NSTEMI|1 Year Follow-up Period|Completed through 1 year|3878||
59530514|NCT00305162|75626965|FG000|Intent-to-treat (ITT): STEMI|1 Year Follow-up Period|Completed through 1 year|480||
59530515|NCT00305162|75626966|FG001|Intent-to-treat (ITT): STEMI|1 Year Follow-up Period|Completed through 1 year|504||
59530516|NCT00305162|75626965|FG000|Modified ITT (mITT): SA/UA/NSTEMI|1 Year Follow-up Period|Completed through 1 year; Excludes those who did not receive study drug or undergo index PCI.|3851||
59530517|NCT00305162|75626966|FG001|Modified ITT (mITT): SA/UA/NSTEMI|1 Year Follow-up Period|Completed through 1 year; Excludes those who did not receive study drug or undergo index PCI.|3818||
59530518|NCT00305162|75626965|FG000|Modified ITT (mITT): STEMI|1 Year Follow-up Period|Completed through 1 year; Excludes those who did not receive study drug or undergo index PCI.|446||
59530519|NCT00305162|75626966|FG001|Modified ITT (mITT): STEMI|1 Year Follow-up Period|Completed through 1 year; Excludes those who did not receive study drug or undergo index PCI.|444||
59530520|NCT00305162|75626965|FG000|COMPLETED|1 Year Follow-up Period|intent-to-treat (ITT) completers at 1-year follow-up|4380||
59530521|NCT00305162|75626966|FG001|COMPLETED|1 Year Follow-up Period|intent-to-treat (ITT) completers at 1-year follow-up|4382||
59530522|NCT00305162|75626965|FG000|NOT COMPLETED|1 Year Follow-up Period||55||
59530523|NCT00305162|75626966|FG001|NOT COMPLETED|1 Year Follow-up Period||65||
59530524|NCT00351416|75626975|FG000|STARTED|Overall Study||6||
59530525|NCT00351416|75626976|FG001|STARTED|Overall Study||9||
59987707|NCT00966953|76102945|FG000|COMPLETED|1 Week Washout After 2nd Intervention||6||
59987708|NCT00966953|76102946|FG001|COMPLETED|1 Week Washout After 2nd Intervention||6||
59987709|NCT00966953|76102947|FG002|COMPLETED|1 Week Washout After 2nd Intervention||6||
59987710|NCT00966953|76102948|FG003|COMPLETED|1 Week Washout After 2nd Intervention||7||
59987711|NCT00966953|76102945|FG000|NOT COMPLETED|1 Week Washout After 2nd Intervention||0||
59530526|NCT00351416|75626975|FG000|COMPLETED|Overall Study||6||
59530527|NCT00351416|75626976|FG001|COMPLETED|Overall Study||9||
59530528|NCT00351416|75626975|FG000|NOT COMPLETED|Overall Study||0||
59530529|NCT00351416|75626976|FG001|NOT COMPLETED|Overall Study||0||
59530530|NCT00305942|75626982|FG000|STARTED|Overall Study||61||
59530531|NCT00305942|75626982|FG000|COMPLETED|Overall Study||23||
59530532|NCT00305942|75626982|FG000|NOT COMPLETED|Overall Study||38||
59530533|NCT00352976|75626986|FG000|STARTED|Overall Study||83||
59530534|NCT00352976|75626986|FG000|COMPLETED|Overall Study||83||
59530535|NCT00352976|75626986|FG000|NOT COMPLETED|Overall Study||0||
59530536|NCT00306488|75626991|FG000|STARTED|Overall Study||11||
59530537|NCT00306488|75626991|FG000|COMPLETED|Overall Study||10||
59530538|NCT00306488|75626991|FG000|NOT COMPLETED|Overall Study||1||
59530539|NCT00308282|75627000|FG000|STARTED|Overall Study||34||
59530540|NCT00308282|75627001|FG001|STARTED|Overall Study||34||
59530541|NCT00308282|75627002|FG002|STARTED|Overall Study||34||
59530542|NCT00308282|75627003|FG003|STARTED|Overall Study||34||
59530543|NCT00308282|75627000|FG000|Received at Least One Dose of Study Drug|Overall Study||34||
59530544|NCT00308282|75627001|FG001|Received at Least One Dose of Study Drug|Overall Study||34||
59530545|NCT00308282|75627002|FG002|Received at Least One Dose of Study Drug|Overall Study||34||
59530546|NCT00308282|75627003|FG003|Received at Least One Dose of Study Drug|Overall Study||34||
59530547|NCT00308282|75627000|FG000|COMPLETED|Overall Study||31||
59530548|NCT00308282|75627001|FG001|COMPLETED|Overall Study||30||
59530549|NCT00308282|75627002|FG002|COMPLETED|Overall Study||33||
59530550|NCT00308282|75627003|FG003|COMPLETED|Overall Study||32||
59530551|NCT00308282|75627000|FG000|NOT COMPLETED|Overall Study||3||
59530552|NCT00308282|75627001|FG001|NOT COMPLETED|Overall Study||4||
59995436|NCT02994355|76111250|FG000|NOT COMPLETED|Overall Study||||1
59530553|NCT00308282|75627002|FG002|NOT COMPLETED|Overall Study||1||
59530554|NCT00308282|75627003|FG003|NOT COMPLETED|Overall Study||2||
59530555|NCT00343460|75627022|FG000|STARTED|Cycle 1||475||
59530556|NCT00343460|75627023|FG001|STARTED|Cycle 1||481||
59530557|NCT00343460|75627024|FG002|STARTED|Cycle 1||472||
59530558|NCT00343460|75627022|FG000|COMPLETED|Cycle 1||453||
59530559|NCT00343460|75627023|FG001|COMPLETED|Cycle 1||459||
59530560|NCT00343460|75627024|FG002|COMPLETED|Cycle 1||454||
59530561|NCT00343460|75627022|FG000|NOT COMPLETED|Cycle 1||22||
59530562|NCT00343460|75627023|FG001|NOT COMPLETED|Cycle 1||22||
59530563|NCT00343460|75627024|FG002|NOT COMPLETED|Cycle 1||18||
59530564|NCT00343460|75627022|FG000|STARTED|Cycle 2 - 4||584||
59530565|NCT00343460|75627023|FG001|STARTED|Cycle 2 - 4||565||
59530566|NCT00343460|75627024|FG002|STARTED|Cycle 2 - 4||0||
59530567|NCT00343460|75627022|FG000|COMPLETED|Cycle 2 - 4||528||
59530568|NCT00343460|75627023|FG001|COMPLETED|Cycle 2 - 4||515||
59530569|NCT00343460|75627024|FG002|COMPLETED|Cycle 2 - 4||0||
59530570|NCT00343460|75627022|FG000|NOT COMPLETED|Cycle 2 - 4||56||
59530571|NCT00343460|75627023|FG001|NOT COMPLETED|Cycle 2 - 4||50||
59530572|NCT00343460|75627024|FG002|NOT COMPLETED|Cycle 2 - 4||0||
59530573|NCT01659996|75627045|FG000|STARTED|Overall Study||421||
59530574|NCT01659996|75627046|FG001|STARTED|Overall Study||395||
59530575|NCT01659996|75627047|FG002|STARTED|Overall Study||472||
59530576|NCT01659996|75627045|FG000|COMPLETED|Overall Study||413||
59530577|NCT01659996|75627046|FG001|COMPLETED|Overall Study||388||
59530578|NCT01659996|75627047|FG002|COMPLETED|Overall Study||461||
60075453|NCT02505919|76190748|FG001|STARTED|36 Months Follow-Up||60||
60075454|NCT02505919|76190747|FG000|COMPLETED|36 Months Follow-Up||97||
59530579|NCT01659996|75627045|FG000|NOT COMPLETED|Overall Study||8||
59530580|NCT01659996|75627046|FG001|NOT COMPLETED|Overall Study||7||
59530581|NCT01659996|75627047|FG002|NOT COMPLETED|Overall Study||11||
59530582|NCT00309140|75627057|FG000|STARTED|Overall Study||23||
59530583|NCT00309140|75627057|FG000|Received at Least 1 Dose of Study Drug|Overall Study||23||
59530584|NCT00309140|75627057|FG000|COMPLETED|Overall Study||23||
59530585|NCT00309140|75627057|FG000|NOT COMPLETED|Overall Study||0||
59530586|NCT00353522|75627063|FG000|STARTED|Overall Study||89||
60075455|NCT02505919|76190748|FG001|COMPLETED|36 Months Follow-Up||55||
60075456|NCT02505919|76190747|FG000|NOT COMPLETED|36 Months Follow-Up||15||
60075457|NCT02505919|76190748|FG001|NOT COMPLETED|36 Months Follow-Up||5||
60075458|NCT02505919|76190747|FG000|STARTED|60 Months Follow-Up||97||
60075459|NCT02505919|76190748|FG001|STARTED|60 Months Follow-Up||55||
59530587|NCT00353522|75627064|FG001|STARTED|Overall Study||46||
59530588|NCT00353522|75627063|FG000|COMPLETED|Overall Study||74||
59530589|NCT00353522|75627064|FG001|COMPLETED|Overall Study||37||
59530590|NCT00353522|75627063|FG000|NOT COMPLETED|Overall Study||15||
59530591|NCT00353522|75627064|FG001|NOT COMPLETED|Overall Study||9||
59530592|NCT00310076|75627070|FG000|STARTED|Overall Study||29||
59530593|NCT00310076|75627070|FG000|COMPLETED|Overall Study||26||
59530594|NCT00310076|75627070|FG000|NOT COMPLETED|Overall Study||3||
59530595|NCT00353834|75627076|FG000|STARTED|Overall Study||26||
59530596|NCT00353834|75627077|FG001|STARTED|Overall Study||27||
59530597|NCT00353834|75627076|FG000|COMPLETED|Overall Study||26||
59530598|NCT00353834|75627077|FG001|COMPLETED|Overall Study||27||
59530599|NCT00353834|75627076|FG000|NOT COMPLETED|Overall Study||0||
59530600|NCT00353834|75627077|FG001|NOT COMPLETED|Overall Study||0||
59530601|NCT00354224|75627083|FG000|STARTED|Overall Study||10||
59530602|NCT00354224|75627083|FG000|COMPLETED|Overall Study||10||
59530603|NCT00354224|75627083|FG000|NOT COMPLETED|Overall Study||0||
59530604|NCT00310310|75627089|FG000|STARTED|Overall Study||120||
59530605|NCT00310310|75627090|FG001|STARTED|Overall Study||120||
59530606|NCT00310310|75627089|FG000|COMPLETED|Overall Study||90||
59530607|NCT00310310|75627090|FG001|COMPLETED|Overall Study||100||
59530608|NCT00310310|75627089|FG000|NOT COMPLETED|Overall Study||30||
59530609|NCT00310310|75627090|FG001|NOT COMPLETED|Overall Study||20||
59530610|NCT00310466|75627098|FG000|STARTED|Overall Study||113||
59530611|NCT00310466|75627099|FG001|STARTED|Overall Study||113||
59530612|NCT00310466|75627098|FG000|COMPLETED|Overall Study||95||
59530613|NCT00310466|75627099|FG001|COMPLETED|Overall Study||101||
59530614|NCT00310466|75627098|FG000|NOT COMPLETED|Overall Study||18||
59530615|NCT00310466|75627099|FG001|NOT COMPLETED|Overall Study||12||
59530616|NCT00355394|75627107|FG000|STARTED|Overall Study||15||
59530617|NCT00355394|75627108|FG001|STARTED|Overall Study||16||
59530618|NCT00355394|75627107|FG000|COMPLETED|Overall Study||15||
59530619|NCT00355394|75627108|FG001|COMPLETED|Overall Study||16||
59530620|NCT00355394|75627107|FG000|NOT COMPLETED|Overall Study||0||
59530621|NCT00355394|75627108|FG001|NOT COMPLETED|Overall Study||0||
59530622|NCT00355706|75627118|FG000|STARTED|Overall Study||50||
59530623|NCT00355706|75627119|FG001|STARTED|Overall Study||50||
59530624|NCT00355706|75627118|FG000|COMPLETED|Overall Study||50||
59530625|NCT00355706|75627119|FG001|COMPLETED|Overall Study||50||
59530626|NCT00355706|75627118|FG000|NOT COMPLETED|Overall Study||0||
59530627|NCT00355706|75627119|FG001|NOT COMPLETED|Overall Study||0||
59530628|NCT00311246|75627127|FG000|STARTED|Overall Study||11||
59530629|NCT00311246|75627127|FG000|COMPLETED|Overall Study||11||
59530630|NCT00311246|75627127|FG000|NOT COMPLETED|Overall Study||0||
59530631|NCT02105246|75627136|FG000|STARTED|Overall Study||557||
59530632|NCT02105246|75627137|FG001|STARTED|Overall Study||597||
59530633|NCT02105246|75627136|FG000|COMPLETED|Overall Study||557||
59530634|NCT02105246|75627137|FG001|COMPLETED|Overall Study||597||
59530635|NCT02105246|75627136|FG000|NOT COMPLETED|Overall Study||0||
59530636|NCT02105246|75627137|FG001|NOT COMPLETED|Overall Study||0||
59530637|NCT02105324|75627147|FG000|STARTED|Period 1||9||
59530638|NCT02105324|75627148|FG001|STARTED|Period 1||10||
59530639|NCT02105324|75627147|FG000|COMPLETED|Period 1||9||
59530640|NCT02105324|75627148|FG001|COMPLETED|Period 1||10||
59530641|NCT02105324|75627147|FG000|NOT COMPLETED|Period 1||0||
59530642|NCT02105324|75627148|FG001|NOT COMPLETED|Period 1||0||
59530643|NCT02105324|75627147|FG000|STARTED|Period 2||9||
59530644|NCT02105324|75627148|FG001|STARTED|Period 2||10||
59530645|NCT02105324|75627147|FG000|COMPLETED|Period 2||9||
59530646|NCT02105324|75627148|FG001|COMPLETED|Period 2||10||
59530647|NCT02105324|75627147|FG000|NOT COMPLETED|Period 2||0||
59530648|NCT02105324|75627148|FG001|NOT COMPLETED|Period 2||0||
59530649|NCT02105558|75627159|FG000|STARTED|Overall Study||15||
59530650|NCT02105558|75627160|FG001|STARTED|Overall Study||28||
59530651|NCT02105558|75627159|FG000|COMPLETED|Overall Study||15||
59530652|NCT02105558|75627160|FG001|COMPLETED|Overall Study||28||
59530653|NCT02105558|75627159|FG000|NOT COMPLETED|Overall Study||0||
59530654|NCT02105558|75627160|FG001|NOT COMPLETED|Overall Study||0||
59530655|NCT00312884|75627168|FG000|STARTED|Overall Study||91||
59530656|NCT00312884|75627169|FG001|STARTED|Overall Study||91||
59530657|NCT00312884|75627168|FG000|COMPLETED|Overall Study||74||
59530658|NCT00312884|75627169|FG001|COMPLETED|Overall Study||79||
59530659|NCT00312884|75627168|FG000|NOT COMPLETED|Overall Study||17||
59530660|NCT00312884|75627169|FG001|NOT COMPLETED|Overall Study||12||
59530661|NCT02106728|75627177|FG000|STARTED|Overall Study||70||
59530662|NCT02106728|75627178|FG001|STARTED|Overall Study||47||
59530663|NCT02106728|75627177|FG000|COMPLETED|Overall Study||70||
59530664|NCT02106728|75627178|FG001|COMPLETED|Overall Study||47||
59530665|NCT02106728|75627177|FG000|NOT COMPLETED|Overall Study||0||
59530666|NCT02106728|75627178|FG001|NOT COMPLETED|Overall Study||0||
59530667|NCT02106962|75627192|FG000|STARTED|Overall Study||8||
59622723|NCT00439296|75734611|FG001|NOT COMPLETED|Overall Study||0||
60075460|NCT02505919|76190747|FG000|COMPLETED|60 Months Follow-Up||58||
60075461|NCT02505919|76190748|FG001|COMPLETED|60 Months Follow-Up||32||
60075462|NCT02505919|76190747|FG000|NOT COMPLETED|60 Months Follow-Up||39||
60075463|NCT02505919|76190748|FG001|NOT COMPLETED|60 Months Follow-Up||23||
60075464|NCT02315703|76190763|FG000|STARTED|Main Study (From Week 0 up to Week 96)||50||
60075465|NCT02315703|76190764|FG001|STARTED|Main Study (From Week 0 up to Week 96)||49||
60075466|NCT02315703|76190765|FG002|STARTED|Main Study (From Week 0 up to Week 96)||49||
59530668|NCT02106962|75627193|FG001|STARTED|Overall Study||9||
59530669|NCT02106962|75627192|FG000|COMPLETED|Overall Study||8||
59530670|NCT02106962|75627193|FG001|COMPLETED|Overall Study||9||
59530671|NCT02106962|75627192|FG000|NOT COMPLETED|Overall Study||0||
59530672|NCT02106962|75627193|FG001|NOT COMPLETED|Overall Study||0||
59530673|NCT00315146|75627205|FG000|STARTED|Overall Study||22||
59530674|NCT00315146|75627206|FG001|STARTED|Overall Study||22||
59530675|NCT00315146|75627207|FG002|STARTED|Overall Study||22||
59530676|NCT00315146|75627208|FG003|STARTED|Overall Study||22||
59530677|NCT00315146|75627205|FG000|COMPLETED|Overall Study||20||
59530678|NCT00315146|75627206|FG001|COMPLETED|Overall Study||19||
59530679|NCT00315146|75627207|FG002|COMPLETED|Overall Study||20||
59530680|NCT00315146|75627208|FG003|COMPLETED|Overall Study||22||
59530681|NCT00315146|75627205|FG000|NOT COMPLETED|Overall Study||2||
59530682|NCT00315146|75627206|FG001|NOT COMPLETED|Overall Study||3||
59530683|NCT00315146|75627207|FG002|NOT COMPLETED|Overall Study||2||
59530684|NCT00315146|75627208|FG003|NOT COMPLETED|Overall Study||0||
59530685|NCT00315302|75627226|FG000|STARTED|Overall Study||90||
59530686|NCT00315302|75627227|FG001|STARTED|Overall Study||90||
59530687|NCT00315302|75627228|FG002|STARTED|Overall Study||26||
59530688|NCT00315302|75627229|FG003|STARTED|Overall Study||34||
59530689|NCT00315302|75627226|FG000|5 Week Visit|Overall Study||85||
59530690|NCT00315302|75627227|FG001|5 Week Visit|Overall Study||86||
59530691|NCT00315302|75627228|FG002|5 Week Visit|Overall Study||26||
59530692|NCT00315302|75627229|FG003|5 Week Visit|Overall Study||30||
59530693|NCT00315302|75627226|FG000|10 Week Visit|Overall Study|Can be higher as includes subjects who may have missed the 5 week visit|86||
59530694|NCT00315302|75627227|FG001|10 Week Visit|Overall Study||85||
59530695|NCT00315302|75627228|FG002|10 Week Visit|Overall Study||24||
59530696|NCT00315302|75627229|FG003|10 Week Visit|Overall Study||29||
59530697|NCT00315302|75627226|FG000|18 Week Primary Outcome Visit|Overall Study||84||
59530698|NCT00315302|75627227|FG001|18 Week Primary Outcome Visit|Overall Study|Can be higher as includes subjects who may have missed the 10 week or other visit|88||
59530699|NCT00315302|75627228|FG002|18 Week Primary Outcome Visit|Overall Study||24||
59530700|NCT00315302|75627229|FG003|18 Week Primary Outcome Visit|Overall Study|Can be higher as includes subjects who may have missed the 10 week or other visit|31||
59530701|NCT00315302|75627226|FG000|Partial Responder Phase (Post 18 Weeks)|Overall Study|Those who improved in the amblyopic eye at 18wk outcome continued on treatment w/ visits every 8wks.|16||
59530702|NCT00315302|75627227|FG001|Partial Responder Phase (Post 18 Weeks)|Overall Study|Those who improved in the amblyopic eye at 18wk outcome continued on treatment w/ visits every 8wks.|13||
59530703|NCT00315302|75627228|FG002|Partial Responder Phase (Post 18 Weeks)|Overall Study|Those who improved in the amblyopic eye at 18wk outcome continued on treatment w/ visits every 8wks.|9||
59530704|NCT00315302|75627229|FG003|Partial Responder Phase (Post 18 Weeks)|Overall Study|Those who improved in the amblyopic eye at 18wk outcome continued on treatment w/ visits every 8wks.|11||
59530705|NCT00315302|75627226|FG000|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|84||
59530706|NCT00315302|75627227|FG001|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|88||
59530707|NCT00315302|75627228|FG002|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|24||
59530708|NCT00315302|75627229|FG003|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|31||
59530709|NCT00315302|75627226|FG000|NOT COMPLETED|Overall Study||6||
59530710|NCT00315302|75627227|FG001|NOT COMPLETED|Overall Study||2||
59530711|NCT00315302|75627228|FG002|NOT COMPLETED|Overall Study||2||
59530712|NCT00315302|75627229|FG003|NOT COMPLETED|Overall Study||3||
59530713|NCT00315614|75627239|FG000|STARTED|Overall Study||3||
59530714|NCT00315614|75627239|FG000|COMPLETED|Overall Study||3||
59530715|NCT00315614|75627239|FG000|NOT COMPLETED|Overall Study||0||
59530716|NCT00316862|75627244|FG000|STARTED|Overall Study||82||
59530717|NCT00316862|75627244|FG000|COMPLETED|Overall Study||82||
59530718|NCT00316862|75627244|FG000|NOT COMPLETED|Overall Study||0||
59530719|NCT00357032|75627248|FG000|STARTED|Overall Study||12||
59530720|NCT00357032|75627248|FG000|COMPLETED|Overall Study||12||
59530721|NCT00357032|75627248|FG000|NOT COMPLETED|Overall Study||0||
59530722|NCT00357734|75627252|FG000|STARTED|Overall Study||14||
59530723|NCT00357734|75627252|FG000|Patients Received 250 mg of ZD1839|Overall Study||13||
59530724|NCT00357734|75627252|FG000|Patient Received 500 mg of ZD1839|Overall Study||1||
59530725|NCT00357734|75627252|FG000|COMPLETED|Overall Study||10||
59530726|NCT00357734|75627252|FG000|NOT COMPLETED|Overall Study||4||
59530727|NCT00318812|75627258|FG000|STARTED|Overall Study||18||
59530728|NCT00318812|75627259|FG001|STARTED|Overall Study||22||
59530729|NCT00318812|75627258|FG000|COMPLETED|Overall Study||18||
59530730|NCT00318812|75627259|FG001|COMPLETED|Overall Study||22||
59530731|NCT00318812|75627258|FG000|NOT COMPLETED|Overall Study||0||
59530732|NCT00318812|75627259|FG001|NOT COMPLETED|Overall Study||0||
59530733|NCT02109458|75627265|FG000|STARTED|Overall Study||24||
59815238|NCT05080179|75937682|FG002|STARTED|Overall Study||4211||
59815239|NCT05080179|75937683|FG003|STARTED|Overall Study||4214||
59815240|NCT05080179|75937680|FG000|COMPLETED|Overall Study||353||
59815241|NCT05080179|75937681|FG001|COMPLETED|Overall Study||380||
59815242|NCT05080179|75937682|FG002|COMPLETED|Overall Study||355||
59815243|NCT05080179|75937683|FG003|COMPLETED|Overall Study||744||
59815244|NCT05080179|75937680|FG000|NOT COMPLETED|Overall Study||3879||
59815245|NCT05080179|75937681|FG001|NOT COMPLETED|Overall Study||3866||
59815246|NCT05080179|75937682|FG002|NOT COMPLETED|Overall Study||3856||
59815247|NCT05080179|75937683|FG003|NOT COMPLETED|Overall Study||3470||
59815248|NCT05025345|75937695|FG000|STARTED|Overall Study||107||
59815249|NCT05025345|75937696|FG001|STARTED|Overall Study||107||
59815250|NCT05025345|75937695|FG000|COMPLETED|Overall Study||103||
59815251|NCT05025345|75937696|FG001|COMPLETED|Overall Study||107||
59815252|NCT05025345|75937695|FG000|NOT COMPLETED|Overall Study||4||
59815253|NCT05025345|75937696|FG001|NOT COMPLETED|Overall Study||0||
59815254|NCT04720664|75937702|FG000|STARTED|Overall Study||11||
59530734|NCT02109458|75627265|FG000|COMPLETED|Overall Study||24||
59530735|NCT02109458|75627265|FG000|NOT COMPLETED|Overall Study||0||
59530736|NCT00319748|75627269|FG000|STARTED|Overall Study||13||
59530737|NCT00319748|75627269|FG000|COMPLETED|Overall Study||13||
59530738|NCT00319748|75627269|FG000|NOT COMPLETED|Overall Study||0||
59530739|NCT00361712|75627281|FG000|STARTED|Overall Study||20||
59530740|NCT00361712|75627282|FG001|STARTED|Overall Study||21||
59530741|NCT00361712|75627281|FG000|COMPLETED|Overall Study||20||
59530742|NCT00361712|75627282|FG001|COMPLETED|Overall Study||21||
59530743|NCT00361712|75627281|FG000|NOT COMPLETED|Overall Study||0||
59530744|NCT00361712|75627282|FG001|NOT COMPLETED|Overall Study||0||
59530745|NCT00362882|75627290|FG000|STARTED|Overall Study||40||
59530746|NCT00362882|75627291|FG001|STARTED|Overall Study||41||
59987712|NCT00966953|76102946|FG001|NOT COMPLETED|1 Week Washout After 2nd Intervention||0||
59987713|NCT00966953|76102947|FG002|NOT COMPLETED|1 Week Washout After 2nd Intervention||0||
59987714|NCT00966953|76102948|FG003|NOT COMPLETED|1 Week Washout After 2nd Intervention||0||
59987715|NCT00966953|76102945|FG000|STARTED|3rd Intervention Order||6||
59987716|NCT00966953|76102946|FG001|STARTED|3rd Intervention Order||6||
59987717|NCT00966953|76102947|FG002|STARTED|3rd Intervention Order||6||
59987718|NCT00966953|76102948|FG003|STARTED|3rd Intervention Order||7||
60075467|NCT02315703|76190766|FG003|STARTED|Main Study (From Week 0 up to Week 96)||48||
60075468|NCT02315703|76190767|FG004|STARTED|Main Study (From Week 0 up to Week 96)||49||
60075469|NCT02315703|76190768|FG005|STARTED|Main Study (From Week 0 up to Week 96)||49||
60075470|NCT02315703|76190769|FG006|STARTED|Main Study (From Week 0 up to Week 96)||50||
59530747|NCT00362882|75627290|FG000|COMPLETED|Overall Study||40||
59530748|NCT00362882|75627291|FG001|COMPLETED|Overall Study||41||
59530749|NCT00362882|75627290|FG000|NOT COMPLETED|Overall Study||0||
59530750|NCT00362882|75627291|FG001|NOT COMPLETED|Overall Study||0||
59530751|NCT00365144|75627297|FG000|STARTED|Overall Study||36||
59530752|NCT00365144|75627297|FG000|COMPLETED|Overall Study||36||
59530753|NCT00365144|75627297|FG000|NOT COMPLETED|Overall Study||0||
59530754|NCT00365768|75627304|FG000|STARTED|Overall Study||24||
59530755|NCT00365768|75627305|FG001|STARTED|Overall Study||25||
59530756|NCT00365768|75627304|FG000|COMPLETED|Overall Study||24||
59530757|NCT00365768|75627305|FG001|COMPLETED|Overall Study||25||
59530758|NCT00365768|75627304|FG000|NOT COMPLETED|Overall Study||0||
59530759|NCT00365768|75627305|FG001|NOT COMPLETED|Overall Study||0||
59530760|NCT00366626|75627313|FG000|STARTED|Overall Study||38||
59530761|NCT00366626|75627314|FG001|STARTED|Overall Study||45||
59530762|NCT00366626|75627313|FG000|COMPLETED|Overall Study||38||
59530763|NCT00366626|75627314|FG001|COMPLETED|Overall Study||45||
59530764|NCT00366626|75627313|FG000|NOT COMPLETED|Overall Study||0||
59530765|NCT00366626|75627314|FG001|NOT COMPLETED|Overall Study||0||
59530766|NCT00367016|75627324|FG000|STARTED|Overall Study||3||
59530767|NCT00367016|75627325|FG001|STARTED|Overall Study||3||
59530768|NCT00367016|75627324|FG000|First Intervention|Overall Study||3||
59530769|NCT00367016|75627325|FG001|First Intervention|Overall Study||3||
59530770|NCT00367016|75627324|FG000|Second Intervention|Overall Study||3||
59530771|NCT00367016|75627325|FG001|Second Intervention|Overall Study||3||
59530772|NCT00367016|75627324|FG000|COMPLETED|Overall Study||3||
59530773|NCT00367016|75627325|FG001|COMPLETED|Overall Study||3||
60075471|NCT02315703|76190770|FG007|STARTED|Main Study (From Week 0 up to Week 96)||49||
60075472|NCT02315703|76190763|FG000|COMPLETED|Main Study (From Week 0 up to Week 96)||44||
60075473|NCT02315703|76190764|FG001|COMPLETED|Main Study (From Week 0 up to Week 96)||39||
60075474|NCT02315703|76190765|FG002|COMPLETED|Main Study (From Week 0 up to Week 96)||44||
60075475|NCT02315703|76190766|FG003|COMPLETED|Main Study (From Week 0 up to Week 96)||39||
60075476|NCT02315703|76190767|FG004|COMPLETED|Main Study (From Week 0 up to Week 96)||41||
59530774|NCT00367016|75627324|FG000|NOT COMPLETED|Overall Study||0||
59622724|NCT00542490|75734617|FG000|STARTED|Overall Study||23||
59987719|NCT00966953|76102945|FG000|COMPLETED|3rd Intervention Order||6||
59987720|NCT00966953|76102946|FG001|COMPLETED|3rd Intervention Order||6||
59987721|NCT00966953|76102947|FG002|COMPLETED|3rd Intervention Order||6||
59987722|NCT00966953|76102948|FG003|COMPLETED|3rd Intervention Order||7||
59987723|NCT00966953|76102945|FG000|NOT COMPLETED|3rd Intervention Order||0||
59987724|NCT00966953|76102946|FG001|NOT COMPLETED|3rd Intervention Order||0||
60075477|NCT02315703|76190768|FG005|COMPLETED|Main Study (From Week 0 up to Week 96)||43||
60075478|NCT02315703|76190769|FG006|COMPLETED|Main Study (From Week 0 up to Week 96)||37||
59530775|NCT00367016|75627325|FG001|NOT COMPLETED|Overall Study||0||
59530776|NCT00573378|75627333|FG000|STARTED|Overall Study||12||
59530777|NCT00573378|75627333|FG000|Evaluable for Primary Outcome Measure|Overall Study||1||
59530778|NCT00573378|75627333|FG000|COMPLETED|Overall Study||0||
59530779|NCT00573378|75627333|FG000|NOT COMPLETED|Overall Study||12||
59530780|NCT00369512|75627337|FG000|STARTED|Overall Study||15||
59987725|NCT00966953|76102947|FG002|NOT COMPLETED|3rd Intervention Order||0||
59987726|NCT00966953|76102948|FG003|NOT COMPLETED|3rd Intervention Order||0||
59987727|NCT00966953|76102945|FG000|STARTED|1 Week Washout After 3rd Intervention||6||
59987728|NCT00966953|76102946|FG001|STARTED|1 Week Washout After 3rd Intervention||6||
59987729|NCT00966953|76102947|FG002|STARTED|1 Week Washout After 3rd Intervention||6||
59987730|NCT00966953|76102948|FG003|STARTED|1 Week Washout After 3rd Intervention||7||
59815255|NCT04720664|75937702|FG000|COMPLETED|Overall Study||0||
59815256|NCT04720664|75937702|FG000|NOT COMPLETED|Overall Study||11||
59815257|NCT04612400|75937708|FG000|STARTED|Overall Study||4||
59815258|NCT04612400|75937709|FG001|STARTED|Overall Study||4||
59815259|NCT04612400|75937708|FG000|COMPLETED|Overall Study||4||
59815260|NCT04612400|75937709|FG001|COMPLETED|Overall Study||4||
59530781|NCT00369512|75627337|FG000|COMPLETED|Overall Study||15||
59530782|NCT00369512|75627337|FG000|NOT COMPLETED|Overall Study||0||
59530783|NCT00324272|75627345|FG000|STARTED|Overall Study||18||
59530784|NCT00324272|75627346|FG001|STARTED|Overall Study||20||
59530785|NCT00324272|75627347|FG002|STARTED|Overall Study||18||
59530786|NCT00324272|75627348|FG003|STARTED|Overall Study||18||
59530787|NCT00324272|75627345|FG000|COMPLETED|Overall Study||18||
59530788|NCT00324272|75627346|FG001|COMPLETED|Overall Study||20||
59530789|NCT00324272|75627347|FG002|COMPLETED|Overall Study||18||
59530790|NCT00324272|75627348|FG003|COMPLETED|Overall Study||18||
59530791|NCT00324272|75627345|FG000|NOT COMPLETED|Overall Study||0||
59530792|NCT00324272|75627346|FG001|NOT COMPLETED|Overall Study||0||
59530793|NCT00324272|75627347|FG002|NOT COMPLETED|Overall Study||0||
59530794|NCT00324272|75627348|FG003|NOT COMPLETED|Overall Study||0||
59530795|NCT00369590|75627360|FG000|STARTED|Overall Study||16||
59530796|NCT00369590|75627361|FG001|STARTED|Overall Study||42||
59530797|NCT00369590|75627360|FG000|COMPLETED|Overall Study||16||
59530798|NCT00369590|75627361|FG001|COMPLETED|Overall Study||42||
59530799|NCT00369590|75627360|FG000|NOT COMPLETED|Overall Study||0||
59530800|NCT00369590|75627361|FG001|NOT COMPLETED|Overall Study||0||
59530801|NCT03367910|75627366|FG000|STARTED|Overall Study||1||
59530802|NCT03367910|75627366|FG000|COMPLETED|Overall Study||1||
59530803|NCT03367910|75627366|FG000|NOT COMPLETED|Overall Study||0||
59530804|NCT00324350|75627372|FG000|STARTED|Overall Study||3655||
59530805|NCT00324350|75627373|FG001|STARTED|Overall Study||3632||
59530806|NCT00324350|75627372|FG000|Non-Vertebral Fracture Follow-Up|Overall Study||3655||
59530807|NCT00324350|75627373|FG001|Non-Vertebral Fracture Follow-Up|Overall Study||3632||
59530808|NCT00324350|75627372|FG000|Falls Follow-Up|Overall Study||3364||
59815261|NCT04612400|75937708|FG000|NOT COMPLETED|Overall Study||0||
59815262|NCT04612400|75937709|FG001|NOT COMPLETED|Overall Study||0||
59815263|NCT04371198|75937715|FG000|STARTED|Overall Study||20||
59815264|NCT04371198|75937715|FG000|COMPLETED|Overall Study||16||
59815265|NCT04371198|75937715|FG000|NOT COMPLETED|Overall Study||4||
59815266|NCT04288154|75937721|FG000|STARTED|Overall Study||46||
59987731|NCT00966953|76102945|FG000|COMPLETED|1 Week Washout After 3rd Intervention||6||
59987732|NCT00966953|76102946|FG001|COMPLETED|1 Week Washout After 3rd Intervention||6||
59987733|NCT00966953|76102947|FG002|COMPLETED|1 Week Washout After 3rd Intervention||6||
59987734|NCT00966953|76102948|FG003|COMPLETED|1 Week Washout After 3rd Intervention||7||
59987735|NCT00966953|76102945|FG000|NOT COMPLETED|1 Week Washout After 3rd Intervention||0||
59987736|NCT00966953|76102946|FG001|NOT COMPLETED|1 Week Washout After 3rd Intervention||0||
59987737|NCT00966953|76102947|FG002|NOT COMPLETED|1 Week Washout After 3rd Intervention||0||
59987738|NCT00966953|76102948|FG003|NOT COMPLETED|1 Week Washout After 3rd Intervention||0||
59987739|NCT00966953|76102945|FG000|STARTED|4th Intervention Order||6||
59530809|NCT00324350|75627373|FG001|Falls Follow-Up|Overall Study||3418||
59530810|NCT00324350|75627372|FG000|COMPLETED|Overall Study||3655||
59530811|NCT00324350|75627373|FG001|COMPLETED|Overall Study||3632||
59530812|NCT00324350|75627372|FG000|NOT COMPLETED|Overall Study||0||
59530813|NCT00324350|75627373|FG001|NOT COMPLETED|Overall Study||0||
59530814|NCT00390182|75627380|FG000|STARTED|Overall Study||38||
59530815|NCT00390182|75627380|FG000|COMPLETED|Overall Study||33||
59530816|NCT00390182|75627380|FG000|NOT COMPLETED|Overall Study||5||
59530817|NCT00369746|75627386|FG000|STARTED|Overall Study||138||
59530818|NCT00369746|75627387|FG001|STARTED|Overall Study||536||
59530819|NCT00369746|75627386|FG000|COMPLETED|Overall Study||138||
59530820|NCT00369746|75627387|FG001|COMPLETED|Overall Study||536||
59530821|NCT00369746|75627386|FG000|NOT COMPLETED|Overall Study||0||
59530822|NCT00369746|75627387|FG001|NOT COMPLETED|Overall Study||0||
59815267|NCT04288154|75937722|FG001|STARTED|Overall Study||32||
59815268|NCT04288154|75937721|FG000|COMPLETED|Overall Study||37||
59815269|NCT04288154|75937722|FG001|COMPLETED|Overall Study||23||
59815270|NCT04288154|75937721|FG000|NOT COMPLETED|Overall Study||9||
59815271|NCT04288154|75937722|FG001|NOT COMPLETED|Overall Study||9||
59815272|NCT04258579|75937728|FG000|STARTED|Overall Study||40||
59815273|NCT04258579|75937728|FG000|COMPLETED|Overall Study||27||
59815274|NCT04258579|75937728|FG000|NOT COMPLETED|Overall Study||13||
59815275|NCT03945214|75937736|FG000|STARTED|Overall Study||39||
59815276|NCT03945214|75937737|FG001|STARTED|Overall Study||41||
59530823|NCT00392054|75627395|FG000|STARTED|Overall Study|All participants randomized are included in final analysis|66||
59815277|NCT03945214|75937738|FG002|STARTED|Overall Study||41||
59530824|NCT00392054|75627396|FG001|STARTED|Overall Study|All participants randomized are included in final analysis|61||
59530825|NCT00392054|75627395|FG000|Received Allocated Intervention|Overall Study||65||
59530826|NCT00392054|75627396|FG001|Received Allocated Intervention|Overall Study||60||
59530827|NCT00392054|75627395|FG000|COMPLETED|Overall Study||66||
59530828|NCT00392054|75627396|FG001|COMPLETED|Overall Study||61||
59530829|NCT00392054|75627395|FG000|NOT COMPLETED|Overall Study||0||
59530830|NCT00392054|75627396|FG001|NOT COMPLETED|Overall Study||0||
59530831|NCT02525874|75627406|FG000|STARTED|Overall Study||218||
59530832|NCT02525874|75627406|FG000|COMPLETED|Overall Study||158||
59530833|NCT02525874|75627406|FG000|NOT COMPLETED|Overall Study||60||
59530834|NCT00392444|75627410|FG000|STARTED|Overall Study||39||
59530835|NCT00392444|75627410|FG000|COMPLETED|Overall Study||39||
59530836|NCT00392444|75627410|FG000|NOT COMPLETED|Overall Study||0||
59530837|NCT02528214|75627416|FG000|STARTED|Overall Study||107||
59530838|NCT02528214|75627417|FG001|STARTED|Overall Study||103||
59530839|NCT02528214|75627416|FG000|Treated|Overall Study||107||
59530840|NCT02528214|75627417|FG001|Treated|Overall Study||103||
59530841|NCT02528214|75627416|FG000|COMPLETED|Overall Study||107||
59530842|NCT02528214|75627417|FG001|COMPLETED|Overall Study||100||
59530843|NCT02528214|75627416|FG000|NOT COMPLETED|Overall Study||0||
59530844|NCT02528214|75627417|FG001|NOT COMPLETED|Overall Study||3||
59530845|NCT00392678|75627428|FG000|STARTED|Overall Study||27||
59530846|NCT00392678|75627429|FG001|STARTED|Overall Study||27||
59530847|NCT00392678|75627430|FG002|STARTED|Overall Study||27||
59530848|NCT00392678|75627431|FG003|STARTED|Overall Study||27||
59530849|NCT00392678|75627428|FG000|COMPLETED|Overall Study||27||
59530850|NCT00392678|75627429|FG001|COMPLETED|Overall Study||26||
59530851|NCT00392678|75627430|FG002|COMPLETED|Overall Study||25||
59530852|NCT00392678|75627431|FG003|COMPLETED|Overall Study||26||
59530853|NCT00392678|75627428|FG000|NOT COMPLETED|Overall Study||0||
59530854|NCT00392678|75627429|FG001|NOT COMPLETED|Overall Study||1||
59530855|NCT00392678|75627430|FG002|NOT COMPLETED|Overall Study||2||
59530856|NCT00392678|75627431|FG003|NOT COMPLETED|Overall Study||1||
59530857|NCT05736861|75627452|FG000|STARTED|Overall Study||919||
59530858|NCT05736861|75627453|FG001|STARTED|Overall Study||881||
59530859|NCT05736861|75627452|FG000|COMPLETED|Overall Study||817||
59530860|NCT05736861|75627453|FG001|COMPLETED|Overall Study||774||
59530861|NCT05736861|75627452|FG000|NOT COMPLETED|Overall Study||102||
59530862|NCT05736861|75627453|FG001|NOT COMPLETED|Overall Study||107||
59530863|NCT05348681|75627461|FG000|STARTED|Overall Study||17||
59530864|NCT05348681|75627462|FG001|STARTED|Overall Study||8||
59530865|NCT05348681|75627461|FG000|COMPLETED|Overall Study||4||
59530866|NCT05348681|75627462|FG001|COMPLETED|Overall Study||2||
59530867|NCT05348681|75627461|FG000|NOT COMPLETED|Overall Study||13||
59530868|NCT05348681|75627462|FG001|NOT COMPLETED|Overall Study||6||
59530869|NCT04662060|75627470|FG000|STARTED|Overall Study||60||
59530870|NCT04662060|75627471|FG001|STARTED|Overall Study||60||
59530871|NCT04662060|75627470|FG000|Received Allocated Treatment|Overall Study||59||
59530872|NCT04662060|75627471|FG001|Received Allocated Treatment|Overall Study||59||
59530873|NCT04662060|75627470|FG000|COMPLETED|Overall Study||55||
59530874|NCT04662060|75627471|FG001|COMPLETED|Overall Study||56||
59530875|NCT04662060|75627470|FG000|NOT COMPLETED|Overall Study||5||
59530876|NCT04662060|75627471|FG001|NOT COMPLETED|Overall Study||4||
59530877|NCT04644796|75627479|FG000|STARTED|Overall Study||17||
59530878|NCT04644796|75627480|FG001|STARTED|Overall Study||17||
59530879|NCT04644796|75627479|FG000|COMPLETED|Overall Study||17||
59530880|NCT04644796|75627480|FG001|COMPLETED|Overall Study||17||
59530881|NCT04644796|75627479|FG000|NOT COMPLETED|Overall Study||0||
59530882|NCT04644796|75627480|FG001|NOT COMPLETED|Overall Study||0||
59530883|NCT04423757|75627488|FG000|STARTED|Overall Study||21||
59530884|NCT04423757|75627489|FG001|STARTED|Overall Study||24||
59530885|NCT04423757|75627488|FG000|Treated|Overall Study||20||
59530886|NCT04423757|75627489|FG001|Treated|Overall Study||23||
59530887|NCT04423757|75627488|FG000|COMPLETED|Overall Study||18|Based on completion of protocol specified treatment.|
59530888|NCT04423757|75627489|FG001|COMPLETED|Overall Study||23|Based on completion of protocol specified treatment.|
59530889|NCT04423757|75627488|FG000|NOT COMPLETED|Overall Study||3||
59530890|NCT04423757|75627489|FG001|NOT COMPLETED|Overall Study||1||
59530891|NCT04379713|75627497|FG000|STARTED|Overall Study||1006||
59530892|NCT04379713|75627498|FG001|STARTED|Overall Study||505||
59530893|NCT04379713|75627497|FG000|Dose 1|Overall Study||1000||
59530894|NCT04379713|75627498|FG001|Dose 1|Overall Study|One participant who was randomized to 13vPnC group incorrectly received 20vPnC vaccination.|504||
59530895|NCT04379713|75627497|FG000|Dose 2|Overall Study||972||
59530896|NCT04379713|75627498|FG001|Dose 2|Overall Study||492||
59530897|NCT04379713|75627497|FG000|Dose 3|Overall Study||964||
59530898|NCT04379713|75627498|FG001|Dose 3|Overall Study||483||
59530899|NCT04379713|75627497|FG000|Dose 4|Overall Study||923||
59530900|NCT04379713|75627498|FG001|Dose 4|Overall Study||462||
59530901|NCT04379713|75627497|FG000|COMPLETED|Overall Study||910||
59530902|NCT04379713|75627498|FG001|COMPLETED|Overall Study||451||
59530903|NCT04379713|75627497|FG000|NOT COMPLETED|Overall Study||96||
59530904|NCT04379713|75627498|FG001|NOT COMPLETED|Overall Study||54||
59530905|NCT04085328|75627506|FG000|STARTED|Overall Study||323|Includes Primary Cohort and Supplemental Cohort|646
59530906|NCT04085328|75627507|FG001|STARTED|Overall Study||322|Includes Primary Cohort and Supplemental Cohort|644
59530907|NCT04085328|75627506|FG000|Primary Cohort Started|Overall Study||291||582
59530908|NCT04085328|75627507|FG001|Primary Cohort Started|Overall Study||290||580
59530909|NCT04085328|75627506|FG000|Primary Cohort Completed|Overall Study||256||512
59530910|NCT04085328|75627507|FG001|Primary Cohort Completed|Overall Study||257||514
59530911|NCT04085328|75627506|FG000|Primary Cohort Discontinued|Overall Study||35||70
59530912|NCT04085328|75627507|FG001|Primary Cohort Discontinued|Overall Study||33||66
59530913|NCT04085328|75627506|FG000|COMPLETED|Overall Study||285|Includes Primary Cohort and Supplemental Cohort|570
59530914|NCT04085328|75627507|FG001|COMPLETED|Overall Study||286|Includes Primary Cohort and Supplemental Cohort|572
59530915|NCT04085328|75627506|FG000|NOT COMPLETED|Overall Study||38||76
59530916|NCT04085328|75627507|FG001|NOT COMPLETED|Overall Study||36||72
59530917|NCT04070144|75627516|FG000|STARTED|Overall Study||50||152
59530918|NCT04070144|75627516|FG000|COMPLETED|Overall Study||50||152
59530919|NCT04070144|75627516|FG000|NOT COMPLETED|Overall Study||0||0
59530920|NCT03775915|75627522|FG000|STARTED|Overall Study||12||
59530921|NCT03775915|75627523|FG001|STARTED|Overall Study||12||
59530922|NCT03775915|75627522|FG000|COMPLETED|Overall Study||12||
59530923|NCT03775915|75627523|FG001|COMPLETED|Overall Study||12||
59530924|NCT03775915|75627522|FG000|NOT COMPLETED|Overall Study||0||
59530925|NCT03775915|75627523|FG001|NOT COMPLETED|Overall Study||0||
59530926|NCT03427047|75627531|FG000|STARTED|Overall Study||46||
59530927|NCT03427047|75627532|FG001|STARTED|Overall Study||36||
59530928|NCT03427047|75627531|FG000|COMPLETED|Overall Study||46||
59530929|NCT03427047|75627532|FG001|COMPLETED|Overall Study||34||
59530930|NCT03427047|75627531|FG000|NOT COMPLETED|Overall Study||0||
59530931|NCT03427047|75627532|FG001|NOT COMPLETED|Overall Study||2||
59530932|NCT03074474|75627538|FG000|STARTED|Overall Study||92||
59530933|NCT03074474|75627538|FG000|COMPLETED|Overall Study||65||
59530934|NCT03074474|75627538|FG000|NOT COMPLETED|Overall Study||27||
59530935|NCT02903381|75627543|FG000|STARTED|Overall Study||8||
59530936|NCT02903381|75627543|FG000|COMPLETED|Overall Study||8||
59530937|NCT02903381|75627543|FG000|NOT COMPLETED|Overall Study||0||
59530938|NCT02744391|75627547|FG000|STARTED|Overall Study||47||
59530939|NCT02744391|75627547|FG000|COMPLETED|Overall Study||33||
59530940|NCT02744391|75627547|FG000|NOT COMPLETED|Overall Study||14||
59530941|NCT02462837|75627553|FG000|STARTED|Overall Study||4||
59530942|NCT02462837|75627554|FG001|STARTED|Overall Study||3||
59530943|NCT02462837|75627553|FG000|COMPLETED|Overall Study||2||
59530944|NCT02462837|75627554|FG001|COMPLETED|Overall Study||3||
59530945|NCT02462837|75627553|FG000|NOT COMPLETED|Overall Study||2||
59530946|NCT02462837|75627554|FG001|NOT COMPLETED|Overall Study||0||
59530947|NCT02346201|75627562|FG000|STARTED|Overall Study||99||
59530948|NCT02346201|75627563|FG001|STARTED|Overall Study||101||
59530949|NCT02346201|75627562|FG000|COMPLETED|Overall Study||89||
59530950|NCT02346201|75627563|FG001|COMPLETED|Overall Study||92||
59530951|NCT02346201|75627562|FG000|NOT COMPLETED|Overall Study||10||
59530952|NCT02346201|75627563|FG001|NOT COMPLETED|Overall Study||9||
59530953|NCT01956942|75627571|FG000|STARTED|Overall Study||38||
59530954|NCT01956942|75627572|FG001|STARTED|Overall Study||31||
59530955|NCT01956942|75627571|FG000|COMPLETED|Overall Study||38||
59530956|NCT01956942|75627572|FG001|COMPLETED|Overall Study||31||
59530957|NCT01956942|75627571|FG000|NOT COMPLETED|Overall Study||0||
59530958|NCT01956942|75627572|FG001|NOT COMPLETED|Overall Study||0||
59530959|NCT01866930|75627583|FG000|STARTED|Treatment Period||104||
59530960|NCT01866930|75627584|FG001|STARTED|Treatment Period||196||
59530961|NCT01866930|75627583|FG000|COMPLETED|Treatment Period||95||
59530962|NCT01866930|75627584|FG001|COMPLETED|Treatment Period||161||
59987740|NCT00966953|76102946|FG001|STARTED|4th Intervention Order||6||
59987741|NCT00966953|76102947|FG002|STARTED|4th Intervention Order||6||
59987742|NCT00966953|76102948|FG003|STARTED|4th Intervention Order||7||
59987743|NCT00966953|76102945|FG000|COMPLETED|4th Intervention Order||6||
59530963|NCT01866930|75627583|FG000|NOT COMPLETED|Treatment Period||9||
59530964|NCT01866930|75627584|FG001|NOT COMPLETED|Treatment Period||35||
59530965|NCT01866930|75627583|FG000|STARTED|Follow-up Period|Includes 7 participants who re-joined from previous period to follow-up period|102||
59530966|NCT01866930|75627584|FG001|STARTED|Follow-up Period|Includes 24 participants who re-joined from previous period to follow-up period|185||
59530967|NCT01866930|75627583|FG000|COMPLETED|Follow-up Period||96||
59530968|NCT01866930|75627584|FG001|COMPLETED|Follow-up Period||176||
59530969|NCT01866930|75627583|FG000|NOT COMPLETED|Follow-up Period||6||
59530970|NCT01866930|75627584|FG001|NOT COMPLETED|Follow-up Period||9||
59530971|NCT01621568|75627592|FG000|STARTED|Treatment Week 1-4||41||
59530972|NCT01621568|75627593|FG001|STARTED|Treatment Week 1-4||15||
59530973|NCT01621568|75627592|FG000|COMPLETED|Treatment Week 1-4||41||
59987744|NCT00966953|76102946|FG001|COMPLETED|4th Intervention Order||6||
59530974|NCT01621568|75627593|FG001|COMPLETED|Treatment Week 1-4||15||
59530975|NCT01621568|75627592|FG000|NOT COMPLETED|Treatment Week 1-4||0||
59530976|NCT01621568|75627593|FG001|NOT COMPLETED|Treatment Week 1-4||0||
59530977|NCT01621568|75627592|FG000|STARTED|Week 5-6 No Treatment||41||
59530978|NCT01621568|75627593|FG001|STARTED|Week 5-6 No Treatment||15||
59530979|NCT01621568|75627592|FG000|COMPLETED|Week 5-6 No Treatment||39||
59530980|NCT01621568|75627593|FG001|COMPLETED|Week 5-6 No Treatment||15||
59530981|NCT01621568|75627592|FG000|NOT COMPLETED|Week 5-6 No Treatment||2||
59530982|NCT01621568|75627593|FG001|NOT COMPLETED|Week 5-6 No Treatment||0||
59530983|NCT01366612|75627604|FG000|STARTED|Overall Study||25||
59530984|NCT01366612|75627605|FG001|STARTED|Overall Study||22||
59530985|NCT01366612|75627604|FG000|COMPLETED|Overall Study||25||
59530986|NCT01366612|75627605|FG001|COMPLETED|Overall Study||22||
59530987|NCT01366612|75627604|FG000|NOT COMPLETED|Overall Study||0||
59530988|NCT01366612|75627605|FG001|NOT COMPLETED|Overall Study||0||
59530989|NCT00813293|75627613|FG000|STARTED|Overall Study||10||
59530990|NCT00813293|75627614|FG001|STARTED|Overall Study||10||
59530991|NCT00813293|75627613|FG000|Started Treatment|Overall Study||9||
59530992|NCT00813293|75627614|FG001|Started Treatment|Overall Study||10||
59530993|NCT00813293|75627613|FG000|Evaluable RFA|Overall Study||7||
59530994|NCT00813293|75627614|FG001|Evaluable RFA|Overall Study||8||
59530995|NCT00813293|75627613|FG000|COMPLETED|Overall Study||9||
59530996|NCT00813293|75627614|FG001|COMPLETED|Overall Study||9||
59530997|NCT00813293|75627613|FG000|NOT COMPLETED|Overall Study||1||
59530998|NCT00813293|75627614|FG001|NOT COMPLETED|Overall Study||1||
59530999|NCT00481091|75627630|FG000|STARTED|Overall Study||3||
59531000|NCT00481091|75627631|FG001|STARTED|Overall Study||6||
59531001|NCT00481091|75627632|FG002|STARTED|Overall Study||3||
59531002|NCT00481091|75627633|FG003|STARTED|Overall Study||3||
59531003|NCT00481091|75627634|FG004|STARTED|Overall Study||3||
59531004|NCT00481091|75627635|FG005|STARTED|Overall Study||4||
59531005|NCT00481091|75627636|FG006|STARTED|Overall Study||3||
59531006|NCT00481091|75627637|FG007|STARTED|Overall Study||4||
59531007|NCT00481091|75627638|FG008|STARTED|Overall Study||4||
59531008|NCT00481091|75627639|FG009|STARTED|Overall Study||27||
59531009|NCT00481091|75627630|FG000|COMPLETED|Overall Study||0||
59531010|NCT00481091|75627631|FG001|COMPLETED|Overall Study||0||
59531011|NCT00481091|75627632|FG002|COMPLETED|Overall Study||0||
59531012|NCT00481091|75627633|FG003|COMPLETED|Overall Study||0||
59531013|NCT00481091|75627634|FG004|COMPLETED|Overall Study||0||
59531014|NCT00481091|75627635|FG005|COMPLETED|Overall Study||0||
59531015|NCT00481091|75627636|FG006|COMPLETED|Overall Study||0||
59531016|NCT00481091|75627637|FG007|COMPLETED|Overall Study||0||
59531017|NCT00481091|75627638|FG008|COMPLETED|Overall Study||0||
59531018|NCT00481091|75627639|FG009|COMPLETED|Overall Study||0||
59531019|NCT00481091|75627630|FG000|NOT COMPLETED|Overall Study||3||
59531020|NCT00481091|75627631|FG001|NOT COMPLETED|Overall Study||6||
59531021|NCT00481091|75627632|FG002|NOT COMPLETED|Overall Study||3||
59531022|NCT00481091|75627633|FG003|NOT COMPLETED|Overall Study||3||
59531023|NCT00481091|75627634|FG004|NOT COMPLETED|Overall Study||3||
59531024|NCT00481091|75627635|FG005|NOT COMPLETED|Overall Study||4||
59531025|NCT00481091|75627636|FG006|NOT COMPLETED|Overall Study||3||
59531026|NCT00481091|75627637|FG007|NOT COMPLETED|Overall Study||4||
59531027|NCT00481091|75627638|FG008|NOT COMPLETED|Overall Study||4||
59531028|NCT00481091|75627639|FG009|NOT COMPLETED|Overall Study||27||
59531029|NCT00085982|75627664|FG000|STARTED|Overall Study||11||
59531030|NCT00085982|75627664|FG000|COMPLETED|Overall Study||5||
59531031|NCT00085982|75627664|FG000|NOT COMPLETED|Overall Study||6||
59531032|NCT00003641|75627670|FG000|STARTED|Overall Study||569||
59531033|NCT00003641|75627671|FG001|STARTED|Overall Study||581||
59531034|NCT00003641|75627670|FG000|Treated|Overall Study|Patients on arm I should undergo observation, but 2 patients received interferon therapy|2||
59531035|NCT00003641|75627671|FG001|Treated|Overall Study||569||
59531036|NCT00003641|75627670|FG000|Toxicity Assessed|Overall Study|439 patients on arm I had their toxicity assessed even though they did not receive any treatment|439||
59531037|NCT00003641|75627671|FG001|Toxicity Assessed|Overall Study||568||
59531038|NCT00003641|75627670|FG000|COMPLETED|Overall Study||0||
59531039|NCT00003641|75627671|FG001|COMPLETED|Overall Study||407||
59531040|NCT00003641|75627670|FG000|NOT COMPLETED|Overall Study||569||
59531041|NCT00003641|75627671|FG001|NOT COMPLETED|Overall Study||174||
59815278|NCT03945214|75937739|FG003|STARTED|Overall Study||42||
59815279|NCT03945214|75937736|FG000|COMPLETED|Overall Study||36||
59531042|NCT00392834|75627679|FG000|STARTED|Overall Study||2||
59531043|NCT00392834|75627680|FG001|STARTED|Overall Study||32||
59531044|NCT00392834|75627679|FG000|COMPLETED|Overall Study||2||
59815280|NCT03945214|75937737|FG001|COMPLETED|Overall Study||37||
59531045|NCT00392834|75627680|FG001|COMPLETED|Overall Study||32||
59531046|NCT00392834|75627679|FG000|NOT COMPLETED|Overall Study||0||
59531047|NCT00392834|75627680|FG001|NOT COMPLETED|Overall Study||0||
59531048|NCT00393380|75627686|FG000|STARTED|Overall Study||13||
59531049|NCT00393380|75627686|FG000|COMPLETED|Overall Study||13||
59531050|NCT00393380|75627686|FG000|NOT COMPLETED|Overall Study||0||
59531051|NCT00395876|75627692|FG000|STARTED|Overall Study||50||
59531052|NCT00395876|75627693|FG001|STARTED|Overall Study||50||
59815281|NCT03945214|75937738|FG002|COMPLETED|Overall Study||34||
59531053|NCT00395876|75627692|FG000|COMPLETED|Overall Study||47||
59531054|NCT00395876|75627693|FG001|COMPLETED|Overall Study||50||
59531055|NCT00395876|75627692|FG000|NOT COMPLETED|Overall Study||3||
59531056|NCT00395876|75627693|FG001|NOT COMPLETED|Overall Study||0||
59531057|NCT02524158|75627701|FG000|STARTED|12-weeks Assessment||76||
59531058|NCT02524158|75627702|FG001|STARTED|12-weeks Assessment||76||
59531059|NCT02524158|75627701|FG000|COMPLETED|12-weeks Assessment||57||
59531060|NCT02524158|75627702|FG001|COMPLETED|12-weeks Assessment||63||
59531061|NCT02524158|75627701|FG000|NOT COMPLETED|12-weeks Assessment||19||
59531062|NCT02524158|75627702|FG001|NOT COMPLETED|12-weeks Assessment||13||
59531063|NCT02524158|75627701|FG000|STARTED|6-month Assessment||76||
59531064|NCT02524158|75627702|FG001|STARTED|6-month Assessment||76||
59531065|NCT02524158|75627701|FG000|COMPLETED|6-month Assessment||54||
59531066|NCT02524158|75627702|FG001|COMPLETED|6-month Assessment||55||
59531067|NCT02524158|75627701|FG000|NOT COMPLETED|6-month Assessment||22||
59531068|NCT02524158|75627702|FG001|NOT COMPLETED|6-month Assessment||21||
59531069|NCT00396032|75627713|FG000|STARTED|Overall Study||74||
59531070|NCT00396032|75627714|FG001|STARTED|Overall Study||76||
59531071|NCT00396032|75627713|FG000|COMPLETED|Overall Study||70||
59531072|NCT00396032|75627714|FG001|COMPLETED|Overall Study||71||
59531073|NCT00396032|75627713|FG000|NOT COMPLETED|Overall Study||4||
59531074|NCT00396032|75627714|FG001|NOT COMPLETED|Overall Study||5||
59531075|NCT02525094|75627722|FG000|STARTED|Overall Study||57||
59531076|NCT02525094|75627723|FG001|STARTED|Overall Study||56||
59531077|NCT02525094|75627722|FG000|Treated|Overall Study||56||
59531078|NCT02525094|75627723|FG001|Treated|Overall Study||55||
59531079|NCT02525094|75627722|FG000|COMPLETED|Overall Study||49||
59531080|NCT02525094|75627723|FG001|COMPLETED|Overall Study||48||
59531081|NCT02525094|75627722|FG000|NOT COMPLETED|Overall Study||8||
59531082|NCT02525094|75627723|FG001|NOT COMPLETED|Overall Study||8||
59531083|NCT02271230|75627734|FG000|STARTED|Overall Study||6463||
59531084|NCT02271230|75627735|FG001|STARTED|Overall Study||6464||
59531085|NCT02271230|75627736|FG002|STARTED|Overall Study||6470||
59531086|NCT02271230|75627737|FG003|STARTED|Overall Study||6474||
59531087|NCT02271230|75627734|FG000|COMPLETED|Overall Study||6463||
59531088|NCT02271230|75627735|FG001|COMPLETED|Overall Study||6464||
59531089|NCT02271230|75627736|FG002|COMPLETED|Overall Study||6470||
59531090|NCT02271230|75627737|FG003|COMPLETED|Overall Study||6474||
59531091|NCT02271230|75627734|FG000|NOT COMPLETED|Overall Study||0||
59531092|NCT02271230|75627735|FG001|NOT COMPLETED|Overall Study||0||
59531093|NCT02271230|75627736|FG002|NOT COMPLETED|Overall Study||0||
59531094|NCT02271230|75627737|FG003|NOT COMPLETED|Overall Study||0||
59531095|NCT00396266|75627749|FG000|STARTED|Overall Study||8||
59531096|NCT00396266|75627750|FG001|STARTED|Overall Study||14||
59531097|NCT00396266|75627749|FG000|COMPLETED|Overall Study||8||
59531098|NCT00396266|75627750|FG001|COMPLETED|Overall Study||14||
59531099|NCT00396266|75627749|FG000|NOT COMPLETED|Overall Study||0||
59531100|NCT00396266|75627750|FG001|NOT COMPLETED|Overall Study||0||
59531101|NCT00397904|75627760|FG000|STARTED|Overall Study||16||
59531102|NCT00397904|75627760|FG000|COMPLETED|Overall Study||16||
59531103|NCT00397904|75627760|FG000|NOT COMPLETED|Overall Study||0||
59531104|NCT00398918|75627764|FG000|STARTED|Overall Study||10||
59531105|NCT00398918|75627764|FG000|COMPLETED|Overall Study||10||
59531106|NCT00398918|75627764|FG000|NOT COMPLETED|Overall Study||0||
59531107|NCT00399308|75627771|FG000|STARTED|Overall Study||13||
59531108|NCT00399308|75627772|FG001|STARTED|Overall Study||15||
59531109|NCT00399308|75627773|FG002|STARTED|Overall Study||12||
59531110|NCT00399308|75627771|FG000|COMPLETED|Overall Study||13||
59531111|NCT00399308|75627772|FG001|COMPLETED|Overall Study||15||
59531112|NCT00399308|75627773|FG002|COMPLETED|Overall Study|One patient withdrew: did not want to comply with study requirements|11||
59531113|NCT00399308|75627771|FG000|NOT COMPLETED|Overall Study||0||
59531114|NCT00399308|75627772|FG001|NOT COMPLETED|Overall Study||0||
59531115|NCT00399308|75627773|FG002|NOT COMPLETED|Overall Study||1||
59531116|NCT00401102|75627781|FG000|STARTED|Overall Study||12||
59531117|NCT00401102|75627781|FG000|COMPLETED|Overall Study||5||
59531118|NCT00401102|75627781|FG000|NOT COMPLETED|Overall Study||7||
59531119|NCT00401414|75627788|FG000|STARTED|Overall Study||118||
59531120|NCT00401414|75627789|FG001|STARTED|Overall Study||147||
59531121|NCT00401414|75627790|FG002|STARTED|Overall Study||79||
59531122|NCT00401414|75627788|FG000|COMPLETED|Overall Study||118||
59531123|NCT00401414|75627789|FG001|COMPLETED|Overall Study||147||
59531124|NCT00401414|75627790|FG002|COMPLETED|Overall Study||79||
59531125|NCT00401414|75627788|FG000|NOT COMPLETED|Overall Study||0||
59531126|NCT00401414|75627789|FG001|NOT COMPLETED|Overall Study||0||
59531127|NCT00401414|75627790|FG002|NOT COMPLETED|Overall Study||0||
59531128|NCT00370838|75627802|FG000|STARTED|Period 1 (Days 8-50)||7||
59531129|NCT00370838|75627803|FG001|STARTED|Period 1 (Days 8-50)||3||
59531130|NCT00370838|75627802|FG000|COMPLETED|Period 1 (Days 8-50)||7||
59531131|NCT00370838|75627803|FG001|COMPLETED|Period 1 (Days 8-50)||3||
59531132|NCT00370838|75627802|FG000|NOT COMPLETED|Period 1 (Days 8-50)||0||
59531133|NCT00370838|75627803|FG001|NOT COMPLETED|Period 1 (Days 8-50)||0||
59531134|NCT00370838|75627802|FG000|STARTED|Washout (Days 51-64)||7||
59531135|NCT00370838|75627803|FG001|STARTED|Washout (Days 51-64)||3||
59531136|NCT00370838|75627802|FG000|COMPLETED|Washout (Days 51-64)||7||
59531137|NCT00370838|75627803|FG001|COMPLETED|Washout (Days 51-64)||3||
59531138|NCT00370838|75627802|FG000|NOT COMPLETED|Washout (Days 51-64)||0||
59531139|NCT00370838|75627803|FG001|NOT COMPLETED|Washout (Days 51-64)||0||
59531140|NCT00370838|75627802|FG000|STARTED|Period 2 (Days 65-107)||7||
59531141|NCT00370838|75627803|FG001|STARTED|Period 2 (Days 65-107)||3||
59531142|NCT00370838|75627802|FG000|COMPLETED|Period 2 (Days 65-107)||7||
59531143|NCT00370838|75627803|FG001|COMPLETED|Period 2 (Days 65-107)||3||
59531144|NCT00370838|75627802|FG000|NOT COMPLETED|Period 2 (Days 65-107)||0||
59531145|NCT00370838|75627803|FG001|NOT COMPLETED|Period 2 (Days 65-107)||0||
59531146|NCT00370838|75627802|FG000|STARTED|Taper||7||
59531147|NCT00370838|75627803|FG001|STARTED|Taper||3||
59531148|NCT00370838|75627802|FG000|COMPLETED|Taper||7||
59531149|NCT00370838|75627803|FG001|COMPLETED|Taper||3||
59531150|NCT00370838|75627802|FG000|NOT COMPLETED|Taper||0||
59531151|NCT00370838|75627803|FG001|NOT COMPLETED|Taper||0||
59531152|NCT00370994|75627811|FG000|STARTED|Overall Study|Sample size was 200, due to the difficulties of recruiting we changed to 120|60||
59531153|NCT00370994|75627812|FG001|STARTED|Overall Study||60||
59531154|NCT00370994|75627811|FG000|COMPLETED|Overall Study||60||
59531155|NCT00370994|75627812|FG001|COMPLETED|Overall Study||60||
59531156|NCT00370994|75627811|FG000|NOT COMPLETED|Overall Study||0||
60075479|NCT02315703|76190770|FG007|COMPLETED|Main Study (From Week 0 up to Week 96)||42||
60075480|NCT02315703|76190763|FG000|NOT COMPLETED|Main Study (From Week 0 up to Week 96)||6||
60075481|NCT02315703|76190764|FG001|NOT COMPLETED|Main Study (From Week 0 up to Week 96)||10||
60075482|NCT02315703|76190765|FG002|NOT COMPLETED|Main Study (From Week 0 up to Week 96)||5||
60075483|NCT02315703|76190766|FG003|NOT COMPLETED|Main Study (From Week 0 up to Week 96)||9||
60075484|NCT02315703|76190767|FG004|NOT COMPLETED|Main Study (From Week 0 up to Week 96)||8||
60075485|NCT02315703|76190768|FG005|NOT COMPLETED|Main Study (From Week 0 up to Week 96)||6||
60075486|NCT02315703|76190769|FG006|NOT COMPLETED|Main Study (From Week 0 up to Week 96)||13||
60075487|NCT02315703|76190770|FG007|NOT COMPLETED|Main Study (From Week 0 up to Week 96)||7||
60075488|NCT02315703|76190763|FG000|STARTED|LTE (After Week 96 up to Week 336)||31||
60075489|NCT02315703|76190764|FG001|STARTED|LTE (After Week 96 up to Week 336)||32||
60075490|NCT02315703|76190765|FG002|STARTED|LTE (After Week 96 up to Week 336)||0||
60075491|NCT02315703|76190766|FG003|STARTED|LTE (After Week 96 up to Week 336)||0||
60075492|NCT02315703|76190767|FG004|STARTED|LTE (After Week 96 up to Week 336)||0||
60075493|NCT02315703|76190768|FG005|STARTED|LTE (After Week 96 up to Week 336)||0||
60075494|NCT02315703|76190769|FG006|STARTED|LTE (After Week 96 up to Week 336)||0||
60075495|NCT02315703|76190770|FG007|STARTED|LTE (After Week 96 up to Week 336)||0||
60075496|NCT02315703|76190763|FG000|COMPLETED|LTE (After Week 96 up to Week 336)||29||
60075497|NCT02315703|76190764|FG001|COMPLETED|LTE (After Week 96 up to Week 336)||27||
60075498|NCT02315703|76190765|FG002|COMPLETED|LTE (After Week 96 up to Week 336)||0||
60075499|NCT02315703|76190766|FG003|COMPLETED|LTE (After Week 96 up to Week 336)||0||
60075500|NCT02315703|76190767|FG004|COMPLETED|LTE (After Week 96 up to Week 336)||0||
60075501|NCT02315703|76190768|FG005|COMPLETED|LTE (After Week 96 up to Week 336)||0||
60075502|NCT02315703|76190769|FG006|COMPLETED|LTE (After Week 96 up to Week 336)||0||
60075503|NCT02315703|76190770|FG007|COMPLETED|LTE (After Week 96 up to Week 336)||0||
60075504|NCT02315703|76190763|FG000|NOT COMPLETED|LTE (After Week 96 up to Week 336)||2||
60075505|NCT02315703|76190764|FG001|NOT COMPLETED|LTE (After Week 96 up to Week 336)||5||
60075506|NCT02315703|76190765|FG002|NOT COMPLETED|LTE (After Week 96 up to Week 336)||0||
60075507|NCT02315703|76190766|FG003|NOT COMPLETED|LTE (After Week 96 up to Week 336)||0||
60075508|NCT02315703|76190767|FG004|NOT COMPLETED|LTE (After Week 96 up to Week 336)||0||
60075509|NCT02315703|76190768|FG005|NOT COMPLETED|LTE (After Week 96 up to Week 336)||0||
60075510|NCT02315703|76190769|FG006|NOT COMPLETED|LTE (After Week 96 up to Week 336)||0||
60075511|NCT02315703|76190770|FG007|NOT COMPLETED|LTE (After Week 96 up to Week 336)||0||
60075512|NCT02049359|76190790|FG000|STARTED|Overall Study||95||
60075513|NCT02049359|76190791|FG001|STARTED|Overall Study||75||
60075514|NCT02049359|76190790|FG000|COMPLETED|Overall Study||69||
60075515|NCT02049359|76190791|FG001|COMPLETED|Overall Study||56||
60075516|NCT02049359|76190790|FG000|NOT COMPLETED|Overall Study||26||
60075517|NCT02049359|76190791|FG001|NOT COMPLETED|Overall Study||19||
60075518|NCT01946516|76190797|FG000|STARTED|Overall Study||3051||
60075519|NCT01946516|76190797|FG000|Evaluated for HBV Status|Overall Study||3050||
60075520|NCT01946516|76190797|FG000|Evaluated for HCV Status|Overall Study||2990||
60075521|NCT01946516|76190797|FG000|Evaluated for HIV Status|Overall Study||3045||
60075522|NCT01946516|76190797|FG000|COMPLETED|Overall Study||3051||
60075523|NCT01946516|76190797|FG000|NOT COMPLETED|Overall Study||0||
60075524|NCT01839695|76190817|FG000|STARTED|Overall Study||9||
60075525|NCT01839695|76190817|FG000|COMPLETED|Overall Study||9||
60075526|NCT01839695|76190817|FG000|NOT COMPLETED|Overall Study||0||
60075527|NCT01698905|76190821|FG000|STARTED|Overall Study||163||
60075528|NCT01698905|76190821|FG000|Still on Study Phase|Overall Study||0||
60075529|NCT01698905|76190821|FG000|TFR Phase|Overall Study||126||
60075530|NCT01698905|76190821|FG000|NTRI Phase|Overall Study||51||
60075531|NCT01698905|76190821|FG000|NTCT Phase|Overall Study||26||
60075532|NCT01698905|76190821|FG000|TFR-2 Phase|Overall Study||2||
60075533|NCT01698905|76190821|FG000|NTRI-2 Phase|Overall Study||1||
59531157|NCT00370994|75627812|FG001|NOT COMPLETED|Overall Study||0||
59531158|NCT00401882|75627820|FG000|STARTED|Overall Study||2||
60075534|NCT01698905|76190821|FG000|NTCT-P Phase Phase|Overall Study||6||
60075535|NCT01698905|76190821|FG000|COMPLETED|Overall Study||152|Completed = Completed 52 weeks of NTCS phase|
60075536|NCT01698905|76190821|FG000|NOT COMPLETED|Overall Study||11||
60075537|NCT01466686|76190832|FG000|STARTED|Overall Study||31||
60075538|NCT01466686|76190832|FG000|COMPLETED|Overall Study||30||
59531159|NCT00401882|75627821|FG001|STARTED|Overall Study||5||
59531160|NCT00401882|75627820|FG000|COMPLETED|Overall Study||2||
59531161|NCT00401882|75627821|FG001|COMPLETED|Overall Study||5||
59531162|NCT00401882|75627820|FG000|NOT COMPLETED|Overall Study||0||
59531163|NCT00401882|75627821|FG001|NOT COMPLETED|Overall Study||0||
59531164|NCT00371540|75627835|FG000|STARTED|Overall Study||112||
59531165|NCT00371540|75627836|FG001|STARTED|Overall Study||96||
59531166|NCT00371540|75627835|FG000|COMPLETED|Overall Study||102||
59531167|NCT00371540|75627836|FG001|COMPLETED|Overall Study||87||
59531168|NCT00371540|75627835|FG000|NOT COMPLETED|Overall Study||10||
59531169|NCT00371540|75627836|FG001|NOT COMPLETED|Overall Study||9||
59531170|NCT00373334|75627845|FG000|STARTED|Overall Study||43||
59531171|NCT00373334|75627846|FG001|STARTED|Overall Study||50||
59531172|NCT00373334|75627847|FG002|STARTED|Overall Study||45||
59531173|NCT00373334|75627845|FG000|COMPLETED|Overall Study||33||
59531174|NCT00373334|75627846|FG001|COMPLETED|Overall Study||32||
59531175|NCT00373334|75627847|FG002|COMPLETED|Overall Study||32||
59531176|NCT00373334|75627845|FG000|NOT COMPLETED|Overall Study||10||
59531177|NCT00373334|75627846|FG001|NOT COMPLETED|Overall Study||18||
59531178|NCT00373334|75627847|FG002|NOT COMPLETED|Overall Study||13||
59815282|NCT03945214|75937739|FG003|COMPLETED|Overall Study||38||
59531179|NCT00402194|75627857|FG000|STARTED|Overall Study||9||
59531180|NCT00402194|75627858|FG001|STARTED|Overall Study||8||
59531181|NCT00402194|75627857|FG000|COMPLETED|Overall Study||9||
59531182|NCT00402194|75627858|FG001|COMPLETED|Overall Study||8||
59531183|NCT00402194|75627857|FG000|NOT COMPLETED|Overall Study||0||
59531184|NCT00402194|75627858|FG001|NOT COMPLETED|Overall Study||0||
59531185|NCT00402896|75627864|FG000|STARTED|Overall Study||20||
59531186|NCT00402896|75627864|FG000|COMPLETED|Overall Study||20||
59531187|NCT00402896|75627864|FG000|NOT COMPLETED|Overall Study||0||
59531188|NCT00405704|75627870|FG000|STARTED|Overall Study||302||
59531189|NCT00405704|75627871|FG001|STARTED|Overall Study||305||
59531190|NCT00405704|75627870|FG000|Completed Outcome Renal Scan|Overall Study||227||
59531191|NCT00405704|75627871|FG001|Completed Outcome Renal Scan|Overall Study||235||
59531192|NCT00405704|75627870|FG000|Completed Assessments for New Scarring|Overall Study||220||
59531193|NCT00405704|75627871|FG001|Completed Assessments for New Scarring|Overall Study||227||
59531194|NCT00405704|75627870|FG000|Outcome Stool Assessed|Overall Study||203||
59531195|NCT00405704|75627871|FG001|Outcome Stool Assessed|Overall Study||210||
59531196|NCT00405704|75627870|FG000|Recurrent UTI With E. Coli|Overall Study||30||
59531197|NCT00405704|75627871|FG001|Recurrent UTI With E. Coli|Overall Study||57||
59531198|NCT00405704|75627870|FG000|Recurrent UTI With TMP-SMZ Panel|Overall Study||38||
59531199|NCT00405704|75627871|FG001|Recurrent UTI With TMP-SMZ Panel|Overall Study||69||
59531200|NCT00405704|75627870|FG000|COMPLETED|Overall Study||261||
59531201|NCT00405704|75627871|FG001|COMPLETED|Overall Study||259||
59531202|NCT00405704|75627870|FG000|NOT COMPLETED|Overall Study||41||
59531203|NCT00405704|75627871|FG001|NOT COMPLETED|Overall Study||46||
59531204|NCT01657266|75627880|FG000|STARTED|Overall Study||73||
59987745|NCT00966953|76102947|FG002|COMPLETED|4th Intervention Order||6||
59531205|NCT01657266|75627881|FG001|STARTED|Overall Study||75||
59531206|NCT01657266|75627880|FG000|COMPLETED|Overall Study||69||
59531207|NCT01657266|75627881|FG001|COMPLETED|Overall Study||70||
59531208|NCT01657266|75627880|FG000|NOT COMPLETED|Overall Study||4||
59531209|NCT01657266|75627881|FG001|NOT COMPLETED|Overall Study||5||
59531210|NCT00405938|75627889|FG000|STARTED|Overall Study||38||
59531211|NCT00405938|75627890|FG001|STARTED|Overall Study||41||
59531212|NCT00405938|75627889|FG000|COMPLETED|Overall Study||38||
59531213|NCT00405938|75627890|FG001|COMPLETED|Overall Study||41||
59531214|NCT00405938|75627889|FG000|NOT COMPLETED|Overall Study||0||
59531215|NCT00405938|75627890|FG001|NOT COMPLETED|Overall Study||0||
59531216|NCT00407420|75627898|FG000|STARTED|Overall Study||54||
59531217|NCT00407420|75627899|FG001|STARTED|Overall Study||52||
59531218|NCT00407420|75627898|FG000|COMPLETED|Overall Study||45||
59531219|NCT00407420|75627899|FG001|COMPLETED|Overall Study||46||
59531220|NCT00407420|75627898|FG000|NOT COMPLETED|Overall Study||9||
59531221|NCT00407420|75627899|FG001|NOT COMPLETED|Overall Study||6||
59531222|NCT00379574|75627907|FG000|STARTED|Overall Study|Phase I (9) + Phase II (40)|49||
59531223|NCT00379574|75627907|FG000|COMPLETED|Overall Study|Phase I (9) + Phase II (40)|49||
59531224|NCT00379574|75627907|FG000|NOT COMPLETED|Overall Study||0||
59987746|NCT00966953|76102948|FG003|COMPLETED|4th Intervention Order||7||
59987747|NCT00966953|76102945|FG000|NOT COMPLETED|4th Intervention Order||0||
59531225|NCT00407654|75627911|FG000|STARTED|Overall Study||75||
59531226|NCT00407654|75627911|FG000|COMPLETED|Overall Study||75||
59815283|NCT03945214|75937736|FG000|NOT COMPLETED|Overall Study||3||
59531227|NCT00407654|75627911|FG000|NOT COMPLETED|Overall Study||0||
59531228|NCT00407888|75627916|FG000|STARTED|Overall Study||60||
59531229|NCT00407888|75627916|FG000|COMPLETED|Overall Study||60||
59531230|NCT00407888|75627916|FG000|NOT COMPLETED|Overall Study||0||
59531231|NCT00407966|75627920|FG000|STARTED|Overall Study||45||
59531232|NCT00407966|75627920|FG000|CR|Overall Study||30||
59531233|NCT00407966|75627920|FG000|COMPLETED|Overall Study||45||
59531234|NCT00407966|75627920|FG000|NOT COMPLETED|Overall Study||0||
59815284|NCT03945214|75937737|FG001|NOT COMPLETED|Overall Study||4||
59531235|NCT00408200|75627926|FG000|STARTED|Overall Study||57||
59531236|NCT00408200|75627927|FG001|STARTED|Overall Study||53||
59531237|NCT00408200|75627926|FG000|COMPLETED|Overall Study||57||
59531238|NCT00408200|75627927|FG001|COMPLETED|Overall Study||53||
59531239|NCT00408200|75627926|FG000|NOT COMPLETED|Overall Study||0||
59531240|NCT00408200|75627927|FG001|NOT COMPLETED|Overall Study||0||
59531241|NCT01657032|75627935|FG000|STARTED|Overall Study||44||
59531242|NCT01657032|75627936|FG001|STARTED|Overall Study||44||
59531243|NCT01657032|75627935|FG000|COMPLETED|Overall Study||44||
59531244|NCT01657032|75627936|FG001|COMPLETED|Overall Study||37||
59531245|NCT01657032|75627935|FG000|NOT COMPLETED|Overall Study||0||
59531246|NCT01657032|75627936|FG001|NOT COMPLETED|Overall Study||7||
59531247|NCT00382148|75627944|FG000|STARTED|Overall Study||4||
59531248|NCT00382148|75627945|FG001|STARTED|Overall Study||7||
59531249|NCT00382148|75627944|FG000|COMPLETED|Overall Study||3||
59531250|NCT00382148|75627945|FG001|COMPLETED|Overall Study||7||
59531251|NCT00382148|75627944|FG000|NOT COMPLETED|Overall Study||1||
59531252|NCT00382148|75627945|FG001|NOT COMPLETED|Overall Study||0||
59531253|NCT02111252|75627951|FG000|STARTED|Overall Study||55||
59531254|NCT02111252|75627951|FG000|COMPLETED|Overall Study||55||
59531255|NCT02111252|75627951|FG000|NOT COMPLETED|Overall Study||0||
59531256|NCT02111798|75627959|FG000|STARTED|Overall Study||31||
59531257|NCT02111798|75627960|FG001|STARTED|Overall Study||32||
59531258|NCT02111798|75627961|FG002|STARTED|Overall Study||10||
59531259|NCT02111798|75627962|FG003|STARTED|Overall Study||10||
59531260|NCT02111798|75627959|FG000|COMPLETED|Overall Study||20||
59531261|NCT02111798|75627960|FG001|COMPLETED|Overall Study||16||
59531262|NCT02111798|75627961|FG002|COMPLETED|Overall Study||10||
59531263|NCT02111798|75627962|FG003|COMPLETED|Overall Study||7||
59531264|NCT02111798|75627959|FG000|NOT COMPLETED|Overall Study||11||
59531265|NCT02111798|75627960|FG001|NOT COMPLETED|Overall Study||16||
59531266|NCT02111798|75627961|FG002|NOT COMPLETED|Overall Study||0||
59531267|NCT02111798|75627962|FG003|NOT COMPLETED|Overall Study||3||
59531268|NCT00382928|75627975|FG000|STARTED|Overall Study||97||
59531269|NCT00382928|75627976|FG001|STARTED|Overall Study||95||
59531270|NCT00382928|75627975|FG000|COMPLETED|Overall Study||97||
59531271|NCT00382928|75627976|FG001|COMPLETED|Overall Study||95||
59531272|NCT00382928|75627975|FG000|NOT COMPLETED|Overall Study||0||
59531273|NCT00382928|75627976|FG001|NOT COMPLETED|Overall Study||0||
59531274|NCT00409292|75627987|FG000|STARTED|Overall Study||33||
59531275|NCT00409292|75627987|FG000|COMPLETED|Overall Study||33||
59531276|NCT00409292|75627987|FG000|NOT COMPLETED|Overall Study||0||
59531277|NCT00383942|75627995|FG000|STARTED|Overall Study||40||
59531278|NCT00383942|75627996|FG001|STARTED|Overall Study||40||
59531279|NCT00383942|75627995|FG000|COMPLETED|Overall Study||40||
59531280|NCT00383942|75627996|FG001|COMPLETED|Overall Study||40||
59531281|NCT00383942|75627995|FG000|NOT COMPLETED|Overall Study||0||
59531282|NCT00383942|75627996|FG001|NOT COMPLETED|Overall Study||0||
59531283|NCT00454532|75628006|FG000|STARTED|Overall Study||11||
59531284|NCT00454532|75628007|FG001|STARTED|Overall Study||6||
59531285|NCT00454532|75628008|FG002|STARTED|Overall Study||3||
59531286|NCT00454532|75628009|FG003|STARTED|Overall Study||7||
59531287|NCT00454532|75628006|FG000|COMPLETED|Overall Study||11||
59531288|NCT00454532|75628007|FG001|COMPLETED|Overall Study||6||
59531289|NCT00454532|75628008|FG002|COMPLETED|Overall Study||3||
59531290|NCT00454532|75628009|FG003|COMPLETED|Overall Study||7||
59531291|NCT00454532|75628006|FG000|NOT COMPLETED|Overall Study||0||
59531292|NCT00454532|75628007|FG001|NOT COMPLETED|Overall Study||0||
59531293|NCT00454532|75628008|FG002|NOT COMPLETED|Overall Study||0||
59531294|NCT00454532|75628009|FG003|NOT COMPLETED|Overall Study||0||
59531295|NCT00410150|75628021|FG000|STARTED|Overall Study||22||
59531296|NCT00410150|75628022|FG001|STARTED|Overall Study||20||
59531297|NCT00410150|75628021|FG000|COMPLETED|Overall Study|2 study withdrawals (analyzed by intention-to-treat)|20||
59531298|NCT00410150|75628022|FG001|COMPLETED|Overall Study|3 study withdrawals (analyzed by intention-to-treat0|17||
59531299|NCT00410150|75628021|FG000|NOT COMPLETED|Overall Study||2||
59531300|NCT00410150|75628022|FG001|NOT COMPLETED|Overall Study||3||
59531301|NCT00385268|75628030|FG000|STARTED|Overall Study||34||
59531302|NCT00385268|75628031|FG001|STARTED|Overall Study||26||
59531303|NCT00385268|75628030|FG000|COMPLETED|Overall Study||18||
59531304|NCT00385268|75628031|FG001|COMPLETED|Overall Study||18||
59531305|NCT00385268|75628030|FG000|NOT COMPLETED|Overall Study||16||
59531306|NCT00385268|75628031|FG001|NOT COMPLETED|Overall Study||8||
59531307|NCT01657500|75628039|FG000|STARTED|Overall Study||32||
59531308|NCT01657500|75628040|FG001|STARTED|Overall Study||32||
59531309|NCT01657500|75628039|FG000|COMPLETED|Overall Study||27||
59531310|NCT01657500|75628040|FG001|COMPLETED|Overall Study||27||
59531311|NCT01657500|75628039|FG000|NOT COMPLETED|Overall Study||5||
59531312|NCT01657500|75628040|FG001|NOT COMPLETED|Overall Study||5||
59531313|NCT00411086|75628046|FG000|STARTED|Overall Study||52||
59531314|NCT00411086|75628046|FG000|COMPLETED|Overall Study||52||
59531315|NCT00411086|75628046|FG000|NOT COMPLETED|Overall Study||0||
59531316|NCT01658904|75628053|FG000|STARTED|Overall Study||3||
59531317|NCT01658904|75628054|FG001|STARTED|Overall Study||0||
59531318|NCT01658904|75628055|FG002|STARTED|Overall Study||0||
59531319|NCT01658904|75628053|FG000|COMPLETED|Overall Study||1||
59531320|NCT01658904|75628054|FG001|COMPLETED|Overall Study||0||
59531321|NCT01658904|75628055|FG002|COMPLETED|Overall Study||0||
59531322|NCT01658904|75628053|FG000|NOT COMPLETED|Overall Study||2||
59531323|NCT01658904|75628054|FG001|NOT COMPLETED|Overall Study||0||
59531324|NCT01658904|75628055|FG002|NOT COMPLETED|Overall Study||0||
59531325|NCT00385580|75628068|FG000|STARTED|Overall Study|Number of participants treated.|48||
59531326|NCT00385580|75628069|FG001|STARTED|Overall Study|Number of participants treated.|47||
59531327|NCT00385580|75628068|FG000|COMPLETED|Overall Study|Completed=off study. Major reasons for being off study are disease progression, and study toxicity.|48||
59531328|NCT00385580|75628069|FG001|COMPLETED|Overall Study|Completed=off study. Major reasons for being off study are disease progression, and study toxicity.|47||
59531329|NCT00385580|75628068|FG000|NOT COMPLETED|Overall Study||0||
59531330|NCT00385580|75628069|FG001|NOT COMPLETED|Overall Study||0||
59531331|NCT00455702|75628087|FG000|STARTED|Overall Study||19||
59531332|NCT00455702|75628088|FG001|STARTED|Overall Study||19||
59531333|NCT00455702|75628087|FG000|COMPLETED|Overall Study||16||
59531334|NCT00455702|75628088|FG001|COMPLETED|Overall Study||16||
59531335|NCT00455702|75628087|FG000|NOT COMPLETED|Overall Study||3||
59531336|NCT00455702|75628088|FG001|NOT COMPLETED|Overall Study||3||
59531337|NCT00456014|75628096|FG000|STARTED|SSRI Phase||37||
59531338|NCT00456014|75628096|FG000|COMPLETED|SSRI Phase||28||
59531339|NCT00456014|75628096|FG000|NOT COMPLETED|SSRI Phase||9||
59531340|NCT00456014|75628096|FG000|STARTED|Tricyclic Phase|Only non-remitters from phase 1 were eligible for phase 2, and not all those eligible continued.|4||
59531341|NCT00456014|75628096|FG000|COMPLETED|Tricyclic Phase||1||
59531342|NCT00456014|75628096|FG000|NOT COMPLETED|Tricyclic Phase||3||
59531343|NCT00411398|75628102|FG000|STARTED|Overall Study||15||
59531344|NCT00411398|75628102|FG000|COMPLETED|Overall Study||10||
59531345|NCT00411398|75628102|FG000|NOT COMPLETED|Overall Study||5||
59531346|NCT00457730|75628108|FG000|STARTED|Overall Study||18||
59531347|NCT00457730|75628109|FG001|STARTED|Overall Study||20||
59531348|NCT00457730|75628108|FG000|COMPLETED|Overall Study||14||
59531349|NCT00457730|75628109|FG001|COMPLETED|Overall Study||19||
59531350|NCT00457730|75628108|FG000|NOT COMPLETED|Overall Study||4||
59531351|NCT00457730|75628109|FG001|NOT COMPLETED|Overall Study||1||
59531352|NCT00458822|75628119|FG000|STARTED|Overall Study||40||
59531353|NCT00458822|75628119|FG000|COMPLETED|Overall Study||40||
59531354|NCT00458822|75628119|FG000|NOT COMPLETED|Overall Study||0||
59531355|NCT00459368|75628125|FG000|STARTED|Overall Study||1335||
59531356|NCT00459368|75628126|FG001|STARTED|Overall Study||1363||
59531357|NCT00459368|75628125|FG000|COMPLETED|Overall Study||1040||
59531358|NCT00459368|75628126|FG001|COMPLETED|Overall Study||1034||
59531359|NCT00459368|75628125|FG000|NOT COMPLETED|Overall Study||295||
59531360|NCT00459368|75628126|FG001|NOT COMPLETED|Overall Study||329||
59531361|NCT00413582|75628134|FG000|STARTED|Overall Study|all enrolled completed|55||
59531362|NCT00413582|75628135|FG001|STARTED|Overall Study|all enrolled completed|55||
59531363|NCT00413582|75628134|FG000|Completion of Study|Overall Study|all enrolled completed|55||
59531364|NCT00413582|75628135|FG001|Completion of Study|Overall Study|all enrolled completed|55||
59531365|NCT00413582|75628134|FG000|COMPLETED|Overall Study|all enrolled completed|55||
59531366|NCT00413582|75628135|FG001|COMPLETED|Overall Study|all enrolled completed|55||
59531367|NCT00413582|75628134|FG000|NOT COMPLETED|Overall Study||0||
59531368|NCT00413582|75628135|FG001|NOT COMPLETED|Overall Study||0||
59531369|NCT00389168|75628143|FG000|STARTED|Overall Study||56||
59531370|NCT00389168|75628144|FG001|STARTED|Overall Study||58||
59531371|NCT00389168|75628143|FG000|COMPLETED|Overall Study||47||
59531372|NCT00389168|75628144|FG001|COMPLETED|Overall Study||53||
59531373|NCT00389168|75628143|FG000|NOT COMPLETED|Overall Study||9||
59531374|NCT00389168|75628144|FG001|NOT COMPLETED|Overall Study||5||
59531375|NCT00462020|75628152|FG000|STARTED|Overall Study||52||
59531376|NCT00462020|75628153|FG001|STARTED|Overall Study||50||
59531377|NCT00462020|75628152|FG000|COMPLETED|Overall Study||52||
59531378|NCT00462020|75628153|FG001|COMPLETED|Overall Study||50||
59531379|NCT00462020|75628152|FG000|NOT COMPLETED|Overall Study||0||
59531380|NCT00462020|75628153|FG001|NOT COMPLETED|Overall Study||0||
59531381|NCT00414206|75628162|FG000|STARTED|Overall Study||115||
59531382|NCT00414206|75628163|FG001|STARTED|Overall Study||114||
59531383|NCT00414206|75628164|FG002|STARTED|Overall Study||114||
59531384|NCT00414206|75628162|FG000|COMPLETED|Overall Study||57||
59531385|NCT00414206|75628163|FG001|COMPLETED|Overall Study||58||
59531386|NCT00414206|75628164|FG002|COMPLETED|Overall Study||59||
59531387|NCT00414206|75628162|FG000|NOT COMPLETED|Overall Study||58||
59531388|NCT00414206|75628163|FG001|NOT COMPLETED|Overall Study||56||
59531389|NCT00414206|75628164|FG002|NOT COMPLETED|Overall Study||55||
59531390|NCT00462332|75628174|FG000|STARTED|Overall Study||45||
59531391|NCT00462332|75628175|FG001|STARTED|Overall Study||41||
59531392|NCT00462332|75628174|FG000|COMPLETED|Overall Study||45||
59531393|NCT00462332|75628175|FG001|COMPLETED|Overall Study||41||
59531394|NCT00462332|75628174|FG000|NOT COMPLETED|Overall Study||0||
59531395|NCT00462332|75628175|FG001|NOT COMPLETED|Overall Study||0||
59531396|NCT00462644|75628185|FG000|STARTED|Overall Study||18||
59531397|NCT00462644|75628186|FG001|STARTED|Overall Study||12||
59531398|NCT00462644|75628185|FG000|COMPLETED|Overall Study||18||
59531399|NCT00462644|75628186|FG001|COMPLETED|Overall Study||12||
59531400|NCT00462644|75628185|FG000|NOT COMPLETED|Overall Study||0||
59531401|NCT00462644|75628186|FG001|NOT COMPLETED|Overall Study||0||
59531402|NCT00462722|75628195|FG000|STARTED|Overall Study||50||
59531403|NCT00462722|75628196|FG001|STARTED|Overall Study||55||
59531404|NCT00462722|75628197|FG002|STARTED|Overall Study||54||
59531405|NCT00462722|75628195|FG000|COMPLETED|Overall Study||37||
59531406|NCT00462722|75628196|FG001|COMPLETED|Overall Study||51||
59531407|NCT00462722|75628197|FG002|COMPLETED|Overall Study||42||
59531408|NCT00462722|75628195|FG000|NOT COMPLETED|Overall Study||13||
59531409|NCT00462722|75628196|FG001|NOT COMPLETED|Overall Study||4||
59531410|NCT00462722|75628197|FG002|NOT COMPLETED|Overall Study||12||
59531411|NCT00528398|75628205|FG000|STARTED|Overall Study||111||
59531412|NCT00528398|75628205|FG000|COMPLETED|Overall Study||111||
59531413|NCT00528398|75628205|FG000|NOT COMPLETED|Overall Study||0||
59531414|NCT00528788|75628209|FG000|STARTED|Overall Study||24||
59531415|NCT00528788|75628209|FG000|COMPLETED|Overall Study||20||
59531416|NCT00528788|75628209|FG000|NOT COMPLETED|Overall Study||4||
59531417|NCT00414518|75628215|FG000|STARTED|Overall Study||7||
59531418|NCT00414518|75628216|FG001|STARTED|Overall Study||9||
59531419|NCT00414518|75628215|FG000|COMPLETED|Overall Study||7||
59531420|NCT00414518|75628216|FG001|COMPLETED|Overall Study||9||
59531421|NCT00414518|75628215|FG000|NOT COMPLETED|Overall Study||0||
59531422|NCT00414518|75628216|FG001|NOT COMPLETED|Overall Study||0||
59531423|NCT00531518|75628228|FG000|STARTED|Overall Study||87||
59531424|NCT00531518|75628229|FG001|STARTED|Overall Study||205||
59531425|NCT00531518|75628228|FG000|COMPLETED|Overall Study||55||
59531426|NCT00531518|75628229|FG001|COMPLETED|Overall Study||134||
59531427|NCT00531518|75628228|FG000|NOT COMPLETED|Overall Study||32||
59531428|NCT00531518|75628229|FG001|NOT COMPLETED|Overall Study||71||
59531429|NCT01658514|75628239|FG000|STARTED|Overall Study||14||
59531430|NCT01658514|75628240|FG001|STARTED|Overall Study||11||
59531431|NCT01658514|75628241|FG002|STARTED|Overall Study||14||
59531432|NCT01658514|75628239|FG000|Completed Treatment A|Overall Study||14||
59531433|NCT01658514|75628240|FG001|Completed Treatment A|Overall Study||11||
59531434|NCT01658514|75628241|FG002|Completed Treatment A|Overall Study||12||
59531435|NCT01658514|75628239|FG000|Completed Treatment B|Overall Study||13||
59531436|NCT01658514|75628240|FG001|Completed Treatment B|Overall Study||11||
59531437|NCT01658514|75628241|FG002|Completed Treatment B|Overall Study||14||
59531438|NCT01658514|75628239|FG000|Completed Treatment C|Overall Study||13||
59531439|NCT01658514|75628240|FG001|Completed Treatment C|Overall Study||11||
59531440|NCT01658514|75628241|FG002|Completed Treatment C|Overall Study||12||
59531441|NCT01658514|75628239|FG000|Started - Normal RF Cohort Only|Overall Study||3||
59531442|NCT01658514|75628240|FG001|Started - Normal RF Cohort Only|Overall Study||2||
59531443|NCT01658514|75628241|FG002|Started - Normal RF Cohort Only|Overall Study||3||
59531444|NCT01658514|75628239|FG000|Completed - Normal RF Cohort Only|Overall Study||3||
59531445|NCT01658514|75628240|FG001|Completed - Normal RF Cohort Only|Overall Study||2||
59531446|NCT01658514|75628241|FG002|Completed - Normal RF Cohort Only|Overall Study||3||
59531447|NCT01658514|75628239|FG000|Started - Mild RI Cohort Only|Overall Study||4||
59531448|NCT01658514|75628240|FG001|Started - Mild RI Cohort Only|Overall Study||3||
59531449|NCT01658514|75628241|FG002|Started - Mild RI Cohort Only|Overall Study||4||
59531450|NCT01658514|75628239|FG000|Completed - Mild RI Cohort Only|Overall Study||4||
59531451|NCT01658514|75628240|FG001|Completed - Mild RI Cohort Only|Overall Study||3||
59531452|NCT01658514|75628241|FG002|Completed - Mild RI Cohort Only|Overall Study||4||
59531453|NCT01658514|75628239|FG000|Started - Moderate RI Cohort Only|Overall Study||4||
59531454|NCT01658514|75628240|FG001|Started - Moderate RI Cohort Only|Overall Study||4||
59531455|NCT01658514|75628241|FG002|Started - Moderate RI Cohort Only|Overall Study||4||
59531456|NCT01658514|75628239|FG000|Completed - Moderate RI Cohort Only|Overall Study||3||
59531457|NCT01658514|75628240|FG001|Completed - Moderate RI Cohort Only|Overall Study||4||
59531458|NCT01658514|75628241|FG002|Completed - Moderate RI Cohort Only|Overall Study||2||
59531459|NCT01658514|75628239|FG000|Started - Severe RI Cohort Only|Overall Study||3||
59531460|NCT01658514|75628240|FG001|Started - Severe RI Cohort Only|Overall Study||2||
59531461|NCT01658514|75628241|FG002|Started - Severe RI Cohort Only|Overall Study||3||
59531462|NCT01658514|75628239|FG000|Completed - Severe RI Cohort Only|Overall Study||3||
59531463|NCT01658514|75628240|FG001|Completed - Severe RI Cohort Only|Overall Study||2||
59531464|NCT01658514|75628241|FG002|Completed - Severe RI Cohort Only|Overall Study||3||
59815285|NCT03945214|75937738|FG002|NOT COMPLETED|Overall Study||7||
59815286|NCT03945214|75937739|FG003|NOT COMPLETED|Overall Study||4||
59531465|NCT01658514|75628239|FG000|COMPLETED|Overall Study||13||
59531466|NCT01658514|75628240|FG001|COMPLETED|Overall Study||11||
59531467|NCT01658514|75628241|FG002|COMPLETED|Overall Study||12||
59531468|NCT01658514|75628239|FG000|NOT COMPLETED|Overall Study||1||
59531469|NCT01658514|75628240|FG001|NOT COMPLETED|Overall Study||0||
59531470|NCT01658514|75628241|FG002|NOT COMPLETED|Overall Study||2||
59531471|NCT00533546|75628248|FG000|STARTED|Overall Study||12||
59531472|NCT00533546|75628248|FG000|COMPLETED|Overall Study||12||
59531473|NCT00533546|75628248|FG000|NOT COMPLETED|Overall Study||0||
59531474|NCT00534794|75628255|FG000|STARTED|Overall Study||40||
59531475|NCT00534794|75628256|FG001|STARTED|Overall Study||39||
59531476|NCT00534794|75628255|FG000|COMPLETED|Overall Study||40||
59531477|NCT00534794|75628256|FG001|COMPLETED|Overall Study||39||
59531478|NCT00534794|75628255|FG000|NOT COMPLETED|Overall Study||0||
59531479|NCT00534794|75628256|FG001|NOT COMPLETED|Overall Study||0||
59531480|NCT01658436|75628262|FG000|STARTED|Overall Study||20||
59531481|NCT01658436|75628263|FG001|STARTED|Overall Study||11||
59531482|NCT01658436|75628262|FG000|COMPLETED|Overall Study||0||
59531483|NCT01658436|75628263|FG001|COMPLETED|Overall Study||0||
59531484|NCT01658436|75628262|FG000|NOT COMPLETED|Overall Study||20||
59531485|NCT01658436|75628263|FG001|NOT COMPLETED|Overall Study||11||
59531486|NCT00464204|75628270|FG000|STARTED|Overall Study||100||
59531487|NCT00464204|75628271|FG001|STARTED|Overall Study||96||
59531488|NCT00464204|75628270|FG000|Completed Treatment|Overall Study||81||
59531489|NCT00464204|75628271|FG001|Completed Treatment|Overall Study||83||
59531490|NCT00464204|75628270|FG000|Day 30 Follow-up Performed|Overall Study||89||
59531491|NCT00464204|75628271|FG001|Day 30 Follow-up Performed|Overall Study||83||
59531492|NCT00464204|75628270|FG000|Day 90 Follow-up Performed|Overall Study||69||
59531493|NCT00464204|75628271|FG001|Day 90 Follow-up Performed|Overall Study||74||
59531494|NCT00464204|75628270|FG000|Withdrawal Due to Discharge From ICU|Overall Study||18||
59531495|NCT00464204|75628271|FG001|Withdrawal Due to Discharge From ICU|Overall Study||11||
59531496|NCT00464204|75628270|FG000|COMPLETED|Overall Study|Completed=no withdrawal until day 8.|51||
59531497|NCT00464204|75628271|FG001|COMPLETED|Overall Study|Completed=no withdrawal until day 8.|64||
59531498|NCT00464204|75628270|FG000|NOT COMPLETED|Overall Study||49||
59531499|NCT00464204|75628271|FG001|NOT COMPLETED|Overall Study||32||
59531500|NCT00464438|75628281|FG000|STARTED|Overall Study||85||
60075539|NCT01466686|76190832|FG000|NOT COMPLETED|Overall Study||1||
60075540|NCT01550289|76190838|FG000|STARTED|Overall Study||128||
60075541|NCT01550289|76190839|FG001|STARTED|Overall Study||61||
60075542|NCT01550289|76190838|FG000|COMPLETED|Overall Study||115||
59531501|NCT00464438|75628282|FG001|STARTED|Overall Study||86||
59531502|NCT00464438|75628281|FG000|COMPLETED|Overall Study||83||
59531503|NCT00464438|75628282|FG001|COMPLETED|Overall Study||80||
59531504|NCT00464438|75628281|FG000|NOT COMPLETED|Overall Study||2||
59531505|NCT00464438|75628282|FG001|NOT COMPLETED|Overall Study||6||
59531506|NCT00465530|75628290|FG000|STARTED|Overall Study||21||
59531507|NCT00465530|75628291|FG001|STARTED|Overall Study||19||
59531508|NCT00465530|75628290|FG000|COMPLETED|Overall Study||19||
59531509|NCT00465530|75628291|FG001|COMPLETED|Overall Study||15||
59531510|NCT00465530|75628290|FG000|NOT COMPLETED|Overall Study||2||
59531511|NCT00465530|75628291|FG001|NOT COMPLETED|Overall Study||4||
59531512|NCT00465998|75628297|FG000|STARTED|Overall Study||275||
59531513|NCT00465998|75628297|FG000|COMPLETED|Overall Study||275||
59531514|NCT00465998|75628297|FG000|NOT COMPLETED|Overall Study||0||
59531515|NCT00466310|75628305|FG000|STARTED|Overall Study||20||
59531516|NCT00466310|75628306|FG001|STARTED|Overall Study||20||
59531517|NCT00466310|75628307|FG002|STARTED|Overall Study||31||
59531518|NCT00466310|75628305|FG000|COMPLETED|Overall Study||20||
59531519|NCT00466310|75628306|FG001|COMPLETED|Overall Study||20||
59531520|NCT00466310|75628307|FG002|COMPLETED|Overall Study||31||
59531521|NCT00466310|75628305|FG000|NOT COMPLETED|Overall Study||0||
59531522|NCT00466310|75628306|FG001|NOT COMPLETED|Overall Study||0||
59531523|NCT00466310|75628307|FG002|NOT COMPLETED|Overall Study||0||
59531524|NCT02116322|75628315|FG000|STARTED|Overall Study||1||
59531525|NCT02116322|75628315|FG000|COMPLETED|Overall Study||1||
59531526|NCT02116322|75628315|FG000|NOT COMPLETED|Overall Study||0||
59531527|NCT00535652|75628319|FG000|STARTED|Overall Study||23||
59531528|NCT00535652|75628319|FG000|COMPLETED|Overall Study||20||
59531529|NCT00535652|75628319|FG000|NOT COMPLETED|Overall Study||3||
59531530|NCT00418028|75628325|FG000|STARTED|Overall Study||97||
59531531|NCT00418028|75628326|FG001|STARTED|Overall Study||98||
59531532|NCT00418028|75628325|FG000|COMPLETED|Overall Study||95||
59531533|NCT00418028|75628326|FG001|COMPLETED|Overall Study||97||
59531534|NCT00418028|75628325|FG000|NOT COMPLETED|Overall Study||2||
59531535|NCT00418028|75628326|FG001|NOT COMPLETED|Overall Study||1||
59531536|NCT00537290|75628332|FG000|STARTED|Overall Study||19||
59531537|NCT00537290|75628332|FG000|COMPLETED|Overall Study||19||
59531538|NCT00537290|75628332|FG000|NOT COMPLETED|Overall Study||0||
59531539|NCT00538304|75628338|FG000|STARTED|Overall Study||151||
60075543|NCT01550289|76190839|FG001|COMPLETED|Overall Study||57||
59531540|NCT00538304|75628339|FG001|STARTED|Overall Study||71||
59531541|NCT00538304|75628338|FG000|COMPLETED|Overall Study||144||
59531542|NCT00538304|75628339|FG001|COMPLETED|Overall Study||66||
59531543|NCT00538304|75628338|FG000|NOT COMPLETED|Overall Study||7||
59531544|NCT00538304|75628339|FG001|NOT COMPLETED|Overall Study||5||
59531545|NCT00538616|75628347|FG000|STARTED|Overall Study||5||
59531546|NCT00538616|75628348|FG001|STARTED|Overall Study||3||
59531547|NCT00538616|75628347|FG000|COMPLETED|Overall Study||5||
59531548|NCT00538616|75628348|FG001|COMPLETED|Overall Study||3||
59531549|NCT00538616|75628347|FG000|NOT COMPLETED|Overall Study||0||
59531550|NCT00538616|75628348|FG001|NOT COMPLETED|Overall Study||0||
59531551|NCT00469274|75628356|FG000|STARTED|Overall Study||44||
59531552|NCT00469274|75628357|FG001|STARTED|Overall Study||42||
59531553|NCT00469274|75628356|FG000|COMPLETED|Overall Study||44||
59531554|NCT00469274|75628357|FG001|COMPLETED|Overall Study||42||
59531555|NCT00469274|75628356|FG000|NOT COMPLETED|Overall Study||0||
59531556|NCT00469274|75628357|FG001|NOT COMPLETED|Overall Study||0||
59531557|NCT00469508|75628365|FG000|STARTED|Overall Study||34||
59531558|NCT00469508|75628366|FG001|STARTED|Overall Study||37||
59531559|NCT00469508|75628365|FG000|COMPLETED|Overall Study||14||
59531560|NCT00469508|75628366|FG001|COMPLETED|Overall Study||13||
59531561|NCT00469508|75628365|FG000|NOT COMPLETED|Overall Study||20||
59531562|NCT00469508|75628366|FG001|NOT COMPLETED|Overall Study||24||
59531563|NCT00470600|75628374|FG000|STARTED|Overall Study||86||
59531564|NCT00470600|75628375|FG001|STARTED|Overall Study||99||
60075544|NCT01550289|76190838|FG000|NOT COMPLETED|Overall Study||13||
60075545|NCT01550289|76190839|FG001|NOT COMPLETED|Overall Study||4||
60075546|NCT01968031|76190850|FG000|STARTED|Overall Study||204||
60075547|NCT01968031|76190851|FG001|STARTED|Overall Study||202||
60075548|NCT01968031|76190852|FG002|STARTED|Overall Study||207||
60075549|NCT01968031|76190850|FG000|Completed Week 2|Overall Study||197||
60075550|NCT01968031|76190851|FG001|Completed Week 2|Overall Study||190||
60075551|NCT01968031|76190852|FG002|Completed Week 2|Overall Study||199||
60075552|NCT01968031|76190850|FG000|Completed Week 6|Overall Study||191||
60075553|NCT01968031|76190851|FG001|Completed Week 6|Overall Study||183||
60075554|NCT01968031|76190852|FG002|Completed Week 6|Overall Study||187||
60075555|NCT01968031|76190850|FG000|Completed Week 10|Overall Study||187||
60075556|NCT01968031|76190851|FG001|Completed Week 10|Overall Study||181||
60075557|NCT01968031|76190852|FG002|Completed Week 10|Overall Study||181||
60075558|NCT01968031|76190850|FG000|COMPLETED|Overall Study||186||
59531565|NCT00470600|75628374|FG000|COMPLETED|Overall Study|Two subjects were randomized to incorrect stratification categories (weight).|86||
59531566|NCT00470600|75628375|FG001|COMPLETED|Overall Study|One subject was randomized to incorrect stratification categories (weight).|99||
59531567|NCT00470600|75628374|FG000|NOT COMPLETED|Overall Study||0||
59531568|NCT00470600|75628375|FG001|NOT COMPLETED|Overall Study||0||
59531569|NCT00471068|75628383|FG000|STARTED|Overall Study||21||
59531570|NCT00471068|75628384|FG001|STARTED|Overall Study||25||
59531571|NCT00471068|75628383|FG000|COMPLETED|Overall Study||20||
59531572|NCT00471068|75628384|FG001|COMPLETED|Overall Study||24||
59531573|NCT00471068|75628383|FG000|NOT COMPLETED|Overall Study||1||
59815287|NCT03829683|75937751|FG000|STARTED|Overall Study||10||
60075559|NCT01968031|76190851|FG001|COMPLETED|Overall Study||182||
60075560|NCT01968031|76190852|FG002|COMPLETED|Overall Study||178||
60075561|NCT01968031|76190850|FG000|NOT COMPLETED|Overall Study||18||
60075562|NCT01968031|76190851|FG001|NOT COMPLETED|Overall Study||20||
60075563|NCT01968031|76190852|FG002|NOT COMPLETED|Overall Study||29||
60075564|NCT01684215|76190864|FG000|STARTED|Phase 1, Part 1||6||
60075565|NCT01684215|76190865|FG001|STARTED|Phase 1, Part 1||6||
60075566|NCT01684215|76190866|FG002|STARTED|Phase 1, Part 1||0||
60075567|NCT01684215|76190867|FG003|STARTED|Phase 1, Part 1||0||
59815288|NCT03829683|75937752|FG001|STARTED|Overall Study||10||
59815289|NCT03829683|75937751|FG000|COMPLETED|Overall Study||5||
59815290|NCT03829683|75937752|FG001|COMPLETED|Overall Study||8||
59815291|NCT03829683|75937751|FG000|NOT COMPLETED|Overall Study||5||
59815292|NCT03829683|75937752|FG001|NOT COMPLETED|Overall Study||2||
59815293|NCT03810456|75937761|FG000|STARTED|Enrolled and Randomized||99|Participants enrolled and randomized to a treatment condition.|
59817893|NCT04488770|75940332|FG006|COMPLETED|Part 1-Cohort 2: Period 1 (Up to 5 Days)||1||
60075568|NCT01684215|76190864|FG000|Treated|Phase 1, Part 1||6||
60075569|NCT01684215|76190865|FG001|Treated|Phase 1, Part 1||6||
60075570|NCT01684215|76190866|FG002|Treated|Phase 1, Part 1||0||
60075571|NCT01684215|76190867|FG003|Treated|Phase 1, Part 1||0||
60075572|NCT01684215|76190864|FG000|COMPLETED|Phase 1, Part 1||0||
59531574|NCT00471068|75628384|FG001|NOT COMPLETED|Overall Study||1||
59531575|NCT00471380|75628390|FG000|STARTED|First Intervention||22||
59531576|NCT00471380|75628391|FG001|STARTED|First Intervention||24||
59531577|NCT00471380|75628390|FG000|COMPLETED|First Intervention||18||
59531578|NCT00471380|75628391|FG001|COMPLETED|First Intervention||20||
59531579|NCT00471380|75628390|FG000|NOT COMPLETED|First Intervention||4||
59531580|NCT00471380|75628391|FG001|NOT COMPLETED|First Intervention||4||
59531581|NCT00471380|75628390|FG000|STARTED|Second Intervention||18||
59531582|NCT00471380|75628391|FG001|STARTED|Second Intervention||20||
59531583|NCT00471380|75628390|FG000|COMPLETED|Second Intervention||18||
59531584|NCT00471380|75628391|FG001|COMPLETED|Second Intervention||16||
59531585|NCT00471380|75628390|FG000|NOT COMPLETED|Second Intervention||0||
59531586|NCT00471380|75628391|FG001|NOT COMPLETED|Second Intervention||4||
59531587|NCT00471380|75628390|FG000|STARTED|Third Intervention||18||
59531588|NCT00471380|75628391|FG001|STARTED|Third Intervention||16||
59531589|NCT00471380|75628390|FG000|COMPLETED|Third Intervention||17||
59531590|NCT00471380|75628391|FG001|COMPLETED|Third Intervention||14||
59531591|NCT00471380|75628390|FG000|NOT COMPLETED|Third Intervention||1||
59531592|NCT00471380|75628391|FG001|NOT COMPLETED|Third Intervention||2||
59531593|NCT00538850|75628397|FG000|STARTED|Titration Period||130||
59531594|NCT00538850|75628398|FG001|STARTED|Titration Period|There were no participants in this reporting group in the titration period.|0||
59531595|NCT00538850|75628399|FG002|STARTED|Titration Period|There were no participants in this reporting group in the titration period.|0||
59531596|NCT00538850|75628397|FG000|COMPLETED|Titration Period||98||
59531597|NCT00538850|75628398|FG001|COMPLETED|Titration Period||0||
59531598|NCT00538850|75628399|FG002|COMPLETED|Titration Period||0||
59531599|NCT00538850|75628397|FG000|NOT COMPLETED|Titration Period||32||
59531600|NCT00538850|75628398|FG001|NOT COMPLETED|Titration Period||0||
59531601|NCT00538850|75628399|FG002|NOT COMPLETED|Titration Period||0||
59531602|NCT00538850|75628397|FG000|STARTED|Fentanyl Sublingual Spray - Double-blind|There were no participants in this reporting group in the double-blind period.|0||
59531603|NCT00538850|75628398|FG001|STARTED|Fentanyl Sublingual Spray - Double-blind||98||
59531604|NCT00538850|75628399|FG002|STARTED|Fentanyl Sublingual Spray - Double-blind|There were no participants in this reporting group in the double-blind period.|0||
59531605|NCT00538850|75628397|FG000|COMPLETED|Fentanyl Sublingual Spray - Double-blind||0||
59531606|NCT00538850|75628398|FG001|COMPLETED|Fentanyl Sublingual Spray - Double-blind||95||
59531607|NCT00538850|75628399|FG002|COMPLETED|Fentanyl Sublingual Spray - Double-blind||0||
59531608|NCT00538850|75628397|FG000|NOT COMPLETED|Fentanyl Sublingual Spray - Double-blind||0||
59531609|NCT00538850|75628398|FG001|NOT COMPLETED|Fentanyl Sublingual Spray - Double-blind||3||
59531610|NCT00538850|75628399|FG002|NOT COMPLETED|Fentanyl Sublingual Spray - Double-blind||0||
59531611|NCT00538850|75628397|FG000|STARTED|Placebo - Double-blind|There were no participants in this reporting group in the double-blind period.|0||
59531612|NCT00538850|75628398|FG001|STARTED|Placebo - Double-blind|There were no participants in this reporting group in the double-blind period.|0||
59531613|NCT00538850|75628399|FG002|STARTED|Placebo - Double-blind||98||
59531614|NCT00538850|75628397|FG000|COMPLETED|Placebo - Double-blind||0||
59531615|NCT00538850|75628398|FG001|COMPLETED|Placebo - Double-blind||0||
59531616|NCT00538850|75628399|FG002|COMPLETED|Placebo - Double-blind||95||
59531617|NCT00538850|75628397|FG000|NOT COMPLETED|Placebo - Double-blind||0||
59531618|NCT00538850|75628398|FG001|NOT COMPLETED|Placebo - Double-blind||0||
59531619|NCT00538850|75628399|FG002|NOT COMPLETED|Placebo - Double-blind||3||
59531620|NCT00418262|75628405|FG000|STARTED|Visits 1 (Baseline) Thru 5||27||
59531621|NCT00418262|75628405|FG000|COMPLETED|Visits 1 (Baseline) Thru 5||25||
59531622|NCT00418262|75628405|FG000|NOT COMPLETED|Visits 1 (Baseline) Thru 5||2||
59531623|NCT00418262|75628405|FG000|STARTED|Visits 5 Thru 8||25||
59531624|NCT00418262|75628405|FG000|COMPLETED|Visits 5 Thru 8||16||
59531625|NCT00418262|75628405|FG000|NOT COMPLETED|Visits 5 Thru 8||9||
59531626|NCT00418262|75628405|FG000|STARTED|Visits 8 Thru 10||16||
59531627|NCT00418262|75628405|FG000|COMPLETED|Visits 8 Thru 10||11||
59531628|NCT00418262|75628405|FG000|NOT COMPLETED|Visits 8 Thru 10||5||
59531629|NCT00418574|75628415|FG000|STARTED|Overall Study||593||
59531630|NCT00418574|75628416|FG001|STARTED|Overall Study||295||
59531631|NCT00418574|75628415|FG000|TREATED|Overall Study||592||
59531632|NCT00418574|75628416|FG001|TREATED|Overall Study||294||
59531633|NCT00418574|75628415|FG000|COMPLETED|Overall Study||545||
59531634|NCT00418574|75628416|FG001|COMPLETED|Overall Study||272||
59531635|NCT00418574|75628415|FG000|NOT COMPLETED|Overall Study||48||
59531636|NCT00418574|75628416|FG001|NOT COMPLETED|Overall Study||23||
59531637|NCT00473642|75628425|FG000|STARTED|Overall Study||10||
59531638|NCT00473642|75628426|FG001|STARTED|Overall Study||11||
59531639|NCT00473642|75628427|FG002|STARTED|Overall Study||10||
59531640|NCT00473642|75628425|FG000|COMPLETED|Overall Study||8||
59531641|NCT00473642|75628426|FG001|COMPLETED|Overall Study||10||
59531642|NCT00473642|75628427|FG002|COMPLETED|Overall Study||8||
59531643|NCT00473642|75628425|FG000|NOT COMPLETED|Overall Study||2||
59531644|NCT00473642|75628426|FG001|NOT COMPLETED|Overall Study||1||
59531645|NCT00473642|75628427|FG002|NOT COMPLETED|Overall Study||2||
59531646|NCT00418964|75628441|FG000|STARTED|Overall Study||22||
59531647|NCT00418964|75628442|FG001|STARTED|Overall Study||20||
59531648|NCT00418964|75628443|FG002|STARTED|Overall Study||20||
59531649|NCT00418964|75628441|FG000|COMPLETED|Overall Study||21||
59531650|NCT00418964|75628442|FG001|COMPLETED|Overall Study||17||
59531651|NCT00418964|75628443|FG002|COMPLETED|Overall Study||14||
59531652|NCT00418964|75628441|FG000|NOT COMPLETED|Overall Study||1||
59531653|NCT00418964|75628442|FG001|NOT COMPLETED|Overall Study||3||
59531654|NCT00418964|75628443|FG002|NOT COMPLETED|Overall Study||6||
59531655|NCT00539942|75628453|FG000|STARTED|Overall Study||4||
59531656|NCT00539942|75628454|FG001|STARTED|Overall Study||3||
59531657|NCT00539942|75628453|FG000|COMPLETED|Overall Study||4||
59531658|NCT00539942|75628454|FG001|COMPLETED|Overall Study||3||
59531659|NCT00539942|75628453|FG000|NOT COMPLETED|Overall Study||0||
59531660|NCT00539942|75628454|FG001|NOT COMPLETED|Overall Study||0||
59531661|NCT00419666|75628460|FG000|STARTED|Overall Study||25||
59531662|NCT00419666|75628460|FG000|COMPLETED|Overall Study||25||
59531663|NCT00419666|75628460|FG000|NOT COMPLETED|Overall Study||0||
59531664|NCT00540722|75628464|FG000|STARTED|Overall Study||56||
59531665|NCT00540722|75628464|FG000|COMPLETED|Overall Study||56||
59531666|NCT00540722|75628464|FG000|NOT COMPLETED|Overall Study||0||
59531667|NCT00541190|75628471|FG000|STARTED|Overall Study||10||
59531668|NCT00541190|75628472|FG001|STARTED|Overall Study||11||
59531669|NCT00541190|75628471|FG000|COMPLETED|Overall Study||10||
59531670|NCT00541190|75628472|FG001|COMPLETED|Overall Study||11||
59531671|NCT00541190|75628471|FG000|NOT COMPLETED|Overall Study||0||
59531672|NCT00541190|75628472|FG001|NOT COMPLETED|Overall Study||0||
59531673|NCT00542750|75628480|FG000|STARTED|Overall Study||24||
59531674|NCT00542750|75628480|FG000|COMPLETED|Overall Study||24||
59531675|NCT00542750|75628480|FG000|NOT COMPLETED|Overall Study||0||
59531676|NCT00475904|75628487|FG000|STARTED|Overall Study||140||
59531677|NCT00475904|75628488|FG001|STARTED|Overall Study||144||
59531678|NCT00475904|75628489|FG002|STARTED|Overall Study||76||
59531679|NCT00475904|75628487|FG000|COMPLETED|Overall Study||125||
59531680|NCT00475904|75628488|FG001|COMPLETED|Overall Study||131||
59531681|NCT00475904|75628489|FG002|COMPLETED|Overall Study||72||
59531682|NCT00475904|75628487|FG000|NOT COMPLETED|Overall Study||15||
59531683|NCT00475904|75628488|FG001|NOT COMPLETED|Overall Study||13||
59531684|NCT00475904|75628489|FG002|NOT COMPLETED|Overall Study||4||
59531685|NCT00420992|75628499|FG000|STARTED|Titration Phase|All patients received ALO-01 during open-label titration phase|547||
59531686|NCT00420992|75628500|FG001|STARTED|Titration Phase||0||
59531687|NCT00420992|75628499|FG000|COMPLETED|Titration Phase||344||
59531688|NCT00420992|75628500|FG001|COMPLETED|Titration Phase||0||
59531689|NCT00420992|75628499|FG000|NOT COMPLETED|Titration Phase||203||
59531690|NCT00420992|75628500|FG001|NOT COMPLETED|Titration Phase||0||
59531691|NCT00420992|75628499|FG000|STARTED|Maintenance Phase||171||
59531692|NCT00420992|75628500|FG001|STARTED|Maintenance Phase||173||
59531693|NCT00420992|75628499|FG000|COMPLETED|Maintenance Phase||110||
59531694|NCT00420992|75628500|FG001|COMPLETED|Maintenance Phase||98||
59531695|NCT00420992|75628499|FG000|NOT COMPLETED|Maintenance Phase||61||
59531696|NCT00420992|75628500|FG001|NOT COMPLETED|Maintenance Phase||75||
59531697|NCT00423878|75628509|FG000|STARTED|Overall Study||109||
59531698|NCT00423878|75628510|FG001|STARTED|Overall Study||106||
59531699|NCT00423878|75628509|FG000|COMPLETED|Overall Study||89||
59531700|NCT00423878|75628510|FG001|COMPLETED|Overall Study||98||
59531701|NCT00423878|75628509|FG000|NOT COMPLETED|Overall Study||20||
59531702|NCT00423878|75628510|FG001|NOT COMPLETED|Overall Study||8||
59531703|NCT00478556|75628518|FG000|STARTED|Overall Study||151||
59531704|NCT00478556|75628519|FG001|STARTED|Overall Study||149||
59531705|NCT00478556|75628518|FG000|COMPLETED|Overall Study||151||
59531706|NCT00478556|75628519|FG001|COMPLETED|Overall Study||149||
59531707|NCT00478556|75628518|FG000|NOT COMPLETED|Overall Study||0||
59531708|NCT00478556|75628519|FG001|NOT COMPLETED|Overall Study||0||
59531709|NCT00480740|75628528|FG000|STARTED|Overall Study||26||
59531710|NCT00480740|75628529|FG001|STARTED|Overall Study||9||
59531711|NCT00480740|75628530|FG002|STARTED|Overall Study||6||
59531712|NCT00480740|75628528|FG000|COMPLETED|Overall Study||26||
59531713|NCT00480740|75628529|FG001|COMPLETED|Overall Study||9||
59531714|NCT00480740|75628530|FG002|COMPLETED|Overall Study||6||
59531715|NCT00480740|75628528|FG000|NOT COMPLETED|Overall Study||0||
59531716|NCT00480740|75628529|FG001|NOT COMPLETED|Overall Study||0||
59531717|NCT00480740|75628530|FG002|NOT COMPLETED|Overall Study||0||
59531718|NCT00424268|75628540|FG000|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|371||
59531719|NCT00424268|75628541|FG001|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|372||
59531720|NCT00424268|75628540|FG000|COMPLETED|Overall Study||309||
59531721|NCT00424268|75628541|FG001|COMPLETED|Overall Study||333||
59531722|NCT00424268|75628540|FG000|NOT COMPLETED|Overall Study||62||
59531723|NCT00424268|75628541|FG001|NOT COMPLETED|Overall Study||39||
59531724|NCT00424502|75628547|FG000|STARTED|Overall Study||20||
59531725|NCT00424502|75628547|FG000|COMPLETED|Overall Study||20||
59531726|NCT00424502|75628547|FG000|NOT COMPLETED|Overall Study||0||
59531727|NCT00425672|75628551|FG000|STARTED|Overall Study||15||
59531728|NCT00425672|75628551|FG000|COMPLETED|Overall Study||14||
59531729|NCT00425672|75628551|FG000|NOT COMPLETED|Overall Study||1||
59531730|NCT00543764|75628557|FG000|STARTED|Overall Study||100||
59531731|NCT00543764|75628558|FG001|STARTED|Overall Study||50||
59531732|NCT00543764|75628557|FG000|COMPLETED|Overall Study||100||
59531733|NCT00543764|75628558|FG001|COMPLETED|Overall Study||50||
59531734|NCT00543764|75628557|FG000|NOT COMPLETED|Overall Study||0||
59531735|NCT00543764|75628558|FG001|NOT COMPLETED|Overall Study||0||
59531736|NCT00544076|75628567|FG000|STARTED|Overall Study||34||
59531737|NCT00544076|75628568|FG001|STARTED|Overall Study||35||
59531738|NCT00544076|75628569|FG002|STARTED|Overall Study||31||
59531739|NCT00544076|75628567|FG000|COMPLETED|Overall Study||17||
59531740|NCT00544076|75628568|FG001|COMPLETED|Overall Study||19||
59531741|NCT00544076|75628569|FG002|COMPLETED|Overall Study||20||
59531742|NCT00544076|75628567|FG000|NOT COMPLETED|Overall Study||17||
59531743|NCT00544076|75628568|FG001|NOT COMPLETED|Overall Study||16||
59531744|NCT00544076|75628569|FG002|NOT COMPLETED|Overall Study||11||
59531745|NCT00544778|75628578|FG000|STARTED|Overall Study||7||
59531746|NCT00544778|75628578|FG000|COMPLETED|Overall Study||7||
59531747|NCT00544778|75628578|FG000|NOT COMPLETED|Overall Study||0||
59531748|NCT02122796|75628584|FG000|STARTED|Visit 1||15||
59531749|NCT02122796|75628585|FG001|STARTED|Visit 1||15||
59531750|NCT02122796|75628584|FG000|COMPLETED|Visit 1||15||
59531751|NCT02122796|75628585|FG001|COMPLETED|Visit 1||15||
59531752|NCT02122796|75628584|FG000|NOT COMPLETED|Visit 1||0||
59531753|NCT02122796|75628585|FG001|NOT COMPLETED|Visit 1||0||
59531754|NCT02122796|75628584|FG000|STARTED|Visit 2||15||
59531755|NCT02122796|75628585|FG001|STARTED|Visit 2||15||
59531756|NCT02122796|75628584|FG000|COMPLETED|Visit 2||12||
59531757|NCT02122796|75628585|FG001|COMPLETED|Visit 2||14||
59531758|NCT02122796|75628584|FG000|NOT COMPLETED|Visit 2||3||
59531759|NCT02122796|75628585|FG001|NOT COMPLETED|Visit 2||1||
59531760|NCT00484874|75628592|FG000|STARTED|Overall Study||12||
59531761|NCT00484874|75628592|FG000|COMPLETED|Overall Study||12||
59531762|NCT00484874|75628592|FG000|NOT COMPLETED|Overall Study||0||
59531763|NCT00486824|75628601|FG000|STARTED|Overall Study||5||
59531764|NCT00486824|75628602|FG001|STARTED|Overall Study||5||
59531765|NCT00486824|75628601|FG000|COMPLETED|Overall Study||3||
59531766|NCT00486824|75628602|FG001|COMPLETED|Overall Study||3||
59531767|NCT00486824|75628601|FG000|NOT COMPLETED|Overall Study||2||
59531768|NCT00486824|75628602|FG001|NOT COMPLETED|Overall Study||2||
59531769|NCT00489086|75628608|FG000|STARTED|Overall Study||36||
59531770|NCT00489086|75628608|FG000|Completed 18 Months|Overall Study||23||
59531771|NCT00489086|75628608|FG000|COMPLETED|Overall Study||13||
59531772|NCT00489086|75628608|FG000|NOT COMPLETED|Overall Study||23||
59531773|NCT02119442|75628612|FG000|STARTED|Overall Study||90||
59531774|NCT02119442|75628612|FG000|COMPLETED|Overall Study||90||
59531775|NCT02119442|75628612|FG000|NOT COMPLETED|Overall Study||0||
59531776|NCT00489866|75628618|FG000|STARTED|Overall Study||7||
59531777|NCT00489866|75628619|FG001|STARTED|Overall Study||7||
59531778|NCT00489866|75628618|FG000|COMPLETED|Overall Study||5||
59531779|NCT00489866|75628619|FG001|COMPLETED|Overall Study||7||
59531780|NCT00489866|75628618|FG000|NOT COMPLETED|Overall Study||2||
59531781|NCT00489866|75628619|FG001|NOT COMPLETED|Overall Study||0||
59531782|NCT00546104|75628633|FG000|STARTED|Overall Study||31||
59531783|NCT00546104|75628633|FG000|COMPLETED|Overall Study||31||
59531784|NCT00546104|75628633|FG000|NOT COMPLETED|Overall Study||0||
59815294|NCT03810456|75937762|FG001|STARTED|Enrolled and Randomized||99|Participants enrolled and randomized to a treatment condition.|
59531785|NCT00546728|75628639|FG000|STARTED|Overall Study||25||
59531786|NCT00546728|75628640|FG001|STARTED|Overall Study||25||
59531787|NCT00546728|75628639|FG000|COMPLETED|Overall Study||25||
59531788|NCT00546728|75628640|FG001|COMPLETED|Overall Study||25||
59531789|NCT00546728|75628639|FG000|NOT COMPLETED|Overall Study||0||
59531790|NCT00546728|75628640|FG001|NOT COMPLETED|Overall Study||0||
59531791|NCT00546884|75628648|FG000|STARTED|Overall Study||145||
59531792|NCT00546884|75628649|FG001|STARTED|Overall Study||117||
59531793|NCT00546884|75628648|FG000|COMPLETED|Overall Study||145||
59531794|NCT00546884|75628649|FG001|COMPLETED|Overall Study||117||
59531795|NCT00546884|75628648|FG000|NOT COMPLETED|Overall Study||0||
59531796|NCT00546884|75628649|FG001|NOT COMPLETED|Overall Study||0||
59531797|NCT00547586|75628660|FG000|STARTED|Overall Study||33||
59531798|NCT00547586|75628661|FG001|STARTED|Overall Study||7||
59531799|NCT00547586|75628662|FG002|STARTED|Overall Study||14||
59531800|NCT00547586|75628663|FG003|STARTED|Overall Study||33||
59531801|NCT00547586|75628664|FG004|STARTED|Overall Study||35||
59531802|NCT00547586|75628660|FG000|COMPLETED|Overall Study||28||
59531803|NCT00547586|75628661|FG001|COMPLETED|Overall Study||6||
59531804|NCT00547586|75628662|FG002|COMPLETED|Overall Study||13||
59531805|NCT00547586|75628663|FG003|COMPLETED|Overall Study||27||
59531806|NCT00547586|75628664|FG004|COMPLETED|Overall Study||32||
59531807|NCT00547586|75628660|FG000|NOT COMPLETED|Overall Study||5||
59531808|NCT00547586|75628661|FG001|NOT COMPLETED|Overall Study||1||
59531809|NCT00547586|75628662|FG002|NOT COMPLETED|Overall Study||1||
59531810|NCT00547586|75628663|FG003|NOT COMPLETED|Overall Study||6||
59531811|NCT00547586|75628664|FG004|NOT COMPLETED|Overall Study||3||
59531812|NCT00547898|75628680|FG000|STARTED|Overall Study||138||
59531813|NCT00547898|75628681|FG001|STARTED|Overall Study||136||
59531814|NCT00547898|75628682|FG002|STARTED|Overall Study||54||
59531815|NCT00547898|75628683|FG003|STARTED|Overall Study||46||
59531816|NCT00547898|75628680|FG000|COMPLETED|Overall Study||129||
59531817|NCT00547898|75628681|FG001|COMPLETED|Overall Study||126||
59531818|NCT00547898|75628682|FG002|COMPLETED|Overall Study||54||
59531819|NCT00547898|75628683|FG003|COMPLETED|Overall Study||40||
59531820|NCT00547898|75628680|FG000|NOT COMPLETED|Overall Study||9||
59531821|NCT00547898|75628681|FG001|NOT COMPLETED|Overall Study||10||
59531822|NCT00547898|75628682|FG002|NOT COMPLETED|Overall Study||0||
59531823|NCT00547898|75628683|FG003|NOT COMPLETED|Overall Study||6||
59815295|NCT03810456|75937763|FG002|STARTED|Enrolled and Randomized||67|Participants enrolled and randomized to a treatment condition.|
59995437|NCT02994355|76111251|FG001|NOT COMPLETED|Overall Study||||1
59531824|NCT00548132|75628697|FG000|STARTED|Overall Study||534||
59531825|NCT00548132|75628698|FG001|STARTED|Overall Study||554||
59531826|NCT00548132|75628697|FG000|Consented to Study|Overall Study||534||
59531827|NCT00548132|75628698|FG001|Consented to Study|Overall Study||554||
59531828|NCT00548132|75628697|FG000|COMPLETED|Overall Study||534||
59531829|NCT00548132|75628698|FG001|COMPLETED|Overall Study||554||
59531830|NCT00548132|75628697|FG000|NOT COMPLETED|Overall Study||0||
59531831|NCT00548132|75628698|FG001|NOT COMPLETED|Overall Study||0||
59531832|NCT00490100|75628706|FG000|STARTED|Overall Study||6||
59531833|NCT00490100|75628706|FG000|COMPLETED|Overall Study||3||
59531834|NCT00490100|75628706|FG000|NOT COMPLETED|Overall Study||3||
59531835|NCT00490256|75628713|FG000|STARTED|Overall Study||7||
59531836|NCT00490256|75628714|FG001|STARTED|Overall Study||7||
59531837|NCT00490256|75628713|FG000|Intraoperative Portion of the Study|Overall Study|Intraoperative management|7||
59531838|NCT00490256|75628714|FG001|Intraoperative Portion of the Study|Overall Study|Intraoperative management|7||
59531839|NCT00490256|75628713|FG000|COMPLETED|Overall Study||7||
59531840|NCT00490256|75628714|FG001|COMPLETED|Overall Study||7||
59531841|NCT00490256|75628713|FG000|NOT COMPLETED|Overall Study||0||
59531842|NCT00490256|75628714|FG001|NOT COMPLETED|Overall Study||0||
59531843|NCT00490802|75628722|FG000|STARTED|Overall Study||10||
59531844|NCT00490802|75628723|FG001|STARTED|Overall Study||9||
59531845|NCT00490802|75628722|FG000|COMPLETED|Overall Study||9||
59531846|NCT00490802|75628723|FG001|COMPLETED|Overall Study||7||
59531847|NCT00490802|75628722|FG000|NOT COMPLETED|Overall Study||1||
59531848|NCT00490802|75628723|FG001|NOT COMPLETED|Overall Study||2||
59531849|NCT00550394|75628732|FG000|STARTED|Overall Study||21||
59531850|NCT00550394|75628733|FG001|STARTED|Overall Study||18||
59531851|NCT00550394|75628732|FG000|COMPLETED|Overall Study||9||
59531852|NCT00550394|75628733|FG001|COMPLETED|Overall Study||5||
59531853|NCT00550394|75628732|FG000|NOT COMPLETED|Overall Study||12||
59531854|NCT00550394|75628733|FG001|NOT COMPLETED|Overall Study||13||
59531855|NCT00550862|75628745|FG000|STARTED|Overall Study||38||
59531856|NCT00550862|75628746|FG001|STARTED|Overall Study||48||
59531857|NCT00550862|75628747|FG002|STARTED|Overall Study||41||
59531858|NCT00550862|75628748|FG003|STARTED|Overall Study||38||
59531859|NCT00550862|75628745|FG000|COMPLETED|Overall Study||32||
59531860|NCT00550862|75628746|FG001|COMPLETED|Overall Study||42||
59531861|NCT00550862|75628747|FG002|COMPLETED|Overall Study||25||
59531862|NCT00550862|75628748|FG003|COMPLETED|Overall Study||37||
59531863|NCT00550862|75628745|FG000|NOT COMPLETED|Overall Study||6||
59531864|NCT00550862|75628746|FG001|NOT COMPLETED|Overall Study||6||
59531865|NCT00550862|75628747|FG002|NOT COMPLETED|Overall Study||16||
59531866|NCT00550862|75628748|FG003|NOT COMPLETED|Overall Study||1||
59531867|NCT00551174|75628760|FG000|STARTED|Overall Study||381||
59531868|NCT00551174|75628761|FG001|STARTED|Overall Study||400||
59531869|NCT00551174|75628760|FG000|COMPLETED|Overall Study|Intent-to-Treat (ITT) Population|362||
59531870|NCT00551174|75628761|FG001|COMPLETED|Overall Study|Intent-to-Treat (ITT) Population|394||
59531871|NCT00551174|75628760|FG000|NOT COMPLETED|Overall Study||19||
59531872|NCT00551174|75628761|FG001|NOT COMPLETED|Overall Study||6||
59531873|NCT00492206|75628767|FG000|STARTED|Overall Study||40||
59531874|NCT00492206|75628767|FG000|COMPLETED|Overall Study||40||
59531875|NCT00492206|75628767|FG000|NOT COMPLETED|Overall Study||0||
59531876|NCT00431132|75628773|FG000|STARTED|Overall Study||336||
59531877|NCT00431132|75628773|FG000|COMPLETED|Overall Study||292||
59531878|NCT00431132|75628773|FG000|NOT COMPLETED|Overall Study||44||
59531879|NCT00493064|75628777|FG000|STARTED|Overall Study||63||
59531880|NCT00493064|75628777|FG000|COMPLETED|Overall Study||52||
59531881|NCT00493064|75628777|FG000|NOT COMPLETED|Overall Study||11||
59531882|NCT00552422|75628781|FG000|STARTED|Overall Study||6||
59531883|NCT00552422|75628781|FG000|COMPLETED|Overall Study||6||
59531884|NCT00552422|75628781|FG000|NOT COMPLETED|Overall Study||0||
59531885|NCT00552812|75628785|FG000|STARTED|Overall Study|168 consents, 57 failed cath criteria, 5 met criteria but received covered stent, 1 withdrew consent|105||
59531886|NCT00552812|75628785|FG000|COMPLETED|Overall Study|Some still remain inside the 2 year follow up window. 2 year follow up data is not yet complete.|85||
59531887|NCT00552812|75628785|FG000|NOT COMPLETED|Overall Study||20||
59531888|NCT00432458|75628791|FG000|STARTED|Overall Study||35||
59531889|NCT00432458|75628792|FG001|STARTED|Overall Study||33||
59531890|NCT00432458|75628791|FG000|COMPLETED|Overall Study||30||
59531891|NCT00432458|75628792|FG001|COMPLETED|Overall Study||32||
59531892|NCT00432458|75628791|FG000|NOT COMPLETED|Overall Study||5||
59531893|NCT00432458|75628792|FG001|NOT COMPLETED|Overall Study||1||
59531894|NCT01656408|75628808|FG000|STARTED|Overall Study||8||
59531895|NCT01656408|75628809|FG001|STARTED|Overall Study||8||
59531896|NCT01656408|75628810|FG002|STARTED|Overall Study||8||
59531897|NCT01656408|75628811|FG003|STARTED|Overall Study||7||
59531898|NCT01656408|75628812|FG004|STARTED|Overall Study||9||
59531899|NCT01656408|75628813|FG005|STARTED|Overall Study||9||
59531900|NCT01656408|75628814|FG006|STARTED|Overall Study||10||
59531901|NCT01656408|75628815|FG007|STARTED|Overall Study||8||
59531902|NCT01656408|75628816|FG008|STARTED|Overall Study||18||
59531903|NCT01656408|75628817|FG009|STARTED|Overall Study||18||
59531904|NCT01656408|75628808|FG000|COMPLETED|Overall Study||7||
59531905|NCT01656408|75628809|FG001|COMPLETED|Overall Study||8||
59531906|NCT01656408|75628810|FG002|COMPLETED|Overall Study||6||
59531907|NCT01656408|75628811|FG003|COMPLETED|Overall Study||7||
59531908|NCT01656408|75628812|FG004|COMPLETED|Overall Study||8||
59531909|NCT01656408|75628813|FG005|COMPLETED|Overall Study||7||
59531910|NCT01656408|75628814|FG006|COMPLETED|Overall Study||9||
59531911|NCT01656408|75628815|FG007|COMPLETED|Overall Study||7||
59531912|NCT01656408|75628816|FG008|COMPLETED|Overall Study||16||
59531913|NCT01656408|75628817|FG009|COMPLETED|Overall Study||15||
59531914|NCT01656408|75628808|FG000|NOT COMPLETED|Overall Study||1||
59531915|NCT01656408|75628809|FG001|NOT COMPLETED|Overall Study||0||
59531916|NCT01656408|75628810|FG002|NOT COMPLETED|Overall Study||2||
59531917|NCT01656408|75628811|FG003|NOT COMPLETED|Overall Study||0||
59531918|NCT01656408|75628812|FG004|NOT COMPLETED|Overall Study||1||
59531919|NCT01656408|75628813|FG005|NOT COMPLETED|Overall Study||2||
59531920|NCT01656408|75628814|FG006|NOT COMPLETED|Overall Study||1||
59531921|NCT01656408|75628815|FG007|NOT COMPLETED|Overall Study||1||
59531922|NCT01656408|75628816|FG008|NOT COMPLETED|Overall Study||2||
59531923|NCT01656408|75628817|FG009|NOT COMPLETED|Overall Study||3||
59531924|NCT00433550|75628866|FG000|STARTED|Overall Study||17||
59531925|NCT00433550|75628867|FG001|STARTED|Overall Study||10||
59531926|NCT00433550|75628868|FG002|STARTED|Overall Study||6||
59531927|NCT00433550|75628866|FG000|COMPLETED|Overall Study||17||
59531928|NCT00433550|75628867|FG001|COMPLETED|Overall Study||10||
59531929|NCT00433550|75628868|FG002|COMPLETED|Overall Study||6||
59531930|NCT00433550|75628866|FG000|NOT COMPLETED|Overall Study||0||
59531931|NCT00433550|75628867|FG001|NOT COMPLETED|Overall Study||0||
59531932|NCT00433550|75628868|FG002|NOT COMPLETED|Overall Study||0||
59531933|NCT02208037|75628879|FG000|STARTED|Overall Study||93||
59531934|NCT02208037|75628880|FG001|STARTED|Overall Study||93||
59531935|NCT02208037|75628881|FG002|STARTED|Overall Study||93||
59531936|NCT02208037|75628879|FG000|COMPLETED|Overall Study||89||
59531937|NCT02208037|75628880|FG001|COMPLETED|Overall Study||92||
59531938|NCT02208037|75628881|FG002|COMPLETED|Overall Study||92||
59531939|NCT02208037|75628879|FG000|NOT COMPLETED|Overall Study||4||
59531940|NCT02208037|75628880|FG001|NOT COMPLETED|Overall Study||1||
59531941|NCT02208037|75628881|FG002|NOT COMPLETED|Overall Study||1||
59531942|NCT00496262|75628889|FG000|STARTED|Overall Study||15||
59531943|NCT00496262|75628889|FG000|COMPLETED|Overall Study||15||
59531944|NCT00496262|75628889|FG000|NOT COMPLETED|Overall Study||0||
59531945|NCT01483807|75628895|FG000|STARTED|First Treatment Phase (7 Weeks)||10||
59531946|NCT01483807|75628896|FG001|STARTED|First Treatment Phase (7 Weeks)||10||
59531947|NCT01483807|75628895|FG000|COMPLETED|First Treatment Phase (7 Weeks)||10||
59531948|NCT01483807|75628896|FG001|COMPLETED|First Treatment Phase (7 Weeks)||10||
59531949|NCT01483807|75628895|FG000|NOT COMPLETED|First Treatment Phase (7 Weeks)||0||
59531950|NCT01483807|75628896|FG001|NOT COMPLETED|First Treatment Phase (7 Weeks)||0||
59531951|NCT01483807|75628895|FG000|STARTED|Washout (2 Weeks)||10||
59531952|NCT01483807|75628896|FG001|STARTED|Washout (2 Weeks)||10||
59531953|NCT01483807|75628895|FG000|COMPLETED|Washout (2 Weeks)||10||
59531954|NCT01483807|75628896|FG001|COMPLETED|Washout (2 Weeks)||10||
59531955|NCT01483807|75628895|FG000|NOT COMPLETED|Washout (2 Weeks)||0||
59531956|NCT01483807|75628896|FG001|NOT COMPLETED|Washout (2 Weeks)||0||
59531957|NCT01483807|75628895|FG000|STARTED|Second Treatment Phase (7 Weeks)||10||
59531958|NCT01483807|75628896|FG001|STARTED|Second Treatment Phase (7 Weeks)||10||
59531959|NCT01483807|75628895|FG000|COMPLETED|Second Treatment Phase (7 Weeks)||10||
59531960|NCT01483807|75628896|FG001|COMPLETED|Second Treatment Phase (7 Weeks)||10||
59531961|NCT01483807|75628895|FG000|NOT COMPLETED|Second Treatment Phase (7 Weeks)||0||
59531962|NCT01483807|75628896|FG001|NOT COMPLETED|Second Treatment Phase (7 Weeks)||0||
59531963|NCT00434018|75628906|FG000|STARTED|Overall Study||69||
59531964|NCT00434018|75628907|FG001|STARTED|Overall Study||69||
59531965|NCT00434018|75628906|FG000|COMPLETED|Overall Study||52||
59531966|NCT00434018|75628907|FG001|COMPLETED|Overall Study||57||
59531967|NCT00434018|75628906|FG000|NOT COMPLETED|Overall Study||17||
59531968|NCT00434018|75628907|FG001|NOT COMPLETED|Overall Study||12||
59531969|NCT00496340|75628914|FG000|STARTED|Overall Study||42||
59531970|NCT00496340|75628914|FG000|COMPLETED|Overall Study||42||
59531971|NCT00496340|75628914|FG000|NOT COMPLETED|Overall Study||0||
59531972|NCT00496808|75628918|FG000|STARTED|Overall Study||69||
59531973|NCT00496808|75628918|FG000|COMPLETED|Overall Study||69||
59531974|NCT00496808|75628918|FG000|NOT COMPLETED|Overall Study||0||
59531975|NCT05039268|75628924|FG000|STARTED|Overall Study||8||
59531976|NCT05039268|75628925|FG001|STARTED|Overall Study||8||
59531977|NCT05039268|75628924|FG000|COMPLETED|Overall Study||8||
59531978|NCT05039268|75628925|FG001|COMPLETED|Overall Study||8||
59531979|NCT05039268|75628924|FG000|NOT COMPLETED|Overall Study||0||
59531980|NCT05039268|75628925|FG001|NOT COMPLETED|Overall Study||0||
59531981|NCT00554372|75628933|FG000|STARTED|Overall Study||14||
59531982|NCT00554372|75628934|FG001|STARTED|Overall Study||16||
59531983|NCT00554372|75628933|FG000|COMPLETED|Overall Study||14||
59531984|NCT00554372|75628934|FG001|COMPLETED|Overall Study||16||
59531985|NCT00554372|75628933|FG000|NOT COMPLETED|Overall Study||0||
59531986|NCT00554372|75628934|FG001|NOT COMPLETED|Overall Study||0||
59531987|NCT00554996|75628942|FG000|STARTED|Overall Study||10||
59531988|NCT00554996|75628942|FG000|COMPLETED|Overall Study||10||
59531989|NCT00554996|75628942|FG000|NOT COMPLETED|Overall Study||0||
59531990|NCT01483963|75628951|FG000|STARTED|Overall Study||10||
59531991|NCT01483963|75628952|FG001|STARTED|Overall Study||10||
59531992|NCT01483963|75628953|FG002|STARTED|Overall Study||10||
59531993|NCT01483963|75628954|FG003|STARTED|Overall Study||10||
59531994|NCT01483963|75628955|FG004|STARTED|Overall Study||10||
59531995|NCT01483963|75628951|FG000|COMPLETED|Overall Study||10||
59531996|NCT01483963|75628952|FG001|COMPLETED|Overall Study||10||
59531997|NCT01483963|75628953|FG002|COMPLETED|Overall Study||10||
59531998|NCT01483963|75628954|FG003|COMPLETED|Overall Study||10||
59531999|NCT01483963|75628955|FG004|COMPLETED|Overall Study||10||
59532000|NCT01483963|75628951|FG000|NOT COMPLETED|Overall Study||0||
59532001|NCT01483963|75628952|FG001|NOT COMPLETED|Overall Study||0||
59532002|NCT01483963|75628953|FG002|NOT COMPLETED|Overall Study||0||
59532003|NCT01483963|75628954|FG003|NOT COMPLETED|Overall Study||0||
59532004|NCT01483963|75628955|FG004|NOT COMPLETED|Overall Study||0||
59532005|NCT01484041|75628968|FG000|STARTED|Overall Study||12||
59532006|NCT01484041|75628968|FG000|COMPLETED|Overall Study||12||
59532007|NCT01484041|75628968|FG000|NOT COMPLETED|Overall Study||0||
59532008|NCT00555152|75628976|FG000|STARTED|Period Open at BCM: 1/17/08-3/8/10||2||
59532009|NCT00555152|75628977|FG001|STARTED|Period Open at BCM: 1/17/08-3/8/10|Participants in initial and second study registration periods reported separately.|0||
59532010|NCT00555152|75628978|FG002|STARTED|Period Open at BCM: 1/17/08-3/8/10||0||
59532011|NCT00555152|75628979|FG003|STARTED|Period Open at BCM: 1/17/08-3/8/10||1||
59532012|NCT00555152|75628976|FG000|COMPLETED|Period Open at BCM: 1/17/08-3/8/10||2||
59532013|NCT00555152|75628977|FG001|COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0||
59532014|NCT00555152|75628978|FG002|COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0||
59532015|NCT00555152|75628979|FG003|COMPLETED|Period Open at BCM: 1/17/08-3/8/10||1||
59532016|NCT00555152|75628976|FG000|NOT COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0||
59532017|NCT00555152|75628977|FG001|NOT COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0||
59532018|NCT00555152|75628978|FG002|NOT COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0||
59532019|NCT00555152|75628979|FG003|NOT COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0||
59532020|NCT00555152|75628976|FG000|STARTED|Transfer to MD Anderson: 9/19/11-8/28/14|Participants in initial and second study registration periods reported separately.|0||
59532021|NCT00555152|75628977|FG001|STARTED|Transfer to MD Anderson: 9/19/11-8/28/14||10||
59532022|NCT00555152|75628978|FG002|STARTED|Transfer to MD Anderson: 9/19/11-8/28/14||0||
59532023|NCT00555152|75628979|FG003|STARTED|Transfer to MD Anderson: 9/19/11-8/28/14||9||
59532024|NCT00555152|75628976|FG000|COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0||
59532025|NCT00555152|75628977|FG001|COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||10||
59532026|NCT00555152|75628978|FG002|COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0||
59532027|NCT00555152|75628979|FG003|COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||9||
59532028|NCT00555152|75628976|FG000|NOT COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0||
59532029|NCT00555152|75628977|FG001|NOT COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0||
59532030|NCT00555152|75628978|FG002|NOT COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0||
59532031|NCT00555152|75628979|FG003|NOT COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0||
59532032|NCT01461499|75628991|FG000|STARTED|Overall Study||119||
59532033|NCT01461499|75628992|FG001|STARTED|Overall Study||118||
59532034|NCT01461499|75628991|FG000|COMPLETED|Overall Study||111||
59532035|NCT01461499|75628992|FG001|COMPLETED|Overall Study||114||
59532036|NCT01461499|75628991|FG000|NOT COMPLETED|Overall Study||8||
59532037|NCT01461499|75628992|FG001|NOT COMPLETED|Overall Study||4||
59532038|NCT00555464|75629002|FG000|STARTED|Overall Study||4||
60075573|NCT01684215|76190865|FG001|COMPLETED|Phase 1, Part 1||0||
59532039|NCT00555464|75629003|FG001|STARTED|Overall Study||4||
59532040|NCT00555464|75629002|FG000|COMPLETED|Overall Study||4||
59532041|NCT00555464|75629003|FG001|COMPLETED|Overall Study||1||
59532042|NCT00555464|75629002|FG000|NOT COMPLETED|Overall Study||0||
59532043|NCT00555464|75629003|FG001|NOT COMPLETED|Overall Study||3||
59532044|NCT01461655|75629009|FG000|STARTED|Overall Study||40||
59532045|NCT01461655|75629009|FG000|COMPLETED|Overall Study||40||
59532046|NCT01461655|75629009|FG000|NOT COMPLETED|Overall Study||0||
59532047|NCT01461733|75629016|FG000|STARTED|Overall Study||12||
59532048|NCT01461733|75629017|FG001|STARTED|Overall Study||12||
59532049|NCT01461733|75629016|FG000|COMPLETED|Overall Study||8||
59532050|NCT01461733|75629017|FG001|COMPLETED|Overall Study||8||
59532051|NCT01461733|75629016|FG000|NOT COMPLETED|Overall Study||4||
59532052|NCT01461733|75629017|FG001|NOT COMPLETED|Overall Study||4||
59532053|NCT01462279|75629023|FG000|STARTED|Overall Study||20||
59532054|NCT01462279|75629023|FG000|COMPLETED|Overall Study||17||
59532055|NCT01462279|75629023|FG000|NOT COMPLETED|Overall Study||3||
59532056|NCT02207803|75629029|FG000|STARTED|Overall Study||125||
59532057|NCT02207803|75629030|FG001|STARTED|Overall Study||125||
60075574|NCT01684215|76190866|FG002|COMPLETED|Phase 1, Part 1||0||
59532058|NCT02207803|75629029|FG000|COMPLETED|Overall Study||110||
59532059|NCT02207803|75629030|FG001|COMPLETED|Overall Study||108||
59532060|NCT02207803|75629029|FG000|NOT COMPLETED|Overall Study||15||
59532061|NCT02207803|75629030|FG001|NOT COMPLETED|Overall Study||17||
60075575|NCT01684215|76190867|FG003|COMPLETED|Phase 1, Part 1||0||
59532062|NCT00435812|75629038|FG000|STARTED|Overall Study||1820||
59532063|NCT00435812|75629039|FG001|STARTED|Overall Study||608||
59532064|NCT00435812|75629038|FG000|COMPLETED|Overall Study||1757||
59532065|NCT00435812|75629039|FG001|COMPLETED|Overall Study||590||
59532066|NCT00435812|75629038|FG000|NOT COMPLETED|Overall Study||63||
59532067|NCT00435812|75629039|FG001|NOT COMPLETED|Overall Study||18||
59532068|NCT01464229|75629047|FG000|STARTED|Overall Study||10||
59532069|NCT01464229|75629048|FG001|STARTED|Overall Study||10||
59532070|NCT01464229|75629047|FG000|COMPLETED|Overall Study||5||
59532071|NCT01464229|75629048|FG001|COMPLETED|Overall Study||8||
59532072|NCT01464229|75629047|FG000|NOT COMPLETED|Overall Study||5||
59532073|NCT01464229|75629048|FG001|NOT COMPLETED|Overall Study||2||
59532074|NCT00556478|75629056|FG000|STARTED|Double-blind Phase||171||
59532075|NCT00556478|75629057|FG001|STARTED|Double-blind Phase||85||
59532076|NCT00556478|75629056|FG000|ITT|Double-blind Phase||167||
59532077|NCT00556478|75629057|FG001|ITT|Double-blind Phase||82||
59532078|NCT00556478|75629056|FG000|COMPLETED|Double-blind Phase||150||
59532079|NCT00556478|75629057|FG001|COMPLETED|Double-blind Phase||77||
59532080|NCT00556478|75629056|FG000|NOT COMPLETED|Double-blind Phase||21||
59532081|NCT00556478|75629057|FG001|NOT COMPLETED|Double-blind Phase||8||
59532082|NCT00556478|75629056|FG000|STARTED|Open-Label Phase||146||
59532083|NCT00556478|75629057|FG001|STARTED|Open-Label Phase||77||
59532084|NCT00556478|75629056|FG000|Treated in Open-label|Open-Label Phase||142||
59532085|NCT00556478|75629057|FG001|Treated in Open-label|Open-Label Phase||71||
59532086|NCT00556478|75629056|FG000|COMPLETED|Open-Label Phase||132||
59532087|NCT00556478|75629057|FG001|COMPLETED|Open-Label Phase||67||
59532088|NCT00556478|75629056|FG000|NOT COMPLETED|Open-Label Phase||14||
59532089|NCT00556478|75629057|FG001|NOT COMPLETED|Open-Label Phase||10||
59532090|NCT01467037|75629068|FG000|STARTED|Overall Study||374||
59532091|NCT01467037|75629068|FG000|COMPLETED|Overall Study||374||
59532092|NCT01467037|75629068|FG000|NOT COMPLETED|Overall Study||0||
59532093|NCT01468675|75629077|FG000|STARTED|Overall Study||2699||
59532094|NCT01468675|75629078|FG001|STARTED|Overall Study||3376||
59532095|NCT01468675|75629077|FG000|COMPLETED|Overall Study||1699||
59532096|NCT01468675|75629078|FG001|COMPLETED|Overall Study||2004||
59532097|NCT01468675|75629077|FG000|NOT COMPLETED|Overall Study||1000||
59532098|NCT01468675|75629078|FG001|NOT COMPLETED|Overall Study||1372||
59532099|NCT00500240|75629086|FG000|STARTED|Overall Study||25||
59532100|NCT00500240|75629087|FG001|STARTED|Overall Study||26||
59532101|NCT00500240|75629086|FG000|COMPLETED|Overall Study||25||
59532102|NCT00500240|75629087|FG001|COMPLETED|Overall Study||26||
59532103|NCT00500240|75629086|FG000|NOT COMPLETED|Overall Study||0||
59532104|NCT00500240|75629087|FG001|NOT COMPLETED|Overall Study||0||
59532105|NCT01469767|75629095|FG000|STARTED|Overall Study||10||
59532106|NCT01469767|75629095|FG000|COMPLETED|Overall Study||10||
59532107|NCT01469767|75629095|FG000|NOT COMPLETED|Overall Study||0||
59532108|NCT01470781|75629101|FG000|STARTED|Overall Study||39||
59532109|NCT01470781|75629102|FG001|STARTED|Overall Study||33||
59532110|NCT01470781|75629101|FG000|Midpoint Assessment|Overall Study||30||
59532111|NCT01470781|75629102|FG001|Midpoint Assessment|Overall Study||30||
59532112|NCT01470781|75629101|FG000|Post-Treatment Assessment|Overall Study||22||
59532113|NCT01470781|75629102|FG001|Post-Treatment Assessment|Overall Study||23||
59532114|NCT01470781|75629101|FG000|COMPLETED|Overall Study||21||
59532115|NCT01470781|75629102|FG001|COMPLETED|Overall Study||21||
59532116|NCT01470781|75629101|FG000|NOT COMPLETED|Overall Study||18||
59532117|NCT01470781|75629102|FG001|NOT COMPLETED|Overall Study||12||
59532118|NCT01470859|75629111|FG000|STARTED|Overall Study||15||
59532119|NCT01470859|75629112|FG001|STARTED|Overall Study||15||
59532120|NCT01470859|75629111|FG000|COMPLETED|Overall Study||14||
59532121|NCT01470859|75629112|FG001|COMPLETED|Overall Study||15||
59532122|NCT01470859|75629111|FG000|NOT COMPLETED|Overall Study||1||
59532123|NCT01470859|75629112|FG001|NOT COMPLETED|Overall Study||0||
59532124|NCT00436046|75629121|FG000|STARTED|Overall Study||32||
59532125|NCT00436046|75629122|FG001|STARTED|Overall Study||32||
59532126|NCT00436046|75629123|FG002|STARTED|Overall Study||31||
59532127|NCT00436046|75629121|FG000|COMPLETED|Overall Study||32||
59532128|NCT00436046|75629122|FG001|COMPLETED|Overall Study||32||
59532129|NCT00436046|75629123|FG002|COMPLETED|Overall Study||31||
59532130|NCT00436046|75629121|FG000|NOT COMPLETED|Overall Study||0||
59532131|NCT00436046|75629122|FG001|NOT COMPLETED|Overall Study||0||
59532132|NCT00436046|75629123|FG002|NOT COMPLETED|Overall Study||0||
59532133|NCT01471639|75629131|FG000|STARTED|Overall Study||37||
59532134|NCT01471639|75629131|FG000|COMPLETED|Overall Study||37||
59532135|NCT01471639|75629131|FG000|NOT COMPLETED|Overall Study||0||
59532136|NCT01540045|75629135|FG000|STARTED|Overall Study||40||
59532137|NCT01540045|75629135|FG000|COMPLETED|Overall Study||40||
59532138|NCT01540045|75629135|FG000|NOT COMPLETED|Overall Study||0||
59532139|NCT00436904|75629160|FG000|STARTED|Overall Study||30||
59532140|NCT00436904|75629160|FG000|COMPLETED|Overall Study||30||
59532141|NCT00436904|75629160|FG000|NOT COMPLETED|Overall Study||0||
59532142|NCT00438854|75629164|FG000|STARTED|Overall Study||15||
59532143|NCT00438854|75629164|FG000|COMPLETED|Overall Study||15||
59532144|NCT00438854|75629164|FG000|NOT COMPLETED|Overall Study||0||
59532145|NCT01485055|75629168|FG000|STARTED|Overall Study||11||
59532146|NCT01485055|75629168|FG000|COMPLETED|Overall Study||11||
59532147|NCT01485055|75629168|FG000|NOT COMPLETED|Overall Study||0||
59532148|NCT01486615|75629176|FG000|STARTED|Overall Study||20||
59532149|NCT01486615|75629177|FG001|STARTED|Overall Study||20||
59532150|NCT01486615|75629178|FG002|STARTED|Overall Study||20||
59532151|NCT01486615|75629179|FG003|STARTED|Overall Study||20||
59532152|NCT01486615|75629176|FG000|COMPLETED|Overall Study||20||
59532153|NCT01486615|75629177|FG001|COMPLETED|Overall Study|observed till 2 hrs after premedication, not available after 24 hours as surgery was postponed|19||
59532154|NCT01486615|75629178|FG002|COMPLETED|Overall Study|observed till 2 hrs after premedication, not available after 24 hours as surgery was postponed|18||
59532155|NCT01486615|75629179|FG003|COMPLETED|Overall Study|observed till 2 hrs after premedication, not available after 24 hours as surgery was postponed|18||
59532156|NCT01486615|75629176|FG000|NOT COMPLETED|Overall Study||0||
59532157|NCT01486615|75629177|FG001|NOT COMPLETED|Overall Study||1||
59532158|NCT01486615|75629178|FG002|NOT COMPLETED|Overall Study||2||
59532159|NCT01486615|75629179|FG003|NOT COMPLETED|Overall Study||2||
59532160|NCT00503750|75629189|FG000|STARTED|Overall Study||27||
59532161|NCT00503750|75629189|FG000|COMPLETED|Overall Study||27||
59532162|NCT00503750|75629189|FG000|NOT COMPLETED|Overall Study||0||
59532163|NCT00438932|75629197|FG000|STARTED|Overall Study||4||
59532164|NCT00438932|75629198|FG001|STARTED|Overall Study||4||
59532165|NCT00438932|75629199|FG002|STARTED|Overall Study||4||
59532166|NCT00438932|75629200|FG003|STARTED|Overall Study||4||
59532167|NCT00438932|75629197|FG000|COMPLETED|Overall Study||4||
59532168|NCT00438932|75629198|FG001|COMPLETED|Overall Study||4||
59532169|NCT00438932|75629199|FG002|COMPLETED|Overall Study||4||
59532170|NCT00438932|75629200|FG003|COMPLETED|Overall Study||4||
59532171|NCT00438932|75629197|FG000|NOT COMPLETED|Overall Study||0||
59532172|NCT00438932|75629198|FG001|NOT COMPLETED|Overall Study||0||
59532173|NCT00438932|75629199|FG002|NOT COMPLETED|Overall Study||0||
59532174|NCT00438932|75629200|FG003|NOT COMPLETED|Overall Study||0||
59532175|NCT00506714|75629212|FG000|STARTED|Overall Study||13||
59532176|NCT00506714|75629213|FG001|STARTED|Overall Study||13||
59532177|NCT00506714|75629212|FG000|COMPLETED|Overall Study||13||
59532178|NCT00506714|75629213|FG001|COMPLETED|Overall Study||13||
59532179|NCT00506714|75629212|FG000|NOT COMPLETED|Overall Study||0||
59532180|NCT00506714|75629213|FG001|NOT COMPLETED|Overall Study||0||
59532181|NCT00508118|75629223|FG000|STARTED|Overall Study||3||
59532182|NCT00508118|75629224|FG001|STARTED|Overall Study|Documentation is not available for the 7th subject and treatment arm.|4||
59532183|NCT00508118|75629223|FG000|COMPLETED|Overall Study||3||
59532184|NCT00508118|75629224|FG001|COMPLETED|Overall Study||4||
59532185|NCT00508118|75629223|FG000|NOT COMPLETED|Overall Study||0||
59532186|NCT00508118|75629224|FG001|NOT COMPLETED|Overall Study||0||
59532187|NCT00508196|75629231|FG000|STARTED|Overall Study||11||
59532188|NCT00508196|75629232|FG001|STARTED|Overall Study||11||
59532189|NCT00508196|75629231|FG000|COMPLETED|Overall Study||11||
59532190|NCT00508196|75629232|FG001|COMPLETED|Overall Study||11||
59532191|NCT00508196|75629231|FG000|NOT COMPLETED|Overall Study||0||
59532192|NCT00508196|75629232|FG001|NOT COMPLETED|Overall Study||0||
59815296|NCT03810456|75937761|FG000|COMPLETED|Enrolled and Randomized||69|Participants who started treatment.|
59817894|NCT04488770|75940333|FG007|COMPLETED|Part 1-Cohort 2: Period 1 (Up to 5 Days)||2||
59532193|NCT00440180|75629240|FG000|STARTED|Overall Study||10||
59532194|NCT00440180|75629241|FG001|STARTED|Overall Study||10||
59532195|NCT00440180|75629240|FG000|COMPLETED|Overall Study||10||
59532196|NCT00440180|75629241|FG001|COMPLETED|Overall Study||10||
59532197|NCT00440180|75629240|FG000|NOT COMPLETED|Overall Study||0||
59532198|NCT00440180|75629241|FG001|NOT COMPLETED|Overall Study||0||
59532199|NCT02114216|75629250|FG000|STARTED|Overall Study||16||
59532200|NCT02114216|75629251|FG001|STARTED|Overall Study||45||
59532201|NCT02114216|75629252|FG002|STARTED|Overall Study||14||
59532202|NCT02114216|75629250|FG000|COMPLETED|Overall Study||16||
59532203|NCT02114216|75629251|FG001|COMPLETED|Overall Study||45||
59532204|NCT02114216|75629252|FG002|COMPLETED|Overall Study||14||
59532205|NCT02114216|75629250|FG000|NOT COMPLETED|Overall Study||0||
59532206|NCT02114216|75629251|FG001|NOT COMPLETED|Overall Study||0||
59532207|NCT02114216|75629252|FG002|NOT COMPLETED|Overall Study||0||
59622725|NCT00542490|75734617|FG000|COMPLETED|Overall Study||21||
59622726|NCT00542490|75734617|FG000|NOT COMPLETED|Overall Study||2||
59532208|NCT01364298|75629265|FG000|STARTED|Overall Study||176||
59532209|NCT01364298|75629266|FG001|STARTED|Overall Study||177||
59532210|NCT01364298|75629265|FG000|Treated|Overall Study||174||
59532211|NCT01364298|75629266|FG001|Treated|Overall Study||174||
59532212|NCT01364298|75629265|FG000|COMPLETED|Overall Study||162||
59532213|NCT01364298|75629266|FG001|COMPLETED|Overall Study||154||
59532214|NCT01364298|75629265|FG000|NOT COMPLETED|Overall Study||14||
59532215|NCT01364298|75629266|FG001|NOT COMPLETED|Overall Study||23||
59532216|NCT00441350|75629274|FG000|STARTED|Phase A: Randomization to Week 8||285||
59532217|NCT00441350|75629275|FG001|STARTED|Phase A: Randomization to Week 8||561||
59532218|NCT00441350|75629276|FG002|STARTED|Phase A: Randomization to Week 8||0||
59532219|NCT00441350|75629277|FG003|STARTED|Phase A: Randomization to Week 8||0||
59532220|NCT00441350|75629278|FG004|STARTED|Phase A: Randomization to Week 8||0||
59532221|NCT00441350|75629279|FG005|STARTED|Phase A: Randomization to Week 8||0||
59532222|NCT00441350|75629274|FG000|COMPLETED|Phase A: Randomization to Week 8||268||
59532223|NCT00441350|75629275|FG001|COMPLETED|Phase A: Randomization to Week 8||524||
59532224|NCT00441350|75629276|FG002|COMPLETED|Phase A: Randomization to Week 8||0||
59532225|NCT00441350|75629277|FG003|COMPLETED|Phase A: Randomization to Week 8||0||
59532226|NCT00441350|75629278|FG004|COMPLETED|Phase A: Randomization to Week 8||0||
59532227|NCT00441350|75629279|FG005|COMPLETED|Phase A: Randomization to Week 8||0||
59532228|NCT00441350|75629274|FG000|NOT COMPLETED|Phase A: Randomization to Week 8||17||
59532229|NCT00441350|75629275|FG001|NOT COMPLETED|Phase A: Randomization to Week 8||37||
59532230|NCT00441350|75629276|FG002|NOT COMPLETED|Phase A: Randomization to Week 8||0||
59532231|NCT00441350|75629277|FG003|NOT COMPLETED|Phase A: Randomization to Week 8||0||
59532232|NCT00441350|75629278|FG004|NOT COMPLETED|Phase A: Randomization to Week 8||0||
59532233|NCT00441350|75629279|FG005|NOT COMPLETED|Phase A: Randomization to Week 8||0||
59532234|NCT00441350|75629274|FG000|STARTED|Phase B: Week 8 to Week 16||0||
59532235|NCT00441350|75629275|FG001|STARTED|Phase B: Week 8 to Week 16||0||
59532236|NCT00441350|75629276|FG002|STARTED|Phase B: Week 8 to Week 16||129||
59532237|NCT00441350|75629277|FG003|STARTED|Phase B: Week 8 to Week 16||139||
59532238|NCT00441350|75629278|FG004|STARTED|Phase B: Week 8 to Week 16||336||
59532239|NCT00441350|75629279|FG005|STARTED|Phase B: Week 8 to Week 16||188||
59532240|NCT00441350|75629274|FG000|COMPLETED|Phase B: Week 8 to Week 16||0||
59532241|NCT00441350|75629275|FG001|COMPLETED|Phase B: Week 8 to Week 16||0||
59532242|NCT00441350|75629276|FG002|COMPLETED|Phase B: Week 8 to Week 16||128||
59532243|NCT00441350|75629277|FG003|COMPLETED|Phase B: Week 8 to Week 16||137||
59532244|NCT00441350|75629278|FG004|COMPLETED|Phase B: Week 8 to Week 16||333||
59532245|NCT00441350|75629279|FG005|COMPLETED|Phase B: Week 8 to Week 16||186||
59532246|NCT00441350|75629274|FG000|NOT COMPLETED|Phase B: Week 8 to Week 16||0||
59532247|NCT00441350|75629275|FG001|NOT COMPLETED|Phase B: Week 8 to Week 16||0||
59532248|NCT00441350|75629276|FG002|NOT COMPLETED|Phase B: Week 8 to Week 16||1||
59532249|NCT00441350|75629277|FG003|NOT COMPLETED|Phase B: Week 8 to Week 16||2||
59532250|NCT00441350|75629278|FG004|NOT COMPLETED|Phase B: Week 8 to Week 16||3||
59532251|NCT00441350|75629279|FG005|NOT COMPLETED|Phase B: Week 8 to Week 16||2||
59532252|NCT01488019|75629295|FG000|STARTED|Overall Study||541||
59532253|NCT01488019|75629296|FG001|STARTED|Overall Study||530||
59532254|NCT01488019|75629295|FG000|COMPLETED|Overall Study||294||
59532255|NCT01488019|75629296|FG001|COMPLETED|Overall Study||226||
59532256|NCT01488019|75629295|FG000|NOT COMPLETED|Overall Study||247||
59532257|NCT01488019|75629296|FG001|NOT COMPLETED|Overall Study||304||
59532258|NCT01488409|75629306|FG000|STARTED|Overall Study||20||
59532259|NCT01488409|75629307|FG001|STARTED|Overall Study||19||
59532260|NCT01488409|75629306|FG000|COMPLETED|Overall Study||16||
59532261|NCT01488409|75629307|FG001|COMPLETED|Overall Study||15||
59532262|NCT01488409|75629306|FG000|NOT COMPLETED|Overall Study||4||
59532263|NCT01488409|75629307|FG001|NOT COMPLETED|Overall Study||4||
59532264|NCT01488877|75629313|FG000|STARTED|Initial Randomization||1||
59532265|NCT01488877|75629314|FG001|STARTED|Initial Randomization||5||
59532266|NCT01488877|75629315|FG002|STARTED|Initial Randomization||0||
59532267|NCT01488877|75629313|FG000|COMPLETED|Initial Randomization||1||
59532268|NCT01488877|75629314|FG001|COMPLETED|Initial Randomization||5||
59532269|NCT01488877|75629315|FG002|COMPLETED|Initial Randomization||0||
59532270|NCT01488877|75629313|FG000|NOT COMPLETED|Initial Randomization||0||
59532271|NCT01488877|75629314|FG001|NOT COMPLETED|Initial Randomization||0||
59532272|NCT01488877|75629315|FG002|NOT COMPLETED|Initial Randomization||0||
59532273|NCT01488877|75629313|FG000|STARTED|Re-randomization||0||
59532274|NCT01488877|75629314|FG001|STARTED|Re-randomization||0||
59532275|NCT01488877|75629315|FG002|STARTED|Re-randomization|Three participants were re-randomized from PF-03882845 3 mg arm.|3||
59532276|NCT01488877|75629313|FG000|COMPLETED|Re-randomization||0||
59532277|NCT01488877|75629314|FG001|COMPLETED|Re-randomization||0||
59532278|NCT01488877|75629315|FG002|COMPLETED|Re-randomization||3||
59532279|NCT01488877|75629313|FG000|NOT COMPLETED|Re-randomization||0||
59532280|NCT01488877|75629314|FG001|NOT COMPLETED|Re-randomization||0||
59532281|NCT01488877|75629315|FG002|NOT COMPLETED|Re-randomization||0||
59532282|NCT01364922|75629325|FG000|STARTED|Open-label (OL) Period||168||
59532283|NCT01364922|75629326|FG001|STARTED|Open-label (OL) Period||0||
59532284|NCT01364922|75629327|FG002|STARTED|Open-label (OL) Period||0||
59532285|NCT01364922|75629325|FG000|COMPLETED|Open-label (OL) Period||146||
59532286|NCT01364922|75629326|FG001|COMPLETED|Open-label (OL) Period||0||
59532287|NCT01364922|75629327|FG002|COMPLETED|Open-label (OL) Period||0||
59532288|NCT01364922|75629325|FG000|NOT COMPLETED|Open-label (OL) Period||22||
59532289|NCT01364922|75629326|FG001|NOT COMPLETED|Open-label (OL) Period||0||
59532290|NCT01364922|75629327|FG002|NOT COMPLETED|Open-label (OL) Period||0||
59532291|NCT01364922|75629325|FG000|STARTED|Double-Blind (DB) Period||0||
59532292|NCT01364922|75629326|FG001|STARTED|Double-Blind (DB) Period||99||
59532293|NCT01364922|75629327|FG002|STARTED|Double-Blind (DB) Period||47||
59532294|NCT01364922|75629325|FG000|COMPLETED|Double-Blind (DB) Period||0||
59532295|NCT01364922|75629326|FG001|COMPLETED|Double-Blind (DB) Period||94||
59532296|NCT01364922|75629327|FG002|COMPLETED|Double-Blind (DB) Period||42||
59532297|NCT01364922|75629325|FG000|NOT COMPLETED|Double-Blind (DB) Period||0||
59532298|NCT01364922|75629326|FG001|NOT COMPLETED|Double-Blind (DB) Period||5||
59532299|NCT01364922|75629327|FG002|NOT COMPLETED|Double-Blind (DB) Period||5||
59532300|NCT01489579|75629336|FG000|STARTED|Overall Study||56||
59532301|NCT01489579|75629337|FG001|STARTED|Overall Study||64||
59532302|NCT01489579|75629336|FG000|COMPLETED|Overall Study||47||
59532303|NCT01489579|75629337|FG001|COMPLETED|Overall Study||57||
59532304|NCT01489579|75629336|FG000|NOT COMPLETED|Overall Study||9||
59532305|NCT01489579|75629337|FG001|NOT COMPLETED|Overall Study||7||
59532306|NCT01489969|75629348|FG000|STARTED|Overall Study||45||
59532307|NCT01489969|75629349|FG001|STARTED|Overall Study||47||
59532308|NCT01489969|75629350|FG002|STARTED|Overall Study||45||
59532309|NCT01489969|75629348|FG000|COMPLETED|Overall Study||40||
60075576|NCT01684215|76190864|FG000|NOT COMPLETED|Phase 1, Part 1||6||
60075577|NCT01684215|76190865|FG001|NOT COMPLETED|Phase 1, Part 1||6||
60075578|NCT01684215|76190866|FG002|NOT COMPLETED|Phase 1, Part 1||0||
60075579|NCT01684215|76190867|FG003|NOT COMPLETED|Phase 1, Part 1||0||
60075580|NCT01684215|76190864|FG000|STARTED|Phase 1, Part 2||0||
60075581|NCT01684215|76190865|FG001|STARTED|Phase 1, Part 2||0||
60075582|NCT01684215|76190866|FG002|STARTED|Phase 1, Part 2|Eligible participants who consented for Phase 1 Part 2.|6||
60075583|NCT01684215|76190867|FG003|STARTED|Phase 1, Part 2||0||
60075584|NCT01684215|76190864|FG000|COMPLETED|Phase 1, Part 2||0||
60075585|NCT01684215|76190865|FG001|COMPLETED|Phase 1, Part 2||0||
60075586|NCT01684215|76190866|FG002|COMPLETED|Phase 1, Part 2||0||
60075587|NCT01684215|76190867|FG003|COMPLETED|Phase 1, Part 2||0||
60075588|NCT01684215|76190864|FG000|NOT COMPLETED|Phase 1, Part 2||0||
60075589|NCT01684215|76190865|FG001|NOT COMPLETED|Phase 1, Part 2||0||
60075590|NCT01684215|76190866|FG002|NOT COMPLETED|Phase 1, Part 2||6||
60075591|NCT01684215|76190867|FG003|NOT COMPLETED|Phase 1, Part 2||0||
60075592|NCT01684215|76190864|FG000|STARTED|Phase 2||0||
59532310|NCT01489969|75629349|FG001|COMPLETED|Overall Study||43||
59532311|NCT01489969|75629350|FG002|COMPLETED|Overall Study||44||
59532312|NCT01489969|75629348|FG000|NOT COMPLETED|Overall Study||5||
59532313|NCT01489969|75629349|FG001|NOT COMPLETED|Overall Study||4||
59532314|NCT01489969|75629350|FG002|NOT COMPLETED|Overall Study||1||
59532315|NCT00509288|75629360|FG000|STARTED|Overall Study||21||
59532316|NCT00509288|75629361|FG001|STARTED|Overall Study||3||
59532317|NCT00509288|75629360|FG000|COMPLETED|Overall Study||21||
59532318|NCT00509288|75629361|FG001|COMPLETED|Overall Study||3||
59532319|NCT00509288|75629360|FG000|NOT COMPLETED|Overall Study||0||
59532320|NCT00509288|75629361|FG001|NOT COMPLETED|Overall Study||0||
59532321|NCT01490359|75629369|FG000|STARTED|Overall Study||609||
59532322|NCT01490359|75629370|FG001|STARTED|Overall Study||572||
59532323|NCT01490359|75629369|FG000|Followed-up at 6 mo|Overall Study||558||
59532324|NCT01490359|75629370|FG001|Followed-up at 6 mo|Overall Study||535||
59532325|NCT01490359|75629369|FG000|Followed-up at 12 mo|Overall Study||569||
59532326|NCT01490359|75629370|FG001|Followed-up at 12 mo|Overall Study||537||
59532327|NCT01490359|75629369|FG000|COMPLETED|Overall Study||585||
59532328|NCT01490359|75629370|FG001|COMPLETED|Overall Study||555||
59532329|NCT01490359|75629369|FG000|NOT COMPLETED|Overall Study||24||
59532330|NCT01490359|75629370|FG001|NOT COMPLETED|Overall Study||17||
59532331|NCT00442364|75629377|FG000|STARTED|Overall Study||60||
59532332|NCT00442364|75629377|FG000|COMPLETED|Overall Study||60||
59532333|NCT00442364|75629377|FG000|NOT COMPLETED|Overall Study||0||
59532334|NCT01492309|75629383|FG000|STARTED|Overall Study||11||
59532335|NCT01492309|75629384|FG001|STARTED|Overall Study||11||
59532336|NCT01492309|75629383|FG000|COMPLETED|Overall Study||11||
59532337|NCT01492309|75629384|FG001|COMPLETED|Overall Study||11||
59532338|NCT01492309|75629383|FG000|NOT COMPLETED|Overall Study||0||
59532339|NCT01492309|75629384|FG001|NOT COMPLETED|Overall Study||0||
59532340|NCT00444080|75629392|FG000|STARTED|Overall Study||61||
59532341|NCT00444080|75629393|FG001|STARTED|Overall Study||59||
59532342|NCT00444080|75629392|FG000|COMPLETED|Overall Study||61||
59532343|NCT00444080|75629393|FG001|COMPLETED|Overall Study||59||
59532344|NCT00444080|75629392|FG000|NOT COMPLETED|Overall Study||0||
59532345|NCT00444080|75629393|FG001|NOT COMPLETED|Overall Study||0||
60075593|NCT01684215|76190865|FG001|STARTED|Phase 2||0||
60075594|NCT01684215|76190866|FG002|STARTED|Phase 2||0||
60075595|NCT01684215|76190867|FG003|STARTED|Phase 2|Eligible participants who consented for Phase 2.|43||
60075596|NCT01684215|76190864|FG000|Treated|Phase 2||0||
60075597|NCT01684215|76190865|FG001|Treated|Phase 2||0||
59532346|NCT01493167|75629402|FG000|STARTED|Overall Study||97||
59532347|NCT01493167|75629402|FG000|COMPLETED|Overall Study||97||
59532348|NCT01493167|75629402|FG000|NOT COMPLETED|Overall Study||0||
59532349|NCT00510224|75629406|FG000|STARTED|Overall Study||13||
59532350|NCT00510224|75629406|FG000|COMPLETED|Overall Study||10||
59532351|NCT00510224|75629406|FG000|NOT COMPLETED|Overall Study||3||
60075598|NCT01684215|76190866|FG002|Treated|Phase 2||0||
60075599|NCT01684215|76190867|FG003|Treated|Phase 2||42||
60075600|NCT01684215|76190864|FG000|COMPLETED|Phase 2||0||
60075601|NCT01684215|76190865|FG001|COMPLETED|Phase 2||0||
60075602|NCT01684215|76190866|FG002|COMPLETED|Phase 2||0||
59532352|NCT00511706|75629412|FG000|STARTED|Overall Study||123||
59532353|NCT00511706|75629413|FG001|STARTED|Overall Study||120||
59532354|NCT00511706|75629412|FG000|COMPLETED|Overall Study||115||
59532355|NCT00511706|75629413|FG001|COMPLETED|Overall Study||115||
59532356|NCT00511706|75629412|FG000|NOT COMPLETED|Overall Study||8||
59532357|NCT00511706|75629413|FG001|NOT COMPLETED|Overall Study||5||
59532358|NCT00511862|75629422|FG000|STARTED|Overall Study||61||
59532359|NCT00511862|75629423|FG001|STARTED|Overall Study||43||
59532360|NCT00511862|75629424|FG002|STARTED|Overall Study||47||
59532361|NCT00511862|75629422|FG000|COMPLETED|Overall Study||61||
59532362|NCT00511862|75629423|FG001|COMPLETED|Overall Study||43||
59532363|NCT00511862|75629424|FG002|COMPLETED|Overall Study||47||
59532364|NCT00511862|75629422|FG000|NOT COMPLETED|Overall Study||0||
59532365|NCT00511862|75629423|FG001|NOT COMPLETED|Overall Study||0||
59532366|NCT00511862|75629424|FG002|NOT COMPLETED|Overall Study||0||
59532367|NCT01493947|75629436|FG000|STARTED|Period A Efficacy and Safety Data||478||
59532368|NCT01493947|75629437|FG001|STARTED|Period A Efficacy and Safety Data||484||
59532369|NCT01493947|75629436|FG000|COMPLETED|Period A Efficacy and Safety Data||446||
59532370|NCT01493947|75629437|FG001|COMPLETED|Period A Efficacy and Safety Data||456||
59532371|NCT01493947|75629436|FG000|NOT COMPLETED|Period A Efficacy and Safety Data||32||
59532372|NCT01493947|75629437|FG001|NOT COMPLETED|Period A Efficacy and Safety Data||28||
59532373|NCT01493947|75629436|FG000|STARTED|Period B Extension Period|Only 399 /446 subjects were eligible to enter in Period B (i.e IGA=0 or1 at end of Period A).|399||
59532374|NCT01493947|75629437|FG001|STARTED|Period B Extension Period|358 / 456 subjects were eligible to enter in Period B (i.e IGA =0 or 1 at end of Period A).|358||
59532375|NCT01493947|75629436|FG000|COMPLETED|Period B Extension Period||366||
59532376|NCT01493947|75629437|FG001|COMPLETED|Period B Extension Period||326||
59532377|NCT01493947|75629436|FG000|NOT COMPLETED|Period B Extension Period||33||
59532378|NCT01493947|75629437|FG001|NOT COMPLETED|Period B Extension Period||32||
59532379|NCT00445484|75629448|FG000|STARTED|Overall Study||11||
59532380|NCT00445484|75629449|FG001|STARTED|Overall Study||11||
59532381|NCT00445484|75629448|FG000|COMPLETED|Overall Study||7||
59532382|NCT00445484|75629449|FG001|COMPLETED|Overall Study||10||
59532383|NCT00445484|75629448|FG000|NOT COMPLETED|Overall Study||4||
59532384|NCT00445484|75629449|FG001|NOT COMPLETED|Overall Study||1||
59532385|NCT01495585|75629458|FG000|STARTED|Overall Study||4||
59532386|NCT01495585|75629459|FG001|STARTED|Overall Study||6||
59532387|NCT01495585|75629460|FG002|STARTED|Overall Study||4||
59532388|NCT01495585|75629458|FG000|Open Label Lonafarnib 200 mg|Overall Study||2||
59532389|NCT01495585|75629459|FG001|Open Label Lonafarnib 200 mg|Overall Study||0||
59532390|NCT01495585|75629460|FG002|Open Label Lonafarnib 200 mg|Overall Study||0||
59532391|NCT01495585|75629458|FG000|COMPLETED|Overall Study||4||
59532392|NCT01495585|75629459|FG001|COMPLETED|Overall Study||6||
59532393|NCT01495585|75629460|FG002|COMPLETED|Overall Study||4||
59532394|NCT01495585|75629458|FG000|NOT COMPLETED|Overall Study||0||
59532395|NCT01495585|75629459|FG001|NOT COMPLETED|Overall Study||0||
59532396|NCT01495585|75629460|FG002|NOT COMPLETED|Overall Study||0||
59532397|NCT00446264|75629468|FG000|STARTED|Overall Study||14||
59532398|NCT00446264|75629468|FG000|COMPLETED|Overall Study||14||
59532399|NCT00446264|75629468|FG000|NOT COMPLETED|Overall Study||0||
59532400|NCT01495819|75629472|FG000|STARTED|Overall Study||34||
59532401|NCT01495819|75629472|FG000|Nicotine 0.0125|Overall Study||31||
59532402|NCT01495819|75629472|FG000|Nicotine 0.025|Overall Study||32||
59532403|NCT01495819|75629472|FG000|Nicotine 0.05|Overall Study||33||
59532404|NCT01495819|75629472|FG000|Nicotine 0.1|Overall Study||31||
59532405|NCT01495819|75629472|FG000|NIcotine 0.2|Overall Study||33||
59532406|NCT01495819|75629472|FG000|COMPLETED|Overall Study||30||
59532407|NCT01495819|75629472|FG000|NOT COMPLETED|Overall Study||4||
59532408|NCT00512876|75629481|FG000|STARTED|Overall Study||24||
59532409|NCT00512876|75629481|FG000|COMPLETED|Overall Study||20||
59532410|NCT00512876|75629481|FG000|NOT COMPLETED|Overall Study||4||
59532411|NCT00513344|75629485|FG000|STARTED|Diet Restriction (3 Days)||5||
59532412|NCT00513344|75629485|FG000|COMPLETED|Diet Restriction (3 Days)||5||
59532413|NCT00513344|75629485|FG000|NOT COMPLETED|Diet Restriction (3 Days)||0||
59532414|NCT00513344|75629485|FG000|STARTED|1st Intervention 1 Day||5||
59532415|NCT00513344|75629485|FG000|COMPLETED|1st Intervention 1 Day||5||
59532416|NCT00513344|75629485|FG000|NOT COMPLETED|1st Intervention 1 Day||0||
59532417|NCT00513344|75629485|FG000|STARTED|Washout Period 3 Days||5||
59532418|NCT00513344|75629485|FG000|COMPLETED|Washout Period 3 Days||5||
59532419|NCT00513344|75629485|FG000|NOT COMPLETED|Washout Period 3 Days||0||
59532420|NCT00513344|75629485|FG000|STARTED|2nd Intervention 1 Day||5||
59532421|NCT00513344|75629485|FG000|COMPLETED|2nd Intervention 1 Day||5||
59532422|NCT00513344|75629485|FG000|NOT COMPLETED|2nd Intervention 1 Day||0||
59532423|NCT00513344|75629485|FG000|STARTED|Washout Period 3 Days||5||
59532424|NCT00513344|75629485|FG000|COMPLETED|Washout Period 3 Days||5||
59532425|NCT00513344|75629485|FG000|NOT COMPLETED|Washout Period 3 Days||0||
59532426|NCT00513344|75629485|FG000|STARTED|3rd Intervention 1 Day||5||
59532427|NCT00513344|75629485|FG000|COMPLETED|3rd Intervention 1 Day||5||
59532428|NCT00513344|75629485|FG000|NOT COMPLETED|3rd Intervention 1 Day||0||
59532429|NCT00514592|75629493|FG000|STARTED|Overall Study||230||
59532430|NCT00514592|75629493|FG000|COMPLETED|Overall Study||230||
59532431|NCT00514592|75629493|FG000|NOT COMPLETED|Overall Study||0||
59532432|NCT02522286|75629501|FG000|STARTED|Overall Study||78||
59532433|NCT02522286|75629502|FG001|STARTED|Overall Study||75||
59532434|NCT02522286|75629503|FG002|STARTED|Overall Study||75||
59532435|NCT02522286|75629504|FG003|STARTED|Overall Study||78||
59532436|NCT02522286|75629501|FG000|COMPLETED|Overall Study||75||
59532437|NCT02522286|75629502|FG001|COMPLETED|Overall Study||75||
59532438|NCT02522286|75629503|FG002|COMPLETED|Overall Study||75||
59532439|NCT02522286|75629504|FG003|COMPLETED|Overall Study||75||
59532440|NCT02522286|75629501|FG000|NOT COMPLETED|Overall Study||3||
59532441|NCT02522286|75629502|FG001|NOT COMPLETED|Overall Study||0||
59532442|NCT02522286|75629503|FG002|NOT COMPLETED|Overall Study||0||
59532443|NCT02522286|75629504|FG003|NOT COMPLETED|Overall Study||3||
59532444|NCT01496131|75629516|FG000|STARTED|Overall Study||14||
59532445|NCT01496131|75629517|FG001|STARTED|Overall Study||14||
59532446|NCT01496131|75629516|FG000|COMPLETED|Overall Study||14||
59532447|NCT01496131|75629517|FG001|COMPLETED|Overall Study||14||
59532448|NCT01496131|75629516|FG000|NOT COMPLETED|Overall Study||0||
59532449|NCT01496131|75629517|FG001|NOT COMPLETED|Overall Study||0||
59532450|NCT02520726|75629525|FG000|STARTED|Overall Study||3||
59532451|NCT02520726|75629526|FG001|STARTED|Overall Study||2||
59532452|NCT02520726|75629525|FG000|COMPLETED|Overall Study||0||
59532453|NCT02520726|75629526|FG001|COMPLETED|Overall Study||0||
59532454|NCT02520726|75629525|FG000|NOT COMPLETED|Overall Study||3||
59532455|NCT02520726|75629526|FG001|NOT COMPLETED|Overall Study||2||
59532456|NCT01497613|75629534|FG000|STARTED|Overall Study||150||
59532457|NCT01497613|75629535|FG001|STARTED|Overall Study||150||
59532458|NCT01497613|75629534|FG000|COMPLETED|Overall Study||113||
59532459|NCT01497613|75629535|FG001|COMPLETED|Overall Study||131||
59532460|NCT01497613|75629534|FG000|NOT COMPLETED|Overall Study||37||
59532461|NCT01497613|75629535|FG001|NOT COMPLETED|Overall Study||19||
59532462|NCT02115542|75629541|FG000|STARTED|Overall Study||39||
59532463|NCT02115542|75629541|FG000|COMPLETED|Overall Study||39||
59532464|NCT02115542|75629541|FG000|NOT COMPLETED|Overall Study||0||
59532465|NCT01540513|75629545|FG000|STARTED|Overall Study||12||
59532466|NCT01540513|75629545|FG000|COMPLETED|Overall Study||12||
59532467|NCT01540513|75629545|FG000|NOT COMPLETED|Overall Study||0||
59532468|NCT02519712|75629549|FG000|STARTED|Overall Study||4||
59532469|NCT02519712|75629549|FG000|COMPLETED|Overall Study||0||
59532470|NCT02519712|75629549|FG000|NOT COMPLETED|Overall Study||4||
59532471|NCT00450242|75629555|FG000|STARTED|Overall Study||7||
59532472|NCT00450242|75629556|FG001|STARTED|Overall Study||7||
59532473|NCT00450242|75629555|FG000|COMPLETED|Overall Study||4||
59532474|NCT00450242|75629556|FG001|COMPLETED|Overall Study||6||
59532475|NCT00450242|75629555|FG000|NOT COMPLETED|Overall Study||3||
59532476|NCT00450242|75629556|FG001|NOT COMPLETED|Overall Study||1||
59532477|NCT00515528|75629566|FG000|STARTED|Overall Study||10||
59532478|NCT00515528|75629567|FG001|STARTED|Overall Study||7||
59815297|NCT03810456|75937762|FG001|COMPLETED|Enrolled and Randomized||79|Participants who started treatment.|
59815298|NCT03810456|75937763|FG002|COMPLETED|Enrolled and Randomized|These individuals may have received standard care.|67|Participants who started treatment.|
59815299|NCT03810456|75937761|FG000|NOT COMPLETED|Enrolled and Randomized||30||
59815300|NCT03810456|75937762|FG001|NOT COMPLETED|Enrolled and Randomized||20||
59815301|NCT03810456|75937763|FG002|NOT COMPLETED|Enrolled and Randomized||0||
59815302|NCT03810456|75937761|FG000|STARTED|Treatment||69|Participants who started treatment.|
59815303|NCT03810456|75937762|FG001|STARTED|Treatment||79|Participants who started treatment.|
59815304|NCT03810456|75937763|FG002|STARTED|Treatment||67|Participants who started treatment.|
59815305|NCT03810456|75937761|FG000|COMPLETED|Treatment||66|Participants who completed treatment.|
59815306|NCT03810456|75937762|FG001|COMPLETED|Treatment||55|Participants who completed treatment.|
59995438|NCT02911792|76111261|FG000|STARTED|Overall Study||18||
59532479|NCT00515528|75629566|FG000|COMPLETED|Overall Study||10||
59532480|NCT00515528|75629567|FG001|COMPLETED|Overall Study||7||
59532481|NCT00515528|75629566|FG000|NOT COMPLETED|Overall Study||0||
59532482|NCT00515528|75629567|FG001|NOT COMPLETED|Overall Study||0||
59532483|NCT00517010|75629573|FG000|STARTED|Overall Study||6||
59532484|NCT00517010|75629573|FG000|COMPLETED|Overall Study||5||
59532485|NCT00517010|75629573|FG000|NOT COMPLETED|Overall Study||1||
59532486|NCT00517556|75629579|FG000|STARTED|Overall Study||19||
59532487|NCT00517556|75629580|FG001|STARTED|Overall Study||19||
59532488|NCT00517556|75629579|FG000|COMPLETED|Overall Study||15||
59532489|NCT00517556|75629580|FG001|COMPLETED|Overall Study||14||
59532490|NCT00517556|75629579|FG000|NOT COMPLETED|Overall Study||4||
59532491|NCT00517556|75629580|FG001|NOT COMPLETED|Overall Study||5||
59532492|NCT00519584|75629590|FG000|STARTED|Overall Study||54||
59532493|NCT00519584|75629591|FG001|STARTED|Overall Study||54||
59532494|NCT00519584|75629592|FG002|STARTED|Overall Study||54||
59532495|NCT00519584|75629593|FG003|STARTED|Overall Study||56||
59532496|NCT00519584|75629590|FG000|COMPLETED|Overall Study||54||
59532497|NCT00519584|75629591|FG001|COMPLETED|Overall Study||54||
59532498|NCT00519584|75629592|FG002|COMPLETED|Overall Study||54||
59532499|NCT00519584|75629593|FG003|COMPLETED|Overall Study||56||
59532500|NCT00519584|75629590|FG000|NOT COMPLETED|Overall Study||0||
59532501|NCT00519584|75629591|FG001|NOT COMPLETED|Overall Study||0||
59532502|NCT00519584|75629592|FG002|NOT COMPLETED|Overall Study||0||
59532503|NCT00519584|75629593|FG003|NOT COMPLETED|Overall Study||0||
59532504|NCT00520286|75629605|FG000|STARTED|Overall Study||142||
59532505|NCT00520286|75629606|FG001|STARTED|Overall Study||68||
59532506|NCT00520286|75629605|FG000|COMPLETED|Overall Study||76||
59532507|NCT00520286|75629606|FG001|COMPLETED|Overall Study||36||
59532508|NCT00520286|75629605|FG000|NOT COMPLETED|Overall Study||66||
59532509|NCT00520286|75629606|FG001|NOT COMPLETED|Overall Study||32||
59532510|NCT01540825|75629623|FG000|STARTED|Overall Study||20||
59532511|NCT01540825|75629624|FG001|STARTED|Overall Study||6||
59532512|NCT01540825|75629625|FG002|STARTED|Overall Study||6||
59532513|NCT01540825|75629626|FG003|STARTED|Overall Study||6||
59532514|NCT01540825|75629627|FG004|STARTED|Overall Study||6||
59532515|NCT01540825|75629628|FG005|STARTED|Overall Study||6||
59532516|NCT01540825|75629629|FG006|STARTED|Overall Study||6||
59532517|NCT01540825|75629630|FG007|STARTED|Overall Study||6||
59532518|NCT01540825|75629631|FG008|STARTED|Overall Study||6||
59532519|NCT01540825|75629632|FG009|STARTED|Overall Study||6||
59532520|NCT01540825|75629633|FG010|STARTED|Overall Study||6||
59532521|NCT01540825|75629623|FG000|COMPLETED|Overall Study||20||
59532522|NCT01540825|75629624|FG001|COMPLETED|Overall Study||6||
59532523|NCT01540825|75629625|FG002|COMPLETED|Overall Study||6||
59532524|NCT01540825|75629626|FG003|COMPLETED|Overall Study||6||
59532525|NCT01540825|75629627|FG004|COMPLETED|Overall Study||6||
59532526|NCT01540825|75629628|FG005|COMPLETED|Overall Study||6||
59532527|NCT01540825|75629629|FG006|COMPLETED|Overall Study||6||
59532528|NCT01540825|75629630|FG007|COMPLETED|Overall Study||6||
59532529|NCT01540825|75629631|FG008|COMPLETED|Overall Study||6||
59532530|NCT01540825|75629632|FG009|COMPLETED|Overall Study||6||
59532531|NCT01540825|75629633|FG010|COMPLETED|Overall Study||6||
59532532|NCT01540825|75629623|FG000|NOT COMPLETED|Overall Study||0||
59532533|NCT01540825|75629624|FG001|NOT COMPLETED|Overall Study||0||
59532534|NCT01540825|75629625|FG002|NOT COMPLETED|Overall Study||0||
59532535|NCT01540825|75629626|FG003|NOT COMPLETED|Overall Study||0||
59532536|NCT01540825|75629627|FG004|NOT COMPLETED|Overall Study||0||
59532537|NCT01540825|75629628|FG005|NOT COMPLETED|Overall Study||0||
59532538|NCT01540825|75629629|FG006|NOT COMPLETED|Overall Study||0||
59532539|NCT01540825|75629630|FG007|NOT COMPLETED|Overall Study||0||
59532540|NCT01540825|75629631|FG008|NOT COMPLETED|Overall Study||0||
59815307|NCT03810456|75937763|FG002|COMPLETED|Treatment||67|Participants who completed treatment.|
59815308|NCT03810456|75937761|FG000|NOT COMPLETED|Treatment||3||
59815309|NCT03810456|75937762|FG001|NOT COMPLETED|Treatment||24||
59815310|NCT03810456|75937763|FG002|NOT COMPLETED|Treatment||0||
59815311|NCT03810456|75937761|FG000|STARTED|1 Month Follow-Up||66|Participants who completed treatment.|
59532541|NCT01540825|75629632|FG009|NOT COMPLETED|Overall Study||0||
59532542|NCT01540825|75629633|FG010|NOT COMPLETED|Overall Study||0||
59532543|NCT01395043|75629667|FG000|STARTED|Overall Study||15||
59532544|NCT01395043|75629667|FG000|COMPLETED|Overall Study||15||
59532545|NCT01395043|75629667|FG000|NOT COMPLETED|Overall Study||0||
59532546|NCT01542229|75629674|FG000|STARTED|Overall Study||68||
59532547|NCT01542229|75629675|FG001|STARTED|Overall Study||66||
59532548|NCT01542229|75629674|FG000|COMPLETED|Overall Study||45||
59532549|NCT01542229|75629675|FG001|COMPLETED|Overall Study||30||
59532550|NCT01542229|75629674|FG000|NOT COMPLETED|Overall Study||23||
59532551|NCT01542229|75629675|FG001|NOT COMPLETED|Overall Study||36||
59532552|NCT00520910|75629684|FG000|STARTED|Overall Study||5||
59532553|NCT00520910|75629685|FG001|STARTED|Overall Study||5||
59532554|NCT00520910|75629684|FG000|COMPLETED|Overall Study||5||
59532555|NCT00520910|75629685|FG001|COMPLETED|Overall Study||5||
59815312|NCT03810456|75937762|FG001|STARTED|1 Month Follow-Up||55|Participants who completed treatment.|
59815313|NCT03810456|75937763|FG002|STARTED|1 Month Follow-Up||67|Participants who completed treatment.|
59815314|NCT03810456|75937761|FG000|COMPLETED|1 Month Follow-Up||57|Participants who completed 1-Month Follow-Up.|
59532556|NCT00520910|75629684|FG000|NOT COMPLETED|Overall Study||0||
59532557|NCT00520910|75629685|FG001|NOT COMPLETED|Overall Study||0||
59532558|NCT00521456|75629693|FG000|STARTED|Overall Study||176||
59532559|NCT00521456|75629694|FG001|STARTED|Overall Study||87||
59532560|NCT00521456|75629693|FG000|COMPLETED|Overall Study||163||
59532561|NCT00521456|75629694|FG001|COMPLETED|Overall Study||59||
59532562|NCT00521456|75629693|FG000|NOT COMPLETED|Overall Study||13||
59532563|NCT00521456|75629694|FG001|NOT COMPLETED|Overall Study||28||
59532564|NCT01542307|75629700|FG000|STARTED|Overall Study|Each subject inhaled Oxygen for 30 minutes in blinded fashion for 2 of the 4 migraine attacks|22||33
59532565|NCT01542307|75629701|FG001|STARTED|Overall Study|Each subject inhaled Medical Air for 30 minutes in blinded fashion for 2 of the 4 migraine attacks|22||31
59532566|NCT01542307|75629700|FG000|COMPLETED|Overall Study||22||33
59532567|NCT01542307|75629701|FG001|COMPLETED|Overall Study||22||30
59532568|NCT01542307|75629700|FG000|NOT COMPLETED|Overall Study||0||0
59532569|NCT01542307|75629701|FG001|NOT COMPLETED|Overall Study||0||1
59532570|NCT01498549|75629707|FG000|STARTED|Overall Study||39||
59532571|NCT01498549|75629707|FG000|Atomoxetine 40 mg|Overall Study||39||
59815315|NCT03810456|75937762|FG001|COMPLETED|1 Month Follow-Up||51|Participants who completed 1-Month Follow-Up.|
59815316|NCT03810456|75937763|FG002|COMPLETED|1 Month Follow-Up||51|Participants who completed 1-Month Follow-Up.|
59815317|NCT03810456|75937761|FG000|NOT COMPLETED|1 Month Follow-Up||9||
59532572|NCT01498549|75629707|FG000|Atomoxetine 80 mg|Overall Study||37||
59532573|NCT01498549|75629707|FG000|Sugar Pill 0 mg|Overall Study||36||
59532574|NCT01498549|75629707|FG000|COMPLETED|Overall Study||35|Completed all 3 days for each arm in the crossover design.|
59532575|NCT01498549|75629707|FG000|NOT COMPLETED|Overall Study||4||
59532576|NCT01499173|75629716|FG000|STARTED|Overall Study||101||
59532577|NCT01499173|75629716|FG000|COMPLETED|Overall Study||64||
59532578|NCT01499173|75629716|FG000|NOT COMPLETED|Overall Study||37||
59532579|NCT01542541|75629723|FG000|STARTED|Overall Study||38||
59532580|NCT01542541|75629724|FG001|STARTED|Overall Study||30||
59532581|NCT01542541|75629723|FG000|COMPLETED|Overall Study||30||
59532582|NCT01542541|75629724|FG001|COMPLETED|Overall Study||30||
59532583|NCT01542541|75629723|FG000|NOT COMPLETED|Overall Study||8||
59532584|NCT01542541|75629724|FG001|NOT COMPLETED|Overall Study||0||
59532585|NCT00524264|75629732|FG000|STARTED|Overall Study||164||
59532586|NCT00524264|75629733|FG001|STARTED|Overall Study||84||
59532587|NCT00524264|75629732|FG000|COMPLETED|Overall Study||144||
59532588|NCT00524264|75629733|FG001|COMPLETED|Overall Study||57||
59532589|NCT00524264|75629732|FG000|NOT COMPLETED|Overall Study||20||
59532590|NCT00524264|75629733|FG001|NOT COMPLETED|Overall Study||27||
59532591|NCT01395277|75629741|FG000|STARTED|Overall Study||15||
59532592|NCT01395277|75629742|FG001|STARTED|Overall Study||15||
59532593|NCT01395277|75629741|FG000|COMPLETED|Overall Study||15||
59532594|NCT01395277|75629742|FG001|COMPLETED|Overall Study||15||
59532595|NCT01395277|75629741|FG000|NOT COMPLETED|Overall Study||0||
59532596|NCT01395277|75629742|FG001|NOT COMPLETED|Overall Study||0||
59532597|NCT00452426|75629752|FG000|STARTED|Overall Study||496||
59532598|NCT00452426|75629753|FG001|STARTED|Overall Study||504||
59532599|NCT00452426|75629752|FG000|COMPLETED|Overall Study||489||
59532600|NCT00452426|75629753|FG001|COMPLETED|Overall Study||493||
59532601|NCT00452426|75629752|FG000|NOT COMPLETED|Overall Study||7||
59532602|NCT00452426|75629753|FG001|NOT COMPLETED|Overall Study||11||
59532603|NCT01396837|75629759|FG000|STARTED|Overall Study||20||
59532604|NCT01396837|75629759|FG000|COMPLETED|Overall Study||16||
59532605|NCT01396837|75629759|FG000|NOT COMPLETED|Overall Study||4||
59532606|NCT01544023|75629763|FG000|STARTED|Overall Study|retrospective|207||
59532607|NCT01544023|75629763|FG000|COMPLETED|Overall Study||207||
59532608|NCT01544023|75629763|FG000|NOT COMPLETED|Overall Study||0||
59532609|NCT00524342|75629767|FG000|STARTED|Overall Study||7||
59532610|NCT00524342|75629767|FG000|COMPLETED|Overall Study||7||
59532611|NCT00524342|75629767|FG000|NOT COMPLETED|Overall Study||0||
59532612|NCT01545193|75629773|FG000|STARTED|Overall Study||150||
59532613|NCT01545193|75629774|FG001|STARTED|Overall Study||150||
59532614|NCT01545193|75629773|FG000|COMPLETED|Overall Study||150||
59532615|NCT01545193|75629774|FG001|COMPLETED|Overall Study||149||
59532616|NCT01545193|75629773|FG000|NOT COMPLETED|Overall Study||0||
59532617|NCT01545193|75629774|FG001|NOT COMPLETED|Overall Study||1||
59532618|NCT00524576|75629782|FG000|STARTED|Overall Study||97||
59532619|NCT00524576|75629783|FG001|STARTED|Overall Study||47||
59532620|NCT00524576|75629782|FG000|COMPLETED|Overall Study||97||
59532621|NCT00524576|75629783|FG001|COMPLETED|Overall Study||47||
59532622|NCT00524576|75629782|FG000|NOT COMPLETED|Overall Study||0||
59532623|NCT00524576|75629783|FG001|NOT COMPLETED|Overall Study||0||
59532624|NCT02516202|75629792|FG000|STARTED|Overall Study||102||
59532625|NCT02516202|75629793|FG001|STARTED|Overall Study||100||
59532626|NCT02516202|75629794|FG002|STARTED|Overall Study||100||
59532627|NCT02516202|75629792|FG000|COMPLETED|Overall Study||100||
59532628|NCT02516202|75629793|FG001|COMPLETED|Overall Study||99||
59532629|NCT02516202|75629794|FG002|COMPLETED|Overall Study||97||
59532630|NCT02516202|75629792|FG000|NOT COMPLETED|Overall Study||2||
59532631|NCT02516202|75629793|FG001|NOT COMPLETED|Overall Study||1||
59532632|NCT02516202|75629794|FG002|NOT COMPLETED|Overall Study||3||
59532633|NCT00526058|75629804|FG000|STARTED|Period: First Intervention||9||
59532634|NCT00526058|75629805|FG001|STARTED|Period: First Intervention||9||
59532635|NCT00526058|75629804|FG000|COMPLETED|Period: First Intervention||9||
59532636|NCT00526058|75629805|FG001|COMPLETED|Period: First Intervention||9||
59532637|NCT00526058|75629804|FG000|NOT COMPLETED|Period: First Intervention||0||
59532638|NCT00526058|75629805|FG001|NOT COMPLETED|Period: First Intervention||0||
59532639|NCT00526058|75629804|FG000|STARTED|Period: Second Intervention||9||
59532640|NCT00526058|75629805|FG001|STARTED|Period: Second Intervention||9||
59532641|NCT00526058|75629804|FG000|COMPLETED|Period: Second Intervention||9||
59532642|NCT00526058|75629805|FG001|COMPLETED|Period: Second Intervention||9||
59532643|NCT00526058|75629804|FG000|NOT COMPLETED|Period: Second Intervention||0||
59532644|NCT00526058|75629805|FG001|NOT COMPLETED|Period: Second Intervention||0||
59532645|NCT00526292|75629811|FG000|STARTED|Overall Study||6||
59532646|NCT00526292|75629811|FG000|COMPLETED|Overall Study||6||
59532647|NCT00526292|75629811|FG000|NOT COMPLETED|Overall Study||0||
59532648|NCT02121860|75629819|FG000|STARTED|Overall Study||8||
59532649|NCT02121860|75629820|FG001|STARTED|Overall Study||12||
59532650|NCT02121860|75629821|FG002|STARTED|Overall Study||8||
59532651|NCT02121860|75629822|FG003|STARTED|Overall Study||8||
59532652|NCT02121860|75629819|FG000|COMPLETED|Overall Study||8||
59532653|NCT02121860|75629820|FG001|COMPLETED|Overall Study||12||
59532654|NCT02121860|75629821|FG002|COMPLETED|Overall Study||8||
59532655|NCT02121860|75629822|FG003|COMPLETED|Overall Study||8||
59532656|NCT02121860|75629819|FG000|NOT COMPLETED|Overall Study||0||
59532657|NCT02121860|75629820|FG001|NOT COMPLETED|Overall Study||0||
59532658|NCT02121860|75629821|FG002|NOT COMPLETED|Overall Study||0||
59532659|NCT02121860|75629822|FG003|NOT COMPLETED|Overall Study||0||
59532660|NCT02122406|75629829|FG000|STARTED|Overall Study||200||
59532661|NCT02122406|75629829|FG000|COMPLETED|Overall Study||200||
59532662|NCT02122406|75629829|FG000|NOT COMPLETED|Overall Study||0||
59532663|NCT01545583|75629842|FG000|STARTED|Overall Study||12||
59532664|NCT01545583|75629843|FG001|STARTED|Overall Study||2||
59532665|NCT01545583|75629844|FG002|STARTED|Overall Study||6||
59532666|NCT01545583|75629845|FG003|STARTED|Overall Study||6||
59532667|NCT01545583|75629846|FG004|STARTED|Overall Study||6||
59532668|NCT01545583|75629847|FG005|STARTED|Overall Study||6||
59532669|NCT01545583|75629848|FG006|STARTED|Overall Study||6||
59532670|NCT01545583|75629849|FG007|STARTED|Overall Study||6||
59532671|NCT01545583|75629850|FG008|STARTED|Overall Study||6||
59532672|NCT01545583|75629842|FG000|Received at Least 1 Dose of Study Drug|Overall Study||12||
59532673|NCT01545583|75629843|FG001|Received at Least 1 Dose of Study Drug|Overall Study||2||
59532674|NCT01545583|75629844|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6||
59532675|NCT01545583|75629845|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6||
59532676|NCT01545583|75629846|FG004|Received at Least 1 Dose of Study Drug|Overall Study||6||
59532677|NCT01545583|75629847|FG005|Received at Least 1 Dose of Study Drug|Overall Study||6||
59532678|NCT01545583|75629848|FG006|Received at Least 1 Dose of Study Drug|Overall Study||6||
59532679|NCT01545583|75629849|FG007|Received at Least 1 Dose of Study Drug|Overall Study||6||
59532680|NCT01545583|75629850|FG008|Received at Least 1 Dose of Study Drug|Overall Study||6||
59532681|NCT01545583|75629842|FG000|COMPLETED|Overall Study||12||
59532682|NCT01545583|75629843|FG001|COMPLETED|Overall Study||2||
59532683|NCT01545583|75629844|FG002|COMPLETED|Overall Study||6||
59532684|NCT01545583|75629845|FG003|COMPLETED|Overall Study||6||
59532685|NCT01545583|75629846|FG004|COMPLETED|Overall Study||6||
59532686|NCT01545583|75629847|FG005|COMPLETED|Overall Study||6||
59532687|NCT01545583|75629848|FG006|COMPLETED|Overall Study||6||
59532688|NCT01545583|75629849|FG007|COMPLETED|Overall Study||6||
59532689|NCT01545583|75629850|FG008|COMPLETED|Overall Study||6||
59532690|NCT01545583|75629842|FG000|NOT COMPLETED|Overall Study||0||
59532691|NCT01545583|75629843|FG001|NOT COMPLETED|Overall Study||0||
59532692|NCT01545583|75629844|FG002|NOT COMPLETED|Overall Study||0||
59532693|NCT01545583|75629845|FG003|NOT COMPLETED|Overall Study||0||
59532694|NCT01545583|75629846|FG004|NOT COMPLETED|Overall Study||0||
59532695|NCT01545583|75629847|FG005|NOT COMPLETED|Overall Study||0||
59532696|NCT01545583|75629848|FG006|NOT COMPLETED|Overall Study||0||
59532697|NCT01545583|75629849|FG007|NOT COMPLETED|Overall Study||0||
59532698|NCT01545583|75629850|FG008|NOT COMPLETED|Overall Study||0||
59532699|NCT02124044|75629879|FG000|STARTED|Overall Study||20||
59532700|NCT02124044|75629880|FG001|STARTED|Overall Study||10||
59532701|NCT02124044|75629879|FG000|COMPLETED|Overall Study||20||
59532702|NCT02124044|75629880|FG001|COMPLETED|Overall Study||9||
59532703|NCT02124044|75629879|FG000|NOT COMPLETED|Overall Study||0||
59532704|NCT02124044|75629880|FG001|NOT COMPLETED|Overall Study||1||
59532705|NCT01502761|75629890|FG000|STARTED|Overall Study||4||
59532706|NCT01502761|75629891|FG001|STARTED|Overall Study||0||
59532707|NCT01502761|75629892|FG002|STARTED|Overall Study||0||
59532708|NCT01502761|75629893|FG003|STARTED|Overall Study||0||
59532709|NCT01502761|75629890|FG000|COMPLETED|Overall Study||4||
59532710|NCT01502761|75629891|FG001|COMPLETED|Overall Study||0||
59532711|NCT01502761|75629892|FG002|COMPLETED|Overall Study||0||
59532712|NCT01502761|75629893|FG003|COMPLETED|Overall Study||0||
59532713|NCT01502761|75629890|FG000|NOT COMPLETED|Overall Study||0||
59532714|NCT01502761|75629891|FG001|NOT COMPLETED|Overall Study||0||
59532715|NCT01502761|75629892|FG002|NOT COMPLETED|Overall Study||0||
59532716|NCT01502761|75629893|FG003|NOT COMPLETED|Overall Study||0||
59532717|NCT02124122|75629905|FG000|STARTED|Overall Study||41||
59532718|NCT02124122|75629906|FG001|STARTED|Overall Study||19||
59532719|NCT02124122|75629905|FG000|COMPLETED|Overall Study||41||
59532720|NCT02124122|75629906|FG001|COMPLETED|Overall Study||19||
59532721|NCT02124122|75629905|FG000|NOT COMPLETED|Overall Study||0||
59532722|NCT02124122|75629906|FG001|NOT COMPLETED|Overall Study||0||
59532723|NCT01504477|75629912|FG000|STARTED|Overall Study||6||
59532724|NCT01504477|75629912|FG000|COMPLETED|Overall Study||6||
59532725|NCT01504477|75629912|FG000|NOT COMPLETED|Overall Study||0||
59532726|NCT02124512|75629918|FG000|STARTED|Overall Study||6||
59532727|NCT02124512|75629919|FG001|STARTED|Overall Study||6||
59532728|NCT02124512|75629918|FG000|COMPLETED|Overall Study||6||
59532729|NCT02124512|75629919|FG001|COMPLETED|Overall Study||6||
59532730|NCT02124512|75629918|FG000|NOT COMPLETED|Overall Study||0||
59532731|NCT02124512|75629919|FG001|NOT COMPLETED|Overall Study||0||
59532732|NCT01504711|75629925|FG000|STARTED|Overall Study||30||
59532733|NCT01504711|75629925|FG000|COMPLETED|Overall Study||27||
59532734|NCT01504711|75629925|FG000|NOT COMPLETED|Overall Study||3||
59622727|NCT00439374|75734623|FG000|STARTED|Overall Study||327||
59532735|NCT02208349|75629931|FG000|STARTED|Initial 6 Months||16||3
59532736|NCT02208349|75629932|FG001|STARTED|Initial 6 Months||9||3
59532737|NCT02208349|75629931|FG000|COMPLETED|Initial 6 Months||16||3
59532738|NCT02208349|75629932|FG001|COMPLETED|Initial 6 Months||9||3
59532739|NCT02208349|75629931|FG000|NOT COMPLETED|Initial 6 Months||0||0
59532740|NCT02208349|75629932|FG001|NOT COMPLETED|Initial 6 Months||0||0
59532741|NCT02208349|75629931|FG000|STARTED|Second 6 Months||11||3
59532742|NCT02208349|75629932|FG001|STARTED|Second 6 Months||7||3
59532743|NCT02208349|75629931|FG000|COMPLETED|Second 6 Months||11||3
59532744|NCT02208349|75629932|FG001|COMPLETED|Second 6 Months||7||3
59532745|NCT02208349|75629931|FG000|NOT COMPLETED|Second 6 Months||0||0
59532746|NCT02208349|75629932|FG001|NOT COMPLETED|Second 6 Months||0||0
59532747|NCT02208349|75629931|FG000|STARTED|Third 6 Month||6||3
59532748|NCT02208349|75629932|FG001|STARTED|Third 6 Month||3||3
59532749|NCT02208349|75629931|FG000|COMPLETED|Third 6 Month||6||3
59532750|NCT02208349|75629932|FG001|COMPLETED|Third 6 Month||3||3
59532751|NCT02208349|75629931|FG000|NOT COMPLETED|Third 6 Month||0||0
59532752|NCT02208349|75629932|FG001|NOT COMPLETED|Third 6 Month||0||0
59532753|NCT02208349|75629931|FG000|STARTED|Fourth 6 Month||14||3
59532754|NCT02208349|75629932|FG001|STARTED|Fourth 6 Month||2||3
59532755|NCT02208349|75629931|FG000|COMPLETED|Fourth 6 Month||14||3
59532756|NCT02208349|75629932|FG001|COMPLETED|Fourth 6 Month||2||3
59532757|NCT02208349|75629931|FG000|NOT COMPLETED|Fourth 6 Month||0||0
59532758|NCT02208349|75629932|FG001|NOT COMPLETED|Fourth 6 Month||0||0
59532759|NCT02208349|75629931|FG000|STARTED|Fifth 6 Month||7||3
59532760|NCT02208349|75629932|FG001|STARTED|Fifth 6 Month||2||3
59532761|NCT02208349|75629931|FG000|COMPLETED|Fifth 6 Month||7||3
59532762|NCT02208349|75629932|FG001|COMPLETED|Fifth 6 Month||2||3
59532763|NCT02208349|75629931|FG000|NOT COMPLETED|Fifth 6 Month||0||0
59532764|NCT02208349|75629932|FG001|NOT COMPLETED|Fifth 6 Month||0||0
59532765|NCT02208349|75629931|FG000|STARTED|Sixth 6 Month||3||3
59532766|NCT02208349|75629932|FG001|STARTED|Sixth 6 Month||2||3
59532767|NCT02208349|75629931|FG000|COMPLETED|Sixth 6 Month||3||3
59532768|NCT02208349|75629932|FG001|COMPLETED|Sixth 6 Month||2||3
59532769|NCT02208349|75629931|FG000|NOT COMPLETED|Sixth 6 Month||0||0
59532770|NCT02208349|75629932|FG001|NOT COMPLETED|Sixth 6 Month||0||0
59532771|NCT02209519|75629942|FG000|STARTED|Overall Study||107||
59532772|NCT02209519|75629943|FG001|STARTED|Overall Study||107||
59532773|NCT02209519|75629942|FG000|COMPLETED|Overall Study||107||
59532774|NCT02209519|75629943|FG001|COMPLETED|Overall Study||107||
59532775|NCT02209519|75629942|FG000|NOT COMPLETED|Overall Study||0||
59532776|NCT02209519|75629943|FG001|NOT COMPLETED|Overall Study||0||
59532777|NCT01546285|75629950|FG000|STARTED|Overall Study||66||
59532778|NCT01546285|75629950|FG000|COMPLETED|Overall Study||66||
59532779|NCT01546285|75629950|FG000|NOT COMPLETED|Overall Study||0||
59532780|NCT01397071|75629956|FG000|STARTED|Consumption of Beef Patty Alone||11||
59532781|NCT01397071|75629956|FG000|COMPLETED|Consumption of Beef Patty Alone||11||
59532782|NCT01397071|75629956|FG000|NOT COMPLETED|Consumption of Beef Patty Alone||0||
59532783|NCT01397071|75629956|FG000|STARTED|Consumption of Beef Patty With Avocado||11||
59532784|NCT01397071|75629956|FG000|COMPLETED|Consumption of Beef Patty With Avocado||11||
59532785|NCT01397071|75629956|FG000|NOT COMPLETED|Consumption of Beef Patty With Avocado||0||
59532786|NCT01546675|75629966|FG000|STARTED|Overall Study||1||
59532787|NCT01546675|75629967|FG001|STARTED|Overall Study||1||
59532788|NCT01546675|75629966|FG000|COMPLETED|Overall Study||1||
59532789|NCT01546675|75629967|FG001|COMPLETED|Overall Study||1||
59532790|NCT01546675|75629966|FG000|NOT COMPLETED|Overall Study||0||
59532791|NCT01546675|75629967|FG001|NOT COMPLETED|Overall Study||0||
59532792|NCT01397617|75629976|FG000|STARTED|Overall Study||64||
59532793|NCT01397617|75629977|FG001|STARTED|Overall Study||53||
59532794|NCT01397617|75629978|FG002|STARTED|Overall Study||60||
59532795|NCT01397617|75629976|FG000|COMPLETED|Overall Study||33||
59532796|NCT01397617|75629977|FG001|COMPLETED|Overall Study||30||
59532797|NCT01397617|75629978|FG002|COMPLETED|Overall Study||31||
59532798|NCT01397617|75629976|FG000|NOT COMPLETED|Overall Study||31||
59532799|NCT01397617|75629977|FG001|NOT COMPLETED|Overall Study||23||
59532800|NCT01397617|75629978|FG002|NOT COMPLETED|Overall Study||29||
59532801|NCT02518620|75629991|FG000|STARTED|Overall Study||257||
59532802|NCT02518620|75629992|FG001|STARTED|Overall Study||149||
59532803|NCT02518620|75629991|FG000|COMPLETED|Overall Study||205||
59532804|NCT02518620|75629992|FG001|COMPLETED|Overall Study||123||
59532805|NCT02518620|75629991|FG000|NOT COMPLETED|Overall Study||52||
59532806|NCT02518620|75629992|FG001|NOT COMPLETED|Overall Study||26||
59532807|NCT02129660|75630005|FG000|STARTED|Overall Study||21||
59532808|NCT02129660|75630006|FG001|STARTED|Overall Study||20||
59532809|NCT02129660|75630007|FG002|STARTED|Overall Study||22||
59532810|NCT02129660|75630008|FG003|STARTED|Overall Study||20||
59532811|NCT02129660|75630009|FG004|STARTED|Overall Study||22||
59532812|NCT02129660|75630005|FG000|COMPLETED|Overall Study||19||
59532813|NCT02129660|75630006|FG001|COMPLETED|Overall Study||20||
59532814|NCT02129660|75630007|FG002|COMPLETED|Overall Study||21||
59532815|NCT02129660|75630008|FG003|COMPLETED|Overall Study||20||
59532816|NCT02129660|75630009|FG004|COMPLETED|Overall Study||20||
59532817|NCT02129660|75630005|FG000|NOT COMPLETED|Overall Study||2||
59532818|NCT02129660|75630006|FG001|NOT COMPLETED|Overall Study||0||
59532819|NCT02129660|75630007|FG002|NOT COMPLETED|Overall Study||1||
59532820|NCT02129660|75630008|FG003|NOT COMPLETED|Overall Study||0||
59532821|NCT02129660|75630009|FG004|NOT COMPLETED|Overall Study||2||
59532822|NCT01398475|75630022|FG000|STARTED|Overall Study||4||
59532823|NCT01398475|75630023|FG001|STARTED|Overall Study||3||
59532824|NCT01398475|75630024|FG002|STARTED|Overall Study||4||
59532825|NCT01398475|75630025|FG003|STARTED|Overall Study||4||
59532826|NCT01398475|75630022|FG000|Received First Intervention|Overall Study||4||
59532827|NCT01398475|75630023|FG001|Received First Intervention|Overall Study||3||
59532828|NCT01398475|75630024|FG002|Received First Intervention|Overall Study||4||
59532829|NCT01398475|75630025|FG003|Received First Intervention|Overall Study||4||
59532830|NCT01398475|75630022|FG000|Received Second Intervention|Overall Study||4||
59532831|NCT01398475|75630023|FG001|Received Second Intervention|Overall Study||3||
59532832|NCT01398475|75630024|FG002|Received Second Intervention|Overall Study||4||
59532833|NCT01398475|75630025|FG003|Received Second Intervention|Overall Study||4||
59532834|NCT01398475|75630022|FG000|Received Third Intervention|Overall Study||4||
59532835|NCT01398475|75630023|FG001|Received Third Intervention|Overall Study||3||
59532836|NCT01398475|75630024|FG002|Received Third Intervention|Overall Study||4||
59532837|NCT01398475|75630025|FG003|Received Third Intervention|Overall Study||4||
59532838|NCT01398475|75630022|FG000|Received Fourth Intervention|Overall Study||4||
59532839|NCT01398475|75630023|FG001|Received Fourth Intervention|Overall Study||3||
59532840|NCT01398475|75630024|FG002|Received Fourth Intervention|Overall Study||4||
59532841|NCT01398475|75630025|FG003|Received Fourth Intervention|Overall Study||4||
59532842|NCT01398475|75630022|FG000|COMPLETED|Overall Study||4||
59532843|NCT01398475|75630023|FG001|COMPLETED|Overall Study||3||
59532844|NCT01398475|75630024|FG002|COMPLETED|Overall Study||4||
59815318|NCT03810456|75937762|FG001|NOT COMPLETED|1 Month Follow-Up||4||
59815319|NCT03810456|75937763|FG002|NOT COMPLETED|1 Month Follow-Up||16||
59815320|NCT03810456|75937761|FG000|STARTED|3 Month Follow-Up||66||
59815321|NCT03810456|75937762|FG001|STARTED|3 Month Follow-Up||55||
59815322|NCT03810456|75937763|FG002|STARTED|3 Month Follow-Up||67||
59815323|NCT03810456|75937761|FG000|COMPLETED|3 Month Follow-Up||54||
59815324|NCT03810456|75937762|FG001|COMPLETED|3 Month Follow-Up||44||
59815325|NCT03810456|75937763|FG002|COMPLETED|3 Month Follow-Up||53||
59815326|NCT03810456|75937761|FG000|NOT COMPLETED|3 Month Follow-Up||12||
59815327|NCT03810456|75937762|FG001|NOT COMPLETED|3 Month Follow-Up||11||
59815328|NCT03810456|75937763|FG002|NOT COMPLETED|3 Month Follow-Up||14||
59815329|NCT03810456|75937761|FG000|STARTED|6 Month Follow-Up||66||
59532845|NCT01398475|75630025|FG003|COMPLETED|Overall Study||4||
59532846|NCT01398475|75630022|FG000|NOT COMPLETED|Overall Study||0||
59532847|NCT01398475|75630023|FG001|NOT COMPLETED|Overall Study||0||
59532848|NCT01398475|75630024|FG002|NOT COMPLETED|Overall Study||0||
59532849|NCT01398475|75630025|FG003|NOT COMPLETED|Overall Study||0||
59532850|NCT04235582|75630038|FG000|STARTED|Overall Study||12||
59532851|NCT04235582|75630039|FG001|STARTED|Overall Study||13||
59532852|NCT04235582|75630040|FG002|STARTED|Overall Study||11||
59532853|NCT04235582|75630038|FG000|COMPLETED|Overall Study||12||
59532854|NCT04235582|75630039|FG001|COMPLETED|Overall Study||12||
59532855|NCT04235582|75630040|FG002|COMPLETED|Overall Study||8||
59532856|NCT04235582|75630038|FG000|NOT COMPLETED|Overall Study||0||
59532857|NCT04235582|75630039|FG001|NOT COMPLETED|Overall Study||1||
59532858|NCT04235582|75630040|FG002|NOT COMPLETED|Overall Study||3||
59532859|NCT01549405|75630050|FG000|STARTED|Overall Study||20||
59532860|NCT01549405|75630051|FG001|STARTED|Overall Study||20||
59532861|NCT01549405|75630050|FG000|COMPLETED|Overall Study||20||
59532862|NCT01549405|75630051|FG001|COMPLETED|Overall Study||20||
59532863|NCT01549405|75630050|FG000|NOT COMPLETED|Overall Study||0||
59532864|NCT01549405|75630051|FG001|NOT COMPLETED|Overall Study||0||
59532865|NCT01505179|75630061|FG000|STARTED|Overall Study||6||
59532866|NCT01505179|75630062|FG001|STARTED|Overall Study||4||
59532867|NCT01505179|75630061|FG000|COMPLETED|Overall Study||6||
59532868|NCT01505179|75630062|FG001|COMPLETED|Overall Study||4||
59532869|NCT01505179|75630061|FG000|NOT COMPLETED|Overall Study||0||
59532870|NCT01505179|75630062|FG001|NOT COMPLETED|Overall Study||0||
59532871|NCT01398943|75630070|FG000|STARTED|First Intervention (1 Day)||15||
59532872|NCT01398943|75630071|FG001|STARTED|First Intervention (1 Day)||15||
59532873|NCT01398943|75630072|FG002|STARTED|First Intervention (1 Day)||15||
59532874|NCT01398943|75630073|FG003|STARTED|First Intervention (1 Day)||15||
59532875|NCT01398943|75630070|FG000|COMPLETED|First Intervention (1 Day)||15||
59532876|NCT01398943|75630071|FG001|COMPLETED|First Intervention (1 Day)||15||
59532877|NCT01398943|75630072|FG002|COMPLETED|First Intervention (1 Day)||15||
59532878|NCT01398943|75630073|FG003|COMPLETED|First Intervention (1 Day)||15||
59532879|NCT01398943|75630070|FG000|NOT COMPLETED|First Intervention (1 Day)||0||
59532880|NCT01398943|75630071|FG001|NOT COMPLETED|First Intervention (1 Day)||0||
59532881|NCT01398943|75630072|FG002|NOT COMPLETED|First Intervention (1 Day)||0||
59532882|NCT01398943|75630073|FG003|NOT COMPLETED|First Intervention (1 Day)||0||
59532883|NCT01398943|75630070|FG000|STARTED|Washout (2-7 Days)||15||
59532884|NCT01398943|75630071|FG001|STARTED|Washout (2-7 Days)||15||
59532885|NCT01398943|75630072|FG002|STARTED|Washout (2-7 Days)||15||
59532886|NCT01398943|75630073|FG003|STARTED|Washout (2-7 Days)||15||
59532887|NCT01398943|75630070|FG000|COMPLETED|Washout (2-7 Days)||15||
59532888|NCT01398943|75630071|FG001|COMPLETED|Washout (2-7 Days)||15||
59532889|NCT01398943|75630072|FG002|COMPLETED|Washout (2-7 Days)||15||
59532890|NCT01398943|75630073|FG003|COMPLETED|Washout (2-7 Days)||15||
59532891|NCT01398943|75630070|FG000|NOT COMPLETED|Washout (2-7 Days)||0||
59532892|NCT01398943|75630071|FG001|NOT COMPLETED|Washout (2-7 Days)||0||
59532893|NCT01398943|75630072|FG002|NOT COMPLETED|Washout (2-7 Days)||0||
59532894|NCT01398943|75630073|FG003|NOT COMPLETED|Washout (2-7 Days)||0||
59532895|NCT01398943|75630070|FG000|STARTED|Second Intervention (1 Day)||15||
59532896|NCT01398943|75630071|FG001|STARTED|Second Intervention (1 Day)||15||
59532897|NCT01398943|75630072|FG002|STARTED|Second Intervention (1 Day)||15||
59532898|NCT01398943|75630073|FG003|STARTED|Second Intervention (1 Day)||15||
59532899|NCT01398943|75630070|FG000|COMPLETED|Second Intervention (1 Day)||15||
59532900|NCT01398943|75630071|FG001|COMPLETED|Second Intervention (1 Day)||15||
59532901|NCT01398943|75630072|FG002|COMPLETED|Second Intervention (1 Day)||15||
59532902|NCT01398943|75630073|FG003|COMPLETED|Second Intervention (1 Day)||15||
59532903|NCT01398943|75630070|FG000|NOT COMPLETED|Second Intervention (1 Day)||0||
59532904|NCT01398943|75630071|FG001|NOT COMPLETED|Second Intervention (1 Day)||0||
59532905|NCT01398943|75630072|FG002|NOT COMPLETED|Second Intervention (1 Day)||0||
59532906|NCT01398943|75630073|FG003|NOT COMPLETED|Second Intervention (1 Day)||0||
59532907|NCT01550341|75630083|FG000|STARTED|Overall Study||32||
59532908|NCT01550341|75630084|FG001|STARTED|Overall Study||18||
59532909|NCT01550341|75630083|FG000|COMPLETED|Overall Study||32||
59532910|NCT01550341|75630084|FG001|COMPLETED|Overall Study||18||
59532911|NCT01550341|75630083|FG000|NOT COMPLETED|Overall Study||0||
59532912|NCT01550341|75630084|FG001|NOT COMPLETED|Overall Study||0||
59532913|NCT02125292|75630090|FG000|STARTED|First Intervention (1 Hour)||3||
59532914|NCT02125292|75630091|FG001|STARTED|First Intervention (1 Hour)||3||
59532915|NCT02125292|75630092|FG002|STARTED|First Intervention (1 Hour)||3||
59532916|NCT02125292|75630093|FG003|STARTED|First Intervention (1 Hour)||3||
59532917|NCT02125292|75630094|FG004|STARTED|First Intervention (1 Hour)||3||
59532918|NCT02125292|75630095|FG005|STARTED|First Intervention (1 Hour)||3||
59532919|NCT02125292|75630090|FG000|COMPLETED|First Intervention (1 Hour)||3||
59532920|NCT02125292|75630091|FG001|COMPLETED|First Intervention (1 Hour)||3||
59532921|NCT02125292|75630092|FG002|COMPLETED|First Intervention (1 Hour)||3||
59532922|NCT02125292|75630093|FG003|COMPLETED|First Intervention (1 Hour)||3||
59532923|NCT02125292|75630094|FG004|COMPLETED|First Intervention (1 Hour)||3||
59532924|NCT02125292|75630095|FG005|COMPLETED|First Intervention (1 Hour)||3||
59532925|NCT02125292|75630090|FG000|NOT COMPLETED|First Intervention (1 Hour)||0||
59532926|NCT02125292|75630091|FG001|NOT COMPLETED|First Intervention (1 Hour)||0||
59532927|NCT02125292|75630092|FG002|NOT COMPLETED|First Intervention (1 Hour)||0||
59532928|NCT02125292|75630093|FG003|NOT COMPLETED|First Intervention (1 Hour)||0||
59532929|NCT02125292|75630094|FG004|NOT COMPLETED|First Intervention (1 Hour)||0||
59532930|NCT02125292|75630095|FG005|NOT COMPLETED|First Intervention (1 Hour)||0||
59532931|NCT02125292|75630090|FG000|STARTED|Washout (2 Hours)||3||
59532932|NCT02125292|75630091|FG001|STARTED|Washout (2 Hours)||3||
59532933|NCT02125292|75630092|FG002|STARTED|Washout (2 Hours)||3||
59532934|NCT02125292|75630093|FG003|STARTED|Washout (2 Hours)||3||
59532935|NCT02125292|75630094|FG004|STARTED|Washout (2 Hours)||3||
59532936|NCT02125292|75630095|FG005|STARTED|Washout (2 Hours)||3||
59532937|NCT02125292|75630090|FG000|COMPLETED|Washout (2 Hours)||3||
59532938|NCT02125292|75630091|FG001|COMPLETED|Washout (2 Hours)||3||
59532939|NCT02125292|75630092|FG002|COMPLETED|Washout (2 Hours)||3||
59532940|NCT02125292|75630093|FG003|COMPLETED|Washout (2 Hours)||3||
59532941|NCT02125292|75630094|FG004|COMPLETED|Washout (2 Hours)||3||
59532942|NCT02125292|75630095|FG005|COMPLETED|Washout (2 Hours)||3||
59532943|NCT02125292|75630090|FG000|NOT COMPLETED|Washout (2 Hours)||0||
59532944|NCT02125292|75630091|FG001|NOT COMPLETED|Washout (2 Hours)||0||
59532945|NCT02125292|75630092|FG002|NOT COMPLETED|Washout (2 Hours)||0||
59532946|NCT02125292|75630093|FG003|NOT COMPLETED|Washout (2 Hours)||0||
59532947|NCT02125292|75630094|FG004|NOT COMPLETED|Washout (2 Hours)||0||
59532948|NCT02125292|75630095|FG005|NOT COMPLETED|Washout (2 Hours)||0||
59532949|NCT02125292|75630090|FG000|STARTED|Second Intervention (1 Hour)||3||
59532950|NCT02125292|75630091|FG001|STARTED|Second Intervention (1 Hour)||3||
59532951|NCT02125292|75630092|FG002|STARTED|Second Intervention (1 Hour)||3||
59532952|NCT02125292|75630093|FG003|STARTED|Second Intervention (1 Hour)||3||
59532953|NCT02125292|75630094|FG004|STARTED|Second Intervention (1 Hour)||3||
59532954|NCT02125292|75630095|FG005|STARTED|Second Intervention (1 Hour)||3||
59532955|NCT02125292|75630090|FG000|COMPLETED|Second Intervention (1 Hour)||3||
59532956|NCT02125292|75630091|FG001|COMPLETED|Second Intervention (1 Hour)||3||
59532957|NCT02125292|75630092|FG002|COMPLETED|Second Intervention (1 Hour)||3||
59532958|NCT02125292|75630093|FG003|COMPLETED|Second Intervention (1 Hour)||3||
59532959|NCT02125292|75630094|FG004|COMPLETED|Second Intervention (1 Hour)||3||
59532960|NCT02125292|75630095|FG005|COMPLETED|Second Intervention (1 Hour)||3||
59532961|NCT02125292|75630090|FG000|NOT COMPLETED|Second Intervention (1 Hour)||0||
59532962|NCT02125292|75630091|FG001|NOT COMPLETED|Second Intervention (1 Hour)||0||
59532963|NCT02125292|75630092|FG002|NOT COMPLETED|Second Intervention (1 Hour)||0||
59532964|NCT02125292|75630093|FG003|NOT COMPLETED|Second Intervention (1 Hour)||0||
59532965|NCT02125292|75630094|FG004|NOT COMPLETED|Second Intervention (1 Hour)||0||
59532966|NCT02125292|75630095|FG005|NOT COMPLETED|Second Intervention (1 Hour)||0||
59532967|NCT02125292|75630090|FG000|STARTED|Washout (2 Hours)||3||
59532968|NCT02125292|75630091|FG001|STARTED|Washout (2 Hours)||3||
59532969|NCT02125292|75630092|FG002|STARTED|Washout (2 Hours)||3||
59532970|NCT02125292|75630093|FG003|STARTED|Washout (2 Hours)||3||
59532971|NCT02125292|75630094|FG004|STARTED|Washout (2 Hours)||3||
59532972|NCT02125292|75630095|FG005|STARTED|Washout (2 Hours)||3||
59532973|NCT02125292|75630090|FG000|COMPLETED|Washout (2 Hours)||3||
59532974|NCT02125292|75630091|FG001|COMPLETED|Washout (2 Hours)||3||
59532975|NCT02125292|75630092|FG002|COMPLETED|Washout (2 Hours)||3||
59532976|NCT02125292|75630093|FG003|COMPLETED|Washout (2 Hours)||3||
59532977|NCT02125292|75630094|FG004|COMPLETED|Washout (2 Hours)||3||
59532978|NCT02125292|75630095|FG005|COMPLETED|Washout (2 Hours)||3||
59532979|NCT02125292|75630090|FG000|NOT COMPLETED|Washout (2 Hours)||0||
59532980|NCT02125292|75630091|FG001|NOT COMPLETED|Washout (2 Hours)||0||
59532981|NCT02125292|75630092|FG002|NOT COMPLETED|Washout (2 Hours)||0||
59532982|NCT02125292|75630093|FG003|NOT COMPLETED|Washout (2 Hours)||0||
59532983|NCT02125292|75630094|FG004|NOT COMPLETED|Washout (2 Hours)||0||
59532984|NCT02125292|75630095|FG005|NOT COMPLETED|Washout (2 Hours)||0||
59532985|NCT02125292|75630090|FG000|STARTED|Third Intervention (1 Hour)||3||
59532986|NCT02125292|75630091|FG001|STARTED|Third Intervention (1 Hour)||3||
59532987|NCT02125292|75630092|FG002|STARTED|Third Intervention (1 Hour)||3||
59532988|NCT02125292|75630093|FG003|STARTED|Third Intervention (1 Hour)||3||
59532989|NCT02125292|75630094|FG004|STARTED|Third Intervention (1 Hour)||3||
59532990|NCT02125292|75630095|FG005|STARTED|Third Intervention (1 Hour)||3||
59532991|NCT02125292|75630090|FG000|COMPLETED|Third Intervention (1 Hour)||3||
59532992|NCT02125292|75630091|FG001|COMPLETED|Third Intervention (1 Hour)||3||
59532993|NCT02125292|75630092|FG002|COMPLETED|Third Intervention (1 Hour)||3||
59532994|NCT02125292|75630093|FG003|COMPLETED|Third Intervention (1 Hour)||3||
59532995|NCT02125292|75630094|FG004|COMPLETED|Third Intervention (1 Hour)||3||
59532996|NCT02125292|75630095|FG005|COMPLETED|Third Intervention (1 Hour)||3||
59532997|NCT02125292|75630090|FG000|NOT COMPLETED|Third Intervention (1 Hour)||0||
59532998|NCT02125292|75630091|FG001|NOT COMPLETED|Third Intervention (1 Hour)||0||
60075603|NCT01684215|76190867|FG003|COMPLETED|Phase 2||0||
60075604|NCT01684215|76190864|FG000|NOT COMPLETED|Phase 2||0||
60075605|NCT01684215|76190865|FG001|NOT COMPLETED|Phase 2||0||
60075606|NCT01684215|76190866|FG002|NOT COMPLETED|Phase 2||0||
60075607|NCT01684215|76190867|FG003|NOT COMPLETED|Phase 2||43||
60075608|NCT01549275|76190882|FG000|STARTED|Overall Study||76||
60075609|NCT01549275|76190883|FG001|STARTED|Overall Study||29||
60075610|NCT01549275|76190882|FG000|COMPLETED|Overall Study||75||
60075611|NCT01549275|76190883|FG001|COMPLETED|Overall Study||29||
60075612|NCT01549275|76190882|FG000|NOT COMPLETED|Overall Study||1||
60075613|NCT01549275|76190883|FG001|NOT COMPLETED|Overall Study||0||
60075614|NCT01908205|76190895|FG000|STARTED|Overall Study||30||
60075615|NCT01908205|76190896|FG001|STARTED|Overall Study||30||
60075616|NCT01908205|76190895|FG000|COMPLETED|Overall Study||25||
60075617|NCT01908205|76190896|FG001|COMPLETED|Overall Study||29||
60075618|NCT01908205|76190895|FG000|NOT COMPLETED|Overall Study||5||
60075619|NCT01908205|76190896|FG001|NOT COMPLETED|Overall Study||1||
60075620|NCT01549041|76190917|FG000|STARTED|Overall Study||12||
60075621|NCT01549041|76190918|FG001|STARTED|Overall Study||18||
59532999|NCT02125292|75630092|FG002|NOT COMPLETED|Third Intervention (1 Hour)||0||
59533000|NCT02125292|75630093|FG003|NOT COMPLETED|Third Intervention (1 Hour)||0||
59533001|NCT02125292|75630094|FG004|NOT COMPLETED|Third Intervention (1 Hour)||0||
59533002|NCT02125292|75630095|FG005|NOT COMPLETED|Third Intervention (1 Hour)||0||
59533003|NCT01401517|75630107|FG000|STARTED|Overall Study||18||
59533004|NCT01401517|75630108|FG001|STARTED|Overall Study||19||
59533005|NCT01401517|75630109|FG002|STARTED|Overall Study||18||
59533006|NCT01401517|75630107|FG000|COMPLETED|Overall Study||15||
59533007|NCT01401517|75630108|FG001|COMPLETED|Overall Study||17||
59533008|NCT01401517|75630109|FG002|COMPLETED|Overall Study||15||
59533009|NCT01401517|75630107|FG000|NOT COMPLETED|Overall Study||3||
59533010|NCT01401517|75630108|FG001|NOT COMPLETED|Overall Study||2||
59533011|NCT01401517|75630109|FG002|NOT COMPLETED|Overall Study||3||
59533012|NCT02214277|75630120|FG000|STARTED|Overall Study||123||
59533013|NCT02214277|75630121|FG001|STARTED|Overall Study||121||
59533014|NCT02214277|75630122|FG002|STARTED|Overall Study||119||
60075622|NCT01549041|76190917|FG000|COMPLETED|Overall Study||10||
59533015|NCT02214277|75630120|FG000|COMPLETED|Overall Study||104||
59533016|NCT02214277|75630121|FG001|COMPLETED|Overall Study||96||
59533017|NCT02214277|75630122|FG002|COMPLETED|Overall Study||85||
59533018|NCT02214277|75630120|FG000|NOT COMPLETED|Overall Study||19||
59533019|NCT02214277|75630121|FG001|NOT COMPLETED|Overall Study||25||
59533020|NCT02214277|75630122|FG002|NOT COMPLETED|Overall Study||34||
59533021|NCT02126306|75630131|FG000|STARTED|Overall Study||10||
59533022|NCT02126306|75630132|FG001|STARTED|Overall Study||13||
59533023|NCT02126306|75630131|FG000|COMPLETED|Overall Study||10||
59533024|NCT02126306|75630132|FG001|COMPLETED|Overall Study||13||
59533025|NCT02126306|75630131|FG000|NOT COMPLETED|Overall Study||0||
59533026|NCT02126306|75630132|FG001|NOT COMPLETED|Overall Study||0||
59533027|NCT01550731|75630140|FG000|STARTED|Overall Study||205||
59533028|NCT01550731|75630141|FG001|STARTED|Overall Study||209||
59533029|NCT01550731|75630140|FG000|COMPLETED|Overall Study||205||
59533030|NCT01550731|75630141|FG001|COMPLETED|Overall Study||209||
59533031|NCT01550731|75630140|FG000|NOT COMPLETED|Overall Study||0||
59533032|NCT01550731|75630141|FG001|NOT COMPLETED|Overall Study||0||
59533033|NCT02127632|75630149|FG000|STARTED|Overall Study||50||
59533034|NCT02127632|75630150|FG001|STARTED|Overall Study||50||
59533035|NCT02127632|75630149|FG000|COMPLETED|Overall Study||50||
59533036|NCT02127632|75630150|FG001|COMPLETED|Overall Study||50||
59533037|NCT02127632|75630149|FG000|NOT COMPLETED|Overall Study||0||
59533038|NCT02127632|75630150|FG001|NOT COMPLETED|Overall Study||0||
59533039|NCT01550809|75630158|FG000|STARTED|Overall Study|Six patients started with the tBolus, the others with the iBolus, according to a crossover design.|6||
59533040|NCT01550809|75630159|FG001|STARTED|Overall Study|Six patients started with the iBolus, the others with the tBolus, according to a crossover design.|6||
59533041|NCT01550809|75630158|FG000|COMPLETED|Overall Study||6||
59533042|NCT01550809|75630159|FG001|COMPLETED|Overall Study||6||
59533043|NCT01550809|75630158|FG000|NOT COMPLETED|Overall Study||0||
59533044|NCT01550809|75630159|FG001|NOT COMPLETED|Overall Study||0||
59533045|NCT01551199|75630165|FG000|STARTED|Overall Study||7||
59533046|NCT01551199|75630165|FG000|COMPLETED|Overall Study||2||
59533047|NCT01551199|75630165|FG000|NOT COMPLETED|Overall Study||5||
59533048|NCT01653912|75630171|FG000|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||4||
59533049|NCT01653912|75630172|FG001|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||0||
59533050|NCT01653912|75630173|FG002|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||0||
59533051|NCT01653912|75630174|FG003|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||0||
59533052|NCT01653912|75630175|FG004|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||0||
59533053|NCT01653912|75630176|FG005|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||0||
59533054|NCT01653912|75630171|FG000|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||4||
59533055|NCT01653912|75630172|FG001|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0||
59533056|NCT01653912|75630173|FG002|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0||
59533057|NCT01653912|75630174|FG003|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0||
59533058|NCT01653912|75630175|FG004|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0||
59533059|NCT01653912|75630176|FG005|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0||
59533060|NCT01653912|75630171|FG000|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0||
59533061|NCT01653912|75630172|FG001|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0||
59533062|NCT01653912|75630173|FG002|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0||
59533063|NCT01653912|75630174|FG003|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0||
59533064|NCT01653912|75630175|FG004|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0||
59533065|NCT01653912|75630176|FG005|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0||
59533066|NCT01653912|75630171|FG000|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0||
59533067|NCT01653912|75630172|FG001|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||4||
59533068|NCT01653912|75630173|FG002|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0||
59533069|NCT01653912|75630174|FG003|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0||
59533070|NCT01653912|75630175|FG004|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0||
59533071|NCT01653912|75630176|FG005|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0||
59533072|NCT01653912|75630171|FG000|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0||
59533073|NCT01653912|75630172|FG001|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||3||
59533074|NCT01653912|75630173|FG002|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0||
59533075|NCT01653912|75630174|FG003|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0||
59533076|NCT01653912|75630175|FG004|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0||
59533077|NCT01653912|75630176|FG005|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0||
59533078|NCT01653912|75630171|FG000|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0||
59533079|NCT01653912|75630172|FG001|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||1||
59533080|NCT01653912|75630173|FG002|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0||
59533081|NCT01653912|75630174|FG003|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0||
59533082|NCT01653912|75630175|FG004|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0||
59533083|NCT01653912|75630176|FG005|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0||
59533084|NCT01653912|75630171|FG000|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||0||
59533085|NCT01653912|75630172|FG001|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||0||
59533086|NCT01653912|75630173|FG002|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||6||
59533087|NCT01653912|75630174|FG003|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||0||
59533088|NCT01653912|75630175|FG004|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||0||
59533089|NCT01653912|75630176|FG005|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||0||
59533090|NCT01653912|75630171|FG000|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0||
59533091|NCT01653912|75630172|FG001|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0||
59533092|NCT01653912|75630173|FG002|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||4||
59533093|NCT01653912|75630174|FG003|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0||
59533094|NCT01653912|75630175|FG004|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0||
59533095|NCT01653912|75630176|FG005|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0||
59533096|NCT01653912|75630171|FG000|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0||
59533097|NCT01653912|75630172|FG001|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0||
59533098|NCT01653912|75630173|FG002|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||2||
59533099|NCT01653912|75630174|FG003|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0||
59533100|NCT01653912|75630175|FG004|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0||
59533101|NCT01653912|75630176|FG005|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0||
59533102|NCT01653912|75630171|FG000|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||0||
59533103|NCT01653912|75630172|FG001|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||0||
59533104|NCT01653912|75630173|FG002|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||0||
59533105|NCT01653912|75630174|FG003|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||12||
59533106|NCT01653912|75630175|FG004|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||0||
59533107|NCT01653912|75630176|FG005|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||0||
59533108|NCT01653912|75630171|FG000|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0||
59533109|NCT01653912|75630172|FG001|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0||
59533110|NCT01653912|75630173|FG002|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0||
59533111|NCT01653912|75630174|FG003|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||10||
59533112|NCT01653912|75630175|FG004|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0||
59533113|NCT01653912|75630176|FG005|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0||
59533114|NCT01653912|75630171|FG000|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0||
59533115|NCT01653912|75630172|FG001|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0||
59533116|NCT01653912|75630173|FG002|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0||
59533117|NCT01653912|75630174|FG003|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||2||
59533118|NCT01653912|75630175|FG004|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0||
59533119|NCT01653912|75630176|FG005|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0||
59533120|NCT01653912|75630171|FG000|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||0||
59533121|NCT01653912|75630172|FG001|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||0||
59533122|NCT01653912|75630173|FG002|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||0||
59533123|NCT01653912|75630174|FG003|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||0||
59533124|NCT01653912|75630175|FG004|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||3||
59533125|NCT01653912|75630176|FG005|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||0||
59533126|NCT01653912|75630171|FG000|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0||
59533127|NCT01653912|75630172|FG001|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0||
59533128|NCT01653912|75630173|FG002|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0||
59533129|NCT01653912|75630174|FG003|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0||
59533130|NCT01653912|75630175|FG004|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||3||
59533131|NCT01653912|75630176|FG005|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0||
59533132|NCT01653912|75630171|FG000|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0||
59533133|NCT01653912|75630172|FG001|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0||
59533134|NCT01653912|75630173|FG002|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0||
59533135|NCT01653912|75630174|FG003|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0||
59533136|NCT01653912|75630175|FG004|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0||
59533137|NCT01653912|75630176|FG005|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0||
59533138|NCT01653912|75630171|FG000|STARTED|Phase 2: GSK2110183 125 mg||0||
59533139|NCT01653912|75630172|FG001|STARTED|Phase 2: GSK2110183 125 mg||0||
59533140|NCT01653912|75630173|FG002|STARTED|Phase 2: GSK2110183 125 mg||0||
59533141|NCT01653912|75630174|FG003|STARTED|Phase 2: GSK2110183 125 mg||0||
59533142|NCT01653912|75630175|FG004|STARTED|Phase 2: GSK2110183 125 mg||0||
59533143|NCT01653912|75630176|FG005|STARTED|Phase 2: GSK2110183 125 mg|Per SAP, Cohort B (n=2) data was summarized in phase 2 total column as cohort B had <10 subjects.|30||
59533144|NCT01653912|75630171|FG000|COMPLETED|Phase 2: GSK2110183 125 mg||0||
59533145|NCT01653912|75630172|FG001|COMPLETED|Phase 2: GSK2110183 125 mg||0||
59533146|NCT01653912|75630173|FG002|COMPLETED|Phase 2: GSK2110183 125 mg||0||
59533147|NCT01653912|75630174|FG003|COMPLETED|Phase 2: GSK2110183 125 mg||0||
59533148|NCT01653912|75630175|FG004|COMPLETED|Phase 2: GSK2110183 125 mg||0||
59533149|NCT01653912|75630176|FG005|COMPLETED|Phase 2: GSK2110183 125 mg||22||
59533150|NCT01653912|75630171|FG000|NOT COMPLETED|Phase 2: GSK2110183 125 mg||0||
59533151|NCT01653912|75630172|FG001|NOT COMPLETED|Phase 2: GSK2110183 125 mg||0||
59533152|NCT01653912|75630173|FG002|NOT COMPLETED|Phase 2: GSK2110183 125 mg||0||
59533153|NCT01653912|75630174|FG003|NOT COMPLETED|Phase 2: GSK2110183 125 mg||0||
59622728|NCT00439374|75734624|FG001|STARTED|Overall Study||330||
59622729|NCT00439374|75734623|FG000|COMPLETED|Overall Study||327||
59622730|NCT00439374|75734624|FG001|COMPLETED|Overall Study||330||
59622731|NCT00439374|75734623|FG000|NOT COMPLETED|Overall Study||0||
59622732|NCT00439374|75734624|FG001|NOT COMPLETED|Overall Study||0||
59622733|NCT00439608|75734630|FG000|STARTED|Overall Study||60||
59622734|NCT00439608|75734630|FG000|COMPLETED|Overall Study||60||
59533154|NCT01653912|75630175|FG004|NOT COMPLETED|Phase 2: GSK2110183 125 mg||0||
59533155|NCT01653912|75630176|FG005|NOT COMPLETED|Phase 2: GSK2110183 125 mg||8||
59533156|NCT01551979|75630184|FG000|STARTED|Overall Study||10||
59533157|NCT01551979|75630185|FG001|STARTED|Overall Study||7||
59533158|NCT01551979|75630184|FG000|Last Day of Treatment (After 5 Days)|Overall Study||10||
59533159|NCT01551979|75630185|FG001|Last Day of Treatment (After 5 Days)|Overall Study||7||
59533160|NCT01551979|75630184|FG000|1 Week Post Treatment|Overall Study||10||
59533161|NCT01551979|75630185|FG001|1 Week Post Treatment|Overall Study||6||
59533162|NCT01551979|75630184|FG000|COMPLETED|Overall Study||8||
59533163|NCT01551979|75630185|FG001|COMPLETED|Overall Study||5||
59533164|NCT01551979|75630184|FG000|NOT COMPLETED|Overall Study||2||
59533165|NCT01551979|75630185|FG001|NOT COMPLETED|Overall Study||2||
59533166|NCT01552213|75630193|FG000|STARTED|Overall Study||50|Number of subjects randomized|
59533167|NCT01552213|75630194|FG001|STARTED|Overall Study||45|Number of subjects randomized|
59533168|NCT01552213|75630193|FG000|Analyzed|Overall Study||42|Subjects who completed the OGTT or were started on insulin prior to the OGTT|
59533169|NCT01552213|75630194|FG001|Analyzed|Overall Study||41|Subjects who completed the OGTT or were started on insulin prior to the OGTT|
59533170|NCT01552213|75630193|FG000|COMPLETED|Overall Study||37|Pregnancy outcome data available|
59533171|NCT01552213|75630194|FG001|COMPLETED|Overall Study||37|Pregnancy outcome data available|
59533172|NCT01552213|75630193|FG000|NOT COMPLETED|Overall Study||13||
59533173|NCT01552213|75630194|FG001|NOT COMPLETED|Overall Study||8||
59533174|NCT02483520|75630202|FG000|STARTED|Overall Study||92||
59533175|NCT02483520|75630203|FG001|STARTED|Overall Study||97||
59533176|NCT02483520|75630202|FG000|Caregivers|Overall Study||50||
59533177|NCT02483520|75630203|FG001|Caregivers|Overall Study||56||
59533178|NCT02483520|75630202|FG000|Persons With Dementia|Overall Study||42||
59533179|NCT02483520|75630203|FG001|Persons With Dementia|Overall Study||41||
59533180|NCT02483520|75630202|FG000|COMPLETED|Overall Study||81||
59533181|NCT02483520|75630203|FG001|COMPLETED|Overall Study||73||
59533182|NCT02483520|75630202|FG000|NOT COMPLETED|Overall Study||11||
59533183|NCT02483520|75630203|FG001|NOT COMPLETED|Overall Study||24||
59533184|NCT02514174|75630209|FG000|STARTED|Overall Study||25|(Participants who were dispensed afatinib and were documented to have taken at least one dose.)|
59533185|NCT02514174|75630209|FG000|COMPLETED|Overall Study||0||
59533186|NCT02514174|75630209|FG000|NOT COMPLETED|Overall Study||25||
59533187|NCT02132468|75630213|FG000|STARTED|Overall Study||18||
59533188|NCT02132468|75630213|FG000|COMPLETED|Overall Study||11||
59533189|NCT02132468|75630213|FG000|NOT COMPLETED|Overall Study||7||
59533190|NCT01507987|75630217|FG000|STARTED|Overall Study||982||982
59533191|NCT01507987|75630218|FG001|STARTED|Overall Study||670||670
59533192|NCT01507987|75630219|FG002|STARTED|Overall Study||458||458
59533193|NCT01507987|75630220|FG003|STARTED|Overall Study||737||737
60075623|NCT01549041|76190918|FG001|COMPLETED|Overall Study||10||
60075624|NCT01549041|76190917|FG000|NOT COMPLETED|Overall Study||2||
60075625|NCT01549041|76190918|FG001|NOT COMPLETED|Overall Study||8||
60075626|NCT01907815|76190926|FG000|STARTED|Overall Study||17||
60075627|NCT01907815|76190927|FG001|STARTED|Overall Study||7||
60075628|NCT01907815|76190926|FG000|COMPLETED|Overall Study||16||
60075629|NCT01907815|76190927|FG001|COMPLETED|Overall Study||7||
60075630|NCT01907815|76190926|FG000|NOT COMPLETED|Overall Study||1||
60075631|NCT01907815|76190927|FG001|NOT COMPLETED|Overall Study||0||
60075632|NCT01548573|76190935|FG000|STARTED|Overall Study||19||
60075633|NCT01548573|76190935|FG000|COMPLETED|Overall Study||14||
60075634|NCT01548573|76190935|FG000|NOT COMPLETED|Overall Study||5||
59533194|NCT01507987|75630217|FG000|COMPLETED|Overall Study||618||618
59533195|NCT01507987|75630218|FG001|COMPLETED|Overall Study||335||335
59533196|NCT01507987|75630219|FG002|COMPLETED|Overall Study||252||252
59533197|NCT01507987|75630220|FG003|COMPLETED|Overall Study||480||480
59533198|NCT01507987|75630217|FG000|NOT COMPLETED|Overall Study||364||364
59533199|NCT01507987|75630218|FG001|NOT COMPLETED|Overall Study||335||335
59533200|NCT01507987|75630219|FG002|NOT COMPLETED|Overall Study||206||206
59533201|NCT01507987|75630220|FG003|NOT COMPLETED|Overall Study||257||257
59533202|NCT01508455|75630247|FG000|STARTED|Overall Study||6||
59533203|NCT01508455|75630247|FG000|COMPLETED|Overall Study||6||
59533204|NCT01508455|75630247|FG000|NOT COMPLETED|Overall Study||0||
59533205|NCT01509625|75630251|FG000|STARTED|Overall Study||272||
59533206|NCT01509625|75630251|FG000|COMPLETED|Overall Study||263||
59533207|NCT01509625|75630251|FG000|NOT COMPLETED|Overall Study||9||
59533208|NCT02482428|75630269|FG000|STARTED|Overall Study||24||
59533209|NCT02482428|75630270|FG001|STARTED|Overall Study||22||
59533210|NCT02482428|75630271|FG002|STARTED|Overall Study||10||
59533211|NCT02482428|75630272|FG003|STARTED|Overall Study||10||
59533212|NCT02482428|75630273|FG004|STARTED|Overall Study||22||
59533213|NCT02482428|75630269|FG000|COMPLETED|Overall Study||15||
59533214|NCT02482428|75630270|FG001|COMPLETED|Overall Study||10||
59533215|NCT02482428|75630271|FG002|COMPLETED|Overall Study||9||
59533216|NCT02482428|75630272|FG003|COMPLETED|Overall Study||8||
60075635|NCT01907737|76190940|FG000|STARTED|Overall Study||22||
60075636|NCT01907737|76190940|FG000|COMPLETED|Overall Study||21||
60075637|NCT01907737|76190940|FG000|NOT COMPLETED|Overall Study||1||
60075638|NCT01570491|76190952|FG000|STARTED|Overall Study||19||
60075639|NCT01570491|76190953|FG001|STARTED|Overall Study||19||
59533217|NCT02482428|75630273|FG004|COMPLETED|Overall Study||15||
59533218|NCT02482428|75630269|FG000|NOT COMPLETED|Overall Study||9||
59533219|NCT02482428|75630270|FG001|NOT COMPLETED|Overall Study||12||
59533220|NCT02482428|75630271|FG002|NOT COMPLETED|Overall Study||1||
59533221|NCT02482428|75630272|FG003|NOT COMPLETED|Overall Study||2||
59533222|NCT02482428|75630273|FG004|NOT COMPLETED|Overall Study||7||
59533223|NCT02319824|75630287|FG000|STARTED|Overall Study||2||2
59533224|NCT02319824|75630287|FG000|COMPLETED|Overall Study||2||2
59533225|NCT02319824|75630287|FG000|NOT COMPLETED|Overall Study||0||0
60075640|NCT01570491|76190952|FG000|COMPLETED|Overall Study||14||
60075641|NCT01570491|76190953|FG001|COMPLETED|Overall Study||18||
60075642|NCT01570491|76190952|FG000|NOT COMPLETED|Overall Study||5||
60075643|NCT01570491|76190953|FG001|NOT COMPLETED|Overall Study||1||
60075644|NCT01929109|76190964|FG000|STARTED|Period 1 (All Groups)||14||
60075645|NCT01929109|76190965|FG001|STARTED|Period 1 (All Groups)||8||
60075646|NCT01929109|76190966|FG002|STARTED|Period 1 (All Groups)||9||
60075647|NCT01929109|76190967|FG003|STARTED|Period 1 (All Groups)||8||
60075648|NCT01929109|76190968|FG004|STARTED|Period 1 (All Groups)||8||
60075649|NCT01929109|76190964|FG000|COMPLETED|Period 1 (All Groups)||14||
60075650|NCT01929109|76190965|FG001|COMPLETED|Period 1 (All Groups)||8||
59533226|NCT01510327|75630292|FG000|STARTED|Overall Study||22||
59533227|NCT01510327|75630292|FG000|COMPLETED|Overall Study||22||
59533228|NCT01510327|75630292|FG000|NOT COMPLETED|Overall Study||0||
59533229|NCT01401595|75630304|FG000|STARTED|Recruitment and Screening|Of 345 calls, 75 potential NES subjects attended the screening visit and provided informed consent.|75||
59533230|NCT01401595|75630305|FG001|STARTED|Recruitment and Screening|Of 32 calls, 12 control subjects attended an initial screening visit.|12||
59533231|NCT01401595|75630304|FG000|COMPLETED|Recruitment and Screening|Of the 75, 32 remained interested/eligible after the initial screening period.|32||
59533232|NCT01401595|75630305|FG001|COMPLETED|Recruitment and Screening|10 of the 12 remained eligible/interested after the initial screening visit.|10||
59533233|NCT01401595|75630304|FG000|NOT COMPLETED|Recruitment and Screening||43||
59533234|NCT01401595|75630305|FG001|NOT COMPLETED|Recruitment and Screening||2||
59533235|NCT01401595|75630304|FG000|STARTED|Imaging and Treatment (for NE Arm)||32||
59533236|NCT01401595|75630305|FG001|STARTED|Imaging and Treatment (for NE Arm)||10||
59533237|NCT01401595|75630304|FG000|COMPLETED|Imaging and Treatment (for NE Arm)||18||
59533238|NCT01401595|75630305|FG001|COMPLETED|Imaging and Treatment (for NE Arm)||10||
59533239|NCT01401595|75630304|FG000|NOT COMPLETED|Imaging and Treatment (for NE Arm)||14||
59533240|NCT01401595|75630305|FG001|NOT COMPLETED|Imaging and Treatment (for NE Arm)||0||
59533241|NCT01511809|75630314|FG000|STARTED|Overall Study||58||
59533242|NCT01511809|75630315|FG001|STARTED|Overall Study||59||
59533243|NCT01511809|75630314|FG000|COMPLETED|Overall Study||51||
59533244|NCT01511809|75630315|FG001|COMPLETED|Overall Study||52||
59533245|NCT01511809|75630314|FG000|NOT COMPLETED|Overall Study||7||
59533246|NCT01511809|75630315|FG001|NOT COMPLETED|Overall Study||7||
59533247|NCT02480712|75630321|FG000|STARTED|Overall Study||107||
59533248|NCT02480712|75630321|FG000|COMPLETED|Overall Study||96||
59533249|NCT02480712|75630321|FG000|NOT COMPLETED|Overall Study||11||
59533250|NCT01512667|75630333|FG000|STARTED|Overall Study||13||
59533251|NCT01512667|75630334|FG001|STARTED|Overall Study||12||
59533252|NCT01512667|75630333|FG000|Matched Participants|Overall Study||12||
59533253|NCT01512667|75630334|FG001|Matched Participants|Overall Study||12||
59533254|NCT01512667|75630333|FG000|Unmatched Participants|Overall Study|Participant was not matched to a healthy control participant.|1||
59533255|NCT01512667|75630334|FG001|Unmatched Participants|Overall Study||0||
59533256|NCT01512667|75630333|FG000|COMPLETED|Overall Study||13||
59533257|NCT01512667|75630334|FG001|COMPLETED|Overall Study||12||
59533258|NCT01512667|75630333|FG000|NOT COMPLETED|Overall Study||0||
59533259|NCT01512667|75630334|FG001|NOT COMPLETED|Overall Study||0||
59533260|NCT03628976|75630342|FG000|STARTED|Overall Study||12||
59533261|NCT03628976|75630343|FG001|STARTED|Overall Study||12||
59533262|NCT03628976|75630342|FG000|COMPLETED|Overall Study||12||
59533263|NCT03628976|75630343|FG001|COMPLETED|Overall Study||12||
59533264|NCT03628976|75630342|FG000|NOT COMPLETED|Overall Study||0||
59533265|NCT03628976|75630343|FG001|NOT COMPLETED|Overall Study||0||
59533266|NCT01553539|75630349|FG000|STARTED|Overall Study||20||
59533267|NCT01553539|75630349|FG000|COMPLETED|Overall Study||20||
59533268|NCT01553539|75630349|FG000|NOT COMPLETED|Overall Study||0||
59533269|NCT00557882|75630355|FG000|STARTED|Overall Study||32||
59533270|NCT00557882|75630356|FG001|STARTED|Overall Study||33||
59533271|NCT00557882|75630355|FG000|COMPLETED|Overall Study||27||
59533272|NCT00557882|75630356|FG001|COMPLETED|Overall Study||33||
59533273|NCT00557882|75630355|FG000|NOT COMPLETED|Overall Study||5||
59533274|NCT00557882|75630356|FG001|NOT COMPLETED|Overall Study||0||
59533275|NCT01555567|75630366|FG000|STARTED|12 Week||12||
59533276|NCT01555567|75630367|FG001|STARTED|12 Week||13||
60075651|NCT01929109|76190966|FG002|COMPLETED|Period 1 (All Groups)||8||
60075652|NCT01929109|76190967|FG003|COMPLETED|Period 1 (All Groups)||8||
60075653|NCT01929109|76190968|FG004|COMPLETED|Period 1 (All Groups)||8||
60075654|NCT01929109|76190964|FG000|NOT COMPLETED|Period 1 (All Groups)||0||
60075655|NCT01929109|76190965|FG001|NOT COMPLETED|Period 1 (All Groups)||0||
60075656|NCT01929109|76190966|FG002|NOT COMPLETED|Period 1 (All Groups)||1||
60075657|NCT01929109|76190967|FG003|NOT COMPLETED|Period 1 (All Groups)||0||
59533277|NCT01555567|75630368|FG002|STARTED|12 Week||9||
59533278|NCT01555567|75630369|FG003|STARTED|12 Week||9||
59533279|NCT01555567|75630366|FG000|COMPLETED|12 Week||11||
59533280|NCT01555567|75630367|FG001|COMPLETED|12 Week||12||
59533281|NCT01555567|75630368|FG002|COMPLETED|12 Week||8||
59533282|NCT01555567|75630369|FG003|COMPLETED|12 Week||9||
59533283|NCT01555567|75630366|FG000|NOT COMPLETED|12 Week||1||
59533284|NCT01555567|75630367|FG001|NOT COMPLETED|12 Week||1||
59533285|NCT01555567|75630368|FG002|NOT COMPLETED|12 Week||1||
59533286|NCT01555567|75630369|FG003|NOT COMPLETED|12 Week||0||
59533287|NCT01555567|75630366|FG000|STARTED|Return to Activity||11||
59533288|NCT01555567|75630367|FG001|STARTED|Return to Activity||12||
59533289|NCT01555567|75630368|FG002|STARTED|Return to Activity||8||
59533290|NCT01555567|75630369|FG003|STARTED|Return to Activity||9||
59533291|NCT01555567|75630366|FG000|COMPLETED|Return to Activity||10||
59533292|NCT01555567|75630367|FG001|COMPLETED|Return to Activity||10||
59533293|NCT01555567|75630368|FG002|COMPLETED|Return to Activity||8||
59533294|NCT01555567|75630369|FG003|COMPLETED|Return to Activity||8||
59533295|NCT01555567|75630366|FG000|NOT COMPLETED|Return to Activity||1||
59533296|NCT01555567|75630367|FG001|NOT COMPLETED|Return to Activity||2||
59533297|NCT01555567|75630368|FG002|NOT COMPLETED|Return to Activity||0||
59533298|NCT01555567|75630369|FG003|NOT COMPLETED|Return to Activity||1||
59533299|NCT01555957|75630381|FG000|STARTED|Overall Study||20||
59533300|NCT01555957|75630382|FG001|STARTED|Overall Study||20||
59533301|NCT01555957|75630381|FG000|COMPLETED|Overall Study||20||
59533302|NCT01555957|75630382|FG001|COMPLETED|Overall Study||20||
59533303|NCT01555957|75630381|FG000|NOT COMPLETED|Overall Study||0||
59533304|NCT01555957|75630382|FG001|NOT COMPLETED|Overall Study||0||
59533305|NCT00560612|75630390|FG000|STARTED|Overall Study||5||
59533306|NCT00560612|75630391|FG001|STARTED|Overall Study||7||
59533307|NCT00560612|75630390|FG000|COMPLETED|Overall Study||5||
59533308|NCT00560612|75630391|FG001|COMPLETED|Overall Study||7||
59533309|NCT00560612|75630390|FG000|NOT COMPLETED|Overall Study||0||
59533310|NCT00560612|75630391|FG001|NOT COMPLETED|Overall Study||0||
59533311|NCT01556347|75630397|FG000|STARTED|Induction Immunotherapy||2||
59533312|NCT01556347|75630397|FG000|COMPLETED|Induction Immunotherapy||2||
59533313|NCT01556347|75630397|FG000|NOT COMPLETED|Induction Immunotherapy||0||
59533314|NCT01556347|75630397|FG000|STARTED|Bortezomib Treatment Phase||2||
59533315|NCT01556347|75630397|FG000|COMPLETED|Bortezomib Treatment Phase||2||
59533316|NCT01556347|75630397|FG000|NOT COMPLETED|Bortezomib Treatment Phase||0||
59533317|NCT01556347|75630397|FG000|STARTED|Recovery Phase||2||
59533318|NCT01556347|75630397|FG000|COMPLETED|Recovery Phase||2||
59533319|NCT01556347|75630397|FG000|NOT COMPLETED|Recovery Phase||0||
59533320|NCT00561002|75630427|FG000|STARTED|Overall Study||23||
59533321|NCT00561002|75630428|FG001|STARTED|Overall Study||9||
59815330|NCT03810456|75937762|FG001|STARTED|6 Month Follow-Up||55||
59815331|NCT03810456|75937763|FG002|STARTED|6 Month Follow-Up||67||
59533322|NCT00561002|75630427|FG000|COMPLETED|Overall Study||23||
59533323|NCT00561002|75630428|FG001|COMPLETED|Overall Study||9||
59533324|NCT00561002|75630427|FG000|NOT COMPLETED|Overall Study||0||
59533325|NCT00561002|75630428|FG001|NOT COMPLETED|Overall Study||0||
59533326|NCT01556425|75630438|FG000|STARTED|Overall Study||25||
59533327|NCT01556425|75630439|FG001|STARTED|Overall Study||23||
59533328|NCT01556425|75630440|FG002|STARTED|Overall Study||18||
59533329|NCT01556425|75630441|FG003|STARTED|Overall Study||18||
59533330|NCT01556425|75630438|FG000|COMPLETED|Overall Study||25||
59533331|NCT01556425|75630439|FG001|COMPLETED|Overall Study||23||
59533332|NCT01556425|75630440|FG002|COMPLETED|Overall Study||18||
59533333|NCT01556425|75630441|FG003|COMPLETED|Overall Study||18||
59533334|NCT01556425|75630438|FG000|NOT COMPLETED|Overall Study||0||
59533335|NCT01556425|75630439|FG001|NOT COMPLETED|Overall Study||0||
59533336|NCT01556425|75630440|FG002|NOT COMPLETED|Overall Study||0||
59533337|NCT01556425|75630441|FG003|NOT COMPLETED|Overall Study||0||
59533338|NCT01513447|75630453|FG000|STARTED|Overall Study||3||
59533339|NCT01513447|75630454|FG001|STARTED|Overall Study||5||
59533340|NCT01513447|75630453|FG000|COMPLETED|Overall Study||3||
59533341|NCT01513447|75630454|FG001|COMPLETED|Overall Study||5||
59533342|NCT01513447|75630453|FG000|NOT COMPLETED|Overall Study||0||
59533343|NCT01513447|75630454|FG001|NOT COMPLETED|Overall Study||0||
59533344|NCT00562328|75630460|FG000|STARTED|Overall Study||33||
59533345|NCT00562328|75630460|FG000|COMPLETED|Overall Study||33||
59533346|NCT00562328|75630460|FG000|NOT COMPLETED|Overall Study||0||
59815332|NCT03810456|75937761|FG000|COMPLETED|6 Month Follow-Up||53||
59533347|NCT01514149|75630469|FG000|STARTED|Overall Study||15||
59533348|NCT01514149|75630470|FG001|STARTED|Overall Study||15||
59533349|NCT01514149|75630471|FG002|STARTED|Overall Study||14||
59533350|NCT01514149|75630472|FG003|STARTED|Overall Study||14||
59533351|NCT01514149|75630473|FG004|STARTED|Overall Study||15||
59533352|NCT01514149|75630469|FG000|COMPLETED|Overall Study||12||
59533353|NCT01514149|75630470|FG001|COMPLETED|Overall Study||14||
59533354|NCT01514149|75630471|FG002|COMPLETED|Overall Study||11||
59533355|NCT01514149|75630472|FG003|COMPLETED|Overall Study||13||
59533356|NCT01514149|75630473|FG004|COMPLETED|Overall Study||14||
59533357|NCT01514149|75630469|FG000|NOT COMPLETED|Overall Study||3||
59533358|NCT01514149|75630470|FG001|NOT COMPLETED|Overall Study||1||
59533359|NCT01514149|75630471|FG002|NOT COMPLETED|Overall Study||3||
59533360|NCT01514149|75630472|FG003|NOT COMPLETED|Overall Study||1||
59533361|NCT01514149|75630473|FG004|NOT COMPLETED|Overall Study||1||
59533362|NCT01514383|75630485|FG000|STARTED|Overall Study||34||
59533363|NCT01514383|75630485|FG000|COMPLETED|Overall Study||34||
59533364|NCT01514383|75630485|FG000|NOT COMPLETED|Overall Study||0||
59533365|NCT01556581|75630492|FG000|STARTED|Overall Study||61||
59533366|NCT01556581|75630493|FG001|STARTED|Overall Study||58||
59533367|NCT01556581|75630492|FG000|COMPLETED|Overall Study||61||
59533368|NCT01556581|75630493|FG001|COMPLETED|Overall Study||58||
59533369|NCT01556581|75630492|FG000|NOT COMPLETED|Overall Study||0||
59533370|NCT01556581|75630493|FG001|NOT COMPLETED|Overall Study||0||
59533371|NCT01557595|75630499|FG000|STARTED|Overall Study||22||
59533372|NCT01557595|75630499|FG000|COMPLETED|Overall Study||14||
59533373|NCT01557595|75630499|FG000|NOT COMPLETED|Overall Study||8||
59533374|NCT02127710|75630506|FG000|STARTED|Overall Study||46||
59533375|NCT02127710|75630507|FG001|STARTED|Overall Study||47||
59533376|NCT02127710|75630508|FG002|STARTED|Overall Study||16||
59533377|NCT02127710|75630506|FG000|COMPLETED|Overall Study||46||
59533378|NCT02127710|75630507|FG001|COMPLETED|Overall Study||47||
59533379|NCT02127710|75630508|FG002|COMPLETED|Overall Study||16||
59533380|NCT02127710|75630506|FG000|NOT COMPLETED|Overall Study||0||
59533381|NCT02127710|75630507|FG001|NOT COMPLETED|Overall Study||0||
59533382|NCT02127710|75630508|FG002|NOT COMPLETED|Overall Study||0||
59533383|NCT01558063|75630525|FG000|STARTED|Overall Study||5||
59533384|NCT01558063|75630526|FG001|STARTED|Overall Study||6||
59533385|NCT01558063|75630527|FG002|STARTED|Overall Study||8||
59533386|NCT01558063|75630528|FG003|STARTED|Overall Study||5||
59533387|NCT01558063|75630529|FG004|STARTED|Overall Study||9||
59533388|NCT01558063|75630530|FG005|STARTED|Overall Study||5||
59533389|NCT01558063|75630525|FG000|COMPLETED|Overall Study||5||
59533390|NCT01558063|75630526|FG001|COMPLETED|Overall Study||6||
59533391|NCT01558063|75630527|FG002|COMPLETED|Overall Study||8||
59533392|NCT01558063|75630528|FG003|COMPLETED|Overall Study||5||
59533393|NCT01558063|75630529|FG004|COMPLETED|Overall Study||9||
59533394|NCT01558063|75630530|FG005|COMPLETED|Overall Study||5||
59533395|NCT01558063|75630525|FG000|NOT COMPLETED|Overall Study||0||
59533396|NCT01558063|75630526|FG001|NOT COMPLETED|Overall Study||0||
59533397|NCT01558063|75630527|FG002|NOT COMPLETED|Overall Study||0||
59533398|NCT01558063|75630528|FG003|NOT COMPLETED|Overall Study||0||
59533399|NCT01558063|75630529|FG004|NOT COMPLETED|Overall Study||0||
59533400|NCT01558063|75630530|FG005|NOT COMPLETED|Overall Study||0||
59533401|NCT01515943|75630542|FG000|STARTED|Overall Study||75||
59533402|NCT01515943|75630543|FG001|STARTED|Overall Study||85||
59533403|NCT01515943|75630544|FG002|STARTED|Overall Study||44||
59533404|NCT01515943|75630542|FG000|COMPLETED|Overall Study||69||
59533405|NCT01515943|75630543|FG001|COMPLETED|Overall Study||69||
59533406|NCT01515943|75630544|FG002|COMPLETED|Overall Study||31||
59533407|NCT01515943|75630542|FG000|NOT COMPLETED|Overall Study||6||
59533408|NCT01515943|75630543|FG001|NOT COMPLETED|Overall Study||16||
59533409|NCT01515943|75630544|FG002|NOT COMPLETED|Overall Study||13||
59533410|NCT01516957|75630557|FG000|STARTED|Placebo-controlled Phase||55||
59533411|NCT01516957|75630558|FG001|STARTED|Placebo-controlled Phase||57||
59533412|NCT01516957|75630559|FG002|STARTED|Placebo-controlled Phase||56||
59533413|NCT01516957|75630560|FG003|STARTED|Placebo-controlled Phase||0||
59533414|NCT01516957|75630557|FG000|COMPLETED|Placebo-controlled Phase||52||
59533415|NCT01516957|75630558|FG001|COMPLETED|Placebo-controlled Phase||53||
59533416|NCT01516957|75630559|FG002|COMPLETED|Placebo-controlled Phase||51||
59533417|NCT01516957|75630560|FG003|COMPLETED|Placebo-controlled Phase||0||
59533418|NCT01516957|75630557|FG000|NOT COMPLETED|Placebo-controlled Phase||3||
59533419|NCT01516957|75630558|FG001|NOT COMPLETED|Placebo-controlled Phase||4||
59533420|NCT01516957|75630559|FG002|NOT COMPLETED|Placebo-controlled Phase||5||
59533421|NCT01516957|75630560|FG003|NOT COMPLETED|Placebo-controlled Phase||0||
59533422|NCT01516957|75630557|FG000|STARTED|Open-label Phase||0||
59533423|NCT01516957|75630558|FG001|STARTED|Open-label Phase||0||
59533424|NCT01516957|75630559|FG002|STARTED|Open-label Phase||0||
59533425|NCT01516957|75630560|FG003|STARTED|Open-label Phase||156||
59533426|NCT01516957|75630557|FG000|COMPLETED|Open-label Phase||0||
59533427|NCT01516957|75630558|FG001|COMPLETED|Open-label Phase||0||
59533428|NCT01516957|75630559|FG002|COMPLETED|Open-label Phase||0||
59533429|NCT01516957|75630560|FG003|COMPLETED|Open-label Phase||0||
59533430|NCT01516957|75630557|FG000|NOT COMPLETED|Open-label Phase||0||
59533431|NCT01516957|75630558|FG001|NOT COMPLETED|Open-label Phase||0||
59533432|NCT01516957|75630559|FG002|NOT COMPLETED|Open-label Phase||0||
59533433|NCT01516957|75630560|FG003|NOT COMPLETED|Open-label Phase||156||
59533434|NCT01519063|75630571|FG000|STARTED|Overall Study||26||
59533435|NCT01519063|75630572|FG001|STARTED|Overall Study||30||
59533436|NCT01519063|75630571|FG000|COMPLETED|Overall Study||19||
59533437|NCT01519063|75630572|FG001|COMPLETED|Overall Study||25||
59533438|NCT01519063|75630571|FG000|NOT COMPLETED|Overall Study||7||
59533439|NCT01519063|75630572|FG001|NOT COMPLETED|Overall Study||5||
59533440|NCT01559857|75630580|FG000|STARTED|Overall Study||19||
59533441|NCT01559857|75630581|FG001|STARTED|Overall Study||18||
59533442|NCT01559857|75630580|FG000|COMPLETED|Overall Study||19||
59533443|NCT01559857|75630581|FG001|COMPLETED|Overall Study||18||
59533444|NCT01559857|75630580|FG000|NOT COMPLETED|Overall Study||0||
59533445|NCT01559857|75630581|FG001|NOT COMPLETED|Overall Study||0||
59533446|NCT01562041|75630589|FG000|STARTED|Overall Study||14||
59533447|NCT01562041|75630589|FG000|COMPLETED|Overall Study||14||
59533448|NCT01562041|75630589|FG000|NOT COMPLETED|Overall Study||0||
59533449|NCT01519453|75630595|FG000|STARTED|Overall Study|Number of dyads (caregiver-child pairs) or 398 individuals|199||
59533450|NCT01519453|75630596|FG001|STARTED|Overall Study|Number of dyads (caregiver-child pairs) or 398 individuals|199||
59533451|NCT01519453|75630595|FG000|3 Month|Overall Study|Number of dyads (caregiver-child pairs) or 320 individuals|160||
59533452|NCT01519453|75630596|FG001|3 Month|Overall Study|Number of dyads (caregiver-child pairs) or 362 individuals|181||
59533453|NCT01519453|75630595|FG000|6 Month|Overall Study|Number of dyads (caregiver-child pairs) or 306 individuals|153||
59533454|NCT01519453|75630596|FG001|6 Month|Overall Study|Number of dyads (caregiver-child pairs) or 350 individuals|175||
59533455|NCT01519453|75630595|FG000|9 Month|Overall Study|Number of dyads (caregiver-child pairs) or 318 individuals|159||
59533456|NCT01519453|75630596|FG001|9 Month|Overall Study|Number of dyads (caregiver-child pairs) or 332 individuals|166||
59533457|NCT01519453|75630595|FG000|COMPLETED|Overall Study|Number of dyads (caregiver-child pairs) or 294 individuals|147|Number completing 12 month follow up assessment|
59533458|NCT01519453|75630596|FG001|COMPLETED|Overall Study|Number of dyads (caregiver-child pairs) or 326 individuals|163|Number completing 12 month follow up assessment|
59533459|NCT01519453|75630595|FG000|NOT COMPLETED|Overall Study||52||
59533460|NCT01519453|75630596|FG001|NOT COMPLETED|Overall Study||36||
59533461|NCT02210065|75630602|FG000|STARTED|Overall Study||1||
59533462|NCT02210065|75630602|FG000|COMPLETED|Overall Study||1||
59533463|NCT02210065|75630602|FG000|NOT COMPLETED|Overall Study||0||
59533464|NCT00634166|75630608|FG000|STARTED|Overall Study||82||
59533465|NCT00634166|75630609|FG001|STARTED|Overall Study||138||
59533466|NCT00634166|75630608|FG000|COMPLETED|Overall Study||22||
59533467|NCT00634166|75630609|FG001|COMPLETED|Overall Study||78||
59533468|NCT00634166|75630608|FG000|NOT COMPLETED|Overall Study||60||
59533469|NCT00634166|75630609|FG001|NOT COMPLETED|Overall Study||60||
59533470|NCT00565370|75630617|FG000|STARTED|Overall Study||21||
59533471|NCT00565370|75630617|FG000|COMPLETED|Overall Study||21||
59533472|NCT00565370|75630617|FG000|NOT COMPLETED|Overall Study||0||
59533473|NCT03303950|75630621|FG000|STARTED|Overall Study||6||
59533474|NCT03303950|75630621|FG000|COMPLETED|Overall Study||6||
59533475|NCT03303950|75630621|FG000|NOT COMPLETED|Overall Study||0||
59533476|NCT01563055|75630626|FG000|STARTED|Overall Study||10||
59533477|NCT01563055|75630626|FG000|COMPLETED|Overall Study||10||
59533478|NCT01563055|75630626|FG000|NOT COMPLETED|Overall Study||0||
59533479|NCT00565916|75630635|FG000|STARTED|Overall Study||11||
59533480|NCT00565916|75630636|FG001|STARTED|Overall Study||11||
59533481|NCT00565916|75630635|FG000|COMPLETED|Overall Study||11||
59533482|NCT00565916|75630636|FG001|COMPLETED|Overall Study||11||
59533483|NCT00565916|75630635|FG000|NOT COMPLETED|Overall Study||0||
59533484|NCT00565916|75630636|FG001|NOT COMPLETED|Overall Study||0||
59533485|NCT01564693|75630645|FG000|STARTED|Overall Study|Originally we planned to study 4 patients. We expanded to 9 to improve consistency of the results.|9||
59533486|NCT01564693|75630646|FG001|STARTED|Overall Study||4||
59533487|NCT01564693|75630647|FG002|STARTED|Overall Study|Only 2 patients were found necessary to give statistical relevance to the patients' results.|2||
59533488|NCT01564693|75630645|FG000|COMPLETED|Overall Study||9||
59533489|NCT01564693|75630646|FG001|COMPLETED|Overall Study||4||
59533490|NCT01564693|75630647|FG002|COMPLETED|Overall Study||2||
59533491|NCT01564693|75630645|FG000|NOT COMPLETED|Overall Study||0||
59533492|NCT01564693|75630646|FG001|NOT COMPLETED|Overall Study||0||
59533493|NCT01564693|75630647|FG002|NOT COMPLETED|Overall Study||0||
59533494|NCT01521871|75630657|FG000|STARTED|Overall Study||32||
59533495|NCT01521871|75630658|FG001|STARTED|Overall Study||32||
59533496|NCT01521871|75630657|FG000|COMPLETED|Overall Study||32||
59533497|NCT01521871|75630658|FG001|COMPLETED|Overall Study||32||
59533498|NCT01521871|75630657|FG000|NOT COMPLETED|Overall Study||0||
59533499|NCT01521871|75630658|FG001|NOT COMPLETED|Overall Study||0||
59533500|NCT00566150|75630666|FG000|STARTED|Overall Study||19||
59533501|NCT00566150|75630667|FG001|STARTED|Overall Study||16||
59533502|NCT00566150|75630666|FG000|COMPLETED|Overall Study||10||
59533503|NCT00566150|75630667|FG001|COMPLETED|Overall Study||11||
59533504|NCT00566150|75630666|FG000|NOT COMPLETED|Overall Study||9||
59533505|NCT00566150|75630667|FG001|NOT COMPLETED|Overall Study||5||
59533506|NCT01521949|75630673|FG000|STARTED|Overall Study||21||
59533507|NCT01521949|75630673|FG000|COMPLETED|Overall Study||21||
59533508|NCT01521949|75630673|FG000|NOT COMPLETED|Overall Study||0||
59533509|NCT01522339|75630677|FG000|STARTED|Overall Study||15||
59533510|NCT01522339|75630677|FG000|COMPLETED|Overall Study||15||
59533511|NCT01522339|75630677|FG000|NOT COMPLETED|Overall Study||0||
59533512|NCT00566540|75630682|FG000|STARTED|Overall Study||11||
59533513|NCT00566540|75630682|FG000|COMPLETED|Overall Study||11||
59533514|NCT00566540|75630682|FG000|NOT COMPLETED|Overall Study||0||
59533515|NCT00566930|75630689|FG000|STARTED|Overall Study||29||
59533516|NCT00566930|75630690|FG001|STARTED|Overall Study||36||
59533517|NCT00566930|75630691|FG002|STARTED|Overall Study||33||
59533518|NCT00566930|75630689|FG000|COMPLETED|Overall Study||27||
59533519|NCT00566930|75630690|FG001|COMPLETED|Overall Study||32||
59533520|NCT00566930|75630691|FG002|COMPLETED|Overall Study||32||
59533521|NCT00566930|75630689|FG000|NOT COMPLETED|Overall Study||2||
59533522|NCT00566930|75630690|FG001|NOT COMPLETED|Overall Study||4||
59533523|NCT00566930|75630691|FG002|NOT COMPLETED|Overall Study||1||
59533524|NCT00567008|75630701|FG000|STARTED|Overall Study||18||
59533525|NCT00567008|75630702|FG001|STARTED|Overall Study||19||
59533526|NCT00567008|75630701|FG000|COMPLETED|Overall Study||17||
59533527|NCT00567008|75630702|FG001|COMPLETED|Overall Study||18||
59533528|NCT00567008|75630701|FG000|NOT COMPLETED|Overall Study||1||
59533529|NCT00567008|75630702|FG001|NOT COMPLETED|Overall Study||1||
59533530|NCT00567242|75630710|FG000|STARTED|Overall Study||7||
59533531|NCT00567242|75630711|FG001|STARTED|Overall Study||7||
59533532|NCT00567242|75630710|FG000|COMPLETED|Overall Study||7||
59533533|NCT00567242|75630711|FG001|COMPLETED|Overall Study||7||
59533534|NCT00567242|75630710|FG000|NOT COMPLETED|Overall Study||0||
59533535|NCT00567242|75630711|FG001|NOT COMPLETED|Overall Study||0||
59533536|NCT00567320|75630719|FG000|STARTED|Overall Study||13||
59533537|NCT00567320|75630720|FG001|STARTED|Overall Study||18||
59533538|NCT00567320|75630719|FG000|COMPLETED|Overall Study||13||
59533539|NCT00567320|75630720|FG001|COMPLETED|Overall Study||18||
59533540|NCT00567320|75630719|FG000|NOT COMPLETED|Overall Study||0||
59533541|NCT00567320|75630720|FG001|NOT COMPLETED|Overall Study||0||
59533542|NCT01522417|75630729|FG000|STARTED|Overall Study||209||
59533543|NCT01522417|75630730|FG001|STARTED|Overall Study||202||
59533544|NCT01522417|75630731|FG002|STARTED|Overall Study|Randomization into the long tirofiban arm was initiated on 14 June 2013.|124||
59533545|NCT01522417|75630729|FG000|COMPLETED|Overall Study||209||
59533546|NCT01522417|75630730|FG001|COMPLETED|Overall Study||202||
59533547|NCT01522417|75630731|FG002|COMPLETED|Overall Study|Randomization into the long tirofiban arm was completed on 1 February 2018.|124||
59533548|NCT01522417|75630729|FG000|NOT COMPLETED|Overall Study||0||
59533549|NCT01522417|75630730|FG001|NOT COMPLETED|Overall Study||0||
59533550|NCT01522417|75630731|FG002|NOT COMPLETED|Overall Study||0||
59533551|NCT00568022|75630742|FG000|STARTED|Overall Study||3||
59533552|NCT00568022|75630743|FG001|STARTED|Overall Study||3||
59533553|NCT00568022|75630744|FG002|STARTED|Overall Study||3||
59533554|NCT00568022|75630742|FG000|COMPLETED|Overall Study||3||
59533555|NCT00568022|75630743|FG001|COMPLETED|Overall Study||3||
59533556|NCT00568022|75630744|FG002|COMPLETED|Overall Study||3||
59533557|NCT00568022|75630742|FG000|NOT COMPLETED|Overall Study||0||
59533558|NCT00568022|75630743|FG001|NOT COMPLETED|Overall Study||0||
59533559|NCT00568022|75630744|FG002|NOT COMPLETED|Overall Study||0||
59533560|NCT01522963|75630757|FG000|STARTED|Overall Study||24||
59533561|NCT01522963|75630758|FG001|STARTED|Overall Study||25||
59533562|NCT01522963|75630759|FG002|STARTED|Overall Study||25||
59533563|NCT01522963|75630760|FG003|STARTED|Overall Study||24||
59533564|NCT01522963|75630757|FG000|COMPLETED|Overall Study||22||
59533565|NCT01522963|75630758|FG001|COMPLETED|Overall Study||22||
59533566|NCT01522963|75630759|FG002|COMPLETED|Overall Study||22||
60075658|NCT01929109|76190968|FG004|NOT COMPLETED|Period 1 (All Groups)||0||
59533567|NCT01522963|75630760|FG003|COMPLETED|Overall Study||18||
59533568|NCT01522963|75630757|FG000|NOT COMPLETED|Overall Study||2||
59533569|NCT01522963|75630758|FG001|NOT COMPLETED|Overall Study||3||
59533570|NCT01522963|75630759|FG002|NOT COMPLETED|Overall Study||3||
59533571|NCT01522963|75630760|FG003|NOT COMPLETED|Overall Study||6||
59533572|NCT02129426|75630770|FG000|STARTED|Overall Study||7||
59533573|NCT02129426|75630771|FG001|STARTED|Overall Study||13||
59533574|NCT02129426|75630770|FG000|COMPLETED|Overall Study||0||
59533575|NCT02129426|75630771|FG001|COMPLETED|Overall Study||0||
59533576|NCT02129426|75630770|FG000|NOT COMPLETED|Overall Study||7||
59533577|NCT02129426|75630771|FG001|NOT COMPLETED|Overall Study||13||
59533578|NCT01523821|75630780|FG000|STARTED|Overall Study||8||
59533579|NCT01523821|75630781|FG001|STARTED|Overall Study||6||
59533580|NCT01523821|75630782|FG002|STARTED|Overall Study||6||
59533581|NCT01523821|75630780|FG000|COMPLETED|Overall Study||8||
59533582|NCT01523821|75630781|FG001|COMPLETED|Overall Study||6||
59533583|NCT01523821|75630782|FG002|COMPLETED|Overall Study||6||
59533584|NCT01523821|75630780|FG000|NOT COMPLETED|Overall Study||0||
59533585|NCT01523821|75630781|FG001|NOT COMPLETED|Overall Study||0||
59533586|NCT01523821|75630782|FG002|NOT COMPLETED|Overall Study||0||
59533587|NCT01523899|75630792|FG000|STARTED|Overall Study||126||
59533588|NCT01523899|75630793|FG001|STARTED|Overall Study||126||
59533589|NCT01523899|75630792|FG000|COMPLETED|Overall Study||126||
59533590|NCT01523899|75630793|FG001|COMPLETED|Overall Study||126||
59533591|NCT01523899|75630792|FG000|NOT COMPLETED|Overall Study||0||
59533592|NCT01523899|75630793|FG001|NOT COMPLETED|Overall Study||0||
59533593|NCT01565551|75630802|FG000|STARTED|Overall Study||586||
59533594|NCT01565551|75630803|FG001|STARTED|Overall Study||51||
59533595|NCT01565551|75630802|FG000|Clinical/Demographics|Overall Study||586||
59533596|NCT01565551|75630803|FG001|Clinical/Demographics|Overall Study||51||
59533597|NCT01565551|75630802|FG000|Biospecimens/Biomarkers|Overall Study||479||
59533598|NCT01565551|75630803|FG001|Biospecimens/Biomarkers|Overall Study||22||
59533599|NCT01565551|75630802|FG000|Neuroimaging|Overall Study||233||
59533600|NCT01565551|75630803|FG001|Neuroimaging|Overall Study||25||
59533601|NCT01565551|75630802|FG000|6-Month Outcomes|Overall Study||412||
59533602|NCT01565551|75630803|FG001|6-Month Outcomes|Overall Study||30||
59533603|NCT01565551|75630802|FG000|COMPLETED|Overall Study||586||
59533604|NCT01565551|75630803|FG001|COMPLETED|Overall Study||51||
59533605|NCT01565551|75630802|FG000|NOT COMPLETED|Overall Study||0||
59533606|NCT01565551|75630803|FG001|NOT COMPLETED|Overall Study||0||
59533607|NCT01566331|75630811|FG000|STARTED|Overall Study||40||
59533608|NCT01566331|75630812|FG001|STARTED|Overall Study||40||
59533609|NCT01566331|75630811|FG000|COMPLETED|Overall Study||40||
59533610|NCT01566331|75630812|FG001|COMPLETED|Overall Study||40||
59533611|NCT01566331|75630811|FG000|NOT COMPLETED|Overall Study||0||
59533612|NCT01566331|75630812|FG001|NOT COMPLETED|Overall Study||0||
59533613|NCT01566409|75630820|FG000|STARTED|Overall Study||49||
59533614|NCT01566409|75630821|FG001|STARTED|Overall Study||53||
59533615|NCT01566409|75630820|FG000|COMPLETED|Overall Study||47||
59533616|NCT01566409|75630821|FG001|COMPLETED|Overall Study||48||
59533617|NCT01566409|75630820|FG000|NOT COMPLETED|Overall Study||2||
59533618|NCT01566409|75630821|FG001|NOT COMPLETED|Overall Study||5||
59533619|NCT01567891|75630827|FG000|STARTED|Overall Study||9||
59533620|NCT01567891|75630827|FG000|Received T-cell|Overall Study||6||
59533621|NCT01567891|75630827|FG000|COMPLETED|Overall Study||6||
59533622|NCT01567891|75630827|FG000|NOT COMPLETED|Overall Study||3||
59533623|NCT01568827|75630842|FG000|STARTED|First Intervention (6 Days)||5||
59533624|NCT01568827|75630843|FG001|STARTED|First Intervention (6 Days)||5||
59533625|NCT01568827|75630842|FG000|COMPLETED|First Intervention (6 Days)||5||
59533626|NCT01568827|75630843|FG001|COMPLETED|First Intervention (6 Days)||5||
59533627|NCT01568827|75630842|FG000|NOT COMPLETED|First Intervention (6 Days)||0||
59533628|NCT01568827|75630843|FG001|NOT COMPLETED|First Intervention (6 Days)||0||
59533629|NCT01568827|75630842|FG000|STARTED|Washout (2 Days)||5||
59533630|NCT01568827|75630843|FG001|STARTED|Washout (2 Days)||5||
59533631|NCT01568827|75630842|FG000|COMPLETED|Washout (2 Days)||5||
59533632|NCT01568827|75630843|FG001|COMPLETED|Washout (2 Days)||5||
59533633|NCT01568827|75630842|FG000|NOT COMPLETED|Washout (2 Days)||0||
59533634|NCT01568827|75630843|FG001|NOT COMPLETED|Washout (2 Days)||0||
59533635|NCT01568827|75630842|FG000|STARTED|Intervention 2 (5 Days)||5||
59533636|NCT01568827|75630843|FG001|STARTED|Intervention 2 (5 Days)||5||
59533637|NCT01568827|75630842|FG000|COMPLETED|Intervention 2 (5 Days)||5||
59533638|NCT01568827|75630843|FG001|COMPLETED|Intervention 2 (5 Days)||5||
59533639|NCT01568827|75630842|FG000|NOT COMPLETED|Intervention 2 (5 Days)||0||
59533640|NCT01568827|75630843|FG001|NOT COMPLETED|Intervention 2 (5 Days)||0||
59533641|NCT01568905|75630852|FG000|STARTED|Overall Study||13||
59533642|NCT01568905|75630853|FG001|STARTED|Overall Study||11||
59533643|NCT01568905|75630854|FG002|STARTED|Overall Study||12||
59533644|NCT01568905|75630852|FG000|COMPLETED|Overall Study||12||
59533645|NCT01568905|75630853|FG001|COMPLETED|Overall Study||11||
59533646|NCT01568905|75630854|FG002|COMPLETED|Overall Study||12||
59533647|NCT01568905|75630852|FG000|NOT COMPLETED|Overall Study||1||
59533648|NCT01568905|75630853|FG001|NOT COMPLETED|Overall Study||0||
59533649|NCT01568905|75630854|FG002|NOT COMPLETED|Overall Study||0||
59533650|NCT01569451|75630864|FG000|STARTED|Overall Study||26||
59533651|NCT01569451|75630865|FG001|STARTED|Overall Study||27||
59533652|NCT01569451|75630864|FG000|COMPLETED|Overall Study||12|Represents patients who completed the entire protocol. The analysis of key outcomes included 53|
59533653|NCT01569451|75630865|FG001|COMPLETED|Overall Study||14|Represents patients who completed the entire protocol. The analysis of key outcomes included 53|
59533654|NCT01569451|75630864|FG000|NOT COMPLETED|Overall Study||14||
59533655|NCT01569451|75630865|FG001|NOT COMPLETED|Overall Study||13||
59533656|NCT01569529|75630875|FG000|STARTED|Overall Study||2676||
59533657|NCT01569529|75630876|FG001|STARTED|Overall Study||394||
59533658|NCT01569529|75630875|FG000|COMPLETED|Overall Study||2676||
59533659|NCT01569529|75630876|FG001|COMPLETED|Overall Study||394||
59533660|NCT01569529|75630875|FG000|NOT COMPLETED|Overall Study||0||
59533661|NCT01569529|75630876|FG001|NOT COMPLETED|Overall Study||0||
59533662|NCT01569607|75630884|FG000|STARTED|Overall Study||11||
59533663|NCT01569607|75630885|FG001|STARTED|Overall Study||11||
59533664|NCT01569607|75630884|FG000|COMPLETED|Overall Study||10||
59533665|NCT01569607|75630885|FG001|COMPLETED|Overall Study||10||
59533666|NCT01569607|75630884|FG000|NOT COMPLETED|Overall Study||1||
59533667|NCT01569607|75630885|FG001|NOT COMPLETED|Overall Study||1||
59533668|NCT01526629|75630891|FG000|STARTED|Overall Study||354||
59533669|NCT01526629|75630891|FG000|COMPLETED|Overall Study||308||
59533670|NCT01526629|75630891|FG000|NOT COMPLETED|Overall Study||46||
59533671|NCT02132936|75630899|FG000|STARTED|Overall Study||185||
59533672|NCT02132936|75630900|FG001|STARTED|Overall Study||47||
59533673|NCT02132936|75630901|FG002|STARTED|Overall Study||188||
59533674|NCT02132936|75630902|FG003|STARTED|Overall Study||43||
59533675|NCT02132936|75630899|FG000|COMPLETED|Overall Study||175||
59533676|NCT02132936|75630900|FG001|COMPLETED|Overall Study||38||
59533677|NCT02132936|75630901|FG002|COMPLETED|Overall Study||174||
59533678|NCT02132936|75630902|FG003|COMPLETED|Overall Study||29||
59533679|NCT02132936|75630899|FG000|NOT COMPLETED|Overall Study||10||
59533680|NCT02132936|75630900|FG001|NOT COMPLETED|Overall Study||9||
59533681|NCT02132936|75630901|FG002|NOT COMPLETED|Overall Study||14||
59533682|NCT02132936|75630902|FG003|NOT COMPLETED|Overall Study||14||
59533683|NCT01528891|75630915|FG000|STARTED|Overall Study||200||
59533684|NCT01528891|75630916|FG001|STARTED|Overall Study||200||
59533685|NCT01528891|75630915|FG000|COMPLETED|Overall Study||200||
59533686|NCT01528891|75630916|FG001|COMPLETED|Overall Study||200||
59533687|NCT01528891|75630915|FG000|NOT COMPLETED|Overall Study||0||
59533688|NCT01528891|75630916|FG001|NOT COMPLETED|Overall Study||0||
59533689|NCT01529203|75630924|FG000|STARTED|Overall Study||60||
59533690|NCT01529203|75630924|FG000|COMPLETED|Overall Study||57||
59533691|NCT01529203|75630924|FG000|NOT COMPLETED|Overall Study||3||
59533692|NCT01529827|75630928|FG000|STARTED|Overall Study||94||
59533693|NCT01529827|75630928|FG000|COMPLETED|Overall Study||94||
59533694|NCT01529827|75630928|FG000|NOT COMPLETED|Overall Study||0||
59533695|NCT00569192|75630935|FG000|STARTED|Overall Study||111||
59533696|NCT00569192|75630936|FG001|STARTED|Overall Study||125||
59533697|NCT00569192|75630937|FG002|STARTED|Overall Study||124||
59533698|NCT00569192|75630935|FG000|COMPLETED|Overall Study||88||
59533699|NCT00569192|75630936|FG001|COMPLETED|Overall Study||105||
59533700|NCT00569192|75630937|FG002|COMPLETED|Overall Study||99||
59533701|NCT00569192|75630935|FG000|NOT COMPLETED|Overall Study||23||
59533702|NCT00569192|75630936|FG001|NOT COMPLETED|Overall Study||20||
59533703|NCT00569192|75630937|FG002|NOT COMPLETED|Overall Study||25||
59533704|NCT01571557|75630945|FG000|STARTED|Overall Study||573||
59533705|NCT01571557|75630945|FG000|COMPLETED|Overall Study||573||
59533706|NCT01571557|75630945|FG000|NOT COMPLETED|Overall Study||0||
59533707|NCT00569660|75630949|FG000|STARTED|Overall Study||34||
59533708|NCT00569660|75630949|FG000|COMPLETED|Overall Study||34||
59533709|NCT00569660|75630949|FG000|NOT COMPLETED|Overall Study||0||
59533710|NCT00570362|75630955|FG000|STARTED|Overall Study||19||
59533711|NCT00570362|75630956|FG001|STARTED|Overall Study||30||
59533712|NCT00570362|75630955|FG000|COMPLETED|Overall Study||19||
59533713|NCT00570362|75630956|FG001|COMPLETED|Overall Study||30||
59533714|NCT00570362|75630955|FG000|NOT COMPLETED|Overall Study||0||
59533715|NCT00570362|75630956|FG001|NOT COMPLETED|Overall Study||0||
59533716|NCT01573273|75630966|FG000|STARTED|TSST : Trier Social Stress Task||24||
59533717|NCT01573273|75630967|FG001|STARTED|TSST : Trier Social Stress Task||25||
59533718|NCT01573273|75630968|FG002|STARTED|TSST : Trier Social Stress Task||0||
59533719|NCT01573273|75630969|FG003|STARTED|TSST : Trier Social Stress Task||0||
59533720|NCT01573273|75630970|FG004|STARTED|TSST : Trier Social Stress Task||0||
59533721|NCT01573273|75630971|FG005|STARTED|TSST : Trier Social Stress Task||0||
59533722|NCT01573273|75630972|FG006|STARTED|TSST : Trier Social Stress Task||32||
59533723|NCT01573273|75630973|FG007|STARTED|TSST : Trier Social Stress Task||31||
59533724|NCT01573273|75630974|FG008|STARTED|TSST : Trier Social Stress Task||0||
59533725|NCT01573273|75630975|FG009|STARTED|TSST : Trier Social Stress Task||0||
59533726|NCT01573273|75630976|FG010|STARTED|TSST : Trier Social Stress Task||0||
59533727|NCT01573273|75630977|FG011|STARTED|TSST : Trier Social Stress Task||0||
59533728|NCT01573273|75630966|FG000|COMPLETED|TSST : Trier Social Stress Task||24||
59533729|NCT01573273|75630967|FG001|COMPLETED|TSST : Trier Social Stress Task||25||
59533730|NCT01573273|75630968|FG002|COMPLETED|TSST : Trier Social Stress Task||0||
59533731|NCT01573273|75630969|FG003|COMPLETED|TSST : Trier Social Stress Task||0||
59533732|NCT01573273|75630970|FG004|COMPLETED|TSST : Trier Social Stress Task||0||
59533733|NCT01573273|75630971|FG005|COMPLETED|TSST : Trier Social Stress Task||0||
59533734|NCT01573273|75630972|FG006|COMPLETED|TSST : Trier Social Stress Task||32||
59533735|NCT01573273|75630973|FG007|COMPLETED|TSST : Trier Social Stress Task||31||
59533736|NCT01573273|75630974|FG008|COMPLETED|TSST : Trier Social Stress Task||0||
59533737|NCT01573273|75630975|FG009|COMPLETED|TSST : Trier Social Stress Task||0||
59533738|NCT01573273|75630976|FG010|COMPLETED|TSST : Trier Social Stress Task||0||
59533739|NCT01573273|75630977|FG011|COMPLETED|TSST : Trier Social Stress Task||0||
59533740|NCT01573273|75630966|FG000|NOT COMPLETED|TSST : Trier Social Stress Task||0||
59533741|NCT01573273|75630967|FG001|NOT COMPLETED|TSST : Trier Social Stress Task||0||
59533742|NCT01573273|75630968|FG002|NOT COMPLETED|TSST : Trier Social Stress Task||0||
59533743|NCT01573273|75630969|FG003|NOT COMPLETED|TSST : Trier Social Stress Task||0||
59533744|NCT01573273|75630970|FG004|NOT COMPLETED|TSST : Trier Social Stress Task||0||
59533745|NCT01573273|75630971|FG005|NOT COMPLETED|TSST : Trier Social Stress Task||0||
59533746|NCT01573273|75630972|FG006|NOT COMPLETED|TSST : Trier Social Stress Task||0||
59533747|NCT01573273|75630973|FG007|NOT COMPLETED|TSST : Trier Social Stress Task||0||
59533748|NCT01573273|75630974|FG008|NOT COMPLETED|TSST : Trier Social Stress Task||0||
59533749|NCT01573273|75630975|FG009|NOT COMPLETED|TSST : Trier Social Stress Task||0||
59533750|NCT01573273|75630976|FG010|NOT COMPLETED|TSST : Trier Social Stress Task||0||
59533751|NCT01573273|75630977|FG011|NOT COMPLETED|TSST : Trier Social Stress Task||0||
59533752|NCT01573273|75630966|FG000|STARTED|MRI 1||0||
59533753|NCT01573273|75630967|FG001|STARTED|MRI 1||0||
59533754|NCT01573273|75630968|FG002|STARTED|MRI 1||19||
59815333|NCT03810456|75937762|FG001|COMPLETED|6 Month Follow-Up||46||
59533755|NCT01573273|75630969|FG003|STARTED|MRI 1||23||
59533756|NCT01573273|75630970|FG004|STARTED|MRI 1||0||
59533757|NCT01573273|75630971|FG005|STARTED|MRI 1||0||
59533758|NCT01573273|75630972|FG006|STARTED|MRI 1||0||
59533759|NCT01573273|75630973|FG007|STARTED|MRI 1||0||
59533760|NCT01573273|75630974|FG008|STARTED|MRI 1||28||
59533761|NCT01573273|75630975|FG009|STARTED|MRI 1||29||
59533762|NCT01573273|75630976|FG010|STARTED|MRI 1||0||
59815334|NCT03810456|75937763|FG002|COMPLETED|6 Month Follow-Up||49||
59533763|NCT01573273|75630977|FG011|STARTED|MRI 1||0||
59533764|NCT01573273|75630966|FG000|COMPLETED|MRI 1||0||
59533765|NCT01573273|75630967|FG001|COMPLETED|MRI 1||0||
59533766|NCT01573273|75630968|FG002|COMPLETED|MRI 1||19||
60075659|NCT01929109|76190964|FG000|STARTED|Period 2 (End Stage Renal Disease Only)||0||
60075660|NCT01929109|76190965|FG001|STARTED|Period 2 (End Stage Renal Disease Only)||0||
60075661|NCT01929109|76190966|FG002|STARTED|Period 2 (End Stage Renal Disease Only)||0||
59533767|NCT01573273|75630969|FG003|COMPLETED|MRI 1||23||
59533768|NCT01573273|75630970|FG004|COMPLETED|MRI 1||0||
59533769|NCT01573273|75630971|FG005|COMPLETED|MRI 1||0||
59533770|NCT01573273|75630972|FG006|COMPLETED|MRI 1||0||
59533771|NCT01573273|75630973|FG007|COMPLETED|MRI 1||0||
59533772|NCT01573273|75630974|FG008|COMPLETED|MRI 1||28||
59533773|NCT01573273|75630975|FG009|COMPLETED|MRI 1||29||
59533774|NCT01573273|75630976|FG010|COMPLETED|MRI 1||0||
59533775|NCT01573273|75630977|FG011|COMPLETED|MRI 1||0||
59533776|NCT01573273|75630966|FG000|NOT COMPLETED|MRI 1||0||
59533777|NCT01573273|75630967|FG001|NOT COMPLETED|MRI 1||0||
59533778|NCT01573273|75630968|FG002|NOT COMPLETED|MRI 1||0||
59533779|NCT01573273|75630969|FG003|NOT COMPLETED|MRI 1||0||
59533780|NCT01573273|75630970|FG004|NOT COMPLETED|MRI 1||0||
59533781|NCT01573273|75630971|FG005|NOT COMPLETED|MRI 1||0||
59533782|NCT01573273|75630972|FG006|NOT COMPLETED|MRI 1||0||
59533783|NCT01573273|75630973|FG007|NOT COMPLETED|MRI 1||0||
59533784|NCT01573273|75630974|FG008|NOT COMPLETED|MRI 1||0||
59533785|NCT01573273|75630975|FG009|NOT COMPLETED|MRI 1||0||
59533786|NCT01573273|75630976|FG010|NOT COMPLETED|MRI 1||0||
59533787|NCT01573273|75630977|FG011|NOT COMPLETED|MRI 1||0||
59533788|NCT01573273|75630966|FG000|STARTED|MRI 2||0||
59533789|NCT01573273|75630967|FG001|STARTED|MRI 2||0||
59533790|NCT01573273|75630968|FG002|STARTED|MRI 2||0||
59533791|NCT01573273|75630969|FG003|STARTED|MRI 2||0||
59533792|NCT01573273|75630970|FG004|STARTED|MRI 2||23||
59533793|NCT01573273|75630971|FG005|STARTED|MRI 2||18||
59533794|NCT01573273|75630972|FG006|STARTED|MRI 2||0||
59533795|NCT01573273|75630973|FG007|STARTED|MRI 2||0||
59533796|NCT01573273|75630974|FG008|STARTED|MRI 2||0||
59533797|NCT01573273|75630975|FG009|STARTED|MRI 2||0||
59533798|NCT01573273|75630976|FG010|STARTED|MRI 2||27||
59533799|NCT01573273|75630977|FG011|STARTED|MRI 2||28||
59533800|NCT01573273|75630966|FG000|COMPLETED|MRI 2||0||
59533801|NCT01573273|75630967|FG001|COMPLETED|MRI 2||0||
59533802|NCT01573273|75630968|FG002|COMPLETED|MRI 2||0||
59533803|NCT01573273|75630969|FG003|COMPLETED|MRI 2||0||
59622735|NCT00439608|75734630|FG000|NOT COMPLETED|Overall Study||0||
59533804|NCT01573273|75630970|FG004|COMPLETED|MRI 2||23||
59533805|NCT01573273|75630971|FG005|COMPLETED|MRI 2||18||
59533806|NCT01573273|75630972|FG006|COMPLETED|MRI 2||0||
59533807|NCT01573273|75630973|FG007|COMPLETED|MRI 2||0||
59533808|NCT01573273|75630974|FG008|COMPLETED|MRI 2||0||
59533809|NCT01573273|75630975|FG009|COMPLETED|MRI 2||0||
59533810|NCT01573273|75630976|FG010|COMPLETED|MRI 2||27||
59533811|NCT01573273|75630977|FG011|COMPLETED|MRI 2||28||
59533812|NCT01573273|75630966|FG000|NOT COMPLETED|MRI 2||0||
59533813|NCT01573273|75630967|FG001|NOT COMPLETED|MRI 2||0||
59533814|NCT01573273|75630968|FG002|NOT COMPLETED|MRI 2||0||
59533815|NCT01573273|75630969|FG003|NOT COMPLETED|MRI 2||0||
59533816|NCT01573273|75630970|FG004|NOT COMPLETED|MRI 2||0||
59533817|NCT01573273|75630971|FG005|NOT COMPLETED|MRI 2||0||
59622736|NCT00500448|75734636|FG000|STARTED|Overall Study||14||
59622737|NCT00500448|75734637|FG001|STARTED|Overall Study||16||
59622738|NCT00500448|75734636|FG000|COMPLETED|Overall Study||14||
59815335|NCT03810456|75937761|FG000|NOT COMPLETED|6 Month Follow-Up||13||
59622739|NCT00500448|75734637|FG001|COMPLETED|Overall Study||16||
59533818|NCT01573273|75630972|FG006|NOT COMPLETED|MRI 2||0||
59533819|NCT01573273|75630973|FG007|NOT COMPLETED|MRI 2||0||
59533820|NCT01573273|75630974|FG008|NOT COMPLETED|MRI 2||0||
59533821|NCT01573273|75630975|FG009|NOT COMPLETED|MRI 2||0||
59533822|NCT01573273|75630976|FG010|NOT COMPLETED|MRI 2||0||
59533823|NCT01573273|75630977|FG011|NOT COMPLETED|MRI 2||0||
59533824|NCT01574287|75631003|FG000|STARTED|Overall Study||4||
59533825|NCT01574287|75631003|FG000|COMPLETED|Overall Study||4||
59533826|NCT01574287|75631003|FG000|NOT COMPLETED|Overall Study||0||
59533827|NCT00572468|75631009|FG000|STARTED|Overall Study||22||
59533828|NCT00572468|75631010|FG001|STARTED|Overall Study||20||
59533829|NCT00572468|75631009|FG000|COMPLETED|Overall Study||20||
59533830|NCT00572468|75631010|FG001|COMPLETED|Overall Study||16||
59533831|NCT00572468|75631009|FG000|NOT COMPLETED|Overall Study||2||
59533832|NCT00572468|75631010|FG001|NOT COMPLETED|Overall Study||4||
59533833|NCT02339246|75631018|FG000|STARTED|First Intervention (7 Days)||0||
59533834|NCT02339246|75631019|FG001|STARTED|First Intervention (7 Days)||0||
59533835|NCT02339246|75631020|FG002|STARTED|First Intervention (7 Days)||31||
59533836|NCT02339246|75631018|FG000|COMPLETED|First Intervention (7 Days)||0||
59533837|NCT02339246|75631019|FG001|COMPLETED|First Intervention (7 Days)||0||
59533838|NCT02339246|75631020|FG002|COMPLETED|First Intervention (7 Days)||31||
59533839|NCT02339246|75631018|FG000|NOT COMPLETED|First Intervention (7 Days)||0||
59533840|NCT02339246|75631019|FG001|NOT COMPLETED|First Intervention (7 Days)||0||
59533841|NCT02339246|75631020|FG002|NOT COMPLETED|First Intervention (7 Days)||0||
59533842|NCT02339246|75631018|FG000|STARTED|Second Intervention (7 Days)||16||
59533843|NCT02339246|75631019|FG001|STARTED|Second Intervention (7 Days)||15||
59533844|NCT02339246|75631020|FG002|STARTED|Second Intervention (7 Days)||0||
59533845|NCT02339246|75631018|FG000|COMPLETED|Second Intervention (7 Days)||16||
59533846|NCT02339246|75631019|FG001|COMPLETED|Second Intervention (7 Days)||15||
59533847|NCT02339246|75631020|FG002|COMPLETED|Second Intervention (7 Days)||0||
59533848|NCT02339246|75631018|FG000|NOT COMPLETED|Second Intervention (7 Days)||0||
59533849|NCT02339246|75631019|FG001|NOT COMPLETED|Second Intervention (7 Days)||0||
59533850|NCT02339246|75631020|FG002|NOT COMPLETED|Second Intervention (7 Days)||0||
59533851|NCT02339246|75631018|FG000|STARTED|Third Period (7 Days)||15||
59533852|NCT02339246|75631019|FG001|STARTED|Third Period (7 Days)||16||
59533853|NCT02339246|75631020|FG002|STARTED|Third Period (7 Days)||0||
59533854|NCT02339246|75631018|FG000|COMPLETED|Third Period (7 Days)||15||
59533855|NCT02339246|75631019|FG001|COMPLETED|Third Period (7 Days)||16||
59533856|NCT02339246|75631020|FG002|COMPLETED|Third Period (7 Days)||0||
59533857|NCT02339246|75631018|FG000|NOT COMPLETED|Third Period (7 Days)||0||
59533858|NCT02339246|75631019|FG001|NOT COMPLETED|Third Period (7 Days)||0||
59533859|NCT02339246|75631020|FG002|NOT COMPLETED|Third Period (7 Days)||0||
59533860|NCT00573872|75631028|FG000|STARTED|Overall Study|# of patients that signed consent|43||
59533861|NCT00573872|75631028|FG000|COMPLETED|Overall Study|# of patients that completed treatment|32||
59533862|NCT00573872|75631028|FG000|NOT COMPLETED|Overall Study||11||
59533863|NCT00574340|75631032|FG000|STARTED|Study 1 (2 Days)||10||
59533864|NCT00574340|75631033|FG001|STARTED|Study 1 (2 Days)||10||
59533865|NCT00574340|75631032|FG000|COMPLETED|Study 1 (2 Days)||10||
59533866|NCT00574340|75631033|FG001|COMPLETED|Study 1 (2 Days)||10||
59533867|NCT00574340|75631032|FG000|NOT COMPLETED|Study 1 (2 Days)||0||
59533868|NCT00574340|75631033|FG001|NOT COMPLETED|Study 1 (2 Days)||0||
59533869|NCT00574340|75631032|FG000|STARTED|Study 2 (2 Days)||6||
59533870|NCT00574340|75631033|FG001|STARTED|Study 2 (2 Days)||6||
59533871|NCT00574340|75631032|FG000|COMPLETED|Study 2 (2 Days)||6||
59533872|NCT00574340|75631033|FG001|COMPLETED|Study 2 (2 Days)||6||
59533873|NCT00574340|75631032|FG000|NOT COMPLETED|Study 2 (2 Days)||0||
59533874|NCT00574340|75631033|FG001|NOT COMPLETED|Study 2 (2 Days)||0||
59533875|NCT00576680|75631039|FG000|STARTED|Overall Study||43||
59533876|NCT00576680|75631039|FG000|COMPLETED|Overall Study||43||
59533877|NCT00576680|75631039|FG000|NOT COMPLETED|Overall Study||0||
59622740|NCT00500448|75734636|FG000|NOT COMPLETED|Overall Study||0||
59622741|NCT00500448|75734637|FG001|NOT COMPLETED|Overall Study||0||
59622742|NCT00441558|75734643|FG000|STARTED|Overall Study||1723||
59533878|NCT00578552|75631046|FG000|STARTED|Overall Study||27||
59533879|NCT00578552|75631047|FG001|STARTED|Overall Study||27||
59533880|NCT00578552|75631048|FG002|STARTED|Overall Study||26||
59533881|NCT00578552|75631046|FG000|COMPLETED|Overall Study||12||
59533882|NCT00578552|75631047|FG001|COMPLETED|Overall Study||13||
59533883|NCT00578552|75631048|FG002|COMPLETED|Overall Study||11||
59533884|NCT00578552|75631046|FG000|NOT COMPLETED|Overall Study||15||
59533885|NCT00578552|75631047|FG001|NOT COMPLETED|Overall Study||14||
59533886|NCT00578552|75631048|FG002|NOT COMPLETED|Overall Study||15||
59533887|NCT01532089|75631058|FG000|STARTED|Overall Study||45|Randomized|
59533888|NCT01532089|75631059|FG001|STARTED|Overall Study||43|Randomized|
59622743|NCT00441558|75734643|FG000|COMPLETED|Overall Study||667||
59533889|NCT01532089|75631058|FG000|COMPLETED|Overall Study||45||
59533890|NCT01532089|75631059|FG001|COMPLETED|Overall Study||43||
59533891|NCT01532089|75631058|FG000|NOT COMPLETED|Overall Study||0||
59533892|NCT01532089|75631059|FG001|NOT COMPLETED|Overall Study||0||
59533893|NCT01533259|75631067|FG000|STARTED|Overall Study||48||
59533894|NCT01533259|75631067|FG000|COMPLETED|Overall Study||48||
59533895|NCT01533259|75631067|FG000|NOT COMPLETED|Overall Study||0||
59533896|NCT02135432|75631073|FG000|STARTED|Overall Study||8||
59533897|NCT02135432|75631074|FG001|STARTED|Overall Study||4||
59533898|NCT02135432|75631073|FG000|COMPLETED|Overall Study||8||
59533899|NCT02135432|75631074|FG001|COMPLETED|Overall Study||4||
59533900|NCT02135432|75631073|FG000|NOT COMPLETED|Overall Study||0||
59533901|NCT02135432|75631074|FG001|NOT COMPLETED|Overall Study||0||
59533902|NCT01576003|75631084|FG000|STARTED|Overall Study||2||
59622744|NCT00441558|75734643|FG000|NOT COMPLETED|Overall Study||1056||
59622745|NCT00443352|75734647|FG000|STARTED|Overall Study||27||
59622746|NCT00443352|75734647|FG000|COMPLETED|Overall Study||22||
59533903|NCT01576003|75631085|FG001|STARTED|Overall Study||3||
59533904|NCT01576003|75631086|FG002|STARTED|Overall Study||4||
59533905|NCT01576003|75631084|FG000|COMPLETED|Overall Study||1||
59533906|NCT01576003|75631085|FG001|COMPLETED|Overall Study||1||
59533907|NCT01576003|75631086|FG002|COMPLETED|Overall Study||4||
59533908|NCT01576003|75631084|FG000|NOT COMPLETED|Overall Study||1||
59533909|NCT01576003|75631085|FG001|NOT COMPLETED|Overall Study||2||
59533910|NCT01576003|75631086|FG002|NOT COMPLETED|Overall Study||0||
59533911|NCT01576471|75631096|FG000|STARTED|Overall Study||125||
59533912|NCT01576471|75631097|FG001|STARTED|Overall Study||125||
59533913|NCT01576471|75631096|FG000|COMPLETED|Overall Study||117||
59533914|NCT01576471|75631097|FG001|COMPLETED|Overall Study||116||
59533915|NCT01576471|75631096|FG000|NOT COMPLETED|Overall Study||8||
59533916|NCT01576471|75631097|FG001|NOT COMPLETED|Overall Study||9||
59533917|NCT00580502|75631103|FG000|STARTED|Overall Study||50||
59533918|NCT00580502|75631103|FG000|COMPLETED|Overall Study||50||
59533919|NCT00580502|75631103|FG000|NOT COMPLETED|Overall Study||0||
59533920|NCT01576939|75631107|FG000|STARTED|Overall Study||30||
59533921|NCT01576939|75631107|FG000|COMPLETED|Overall Study||30||
59533922|NCT01576939|75631107|FG000|NOT COMPLETED|Overall Study||0||
59533923|NCT00581048|75631111|FG000|STARTED|Overall Study||33||
59533924|NCT00581048|75631111|FG000|COMPLETED|Overall Study||33||
59533925|NCT00581048|75631111|FG000|NOT COMPLETED|Overall Study||0||
59533926|NCT01577329|75631118|FG000|STARTED|Overall Study||19||
59533927|NCT01577329|75631119|FG001|STARTED|Overall Study||22||
59533928|NCT01577329|75631118|FG000|COMPLETED|Overall Study||16||
59533929|NCT01577329|75631119|FG001|COMPLETED|Overall Study||22||
59533930|NCT01577329|75631118|FG000|NOT COMPLETED|Overall Study||3||
59533931|NCT01577329|75631119|FG001|NOT COMPLETED|Overall Study||0||
59533932|NCT01578031|75631129|FG000|STARTED|Overall Study||129||
59533933|NCT01578031|75631130|FG001|STARTED|Overall Study||69||
59533934|NCT01578031|75631131|FG002|STARTED|Overall Study||12||
59533935|NCT01578031|75631132|FG003|STARTED|Overall Study||30||
59533936|NCT01578031|75631129|FG000|COMPLETED|Overall Study|Follow-up obtained only in subjects with average PAP use at least 4 hr/day|67||
59533937|NCT01578031|75631130|FG001|COMPLETED|Overall Study|Follow-up obtained only in subjects with average PAP use at least 4 hr/day|35||
59533938|NCT01578031|75631131|FG002|COMPLETED|Overall Study|Only baseline data collected|12||
59533939|NCT01578031|75631132|FG003|COMPLETED|Overall Study|Only baseline data collected|30||
59533940|NCT01578031|75631129|FG000|NOT COMPLETED|Overall Study||62||
59533941|NCT01578031|75631130|FG001|NOT COMPLETED|Overall Study||34||
59533942|NCT01578031|75631131|FG002|NOT COMPLETED|Overall Study||0||
59533943|NCT01578031|75631132|FG003|NOT COMPLETED|Overall Study||0||
59533944|NCT01578577|75631143|FG000|STARTED|Overall Study||305||
59533945|NCT01578577|75631144|FG001|STARTED|Overall Study||302||
59533946|NCT01578577|75631145|FG002|STARTED|Overall Study||313||
59533947|NCT01578577|75631143|FG000|COMPLETED|Overall Study||254||
59533948|NCT01578577|75631144|FG001|COMPLETED|Overall Study||262||
59533949|NCT01578577|75631145|FG002|COMPLETED|Overall Study||278||
59533950|NCT01578577|75631143|FG000|NOT COMPLETED|Overall Study||51||
59533951|NCT01578577|75631144|FG001|NOT COMPLETED|Overall Study||40||
59533952|NCT01578577|75631145|FG002|NOT COMPLETED|Overall Study||35||
59533953|NCT01579045|75631163|FG000|STARTED|Overall Study||24||
59533954|NCT01579045|75631163|FG000|COMPLETED|Overall Study||24||
59533955|NCT01579045|75631163|FG000|NOT COMPLETED|Overall Study||0||
59533956|NCT00582998|75631177|FG000|STARTED|Overall Study||119||122
59533957|NCT00582998|75631178|FG001|STARTED|Overall Study||130||141
59533958|NCT00582998|75631177|FG000|COMPLETED|Overall Study||119||122
59533959|NCT00582998|75631178|FG001|COMPLETED|Overall Study||130||141
59533960|NCT00582998|75631177|FG000|NOT COMPLETED|Overall Study||0||0
59533961|NCT00582998|75631178|FG001|NOT COMPLETED|Overall Study||0||0
59533962|NCT01579513|75631186|FG000|STARTED|Primary Hospitalization||91||
59533963|NCT01579513|75631187|FG001|STARTED|Primary Hospitalization||99||
59533964|NCT01579513|75631186|FG000|COMPLETED|Primary Hospitalization||81||
59533965|NCT01579513|75631187|FG001|COMPLETED|Primary Hospitalization||95||
59622747|NCT00443352|75734647|FG000|NOT COMPLETED|Overall Study||5||
59533966|NCT01579513|75631186|FG000|NOT COMPLETED|Primary Hospitalization||10||
59533967|NCT01579513|75631187|FG001|NOT COMPLETED|Primary Hospitalization||4||
59533968|NCT01579513|75631186|FG000|STARTED|1 Year Neurodevelopmental Follow up||81||
59533969|NCT01579513|75631187|FG001|STARTED|1 Year Neurodevelopmental Follow up||95||
59533970|NCT01579513|75631186|FG000|COMPLETED|1 Year Neurodevelopmental Follow up||61||
59533971|NCT01579513|75631187|FG001|COMPLETED|1 Year Neurodevelopmental Follow up||68||
59533972|NCT01579513|75631186|FG000|NOT COMPLETED|1 Year Neurodevelopmental Follow up||20||
59533973|NCT01579513|75631187|FG001|NOT COMPLETED|1 Year Neurodevelopmental Follow up||27||
59533974|NCT01534897|75631193|FG000|STARTED|Overall Study||10||
59533975|NCT01534897|75631193|FG000|Day 25 Iodine-131 Scan|Overall Study||10||
59533976|NCT01534897|75631193|FG000|Day 37 Iodine-131 Treatment|Overall Study||6||
59533977|NCT01534897|75631193|FG000|COMPLETED|Overall Study||10||
59533978|NCT01534897|75631193|FG000|NOT COMPLETED|Overall Study||0||
59533979|NCT01534975|75631202|FG000|STARTED|Overall Study||136||
59533980|NCT01534975|75631203|FG001|STARTED|Overall Study||133||
59533981|NCT01534975|75631204|FG002|STARTED|Overall Study||160||
59622748|NCT00445302|75734655|FG000|STARTED|Overall Study||6||
59533982|NCT01534975|75631205|FG003|STARTED|Overall Study||84||
59533983|NCT01534975|75631202|FG000|COMPLETED|Overall Study||136||
59533984|NCT01534975|75631203|FG001|COMPLETED|Overall Study||133||
59533985|NCT01534975|75631204|FG002|COMPLETED|Overall Study||160||
59533986|NCT01534975|75631205|FG003|COMPLETED|Overall Study||84||
59533987|NCT01534975|75631202|FG000|NOT COMPLETED|Overall Study||0||
59533988|NCT01534975|75631203|FG001|NOT COMPLETED|Overall Study||0||
59533989|NCT01534975|75631204|FG002|NOT COMPLETED|Overall Study||0||
59533990|NCT01534975|75631205|FG003|NOT COMPLETED|Overall Study||0||
59533991|NCT00583622|75631215|FG000|STARTED|Overall Study||12||
59533992|NCT00583622|75631215|FG000|COMPLETED|Overall Study||12||
59533993|NCT00583622|75631215|FG000|NOT COMPLETED|Overall Study||0||
59533994|NCT01535365|75631221|FG000|STARTED|Overall Study||31||
59533995|NCT01535365|75631222|FG001|STARTED|Overall Study||29||
59533996|NCT01535365|75631221|FG000|COMPLETED|Overall Study||31||
59533997|NCT01535365|75631222|FG001|COMPLETED|Overall Study||29||
59533998|NCT01535365|75631221|FG000|NOT COMPLETED|Overall Study||0||
59533999|NCT01535365|75631222|FG001|NOT COMPLETED|Overall Study||0||
59534000|NCT00583700|75631232|FG000|STARTED|Overall Study||27||
59534001|NCT00583700|75631233|FG001|STARTED|Overall Study||27||
59534002|NCT00583700|75631232|FG000|COMPLETED|Overall Study||24||
59534003|NCT00583700|75631233|FG001|COMPLETED|Overall Study||23||
59534004|NCT00583700|75631232|FG000|NOT COMPLETED|Overall Study||3||
59534005|NCT00583700|75631233|FG001|NOT COMPLETED|Overall Study||4||
59534006|NCT00584402|75631239|FG000|STARTED|Overall Study||8||
59534007|NCT00584402|75631239|FG000|COMPLETED|Overall Study||8||
59534008|NCT00584402|75631239|FG000|NOT COMPLETED|Overall Study||0||
59534009|NCT01537315|75631245|FG000|STARTED|Overall Study||1||
59534010|NCT01537315|75631246|FG001|STARTED|Overall Study||7||
59534011|NCT01537315|75631245|FG000|COMPLETED|Overall Study||1||
59534012|NCT01537315|75631246|FG001|COMPLETED|Overall Study||7||
59534013|NCT01537315|75631245|FG000|NOT COMPLETED|Overall Study||0||
59534014|NCT01537315|75631246|FG001|NOT COMPLETED|Overall Study||0||
59534015|NCT01579669|75631254|FG000|STARTED|Overall Study||170||
59534016|NCT01579669|75631255|FG001|STARTED|Overall Study||41||
59534017|NCT01579669|75631254|FG000|COMPLETED|Overall Study||134||
59534018|NCT01579669|75631255|FG001|COMPLETED|Overall Study||41||
59534019|NCT01579669|75631254|FG000|NOT COMPLETED|Overall Study||36||
59534020|NCT01579669|75631255|FG001|NOT COMPLETED|Overall Study||0||
59534021|NCT01579747|75631263|FG000|STARTED|Overall Study||12||
59534022|NCT01579747|75631264|FG001|STARTED|Overall Study||12||
59534023|NCT01579747|75631263|FG000|COMPLETED|Overall Study||12||
59534024|NCT01579747|75631264|FG001|COMPLETED|Overall Study||12||
59534025|NCT01579747|75631263|FG000|NOT COMPLETED|Overall Study||0||
59534026|NCT01579747|75631264|FG001|NOT COMPLETED|Overall Study||0||
59534027|NCT00584480|75631270|FG000|STARTED|First 8 Weeks (40 Treatments)||10||
59534028|NCT00584480|75631270|FG000|COMPLETED|First 8 Weeks (40 Treatments)||10||
59534029|NCT00584480|75631270|FG000|NOT COMPLETED|First 8 Weeks (40 Treatments)||0||
59534030|NCT00584480|75631270|FG000|STARTED|4-Week Break From Treatment||10||
59534031|NCT00584480|75631270|FG000|COMPLETED|4-Week Break From Treatment||10||
59534032|NCT00584480|75631270|FG000|NOT COMPLETED|4-Week Break From Treatment||0||
59534033|NCT00584480|75631270|FG000|STARTED|Second 8 Weeks (40 Treatments)||10||
59534034|NCT00584480|75631270|FG000|COMPLETED|Second 8 Weeks (40 Treatments)||10||
59534035|NCT00584480|75631270|FG000|NOT COMPLETED|Second 8 Weeks (40 Treatments)||0||
59534036|NCT00584558|75631274|FG000|STARTED|Overall Study||2420||
59534037|NCT00584558|75631274|FG000|COMPLETED|Overall Study||2420||
59534038|NCT00584558|75631274|FG000|NOT COMPLETED|Overall Study||0||
59987748|NCT00966953|76102946|FG001|NOT COMPLETED|4th Intervention Order||0||
59987749|NCT00966953|76102947|FG002|NOT COMPLETED|4th Intervention Order||0||
59987750|NCT00966953|76102948|FG003|NOT COMPLETED|4th Intervention Order||0||
59987751|NCT02280304|76102956|FG000|STARTED|Overall Study||19||
59534039|NCT02215369|75631279|FG000|STARTED|Overall Study||112|Enrolled Population|146
59534040|NCT02215369|75631279|FG000|COMPLETED|Overall Study||70||113
59534041|NCT02215369|75631279|FG000|NOT COMPLETED|Overall Study||42||33
59534042|NCT00584948|75631285|FG000|STARTED|Overall Study||47||
59987752|NCT02280304|76102957|FG001|STARTED|Overall Study||18||
59534043|NCT00584948|75631286|FG001|STARTED|Overall Study||47||
59534044|NCT00584948|75631285|FG000|COMPLETED|Overall Study||34||
59534045|NCT00584948|75631286|FG001|COMPLETED|Overall Study||36||
59534046|NCT00584948|75631285|FG000|NOT COMPLETED|Overall Study||13||
59534047|NCT00584948|75631286|FG001|NOT COMPLETED|Overall Study||11||
59534048|NCT00605072|75631295|FG000|STARTED|Overall Study||18||
59534049|NCT00605072|75631296|FG001|STARTED|Overall Study||20||
59534050|NCT00605072|75631297|FG002|STARTED|Overall Study||15||
59534051|NCT00605072|75631295|FG000|COMPLETED|Overall Study||11||
59534052|NCT00605072|75631296|FG001|COMPLETED|Overall Study||9||
59534053|NCT00605072|75631297|FG002|COMPLETED|Overall Study||11||
59534054|NCT00605072|75631295|FG000|NOT COMPLETED|Overall Study||7||
59534055|NCT00605072|75631296|FG001|NOT COMPLETED|Overall Study||11||
59534056|NCT00605072|75631297|FG002|NOT COMPLETED|Overall Study||4||
59534057|NCT00585104|75631305|FG000|STARTED|Overall Study||10||
59534058|NCT00585104|75631305|FG000|COMPLETED|Overall Study||6||
59534059|NCT00585104|75631305|FG000|NOT COMPLETED|Overall Study||4||
59534060|NCT00585182|75631309|FG000|STARTED|Overall Study||28||
59534061|NCT00585182|75631309|FG000|COMPLETED|Overall Study||28||
59534062|NCT00585182|75631309|FG000|NOT COMPLETED|Overall Study||0||
59534063|NCT00585494|75631313|FG000|STARTED|Overall Study||300||
59534064|NCT00585494|75631313|FG000|COMPLETED|Overall Study||244||
59534065|NCT00585494|75631313|FG000|NOT COMPLETED|Overall Study||56||
59534066|NCT00605384|75631319|FG000|STARTED|Overall Study||1||
59534067|NCT00605384|75631320|FG001|STARTED|Overall Study||1||
59534068|NCT00605384|75631319|FG000|COMPLETED|Overall Study|study terminated early|0||
59534069|NCT00605384|75631320|FG001|COMPLETED|Overall Study|study terminated early|0||
59534070|NCT00605384|75631319|FG000|NOT COMPLETED|Overall Study||1||
59534071|NCT00605384|75631320|FG001|NOT COMPLETED|Overall Study||1||
59534072|NCT00586196|75631328|FG000|STARTED|Overall Study||7||
59534073|NCT00586196|75631329|FG001|STARTED|Overall Study||9||
59534074|NCT00586196|75631328|FG000|COMPLETED|Overall Study||7||
59534075|NCT00586196|75631329|FG001|COMPLETED|Overall Study||9||
59534076|NCT00586196|75631328|FG000|NOT COMPLETED|Overall Study||0||
59534077|NCT00586196|75631329|FG001|NOT COMPLETED|Overall Study||0||
59534078|NCT00605696|75631337|FG000|STARTED|Overall Study||7||
59534079|NCT00605696|75631338|FG001|STARTED|Overall Study||11||
59534080|NCT00605696|75631337|FG000|COMPLETED|Overall Study||7||
59534081|NCT00605696|75631338|FG001|COMPLETED|Overall Study||11||
59534082|NCT00605696|75631337|FG000|NOT COMPLETED|Overall Study||0||
59534083|NCT00605696|75631338|FG001|NOT COMPLETED|Overall Study||0||
59534084|NCT00606554|75631346|FG000|STARTED|Overall Study||15||
59534085|NCT00606554|75631347|FG001|STARTED|Overall Study||18||
59534086|NCT00606554|75631346|FG000|COMPLETED|Overall Study||15||
59534087|NCT00606554|75631347|FG001|COMPLETED|Overall Study||18||
59534088|NCT00606554|75631346|FG000|NOT COMPLETED|Overall Study||0||
59534089|NCT00606554|75631347|FG001|NOT COMPLETED|Overall Study||0||
59534090|NCT00587132|75631361|FG000|STARTED|Overall Study||4||
59534091|NCT00587132|75631362|FG001|STARTED|Overall Study||0||
59534092|NCT00587132|75631363|FG002|STARTED|Overall Study||0||
59534093|NCT00587132|75631364|FG003|STARTED|Overall Study||0||
59534094|NCT00587132|75631361|FG000|COMPLETED|Overall Study||4||
59534095|NCT00587132|75631362|FG001|COMPLETED|Overall Study||0||
59534096|NCT00587132|75631363|FG002|COMPLETED|Overall Study||0||
59534097|NCT00587132|75631364|FG003|COMPLETED|Overall Study||0||
59534098|NCT00587132|75631361|FG000|NOT COMPLETED|Overall Study||0||
59534099|NCT00587132|75631362|FG001|NOT COMPLETED|Overall Study||0||
59534100|NCT00587132|75631363|FG002|NOT COMPLETED|Overall Study||0||
59534101|NCT00587132|75631364|FG003|NOT COMPLETED|Overall Study||0||
59534102|NCT00606944|75631376|FG000|STARTED|Overall Study||98||
59534103|NCT00606944|75631377|FG001|STARTED|Overall Study||100||
59534104|NCT00606944|75631376|FG000|COMPLETED|Overall Study||98||
59534105|NCT00606944|75631377|FG001|COMPLETED|Overall Study||100||
59534106|NCT00606944|75631376|FG000|NOT COMPLETED|Overall Study||0||
59534107|NCT00606944|75631377|FG001|NOT COMPLETED|Overall Study||0||
59534108|NCT00587678|75631386|FG000|STARTED|Overall Study||22||
59534109|NCT00587678|75631387|FG001|STARTED|Overall Study||22||
59534110|NCT00587678|75631388|FG002|STARTED|Overall Study||41||
59534111|NCT00587678|75631386|FG000|COMPLETED|Overall Study||16||
59534112|NCT00587678|75631387|FG001|COMPLETED|Overall Study||18||
59534113|NCT00587678|75631388|FG002|COMPLETED|Overall Study||33||
59622749|NCT00445302|75734656|FG001|STARTED|Overall Study||5||
59622750|NCT00445302|75734657|FG002|STARTED|Overall Study||6||
59534114|NCT00587678|75631386|FG000|NOT COMPLETED|Overall Study||6||
59534115|NCT00587678|75631387|FG001|NOT COMPLETED|Overall Study||4||
59534116|NCT00587678|75631388|FG002|NOT COMPLETED|Overall Study||8||
59534117|NCT02138006|75631398|FG000|STARTED|Overall Study||48||
59534118|NCT02138006|75631399|FG001|STARTED|Overall Study||54||
59534119|NCT02138006|75631398|FG000|COMPLETED|Overall Study||48||
59622751|NCT00445302|75734658|FG003|STARTED|Overall Study||6||
59622752|NCT00445302|75734655|FG000|COMPLETED|Overall Study||6||
59622753|NCT00445302|75734656|FG001|COMPLETED|Overall Study||5||
59622754|NCT00445302|75734657|FG002|COMPLETED|Overall Study||6||
59622755|NCT00445302|75734658|FG003|COMPLETED|Overall Study||6||
59622756|NCT00445302|75734655|FG000|NOT COMPLETED|Overall Study||0||
59534120|NCT02138006|75631399|FG001|COMPLETED|Overall Study||54||
59534121|NCT02138006|75631398|FG000|NOT COMPLETED|Overall Study||0||
59534122|NCT02138006|75631399|FG001|NOT COMPLETED|Overall Study||0||
59534123|NCT00587834|75631405|FG000|STARTED|Overall Study||96||
59534124|NCT00587834|75631405|FG000|COMPLETED|Overall Study||96||
59534125|NCT00587834|75631405|FG000|NOT COMPLETED|Overall Study||0||
59534126|NCT04545008|75631420|FG000|STARTED|Overall Study||2||
59534127|NCT04545008|75631420|FG000|COMPLETED|Overall Study||2||
59534128|NCT04545008|75631420|FG000|NOT COMPLETED|Overall Study||0||
59534129|NCT02138240|75631424|FG000|STARTED|Overall Study||34||
59534130|NCT02138240|75631424|FG000|COMPLETED|Overall Study||34||
59534131|NCT02138240|75631424|FG000|NOT COMPLETED|Overall Study||0||
59534132|NCT02139176|75631430|FG000|STARTED|Overall Study||100||
59534133|NCT02139176|75631431|FG001|STARTED|Overall Study||100||
59534134|NCT02139176|75631430|FG000|COMPLETED|Overall Study||100||
59534135|NCT02139176|75631431|FG001|COMPLETED|Overall Study||100||
59534136|NCT02139176|75631430|FG000|NOT COMPLETED|Overall Study||0||
59534137|NCT02139176|75631431|FG001|NOT COMPLETED|Overall Study||0||
59534138|NCT00609128|75631438|FG000|STARTED|Overall Study||21||
59534139|NCT00609128|75631438|FG000|COMPLETED|Overall Study||21||
59534140|NCT00609128|75631438|FG000|NOT COMPLETED|Overall Study||0||
59534141|NCT00668564|75631443|FG000|STARTED|Overall Study||18||
59534142|NCT00668564|75631443|FG000|COMPLETED|Overall Study||18||
59534143|NCT00668564|75631443|FG000|NOT COMPLETED|Overall Study||0||
59534144|NCT00610688|75631450|FG000|STARTED|Overall Study||64||
59534145|NCT00610688|75631451|FG001|STARTED|Overall Study||65||
59534146|NCT00610688|75631452|FG002|STARTED|Overall Study||63||
59534147|NCT00610688|75631450|FG000|COMPLETED|Overall Study||55||
59534148|NCT00610688|75631451|FG001|COMPLETED|Overall Study||52||
59534149|NCT00610688|75631452|FG002|COMPLETED|Overall Study||55||
59534150|NCT00610688|75631450|FG000|NOT COMPLETED|Overall Study||9||
59534151|NCT00610688|75631451|FG001|NOT COMPLETED|Overall Study||13||
59534152|NCT00610688|75631452|FG002|NOT COMPLETED|Overall Study||8||
59534153|NCT00669578|75631462|FG000|STARTED|Overall Study||12||
59534154|NCT00669578|75631463|FG001|STARTED|Overall Study||65||
59534155|NCT00669578|75631462|FG000|COMPLETED|Overall Study||12||
59534156|NCT00669578|75631463|FG001|COMPLETED|Overall Study||65||
59534157|NCT00669578|75631462|FG000|NOT COMPLETED|Overall Study||0||
59534158|NCT00669578|75631463|FG001|NOT COMPLETED|Overall Study||0||
59534159|NCT02135900|75631470|FG000|STARTED|Overall Study|32 subjects started the study. 50 subjects were screened.|32||
59534160|NCT02135900|75631470|FG000|COMPLETED|Overall Study||32||
59534161|NCT02135900|75631470|FG000|NOT COMPLETED|Overall Study||0||
59534162|NCT02137382|75631474|FG000|STARTED|Cross-over Period 1||20||
59534163|NCT02137382|75631475|FG001|STARTED|Cross-over Period 1||21||
59534164|NCT02137382|75631474|FG000|COMPLETED|Cross-over Period 1||18||
59534165|NCT02137382|75631475|FG001|COMPLETED|Cross-over Period 1||21||
59534166|NCT02137382|75631474|FG000|NOT COMPLETED|Cross-over Period 1||2||
59534167|NCT02137382|75631475|FG001|NOT COMPLETED|Cross-over Period 1||0||
59534168|NCT02137382|75631474|FG000|STARTED|Wash Out||18||
59534169|NCT02137382|75631475|FG001|STARTED|Wash Out||21||
59534170|NCT02137382|75631474|FG000|COMPLETED|Wash Out||18||
59534171|NCT02137382|75631475|FG001|COMPLETED|Wash Out||21||
59987753|NCT02280304|76102956|FG000|COMPLETED|Overall Study||12||
59987754|NCT02280304|76102957|FG001|COMPLETED|Overall Study|A non completer received the allocated intervention before being lost to follow-up.|10||
59987755|NCT02280304|76102956|FG000|NOT COMPLETED|Overall Study||7||
59987756|NCT02280304|76102957|FG001|NOT COMPLETED|Overall Study||8||
59987757|NCT00961805|76102972|FG000|STARTED|Overall Study||40||
59987758|NCT00961805|76102973|FG001|STARTED|Overall Study||40||
59987759|NCT00961805|76102972|FG000|COMPLETED|Overall Study||40||
59987760|NCT00961805|76102973|FG001|COMPLETED|Overall Study||40||
59987761|NCT00961805|76102972|FG000|NOT COMPLETED|Overall Study||0||
59987762|NCT00961805|76102973|FG001|NOT COMPLETED|Overall Study||0||
59987763|NCT02283658|76102977|FG000|STARTED|Overall Study||20||
59987764|NCT02283658|76102977|FG000|COMPLETED|Overall Study||19||
59987765|NCT02283658|76102977|FG000|NOT COMPLETED|Overall Study||1||
59987766|NCT03122691|76102981|FG000|STARTED|Overall Study||23||
59987767|NCT03122691|76102981|FG000|Oral 0mg|Overall Study||22||
59987768|NCT03122691|76102981|FG000|Oral 10mg|Overall Study||22||
60075662|NCT01929109|76190967|FG003|STARTED|Period 2 (End Stage Renal Disease Only)||0||
60075663|NCT01929109|76190968|FG004|STARTED|Period 2 (End Stage Renal Disease Only)||8||
60075664|NCT01929109|76190964|FG000|COMPLETED|Period 2 (End Stage Renal Disease Only)||0||
60075665|NCT01929109|76190965|FG001|COMPLETED|Period 2 (End Stage Renal Disease Only)||0||
60075666|NCT01929109|76190966|FG002|COMPLETED|Period 2 (End Stage Renal Disease Only)||0||
60075667|NCT01929109|76190967|FG003|COMPLETED|Period 2 (End Stage Renal Disease Only)||0||
60075668|NCT01929109|76190968|FG004|COMPLETED|Period 2 (End Stage Renal Disease Only)||8||
59987769|NCT03122691|76102981|FG000|Oral 25mg|Overall Study||21||
59987770|NCT03122691|76102981|FG000|Vape 0mg|Overall Study||20||
60075669|NCT01929109|76190964|FG000|NOT COMPLETED|Period 2 (End Stage Renal Disease Only)||0||
59534172|NCT02137382|75631474|FG000|NOT COMPLETED|Wash Out||0||
59534173|NCT02137382|75631475|FG001|NOT COMPLETED|Wash Out||0||
59534174|NCT02137382|75631474|FG000|STARTED|Cross-over Period 2||18||
59534175|NCT02137382|75631475|FG001|STARTED|Cross-over Period 2||21||
59534176|NCT02137382|75631474|FG000|COMPLETED|Cross-over Period 2||18||
59534177|NCT02137382|75631475|FG001|COMPLETED|Cross-over Period 2||21||
59534178|NCT02137382|75631474|FG000|NOT COMPLETED|Cross-over Period 2||0||
59534179|NCT02137382|75631475|FG001|NOT COMPLETED|Cross-over Period 2||0||
59534180|NCT00611468|75631482|FG000|STARTED|Overall Study||3||
59534181|NCT00611468|75631483|FG001|STARTED|Overall Study||7||
59534182|NCT00611468|75631484|FG002|STARTED|Overall Study||6||
59815336|NCT03810456|75937762|FG001|NOT COMPLETED|6 Month Follow-Up||9||
59815337|NCT03810456|75937763|FG002|NOT COMPLETED|6 Month Follow-Up||18||
59815338|NCT03566732|75937771|FG000|STARTED|Overall Study|1683 eligible cases identified and screened, 914 participants enrolled.|914||
59815339|NCT03566732|75937771|FG000|COMPLETED|Overall Study|914 completed questionnaires|914||
59815340|NCT03566732|75937771|FG000|NOT COMPLETED|Overall Study||0||
59815341|NCT03450057|75937775|FG000|STARTED|Overall Study||38||
59815342|NCT03450057|75937775|FG000|COMPLETED|Overall Study||15||
59815343|NCT03450057|75937775|FG000|NOT COMPLETED|Overall Study||23||
59815344|NCT03360396|75937781|FG000|STARTED|Overall Study||80||
59534183|NCT00611468|75631485|FG003|STARTED|Overall Study||13||
59534184|NCT00611468|75631482|FG000|COMPLETED|Overall Study||3||
59534185|NCT00611468|75631483|FG001|COMPLETED|Overall Study|One subject did not complete Cycle 1 of treatment and was replaced.|6||
59534186|NCT00611468|75631484|FG002|COMPLETED|Overall Study||6||
59534187|NCT00611468|75631485|FG003|COMPLETED|Overall Study||13||
59534188|NCT00611468|75631482|FG000|NOT COMPLETED|Overall Study||0||
59534189|NCT00611468|75631483|FG001|NOT COMPLETED|Overall Study||1||
59534190|NCT00611468|75631484|FG002|NOT COMPLETED|Overall Study||0||
59534191|NCT00611468|75631485|FG003|NOT COMPLETED|Overall Study||0||
59534192|NCT00670202|75631491|FG000|STARTED|Overall Study|Investigators blinded to study drug assignment due to early termination of study|2||
59534193|NCT00670202|75631492|FG001|STARTED|Overall Study||0||
59534194|NCT00670202|75631491|FG000|COMPLETED|Overall Study|Investigators blinded to study drug assignment due to early termination of study|2||
59534195|NCT00670202|75631492|FG001|COMPLETED|Overall Study||0||
59534196|NCT00670202|75631491|FG000|NOT COMPLETED|Overall Study||0||
59534197|NCT00670202|75631492|FG001|NOT COMPLETED|Overall Study||0||
59534198|NCT00670982|75631500|FG000|STARTED|Overall Study||22||
59534199|NCT00670982|75631501|FG001|STARTED|Overall Study||7||
59534200|NCT00670982|75631500|FG000|COMPLETED|Overall Study||22||
59534201|NCT00670982|75631501|FG001|COMPLETED|Overall Study||7||
59534202|NCT00670982|75631500|FG000|NOT COMPLETED|Overall Study||0||
59534203|NCT00670982|75631501|FG001|NOT COMPLETED|Overall Study||0||
59534204|NCT00611624|75631506|FG000|STARTED|Overall Study||28||
59534205|NCT00611624|75631506|FG000|COMPLETED|Overall Study||28||
59534206|NCT00611624|75631506|FG000|NOT COMPLETED|Overall Study||0||
59534207|NCT00612560|75631515|FG000|STARTED|Overall Study||7||
59534208|NCT00612560|75631516|FG001|STARTED|Overall Study||7||
59534209|NCT00612560|75631517|FG002|STARTED|Overall Study||8||
59534210|NCT00612560|75631518|FG003|STARTED|Overall Study||6||
59534211|NCT00612560|75631515|FG000|COMPLETED|Overall Study||7||
59534212|NCT00612560|75631516|FG001|COMPLETED|Overall Study||7||
59534213|NCT00612560|75631517|FG002|COMPLETED|Overall Study||8||
59534214|NCT00612560|75631518|FG003|COMPLETED|Overall Study||6||
59534215|NCT00612560|75631515|FG000|NOT COMPLETED|Overall Study||0||
59534216|NCT00612560|75631516|FG001|NOT COMPLETED|Overall Study||0||
59534217|NCT00612560|75631517|FG002|NOT COMPLETED|Overall Study||0||
59534218|NCT00612560|75631518|FG003|NOT COMPLETED|Overall Study||0||
59534219|NCT00671918|75631528|FG000|STARTED|Overall Study||186||
59534220|NCT00671918|75631528|FG000|COMPLETED|Overall Study||169||
59534221|NCT00671918|75631528|FG000|NOT COMPLETED|Overall Study||17||
59534222|NCT00612716|75631533|FG000|STARTED|Overall Study||6||
59534223|NCT00612716|75631533|FG000|COMPLETED|Overall Study||6||
59534224|NCT00612716|75631533|FG000|NOT COMPLETED|Overall Study||0||
59534225|NCT00613028|75631539|FG000|STARTED|Overall Study||10||
59534226|NCT00613028|75631540|FG001|STARTED|Overall Study||13||
59534227|NCT00613028|75631539|FG000|COMPLETED|Overall Study||10||
59534228|NCT00613028|75631540|FG001|COMPLETED|Overall Study||12||
59534229|NCT00613028|75631539|FG000|NOT COMPLETED|Overall Study||0||
59534230|NCT00613028|75631540|FG001|NOT COMPLETED|Overall Study||1||
59534231|NCT00614198|75631548|FG000|STARTED|Stage 1||38||
59534232|NCT00614198|75631549|FG001|STARTED|Stage 1||34||
59534233|NCT00614198|75631548|FG000|COMPLETED|Stage 1||26||
59534234|NCT00614198|75631549|FG001|COMPLETED|Stage 1||29||
59534235|NCT00614198|75631548|FG000|NOT COMPLETED|Stage 1||12||
59534236|NCT00614198|75631549|FG001|NOT COMPLETED|Stage 1||5||
59534237|NCT00614198|75631548|FG000|STARTED|Stage 2||26||
59534238|NCT00614198|75631549|FG001|STARTED|Stage 2|Reallocated to gluten- and casein-free dietary intervention|29||
59534239|NCT00614198|75631548|FG000|COMPLETED|Stage 2||18||
59534240|NCT00614198|75631549|FG001|COMPLETED|Stage 2||17||
59815345|NCT03360396|75937782|FG001|STARTED|Overall Study||40||
59815346|NCT03360396|75937781|FG000|COMPLETED|Overall Study||0||
59815347|NCT03360396|75937782|FG001|COMPLETED|Overall Study||0||
59534241|NCT00614198|75631548|FG000|NOT COMPLETED|Stage 2||8||
59534242|NCT00614198|75631549|FG001|NOT COMPLETED|Stage 2||12||
59534243|NCT00616772|75631557|FG000|STARTED|Overall Study||340||
59534244|NCT00616772|75631558|FG001|STARTED|Overall Study||342||
59534245|NCT00616772|75631557|FG000|Treated|Overall Study||337||
59534246|NCT00616772|75631558|FG001|Treated|Overall Study||339||
59534247|NCT00616772|75631557|FG000|COMPLETED|Overall Study||225||
59534248|NCT00616772|75631558|FG001|COMPLETED|Overall Study||240||
59534249|NCT00616772|75631557|FG000|NOT COMPLETED|Overall Study||115||
59534250|NCT00616772|75631558|FG001|NOT COMPLETED|Overall Study||102||
59534251|NCT00672854|75631566|FG000|STARTED|Overall Study||49||
59534252|NCT00672854|75631567|FG001|STARTED|Overall Study||51||
59815348|NCT03360396|75937781|FG000|NOT COMPLETED|Overall Study||80||
59534253|NCT00672854|75631566|FG000|COMPLETED|Overall Study||49||
59534254|NCT00672854|75631567|FG001|COMPLETED|Overall Study||51||
59534255|NCT00672854|75631566|FG000|NOT COMPLETED|Overall Study||0||
59534256|NCT00672854|75631567|FG001|NOT COMPLETED|Overall Study||0||
59815349|NCT03360396|75937782|FG001|NOT COMPLETED|Overall Study||40||
59815350|NCT03353415|75937788|FG000|STARTED|Masked CGM Wear||25|"26 individuals were enrolled, however one individual was withdrawn prior to participation due to hospitalization. No study visits were attended or study related activities initiated for this person.~25 participants completed the visit 1 baseline evaluation."|
59815351|NCT03353415|75937788|FG000|COMPLETED|Masked CGM Wear||23||
59534257|NCT00672932|75631577|FG000|STARTED|Overall Study||9||
59534258|NCT00672932|75631578|FG001|STARTED|Overall Study||9||
59534259|NCT00672932|75631577|FG000|Completed Initial 12-week Assignment|Overall Study||9||
59534260|NCT00672932|75631578|FG001|Completed Initial 12-week Assignment|Overall Study||9||
59534261|NCT00672932|75631577|FG000|Provided Analyzable Blood and CSF Sample|Overall Study|one subject was censored when pharmacological study showed no drug in plasma or CSF|8||
59534262|NCT00672932|75631578|FG001|Provided Analyzable Blood and CSF Sample|Overall Study||9||
59534263|NCT00672932|75631577|FG000|Rolled Over to Raltegravir|Overall Study||0||
59534264|NCT00672932|75631578|FG001|Rolled Over to Raltegravir|Overall Study|6 subjects randomized to no drug later rolled over to receive raltegravir|6||
59534265|NCT00672932|75631577|FG000|COMPLETED|Overall Study||9||
59534266|NCT00672932|75631578|FG001|COMPLETED|Overall Study||9||
59534267|NCT00672932|75631577|FG000|NOT COMPLETED|Overall Study||0||
59534268|NCT00672932|75631578|FG001|NOT COMPLETED|Overall Study||0||
59534269|NCT02513550|75631590|FG000|STARTED|Double Blind Treatment Period||310||
59534270|NCT02513550|75631591|FG001|STARTED|Double Blind Treatment Period||306||
59534271|NCT02513550|75631592|FG002|STARTED|Double Blind Treatment Period||611||
59534272|NCT02513550|75631593|FG003|STARTED|Double Blind Treatment Period||9||
59534273|NCT02513550|75631594|FG004|STARTED|Double Blind Treatment Period||5||
59534274|NCT02513550|75631595|FG005|STARTED|Double Blind Treatment Period||16||
59534275|NCT02513550|75631590|FG000|Received at Least One Dose of Study Drug|Double Blind Treatment Period||310||
59534276|NCT02513550|75631591|FG001|Received at Least One Dose of Study Drug|Double Blind Treatment Period||306||
59534277|NCT02513550|75631592|FG002|Received at Least One Dose of Study Drug|Double Blind Treatment Period||609||
59534278|NCT02513550|75631593|FG003|Received at Least One Dose of Study Drug|Double Blind Treatment Period||9||
59534279|NCT02513550|75631594|FG004|Received at Least One Dose of Study Drug|Double Blind Treatment Period||5||
59534280|NCT02513550|75631595|FG005|Received at Least One Dose of Study Drug|Double Blind Treatment Period||16||
59534281|NCT02513550|75631590|FG000|COMPLETED|Double Blind Treatment Period||274||
59534282|NCT02513550|75631591|FG001|COMPLETED|Double Blind Treatment Period||268||
59534283|NCT02513550|75631592|FG002|COMPLETED|Double Blind Treatment Period||537||
59534284|NCT02513550|75631593|FG003|COMPLETED|Double Blind Treatment Period||9||
59534285|NCT02513550|75631594|FG004|COMPLETED|Double Blind Treatment Period||4||
59534286|NCT02513550|75631595|FG005|COMPLETED|Double Blind Treatment Period||15||
59534287|NCT02513550|75631590|FG000|NOT COMPLETED|Double Blind Treatment Period||36||
59534288|NCT02513550|75631591|FG001|NOT COMPLETED|Double Blind Treatment Period||38||
59534289|NCT02513550|75631592|FG002|NOT COMPLETED|Double Blind Treatment Period||74||
59534290|NCT02513550|75631593|FG003|NOT COMPLETED|Double Blind Treatment Period||0||
59534291|NCT02513550|75631594|FG004|NOT COMPLETED|Double Blind Treatment Period||1||
59534292|NCT02513550|75631595|FG005|NOT COMPLETED|Double Blind Treatment Period||1||
59534293|NCT02513550|75631590|FG000|STARTED|Post-Treatment Follow-up Period|Participants who discontinued double blind phase had an option to enter post-treatment phase.|285||
59534294|NCT02513550|75631591|FG001|STARTED|Post-Treatment Follow-up Period|Participants who discontinued double blind phase had an option to enter post-treatment phase.|283||
59534295|NCT02513550|75631592|FG002|STARTED|Post-Treatment Follow-up Period|Participants who discontinued double blind phase had an option to enter post-treatment phase.|559||
59815352|NCT03353415|75937788|FG000|NOT COMPLETED|Masked CGM Wear||2||
59815353|NCT03353415|75937788|FG000|STARTED|Unmasked CGM Wear||23||
59815354|NCT03353415|75937788|FG000|COMPLETED|Unmasked CGM Wear||22||
59815355|NCT03353415|75937788|FG000|NOT COMPLETED|Unmasked CGM Wear||1||
59815356|NCT02879318|75937796|FG000|STARTED|Overall Study||61||
60075670|NCT01929109|76190965|FG001|NOT COMPLETED|Period 2 (End Stage Renal Disease Only)||0||
60075671|NCT01929109|76190966|FG002|NOT COMPLETED|Period 2 (End Stage Renal Disease Only)||0||
60075672|NCT01929109|76190967|FG003|NOT COMPLETED|Period 2 (End Stage Renal Disease Only)||0||
60075673|NCT01929109|76190968|FG004|NOT COMPLETED|Period 2 (End Stage Renal Disease Only)||0||
60075674|NCT01518153|76190983|FG000|STARTED|Stem Cell Transplant||16||
60075675|NCT01518153|76190984|FG001|STARTED|Stem Cell Transplant||0||
60075676|NCT01518153|76190985|FG002|STARTED|Stem Cell Transplant||0||
60075677|NCT01518153|76190983|FG000|COMPLETED|Stem Cell Transplant||7||
60075678|NCT01518153|76190984|FG001|COMPLETED|Stem Cell Transplant||0||
60075679|NCT01518153|76190985|FG002|COMPLETED|Stem Cell Transplant||0||
60075680|NCT01518153|76190983|FG000|NOT COMPLETED|Stem Cell Transplant||9||
60075681|NCT01518153|76190984|FG001|NOT COMPLETED|Stem Cell Transplant||0||
60075682|NCT01518153|76190985|FG002|NOT COMPLETED|Stem Cell Transplant||0||
60075683|NCT01518153|76190983|FG000|STARTED|Donor Lymphocyte Infusion||0||
60075684|NCT01518153|76190984|FG001|STARTED|Donor Lymphocyte Infusion||3||
60075685|NCT01518153|76190985|FG002|STARTED|Donor Lymphocyte Infusion||4||
60075686|NCT01518153|76190983|FG000|COMPLETED|Donor Lymphocyte Infusion||0||
60075687|NCT01518153|76190984|FG001|COMPLETED|Donor Lymphocyte Infusion||1||
60075688|NCT01518153|76190985|FG002|COMPLETED|Donor Lymphocyte Infusion||3||
60075689|NCT01518153|76190983|FG000|NOT COMPLETED|Donor Lymphocyte Infusion||0||
60075690|NCT01518153|76190984|FG001|NOT COMPLETED|Donor Lymphocyte Infusion||2||
60075691|NCT01518153|76190985|FG002|NOT COMPLETED|Donor Lymphocyte Infusion||1||
60075692|NCT01906489|76190995|FG000|STARTED|Overall Study||138||
60075693|NCT01906489|76190996|FG001|STARTED|Overall Study||72||
60075694|NCT01906489|76190995|FG000|COMPLETED|Overall Study||112||
60075695|NCT01906489|76190996|FG001|COMPLETED|Overall Study||63||
60075696|NCT01906489|76190995|FG000|NOT COMPLETED|Overall Study||26||
60075697|NCT01906489|76190996|FG001|NOT COMPLETED|Overall Study||9||
60075698|NCT01517373|76191007|FG000|STARTED|Run-in Period||361||
60075699|NCT01517373|76191008|FG001|STARTED|Run-in Period||0||
60075700|NCT01517373|76191009|FG002|STARTED|Run-in Period||0||
60075701|NCT01517373|76191010|FG003|STARTED|Run-in Period||0||
60075702|NCT01517373|76191011|FG004|STARTED|Run-in Period||0||
60075703|NCT01517373|76191012|FG005|STARTED|Run-in Period||0||
60075704|NCT01517373|76191007|FG000|COMPLETED|Run-in Period||304||
60075705|NCT01517373|76191008|FG001|COMPLETED|Run-in Period||0||
60075706|NCT01517373|76191009|FG002|COMPLETED|Run-in Period||0||
60075707|NCT01517373|76191010|FG003|COMPLETED|Run-in Period||0||
60075708|NCT01517373|76191011|FG004|COMPLETED|Run-in Period||0||
60075709|NCT01517373|76191012|FG005|COMPLETED|Run-in Period||0||
60075710|NCT01517373|76191007|FG000|NOT COMPLETED|Run-in Period||57||
60075711|NCT01517373|76191008|FG001|NOT COMPLETED|Run-in Period||0||
60075712|NCT01517373|76191009|FG002|NOT COMPLETED|Run-in Period||0||
60075713|NCT01517373|76191010|FG003|NOT COMPLETED|Run-in Period||0||
60075714|NCT01517373|76191011|FG004|NOT COMPLETED|Run-in Period||0||
60075715|NCT01517373|76191012|FG005|NOT COMPLETED|Run-in Period||0||
60075716|NCT01517373|76191007|FG000|STARTED|Treatment Period||0||
60075717|NCT01517373|76191008|FG001|STARTED|Treatment Period||61||
60075718|NCT01517373|76191009|FG002|STARTED|Treatment Period||60||
60075719|NCT01517373|76191010|FG003|STARTED|Treatment Period||61||
60075720|NCT01517373|76191011|FG004|STARTED|Treatment Period||61||
60075721|NCT01517373|76191012|FG005|STARTED|Treatment Period||61||
60075722|NCT01517373|76191007|FG000|COMPLETED|Treatment Period||0||
60075723|NCT01517373|76191008|FG001|COMPLETED|Treatment Period||57||
60075724|NCT01517373|76191009|FG002|COMPLETED|Treatment Period||54||
60075725|NCT01517373|76191010|FG003|COMPLETED|Treatment Period||54||
60075726|NCT01517373|76191011|FG004|COMPLETED|Treatment Period||55||
60075727|NCT01517373|76191012|FG005|COMPLETED|Treatment Period||54||
60075728|NCT01517373|76191007|FG000|NOT COMPLETED|Treatment Period||0||
60075729|NCT01517373|76191008|FG001|NOT COMPLETED|Treatment Period||4||
60075730|NCT01517373|76191009|FG002|NOT COMPLETED|Treatment Period||6||
60075731|NCT01517373|76191010|FG003|NOT COMPLETED|Treatment Period||7||
60075732|NCT01517373|76191011|FG004|NOT COMPLETED|Treatment Period||6||
60075733|NCT01517373|76191012|FG005|NOT COMPLETED|Treatment Period||7||
60075734|NCT01517295|76191027|FG000|STARTED|Overall Study||16||
60075735|NCT01517295|76191028|FG001|STARTED|Overall Study||14||
60075736|NCT01517295|76191027|FG000|COMPLETED|Overall Study||15||
60075737|NCT01517295|76191028|FG001|COMPLETED|Overall Study||14||
60075738|NCT01517295|76191027|FG000|NOT COMPLETED|Overall Study||1||
60075739|NCT01517295|76191028|FG001|NOT COMPLETED|Overall Study||0||
60075740|NCT01541865|76191034|FG000|STARTED|Overall Study||146||
60075741|NCT01541865|76191034|FG000|COMPLETED|Overall Study||124||
60075742|NCT01541865|76191034|FG000|NOT COMPLETED|Overall Study||22||
60075743|NCT01541397|76191040|FG000|STARTED|Overall Study||4||
60075744|NCT01541397|76191041|FG001|STARTED|Overall Study||2||
60075745|NCT01541397|76191040|FG000|COMPLETED|Overall Study||0||
60075746|NCT01541397|76191041|FG001|COMPLETED|Overall Study||0||
59534296|NCT02513550|75631593|FG003|STARTED|Post-Treatment Follow-up Period|Participants who discontinued double blind phase had an option to enter post-treatment phase.|9||
59534297|NCT02513550|75631594|FG004|STARTED|Post-Treatment Follow-up Period|Participants who discontinued double blind phase had an option to enter post-treatment phase.|4||
59534298|NCT02513550|75631595|FG005|STARTED|Post-Treatment Follow-up Period|Participants who discontinued double blind phase had an option to enter post-treatment phase.|15||
59534299|NCT02513550|75631590|FG000|COMPLETED|Post-Treatment Follow-up Period||254||
59534300|NCT02513550|75631591|FG001|COMPLETED|Post-Treatment Follow-up Period||244||
59534301|NCT02513550|75631592|FG002|COMPLETED|Post-Treatment Follow-up Period||496||
59534302|NCT02513550|75631593|FG003|COMPLETED|Post-Treatment Follow-up Period||9||
59534303|NCT02513550|75631594|FG004|COMPLETED|Post-Treatment Follow-up Period||4||
59534304|NCT02513550|75631595|FG005|COMPLETED|Post-Treatment Follow-up Period||15||
59534305|NCT02513550|75631590|FG000|NOT COMPLETED|Post-Treatment Follow-up Period||31||
59534306|NCT02513550|75631591|FG001|NOT COMPLETED|Post-Treatment Follow-up Period||39||
59534307|NCT02513550|75631592|FG002|NOT COMPLETED|Post-Treatment Follow-up Period||63||
59534308|NCT02513550|75631593|FG003|NOT COMPLETED|Post-Treatment Follow-up Period||0||
59534309|NCT02513550|75631594|FG004|NOT COMPLETED|Post-Treatment Follow-up Period||0||
59534310|NCT02513550|75631595|FG005|NOT COMPLETED|Post-Treatment Follow-up Period||0||
59534311|NCT00673400|75631617|FG000|STARTED|Overall Study||52||
59534312|NCT00673400|75631617|FG000|COMPLETED|Overall Study||52||
59534313|NCT00673400|75631617|FG000|NOT COMPLETED|Overall Study||0||
59534314|NCT00673712|75631629|FG000|STARTED|Overall Study||321||
59534315|NCT00673712|75631630|FG001|STARTED|Overall Study||326||
59534316|NCT00673712|75631629|FG000|COMPLETED|Overall Study||321||
59534317|NCT00673712|75631630|FG001|COMPLETED|Overall Study||326||
59534318|NCT00673712|75631629|FG000|NOT COMPLETED|Overall Study||0||
59534319|NCT00673712|75631630|FG001|NOT COMPLETED|Overall Study||0||
59534320|NCT00617396|75631636|FG000|STARTED|Overall Study||25||
59534321|NCT00617396|75631636|FG000|COMPLETED|Overall Study||25||
59534322|NCT00617396|75631636|FG000|NOT COMPLETED|Overall Study||0||
59534323|NCT01581541|75631640|FG000|STARTED|Overall Study||1||
59534324|NCT01581541|75631641|FG001|STARTED|Overall Study||1||
59534325|NCT01581541|75631642|FG002|STARTED|Overall Study||1||
59534326|NCT01581541|75631643|FG003|STARTED|Overall Study||1||
59534327|NCT01581541|75631644|FG004|STARTED|Overall Study||2||
59534328|NCT01581541|75631645|FG005|STARTED|Overall Study||3||
59534329|NCT01581541|75631646|FG006|STARTED|Overall Study||1||
59534330|NCT01581541|75631647|FG007|STARTED|Overall Study||2||
59534331|NCT01581541|75631648|FG008|STARTED|Overall Study||1||
59534332|NCT01581541|75631649|FG009|STARTED|Overall Study||3||
59534333|NCT01581541|75631650|FG010|STARTED|Overall Study||1||
59534334|NCT01581541|75631640|FG000|COMPLETED|Overall Study||1||
59534335|NCT01581541|75631641|FG001|COMPLETED|Overall Study||1||
59534336|NCT01581541|75631642|FG002|COMPLETED|Overall Study||1||
59534337|NCT01581541|75631643|FG003|COMPLETED|Overall Study||1||
59534338|NCT01581541|75631644|FG004|COMPLETED|Overall Study||2||
59534339|NCT01581541|75631645|FG005|COMPLETED|Overall Study||3||
59534340|NCT01581541|75631646|FG006|COMPLETED|Overall Study||1||
59534341|NCT01581541|75631647|FG007|COMPLETED|Overall Study||2||
59534342|NCT01581541|75631648|FG008|COMPLETED|Overall Study||1||
59534343|NCT01581541|75631649|FG009|COMPLETED|Overall Study||3||
59534344|NCT01581541|75631650|FG010|COMPLETED|Overall Study||1||
59534345|NCT01581541|75631640|FG000|NOT COMPLETED|Overall Study||0||
59534346|NCT01581541|75631641|FG001|NOT COMPLETED|Overall Study||0||
59534347|NCT01581541|75631642|FG002|NOT COMPLETED|Overall Study||0||
59534348|NCT01581541|75631643|FG003|NOT COMPLETED|Overall Study||0||
59534349|NCT01581541|75631644|FG004|NOT COMPLETED|Overall Study||0||
59534350|NCT01581541|75631645|FG005|NOT COMPLETED|Overall Study||0||
59534351|NCT01581541|75631646|FG006|NOT COMPLETED|Overall Study||0||
59534352|NCT01581541|75631647|FG007|NOT COMPLETED|Overall Study||0||
59534353|NCT01581541|75631648|FG008|NOT COMPLETED|Overall Study||0||
59534354|NCT01581541|75631649|FG009|NOT COMPLETED|Overall Study||0||
59534355|NCT01581541|75631650|FG010|NOT COMPLETED|Overall Study||0||
59534356|NCT02142608|75631675|FG000|STARTED|Overall Study||18||
59534357|NCT02142608|75631675|FG000|COMPLETED|Overall Study||18||
59534358|NCT02142608|75631675|FG000|NOT COMPLETED|Overall Study||0||
59534359|NCT02143310|75631680|FG000|STARTED|Overall Study||209||
59534360|NCT02143310|75631680|FG000|COMPLETED|Overall Study||102||
59534361|NCT02143310|75631680|FG000|NOT COMPLETED|Overall Study||107||
59534362|NCT01582477|75631686|FG000|STARTED|Overall Study||12||
59534363|NCT01582477|75631687|FG001|STARTED|Overall Study||12||
59534364|NCT01582477|75631686|FG000|COMPLETED|Overall Study||12||
59534365|NCT01582477|75631687|FG001|COMPLETED|Overall Study||12||
59534366|NCT01582477|75631686|FG000|NOT COMPLETED|Overall Study||0||
59534367|NCT01582477|75631687|FG001|NOT COMPLETED|Overall Study||0||
59534368|NCT01583101|75631695|FG000|STARTED|Overall Study||1076||
59534369|NCT01583101|75631696|FG001|STARTED|Overall Study||1161||
59534370|NCT01583101|75631695|FG000|COMPLETED|Overall Study||1076||
59534371|NCT01583101|75631696|FG001|COMPLETED|Overall Study||1161||
59534372|NCT01583101|75631695|FG000|NOT COMPLETED|Overall Study||0||
59534373|NCT01583101|75631696|FG001|NOT COMPLETED|Overall Study||0||
59534374|NCT01585129|75631704|FG000|STARTED|Overall Study||41||
59534375|NCT01585129|75631705|FG001|STARTED|Overall Study||39||
59534376|NCT01585129|75631704|FG000|COMPLETED|Overall Study||41||
59534377|NCT01585129|75631705|FG001|COMPLETED|Overall Study||39||
59622757|NCT00445302|75734656|FG001|NOT COMPLETED|Overall Study||0||
59622758|NCT00445302|75734657|FG002|NOT COMPLETED|Overall Study||0||
59622759|NCT00445302|75734658|FG003|NOT COMPLETED|Overall Study||0||
59622760|NCT00502944|75734670|FG000|STARTED|Overall Study||2446||
59622761|NCT00502944|75734671|FG001|STARTED|Overall Study||2409||
59622762|NCT00502944|75734670|FG000|COMPLETED|Overall Study||1382||
59622763|NCT00502944|75734671|FG001|COMPLETED|Overall Study||643||
59622764|NCT00502944|75734670|FG000|NOT COMPLETED|Overall Study||1064||
59622765|NCT00502944|75734671|FG001|NOT COMPLETED|Overall Study||1766||
59622766|NCT00504504|75734677|FG000|STARTED|Overall Study||82||
59622767|NCT00504504|75734677|FG000|COMPLETED|Overall Study||82||
59622768|NCT00504504|75734677|FG000|NOT COMPLETED|Overall Study||0||
59622769|NCT00504660|75734683|FG000|STARTED|Overall Study||31||
59622770|NCT00504660|75734684|FG001|STARTED|Overall Study||43||
59622771|NCT00504660|75734683|FG000|COMPLETED|Overall Study||31||
59622772|NCT00504660|75734684|FG001|COMPLETED|Overall Study||43||
59622773|NCT00504660|75734683|FG000|NOT COMPLETED|Overall Study||0||
59622774|NCT00504660|75734684|FG001|NOT COMPLETED|Overall Study||0||
59622775|NCT00505362|75734692|FG000|STARTED|Overall Study||35||
59622776|NCT00505362|75734693|FG001|STARTED|Overall Study||28||
59622777|NCT00505362|75734692|FG000|COMPLETED|Overall Study||35||
59622778|NCT00505362|75734693|FG001|COMPLETED|Overall Study||28||
59622779|NCT00505362|75734692|FG000|NOT COMPLETED|Overall Study||0||
59622780|NCT00505362|75734693|FG001|NOT COMPLETED|Overall Study||0||
59622781|NCT00505518|75734699|FG000|STARTED|Overall Study||9||
59622782|NCT00505518|75734699|FG000|COMPLETED|Overall Study||9||
59622783|NCT00505518|75734699|FG000|NOT COMPLETED|Overall Study||0||
59534378|NCT01585129|75631704|FG000|NOT COMPLETED|Overall Study||0||
59622784|NCT00544674|75734703|FG000|STARTED|Overall Study|1 subject registered and expired prior to dosing|5||
59622785|NCT00544674|75734703|FG000|COMPLETED|Overall Study||4||
59622786|NCT00544674|75734703|FG000|NOT COMPLETED|Overall Study||1||
59622787|NCT00544908|75734707|FG000|STARTED|Overall Study||7||
59622788|NCT00544908|75734707|FG000|COMPLETED|Overall Study||7||
59622789|NCT00544908|75734707|FG000|NOT COMPLETED|Overall Study||0||
59622790|NCT00447330|75734711|FG000|STARTED|Overall Study|2 subjects signed the ICF, but were withdrawn from study prior to receiving any study drug|60||
59622791|NCT00447330|75734711|FG000|COMPLETED|Overall Study||58||
59622792|NCT00447330|75734711|FG000|NOT COMPLETED|Overall Study||2||
59622793|NCT02115048|75734718|FG000|STARTED|Overall Study||23||
59622794|NCT02115048|75734719|FG001|STARTED|Overall Study||21||
59622795|NCT02115048|75734718|FG000|COMPLETED|Overall Study||23|Trial terminated early and only 44 patients enrolled, preventing appropriate statistical calculation|
59622796|NCT02115048|75734719|FG001|COMPLETED|Overall Study||21|Trial terminated early and only 44 patients enrolled, preventing appropriate statistical calculation|
59622797|NCT02115048|75734718|FG000|NOT COMPLETED|Overall Study||0||
59622798|NCT02115048|75734719|FG001|NOT COMPLETED|Overall Study||0||
59622799|NCT00546156|75734727|FG000|STARTED|Overall Study||84||
59622800|NCT00546156|75734728|FG001|STARTED|Overall Study||20||
59622801|NCT00546156|75734727|FG000|COMPLETED|Overall Study||70||
59622802|NCT00546156|75734728|FG001|COMPLETED|Overall Study||19||
59622803|NCT00546156|75734727|FG000|NOT COMPLETED|Overall Study||14||
59622804|NCT00546156|75734728|FG001|NOT COMPLETED|Overall Study||1||
59622805|NCT00449046|75734733|FG000|STARTED|Overall Study||40||
59622806|NCT00449046|75734733|FG000|COMPLETED|Overall Study||40||
59622807|NCT00449046|75734733|FG000|NOT COMPLETED|Overall Study||0||
59622808|NCT00508716|75734739|FG000|STARTED|Overall Study||61||
59622809|NCT00508716|75734740|FG001|STARTED|Overall Study||63||
59622810|NCT00508716|75734739|FG000|COMPLETED|Overall Study||61||
59622811|NCT00508716|75734740|FG001|COMPLETED|Overall Study||63||
59622812|NCT00508716|75734739|FG000|NOT COMPLETED|Overall Study||0||
59622813|NCT00508716|75734740|FG001|NOT COMPLETED|Overall Study||0||
59622814|NCT00509496|75734748|FG000|STARTED|Overall Study||19||
59622815|NCT00509496|75734749|FG001|STARTED|Overall Study||2||
59622816|NCT00509496|75734748|FG000|COMPLETED|Overall Study||19||
59622817|NCT00509496|75734749|FG001|COMPLETED|Overall Study||2||
59622818|NCT00509496|75734748|FG000|NOT COMPLETED|Overall Study||0||
59622819|NCT00509496|75734749|FG001|NOT COMPLETED|Overall Study||0||
59622820|NCT00450294|75734755|FG000|STARTED|Overall Study||10||
59622821|NCT00450294|75734755|FG000|COMPLETED|Overall Study||10||
59622822|NCT00450294|75734755|FG000|NOT COMPLETED|Overall Study||0||
59622823|NCT00547638|75734762|FG000|STARTED|Overall Study||143||
59534379|NCT01585129|75631705|FG001|NOT COMPLETED|Overall Study||0||
59534380|NCT01585207|75631711|FG000|STARTED|Overall Study||4||
59534381|NCT01585207|75631711|FG000|COMPLETED|Overall Study||4||
59534382|NCT01585207|75631711|FG000|NOT COMPLETED|Overall Study||0||
59534383|NCT01585441|75631717|FG000|STARTED|Overall Study||3||
59534384|NCT01585441|75631718|FG001|STARTED|Overall Study||3||
59534385|NCT01585441|75631717|FG000|Month 3|Overall Study|One participant was not evaluated at Month 3 but at the final visit due to study terminating early.|2||
59534386|NCT01585441|75631718|FG001|Month 3|Overall Study||3||
59534387|NCT01585441|75631717|FG000|Received Finasteride at Month 3|Overall Study||2||
59534388|NCT01585441|75631718|FG001|Received Finasteride at Month 3|Overall Study||2||
59534389|NCT01585441|75631717|FG000|Final Study Safety Visit|Overall Study||3||
59565811|NCT02335242|75668229|FG000|COMPLETED|Open-label Phase (20 Weeks)||6||
59534390|NCT01585441|75631718|FG001|Final Study Safety Visit|Overall Study|A final study visit was not required for the placebo participant who completed the study at Month 3.|2||
59534391|NCT01585441|75631717|FG000|COMPLETED|Overall Study|Defined as completing the Month 3 masked phase of the study and/or the final safety visit|3||
59534392|NCT01585441|75631718|FG001|COMPLETED|Overall Study|Defined as completing the Month 3 masked phase of the study and/or the final safety visit|3||
59534393|NCT01585441|75631717|FG000|NOT COMPLETED|Overall Study||0||
59534394|NCT01585441|75631718|FG001|NOT COMPLETED|Overall Study||0||
59534395|NCT00617942|75631726|FG000|STARTED|Overall Study||37||
59534396|NCT00617942|75631727|FG001|STARTED|Overall Study||23||
59534397|NCT00617942|75631726|FG000|COMPLETED|Overall Study||29||
59534398|NCT00617942|75631727|FG001|COMPLETED|Overall Study||19||
59534399|NCT00617942|75631726|FG000|NOT COMPLETED|Overall Study||8||
59534400|NCT00617942|75631727|FG001|NOT COMPLETED|Overall Study||4||
59534401|NCT00618332|75631741|FG000|STARTED|Overall Study||20||
59534402|NCT00618332|75631742|FG001|STARTED|Overall Study||20||
59534403|NCT00618332|75631741|FG000|COMPLETED|Overall Study||20||
59534404|NCT00618332|75631742|FG001|COMPLETED|Overall Study||20||
59534405|NCT00618332|75631741|FG000|NOT COMPLETED|Overall Study||0||
59534406|NCT00618332|75631742|FG001|NOT COMPLETED|Overall Study||0||
59534407|NCT01585597|75631748|FG000|STARTED|Overall Study||20||
59534408|NCT01585597|75631748|FG000|COMPLETED|Overall Study||20||
59534409|NCT01585597|75631748|FG000|NOT COMPLETED|Overall Study||0||
59534410|NCT01588561|75631752|FG000|STARTED|Overall Study||14||
59534411|NCT01588561|75631753|FG001|STARTED|Overall Study||1||
59534412|NCT01588561|75631752|FG000|First Injection (Visit 1)|Overall Study||14||
59534413|NCT01588561|75631753|FG001|First Injection (Visit 1)|Overall Study||1||
59534414|NCT01588561|75631752|FG000|Rest Period|Overall Study||14|Generally 2-3 week rest period but a minimum of 1 month for women, based on menstrual cycles.|
59534415|NCT01588561|75631753|FG001|Rest Period|Overall Study||1|Generally 2-3 week rest period but a minimum of 1 month for women, based on menstrual cycles.|
59534416|NCT01588561|75631752|FG000|Second Injection (Visit 2)|Overall Study||14||
59534417|NCT01588561|75631753|FG001|Second Injection (Visit 2)|Overall Study||1||
59534418|NCT01588561|75631752|FG000|COMPLETED|Overall Study||14||
59534419|NCT01588561|75631753|FG001|COMPLETED|Overall Study||1||
59534420|NCT01588561|75631752|FG000|NOT COMPLETED|Overall Study||0||
59534421|NCT01588561|75631753|FG001|NOT COMPLETED|Overall Study||0||
59534422|NCT00619190|75631761|FG000|STARTED|Overall Study||21||
59534423|NCT00619190|75631762|FG001|STARTED|Overall Study||9||
59534424|NCT00619190|75631761|FG000|COMPLETED|Overall Study||20||
60075747|NCT01541397|76191040|FG000|NOT COMPLETED|Overall Study||4||
60075748|NCT01541397|76191041|FG001|NOT COMPLETED|Overall Study||2||
60075749|NCT01548417|76191049|FG000|STARTED|Overall Study||28||
60075750|NCT01548417|76191050|FG001|STARTED|Overall Study||28||
60075751|NCT01548417|76191049|FG000|COMPLETED|Overall Study||28||
60075752|NCT01548417|76191050|FG001|COMPLETED|Overall Study||26||
60075753|NCT01548417|76191049|FG000|NOT COMPLETED|Overall Study||0||
60075754|NCT01548417|76191050|FG001|NOT COMPLETED|Overall Study||2||
60075755|NCT01546857|76191058|FG000|STARTED|Overall Study||14||
60075756|NCT01546857|76191059|FG001|STARTED|Overall Study||20||
59534425|NCT00619190|75631762|FG001|COMPLETED|Overall Study||9||
59534426|NCT00619190|75631761|FG000|NOT COMPLETED|Overall Study||1||
59534427|NCT00619190|75631762|FG001|NOT COMPLETED|Overall Study||0||
59534428|NCT01589263|75631770|FG000|STARTED|Overall Study||9||
59534429|NCT01589263|75631771|FG001|STARTED|Overall Study||12||
59534430|NCT01589263|75631770|FG000|COMPLETED|Overall Study||9||
59534431|NCT01589263|75631771|FG001|COMPLETED|Overall Study||12||
59534432|NCT01589263|75631770|FG000|NOT COMPLETED|Overall Study||0||
59534433|NCT01589263|75631771|FG001|NOT COMPLETED|Overall Study||0||
59534434|NCT00674492|75631777|FG000|STARTED|Overall Study||21||
59534435|NCT00674492|75631777|FG000|COMPLETED|Overall Study||21||
59534436|NCT00674492|75631777|FG000|NOT COMPLETED|Overall Study||0||
59534437|NCT01590979|75631783|FG000|STARTED|Overall Study||27||
59534438|NCT01590979|75631784|FG001|STARTED|Overall Study||27||
59534439|NCT01590979|75631783|FG000|COMPLETED|Overall Study||27||
59534440|NCT01590979|75631784|FG001|COMPLETED|Overall Study||27||
59534441|NCT01590979|75631783|FG000|NOT COMPLETED|Overall Study||0||
59534442|NCT01590979|75631784|FG001|NOT COMPLETED|Overall Study||0||
59534443|NCT00619970|75631793|FG000|STARTED|Overall Study||40||
59534444|NCT00619970|75631794|FG001|STARTED|Overall Study||49||
59534445|NCT00619970|75631795|FG002|STARTED|Overall Study||26||
59534446|NCT00619970|75631793|FG000|COMPLETED|Overall Study||40||
59534447|NCT00619970|75631794|FG001|COMPLETED|Overall Study||46||
59534448|NCT00619970|75631795|FG002|COMPLETED|Overall Study||24||
59534449|NCT00619970|75631793|FG000|NOT COMPLETED|Overall Study||0||
59534450|NCT00619970|75631794|FG001|NOT COMPLETED|Overall Study||3||
59534451|NCT00619970|75631795|FG002|NOT COMPLETED|Overall Study||2||
59534452|NCT01591837|75631807|FG000|STARTED|Overall Study||60||
59534453|NCT01591837|75631808|FG001|STARTED|Overall Study||60||
59534454|NCT01591837|75631807|FG000|COMPLETED|Overall Study||60||
59534455|NCT01591837|75631808|FG001|COMPLETED|Overall Study||60||
59534456|NCT01591837|75631807|FG000|NOT COMPLETED|Overall Study||0||
59534457|NCT01591837|75631808|FG001|NOT COMPLETED|Overall Study||0||
59534458|NCT01592071|75631814|FG000|STARTED|Overall Study||120||
59534459|NCT01592071|75631814|FG000|COMPLETED|Overall Study||120||
59534460|NCT01592071|75631814|FG000|NOT COMPLETED|Overall Study||0||
59534461|NCT03531788|75631820|FG000|STARTED|Overall Study||12||
59534462|NCT03531788|75631821|FG001|STARTED|Overall Study||6||
59534463|NCT03531788|75631820|FG000|COMPLETED|Overall Study||11||
59534464|NCT03531788|75631821|FG001|COMPLETED|Overall Study||6||
59534465|NCT03531788|75631820|FG000|NOT COMPLETED|Overall Study||1||
59534466|NCT03531788|75631821|FG001|NOT COMPLETED|Overall Study||0||
59534467|NCT01592851|75631829|FG000|STARTED|Overall Study||56||
59534468|NCT01592851|75631830|FG001|STARTED|Overall Study||57||
59534469|NCT01592851|75631829|FG000|COMPLETED|Overall Study||56||
59534470|NCT01592851|75631830|FG001|COMPLETED|Overall Study||57||
59534471|NCT01592851|75631829|FG000|NOT COMPLETED|Overall Study||0||
59534472|NCT01592851|75631830|FG001|NOT COMPLETED|Overall Study||0||
59534473|NCT00675584|75631838|FG000|STARTED|Overall Study||139||
59534474|NCT00675584|75631839|FG001|STARTED|Overall Study||139||
59534475|NCT00675584|75631838|FG000|COMPLETED|Overall Study||100||
59534476|NCT00675584|75631839|FG001|COMPLETED|Overall Study||113||
59534477|NCT00675584|75631838|FG000|NOT COMPLETED|Overall Study||39||
59534478|NCT00675584|75631839|FG001|NOT COMPLETED|Overall Study||26||
59534479|NCT00620126|75631847|FG000|STARTED|Overall Study||25||
59534480|NCT00620126|75631848|FG001|STARTED|Overall Study||22||
59534481|NCT00620126|75631847|FG000|COMPLETED|Overall Study||14||
59534482|NCT00620126|75631848|FG001|COMPLETED|Overall Study||17||
59534483|NCT00620126|75631847|FG000|NOT COMPLETED|Overall Study||11||
59534484|NCT00620126|75631848|FG001|NOT COMPLETED|Overall Study||5||
59534485|NCT00620828|75631856|FG000|STARTED|Overall Study||32||
59534486|NCT00620828|75631857|FG001|STARTED|Overall Study||35||
59534487|NCT00620828|75631856|FG000|Number of Subjects Enrolled = 67|Overall Study||32||
59534488|NCT00620828|75631857|FG001|Number of Subjects Enrolled = 67|Overall Study||35||
59534489|NCT00620828|75631856|FG000|COMPLETED|Overall Study||32||
59534490|NCT00620828|75631857|FG001|COMPLETED|Overall Study||35||
59534491|NCT00620828|75631856|FG000|NOT COMPLETED|Overall Study||0||
59534492|NCT00620828|75631857|FG001|NOT COMPLETED|Overall Study||0||
59534493|NCT01596283|75631865|FG000|STARTED|Overall Study||69||
59534494|NCT01596283|75631866|FG001|STARTED|Overall Study||66||
59534495|NCT01596283|75631865|FG000|COMPLETED|Overall Study||69||
59534496|NCT01596283|75631866|FG001|COMPLETED|Overall Study||66||
59534497|NCT01596283|75631865|FG000|NOT COMPLETED|Overall Study||0||
59534498|NCT01596283|75631866|FG001|NOT COMPLETED|Overall Study||0||
59534499|NCT00676364|75631876|FG000|STARTED|Overall Study||57||
59534500|NCT00676364|75631877|FG001|STARTED|Overall Study||57||
59534501|NCT00676364|75631876|FG000|COMPLETED|Overall Study||57||
59534502|NCT00676364|75631877|FG001|COMPLETED|Overall Study||57||
59534503|NCT00676364|75631876|FG000|NOT COMPLETED|Overall Study||0||
59534504|NCT00676364|75631877|FG001|NOT COMPLETED|Overall Study||0||
59534505|NCT00676676|75631885|FG000|STARTED|Overall Study||9||
59534506|NCT00676676|75631885|FG000|COMPLETED|Overall Study||9||
59534507|NCT00676676|75631885|FG000|NOT COMPLETED|Overall Study||0||
59534508|NCT00677690|75631891|FG000|STARTED|Overall Study||42||
59534509|NCT00677690|75631892|FG001|STARTED|Overall Study||41||
59534510|NCT00677690|75631891|FG000|COMPLETED|Overall Study||42||
59534511|NCT00677690|75631892|FG001|COMPLETED|Overall Study||41||
59534512|NCT00677690|75631891|FG000|NOT COMPLETED|Overall Study||0||
59534513|NCT00677690|75631892|FG001|NOT COMPLETED|Overall Study||0||
59534514|NCT00621530|75631900|FG000|STARTED|Overall Study||30||
59534515|NCT00621530|75631901|FG001|STARTED|Overall Study||32||
59534516|NCT00621530|75631900|FG000|COMPLETED|Overall Study||28||
59534517|NCT00621530|75631901|FG001|COMPLETED|Overall Study||29||
59534518|NCT00621530|75631900|FG000|NOT COMPLETED|Overall Study||2||
59534519|NCT00621530|75631901|FG001|NOT COMPLETED|Overall Study||3||
59534520|NCT02513472|75631912|FG000|STARTED|Overall Study||66||
59534521|NCT02513472|75631913|FG001|STARTED|Overall Study||101||
59534522|NCT02513472|75631912|FG000|Phase 1b Safety run-in|Overall Study||3||
59534523|NCT02513472|75631913|FG001|Phase 1b Safety run-in|Overall Study||4||
59534524|NCT02513472|75631912|FG000|Phase 2|Overall Study||63||
59534525|NCT02513472|75631913|FG001|Phase 2|Overall Study||97||
59534526|NCT02513472|75631912|FG000|COMPLETED|Overall Study||0||
59534527|NCT02513472|75631913|FG001|COMPLETED|Overall Study||0||
59534528|NCT02513472|75631912|FG000|NOT COMPLETED|Overall Study||66||
59534529|NCT02513472|75631913|FG001|NOT COMPLETED|Overall Study||101||
59534530|NCT01596595|75631921|FG000|STARTED|Overall Study||1779||
59534531|NCT01596595|75631921|FG000|COMPLETED|Overall Study||814||
59534532|NCT01596595|75631921|FG000|NOT COMPLETED|Overall Study||965||
59534533|NCT00621686|75631927|FG000|STARTED|Overall Study||19||
59534534|NCT00621686|75631928|FG001|STARTED|Overall Study||35||
59534535|NCT00621686|75631927|FG000|COMPLETED|Overall Study||19||
59534536|NCT00621686|75631928|FG001|COMPLETED|Overall Study||35||
59534537|NCT00621686|75631927|FG000|NOT COMPLETED|Overall Study||0||
59534538|NCT00621686|75631928|FG001|NOT COMPLETED|Overall Study||0||
59534539|NCT00678470|75631935|FG000|STARTED|Overall Study||18||
59534540|NCT00678470|75631935|FG000|COMPLETED|Overall Study||14||
59534541|NCT00678470|75631935|FG000|NOT COMPLETED|Overall Study||4||
59534542|NCT00622544|75631939|FG000|STARTED|Overall Study||44||
59534543|NCT00622544|75631939|FG000|COMPLETED|Overall Study|35|35||
59534544|NCT00622544|75631939|FG000|NOT COMPLETED|Overall Study||9||
59534545|NCT00679952|75631945|FG000|STARTED|Overall Study||86||
59534546|NCT00679952|75631946|FG001|STARTED|Overall Study||82||
59534547|NCT00679952|75631945|FG000|COMPLETED|Overall Study||86||
59534548|NCT00679952|75631946|FG001|COMPLETED|Overall Study||82||
59534549|NCT00679952|75631945|FG000|NOT COMPLETED|Overall Study||0||
59534550|NCT00679952|75631946|FG001|NOT COMPLETED|Overall Study||0||
59534551|NCT00623012|75631952|FG000|STARTED|Overall Study||2||
59534552|NCT00623012|75631952|FG000|COMPLETED|Overall Study||2||
59534553|NCT00623012|75631952|FG000|NOT COMPLETED|Overall Study||0||
59534554|NCT02699060|75631959|FG000|STARTED|Overall Study||68||
59534555|NCT02699060|75631959|FG000|COMPLETED|Overall Study||68||
59534556|NCT02699060|75631959|FG000|NOT COMPLETED|Overall Study||0||
59534557|NCT00623636|75631969|FG000|STARTED|Double Blind||452||
59534558|NCT00623636|75631970|FG001|STARTED|Double Blind||450||
59534559|NCT00623636|75631969|FG000|COMPLETED|Double Blind||419||
59534560|NCT00623636|75631970|FG001|COMPLETED|Double Blind||422||
59534561|NCT00623636|75631969|FG000|NOT COMPLETED|Double Blind||33||
59534562|NCT00623636|75631970|FG001|NOT COMPLETED|Double Blind||28||
59534563|NCT00623636|75631969|FG000|STARTED|Open Label|Eligible double-blind placebo patients received MAP0004 in the open-label period.|0||
59534564|NCT00623636|75631970|FG001|STARTED|Open Label|Includes eligible Placebo and MAP0004 patients from the double-blind period.|675||
59534565|NCT00623636|75631969|FG000|COMPLETED|Open Label||0||
59534566|NCT00623636|75631970|FG001|COMPLETED|Open Label||263||
59534567|NCT00623636|75631969|FG000|NOT COMPLETED|Open Label||0||
59534568|NCT00623636|75631970|FG001|NOT COMPLETED|Open Label||412||
59534569|NCT00623714|75631977|FG000|STARTED|Period 1||6||
59534570|NCT00623714|75631978|FG001|STARTED|Period 1||7||
59534571|NCT00623714|75631977|FG000|COMPLETED|Period 1||6||
59534572|NCT00623714|75631978|FG001|COMPLETED|Period 1||7||
59534573|NCT00623714|75631977|FG000|NOT COMPLETED|Period 1||0||
59534574|NCT00623714|75631978|FG001|NOT COMPLETED|Period 1||0||
59534575|NCT00623714|75631977|FG000|STARTED|Period 2||6||
59534576|NCT00623714|75631978|FG001|STARTED|Period 2||7||
59534577|NCT00623714|75631977|FG000|COMPLETED|Period 2||6||
59534578|NCT00623714|75631978|FG001|COMPLETED|Period 2||7||
59534579|NCT00623714|75631977|FG000|NOT COMPLETED|Period 2||0||
59534580|NCT00623714|75631978|FG001|NOT COMPLETED|Period 2||0||
59534581|NCT02139800|75631986|FG000|STARTED|Overall Study||224||
59534582|NCT02139800|75631987|FG001|STARTED|Overall Study||236||
59534583|NCT02139800|75631986|FG000|COMPLETED|Overall Study||211|These infants have completed their 36 week PMA primary outcome|
59534584|NCT02139800|75631987|FG001|COMPLETED|Overall Study||215|These infants have completed their 36 week PMA primary outcome|
59534585|NCT02139800|75631986|FG000|NOT COMPLETED|Overall Study||13||
59534586|NCT02139800|75631987|FG001|NOT COMPLETED|Overall Study||21||
59534587|NCT02139878|75631993|FG000|STARTED|First Intervention (7 Days)||10||
59534588|NCT02139878|75631994|FG001|STARTED|First Intervention (7 Days)||10||
59534589|NCT02139878|75631993|FG000|COMPLETED|First Intervention (7 Days)||9||
59534590|NCT02139878|75631994|FG001|COMPLETED|First Intervention (7 Days)||10||
59534591|NCT02139878|75631993|FG000|NOT COMPLETED|First Intervention (7 Days)||1||
59622824|NCT00547638|75734763|FG001|STARTED|Overall Study||73||
59622825|NCT00547638|75734762|FG000|COMPLETED|Overall Study||119||
59622826|NCT00547638|75734763|FG001|COMPLETED|Overall Study||59||
59622827|NCT00547638|75734762|FG000|NOT COMPLETED|Overall Study||24||
59622828|NCT00547638|75734763|FG001|NOT COMPLETED|Overall Study||14||
59622829|NCT00510744|75734769|FG000|STARTED|Overall Study||5||
59622830|NCT00510744|75734769|FG000|COMPLETED|Overall Study||5||
59622831|NCT00510744|75734769|FG000|NOT COMPLETED|Overall Study||0||
59622832|NCT00548418|75734773|FG000|STARTED|Overall Study||27||
59622833|NCT00548418|75734773|FG000|COMPLETED|Overall Study||27||
59622834|NCT00548418|75734773|FG000|NOT COMPLETED|Overall Study||0||
59622835|NCT00511914|75734779|FG000|STARTED|Overall Study||68||
59622836|NCT00511914|75734780|FG001|STARTED|Overall Study||67||
59622837|NCT00511914|75734779|FG000|COMPLETED|Overall Study||68||
59622838|NCT00511914|75734780|FG001|COMPLETED|Overall Study||67||
59622839|NCT00511914|75734779|FG000|NOT COMPLETED|Overall Study||0||
59622840|NCT00511914|75734780|FG001|NOT COMPLETED|Overall Study||0||
59622841|NCT00511992|75734786|FG000|STARTED|Overall Study||20||
59622842|NCT00511992|75734786|FG000|COMPLETED|Overall Study||13||
59622843|NCT00511992|75734786|FG000|NOT COMPLETED|Overall Study||7||
59622844|NCT00451698|75734792|FG000|STARTED|Overall Study||3||
59622845|NCT00451698|75734793|FG001|STARTED|Overall Study||6||
59622846|NCT00451698|75734792|FG000|COMPLETED|Overall Study||3||
59622847|NCT00451698|75734793|FG001|COMPLETED|Overall Study||6||
59622848|NCT00451698|75734792|FG000|NOT COMPLETED|Overall Study||0||
59622849|NCT00451698|75734793|FG001|NOT COMPLETED|Overall Study||0||
59622850|NCT00548652|75734804|FG000|STARTED|Overall Study||18||
59622851|NCT00548652|75734805|FG001|STARTED|Overall Study||38||
59622852|NCT00548652|75734806|FG002|STARTED|Overall Study||45||
59622853|NCT00548652|75734804|FG000|COMPLETED|Overall Study||16||
59622854|NCT00548652|75734805|FG001|COMPLETED|Overall Study||29||
59622855|NCT00548652|75734806|FG002|COMPLETED|Overall Study||34||
59622856|NCT00548652|75734804|FG000|NOT COMPLETED|Overall Study||2||
59622857|NCT00548652|75734805|FG001|NOT COMPLETED|Overall Study||9||
59622858|NCT00548652|75734806|FG002|NOT COMPLETED|Overall Study||11||
59622859|NCT00549042|75734816|FG000|STARTED|Conversion and Titration Phase||459||
59622860|NCT00549042|75734817|FG001|STARTED|Conversion and Titration Phase|Per the study design, no patients received placebo during this phase.|0||
59622861|NCT00549042|75734816|FG000|COMPLETED|Conversion and Titration Phase||268||
59622862|NCT00549042|75734817|FG001|COMPLETED|Conversion and Titration Phase|Per the study design, no patients received placebo during this phase.|0||
59622863|NCT00549042|75734816|FG000|NOT COMPLETED|Conversion and Titration Phase||191||
59622864|NCT00549042|75734817|FG001|NOT COMPLETED|Conversion and Titration Phase||0||
59622865|NCT00549042|75734816|FG000|STARTED|Double-blind Phase||134|Patients who completed titration and conversion were allowed in the double-blind phase.|
59622866|NCT00549042|75734817|FG001|STARTED|Double-blind Phase||134|Patients who completed titration and conversion were allowed in the double-blind phase.|
59622867|NCT00549042|75734816|FG000|COMPLETED|Double-blind Phase||66||
59622868|NCT00549042|75734817|FG001|COMPLETED|Double-blind Phase||44||
59622869|NCT00549042|75734816|FG000|NOT COMPLETED|Double-blind Phase||68||
59622870|NCT00549042|75734817|FG001|NOT COMPLETED|Double-blind Phase||90||
59622871|NCT00452868|75734824|FG000|STARTED|Overall Study||13||
59622872|NCT00452868|75734824|FG000|COMPLETED|Overall Study||11||
59622873|NCT00452868|75734824|FG000|NOT COMPLETED|Overall Study||2||
59622874|NCT00453336|75734828|FG000|STARTED|Overall Study||45||
59622875|NCT00453336|75734828|FG000|COMPLETED|Overall Study||45||
59622876|NCT00453336|75734828|FG000|NOT COMPLETED|Overall Study||0||
59622877|NCT00549822|75734832|FG000|STARTED|Overall Study||3||
59622878|NCT00549822|75734832|FG000|COMPLETED|Overall Study||3||
59622879|NCT00549822|75734832|FG000|NOT COMPLETED|Overall Study||0||
59622880|NCT00550290|75734838|FG000|STARTED|Overall Study||10||
59622881|NCT00550290|75734839|FG001|STARTED|Overall Study||8||
59622882|NCT00550290|75734838|FG000|COMPLETED|Overall Study||10||
59622883|NCT00550290|75734839|FG001|COMPLETED|Overall Study||8||
59622884|NCT00550290|75734838|FG000|NOT COMPLETED|Overall Study||0||
59622885|NCT00550290|75734839|FG001|NOT COMPLETED|Overall Study||0||
59622886|NCT00550368|75734847|FG000|STARTED|Overall Study||26||
59622887|NCT00550368|75734848|FG001|STARTED|Overall Study||19||
59622888|NCT00550368|75734847|FG000|COMPLETED|Overall Study||26||
59622889|NCT00550368|75734848|FG001|COMPLETED|Overall Study||19||
59622890|NCT00550368|75734847|FG000|NOT COMPLETED|Overall Study||0||
59622891|NCT00550368|75734848|FG001|NOT COMPLETED|Overall Study||0||
59622892|NCT00551070|75734854|FG000|STARTED|Overall Study||52||
59622893|NCT00551070|75734854|FG000|COMPLETED|Overall Study||52||
59622894|NCT00551070|75734854|FG000|NOT COMPLETED|Overall Study||0||
59622895|NCT00552786|75734860|FG000|STARTED|First Intervention||25||
59622896|NCT00552786|75734861|FG001|STARTED|First Intervention||28||
59622897|NCT00552786|75734860|FG000|Medication and Hearing Evaluation|First Intervention||25||
59622898|NCT00552786|75734861|FG001|Medication and Hearing Evaluation|First Intervention||28||
59622899|NCT00552786|75734860|FG000|COMPLETED|First Intervention||25||
59622900|NCT00552786|75734861|FG001|COMPLETED|First Intervention||28||
59622901|NCT00552786|75734860|FG000|NOT COMPLETED|First Intervention||0||
59622902|NCT00552786|75734861|FG001|NOT COMPLETED|First Intervention||0||
59622903|NCT00552786|75734860|FG000|STARTED|Washout Period of 2 Weeks||25||
59622904|NCT00552786|75734861|FG001|STARTED|Washout Period of 2 Weeks||28||
59534592|NCT02139878|75631994|FG001|NOT COMPLETED|First Intervention (7 Days)||0||
59534593|NCT02139878|75631993|FG000|STARTED|Washout Period (8 Days)||9||
59534594|NCT02139878|75631994|FG001|STARTED|Washout Period (8 Days)||10||
59534595|NCT02139878|75631993|FG000|COMPLETED|Washout Period (8 Days)||9||
59534596|NCT02139878|75631994|FG001|COMPLETED|Washout Period (8 Days)||10||
59534597|NCT02139878|75631993|FG000|NOT COMPLETED|Washout Period (8 Days)||0||
59534598|NCT02139878|75631994|FG001|NOT COMPLETED|Washout Period (8 Days)||0||
59534599|NCT02139878|75631993|FG000|STARTED|Second Intervention (7 Days)||9||
59534600|NCT02139878|75631994|FG001|STARTED|Second Intervention (7 Days)||10||
59534601|NCT02139878|75631993|FG000|COMPLETED|Second Intervention (7 Days)||9||
59534602|NCT02139878|75631994|FG001|COMPLETED|Second Intervention (7 Days)||10||
59534603|NCT02139878|75631993|FG000|NOT COMPLETED|Second Intervention (7 Days)||0||
59534604|NCT02139878|75631994|FG001|NOT COMPLETED|Second Intervention (7 Days)||0||
59534605|NCT00624416|75632000|FG000|STARTED|Overall Study||10||
59534606|NCT00624416|75632000|FG000|COMPLETED|Overall Study||10||
59534607|NCT00624416|75632000|FG000|NOT COMPLETED|Overall Study||0||
59534608|NCT00682838|75632008|FG000|STARTED|Overall Study||65||
59534609|NCT00682838|75632009|FG001|STARTED|Overall Study||67||
59534610|NCT00682838|75632010|FG002|STARTED|Overall Study||75||
59534611|NCT00682838|75632011|FG003|STARTED|Overall Study||73||
59534612|NCT00682838|75632008|FG000|COMPLETED|Overall Study||65||
59534613|NCT00682838|75632009|FG001|COMPLETED|Overall Study||67||
59534614|NCT00682838|75632010|FG002|COMPLETED|Overall Study||75||
59534615|NCT00682838|75632011|FG003|COMPLETED|Overall Study||73||
59534616|NCT00682838|75632008|FG000|NOT COMPLETED|Overall Study||0||
59534617|NCT00682838|75632009|FG001|NOT COMPLETED|Overall Study||0||
59534618|NCT00682838|75632010|FG002|NOT COMPLETED|Overall Study||0||
59534619|NCT00682838|75632011|FG003|NOT COMPLETED|Overall Study||0||
59534620|NCT00624806|75632023|FG000|STARTED|Overall Study||10||
59534621|NCT00624806|75632024|FG001|STARTED|Overall Study||8||
59534622|NCT00624806|75632023|FG000|COMPLETED|Overall Study||10||
59534623|NCT00624806|75632024|FG001|COMPLETED|Overall Study||8||
59534624|NCT00624806|75632023|FG000|NOT COMPLETED|Overall Study||0||
59534625|NCT00624806|75632024|FG001|NOT COMPLETED|Overall Study||0||
59534626|NCT00626210|75632030|FG000|STARTED|Overall Study||2||
59534627|NCT00626210|75632030|FG000|COMPLETED|Overall Study||2||
59534628|NCT00626210|75632030|FG000|NOT COMPLETED|Overall Study||0||
59534629|NCT00683852|75632036|FG000|STARTED|30-Day Phase 1 Period||56||
59534630|NCT00683852|75632037|FG001|STARTED|30-Day Phase 1 Period||84||
59534631|NCT00683852|75632038|FG002|STARTED|30-Day Phase 1 Period||85||
59534632|NCT00683852|75632036|FG000|COMPLETED|30-Day Phase 1 Period||54||
59534633|NCT00683852|75632037|FG001|COMPLETED|30-Day Phase 1 Period||83||
59534634|NCT00683852|75632038|FG002|COMPLETED|30-Day Phase 1 Period||84||
59534635|NCT00683852|75632036|FG000|NOT COMPLETED|30-Day Phase 1 Period||2||
59534636|NCT00683852|75632037|FG001|NOT COMPLETED|30-Day Phase 1 Period||1||
59534637|NCT00683852|75632038|FG002|NOT COMPLETED|30-Day Phase 1 Period||1||
59534638|NCT00683852|75632036|FG000|STARTED|30-Day Phase 2 Period||54||
59534639|NCT00683852|75632037|FG001|STARTED|30-Day Phase 2 Period||83||
59534640|NCT00683852|75632038|FG002|STARTED|30-Day Phase 2 Period||84||
59534641|NCT00683852|75632036|FG000|COMPLETED|30-Day Phase 2 Period||48||
59534642|NCT00683852|75632037|FG001|COMPLETED|30-Day Phase 2 Period||78||
59534643|NCT00683852|75632038|FG002|COMPLETED|30-Day Phase 2 Period||75||
59534644|NCT00683852|75632036|FG000|NOT COMPLETED|30-Day Phase 2 Period||6||
59534645|NCT00683852|75632037|FG001|NOT COMPLETED|30-Day Phase 2 Period||5||
59534646|NCT00683852|75632038|FG002|NOT COMPLETED|30-Day Phase 2 Period||9||
59534647|NCT01596751|75632061|FG000|STARTED|Overall Study||5||
59534648|NCT01596751|75632062|FG001|STARTED|Overall Study||4||
59534649|NCT01596751|75632063|FG002|STARTED|Overall Study||3||
59534650|NCT01596751|75632064|FG003|STARTED|Overall Study||6||
59534651|NCT01596751|75632065|FG004|STARTED|Overall Study||4||
59534652|NCT01596751|75632066|FG005|STARTED|Overall Study||6||
59534653|NCT01596751|75632067|FG006|STARTED|Overall Study||17||
59534654|NCT01596751|75632068|FG007|STARTED|Overall Study||22||
59534655|NCT01596751|75632061|FG000|COMPLETED|Overall Study||5||
59534656|NCT01596751|75632062|FG001|COMPLETED|Overall Study||4||
59534657|NCT01596751|75632063|FG002|COMPLETED|Overall Study||3||
59534658|NCT01596751|75632064|FG003|COMPLETED|Overall Study||6||
59534659|NCT01596751|75632065|FG004|COMPLETED|Overall Study||4||
59534660|NCT01596751|75632066|FG005|COMPLETED|Overall Study||6||
59534661|NCT01596751|75632067|FG006|COMPLETED|Overall Study||17||
59534662|NCT01596751|75632068|FG007|COMPLETED|Overall Study||22||
59534663|NCT01596751|75632061|FG000|NOT COMPLETED|Overall Study||0||
59534664|NCT01596751|75632062|FG001|NOT COMPLETED|Overall Study||0||
59534665|NCT01596751|75632063|FG002|NOT COMPLETED|Overall Study||0||
59534666|NCT01596751|75632064|FG003|NOT COMPLETED|Overall Study||0||
59534667|NCT01596751|75632065|FG004|NOT COMPLETED|Overall Study||0||
59534668|NCT01596751|75632066|FG005|NOT COMPLETED|Overall Study||0||
59534669|NCT01596751|75632067|FG006|NOT COMPLETED|Overall Study||0||
59534670|NCT01596751|75632068|FG007|NOT COMPLETED|Overall Study||0||
59534671|NCT02216695|75632086|FG000|STARTED|Overall Study||64882||
59534672|NCT02216695|75632086|FG000|COMPLETED|Overall Study|This is a database study and hence, 64882 patients were finally included|64882||
59534673|NCT02216695|75632086|FG000|NOT COMPLETED|Overall Study||0||
59534674|NCT00683930|75632098|FG000|STARTED|Overall Study|One subject not included: no study drug dispensed.|36||
59534675|NCT00683930|75632099|FG001|STARTED|Overall Study|One subject not included: no study drug dispensed.|21||
59534676|NCT00683930|75632100|FG002|STARTED|Overall Study||37||
59534677|NCT00683930|75632098|FG000|COMPLETED|Overall Study||29||
59534678|NCT00683930|75632099|FG001|COMPLETED|Overall Study||18||
59534679|NCT00683930|75632100|FG002|COMPLETED|Overall Study||28||
59534680|NCT00683930|75632098|FG000|NOT COMPLETED|Overall Study||7||
59534681|NCT00683930|75632099|FG001|NOT COMPLETED|Overall Study||3||
59534682|NCT00683930|75632100|FG002|NOT COMPLETED|Overall Study||9||
59534683|NCT00684242|75632109|FG000|STARTED|Overall Study||3||
59534684|NCT00684242|75632109|FG000|COMPLETED|Overall Study||3||
59534685|NCT00684242|75632109|FG000|NOT COMPLETED|Overall Study||0||
59534686|NCT00684320|75632115|FG000|STARTED|Overall Study||26||
59534687|NCT00684320|75632116|FG001|STARTED|Overall Study||22||
59534688|NCT00684320|75632115|FG000|COMPLETED|Overall Study||22||
59534689|NCT00684320|75632116|FG001|COMPLETED|Overall Study||22||
59534690|NCT00684320|75632115|FG000|NOT COMPLETED|Overall Study||4||
59534691|NCT00684320|75632116|FG001|NOT COMPLETED|Overall Study||0||
59534692|NCT00684554|75632124|FG000|STARTED|Overall Study||10||
59534693|NCT00684554|75632125|FG001|STARTED|Overall Study||10||
59534694|NCT00684554|75632124|FG000|COMPLETED|Overall Study||10||
59534695|NCT00684554|75632125|FG001|COMPLETED|Overall Study||10||
59534696|NCT00684554|75632124|FG000|NOT COMPLETED|Overall Study||0||
59534697|NCT00684554|75632125|FG001|NOT COMPLETED|Overall Study||0||
59534698|NCT04490395|75632133|FG000|STARTED|Overall Study||19||
59534699|NCT04490395|75632134|FG001|STARTED|Overall Study||20||
59534700|NCT04490395|75632133|FG000|COMPLETED|Overall Study||19||
59534701|NCT04490395|75632134|FG001|COMPLETED|Overall Study||19||
59534702|NCT04490395|75632133|FG000|NOT COMPLETED|Overall Study||0||
59534703|NCT04490395|75632134|FG001|NOT COMPLETED|Overall Study||1||
59534704|NCT00626912|75632142|FG000|STARTED|Overall Study||222||
59534705|NCT00626912|75632143|FG001|STARTED|Overall Study||225||
59534706|NCT00626912|75632142|FG000|COMPLETED|Overall Study||220||
59534707|NCT00626912|75632143|FG001|COMPLETED|Overall Study||215||
59534708|NCT00626912|75632142|FG000|NOT COMPLETED|Overall Study||2||
59534709|NCT00626912|75632143|FG001|NOT COMPLETED|Overall Study||10||
59534710|NCT00628394|75632153|FG000|STARTED|Overall Study||14|Participants that made it past Randomization and one session of CR/Control.|
59534711|NCT00628394|75632154|FG001|STARTED|Overall Study||13|Participants that made it past Randomization and one session of CR/Control.|
59534712|NCT00628394|75632155|FG002|STARTED|Overall Study||13|Participants that made it past Randomization and one session of CR/Control.|
59534713|NCT00628394|75632156|FG003|STARTED|Overall Study||13|Participants that made it past Randomization and one session of CR/Control.|
59534714|NCT00628394|75632153|FG000|COMPLETED|Overall Study||10||
59534715|NCT00628394|75632154|FG001|COMPLETED|Overall Study||9||
59534716|NCT00628394|75632155|FG002|COMPLETED|Overall Study||11||
59534717|NCT00628394|75632156|FG003|COMPLETED|Overall Study||10||
59534718|NCT00628394|75632153|FG000|NOT COMPLETED|Overall Study||4||
59534719|NCT00628394|75632154|FG001|NOT COMPLETED|Overall Study||4||
59534720|NCT00628394|75632155|FG002|NOT COMPLETED|Overall Study||2||
59534721|NCT00628394|75632156|FG003|NOT COMPLETED|Overall Study||3||
59534722|NCT00684788|75632168|FG000|STARTED|Overall Study||17||
59534723|NCT00684788|75632169|FG001|STARTED|Overall Study||18||
59534724|NCT00684788|75632168|FG000|COMPLETED|Overall Study||17||
59534725|NCT00684788|75632169|FG001|COMPLETED|Overall Study||18||
59534726|NCT00684788|75632168|FG000|NOT COMPLETED|Overall Study||0||
59534727|NCT00684788|75632169|FG001|NOT COMPLETED|Overall Study||0||
59534728|NCT00628628|75632183|FG000|STARTED|Overall Study||40||
59534729|NCT00628628|75632184|FG001|STARTED|Overall Study||40||
59534730|NCT00628628|75632183|FG000|COMPLETED|Overall Study||40||
59534731|NCT00628628|75632184|FG001|COMPLETED|Overall Study||40||
59534732|NCT00628628|75632183|FG000|NOT COMPLETED|Overall Study||0||
59534733|NCT00628628|75632184|FG001|NOT COMPLETED|Overall Study||0||
59534734|NCT00629018|75632192|FG000|STARTED|Overall Study||55||
59534735|NCT00629018|75632193|FG001|STARTED|Overall Study||55||
59534736|NCT00629018|75632192|FG000|COMPLETED|Overall Study||55||
59534737|NCT00629018|75632193|FG001|COMPLETED|Overall Study||55||
59534738|NCT00629018|75632192|FG000|NOT COMPLETED|Overall Study||0||
59534739|NCT00629018|75632193|FG001|NOT COMPLETED|Overall Study||0||
59534740|NCT00630734|75632202|FG000|STARTED|Overall Study||11||
59534741|NCT00630734|75632203|FG001|STARTED|Overall Study||13||
59534742|NCT00630734|75632204|FG002|STARTED|Overall Study||8||
59534743|NCT00630734|75632202|FG000|COMPLETED|Overall Study||9||
59534744|NCT00630734|75632203|FG001|COMPLETED|Overall Study||12||
59534745|NCT00630734|75632204|FG002|COMPLETED|Overall Study||7||
59534746|NCT00630734|75632202|FG000|NOT COMPLETED|Overall Study||2||
59534747|NCT00630734|75632203|FG001|NOT COMPLETED|Overall Study||1||
59534748|NCT00630734|75632204|FG002|NOT COMPLETED|Overall Study||1||
59534749|NCT00686582|75632217|FG000|STARTED|Overall Study||92|Blood Draw for Antibody Persistence 2 yrs after study POX-MVA-005|
59534750|NCT00686582|75632218|FG001|STARTED|Overall Study||91|Blood Draw for Antibody Persistence 2 yrs after study POX-MVA-005|
59534751|NCT00686582|75632219|FG002|STARTED|Overall Study||121|Blood Draw for Antibody Persistence 2 yrs after study POX-MVA-005|
59534752|NCT00686582|75632217|FG000|Booster Vaccination|Overall Study||75||
59534753|NCT00686582|75632218|FG001|Booster Vaccination|Overall Study||77||
59534754|NCT00686582|75632219|FG002|Booster Vaccination|Overall Study||0||
59534755|NCT00686582|75632217|FG000|COMPLETED|Overall Study||74|Active trial phase|
59534756|NCT00686582|75632218|FG001|COMPLETED|Overall Study||77|Active trial phase|
59534757|NCT00686582|75632219|FG002|COMPLETED|Overall Study||121|Active trial phase|
59534758|NCT00686582|75632217|FG000|NOT COMPLETED|Overall Study||18||
59534759|NCT00686582|75632218|FG001|NOT COMPLETED|Overall Study||14||
59534760|NCT00686582|75632219|FG002|NOT COMPLETED|Overall Study||0||
59534761|NCT02223637|75632225|FG000|STARTED|Overall Study||82||
59534762|NCT02223637|75632225|FG000|COMPLETED|Overall Study||82||
59534763|NCT02223637|75632225|FG000|NOT COMPLETED|Overall Study||0||
59534764|NCT00631358|75632232|FG000|STARTED|Overall Study||50||
59534765|NCT00631358|75632233|FG001|STARTED|Overall Study||47||
59534766|NCT00631358|75632232|FG000|COMPLETED|Overall Study||44||
59534767|NCT00631358|75632233|FG001|COMPLETED|Overall Study||45||
59534768|NCT00631358|75632232|FG000|NOT COMPLETED|Overall Study||6||
59534769|NCT00631358|75632233|FG001|NOT COMPLETED|Overall Study||2||
59534770|NCT00687674|75632239|FG000|STARTED|Overall Study||13||
59534771|NCT00687674|75632239|FG000|COMPLETED|Overall Study||11||
59534772|NCT00687674|75632239|FG000|NOT COMPLETED|Overall Study||2||
59534773|NCT00687830|75632245|FG000|STARTED|Overall Study||68||
59534774|NCT00687830|75632246|FG001|STARTED|Overall Study||68||
59534775|NCT00687830|75632245|FG000|COMPLETED|Overall Study||68||
59534776|NCT00687830|75632246|FG001|COMPLETED|Overall Study||68||
59534777|NCT00687830|75632245|FG000|NOT COMPLETED|Overall Study||0||
59534778|NCT00687830|75632246|FG001|NOT COMPLETED|Overall Study||0||
59534779|NCT00687908|75632254|FG000|STARTED|Overall Study||123||
59534780|NCT00687908|75632255|FG001|STARTED|Overall Study||120||
59534781|NCT00687908|75632254|FG000|COMPLETED|Overall Study||105||
59534782|NCT00687908|75632255|FG001|COMPLETED|Overall Study||78||
59622905|NCT00552786|75734860|FG000|COMPLETED|Washout Period of 2 Weeks||25||
59622906|NCT00552786|75734861|FG001|COMPLETED|Washout Period of 2 Weeks||28||
59622907|NCT00552786|75734860|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0||
59622908|NCT00552786|75734861|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0||
59622909|NCT00552786|75734860|FG000|STARTED|Second Intervention||25||
60075757|NCT01546857|76191058|FG000|COMPLETED|Overall Study||12||
60075758|NCT01546857|76191059|FG001|COMPLETED|Overall Study||17||
60075759|NCT01546857|76191058|FG000|NOT COMPLETED|Overall Study||2||
60075760|NCT01546857|76191059|FG001|NOT COMPLETED|Overall Study||3||
60075761|NCT01540851|76191068|FG000|STARTED|Overall Study||154||
60075762|NCT01540851|76191069|FG001|STARTED|Overall Study||154||
60075763|NCT01540851|76191068|FG000|COMPLETED|Overall Study||133||
60075764|NCT01540851|76191069|FG001|COMPLETED|Overall Study||136||
60075765|NCT01540851|76191068|FG000|NOT COMPLETED|Overall Study||21||
59622910|NCT00552786|75734861|FG001|STARTED|Second Intervention||28||
59622911|NCT00552786|75734860|FG000|COMPLETED|Second Intervention||25||
59622912|NCT00552786|75734861|FG001|COMPLETED|Second Intervention||28||
59622913|NCT00552786|75734860|FG000|NOT COMPLETED|Second Intervention||0||
59622914|NCT00552786|75734861|FG001|NOT COMPLETED|Second Intervention||0||
59622915|NCT00517530|75734874|FG000|STARTED|Overall Study||21||
59622916|NCT00517530|75734875|FG001|STARTED|Overall Study||13||
59622917|NCT00517530|75734876|FG002|STARTED|Overall Study||18||
59622918|NCT00517530|75734877|FG003|STARTED|Overall Study||22||
59622919|NCT00517530|75734878|FG004|STARTED|Overall Study||21||
59622920|NCT00517530|75734879|FG005|STARTED|Overall Study||19||
59622921|NCT00517530|75734880|FG006|STARTED|Overall Study||20||
59622922|NCT00517530|75734874|FG000|Completed Treatment|Overall Study||11||
59622923|NCT00517530|75734875|FG001|Completed Treatment|Overall Study||13||
59622924|NCT00517530|75734876|FG002|Completed Treatment|Overall Study||13||
59622925|NCT00517530|75734877|FG003|Completed Treatment|Overall Study||18||
59622926|NCT00517530|75734878|FG004|Completed Treatment|Overall Study||9||
59622927|NCT00517530|75734879|FG005|Completed Treatment|Overall Study||9||
59622928|NCT00517530|75734880|FG006|Completed Treatment|Overall Study||13||
59622929|NCT00517530|75734874|FG000|Started Follow-up|Overall Study||20||
59622930|NCT00517530|75734875|FG001|Started Follow-up|Overall Study||13||
60075766|NCT01540851|76191069|FG001|NOT COMPLETED|Overall Study||18||
60075767|NCT01516749|76191077|FG000|STARTED|Active Therapy||6||
60075768|NCT01516749|76191077|FG000|COMPLETED|Active Therapy||5||
59534783|NCT00687908|75632254|FG000|NOT COMPLETED|Overall Study||18||
59534784|NCT00687908|75632255|FG001|NOT COMPLETED|Overall Study||42||
59534785|NCT00689078|75632265|FG000|STARTED|Overall Study||9||
59534786|NCT00689078|75632266|FG001|STARTED|Overall Study||9||
59534787|NCT00689078|75632267|FG002|STARTED|Overall Study||9||
59534788|NCT00689078|75632268|FG003|STARTED|Overall Study||9||
59622931|NCT00517530|75734876|FG002|Started Follow-up|Overall Study||17||
59622932|NCT00517530|75734877|FG003|Started Follow-up|Overall Study||21||
60075769|NCT01516749|76191077|FG000|NOT COMPLETED|Active Therapy||1||
60075770|NCT01516749|76191077|FG000|STARTED|Follow-up Off Therapy||5||
59534789|NCT00689078|75632265|FG000|Intent to Treat|Overall Study||9||
59534790|NCT00689078|75632266|FG001|Intent to Treat|Overall Study||7||
59534791|NCT00689078|75632267|FG002|Intent to Treat|Overall Study||8||
59534792|NCT00689078|75632268|FG003|Intent to Treat|Overall Study||8||
59534793|NCT00689078|75632265|FG000|COMPLETED|Overall Study||9||
60075771|NCT01516749|76191077|FG000|COMPLETED|Follow-up Off Therapy||4||
59534794|NCT00689078|75632266|FG001|COMPLETED|Overall Study||7||
59534795|NCT00689078|75632267|FG002|COMPLETED|Overall Study||8||
59534796|NCT00689078|75632268|FG003|COMPLETED|Overall Study||8||
59534797|NCT00689078|75632265|FG000|NOT COMPLETED|Overall Study||0||
59534798|NCT00689078|75632266|FG001|NOT COMPLETED|Overall Study||2||
59534799|NCT00689078|75632267|FG002|NOT COMPLETED|Overall Study||1||
59534800|NCT00689078|75632268|FG003|NOT COMPLETED|Overall Study||1||
59534801|NCT00588380|75632278|FG000|STARTED|Overall Study||88||
59534802|NCT00588380|75632278|FG000|COMPLETED|Overall Study||88||
59534803|NCT00588380|75632278|FG000|NOT COMPLETED|Overall Study||0||
59534804|NCT00588536|75632283|FG000|STARTED|Overall Study||5||
59534805|NCT00588536|75632283|FG000|COMPLETED|Overall Study||5||
59534806|NCT00588536|75632283|FG000|NOT COMPLETED|Overall Study||0||
59534807|NCT00590018|75632289|FG000|STARTED|Overall Study||9||
59534808|NCT00590018|75632290|FG001|STARTED|Overall Study||9||
59534809|NCT00590018|75632289|FG000|COMPLETED|Overall Study||9||
59534810|NCT00590018|75632290|FG001|COMPLETED|Overall Study||9||
59534811|NCT00590018|75632289|FG000|NOT COMPLETED|Overall Study||0||
59534812|NCT00590018|75632290|FG001|NOT COMPLETED|Overall Study||0||
59534813|NCT02219503|75632296|FG000|STARTED|Overall Study||60||
59534814|NCT02219503|75632296|FG000|COMPLETED|Overall Study||60||
59534815|NCT02219503|75632296|FG000|NOT COMPLETED|Overall Study||0||
59534816|NCT02219815|75632302|FG000|STARTED|Overall Study||44||
59534817|NCT02219815|75632303|FG001|STARTED|Overall Study||45||
59534818|NCT02219815|75632302|FG000|Post Hospital Discharge Analysis|Overall Study||42|The study analysis for the primary outcome was based on this milestone. Post discharge is defined as completed surgery and discharged from hospital. This would complete the requirement for our analysis.|
59534819|NCT02219815|75632303|FG001|Post Hospital Discharge Analysis|Overall Study||39|The study analysis for the primary outcome was based on this milestone. Post discharge is defined as completed surgery and discharged from hospital. This would complete the requirement for our analysis.|
59534820|NCT02219815|75632302|FG000|3 Month Post Surgery|Overall Study||34||
59534821|NCT02219815|75632303|FG001|3 Month Post Surgery|Overall Study||31||
59534822|NCT02219815|75632302|FG000|COMPLETED|Overall Study||22||
59534823|NCT02219815|75632303|FG001|COMPLETED|Overall Study||21||
59534824|NCT02219815|75632302|FG000|NOT COMPLETED|Overall Study||22||
59534825|NCT02219815|75632303|FG001|NOT COMPLETED|Overall Study||24||
59534826|NCT00592124|75632315|FG000|STARTED|Overall Study||28||
59534827|NCT00592124|75632316|FG001|STARTED|Overall Study||29||
59534828|NCT00592124|75632317|FG002|STARTED|Overall Study||30||
59534829|NCT00592124|75632318|FG003|STARTED|Overall Study||27||
59534830|NCT00592124|75632319|FG004|STARTED|Overall Study||27||
59534831|NCT00592124|75632320|FG005|STARTED|Overall Study||27||
59534832|NCT00592124|75632315|FG000|COMPLETED|Overall Study||24||
59534833|NCT00592124|75632316|FG001|COMPLETED|Overall Study||24||
59534834|NCT00592124|75632317|FG002|COMPLETED|Overall Study||24||
59534835|NCT00592124|75632318|FG003|COMPLETED|Overall Study||24||
59534836|NCT00592124|75632319|FG004|COMPLETED|Overall Study||24||
59534837|NCT00592124|75632320|FG005|COMPLETED|Overall Study||24||
59534838|NCT00592124|75632315|FG000|NOT COMPLETED|Overall Study||4||
59534839|NCT00592124|75632316|FG001|NOT COMPLETED|Overall Study||5||
59534840|NCT00592124|75632317|FG002|NOT COMPLETED|Overall Study||6||
59534841|NCT00592124|75632318|FG003|NOT COMPLETED|Overall Study||3||
59534842|NCT00592124|75632319|FG004|NOT COMPLETED|Overall Study||3||
59534843|NCT00592124|75632320|FG005|NOT COMPLETED|Overall Study||3||
59534844|NCT00593372|75632332|FG000|STARTED|Overall Study|Eight enrolled in behavioral treatment.|8||
59534845|NCT00593372|75632333|FG001|STARTED|Overall Study|Three evaluated but only maintained medical treatment.|3||
59534846|NCT00593372|75632332|FG000|COMPLETED|Overall Study|Eight completed behavioral treatment.|8||
59534847|NCT00593372|75632333|FG001|COMPLETED|Overall Study|Three evaluated and completed protocol.|3||
59622933|NCT00517530|75734878|FG004|Started Follow-up|Overall Study||17||
59622934|NCT00517530|75734879|FG005|Started Follow-up|Overall Study||16||
59534848|NCT00593372|75632332|FG000|NOT COMPLETED|Overall Study||0||
59534849|NCT00593372|75632333|FG001|NOT COMPLETED|Overall Study||0||
59534850|NCT02221219|75632343|FG000|STARTED|Overall Study||36||
59534851|NCT02221219|75632344|FG001|STARTED|Overall Study||87||
59534852|NCT02221219|75632345|FG002|STARTED|Overall Study||41||
59534853|NCT02221219|75632346|FG003|STARTED|Overall Study||92||
59534854|NCT02221219|75632343|FG000|COMPLETED|Overall Study||36||
59534855|NCT02221219|75632344|FG001|COMPLETED|Overall Study||87||
59534856|NCT02221219|75632345|FG002|COMPLETED|Overall Study||41||
59534857|NCT02221219|75632346|FG003|COMPLETED|Overall Study||92||
59534858|NCT02221219|75632343|FG000|NOT COMPLETED|Overall Study||0||
59534859|NCT02221219|75632344|FG001|NOT COMPLETED|Overall Study||0||
59534860|NCT02221219|75632345|FG002|NOT COMPLETED|Overall Study||0||
59534861|NCT02221219|75632346|FG003|NOT COMPLETED|Overall Study||0||
59534862|NCT00593450|75632360|FG000|STARTED|Overall Study||301||
59534863|NCT00593450|75632361|FG001|STARTED|Overall Study||286||
59534864|NCT00593450|75632362|FG002|STARTED|Overall Study||298||
59534865|NCT00593450|75632363|FG003|STARTED|Overall Study||300||
59534866|NCT00593450|75632360|FG000|COMPLETED|Overall Study||284||
59534867|NCT00593450|75632361|FG001|COMPLETED|Overall Study||265||
59534868|NCT00593450|75632362|FG002|COMPLETED|Overall Study||285||
59534869|NCT00593450|75632363|FG003|COMPLETED|Overall Study||271||
59534870|NCT00593450|75632360|FG000|NOT COMPLETED|Overall Study||17||
59534871|NCT00593450|75632361|FG001|NOT COMPLETED|Overall Study||21||
59534872|NCT00593450|75632362|FG002|NOT COMPLETED|Overall Study||13||
59534873|NCT00593450|75632363|FG003|NOT COMPLETED|Overall Study||29||
59534874|NCT00631670|75632375|FG000|STARTED|Overall Study||21||
59534875|NCT00631670|75632376|FG001|STARTED|Overall Study||0||
59534876|NCT00631670|75632375|FG000|COMPLETED|Overall Study||21||
59534877|NCT00631670|75632376|FG001|COMPLETED|Overall Study||0||
59534878|NCT00631670|75632375|FG000|NOT COMPLETED|Overall Study||0||
59534879|NCT00631670|75632376|FG001|NOT COMPLETED|Overall Study||0||
59534880|NCT00631748|75632388|FG000|STARTED|Overall Study||29||
59534881|NCT00631748|75632389|FG001|STARTED|Overall Study||31||
59534882|NCT00631748|75632388|FG000|COMPLETED|Overall Study|11 participants completed the double-blind portion of the study; 8 participants completed follow-up.|11||
59534883|NCT00631748|75632389|FG001|COMPLETED|Overall Study|9 participants completed the double-blind portion of the study; 5 participants completed follow-up.|9||
59534884|NCT00631748|75632388|FG000|NOT COMPLETED|Overall Study||18||
59534885|NCT00631748|75632389|FG001|NOT COMPLETED|Overall Study||22||
59534886|NCT00594230|75632398|FG000|STARTED|Overall Study||16||
59534887|NCT00594230|75632399|FG001|STARTED|Overall Study||10||
59534888|NCT00594230|75632398|FG000|COMPLETED|Overall Study||1||
59534889|NCT00594230|75632399|FG001|COMPLETED|Overall Study||1||
59622935|NCT00517530|75734880|FG006|Started Follow-up|Overall Study||19||
59622936|NCT00517530|75734874|FG000|Completed Follow-up|Overall Study||2||
59622937|NCT00517530|75734875|FG001|Completed Follow-up|Overall Study||0||
59622938|NCT00517530|75734876|FG002|Completed Follow-up|Overall Study||0||
59622939|NCT00517530|75734877|FG003|Completed Follow-up|Overall Study||1||
59622940|NCT00517530|75734878|FG004|Completed Follow-up|Overall Study||0||
59622941|NCT00517530|75734879|FG005|Completed Follow-up|Overall Study||0||
59622942|NCT00517530|75734880|FG006|Completed Follow-up|Overall Study||1||
59622943|NCT00517530|75734874|FG000|Retreated Population|Overall Study||2||
59622944|NCT00517530|75734875|FG001|Retreated Population|Overall Study||2||
59622945|NCT00517530|75734876|FG002|Retreated Population|Overall Study||1||
59622946|NCT00517530|75734877|FG003|Retreated Population|Overall Study||4||
59622947|NCT00517530|75734878|FG004|Retreated Population|Overall Study||2||
59622948|NCT00517530|75734879|FG005|Retreated Population|Overall Study||2||
59622949|NCT00517530|75734880|FG006|Retreated Population|Overall Study||0||
59622950|NCT00517530|75734874|FG000|COMPLETED|Overall Study||2||
59622951|NCT00517530|75734875|FG001|COMPLETED|Overall Study||0||
59622952|NCT00517530|75734876|FG002|COMPLETED|Overall Study||0||
59622953|NCT00517530|75734877|FG003|COMPLETED|Overall Study||1||
59622954|NCT00517530|75734878|FG004|COMPLETED|Overall Study||1||
59622955|NCT00517530|75734879|FG005|COMPLETED|Overall Study||0||
59622956|NCT00517530|75734880|FG006|COMPLETED|Overall Study||1||
59622957|NCT00517530|75734874|FG000|NOT COMPLETED|Overall Study||19||
59622958|NCT00517530|75734875|FG001|NOT COMPLETED|Overall Study||13||
59622959|NCT00517530|75734876|FG002|NOT COMPLETED|Overall Study||18||
59622960|NCT00517530|75734877|FG003|NOT COMPLETED|Overall Study||21||
59622961|NCT00517530|75734878|FG004|NOT COMPLETED|Overall Study||20||
59622962|NCT00517530|75734879|FG005|NOT COMPLETED|Overall Study||19||
59622963|NCT00517530|75734880|FG006|NOT COMPLETED|Overall Study||19||
59622964|NCT00518154|75734911|FG000|STARTED|Overall Study||7||
59622965|NCT00518154|75734911|FG000|COMPLETED|Overall Study||7||
59622966|NCT00518154|75734911|FG000|NOT COMPLETED|Overall Study||0||
59622967|NCT00553098|75734915|FG000|STARTED|Overall Study||29||
59622968|NCT00553098|75734915|FG000|COMPLETED|Overall Study||28||
59622969|NCT00553098|75734915|FG000|NOT COMPLETED|Overall Study||1||
59622970|NCT00553410|75734925|FG000|STARTED|Overall Study||2441||
59622971|NCT00553410|75734926|FG001|STARTED|Overall Study||2443||
59622972|NCT00553410|75734925|FG000|COMPLETED|Overall Study||2426||
59622973|NCT00553410|75734926|FG001|COMPLETED|Overall Study||2425||
59534890|NCT00594230|75632398|FG000|NOT COMPLETED|Overall Study||15||
59622974|NCT00553410|75734925|FG000|NOT COMPLETED|Overall Study||15||
59622975|NCT00553410|75734926|FG001|NOT COMPLETED|Overall Study||18||
59622976|NCT00554970|75734936|FG000|STARTED|Period 1||8||
59622977|NCT00554970|75734937|FG001|STARTED|Period 1||8||
59622978|NCT00554970|75734938|FG002|STARTED|Period 1||8||
59622979|NCT00554970|75734939|FG003|STARTED|Period 1||8||
59622980|NCT00554970|75734936|FG000|COMPLETED|Period 1||7||
59622981|NCT00554970|75734937|FG001|COMPLETED|Period 1||8||
59622982|NCT00554970|75734938|FG002|COMPLETED|Period 1||8||
59622983|NCT00554970|75734939|FG003|COMPLETED|Period 1||8||
59622984|NCT00554970|75734936|FG000|NOT COMPLETED|Period 1||1||
59622985|NCT00554970|75734937|FG001|NOT COMPLETED|Period 1||0||
59622986|NCT00554970|75734938|FG002|NOT COMPLETED|Period 1||0||
59622987|NCT00554970|75734939|FG003|NOT COMPLETED|Period 1||0||
59622988|NCT00554970|75734936|FG000|STARTED|Period 2||7||
59622989|NCT00554970|75734937|FG001|STARTED|Period 2||8||
59622990|NCT00554970|75734938|FG002|STARTED|Period 2||8||
59622991|NCT00554970|75734939|FG003|STARTED|Period 2||8||
59622992|NCT00554970|75734936|FG000|COMPLETED|Period 2||7||
59815357|NCT02879318|75937797|FG001|STARTED|Overall Study||119||
60075772|NCT01516749|76191077|FG000|NOT COMPLETED|Follow-up Off Therapy||1||
60075773|NCT01516437|76191085|FG000|STARTED|Overall Study||24||
60075774|NCT01516437|76191086|FG001|STARTED|Overall Study||24||
60075775|NCT01516437|76191087|FG002|STARTED|Overall Study||15||
60075776|NCT01516437|76191088|FG003|STARTED|Overall Study||7||
60075777|NCT01516437|76191085|FG000|COMPLETED|Overall Study||24||
60075778|NCT01516437|76191086|FG001|COMPLETED|Overall Study||24||
60075779|NCT01516437|76191087|FG002|COMPLETED|Overall Study||14||
60075780|NCT01516437|76191088|FG003|COMPLETED|Overall Study||6||
60075781|NCT01516437|76191085|FG000|NOT COMPLETED|Overall Study||0||
60075782|NCT01516437|76191086|FG001|NOT COMPLETED|Overall Study||0||
60075783|NCT01516437|76191087|FG002|NOT COMPLETED|Overall Study||1||
60075784|NCT01516437|76191088|FG003|NOT COMPLETED|Overall Study||1||
60075785|NCT01515423|76191102|FG000|STARTED|Open Label Phase||1429||
60075786|NCT01515423|76191103|FG001|STARTED|Open Label Phase||0||
60075787|NCT01515423|76191104|FG002|STARTED|Open Label Phase||0||
60075788|NCT01515423|76191102|FG000|COMPLETED|Open Label Phase||1016||
60075789|NCT01515423|76191103|FG001|COMPLETED|Open Label Phase||0||
59534891|NCT00594230|75632399|FG001|NOT COMPLETED|Overall Study||9||
59534892|NCT00594308|75632405|FG000|STARTED|Overall Study||10||
60075790|NCT01515423|76191104|FG002|COMPLETED|Open Label Phase||0||
60075791|NCT01515423|76191102|FG000|NOT COMPLETED|Open Label Phase||413||
59534893|NCT00594308|75632405|FG000|COMPLETED|Overall Study||10||
59534894|NCT00594308|75632405|FG000|NOT COMPLETED|Overall Study||0||
59534895|NCT00595088|75632409|FG000|STARTED|Overall Study||47||
59534896|NCT00595088|75632409|FG000|COMPLETED|Overall Study|5 patients ongoing, 7 completed the study (week 46)and 35 withdrew prematurely|7||
59534897|NCT00595088|75632409|FG000|NOT COMPLETED|Overall Study||40||
59534898|NCT02137538|75632415|FG000|STARTED|Overall Study||39||
59534899|NCT02137538|75632416|FG001|STARTED|Overall Study||40||
59534900|NCT02137538|75632415|FG000|COMPLETED|Overall Study||23||
59534901|NCT02137538|75632416|FG001|COMPLETED|Overall Study||26||
59534902|NCT02137538|75632415|FG000|NOT COMPLETED|Overall Study||16||
59534903|NCT02137538|75632416|FG001|NOT COMPLETED|Overall Study||14||
59534904|NCT00595556|75632424|FG000|STARTED|Overall Study||20||
59534905|NCT00595556|75632425|FG001|STARTED|Overall Study||20||
59534906|NCT00595556|75632424|FG000|COMPLETED|Overall Study||17||
59622993|NCT00554970|75734937|FG001|COMPLETED|Period 2||8||
59622994|NCT00554970|75734938|FG002|COMPLETED|Period 2||7||
59622995|NCT00554970|75734939|FG003|COMPLETED|Period 2||8||
59622996|NCT00554970|75734936|FG000|NOT COMPLETED|Period 2||0||
60075792|NCT01515423|76191103|FG001|NOT COMPLETED|Open Label Phase||0||
60075793|NCT01515423|76191104|FG002|NOT COMPLETED|Open Label Phase||0||
60075794|NCT01515423|76191102|FG000|STARTED|DOUBLE BLIND||0||
60075795|NCT01515423|76191103|FG001|STARTED|DOUBLE BLIND||504||
60075796|NCT01515423|76191104|FG002|STARTED|DOUBLE BLIND||512||
60075797|NCT01515423|76191102|FG000|COMPLETED|DOUBLE BLIND||0||
60075798|NCT01515423|76191103|FG001|COMPLETED|DOUBLE BLIND||422||
60075799|NCT01515423|76191104|FG002|COMPLETED|DOUBLE BLIND||420||
60075800|NCT01515423|76191102|FG000|NOT COMPLETED|DOUBLE BLIND||0||
59815358|NCT02879318|75937796|FG000|COMPLETED|Overall Study||61||
60075801|NCT01515423|76191103|FG001|NOT COMPLETED|DOUBLE BLIND||82||
60075802|NCT01515423|76191104|FG002|NOT COMPLETED|DOUBLE BLIND||92||
60075803|NCT00637156|76191113|FG000|STARTED|Overall Study||209||
60075804|NCT00637156|76191114|FG001|STARTED|Overall Study||188||
59534907|NCT00595556|75632425|FG001|COMPLETED|Overall Study||19||
59534908|NCT00595556|75632424|FG000|NOT COMPLETED|Overall Study||3||
59534909|NCT00595556|75632425|FG001|NOT COMPLETED|Overall Study||1||
59534910|NCT00595790|75632434|FG000|STARTED|Overall Study||125||
59534911|NCT00595790|75632435|FG001|STARTED|Overall Study|124 subjects randomized to this group, 125 subjects received 1x12 mcg.(Safety Population: N=125)|124||
59534912|NCT00595790|75632436|FG002|STARTED|Overall Study|125 subjects randomized to this group, 124 subjects received 1x6 mcg.(Safety Population: N=124)|125||
59534913|NCT00595790|75632434|FG000|COMPLETED|Overall Study|The Participant Flow shows all study participants randomized.Prim. Outcome is based on PP Population|123||
59534914|NCT00595790|75632435|FG001|COMPLETED|Overall Study|The Participant Flow shows all study participants randomized.Prim. Outcome is based on PP Population|123||
59534915|NCT00595790|75632436|FG002|COMPLETED|Overall Study|The Participant Flow shows all study participants randomized.Prim. Outcome is based on PP Population|122||
59534916|NCT00595790|75632434|FG000|NOT COMPLETED|Overall Study||2||
59534917|NCT00595790|75632435|FG001|NOT COMPLETED|Overall Study||1||
59534918|NCT00595790|75632436|FG002|NOT COMPLETED|Overall Study||3||
59534919|NCT00595946|75632446|FG000|STARTED|Overall Study||218||
59534920|NCT00595946|75632447|FG001|STARTED|Overall Study||221||
59534921|NCT00595946|75632446|FG000|COMPLETED|Overall Study||154||
59534922|NCT00595946|75632447|FG001|COMPLETED|Overall Study||152||
59534923|NCT00595946|75632446|FG000|NOT COMPLETED|Overall Study||64||
59534924|NCT00595946|75632447|FG001|NOT COMPLETED|Overall Study||69||
59534925|NCT00596102|75632456|FG000|STARTED|Up to Month 6||2283||
59534926|NCT00596102|75632457|FG001|STARTED|Up to Month 6||338||
59534927|NCT00596102|75632458|FG002|STARTED|Up to Month 6||637||
59534928|NCT00596102|75632456|FG000|COMPLETED|Up to Month 6||2283||
59534929|NCT00596102|75632457|FG001|COMPLETED|Up to Month 6||338||
59534930|NCT00596102|75632458|FG002|COMPLETED|Up to Month 6||637||
59534931|NCT00596102|75632456|FG000|NOT COMPLETED|Up to Month 6||0||
59534932|NCT00596102|75632457|FG001|NOT COMPLETED|Up to Month 6||0||
59534933|NCT00596102|75632458|FG002|NOT COMPLETED|Up to Month 6||0||
59534934|NCT00596102|75632456|FG000|STARTED|Up to Month 60||2283||
59534935|NCT00596102|75632457|FG001|STARTED|Up to Month 60||338||
59534936|NCT00596102|75632458|FG002|STARTED|Up to Month 60||637||
59534937|NCT00596102|75632456|FG000|COMPLETED|Up to Month 60|"long-term safety follow-up beyond Month 6 for a sub-set of subjects in IC51 group only"|102||
59534938|NCT00596102|75632457|FG001|COMPLETED|Up to Month 60||0||
59534939|NCT00596102|75632458|FG002|COMPLETED|Up to Month 60||0||
59534940|NCT00596102|75632456|FG000|NOT COMPLETED|Up to Month 60||2181||
59534941|NCT00596102|75632457|FG001|NOT COMPLETED|Up to Month 60||338||
59534942|NCT00596102|75632458|FG002|NOT COMPLETED|Up to Month 60||637||
59534943|NCT00638924|75632465|FG000|STARTED|Overall Study||40||
59534944|NCT00638924|75632465|FG000|2 Months|Overall Study||40||
59534945|NCT00638924|75632465|FG000|COMPLETED|Overall Study||40||
59534946|NCT00638924|75632465|FG000|NOT COMPLETED|Overall Study||0||
59534947|NCT00597038|75632471|FG000|STARTED|Overall Study||16||
59534948|NCT00597038|75632472|FG001|STARTED|Overall Study||34||
59534949|NCT00597038|75632471|FG000|COMPLETED|Overall Study|One did not complete due to PI decision, one did not complete due to progressive disease.|14||
59534950|NCT00597038|75632472|FG001|COMPLETED|Overall Study|Two patients withdrew, one did not complete due to progressive disease, one patient died.|30||
59534951|NCT00597038|75632471|FG000|NOT COMPLETED|Overall Study||2||
59534952|NCT00597038|75632472|FG001|NOT COMPLETED|Overall Study||4||
59534953|NCT00597272|75632487|FG000|STARTED|Overall Study||1||
59534954|NCT00597272|75632488|FG001|STARTED|Overall Study||1||
59534955|NCT00597272|75632489|FG002|STARTED|Overall Study||10||
59534956|NCT00597272|75632490|FG003|STARTED|Overall Study||1||
59534957|NCT00597272|75632491|FG004|STARTED|Overall Study||1||
59534958|NCT00597272|75632492|FG005|STARTED|Overall Study||10||
59534959|NCT00597272|75632493|FG006|STARTED|Overall Study||10||
59534960|NCT00597272|75632487|FG000|COMPLETED|Overall Study||1||
59534961|NCT00597272|75632488|FG001|COMPLETED|Overall Study||1||
59534962|NCT00597272|75632489|FG002|COMPLETED|Overall Study||10||
59534963|NCT00597272|75632490|FG003|COMPLETED|Overall Study||1||
59534964|NCT00597272|75632491|FG004|COMPLETED|Overall Study||1||
59534965|NCT00597272|75632492|FG005|COMPLETED|Overall Study||10||
59534966|NCT00597272|75632493|FG006|COMPLETED|Overall Study||10||
59534967|NCT00597272|75632487|FG000|NOT COMPLETED|Overall Study||0||
59815359|NCT02879318|75937797|FG001|COMPLETED|Overall Study||119||
59815360|NCT02879318|75937796|FG000|NOT COMPLETED|Overall Study||0||
59815361|NCT02879318|75937797|FG001|NOT COMPLETED|Overall Study||0||
59815362|NCT02658890|75937830|FG000|STARTED|Pre-Treatment Phase||7||
59815363|NCT02658890|75937831|FG001|STARTED|Pre-Treatment Phase||11||
59815364|NCT02658890|75937832|FG002|STARTED|Pre-Treatment Phase||12||
59815365|NCT02658890|75937833|FG003|STARTED|Pre-Treatment Phase||18||
59815366|NCT02658890|75937834|FG004|STARTED|Pre-Treatment Phase||7||
59815367|NCT02658890|75937835|FG005|STARTED|Pre-Treatment Phase||18||
59815368|NCT02658890|75937836|FG006|STARTED|Pre-Treatment Phase||17||
59815369|NCT02658890|75937837|FG007|STARTED|Pre-Treatment Phase||22||
59534968|NCT00597272|75632488|FG001|NOT COMPLETED|Overall Study||0||
59815370|NCT02658890|75937838|FG008|STARTED|Pre-Treatment Phase||36||
59815371|NCT02658890|75937839|FG009|STARTED|Pre-Treatment Phase||15||
59815372|NCT02658890|75937840|FG010|STARTED|Pre-Treatment Phase||14||
59987771|NCT03122691|76102981|FG000|Vape 5mg|Overall Study||21||
59815373|NCT02658890|75937841|FG011|STARTED|Pre-Treatment Phase||14||
59815374|NCT02658890|75937842|FG012|STARTED|Pre-Treatment Phase||16||
59815375|NCT02658890|75937843|FG013|STARTED|Pre-Treatment Phase||79||
59815376|NCT02658890|75937844|FG014|STARTED|Pre-Treatment Phase||9||
59815377|NCT02658890|75937845|FG015|STARTED|Pre-Treatment Phase||6||
59987772|NCT03122691|76102981|FG000|Vape 20mg|Overall Study||21||
59987773|NCT03122691|76102981|FG000|COMPLETED|Overall Study||20||
59987774|NCT03122691|76102981|FG000|NOT COMPLETED|Overall Study||3||
59987775|NCT02279524|76103004|FG000|STARTED|Overall Study||98||
59622997|NCT00554970|75734937|FG001|NOT COMPLETED|Period 2||0||
59622998|NCT00554970|75734938|FG002|NOT COMPLETED|Period 2||1||
59622999|NCT00554970|75734939|FG003|NOT COMPLETED|Period 2||0||
59623000|NCT00520884|75734951|FG000|STARTED|Overall Study||3||
59623001|NCT00520884|75734952|FG001|STARTED|Overall Study||2||
59623002|NCT00520884|75734953|FG002|STARTED|Overall Study||2||
59623003|NCT00520884|75734954|FG003|STARTED|Overall Study||3||
59623004|NCT00520884|75734951|FG000|COMPLETED|Overall Study||3|Crossover study, randomized in two strata|
59623005|NCT00520884|75734952|FG001|COMPLETED|Overall Study||2|Crossover study, randomized in two strata|
59623006|NCT00520884|75734953|FG002|COMPLETED|Overall Study||2|Crossover study, randomized in two strata|
59623007|NCT00520884|75734954|FG003|COMPLETED|Overall Study||3|Crossover study, randomized in two strata|
59623008|NCT00520884|75734951|FG000|NOT COMPLETED|Overall Study||0||
59623009|NCT00520884|75734952|FG001|NOT COMPLETED|Overall Study||0||
59623010|NCT00520884|75734953|FG002|NOT COMPLETED|Overall Study||0||
59623011|NCT00520884|75734954|FG003|NOT COMPLETED|Overall Study||0||
59623012|NCT00521352|75734963|FG000|STARTED|Overall Study||12||
59623013|NCT00521352|75734964|FG001|STARTED|Overall Study||13||
59623014|NCT00521352|75734963|FG000|COMPLETED|Overall Study||11||
59623015|NCT00521352|75734964|FG001|COMPLETED|Overall Study||10||
59623016|NCT00521352|75734963|FG000|NOT COMPLETED|Overall Study||1||
59623017|NCT00521352|75734964|FG001|NOT COMPLETED|Overall Study||3||
59623018|NCT00521976|75734970|FG000|STARTED|Overall Study||871||
59623019|NCT00521976|75734970|FG000|COMPLETED|Overall Study||871||
59623020|NCT00521976|75734970|FG000|NOT COMPLETED|Overall Study||0||
59623021|NCT00523302|75734976|FG000|STARTED|Overall Study||10||
59623022|NCT00523302|75734977|FG001|STARTED|Overall Study||10||
59623023|NCT00523302|75734976|FG000|COMPLETED|Overall Study||10||
59623024|NCT00523302|75734977|FG001|COMPLETED|Overall Study||10||
59623025|NCT00523302|75734976|FG000|NOT COMPLETED|Overall Study||0||
59623026|NCT00523302|75734977|FG001|NOT COMPLETED|Overall Study||0||
59623027|NCT00523614|75734985|FG000|STARTED|Overall Study|"As this is a case-control study the categories started and completed are not really applicable."|680||
59623028|NCT00523614|75734986|FG001|STARTED|Overall Study|"As this is a case-control study the categories started and completed are not really applicable."|2720||
59623029|NCT00523614|75734985|FG000|COMPLETED|Overall Study|"As this is a case-control study the categories started and completed are not really applicable."|680||
59623030|NCT00523614|75734986|FG001|COMPLETED|Overall Study|"As this is a case-control study the categories started and completed are not really applicable."|2720||
59623031|NCT00523614|75734985|FG000|NOT COMPLETED|Overall Study||0||
59815378|NCT02658890|75937846|FG016|STARTED|Pre-Treatment Phase||37||
59815379|NCT02658890|75937847|FG017|STARTED|Pre-Treatment Phase||17||
59815380|NCT02658890|75937848|FG018|STARTED|Pre-Treatment Phase||80||
59815381|NCT02658890|75937849|FG019|STARTED|Pre-Treatment Phase||41||
59815382|NCT02658890|75937850|FG020|STARTED|Pre-Treatment Phase||32||
59815383|NCT02658890|75937851|FG021|STARTED|Pre-Treatment Phase||42||
59815384|NCT02658890|75937852|FG022|STARTED|Pre-Treatment Phase||41||
59815385|NCT02658890|75937853|FG023|STARTED|Pre-Treatment Phase||1||
59815386|NCT02658890|75937854|FG024|STARTED|Pre-Treatment Phase||1||
59815387|NCT02658890|75937855|FG025|STARTED|Pre-Treatment Phase||20||
59623032|NCT00523614|75734986|FG001|NOT COMPLETED|Overall Study||0||
59815388|NCT02658890|75937856|FG026|STARTED|Pre-Treatment Phase||14||
59815389|NCT02658890|75937830|FG000|COMPLETED|Pre-Treatment Phase||7||
59815390|NCT02658890|75937831|FG001|COMPLETED|Pre-Treatment Phase||11||
59623033|NCT00524472|75734994|FG000|STARTED|Overall Study||709||
59623034|NCT00524472|75734995|FG001|STARTED|Overall Study||730||
59623035|NCT00524472|75734994|FG000|COMPLETED|Overall Study||709||
59623036|NCT00524472|75734995|FG001|COMPLETED|Overall Study||730||
59815391|NCT02658890|75937832|FG002|COMPLETED|Pre-Treatment Phase||12||
59815392|NCT02658890|75937833|FG003|COMPLETED|Pre-Treatment Phase||18||
59987776|NCT02279524|76103005|FG001|STARTED|Overall Study||101||
59623037|NCT00524472|75734994|FG000|NOT COMPLETED|Overall Study||0||
59623038|NCT00524472|75734995|FG001|NOT COMPLETED|Overall Study||0||
59623039|NCT00524940|75735001|FG000|STARTED|Overall Study||124||
59623040|NCT00524940|75735001|FG000|COMPLETED|Overall Study||124||
59623041|NCT00524940|75735001|FG000|NOT COMPLETED|Overall Study||0||
59815393|NCT02658890|75937834|FG004|COMPLETED|Pre-Treatment Phase||7||
59987777|NCT02279524|76103006|FG002|STARTED|Overall Study||48||
59534969|NCT00597272|75632489|FG002|NOT COMPLETED|Overall Study||0||
59534970|NCT00597272|75632490|FG003|NOT COMPLETED|Overall Study||0||
59534971|NCT00597272|75632491|FG004|NOT COMPLETED|Overall Study||0||
59534972|NCT00597272|75632492|FG005|NOT COMPLETED|Overall Study||0||
59534973|NCT00597272|75632493|FG006|NOT COMPLETED|Overall Study||0||
59534974|NCT00597428|75632511|FG000|STARTED|Overall Study||214||
59534975|NCT00597428|75632512|FG001|STARTED|Overall Study||223||
59534976|NCT00597428|75632511|FG000|COMPLETED|Overall Study||153||
59534977|NCT00597428|75632512|FG001|COMPLETED|Overall Study||152||
59534978|NCT00597428|75632511|FG000|NOT COMPLETED|Overall Study||61||
59534979|NCT00597428|75632512|FG001|NOT COMPLETED|Overall Study||71||
59534980|NCT00597818|75632522|FG000|STARTED|Overall Study||30||
59534981|NCT00597818|75632523|FG001|STARTED|Overall Study||30||
59534982|NCT00597818|75632524|FG002|STARTED|Overall Study||31||
59534983|NCT00597818|75632525|FG003|STARTED|Overall Study||30||
59534984|NCT00597818|75632522|FG000|COMPLETED|Overall Study||12||
59534985|NCT00597818|75632523|FG001|COMPLETED|Overall Study||14||
59534986|NCT00597818|75632524|FG002|COMPLETED|Overall Study||12||
59534987|NCT00597818|75632525|FG003|COMPLETED|Overall Study||20||
59534988|NCT00597818|75632522|FG000|NOT COMPLETED|Overall Study||18||
59534989|NCT00597818|75632523|FG001|NOT COMPLETED|Overall Study||16||
59534990|NCT00597818|75632524|FG002|NOT COMPLETED|Overall Study||19||
59534991|NCT00597818|75632525|FG003|NOT COMPLETED|Overall Study||10||
59534992|NCT00597896|75632537|FG000|STARTED|Overall Study||24||
59534993|NCT00597896|75632538|FG001|STARTED|Overall Study||26||
59534994|NCT00597896|75632537|FG000|COMPLETED|Overall Study||21||
59534995|NCT00597896|75632538|FG001|COMPLETED|Overall Study||24||
59623042|NCT00525174|75735007|FG000|STARTED|Overall Study||97||
59623043|NCT00525174|75735008|FG001|STARTED|Overall Study||89||
59623044|NCT00525174|75735007|FG000|COMPLETED|Overall Study||88||
59623045|NCT00525174|75735008|FG001|COMPLETED|Overall Study||81||
59623046|NCT00525174|75735007|FG000|NOT COMPLETED|Overall Study||9||
59623047|NCT00525174|75735008|FG001|NOT COMPLETED|Overall Study||8||
59623048|NCT00555048|75735014|FG000|STARTED|Overall Study||1||
59623049|NCT00555048|75735014|FG000|COMPLETED|Overall Study||1||
59534996|NCT00597896|75632537|FG000|NOT COMPLETED|Overall Study||3||
59534997|NCT00597896|75632538|FG001|NOT COMPLETED|Overall Study||2||
59534998|NCT00600080|75632545|FG000|STARTED|Period 1: Baseline to One-week||28||
59534999|NCT00600080|75632546|FG001|STARTED|Period 1: Baseline to One-week||32||
59535000|NCT00600080|75632545|FG000|COMPLETED|Period 1: Baseline to One-week||28||
59535001|NCT00600080|75632546|FG001|COMPLETED|Period 1: Baseline to One-week||32||
59535002|NCT00600080|75632545|FG000|NOT COMPLETED|Period 1: Baseline to One-week||0||
59535003|NCT00600080|75632546|FG001|NOT COMPLETED|Period 1: Baseline to One-week||0||
59535004|NCT00600080|75632545|FG000|STARTED|Period 2: One-week to Two-weeks|This is a crossover study, arms are switched at period change.|28||
59535005|NCT00600080|75632546|FG001|STARTED|Period 2: One-week to Two-weeks|This is a crossover study, arms are switched at period change.|32||
59535006|NCT00600080|75632545|FG000|COMPLETED|Period 2: One-week to Two-weeks||28||
59535007|NCT00600080|75632546|FG001|COMPLETED|Period 2: One-week to Two-weeks||32||
59535008|NCT00600080|75632545|FG000|NOT COMPLETED|Period 2: One-week to Two-weeks||0||
59535009|NCT00600080|75632546|FG001|NOT COMPLETED|Period 2: One-week to Two-weeks||0||
59535010|NCT00600704|75632554|FG000|STARTED|Overall Study||100||
59535011|NCT00600704|75632555|FG001|STARTED|Overall Study||92||
59535012|NCT00600704|75632554|FG000|COMPLETED|Overall Study||100||
59535013|NCT00600704|75632555|FG001|COMPLETED|Overall Study||92||
59535014|NCT00600704|75632554|FG000|NOT COMPLETED|Overall Study||0||
59535015|NCT00600704|75632555|FG001|NOT COMPLETED|Overall Study||0||
59535016|NCT00691808|75632564|FG000|STARTED|Overall Study||35||
59535017|NCT00691808|75632565|FG001|STARTED|Overall Study||36||
59535018|NCT00691808|75632566|FG002|STARTED|Overall Study||32||
59535019|NCT00691808|75632564|FG000|COMPLETED|Overall Study||35||
59535020|NCT00691808|75632565|FG001|COMPLETED|Overall Study||35||
59535021|NCT00691808|75632566|FG002|COMPLETED|Overall Study||32||
59535022|NCT00691808|75632564|FG000|NOT COMPLETED|Overall Study||0||
59535023|NCT00691808|75632565|FG001|NOT COMPLETED|Overall Study||1||
59535024|NCT00691808|75632566|FG002|NOT COMPLETED|Overall Study||0||
59535025|NCT03843541|75632577|FG000|STARTED|Overall Study||111||
59535026|NCT03843541|75632578|FG001|STARTED|Overall Study||111||
59535027|NCT03843541|75632579|FG002|STARTED|Overall Study||111||
59535028|NCT03843541|75632577|FG000|Modified ITT|Overall Study||108||
59535029|NCT03843541|75632578|FG001|Modified ITT|Overall Study||110||
59535030|NCT03843541|75632579|FG002|Modified ITT|Overall Study||110||
59535031|NCT03843541|75632577|FG000|COMPLETED|Overall Study||96||
59535032|NCT03843541|75632578|FG001|COMPLETED|Overall Study||95||
59535033|NCT03843541|75632579|FG002|COMPLETED|Overall Study||97||
59535034|NCT03843541|75632577|FG000|NOT COMPLETED|Overall Study||15||
59535035|NCT03843541|75632578|FG001|NOT COMPLETED|Overall Study||16||
59535036|NCT03843541|75632579|FG002|NOT COMPLETED|Overall Study||14||
59535037|NCT00692198|75632595|FG000|STARTED|Overall Study||368||
59535038|NCT00692198|75632596|FG001|STARTED|Overall Study||370||
59535039|NCT00692198|75632595|FG000|COMPLETED|Overall Study||368||
59535040|NCT00692198|75632596|FG001|COMPLETED|Overall Study||370||
59535041|NCT00692198|75632595|FG000|NOT COMPLETED|Overall Study||0||
59535042|NCT00692198|75632596|FG001|NOT COMPLETED|Overall Study||0||
59535043|NCT00639158|75632605|FG000|STARTED|Overall Study|All randomized subjects were treated.|272||
59535044|NCT00639158|75632606|FG001|STARTED|Overall Study|1 subject was randomized but not treated because of an abnormal ECG that precluded treatment.|270||
59535045|NCT00639158|75632605|FG000|COMPLETED|Overall Study|26 subjects prematurely discontinued treatment.|246||
59535046|NCT00639158|75632606|FG001|COMPLETED|Overall Study|30 subjects prematurely discontinued treatment|240||
59535047|NCT00639158|75632605|FG000|NOT COMPLETED|Overall Study||26||
59535048|NCT00639158|75632606|FG001|NOT COMPLETED|Overall Study||30||
59535049|NCT00692276|75632614|FG000|STARTED|Randomized Population||190||
59535050|NCT00692276|75632615|FG001|STARTED|Randomized Population||201||
59535051|NCT00692276|75632614|FG000|COMPLETED|Randomized Population||190||
59535052|NCT00692276|75632615|FG001|COMPLETED|Randomized Population||201||
59535053|NCT00692276|75632614|FG000|NOT COMPLETED|Randomized Population||0||
59535054|NCT00692276|75632615|FG001|NOT COMPLETED|Randomized Population||0||
59535055|NCT00692276|75632614|FG000|STARTED|Completed 24 Months||190||
59535056|NCT00692276|75632615|FG001|STARTED|Completed 24 Months||201||
59535057|NCT00692276|75632614|FG000|COMPLETED|Completed 24 Months||183||
59535058|NCT00692276|75632615|FG001|COMPLETED|Completed 24 Months||187||
59535059|NCT00692276|75632614|FG000|NOT COMPLETED|Completed 24 Months||7||
59535060|NCT00692276|75632615|FG001|NOT COMPLETED|Completed 24 Months||14||
59535061|NCT00639860|75632621|FG000|STARTED|Overall Study||10||
59535062|NCT00639860|75632621|FG000|COMPLETED|Overall Study||10||
59535063|NCT00639860|75632621|FG000|NOT COMPLETED|Overall Study||0||
59535064|NCT00692978|75632627|FG000|STARTED|FP From Active 250 ug MDI Inhaler||15||
59535065|NCT00692978|75632628|FG001|STARTED|FP From Active 250 ug MDI Inhaler||15||
59535066|NCT00692978|75632627|FG000|COMPLETED|FP From Active 250 ug MDI Inhaler||15||
59623050|NCT00555048|75735014|FG000|NOT COMPLETED|Overall Study||0||
59535067|NCT00692978|75632628|FG001|COMPLETED|FP From Active 250 ug MDI Inhaler||15||
59535068|NCT00692978|75632627|FG000|NOT COMPLETED|FP From Active 250 ug MDI Inhaler||0||
59535069|NCT00692978|75632628|FG001|NOT COMPLETED|FP From Active 250 ug MDI Inhaler||0||
59535070|NCT00692978|75632627|FG000|STARTED|FP1.5 Microns Size With MDI Inhaler||15||
59535071|NCT00692978|75632628|FG001|STARTED|FP1.5 Microns Size With MDI Inhaler||15||
59535072|NCT00692978|75632627|FG000|COMPLETED|FP1.5 Microns Size With MDI Inhaler||15||
59535073|NCT00692978|75632628|FG001|COMPLETED|FP1.5 Microns Size With MDI Inhaler||15||
59535074|NCT00692978|75632627|FG000|NOT COMPLETED|FP1.5 Microns Size With MDI Inhaler||0||
59535075|NCT00692978|75632628|FG001|NOT COMPLETED|FP1.5 Microns Size With MDI Inhaler||0||
59623051|NCT00525798|75735020|FG000|STARTED|Overall Study||2334||
59623052|NCT00525798|75735021|FG001|STARTED|Overall Study||2331||
59535076|NCT00692978|75632627|FG000|STARTED|FP 3 Microns Size With MDI Inhaler||15||
59535077|NCT00692978|75632628|FG001|STARTED|FP 3 Microns Size With MDI Inhaler||15||
59535078|NCT00692978|75632627|FG000|COMPLETED|FP 3 Microns Size With MDI Inhaler||15||
59535079|NCT00692978|75632628|FG001|COMPLETED|FP 3 Microns Size With MDI Inhaler||15||
59535080|NCT00692978|75632627|FG000|NOT COMPLETED|FP 3 Microns Size With MDI Inhaler||0||
59535081|NCT00692978|75632628|FG001|NOT COMPLETED|FP 3 Microns Size With MDI Inhaler||0||
59535082|NCT00692978|75632627|FG000|STARTED|FP 6 Microns Size With MDI Inhaler||15||
59535083|NCT00692978|75632628|FG001|STARTED|FP 6 Microns Size With MDI Inhaler||15||
59535084|NCT00692978|75632627|FG000|COMPLETED|FP 6 Microns Size With MDI Inhaler||15||
59535085|NCT00692978|75632628|FG001|COMPLETED|FP 6 Microns Size With MDI Inhaler||15||
59535086|NCT00692978|75632627|FG000|NOT COMPLETED|FP 6 Microns Size With MDI Inhaler||0||
59535087|NCT00692978|75632628|FG001|NOT COMPLETED|FP 6 Microns Size With MDI Inhaler||0||
59535088|NCT00601718|75632646|FG000|STARTED|Overall Study||29||
59535089|NCT00601718|75632646|FG000|COMPLETED|Overall Study||29||
59535090|NCT00601718|75632646|FG000|NOT COMPLETED|Overall Study||0||
59535091|NCT00640250|75632650|FG000|STARTED|Overall Study||48||
59535092|NCT00640250|75632650|FG000|COMPLETED|Overall Study||48||
59535093|NCT00640250|75632650|FG000|NOT COMPLETED|Overall Study||0||
59535094|NCT00601796|75632753|FG000|STARTED|Overall Study||24||
59535095|NCT00601796|75632753|FG000|COMPLETED|Overall Study||24||
59535096|NCT00601796|75632753|FG000|NOT COMPLETED|Overall Study||0||
59535097|NCT00601952|75632759|FG000|STARTED|Overall Study||14||
59535098|NCT00601952|75632760|FG001|STARTED|Overall Study||17||
59535099|NCT00601952|75632759|FG000|COMPLETED|Overall Study||12||
59535100|NCT00601952|75632760|FG001|COMPLETED|Overall Study||17||
59815394|NCT02658890|75937835|FG005|COMPLETED|Pre-Treatment Phase||18||
59815395|NCT02658890|75937836|FG006|COMPLETED|Pre-Treatment Phase||17||
59815396|NCT02658890|75937837|FG007|COMPLETED|Pre-Treatment Phase||22||
59815397|NCT02658890|75937838|FG008|COMPLETED|Pre-Treatment Phase||35||
59815398|NCT02658890|75937839|FG009|COMPLETED|Pre-Treatment Phase||15||
59815399|NCT02658890|75937840|FG010|COMPLETED|Pre-Treatment Phase||14||
59815400|NCT02658890|75937841|FG011|COMPLETED|Pre-Treatment Phase||14||
59815401|NCT02658890|75937842|FG012|COMPLETED|Pre-Treatment Phase||16||
59815402|NCT02658890|75937843|FG013|COMPLETED|Pre-Treatment Phase||79||
59815403|NCT02658890|75937844|FG014|COMPLETED|Pre-Treatment Phase||9||
59815404|NCT02658890|75937845|FG015|COMPLETED|Pre-Treatment Phase||6||
59815405|NCT02658890|75937846|FG016|COMPLETED|Pre-Treatment Phase||37||
59815406|NCT02658890|75937847|FG017|COMPLETED|Pre-Treatment Phase||17||
59815407|NCT02658890|75937848|FG018|COMPLETED|Pre-Treatment Phase||80||
59815408|NCT02658890|75937849|FG019|COMPLETED|Pre-Treatment Phase||41||
59815409|NCT02658890|75937850|FG020|COMPLETED|Pre-Treatment Phase||32||
59815410|NCT02658890|75937851|FG021|COMPLETED|Pre-Treatment Phase||42||
59535101|NCT00601952|75632759|FG000|NOT COMPLETED|Overall Study||2||
59535102|NCT00601952|75632760|FG001|NOT COMPLETED|Overall Study||0||
59535103|NCT00693992|75632768|FG000|STARTED|Overall Study||106||
59535104|NCT00693992|75632769|FG001|STARTED|Overall Study||104||
59535105|NCT00693992|75632768|FG000|COMPLETED|Overall Study||106||
59535106|NCT00693992|75632769|FG001|COMPLETED|Overall Study||104||
59535107|NCT00693992|75632768|FG000|NOT COMPLETED|Overall Study||0||
59535108|NCT00693992|75632769|FG001|NOT COMPLETED|Overall Study||0||
59535109|NCT00694070|75632775|FG000|STARTED|Overall Study||51||
59535110|NCT00694070|75632775|FG000|COMPLETED|Overall Study||51||
59535111|NCT00694070|75632775|FG000|NOT COMPLETED|Overall Study||0||
59535112|NCT00645710|75632782|FG000|STARTED|Overall Study||3||
59535113|NCT00645710|75632783|FG001|STARTED|Overall Study||3||
59535114|NCT00645710|75632784|FG002|STARTED|Overall Study||10||
59535115|NCT00645710|75632782|FG000|COMPLETED|Overall Study||3||
59535116|NCT00645710|75632783|FG001|COMPLETED|Overall Study||3||
59623053|NCT00525798|75735020|FG000|COMPLETED|Overall Study||1578||
59623054|NCT00525798|75735021|FG001|COMPLETED|Overall Study||1732||
59623055|NCT00525798|75735020|FG000|NOT COMPLETED|Overall Study||756||
59623056|NCT00525798|75735021|FG001|NOT COMPLETED|Overall Study||599||
59815411|NCT02658890|75937852|FG022|COMPLETED|Pre-Treatment Phase||41||
59815412|NCT02658890|75937853|FG023|COMPLETED|Pre-Treatment Phase||1||
59815413|NCT02658890|75937854|FG024|COMPLETED|Pre-Treatment Phase||1||
59815414|NCT02658890|75937855|FG025|COMPLETED|Pre-Treatment Phase||20||
59815415|NCT02658890|75937856|FG026|COMPLETED|Pre-Treatment Phase||14||
59815416|NCT02658890|75937830|FG000|NOT COMPLETED|Pre-Treatment Phase||0||
59815417|NCT02658890|75937831|FG001|NOT COMPLETED|Pre-Treatment Phase||0||
59815418|NCT02658890|75937832|FG002|NOT COMPLETED|Pre-Treatment Phase||0||
59535117|NCT00645710|75632784|FG002|COMPLETED|Overall Study||10||
59535118|NCT00645710|75632782|FG000|NOT COMPLETED|Overall Study||0||
59815419|NCT02658890|75937833|FG003|NOT COMPLETED|Pre-Treatment Phase||0||
59815420|NCT02658890|75937834|FG004|NOT COMPLETED|Pre-Treatment Phase||0||
59535119|NCT00645710|75632783|FG001|NOT COMPLETED|Overall Study||0||
59535120|NCT00645710|75632784|FG002|NOT COMPLETED|Overall Study||0||
59623057|NCT00555360|75735029|FG000|STARTED|Overall Study||183||
59623058|NCT00555360|75735030|FG001|STARTED|Overall Study||189||
59815421|NCT02658890|75937835|FG005|NOT COMPLETED|Pre-Treatment Phase||0||
59815422|NCT02658890|75937836|FG006|NOT COMPLETED|Pre-Treatment Phase||0||
59623059|NCT00555360|75735029|FG000|COMPLETED|Overall Study||156||
59535121|NCT00603044|75632795|FG000|STARTED|Overall Study||11||
59535122|NCT00603044|75632796|FG001|STARTED|Overall Study||13||
59535123|NCT00603044|75632795|FG000|COMPLETED|Overall Study||11||
59535124|NCT00603044|75632796|FG001|COMPLETED|Overall Study||13||
59535125|NCT00603044|75632795|FG000|NOT COMPLETED|Overall Study||0||
59535126|NCT00603044|75632796|FG001|NOT COMPLETED|Overall Study||0||
59535127|NCT00603902|75632805|FG000|STARTED|Overall Study||802||
59535128|NCT00603902|75632806|FG001|STARTED|Overall Study||1603||
59535129|NCT00603902|75632807|FG002|STARTED|Overall Study||1603||
59535130|NCT00603902|75632805|FG000|COMPLETED|Overall Study||473||
59535131|NCT00603902|75632806|FG001|COMPLETED|Overall Study||917||
59535132|NCT00603902|75632807|FG002|COMPLETED|Overall Study||834||
59535133|NCT00603902|75632805|FG000|NOT COMPLETED|Overall Study||329||
59535134|NCT00603902|75632806|FG001|NOT COMPLETED|Overall Study||686||
59535135|NCT00603902|75632807|FG002|NOT COMPLETED|Overall Study||769||
59535136|NCT00646646|75632819|FG000|STARTED|Overall Study||15||
59535137|NCT00646646|75632820|FG001|STARTED|Overall Study||15||
59535138|NCT00646646|75632821|FG002|STARTED|Overall Study||15||
59987778|NCT02279524|76103004|FG000|COMPLETED|Overall Study||88||
59987779|NCT02279524|76103005|FG001|COMPLETED|Overall Study||90||
59987780|NCT02279524|76103006|FG002|COMPLETED|Overall Study||41||
59987781|NCT02279524|76103004|FG000|NOT COMPLETED|Overall Study||10||
59987782|NCT02279524|76103005|FG001|NOT COMPLETED|Overall Study||11||
59535139|NCT00646646|75632822|FG003|STARTED|Overall Study||20||
59535140|NCT00646646|75632819|FG000|COMPLETED|Overall Study||15||
59535141|NCT00646646|75632820|FG001|COMPLETED|Overall Study||15||
59535142|NCT00646646|75632821|FG002|COMPLETED|Overall Study||15||
59535143|NCT00646646|75632822|FG003|COMPLETED|Overall Study||20||
59535144|NCT00646646|75632819|FG000|NOT COMPLETED|Overall Study||0||
59535145|NCT00646646|75632820|FG001|NOT COMPLETED|Overall Study||0||
59535146|NCT00646646|75632821|FG002|NOT COMPLETED|Overall Study||0||
59535147|NCT00646646|75632822|FG003|NOT COMPLETED|Overall Study||0||
59535148|NCT00696488|75632832|FG000|STARTED|Overall Study||20||
59535149|NCT00696488|75632832|FG000|COMPLETED|Overall Study||20||
59535150|NCT00696488|75632832|FG000|NOT COMPLETED|Overall Study||0||
59535151|NCT00648908|75632836|FG000|STARTED|Overall Study||269||
59535152|NCT00648908|75632836|FG000|COMPLETED|Overall Study||154||
59535153|NCT00648908|75632836|FG000|NOT COMPLETED|Overall Study||115||
59535154|NCT00697190|75632841|FG000|STARTED|First Intervention||19||
59535155|NCT00697190|75632842|FG001|STARTED|First Intervention||20||
59535156|NCT00697190|75632841|FG000|COMPLETED|First Intervention||19||
59535157|NCT00697190|75632842|FG001|COMPLETED|First Intervention||20||
59535158|NCT00697190|75632841|FG000|NOT COMPLETED|First Intervention||0||
59535159|NCT00697190|75632842|FG001|NOT COMPLETED|First Intervention||0||
59535160|NCT00697190|75632841|FG000|STARTED|Second Intervention|one subject moved away between the first period and second period.|18||
59535161|NCT00697190|75632842|FG001|STARTED|Second Intervention||20||
59535162|NCT00697190|75632841|FG000|COMPLETED|Second Intervention||18||
59535163|NCT00697190|75632842|FG001|COMPLETED|Second Intervention||20||
59535164|NCT00697190|75632841|FG000|NOT COMPLETED|Second Intervention||0||
59535165|NCT00697190|75632842|FG001|NOT COMPLETED|Second Intervention||0||
59535166|NCT00650078|75632854|FG000|STARTED|Overall Study||231||
59535167|NCT00650078|75632855|FG001|STARTED|Overall Study||119||
59535168|NCT00650078|75632854|FG000|COMPLETED|Overall Study||217||
59535169|NCT00650078|75632855|FG001|COMPLETED|Overall Study||106||
59535170|NCT00650078|75632854|FG000|NOT COMPLETED|Overall Study||14||
59535171|NCT00650078|75632855|FG001|NOT COMPLETED|Overall Study||13||
59535172|NCT00699140|75632861|FG000|STARTED|Overall Study||18||
59535173|NCT00699140|75632861|FG000|COMPLETED|Overall Study||18||
59535174|NCT00699140|75632861|FG000|NOT COMPLETED|Overall Study||0||
59535175|NCT02320838|75632869|FG000|STARTED|First Intervention (1 Day)||8||
59535176|NCT02320838|75632870|FG001|STARTED|First Intervention (1 Day)||8||
59535177|NCT02320838|75632871|FG002|STARTED|First Intervention (1 Day)||8||
59535178|NCT02320838|75632872|FG003|STARTED|First Intervention (1 Day)||7||
59535179|NCT02320838|75632873|FG004|STARTED|First Intervention (1 Day)||7||
59535180|NCT02320838|75632869|FG000|COMPLETED|First Intervention (1 Day)||8||
59535181|NCT02320838|75632870|FG001|COMPLETED|First Intervention (1 Day)||8||
59987783|NCT02279524|76103006|FG002|NOT COMPLETED|Overall Study||7||
59535182|NCT02320838|75632871|FG002|COMPLETED|First Intervention (1 Day)||8||
59535183|NCT02320838|75632872|FG003|COMPLETED|First Intervention (1 Day)||7||
59535184|NCT02320838|75632873|FG004|COMPLETED|First Intervention (1 Day)||7||
59535185|NCT02320838|75632869|FG000|NOT COMPLETED|First Intervention (1 Day)||0||
59535186|NCT02320838|75632870|FG001|NOT COMPLETED|First Intervention (1 Day)||0||
59535187|NCT02320838|75632871|FG002|NOT COMPLETED|First Intervention (1 Day)||0||
59535188|NCT02320838|75632872|FG003|NOT COMPLETED|First Intervention (1 Day)||0||
59535189|NCT02320838|75632873|FG004|NOT COMPLETED|First Intervention (1 Day)||0||
59535190|NCT02320838|75632869|FG000|STARTED|Washout (1 Day)||8||
59535191|NCT02320838|75632870|FG001|STARTED|Washout (1 Day)||8||
59535192|NCT02320838|75632871|FG002|STARTED|Washout (1 Day)||8||
59535193|NCT02320838|75632872|FG003|STARTED|Washout (1 Day)||7||
59987784|NCT02283268|76103014|FG000|STARTED|Overall Study||15||
59987785|NCT02283268|76103014|FG000|COMPLETED|Overall Study||14||
59987786|NCT02283268|76103014|FG000|NOT COMPLETED|Overall Study||1||
59535194|NCT02320838|75632873|FG004|STARTED|Washout (1 Day)||7||
59535195|NCT02320838|75632869|FG000|COMPLETED|Washout (1 Day)||8||
59535196|NCT02320838|75632870|FG001|COMPLETED|Washout (1 Day)||8||
59535197|NCT02320838|75632871|FG002|COMPLETED|Washout (1 Day)||8||
59535198|NCT02320838|75632872|FG003|COMPLETED|Washout (1 Day)||7||
59535199|NCT02320838|75632873|FG004|COMPLETED|Washout (1 Day)||7||
59535200|NCT02320838|75632869|FG000|NOT COMPLETED|Washout (1 Day)||0||
59535201|NCT02320838|75632870|FG001|NOT COMPLETED|Washout (1 Day)||0||
59535202|NCT02320838|75632871|FG002|NOT COMPLETED|Washout (1 Day)||0||
59535203|NCT02320838|75632872|FG003|NOT COMPLETED|Washout (1 Day)||0||
59535204|NCT02320838|75632873|FG004|NOT COMPLETED|Washout (1 Day)||0||
59535205|NCT02320838|75632869|FG000|STARTED|Second Intervention (1 Day)||8||
59535206|NCT02320838|75632870|FG001|STARTED|Second Intervention (1 Day)||8||
59535207|NCT02320838|75632871|FG002|STARTED|Second Intervention (1 Day)||8||
59535208|NCT02320838|75632872|FG003|STARTED|Second Intervention (1 Day)||7||
59535209|NCT02320838|75632873|FG004|STARTED|Second Intervention (1 Day)||7||
59535210|NCT02320838|75632869|FG000|COMPLETED|Second Intervention (1 Day)||8||
59535211|NCT02320838|75632870|FG001|COMPLETED|Second Intervention (1 Day)||8||
59535212|NCT02320838|75632871|FG002|COMPLETED|Second Intervention (1 Day)||8||
59535213|NCT02320838|75632872|FG003|COMPLETED|Second Intervention (1 Day)||7||
59535214|NCT02320838|75632873|FG004|COMPLETED|Second Intervention (1 Day)||7||
59535215|NCT02320838|75632869|FG000|NOT COMPLETED|Second Intervention (1 Day)||0||
59535216|NCT02320838|75632870|FG001|NOT COMPLETED|Second Intervention (1 Day)||0||
59535217|NCT02320838|75632871|FG002|NOT COMPLETED|Second Intervention (1 Day)||0||
59535218|NCT02320838|75632872|FG003|NOT COMPLETED|Second Intervention (1 Day)||0||
59535219|NCT02320838|75632873|FG004|NOT COMPLETED|Second Intervention (1 Day)||0||
59535220|NCT02320838|75632869|FG000|STARTED|Washout (1 Day)||8||
59535221|NCT02320838|75632870|FG001|STARTED|Washout (1 Day)||8||
59535222|NCT02320838|75632871|FG002|STARTED|Washout (1 Day)||8||
59535223|NCT02320838|75632872|FG003|STARTED|Washout (1 Day)||7||
59535224|NCT02320838|75632873|FG004|STARTED|Washout (1 Day)||7||
59535225|NCT02320838|75632869|FG000|COMPLETED|Washout (1 Day)||8||
59535226|NCT02320838|75632870|FG001|COMPLETED|Washout (1 Day)||8||
59535227|NCT02320838|75632871|FG002|COMPLETED|Washout (1 Day)||8||
59535228|NCT02320838|75632872|FG003|COMPLETED|Washout (1 Day)||7||
59535229|NCT02320838|75632873|FG004|COMPLETED|Washout (1 Day)||7||
59535230|NCT02320838|75632869|FG000|NOT COMPLETED|Washout (1 Day)||0||
59535231|NCT02320838|75632870|FG001|NOT COMPLETED|Washout (1 Day)||0||
59535232|NCT02320838|75632871|FG002|NOT COMPLETED|Washout (1 Day)||0||
59535233|NCT02320838|75632872|FG003|NOT COMPLETED|Washout (1 Day)||0||
59535234|NCT02320838|75632873|FG004|NOT COMPLETED|Washout (1 Day)||0||
59535235|NCT02320838|75632869|FG000|STARTED|Third Intervention (1 Day)||8||
59535236|NCT02320838|75632870|FG001|STARTED|Third Intervention (1 Day)||8||
59535237|NCT02320838|75632871|FG002|STARTED|Third Intervention (1 Day)||8||
59535238|NCT02320838|75632872|FG003|STARTED|Third Intervention (1 Day)||7||
59535239|NCT02320838|75632873|FG004|STARTED|Third Intervention (1 Day)||7||
59535240|NCT02320838|75632869|FG000|COMPLETED|Third Intervention (1 Day)||8||
59535241|NCT02320838|75632870|FG001|COMPLETED|Third Intervention (1 Day)||8||
59535242|NCT02320838|75632871|FG002|COMPLETED|Third Intervention (1 Day)||8||
59535243|NCT02320838|75632872|FG003|COMPLETED|Third Intervention (1 Day)||7||
59535244|NCT02320838|75632873|FG004|COMPLETED|Third Intervention (1 Day)||7||
59535245|NCT02320838|75632869|FG000|NOT COMPLETED|Third Intervention (1 Day)||0||
59535246|NCT02320838|75632870|FG001|NOT COMPLETED|Third Intervention (1 Day)||0||
59535247|NCT02320838|75632871|FG002|NOT COMPLETED|Third Intervention (1 Day)||0||
59535248|NCT02320838|75632872|FG003|NOT COMPLETED|Third Intervention (1 Day)||0||
59535249|NCT02320838|75632873|FG004|NOT COMPLETED|Third Intervention (1 Day)||0||
59535250|NCT00650546|75632881|FG000|STARTED|Overall Study||8||
59535251|NCT00650546|75632881|FG000|COMPLETED|Overall Study||8||
59535252|NCT00650546|75632881|FG000|NOT COMPLETED|Overall Study||0||
59535253|NCT00699218|75632886|FG000|STARTED|Overall Study||15||
59535254|NCT00699218|75632886|FG000|COMPLETED|Overall Study||15||
59535255|NCT00699218|75632886|FG000|NOT COMPLETED|Overall Study||0||
59535256|NCT00650858|75632893|FG000|STARTED|Overall Study||8||
59535257|NCT00650858|75632894|FG001|STARTED|Overall Study||8||
59535258|NCT00650858|75632895|FG002|STARTED|Overall Study||36||
59535259|NCT00650858|75632893|FG000|COMPLETED|Overall Study||8||
59535260|NCT00650858|75632894|FG001|COMPLETED|Overall Study||8||
59535261|NCT00650858|75632895|FG002|COMPLETED|Overall Study||36||
59535262|NCT00650858|75632893|FG000|NOT COMPLETED|Overall Study||0||
59535263|NCT00650858|75632894|FG001|NOT COMPLETED|Overall Study||0||
59535264|NCT00650858|75632895|FG002|NOT COMPLETED|Overall Study||0||
59535265|NCT00650936|75632903|FG000|STARTED|Overall Study||1000||
59535266|NCT00650936|75632903|FG000|COMPLETED|Overall Study||930||
59535267|NCT00650936|75632903|FG000|NOT COMPLETED|Overall Study||70||
59535268|NCT00651482|75632907|FG000|STARTED|Overall Study||10||
59535269|NCT00651482|75632907|FG000|COMPLETED|Overall Study||10||
59535270|NCT00651482|75632907|FG000|NOT COMPLETED|Overall Study||0||
59535271|NCT00651794|75632915|FG000|STARTED|Overall Study||36||
59535272|NCT00651794|75632916|FG001|STARTED|Overall Study||31||
59535273|NCT00651794|75632917|FG002|STARTED|Overall Study||31||
59535274|NCT00651794|75632915|FG000|COMPLETED|Overall Study||15||
59535275|NCT00651794|75632916|FG001|COMPLETED|Overall Study||9||
59535276|NCT00651794|75632917|FG002|COMPLETED|Overall Study||10||
59535277|NCT00651794|75632915|FG000|NOT COMPLETED|Overall Study||21||
59535278|NCT00651794|75632916|FG001|NOT COMPLETED|Overall Study||22||
59535279|NCT00651794|75632917|FG002|NOT COMPLETED|Overall Study||21||
59535280|NCT00654836|75632925|FG000|STARTED|Overall Study||32||
59535281|NCT00654836|75632925|FG000|COMPLETED|Overall Study||32||
59535282|NCT00654836|75632925|FG000|NOT COMPLETED|Overall Study||0||
59535283|NCT00701636|75632931|FG000|STARTED|Overall Study||15||
59535284|NCT00701636|75632932|FG001|STARTED|Overall Study||15||
59535285|NCT00701636|75632931|FG000|COMPLETED|Overall Study||15||
59535286|NCT00701636|75632932|FG001|COMPLETED|Overall Study||15||
59535287|NCT00701636|75632931|FG000|NOT COMPLETED|Overall Study||0||
59535288|NCT00701636|75632932|FG001|NOT COMPLETED|Overall Study||0||
59535289|NCT00701714|75632939|FG000|STARTED|Treatment Period (up to 1 Year)||174||
59535290|NCT00701714|75632940|FG001|STARTED|Treatment Period (up to 1 Year)||163||
59535291|NCT00701714|75632939|FG000|COMPLETED|Treatment Period (up to 1 Year)||37||
59535292|NCT00701714|75632940|FG001|COMPLETED|Treatment Period (up to 1 Year)||29||
59535293|NCT00701714|75632939|FG000|NOT COMPLETED|Treatment Period (up to 1 Year)||137||
59535294|NCT00701714|75632940|FG001|NOT COMPLETED|Treatment Period (up to 1 Year)||134||
59535295|NCT00701714|75632939|FG000|STARTED|Safety Follow-up Period (6 Months)|Study terminated prematurely, all available randomized patients followed-up 6 months for safety|151||
59535296|NCT00701714|75632940|FG001|STARTED|Safety Follow-up Period (6 Months)|Study terminated prematurely, all available randomized patients followed-up 6 months for safety|119||
59535297|NCT00701714|75632939|FG000|COMPLETED|Safety Follow-up Period (6 Months)||144||
59535298|NCT00701714|75632940|FG001|COMPLETED|Safety Follow-up Period (6 Months)||112||
59535299|NCT00701714|75632939|FG000|NOT COMPLETED|Safety Follow-up Period (6 Months)||7||
59535300|NCT00701714|75632940|FG001|NOT COMPLETED|Safety Follow-up Period (6 Months)||7||
59535301|NCT00655538|75632952|FG000|STARTED|Overall Study||238||
59535302|NCT00655538|75632953|FG001|STARTED|Overall Study||238||
59535303|NCT00655538|75632952|FG000|COMPLETED|Overall Study||214||
59535304|NCT00655538|75632953|FG001|COMPLETED|Overall Study||211||
59535305|NCT00655538|75632952|FG000|NOT COMPLETED|Overall Study||24||
59535306|NCT00655538|75632953|FG001|NOT COMPLETED|Overall Study||27||
59535307|NCT00656630|75632962|FG000|STARTED|Overall Study||22||
59535308|NCT00656630|75632963|FG001|STARTED|Overall Study||27||
59535309|NCT00656630|75632964|FG002|STARTED|Overall Study||19||
59535310|NCT00656630|75632962|FG000|COMPLETED|Overall Study||20||
59535311|NCT00656630|75632963|FG001|COMPLETED|Overall Study||25||
59535312|NCT00656630|75632964|FG002|COMPLETED|Overall Study||17||
59535313|NCT00656630|75632962|FG000|NOT COMPLETED|Overall Study||2||
59535314|NCT00656630|75632963|FG001|NOT COMPLETED|Overall Study||2||
59535315|NCT00656630|75632964|FG002|NOT COMPLETED|Overall Study||2||
59535316|NCT01362998|75632974|FG000|STARTED|Overall Study||0||
59535317|NCT01362998|75632975|FG001|STARTED|Overall Study||2||
59535318|NCT01362998|75632974|FG000|COMPLETED|Overall Study|Note: No participants in this arm.|0||
59535319|NCT01362998|75632975|FG001|COMPLETED|Overall Study||1||
59535320|NCT01362998|75632974|FG000|NOT COMPLETED|Overall Study||0||
59535321|NCT01362998|75632975|FG001|NOT COMPLETED|Overall Study||1||
59535322|NCT00658112|75632981|FG000|STARTED|Overall Study||20||
59535323|NCT00658112|75632981|FG000|COMPLETED|Overall Study||11||
59535324|NCT00658112|75632981|FG000|NOT COMPLETED|Overall Study||9||
59535325|NCT00702884|75632985|FG000|STARTED|Overall Study||25||
59535326|NCT00702884|75632985|FG000|COMPLETED|Overall Study||25||
59535327|NCT00702884|75632985|FG000|NOT COMPLETED|Overall Study||0||
59535328|NCT00703508|75632992|FG000|STARTED|Overall Study||26||
59535329|NCT00703508|75632992|FG000|COMPLETED|Overall Study||26||
59535330|NCT00703508|75632992|FG000|NOT COMPLETED|Overall Study||0||
59535331|NCT01284335|75633011|FG000|STARTED|Overall Study||25||
59535332|NCT01284335|75633012|FG001|STARTED|Overall Study||33||
59535333|NCT01284335|75633013|FG002|STARTED|Overall Study||5||
59535334|NCT01284335|75633014|FG003|STARTED|Overall Study||5||
59535335|NCT01284335|75633015|FG004|STARTED|Overall Study||24||
59535336|NCT01284335|75633016|FG005|STARTED|Overall Study||26||
59535337|NCT01284335|75633017|FG006|STARTED|Overall Study||19||
59987787|NCT00857285|76103028|FG000|STARTED|Overall Study||65||
59987788|NCT00857285|76103029|FG001|STARTED|Overall Study||65||
59987789|NCT00857285|76103028|FG000|COMPLETED|Overall Study||53||
59987790|NCT00857285|76103029|FG001|COMPLETED|Overall Study||59||
59987791|NCT00857285|76103028|FG000|NOT COMPLETED|Overall Study||12||
59987792|NCT00857285|76103029|FG001|NOT COMPLETED|Overall Study||6||
59987793|NCT02278354|76103035|FG000|STARTED|Overall Study||12||
59987794|NCT02278354|76103036|FG001|STARTED|Overall Study||23||
59987795|NCT02278354|76103035|FG000|Flortaucipir PET Scan|Overall Study||10||
59987796|NCT02278354|76103036|FG001|Flortaucipir PET Scan|Overall Study||20||
59535338|NCT01284335|75633018|FG007|STARTED|Overall Study||6||
59535339|NCT01284335|75633019|FG008|STARTED|Overall Study||4||
59535340|NCT01284335|75633020|FG009|STARTED|Overall Study||14||
59535341|NCT01284335|75633021|FG010|STARTED|Overall Study||45||
59535342|NCT01284335|75633022|FG011|STARTED|Overall Study||16||
59987797|NCT02278354|76103035|FG000|COMPLETED|Overall Study||8||
59535343|NCT01284335|75633023|FG012|STARTED|Overall Study||12||
59623060|NCT00555360|75735030|FG001|COMPLETED|Overall Study||153||
60075805|NCT00637156|76191113|FG000|COMPLETED|Overall Study||199||
59987798|NCT02278354|76103036|FG001|COMPLETED|Overall Study||20||
59815423|NCT02658890|75937837|FG007|NOT COMPLETED|Pre-Treatment Phase||0||
59815424|NCT02658890|75937838|FG008|NOT COMPLETED|Pre-Treatment Phase||1||
59987799|NCT02278354|76103035|FG000|NOT COMPLETED|Overall Study||4||
59987800|NCT02278354|76103036|FG001|NOT COMPLETED|Overall Study||3||
60075806|NCT00637156|76191114|FG001|COMPLETED|Overall Study||164||
60075807|NCT00637156|76191113|FG000|NOT COMPLETED|Overall Study||10||
60075808|NCT00637156|76191114|FG001|NOT COMPLETED|Overall Study||24||
60075809|NCT00637000|76191122|FG000|STARTED|Overall Study|Randomized and treated|20||
60075810|NCT00637000|76191123|FG001|STARTED|Overall Study|Randomized and treated|18||
60075811|NCT00637000|76191122|FG000|Evaluable|Overall Study||18||
60075812|NCT00637000|76191123|FG001|Evaluable|Overall Study||16||
60075813|NCT00637000|76191122|FG000|COMPLETED|Overall Study||16||
60075814|NCT00637000|76191123|FG001|COMPLETED|Overall Study||15||
60075815|NCT00637000|76191122|FG000|NOT COMPLETED|Overall Study||4||
59987801|NCT01517659|76103044|FG000|STARTED|Overall Study||45||
59987802|NCT01517659|76103044|FG000|COMPLETED|Overall Study||45||
59987803|NCT01517659|76103044|FG000|NOT COMPLETED|Overall Study||0||
59987804|NCT01657370|76103055|FG000|STARTED|Overall Study||33||
59987805|NCT01657370|76103056|FG001|STARTED|Overall Study||32||
59987806|NCT01657370|76103057|FG002|STARTED|Overall Study||32||
59987807|NCT01657370|76103058|FG003|STARTED|Overall Study||33||
59987808|NCT01657370|76103059|FG004|STARTED|Overall Study||34||
59987809|NCT01657370|76103060|FG005|STARTED|Overall Study||31||
59987810|NCT01657370|76103055|FG000|COMPLETED|Overall Study||27||
59987811|NCT01657370|76103056|FG001|COMPLETED|Overall Study||28||
59987812|NCT01657370|76103057|FG002|COMPLETED|Overall Study||25||
59987813|NCT01657370|76103058|FG003|COMPLETED|Overall Study||28||
59987814|NCT01657370|76103059|FG004|COMPLETED|Overall Study||27||
59987815|NCT01657370|76103060|FG005|COMPLETED|Overall Study||27||
59987816|NCT01657370|76103055|FG000|NOT COMPLETED|Overall Study||6||
59987817|NCT01657370|76103056|FG001|NOT COMPLETED|Overall Study||4||
59987818|NCT01657370|76103057|FG002|NOT COMPLETED|Overall Study||7||
59987819|NCT01657370|76103058|FG003|NOT COMPLETED|Overall Study||5||
59987820|NCT01657370|76103059|FG004|NOT COMPLETED|Overall Study||7||
59987821|NCT01657370|76103060|FG005|NOT COMPLETED|Overall Study||4||
59987822|NCT00838981|76103083|FG000|STARTED|Week 1 Days 1-3||26||
59987823|NCT00838981|76103084|FG001|STARTED|Week 1 Days 1-3||19||
59987824|NCT00838981|76103085|FG002|STARTED|Week 1 Days 1-3||27||
59987825|NCT00838981|76103086|FG003|STARTED|Week 1 Days 1-3||19||
59987826|NCT00838981|76103083|FG000|COMPLETED|Week 1 Days 1-3||26||
59987827|NCT00838981|76103084|FG001|COMPLETED|Week 1 Days 1-3||19||
59987828|NCT00838981|76103085|FG002|COMPLETED|Week 1 Days 1-3||27||
59987829|NCT00838981|76103086|FG003|COMPLETED|Week 1 Days 1-3||19||
60075816|NCT00637000|76191123|FG001|NOT COMPLETED|Overall Study||3||
60075817|NCT01515189|76191131|FG000|STARTED|Induction|Includes 1 subject who was randomized but not treated due to an Adverse Event before treatment|365||
60075818|NCT01515189|76191132|FG001|STARTED|Induction||362||
60075819|NCT01515189|76191131|FG000|COMPLETED|Induction||128||
59623061|NCT00555360|75735029|FG000|NOT COMPLETED|Overall Study||27||
59623062|NCT00555360|75735030|FG001|NOT COMPLETED|Overall Study||36||
59623063|NCT00525876|75735039|FG000|STARTED|Overall Study||16||
59623064|NCT00525876|75735040|FG001|STARTED|Overall Study||20||
60075820|NCT01515189|76191132|FG001|COMPLETED|Induction||130||
60075821|NCT01515189|76191131|FG000|NOT COMPLETED|Induction||237||
60075822|NCT01515189|76191132|FG001|NOT COMPLETED|Induction||232||
60075823|NCT01515189|76191131|FG000|STARTED|First Re-Induction Phase||23||
60075824|NCT01515189|76191132|FG001|STARTED|First Re-Induction Phase||32||
59623065|NCT00525876|75735039|FG000|COMPLETED|Overall Study||16||
59987830|NCT00838981|76103083|FG000|NOT COMPLETED|Week 1 Days 1-3||0||
59987831|NCT00838981|76103084|FG001|NOT COMPLETED|Week 1 Days 1-3||0||
59987832|NCT00838981|76103085|FG002|NOT COMPLETED|Week 1 Days 1-3||0||
59987833|NCT00838981|76103086|FG003|NOT COMPLETED|Week 1 Days 1-3||0||
59987834|NCT00838981|76103083|FG000|STARTED|Day 4 to Week 11||26||
59987835|NCT00838981|76103084|FG001|STARTED|Day 4 to Week 11||19||
60075825|NCT01515189|76191131|FG000|COMPLETED|First Re-Induction Phase||9||
60075826|NCT01515189|76191132|FG001|COMPLETED|First Re-Induction Phase||17||
60075827|NCT01515189|76191131|FG000|NOT COMPLETED|First Re-Induction Phase||14||
60075828|NCT01515189|76191132|FG001|NOT COMPLETED|First Re-Induction Phase||15||
60075829|NCT01546623|76191140|FG000|STARTED|Overall Study||82||
60075830|NCT01546623|76191141|FG001|STARTED|Overall Study||80||
60075831|NCT01546623|76191140|FG000|Received Study Drug|Overall Study||81||
60075832|NCT01546623|76191141|FG001|Received Study Drug|Overall Study||79||
60075833|NCT01546623|76191140|FG000|COMPLETED|Overall Study||76||
60075834|NCT01546623|76191141|FG001|COMPLETED|Overall Study||74||
60075835|NCT01546623|76191140|FG000|NOT COMPLETED|Overall Study||6||
60075836|NCT01546623|76191141|FG001|NOT COMPLETED|Overall Study||6||
60075837|NCT01546155|76191147|FG000|STARTED|Overall Study||11||
60075838|NCT01546155|76191147|FG000|COMPLETED|Overall Study||8||
60075839|NCT01546155|76191147|FG000|NOT COMPLETED|Overall Study||3||
60075840|NCT00636610|76191153|FG000|STARTED|Overall Study||98||
59987836|NCT00838981|76103085|FG002|STARTED|Day 4 to Week 11||27||
59987837|NCT00838981|76103086|FG003|STARTED|Day 4 to Week 11||19||
59987838|NCT00838981|76103083|FG000|Completed Main Treatment on 400mg|Day 4 to Week 11||22||
59987839|NCT00838981|76103084|FG001|Completed Main Treatment on 400mg|Day 4 to Week 11||13||
59987840|NCT00838981|76103085|FG002|Completed Main Treatment on 400mg|Day 4 to Week 11||17||
59987841|NCT00838981|76103086|FG003|Completed Main Treatment on 400mg|Day 4 to Week 11||14||
59987842|NCT00838981|76103083|FG000|COMPLETED|Day 4 to Week 11||19|'Completed' numbers reflect those that completed the post treatment assessments and 'Not Completed' numbers reflect those that did not complete the post treatment assessments.|
59987843|NCT00838981|76103084|FG001|COMPLETED|Day 4 to Week 11||11|'Completed' numbers reflect those that completed the post treatment assessments and 'Not Completed' numbers reflect those that did not complete the post treatment assessments.|
59987844|NCT00838981|76103085|FG002|COMPLETED|Day 4 to Week 11||16|'Completed' numbers reflect those that completed the post treatment assessments and 'Not Completed' numbers reflect those that did not complete the post treatment assessments.|
59987845|NCT00838981|76103086|FG003|COMPLETED|Day 4 to Week 11||12|'Completed' numbers reflect those that completed the post treatment assessments and 'Not Completed' numbers reflect those that did not complete the post treatment assessments.|
59987846|NCT00838981|76103083|FG000|NOT COMPLETED|Day 4 to Week 11||7||
59987847|NCT00838981|76103084|FG001|NOT COMPLETED|Day 4 to Week 11||8||
59987848|NCT00838981|76103085|FG002|NOT COMPLETED|Day 4 to Week 11||11||
59987849|NCT00838981|76103086|FG003|NOT COMPLETED|Day 4 to Week 11||7||
59987850|NCT00849797|76103102|FG000|STARTED|First Intervention||60||
59987851|NCT00849797|76103103|FG001|STARTED|First Intervention||60||
59987852|NCT00849797|76103102|FG000|COMPLETED|First Intervention||59||
59987853|NCT00849797|76103103|FG001|COMPLETED|First Intervention||59||
59987854|NCT00849797|76103102|FG000|NOT COMPLETED|First Intervention||1||
59987855|NCT00849797|76103103|FG001|NOT COMPLETED|First Intervention||1||
59987856|NCT00849797|76103102|FG000|STARTED|Washout: One Week||59||
59987857|NCT00849797|76103103|FG001|STARTED|Washout: One Week||59||
59987858|NCT00849797|76103102|FG000|COMPLETED|Washout: One Week||59||
59987859|NCT00849797|76103103|FG001|COMPLETED|Washout: One Week||57||
59987860|NCT00849797|76103102|FG000|NOT COMPLETED|Washout: One Week||0||
59987861|NCT00849797|76103103|FG001|NOT COMPLETED|Washout: One Week||2||
59987862|NCT00849797|76103102|FG000|STARTED|Second Intervention||59||
59987863|NCT00849797|76103103|FG001|STARTED|Second Intervention||57||
59987864|NCT00849797|76103102|FG000|COMPLETED|Second Intervention||59||
59987865|NCT00849797|76103103|FG001|COMPLETED|Second Intervention||57||
59987866|NCT00849797|76103102|FG000|NOT COMPLETED|Second Intervention||0||
59987867|NCT00849797|76103103|FG001|NOT COMPLETED|Second Intervention||0||
59987868|NCT00849485|76103110|FG000|STARTED|First Intervention||11||
59987869|NCT00849485|76103111|FG001|STARTED|First Intervention||11||
59987870|NCT00849485|76103110|FG000|COMPLETED|First Intervention||11||
59987871|NCT00849485|76103111|FG001|COMPLETED|First Intervention||11||
59987872|NCT00849485|76103110|FG000|NOT COMPLETED|First Intervention||0||
59987873|NCT00849485|76103111|FG001|NOT COMPLETED|First Intervention||0||
59987874|NCT00849485|76103110|FG000|STARTED|Washout: 7 Days||11||
59987875|NCT00849485|76103111|FG001|STARTED|Washout: 7 Days||11||
59987876|NCT00849485|76103110|FG000|COMPLETED|Washout: 7 Days||11||
59987877|NCT00849485|76103111|FG001|COMPLETED|Washout: 7 Days||11||
59987878|NCT00849485|76103110|FG000|NOT COMPLETED|Washout: 7 Days||0||
59987879|NCT00849485|76103111|FG001|NOT COMPLETED|Washout: 7 Days||0||
59987880|NCT00849485|76103110|FG000|STARTED|Second Intervention||11||
59987881|NCT00849485|76103111|FG001|STARTED|Second Intervention||11||
59987882|NCT00849485|76103110|FG000|COMPLETED|Second Intervention||11||
59987883|NCT00849485|76103111|FG001|COMPLETED|Second Intervention||11||
59987884|NCT00849485|76103110|FG000|NOT COMPLETED|Second Intervention||0||
59987885|NCT00849485|76103111|FG001|NOT COMPLETED|Second Intervention||0||
59987886|NCT05074251|76103117|FG000|STARTED|Overall Study||86||
59987887|NCT05074251|76103118|FG001|STARTED|Overall Study||94||
59987888|NCT05074251|76103117|FG000|COMPLETED|Overall Study||85||
59987889|NCT05074251|76103118|FG001|COMPLETED|Overall Study||91||
59987890|NCT05074251|76103117|FG000|NOT COMPLETED|Overall Study||1||
59987891|NCT05074251|76103118|FG001|NOT COMPLETED|Overall Study||3||
59987892|NCT00840281|76103126|FG000|STARTED|First Intervention||19||
59987893|NCT00840281|76103127|FG001|STARTED|First Intervention||19||
59987894|NCT00840281|76103126|FG000|COMPLETED|First Intervention||19||
59987895|NCT00840281|76103127|FG001|COMPLETED|First Intervention||19||
59987896|NCT00840281|76103126|FG000|NOT COMPLETED|First Intervention||0||
59987897|NCT00840281|76103127|FG001|NOT COMPLETED|First Intervention||0||
59987898|NCT00840281|76103126|FG000|STARTED|Washout of 7 Days||19||
59987899|NCT00840281|76103127|FG001|STARTED|Washout of 7 Days||19||
59987900|NCT00840281|76103126|FG000|COMPLETED|Washout of 7 Days||19||
59987901|NCT00840281|76103127|FG001|COMPLETED|Washout of 7 Days||19||
59987902|NCT00840281|76103126|FG000|NOT COMPLETED|Washout of 7 Days||0||
59987903|NCT00840281|76103127|FG001|NOT COMPLETED|Washout of 7 Days||0||
59987904|NCT00840281|76103126|FG000|STARTED|Second Intervention||19||
59987905|NCT00840281|76103127|FG001|STARTED|Second Intervention||19||
59987906|NCT00840281|76103126|FG000|COMPLETED|Second Intervention||19||
60075841|NCT00636610|76191154|FG001|STARTED|Overall Study||101||
59987907|NCT00840281|76103127|FG001|COMPLETED|Second Intervention||19||
59987908|NCT00840281|76103126|FG000|NOT COMPLETED|Second Intervention||0||
60075842|NCT00636610|76191153|FG000|COMPLETED|Overall Study||6||
60075843|NCT00636610|76191154|FG001|COMPLETED|Overall Study||18||
60075844|NCT00636610|76191153|FG000|NOT COMPLETED|Overall Study||92||
60075845|NCT00636610|76191154|FG001|NOT COMPLETED|Overall Study||83||
60075846|NCT00635050|76191162|FG000|STARTED|Overall Study|No patient received regimen B due to grade 3 toxicity in the third patient treated on regimen A.|32||
60075847|NCT00635050|76191162|FG000|COMPLETED|Overall Study|Followup through 10 years planned.|31||
60075848|NCT00635050|76191162|FG000|NOT COMPLETED|Overall Study||1||
60075849|NCT00634504|76191171|FG000|STARTED|Overall Study||11||
60075850|NCT00634504|76191172|FG001|STARTED|Overall Study||9||
60075851|NCT00634504|76191171|FG000|COMPLETED|Overall Study||10||
60075852|NCT00634504|76191172|FG001|COMPLETED|Overall Study||9||
60075853|NCT00634504|76191171|FG000|NOT COMPLETED|Overall Study||1||
60075854|NCT00634504|76191172|FG001|NOT COMPLETED|Overall Study||0||
60075855|NCT00634114|76191181|FG000|STARTED|Overall Study|Randomised|188||
60075856|NCT00634114|76191182|FG001|STARTED|Overall Study|Randomised|189||
60075857|NCT00634114|76191183|FG002|STARTED|Overall Study|Randomised|187||
60075858|NCT00634114|76191181|FG000|COMPLETED|Overall Study|Completed|160||
60075859|NCT00634114|76191182|FG001|COMPLETED|Overall Study|Completed|154||
60075860|NCT00634114|76191183|FG002|COMPLETED|Overall Study|Completed|148||
60075861|NCT00634114|76191181|FG000|NOT COMPLETED|Overall Study||28||
60075862|NCT00634114|76191182|FG001|NOT COMPLETED|Overall Study||35||
60075863|NCT00634114|76191183|FG002|NOT COMPLETED|Overall Study||39||
60075864|NCT00634036|76191193|FG000|STARTED|Overall Study||12||
60075865|NCT00634036|76191194|FG001|STARTED|Overall Study||11||
60075866|NCT00634036|76191193|FG000|COMPLETED|Overall Study||10||
60075867|NCT00634036|76191194|FG001|COMPLETED|Overall Study||9||
60075868|NCT00634036|76191193|FG000|NOT COMPLETED|Overall Study||2||
60075869|NCT00634036|76191194|FG001|NOT COMPLETED|Overall Study||2||
60075870|NCT01545375|76191202|FG000|STARTED|Overall Study||900||
60075871|NCT01545375|76191203|FG001|STARTED|Overall Study||903||
60075872|NCT01545375|76191202|FG000|COMPLETED|Overall Study||803||
60075873|NCT01545375|76191203|FG001|COMPLETED|Overall Study||813||
60075874|NCT01545375|76191202|FG000|NOT COMPLETED|Overall Study||97||
60075875|NCT01545375|76191203|FG001|NOT COMPLETED|Overall Study||90||
60075876|NCT01539837|76191212|FG000|STARTED|Overall Study||8||
60075877|NCT01539837|76191213|FG001|STARTED|Overall Study||7||
60075878|NCT01539837|76191214|FG002|STARTED|Overall Study||7||
60075879|NCT01539837|76191212|FG000|COMPLETED|Overall Study||8||
60075880|NCT01539837|76191213|FG001|COMPLETED|Overall Study||6||
60075881|NCT01539837|76191214|FG002|COMPLETED|Overall Study||5||
60075882|NCT01539837|76191212|FG000|NOT COMPLETED|Overall Study||0||
60075883|NCT01539837|76191213|FG001|NOT COMPLETED|Overall Study||1||
60075884|NCT01539837|76191214|FG002|NOT COMPLETED|Overall Study||2||
60075885|NCT01539759|76191224|FG000|STARTED|Overall Study||56||
60075886|NCT01539759|76191225|FG001|STARTED|Overall Study||56||
60075887|NCT01539759|76191224|FG000|Had Successful IUD Placement|Overall Study||34||
60075888|NCT01539759|76191225|FG001|Had Successful IUD Placement|Overall Study||53||
60075889|NCT01539759|76191224|FG000|IUD Expulsion|Overall Study||1||
60075890|NCT01539759|76191225|FG001|IUD Expulsion|Overall Study||4||
60075891|NCT01539759|76191224|FG000|IUD Removal|Overall Study||2||
60075892|NCT01539759|76191225|FG001|IUD Removal|Overall Study||7||
60075893|NCT01539759|76191224|FG000|IUD in Place at 6 Months Posptartum|Overall Study||32||
60075894|NCT01539759|76191225|FG001|IUD in Place at 6 Months Posptartum|Overall Study||40||
60075895|NCT01539759|76191224|FG000|COMPLETED|Overall Study||50||
60075896|NCT01539759|76191225|FG001|COMPLETED|Overall Study||48||
60075897|NCT01539759|76191224|FG000|NOT COMPLETED|Overall Study||6||
60075898|NCT01539759|76191225|FG001|NOT COMPLETED|Overall Study||8||
60075899|NCT00633022|76191234|FG000|STARTED|Overall Study||34||
60075900|NCT00633022|76191235|FG001|STARTED|Overall Study||33||
60075901|NCT00633022|76191236|FG002|STARTED|Overall Study||32||
60075902|NCT00633022|76191234|FG000|COMPLETED|Overall Study||33||
60075903|NCT00633022|76191235|FG001|COMPLETED|Overall Study||32||
60075904|NCT00633022|76191236|FG002|COMPLETED|Overall Study||27||
60075905|NCT00633022|76191234|FG000|NOT COMPLETED|Overall Study||1||
60075906|NCT00633022|76191235|FG001|NOT COMPLETED|Overall Study||1||
60075907|NCT00633022|76191236|FG002|NOT COMPLETED|Overall Study||5||
60075908|NCT00630994|76191244|FG000|STARTED|Overall Study||4||
60075909|NCT00630994|76191244|FG000|COMPLETED|Overall Study||0||
60075910|NCT00630994|76191244|FG000|NOT COMPLETED|Overall Study||4||
60075911|NCT00630838|76191250|FG000|STARTED|Overall Study||32||
60075912|NCT00630838|76191251|FG001|STARTED|Overall Study||30||
60075913|NCT00630838|76191250|FG000|COMPLETED|Overall Study||32||
60075914|NCT00630838|76191251|FG001|COMPLETED|Overall Study||28||
60075915|NCT00630838|76191250|FG000|NOT COMPLETED|Overall Study||0||
60075916|NCT00630838|76191251|FG001|NOT COMPLETED|Overall Study||2||
60075917|NCT00630058|76191261|FG000|STARTED|Overall Study||10||
60075918|NCT00630058|76191262|FG001|STARTED|Overall Study||10||
60075919|NCT00630058|76191261|FG000|COMPLETED|Overall Study||6||
60075920|NCT00630058|76191262|FG001|COMPLETED|Overall Study||6||
60075921|NCT00630058|76191261|FG000|NOT COMPLETED|Overall Study||4||
60075922|NCT00630058|76191262|FG001|NOT COMPLETED|Overall Study||4||
60075923|NCT01925794|76191268|FG000|STARTED|30 Days||296||
60075924|NCT01925794|76191268|FG000|COMPLETED|30 Days||296||
60075925|NCT01925794|76191268|FG000|NOT COMPLETED|30 Days||0||
60075926|NCT01925794|76191268|FG000|STARTED|180 Days||296||
60075927|NCT01925794|76191268|FG000|COMPLETED|180 Days||292||
60075928|NCT01925794|76191268|FG000|NOT COMPLETED|180 Days||4||
60075929|NCT01925794|76191268|FG000|STARTED|270 Days||292||
60075930|NCT01925794|76191268|FG000|COMPLETED|270 Days||287||
60075931|NCT01925794|76191268|FG000|NOT COMPLETED|270 Days||5||
60075932|NCT00989950|76191280|FG000|STARTED|Open Label Dose Optimization||6||
60075933|NCT00989950|76191281|FG001|STARTED|Open Label Dose Optimization||9||
60075934|NCT00989950|76191282|FG002|STARTED|Open Label Dose Optimization||4||
60075935|NCT00989950|76191283|FG003|STARTED|Open Label Dose Optimization||7||
60075936|NCT00989950|76191280|FG000|COMPLETED|Open Label Dose Optimization||6||
60075937|NCT00989950|76191281|FG001|COMPLETED|Open Label Dose Optimization||9||
60075938|NCT00989950|76191282|FG002|COMPLETED|Open Label Dose Optimization||4||
60075939|NCT00989950|76191283|FG003|COMPLETED|Open Label Dose Optimization||7||
60075940|NCT00989950|76191280|FG000|NOT COMPLETED|Open Label Dose Optimization||0||
60075941|NCT00989950|76191281|FG001|NOT COMPLETED|Open Label Dose Optimization||0||
60075942|NCT00989950|76191282|FG002|NOT COMPLETED|Open Label Dose Optimization||0||
60075943|NCT00989950|76191283|FG003|NOT COMPLETED|Open Label Dose Optimization||0||
60075944|NCT00989950|76191280|FG000|STARTED|Randomized Phase||6||
60075945|NCT00989950|76191281|FG001|STARTED|Randomized Phase||9||
60075946|NCT00989950|76191282|FG002|STARTED|Randomized Phase||4||
60075947|NCT00989950|76191283|FG003|STARTED|Randomized Phase||7||
60075948|NCT00989950|76191280|FG000|COMPLETED|Randomized Phase||5||
60075949|NCT00989950|76191281|FG001|COMPLETED|Randomized Phase||8||
60075950|NCT00989950|76191282|FG002|COMPLETED|Randomized Phase||4||
60075951|NCT00989950|76191283|FG003|COMPLETED|Randomized Phase||7||
60075952|NCT00989950|76191280|FG000|NOT COMPLETED|Randomized Phase||1||
60075953|NCT00989950|76191281|FG001|NOT COMPLETED|Randomized Phase||1||
60075954|NCT00989950|76191282|FG002|NOT COMPLETED|Randomized Phase||0||
60075955|NCT00989950|76191283|FG003|NOT COMPLETED|Randomized Phase||0||
60075956|NCT01905943|76191293|FG000|STARTED|Overall Study||972||
60075957|NCT01905943|76191293|FG000|COMPLETED|Overall Study|All patients provide reason at final analysis|658||
60075958|NCT01905943|76191293|FG000|NOT COMPLETED|Overall Study||314||
60075959|NCT01905553|76191314|FG000|STARTED|Period 1||5||
60075960|NCT01905553|76191315|FG001|STARTED|Period 1||4||
60075961|NCT01905553|76191314|FG000|COMPLETED|Period 1||5||
60075962|NCT01905553|76191315|FG001|COMPLETED|Period 1||4||
60075963|NCT01905553|76191314|FG000|NOT COMPLETED|Period 1||0||
60075964|NCT01905553|76191315|FG001|NOT COMPLETED|Period 1||0||
60075965|NCT01905553|76191314|FG000|STARTED|Period 2||5||
60075966|NCT01905553|76191315|FG001|STARTED|Period 2||4||
60075967|NCT01905553|76191314|FG000|COMPLETED|Period 2||4||
60075968|NCT01905553|76191315|FG001|COMPLETED|Period 2||4||
60075969|NCT01905553|76191314|FG000|NOT COMPLETED|Period 2||1||
60075970|NCT01905553|76191315|FG001|NOT COMPLETED|Period 2||0||
60075971|NCT01929031|76191325|FG000|STARTED|Overall Study||213||
60075972|NCT01929031|76191326|FG001|STARTED|Overall Study||209||
60075973|NCT01929031|76191327|FG002|STARTED|Overall Study||35||
60075974|NCT01929031|76191328|FG003|STARTED|Overall Study||35||
60075975|NCT01929031|76191329|FG004|STARTED|Overall Study||34||
60075976|NCT01929031|76191330|FG005|STARTED|Overall Study||36||
60075977|NCT01929031|76191325|FG000|COMPLETED|Overall Study||209||
60075978|NCT01929031|76191326|FG001|COMPLETED|Overall Study||207||
60075979|NCT01929031|76191327|FG002|COMPLETED|Overall Study||34||
60075980|NCT01929031|76191328|FG003|COMPLETED|Overall Study||35||
60075981|NCT01929031|76191329|FG004|COMPLETED|Overall Study||33||
60075982|NCT01929031|76191330|FG005|COMPLETED|Overall Study||35||
60075983|NCT01929031|76191325|FG000|NOT COMPLETED|Overall Study||4||
60075984|NCT01929031|76191326|FG001|NOT COMPLETED|Overall Study||2||
60075985|NCT01929031|76191327|FG002|NOT COMPLETED|Overall Study||1||
60075986|NCT01929031|76191328|FG003|NOT COMPLETED|Overall Study||0||
60075987|NCT01929031|76191329|FG004|NOT COMPLETED|Overall Study||1||
60075988|NCT01929031|76191330|FG005|NOT COMPLETED|Overall Study||1||
60075989|NCT00989092|76191342|FG000|STARTED|Overall Study||228||
60075990|NCT00989092|76191343|FG001|STARTED|Overall Study||59||
60075991|NCT00989092|76191342|FG000|Treated With Darbepoetin Alfa|Overall Study||226||
60075992|NCT00989092|76191343|FG001|Treated With Darbepoetin Alfa|Overall Study||33||
60075993|NCT00989092|76191342|FG000|COMPLETED|Overall Study||138||
60075994|NCT00989092|76191343|FG001|COMPLETED|Overall Study||31||
60075995|NCT00989092|76191342|FG000|NOT COMPLETED|Overall Study||90||
60075996|NCT00989092|76191343|FG001|NOT COMPLETED|Overall Study||28||
60075997|NCT00988858|76191350|FG000|STARTED|Overall Study||55||
60075998|NCT00988858|76191350|FG000|COMPLETED|Overall Study||45||
60075999|NCT00988858|76191350|FG000|NOT COMPLETED|Overall Study||10||
60076000|NCT00986986|76191356|FG000|STARTED|Overall Study||10||
60076001|NCT00986986|76191357|FG001|STARTED|Overall Study||10||
60076002|NCT00986986|76191356|FG000|COMPLETED|Overall Study||10||
60076003|NCT00986986|76191357|FG001|COMPLETED|Overall Study||9||
60076004|NCT00986986|76191356|FG000|NOT COMPLETED|Overall Study||0||
60076005|NCT00986986|76191357|FG001|NOT COMPLETED|Overall Study||1||
60076006|NCT01904773|76191364|FG000|STARTED|Screen||28||
60076007|NCT01904773|76191365|FG001|STARTED|Screen||0||
60076008|NCT01904773|76191366|FG002|STARTED|Screen||0||
59987909|NCT00840281|76103127|FG001|NOT COMPLETED|Second Intervention||0||
59987910|NCT00840203|76103133|FG000|STARTED|First Intervention||37||
59987911|NCT00840203|76103134|FG001|STARTED|First Intervention||35||
59987912|NCT00840203|76103133|FG000|COMPLETED|First Intervention||36||
59987913|NCT00840203|76103134|FG001|COMPLETED|First Intervention||34||
59987914|NCT00840203|76103133|FG000|NOT COMPLETED|First Intervention||1||
59987915|NCT00840203|76103134|FG001|NOT COMPLETED|First Intervention||1||
59987916|NCT00840203|76103133|FG000|STARTED|Washout||36||
59987917|NCT00840203|76103134|FG001|STARTED|Washout||34||
59987918|NCT00840203|76103133|FG000|COMPLETED|Washout||35||
59987919|NCT00840203|76103134|FG001|COMPLETED|Washout||34||
59987920|NCT00840203|76103133|FG000|NOT COMPLETED|Washout||1||
59987921|NCT00840203|76103134|FG001|NOT COMPLETED|Washout||0||
59987922|NCT00840203|76103133|FG000|STARTED|Second Intervention||35||
59987923|NCT00840203|76103134|FG001|STARTED|Second Intervention||34||
59987924|NCT00840203|76103133|FG000|COMPLETED|Second Intervention||35||
59987925|NCT00840203|76103134|FG001|COMPLETED|Second Intervention||34||
59987926|NCT00840203|76103133|FG000|NOT COMPLETED|Second Intervention||0||
59987927|NCT00840203|76103134|FG001|NOT COMPLETED|Second Intervention||0||
59987928|NCT00835991|76103140|FG000|STARTED|First Intervention||30||
59987929|NCT00835991|76103141|FG001|STARTED|First Intervention||30||
59987930|NCT00835991|76103140|FG000|COMPLETED|First Intervention||30||
59987931|NCT00835991|76103141|FG001|COMPLETED|First Intervention||29||
59987932|NCT00835991|76103140|FG000|NOT COMPLETED|First Intervention||0||
59987933|NCT00835991|76103141|FG001|NOT COMPLETED|First Intervention||1||
59987934|NCT00835991|76103140|FG000|STARTED|Washout||30||
59987935|NCT00835991|76103141|FG001|STARTED|Washout||29||
59987936|NCT00835991|76103140|FG000|COMPLETED|Washout||27||
60076009|NCT01904773|76191367|FG003|STARTED|Screen||0||
60076010|NCT01904773|76191368|FG004|STARTED|Screen||0||
60076011|NCT01904773|76191369|FG005|STARTED|Screen||0||
60076012|NCT01904773|76191370|FG006|STARTED|Screen||0||
60076013|NCT01904773|76191371|FG007|STARTED|Screen||0||
60076014|NCT01904773|76191372|FG008|STARTED|Screen||0||
60076015|NCT01904773|76191364|FG000|COMPLETED|Screen||24||
59535344|NCT01284335|75633011|FG000|Received at Least One Dose of Study Drug|Overall Study||25||
59535345|NCT01284335|75633012|FG001|Received at Least One Dose of Study Drug|Overall Study||33||
59535346|NCT01284335|75633013|FG002|Received at Least One Dose of Study Drug|Overall Study||5||
59535347|NCT01284335|75633014|FG003|Received at Least One Dose of Study Drug|Overall Study||5||
59535348|NCT01284335|75633015|FG004|Received at Least One Dose of Study Drug|Overall Study||24||
59535349|NCT01284335|75633016|FG005|Received at Least One Dose of Study Drug|Overall Study||26||
59535350|NCT01284335|75633017|FG006|Received at Least One Dose of Study Drug|Overall Study||19||
59535351|NCT01284335|75633018|FG007|Received at Least One Dose of Study Drug|Overall Study||6||
59535352|NCT01284335|75633019|FG008|Received at Least One Dose of Study Drug|Overall Study||4||
59535353|NCT01284335|75633020|FG009|Received at Least One Dose of Study Drug|Overall Study||14||
59535354|NCT01284335|75633021|FG010|Received at Least One Dose of Study Drug|Overall Study||45||
59535355|NCT01284335|75633022|FG011|Received at Least One Dose of Study Drug|Overall Study||16||
59535356|NCT01284335|75633023|FG012|Received at Least One Dose of Study Drug|Overall Study||12||
59535357|NCT01284335|75633011|FG000|COMPLETED|Overall Study||25||
59535358|NCT01284335|75633012|FG001|COMPLETED|Overall Study||33||
59535359|NCT01284335|75633013|FG002|COMPLETED|Overall Study||5||
59535360|NCT01284335|75633014|FG003|COMPLETED|Overall Study||5||
59535361|NCT01284335|75633015|FG004|COMPLETED|Overall Study||24||
59535362|NCT01284335|75633016|FG005|COMPLETED|Overall Study||26||
59535363|NCT01284335|75633017|FG006|COMPLETED|Overall Study||19||
59535364|NCT01284335|75633018|FG007|COMPLETED|Overall Study||6||
59535365|NCT01284335|75633019|FG008|COMPLETED|Overall Study||4||
59535366|NCT01284335|75633020|FG009|COMPLETED|Overall Study||14||
59535367|NCT01284335|75633021|FG010|COMPLETED|Overall Study||45||
59535368|NCT01284335|75633022|FG011|COMPLETED|Overall Study||16||
59535369|NCT01284335|75633023|FG012|COMPLETED|Overall Study||12||
59535370|NCT01284335|75633011|FG000|NOT COMPLETED|Overall Study||0||
59535371|NCT01284335|75633012|FG001|NOT COMPLETED|Overall Study||0||
59535372|NCT01284335|75633013|FG002|NOT COMPLETED|Overall Study||0||
59535373|NCT01284335|75633014|FG003|NOT COMPLETED|Overall Study||0||
59535374|NCT01284335|75633015|FG004|NOT COMPLETED|Overall Study||0||
59535375|NCT01284335|75633016|FG005|NOT COMPLETED|Overall Study||0||
59535376|NCT01284335|75633017|FG006|NOT COMPLETED|Overall Study||0||
59987937|NCT00835991|76103141|FG001|COMPLETED|Washout||26||
59987938|NCT00835991|76103140|FG000|NOT COMPLETED|Washout||3||
59987939|NCT00835991|76103141|FG001|NOT COMPLETED|Washout||3||
59987940|NCT00835991|76103140|FG000|STARTED|Second Intervention||27||
59987941|NCT00835991|76103141|FG001|STARTED|Second Intervention||26||
59987942|NCT00835991|76103140|FG000|COMPLETED|Second Intervention||27||
59987943|NCT00835991|76103141|FG001|COMPLETED|Second Intervention||26||
59987944|NCT00835991|76103140|FG000|NOT COMPLETED|Second Intervention||0||
59987945|NCT00835991|76103141|FG001|NOT COMPLETED|Second Intervention||0||
59987946|NCT02276872|76103148|FG000|STARTED|Overall Study||10||
59987947|NCT02276872|76103149|FG001|STARTED|Overall Study||10||
59987948|NCT02276872|76103150|FG002|STARTED|Overall Study||12||
60076016|NCT01904773|76191365|FG001|COMPLETED|Screen||0||
60076017|NCT01904773|76191366|FG002|COMPLETED|Screen||0||
60076018|NCT01904773|76191367|FG003|COMPLETED|Screen||0||
59535377|NCT01284335|75633018|FG007|NOT COMPLETED|Overall Study||0||
59535378|NCT01284335|75633019|FG008|NOT COMPLETED|Overall Study||0||
59535379|NCT01284335|75633020|FG009|NOT COMPLETED|Overall Study||0||
59535380|NCT01284335|75633021|FG010|NOT COMPLETED|Overall Study||0||
59535381|NCT01284335|75633022|FG011|NOT COMPLETED|Overall Study||0||
59535382|NCT01284335|75633023|FG012|NOT COMPLETED|Overall Study||0||
59535383|NCT01230125|75633065|FG000|STARTED|Overall Study||207||
59535384|NCT01230125|75633066|FG001|STARTED|Overall Study||104||
59535385|NCT01230125|75633065|FG000|COMPLETED|Overall Study||134||
59535386|NCT01230125|75633066|FG001|COMPLETED|Overall Study||54||
59535387|NCT01230125|75633065|FG000|NOT COMPLETED|Overall Study||73||
59535388|NCT01230125|75633066|FG001|NOT COMPLETED|Overall Study||50||
59535389|NCT01194479|75633074|FG000|STARTED|Overall Study||3||
59535390|NCT01194479|75633075|FG001|STARTED|Overall Study||4||
59535391|NCT01194479|75633076|FG002|STARTED|Overall Study||2||
59535392|NCT01194479|75633077|FG003|STARTED|Overall Study||5||
59535393|NCT01194479|75633074|FG000|Cross-over at Second Visit|Overall Study||3||
59535394|NCT01194479|75633075|FG001|Cross-over at Second Visit|Overall Study||4||
59535395|NCT01194479|75633076|FG002|Cross-over at Second Visit|Overall Study||2||
59535396|NCT01194479|75633077|FG003|Cross-over at Second Visit|Overall Study||5||
59535397|NCT01194479|75633074|FG000|COMPLETED|Overall Study||3||
59535398|NCT01194479|75633075|FG001|COMPLETED|Overall Study||4||
59535399|NCT01194479|75633076|FG002|COMPLETED|Overall Study||2||
59535400|NCT01194479|75633077|FG003|COMPLETED|Overall Study||5||
59535401|NCT01194479|75633074|FG000|NOT COMPLETED|Overall Study||0||
59535402|NCT01194479|75633075|FG001|NOT COMPLETED|Overall Study||0||
59535403|NCT01194479|75633076|FG002|NOT COMPLETED|Overall Study||0||
59535404|NCT01194479|75633077|FG003|NOT COMPLETED|Overall Study||0||
59535405|NCT01230593|75633090|FG000|STARTED|Overall Study||50||
59535406|NCT01230593|75633091|FG001|STARTED|Overall Study||50||
59535407|NCT01230593|75633092|FG002|STARTED|Overall Study||50||
59535408|NCT01230593|75633090|FG000|COMPLETED|Overall Study||35||
59535409|NCT01230593|75633091|FG001|COMPLETED|Overall Study||32||
59535410|NCT01230593|75633092|FG002|COMPLETED|Overall Study||38||
59535411|NCT01230593|75633090|FG000|NOT COMPLETED|Overall Study||15||
59535412|NCT01230593|75633091|FG001|NOT COMPLETED|Overall Study||18||
59535413|NCT01230593|75633092|FG002|NOT COMPLETED|Overall Study||12||
59535414|NCT01195025|75633100|FG000|STARTED|First Intervention A||2||
59535415|NCT01195025|75633101|FG001|STARTED|First Intervention A||3||
59535416|NCT01195025|75633102|FG002|STARTED|First Intervention A||2||
59535417|NCT01195025|75633103|FG003|STARTED|First Intervention A||2||
59535418|NCT01195025|75633104|FG004|STARTED|First Intervention A||1||
59535419|NCT01195025|75633100|FG000|COMPLETED|First Intervention A||2||
59535420|NCT01195025|75633101|FG001|COMPLETED|First Intervention A||3||
59535421|NCT01195025|75633102|FG002|COMPLETED|First Intervention A||2||
59535422|NCT01195025|75633103|FG003|COMPLETED|First Intervention A||2||
59535423|NCT01195025|75633104|FG004|COMPLETED|First Intervention A||1||
59535424|NCT01195025|75633100|FG000|NOT COMPLETED|First Intervention A||0||
59535425|NCT01195025|75633101|FG001|NOT COMPLETED|First Intervention A||0||
59535426|NCT01195025|75633102|FG002|NOT COMPLETED|First Intervention A||0||
59535427|NCT01195025|75633103|FG003|NOT COMPLETED|First Intervention A||0||
59535428|NCT01195025|75633104|FG004|NOT COMPLETED|First Intervention A||0||
59535429|NCT01195025|75633100|FG000|STARTED|Second Intervention B||2||
59535430|NCT01195025|75633101|FG001|STARTED|Second Intervention B||3||
59535431|NCT01195025|75633102|FG002|STARTED|Second Intervention B||2||
59623066|NCT00525876|75735040|FG001|COMPLETED|Overall Study||20||
59623067|NCT00525876|75735039|FG000|NOT COMPLETED|Overall Study||0||
59535432|NCT01195025|75633103|FG003|STARTED|Second Intervention B||2||
59535433|NCT01195025|75633104|FG004|STARTED|Second Intervention B||1||
59535434|NCT01195025|75633100|FG000|COMPLETED|Second Intervention B||2||
59535435|NCT01195025|75633101|FG001|COMPLETED|Second Intervention B||3||
59535436|NCT01195025|75633102|FG002|COMPLETED|Second Intervention B||2||
59535437|NCT01195025|75633103|FG003|COMPLETED|Second Intervention B||2||
59535438|NCT01195025|75633104|FG004|COMPLETED|Second Intervention B||1||
59535439|NCT01195025|75633100|FG000|NOT COMPLETED|Second Intervention B||0||
59535440|NCT01195025|75633101|FG001|NOT COMPLETED|Second Intervention B||0||
59535441|NCT01195025|75633102|FG002|NOT COMPLETED|Second Intervention B||0||
59535442|NCT01195025|75633103|FG003|NOT COMPLETED|Second Intervention B||0||
59535443|NCT01195025|75633104|FG004|NOT COMPLETED|Second Intervention B||0||
59535444|NCT01195025|75633100|FG000|STARTED|Third Intervention C||2||
59535445|NCT01195025|75633101|FG001|STARTED|Third Intervention C||3||
59535446|NCT01195025|75633102|FG002|STARTED|Third Intervention C||2||
59535447|NCT01195025|75633103|FG003|STARTED|Third Intervention C||2||
59535448|NCT01195025|75633104|FG004|STARTED|Third Intervention C||1||
59535449|NCT01195025|75633100|FG000|COMPLETED|Third Intervention C||2||
59535450|NCT01195025|75633101|FG001|COMPLETED|Third Intervention C||3||
59535451|NCT01195025|75633102|FG002|COMPLETED|Third Intervention C||2||
59535452|NCT01195025|75633103|FG003|COMPLETED|Third Intervention C||2||
59535453|NCT01195025|75633104|FG004|COMPLETED|Third Intervention C||1||
59535454|NCT01195025|75633100|FG000|NOT COMPLETED|Third Intervention C||0||
59535455|NCT01195025|75633101|FG001|NOT COMPLETED|Third Intervention C||0||
59535456|NCT01195025|75633102|FG002|NOT COMPLETED|Third Intervention C||0||
59535457|NCT01195025|75633103|FG003|NOT COMPLETED|Third Intervention C||0||
59535458|NCT01195025|75633104|FG004|NOT COMPLETED|Third Intervention C||0||
59535459|NCT01285427|75633110|FG000|STARTED|Overall Study||300||
59535460|NCT01285427|75633110|FG000|COMPLETED|Overall Study|One sample be discarded per FDA, sample drawn with heparin tube, not specified in protocol.|299||
59535461|NCT01285427|75633110|FG000|NOT COMPLETED|Overall Study||1||
59535462|NCT01286441|75633126|FG000|STARTED|Overall Study||45||
59535463|NCT01286441|75633127|FG001|STARTED|Overall Study||44||
59535464|NCT01286441|75633128|FG002|STARTED|Overall Study||46||
59535465|NCT01286441|75633129|FG003|STARTED|Overall Study||48||
59535466|NCT01286441|75633126|FG000|COMPLETED|Overall Study||38||
59535467|NCT01286441|75633127|FG001|COMPLETED|Overall Study||37||
59535468|NCT01286441|75633128|FG002|COMPLETED|Overall Study||39||
59535469|NCT01286441|75633129|FG003|COMPLETED|Overall Study||37||
59535470|NCT01286441|75633126|FG000|NOT COMPLETED|Overall Study||7||
59535471|NCT01286441|75633127|FG001|NOT COMPLETED|Overall Study||7||
59535472|NCT01286441|75633128|FG002|NOT COMPLETED|Overall Study||7||
59535473|NCT01286441|75633129|FG003|NOT COMPLETED|Overall Study||11||
59535474|NCT01195883|75633141|FG000|STARTED|Overall Study||553||
59535475|NCT01195883|75633142|FG001|STARTED|Overall Study||549||
59535476|NCT01195883|75633141|FG000|COMPLETED|Overall Study||534||
59535477|NCT01195883|75633142|FG001|COMPLETED|Overall Study||523||
59535478|NCT01195883|75633141|FG000|NOT COMPLETED|Overall Study||19||
59535479|NCT01195883|75633142|FG001|NOT COMPLETED|Overall Study||26||
59535480|NCT01196117|75633148|FG000|STARTED|Placebo, Then CPAP||18||
59535481|NCT01196117|75633149|FG001|STARTED|Placebo, Then CPAP||0||
59535482|NCT01196117|75633148|FG000|COMPLETED|Placebo, Then CPAP||18||
59535483|NCT01196117|75633149|FG001|COMPLETED|Placebo, Then CPAP||0||
59535484|NCT01196117|75633148|FG000|NOT COMPLETED|Placebo, Then CPAP||0||
59535485|NCT01196117|75633149|FG001|NOT COMPLETED|Placebo, Then CPAP||0||
59535486|NCT01196117|75633148|FG000|STARTED|CPAP||0||
59535487|NCT01196117|75633149|FG001|STARTED|CPAP||18||
59535488|NCT01196117|75633148|FG000|COMPLETED|CPAP||0||
59535489|NCT01196117|75633149|FG001|COMPLETED|CPAP||18||
59535490|NCT01196117|75633148|FG000|NOT COMPLETED|CPAP||0||
59535491|NCT01196117|75633149|FG001|NOT COMPLETED|CPAP||0||
59535492|NCT00703664|75633162|FG000|STARTED|Overall Study||22||
59535493|NCT00703664|75633163|FG001|STARTED|Overall Study||4||
59535494|NCT00703664|75633164|FG002|STARTED|Overall Study||39||
59535495|NCT00703664|75633162|FG000|COMPLETED|Overall Study||22||
59535496|NCT00703664|75633163|FG001|COMPLETED|Overall Study||4||
59535497|NCT00703664|75633164|FG002|COMPLETED|Overall Study||39||
59535498|NCT00703664|75633162|FG000|NOT COMPLETED|Overall Study||0||
59535499|NCT00703664|75633163|FG001|NOT COMPLETED|Overall Study||0||
59535500|NCT00703664|75633164|FG002|NOT COMPLETED|Overall Study||0||
59987949|NCT02276872|76103148|FG000|COMPLETED|Overall Study||9||
59987950|NCT02276872|76103149|FG001|COMPLETED|Overall Study||10||
59987951|NCT02276872|76103150|FG002|COMPLETED|Overall Study||12||
59987952|NCT02276872|76103148|FG000|NOT COMPLETED|Overall Study||1||
59987953|NCT02276872|76103149|FG001|NOT COMPLETED|Overall Study||0||
59987954|NCT02276872|76103150|FG002|NOT COMPLETED|Overall Study||0||
59535501|NCT01232465|75633174|FG000|STARTED|Overall Study||337||
59535502|NCT01232465|75633175|FG001|STARTED|Overall Study||402||
59535503|NCT01232465|75633174|FG000|COMPLETED|Overall Study||337||
59535504|NCT01232465|75633175|FG001|COMPLETED|Overall Study||402||
59535505|NCT01232465|75633174|FG000|NOT COMPLETED|Overall Study||0||
59535506|NCT01232465|75633175|FG001|NOT COMPLETED|Overall Study||0||
59535507|NCT00658736|75633183|FG000|STARTED|Overall Study||19||
59535508|NCT00658736|75633184|FG001|STARTED|Overall Study||21||
59535509|NCT00658736|75633183|FG000|COMPLETED|Overall Study||13||
59535510|NCT00658736|75633184|FG001|COMPLETED|Overall Study||19||
59535511|NCT00658736|75633183|FG000|NOT COMPLETED|Overall Study||6||
59535512|NCT00658736|75633184|FG001|NOT COMPLETED|Overall Study||2||
59623068|NCT00525876|75735040|FG001|NOT COMPLETED|Overall Study||0||
59623069|NCT00555750|75735048|FG000|STARTED|Overall Study||10||
59623070|NCT00555750|75735049|FG001|STARTED|Overall Study||10||
59623071|NCT00555750|75735048|FG000|COMPLETED|Overall Study||10||
59623072|NCT00555750|75735049|FG001|COMPLETED|Overall Study||10||
59987955|NCT00835367|76103165|FG000|STARTED|First Intervention||34||
59987956|NCT00835367|76103166|FG001|STARTED|First Intervention||34||
59987957|NCT00835367|76103165|FG000|COMPLETED|First Intervention||34||
59987958|NCT00835367|76103166|FG001|COMPLETED|First Intervention||34||
59535513|NCT01196819|75633192|FG000|STARTED|Overall Study||231||
59535514|NCT01196819|75633193|FG001|STARTED|Overall Study||227||
59535515|NCT01196819|75633192|FG000|COMPLETED|Overall Study||225||
59535516|NCT01196819|75633193|FG001|COMPLETED|Overall Study||227||
59535517|NCT01196819|75633192|FG000|NOT COMPLETED|Overall Study||6||
59535518|NCT01196819|75633193|FG001|NOT COMPLETED|Overall Study||0||
59535519|NCT00659360|75633199|FG000|STARTED|Overall Study||17||
59535520|NCT00659360|75633199|FG000|COMPLETED|Overall Study||17||
59535521|NCT00659360|75633199|FG000|NOT COMPLETED|Overall Study||0||
59535522|NCT01197833|75633208|FG000|STARTED|Overall Study||38||
59535523|NCT01197833|75633209|FG001|STARTED|Overall Study||39||
59535524|NCT01197833|75633210|FG002|STARTED|Overall Study||40||
59535525|NCT01197833|75633208|FG000|COMPLETED|Overall Study||38||
59535526|NCT01197833|75633209|FG001|COMPLETED|Overall Study||39||
59535527|NCT01197833|75633210|FG002|COMPLETED|Overall Study||40||
59535528|NCT01197833|75633208|FG000|NOT COMPLETED|Overall Study||0||
59535529|NCT01197833|75633209|FG001|NOT COMPLETED|Overall Study||0||
59535530|NCT01197833|75633210|FG002|NOT COMPLETED|Overall Study||0||
59535531|NCT01288781|75633220|FG000|STARTED|Overall Study||11||
59535532|NCT01288781|75633221|FG001|STARTED|Overall Study||12||
59535533|NCT01288781|75633220|FG000|COMPLETED|Overall Study||11||
59535534|NCT01288781|75633221|FG001|COMPLETED|Overall Study||12||
59623073|NCT00555750|75735048|FG000|NOT COMPLETED|Overall Study||0||
59535535|NCT01288781|75633220|FG000|NOT COMPLETED|Overall Study||0||
59535536|NCT01288781|75633221|FG001|NOT COMPLETED|Overall Study||0||
59535537|NCT01288859|75633227|FG000|STARTED|Free Then Encapsulated Curcumin (1 Day)||5||
59535538|NCT01288859|75633228|FG001|STARTED|Free Then Encapsulated Curcumin (1 Day)||0||
59535539|NCT01288859|75633229|FG002|STARTED|Free Then Encapsulated Curcumin (1 Day)||0||
59535540|NCT01288859|75633230|FG003|STARTED|Free Then Encapsulated Curcumin (1 Day)||0||
59987959|NCT00835367|76103165|FG000|NOT COMPLETED|First Intervention||0||
59623074|NCT00555750|75735049|FG001|NOT COMPLETED|Overall Study||0||
59623075|NCT00526188|75735055|FG000|STARTED|Overall Study||234||
59623076|NCT00526188|75735055|FG000|COMPLETED|Overall Study||234||
59987960|NCT00835367|76103166|FG001|NOT COMPLETED|First Intervention||0||
59987961|NCT00835367|76103165|FG000|STARTED|Washout||34||
59987962|NCT00835367|76103166|FG001|STARTED|Washout||34||
59987963|NCT00835367|76103165|FG000|COMPLETED|Washout||31||
59623077|NCT00526188|75735055|FG000|NOT COMPLETED|Overall Study||0||
59987964|NCT00835367|76103166|FG001|COMPLETED|Washout||34||
59987965|NCT00835367|76103165|FG000|NOT COMPLETED|Washout||3||
59987966|NCT00835367|76103166|FG001|NOT COMPLETED|Washout||0||
59987967|NCT00835367|76103165|FG000|STARTED|Second Intervention||31||
59987968|NCT00835367|76103166|FG001|STARTED|Second Intervention||34||
59987969|NCT00835367|76103165|FG000|COMPLETED|Second Intervention||30||
59987970|NCT00835367|76103166|FG001|COMPLETED|Second Intervention||33||
59987971|NCT00835367|76103165|FG000|NOT COMPLETED|Second Intervention||1||
59987972|NCT00835367|76103166|FG001|NOT COMPLETED|Second Intervention||1||
59623078|NCT00556140|75735059|FG000|STARTED|Overall Study||16||
59623079|NCT00556140|75735059|FG000|COMPLETED|Overall Study||13||
59623080|NCT00556140|75735059|FG000|NOT COMPLETED|Overall Study||3||
59623081|NCT00527124|75735065|FG000|STARTED|Overall Study||29||
59623082|NCT00527124|75735066|FG001|STARTED|Overall Study||28||
59623083|NCT00527124|75735065|FG000|COMPLETED|Overall Study||29||
59623084|NCT00527124|75735066|FG001|COMPLETED|Overall Study||28||
59623085|NCT00527124|75735065|FG000|NOT COMPLETED|Overall Study||0||
59623086|NCT00527124|75735066|FG001|NOT COMPLETED|Overall Study||0||
59623087|NCT00527592|75735072|FG000|STARTED|Overall Study||54||
59987973|NCT02276560|76103173|FG000|STARTED|Overall Study||1||
59987974|NCT02276560|76103174|FG001|STARTED|Overall Study||0||
59987975|NCT02276560|76103175|FG002|STARTED|Overall Study||0||
59987976|NCT02276560|76103173|FG000|COMPLETED|Overall Study||0||
59987977|NCT02276560|76103174|FG001|COMPLETED|Overall Study||0||
59987978|NCT02276560|76103175|FG002|COMPLETED|Overall Study||0||
59987979|NCT02276560|76103173|FG000|NOT COMPLETED|Overall Study||1||
59987980|NCT02276560|76103174|FG001|NOT COMPLETED|Overall Study||0||
59987981|NCT02276560|76103175|FG002|NOT COMPLETED|Overall Study||0||
59987982|NCT02276482|76103185|FG000|STARTED|Overall Study||91||
59535541|NCT01288859|75633231|FG004|STARTED|Free Then Encapsulated Curcumin (1 Day)||0||
59535542|NCT01288859|75633232|FG005|STARTED|Free Then Encapsulated Curcumin (1 Day)||5||
59535543|NCT01288859|75633227|FG000|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||5||
59535544|NCT01288859|75633228|FG001|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0||
59535545|NCT01288859|75633229|FG002|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0||
59535546|NCT01288859|75633230|FG003|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0||
59535547|NCT01288859|75633231|FG004|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0||
59535548|NCT01288859|75633232|FG005|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||5||
59535549|NCT01288859|75633227|FG000|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0||
59535550|NCT01288859|75633228|FG001|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0||
59535551|NCT01288859|75633229|FG002|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0||
59535552|NCT01288859|75633230|FG003|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0||
59535553|NCT01288859|75633231|FG004|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0||
59535554|NCT01288859|75633232|FG005|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0||
59535555|NCT01288859|75633227|FG000|STARTED|Washout Period of 1 Week||5||
59535556|NCT01288859|75633228|FG001|STARTED|Washout Period of 1 Week||0||
59535557|NCT01288859|75633229|FG002|STARTED|Washout Period of 1 Week||0||
59535558|NCT01288859|75633230|FG003|STARTED|Washout Period of 1 Week||0||
59535559|NCT01288859|75633231|FG004|STARTED|Washout Period of 1 Week||0||
59535560|NCT01288859|75633232|FG005|STARTED|Washout Period of 1 Week||5||
59535561|NCT01288859|75633227|FG000|COMPLETED|Washout Period of 1 Week||5||
59535562|NCT01288859|75633228|FG001|COMPLETED|Washout Period of 1 Week||0||
59535563|NCT01288859|75633229|FG002|COMPLETED|Washout Period of 1 Week||0||
59535564|NCT01288859|75633230|FG003|COMPLETED|Washout Period of 1 Week||0||
59535565|NCT01288859|75633231|FG004|COMPLETED|Washout Period of 1 Week||0||
59535566|NCT01288859|75633232|FG005|COMPLETED|Washout Period of 1 Week||5||
59535567|NCT01288859|75633227|FG000|NOT COMPLETED|Washout Period of 1 Week||0||
59535568|NCT01288859|75633228|FG001|NOT COMPLETED|Washout Period of 1 Week||0||
59535569|NCT01288859|75633229|FG002|NOT COMPLETED|Washout Period of 1 Week||0||
59535570|NCT01288859|75633230|FG003|NOT COMPLETED|Washout Period of 1 Week||0||
59535571|NCT01288859|75633231|FG004|NOT COMPLETED|Washout Period of 1 Week||0||
59535572|NCT01288859|75633232|FG005|NOT COMPLETED|Washout Period of 1 Week||0||
59535573|NCT01288859|75633227|FG000|STARTED|Encapsulated Then Free Curcumin (1 Day)||5||
59535574|NCT01288859|75633228|FG001|STARTED|Encapsulated Then Free Curcumin (1 Day)||0||
59535575|NCT01288859|75633229|FG002|STARTED|Encapsulated Then Free Curcumin (1 Day)||0||
59535576|NCT01288859|75633230|FG003|STARTED|Encapsulated Then Free Curcumin (1 Day)||0||
59535577|NCT01288859|75633231|FG004|STARTED|Encapsulated Then Free Curcumin (1 Day)||0||
59535578|NCT01288859|75633232|FG005|STARTED|Encapsulated Then Free Curcumin (1 Day)||5||
59535579|NCT01288859|75633227|FG000|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||5||
59535580|NCT01288859|75633228|FG001|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0||
59535581|NCT01288859|75633229|FG002|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0||
59987983|NCT02276482|76103186|FG001|STARTED|Overall Study||29||
59987984|NCT02276482|76103185|FG000|COMPLETED|Overall Study||88||
59987985|NCT02276482|76103186|FG001|COMPLETED|Overall Study||28||
59987986|NCT02276482|76103185|FG000|NOT COMPLETED|Overall Study||3||
59987987|NCT02276482|76103186|FG001|NOT COMPLETED|Overall Study||1||
59987988|NCT00924833|76103195|FG000|STARTED|Overall Study||9||
59535582|NCT01288859|75633230|FG003|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0||
59535583|NCT01288859|75633231|FG004|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0||
59535584|NCT01288859|75633232|FG005|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||5||
59535585|NCT01288859|75633227|FG000|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0||
59535586|NCT01288859|75633228|FG001|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0||
59535587|NCT01288859|75633229|FG002|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0||
59987989|NCT00924833|76103196|FG001|STARTED|Overall Study||9||
59987990|NCT00924833|76103197|FG002|STARTED|Overall Study||9||
59535588|NCT01288859|75633230|FG003|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0||
59535589|NCT01288859|75633231|FG004|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0||
59535590|NCT01288859|75633232|FG005|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0||
59535591|NCT01288859|75633227|FG000|STARTED|Washout Period of 1 Week||5||
59623088|NCT00527592|75735072|FG000|COMPLETED|Overall Study||54||
59535592|NCT01288859|75633228|FG001|STARTED|Washout Period of 1 Week||0||
59535593|NCT01288859|75633229|FG002|STARTED|Washout Period of 1 Week||0||
59987991|NCT00924833|76103195|FG000|COMPLETED|Overall Study|7 subjects analyzed (2 were excluded for poor cardiopulmonary exercise stress test quality).|9||
59987992|NCT00924833|76103196|FG001|COMPLETED|Overall Study|1 subject was excluded from the analysis for incomplete data.|9||
59987993|NCT00924833|76103197|FG002|COMPLETED|Overall Study|1 subject was excluded from the analysis for medical problems unrelated to the study.|9||
59535594|NCT01288859|75633230|FG003|STARTED|Washout Period of 1 Week||0||
59535595|NCT01288859|75633231|FG004|STARTED|Washout Period of 1 Week||0||
59535596|NCT01288859|75633232|FG005|STARTED|Washout Period of 1 Week||5||
59535597|NCT01288859|75633227|FG000|COMPLETED|Washout Period of 1 Week||5||
59535598|NCT01288859|75633228|FG001|COMPLETED|Washout Period of 1 Week||0||
59535599|NCT01288859|75633229|FG002|COMPLETED|Washout Period of 1 Week||0||
59535600|NCT01288859|75633230|FG003|COMPLETED|Washout Period of 1 Week||0||
59535601|NCT01288859|75633231|FG004|COMPLETED|Washout Period of 1 Week||0||
59535602|NCT01288859|75633232|FG005|COMPLETED|Washout Period of 1 Week||5||
59535603|NCT01288859|75633227|FG000|NOT COMPLETED|Washout Period of 1 Week||0||
59535604|NCT01288859|75633228|FG001|NOT COMPLETED|Washout Period of 1 Week||0||
59535605|NCT01288859|75633229|FG002|NOT COMPLETED|Washout Period of 1 Week||0||
59535606|NCT01288859|75633230|FG003|NOT COMPLETED|Washout Period of 1 Week||0||
59535607|NCT01288859|75633231|FG004|NOT COMPLETED|Washout Period of 1 Week||0||
59535608|NCT01288859|75633232|FG005|NOT COMPLETED|Washout Period of 1 Week||0||
59535609|NCT01288859|75633227|FG000|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||0||
59535610|NCT01288859|75633228|FG001|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||5||
59535611|NCT01288859|75633229|FG002|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||5||
59535612|NCT01288859|75633230|FG003|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||0||
59535613|NCT01288859|75633231|FG004|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||0||
59535614|NCT01288859|75633232|FG005|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||0||
59535615|NCT01288859|75633227|FG000|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0||
59535616|NCT01288859|75633228|FG001|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||5||
59535617|NCT01288859|75633229|FG002|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||5||
59535618|NCT01288859|75633230|FG003|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0||
59535619|NCT01288859|75633231|FG004|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0||
59535620|NCT01288859|75633232|FG005|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0||
59535621|NCT01288859|75633227|FG000|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0||
59535622|NCT01288859|75633228|FG001|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0||
59535623|NCT01288859|75633229|FG002|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0||
59535624|NCT01288859|75633230|FG003|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0||
59535625|NCT01288859|75633231|FG004|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0||
59535626|NCT01288859|75633232|FG005|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0||
59535627|NCT01288859|75633227|FG000|STARTED|Washout Period of 1 Week||0||
59535628|NCT01288859|75633228|FG001|STARTED|Washout Period of 1 Week||5||
59535629|NCT01288859|75633229|FG002|STARTED|Washout Period of 1 Week||5||
59535630|NCT01288859|75633230|FG003|STARTED|Washout Period of 1 Week||0||
59535631|NCT01288859|75633231|FG004|STARTED|Washout Period of 1 Week||0||
59535632|NCT01288859|75633232|FG005|STARTED|Washout Period of 1 Week||0||
59535633|NCT01288859|75633227|FG000|COMPLETED|Washout Period of 1 Week||0||
59535634|NCT01288859|75633228|FG001|COMPLETED|Washout Period of 1 Week||5||
59535635|NCT01288859|75633229|FG002|COMPLETED|Washout Period of 1 Week||5||
59535636|NCT01288859|75633230|FG003|COMPLETED|Washout Period of 1 Week||0||
59535637|NCT01288859|75633231|FG004|COMPLETED|Washout Period of 1 Week||0||
59535638|NCT01288859|75633232|FG005|COMPLETED|Washout Period of 1 Week||0||
59535639|NCT01288859|75633227|FG000|NOT COMPLETED|Washout Period of 1 Week||0||
59535640|NCT01288859|75633228|FG001|NOT COMPLETED|Washout Period of 1 Week||0||
59535641|NCT01288859|75633229|FG002|NOT COMPLETED|Washout Period of 1 Week||0||
59535642|NCT01288859|75633230|FG003|NOT COMPLETED|Washout Period of 1 Week||0||
59535643|NCT01288859|75633231|FG004|NOT COMPLETED|Washout Period of 1 Week||0||
59535644|NCT01288859|75633232|FG005|NOT COMPLETED|Washout Period of 1 Week||0||
59535645|NCT01288859|75633227|FG000|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||0||
59535646|NCT01288859|75633228|FG001|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||5||
59535647|NCT01288859|75633229|FG002|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||5||
59535648|NCT01288859|75633230|FG003|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||0||
59535649|NCT01288859|75633231|FG004|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||0||
59535650|NCT01288859|75633232|FG005|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||0||
59535651|NCT01288859|75633227|FG000|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0||
59535652|NCT01288859|75633228|FG001|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||5||
59535653|NCT01288859|75633229|FG002|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||5||
59535654|NCT01288859|75633230|FG003|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0||
59535655|NCT01288859|75633231|FG004|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0||
59535656|NCT01288859|75633232|FG005|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0||
59535657|NCT01288859|75633227|FG000|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0||
59535658|NCT01288859|75633228|FG001|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0||
59535659|NCT01288859|75633229|FG002|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0||
59535660|NCT01288859|75633230|FG003|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0||
59535661|NCT01288859|75633231|FG004|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0||
59535662|NCT01288859|75633232|FG005|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0||
59623089|NCT00527592|75735072|FG000|NOT COMPLETED|Overall Study||0||
59623090|NCT02121912|75735080|FG000|STARTED|Overall Study||25||
59623091|NCT02121912|75735081|FG001|STARTED|Overall Study||25||
59535663|NCT01288859|75633227|FG000|STARTED|Washout Period of 1 Week||0||
59535664|NCT01288859|75633228|FG001|STARTED|Washout Period of 1 Week||0||
59535665|NCT01288859|75633229|FG002|STARTED|Washout Period of 1 Week||0||
59535666|NCT01288859|75633230|FG003|STARTED|Washout Period of 1 Week||5||
59535667|NCT01288859|75633231|FG004|STARTED|Washout Period of 1 Week||5||
59535668|NCT01288859|75633232|FG005|STARTED|Washout Period of 1 Week||0||
59535669|NCT01288859|75633227|FG000|COMPLETED|Washout Period of 1 Week||0||
59535670|NCT01288859|75633228|FG001|COMPLETED|Washout Period of 1 Week||0||
59535671|NCT01288859|75633229|FG002|COMPLETED|Washout Period of 1 Week||0||
59535672|NCT01288859|75633230|FG003|COMPLETED|Washout Period of 1 Week||5||
59535673|NCT01288859|75633231|FG004|COMPLETED|Washout Period of 1 Week||5||
59535674|NCT01288859|75633232|FG005|COMPLETED|Washout Period of 1 Week||0||
59535675|NCT01288859|75633227|FG000|NOT COMPLETED|Washout Period of 1 Week||0||
59535676|NCT01288859|75633228|FG001|NOT COMPLETED|Washout Period of 1 Week||0||
59535677|NCT01288859|75633229|FG002|NOT COMPLETED|Washout Period of 1 Week||0||
59535678|NCT01288859|75633230|FG003|NOT COMPLETED|Washout Period of 1 Week||0||
59535679|NCT01288859|75633231|FG004|NOT COMPLETED|Washout Period of 1 Week||0||
59535680|NCT01288859|75633232|FG005|NOT COMPLETED|Washout Period of 1 Week||0||
59535681|NCT01288859|75633227|FG000|STARTED|Enc Polyph. Then Control Cream (1 Day)||0||
59535682|NCT01288859|75633228|FG001|STARTED|Enc Polyph. Then Control Cream (1 Day)||0||
59535683|NCT01288859|75633229|FG002|STARTED|Enc Polyph. Then Control Cream (1 Day)||0||
59535684|NCT01288859|75633230|FG003|STARTED|Enc Polyph. Then Control Cream (1 Day)||5||
59535685|NCT01288859|75633231|FG004|STARTED|Enc Polyph. Then Control Cream (1 Day)||5||
59535686|NCT01288859|75633232|FG005|STARTED|Enc Polyph. Then Control Cream (1 Day)||0||
59535687|NCT01288859|75633227|FG000|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0||
59535688|NCT01288859|75633228|FG001|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0||
59535689|NCT01288859|75633229|FG002|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0||
59535690|NCT01288859|75633230|FG003|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||5||
59535691|NCT01288859|75633231|FG004|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||5||
59535692|NCT01288859|75633232|FG005|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0||
59535693|NCT01288859|75633227|FG000|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0||
59535694|NCT01288859|75633228|FG001|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0||
59535695|NCT01288859|75633229|FG002|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0||
59535696|NCT01288859|75633230|FG003|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0||
59535697|NCT01288859|75633231|FG004|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0||
59535698|NCT01288859|75633232|FG005|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0||
59535699|NCT01288859|75633227|FG000|STARTED|Washout Period of 1 Week||0||
59535700|NCT01288859|75633228|FG001|STARTED|Washout Period of 1 Week||0||
59535701|NCT01288859|75633229|FG002|STARTED|Washout Period of 1 Week||0||
59535702|NCT01288859|75633230|FG003|STARTED|Washout Period of 1 Week||5||
59535703|NCT01288859|75633231|FG004|STARTED|Washout Period of 1 Week||5||
59535704|NCT01288859|75633232|FG005|STARTED|Washout Period of 1 Week||0||
59535705|NCT01288859|75633227|FG000|COMPLETED|Washout Period of 1 Week||0||
59535706|NCT01288859|75633228|FG001|COMPLETED|Washout Period of 1 Week||0||
59535707|NCT01288859|75633229|FG002|COMPLETED|Washout Period of 1 Week||0||
59535708|NCT01288859|75633230|FG003|COMPLETED|Washout Period of 1 Week||5||
59535709|NCT01288859|75633231|FG004|COMPLETED|Washout Period of 1 Week||5||
59535710|NCT01288859|75633232|FG005|COMPLETED|Washout Period of 1 Week||0||
59535711|NCT01288859|75633227|FG000|NOT COMPLETED|Washout Period of 1 Week||0||
59535712|NCT01288859|75633228|FG001|NOT COMPLETED|Washout Period of 1 Week||0||
59535713|NCT01288859|75633229|FG002|NOT COMPLETED|Washout Period of 1 Week||0||
59535714|NCT01288859|75633230|FG003|NOT COMPLETED|Washout Period of 1 Week||0||
59535715|NCT01288859|75633231|FG004|NOT COMPLETED|Washout Period of 1 Week||0||
59535716|NCT01288859|75633232|FG005|NOT COMPLETED|Washout Period of 1 Week||0||
59535717|NCT01288859|75633227|FG000|STARTED|Control Cream Then Enc Polyph. (1 Day)||0||
59535718|NCT01288859|75633228|FG001|STARTED|Control Cream Then Enc Polyph. (1 Day)||0||
59535719|NCT01288859|75633229|FG002|STARTED|Control Cream Then Enc Polyph. (1 Day)||0||
59535720|NCT01288859|75633230|FG003|STARTED|Control Cream Then Enc Polyph. (1 Day)||5||
59535721|NCT01288859|75633231|FG004|STARTED|Control Cream Then Enc Polyph. (1 Day)||5||
59535722|NCT01288859|75633232|FG005|STARTED|Control Cream Then Enc Polyph. (1 Day)||0||
59535723|NCT01288859|75633227|FG000|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0||
59535724|NCT01288859|75633228|FG001|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0||
59535725|NCT01288859|75633229|FG002|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0||
59535726|NCT01288859|75633230|FG003|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||5||
59535727|NCT01288859|75633231|FG004|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||5||
59535728|NCT01288859|75633232|FG005|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0||
59535729|NCT01288859|75633227|FG000|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0||
59535730|NCT01288859|75633228|FG001|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0||
59535731|NCT01288859|75633229|FG002|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0||
59535732|NCT01288859|75633230|FG003|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0||
59535733|NCT01288859|75633231|FG004|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0||
59535734|NCT01288859|75633232|FG005|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0||
59535735|NCT00659828|75633252|FG000|STARTED|Overall Study||1||
59535736|NCT00659828|75633252|FG000|COMPLETED|Overall Study||1||
59535737|NCT00659828|75633252|FG000|NOT COMPLETED|Overall Study||0||
59535738|NCT01235195|75633256|FG000|STARTED|First Intervention||15||
59535739|NCT01235195|75633257|FG001|STARTED|First Intervention||15||
59535740|NCT01235195|75633256|FG000|COMPLETED|First Intervention||15||
59535741|NCT01235195|75633257|FG001|COMPLETED|First Intervention||15||
59535742|NCT01235195|75633256|FG000|NOT COMPLETED|First Intervention||0||
59535743|NCT01235195|75633257|FG001|NOT COMPLETED|First Intervention||0||
59535744|NCT01235195|75633256|FG000|STARTED|Washout Period of At Least 8 Days||15||
59535745|NCT01235195|75633257|FG001|STARTED|Washout Period of At Least 8 Days||15||
59535746|NCT01235195|75633256|FG000|COMPLETED|Washout Period of At Least 8 Days||15||
59535747|NCT01235195|75633257|FG001|COMPLETED|Washout Period of At Least 8 Days||15||
59535748|NCT01235195|75633256|FG000|NOT COMPLETED|Washout Period of At Least 8 Days||0||
59535749|NCT01235195|75633257|FG001|NOT COMPLETED|Washout Period of At Least 8 Days||0||
59535750|NCT01235195|75633256|FG000|STARTED|Second Intervention||15||
59535751|NCT01235195|75633257|FG001|STARTED|Second Intervention||15||
59535752|NCT01235195|75633256|FG000|COMPLETED|Second Intervention||15||
59535753|NCT01235195|75633257|FG001|COMPLETED|Second Intervention||15||
60076019|NCT01904773|76191368|FG004|COMPLETED|Screen||0||
60076020|NCT01904773|76191369|FG005|COMPLETED|Screen||0||
60076021|NCT01904773|76191370|FG006|COMPLETED|Screen||0||
60076022|NCT01904773|76191371|FG007|COMPLETED|Screen||0||
60076023|NCT01904773|76191372|FG008|COMPLETED|Screen||0||
59535754|NCT01235195|75633256|FG000|NOT COMPLETED|Second Intervention||0||
59535755|NCT01235195|75633257|FG001|NOT COMPLETED|Second Intervention||0||
59535756|NCT01198691|75633265|FG000|STARTED|Completed Surgery -Received Intervention||50||
59535757|NCT01198691|75633266|FG001|STARTED|Completed Surgery -Received Intervention||50||
59535758|NCT01198691|75633265|FG000|COMPLETED|Completed Surgery -Received Intervention||50||
59535759|NCT01198691|75633266|FG001|COMPLETED|Completed Surgery -Received Intervention||50||
59535760|NCT01198691|75633265|FG000|NOT COMPLETED|Completed Surgery -Received Intervention||0||
59535761|NCT01198691|75633266|FG001|NOT COMPLETED|Completed Surgery -Received Intervention||0||
59535762|NCT01198691|75633265|FG000|STARTED|Completed VAS Score Postop Day 1||50||
59535763|NCT01198691|75633266|FG001|STARTED|Completed VAS Score Postop Day 1||50||
59535764|NCT01198691|75633265|FG000|COMPLETED|Completed VAS Score Postop Day 1||47||
59535765|NCT01198691|75633266|FG001|COMPLETED|Completed VAS Score Postop Day 1||46||
59535766|NCT01198691|75633265|FG000|NOT COMPLETED|Completed VAS Score Postop Day 1||3||
59535767|NCT01198691|75633266|FG001|NOT COMPLETED|Completed VAS Score Postop Day 1||4||
59535768|NCT01198691|75633265|FG000|STARTED|Completed VAS Score at Discharge|Missing a VAS score on postop day one did not exclude participants from having a score at discharge.|50||
59535769|NCT01198691|75633266|FG001|STARTED|Completed VAS Score at Discharge|Missing a VAS score on postop day one did not exclude participants from having a score at discharge.|50||
59535770|NCT01198691|75633265|FG000|COMPLETED|Completed VAS Score at Discharge||45||
59535771|NCT01198691|75633266|FG001|COMPLETED|Completed VAS Score at Discharge||44||
59535772|NCT01198691|75633265|FG000|NOT COMPLETED|Completed VAS Score at Discharge||5||
59535773|NCT01198691|75633266|FG001|NOT COMPLETED|Completed VAS Score at Discharge||6||
59535774|NCT01198691|75633265|FG000|STARTED|Survey Prior to Discharge|Survey was given to all participants even if they were missing data from previous periods.|50||
59535775|NCT01198691|75633266|FG001|STARTED|Survey Prior to Discharge|Survey was given to all participants even if they were missing data from previous periods.|50||
59535776|NCT01198691|75633265|FG000|COMPLETED|Survey Prior to Discharge||18||
59535777|NCT01198691|75633266|FG001|COMPLETED|Survey Prior to Discharge||17||
59535778|NCT01198691|75633265|FG000|NOT COMPLETED|Survey Prior to Discharge||32||
59535779|NCT01198691|75633266|FG001|NOT COMPLETED|Survey Prior to Discharge||33||
59535780|NCT01198691|75633265|FG000|STARTED|6 Week Post-partum Survey|Survey was sent to all participants even if they were missing data from the previous two periods.|50||
59535781|NCT01198691|75633266|FG001|STARTED|6 Week Post-partum Survey|Survey was sent to all participants even if they were missing data from the previous two periods.|50||
59535782|NCT01198691|75633265|FG000|COMPLETED|6 Week Post-partum Survey||21||
59535783|NCT01198691|75633266|FG001|COMPLETED|6 Week Post-partum Survey||26||
59535784|NCT01198691|75633265|FG000|NOT COMPLETED|6 Week Post-partum Survey||29||
59535785|NCT01198691|75633266|FG001|NOT COMPLETED|6 Week Post-partum Survey||24||
59535786|NCT00660530|75633272|FG000|STARTED|Overall Study||11||
59535787|NCT00660530|75633272|FG000|COMPLETED|Overall Study||11||
59535788|NCT00660530|75633272|FG000|NOT COMPLETED|Overall Study||0||
59535789|NCT01198769|75633278|FG000|STARTED|Overall Study||15||
59535790|NCT01198769|75633278|FG000|COMPLETED|Overall Study||15||
59535791|NCT01198769|75633278|FG000|NOT COMPLETED|Overall Study||0||
59535792|NCT01199237|75633284|FG000|STARTED|Overall Study||41||
59535793|NCT01199237|75633285|FG001|STARTED|Overall Study||40||
59535794|NCT01199237|75633284|FG000|COMPLETED|Overall Study||41||
59535795|NCT01199237|75633285|FG001|COMPLETED|Overall Study||40||
59535796|NCT01199237|75633284|FG000|NOT COMPLETED|Overall Study||0||
59535797|NCT01199237|75633285|FG001|NOT COMPLETED|Overall Study||0||
59535798|NCT01235897|75633293|FG000|STARTED|Overall Study||16||
59535799|NCT01235897|75633293|FG000|COMPLETED|Overall Study||16||
59535800|NCT01235897|75633293|FG000|NOT COMPLETED|Overall Study||0||
60076024|NCT01904773|76191364|FG000|NOT COMPLETED|Screen||4||
60076025|NCT01904773|76191365|FG001|NOT COMPLETED|Screen||0||
60076026|NCT01904773|76191366|FG002|NOT COMPLETED|Screen||0||
59535801|NCT01236053|75633320|FG000|STARTED|Overall Study||179138||
59535802|NCT01236053|75633321|FG001|STARTED|Overall Study||1710950||
59535803|NCT01236053|75633322|FG002|STARTED|Overall Study||1877||
59535804|NCT01236053|75633323|FG003|STARTED|Overall Study||17853||
59535805|NCT01236053|75633324|FG004|STARTED|Overall Study||212||
59535806|NCT01236053|75633325|FG005|STARTED|Overall Study||2067||
59535807|NCT01236053|75633326|FG006|STARTED|Overall Study||10855||
59535808|NCT01236053|75633327|FG007|STARTED|Overall Study||102836||
59535809|NCT01236053|75633328|FG008|STARTED|Overall Study||300||
59535810|NCT01236053|75633329|FG009|STARTED|Overall Study||2935||
59535811|NCT01236053|75633330|FG010|STARTED|Overall Study||19564||
59535812|NCT01236053|75633331|FG011|STARTED|Overall Study||188924||
59535813|NCT01236053|75633332|FG012|STARTED|Overall Study||148||
59535814|NCT01236053|75633333|FG013|STARTED|Overall Study||1396||
59535815|NCT01236053|75633334|FG014|STARTED|Overall Study||4600||
59535816|NCT01236053|75633335|FG015|STARTED|Overall Study||43559||
59535817|NCT01236053|75633336|FG016|STARTED|Overall Study||38||
59535818|NCT01236053|75633337|FG017|STARTED|Overall Study||380||
59535819|NCT01236053|75633338|FG018|STARTED|Overall Study||2155||
59535820|NCT01236053|75633339|FG019|STARTED|Overall Study||20382||
59535821|NCT01236053|75633340|FG020|STARTED|Overall Study||1272||
59535822|NCT01236053|75633341|FG021|STARTED|Overall Study||12167||
59535823|NCT01236053|75633320|FG000|COMPLETED|Overall Study||179138||
59535824|NCT01236053|75633321|FG001|COMPLETED|Overall Study||1710950||
59535825|NCT01236053|75633322|FG002|COMPLETED|Overall Study||1877||
59535826|NCT01236053|75633323|FG003|COMPLETED|Overall Study||17853||
59535827|NCT01236053|75633324|FG004|COMPLETED|Overall Study||212||
59535828|NCT01236053|75633325|FG005|COMPLETED|Overall Study||2067||
59535829|NCT01236053|75633326|FG006|COMPLETED|Overall Study||10855||
59535830|NCT01236053|75633327|FG007|COMPLETED|Overall Study||102836||
59535831|NCT01236053|75633328|FG008|COMPLETED|Overall Study||300||
59535832|NCT01236053|75633329|FG009|COMPLETED|Overall Study||2935||
59535833|NCT01236053|75633330|FG010|COMPLETED|Overall Study||19564||
59535834|NCT01236053|75633331|FG011|COMPLETED|Overall Study||188924||
59535835|NCT01236053|75633332|FG012|COMPLETED|Overall Study||148||
59535836|NCT01236053|75633333|FG013|COMPLETED|Overall Study||1396||
59535837|NCT01236053|75633334|FG014|COMPLETED|Overall Study||4600||
59535838|NCT01236053|75633335|FG015|COMPLETED|Overall Study||43559||
59535839|NCT01236053|75633336|FG016|COMPLETED|Overall Study||38||
59535840|NCT01236053|75633337|FG017|COMPLETED|Overall Study||380||
59535841|NCT01236053|75633338|FG018|COMPLETED|Overall Study||2155||
59535842|NCT01236053|75633339|FG019|COMPLETED|Overall Study||20382||
59535843|NCT01236053|75633340|FG020|COMPLETED|Overall Study||1272||
59535844|NCT01236053|75633341|FG021|COMPLETED|Overall Study||12167||
59535845|NCT01236053|75633320|FG000|NOT COMPLETED|Overall Study||0||
59535846|NCT01236053|75633321|FG001|NOT COMPLETED|Overall Study||0||
59535847|NCT01236053|75633322|FG002|NOT COMPLETED|Overall Study||0||
59535848|NCT01236053|75633323|FG003|NOT COMPLETED|Overall Study||0||
59535849|NCT01236053|75633324|FG004|NOT COMPLETED|Overall Study||0||
59535850|NCT01236053|75633325|FG005|NOT COMPLETED|Overall Study||0||
59535851|NCT01236053|75633326|FG006|NOT COMPLETED|Overall Study||0||
59535852|NCT01236053|75633327|FG007|NOT COMPLETED|Overall Study||0||
59535853|NCT01236053|75633328|FG008|NOT COMPLETED|Overall Study||0||
59535854|NCT01236053|75633329|FG009|NOT COMPLETED|Overall Study||0||
59535855|NCT01236053|75633330|FG010|NOT COMPLETED|Overall Study||0||
59535856|NCT01236053|75633331|FG011|NOT COMPLETED|Overall Study||0||
59535857|NCT01236053|75633332|FG012|NOT COMPLETED|Overall Study||0||
59535858|NCT01236053|75633333|FG013|NOT COMPLETED|Overall Study||0||
59535859|NCT01236053|75633334|FG014|NOT COMPLETED|Overall Study||0||
59623092|NCT02121912|75735080|FG000|COMPLETED|Overall Study||21||
59535860|NCT01236053|75633335|FG015|NOT COMPLETED|Overall Study||0||
59535861|NCT01236053|75633336|FG016|NOT COMPLETED|Overall Study||0||
59535862|NCT01236053|75633337|FG017|NOT COMPLETED|Overall Study||0||
59535863|NCT01236053|75633338|FG018|NOT COMPLETED|Overall Study||0||
59535864|NCT01236053|75633339|FG019|NOT COMPLETED|Overall Study||0||
59623093|NCT02121912|75735081|FG001|COMPLETED|Overall Study||25||
59535865|NCT01236053|75633340|FG020|NOT COMPLETED|Overall Study||0||
59535866|NCT01236053|75633341|FG021|NOT COMPLETED|Overall Study||0||
59535867|NCT00703976|75633392|FG000|STARTED|Overall Study||37||
59535868|NCT00703976|75633393|FG001|STARTED|Overall Study||41||
59535869|NCT00703976|75633392|FG000|COMPLETED|Overall Study||37||
59535870|NCT00703976|75633393|FG001|COMPLETED|Overall Study||41||
59535871|NCT00703976|75633392|FG000|NOT COMPLETED|Overall Study||0||
59535872|NCT00703976|75633393|FG001|NOT COMPLETED|Overall Study||0||
59535873|NCT02320214|75633401|FG000|STARTED|Overall Study||30||
59535874|NCT02320214|75633401|FG000|COMPLETED|Overall Study||30||
59623094|NCT02121912|75735080|FG000|NOT COMPLETED|Overall Study||4||
59535875|NCT02320214|75633401|FG000|NOT COMPLETED|Overall Study||0||
59535876|NCT00661544|75633405|FG000|STARTED|Overall Study||48||
59535877|NCT00661544|75633405|FG000|COMPLETED|Overall Study||48||
59535878|NCT00661544|75633405|FG000|NOT COMPLETED|Overall Study||0||
59535879|NCT00706394|75633409|FG000|STARTED|Overall Study||19||
59535880|NCT00706394|75633409|FG000|COMPLETED|Overall Study||8||
59535881|NCT00706394|75633409|FG000|NOT COMPLETED|Overall Study||11||
59535882|NCT00706550|75633415|FG000|STARTED|Overall Study||43||
59535883|NCT00706550|75633416|FG001|STARTED|Overall Study||64||
59987994|NCT00924833|76103195|FG000|NOT COMPLETED|Overall Study||0||
59987995|NCT00924833|76103196|FG001|NOT COMPLETED|Overall Study||0||
59987996|NCT00924833|76103197|FG002|NOT COMPLETED|Overall Study||0||
59987997|NCT00835211|76103204|FG000|STARTED|First Intervention||24||
59987998|NCT00835211|76103205|FG001|STARTED|First Intervention||24||
59987999|NCT00835211|76103204|FG000|COMPLETED|First Intervention||24||
59988000|NCT00835211|76103205|FG001|COMPLETED|First Intervention||23||
59988001|NCT00835211|76103204|FG000|NOT COMPLETED|First Intervention||0||
59988002|NCT00835211|76103205|FG001|NOT COMPLETED|First Intervention||1||
59988003|NCT00835211|76103204|FG000|STARTED|Washout: 7 Days||24||
59988004|NCT00835211|76103205|FG001|STARTED|Washout: 7 Days||23||
60076027|NCT01904773|76191367|FG003|NOT COMPLETED|Screen||0||
60076028|NCT01904773|76191368|FG004|NOT COMPLETED|Screen||0||
60076029|NCT01904773|76191369|FG005|NOT COMPLETED|Screen||0||
59623095|NCT02121912|75735081|FG001|NOT COMPLETED|Overall Study||0||
59623096|NCT00556452|75735090|FG000|STARTED|Overall Study||6||
59623097|NCT00556452|75735091|FG001|STARTED|Overall Study||21||
59623098|NCT00556452|75735092|FG002|STARTED|Overall Study||19||
59988005|NCT00835211|76103204|FG000|COMPLETED|Washout: 7 Days||21||
60076030|NCT01904773|76191370|FG006|NOT COMPLETED|Screen||0||
60076031|NCT01904773|76191371|FG007|NOT COMPLETED|Screen||0||
60076032|NCT01904773|76191372|FG008|NOT COMPLETED|Screen||0||
60076033|NCT01904773|76191364|FG000|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||24||
60076034|NCT01904773|76191365|FG001|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0||
60076035|NCT01904773|76191366|FG002|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0||
60076036|NCT01904773|76191367|FG003|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0||
59535884|NCT00706550|75633415|FG000|COMPLETED|Overall Study||36||
59623099|NCT00556452|75735090|FG000|COMPLETED|Overall Study||6||
59623100|NCT00556452|75735091|FG001|COMPLETED|Overall Study||21||
59623101|NCT00556452|75735092|FG002|COMPLETED|Overall Study||19||
59623102|NCT00556452|75735090|FG000|NOT COMPLETED|Overall Study||0||
59623103|NCT00556452|75735091|FG001|NOT COMPLETED|Overall Study||0||
59988006|NCT00835211|76103205|FG001|COMPLETED|Washout: 7 Days||22||
60076037|NCT01904773|76191368|FG004|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0||
60076038|NCT01904773|76191369|FG005|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0||
60076039|NCT01904773|76191370|FG006|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0||
60076040|NCT01904773|76191371|FG007|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0||
60076041|NCT01904773|76191372|FG008|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0||
59988007|NCT00835211|76103204|FG000|NOT COMPLETED|Washout: 7 Days||3||
59988008|NCT00835211|76103205|FG001|NOT COMPLETED|Washout: 7 Days||1||
60076042|NCT01904773|76191364|FG000|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||24||
60076043|NCT01904773|76191365|FG001|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0||
60076044|NCT01904773|76191366|FG002|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0||
60076045|NCT01904773|76191367|FG003|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0||
60076046|NCT01904773|76191368|FG004|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0||
59535885|NCT00706550|75633416|FG001|COMPLETED|Overall Study||36||
59535886|NCT00706550|75633415|FG000|NOT COMPLETED|Overall Study||7||
59535887|NCT00706550|75633416|FG001|NOT COMPLETED|Overall Study||28||
59535888|NCT01237301|75633425|FG000|STARTED|Overall Study||65||
59535889|NCT01237301|75633426|FG001|STARTED|Overall Study||59||
59535890|NCT01237301|75633425|FG000|COMPLETED|Overall Study||60||
59535891|NCT01237301|75633426|FG001|COMPLETED|Overall Study||55||
59535892|NCT01237301|75633425|FG000|NOT COMPLETED|Overall Study||5||
59535893|NCT01237301|75633426|FG001|NOT COMPLETED|Overall Study||4||
59535894|NCT01200875|75633434|FG000|STARTED|Overall Study||25||
59535895|NCT01200875|75633434|FG000|COMPLETED|Overall Study||25||
59535896|NCT01200875|75633434|FG000|NOT COMPLETED|Overall Study||0||
59535897|NCT01238471|75633440|FG000|STARTED|Overall Study||10||
59535898|NCT01238471|75633441|FG001|STARTED|Overall Study||10||
59535899|NCT01238471|75633440|FG000|COMPLETED|Overall Study||10||
59535900|NCT01238471|75633441|FG001|COMPLETED|Overall Study||10||
59535901|NCT01238471|75633440|FG000|NOT COMPLETED|Overall Study||0||
59535902|NCT01238471|75633441|FG001|NOT COMPLETED|Overall Study||0||
59535903|NCT00706784|75633449|FG000|STARTED|Overall Study||3||
59535904|NCT00706784|75633450|FG001|STARTED|Overall Study||3||
59535905|NCT00706784|75633449|FG000|COMPLETED|Overall Study||3||
59535906|NCT00706784|75633450|FG001|COMPLETED|Overall Study||3||
59535907|NCT00706784|75633449|FG000|NOT COMPLETED|Overall Study||0||
59535908|NCT00706784|75633450|FG001|NOT COMPLETED|Overall Study||0||
59535909|NCT00664430|75633456|FG000|STARTED|Overall Study||13||
59535910|NCT00664430|75633456|FG000|COMPLETED|Overall Study|Study terminated early due to low enrollment rate.|0||
59535911|NCT00664430|75633456|FG000|NOT COMPLETED|Overall Study||13||
59535912|NCT01292135|75633462|FG000|STARTED|Overall Study||3||
59535913|NCT01292135|75633463|FG001|STARTED|Overall Study||30||
59535914|NCT01292135|75633462|FG000|COMPLETED|Overall Study||3||
59535915|NCT01292135|75633463|FG001|COMPLETED|Overall Study||21||
59535916|NCT01292135|75633462|FG000|NOT COMPLETED|Overall Study||0||
59535917|NCT01292135|75633463|FG001|NOT COMPLETED|Overall Study||9||
59535918|NCT01238549|75633471|FG000|STARTED|Overall Study||284||
59535919|NCT01238549|75633471|FG000|COMPLETED|Overall Study||248||
59535920|NCT01238549|75633471|FG000|NOT COMPLETED|Overall Study||36||
59535921|NCT01241435|75633479|FG000|STARTED|Overall Study||12||
59535922|NCT01241435|75633480|FG001|STARTED|Overall Study||8||
59535923|NCT01241435|75633481|FG002|STARTED|Overall Study||8||
59535924|NCT01241435|75633482|FG003|STARTED|Overall Study||8||
59535925|NCT01241435|75633479|FG000|Received at Least 1 Dose of Study Drug|Overall Study||12||
59535926|NCT01241435|75633480|FG001|Received at Least 1 Dose of Study Drug|Overall Study||8||
59535927|NCT01241435|75633481|FG002|Received at Least 1 Dose of Study Drug|Overall Study||8||
59535928|NCT01241435|75633482|FG003|Received at Least 1 Dose of Study Drug|Overall Study||8||
59535929|NCT01241435|75633479|FG000|COMPLETED|Overall Study||12||
59535930|NCT01241435|75633480|FG001|COMPLETED|Overall Study||8||
59535931|NCT01241435|75633481|FG002|COMPLETED|Overall Study||8||
59535932|NCT01241435|75633482|FG003|COMPLETED|Overall Study||8||
59535933|NCT01241435|75633479|FG000|NOT COMPLETED|Overall Study||0||
59535934|NCT01241435|75633480|FG001|NOT COMPLETED|Overall Study||0||
59535935|NCT01241435|75633481|FG002|NOT COMPLETED|Overall Study||0||
59535936|NCT01241435|75633482|FG003|NOT COMPLETED|Overall Study||0||
59535937|NCT01292447|75633494|FG000|STARTED|Overall Study||75||
59535938|NCT01292447|75633495|FG001|STARTED|Overall Study||75||
59535939|NCT01292447|75633494|FG000|COMPLETED|Overall Study||73||
59535940|NCT01292447|75633495|FG001|COMPLETED|Overall Study||72||
59535941|NCT01292447|75633494|FG000|NOT COMPLETED|Overall Study||2||
59535942|NCT01292447|75633495|FG001|NOT COMPLETED|Overall Study||3||
59535943|NCT02194439|75633501|FG000|STARTED|Overall Study||415||
59535944|NCT02194439|75633501|FG000|COMPLETED|Overall Study||415||
59535945|NCT02194439|75633501|FG000|NOT COMPLETED|Overall Study||0||
59535946|NCT00704912|75633508|FG000|STARTED|Overall Study||50||
59535947|NCT00704912|75633509|FG001|STARTED|Overall Study||49||
59535948|NCT00704912|75633510|FG002|STARTED|Overall Study||50||
59535949|NCT00704912|75633508|FG000|COMPLETED|Overall Study||44||
59535950|NCT00704912|75633509|FG001|COMPLETED|Overall Study||45||
59535951|NCT00704912|75633510|FG002|COMPLETED|Overall Study||43||
59535952|NCT00704912|75633508|FG000|NOT COMPLETED|Overall Study||6||
59535953|NCT00704912|75633509|FG001|NOT COMPLETED|Overall Study||4||
59535954|NCT00704912|75633510|FG002|NOT COMPLETED|Overall Study||7||
59535955|NCT02195921|75633522|FG000|STARTED|Overall Study||40||
59535956|NCT02195921|75633523|FG001|STARTED|Overall Study||40||
59535957|NCT02195921|75633524|FG002|STARTED|Overall Study||40||
59535958|NCT02195921|75633525|FG003|STARTED|Overall Study||40||
59535959|NCT02195921|75633522|FG000|COMPLETED|Overall Study||39||
59535960|NCT02195921|75633523|FG001|COMPLETED|Overall Study||39||
59535961|NCT02195921|75633524|FG002|COMPLETED|Overall Study||39||
59535962|NCT02195921|75633525|FG003|COMPLETED|Overall Study||40||
59535963|NCT02195921|75633522|FG000|NOT COMPLETED|Overall Study||1||
59535964|NCT02195921|75633523|FG001|NOT COMPLETED|Overall Study||1||
59535965|NCT02195921|75633524|FG002|NOT COMPLETED|Overall Study||1||
59535966|NCT02195921|75633525|FG003|NOT COMPLETED|Overall Study||0||
59535967|NCT02189213|75633542|FG000|STARTED|Overall Study||13||
59535968|NCT02189213|75633543|FG001|STARTED|Overall Study||1||
59535969|NCT02189213|75633542|FG000|COMPLETED|Overall Study||7||
59535970|NCT02189213|75633543|FG001|COMPLETED|Overall Study||1||
59535971|NCT02189213|75633542|FG000|NOT COMPLETED|Overall Study||6||
59535972|NCT02189213|75633543|FG001|NOT COMPLETED|Overall Study||0||
59535973|NCT01241513|75633551|FG000|STARTED|Overall Study||10||
59535974|NCT01241513|75633552|FG001|STARTED|Overall Study||9||
59535975|NCT01241513|75633551|FG000|COMPLETED|Overall Study|Study has been completed|10||
59535976|NCT01241513|75633552|FG001|COMPLETED|Overall Study||9||
59535977|NCT01241513|75633551|FG000|NOT COMPLETED|Overall Study||0||
59535978|NCT01241513|75633552|FG001|NOT COMPLETED|Overall Study||0||
59535979|NCT00665132|75633557|FG000|STARTED|Overall Study||10||
59535980|NCT00665132|75633557|FG000|COMPLETED|Overall Study||10||
59535981|NCT00665132|75633557|FG000|NOT COMPLETED|Overall Study||0||
59535982|NCT01241903|75633563|FG000|STARTED|Overall Study||27||
59535983|NCT01241903|75633564|FG001|STARTED|Overall Study||27||
59535984|NCT01241903|75633563|FG000|COMPLETED|Overall Study||26||
59535985|NCT01241903|75633564|FG001|COMPLETED|Overall Study||27||
59535986|NCT01241903|75633563|FG000|NOT COMPLETED|Overall Study||1||
59535987|NCT01241903|75633564|FG001|NOT COMPLETED|Overall Study||0||
59535988|NCT00666848|75633573|FG000|STARTED|Overall Study|15 didn't meet inclusion criteria. 3 withdrew before randomized. 1 withdrawn before randomized.|8||
59535989|NCT00666848|75633574|FG001|STARTED|Overall Study|15 didn't meet inclusion criteria. 3 withdrew before randomized. 1 withdrawn before randomized.|9||
59535990|NCT00666848|75633575|FG002|STARTED|Overall Study|15 didn't meet inclusion criteria. 3 withdrew before randomized. 1 withdrawn before randomized.|7||
59535991|NCT00666848|75633573|FG000|COMPLETED|Overall Study|finished Aim 2|8||
59535992|NCT00666848|75633574|FG001|COMPLETED|Overall Study|finished Aim 1|9||
59535993|NCT00666848|75633575|FG002|COMPLETED|Overall Study|finished Aim 3|7||
59535994|NCT00666848|75633573|FG000|NOT COMPLETED|Overall Study||0||
59535995|NCT00666848|75633574|FG001|NOT COMPLETED|Overall Study||0||
59535996|NCT00666848|75633575|FG002|NOT COMPLETED|Overall Study||0||
59535997|NCT01287377|75633586|FG000|STARTED|Overall Study||80||
59535998|NCT01287377|75633587|FG001|STARTED|Overall Study||81||
59535999|NCT01287377|75633588|FG002|STARTED|Overall Study||82||
59536000|NCT01287377|75633586|FG000|COMPLETED|Overall Study|Study Complete|80||
59536001|NCT01287377|75633587|FG001|COMPLETED|Overall Study|Study Complete|81||
59536002|NCT01287377|75633588|FG002|COMPLETED|Overall Study|Study Complete|82||
59536003|NCT01287377|75633586|FG000|NOT COMPLETED|Overall Study||0||
59536004|NCT01287377|75633587|FG001|NOT COMPLETED|Overall Study||0||
59536005|NCT01287377|75633588|FG002|NOT COMPLETED|Overall Study||0||
59536006|NCT01242527|75633600|FG000|STARTED|Overall Study||99||
59536007|NCT01242527|75633601|FG001|STARTED|Overall Study||100||
59536008|NCT01242527|75633602|FG002|STARTED|Overall Study||101||
59536009|NCT01242527|75633603|FG003|STARTED|Overall Study||99||
59536010|NCT01242527|75633600|FG000|COMPLETED|Overall Study||94||
59536011|NCT01242527|75633601|FG001|COMPLETED|Overall Study||93||
59536012|NCT01242527|75633602|FG002|COMPLETED|Overall Study||87||
59536013|NCT01242527|75633603|FG003|COMPLETED|Overall Study||90||
59536014|NCT01242527|75633600|FG000|NOT COMPLETED|Overall Study||5||
59536015|NCT01242527|75633601|FG001|NOT COMPLETED|Overall Study||7||
59536016|NCT01242527|75633602|FG002|NOT COMPLETED|Overall Study||14||
59536017|NCT01242527|75633603|FG003|NOT COMPLETED|Overall Study||9||
59536018|NCT00667004|75633615|FG000|STARTED|Overall Study||95||
59536019|NCT00667004|75633616|FG001|STARTED|Overall Study||88||
59536020|NCT00667004|75633615|FG000|COMPLETED|Overall Study||93||
59536021|NCT00667004|75633616|FG001|COMPLETED|Overall Study||85||
59536022|NCT00667004|75633615|FG000|NOT COMPLETED|Overall Study||2||
59536023|NCT00667004|75633616|FG001|NOT COMPLETED|Overall Study||3||
59536024|NCT01204853|75633622|FG000|STARTED|Overall Study||2||
59536025|NCT01204853|75633622|FG000|COMPLETED|Overall Study||2||
59536026|NCT01204853|75633622|FG000|NOT COMPLETED|Overall Study||0||
59536027|NCT00714272|75633628|FG000|STARTED|Overall Study||2||
59536028|NCT00714272|75633629|FG001|STARTED|Overall Study||2||
59536029|NCT00714272|75633628|FG000|COMPLETED|Overall Study||2||
59536030|NCT00714272|75633629|FG001|COMPLETED|Overall Study||2||
59536031|NCT00714272|75633628|FG000|NOT COMPLETED|Overall Study||0||
59536032|NCT00714272|75633629|FG001|NOT COMPLETED|Overall Study||0||
59536033|NCT01205399|75633635|FG000|STARTED|Overall Study||78||
59536034|NCT01205399|75633635|FG000|COMPLETED|Overall Study||78||
59536035|NCT01205399|75633635|FG000|NOT COMPLETED|Overall Study||0||
59536036|NCT01243619|75633639|FG000|STARTED|Overall Study||5||
59536037|NCT01243619|75633639|FG000|COMPLETED|Overall Study|Patient enrollment is complete, data analysis is ongoing|5||
59536038|NCT01243619|75633639|FG000|NOT COMPLETED|Overall Study||0||
59536039|NCT00725504|75633643|FG000|STARTED|Overall Study||71||
59536040|NCT00725504|75633643|FG000|COMPLETED|Overall Study||71||
59536041|NCT00725504|75633643|FG000|NOT COMPLETED|Overall Study||0||
59536042|NCT00727064|75633652|FG000|STARTED|Overall Study||7||
59536043|NCT00727064|75633653|FG001|STARTED|Overall Study||7||
59536044|NCT00727064|75633652|FG000|COMPLETED|Overall Study||7||
59536045|NCT00727064|75633653|FG001|COMPLETED|Overall Study||7||
59536046|NCT00727064|75633652|FG000|NOT COMPLETED|Overall Study||0||
59536047|NCT00727064|75633653|FG001|NOT COMPLETED|Overall Study||0||
59536048|NCT00727220|75633661|FG000|STARTED|Overall Study||21||
59536049|NCT00727220|75633662|FG001|STARTED|Overall Study||21||
59536050|NCT00727220|75633661|FG000|COMPLETED|Overall Study||20||
59536051|NCT00727220|75633662|FG001|COMPLETED|Overall Study||17||
59536052|NCT00727220|75633661|FG000|NOT COMPLETED|Overall Study||1||
59536053|NCT00727220|75633662|FG001|NOT COMPLETED|Overall Study||4||
59536054|NCT01294163|75633671|FG000|STARTED|Overall Study||178||
59536055|NCT01294163|75633672|FG001|STARTED|Overall Study||165||
59536056|NCT01294163|75633673|FG002|STARTED|Overall Study||166||
59536057|NCT01294163|75633671|FG000|COMPLETED|Overall Study||177||
59536058|NCT01294163|75633672|FG001|COMPLETED|Overall Study||165||
59536059|NCT01294163|75633673|FG002|COMPLETED|Overall Study||163||
59536060|NCT01294163|75633671|FG000|NOT COMPLETED|Overall Study||1||
59536061|NCT01294163|75633672|FG001|NOT COMPLETED|Overall Study||0||
59536062|NCT01294163|75633673|FG002|NOT COMPLETED|Overall Study||3||
59536063|NCT01294241|75633680|FG000|STARTED|Overall Study||10||12
59536064|NCT01294241|75633680|FG000|COMPLETED|Overall Study||10||12
59536065|NCT01294241|75633680|FG000|NOT COMPLETED|Overall Study||0||0
59536066|NCT01244243|75633686|FG000|STARTED|Overall Study||41||
59536067|NCT01244243|75633686|FG000|COMPLETED|Overall Study||41||
59536068|NCT01244243|75633686|FG000|NOT COMPLETED|Overall Study||0||
59536069|NCT01294319|75633698|FG000|STARTED|Overall Study||4||
59536070|NCT01294319|75633699|FG001|STARTED|Overall Study||6||
59536071|NCT01294319|75633700|FG002|STARTED|Overall Study||5||
59536072|NCT01294319|75633701|FG003|STARTED|Overall Study||5||
59536073|NCT01294319|75633702|FG004|STARTED|Overall Study||5||
59536074|NCT01294319|75633703|FG005|STARTED|Overall Study||4||
59536075|NCT01294319|75633704|FG006|STARTED|Overall Study||5||
59536076|NCT01294319|75633705|FG007|STARTED|Overall Study||5||
59536077|NCT01294319|75633698|FG000|COMPLETED|Overall Study||4||
59536078|NCT01294319|75633699|FG001|COMPLETED|Overall Study||6||
59536079|NCT01294319|75633700|FG002|COMPLETED|Overall Study||5||
59536080|NCT01294319|75633701|FG003|COMPLETED|Overall Study||5||
59536081|NCT01294319|75633702|FG004|COMPLETED|Overall Study||5||
59536082|NCT01294319|75633703|FG005|COMPLETED|Overall Study||4||
59536083|NCT01294319|75633704|FG006|COMPLETED|Overall Study||5||
59536084|NCT01294319|75633705|FG007|COMPLETED|Overall Study||5||
59536085|NCT01294319|75633698|FG000|NOT COMPLETED|Overall Study||0||
59536086|NCT01294319|75633699|FG001|NOT COMPLETED|Overall Study||0||
59536087|NCT01294319|75633700|FG002|NOT COMPLETED|Overall Study||0||
59536088|NCT01294319|75633701|FG003|NOT COMPLETED|Overall Study||0||
59536089|NCT01294319|75633702|FG004|NOT COMPLETED|Overall Study||0||
59536090|NCT01294319|75633703|FG005|NOT COMPLETED|Overall Study||0||
59536091|NCT01294319|75633704|FG006|NOT COMPLETED|Overall Study||0||
59536092|NCT01294319|75633705|FG007|NOT COMPLETED|Overall Study||0||
59536093|NCT00727298|75633712|FG000|STARTED|Overall Study||4485||
59536094|NCT00727298|75633712|FG000|COMPLETED|Overall Study||3228||
59536095|NCT00727298|75633712|FG000|NOT COMPLETED|Overall Study||1257||
59536096|NCT01244477|75633718|FG000|STARTED|Overall Study||38||
59536097|NCT01244477|75633719|FG001|STARTED|Overall Study||23||
59536098|NCT01244477|75633718|FG000|COMPLETED|Overall Study||18||
59536099|NCT01244477|75633719|FG001|COMPLETED|Overall Study||20||
59536100|NCT01244477|75633718|FG000|NOT COMPLETED|Overall Study||20||
59536101|NCT01244477|75633719|FG001|NOT COMPLETED|Overall Study||3||
59536102|NCT01294709|75633727|FG000|STARTED|Period 1||31||
59536103|NCT01294709|75633728|FG001|STARTED|Period 1||33||
59536104|NCT01294709|75633727|FG000|COMPLETED|Period 1||30||
59536105|NCT01294709|75633728|FG001|COMPLETED|Period 1||32||
59536106|NCT01294709|75633727|FG000|NOT COMPLETED|Period 1||1||
59536107|NCT01294709|75633728|FG001|NOT COMPLETED|Period 1||1||
59536108|NCT01294709|75633727|FG000|STARTED|Washout Period||30||
59536109|NCT01294709|75633728|FG001|STARTED|Washout Period||32||
59536110|NCT01294709|75633727|FG000|COMPLETED|Washout Period||29||
59536111|NCT01294709|75633728|FG001|COMPLETED|Washout Period||31||
59536112|NCT01294709|75633727|FG000|NOT COMPLETED|Washout Period||1||
59536113|NCT01294709|75633728|FG001|NOT COMPLETED|Washout Period||1||
59536114|NCT01294709|75633727|FG000|STARTED|Period 2||29||
59536115|NCT01294709|75633728|FG001|STARTED|Period 2||31||
59536116|NCT01294709|75633727|FG000|COMPLETED|Period 2||28||
59536117|NCT01294709|75633728|FG001|COMPLETED|Period 2||31||
59536118|NCT01294709|75633727|FG000|NOT COMPLETED|Period 2||1||
59536119|NCT01294709|75633728|FG001|NOT COMPLETED|Period 2||0||
59536120|NCT01295879|75633739|FG000|STARTED|Overall Study||29||
59536121|NCT01295879|75633739|FG000|COMPLETED|Overall Study||29||
59536122|NCT01295879|75633739|FG000|NOT COMPLETED|Overall Study||0||
59536123|NCT01244633|75633743|FG000|STARTED|Overall Study||18||
59536124|NCT01244633|75633743|FG000|COMPLETED|Overall Study||15||
59536125|NCT01244633|75633743|FG000|NOT COMPLETED|Overall Study||3||
59536126|NCT01296191|75633749|FG000|STARTED|Overall Study||60||
59536127|NCT01296191|75633750|FG001|STARTED|Overall Study||60||
59536128|NCT01296191|75633749|FG000|COMPLETED|Overall Study||57||
59536129|NCT01296191|75633750|FG001|COMPLETED|Overall Study||59||
59536130|NCT01296191|75633749|FG000|NOT COMPLETED|Overall Study||3||
59536131|NCT01296191|75633750|FG001|NOT COMPLETED|Overall Study||1||
59536132|NCT01244711|75633756|FG000|STARTED|Overall Study||1||
59536133|NCT01244711|75633756|FG000|COMPLETED|Overall Study||1||
59536134|NCT01244711|75633756|FG000|NOT COMPLETED|Overall Study||0||
59536135|NCT01245413|75633760|FG000|STARTED|Sensura First,||16||
59536136|NCT01245413|75633761|FG001|STARTED|Sensura First,||16||
59536137|NCT01245413|75633760|FG000|COMPLETED|Sensura First,||16||
59536138|NCT01245413|75633761|FG001|COMPLETED|Sensura First,||16||
59536139|NCT01245413|75633760|FG000|NOT COMPLETED|Sensura First,||0||
59536140|NCT01245413|75633761|FG001|NOT COMPLETED|Sensura First,||0||
59536141|NCT01245413|75633760|FG000|STARTED|Athena First,||16||
59536142|NCT01245413|75633761|FG001|STARTED|Athena First,||16||
59536143|NCT01245413|75633760|FG000|COMPLETED|Athena First,||16||
59536144|NCT01245413|75633761|FG001|COMPLETED|Athena First,||16||
59536145|NCT01245413|75633760|FG000|NOT COMPLETED|Athena First,||0||
59536146|NCT01245413|75633761|FG001|NOT COMPLETED|Athena First,||0||
59536147|NCT01210079|75633769|FG000|STARTED|Overall Study||10||
59536148|NCT01210079|75633770|FG001|STARTED|Overall Study||16||
59536149|NCT01210079|75633769|FG000|COMPLETED|Overall Study||10||
59536150|NCT01210079|75633770|FG001|COMPLETED|Overall Study||16||
59536151|NCT01210079|75633769|FG000|NOT COMPLETED|Overall Study||0||
59536152|NCT01210079|75633770|FG001|NOT COMPLETED|Overall Study||0||
59536153|NCT01245647|75633778|FG000|STARTED|Overall Study||7||
59536154|NCT01245647|75633779|FG001|STARTED|Overall Study||12||
59536155|NCT01245647|75633778|FG000|COMPLETED|Overall Study||7||
59536156|NCT01245647|75633779|FG001|COMPLETED|Overall Study||8||
59536157|NCT01245647|75633778|FG000|NOT COMPLETED|Overall Study||0||
59536158|NCT01245647|75633779|FG001|NOT COMPLETED|Overall Study||4||
59536159|NCT00708110|75633789|FG000|STARTED|Overall Study||7||
59536160|NCT00708110|75633790|FG001|STARTED|Overall Study||9||
59536161|NCT00708110|75633791|FG002|STARTED|Overall Study||9||
59536162|NCT00708110|75633792|FG003|STARTED|Overall Study||10||
59536163|NCT00708110|75633789|FG000|COMPLETED|Overall Study||7||
59536164|NCT00708110|75633790|FG001|COMPLETED|Overall Study||9||
59536165|NCT00708110|75633791|FG002|COMPLETED|Overall Study||9||
59536166|NCT00708110|75633792|FG003|COMPLETED|Overall Study||10||
59536167|NCT00708110|75633789|FG000|NOT COMPLETED|Overall Study||0||
59536168|NCT00708110|75633790|FG001|NOT COMPLETED|Overall Study||0||
59536169|NCT00708110|75633791|FG002|NOT COMPLETED|Overall Study||0||
59536170|NCT00708110|75633792|FG003|NOT COMPLETED|Overall Study||0||
59536171|NCT01296815|75633804|FG000|STARTED|Overall Study||7||
59536172|NCT01296815|75633805|FG001|STARTED|Overall Study||7||
59536173|NCT01296815|75633804|FG000|COMPLETED|Overall Study||7||
59536174|NCT01296815|75633805|FG001|COMPLETED|Overall Study||7||
59536175|NCT01296815|75633804|FG000|NOT COMPLETED|Overall Study||0||
59536176|NCT01296815|75633805|FG001|NOT COMPLETED|Overall Study||0||
59536177|NCT01246349|75633813|FG000|STARTED|Overall Study||20||
59536178|NCT01246349|75633814|FG001|STARTED|Overall Study||20||
59536179|NCT01246349|75633813|FG000|COMPLETED|Overall Study||20||
59536180|NCT01246349|75633814|FG001|COMPLETED|Overall Study||20||
59536181|NCT01246349|75633813|FG000|NOT COMPLETED|Overall Study||0||
59536182|NCT01246349|75633814|FG001|NOT COMPLETED|Overall Study||0||
59536183|NCT01297283|75633820|FG000|STARTED|Overall Study||195||
59536184|NCT01297283|75633820|FG000|COMPLETED|Overall Study||176||
59536185|NCT01297283|75633820|FG000|NOT COMPLETED|Overall Study||19||
59536186|NCT01297595|75633824|FG000|STARTED|First Intervention Period||11||
59536187|NCT01297595|75633825|FG001|STARTED|First Intervention Period||11||
59536188|NCT01297595|75633824|FG000|COMPLETED|First Intervention Period||11||
59536189|NCT01297595|75633825|FG001|COMPLETED|First Intervention Period||11||
59536190|NCT01297595|75633824|FG000|NOT COMPLETED|First Intervention Period||0||
59536191|NCT01297595|75633825|FG001|NOT COMPLETED|First Intervention Period||0||
59536192|NCT01297595|75633824|FG000|STARTED|Washout Period (At Least 14 Days)||11||
59536193|NCT01297595|75633825|FG001|STARTED|Washout Period (At Least 14 Days)||11||
59536194|NCT01297595|75633824|FG000|COMPLETED|Washout Period (At Least 14 Days)||11||
59536195|NCT01297595|75633825|FG001|COMPLETED|Washout Period (At Least 14 Days)||11||
59536196|NCT01297595|75633824|FG000|NOT COMPLETED|Washout Period (At Least 14 Days)||0||
59536197|NCT01297595|75633825|FG001|NOT COMPLETED|Washout Period (At Least 14 Days)||0||
59536198|NCT01297595|75633824|FG000|STARTED|Second Intervention Period||11||
59536199|NCT01297595|75633825|FG001|STARTED|Second Intervention Period||11||
59536200|NCT01297595|75633824|FG000|COMPLETED|Second Intervention Period||11||
59536201|NCT01297595|75633825|FG001|COMPLETED|Second Intervention Period||11||
59536202|NCT01297595|75633824|FG000|NOT COMPLETED|Second Intervention Period||0||
59536203|NCT01297595|75633825|FG001|NOT COMPLETED|Second Intervention Period||0||
59536204|NCT01297985|75633833|FG000|STARTED|Overall Study||212||
59536205|NCT01297985|75633834|FG001|STARTED|Overall Study||216||
59536206|NCT01297985|75633833|FG000|COMPLETED|Overall Study||157||
59536207|NCT01297985|75633834|FG001|COMPLETED|Overall Study||163||
59536208|NCT01297985|75633833|FG000|NOT COMPLETED|Overall Study||55||
59536209|NCT01297985|75633834|FG001|NOT COMPLETED|Overall Study||53||
59536210|NCT02992418|75633842|FG000|STARTED|Overall Study||346||
59536211|NCT02992418|75633843|FG001|STARTED|Overall Study||342||
59536212|NCT02992418|75633842|FG000|Safety Analysis Set (SafAS)|Overall Study||338|SafAS: Participants who received at least one dose of the study vaccines (CYD and Tdap).|
59536213|NCT02992418|75633843|FG001|Safety Analysis Set (SafAS)|Overall Study||342|SafAS: Participants who received at least one dose of the study vaccines (CYD and Tdap).|
59536214|NCT02992418|75633842|FG000|COMPLETED|Overall Study||0||
59536215|NCT02992418|75633843|FG001|COMPLETED|Overall Study||0||
59536216|NCT02992418|75633842|FG000|NOT COMPLETED|Overall Study||346||
59536217|NCT02992418|75633843|FG001|NOT COMPLETED|Overall Study||342||
59536218|NCT01298063|75633854|FG000|STARTED|Overall Study||8||
59536219|NCT01298063|75633855|FG001|STARTED|Overall Study||3||
59536220|NCT01298063|75633856|FG002|STARTED|Overall Study||8||
59536221|NCT01298063|75633857|FG003|STARTED|Overall Study||8||
59536222|NCT01298063|75633858|FG004|STARTED|Overall Study||8||
59536223|NCT01298063|75633854|FG000|COMPLETED|Overall Study||8||
59536224|NCT01298063|75633855|FG001|COMPLETED|Overall Study||3||
59536225|NCT01298063|75633856|FG002|COMPLETED|Overall Study||8||
59536226|NCT01298063|75633857|FG003|COMPLETED|Overall Study||8||
59536227|NCT01298063|75633858|FG004|COMPLETED|Overall Study||8||
59536228|NCT01298063|75633854|FG000|NOT COMPLETED|Overall Study||0||
59536229|NCT01298063|75633855|FG001|NOT COMPLETED|Overall Study||0||
59536230|NCT01298063|75633856|FG002|NOT COMPLETED|Overall Study||0||
59536231|NCT01298063|75633857|FG003|NOT COMPLETED|Overall Study||0||
59536232|NCT01298063|75633858|FG004|NOT COMPLETED|Overall Study||0||
59536233|NCT01298219|75633873|FG000|STARTED|Overall Study||219||
59536234|NCT01298219|75633874|FG001|STARTED|Overall Study||220||
59536235|NCT01298219|75633873|FG000|Intention to Treat (ITT)|Overall Study||219||
59536236|NCT01298219|75633874|FG001|Intention to Treat (ITT)|Overall Study||220||
59536237|NCT01298219|75633873|FG000|Safety Analysis Set|Overall Study||219||
59536238|NCT01298219|75633874|FG001|Safety Analysis Set|Overall Study||220||
59536239|NCT01298219|75633873|FG000|COMPLETED|Overall Study||169||
59536240|NCT01298219|75633874|FG001|COMPLETED|Overall Study||184||
59536241|NCT01298219|75633873|FG000|NOT COMPLETED|Overall Study||50||
59536242|NCT01298219|75633874|FG001|NOT COMPLETED|Overall Study||36||
59536243|NCT02322242|75633882|FG000|STARTED|Overall Study||92||
59536244|NCT02322242|75633883|FG001|STARTED|Overall Study||90||
59536245|NCT02322242|75633882|FG000|Primary Outcome|Overall Study||92||
59536246|NCT02322242|75633883|FG001|Primary Outcome|Overall Study||90||
59536247|NCT02322242|75633882|FG000|1 Week Follow-up|Overall Study|2 lost to follow-up for secondary outcomes|90||
59536248|NCT02322242|75633883|FG001|1 Week Follow-up|Overall Study|1 lost to follow-up for secondary outcomes|89||
59536249|NCT02322242|75633882|FG000|COMPLETED|Overall Study||92||
59536250|NCT02322242|75633883|FG001|COMPLETED|Overall Study||90||
59536251|NCT02322242|75633882|FG000|NOT COMPLETED|Overall Study||0||
59536252|NCT02322242|75633883|FG001|NOT COMPLETED|Overall Study||0||
59536253|NCT01211873|75633892|FG000|STARTED|Overall Study||245||
59536254|NCT01211873|75633893|FG001|STARTED|Overall Study||119||
59536255|NCT01211873|75633894|FG002|STARTED|Overall Study||38||
59536256|NCT01211873|75633892|FG000|COMPLETED|Overall Study||240||
59536257|NCT01211873|75633893|FG001|COMPLETED|Overall Study||117||
59536258|NCT01211873|75633894|FG002|COMPLETED|Overall Study||36||
59536259|NCT01211873|75633892|FG000|NOT COMPLETED|Overall Study||5||
59536260|NCT01211873|75633893|FG001|NOT COMPLETED|Overall Study||2||
59536261|NCT01211873|75633894|FG002|NOT COMPLETED|Overall Study||2||
59536262|NCT00715754|75633903|FG000|STARTED|Overall Study||47||
59536263|NCT00715754|75633903|FG000|COMPLETED|Overall Study||47||
59536264|NCT00715754|75633903|FG000|NOT COMPLETED|Overall Study||0||
59536265|NCT00729482|75633907|FG000|STARTED|Overall Study||54||
59536266|NCT00729482|75633907|FG000|COMPLETED|Overall Study||54||
59536267|NCT00729482|75633907|FG000|NOT COMPLETED|Overall Study||0||
59536268|NCT00709826|75633913|FG000|STARTED|Overall Study||70||
59536269|NCT00709826|75633914|FG001|STARTED|Overall Study||39||
59536270|NCT00709826|75633913|FG000|COMPLETED|Overall Study||68||
59536271|NCT00709826|75633914|FG001|COMPLETED|Overall Study||38||
59536272|NCT00709826|75633913|FG000|NOT COMPLETED|Overall Study||2||
59536273|NCT00709826|75633914|FG001|NOT COMPLETED|Overall Study||1||
59536274|NCT00710840|75633922|FG000|STARTED|Overall Study||22||
59536275|NCT00710840|75633923|FG001|STARTED|Overall Study||22||
59536276|NCT00710840|75633922|FG000|COMPLETED|Overall Study||22||
59536277|NCT00710840|75633923|FG001|COMPLETED|Overall Study||19||
59536278|NCT00710840|75633922|FG000|NOT COMPLETED|Overall Study||0||
59536279|NCT00710840|75633923|FG001|NOT COMPLETED|Overall Study||3||
59536280|NCT00710996|75633932|FG000|STARTED|Overall Study||17||
59536281|NCT00710996|75633933|FG001|STARTED|Overall Study||20||
59536282|NCT00710996|75633934|FG002|STARTED|Overall Study||21||
59536283|NCT00710996|75633932|FG000|COMPLETED|Overall Study||16||
59536284|NCT00710996|75633933|FG001|COMPLETED|Overall Study||16||
59536285|NCT00710996|75633934|FG002|COMPLETED|Overall Study||21||
59536286|NCT00710996|75633932|FG000|NOT COMPLETED|Overall Study||1||
59536287|NCT00710996|75633933|FG001|NOT COMPLETED|Overall Study||4||
59536288|NCT00710996|75633934|FG002|NOT COMPLETED|Overall Study||0||
59536289|NCT00711464|75633942|FG000|STARTED|Overall Study||29||
59536290|NCT00711464|75633942|FG000|COMPLETED|Overall Study||29||
59536291|NCT00711464|75633942|FG000|NOT COMPLETED|Overall Study||0||
59536292|NCT02339558|75633952|FG000|STARTED|Overall Study||45||
59536293|NCT02339558|75633952|FG000|COMPLETED|Overall Study||45||
59536294|NCT02339558|75633952|FG000|NOT COMPLETED|Overall Study||0||
59536295|NCT00730730|75633956|FG000|STARTED|Overall Study||50||
59536296|NCT00730730|75633956|FG000|COMPLETED|Overall Study||50||
59536297|NCT00730730|75633956|FG000|NOT COMPLETED|Overall Study||0||
59536298|NCT00730964|75633960|FG000|STARTED|Overall Study||1039||
59536299|NCT00730964|75633960|FG000|COMPLETED|Overall Study||1039||
59536300|NCT00730964|75633960|FG000|NOT COMPLETED|Overall Study||0||
59536301|NCT00731198|75633967|FG000|STARTED|Overall Study||325||
59536302|NCT00731198|75633968|FG001|STARTED|Overall Study||325||
59536303|NCT00731198|75633967|FG000|COMPLETED|Overall Study||319||
59536304|NCT00731198|75633968|FG001|COMPLETED|Overall Study||319||
59536305|NCT00731198|75633967|FG000|NOT COMPLETED|Overall Study||6||
59536306|NCT00731198|75633968|FG001|NOT COMPLETED|Overall Study||6||
59536307|NCT00712244|75633978|FG000|STARTED|Overall Study||29||
59536308|NCT00712244|75633979|FG001|STARTED|Overall Study||29||
59536309|NCT00712244|75633980|FG002|STARTED|Overall Study||27||
59536310|NCT00712244|75633981|FG003|STARTED|Overall Study||27||
59536311|NCT00712244|75633978|FG000|COMPLETED|Overall Study||25||
59536312|NCT00712244|75633979|FG001|COMPLETED|Overall Study||28||
59536313|NCT00712244|75633980|FG002|COMPLETED|Overall Study||25||
59536314|NCT00712244|75633981|FG003|COMPLETED|Overall Study||26||
59536315|NCT00712244|75633978|FG000|NOT COMPLETED|Overall Study||4||
59623104|NCT00556452|75735092|FG002|NOT COMPLETED|Overall Study||0||
59623105|NCT02126748|75735100|FG000|STARTED|Overall Study||33||
60076047|NCT01904773|76191369|FG005|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0||
60076048|NCT01904773|76191370|FG006|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0||
60076049|NCT01904773|76191371|FG007|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0||
60076050|NCT01904773|76191372|FG008|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0||
60076051|NCT01904773|76191364|FG000|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0||
60076052|NCT01904773|76191365|FG001|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0||
60076053|NCT01904773|76191366|FG002|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0||
60076054|NCT01904773|76191367|FG003|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0||
59623106|NCT02126748|75735101|FG001|STARTED|Overall Study||34||
59623107|NCT02126748|75735102|FG002|STARTED|Overall Study||36||
59623108|NCT02126748|75735100|FG000|COMPLETED|Overall Study||31||
59536316|NCT00712244|75633979|FG001|NOT COMPLETED|Overall Study||1||
59536317|NCT00712244|75633980|FG002|NOT COMPLETED|Overall Study||2||
59536318|NCT00712244|75633981|FG003|NOT COMPLETED|Overall Study||1||
59536319|NCT00731588|75633993|FG000|STARTED|Overall Study||9||
59623109|NCT02126748|75735101|FG001|COMPLETED|Overall Study||31||
59623110|NCT02126748|75735102|FG002|COMPLETED|Overall Study||31||
59623111|NCT02126748|75735100|FG000|NOT COMPLETED|Overall Study||2||
59623112|NCT02126748|75735101|FG001|NOT COMPLETED|Overall Study||3||
60076055|NCT01904773|76191368|FG004|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0||
59623113|NCT02126748|75735102|FG002|NOT COMPLETED|Overall Study||5||
59623114|NCT03746808|75735112|FG000|STARTED|Overall Study||78||
59623115|NCT03746808|75735113|FG001|STARTED|Overall Study||41||
59623116|NCT03746808|75735112|FG000|COMPLETED|Overall Study||71||
59623117|NCT03746808|75735113|FG001|COMPLETED|Overall Study||34||
59623118|NCT03746808|75735112|FG000|NOT COMPLETED|Overall Study||7||
59623119|NCT03746808|75735113|FG001|NOT COMPLETED|Overall Study||7||
59623120|NCT02319486|75735119|FG000|STARTED|Overall Study||26||
59623121|NCT02319486|75735119|FG000|COMPLETED|Overall Study||26||
59623122|NCT02319486|75735119|FG000|NOT COMPLETED|Overall Study||0||
59623123|NCT03093636|75735127|FG000|STARTED|Overall Study||57||
59623124|NCT03093636|75735128|FG001|STARTED|Overall Study||23||
59623125|NCT03093636|75735127|FG000|COMPLETED|Overall Study||57||
59536320|NCT00731588|75633994|FG001|STARTED|Overall Study||95||
59536321|NCT00731588|75633993|FG000|COMPLETED|Overall Study||9||
59536322|NCT00731588|75633994|FG001|COMPLETED|Overall Study||53||
59536323|NCT00731588|75633993|FG000|NOT COMPLETED|Overall Study||0||
59536324|NCT00731588|75633994|FG001|NOT COMPLETED|Overall Study||42||
59536325|NCT00717626|75634001|FG000|STARTED|Overall Study||14||
59536326|NCT00717626|75634001|FG000|COMPLETED|Overall Study||14||
59536327|NCT00717626|75634001|FG000|NOT COMPLETED|Overall Study||0||
59536328|NCT00718094|75634007|FG000|STARTED|Overall Study||15||
59536329|NCT00718094|75634008|FG001|STARTED|Overall Study||5||
59536330|NCT00718094|75634007|FG000|COMPLETED|Overall Study||15||
59536331|NCT00718094|75634008|FG001|COMPLETED|Overall Study||5||
59988009|NCT00835211|76103204|FG000|STARTED|Second Intervention||21||
59988010|NCT00835211|76103205|FG001|STARTED|Second Intervention||22||
59988011|NCT00835211|76103204|FG000|COMPLETED|Second Intervention||21||
59988012|NCT00835211|76103205|FG001|COMPLETED|Second Intervention||22||
59988013|NCT00835211|76103204|FG000|NOT COMPLETED|Second Intervention||0||
59988014|NCT00835211|76103205|FG001|NOT COMPLETED|Second Intervention||0||
59536332|NCT00718094|75634007|FG000|NOT COMPLETED|Overall Study||0||
59536333|NCT00718094|75634008|FG001|NOT COMPLETED|Overall Study||0||
59536334|NCT00719186|75634016|FG000|STARTED|Overall Study||376||
59536335|NCT00719186|75634017|FG001|STARTED|Overall Study||374||
59536336|NCT00719186|75634016|FG000|COMPLETED|Overall Study||376||
59536337|NCT00719186|75634017|FG001|COMPLETED|Overall Study||374||
59536338|NCT00719186|75634016|FG000|NOT COMPLETED|Overall Study||0||
59536339|NCT00719186|75634017|FG001|NOT COMPLETED|Overall Study||0||
59536340|NCT00719576|75634025|FG000|STARTED|Overall Study||72||
59536341|NCT00719576|75634026|FG001|STARTED|Overall Study||72||
59536342|NCT00719576|75634025|FG000|COMPLETED|Overall Study||70||
59536343|NCT00719576|75634026|FG001|COMPLETED|Overall Study||67||
59536344|NCT00719576|75634025|FG000|NOT COMPLETED|Overall Study||2||
59536345|NCT00719576|75634026|FG001|NOT COMPLETED|Overall Study||5||
59536346|NCT00721136|75634038|FG000|STARTED|Overall Study||42||
59536347|NCT00721136|75634039|FG001|STARTED|Overall Study||42||
59536348|NCT00721136|75634040|FG002|STARTED|Overall Study||8||
59536349|NCT00721136|75634041|FG003|STARTED|Overall Study||8||
59536350|NCT00721136|75634038|FG000|COMPLETED|Overall Study||42||
59536351|NCT00721136|75634039|FG001|COMPLETED|Overall Study||42||
59536352|NCT00721136|75634040|FG002|COMPLETED|Overall Study||8||
59536353|NCT00721136|75634041|FG003|COMPLETED|Overall Study||8||
59536354|NCT00721136|75634038|FG000|NOT COMPLETED|Overall Study||0||
59988015|NCT00834977|76103211|FG000|STARTED|First Intervention||24||
59988016|NCT00834977|76103212|FG001|STARTED|First Intervention||24||
59988017|NCT00834977|76103211|FG000|COMPLETED|First Intervention||24||
59988018|NCT00834977|76103212|FG001|COMPLETED|First Intervention||24||
59988019|NCT00834977|76103211|FG000|NOT COMPLETED|First Intervention||0||
59988020|NCT00834977|76103212|FG001|NOT COMPLETED|First Intervention||0||
59988021|NCT00834977|76103211|FG000|STARTED|Second Intervention||24||
59988022|NCT00834977|76103212|FG001|STARTED|Second Intervention||24||
59988023|NCT00834977|76103211|FG000|COMPLETED|Second Intervention||24||
59988024|NCT00834977|76103212|FG001|COMPLETED|Second Intervention||24||
60076056|NCT01904773|76191369|FG005|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0||
59536355|NCT00721136|75634039|FG001|NOT COMPLETED|Overall Study||0||
59536356|NCT00721136|75634040|FG002|NOT COMPLETED|Overall Study||0||
59988025|NCT00834977|76103211|FG000|NOT COMPLETED|Second Intervention||0||
59988026|NCT00834977|76103212|FG001|NOT COMPLETED|Second Intervention||0||
59988027|NCT00834743|76103218|FG000|STARTED|First Intervention||16||
59988028|NCT00834743|76103219|FG001|STARTED|First Intervention||16||
60076057|NCT01904773|76191370|FG006|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0||
60076058|NCT01904773|76191371|FG007|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0||
60076059|NCT01904773|76191372|FG008|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0||
60076060|NCT01904773|76191364|FG000|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||24||
60076061|NCT01904773|76191365|FG001|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0||
60076062|NCT01904773|76191366|FG002|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0||
60076063|NCT01904773|76191367|FG003|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0||
59536357|NCT00721136|75634041|FG003|NOT COMPLETED|Overall Study||0||
59536358|NCT00736580|75634057|FG000|STARTED|Overall Study||117||
59536359|NCT00736580|75634058|FG001|STARTED|Overall Study||123||
59536360|NCT00736580|75634057|FG000|COMPLETED|Overall Study||117||
59536361|NCT00736580|75634058|FG001|COMPLETED|Overall Study||123||
59536362|NCT00736580|75634057|FG000|NOT COMPLETED|Overall Study||0||
59536363|NCT00736580|75634058|FG001|NOT COMPLETED|Overall Study||0||
59536364|NCT00737204|75634066|FG000|STARTED|Overall Study||36||
59536365|NCT00737204|75634067|FG001|STARTED|Overall Study||34||
59536366|NCT00737204|75634066|FG000|COMPLETED|Overall Study||36||
59536367|NCT00737204|75634067|FG001|COMPLETED|Overall Study||28||
59536368|NCT00737204|75634066|FG000|NOT COMPLETED|Overall Study||0||
59536369|NCT00737204|75634067|FG001|NOT COMPLETED|Overall Study||6||
59536370|NCT00722072|75634073|FG000|STARTED|Overall Study||12||
59536371|NCT00722072|75634073|FG000|COMPLETED|Overall Study||9||
59536372|NCT00722072|75634073|FG000|NOT COMPLETED|Overall Study||3||
59536373|NCT00737360|75634077|FG000|STARTED|Overall Study||27||
59536374|NCT00737360|75634077|FG000|COMPLETED|Overall Study||27||
59536375|NCT00737360|75634077|FG000|NOT COMPLETED|Overall Study||0||
59536376|NCT01276106|75634085|FG000|STARTED|Overall Study||65||
59536377|NCT01276106|75634086|FG001|STARTED|Overall Study||64||
59536378|NCT01276106|75634087|FG002|STARTED|Overall Study||65||
59536379|NCT01276106|75634088|FG003|STARTED|Overall Study||65||
59536380|NCT01276106|75634085|FG000|COMPLETED|Overall Study||53||
59536381|NCT01276106|75634086|FG001|COMPLETED|Overall Study||55||
59536382|NCT01276106|75634087|FG002|COMPLETED|Overall Study||49||
59536383|NCT01276106|75634088|FG003|COMPLETED|Overall Study||52||
59536384|NCT01276106|75634085|FG000|NOT COMPLETED|Overall Study||12||
59536385|NCT01276106|75634086|FG001|NOT COMPLETED|Overall Study||9||
59536386|NCT01276106|75634087|FG002|NOT COMPLETED|Overall Study||16||
59536387|NCT01276106|75634088|FG003|NOT COMPLETED|Overall Study||13||
59536388|NCT01275170|75634106|FG000|STARTED|Part 1: Period 1||7|Randomized|
59536389|NCT01275170|75634107|FG001|STARTED|Part 1: Period 1||6|Randomized|
59536390|NCT01275170|75634108|FG002|STARTED|Part 1: Period 1||6|Randomized|
59536391|NCT01275170|75634109|FG003|STARTED|Part 1: Period 1||6|Randomized|
59536392|NCT01275170|75634110|FG004|STARTED|Part 1: Period 1||6|Randomized|
59536393|NCT01275170|75634111|FG005|STARTED|Part 1: Period 1||6|Randomized|
59536394|NCT01275170|75634112|FG006|STARTED|Part 1: Period 1||6|Randomized|
59536395|NCT01275170|75634113|FG007|STARTED|Part 1: Period 1||6|Randomized|
59536396|NCT01275170|75634106|FG000|Treated|Part 1: Period 1||6||
59536397|NCT01275170|75634107|FG001|Treated|Part 1: Period 1||6||
59536398|NCT01275170|75634108|FG002|Treated|Part 1: Period 1||6||
59536399|NCT01275170|75634109|FG003|Treated|Part 1: Period 1||6||
59536400|NCT01275170|75634110|FG004|Treated|Part 1: Period 1||6||
59536401|NCT01275170|75634111|FG005|Treated|Part 1: Period 1||6||
59536402|NCT01275170|75634112|FG006|Treated|Part 1: Period 1||6||
59536403|NCT01275170|75634113|FG007|Treated|Part 1: Period 1||6||
59536404|NCT01275170|75634106|FG000|COMPLETED|Part 1: Period 1||6||
59536405|NCT01275170|75634107|FG001|COMPLETED|Part 1: Period 1||6||
59536406|NCT01275170|75634108|FG002|COMPLETED|Part 1: Period 1||6||
59536407|NCT01275170|75634109|FG003|COMPLETED|Part 1: Period 1||6||
59536408|NCT01275170|75634110|FG004|COMPLETED|Part 1: Period 1||6||
59536409|NCT01275170|75634111|FG005|COMPLETED|Part 1: Period 1||6||
59536410|NCT01275170|75634112|FG006|COMPLETED|Part 1: Period 1||6||
59536411|NCT01275170|75634113|FG007|COMPLETED|Part 1: Period 1||6||
59536412|NCT01275170|75634106|FG000|NOT COMPLETED|Part 1: Period 1||1||
59536413|NCT01275170|75634107|FG001|NOT COMPLETED|Part 1: Period 1||0||
59536414|NCT01275170|75634108|FG002|NOT COMPLETED|Part 1: Period 1||0||
59536415|NCT01275170|75634109|FG003|NOT COMPLETED|Part 1: Period 1||0||
59536416|NCT01275170|75634110|FG004|NOT COMPLETED|Part 1: Period 1||0||
59536417|NCT01275170|75634111|FG005|NOT COMPLETED|Part 1: Period 1||0||
59536418|NCT01275170|75634112|FG006|NOT COMPLETED|Part 1: Period 1||0||
59536419|NCT01275170|75634113|FG007|NOT COMPLETED|Part 1: Period 1||0||
59536420|NCT01275170|75634106|FG000|STARTED|Part 1: Period 2|Panel A participated in Part 1, Period 1 only.|0||
59536421|NCT01275170|75634107|FG001|STARTED|Part 1: Period 2|Panel B participated in Part 1, Period 1 only.|0||
59536422|NCT01275170|75634108|FG002|STARTED|Part 1: Period 2|Panel C participated in Part 1, Period 1 only.|0||
59536423|NCT01275170|75634109|FG003|STARTED|Part 1: Period 2|Panel D participated in Part 1, Period 1 only.|0||
59536424|NCT01275170|75634110|FG004|STARTED|Part 1: Period 2|Panel E participated in Part 1, Period 1 and Part 2, Period 1.|0||
59536425|NCT01275170|75634111|FG005|STARTED|Part 1: Period 2|Panel E participated in Part 1, Period 1 and Part 2, Period 1.|0||
59536426|NCT01275170|75634112|FG006|STARTED|Part 1: Period 2||6||
59536427|NCT01275170|75634113|FG007|STARTED|Part 1: Period 2||6||
59536428|NCT01275170|75634106|FG000|COMPLETED|Part 1: Period 2||0||
59536429|NCT01275170|75634107|FG001|COMPLETED|Part 1: Period 2||0||
59536430|NCT01275170|75634108|FG002|COMPLETED|Part 1: Period 2||0||
59536431|NCT01275170|75634109|FG003|COMPLETED|Part 1: Period 2||0||
59536432|NCT01275170|75634110|FG004|COMPLETED|Part 1: Period 2||0||
59536433|NCT01275170|75634111|FG005|COMPLETED|Part 1: Period 2||0||
59536434|NCT01275170|75634112|FG006|COMPLETED|Part 1: Period 2||6||
59536435|NCT01275170|75634113|FG007|COMPLETED|Part 1: Period 2||6||
59536436|NCT01275170|75634106|FG000|NOT COMPLETED|Part 1: Period 2||0||
59536437|NCT01275170|75634107|FG001|NOT COMPLETED|Part 1: Period 2||0||
59536438|NCT01275170|75634108|FG002|NOT COMPLETED|Part 1: Period 2||0||
59536439|NCT01275170|75634109|FG003|NOT COMPLETED|Part 1: Period 2||0||
59536440|NCT01275170|75634110|FG004|NOT COMPLETED|Part 1: Period 2||0||
59536441|NCT01275170|75634111|FG005|NOT COMPLETED|Part 1: Period 2||0||
59536442|NCT01275170|75634112|FG006|NOT COMPLETED|Part 1: Period 2||0||
59536443|NCT01275170|75634113|FG007|NOT COMPLETED|Part 1: Period 2||0||
59536444|NCT01275170|75634106|FG000|STARTED|Part 2: Period 1||0||
59536445|NCT01275170|75634107|FG001|STARTED|Part 2: Period 1||0||
59536446|NCT01275170|75634108|FG002|STARTED|Part 2: Period 1||0||
59536447|NCT01275170|75634109|FG003|STARTED|Part 2: Period 1||0||
59536448|NCT01275170|75634110|FG004|STARTED|Part 2: Period 1||6||
59536449|NCT01275170|75634111|FG005|STARTED|Part 2: Period 1||6||
59536450|NCT01275170|75634112|FG006|STARTED|Part 2: Period 1||6||
59536451|NCT01275170|75634113|FG007|STARTED|Part 2: Period 1||6||
59536452|NCT01275170|75634106|FG000|COMPLETED|Part 2: Period 1||0||
59536453|NCT01275170|75634107|FG001|COMPLETED|Part 2: Period 1||0||
59536454|NCT01275170|75634108|FG002|COMPLETED|Part 2: Period 1||0||
59536455|NCT01275170|75634109|FG003|COMPLETED|Part 2: Period 1||0||
59536456|NCT01275170|75634110|FG004|COMPLETED|Part 2: Period 1||6||
59536457|NCT01275170|75634111|FG005|COMPLETED|Part 2: Period 1||6||
59536458|NCT01275170|75634112|FG006|COMPLETED|Part 2: Period 1||6||
59536459|NCT01275170|75634113|FG007|COMPLETED|Part 2: Period 1||6||
59536460|NCT01275170|75634106|FG000|NOT COMPLETED|Part 2: Period 1||0||
59536461|NCT01275170|75634107|FG001|NOT COMPLETED|Part 2: Period 1||0||
59536462|NCT01275170|75634108|FG002|NOT COMPLETED|Part 2: Period 1||0||
59536463|NCT01275170|75634109|FG003|NOT COMPLETED|Part 2: Period 1||0||
59536464|NCT01275170|75634110|FG004|NOT COMPLETED|Part 2: Period 1||0||
59536465|NCT01275170|75634111|FG005|NOT COMPLETED|Part 2: Period 1||0||
59536466|NCT01275170|75634112|FG006|NOT COMPLETED|Part 2: Period 1||0||
59536467|NCT01275170|75634113|FG007|NOT COMPLETED|Part 2: Period 1||0||
59536468|NCT01275170|75634106|FG000|STARTED|Part 2: Period 2||0||
59536469|NCT01275170|75634107|FG001|STARTED|Part 2: Period 2||0||
59536470|NCT01275170|75634108|FG002|STARTED|Part 2: Period 2||0||
59536471|NCT01275170|75634109|FG003|STARTED|Part 2: Period 2||0||
59536472|NCT01275170|75634110|FG004|STARTED|Part 2: Period 2|Panel E participated in Part 1, Period 1 and Part 2, Period 1.|0||
59536473|NCT01275170|75634111|FG005|STARTED|Part 2: Period 2|Panel F participated in Part 1, Period 1 and Part 2, Period 1.|0||
59536474|NCT01275170|75634112|FG006|STARTED|Part 2: Period 2||6||
59536475|NCT01275170|75634113|FG007|STARTED|Part 2: Period 2||6||
59536476|NCT01275170|75634106|FG000|COMPLETED|Part 2: Period 2||0||
59536477|NCT01275170|75634107|FG001|COMPLETED|Part 2: Period 2||0||
59536478|NCT01275170|75634108|FG002|COMPLETED|Part 2: Period 2||0||
59536479|NCT01275170|75634109|FG003|COMPLETED|Part 2: Period 2||0||
59536480|NCT01275170|75634110|FG004|COMPLETED|Part 2: Period 2||0||
59536481|NCT01275170|75634111|FG005|COMPLETED|Part 2: Period 2||0||
59536482|NCT01275170|75634112|FG006|COMPLETED|Part 2: Period 2||6||
59536483|NCT01275170|75634113|FG007|COMPLETED|Part 2: Period 2||6||
59536484|NCT01275170|75634106|FG000|NOT COMPLETED|Part 2: Period 2||0||
59536485|NCT01275170|75634107|FG001|NOT COMPLETED|Part 2: Period 2||0||
59536486|NCT01275170|75634108|FG002|NOT COMPLETED|Part 2: Period 2||0||
59536487|NCT01275170|75634109|FG003|NOT COMPLETED|Part 2: Period 2||0||
59536488|NCT01275170|75634110|FG004|NOT COMPLETED|Part 2: Period 2||0||
59536489|NCT01275170|75634111|FG005|NOT COMPLETED|Part 2: Period 2||0||
59536490|NCT01275170|75634112|FG006|NOT COMPLETED|Part 2: Period 2||0||
59623126|NCT03093636|75735128|FG001|COMPLETED|Overall Study||23||
59623127|NCT03093636|75735127|FG000|NOT COMPLETED|Overall Study||0||
59623128|NCT03093636|75735128|FG001|NOT COMPLETED|Overall Study||0||
59623129|NCT00546390|75735136|FG000|STARTED|Overall Study||27||
59623130|NCT00546390|75735137|FG001|STARTED|Overall Study||28||
59536491|NCT01275170|75634113|FG007|NOT COMPLETED|Part 2: Period 2||0||
59536492|NCT00400634|75634148|FG000|STARTED|Overall Study||38||
59536493|NCT00400634|75634149|FG001|STARTED|Overall Study||20||
59536494|NCT00400634|75634148|FG000|COMPLETED|Overall Study||34||
59536495|NCT00400634|75634149|FG001|COMPLETED|Overall Study||19||
59536496|NCT00400634|75634148|FG000|NOT COMPLETED|Overall Study||4||
59536497|NCT00400634|75634149|FG001|NOT COMPLETED|Overall Study||1||
59536498|NCT01273064|75634160|FG000|STARTED|Overall Study||23||
59536499|NCT01273064|75634161|FG001|STARTED|Overall Study||30||
59536500|NCT01273064|75634162|FG002|STARTED|Overall Study||31||
59536501|NCT01273064|75634163|FG003|STARTED|Overall Study||20||
59536502|NCT01273064|75634164|FG004|STARTED|Overall Study|Began study on the placebo arm, and crossed over to CTS-1027 15 mg at Wk 12 due to lack of response|10||
59536503|NCT01273064|75634160|FG000|COMPLETED|Overall Study||0||
59536504|NCT01273064|75634161|FG001|COMPLETED|Overall Study||0||
59623131|NCT00546390|75735136|FG000|COMPLETED|Overall Study||27||
59623132|NCT00546390|75735137|FG001|COMPLETED|Overall Study||28||
59623133|NCT00546390|75735136|FG000|NOT COMPLETED|Overall Study||0||
59623134|NCT00546390|75735137|FG001|NOT COMPLETED|Overall Study||0||
59623135|NCT00556842|75735146|FG000|STARTED|Overall Study||749||
59623136|NCT00556842|75735147|FG001|STARTED|Overall Study||746||
59623137|NCT00556842|75735146|FG000|COMPLETED|Overall Study||718||
59623138|NCT00556842|75735147|FG001|COMPLETED|Overall Study||723||
59623139|NCT00556842|75735146|FG000|NOT COMPLETED|Overall Study||31||
59536505|NCT01273064|75634162|FG002|COMPLETED|Overall Study||0||
59536506|NCT01273064|75634163|FG003|COMPLETED|Overall Study||0||
59536507|NCT01273064|75634164|FG004|COMPLETED|Overall Study||0||
59536508|NCT01273064|75634160|FG000|NOT COMPLETED|Overall Study||23||
59536509|NCT01273064|75634161|FG001|NOT COMPLETED|Overall Study||30||
59536510|NCT01273064|75634162|FG002|NOT COMPLETED|Overall Study||31||
59623140|NCT00556842|75735147|FG001|NOT COMPLETED|Overall Study||23||
59623141|NCT00558012|75735163|FG000|STARTED|Overall Study||89||
59536511|NCT01273064|75634163|FG003|NOT COMPLETED|Overall Study||20||
59536512|NCT01273064|75634164|FG004|NOT COMPLETED|Overall Study||10||
59536513|NCT01272908|75634176|FG000|STARTED|Initial Treatment Period||120||
59536514|NCT01272908|75634176|FG000|COMPLETED|Initial Treatment Period||112||
59536515|NCT01272908|75634176|FG000|NOT COMPLETED|Initial Treatment Period||8||
59536516|NCT01272908|75634176|FG000|STARTED|Re-Treatment Period|Only participants with active disease as characterized by DAS-28 score ≥2.6 were included.|77||
59536517|NCT01272908|75634176|FG000|COMPLETED|Re-Treatment Period||71||
59536518|NCT01272908|75634176|FG000|NOT COMPLETED|Re-Treatment Period||6||
59536519|NCT01271504|75634186|FG000|STARTED|Overall Study||7||
59536520|NCT01271504|75634187|FG001|STARTED|Overall Study||8||
59536521|NCT01271504|75634188|FG002|STARTED|Overall Study||44||
59536522|NCT01271504|75634189|FG003|STARTED|Overall Study||43||
59536523|NCT01271504|75634186|FG000|Treated|Overall Study||7||
59536524|NCT01271504|75634187|FG001|Treated|Overall Study||7||
59536525|NCT01271504|75634188|FG002|Treated|Overall Study||42||
59536526|NCT01271504|75634189|FG003|Treated|Overall Study||42||
59536527|NCT01271504|75634186|FG000|COMPLETED|Overall Study||0||
59536528|NCT01271504|75634187|FG001|COMPLETED|Overall Study||0||
59815425|NCT02658890|75937839|FG009|NOT COMPLETED|Pre-Treatment Phase||0||
59988029|NCT00834743|76103218|FG000|COMPLETED|First Intervention||16||
59988030|NCT00834743|76103219|FG001|COMPLETED|First Intervention||16||
59536529|NCT01271504|75634188|FG002|COMPLETED|Overall Study||0||
59536530|NCT01271504|75634189|FG003|COMPLETED|Overall Study||0||
59536531|NCT01271504|75634186|FG000|NOT COMPLETED|Overall Study||7||
59536532|NCT01271504|75634187|FG001|NOT COMPLETED|Overall Study||8||
59536533|NCT01271504|75634188|FG002|NOT COMPLETED|Overall Study||44||
59536534|NCT01271504|75634189|FG003|NOT COMPLETED|Overall Study||43||
59536535|NCT02144714|75634212|FG000|STARTED|Overall Study||63||
59536536|NCT02144714|75634213|FG001|STARTED|Overall Study||63||
59536537|NCT02144714|75634214|FG002|STARTED|Overall Study||63||
59536538|NCT02144714|75634212|FG000|COMPLETED|Overall Study||63||
59536539|NCT02144714|75634213|FG001|COMPLETED|Overall Study||63||
59536540|NCT02144714|75634214|FG002|COMPLETED|Overall Study||63||
59536541|NCT02144714|75634212|FG000|NOT COMPLETED|Overall Study||0||
59536542|NCT02144714|75634213|FG001|NOT COMPLETED|Overall Study||0||
59536543|NCT02144714|75634214|FG002|NOT COMPLETED|Overall Study||0||
59536544|NCT00741026|75634222|FG000|STARTED|Overall Study||15||
59536545|NCT00741026|75634222|FG000|COMPLETED|Overall Study||15||
59536546|NCT00741026|75634222|FG000|NOT COMPLETED|Overall Study||0||
59536547|NCT00741104|75634228|FG000|STARTED|Overall Study||363||
59536548|NCT00741104|75634228|FG000|COMPLETED|Overall Study||363||
59536549|NCT00741104|75634228|FG000|NOT COMPLETED|Overall Study||0||
59536550|NCT01270958|75634232|FG000|STARTED|Overall Study||60||
59536551|NCT01270958|75634232|FG000|COMPLETED|Overall Study||56||
59536552|NCT01270958|75634232|FG000|NOT COMPLETED|Overall Study||4||
59536553|NCT01270880|75634236|FG000|STARTED|Overall Study||18||
59536554|NCT01270880|75634236|FG000|COMPLETED|Overall Study||17||
59536555|NCT01270880|75634236|FG000|NOT COMPLETED|Overall Study||1||
59536556|NCT01270802|75634242|FG000|STARTED|Overall Study||15||
59536557|NCT01270802|75634243|FG001|STARTED|Overall Study||15||
59536558|NCT01270802|75634242|FG000|COMPLETED|Overall Study||13||
59536559|NCT01270802|75634243|FG001|COMPLETED|Overall Study||14||
59536560|NCT01270802|75634242|FG000|NOT COMPLETED|Overall Study||2||
59536561|NCT01270802|75634243|FG001|NOT COMPLETED|Overall Study||1||
59536562|NCT01270256|75634252|FG000|STARTED|Overall Study||21||
59536563|NCT01270256|75634253|FG001|STARTED|Overall Study||20||
59536564|NCT01270256|75634252|FG000|COMPLETED|Overall Study||20||
59536565|NCT01270256|75634253|FG001|COMPLETED|Overall Study||20||
59536566|NCT01270256|75634252|FG000|NOT COMPLETED|Overall Study||1||
59536567|NCT01270256|75634253|FG001|NOT COMPLETED|Overall Study||0||
59536568|NCT00744380|75634261|FG000|STARTED|Overall Study||12||
59536569|NCT00744380|75634262|FG001|STARTED|Overall Study||11||
59536570|NCT00744380|75634261|FG000|COMPLETED|Overall Study||12||
59536571|NCT00744380|75634262|FG001|COMPLETED|Overall Study||11||
59536572|NCT00744380|75634261|FG000|NOT COMPLETED|Overall Study||0||
59536573|NCT00744380|75634262|FG001|NOT COMPLETED|Overall Study||0||
59536574|NCT00744692|75634269|FG000|STARTED|Overall Study||22||
59536575|NCT00744692|75634269|FG000|COMPLETED|Overall Study||22||
59536576|NCT00744692|75634269|FG000|NOT COMPLETED|Overall Study||0||
59536577|NCT00744848|75634275|FG000|STARTED|Overall Study||103||
59536578|NCT00744848|75634276|FG001|STARTED|Overall Study||101||
59536579|NCT00744848|75634275|FG000|COMPLETED|Overall Study||103||
59536580|NCT00744848|75634276|FG001|COMPLETED|Overall Study||101||
59536581|NCT00744848|75634275|FG000|NOT COMPLETED|Overall Study||0||
59536582|NCT00744848|75634276|FG001|NOT COMPLETED|Overall Study||0||
59536583|NCT00745940|75634284|FG000|STARTED|Overall Study||57||
59536584|NCT00745940|75634285|FG001|STARTED|Overall Study||48||
59536585|NCT00745940|75634284|FG000|COMPLETED|Overall Study||38||
59536586|NCT00745940|75634285|FG001|COMPLETED|Overall Study||38||
59536587|NCT00745940|75634284|FG000|NOT COMPLETED|Overall Study||19||
59536588|NCT00745940|75634285|FG001|NOT COMPLETED|Overall Study||10||
59536589|NCT00751634|75634291|FG000|STARTED|Overall Study||20||
59536590|NCT00751634|75634291|FG000|COMPLETED|Overall Study||20||
59536591|NCT00751634|75634291|FG000|NOT COMPLETED|Overall Study||0||
59536592|NCT00746954|75634296|FG000|STARTED|Overall Study||3||
59536593|NCT00746954|75634297|FG001|STARTED|Overall Study||3||
59536594|NCT00746954|75634298|FG002|STARTED|Overall Study||2||
59536595|NCT00746954|75634296|FG000|COMPLETED|Overall Study||3||
59536596|NCT00746954|75634297|FG001|COMPLETED|Overall Study||3||
59536597|NCT00746954|75634298|FG002|COMPLETED|Overall Study||2||
59536598|NCT00746954|75634296|FG000|NOT COMPLETED|Overall Study||0||
59536599|NCT00746954|75634297|FG001|NOT COMPLETED|Overall Study||0||
59536600|NCT00746954|75634298|FG002|NOT COMPLETED|Overall Study||0||
59536601|NCT00752102|75634306|FG000|STARTED|Overall Study||22||
59536602|NCT00752102|75634307|FG001|STARTED|Overall Study||22||
59536603|NCT00752102|75634306|FG000|COMPLETED|Overall Study||19||
59536604|NCT00752102|75634307|FG001|COMPLETED|Overall Study||21||
59536605|NCT00752102|75634306|FG000|NOT COMPLETED|Overall Study||3||
59536606|NCT00752102|75634307|FG001|NOT COMPLETED|Overall Study||1||
59536607|NCT00723632|75634313|FG000|STARTED|Overall Study||901||
59536608|NCT00723632|75634313|FG000|COMPLETED|Overall Study|Completed initial exam form and >= 1 follow up visit form; end of treatment and SVR status recorded|698||
59536609|NCT00723632|75634313|FG000|NOT COMPLETED|Overall Study||203||
59536610|NCT00723788|75634317|FG000|STARTED|Overall Study||21||
59536611|NCT00723788|75634317|FG000|COMPLETED|Overall Study||21||
59536612|NCT00723788|75634317|FG000|NOT COMPLETED|Overall Study||0||
59536613|NCT01279616|75634323|FG000|STARTED|Overall Study||8||
59536614|NCT01279616|75634323|FG000|COMPLETED|Overall Study||1||
59536615|NCT01279616|75634323|FG000|NOT COMPLETED|Overall Study||7||
59536616|NCT00724568|75634327|FG000|STARTED|Overall Study||42||
59536617|NCT00724568|75634328|FG001|STARTED|Overall Study||32||
59536618|NCT00724568|75634327|FG000|COMPLETED|Overall Study||42||
59536619|NCT00724568|75634328|FG001|COMPLETED|Overall Study||32||
59536620|NCT00724568|75634327|FG000|NOT COMPLETED|Overall Study||0||
59536621|NCT00724568|75634328|FG001|NOT COMPLETED|Overall Study||0||
59536622|NCT01279070|75634334|FG000|STARTED|Overall Study|34 outpatients were randomly assigned to 32 sessions of REPYFLEC.|34||
59536623|NCT01279070|75634335|FG001|STARTED|Overall Study|28 outpatients were randomly assigned to 32 sessions of leisure group.|28||
59536624|NCT01279070|75634334|FG000|COMPLETED|Overall Study|5 outpatients left the treatment up to 2 months after starting REPYFLEC.|29||
59536625|NCT01279070|75634335|FG001|COMPLETED|Overall Study|4 outpatients left the leisure group up to 2 months after starting Leisure group.|24||
59536626|NCT01279070|75634334|FG000|NOT COMPLETED|Overall Study||5||
59536627|NCT01279070|75634335|FG001|NOT COMPLETED|Overall Study||4||
59536628|NCT01277744|75634345|FG000|STARTED|Overall Study||22||
59536629|NCT01277744|75634345|FG000|COMPLETED|Overall Study||20||
59536630|NCT01277744|75634345|FG000|NOT COMPLETED|Overall Study||2||
59536631|NCT01277822|75634351|FG000|STARTED|Overall Study||168||
59536632|NCT01277822|75634352|FG001|STARTED|Overall Study||166||
59536633|NCT01277822|75634351|FG000|COMPLETED|Overall Study||153||
59536634|NCT01277822|75634352|FG001|COMPLETED|Overall Study||155||
59536635|NCT01277822|75634351|FG000|NOT COMPLETED|Overall Study||15||
59536636|NCT01277822|75634352|FG001|NOT COMPLETED|Overall Study||11||
59536637|NCT01277666|75634361|FG000|STARTED|Overall Study||203||
59536638|NCT01277666|75634362|FG001|STARTED|Overall Study||203||
59536639|NCT01277666|75634363|FG002|STARTED|Overall Study||202||
59536640|NCT01277666|75634361|FG000|COMPLETED|Overall Study||158||
59536641|NCT01277666|75634362|FG001|COMPLETED|Overall Study||144||
59536642|NCT01277666|75634363|FG002|COMPLETED|Overall Study||153||
59536643|NCT01277666|75634361|FG000|NOT COMPLETED|Overall Study||45||
59536644|NCT01277666|75634362|FG001|NOT COMPLETED|Overall Study||59||
59536645|NCT01277666|75634363|FG002|NOT COMPLETED|Overall Study||49||
59536646|NCT00249002|75634371|FG000|STARTED|Overall Study||9||
59536647|NCT00249002|75634371|FG000|COMPLETED|Overall Study||2||
59536648|NCT00249002|75634371|FG000|NOT COMPLETED|Overall Study||7||
59536649|NCT01277042|75634377|FG000|STARTED|Overall Study||606||
59536650|NCT01277042|75634378|FG001|STARTED|Overall Study||606||
59536651|NCT01277042|75634377|FG000|COMPLETED|Overall Study||598||
59536652|NCT01277042|75634378|FG001|COMPLETED|Overall Study||601||
59536653|NCT01277042|75634377|FG000|NOT COMPLETED|Overall Study||8||
59536654|NCT01277042|75634378|FG001|NOT COMPLETED|Overall Study||5||
59536655|NCT00748826|75634385|FG000|STARTED|Overall Study|Of 576 total enrolled, 68 out of scope participants were not used for analyses|508||
59536656|NCT00748826|75634385|FG000|COMPLETED|Overall Study||207||
59536657|NCT00748826|75634385|FG000|NOT COMPLETED|Overall Study||301||
59536658|NCT00754130|75634395|FG000|STARTED|Period 1 (5 Days)||2||
59536659|NCT00754130|75634396|FG001|STARTED|Period 1 (5 Days)||2||
59536660|NCT00754130|75634397|FG002|STARTED|Period 1 (5 Days)||4||
59536661|NCT00754130|75634398|FG003|STARTED|Period 1 (5 Days)||2||
59988031|NCT00834743|76103218|FG000|NOT COMPLETED|First Intervention||0||
59988032|NCT00834743|76103219|FG001|NOT COMPLETED|First Intervention||0||
59988033|NCT00834743|76103218|FG000|STARTED|Washout of 7 Days||16||
59988034|NCT00834743|76103219|FG001|STARTED|Washout of 7 Days||16||
59988035|NCT00834743|76103218|FG000|COMPLETED|Washout of 7 Days||16||
59988036|NCT00834743|76103219|FG001|COMPLETED|Washout of 7 Days||16||
59988037|NCT00834743|76103218|FG000|NOT COMPLETED|Washout of 7 Days||0||
59988038|NCT00834743|76103219|FG001|NOT COMPLETED|Washout of 7 Days||0||
59988039|NCT00834743|76103218|FG000|STARTED|Second Intervention||16||
59988040|NCT00834743|76103219|FG001|STARTED|Second Intervention||16||
59988041|NCT00834743|76103218|FG000|COMPLETED|Second Intervention||15||
59988042|NCT00834743|76103219|FG001|COMPLETED|Second Intervention||16||
59988043|NCT00834743|76103218|FG000|NOT COMPLETED|Second Intervention||1||
59988044|NCT00834743|76103219|FG001|NOT COMPLETED|Second Intervention||0||
60076064|NCT01904773|76191368|FG004|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0||
60076065|NCT01904773|76191369|FG005|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0||
60076066|NCT01904773|76191370|FG006|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0||
60076067|NCT01904773|76191371|FG007|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0||
59536662|NCT00754130|75634399|FG004|STARTED|Period 1 (5 Days)||2||
59536663|NCT00754130|75634400|FG005|STARTED|Period 1 (5 Days)|One participant received MK-0941 10 mg in both Periods 1 and 2.|4||
59536664|NCT00754130|75634395|FG000|COMPLETED|Period 1 (5 Days)||2||
59536665|NCT00754130|75634396|FG001|COMPLETED|Period 1 (5 Days)||2||
59536666|NCT00754130|75634397|FG002|COMPLETED|Period 1 (5 Days)||4||
60076068|NCT01904773|76191372|FG008|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0||
60076069|NCT01904773|76191364|FG000|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||20||
60076070|NCT01904773|76191365|FG001|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0||
60076071|NCT01904773|76191366|FG002|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0||
60076072|NCT01904773|76191367|FG003|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0||
60076073|NCT01904773|76191368|FG004|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0||
59536667|NCT00754130|75634398|FG003|COMPLETED|Period 1 (5 Days)||2||
59536668|NCT00754130|75634399|FG004|COMPLETED|Period 1 (5 Days)||2||
59536669|NCT00754130|75634400|FG005|COMPLETED|Period 1 (5 Days)||4||
59536670|NCT00754130|75634395|FG000|NOT COMPLETED|Period 1 (5 Days)||0||
59623142|NCT00558012|75735164|FG001|STARTED|Overall Study||92||
59623143|NCT00558012|75735163|FG000|COMPLETED|Overall Study||64||
59623144|NCT00558012|75735164|FG001|COMPLETED|Overall Study||74||
59623145|NCT00558012|75735163|FG000|NOT COMPLETED|Overall Study||25||
59623146|NCT00558012|75735164|FG001|NOT COMPLETED|Overall Study||18||
59623147|NCT00558246|75735170|FG000|STARTED|Overall Study||79||
59988045|NCT00834587|76103225|FG000|STARTED|First Intervention||20||
59988046|NCT00834587|76103226|FG001|STARTED|First Intervention||20||
59988047|NCT00834587|76103225|FG000|COMPLETED|First Intervention||20||
59988048|NCT00834587|76103226|FG001|COMPLETED|First Intervention||20||
60076074|NCT01904773|76191369|FG005|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0||
60076075|NCT01904773|76191370|FG006|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0||
60076076|NCT01904773|76191371|FG007|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0||
60076077|NCT01904773|76191372|FG008|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0||
60076078|NCT01904773|76191364|FG000|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||4||
59623148|NCT00558246|75735170|FG000|COMPLETED|Overall Study||79||
60076079|NCT01904773|76191365|FG001|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0||
60076080|NCT01904773|76191366|FG002|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0||
60076081|NCT01904773|76191367|FG003|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0||
60076082|NCT01904773|76191368|FG004|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0||
60076083|NCT01904773|76191369|FG005|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0||
60076084|NCT01904773|76191370|FG006|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0||
60076085|NCT01904773|76191371|FG007|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0||
59536671|NCT00754130|75634396|FG001|NOT COMPLETED|Period 1 (5 Days)||0||
59536672|NCT00754130|75634397|FG002|NOT COMPLETED|Period 1 (5 Days)||0||
59536673|NCT00754130|75634398|FG003|NOT COMPLETED|Period 1 (5 Days)||0||
59536674|NCT00754130|75634399|FG004|NOT COMPLETED|Period 1 (5 Days)||0||
59536675|NCT00754130|75634400|FG005|NOT COMPLETED|Period 1 (5 Days)||0||
59536676|NCT00754130|75634395|FG000|STARTED|Washout Period (>=8 Days)||2||
59536677|NCT00754130|75634396|FG001|STARTED|Washout Period (>=8 Days)||2||
59536678|NCT00754130|75634397|FG002|STARTED|Washout Period (>=8 Days)||4||
59536679|NCT00754130|75634398|FG003|STARTED|Washout Period (>=8 Days)||2||
59536680|NCT00754130|75634399|FG004|STARTED|Washout Period (>=8 Days)||2||
59536681|NCT00754130|75634400|FG005|STARTED|Washout Period (>=8 Days)||4||
59536682|NCT00754130|75634395|FG000|COMPLETED|Washout Period (>=8 Days)||2||
59536683|NCT00754130|75634396|FG001|COMPLETED|Washout Period (>=8 Days)||2||
59536684|NCT00754130|75634397|FG002|COMPLETED|Washout Period (>=8 Days)||4||
59536685|NCT00754130|75634398|FG003|COMPLETED|Washout Period (>=8 Days)||2||
59536686|NCT00754130|75634399|FG004|COMPLETED|Washout Period (>=8 Days)||2||
59536687|NCT00754130|75634400|FG005|COMPLETED|Washout Period (>=8 Days)||4||
59536688|NCT00754130|75634395|FG000|NOT COMPLETED|Washout Period (>=8 Days)||0||
59536689|NCT00754130|75634396|FG001|NOT COMPLETED|Washout Period (>=8 Days)||0||
59536690|NCT00754130|75634397|FG002|NOT COMPLETED|Washout Period (>=8 Days)||0||
59536691|NCT00754130|75634398|FG003|NOT COMPLETED|Washout Period (>=8 Days)||0||
59536692|NCT00754130|75634399|FG004|NOT COMPLETED|Washout Period (>=8 Days)||0||
59536693|NCT00754130|75634400|FG005|NOT COMPLETED|Washout Period (>=8 Days)||0||
59536694|NCT00754130|75634395|FG000|STARTED|Period 2 (5 Days)|One participant received MK-0941 15 mg starting with Dose 2 on Day 2.|2||
59536695|NCT00754130|75634396|FG001|STARTED|Period 2 (5 Days)||2||
59536696|NCT00754130|75634397|FG002|STARTED|Period 2 (5 Days)||4||
59536697|NCT00754130|75634398|FG003|STARTED|Period 2 (5 Days)||2||
59536698|NCT00754130|75634399|FG004|STARTED|Period 2 (5 Days)||2||
59536699|NCT00754130|75634400|FG005|STARTED|Period 2 (5 Days)|One participant received MK-0941 35 mg starting with Dose 3 on Day 3.|4||
59536700|NCT00754130|75634395|FG000|COMPLETED|Period 2 (5 Days)||2||
59536701|NCT00754130|75634396|FG001|COMPLETED|Period 2 (5 Days)||2||
59536702|NCT00754130|75634397|FG002|COMPLETED|Period 2 (5 Days)||4||
59536703|NCT00754130|75634398|FG003|COMPLETED|Period 2 (5 Days)||2||
59536704|NCT00754130|75634399|FG004|COMPLETED|Period 2 (5 Days)||2||
59536705|NCT00754130|75634400|FG005|COMPLETED|Period 2 (5 Days)||4||
59536706|NCT00754130|75634395|FG000|NOT COMPLETED|Period 2 (5 Days)||0||
59536707|NCT00754130|75634396|FG001|NOT COMPLETED|Period 2 (5 Days)||0||
59536708|NCT00754130|75634397|FG002|NOT COMPLETED|Period 2 (5 Days)||0||
59536709|NCT00754130|75634398|FG003|NOT COMPLETED|Period 2 (5 Days)||0||
59536710|NCT00754130|75634399|FG004|NOT COMPLETED|Period 2 (5 Days)||0||
59536711|NCT00754130|75634400|FG005|NOT COMPLETED|Period 2 (5 Days)||0||
59536712|NCT00246740|75634418|FG000|STARTED|Initial Enrollment||28||
59536713|NCT00246740|75634419|FG001|STARTED|Initial Enrollment||28||
59536714|NCT00246740|75634418|FG000|COMPLETED|Initial Enrollment||22||
59536715|NCT00246740|75634419|FG001|COMPLETED|Initial Enrollment||20||
59536716|NCT00246740|75634418|FG000|NOT COMPLETED|Initial Enrollment||6||
59536717|NCT00246740|75634419|FG001|NOT COMPLETED|Initial Enrollment||8||
59536718|NCT00246740|75634418|FG000|STARTED|Experimental Phase||22||
59536719|NCT00246740|75634419|FG001|STARTED|Experimental Phase||20||
59536720|NCT00246740|75634418|FG000|COMPLETED|Experimental Phase||22||
59536721|NCT00246740|75634419|FG001|COMPLETED|Experimental Phase||20||
59536722|NCT00246740|75634418|FG000|NOT COMPLETED|Experimental Phase||0||
59536723|NCT00246740|75634419|FG001|NOT COMPLETED|Experimental Phase||0||
59536724|NCT00748982|75634427|FG000|STARTED|Overall Study||12||
59536725|NCT00748982|75634428|FG001|STARTED|Overall Study||4||
59536726|NCT00748982|75634427|FG000|COMPLETED|Overall Study||12||
59536727|NCT00748982|75634428|FG001|COMPLETED|Overall Study||4||
59536728|NCT00748982|75634427|FG000|NOT COMPLETED|Overall Study||0||
59536729|NCT00748982|75634428|FG001|NOT COMPLETED|Overall Study||0||
59536730|NCT00749606|75634436|FG000|STARTED|Year 1||129||
59536731|NCT00749606|75634437|FG001|STARTED|Year 1||128||
59536732|NCT00749606|75634436|FG000|COMPLETED|Year 1||74||
59536733|NCT00749606|75634437|FG001|COMPLETED|Year 1||80||
59815426|NCT02658890|75937840|FG010|NOT COMPLETED|Pre-Treatment Phase||0||
59815427|NCT02658890|75937841|FG011|NOT COMPLETED|Pre-Treatment Phase||0||
59536734|NCT00749606|75634436|FG000|NOT COMPLETED|Year 1||55||
59536735|NCT00749606|75634437|FG001|NOT COMPLETED|Year 1||48||
59536736|NCT00749606|75634436|FG000|STARTED|Year 2||74||
59536737|NCT00749606|75634437|FG001|STARTED|Year 2||80||
59536738|NCT00749606|75634436|FG000|COMPLETED|Year 2||63||
59536739|NCT00749606|75634437|FG001|COMPLETED|Year 2||72||
59536740|NCT00749606|75634436|FG000|NOT COMPLETED|Year 2||11||
59815428|NCT02658890|75937842|FG012|NOT COMPLETED|Pre-Treatment Phase||0||
59815429|NCT02658890|75937843|FG013|NOT COMPLETED|Pre-Treatment Phase||0||
59536741|NCT00749606|75634437|FG001|NOT COMPLETED|Year 2||8||
59536742|NCT00749606|75634436|FG000|STARTED|Year 3 (Observation)||63||
59536743|NCT00749606|75634437|FG001|STARTED|Year 3 (Observation)||72||
59536744|NCT00749606|75634436|FG000|COMPLETED|Year 3 (Observation)||63||
59536745|NCT00749606|75634437|FG001|COMPLETED|Year 3 (Observation)||69||
59536746|NCT00749606|75634436|FG000|NOT COMPLETED|Year 3 (Observation)||0||
59536747|NCT00749606|75634437|FG001|NOT COMPLETED|Year 3 (Observation)||3||
59815430|NCT02658890|75937844|FG014|NOT COMPLETED|Pre-Treatment Phase||0||
59815431|NCT02658890|75937845|FG015|NOT COMPLETED|Pre-Treatment Phase||0||
59815432|NCT02658890|75937846|FG016|NOT COMPLETED|Pre-Treatment Phase||0||
59815433|NCT02658890|75937847|FG017|NOT COMPLETED|Pre-Treatment Phase||0||
59815434|NCT02658890|75937848|FG018|NOT COMPLETED|Pre-Treatment Phase||0||
59815435|NCT02658890|75937849|FG019|NOT COMPLETED|Pre-Treatment Phase||0||
59815436|NCT02658890|75937850|FG020|NOT COMPLETED|Pre-Treatment Phase||0||
59815437|NCT02658890|75937851|FG021|NOT COMPLETED|Pre-Treatment Phase||0||
59815438|NCT02658890|75937852|FG022|NOT COMPLETED|Pre-Treatment Phase||0||
59536748|NCT00761930|75634448|FG000|STARTED|Overall Study||34||
59536749|NCT00761930|75634449|FG001|STARTED|Overall Study||34||
59536750|NCT00761930|75634450|FG002|STARTED|Overall Study||35||
59536751|NCT00761930|75634448|FG000|COMPLETED|Overall Study||34||
59536752|NCT00761930|75634449|FG001|COMPLETED|Overall Study||34||
59536753|NCT00761930|75634450|FG002|COMPLETED|Overall Study||35||
59536754|NCT00761930|75634448|FG000|NOT COMPLETED|Overall Study||0||
59536755|NCT00761930|75634449|FG001|NOT COMPLETED|Overall Study||0||
59536756|NCT00761930|75634450|FG002|NOT COMPLETED|Overall Study||0||
59536757|NCT00245102|75634464|FG000|STARTED|Overall Study||44||
59536758|NCT00245102|75634465|FG001|STARTED|Overall Study||16||
59536759|NCT00245102|75634466|FG002|STARTED|Overall Study||46||
59536760|NCT00245102|75634467|FG003|STARTED|Overall Study||13||
59536761|NCT00245102|75634468|FG004|STARTED|Overall Study||5||
59536762|NCT00245102|75634469|FG005|STARTED|Overall Study||23||
59536763|NCT00245102|75634464|FG000|COMPLETED|Overall Study||37||
59536764|NCT00245102|75634465|FG001|COMPLETED|Overall Study||12||
59536765|NCT00245102|75634466|FG002|COMPLETED|Overall Study||39||
59536766|NCT00245102|75634467|FG003|COMPLETED|Overall Study||10||
59536767|NCT00245102|75634468|FG004|COMPLETED|Overall Study||5||
59536768|NCT00245102|75634469|FG005|COMPLETED|Overall Study||19||
59536769|NCT00245102|75634464|FG000|NOT COMPLETED|Overall Study||7||
59536770|NCT00245102|75634465|FG001|NOT COMPLETED|Overall Study||4||
59536771|NCT00245102|75634466|FG002|NOT COMPLETED|Overall Study||7||
59536772|NCT00245102|75634467|FG003|NOT COMPLETED|Overall Study||3||
59536773|NCT00245102|75634468|FG004|NOT COMPLETED|Overall Study||0||
59536774|NCT00245102|75634469|FG005|NOT COMPLETED|Overall Study||4||
59536775|NCT00754832|75634483|FG000|STARTED|First 6 Weeks Intervention||26||
59536776|NCT00754832|75634484|FG001|STARTED|First 6 Weeks Intervention||30||
59536777|NCT00754832|75634483|FG000|COMPLETED|First 6 Weeks Intervention||18||
59536778|NCT00754832|75634484|FG001|COMPLETED|First 6 Weeks Intervention||28||
59536779|NCT00754832|75634483|FG000|NOT COMPLETED|First 6 Weeks Intervention||8||
59536780|NCT00754832|75634484|FG001|NOT COMPLETED|First 6 Weeks Intervention||2||
59536781|NCT00754832|75634483|FG000|STARTED|2 Weeks Washout||18||
59536782|NCT00754832|75634484|FG001|STARTED|2 Weeks Washout||28||
59536783|NCT00754832|75634483|FG000|COMPLETED|2 Weeks Washout||17||
59536784|NCT00754832|75634484|FG001|COMPLETED|2 Weeks Washout||26||
59536785|NCT00754832|75634483|FG000|NOT COMPLETED|2 Weeks Washout||1||
59536786|NCT00754832|75634484|FG001|NOT COMPLETED|2 Weeks Washout||2||
59536787|NCT00754832|75634483|FG000|STARTED|Second 6 Weeks Intervention||17||
59536788|NCT00754832|75634484|FG001|STARTED|Second 6 Weeks Intervention||26||
59536789|NCT00754832|75634483|FG000|COMPLETED|Second 6 Weeks Intervention||17||
59536790|NCT00754832|75634484|FG001|COMPLETED|Second 6 Weeks Intervention||24||
59536791|NCT00754832|75634483|FG000|NOT COMPLETED|Second 6 Weeks Intervention||0||
59536792|NCT00754832|75634484|FG001|NOT COMPLETED|Second 6 Weeks Intervention||2||
59536793|NCT00756236|75634493|FG000|STARTED|Overall Study||20||
59536794|NCT00756236|75634494|FG001|STARTED|Overall Study||20||
59536795|NCT00756236|75634495|FG002|STARTED|Overall Study||20||
59536796|NCT00756236|75634493|FG000|COMPLETED|Overall Study||20||
59536797|NCT00756236|75634494|FG001|COMPLETED|Overall Study||20||
59815439|NCT02658890|75937853|FG023|NOT COMPLETED|Pre-Treatment Phase||0||
59815440|NCT02658890|75937854|FG024|NOT COMPLETED|Pre-Treatment Phase||0||
59815441|NCT02658890|75937855|FG025|NOT COMPLETED|Pre-Treatment Phase||0||
59815442|NCT02658890|75937856|FG026|NOT COMPLETED|Pre-Treatment Phase||0||
59815443|NCT02658890|75937830|FG000|STARTED|Treatment Phase||7||
59536798|NCT00756236|75634495|FG002|COMPLETED|Overall Study||20||
59536799|NCT00756236|75634493|FG000|NOT COMPLETED|Overall Study||0||
59536800|NCT00756236|75634494|FG001|NOT COMPLETED|Overall Study||0||
59815444|NCT02658890|75937831|FG001|STARTED|Treatment Phase||11||
59815445|NCT02658890|75937832|FG002|STARTED|Treatment Phase||12||
59536801|NCT00756236|75634495|FG002|NOT COMPLETED|Overall Study||0||
59536802|NCT00762320|75634503|FG000|STARTED|Overall Study||8||
59536803|NCT00762320|75634503|FG000|COMPLETED|Overall Study||8||
59536804|NCT00762320|75634503|FG000|NOT COMPLETED|Overall Study||0||
59536805|NCT00244712|75634514|FG000|STARTED|Overall Study||343||
59815446|NCT02658890|75937833|FG003|STARTED|Treatment Phase||18||
59815447|NCT02658890|75937834|FG004|STARTED|Treatment Phase||7||
59536806|NCT00244712|75634515|FG001|STARTED|Overall Study||345||
59536807|NCT00244712|75634514|FG000|COMPLETED|Overall Study||234||
59536808|NCT00244712|75634515|FG001|COMPLETED|Overall Study||221||
59536809|NCT00244712|75634514|FG000|NOT COMPLETED|Overall Study||109||
59536810|NCT00244712|75634515|FG001|NOT COMPLETED|Overall Study||124||
59815448|NCT02658890|75937835|FG005|STARTED|Treatment Phase||18||
59815449|NCT02658890|75937836|FG006|STARTED|Treatment Phase||17||
59815450|NCT02658890|75937837|FG007|STARTED|Treatment Phase||22||
59815451|NCT02658890|75937838|FG008|STARTED|Treatment Phase||35||
59815452|NCT02658890|75937839|FG009|STARTED|Treatment Phase||15||
59815453|NCT02658890|75937840|FG010|STARTED|Treatment Phase||14||
59815454|NCT02658890|75937841|FG011|STARTED|Treatment Phase||14||
59815455|NCT02658890|75937842|FG012|STARTED|Treatment Phase||16||
59815456|NCT02658890|75937843|FG013|STARTED|Treatment Phase||79||
59815457|NCT02658890|75937844|FG014|STARTED|Treatment Phase||9||
59815458|NCT02658890|75937845|FG015|STARTED|Treatment Phase||6||
59815459|NCT02658890|75937846|FG016|STARTED|Treatment Phase||37||
59815460|NCT02658890|75937847|FG017|STARTED|Treatment Phase||17||
59815461|NCT02658890|75937848|FG018|STARTED|Treatment Phase||80||
59536811|NCT00725270|75634523|FG000|STARTED|Overall Study||5||
59536812|NCT00725270|75634524|FG001|STARTED|Overall Study||7||
59536813|NCT00725270|75634523|FG000|COMPLETED|Overall Study||5||
59536814|NCT00725270|75634524|FG001|COMPLETED|Overall Study||7||
59536815|NCT00725270|75634523|FG000|NOT COMPLETED|Overall Study||0||
59536816|NCT00725270|75634524|FG001|NOT COMPLETED|Overall Study||0||
59536817|NCT00243932|75634533|FG000|STARTED|Stage 1: Dose Selection||35||
59536818|NCT00243932|75634534|FG001|STARTED|Stage 1: Dose Selection||35||
59536819|NCT00243932|75634535|FG002|STARTED|Stage 1: Dose Selection||35||
59536820|NCT00243932|75634533|FG000|COMPLETED|Stage 1: Dose Selection||33||
59536821|NCT00243932|75634534|FG001|COMPLETED|Stage 1: Dose Selection||35||
59536822|NCT00243932|75634535|FG002|COMPLETED|Stage 1: Dose Selection||35||
59536823|NCT00243932|75634533|FG000|NOT COMPLETED|Stage 1: Dose Selection||2||
59536824|NCT00243932|75634534|FG001|NOT COMPLETED|Stage 1: Dose Selection||0||
59536825|NCT00243932|75634535|FG002|NOT COMPLETED|Stage 1: Dose Selection||0||
59536826|NCT00243932|75634533|FG000|STARTED|Stage 2: Efficacy|40 newly randomized pts. Efficacy analysis included Stage 1 + Stage 2 patients|40||
59536827|NCT00243932|75634534|FG001|STARTED|Stage 2: Efficacy|40 newly randomized pts. Efficacy analysis included Stage 1 + Stage 2 patients|40||
59536828|NCT00243932|75634535|FG002|STARTED|Stage 2: Efficacy|No new pts. randomized because selection procedure in Stage 1 selected the 2,700 mg dose.|0||
59536829|NCT00243932|75634533|FG000|COMPLETED|Stage 2: Efficacy||40||
59536830|NCT00243932|75634534|FG001|COMPLETED|Stage 2: Efficacy||40||
59536831|NCT00243932|75634535|FG002|COMPLETED|Stage 2: Efficacy||0||
59536832|NCT00243932|75634533|FG000|NOT COMPLETED|Stage 2: Efficacy||0||
59536833|NCT00243932|75634534|FG001|NOT COMPLETED|Stage 2: Efficacy||0||
59536834|NCT00243932|75634535|FG002|NOT COMPLETED|Stage 2: Efficacy||0||
59536835|NCT00243386|75634543|FG000|STARTED|On-Demand Regimen (Study Part 1)||73||
59536836|NCT00243386|75634544|FG001|STARTED|On-Demand Regimen (Study Part 1)|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0||
59536837|NCT00243386|75634545|FG002|STARTED|On-Demand Regimen (Study Part 1)|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0||
59536838|NCT00243386|75634543|FG000|COMPLETED|On-Demand Regimen (Study Part 1)||69||
59536839|NCT00243386|75634544|FG001|COMPLETED|On-Demand Regimen (Study Part 1)||0||
59536840|NCT00243386|75634545|FG002|COMPLETED|On-Demand Regimen (Study Part 1)||0||
59536841|NCT00243386|75634543|FG000|NOT COMPLETED|On-Demand Regimen (Study Part 1)||4||
59536842|NCT00243386|75634544|FG001|NOT COMPLETED|On-Demand Regimen (Study Part 1)||0||
59536843|NCT00243386|75634545|FG002|NOT COMPLETED|On-Demand Regimen (Study Part 1)||0||
59536844|NCT00243386|75634543|FG000|STARTED|End of Part 1, But Prior to Prophylaxis||69||
59536845|NCT00243386|75634544|FG001|STARTED|End of Part 1, But Prior to Prophylaxis|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0||
59815462|NCT02658890|75937849|FG019|STARTED|Treatment Phase||41||
59815463|NCT02658890|75937850|FG020|STARTED|Treatment Phase||32||
59815464|NCT02658890|75937851|FG021|STARTED|Treatment Phase||42||
59536846|NCT00243386|75634545|FG002|STARTED|End of Part 1, But Prior to Prophylaxis|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0||
59536847|NCT00243386|75634543|FG000|COMPLETED|End of Part 1, But Prior to Prophylaxis||66||
59536848|NCT00243386|75634544|FG001|COMPLETED|End of Part 1, But Prior to Prophylaxis||0||
59815465|NCT02658890|75937852|FG022|STARTED|Treatment Phase||41||
59815466|NCT02658890|75937853|FG023|STARTED|Treatment Phase||1||
59815467|NCT02658890|75937854|FG024|STARTED|Treatment Phase||1||
59815468|NCT02658890|75937855|FG025|STARTED|Treatment Phase||20||
59815469|NCT02658890|75937856|FG026|STARTED|Treatment Phase||14||
59815470|NCT02658890|75937830|FG000|COMPLETED|Treatment Phase||1||
59815471|NCT02658890|75937831|FG001|COMPLETED|Treatment Phase||2||
59536849|NCT00243386|75634545|FG002|COMPLETED|End of Part 1, But Prior to Prophylaxis||0||
59536850|NCT00243386|75634543|FG000|NOT COMPLETED|End of Part 1, But Prior to Prophylaxis||3||
59536851|NCT00243386|75634544|FG001|NOT COMPLETED|End of Part 1, But Prior to Prophylaxis||0||
59536852|NCT00243386|75634545|FG002|NOT COMPLETED|End of Part 1, But Prior to Prophylaxis||0||
59536853|NCT00243386|75634543|FG000|STARTED|PK-Driven or Standard Prophylaxis|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0||
59536854|NCT00243386|75634544|FG001|STARTED|PK-Driven or Standard Prophylaxis||34||
59536855|NCT00243386|75634545|FG002|STARTED|PK-Driven or Standard Prophylaxis||32||
59536856|NCT00243386|75634543|FG000|COMPLETED|PK-Driven or Standard Prophylaxis||0||
59536857|NCT00243386|75634544|FG001|COMPLETED|PK-Driven or Standard Prophylaxis||31||
59815472|NCT02658890|75937832|FG002|COMPLETED|Treatment Phase||1||
59815473|NCT02658890|75937833|FG003|COMPLETED|Treatment Phase||3||
59815474|NCT02658890|75937834|FG004|COMPLETED|Treatment Phase||0||
59815475|NCT02658890|75937835|FG005|COMPLETED|Treatment Phase||0||
59536858|NCT00243386|75634545|FG002|COMPLETED|PK-Driven or Standard Prophylaxis||32||
59536859|NCT00243386|75634543|FG000|NOT COMPLETED|PK-Driven or Standard Prophylaxis||0||
59536860|NCT00243386|75634544|FG001|NOT COMPLETED|PK-Driven or Standard Prophylaxis||3||
59536861|NCT00243386|75634545|FG002|NOT COMPLETED|PK-Driven or Standard Prophylaxis||0||
59536862|NCT00762710|75634583|FG000|STARTED|Overall Study||48||
59536863|NCT00762710|75634584|FG001|STARTED|Overall Study||44||
59536864|NCT00762710|75634583|FG000|COMPLETED|Overall Study||27||
59536865|NCT00762710|75634584|FG001|COMPLETED|Overall Study||29||
59536866|NCT00762710|75634583|FG000|NOT COMPLETED|Overall Study||21||
59536867|NCT00762710|75634584|FG001|NOT COMPLETED|Overall Study||15||
59536868|NCT00756548|75634592|FG000|STARTED|Overall Study||186||
59536869|NCT00756548|75634593|FG001|STARTED|Overall Study||185||
59536870|NCT00756548|75634592|FG000|COMPLETED|Overall Study||184||
59536871|NCT00756548|75634593|FG001|COMPLETED|Overall Study||185||
59536872|NCT00756548|75634592|FG000|NOT COMPLETED|Overall Study||2||
59536873|NCT00756548|75634593|FG001|NOT COMPLETED|Overall Study||0||
59536874|NCT00243230|75634604|FG000|STARTED|Double-Blind Period||39||
59536875|NCT00243230|75634605|FG001|STARTED|Double-Blind Period||40||
59536876|NCT00243230|75634606|FG002|STARTED|Double-Blind Period||37||
59536877|NCT00243230|75634607|FG003|STARTED|Double-Blind Period||0||
59536878|NCT00243230|75634604|FG000|Treated|Double-Blind Period||39||
59536879|NCT00243230|75634605|FG001|Treated|Double-Blind Period||40||
59536880|NCT00243230|75634606|FG002|Treated|Double-Blind Period||35||
59536881|NCT00243230|75634607|FG003|Treated|Double-Blind Period||0||
59536882|NCT00243230|75634604|FG000|COMPLETED|Double-Blind Period||33||
59536883|NCT00243230|75634605|FG001|COMPLETED|Double-Blind Period||35||
59536884|NCT00243230|75634606|FG002|COMPLETED|Double-Blind Period||18||
59536885|NCT00243230|75634607|FG003|COMPLETED|Double-Blind Period||0||
59536886|NCT00243230|75634604|FG000|NOT COMPLETED|Double-Blind Period||6||
59536887|NCT00243230|75634605|FG001|NOT COMPLETED|Double-Blind Period||5||
59536888|NCT00243230|75634606|FG002|NOT COMPLETED|Double-Blind Period||19||
59536889|NCT00243230|75634607|FG003|NOT COMPLETED|Double-Blind Period||0||
59536890|NCT00243230|75634604|FG000|STARTED|Open Label Period||0||
59536891|NCT00243230|75634605|FG001|STARTED|Open Label Period||0||
59536892|NCT00243230|75634606|FG002|STARTED|Open Label Period||0||
59536893|NCT00243230|75634607|FG003|STARTED|Open Label Period||85||
59536894|NCT00243230|75634604|FG000|COMPLETED|Open Label Period||0||
59536895|NCT00243230|75634605|FG001|COMPLETED|Open Label Period||0||
59536896|NCT00243230|75634606|FG002|COMPLETED|Open Label Period||0||
59536897|NCT00243230|75634607|FG003|COMPLETED|Open Label Period||0||
59536898|NCT00243230|75634604|FG000|NOT COMPLETED|Open Label Period||0||
59536899|NCT00243230|75634605|FG001|NOT COMPLETED|Open Label Period||0||
59536900|NCT00243230|75634606|FG002|NOT COMPLETED|Open Label Period||0||
59536901|NCT00243230|75634607|FG003|NOT COMPLETED|Open Label Period||85||
59536902|NCT00243074|75634617|FG000|STARTED|Overall Study||54||
59536903|NCT00243074|75634617|FG000|COMPLETED|Overall Study||0||
59536904|NCT00243074|75634617|FG000|NOT COMPLETED|Overall Study||54||
59536905|NCT00241358|75634625|FG000|STARTED|Overall Study||25||
59536906|NCT00241358|75634626|FG001|STARTED|Overall Study||46||
59536907|NCT00241358|75634627|FG002|STARTED|Overall Study||21||
59536908|NCT00241358|75634625|FG000|COMPLETED|Overall Study||25||
59536909|NCT00241358|75634626|FG001|COMPLETED|Overall Study||45||
59536910|NCT00241358|75634627|FG002|COMPLETED|Overall Study||20||
59536911|NCT00241358|75634625|FG000|NOT COMPLETED|Overall Study||0||
59536912|NCT00241358|75634626|FG001|NOT COMPLETED|Overall Study||1||
59536913|NCT00241358|75634627|FG002|NOT COMPLETED|Overall Study||1||
59536914|NCT00241280|75634636|FG000|STARTED|Overall Study||247||
59536915|NCT00241280|75634637|FG001|STARTED|Overall Study||254||
59536916|NCT00241280|75634636|FG000|COMPLETED|Overall Study||199||
59536917|NCT00241280|75634637|FG001|COMPLETED|Overall Study||186||
59536918|NCT00241280|75634636|FG000|NOT COMPLETED|Overall Study||48||
59536919|NCT00241280|75634637|FG001|NOT COMPLETED|Overall Study||68||
59536920|NCT00240500|75634650|FG000|STARTED|Overall Study||17||
59536921|NCT00240500|75634651|FG001|STARTED|Overall Study||20||
59536922|NCT00240500|75634652|FG002|STARTED|Overall Study||17||
59536923|NCT00240500|75634653|FG003|STARTED|Overall Study||23||
59536924|NCT00240500|75634654|FG004|STARTED|Overall Study||29||
59536925|NCT00240500|75634655|FG005|STARTED|Overall Study||3||
59536926|NCT00240500|75634650|FG000|COMPLETED|Overall Study||16||
59536927|NCT00240500|75634651|FG001|COMPLETED|Overall Study||17||
59536928|NCT00240500|75634652|FG002|COMPLETED|Overall Study||14||
59536929|NCT00240500|75634653|FG003|COMPLETED|Overall Study||19||
59536930|NCT00240500|75634654|FG004|COMPLETED|Overall Study||26||
59536931|NCT00240500|75634655|FG005|COMPLETED|Overall Study||2||
59536932|NCT00240500|75634650|FG000|NOT COMPLETED|Overall Study||1||
59536933|NCT00240500|75634651|FG001|NOT COMPLETED|Overall Study||3||
59536934|NCT00240500|75634652|FG002|NOT COMPLETED|Overall Study||3||
59536935|NCT00240500|75634653|FG003|NOT COMPLETED|Overall Study||4||
59536936|NCT00240500|75634654|FG004|NOT COMPLETED|Overall Study||3||
59536937|NCT00240500|75634655|FG005|NOT COMPLETED|Overall Study||1||
59536938|NCT00778310|75634665|FG000|STARTED|Overall Study||17||
59536939|NCT00778310|75634666|FG001|STARTED|Overall Study||26||
59536940|NCT00778310|75634665|FG000|Usable Data|Overall Study||14||
59536941|NCT00778310|75634666|FG001|Usable Data|Overall Study||21||
59536942|NCT00778310|75634665|FG000|COMPLETED|Overall Study||17||
59536943|NCT00778310|75634666|FG001|COMPLETED|Overall Study||26||
59536944|NCT00778310|75634665|FG000|NOT COMPLETED|Overall Study||0||
59536945|NCT00778310|75634666|FG001|NOT COMPLETED|Overall Study||0||
59536946|NCT01212107|75634686|FG000|STARTED|Overall Study||3||
59536947|NCT01212107|75634687|FG001|STARTED|Overall Study||3||
59536948|NCT01212107|75634688|FG002|STARTED|Overall Study||6||
59536949|NCT01212107|75634689|FG003|STARTED|Overall Study||3||
59536950|NCT01212107|75634690|FG004|STARTED|Overall Study||3||
59815476|NCT02658890|75937836|FG006|COMPLETED|Treatment Phase||2||
59815477|NCT02658890|75937837|FG007|COMPLETED|Treatment Phase||1||
59815478|NCT02658890|75937838|FG008|COMPLETED|Treatment Phase||4||
59815479|NCT02658890|75937839|FG009|COMPLETED|Treatment Phase||3||
59815480|NCT02658890|75937840|FG010|COMPLETED|Treatment Phase||3||
59815481|NCT02658890|75937841|FG011|COMPLETED|Treatment Phase||4||
59815482|NCT02658890|75937842|FG012|COMPLETED|Treatment Phase||4||
59815483|NCT02658890|75937843|FG013|COMPLETED|Treatment Phase||31||
59815484|NCT02658890|75937844|FG014|COMPLETED|Treatment Phase||3||
59815485|NCT02658890|75937845|FG015|COMPLETED|Treatment Phase||3||
59815486|NCT02658890|75937846|FG016|COMPLETED|Treatment Phase||3||
59815487|NCT02658890|75937847|FG017|COMPLETED|Treatment Phase||3||
59815488|NCT02658890|75937848|FG018|COMPLETED|Treatment Phase||18||
59815489|NCT02658890|75937849|FG019|COMPLETED|Treatment Phase||2||
59815490|NCT02658890|75937850|FG020|COMPLETED|Treatment Phase||8||
59815491|NCT02658890|75937851|FG021|COMPLETED|Treatment Phase||8||
59815492|NCT02658890|75937852|FG022|COMPLETED|Treatment Phase||9||
59815493|NCT02658890|75937853|FG023|COMPLETED|Treatment Phase||0||
59815494|NCT02658890|75937854|FG024|COMPLETED|Treatment Phase||0||
59815495|NCT02658890|75937855|FG025|COMPLETED|Treatment Phase||2||
59815496|NCT02658890|75937856|FG026|COMPLETED|Treatment Phase||1||
59815497|NCT02658890|75937830|FG000|NOT COMPLETED|Treatment Phase||6||
59815498|NCT02658890|75937831|FG001|NOT COMPLETED|Treatment Phase||9||
59815499|NCT02658890|75937832|FG002|NOT COMPLETED|Treatment Phase||11||
59815500|NCT02658890|75937833|FG003|NOT COMPLETED|Treatment Phase||15||
59815501|NCT02658890|75937834|FG004|NOT COMPLETED|Treatment Phase||7||
59815502|NCT02658890|75937835|FG005|NOT COMPLETED|Treatment Phase||18||
59815503|NCT02658890|75937836|FG006|NOT COMPLETED|Treatment Phase||15||
59815504|NCT02658890|75937837|FG007|NOT COMPLETED|Treatment Phase||21||
59815505|NCT02658890|75937838|FG008|NOT COMPLETED|Treatment Phase||31||
59815506|NCT02658890|75937839|FG009|NOT COMPLETED|Treatment Phase||12||
59815507|NCT02658890|75937840|FG010|NOT COMPLETED|Treatment Phase||11||
59815508|NCT02658890|75937841|FG011|NOT COMPLETED|Treatment Phase||10||
59815509|NCT02658890|75937842|FG012|NOT COMPLETED|Treatment Phase||12||
59815510|NCT02658890|75937843|FG013|NOT COMPLETED|Treatment Phase||48||
59815511|NCT02658890|75937844|FG014|NOT COMPLETED|Treatment Phase||6||
59815512|NCT02658890|75937845|FG015|NOT COMPLETED|Treatment Phase||3||
59815513|NCT02658890|75937846|FG016|NOT COMPLETED|Treatment Phase||34||
59815514|NCT02658890|75937847|FG017|NOT COMPLETED|Treatment Phase||14||
59815515|NCT02658890|75937848|FG018|NOT COMPLETED|Treatment Phase||62||
59815516|NCT02658890|75937849|FG019|NOT COMPLETED|Treatment Phase||39||
59815517|NCT02658890|75937850|FG020|NOT COMPLETED|Treatment Phase||24||
59815518|NCT02658890|75937851|FG021|NOT COMPLETED|Treatment Phase||34||
59815519|NCT02658890|75937852|FG022|NOT COMPLETED|Treatment Phase||32||
59815520|NCT02658890|75937853|FG023|NOT COMPLETED|Treatment Phase||1||
59988049|NCT00834587|76103225|FG000|NOT COMPLETED|First Intervention||0||
59536951|NCT01212107|75634691|FG005|STARTED|Overall Study||3||
59536952|NCT01212107|75634692|FG006|STARTED|Overall Study||3||
59536953|NCT01212107|75634693|FG007|STARTED|Overall Study||3||
59536954|NCT01212107|75634694|FG008|STARTED|Overall Study||3||
59536955|NCT01212107|75634695|FG009|STARTED|Overall Study||3||
59536956|NCT01212107|75634696|FG010|STARTED|Overall Study||3||
59536957|NCT01212107|75634697|FG011|STARTED|Overall Study||58||
59536958|NCT01212107|75634686|FG000|COMPLETED|Overall Study||2||
59815521|NCT02658890|75937854|FG024|NOT COMPLETED|Treatment Phase||1||
59815522|NCT02658890|75937855|FG025|NOT COMPLETED|Treatment Phase||18||
59815523|NCT02658890|75937856|FG026|NOT COMPLETED|Treatment Phase||13||
59815524|NCT02597062|75937948|FG000|STARTED|Overall Study||76||
59815525|NCT02597062|75937948|FG000|COMPLETED|Overall Study||75||
59815526|NCT02597062|75937948|FG000|NOT COMPLETED|Overall Study||1||
59815527|NCT01830621|75937954|FG000|STARTED|Overall Study||138||
59815528|NCT01830621|75937955|FG001|STARTED|Overall Study||144||
59815529|NCT01830621|75937954|FG000|COMPLETED|Overall Study||138||
59536959|NCT01212107|75634687|FG001|COMPLETED|Overall Study||2||
59536960|NCT01212107|75634688|FG002|COMPLETED|Overall Study||3||
59536961|NCT01212107|75634689|FG003|COMPLETED|Overall Study||3||
59536962|NCT01212107|75634690|FG004|COMPLETED|Overall Study||2||
59536963|NCT01212107|75634691|FG005|COMPLETED|Overall Study||2||
59536964|NCT01212107|75634692|FG006|COMPLETED|Overall Study||3||
59815530|NCT01830621|75937955|FG001|COMPLETED|Overall Study||144||
59988050|NCT00834587|76103226|FG001|NOT COMPLETED|First Intervention||0||
59815531|NCT01830621|75937954|FG000|NOT COMPLETED|Overall Study||0||
59815532|NCT01830621|75937955|FG001|NOT COMPLETED|Overall Study||0||
59815533|NCT01248585|75937963|FG000|STARTED|Overall Study||148||
59815534|NCT01248585|75937964|FG001|STARTED|Overall Study||150||
59815535|NCT01248585|75937963|FG000|COMPLETED|Overall Study||148||
59536965|NCT01212107|75634693|FG007|COMPLETED|Overall Study||2||
59536966|NCT01212107|75634694|FG008|COMPLETED|Overall Study||1||
59536967|NCT01212107|75634695|FG009|COMPLETED|Overall Study||1||
59536968|NCT01212107|75634696|FG010|COMPLETED|Overall Study||2||
59536969|NCT01212107|75634697|FG011|COMPLETED|Overall Study||26||
59536970|NCT01212107|75634686|FG000|NOT COMPLETED|Overall Study||1||
59536971|NCT01212107|75634687|FG001|NOT COMPLETED|Overall Study||1||
59536972|NCT01212107|75634688|FG002|NOT COMPLETED|Overall Study||3||
59536973|NCT01212107|75634689|FG003|NOT COMPLETED|Overall Study||0||
59536974|NCT01212107|75634690|FG004|NOT COMPLETED|Overall Study||1||
59536975|NCT01212107|75634691|FG005|NOT COMPLETED|Overall Study||1||
59536976|NCT01212107|75634692|FG006|NOT COMPLETED|Overall Study||0||
59536977|NCT01212107|75634693|FG007|NOT COMPLETED|Overall Study||1||
59536978|NCT01212107|75634694|FG008|NOT COMPLETED|Overall Study||2||
59536979|NCT01212107|75634695|FG009|NOT COMPLETED|Overall Study||2||
59536980|NCT01212107|75634696|FG010|NOT COMPLETED|Overall Study||1||
59536981|NCT01212107|75634697|FG011|NOT COMPLETED|Overall Study||32||
59536982|NCT01246895|75634741|FG000|STARTED|Overall Study||37||
59536983|NCT01246895|75634742|FG001|STARTED|Overall Study||30||
59536984|NCT01246895|75634741|FG000|COMPLETED|Overall Study||34||
59536985|NCT01246895|75634742|FG001|COMPLETED|Overall Study||26||
59536986|NCT01246895|75634741|FG000|NOT COMPLETED|Overall Study||3||
59536987|NCT01246895|75634742|FG001|NOT COMPLETED|Overall Study||4||
59536988|NCT03800420|75634752|FG000|STARTED|Overall Study||12||
59536989|NCT03800420|75634753|FG001|STARTED|Overall Study||4||
59536990|NCT03800420|75634752|FG000|COMPLETED|Overall Study||10||
59536991|NCT03800420|75634753|FG001|COMPLETED|Overall Study||3||
59536992|NCT03800420|75634752|FG000|NOT COMPLETED|Overall Study||2||
59536993|NCT03800420|75634753|FG001|NOT COMPLETED|Overall Study||1||
59536994|NCT00757484|75634763|FG000|STARTED|Overall Study||491||
59536995|NCT00757484|75634763|FG000|COMPLETED|Overall Study||491||
59536996|NCT00757484|75634763|FG000|NOT COMPLETED|Overall Study||0||
59536997|NCT01299077|75634769|FG000|STARTED|Overall Study||478||
59536998|NCT01299077|75634769|FG000|COMPLETED|Overall Study||478||
59536999|NCT01299077|75634769|FG000|NOT COMPLETED|Overall Study||0||
59537000|NCT01247285|75634775|FG000|STARTED|First Intervention||13||
59537001|NCT01247285|75634776|FG001|STARTED|First Intervention||13||
59537002|NCT01247285|75634775|FG000|COMPLETED|First Intervention||13||
59537003|NCT01247285|75634776|FG001|COMPLETED|First Intervention||13||
59537004|NCT01247285|75634775|FG000|NOT COMPLETED|First Intervention||0||
59537005|NCT01247285|75634776|FG001|NOT COMPLETED|First Intervention||0||
59537006|NCT01247285|75634775|FG000|STARTED|Washout of 28 Days||13||
59537007|NCT01247285|75634776|FG001|STARTED|Washout of 28 Days||13||
59537008|NCT01247285|75634775|FG000|COMPLETED|Washout of 28 Days||13||
59537009|NCT01247285|75634776|FG001|COMPLETED|Washout of 28 Days||13||
59537010|NCT01247285|75634775|FG000|NOT COMPLETED|Washout of 28 Days||0||
59537011|NCT01247285|75634776|FG001|NOT COMPLETED|Washout of 28 Days||0||
59537012|NCT01247285|75634775|FG000|STARTED|Second Intervention||13||
59537013|NCT01247285|75634776|FG001|STARTED|Second Intervention||13||
59537014|NCT01247285|75634775|FG000|COMPLETED|Second Intervention||13||
59537015|NCT01247285|75634776|FG001|COMPLETED|Second Intervention||13||
59537016|NCT01247285|75634775|FG000|NOT COMPLETED|Second Intervention||0||
59537017|NCT01247285|75634776|FG001|NOT COMPLETED|Second Intervention||0||
59537018|NCT00779558|75634784|FG000|STARTED|Overall Study||57||
59537019|NCT00779558|75634785|FG001|STARTED|Overall Study||44||
59537020|NCT00779558|75634784|FG000|COMPLETED|Overall Study||53||
59537021|NCT00779558|75634785|FG001|COMPLETED|Overall Study||37||
59537022|NCT00779558|75634784|FG000|NOT COMPLETED|Overall Study||4||
59537023|NCT00779558|75634785|FG001|NOT COMPLETED|Overall Study||7||
59537024|NCT01300559|75634793|FG000|STARTED|Overall Study||30||
59537025|NCT01300559|75634794|FG001|STARTED|Overall Study||30||
59537026|NCT01300559|75634793|FG000|COMPLETED|Overall Study||30||
59537027|NCT01300559|75634794|FG001|COMPLETED|Overall Study||30||
59537028|NCT01300559|75634793|FG000|NOT COMPLETED|Overall Study||0||
59537029|NCT01300559|75634794|FG001|NOT COMPLETED|Overall Study||0||
59537030|NCT01300949|75634803|FG000|STARTED|Overall Study||154||
59537031|NCT01300949|75634804|FG001|STARTED|Overall Study||125||
59537032|NCT01300949|75634805|FG002|STARTED|Overall Study||35||
59537033|NCT01300949|75634803|FG000|COMPLETED|Overall Study||154||
59537034|NCT01300949|75634804|FG001|COMPLETED|Overall Study||125||
59537035|NCT01300949|75634805|FG002|COMPLETED|Overall Study||35||
59537036|NCT01300949|75634803|FG000|NOT COMPLETED|Overall Study||0||
59537037|NCT01300949|75634804|FG001|NOT COMPLETED|Overall Study||0||
59537038|NCT01300949|75634805|FG002|NOT COMPLETED|Overall Study||0||
59537039|NCT01301183|75634815|FG000|STARTED|Overall Study||38||
59537040|NCT01301183|75634816|FG001|STARTED|Overall Study||37||
59537041|NCT01301183|75634815|FG000|COMPLETED|Overall Study||12||
59537042|NCT01301183|75634816|FG001|COMPLETED|Overall Study||21||
59537043|NCT01301183|75634815|FG000|NOT COMPLETED|Overall Study||26||
59537044|NCT01301183|75634816|FG001|NOT COMPLETED|Overall Study||16||
59537045|NCT00758420|75634824|FG000|STARTED|Overall Study||39||
59537046|NCT00758420|75634825|FG001|STARTED|Overall Study||38||
59537047|NCT00758420|75634824|FG000|COMPLETED|Overall Study||39||
59537048|NCT00758420|75634825|FG001|COMPLETED|Overall Study||38||
59537049|NCT00758420|75634824|FG000|NOT COMPLETED|Overall Study||0||
59537050|NCT00758420|75634825|FG001|NOT COMPLETED|Overall Study||0||
59537051|NCT00779870|75634834|FG000|STARTED|Overall Study||5||
59537052|NCT00779870|75634835|FG001|STARTED|Overall Study||6||
59537053|NCT00779870|75634836|FG002|STARTED|Overall Study||7||
59537054|NCT00779870|75634834|FG000|COMPLETED|Overall Study||5||
59537055|NCT00779870|75634835|FG001|COMPLETED|Overall Study||6||
59537056|NCT00779870|75634836|FG002|COMPLETED|Overall Study||7||
59537057|NCT00779870|75634834|FG000|NOT COMPLETED|Overall Study||0||
59537058|NCT00779870|75634835|FG001|NOT COMPLETED|Overall Study||0||
59537059|NCT00779870|75634836|FG002|NOT COMPLETED|Overall Study||0||
59537060|NCT01213043|75634846|FG000|STARTED|Treatment Period 1||15||
59537061|NCT01213043|75634847|FG001|STARTED|Treatment Period 1||15||
59537062|NCT01213043|75634846|FG000|COMPLETED|Treatment Period 1||15||
59537063|NCT01213043|75634847|FG001|COMPLETED|Treatment Period 1||15||
59537064|NCT01213043|75634846|FG000|NOT COMPLETED|Treatment Period 1||0||
59537065|NCT01213043|75634847|FG001|NOT COMPLETED|Treatment Period 1||0||
59537066|NCT01213043|75634846|FG000|STARTED|Washout Period||15||
59537067|NCT01213043|75634847|FG001|STARTED|Washout Period||15||
59537068|NCT01213043|75634846|FG000|COMPLETED|Washout Period||15||
59537069|NCT01213043|75634847|FG001|COMPLETED|Washout Period||15||
59537070|NCT01213043|75634846|FG000|NOT COMPLETED|Washout Period||0||
59537071|NCT01213043|75634847|FG001|NOT COMPLETED|Washout Period||0||
59537072|NCT01213043|75634846|FG000|STARTED|Treatment Period 2||15||
59537073|NCT01213043|75634847|FG001|STARTED|Treatment Period 2||15||
59537074|NCT01213043|75634846|FG000|COMPLETED|Treatment Period 2||15||
59537075|NCT01213043|75634847|FG001|COMPLETED|Treatment Period 2||15||
59537076|NCT01213043|75634846|FG000|NOT COMPLETED|Treatment Period 2||0||
59537077|NCT01213043|75634847|FG001|NOT COMPLETED|Treatment Period 2||0||
59537078|NCT01213043|75634846|FG000|STARTED|Follow-up||15||
59537079|NCT01213043|75634847|FG001|STARTED|Follow-up||15||
59537080|NCT01213043|75634846|FG000|COMPLETED|Follow-up||15||
59537081|NCT01213043|75634847|FG001|COMPLETED|Follow-up||15||
59537082|NCT01213043|75634846|FG000|NOT COMPLETED|Follow-up||0||
59537083|NCT01213043|75634847|FG001|NOT COMPLETED|Follow-up||0||
59537084|NCT00758576|75634853|FG000|STARTED|Overall Study||64||
59537085|NCT00758576|75634853|FG000|COMPLETED|Overall Study||63||
59537086|NCT00758576|75634853|FG000|NOT COMPLETED|Overall Study||1||
59537087|NCT01213199|75634857|FG000|STARTED|Overall Study||20||
59537088|NCT01213199|75634857|FG000|COMPLETED|Overall Study||16||
59537089|NCT01213199|75634857|FG000|NOT COMPLETED|Overall Study||4||
59537090|NCT01213589|75634864|FG000|STARTED|Overall Study||50||
59537091|NCT01213589|75634865|FG001|STARTED|Overall Study||24||
59537092|NCT01213589|75634866|FG002|STARTED|Overall Study||26||
59537093|NCT01213589|75634864|FG000|COMPLETED|Overall Study||37||
59537094|NCT01213589|75634865|FG001|COMPLETED|Overall Study||19||
59537095|NCT01213589|75634866|FG002|COMPLETED|Overall Study||18||
59537096|NCT01213589|75634864|FG000|NOT COMPLETED|Overall Study||13||
59537097|NCT01213589|75634865|FG001|NOT COMPLETED|Overall Study||5||
59537098|NCT01213589|75634866|FG002|NOT COMPLETED|Overall Study||8||
59537099|NCT01213823|75634876|FG000|STARTED|Overall Study||69||
59537100|NCT01213823|75634877|FG001|STARTED|Overall Study||467||
59537101|NCT01213823|75634876|FG000|COMPLETED|Overall Study||69||
59537102|NCT01213823|75634877|FG001|COMPLETED|Overall Study||467||
59537103|NCT01213823|75634876|FG000|NOT COMPLETED|Overall Study||0||
59537104|NCT01213823|75634877|FG001|NOT COMPLETED|Overall Study||0||
59537105|NCT00780026|75634885|FG000|STARTED|Overall Study||50||
59537106|NCT00780026|75634886|FG001|STARTED|Overall Study||50||
59537107|NCT00780026|75634885|FG000|COMPLETED|Overall Study||50||
59537108|NCT00780026|75634886|FG001|COMPLETED|Overall Study||50||
59537109|NCT00780026|75634885|FG000|NOT COMPLETED|Overall Study||0||
59537110|NCT00780026|75634886|FG001|NOT COMPLETED|Overall Study||0||
59537111|NCT01214057|75634894|FG000|STARTED|Overall Study||12||
59537112|NCT01214057|75634895|FG001|STARTED|Overall Study||11||
59537113|NCT01214057|75634894|FG000|COMPLETED|Overall Study||12||
59537114|NCT01214057|75634895|FG001|COMPLETED|Overall Study||11||
59537115|NCT01214057|75634894|FG000|NOT COMPLETED|Overall Study||0||
59815536|NCT01248585|75937964|FG001|COMPLETED|Overall Study||150||
59537116|NCT01214057|75634895|FG001|NOT COMPLETED|Overall Study||0||
59537117|NCT00780338|75634903|FG000|STARTED|Baseline to Mid (1 Year)||174||
59537118|NCT00780338|75634904|FG001|STARTED|Baseline to Mid (1 Year)||202||
59537119|NCT00780338|75634903|FG000|COMPLETED|Baseline to Mid (1 Year)||169||
59537120|NCT00780338|75634904|FG001|COMPLETED|Baseline to Mid (1 Year)||164||
59537121|NCT00780338|75634903|FG000|NOT COMPLETED|Baseline to Mid (1 Year)||5||
59537122|NCT00780338|75634904|FG001|NOT COMPLETED|Baseline to Mid (1 Year)||38||
59537123|NCT00780338|75634903|FG000|STARTED|Mid to Post (1 Year; 2 Years in Total)||169||
59537124|NCT00780338|75634904|FG001|STARTED|Mid to Post (1 Year; 2 Years in Total)||164||
59537125|NCT00780338|75634903|FG000|COMPLETED|Mid to Post (1 Year; 2 Years in Total)||156||
59537126|NCT00780338|75634904|FG001|COMPLETED|Mid to Post (1 Year; 2 Years in Total)||159||
59537127|NCT00780338|75634903|FG000|NOT COMPLETED|Mid to Post (1 Year; 2 Years in Total)||13||
59537128|NCT00780338|75634904|FG001|NOT COMPLETED|Mid to Post (1 Year; 2 Years in Total)||5||
59537129|NCT01247363|75634914|FG000|STARTED|Overall Study||20||
59537130|NCT01247363|75634914|FG000|COMPLETED|Overall Study||20||
59537131|NCT01247363|75634914|FG000|NOT COMPLETED|Overall Study||0||
59537132|NCT00780494|75634929|FG000|STARTED|Overall Study||35||
60076086|NCT01904773|76191372|FG008|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0||
60076087|NCT01904773|76191364|FG000|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||23||
60076088|NCT01904773|76191365|FG001|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0||
60076089|NCT01904773|76191366|FG002|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0||
60076090|NCT01904773|76191367|FG003|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0||
60076091|NCT01904773|76191368|FG004|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0||
60076092|NCT01904773|76191369|FG005|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0||
60076093|NCT01904773|76191370|FG006|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0||
60076094|NCT01904773|76191371|FG007|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0||
60076095|NCT01904773|76191372|FG008|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0||
59623149|NCT00558246|75735170|FG000|NOT COMPLETED|Overall Study||0||
59623150|NCT00558792|75735180|FG000|STARTED|Overall Study||68||
59623151|NCT00558792|75735181|FG001|STARTED|Overall Study||63||
59623152|NCT00558792|75735182|FG002|STARTED|Overall Study||60||
59623153|NCT00558792|75735180|FG000|COMPLETED|Overall Study||68||
59623154|NCT00558792|75735181|FG001|COMPLETED|Overall Study||63||
59623155|NCT00558792|75735182|FG002|COMPLETED|Overall Study||60||
59623156|NCT00558792|75735180|FG000|NOT COMPLETED|Overall Study||0||
59623157|NCT00558792|75735181|FG001|NOT COMPLETED|Overall Study||0||
59623158|NCT00558792|75735182|FG002|NOT COMPLETED|Overall Study||0||
59623159|NCT00561600|75735195|FG000|STARTED|Overall Study||130||
59623160|NCT00561600|75735196|FG001|STARTED|Overall Study||135||
59623161|NCT00561600|75735195|FG000|COMPLETED|Overall Study||112||
59623162|NCT00561600|75735196|FG001|COMPLETED|Overall Study||119||
59623163|NCT00561600|75735195|FG000|NOT COMPLETED|Overall Study||18||
59623164|NCT00561600|75735196|FG001|NOT COMPLETED|Overall Study||16||
59623165|NCT00561834|75735204|FG000|STARTED|Overall Study||2||
59623166|NCT00561834|75735204|FG000|COMPLETED|Overall Study||2||
60076096|NCT01904773|76191364|FG000|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||1||
59537133|NCT00780494|75634929|FG000|COMPLETED|Overall Study||35||
59537134|NCT00780494|75634929|FG000|NOT COMPLETED|Overall Study||0||
59537135|NCT00763412|75634935|FG000|STARTED|Overall Study||8||
59537136|NCT00763412|75634936|FG001|STARTED|Overall Study||8||
59537137|NCT00763412|75634935|FG000|COMPLETED|Overall Study||4||
59537138|NCT00763412|75634936|FG001|COMPLETED|Overall Study||4||
59537139|NCT00763412|75634935|FG000|NOT COMPLETED|Overall Study||4||
59537140|NCT00763412|75634936|FG001|NOT COMPLETED|Overall Study||4||
59537141|NCT01302743|75634945|FG000|STARTED|Overall Study||7||
59623167|NCT00561834|75735204|FG000|NOT COMPLETED|Overall Study||0||
59623168|NCT02128074|75735208|FG000|STARTED|Overall Study||32||
59623169|NCT02128074|75735208|FG000|COMPLETED|Overall Study||26||
59623170|NCT02128074|75735208|FG000|NOT COMPLETED|Overall Study||6||
59623171|NCT02128230|75735212|FG000|STARTED|Overall Study||20||
59623172|NCT02128230|75735212|FG000|COMPLETED|Overall Study||1||
59623173|NCT02128230|75735212|FG000|NOT COMPLETED|Overall Study||19||
59623174|NCT02130258|75735218|FG000|STARTED|Overall Study||9||
59623175|NCT02130258|75735219|FG001|STARTED|Overall Study||11||
59623176|NCT02130258|75735218|FG000|COMPLETED|Overall Study||9||
59623177|NCT02130258|75735219|FG001|COMPLETED|Overall Study||11||
59623178|NCT02130258|75735218|FG000|NOT COMPLETED|Overall Study||0||
59623179|NCT02130258|75735219|FG001|NOT COMPLETED|Overall Study||0||
59623180|NCT00564954|75735227|FG000|STARTED|Period 1- 1 Week||44||
59623181|NCT00564954|75735228|FG001|STARTED|Period 1- 1 Week||42||
59623182|NCT00564954|75735227|FG000|COMPLETED|Period 1- 1 Week||44||
59623183|NCT00564954|75735228|FG001|COMPLETED|Period 1- 1 Week||42||
59623184|NCT00564954|75735227|FG000|NOT COMPLETED|Period 1- 1 Week||0||
59623185|NCT00564954|75735228|FG001|NOT COMPLETED|Period 1- 1 Week||0||
59623186|NCT00564954|75735227|FG000|STARTED|Period 2- 1 Week||44||
59623187|NCT00564954|75735228|FG001|STARTED|Period 2- 1 Week||42||
59623188|NCT00564954|75735227|FG000|COMPLETED|Period 2- 1 Week||44||
59623189|NCT00564954|75735228|FG001|COMPLETED|Period 2- 1 Week||42||
59623190|NCT00564954|75735227|FG000|NOT COMPLETED|Period 2- 1 Week||0||
59623191|NCT00564954|75735228|FG001|NOT COMPLETED|Period 2- 1 Week||0||
59623192|NCT00565110|75735236|FG000|STARTED|Overall Study||230||
59623193|NCT00565110|75735237|FG001|STARTED|Overall Study||242||
59623194|NCT00565110|75735236|FG000|12-Month|Overall Study||114||
59623195|NCT00565110|75735237|FG001|12-Month|Overall Study||144||
59623196|NCT00565110|75735236|FG000|COMPLETED|Overall Study||99||
59623197|NCT00565110|75735237|FG001|COMPLETED|Overall Study||111||
59623198|NCT00565110|75735236|FG000|NOT COMPLETED|Overall Study||131||
59623199|NCT00565110|75735237|FG001|NOT COMPLETED|Overall Study||131||
59623200|NCT00565266|75735243|FG000|STARTED|Overall Study||210||
59623201|NCT00565266|75735243|FG000|COMPLETED|Overall Study||174||
59623202|NCT00565266|75735243|FG000|NOT COMPLETED|Overall Study||36||
59623203|NCT02124018|75735254|FG000|STARTED|Overall Study||371||
59623204|NCT02124018|75735255|FG001|STARTED|Overall Study||111||
59623205|NCT02124018|75735256|FG002|STARTED|Overall Study||41||
59623206|NCT02124018|75735254|FG000|COMPLETED|Overall Study||371||
59623207|NCT02124018|75735255|FG001|COMPLETED|Overall Study||111||
59623208|NCT02124018|75735256|FG002|COMPLETED|Overall Study|Numbers do not add up to 575 (enrolled) due to refusals of programmed ventricular stimulation|41||
59623209|NCT02124018|75735254|FG000|NOT COMPLETED|Overall Study||0||
59623210|NCT02124018|75735255|FG001|NOT COMPLETED|Overall Study||0||
59623211|NCT02124018|75735256|FG002|NOT COMPLETED|Overall Study||0||
59623212|NCT00567840|75735272|FG000|STARTED|Overall Study||15||
59623213|NCT00567840|75735273|FG001|STARTED|Overall Study||15||
59623214|NCT00567840|75735274|FG002|STARTED|Overall Study||16||
59623215|NCT00567840|75735275|FG003|STARTED|Overall Study||15||
59988051|NCT00834587|76103225|FG000|STARTED|Washout: 7 Days||20||
59988052|NCT00834587|76103226|FG001|STARTED|Washout: 7 Days||20||
59988053|NCT00834587|76103225|FG000|COMPLETED|Washout: 7 Days||19||
59988054|NCT00834587|76103226|FG001|COMPLETED|Washout: 7 Days||20||
59988055|NCT00834587|76103225|FG000|NOT COMPLETED|Washout: 7 Days||1||
59988056|NCT00834587|76103226|FG001|NOT COMPLETED|Washout: 7 Days||0||
59988057|NCT00834587|76103225|FG000|STARTED|Second Intervention||19||
59988058|NCT00834587|76103226|FG001|STARTED|Second Intervention||20||
59988059|NCT00834587|76103225|FG000|COMPLETED|Second Intervention||19||
59988060|NCT00834587|76103226|FG001|COMPLETED|Second Intervention||20||
59988061|NCT00834587|76103225|FG000|NOT COMPLETED|Second Intervention||0||
59988062|NCT00834587|76103226|FG001|NOT COMPLETED|Second Intervention||0||
59988063|NCT00834431|76103232|FG000|STARTED|First Intervention||18||
59623216|NCT00567840|75735276|FG004|STARTED|Overall Study||8||
59623217|NCT00567840|75735272|FG000|COMPLETED|Overall Study||13||
59623218|NCT00567840|75735273|FG001|COMPLETED|Overall Study||15||
59623219|NCT00567840|75735274|FG002|COMPLETED|Overall Study||15||
59623220|NCT00567840|75735275|FG003|COMPLETED|Overall Study||14||
59988064|NCT00834431|76103233|FG001|STARTED|First Intervention||18||
59988065|NCT00834431|76103232|FG000|COMPLETED|First Intervention||18||
59988066|NCT00834431|76103233|FG001|COMPLETED|First Intervention||17||
59988067|NCT00834431|76103232|FG000|NOT COMPLETED|First Intervention||0||
59988068|NCT00834431|76103233|FG001|NOT COMPLETED|First Intervention||1||
59988069|NCT00834431|76103232|FG000|STARTED|Washout of 7 Days||18||
59988070|NCT00834431|76103233|FG001|STARTED|Washout of 7 Days||17||
60076097|NCT01904773|76191365|FG001|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0||
60076098|NCT01904773|76191366|FG002|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0||
60076099|NCT01904773|76191367|FG003|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0||
60076100|NCT01904773|76191368|FG004|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0||
60076101|NCT01904773|76191369|FG005|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0||
60076102|NCT01904773|76191370|FG006|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0||
60076103|NCT01904773|76191371|FG007|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0||
60076104|NCT01904773|76191372|FG008|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0||
60076105|NCT01904773|76191364|FG000|STARTED|First Intervention||0||
60076106|NCT01904773|76191365|FG001|STARTED|First Intervention||2||
60076107|NCT01904773|76191366|FG002|STARTED|First Intervention||1||
60076108|NCT01904773|76191367|FG003|STARTED|First Intervention||2||
60076109|NCT01904773|76191368|FG004|STARTED|First Intervention||3||
60076110|NCT01904773|76191369|FG005|STARTED|First Intervention||4||
60076111|NCT01904773|76191370|FG006|STARTED|First Intervention||4||
60076112|NCT01904773|76191371|FG007|STARTED|First Intervention||3||
60076113|NCT01904773|76191372|FG008|STARTED|First Intervention||4||
60076114|NCT01904773|76191364|FG000|COMPLETED|First Intervention||0||
60076115|NCT01904773|76191365|FG001|COMPLETED|First Intervention||2||
60076116|NCT01904773|76191366|FG002|COMPLETED|First Intervention||1||
60076117|NCT01904773|76191367|FG003|COMPLETED|First Intervention||2||
60076118|NCT01904773|76191368|FG004|COMPLETED|First Intervention||3||
60076119|NCT01904773|76191369|FG005|COMPLETED|First Intervention||4||
60076120|NCT01904773|76191370|FG006|COMPLETED|First Intervention||3||
60076121|NCT01904773|76191371|FG007|COMPLETED|First Intervention||3||
60076122|NCT01904773|76191372|FG008|COMPLETED|First Intervention||4||
60076123|NCT01904773|76191364|FG000|NOT COMPLETED|First Intervention||0||
60076124|NCT01904773|76191365|FG001|NOT COMPLETED|First Intervention||0||
60076125|NCT01904773|76191366|FG002|NOT COMPLETED|First Intervention||0||
60076126|NCT01904773|76191367|FG003|NOT COMPLETED|First Intervention||0||
60076127|NCT01904773|76191368|FG004|NOT COMPLETED|First Intervention||0||
60076128|NCT01904773|76191369|FG005|NOT COMPLETED|First Intervention||0||
60076129|NCT01904773|76191370|FG006|NOT COMPLETED|First Intervention||1||
60076130|NCT01904773|76191371|FG007|NOT COMPLETED|First Intervention||0||
60076131|NCT01904773|76191372|FG008|NOT COMPLETED|First Intervention||0||
60076132|NCT01904773|76191364|FG000|STARTED|Placebo Washout First Intervention||0||
60076133|NCT01904773|76191365|FG001|STARTED|Placebo Washout First Intervention||2||
60076134|NCT01904773|76191366|FG002|STARTED|Placebo Washout First Intervention||1||
60076135|NCT01904773|76191367|FG003|STARTED|Placebo Washout First Intervention||2||
59623221|NCT00567840|75735276|FG004|COMPLETED|Overall Study||8||
59623222|NCT00567840|75735272|FG000|NOT COMPLETED|Overall Study||2||
59623223|NCT00567840|75735273|FG001|NOT COMPLETED|Overall Study||0||
59988071|NCT00834431|76103232|FG000|COMPLETED|Washout of 7 Days||18||
60076136|NCT01904773|76191368|FG004|STARTED|Placebo Washout First Intervention||3||
60076137|NCT01904773|76191369|FG005|STARTED|Placebo Washout First Intervention||4||
60076138|NCT01904773|76191370|FG006|STARTED|Placebo Washout First Intervention||3||
59988072|NCT00834431|76103233|FG001|COMPLETED|Washout of 7 Days||16||
59537142|NCT01302743|75634946|FG001|STARTED|Overall Study||8||
59537143|NCT01302743|75634947|FG002|STARTED|Overall Study||10||
59537144|NCT01302743|75634945|FG000|COMPLETED|Overall Study||6||
59537145|NCT01302743|75634946|FG001|COMPLETED|Overall Study||7||
59537146|NCT01302743|75634947|FG002|COMPLETED|Overall Study||8||
59537147|NCT01302743|75634945|FG000|NOT COMPLETED|Overall Study||1||
59537148|NCT01302743|75634946|FG001|NOT COMPLETED|Overall Study||1||
59537149|NCT01302743|75634947|FG002|NOT COMPLETED|Overall Study||2||
59537150|NCT01248221|75634957|FG000|STARTED|Overall Study||15||
59537151|NCT01248221|75634958|FG001|STARTED|Overall Study||15||
59537152|NCT01248221|75634957|FG000|COMPLETED|Overall Study||15||
59537153|NCT01248221|75634958|FG001|COMPLETED|Overall Study||15||
59537154|NCT01248221|75634957|FG000|NOT COMPLETED|Overall Study||0||
59537155|NCT01248221|75634958|FG001|NOT COMPLETED|Overall Study||0||
59537156|NCT00763490|75634966|FG000|STARTED|Overall Study||20||
59537157|NCT00763490|75634966|FG000|COMPLETED|Overall Study||20||
59537158|NCT00763490|75634966|FG000|NOT COMPLETED|Overall Study||0||
59537159|NCT01214759|75634970|FG000|STARTED|Overall Study||103||
59537160|NCT01214759|75634970|FG000|28 Days nPEP Completion|Overall Study||85||
59537161|NCT01214759|75634970|FG000|COMPLETED|Overall Study||55||
59537162|NCT01214759|75634970|FG000|NOT COMPLETED|Overall Study||48||
59537163|NCT01249625|75634976|FG000|STARTED|Overall Study||1374||
59537164|NCT01249625|75634977|FG001|STARTED|Overall Study||1488||
59537165|NCT01249625|75634976|FG000|COMPLETED|Overall Study||1374||
59537166|NCT01249625|75634977|FG001|COMPLETED|Overall Study||1488||
59537167|NCT01249625|75634976|FG000|NOT COMPLETED|Overall Study||0||
59537168|NCT01249625|75634977|FG001|NOT COMPLETED|Overall Study||0||
59537169|NCT00759668|75634985|FG000|STARTED|Overall Study||17||
59537170|NCT00759668|75634986|FG001|STARTED|Overall Study||18||
59537171|NCT00759668|75634985|FG000|COMPLETED|Overall Study||16||
59537172|NCT00759668|75634986|FG001|COMPLETED|Overall Study||15||
59537173|NCT00759668|75634985|FG000|NOT COMPLETED|Overall Study||1||
59537174|NCT00759668|75634986|FG001|NOT COMPLETED|Overall Study||3||
59537175|NCT00780572|75634994|FG000|STARTED|Overall Study||297||
59537176|NCT00780572|75634995|FG001|STARTED|Overall Study||298||
59537177|NCT00780572|75634994|FG000|COMPLETED|Overall Study||297||
59537178|NCT00780572|75634995|FG001|COMPLETED|Overall Study||298||
59537179|NCT00780572|75634994|FG000|NOT COMPLETED|Overall Study||0||
59537180|NCT00780572|75634995|FG001|NOT COMPLETED|Overall Study||0||
59537181|NCT00780962|75635003|FG000|STARTED|Overall Study||200||
59537182|NCT00780962|75635004|FG001|STARTED|Overall Study||199||
59537183|NCT00780962|75635003|FG000|Second Blood Draw (Outcome Measurement)|Overall Study||185||
59537184|NCT00780962|75635004|FG001|Second Blood Draw (Outcome Measurement)|Overall Study||172||
59537185|NCT00780962|75635003|FG000|COMPLETED|Overall Study||185||
59537186|NCT00780962|75635004|FG001|COMPLETED|Overall Study||172||
59537187|NCT00780962|75635003|FG000|NOT COMPLETED|Overall Study||15||
59537188|NCT00780962|75635004|FG001|NOT COMPLETED|Overall Study||27||
59537189|NCT00764738|75635014|FG000|STARTED|Overall Study||24||
59537190|NCT00764738|75635015|FG001|STARTED|Overall Study||28||
59537191|NCT00764738|75635016|FG002|STARTED|Overall Study||15||
59537192|NCT00764738|75635017|FG003|STARTED|Overall Study||24||
59537193|NCT00764738|75635014|FG000|COMPLETED|Overall Study||22||
59537194|NCT00764738|75635015|FG001|COMPLETED|Overall Study||25||
59537195|NCT00764738|75635016|FG002|COMPLETED|Overall Study||12||
59537196|NCT00764738|75635017|FG003|COMPLETED|Overall Study||18||
59537197|NCT00764738|75635014|FG000|NOT COMPLETED|Overall Study||2||
59537198|NCT00764738|75635015|FG001|NOT COMPLETED|Overall Study||3||
59537199|NCT00764738|75635016|FG002|NOT COMPLETED|Overall Study||3||
59537200|NCT00764738|75635017|FG003|NOT COMPLETED|Overall Study||6||
59537201|NCT00781508|75635029|FG000|STARTED|Overall Study|"First Intervention (1 day), Washout (48 hours), Second Intervention (1 day)"|5||
59537202|NCT00781508|75635030|FG001|STARTED|Overall Study|"First Intervention (1 day), Washout (48 hours), Second Intervention (1 day)"|5||
59537203|NCT00781508|75635029|FG000|COMPLETED|Overall Study||5||
59537204|NCT00781508|75635030|FG001|COMPLETED|Overall Study||5||
59537205|NCT00781508|75635029|FG000|NOT COMPLETED|Overall Study||0||
59537206|NCT00781508|75635030|FG001|NOT COMPLETED|Overall Study||0||
59537207|NCT00781898|75635040|FG000|STARTED|Overall Study||153||
59537208|NCT00781898|75635041|FG001|STARTED|Overall Study||155||
59537209|NCT00781898|75635040|FG000|COMPLETED|Overall Study||119||
59537210|NCT00781898|75635041|FG001|COMPLETED|Overall Study||126||
59537211|NCT00781898|75635040|FG000|NOT COMPLETED|Overall Study||34||
59537212|NCT00781898|75635041|FG001|NOT COMPLETED|Overall Study||29||
59537213|NCT00765128|75635049|FG000|STARTED|Overall Study||8||
59537214|NCT00765128|75635050|FG001|STARTED|Overall Study||9||
59537215|NCT00765128|75635049|FG000|COMPLETED|Overall Study||8||
59537216|NCT00765128|75635050|FG001|COMPLETED|Overall Study||9||
59537217|NCT00765128|75635049|FG000|NOT COMPLETED|Overall Study||0||
59537218|NCT00765128|75635050|FG001|NOT COMPLETED|Overall Study||0||
59537219|NCT00765206|75635056|FG000|STARTED|First Intervention||15||
59537220|NCT00765206|75635057|FG001|STARTED|First Intervention||15||
59537221|NCT00765206|75635058|FG002|STARTED|First Intervention||15||
59537222|NCT00765206|75635059|FG003|STARTED|First Intervention||15||
59537223|NCT00765206|75635056|FG000|COMPLETED|First Intervention||15||
59537224|NCT00765206|75635057|FG001|COMPLETED|First Intervention||15||
59537225|NCT00765206|75635058|FG002|COMPLETED|First Intervention||15||
59537226|NCT00765206|75635059|FG003|COMPLETED|First Intervention||15||
59537227|NCT00765206|75635056|FG000|NOT COMPLETED|First Intervention||0||
59537228|NCT00765206|75635057|FG001|NOT COMPLETED|First Intervention||0||
59537229|NCT00765206|75635058|FG002|NOT COMPLETED|First Intervention||0||
59537230|NCT00765206|75635059|FG003|NOT COMPLETED|First Intervention||0||
59537231|NCT00765206|75635056|FG000|STARTED|Washout Period of 14 Days||15||
59537232|NCT00765206|75635057|FG001|STARTED|Washout Period of 14 Days||15||
59537233|NCT00765206|75635058|FG002|STARTED|Washout Period of 14 Days||15||
59537234|NCT00765206|75635059|FG003|STARTED|Washout Period of 14 Days||15||
59537235|NCT00765206|75635056|FG000|COMPLETED|Washout Period of 14 Days||15||
59537236|NCT00765206|75635057|FG001|COMPLETED|Washout Period of 14 Days||15||
59537237|NCT00765206|75635058|FG002|COMPLETED|Washout Period of 14 Days||15||
59537238|NCT00765206|75635059|FG003|COMPLETED|Washout Period of 14 Days||15||
59537239|NCT00765206|75635056|FG000|NOT COMPLETED|Washout Period of 14 Days||0||
59537240|NCT00765206|75635057|FG001|NOT COMPLETED|Washout Period of 14 Days||0||
59537241|NCT00765206|75635058|FG002|NOT COMPLETED|Washout Period of 14 Days||0||
59537242|NCT00765206|75635059|FG003|NOT COMPLETED|Washout Period of 14 Days||0||
59537243|NCT00765206|75635056|FG000|STARTED|Second Intervention||15||
59537244|NCT00765206|75635057|FG001|STARTED|Second Intervention||15||
59537245|NCT00765206|75635058|FG002|STARTED|Second Intervention||15||
59537246|NCT00765206|75635059|FG003|STARTED|Second Intervention||15||
59537247|NCT00765206|75635056|FG000|COMPLETED|Second Intervention||15||
59537248|NCT00765206|75635057|FG001|COMPLETED|Second Intervention||15||
59537249|NCT00765206|75635058|FG002|COMPLETED|Second Intervention||15||
59537250|NCT00765206|75635059|FG003|COMPLETED|Second Intervention||15||
59537251|NCT00765206|75635056|FG000|NOT COMPLETED|Second Intervention||0||
59537252|NCT00765206|75635057|FG001|NOT COMPLETED|Second Intervention||0||
59537253|NCT00765206|75635058|FG002|NOT COMPLETED|Second Intervention||0||
59537254|NCT00765206|75635059|FG003|NOT COMPLETED|Second Intervention||0||
59537255|NCT01303835|75635067|FG000|STARTED|Overall Study||54||
59537256|NCT01303835|75635068|FG001|STARTED|Overall Study||56||
59537257|NCT01303835|75635067|FG000|COMPLETED|Overall Study||35||
59537258|NCT01303835|75635068|FG001|COMPLETED|Overall Study||31||
59537259|NCT01303835|75635067|FG000|NOT COMPLETED|Overall Study||19||
59537260|NCT01303835|75635068|FG001|NOT COMPLETED|Overall Study||25||
59537261|NCT01250717|75635074|FG000|STARTED|Overall Study||28||
59537262|NCT01250717|75635074|FG000|COMPLETED|Overall Study||28||
59537263|NCT01250717|75635074|FG000|NOT COMPLETED|Overall Study||0||
59537264|NCT02189915|75635078|FG000|STARTED|Overall Study||14||
59537265|NCT02189915|75635078|FG000|COMPLETED|Overall Study||11||
59537266|NCT02189915|75635078|FG000|NOT COMPLETED|Overall Study||3||
59537267|NCT01251575|75635082|FG000|STARTED|Overall Study||77||
59537268|NCT01251575|75635082|FG000|COMPLETED|Overall Study||76||
59537269|NCT01251575|75635082|FG000|NOT COMPLETED|Overall Study||1||
59537270|NCT00782756|75635088|FG000|STARTED|Overall Study||40||
59537271|NCT00782756|75635088|FG000|COMPLETED|Overall Study||40||
59537272|NCT00782756|75635088|FG000|NOT COMPLETED|Overall Study||0||
59537273|NCT01215695|75635094|FG000|STARTED|Overall Study||70||
59537274|NCT01215695|75635095|FG001|STARTED|Overall Study||70||
59537275|NCT01215695|75635094|FG000|COMPLETED|Overall Study||70||
59537276|NCT01215695|75635095|FG001|COMPLETED|Overall Study||70||
59537277|NCT01215695|75635094|FG000|NOT COMPLETED|Overall Study||0||
59537278|NCT01215695|75635095|FG001|NOT COMPLETED|Overall Study||0||
59537279|NCT01305473|75635101|FG000|STARTED|Overall Study||90||
59537280|NCT01305473|75635101|FG000|COMPLETED|Overall Study||90||
59537281|NCT01305473|75635101|FG000|NOT COMPLETED|Overall Study||0||
59537282|NCT00760526|75635107|FG000|STARTED|Overall Study||74||
59537283|NCT00760526|75635108|FG001|STARTED|Overall Study||72||
59537284|NCT00760526|75635107|FG000|COMPLETED|Overall Study||69||
59537285|NCT00760526|75635108|FG001|COMPLETED|Overall Study||68||
59537286|NCT00760526|75635107|FG000|NOT COMPLETED|Overall Study||5||
59537287|NCT00760526|75635108|FG001|NOT COMPLETED|Overall Study||4||
59537288|NCT01306175|75635121|FG000|STARTED|First Intervention||20||
59537289|NCT01306175|75635121|FG000|COMPLETED|First Intervention||20||
59537290|NCT01306175|75635121|FG000|NOT COMPLETED|First Intervention||0||
59537291|NCT01306175|75635121|FG000|STARTED|Washout Period of at Least 14 Days||20||
59537292|NCT01306175|75635121|FG000|COMPLETED|Washout Period of at Least 14 Days||20||
59537293|NCT01306175|75635121|FG000|NOT COMPLETED|Washout Period of at Least 14 Days||0||
59537294|NCT01306175|75635121|FG000|STARTED|Second Intervention||20||
59537295|NCT01306175|75635121|FG000|COMPLETED|Second Intervention||20||
59537296|NCT01306175|75635121|FG000|NOT COMPLETED|Second Intervention||0||
59537297|NCT01215929|75635129|FG000|STARTED|Overall Study||18||
59537298|NCT01215929|75635130|FG001|STARTED|Overall Study||17||
59537299|NCT01215929|75635129|FG000|COMPLETED|Overall Study||12||
59537300|NCT01215929|75635130|FG001|COMPLETED|Overall Study||12||
59537301|NCT01215929|75635129|FG000|NOT COMPLETED|Overall Study||6||
59537302|NCT01215929|75635130|FG001|NOT COMPLETED|Overall Study||5||
59537303|NCT01252277|75635136|FG000|STARTED|Overall Study||36||
59537304|NCT01252277|75635136|FG000|COMPLETED|Overall Study||34||
59537305|NCT01252277|75635136|FG000|NOT COMPLETED|Overall Study||2||
59537306|NCT00767624|75635143|FG000|STARTED|Overall Study||75||
59537307|NCT00767624|75635144|FG001|STARTED|Overall Study||75||
59537308|NCT00767624|75635143|FG000|COMPLETED|Overall Study||51||
59537309|NCT00767624|75635144|FG001|COMPLETED|Overall Study||58||
59537310|NCT00767624|75635143|FG000|NOT COMPLETED|Overall Study||24||
59537311|NCT00767624|75635144|FG001|NOT COMPLETED|Overall Study||17||
59537312|NCT01216241|75635152|FG000|STARTED|Overall Study|18 subjects randomized. All didn't receive study drug/placebo if they didn't have neutropenic fever|18||
59537313|NCT01216241|75635153|FG001|STARTED|Overall Study|18 subjects randomized. All didn't receive study drug/placebo if they didn't have neutropenic fever|18||
59537314|NCT01216241|75635152|FG000|COMPLETED|Overall Study|Reporter remains blinded so the 4 completed could have been either study drug or placebo.|18||
59537315|NCT01216241|75635153|FG001|COMPLETED|Overall Study|Reporter remains blinded so the 4 completed could have been either study drug or placebo.|18||
59537316|NCT01216241|75635152|FG000|NOT COMPLETED|Overall Study||0||
59537317|NCT01216241|75635153|FG001|NOT COMPLETED|Overall Study||0||
59537318|NCT01216397|75635159|FG000|STARTED|Period 1||20||
59537319|NCT01216397|75635160|FG001|STARTED|Period 1||20||
59537320|NCT01216397|75635159|FG000|COMPLETED|Period 1||20||
59537321|NCT01216397|75635160|FG001|COMPLETED|Period 1||20||
59537322|NCT01216397|75635159|FG000|NOT COMPLETED|Period 1||0||
59537323|NCT01216397|75635160|FG001|NOT COMPLETED|Period 1||0||
59537324|NCT01216397|75635159|FG000|STARTED|Washout (35 Days)||20||
59537325|NCT01216397|75635160|FG001|STARTED|Washout (35 Days)||20||
59537326|NCT01216397|75635159|FG000|COMPLETED|Washout (35 Days)||20||
59537327|NCT01216397|75635160|FG001|COMPLETED|Washout (35 Days)||20||
59537328|NCT01216397|75635159|FG000|NOT COMPLETED|Washout (35 Days)||0||
59537329|NCT01216397|75635160|FG001|NOT COMPLETED|Washout (35 Days)||0||
59537330|NCT01216397|75635159|FG000|STARTED|Period 2||20||
59537331|NCT01216397|75635160|FG001|STARTED|Period 2||20||
59537332|NCT01216397|75635159|FG000|COMPLETED|Period 2||20||
59537333|NCT01216397|75635160|FG001|COMPLETED|Period 2||20||
59537334|NCT01216397|75635159|FG000|NOT COMPLETED|Period 2||0||
59537335|NCT01216397|75635160|FG001|NOT COMPLETED|Period 2||0||
59537336|NCT01216943|75635166|FG000|STARTED|Overall Study||126||
59537337|NCT01216943|75635166|FG000|COMPLETED|Overall Study||113||
59537338|NCT01216943|75635166|FG000|NOT COMPLETED|Overall Study||13||
59537339|NCT00783614|75635174|FG000|STARTED|Overall Study||6||
59537340|NCT00783614|75635175|FG001|STARTED|Overall Study||6||
59537341|NCT00783614|75635176|FG002|STARTED|Overall Study||5||
59537342|NCT00783614|75635177|FG003|STARTED|Overall Study||5||
59537343|NCT00783614|75635174|FG000|COMPLETED|Overall Study||6||
59537344|NCT00783614|75635175|FG001|COMPLETED|Overall Study||6||
59537345|NCT00783614|75635176|FG002|COMPLETED|Overall Study||5||
59537346|NCT00783614|75635177|FG003|COMPLETED|Overall Study||5||
59537347|NCT00783614|75635174|FG000|NOT COMPLETED|Overall Study||0||
59537348|NCT00783614|75635175|FG001|NOT COMPLETED|Overall Study||0||
59537349|NCT00783614|75635176|FG002|NOT COMPLETED|Overall Study||0||
59537350|NCT00783614|75635177|FG003|NOT COMPLETED|Overall Study||0||
59537351|NCT01252745|75635190|FG000|STARTED|Overall Study||8||
59537352|NCT01252745|75635191|FG001|STARTED|Overall Study||7||
59537353|NCT01252745|75635192|FG002|STARTED|Overall Study||7||
59537354|NCT01252745|75635190|FG000|COMPLETED|Overall Study||8||
59537355|NCT01252745|75635191|FG001|COMPLETED|Overall Study||7||
59537356|NCT01252745|75635192|FG002|COMPLETED|Overall Study||7||
59537357|NCT01252745|75635190|FG000|NOT COMPLETED|Overall Study||0||
59815537|NCT01248585|75937963|FG000|NOT COMPLETED|Overall Study||0||
59815538|NCT01248585|75937964|FG001|NOT COMPLETED|Overall Study||0||
59815539|NCT00993655|75937973|FG000|STARTED|Overall Study||101||
59537358|NCT01252745|75635191|FG001|NOT COMPLETED|Overall Study||0||
59537359|NCT01252745|75635192|FG002|NOT COMPLETED|Overall Study||0||
59537360|NCT04278872|75635205|FG000|STARTED|Overall Study||7||
59537361|NCT04278872|75635206|FG001|STARTED|Overall Study||6||
59537362|NCT04278872|75635205|FG000|COMPLETED|Overall Study||4||
59537363|NCT04278872|75635206|FG001|COMPLETED|Overall Study||5||
59537364|NCT04278872|75635205|FG000|NOT COMPLETED|Overall Study||3||
59537365|NCT04278872|75635206|FG001|NOT COMPLETED|Overall Study||1||
59537366|NCT02147522|75635214|FG000|STARTED|Overall Study||178||
59537367|NCT02147522|75635215|FG001|STARTED|Overall Study||170||
59537368|NCT02147522|75635214|FG000|COMPLETED|Overall Study||122||
59537369|NCT02147522|75635215|FG001|COMPLETED|Overall Study||122||
59537370|NCT02147522|75635214|FG000|NOT COMPLETED|Overall Study||56||
59537371|NCT02147522|75635215|FG001|NOT COMPLETED|Overall Study||48||
59537372|NCT01217411|75635223|FG000|STARTED|Overall Study||3||
59537373|NCT01217411|75635224|FG001|STARTED|Overall Study||2||
59537374|NCT01217411|75635223|FG000|5mg|Overall Study||3||
59537375|NCT01217411|75635224|FG001|5mg|Overall Study||2||
59537376|NCT01217411|75635223|FG000|10mg|Overall Study||0||
59537377|NCT01217411|75635224|FG001|10mg|Overall Study||0||
59537378|NCT01217411|75635223|FG000|20mg|Overall Study||0||
59537379|NCT01217411|75635224|FG001|20mg|Overall Study||0||
59537380|NCT01217411|75635223|FG000|COMPLETED|Overall Study||0||
59537381|NCT01217411|75635224|FG001|COMPLETED|Overall Study||0||
59537382|NCT01217411|75635223|FG000|NOT COMPLETED|Overall Study||3||
59537383|NCT01217411|75635224|FG001|NOT COMPLETED|Overall Study||2||
59537384|NCT01253525|75635232|FG000|STARTED|Overall Study||6||
59537385|NCT01253525|75635232|FG000|Received Any Quantity of Study Drug|Overall Study||6||
59537386|NCT01253525|75635232|FG000|COMPLETED|Overall Study||6||
59537387|NCT01253525|75635232|FG000|NOT COMPLETED|Overall Study||0||
59537388|NCT01247675|75635240|FG000|STARTED|Overall Study||10||
59537389|NCT01247675|75635241|FG001|STARTED|Overall Study||10||
59537390|NCT01247675|75635242|FG002|STARTED|Overall Study||9||
59537391|NCT01247675|75635243|FG003|STARTED|Overall Study||8||
59537392|NCT01247675|75635240|FG000|COMPLETED|Overall Study||8||
59537393|NCT01247675|75635241|FG001|COMPLETED|Overall Study||8||
59537394|NCT01247675|75635242|FG002|COMPLETED|Overall Study||9||
59537395|NCT01247675|75635243|FG003|COMPLETED|Overall Study||8||
59537396|NCT01247675|75635240|FG000|NOT COMPLETED|Overall Study||2||
59537397|NCT01247675|75635241|FG001|NOT COMPLETED|Overall Study||2||
59537398|NCT01247675|75635242|FG002|NOT COMPLETED|Overall Study||0||
59537399|NCT01247675|75635243|FG003|NOT COMPLETED|Overall Study||0||
59537400|NCT01254851|75635257|FG000|STARTED|Overall Study||69||
59537401|NCT01254851|75635258|FG001|STARTED|Overall Study||77||
59537402|NCT01254851|75635257|FG000|COMPLETED|Overall Study||61||
59537403|NCT01254851|75635258|FG001|COMPLETED|Overall Study||68||
59537404|NCT01254851|75635257|FG000|NOT COMPLETED|Overall Study||8||
59537405|NCT01254851|75635258|FG001|NOT COMPLETED|Overall Study||9||
59537406|NCT00768716|75635266|FG000|STARTED|Overall Study||54||
59537407|NCT00768716|75635267|FG001|STARTED|Overall Study||41||
59537408|NCT00768716|75635266|FG000|COMPLETED|Overall Study||54||
59537409|NCT00768716|75635267|FG001|COMPLETED|Overall Study||41||
59537410|NCT00768716|75635266|FG000|NOT COMPLETED|Overall Study||0||
59537411|NCT00768716|75635267|FG001|NOT COMPLETED|Overall Study||0||
59537412|NCT01218971|75635278|FG000|STARTED|Overall Study||175||
59537413|NCT01218971|75635279|FG001|STARTED|Overall Study||157||
59537414|NCT01218971|75635278|FG000|COMPLETED|Overall Study||71||
59537415|NCT01218971|75635279|FG001|COMPLETED|Overall Study||77||
59537416|NCT01218971|75635278|FG000|NOT COMPLETED|Overall Study||104||
59537417|NCT01218971|75635279|FG001|NOT COMPLETED|Overall Study||80||
59537418|NCT01337687|75635291|FG000|STARTED|Overall Study||10||
59537419|NCT01337687|75635292|FG001|STARTED|Overall Study||9||
59537420|NCT01337687|75635291|FG000|COMPLETED|Overall Study||10||
59537421|NCT01337687|75635292|FG001|COMPLETED|Overall Study||9||
59537422|NCT01337687|75635291|FG000|NOT COMPLETED|Overall Study||0||
59537423|NCT01337687|75635292|FG001|NOT COMPLETED|Overall Study||0||
59537424|NCT00769808|75635298|FG000|STARTED|Overall Study||72||
59537425|NCT00769808|75635298|FG000|COMPLETED|Overall Study||64||
59537426|NCT00769808|75635298|FG000|NOT COMPLETED|Overall Study||8||
59537427|NCT00769886|75635306|FG000|STARTED|Overall Study||36||
59537428|NCT00769886|75635307|FG001|STARTED|Overall Study||36||
59537429|NCT00769886|75635308|FG002|STARTED|Overall Study||35||
59537430|NCT00769886|75635309|FG003|STARTED|Overall Study||37||
59537431|NCT00769886|75635306|FG000|COMPLETED|Overall Study||31||
59537432|NCT00769886|75635307|FG001|COMPLETED|Overall Study||32||
59537433|NCT00769886|75635308|FG002|COMPLETED|Overall Study||34||
59537434|NCT00769886|75635309|FG003|COMPLETED|Overall Study||35||
59537435|NCT00769886|75635306|FG000|NOT COMPLETED|Overall Study||5||
59537436|NCT00769886|75635307|FG001|NOT COMPLETED|Overall Study||4||
59537437|NCT00769886|75635308|FG002|NOT COMPLETED|Overall Study||1||
59537438|NCT00769886|75635309|FG003|NOT COMPLETED|Overall Study||2||
59537439|NCT00794144|75635321|FG000|STARTED|Overall Study||66||
59537440|NCT00794144|75635322|FG001|STARTED|Overall Study||66||
59537441|NCT00794144|75635321|FG000|COMPLETED|Overall Study||63||
59537442|NCT00794144|75635322|FG001|COMPLETED|Overall Study||63||
59537443|NCT00794144|75635321|FG000|NOT COMPLETED|Overall Study||3||
59537444|NCT00794144|75635322|FG001|NOT COMPLETED|Overall Study||3||
59537445|NCT01309451|75635330|FG000|STARTED|Overall Study|unit of measure is number of eyes|19||
59537446|NCT01309451|75635331|FG001|STARTED|Overall Study|unit of measure is number of eyes|21||
59537447|NCT01309451|75635330|FG000|COMPLETED|Overall Study|unit of measure is number of eyes|17||
59537448|NCT01309451|75635331|FG001|COMPLETED|Overall Study|unit of measure is number of eyes|18||
59537449|NCT01309451|75635330|FG000|NOT COMPLETED|Overall Study||2||
59537450|NCT01309451|75635331|FG001|NOT COMPLETED|Overall Study||3||
59537451|NCT00787904|75635341|FG000|STARTED|Overall Study||6||
59537452|NCT00787904|75635342|FG001|STARTED|Overall Study||13||
59537453|NCT00787904|75635341|FG000|COMPLETED|Overall Study||6||
59623224|NCT00567840|75735274|FG002|NOT COMPLETED|Overall Study||1||
59537454|NCT00787904|75635342|FG001|COMPLETED|Overall Study||13||
59537455|NCT00787904|75635341|FG000|NOT COMPLETED|Overall Study||0||
59537456|NCT00787904|75635342|FG001|NOT COMPLETED|Overall Study||0||
59537457|NCT01255865|75635355|FG000|STARTED|Overall Study||1||
59537458|NCT01255865|75635356|FG001|STARTED|Overall Study||10||
59537459|NCT01255865|75635357|FG002|STARTED|Overall Study||10||
59537460|NCT01255865|75635358|FG003|STARTED|Overall Study||30||
59537461|NCT01255865|75635359|FG004|STARTED|Overall Study||20||
59537462|NCT01255865|75635360|FG005|STARTED|Overall Study||20||
59537463|NCT01255865|75635361|FG006|STARTED|Overall Study||20||
59537464|NCT01255865|75635355|FG000|COMPLETED|Overall Study||1||
59537465|NCT01255865|75635356|FG001|COMPLETED|Overall Study||10||
59537466|NCT01255865|75635357|FG002|COMPLETED|Overall Study||10||
59537467|NCT01255865|75635358|FG003|COMPLETED|Overall Study||30||
59537468|NCT01255865|75635359|FG004|COMPLETED|Overall Study||20||
59537469|NCT01255865|75635360|FG005|COMPLETED|Overall Study||20||
59537470|NCT01255865|75635361|FG006|COMPLETED|Overall Study||20||
59537471|NCT01255865|75635355|FG000|NOT COMPLETED|Overall Study||0||
59537472|NCT01255865|75635356|FG001|NOT COMPLETED|Overall Study||0||
59537473|NCT01255865|75635357|FG002|NOT COMPLETED|Overall Study||0||
59537474|NCT01255865|75635358|FG003|NOT COMPLETED|Overall Study||0||
59537475|NCT01255865|75635359|FG004|NOT COMPLETED|Overall Study||0||
59537476|NCT01255865|75635360|FG005|NOT COMPLETED|Overall Study||0||
59537477|NCT01255865|75635361|FG006|NOT COMPLETED|Overall Study||0||
59537478|NCT00771056|75635377|FG000|STARTED|Overall Study||23||
59537479|NCT00771056|75635377|FG000|COMPLETED|Overall Study||18||
59537480|NCT00771056|75635377|FG000|NOT COMPLETED|Overall Study||5||
59537481|NCT00795002|75635383|FG000|STARTED|Overall Study||37||
59537482|NCT00795002|75635384|FG001|STARTED|Overall Study||37||
59537483|NCT00795002|75635383|FG000|COMPLETED|Overall Study||37||
59537484|NCT00795002|75635384|FG001|COMPLETED|Overall Study||37||
59537485|NCT00795002|75635383|FG000|NOT COMPLETED|Overall Study||0||
59537486|NCT00795002|75635384|FG001|NOT COMPLETED|Overall Study||0||
59537487|NCT00772304|75635390|FG000|STARTED|Overall Study||102||
59537488|NCT00772304|75635390|FG000|COMPLETED|Overall Study||102||
59537489|NCT00772304|75635390|FG000|NOT COMPLETED|Overall Study||0||
59537490|NCT01310231|75635396|FG000|STARTED|Overall Study||22||
59537491|NCT01310231|75635397|FG001|STARTED|Overall Study||18||
59537492|NCT01310231|75635396|FG000|Received Intervention|Overall Study||22||
59537493|NCT01310231|75635397|FG001|Received Intervention|Overall Study||17||
59537494|NCT01310231|75635396|FG000|Discontinued Intervention|Overall Study||0||
59537495|NCT01310231|75635397|FG001|Discontinued Intervention|Overall Study||1||
59537496|NCT01310231|75635396|FG000|Analyzed for Survival|Overall Study||22||
59537497|NCT01310231|75635397|FG001|Analyzed for Survival|Overall Study||18||
59537498|NCT01310231|75635396|FG000|Analyzed for Response, Toxicity, QOL|Overall Study||22||
59537499|NCT01310231|75635397|FG001|Analyzed for Response, Toxicity, QOL|Overall Study||17||
59537500|NCT01310231|75635396|FG000|COMPLETED|Overall Study||22||
59537501|NCT01310231|75635397|FG001|COMPLETED|Overall Study||17||
59537502|NCT01310231|75635396|FG000|NOT COMPLETED|Overall Study||0||
59537503|NCT01310231|75635397|FG001|NOT COMPLETED|Overall Study||1||
59537504|NCT00789074|75635405|FG000|STARTED|Overall Study||53||
59537505|NCT00789074|75635406|FG001|STARTED|Overall Study||48||
59537506|NCT00789074|75635405|FG000|COMPLETED|Overall Study||42||
59537507|NCT00789074|75635406|FG001|COMPLETED|Overall Study||35||
59537508|NCT00789074|75635405|FG000|NOT COMPLETED|Overall Study||11||
59537509|NCT00789074|75635406|FG001|NOT COMPLETED|Overall Study||13||
59537510|NCT01338857|75635415|FG000|STARTED|Overall Study||12||
59537511|NCT01338857|75635415|FG000|COMPLETED|Overall Study||1||
59537512|NCT01338857|75635415|FG000|NOT COMPLETED|Overall Study||11||
59537513|NCT01339013|75635419|FG000|STARTED|Overall Study||6||
59537514|NCT01339013|75635419|FG000|COMPLETED|Overall Study||6||
59537515|NCT01339013|75635419|FG000|NOT COMPLETED|Overall Study||0||
59537516|NCT01339091|75635425|FG000|STARTED|Overall Study||288||
59537517|NCT01339091|75635426|FG001|STARTED|Overall Study||285||
59537518|NCT01339091|75635425|FG000|Safety Population|Overall Study||284||
59537519|NCT01339091|75635426|FG001|Safety Population|Overall Study||284||
59537520|NCT01339091|75635425|FG000|COMPLETED|Overall Study||261||
59537521|NCT01339091|75635426|FG001|COMPLETED|Overall Study||257||
59537522|NCT01339091|75635425|FG000|NOT COMPLETED|Overall Study||27||
59537523|NCT01339091|75635426|FG001|NOT COMPLETED|Overall Study||28||
59537524|NCT01257347|75635436|FG000|STARTED|Overall Study|Median patients per provider = 3; range 1-10 (35 patients)|12||
59537525|NCT01257347|75635437|FG001|STARTED|Overall Study|Median patients per provider = 4; range 1-13 (65 patients)|12||
59537526|NCT01257347|75635438|FG002|STARTED|Overall Study||35||
59537527|NCT01257347|75635439|FG003|STARTED|Overall Study||65||
59537528|NCT01257347|75635436|FG000|COMPLETED|Overall Study||12||
59537529|NCT01257347|75635437|FG001|COMPLETED|Overall Study||12||
59537530|NCT01257347|75635438|FG002|COMPLETED|Overall Study||35||
59537531|NCT01257347|75635439|FG003|COMPLETED|Overall Study||65||
59537532|NCT01257347|75635436|FG000|NOT COMPLETED|Overall Study||0||
59537533|NCT01257347|75635437|FG001|NOT COMPLETED|Overall Study||0||
59537534|NCT01257347|75635438|FG002|NOT COMPLETED|Overall Study||0||
59537535|NCT01257347|75635439|FG003|NOT COMPLETED|Overall Study||0||
59537536|NCT01339247|75635452|FG000|STARTED|Period 1||30||
59537537|NCT01339247|75635453|FG001|STARTED|Period 1||30||
59537538|NCT01339247|75635452|FG000|COMPLETED|Period 1||30||
59537539|NCT01339247|75635453|FG001|COMPLETED|Period 1||30||
59537540|NCT01339247|75635452|FG000|NOT COMPLETED|Period 1||0||
59537541|NCT01339247|75635453|FG001|NOT COMPLETED|Period 1||0||
59537542|NCT01339247|75635452|FG000|STARTED|Period 2||30||
59537543|NCT01339247|75635453|FG001|STARTED|Period 2||30||
59537544|NCT01339247|75635452|FG000|COMPLETED|Period 2||30||
59537545|NCT01339247|75635453|FG001|COMPLETED|Period 2||30||
59537546|NCT01339247|75635452|FG000|NOT COMPLETED|Period 2||0||
59537547|NCT01339247|75635453|FG001|NOT COMPLETED|Period 2||0||
59537548|NCT00772772|75635459|FG000|STARTED|Overall Study||12||
59537549|NCT00772772|75635459|FG000|COMPLETED|Overall Study||12||
59537550|NCT00772772|75635459|FG000|NOT COMPLETED|Overall Study||0||
59537551|NCT01339403|75635466|FG000|STARTED|Overall Study||24768||
59537552|NCT01339403|75635467|FG001|STARTED|Overall Study||257600||
59537553|NCT01339403|75635466|FG000|COMPLETED|Overall Study||24768||
59537554|NCT01339403|75635467|FG001|COMPLETED|Overall Study||257600||
59537555|NCT01339403|75635466|FG000|NOT COMPLETED|Overall Study||0||
59537556|NCT01339403|75635467|FG001|NOT COMPLETED|Overall Study||0||
59537557|NCT02197481|75635475|FG000|STARTED|Overall Study|October 2014|43||
59537558|NCT02197481|75635476|FG001|STARTED|Overall Study||43||
59537559|NCT02197481|75635475|FG000|COMPLETED|Overall Study|February 2016|43||
59537560|NCT02197481|75635476|FG001|COMPLETED|Overall Study||43||
59537561|NCT02197481|75635475|FG000|NOT COMPLETED|Overall Study||0||
59537562|NCT02197481|75635476|FG001|NOT COMPLETED|Overall Study||0||
59537563|NCT00773474|75635482|FG000|STARTED|Overall Study||29||
59537564|NCT00773474|75635482|FG000|COMPLETED|Overall Study||29||
59537565|NCT00773474|75635482|FG000|NOT COMPLETED|Overall Study||0||
59537566|NCT01310855|75635488|FG000|STARTED|Overall Study||19|112 patients were to be recruited but 38 recruited due to the early discontinuation of cediranib|
59537567|NCT01310855|75635489|FG001|STARTED|Overall Study||19|112 patients were to be recruited but 38 recruited due to the early discontinuation of cediranib|
59537568|NCT01310855|75635488|FG000|COMPLETED|Overall Study||19||
59537569|NCT01310855|75635489|FG001|COMPLETED|Overall Study||19||
59537570|NCT01310855|75635488|FG000|NOT COMPLETED|Overall Study||0||
59537571|NCT01310855|75635489|FG001|NOT COMPLETED|Overall Study||0||
59537572|NCT00773786|75635495|FG000|STARTED|First Intervention (1 Week)||10||
59537573|NCT00773786|75635496|FG001|STARTED|First Intervention (1 Week)||10||
59537574|NCT00773786|75635495|FG000|COMPLETED|First Intervention (1 Week)||10||
59537575|NCT00773786|75635496|FG001|COMPLETED|First Intervention (1 Week)||10||
59537576|NCT00773786|75635495|FG000|NOT COMPLETED|First Intervention (1 Week)||0||
59537577|NCT00773786|75635496|FG001|NOT COMPLETED|First Intervention (1 Week)||0||
59537578|NCT00773786|75635495|FG000|STARTED|Washout (1 Week)||10||
59537579|NCT00773786|75635496|FG001|STARTED|Washout (1 Week)||10||
59537580|NCT00773786|75635495|FG000|COMPLETED|Washout (1 Week)||10||
59537581|NCT00773786|75635496|FG001|COMPLETED|Washout (1 Week)||10||
59537582|NCT00773786|75635495|FG000|NOT COMPLETED|Washout (1 Week)||0||
59537583|NCT00773786|75635496|FG001|NOT COMPLETED|Washout (1 Week)||0||
59537584|NCT00773786|75635495|FG000|STARTED|Second Intervention (1 Week)||10||
59537585|NCT00773786|75635496|FG001|STARTED|Second Intervention (1 Week)||10||
59537586|NCT00773786|75635495|FG000|COMPLETED|Second Intervention (1 Week)||10||
59537587|NCT00773786|75635496|FG001|COMPLETED|Second Intervention (1 Week)||10||
59537588|NCT00773786|75635495|FG000|NOT COMPLETED|Second Intervention (1 Week)||0||
59537589|NCT00773786|75635496|FG001|NOT COMPLETED|Second Intervention (1 Week)||0||
59537590|NCT01312181|75635506|FG000|STARTED|Overall Study||80||
59537591|NCT01312181|75635507|FG001|STARTED|Overall Study||77||
59537592|NCT01312181|75635508|FG002|STARTED|Overall Study||83||
59537593|NCT01312181|75635506|FG000|COMPLETED|Overall Study||78||
59537594|NCT01312181|75635507|FG001|COMPLETED|Overall Study||71||
59537595|NCT01312181|75635508|FG002|COMPLETED|Overall Study||75||
59537596|NCT01312181|75635506|FG000|NOT COMPLETED|Overall Study||2||
59537597|NCT01312181|75635507|FG001|NOT COMPLETED|Overall Study||6||
59537598|NCT01312181|75635508|FG002|NOT COMPLETED|Overall Study||8||
59537599|NCT01258049|75635518|FG000|STARTED|Overall Study||77||
59537600|NCT01258049|75635519|FG001|STARTED|Overall Study||74||
59537601|NCT01258049|75635518|FG000|COMPLETED|Overall Study||75||
59537602|NCT01258049|75635519|FG001|COMPLETED|Overall Study||72||
59537603|NCT01258049|75635518|FG000|NOT COMPLETED|Overall Study||2||
59537604|NCT01258049|75635519|FG001|NOT COMPLETED|Overall Study||2||
59537605|NCT00775346|75635525|FG000|STARTED|Overall Study||92||
59537606|NCT00775346|75635525|FG000|COMPLETED|Overall Study||92||
59537607|NCT00775346|75635525|FG000|NOT COMPLETED|Overall Study||0||
59537608|NCT02199041|75635529|FG000|STARTED|Overall Study||12||
59537609|NCT02199041|75635529|FG000|COMPLETED|Overall Study||12||
59537610|NCT02199041|75635529|FG000|NOT COMPLETED|Overall Study||0||
59537611|NCT00789776|75635536|FG000|STARTED|Overall Study||5||
59537612|NCT00789776|75635537|FG001|STARTED|Overall Study||36||
59537613|NCT00789776|75635536|FG000|COMPLETED|Overall Study||5||
59537614|NCT00789776|75635537|FG001|COMPLETED|Overall Study||35||
59537615|NCT00789776|75635536|FG000|NOT COMPLETED|Overall Study||0||
59537616|NCT00789776|75635537|FG001|NOT COMPLETED|Overall Study||1||
59537617|NCT00775658|75635543|FG000|STARTED|First Intervention||10||
59537618|NCT00775658|75635544|FG001|STARTED|First Intervention||11||
59537619|NCT00775658|75635543|FG000|COMPLETED|First Intervention||10||
59537620|NCT00775658|75635544|FG001|COMPLETED|First Intervention||11||
59537621|NCT00775658|75635543|FG000|NOT COMPLETED|First Intervention||0||
59537622|NCT00775658|75635544|FG001|NOT COMPLETED|First Intervention||0||
59537623|NCT00775658|75635543|FG000|STARTED|Second Intervention||10||
59537624|NCT00775658|75635544|FG001|STARTED|Second Intervention||11||
59537625|NCT00775658|75635543|FG000|COMPLETED|Second Intervention||10||
59537626|NCT00775658|75635544|FG001|COMPLETED|Second Intervention||11||
59537627|NCT00775658|75635543|FG000|NOT COMPLETED|Second Intervention||0||
59537628|NCT00775658|75635544|FG001|NOT COMPLETED|Second Intervention||0||
59537629|NCT02199197|75635552|FG000|STARTED|Overall Study||35||
59537630|NCT02199197|75635553|FG001|STARTED|Overall Study||14||
59537631|NCT02199197|75635552|FG000|COMPLETED|Overall Study||35||
59537632|NCT02199197|75635553|FG001|COMPLETED|Overall Study||12||
59537633|NCT02199197|75635552|FG000|NOT COMPLETED|Overall Study||0||
59537634|NCT02199197|75635553|FG001|NOT COMPLETED|Overall Study||2||
59537635|NCT01258985|75635562|FG000|STARTED|Overall Study||106||
59537636|NCT01258985|75635563|FG001|STARTED|Overall Study||98||
59537637|NCT01258985|75635562|FG000|COMPLETED|Overall Study||106||
59537638|NCT01258985|75635563|FG001|COMPLETED|Overall Study||98||
59537639|NCT01258985|75635562|FG000|NOT COMPLETED|Overall Study||0||
59537640|NCT01258985|75635563|FG001|NOT COMPLETED|Overall Study||0||
59537641|NCT00799604|75635572|FG000|STARTED|Bolus 1 (Pre-anesthesia)||10||
59537642|NCT00799604|75635573|FG001|STARTED|Bolus 1 (Pre-anesthesia)||10||
59537643|NCT00799604|75635574|FG002|STARTED|Bolus 1 (Pre-anesthesia)||10||
59537644|NCT00799604|75635572|FG000|COMPLETED|Bolus 1 (Pre-anesthesia)||10||
59537645|NCT00799604|75635573|FG001|COMPLETED|Bolus 1 (Pre-anesthesia)||10||
59537646|NCT00799604|75635574|FG002|COMPLETED|Bolus 1 (Pre-anesthesia)||10||
59537647|NCT00799604|75635572|FG000|NOT COMPLETED|Bolus 1 (Pre-anesthesia)||0||
59537648|NCT00799604|75635573|FG001|NOT COMPLETED|Bolus 1 (Pre-anesthesia)||0||
59537649|NCT00799604|75635574|FG002|NOT COMPLETED|Bolus 1 (Pre-anesthesia)||0||
59537650|NCT00799604|75635572|FG000|STARTED|Bolus 2 (With Anesthesia)|Dose determined per discretion of investigator at 250, 500 or 125μg, based on response to Bolus 1.|6||
59537651|NCT00799604|75635573|FG001|STARTED|Bolus 2 (With Anesthesia)|Dose determined per discretion of investigator at 250, 500 or 125μg, based on response to Bolus 1.|12||
59537652|NCT00799604|75635574|FG002|STARTED|Bolus 2 (With Anesthesia)|Dose determined per discretion of investigator at 250, 500 or 125μg, based on response to Bolus 1.|3||
59537653|NCT00799604|75635572|FG000|COMPLETED|Bolus 2 (With Anesthesia)||6||
59537654|NCT00799604|75635573|FG001|COMPLETED|Bolus 2 (With Anesthesia)||12||
59537655|NCT00799604|75635574|FG002|COMPLETED|Bolus 2 (With Anesthesia)||3||
59537656|NCT00799604|75635572|FG000|NOT COMPLETED|Bolus 2 (With Anesthesia)||0||
59537657|NCT00799604|75635573|FG001|NOT COMPLETED|Bolus 2 (With Anesthesia)||0||
59537658|NCT00799604|75635574|FG002|NOT COMPLETED|Bolus 2 (With Anesthesia)||0||
59537659|NCT00791102|75635582|FG000|STARTED|Period 1||10||
59537660|NCT00791102|75635583|FG001|STARTED|Period 1||10||
59537661|NCT00791102|75635582|FG000|COMPLETED|Period 1||10||
59537662|NCT00791102|75635583|FG001|COMPLETED|Period 1||10||
59537663|NCT00791102|75635582|FG000|NOT COMPLETED|Period 1||0||
59537664|NCT00791102|75635583|FG001|NOT COMPLETED|Period 1||0||
59537665|NCT00791102|75635582|FG000|STARTED|Washout Period of 2 Weeks||10||
59537666|NCT00791102|75635583|FG001|STARTED|Washout Period of 2 Weeks||10||
59537667|NCT00791102|75635582|FG000|COMPLETED|Washout Period of 2 Weeks||10||
59537668|NCT00791102|75635583|FG001|COMPLETED|Washout Period of 2 Weeks||10||
59537669|NCT00791102|75635582|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0||
59537670|NCT00791102|75635583|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0||
59537671|NCT00791102|75635582|FG000|STARTED|Period 2||10||
59537672|NCT00791102|75635583|FG001|STARTED|Period 2||10||
59537673|NCT00791102|75635582|FG000|COMPLETED|Period 2||10||
59537674|NCT00791102|75635583|FG001|COMPLETED|Period 2||10||
59537675|NCT00791102|75635582|FG000|NOT COMPLETED|Period 2||0||
59537676|NCT00791102|75635583|FG001|NOT COMPLETED|Period 2||0||
59537677|NCT01259063|75635589|FG000|STARTED|Overall Study||33||
59537678|NCT01259063|75635589|FG000|COMPLETED|Overall Study||33||
59537679|NCT01259063|75635589|FG000|NOT COMPLETED|Overall Study||0||
59537680|NCT01312805|75635595|FG000|STARTED|Overall Study||1016||
59537681|NCT01312805|75635596|FG001|STARTED|Overall Study||1082||
59537682|NCT01312805|75635595|FG000|COMPLETED|Overall Study||1016||
59537683|NCT01312805|75635596|FG001|COMPLETED|Overall Study||1082||
59537684|NCT01312805|75635595|FG000|NOT COMPLETED|Overall Study||0||
59537685|NCT01312805|75635596|FG001|NOT COMPLETED|Overall Study||0||
59537686|NCT01313507|75635602|FG000|STARTED|Overall Study||21||
59537687|NCT01313507|75635602|FG000|COMPLETED|Overall Study||21||
59537688|NCT01313507|75635602|FG000|NOT COMPLETED|Overall Study||0||
59537689|NCT01313897|75635606|FG000|STARTED|Overall Study||10||
59537690|NCT01313897|75635606|FG000|COMPLETED|Overall Study||8||
59537691|NCT01313897|75635606|FG000|NOT COMPLETED|Overall Study||2||
59537692|NCT01341977|75635612|FG000|STARTED|Overall Study||288||
59537693|NCT01341977|75635613|FG001|STARTED|Overall Study||285||
59537694|NCT01341977|75635612|FG000|COMPLETED|Overall Study||274||
59537695|NCT01341977|75635613|FG001|COMPLETED|Overall Study||270||
59537696|NCT01341977|75635612|FG000|NOT COMPLETED|Overall Study||14||
59537697|NCT01341977|75635613|FG001|NOT COMPLETED|Overall Study||15||
59537698|NCT02192879|75635622|FG000|STARTED|Overall Study||3||
59537699|NCT02192879|75635623|FG001|STARTED|Overall Study||4||
59537700|NCT02192879|75635624|FG002|STARTED|Overall Study||3||
59537701|NCT02192879|75635622|FG000|COMPLETED|Overall Study||3||
59623225|NCT00567840|75735275|FG003|NOT COMPLETED|Overall Study||1||
59623226|NCT00567840|75735276|FG004|NOT COMPLETED|Overall Study||0||
59537702|NCT02192879|75635623|FG001|COMPLETED|Overall Study||4||
59537703|NCT02192879|75635624|FG002|COMPLETED|Overall Study||3||
59537704|NCT02192879|75635622|FG000|NOT COMPLETED|Overall Study||0||
59537705|NCT02192879|75635623|FG001|NOT COMPLETED|Overall Study||0||
59537706|NCT02192879|75635624|FG002|NOT COMPLETED|Overall Study||0||
59537707|NCT00801398|75635638|FG000|STARTED|Overall Study||13||
59537708|NCT00801398|75635639|FG001|STARTED|Overall Study||9||
59537709|NCT00801398|75635640|FG002|STARTED|Overall Study||11||
59537710|NCT00801398|75635641|FG003|STARTED|Overall Study||9||
59537711|NCT00801398|75635642|FG004|STARTED|Overall Study||8||
59537712|NCT00801398|75635643|FG005|STARTED|Overall Study||8||
59537713|NCT00801398|75635638|FG000|COMPLETED|Overall Study||7||
59537714|NCT00801398|75635639|FG001|COMPLETED|Overall Study||0||
59537715|NCT00801398|75635640|FG002|COMPLETED|Overall Study||4||
59537716|NCT00801398|75635641|FG003|COMPLETED|Overall Study||3||
59537717|NCT00801398|75635642|FG004|COMPLETED|Overall Study||1||
59537718|NCT00801398|75635643|FG005|COMPLETED|Overall Study||5||
59537719|NCT00801398|75635638|FG000|NOT COMPLETED|Overall Study||6||
59537720|NCT00801398|75635639|FG001|NOT COMPLETED|Overall Study||9||
59537721|NCT00801398|75635640|FG002|NOT COMPLETED|Overall Study||7||
59537722|NCT00801398|75635641|FG003|NOT COMPLETED|Overall Study||6||
59537723|NCT00801398|75635642|FG004|NOT COMPLETED|Overall Study||7||
59537724|NCT00801398|75635643|FG005|NOT COMPLETED|Overall Study||3||
59537725|NCT01342523|75635703|FG000|STARTED|Overall Study||35||
59537726|NCT01342523|75635704|FG001|STARTED|Overall Study||32||
59537727|NCT01342523|75635705|FG002|STARTED|Overall Study||36||
59537728|NCT01342523|75635706|FG003|STARTED|Overall Study||33||
59537729|NCT01342523|75635707|FG004|STARTED|Overall Study||36||
59537730|NCT01342523|75635708|FG005|STARTED|Overall Study||36||
59537731|NCT01342523|75635709|FG006|STARTED|Overall Study||22||
59537732|NCT01342523|75635710|FG007|STARTED|Overall Study||27||
59537733|NCT01342523|75635711|FG008|STARTED|Overall Study||28||
59537734|NCT01342523|75635712|FG009|STARTED|Overall Study||28||
59537735|NCT01342523|75635713|FG010|STARTED|Overall Study||38||
59537736|NCT01342523|75635714|FG011|STARTED|Overall Study||38||
59537737|NCT01342523|75635715|FG012|STARTED|Overall Study||39||
59537738|NCT01342523|75635716|FG013|STARTED|Overall Study||38||
59537739|NCT01342523|75635717|FG014|STARTED|Overall Study||38||
59537740|NCT01342523|75635718|FG015|STARTED|Overall Study||32||
59537741|NCT01342523|75635719|FG016|STARTED|Overall Study||29||
59537742|NCT01342523|75635720|FG017|STARTED|Overall Study||27||
59537743|NCT01342523|75635721|FG018|STARTED|Overall Study||21||
59537744|NCT01342523|75635722|FG019|STARTED|Overall Study||27||
59537745|NCT01342523|75635723|FG020|STARTED|Overall Study||29||
59537746|NCT01342523|75635724|FG021|STARTED|Overall Study||30||
59537747|NCT01342523|75635725|FG022|STARTED|Overall Study||36||
59537748|NCT01342523|75635726|FG023|STARTED|Overall Study||36||
59537749|NCT01342523|75635727|FG024|STARTED|Overall Study||37||
59537750|NCT01342523|75635728|FG025|STARTED|Overall Study||38||
59537751|NCT01342523|75635729|FG026|STARTED|Overall Study||34||
59537752|NCT01342523|75635730|FG027|STARTED|Overall Study||31||
59537753|NCT01342523|75635731|FG028|STARTED|Overall Study||35||
59537754|NCT01342523|75635732|FG029|STARTED|Overall Study||29||
59537755|NCT01342523|75635733|FG030|STARTED|Overall Study||31||
59537756|NCT01342523|75635734|FG031|STARTED|Overall Study||28||
59537757|NCT01342523|75635703|FG000|COMPLETED|Overall Study||34||
59537758|NCT01342523|75635704|FG001|COMPLETED|Overall Study||32||
59537759|NCT01342523|75635705|FG002|COMPLETED|Overall Study||36||
59537760|NCT01342523|75635706|FG003|COMPLETED|Overall Study||32||
59537761|NCT01342523|75635707|FG004|COMPLETED|Overall Study||36||
59537762|NCT01342523|75635708|FG005|COMPLETED|Overall Study||36||
59537763|NCT01342523|75635709|FG006|COMPLETED|Overall Study||22||
59537764|NCT01342523|75635710|FG007|COMPLETED|Overall Study||27||
59537765|NCT01342523|75635711|FG008|COMPLETED|Overall Study||28||
59537766|NCT01342523|75635712|FG009|COMPLETED|Overall Study||28||
59537767|NCT01342523|75635713|FG010|COMPLETED|Overall Study||38||
59537768|NCT01342523|75635714|FG011|COMPLETED|Overall Study||36||
59537769|NCT01342523|75635715|FG012|COMPLETED|Overall Study||39||
59537770|NCT01342523|75635716|FG013|COMPLETED|Overall Study||36||
59537771|NCT01342523|75635717|FG014|COMPLETED|Overall Study||37||
59537772|NCT01342523|75635718|FG015|COMPLETED|Overall Study||32||
59537773|NCT01342523|75635719|FG016|COMPLETED|Overall Study||28||
59537774|NCT01342523|75635720|FG017|COMPLETED|Overall Study||27||
59537775|NCT01342523|75635721|FG018|COMPLETED|Overall Study||21||
59537776|NCT01342523|75635722|FG019|COMPLETED|Overall Study||27||
59537777|NCT01342523|75635723|FG020|COMPLETED|Overall Study||29||
59537778|NCT01342523|75635724|FG021|COMPLETED|Overall Study||30||
59537779|NCT01342523|75635725|FG022|COMPLETED|Overall Study||36||
59815540|NCT00993655|75937974|FG001|STARTED|Overall Study||72||
59537780|NCT01342523|75635726|FG023|COMPLETED|Overall Study||35||
59537781|NCT01342523|75635727|FG024|COMPLETED|Overall Study||36||
59537782|NCT01342523|75635728|FG025|COMPLETED|Overall Study||36||
59537783|NCT01342523|75635729|FG026|COMPLETED|Overall Study||33||
59815541|NCT00993655|75937975|FG002|STARTED|Overall Study||102||
59537784|NCT01342523|75635730|FG027|COMPLETED|Overall Study||30||
59537785|NCT01342523|75635731|FG028|COMPLETED|Overall Study||34||
59537786|NCT01342523|75635732|FG029|COMPLETED|Overall Study||28||
59537787|NCT01342523|75635733|FG030|COMPLETED|Overall Study||30||
59537788|NCT01342523|75635734|FG031|COMPLETED|Overall Study||27||
59537789|NCT01342523|75635703|FG000|NOT COMPLETED|Overall Study||1||
59537790|NCT01342523|75635704|FG001|NOT COMPLETED|Overall Study||0||
59537791|NCT01342523|75635705|FG002|NOT COMPLETED|Overall Study||0||
59537792|NCT01342523|75635706|FG003|NOT COMPLETED|Overall Study||1||
59537793|NCT01342523|75635707|FG004|NOT COMPLETED|Overall Study||0||
59537794|NCT01342523|75635708|FG005|NOT COMPLETED|Overall Study||0||
59537795|NCT01342523|75635709|FG006|NOT COMPLETED|Overall Study||0||
59537796|NCT01342523|75635710|FG007|NOT COMPLETED|Overall Study||0||
59537797|NCT01342523|75635711|FG008|NOT COMPLETED|Overall Study||0||
59537798|NCT01342523|75635712|FG009|NOT COMPLETED|Overall Study||0||
59537799|NCT01342523|75635713|FG010|NOT COMPLETED|Overall Study||0||
59537800|NCT01342523|75635714|FG011|NOT COMPLETED|Overall Study||2||
59537801|NCT01342523|75635715|FG012|NOT COMPLETED|Overall Study||0||
59537802|NCT01342523|75635716|FG013|NOT COMPLETED|Overall Study||2||
59537803|NCT01342523|75635717|FG014|NOT COMPLETED|Overall Study||1||
59537804|NCT01342523|75635718|FG015|NOT COMPLETED|Overall Study||0||
59537805|NCT01342523|75635719|FG016|NOT COMPLETED|Overall Study||1||
59537806|NCT01342523|75635720|FG017|NOT COMPLETED|Overall Study||0||
59537807|NCT01342523|75635721|FG018|NOT COMPLETED|Overall Study||0||
59537808|NCT01342523|75635722|FG019|NOT COMPLETED|Overall Study||0||
59537809|NCT01342523|75635723|FG020|NOT COMPLETED|Overall Study||0||
59537810|NCT01342523|75635724|FG021|NOT COMPLETED|Overall Study||0||
59537811|NCT01342523|75635725|FG022|NOT COMPLETED|Overall Study||0||
59537812|NCT01342523|75635726|FG023|NOT COMPLETED|Overall Study||1||
59537813|NCT01342523|75635727|FG024|NOT COMPLETED|Overall Study||1||
59537814|NCT01342523|75635728|FG025|NOT COMPLETED|Overall Study||2||
59537815|NCT01342523|75635729|FG026|NOT COMPLETED|Overall Study||1||
59537816|NCT01342523|75635730|FG027|NOT COMPLETED|Overall Study||1||
59537817|NCT01342523|75635731|FG028|NOT COMPLETED|Overall Study||1||
59537818|NCT01342523|75635732|FG029|NOT COMPLETED|Overall Study||1||
59537819|NCT01342523|75635733|FG030|NOT COMPLETED|Overall Study||1||
59537820|NCT01342523|75635734|FG031|NOT COMPLETED|Overall Study||1||
59537821|NCT01261559|75635749|FG000|STARTED|Overall Study||36||
59537822|NCT01261559|75635750|FG001|STARTED|Overall Study||36||
59537823|NCT01261559|75635749|FG000|COMPLETED|Overall Study||36||
59537824|NCT01261559|75635750|FG001|COMPLETED|Overall Study||36||
59537825|NCT01261559|75635749|FG000|NOT COMPLETED|Overall Study||0||
59537826|NCT01261559|75635750|FG001|NOT COMPLETED|Overall Study||0||
59537827|NCT01342757|75635757|FG000|STARTED|Overall Study||12||
59537828|NCT01342757|75635757|FG000|COMPLETED|Overall Study||12||
59537829|NCT01342757|75635757|FG000|NOT COMPLETED|Overall Study||0||
59537830|NCT02199743|75635763|FG000|STARTED|Overall Study||14||
59537831|NCT02199743|75635764|FG001|STARTED|Overall Study||10||
59537832|NCT02199743|75635763|FG000|COMPLETED|Overall Study||14||
59537833|NCT02199743|75635764|FG001|COMPLETED|Overall Study||8||
59537834|NCT02199743|75635763|FG000|NOT COMPLETED|Overall Study||0||
59537835|NCT02199743|75635764|FG001|NOT COMPLETED|Overall Study||2||
59537836|NCT01315145|75635774|FG000|STARTED|Overall Study||122||
59537837|NCT01315145|75635775|FG001|STARTED|Overall Study||16||
59537838|NCT01315145|75635774|FG000|COMPLETED|Overall Study||105||
59537839|NCT01315145|75635775|FG001|COMPLETED|Overall Study||11||
59537840|NCT01315145|75635774|FG000|NOT COMPLETED|Overall Study||17||
59537841|NCT01315145|75635775|FG001|NOT COMPLETED|Overall Study||5||
59537842|NCT01316315|75635783|FG000|STARTED|Sequence 1||7||
59537843|NCT01316315|75635784|FG001|STARTED|Sequence 1||7||
59537844|NCT01316315|75635783|FG000|COMPLETED|Sequence 1||7||
59537845|NCT01316315|75635784|FG001|COMPLETED|Sequence 1||7||
59537846|NCT01316315|75635783|FG000|NOT COMPLETED|Sequence 1||0||
59537847|NCT01316315|75635784|FG001|NOT COMPLETED|Sequence 1||0||
59537848|NCT01316315|75635783|FG000|STARTED|Sequence 2||7||
59537849|NCT01316315|75635784|FG001|STARTED|Sequence 2||7||
59537850|NCT01316315|75635783|FG000|COMPLETED|Sequence 2||7||
59537851|NCT01316315|75635784|FG001|COMPLETED|Sequence 2||7||
59537852|NCT01316315|75635783|FG000|NOT COMPLETED|Sequence 2||0||
59537853|NCT01316315|75635784|FG001|NOT COMPLETED|Sequence 2||0||
59537854|NCT00776594|75635794|FG000|STARTED|Overall Study||66||
59537855|NCT00776594|75635795|FG001|STARTED|Overall Study||36||
59537856|NCT00776594|75635794|FG000|COMPLETED|Overall Study||62||
59537857|NCT00776594|75635795|FG001|COMPLETED|Overall Study||34||
59537858|NCT00776594|75635794|FG000|NOT COMPLETED|Overall Study||4||
59537859|NCT00776594|75635795|FG001|NOT COMPLETED|Overall Study||2||
59537860|NCT01262105|75635805|FG000|STARTED|Overall Study||13||
59537861|NCT01262105|75635806|FG001|STARTED|Overall Study||10||
59537862|NCT01262105|75635805|FG000|COMPLETED|Overall Study||13||
59537863|NCT01262105|75635806|FG001|COMPLETED|Overall Study||10||
59537864|NCT01262105|75635805|FG000|NOT COMPLETED|Overall Study||0||
59988073|NCT00834431|76103232|FG000|NOT COMPLETED|Washout of 7 Days||0||
59537865|NCT01262105|75635806|FG001|NOT COMPLETED|Overall Study||0||
59537866|NCT00777062|75635814|FG000|STARTED|Overall Study||39||
59537867|NCT00777062|75635815|FG001|STARTED|Overall Study||41||
59537868|NCT00777062|75635814|FG000|COMPLETED|Overall Study||36||
59537869|NCT00777062|75635815|FG001|COMPLETED|Overall Study||36||
59537870|NCT00777062|75635814|FG000|NOT COMPLETED|Overall Study||3||
59537871|NCT00777062|75635815|FG001|NOT COMPLETED|Overall Study||5||
59537872|NCT01264601|75635823|FG000|STARTED|Overall Study||17||
59537873|NCT01264601|75635824|FG001|STARTED|Overall Study||14||
59537874|NCT01264601|75635823|FG000|COMPLETED|Overall Study||17||
59537875|NCT01264601|75635824|FG001|COMPLETED|Overall Study||14||
59537876|NCT01264601|75635823|FG000|NOT COMPLETED|Overall Study||0||
59537877|NCT01264601|75635824|FG001|NOT COMPLETED|Overall Study||0||
59537878|NCT01317095|75635832|FG000|STARTED|Overall Study||39||
59537879|NCT01317095|75635833|FG001|STARTED|Overall Study||41||
59537880|NCT01317095|75635832|FG000|COMPLETED|Overall Study||39||
59537881|NCT01317095|75635833|FG001|COMPLETED|Overall Study||41||
59537882|NCT01317095|75635832|FG000|NOT COMPLETED|Overall Study||0||
59537883|NCT01317095|75635833|FG001|NOT COMPLETED|Overall Study||0||
59537884|NCT01345721|75635842|FG000|STARTED|Overall Study||74||
59537885|NCT01345721|75635843|FG001|STARTED|Overall Study||66||
59537886|NCT01345721|75635844|FG002|STARTED|Overall Study||65||
59537887|NCT01345721|75635842|FG000|COMPLETED|Overall Study||74||
59537888|NCT01345721|75635843|FG001|COMPLETED|Overall Study||66||
59537889|NCT01345721|75635844|FG002|COMPLETED|Overall Study||65||
59537890|NCT01345721|75635842|FG000|NOT COMPLETED|Overall Study||0||
59537891|NCT01345721|75635843|FG001|NOT COMPLETED|Overall Study||0||
59537892|NCT01345721|75635844|FG002|NOT COMPLETED|Overall Study||0||
59537893|NCT01346267|75635858|FG000|STARTED|Overall Study||93||
59537894|NCT01346267|75635859|FG001|STARTED|Overall Study||94||
59537895|NCT01346267|75635858|FG000|COMPLETED|Overall Study||70||
59537896|NCT01346267|75635859|FG001|COMPLETED|Overall Study||67||
59537897|NCT01346267|75635858|FG000|NOT COMPLETED|Overall Study||23||
59537898|NCT01346267|75635859|FG001|NOT COMPLETED|Overall Study||27||
59537899|NCT01318577|75635867|FG000|STARTED|Overall Study||224||
59537900|NCT01318577|75635868|FG001|STARTED|Overall Study||220||
59537901|NCT01318577|75635867|FG000|COMPLETED|Overall Study||211||
59537902|NCT01318577|75635868|FG001|COMPLETED|Overall Study||212||
59537903|NCT01318577|75635867|FG000|NOT COMPLETED|Overall Study||13||
59537904|NCT01318577|75635868|FG001|NOT COMPLETED|Overall Study||8||
59537905|NCT01318733|75635874|FG000|STARTED|Overall Study||449||
59537906|NCT01318733|75635874|FG000|COMPLETED|Overall Study||279||
59537907|NCT01318733|75635874|FG000|NOT COMPLETED|Overall Study||170||
59537908|NCT01318967|75635878|FG000|STARTED|Overall Study||10||
59537909|NCT01318967|75635878|FG000|COMPLETED|Overall Study||10||
59537910|NCT01318967|75635878|FG000|NOT COMPLETED|Overall Study||0||
59537911|NCT01319045|75635883|FG000|STARTED|Overall Study||5||
59537912|NCT01319045|75635883|FG000|COMPLETED|Overall Study|Study was discontinued due to low enrollment|3||
59537913|NCT01319045|75635883|FG000|NOT COMPLETED|Overall Study||2||
59537914|NCT01267019|75635890|FG000|STARTED|Overall Study||47||
59537915|NCT01267019|75635891|FG001|STARTED|Overall Study||53||
59537916|NCT01267019|75635892|FG002|STARTED|Overall Study||53||
59537917|NCT01267019|75635890|FG000|COMPLETED|Overall Study||41||
59537918|NCT01267019|75635891|FG001|COMPLETED|Overall Study||47||
59537919|NCT01267019|75635892|FG002|COMPLETED|Overall Study||47||
59537920|NCT01267019|75635890|FG000|NOT COMPLETED|Overall Study||6||
59537921|NCT01267019|75635891|FG001|NOT COMPLETED|Overall Study||6||
59537922|NCT01267019|75635892|FG002|NOT COMPLETED|Overall Study||6||
59537923|NCT01348607|75635903|FG000|STARTED|Overall Study||1||
59537924|NCT01348607|75635904|FG001|STARTED|Overall Study||0||
59537925|NCT01348607|75635905|FG002|STARTED|Overall Study||0||
59537926|NCT01348607|75635903|FG000|COMPLETED|Overall Study||1||
59537927|NCT01348607|75635904|FG001|COMPLETED|Overall Study||0||
59537928|NCT01348607|75635905|FG002|COMPLETED|Overall Study||0||
59537929|NCT01348607|75635903|FG000|NOT COMPLETED|Overall Study||0||
59537930|NCT01348607|75635904|FG001|NOT COMPLETED|Overall Study||0||
59537931|NCT01348607|75635905|FG002|NOT COMPLETED|Overall Study||0||
59537932|NCT05497557|75635913|FG000|STARTED|Period 1: Sotorasib Alone||16||
59537933|NCT05497557|75635914|FG001|STARTED|Period 1: Sotorasib Alone||0||
59537934|NCT05497557|75635915|FG002|STARTED|Period 1: Sotorasib Alone||0||
59537935|NCT05497557|75635913|FG000|COMPLETED|Period 1: Sotorasib Alone||16|Participants who completed Period 1, in which they received sotorasib alone on Day 1. All completed participants continued onto Period 2.|
59537936|NCT05497557|75635914|FG001|COMPLETED|Period 1: Sotorasib Alone||0|Participants who completed Period 1, in which they received sotorasib alone on Day 1. All completed participants continued onto Period 2.|
59537937|NCT05497557|75635915|FG002|COMPLETED|Period 1: Sotorasib Alone||0|Participants who completed Period 1, in which they received sotorasib alone on Day 1. All completed participants continued onto Period 2.|
59537938|NCT05497557|75635913|FG000|NOT COMPLETED|Period 1: Sotorasib Alone||0||
59537939|NCT05497557|75635914|FG001|NOT COMPLETED|Period 1: Sotorasib Alone||0||
59537940|NCT05497557|75635915|FG002|NOT COMPLETED|Period 1: Sotorasib Alone||0||
59537941|NCT05497557|75635913|FG000|STARTED|Period 2: Omeprazole Alone||0||
59537942|NCT05497557|75635914|FG001|STARTED|Period 2: Omeprazole Alone||16||
59537943|NCT05497557|75635915|FG002|STARTED|Period 2: Omeprazole Alone||0||
59537944|NCT05497557|75635913|FG000|COMPLETED|Period 2: Omeprazole Alone||0|Participants who completed Period 2, in which they received omeprazole alone on Days 4 to 8. All completed participants continued onto Period 3.|
59537945|NCT05497557|75635914|FG001|COMPLETED|Period 2: Omeprazole Alone||14|Participants who completed Period 2, in which they received omeprazole alone on Days 4 to 8. All completed participants continued onto Period 3.|
59537946|NCT05497557|75635915|FG002|COMPLETED|Period 2: Omeprazole Alone||0|Participants who completed Period 2, in which they received omeprazole alone on Days 4 to 8. All completed participants continued onto Period 3.|
59537947|NCT05497557|75635913|FG000|NOT COMPLETED|Period 2: Omeprazole Alone||0||
59537948|NCT05497557|75635914|FG001|NOT COMPLETED|Period 2: Omeprazole Alone||2||
59537949|NCT05497557|75635915|FG002|NOT COMPLETED|Period 2: Omeprazole Alone||0||
59537950|NCT05497557|75635913|FG000|STARTED|Period 3: Omeprazole With Sotorasib||0||
59537951|NCT05497557|75635914|FG001|STARTED|Period 3: Omeprazole With Sotorasib||0||
59537952|NCT05497557|75635915|FG002|STARTED|Period 3: Omeprazole With Sotorasib||14||
59565812|NCT02335242|75668230|FG001|COMPLETED|Open-label Phase (20 Weeks)||0||
59537953|NCT05497557|75635913|FG000|COMPLETED|Period 3: Omeprazole With Sotorasib||0|Participants who completed Period 3, in which they received omeprazole co-administered with sotorasib on Day 9.|
59537954|NCT05497557|75635914|FG001|COMPLETED|Period 3: Omeprazole With Sotorasib||0|Participants who completed Period 3, in which they received omeprazole co-administered with sotorasib on Day 9.|
59537955|NCT05497557|75635915|FG002|COMPLETED|Period 3: Omeprazole With Sotorasib||14|Participants who completed Period 3, in which they received omeprazole co-administered with sotorasib on Day 9.|
59537956|NCT05497557|75635913|FG000|NOT COMPLETED|Period 3: Omeprazole With Sotorasib||0||
59537957|NCT05497557|75635914|FG001|NOT COMPLETED|Period 3: Omeprazole With Sotorasib||0||
59537958|NCT05497557|75635915|FG002|NOT COMPLETED|Period 3: Omeprazole With Sotorasib||0||
59537959|NCT05024032|75635927|FG000|STARTED|Overall Study||70||
59537960|NCT05024032|75635928|FG001|STARTED|Overall Study||71||
59537961|NCT05024032|75635929|FG002|STARTED|Overall Study||69||
59537962|NCT05024032|75635927|FG000|Received At Least One Dose|Overall Study||70||
59537963|NCT05024032|75635928|FG001|Received At Least One Dose|Overall Study||71||
59537964|NCT05024032|75635929|FG002|Received At Least One Dose|Overall Study||69||
59537965|NCT05024032|75635927|FG000|COMPLETED|Overall Study||69||
59537966|NCT05024032|75635928|FG001|COMPLETED|Overall Study||67||
59537967|NCT05024032|75635929|FG002|COMPLETED|Overall Study||65||
59537968|NCT05024032|75635927|FG000|NOT COMPLETED|Overall Study||1||
59537969|NCT05024032|75635928|FG001|NOT COMPLETED|Overall Study||4||
59537970|NCT05024032|75635929|FG002|NOT COMPLETED|Overall Study||4||
59537971|NCT04696055|75635941|FG000|STARTED|Overall Study||68||
59537972|NCT04696055|75635942|FG001|STARTED|Overall Study||27||
59537973|NCT04696055|75635941|FG000|COMPLETED|Overall Study||0||
59537974|NCT04696055|75635942|FG001|COMPLETED|Overall Study||0||
59537975|NCT04696055|75635941|FG000|NOT COMPLETED|Overall Study||68||
59537976|NCT04696055|75635942|FG001|NOT COMPLETED|Overall Study||27||
59537977|NCT04432376|75635951|FG000|STARTED|Double-blind Treatment Period||89||
59537978|NCT04432376|75635952|FG001|STARTED|Double-blind Treatment Period||90||
59537979|NCT04432376|75635953|FG002|STARTED|Double-blind Treatment Period|Open-label treatment group started under Period 2. Not applicable for Period 1.|0||
59537980|NCT04432376|75635951|FG000|COMPLETED|Double-blind Treatment Period||84||
59537981|NCT04432376|75635952|FG001|COMPLETED|Double-blind Treatment Period||79||
59537982|NCT04432376|75635953|FG002|COMPLETED|Double-blind Treatment Period|Open-label treatment group started under Period 2. Not applicable for Period 1.|0||
59537983|NCT04432376|75635951|FG000|NOT COMPLETED|Double-blind Treatment Period||5||
59537984|NCT04432376|75635952|FG001|NOT COMPLETED|Double-blind Treatment Period||11||
59537985|NCT04432376|75635953|FG002|NOT COMPLETED|Double-blind Treatment Period||0||
59537986|NCT04432376|75635951|FG000|STARTED|Enrollment B, Open Label Safety Group.|Participants randomized to Active-treatment included in Period 1 only, double-blind randomized period.|0||
59537987|NCT04432376|75635952|FG001|STARTED|Enrollment B, Open Label Safety Group.|Participants randomized to Placebo-treatment included in Period 1 only, double-blind randomized period.|0||
59537988|NCT04432376|75635953|FG002|STARTED|Enrollment B, Open Label Safety Group.|Participants/subjects enrolled in open-label treatment arm were not required to have otomycosis, hence were not assessed for efficacy and not included in Period 1. This population was Not randomized, assessed only for safety, and included in Period 2 only.|203||
59537989|NCT04432376|75635951|FG000|COMPLETED|Enrollment B, Open Label Safety Group.||0||
59537990|NCT04432376|75635952|FG001|COMPLETED|Enrollment B, Open Label Safety Group.||0||
59537991|NCT04432376|75635953|FG002|COMPLETED|Enrollment B, Open Label Safety Group.||203||
59537992|NCT04432376|75635951|FG000|NOT COMPLETED|Enrollment B, Open Label Safety Group.||0||
59537993|NCT04432376|75635952|FG001|NOT COMPLETED|Enrollment B, Open Label Safety Group.||0||
59537994|NCT04432376|75635953|FG002|NOT COMPLETED|Enrollment B, Open Label Safety Group.||0||
59537995|NCT04409834|75635962|FG000|STARTED|Overall Study||197||
59537996|NCT04409834|75635963|FG001|STARTED|Overall Study||193||
59537997|NCT04409834|75635962|FG000|Randomized to Anti-platelet Therapy|Overall Study||74||
59537998|NCT04409834|75635963|FG001|Randomized to Anti-platelet Therapy|Overall Study||78||
59623227|NCT00568386|75735290|FG000|STARTED|Overall Study||20||
59623228|NCT00568386|75735291|FG001|STARTED|Overall Study||20||
59623229|NCT00568386|75735290|FG000|COMPLETED|Overall Study||20||
59623230|NCT00568386|75735291|FG001|COMPLETED|Overall Study||20||
59623231|NCT00568386|75735290|FG000|NOT COMPLETED|Overall Study||0||
59623232|NCT00568386|75735291|FG001|NOT COMPLETED|Overall Study||0||
59623233|NCT02129478|75735297|FG000|STARTED|Overall Study||15||
59623234|NCT02129478|75735297|FG000|COMPLETED|Overall Study||15||
59623235|NCT02129478|75735297|FG000|NOT COMPLETED|Overall Study||0||
59988074|NCT00834431|76103233|FG001|NOT COMPLETED|Washout of 7 Days||1||
59537999|NCT04409834|75635962|FG000|Randomized to no Antiplatelet Therapy|Overall Study||73||
59623236|NCT02129556|75735304|FG000|STARTED|Overall Study||3||
59623237|NCT02129556|75735305|FG001|STARTED|Overall Study||3||
59623238|NCT02129556|75735306|FG002|STARTED|Overall Study||40||
59623239|NCT02129556|75735307|FG003|STARTED|Overall Study||12||
59623240|NCT02129556|75735304|FG000|COMPLETED|Overall Study||3||
59623241|NCT02129556|75735305|FG001|COMPLETED|Overall Study||3||
59623242|NCT02129556|75735306|FG002|COMPLETED|Overall Study||37||
59623243|NCT02129556|75735307|FG003|COMPLETED|Overall Study||12||
59623244|NCT02129556|75735304|FG000|NOT COMPLETED|Overall Study||0||
59623245|NCT02129556|75735305|FG001|NOT COMPLETED|Overall Study||0||
59988075|NCT00834431|76103232|FG000|STARTED|Second Intervention||18||
59623246|NCT02129556|75735306|FG002|NOT COMPLETED|Overall Study||3||
59538000|NCT04409834|75635963|FG001|Randomized to no Antiplatelet Therapy|Overall Study||67||
59538001|NCT04409834|75635962|FG000|COMPLETED|Overall Study||142||
59538002|NCT04409834|75635963|FG001|COMPLETED|Overall Study||131||
59538003|NCT04409834|75635962|FG000|NOT COMPLETED|Overall Study||55||
59538004|NCT04409834|75635963|FG001|NOT COMPLETED|Overall Study||62||
59538005|NCT04320849|75635975|FG000|STARTED|Overall Study||117||
59538006|NCT04320849|75635975|FG000|COMPLETED|Overall Study||109||
59538007|NCT04320849|75635975|FG000|NOT COMPLETED|Overall Study||8||
59538008|NCT03946670|75635981|FG000|STARTED|Overall Study||65||
59538009|NCT03946670|75635982|FG001|STARTED|Overall Study||62||
59538010|NCT03946670|75635981|FG000|Treated|Overall Study||64||
59538011|NCT03946670|75635982|FG001|Treated|Overall Study||61||
59538012|NCT03946670|75635981|FG000|Not Treated|Overall Study||1||
59538013|NCT03946670|75635982|FG001|Not Treated|Overall Study||1||
59538014|NCT03946670|75635981|FG000|Treatment Ongoing|Overall Study||13||
59538015|NCT03946670|75635982|FG001|Treatment Ongoing|Overall Study||10||
59538016|NCT03946670|75635981|FG000|Discontinued From Treatment|Overall Study||51||
59538017|NCT03946670|75635982|FG001|Discontinued From Treatment|Overall Study||51||
59538018|NCT03946670|75635981|FG000|COMPLETED|Overall Study||13|Completed = Ongoing|
59538019|NCT03946670|75635982|FG001|COMPLETED|Overall Study||10|Completed = Ongoing|
59538020|NCT03946670|75635981|FG000|NOT COMPLETED|Overall Study||52||
59538021|NCT03946670|75635982|FG001|NOT COMPLETED|Overall Study||52||
59538022|NCT03819478|75635991|FG000|STARTED|Overall Study||62||
59538023|NCT03819478|75635992|FG001|STARTED|Overall Study||62||
59538024|NCT03819478|75635993|FG002|STARTED|Overall Study||63||
59815542|NCT00993655|75937973|FG000|COMPLETED|Overall Study||101||
59815543|NCT00993655|75937974|FG001|COMPLETED|Overall Study||72||
59815544|NCT00993655|75937975|FG002|COMPLETED|Overall Study||102||
60076139|NCT01904773|76191371|FG007|STARTED|Placebo Washout First Intervention||3||
59538025|NCT03819478|75635991|FG000|COMPLETED|Overall Study||51||
59538026|NCT03819478|75635992|FG001|COMPLETED|Overall Study||50||
59538027|NCT03819478|75635993|FG002|COMPLETED|Overall Study||52||
59538028|NCT03819478|75635991|FG000|NOT COMPLETED|Overall Study||11||
59538029|NCT03819478|75635992|FG001|NOT COMPLETED|Overall Study||12||
59538030|NCT03819478|75635993|FG002|NOT COMPLETED|Overall Study||11||
59538031|NCT03750838|75636005|FG000|STARTED|Overall Study||49||
59538032|NCT03750838|75636006|FG001|STARTED|Overall Study||50||
59538033|NCT03750838|75636005|FG000|6 Week Follow-up|Overall Study||40||
59538034|NCT03750838|75636006|FG001|6 Week Follow-up|Overall Study||43||
59538035|NCT03750838|75636005|FG000|3 Month Follow-up|Overall Study||32||
59538036|NCT03750838|75636006|FG001|3 Month Follow-up|Overall Study||40||
59538037|NCT03750838|75636005|FG000|6 Month Follow-up|Overall Study||37||
59538038|NCT03750838|75636006|FG001|6 Month Follow-up|Overall Study||44||
59538039|NCT03750838|75636005|FG000|COMPLETED|Overall Study||39|9 month follow-up|
59538040|NCT03750838|75636006|FG001|COMPLETED|Overall Study||44|9 month follow-up|
59538041|NCT03750838|75636005|FG000|NOT COMPLETED|Overall Study||10||
59538042|NCT03750838|75636006|FG001|NOT COMPLETED|Overall Study||6||
59538043|NCT03692052|75636015|FG000|STARTED|Core Period (Day 1 to Week 24)||20||
59538044|NCT03692052|75636015|FG000|COMPLETED|Core Period (Day 1 to Week 24)||19||
59538045|NCT03692052|75636015|FG000|NOT COMPLETED|Core Period (Day 1 to Week 24)||1||
59538046|NCT03692052|75636015|FG000|STARTED|Extension Period (Week 25 to 10 Years)||19||
59538047|NCT03692052|75636015|FG000|COMPLETED|Extension Period (Week 25 to 10 Years)||0||
59538048|NCT03692052|75636015|FG000|NOT COMPLETED|Extension Period (Week 25 to 10 Years)||19||
59538049|NCT03554798|75636028|FG000|STARTED|Overall Study||50||
59538050|NCT03554798|75636029|FG001|STARTED|Overall Study||50||
59538051|NCT03554798|75636030|FG002|STARTED|Overall Study||51||
59538052|NCT03554798|75636031|FG003|STARTED|Overall Study||156||
59538053|NCT03554798|75636032|FG004|STARTED|Overall Study||144||
59538054|NCT03554798|75636033|FG005|STARTED|Overall Study||138||
59538055|NCT03554798|75636034|FG006|STARTED|Overall Study||150||
59538056|NCT03554798|75636035|FG007|STARTED|Overall Study||135||
59538057|NCT03554798|75636036|FG008|STARTED|Overall Study||151||
59815545|NCT00993655|75937973|FG000|NOT COMPLETED|Overall Study||0||
59538058|NCT03554798|75636028|FG000|COMPLETED|Overall Study||45||
59815546|NCT00993655|75937974|FG001|NOT COMPLETED|Overall Study||0||
59538059|NCT03554798|75636029|FG001|COMPLETED|Overall Study||47||
59538060|NCT03554798|75636030|FG002|COMPLETED|Overall Study||48||
59538061|NCT03554798|75636031|FG003|COMPLETED|Overall Study||154||
59538062|NCT03554798|75636032|FG004|COMPLETED|Overall Study||141||
59538063|NCT03554798|75636033|FG005|COMPLETED|Overall Study||137||
59538064|NCT03554798|75636034|FG006|COMPLETED|Overall Study||149||
59538065|NCT03554798|75636035|FG007|COMPLETED|Overall Study||133||
59623247|NCT02129556|75735307|FG003|NOT COMPLETED|Overall Study||0||
59623248|NCT05161806|75735316|FG000|STARTED|Overall Study||30||
59815547|NCT00993655|75937975|FG002|NOT COMPLETED|Overall Study||0||
59815548|NCT05346653|75937988|FG000|STARTED|Overall Study||0||
60076140|NCT01904773|76191372|FG008|STARTED|Placebo Washout First Intervention||4||
59538066|NCT03554798|75636036|FG008|COMPLETED|Overall Study||149||
59538067|NCT03554798|75636028|FG000|NOT COMPLETED|Overall Study||5||
59538068|NCT03554798|75636029|FG001|NOT COMPLETED|Overall Study||3||
59538069|NCT03554798|75636030|FG002|NOT COMPLETED|Overall Study||3||
59538070|NCT03554798|75636031|FG003|NOT COMPLETED|Overall Study||2||
59538071|NCT03554798|75636032|FG004|NOT COMPLETED|Overall Study||3||
59538072|NCT03554798|75636033|FG005|NOT COMPLETED|Overall Study||1||
59538073|NCT03554798|75636034|FG006|NOT COMPLETED|Overall Study||1||
59538074|NCT03554798|75636035|FG007|NOT COMPLETED|Overall Study||2||
59538075|NCT03554798|75636036|FG008|NOT COMPLETED|Overall Study||2||
59538076|NCT03496571|75636068|FG000|STARTED|Overall Study||22||
59538077|NCT03496571|75636069|FG001|STARTED|Overall Study||21||
59538078|NCT03496571|75636070|FG002|STARTED|Overall Study||22||
59538079|NCT03496571|75636068|FG000|COMPLETED|Overall Study||20||
59538080|NCT03496571|75636069|FG001|COMPLETED|Overall Study||19||
59538081|NCT03496571|75636070|FG002|COMPLETED|Overall Study||20||
59538082|NCT03496571|75636068|FG000|NOT COMPLETED|Overall Study||2||
59538083|NCT03496571|75636069|FG001|NOT COMPLETED|Overall Study||2||
59538084|NCT03496571|75636070|FG002|NOT COMPLETED|Overall Study||2||
59538085|NCT03395197|75636085|FG000|STARTED|Study Recruitment||13||
59538086|NCT03395197|75636086|FG001|STARTED|Study Recruitment||6||
59538087|NCT03395197|75636087|FG002|STARTED|Study Recruitment||402||
59538088|NCT03395197|75636088|FG003|STARTED|Study Recruitment||403||
59538089|NCT03395197|75636089|FG004|STARTED|Study Recruitment||115||
59538090|NCT03395197|75636090|FG005|STARTED|Study Recruitment||115||
59538091|NCT03395197|75636085|FG000|COMPLETED|Study Recruitment||13||
59538092|NCT03395197|75636086|FG001|COMPLETED|Study Recruitment||6||
59538093|NCT03395197|75636087|FG002|COMPLETED|Study Recruitment||402||
59538094|NCT03395197|75636088|FG003|COMPLETED|Study Recruitment||403||
59538095|NCT03395197|75636089|FG004|COMPLETED|Study Recruitment||115||
59538096|NCT03395197|75636090|FG005|COMPLETED|Study Recruitment||115||
59538097|NCT03395197|75636085|FG000|NOT COMPLETED|Study Recruitment||0||
59538098|NCT03395197|75636086|FG001|NOT COMPLETED|Study Recruitment||0||
59538099|NCT03395197|75636087|FG002|NOT COMPLETED|Study Recruitment||0||
59538100|NCT03395197|75636088|FG003|NOT COMPLETED|Study Recruitment||0||
59538101|NCT03395197|75636089|FG004|NOT COMPLETED|Study Recruitment||0||
59538102|NCT03395197|75636090|FG005|NOT COMPLETED|Study Recruitment||0||
59538103|NCT03395197|75636085|FG000|STARTED|Analysis for Part 1 and Part 2 Cohort 1||13||
59538104|NCT03395197|75636086|FG001|STARTED|Analysis for Part 1 and Part 2 Cohort 1||6||
59538105|NCT03395197|75636087|FG002|STARTED|Analysis for Part 1 and Part 2 Cohort 1||402||
59538106|NCT03395197|75636088|FG003|STARTED|Analysis for Part 1 and Part 2 Cohort 1||403||
59538107|NCT03395197|75636089|FG004|STARTED|Analysis for Part 1 and Part 2 Cohort 1||0||
59538108|NCT03395197|75636090|FG005|STARTED|Analysis for Part 1 and Part 2 Cohort 1||0||
59538109|NCT03395197|75636085|FG000|COMPLETED|Analysis for Part 1 and Part 2 Cohort 1||0||
59538110|NCT03395197|75636086|FG001|COMPLETED|Analysis for Part 1 and Part 2 Cohort 1||0||
59538111|NCT03395197|75636087|FG002|COMPLETED|Analysis for Part 1 and Part 2 Cohort 1||0||
59538112|NCT03395197|75636088|FG003|COMPLETED|Analysis for Part 1 and Part 2 Cohort 1||0||
59538113|NCT03395197|75636089|FG004|COMPLETED|Analysis for Part 1 and Part 2 Cohort 1||0||
59538114|NCT03395197|75636090|FG005|COMPLETED|Analysis for Part 1 and Part 2 Cohort 1||0||
59538115|NCT03395197|75636085|FG000|NOT COMPLETED|Analysis for Part 1 and Part 2 Cohort 1||13||
59538116|NCT03395197|75636086|FG001|NOT COMPLETED|Analysis for Part 1 and Part 2 Cohort 1||6||
59538117|NCT03395197|75636087|FG002|NOT COMPLETED|Analysis for Part 1 and Part 2 Cohort 1||402||
59538118|NCT03395197|75636088|FG003|NOT COMPLETED|Analysis for Part 1 and Part 2 Cohort 1||403||
59538119|NCT03395197|75636089|FG004|NOT COMPLETED|Analysis for Part 1 and Part 2 Cohort 1||0||
59538120|NCT03395197|75636090|FG005|NOT COMPLETED|Analysis for Part 1 and Part 2 Cohort 1||0||
59538121|NCT03395197|75636085|FG000|STARTED|Analysis for DDR-Deficient Participants||0||
59538122|NCT03395197|75636086|FG001|STARTED|Analysis for DDR-Deficient Participants||0||
59538123|NCT03395197|75636087|FG002|STARTED|Analysis for DDR-Deficient Participants||0||
59538124|NCT03395197|75636088|FG003|STARTED|Analysis for DDR-Deficient Participants||0||
59538125|NCT03395197|75636089|FG004|STARTED|Analysis for DDR-Deficient Participants|Participants who were DDR-deficient and received talazoparib+enzalutamide in Part 2 Cohort 1 (85 total) were combined with participants enrolled in Part 2 Cohort 2 (115 total) and included in the analysis of discontinuation reasons for participants with DDR deficiencies (combined 200 total).|200||
59538126|NCT03395197|75636090|FG005|STARTED|Analysis for DDR-Deficient Participants|Participants who were DDR-deficient and received placebo+enzalutamide in Part 2 Cohort 1 (84 total) were combined with participants enrolled in Part 2 Cohort 2 (115 total) and included in the analysis of discontinuation reasons for participants with DDR deficiencies (combined 199 total).|199||
59538127|NCT03395197|75636085|FG000|COMPLETED|Analysis for DDR-Deficient Participants||0||
59538128|NCT03395197|75636086|FG001|COMPLETED|Analysis for DDR-Deficient Participants||0||
59538129|NCT03395197|75636087|FG002|COMPLETED|Analysis for DDR-Deficient Participants||0||
59538130|NCT03395197|75636088|FG003|COMPLETED|Analysis for DDR-Deficient Participants||0||
59538131|NCT03395197|75636089|FG004|COMPLETED|Analysis for DDR-Deficient Participants||0||
59538132|NCT03395197|75636090|FG005|COMPLETED|Analysis for DDR-Deficient Participants||0||
59538133|NCT03395197|75636085|FG000|NOT COMPLETED|Analysis for DDR-Deficient Participants||0||
59538134|NCT03395197|75636086|FG001|NOT COMPLETED|Analysis for DDR-Deficient Participants||0||
59538135|NCT03395197|75636087|FG002|NOT COMPLETED|Analysis for DDR-Deficient Participants||0||
59538136|NCT03395197|75636088|FG003|NOT COMPLETED|Analysis for DDR-Deficient Participants||0||
59538137|NCT03395197|75636089|FG004|NOT COMPLETED|Analysis for DDR-Deficient Participants||200||
59538138|NCT03395197|75636090|FG005|NOT COMPLETED|Analysis for DDR-Deficient Participants||199||
59538139|NCT02726386|75636106|FG000|STARTED|Overall Study||90||
59538140|NCT02726386|75636107|FG001|STARTED|Overall Study||124||
59538141|NCT02726386|75636106|FG000|COMPLETED|Overall Study||52||
59538142|NCT02726386|75636107|FG001|COMPLETED|Overall Study||68||
59538143|NCT02726386|75636106|FG000|NOT COMPLETED|Overall Study||38||
59538144|NCT02726386|75636107|FG001|NOT COMPLETED|Overall Study||56||
59538145|NCT02711553|75636117|FG000|STARTED|Overall Study||106||
59538146|NCT02711553|75636118|FG001|STARTED|Overall Study||52||
59538147|NCT02711553|75636119|FG002|STARTED|Overall Study||102||
59538148|NCT02711553|75636120|FG003|STARTED|Overall Study||49||
59538149|NCT02711553|75636117|FG000|Received at Least 1 Dose of Study Drug|Overall Study||104||
59538150|NCT02711553|75636118|FG001|Received at Least 1 Dose of Study Drug|Overall Study||52||
59538151|NCT02711553|75636119|FG002|Received at Least 1 Dose of Study Drug|Overall Study||102||
59538152|NCT02711553|75636120|FG003|Received at Least 1 Dose of Study Drug|Overall Study||48||
59538153|NCT02711553|75636117|FG000|COMPLETED|Overall Study||100||
59538154|NCT02711553|75636118|FG001|COMPLETED|Overall Study||47||
59538155|NCT02711553|75636119|FG002|COMPLETED|Overall Study||92||
59538156|NCT02711553|75636120|FG003|COMPLETED|Overall Study||45||
59538157|NCT02711553|75636117|FG000|NOT COMPLETED|Overall Study||6||
59538158|NCT02711553|75636118|FG001|NOT COMPLETED|Overall Study||5||
59538159|NCT02711553|75636119|FG002|NOT COMPLETED|Overall Study||10||
59538160|NCT02711553|75636120|FG003|NOT COMPLETED|Overall Study||4||
59538161|NCT02667587|75636134|FG000|STARTED|Pre-Treatment||358||
59538162|NCT02667587|75636135|FG001|STARTED|Pre-Treatment||358||
59538163|NCT02667587|75636134|FG000|COMPLETED|Pre-Treatment||354||
59538164|NCT02667587|75636135|FG001|COMPLETED|Pre-Treatment||355||
59538165|NCT02667587|75636134|FG000|NOT COMPLETED|Pre-Treatment||4||
59538166|NCT02667587|75636135|FG001|NOT COMPLETED|Pre-Treatment||3||
59538167|NCT02667587|75636134|FG000|STARTED|End of Treatment|1 participant was randomized to Radiotherapy, Temozolomide plus Placebo but received Radiotherapy, Temozolomide plus Nivolumab.|355||
59538168|NCT02667587|75636135|FG001|STARTED|End of Treatment|1 participant was randomized to Radiotherapy, Temozolomide plus Placebo but received Radiotherapy, Temozolomide plus Nivolumab.|354||
59538169|NCT02667587|75636134|FG000|COMPLETED|End of Treatment||37|CONTINUING IN THE TREATMENT PERIOD|
59538170|NCT02667587|75636135|FG001|COMPLETED|End of Treatment||44|CONTINUING IN THE TREATMENT PERIOD|
59538171|NCT02667587|75636134|FG000|NOT COMPLETED|End of Treatment||318||
59538172|NCT02667587|75636135|FG001|NOT COMPLETED|End of Treatment||310||
59538173|NCT02576509|75636143|FG000|STARTED|Pre-Treatment Period||371|Started = Assigned to treatment (randomized/enrolled)|
59538174|NCT02576509|75636144|FG001|STARTED|Pre-Treatment Period||372|Started = Assigned to treatment (randomized/enrolled)|
59538175|NCT02576509|75636143|FG000|COMPLETED|Pre-Treatment Period||367|Completed = Entering treatment period|
59538176|NCT02576509|75636144|FG001|COMPLETED|Pre-Treatment Period||363|Completed = Entering treatment period|
59538177|NCT02576509|75636143|FG000|NOT COMPLETED|Pre-Treatment Period||4||
59538178|NCT02576509|75636144|FG001|NOT COMPLETED|Pre-Treatment Period||9||
59538179|NCT02576509|75636143|FG000|STARTED|Treatment Period||367|Started = Received treatment|
59538180|NCT02576509|75636144|FG001|STARTED|Treatment Period||363|Started = Received treatment|
59538181|NCT02576509|75636143|FG000|COMPLETED|Treatment Period||38|Completed = Continuing in the treatment period|
59538182|NCT02576509|75636144|FG001|COMPLETED|Treatment Period||8|Completed = Continuing in the treatment period|
59538183|NCT02576509|75636143|FG000|NOT COMPLETED|Treatment Period||329||
59538184|NCT02576509|75636144|FG001|NOT COMPLETED|Treatment Period||355||
59538185|NCT02576509|75636143|FG000|STARTED|Follow-up Period||367|Started = Received treatment|
59538186|NCT02576509|75636144|FG001|STARTED|Follow-up Period||363|Started = Received treatment|
59538187|NCT02576509|75636143|FG000|COMPLETED|Follow-up Period||318|Completed = Continuing in the study|
59538188|NCT02576509|75636144|FG001|COMPLETED|Follow-up Period||311|Completed = Continuing in the study|
59538189|NCT02576509|75636143|FG000|NOT COMPLETED|Follow-up Period||49||
59538190|NCT02576509|75636144|FG001|NOT COMPLETED|Follow-up Period||52||
59538191|NCT02476916|75636152|FG000|STARTED|Core Period||27||
59538192|NCT02476916|75636153|FG001|STARTED|Core Period||25||
59538193|NCT02476916|75636152|FG000|COMPLETED|Core Period||21||
59538194|NCT02476916|75636153|FG001|COMPLETED|Core Period||22||
59538195|NCT02476916|75636152|FG000|NOT COMPLETED|Core Period||6||
59538196|NCT02476916|75636153|FG001|NOT COMPLETED|Core Period||3||
59538197|NCT02476916|75636152|FG000|STARTED|Extension Period||18|A total of 36 participants who had clinical activity and tolerated dose entered Extension Period.|
59538198|NCT02476916|75636153|FG001|STARTED|Extension Period||18|A total of 36 participants who had clinical activity and tolerated dose entered Extension Period.|
59538199|NCT02476916|75636152|FG000|COMPLETED|Extension Period||0||
59538200|NCT02476916|75636153|FG001|COMPLETED|Extension Period||0||
59538201|NCT02476916|75636152|FG000|NOT COMPLETED|Extension Period||18||
59538202|NCT02476916|75636153|FG001|NOT COMPLETED|Extension Period||18||
59538203|NCT02203799|75636160|FG000|STARTED|Overall Study||15||
59538204|NCT02203799|75636160|FG000|COMPLETED|Overall Study||12||
59538205|NCT02203799|75636160|FG000|NOT COMPLETED|Overall Study||3||
59538206|NCT02180724|75636167|FG000|STARTED|Overall Study||92||
59538207|NCT02180724|75636168|FG001|STARTED|Overall Study||14||
59538208|NCT02180724|75636167|FG000|200 mg QD|Overall Study||7|In the original protocol, previously treated subjects were planned to be randomized 1:1 into 2 cohorts: Cohort 1 to receive Acala 100 mg BID for 28 days and Cohort 2 to receive Acala 200 mg once daily (QD) for 28 days. After enrollment started, the dose regimen was amended. The 200 mg QD dose was eliminated, and subjects who were enrolled under the original protocol and received treatment with 200 mg QD were switched to 100 mg BID. Results are combined.|
59538209|NCT02180724|75636168|FG001|200 mg QD|Overall Study||1|In the original protocol, previously treated subjects were planned to be randomized 1:1 into 2 cohorts: Cohort 1 to receive Acala 100 mg BID for 28 days and Cohort 2 to receive Acala 200 mg once daily (QD) for 28 days. After enrollment started, the dose regimen was amended. The 200 mg QD dose was eliminated, and subjects who were enrolled under the original protocol and received treatment with 200 mg QD were switched to 100 mg BID. Results are combined.|
59538210|NCT02180724|75636167|FG000|100 mg BID|Overall Study||85|In the original protocol, previously treated subjects were planned to be randomized 1:1 into 2 cohorts: Cohort 1 to receive Acala 100 mg BID for 28 days and Cohort 2 to receive Acala 200 mg once daily (QD) for 28 days. After enrollment started, the dose regimen was amended. The 200 mg QD dose was eliminated, and subjects who were enrolled under the original protocol and received treatment with 200 mg QD were switched to 100 mg BID. Results are combined.|
59538211|NCT02180724|75636168|FG001|100 mg BID|Overall Study||13|In the original protocol, previously treated subjects were planned to be randomized 1:1 into 2 cohorts: Cohort 1 to receive Acala 100 mg BID for 28 days and Cohort 2 to receive Acala 200 mg once daily (QD) for 28 days. After enrollment started, the dose regimen was amended. The 200 mg QD dose was eliminated, and subjects who were enrolled under the original protocol and received treatment with 200 mg QD were switched to 100 mg BID. Results are combined.|
59538212|NCT02180724|75636167|FG000|COMPLETED|Overall Study||0||
59538213|NCT02180724|75636168|FG001|COMPLETED|Overall Study||0||
59538214|NCT02180724|75636167|FG000|NOT COMPLETED|Overall Study||92||
59538215|NCT02180724|75636168|FG001|NOT COMPLETED|Overall Study||14||
59538216|NCT02135419|75636182|FG000|STARTED|Overall Study||2227||
59538217|NCT02135419|75636183|FG001|STARTED|Overall Study||2219||
59538218|NCT02135419|75636182|FG000|COMPLETED|Overall Study||2071||
59538219|NCT02135419|75636183|FG001|COMPLETED|Overall Study||2080||
59538220|NCT02135419|75636182|FG000|NOT COMPLETED|Overall Study||156||
59538221|NCT02135419|75636183|FG001|NOT COMPLETED|Overall Study||139||
59538222|NCT02043678|75636191|FG000|STARTED|Overall Study||401||
59538223|NCT02043678|75636192|FG001|STARTED|Overall Study||405||
59538224|NCT02043678|75636191|FG000|Treated|Overall Study||390||
59538225|NCT02043678|75636192|FG001|Treated|Overall Study||396||
59538226|NCT02043678|75636191|FG000|COMPLETED|Overall Study||0|Completed treatment|
59538227|NCT02043678|75636192|FG001|COMPLETED|Overall Study||0|Completed treatment|
59538228|NCT02043678|75636191|FG000|NOT COMPLETED|Overall Study||401||
59538229|NCT02043678|75636192|FG001|NOT COMPLETED|Overall Study||405||
59538230|NCT01853748|75636200|FG000|STARTED|Allocation||384||
59538231|NCT01853748|75636201|FG001|STARTED|Allocation||128||
59538232|NCT01853748|75636200|FG000|COMPLETED|Allocation||383||
59538233|NCT01853748|75636201|FG001|COMPLETED|Allocation||114||
59538234|NCT01853748|75636200|FG000|NOT COMPLETED|Allocation||1||
59538235|NCT01853748|75636201|FG001|NOT COMPLETED|Allocation||14||
59538236|NCT01853748|75636200|FG000|STARTED|Follow-Up||383||
59538237|NCT01853748|75636201|FG001|STARTED|Follow-Up||114||
59538238|NCT01853748|75636200|FG000|COMPLETED|Follow-Up||293||
59538239|NCT01853748|75636201|FG001|COMPLETED|Follow-Up||97||
59538240|NCT01853748|75636200|FG000|NOT COMPLETED|Follow-Up||90||
59538241|NCT01853748|75636201|FG001|NOT COMPLETED|Follow-Up||17||
59538242|NCT01843374|75636218|FG000|STARTED|Overall Study||189||
59538243|NCT01843374|75636219|FG001|STARTED|Overall Study||382||
59538244|NCT01843374|75636218|FG000|RANDOMIZED|Overall Study||189||
59538245|NCT01843374|75636219|FG001|RANDOMIZED|Overall Study||382||
59538246|NCT01843374|75636218|FG000|COMPLETED|Overall Study||0||
59538247|NCT01843374|75636219|FG001|COMPLETED|Overall Study||3||
59538248|NCT01843374|75636218|FG000|NOT COMPLETED|Overall Study||189||
59538249|NCT01843374|75636219|FG001|NOT COMPLETED|Overall Study||379||
59538250|NCT01773733|75636230|FG000|STARTED|Overall Study||80146||
59538251|NCT01773733|75636231|FG001|STARTED|Overall Study||13167||
59538252|NCT01773733|75636230|FG000|3 Months of Treatment|Overall Study||54841||
59538253|NCT01773733|75636231|FG001|3 Months of Treatment|Overall Study||11365||
59538254|NCT01773733|75636230|FG000|6 Months of Treatment|Overall Study||33424||
59538255|NCT01773733|75636231|FG001|6 Months of Treatment|Overall Study||8007||
59538256|NCT01773733|75636230|FG000|COMPLETED|Overall Study||21417||
59538257|NCT01773733|75636231|FG001|COMPLETED|Overall Study||4846||
59538258|NCT01773733|75636230|FG000|NOT COMPLETED|Overall Study||58729||
59538259|NCT01773733|75636231|FG001|NOT COMPLETED|Overall Study||8321||
59538260|NCT01757535|75636241|FG000|STARTED|Overall Study||238|Treatment Phase|
59538261|NCT01757535|75636242|FG001|STARTED|Overall Study||234|Treatment Phase|
59538262|NCT01757535|75636241|FG000|Received Treatment|Overall Study||236||
59538263|NCT01757535|75636242|FG001|Received Treatment|Overall Study||233||
59538264|NCT01757535|75636241|FG000|COMPLETED|Overall Study||45|Completed = treatment ongoing|
59538265|NCT01757535|75636242|FG001|COMPLETED|Overall Study||26|Completed = treatment ongoing|
59538266|NCT01757535|75636241|FG000|NOT COMPLETED|Overall Study||193||
59623249|NCT05161806|75735316|FG000|Full Analysis Set (FAS)|Overall Study||30|FAS included all participants who received an injection of study treatment.|
59623250|NCT05161806|75735316|FG000|COMPLETED|Overall Study||30||
59538267|NCT01757535|75636242|FG001|NOT COMPLETED|Overall Study||208||
59538268|NCT01447329|75636250|FG000|STARTED|Overall Study||24||
59538269|NCT01447329|75636251|FG001|STARTED|Overall Study||25||
59538270|NCT01447329|75636250|FG000|COMPLETED|Overall Study||18||
59538271|NCT01447329|75636251|FG001|COMPLETED|Overall Study||16||
59538272|NCT01447329|75636250|FG000|NOT COMPLETED|Overall Study||6||
59538273|NCT01447329|75636251|FG001|NOT COMPLETED|Overall Study||9||
59538274|NCT01117779|75636257|FG000|STARTED|Overall Study||246||
59538275|NCT01117779|75636257|FG000|COMPLETED|Overall Study||246||
59538276|NCT01117779|75636257|FG000|NOT COMPLETED|Overall Study||0||
59538277|NCT01110005|75636270|FG000|STARTED|Overall Study||157||
59538278|NCT01110005|75636271|FG001|STARTED|Overall Study||161||
59538279|NCT01110005|75636270|FG000|COMPLETED|Overall Study||153||
59538280|NCT01110005|75636271|FG001|COMPLETED|Overall Study||156||
59538281|NCT01110005|75636270|FG000|NOT COMPLETED|Overall Study||4||
59538282|NCT01110005|75636271|FG001|NOT COMPLETED|Overall Study||5||
59538283|NCT00840801|75636279|FG000|STARTED|Part A: Screening- Day 28 Postdose 2||150||
59538284|NCT00840801|75636280|FG001|STARTED|Part A: Screening- Day 28 Postdose 2||152||
59538285|NCT00840801|75636281|FG002|STARTED|Part A: Screening- Day 28 Postdose 2||0||
59538286|NCT00840801|75636279|FG000|COMPLETED|Part A: Screening- Day 28 Postdose 2||149||
59538287|NCT00840801|75636280|FG001|COMPLETED|Part A: Screening- Day 28 Postdose 2||152||
59538288|NCT00840801|75636281|FG002|COMPLETED|Part A: Screening- Day 28 Postdose 2||0||
59538289|NCT00840801|75636279|FG000|NOT COMPLETED|Part A: Screening- Day 28 Postdose 2||1||
59538290|NCT00840801|75636280|FG001|NOT COMPLETED|Part A: Screening- Day 28 Postdose 2||0||
59538291|NCT00840801|75636281|FG002|NOT COMPLETED|Part A: Screening- Day 28 Postdose 2||0||
59538292|NCT00840801|75636279|FG000|STARTED|Part B:Day 28 Postdose2-Day 28 Postdose3|All participants received FSME-IMMUN. Thus, the participant flow for this arm has not been reported.|0||
59538293|NCT00840801|75636280|FG001|STARTED|Part B:Day 28 Postdose2-Day 28 Postdose3|All participants received FSME-IMMUN. Thus, the participant flow for this arm has not been reported.|0||
59538294|NCT00840801|75636281|FG002|STARTED|Part B:Day 28 Postdose2-Day 28 Postdose3|Participants received FSME-IMMUN (encompassing both Part A: FSME-IMMUN and Part A: Encepur arms).|301||
59538295|NCT00840801|75636279|FG000|COMPLETED|Part B:Day 28 Postdose2-Day 28 Postdose3|All participants received FSME-IMMUN. Thus, the participant flow for this arm has not been reported.|0||
59538296|NCT00840801|75636280|FG001|COMPLETED|Part B:Day 28 Postdose2-Day 28 Postdose3|All participants received FSME-IMMUN. Thus, the participant flow for this arm has not been reported.|0||
59538297|NCT00840801|75636281|FG002|COMPLETED|Part B:Day 28 Postdose2-Day 28 Postdose3|Participants received FSME-IMMUN (encompassing both Part A: FSME-IMMUN and Part A: Encepur arms).|297||
59538298|NCT00840801|75636279|FG000|NOT COMPLETED|Part B:Day 28 Postdose2-Day 28 Postdose3||0||
59538299|NCT00840801|75636280|FG001|NOT COMPLETED|Part B:Day 28 Postdose2-Day 28 Postdose3||0||
59538300|NCT00840801|75636281|FG002|NOT COMPLETED|Part B:Day 28 Postdose2-Day 28 Postdose3||4||
59538301|NCT00533780|75636309|FG000|STARTED|Overall Study||51||
59538302|NCT00533780|75636309|FG000|COMPLETED|Overall Study||51||
59538303|NCT00533780|75636309|FG000|NOT COMPLETED|Overall Study||0||
59538304|NCT00494234|75636315|FG000|STARTED|Overall Study||27||
59538305|NCT00494234|75636316|FG001|STARTED|Overall Study||27||
59538306|NCT00494234|75636315|FG000|COMPLETED|Overall Study||13||
59538307|NCT00494234|75636316|FG001|COMPLETED|Overall Study||18||
59538308|NCT00494234|75636315|FG000|NOT COMPLETED|Overall Study||14||
59538309|NCT00494234|75636316|FG001|NOT COMPLETED|Overall Study||9||
59538310|NCT01268111|75636324|FG000|STARTED|Overall Study||6||
59538311|NCT01268111|75636325|FG001|STARTED|Overall Study||6||
59538312|NCT01268111|75636324|FG000|COMPLETED|Overall Study||6||
59538313|NCT01268111|75636325|FG001|COMPLETED|Overall Study||6||
59538314|NCT01268111|75636324|FG000|NOT COMPLETED|Overall Study||0||
59538315|NCT01268111|75636325|FG001|NOT COMPLETED|Overall Study||0||
59538316|NCT01349231|75636331|FG000|STARTED|Overall Study||10||
59538317|NCT01349231|75636331|FG000|COMPLETED|Overall Study||10||
59538318|NCT01349231|75636331|FG000|NOT COMPLETED|Overall Study||0||
59988076|NCT00834431|76103233|FG001|STARTED|Second Intervention||16||
59988077|NCT00834431|76103232|FG000|COMPLETED|Second Intervention||18||
59988078|NCT00834431|76103233|FG001|COMPLETED|Second Intervention||16||
59988079|NCT00834431|76103232|FG000|NOT COMPLETED|Second Intervention||0||
59988080|NCT00834431|76103233|FG001|NOT COMPLETED|Second Intervention||0||
59988081|NCT00834275|76103239|FG000|STARTED|First Intervention||13||
59988082|NCT00834275|76103240|FG001|STARTED|First Intervention||13||
59988083|NCT00834275|76103239|FG000|COMPLETED|First Intervention||13||
59988084|NCT00834275|76103240|FG001|COMPLETED|First Intervention||13||
59988085|NCT00834275|76103239|FG000|NOT COMPLETED|First Intervention||0||
59988086|NCT00834275|76103240|FG001|NOT COMPLETED|First Intervention||0||
59988087|NCT00834275|76103239|FG000|STARTED|Washout of 7 Days||13||
59988088|NCT00834275|76103240|FG001|STARTED|Washout of 7 Days||13||
59623251|NCT05161806|75735316|FG000|NOT COMPLETED|Overall Study||0||
59623252|NCT02132520|75735323|FG000|STARTED|Overall Study||0||
59623253|NCT02132520|75735324|FG001|STARTED|Overall Study||1||
59623254|NCT02132520|75735325|FG002|STARTED|Overall Study||2||
59538319|NCT01349933|75636335|FG000|STARTED|Overall Study||21||
59538320|NCT01349933|75636335|FG000|COMPLETED|Overall Study||21||
59623255|NCT02132520|75735323|FG000|COMPLETED|Overall Study||0||
59623256|NCT02132520|75735324|FG001|COMPLETED|Overall Study||1||
59623257|NCT02132520|75735325|FG002|COMPLETED|Overall Study||2||
59623258|NCT02132520|75735323|FG000|NOT COMPLETED|Overall Study||0||
59623259|NCT02132520|75735324|FG001|NOT COMPLETED|Overall Study||0||
59623260|NCT02132520|75735325|FG002|NOT COMPLETED|Overall Study||0||
59988089|NCT00834275|76103239|FG000|COMPLETED|Washout of 7 Days||13||
59988090|NCT00834275|76103240|FG001|COMPLETED|Washout of 7 Days||13||
59623261|NCT00604890|75735336|FG000|STARTED|Overall Study||47||
59988091|NCT00834275|76103239|FG000|NOT COMPLETED|Washout of 7 Days||0||
59988092|NCT00834275|76103240|FG001|NOT COMPLETED|Washout of 7 Days||0||
59988093|NCT00834275|76103239|FG000|STARTED|Second Intervention||13||
59988094|NCT00834275|76103240|FG001|STARTED|Second Intervention||13||
59988095|NCT00834275|76103239|FG000|COMPLETED|Second Intervention||13||
59988096|NCT00834275|76103240|FG001|COMPLETED|Second Intervention||13||
59988097|NCT00834275|76103239|FG000|NOT COMPLETED|Second Intervention||0||
59988098|NCT00834275|76103240|FG001|NOT COMPLETED|Second Intervention||0||
59988099|NCT00834197|76103246|FG000|STARTED|First Intervention||16||
59988100|NCT00834197|76103247|FG001|STARTED|First Intervention||16||
59988101|NCT00834197|76103246|FG000|COMPLETED|First Intervention||16||
59988102|NCT00834197|76103247|FG001|COMPLETED|First Intervention||16||
59988103|NCT00834197|76103246|FG000|NOT COMPLETED|First Intervention||0||
59988104|NCT00834197|76103247|FG001|NOT COMPLETED|First Intervention||0||
59538321|NCT01349933|75636335|FG000|NOT COMPLETED|Overall Study||0||
59538322|NCT01350245|75636339|FG000|STARTED|Overall Study||28||
59538323|NCT01350245|75636339|FG000|COMPLETED|Overall Study||28||
59538324|NCT01350245|75636339|FG000|NOT COMPLETED|Overall Study||0||
59538325|NCT01350401|75636343|FG000|STARTED|Overall Study||4||
59538326|NCT01350401|75636343|FG000|COMPLETED|Overall Study||4||
59538327|NCT01350401|75636343|FG000|NOT COMPLETED|Overall Study||0||
59538328|NCT01350479|75636353|FG000|STARTED|Overall Study||94||
59538329|NCT01350479|75636354|FG001|STARTED|Overall Study||106||
59538330|NCT01350479|75636353|FG000|COMPLETED|Overall Study||94||
59538331|NCT01350479|75636354|FG001|COMPLETED|Overall Study||106||
59538332|NCT01350479|75636353|FG000|NOT COMPLETED|Overall Study||0||
59538333|NCT01350479|75636354|FG001|NOT COMPLETED|Overall Study||0||
59538334|NCT01320137|75636362|FG000|STARTED|Overall Study||40||
59538335|NCT01320137|75636363|FG001|STARTED|Overall Study||40||
59538336|NCT01320137|75636362|FG000|COMPLETED|Overall Study||40||
59538337|NCT01320137|75636363|FG001|COMPLETED|Overall Study||40||
59538338|NCT01320137|75636362|FG000|NOT COMPLETED|Overall Study||0||
59538339|NCT01320137|75636363|FG001|NOT COMPLETED|Overall Study||0||
59538340|NCT01321151|75636371|FG000|STARTED|Overall Study|The boxer was treated once-a-day for 30 days.|6||
59538341|NCT01321151|75636372|FG001|STARTED|Overall Study|The boxer was treated with once-a-day for 30 days.|6||
59538342|NCT01321151|75636371|FG000|COMPLETED|Overall Study||6||
59538343|NCT01321151|75636372|FG001|COMPLETED|Overall Study||6||
59538344|NCT01321151|75636371|FG000|NOT COMPLETED|Overall Study||0||
59538345|NCT01321151|75636372|FG001|NOT COMPLETED|Overall Study||0||
59538346|NCT01350947|75636378|FG000|STARTED|Overall Study||11||
59538347|NCT01350947|75636378|FG000|COMPLETED|Overall Study||11||
59538348|NCT01350947|75636378|FG000|NOT COMPLETED|Overall Study||0||
59538349|NCT01268189|75636382|FG000|STARTED|Overall Study||20||
59538350|NCT01268189|75636382|FG000|COMPLETED|Overall Study||17||
59538351|NCT01268189|75636382|FG000|NOT COMPLETED|Overall Study||3||
59538352|NCT01269047|75636391|FG000|STARTED|Overall Study||13||
59538353|NCT01269047|75636392|FG001|STARTED|Overall Study||13||
59538354|NCT01269047|75636393|FG002|STARTED|Overall Study||11||
59538355|NCT01269047|75636391|FG000|COMPLETED|Overall Study||12||
59538356|NCT01269047|75636392|FG001|COMPLETED|Overall Study||11||
59538357|NCT01269047|75636393|FG002|COMPLETED|Overall Study||10||
59538358|NCT01269047|75636391|FG000|NOT COMPLETED|Overall Study||1||
59538359|NCT01269047|75636392|FG001|NOT COMPLETED|Overall Study||2||
59538360|NCT01269047|75636393|FG002|NOT COMPLETED|Overall Study||1||
59538361|NCT01351337|75636403|FG000|STARTED|Overall Study||58||
59538362|NCT01351337|75636403|FG000|COMPLETED|Overall Study||58||
59538363|NCT01351337|75636403|FG000|NOT COMPLETED|Overall Study||0||
59538364|NCT02147990|75636411|FG000|STARTED|Overall Study||154||
59538365|NCT02147990|75636412|FG001|STARTED|Overall Study||100||
59538366|NCT02147990|75636413|FG002|STARTED|Overall Study||63||
59538367|NCT02147990|75636411|FG000|COMPLETED|Overall Study||154||
59988105|NCT00834197|76103246|FG000|STARTED|Washout of 14 Days||16||
59988106|NCT00834197|76103247|FG001|STARTED|Washout of 14 Days||16||
59988107|NCT00834197|76103246|FG000|COMPLETED|Washout of 14 Days||16||
59988108|NCT00834197|76103247|FG001|COMPLETED|Washout of 14 Days||16||
59538368|NCT02147990|75636412|FG001|COMPLETED|Overall Study||100||
59538369|NCT02147990|75636413|FG002|COMPLETED|Overall Study||63||
59538370|NCT02147990|75636411|FG000|NOT COMPLETED|Overall Study||0||
59538371|NCT02147990|75636412|FG001|NOT COMPLETED|Overall Study||0||
59538372|NCT02147990|75636413|FG002|NOT COMPLETED|Overall Study||0||
59538373|NCT02148302|75636424|FG000|STARTED|Overall Study||57||
59538374|NCT02148302|75636425|FG001|STARTED|Overall Study||66||
59988109|NCT00834197|76103246|FG000|NOT COMPLETED|Washout of 14 Days||0||
59988110|NCT00834197|76103247|FG001|NOT COMPLETED|Washout of 14 Days||0||
59988111|NCT00834197|76103246|FG000|STARTED|Second Intervention||16||
59988112|NCT00834197|76103247|FG001|STARTED|Second Intervention||16||
59538375|NCT02148302|75636424|FG000|COMPLETED|Overall Study||57||
59538376|NCT02148302|75636425|FG001|COMPLETED|Overall Study||66||
59988113|NCT00834197|76103246|FG000|COMPLETED|Second Intervention||16||
59538377|NCT02148302|75636424|FG000|NOT COMPLETED|Overall Study||0||
59538378|NCT02148302|75636425|FG001|NOT COMPLETED|Overall Study||0||
59538379|NCT01321541|75636433|FG000|STARTED|Overall Study||155||
59538380|NCT01321541|75636434|FG001|STARTED|Overall Study||157||
59538381|NCT01321541|75636433|FG000|COMPLETED|Overall Study||72||
59538382|NCT01321541|75636434|FG001|COMPLETED|Overall Study||61||
59538383|NCT01321541|75636433|FG000|NOT COMPLETED|Overall Study||83||
59538384|NCT01321541|75636434|FG001|NOT COMPLETED|Overall Study||96||
59538385|NCT01270529|75636443|FG000|STARTED|Overall Study||12||
59538386|NCT01270529|75636444|FG001|STARTED|Overall Study||7||
59538387|NCT01270529|75636445|FG002|STARTED|Overall Study||25||
59538388|NCT01270529|75636443|FG000|COMPLETED|Overall Study||12||
59538389|NCT01270529|75636444|FG001|COMPLETED|Overall Study||7||
59538390|NCT01270529|75636445|FG002|COMPLETED|Overall Study||25||
59538391|NCT01270529|75636443|FG000|NOT COMPLETED|Overall Study||0||
59538392|NCT01270529|75636444|FG001|NOT COMPLETED|Overall Study||0||
59538393|NCT01270529|75636445|FG002|NOT COMPLETED|Overall Study||0||
59538394|NCT01322633|75636455|FG000|STARTED|Overall Study||34178||
59538395|NCT01322633|75636456|FG001|STARTED|Overall Study||27686||
59538396|NCT01322633|75636455|FG000|COMPLETED|Overall Study||34178||
59538397|NCT01322633|75636456|FG001|COMPLETED|Overall Study||27686||
59538398|NCT01322633|75636455|FG000|NOT COMPLETED|Overall Study||0||
59538399|NCT01322633|75636456|FG001|NOT COMPLETED|Overall Study||0||
59538400|NCT01322945|75636464|FG000|STARTED|Overall Study||52||
59538401|NCT01322945|75636465|FG001|STARTED|Overall Study||42||
59538402|NCT01322945|75636464|FG000|COMPLETED|Overall Study||52||
59538403|NCT01322945|75636465|FG001|COMPLETED|Overall Study||42||
59538404|NCT01322945|75636464|FG000|NOT COMPLETED|Overall Study||0||
59538405|NCT01322945|75636465|FG001|NOT COMPLETED|Overall Study||0||
59538406|NCT01271543|75636475|FG000|STARTED|Overall Study||30||
59538407|NCT01271543|75636476|FG001|STARTED|Overall Study||30||
59538408|NCT01271543|75636475|FG000|COMPLETED|Overall Study||29||
59538409|NCT01271543|75636476|FG001|COMPLETED|Overall Study||29||
59538410|NCT01271543|75636475|FG000|NOT COMPLETED|Overall Study||1||
59538411|NCT01271543|75636476|FG001|NOT COMPLETED|Overall Study||1||
59538412|NCT01323959|75636486|FG000|STARTED|Overall Study||67||
59538413|NCT01323959|75636487|FG001|STARTED|Overall Study||72||
59538414|NCT01323959|75636488|FG002|STARTED|Overall Study||72||
59538415|NCT01323959|75636486|FG000|COMPLETED|Overall Study||67||
59538416|NCT01323959|75636487|FG001|COMPLETED|Overall Study||72||
59538417|NCT01323959|75636488|FG002|COMPLETED|Overall Study||72||
59538418|NCT01323959|75636486|FG000|NOT COMPLETED|Overall Study||0||
59538419|NCT01323959|75636487|FG001|NOT COMPLETED|Overall Study||0||
59538420|NCT01323959|75636488|FG002|NOT COMPLETED|Overall Study||0||
59538421|NCT00792428|75636498|FG000|STARTED|Overall Study||10||
59538422|NCT00792428|75636499|FG001|STARTED|Overall Study||10||
59538423|NCT00792428|75636498|FG000|COMPLETED|Overall Study||10||
59538424|NCT00792428|75636499|FG001|COMPLETED|Overall Study||10||
59538425|NCT00792428|75636498|FG000|NOT COMPLETED|Overall Study||0||
59538426|NCT00792428|75636499|FG001|NOT COMPLETED|Overall Study||0||
59538427|NCT01271855|75636507|FG000|STARTED|Overall Study||48||
59538428|NCT01271855|75636508|FG001|STARTED|Overall Study||52||
59538429|NCT01271855|75636507|FG000|COMPLETED|Overall Study||48||
59538430|NCT01271855|75636508|FG001|COMPLETED|Overall Study||52||
59538431|NCT01271855|75636507|FG000|NOT COMPLETED|Overall Study||0||
59538432|NCT01271855|75636508|FG001|NOT COMPLETED|Overall Study||0||
59538433|NCT00777764|75636516|FG000|STARTED|Overall Study||30||
59538434|NCT00777764|75636517|FG001|STARTED|Overall Study||30||
59538435|NCT00777764|75636516|FG000|COMPLETED|Overall Study||30||
59538436|NCT00777764|75636517|FG001|COMPLETED|Overall Study||29||
59538437|NCT00777764|75636516|FG000|NOT COMPLETED|Overall Study||0||
59538438|NCT00777764|75636517|FG001|NOT COMPLETED|Overall Study||1||
59538439|NCT00808340|75636525|FG000|STARTED|First Intervention||4||
59538440|NCT00808340|75636526|FG001|STARTED|First Intervention||9||
59538441|NCT00808340|75636527|FG002|STARTED|First Intervention||7||
59538442|NCT00808340|75636528|FG003|STARTED|First Intervention||3||
59538443|NCT00808340|75636529|FG004|STARTED|First Intervention||5||
59538444|NCT00808340|75636530|FG005|STARTED|First Intervention||6||
59538445|NCT00808340|75636525|FG000|COMPLETED|First Intervention||4||
59538446|NCT00808340|75636526|FG001|COMPLETED|First Intervention||9||
59538447|NCT00808340|75636527|FG002|COMPLETED|First Intervention||7||
59538448|NCT00808340|75636528|FG003|COMPLETED|First Intervention||3||
59538449|NCT00808340|75636529|FG004|COMPLETED|First Intervention||5||
59538450|NCT00808340|75636530|FG005|COMPLETED|First Intervention||6||
59538451|NCT00808340|75636525|FG000|NOT COMPLETED|First Intervention||0||
59538452|NCT00808340|75636526|FG001|NOT COMPLETED|First Intervention||0||
59538453|NCT00808340|75636527|FG002|NOT COMPLETED|First Intervention||0||
59538454|NCT00808340|75636528|FG003|NOT COMPLETED|First Intervention||0||
59538455|NCT00808340|75636529|FG004|NOT COMPLETED|First Intervention||0||
59538456|NCT00808340|75636530|FG005|NOT COMPLETED|First Intervention||0||
59538457|NCT00808340|75636525|FG000|STARTED|Second Intervention||4||
59538458|NCT00808340|75636526|FG001|STARTED|Second Intervention||9||
59538459|NCT00808340|75636527|FG002|STARTED|Second Intervention||7||
59538460|NCT00808340|75636528|FG003|STARTED|Second Intervention||3||
59538461|NCT00808340|75636529|FG004|STARTED|Second Intervention||5||
59538462|NCT00808340|75636530|FG005|STARTED|Second Intervention||6||
59538463|NCT00808340|75636525|FG000|COMPLETED|Second Intervention||4||
59538464|NCT00808340|75636526|FG001|COMPLETED|Second Intervention||9||
59538465|NCT00808340|75636527|FG002|COMPLETED|Second Intervention||7||
59538466|NCT00808340|75636528|FG003|COMPLETED|Second Intervention||3||
59538467|NCT00808340|75636529|FG004|COMPLETED|Second Intervention||5||
59538468|NCT00808340|75636530|FG005|COMPLETED|Second Intervention||6||
59538469|NCT00808340|75636525|FG000|NOT COMPLETED|Second Intervention||0||
59538470|NCT00808340|75636526|FG001|NOT COMPLETED|Second Intervention||0||
59538471|NCT00808340|75636527|FG002|NOT COMPLETED|Second Intervention||0||
59538472|NCT00808340|75636528|FG003|NOT COMPLETED|Second Intervention||0||
59538473|NCT00808340|75636529|FG004|NOT COMPLETED|Second Intervention||0||
59538474|NCT00808340|75636530|FG005|NOT COMPLETED|Second Intervention||0||
59538475|NCT00808340|75636525|FG000|STARTED|Third Intervention||4||
59538476|NCT00808340|75636526|FG001|STARTED|Third Intervention||9||
59538477|NCT00808340|75636527|FG002|STARTED|Third Intervention||7||
59538478|NCT00808340|75636528|FG003|STARTED|Third Intervention||3||
59538479|NCT00808340|75636529|FG004|STARTED|Third Intervention||5||
59538480|NCT00808340|75636530|FG005|STARTED|Third Intervention||6||
59538481|NCT00808340|75636525|FG000|COMPLETED|Third Intervention||4||
59538482|NCT00808340|75636526|FG001|COMPLETED|Third Intervention||9||
59538483|NCT00808340|75636527|FG002|COMPLETED|Third Intervention||7||
59538484|NCT00808340|75636528|FG003|COMPLETED|Third Intervention||3||
59538485|NCT00808340|75636529|FG004|COMPLETED|Third Intervention||5||
59538486|NCT00808340|75636530|FG005|COMPLETED|Third Intervention||6||
59538487|NCT00808340|75636525|FG000|NOT COMPLETED|Third Intervention||0||
59538488|NCT00808340|75636526|FG001|NOT COMPLETED|Third Intervention||0||
59815549|NCT05346653|75937989|FG001|STARTED|Overall Study||0||
59815550|NCT05346653|75937988|FG000|COMPLETED|Overall Study||0||
59538489|NCT00808340|75636527|FG002|NOT COMPLETED|Third Intervention||0||
59538490|NCT00808340|75636528|FG003|NOT COMPLETED|Third Intervention||0||
59538491|NCT00808340|75636529|FG004|NOT COMPLETED|Third Intervention||0||
59538492|NCT00808340|75636530|FG005|NOT COMPLETED|Third Intervention||0||
59538493|NCT01354145|75636540|FG000|STARTED|Overall Study||97||
59538494|NCT01354145|75636541|FG001|STARTED|Overall Study||97||
59538495|NCT01354145|75636540|FG000|COMPLETED|Overall Study||58||
59538496|NCT01354145|75636541|FG001|COMPLETED|Overall Study||63||
59538497|NCT01354145|75636540|FG000|NOT COMPLETED|Overall Study||39||
59538498|NCT01354145|75636541|FG001|NOT COMPLETED|Overall Study||34||
59538499|NCT02196857|75636547|FG000|STARTED|Overall Study||16||
59538500|NCT02196857|75636547|FG000|COMPLETED|Overall Study||16||
59538501|NCT02196857|75636547|FG000|NOT COMPLETED|Overall Study||0||
59538502|NCT01272245|75636551|FG000|STARTED|Overall Study||36||
59538503|NCT01272245|75636551|FG000|COMPLETED|Overall Study||36||
59815551|NCT05346653|75937989|FG001|COMPLETED|Overall Study||0||
59815552|NCT05346653|75937988|FG000|NOT COMPLETED|Overall Study||0||
59815553|NCT05346653|75937989|FG001|NOT COMPLETED|Overall Study||0||
59815554|NCT05159362|75937998|FG000|STARTED|Usability Testing (1 Day)||0||
59815555|NCT05159362|75937999|FG001|STARTED|Usability Testing (1 Day)||12||
59815556|NCT05159362|75938000|FG002|STARTED|Usability Testing (1 Day)||4||
59538504|NCT01272245|75636551|FG000|NOT COMPLETED|Overall Study||0||
59538505|NCT00802100|75636558|FG000|STARTED|Overall Study||6||
59538506|NCT00802100|75636559|FG001|STARTED|Overall Study||9||
59538507|NCT00802100|75636560|FG002|STARTED|Overall Study||6||
59538508|NCT00802100|75636558|FG000|COMPLETED|Overall Study||0||
59538509|NCT00802100|75636559|FG001|COMPLETED|Overall Study||2||
59538510|NCT00802100|75636560|FG002|COMPLETED|Overall Study||2||
59538511|NCT00802100|75636558|FG000|NOT COMPLETED|Overall Study||6||
59538512|NCT00802100|75636559|FG001|NOT COMPLETED|Overall Study||7||
59538513|NCT00802100|75636560|FG002|NOT COMPLETED|Overall Study||4||
59538514|NCT01354691|75636571|FG000|STARTED|Overall Study||101||
59538515|NCT01354691|75636572|FG001|STARTED|Overall Study||99||
59538516|NCT01354691|75636571|FG000|ITT|Overall Study||99||
59538517|NCT01354691|75636572|FG001|ITT|Overall Study||96||
59538518|NCT01354691|75636571|FG000|PP|Overall Study||79||
59538519|NCT01354691|75636572|FG001|PP|Overall Study||75||
59538520|NCT01354691|75636571|FG000|COMPLETED|Overall Study||80||
59538521|NCT01354691|75636572|FG001|COMPLETED|Overall Study||77||
59538522|NCT01354691|75636571|FG000|NOT COMPLETED|Overall Study||21||
59538523|NCT01354691|75636572|FG001|NOT COMPLETED|Overall Study||22||
59538524|NCT00809276|75636578|FG000|STARTED|Overall Study||92||
59815557|NCT05159362|75937998|FG000|COMPLETED|Usability Testing (1 Day)||0||
59538525|NCT00809276|75636578|FG000|COMPLETED|Overall Study||92||
59538526|NCT00809276|75636578|FG000|NOT COMPLETED|Overall Study||0||
59538527|NCT01355471|75636584|FG000|STARTED|Overall Study||148||
59538528|NCT01355471|75636585|FG001|STARTED|Overall Study||145||
59815558|NCT05159362|75937999|FG001|COMPLETED|Usability Testing (1 Day)||12||
59815559|NCT05159362|75938000|FG002|COMPLETED|Usability Testing (1 Day)||4||
59538529|NCT01355471|75636584|FG000|COMPLETED|Overall Study||141||
59538530|NCT01355471|75636585|FG001|COMPLETED|Overall Study||142||
59538531|NCT01355471|75636584|FG000|NOT COMPLETED|Overall Study||7||
59538532|NCT01355471|75636585|FG001|NOT COMPLETED|Overall Study||3||
59538533|NCT00802412|75636593|FG000|STARTED|Overall Study||65||
59538534|NCT00802412|75636594|FG001|STARTED|Overall Study||67||
59538535|NCT00802412|75636593|FG000|COMPLETED|Overall Study||63||
59538536|NCT00802412|75636594|FG001|COMPLETED|Overall Study||66||
59538537|NCT00802412|75636593|FG000|NOT COMPLETED|Overall Study||2||
59538538|NCT00802412|75636594|FG001|NOT COMPLETED|Overall Study||1||
59538539|NCT01355705|75636600|FG000|STARTED|Overall Study||14||
59538540|NCT01355705|75636600|FG000|COMPLETED|Overall Study||14|1 subject completed but was not evaluable.|
59538541|NCT01355705|75636600|FG000|NOT COMPLETED|Overall Study||0||
59538542|NCT01274585|75636607|FG000|STARTED|Overall Study||2||
59538543|NCT01274585|75636608|FG001|STARTED|Overall Study||3||
59538544|NCT01274585|75636607|FG000|COMPLETED|Overall Study||2||
59538545|NCT01274585|75636608|FG001|COMPLETED|Overall Study||3||
59538546|NCT01274585|75636607|FG000|NOT COMPLETED|Overall Study||0||
59538547|NCT01274585|75636608|FG001|NOT COMPLETED|Overall Study||0||
59538548|NCT01327157|75636616|FG000|STARTED|01-90||7||
59538549|NCT01327157|75636617|FG001|STARTED|01-90||7||
59538550|NCT01327157|75636616|FG000|COMPLETED|01-90||7||
59538551|NCT01327157|75636617|FG001|COMPLETED|01-90||7||
59538552|NCT01327157|75636616|FG000|NOT COMPLETED|01-90||0||
59538553|NCT01327157|75636617|FG001|NOT COMPLETED|01-90||0||
59538554|NCT01327157|75636616|FG000|STARTED|91-180||7||
59538555|NCT01327157|75636617|FG001|STARTED|91-180||0||
59538556|NCT01327157|75636616|FG000|COMPLETED|91-180||7||
59538557|NCT01327157|75636617|FG001|COMPLETED|91-180||0||
59538558|NCT01327157|75636616|FG000|NOT COMPLETED|91-180||0||
59538559|NCT01327157|75636617|FG001|NOT COMPLETED|91-180||0||
59538560|NCT00802880|75636628|FG000|STARTED|Overall Study||80||
59538561|NCT00802880|75636628|FG000|COMPLETED|Overall Study||80||
59538562|NCT00802880|75636628|FG000|NOT COMPLETED|Overall Study||0||
59538563|NCT00804596|75636636|FG000|STARTED|Overall Study||74||
59538564|NCT00804596|75636636|FG000|COMPLETED|Overall Study||74||
59538565|NCT00804596|75636636|FG000|NOT COMPLETED|Overall Study||0||
59538566|NCT01327313|75636644|FG000|STARTED|Overall Study||8||
59538567|NCT01327313|75636645|FG001|STARTED|Overall Study||6||
59538568|NCT01327313|75636646|FG002|STARTED|Overall Study||6||
59538569|NCT01327313|75636647|FG003|STARTED|Overall Study||7||
59538570|NCT01327313|75636644|FG000|COMPLETED|Overall Study||8||
59538571|NCT01327313|75636645|FG001|COMPLETED|Overall Study||6||
59538572|NCT01327313|75636646|FG002|COMPLETED|Overall Study||6||
59538573|NCT01327313|75636647|FG003|COMPLETED|Overall Study||7||
59538574|NCT01327313|75636644|FG000|NOT COMPLETED|Overall Study||0||
59538575|NCT01327313|75636645|FG001|NOT COMPLETED|Overall Study||0||
59538576|NCT01327313|75636646|FG002|NOT COMPLETED|Overall Study||0||
59538577|NCT01327313|75636647|FG003|NOT COMPLETED|Overall Study||0||
59538578|NCT02200055|75636657|FG000|STARTED|Overall Study||86||
59538579|NCT02200055|75636657|FG000|COMPLETED|Overall Study||86||
59538580|NCT02200055|75636657|FG000|NOT COMPLETED|Overall Study||0||
59538581|NCT02200523|75636665|FG000|STARTED|Overall Study||20||
59538582|NCT02200523|75636666|FG001|STARTED|Overall Study||20||
59538583|NCT02200523|75636665|FG000|COMPLETED|Overall Study||20||
59538584|NCT02200523|75636666|FG001|COMPLETED|Overall Study||20||
59538585|NCT02200523|75636665|FG000|NOT COMPLETED|Overall Study||0||
59538586|NCT02200523|75636666|FG001|NOT COMPLETED|Overall Study||0||
59538587|NCT01328405|75636674|FG000|STARTED|Overall Study||52||
59538588|NCT01328405|75636675|FG001|STARTED|Overall Study||48||
59538589|NCT01328405|75636674|FG000|COMPLETED|Overall Study||52||
59538590|NCT01328405|75636675|FG001|COMPLETED|Overall Study||48||
59538591|NCT01328405|75636674|FG000|NOT COMPLETED|Overall Study||0||
59538592|NCT01328405|75636675|FG001|NOT COMPLETED|Overall Study||0||
59538593|NCT01274897|75636683|FG000|STARTED|Overall Study||297||
59538594|NCT01274897|75636684|FG001|STARTED|Overall Study||153||
59538595|NCT01274897|75636683|FG000|COMPLETED|Overall Study||297||
59538596|NCT01274897|75636684|FG001|COMPLETED|Overall Study||153||
59538597|NCT01274897|75636683|FG000|NOT COMPLETED|Overall Study||0||
59538598|NCT01274897|75636684|FG001|NOT COMPLETED|Overall Study||0||
59623262|NCT00604890|75735337|FG001|STARTED|Overall Study||45||
59623263|NCT00604890|75735338|FG002|STARTED|Overall Study||48||
59623264|NCT00604890|75735339|FG003|STARTED|Overall Study||46||
59623265|NCT00604890|75735336|FG000|COMPLETED|Overall Study||44||
59623266|NCT00604890|75735337|FG001|COMPLETED|Overall Study||45||
59623267|NCT00604890|75735338|FG002|COMPLETED|Overall Study||47||
59538599|NCT02323217|75636690|FG000|STARTED|Overall Study||18||
59538600|NCT02323217|75636690|FG000|COMPLETED|Overall Study||18||
59538601|NCT02323217|75636690|FG000|NOT COMPLETED|Overall Study||0||
59538602|NCT01275053|75636694|FG000|STARTED|Overall Study||12||
59538603|NCT01275053|75636694|FG000|COMPLETED|Overall Study||12||
59538604|NCT01275053|75636694|FG000|NOT COMPLETED|Overall Study||0||
59623268|NCT00604890|75735339|FG003|COMPLETED|Overall Study||42||
59538605|NCT02324075|75636700|FG000|STARTED|Overall Study||612||612
59623269|NCT00604890|75735336|FG000|NOT COMPLETED|Overall Study||3||
59538606|NCT02324075|75636701|FG001|STARTED|Overall Study||614||614
59538607|NCT02324075|75636700|FG000|COMPLETED|Overall Study||609||605
59538608|NCT02324075|75636701|FG001|COMPLETED|Overall Study||605||605
59538609|NCT02324075|75636700|FG000|NOT COMPLETED|Overall Study||3||7
59538610|NCT02324075|75636701|FG001|NOT COMPLETED|Overall Study||9||9
59623270|NCT00604890|75735337|FG001|NOT COMPLETED|Overall Study||0||
59623271|NCT00604890|75735338|FG002|NOT COMPLETED|Overall Study||1||
59538611|NCT00811382|75636710|FG000|STARTED|Overall Study||88||
59538612|NCT00811382|75636711|FG001|STARTED|Overall Study||75||
59538613|NCT00811382|75636710|FG000|COMPLETED|Overall Study||88||
59538614|NCT00811382|75636711|FG001|COMPLETED|Overall Study||75||
59538615|NCT00811382|75636710|FG000|NOT COMPLETED|Overall Study||0||
59538616|NCT00811382|75636711|FG001|NOT COMPLETED|Overall Study||0||
59538617|NCT00806078|75636721|FG000|STARTED|First Intervention||9||
59538618|NCT00806078|75636722|FG001|STARTED|First Intervention||9||
59538619|NCT00806078|75636721|FG000|COMPLETED|First Intervention||9||
59538620|NCT00806078|75636722|FG001|COMPLETED|First Intervention||9||
59538621|NCT00806078|75636721|FG000|NOT COMPLETED|First Intervention||0||
59538622|NCT00806078|75636722|FG001|NOT COMPLETED|First Intervention||0||
59538623|NCT00806078|75636721|FG000|STARTED|7 Day Washout Period||9||
59538624|NCT00806078|75636722|FG001|STARTED|7 Day Washout Period||9||
59538625|NCT00806078|75636721|FG000|COMPLETED|7 Day Washout Period||9||
59538626|NCT00806078|75636722|FG001|COMPLETED|7 Day Washout Period||9||
59538627|NCT00806078|75636721|FG000|NOT COMPLETED|7 Day Washout Period||0||
59538628|NCT00806078|75636722|FG001|NOT COMPLETED|7 Day Washout Period||0||
59538629|NCT00806078|75636721|FG000|STARTED|Second Intervention||9||
59538630|NCT00806078|75636722|FG001|STARTED|Second Intervention||9||
59538631|NCT00806078|75636721|FG000|COMPLETED|Second Intervention||9||
59538632|NCT00806078|75636722|FG001|COMPLETED|Second Intervention||9||
59538633|NCT00806078|75636721|FG000|NOT COMPLETED|Second Intervention||0||
59538634|NCT00806078|75636722|FG001|NOT COMPLETED|Second Intervention||0||
59538635|NCT00806234|75636731|FG000|STARTED|Overall Study||47||
59538636|NCT00806234|75636732|FG001|STARTED|Overall Study||31||
59538637|NCT00806234|75636733|FG002|STARTED|Overall Study||49||
59538638|NCT00806234|75636731|FG000|COMPLETED|Overall Study||34||
59538639|NCT00806234|75636732|FG001|COMPLETED|Overall Study||19||
59538640|NCT00806234|75636733|FG002|COMPLETED|Overall Study||37||
59538641|NCT00806234|75636731|FG000|NOT COMPLETED|Overall Study||13||
59538642|NCT00806234|75636732|FG001|NOT COMPLETED|Overall Study||12||
59538643|NCT00806234|75636733|FG002|NOT COMPLETED|Overall Study||12||
59538644|NCT00807560|75636743|FG000|STARTED|Overall Study||38||
59538645|NCT00807560|75636744|FG001|STARTED|Overall Study||39||
59538646|NCT00807560|75636743|FG000|COMPLETED|Overall Study||38||
59538647|NCT00807560|75636744|FG001|COMPLETED|Overall Study||39||
59538648|NCT00807560|75636743|FG000|NOT COMPLETED|Overall Study||0||
59538649|NCT00807560|75636744|FG001|NOT COMPLETED|Overall Study||0||
59538650|NCT01275365|75636754|FG000|STARTED|Overall Study||24||
59538651|NCT01275365|75636755|FG001|STARTED|Overall Study||24||
59538652|NCT01275365|75636756|FG002|STARTED|Overall Study||22||
59538653|NCT01275365|75636757|FG003|STARTED|Overall Study||22||
59538654|NCT01275365|75636754|FG000|COMPLETED|Overall Study||21||
59538655|NCT01275365|75636755|FG001|COMPLETED|Overall Study||21||
59538656|NCT01275365|75636756|FG002|COMPLETED|Overall Study||17||
59538657|NCT01275365|75636757|FG003|COMPLETED|Overall Study||19||
59538658|NCT01275365|75636754|FG000|NOT COMPLETED|Overall Study||3||
59538659|NCT01275365|75636755|FG001|NOT COMPLETED|Overall Study||3||
59623272|NCT00604890|75735339|FG003|NOT COMPLETED|Overall Study||4||
59623273|NCT00604968|75735350|FG000|STARTED|Overall Study||25||
59623274|NCT00604968|75735350|FG000|COMPLETED|Overall Study|Due to the nature of study, all subjects receiving drug were considered to have completed.|25||
59623275|NCT00604968|75735350|FG000|NOT COMPLETED|Overall Study||0||
59623276|NCT00605202|75735354|FG000|STARTED|First Intervention||5||
59623277|NCT00605202|75735355|FG001|STARTED|First Intervention||5||
59623278|NCT00605202|75735354|FG000|COMPLETED|First Intervention||5||
59623279|NCT00605202|75735355|FG001|COMPLETED|First Intervention||5||
59623280|NCT00605202|75735354|FG000|NOT COMPLETED|First Intervention||0||
59623281|NCT00605202|75735355|FG001|NOT COMPLETED|First Intervention||0||
59623282|NCT00605202|75735354|FG000|STARTED|Washout Period of 3 Weeks||5||
59623283|NCT00605202|75735355|FG001|STARTED|Washout Period of 3 Weeks||5||
59623284|NCT00605202|75735354|FG000|COMPLETED|Washout Period of 3 Weeks||5||
59623285|NCT00605202|75735355|FG001|COMPLETED|Washout Period of 3 Weeks||5||
59623286|NCT00605202|75735354|FG000|NOT COMPLETED|Washout Period of 3 Weeks||0||
59623287|NCT00605202|75735355|FG001|NOT COMPLETED|Washout Period of 3 Weeks||0||
59623288|NCT00605202|75735354|FG000|STARTED|Second Intervention||5||
59623289|NCT00605202|75735355|FG001|STARTED|Second Intervention||5||
59623290|NCT00605202|75735354|FG000|COMPLETED|Second Intervention||5||
59815560|NCT05159362|75937998|FG000|NOT COMPLETED|Usability Testing (1 Day)||0||
59815561|NCT05159362|75937999|FG001|NOT COMPLETED|Usability Testing (1 Day)||0||
59538660|NCT01275365|75636756|FG002|NOT COMPLETED|Overall Study||5||
59538661|NCT01275365|75636757|FG003|NOT COMPLETED|Overall Study||3||
59538662|NCT00811850|75636767|FG000|STARTED|Treatment Period 1: Combigan® or Cosopt®||15||
59538663|NCT00811850|75636767|FG000|COMPLETED|Treatment Period 1: Combigan® or Cosopt®||15||
59538664|NCT00811850|75636767|FG000|NOT COMPLETED|Treatment Period 1: Combigan® or Cosopt®||0||
59538665|NCT00811850|75636767|FG000|STARTED|Treatment Period 2: Wash Out||15||
59538666|NCT00811850|75636767|FG000|COMPLETED|Treatment Period 2: Wash Out||15||
59538667|NCT00811850|75636767|FG000|NOT COMPLETED|Treatment Period 2: Wash Out||0||
59538668|NCT00811850|75636767|FG000|STARTED|Treatment Period 3: Combigan® or Cosopt®||15||
59538669|NCT00811850|75636767|FG000|COMPLETED|Treatment Period 3: Combigan® or Cosopt®||15||
59538670|NCT00811850|75636767|FG000|NOT COMPLETED|Treatment Period 3: Combigan® or Cosopt®||0||
59623291|NCT00605202|75735355|FG001|COMPLETED|Second Intervention||5||
59623292|NCT00605202|75735354|FG000|NOT COMPLETED|Second Intervention||0||
59538671|NCT01328873|75636773|FG000|STARTED|Overall Study||49||
59538672|NCT01328873|75636773|FG000|COMPLETED|Overall Study||49||
59623293|NCT00605202|75735355|FG001|NOT COMPLETED|Second Intervention||0||
59623294|NCT00605358|75735363|FG000|STARTED|Overall Study||81||
59623295|NCT00605358|75735364|FG001|STARTED|Overall Study||80||
59623296|NCT00605358|75735363|FG000|COMPLETED|Overall Study||81||
59623297|NCT00605358|75735364|FG001|COMPLETED|Overall Study||80||
59538673|NCT01328873|75636773|FG000|NOT COMPLETED|Overall Study||0||
59538674|NCT00844298|75636779|FG000|STARTED|Overall Study||91||
59538675|NCT00844298|75636779|FG000|COMPLETED|Overall Study||91||
59538676|NCT00844298|75636779|FG000|NOT COMPLETED|Overall Study||0||
59538677|NCT01329185|75636785|FG000|STARTED|Overall Study||10||
59538678|NCT01329185|75636786|FG001|STARTED|Overall Study||7||
59538679|NCT01329185|75636785|FG000|CMV Disease|Overall Study||1||
59538680|NCT01329185|75636786|FG001|CMV Disease|Overall Study||0||
59538681|NCT01329185|75636785|FG000|PTLD|Overall Study||1||
59538682|NCT01329185|75636786|FG001|PTLD|Overall Study||0||
59538683|NCT01329185|75636785|FG000|COMPLETED|Overall Study||10||
59538684|NCT01329185|75636786|FG001|COMPLETED|Overall Study||7||
59538685|NCT01329185|75636785|FG000|NOT COMPLETED|Overall Study||0||
59538686|NCT01329185|75636786|FG001|NOT COMPLETED|Overall Study||0||
59538687|NCT01276301|75636792|FG000|STARTED|First Intervention||8||
59538688|NCT01276301|75636793|FG001|STARTED|First Intervention||8||
59538689|NCT01276301|75636792|FG000|COMPLETED|First Intervention||8||
59538690|NCT01276301|75636793|FG001|COMPLETED|First Intervention||8||
59538691|NCT01276301|75636792|FG000|NOT COMPLETED|First Intervention||0||
59538692|NCT01276301|75636793|FG001|NOT COMPLETED|First Intervention||0||
59538693|NCT01276301|75636792|FG000|STARTED|Washout Period of 7 Days||8||
59623298|NCT00605358|75735363|FG000|NOT COMPLETED|Overall Study||0||
59623299|NCT00605358|75735364|FG001|NOT COMPLETED|Overall Study||0||
60076141|NCT01904773|76191364|FG000|COMPLETED|Placebo Washout First Intervention||0||
60076142|NCT01904773|76191365|FG001|COMPLETED|Placebo Washout First Intervention||1||
60076143|NCT01904773|76191366|FG002|COMPLETED|Placebo Washout First Intervention||1||
60076144|NCT01904773|76191367|FG003|COMPLETED|Placebo Washout First Intervention||2||
60076145|NCT01904773|76191368|FG004|COMPLETED|Placebo Washout First Intervention||3||
60076146|NCT01904773|76191369|FG005|COMPLETED|Placebo Washout First Intervention||4||
60076147|NCT01904773|76191370|FG006|COMPLETED|Placebo Washout First Intervention||3||
60076148|NCT01904773|76191371|FG007|COMPLETED|Placebo Washout First Intervention||3||
60076149|NCT01904773|76191372|FG008|COMPLETED|Placebo Washout First Intervention||4||
60076150|NCT01904773|76191364|FG000|NOT COMPLETED|Placebo Washout First Intervention||0||
60076151|NCT01904773|76191365|FG001|NOT COMPLETED|Placebo Washout First Intervention||1||
60076152|NCT01904773|76191366|FG002|NOT COMPLETED|Placebo Washout First Intervention||0||
60076153|NCT01904773|76191367|FG003|NOT COMPLETED|Placebo Washout First Intervention||0||
59623300|NCT00605826|75735372|FG000|STARTED|Overall Study||136||
59623301|NCT00605826|75735373|FG001|STARTED|Overall Study||70||
59623302|NCT00605826|75735372|FG000|COMPLETED|Overall Study||129||
59623303|NCT00605826|75735373|FG001|COMPLETED|Overall Study||60||
59623304|NCT00605826|75735372|FG000|NOT COMPLETED|Overall Study||7||
59623305|NCT00605826|75735373|FG001|NOT COMPLETED|Overall Study||10||
59623306|NCT02132598|75735379|FG000|STARTED|Overall Study||5||
59623307|NCT02132598|75735379|FG000|COMPLETED|Overall Study||5||
59623308|NCT02132598|75735379|FG000|NOT COMPLETED|Overall Study||0||
59623309|NCT00605904|75735385|FG000|STARTED|Baseline Data Collection and Dosing|While 37 subjects were enrolled in the protocol, only 34 were randomized to a study arm|13||
59623310|NCT00605904|75735386|FG001|STARTED|Baseline Data Collection and Dosing|While 37 subjects were enrolled in the protocol, only 34 were randomized to a study arm|21||
59623311|NCT00605904|75735385|FG000|COMPLETED|Baseline Data Collection and Dosing||13||
59623312|NCT00605904|75735386|FG001|COMPLETED|Baseline Data Collection and Dosing||16||
59623313|NCT00605904|75735385|FG000|NOT COMPLETED|Baseline Data Collection and Dosing||0||
59623314|NCT00605904|75735386|FG001|NOT COMPLETED|Baseline Data Collection and Dosing||5||
59623315|NCT00605904|75735385|FG000|STARTED|Infusion Sessions||13||
59623316|NCT00605904|75735386|FG001|STARTED|Infusion Sessions||16||
60076154|NCT01904773|76191368|FG004|NOT COMPLETED|Placebo Washout First Intervention||0||
60076155|NCT01904773|76191369|FG005|NOT COMPLETED|Placebo Washout First Intervention||0||
59538694|NCT01276301|75636793|FG001|STARTED|Washout Period of 7 Days||8||
59538695|NCT01276301|75636792|FG000|COMPLETED|Washout Period of 7 Days||8||
59538696|NCT01276301|75636793|FG001|COMPLETED|Washout Period of 7 Days||8||
59538697|NCT01276301|75636792|FG000|NOT COMPLETED|Washout Period of 7 Days||0||
59538698|NCT01276301|75636793|FG001|NOT COMPLETED|Washout Period of 7 Days||0||
59538699|NCT01276301|75636792|FG000|STARTED|Second Intervention||8||
59538700|NCT01276301|75636793|FG001|STARTED|Second Intervention||8||
59538701|NCT01276301|75636792|FG000|COMPLETED|Second Intervention||8||
59538702|NCT01276301|75636793|FG001|COMPLETED|Second Intervention||8||
59538703|NCT01276301|75636792|FG000|NOT COMPLETED|Second Intervention||0||
59538704|NCT01276301|75636793|FG001|NOT COMPLETED|Second Intervention||0||
59538705|NCT00845000|75636806|FG000|STARTED|Period 1||2||
59538706|NCT00845000|75636807|FG001|STARTED|Period 1||2||
59538707|NCT00845000|75636808|FG002|STARTED|Period 1||2||
59538708|NCT00845000|75636809|FG003|STARTED|Period 1||2||
59538709|NCT00845000|75636810|FG004|STARTED|Period 1||2||
59538710|NCT00845000|75636811|FG005|STARTED|Period 1||2||
59538711|NCT00845000|75636806|FG000|COMPLETED|Period 1||2||
59538712|NCT00845000|75636807|FG001|COMPLETED|Period 1||2||
59815562|NCT05159362|75938000|FG002|NOT COMPLETED|Usability Testing (1 Day)||0||
59815563|NCT05159362|75937998|FG000|STARTED|Field Testing (4 Weeks)||11||
59815564|NCT05159362|75937999|FG001|STARTED|Field Testing (4 Weeks)||0||
59815565|NCT05159362|75938000|FG002|STARTED|Field Testing (4 Weeks)||0||
59815566|NCT05159362|75937998|FG000|COMPLETED|Field Testing (4 Weeks)||10||
59815567|NCT05159362|75937999|FG001|COMPLETED|Field Testing (4 Weeks)||0||
59815568|NCT05159362|75938000|FG002|COMPLETED|Field Testing (4 Weeks)||0||
59815569|NCT05159362|75937998|FG000|NOT COMPLETED|Field Testing (4 Weeks)||1||
59988114|NCT00834197|76103247|FG001|COMPLETED|Second Intervention||16||
59988115|NCT00834197|76103246|FG000|NOT COMPLETED|Second Intervention||0||
59988116|NCT00834197|76103247|FG001|NOT COMPLETED|Second Intervention||0||
59988117|NCT00830219|76103253|FG000|STARTED|First Intervention||23||
59538713|NCT00845000|75636808|FG002|COMPLETED|Period 1||2||
59538714|NCT00845000|75636809|FG003|COMPLETED|Period 1||2||
59538715|NCT00845000|75636810|FG004|COMPLETED|Period 1||2||
59538716|NCT00845000|75636811|FG005|COMPLETED|Period 1||2||
59538717|NCT00845000|75636806|FG000|NOT COMPLETED|Period 1||0||
59538718|NCT00845000|75636807|FG001|NOT COMPLETED|Period 1||0||
59538719|NCT00845000|75636808|FG002|NOT COMPLETED|Period 1||0||
59538720|NCT00845000|75636809|FG003|NOT COMPLETED|Period 1||0||
59538721|NCT00845000|75636810|FG004|NOT COMPLETED|Period 1||0||
59538722|NCT00845000|75636811|FG005|NOT COMPLETED|Period 1||0||
59538723|NCT00845000|75636806|FG000|STARTED|Period 2||2||
59538724|NCT00845000|75636807|FG001|STARTED|Period 2||2||
59538725|NCT00845000|75636808|FG002|STARTED|Period 2||2||
59538726|NCT00845000|75636809|FG003|STARTED|Period 2||2||
59538727|NCT00845000|75636810|FG004|STARTED|Period 2||2||
59538728|NCT00845000|75636811|FG005|STARTED|Period 2||2||
59538729|NCT00845000|75636806|FG000|COMPLETED|Period 2||2||
59538730|NCT00845000|75636807|FG001|COMPLETED|Period 2||2||
59538731|NCT00845000|75636808|FG002|COMPLETED|Period 2||2||
59538732|NCT00845000|75636809|FG003|COMPLETED|Period 2||2||
59538733|NCT00845000|75636810|FG004|COMPLETED|Period 2||2||
59538734|NCT00845000|75636811|FG005|COMPLETED|Period 2||2||
59538735|NCT00845000|75636806|FG000|NOT COMPLETED|Period 2||0||
59538736|NCT00845000|75636807|FG001|NOT COMPLETED|Period 2||0||
59538737|NCT00845000|75636808|FG002|NOT COMPLETED|Period 2||0||
59538738|NCT00845000|75636809|FG003|NOT COMPLETED|Period 2||0||
59538739|NCT00845000|75636810|FG004|NOT COMPLETED|Period 2||0||
59538740|NCT00845000|75636811|FG005|NOT COMPLETED|Period 2||0||
59538741|NCT00845000|75636806|FG000|STARTED|Period 3||2||
59988118|NCT00830219|76103254|FG001|STARTED|First Intervention||23||
59538742|NCT00845000|75636807|FG001|STARTED|Period 3||2||
59988119|NCT00830219|76103253|FG000|COMPLETED|First Intervention||23||
59538743|NCT00845000|75636808|FG002|STARTED|Period 3||2||
59538744|NCT00845000|75636809|FG003|STARTED|Period 3||2||
59538745|NCT00845000|75636810|FG004|STARTED|Period 3||2||
59538746|NCT00845000|75636811|FG005|STARTED|Period 3||2||
59815570|NCT05159362|75937999|FG001|NOT COMPLETED|Field Testing (4 Weeks)||0||
59815571|NCT05159362|75938000|FG002|NOT COMPLETED|Field Testing (4 Weeks)||0||
59815572|NCT05057923|75938007|FG000|STARTED|Overall Study||6||
59815573|NCT05057923|75938007|FG000|COMPLETED|Overall Study||6||
59815574|NCT05057923|75938007|FG000|NOT COMPLETED|Overall Study||0||
59815575|NCT04975191|75938015|FG000|STARTED|Overall Study||66||
59815576|NCT04975191|75938016|FG001|STARTED|Overall Study||61||
59538747|NCT00845000|75636806|FG000|COMPLETED|Period 3||2||
59538748|NCT00845000|75636807|FG001|COMPLETED|Period 3||2||
59538749|NCT00845000|75636808|FG002|COMPLETED|Period 3||2||
59538750|NCT00845000|75636809|FG003|COMPLETED|Period 3||2||
59538751|NCT00845000|75636810|FG004|COMPLETED|Period 3||2||
59538752|NCT00845000|75636811|FG005|COMPLETED|Period 3||2||
59538753|NCT00845000|75636806|FG000|NOT COMPLETED|Period 3||0||
59538754|NCT00845000|75636807|FG001|NOT COMPLETED|Period 3||0||
59538755|NCT00845000|75636808|FG002|NOT COMPLETED|Period 3||0||
59538756|NCT00845000|75636809|FG003|NOT COMPLETED|Period 3||0||
59538757|NCT00845000|75636810|FG004|NOT COMPLETED|Period 3||0||
59538758|NCT00845000|75636811|FG005|NOT COMPLETED|Period 3||0||
59538759|NCT01330043|75636821|FG000|STARTED|Overall Study||111||
59538760|NCT01330043|75636822|FG001|STARTED|Overall Study||112||
59538761|NCT01330043|75636821|FG000|COMPLETED|Overall Study||111||
59538762|NCT01330043|75636822|FG001|COMPLETED|Overall Study||108||
59538763|NCT01330043|75636821|FG000|NOT COMPLETED|Overall Study||0||
59538764|NCT01330043|75636822|FG001|NOT COMPLETED|Overall Study||4||
59538765|NCT01330355|75636830|FG000|STARTED|Overall Study||16||
59538766|NCT01330355|75636831|FG001|STARTED|Overall Study||17||
59538767|NCT01330355|75636830|FG000|COMPLETED|Overall Study||16||
59538768|NCT01330355|75636831|FG001|COMPLETED|Overall Study||17||
59538769|NCT01330355|75636830|FG000|NOT COMPLETED|Overall Study||0||
59538770|NCT01330355|75636831|FG001|NOT COMPLETED|Overall Study||0||
59538771|NCT01359371|75636837|FG000|STARTED|Overall Study||131||
59538772|NCT01359371|75636837|FG000|COMPLETED|Overall Study||131||
59538773|NCT01359371|75636837|FG000|NOT COMPLETED|Overall Study||0||
59538774|NCT01276535|75636846|FG000|STARTED|Overall Study||12||
59538775|NCT01276535|75636846|FG000|COMPLETED|Overall Study||12||
59538776|NCT01276535|75636846|FG000|NOT COMPLETED|Overall Study||0||
59538777|NCT01360229|75636852|FG000|STARTED|Overall Study||47||
59538778|NCT01360229|75636853|FG001|STARTED|Overall Study||47||
59538779|NCT01360229|75636852|FG000|COMPLETED|Overall Study||44||
59538780|NCT01360229|75636853|FG001|COMPLETED|Overall Study||45||
59538781|NCT01360229|75636852|FG000|NOT COMPLETED|Overall Study||3||
59538782|NCT01360229|75636853|FG001|NOT COMPLETED|Overall Study||2||
59538783|NCT02193815|75636859|FG000|STARTED|Overall Study||15||
59538784|NCT02193815|75636859|FG000|COMPLETED|Overall Study||15||
59538785|NCT02193815|75636859|FG000|NOT COMPLETED|Overall Study||0||
59538786|NCT01277081|75636875|FG000|STARTED|Overall Study||100||
59538787|NCT01277081|75636876|FG001|STARTED|Overall Study||100||
59538788|NCT01277081|75636875|FG000|COMPLETED|Overall Study||100||
59538789|NCT01277081|75636876|FG001|COMPLETED|Overall Study||100||
59538790|NCT01277081|75636875|FG000|NOT COMPLETED|Overall Study||0||
59538791|NCT01277081|75636876|FG001|NOT COMPLETED|Overall Study||0||
59538792|NCT01361633|75636884|FG000|STARTED|Overall Study||25||
59538793|NCT01361633|75636885|FG001|STARTED|Overall Study||26||
59538794|NCT01361633|75636884|FG000|COMPLETED|Overall Study||19||
59538795|NCT01361633|75636885|FG001|COMPLETED|Overall Study||23||
59538796|NCT01361633|75636884|FG000|NOT COMPLETED|Overall Study||6||
59538797|NCT01361633|75636885|FG001|NOT COMPLETED|Overall Study||3||
59538798|NCT01331213|75636895|FG000|STARTED|Overall Study||8||
59538799|NCT01331213|75636896|FG001|STARTED|Overall Study||10||
59538800|NCT01331213|75636895|FG000|COMPLETED|Overall Study||8||
59538801|NCT01331213|75636896|FG001|COMPLETED|Overall Study||10||
59538802|NCT01331213|75636895|FG000|NOT COMPLETED|Overall Study||0||
59538803|NCT01331213|75636896|FG001|NOT COMPLETED|Overall Study||0||
59538804|NCT01332071|75636902|FG000|STARTED|Period 1||13||
59538805|NCT01332071|75636903|FG001|STARTED|Period 1||13||
59538806|NCT01332071|75636902|FG000|COMPLETED|Period 1||13||
59538807|NCT01332071|75636903|FG001|COMPLETED|Period 1||13||
59538808|NCT01332071|75636902|FG000|NOT COMPLETED|Period 1||0||
59538809|NCT01332071|75636903|FG001|NOT COMPLETED|Period 1||0||
59538810|NCT01332071|75636902|FG000|STARTED|7-Day Washout Period||13||
59538811|NCT01332071|75636903|FG001|STARTED|7-Day Washout Period||13||
59538812|NCT01332071|75636902|FG000|COMPLETED|7-Day Washout Period||13||
59538813|NCT01332071|75636903|FG001|COMPLETED|7-Day Washout Period||13||
59538814|NCT01332071|75636902|FG000|NOT COMPLETED|7-Day Washout Period||0||
59538815|NCT01332071|75636903|FG001|NOT COMPLETED|7-Day Washout Period||0||
59538816|NCT01332071|75636902|FG000|STARTED|Period 2||13||
59538817|NCT01332071|75636903|FG001|STARTED|Period 2||13||
59538818|NCT01332071|75636902|FG000|COMPLETED|Period 2||13||
59538819|NCT01332071|75636903|FG001|COMPLETED|Period 2||13||
59538820|NCT01332071|75636902|FG000|NOT COMPLETED|Period 2||0||
59538821|NCT01332071|75636903|FG001|NOT COMPLETED|Period 2||0||
59538822|NCT01277159|75636916|FG000|STARTED|Overall Study||21||
59538823|NCT01277159|75636917|FG001|STARTED|Overall Study||22||
59538824|NCT01277159|75636918|FG002|STARTED|Overall Study||22||
59538825|NCT01277159|75636919|FG003|STARTED|Overall Study||22||
59538826|NCT01277159|75636920|FG004|STARTED|Overall Study||21||
59538827|NCT01277159|75636916|FG000|COMPLETED|Overall Study||17||
59538828|NCT01277159|75636917|FG001|COMPLETED|Overall Study||21||
59538829|NCT01277159|75636918|FG002|COMPLETED|Overall Study||19||
59538830|NCT01277159|75636919|FG003|COMPLETED|Overall Study||19||
59538831|NCT01277159|75636920|FG004|COMPLETED|Overall Study||16||
59538832|NCT01277159|75636916|FG000|NOT COMPLETED|Overall Study||4||
59538833|NCT01277159|75636917|FG001|NOT COMPLETED|Overall Study||1||
59538834|NCT01277159|75636918|FG002|NOT COMPLETED|Overall Study||3||
59538835|NCT01277159|75636919|FG003|NOT COMPLETED|Overall Study||3||
59538836|NCT01277159|75636920|FG004|NOT COMPLETED|Overall Study||5||
59538837|NCT01361867|75636932|FG000|STARTED|Overall Study||15||
59538838|NCT01361867|75636932|FG000|COMPLETED|Overall Study||15||
59538839|NCT01361867|75636932|FG000|NOT COMPLETED|Overall Study||0||
59538840|NCT01277783|75636936|FG000|STARTED|Overall Study||138||
59538841|NCT01277783|75636936|FG000|COMPLETED|Overall Study||138||
59538842|NCT01277783|75636936|FG000|NOT COMPLETED|Overall Study||0||
59538843|NCT01278485|75636941|FG000|STARTED|Overall Study||719||
59538844|NCT01278485|75636941|FG000|COMPLETED|Overall Study||719||
59538845|NCT01278485|75636941|FG000|NOT COMPLETED|Overall Study||0||
59538846|NCT01362959|75636947|FG000|STARTED|Overall Study||21||
59538847|NCT01362959|75636948|FG001|STARTED|Overall Study||26||
59538848|NCT01362959|75636947|FG000|COMPLETED|Overall Study||21||
59538849|NCT01362959|75636948|FG001|COMPLETED|Overall Study||26||
59538850|NCT01362959|75636947|FG000|NOT COMPLETED|Overall Study||0||
59538851|NCT01362959|75636948|FG001|NOT COMPLETED|Overall Study||0||
59538852|NCT01278953|75636956|FG000|STARTED|Overall Study||155||
59538853|NCT01278953|75636957|FG001|STARTED|Overall Study||145||
59538854|NCT01278953|75636956|FG000|COMPLETED|Overall Study||146||
59538855|NCT01278953|75636957|FG001|COMPLETED|Overall Study||134||
59538856|NCT01278953|75636956|FG000|NOT COMPLETED|Overall Study||9||
59538857|NCT01278953|75636957|FG001|NOT COMPLETED|Overall Study||11||
59538858|NCT01332461|75636965|FG000|STARTED|Overall Study||1291||
59538859|NCT01332461|75636966|FG001|STARTED|Overall Study||4386||
59538860|NCT01332461|75636965|FG000|COMPLETED|Overall Study||1291||
59538861|NCT01332461|75636966|FG001|COMPLETED|Overall Study||4386||
59538862|NCT01332461|75636965|FG000|NOT COMPLETED|Overall Study||0||
59538863|NCT01332461|75636966|FG001|NOT COMPLETED|Overall Study||0||
59538864|NCT01279109|75636974|FG000|STARTED|Overall Study||68||
59538865|NCT01279109|75636975|FG001|STARTED|Overall Study||67||
59538866|NCT01279109|75636974|FG000|COMPLETED|Overall Study||55||
59538867|NCT01279109|75636975|FG001|COMPLETED|Overall Study||55||
59538868|NCT01279109|75636974|FG000|NOT COMPLETED|Overall Study||13||
59538869|NCT01279109|75636975|FG001|NOT COMPLETED|Overall Study||12||
59538870|NCT01279187|75636983|FG000|STARTED|Overall Study||14||
59538871|NCT01279187|75636984|FG001|STARTED|Overall Study||13||
59623317|NCT00605904|75735385|FG000|Saline Infusion|Infusion Sessions||13||
59623318|NCT00605904|75735386|FG001|Saline Infusion|Infusion Sessions||14||
59623319|NCT00605904|75735385|FG000|mCPP Infusion|Infusion Sessions||12||
59623320|NCT00605904|75735386|FG001|mCPP Infusion|Infusion Sessions||13||
59623321|NCT00605904|75735385|FG000|Yohimbine Infusion|Infusion Sessions||12||
59623322|NCT00605904|75735386|FG001|Yohimbine Infusion|Infusion Sessions|Milestones (infusions) were not received in the same order for each subjects so are not consecutive.|15||
59623323|NCT00605904|75735385|FG000|COMPLETED|Infusion Sessions|Subjects who completed all three types of infusion (given in a different order for each subject)|12||
59623324|NCT00605904|75735386|FG001|COMPLETED|Infusion Sessions|Subjects who completed all three types of infusion (given in a different order for each subject)|13||
59623325|NCT00605904|75735385|FG000|NOT COMPLETED|Infusion Sessions||1||
59623326|NCT00605904|75735386|FG001|NOT COMPLETED|Infusion Sessions||3||
59623327|NCT02132676|75735394|FG000|STARTED|Overall Study||727||
59623328|NCT02132676|75735395|FG001|STARTED|Overall Study||809||
59623329|NCT02132676|75735394|FG000|COMPLETED|Overall Study||727||
59623330|NCT02132676|75735395|FG001|COMPLETED|Overall Study||809||
59623331|NCT02132676|75735394|FG000|NOT COMPLETED|Overall Study||0||
59623332|NCT02132676|75735395|FG001|NOT COMPLETED|Overall Study||0||
59623333|NCT00607620|75735404|FG000|STARTED|Overall Study||409||
59623334|NCT00607620|75735405|FG001|STARTED|Overall Study||469||
59623335|NCT00607620|75735404|FG000|COMPLETED|Overall Study||409||
59623336|NCT00607620|75735405|FG001|COMPLETED|Overall Study||469||
59623337|NCT00607620|75735404|FG000|NOT COMPLETED|Overall Study||0||
59623338|NCT00607620|75735405|FG001|NOT COMPLETED|Overall Study||0||
59623339|NCT00608634|75735414|FG000|STARTED|Overall Study||28||
59623340|NCT00608634|75735415|FG001|STARTED|Overall Study||27||
59623341|NCT00608634|75735416|FG002|STARTED|Overall Study||28||
59623342|NCT00608634|75735414|FG000|COMPLETED|Overall Study||26||
59623343|NCT00608634|75735415|FG001|COMPLETED|Overall Study||26||
59623344|NCT00608634|75735416|FG002|COMPLETED|Overall Study||27||
59623345|NCT00608634|75735414|FG000|NOT COMPLETED|Overall Study||2||
59623346|NCT00608634|75735415|FG001|NOT COMPLETED|Overall Study||1||
59623347|NCT00608634|75735416|FG002|NOT COMPLETED|Overall Study||1||
59623354|NCT02740374|75735437|FG000|STARTED|Overall Study||55||
59623355|NCT02740374|75735438|FG001|STARTED|Overall Study||57||
59623356|NCT02740374|75735437|FG000|COMPLETED|Overall Study||55||
59623357|NCT02740374|75735438|FG001|COMPLETED|Overall Study||57||
59623358|NCT02740374|75735437|FG000|NOT COMPLETED|Overall Study||0||
59538872|NCT01279187|75636983|FG000|COMPLETED|Overall Study||14||
59623359|NCT02740374|75735438|FG001|NOT COMPLETED|Overall Study||0||
59623360|NCT00609804|75735446|FG000|STARTED|Overall Study||25||
59623361|NCT00609804|75735447|FG001|STARTED|Overall Study||28||
59623362|NCT00609804|75735446|FG000|COMPLETED|Overall Study|Pts remained on study until required to end treatment due to progression/toxicity/MD decision/etc|0||
59623363|NCT00609804|75735447|FG001|COMPLETED|Overall Study|Pts remained on study until required to end treatment due to progression/toxicity/MD decision/etc|0||
59623364|NCT00609804|75735446|FG000|NOT COMPLETED|Overall Study||25||
59623365|NCT00609804|75735447|FG001|NOT COMPLETED|Overall Study||28||
59538873|NCT01279187|75636984|FG001|COMPLETED|Overall Study||13||
59538874|NCT01279187|75636983|FG000|NOT COMPLETED|Overall Study||0||
59538875|NCT01279187|75636984|FG001|NOT COMPLETED|Overall Study||0||
59538876|NCT01279265|75636992|FG000|STARTED|Overall Study||13||
59538877|NCT01279265|75636993|FG001|STARTED|Overall Study||17||
59623366|NCT00610116|75735456|FG000|STARTED|Overall Study||305||
59623367|NCT00610116|75735456|FG000|COMPLETED|Overall Study|Number of analyzable patients|292||
59538878|NCT01279265|75636992|FG000|COMPLETED|Overall Study||9||
59538879|NCT01279265|75636993|FG001|COMPLETED|Overall Study||11||
59538880|NCT01279265|75636992|FG000|NOT COMPLETED|Overall Study||4||
59538881|NCT01279265|75636993|FG001|NOT COMPLETED|Overall Study||6||
59538882|NCT00848510|75637005|FG000|STARTED|Overall Study||10||
59538883|NCT00848510|75637006|FG001|STARTED|Overall Study||13||
59538884|NCT00848510|75637007|FG002|STARTED|Overall Study||8||
59538885|NCT00848510|75637008|FG003|STARTED|Overall Study||10||
59538886|NCT00848510|75637005|FG000|COMPLETED|Overall Study||10||
59538887|NCT00848510|75637006|FG001|COMPLETED|Overall Study||13||
59538888|NCT00848510|75637007|FG002|COMPLETED|Overall Study||8||
59538889|NCT00848510|75637008|FG003|COMPLETED|Overall Study||10||
59538890|NCT00848510|75637005|FG000|NOT COMPLETED|Overall Study||0||
59538891|NCT00848510|75637006|FG001|NOT COMPLETED|Overall Study||0||
59538892|NCT00848510|75637007|FG002|NOT COMPLETED|Overall Study||0||
59538893|NCT00848510|75637008|FG003|NOT COMPLETED|Overall Study||0||
59538894|NCT00848744|75637018|FG000|STARTED|Overall Study||10||
59538895|NCT00848744|75637018|FG000|COMPLETED|Overall Study||10||
59538896|NCT00848744|75637018|FG000|NOT COMPLETED|Overall Study||0||
59538897|NCT03698708|75637025|FG000|STARTED|Overall Study||17||
59538898|NCT03698708|75637026|FG001|STARTED|Overall Study||20||
59538899|NCT03698708|75637025|FG000|COMPLETED|Overall Study||13||
59538900|NCT03698708|75637026|FG001|COMPLETED|Overall Study||16||
59538901|NCT03698708|75637025|FG000|NOT COMPLETED|Overall Study||4||
59538902|NCT03698708|75637026|FG001|NOT COMPLETED|Overall Study||4||
59538903|NCT01280123|75637035|FG000|STARTED|Overall Study||72||
59538904|NCT01280123|75637036|FG001|STARTED|Overall Study||67||
59538905|NCT01280123|75637037|FG002|STARTED|Overall Study||71||
59538906|NCT01280123|75637035|FG000|COMPLETED|Overall Study||71||
59538907|NCT01280123|75637036|FG001|COMPLETED|Overall Study||63||
59538908|NCT01280123|75637037|FG002|COMPLETED|Overall Study||70||
59538909|NCT01280123|75637035|FG000|NOT COMPLETED|Overall Study||1||
59538910|NCT01280123|75637036|FG001|NOT COMPLETED|Overall Study||4||
59538911|NCT01280123|75637037|FG002|NOT COMPLETED|Overall Study||1||
59538912|NCT01280201|75637045|FG000|STARTED|Overall Study||44||
59538913|NCT01280201|75637045|FG000|COMPLETED|Overall Study||44||
59538914|NCT01280201|75637045|FG000|NOT COMPLETED|Overall Study||0||
59538915|NCT00851006|75637049|FG000|STARTED|Overall Study||7||
59538916|NCT00851006|75637050|FG001|STARTED|Overall Study||6||
59538917|NCT00851006|75637049|FG000|COMPLETED|Overall Study||7||
59538918|NCT00851006|75637050|FG001|COMPLETED|Overall Study||6||
59538919|NCT00851006|75637049|FG000|NOT COMPLETED|Overall Study||0||
59538920|NCT00851006|75637050|FG001|NOT COMPLETED|Overall Study||0||
59538921|NCT01364207|75637057|FG000|STARTED|First Visit (~1.5-2 Hours)||54||
59538922|NCT01364207|75637058|FG001|STARTED|First Visit (~1.5-2 Hours)||58||
59538923|NCT01364207|75637057|FG000|COMPLETED|First Visit (~1.5-2 Hours)||54||
59538924|NCT01364207|75637058|FG001|COMPLETED|First Visit (~1.5-2 Hours)||58||
59538925|NCT01364207|75637057|FG000|NOT COMPLETED|First Visit (~1.5-2 Hours)||0||
59538926|NCT01364207|75637058|FG001|NOT COMPLETED|First Visit (~1.5-2 Hours)||0||
59538927|NCT01364207|75637057|FG000|STARTED|Time Between Visits (2 Days to 4 Weeks)||54||
59538928|NCT01364207|75637058|FG001|STARTED|Time Between Visits (2 Days to 4 Weeks)||58||
59538929|NCT01364207|75637057|FG000|COMPLETED|Time Between Visits (2 Days to 4 Weeks)||52||
59538930|NCT01364207|75637058|FG001|COMPLETED|Time Between Visits (2 Days to 4 Weeks)||54||
59538931|NCT01364207|75637057|FG000|NOT COMPLETED|Time Between Visits (2 Days to 4 Weeks)||2||
59538932|NCT01364207|75637058|FG001|NOT COMPLETED|Time Between Visits (2 Days to 4 Weeks)||4||
59538933|NCT01364207|75637057|FG000|STARTED|Second Visit (~1.5-2 Hours)||52||
59538934|NCT01364207|75637058|FG001|STARTED|Second Visit (~1.5-2 Hours)||54||
59538935|NCT01364207|75637057|FG000|COMPLETED|Second Visit (~1.5-2 Hours)||52||
59538936|NCT01364207|75637058|FG001|COMPLETED|Second Visit (~1.5-2 Hours)||54||
59538937|NCT01364207|75637057|FG000|NOT COMPLETED|Second Visit (~1.5-2 Hours)||0||
59538938|NCT01364207|75637058|FG001|NOT COMPLETED|Second Visit (~1.5-2 Hours)||0||
59538939|NCT03608696|75637064|FG000|STARTED|Overall Study||10||
59538940|NCT03608696|75637064|FG000|COMPLETED|Overall Study||10||
59538941|NCT03608696|75637064|FG000|NOT COMPLETED|Overall Study||0||
59538942|NCT01334723|75637070|FG000|STARTED|Overall Study||17293||
59538943|NCT01334723|75637071|FG001|STARTED|Overall Study||17739||
59538944|NCT01334723|75637070|FG000|COMPLETED|Overall Study||17293||
59538945|NCT01334723|75637071|FG001|COMPLETED|Overall Study||17739||
59538946|NCT01334723|75637070|FG000|NOT COMPLETED|Overall Study||0||
59538947|NCT01334723|75637071|FG001|NOT COMPLETED|Overall Study||0||
59538948|NCT01334957|75637089|FG000|STARTED|Overall Study||300||
59538949|NCT01334957|75637089|FG000|Received Single Dose|Overall Study||252||
59538950|NCT01334957|75637089|FG000|Received Multiple Doses|Overall Study||48||
59538951|NCT01334957|75637089|FG000|COMPLETED|Overall Study||300||
59538952|NCT01334957|75637089|FG000|NOT COMPLETED|Overall Study||0||
59538953|NCT01402427|75637095|FG000|STARTED|Overall Study||297||
59538954|NCT01402427|75637096|FG001|STARTED|Overall Study||294||
59538955|NCT01402427|75637095|FG000|COMPLETED|Overall Study||297||
59538956|NCT01402427|75637096|FG001|COMPLETED|Overall Study||294||
59538957|NCT01402427|75637095|FG000|NOT COMPLETED|Overall Study||0||
59538958|NCT01402427|75637096|FG001|NOT COMPLETED|Overall Study||0||
59538959|NCT00813176|75637104|FG000|STARTED|Overall Study||25||
59538960|NCT00813176|75637105|FG001|STARTED|Overall Study||25||
59538961|NCT00813176|75637104|FG000|COMPLETED|Overall Study||25||
59538962|NCT00813176|75637105|FG001|COMPLETED|Overall Study||25||
59538963|NCT00813176|75637104|FG000|NOT COMPLETED|Overall Study||0||
59538964|NCT00813176|75637105|FG001|NOT COMPLETED|Overall Study||0||
59538965|NCT01335191|75637115|FG000|STARTED|Overall Study||16||
59538966|NCT01335191|75637116|FG001|STARTED|Overall Study||11||
59538967|NCT01335191|75637115|FG000|COMPLETED|Overall Study||16||
59538968|NCT01335191|75637116|FG001|COMPLETED|Overall Study||11||
59538969|NCT01335191|75637115|FG000|NOT COMPLETED|Overall Study||0||
59538970|NCT01335191|75637116|FG001|NOT COMPLETED|Overall Study||0||
59538971|NCT01365611|75637122|FG000|STARTED|Overall Study||36||
59538972|NCT01365611|75637122|FG000|COMPLETED|Overall Study||36||
59538973|NCT01365611|75637122|FG000|NOT COMPLETED|Overall Study||0||
59538974|NCT01403441|75637128|FG000|STARTED|Overall Study||3||
59623368|NCT00610116|75735456|FG000|NOT COMPLETED|Overall Study||13||
59623369|NCT00610428|75735463|FG000|STARTED|Overall Study||24||
59623370|NCT00610428|75735464|FG001|STARTED|Overall Study||24||
59623371|NCT00610428|75735465|FG002|STARTED|Overall Study||27||
59623372|NCT00610428|75735463|FG000|COMPLETED|Overall Study||24||
59623373|NCT00610428|75735464|FG001|COMPLETED|Overall Study||23||
59623374|NCT00610428|75735465|FG002|COMPLETED|Overall Study||25||
59623375|NCT00610428|75735463|FG000|NOT COMPLETED|Overall Study||0||
59623376|NCT00610428|75735464|FG001|NOT COMPLETED|Overall Study||1||
59623377|NCT00610428|75735465|FG002|NOT COMPLETED|Overall Study||2||
59623378|NCT00610740|75735473|FG000|STARTED|Overall Study||18||
59623379|NCT00610740|75735473|FG000|COMPLETED|Overall Study||18||
59623380|NCT00610740|75735473|FG000|NOT COMPLETED|Overall Study||0||
59623381|NCT00611442|75735479|FG000|STARTED|Overall Study||95||
59623382|NCT00611442|75735480|FG001|STARTED|Overall Study||96||
59623383|NCT00611442|75735479|FG000|COMPLETED|Overall Study||94||
59623384|NCT00611442|75735480|FG001|COMPLETED|Overall Study||94||
59623385|NCT00611442|75735479|FG000|NOT COMPLETED|Overall Study||1||
59623386|NCT00611442|75735480|FG001|NOT COMPLETED|Overall Study||2||
59623387|NCT02136420|75735490|FG000|STARTED|Overall Study||10||
59623388|NCT02136420|75735491|FG001|STARTED|Overall Study||0||
59623389|NCT02136420|75735492|FG002|STARTED|Overall Study||0||
59623390|NCT02136420|75735493|FG003|STARTED|Overall Study||0||
59623391|NCT02136420|75735494|FG004|STARTED|Overall Study||10||
59623392|NCT02136420|75735495|FG005|STARTED|Overall Study||0||
59623393|NCT02136420|75735496|FG006|STARTED|Overall Study||0||
59623394|NCT02136420|75735497|FG007|STARTED|Overall Study||0||
59623395|NCT02136420|75735498|FG008|STARTED|Overall Study||5||
59623396|NCT02136420|75735499|FG009|STARTED|Overall Study||5||
59623397|NCT02136420|75735490|FG000|COMPLETED|Overall Study||9||
59623398|NCT02136420|75735491|FG001|COMPLETED|Overall Study||0||
59623399|NCT02136420|75735492|FG002|COMPLETED|Overall Study||0||
59623400|NCT02136420|75735493|FG003|COMPLETED|Overall Study||0||
59815577|NCT04975191|75938017|FG002|STARTED|Overall Study||63||
59538975|NCT01403441|75637128|FG000|COMPLETED|Overall Study||3||
59538976|NCT01403441|75637128|FG000|NOT COMPLETED|Overall Study||0||
59623401|NCT02136420|75735494|FG004|COMPLETED|Overall Study||10||
59623402|NCT02136420|75735495|FG005|COMPLETED|Overall Study||0||
59623403|NCT02136420|75735496|FG006|COMPLETED|Overall Study||0||
59623404|NCT02136420|75735497|FG007|COMPLETED|Overall Study||0||
59623405|NCT02136420|75735498|FG008|COMPLETED|Overall Study||5||
59623406|NCT02136420|75735499|FG009|COMPLETED|Overall Study||5||
59623407|NCT02136420|75735490|FG000|NOT COMPLETED|Overall Study||1||
59538977|NCT01404611|75637137|FG000|STARTED|Overall Study||112||
59538978|NCT01404611|75637138|FG001|STARTED|Overall Study||108||
59538979|NCT01404611|75637139|FG002|STARTED|Overall Study||111||
59538980|NCT01404611|75637137|FG000|COMPLETED|Overall Study||104||
59538981|NCT01404611|75637138|FG001|COMPLETED|Overall Study||89||
59538982|NCT01404611|75637139|FG002|COMPLETED|Overall Study||106||
59538983|NCT01404611|75637137|FG000|NOT COMPLETED|Overall Study||8||
59538984|NCT01404611|75637138|FG001|NOT COMPLETED|Overall Study||19||
59538985|NCT01404611|75637139|FG002|NOT COMPLETED|Overall Study||5||
59538986|NCT01365845|75637147|FG000|STARTED|Induction Phase||18||
59538987|NCT01365845|75637148|FG001|STARTED|Induction Phase||0||
59623408|NCT02136420|75735491|FG001|NOT COMPLETED|Overall Study||0||
59623409|NCT02136420|75735492|FG002|NOT COMPLETED|Overall Study||0||
59623410|NCT02136420|75735493|FG003|NOT COMPLETED|Overall Study||0||
59623411|NCT02136420|75735494|FG004|NOT COMPLETED|Overall Study||0||
59623412|NCT02136420|75735495|FG005|NOT COMPLETED|Overall Study||0||
59623413|NCT02136420|75735496|FG006|NOT COMPLETED|Overall Study||0||
59815578|NCT04975191|75938018|FG003|STARTED|Overall Study||62||
59538988|NCT01365845|75637149|FG002|STARTED|Induction Phase||0||
59538989|NCT01365845|75637147|FG000|COMPLETED|Induction Phase||18||
59815579|NCT04975191|75938015|FG000|COMPLETED|Overall Study||52||
59538990|NCT01365845|75637148|FG001|COMPLETED|Induction Phase||0||
59538991|NCT01365845|75637149|FG002|COMPLETED|Induction Phase||0||
59538992|NCT01365845|75637147|FG000|NOT COMPLETED|Induction Phase||0||
59623414|NCT02136420|75735497|FG007|NOT COMPLETED|Overall Study||0||
59623415|NCT02136420|75735498|FG008|NOT COMPLETED|Overall Study||0||
59623416|NCT02136420|75735499|FG009|NOT COMPLETED|Overall Study||0||
59623417|NCT02136498|75735516|FG000|STARTED|Overall Study||33||
59623418|NCT02136498|75735517|FG001|STARTED|Overall Study||33||
59623419|NCT02136498|75735516|FG000|COMPLETED|Overall Study||33||
59623420|NCT02136498|75735517|FG001|COMPLETED|Overall Study||33||
59623421|NCT02136498|75735516|FG000|NOT COMPLETED|Overall Study||0||
59623422|NCT02136498|75735517|FG001|NOT COMPLETED|Overall Study||0||
59623423|NCT00612222|75735523|FG000|STARTED|Overall Study||4||
59623424|NCT00612222|75735523|FG000|COMPLETED|Overall Study||4||
59623425|NCT00612222|75735523|FG000|NOT COMPLETED|Overall Study||0||
59623426|NCT00612768|75735527|FG000|STARTED|Overall Study||50||
59623427|NCT00612768|75735527|FG000|COMPLETED|Overall Study||50||
59623428|NCT00612768|75735527|FG000|NOT COMPLETED|Overall Study||0||
59623429|NCT01285362|75735554|FG000|STARTED|Overall Study||4||
59623430|NCT01285362|75735555|FG001|STARTED|Overall Study||4||
59623431|NCT01285362|75735554|FG000|COMPLETED|Overall Study||4||
59623432|NCT01285362|75735555|FG001|COMPLETED|Overall Study||4||
59623433|NCT01285362|75735554|FG000|NOT COMPLETED|Overall Study||0||
59623434|NCT01285362|75735555|FG001|NOT COMPLETED|Overall Study||0||
59623435|NCT00612924|75735563|FG000|STARTED|Overall Study||101||
59623436|NCT00612924|75735564|FG001|STARTED|Overall Study||94||
59623437|NCT00612924|75735563|FG000|COMPLETED|Overall Study||94||
59623438|NCT00612924|75735564|FG001|COMPLETED|Overall Study||85||
59623439|NCT00612924|75735563|FG000|NOT COMPLETED|Overall Study||7||
59623440|NCT00612924|75735564|FG001|NOT COMPLETED|Overall Study||9||
59623441|NCT02132832|75735573|FG000|STARTED|Overall Study||19||
59623442|NCT02132832|75735574|FG001|STARTED|Overall Study||23||
59623443|NCT02132832|75735573|FG000|COMPLETED|Overall Study||16||
59623444|NCT02132832|75735574|FG001|COMPLETED|Overall Study||16||
59623445|NCT02132832|75735573|FG000|NOT COMPLETED|Overall Study||3||
59623446|NCT02132832|75735574|FG001|NOT COMPLETED|Overall Study||7||
59623447|NCT00614406|75735582|FG000|STARTED|Overall Study||7||
59623448|NCT00614406|75735583|FG001|STARTED|Overall Study||4||
59623449|NCT00614406|75735582|FG000|COMPLETED|Overall Study||7||
59623450|NCT00614406|75735583|FG001|COMPLETED|Overall Study||4||
59623451|NCT00614406|75735582|FG000|NOT COMPLETED|Overall Study||0||
59623452|NCT00614406|75735583|FG001|NOT COMPLETED|Overall Study||0||
59623453|NCT02132910|75735591|FG000|STARTED|Overall Study||34||
59623454|NCT02132910|75735592|FG001|STARTED|Overall Study||34||
59623455|NCT02132910|75735591|FG000|COMPLETED|Overall Study||34||
59623456|NCT02132910|75735592|FG001|COMPLETED|Overall Study||34||
59623457|NCT02132910|75735591|FG000|NOT COMPLETED|Overall Study||0||
59623458|NCT02132910|75735592|FG001|NOT COMPLETED|Overall Study||0||
59623459|NCT02133066|75735600|FG000|STARTED|Overall Study||64||
59623460|NCT02133066|75735601|FG001|STARTED|Overall Study||64||
59623461|NCT02133066|75735600|FG000|COMPLETED|Overall Study||64||
59623462|NCT02133066|75735601|FG001|COMPLETED|Overall Study||64||
59623463|NCT02133066|75735600|FG000|NOT COMPLETED|Overall Study||0||
59623464|NCT02133066|75735601|FG001|NOT COMPLETED|Overall Study||0||
59623465|NCT00614484|75735607|FG000|STARTED|Overall Study||28||
59623466|NCT00614484|75735607|FG000|COMPLETED|Overall Study||28||
59623467|NCT00614484|75735607|FG000|NOT COMPLETED|Overall Study||0||
59623468|NCT00615420|75735614|FG000|STARTED|Overall Study||54||
59623469|NCT00615420|75735615|FG001|STARTED|Overall Study||52||
59623470|NCT00615420|75735614|FG000|COMPLETED|Overall Study||23||
59623471|NCT00615420|75735615|FG001|COMPLETED|Overall Study||25||
59623472|NCT00615420|75735614|FG000|NOT COMPLETED|Overall Study||31||
59623473|NCT00615420|75735615|FG001|NOT COMPLETED|Overall Study||27||
59623474|NCT00568854|75735623|FG000|STARTED|Overall Study||6||
59538993|NCT01365845|75637148|FG001|NOT COMPLETED|Induction Phase||0||
59623475|NCT00568854|75735624|FG001|STARTED|Overall Study||4||
59623476|NCT00568854|75735623|FG000|COMPLETED|Overall Study||6||
59623477|NCT00568854|75735624|FG001|COMPLETED|Overall Study||4||
59623478|NCT00568854|75735623|FG000|NOT COMPLETED|Overall Study||0||
59538994|NCT01365845|75637149|FG002|NOT COMPLETED|Induction Phase||0||
59538995|NCT01365845|75637147|FG000|STARTED|Treatment Phase||0||
59538996|NCT01365845|75637148|FG001|STARTED|Treatment Phase||0||
59538997|NCT01365845|75637149|FG002|STARTED|Treatment Phase||18||
59538998|NCT01365845|75637147|FG000|COMPLETED|Treatment Phase||0||
59538999|NCT01365845|75637148|FG001|COMPLETED|Treatment Phase||0||
59539000|NCT01365845|75637149|FG002|COMPLETED|Treatment Phase||18||
59539001|NCT01365845|75637147|FG000|NOT COMPLETED|Treatment Phase||0||
59539002|NCT01365845|75637148|FG001|NOT COMPLETED|Treatment Phase||0||
59539003|NCT01365845|75637149|FG002|NOT COMPLETED|Treatment Phase||0||
59539004|NCT01472549|75637156|FG000|STARTED|Overall Study||572||
59539005|NCT01472549|75637157|FG001|STARTED|Overall Study||575||
59539006|NCT01472549|75637156|FG000|COMPLETED|Overall Study||572||
59539007|NCT01472549|75637157|FG001|COMPLETED|Overall Study||575||
59539008|NCT01472549|75637156|FG000|NOT COMPLETED|Overall Study||0||
59539009|NCT01472549|75637157|FG001|NOT COMPLETED|Overall Study||0||
59539010|NCT00852644|75637163|FG000|STARTED|Overall Study||3||
59539011|NCT00852644|75637164|FG001|STARTED|Overall Study||3||
59539012|NCT00852644|75637165|FG002|STARTED|Overall Study||0||
59539013|NCT00852644|75637166|FG003|STARTED|Overall Study||3||
59539014|NCT00852644|75637167|FG004|STARTED|Overall Study||0||
59539015|NCT00852644|75637168|FG005|STARTED|Overall Study||0||
59539016|NCT00852644|75637163|FG000|COMPLETED|Overall Study||3||
59539017|NCT00852644|75637164|FG001|COMPLETED|Overall Study||3||
59539018|NCT00852644|75637165|FG002|COMPLETED|Overall Study||0||
59539019|NCT00852644|75637166|FG003|COMPLETED|Overall Study||3||
59539020|NCT00852644|75637167|FG004|COMPLETED|Overall Study||0||
59539021|NCT00852644|75637168|FG005|COMPLETED|Overall Study||0||
59539022|NCT00852644|75637163|FG000|NOT COMPLETED|Overall Study||0||
59539023|NCT00852644|75637164|FG001|NOT COMPLETED|Overall Study||0||
59539024|NCT00852644|75637165|FG002|NOT COMPLETED|Overall Study||0||
59539025|NCT00852644|75637166|FG003|NOT COMPLETED|Overall Study||0||
59539026|NCT00852644|75637167|FG004|NOT COMPLETED|Overall Study||0||
59539027|NCT00852644|75637168|FG005|NOT COMPLETED|Overall Study||0||
59539028|NCT01404923|75637185|FG000|STARTED|Overall Study||222||
59539029|NCT01404923|75637186|FG001|STARTED|Overall Study||214||
59539030|NCT01404923|75637185|FG000|COMPLETED|Overall Study||199||
59815580|NCT04975191|75938016|FG001|COMPLETED|Overall Study||56||
59815581|NCT04975191|75938017|FG002|COMPLETED|Overall Study||53||
59815582|NCT04975191|75938018|FG003|COMPLETED|Overall Study||52||
59815583|NCT04975191|75938015|FG000|NOT COMPLETED|Overall Study||14||
59815584|NCT04975191|75938016|FG001|NOT COMPLETED|Overall Study||5||
59815585|NCT04975191|75938017|FG002|NOT COMPLETED|Overall Study||10||
59815586|NCT04975191|75938018|FG003|NOT COMPLETED|Overall Study||10||
59539031|NCT01404923|75637186|FG001|COMPLETED|Overall Study||197||
59539032|NCT01404923|75637185|FG000|NOT COMPLETED|Overall Study||23||
59539033|NCT01404923|75637186|FG001|NOT COMPLETED|Overall Study||17||
59539034|NCT00854594|75637194|FG000|STARTED|Overall Study|9 sites randomized to control arm, providers completed surveys before and/or after study period|48||
59539035|NCT00854594|75637195|FG001|STARTED|Overall Study|9 sites randomized to intervention, providers completed surveys before and/or after study period|69||
59539036|NCT00854594|75637194|FG000|COMPLETED|Overall Study||48||
59539037|NCT00854594|75637195|FG001|COMPLETED|Overall Study||69||
59539038|NCT00854594|75637194|FG000|NOT COMPLETED|Overall Study||0||
59539039|NCT00854594|75637195|FG001|NOT COMPLETED|Overall Study||0||
59539040|NCT01368263|75637204|FG000|STARTED|Overall Study||6||
59539041|NCT01368263|75637205|FG001|STARTED|Overall Study||1||
59539042|NCT01368263|75637206|FG002|STARTED|Overall Study||1||
59539043|NCT01368263|75637204|FG000|COMPLETED|Overall Study||6||
59539044|NCT01368263|75637205|FG001|COMPLETED|Overall Study||1||
59539045|NCT01368263|75637206|FG002|COMPLETED|Overall Study||1||
59539046|NCT01368263|75637204|FG000|NOT COMPLETED|Overall Study||0||
59539047|NCT01368263|75637205|FG001|NOT COMPLETED|Overall Study||0||
59539048|NCT01368263|75637206|FG002|NOT COMPLETED|Overall Study||0||
59539049|NCT01405313|75637214|FG000|STARTED|Overall Study||21||
59539050|NCT01405313|75637214|FG000|COMPLETED|Overall Study||21||
59539051|NCT01405313|75637214|FG000|NOT COMPLETED|Overall Study||0||
59539052|NCT00814970|75637222|FG000|STARTED|Overall Study||196||
59539053|NCT00814970|75637222|FG000|COMPLETED|Overall Study||146||
59539054|NCT00814970|75637222|FG000|NOT COMPLETED|Overall Study||50||
59539055|NCT00815360|75637230|FG000|STARTED|Overall Study||11||
59539056|NCT00815360|75637231|FG001|STARTED|Overall Study||11||
59539057|NCT00815360|75637230|FG000|COMPLETED|Overall Study||11||
59539058|NCT00815360|75637231|FG001|COMPLETED|Overall Study||11||
59539059|NCT00815360|75637230|FG000|NOT COMPLETED|Overall Study||0||
59539060|NCT00815360|75637231|FG001|NOT COMPLETED|Overall Study||0||
59539061|NCT00855842|75637237|FG000|STARTED|Overall Study||4||
59539062|NCT00855842|75637237|FG000|COMPLETED|Overall Study||4||
59539063|NCT00855842|75637237|FG000|NOT COMPLETED|Overall Study||0||
59539064|NCT00856232|75637244|FG000|STARTED|Overall Study||26||
59815587|NCT04943432|75938028|FG000|STARTED|Overall Study||23||
59815588|NCT04943432|75938028|FG000|Received Intervention|Overall Study||19||
59815589|NCT04943432|75938028|FG000|COMPLETED|Overall Study||17||
59815590|NCT04943432|75938028|FG000|NOT COMPLETED|Overall Study||6||
59815591|NCT04884737|75938035|FG000|STARTED|Overall Study||50||
59539065|NCT00856232|75637245|FG001|STARTED|Overall Study||29||
59539066|NCT00856232|75637246|FG002|STARTED|Overall Study||36||
59539067|NCT00856232|75637244|FG000|COMPLETED|Overall Study||26||
59539068|NCT00856232|75637245|FG001|COMPLETED|Overall Study||29||
59539069|NCT00856232|75637246|FG002|COMPLETED|Overall Study||36||
59539070|NCT00856232|75637244|FG000|NOT COMPLETED|Overall Study||0||
59539071|NCT00856232|75637245|FG001|NOT COMPLETED|Overall Study||0||
59539072|NCT00856232|75637246|FG002|NOT COMPLETED|Overall Study||0||
59539073|NCT01474109|75637259|FG000|STARTED|Period 1: Baseline to Week 16||95||
59539074|NCT01474109|75637260|FG001|STARTED|Period 1: Baseline to Week 16||97||
59539075|NCT01474109|75637261|FG002|STARTED|Period 1: Baseline to Week 16||97||
59539076|NCT01474109|75637259|FG000|COMPLETED|Period 1: Baseline to Week 16||88||
59539077|NCT01474109|75637260|FG001|COMPLETED|Period 1: Baseline to Week 16||91||
59539078|NCT01474109|75637261|FG002|COMPLETED|Period 1: Baseline to Week 16||95||
59539079|NCT01474109|75637259|FG000|NOT COMPLETED|Period 1: Baseline to Week 16||7||
59539080|NCT01474109|75637260|FG001|NOT COMPLETED|Period 1: Baseline to Week 16||6||
59539081|NCT01474109|75637261|FG002|NOT COMPLETED|Period 1: Baseline to Week 16||2||
59623479|NCT00568854|75735624|FG001|NOT COMPLETED|Overall Study||0||
59623480|NCT00569010|75735634|FG000|STARTED|Overall Study||6||
59623481|NCT00569010|75735635|FG001|STARTED|Overall Study||6||
59623482|NCT00569010|75735636|FG002|STARTED|Overall Study||11||
59623483|NCT00569010|75735637|FG003|STARTED|Overall Study||11||
59623484|NCT00569010|75735634|FG000|COMPLETED|Overall Study||6||
59623485|NCT00569010|75735635|FG001|COMPLETED|Overall Study||6||
59623486|NCT00569010|75735636|FG002|COMPLETED|Overall Study||11||
59623487|NCT00569010|75735637|FG003|COMPLETED|Overall Study||11||
59623488|NCT00569010|75735634|FG000|NOT COMPLETED|Overall Study||0||
59623489|NCT00569010|75735635|FG001|NOT COMPLETED|Overall Study||0||
59623490|NCT00569010|75735636|FG002|NOT COMPLETED|Overall Study||0||
59623491|NCT00569010|75735637|FG003|NOT COMPLETED|Overall Study||0||
59623492|NCT00616122|75735647|FG000|STARTED|Overall Study||4||
59623493|NCT00616122|75735648|FG001|STARTED|Overall Study||7||
59623494|NCT00616122|75735649|FG002|STARTED|Overall Study||10||
59623495|NCT00616122|75735650|FG003|STARTED|Overall Study||11||
59623496|NCT00616122|75735647|FG000|COMPLETED|Overall Study||4||
59623497|NCT00616122|75735648|FG001|COMPLETED|Overall Study||7||
59623498|NCT00616122|75735649|FG002|COMPLETED|Overall Study||10||
59623499|NCT00616122|75735650|FG003|COMPLETED|Overall Study||0||
59623500|NCT00616122|75735647|FG000|NOT COMPLETED|Overall Study||0||
59623501|NCT00616122|75735648|FG001|NOT COMPLETED|Overall Study||0||
59623502|NCT00616122|75735649|FG002|NOT COMPLETED|Overall Study||0||
59623503|NCT00616122|75735650|FG003|NOT COMPLETED|Overall Study||11||
59623504|NCT00616200|75735657|FG000|STARTED|Two Week Standard Diet||17||
59623505|NCT00616200|75735657|FG000|COMPLETED|Two Week Standard Diet||16||
59623506|NCT00616200|75735657|FG000|NOT COMPLETED|Two Week Standard Diet||1||
59623507|NCT00616200|75735657|FG000|STARTED|Four Week Very Low Carbohydrate Diet||16||
59623508|NCT00616200|75735657|FG000|COMPLETED|Four Week Very Low Carbohydrate Diet||13||
59623509|NCT00616200|75735657|FG000|NOT COMPLETED|Four Week Very Low Carbohydrate Diet||3||
59623510|NCT00617058|75735664|FG000|STARTED|Overall Study||1||
59623511|NCT00617058|75735665|FG001|STARTED|Overall Study||0||
59623512|NCT00617058|75735666|FG002|STARTED|Overall Study||0||
59623513|NCT00617058|75735664|FG000|COMPLETED|Overall Study||1||
59623514|NCT00617058|75735665|FG001|COMPLETED|Overall Study||0||
59623515|NCT00617058|75735666|FG002|COMPLETED|Overall Study||0||
59623516|NCT00617058|75735664|FG000|NOT COMPLETED|Overall Study||0||
59623517|NCT00617058|75735665|FG001|NOT COMPLETED|Overall Study||0||
59623518|NCT00617058|75735666|FG002|NOT COMPLETED|Overall Study||0||
59623519|NCT00618540|75735674|FG000|STARTED|Overall Study||1||
59623520|NCT00618540|75735674|FG000|COMPLETED|Overall Study||1||
59623521|NCT00618540|75735674|FG000|NOT COMPLETED|Overall Study||0||
59623522|NCT00570960|75735681|FG000|STARTED|Overall Study||4||
59623523|NCT00570960|75735682|FG001|STARTED|Overall Study||4||
59623524|NCT00570960|75735681|FG000|COMPLETED|Overall Study||4||
59623525|NCT00570960|75735682|FG001|COMPLETED|Overall Study||4||
59623526|NCT00570960|75735681|FG000|NOT COMPLETED|Overall Study||0||
59623527|NCT00570960|75735682|FG001|NOT COMPLETED|Overall Study||0||
59623528|NCT00571428|75735690|FG000|STARTED|Overall Study||15||
59623529|NCT00571428|75735691|FG001|STARTED|Overall Study||18||
59623530|NCT00571428|75735690|FG000|COMPLETED|Overall Study||15||
59623531|NCT00571428|75735691|FG001|COMPLETED|Overall Study||18||
59623532|NCT00571428|75735690|FG000|NOT COMPLETED|Overall Study||0||
59623533|NCT00571428|75735691|FG001|NOT COMPLETED|Overall Study||0||
59623534|NCT00571974|75735699|FG000|STARTED|Phase I||9||
59623535|NCT00571974|75735700|FG001|STARTED|Phase I||0||
59623536|NCT00571974|75735699|FG000|COMPLETED|Phase I||9||
59623537|NCT00571974|75735700|FG001|COMPLETED|Phase I||0||
59623538|NCT00571974|75735699|FG000|NOT COMPLETED|Phase I||0||
59623539|NCT00571974|75735700|FG001|NOT COMPLETED|Phase I||0||
59623540|NCT00571974|75735699|FG000|STARTED|Phase II||0||
59623541|NCT00571974|75735700|FG001|STARTED|Phase II|3 participants are from phase I|21||
59623542|NCT00571974|75735699|FG000|COMPLETED|Phase II||0||
59623543|NCT00571974|75735700|FG001|COMPLETED|Phase II||17||
59623544|NCT00571974|75735699|FG000|NOT COMPLETED|Phase II||0||
59623545|NCT00571974|75735700|FG001|NOT COMPLETED|Phase II||4||
59623546|NCT00621348|75735709|FG000|STARTED|Overall Study||58||
59623547|NCT00621348|75735710|FG001|STARTED|Overall Study||53||
59623548|NCT00621348|75735711|FG002|STARTED|Overall Study||56||
59623549|NCT00621348|75735709|FG000|COMPLETED|Overall Study||58||
59623550|NCT00621348|75735710|FG001|COMPLETED|Overall Study||53||
59623551|NCT00621348|75735711|FG002|COMPLETED|Overall Study||56||
59623552|NCT00621348|75735709|FG000|NOT COMPLETED|Overall Study||0||
59623553|NCT00621348|75735710|FG001|NOT COMPLETED|Overall Study||0||
59623554|NCT00621348|75735711|FG002|NOT COMPLETED|Overall Study||0||
59623555|NCT00574236|75735719|FG000|STARTED|Overall Study||4||
59623556|NCT00574236|75735719|FG000|COMPLETED|Overall Study||4||
59623557|NCT00574236|75735719|FG000|NOT COMPLETED|Overall Study||0||
59623558|NCT00574548|75735725|FG000|STARTED|Overall Study||482||
59623559|NCT00574548|75735726|FG001|STARTED|Overall Study||238||
59623560|NCT00574548|75735725|FG000|Received Vaccination 1 (Vax 1)|Overall Study||478||
59623561|NCT00574548|75735726|FG001|Received Vaccination 1 (Vax 1)|Overall Study||237||
59623562|NCT00574548|75735725|FG000|Completed Vax 1 (6 Month Contact)|Overall Study||468||
59815592|NCT04884737|75938036|FG001|STARTED|Overall Study||57||
59623563|NCT00574548|75735726|FG001|Completed Vax 1 (6 Month Contact)|Overall Study||234||
59623564|NCT00574548|75735725|FG000|Withdrawn After Vax 1 (6 Month Contact)|Overall Study||7||
59623565|NCT00574548|75735726|FG001|Withdrawn After Vax 1 (6 Month Contact)|Overall Study||3||
59623566|NCT00574548|75735725|FG000|Withdrawn Before Vax 2|Overall Study||41||
59623567|NCT00574548|75735726|FG001|Withdrawn Before Vax 2|Overall Study||11||
59623568|NCT00574548|75735725|FG000|Received Vax 2|Overall Study||427||
59623569|NCT00574548|75735726|FG001|Received Vax 2|Overall Study||223||
59623570|NCT00574548|75735725|FG000|Completed Vax 2 (6 Month Contact)|Overall Study||421||
59623571|NCT00574548|75735726|FG001|Completed Vax 2 (6 Month Contact)|Overall Study||222||
59623572|NCT00574548|75735725|FG000|COMPLETED|Overall Study||421||
59623573|NCT00574548|75735726|FG001|COMPLETED|Overall Study||222||
59623574|NCT00574548|75735725|FG000|NOT COMPLETED|Overall Study||61||
59623575|NCT00574548|75735726|FG001|NOT COMPLETED|Overall Study||16||
59623576|NCT00574704|75735754|FG000|STARTED|Overall Study||10||
59623577|NCT00574704|75735755|FG001|STARTED|Overall Study||10||
59623578|NCT00574704|75735756|FG002|STARTED|Overall Study||10||
59623579|NCT00574704|75735757|FG003|STARTED|Overall Study||10||
59623580|NCT00574704|75735754|FG000|COMPLETED|Overall Study||10||
59623581|NCT00574704|75735755|FG001|COMPLETED|Overall Study||10||
59623582|NCT00574704|75735756|FG002|COMPLETED|Overall Study||9||
59623583|NCT00574704|75735757|FG003|COMPLETED|Overall Study||10||
59623584|NCT00574704|75735754|FG000|NOT COMPLETED|Overall Study||0||
59623585|NCT00574704|75735755|FG001|NOT COMPLETED|Overall Study||0||
59623586|NCT00574704|75735756|FG002|NOT COMPLETED|Overall Study||1||
59623587|NCT00574704|75735757|FG003|NOT COMPLETED|Overall Study||0||
59623588|NCT01168219|75735767|FG000|STARTED|Overall Study||68||
59623589|NCT01168219|75735767|FG000|COMPLETED|Overall Study||63||
59623590|NCT01168219|75735767|FG000|NOT COMPLETED|Overall Study||5||
59623591|NCT01115803|75735778|FG000|STARTED|Overall Study||4||
59623592|NCT01115803|75735779|FG001|STARTED|Overall Study||5||
59623593|NCT01115803|75735780|FG002|STARTED|Overall Study||3||
59623594|NCT01115803|75735781|FG003|STARTED|Overall Study||5||
59623595|NCT01115803|75735782|FG004|STARTED|Overall Study||3||
59623596|NCT01115803|75735783|FG005|STARTED|Overall Study||3||
59623597|NCT01115803|75735784|FG006|STARTED|Overall Study||6||
59623598|NCT01115803|75735778|FG000|Received at Least 1 Dose of Study Drug|Overall Study||4||
59623599|NCT01115803|75735779|FG001|Received at Least 1 Dose of Study Drug|Overall Study||5||
59623600|NCT01115803|75735780|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3||
59623601|NCT01115803|75735781|FG003|Received at Least 1 Dose of Study Drug|Overall Study||5||
59623602|NCT01115803|75735782|FG004|Received at Least 1 Dose of Study Drug|Overall Study||3||
59623603|NCT01115803|75735783|FG005|Received at Least 1 Dose of Study Drug|Overall Study||3||
59623604|NCT01115803|75735784|FG006|Received at Least 1 Dose of Study Drug|Overall Study||6||
59623605|NCT01115803|75735778|FG000|COMPLETED|Overall Study||4||
59623606|NCT01115803|75735779|FG001|COMPLETED|Overall Study||5||
59623607|NCT01115803|75735780|FG002|COMPLETED|Overall Study||2||
59623608|NCT01115803|75735781|FG003|COMPLETED|Overall Study||5||
59623609|NCT01115803|75735782|FG004|COMPLETED|Overall Study||3||
59623610|NCT01115803|75735783|FG005|COMPLETED|Overall Study||3||
59623611|NCT01115803|75735784|FG006|COMPLETED|Overall Study||4||
59623612|NCT01115803|75735778|FG000|NOT COMPLETED|Overall Study||0||
59623613|NCT01115803|75735779|FG001|NOT COMPLETED|Overall Study||0||
59623614|NCT01115803|75735780|FG002|NOT COMPLETED|Overall Study||1||
59623615|NCT01115803|75735781|FG003|NOT COMPLETED|Overall Study||0||
59623616|NCT01115803|75735782|FG004|NOT COMPLETED|Overall Study||0||
59623617|NCT01115803|75735783|FG005|NOT COMPLETED|Overall Study||0||
59623618|NCT01115803|75735784|FG006|NOT COMPLETED|Overall Study||2||
59623619|NCT01115569|75735805|FG000|STARTED|Conversion/Titration Phase||638||
59623620|NCT01115569|75735806|FG001|STARTED|Conversion/Titration Phase||0||
59623621|NCT01115569|75735805|FG000|COMPLETED|Conversion/Titration Phase||424||
59623622|NCT01115569|75735806|FG001|COMPLETED|Conversion/Titration Phase||0||
59623623|NCT01115569|75735805|FG000|NOT COMPLETED|Conversion/Titration Phase||214||
59623624|NCT01115569|75735806|FG001|NOT COMPLETED|Conversion/Titration Phase||0||
59623625|NCT01115569|75735805|FG000|STARTED|Maintenance Phase||0||
59623626|NCT01115569|75735806|FG001|STARTED|Maintenance Phase||424||
59623627|NCT01115569|75735805|FG000|COMPLETED|Maintenance Phase||0||
59623628|NCT01115569|75735806|FG001|COMPLETED|Maintenance Phase||285||
59623629|NCT01115569|75735805|FG000|NOT COMPLETED|Maintenance Phase||0||
59623630|NCT01115569|75735806|FG001|NOT COMPLETED|Maintenance Phase||139||
59623631|NCT01107886|75735813|FG000|STARTED|Overall Study|Randomized subjects|8280||
59623632|NCT01107886|75735814|FG001|STARTED|Overall Study|Randomized subjects|8212||
59623633|NCT01107886|75735813|FG000|COMPLETED|Overall Study|Completed subjects|8078||
59623634|NCT01107886|75735814|FG001|COMPLETED|Overall Study|Completed subjects|7998||
59623635|NCT01107886|75735813|FG000|NOT COMPLETED|Overall Study||202||
59623636|NCT01107886|75735814|FG001|NOT COMPLETED|Overall Study||214||
59623637|NCT01107457|75735825|FG000|STARTED|Part A||27||
59623638|NCT01107457|75735826|FG001|STARTED|Part A||28||
59623639|NCT01107457|75735827|FG002|STARTED|Part A||30||
59623640|NCT01107457|75735828|FG003|STARTED|Part A||29||
59623641|NCT01107457|75735829|FG004|STARTED|Part A||28||
59623642|NCT01107457|75735830|FG005|STARTED|Part A|120 mg and 80 mg ixekizumab were administered during Part B and C.|0||
59623643|NCT01107457|75735825|FG000|Received at Least 1 Dose of Study Drug|Part A||27||
59623644|NCT01107457|75735826|FG001|Received at Least 1 Dose of Study Drug|Part A||28||
59623645|NCT01107457|75735827|FG002|Received at Least 1 Dose of Study Drug|Part A||30||
59623646|NCT01107457|75735828|FG003|Received at Least 1 Dose of Study Drug|Part A||29||
59623647|NCT01107457|75735829|FG004|Received at Least 1 Dose of Study Drug|Part A||28||
59623648|NCT01107457|75735830|FG005|Received at Least 1 Dose of Study Drug|Part A|120 mg and 80 mg ixekizumab were administered during Part B and C.|0||
59623649|NCT01107457|75735825|FG000|COMPLETED|Part A||22||
59623650|NCT01107457|75735826|FG001|COMPLETED|Part A||21||
59623651|NCT01107457|75735827|FG002|COMPLETED|Part A||29||
59623652|NCT01107457|75735828|FG003|COMPLETED|Part A||26||
59623653|NCT01107457|75735829|FG004|COMPLETED|Part A||27||
59623654|NCT01107457|75735830|FG005|COMPLETED|Part A|120 mg and 80 mg ixekizumab were administered during Part B and C.|0||
59623655|NCT01107457|75735825|FG000|NOT COMPLETED|Part A||5||
59623656|NCT01107457|75735826|FG001|NOT COMPLETED|Part A||7||
59623657|NCT01107457|75735827|FG002|NOT COMPLETED|Part A||1||
59623658|NCT01107457|75735828|FG003|NOT COMPLETED|Part A||3||
59623659|NCT01107457|75735829|FG004|NOT COMPLETED|Part A||1||
59623660|NCT01107457|75735830|FG005|NOT COMPLETED|Part A||0||
59623661|NCT01107457|75735825|FG000|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0||
59623662|NCT01107457|75735826|FG001|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0||
59623663|NCT01107457|75735827|FG002|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0||
59623664|NCT01107457|75735828|FG003|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0||
59623665|NCT01107457|75735829|FG004|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0||
59623666|NCT01107457|75735830|FG005|STARTED|Part B and C|80 and 120 mg ixekizumab were administered during Part B and C.|120||
59623667|NCT01107457|75735825|FG000|Completed Part B (Week 240)|Part B and C||0||
59623668|NCT01107457|75735826|FG001|Completed Part B (Week 240)|Part B and C||0||
59623669|NCT01107457|75735827|FG002|Completed Part B (Week 240)|Part B and C||0||
59623670|NCT01107457|75735828|FG003|Completed Part B (Week 240)|Part B and C||0||
59623671|NCT01107457|75735829|FG004|Completed Part B (Week 240)|Part B and C||0||
59623672|NCT01107457|75735830|FG005|Completed Part B (Week 240)|Part B and C||74||
59623673|NCT01107457|75735825|FG000|Completed Part C|Part B and C||0||
59623674|NCT01107457|75735826|FG001|Completed Part C|Part B and C||0||
59623675|NCT01107457|75735827|FG002|Completed Part C|Part B and C||0||
59623676|NCT01107457|75735828|FG003|Completed Part C|Part B and C||0||
59623677|NCT01107457|75735829|FG004|Completed Part C|Part B and C||0||
59623678|NCT01107457|75735830|FG005|Completed Part C|Part B and C|Part C was stopped once ixekizumab became available through marketing authorization.|0||
59623679|NCT01107457|75735825|FG000|Post Treatment Safety Visits|Part B and C||0||
59623680|NCT01107457|75735826|FG001|Post Treatment Safety Visits|Part B and C||0||
59623681|NCT01107457|75735827|FG002|Post Treatment Safety Visits|Part B and C||0||
59623682|NCT01107457|75735828|FG003|Post Treatment Safety Visits|Part B and C||0||
59623683|NCT01107457|75735829|FG004|Post Treatment Safety Visits|Part B and C||0||
59623684|NCT01107457|75735830|FG005|Post Treatment Safety Visits|Part B and C|Only participants with neutropenia entered the post treatment safety visits.|6||
59623685|NCT01107457|75735825|FG000|COMPLETED|Part B and C||0||
59623686|NCT01107457|75735826|FG001|COMPLETED|Part B and C||0||
59623687|NCT01107457|75735827|FG002|COMPLETED|Part B and C||0||
59623688|NCT01107457|75735828|FG003|COMPLETED|Part B and C||0||
59623689|NCT01107457|75735829|FG004|COMPLETED|Part B and C||0||
59623690|NCT01107457|75735830|FG005|COMPLETED|Part B and C|No participants completed the study as Part C was stopped.|0||
59623691|NCT01107457|75735825|FG000|NOT COMPLETED|Part B and C||0||
59623692|NCT01107457|75735826|FG001|NOT COMPLETED|Part B and C||0||
59623693|NCT01107457|75735827|FG002|NOT COMPLETED|Part B and C||0||
59623694|NCT01107457|75735828|FG003|NOT COMPLETED|Part B and C||0||
59623695|NCT01107457|75735829|FG004|NOT COMPLETED|Part B and C||0||
59623696|NCT01107457|75735830|FG005|NOT COMPLETED|Part B and C||120||
59623697|NCT04882540|75735848|FG000|STARTED|Overall Study||12||
59623698|NCT04882540|75735848|FG000|COMPLETED|Overall Study||12||
59623699|NCT04882540|75735848|FG000|NOT COMPLETED|Overall Study||0||
59623700|NCT04656301|75735854|FG000|STARTED|Overall Study||12||
59623701|NCT04656301|75735854|FG000|COMPLETED|Overall Study||12||
59623702|NCT04656301|75735854|FG000|NOT COMPLETED|Overall Study||0||
59623703|NCT04545385|75735860|FG000|STARTED|Overall Study||32||
59623704|NCT04545385|75735861|FG001|STARTED|Overall Study||33||
59623705|NCT04545385|75735860|FG000|Received at Least 1 Dose of Study Drug|Overall Study||31||
59623706|NCT04545385|75735861|FG001|Received at Least 1 Dose of Study Drug|Overall Study||33||
59623707|NCT04545385|75735860|FG000|COMPLETED|Overall Study||17||
59623708|NCT04545385|75735861|FG001|COMPLETED|Overall Study||20||
59623709|NCT04545385|75735860|FG000|NOT COMPLETED|Overall Study||15||
59623710|NCT04545385|75735861|FG001|NOT COMPLETED|Overall Study||13||
59623711|NCT04542421|75735869|FG000|STARTED|Overall Study||86||
59623712|NCT04542421|75735870|FG001|STARTED|Overall Study||298||
59623713|NCT04542421|75735869|FG000|COMPLETED|Overall Study||86||
59623714|NCT04542421|75735870|FG001|COMPLETED|Overall Study||298||
59623715|NCT04542421|75735869|FG000|NOT COMPLETED|Overall Study||0||
59623716|NCT04542421|75735870|FG001|NOT COMPLETED|Overall Study||0||
59623717|NCT03783026|75735876|FG000|STARTED|Treatment Phase||123||
59623718|NCT03783026|75735876|FG000|Received Apremilast|Treatment Phase||122||
59623719|NCT03783026|75735876|FG000|COMPLETED|Treatment Phase||80|Completed Treatment Phase|
59623720|NCT03783026|75735876|FG000|NOT COMPLETED|Treatment Phase||43||
59623721|NCT03783026|75735876|FG000|STARTED|Observational Follow-up Phase||111|Per protocol, all participants who terminated early or completed the study treatment were asked to continue the 4-week post-treatment observational follow-up. Eleven participants did not enter the follow-up phase.|
59623722|NCT03783026|75735876|FG000|COMPLETED|Observational Follow-up Phase||108||
59623723|NCT03783026|75735876|FG000|NOT COMPLETED|Observational Follow-up Phase||3||
59623724|NCT03635112|75735883|FG000|STARTED|Overall Study||38||
59623725|NCT03635112|75735884|FG001|STARTED|Overall Study||58||
59623726|NCT03635112|75735885|FG002|STARTED|Overall Study||63||
59623727|NCT03635112|75735883|FG000|Completed Week 12 Visit|Overall Study||33||
59623728|NCT03635112|75735884|FG001|Completed Week 12 Visit|Overall Study||48||
59623729|NCT03635112|75735885|FG002|Completed Week 12 Visit|Overall Study||49||
59623730|NCT03635112|75735883|FG000|Switched From Placebo to TD-1473 80 mg|Overall Study||33||
59623731|NCT03635112|75735884|FG001|Switched From Placebo to TD-1473 80 mg|Overall Study||0||
59623732|NCT03635112|75735885|FG002|Switched From Placebo to TD-1473 80 mg|Overall Study||0||
59623733|NCT03635112|75735883|FG000|COMPLETED|Overall Study||12||
59623734|NCT03635112|75735884|FG001|COMPLETED|Overall Study||16||
59623735|NCT03635112|75735885|FG002|COMPLETED|Overall Study||13||
59623736|NCT03635112|75735883|FG000|NOT COMPLETED|Overall Study||26||
59623737|NCT03635112|75735884|FG001|NOT COMPLETED|Overall Study||42||
59623738|NCT03635112|75735885|FG002|NOT COMPLETED|Overall Study||50||
59623739|NCT03588728|75735898|FG000|STARTED|Overall Study||10||
59623740|NCT03588728|75735899|FG001|STARTED|Overall Study||6||
59623741|NCT03588728|75735900|FG002|STARTED|Overall Study||12||
59623742|NCT03588728|75735901|FG003|STARTED|Overall Study||11||
59623743|NCT03588728|75735898|FG000|COMPLETED|Overall Study||7||
59623744|NCT03588728|75735899|FG001|COMPLETED|Overall Study||6||
59623745|NCT03588728|75735900|FG002|COMPLETED|Overall Study||9||
59623746|NCT03588728|75735901|FG003|COMPLETED|Overall Study||8||
59623747|NCT03588728|75735898|FG000|NOT COMPLETED|Overall Study||3||
59623748|NCT03588728|75735899|FG001|NOT COMPLETED|Overall Study||0||
59623749|NCT03588728|75735900|FG002|NOT COMPLETED|Overall Study||3||
59623750|NCT03588728|75735901|FG003|NOT COMPLETED|Overall Study||3||
59623751|NCT03439033|75735911|FG000|STARTED|Overall Study||273||
59623752|NCT03439033|75735911|FG000|Participants With Biochemical Reoccurrence at Baseline|Overall Study||114||
59623753|NCT03439033|75735911|FG000|PSMA PET/MRI|Overall Study||108||
59623754|NCT03439033|75735911|FG000|PSMA PET/CT|Overall Study||1||
59623755|NCT03439033|75735911|FG000|PSMA Multiple PET/MRI|Overall Study||0||
59623756|NCT03439033|75735911|FG000|COMPLETED|Overall Study||109||
59623757|NCT03439033|75735911|FG000|NOT COMPLETED|Overall Study||164||
59623758|NCT02987543|75735923|FG000|STARTED|Overall Study||162||
59623759|NCT02987543|75735924|FG001|STARTED|Overall Study||83||
59623760|NCT02987543|75735925|FG002|STARTED|Overall Study||94||
59623761|NCT02987543|75735926|FG003|STARTED|Overall Study||48||
59623762|NCT02987543|75735923|FG000|COMPLETED|Overall Study||0||
59623763|NCT02987543|75735924|FG001|COMPLETED|Overall Study||0||
59623764|NCT02987543|75735925|FG002|COMPLETED|Overall Study||0||
59623765|NCT02987543|75735926|FG003|COMPLETED|Overall Study||0||
59623766|NCT02987543|75735923|FG000|NOT COMPLETED|Overall Study||162||
59623767|NCT02987543|75735924|FG001|NOT COMPLETED|Overall Study||83||
59623768|NCT02987543|75735925|FG002|NOT COMPLETED|Overall Study||94||
59623769|NCT02987543|75735926|FG003|NOT COMPLETED|Overall Study||48||
59623770|NCT02983045|75735942|FG000|STARTED|Overall Study||4||
59623771|NCT02983045|75735943|FG001|STARTED|Overall Study||3||
59623772|NCT02983045|75735944|FG002|STARTED|Overall Study||3||
59623773|NCT02983045|75735945|FG003|STARTED|Overall Study||25||
59623774|NCT02983045|75735946|FG004|STARTED|Overall Study||3||
59623775|NCT02983045|75735947|FG005|STARTED|Overall Study||476||
59623776|NCT02983045|75735948|FG006|STARTED|Overall Study||10||
59623777|NCT02983045|75735949|FG007|STARTED|Overall Study||8||
59623778|NCT02983045|75735950|FG008|STARTED|Overall Study||6||
59623779|NCT02983045|75735951|FG009|STARTED|Overall Study||19||
59623780|NCT02983045|75735942|FG000|COMPLETED|Overall Study||4||
59623781|NCT02983045|75735943|FG001|COMPLETED|Overall Study||2||
59623782|NCT02983045|75735944|FG002|COMPLETED|Overall Study||3||
59623783|NCT02983045|75735945|FG003|COMPLETED|Overall Study||20||
59623784|NCT02983045|75735946|FG004|COMPLETED|Overall Study||3||
59623785|NCT02983045|75735947|FG005|COMPLETED|Overall Study||394||
59623786|NCT02983045|75735948|FG006|COMPLETED|Overall Study||10||
59623787|NCT02983045|75735949|FG007|COMPLETED|Overall Study||8||
59623788|NCT02983045|75735950|FG008|COMPLETED|Overall Study||6||
59623789|NCT02983045|75735951|FG009|COMPLETED|Overall Study||17||
59623790|NCT02983045|75735942|FG000|NOT COMPLETED|Overall Study||0||
59623791|NCT02983045|75735943|FG001|NOT COMPLETED|Overall Study||1||
59623792|NCT02983045|75735944|FG002|NOT COMPLETED|Overall Study||0||
59623793|NCT02983045|75735945|FG003|NOT COMPLETED|Overall Study||5||
59623794|NCT02983045|75735946|FG004|NOT COMPLETED|Overall Study||0||
59623795|NCT02983045|75735947|FG005|NOT COMPLETED|Overall Study||82||
59623796|NCT02983045|75735948|FG006|NOT COMPLETED|Overall Study||0||
59623797|NCT02983045|75735949|FG007|NOT COMPLETED|Overall Study||0||
59623798|NCT02983045|75735950|FG008|NOT COMPLETED|Overall Study||0||
59623799|NCT02983045|75735951|FG009|NOT COMPLETED|Overall Study||2||
59623800|NCT02564263|75735975|FG000|STARTED|Overall Study||314||
59623801|NCT02564263|75735976|FG001|STARTED|Overall Study||314||
59623802|NCT02564263|75735975|FG000|Treated|Overall Study||314||
59623803|NCT02564263|75735976|FG001|Treated|Overall Study||296||
59623804|NCT02564263|75735975|FG000|Received Second Course of Pembrolizumab|Overall Study||5||
59623805|NCT02564263|75735976|FG001|Received Second Course of Pembrolizumab|Overall Study||0||
59623806|NCT02564263|75735975|FG000|COMPLETED|Overall Study||0||
59623807|NCT02564263|75735976|FG001|COMPLETED|Overall Study||0||
59623808|NCT02564263|75735975|FG000|NOT COMPLETED|Overall Study||314||
59623809|NCT02564263|75735976|FG001|NOT COMPLETED|Overall Study||314||
59623810|NCT02379819|75735983|FG000|STARTED|Overall Study||52||
59623811|NCT02379819|75735983|FG000|COMPLETED|Overall Study||38||
59623812|NCT02379819|75735983|FG000|NOT COMPLETED|Overall Study||14||
59623813|NCT02368886|75735991|FG000|STARTED|Overall Study||29||
59623814|NCT02368886|75735992|FG001|STARTED|Overall Study||27||
59623815|NCT02368886|75735993|FG002|STARTED|Overall Study||34||
59623816|NCT02368886|75735994|FG003|STARTED|Overall Study||33||
59623817|NCT02368886|75735991|FG000|COMPLETED|Overall Study||28||
59623818|NCT02368886|75735992|FG001|COMPLETED|Overall Study||26||
59623819|NCT02368886|75735993|FG002|COMPLETED|Overall Study||33||
59623820|NCT02368886|75735994|FG003|COMPLETED|Overall Study||29||
59623821|NCT02368886|75735991|FG000|NOT COMPLETED|Overall Study||1||
59623822|NCT02368886|75735992|FG001|NOT COMPLETED|Overall Study||1||
59623823|NCT02368886|75735993|FG002|NOT COMPLETED|Overall Study||1||
59623824|NCT02368886|75735994|FG003|NOT COMPLETED|Overall Study||4||
59623825|NCT02227238|75736008|FG000|STARTED|Randomized Phase (Up to Week 52)||312|Randomized|
59623826|NCT02227238|75736009|FG001|STARTED|Randomized Phase (Up to Week 52)||315|Randomized|
59623827|NCT02227238|75736010|FG002|STARTED|Randomized Phase (Up to Week 52)||0|Randomized|
59623828|NCT02227238|75736008|FG000|ITT-E Population|Randomized Phase (Up to Week 52)||312||
59623829|NCT02227238|75736009|FG001|ITT-E Population|Randomized Phase (Up to Week 52)||312||
59623830|NCT02227238|75736010|FG002|ITT-E Population|Randomized Phase (Up to Week 52)||0||
59623831|NCT02227238|75736008|FG000|COMPLETED|Randomized Phase (Up to Week 52)||275||
59623832|NCT02227238|75736009|FG001|COMPLETED|Randomized Phase (Up to Week 52)||245||
59623833|NCT02227238|75736010|FG002|COMPLETED|Randomized Phase (Up to Week 52)||0||
59623834|NCT02227238|75736008|FG000|NOT COMPLETED|Randomized Phase (Up to Week 52)||37||
59623835|NCT02227238|75736009|FG001|NOT COMPLETED|Randomized Phase (Up to Week 52)||70||
59623836|NCT02227238|75736010|FG002|NOT COMPLETED|Randomized Phase (Up to Week 52)||0||
59623837|NCT02227238|75736008|FG000|STARTED|Continuation Phase(From Weeks 52 to 295)||0||
59623838|NCT02227238|75736009|FG001|STARTED|Continuation Phase(From Weeks 52 to 295)||0||
59623839|NCT02227238|75736010|FG002|STARTED|Continuation Phase(From Weeks 52 to 295)|274 participants from the Randomized entered in the Continuation Phase.|274||
59623840|NCT02227238|75736008|FG000|COMPLETED|Continuation Phase(From Weeks 52 to 295)||0||
59623841|NCT02227238|75736009|FG001|COMPLETED|Continuation Phase(From Weeks 52 to 295)||0||
59623842|NCT02227238|75736010|FG002|COMPLETED|Continuation Phase(From Weeks 52 to 295)||225||
59623843|NCT02227238|75736008|FG000|NOT COMPLETED|Continuation Phase(From Weeks 52 to 295)||0||
59623844|NCT02227238|75736009|FG001|NOT COMPLETED|Continuation Phase(From Weeks 52 to 295)||0||
59623845|NCT02227238|75736010|FG002|NOT COMPLETED|Continuation Phase(From Weeks 52 to 295)||49||
59623846|NCT02225925|75736025|FG000|STARTED|Overall Study||45||
59623847|NCT02225925|75736025|FG000|COMPLETED|Overall Study||45||
59623848|NCT02225925|75736025|FG000|NOT COMPLETED|Overall Study||0||
59623849|NCT02126969|75736031|FG000|STARTED|Overall Study||23||
59623850|NCT02126969|75736032|FG001|STARTED|Overall Study||22||
59623851|NCT02126969|75736031|FG000|COMPLETED|Overall Study||22||
59623852|NCT02126969|75736032|FG001|COMPLETED|Overall Study||20||
59623853|NCT02126969|75736031|FG000|NOT COMPLETED|Overall Study||1||
59623854|NCT02126969|75736032|FG001|NOT COMPLETED|Overall Study||2||
59623855|NCT01715285|75736040|FG000|STARTED|Double Blind Period (Up to 23 Months)||597||
59623856|NCT01715285|75736041|FG001|STARTED|Double Blind Period (Up to 23 Months)||602||
59623857|NCT01715285|75736042|FG002|STARTED|Double Blind Period (Up to 23 Months)||0||
59623858|NCT01715285|75736040|FG000|COMPLETED|Double Blind Period (Up to 23 Months)||0||
59623859|NCT01715285|75736041|FG001|COMPLETED|Double Blind Period (Up to 23 Months)||0||
59623860|NCT01715285|75736042|FG002|COMPLETED|Double Blind Period (Up to 23 Months)||0||
59623861|NCT01715285|75736040|FG000|NOT COMPLETED|Double Blind Period (Up to 23 Months)||597||
59623862|NCT01715285|75736041|FG001|NOT COMPLETED|Double Blind Period (Up to 23 Months)||602||
59623863|NCT01715285|75736042|FG002|NOT COMPLETED|Double Blind Period (Up to 23 Months)||0||
59623864|NCT01715285|75736040|FG000|STARTED|OLE Phase (Up to 15.6 Months)||0||
59623865|NCT01715285|75736041|FG001|STARTED|OLE Phase (Up to 15.6 Months)||0||
59623866|NCT01715285|75736042|FG002|STARTED|OLE Phase (Up to 15.6 Months)|Post unblinding, participants crossed over to OLE Phase.|72||
59623867|NCT01715285|75736040|FG000|COMPLETED|OLE Phase (Up to 15.6 Months)||0||
59623868|NCT01715285|75736041|FG001|COMPLETED|OLE Phase (Up to 15.6 Months)||0||
59623869|NCT01715285|75736042|FG002|COMPLETED|OLE Phase (Up to 15.6 Months)||0||
59623870|NCT01715285|75736040|FG000|NOT COMPLETED|OLE Phase (Up to 15.6 Months)||0||
59623871|NCT01715285|75736041|FG001|NOT COMPLETED|OLE Phase (Up to 15.6 Months)||0||
59815593|NCT04884737|75938035|FG000|COMPLETED|Overall Study||39||
59623872|NCT01715285|75736042|FG002|NOT COMPLETED|OLE Phase (Up to 15.6 Months)||72||
59623873|NCT01250496|75736051|FG000|STARTED|Overall Study||124||
59623874|NCT01250496|75736052|FG001|STARTED|Overall Study||124||
59623875|NCT01250496|75736051|FG000|COMPLETED|Overall Study||0||
59623876|NCT01250496|75736052|FG001|COMPLETED|Overall Study||0||
59623877|NCT01250496|75736051|FG000|NOT COMPLETED|Overall Study||124||
59623878|NCT01250496|75736052|FG001|NOT COMPLETED|Overall Study||124||
59623879|NCT01105975|75736068|FG000|STARTED|Overall Study||40||
59623880|NCT01105975|75736069|FG001|STARTED|Overall Study||39||
59623881|NCT01105975|75736070|FG002|STARTED|Overall Study||42||
59623882|NCT01105975|75736071|FG003|STARTED|Overall Study||38||
59623883|NCT01105975|75736072|FG004|STARTED|Overall Study||41||
59623884|NCT01105975|75736073|FG005|STARTED|Overall Study||35||
59623885|NCT01105975|75736074|FG006|STARTED|Overall Study||42||
59623886|NCT01105975|75736075|FG007|STARTED|Overall Study||40||
59623887|NCT01105975|75736076|FG008|STARTED|Overall Study||40||
59623888|NCT01105975|75736077|FG009|STARTED|Overall Study||41||
59623889|NCT01105975|75736068|FG000|Took at Least One Dose of Study Drug|Overall Study||40||
59623890|NCT01105975|75736069|FG001|Took at Least One Dose of Study Drug|Overall Study||38||
59623891|NCT01105975|75736070|FG002|Took at Least One Dose of Study Drug|Overall Study||40||
59623892|NCT01105975|75736071|FG003|Took at Least One Dose of Study Drug|Overall Study||38||
59623893|NCT01105975|75736072|FG004|Took at Least One Dose of Study Drug|Overall Study||41||
59623894|NCT01105975|75736073|FG005|Took at Least One Dose of Study Drug|Overall Study||35||
59623895|NCT01105975|75736074|FG006|Took at Least One Dose of Study Drug|Overall Study||41||
59623896|NCT01105975|75736075|FG007|Took at Least One Dose of Study Drug|Overall Study||40||
59623897|NCT01105975|75736076|FG008|Took at Least One Dose of Study Drug|Overall Study||39||
59623898|NCT01105975|75736077|FG009|Took at Least One Dose of Study Drug|Overall Study||41||
59623899|NCT01105975|75736068|FG000|COMPLETED|Overall Study||35||
59623900|NCT01105975|75736069|FG001|COMPLETED|Overall Study||34||
59623901|NCT01105975|75736070|FG002|COMPLETED|Overall Study||32||
59623902|NCT01105975|75736071|FG003|COMPLETED|Overall Study||36||
59623903|NCT01105975|75736072|FG004|COMPLETED|Overall Study||35||
59623904|NCT01105975|75736073|FG005|COMPLETED|Overall Study||30||
59623905|NCT01105975|75736074|FG006|COMPLETED|Overall Study||34||
59623906|NCT01105975|75736075|FG007|COMPLETED|Overall Study||33||
59623907|NCT01105975|75736076|FG008|COMPLETED|Overall Study||34||
59623908|NCT01105975|75736077|FG009|COMPLETED|Overall Study||32||
59623909|NCT01105975|75736068|FG000|NOT COMPLETED|Overall Study||5||
59623910|NCT01105975|75736069|FG001|NOT COMPLETED|Overall Study||5||
59623911|NCT01105975|75736070|FG002|NOT COMPLETED|Overall Study||10||
59623912|NCT01105975|75736071|FG003|NOT COMPLETED|Overall Study||2||
59623913|NCT01105975|75736072|FG004|NOT COMPLETED|Overall Study||6||
59623914|NCT01105975|75736073|FG005|NOT COMPLETED|Overall Study||5||
59623915|NCT01105975|75736074|FG006|NOT COMPLETED|Overall Study||8||
59623916|NCT01105975|75736075|FG007|NOT COMPLETED|Overall Study||7||
59623917|NCT01105975|75736076|FG008|NOT COMPLETED|Overall Study||6||
59623918|NCT01105975|75736077|FG009|NOT COMPLETED|Overall Study||9||
59623919|NCT00831623|75736118|FG000|STARTED|Overall Study||167||
59623920|NCT00831623|75736118|FG000|Treated Per Protocol|Overall Study||158||
59623921|NCT00831623|75736118|FG000|At Least 2 Years Since Completing Treatment|Overall Study||146||
59623922|NCT00831623|75736118|FG000|COMPLETED|Overall Study||145|At least two years since completing treatment|
59623923|NCT00831623|75736118|FG000|NOT COMPLETED|Overall Study||22||
59623924|NCT00079417|75736122|FG000|STARTED|Overall Study||28||
59623925|NCT00079417|75736122|FG000|COMPLETED|Overall Study||19||
59623926|NCT00079417|75736122|FG000|NOT COMPLETED|Overall Study||9||
59623927|NCT01628250|75736128|FG000|STARTED|Overall Study||49||
59623928|NCT01628250|75736129|FG001|STARTED|Overall Study||50||
59623929|NCT01628250|75736128|FG000|COMPLETED|Overall Study||49||
59623930|NCT01628250|75736129|FG001|COMPLETED|Overall Study||50||
59623931|NCT01628250|75736128|FG000|NOT COMPLETED|Overall Study||0||
59623932|NCT01628250|75736129|FG001|NOT COMPLETED|Overall Study||0||
59623933|NCT03956082|75736135|FG000|STARTED|Overall Study||15||
59815594|NCT04884737|75938036|FG001|COMPLETED|Overall Study||48||
59623934|NCT03956082|75736135|FG000|COMPLETED|Overall Study||9||
59623935|NCT03956082|75736135|FG000|NOT COMPLETED|Overall Study||6||
59623936|NCT00807456|75736139|FG000|STARTED|Overall Study||65||
59623937|NCT00807456|75736139|FG000|Surgical Re-entry (Implant Placement + 16-17 Weeks)|Overall Study||65||
59623938|NCT00807456|75736139|FG000|COMPLETED|Overall Study||57||
59623939|NCT00807456|75736139|FG000|NOT COMPLETED|Overall Study||8||
59623940|NCT00575016|75736151|FG000|STARTED|Treatment Cycle 1||17||
59623941|NCT00575016|75736152|FG001|STARTED|Treatment Cycle 1||21||
59623942|NCT00575016|75736153|FG002|STARTED|Treatment Cycle 1||19||
59623943|NCT00575016|75736154|FG003|STARTED|Treatment Cycle 1|1 pt randomized to Placebo never received treatment|17||
59623944|NCT00575016|75736151|FG000|COMPLETED|Treatment Cycle 1|3 pts from 200U group entered Cycle 2|8||
59623945|NCT00575016|75736152|FG001|COMPLETED|Treatment Cycle 1|11 pts from 100U group entered Cycle 2|16||
59623946|NCT00575016|75736153|FG002|COMPLETED|Treatment Cycle 1|8 pts from 50U group entered Cycle 2|15||
59623947|NCT00575016|75736154|FG003|COMPLETED|Treatment Cycle 1|9 pts from Placebo group entered Cycle 2|12||
59623948|NCT00575016|75736151|FG000|NOT COMPLETED|Treatment Cycle 1||9||
59623949|NCT00575016|75736152|FG001|NOT COMPLETED|Treatment Cycle 1||5||
59623950|NCT00575016|75736153|FG002|NOT COMPLETED|Treatment Cycle 1||4||
59623951|NCT00575016|75736154|FG003|NOT COMPLETED|Treatment Cycle 1||5||
59623952|NCT00575016|75736151|FG000|STARTED|Treatment Cycle 2|All patients received 200U in Treatment Cycle 2.|31||
59623953|NCT00575016|75736152|FG001|STARTED|Treatment Cycle 2|All patients received 200U in Treatment Cycle 2.|0||
59623954|NCT00575016|75736153|FG002|STARTED|Treatment Cycle 2|All patients received 200U in Treatment Cycle 2.|0||
59623955|NCT00575016|75736154|FG003|STARTED|Treatment Cycle 2|All patients received 200U in Treatment Cycle 2.|0||
59623956|NCT00575016|75736151|FG000|COMPLETED|Treatment Cycle 2||30||
59623957|NCT00575016|75736152|FG001|COMPLETED|Treatment Cycle 2||0||
59623958|NCT00575016|75736153|FG002|COMPLETED|Treatment Cycle 2||0||
59623959|NCT00575016|75736154|FG003|COMPLETED|Treatment Cycle 2||0||
59623960|NCT00575016|75736151|FG000|NOT COMPLETED|Treatment Cycle 2||1||
59623961|NCT00575016|75736152|FG001|NOT COMPLETED|Treatment Cycle 2||0||
59623962|NCT00575016|75736153|FG002|NOT COMPLETED|Treatment Cycle 2||0||
59623963|NCT00575016|75736154|FG003|NOT COMPLETED|Treatment Cycle 2||0||
59623964|NCT00577512|75736164|FG000|STARTED|Overall Study||4||
59623965|NCT00577512|75736164|FG000|COMPLETED|Overall Study||0||
59623966|NCT00577512|75736164|FG000|NOT COMPLETED|Overall Study||4||
59623967|NCT00577590|75736171|FG000|STARTED|Overall Study||28||
59623968|NCT00577590|75736172|FG001|STARTED|Overall Study||27||
59623969|NCT00577590|75736173|FG002|STARTED|Overall Study||23||
59623970|NCT00577590|75736171|FG000|COMPLETED|Overall Study||28||
59623971|NCT00577590|75736172|FG001|COMPLETED|Overall Study||27||
59623972|NCT00577590|75736173|FG002|COMPLETED|Overall Study||23||
59623973|NCT00577590|75736171|FG000|NOT COMPLETED|Overall Study||0||
59623974|NCT00577590|75736172|FG001|NOT COMPLETED|Overall Study||0||
59623975|NCT00577590|75736173|FG002|NOT COMPLETED|Overall Study||0||
59623976|NCT00578214|75736184|FG000|STARTED|Overall Study||22||
59623977|NCT00578214|75736185|FG001|STARTED|Overall Study||22||
59623978|NCT00578214|75736186|FG002|STARTED|Overall Study||31||
59623979|NCT00578214|75736184|FG000|COMPLETED|Overall Study||22||
59623980|NCT00578214|75736185|FG001|COMPLETED|Overall Study||22||
59623981|NCT00578214|75736186|FG002|COMPLETED|Overall Study||31||
59623982|NCT00578214|75736184|FG000|NOT COMPLETED|Overall Study||0||
59623983|NCT00578214|75736185|FG001|NOT COMPLETED|Overall Study||0||
59623984|NCT00578214|75736186|FG002|NOT COMPLETED|Overall Study||0||
59623985|NCT00580398|75736196|FG000|STARTED|Overall Study||17||
59623986|NCT00580398|75736197|FG001|STARTED|Overall Study||32||
59623987|NCT00580398|75736196|FG000|COMPLETED|Overall Study||17||
59623988|NCT00580398|75736197|FG001|COMPLETED|Overall Study||32||
59623989|NCT00580398|75736196|FG000|NOT COMPLETED|Overall Study||0||
59623990|NCT00580398|75736197|FG001|NOT COMPLETED|Overall Study||0||
59623991|NCT00581256|75736205|FG000|STARTED|Overall Study||28||
59623992|NCT00581256|75736206|FG001|STARTED|Overall Study||26||
59623993|NCT00581256|75736205|FG000|COMPLETED|Overall Study||28||
59623994|NCT00581256|75736206|FG001|COMPLETED|Overall Study||26||
59623995|NCT00581256|75736205|FG000|NOT COMPLETED|Overall Study||0||
59623996|NCT00581256|75736206|FG001|NOT COMPLETED|Overall Study||0||
59623997|NCT00582660|75736214|FG000|STARTED|Overall Study||20||
60076156|NCT01904773|76191370|FG006|NOT COMPLETED|Placebo Washout First Intervention||0||
60076157|NCT01904773|76191371|FG007|NOT COMPLETED|Placebo Washout First Intervention||0||
60076158|NCT01904773|76191372|FG008|NOT COMPLETED|Placebo Washout First Intervention||0||
60076159|NCT01904773|76191364|FG000|STARTED|Second Intervention||0||
60076160|NCT01904773|76191365|FG001|STARTED|Second Intervention||1||
60076161|NCT01904773|76191366|FG002|STARTED|Second Intervention||1||
60076162|NCT01904773|76191367|FG003|STARTED|Second Intervention||2||
60076163|NCT01904773|76191368|FG004|STARTED|Second Intervention||3||
60076164|NCT01904773|76191369|FG005|STARTED|Second Intervention||4||
60076165|NCT01904773|76191370|FG006|STARTED|Second Intervention||3||
60076166|NCT01904773|76191371|FG007|STARTED|Second Intervention||3||
60076167|NCT01904773|76191372|FG008|STARTED|Second Intervention||4||
60076168|NCT01904773|76191364|FG000|COMPLETED|Second Intervention||0||
60076169|NCT01904773|76191365|FG001|COMPLETED|Second Intervention||1||
60076170|NCT01904773|76191366|FG002|COMPLETED|Second Intervention||1||
60076171|NCT01904773|76191367|FG003|COMPLETED|Second Intervention||2||
60076172|NCT01904773|76191368|FG004|COMPLETED|Second Intervention||3||
59623998|NCT00582660|75736215|FG001|STARTED|Overall Study||20||
59623999|NCT00582660|75736214|FG000|COMPLETED|Overall Study||20||
59624000|NCT00582660|75736215|FG001|COMPLETED|Overall Study||20||
59624001|NCT00582660|75736214|FG000|NOT COMPLETED|Overall Study||0||
59624002|NCT00582660|75736215|FG001|NOT COMPLETED|Overall Study||0||
59624003|NCT00582894|75736221|FG000|STARTED|Overall Study||17||
59624004|NCT00582894|75736221|FG000|Day 100 Post Transplant|Overall Study||17||
59624005|NCT00582894|75736221|FG000|COMPLETED|Overall Study||17||
59624006|NCT00582894|75736221|FG000|NOT COMPLETED|Overall Study||0||
59624007|NCT00583050|75736225|FG000|STARTED|Overall Study||1366||
59624008|NCT00583050|75736225|FG000|COMPLETED|Overall Study||1366||
59624009|NCT00583050|75736225|FG000|NOT COMPLETED|Overall Study||0||
59624010|NCT00583908|75736229|FG000|STARTED|Period 1 - First Intervention||1||
59624011|NCT00583908|75736230|FG001|STARTED|Period 1 - First Intervention||2||
59624012|NCT00583908|75736231|FG002|STARTED|Period 1 - First Intervention||1||
60076173|NCT01904773|76191369|FG005|COMPLETED|Second Intervention||4||
59624013|NCT00583908|75736232|FG003|STARTED|Period 1 - First Intervention||1||
59624014|NCT00583908|75736233|FG004|STARTED|Period 1 - First Intervention||2||
59624015|NCT00583908|75736234|FG005|STARTED|Period 1 - First Intervention||1||
59624016|NCT00583908|75736235|FG006|STARTED|Period 1 - First Intervention||1||
59624017|NCT00583908|75736236|FG007|STARTED|Period 1 - First Intervention||1||
59624018|NCT00583908|75736237|FG008|STARTED|Period 1 - First Intervention||1||
59624019|NCT00583908|75736238|FG009|STARTED|Period 1 - First Intervention||1||
59624020|NCT00583908|75736239|FG010|STARTED|Period 1 - First Intervention||1||
59624021|NCT00583908|75736240|FG011|STARTED|Period 1 - First Intervention||1||
59624022|NCT00583908|75736229|FG000|COMPLETED|Period 1 - First Intervention||1||
59624023|NCT00583908|75736230|FG001|COMPLETED|Period 1 - First Intervention||2||
59624024|NCT00583908|75736231|FG002|COMPLETED|Period 1 - First Intervention||1||
59624025|NCT00583908|75736232|FG003|COMPLETED|Period 1 - First Intervention||1||
59624026|NCT00583908|75736233|FG004|COMPLETED|Period 1 - First Intervention||2||
59624027|NCT00583908|75736234|FG005|COMPLETED|Period 1 - First Intervention||1||
59624028|NCT00583908|75736235|FG006|COMPLETED|Period 1 - First Intervention||1||
59624029|NCT00583908|75736236|FG007|COMPLETED|Period 1 - First Intervention||1||
59624030|NCT00583908|75736237|FG008|COMPLETED|Period 1 - First Intervention||1||
59624031|NCT00583908|75736238|FG009|COMPLETED|Period 1 - First Intervention||1||
59624032|NCT00583908|75736239|FG010|COMPLETED|Period 1 - First Intervention||1||
59624033|NCT00583908|75736240|FG011|COMPLETED|Period 1 - First Intervention||1||
59624034|NCT00583908|75736229|FG000|NOT COMPLETED|Period 1 - First Intervention||0||
59988120|NCT00830219|76103254|FG001|COMPLETED|First Intervention||23||
59988121|NCT00830219|76103253|FG000|NOT COMPLETED|First Intervention||0||
59624035|NCT00583908|75736230|FG001|NOT COMPLETED|Period 1 - First Intervention||0||
59624036|NCT00583908|75736231|FG002|NOT COMPLETED|Period 1 - First Intervention||0||
59624037|NCT00583908|75736232|FG003|NOT COMPLETED|Period 1 - First Intervention||0||
59624038|NCT00583908|75736233|FG004|NOT COMPLETED|Period 1 - First Intervention||0||
59624039|NCT00583908|75736234|FG005|NOT COMPLETED|Period 1 - First Intervention||0||
59624040|NCT00583908|75736235|FG006|NOT COMPLETED|Period 1 - First Intervention||0||
59624041|NCT00583908|75736236|FG007|NOT COMPLETED|Period 1 - First Intervention||0||
59624042|NCT00583908|75736237|FG008|NOT COMPLETED|Period 1 - First Intervention||0||
59624043|NCT00583908|75736238|FG009|NOT COMPLETED|Period 1 - First Intervention||0||
59624044|NCT00583908|75736239|FG010|NOT COMPLETED|Period 1 - First Intervention||0||
59624045|NCT00583908|75736240|FG011|NOT COMPLETED|Period 1 - First Intervention||0||
59624046|NCT00583908|75736229|FG000|STARTED|Period 2 - Second Intervention||1||
59624047|NCT00583908|75736230|FG001|STARTED|Period 2 - Second Intervention||2||
59624048|NCT00583908|75736231|FG002|STARTED|Period 2 - Second Intervention||1||
59624049|NCT00583908|75736232|FG003|STARTED|Period 2 - Second Intervention||1||
59624050|NCT00583908|75736233|FG004|STARTED|Period 2 - Second Intervention||2||
59624051|NCT00583908|75736234|FG005|STARTED|Period 2 - Second Intervention||1||
59624052|NCT00583908|75736235|FG006|STARTED|Period 2 - Second Intervention||1||
59624053|NCT00583908|75736236|FG007|STARTED|Period 2 - Second Intervention||1||
59624054|NCT00583908|75736237|FG008|STARTED|Period 2 - Second Intervention||1||
59624055|NCT00583908|75736238|FG009|STARTED|Period 2 - Second Intervention||1||
59624056|NCT00583908|75736239|FG010|STARTED|Period 2 - Second Intervention||1||
59624057|NCT00583908|75736240|FG011|STARTED|Period 2 - Second Intervention||1||
59624058|NCT00583908|75736229|FG000|COMPLETED|Period 2 - Second Intervention||1||
59624059|NCT00583908|75736230|FG001|COMPLETED|Period 2 - Second Intervention||2||
59624060|NCT00583908|75736231|FG002|COMPLETED|Period 2 - Second Intervention||1||
59624061|NCT00583908|75736232|FG003|COMPLETED|Period 2 - Second Intervention||1||
59624062|NCT00583908|75736233|FG004|COMPLETED|Period 2 - Second Intervention||2||
59988122|NCT00830219|76103254|FG001|NOT COMPLETED|First Intervention||0||
59988123|NCT00830219|76103253|FG000|STARTED|Washout of 7 Days||23||
59624063|NCT00583908|75736234|FG005|COMPLETED|Period 2 - Second Intervention||1||
59624064|NCT00583908|75736235|FG006|COMPLETED|Period 2 - Second Intervention||1||
59624065|NCT00583908|75736236|FG007|COMPLETED|Period 2 - Second Intervention||1||
59624066|NCT00583908|75736237|FG008|COMPLETED|Period 2 - Second Intervention||1||
59624067|NCT00583908|75736238|FG009|COMPLETED|Period 2 - Second Intervention||1||
59624068|NCT00583908|75736239|FG010|COMPLETED|Period 2 - Second Intervention||1||
59624069|NCT00583908|75736240|FG011|COMPLETED|Period 2 - Second Intervention||1||
59624070|NCT00583908|75736229|FG000|NOT COMPLETED|Period 2 - Second Intervention||0||
59624071|NCT00583908|75736230|FG001|NOT COMPLETED|Period 2 - Second Intervention||0||
59624072|NCT00583908|75736231|FG002|NOT COMPLETED|Period 2 - Second Intervention||0||
59988124|NCT00830219|76103254|FG001|STARTED|Washout of 7 Days||23||
59988125|NCT00830219|76103253|FG000|COMPLETED|Washout of 7 Days||22||
59988126|NCT00830219|76103254|FG001|COMPLETED|Washout of 7 Days||22||
59624073|NCT00583908|75736232|FG003|NOT COMPLETED|Period 2 - Second Intervention||0||
59624074|NCT00583908|75736233|FG004|NOT COMPLETED|Period 2 - Second Intervention||0||
59624075|NCT00583908|75736234|FG005|NOT COMPLETED|Period 2 - Second Intervention||0||
59624076|NCT00583908|75736235|FG006|NOT COMPLETED|Period 2 - Second Intervention||0||
59988127|NCT00830219|76103253|FG000|NOT COMPLETED|Washout of 7 Days||1||
59988128|NCT00830219|76103254|FG001|NOT COMPLETED|Washout of 7 Days||1||
59988129|NCT00830219|76103253|FG000|STARTED|Second Intervention||22||
59988130|NCT00830219|76103254|FG001|STARTED|Second Intervention||22||
59624077|NCT00583908|75736236|FG007|NOT COMPLETED|Period 2 - Second Intervention||0||
59624078|NCT00583908|75736237|FG008|NOT COMPLETED|Period 2 - Second Intervention||0||
59624079|NCT00583908|75736238|FG009|NOT COMPLETED|Period 2 - Second Intervention||0||
59624080|NCT00583908|75736239|FG010|NOT COMPLETED|Period 2 - Second Intervention||0||
59624081|NCT00583908|75736240|FG011|NOT COMPLETED|Period 2 - Second Intervention||0||
59624082|NCT00583908|75736229|FG000|STARTED|Period 3 - Third Intervention||1||
59624083|NCT00583908|75736230|FG001|STARTED|Period 3 - Third Intervention||2||
59624084|NCT00583908|75736231|FG002|STARTED|Period 3 - Third Intervention||1||
59624085|NCT00583908|75736232|FG003|STARTED|Period 3 - Third Intervention||1||
59624086|NCT00583908|75736233|FG004|STARTED|Period 3 - Third Intervention||2||
59624087|NCT00583908|75736234|FG005|STARTED|Period 3 - Third Intervention||1||
59624088|NCT00583908|75736235|FG006|STARTED|Period 3 - Third Intervention||1||
59624089|NCT00583908|75736236|FG007|STARTED|Period 3 - Third Intervention||1||
59624090|NCT00583908|75736237|FG008|STARTED|Period 3 - Third Intervention||1||
59624091|NCT00583908|75736238|FG009|STARTED|Period 3 - Third Intervention||1||
59624092|NCT00583908|75736239|FG010|STARTED|Period 3 - Third Intervention||1||
59624093|NCT00583908|75736240|FG011|STARTED|Period 3 - Third Intervention||1||
59624094|NCT00583908|75736229|FG000|COMPLETED|Period 3 - Third Intervention||1||
59624095|NCT00583908|75736230|FG001|COMPLETED|Period 3 - Third Intervention||2||
59624096|NCT00583908|75736231|FG002|COMPLETED|Period 3 - Third Intervention||1||
59624097|NCT00583908|75736232|FG003|COMPLETED|Period 3 - Third Intervention||1||
59624098|NCT00583908|75736233|FG004|COMPLETED|Period 3 - Third Intervention||2||
59624099|NCT00583908|75736234|FG005|COMPLETED|Period 3 - Third Intervention||1||
59624100|NCT00583908|75736235|FG006|COMPLETED|Period 3 - Third Intervention||1||
59624101|NCT00583908|75736236|FG007|COMPLETED|Period 3 - Third Intervention||1||
59624102|NCT00583908|75736237|FG008|COMPLETED|Period 3 - Third Intervention||1||
59624103|NCT00583908|75736238|FG009|COMPLETED|Period 3 - Third Intervention||1||
59624104|NCT00583908|75736239|FG010|COMPLETED|Period 3 - Third Intervention||1||
59624105|NCT00583908|75736240|FG011|COMPLETED|Period 3 - Third Intervention||1||
59624106|NCT00583908|75736229|FG000|NOT COMPLETED|Period 3 - Third Intervention||0||
59624107|NCT00583908|75736230|FG001|NOT COMPLETED|Period 3 - Third Intervention||0||
59624108|NCT00583908|75736231|FG002|NOT COMPLETED|Period 3 - Third Intervention||0||
59624109|NCT00583908|75736232|FG003|NOT COMPLETED|Period 3 - Third Intervention||0||
59624110|NCT00583908|75736233|FG004|NOT COMPLETED|Period 3 - Third Intervention||0||
59624111|NCT00583908|75736234|FG005|NOT COMPLETED|Period 3 - Third Intervention||0||
59624112|NCT00583908|75736235|FG006|NOT COMPLETED|Period 3 - Third Intervention||0||
59624113|NCT00583908|75736236|FG007|NOT COMPLETED|Period 3 - Third Intervention||0||
59624114|NCT00583908|75736237|FG008|NOT COMPLETED|Period 3 - Third Intervention||0||
59624115|NCT00583908|75736238|FG009|NOT COMPLETED|Period 3 - Third Intervention||0||
59624116|NCT00583908|75736239|FG010|NOT COMPLETED|Period 3 - Third Intervention||0||
59624117|NCT00583908|75736240|FG011|NOT COMPLETED|Period 3 - Third Intervention||0||
59624118|NCT00583908|75736229|FG000|STARTED|Period 4 - Fourth Intervention||1||
59624119|NCT00583908|75736230|FG001|STARTED|Period 4 - Fourth Intervention||2||
59624120|NCT00583908|75736231|FG002|STARTED|Period 4 - Fourth Intervention||1||
59624121|NCT00583908|75736232|FG003|STARTED|Period 4 - Fourth Intervention||1||
59624122|NCT00583908|75736233|FG004|STARTED|Period 4 - Fourth Intervention||2||
59624123|NCT00583908|75736234|FG005|STARTED|Period 4 - Fourth Intervention||1||
59624124|NCT00583908|75736235|FG006|STARTED|Period 4 - Fourth Intervention||1||
59624125|NCT00583908|75736236|FG007|STARTED|Period 4 - Fourth Intervention||1||
59624126|NCT00583908|75736237|FG008|STARTED|Period 4 - Fourth Intervention||1||
59624127|NCT00583908|75736238|FG009|STARTED|Period 4 - Fourth Intervention||1||
59624128|NCT00583908|75736239|FG010|STARTED|Period 4 - Fourth Intervention||1||
59624129|NCT00583908|75736240|FG011|STARTED|Period 4 - Fourth Intervention||1||
59624130|NCT00583908|75736229|FG000|COMPLETED|Period 4 - Fourth Intervention||1||
59624131|NCT00583908|75736230|FG001|COMPLETED|Period 4 - Fourth Intervention||2||
59624132|NCT00583908|75736231|FG002|COMPLETED|Period 4 - Fourth Intervention||1||
59624133|NCT00583908|75736232|FG003|COMPLETED|Period 4 - Fourth Intervention||1||
59624134|NCT00583908|75736233|FG004|COMPLETED|Period 4 - Fourth Intervention||2||
59624135|NCT00583908|75736234|FG005|COMPLETED|Period 4 - Fourth Intervention||1||
59624136|NCT00583908|75736235|FG006|COMPLETED|Period 4 - Fourth Intervention||1||
59624137|NCT00583908|75736236|FG007|COMPLETED|Period 4 - Fourth Intervention||1||
59624138|NCT00583908|75736237|FG008|COMPLETED|Period 4 - Fourth Intervention||1||
59624139|NCT00583908|75736238|FG009|COMPLETED|Period 4 - Fourth Intervention||1||
59624140|NCT00583908|75736239|FG010|COMPLETED|Period 4 - Fourth Intervention||1||
59624141|NCT00583908|75736240|FG011|COMPLETED|Period 4 - Fourth Intervention||1||
59624142|NCT00583908|75736229|FG000|NOT COMPLETED|Period 4 - Fourth Intervention||0||
59624143|NCT00583908|75736230|FG001|NOT COMPLETED|Period 4 - Fourth Intervention||0||
59624144|NCT00583908|75736231|FG002|NOT COMPLETED|Period 4 - Fourth Intervention||0||
59624145|NCT00583908|75736232|FG003|NOT COMPLETED|Period 4 - Fourth Intervention||0||
59624146|NCT00583908|75736233|FG004|NOT COMPLETED|Period 4 - Fourth Intervention||0||
59624147|NCT00583908|75736234|FG005|NOT COMPLETED|Period 4 - Fourth Intervention||0||
59624148|NCT00583908|75736235|FG006|NOT COMPLETED|Period 4 - Fourth Intervention||0||
59624149|NCT00583908|75736236|FG007|NOT COMPLETED|Period 4 - Fourth Intervention||0||
59624150|NCT00583908|75736237|FG008|NOT COMPLETED|Period 4 - Fourth Intervention||0||
59624151|NCT00583908|75736238|FG009|NOT COMPLETED|Period 4 - Fourth Intervention||0||
59624152|NCT00583908|75736239|FG010|NOT COMPLETED|Period 4 - Fourth Intervention||0||
59624153|NCT00583908|75736240|FG011|NOT COMPLETED|Period 4 - Fourth Intervention||0||
59624154|NCT00584220|75736258|FG000|STARTED|First Period||48||
59624155|NCT00584220|75736259|FG001|STARTED|First Period||39||
59624156|NCT00584220|75736258|FG000|COMPLETED|First Period||48||
59624157|NCT00584220|75736259|FG001|COMPLETED|First Period||39||
59624158|NCT00584220|75736258|FG000|NOT COMPLETED|First Period||0||
59624159|NCT00584220|75736259|FG001|NOT COMPLETED|First Period||0||
59624160|NCT00584220|75736258|FG000|STARTED|Second Period||48||
59624161|NCT00584220|75736259|FG001|STARTED|Second Period||39||
59624162|NCT00584220|75736258|FG000|COMPLETED|Second Period||48||
59624163|NCT00584220|75736259|FG001|COMPLETED|Second Period||39||
59624164|NCT00584220|75736258|FG000|NOT COMPLETED|Second Period||0||
59624165|NCT00584220|75736259|FG001|NOT COMPLETED|Second Period||0||
59624166|NCT00584922|75736265|FG000|STARTED|Overall Study||175||
59624167|NCT00584922|75736265|FG000|COMPLETED|Overall Study||175||
59624168|NCT00584922|75736265|FG000|NOT COMPLETED|Overall Study||0||
59624169|NCT00585780|75736273|FG000|STARTED|Overall Study||21||
59624170|NCT00585780|75736274|FG001|STARTED|Overall Study||23||
59624171|NCT00585780|75736275|FG002|STARTED|Overall Study||34||
59624172|NCT00585780|75736276|FG003|STARTED|Overall Study||22||
59624173|NCT00585780|75736273|FG000|COMPLETED|Overall Study||13||
59624174|NCT00585780|75736274|FG001|COMPLETED|Overall Study||14||
59624175|NCT00585780|75736275|FG002|COMPLETED|Overall Study||21||
59624176|NCT00585780|75736276|FG003|COMPLETED|Overall Study||14||
59624177|NCT00585780|75736273|FG000|NOT COMPLETED|Overall Study||8||
59624178|NCT00585780|75736274|FG001|NOT COMPLETED|Overall Study||9||
59624179|NCT00585780|75736275|FG002|NOT COMPLETED|Overall Study||13||
59624180|NCT00585780|75736276|FG003|NOT COMPLETED|Overall Study||8||
59624181|NCT00586170|75736292|FG000|STARTED|Overall Study||5||
59624182|NCT00586170|75736293|FG001|STARTED|Overall Study|Initially enrollment was listed as 9. 1 placebo patient withdrew prior to surgery, so enrollment=8.|3||
59624183|NCT00586170|75736292|FG000|COMPLETED|Overall Study||5||
59624184|NCT00586170|75736293|FG001|COMPLETED|Overall Study||3||
59624185|NCT00586170|75736292|FG000|NOT COMPLETED|Overall Study||0||
59624186|NCT00586170|75736293|FG001|NOT COMPLETED|Overall Study||0||
59624187|NCT00586482|75736301|FG000|STARTED|Overall Study||22||
59624188|NCT00586482|75736302|FG001|STARTED|Overall Study||24||
59624189|NCT00586482|75736301|FG000|COMPLETED|Overall Study||22||
59624190|NCT00586482|75736302|FG001|COMPLETED|Overall Study||24||
59624191|NCT00586482|75736301|FG000|NOT COMPLETED|Overall Study||0||
59624192|NCT00586482|75736302|FG001|NOT COMPLETED|Overall Study||0||
59624193|NCT00588900|75736308|FG000|STARTED|Overall Study||5||
59624194|NCT00588900|75736308|FG000|COMPLETED|Overall Study||5||
59624195|NCT00588900|75736308|FG000|NOT COMPLETED|Overall Study||0||
59624196|NCT00589056|75736312|FG000|STARTED|Overall Study||55||
59624197|NCT00589056|75736312|FG000|COMPLETED|Overall Study||52||
59624198|NCT00589056|75736312|FG000|NOT COMPLETED|Overall Study||3||
59624199|NCT00589836|75736316|FG000|STARTED|Overall Study||20||
59624200|NCT00589836|75736316|FG000|COMPLETED|Overall Study||20||
59624201|NCT00589836|75736316|FG000|NOT COMPLETED|Overall Study||0||
59624202|NCT00590226|75736322|FG000|STARTED|Overall Study||67||
59624203|NCT00590226|75736323|FG001|STARTED|Overall Study||63||
59624204|NCT00590226|75736322|FG000|COMPLETED|Overall Study||67||
59624205|NCT00590226|75736323|FG001|COMPLETED|Overall Study||63||
59624206|NCT00590226|75736322|FG000|NOT COMPLETED|Overall Study||0||
59624207|NCT00590226|75736323|FG001|NOT COMPLETED|Overall Study||0||
59624208|NCT00590460|75736329|FG000|STARTED|Overall Study||5||
59624209|NCT00590460|75736329|FG000|COMPLETED|Overall Study||5||
59624210|NCT00590460|75736329|FG000|NOT COMPLETED|Overall Study||0||
59624211|NCT00590772|75736337|FG000|STARTED|Overall Study||31||
59624212|NCT00590772|75736337|FG000|COMPLETED|Overall Study||31||
59624213|NCT00590772|75736337|FG000|NOT COMPLETED|Overall Study||0||
59624214|NCT00591240|75736345|FG000|STARTED|Overall Study||116||
59624215|NCT00591240|75736346|FG001|STARTED|Overall Study||222||
59624216|NCT00591240|75736345|FG000|COMPLETED|Overall Study||116||
59624217|NCT00591240|75736346|FG001|COMPLETED|Overall Study||222||
59624218|NCT00591240|75736345|FG000|NOT COMPLETED|Overall Study||0||
59624219|NCT00591240|75736346|FG001|NOT COMPLETED|Overall Study||0||
59624220|NCT00591942|75736352|FG000|STARTED|Overall Study||36|Participants enrolled in both arms. 2 teeth were used in each subject, each with differing cement.|36
59624221|NCT00591942|75736353|FG001|STARTED|Overall Study||36|Participants enrolled in both arms. 2 teeth were used in each subject, each with differing cement.|36
59624222|NCT00591942|75736352|FG000|COMPLETED|Overall Study||36||36
59624223|NCT00591942|75736353|FG001|COMPLETED|Overall Study||36||36
59624224|NCT00591942|75736352|FG000|NOT COMPLETED|Overall Study||0||0
59624225|NCT00591942|75736353|FG001|NOT COMPLETED|Overall Study||0||0
59624226|NCT00592176|75736359|FG000|STARTED|Overall Study||5||
59624227|NCT00592176|75736359|FG000|COMPLETED|Overall Study||5||
59624228|NCT00592176|75736359|FG000|NOT COMPLETED|Overall Study||0||
59624229|NCT00592488|75736365|FG000|STARTED|Overall Study||6||
59624230|NCT00592488|75736366|FG001|STARTED|Overall Study||7||
59624231|NCT00592488|75736365|FG000|COMPLETED|Overall Study||6||
59624232|NCT00592488|75736366|FG001|COMPLETED|Overall Study||7||
59624233|NCT00592488|75736365|FG000|NOT COMPLETED|Overall Study||0||
59624234|NCT00592488|75736366|FG001|NOT COMPLETED|Overall Study||0||
59624235|NCT00593346|75736374|FG000|STARTED|Overall Study||151||
59624236|NCT00593346|75736374|FG000|COMPLETED|Overall Study||151||
59988131|NCT00830219|76103253|FG000|COMPLETED|Second Intervention||22||
59988132|NCT00830219|76103254|FG001|COMPLETED|Second Intervention||22||
59988133|NCT00830219|76103253|FG000|NOT COMPLETED|Second Intervention||0||
59988134|NCT00830219|76103254|FG001|NOT COMPLETED|Second Intervention||0||
59988135|NCT02274766|76103260|FG000|STARTED|Overall Study||39||
59624237|NCT00593346|75736374|FG000|NOT COMPLETED|Overall Study||0||
59624238|NCT00595530|75736379|FG000|STARTED|Overall Study||3||
59624239|NCT00595530|75736379|FG000|COMPLETED|Overall Study||3||
59624240|NCT00595530|75736379|FG000|NOT COMPLETED|Overall Study||0||
59624241|NCT00596622|75736387|FG000|STARTED|Overall Study||46||
59624242|NCT00596622|75736387|FG000|COMPLETED|Overall Study||33||
59624243|NCT00596622|75736387|FG000|NOT COMPLETED|Overall Study||13||
59624244|NCT00597246|75736396|FG000|STARTED|Overall Study||30||
59624245|NCT00597246|75736396|FG000|COMPLETED|Overall Study||30||
59624246|NCT00597246|75736396|FG000|NOT COMPLETED|Overall Study||0||
59624247|NCT00597402|75736400|FG000|STARTED|Overall Study||125||
59624248|NCT00597402|75736400|FG000|COMPLETED|Overall Study||125||
59624249|NCT00597402|75736400|FG000|NOT COMPLETED|Overall Study||0||
59624250|NCT00597558|75736404|FG000|STARTED|Overall Study||13||
59624251|NCT00597558|75736404|FG000|COMPLETED|Overall Study||9||
59624252|NCT00597558|75736404|FG000|NOT COMPLETED|Overall Study||4||
59624253|NCT00598806|75736410|FG000|STARTED|Overall Study||402||
59624254|NCT00598806|75736411|FG001|STARTED|Overall Study||410||
59624255|NCT00598806|75736410|FG000|COMPLETED|Overall Study||329||
59624256|NCT00598806|75736411|FG001|COMPLETED|Overall Study||346||
59624257|NCT00598806|75736410|FG000|NOT COMPLETED|Overall Study||73||
59624258|NCT00598806|75736411|FG001|NOT COMPLETED|Overall Study||64||
59624259|NCT00601146|75736417|FG000|STARTED|Overall Study||39||
59624260|NCT00601146|75736417|FG000|COMPLETED|Overall Study||39|Study stopped early due to low accrual. Study is close to enrollment|
59624261|NCT00601146|75736417|FG000|NOT COMPLETED|Overall Study||0||
59624262|NCT00601926|75736421|FG000|STARTED|Overall Study||5||
59624263|NCT00601926|75736421|FG000|COMPLETED|Overall Study||5||
59624264|NCT00601926|75736421|FG000|NOT COMPLETED|Overall Study||0||
59624265|NCT00603018|75736425|FG000|STARTED|Overall Study||23||
59624266|NCT00603018|75736425|FG000|COMPLETED|Overall Study||23||
59624267|NCT00603018|75736425|FG000|NOT COMPLETED|Overall Study||0||
59624268|NCT00603408|75736430|FG000|STARTED|Overall Study||5||
59624269|NCT00603408|75736430|FG000|COMPLETED|Overall Study||5||
59624270|NCT00603408|75736430|FG000|NOT COMPLETED|Overall Study||0||
59624271|NCT00603564|75736437|FG000|STARTED|Overall Study|January 2006|20||
59624272|NCT00603564|75736438|FG001|STARTED|Overall Study|January 2006|27||
59624273|NCT00603564|75736437|FG000|COMPLETED|Overall Study|February 2008|20||
59624274|NCT00603564|75736438|FG001|COMPLETED|Overall Study|February 2008|27||
59624275|NCT00603564|75736437|FG000|NOT COMPLETED|Overall Study||0||
59624276|NCT00603564|75736438|FG001|NOT COMPLETED|Overall Study||0||
59624277|NCT00603720|75736449|FG000|STARTED|Overall Study||10||
59624278|NCT00603720|75736450|FG001|STARTED|Overall Study||10||
60076174|NCT01904773|76191370|FG006|COMPLETED|Second Intervention||3||
60076175|NCT01904773|76191371|FG007|COMPLETED|Second Intervention||3||
59624279|NCT00603720|75736451|FG002|STARTED|Overall Study||12||
59624280|NCT00603720|75736452|FG003|STARTED|Overall Study||10||
59624281|NCT00603720|75736453|FG004|STARTED|Overall Study||12||
59624282|NCT00603720|75736449|FG000|COMPLETED|Overall Study||10||
59624283|NCT00603720|75736450|FG001|COMPLETED|Overall Study||10||
59624284|NCT00603720|75736451|FG002|COMPLETED|Overall Study||12||
59988136|NCT02274766|76103261|FG001|STARTED|Overall Study||38||
59988137|NCT02274766|76103260|FG000|Received Study Drug|Overall Study||38||
59988138|NCT02274766|76103261|FG001|Received Study Drug|Overall Study||37||
59988139|NCT02274766|76103260|FG000|COMPLETED|Overall Study||35||
59624285|NCT00603720|75736452|FG003|COMPLETED|Overall Study||10||
59624286|NCT00603720|75736453|FG004|COMPLETED|Overall Study||12||
59988140|NCT02274766|76103261|FG001|COMPLETED|Overall Study||29||
59988141|NCT02274766|76103260|FG000|NOT COMPLETED|Overall Study||4||
59988142|NCT02274766|76103261|FG001|NOT COMPLETED|Overall Study||9||
59624287|NCT00603720|75736449|FG000|NOT COMPLETED|Overall Study||0||
59624288|NCT00603720|75736450|FG001|NOT COMPLETED|Overall Study||0||
59624289|NCT00603720|75736451|FG002|NOT COMPLETED|Overall Study||0||
59624290|NCT00603720|75736452|FG003|NOT COMPLETED|Overall Study||0||
59624291|NCT00603720|75736453|FG004|NOT COMPLETED|Overall Study||0||
59624292|NCT00622518|75736467|FG000|STARTED|Overall Study||59||
59624293|NCT00622518|75736468|FG001|STARTED|Overall Study||60||
59624294|NCT00622518|75736467|FG000|COMPLETED|Overall Study||59||
59624295|NCT00622518|75736468|FG001|COMPLETED|Overall Study||60||
59624296|NCT00622518|75736467|FG000|NOT COMPLETED|Overall Study||0||
59624297|NCT00622518|75736468|FG001|NOT COMPLETED|Overall Study||0||
59624298|NCT00625404|75736476|FG000|STARTED|Overall Study||1062||
59624299|NCT00625404|75736477|FG001|STARTED|Overall Study||1058||
59624300|NCT00625404|75736476|FG000|COMPLETED|Overall Study||855||
59624301|NCT00625404|75736477|FG001|COMPLETED|Overall Study||885||
59624302|NCT00625404|75736476|FG000|NOT COMPLETED|Overall Study||207||
59624303|NCT00625404|75736477|FG001|NOT COMPLETED|Overall Study||173||
59624304|NCT00626340|75736487|FG000|STARTED|Overall Study||18||
59624305|NCT00626340|75736487|FG000|COMPLETED|Overall Study||18||
59624306|NCT00626340|75736487|FG000|NOT COMPLETED|Overall Study||0||
59624307|NCT00626574|75736493|FG000|STARTED|Overall Study||2||
59624308|NCT00626574|75736494|FG001|STARTED|Overall Study||1||
59624309|NCT00626574|75736493|FG000|COMPLETED|Overall Study||2||
59624310|NCT00626574|75736494|FG001|COMPLETED|Overall Study||1||
59624311|NCT00626574|75736493|FG000|NOT COMPLETED|Overall Study||0||
59624312|NCT00626574|75736494|FG001|NOT COMPLETED|Overall Study||0||
59624313|NCT00626808|75736506|FG000|STARTED|Overall Study||254464||
59624314|NCT00626808|75736507|FG001|STARTED|Overall Study||34316||
59624315|NCT00626808|75736508|FG002|STARTED|Overall Study||30011||
59624316|NCT00626808|75736509|FG003|STARTED|Overall Study||2906||
59624317|NCT00626808|75736506|FG000|COMPLETED|Overall Study||254464||
59624318|NCT00626808|75736507|FG001|COMPLETED|Overall Study||34316||
59624319|NCT00626808|75736508|FG002|COMPLETED|Overall Study||30011||
59624320|NCT00626808|75736509|FG003|COMPLETED|Overall Study||2906||
59624321|NCT00626808|75736506|FG000|NOT COMPLETED|Overall Study||0||
59624322|NCT00626808|75736507|FG001|NOT COMPLETED|Overall Study||0||
59624323|NCT00626808|75736508|FG002|NOT COMPLETED|Overall Study||0||
59624324|NCT00626808|75736509|FG003|NOT COMPLETED|Overall Study||0||
59624325|NCT00626886|75736521|FG000|STARTED|Overall Study||24||
59624326|NCT00626886|75736522|FG001|STARTED|Overall Study||29||
59624327|NCT00626886|75736521|FG000|COMPLETED|Overall Study||24||
59624328|NCT00626886|75736522|FG001|COMPLETED|Overall Study||29||
59624329|NCT00626886|75736521|FG000|NOT COMPLETED|Overall Study||0||
59624330|NCT00626886|75736522|FG001|NOT COMPLETED|Overall Study||0||
59624331|NCT00627978|75736530|FG000|STARTED|Overall Study||10||
59624332|NCT00627978|75736531|FG001|STARTED|Overall Study||5||
59624333|NCT00627978|75736530|FG000|COMPLETED|Overall Study||10||
59624334|NCT00627978|75736531|FG001|COMPLETED|Overall Study||5||
59624335|NCT00627978|75736530|FG000|NOT COMPLETED|Overall Study||0||
59624336|NCT00627978|75736531|FG001|NOT COMPLETED|Overall Study||0||
59624337|NCT00628134|75736537|FG000|STARTED|Overall Study||4||
59624338|NCT00628134|75736538|FG001|STARTED|Overall Study||4||
59624339|NCT00628134|75736537|FG000|COMPLETED|Overall Study||4||
59624340|NCT00628134|75736538|FG001|COMPLETED|Overall Study||4||
59624341|NCT00628134|75736537|FG000|NOT COMPLETED|Overall Study||0||
59624342|NCT00628134|75736538|FG001|NOT COMPLETED|Overall Study||0||
59624343|NCT00632814|75736547|FG000|STARTED|Overall Study||11||
59624344|NCT00632814|75736548|FG001|STARTED|Overall Study||13||
59624345|NCT00632814|75736549|FG002|STARTED|Overall Study||8||
59624346|NCT00632814|75736547|FG000|COMPLETED|Overall Study||11||
59624347|NCT00632814|75736548|FG001|COMPLETED|Overall Study||13||
59624348|NCT00632814|75736549|FG002|COMPLETED|Overall Study||8||
59624349|NCT00632814|75736547|FG000|NOT COMPLETED|Overall Study||0||
59624350|NCT00632814|75736548|FG001|NOT COMPLETED|Overall Study||0||
59624351|NCT00632814|75736549|FG002|NOT COMPLETED|Overall Study||0||
59624352|NCT00632970|75736559|FG000|STARTED|Overall Study||3||
59624353|NCT00632970|75736560|FG001|STARTED|Overall Study||3||
59624354|NCT00632970|75736559|FG000|COMPLETED|Overall Study||3||
59624355|NCT00632970|75736560|FG001|COMPLETED|Overall Study||3||
59624356|NCT00632970|75736559|FG000|NOT COMPLETED|Overall Study||0||
59624357|NCT00632970|75736560|FG001|NOT COMPLETED|Overall Study||0||
59624358|NCT00635232|75736571|FG000|STARTED|Overall Study||58||
59624359|NCT00635232|75736572|FG001|STARTED|Overall Study||59||
59624360|NCT00635232|75736573|FG002|STARTED|Overall Study||58||
59624361|NCT00635232|75736574|FG003|STARTED|Overall Study||58||
59624362|NCT00635232|75736575|FG004|STARTED|Overall Study||28||
59624363|NCT00635232|75736571|FG000|COMPLETED|Overall Study||44||
59624364|NCT00635232|75736572|FG001|COMPLETED|Overall Study||39||
59624365|NCT00635232|75736573|FG002|COMPLETED|Overall Study||55||
59624366|NCT00635232|75736574|FG003|COMPLETED|Overall Study||48||
59624367|NCT00635232|75736575|FG004|COMPLETED|Overall Study||20||
59624368|NCT00635232|75736571|FG000|NOT COMPLETED|Overall Study||14||
59624369|NCT00635232|75736572|FG001|NOT COMPLETED|Overall Study||20||
59624370|NCT00635232|75736573|FG002|NOT COMPLETED|Overall Study||3||
59624371|NCT00635232|75736574|FG003|NOT COMPLETED|Overall Study||10||
59624372|NCT00635232|75736575|FG004|NOT COMPLETED|Overall Study||8||
59624373|NCT00637494|75736589|FG000|STARTED|Overall Study||141||
59624374|NCT00637494|75736590|FG001|STARTED|Overall Study||151||
59624375|NCT00637494|75736589|FG000|COMPLETED|Overall Study||109||
59624376|NCT00637494|75736590|FG001|COMPLETED|Overall Study||108||
59624377|NCT00637494|75736589|FG000|NOT COMPLETED|Overall Study||32||
59624378|NCT00637494|75736590|FG001|NOT COMPLETED|Overall Study||43||
59624379|NCT00638274|75736598|FG000|STARTED|Overall Study||179||
59624380|NCT00638274|75736599|FG001|STARTED|Overall Study||177||
59624381|NCT00638274|75736598|FG000|COMPLETED|Overall Study||173||
59624382|NCT00638274|75736599|FG001|COMPLETED|Overall Study||172||
59624383|NCT00638274|75736598|FG000|NOT COMPLETED|Overall Study||6||
59624384|NCT00638274|75736599|FG001|NOT COMPLETED|Overall Study||5||
59624385|NCT00638820|75736605|FG000|STARTED|Overall Study||3||
59624386|NCT00638820|75736605|FG000|COMPLETED|Overall Study||3||
59624387|NCT00638820|75736605|FG000|NOT COMPLETED|Overall Study||0||
59624388|NCT00641862|75736611|FG000|STARTED|Overall Study||183||
59624389|NCT00641862|75736612|FG001|STARTED|Overall Study||183||
59624390|NCT00641862|75736611|FG000|COMPLETED|Overall Study||139||
59624391|NCT00641862|75736612|FG001|COMPLETED|Overall Study||145||
59624392|NCT00641862|75736611|FG000|NOT COMPLETED|Overall Study||44||
59624393|NCT00641862|75736612|FG001|NOT COMPLETED|Overall Study||38||
59624394|NCT00643578|75736618|FG000|STARTED|Overall Study||6||
59624395|NCT00643578|75736619|FG001|STARTED|Overall Study||6||
59624396|NCT00643578|75736618|FG000|COMPLETED|Overall Study||4||
59624397|NCT00643578|75736619|FG001|COMPLETED|Overall Study||6||
59624398|NCT00643578|75736618|FG000|NOT COMPLETED|Overall Study||2||
59624399|NCT00643578|75736619|FG001|NOT COMPLETED|Overall Study||0||
59624400|NCT00644592|75736629|FG000|STARTED|Overall Study||5||
59624401|NCT00644592|75736630|FG001|STARTED|Overall Study||6||
59624402|NCT00644592|75736629|FG000|COMPLETED|Overall Study||5||
59624403|NCT00644592|75736630|FG001|COMPLETED|Overall Study||6||
59624404|NCT00644592|75736629|FG000|NOT COMPLETED|Overall Study||0||
59624405|NCT00644592|75736630|FG001|NOT COMPLETED|Overall Study||0||
59624406|NCT00645450|75736638|FG000|STARTED|Overall Study||5||
59624407|NCT00645450|75736639|FG001|STARTED|Overall Study||4||
59624408|NCT00645450|75736638|FG000|COMPLETED|Overall Study||5||
59624409|NCT00645450|75736639|FG001|COMPLETED|Overall Study||4||
59624410|NCT00645450|75736638|FG000|NOT COMPLETED|Overall Study||0||
59624411|NCT00645450|75736639|FG001|NOT COMPLETED|Overall Study||0||
59624412|NCT00645762|75736645|FG000|STARTED|Overall Study||71||
59624413|NCT00645762|75736645|FG000|COMPLETED|Overall Study||67||
59624414|NCT00645762|75736645|FG000|NOT COMPLETED|Overall Study||4||
59624415|NCT00647400|75736653|FG000|STARTED|Overall Study||89||
59624416|NCT00647400|75736654|FG001|STARTED|Overall Study||58||
59624417|NCT00647400|75736653|FG000|COMPLETED|Overall Study||67||
59624418|NCT00647400|75736654|FG001|COMPLETED|Overall Study||45||
59624419|NCT00647400|75736653|FG000|NOT COMPLETED|Overall Study||22||
59624420|NCT00647400|75736654|FG001|NOT COMPLETED|Overall Study||13||
59624421|NCT00652080|75736660|FG000|STARTED|Overall Study||35||
59624422|NCT00652080|75736660|FG000|COMPLETED|Overall Study||31||
59624423|NCT00652080|75736660|FG000|NOT COMPLETED|Overall Study||4||
59624424|NCT00652314|75736668|FG000|STARTED|Overall Study||62||
59624425|NCT00652314|75736669|FG001|STARTED|Overall Study||35||
59624426|NCT00652314|75736668|FG000|COMPLETED|Overall Study||53||
59624427|NCT00652314|75736669|FG001|COMPLETED|Overall Study||26||
59624428|NCT00652314|75736668|FG000|NOT COMPLETED|Overall Study||9||
59624429|NCT00652314|75736669|FG001|NOT COMPLETED|Overall Study||9||
59624430|NCT00654030|75736675|FG000|STARTED|Overall Study||12||
59624431|NCT00654030|75736675|FG000|COMPLETED|Overall Study||11||
59624432|NCT00654030|75736675|FG000|NOT COMPLETED|Overall Study||1||
59624433|NCT00654654|75736679|FG000|STARTED|Overall Study||50||
59624434|NCT00654654|75736679|FG000|COMPLETED|Overall Study||43||
59624435|NCT00654654|75736679|FG000|NOT COMPLETED|Overall Study||7||
59624436|NCT00656448|75736685|FG000|STARTED|Overall Study||25||
59624437|NCT00656448|75736686|FG001|STARTED|Overall Study||25||
59624438|NCT00656448|75736685|FG000|COMPLETED|Overall Study||25||
59624439|NCT00656448|75736686|FG001|COMPLETED|Overall Study||25||
59624440|NCT00656448|75736685|FG000|NOT COMPLETED|Overall Study||0||
59624441|NCT00656448|75736686|FG001|NOT COMPLETED|Overall Study||0||
59624442|NCT00659724|75736693|FG000|STARTED|Weeks 1-2: Assessment of 180NR or 200NR||33||
59624443|NCT00659724|75736693|FG000|COMPLETED|Weeks 1-2: Assessment of 180NR or 200NR||33||
59624444|NCT00659724|75736693|FG000|NOT COMPLETED|Weeks 1-2: Assessment of 180NR or 200NR||0||
59624445|NCT00659724|75736693|FG000|STARTED|Weeks 3-4: Assessment of HD-C4 Big||33||
59624446|NCT00659724|75736693|FG000|COMPLETED|Weeks 3-4: Assessment of HD-C4 Big||33||
59624447|NCT00659724|75736693|FG000|NOT COMPLETED|Weeks 3-4: Assessment of HD-C4 Big||0||
59624448|NCT00659802|75736702|FG000|STARTED|Overall Study||74||
59624449|NCT00659802|75736703|FG001|STARTED|Overall Study|One patient was incorrectly randomized and was excluded from the efficacy analyses.|75||
59624450|NCT00659802|75736704|FG002|STARTED|Overall Study||75||
59624451|NCT00659802|75736702|FG000|COMPLETED|Overall Study||59||
59624452|NCT00659802|75736703|FG001|COMPLETED|Overall Study||57||
59624453|NCT00659802|75736704|FG002|COMPLETED|Overall Study||64||
59624454|NCT00659802|75736702|FG000|NOT COMPLETED|Overall Study||15||
59624455|NCT00659802|75736703|FG001|NOT COMPLETED|Overall Study||18||
59624456|NCT00659802|75736704|FG002|NOT COMPLETED|Overall Study||11||
59624457|NCT00660504|75736714|FG000|STARTED|Overall Study||149||
59624458|NCT00660504|75736715|FG001|STARTED|Overall Study||151||
59624459|NCT00660504|75736714|FG000|COMPLETED|Overall Study||149||
59624460|NCT00660504|75736715|FG001|COMPLETED|Overall Study||150||
59624461|NCT00660504|75736714|FG000|NOT COMPLETED|Overall Study||0||
59624462|NCT00660504|75736715|FG001|NOT COMPLETED|Overall Study||1||
59624463|NCT00661674|75736721|FG000|STARTED|Overall Study|Participants 1 & 10 were assigned to sequence 1|2|Only 1 intervention per sequence was given each week based on sequence assignment|
59624464|NCT00661674|75736722|FG001|STARTED|Overall Study|Participants 2 & 3 were assigned to sequence 2|2|Only 1 intervention per sequence was given each week based on sequence assignment|
59624465|NCT00661674|75736723|FG002|STARTED|Overall Study|Participants 4 & 7 were assigned to sequence 3|2|Only 1 intervention per sequence was given each week based on sequence assignment|
59624466|NCT00661674|75736724|FG003|STARTED|Overall Study|Participant 5 was assigned to sequence 4|1|Only 1 intervention per sequence was given each week based on sequence assignment|
59624467|NCT00661674|75736725|FG004|STARTED|Overall Study|Participants 6 & 8 were assigned to sequence 5|2|Only 1 intervention per sequence was given each week based on sequence assignment|
59624468|NCT00661674|75736726|FG005|STARTED|Overall Study|Participant 9 was assigned to sequence 6|1|Only 1 intervention per sequence was given each week based on sequence assignment|
59624469|NCT00661674|75736721|FG000|COMPLETED|Overall Study|Participants 1 & 10 completed sequence 1|2||
59624470|NCT00661674|75736722|FG001|COMPLETED|Overall Study|Participants 2 & 3 completed sequence 2|2||
59624471|NCT00661674|75736723|FG002|COMPLETED|Overall Study|Participants 4 & 7 completed sequence 3|2||
59624472|NCT00661674|75736724|FG003|COMPLETED|Overall Study|Participant 5 completed sequence 4|1||
59624473|NCT00661674|75736725|FG004|COMPLETED|Overall Study|Participants 6 & 8 completed sequence 5|2||
59624474|NCT00661674|75736726|FG005|COMPLETED|Overall Study|Participant 9 completed sequence 6|1||
59624475|NCT00661674|75736721|FG000|NOT COMPLETED|Overall Study||0||
59624476|NCT00661674|75736722|FG001|NOT COMPLETED|Overall Study||0||
59624477|NCT00661674|75736723|FG002|NOT COMPLETED|Overall Study||0||
59624478|NCT00661674|75736724|FG003|NOT COMPLETED|Overall Study||0||
59624479|NCT00661674|75736725|FG004|NOT COMPLETED|Overall Study||0||
59988143|NCT00829673|76103269|FG000|STARTED|First Intervention||12||
59988144|NCT00829673|76103270|FG001|STARTED|First Intervention||12||
59988145|NCT00829673|76103269|FG000|COMPLETED|First Intervention||12||
59988146|NCT00829673|76103270|FG001|COMPLETED|First Intervention||12||
59624480|NCT00661674|75736726|FG005|NOT COMPLETED|Overall Study||0||
59624481|NCT00662298|75736734|FG000|STARTED|Overall Study||5||
59624482|NCT00662298|75736734|FG000|COMPLETED|Overall Study||5||
59624483|NCT00662298|75736734|FG000|NOT COMPLETED|Overall Study||0||
59624484|NCT00666666|75736738|FG000|STARTED|Overall Study||55||
59624485|NCT00666666|75736738|FG000|COMPLETED|Overall Study||55||
59624486|NCT00666666|75736738|FG000|NOT COMPLETED|Overall Study||0||
59624487|NCT00666978|75736744|FG000|STARTED|Overall Study||270||
59624488|NCT00666978|75736745|FG001|STARTED|Overall Study||270||
59624489|NCT00666978|75736744|FG000|COMPLETED|Overall Study||192||
59624490|NCT00666978|75736745|FG001|COMPLETED|Overall Study||187||
59624491|NCT00666978|75736744|FG000|NOT COMPLETED|Overall Study||78||
59624492|NCT00666978|75736745|FG001|NOT COMPLETED|Overall Study||83||
59624493|NCT00668382|75736753|FG000|STARTED|Overall Study|beginning of trial|11||
59624494|NCT00668382|75736753|FG000|COMPLETED|Overall Study||11||
59624495|NCT00668382|75736753|FG000|NOT COMPLETED|Overall Study||0||
59624496|NCT00669552|75736757|FG000|STARTED|Overall Study||11||
59624497|NCT00669552|75736757|FG000|COMPLETED|Overall Study||11||
59624498|NCT00669552|75736757|FG000|NOT COMPLETED|Overall Study||0||
59624499|NCT00670956|75736761|FG000|STARTED|Overall Study||1||
59624500|NCT00670956|75736761|FG000|COMPLETED|Overall Study||1||
59624501|NCT00670956|75736761|FG000|NOT COMPLETED|Overall Study||0||
59624502|NCT00671502|75736768|FG000|STARTED|Overall Study||281||
59624503|NCT00671502|75736769|FG001|STARTED|Overall Study||280||
59624504|NCT00671502|75736770|FG002|STARTED|Overall Study||279||
59624505|NCT00671502|75736768|FG000|COMPLETED|Overall Study||242||
59624506|NCT00671502|75736769|FG001|COMPLETED|Overall Study||241||
59624507|NCT00671502|75736770|FG002|COMPLETED|Overall Study||252||
59624508|NCT00671502|75736768|FG000|NOT COMPLETED|Overall Study||39||
59624509|NCT00671502|75736769|FG001|NOT COMPLETED|Overall Study||39||
59624510|NCT00671502|75736770|FG002|NOT COMPLETED|Overall Study||27||
59624511|NCT00671970|75736780|FG000|STARTED|Overall Study||32||
59624512|NCT00671970|75736781|FG001|STARTED|Overall Study||25||
59624513|NCT00671970|75736780|FG000|COMPLETED|Overall Study||32||
59624514|NCT00671970|75736781|FG001|COMPLETED|Overall Study||25||
59624515|NCT00671970|75736780|FG000|NOT COMPLETED|Overall Study||0||
59624516|NCT00671970|75736781|FG001|NOT COMPLETED|Overall Study||0||
59624517|NCT00672204|75736799|FG000|STARTED|Overall Study||23||
59624518|NCT00672204|75736799|FG000|COMPLETED|Overall Study||3||
59624519|NCT00672204|75736799|FG000|NOT COMPLETED|Overall Study||20||
59624520|NCT00672438|75736805|FG000|STARTED|Infusion 1||119||
59624521|NCT00672438|75736806|FG001|STARTED|Infusion 1||118||
59624522|NCT00672438|75736805|FG000|COMPLETED|Infusion 1||119||
59624523|NCT00672438|75736806|FG001|COMPLETED|Infusion 1||118||
59624524|NCT00672438|75736805|FG000|NOT COMPLETED|Infusion 1||0||
59988147|NCT00829673|76103269|FG000|NOT COMPLETED|First Intervention||0||
59988148|NCT00829673|76103270|FG001|NOT COMPLETED|First Intervention||0||
59988149|NCT00829673|76103269|FG000|STARTED|Washout of 7 Days||12||
59624525|NCT00672438|75736806|FG001|NOT COMPLETED|Infusion 1||0||
59624526|NCT00672438|75736805|FG000|STARTED|Washout||119||
59624527|NCT00672438|75736806|FG001|STARTED|Washout||118||
59624528|NCT00672438|75736805|FG000|COMPLETED|Washout||119||
59624529|NCT00672438|75736806|FG001|COMPLETED|Washout||118||
59624530|NCT00672438|75736805|FG000|NOT COMPLETED|Washout||0||
59624531|NCT00672438|75736806|FG001|NOT COMPLETED|Washout||0||
59624532|NCT00672438|75736805|FG000|STARTED|Infusion 2||119||
59624533|NCT00672438|75736806|FG001|STARTED|Infusion 2||118||
59988150|NCT00829673|76103270|FG001|STARTED|Washout of 7 Days||12||
60076176|NCT01904773|76191372|FG008|COMPLETED|Second Intervention||4||
59624534|NCT00672438|75736805|FG000|COMPLETED|Infusion 2||119||
59624535|NCT00672438|75736806|FG001|COMPLETED|Infusion 2||118||
59624536|NCT00672438|75736805|FG000|NOT COMPLETED|Infusion 2||0||
59624537|NCT00672438|75736806|FG001|NOT COMPLETED|Infusion 2||0||
59624538|NCT00672594|75736812|FG000|STARTED|Overall Study||30||
59624539|NCT00672594|75736812|FG000|COMPLETED|Overall Study||27||
59624540|NCT00672594|75736812|FG000|NOT COMPLETED|Overall Study||3||
59624541|NCT00673764|75736816|FG000|STARTED|Overall Study||24||
59624542|NCT00673764|75736817|FG001|STARTED|Overall Study||24||
59624543|NCT00673764|75736816|FG000|COMPLETED|Overall Study||24||
59624544|NCT00673764|75736817|FG001|COMPLETED|Overall Study||24||
59624545|NCT00673764|75736816|FG000|NOT COMPLETED|Overall Study||0||
59624546|NCT00673764|75736817|FG001|NOT COMPLETED|Overall Study||0||
59624547|NCT00674466|75736826|FG000|STARTED|Overall Study||30||
59624548|NCT00674466|75736827|FG001|STARTED|Overall Study||30||
59624549|NCT00674466|75736828|FG002|STARTED|Overall Study||30||
59624550|NCT00674466|75736826|FG000|COMPLETED|Overall Study||23||
59624551|NCT00674466|75736827|FG001|COMPLETED|Overall Study||22||
59624552|NCT00674466|75736828|FG002|COMPLETED|Overall Study||21||
59624553|NCT00674466|75736826|FG000|NOT COMPLETED|Overall Study||7||
59624554|NCT00674466|75736827|FG001|NOT COMPLETED|Overall Study||8||
59624555|NCT00674466|75736828|FG002|NOT COMPLETED|Overall Study||9||
59624556|NCT00674622|75736839|FG000|STARTED|Overall Study||22||
59624557|NCT00674622|75736840|FG001|STARTED|Overall Study||22||
59624558|NCT00674622|75736841|FG002|STARTED|Overall Study||22||
59624559|NCT00674622|75736839|FG000|COMPLETED|Overall Study||21||
59624560|NCT00674622|75736840|FG001|COMPLETED|Overall Study||18||
59624561|NCT00674622|75736841|FG002|COMPLETED|Overall Study||22||
59624562|NCT00674622|75736839|FG000|NOT COMPLETED|Overall Study||1||
59624563|NCT00674622|75736840|FG001|NOT COMPLETED|Overall Study||4||
59624564|NCT00674622|75736841|FG002|NOT COMPLETED|Overall Study||0||
59624565|NCT00675558|75736852|FG000|STARTED|Surgery||10||
59624566|NCT00675558|75736853|FG001|STARTED|Surgery||10||
59624567|NCT00675558|75736854|FG002|STARTED|Surgery||30||
59624568|NCT00675558|75736852|FG000|COMPLETED|Surgery||10||
59624569|NCT00675558|75736853|FG001|COMPLETED|Surgery||10||
59624570|NCT00675558|75736854|FG002|COMPLETED|Surgery||30||
59624571|NCT00675558|75736852|FG000|NOT COMPLETED|Surgery||0||
59624572|NCT00675558|75736853|FG001|NOT COMPLETED|Surgery||0||
59624573|NCT00675558|75736854|FG002|NOT COMPLETED|Surgery||0||
59624574|NCT00675558|75736852|FG000|STARTED|Second Operation|No medical reason, and no study-related reason for non-obese pts to have a second procedure.|0||
59624575|NCT00675558|75736853|FG001|STARTED|Second Operation|No medical reason, and none for the goals of the study, for MO pts to have a second procedure .|0||
59624576|NCT00675558|75736854|FG002|STARTED|Second Operation|As predicted, only 10 SMO patients medically required a second operation, and thus met study goals.|10||
59624577|NCT00675558|75736852|FG000|COMPLETED|Second Operation||0||
59624578|NCT00675558|75736853|FG001|COMPLETED|Second Operation||0||
59624579|NCT00675558|75736854|FG002|COMPLETED|Second Operation||10||
59624580|NCT00675558|75736852|FG000|NOT COMPLETED|Second Operation||0||
59624581|NCT00675558|75736853|FG001|NOT COMPLETED|Second Operation||0||
59624582|NCT00675558|75736854|FG002|NOT COMPLETED|Second Operation||0||
59624583|NCT00675792|75736864|FG000|STARTED|Overall Study||51||
59624584|NCT00675792|75736865|FG001|STARTED|Overall Study||49||
59624585|NCT00675792|75736864|FG000|COMPLETED|Overall Study||51||
59624586|NCT00675792|75736865|FG001|COMPLETED|Overall Study||49||
59624587|NCT00675792|75736864|FG000|NOT COMPLETED|Overall Study||0||
59624588|NCT00675792|75736865|FG001|NOT COMPLETED|Overall Study||0||
59624589|NCT00676182|75736873|FG000|STARTED|Overall Study||75||
59624590|NCT00676182|75736873|FG000|COMPLETED|Overall Study||75||
59624591|NCT00676182|75736873|FG000|NOT COMPLETED|Overall Study||0||
59624592|NCT00676572|75736885|FG000|STARTED|Overall Study||6||
59624593|NCT00676572|75736886|FG001|STARTED|Overall Study||6||
59624594|NCT00676572|75736885|FG000|COMPLETED|Overall Study||6||
59624595|NCT00676572|75736886|FG001|COMPLETED|Overall Study||6||
59624596|NCT00676572|75736885|FG000|NOT COMPLETED|Overall Study||0||
59624597|NCT00676572|75736886|FG001|NOT COMPLETED|Overall Study||0||
59624598|NCT00676806|75736894|FG000|STARTED|Overall Study||3||
59624599|NCT00676806|75736895|FG001|STARTED|Overall Study||3||
59624600|NCT00676806|75736894|FG000|COMPLETED|Overall Study||3||
59624601|NCT00676806|75736895|FG001|COMPLETED|Overall Study||3||
59624602|NCT00676806|75736894|FG000|NOT COMPLETED|Overall Study||0||
59624603|NCT00676806|75736895|FG001|NOT COMPLETED|Overall Study||0||
59624604|NCT00677898|75736907|FG000|STARTED|Overall Study||119||
59624605|NCT00677898|75736908|FG001|STARTED|Overall Study||120||
59624606|NCT00677898|75736907|FG000|COMPLETED|Overall Study||99||
59624607|NCT00677898|75736908|FG001|COMPLETED|Overall Study||102||
59624608|NCT00677898|75736907|FG000|NOT COMPLETED|Overall Study||20||
59624609|NCT00677898|75736908|FG001|NOT COMPLETED|Overall Study||18||
59624610|NCT00678444|75736916|FG000|STARTED|Overall Study||100||
59624611|NCT00678444|75736917|FG001|STARTED|Overall Study||99||
59624612|NCT00678444|75736916|FG000|COMPLETED|Overall Study||100||
59624613|NCT00678444|75736917|FG001|COMPLETED|Overall Study||99||
59624614|NCT00678444|75736916|FG000|NOT COMPLETED|Overall Study||0||
59624615|NCT00678444|75736917|FG001|NOT COMPLETED|Overall Study||0||
59624616|NCT00678834|75736926|FG000|STARTED|Overall Study||40||
59624617|NCT00678834|75736927|FG001|STARTED|Overall Study||15||
59624618|NCT00678834|75736928|FG002|STARTED|Overall Study||25||
59624619|NCT00678834|75736926|FG000|COMPLETED|Overall Study||24||
59624620|NCT00678834|75736927|FG001|COMPLETED|Overall Study||15||
59624621|NCT00678834|75736928|FG002|COMPLETED|Overall Study||16||
59624622|NCT00678834|75736926|FG000|NOT COMPLETED|Overall Study||16||
59624623|NCT00678834|75736927|FG001|NOT COMPLETED|Overall Study||0||
59624624|NCT00678834|75736928|FG002|NOT COMPLETED|Overall Study||9||
59624625|NCT00679380|75736950|FG000|STARTED|Overall Study||109||
59624626|NCT00679380|75736951|FG001|STARTED|Overall Study||109||
59624627|NCT00679380|75736952|FG002|STARTED|Overall Study||103||
59624628|NCT00679380|75736953|FG003|STARTED|Overall Study||89||
59624629|NCT00679380|75736950|FG000|COMPLETED|Overall Study||67||
59624630|NCT00679380|75736951|FG001|COMPLETED|Overall Study||76||
59624631|NCT00679380|75736952|FG002|COMPLETED|Overall Study||68||
59624632|NCT00679380|75736953|FG003|COMPLETED|Overall Study||61||
59624633|NCT00679380|75736950|FG000|NOT COMPLETED|Overall Study||42||
59624634|NCT00679380|75736951|FG001|NOT COMPLETED|Overall Study||33||
59624635|NCT00679380|75736952|FG002|NOT COMPLETED|Overall Study||35||
59624636|NCT00679380|75736953|FG003|NOT COMPLETED|Overall Study||28||
59624637|NCT00680706|75736965|FG000|STARTED|Overall Study||70||
59624638|NCT00680706|75736966|FG001|STARTED|Overall Study||60||
59624639|NCT00680706|75736965|FG000|COMPLETED|Overall Study||63||
59624640|NCT00680706|75736966|FG001|COMPLETED|Overall Study||55||
59624641|NCT00680706|75736965|FG000|NOT COMPLETED|Overall Study||7||
59624642|NCT00680706|75736966|FG001|NOT COMPLETED|Overall Study||5||
59624643|NCT00680862|75736972|FG000|STARTED|Overall Study||25||
59624644|NCT00680862|75736972|FG000|COMPLETED|Overall Study||25||
59624645|NCT00680862|75736972|FG000|NOT COMPLETED|Overall Study||0||
59624646|NCT00682734|75736979|FG000|STARTED|Emergency Department Portion||113||
59624647|NCT00682734|75736980|FG001|STARTED|Emergency Department Portion||118||
59624648|NCT00682734|75736981|FG002|STARTED|Emergency Department Portion||118||
59624649|NCT00682734|75736979|FG000|COMPLETED|Emergency Department Portion||113||
59624650|NCT00682734|75736980|FG001|COMPLETED|Emergency Department Portion||117||
59624651|NCT00682734|75736981|FG002|COMPLETED|Emergency Department Portion||117||
59624652|NCT00682734|75736979|FG000|NOT COMPLETED|Emergency Department Portion||0||
59624653|NCT00682734|75736980|FG001|NOT COMPLETED|Emergency Department Portion||1||
59624654|NCT00682734|75736981|FG002|NOT COMPLETED|Emergency Department Portion||1||
59624655|NCT00682734|75736979|FG000|STARTED|48 Hour Follow-up||113||
59624656|NCT00682734|75736980|FG001|STARTED|48 Hour Follow-up||117||
59624657|NCT00682734|75736981|FG002|STARTED|48 Hour Follow-up||117||
59624658|NCT00682734|75736979|FG000|COMPLETED|48 Hour Follow-up||107||
59624659|NCT00682734|75736980|FG001|COMPLETED|48 Hour Follow-up||111||
59624660|NCT00682734|75736981|FG002|COMPLETED|48 Hour Follow-up||106||
59624661|NCT00682734|75736979|FG000|NOT COMPLETED|48 Hour Follow-up||6||
59624662|NCT00682734|75736980|FG001|NOT COMPLETED|48 Hour Follow-up||6||
59624663|NCT00682734|75736981|FG002|NOT COMPLETED|48 Hour Follow-up||11||
59624664|NCT00683046|75736989|FG000|STARTED|Overall Study||204||
59624665|NCT00683046|75736989|FG000|COMPLETED|Overall Study||204||
59624666|NCT00683046|75736989|FG000|NOT COMPLETED|Overall Study||0||
60076177|NCT01904773|76191364|FG000|NOT COMPLETED|Second Intervention||0||
60076178|NCT01904773|76191365|FG001|NOT COMPLETED|Second Intervention||0||
60076179|NCT01904773|76191366|FG002|NOT COMPLETED|Second Intervention||0||
60076180|NCT01904773|76191367|FG003|NOT COMPLETED|Second Intervention||0||
60076181|NCT01904773|76191368|FG004|NOT COMPLETED|Second Intervention||0||
60076182|NCT01904773|76191369|FG005|NOT COMPLETED|Second Intervention||0||
60076183|NCT01904773|76191370|FG006|NOT COMPLETED|Second Intervention||0||
60076184|NCT01904773|76191371|FG007|NOT COMPLETED|Second Intervention||0||
60076185|NCT01904773|76191372|FG008|NOT COMPLETED|Second Intervention||0||
60076186|NCT01904773|76191364|FG000|STARTED|Placebo Washout Second Intervention||0||
60076187|NCT01904773|76191365|FG001|STARTED|Placebo Washout Second Intervention||1||
60076188|NCT01904773|76191366|FG002|STARTED|Placebo Washout Second Intervention||1||
59624667|NCT00683826|75736996|FG000|STARTED|Overall Study||8||
59624668|NCT00683826|75736996|FG000|0g Leucine|Overall Study||8||
59624669|NCT00683826|75736996|FG000|8g Leucine|Overall Study||8||
59624670|NCT00683826|75736996|FG000|4g Leucine|Overall Study||7||
59624671|NCT00683826|75736996|FG000|COMPLETED|Overall Study||7||
59624672|NCT00683826|75736996|FG000|NOT COMPLETED|Overall Study||1||
59624673|NCT00684138|75737006|FG000|STARTED|Overall Study||141||
59624674|NCT00684138|75737007|FG001|STARTED|Overall Study||139||
59624675|NCT00684138|75737006|FG000|COMPLETED|Overall Study||138||
59624676|NCT00684138|75737007|FG001|COMPLETED|Overall Study||131||
59624677|NCT00684138|75737006|FG000|NOT COMPLETED|Overall Study||3||
59624678|NCT00684138|75737007|FG001|NOT COMPLETED|Overall Study||8||
59624679|NCT00685932|75737017|FG000|STARTED|Overall Study||76||
59624680|NCT00685932|75737018|FG001|STARTED|Overall Study||78||
59624681|NCT00685932|75737017|FG000|COMPLETED|Overall Study||55||
59624682|NCT00685932|75737018|FG001|COMPLETED|Overall Study||58||
59624683|NCT00685932|75737017|FG000|NOT COMPLETED|Overall Study||21||
59624684|NCT00685932|75737018|FG001|NOT COMPLETED|Overall Study||20||
59624685|NCT00687102|75737026|FG000|STARTED|Overall Study||733||
59624686|NCT00687102|75737027|FG001|STARTED|Overall Study||765||
59624687|NCT00687102|75737026|FG000|COMPLETED|Overall Study||733||
60076189|NCT01904773|76191367|FG003|STARTED|Placebo Washout Second Intervention||2||
60076190|NCT01904773|76191368|FG004|STARTED|Placebo Washout Second Intervention||3||
59624688|NCT00687102|75737027|FG001|COMPLETED|Overall Study||765||
59624689|NCT00687102|75737026|FG000|NOT COMPLETED|Overall Study||0||
59624690|NCT00687102|75737027|FG001|NOT COMPLETED|Overall Study||0||
59624691|NCT00688662|75737035|FG000|STARTED|Overall Study||141||
59624692|NCT00688662|75737036|FG001|STARTED|Overall Study||73||
59624693|NCT00688662|75737035|FG000|COMPLETED|Overall Study||118||
59624694|NCT00688662|75737036|FG001|COMPLETED|Overall Study||55||
59624695|NCT00688662|75737035|FG000|NOT COMPLETED|Overall Study||23||
59624696|NCT00688662|75737036|FG001|NOT COMPLETED|Overall Study||18||
59624697|NCT00690924|75737043|FG000|STARTED|Overall Study||16||
59624698|NCT00690924|75737043|FG000|COMPLETED|Overall Study||16||
59624699|NCT00690924|75737043|FG000|NOT COMPLETED|Overall Study||0||
59624700|NCT00691002|75737051|FG000|STARTED|8-week, Double-blind, 4-arm||353||
59624701|NCT00691002|75737052|FG001|STARTED|8-week, Double-blind, 4-arm||342||
59624702|NCT00691002|75737053|FG002|STARTED|8-week, Double-blind, 4-arm||363||
59624703|NCT00691002|75737054|FG003|STARTED|8-week, Double-blind, 4-arm||181||
59624704|NCT00691002|75737055|FG004|STARTED|8-week, Double-blind, 4-arm||0||
59624705|NCT00691002|75737051|FG000|COMPLETED|8-week, Double-blind, 4-arm||325||
59624706|NCT00691002|75737052|FG001|COMPLETED|8-week, Double-blind, 4-arm||308||
59624707|NCT00691002|75737053|FG002|COMPLETED|8-week, Double-blind, 4-arm||340||
59624708|NCT00691002|75737054|FG003|COMPLETED|8-week, Double-blind, 4-arm||169||
59624709|NCT00691002|75737055|FG004|COMPLETED|8-week, Double-blind, 4-arm||0||
59624710|NCT00691002|75737051|FG000|NOT COMPLETED|8-week, Double-blind, 4-arm||28||
59624711|NCT00691002|75737052|FG001|NOT COMPLETED|8-week, Double-blind, 4-arm||34||
59624712|NCT00691002|75737053|FG002|NOT COMPLETED|8-week, Double-blind, 4-arm||23||
59624713|NCT00691002|75737054|FG003|NOT COMPLETED|8-week, Double-blind, 4-arm||12||
59624714|NCT00691002|75737055|FG004|NOT COMPLETED|8-week, Double-blind, 4-arm||0||
59624715|NCT00691002|75737051|FG000|STARTED|52-week, Open-label, Single Arm||454||
59624716|NCT00691002|75737052|FG001|STARTED|52-week, Open-label, Single Arm||0||
59624717|NCT00691002|75737053|FG002|STARTED|52-week, Open-label, Single Arm||0||
59624718|NCT00691002|75737054|FG003|STARTED|52-week, Open-label, Single Arm||0||
59624719|NCT00691002|75737055|FG004|STARTED|52-week, Open-label, Single Arm||0||
59624720|NCT00691002|75737051|FG000|COMPLETED|52-week, Open-label, Single Arm||403||
59624721|NCT00691002|75737052|FG001|COMPLETED|52-week, Open-label, Single Arm||0||
59624722|NCT00691002|75737053|FG002|COMPLETED|52-week, Open-label, Single Arm||0||
59624723|NCT00691002|75737054|FG003|COMPLETED|52-week, Open-label, Single Arm||0||
59624724|NCT00691002|75737055|FG004|COMPLETED|52-week, Open-label, Single Arm||0||
59624725|NCT00691002|75737051|FG000|NOT COMPLETED|52-week, Open-label, Single Arm||51||
59624726|NCT00691002|75737052|FG001|NOT COMPLETED|52-week, Open-label, Single Arm||0||
59624727|NCT00691002|75737053|FG002|NOT COMPLETED|52-week, Open-label, Single Arm||0||
59624728|NCT00691002|75737054|FG003|NOT COMPLETED|52-week, Open-label, Single Arm||0||
59624729|NCT00691002|75737055|FG004|NOT COMPLETED|52-week, Open-label, Single Arm||0||
59624730|NCT00693498|75737068|FG000|STARTED|Overall Study||81||
59624731|NCT00693498|75737069|FG001|STARTED|Overall Study||81||
59624732|NCT00693498|75737068|FG000|COMPLETED|Overall Study||81||
59624733|NCT00693498|75737069|FG001|COMPLETED|Overall Study||81||
59624734|NCT00693498|75737068|FG000|NOT COMPLETED|Overall Study||0||
59815595|NCT04884737|75938035|FG000|NOT COMPLETED|Overall Study||11||
59988151|NCT00829673|76103269|FG000|COMPLETED|Washout of 7 Days||11||
59988152|NCT00829673|76103270|FG001|COMPLETED|Washout of 7 Days||12||
59988153|NCT00829673|76103269|FG000|NOT COMPLETED|Washout of 7 Days||1||
59988154|NCT00829673|76103270|FG001|NOT COMPLETED|Washout of 7 Days||0||
59988155|NCT00829673|76103269|FG000|STARTED|Second Intervention||11||
59988156|NCT00829673|76103270|FG001|STARTED|Second Intervention||12||
60076191|NCT01904773|76191369|FG005|STARTED|Placebo Washout Second Intervention||4||
60076192|NCT01904773|76191370|FG006|STARTED|Placebo Washout Second Intervention||3||
60076193|NCT01904773|76191371|FG007|STARTED|Placebo Washout Second Intervention||3||
60076194|NCT01904773|76191372|FG008|STARTED|Placebo Washout Second Intervention||4||
59624735|NCT00693498|75737069|FG001|NOT COMPLETED|Overall Study||0||
59815596|NCT04884737|75938036|FG001|NOT COMPLETED|Overall Study||9||
60076195|NCT01904773|76191364|FG000|COMPLETED|Placebo Washout Second Intervention||0||
60076196|NCT01904773|76191365|FG001|COMPLETED|Placebo Washout Second Intervention||1||
59624736|NCT00693654|75737077|FG000|STARTED|Overall Study||14||
59624737|NCT00693654|75737078|FG001|STARTED|Overall Study||14||
59988157|NCT00829673|76103269|FG000|COMPLETED|Second Intervention||11||
59624738|NCT00693654|75737077|FG000|COMPLETED|Overall Study||14||
59624739|NCT00693654|75737078|FG001|COMPLETED|Overall Study||14||
59624740|NCT00693654|75737077|FG000|NOT COMPLETED|Overall Study||0||
59624741|NCT00693654|75737078|FG001|NOT COMPLETED|Overall Study||0||
59624742|NCT00695292|75737085|FG000|STARTED|Overall Study||37||
59624743|NCT00695292|75737085|FG000|COMPLETED|Overall Study||37||
59624744|NCT00695292|75737085|FG000|NOT COMPLETED|Overall Study||0||
59988158|NCT00829673|76103270|FG001|COMPLETED|Second Intervention||12||
59988159|NCT00829673|76103269|FG000|NOT COMPLETED|Second Intervention||0||
59988160|NCT00829673|76103270|FG001|NOT COMPLETED|Second Intervention||0||
59988161|NCT02370238|76103276|FG000|STARTED|Overall Study||62||
59988162|NCT02370238|76103277|FG001|STARTED|Overall Study||61||
60076197|NCT01904773|76191366|FG002|COMPLETED|Placebo Washout Second Intervention||1||
60076198|NCT01904773|76191367|FG003|COMPLETED|Placebo Washout Second Intervention||2||
60076199|NCT01904773|76191368|FG004|COMPLETED|Placebo Washout Second Intervention||3||
60076200|NCT01904773|76191369|FG005|COMPLETED|Placebo Washout Second Intervention||4||
60076201|NCT01904773|76191370|FG006|COMPLETED|Placebo Washout Second Intervention||3||
60076202|NCT01904773|76191371|FG007|COMPLETED|Placebo Washout Second Intervention||3||
60076203|NCT01904773|76191372|FG008|COMPLETED|Placebo Washout Second Intervention||4||
60076204|NCT01904773|76191364|FG000|NOT COMPLETED|Placebo Washout Second Intervention||0||
60076205|NCT01904773|76191365|FG001|NOT COMPLETED|Placebo Washout Second Intervention||0||
60076206|NCT01904773|76191366|FG002|NOT COMPLETED|Placebo Washout Second Intervention||0||
60076207|NCT01904773|76191367|FG003|NOT COMPLETED|Placebo Washout Second Intervention||0||
59624745|NCT00696618|75737092|FG000|STARTED|Overall Study||3||
59624746|NCT00696618|75737093|FG001|STARTED|Overall Study||3||
59624747|NCT00696618|75737094|FG002|STARTED|Overall Study||3||
59624748|NCT00696618|75737092|FG000|COMPLETED|Overall Study||3||
59624749|NCT00696618|75737093|FG001|COMPLETED|Overall Study||3||
59624750|NCT00696618|75737094|FG002|COMPLETED|Overall Study||3||
59624751|NCT00696618|75737092|FG000|NOT COMPLETED|Overall Study||0||
59624752|NCT00696618|75737093|FG001|NOT COMPLETED|Overall Study||0||
59624753|NCT00696618|75737094|FG002|NOT COMPLETED|Overall Study||0||
59624754|NCT00700440|75737102|FG000|STARTED|Overall Study||100||
59624755|NCT00700440|75737102|FG000|COMPLETED|Overall Study||100||
59624756|NCT00700440|75737102|FG000|NOT COMPLETED|Overall Study||0||
59624757|NCT00701376|75737106|FG000|STARTED|Overall Study||106||
59624758|NCT00701376|75737106|FG000|COMPLETED|Overall Study||105||
59624759|NCT00701376|75737106|FG000|NOT COMPLETED|Overall Study||1||
59624760|NCT00702780|75737113|FG000|STARTED|Overall Study||37||
59624761|NCT00702780|75737114|FG001|STARTED|Overall Study||37||
59624762|NCT00702780|75737113|FG000|COMPLETED|Overall Study||28||
59624763|NCT00702780|75737114|FG001|COMPLETED|Overall Study||29||
59624764|NCT00702780|75737113|FG000|NOT COMPLETED|Overall Study||9||
59624765|NCT00702780|75737114|FG001|NOT COMPLETED|Overall Study||8||
59624766|NCT00704028|75737122|FG000|STARTED|Overall Study||82||
59624767|NCT00704028|75737123|FG001|STARTED|Overall Study|A subject randomized to iron dextran never received study drug and was d/c due to subject request.|78||
59624768|NCT00704028|75737122|FG000|COMPLETED|Overall Study||70||
59624769|NCT00704028|75737123|FG001|COMPLETED|Overall Study||57||
59624770|NCT00704028|75737122|FG000|NOT COMPLETED|Overall Study||12||
59624771|NCT00704028|75737123|FG001|NOT COMPLETED|Overall Study||21||
59624772|NCT00704262|75737129|FG000|STARTED|Overall Study||33||
59624773|NCT00704262|75737129|FG000|COMPLETED|Overall Study||31||
59624774|NCT00704262|75737129|FG000|NOT COMPLETED|Overall Study||2||
59624775|NCT00706446|75737139|FG000|STARTED|Overall Study||29||
59624776|NCT00706446|75737140|FG001|STARTED|Overall Study||57||
59624777|NCT00706446|75737141|FG002|STARTED|Overall Study||44||
59624778|NCT00706446|75737142|FG003|STARTED|Overall Study||26||
59624779|NCT00706446|75737143|FG004|STARTED|Overall Study||54||
59624780|NCT00706446|75737144|FG005|STARTED|Overall Study||45||
59624781|NCT00706446|75737139|FG000|COMPLETED|Overall Study||3||
59624782|NCT00706446|75737140|FG001|COMPLETED|Overall Study||8||
59624783|NCT00706446|75737141|FG002|COMPLETED|Overall Study||7||
59624784|NCT00706446|75737142|FG003|COMPLETED|Overall Study||4||
59624785|NCT00706446|75737143|FG004|COMPLETED|Overall Study||10||
59624786|NCT00706446|75737144|FG005|COMPLETED|Overall Study||7||
59624787|NCT00706446|75737139|FG000|NOT COMPLETED|Overall Study||26||
59624788|NCT00706446|75737140|FG001|NOT COMPLETED|Overall Study||49||
59624789|NCT00706446|75737141|FG002|NOT COMPLETED|Overall Study||37||
59624790|NCT00706446|75737142|FG003|NOT COMPLETED|Overall Study||22||
59624791|NCT00706446|75737143|FG004|NOT COMPLETED|Overall Study||44||
59624792|NCT00706446|75737144|FG005|NOT COMPLETED|Overall Study||38||
59817895|NCT04488770|75940334|FG008|COMPLETED|Part 1-Cohort 2: Period 1 (Up to 5 Days)||0||
60076208|NCT01904773|76191368|FG004|NOT COMPLETED|Placebo Washout Second Intervention||0||
60076209|NCT01904773|76191369|FG005|NOT COMPLETED|Placebo Washout Second Intervention||0||
60076210|NCT01904773|76191370|FG006|NOT COMPLETED|Placebo Washout Second Intervention||0||
60076211|NCT01904773|76191371|FG007|NOT COMPLETED|Placebo Washout Second Intervention||0||
60076212|NCT01904773|76191372|FG008|NOT COMPLETED|Placebo Washout Second Intervention||0||
60076213|NCT01904773|76191364|FG000|STARTED|Third Intervention||0||
60076214|NCT01904773|76191365|FG001|STARTED|Third Intervention||1||
60076215|NCT01904773|76191366|FG002|STARTED|Third Intervention||1||
60076216|NCT01904773|76191367|FG003|STARTED|Third Intervention||2||
60076217|NCT01904773|76191368|FG004|STARTED|Third Intervention||3||
60076218|NCT01904773|76191369|FG005|STARTED|Third Intervention||4||
59624793|NCT00706836|75737158|FG000|STARTED|Overall Study||16||
59624794|NCT00706836|75737158|FG000|COMPLETED|Overall Study||16||
59624795|NCT00706836|75737158|FG000|NOT COMPLETED|Overall Study||0||
59624796|NCT00708942|75737171|FG000|STARTED|Overall Study||47||
59624797|NCT00708942|75737172|FG001|STARTED|Overall Study||12||
59624798|NCT00708942|75737173|FG002|STARTED|Overall Study||11||
59624799|NCT00708942|75737174|FG003|STARTED|Overall Study||10||
59624800|NCT00708942|75737175|FG004|STARTED|Overall Study||3||
59624801|NCT00708942|75737171|FG000|COMPLETED|Overall Study||40||
60076219|NCT01904773|76191370|FG006|STARTED|Third Intervention||3||
59624802|NCT00708942|75737172|FG001|COMPLETED|Overall Study||11||
59624803|NCT00708942|75737173|FG002|COMPLETED|Overall Study||9||
59624804|NCT00708942|75737174|FG003|COMPLETED|Overall Study||10||
59624805|NCT00708942|75737175|FG004|COMPLETED|Overall Study||2||
59624806|NCT00708942|75737171|FG000|NOT COMPLETED|Overall Study||7||
59624807|NCT00708942|75737172|FG001|NOT COMPLETED|Overall Study||1||
59624808|NCT00708942|75737173|FG002|NOT COMPLETED|Overall Study||2||
59624809|NCT00708942|75737174|FG003|NOT COMPLETED|Overall Study||0||
59624810|NCT00708942|75737175|FG004|NOT COMPLETED|Overall Study||1||
59624811|NCT00709878|75737191|FG000|STARTED|Overall Study||8||
59624812|NCT00709878|75737192|FG001|STARTED|Overall Study||8||
59624813|NCT00709878|75737193|FG002|STARTED|Overall Study||8||
59624814|NCT00709878|75737194|FG003|STARTED|Overall Study||8||
59624815|NCT00709878|75737191|FG000|COMPLETED|Overall Study||8||
59624816|NCT00709878|75737192|FG001|COMPLETED|Overall Study||8||
59624817|NCT00709878|75737193|FG002|COMPLETED|Overall Study||8||
59624818|NCT00709878|75737194|FG003|COMPLETED|Overall Study||8||
59624819|NCT00709878|75737191|FG000|NOT COMPLETED|Overall Study||0||
59624820|NCT00709878|75737192|FG001|NOT COMPLETED|Overall Study||0||
59624821|NCT00709878|75737193|FG002|NOT COMPLETED|Overall Study||0||
59624822|NCT00709878|75737194|FG003|NOT COMPLETED|Overall Study||0||
59624823|NCT00710814|75737206|FG000|STARTED|Overall Study||15||
59624824|NCT00710814|75737207|FG001|STARTED|Overall Study||16||
59624825|NCT00710814|75737206|FG000|COMPLETED|Overall Study||14||
59624826|NCT00710814|75737207|FG001|COMPLETED|Overall Study||13||
59624827|NCT00710814|75737206|FG000|NOT COMPLETED|Overall Study||1||
59624828|NCT00710814|75737207|FG001|NOT COMPLETED|Overall Study||3||
59624829|NCT00711828|75737213|FG000|STARTED|Overall Study||21||
59624830|NCT00711828|75737213|FG000|COMPLETED|Overall Study||21||
59624831|NCT00711828|75737213|FG000|NOT COMPLETED|Overall Study||0||
59624832|NCT00712296|75737222|FG000|STARTED|Phase I ( 1 Week)||12||
59624833|NCT00712296|75737223|FG001|STARTED|Phase I ( 1 Week)||8||
59624834|NCT00712296|75737224|FG002|STARTED|Phase I ( 1 Week)||0||
59624835|NCT00712296|75737225|FG003|STARTED|Phase I ( 1 Week)||0||
59624836|NCT00712296|75737226|FG004|STARTED|Phase I ( 1 Week)||0||
59624837|NCT00712296|75737222|FG000|COMPLETED|Phase I ( 1 Week)||12||
59624838|NCT00712296|75737223|FG001|COMPLETED|Phase I ( 1 Week)||8||
59624839|NCT00712296|75737224|FG002|COMPLETED|Phase I ( 1 Week)||0||
59624840|NCT00712296|75737225|FG003|COMPLETED|Phase I ( 1 Week)||0||
59624841|NCT00712296|75737226|FG004|COMPLETED|Phase I ( 1 Week)||0||
59624842|NCT00712296|75737222|FG000|NOT COMPLETED|Phase I ( 1 Week)||0||
59624843|NCT00712296|75737223|FG001|NOT COMPLETED|Phase I ( 1 Week)||0||
59624844|NCT00712296|75737224|FG002|NOT COMPLETED|Phase I ( 1 Week)||0||
59624845|NCT00712296|75737225|FG003|NOT COMPLETED|Phase I ( 1 Week)||0||
59624846|NCT00712296|75737226|FG004|NOT COMPLETED|Phase I ( 1 Week)||0||
59624847|NCT00712296|75737222|FG000|STARTED|Phase II (28 Weeks)||0||
59624848|NCT00712296|75737223|FG001|STARTED|Phase II (28 Weeks)||0||
59624849|NCT00712296|75737224|FG002|STARTED|Phase II (28 Weeks)||15||
59624850|NCT00712296|75737225|FG003|STARTED|Phase II (28 Weeks)||16||
59624851|NCT00712296|75737226|FG004|STARTED|Phase II (28 Weeks)||15||
59624852|NCT00712296|75737222|FG000|COMPLETED|Phase II (28 Weeks)||0||
59624853|NCT00712296|75737223|FG001|COMPLETED|Phase II (28 Weeks)||0||
59624854|NCT00712296|75737224|FG002|COMPLETED|Phase II (28 Weeks)|ASHMI/Placebo was discontinued on 9/29/10.20 participants were re-randomized into the Phase II.|2||
59624855|NCT00712296|75737225|FG003|COMPLETED|Phase II (28 Weeks)||1||
59624856|NCT00712296|75737226|FG004|COMPLETED|Phase II (28 Weeks)||3||
59624857|NCT00712296|75737222|FG000|NOT COMPLETED|Phase II (28 Weeks)||0||
59624858|NCT00712296|75737223|FG001|NOT COMPLETED|Phase II (28 Weeks)||0||
59624859|NCT00712296|75737224|FG002|NOT COMPLETED|Phase II (28 Weeks)||13||
59624860|NCT00712296|75737225|FG003|NOT COMPLETED|Phase II (28 Weeks)||15||
59624861|NCT00712296|75737226|FG004|NOT COMPLETED|Phase II (28 Weeks)||12||
59624862|NCT00712530|75737260|FG000|STARTED|Overall Study||3||
59624863|NCT00712530|75737261|FG001|STARTED|Overall Study||3||
59624864|NCT00712530|75737262|FG002|STARTED|Overall Study|Screened 4 patients, but one failed to meet entry criteria due to a history of bleeding and diabetes|3||
59624865|NCT00712530|75737260|FG000|COMPLETED|Overall Study||3||
59624866|NCT00712530|75737261|FG001|COMPLETED|Overall Study||3||
59624867|NCT00712530|75737262|FG002|COMPLETED|Overall Study||3||
59624868|NCT00712530|75737260|FG000|NOT COMPLETED|Overall Study||0||
59624869|NCT00712530|75737261|FG001|NOT COMPLETED|Overall Study||0||
59624870|NCT00712530|75737262|FG002|NOT COMPLETED|Overall Study||0||
59624871|NCT00714792|75737272|FG000|STARTED|Overall Study||10||
59624872|NCT00714792|75737273|FG001|STARTED|Overall Study||8||
59624873|NCT00714792|75737272|FG000|COMPLETED|Overall Study||10||
59624874|NCT00714792|75737273|FG001|COMPLETED|Overall Study||8||
59624875|NCT00714792|75737272|FG000|NOT COMPLETED|Overall Study||0||
59624876|NCT00714792|75737273|FG001|NOT COMPLETED|Overall Study||0||
59624877|NCT00715104|75737282|FG000|STARTED|Overall Study||18||
59624878|NCT00715104|75737283|FG001|STARTED|Overall Study||16||
59624879|NCT00715104|75737284|FG002|STARTED|Overall Study||8||
59624880|NCT00715104|75737282|FG000|COMPLETED|Overall Study||18||
59624881|NCT00715104|75737283|FG001|COMPLETED|Overall Study||16||
59624882|NCT00715104|75737284|FG002|COMPLETED|Overall Study||8||
59624883|NCT00715104|75737282|FG000|NOT COMPLETED|Overall Study||0||
59539082|NCT01474109|75637259|FG000|STARTED|Period 2: Week 16 to End of Study||88||
59539083|NCT01474109|75637260|FG001|STARTED|Period 2: Week 16 to End of Study||91||
59539084|NCT01474109|75637261|FG002|STARTED|Period 2: Week 16 to End of Study||95||
59539085|NCT01474109|75637259|FG000|COMPLETED|Period 2: Week 16 to End of Study||70||
59539086|NCT01474109|75637260|FG001|COMPLETED|Period 2: Week 16 to End of Study||73||
59539087|NCT01474109|75637261|FG002|COMPLETED|Period 2: Week 16 to End of Study||83||
59539088|NCT01474109|75637259|FG000|NOT COMPLETED|Period 2: Week 16 to End of Study||18||
59539089|NCT01474109|75637260|FG001|NOT COMPLETED|Period 2: Week 16 to End of Study||18||
59539090|NCT01474109|75637261|FG002|NOT COMPLETED|Period 2: Week 16 to End of Study||12||
59539091|NCT01405469|75637269|FG000|STARTED|Overall Study||16||
59539092|NCT01405469|75637269|FG000|COMPLETED|Overall Study||16||
59539093|NCT01405469|75637269|FG000|NOT COMPLETED|Overall Study||0||
59539094|NCT01405937|75637276|FG000|STARTED|Overall Study||25||
59539095|NCT01405937|75637277|FG001|STARTED|Overall Study||26||
59539096|NCT01405937|75637276|FG000|COMPLETED|Overall Study||25||
59539097|NCT01405937|75637277|FG001|COMPLETED|Overall Study||26||
59539098|NCT01405937|75637276|FG000|NOT COMPLETED|Overall Study||0||
59539099|NCT01405937|75637277|FG001|NOT COMPLETED|Overall Study||0||
59539100|NCT01368653|75637285|FG000|STARTED|Overall Study||47||
59539101|NCT01368653|75637286|FG001|STARTED|Overall Study||46||
59539102|NCT01368653|75637285|FG000|Completed 4-week Follow-up|Overall Study||44||
59539103|NCT01368653|75637286|FG001|Completed 4-week Follow-up|Overall Study||37||
59539104|NCT01368653|75637285|FG000|Smoked in Past 7 Days at 4-weeks|Overall Study|The first 40 who smoked between weeks 3 and 4 post-quit were eligible for Phase 2 (VLNC vs. Advice)|29||
59539105|NCT01368653|75637286|FG001|Smoked in Past 7 Days at 4-weeks|Overall Study|The first 40 who smoked between weeks 3 and 4 post-quit were eligible for Phase 2 (VLNC vs. Advice)|20||
59539106|NCT01368653|75637285|FG000|Randomized to Phase 2|Overall Study|The first 40 who smoked between weeks 3 and 4 post-quit were eligible for Phase 2 (VLNC vs. Advice)|21||
59539107|NCT01368653|75637286|FG001|Randomized to Phase 2|Overall Study|The first 40 who smoked between weeks 3 and 4 post-quit were eligible for Phase 2 (VLNC vs. Advice)|19||
59539108|NCT01368653|75637285|FG000|Randomized to VLNC in Phase 2|Overall Study|VLNC=6-week supply of Very Low Nicotine Cigarettes plus Advice to Quit (vs. Advice Only)|11||
59539109|NCT01368653|75637286|FG001|Randomized to VLNC in Phase 2|Overall Study|VLNC=6-week supply of Very Low Nicotine Cigarettes plus Advice to Quit (vs. Advice Only)|9||
59539110|NCT01368653|75637285|FG000|Randomized to Advice Only in Phase 2|Overall Study||10||
59539111|NCT01368653|75637286|FG001|Randomized to Advice Only in Phase 2|Overall Study||10||
59539112|NCT01368653|75637285|FG000|COMPLETED|Overall Study||41||
59539113|NCT01368653|75637286|FG001|COMPLETED|Overall Study||37||
59539114|NCT01368653|75637285|FG000|NOT COMPLETED|Overall Study||6||
59539115|NCT01368653|75637286|FG001|NOT COMPLETED|Overall Study||9||
59539116|NCT01407107|75637302|FG000|STARTED|Overall Study||7||
59539117|NCT01407107|75637303|FG001|STARTED|Overall Study||3||
59539118|NCT01407107|75637304|FG002|STARTED|Overall Study||3||
59539119|NCT01407107|75637302|FG000|COMPLETED|Overall Study||7||
59539120|NCT01407107|75637303|FG001|COMPLETED|Overall Study||3||
59539121|NCT01407107|75637304|FG002|COMPLETED|Overall Study||3||
59539122|NCT01407107|75637302|FG000|NOT COMPLETED|Overall Study||0||
59539123|NCT01407107|75637303|FG001|NOT COMPLETED|Overall Study||0||
59539124|NCT01407107|75637304|FG002|NOT COMPLETED|Overall Study||0||
59539125|NCT01368809|75637314|FG000|STARTED|Overall Study||50||
59539126|NCT01368809|75637315|FG001|STARTED|Overall Study||50||
59539127|NCT01368809|75637314|FG000|COMPLETED|Overall Study||50||
59539128|NCT01368809|75637315|FG001|COMPLETED|Overall Study||50||
59539129|NCT01368809|75637314|FG000|NOT COMPLETED|Overall Study||0||
59539130|NCT01368809|75637315|FG001|NOT COMPLETED|Overall Study||0||
59539131|NCT01369745|75637328|FG000|STARTED|Overall Study||32||
59539132|NCT01369745|75637329|FG001|STARTED|Overall Study||41||
59539133|NCT01369745|75637330|FG002|STARTED|Overall Study||18||
59539134|NCT01369745|75637331|FG003|STARTED|Overall Study||84||
59539135|NCT01369745|75637332|FG004|STARTED|Overall Study||83||
59539136|NCT01369745|75637328|FG000|COMPLETED|Overall Study||25||
59539137|NCT01369745|75637329|FG001|COMPLETED|Overall Study||28||
59539138|NCT01369745|75637330|FG002|COMPLETED|Overall Study||16||
59539139|NCT01369745|75637331|FG003|COMPLETED|Overall Study||64||
59539140|NCT01369745|75637332|FG004|COMPLETED|Overall Study||65||
59539141|NCT01369745|75637328|FG000|NOT COMPLETED|Overall Study||7||
59539142|NCT01369745|75637329|FG001|NOT COMPLETED|Overall Study||13||
59539143|NCT01369745|75637330|FG002|NOT COMPLETED|Overall Study||2||
59539144|NCT01369745|75637331|FG003|NOT COMPLETED|Overall Study||20||
59539145|NCT01369745|75637332|FG004|NOT COMPLETED|Overall Study||18||
59539146|NCT01475513|75637346|FG000|STARTED|Overall Study||20||
59539147|NCT01475513|75637347|FG001|STARTED|Overall Study||26||
59539148|NCT01475513|75637346|FG000|COMPLETED|Overall Study||17||
59539149|NCT01475513|75637347|FG001|COMPLETED|Overall Study||16||
59539150|NCT01475513|75637346|FG000|NOT COMPLETED|Overall Study||3||
59539151|NCT01475513|75637347|FG001|NOT COMPLETED|Overall Study||10||
59539152|NCT01407575|75637357|FG000|STARTED|Overall Study||7||
59539153|NCT01407575|75637358|FG001|STARTED|Overall Study||6||
59539154|NCT01407575|75637357|FG000|COMPLETED|Overall Study||5||
59539155|NCT01407575|75637358|FG001|COMPLETED|Overall Study||5||
59539156|NCT01407575|75637357|FG000|NOT COMPLETED|Overall Study||2||
59539157|NCT01407575|75637358|FG001|NOT COMPLETED|Overall Study||1||
59539158|NCT01409213|75637366|FG000|STARTED|Overall Study||1523||
59539159|NCT01409213|75637366|FG000|COMPLETED|Overall Study||1523||
59539160|NCT01409213|75637366|FG000|NOT COMPLETED|Overall Study||0||
59539161|NCT01476449|75637372|FG000|STARTED|Overall Study||10||
59539162|NCT01476449|75637373|FG001|STARTED|Overall Study||10||
59539163|NCT01476449|75637372|FG000|COMPLETED|Overall Study||8||
59539164|NCT01476449|75637373|FG001|COMPLETED|Overall Study||8||
59539165|NCT01476449|75637372|FG000|NOT COMPLETED|Overall Study||2||
59539166|NCT01476449|75637373|FG001|NOT COMPLETED|Overall Study||2||
59815597|NCT04492020|75938044|FG000|STARTED|Overall Study||264|Intent-to-Treat population consists of all randomized participants|
59539167|NCT01370369|75637379|FG000|STARTED|Overall Study||20||
59539168|NCT01370369|75637379|FG000|COMPLETED|Overall Study||20||
59539169|NCT01370369|75637379|FG000|NOT COMPLETED|Overall Study||0||
59539170|NCT01370837|75637395|FG000|STARTED|Overall Study||12||
59539171|NCT01370837|75637396|FG001|STARTED|Overall Study||12||
59539172|NCT01370837|75637397|FG002|STARTED|Overall Study||17||
59539173|NCT01370837|75637395|FG000|COMPLETED|Overall Study||12||
59539174|NCT01370837|75637396|FG001|COMPLETED|Overall Study||12||
59539175|NCT01370837|75637397|FG002|COMPLETED|Overall Study||17||
59539176|NCT01370837|75637395|FG000|NOT COMPLETED|Overall Study||0||
59539177|NCT01370837|75637396|FG001|NOT COMPLETED|Overall Study||0||
59815598|NCT04492020|75938045|FG001|STARTED|Overall Study||254|Intent-to-Treat population consists of all randomized participants|
59815599|NCT04492020|75938044|FG000|Safety Population|Overall Study||247|Safety population consists of all treated participants who take at least 1 administration of study intervention|
59539178|NCT01370837|75637397|FG002|NOT COMPLETED|Overall Study||0||
59539179|NCT01409291|75637407|FG000|STARTED|Overall Study||36||
59539180|NCT01409291|75637408|FG001|STARTED|Overall Study||28||
59539181|NCT01409291|75637407|FG000|COMPLETED|Overall Study||29||
59539182|NCT01409291|75637408|FG001|COMPLETED|Overall Study||19||
59539183|NCT01409291|75637407|FG000|NOT COMPLETED|Overall Study||7||
59539184|NCT01409291|75637408|FG001|NOT COMPLETED|Overall Study||9||
59539185|NCT01477463|75637416|FG000|STARTED|Overall Study||18||
59539186|NCT01477463|75637417|FG001|STARTED|Overall Study||6||
59539187|NCT01477463|75637416|FG000|COMPLETED|Overall Study||18||
59539188|NCT01477463|75637417|FG001|COMPLETED|Overall Study||6||
59539189|NCT01477463|75637416|FG000|NOT COMPLETED|Overall Study||0||
59539190|NCT01477463|75637417|FG001|NOT COMPLETED|Overall Study||0||
59539191|NCT01410773|75637425|FG000|STARTED|Overall Study||110||
59539192|NCT01410773|75637425|FG000|COMPLETED|Overall Study||110||
59539193|NCT01410773|75637425|FG000|NOT COMPLETED|Overall Study||0||
59815600|NCT04492020|75938045|FG001|Safety Population|Overall Study||233|Safety population consists of all treated participants who take at least 1 administration of study intervention|
59815601|NCT04492020|75938044|FG000|COMPLETED|Overall Study||223||
59815602|NCT04492020|75938045|FG001|COMPLETED|Overall Study||215||
59815603|NCT04492020|75938044|FG000|NOT COMPLETED|Overall Study||41||
59815604|NCT04492020|75938045|FG001|NOT COMPLETED|Overall Study||39||
59988163|NCT02370238|76103276|FG000|ITT Population|Overall Study||62||
59539194|NCT01478009|75637431|FG000|STARTED|Overall Study||50||
59539195|NCT01478009|75637432|FG001|STARTED|Overall Study||50||
59539196|NCT01478009|75637431|FG000|COMPLETED|Overall Study||49||
59539197|NCT01478009|75637432|FG001|COMPLETED|Overall Study||49||
59539198|NCT01478009|75637431|FG000|NOT COMPLETED|Overall Study||1||
59539199|NCT01478009|75637432|FG001|NOT COMPLETED|Overall Study||1||
59539200|NCT02203565|75637438|FG000|STARTED|Overall Study||20||
59539201|NCT02203565|75637438|FG000|COMPLETED|Overall Study||19||
59539202|NCT02203565|75637438|FG000|NOT COMPLETED|Overall Study||1||
59539203|NCT01375127|75637448|FG000|STARTED|Overall Study||1||
59539204|NCT01375127|75637449|FG001|STARTED|Overall Study||1||
59539205|NCT01375127|75637450|FG002|STARTED|Overall Study||40||
59539206|NCT01375127|75637451|FG003|STARTED|Overall Study||33||
59539207|NCT01375127|75637452|FG004|STARTED|Overall Study||5||
59539208|NCT01375127|75637453|FG005|STARTED|Overall Study||3||
59539209|NCT01375127|75637448|FG000|COMPLETED|Overall Study||1||
59539210|NCT01375127|75637449|FG001|COMPLETED|Overall Study||1||
59539211|NCT01375127|75637450|FG002|COMPLETED|Overall Study||40||
59539212|NCT01375127|75637451|FG003|COMPLETED|Overall Study||33||
59539213|NCT01375127|75637452|FG004|COMPLETED|Overall Study||5||
59539214|NCT01375127|75637453|FG005|COMPLETED|Overall Study||3||
59539215|NCT01375127|75637448|FG000|NOT COMPLETED|Overall Study||0||
59539216|NCT01375127|75637449|FG001|NOT COMPLETED|Overall Study||0||
59539217|NCT01375127|75637450|FG002|NOT COMPLETED|Overall Study||0||
59539218|NCT01375127|75637451|FG003|NOT COMPLETED|Overall Study||0||
59988164|NCT02370238|76103277|FG001|ITT Population|Overall Study||61||
59539219|NCT01375127|75637452|FG004|NOT COMPLETED|Overall Study||0||
59539220|NCT01375127|75637453|FG005|NOT COMPLETED|Overall Study||0||
59539221|NCT02960204|75637471|FG000|STARTED|Overall Study||65||
59539222|NCT02960204|75637472|FG001|STARTED|Overall Study||65||
59539223|NCT02960204|75637473|FG002|STARTED|Overall Study||66||
59539224|NCT02960204|75637474|FG003|STARTED|Overall Study||67||
59539225|NCT02960204|75637471|FG000|Randomized|Overall Study||65||
59539226|NCT02960204|75637472|FG001|Randomized|Overall Study||65||
59539227|NCT02960204|75637473|FG002|Randomized|Overall Study||66||
59539228|NCT02960204|75637474|FG003|Randomized|Overall Study||67||
59539229|NCT02960204|75637471|FG000|Completed Week 24 of Study|Overall Study||62||
59624884|NCT00715104|75737283|FG001|NOT COMPLETED|Overall Study||0||
59624885|NCT00715104|75737284|FG002|NOT COMPLETED|Overall Study||0||
59624886|NCT00715650|75737328|FG000|STARTED|Intervention||47||
59624887|NCT00715650|75737329|FG001|STARTED|Intervention||45||
59624888|NCT00715650|75737328|FG000|Received Any Session|Intervention||39||
59624889|NCT00715650|75737329|FG001|Received Any Session|Intervention||38||
59624890|NCT00715650|75737328|FG000|Attended ≥ 2 Sessions|Intervention||36||
59624891|NCT00715650|75737329|FG001|Attended ≥ 2 Sessions|Intervention||33||
59624892|NCT00715650|75737328|FG000|Attended ≥ 3 Sessions|Intervention||23||
59624893|NCT00715650|75737329|FG001|Attended ≥ 3 Sessions|Intervention||17||
59624894|NCT00715650|75737328|FG000|COMPLETED|Intervention||42||
59624895|NCT00715650|75737329|FG001|COMPLETED|Intervention||42||
59624896|NCT00715650|75737328|FG000|NOT COMPLETED|Intervention||5||
59624897|NCT00715650|75737329|FG001|NOT COMPLETED|Intervention||3||
59624898|NCT00715650|75737328|FG000|STARTED|Follow-up||42||
59624899|NCT00715650|75737329|FG001|STARTED|Follow-up||42||
59624900|NCT00715650|75737328|FG000|Completed Month 1 Follow-up|Follow-up||40||
59624901|NCT00715650|75737329|FG001|Completed Month 1 Follow-up|Follow-up||38||
59624902|NCT00715650|75737328|FG000|Completed Month 3 Follow-up|Follow-up||35||
59624903|NCT00715650|75737329|FG001|Completed Month 3 Follow-up|Follow-up||40||
59624904|NCT00715650|75737328|FG000|Completed Month 6 Follow-up|Follow-up||29||
59624905|NCT00715650|75737329|FG001|Completed Month 6 Follow-up|Follow-up||37||
59624906|NCT00715650|75737328|FG000|COMPLETED|Follow-up||29||
59624907|NCT00715650|75737329|FG001|COMPLETED|Follow-up||37||
59624908|NCT00715650|75737328|FG000|NOT COMPLETED|Follow-up||13||
59624909|NCT00715650|75737329|FG001|NOT COMPLETED|Follow-up||5||
59624910|NCT00715728|75737337|FG000|STARTED|Overall Study||14||
59624911|NCT00715728|75737338|FG001|STARTED|Overall Study||14||
59624912|NCT00715728|75737337|FG000|COMPLETED|Overall Study||14||
59624913|NCT00715728|75737338|FG001|COMPLETED|Overall Study||14||
59624914|NCT00715728|75737337|FG000|NOT COMPLETED|Overall Study||0||
59624915|NCT00715728|75737338|FG001|NOT COMPLETED|Overall Study||0||
59624916|NCT00715884|75737348|FG000|STARTED|Overall Study||452||
59624917|NCT00715884|75737349|FG001|STARTED|Overall Study||226||
59624918|NCT00715884|75737348|FG000|COMPLETED|Overall Study||444||
59624919|NCT00715884|75737349|FG001|COMPLETED|Overall Study||225||
59624920|NCT00715884|75737348|FG000|NOT COMPLETED|Overall Study||8||
59624921|NCT00715884|75737349|FG001|NOT COMPLETED|Overall Study||1||
59624922|NCT00715962|75737357|FG000|STARTED|Overall Study||50||
59624923|NCT00715962|75737358|FG001|STARTED|Overall Study||50||
59624924|NCT00715962|75737357|FG000|COMPLETED|Overall Study||44||
59624925|NCT00715962|75737358|FG001|COMPLETED|Overall Study||48||
59624926|NCT00715962|75737357|FG000|NOT COMPLETED|Overall Study||6||
59624927|NCT00715962|75737358|FG001|NOT COMPLETED|Overall Study||2||
59624928|NCT00716586|75737365|FG000|STARTED|Overall Study||44||
59624929|NCT00716586|75737365|FG000|COMPLETED|Overall Study||44||
59624930|NCT00716586|75737365|FG000|NOT COMPLETED|Overall Study||0||
59624931|NCT00716742|75737373|FG000|STARTED|Baseline||364||
59624932|NCT00716742|75737374|FG001|STARTED|Baseline||370||
59624933|NCT00716742|75737375|FG002|STARTED|Baseline||365||
59624934|NCT00716742|75737373|FG000|COMPLETED|Baseline||347||
59624935|NCT00716742|75737374|FG001|COMPLETED|Baseline||356||
59624936|NCT00716742|75737375|FG002|COMPLETED|Baseline||352||
59624937|NCT00716742|75737373|FG000|NOT COMPLETED|Baseline||17||
59624938|NCT00716742|75737374|FG001|NOT COMPLETED|Baseline||14||
59624939|NCT00716742|75737375|FG002|NOT COMPLETED|Baseline||13||
59624940|NCT00716742|75737373|FG000|STARTED|1 Year Follow-up||347||
59624941|NCT00716742|75737374|FG001|STARTED|1 Year Follow-up||356||
59624942|NCT00716742|75737375|FG002|STARTED|1 Year Follow-up||352||
59624943|NCT00716742|75737373|FG000|COMPLETED|1 Year Follow-up||160||
59624944|NCT00716742|75737374|FG001|COMPLETED|1 Year Follow-up||163||
60076220|NCT01904773|76191371|FG007|STARTED|Third Intervention||3||
60076221|NCT01904773|76191372|FG008|STARTED|Third Intervention||4||
60076222|NCT01904773|76191364|FG000|COMPLETED|Third Intervention||0||
60076223|NCT01904773|76191365|FG001|COMPLETED|Third Intervention||1||
60076224|NCT01904773|76191366|FG002|COMPLETED|Third Intervention||1||
60076225|NCT01904773|76191367|FG003|COMPLETED|Third Intervention||2||
60076226|NCT01904773|76191368|FG004|COMPLETED|Third Intervention||3||
59624945|NCT00716742|75737375|FG002|COMPLETED|1 Year Follow-up||152||
60076227|NCT01904773|76191369|FG005|COMPLETED|Third Intervention||4||
60076228|NCT01904773|76191370|FG006|COMPLETED|Third Intervention||3||
60076229|NCT01904773|76191371|FG007|COMPLETED|Third Intervention||3||
59624946|NCT00716742|75737373|FG000|NOT COMPLETED|1 Year Follow-up||187||
59624947|NCT00716742|75737374|FG001|NOT COMPLETED|1 Year Follow-up||193||
59624948|NCT00716742|75737375|FG002|NOT COMPLETED|1 Year Follow-up||200||
59624949|NCT00716742|75737373|FG000|STARTED|2 Year Follow-up||160||
59624950|NCT00716742|75737374|FG001|STARTED|2 Year Follow-up||163||
59624951|NCT00716742|75737375|FG002|STARTED|2 Year Follow-up||152||
59624952|NCT00716742|75737373|FG000|COMPLETED|2 Year Follow-up||56||
59624953|NCT00716742|75737374|FG001|COMPLETED|2 Year Follow-up||67||
60076230|NCT01904773|76191372|FG008|COMPLETED|Third Intervention||4||
59624954|NCT00716742|75737375|FG002|COMPLETED|2 Year Follow-up||50||
59624955|NCT00716742|75737373|FG000|NOT COMPLETED|2 Year Follow-up||104||
59624956|NCT00716742|75737374|FG001|NOT COMPLETED|2 Year Follow-up||96||
59624957|NCT00716742|75737375|FG002|NOT COMPLETED|2 Year Follow-up||102||
59624958|NCT00716742|75737373|FG000|STARTED|3 Year Follow-up||56||
59624959|NCT00716742|75737374|FG001|STARTED|3 Year Follow-up||67||
59624960|NCT00716742|75737375|FG002|STARTED|3 Year Follow-up||50||
59624961|NCT00716742|75737373|FG000|COMPLETED|3 Year Follow-up||26||
59624962|NCT00716742|75737374|FG001|COMPLETED|3 Year Follow-up||35||
59624963|NCT00716742|75737375|FG002|COMPLETED|3 Year Follow-up||29||
59624964|NCT00716742|75737373|FG000|NOT COMPLETED|3 Year Follow-up||30||
59624965|NCT00716742|75737374|FG001|NOT COMPLETED|3 Year Follow-up||32||
59624966|NCT00716742|75737375|FG002|NOT COMPLETED|3 Year Follow-up||21||
59624967|NCT00716820|75737383|FG000|STARTED|Overall Study||472||
59624968|NCT00716820|75737383|FG000|COMPLETED|Overall Study||472||
59624969|NCT00716820|75737383|FG000|NOT COMPLETED|Overall Study||0||
59624970|NCT00717054|75737410|FG000|STARTED|Overall Study||58||
59624971|NCT00717054|75737411|FG001|STARTED|Overall Study||57||
59624972|NCT00717054|75737410|FG000|COMPLETED|Overall Study||58||
59624973|NCT00717054|75737411|FG001|COMPLETED|Overall Study||57||
59624974|NCT00717054|75737410|FG000|NOT COMPLETED|Overall Study||0||
59624975|NCT00717054|75737411|FG001|NOT COMPLETED|Overall Study||0||
59624976|NCT00717288|75737421|FG000|STARTED|Overall Study||28||
59624977|NCT00717288|75737422|FG001|STARTED|Overall Study||29||
59624978|NCT00717288|75737423|FG002|STARTED|Overall Study||25||
59624979|NCT00717288|75737421|FG000|COMPLETED|Overall Study||28||
59624980|NCT00717288|75737422|FG001|COMPLETED|Overall Study||29||
59624981|NCT00717288|75737423|FG002|COMPLETED|Overall Study||25||
59624982|NCT00717288|75737421|FG000|NOT COMPLETED|Overall Study||0||
59624983|NCT00717288|75737422|FG001|NOT COMPLETED|Overall Study||0||
59624984|NCT00717288|75737423|FG002|NOT COMPLETED|Overall Study||0||
59624985|NCT00717912|75737437|FG000|STARTED|Overall Study||1||
59624986|NCT00717912|75737438|FG001|STARTED|Overall Study||1||
59624987|NCT00717912|75737439|FG002|STARTED|Overall Study||1||
59624988|NCT00717912|75737440|FG003|STARTED|Overall Study||1||
59624989|NCT00717912|75737441|FG004|STARTED|Overall Study||1||
59624990|NCT00717912|75737442|FG005|STARTED|Overall Study||1||
59624991|NCT00717912|75737437|FG000|COMPLETED|Overall Study||1||
59624992|NCT00717912|75737438|FG001|COMPLETED|Overall Study||1||
59624993|NCT00717912|75737439|FG002|COMPLETED|Overall Study||1||
59624994|NCT00717912|75737440|FG003|COMPLETED|Overall Study||1||
59624995|NCT00717912|75737441|FG004|COMPLETED|Overall Study||1||
59624996|NCT00717912|75737442|FG005|COMPLETED|Overall Study||1||
59624997|NCT00717912|75737437|FG000|NOT COMPLETED|Overall Study||0||
59624998|NCT00717912|75737438|FG001|NOT COMPLETED|Overall Study||0||
59624999|NCT00717912|75737439|FG002|NOT COMPLETED|Overall Study||0||
59625000|NCT00717912|75737440|FG003|NOT COMPLETED|Overall Study||0||
59625001|NCT00717912|75737441|FG004|NOT COMPLETED|Overall Study||0||
59625002|NCT00717912|75737442|FG005|NOT COMPLETED|Overall Study||0||
59625003|NCT00718302|75737453|FG000|STARTED|Overall Study||119||
59625004|NCT00718302|75737454|FG001|STARTED|Overall Study||114||
59625005|NCT00718302|75737453|FG000|COMPLETED|Overall Study||119||
59625006|NCT00718302|75737454|FG001|COMPLETED|Overall Study||114||
59625007|NCT00718302|75737453|FG000|NOT COMPLETED|Overall Study||0||
59625008|NCT00718302|75737454|FG001|NOT COMPLETED|Overall Study||0||
59625009|NCT00719160|75737462|FG000|STARTED|Overall Study||6||
59625010|NCT00719160|75737463|FG001|STARTED|Overall Study||6||
59625011|NCT00719160|75737462|FG000|COMPLETED|Overall Study||6||
59625012|NCT00719160|75737463|FG001|COMPLETED|Overall Study||6||
59625013|NCT00719160|75737462|FG000|NOT COMPLETED|Overall Study||0||
59625014|NCT00719160|75737463|FG001|NOT COMPLETED|Overall Study||0||
59625015|NCT00720330|75737473|FG000|STARTED|Overall Study||5||
59625016|NCT00720330|75737474|FG001|STARTED|Overall Study||4||
59625017|NCT00720330|75737475|FG002|STARTED|Overall Study||3||
59625018|NCT00720330|75737473|FG000|COMPLETED|Overall Study||5||
59625019|NCT00720330|75737474|FG001|COMPLETED|Overall Study||4||
59625020|NCT00720330|75737475|FG002|COMPLETED|Overall Study||3||
59625021|NCT00720330|75737473|FG000|NOT COMPLETED|Overall Study||0||
59625022|NCT00720330|75737474|FG001|NOT COMPLETED|Overall Study||0||
59625023|NCT00720330|75737475|FG002|NOT COMPLETED|Overall Study||0||
59625024|NCT00721188|75737483|FG000|STARTED|Overall Study||11||
59625025|NCT00721188|75737483|FG000|COMPLETED|Overall Study||11||
59625026|NCT00721188|75737483|FG000|NOT COMPLETED|Overall Study||0||
59625027|NCT00721500|75737487|FG000|STARTED|Period One||6||
59625028|NCT00721500|75737488|FG001|STARTED|Period One||7||
59625029|NCT00721500|75737489|FG002|STARTED|Period One||6||
59625030|NCT00721500|75737490|FG003|STARTED|Period One||6||
59625031|NCT00721500|75737487|FG000|COMPLETED|Period One||6||
59625032|NCT00721500|75737488|FG001|COMPLETED|Period One||7||
59625033|NCT00721500|75737489|FG002|COMPLETED|Period One||6||
59625034|NCT00721500|75737490|FG003|COMPLETED|Period One||6||
59625035|NCT00721500|75737487|FG000|NOT COMPLETED|Period One||0||
59625036|NCT00721500|75737488|FG001|NOT COMPLETED|Period One||0||
59625037|NCT00721500|75737489|FG002|NOT COMPLETED|Period One||0||
59625038|NCT00721500|75737490|FG003|NOT COMPLETED|Period One||0||
59625039|NCT00721500|75737487|FG000|STARTED|Period Two||6||
59625040|NCT00721500|75737488|FG001|STARTED|Period Two||7||
59625041|NCT00721500|75737489|FG002|STARTED|Period Two||6||
59625042|NCT00721500|75737490|FG003|STARTED|Period Two||6||
59625043|NCT00721500|75737487|FG000|COMPLETED|Period Two||6||
59625044|NCT00721500|75737488|FG001|COMPLETED|Period Two||7||
59625045|NCT00721500|75737489|FG002|COMPLETED|Period Two||6||
59625046|NCT00721500|75737490|FG003|COMPLETED|Period Two||6||
59625047|NCT00721500|75737487|FG000|NOT COMPLETED|Period Two||0||
59625048|NCT00721500|75737488|FG001|NOT COMPLETED|Period Two||0||
59625049|NCT00721500|75737489|FG002|NOT COMPLETED|Period Two||0||
59625050|NCT00721500|75737490|FG003|NOT COMPLETED|Period Two||0||
59625051|NCT00721500|75737487|FG000|STARTED|Period Three||6||
59625052|NCT00721500|75737488|FG001|STARTED|Period Three||7||
59625053|NCT00721500|75737489|FG002|STARTED|Period Three||6||
59625054|NCT00721500|75737490|FG003|STARTED|Period Three||6||
59625055|NCT00721500|75737487|FG000|COMPLETED|Period Three||6||
59625056|NCT00721500|75737488|FG001|COMPLETED|Period Three||7||
59625057|NCT00721500|75737489|FG002|COMPLETED|Period Three||6||
59625058|NCT00721500|75737490|FG003|COMPLETED|Period Three||6||
59625059|NCT00721500|75737487|FG000|NOT COMPLETED|Period Three||0||
59625060|NCT00721500|75737488|FG001|NOT COMPLETED|Period Three||0||
59625061|NCT00721500|75737489|FG002|NOT COMPLETED|Period Three||0||
59625062|NCT00721500|75737490|FG003|NOT COMPLETED|Period Three||0||
59625063|NCT00722124|75737505|FG000|STARTED|Overall Study||40||
59625064|NCT00722124|75737506|FG001|STARTED|Overall Study||40||
59625065|NCT00722124|75737507|FG002|STARTED|Overall Study||40||
59625066|NCT00722124|75737505|FG000|COMPLETED|Overall Study||23||
59625067|NCT00722124|75737506|FG001|COMPLETED|Overall Study||26||
59625068|NCT00722124|75737507|FG002|COMPLETED|Overall Study||20||
59625069|NCT00722124|75737505|FG000|NOT COMPLETED|Overall Study||17||
59625070|NCT00722124|75737506|FG001|NOT COMPLETED|Overall Study||14||
59625071|NCT00722124|75737507|FG002|NOT COMPLETED|Overall Study||20||
59625072|NCT00722436|75737517|FG000|STARTED|Overall Study||9||
59625073|NCT00722436|75737518|FG001|STARTED|Overall Study||11||
59625074|NCT00722436|75737517|FG000|COMPLETED|Overall Study||9||
59625075|NCT00722436|75737518|FG001|COMPLETED|Overall Study||11||
59625076|NCT00722436|75737517|FG000|NOT COMPLETED|Overall Study||0||
59625077|NCT00722436|75737518|FG001|NOT COMPLETED|Overall Study||0||
59625078|NCT00724308|75737526|FG000|STARTED|Overall Study||270||
59625079|NCT00724308|75737527|FG001|STARTED|Overall Study||307||
59625080|NCT00724308|75737526|FG000|COMPLETED|Overall Study||190||
59625081|NCT00724308|75737527|FG001|COMPLETED|Overall Study||210||
59625082|NCT00724308|75737526|FG000|NOT COMPLETED|Overall Study||80||
59625083|NCT00724308|75737527|FG001|NOT COMPLETED|Overall Study||97||
59625084|NCT00724464|75737533|FG000|STARTED|Overall Study||332||
59625085|NCT00724464|75737533|FG000|COMPLETED|Overall Study||309||
59625086|NCT00724464|75737533|FG000|NOT COMPLETED|Overall Study||23||
59625087|NCT00726414|75737538|FG000|STARTED|First Intervention||11||
59625088|NCT00726414|75737539|FG001|STARTED|First Intervention||11||
59625089|NCT00726414|75737538|FG000|COMPLETED|First Intervention||11||
59625090|NCT00726414|75737539|FG001|COMPLETED|First Intervention||11||
59625091|NCT00726414|75737538|FG000|NOT COMPLETED|First Intervention||0||
59625092|NCT00726414|75737539|FG001|NOT COMPLETED|First Intervention||0||
59625093|NCT00726414|75737538|FG000|STARTED|Washout Period of 7 Days||11||
59625094|NCT00726414|75737539|FG001|STARTED|Washout Period of 7 Days||11||
59625095|NCT00726414|75737538|FG000|COMPLETED|Washout Period of 7 Days||11||
59625096|NCT00726414|75737539|FG001|COMPLETED|Washout Period of 7 Days||11||
59625097|NCT00726414|75737538|FG000|NOT COMPLETED|Washout Period of 7 Days||0||
59625098|NCT00726414|75737539|FG001|NOT COMPLETED|Washout Period of 7 Days||0||
59625099|NCT00726414|75737538|FG000|STARTED|Second Intervention||11||
59625100|NCT00726414|75737539|FG001|STARTED|Second Intervention||11||
59625101|NCT00726414|75737538|FG000|COMPLETED|Second Intervention||11||
59625102|NCT00726414|75737539|FG001|COMPLETED|Second Intervention||11||
59625103|NCT00726414|75737538|FG000|NOT COMPLETED|Second Intervention||0||
59625104|NCT00726414|75737539|FG001|NOT COMPLETED|Second Intervention||0||
59625105|NCT00727740|75737547|FG000|STARTED|Overall Study||56||
59625106|NCT00727740|75737548|FG001|STARTED|Overall Study||61||
59625107|NCT00727740|75737547|FG000|COMPLETED|Overall Study||56||
59625108|NCT00727740|75737548|FG001|COMPLETED|Overall Study||61||
59625109|NCT00727740|75737547|FG000|NOT COMPLETED|Overall Study||0||
59625110|NCT00727740|75737548|FG001|NOT COMPLETED|Overall Study||0||
59625111|NCT00728910|75737554|FG000|STARTED|Atorvastatin||25||
59625112|NCT00728910|75737554|FG000|COMPLETED|Atorvastatin||22||
59625113|NCT00728910|75737554|FG000|NOT COMPLETED|Atorvastatin||3||
59625114|NCT00728910|75737554|FG000|STARTED|Atorvastatin+ABT335||22||
59625115|NCT00728910|75737554|FG000|COMPLETED|Atorvastatin+ABT335||22||
59625116|NCT00728910|75737554|FG000|NOT COMPLETED|Atorvastatin+ABT335||0||
59625117|NCT00728910|75737554|FG000|STARTED|Atorvastatin+ABT335+ER Niacin||22||
59625118|NCT00728910|75737554|FG000|COMPLETED|Atorvastatin+ABT335+ER Niacin||22||
59625119|NCT00728910|75737554|FG000|NOT COMPLETED|Atorvastatin+ABT335+ER Niacin||0||
59625120|NCT00729846|75737565|FG000|STARTED|Overall Study||11||
59625121|NCT00729846|75737566|FG001|STARTED|Overall Study||11||
59625122|NCT00729846|75737565|FG000|COMPLETED|Overall Study||11||
59625123|NCT00729846|75737566|FG001|COMPLETED|Overall Study||11||
59625124|NCT00729846|75737565|FG000|NOT COMPLETED|Overall Study||0||
59625125|NCT00729846|75737566|FG001|NOT COMPLETED|Overall Study||0||
59625126|NCT00729924|75737572|FG000|STARTED|Overall Study||40||
59625127|NCT00729924|75737572|FG000|COMPLETED|Overall Study||40||
59625128|NCT00729924|75737572|FG000|NOT COMPLETED|Overall Study||0||
59625129|NCT00731094|75737581|FG000|STARTED|Overall Study||116||
59625130|NCT00731094|75737582|FG001|STARTED|Overall Study||116||
59625131|NCT00731094|75737581|FG000|Month 6|Overall Study||101||
59625132|NCT00731094|75737582|FG001|Month 6|Overall Study||107||
59625133|NCT00731094|75737581|FG000|COMPLETED|Overall Study||98||
59625134|NCT00731094|75737582|FG001|COMPLETED|Overall Study||105||
59625135|NCT00731094|75737581|FG000|NOT COMPLETED|Overall Study||18||
59625136|NCT00731094|75737582|FG001|NOT COMPLETED|Overall Study||11||
59625137|NCT00731484|75737588|FG000|STARTED|Overall Study||233||
59625138|NCT00731484|75737588|FG000|COMPLETED|Overall Study||233||
59625139|NCT00731484|75737588|FG000|NOT COMPLETED|Overall Study||0||
59625140|NCT00731640|75737594|FG000|STARTED|Overall Study||20||
59625141|NCT00731640|75737595|FG001|STARTED|Overall Study||32||
59625142|NCT00731640|75737594|FG000|COMPLETED|Overall Study||20||
59625143|NCT00731640|75737595|FG001|COMPLETED|Overall Study||32||
59625144|NCT00731640|75737594|FG000|NOT COMPLETED|Overall Study||0||
59625145|NCT00731640|75737595|FG001|NOT COMPLETED|Overall Study||0||
59625146|NCT00731874|75737603|FG000|STARTED|Overall Study||10||
59625147|NCT00731874|75737604|FG001|STARTED|Overall Study||13||
59625148|NCT00731874|75737603|FG000|COMPLETED|Overall Study||10||
59625149|NCT00731874|75737604|FG001|COMPLETED|Overall Study||13||
59625150|NCT00731874|75737603|FG000|NOT COMPLETED|Overall Study||0||
59625151|NCT00731874|75737604|FG001|NOT COMPLETED|Overall Study||0||
59625152|NCT00732030|75737610|FG000|STARTED|Overall Study||26||
59625153|NCT00732030|75737610|FG000|COMPLETED|Overall Study||24||
59625154|NCT00732030|75737610|FG000|NOT COMPLETED|Overall Study||2||
59625155|NCT00732654|75737617|FG000|STARTED|Overall Study||10||
59625156|NCT00732654|75737618|FG001|STARTED|Overall Study||10||
59625157|NCT00732654|75737619|FG002|STARTED|Overall Study||10||
59625158|NCT00732654|75737617|FG000|COMPLETED|Overall Study||10||
59625159|NCT00732654|75737618|FG001|COMPLETED|Overall Study||9||
59625160|NCT00732654|75737619|FG002|COMPLETED|Overall Study||10||
59625161|NCT00732654|75737617|FG000|NOT COMPLETED|Overall Study||0||
59625162|NCT00732654|75737618|FG001|NOT COMPLETED|Overall Study||1||
59625163|NCT00732654|75737619|FG002|NOT COMPLETED|Overall Study||0||
59625164|NCT00733278|75737627|FG000|STARTED|Overall Study||7||
59625165|NCT00733278|75737627|FG000|COMPLETED|Overall Study||7||
59625166|NCT00733278|75737627|FG000|NOT COMPLETED|Overall Study||0||
59625167|NCT00733356|75737632|FG000|STARTED|Vyvanse Dose Titration||28||
59625168|NCT00733356|75737632|FG000|COMPLETED|Vyvanse Dose Titration||26||
59625169|NCT00733356|75737632|FG000|NOT COMPLETED|Vyvanse Dose Titration||2||
59625170|NCT00733356|75737632|FG000|STARTED|Modified Lab School, Reading Evaluation||26||
59625171|NCT00733356|75737632|FG000|COMPLETED|Modified Lab School, Reading Evaluation||26||
59625172|NCT00733356|75737632|FG000|NOT COMPLETED|Modified Lab School, Reading Evaluation||0||
59625173|NCT00733512|75737636|FG000|STARTED|Overall Study||146||
59625174|NCT00733512|75737636|FG000|COMPLETED|Overall Study||146||
59625175|NCT00733512|75737636|FG000|NOT COMPLETED|Overall Study||0||
59625176|NCT00735306|75737640|FG000|STARTED|Overall Study||12||
59625177|NCT00735306|75737640|FG000|COMPLETED|Overall Study||12||
59625178|NCT00735306|75737640|FG000|NOT COMPLETED|Overall Study||0||
59625179|NCT00735462|75737648|FG000|STARTED|Overall Study||202||
59625180|NCT00735462|75737649|FG001|STARTED|Overall Study||204||
59625181|NCT00735462|75737650|FG002|STARTED|Overall Study||105||
59625182|NCT00735462|75737648|FG000|COMPLETED|Overall Study||139||
59625183|NCT00735462|75737649|FG001|COMPLETED|Overall Study||149||
59625184|NCT00735462|75737650|FG002|COMPLETED|Overall Study||77||
59625185|NCT00735462|75737648|FG000|NOT COMPLETED|Overall Study||63||
59625186|NCT00735462|75737649|FG001|NOT COMPLETED|Overall Study||55||
59625187|NCT00735462|75737650|FG002|NOT COMPLETED|Overall Study||28||
59625188|NCT00735618|75737658|FG000|STARTED|Overall Study||19||
59625189|NCT00735618|75737658|FG000|COMPLETED|Overall Study||19||
59625190|NCT00735618|75737658|FG000|NOT COMPLETED|Overall Study||0||
59625191|NCT00736242|75737662|FG000|STARTED|Overall Study||232||
59625192|NCT00736242|75737662|FG000|Participants in Safety Analysis Set|Overall Study||229||
59625193|NCT00736242|75737662|FG000|COMPLETED|Overall Study||107||
59625194|NCT00736242|75737662|FG000|NOT COMPLETED|Overall Study||125||
59625195|NCT00736632|75737669|FG000|STARTED|Overall Study||44||
59625196|NCT00736632|75737670|FG001|STARTED|Overall Study||50||
59625197|NCT00736632|75737671|FG002|STARTED|Overall Study||31||
59625198|NCT00736632|75737669|FG000|COMPLETED|Overall Study||44||
59625199|NCT00736632|75737670|FG001|COMPLETED|Overall Study||50||
59625200|NCT00736632|75737671|FG002|COMPLETED|Overall Study||31||
59625201|NCT00736632|75737669|FG000|NOT COMPLETED|Overall Study||0||
59625202|NCT00736632|75737670|FG001|NOT COMPLETED|Overall Study||0||
59625203|NCT00736632|75737671|FG002|NOT COMPLETED|Overall Study||0||
59625204|NCT00737178|75737679|FG000|STARTED|Overall Study||71||
59625205|NCT00737178|75737680|FG001|STARTED|Overall Study||85||
59625206|NCT00737178|75737679|FG000|COMPLETED|Overall Study||66||
59625207|NCT00737178|75737680|FG001|COMPLETED|Overall Study||76||
59625208|NCT00737178|75737679|FG000|NOT COMPLETED|Overall Study||5||
59625209|NCT00737178|75737680|FG001|NOT COMPLETED|Overall Study||9||
59625210|NCT00738426|75737688|FG000|STARTED|Overall Study||37||
59625211|NCT00738426|75737689|FG001|STARTED|Overall Study||35||
59625212|NCT00738426|75737688|FG000|COMPLETED|Overall Study||35||
59625213|NCT00738426|75737689|FG001|COMPLETED|Overall Study||32||
59625214|NCT00738426|75737688|FG000|NOT COMPLETED|Overall Study||2||
59625215|NCT00738426|75737689|FG001|NOT COMPLETED|Overall Study||3||
59625216|NCT00739752|75737701|FG000|STARTED|Overall Study||299||
59625217|NCT00739752|75737702|FG001|STARTED|Overall Study||284||
59625218|NCT00739752|75737703|FG002|STARTED|Overall Study||292||
59625219|NCT00739752|75737704|FG003|STARTED|Overall Study||288||
59625220|NCT00739752|75737705|FG004|STARTED|Overall Study||291||
59625221|NCT00739752|75737706|FG005|STARTED|Overall Study||293||
59625222|NCT00739752|75737701|FG000|COMPLETED|Overall Study||299||
59625223|NCT00739752|75737702|FG001|COMPLETED|Overall Study||284||
59625224|NCT00739752|75737703|FG002|COMPLETED|Overall Study||292||
59625225|NCT00739752|75737704|FG003|COMPLETED|Overall Study||288||
59625226|NCT00739752|75737705|FG004|COMPLETED|Overall Study||291||
59625227|NCT00739752|75737706|FG005|COMPLETED|Overall Study||293||
59625228|NCT00739752|75737701|FG000|NOT COMPLETED|Overall Study||0||
59625229|NCT00739752|75737702|FG001|NOT COMPLETED|Overall Study||0||
59625230|NCT00739752|75737703|FG002|NOT COMPLETED|Overall Study||0||
59625231|NCT00739752|75737704|FG003|NOT COMPLETED|Overall Study||0||
59625232|NCT00739752|75737705|FG004|NOT COMPLETED|Overall Study||0||
59625233|NCT00739752|75737706|FG005|NOT COMPLETED|Overall Study||0||
59625234|NCT00740376|75737722|FG000|STARTED|Overall Study||22||26
59625235|NCT00740376|75737723|FG001|STARTED|Overall Study||15||21
59625236|NCT00740376|75737722|FG000|COMPLETED|Overall Study||19||22
59625237|NCT00740376|75737723|FG001|COMPLETED|Overall Study||12||18
59625238|NCT00740376|75737722|FG000|NOT COMPLETED|Overall Study||3||4
59625239|NCT00740376|75737723|FG001|NOT COMPLETED|Overall Study||3||3
59625240|NCT00741156|75737729|FG000|STARTED|Overall Study||12||
59625241|NCT00741156|75737729|FG000|COMPLETED|Overall Study||12||
59625242|NCT00741156|75737729|FG000|NOT COMPLETED|Overall Study||0||
59625243|NCT00741390|75737744|FG000|STARTED|Visit 1||62||
59625244|NCT00741390|75737745|FG001|STARTED|Visit 1||63||
59625245|NCT00741390|75737746|FG002|STARTED|Visit 1||62||
59625246|NCT00741390|75737747|FG003|STARTED|Visit 1||63||
59625247|NCT00741390|75737744|FG000|COMPLETED|Visit 1||60||
59625248|NCT00741390|75737745|FG001|COMPLETED|Visit 1||63||
59625249|NCT00741390|75737746|FG002|COMPLETED|Visit 1||55||
59625250|NCT00741390|75737747|FG003|COMPLETED|Visit 1||62||
59625251|NCT00741390|75737744|FG000|NOT COMPLETED|Visit 1||2||
59625252|NCT00741390|75737745|FG001|NOT COMPLETED|Visit 1||0||
59625253|NCT00741390|75737746|FG002|NOT COMPLETED|Visit 1||7||
59625254|NCT00741390|75737747|FG003|NOT COMPLETED|Visit 1||1||
59625255|NCT00741390|75737744|FG000|STARTED|Visit 2|1 subject lost to follow-up between Visit 1 and Visit 2.|59||
59625256|NCT00741390|75737745|FG001|STARTED|Visit 2|2 subjects lost to follow-up between Visit 1 and Visit 2.|61||
59625257|NCT00741390|75737746|FG002|STARTED|Visit 2||55||
59625258|NCT00741390|75737747|FG003|STARTED|Visit 2|1 subject lost to follow-up between Visit 1 and Visit 2.|61||
59625259|NCT00741390|75737744|FG000|COMPLETED|Visit 2||59||
59625260|NCT00741390|75737745|FG001|COMPLETED|Visit 2||61||
59625261|NCT00741390|75737746|FG002|COMPLETED|Visit 2||54||
59625262|NCT00741390|75737747|FG003|COMPLETED|Visit 2||60||
59625263|NCT00741390|75737744|FG000|NOT COMPLETED|Visit 2||0||
59625264|NCT00741390|75737745|FG001|NOT COMPLETED|Visit 2||0||
59625265|NCT00741390|75737746|FG002|NOT COMPLETED|Visit 2||1||
59625266|NCT00741390|75737747|FG003|NOT COMPLETED|Visit 2||1||
59625267|NCT00741468|75737766|FG000|STARTED|Overall Study||18||
59625268|NCT00741468|75737766|FG000|COMPLETED|Overall Study||18||
59625269|NCT00741468|75737766|FG000|NOT COMPLETED|Overall Study||0||
59625270|NCT00741858|75737776|FG000|STARTED|Overall Study||16||
59625271|NCT00741858|75737777|FG001|STARTED|Overall Study||18||
59625272|NCT00741858|75737776|FG000|COMPLETED|Overall Study||16||
59625273|NCT00741858|75737777|FG001|COMPLETED|Overall Study||18||
59625274|NCT00741858|75737776|FG000|NOT COMPLETED|Overall Study||0||
59625275|NCT00741858|75737777|FG001|NOT COMPLETED|Overall Study||0||
59625276|NCT00742170|75737785|FG000|STARTED|Overall Study||26||
59625277|NCT00742170|75737786|FG001|STARTED|Overall Study||29||
59625278|NCT00742170|75737785|FG000|COMPLETED|Overall Study||24||
59625279|NCT00742170|75737786|FG001|COMPLETED|Overall Study||24||
59625280|NCT00742170|75737785|FG000|NOT COMPLETED|Overall Study||2||
59625281|NCT00742170|75737786|FG001|NOT COMPLETED|Overall Study||5||
59625282|NCT00742872|75737794|FG000|STARTED|Overall Study||21||
59625283|NCT00742872|75737795|FG001|STARTED|Overall Study||20||
59625284|NCT00742872|75737794|FG000|COMPLETED|Overall Study||9||
59625285|NCT00742872|75737795|FG001|COMPLETED|Overall Study||12||
59625286|NCT00742872|75737794|FG000|NOT COMPLETED|Overall Study||12||
59625287|NCT00742872|75737795|FG001|NOT COMPLETED|Overall Study||8||
59625288|NCT00743574|75737801|FG000|STARTED|Overall Study||36||
59625289|NCT00743574|75737801|FG000|Dropped Out Before Eligibility Testing|Overall Study||13||
59625290|NCT00743574|75737801|FG000|Further Exclusions|Overall Study||8||
59625291|NCT00743574|75737801|FG000|Dropped Out After Initiating Trial|Overall Study||3||
59625292|NCT00743574|75737801|FG000|COMPLETED|Overall Study||12||
59625293|NCT00743574|75737801|FG000|NOT COMPLETED|Overall Study||24||
59625294|NCT00743730|75737808|FG000|STARTED|Overall Study||27||
59625295|NCT00743730|75737809|FG001|STARTED|Overall Study||34||
59625296|NCT00743730|75737810|FG002|STARTED|Overall Study||33||
59625297|NCT00743730|75737808|FG000|COMPLETED|Overall Study||22||
59625298|NCT00743730|75737809|FG001|COMPLETED|Overall Study||30||
59625299|NCT00743730|75737810|FG002|COMPLETED|Overall Study||28||
59625300|NCT00743730|75737808|FG000|NOT COMPLETED|Overall Study||5||
59625301|NCT00743730|75737809|FG001|NOT COMPLETED|Overall Study||4||
59625302|NCT00743730|75737810|FG002|NOT COMPLETED|Overall Study||5||
59625303|NCT00745290|75737824|FG000|STARTED|Overall Study||123||
59625304|NCT00745290|75737825|FG001|STARTED|Overall Study||122||
59625305|NCT00745290|75737824|FG000|COMPLETED|Overall Study||123||
59625306|NCT00745290|75737825|FG001|COMPLETED|Overall Study||122||
59625307|NCT00745290|75737824|FG000|NOT COMPLETED|Overall Study||0||
59625308|NCT00745290|75737825|FG001|NOT COMPLETED|Overall Study||0||
59625309|NCT00746694|75737831|FG000|STARTED|Overall Study||154||
59625310|NCT00746694|75737831|FG000|COMPLETED|Overall Study||154||
59625311|NCT00746694|75737831|FG000|NOT COMPLETED|Overall Study||0||
59625312|NCT00747552|75737835|FG000|STARTED|Overall Study|This number does not include the 2 who were enrolled but had no data collected on them.|30||
59625313|NCT00747552|75737835|FG000|COMPLETED|Overall Study||30||
59625314|NCT00747552|75737835|FG000|NOT COMPLETED|Overall Study||0||
59625315|NCT00748410|75737841|FG000|STARTED|Overall Study||1||
59625316|NCT00748410|75737842|FG001|STARTED|Overall Study||2||
59625317|NCT00748410|75737841|FG000|COMPLETED|Overall Study||1||
59625318|NCT00748410|75737842|FG001|COMPLETED|Overall Study||2||
59625319|NCT00748410|75737841|FG000|NOT COMPLETED|Overall Study||0||
59625320|NCT00748410|75737842|FG001|NOT COMPLETED|Overall Study||0||
59625321|NCT00748956|75737851|FG000|STARTED|Overall Study||0||
59625322|NCT00748956|75737852|FG001|STARTED|Overall Study||5||
59625323|NCT00748956|75737853|FG002|STARTED|Overall Study||5||
59625324|NCT00748956|75737851|FG000|COMPLETED|Overall Study||0||
59625325|NCT00748956|75737852|FG001|COMPLETED|Overall Study||5||
59625326|NCT00748956|75737853|FG002|COMPLETED|Overall Study||5||
59625327|NCT00748956|75737851|FG000|NOT COMPLETED|Overall Study||0||
59625328|NCT00748956|75737852|FG001|NOT COMPLETED|Overall Study||0||
59625329|NCT00748956|75737853|FG002|NOT COMPLETED|Overall Study||0||
59625330|NCT00749268|75737865|FG000|STARTED|Overall Study||106||
59625331|NCT00749268|75737866|FG001|STARTED|Overall Study||110||
59625332|NCT00749268|75737865|FG000|COMPLETED|Overall Study||72||
59625333|NCT00749268|75737866|FG001|COMPLETED|Overall Study||74||
59625334|NCT00749268|75737865|FG000|NOT COMPLETED|Overall Study||34||
59625335|NCT00749268|75737866|FG001|NOT COMPLETED|Overall Study||36||
59625336|NCT00750282|75737880|FG000|STARTED|Overall Study||69||
59625337|NCT00750282|75737881|FG001|STARTED|Overall Study||82||
59625338|NCT00750282|75737882|FG002|STARTED|Overall Study||126||
59625339|NCT00750282|75737883|FG003|STARTED|Overall Study||148||
59625340|NCT00750282|75737880|FG000|COMPLETED|Overall Study||69||
59625341|NCT00750282|75737881|FG001|COMPLETED|Overall Study||81||
59625342|NCT00750282|75737882|FG002|COMPLETED|Overall Study||125||
59625343|NCT00750282|75737883|FG003|COMPLETED|Overall Study||147||
59625344|NCT00750282|75737880|FG000|NOT COMPLETED|Overall Study||0||
59625345|NCT00750282|75737881|FG001|NOT COMPLETED|Overall Study||1||
59625346|NCT00750282|75737882|FG002|NOT COMPLETED|Overall Study||1||
59625347|NCT00750282|75737883|FG003|NOT COMPLETED|Overall Study||1||
59625348|NCT00750360|75737913|FG000|STARTED|Overall Study|"Seven subjects enrolled in this group were not vaccinated and as such not included as STARTED."|294||
59625349|NCT00750360|75737914|FG001|STARTED|Overall Study|"One subject enrolled in this group was not vaccinated and as such not included as STARTED."|1||
59625350|NCT00750360|75737915|FG002|STARTED|Overall Study||384||
59625351|NCT00750360|75737916|FG003|STARTED|Overall Study||79||
59625352|NCT00750360|75737917|FG004|STARTED|Overall Study||46||
59625353|NCT00750360|75737918|FG005|STARTED|Overall Study||71||
59625354|NCT00750360|75737913|FG000|COMPLETED|Overall Study||294||
59625355|NCT00750360|75737914|FG001|COMPLETED|Overall Study||1||
59625356|NCT00750360|75737915|FG002|COMPLETED|Overall Study||384||
59625357|NCT00750360|75737916|FG003|COMPLETED|Overall Study||79||
59625358|NCT00750360|75737917|FG004|COMPLETED|Overall Study||46||
59625359|NCT00750360|75737918|FG005|COMPLETED|Overall Study||71||
59625360|NCT00750360|75737913|FG000|NOT COMPLETED|Overall Study||0||
59625361|NCT00750360|75737914|FG001|NOT COMPLETED|Overall Study||0||
59625362|NCT00750360|75737915|FG002|NOT COMPLETED|Overall Study||0||
59625363|NCT00750360|75737916|FG003|NOT COMPLETED|Overall Study||0||
59625364|NCT00750360|75737917|FG004|NOT COMPLETED|Overall Study||0||
59625365|NCT00750360|75737918|FG005|NOT COMPLETED|Overall Study||0||
59625366|NCT00751530|75737940|FG000|STARTED|Overall Study||332||
59625367|NCT00751530|75737941|FG001|STARTED|Overall Study||110||
59625368|NCT00751530|75737940|FG000|COMPLETED|Overall Study||332||
59625369|NCT00751530|75737941|FG001|COMPLETED|Overall Study||110||
59625370|NCT00751530|75737940|FG000|NOT COMPLETED|Overall Study||0||
59625371|NCT00751530|75737941|FG001|NOT COMPLETED|Overall Study||0||
59625372|NCT00753636|75737947|FG000|STARTED|Overall Study||31||
59625373|NCT00753636|75737947|FG000|COMPLETED|Overall Study||25||
59625374|NCT00753636|75737947|FG000|NOT COMPLETED|Overall Study||6||
59625375|NCT00753948|75737954|FG000|STARTED|Overall Study||9||
59625376|NCT00753948|75737955|FG001|STARTED|Overall Study||7||
59625377|NCT00753948|75737956|FG002|STARTED|Overall Study||7||
59625378|NCT00753948|75737954|FG000|COMPLETED|Overall Study||9||
59625379|NCT00753948|75737955|FG001|COMPLETED|Overall Study||7||
60076231|NCT01904773|76191364|FG000|NOT COMPLETED|Third Intervention||0||
60076232|NCT01904773|76191365|FG001|NOT COMPLETED|Third Intervention||0||
60076233|NCT01904773|76191366|FG002|NOT COMPLETED|Third Intervention||0||
60076234|NCT01904773|76191367|FG003|NOT COMPLETED|Third Intervention||0||
59539230|NCT02960204|75637472|FG001|Completed Week 24 of Study|Overall Study||62||
59539231|NCT02960204|75637473|FG002|Completed Week 24 of Study|Overall Study||60||
59539232|NCT02960204|75637474|FG003|Completed Week 24 of Study|Overall Study||66||
59539233|NCT02960204|75637471|FG000|Completed Week 48 of Study|Overall Study||55||
59539234|NCT02960204|75637472|FG001|Completed Week 48 of Study|Overall Study||55||
59539235|NCT02960204|75637473|FG002|Completed Week 48 of Study|Overall Study||50||
59539236|NCT02960204|75637474|FG003|Completed Week 48 of Study|Overall Study||59||
59539237|NCT02960204|75637471|FG000|COMPLETED|Overall Study||36|Follow-Up|
59539238|NCT02960204|75637472|FG001|COMPLETED|Overall Study||44|Follow-Up|
59539239|NCT02960204|75637473|FG002|COMPLETED|Overall Study||37|Follow-Up|
59539240|NCT02960204|75637474|FG003|COMPLETED|Overall Study||38|Follow-Up|
59539241|NCT02960204|75637471|FG000|NOT COMPLETED|Overall Study||29||
59539242|NCT02960204|75637472|FG001|NOT COMPLETED|Overall Study||21||
59539243|NCT02960204|75637473|FG002|NOT COMPLETED|Overall Study||29||
59539244|NCT02960204|75637474|FG003|NOT COMPLETED|Overall Study||29||
59539245|NCT02152826|75637486|FG000|STARTED|Overall Study||45||
59539246|NCT02152826|75637487|FG001|STARTED|Overall Study||35||
59539247|NCT02152826|75637486|FG000|COMPLETED|Overall Study||44||
59539248|NCT02152826|75637487|FG001|COMPLETED|Overall Study||34||
59539249|NCT02152826|75637486|FG000|NOT COMPLETED|Overall Study||1||
59539250|NCT02152826|75637487|FG001|NOT COMPLETED|Overall Study||1||
59539251|NCT00857714|75637493|FG000|STARTED|Overall Study||1||
59539252|NCT00857714|75637493|FG000|COMPLETED|Overall Study||1||
59539253|NCT00857714|75637493|FG000|NOT COMPLETED|Overall Study||0||
59539254|NCT00858494|75637497|FG000|STARTED|Overall Study||49||
59539255|NCT00858494|75637497|FG000|COMPLETED|Overall Study|2 participants dropped out before giving study medication. Symptoms resolved without a dose in 2.|45||
59539256|NCT00858494|75637497|FG000|NOT COMPLETED|Overall Study||4||
59539257|NCT00858962|75637501|FG000|STARTED|Overall Study||12||
59539258|NCT00858962|75637501|FG000|COMPLETED|Overall Study||12||
59539259|NCT00858962|75637501|FG000|NOT COMPLETED|Overall Study||0||
59539260|NCT01376297|75637507|FG000|STARTED|Overall Study|number of randomised patients|309||
59539261|NCT01376297|75637508|FG001|STARTED|Overall Study|number of randomised patients|104||
59539262|NCT01376297|75637507|FG000|COMPLETED|Overall Study|number of patients completing planned/unplanned chemotherapy cycles|181||
59539263|NCT01376297|75637508|FG001|COMPLETED|Overall Study|number of patients completing planned/unplanned chemotherapy cycles|55||
59539264|NCT01376297|75637507|FG000|NOT COMPLETED|Overall Study||128||
59539265|NCT01376297|75637508|FG001|NOT COMPLETED|Overall Study||49||
59539266|NCT00859040|75637516|FG000|STARTED|Overall Study||18||
59539267|NCT00859040|75637517|FG001|STARTED|Overall Study||16||
59539268|NCT00859040|75637516|FG000|COMPLETED|Overall Study||18||
59539269|NCT00859040|75637517|FG001|COMPLETED|Overall Study||16||
59539270|NCT00859040|75637516|FG000|NOT COMPLETED|Overall Study||0||
59539271|NCT00859040|75637517|FG001|NOT COMPLETED|Overall Study||0||
59539272|NCT00859508|75637525|FG000|STARTED|Overall Study||68||
59539273|NCT00859508|75637526|FG001|STARTED|Overall Study||37||
59539274|NCT00859508|75637525|FG000|COMPLETED|Overall Study||62||
59539275|NCT00859508|75637526|FG001|COMPLETED|Overall Study||37||
59539276|NCT00859508|75637525|FG000|NOT COMPLETED|Overall Study||6||
59539277|NCT00859508|75637526|FG001|NOT COMPLETED|Overall Study||0||
59539278|NCT01377467|75637534|FG000|STARTED|Overall Study||46||
59539279|NCT01377467|75637535|FG001|STARTED|Overall Study||44||
59539280|NCT01377467|75637534|FG000|COMPLETED|Overall Study||46||
59539281|NCT01377467|75637535|FG001|COMPLETED|Overall Study||44||
59539282|NCT01377467|75637534|FG000|NOT COMPLETED|Overall Study||0||
59539283|NCT01377467|75637535|FG001|NOT COMPLETED|Overall Study||0||
59539284|NCT00859976|75637543|FG000|STARTED|Overall Study||82||
59539285|NCT00859976|75637544|FG001|STARTED|Overall Study||85||
59539286|NCT00859976|75637543|FG000|COMPLETED|Overall Study||66||
59539287|NCT00859976|75637544|FG001|COMPLETED|Overall Study||67||
59539288|NCT00859976|75637543|FG000|NOT COMPLETED|Overall Study||16||
59539289|NCT00859976|75637544|FG001|NOT COMPLETED|Overall Study||18||
59539290|NCT01377623|75637552|FG000|STARTED|Overall Study||33||
59539291|NCT01377623|75637553|FG001|STARTED|Overall Study||33||
59539292|NCT01377623|75637552|FG000|COMPLETED|Overall Study||26||
59539293|NCT01377623|75637553|FG001|COMPLETED|Overall Study||28||
59815605|NCT04382911|75938051|FG000|STARTED|Overall Study||8||
60076235|NCT01904773|76191368|FG004|NOT COMPLETED|Third Intervention||0||
59539294|NCT01377623|75637552|FG000|NOT COMPLETED|Overall Study||7||
59539295|NCT01377623|75637553|FG001|NOT COMPLETED|Overall Study||5||
59539296|NCT01479725|75637561|FG000|STARTED|Overall Study||6||
59539297|NCT01479725|75637562|FG001|STARTED|Overall Study||2||
59539298|NCT01479725|75637561|FG000|COMPLETED|Overall Study||4||
59539299|NCT01479725|75637562|FG001|COMPLETED|Overall Study||1||
59539300|NCT01479725|75637561|FG000|NOT COMPLETED|Overall Study||2||
59539301|NCT01479725|75637562|FG001|NOT COMPLETED|Overall Study||1||
59539302|NCT01481129|75637568|FG000|STARTED|Overall Study||22||
59539303|NCT01481129|75637568|FG000|COMPLETED|Overall Study||22||
59539304|NCT01481129|75637568|FG000|NOT COMPLETED|Overall Study||0||
59625380|NCT00753948|75737956|FG002|COMPLETED|Overall Study||7||
59625381|NCT00753948|75737954|FG000|NOT COMPLETED|Overall Study||0||
59625382|NCT00753948|75737955|FG001|NOT COMPLETED|Overall Study||0||
59625383|NCT00753948|75737956|FG002|NOT COMPLETED|Overall Study||0||
59625384|NCT00754494|75737967|FG000|STARTED|Overall Study||15||
59625385|NCT00754494|75737968|FG001|STARTED|Overall Study||15||
59625386|NCT00754494|75737969|FG002|STARTED|Overall Study||15||
59625387|NCT00754494|75737967|FG000|COMPLETED|Overall Study||13||
59625388|NCT00754494|75737968|FG001|COMPLETED|Overall Study||15||
59625389|NCT00754494|75737969|FG002|COMPLETED|Overall Study||14||
59625390|NCT00754494|75737967|FG000|NOT COMPLETED|Overall Study||2||
59625391|NCT00754494|75737968|FG001|NOT COMPLETED|Overall Study||0||
59625392|NCT00754494|75737969|FG002|NOT COMPLETED|Overall Study||1||
59625393|NCT00755040|75737979|FG000|STARTED|Overall Study||83||
59625394|NCT00755040|75737980|FG001|STARTED|Overall Study||81||
59625395|NCT00755040|75737979|FG000|COMPLETED|Overall Study||40||
59625396|NCT00755040|75737980|FG001|COMPLETED|Overall Study||47||
59625397|NCT00755040|75737979|FG000|NOT COMPLETED|Overall Study||43||
59625398|NCT00755040|75737980|FG001|NOT COMPLETED|Overall Study||34||
59625399|NCT00755274|75737988|FG000|STARTED|Overall Study||24||
59625400|NCT00755274|75737989|FG001|STARTED|Overall Study||8||
59625401|NCT00755274|75737988|FG000|COMPLETED|Overall Study||24||
59625402|NCT00755274|75737989|FG001|COMPLETED|Overall Study||8||
59625403|NCT00755274|75737988|FG000|NOT COMPLETED|Overall Study||0||
59625404|NCT00755274|75737989|FG001|NOT COMPLETED|Overall Study||0||
59625405|NCT00756600|75737997|FG000|STARTED|Overall Study||287||
59625406|NCT00756600|75737998|FG001|STARTED|Overall Study||356||
59625407|NCT00756600|75737997|FG000|COMPLETED|Overall Study||287||
59625408|NCT00756600|75737998|FG001|COMPLETED|Overall Study||356||
59625409|NCT00756600|75737997|FG000|NOT COMPLETED|Overall Study||0||
59625410|NCT00756600|75737998|FG001|NOT COMPLETED|Overall Study||0||
59625411|NCT00756678|75738005|FG000|STARTED|Overall Study||51||
59625412|NCT00756678|75738005|FG000|COMPLETED|Overall Study||50||
59625413|NCT00756678|75738005|FG000|NOT COMPLETED|Overall Study||1||
59625414|NCT00758550|75738012|FG000|STARTED|Overall Study||30||
59625415|NCT00758550|75738013|FG001|STARTED|Overall Study||30||
59625416|NCT00758550|75738012|FG000|COMPLETED|Overall Study||30||
59625417|NCT00758550|75738013|FG001|COMPLETED|Overall Study||30||
59625418|NCT00758550|75738012|FG000|NOT COMPLETED|Overall Study||0||
59625419|NCT00758550|75738013|FG001|NOT COMPLETED|Overall Study||0||
59625420|NCT00758784|75738019|FG000|STARTED|Overall Study||38||
59625421|NCT00758784|75738019|FG000|COMPLETED|Overall Study||36||
59625422|NCT00758784|75738019|FG000|NOT COMPLETED|Overall Study||2||
59625423|NCT00758862|75738023|FG000|STARTED|Overall Study||20||
59625424|NCT00758862|75738023|FG000|COMPLETED|Overall Study||19||
59625425|NCT00758862|75738023|FG000|NOT COMPLETED|Overall Study||1||
59625426|NCT00759330|75738031|FG000|STARTED|Overall Study||20||
59625427|NCT00759330|75738032|FG001|STARTED|Overall Study||42||
59625428|NCT00759330|75738033|FG002|STARTED|Overall Study||22||
59625429|NCT00759330|75738034|FG003|STARTED|Overall Study||43||
59625430|NCT00759330|75738031|FG000|COMPLETED|Overall Study||19||
59625431|NCT00759330|75738032|FG001|COMPLETED|Overall Study||41||
59625432|NCT00759330|75738033|FG002|COMPLETED|Overall Study||22||
59625433|NCT00759330|75738034|FG003|COMPLETED|Overall Study||41||
59625434|NCT00759330|75738031|FG000|NOT COMPLETED|Overall Study||1||
59625435|NCT00759330|75738032|FG001|NOT COMPLETED|Overall Study||1||
59625436|NCT00759330|75738033|FG002|NOT COMPLETED|Overall Study||0||
59625437|NCT00759330|75738034|FG003|NOT COMPLETED|Overall Study||2||
59625438|NCT00759408|75738045|FG000|STARTED|Overall Study||38||
59625439|NCT00759408|75738045|FG000|COMPLETED|Overall Study||19||
59625440|NCT00759408|75738045|FG000|NOT COMPLETED|Overall Study||19||
59625441|NCT00759642|75738049|FG000|STARTED|Overall Study||33||
59625442|NCT00759642|75738049|FG000|COMPLETED|Overall Study||33||
59625443|NCT00759642|75738049|FG000|NOT COMPLETED|Overall Study||0||
59625444|NCT00759798|75738053|FG000|STARTED|Overall Study||289||
59625445|NCT00759798|75738053|FG000|COMPLETED|Overall Study||289||
59625446|NCT00759798|75738053|FG000|NOT COMPLETED|Overall Study||0||
59625447|NCT00760578|75738061|FG000|STARTED|Overall Study||22||
59625448|NCT00760578|75738062|FG001|STARTED|Overall Study||21||
59625449|NCT00760578|75738063|FG002|STARTED|Overall Study||21||
59625450|NCT00760578|75738064|FG003|STARTED|Overall Study||22||
59625451|NCT00760578|75738061|FG000|Entered Drug Treatment Period|Overall Study||21||
59625452|NCT00760578|75738062|FG001|Entered Drug Treatment Period|Overall Study||20||
59625453|NCT00760578|75738063|FG002|Entered Drug Treatment Period|Overall Study||19||
59625454|NCT00760578|75738064|FG003|Entered Drug Treatment Period|Overall Study||22||
59625455|NCT00760578|75738061|FG000|COMPLETED|Overall Study||19||
59625456|NCT00760578|75738062|FG001|COMPLETED|Overall Study||19||
59625457|NCT00760578|75738063|FG002|COMPLETED|Overall Study||16||
59625458|NCT00760578|75738064|FG003|COMPLETED|Overall Study||18||
59625459|NCT00760578|75738061|FG000|NOT COMPLETED|Overall Study||3||
59625460|NCT00760578|75738062|FG001|NOT COMPLETED|Overall Study||2||
59625461|NCT00760578|75738063|FG002|NOT COMPLETED|Overall Study||5||
59625462|NCT00760578|75738064|FG003|NOT COMPLETED|Overall Study||4||
59625463|NCT00761202|75738081|FG000|STARTED|Overall Study||22||
59625464|NCT00761202|75738082|FG001|STARTED|Overall Study||28||
59625465|NCT00761202|75738081|FG000|COMPLETED|Overall Study||21||
59625466|NCT00761202|75738082|FG001|COMPLETED|Overall Study||26||
59625467|NCT00761202|75738081|FG000|NOT COMPLETED|Overall Study||1||
59625468|NCT00761202|75738082|FG001|NOT COMPLETED|Overall Study||2||
59625469|NCT00761592|75738090|FG000|STARTED|Overall Study||32||
59625470|NCT00761592|75738091|FG001|STARTED|Overall Study||33||
59625471|NCT00761592|75738090|FG000|COMPLETED|Overall Study||31||
59625472|NCT00761592|75738091|FG001|COMPLETED|Overall Study||32||
59625473|NCT00761592|75738090|FG000|NOT COMPLETED|Overall Study||1||
59625474|NCT00761592|75738091|FG001|NOT COMPLETED|Overall Study||1||
59625475|NCT00762216|75738097|FG000|STARTED|Overall Study||71||
59625476|NCT00762216|75738097|FG000|COMPLETED|Overall Study||71||
59625477|NCT00762216|75738097|FG000|NOT COMPLETED|Overall Study||0||
59625478|NCT00762450|75738104|FG000|STARTED|1st Treatment Period||2||
59625479|NCT00762450|75738105|FG001|STARTED|1st Treatment Period||2||
59625480|NCT00762450|75738106|FG002|STARTED|1st Treatment Period||2||
59625481|NCT00762450|75738104|FG000|COMPLETED|1st Treatment Period||2||
59625482|NCT00762450|75738105|FG001|COMPLETED|1st Treatment Period||2||
59625483|NCT00762450|75738106|FG002|COMPLETED|1st Treatment Period||2||
59625484|NCT00762450|75738104|FG000|NOT COMPLETED|1st Treatment Period||0||
59625485|NCT00762450|75738105|FG001|NOT COMPLETED|1st Treatment Period||0||
59625486|NCT00762450|75738106|FG002|NOT COMPLETED|1st Treatment Period||0||
59625487|NCT00762450|75738104|FG000|STARTED|Washout After 1st Treatment Period||2||
59625488|NCT00762450|75738105|FG001|STARTED|Washout After 1st Treatment Period||2||
59625489|NCT00762450|75738106|FG002|STARTED|Washout After 1st Treatment Period||2||
59625490|NCT00762450|75738104|FG000|COMPLETED|Washout After 1st Treatment Period||2||
59625491|NCT00762450|75738105|FG001|COMPLETED|Washout After 1st Treatment Period||2||
59625492|NCT00762450|75738106|FG002|COMPLETED|Washout After 1st Treatment Period||2||
59625493|NCT00762450|75738104|FG000|NOT COMPLETED|Washout After 1st Treatment Period||0||
59625494|NCT00762450|75738105|FG001|NOT COMPLETED|Washout After 1st Treatment Period||0||
59625495|NCT00762450|75738106|FG002|NOT COMPLETED|Washout After 1st Treatment Period||0||
59625496|NCT00762450|75738104|FG000|STARTED|2nd Treatment Period||2||
60076236|NCT01904773|76191369|FG005|NOT COMPLETED|Third Intervention||0||
59625497|NCT00762450|75738105|FG001|STARTED|2nd Treatment Period||2||
59625498|NCT00762450|75738106|FG002|STARTED|2nd Treatment Period||2||
59625499|NCT00762450|75738104|FG000|COMPLETED|2nd Treatment Period||2||
59625500|NCT00762450|75738105|FG001|COMPLETED|2nd Treatment Period||2||
59625501|NCT00762450|75738106|FG002|COMPLETED|2nd Treatment Period||2||
59625502|NCT00762450|75738104|FG000|NOT COMPLETED|2nd Treatment Period||0||
59625503|NCT00762450|75738105|FG001|NOT COMPLETED|2nd Treatment Period||0||
59625504|NCT00762450|75738106|FG002|NOT COMPLETED|2nd Treatment Period||0||
59625505|NCT00762450|75738104|FG000|STARTED|Washout After 2nd Treatment Period||2||
59625506|NCT00762450|75738105|FG001|STARTED|Washout After 2nd Treatment Period||2||
59625507|NCT00762450|75738106|FG002|STARTED|Washout After 2nd Treatment Period||2||
59625508|NCT00762450|75738104|FG000|COMPLETED|Washout After 2nd Treatment Period||2||
59625509|NCT00762450|75738105|FG001|COMPLETED|Washout After 2nd Treatment Period||2||
59625510|NCT00762450|75738106|FG002|COMPLETED|Washout After 2nd Treatment Period||2||
59625511|NCT00762450|75738104|FG000|NOT COMPLETED|Washout After 2nd Treatment Period||0||
59625512|NCT00762450|75738105|FG001|NOT COMPLETED|Washout After 2nd Treatment Period||0||
59625513|NCT00762450|75738106|FG002|NOT COMPLETED|Washout After 2nd Treatment Period||0||
59625514|NCT00762450|75738104|FG000|STARTED|3rd Treatment Period||2||
59625515|NCT00762450|75738105|FG001|STARTED|3rd Treatment Period||2||
59625516|NCT00762450|75738106|FG002|STARTED|3rd Treatment Period||2||
59625517|NCT00762450|75738104|FG000|COMPLETED|3rd Treatment Period||2||
59625518|NCT00762450|75738105|FG001|COMPLETED|3rd Treatment Period||2||
59625519|NCT00762450|75738106|FG002|COMPLETED|3rd Treatment Period||2||
59625520|NCT00762450|75738104|FG000|NOT COMPLETED|3rd Treatment Period||0||
59625521|NCT00762450|75738105|FG001|NOT COMPLETED|3rd Treatment Period||0||
59625522|NCT00762450|75738106|FG002|NOT COMPLETED|3rd Treatment Period||0||
59625523|NCT00762528|75738116|FG000|STARTED|Overall Study||24||
59625524|NCT00762528|75738117|FG001|STARTED|Overall Study||25||
59625525|NCT00762528|75738116|FG000|COMPLETED|Overall Study||24||
59625526|NCT00762528|75738117|FG001|COMPLETED|Overall Study||25||
59625527|NCT00762528|75738116|FG000|NOT COMPLETED|Overall Study||0||
59625528|NCT00762528|75738117|FG001|NOT COMPLETED|Overall Study||0||
59625529|NCT00765570|75738125|FG000|STARTED|Overall Study||9||
59625530|NCT00765570|75738126|FG001|STARTED|Overall Study||3||
59625531|NCT00765570|75738125|FG000|COMPLETED|Overall Study||7||
59625532|NCT00765570|75738126|FG001|COMPLETED|Overall Study||3||
59625533|NCT00765570|75738125|FG000|NOT COMPLETED|Overall Study||2||
59625534|NCT00765570|75738126|FG001|NOT COMPLETED|Overall Study||0||
59625535|NCT00765648|75738134|FG000|STARTED|Overall Study||110||
59625536|NCT00765648|75738135|FG001|STARTED|Overall Study||116||
59625537|NCT00765648|75738134|FG000|COMPLETED|Overall Study||109||
59625538|NCT00765648|75738135|FG001|COMPLETED|Overall Study||114||
59625539|NCT00765648|75738134|FG000|NOT COMPLETED|Overall Study||1||
59625540|NCT00765648|75738135|FG001|NOT COMPLETED|Overall Study||2||
59625541|NCT00766116|75738141|FG000|STARTED|Overall Study||50||
59625542|NCT00766116|75738141|FG000|COMPLETED|Overall Study||50||
59539305|NCT01486043|75637572|FG000|STARTED|Overall Study||4||
59539306|NCT01486043|75637572|FG000|COMPLETED|Overall Study|Study terminated due to insufficient recruitment|2||
59539307|NCT01486043|75637572|FG000|NOT COMPLETED|Overall Study||2||
59539308|NCT01490723|75637576|FG000|STARTED|Overall Study||20||
59539309|NCT01490723|75637576|FG000|COMPLETED|Overall Study||20||
59539310|NCT01490723|75637576|FG000|NOT COMPLETED|Overall Study||0||
59539311|NCT01491113|75637585|FG000|STARTED|Overall Study||6||
59539312|NCT01491113|75637586|FG001|STARTED|Overall Study||6||
59539313|NCT01491113|75637587|FG002|STARTED|Overall Study||6||
59539314|NCT01491113|75637588|FG003|STARTED|Overall Study||6||
59539315|NCT01491113|75637589|FG004|STARTED|Overall Study||6||
59539316|NCT01491113|75637585|FG000|COMPLETED|Overall Study||6||
59539317|NCT01491113|75637586|FG001|COMPLETED|Overall Study||6||
59539318|NCT01491113|75637587|FG002|COMPLETED|Overall Study||6||
59539319|NCT01491113|75637588|FG003|COMPLETED|Overall Study||6||
59539320|NCT01491113|75637589|FG004|COMPLETED|Overall Study||6||
59539321|NCT01491113|75637585|FG000|NOT COMPLETED|Overall Study||0||
59539322|NCT01491113|75637586|FG001|NOT COMPLETED|Overall Study||0||
59539323|NCT01491113|75637587|FG002|NOT COMPLETED|Overall Study||0||
59539324|NCT01491113|75637588|FG003|NOT COMPLETED|Overall Study||0||
59539325|NCT01491113|75637589|FG004|NOT COMPLETED|Overall Study||0||
59539326|NCT00816062|75637603|FG000|STARTED|Overall Study||260||
59539327|NCT00816062|75637603|FG000|COMPLETED|Overall Study||133||
59539328|NCT00816062|75637603|FG000|NOT COMPLETED|Overall Study||127||
59539329|NCT01415453|75637608|FG000|STARTED|Overall Study||1||
59539330|NCT01415453|75637608|FG000|Imaging Study|Overall Study||1||
59539331|NCT01415453|75637608|FG000|COMPLETED|Overall Study||1||
59539332|NCT01415453|75637608|FG000|NOT COMPLETED|Overall Study||0||
59539333|NCT01492673|75637612|FG000|STARTED|Overall Study||9||
59539334|NCT01492673|75637612|FG000|COMPLETED|Overall Study||9||
59539335|NCT01492673|75637612|FG000|NOT COMPLETED|Overall Study||0||
59539336|NCT01494545|75637616|FG000|STARTED|Overall Study||102||
59539337|NCT01494545|75637616|FG000|COMPLETED|Overall Study||92||
59539338|NCT01494545|75637616|FG000|NOT COMPLETED|Overall Study||10||
59539339|NCT00818324|75637623|FG000|STARTED|Overall Study||154||
59539340|NCT00818324|75637623|FG000|COMPLETED|Overall Study||127||
59539341|NCT00818324|75637623|FG000|NOT COMPLETED|Overall Study||27||
59539342|NCT01419275|75637627|FG000|STARTED|Overall Study||126||
59539343|NCT01419275|75637627|FG000|COMPLETED|Overall Study||126||
59539344|NCT01419275|75637627|FG000|NOT COMPLETED|Overall Study||0||
59539345|NCT02155010|75637633|FG000|STARTED|Overall Study||37||
59539346|NCT02155010|75637634|FG001|STARTED|Overall Study||37||
59539347|NCT02155010|75637633|FG000|COMPLETED|Overall Study||31||
59539348|NCT02155010|75637634|FG001|COMPLETED|Overall Study||31||
59539349|NCT02155010|75637633|FG000|NOT COMPLETED|Overall Study||6||
59539350|NCT02155010|75637634|FG001|NOT COMPLETED|Overall Study||6||
59539351|NCT01495481|75637640|FG000|STARTED|Adenosine|Patients first received adenosine and then dexmedetomidine.|22||
59539352|NCT01495481|75637640|FG000|COMPLETED|Adenosine||22||
59539353|NCT01495481|75637640|FG000|NOT COMPLETED|Adenosine||0||
59539354|NCT01495481|75637640|FG000|STARTED|Washout||22||
59539355|NCT01495481|75637640|FG000|COMPLETED|Washout||22||
59539356|NCT01495481|75637640|FG000|NOT COMPLETED|Washout||0||
59539357|NCT01495481|75637640|FG000|STARTED|Dexmedetomidine||22||
59539358|NCT01495481|75637640|FG000|COMPLETED|Dexmedetomidine||22||
59539359|NCT01495481|75637640|FG000|NOT COMPLETED|Dexmedetomidine||0||
59539360|NCT00861146|75637650|FG000|STARTED|Overall Study||105||
59539361|NCT00861146|75637651|FG001|STARTED|Overall Study||46||
59539362|NCT00861146|75637650|FG000|Week 2 Assessment|Overall Study||97||
59539363|NCT00861146|75637651|FG001|Week 2 Assessment|Overall Study||45||
59539364|NCT00861146|75637650|FG000|Week 13 Assessment|Overall Study||85||
59539365|NCT00861146|75637651|FG001|Week 13 Assessment|Overall Study||38||
59539366|NCT00861146|75637650|FG000|COMPLETED|Overall Study||85||
59539367|NCT00861146|75637651|FG001|COMPLETED|Overall Study||38||
59539368|NCT00861146|75637650|FG000|NOT COMPLETED|Overall Study||20||
59539369|NCT00861146|75637651|FG001|NOT COMPLETED|Overall Study||8||
59539370|NCT00819182|75637660|FG000|STARTED|Overall Study|Consented participants allocated to this arm.|88||
59539371|NCT00819182|75637661|FG001|STARTED|Overall Study|Consented participants allocated to this arm.|86||
59539372|NCT00819182|75637662|FG002|STARTED|Overall Study|Consented participants allocated to this arm.|44||
59539373|NCT00819182|75637660|FG000|Week 16 Visit|Overall Study||75||
59539374|NCT00819182|75637661|FG001|Week 16 Visit|Overall Study||78||
59539375|NCT00819182|75637662|FG002|Week 16 Visit|Overall Study||43||
59539376|NCT00819182|75637660|FG000|COMPLETED|Overall Study||75||
59539377|NCT00819182|75637661|FG001|COMPLETED|Overall Study||78||
59539378|NCT00819182|75637662|FG002|COMPLETED|Overall Study||43||
59539379|NCT00819182|75637660|FG000|NOT COMPLETED|Overall Study||13||
59539380|NCT00819182|75637661|FG001|NOT COMPLETED|Overall Study||8||
59539381|NCT00819182|75637662|FG002|NOT COMPLETED|Overall Study||1||
59539382|NCT01497665|75637670|FG000|STARTED|Overall Study||16||
59539383|NCT01497665|75637670|FG000|Completed Effifcacy Assessment|Overall Study|Number of patients who completed efficacy assessment with CNS lesions per Overall RECIST 1.1.|10||
59539384|NCT01497665|75637670|FG000|COMPLETED|Overall Study||16||
59539385|NCT01497665|75637670|FG000|NOT COMPLETED|Overall Study||0||
59539386|NCT00819260|75637674|FG000|STARTED|Overall Study||31||
59625543|NCT00766116|75738141|FG000|NOT COMPLETED|Overall Study||0||
59625544|NCT00767364|75738150|FG000|STARTED|Overall Study||5||
59625545|NCT00767364|75738151|FG001|STARTED|Overall Study||3||
59625546|NCT00767364|75738150|FG000|COMPLETED|Overall Study||5||
59625547|NCT00767364|75738151|FG001|COMPLETED|Overall Study||3||
59625548|NCT00767364|75738150|FG000|NOT COMPLETED|Overall Study||0||
59625549|NCT00767364|75738151|FG001|NOT COMPLETED|Overall Study||0||
59625550|NCT00769314|75738159|FG000|STARTED|Overall Study|The number of participants started is defined as those that were randomized and received treatment.|378||
59625551|NCT00769314|75738160|FG001|STARTED|Overall Study|The number of participants started is defined as those that were randomized and received treatment.|397||
59625552|NCT00769314|75738159|FG000|COMPLETED|Overall Study||361||
59625553|NCT00769314|75738160|FG001|COMPLETED|Overall Study||384||
59625554|NCT00769314|75738159|FG000|NOT COMPLETED|Overall Study||17||
59625555|NCT00769314|75738160|FG001|NOT COMPLETED|Overall Study||13||
59625556|NCT00769392|75738166|FG000|STARTED|Overall Study||28||
59625557|NCT00769392|75738166|FG000|COMPLETED|Overall Study||24||
59625558|NCT00769392|75738166|FG000|NOT COMPLETED|Overall Study||4||
59625559|NCT00770874|75738172|FG000|STARTED|Overall Study||188||
59625560|NCT00770874|75738173|FG001|STARTED|Overall Study||176||
59625561|NCT00770874|75738172|FG000|COMPLETED|Overall Study||188||
59625562|NCT00770874|75738173|FG001|COMPLETED|Overall Study||176||
59625563|NCT00770874|75738172|FG000|NOT COMPLETED|Overall Study||0||
59625564|NCT00770874|75738173|FG001|NOT COMPLETED|Overall Study||0||
59625565|NCT00771264|75738181|FG000|STARTED|Overall Study||110||
59625566|NCT00771264|75738182|FG001|STARTED|Overall Study||110||
59625567|NCT00771264|75738181|FG000|COMPLETED|Overall Study||103||
59625568|NCT00771264|75738182|FG001|COMPLETED|Overall Study||105||
59625569|NCT00771264|75738181|FG000|NOT COMPLETED|Overall Study||7||
59625570|NCT00771264|75738182|FG001|NOT COMPLETED|Overall Study||5||
59625571|NCT00772590|75738192|FG000|STARTED|Overall Study||19||
59625572|NCT00772590|75738193|FG001|STARTED|Overall Study||19||
59625573|NCT00772590|75738194|FG002|STARTED|Overall Study||18||
59625574|NCT00772590|75738195|FG003|STARTED|Overall Study||17||
59625575|NCT00772590|75738192|FG000|COMPLETED|Overall Study||19||
59625576|NCT00772590|75738193|FG001|COMPLETED|Overall Study||19||
59625577|NCT00772590|75738194|FG002|COMPLETED|Overall Study||18||
59625578|NCT00772590|75738195|FG003|COMPLETED|Overall Study||17||
59625579|NCT00772590|75738192|FG000|NOT COMPLETED|Overall Study||0||
59625580|NCT00772590|75738193|FG001|NOT COMPLETED|Overall Study||0||
59625581|NCT00772590|75738194|FG002|NOT COMPLETED|Overall Study||0||
59625582|NCT00772590|75738195|FG003|NOT COMPLETED|Overall Study||0||
59625583|NCT00773370|75738207|FG000|STARTED|Overall Study||43||
59625584|NCT00773370|75738208|FG001|STARTED|Overall Study||33||
59625585|NCT00773370|75738207|FG000|COMPLETED|Overall Study||25||
59625586|NCT00773370|75738208|FG001|COMPLETED|Overall Study||23||
59625587|NCT00773370|75738207|FG000|NOT COMPLETED|Overall Study||18||
59625588|NCT00773370|75738208|FG001|NOT COMPLETED|Overall Study||10||
59625589|NCT00773604|75738214|FG000|STARTED|Overall Study||9||
59625590|NCT00773604|75738214|FG000|COMPLETED|Overall Study||9||
59625591|NCT00773604|75738214|FG000|NOT COMPLETED|Overall Study||0||
59625592|NCT00775944|75738222|FG000|STARTED|Overall Study||648||
59625593|NCT00775944|75738223|FG001|STARTED|Overall Study||647||
59625594|NCT00775944|75738224|FG002|STARTED|Overall Study||648||
59625595|NCT00775944|75738225|FG003|STARTED|Overall Study||648||
59625596|NCT00775944|75738222|FG000|COMPLETED|Overall Study|15 participants withdrew consent|633||
59625597|NCT00775944|75738223|FG001|COMPLETED|Overall Study|9 participants withdrew consent|638||
59625598|NCT00775944|75738224|FG002|COMPLETED|Overall Study|16 participants withdrew consent|632||
59625599|NCT00775944|75738225|FG003|COMPLETED|Overall Study|16 participants withdrew consent|632||
59625600|NCT00775944|75738222|FG000|NOT COMPLETED|Overall Study||15||
59625601|NCT00775944|75738223|FG001|NOT COMPLETED|Overall Study||9||
59539387|NCT00819260|75637674|FG000|COMPLETED|Overall Study||31||
59539388|NCT00819260|75637674|FG000|NOT COMPLETED|Overall Study||0||
59539389|NCT01379183|75637682|FG000|STARTED|Overall Study||19||
59539390|NCT01379183|75637683|FG001|STARTED|Overall Study||21||
59539391|NCT01379183|75637682|FG000|COMPLETED|Overall Study||19||
59539392|NCT01379183|75637683|FG001|COMPLETED|Overall Study||21||
59625602|NCT00775944|75738224|FG002|NOT COMPLETED|Overall Study||16||
59539393|NCT01379183|75637682|FG000|NOT COMPLETED|Overall Study||0||
59625603|NCT00775944|75738225|FG003|NOT COMPLETED|Overall Study||16||
59539394|NCT01379183|75637683|FG001|NOT COMPLETED|Overall Study||0||
59539395|NCT01333436|75637693|FG000|STARTED|Overall Study||43||
59539396|NCT01333436|75637694|FG001|STARTED|Overall Study||50||
59539397|NCT01333436|75637693|FG000|COMPLETED|Overall Study||43||
59539398|NCT01333436|75637694|FG001|COMPLETED|Overall Study||50||
59539399|NCT01333436|75637693|FG000|NOT COMPLETED|Overall Study||0||
59539400|NCT01333436|75637694|FG001|NOT COMPLETED|Overall Study||0||
59539401|NCT01379651|75637702|FG000|STARTED|Overall Study||10||
59539402|NCT01379651|75637703|FG001|STARTED|Overall Study||10||
59539403|NCT01379651|75637702|FG000|COMPLETED|Overall Study||10||
59625604|NCT00780234|75738237|FG000|STARTED|Overall Study||47||
59625605|NCT00780234|75738238|FG001|STARTED|Overall Study||45||
59625606|NCT00780234|75738237|FG000|COMPLETED|Overall Study||39||
59625607|NCT00780234|75738238|FG001|COMPLETED|Overall Study||37||
59625608|NCT00780234|75738237|FG000|NOT COMPLETED|Overall Study||8||
59625609|NCT00780234|75738238|FG001|NOT COMPLETED|Overall Study||8||
59625610|NCT00781950|75738246|FG000|STARTED|Overall Study||52||
59625611|NCT00781950|75738247|FG001|STARTED|Overall Study||58||
59625612|NCT00781950|75738246|FG000|COMPLETED|Overall Study||41||
59625613|NCT00781950|75738247|FG001|COMPLETED|Overall Study||45||
59625614|NCT00781950|75738246|FG000|NOT COMPLETED|Overall Study||11||
59625615|NCT00781950|75738247|FG001|NOT COMPLETED|Overall Study||13||
59625616|NCT00784524|75738254|FG000|STARTED|Overall Study||14||
59625617|NCT00784524|75738254|FG000|COMPLETED|Overall Study||14||
59625618|NCT00784524|75738254|FG000|NOT COMPLETED|Overall Study||0||
59625619|NCT00785772|75738258|FG000|STARTED|Overall Study||1||
59625620|NCT00785772|75738258|FG000|COMPLETED|Overall Study||1||
59625621|NCT00785772|75738258|FG000|NOT COMPLETED|Overall Study||0||
59625622|NCT00787020|75738264|FG000|STARTED|Overall Study||24||
59625623|NCT00787020|75738265|FG001|STARTED|Overall Study||13||
59625624|NCT00787020|75738264|FG000|COMPLETED|Overall Study||24||
59625625|NCT00787020|75738265|FG001|COMPLETED|Overall Study||13||
59625626|NCT00787020|75738264|FG000|NOT COMPLETED|Overall Study||0||
59625627|NCT00787020|75738265|FG001|NOT COMPLETED|Overall Study||0||
59625628|NCT00787332|75738273|FG000|STARTED|Overall Study||8||
59625629|NCT00787332|75738274|FG001|STARTED|Overall Study||8||
59625630|NCT00787332|75738273|FG000|COMPLETED|Overall Study||8||
59625631|NCT00787332|75738274|FG001|COMPLETED|Overall Study||8||
59625632|NCT00787332|75738273|FG000|NOT COMPLETED|Overall Study||0||
59625633|NCT00787332|75738274|FG001|NOT COMPLETED|Overall Study||0||
59625634|NCT00787722|75738280|FG000|STARTED|Overall Study||13||
59625635|NCT00787722|75738280|FG000|COMPLETED|Overall Study||12||
59625636|NCT00787722|75738280|FG000|NOT COMPLETED|Overall Study||1||
59625637|NCT00788892|75738287|FG000|STARTED|Overall Study||85||
59625638|NCT00788892|75738288|FG001|STARTED|Overall Study||41||
59625639|NCT00788892|75738287|FG000|COMPLETED|Overall Study||36||
59625640|NCT00788892|75738288|FG001|COMPLETED|Overall Study||18||
59625641|NCT00788892|75738287|FG000|NOT COMPLETED|Overall Study||49||
59625642|NCT00788892|75738288|FG001|NOT COMPLETED|Overall Study||23||
59625643|NCT00789438|75738297|FG000|STARTED|Overall Study||21||
59625644|NCT00789438|75738298|FG001|STARTED|Overall Study||20||
59625645|NCT00789438|75738299|FG002|STARTED|Overall Study||28||
59625646|NCT00789438|75738297|FG000|COMPLETED|Overall Study||21||
59625647|NCT00789438|75738298|FG001|COMPLETED|Overall Study||20||
59625648|NCT00789438|75738299|FG002|COMPLETED|Overall Study||28||
59625649|NCT00789438|75738297|FG000|NOT COMPLETED|Overall Study||0||
59625650|NCT00789438|75738298|FG001|NOT COMPLETED|Overall Study||0||
59625651|NCT00789438|75738299|FG002|NOT COMPLETED|Overall Study||0||
59625652|NCT00789672|75738309|FG000|STARTED|Overall Study||16||
59625653|NCT00789672|75738310|FG001|STARTED|Overall Study||17||
59625654|NCT00789672|75738309|FG000|COMPLETED|Overall Study||16||
59625655|NCT00789672|75738310|FG001|COMPLETED|Overall Study||17||
59625656|NCT00789672|75738309|FG000|NOT COMPLETED|Overall Study||0||
59625657|NCT00789672|75738310|FG001|NOT COMPLETED|Overall Study||0||
59625658|NCT00789750|75738318|FG000|STARTED|Overall Study||280||
59815606|NCT04382911|75938051|FG000|COMPLETED|Overall Study||6||
59625659|NCT00789750|75738319|FG001|STARTED|Overall Study||282||
59625660|NCT00789750|75738318|FG000|Dropped During run-in Period|Overall Study||6||
59625661|NCT00789750|75738319|FG001|Dropped During run-in Period|Overall Study||5||
59625662|NCT00789750|75738318|FG000|Safety Set|Overall Study||274||
59625663|NCT00789750|75738319|FG001|Safety Set|Overall Study||277||
59625664|NCT00789750|75738318|FG000|Intent to Treat Set|Overall Study||271||
59625665|NCT00789750|75738319|FG001|Intent to Treat Set|Overall Study||276||
59625666|NCT00789750|75738318|FG000|COMPLETED|Overall Study||221||
59625667|NCT00789750|75738319|FG001|COMPLETED|Overall Study||222||
59625668|NCT00789750|75738318|FG000|NOT COMPLETED|Overall Study||59||
59625669|NCT00789750|75738319|FG001|NOT COMPLETED|Overall Study||60||
59625670|NCT00790062|75738328|FG000|STARTED|Overall Study||659||
59625671|NCT00790062|75738329|FG001|STARTED|Overall Study||481||
59625672|NCT00790062|75738330|FG002|STARTED|Overall Study||658||
59625673|NCT00790062|75738328|FG000|COMPLETED|Overall Study||659||
59625674|NCT00790062|75738329|FG001|COMPLETED|Overall Study||481||
59625675|NCT00790062|75738330|FG002|COMPLETED|Overall Study||658||
59625676|NCT00790062|75738328|FG000|NOT COMPLETED|Overall Study||0||
59625677|NCT00790062|75738329|FG001|NOT COMPLETED|Overall Study||0||
59625678|NCT00790062|75738330|FG002|NOT COMPLETED|Overall Study||0||
59625679|NCT00793572|75738347|FG000|STARTED|Overall Study||32||
59815607|NCT04382911|75938051|FG000|NOT COMPLETED|Overall Study||2||
59625680|NCT00793572|75738347|FG000|COMPLETED|Overall Study||32||
59625681|NCT00793572|75738347|FG000|NOT COMPLETED|Overall Study||0||
59625682|NCT00793650|75738353|FG000|STARTED|Overall Study||19||
59625683|NCT00793650|75738354|FG001|STARTED|Overall Study||20||
59625684|NCT00793650|75738353|FG000|COMPLETED|Overall Study||19||
59625685|NCT00793650|75738354|FG001|COMPLETED|Overall Study||20||
59625686|NCT00793650|75738353|FG000|NOT COMPLETED|Overall Study||0||
59625687|NCT00793650|75738354|FG001|NOT COMPLETED|Overall Study||0||
59625688|NCT00794508|75738362|FG000|STARTED|Overall Study||10||
59625689|NCT00794508|75738362|FG000|COMPLETED|Overall Study||10||
59625690|NCT00794508|75738362|FG000|NOT COMPLETED|Overall Study||0||
59625691|NCT00795210|75738369|FG000|STARTED|Overall Study||8||
59625692|NCT00795210|75738370|FG001|STARTED|Overall Study||12||
59625693|NCT00795210|75738371|FG002|STARTED|Overall Study||5||
59625694|NCT00795210|75738369|FG000|COMPLETED|Overall Study||8||
59625695|NCT00795210|75738370|FG001|COMPLETED|Overall Study||11||
59625696|NCT00795210|75738371|FG002|COMPLETED|Overall Study||3||
59625697|NCT00795210|75738369|FG000|NOT COMPLETED|Overall Study||0||
59625698|NCT00795210|75738370|FG001|NOT COMPLETED|Overall Study||1||
59625699|NCT00795210|75738371|FG002|NOT COMPLETED|Overall Study||2||
59625700|NCT00795288|75738381|FG000|STARTED|Overall Study||21||
59625701|NCT00795288|75738382|FG001|STARTED|Overall Study||21||
59625702|NCT00795288|75738381|FG000|COMPLETED|Overall Study||21||
59625703|NCT00795288|75738382|FG001|COMPLETED|Overall Study||21||
59625704|NCT00795288|75738381|FG000|NOT COMPLETED|Overall Study||0||
59625705|NCT00795288|75738382|FG001|NOT COMPLETED|Overall Study||0||
59625706|NCT00795366|75738392|FG000|STARTED|Overall Study||42||
59625707|NCT00795366|75738393|FG001|STARTED|Overall Study||54||
59625708|NCT00795366|75738392|FG000|COMPLETED|Overall Study||42||
59625709|NCT00795366|75738393|FG001|COMPLETED|Overall Study||54||
59625710|NCT00795366|75738392|FG000|NOT COMPLETED|Overall Study||0||
59625711|NCT00795366|75738393|FG001|NOT COMPLETED|Overall Study||0||
59625712|NCT00796302|75738401|FG000|STARTED|Overall Study||84||
59625713|NCT00796302|75738402|FG001|STARTED|Overall Study||84||
59625714|NCT00796302|75738401|FG000|COMPLETED|Overall Study||71||
59625715|NCT00796302|75738402|FG001|COMPLETED|Overall Study||66||
59625716|NCT00796302|75738401|FG000|NOT COMPLETED|Overall Study||13||
59625717|NCT00796302|75738402|FG001|NOT COMPLETED|Overall Study||18||
59625718|NCT00796926|75738411|FG000|STARTED|Overall Study||15||
59625719|NCT00796926|75738412|FG001|STARTED|Overall Study||15||
59625720|NCT00796926|75738411|FG000|COMPLETED|Overall Study||14||
59625721|NCT00796926|75738412|FG001|COMPLETED|Overall Study||15||
59625722|NCT00796926|75738411|FG000|NOT COMPLETED|Overall Study||1||
59625723|NCT00796926|75738412|FG001|NOT COMPLETED|Overall Study||0||
59625724|NCT00798018|75738422|FG000|STARTED|Overall Study||25||
59625725|NCT00798018|75738423|FG001|STARTED|Overall Study||25||
59625726|NCT00798018|75738424|FG002|STARTED|Overall Study||25||
59625727|NCT00798018|75738425|FG003|STARTED|Overall Study||25||
59625728|NCT00798018|75738422|FG000|COMPLETED|Overall Study||25||
59625729|NCT00798018|75738423|FG001|COMPLETED|Overall Study||25||
59625730|NCT00798018|75738424|FG002|COMPLETED|Overall Study||25||
59625731|NCT00798018|75738425|FG003|COMPLETED|Overall Study||25||
59625732|NCT00798018|75738422|FG000|NOT COMPLETED|Overall Study||0||
59625733|NCT00798018|75738423|FG001|NOT COMPLETED|Overall Study||0||
59625734|NCT00798018|75738424|FG002|NOT COMPLETED|Overall Study||0||
59625735|NCT00798018|75738425|FG003|NOT COMPLETED|Overall Study||0||
59625736|NCT00798486|75738435|FG000|STARTED|Overall Study||110||
59625737|NCT00798486|75738435|FG000|COMPLETED|Overall Study||110||
59625738|NCT00798486|75738435|FG000|NOT COMPLETED|Overall Study||0||
59625739|NCT00798720|75738439|FG000|STARTED|Overall Study||18||
59625740|NCT00798720|75738439|FG000|COMPLETED|Overall Study||18||
59625741|NCT00798720|75738439|FG000|NOT COMPLETED|Overall Study||0||
59625742|NCT00799578|75738443|FG000|STARTED|Overall Study||13||
59625743|NCT00799578|75738443|FG000|COMPLETED|Overall Study||11||
59625744|NCT00799578|75738443|FG000|NOT COMPLETED|Overall Study||2||
59625745|NCT00799812|75738447|FG000|STARTED|Overall Study||335||1324
59625746|NCT00799812|75738447|FG000|CHG Swabstick (3 @ Once)|Overall Study||139||276
59625747|NCT00799812|75738447|FG000|CHG Swabstick Sequential|Overall Study||138||273
59625748|NCT00799812|75738447|FG000|Hibiclens|Overall Study||133||264
59625749|NCT00799812|75738447|FG000|Sterile Water Swab (3 @ Once)|Overall Study||132||260
59625750|NCT00799812|75738447|FG000|Sterile Water Swabstick (Sequential)|Overall Study||126||251
59625751|NCT00799812|75738447|FG000|COMPLETED|Overall Study||335||1324
59625752|NCT00799812|75738447|FG000|NOT COMPLETED|Overall Study||0||0
59625753|NCT00801138|75738463|FG000|STARTED|Overall Study||54||
59625754|NCT00801138|75738464|FG001|STARTED|Overall Study||56||
59625755|NCT00801138|75738465|FG002|STARTED|Overall Study||54||
59625756|NCT00801138|75738466|FG003|STARTED|Overall Study||54||
59625757|NCT00801138|75738463|FG000|COMPLETED|Overall Study||54||
59625758|NCT00801138|75738464|FG001|COMPLETED|Overall Study||56||
59625759|NCT00801138|75738465|FG002|COMPLETED|Overall Study||54||
59625760|NCT00801138|75738466|FG003|COMPLETED|Overall Study||54||
59625761|NCT00801138|75738463|FG000|NOT COMPLETED|Overall Study||0||
59625762|NCT00801138|75738464|FG001|NOT COMPLETED|Overall Study||0||
59625763|NCT00801138|75738465|FG002|NOT COMPLETED|Overall Study||0||
59625764|NCT00801138|75738466|FG003|NOT COMPLETED|Overall Study||0||
59625765|NCT00801684|75738476|FG000|STARTED|Overall Study||24||
59625766|NCT00801684|75738476|FG000|COMPLETED|Overall Study||24||
59539404|NCT01379651|75637703|FG001|COMPLETED|Overall Study||10||
59539405|NCT01379651|75637702|FG000|NOT COMPLETED|Overall Study||0||
59539406|NCT01379651|75637703|FG001|NOT COMPLETED|Overall Study||0||
59539407|NCT01379963|75637709|FG000|STARTED|Overall Study||780||
59539408|NCT01379963|75637709|FG000|COMPLETED|Overall Study||780||
59539409|NCT01379963|75637709|FG000|NOT COMPLETED|Overall Study||0||
59539410|NCT01380197|75637715|FG000|STARTED|Overall Study||20||
59539411|NCT01380197|75637716|FG001|STARTED|Overall Study||20||
59539412|NCT01380197|75637715|FG000|COMPLETED|Overall Study||20||
59539413|NCT01380197|75637716|FG001|COMPLETED|Overall Study||20||
59539414|NCT01380197|75637715|FG000|NOT COMPLETED|Overall Study||0||
59539415|NCT01380197|75637716|FG001|NOT COMPLETED|Overall Study||0||
59539416|NCT00862784|75637722|FG000|STARTED|Overall Study||48||
59539417|NCT00862784|75637722|FG000|Received Any Amount of Study Drug|Overall Study||48||
59539418|NCT00862784|75637722|FG000|COMPLETED|Overall Study||48||
59539419|NCT00862784|75637722|FG000|NOT COMPLETED|Overall Study||0||
59539420|NCT00864032|75637726|FG000|STARTED|Overall Study||3||
59539421|NCT00864032|75637727|FG001|STARTED|Overall Study||5||
59539422|NCT00864032|75637728|FG002|STARTED|Overall Study||0||
59539423|NCT00864032|75637726|FG000|COMPLETED|Overall Study||3||
59539424|NCT00864032|75637727|FG001|COMPLETED|Overall Study||5||
59539425|NCT00864032|75637728|FG002|COMPLETED|Overall Study||0||
59539426|NCT00864032|75637726|FG000|NOT COMPLETED|Overall Study||0||
59539427|NCT00864032|75637727|FG001|NOT COMPLETED|Overall Study||0||
59539428|NCT00864032|75637728|FG002|NOT COMPLETED|Overall Study||0||
59539429|NCT00820664|75637737|FG000|STARTED|Overall Study||9||
59539430|NCT00820664|75637738|FG001|STARTED|Overall Study||11||
59539431|NCT00820664|75637739|FG002|STARTED|Overall Study||9||
59539432|NCT00820664|75637737|FG000|COMPLETED|Overall Study||9||
59539433|NCT00820664|75637738|FG001|COMPLETED|Overall Study||11||
59815608|NCT04364386|75938055|FG000|STARTED|Overall Study||10||
59815609|NCT04364386|75938055|FG000|COMPLETED|Overall Study||10||
59815610|NCT04364386|75938055|FG000|NOT COMPLETED|Overall Study||0||
59815611|NCT04072575|75938059|FG000|STARTED|Overall Study||178||
59815612|NCT04072575|75938059|FG000|COMPLETED|Overall Study||154||
59815613|NCT04072575|75938059|FG000|NOT COMPLETED|Overall Study||24||
59539434|NCT00820664|75637739|FG002|COMPLETED|Overall Study||9||
59539435|NCT00820664|75637737|FG000|NOT COMPLETED|Overall Study||0||
59539436|NCT00820664|75637738|FG001|NOT COMPLETED|Overall Study||0||
59539437|NCT00820664|75637739|FG002|NOT COMPLETED|Overall Study||0||
59539438|NCT01380743|75637751|FG000|STARTED|Overall Study||6||
59539439|NCT01380743|75637752|FG001|STARTED|Overall Study||6||
59539440|NCT01380743|75637753|FG002|STARTED|Overall Study||6||
59539441|NCT01380743|75637754|FG003|STARTED|Overall Study||7||
59539442|NCT01380743|75637751|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6||
59539443|NCT01380743|75637752|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6||
59539444|NCT01380743|75637753|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6||
59539445|NCT01380743|75637754|FG003|Received at Least 1 Dose of Study Drug|Overall Study||7||
59539446|NCT01380743|75637751|FG000|COMPLETED|Overall Study||6||
59539447|NCT01380743|75637752|FG001|COMPLETED|Overall Study||6||
59539448|NCT01380743|75637753|FG002|COMPLETED|Overall Study||6||
59539449|NCT01380743|75637754|FG003|COMPLETED|Overall Study||7||
59539450|NCT01380743|75637751|FG000|NOT COMPLETED|Overall Study||0||
59539451|NCT01380743|75637752|FG001|NOT COMPLETED|Overall Study||0||
59539452|NCT01380743|75637753|FG002|NOT COMPLETED|Overall Study||0||
59539453|NCT01380743|75637754|FG003|NOT COMPLETED|Overall Study||0||
59539454|NCT01380899|75637767|FG000|STARTED|Overall Study||34||
59539455|NCT01380899|75637768|FG001|STARTED|Overall Study||33||
59539456|NCT01380899|75637769|FG002|STARTED|Overall Study||20||
59815614|NCT03911869|75938065|FG000|STARTED|Safety Lead-in Phase||10||
59815615|NCT03911869|75938066|FG001|STARTED|Safety Lead-in Phase||0||
59539457|NCT01380899|75637767|FG000|COMPLETED|Overall Study||34||
59539458|NCT01380899|75637768|FG001|COMPLETED|Overall Study||33||
59539459|NCT01380899|75637769|FG002|COMPLETED|Overall Study||20||
59625767|NCT00801684|75738476|FG000|NOT COMPLETED|Overall Study||0||
59625768|NCT00802854|75738493|FG000|STARTED|Overall Study||244||
59625769|NCT00802854|75738493|FG000|COMPLETED|Overall Study||244||
59625770|NCT00802854|75738493|FG000|NOT COMPLETED|Overall Study||0||
59815616|NCT03911869|75938067|FG002|STARTED|Safety Lead-in Phase|High dose was not determined safe, hence no participants randomized into this arm.|0||
59815617|NCT03911869|75938065|FG000|COMPLETED|Safety Lead-in Phase||0||
59539460|NCT01380899|75637767|FG000|NOT COMPLETED|Overall Study||0||
59539461|NCT01380899|75637768|FG001|NOT COMPLETED|Overall Study||0||
59539462|NCT01380899|75637769|FG002|NOT COMPLETED|Overall Study||0||
59539463|NCT01498601|75637779|FG000|STARTED|Overall Study||51||
59539464|NCT01498601|75637780|FG001|STARTED|Overall Study||32||
59539465|NCT01498601|75637779|FG000|COMPLETED|Overall Study||51||
59539466|NCT01498601|75637780|FG001|COMPLETED|Overall Study||32||
59539467|NCT01498601|75637779|FG000|NOT COMPLETED|Overall Study||0||
59539468|NCT01498601|75637780|FG001|NOT COMPLETED|Overall Study||0||
59539469|NCT01419977|75637788|FG000|STARTED|Overall Study||16||
59539470|NCT01419977|75637789|FG001|STARTED|Overall Study||13||
59539471|NCT01419977|75637788|FG000|COMPLETED|Overall Study||16||
59539472|NCT01419977|75637789|FG001|COMPLETED|Overall Study||13||
59625771|NCT00803010|75738499|FG000|STARTED|Overall Study||37||
59625772|NCT00803010|75738500|FG001|STARTED|Overall Study||37||
59625773|NCT00803010|75738499|FG000|COMPLETED|Overall Study||37||
59625774|NCT00803010|75738500|FG001|COMPLETED|Overall Study||37||
59625775|NCT00803010|75738499|FG000|NOT COMPLETED|Overall Study||0||
59625776|NCT00803010|75738500|FG001|NOT COMPLETED|Overall Study||0||
59625777|NCT00803400|75738508|FG000|STARTED|Overall Study||75||
59625778|NCT00803400|75738509|FG001|STARTED|Overall Study||75||
59625779|NCT00803400|75738508|FG000|COMPLETED|Overall Study||55||
59625780|NCT00803400|75738509|FG001|COMPLETED|Overall Study||51||
59625781|NCT00803400|75738508|FG000|NOT COMPLETED|Overall Study||20||
59625782|NCT00803400|75738509|FG001|NOT COMPLETED|Overall Study||24||
59625783|NCT00804648|75738516|FG000|STARTED|First Intervention||3||
59625784|NCT00804648|75738517|FG001|STARTED|First Intervention||5||
59625785|NCT00804648|75738518|FG002|STARTED|First Intervention||6||
59625786|NCT00804648|75738519|FG003|STARTED|First Intervention||4||
59625787|NCT00804648|75738520|FG004|STARTED|First Intervention||4||
59625788|NCT00804648|75738521|FG005|STARTED|First Intervention||8||
59625789|NCT00804648|75738516|FG000|COMPLETED|First Intervention||3||
59625790|NCT00804648|75738517|FG001|COMPLETED|First Intervention||5||
59625791|NCT00804648|75738518|FG002|COMPLETED|First Intervention||6||
59625792|NCT00804648|75738519|FG003|COMPLETED|First Intervention||4||
59625793|NCT00804648|75738520|FG004|COMPLETED|First Intervention||4||
59625794|NCT00804648|75738521|FG005|COMPLETED|First Intervention||8||
59625795|NCT00804648|75738516|FG000|NOT COMPLETED|First Intervention||0||
59625796|NCT00804648|75738517|FG001|NOT COMPLETED|First Intervention||0||
59625797|NCT00804648|75738518|FG002|NOT COMPLETED|First Intervention||0||
59625798|NCT00804648|75738519|FG003|NOT COMPLETED|First Intervention||0||
59625799|NCT00804648|75738520|FG004|NOT COMPLETED|First Intervention||0||
59625800|NCT00804648|75738521|FG005|NOT COMPLETED|First Intervention||0||
59625801|NCT00804648|75738516|FG000|STARTED|Second Intervention||3||
59625802|NCT00804648|75738517|FG001|STARTED|Second Intervention||5||
59815618|NCT03911869|75938066|FG001|COMPLETED|Safety Lead-in Phase||0||
59815619|NCT03911869|75938067|FG002|COMPLETED|Safety Lead-in Phase||0||
59815620|NCT03911869|75938065|FG000|NOT COMPLETED|Safety Lead-in Phase||10||
59815621|NCT03911869|75938066|FG001|NOT COMPLETED|Safety Lead-in Phase||0||
59815622|NCT03911869|75938067|FG002|NOT COMPLETED|Safety Lead-in Phase||0||
59815623|NCT03911869|75938065|FG000|STARTED|Phase 2||0||
59815624|NCT03911869|75938066|FG001|STARTED|Phase 2|Participants entered in Phase 2 were included in this period.|3||
59815625|NCT03911869|75938067|FG002|STARTED|Phase 2||0||
59625803|NCT00804648|75738518|FG002|STARTED|Second Intervention||6||
59625804|NCT00804648|75738519|FG003|STARTED|Second Intervention||4||
59625805|NCT00804648|75738520|FG004|STARTED|Second Intervention||4||
59625806|NCT00804648|75738521|FG005|STARTED|Second Intervention||8||
59625807|NCT00804648|75738516|FG000|COMPLETED|Second Intervention||3||
59625808|NCT00804648|75738517|FG001|COMPLETED|Second Intervention||5||
59625809|NCT00804648|75738518|FG002|COMPLETED|Second Intervention||6||
59625810|NCT00804648|75738519|FG003|COMPLETED|Second Intervention||4||
59625811|NCT00804648|75738520|FG004|COMPLETED|Second Intervention||4||
59625812|NCT00804648|75738521|FG005|COMPLETED|Second Intervention||8||
59625813|NCT00804648|75738516|FG000|NOT COMPLETED|Second Intervention||0||
59625814|NCT00804648|75738517|FG001|NOT COMPLETED|Second Intervention||0||
59625815|NCT00804648|75738518|FG002|NOT COMPLETED|Second Intervention||0||
59625816|NCT00804648|75738519|FG003|NOT COMPLETED|Second Intervention||0||
59625817|NCT00804648|75738520|FG004|NOT COMPLETED|Second Intervention||0||
59625818|NCT00804648|75738521|FG005|NOT COMPLETED|Second Intervention||0||
59625819|NCT00804648|75738516|FG000|STARTED|Third Invervention||3||
59625820|NCT00804648|75738517|FG001|STARTED|Third Invervention||5||
59625821|NCT00804648|75738518|FG002|STARTED|Third Invervention||6||
59625822|NCT00804648|75738519|FG003|STARTED|Third Invervention||4||
59625823|NCT00804648|75738520|FG004|STARTED|Third Invervention||4||
59625824|NCT00804648|75738521|FG005|STARTED|Third Invervention||8||
59625825|NCT00804648|75738516|FG000|COMPLETED|Third Invervention||3||
59625826|NCT00804648|75738517|FG001|COMPLETED|Third Invervention||5||
59625827|NCT00804648|75738518|FG002|COMPLETED|Third Invervention||6||
59625828|NCT00804648|75738519|FG003|COMPLETED|Third Invervention||4||
59625829|NCT00804648|75738520|FG004|COMPLETED|Third Invervention||4||
59625830|NCT00804648|75738521|FG005|COMPLETED|Third Invervention||8||
59625831|NCT00804648|75738516|FG000|NOT COMPLETED|Third Invervention||0||
59625832|NCT00804648|75738517|FG001|NOT COMPLETED|Third Invervention||0||
59625833|NCT00804648|75738518|FG002|NOT COMPLETED|Third Invervention||0||
59625834|NCT00804648|75738519|FG003|NOT COMPLETED|Third Invervention||0||
59625835|NCT00804648|75738520|FG004|NOT COMPLETED|Third Invervention||0||
59625836|NCT00804648|75738521|FG005|NOT COMPLETED|Third Invervention||0||
59625837|NCT00805038|75738531|FG000|STARTED|Overall Study||75||
59625838|NCT00805038|75738532|FG001|STARTED|Overall Study||92||
59625839|NCT00805038|75738531|FG000|COMPLETED|Overall Study||75||
59625840|NCT00805038|75738532|FG001|COMPLETED|Overall Study||92||
59625841|NCT00805038|75738531|FG000|NOT COMPLETED|Overall Study||0||
59625842|NCT00805038|75738532|FG001|NOT COMPLETED|Overall Study||0||
59625843|NCT00806598|75738538|FG000|STARTED|Overall Study||48||
59815626|NCT03911869|75938065|FG000|COMPLETED|Phase 2||0||
59625844|NCT00806598|75738538|FG000|COMPLETED|Overall Study||48||
59625845|NCT00806598|75738538|FG000|NOT COMPLETED|Overall Study||0||
59625846|NCT00806676|75738545|FG000|STARTED|Overall Study||29||
59625847|NCT00806676|75738546|FG001|STARTED|Overall Study||9||
59625848|NCT00806676|75738547|FG002|STARTED|Overall Study||29||
59625849|NCT00806676|75738545|FG000|COMPLETED|Overall Study||25||
59625850|NCT00806676|75738546|FG001|COMPLETED|Overall Study||9||
59625851|NCT00806676|75738547|FG002|COMPLETED|Overall Study||23||
59625852|NCT00806676|75738545|FG000|NOT COMPLETED|Overall Study||4||
59625853|NCT00806676|75738546|FG001|NOT COMPLETED|Overall Study||0||
59625854|NCT00806676|75738547|FG002|NOT COMPLETED|Overall Study||6||
59625855|NCT00807768|75738558|FG000|STARTED|Overall Study||301||
59625856|NCT00807768|75738559|FG001|STARTED|Overall Study||300||
59625857|NCT00807768|75738558|FG000|COMPLETED|Overall Study||301||
59625858|NCT00807768|75738559|FG001|COMPLETED|Overall Study||300||
59625859|NCT00807768|75738558|FG000|NOT COMPLETED|Overall Study||0||
59625860|NCT00807768|75738559|FG001|NOT COMPLETED|Overall Study||0||
59625861|NCT00808470|75738567|FG000|STARTED|Overall Study||37||
59625862|NCT00808470|75738568|FG001|STARTED|Overall Study||35||
59625863|NCT00808470|75738567|FG000|COMPLETED|Overall Study||35||
59625864|NCT00808470|75738568|FG001|COMPLETED|Overall Study||35||
59625865|NCT00808470|75738567|FG000|NOT COMPLETED|Overall Study||2||
59625866|NCT00808470|75738568|FG001|NOT COMPLETED|Overall Study||0||
59625867|NCT00810498|75738578|FG000|STARTED|Overall Study||6||
59625868|NCT00810498|75738579|FG001|STARTED|Overall Study||5||
59625869|NCT00810498|75738578|FG000|COMPLETED|Overall Study||6||
59625870|NCT00810498|75738579|FG001|COMPLETED|Overall Study||5||
59625871|NCT00810498|75738578|FG000|NOT COMPLETED|Overall Study||0||
59625872|NCT00810498|75738579|FG001|NOT COMPLETED|Overall Study||0||
59625873|NCT00810576|75738585|FG000|STARTED|Overall Study||1||
59625874|NCT00810576|75738585|FG000|COMPLETED|Overall Study||1||
59625875|NCT00810576|75738585|FG000|NOT COMPLETED|Overall Study||0||
59625876|NCT00810888|75738592|FG000|STARTED|Overall Study||10||
59625877|NCT00810888|75738593|FG001|STARTED|Overall Study||9||
59625878|NCT00810888|75738594|FG002|STARTED|Overall Study||73||
59988165|NCT02370238|76103276|FG000|Safety Population|Overall Study||61||
59988166|NCT02370238|76103277|FG001|Safety Population|Overall Study||60||
59988167|NCT02370238|76103276|FG000|Responsable-evaluable Population|Overall Study||57||
59988168|NCT02370238|76103277|FG001|Responsable-evaluable Population|Overall Study||54||
59625879|NCT00810888|75738592|FG000|COMPLETED|Overall Study||10||
59625880|NCT00810888|75738593|FG001|COMPLETED|Overall Study||9||
59625881|NCT00810888|75738594|FG002|COMPLETED|Overall Study||73||
59625882|NCT00810888|75738592|FG000|NOT COMPLETED|Overall Study||0||
59625883|NCT00810888|75738593|FG001|NOT COMPLETED|Overall Study||0||
59625884|NCT00810888|75738594|FG002|NOT COMPLETED|Overall Study||0||
59625885|NCT00811434|75738602|FG000|STARTED|First Intervention||7||
59625886|NCT00811434|75738603|FG001|STARTED|First Intervention||5||
59625887|NCT00811434|75738602|FG000|COMPLETED|First Intervention||4||
59625888|NCT00811434|75738603|FG001|COMPLETED|First Intervention||5||
59625889|NCT00811434|75738602|FG000|NOT COMPLETED|First Intervention||3||
59625890|NCT00811434|75738603|FG001|NOT COMPLETED|First Intervention||0||
59625891|NCT00811434|75738602|FG000|STARTED|Washout (1 Month)||4||
59625892|NCT00811434|75738603|FG001|STARTED|Washout (1 Month)||5||
59625893|NCT00811434|75738602|FG000|COMPLETED|Washout (1 Month)||4||
59625894|NCT00811434|75738603|FG001|COMPLETED|Washout (1 Month)||5||
59625895|NCT00811434|75738602|FG000|NOT COMPLETED|Washout (1 Month)||0||
59625896|NCT00811434|75738603|FG001|NOT COMPLETED|Washout (1 Month)||0||
59625897|NCT00811434|75738602|FG000|STARTED|Second Intervention||4||
59625898|NCT00811434|75738603|FG001|STARTED|Second Intervention||5||
59625899|NCT00811434|75738602|FG000|COMPLETED|Second Intervention||4||
59625900|NCT00811434|75738603|FG001|COMPLETED|Second Intervention||5||
59988169|NCT02370238|76103276|FG000|COMPLETED|Overall Study||15||
59988170|NCT02370238|76103277|FG001|COMPLETED|Overall Study||16||
59625901|NCT00811434|75738602|FG000|NOT COMPLETED|Second Intervention||0||
59625902|NCT00811434|75738603|FG001|NOT COMPLETED|Second Intervention||0||
59625903|NCT00812604|75738612|FG000|STARTED|Overall Study||28||
59625904|NCT00812604|75738613|FG001|STARTED|Overall Study||27||
59625905|NCT00812604|75738612|FG000|COMPLETED|Overall Study||23||
59625906|NCT00812604|75738613|FG001|COMPLETED|Overall Study||22||
59625907|NCT00812604|75738612|FG000|NOT COMPLETED|Overall Study||5||
59625908|NCT00812604|75738613|FG001|NOT COMPLETED|Overall Study||5||
59625909|NCT00812838|75738621|FG000|STARTED|Treatment Period of 16 Weeks||6||
59625910|NCT00812838|75738622|FG001|STARTED|Treatment Period of 16 Weeks||6||
59625911|NCT00812838|75738621|FG000|COMPLETED|Treatment Period of 16 Weeks||6||
59625912|NCT00812838|75738622|FG001|COMPLETED|Treatment Period of 16 Weeks||6||
59625913|NCT00812838|75738621|FG000|NOT COMPLETED|Treatment Period of 16 Weeks||0||
59625914|NCT00812838|75738622|FG001|NOT COMPLETED|Treatment Period of 16 Weeks||0||
59625915|NCT00812838|75738621|FG000|STARTED|Optional Crossover of 16 Weeks||0|Optional crossover did not apply to the experimental arm (ARM 1)|
59625916|NCT00812838|75738622|FG001|STARTED|Optional Crossover of 16 Weeks||4|Optional crossover did not apply to the experimental arm (ARM 1)|
59625917|NCT00812838|75738621|FG000|COMPLETED|Optional Crossover of 16 Weeks||0||
59625918|NCT00812838|75738622|FG001|COMPLETED|Optional Crossover of 16 Weeks||4||
59625919|NCT00812838|75738621|FG000|NOT COMPLETED|Optional Crossover of 16 Weeks||0||
59625920|NCT00812838|75738622|FG001|NOT COMPLETED|Optional Crossover of 16 Weeks||0||
59625921|NCT00812916|75738630|FG000|STARTED|Overall Study|206 enrolled (consented)|206||
59625922|NCT00812916|75738630|FG000|Data Available|Overall Study||205||
59625923|NCT00812916|75738630|FG000|CFAE - Guided Ablation|Overall Study||203||
59625924|NCT00812916|75738630|FG000|COMPLETED|Overall Study||203||
59625925|NCT00812916|75738630|FG000|NOT COMPLETED|Overall Study||3||
59625926|NCT00814788|75738636|FG000|STARTED|Overall Study||24||
59625927|NCT00814788|75738636|FG000|COMPLETED|Overall Study||24||
59625928|NCT00814788|75738636|FG000|NOT COMPLETED|Overall Study||0||
59625929|NCT00815490|75738644|FG000|STARTED|Overall Study||9||
59625930|NCT00815490|75738645|FG001|STARTED|Overall Study||9||
59625931|NCT00815490|75738644|FG000|COMPLETED|Overall Study||9||
59625932|NCT00815490|75738645|FG001|COMPLETED|Overall Study||9||
59625933|NCT00815490|75738644|FG000|NOT COMPLETED|Overall Study||0||
59625934|NCT00815490|75738645|FG001|NOT COMPLETED|Overall Study||0||
59625935|NCT00816348|75738651|FG000|STARTED|Overall Study||15||
59625936|NCT00816348|75738651|FG000|COMPLETED|Overall Study||15||
59625937|NCT00816348|75738651|FG000|NOT COMPLETED|Overall Study||0||
59625938|NCT00817596|75738655|FG000|STARTED|Overall Study||110||
59625939|NCT00817596|75738655|FG000|COMPLETED|Overall Study||62||
59625940|NCT00817596|75738655|FG000|NOT COMPLETED|Overall Study||48||
59625941|NCT00820872|75738659|FG000|STARTED|Overall Study||30||
59625942|NCT00820872|75738659|FG000|COMPLETED|Overall Study||30||
59625943|NCT00820872|75738659|FG000|NOT COMPLETED|Overall Study||0||
59625944|NCT00821184|75738665|FG000|STARTED|Overall Study||6||
59625945|NCT00821184|75738666|FG001|STARTED|Overall Study||6||
59625946|NCT00821184|75738665|FG000|COMPLETED|Overall Study||6||
59625947|NCT00821184|75738666|FG001|COMPLETED|Overall Study||6||
59988171|NCT02370238|76103276|FG000|NOT COMPLETED|Overall Study||47||
59625948|NCT00821184|75738665|FG000|NOT COMPLETED|Overall Study||0||
59625949|NCT00821184|75738666|FG001|NOT COMPLETED|Overall Study||0||
59625950|NCT02641236|75738677|FG000|STARTED|Overall Study||10||
59625951|NCT02641236|75738678|FG001|STARTED|Overall Study||10||
59625952|NCT02641236|75738679|FG002|STARTED|Overall Study||4||
59625953|NCT02641236|75738677|FG000|COMPLETED|Overall Study||5||
59625954|NCT02641236|75738678|FG001|COMPLETED|Overall Study||3||
59625955|NCT02641236|75738679|FG002|COMPLETED|Overall Study||4||
59625956|NCT02641236|75738677|FG000|NOT COMPLETED|Overall Study||5||
59625957|NCT02641236|75738678|FG001|NOT COMPLETED|Overall Study||7||
59625958|NCT02641236|75738679|FG002|NOT COMPLETED|Overall Study||0||
59625959|NCT00821886|75738688|FG000|STARTED|Overall Study|Two patients were enrolled, but subsequently found to be ineligible|58||
59625960|NCT00821886|75738688|FG000|COMPLETED|Overall Study||49||
59625961|NCT00821886|75738688|FG000|NOT COMPLETED|Overall Study||9||
59625962|NCT00821964|75738692|FG000|STARTED|Overall Study||15||
59625963|NCT00821964|75738692|FG000|Evaluable for Clinical Response|Overall Study||14||
59625964|NCT00821964|75738692|FG000|Evaluable for Pathologic Response|Overall Study||7||
59625965|NCT00821964|75738692|FG000|COMPLETED|Overall Study||9||
59625966|NCT00821964|75738692|FG000|NOT COMPLETED|Overall Study||6||
59625967|NCT00822354|75738701|FG000|STARTED|First Intervention (28 Days)||5||
59625968|NCT00822354|75738702|FG001|STARTED|First Intervention (28 Days)||5||
59625969|NCT00822354|75738701|FG000|COMPLETED|First Intervention (28 Days)||4||
59625970|NCT00822354|75738702|FG001|COMPLETED|First Intervention (28 Days)||5||
59625971|NCT00822354|75738701|FG000|NOT COMPLETED|First Intervention (28 Days)||1||
59625972|NCT00822354|75738702|FG001|NOT COMPLETED|First Intervention (28 Days)||0||
59625973|NCT00822354|75738701|FG000|STARTED|Washout (7 Days)||4||
59625974|NCT00822354|75738702|FG001|STARTED|Washout (7 Days)||5||
59625975|NCT00822354|75738701|FG000|COMPLETED|Washout (7 Days)||4||
59625976|NCT00822354|75738702|FG001|COMPLETED|Washout (7 Days)||5||
59625977|NCT00822354|75738701|FG000|NOT COMPLETED|Washout (7 Days)||0||
59625978|NCT00822354|75738702|FG001|NOT COMPLETED|Washout (7 Days)||0||
59625979|NCT00822354|75738701|FG000|STARTED|Second Intervention (28 Days)||4||
59625980|NCT00822354|75738702|FG001|STARTED|Second Intervention (28 Days)||5||
59625981|NCT00822354|75738701|FG000|COMPLETED|Second Intervention (28 Days)||3||
59625982|NCT00822354|75738702|FG001|COMPLETED|Second Intervention (28 Days)||5||
59625983|NCT00822354|75738701|FG000|NOT COMPLETED|Second Intervention (28 Days)||1||
59625984|NCT00822354|75738702|FG001|NOT COMPLETED|Second Intervention (28 Days)||0||
59625985|NCT00822510|75738712|FG000|STARTED|Overall Study||38||
59625986|NCT00822510|75738713|FG001|STARTED|Overall Study||41||
59625987|NCT00822510|75738712|FG000|COMPLETED|Overall Study||35||
59625988|NCT00822510|75738713|FG001|COMPLETED|Overall Study||36||
59625989|NCT00822510|75738712|FG000|NOT COMPLETED|Overall Study||3||
59625990|NCT00822510|75738713|FG001|NOT COMPLETED|Overall Study||5||
59625991|NCT00822588|75738723|FG000|STARTED|Overall Study|7 participants excluded before surgery. No baseline data available|113||
59625992|NCT00822588|75738724|FG001|STARTED|Overall Study|4 participants excluded before surgery. No baseline data available|114||
59625993|NCT00822588|75738723|FG000|COMPLETED|Overall Study|APT/ITT analysis set|106||
59625994|NCT00822588|75738724|FG001|COMPLETED|Overall Study|APT/ITT analysis set|110||
59625995|NCT00822588|75738723|FG000|NOT COMPLETED|Overall Study||7||
59625996|NCT00822588|75738724|FG001|NOT COMPLETED|Overall Study||4||
59625997|NCT00824070|75738733|FG000|STARTED|Overall Study||34||
59625998|NCT00824070|75738734|FG001|STARTED|Overall Study||35||
59625999|NCT00824070|75738735|FG002|STARTED|Overall Study||36||
59626000|NCT00824070|75738733|FG000|COMPLETED|Overall Study||34||
59626001|NCT00824070|75738734|FG001|COMPLETED|Overall Study||35||
59626002|NCT00824070|75738735|FG002|COMPLETED|Overall Study||36||
59626003|NCT00824070|75738733|FG000|NOT COMPLETED|Overall Study||0||
59626004|NCT00824070|75738734|FG001|NOT COMPLETED|Overall Study||0||
59626005|NCT00824070|75738735|FG002|NOT COMPLETED|Overall Study||0||
59626006|NCT00824460|75738749|FG000|STARTED|Overall Study||26||
59626007|NCT00824460|75738750|FG001|STARTED|Overall Study||26||
59626008|NCT00824460|75738751|FG002|STARTED|Overall Study||25||
59626009|NCT00824460|75738752|FG003|STARTED|Overall Study||27||
59626010|NCT00824460|75738753|FG004|STARTED|Overall Study||24||
59626011|NCT00824460|75738754|FG005|STARTED|Overall Study||26||
59626012|NCT00824460|75738749|FG000|COMPLETED|Overall Study||18||
59626013|NCT00824460|75738750|FG001|COMPLETED|Overall Study||17||
59626014|NCT00824460|75738751|FG002|COMPLETED|Overall Study||20||
59626015|NCT00824460|75738752|FG003|COMPLETED|Overall Study||15||
59626016|NCT00824460|75738753|FG004|COMPLETED|Overall Study||15||
59626017|NCT00824460|75738754|FG005|COMPLETED|Overall Study||18||
59626018|NCT00824460|75738749|FG000|NOT COMPLETED|Overall Study||8||
59626019|NCT00824460|75738750|FG001|NOT COMPLETED|Overall Study||9||
59626020|NCT00824460|75738751|FG002|NOT COMPLETED|Overall Study||5||
59626021|NCT00824460|75738752|FG003|NOT COMPLETED|Overall Study||12||
59626022|NCT00824460|75738753|FG004|NOT COMPLETED|Overall Study||9||
59626023|NCT00824460|75738754|FG005|NOT COMPLETED|Overall Study||8||
59626024|NCT00824538|75738776|FG000|STARTED|Overall Study|13 patients entered the study|13||
59626025|NCT00824538|75738776|FG000|COMPLETED|Overall Study||11||
59626026|NCT00824538|75738776|FG000|NOT COMPLETED|Overall Study||2||
59626027|NCT00825318|75738781|FG000|STARTED|Overall Study||13||
59626028|NCT00825318|75738781|FG000|COMPLETED|Overall Study||12||
59626029|NCT00825318|75738781|FG000|NOT COMPLETED|Overall Study||1||
59626030|NCT00825786|75738791|FG000|STARTED|Overall Study||52||
59626031|NCT00825786|75738792|FG001|STARTED|Overall Study||51||
59626032|NCT00825786|75738791|FG000|COMPLETED|Overall Study||52||
59626033|NCT00825786|75738792|FG001|COMPLETED|Overall Study||51||
59626034|NCT00825786|75738791|FG000|NOT COMPLETED|Overall Study||0||
59626035|NCT00825786|75738792|FG001|NOT COMPLETED|Overall Study||0||
59626036|NCT00826800|75738798|FG000|STARTED|Overall Study||2||
59626037|NCT00826800|75738798|FG000|COMPLETED|Overall Study||2||
59626038|NCT00826800|75738798|FG000|NOT COMPLETED|Overall Study||0||
59626039|NCT00830076|75738802|FG000|STARTED|Sitagliptin + Placebo Metformin||18||
59988172|NCT02370238|76103277|FG001|NOT COMPLETED|Overall Study||45||
59988173|NCT02370160|76103287|FG000|STARTED|Overall Study||9||
59988174|NCT02370160|76103288|FG001|STARTED|Overall Study||6||
59988175|NCT02370160|76103289|FG002|STARTED|Overall Study||3||
59988176|NCT02370160|76103287|FG000|COMPLETED|Overall Study||6||
59988177|NCT02370160|76103288|FG001|COMPLETED|Overall Study||2||
59626040|NCT00830076|75738802|FG000|COMPLETED|Sitagliptin + Placebo Metformin||18||
59626041|NCT00830076|75738802|FG000|NOT COMPLETED|Sitagliptin + Placebo Metformin||0||
59626042|NCT00830076|75738802|FG000|STARTED|7-day Washout||18||
59626043|NCT00830076|75738802|FG000|COMPLETED|7-day Washout||18||
59626044|NCT00830076|75738802|FG000|NOT COMPLETED|7-day Washout||0||
59626045|NCT00830076|75738802|FG000|STARTED|Metformin + Placebo Sitagliptin||18||
59626046|NCT00830076|75738802|FG000|COMPLETED|Metformin + Placebo Sitagliptin||18||
59626047|NCT00830076|75738802|FG000|NOT COMPLETED|Metformin + Placebo Sitagliptin||0||
59626048|NCT00830076|75738802|FG000|STARTED|7-day Washout||18||
59626049|NCT00830076|75738802|FG000|COMPLETED|7-day Washout||18||
59626050|NCT00830076|75738802|FG000|NOT COMPLETED|7-day Washout||0||
59626051|NCT00830076|75738802|FG000|STARTED|Sitagliptin + Metformin||18||
59626052|NCT00830076|75738802|FG000|COMPLETED|Sitagliptin + Metformin||18||
59626053|NCT00830076|75738802|FG000|NOT COMPLETED|Sitagliptin + Metformin||0||
59626054|NCT00830076|75738802|FG000|STARTED|7-day Washout||18||
59626055|NCT00830076|75738802|FG000|COMPLETED|7-day Washout||18||
59626056|NCT00830076|75738802|FG000|NOT COMPLETED|7-day Washout||0||
59626057|NCT00830076|75738802|FG000|STARTED|Placebo Sitagliptin + Placebo Metformin||18||
59626058|NCT00830076|75738802|FG000|COMPLETED|Placebo Sitagliptin + Placebo Metformin||18||
59988178|NCT02370160|76103289|FG002|COMPLETED|Overall Study||2||
59988179|NCT02370160|76103287|FG000|NOT COMPLETED|Overall Study||3||
59626059|NCT00830076|75738802|FG000|NOT COMPLETED|Placebo Sitagliptin + Placebo Metformin||0||
59626060|NCT00830232|75738811|FG000|STARTED|Overall Study||20||
59626061|NCT00830232|75738812|FG001|STARTED|Overall Study||20||
59626062|NCT00830232|75738811|FG000|COMPLETED|Overall Study||20||
59626063|NCT00830232|75738812|FG001|COMPLETED|Overall Study||20||
59626064|NCT00830232|75738811|FG000|NOT COMPLETED|Overall Study||0||
59626065|NCT00830232|75738812|FG001|NOT COMPLETED|Overall Study||0||
59626066|NCT00830310|75738818|FG000|STARTED|Overall Study||43||
59626067|NCT00830310|75738818|FG000|COMPLETED|Overall Study||30||
59626068|NCT00830310|75738818|FG000|NOT COMPLETED|Overall Study||13||
59626069|NCT00830388|75738822|FG000|STARTED|Overall Study||11||
59988180|NCT02370160|76103288|FG001|NOT COMPLETED|Overall Study||4||
59988181|NCT02370160|76103289|FG002|NOT COMPLETED|Overall Study||1||
59988182|NCT02273908|76103304|FG000|STARTED|Overall Study||157||
59988183|NCT02273908|76103305|FG001|STARTED|Overall Study||174||
59988184|NCT02273908|76103304|FG000|COMPLETED|Overall Study||124||
59626070|NCT00830388|75738822|FG000|COMPLETED|Overall Study||11||
59626071|NCT00830388|75738822|FG000|NOT COMPLETED|Overall Study||0||
59626072|NCT00831480|75738826|FG000|STARTED|Overall Study||9||
59626073|NCT00831480|75738826|FG000|COMPLETED|Overall Study||7||
59626074|NCT00831480|75738826|FG000|NOT COMPLETED|Overall Study||2||
59626075|NCT00832260|75738830|FG000|STARTED|Overall Study||70||
59626076|NCT00832260|75738830|FG000|COMPLETED|Overall Study||70||
59626077|NCT00832260|75738830|FG000|NOT COMPLETED|Overall Study||0||
59626078|NCT00832338|75738834|FG000|STARTED|Overall Study||23||
59626079|NCT00832338|75738834|FG000|COMPLETED|Overall Study||23||
59626080|NCT00832338|75738834|FG000|NOT COMPLETED|Overall Study||0||
59626081|NCT00834210|75738840|FG000|STARTED|Overall Study||86||
59626082|NCT00834210|75738841|FG001|STARTED|Overall Study||85||
59626083|NCT00834210|75738840|FG000|COMPLETED|Overall Study||83||
59626084|NCT00834210|75738841|FG001|COMPLETED|Overall Study||77||
59626085|NCT00834210|75738840|FG000|NOT COMPLETED|Overall Study||3||
59626086|NCT00834210|75738841|FG001|NOT COMPLETED|Overall Study||8||
59626087|NCT00834288|75738849|FG000|STARTED|Treatment Phase I||13||
59626088|NCT00834288|75738850|FG001|STARTED|Treatment Phase I||13||
59626089|NCT00834288|75738849|FG000|COMPLETED|Treatment Phase I||13||
59626090|NCT00834288|75738850|FG001|COMPLETED|Treatment Phase I||13||
59626091|NCT00834288|75738849|FG000|NOT COMPLETED|Treatment Phase I||0||
59626092|NCT00834288|75738850|FG001|NOT COMPLETED|Treatment Phase I||0||
59626093|NCT00834288|75738849|FG000|STARTED|Treatment Phase II||13||
59626094|NCT00834288|75738850|FG001|STARTED|Treatment Phase II||13||
59626095|NCT00834288|75738849|FG000|COMPLETED|Treatment Phase II||13||
59626096|NCT00834288|75738850|FG001|COMPLETED|Treatment Phase II||13||
59626097|NCT00834288|75738849|FG000|NOT COMPLETED|Treatment Phase II||0||
59626098|NCT00834288|75738850|FG001|NOT COMPLETED|Treatment Phase II||0||
59626099|NCT00834678|75738856|FG000|STARTED|Overall Study||11||
59626100|NCT00834678|75738856|FG000|COMPLETED|Overall Study||11||
59626101|NCT00834678|75738856|FG000|NOT COMPLETED|Overall Study||0||
59626102|NCT00835224|75738862|FG000|STARTED|Overall Study||34||
59626103|NCT00835224|75738862|FG000|COMPLETED|Overall Study||24||
59626104|NCT00835224|75738862|FG000|NOT COMPLETED|Overall Study||10||
59626105|NCT00835926|75738878|FG000|STARTED|Overall Study||61||
59626106|NCT00835926|75738879|FG001|STARTED|Overall Study||60||
59626107|NCT00835926|75738878|FG000|COMPLETED|Overall Study||61||
59626108|NCT00835926|75738879|FG001|COMPLETED|Overall Study||60||
59626109|NCT00835926|75738878|FG000|NOT COMPLETED|Overall Study||0||
59626110|NCT00835926|75738879|FG001|NOT COMPLETED|Overall Study||0||
59626111|NCT00837252|75738885|FG000|STARTED|Overall Study||5||
59626112|NCT00837252|75738885|FG000|COMPLETED|Overall Study||5||
59626113|NCT00837252|75738885|FG000|NOT COMPLETED|Overall Study||0||
59626114|NCT00839982|75738889|FG000|STARTED|Overall Study||4||
59626115|NCT00839982|75738890|FG001|STARTED|Overall Study||26||
59626116|NCT00839982|75738891|FG002|STARTED|Overall Study||2||
59626117|NCT00839982|75738892|FG003|STARTED|Overall Study||3||
59626118|NCT00839982|75738889|FG000|COMPLETED|Overall Study||4||
59626119|NCT00839982|75738890|FG001|COMPLETED|Overall Study||26||
59626120|NCT00839982|75738891|FG002|COMPLETED|Overall Study||2||
59626121|NCT00839982|75738892|FG003|COMPLETED|Overall Study||3||
59626122|NCT00839982|75738889|FG000|NOT COMPLETED|Overall Study||0||
59626123|NCT00839982|75738890|FG001|NOT COMPLETED|Overall Study||0||
59626124|NCT00839982|75738891|FG002|NOT COMPLETED|Overall Study||0||
59815627|NCT03911869|75938066|FG001|COMPLETED|Phase 2||0||
59988185|NCT02273908|76103305|FG001|COMPLETED|Overall Study||169||
59988186|NCT02273908|76103304|FG000|NOT COMPLETED|Overall Study||33||
59626125|NCT00839982|75738892|FG003|NOT COMPLETED|Overall Study||0||
59626126|NCT00842946|75738902|FG000|STARTED|Overall Study||21||
59626127|NCT00842946|75738903|FG001|STARTED|Overall Study||24||
59626128|NCT00842946|75738902|FG000|COMPLETED|Overall Study||16||
59626129|NCT00842946|75738903|FG001|COMPLETED|Overall Study||19||
59626130|NCT00842946|75738902|FG000|NOT COMPLETED|Overall Study||5||
59626131|NCT00842946|75738903|FG001|NOT COMPLETED|Overall Study||5||
59626132|NCT00843180|75738911|FG000|STARTED|Overall Study||16||
59626133|NCT00843180|75738912|FG001|STARTED|Overall Study||7||
59626134|NCT00843180|75738911|FG000|COMPLETED|Overall Study||16||
59626135|NCT00843180|75738912|FG001|COMPLETED|Overall Study||7||
59626136|NCT00843180|75738911|FG000|NOT COMPLETED|Overall Study||0||
59626137|NCT00843180|75738912|FG001|NOT COMPLETED|Overall Study||0||
59626138|NCT00845130|75738920|FG000|STARTED|Overall Study||20||
59626139|NCT00845130|75738921|FG001|STARTED|Overall Study||22||
59626140|NCT00845130|75738920|FG000|COMPLETED|Overall Study||16||
59626141|NCT00845130|75738921|FG001|COMPLETED|Overall Study||19||
59626142|NCT00845130|75738920|FG000|NOT COMPLETED|Overall Study||4||
59626143|NCT00845130|75738921|FG001|NOT COMPLETED|Overall Study||3||
59626144|NCT00848016|75738929|FG000|STARTED|Overall Study||29||
59626145|NCT00848016|75738929|FG000|COMPLETED|Overall Study||29||
59626146|NCT00848016|75738929|FG000|NOT COMPLETED|Overall Study||0||
59626147|NCT00848172|75738935|FG000|STARTED|Visit 2 - Drug Administration||10||
59626148|NCT00848172|75738936|FG001|STARTED|Visit 2 - Drug Administration||9||
59626149|NCT00848172|75738935|FG000|COMPLETED|Visit 2 - Drug Administration||10||
59539473|NCT01419977|75637788|FG000|NOT COMPLETED|Overall Study||0||
59539474|NCT01419977|75637789|FG001|NOT COMPLETED|Overall Study||0||
59539475|NCT01420289|75637797|FG000|STARTED|Overall Study||18||
59539476|NCT01420289|75637798|FG001|STARTED|Overall Study||16||
59539477|NCT01420289|75637797|FG000|COMPLETED|Overall Study||18||
59539478|NCT01420289|75637798|FG001|COMPLETED|Overall Study||16||
59539479|NCT01420289|75637797|FG000|NOT COMPLETED|Overall Study||0||
59539480|NCT01420289|75637798|FG001|NOT COMPLETED|Overall Study||0||
59539481|NCT01499147|75637806|FG000|STARTED|Overall Study||33||
59539482|NCT01499147|75637807|FG001|STARTED|Overall Study||17||
59539483|NCT01499147|75637806|FG000|COMPLETED|Overall Study||18||
59539484|NCT01499147|75637807|FG001|COMPLETED|Overall Study||12||
59539485|NCT01499147|75637806|FG000|NOT COMPLETED|Overall Study||15||
59539486|NCT01499147|75637807|FG001|NOT COMPLETED|Overall Study||5||
59539487|NCT00823082|75637819|FG000|STARTED|Overall Study||100||
59539488|NCT00823082|75637820|FG001|STARTED|Overall Study||100||
59539489|NCT00823082|75637819|FG000|Safety Population|Overall Study||100||
59539490|NCT00823082|75637820|FG001|Safety Population|Overall Study||99||
59539491|NCT00823082|75637819|FG000|Intent-to-Treat/Per Protocol Populations|Overall Study||100||
59539492|NCT00823082|75637820|FG001|Intent-to-Treat/Per Protocol Populations|Overall Study||94||
59539493|NCT00823082|75637819|FG000|COMPLETED|Overall Study||100||
59539494|NCT00823082|75637820|FG001|COMPLETED|Overall Study||99||
59539495|NCT00823082|75637819|FG000|NOT COMPLETED|Overall Study||0||
59539496|NCT00823082|75637820|FG001|NOT COMPLETED|Overall Study||1||
59539497|NCT01382303|75637828|FG000|STARTED|Overall Study||87||
59539498|NCT01382303|75637829|FG001|STARTED|Overall Study||87||
59539499|NCT01382303|75637828|FG000|COMPLETED|Overall Study||52||
59539500|NCT01382303|75637829|FG001|COMPLETED|Overall Study||70||
59539501|NCT01382303|75637828|FG000|NOT COMPLETED|Overall Study||35||
59539502|NCT01382303|75637829|FG001|NOT COMPLETED|Overall Study||17||
59539503|NCT01383005|75637837|FG000|STARTED|Overall Study||34||
59539504|NCT01383005|75637838|FG001|STARTED|Overall Study||60||
59539505|NCT01383005|75637837|FG000|COMPLETED|Overall Study||34||
59539506|NCT01383005|75637838|FG001|COMPLETED|Overall Study||60||
59539507|NCT01383005|75637837|FG000|NOT COMPLETED|Overall Study||0||
59539508|NCT01383005|75637838|FG001|NOT COMPLETED|Overall Study||0||
59539509|NCT01422161|75637846|FG000|STARTED|Overall Study||10||
59539510|NCT01422161|75637847|FG001|STARTED|Overall Study||6||
59539511|NCT01422161|75637846|FG000|COMPLETED|Overall Study||10||
59539512|NCT01422161|75637847|FG001|COMPLETED|Overall Study||6||
59539513|NCT01422161|75637846|FG000|NOT COMPLETED|Overall Study||0||
59539514|NCT01422161|75637847|FG001|NOT COMPLETED|Overall Study||0||
59539515|NCT01502813|75637861|FG000|STARTED|Overall Study||40||
59539516|NCT01502813|75637861|FG000|COMPLETED|Overall Study||40||
59539517|NCT01502813|75637861|FG000|NOT COMPLETED|Overall Study||0||
59539518|NCT00865202|75637867|FG000|STARTED|Overall Study||152||
59539519|NCT00865202|75637868|FG001|STARTED|Overall Study||149||
59539520|NCT00865202|75637867|FG000|COMPLETED|Overall Study||152||
59539521|NCT00865202|75637868|FG001|COMPLETED|Overall Study||149||
59539522|NCT00865202|75637867|FG000|NOT COMPLETED|Overall Study||0||
59539523|NCT00865202|75637868|FG001|NOT COMPLETED|Overall Study||0||
59539524|NCT01424033|75637875|FG000|STARTED|Overall Study||5||
59539525|NCT01424033|75637875|FG000|COMPLETED|Overall Study||0||
59539526|NCT01424033|75637875|FG000|NOT COMPLETED|Overall Study||5||
59539527|NCT01503749|75637882|FG000|STARTED|Overall Study||3||
59539528|NCT01503749|75637883|FG001|STARTED|Overall Study||3||
59539529|NCT01503749|75637884|FG002|STARTED|Overall Study||3||
59539530|NCT01503749|75637882|FG000|COMPLETED|Overall Study||3||
59539531|NCT01503749|75637883|FG001|COMPLETED|Overall Study||3||
59539532|NCT01503749|75637884|FG002|COMPLETED|Overall Study||3||
59539533|NCT01503749|75637882|FG000|NOT COMPLETED|Overall Study||0||
59539534|NCT01503749|75637883|FG001|NOT COMPLETED|Overall Study||0||
59539535|NCT01503749|75637884|FG002|NOT COMPLETED|Overall Study||0||
59539536|NCT00867932|75637892|FG000|STARTED|Overall Study||7||
59539537|NCT00867932|75637892|FG000|Induction Phase|Overall Study||7||
59626150|NCT00848172|75738936|FG001|COMPLETED|Visit 2 - Drug Administration||8||
59539538|NCT00867932|75637892|FG000|Maintenance Phase|Overall Study||7||
59539539|NCT00867932|75637892|FG000|Received at Least 1 Dose of Study Drug|Overall Study||7||
59626151|NCT00848172|75738935|FG000|NOT COMPLETED|Visit 2 - Drug Administration||0||
59815628|NCT03911869|75938067|FG002|COMPLETED|Phase 2||0||
59539540|NCT00867932|75637892|FG000|Intent-to-Treat (ITT) Population|Overall Study||7|Participants who received at least 1 dose of study drug.|
59539541|NCT00867932|75637892|FG000|COMPLETED|Overall Study||7||
59626152|NCT00848172|75738936|FG001|NOT COMPLETED|Visit 2 - Drug Administration||1||
59539542|NCT00867932|75637892|FG000|NOT COMPLETED|Overall Study||0||
59539543|NCT02209259|75637899|FG000|STARTED|Overall Study||56||
59539544|NCT02209259|75637900|FG001|STARTED|Overall Study||56||
59539545|NCT02209259|75637901|FG002|STARTED|Overall Study||56||
59539546|NCT02209259|75637899|FG000|COMPLETED|Overall Study||56||
59539547|NCT02209259|75637900|FG001|COMPLETED|Overall Study||56||
59539548|NCT02209259|75637901|FG002|COMPLETED|Overall Study||56||
59539549|NCT02209259|75637899|FG000|NOT COMPLETED|Overall Study||0||
59539550|NCT02209259|75637900|FG001|NOT COMPLETED|Overall Study||0||
59539551|NCT02209259|75637901|FG002|NOT COMPLETED|Overall Study||0||
59626153|NCT00848172|75738935|FG000|STARTED|Visit 3 - Follow Up||10||
59626154|NCT00848172|75738936|FG001|STARTED|Visit 3 - Follow Up||8||
59626155|NCT00848172|75738935|FG000|COMPLETED|Visit 3 - Follow Up||10||
59626156|NCT00848172|75738936|FG001|COMPLETED|Visit 3 - Follow Up||8||
59626157|NCT00848172|75738935|FG000|NOT COMPLETED|Visit 3 - Follow Up||0||
59626158|NCT00848172|75738936|FG001|NOT COMPLETED|Visit 3 - Follow Up||0||
59626159|NCT00849810|75738945|FG000|STARTED|Overall Study||1||
59626160|NCT00849810|75738945|FG000|COMPLETED|Overall Study||1||
59626161|NCT00849810|75738945|FG000|NOT COMPLETED|Overall Study||0||
59626162|NCT00856050|75738949|FG000|STARTED|Overall Study||26||
59626163|NCT00856050|75738949|FG000|COMPLETED|Overall Study||26||
59626164|NCT00856050|75738949|FG000|NOT COMPLETED|Overall Study||0||
59626165|NCT00857532|75738953|FG000|STARTED|Overall Study||31||
59626166|NCT00857532|75738953|FG000|COMPLETED|Overall Study||31||
59626167|NCT00857532|75738953|FG000|NOT COMPLETED|Overall Study||0||
59626168|NCT00858390|75738962|FG000|STARTED|Overall Study||18||
59626169|NCT00858390|75738963|FG001|STARTED|Overall Study||18||
59626170|NCT00858390|75738962|FG000|COMPLETED|Overall Study||18||
59626171|NCT00858390|75738963|FG001|COMPLETED|Overall Study||18||
59626172|NCT00858390|75738962|FG000|NOT COMPLETED|Overall Study||0||
59626173|NCT00858390|75738963|FG001|NOT COMPLETED|Overall Study||0||
59626174|NCT00858468|75738971|FG000|STARTED|Overall Study|1 enrolled participant was not vaccinated and removed from analysis|201||
59626175|NCT00858468|75738972|FG001|STARTED|Overall Study||192||
59626176|NCT00858468|75738971|FG000|COMPLETED|Overall Study||201||
59626177|NCT00858468|75738972|FG001|COMPLETED|Overall Study||192||
59626178|NCT00858468|75738971|FG000|NOT COMPLETED|Overall Study||0||
59626179|NCT00858468|75738972|FG001|NOT COMPLETED|Overall Study||0||
59626180|NCT00858858|75738978|FG000|STARTED|Overall Study||60||
59626181|NCT00858858|75738978|FG000|COMPLETED|Overall Study||42||
59626182|NCT00858858|75738978|FG000|NOT COMPLETED|Overall Study||18||
59626183|NCT00859950|75738984|FG000|STARTED|Overall Study||49||
59626184|NCT00859950|75738985|FG001|STARTED|Overall Study||21||
59626185|NCT00859950|75738984|FG000|COMPLETED|Overall Study||49||
59626186|NCT00859950|75738985|FG001|COMPLETED|Overall Study||21||
59626187|NCT00859950|75738984|FG000|NOT COMPLETED|Overall Study||0||
59626188|NCT00859950|75738985|FG001|NOT COMPLETED|Overall Study||0||
59626189|NCT00862446|75738991|FG000|STARTED|Overall Study||48||
59626190|NCT00862446|75738991|FG000|COMPLETED|Overall Study||48||
59626191|NCT00862446|75738991|FG000|NOT COMPLETED|Overall Study||0||
59626192|NCT00864084|75738995|FG000|STARTED|Overall Study||14||
59626193|NCT00864084|75738995|FG000|COMPLETED|Overall Study||11||
59626194|NCT00864084|75738995|FG000|NOT COMPLETED|Overall Study||3||
59626195|NCT00864708|75739004|FG000|STARTED|Overall Study||1||
59626196|NCT00864708|75739004|FG000|COMPLETED|Overall Study||1||
59626197|NCT00864708|75739004|FG000|NOT COMPLETED|Overall Study||0||
59626198|NCT00866034|75739012|FG000|STARTED|Overall Study||308||
59626199|NCT00866034|75739013|FG001|STARTED|Overall Study||309||
59626200|NCT00866034|75739012|FG000|COMPLETED|Overall Study||292||
59626201|NCT00866034|75739013|FG001|COMPLETED|Overall Study||301||
59626202|NCT00866034|75739012|FG000|NOT COMPLETED|Overall Study||16||
59626203|NCT00866034|75739013|FG001|NOT COMPLETED|Overall Study||8||
59626204|NCT00868140|75739021|FG000|STARTED|Overall Study||26||
59626205|NCT00868140|75739022|FG001|STARTED|Overall Study||25||
59626206|NCT00868140|75739021|FG000|COMPLETED|Overall Study||26||
59626207|NCT00868140|75739022|FG001|COMPLETED|Overall Study||25||
59626208|NCT00868140|75739021|FG000|NOT COMPLETED|Overall Study||0||
59626209|NCT00868140|75739022|FG001|NOT COMPLETED|Overall Study||0||
59626210|NCT00868218|75739034|FG000|STARTED|Overall Study||15||
59626211|NCT00868218|75739035|FG001|STARTED|Overall Study||15||
59626212|NCT00868218|75739036|FG002|STARTED|Overall Study||15||
59626213|NCT00868218|75739037|FG003|STARTED|Overall Study||15||
59626214|NCT00868218|75739034|FG000|COMPLETED|Overall Study||15||
59626215|NCT00868218|75739035|FG001|COMPLETED|Overall Study||15||
59626216|NCT00868218|75739036|FG002|COMPLETED|Overall Study||15||
59626217|NCT00868218|75739037|FG003|COMPLETED|Overall Study||15||
59626218|NCT00868218|75739034|FG000|NOT COMPLETED|Overall Study||0||
59626219|NCT00868218|75739035|FG001|NOT COMPLETED|Overall Study||0||
59626220|NCT00868218|75739036|FG002|NOT COMPLETED|Overall Study||0||
59626221|NCT00868218|75739037|FG003|NOT COMPLETED|Overall Study||0||
59626222|NCT00868374|75739053|FG000|STARTED|Overall Study||12||
59626223|NCT00868374|75739054|FG001|STARTED|Overall Study||11||
59626224|NCT00868374|75739053|FG000|COMPLETED|Overall Study||5||
59626225|NCT00868374|75739054|FG001|COMPLETED|Overall Study||4||
59626226|NCT00868374|75739053|FG000|NOT COMPLETED|Overall Study||7||
59626227|NCT00868374|75739054|FG001|NOT COMPLETED|Overall Study||7||
59626228|NCT00868452|75739062|FG000|STARTED|Overall Study||183||
59626229|NCT00868452|75739063|FG001|STARTED|Overall Study||165||
59626230|NCT00868452|75739062|FG000|COMPLETED|Overall Study||143||
59626231|NCT00868452|75739063|FG001|COMPLETED|Overall Study||136||
59626232|NCT00868452|75739062|FG000|NOT COMPLETED|Overall Study||40||
59626233|NCT00868452|75739063|FG001|NOT COMPLETED|Overall Study||29||
59626234|NCT00869622|75739072|FG000|STARTED|Overall Study||40||
59626235|NCT00869622|75739073|FG001|STARTED|Overall Study||40||
59626236|NCT00869622|75739072|FG000|COMPLETED|Overall Study||27||
59626237|NCT00869622|75739073|FG001|COMPLETED|Overall Study||26||
59626238|NCT00869622|75739072|FG000|NOT COMPLETED|Overall Study||13||
59626239|NCT00869622|75739073|FG001|NOT COMPLETED|Overall Study||14||
59626240|NCT00871260|75739080|FG000|STARTED|Overall Study||20||
59626241|NCT00871260|75739080|FG000|COMPLETED|Overall Study||20||
59626242|NCT00871260|75739080|FG000|NOT COMPLETED|Overall Study||0||
59626243|NCT00874614|75739084|FG000|STARTED|Overall Study||74||
59626244|NCT00874614|75739084|FG000|Received at Least One Therapeutic Dose|Overall Study||68||
59626245|NCT00874614|75739084|FG000|Received Two Therapeutic Doses|Overall Study||50||
59626246|NCT00874614|75739084|FG000|COMPLETED|Overall Study|As of December 2017|16|Completed or continuing in long-term follow-up phase|
59626247|NCT00874614|75739084|FG000|NOT COMPLETED|Overall Study||58||
59626248|NCT00875550|75739092|FG000|STARTED|Overall Study||89||
59626249|NCT00875550|75739093|FG001|STARTED|Overall Study||86||
59626250|NCT00875550|75739092|FG000|COMPLETED|Overall Study||77||
59626251|NCT00875550|75739093|FG001|COMPLETED|Overall Study||76||
59626252|NCT00875550|75739092|FG000|NOT COMPLETED|Overall Study||12||
59626253|NCT00875550|75739093|FG001|NOT COMPLETED|Overall Study||10||
59626254|NCT00878436|75739103|FG000|STARTED|Overall Study||28||
59626255|NCT00878436|75739104|FG001|STARTED|Overall Study||24||
59626256|NCT00878436|75739103|FG000|Completed 2 Cycles|Overall Study||21||
59626257|NCT00878436|75739104|FG001|Completed 2 Cycles|Overall Study||20||
59626258|NCT00878436|75739103|FG000|6 Months|Overall Study||8||
59626259|NCT00878436|75739104|FG001|6 Months|Overall Study||0||
59626260|NCT00878436|75739103|FG000|COMPLETED|Overall Study||5||
59626261|NCT00878436|75739104|FG001|COMPLETED|Overall Study||0||
59626262|NCT00878436|75739103|FG000|NOT COMPLETED|Overall Study||23||
59626263|NCT00878436|75739104|FG001|NOT COMPLETED|Overall Study||24||
59626264|NCT00878826|75739113|FG000|STARTED|Overall Study||3||
59626265|NCT00878826|75739114|FG001|STARTED|Overall Study||6||
59626266|NCT00878826|75739115|FG002|STARTED|Overall Study||2||
59626267|NCT00878826|75739113|FG000|COMPLETED|Overall Study||3||
59626268|NCT00878826|75739114|FG001|COMPLETED|Overall Study||6||
59626269|NCT00878826|75739115|FG002|COMPLETED|Overall Study||2||
59626270|NCT00878826|75739113|FG000|NOT COMPLETED|Overall Study||0||
59626271|NCT00878826|75739114|FG001|NOT COMPLETED|Overall Study||0||
59626272|NCT00878826|75739115|FG002|NOT COMPLETED|Overall Study||0||
59626273|NCT00879060|75739125|FG000|STARTED|Overall Study||26||
59626274|NCT00879060|75739126|FG001|STARTED|Overall Study||27||
59626275|NCT00879060|75739125|FG000|COMPLETED|Overall Study||26||
59626276|NCT00879060|75739126|FG001|COMPLETED|Overall Study||27||
59626277|NCT00879060|75739125|FG000|NOT COMPLETED|Overall Study||0||
59626278|NCT00879060|75739126|FG001|NOT COMPLETED|Overall Study||0||
59626279|NCT00880230|75739135|FG000|STARTED|Overall Study||141||
59626280|NCT00880230|75739135|FG000|COMPLETED|Overall Study||134||
60076237|NCT01904773|76191370|FG006|NOT COMPLETED|Third Intervention||0||
60076238|NCT01904773|76191371|FG007|NOT COMPLETED|Third Intervention||0||
60076239|NCT01904773|76191372|FG008|NOT COMPLETED|Third Intervention||0||
60076240|NCT01904773|76191364|FG000|STARTED|Placebo Washout Third Intervention||0||
60076241|NCT01904773|76191365|FG001|STARTED|Placebo Washout Third Intervention||1||
60076242|NCT01904773|76191366|FG002|STARTED|Placebo Washout Third Intervention||1||
60076243|NCT01904773|76191367|FG003|STARTED|Placebo Washout Third Intervention||2||
59626281|NCT00880230|75739135|FG000|NOT COMPLETED|Overall Study||7||
59626282|NCT00880464|75739139|FG000|STARTED|Overall Study||7||
59626283|NCT00880464|75739139|FG000|COMPLETED|Overall Study||7||
59626284|NCT00880464|75739139|FG000|NOT COMPLETED|Overall Study||0||
59626285|NCT00882102|75739143|FG000|STARTED|Overall Study||40||
59626286|NCT00882102|75739143|FG000|COMPLETED|Overall Study||40||
59626287|NCT00882102|75739143|FG000|NOT COMPLETED|Overall Study||0||
59626288|NCT00884052|75739147|FG000|STARTED|Overall Study||6||
59626289|NCT00884052|75739148|FG001|STARTED|Overall Study||12||
59815629|NCT03911869|75938065|FG000|NOT COMPLETED|Phase 2||0||
59815630|NCT03911869|75938066|FG001|NOT COMPLETED|Phase 2||3||
59626290|NCT00884052|75739147|FG000|COMPLETED|Overall Study||6||
59626291|NCT00884052|75739148|FG001|COMPLETED|Overall Study||12||
59626292|NCT00884052|75739147|FG000|NOT COMPLETED|Overall Study||0||
59626293|NCT00884052|75739148|FG001|NOT COMPLETED|Overall Study||0||
59626294|NCT00884754|75739156|FG000|STARTED|Overall Study||30||
59626295|NCT00884754|75739157|FG001|STARTED|Overall Study||30||
59626296|NCT00884754|75739156|FG000|COMPLETED|Overall Study||30||
59626297|NCT00884754|75739157|FG001|COMPLETED|Overall Study||30||
59626298|NCT00884754|75739156|FG000|NOT COMPLETED|Overall Study||0||
59626299|NCT00884754|75739157|FG001|NOT COMPLETED|Overall Study||0||
59626300|NCT00884910|75739163|FG000|STARTED|Overall Study||33||
59626301|NCT00884910|75739163|FG000|COMPLETED|Overall Study|patient diagnosed with primary pulmonary tumor during study|32||
59626302|NCT00884910|75739163|FG000|NOT COMPLETED|Overall Study||1||
59626303|NCT00885768|75739167|FG000|STARTED|Overall Study|all patients with coronary artery stenosis on angiography entered the study|146||
59626304|NCT00885768|75739167|FG000|COMPLETED|Overall Study|all patients with including criteria completed the study|146||
59626305|NCT00885768|75739167|FG000|NOT COMPLETED|Overall Study||0||
59626306|NCT00886236|75739174|FG000|STARTED|Overall Study||20||
59815631|NCT03911869|75938067|FG002|NOT COMPLETED|Phase 2||0||
59626307|NCT00886236|75739175|FG001|STARTED|Overall Study||21||
59626308|NCT00886236|75739176|FG002|STARTED|Overall Study||21||
59626309|NCT00886236|75739174|FG000|COMPLETED|Overall Study||18||
59626310|NCT00886236|75739175|FG001|COMPLETED|Overall Study||17||
59626311|NCT00886236|75739176|FG002|COMPLETED|Overall Study||17||
59626312|NCT00886236|75739174|FG000|NOT COMPLETED|Overall Study||2||
59626313|NCT00886236|75739175|FG001|NOT COMPLETED|Overall Study||4||
59626314|NCT00886236|75739176|FG002|NOT COMPLETED|Overall Study||4||
59626315|NCT00886626|75739184|FG000|STARTED|Period 1 (90 Days)||6||
59626316|NCT00886626|75739185|FG001|STARTED|Period 1 (90 Days)||6||
59626317|NCT00886626|75739184|FG000|COMPLETED|Period 1 (90 Days)||5||
59626318|NCT00886626|75739185|FG001|COMPLETED|Period 1 (90 Days)||6||
59626319|NCT00886626|75739184|FG000|NOT COMPLETED|Period 1 (90 Days)||1||
59626320|NCT00886626|75739185|FG001|NOT COMPLETED|Period 1 (90 Days)||0||
59626321|NCT00886626|75739184|FG000|STARTED|Period 2 (90 Days)||5||
59626322|NCT00886626|75739185|FG001|STARTED|Period 2 (90 Days)||6||
59626323|NCT00886626|75739184|FG000|COMPLETED|Period 2 (90 Days)||5||
59626324|NCT00886626|75739185|FG001|COMPLETED|Period 2 (90 Days)||6||
59626325|NCT00886626|75739184|FG000|NOT COMPLETED|Period 2 (90 Days)||0||
59626326|NCT00886626|75739185|FG001|NOT COMPLETED|Period 2 (90 Days)||0||
59626327|NCT00886704|75739193|FG000|STARTED|Overall Study||40||
59626328|NCT00886704|75739194|FG001|STARTED|Overall Study||10||
59626329|NCT00886704|75739193|FG000|COMPLETED|Overall Study||40||
59626330|NCT00886704|75739194|FG001|COMPLETED|Overall Study||10||
59626331|NCT00886704|75739193|FG000|NOT COMPLETED|Overall Study||0||
59626332|NCT00886704|75739194|FG001|NOT COMPLETED|Overall Study||0||
59626333|NCT00887562|75739205|FG000|STARTED|Overall Study||10||
59626334|NCT00887562|75739206|FG001|STARTED|Overall Study||9||
59626335|NCT00887562|75739207|FG002|STARTED|Overall Study||8||
59626336|NCT00887562|75739205|FG000|COMPLETED|Overall Study||7||
59626337|NCT00887562|75739206|FG001|COMPLETED|Overall Study||7||
59626338|NCT00887562|75739207|FG002|COMPLETED|Overall Study||7||
59626339|NCT00887562|75739205|FG000|NOT COMPLETED|Overall Study||3||
59626340|NCT00887562|75739206|FG001|NOT COMPLETED|Overall Study||2||
59626341|NCT00887562|75739207|FG002|NOT COMPLETED|Overall Study||1||
59626342|NCT00887640|75739217|FG000|STARTED|Overall Study||11||
59988187|NCT02273908|76103305|FG001|NOT COMPLETED|Overall Study||5||
59988188|NCT02273752|76103315|FG000|STARTED|Overall Study||2||
59626343|NCT00887640|75739217|FG000|COMPLETED|Overall Study||11||
59626344|NCT00887640|75739217|FG000|NOT COMPLETED|Overall Study||0||
59626345|NCT00889200|75739221|FG000|STARTED|Overall Study||12||
59626346|NCT00889200|75739221|FG000|COMPLETED|Overall Study||12||
59626347|NCT00889200|75739221|FG000|NOT COMPLETED|Overall Study||0||
59626348|NCT00889512|75739227|FG000|STARTED|Overall Study||5||
59626349|NCT00889512|75739228|FG001|STARTED|Overall Study||9||
59626350|NCT00889512|75739227|FG000|COMPLETED|Overall Study||5||
59626351|NCT00889512|75739228|FG001|COMPLETED|Overall Study||9||
59626352|NCT00889512|75739227|FG000|NOT COMPLETED|Overall Study||0||
59626353|NCT00889512|75739228|FG001|NOT COMPLETED|Overall Study||0||
59626354|NCT00889824|75739234|FG000|STARTED|Overall Study||5||
59626355|NCT00889824|75739234|FG000|COMPLETED|Overall Study||5||
59626356|NCT00889824|75739234|FG000|NOT COMPLETED|Overall Study||0||
59626357|NCT00890682|75739240|FG000|STARTED|Overall Study||97||
59626358|NCT00890682|75739241|FG001|STARTED|Overall Study||96||
59626359|NCT00890682|75739240|FG000|COMPLETED|Overall Study||93||
59626360|NCT00890682|75739241|FG001|COMPLETED|Overall Study||94||
59626361|NCT00890682|75739240|FG000|NOT COMPLETED|Overall Study||4||
59626362|NCT00890682|75739241|FG001|NOT COMPLETED|Overall Study||2||
59626363|NCT00890916|75739247|FG000|STARTED|"Rehab - Neuroprosthesis (NP) On"|First Implanted Stimulator-Telemeter (IST-12) Implant.|10||
59626364|NCT00890916|75739247|FG000|"Grasp Release Pre-Test ON"|"Rehab - Neuroprosthesis (NP) On"||10|Grasp Release Pre-Test results - Neuroprosthesis turned on. See Peckham et al.,Arch PM&R,2001|
59626365|NCT00890916|75739247|FG000|COMPLETED|"Rehab - Neuroprosthesis (NP) On"||10||
59626366|NCT00890916|75739247|FG000|NOT COMPLETED|"Rehab - Neuroprosthesis (NP) On"||0||
59626367|NCT00890916|75739247|FG000|STARTED|"Rehab - NP Off"||10||
59626368|NCT00890916|75739247|FG000|"Grasp Release Pre-Test OFF"|"Rehab - NP Off"||10||
59626369|NCT00890916|75739247|FG000|COMPLETED|"Rehab - NP Off"||10||
59626370|NCT00890916|75739247|FG000|NOT COMPLETED|"Rehab - NP Off"||0||
59626371|NCT00892710|75739254|FG000|STARTED|Overall Study||48||
59626372|NCT00892710|75739255|FG001|STARTED|Overall Study||59||
59626373|NCT00892710|75739256|FG002|STARTED|Overall Study||55||
59626374|NCT00892710|75739254|FG000|COMPLETED|Overall Study|Patients remained on study until disease progression or intolerable toxicity occurred|0||
59626375|NCT00892710|75739255|FG001|COMPLETED|Overall Study|Patients remained on study until disease progression or intolerable toxicity occurred|0||
59626376|NCT00892710|75739256|FG002|COMPLETED|Overall Study|Patients remained on study until disease progression or intolerable toxicity occurred|0||
59626377|NCT00892710|75739254|FG000|NOT COMPLETED|Overall Study||48||
59626378|NCT00892710|75739255|FG001|NOT COMPLETED|Overall Study||59||
59626379|NCT00892710|75739256|FG002|NOT COMPLETED|Overall Study||55||
59626380|NCT00894504|75739264|FG000|STARTED|Overall Study||71||
59626381|NCT00894504|75739264|FG000|COMPLETED|Overall Study||0||
59626382|NCT00894504|75739264|FG000|NOT COMPLETED|Overall Study||71||
59988189|NCT02273752|76103315|FG000|COMPLETED|Overall Study||0||
59626383|NCT00894738|75739280|FG000|STARTED|Overall Study||25||
59626384|NCT00894738|75739281|FG001|STARTED|Overall Study||19||
59626385|NCT00894738|75739280|FG000|COMPLETED|Overall Study||25||
59626386|NCT00894738|75739281|FG001|COMPLETED|Overall Study||19||
59626387|NCT00894738|75739280|FG000|NOT COMPLETED|Overall Study||0||
59626388|NCT00894738|75739281|FG001|NOT COMPLETED|Overall Study||0||
59626389|NCT00895752|75739287|FG000|STARTED|Overall Study||6||
59626390|NCT00895752|75739287|FG000|COMPLETED|Overall Study||6||
59626391|NCT00895752|75739287|FG000|NOT COMPLETED|Overall Study||0||
59626392|NCT00895830|75739298|FG000|STARTED|Overall Study||51||
59626393|NCT00895830|75739299|FG001|STARTED|Overall Study||50||
59626394|NCT00895830|75739300|FG002|STARTED|Overall Study||49||
59626395|NCT00895830|75739301|FG003|STARTED|Overall Study||52||
59626396|NCT00895830|75739302|FG004|STARTED|Overall Study||55||
59626397|NCT00895830|75739298|FG000|COMPLETED|Overall Study||51||
59626398|NCT00895830|75739299|FG001|COMPLETED|Overall Study||50||
59626399|NCT00895830|75739300|FG002|COMPLETED|Overall Study||49||
59626400|NCT00895830|75739301|FG003|COMPLETED|Overall Study||52||
59626401|NCT00895830|75739302|FG004|COMPLETED|Overall Study||55||
59626402|NCT00895830|75739298|FG000|NOT COMPLETED|Overall Study||0||
59626403|NCT00895830|75739299|FG001|NOT COMPLETED|Overall Study||0||
59626404|NCT00895830|75739300|FG002|NOT COMPLETED|Overall Study||0||
59626405|NCT00895830|75739301|FG003|NOT COMPLETED|Overall Study||0||
59626406|NCT00895830|75739302|FG004|NOT COMPLETED|Overall Study||0||
59626407|NCT00896064|75739316|FG000|STARTED|Overall Study||22||
59626408|NCT00896064|75739317|FG001|STARTED|Overall Study||21||
59626409|NCT00896064|75739316|FG000|COMPLETED|Overall Study||22||
59626410|NCT00896064|75739317|FG001|COMPLETED|Overall Study||21||
59626411|NCT00896064|75739316|FG000|NOT COMPLETED|Overall Study||0||
59626412|NCT00896064|75739317|FG001|NOT COMPLETED|Overall Study||0||
59626413|NCT00896298|75739325|FG000|STARTED|Overall Study||13||
59626414|NCT00896298|75739326|FG001|STARTED|Overall Study||12||
59626415|NCT00896298|75739325|FG000|COMPLETED|Overall Study||10||
59626416|NCT00896298|75739326|FG001|COMPLETED|Overall Study||9||
59626417|NCT00896298|75739325|FG000|NOT COMPLETED|Overall Study||3||
59626418|NCT00896298|75739326|FG001|NOT COMPLETED|Overall Study||3||
59626419|NCT00898560|75739332|FG000|STARTED|Overall Study||20||
59626420|NCT00898560|75739332|FG000|COMPLETED|Overall Study||19||
59626421|NCT00898560|75739332|FG000|NOT COMPLETED|Overall Study||1||
59626422|NCT00899574|75739338|FG000|STARTED|Overall Study||10||
59626423|NCT00899574|75739338|FG000|COMPLETED|Overall Study||10||
59626424|NCT00899574|75739338|FG000|NOT COMPLETED|Overall Study||0||
59626425|NCT00900666|75739344|FG000|STARTED|Overall Study||10||
59626426|NCT00900666|75739345|FG001|STARTED|Overall Study||9||
59626427|NCT00900666|75739344|FG000|COMPLETED|Overall Study||10||
59626428|NCT00900666|75739345|FG001|COMPLETED|Overall Study||9||
59626429|NCT00900666|75739344|FG000|NOT COMPLETED|Overall Study||0||
59626430|NCT00900666|75739345|FG001|NOT COMPLETED|Overall Study||0||
59626431|NCT00900822|75739351|FG000|STARTED|9 Months Histological Evaluation||11||
59626432|NCT00900822|75739351|FG000|COMPLETED|9 Months Histological Evaluation||11||
59626433|NCT00900822|75739351|FG000|NOT COMPLETED|9 Months Histological Evaluation||0||
59626434|NCT00900822|75739351|FG000|STARTED|12 Months Clinical Evaluation||11||
59626435|NCT00900822|75739351|FG000|COMPLETED|12 Months Clinical Evaluation||11||
59626436|NCT00900822|75739351|FG000|NOT COMPLETED|12 Months Clinical Evaluation||0||
59626437|NCT00902226|75739358|FG000|STARTED|Overall Study||30||
59626438|NCT00902226|75739358|FG000|COMPLETED|Overall Study||30||
59626439|NCT00902226|75739358|FG000|NOT COMPLETED|Overall Study||0||
59626440|NCT00903162|75739362|FG000|STARTED|Overall Study||16||
59626441|NCT00903162|75739362|FG000|COMPLETED|Overall Study||12||
59626442|NCT00903162|75739362|FG000|NOT COMPLETED|Overall Study||4||
59626443|NCT00904488|75739368|FG000|STARTED|Overall Study||5||
59626444|NCT00904488|75739369|FG001|STARTED|Overall Study||6||
59626445|NCT00904488|75739368|FG000|COMPLETED|Overall Study||5||
59626446|NCT00904488|75739369|FG001|COMPLETED|Overall Study||6||
59626447|NCT00904488|75739368|FG000|NOT COMPLETED|Overall Study||0||
59626448|NCT00904488|75739369|FG001|NOT COMPLETED|Overall Study||0||
59626449|NCT00905580|75739377|FG000|STARTED|Overall Study||49||
59626450|NCT00905580|75739378|FG001|STARTED|Overall Study||50||
59626451|NCT00905580|75739377|FG000|COMPLETED|Overall Study||47||
59626452|NCT00905580|75739378|FG001|COMPLETED|Overall Study||47||
59626453|NCT00905580|75739377|FG000|NOT COMPLETED|Overall Study||2||
59626454|NCT00905580|75739378|FG001|NOT COMPLETED|Overall Study||3||
59626455|NCT00908388|75739384|FG000|STARTED|Overall Study||50||
59626456|NCT00908388|75739384|FG000|COMPLETED|Overall Study||40||
59626457|NCT00908388|75739384|FG000|NOT COMPLETED|Overall Study||10||
59626458|NCT00908466|75739390|FG000|STARTED|Overall Study||15||
59626459|NCT00908466|75739391|FG001|STARTED|Overall Study||15||
59626460|NCT00908466|75739390|FG000|COMPLETED|Overall Study||14||
59626461|NCT00908466|75739391|FG001|COMPLETED|Overall Study||14||
59626462|NCT00908466|75739390|FG000|NOT COMPLETED|Overall Study||1||
59626463|NCT00908466|75739391|FG001|NOT COMPLETED|Overall Study||1||
59626464|NCT00909324|75739399|FG000|STARTED|Overall Study||72||
59626465|NCT00909324|75739400|FG001|STARTED|Overall Study||90||
59626466|NCT00909324|75739399|FG000|COMPLETED|Overall Study||72||
59626467|NCT00909324|75739400|FG001|COMPLETED|Overall Study||90||
59626468|NCT00909324|75739399|FG000|NOT COMPLETED|Overall Study||0||
59626469|NCT00909324|75739400|FG001|NOT COMPLETED|Overall Study||0||
59626470|NCT00911586|75739406|FG000|STARTED|Overall Study||15||
59626471|NCT00911586|75739406|FG000|COMPLETED|Overall Study||15||
59626472|NCT00911586|75739406|FG000|NOT COMPLETED|Overall Study||0||
59626473|NCT00911742|75739413|FG000|STARTED|Treatment Phase I||13||
59626474|NCT00911742|75739414|FG001|STARTED|Treatment Phase I||13||
59626475|NCT00911742|75739413|FG000|COMPLETED|Treatment Phase I||13||
59626476|NCT00911742|75739414|FG001|COMPLETED|Treatment Phase I||13||
59626477|NCT00911742|75739413|FG000|NOT COMPLETED|Treatment Phase I||0||
59626478|NCT00911742|75739414|FG001|NOT COMPLETED|Treatment Phase I||0||
59626479|NCT00911742|75739413|FG000|STARTED|Treatment Phase II||13||
59626480|NCT00911742|75739414|FG001|STARTED|Treatment Phase II||13||
59626481|NCT00911742|75739413|FG000|COMPLETED|Treatment Phase II||13||
59626482|NCT00911742|75739414|FG001|COMPLETED|Treatment Phase II||13||
59626483|NCT00911742|75739413|FG000|NOT COMPLETED|Treatment Phase II||0||
59626484|NCT00911742|75739414|FG001|NOT COMPLETED|Treatment Phase II||0||
59626485|NCT00911898|75739420|FG000|STARTED|Overall Study||20||
59626486|NCT00911898|75739420|FG000|COMPLETED|Overall Study||20||
59626487|NCT00911898|75739420|FG000|NOT COMPLETED|Overall Study||0||
59626488|NCT00912990|75739426|FG000|STARTED|Overall Study||16||
59626489|NCT00912990|75739427|FG001|STARTED|Overall Study||18||
59626490|NCT00912990|75739426|FG000|COMPLETED|Overall Study||16||
59626491|NCT00912990|75739427|FG001|COMPLETED|Overall Study||18||
59626492|NCT00912990|75739426|FG000|NOT COMPLETED|Overall Study||0||
59626493|NCT00912990|75739427|FG001|NOT COMPLETED|Overall Study||0||
59626494|NCT00913068|75739435|FG000|STARTED|Overall Study||56||
59626495|NCT00913068|75739436|FG001|STARTED|Overall Study||54||
59626496|NCT00913068|75739435|FG000|COMPLETED|Overall Study||48||
59626497|NCT00913068|75739436|FG001|COMPLETED|Overall Study||46||
59626498|NCT00913068|75739435|FG000|NOT COMPLETED|Overall Study||8||
59626499|NCT00913068|75739436|FG001|NOT COMPLETED|Overall Study||8||
59626500|NCT00914862|75739447|FG000|STARTED|Overall Study||6||
59626501|NCT00914862|75739448|FG001|STARTED|Overall Study||6||
59626502|NCT00914862|75739449|FG002|STARTED|Overall Study||8||
59626503|NCT00914862|75739450|FG003|STARTED|Overall Study||8||
59626504|NCT00914862|75739451|FG004|STARTED|Overall Study||28||
59626505|NCT00914862|75739447|FG000|COMPLETED|Overall Study||6||
59626506|NCT00914862|75739448|FG001|COMPLETED|Overall Study||6||
59626507|NCT00914862|75739449|FG002|COMPLETED|Overall Study||8||
59626508|NCT00914862|75739450|FG003|COMPLETED|Overall Study||8||
59626509|NCT00914862|75739451|FG004|COMPLETED|Overall Study||28||
59626510|NCT00914862|75739447|FG000|NOT COMPLETED|Overall Study||0||
59626511|NCT00914862|75739448|FG001|NOT COMPLETED|Overall Study||0||
59626512|NCT00914862|75739449|FG002|NOT COMPLETED|Overall Study||0||
59626513|NCT00914862|75739450|FG003|NOT COMPLETED|Overall Study||0||
59626514|NCT00914862|75739451|FG004|NOT COMPLETED|Overall Study||0||
59626515|NCT00915798|75739467|FG000|STARTED|Overall Study||19||
59626516|NCT00915798|75739468|FG001|STARTED|Overall Study||21||
59626517|NCT00915798|75739469|FG002|STARTED|Overall Study||23||
59626518|NCT00915798|75739470|FG003|STARTED|Overall Study||26||
59626519|NCT00915798|75739467|FG000|COMPLETED|Overall Study||19||
59626520|NCT00915798|75739468|FG001|COMPLETED|Overall Study||21||
59626521|NCT00915798|75739469|FG002|COMPLETED|Overall Study||23||
59626522|NCT00915798|75739470|FG003|COMPLETED|Overall Study||26||
59626523|NCT00915798|75739467|FG000|NOT COMPLETED|Overall Study||0||
59988190|NCT02273752|76103315|FG000|NOT COMPLETED|Overall Study||2||
59988191|NCT05180630|76103319|FG000|STARTED|First Intervention||6||
59988192|NCT05180630|76103320|FG001|STARTED|First Intervention||6||
59988193|NCT05180630|76103321|FG002|STARTED|First Intervention||5||
59988194|NCT05180630|76103319|FG000|COMPLETED|First Intervention||6||
59988195|NCT05180630|76103320|FG001|COMPLETED|First Intervention||6||
59988196|NCT05180630|76103321|FG002|COMPLETED|First Intervention||2||
59988197|NCT05180630|76103319|FG000|NOT COMPLETED|First Intervention||0||
59988198|NCT05180630|76103320|FG001|NOT COMPLETED|First Intervention||0||
59988199|NCT05180630|76103321|FG002|NOT COMPLETED|First Intervention||3||
59988200|NCT05180630|76103319|FG000|STARTED|Second Intervention||6||
59988201|NCT05180630|76103320|FG001|STARTED|Second Intervention||6||
59626524|NCT00915798|75739468|FG001|NOT COMPLETED|Overall Study||0||
59626525|NCT00915798|75739469|FG002|NOT COMPLETED|Overall Study||0||
59626526|NCT00915798|75739470|FG003|NOT COMPLETED|Overall Study||0||
59626527|NCT00915954|75739493|FG000|STARTED|Overall Study||10||
59626528|NCT00915954|75739494|FG001|STARTED|Overall Study||8||
59626529|NCT00915954|75739495|FG002|STARTED|Overall Study||10||
59626530|NCT00915954|75739493|FG000|COMPLETED|Overall Study||10||
59626531|NCT00915954|75739494|FG001|COMPLETED|Overall Study||8||
59626532|NCT00915954|75739495|FG002|COMPLETED|Overall Study||10||
59626533|NCT00915954|75739493|FG000|NOT COMPLETED|Overall Study||0||
59626534|NCT00915954|75739494|FG001|NOT COMPLETED|Overall Study||0||
59626535|NCT00915954|75739495|FG002|NOT COMPLETED|Overall Study||0||
59626536|NCT00916032|75739503|FG000|STARTED|Overall Study||12||
59626537|NCT00916032|75739504|FG001|STARTED|Overall Study||11||
59626538|NCT00916032|75739503|FG000|COMPLETED|Overall Study||12||
59626539|NCT00916032|75739504|FG001|COMPLETED|Overall Study||11||
59626540|NCT00916032|75739503|FG000|NOT COMPLETED|Overall Study||0||
59626541|NCT00916032|75739504|FG001|NOT COMPLETED|Overall Study||0||
59626542|NCT00919932|75739512|FG000|STARTED|Overall Study||4||
59626543|NCT00919932|75739513|FG001|STARTED|Overall Study||5||
59626544|NCT00919932|75739512|FG000|COMPLETED|Overall Study||4||
59626545|NCT00919932|75739513|FG001|COMPLETED|Overall Study||5||
59626546|NCT00919932|75739512|FG000|NOT COMPLETED|Overall Study||0||
59626547|NCT00919932|75739513|FG001|NOT COMPLETED|Overall Study||0||
59626548|NCT00922194|75739519|FG000|STARTED|Metformin in Maximum Tolerated Dose|February 2006|102||
59626549|NCT00922194|75739519|FG000|COMPLETED|Metformin in Maximum Tolerated Dose|June 2009|102||
59626550|NCT00922194|75739519|FG000|NOT COMPLETED|Metformin in Maximum Tolerated Dose||0||
59626551|NCT00922194|75739519|FG000|STARTED|Metformin for 12 Months or More|Gradually increasing dose of Extended Release Metformin|102||
59626552|NCT00922194|75739519|FG000|COMPLETED|Metformin for 12 Months or More||102||
59626553|NCT00922194|75739519|FG000|NOT COMPLETED|Metformin for 12 Months or More||0||
59626554|NCT00923598|75739525|FG000|STARTED|Overall Study||23||
59626555|NCT00923598|75739526|FG001|STARTED|Overall Study||22||
59626556|NCT00923598|75739525|FG000|COMPLETED|Overall Study||19||
59626557|NCT00923598|75739526|FG001|COMPLETED|Overall Study||17||
59626558|NCT00923598|75739525|FG000|NOT COMPLETED|Overall Study||4||
59626559|NCT00923598|75739526|FG001|NOT COMPLETED|Overall Study||5||
59626560|NCT00923910|75739534|FG000|STARTED|Period 1||5||
59626561|NCT00923910|75739535|FG001|STARTED|Period 1||5||
59626562|NCT00923910|75739534|FG000|COMPLETED|Period 1||5||
59626563|NCT00923910|75739535|FG001|COMPLETED|Period 1||5||
59626564|NCT00923910|75739534|FG000|NOT COMPLETED|Period 1||0||
59626565|NCT00923910|75739535|FG001|NOT COMPLETED|Period 1||0||
59626566|NCT00923910|75739534|FG000|STARTED|Period 2||5||
59626567|NCT00923910|75739535|FG001|STARTED|Period 2||5||
59626568|NCT00923910|75739534|FG000|COMPLETED|Period 2||5||
59626569|NCT00923910|75739535|FG001|COMPLETED|Period 2||5||
59626570|NCT00923910|75739534|FG000|NOT COMPLETED|Period 2||0||
59626571|NCT00923910|75739535|FG001|NOT COMPLETED|Period 2||0||
59626572|NCT00924066|75739540|FG000|STARTED|Overall Study||41||
59626573|NCT00924066|75739540|FG000|COMPLETED|Overall Study||41||
59626574|NCT00924066|75739540|FG000|NOT COMPLETED|Overall Study||0||
59626575|NCT00924612|75739545|FG000|STARTED|Overall Study||4||
59626576|NCT00924612|75739546|FG001|STARTED|Overall Study||4||
59626577|NCT00924612|75739547|FG002|STARTED|Overall Study||4||
59626578|NCT00924612|75739548|FG003|STARTED|Overall Study||4||
59626579|NCT00924612|75739545|FG000|COMPLETED|Overall Study||4||
59626580|NCT00924612|75739546|FG001|COMPLETED|Overall Study||4||
59626581|NCT00924612|75739547|FG002|COMPLETED|Overall Study||4||
59626582|NCT00924612|75739548|FG003|COMPLETED|Overall Study||4||
59626583|NCT00924612|75739545|FG000|NOT COMPLETED|Overall Study||0||
59626584|NCT00924612|75739546|FG001|NOT COMPLETED|Overall Study||0||
59626585|NCT00924612|75739547|FG002|NOT COMPLETED|Overall Study||0||
59626586|NCT00924612|75739548|FG003|NOT COMPLETED|Overall Study||0||
59626587|NCT00925782|75739560|FG000|STARTED|Pretreatment (Day -30 to Day -3)||12||
59626588|NCT00925782|75739561|FG001|STARTED|Pretreatment (Day -30 to Day -3)||12||
59626589|NCT00925782|75739560|FG000|COMPLETED|Pretreatment (Day -30 to Day -3)||12||
59626590|NCT00925782|75739561|FG001|COMPLETED|Pretreatment (Day -30 to Day -3)||12||
59626591|NCT00925782|75739560|FG000|NOT COMPLETED|Pretreatment (Day -30 to Day -3)||0||
59626592|NCT00925782|75739561|FG001|NOT COMPLETED|Pretreatment (Day -30 to Day -3)||0||
59626593|NCT00925782|75739560|FG000|STARTED|Study Period (Day -3 to Day 0)||12||
59626594|NCT00925782|75739561|FG001|STARTED|Study Period (Day -3 to Day 0)||12||
59626595|NCT00925782|75739560|FG000|COMPLETED|Study Period (Day -3 to Day 0)||12||
59626596|NCT00925782|75739561|FG001|COMPLETED|Study Period (Day -3 to Day 0)||12||
59626597|NCT00925782|75739560|FG000|NOT COMPLETED|Study Period (Day -3 to Day 0)||0||
59626598|NCT00925782|75739561|FG001|NOT COMPLETED|Study Period (Day -3 to Day 0)||0||
59626599|NCT00925782|75739560|FG000|STARTED|Follow-up(Day +1 to Date of Engraftment)||12||
59626600|NCT00925782|75739561|FG001|STARTED|Follow-up(Day +1 to Date of Engraftment)||12||
59626601|NCT00925782|75739560|FG000|COMPLETED|Follow-up(Day +1 to Date of Engraftment)||12||
59626602|NCT00925782|75739561|FG001|COMPLETED|Follow-up(Day +1 to Date of Engraftment)||12||
59626603|NCT00925782|75739560|FG000|NOT COMPLETED|Follow-up(Day +1 to Date of Engraftment)||0||
59626604|NCT00925782|75739561|FG001|NOT COMPLETED|Follow-up(Day +1 to Date of Engraftment)||0||
59626605|NCT00925938|75739571|FG000|STARTED|Overall Study||9||
59626606|NCT00925938|75739572|FG001|STARTED|Overall Study||25||
59626607|NCT00925938|75739573|FG002|STARTED|Overall Study||17||
59626608|NCT00925938|75739571|FG000|COMPLETED|Overall Study||9||
59626609|NCT00925938|75739572|FG001|COMPLETED|Overall Study||25||
59626610|NCT00925938|75739573|FG002|COMPLETED|Overall Study||17||
59626611|NCT00925938|75739571|FG000|NOT COMPLETED|Overall Study||0||
59626612|NCT00925938|75739572|FG001|NOT COMPLETED|Overall Study||0||
59626613|NCT00925938|75739573|FG002|NOT COMPLETED|Overall Study||0||
59626614|NCT00926952|75739581|FG000|STARTED|Overall Study||20||
59626615|NCT00926952|75739581|FG000|COMPLETED|Overall Study||20||
59626616|NCT00926952|75739581|FG000|NOT COMPLETED|Overall Study||0||
59626617|NCT00927264|75739587|FG000|STARTED|Overall Study||165||
59626618|NCT00927264|75739588|FG001|STARTED|Overall Study||165||
59626619|NCT00927264|75739587|FG000|COMPLETED|Overall Study||109||
59626620|NCT00927264|75739588|FG001|COMPLETED|Overall Study||140||
59626621|NCT00927264|75739587|FG000|NOT COMPLETED|Overall Study||56||
59626622|NCT00927264|75739588|FG001|NOT COMPLETED|Overall Study||25||
59626623|NCT00927576|75739598|FG000|STARTED|Overall Study||237||
59626624|NCT00927576|75739599|FG001|STARTED|Overall Study||28||
59626625|NCT00927576|75739598|FG000|Cognitive Testing|Overall Study||237||
59626626|NCT00927576|75739599|FG001|Cognitive Testing|Overall Study||28||
59626627|NCT00927576|75739598|FG000|COMPLETED|Overall Study||237||
59626628|NCT00927576|75739599|FG001|COMPLETED|Overall Study||28||
59626629|NCT00927576|75739598|FG000|NOT COMPLETED|Overall Study||0||
59626630|NCT00927576|75739599|FG001|NOT COMPLETED|Overall Study||0||
59626631|NCT00927888|75739606|FG000|STARTED|Overall Study||29||
59626632|NCT00927888|75739607|FG001|STARTED|Overall Study||27||
59626633|NCT00927888|75739606|FG000|COMPLETED|Overall Study||29||
59626634|NCT00927888|75739607|FG001|COMPLETED|Overall Study||27||
59626635|NCT00927888|75739606|FG000|NOT COMPLETED|Overall Study||0||
59626636|NCT00927888|75739607|FG001|NOT COMPLETED|Overall Study||0||
59626637|NCT00928200|75739615|FG000|STARTED|Overall Study||1||
59626638|NCT00928200|75739615|FG000|COMPLETED|Overall Study||1||
59626639|NCT00928200|75739615|FG000|NOT COMPLETED|Overall Study||0||
59626640|NCT00929838|75739623|FG000|STARTED|Overall Study||63||
59626641|NCT00929838|75739624|FG001|STARTED|Overall Study||65||
59626642|NCT00929838|75739625|FG002|STARTED|Overall Study||63||
59626643|NCT00929838|75739626|FG003|STARTED|Overall Study||64||
59626644|NCT00929838|75739623|FG000|COMPLETED|Overall Study||53||
59626645|NCT00929838|75739624|FG001|COMPLETED|Overall Study||56||
59626646|NCT00929838|75739625|FG002|COMPLETED|Overall Study||53||
59626647|NCT00929838|75739626|FG003|COMPLETED|Overall Study||55||
59626648|NCT00929838|75739623|FG000|NOT COMPLETED|Overall Study||10||
59626649|NCT00929838|75739624|FG001|NOT COMPLETED|Overall Study||9||
59626650|NCT00929838|75739625|FG002|NOT COMPLETED|Overall Study||10||
59626651|NCT00929838|75739626|FG003|NOT COMPLETED|Overall Study||9||
59626652|NCT00931164|75739636|FG000|STARTED|Overall Study||6||
59626653|NCT00931164|75739636|FG000|COMPLETED|Overall Study||6||
59626654|NCT00931164|75739636|FG000|NOT COMPLETED|Overall Study||0||
59626655|NCT00931242|75739642|FG000|STARTED|Overall Study||10||
59626656|NCT00931242|75739643|FG001|STARTED|Overall Study||2||
59626657|NCT00931242|75739642|FG000|COMPLETED|Overall Study||5||
59626658|NCT00931242|75739643|FG001|COMPLETED|Overall Study||0||
59626659|NCT00931242|75739642|FG000|NOT COMPLETED|Overall Study||5||
59626660|NCT00931242|75739643|FG001|NOT COMPLETED|Overall Study||2||
59626661|NCT00932022|75739649|FG000|STARTED|Overall Study||64||
59626662|NCT00932022|75739650|FG001|STARTED|Overall Study||63||
59626663|NCT00932022|75739649|FG000|COMPLETED|Overall Study||59||
59626664|NCT00932022|75739650|FG001|COMPLETED|Overall Study||59||
59626665|NCT00932022|75739649|FG000|NOT COMPLETED|Overall Study||5||
59626666|NCT00932022|75739650|FG001|NOT COMPLETED|Overall Study||4||
59626667|NCT00934596|75739658|FG000|STARTED|Overall Study|Twenty patients were prospectively randomly assigned to the two arms|10||
59626668|NCT00934596|75739659|FG001|STARTED|Overall Study||10||
59626669|NCT00934596|75739658|FG000|COMPLETED|Overall Study||10||
59626670|NCT00934596|75739659|FG001|COMPLETED|Overall Study||10||
59626671|NCT00934596|75739658|FG000|NOT COMPLETED|Overall Study||0||
59626672|NCT00934596|75739659|FG001|NOT COMPLETED|Overall Study||0||
59626673|NCT00935064|75739671|FG000|STARTED|Overall Study||30||
59626674|NCT00935064|75739672|FG001|STARTED|Overall Study||30||
59626675|NCT00935064|75739671|FG000|COMPLETED|Overall Study||30||
59626676|NCT00935064|75739672|FG001|COMPLETED|Overall Study||30||
59626677|NCT00935064|75739671|FG000|NOT COMPLETED|Overall Study||0||
59626678|NCT00935064|75739672|FG001|NOT COMPLETED|Overall Study||0||
59626679|NCT00935766|75739680|FG000|STARTED|Overall Study||42||
59626680|NCT00935766|75739681|FG001|STARTED|Overall Study||34||
59626681|NCT00935766|75739680|FG000|COMPLETED|Overall Study||35||
59626682|NCT00935766|75739681|FG001|COMPLETED|Overall Study||27||
59626683|NCT00935766|75739680|FG000|NOT COMPLETED|Overall Study||7||
59626684|NCT00935766|75739681|FG001|NOT COMPLETED|Overall Study||7||
59626685|NCT00937794|75739687|FG000|STARTED|Overall Study||33||
59626686|NCT00937794|75739687|FG000|COMPLETED|Overall Study||33||
59626687|NCT00937794|75739687|FG000|NOT COMPLETED|Overall Study||0||
59626688|NCT00939120|75739693|FG000|STARTED|Overall Study||23||
59626689|NCT00939120|75739694|FG001|STARTED|Overall Study||23||
59626690|NCT00939120|75739693|FG000|COMPLETED|Overall Study||15||
59626691|NCT00939120|75739694|FG001|COMPLETED|Overall Study||18||
59626692|NCT00939120|75739693|FG000|NOT COMPLETED|Overall Study||8||
59626693|NCT00939120|75739694|FG001|NOT COMPLETED|Overall Study||5||
59626694|NCT00939198|75739700|FG000|STARTED|Overall Study||87||
59626695|NCT00939198|75739700|FG000|COMPLETED|Overall Study||87||
59626696|NCT00939198|75739700|FG000|NOT COMPLETED|Overall Study||0||
59626697|NCT00939900|75739707|FG000|STARTED|Overall Study||55||
59626698|NCT00939900|75739708|FG001|STARTED|Overall Study||55||
59626699|NCT00939900|75739707|FG000|COMPLETED|Overall Study||53||
59626700|NCT00939900|75739708|FG001|COMPLETED|Overall Study||48||
59626701|NCT00939900|75739707|FG000|NOT COMPLETED|Overall Study||2||
59626702|NCT00939900|75739708|FG001|NOT COMPLETED|Overall Study||7||
59626703|NCT00940290|75739718|FG000|STARTED|Overall Study||54||
59626704|NCT00940290|75739719|FG001|STARTED|Overall Study||53||
59626705|NCT00940290|75739720|FG002|STARTED|Overall Study||55||
59626706|NCT00940290|75739721|FG003|STARTED|Overall Study||54||
59626707|NCT00940290|75739718|FG000|COMPLETED|Overall Study||54||
59626708|NCT00940290|75739719|FG001|COMPLETED|Overall Study||53||
59626709|NCT00940290|75739720|FG002|COMPLETED|Overall Study||55||
59626710|NCT00940290|75739721|FG003|COMPLETED|Overall Study||54||
59626711|NCT00940290|75739718|FG000|NOT COMPLETED|Overall Study||0||
59626712|NCT00940290|75739719|FG001|NOT COMPLETED|Overall Study||0||
59626713|NCT00940290|75739720|FG002|NOT COMPLETED|Overall Study||0||
59626714|NCT00940290|75739721|FG003|NOT COMPLETED|Overall Study||0||
59626715|NCT00940446|75739733|FG000|STARTED|Overall Study||30||
59626716|NCT00940446|75739734|FG001|STARTED|Overall Study||30||
59626717|NCT00940446|75739733|FG000|COMPLETED|Overall Study||30||
59626718|NCT00940446|75739734|FG001|COMPLETED|Overall Study||30||
59626719|NCT00940446|75739733|FG000|NOT COMPLETED|Overall Study||0||
59626720|NCT00940446|75739734|FG001|NOT COMPLETED|Overall Study||0||
59626721|NCT00942786|75739742|FG000|STARTED|Overall Study||297||
59626722|NCT00942786|75739742|FG000|COMPLETED|Overall Study|date of last follow-up|297||
59626723|NCT00942786|75739742|FG000|NOT COMPLETED|Overall Study||0||
59626724|NCT00943098|75739751|FG000|STARTED|Overall Study||70||
59626725|NCT00943098|75739752|FG001|STARTED|Overall Study|1 patient was excluded from the ITT and therefore the baseline population is 71|72||
59626726|NCT00943098|75739751|FG000|COMPLETED|Overall Study||70||
59626727|NCT00943098|75739752|FG001|COMPLETED|Overall Study||72||
59626728|NCT00943098|75739751|FG000|NOT COMPLETED|Overall Study||0||
59626729|NCT00943098|75739752|FG001|NOT COMPLETED|Overall Study||0||
59626730|NCT00943488|75739760|FG000|STARTED|Overall Study||204||
59626731|NCT00943488|75739761|FG001|STARTED|Overall Study||204||
59626732|NCT00943488|75739760|FG000|COMPLETED|Overall Study||203||
59626733|NCT00943488|75739761|FG001|COMPLETED|Overall Study||202||
59626734|NCT00943488|75739760|FG000|NOT COMPLETED|Overall Study||1||
59626735|NCT00943488|75739761|FG001|NOT COMPLETED|Overall Study||2||
59626736|NCT00943800|75739767|FG000|STARTED|Overall Study||87||
59626737|NCT00943800|75739767|FG000|COMPLETED|Overall Study||87||
59626738|NCT00943800|75739767|FG000|NOT COMPLETED|Overall Study||0||
59626739|NCT00943878|75739775|FG000|STARTED|Overall Study||202||
59626740|NCT00943878|75739776|FG001|STARTED|Overall Study||200||
59626741|NCT00943878|75739777|FG002|STARTED|Overall Study||203||
59626742|NCT00943878|75739778|FG003|STARTED|Overall Study||200||
59626743|NCT00943878|75739775|FG000|COMPLETED|Overall Study||200||
59626744|NCT00943878|75739776|FG001|COMPLETED|Overall Study||198||
59626745|NCT00943878|75739777|FG002|COMPLETED|Overall Study||197||
59626746|NCT00943878|75739778|FG003|COMPLETED|Overall Study||198||
59626747|NCT00943878|75739775|FG000|NOT COMPLETED|Overall Study||2||
60076244|NCT01904773|76191368|FG004|STARTED|Placebo Washout Third Intervention||3||
60076245|NCT01904773|76191369|FG005|STARTED|Placebo Washout Third Intervention||4||
60076246|NCT01904773|76191370|FG006|STARTED|Placebo Washout Third Intervention||3||
60076247|NCT01904773|76191371|FG007|STARTED|Placebo Washout Third Intervention||3||
60076248|NCT01904773|76191372|FG008|STARTED|Placebo Washout Third Intervention||4||
60076249|NCT01904773|76191364|FG000|COMPLETED|Placebo Washout Third Intervention||0||
60076250|NCT01904773|76191365|FG001|COMPLETED|Placebo Washout Third Intervention||1||
59626748|NCT00943878|75739776|FG001|NOT COMPLETED|Overall Study||2||
59626749|NCT00943878|75739777|FG002|NOT COMPLETED|Overall Study||6||
59626750|NCT00943878|75739778|FG003|NOT COMPLETED|Overall Study||2||
59626751|NCT00945282|75739790|FG000|STARTED|Overall Study||6||
59626752|NCT00945282|75739791|FG001|STARTED|Overall Study||2||
60076251|NCT01904773|76191366|FG002|COMPLETED|Placebo Washout Third Intervention||1||
59626753|NCT00945282|75739790|FG000|COMPLETED|Overall Study||6||
59626754|NCT00945282|75739791|FG001|COMPLETED|Overall Study||2||
59626755|NCT00945282|75739790|FG000|NOT COMPLETED|Overall Study||0||
59626756|NCT00945282|75739791|FG001|NOT COMPLETED|Overall Study||0||
59626757|NCT00945594|75739807|FG000|STARTED|Overall Study||50||
59626758|NCT00945594|75739808|FG001|STARTED|Overall Study||50||
59626759|NCT00945594|75739807|FG000|COMPLETED|Overall Study||50||
59626760|NCT00945594|75739808|FG001|COMPLETED|Overall Study||50||
59626761|NCT00945594|75739807|FG000|NOT COMPLETED|Overall Study||0||
59626762|NCT00945594|75739808|FG001|NOT COMPLETED|Overall Study||0||
59626763|NCT00945750|75739822|FG000|STARTED|Period I||5||
59626764|NCT00945750|75739823|FG001|STARTED|Period I||5||
59626765|NCT00945750|75739824|FG002|STARTED|Period I||5||
59626766|NCT00945750|75739825|FG003|STARTED|Period I||5||
59626767|NCT00945750|75739826|FG004|STARTED|Period I||5||
59626768|NCT00945750|75739827|FG005|STARTED|Period I||5||
59626769|NCT00945750|75739822|FG000|COMPLETED|Period I||5||
59626770|NCT00945750|75739823|FG001|COMPLETED|Period I||5||
59626771|NCT00945750|75739824|FG002|COMPLETED|Period I||5||
59626772|NCT00945750|75739825|FG003|COMPLETED|Period I||5||
59626773|NCT00945750|75739826|FG004|COMPLETED|Period I||5||
59626774|NCT00945750|75739827|FG005|COMPLETED|Period I||5||
59626775|NCT00945750|75739822|FG000|NOT COMPLETED|Period I||0||
59626776|NCT00945750|75739823|FG001|NOT COMPLETED|Period I||0||
59626777|NCT00945750|75739824|FG002|NOT COMPLETED|Period I||0||
59626778|NCT00945750|75739825|FG003|NOT COMPLETED|Period I||0||
59626779|NCT00945750|75739826|FG004|NOT COMPLETED|Period I||0||
59626780|NCT00945750|75739827|FG005|NOT COMPLETED|Period I||0||
59626781|NCT00945750|75739822|FG000|STARTED|Period II||5||
59626782|NCT00945750|75739823|FG001|STARTED|Period II||5||
59626783|NCT00945750|75739824|FG002|STARTED|Period II||5||
59626784|NCT00945750|75739825|FG003|STARTED|Period II||5||
60076252|NCT01904773|76191367|FG003|COMPLETED|Placebo Washout Third Intervention||2||
60076253|NCT01904773|76191368|FG004|COMPLETED|Placebo Washout Third Intervention||3||
60076254|NCT01904773|76191369|FG005|COMPLETED|Placebo Washout Third Intervention||4||
60076255|NCT01904773|76191370|FG006|COMPLETED|Placebo Washout Third Intervention||3||
60076256|NCT01904773|76191371|FG007|COMPLETED|Placebo Washout Third Intervention||3||
59626785|NCT00945750|75739826|FG004|STARTED|Period II||5||
59626786|NCT00945750|75739827|FG005|STARTED|Period II||5||
59626787|NCT00945750|75739822|FG000|COMPLETED|Period II||5||
59626788|NCT00945750|75739823|FG001|COMPLETED|Period II||5||
59626789|NCT00945750|75739824|FG002|COMPLETED|Period II||5||
59626790|NCT00945750|75739825|FG003|COMPLETED|Period II||5||
59626791|NCT00945750|75739826|FG004|COMPLETED|Period II||5||
59626792|NCT00945750|75739827|FG005|COMPLETED|Period II||5||
59626793|NCT00945750|75739822|FG000|NOT COMPLETED|Period II||0||
59626794|NCT00945750|75739823|FG001|NOT COMPLETED|Period II||0||
59626795|NCT00945750|75739824|FG002|NOT COMPLETED|Period II||0||
59626796|NCT00945750|75739825|FG003|NOT COMPLETED|Period II||0||
59626797|NCT00945750|75739826|FG004|NOT COMPLETED|Period II||0||
59626798|NCT00945750|75739827|FG005|NOT COMPLETED|Period II||0||
59626799|NCT00945750|75739822|FG000|STARTED|Period III||5||
59626800|NCT00945750|75739823|FG001|STARTED|Period III||5||
59626801|NCT00945750|75739824|FG002|STARTED|Period III||5||
59626802|NCT00945750|75739825|FG003|STARTED|Period III||5||
59626803|NCT00945750|75739826|FG004|STARTED|Period III||5||
59626804|NCT00945750|75739827|FG005|STARTED|Period III||5||
59626805|NCT00945750|75739822|FG000|COMPLETED|Period III||5||
59626806|NCT00945750|75739823|FG001|COMPLETED|Period III||5||
59626807|NCT00945750|75739824|FG002|COMPLETED|Period III||5||
59626808|NCT00945750|75739825|FG003|COMPLETED|Period III||5||
59626809|NCT00945750|75739826|FG004|COMPLETED|Period III||5||
59626810|NCT00945750|75739827|FG005|COMPLETED|Period III||5||
59626811|NCT00945750|75739822|FG000|NOT COMPLETED|Period III||0||
60076257|NCT01904773|76191372|FG008|COMPLETED|Placebo Washout Third Intervention||4||
60076258|NCT01904773|76191364|FG000|NOT COMPLETED|Placebo Washout Third Intervention||0||
59626812|NCT00945750|75739823|FG001|NOT COMPLETED|Period III||0||
59626813|NCT00945750|75739824|FG002|NOT COMPLETED|Period III||0||
59626814|NCT00945750|75739825|FG003|NOT COMPLETED|Period III||0||
59626815|NCT00945750|75739826|FG004|NOT COMPLETED|Period III||0||
59626816|NCT00945750|75739827|FG005|NOT COMPLETED|Period III||0||
59626817|NCT00947310|75739838|FG000|STARTED|Overall Study||514||
59626818|NCT00947310|75739839|FG001|STARTED|Overall Study||500||
59626819|NCT00947310|75739840|FG002|STARTED|Overall Study||486||
59626820|NCT00947310|75739838|FG000|COMPLETED|Overall Study||514||
59626821|NCT00947310|75739839|FG001|COMPLETED|Overall Study||500||
59626822|NCT00947310|75739840|FG002|COMPLETED|Overall Study||486||
59626823|NCT00947310|75739838|FG000|NOT COMPLETED|Overall Study||0||
59626824|NCT00947310|75739839|FG001|NOT COMPLETED|Overall Study||0||
59626825|NCT00947310|75739840|FG002|NOT COMPLETED|Overall Study||0||
59626826|NCT00948090|75739850|FG000|STARTED|Overall Study||65||
59626827|NCT00948090|75739851|FG001|STARTED|Overall Study||1||
59626828|NCT00948090|75739852|FG002|STARTED|Overall Study||123||
59626829|NCT00948090|75739853|FG003|STARTED|Overall Study||18||
59626830|NCT00948090|75739850|FG000|COMPLETED|Overall Study||22||
59626831|NCT00948090|75739851|FG001|COMPLETED|Overall Study||0||
59626832|NCT00948090|75739852|FG002|COMPLETED|Overall Study||67||
60076259|NCT01904773|76191365|FG001|NOT COMPLETED|Placebo Washout Third Intervention||0||
59626833|NCT00948090|75739853|FG003|COMPLETED|Overall Study||7||
59626834|NCT00948090|75739850|FG000|NOT COMPLETED|Overall Study||43||
59626835|NCT00948090|75739851|FG001|NOT COMPLETED|Overall Study||1||
59626836|NCT00948090|75739852|FG002|NOT COMPLETED|Overall Study||56||
59626837|NCT00948090|75739853|FG003|NOT COMPLETED|Overall Study||11||
59626838|NCT00948792|75739860|FG000|STARTED|Overall Study||21||
59626839|NCT00948792|75739860|FG000|COMPLETED|Overall Study||21||
59626840|NCT00948792|75739860|FG000|NOT COMPLETED|Overall Study||0||
59626841|NCT00950352|75739868|FG000|STARTED|Overall Study||72||
59626842|NCT00950352|75739869|FG001|STARTED|Overall Study||32||
59626843|NCT00950352|75739868|FG000|COMPLETED|Overall Study||30||
59626844|NCT00950352|75739869|FG001|COMPLETED|Overall Study||21||
59626845|NCT00950352|75739868|FG000|NOT COMPLETED|Overall Study||42||
59626846|NCT00950352|75739869|FG001|NOT COMPLETED|Overall Study||11||
59626847|NCT00953862|75739875|FG000|STARTED|Overall Study||18||
59626848|NCT00953862|75739875|FG000|COMPLETED|Overall Study||12||
59626849|NCT00953862|75739875|FG000|NOT COMPLETED|Overall Study||6||
59626850|NCT00955032|75739883|FG000|STARTED|Overall Study||16||
59626851|NCT00955032|75739884|FG001|STARTED|Overall Study||8||
59626852|NCT00955032|75739883|FG000|COMPLETED|Overall Study||16||
59626853|NCT00955032|75739884|FG001|COMPLETED|Overall Study||8||
59626854|NCT00955032|75739883|FG000|NOT COMPLETED|Overall Study||0||
59626855|NCT00955032|75739884|FG001|NOT COMPLETED|Overall Study||0||
59626856|NCT00955266|75739901|FG000|STARTED|Overall Study||4||
59626857|NCT00955266|75739902|FG001|STARTED|Overall Study||4||
59626858|NCT00955266|75739901|FG000|COMPLETED|Overall Study||4||
59626859|NCT00955266|75739902|FG001|COMPLETED|Overall Study||4||
59626860|NCT00955266|75739901|FG000|NOT COMPLETED|Overall Study||0||
59626861|NCT00955266|75739902|FG001|NOT COMPLETED|Overall Study||0||
59626862|NCT00957684|75739912|FG000|STARTED|PART I||102||
59626863|NCT00957684|75739913|FG001|STARTED|PART I||98||
59626864|NCT00957684|75739914|FG002|STARTED|PART I||100||
59626865|NCT00957684|75739915|FG003|STARTED|PART I||102||
59626866|NCT00957684|75739916|FG004|STARTED|PART I||0||
59626867|NCT00957684|75739912|FG000|Randomised (Safety Population)|PART I||102||
59626868|NCT00957684|75739913|FG001|Randomised (Safety Population)|PART I||98||
59626869|NCT00957684|75739914|FG002|Randomised (Safety Population)|PART I||100||
59626870|NCT00957684|75739915|FG003|Randomised (Safety Population)|PART I||102||
59626871|NCT00957684|75739916|FG004|Randomised (Safety Population)|PART I||0||
59626872|NCT00957684|75739912|FG000|Intention-to-treat (ITT) Population|PART I||98||
59626873|NCT00957684|75739913|FG001|Intention-to-treat (ITT) Population|PART I||98||
59626874|NCT00957684|75739914|FG002|Intention-to-treat (ITT) Population|PART I||99||
59626875|NCT00957684|75739915|FG003|Intention-to-treat (ITT) Population|PART I||102||
59626876|NCT00957684|75739916|FG004|Intention-to-treat (ITT) Population|PART I||0||
59626877|NCT00957684|75739912|FG000|Per-protocol (PP)Population|PART I||72||
59626878|NCT00957684|75739913|FG001|Per-protocol (PP)Population|PART I||86||
59626879|NCT00957684|75739914|FG002|Per-protocol (PP)Population|PART I||94||
59626880|NCT00957684|75739915|FG003|Per-protocol (PP)Population|PART I||91||
59626881|NCT00957684|75739916|FG004|Per-protocol (PP)Population|PART I||0||
59626882|NCT00957684|75739912|FG000|COMPLETED|PART I||71||
59626883|NCT00957684|75739913|FG001|COMPLETED|PART I||85||
59626884|NCT00957684|75739914|FG002|COMPLETED|PART I||90||
59626885|NCT00957684|75739915|FG003|COMPLETED|PART I||84||
59626886|NCT00957684|75739916|FG004|COMPLETED|PART I||0||
59626887|NCT00957684|75739912|FG000|NOT COMPLETED|PART I||31||
59626888|NCT00957684|75739913|FG001|NOT COMPLETED|PART I||13||
59626889|NCT00957684|75739914|FG002|NOT COMPLETED|PART I||10||
59626890|NCT00957684|75739915|FG003|NOT COMPLETED|PART I||18||
59626891|NCT00957684|75739916|FG004|NOT COMPLETED|PART I||0||
59626892|NCT00957684|75739912|FG000|STARTED|PART II||0||
59626893|NCT00957684|75739913|FG001|STARTED|PART II||0||
59626894|NCT00957684|75739914|FG002|STARTED|PART II||0||
59626895|NCT00957684|75739915|FG003|STARTED|PART II||0||
59626896|NCT00957684|75739916|FG004|STARTED|PART II||314||
59626897|NCT00957684|75739912|FG000|Patients Entered Part II|PART II||0||
59626898|NCT00957684|75739913|FG001|Patients Entered Part II|PART II||0||
59626899|NCT00957684|75739914|FG002|Patients Entered Part II|PART II||0||
59626900|NCT00957684|75739915|FG003|Patients Entered Part II|PART II||0||
59626901|NCT00957684|75739916|FG004|Patients Entered Part II|PART II||314||
59626902|NCT00957684|75739912|FG000|COMPLETED|PART II||0||
59626903|NCT00957684|75739913|FG001|COMPLETED|PART II||0||
59626904|NCT00957684|75739914|FG002|COMPLETED|PART II||0||
59626905|NCT00957684|75739915|FG003|COMPLETED|PART II||0||
59626906|NCT00957684|75739916|FG004|COMPLETED|PART II||239||
59626907|NCT00957684|75739912|FG000|NOT COMPLETED|PART II||0||
59626908|NCT00957684|75739913|FG001|NOT COMPLETED|PART II||0||
59626909|NCT00957684|75739914|FG002|NOT COMPLETED|PART II||0||
59626910|NCT00957684|75739915|FG003|NOT COMPLETED|PART II||0||
59626911|NCT00957684|75739916|FG004|NOT COMPLETED|PART II||75||
59626912|NCT00958308|75739929|FG000|STARTED|Overall Study||84||
59626913|NCT00958308|75739930|FG001|STARTED|Overall Study||85||
59626914|NCT00958308|75739931|FG002|STARTED|Overall Study||86||
59626915|NCT00958308|75739929|FG000|COMPLETED|Overall Study||84||
59626916|NCT00958308|75739930|FG001|COMPLETED|Overall Study||85||
59626917|NCT00958308|75739931|FG002|COMPLETED|Overall Study||86||
59626918|NCT00958308|75739929|FG000|NOT COMPLETED|Overall Study||0||
59626919|NCT00958308|75739930|FG001|NOT COMPLETED|Overall Study||0||
59626920|NCT00958308|75739931|FG002|NOT COMPLETED|Overall Study||0||
59626921|NCT00959166|75739941|FG000|STARTED|Overall Study||24||
59626922|NCT00959166|75739942|FG001|STARTED|Overall Study||57||
59626923|NCT00959166|75739941|FG000|COMPLETED|Overall Study||24||
59626924|NCT00959166|75739942|FG001|COMPLETED|Overall Study||57||
59626925|NCT00959166|75739941|FG000|NOT COMPLETED|Overall Study||0||
59626926|NCT00959166|75739942|FG001|NOT COMPLETED|Overall Study||0||
59626927|NCT00961662|75739951|FG000|STARTED|Overall Study||57||
59626928|NCT00961662|75739952|FG001|STARTED|Overall Study||51||
59626929|NCT00961662|75739953|FG002|STARTED|Overall Study||53||
59626930|NCT00961662|75739951|FG000|COMPLETED|Overall Study||35||
59626931|NCT00961662|75739952|FG001|COMPLETED|Overall Study||32||
59626932|NCT00961662|75739953|FG002|COMPLETED|Overall Study||34||
59626933|NCT00961662|75739951|FG000|NOT COMPLETED|Overall Study||22||
59626934|NCT00961662|75739952|FG001|NOT COMPLETED|Overall Study||19||
59626935|NCT00961662|75739953|FG002|NOT COMPLETED|Overall Study||19||
59626936|NCT00962598|75739963|FG000|STARTED|Overall Study||7||
59626937|NCT00962598|75739964|FG001|STARTED|Overall Study||9||
59626938|NCT00962598|75739963|FG000|COMPLETED|Overall Study||7||
59626939|NCT00962598|75739964|FG001|COMPLETED|Overall Study||9||
59626940|NCT00962598|75739963|FG000|NOT COMPLETED|Overall Study||0||
59626941|NCT00962598|75739964|FG001|NOT COMPLETED|Overall Study||0||
59626942|NCT00962754|75739972|FG000|STARTED|Overall Study||86||
59626943|NCT00962754|75739973|FG001|STARTED|Overall Study||84||
59626944|NCT00962754|75739972|FG000|COMPLETED|Overall Study||86||
59626945|NCT00962754|75739973|FG001|COMPLETED|Overall Study||84||
59626946|NCT00962754|75739972|FG000|NOT COMPLETED|Overall Study||0||
59626947|NCT00962754|75739973|FG001|NOT COMPLETED|Overall Study||0||
59539552|NCT00825266|75637911|FG000|STARTED|Overall Study||1||
59626948|NCT00964548|75739985|FG000|STARTED|Overall Study||5||
59626949|NCT00964548|75739986|FG001|STARTED|Overall Study||5||
59626950|NCT00964548|75739985|FG000|COMPLETED|Overall Study||5||
59626951|NCT00964548|75739986|FG001|COMPLETED|Overall Study||5||
59626952|NCT00964548|75739985|FG000|NOT COMPLETED|Overall Study||0||
59626953|NCT00964548|75739986|FG001|NOT COMPLETED|Overall Study||0||
59626954|NCT00905268|75739996|FG000|STARTED|Overall Study||57||
59626955|NCT00905268|75739997|FG001|STARTED|Overall Study||57||
59626956|NCT00905268|75739998|FG002|STARTED|Overall Study||59||
59626957|NCT00905268|75739999|FG003|STARTED|Overall Study||59||
59626958|NCT00905268|75739996|FG000|COMPLETED|Overall Study||53||
59626959|NCT00905268|75739997|FG001|COMPLETED|Overall Study||56||
59626960|NCT00905268|75739998|FG002|COMPLETED|Overall Study||59||
59626961|NCT00905268|75739999|FG003|COMPLETED|Overall Study||57||
59626962|NCT00905268|75739996|FG000|NOT COMPLETED|Overall Study||4||
59626963|NCT00905268|75739997|FG001|NOT COMPLETED|Overall Study||1||
59626964|NCT00905268|75739998|FG002|NOT COMPLETED|Overall Study||0||
59626965|NCT00905268|75739999|FG003|NOT COMPLETED|Overall Study||2||
59626966|NCT00965250|75740011|FG000|STARTED|Overall Study||37||
59626967|NCT00965250|75740012|FG001|STARTED|Overall Study||12||
59626968|NCT00965250|75740011|FG000|COMPLETED|Overall Study||37||
59626969|NCT00965250|75740012|FG001|COMPLETED|Overall Study||12||
59626970|NCT00965250|75740011|FG000|NOT COMPLETED|Overall Study||0||
59626971|NCT00965250|75740012|FG001|NOT COMPLETED|Overall Study||0||
59626972|NCT00966186|75740020|FG000|STARTED|Overall Study||60||
59626973|NCT00966186|75740021|FG001|STARTED|Overall Study||60||
59626974|NCT00966186|75740020|FG000|COMPLETED|Overall Study||60||
59626975|NCT00966186|75740021|FG001|COMPLETED|Overall Study||60||
59626976|NCT00966186|75740020|FG000|NOT COMPLETED|Overall Study||0||
59626977|NCT00966186|75740021|FG001|NOT COMPLETED|Overall Study||0||
59626978|NCT00967044|75740027|FG000|STARTED|Overall Study||30||
59626979|NCT00967044|75740027|FG000|COMPLETED|Overall Study||30||
59626980|NCT00967044|75740027|FG000|NOT COMPLETED|Overall Study||0||
59539553|NCT00825266|75637912|FG001|STARTED|Overall Study||1||
59539554|NCT00825266|75637911|FG000|COMPLETED|Overall Study||1||
59539555|NCT00825266|75637912|FG001|COMPLETED|Overall Study||1||
59539556|NCT00825266|75637911|FG000|NOT COMPLETED|Overall Study||0||
59539557|NCT00825266|75637912|FG001|NOT COMPLETED|Overall Study||0||
59539558|NCT01385189|75637923|FG000|STARTED|Overall Study||12||
59539559|NCT01385189|75637924|FG001|STARTED|Overall Study||12||
59626981|NCT00968838|75740033|FG000|STARTED|Overall Study||50||
59626982|NCT00968838|75740034|FG001|STARTED|Overall Study||58||
59626983|NCT00968838|75740033|FG000|COMPLETED|Overall Study||50||
59626984|NCT00968838|75740034|FG001|COMPLETED|Overall Study||58||
59626985|NCT00968838|75740033|FG000|NOT COMPLETED|Overall Study||0||
59626986|NCT00968838|75740034|FG001|NOT COMPLETED|Overall Study||0||
59626987|NCT00970320|75740045|FG000|STARTED|Overall Study||25||
59626988|NCT00970320|75740046|FG001|STARTED|Overall Study||24||
59626989|NCT00970320|75740047|FG002|STARTED|Overall Study||48||
59626990|NCT00970320|75740048|FG003|STARTED|Overall Study||50||
59626991|NCT00970320|75740049|FG004|STARTED|Overall Study||1571||
59626992|NCT00970320|75740045|FG000|COMPLETED|Overall Study||25||
59626993|NCT00970320|75740046|FG001|COMPLETED|Overall Study||13||
59626994|NCT00970320|75740047|FG002|COMPLETED|Overall Study||35||
59626995|NCT00970320|75740048|FG003|COMPLETED|Overall Study||36||
59626996|NCT00970320|75740049|FG004|COMPLETED|Overall Study||1031||
59626997|NCT00970320|75740045|FG000|NOT COMPLETED|Overall Study||0||
59626998|NCT00970320|75740046|FG001|NOT COMPLETED|Overall Study||11||
59626999|NCT00970320|75740047|FG002|NOT COMPLETED|Overall Study||13||
59627000|NCT00970320|75740048|FG003|NOT COMPLETED|Overall Study||14||
59627001|NCT00970320|75740049|FG004|NOT COMPLETED|Overall Study||540||
59627002|NCT00973752|75740061|FG000|STARTED|Overall Study||30||
59627003|NCT00973752|75740061|FG000|COMPLETED|Overall Study||30||
59627004|NCT00973752|75740061|FG000|NOT COMPLETED|Overall Study||0||
59627005|NCT00974142|75740067|FG000|STARTED|Overall Study||8||
59627006|NCT00974142|75740068|FG001|STARTED|Overall Study||9||
59627007|NCT00974142|75740067|FG000|COMPLETED|Overall Study||8||
59627008|NCT00974142|75740068|FG001|COMPLETED|Overall Study||9||
59627009|NCT00974142|75740067|FG000|NOT COMPLETED|Overall Study||0||
59627010|NCT00974142|75740068|FG001|NOT COMPLETED|Overall Study||0||
59627011|NCT00974376|75740076|FG000|STARTED|Overall Study||75||
59627012|NCT00974376|75740077|FG001|STARTED|Overall Study||75||
59627013|NCT00974376|75740076|FG000|COMPLETED|Overall Study||41||
59627014|NCT00974376|75740077|FG001|COMPLETED|Overall Study||42||
59627015|NCT00974376|75740076|FG000|NOT COMPLETED|Overall Study||34||
59627016|NCT00974376|75740077|FG001|NOT COMPLETED|Overall Study||33||
59627017|NCT00976248|75740083|FG000|STARTED|Overall Study||33||
59539560|NCT01385189|75637925|FG002|STARTED|Overall Study||4||
59539561|NCT01385189|75637926|FG003|STARTED|Overall Study||4||
59539562|NCT01385189|75637927|FG004|STARTED|Overall Study||8||
59539563|NCT01385189|75637923|FG000|COMPLETED|Overall Study||11||
59539564|NCT01385189|75637924|FG001|COMPLETED|Overall Study||11||
59539565|NCT01385189|75637925|FG002|COMPLETED|Overall Study||4||
59539566|NCT01385189|75637926|FG003|COMPLETED|Overall Study||3||
59539567|NCT01385189|75637927|FG004|COMPLETED|Overall Study||6||
59539568|NCT01385189|75637923|FG000|NOT COMPLETED|Overall Study||1||
59539569|NCT01385189|75637924|FG001|NOT COMPLETED|Overall Study||1||
59539570|NCT01385189|75637925|FG002|NOT COMPLETED|Overall Study||0||
59539571|NCT01385189|75637926|FG003|NOT COMPLETED|Overall Study||1||
59539572|NCT01385189|75637927|FG004|NOT COMPLETED|Overall Study||2||
59539573|NCT01385579|75637948|FG000|STARTED|Overall Study||98||
59539574|NCT01385579|75637949|FG001|STARTED|Overall Study||104||
59539575|NCT01385579|75637948|FG000|COMPLETED|Overall Study||98||
59539576|NCT01385579|75637949|FG001|COMPLETED|Overall Study||104||
59539577|NCT01385579|75637948|FG000|NOT COMPLETED|Overall Study||0||
59539578|NCT01385579|75637949|FG001|NOT COMPLETED|Overall Study||0||
59627018|NCT00976248|75740083|FG000|COMPLETED|Overall Study||33||
59627019|NCT00976248|75740083|FG000|NOT COMPLETED|Overall Study||0||
59627020|NCT00976404|75740090|FG000|STARTED|Overall Study||14||
59627021|NCT00976404|75740091|FG001|STARTED|Overall Study||14||
59627022|NCT00976404|75740090|FG000|COMPLETED|Overall Study||14||
59627023|NCT00976404|75740091|FG001|COMPLETED|Overall Study||14||
59627024|NCT00976404|75740090|FG000|NOT COMPLETED|Overall Study||0||
59627025|NCT00976404|75740091|FG001|NOT COMPLETED|Overall Study||0||
59627026|NCT00977184|75740101|FG000|STARTED|Overall Study||13||
59627027|NCT00977184|75740102|FG001|STARTED|Overall Study||13||
59627028|NCT00977184|75740101|FG000|COMPLETED|Overall Study||13||
59627029|NCT00977184|75740102|FG001|COMPLETED|Overall Study||13||
59627030|NCT00977184|75740101|FG000|NOT COMPLETED|Overall Study||0||
59627031|NCT00977184|75740102|FG001|NOT COMPLETED|Overall Study||0||
59627032|NCT00977808|75740115|FG000|STARTED|Overall Study||12||
59627033|NCT00977808|75740115|FG000|Completion of Open-Loop Admission|Overall Study||12||
59627034|NCT00977808|75740115|FG000|Completion of Closed-Loop Admission|Overall Study||11||
59627035|NCT00977808|75740115|FG000|COMPLETED|Overall Study||11||
59627036|NCT00977808|75740115|FG000|NOT COMPLETED|Overall Study||1||
59627037|NCT00981474|75740122|FG000|STARTED|Overall Study||228||
59627038|NCT00981474|75740123|FG001|STARTED|Overall Study||232||
59627039|NCT00981474|75740122|FG000|COMPLETED|Overall Study||228||
59627040|NCT00981474|75740123|FG001|COMPLETED|Overall Study||232||
59627041|NCT00981474|75740122|FG000|NOT COMPLETED|Overall Study||0||
59627042|NCT00981474|75740123|FG001|NOT COMPLETED|Overall Study||0||
59627043|NCT00981630|75740135|FG000|STARTED|Overall Study||32||
59627044|NCT00981630|75740136|FG001|STARTED|Overall Study||32||
59627045|NCT00981630|75740137|FG002|STARTED|Overall Study||32||
59627046|NCT00981630|75740138|FG003|STARTED|Overall Study||32||
59627047|NCT00981630|75740135|FG000|COMPLETED|Overall Study||32||
59627048|NCT00981630|75740136|FG001|COMPLETED|Overall Study||32||
59627049|NCT00981630|75740137|FG002|COMPLETED|Overall Study||32||
59627050|NCT00981630|75740138|FG003|COMPLETED|Overall Study||32||
59627051|NCT00981630|75740135|FG000|NOT COMPLETED|Overall Study||0||
59627052|NCT00981630|75740136|FG001|NOT COMPLETED|Overall Study||0||
59627053|NCT00981630|75740137|FG002|NOT COMPLETED|Overall Study||0||
59627054|NCT00981630|75740138|FG003|NOT COMPLETED|Overall Study||0||
59627055|NCT00983346|75740148|FG000|STARTED|Overall Study||17||
59627056|NCT00983346|75740148|FG000|COMPLETED|Overall Study||17||
59627057|NCT00983346|75740148|FG000|NOT COMPLETED|Overall Study||0||
59627058|NCT00985140|75740152|FG000|STARTED|Overall Study||15||
59627059|NCT00985140|75740152|FG000|COMPLETED|Overall Study||15||
59627060|NCT00985140|75740152|FG000|NOT COMPLETED|Overall Study||0||
59627061|NCT00986856|75740158|FG000|STARTED|Overall Study||42||
59627062|NCT00986856|75740159|FG001|STARTED|Overall Study||16||
59627063|NCT00986856|75740158|FG000|COMPLETED|Overall Study||42||
59627064|NCT00986856|75740159|FG001|COMPLETED|Overall Study||16||
59627065|NCT00986856|75740158|FG000|NOT COMPLETED|Overall Study||0||
59627066|NCT00986856|75740159|FG001|NOT COMPLETED|Overall Study||0||
59627067|NCT00987480|75740165|FG000|STARTED|Overall Study||45||
59627068|NCT00987480|75740165|FG000|COMPLETED|Overall Study||45||
59627069|NCT00987480|75740165|FG000|NOT COMPLETED|Overall Study||0||
59627070|NCT00987558|75740169|FG000|STARTED|Overall Study||13||
59627071|NCT00987558|75740170|FG001|STARTED|Overall Study||17||
59627072|NCT00987558|75740169|FG000|Simvastatin|Overall Study||13||
59627073|NCT00987558|75740170|FG001|Simvastatin|Overall Study||12||
59627074|NCT00987558|75740169|FG000|Washout|Overall Study||13||
59627075|NCT00987558|75740170|FG001|Washout|Overall Study||12||
59627076|NCT00987558|75740169|FG000|Eslicarbazepine Acetate + Simvastatin|Overall Study||13||
59627077|NCT00987558|75740170|FG001|Eslicarbazepine Acetate + Simvastatin|Overall Study||17||
59627078|NCT00987558|75740169|FG000|COMPLETED|Overall Study||12||
59627079|NCT00987558|75740170|FG001|COMPLETED|Overall Study||12||
59627080|NCT00987558|75740169|FG000|NOT COMPLETED|Overall Study||1||
59627081|NCT00987558|75740170|FG001|NOT COMPLETED|Overall Study||5||
59627082|NCT00987948|75740177|FG000|STARTED|Overall Study||15||
59627083|NCT00987948|75740177|FG000|COMPLETED|Overall Study||12||
59627084|NCT00987948|75740177|FG000|NOT COMPLETED|Overall Study||3||
59627085|NCT00989586|75740183|FG000|STARTED|Overall Study||18||
59627086|NCT00989586|75740184|FG001|STARTED|Overall Study||17||
59627087|NCT00989586|75740183|FG000|COMPLETED|Overall Study||18||
59627088|NCT00989586|75740184|FG001|COMPLETED|Overall Study||17||
59627089|NCT00989586|75740183|FG000|NOT COMPLETED|Overall Study||0||
59627090|NCT00989586|75740184|FG001|NOT COMPLETED|Overall Study||0||
59627091|NCT00990288|75740193|FG000|STARTED|Overall Study||97||
59627092|NCT00990288|75740194|FG001|STARTED|Overall Study||99||
59627093|NCT00990288|75740193|FG000|COMPLETED|Overall Study||97||
59627094|NCT00990288|75740194|FG001|COMPLETED|Overall Study||99||
59627095|NCT00990288|75740193|FG000|NOT COMPLETED|Overall Study||0||
59627096|NCT00990288|75740194|FG001|NOT COMPLETED|Overall Study||0||
59627097|NCT00991458|75740203|FG000|STARTED|Overall Study||207||
59627098|NCT00991458|75740204|FG001|STARTED|Overall Study||209||
59627099|NCT00991458|75740205|FG002|STARTED|Overall Study||205||
59627100|NCT00991458|75740203|FG000|COMPLETED|Overall Study||187||
59627101|NCT00991458|75740204|FG001|COMPLETED|Overall Study||181||
59627102|NCT00991458|75740205|FG002|COMPLETED|Overall Study||180||
59627103|NCT00991458|75740203|FG000|NOT COMPLETED|Overall Study||20||
59627104|NCT00991458|75740204|FG001|NOT COMPLETED|Overall Study||28||
59627105|NCT00991458|75740205|FG002|NOT COMPLETED|Overall Study||25||
59627106|NCT00993798|75740216|FG000|STARTED|Overall Study||53||
59627107|NCT00993798|75740217|FG001|STARTED|Overall Study||25||
59627108|NCT00993798|75740218|FG002|STARTED|Overall Study||29||
59627109|NCT00993798|75740219|FG003|STARTED|Overall Study||0||
59627110|NCT00993798|75740220|FG004|STARTED|Overall Study||0||
59627111|NCT00993798|75740216|FG000|COMPLETED|Overall Study||53||
59627112|NCT00993798|75740217|FG001|COMPLETED|Overall Study||25||
59627113|NCT00993798|75740218|FG002|COMPLETED|Overall Study||29||
59627114|NCT00993798|75740219|FG003|COMPLETED|Overall Study||0||
59627115|NCT00993798|75740220|FG004|COMPLETED|Overall Study||0||
59627116|NCT00993798|75740216|FG000|NOT COMPLETED|Overall Study||0||
59627117|NCT00993798|75740217|FG001|NOT COMPLETED|Overall Study||0||
59627118|NCT00993798|75740218|FG002|NOT COMPLETED|Overall Study||0||
59627119|NCT00993798|75740219|FG003|NOT COMPLETED|Overall Study||0||
59627120|NCT00993798|75740220|FG004|NOT COMPLETED|Overall Study||0||
59627121|NCT00995904|75740228|FG000|STARTED|Visit 2 (Randomization)||4||
59627122|NCT00995904|75740229|FG001|STARTED|Visit 2 (Randomization)||3||
59627123|NCT00995904|75740230|FG002|STARTED|Visit 2 (Randomization)||4||
59627124|NCT00995904|75740231|FG003|STARTED|Visit 2 (Randomization)||5||
59627125|NCT00995904|75740232|FG004|STARTED|Visit 2 (Randomization)||5||
59627126|NCT00995904|75740233|FG005|STARTED|Visit 2 (Randomization)||4||
59627127|NCT00995904|75740228|FG000|COMPLETED|Visit 2 (Randomization)||4||
59627128|NCT00995904|75740229|FG001|COMPLETED|Visit 2 (Randomization)||3||
59627129|NCT00995904|75740230|FG002|COMPLETED|Visit 2 (Randomization)||4||
59627130|NCT00995904|75740231|FG003|COMPLETED|Visit 2 (Randomization)||5||
59627131|NCT00995904|75740232|FG004|COMPLETED|Visit 2 (Randomization)||5||
59627132|NCT00995904|75740233|FG005|COMPLETED|Visit 2 (Randomization)||4||
59627133|NCT00995904|75740228|FG000|NOT COMPLETED|Visit 2 (Randomization)||0||
59627134|NCT00995904|75740229|FG001|NOT COMPLETED|Visit 2 (Randomization)||0||
59627135|NCT00995904|75740230|FG002|NOT COMPLETED|Visit 2 (Randomization)||0||
59627136|NCT00995904|75740231|FG003|NOT COMPLETED|Visit 2 (Randomization)||0||
59627137|NCT00995904|75740232|FG004|NOT COMPLETED|Visit 2 (Randomization)||0||
59627138|NCT00995904|75740233|FG005|NOT COMPLETED|Visit 2 (Randomization)||0||
59627139|NCT00995904|75740228|FG000|STARTED|Visit 3||4||
59627140|NCT00995904|75740229|FG001|STARTED|Visit 3||3||
59627141|NCT00995904|75740230|FG002|STARTED|Visit 3||4||
59627142|NCT00995904|75740231|FG003|STARTED|Visit 3||5||
59627143|NCT00995904|75740232|FG004|STARTED|Visit 3||5||
59627144|NCT00995904|75740233|FG005|STARTED|Visit 3|One subject was withdrawn from the study after completion of Visit 2 but prior to Visit 3.|3||
59627145|NCT00995904|75740228|FG000|COMPLETED|Visit 3||4||
59627146|NCT00995904|75740229|FG001|COMPLETED|Visit 3||3||
59627147|NCT00995904|75740230|FG002|COMPLETED|Visit 3||4||
59627148|NCT00995904|75740231|FG003|COMPLETED|Visit 3||5||
59627149|NCT00995904|75740232|FG004|COMPLETED|Visit 3||5||
59627150|NCT00995904|75740233|FG005|COMPLETED|Visit 3||3||
59627151|NCT00995904|75740228|FG000|NOT COMPLETED|Visit 3||0||
59627152|NCT00995904|75740229|FG001|NOT COMPLETED|Visit 3||0||
59627153|NCT00995904|75740230|FG002|NOT COMPLETED|Visit 3||0||
59627154|NCT00995904|75740231|FG003|NOT COMPLETED|Visit 3||0||
59627155|NCT00995904|75740232|FG004|NOT COMPLETED|Visit 3||0||
59539579|NCT01386983|75637957|FG000|STARTED|Overall Study||264||
59539580|NCT01386983|75637958|FG001|STARTED|Overall Study||68||
59539581|NCT01386983|75637957|FG000|COMPLETED|Overall Study||264||
59539582|NCT01386983|75637958|FG001|COMPLETED|Overall Study||68||
59539583|NCT01386983|75637957|FG000|NOT COMPLETED|Overall Study||0||
59539584|NCT01386983|75637958|FG001|NOT COMPLETED|Overall Study||0||
59539585|NCT00868712|75637967|FG000|STARTED|Overall Study||31||
59539586|NCT00868712|75637968|FG001|STARTED|Overall Study||11||
59539587|NCT00868712|75637969|FG002|STARTED|Overall Study||28||
59539588|NCT00868712|75637967|FG000|COMPLETED|Overall Study||31||
59539589|NCT00868712|75637968|FG001|COMPLETED|Overall Study||11||
59539590|NCT00868712|75637969|FG002|COMPLETED|Overall Study||28||
59539591|NCT00868712|75637967|FG000|NOT COMPLETED|Overall Study||0||
59539592|NCT00868712|75637968|FG001|NOT COMPLETED|Overall Study||0||
59539593|NCT00868712|75637969|FG002|NOT COMPLETED|Overall Study||0||
59539594|NCT01387139|75637979|FG000|STARTED|Overall Study||99||
59539595|NCT01387139|75637980|FG001|STARTED|Overall Study||84||
59539596|NCT01387139|75637979|FG000|COMPLETED|Overall Study||99||
59539597|NCT01387139|75637980|FG001|COMPLETED|Overall Study||84||
59539598|NCT01387139|75637979|FG000|NOT COMPLETED|Overall Study||0||
59539599|NCT01387139|75637980|FG001|NOT COMPLETED|Overall Study||0||
59539600|NCT00870896|75637986|FG000|STARTED|Overall Study||5||
59539601|NCT00870896|75637986|FG000|COMPLETED|Overall Study||5||
59539602|NCT00870896|75637986|FG000|NOT COMPLETED|Overall Study||0||
59539603|NCT00825344|75637994|FG000|STARTED|Overall Study||34||
59539604|NCT00825344|75637995|FG001|STARTED|Overall Study||43||
59539605|NCT00825344|75637994|FG000|COMPLETED|Overall Study||33||
59539606|NCT00825344|75637995|FG001|COMPLETED|Overall Study||42||
59539607|NCT00825344|75637994|FG000|NOT COMPLETED|Overall Study||1||
59539608|NCT00825344|75637995|FG001|NOT COMPLETED|Overall Study||1||
59539609|NCT00871286|75638003|FG000|STARTED|Overall Study||20||
59627156|NCT00995904|75740233|FG005|NOT COMPLETED|Visit 3||0||
59627157|NCT00995904|75740228|FG000|STARTED|Visit 4||4||
59627158|NCT00995904|75740229|FG001|STARTED|Visit 4||3||
59627159|NCT00995904|75740230|FG002|STARTED|Visit 4||4||
59627160|NCT00995904|75740231|FG003|STARTED|Visit 4||5||
59627161|NCT00995904|75740232|FG004|STARTED|Visit 4||5||
59627162|NCT00995904|75740233|FG005|STARTED|Visit 4||3||
59627163|NCT00995904|75740228|FG000|COMPLETED|Visit 4||4||
59627164|NCT00995904|75740229|FG001|COMPLETED|Visit 4||3||
59627165|NCT00995904|75740230|FG002|COMPLETED|Visit 4||4||
59627166|NCT00995904|75740231|FG003|COMPLETED|Visit 4||5||
59539610|NCT00871286|75638004|FG001|STARTED|Overall Study||20||
59627167|NCT00995904|75740232|FG004|COMPLETED|Visit 4||5||
59627168|NCT00995904|75740233|FG005|COMPLETED|Visit 4||3||
59627169|NCT00995904|75740228|FG000|NOT COMPLETED|Visit 4||0||
59539611|NCT00871286|75638003|FG000|COMPLETED|Overall Study||20||
59539612|NCT00871286|75638004|FG001|COMPLETED|Overall Study||14||
59539613|NCT00871286|75638003|FG000|NOT COMPLETED|Overall Study||0||
59627170|NCT00995904|75740229|FG001|NOT COMPLETED|Visit 4||0||
59627171|NCT00995904|75740230|FG002|NOT COMPLETED|Visit 4||0||
59627172|NCT00995904|75740231|FG003|NOT COMPLETED|Visit 4||0||
59627173|NCT00995904|75740232|FG004|NOT COMPLETED|Visit 4||0||
59627174|NCT00995904|75740233|FG005|NOT COMPLETED|Visit 4||0||
59627175|NCT00995904|75740228|FG000|STARTED|Follow-up Visit (Final Visit)||4||
59627176|NCT00995904|75740229|FG001|STARTED|Follow-up Visit (Final Visit)||3||
59627177|NCT00995904|75740230|FG002|STARTED|Follow-up Visit (Final Visit)||4||
59627178|NCT00995904|75740231|FG003|STARTED|Follow-up Visit (Final Visit)||5||
59627179|NCT00995904|75740232|FG004|STARTED|Follow-up Visit (Final Visit)||5||
59627180|NCT00995904|75740233|FG005|STARTED|Follow-up Visit (Final Visit)||3||
59627181|NCT00995904|75740228|FG000|COMPLETED|Follow-up Visit (Final Visit)||4||
59627182|NCT00995904|75740229|FG001|COMPLETED|Follow-up Visit (Final Visit)||3||
59627183|NCT00995904|75740230|FG002|COMPLETED|Follow-up Visit (Final Visit)||4||
59627184|NCT00995904|75740231|FG003|COMPLETED|Follow-up Visit (Final Visit)||5||
59627185|NCT00995904|75740232|FG004|COMPLETED|Follow-up Visit (Final Visit)||5||
59627186|NCT00995904|75740233|FG005|COMPLETED|Follow-up Visit (Final Visit)||3||
59627187|NCT00995904|75740228|FG000|NOT COMPLETED|Follow-up Visit (Final Visit)||0||
59627188|NCT00995904|75740229|FG001|NOT COMPLETED|Follow-up Visit (Final Visit)||0||
59627189|NCT00995904|75740230|FG002|NOT COMPLETED|Follow-up Visit (Final Visit)||0||
59627190|NCT00995904|75740231|FG003|NOT COMPLETED|Follow-up Visit (Final Visit)||0||
59627191|NCT00995904|75740232|FG004|NOT COMPLETED|Follow-up Visit (Final Visit)||0||
59627192|NCT00995904|75740233|FG005|NOT COMPLETED|Follow-up Visit (Final Visit)||0||
59627193|NCT00996372|75740246|FG000|STARTED|Overall Study||468||
59627194|NCT00996372|75740247|FG001|STARTED|Overall Study||481||
59627195|NCT00996372|75740246|FG000|COMPLETED|Overall Study||365||
59627196|NCT00996372|75740247|FG001|COMPLETED|Overall Study||397||
59627197|NCT00996372|75740246|FG000|NOT COMPLETED|Overall Study||103||
59627198|NCT00996372|75740247|FG001|NOT COMPLETED|Overall Study||84||
59627199|NCT00997620|75740257|FG000|STARTED|Overall Study||19||
59627200|NCT00997620|75740258|FG001|STARTED|Overall Study||21||
59627201|NCT00997620|75740257|FG000|COMPLETED|Overall Study||19||
59627202|NCT00997620|75740258|FG001|COMPLETED|Overall Study||21||
59627203|NCT00997620|75740257|FG000|NOT COMPLETED|Overall Study||0||
59627204|NCT00997620|75740258|FG001|NOT COMPLETED|Overall Study||0||
59627205|NCT00997932|75740267|FG000|STARTED|Overall Study||29||
59627206|NCT00997932|75740267|FG000|COMPLETED|Overall Study||27||
59627207|NCT00997932|75740267|FG000|NOT COMPLETED|Overall Study||2||
59627208|NCT00998010|75740272|FG000|STARTED|Overall Study||24||
59627209|NCT00998010|75740272|FG000|COMPLETED|Overall Study||24||
59627210|NCT00998010|75740272|FG000|NOT COMPLETED|Overall Study||0||
59627211|NCT00998868|75740276|FG000|STARTED|Overall Study|>=10 for each muscle strength per MRC scale, after excluding the cases following exclusion criteria|51||
59627212|NCT00998868|75740276|FG000|COMPLETED|Overall Study||51||
59627213|NCT00998868|75740276|FG000|NOT COMPLETED|Overall Study||0||
59627214|NCT00999102|75740280|FG000|STARTED|4 Weeks at Lower Dose of First Drug||16||
59627215|NCT00999102|75740281|FG001|STARTED|4 Weeks at Lower Dose of First Drug||17||
59627216|NCT00999102|75740280|FG000|COMPLETED|4 Weeks at Lower Dose of First Drug||15||
59627217|NCT00999102|75740281|FG001|COMPLETED|4 Weeks at Lower Dose of First Drug||16||
59627218|NCT00999102|75740280|FG000|NOT COMPLETED|4 Weeks at Lower Dose of First Drug||1||
59627219|NCT00999102|75740281|FG001|NOT COMPLETED|4 Weeks at Lower Dose of First Drug||1||
59627220|NCT00999102|75740280|FG000|STARTED|4 Weeks at Higher Dose of First Drug||15||
59627221|NCT00999102|75740281|FG001|STARTED|4 Weeks at Higher Dose of First Drug||16||
59627222|NCT00999102|75740280|FG000|COMPLETED|4 Weeks at Higher Dose of First Drug||15||
59627223|NCT00999102|75740281|FG001|COMPLETED|4 Weeks at Higher Dose of First Drug||16||
59627224|NCT00999102|75740280|FG000|NOT COMPLETED|4 Weeks at Higher Dose of First Drug||0||
59815632|NCT03897088|75938076|FG000|STARTED|Overall Study||114||
59815633|NCT03897088|75938077|FG001|STARTED|Overall Study||117||
59815634|NCT03897088|75938076|FG000|COMPLETED|Overall Study||88||
59815635|NCT03897088|75938077|FG001|COMPLETED|Overall Study||86||
59815636|NCT03897088|75938076|FG000|NOT COMPLETED|Overall Study||26||
59815637|NCT03897088|75938077|FG001|NOT COMPLETED|Overall Study||31||
59815638|NCT03873272|75938092|FG000|STARTED|Overall Study||20||
59815639|NCT03873272|75938093|FG001|STARTED|Overall Study||22||
59815640|NCT03873272|75938094|FG002|STARTED|Overall Study||21||
59627225|NCT00999102|75740281|FG001|NOT COMPLETED|4 Weeks at Higher Dose of First Drug||0||
59627226|NCT00999102|75740280|FG000|STARTED|4 Weeks at Lower Dose of Second Drug||15||
59627227|NCT00999102|75740281|FG001|STARTED|4 Weeks at Lower Dose of Second Drug||16||
59627228|NCT00999102|75740280|FG000|COMPLETED|4 Weeks at Lower Dose of Second Drug||15||
59627229|NCT00999102|75740281|FG001|COMPLETED|4 Weeks at Lower Dose of Second Drug||16||
59627230|NCT00999102|75740280|FG000|NOT COMPLETED|4 Weeks at Lower Dose of Second Drug||0||
59627231|NCT00999102|75740281|FG001|NOT COMPLETED|4 Weeks at Lower Dose of Second Drug||0||
59627232|NCT00999102|75740280|FG000|STARTED|4 Weeks at Higher Dose of Second Drug||15||
59627233|NCT00999102|75740281|FG001|STARTED|4 Weeks at Higher Dose of Second Drug||16||
59627234|NCT00999102|75740280|FG000|COMPLETED|4 Weeks at Higher Dose of Second Drug||15||
59627235|NCT00999102|75740281|FG001|COMPLETED|4 Weeks at Higher Dose of Second Drug||16||
59627236|NCT00999102|75740280|FG000|NOT COMPLETED|4 Weeks at Higher Dose of Second Drug||0||
59627237|NCT00999102|75740281|FG001|NOT COMPLETED|4 Weeks at Higher Dose of Second Drug||0||
59627238|NCT01000662|75740293|FG000|STARTED|Overall Study||206||
59815641|NCT03873272|75938092|FG000|COMPLETED|Overall Study||18||
59627239|NCT01000662|75740294|FG001|STARTED|Overall Study||206||
59815642|NCT03873272|75938093|FG001|COMPLETED|Overall Study||20||
59627240|NCT01000662|75740293|FG000|COMPLETED|Overall Study||202||
59627241|NCT01000662|75740294|FG001|COMPLETED|Overall Study||198||
59627242|NCT01000662|75740293|FG000|NOT COMPLETED|Overall Study||4||
59627243|NCT01000662|75740294|FG001|NOT COMPLETED|Overall Study||8||
59627244|NCT01000818|75740302|FG000|STARTED|Raltegravir||18||
59627245|NCT01000818|75740302|FG000|COMPLETED|Raltegravir||18||
59627246|NCT01000818|75740302|FG000|NOT COMPLETED|Raltegravir||0||
59627247|NCT01000818|75740302|FG000|STARTED|Famotidine + Raltegravir||18||
59627248|NCT01000818|75740302|FG000|COMPLETED|Famotidine + Raltegravir||18||
59627249|NCT01000818|75740302|FG000|NOT COMPLETED|Famotidine + Raltegravir||0||
59627250|NCT01000818|75740302|FG000|STARTED|Omeprazole + Raltegravir||18||
59627251|NCT01000818|75740302|FG000|COMPLETED|Omeprazole + Raltegravir||18||
59627252|NCT01000818|75740302|FG000|NOT COMPLETED|Omeprazole + Raltegravir||0||
59627253|NCT01001052|75740311|FG000|STARTED|Overall Study||20||
59627254|NCT01001052|75740312|FG001|STARTED|Overall Study||18||
59627255|NCT01001052|75740311|FG000|COMPLETED|Overall Study||20||
59627256|NCT01001052|75740312|FG001|COMPLETED|Overall Study||18||
59627257|NCT01001052|75740311|FG000|NOT COMPLETED|Overall Study||0||
59627258|NCT01001052|75740312|FG001|NOT COMPLETED|Overall Study||0||
59627259|NCT01001442|75740326|FG000|STARTED|Overall Study||4||
59627260|NCT01001442|75740327|FG001|STARTED|Overall Study||3||
59627261|NCT01001442|75740328|FG002|STARTED|Overall Study||4||
59627262|NCT01001442|75740329|FG003|STARTED|Overall Study||3||
59627263|NCT01001442|75740330|FG004|STARTED|Overall Study||4||
59627264|NCT01001442|75740331|FG005|STARTED|Overall Study||3||
59627265|NCT01001442|75740332|FG006|STARTED|Overall Study||10||
59627266|NCT01001442|75740333|FG007|STARTED|Overall Study||4||
59627267|NCT01001442|75740326|FG000|COMPLETED|Overall Study||4||
59627268|NCT01001442|75740327|FG001|COMPLETED|Overall Study||3||
59627269|NCT01001442|75740328|FG002|COMPLETED|Overall Study||4||
59627270|NCT01001442|75740329|FG003|COMPLETED|Overall Study||3||
59627271|NCT01001442|75740330|FG004|COMPLETED|Overall Study||2||
59627272|NCT01001442|75740331|FG005|COMPLETED|Overall Study||3||
59627273|NCT01001442|75740332|FG006|COMPLETED|Overall Study||6||
59627274|NCT01001442|75740333|FG007|COMPLETED|Overall Study||2||
59627275|NCT01001442|75740326|FG000|NOT COMPLETED|Overall Study||0||
59627276|NCT01001442|75740327|FG001|NOT COMPLETED|Overall Study||0||
59627277|NCT01001442|75740328|FG002|NOT COMPLETED|Overall Study||0||
59627278|NCT01001442|75740329|FG003|NOT COMPLETED|Overall Study||0||
59627279|NCT01001442|75740330|FG004|NOT COMPLETED|Overall Study||2||
59627280|NCT01001442|75740331|FG005|NOT COMPLETED|Overall Study||0||
59627281|NCT01001442|75740332|FG006|NOT COMPLETED|Overall Study||4||
59627282|NCT01001442|75740333|FG007|NOT COMPLETED|Overall Study||2||
59627283|NCT01002456|75740357|FG000|STARTED|Overall Study||98||
59627284|NCT01002456|75740358|FG001|STARTED|Overall Study||122||
59627285|NCT01002456|75740357|FG000|COMPLETED|Overall Study||98||
59627286|NCT01002456|75740358|FG001|COMPLETED|Overall Study||122||
59627287|NCT01002456|75740357|FG000|NOT COMPLETED|Overall Study||0||
59627288|NCT01002456|75740358|FG001|NOT COMPLETED|Overall Study||0||
59627289|NCT01003080|75740368|FG000|STARTED|Overall Study||50||
59627290|NCT01003080|75740369|FG001|STARTED|Overall Study||61||
59627291|NCT01003080|75740368|FG000|COMPLETED|Overall Study||50||
59627292|NCT01003080|75740369|FG001|COMPLETED|Overall Study||61||
59627293|NCT01003080|75740368|FG000|NOT COMPLETED|Overall Study||0||
59627294|NCT01003080|75740369|FG001|NOT COMPLETED|Overall Study||0||
59627295|NCT01003938|75740375|FG000|STARTED|Overall Study||6||
59627296|NCT01003938|75740375|FG000|COMPLETED|Overall Study||6||
59627297|NCT01003938|75740375|FG000|NOT COMPLETED|Overall Study||0||
59627298|NCT01004718|75740379|FG000|STARTED|Overall Study||10||
59627299|NCT01004718|75740379|FG000|COMPLETED|Overall Study||10||
59627300|NCT01004718|75740379|FG000|NOT COMPLETED|Overall Study||0||
59627301|NCT01005576|75740384|FG000|STARTED|Overall Study||21||
59627302|NCT01005576|75740384|FG000|COMPLETED|Overall Study|All participants completed the conditioning regimen and received their stem cell transplant|21||
59627303|NCT01005576|75740384|FG000|NOT COMPLETED|Overall Study||0||
59627304|NCT01005810|75740390|FG000|STARTED|Overall Study||58||
59627305|NCT01005810|75740391|FG001|STARTED|Overall Study||58||
59627306|NCT01005810|75740390|FG000|COMPLETED|Overall Study||37||
59627307|NCT01005810|75740391|FG001|COMPLETED|Overall Study||33||
59627308|NCT01005810|75740390|FG000|NOT COMPLETED|Overall Study||21||
59627309|NCT01005810|75740391|FG001|NOT COMPLETED|Overall Study||25||
59627310|NCT01005888|75740401|FG000|STARTED|First Intervention||12||
59627311|NCT01005888|75740402|FG001|STARTED|First Intervention||12||
59627312|NCT01005888|75740401|FG000|COMPLETED|First Intervention||11||
59627313|NCT01005888|75740402|FG001|COMPLETED|First Intervention||11||
59627314|NCT01005888|75740401|FG000|NOT COMPLETED|First Intervention||1||
59627315|NCT01005888|75740402|FG001|NOT COMPLETED|First Intervention||1||
59627316|NCT01005888|75740401|FG000|STARTED|Second Intervention||11||
59627317|NCT01005888|75740402|FG001|STARTED|Second Intervention||11||
59627318|NCT01005888|75740401|FG000|COMPLETED|Second Intervention||10||
59627319|NCT01005888|75740402|FG001|COMPLETED|Second Intervention||10||
59627320|NCT01005888|75740401|FG000|NOT COMPLETED|Second Intervention||1||
59627321|NCT01005888|75740402|FG001|NOT COMPLETED|Second Intervention||1||
59627322|NCT01007136|75740413|FG000|STARTED|Overall Study||19||
59627323|NCT01007136|75740414|FG001|STARTED|Overall Study|One additional subject was excluded prior to randomization due to illicit drug use.|17||
59627324|NCT01007136|75740415|FG002|STARTED|Overall Study||15||
59627325|NCT01007136|75740416|FG003|STARTED|Overall Study||6||
59627326|NCT01007136|75740417|FG004|STARTED|Overall Study||4||
59627327|NCT01007136|75740413|FG000|COMPLETED|Overall Study||15||
59627328|NCT01007136|75740414|FG001|COMPLETED|Overall Study||13||
59627329|NCT01007136|75740415|FG002|COMPLETED|Overall Study||15||
59627330|NCT01007136|75740416|FG003|COMPLETED|Overall Study||6||
59627331|NCT01007136|75740417|FG004|COMPLETED|Overall Study||4||
59627332|NCT01007136|75740413|FG000|NOT COMPLETED|Overall Study||4||
59627333|NCT01007136|75740414|FG001|NOT COMPLETED|Overall Study||4||
59627334|NCT01007136|75740415|FG002|NOT COMPLETED|Overall Study||0||
59627335|NCT01007136|75740416|FG003|NOT COMPLETED|Overall Study||0||
59627336|NCT01007136|75740417|FG004|NOT COMPLETED|Overall Study||0||
59627337|NCT01007526|75740428|FG000|STARTED|Overall Study||31||
59627338|NCT01007526|75740428|FG000|COMPLETED|Overall Study||31||
59627339|NCT01007526|75740428|FG000|NOT COMPLETED|Overall Study||0||
59627340|NCT01007994|75740434|FG000|STARTED|Overall Study||17||
59627341|NCT01007994|75740435|FG001|STARTED|Overall Study||16||
59627342|NCT01007994|75740434|FG000|COMPLETED|Overall Study||15||
59627343|NCT01007994|75740435|FG001|COMPLETED|Overall Study||14||
59627344|NCT01007994|75740434|FG000|NOT COMPLETED|Overall Study||2||
59627345|NCT01007994|75740435|FG001|NOT COMPLETED|Overall Study||2||
59627346|NCT01008462|75740441|FG000|STARTED|Overall Study||16||
59627347|NCT01008462|75740441|FG000|COMPLETED|Overall Study||16||
59627348|NCT01008462|75740441|FG000|NOT COMPLETED|Overall Study||0||
59627349|NCT01010568|75740445|FG000|STARTED|Overall Study||10||
59627350|NCT01010568|75740445|FG000|COMPLETED|Overall Study||5||
59627351|NCT01010568|75740445|FG000|NOT COMPLETED|Overall Study||5||
59627352|NCT01011816|75740452|FG000|STARTED|26-Week Primary Endpoint||164||
59627353|NCT01011816|75740453|FG001|STARTED|26-Week Primary Endpoint||56||
59627354|NCT01011816|75740452|FG000|COMPLETED|26-Week Primary Endpoint||157||
59627355|NCT01011816|75740453|FG001|COMPLETED|26-Week Primary Endpoint||54||
59627356|NCT01011816|75740452|FG000|NOT COMPLETED|26-Week Primary Endpoint||7||
59627357|NCT01011816|75740453|FG001|NOT COMPLETED|26-Week Primary Endpoint||2||
59627358|NCT01011816|75740452|FG000|STARTED|78-Week Extended Follow-up||157||
59627359|NCT01011816|75740453|FG001|STARTED|78-Week Extended Follow-up||54||
59627360|NCT01011816|75740452|FG000|COMPLETED|78-Week Extended Follow-up||85||
59627361|NCT01011816|75740453|FG001|COMPLETED|78-Week Extended Follow-up||26||
59627362|NCT01011816|75740452|FG000|NOT COMPLETED|78-Week Extended Follow-up||72||
59627363|NCT01011816|75740453|FG001|NOT COMPLETED|78-Week Extended Follow-up||28||
59627364|NCT01011894|75740461|FG000|STARTED|Overall Study||26||
59627365|NCT01011894|75740461|FG000|COMPLETED|Overall Study||26||
59627366|NCT01011894|75740461|FG000|NOT COMPLETED|Overall Study||0||
59627367|NCT01012362|75740470|FG000|STARTED|Overall Study||9||
59627368|NCT01012362|75740471|FG001|STARTED|Overall Study||6||
59627369|NCT01012362|75740472|FG002|STARTED|Overall Study||3||
59627370|NCT01012362|75740473|FG003|STARTED|Overall Study||4||
59627371|NCT01012362|75740474|FG004|STARTED|Overall Study||9||
59627372|NCT01012362|75740470|FG000|COMPLETED|Overall Study||9||
59627373|NCT01012362|75740471|FG001|COMPLETED|Overall Study||6||
59627374|NCT01012362|75740472|FG002|COMPLETED|Overall Study||3||
59627375|NCT01012362|75740473|FG003|COMPLETED|Overall Study||4||
59627376|NCT01012362|75740474|FG004|COMPLETED|Overall Study||9||
59627377|NCT01012362|75740470|FG000|NOT COMPLETED|Overall Study||0||
59627378|NCT01012362|75740471|FG001|NOT COMPLETED|Overall Study||0||
59627379|NCT01012362|75740472|FG002|NOT COMPLETED|Overall Study||0||
59627380|NCT01012362|75740473|FG003|NOT COMPLETED|Overall Study||0||
59627381|NCT01012362|75740474|FG004|NOT COMPLETED|Overall Study||0||
59627382|NCT01012674|75740490|FG000|STARTED|Overall Study||211||
59627383|NCT01012674|75740490|FG000|COMPLETED|Overall Study||187||
59627384|NCT01012674|75740490|FG000|NOT COMPLETED|Overall Study||24||
59627385|NCT01013844|75740500|FG000|STARTED|Overall Study||65||
59627386|NCT01013844|75740501|FG001|STARTED|Overall Study||65||
59627387|NCT01013844|75740500|FG000|COMPLETED|Overall Study||65||
59627388|NCT01013844|75740501|FG001|COMPLETED|Overall Study||65||
59627389|NCT01013844|75740500|FG000|NOT COMPLETED|Overall Study||0||
59627390|NCT01013844|75740501|FG001|NOT COMPLETED|Overall Study||0||
59627391|NCT00986544|75740513|FG000|STARTED|Overall Study||53||
59627392|NCT00986544|75740514|FG001|STARTED|Overall Study||53||
59627393|NCT00986544|75740513|FG000|COMPLETED|Overall Study||53||
59627394|NCT00986544|75740514|FG001|COMPLETED|Overall Study||53||
59627395|NCT00986544|75740513|FG000|NOT COMPLETED|Overall Study||0||
59627396|NCT00986544|75740514|FG001|NOT COMPLETED|Overall Study||0||
59627397|NCT01014390|75740521|FG000|STARTED|Overall Study||187||
59627398|NCT01014390|75740521|FG000|COMPLETED|Overall Study||177||
59627399|NCT01014390|75740521|FG000|NOT COMPLETED|Overall Study||10||
59627400|NCT01015170|75740525|FG000|STARTED|Overall Study||454||
59627401|NCT01015170|75740525|FG000|COMPLETED|Overall Study||215||
59627402|NCT01015170|75740525|FG000|NOT COMPLETED|Overall Study||239||
59627403|NCT01015326|75740533|FG000|STARTED|Overall Study||12||
59627404|NCT01015326|75740534|FG001|STARTED|Overall Study||20||
59627405|NCT01015326|75740533|FG000|COMPLETED|Overall Study||11||
59627406|NCT01015326|75740534|FG001|COMPLETED|Overall Study||18||
59627407|NCT01015326|75740533|FG000|NOT COMPLETED|Overall Study||1||
59627408|NCT01015326|75740534|FG001|NOT COMPLETED|Overall Study||2||
59627409|NCT01016106|75740542|FG000|STARTED|Overall Study||17||
59627410|NCT01016106|75740543|FG001|STARTED|Overall Study||18||
59627411|NCT01016106|75740542|FG000|COMPLETED|Overall Study||17||
59627412|NCT01016106|75740543|FG001|COMPLETED|Overall Study||18||
59627413|NCT01016106|75740542|FG000|NOT COMPLETED|Overall Study||0||
59627414|NCT01016106|75740543|FG001|NOT COMPLETED|Overall Study||0||
59627415|NCT01016652|75740551|FG000|STARTED|Period 1||25||
59627416|NCT01016652|75740552|FG001|STARTED|Period 1||24||
59627417|NCT01016652|75740551|FG000|COMPLETED|Period 1||25||
59627418|NCT01016652|75740552|FG001|COMPLETED|Period 1||24||
59627419|NCT01016652|75740551|FG000|NOT COMPLETED|Period 1||0||
59627420|NCT01016652|75740552|FG001|NOT COMPLETED|Period 1||0||
59627421|NCT01016652|75740551|FG000|STARTED|Period 2|Crossover study: the completed from period 1 will crossover in period 2 to the opposite arm.|25||
59627422|NCT01016652|75740552|FG001|STARTED|Period 2|Crossover study: the completed from period 1 will crossover in period 2 to the opposite arm.|24||
59627423|NCT01016652|75740551|FG000|COMPLETED|Period 2||25||
59627424|NCT01016652|75740552|FG001|COMPLETED|Period 2||24||
59627425|NCT01016652|75740551|FG000|NOT COMPLETED|Period 2||0||
59627426|NCT01016652|75740552|FG001|NOT COMPLETED|Period 2||0||
59627427|NCT01017042|75740560|FG000|STARTED|Overall Study||13||
59627428|NCT01017042|75740560|FG000|COMPLETED|Overall Study||13||
59627429|NCT01017042|75740560|FG000|NOT COMPLETED|Overall Study||0||
59627430|NCT01018056|75740572|FG000|STARTED|Overall Study||12||
59627431|NCT01018056|75740573|FG001|STARTED|Overall Study||12||
59627432|NCT01018056|75740574|FG002|STARTED|Overall Study||6||
59627433|NCT01018056|75740572|FG000|COMPLETED|Overall Study||9||
59627434|NCT01018056|75740573|FG001|COMPLETED|Overall Study||10||
59627435|NCT01018056|75740574|FG002|COMPLETED|Overall Study||5||
59627436|NCT01018056|75740572|FG000|NOT COMPLETED|Overall Study||3||
59627437|NCT01018056|75740573|FG001|NOT COMPLETED|Overall Study||2||
59627438|NCT01018056|75740574|FG002|NOT COMPLETED|Overall Study||1||
59627439|NCT01018134|75740591|FG000|STARTED|Overall Study||30||
59627440|NCT01018134|75740592|FG001|STARTED|Overall Study||31||
59627441|NCT01018134|75740593|FG002|STARTED|Overall Study||30||
59627442|NCT01018134|75740594|FG003|STARTED|Overall Study|30 enrolled patients, one who did not use the study medication was excluded from all analyses|29||
59627443|NCT01018134|75740595|FG004|STARTED|Overall Study||15||
59539614|NCT00871286|75638004|FG001|NOT COMPLETED|Overall Study||6||
59539615|NCT01426763|75638012|FG000|STARTED|Overall Study||6||
59539616|NCT01426763|75638013|FG001|STARTED|Overall Study||6||
59539617|NCT01426763|75638012|FG000|COMPLETED|Overall Study||6||
59539618|NCT01426763|75638013|FG001|COMPLETED|Overall Study||6||
59539619|NCT01426763|75638012|FG000|NOT COMPLETED|Overall Study||0||
59627444|NCT01018134|75740596|FG005|STARTED|Overall Study||15||
59627445|NCT01018134|75740591|FG000|COMPLETED|Overall Study||30||
59627446|NCT01018134|75740592|FG001|COMPLETED|Overall Study||30||
59627447|NCT01018134|75740593|FG002|COMPLETED|Overall Study||29||
59539620|NCT01426763|75638013|FG001|NOT COMPLETED|Overall Study||0||
59539621|NCT00825500|75638024|FG000|STARTED|Overall Study||125||
59539622|NCT00825500|75638025|FG001|STARTED|Overall Study||121||
59539623|NCT00825500|75638026|FG002|STARTED|Overall Study||120||
59539624|NCT00825500|75638024|FG000|COMPLETED|Overall Study||125||
59539625|NCT00825500|75638025|FG001|COMPLETED|Overall Study||121||
59539626|NCT00825500|75638026|FG002|COMPLETED|Overall Study||120||
59539627|NCT00825500|75638024|FG000|NOT COMPLETED|Overall Study||0||
59539628|NCT00825500|75638025|FG001|NOT COMPLETED|Overall Study||0||
59539629|NCT00825500|75638026|FG002|NOT COMPLETED|Overall Study||0||
59539630|NCT01504997|75638034|FG000|STARTED|Overall Study||18||
59539631|NCT01504997|75638034|FG000|COMPLETED|Overall Study||18||
59539632|NCT01504997|75638034|FG000|NOT COMPLETED|Overall Study||0||
59539633|NCT01505933|75638040|FG000|STARTED|Overall Study||10||
59539634|NCT01505933|75638041|FG001|STARTED|Overall Study||14||
59539635|NCT01505933|75638040|FG000|COMPLETED|Overall Study||10||
59539636|NCT01505933|75638041|FG001|COMPLETED|Overall Study||14||
59539637|NCT01505933|75638040|FG000|NOT COMPLETED|Overall Study||0||
59539638|NCT01505933|75638041|FG001|NOT COMPLETED|Overall Study||0||
59539639|NCT00825734|75638047|FG000|STARTED|Phase I||4||
59539640|NCT00825734|75638048|FG001|STARTED|Phase I||3||
59627448|NCT01018134|75740594|FG003|COMPLETED|Overall Study||29||
59627449|NCT01018134|75740595|FG004|COMPLETED|Overall Study||15||
59627450|NCT01018134|75740596|FG005|COMPLETED|Overall Study||15||
59627451|NCT01018134|75740591|FG000|NOT COMPLETED|Overall Study||0||
59627452|NCT01018134|75740592|FG001|NOT COMPLETED|Overall Study||1||
59627453|NCT01018134|75740593|FG002|NOT COMPLETED|Overall Study||1||
59627454|NCT01018134|75740594|FG003|NOT COMPLETED|Overall Study||0||
59627455|NCT01018134|75740595|FG004|NOT COMPLETED|Overall Study||0||
59539641|NCT00825734|75638049|FG002|STARTED|Phase I||3||
59539642|NCT00825734|75638047|FG000|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0||
59539643|NCT00825734|75638048|FG001|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0||
59539644|NCT00825734|75638049|FG002|COMPLETED|Phase I||3||
59539645|NCT00825734|75638047|FG000|NOT COMPLETED|Phase I||4||
59539646|NCT00825734|75638048|FG001|NOT COMPLETED|Phase I||3||
59627456|NCT01018134|75740596|FG005|NOT COMPLETED|Overall Study||0||
59627457|NCT01019928|75740612|FG000|STARTED|Period 1||7||
59627458|NCT01019928|75740613|FG001|STARTED|Period 1||7||
59627459|NCT01019928|75740612|FG000|COMPLETED|Period 1||7||
59627460|NCT01019928|75740613|FG001|COMPLETED|Period 1||7||
59627461|NCT01019928|75740612|FG000|NOT COMPLETED|Period 1||0||
59627462|NCT01019928|75740613|FG001|NOT COMPLETED|Period 1||0||
59627463|NCT01019928|75740612|FG000|STARTED|Period 2||7||
59627464|NCT01019928|75740613|FG001|STARTED|Period 2||7||
59627465|NCT01019928|75740612|FG000|COMPLETED|Period 2||7||
59627466|NCT01019928|75740613|FG001|COMPLETED|Period 2|One patient had an SAE, and was withdrawn, prior to receiving AZD1386|6||
59627467|NCT01019928|75740612|FG000|NOT COMPLETED|Period 2||0||
59627468|NCT01019928|75740613|FG001|NOT COMPLETED|Period 2||1||
59627469|NCT01019928|75740612|FG000|STARTED|Period 3||7||
59627470|NCT01019928|75740613|FG001|STARTED|Period 3|One patient had an SAE, and was withdrawn, prior to receiving AZD1386|6||
59627471|NCT01019928|75740612|FG000|COMPLETED|Period 3||7||
59627472|NCT01019928|75740613|FG001|COMPLETED|Period 3|One patient had an SAE, and was withdrawn, prior to receiving AZD1386|6||
59627473|NCT01019928|75740612|FG000|NOT COMPLETED|Period 3||0||
59627474|NCT01019928|75740613|FG001|NOT COMPLETED|Period 3||0||
59627475|NCT01020006|75740622|FG000|STARTED|Overall Study||8||
59627476|NCT01020006|75740623|FG001|STARTED|Overall Study||18||
59627477|NCT01020006|75740624|FG002|STARTED|Overall Study||16||
59627478|NCT01020006|75740622|FG000|COMPLETED|Overall Study|No subjects reached study completion as defined by protocol.|0||
59627479|NCT01020006|75740623|FG001|COMPLETED|Overall Study|No subjects reached study completion as defined by protocol.|0||
59627480|NCT01020006|75740624|FG002|COMPLETED|Overall Study|No subjects reached study completion as defined by protocol.|0||
59627481|NCT01020006|75740622|FG000|NOT COMPLETED|Overall Study||8||
59627482|NCT01020006|75740623|FG001|NOT COMPLETED|Overall Study||18||
59627483|NCT01020006|75740624|FG002|NOT COMPLETED|Overall Study||16||
59627484|NCT03554850|75740632|FG000|STARTED|Overall Study||201||
59627485|NCT03554850|75740632|FG000|COMPLETED|Overall Study||190||
59815643|NCT03873272|75938094|FG002|COMPLETED|Overall Study||19||
59627486|NCT03554850|75740632|FG000|NOT COMPLETED|Overall Study||11||
59627487|NCT03125148|75740642|FG000|STARTED|Overall Study||9||
59627488|NCT03125148|75740643|FG001|STARTED|Overall Study||8||
59627489|NCT03125148|75740642|FG000|COMPLETED|Overall Study||9||
59627490|NCT03125148|75740643|FG001|COMPLETED|Overall Study||8||
59627491|NCT03125148|75740642|FG000|NOT COMPLETED|Overall Study||0||
59627492|NCT03125148|75740643|FG001|NOT COMPLETED|Overall Study||0||
59627493|NCT01021956|75740653|FG000|STARTED|Overall Study||3||
59627494|NCT01021956|75740654|FG001|STARTED|Overall Study||3||
59627495|NCT01021956|75740655|FG002|STARTED|Overall Study||3||
59627496|NCT01021956|75740656|FG003|STARTED|Overall Study||1||
59627497|NCT01021956|75740653|FG000|COMPLETED|Overall Study||3||
59627498|NCT01021956|75740654|FG001|COMPLETED|Overall Study||3||
59627499|NCT01021956|75740655|FG002|COMPLETED|Overall Study||3||
59627500|NCT01021956|75740656|FG003|COMPLETED|Overall Study||1||
59627501|NCT01021956|75740653|FG000|NOT COMPLETED|Overall Study||0||
59627502|NCT01021956|75740654|FG001|NOT COMPLETED|Overall Study||0||
59627503|NCT01021956|75740655|FG002|NOT COMPLETED|Overall Study||0||
59627504|NCT01021956|75740656|FG003|NOT COMPLETED|Overall Study||0||
59627505|NCT01022190|75740667|FG000|STARTED|Overall Study||42||
59627506|NCT01022190|75740667|FG000|COMPLETED|Overall Study||42||
59627507|NCT01022190|75740667|FG000|NOT COMPLETED|Overall Study||0||
59627508|NCT01024296|75740671|FG000|STARTED|Overall Study||4||
59627509|NCT01024296|75740671|FG000|COMPLETED|Overall Study||4||
59627510|NCT01024296|75740671|FG000|NOT COMPLETED|Overall Study||0||
59627511|NCT01024686|75740678|FG000|STARTED|Overall Study|July 11, 2010: unexpected adverse event, (1) participant|6||
59627512|NCT01024686|75740679|FG001|STARTED|Overall Study||0||
59627513|NCT01024686|75740680|FG002|STARTED|Overall Study||0||
59627514|NCT01024686|75740678|FG000|COMPLETED|Overall Study||6||
59627515|NCT01024686|75740679|FG001|COMPLETED|Overall Study|(0) participants because the clinical trial was terminated prior to enrollment.|0||
59627516|NCT01024686|75740680|FG002|COMPLETED|Overall Study|(0) participants because the clinical trial was terminated prior to enrollment.|0||
59627517|NCT01024686|75740678|FG000|NOT COMPLETED|Overall Study||0||
59627518|NCT01024686|75740679|FG001|NOT COMPLETED|Overall Study||0||
59627519|NCT01024686|75740680|FG002|NOT COMPLETED|Overall Study||0||
59627520|NCT01025076|75740688|FG000|STARTED|Overall Study||14||
59627521|NCT01025076|75740688|FG000|COMPLETED|Overall Study||14||
59627522|NCT01025076|75740688|FG000|NOT COMPLETED|Overall Study||0||
59627523|NCT01026402|75740709|FG000|STARTED|Overall Study||6||
59627524|NCT01026402|75740710|FG001|STARTED|Overall Study||8||
59627525|NCT01026402|75740711|FG002|STARTED|Overall Study||33||
59627526|NCT01026402|75740712|FG003|STARTED|Overall Study||18||
59627527|NCT01026402|75740713|FG004|STARTED|Overall Study||3||
59627528|NCT01026402|75740714|FG005|STARTED|Overall Study||5||
59627529|NCT01026402|75740715|FG006|STARTED|Overall Study||8||
59627530|NCT01026402|75740716|FG007|STARTED|Overall Study||3||
59815644|NCT03873272|75938092|FG000|NOT COMPLETED|Overall Study||2||
59627531|NCT01026402|75740717|FG008|STARTED|Overall Study||7||
59627532|NCT01026402|75740718|FG009|STARTED|Overall Study||3||
59627533|NCT01026402|75740719|FG010|STARTED|Overall Study||7||
59627534|NCT01026402|75740720|FG011|STARTED|Overall Study||8||
59627535|NCT01026402|75740721|FG012|STARTED|Overall Study||8||
59627536|NCT01026402|75740722|FG013|STARTED|Overall Study||6||
59627537|NCT01026402|75740723|FG014|STARTED|Overall Study||3||
59627538|NCT01026402|75740724|FG015|STARTED|Overall Study||5||
59627539|NCT01026402|75740725|FG016|STARTED|Overall Study||4||
59627540|NCT01026402|75740709|FG000|COMPLETED|Overall Study||6||
59627541|NCT01026402|75740710|FG001|COMPLETED|Overall Study||8||
59627542|NCT01026402|75740711|FG002|COMPLETED|Overall Study||33||
59627543|NCT01026402|75740712|FG003|COMPLETED|Overall Study||18||
59627544|NCT01026402|75740713|FG004|COMPLETED|Overall Study||3||
59627545|NCT01026402|75740714|FG005|COMPLETED|Overall Study||5||
59627546|NCT01026402|75740715|FG006|COMPLETED|Overall Study||8||
59627547|NCT01026402|75740716|FG007|COMPLETED|Overall Study||3||
59627548|NCT01026402|75740717|FG008|COMPLETED|Overall Study||7||
59627549|NCT01026402|75740718|FG009|COMPLETED|Overall Study||3||
59627550|NCT01026402|75740719|FG010|COMPLETED|Overall Study||7||
59627551|NCT01026402|75740720|FG011|COMPLETED|Overall Study||8||
59627552|NCT01026402|75740721|FG012|COMPLETED|Overall Study||8||
59627553|NCT01026402|75740722|FG013|COMPLETED|Overall Study||6||
59627554|NCT01026402|75740723|FG014|COMPLETED|Overall Study||3||
59627555|NCT01026402|75740724|FG015|COMPLETED|Overall Study||5||
59627556|NCT01026402|75740725|FG016|COMPLETED|Overall Study||4||
59627557|NCT01026402|75740709|FG000|NOT COMPLETED|Overall Study||0||
59627558|NCT01026402|75740710|FG001|NOT COMPLETED|Overall Study||0||
59627559|NCT01026402|75740711|FG002|NOT COMPLETED|Overall Study||0||
59627560|NCT01026402|75740712|FG003|NOT COMPLETED|Overall Study||0||
59627561|NCT01026402|75740713|FG004|NOT COMPLETED|Overall Study||0||
59627562|NCT01026402|75740714|FG005|NOT COMPLETED|Overall Study||0||
59627563|NCT01026402|75740715|FG006|NOT COMPLETED|Overall Study||0||
59627564|NCT01026402|75740716|FG007|NOT COMPLETED|Overall Study||0||
59627565|NCT01026402|75740717|FG008|NOT COMPLETED|Overall Study||0||
59627566|NCT01026402|75740718|FG009|NOT COMPLETED|Overall Study||0||
59627567|NCT01026402|75740719|FG010|NOT COMPLETED|Overall Study||0||
59627568|NCT01026402|75740720|FG011|NOT COMPLETED|Overall Study||0||
59627569|NCT01026402|75740721|FG012|NOT COMPLETED|Overall Study||0||
59627570|NCT01026402|75740722|FG013|NOT COMPLETED|Overall Study||0||
59627571|NCT01026402|75740723|FG014|NOT COMPLETED|Overall Study||0||
59627572|NCT01026402|75740724|FG015|NOT COMPLETED|Overall Study||0||
59627573|NCT01026402|75740725|FG016|NOT COMPLETED|Overall Study||0||
59627574|NCT01027806|75740766|FG000|STARTED|Overall Study||32||
59627575|NCT01027806|75740767|FG001|STARTED|Overall Study||32||
59627576|NCT01027806|75740766|FG000|COMPLETED|Overall Study||28||
59627577|NCT01027806|75740767|FG001|COMPLETED|Overall Study||29||
59627578|NCT01027806|75740766|FG000|NOT COMPLETED|Overall Study||4||
59627579|NCT01027806|75740767|FG001|NOT COMPLETED|Overall Study||3||
59627580|NCT01029054|75740773|FG000|STARTED|Phase I||4||
59627581|NCT01029054|75740774|FG001|STARTED|Phase I||13||
59627582|NCT01029054|75740775|FG002|STARTED|Phase I||18||
59627583|NCT01029054|75740773|FG000|COMPLETED|Phase I||4||
59627584|NCT01029054|75740774|FG001|COMPLETED|Phase I||13||
59627585|NCT01029054|75740775|FG002|COMPLETED|Phase I||18||
59627586|NCT01029054|75740773|FG000|NOT COMPLETED|Phase I||0||
59627587|NCT01029054|75740774|FG001|NOT COMPLETED|Phase I||0||
59627588|NCT01029054|75740775|FG002|NOT COMPLETED|Phase I||0||
59627589|NCT01029054|75740773|FG000|STARTED|Phase II||0||
59627590|NCT01029054|75740774|FG001|STARTED|Phase II||0||
59627591|NCT01029054|75740775|FG002|STARTED|Phase II|35 participants were enrolled in Ph I. 18 additional participants were enrolled in Ph II at the MTD.|18||
59627592|NCT01029054|75740773|FG000|COMPLETED|Phase II||0||
59627593|NCT01029054|75740774|FG001|COMPLETED|Phase II||0||
59627594|NCT01029054|75740775|FG002|COMPLETED|Phase II||18||
59627595|NCT01029054|75740773|FG000|NOT COMPLETED|Phase II||0||
59627596|NCT01029054|75740774|FG001|NOT COMPLETED|Phase II||0||
59627597|NCT01029054|75740775|FG002|NOT COMPLETED|Phase II||0||
59627598|NCT01029912|75740781|FG000|STARTED|Overall Study||14||
59627599|NCT01029912|75740782|FG001|STARTED|Overall Study||12||
59627600|NCT01029912|75740781|FG000|COMPLETED|Overall Study||12||
59627601|NCT01029912|75740782|FG001|COMPLETED|Overall Study||12||
59627602|NCT01029912|75740781|FG000|NOT COMPLETED|Overall Study||2||
59627603|NCT01029912|75740782|FG001|NOT COMPLETED|Overall Study||0||
59627604|NCT01032330|75740792|FG000|STARTED|Overall Study||183||
59627605|NCT01032330|75740793|FG001|STARTED|Overall Study||175||
59627606|NCT01032330|75740794|FG002|STARTED|Overall Study||97||
59627607|NCT01032330|75740795|FG003|STARTED|Overall Study||104||
59627608|NCT01032330|75740792|FG000|COMPLETED|Overall Study||165||
59627609|NCT01032330|75740793|FG001|COMPLETED|Overall Study||151||
59627610|NCT01032330|75740794|FG002|COMPLETED|Overall Study||87||
59627611|NCT01032330|75740795|FG003|COMPLETED|Overall Study||90||
59627612|NCT01032330|75740792|FG000|NOT COMPLETED|Overall Study||18||
59627613|NCT01032330|75740793|FG001|NOT COMPLETED|Overall Study||24||
59627614|NCT01032330|75740794|FG002|NOT COMPLETED|Overall Study||10||
59627615|NCT01032330|75740795|FG003|NOT COMPLETED|Overall Study||14||
59627616|NCT01032954|75740816|FG000|STARTED|Overall Study||30||
59627617|NCT01032954|75740817|FG001|STARTED|Overall Study||30||
59627618|NCT01032954|75740818|FG002|STARTED|Overall Study||30||
59627619|NCT01032954|75740816|FG000|COMPLETED|Overall Study||26||
59627620|NCT01032954|75740817|FG001|COMPLETED|Overall Study||29||
59627621|NCT01032954|75740818|FG002|COMPLETED|Overall Study||30||
59627622|NCT01032954|75740816|FG000|NOT COMPLETED|Overall Study||4||
59627623|NCT01032954|75740817|FG001|NOT COMPLETED|Overall Study||1||
59627624|NCT01032954|75740818|FG002|NOT COMPLETED|Overall Study||0||
59627625|NCT01033422|75740829|FG000|STARTED|Overall Study||34||
59627626|NCT01033422|75740830|FG001|STARTED|Overall Study||32||
59627627|NCT01033422|75740831|FG002|STARTED|Overall Study||23||
59627628|NCT01033422|75740829|FG000|COMPLETED|Overall Study||33||
59627629|NCT01033422|75740830|FG001|COMPLETED|Overall Study||28||
59627630|NCT01033422|75740831|FG002|COMPLETED|Overall Study||22||
59627631|NCT01033422|75740829|FG000|NOT COMPLETED|Overall Study||1||
59627632|NCT01033422|75740830|FG001|NOT COMPLETED|Overall Study||4||
59627633|NCT01033422|75740831|FG002|NOT COMPLETED|Overall Study||1||
59627634|NCT04627038|75740841|FG000|STARTED|Overall Study||135||
59627635|NCT04627038|75740842|FG001|STARTED|Overall Study||67||
59627636|NCT04627038|75740841|FG000|Received at Least One Dose of Study Drug|Overall Study||135||
59627637|NCT04627038|75740842|FG001|Received at Least One Dose of Study Drug|Overall Study||66||
59627638|NCT04627038|75740841|FG000|COMPLETED|Overall Study||81||
59627639|NCT04627038|75740842|FG001|COMPLETED|Overall Study||53||
59627640|NCT04627038|75740841|FG000|NOT COMPLETED|Overall Study||54||
59627641|NCT04627038|75740842|FG001|NOT COMPLETED|Overall Study||14||
59627642|NCT01531374|75740851|FG000|STARTED|Overall Study||1285||
59627643|NCT01531374|75740852|FG001|STARTED|Overall Study||373||
59627644|NCT01531374|75740853|FG002|STARTED|Overall Study||1119||
59627645|NCT01531374|75740851|FG000|COMPLETED|Overall Study||921||
59627646|NCT01531374|75740852|FG001|COMPLETED|Overall Study||231||
59627647|NCT01531374|75740853|FG002|COMPLETED|Overall Study||836||
59627648|NCT01531374|75740851|FG000|NOT COMPLETED|Overall Study||364||
59627649|NCT01531374|75740852|FG001|NOT COMPLETED|Overall Study||142||
59627650|NCT01531374|75740853|FG002|NOT COMPLETED|Overall Study||283||
59627651|NCT01240902|75740867|FG000|STARTED|Overall Study||500||
59627652|NCT01240902|75740868|FG001|STARTED|Overall Study||156||
59627653|NCT01240902|75740869|FG002|STARTED|Overall Study||395||
59627654|NCT01240902|75740870|FG003|STARTED|Overall Study||402||
59627655|NCT01240902|75740867|FG000|COMPLETED|Overall Study||289||
59627656|NCT01240902|75740868|FG001|COMPLETED|Overall Study||77||
59627657|NCT01240902|75740869|FG002|COMPLETED|Overall Study||295||
59627658|NCT01240902|75740870|FG003|COMPLETED|Overall Study||237||
59627659|NCT01240902|75740867|FG000|NOT COMPLETED|Overall Study||211||
59627660|NCT01240902|75740868|FG001|NOT COMPLETED|Overall Study||79||
59627661|NCT01240902|75740869|FG002|NOT COMPLETED|Overall Study||100||
59627662|NCT01240902|75740870|FG003|NOT COMPLETED|Overall Study||165||
59627663|NCT01034592|75740880|FG000|STARTED|Overall Study||2||
59627664|NCT01034592|75740880|FG000|COMPLETED|Overall Study||2||
59627665|NCT01034592|75740880|FG000|NOT COMPLETED|Overall Study||0||
59627666|NCT01037790|75740890|FG000|STARTED|Overall Study||63||
59627667|NCT01037790|75740891|FG001|STARTED|Overall Study||18||
59627668|NCT01037790|75740892|FG002|STARTED|Overall Study||19||
59627669|NCT01037790|75740893|FG003|STARTED|Overall Study||30||
59627670|NCT01037790|75740894|FG004|STARTED|Overall Study||11||
59627671|NCT01037790|75740890|FG000|COMPLETED|Overall Study||63||
59627672|NCT01037790|75740891|FG001|COMPLETED|Overall Study||18||
59627673|NCT01037790|75740892|FG002|COMPLETED|Overall Study||19||
60076260|NCT01904773|76191366|FG002|NOT COMPLETED|Placebo Washout Third Intervention||0||
59627674|NCT01037790|75740893|FG003|COMPLETED|Overall Study||30||
59627675|NCT01037790|75740894|FG004|COMPLETED|Overall Study||11||
59627676|NCT01037790|75740890|FG000|NOT COMPLETED|Overall Study||0||
59627677|NCT01037790|75740891|FG001|NOT COMPLETED|Overall Study||0||
59627678|NCT01037790|75740892|FG002|NOT COMPLETED|Overall Study||0||
59627679|NCT01037790|75740893|FG003|NOT COMPLETED|Overall Study||0||
59627680|NCT01037790|75740894|FG004|NOT COMPLETED|Overall Study||0||
59627681|NCT01038336|75740909|FG000|STARTED|Overall Study||43||
59627682|NCT01038336|75740910|FG001|STARTED|Overall Study||42||
59627683|NCT01038336|75740911|FG002|STARTED|Overall Study||44||
59627684|NCT01038336|75740909|FG000|COMPLETED|Overall Study||43||
59627685|NCT01038336|75740910|FG001|COMPLETED|Overall Study||42||
59627686|NCT01038336|75740911|FG002|COMPLETED|Overall Study||44||
59627687|NCT01038336|75740909|FG000|NOT COMPLETED|Overall Study||0||
59627688|NCT01038336|75740910|FG001|NOT COMPLETED|Overall Study||0||
59627689|NCT01038336|75740911|FG002|NOT COMPLETED|Overall Study||0||
59627690|NCT01040052|75740924|FG000|STARTED|Overall Study||30||
59627691|NCT01040052|75740924|FG000|COMPLETED|Overall Study||30||
59627692|NCT01040052|75740924|FG000|NOT COMPLETED|Overall Study||0||
59627693|NCT01040208|75740931|FG000|STARTED|Overall Study||45||
59627694|NCT01040208|75740932|FG001|STARTED|Overall Study||28||
59627695|NCT01040208|75740933|FG002|STARTED|Overall Study||38||
59627696|NCT01040208|75740931|FG000|COMPLETED|Overall Study||39||
59627697|NCT01040208|75740932|FG001|COMPLETED|Overall Study||15||
59627698|NCT01040208|75740933|FG002|COMPLETED|Overall Study||35||
59627699|NCT01040208|75740931|FG000|NOT COMPLETED|Overall Study||6||
59627700|NCT01040208|75740932|FG001|NOT COMPLETED|Overall Study||13||
59627701|NCT01040208|75740933|FG002|NOT COMPLETED|Overall Study||3||
59627702|NCT01043094|75740948|FG000|STARTED|Overall Study||8||
60076261|NCT01904773|76191367|FG003|NOT COMPLETED|Placebo Washout Third Intervention||0||
59627703|NCT01043094|75740949|FG001|STARTED|Overall Study||8||
59627704|NCT01043094|75740948|FG000|COMPLETED|Overall Study||8||
59627705|NCT01043094|75740949|FG001|COMPLETED|Overall Study||8||
59627706|NCT01043094|75740948|FG000|NOT COMPLETED|Overall Study||0||
59627707|NCT01043094|75740949|FG001|NOT COMPLETED|Overall Study||0||
59627708|NCT01043562|75740955|FG000|STARTED|Overall Study||20||
59627709|NCT01043562|75740955|FG000|COMPLETED|Overall Study||20||
59627710|NCT01043562|75740955|FG000|NOT COMPLETED|Overall Study||0||
59627711|NCT01043640|75740962|FG000|STARTED|Overall Study||46||
59627712|NCT01043640|75740962|FG000|COMPLETED|Overall Study||46||
59627713|NCT01043640|75740962|FG000|NOT COMPLETED|Overall Study||0||
59627714|NCT01044030|75740968|FG000|STARTED|Overall Study||160||
59627715|NCT01044030|75740969|FG001|STARTED|Overall Study||166||
59627716|NCT01044030|75740968|FG000|COMPLETED|Overall Study||141||
59627717|NCT01044030|75740969|FG001|COMPLETED|Overall Study||146||
59627718|NCT01044030|75740968|FG000|NOT COMPLETED|Overall Study||19||
59627719|NCT01044030|75740969|FG001|NOT COMPLETED|Overall Study||20||
59627720|NCT01044576|75740975|FG000|STARTED|Overall Study||200||
59627721|NCT01044576|75740975|FG000|COMPLETED|Overall Study||200||
59627722|NCT01044576|75740975|FG000|NOT COMPLETED|Overall Study||0||
59627723|NCT01044966|75740979|FG000|STARTED|Induction Phase||12||
59627724|NCT01044966|75740979|FG000|COMPLETED|Induction Phase||12||
59627725|NCT01044966|75740979|FG000|NOT COMPLETED|Induction Phase||0||
59627726|NCT01044966|75740979|FG000|STARTED|Consolidation Phase||12||
59627727|NCT01044966|75740979|FG000|COMPLETED|Consolidation Phase||2||
59627728|NCT01044966|75740979|FG000|NOT COMPLETED|Consolidation Phase||10||
59627729|NCT01045122|75740984|FG000|STARTED|Dexmedetomidine Then Propofol||5||
59627730|NCT01045122|75740985|FG001|STARTED|Dexmedetomidine Then Propofol||6||
59627731|NCT01045122|75740984|FG000|COMPLETED|Dexmedetomidine Then Propofol||5||
59627732|NCT01045122|75740985|FG001|COMPLETED|Dexmedetomidine Then Propofol||6||
59627733|NCT01045122|75740984|FG000|NOT COMPLETED|Dexmedetomidine Then Propofol||0||
59627734|NCT01045122|75740985|FG001|NOT COMPLETED|Dexmedetomidine Then Propofol||0||
59627735|NCT01045122|75740984|FG000|STARTED|Propofol Then Dexmedetomidine||5||
59627736|NCT01045122|75740985|FG001|STARTED|Propofol Then Dexmedetomidine||6||
59627737|NCT01045122|75740984|FG000|COMPLETED|Propofol Then Dexmedetomidine||5||
59627738|NCT01045122|75740985|FG001|COMPLETED|Propofol Then Dexmedetomidine||6||
59627739|NCT01045122|75740984|FG000|NOT COMPLETED|Propofol Then Dexmedetomidine||0||
59627740|NCT01045122|75740985|FG001|NOT COMPLETED|Propofol Then Dexmedetomidine||0||
59627741|NCT01049802|75740993|FG000|STARTED|Overall Study||20||
59627742|NCT01049802|75740994|FG001|STARTED|Overall Study||10||
59627743|NCT01049802|75740993|FG000|COMPLETED|Overall Study||20||
59627744|NCT01049802|75740994|FG001|COMPLETED|Overall Study||10||
59627745|NCT01049802|75740993|FG000|NOT COMPLETED|Overall Study||0||
59627746|NCT01049802|75740994|FG001|NOT COMPLETED|Overall Study||0||
59627747|NCT01050582|75741002|FG000|STARTED|Overall Study||133||
59627748|NCT01050582|75741003|FG001|STARTED|Overall Study||51||
59627749|NCT01050582|75741002|FG000|COMPLETED|Overall Study||133||
59627750|NCT01050582|75741003|FG001|COMPLETED|Overall Study||51||
59627751|NCT01050582|75741002|FG000|NOT COMPLETED|Overall Study||0||
59627752|NCT01050582|75741003|FG001|NOT COMPLETED|Overall Study||0||
59627753|NCT01050660|75741011|FG000|STARTED|Overall Study||67||
59627754|NCT01050660|75741012|FG001|STARTED|Overall Study||69||
59627755|NCT01050660|75741011|FG000|COMPLETED|Overall Study||67||
59627756|NCT01050660|75741012|FG001|COMPLETED|Overall Study||69||
59627757|NCT01050660|75741011|FG000|NOT COMPLETED|Overall Study||0||
59627758|NCT01050660|75741012|FG001|NOT COMPLETED|Overall Study||0||
59627759|NCT01051440|75741020|FG000|STARTED|Overall Study||1||
59627760|NCT01051440|75741021|FG001|STARTED|Overall Study||1||
59627761|NCT01051440|75741020|FG000|COMPLETED|Overall Study||1||
59627762|NCT01051440|75741021|FG001|COMPLETED|Overall Study||1||
59627763|NCT01051440|75741020|FG000|NOT COMPLETED|Overall Study||0||
59627764|NCT01051440|75741021|FG001|NOT COMPLETED|Overall Study||0||
59627765|NCT01051518|75741029|FG000|STARTED|Overall Study||126||
59627766|NCT01051518|75741029|FG000|COMPLETED|Overall Study||53||
59627767|NCT01051518|75741029|FG000|NOT COMPLETED|Overall Study||73||
59627768|NCT01051596|75741038|FG000|STARTED|Overall Study||75||
59627769|NCT01051596|75741038|FG000|COMPLETED|Overall Study||75||
59627770|NCT01051596|75741038|FG000|NOT COMPLETED|Overall Study||0||
59627771|NCT01053000|75741042|FG000|STARTED|Overall Study||5||
59627772|NCT01053000|75741043|FG001|STARTED|Overall Study||5||
59627773|NCT01053000|75741042|FG000|COMPLETED|Overall Study||5||
59627774|NCT01053000|75741043|FG001|COMPLETED|Overall Study||5||
59627775|NCT01053000|75741042|FG000|NOT COMPLETED|Overall Study||0||
59627776|NCT01053000|75741043|FG001|NOT COMPLETED|Overall Study||0||
59627777|NCT01028820|75741049|FG000|STARTED|Overall Study||13||
59627778|NCT01028820|75741049|FG000|COMPLETED|Overall Study||12||
59627779|NCT01028820|75741049|FG000|NOT COMPLETED|Overall Study||1||
59627780|NCT05483686|75741056|FG000|STARTED|Overall Study||18||
59627781|NCT05483686|75741057|FG001|STARTED|Overall Study||20||
59627782|NCT05483686|75741056|FG000|COMPLETED|Overall Study||13||
59627783|NCT05483686|75741057|FG001|COMPLETED|Overall Study||13||
59627784|NCT05483686|75741056|FG000|NOT COMPLETED|Overall Study||5||
59627785|NCT05483686|75741057|FG001|NOT COMPLETED|Overall Study||7||
59627786|NCT05292755|75741065|FG000|STARTED|Overall Study||40||
59627787|NCT05292755|75741066|FG001|STARTED|Overall Study||40||
59627788|NCT05292755|75741065|FG000|COMPLETED|Overall Study||35||
59627789|NCT05292755|75741066|FG001|COMPLETED|Overall Study||31||
59627790|NCT05292755|75741065|FG000|NOT COMPLETED|Overall Study||5||
59627791|NCT05292755|75741066|FG001|NOT COMPLETED|Overall Study||9||
59627792|NCT04611542|75741072|FG000|STARTED|Overall Study||30||
59627793|NCT04611542|75741072|FG000|COMPLETED|Overall Study||28||
59627794|NCT04611542|75741072|FG000|NOT COMPLETED|Overall Study||2||
59627795|NCT04590781|75741080|FG000|STARTED|Overall Study||2||
59627796|NCT04590781|75741081|FG001|STARTED|Overall Study||2||
59627797|NCT04590781|75741080|FG000|COMPLETED|Overall Study||0||
59627798|NCT04590781|75741081|FG001|COMPLETED|Overall Study||0||
59627799|NCT04590781|75741080|FG000|NOT COMPLETED|Overall Study||2||
59627800|NCT04590781|75741081|FG001|NOT COMPLETED|Overall Study||2||
59627801|NCT04248868|75741088|FG000|STARTED|Overall Study||109||
59627802|NCT04248868|75741088|FG000|COMPLETED|Overall Study||103||
59627803|NCT04248868|75741088|FG000|NOT COMPLETED|Overall Study||6||
59627804|NCT04211831|75741095|FG000|STARTED|Overall Study||27||
59627805|NCT04211831|75741096|FG001|STARTED|Overall Study||26||
59627806|NCT04211831|75741097|FG002|STARTED|Overall Study||27||
59627807|NCT04211831|75741095|FG000|COMPLETED|Overall Study||23||
59627808|NCT04211831|75741096|FG001|COMPLETED|Overall Study||22||
59627809|NCT04211831|75741097|FG002|COMPLETED|Overall Study||22||
59627810|NCT04211831|75741095|FG000|NOT COMPLETED|Overall Study||4||
59627811|NCT04211831|75741096|FG001|NOT COMPLETED|Overall Study||4||
59627812|NCT04211831|75741097|FG002|NOT COMPLETED|Overall Study||5||
59627813|NCT04139122|75741113|FG000|STARTED|Overall Study||6||
59627814|NCT04139122|75741114|FG001|STARTED|Overall Study||6||
59627815|NCT04139122|75741115|FG002|STARTED|Overall Study||5||
59627816|NCT04139122|75741116|FG003|STARTED|Overall Study||4||
59627817|NCT04139122|75741117|FG004|STARTED|Overall Study||8||
59627818|NCT04139122|75741118|FG005|STARTED|Overall Study||20||
59627819|NCT04139122|75741119|FG006|STARTED|Overall Study||20||
59627820|NCT04139122|75741120|FG007|STARTED|Overall Study||20||
59627821|NCT04139122|75741113|FG000|COMPLETED|Overall Study||5||
59627822|NCT04139122|75741114|FG001|COMPLETED|Overall Study||6||
59627823|NCT04139122|75741115|FG002|COMPLETED|Overall Study||5||
59627824|NCT04139122|75741116|FG003|COMPLETED|Overall Study||4||
59627825|NCT04139122|75741117|FG004|COMPLETED|Overall Study||8||
59627826|NCT04139122|75741118|FG005|COMPLETED|Overall Study||20||
59627827|NCT04139122|75741119|FG006|COMPLETED|Overall Study||20||
59627828|NCT04139122|75741120|FG007|COMPLETED|Overall Study||19||
59627829|NCT04139122|75741113|FG000|NOT COMPLETED|Overall Study||1||
59627830|NCT04139122|75741114|FG001|NOT COMPLETED|Overall Study||0||
59627831|NCT04139122|75741115|FG002|NOT COMPLETED|Overall Study||0||
59627832|NCT04139122|75741116|FG003|NOT COMPLETED|Overall Study||0||
59627833|NCT04139122|75741117|FG004|NOT COMPLETED|Overall Study||0||
59627834|NCT04139122|75741118|FG005|NOT COMPLETED|Overall Study||0||
59627835|NCT04139122|75741119|FG006|NOT COMPLETED|Overall Study||0||
59627836|NCT04139122|75741120|FG007|NOT COMPLETED|Overall Study||1||
59627837|NCT04067518|75741155|FG000|STARTED|Overall Study||3||
59627838|NCT04067518|75741156|FG001|STARTED|Overall Study||25||
59627839|NCT04067518|75741155|FG000|Safety Analysis Set|Overall Study||3|Safety Analysis Set (SAF) included all participants who had received at least one dose of SHP674 in Part 1 or Part 2 of the study.|
59627840|NCT04067518|75741156|FG001|Safety Analysis Set|Overall Study||23|Safety Analysis Set (SAF) included all participants who had received at least one dose of SHP674 in Part 1 or Part 2 of the study.|
59627841|NCT04067518|75741155|FG000|- Standard Risk(SR)/Intermediate Risk (IR)|Overall Study||3||
59627842|NCT04067518|75741156|FG001|- Standard Risk(SR)/Intermediate Risk (IR)|Overall Study||21||
59627843|NCT04067518|75741155|FG000|- Hihg Risk (HR)|Overall Study||0||
59627844|NCT04067518|75741156|FG001|- Hihg Risk (HR)|Overall Study||1||
59627845|NCT04067518|75741155|FG000|- Missing|Overall Study||0||
59627846|NCT04067518|75741156|FG001|- Missing|Overall Study||1||
59627847|NCT04067518|75741155|FG000|Full Analysis Set|Overall Study||0|Full analysis set (FAS) included all participants who were enrolled and received SHP674 in Part 2 of the study.|
59627848|NCT04067518|75741156|FG001|Full Analysis Set|Overall Study||23|Full analysis set (FAS) included all participants who were enrolled and received SHP674 in Part 2 of the study.|
59627849|NCT04067518|75741155|FG000|Immunogenicity Analysis Set|Overall Study||3|Immunogenicity analysis set (IMAS) included all participants who had received at least one dose of SHP674 in Part 1 or Part 2 of the study and had at least one evaluable post-dose sample. If the pre-dose sample was missing it was considered negative.|
59627850|NCT04067518|75741156|FG001|Immunogenicity Analysis Set|Overall Study||22|Immunogenicity analysis set (IMAS) included all participants who had received at least one dose of SHP674 in Part 1 or Part 2 of the study and had at least one evaluable post-dose sample. If the pre-dose sample was missing it was considered negative.|
59627851|NCT04067518|75741155|FG000|Pharmacokinetic Analysis Set|Overall Study||3|Pharmacokinetic (PK) analysis included all participants enrolled in Part 1 or Part 2 who had received first dose of SHP674 at remission induction therapy, who were evaluable for non-compartmental analysis and included only the participants who had sufficient samples collected to provide interpretable PK results with no deviations that might had affected the PK interpretation.|
59709634|NCT01235741|75828429|FG000|COMPLETED|Non-Randomized Low Calorie Diet Lead-In|Study terminated by Sponsor. 72 randomized to treatment at time study halted.|72||
59709635|NCT01235741|75828430|FG001|COMPLETED|Non-Randomized Low Calorie Diet Lead-In||0||
59709636|NCT01235741|75828431|FG002|COMPLETED|Non-Randomized Low Calorie Diet Lead-In||0||
59539647|NCT00825734|75638049|FG002|NOT COMPLETED|Phase I||0||
59539648|NCT00825734|75638047|FG000|STARTED|Phase II||0||
59539649|NCT00825734|75638048|FG001|STARTED|Phase II||0||
59539650|NCT00825734|75638049|FG002|STARTED|Phase II|Includes patients treated at MTD during Phase I and 73 additional patients enrolled for Phase II|76||
59539651|NCT00825734|75638047|FG000|COMPLETED|Phase II||0||
59539652|NCT00825734|75638048|FG001|COMPLETED|Phase II||0||
59539653|NCT00825734|75638049|FG002|COMPLETED|Phase II||0||
59539654|NCT00825734|75638047|FG000|NOT COMPLETED|Phase II||0||
59539655|NCT00825734|75638048|FG001|NOT COMPLETED|Phase II||0||
59539656|NCT00825734|75638049|FG002|NOT COMPLETED|Phase II||76||
59539657|NCT00826202|75638056|FG000|STARTED|Overall Study||20||
59539658|NCT00826202|75638057|FG001|STARTED|Overall Study||24||
59539659|NCT00826202|75638056|FG000|Completed Visit 4 (1st Efficacy Visit)|Overall Study||15||
59539660|NCT00826202|75638057|FG001|Completed Visit 4 (1st Efficacy Visit)|Overall Study||20||
59539661|NCT00826202|75638056|FG000|COMPLETED|Overall Study||10||
59539662|NCT00826202|75638057|FG001|COMPLETED|Overall Study||11||
59539663|NCT00826202|75638056|FG000|NOT COMPLETED|Overall Study||10||
59539664|NCT00826202|75638057|FG001|NOT COMPLETED|Overall Study||13||
59539665|NCT02153528|75638065|FG000|STARTED|Overall Study||348||
59539666|NCT02153528|75638066|FG001|STARTED|Overall Study||353||
59539667|NCT02153528|75638065|FG000|COMPLETED|Overall Study||348||
59539668|NCT02153528|75638066|FG001|COMPLETED|Overall Study||353||
59539669|NCT02153528|75638065|FG000|NOT COMPLETED|Overall Study||0||
59539670|NCT02153528|75638066|FG001|NOT COMPLETED|Overall Study||0||
59539671|NCT00872534|75638076|FG000|STARTED|Overall Study||100||
59539672|NCT00872534|75638077|FG001|STARTED|Overall Study||104||
59539673|NCT00872534|75638076|FG000|COMPLETED|Overall Study||97||
59539674|NCT00872534|75638077|FG001|COMPLETED|Overall Study||101||
59539675|NCT00872534|75638076|FG000|NOT COMPLETED|Overall Study||3||
59539676|NCT00872534|75638077|FG001|NOT COMPLETED|Overall Study||3||
59539677|NCT00873782|75638083|FG000|STARTED|Overall Study||16||
59539678|NCT00873782|75638083|FG000|COMPLETED|Overall Study||16||
59539679|NCT00873782|75638083|FG000|NOT COMPLETED|Overall Study||0||
59539680|NCT02513160|75638091|FG000|STARTED|Run-In Period (Days -14 to Day -1)|Enrolled|713||
59539681|NCT02513160|75638092|FG001|STARTED|Run-In Period (Days -14 to Day -1)||0||
59539682|NCT02513160|75638093|FG002|STARTED|Run-In Period (Days -14 to Day -1)||0||
59539683|NCT02513160|75638094|FG003|STARTED|Run-In Period (Days -14 to Day -1)||0||
59539684|NCT02513160|75638091|FG000|COMPLETED|Run-In Period (Days -14 to Day -1)||425||
59539685|NCT02513160|75638092|FG001|COMPLETED|Run-In Period (Days -14 to Day -1)||0||
59539686|NCT02513160|75638093|FG002|COMPLETED|Run-In Period (Days -14 to Day -1)||0||
59539687|NCT02513160|75638094|FG003|COMPLETED|Run-In Period (Days -14 to Day -1)||0||
59539688|NCT02513160|75638091|FG000|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||288||
59539689|NCT02513160|75638092|FG001|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0||
59539690|NCT02513160|75638093|FG002|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0||
59539691|NCT02513160|75638094|FG003|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0||
59539692|NCT02513160|75638091|FG000|STARTED|Treatment Period (Day 0 to Week 6)|Randomized|107||
59539693|NCT02513160|75638092|FG001|STARTED|Treatment Period (Day 0 to Week 6)|Randomized|108||
59539694|NCT02513160|75638093|FG002|STARTED|Treatment Period (Day 0 to Week 6)|Randomized|105||
59539695|NCT02513160|75638094|FG003|STARTED|Treatment Period (Day 0 to Week 6)|Randomized|105||
59539696|NCT02513160|75638091|FG000|COMPLETED|Treatment Period (Day 0 to Week 6)||101||
59539697|NCT02513160|75638092|FG001|COMPLETED|Treatment Period (Day 0 to Week 6)||104||
59539698|NCT02513160|75638093|FG002|COMPLETED|Treatment Period (Day 0 to Week 6)||104||
59539699|NCT02513160|75638094|FG003|COMPLETED|Treatment Period (Day 0 to Week 6)||103||
59539700|NCT02513160|75638091|FG000|NOT COMPLETED|Treatment Period (Day 0 to Week 6)||6||
59539701|NCT02513160|75638092|FG001|NOT COMPLETED|Treatment Period (Day 0 to Week 6)||4||
59539702|NCT02513160|75638093|FG002|NOT COMPLETED|Treatment Period (Day 0 to Week 6)||1||
59539703|NCT02513160|75638094|FG003|NOT COMPLETED|Treatment Period (Day 0 to Week 6)||2||
59539704|NCT00874094|75638105|FG000|STARTED|Overall Study||15||
59539705|NCT00874094|75638105|FG000|COMPLETED|Overall Study||15||
59539706|NCT00874094|75638105|FG000|NOT COMPLETED|Overall Study||0||
59539707|NCT01507103|75638112|FG000|STARTED|Overall Study||41||
59539708|NCT01507103|75638113|FG001|STARTED|Overall Study||41||
59539709|NCT01507103|75638114|FG002|STARTED|Overall Study||42||
59539710|NCT01507103|75638112|FG000|COMPLETED|Overall Study||41||
59539711|NCT01507103|75638113|FG001|COMPLETED|Overall Study||41||
59539712|NCT01507103|75638114|FG002|COMPLETED|Overall Study||42||
59539713|NCT01507103|75638112|FG000|NOT COMPLETED|Overall Study||0||
59539714|NCT01507103|75638113|FG001|NOT COMPLETED|Overall Study||0||
59539715|NCT01507103|75638114|FG002|NOT COMPLETED|Overall Study||0||
59539716|NCT00874250|75638122|FG000|STARTED|Overall Study||51||
59539717|NCT00874250|75638122|FG000|COMPLETED|Overall Study||0||
59539718|NCT00874250|75638122|FG000|NOT COMPLETED|Overall Study||51||
59539719|NCT02480010|75638129|FG000|STARTED|Overall Study||35||
59539720|NCT02480010|75638130|FG001|STARTED|Overall Study||33||
59539721|NCT02480010|75638129|FG000|COMPLETED|Overall Study||0||
59539722|NCT02480010|75638130|FG001|COMPLETED|Overall Study||0||
59539723|NCT02480010|75638129|FG000|NOT COMPLETED|Overall Study||35||
59539724|NCT02480010|75638130|FG001|NOT COMPLETED|Overall Study||33||
59539725|NCT01388777|75638136|FG000|STARTED|Overall Study||1||
59627852|NCT04067518|75741156|FG001|Pharmacokinetic Analysis Set|Overall Study||23|Pharmacokinetic (PK) analysis included all participants enrolled in Part 1 or Part 2 who had received first dose of SHP674 at remission induction therapy, who were evaluable for non-compartmental analysis and included only the participants who had sufficient samples collected to provide interpretable PK results with no deviations that might had affected the PK interpretation.|
59627853|NCT04067518|75741155|FG000|COMPLETED|Overall Study||2||
59627854|NCT04067518|75741156|FG001|COMPLETED|Overall Study||20||
59627855|NCT04067518|75741155|FG000|NOT COMPLETED|Overall Study||1||
59627856|NCT04067518|75741156|FG001|NOT COMPLETED|Overall Study||5||
59627857|NCT04033419|75741166|FG000|STARTED|Overall Study||51||
59627858|NCT04033419|75741166|FG000|COMPLETED|Overall Study||45||
59627859|NCT04033419|75741166|FG000|NOT COMPLETED|Overall Study||6||
59627860|NCT03912233|75741197|FG000|STARTED|Overall Study||10||
59627861|NCT03912233|75741198|FG001|STARTED|Overall Study||9||
59627862|NCT03912233|75741199|FG002|STARTED|Overall Study||19||
59627863|NCT03912233|75741200|FG003|STARTED|Overall Study||20||
59627864|NCT03912233|75741201|FG004|STARTED|Overall Study||10||
59627865|NCT03912233|75741202|FG005|STARTED|Overall Study||18||
59627866|NCT03912233|75741197|FG000|COMPLETED|Overall Study||8||
59627867|NCT03912233|75741198|FG001|COMPLETED|Overall Study||9||
59627868|NCT03912233|75741199|FG002|COMPLETED|Overall Study||19||
59627869|NCT03912233|75741200|FG003|COMPLETED|Overall Study||20||
59627870|NCT03912233|75741201|FG004|COMPLETED|Overall Study||3||
59627871|NCT03912233|75741202|FG005|COMPLETED|Overall Study||6||
59627872|NCT03912233|75741197|FG000|NOT COMPLETED|Overall Study||2||
59627873|NCT03912233|75741198|FG001|NOT COMPLETED|Overall Study||0||
59627874|NCT03912233|75741199|FG002|NOT COMPLETED|Overall Study||0||
59627875|NCT03912233|75741200|FG003|NOT COMPLETED|Overall Study||0||
59627876|NCT03912233|75741201|FG004|NOT COMPLETED|Overall Study||7||
59627877|NCT03912233|75741202|FG005|NOT COMPLETED|Overall Study||12||
59627878|NCT03834870|75741218|FG000|STARTED|Overall Study||1012||
59627879|NCT03834870|75741218|FG000|COMPLETED|Overall Study||1002||
59627880|NCT03834870|75741218|FG000|NOT COMPLETED|Overall Study||10||
59627881|NCT03781817|75741226|FG000|STARTED|Overall Study||17||
59627882|NCT03781817|75741227|FG001|STARTED|Overall Study||23||
59627883|NCT03781817|75741226|FG000|COMPLETED|Overall Study||17||
59627884|NCT03781817|75741227|FG001|COMPLETED|Overall Study||23||
59627885|NCT03781817|75741226|FG000|NOT COMPLETED|Overall Study||0||
59627886|NCT03781817|75741227|FG001|NOT COMPLETED|Overall Study||0||
59627887|NCT03636451|75741235|FG000|STARTED|Overall Study||57||
59627888|NCT03636451|75741236|FG001|STARTED|Overall Study||57||
59627889|NCT03636451|75741235|FG000|COMPLETED|Overall Study||57||
59627890|NCT03636451|75741236|FG001|COMPLETED|Overall Study||57||
59627891|NCT03636451|75741235|FG000|NOT COMPLETED|Overall Study||0||
59627892|NCT03636451|75741236|FG001|NOT COMPLETED|Overall Study||0||
59627893|NCT03546062|75741245|FG000|STARTED|Overall Study||41||
59627894|NCT03546062|75741246|FG001|STARTED|Overall Study||46||
59627895|NCT03546062|75741247|FG002|STARTED|Overall Study||90||
59627896|NCT03546062|75741245|FG000|COMPLETED|Overall Study||35||
59627897|NCT03546062|75741246|FG001|COMPLETED|Overall Study||41||
59627898|NCT03546062|75741247|FG002|COMPLETED|Overall Study||82||
59627899|NCT03546062|75741245|FG000|NOT COMPLETED|Overall Study||6||
59627900|NCT03546062|75741246|FG001|NOT COMPLETED|Overall Study||5||
59627901|NCT03546062|75741247|FG002|NOT COMPLETED|Overall Study||8||
59627902|NCT03539952|75741257|FG000|STARTED|Penicillamine Baseline Period (Day1-W12)||77||
59627903|NCT03539952|75741258|FG001|STARTED|Penicillamine Baseline Period (Day1-W12)||0||
59627904|NCT03539952|75741257|FG000|COMPLETED|Penicillamine Baseline Period (Day1-W12)||53||
59627905|NCT03539952|75741258|FG001|COMPLETED|Penicillamine Baseline Period (Day1-W12)||0||
59627906|NCT03539952|75741257|FG000|NOT COMPLETED|Penicillamine Baseline Period (Day1-W12)||24||
59627907|NCT03539952|75741258|FG001|NOT COMPLETED|Penicillamine Baseline Period (Day1-W12)||0||
59627908|NCT03539952|75741257|FG000|STARTED|Post-randomization Period (Week 12-36)|Patients completing period 1 and randomized to receive penicillamine|27|The number of participants starting the Post-randomization period in one of the two arms is equal to the number of subjects that completed the baseline period, i.e. before randomisation|
59627909|NCT03539952|75741258|FG001|STARTED|Post-randomization Period (Week 12-36)|Patients completing period 1 and randomized to receive TETA 4HCl|26|The number of participants starting the Post-randomization period in one of the two arms is equal to the number of subjects that completed the baseline period, i.e. before randomisation|
59627910|NCT03539952|75741257|FG000|COMPLETED|Post-randomization Period (Week 12-36)||26||
59627911|NCT03539952|75741258|FG001|COMPLETED|Post-randomization Period (Week 12-36)||26||
59627912|NCT03539952|75741257|FG000|NOT COMPLETED|Post-randomization Period (Week 12-36)||1||
59627913|NCT03539952|75741258|FG001|NOT COMPLETED|Post-randomization Period (Week 12-36)||0||
59627914|NCT03539952|75741257|FG000|STARTED|Extension Post Random. (Week 36-60)||26||
59627915|NCT03539952|75741258|FG001|STARTED|Extension Post Random. (Week 36-60)||26||
59627916|NCT03539952|75741257|FG000|COMPLETED|Extension Post Random. (Week 36-60)||19||
59627917|NCT03539952|75741258|FG001|COMPLETED|Extension Post Random. (Week 36-60)||23||
59627918|NCT03539952|75741257|FG000|NOT COMPLETED|Extension Post Random. (Week 36-60)||7||
59627919|NCT03539952|75741258|FG001|NOT COMPLETED|Extension Post Random. (Week 36-60)||3||
59627920|NCT03539952|75741257|FG000|STARTED|All on TETA 4HCl, From wk 60 Till 108max||19||
59627921|NCT03539952|75741258|FG001|STARTED|All on TETA 4HCl, From wk 60 Till 108max||23||
59627922|NCT03539952|75741257|FG000|COMPLETED|All on TETA 4HCl, From wk 60 Till 108max||19||
59627923|NCT03539952|75741258|FG001|COMPLETED|All on TETA 4HCl, From wk 60 Till 108max||21||
59627924|NCT03539952|75741257|FG000|NOT COMPLETED|All on TETA 4HCl, From wk 60 Till 108max||0||
59627925|NCT03539952|75741258|FG001|NOT COMPLETED|All on TETA 4HCl, From wk 60 Till 108max||2||
59627926|NCT03479697|75741276|FG000|STARTED|Overall Study||2||
59627927|NCT03479697|75741277|FG001|STARTED|Overall Study||3||
59627928|NCT03479697|75741276|FG000|COMPLETED|Overall Study||2||
59627929|NCT03479697|75741277|FG001|COMPLETED|Overall Study||3||
59627930|NCT03479697|75741276|FG000|NOT COMPLETED|Overall Study||0||
59627931|NCT03479697|75741277|FG001|NOT COMPLETED|Overall Study||0||
59627932|NCT02948569|75741283|FG000|STARTED|Overall Study||12||
59627933|NCT02948569|75741283|FG000|COMPLETED|Overall Study||12||
59627934|NCT02948569|75741283|FG000|NOT COMPLETED|Overall Study||0||
59627935|NCT02929108|75741290|FG000|STARTED|Overall Study||122||
59627936|NCT02929108|75741291|FG001|STARTED|Overall Study||75||
59627937|NCT02929108|75741292|FG002|STARTED|Overall Study||39||
59627938|NCT02929108|75741293|FG003|STARTED|Overall Study||60||
59627939|NCT02929108|75741294|FG004|STARTED|Overall Study||73||
59627940|NCT02929108|75741295|FG005|STARTED|Overall Study||32||
59627941|NCT02929108|75741296|FG006|STARTED|Overall Study||88||
59627942|NCT02929108|75741290|FG000|Facebook|Overall Study||94||
59627943|NCT02929108|75741291|FG001|Facebook|Overall Study||0||
59627944|NCT02929108|75741292|FG002|Facebook|Overall Study||0||
59627945|NCT02929108|75741293|FG003|Facebook|Overall Study||11||
59627946|NCT02929108|75741294|FG004|Facebook|Overall Study||57||
59627947|NCT02929108|75741295|FG005|Facebook|Overall Study||10||
59627948|NCT02929108|75741296|FG006|Facebook|Overall Study||42||
59627949|NCT02929108|75741290|FG000|Access|Overall Study||28|Although the hospice site was assigned Facebook and Enhanced Usual Care, there were 5 caregivers that did receive the intervention of Access.|
59627950|NCT02929108|75741291|FG001|Access|Overall Study||47|Although the hospice site was assigned Facebook and Enhanced Usual Care, there were 5 caregivers that did receive the intervention of Access.|
59627951|NCT02929108|75741292|FG002|Access|Overall Study||23|Although the hospice site was assigned Facebook and Enhanced Usual Care, there were 5 caregivers that did receive the intervention of Access.|
59627952|NCT02929108|75741293|FG003|Access|Overall Study||0|Although the hospice site was assigned Facebook and Enhanced Usual Care, there were 5 caregivers that did receive the intervention of Access.|
59627953|NCT02929108|75741294|FG004|Access|Overall Study||5|Although the hospice site was assigned Facebook and Enhanced Usual Care, there were 5 caregivers that did receive the intervention of Access.|
59627954|NCT02929108|75741295|FG005|Access|Overall Study||0|Although the hospice site was assigned Facebook and Enhanced Usual Care, there were 5 caregivers that did receive the intervention of Access.|
59627955|NCT02929108|75741296|FG006|Access|Overall Study||46|Although the hospice site was assigned Facebook and Enhanced Usual Care, there were 5 caregivers that did receive the intervention of Access.|
59627956|NCT02929108|75741290|FG000|Enhanced Usual Care|Overall Study||0||
59627957|NCT02929108|75741291|FG001|Enhanced Usual Care|Overall Study||28||
59627958|NCT02929108|75741292|FG002|Enhanced Usual Care|Overall Study||16||
59627959|NCT02929108|75741293|FG003|Enhanced Usual Care|Overall Study||49||
59627960|NCT02929108|75741294|FG004|Enhanced Usual Care|Overall Study||11||
59627961|NCT02929108|75741295|FG005|Enhanced Usual Care|Overall Study||22||
59627962|NCT02929108|75741296|FG006|Enhanced Usual Care|Overall Study||0||
59627963|NCT02929108|75741290|FG000|COMPLETED|Overall Study||22||
59627964|NCT02929108|75741291|FG001|COMPLETED|Overall Study||11||
59627965|NCT02929108|75741292|FG002|COMPLETED|Overall Study||11||
59627966|NCT02929108|75741293|FG003|COMPLETED|Overall Study||14||
59627967|NCT02929108|75741294|FG004|COMPLETED|Overall Study||18||
59627968|NCT02929108|75741295|FG005|COMPLETED|Overall Study||4||
59627969|NCT02929108|75741296|FG006|COMPLETED|Overall Study||10||
59627970|NCT02929108|75741290|FG000|NOT COMPLETED|Overall Study||100||
59627971|NCT02929108|75741291|FG001|NOT COMPLETED|Overall Study||64||
59627972|NCT02929108|75741292|FG002|NOT COMPLETED|Overall Study||28||
59627973|NCT02929108|75741293|FG003|NOT COMPLETED|Overall Study||46||
59627974|NCT02929108|75741294|FG004|NOT COMPLETED|Overall Study||55||
59627975|NCT02929108|75741295|FG005|NOT COMPLETED|Overall Study||28||
59627976|NCT02929108|75741296|FG006|NOT COMPLETED|Overall Study||78||
59627977|NCT02661295|75741304|FG000|STARTED|Overall Study||38||
59627978|NCT02661295|75741304|FG000|COMPLETED|Overall Study||19||
59627979|NCT02661295|75741304|FG000|NOT COMPLETED|Overall Study||19||
59627980|NCT02412748|75741310|FG000|STARTED|Overall Study||145||
59627981|NCT02412748|75741311|FG001|STARTED|Overall Study||163||
59627982|NCT02412748|75741310|FG000|COMPLETED|Overall Study||107||
59627983|NCT02412748|75741311|FG001|COMPLETED|Overall Study||124||
59627984|NCT02412748|75741310|FG000|NOT COMPLETED|Overall Study||38||
59627985|NCT02412748|75741311|FG001|NOT COMPLETED|Overall Study||39||
59627986|NCT02272946|75741320|FG000|STARTED|Overall Study||10||
59627987|NCT02272946|75741321|FG001|STARTED|Overall Study||25||
59627988|NCT02272946|75741322|FG002|STARTED|Overall Study||8||
59627989|NCT02272946|75741320|FG000|COMPLETED|Overall Study||10||
59627990|NCT02272946|75741321|FG001|COMPLETED|Overall Study||25||
59627991|NCT02272946|75741322|FG002|COMPLETED|Overall Study||8||
59627992|NCT02272946|75741320|FG000|NOT COMPLETED|Overall Study||0||
59627993|NCT02272946|75741321|FG001|NOT COMPLETED|Overall Study||0||
59627994|NCT02272946|75741322|FG002|NOT COMPLETED|Overall Study||0||
59627995|NCT01844726|75741336|FG000|STARTED|Overall Study||22||
59627996|NCT01844726|75741337|FG001|STARTED|Overall Study||22||
59815645|NCT03873272|75938093|FG001|NOT COMPLETED|Overall Study||2||
59539726|NCT01388777|75638136|FG000|Cryoablation|Overall Study||1||
59539727|NCT01388777|75638136|FG000|COMPLETED|Overall Study||1||
59539728|NCT01388777|75638136|FG000|NOT COMPLETED|Overall Study||0||
59539729|NCT00875342|75638142|FG000|STARTED|Overall Study||20||
59539730|NCT00875342|75638143|FG001|STARTED|Overall Study||21||
59539731|NCT00875342|75638142|FG000|COMPLETED|Overall Study||16||
59539732|NCT00875342|75638143|FG001|COMPLETED|Overall Study||16||
59539733|NCT00875342|75638142|FG000|NOT COMPLETED|Overall Study||4||
59539734|NCT00875342|75638143|FG001|NOT COMPLETED|Overall Study||5||
59539735|NCT00876200|75638151|FG000|STARTED|Overall Study||9||
59539736|NCT00876200|75638152|FG001|STARTED|Overall Study||12||
59539737|NCT00876200|75638151|FG000|COMPLETED|Overall Study||8||
59539738|NCT00876200|75638152|FG001|COMPLETED|Overall Study||9||
59539739|NCT00876200|75638151|FG000|NOT COMPLETED|Overall Study||1||
59539740|NCT00876200|75638152|FG001|NOT COMPLETED|Overall Study||3||
59539741|NCT02512302|75638158|FG000|STARTED|Period 1||3||
59539742|NCT02512302|75638159|FG001|STARTED|Period 1||3||
59539743|NCT02512302|75638160|FG002|STARTED|Period 1||4||
59627997|NCT01844726|75741336|FG000|COMPLETED|Overall Study||21||
59627998|NCT01844726|75741337|FG001|COMPLETED|Overall Study||21||
59627999|NCT01844726|75741336|FG000|NOT COMPLETED|Overall Study||1||
59628000|NCT01844726|75741337|FG001|NOT COMPLETED|Overall Study||1||
59628001|NCT00852124|75741345|FG000|STARTED|Overall Study||3||
59628002|NCT00852124|75741346|FG001|STARTED|Overall Study||0||
59628003|NCT00852124|75741345|FG000|COMPLETED|Overall Study||3||
59628004|NCT00852124|75741346|FG001|COMPLETED|Overall Study||0||
59628005|NCT00852124|75741345|FG000|NOT COMPLETED|Overall Study||0||
59628006|NCT00852124|75741346|FG001|NOT COMPLETED|Overall Study||0||
59628007|NCT01053078|75741353|FG000|STARTED|Overall Study||14||
59628008|NCT01053078|75741354|FG001|STARTED|Overall Study||15||
59628009|NCT01053078|75741353|FG000|COMPLETED|Overall Study||10||
59628010|NCT01053078|75741354|FG001|COMPLETED|Overall Study||12||
59628011|NCT01053078|75741353|FG000|NOT COMPLETED|Overall Study||4||
59628012|NCT01053078|75741354|FG001|NOT COMPLETED|Overall Study||3||
59628013|NCT01053156|75741364|FG000|STARTED|First Intervention (Week 1-12)||33||
59628014|NCT01053156|75741365|FG001|STARTED|First Intervention (Week 1-12)||33||
59628015|NCT01053156|75741364|FG000|COMPLETED|First Intervention (Week 1-12)||28||
59628016|NCT01053156|75741365|FG001|COMPLETED|First Intervention (Week 1-12)||27||
59628017|NCT01053156|75741364|FG000|NOT COMPLETED|First Intervention (Week 1-12)||5||
59628018|NCT01053156|75741365|FG001|NOT COMPLETED|First Intervention (Week 1-12)||6||
59628019|NCT01053156|75741364|FG000|STARTED|Second Intervention (Week 13-24)||28||
59628020|NCT01053156|75741365|FG001|STARTED|Second Intervention (Week 13-24)||27||
59628021|NCT01053156|75741364|FG000|COMPLETED|Second Intervention (Week 13-24)||26||
59628022|NCT01053156|75741365|FG001|COMPLETED|Second Intervention (Week 13-24)||22||
59628023|NCT01053156|75741364|FG000|NOT COMPLETED|Second Intervention (Week 13-24)||2||
59628024|NCT01053156|75741365|FG001|NOT COMPLETED|Second Intervention (Week 13-24)||5||
59628025|NCT01053312|75741374|FG000|STARTED|Overall Study||7||
59628026|NCT01053312|75741374|FG000|COMPLETED|Overall Study||7||
59628027|NCT01053312|75741374|FG000|NOT COMPLETED|Overall Study||0||
59628028|NCT01054404|75741394|FG000|STARTED|Overall Study||10||
59628029|NCT01054404|75741395|FG001|STARTED|Overall Study||13||
59628030|NCT01054404|75741394|FG000|COMPLETED|Overall Study||10||
59628031|NCT01054404|75741395|FG001|COMPLETED|Overall Study||13||
59628032|NCT01054404|75741394|FG000|NOT COMPLETED|Overall Study||0||
59628033|NCT01054404|75741395|FG001|NOT COMPLETED|Overall Study||0||
59628034|NCT01055184|75741401|FG000|STARTED|Overall Study||34||
59628035|NCT01055184|75741401|FG000|COMPLETED|Overall Study||34||
59628036|NCT01055184|75741401|FG000|NOT COMPLETED|Overall Study||0||
59628037|NCT01056198|75741407|FG000|STARTED|Overall Study||24||
59628038|NCT01056198|75741408|FG001|STARTED|Overall Study||24||
59628039|NCT01056198|75741407|FG000|COMPLETED|Overall Study||24||
59628040|NCT01056198|75741408|FG001|COMPLETED|Overall Study||24||
59988202|NCT05180630|76103321|FG002|STARTED|Second Intervention||2||
59628041|NCT01056198|75741407|FG000|NOT COMPLETED|Overall Study||0||
59628042|NCT01056198|75741408|FG001|NOT COMPLETED|Overall Study||0||
59628043|NCT01058070|75741416|FG000|STARTED|Overall Study||44||
59628044|NCT01058070|75741416|FG000|COMPLETED|Overall Study||33||
59628045|NCT01058070|75741416|FG000|NOT COMPLETED|Overall Study||11||
59628046|NCT01060020|75741421|FG000|STARTED|Overall Study||20||
59628047|NCT01060020|75741421|FG000|COMPLETED|Overall Study||20||
59628048|NCT01060020|75741421|FG000|NOT COMPLETED|Overall Study||0||
59628049|NCT01060098|75741429|FG000|STARTED|Overall Study||25||
59628050|NCT01060098|75741430|FG001|STARTED|Overall Study||15||
59628051|NCT01060098|75741431|FG002|STARTED|Overall Study||8||
59628052|NCT01060098|75741429|FG000|COMPLETED|Overall Study||25||
59628053|NCT01060098|75741430|FG001|COMPLETED|Overall Study||15||
59988203|NCT05180630|76103319|FG000|COMPLETED|Second Intervention||6||
59628054|NCT01060098|75741431|FG002|COMPLETED|Overall Study||8||
59628055|NCT01060098|75741429|FG000|NOT COMPLETED|Overall Study||0||
59628056|NCT01060098|75741430|FG001|NOT COMPLETED|Overall Study||0||
59628057|NCT01060098|75741431|FG002|NOT COMPLETED|Overall Study||0||
59628058|NCT01061034|75741439|FG000|STARTED|Aspirin||9||
59628059|NCT01061034|75741439|FG000|COMPLETED|Aspirin||9||
59628060|NCT01061034|75741439|FG000|NOT COMPLETED|Aspirin||0||
59628061|NCT01061034|75741439|FG000|STARTED|Aspirin Plus Omeprazole||9||
59815646|NCT03873272|75938094|FG002|NOT COMPLETED|Overall Study||2||
59628062|NCT01061034|75741439|FG000|COMPLETED|Aspirin Plus Omeprazole||9||
59628063|NCT01061034|75741439|FG000|NOT COMPLETED|Aspirin Plus Omeprazole||0||
59628064|NCT01064076|75741443|FG000|STARTED|Overall Study|321 subjects underwent an implant procedure for the S-ICD System|321||
59628065|NCT01064076|75741443|FG000|COMPLETED|Overall Study|303 subjects completed a minimum of 180 days of follow up|303||
59628066|NCT01064076|75741443|FG000|NOT COMPLETED|Overall Study||18||
59628067|NCT01065480|75741450|FG000|STARTED|Overall Study||48||
59628068|NCT01065480|75741451|FG001|STARTED|Overall Study||43||
59628069|NCT01065480|75741450|FG000|COMPLETED|Overall Study||48||
59628070|NCT01065480|75741451|FG001|COMPLETED|Overall Study||43||
59628071|NCT01065480|75741450|FG000|NOT COMPLETED|Overall Study||0||
59628072|NCT01065480|75741451|FG001|NOT COMPLETED|Overall Study||0||
59628073|NCT01065558|75741457|FG000|STARTED|Overall Study||5||
59628074|NCT01065558|75741457|FG000|COMPLETED|Overall Study||5||
59628075|NCT01065558|75741457|FG000|NOT COMPLETED|Overall Study||0||
59628076|NCT01065714|75741461|FG000|STARTED|Overall Study|"This was a split body Study. All participants used both Hydrogel and Eucerin"|20||
59628077|NCT01065714|75741461|FG000|COMPLETED|Overall Study||20||
59628078|NCT01065714|75741461|FG000|NOT COMPLETED|Overall Study||0||
59628079|NCT01066026|75741468|FG000|STARTED|Overall Study|Each patient was injected with hyaluronic acid in each nasolabial fold (total: 2 injections)|25||
59628080|NCT01066026|75741468|FG000|COMPLETED|Overall Study||23||
59628081|NCT01066026|75741468|FG000|NOT COMPLETED|Overall Study||2||
59628082|NCT01072032|75741476|FG000|STARTED|Overall Study||13||
59628083|NCT01072032|75741477|FG001|STARTED|Overall Study||14||
59628084|NCT01072032|75741476|FG000|COMPLETED|Overall Study||5||
59628085|NCT01072032|75741477|FG001|COMPLETED|Overall Study||5||
59628086|NCT01072032|75741476|FG000|NOT COMPLETED|Overall Study||8||
59628087|NCT01072032|75741477|FG001|NOT COMPLETED|Overall Study||9||
59628088|NCT01072188|75741486|FG000|STARTED|Overall Study||22||
59628089|NCT01072188|75741487|FG001|STARTED|Overall Study||23||
59628090|NCT01072188|75741486|FG000|COMPLETED|Overall Study||22||
59628091|NCT01072188|75741487|FG001|COMPLETED|Overall Study||23||
59628092|NCT01072188|75741486|FG000|NOT COMPLETED|Overall Study||0||
59628093|NCT01072188|75741487|FG001|NOT COMPLETED|Overall Study||0||
59628094|NCT01072656|75741495|FG000|STARTED|First Intervention||5||
59628095|NCT01072656|75741496|FG001|STARTED|First Intervention||4||
59628096|NCT01072656|75741495|FG000|COMPLETED|First Intervention||5||
59628097|NCT01072656|75741496|FG001|COMPLETED|First Intervention||4||
59628098|NCT01072656|75741495|FG000|NOT COMPLETED|First Intervention||0||
59628099|NCT01072656|75741496|FG001|NOT COMPLETED|First Intervention||0||
59628100|NCT01072656|75741495|FG000|STARTED|Second Intervention||5||
59628101|NCT01072656|75741496|FG001|STARTED|Second Intervention||4||
59628102|NCT01072656|75741495|FG000|COMPLETED|Second Intervention||5||
59628103|NCT01072656|75741496|FG001|COMPLETED|Second Intervention||4||
59628104|NCT01072656|75741495|FG000|NOT COMPLETED|Second Intervention||0||
59628105|NCT01072656|75741496|FG001|NOT COMPLETED|Second Intervention||0||
59628106|NCT01076244|75741503|FG000|STARTED|Overall Study||46||
59628107|NCT01076244|75741503|FG000|COMPLETED|Overall Study||42||
59628108|NCT01076244|75741503|FG000|NOT COMPLETED|Overall Study||4||
59628109|NCT01082952|75741509|FG000|STARTED|Overall Study||6||
59628110|NCT01082952|75741510|FG001|STARTED|Overall Study||6||
59628111|NCT01082952|75741509|FG000|COMPLETED|Overall Study||6||
59628112|NCT01082952|75741510|FG001|COMPLETED|Overall Study||6||
59628113|NCT01082952|75741509|FG000|NOT COMPLETED|Overall Study||0||
59628114|NCT01082952|75741510|FG001|NOT COMPLETED|Overall Study||0||
59628115|NCT01083654|75741518|FG000|STARTED|Overall Study||53||
59628116|NCT01083654|75741519|FG001|STARTED|Overall Study||50||
59628117|NCT01083654|75741518|FG000|COMPLETED|Overall Study||53||
59628118|NCT01083654|75741519|FG001|COMPLETED|Overall Study||50||
59628119|NCT01083654|75741518|FG000|NOT COMPLETED|Overall Study||0||
59628120|NCT01083654|75741519|FG001|NOT COMPLETED|Overall Study||0||
59628121|NCT01083732|75741528|FG000|STARTED|Overall Study||6||
59628122|NCT01083732|75741529|FG001|STARTED|Overall Study||9||
59628123|NCT01083732|75741530|FG002|STARTED|Overall Study||3||
59628124|NCT01083732|75741528|FG000|COMPLETED|Overall Study||6||
59628125|NCT01083732|75741529|FG001|COMPLETED|Overall Study||9||
59628126|NCT01083732|75741530|FG002|COMPLETED|Overall Study||3||
59628127|NCT01083732|75741528|FG000|NOT COMPLETED|Overall Study||0||
59628128|NCT01083732|75741529|FG001|NOT COMPLETED|Overall Study||0||
59628129|NCT01083732|75741530|FG002|NOT COMPLETED|Overall Study||0||
59628130|NCT01084278|75741546|FG000|STARTED|Overall Study||8||
59628131|NCT01084278|75741547|FG001|STARTED|Overall Study||8||
59628132|NCT01084278|75741548|FG002|STARTED|Overall Study||8||
59628133|NCT01084278|75741549|FG003|STARTED|Overall Study||8||
59628134|NCT01084278|75741550|FG004|STARTED|Overall Study||8||
59628135|NCT01084278|75741546|FG000|COMPLETED|Overall Study||8||
59628136|NCT01084278|75741547|FG001|COMPLETED|Overall Study||8||
59628137|NCT01084278|75741548|FG002|COMPLETED|Overall Study||8||
59628138|NCT01084278|75741549|FG003|COMPLETED|Overall Study||8||
59628139|NCT01084278|75741550|FG004|COMPLETED|Overall Study||8||
59628140|NCT01084278|75741546|FG000|NOT COMPLETED|Overall Study||0||
59628141|NCT01084278|75741547|FG001|NOT COMPLETED|Overall Study||0||
59628142|NCT01084278|75741548|FG002|NOT COMPLETED|Overall Study||0||
59628143|NCT01084278|75741549|FG003|NOT COMPLETED|Overall Study||0||
59628144|NCT01084278|75741550|FG004|NOT COMPLETED|Overall Study||0||
59628145|NCT01085760|75741568|FG000|STARTED|Overall Study||8||
59628146|NCT01085760|75741569|FG001|STARTED|Overall Study||9||
59628147|NCT01085760|75741570|FG002|STARTED|Overall Study||9||
59628148|NCT01085760|75741571|FG003|STARTED|Overall Study||9||
59628149|NCT01085760|75741568|FG000|COMPLETED|Overall Study||7||
59628150|NCT01085760|75741569|FG001|COMPLETED|Overall Study||8||
59628151|NCT01085760|75741570|FG002|COMPLETED|Overall Study||7||
59628152|NCT01085760|75741571|FG003|COMPLETED|Overall Study||6||
59628153|NCT01085760|75741568|FG000|NOT COMPLETED|Overall Study||1||
59628154|NCT01085760|75741569|FG001|NOT COMPLETED|Overall Study||1||
59628155|NCT01085760|75741570|FG002|NOT COMPLETED|Overall Study||2||
59628156|NCT01085760|75741571|FG003|NOT COMPLETED|Overall Study||3||
59628157|NCT01086228|75741581|FG000|STARTED|8 Month Follow-up|Analysis population|2009||
59628158|NCT01086228|75741581|FG000|COMPLETED|8 Month Follow-up||1938||
59628159|NCT01086228|75741581|FG000|NOT COMPLETED|8 Month Follow-up||71||
60076262|NCT01904773|76191368|FG004|NOT COMPLETED|Placebo Washout Third Intervention||0||
60076263|NCT01904773|76191369|FG005|NOT COMPLETED|Placebo Washout Third Intervention||0||
60076264|NCT01904773|76191370|FG006|NOT COMPLETED|Placebo Washout Third Intervention||0||
60076265|NCT01904773|76191371|FG007|NOT COMPLETED|Placebo Washout Third Intervention||0||
60076266|NCT01904773|76191372|FG008|NOT COMPLETED|Placebo Washout Third Intervention||0||
60076267|NCT01904773|76191364|FG000|STARTED|Fourth Intervention||0||
60076268|NCT01904773|76191365|FG001|STARTED|Fourth Intervention||1||
60076269|NCT01904773|76191366|FG002|STARTED|Fourth Intervention||1||
59539744|NCT02512302|75638161|FG003|STARTED|Period 1||3||
59539745|NCT02512302|75638162|FG004|STARTED|Period 1||3||
59539746|NCT02512302|75638163|FG005|STARTED|Period 1||3||
59539747|NCT02512302|75638164|FG006|STARTED|Period 1||2||
59539748|NCT02512302|75638165|FG007|STARTED|Period 1||3||
59539749|NCT02512302|75638166|FG008|STARTED|Period 1||3||
59539750|NCT02512302|75638167|FG009|STARTED|Period 1||3||
59539751|NCT02512302|75638158|FG000|COMPLETED|Period 1||3||
59539752|NCT02512302|75638159|FG001|COMPLETED|Period 1||2||
59539753|NCT02512302|75638160|FG002|COMPLETED|Period 1||4||
59539754|NCT02512302|75638161|FG003|COMPLETED|Period 1||3||
59539755|NCT02512302|75638162|FG004|COMPLETED|Period 1||3||
59539756|NCT02512302|75638163|FG005|COMPLETED|Period 1||3||
59539757|NCT02512302|75638164|FG006|COMPLETED|Period 1||2||
59539758|NCT02512302|75638165|FG007|COMPLETED|Period 1||3||
59539759|NCT02512302|75638166|FG008|COMPLETED|Period 1||3||
59539760|NCT02512302|75638167|FG009|COMPLETED|Period 1||3||
59539761|NCT02512302|75638158|FG000|NOT COMPLETED|Period 1||0||
59539762|NCT02512302|75638159|FG001|NOT COMPLETED|Period 1||1||
59539763|NCT02512302|75638160|FG002|NOT COMPLETED|Period 1||0||
59539764|NCT02512302|75638161|FG003|NOT COMPLETED|Period 1||0||
59539765|NCT02512302|75638162|FG004|NOT COMPLETED|Period 1||0||
59539766|NCT02512302|75638163|FG005|NOT COMPLETED|Period 1||0||
59539767|NCT02512302|75638164|FG006|NOT COMPLETED|Period 1||0||
59539768|NCT02512302|75638165|FG007|NOT COMPLETED|Period 1||0||
59539769|NCT02512302|75638166|FG008|NOT COMPLETED|Period 1||0||
59539770|NCT02512302|75638167|FG009|NOT COMPLETED|Period 1||0||
59539771|NCT02512302|75638158|FG000|STARTED|Period 2||3||
59539772|NCT02512302|75638159|FG001|STARTED|Period 2||2||
59539773|NCT02512302|75638160|FG002|STARTED|Period 2||4||
59539774|NCT02512302|75638161|FG003|STARTED|Period 2||3||
59539775|NCT02512302|75638162|FG004|STARTED|Period 2||3||
59539776|NCT02512302|75638163|FG005|STARTED|Period 2||3||
59539777|NCT02512302|75638164|FG006|STARTED|Period 2||2||
59539778|NCT02512302|75638165|FG007|STARTED|Period 2||3||
59539779|NCT02512302|75638166|FG008|STARTED|Period 2||3||
59539780|NCT02512302|75638167|FG009|STARTED|Period 2||3||
59539781|NCT02512302|75638158|FG000|COMPLETED|Period 2||3||
59539782|NCT02512302|75638159|FG001|COMPLETED|Period 2||2||
59539783|NCT02512302|75638160|FG002|COMPLETED|Period 2||4||
59539784|NCT02512302|75638161|FG003|COMPLETED|Period 2||3||
59539785|NCT02512302|75638162|FG004|COMPLETED|Period 2||3||
59539786|NCT02512302|75638163|FG005|COMPLETED|Period 2||3||
59539787|NCT02512302|75638164|FG006|COMPLETED|Period 2||2||
59539788|NCT02512302|75638165|FG007|COMPLETED|Period 2||3||
59539789|NCT02512302|75638166|FG008|COMPLETED|Period 2||3||
59539790|NCT02512302|75638167|FG009|COMPLETED|Period 2||2||
59539791|NCT02512302|75638158|FG000|NOT COMPLETED|Period 2||0||
59539792|NCT02512302|75638159|FG001|NOT COMPLETED|Period 2||0||
59539793|NCT02512302|75638160|FG002|NOT COMPLETED|Period 2||0||
59539794|NCT02512302|75638161|FG003|NOT COMPLETED|Period 2||0||
59539795|NCT02512302|75638162|FG004|NOT COMPLETED|Period 2||0||
59539796|NCT02512302|75638163|FG005|NOT COMPLETED|Period 2||0||
59539797|NCT02512302|75638164|FG006|NOT COMPLETED|Period 2||0||
59539798|NCT02512302|75638165|FG007|NOT COMPLETED|Period 2||0||
59539799|NCT02512302|75638166|FG008|NOT COMPLETED|Period 2||0||
59539800|NCT02512302|75638167|FG009|NOT COMPLETED|Period 2||1||
59539801|NCT02512302|75638158|FG000|STARTED|Period 3||3||
59539802|NCT02512302|75638159|FG001|STARTED|Period 3||2||
59539803|NCT02512302|75638160|FG002|STARTED|Period 3||4||
59539804|NCT02512302|75638161|FG003|STARTED|Period 3||3||
59539805|NCT02512302|75638162|FG004|STARTED|Period 3||3||
59539806|NCT02512302|75638163|FG005|STARTED|Period 3||3||
59539807|NCT02512302|75638164|FG006|STARTED|Period 3||2||
59628160|NCT01086228|75741581|FG000|STARTED|1-year Follow-up||1938||
59628161|NCT01086228|75741581|FG000|COMPLETED|1-year Follow-up||1894||
59539808|NCT02512302|75638165|FG007|STARTED|Period 3||3||
59539809|NCT02512302|75638166|FG008|STARTED|Period 3||3||
59539810|NCT02512302|75638167|FG009|STARTED|Period 3||2||
59539811|NCT02512302|75638158|FG000|COMPLETED|Period 3||3||
59539812|NCT02512302|75638159|FG001|COMPLETED|Period 3||2||
59539813|NCT02512302|75638160|FG002|COMPLETED|Period 3||3||
59539814|NCT02512302|75638161|FG003|COMPLETED|Period 3||3||
59539815|NCT02512302|75638162|FG004|COMPLETED|Period 3||3||
59539816|NCT02512302|75638163|FG005|COMPLETED|Period 3||3||
59539817|NCT02512302|75638164|FG006|COMPLETED|Period 3||2||
59539818|NCT02512302|75638165|FG007|COMPLETED|Period 3||3||
59539819|NCT02512302|75638166|FG008|COMPLETED|Period 3||3||
59628162|NCT01086228|75741581|FG000|NOT COMPLETED|1-year Follow-up||44||
60076270|NCT01904773|76191367|FG003|STARTED|Fourth Intervention||2||
59628163|NCT01086228|75741581|FG000|STARTED|2-year Follow-up||1894||
59628164|NCT01086228|75741581|FG000|COMPLETED|2-year Follow-up||1834||
59628165|NCT01086228|75741581|FG000|NOT COMPLETED|2-year Follow-up||60||
59628166|NCT01086228|75741581|FG000|STARTED|3-year Follow-up||1834||
59628167|NCT01086228|75741581|FG000|COMPLETED|3-year Follow-up||1767||
59628168|NCT01086228|75741581|FG000|NOT COMPLETED|3-year Follow-up||67||
59628169|NCT01086228|75741581|FG000|STARTED|4-year Follow-up||1767||
59628170|NCT01086228|75741581|FG000|COMPLETED|4-year Follow-up||1664||
59628171|NCT01086228|75741581|FG000|NOT COMPLETED|4-year Follow-up||103||
59628172|NCT01086228|75741581|FG000|STARTED|5-year Follow-up||1664||
59628173|NCT01086228|75741581|FG000|COMPLETED|5-year Follow-up||1012||
59628174|NCT01086228|75741581|FG000|NOT COMPLETED|5-year Follow-up||652||
59628175|NCT01086852|75741585|FG000|STARTED|Overall Study||4||
59628176|NCT01086852|75741585|FG000|COMPLETED|Overall Study||4||
59628177|NCT01086852|75741585|FG000|NOT COMPLETED|Overall Study||0||
59628178|NCT01088646|75741590|FG000|STARTED|Overall Study||25||
59628179|NCT01088646|75741590|FG000|COMPLETED|Overall Study||25||
59628180|NCT01088646|75741590|FG000|NOT COMPLETED|Overall Study||0||
59628181|NCT01090752|75741597|FG000|STARTED|Overall Study||8||
59628182|NCT01090752|75741598|FG001|STARTED|Overall Study||8||
59628183|NCT01090752|75741597|FG000|COMPLETED|Overall Study||8||
59628184|NCT01090752|75741598|FG001|COMPLETED|Overall Study||8||
59628185|NCT01090752|75741597|FG000|NOT COMPLETED|Overall Study||0||
59628186|NCT01090752|75741598|FG001|NOT COMPLETED|Overall Study||0||
59628187|NCT01093014|75741607|FG000|STARTED|Overall Study||12||
59628188|NCT01093014|75741608|FG001|STARTED|Overall Study||9||
59628189|NCT01093014|75741609|FG002|STARTED|Overall Study||12||
59628190|NCT01093014|75741607|FG000|COMPLETED|Overall Study||12||
59628191|NCT01093014|75741608|FG001|COMPLETED|Overall Study||9||
59628192|NCT01093014|75741609|FG002|COMPLETED|Overall Study||12||
59628193|NCT01093014|75741607|FG000|NOT COMPLETED|Overall Study||0||
59628194|NCT01093014|75741608|FG001|NOT COMPLETED|Overall Study||0||
59628195|NCT01093014|75741609|FG002|NOT COMPLETED|Overall Study||0||
59628196|NCT01093482|75741620|FG000|STARTED|Overall Study||8151||
59628197|NCT01093482|75741620|FG000|COMPLETED|Overall Study||8151||
59628198|NCT01093482|75741620|FG000|NOT COMPLETED|Overall Study||0||
59628199|NCT01093794|75741624|FG000|STARTED|Treatment Period 1||7||
59628200|NCT01093794|75741625|FG001|STARTED|Treatment Period 1||7||
59628201|NCT01093794|75741626|FG002|STARTED|Treatment Period 1||7||
59628202|NCT01093794|75741627|FG003|STARTED|Treatment Period 1||7||
59628203|NCT01093794|75741624|FG000|COMPLETED|Treatment Period 1||7||
59628204|NCT01093794|75741625|FG001|COMPLETED|Treatment Period 1||7||
59628205|NCT01093794|75741626|FG002|COMPLETED|Treatment Period 1||7||
59628206|NCT01093794|75741627|FG003|COMPLETED|Treatment Period 1||7||
59628207|NCT01093794|75741624|FG000|NOT COMPLETED|Treatment Period 1||0||
59628208|NCT01093794|75741625|FG001|NOT COMPLETED|Treatment Period 1||0||
59628209|NCT01093794|75741626|FG002|NOT COMPLETED|Treatment Period 1||0||
59628210|NCT01093794|75741627|FG003|NOT COMPLETED|Treatment Period 1||0||
59628211|NCT01093794|75741624|FG000|STARTED|Treatment Period 2||7||
59628212|NCT01093794|75741625|FG001|STARTED|Treatment Period 2||7||
59628213|NCT01093794|75741626|FG002|STARTED|Treatment Period 2|After period 1, one participant was discontinued by the investigator due to a protocol deviation.|6||
59628214|NCT01093794|75741627|FG003|STARTED|Treatment Period 2||7||
59628215|NCT01093794|75741624|FG000|COMPLETED|Treatment Period 2||7||
59628216|NCT01093794|75741625|FG001|COMPLETED|Treatment Period 2||7||
59628217|NCT01093794|75741626|FG002|COMPLETED|Treatment Period 2||6||
59628218|NCT01093794|75741627|FG003|COMPLETED|Treatment Period 2||7||
59628219|NCT01093794|75741624|FG000|NOT COMPLETED|Treatment Period 2||0||
59628220|NCT01093794|75741625|FG001|NOT COMPLETED|Treatment Period 2||0||
59628221|NCT01093794|75741626|FG002|NOT COMPLETED|Treatment Period 2||0||
59628222|NCT01093794|75741627|FG003|NOT COMPLETED|Treatment Period 2||0||
59628223|NCT01093794|75741624|FG000|STARTED|Treatment Period 3||7||
59628224|NCT01093794|75741625|FG001|STARTED|Treatment Period 3||7||
59628225|NCT01093794|75741626|FG002|STARTED|Treatment Period 3||6||
59628226|NCT01093794|75741627|FG003|STARTED|Treatment Period 3||7||
59628227|NCT01093794|75741624|FG000|COMPLETED|Treatment Period 3||7||
59628228|NCT01093794|75741625|FG001|COMPLETED|Treatment Period 3||7||
59628229|NCT01093794|75741626|FG002|COMPLETED|Treatment Period 3||6||
59628230|NCT01093794|75741627|FG003|COMPLETED|Treatment Period 3||7||
59628231|NCT01093794|75741624|FG000|NOT COMPLETED|Treatment Period 3||0||
59628232|NCT01093794|75741625|FG001|NOT COMPLETED|Treatment Period 3||0||
59628233|NCT01093794|75741626|FG002|NOT COMPLETED|Treatment Period 3||0||
59628234|NCT01093794|75741627|FG003|NOT COMPLETED|Treatment Period 3||0||
59628235|NCT01093794|75741624|FG000|STARTED|Treatment Period 4||7||
59628236|NCT01093794|75741625|FG001|STARTED|Treatment Period 4||7||
59628237|NCT01093794|75741626|FG002|STARTED|Treatment Period 4||6||
59628238|NCT01093794|75741627|FG003|STARTED|Treatment Period 4||7||
59628239|NCT01093794|75741624|FG000|COMPLETED|Treatment Period 4||7||
59628240|NCT01093794|75741625|FG001|COMPLETED|Treatment Period 4||7||
59628241|NCT01093794|75741626|FG002|COMPLETED|Treatment Period 4||6||
59628242|NCT01093794|75741627|FG003|COMPLETED|Treatment Period 4||7||
59628243|NCT01093794|75741624|FG000|NOT COMPLETED|Treatment Period 4||0||
59628244|NCT01093794|75741625|FG001|NOT COMPLETED|Treatment Period 4||0||
59628245|NCT01093794|75741626|FG002|NOT COMPLETED|Treatment Period 4||0||
59628246|NCT01093794|75741627|FG003|NOT COMPLETED|Treatment Period 4||0||
59628247|NCT01094106|75741639|FG000|STARTED|Overall Study||33||
59628248|NCT01094106|75741640|FG001|STARTED|Overall Study||34||
59628249|NCT01094106|75741639|FG000|COMPLETED|Overall Study||33||
59628250|NCT01094106|75741640|FG001|COMPLETED|Overall Study||34||
59628251|NCT01094106|75741639|FG000|NOT COMPLETED|Overall Study||0||
59628252|NCT01094106|75741640|FG001|NOT COMPLETED|Overall Study||0||
59628253|NCT01094574|75741652|FG000|STARTED|Overall Study||1||
59628254|NCT01094574|75741653|FG001|STARTED|Overall Study||1||
59628255|NCT01094574|75741654|FG002|STARTED|Overall Study||2||
59628256|NCT01094574|75741655|FG003|STARTED|Overall Study||2||
59628257|NCT01094574|75741656|FG004|STARTED|Overall Study||2||
59628258|NCT01094574|75741657|FG005|STARTED|Overall Study||2||
59628259|NCT01094574|75741652|FG000|COMPLETED|Overall Study||1||
59628260|NCT01094574|75741653|FG001|COMPLETED|Overall Study||1||
59628261|NCT01094574|75741654|FG002|COMPLETED|Overall Study||2||
59628262|NCT01094574|75741655|FG003|COMPLETED|Overall Study||2||
59628263|NCT01094574|75741656|FG004|COMPLETED|Overall Study||2||
59628264|NCT01094574|75741657|FG005|COMPLETED|Overall Study||2||
59628265|NCT01094574|75741652|FG000|NOT COMPLETED|Overall Study||0||
59628266|NCT01094574|75741653|FG001|NOT COMPLETED|Overall Study||0||
59628267|NCT01094574|75741654|FG002|NOT COMPLETED|Overall Study||0||
59628268|NCT01094574|75741655|FG003|NOT COMPLETED|Overall Study||0||
59628269|NCT01094574|75741656|FG004|NOT COMPLETED|Overall Study||0||
59628270|NCT01094574|75741657|FG005|NOT COMPLETED|Overall Study||0||
59628271|NCT01095510|75741671|FG000|STARTED|Overall Study||3||
59628272|NCT01095510|75741672|FG001|STARTED|Overall Study||0||
59628273|NCT01095510|75741673|FG002|STARTED|Overall Study||3||
59628274|NCT01095510|75741674|FG003|STARTED|Overall Study||3||
59628275|NCT01095510|75741671|FG000|COMPLETED|Overall Study||3||
59628276|NCT01095510|75741672|FG001|COMPLETED|Overall Study||0||
59628277|NCT01095510|75741673|FG002|COMPLETED|Overall Study||3||
59628278|NCT01095510|75741674|FG003|COMPLETED|Overall Study||3||
59628279|NCT01095510|75741671|FG000|NOT COMPLETED|Overall Study||0||
59628280|NCT01095510|75741672|FG001|NOT COMPLETED|Overall Study||0||
59628281|NCT01095510|75741673|FG002|NOT COMPLETED|Overall Study||0||
59628282|NCT01095510|75741674|FG003|NOT COMPLETED|Overall Study||0||
59628283|NCT01096290|75741684|FG000|STARTED|Overall Study||9||
59628284|NCT01096290|75741685|FG001|STARTED|Overall Study||14||
59628285|NCT01096290|75741684|FG000|COMPLETED|Overall Study||9||
59628286|NCT01096290|75741685|FG001|COMPLETED|Overall Study||14||
59628287|NCT01096290|75741684|FG000|NOT COMPLETED|Overall Study||0||
59628288|NCT01096290|75741685|FG001|NOT COMPLETED|Overall Study||0||
59628289|NCT01096680|75741696|FG000|STARTED|Overall Study||27||
59628290|NCT01096680|75741697|FG001|STARTED|Overall Study||27||
59628291|NCT01096680|75741698|FG002|STARTED|Overall Study||27||
59628292|NCT01096680|75741699|FG003|STARTED|Overall Study||27||
59628293|NCT01096680|75741700|FG004|STARTED|Overall Study||27||
59628294|NCT01096680|75741696|FG000|COMPLETED|Overall Study||27||
59628295|NCT01096680|75741697|FG001|COMPLETED|Overall Study||27||
59628296|NCT01096680|75741698|FG002|COMPLETED|Overall Study||27||
59628297|NCT01096680|75741699|FG003|COMPLETED|Overall Study||27||
59628298|NCT01096680|75741700|FG004|COMPLETED|Overall Study||27||
59628299|NCT01096680|75741696|FG000|NOT COMPLETED|Overall Study||0||
59628300|NCT01096680|75741697|FG001|NOT COMPLETED|Overall Study||0||
59628301|NCT01096680|75741698|FG002|NOT COMPLETED|Overall Study||0||
59628302|NCT01096680|75741699|FG003|NOT COMPLETED|Overall Study||0||
59628303|NCT01096680|75741700|FG004|NOT COMPLETED|Overall Study||0||
59628304|NCT01096992|75741717|FG000|STARTED|Overall Study||6||
59628305|NCT01096992|75741718|FG001|STARTED|Overall Study||3||
59628306|NCT01096992|75741719|FG002|STARTED|Overall Study||6||
59628307|NCT01096992|75741720|FG003|STARTED|Overall Study||6||
59628308|NCT01096992|75741721|FG004|STARTED|Overall Study||30||
59628309|NCT01096992|75741717|FG000|COMPLETED|Overall Study||6||
59628310|NCT01096992|75741718|FG001|COMPLETED|Overall Study||3||
59628311|NCT01096992|75741719|FG002|COMPLETED|Overall Study||6||
59628312|NCT01096992|75741720|FG003|COMPLETED|Overall Study||6||
59628313|NCT01096992|75741721|FG004|COMPLETED|Overall Study||30||
59628314|NCT01096992|75741717|FG000|NOT COMPLETED|Overall Study||0||
59628315|NCT01096992|75741718|FG001|NOT COMPLETED|Overall Study||0||
59628316|NCT01096992|75741719|FG002|NOT COMPLETED|Overall Study||0||
59628317|NCT01096992|75741720|FG003|NOT COMPLETED|Overall Study||0||
59628318|NCT01096992|75741721|FG004|NOT COMPLETED|Overall Study||0||
59628319|NCT01097304|75741734|FG000|STARTED|Overall Study||36||
59628320|NCT01097304|75741734|FG000|COMPLETED|Overall Study||29||
59628321|NCT01097304|75741734|FG000|NOT COMPLETED|Overall Study||7||
59628322|NCT01097460|75741739|FG000|STARTED|Overall Study||16||
59628323|NCT01097460|75741739|FG000|COMPLETED|Overall Study||16||
59628324|NCT01097460|75741739|FG000|NOT COMPLETED|Overall Study||0||
59628325|NCT01098006|75741747|FG000|STARTED|Overall Study||7||
59628326|NCT01098006|75741748|FG001|STARTED|Overall Study||11||
59628327|NCT01098006|75741749|FG002|STARTED|Overall Study||60||
59628328|NCT01098006|75741750|FG003|STARTED|Overall Study||21||
59628329|NCT01098006|75741747|FG000|COMPLETED|Overall Study||7||
59628330|NCT01098006|75741748|FG001|COMPLETED|Overall Study||11||
59628331|NCT01098006|75741749|FG002|COMPLETED|Overall Study||60||
59628332|NCT01098006|75741750|FG003|COMPLETED|Overall Study||21||
59628333|NCT01098006|75741747|FG000|NOT COMPLETED|Overall Study||0||
59628334|NCT01098006|75741748|FG001|NOT COMPLETED|Overall Study||0||
59628335|NCT01098006|75741749|FG002|NOT COMPLETED|Overall Study||0||
59628336|NCT01098006|75741750|FG003|NOT COMPLETED|Overall Study||0||
59628337|NCT01098318|75741763|FG000|STARTED|Overall Study||20||
59628338|NCT01098318|75741764|FG001|STARTED|Overall Study||19||
59628339|NCT01098318|75741765|FG002|STARTED|Overall Study||18||
59628340|NCT01098318|75741763|FG000|COMPLETED|Overall Study||17||
59628341|NCT01098318|75741764|FG001|COMPLETED|Overall Study||12||
59628342|NCT01098318|75741765|FG002|COMPLETED|Overall Study||15||
59628343|NCT01098318|75741763|FG000|NOT COMPLETED|Overall Study||3||
59628344|NCT01098318|75741764|FG001|NOT COMPLETED|Overall Study||7||
59628345|NCT01098318|75741765|FG002|NOT COMPLETED|Overall Study||3||
59628346|NCT01100112|75741773|FG000|STARTED|Overall Study||60||
59628347|NCT01100112|75741773|FG000|COMPLETED|Overall Study||52||
59628348|NCT01100112|75741773|FG000|NOT COMPLETED|Overall Study||8||
59628349|NCT01100268|75741777|FG000|STARTED|Overall Study||4||
59628350|NCT01100268|75741777|FG000|COMPLETED|Overall Study||4||
59628351|NCT01100268|75741777|FG000|NOT COMPLETED|Overall Study||0||
59628352|NCT01101750|75741781|FG000|STARTED|Overall Study||25||
59628353|NCT01101750|75741781|FG000|COMPLETED|Overall Study||9||
59628354|NCT01101750|75741781|FG000|NOT COMPLETED|Overall Study||16||
59628355|NCT01102218|75741787|FG000|STARTED|Overall Study||24||
59628356|NCT01102218|75741788|FG001|STARTED|Overall Study||24||
59628357|NCT01102218|75741787|FG000|COMPLETED|Overall Study||13||
59628358|NCT01102218|75741788|FG001|COMPLETED|Overall Study||14||
59628359|NCT01102218|75741787|FG000|NOT COMPLETED|Overall Study||11||
59628360|NCT01102218|75741788|FG001|NOT COMPLETED|Overall Study||10||
59628361|NCT01102764|75741796|FG000|STARTED|Overall Study||64||
59628362|NCT01102764|75741797|FG001|STARTED|Overall Study||68||
59628363|NCT01102764|75741796|FG000|COMPLETED|Overall Study||43||
59628364|NCT01102764|75741797|FG001|COMPLETED|Overall Study||55||
59628365|NCT01102764|75741796|FG000|NOT COMPLETED|Overall Study||21||
59628366|NCT01102764|75741797|FG001|NOT COMPLETED|Overall Study||13||
59628367|NCT01103934|75741805|FG000|STARTED|Overall Study||17||
59628368|NCT01103934|75741806|FG001|STARTED|Overall Study||18||
59628369|NCT01103934|75741805|FG000|COMPLETED|Overall Study||17||
59628370|NCT01103934|75741806|FG001|COMPLETED|Overall Study||18||
59628371|NCT01103934|75741805|FG000|NOT COMPLETED|Overall Study||0||
59628372|NCT01103934|75741806|FG001|NOT COMPLETED|Overall Study||0||
59628373|NCT01104090|75741814|FG000|STARTED|Overall Study||25||
59628374|NCT01104090|75741815|FG001|STARTED|Overall Study||25||
59628375|NCT01104090|75741814|FG000|COMPLETED|Overall Study||25||
59628376|NCT01104090|75741815|FG001|COMPLETED|Overall Study||25||
59628377|NCT01104090|75741814|FG000|NOT COMPLETED|Overall Study||0||
59628378|NCT01104090|75741815|FG001|NOT COMPLETED|Overall Study||0||
59628379|NCT01104402|75741825|FG000|STARTED|Overall Study||132||
59628380|NCT01104402|75741826|FG001|STARTED|Overall Study||135||
59628381|NCT01104402|75741825|FG000|COMPLETED|Overall Study||111||
59628382|NCT01104402|75741826|FG001|COMPLETED|Overall Study||102||
59628383|NCT01104402|75741825|FG000|NOT COMPLETED|Overall Study||21||
59628384|NCT01104402|75741826|FG001|NOT COMPLETED|Overall Study||33||
59628385|NCT01105650|75741835|FG000|STARTED|Overall Study||3||
59628386|NCT01105650|75741836|FG001|STARTED|Overall Study||3||
59988204|NCT05180630|76103320|FG001|COMPLETED|Second Intervention||6||
59988205|NCT05180630|76103321|FG002|COMPLETED|Second Intervention||2||
59988206|NCT05180630|76103319|FG000|NOT COMPLETED|Second Intervention||0||
59988207|NCT05180630|76103320|FG001|NOT COMPLETED|Second Intervention||0||
59988208|NCT05180630|76103321|FG002|NOT COMPLETED|Second Intervention||0||
59988209|NCT05180630|76103319|FG000|STARTED|Third Intervention||6||
59988210|NCT05180630|76103320|FG001|STARTED|Third Intervention||6||
59988211|NCT05180630|76103321|FG002|STARTED|Third Intervention||2||
59988212|NCT05180630|76103319|FG000|COMPLETED|Third Intervention||6||
59988213|NCT05180630|76103320|FG001|COMPLETED|Third Intervention||6||
59988214|NCT05180630|76103321|FG002|COMPLETED|Third Intervention||2||
59988215|NCT05180630|76103319|FG000|NOT COMPLETED|Third Intervention||0||
59628387|NCT01105650|75741837|FG002|STARTED|Overall Study||7||
59988216|NCT05180630|76103320|FG001|NOT COMPLETED|Third Intervention||0||
59988217|NCT05180630|76103321|FG002|NOT COMPLETED|Third Intervention||0||
59988218|NCT02273596|76103330|FG000|STARTED|24-Week Treatment Period||29||
59995439|NCT02911792|76111262|FG001|STARTED|Overall Study||18||
59628388|NCT01105650|75741838|FG003|STARTED|Overall Study|Arm 3 was determined to be successful, thus eliminating the need to test Arm 4.|0||
59628389|NCT01105650|75741835|FG000|COMPLETED|Overall Study||3||
59628390|NCT01105650|75741836|FG001|COMPLETED|Overall Study||3||
59628391|NCT01105650|75741837|FG002|COMPLETED|Overall Study||7||
59628392|NCT01105650|75741838|FG003|COMPLETED|Overall Study||0||
59628393|NCT01105650|75741835|FG000|NOT COMPLETED|Overall Study||0||
59628394|NCT01105650|75741836|FG001|NOT COMPLETED|Overall Study||0||
59628395|NCT01105650|75741837|FG002|NOT COMPLETED|Overall Study||0||
59628396|NCT01105650|75741838|FG003|NOT COMPLETED|Overall Study||0||
59628397|NCT01106040|75741846|FG000|STARTED|Overall Study||163||
59628398|NCT01106040|75741846|FG000|COMPLETED|Overall Study||152||
59988219|NCT02273596|76103330|FG000|Received at Least 1 Dose of Study Drug|24-Week Treatment Period||28|One participant was enrolled but not treated|
59988220|NCT02273596|76103330|FG000|COMPLETED|24-Week Treatment Period||22||
59988221|NCT02273596|76103330|FG000|NOT COMPLETED|24-Week Treatment Period||7||
59988222|NCT02273596|76103330|FG000|STARTED|Extension Period||22||
59988223|NCT02273596|76103330|FG000|Received at Least 1 Dose of Study Drug|Extension Period||22||
59988224|NCT02273596|76103330|FG000|COMPLETED|Extension Period||0|19 participants who completed the 24-week treatment period were considered to have discontinued Study WTX101-201 to enter Study WTX101-301 (NCT03403205)|
59988225|NCT02273596|76103330|FG000|NOT COMPLETED|Extension Period||22||
59988226|NCT01656200|76103340|FG000|STARTED|Overall Study||17||
59988227|NCT01656200|76103340|FG000|COMPLETED|Overall Study||16||
59988228|NCT01656200|76103340|FG000|NOT COMPLETED|Overall Study||1||
60076271|NCT01904773|76191368|FG004|STARTED|Fourth Intervention||3||
60076272|NCT01904773|76191369|FG005|STARTED|Fourth Intervention||4||
60076273|NCT01904773|76191370|FG006|STARTED|Fourth Intervention||3||
60076274|NCT01904773|76191371|FG007|STARTED|Fourth Intervention||3||
60076275|NCT01904773|76191372|FG008|STARTED|Fourth Intervention||4||
60076276|NCT01904773|76191364|FG000|COMPLETED|Fourth Intervention||0||
60076277|NCT01904773|76191365|FG001|COMPLETED|Fourth Intervention||1||
60076278|NCT01904773|76191366|FG002|COMPLETED|Fourth Intervention||1||
60076279|NCT01904773|76191367|FG003|COMPLETED|Fourth Intervention||2||
60076280|NCT01904773|76191368|FG004|COMPLETED|Fourth Intervention||3||
60076281|NCT01904773|76191369|FG005|COMPLETED|Fourth Intervention||4||
60076282|NCT01904773|76191370|FG006|COMPLETED|Fourth Intervention||3||
60076283|NCT01904773|76191371|FG007|COMPLETED|Fourth Intervention||3||
60076284|NCT01904773|76191372|FG008|COMPLETED|Fourth Intervention||4||
60076285|NCT01904773|76191364|FG000|NOT COMPLETED|Fourth Intervention||0||
60076286|NCT01904773|76191365|FG001|NOT COMPLETED|Fourth Intervention||0||
60076287|NCT01904773|76191366|FG002|NOT COMPLETED|Fourth Intervention||0||
60076288|NCT01904773|76191367|FG003|NOT COMPLETED|Fourth Intervention||0||
59539820|NCT02512302|75638167|FG009|COMPLETED|Period 3||2||
59539821|NCT02512302|75638158|FG000|NOT COMPLETED|Period 3||0||
59628399|NCT01106040|75741846|FG000|NOT COMPLETED|Overall Study||11||
59988229|NCT02369848|76103344|FG000|STARTED|Overall Study||60||
59988230|NCT02369848|76103344|FG000|30 Day Primary Safety Endpoint|Overall Study||58||
59988231|NCT02369848|76103344|FG000|12 Month Primary Endpoint|Overall Study||30||
59988232|NCT02369848|76103344|FG000|COMPLETED|Overall Study||56||
59988233|NCT02369848|76103344|FG000|NOT COMPLETED|Overall Study||4||
59988234|NCT02368210|76103350|FG000|STARTED|Overall Study||75||
59988235|NCT02368210|76103351|FG001|STARTED|Overall Study||76||
59988236|NCT02368210|76103350|FG000|COMPLETED|Overall Study||74||
59988237|NCT02368210|76103351|FG001|COMPLETED|Overall Study||75||
59988238|NCT02368210|76103350|FG000|NOT COMPLETED|Overall Study||1||
59988239|NCT02368210|76103351|FG001|NOT COMPLETED|Overall Study||1||
59988240|NCT02273050|76103360|FG000|STARTED|Overall Study||210||
59628400|NCT01107834|75741853|FG000|STARTED|Overall Study||30||
59628401|NCT01107834|75741854|FG001|STARTED|Overall Study||30||
59628402|NCT01107834|75741853|FG000|COMPLETED|Overall Study||30||
59628403|NCT01107834|75741854|FG001|COMPLETED|Overall Study||30||
59988241|NCT02273050|76103361|FG001|STARTED|Overall Study||216||
59988242|NCT02273050|76103362|FG002|STARTED|Overall Study||214||
59539822|NCT02512302|75638159|FG001|NOT COMPLETED|Period 3||0||
59539823|NCT02512302|75638160|FG002|NOT COMPLETED|Period 3||1||
59539824|NCT02512302|75638161|FG003|NOT COMPLETED|Period 3||0||
59539825|NCT02512302|75638162|FG004|NOT COMPLETED|Period 3||0||
59539826|NCT02512302|75638163|FG005|NOT COMPLETED|Period 3||0||
59539827|NCT02512302|75638164|FG006|NOT COMPLETED|Period 3||0||
59539828|NCT02512302|75638165|FG007|NOT COMPLETED|Period 3||0||
59539829|NCT02512302|75638166|FG008|NOT COMPLETED|Period 3||0||
59539830|NCT02512302|75638167|FG009|NOT COMPLETED|Period 3||0||
59539831|NCT02512302|75638158|FG000|STARTED|Period 4||3||
59539832|NCT02512302|75638159|FG001|STARTED|Period 4||2||
59539833|NCT02512302|75638160|FG002|STARTED|Period 4||3||
59628404|NCT01107834|75741853|FG000|NOT COMPLETED|Overall Study||0||
59988243|NCT02273050|76103360|FG000|COMPLETED|Overall Study||186||
60076289|NCT01904773|76191368|FG004|NOT COMPLETED|Fourth Intervention||0||
60076290|NCT01904773|76191369|FG005|NOT COMPLETED|Fourth Intervention||0||
60076291|NCT01904773|76191370|FG006|NOT COMPLETED|Fourth Intervention||0||
60076292|NCT01904773|76191371|FG007|NOT COMPLETED|Fourth Intervention||0||
60076293|NCT01904773|76191372|FG008|NOT COMPLETED|Fourth Intervention||0||
59539834|NCT02512302|75638161|FG003|STARTED|Period 4||3||
59539835|NCT02512302|75638162|FG004|STARTED|Period 4||3||
59628405|NCT01107834|75741854|FG001|NOT COMPLETED|Overall Study||0||
59628406|NCT01110252|75741860|FG000|STARTED|Pre-procedure (Stem Cells Infusion)||4||
59628407|NCT01110252|75741860|FG000|COMPLETED|Pre-procedure (Stem Cells Infusion)||4||
59628408|NCT01110252|75741860|FG000|NOT COMPLETED|Pre-procedure (Stem Cells Infusion)||0||
59628409|NCT01110252|75741860|FG000|STARTED|Post-procedure (Stem Cells Infusion)||4||
59628410|NCT01110252|75741860|FG000|COMPLETED|Post-procedure (Stem Cells Infusion)||4||
59628411|NCT01110252|75741860|FG000|NOT COMPLETED|Post-procedure (Stem Cells Infusion)||0||
59628412|NCT01110876|75741867|FG000|STARTED|Overall Study|One received 400 mg Erlotinib dose as result of enzyme inducing anticonvulsants (EIACs)|13||
59628413|NCT01110876|75741868|FG001|STARTED|Overall Study||5||
59628414|NCT01110876|75741867|FG000|COMPLETED|Overall Study||13||
59628415|NCT01110876|75741868|FG001|COMPLETED|Overall Study||5||
59628416|NCT01110876|75741867|FG000|NOT COMPLETED|Overall Study||0||
59988244|NCT02273050|76103361|FG001|COMPLETED|Overall Study||194||
59988245|NCT02273050|76103362|FG002|COMPLETED|Overall Study||185||
59988246|NCT02273050|76103360|FG000|NOT COMPLETED|Overall Study||24||
59988247|NCT02273050|76103361|FG001|NOT COMPLETED|Overall Study||22||
59988248|NCT02273050|76103362|FG002|NOT COMPLETED|Overall Study||29||
59988249|NCT02272816|76103370|FG000|STARTED|Overall Study||48||
59628417|NCT01110876|75741868|FG001|NOT COMPLETED|Overall Study||0||
59628418|NCT01112358|75741877|FG000|STARTED|Overall Study||25||
59628419|NCT01112358|75741878|FG001|STARTED|Overall Study||33||
59628420|NCT01112358|75741877|FG000|COMPLETED|Overall Study||25||
59628421|NCT01112358|75741878|FG001|COMPLETED|Overall Study||33||
59628422|NCT01112358|75741877|FG000|NOT COMPLETED|Overall Study||0||
59628423|NCT01112358|75741878|FG001|NOT COMPLETED|Overall Study||0||
59628424|NCT01112670|75741884|FG000|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||8||
59628425|NCT01112670|75741885|FG001|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||0||
59628426|NCT01112670|75741886|FG002|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||7||
59628427|NCT01112670|75741887|FG003|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||0||
59628428|NCT01112670|75741888|FG004|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||6||
59628429|NCT01112670|75741889|FG005|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||0||
59628430|NCT01112670|75741884|FG000|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||7||
59628431|NCT01112670|75741885|FG001|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0||
59628432|NCT01112670|75741886|FG002|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||6||
59628433|NCT01112670|75741887|FG003|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0||
59628434|NCT01112670|75741888|FG004|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||5||
59628435|NCT01112670|75741889|FG005|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0||
59628436|NCT01112670|75741884|FG000|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||1||
59988250|NCT02272816|76103370|FG000|COMPLETED|Overall Study||47||
59988251|NCT02272816|76103370|FG000|NOT COMPLETED|Overall Study||1||
59628437|NCT01112670|75741885|FG001|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0||
59628438|NCT01112670|75741886|FG002|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||1||
59628439|NCT01112670|75741887|FG003|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0||
59628440|NCT01112670|75741888|FG004|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||1||
59628441|NCT01112670|75741889|FG005|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0||
59628442|NCT01112670|75741884|FG000|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||0||
59628443|NCT01112670|75741885|FG001|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||3||
59628444|NCT01112670|75741886|FG002|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||0||
59628445|NCT01112670|75741887|FG003|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||4||
59628446|NCT01112670|75741888|FG004|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||0||
59628447|NCT01112670|75741889|FG005|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||5||
59628448|NCT01112670|75741884|FG000|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0||
59628449|NCT01112670|75741885|FG001|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||3||
59628450|NCT01112670|75741886|FG002|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0||
60076294|NCT01904773|76191364|FG000|STARTED|Placebo Washout Fourth Intervention||0||
59628451|NCT01112670|75741887|FG003|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||4||
59628452|NCT01112670|75741888|FG004|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0||
59628453|NCT01112670|75741889|FG005|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||5||
59628454|NCT01112670|75741884|FG000|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0||
59628455|NCT01112670|75741885|FG001|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0||
59628456|NCT01112670|75741886|FG002|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0||
59628457|NCT01112670|75741887|FG003|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0||
59628458|NCT01112670|75741888|FG004|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0||
59628459|NCT01112670|75741889|FG005|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0||
59628460|NCT01114620|75741896|FG000|STARTED|Overall Study||50||
59628461|NCT01114620|75741896|FG000|COMPLETED|Overall Study||50||
59628462|NCT01114620|75741896|FG000|NOT COMPLETED|Overall Study||0||
59628463|NCT01115166|75741900|FG000|STARTED|Overall Study||10||
59628464|NCT01115166|75741900|FG000|COMPLETED|Overall Study||10||
59628465|NCT01115166|75741900|FG000|NOT COMPLETED|Overall Study||0||
59628466|NCT01115556|75741906|FG000|STARTED|Overall Study||7||
59628467|NCT01115556|75741907|FG001|STARTED|Overall Study||2||
59628468|NCT01115556|75741906|FG000|COMPLETED|Overall Study||7||
59988252|NCT02271880|76103376|FG000|STARTED|Overall Study||3||
59628469|NCT01115556|75741907|FG001|COMPLETED|Overall Study||2||
59628470|NCT01115556|75741906|FG000|NOT COMPLETED|Overall Study||0||
59628471|NCT01115556|75741907|FG001|NOT COMPLETED|Overall Study||0||
59628472|NCT01116024|75741915|FG000|STARTED|Overall Study|148 subjects left operating room with the device implanted and were included in the analysis.|148||
59628473|NCT01116024|75741915|FG000|COMPLETED|Overall Study|Patient Enrollment stop date|96||
59628474|NCT01116024|75741915|FG000|NOT COMPLETED|Overall Study||52||
59628475|NCT01116102|75741949|FG000|STARTED|Overall Study||2||
59628476|NCT01116102|75741950|FG001|STARTED|Overall Study||3||
59628477|NCT01116102|75741951|FG002|STARTED|Overall Study||3||
59628478|NCT01116102|75741952|FG003|STARTED|Overall Study||3||
59628479|NCT01116102|75741953|FG004|STARTED|Overall Study||2||
59628480|NCT01116102|75741954|FG005|STARTED|Overall Study||2||
59628481|NCT01116102|75741955|FG006|STARTED|Overall Study||2||
59628482|NCT01116102|75741956|FG007|STARTED|Overall Study||3||
59628483|NCT01116102|75741949|FG000|COMPLETED|Overall Study||2||
59628484|NCT01116102|75741950|FG001|COMPLETED|Overall Study||3||
59628485|NCT01116102|75741951|FG002|COMPLETED|Overall Study||3||
59628486|NCT01116102|75741952|FG003|COMPLETED|Overall Study||3||
59628487|NCT01116102|75741953|FG004|COMPLETED|Overall Study||2||
59628488|NCT01116102|75741954|FG005|COMPLETED|Overall Study||2||
59628489|NCT01116102|75741955|FG006|COMPLETED|Overall Study||2||
59628490|NCT01116102|75741956|FG007|COMPLETED|Overall Study||3||
59628491|NCT01116102|75741949|FG000|NOT COMPLETED|Overall Study||0||
59628492|NCT01116102|75741950|FG001|NOT COMPLETED|Overall Study||0||
59628493|NCT01116102|75741951|FG002|NOT COMPLETED|Overall Study||0||
59628494|NCT01116102|75741952|FG003|NOT COMPLETED|Overall Study||0||
59628495|NCT01116102|75741953|FG004|NOT COMPLETED|Overall Study||0||
59628496|NCT01116102|75741954|FG005|NOT COMPLETED|Overall Study||0||
59628497|NCT01116102|75741955|FG006|NOT COMPLETED|Overall Study||0||
59628498|NCT01116102|75741956|FG007|NOT COMPLETED|Overall Study||0||
59628499|NCT01118988|75741977|FG000|STARTED|Overall Study||16||
59628500|NCT01118988|75741978|FG001|STARTED|Overall Study||4||
59628501|NCT01118988|75741979|FG002|STARTED|Overall Study||7||
59628502|NCT01118988|75741977|FG000|COMPLETED|Overall Study||11||
59628503|NCT01118988|75741978|FG001|COMPLETED|Overall Study||3||
59628504|NCT01118988|75741979|FG002|COMPLETED|Overall Study||3||
59628505|NCT01118988|75741977|FG000|NOT COMPLETED|Overall Study||5||
59628506|NCT01118988|75741978|FG001|NOT COMPLETED|Overall Study||1||
59628507|NCT01118988|75741979|FG002|NOT COMPLETED|Overall Study||4||
59628508|NCT01119222|75741986|FG000|STARTED|Overall Study||5||
59628509|NCT01119222|75741987|FG001|STARTED|Overall Study||5||
59628510|NCT01119222|75741988|FG002|STARTED|Overall Study||5||
59628511|NCT01119222|75741989|FG003|STARTED|Overall Study||4||
59628512|NCT01119222|75741986|FG000|COMPLETED|Overall Study||5||
59628513|NCT01119222|75741987|FG001|COMPLETED|Overall Study||5||
59628514|NCT01119222|75741988|FG002|COMPLETED|Overall Study||5||
59628515|NCT01119222|75741989|FG003|COMPLETED|Overall Study||4||
59628516|NCT01119222|75741986|FG000|NOT COMPLETED|Overall Study||0||
59628517|NCT01119222|75741987|FG001|NOT COMPLETED|Overall Study||0||
59628518|NCT01119222|75741988|FG002|NOT COMPLETED|Overall Study||0||
59628519|NCT01119222|75741989|FG003|NOT COMPLETED|Overall Study||0||
59628520|NCT01119456|75742010|FG000|STARTED|Overall Study||7||
59628521|NCT01119456|75742011|FG001|STARTED|Overall Study||3||
59628522|NCT01119456|75742012|FG002|STARTED|Overall Study||3||
59628523|NCT01119456|75742013|FG003|STARTED|Overall Study||13||
59628524|NCT01119456|75742014|FG004|STARTED|Overall Study||4||
59628525|NCT01119456|75742015|FG005|STARTED|Overall Study||3||
59628526|NCT01119456|75742016|FG006|STARTED|Overall Study||3||
59628527|NCT01119456|75742017|FG007|STARTED|Overall Study||3||
59628528|NCT01119456|75742010|FG000|Received at Least 1 Dose of Study Drug|Overall Study||7||
59628529|NCT01119456|75742011|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3||
59628530|NCT01119456|75742012|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3||
59628531|NCT01119456|75742013|FG003|Received at Least 1 Dose of Study Drug|Overall Study||13||
59628532|NCT01119456|75742014|FG004|Received at Least 1 Dose of Study Drug|Overall Study||4||
59628533|NCT01119456|75742015|FG005|Received at Least 1 Dose of Study Drug|Overall Study||3||
59628534|NCT01119456|75742016|FG006|Received at Least 1 Dose of Study Drug|Overall Study||3||
59628535|NCT01119456|75742017|FG007|Received at Least 1 Dose of Study Drug|Overall Study||3||
59628536|NCT01119456|75742010|FG000|COMPLETED|Overall Study||7||
59628537|NCT01119456|75742011|FG001|COMPLETED|Overall Study||3||
59628538|NCT01119456|75742012|FG002|COMPLETED|Overall Study||3||
59628539|NCT01119456|75742013|FG003|COMPLETED|Overall Study||13||
59628540|NCT01119456|75742014|FG004|COMPLETED|Overall Study||4||
59628541|NCT01119456|75742015|FG005|COMPLETED|Overall Study||3||
59628542|NCT01119456|75742016|FG006|COMPLETED|Overall Study||3||
59628543|NCT01119456|75742017|FG007|COMPLETED|Overall Study||3||
59628544|NCT01119456|75742010|FG000|NOT COMPLETED|Overall Study||0||
59628545|NCT01119456|75742011|FG001|NOT COMPLETED|Overall Study||0||
59628546|NCT01119456|75742012|FG002|NOT COMPLETED|Overall Study||0||
59628547|NCT01119456|75742013|FG003|NOT COMPLETED|Overall Study||0||
59628548|NCT01119456|75742014|FG004|NOT COMPLETED|Overall Study||0||
59628549|NCT01119456|75742015|FG005|NOT COMPLETED|Overall Study||0||
59628550|NCT01119456|75742016|FG006|NOT COMPLETED|Overall Study||0||
59628551|NCT01119456|75742017|FG007|NOT COMPLETED|Overall Study||0||
59628552|NCT01120236|75742044|FG000|STARTED|Overall Study||105||
59628553|NCT01120236|75742045|FG001|STARTED|Overall Study||106||
59628554|NCT01120236|75742044|FG000|Ineligble|Overall Study||0||
59628555|NCT01120236|75742045|FG001|Ineligble|Overall Study|Patient ineligible due to no demonstable radiographic metastasis and is excluded from all analyses.|1||
59628556|NCT01120236|75742044|FG000|COMPLETED|Overall Study||105||
59628557|NCT01120236|75742045|FG001|COMPLETED|Overall Study||105||
59628558|NCT01120236|75742044|FG000|NOT COMPLETED|Overall Study||0||
59628559|NCT01120236|75742045|FG001|NOT COMPLETED|Overall Study||1||
59628560|NCT01120704|75742091|FG000|STARTED|Overall Study||13||
59628561|NCT01120704|75742092|FG001|STARTED|Overall Study||17||
59628562|NCT01120704|75742093|FG002|STARTED|Overall Study||14||
59628563|NCT01120704|75742094|FG003|STARTED|Overall Study||19||
59628564|NCT01120704|75742095|FG004|STARTED|Overall Study||16||
59628565|NCT01120704|75742096|FG005|STARTED|Overall Study||19||
59628566|NCT01120704|75742097|FG006|STARTED|Overall Study||15||
59628567|NCT01120704|75742098|FG007|STARTED|Overall Study||15||
59628568|NCT01120704|75742099|FG008|STARTED|Overall Study||22||
59628569|NCT01120704|75742100|FG009|STARTED|Overall Study||20||
59628570|NCT01120704|75742101|FG010|STARTED|Overall Study||17||
59628571|NCT01120704|75742102|FG011|STARTED|Overall Study||16||
59628572|NCT01120704|75742103|FG012|STARTED|Overall Study||17||
59628573|NCT01120704|75742104|FG013|STARTED|Overall Study||19||
59628574|NCT01120704|75742105|FG014|STARTED|Overall Study||18||
59628575|NCT01120704|75742106|FG015|STARTED|Overall Study||18||
59628576|NCT01120704|75742107|FG016|STARTED|Overall Study||14||
59628577|NCT01120704|75742108|FG017|STARTED|Overall Study||16||
59628578|NCT01120704|75742109|FG018|STARTED|Overall Study||17||
59628579|NCT01120704|75742110|FG019|STARTED|Overall Study||18||
59628580|NCT01120704|75742111|FG020|STARTED|Overall Study||17||
59628581|NCT01120704|75742112|FG021|STARTED|Overall Study||16||
59628582|NCT01120704|75742113|FG022|STARTED|Overall Study||21||
59628583|NCT01120704|75742114|FG023|STARTED|Overall Study||16||
59628584|NCT01120704|75742115|FG024|STARTED|Overall Study||18||
59628585|NCT01120704|75742116|FG025|STARTED|Overall Study||14||
59628586|NCT01120704|75742117|FG026|STARTED|Overall Study||18||
59628587|NCT01120704|75742118|FG027|STARTED|Overall Study||18||
59628588|NCT01120704|75742119|FG028|STARTED|Overall Study||19||
59628589|NCT01120704|75742120|FG029|STARTED|Overall Study||15||
59628590|NCT01120704|75742121|FG030|STARTED|Overall Study||14||
59628591|NCT01120704|75742122|FG031|STARTED|Overall Study||18||
59628592|NCT01120704|75742091|FG000|COMPLETED|Overall Study||10||
59628593|NCT01120704|75742092|FG001|COMPLETED|Overall Study||13||
59628594|NCT01120704|75742093|FG002|COMPLETED|Overall Study||13||
59628595|NCT01120704|75742094|FG003|COMPLETED|Overall Study||15||
59628596|NCT01120704|75742095|FG004|COMPLETED|Overall Study||14||
59628597|NCT01120704|75742096|FG005|COMPLETED|Overall Study||18||
59628598|NCT01120704|75742097|FG006|COMPLETED|Overall Study||12||
59628599|NCT01120704|75742098|FG007|COMPLETED|Overall Study||13||
59628600|NCT01120704|75742099|FG008|COMPLETED|Overall Study||19||
59628601|NCT01120704|75742100|FG009|COMPLETED|Overall Study||19||
59628602|NCT01120704|75742101|FG010|COMPLETED|Overall Study||16||
59628603|NCT01120704|75742102|FG011|COMPLETED|Overall Study||14||
59628604|NCT01120704|75742103|FG012|COMPLETED|Overall Study||14||
59628605|NCT01120704|75742104|FG013|COMPLETED|Overall Study||15||
59815647|NCT03700684|75938105|FG000|STARTED|Overall Study||12||
59815648|NCT03700684|75938106|FG001|STARTED|Overall Study||12||
59815649|NCT03700684|75938107|FG002|STARTED|Overall Study||12||
59815650|NCT03700684|75938105|FG000|COMPLETED|Overall Study||12||
59815651|NCT03700684|75938106|FG001|COMPLETED|Overall Study||12||
59815652|NCT03700684|75938107|FG002|COMPLETED|Overall Study||10||
59815653|NCT03700684|75938105|FG000|NOT COMPLETED|Overall Study||0||
59815654|NCT03700684|75938106|FG001|NOT COMPLETED|Overall Study||0||
59815655|NCT03700684|75938107|FG002|NOT COMPLETED|Overall Study||2||
59815656|NCT03659136|75938117|FG000|STARTED|Overall Study||52|Randomised|
59815657|NCT03659136|75938118|FG001|STARTED|Overall Study||51|Randomised|
59815658|NCT03659136|75938117|FG000|Treated|Overall Study||50||
59815659|NCT03659136|75938118|FG001|Treated|Overall Study||51||
59815660|NCT03659136|75938117|FG000|On-treatment at Cut-off Date for Primary Analysis|Overall Study||9||
59815661|NCT03659136|75938118|FG001|On-treatment at Cut-off Date for Primary Analysis|Overall Study||12||
59628606|NCT01120704|75742105|FG014|COMPLETED|Overall Study||17||
59628607|NCT01120704|75742106|FG015|COMPLETED|Overall Study||16||
59628608|NCT01120704|75742107|FG016|COMPLETED|Overall Study||13||
59628609|NCT01120704|75742108|FG017|COMPLETED|Overall Study||16||
59628610|NCT01120704|75742109|FG018|COMPLETED|Overall Study||15||
59628611|NCT01120704|75742110|FG019|COMPLETED|Overall Study||15||
59628612|NCT01120704|75742111|FG020|COMPLETED|Overall Study||14||
59628613|NCT01120704|75742112|FG021|COMPLETED|Overall Study||16||
59628614|NCT01120704|75742113|FG022|COMPLETED|Overall Study||17||
59628615|NCT01120704|75742114|FG023|COMPLETED|Overall Study||13||
59628616|NCT01120704|75742115|FG024|COMPLETED|Overall Study||16||
59628617|NCT01120704|75742116|FG025|COMPLETED|Overall Study||14||
59815662|NCT03659136|75938117|FG000|COMPLETED|Overall Study||0|Completed = Number of participants on treatment at the final analysis cut-off date|
59815663|NCT03659136|75938118|FG001|COMPLETED|Overall Study||0|Completed = Number of participants on treatment at the final analysis cut-off date|
59628618|NCT01120704|75742117|FG026|COMPLETED|Overall Study||15||
59628619|NCT01120704|75742118|FG027|COMPLETED|Overall Study||16||
59628620|NCT01120704|75742119|FG028|COMPLETED|Overall Study||14||
59628621|NCT01120704|75742120|FG029|COMPLETED|Overall Study||12||
59628622|NCT01120704|75742121|FG030|COMPLETED|Overall Study||12||
59628623|NCT01120704|75742122|FG031|COMPLETED|Overall Study||17||
59628624|NCT01120704|75742091|FG000|NOT COMPLETED|Overall Study||3||
59628625|NCT01120704|75742092|FG001|NOT COMPLETED|Overall Study||4||
59628626|NCT01120704|75742093|FG002|NOT COMPLETED|Overall Study||1||
59628627|NCT01120704|75742094|FG003|NOT COMPLETED|Overall Study||4||
59628628|NCT01120704|75742095|FG004|NOT COMPLETED|Overall Study||2||
59628629|NCT01120704|75742096|FG005|NOT COMPLETED|Overall Study||1||
59628630|NCT01120704|75742097|FG006|NOT COMPLETED|Overall Study||3||
59628631|NCT01120704|75742098|FG007|NOT COMPLETED|Overall Study||2||
59628632|NCT01120704|75742099|FG008|NOT COMPLETED|Overall Study||3||
59628633|NCT01120704|75742100|FG009|NOT COMPLETED|Overall Study||1||
59628634|NCT01120704|75742101|FG010|NOT COMPLETED|Overall Study||1||
59628635|NCT01120704|75742102|FG011|NOT COMPLETED|Overall Study||2||
59628636|NCT01120704|75742103|FG012|NOT COMPLETED|Overall Study||3||
59628637|NCT01120704|75742104|FG013|NOT COMPLETED|Overall Study||4||
59628638|NCT01120704|75742105|FG014|NOT COMPLETED|Overall Study||1||
59628639|NCT01120704|75742106|FG015|NOT COMPLETED|Overall Study||2||
59628640|NCT01120704|75742107|FG016|NOT COMPLETED|Overall Study||1||
59628641|NCT01120704|75742108|FG017|NOT COMPLETED|Overall Study||0||
59628642|NCT01120704|75742109|FG018|NOT COMPLETED|Overall Study||2||
59628643|NCT01120704|75742110|FG019|NOT COMPLETED|Overall Study||3||
59628644|NCT01120704|75742111|FG020|NOT COMPLETED|Overall Study||3||
59628645|NCT01120704|75742112|FG021|NOT COMPLETED|Overall Study||0||
59628646|NCT01120704|75742113|FG022|NOT COMPLETED|Overall Study||4||
59628647|NCT01120704|75742114|FG023|NOT COMPLETED|Overall Study||3||
59628648|NCT01120704|75742115|FG024|NOT COMPLETED|Overall Study||2||
59628649|NCT01120704|75742116|FG025|NOT COMPLETED|Overall Study||0||
59628650|NCT01120704|75742117|FG026|NOT COMPLETED|Overall Study||3||
59628651|NCT01120704|75742118|FG027|NOT COMPLETED|Overall Study||2||
59628652|NCT01120704|75742119|FG028|NOT COMPLETED|Overall Study||5||
59628653|NCT01120704|75742120|FG029|NOT COMPLETED|Overall Study||3||
59628654|NCT01120704|75742121|FG030|NOT COMPLETED|Overall Study||2||
59628655|NCT01120704|75742122|FG031|NOT COMPLETED|Overall Study||1||
59628656|NCT01121172|75742138|FG000|STARTED|Overall Study||90||
59628657|NCT01121172|75742139|FG001|STARTED|Overall Study||90||
59628658|NCT01121172|75742138|FG000|COMPLETED|Overall Study||90||
59628659|NCT01121172|75742139|FG001|COMPLETED|Overall Study||90||
59628660|NCT01121172|75742138|FG000|NOT COMPLETED|Overall Study||0||
59628661|NCT01121172|75742139|FG001|NOT COMPLETED|Overall Study||0||
59628662|NCT01121250|75742149|FG000|STARTED|Overall Study||76||
59628663|NCT01121250|75742150|FG001|STARTED|Overall Study||76||
59628664|NCT01121250|75742151|FG002|STARTED|Overall Study||76||
59628665|NCT01121250|75742149|FG000|COMPLETED|Overall Study||76||
59628666|NCT01121250|75742150|FG001|COMPLETED|Overall Study||76||
60076295|NCT01904773|76191365|FG001|STARTED|Placebo Washout Fourth Intervention||1||
59539836|NCT02512302|75638163|FG005|STARTED|Period 4||3||
59539837|NCT02512302|75638164|FG006|STARTED|Period 4||2||
59539838|NCT02512302|75638165|FG007|STARTED|Period 4||3||
59539839|NCT02512302|75638166|FG008|STARTED|Period 4||3||
59628667|NCT01121250|75742151|FG002|COMPLETED|Overall Study||75||
60076296|NCT01904773|76191366|FG002|STARTED|Placebo Washout Fourth Intervention||1||
59628668|NCT01121250|75742149|FG000|NOT COMPLETED|Overall Study||0||
59539840|NCT02512302|75638167|FG009|STARTED|Period 4||2||
59539841|NCT02512302|75638158|FG000|COMPLETED|Period 4||3||
59539842|NCT02512302|75638159|FG001|COMPLETED|Period 4||2||
59539843|NCT02512302|75638160|FG002|COMPLETED|Period 4||3||
59539844|NCT02512302|75638161|FG003|COMPLETED|Period 4||3||
59628669|NCT01121250|75742150|FG001|NOT COMPLETED|Overall Study||0||
59628670|NCT01121250|75742151|FG002|NOT COMPLETED|Overall Study||1||
59628671|NCT01122030|75742166|FG000|STARTED|Overall Study||18||
59628672|NCT01122030|75742167|FG001|STARTED|Overall Study||9||
59628673|NCT01122030|75742168|FG002|STARTED|Overall Study||9||
59628674|NCT01122030|75742169|FG003|STARTED|Overall Study||9||
59628675|NCT01122030|75742170|FG004|STARTED|Overall Study||9||
59628676|NCT01122030|75742171|FG005|STARTED|Overall Study||9||
59628677|NCT01122030|75742172|FG006|STARTED|Overall Study||9||
59628678|NCT01122030|75742166|FG000|Received Treatment|Overall Study||18||
59628679|NCT01122030|75742167|FG001|Received Treatment|Overall Study||9||
59628680|NCT01122030|75742168|FG002|Received Treatment|Overall Study||9||
59628681|NCT01122030|75742169|FG003|Received Treatment|Overall Study||9||
59539845|NCT02512302|75638162|FG004|COMPLETED|Period 4||3||
59628682|NCT01122030|75742170|FG004|Received Treatment|Overall Study||9||
59628683|NCT01122030|75742171|FG005|Received Treatment|Overall Study||9||
59628684|NCT01122030|75742172|FG006|Received Treatment|Overall Study||9||
59628685|NCT01122030|75742166|FG000|COMPLETED|Overall Study||18||
59628686|NCT01122030|75742167|FG001|COMPLETED|Overall Study||9||
59539846|NCT02512302|75638163|FG005|COMPLETED|Period 4||3||
59539847|NCT02512302|75638164|FG006|COMPLETED|Period 4||1||
59628687|NCT01122030|75742168|FG002|COMPLETED|Overall Study||9||
59628688|NCT01122030|75742169|FG003|COMPLETED|Overall Study||9||
59628689|NCT01122030|75742170|FG004|COMPLETED|Overall Study||9||
59628690|NCT01122030|75742171|FG005|COMPLETED|Overall Study||9||
59628691|NCT01122030|75742172|FG006|COMPLETED|Overall Study||9||
59628692|NCT01122030|75742166|FG000|NOT COMPLETED|Overall Study||0||
59628693|NCT01122030|75742167|FG001|NOT COMPLETED|Overall Study||0||
59628694|NCT01122030|75742168|FG002|NOT COMPLETED|Overall Study||0||
59628695|NCT01122030|75742169|FG003|NOT COMPLETED|Overall Study||0||
59628696|NCT01122030|75742170|FG004|NOT COMPLETED|Overall Study||0||
59628697|NCT01122030|75742171|FG005|NOT COMPLETED|Overall Study||0||
59628698|NCT01122030|75742172|FG006|NOT COMPLETED|Overall Study||0||
59628699|NCT01122108|75742194|FG000|STARTED|Overall Study||21||
59628700|NCT01122108|75742195|FG001|STARTED|Overall Study||21||
59628701|NCT01122108|75742194|FG000|COMPLETED|Overall Study||21||
59628702|NCT01122108|75742195|FG001|COMPLETED|Overall Study||21||
59628703|NCT01122108|75742194|FG000|NOT COMPLETED|Overall Study||0||
59628704|NCT01122108|75742195|FG001|NOT COMPLETED|Overall Study||0||
59628705|NCT01123512|75742205|FG000|STARTED|Overall Study||153||
59628706|NCT01123512|75742206|FG001|STARTED|Overall Study||147||
59628707|NCT01123512|75742205|FG000|COMPLETED|Overall Study||127||
59628708|NCT01123512|75742206|FG001|COMPLETED|Overall Study||126||
59628709|NCT01123512|75742205|FG000|NOT COMPLETED|Overall Study||26||
59628710|NCT01123512|75742206|FG001|NOT COMPLETED|Overall Study||21||
59628711|NCT01124370|75742212|FG000|STARTED|Overall Study|Underwent implant attempt|57||
59628712|NCT01124370|75742212|FG000|Successfully Implanted|Overall Study||50||
59628713|NCT01124370|75742212|FG000|Therapy Initiated|Overall Study||48||
59628714|NCT01124370|75742212|FG000|3 Month Visit|Overall Study|Defines evaluable population|47||
59628715|NCT01124370|75742212|FG000|COMPLETED|Overall Study|Completed 2 year post-implant follow-up|37||
59628716|NCT01124370|75742212|FG000|NOT COMPLETED|Overall Study||20||
59628717|NCT04733664|75742216|FG000|STARTED|Overall Study||10||
59628718|NCT04733664|75742216|FG000|COMPLETED|Overall Study||10||
59628719|NCT04733664|75742216|FG000|NOT COMPLETED|Overall Study||0||
59628720|NCT01125774|75742222|FG000|STARTED|Overall Study|Randomized|3018||
59628721|NCT01125774|75742223|FG001|STARTED|Overall Study|Randomized|1502||
59628722|NCT01125774|75742224|FG002|STARTED|Overall Study|Unique participants randomized|22||
59628723|NCT01125774|75742225|FG003|STARTED|Overall Study|Unique participants randomized|6||
59628724|NCT01125774|75742222|FG000|Treated|Overall Study||2638||
59628725|NCT01125774|75742223|FG001|Treated|Overall Study|1 mistakenly took telcagepant and is included with telcagepant group for adverse event analysis|1322||
59628726|NCT01125774|75742224|FG002|Treated|Overall Study|Received telcagepant|21||
59628727|NCT01125774|75742225|FG003|Treated|Overall Study||5||
59628728|NCT01125774|75742222|FG000|COMPLETED|Overall Study||1893||
59628729|NCT01125774|75742223|FG001|COMPLETED|Overall Study||948||
59628730|NCT01125774|75742224|FG002|COMPLETED|Overall Study|"Completed study at least once while treated with telcagepant (otherwise counted Not Completed)"|13||
59628731|NCT01125774|75742225|FG003|COMPLETED|Overall Study|Completed study at least once|3||
59628732|NCT01125774|75742222|FG000|NOT COMPLETED|Overall Study||1125||
59628733|NCT01125774|75742223|FG001|NOT COMPLETED|Overall Study||554||
59628734|NCT01125774|75742224|FG002|NOT COMPLETED|Overall Study||9||
59628735|NCT01125774|75742225|FG003|NOT COMPLETED|Overall Study||3||
59628736|NCT01128192|75742233|FG000|STARTED|Overall Study||19||
59628737|NCT01128192|75742234|FG001|STARTED|Overall Study||19||
59628738|NCT01128192|75742235|FG002|STARTED|Overall Study||7||
59628739|NCT01128192|75742233|FG000|COMPLETED|Overall Study||19||
59628740|NCT01128192|75742234|FG001|COMPLETED|Overall Study||19||
59628741|NCT01128192|75742235|FG002|COMPLETED|Overall Study||7||
59628742|NCT01128192|75742233|FG000|NOT COMPLETED|Overall Study||0||
59628743|NCT01128192|75742234|FG001|NOT COMPLETED|Overall Study||0||
59628744|NCT01128192|75742235|FG002|NOT COMPLETED|Overall Study||0||
59628745|NCT01128270|75742246|FG000|STARTED|Environment Chloral Hydrate and DCA (1A)||7||
59628746|NCT01128270|75742246|FG000|COMPLETED|Environment Chloral Hydrate and DCA (1A)||7||
59628747|NCT01128270|75742246|FG000|NOT COMPLETED|Environment Chloral Hydrate and DCA (1A)||0||
59628748|NCT01128270|75742246|FG000|STARTED|Environmental Chloral Hydrate (1B)|Per the suggestion from Heather, periods are not in chronological order, but defined by treatment.|8||
59628749|NCT01128270|75742246|FG000|COMPLETED|Environmental Chloral Hydrate (1B)||8||
59628750|NCT01128270|75742246|FG000|NOT COMPLETED|Environmental Chloral Hydrate (1B)||0||
59628751|NCT01128270|75742246|FG000|STARTED|Therapeutic Chloral Hydrate and DCA (2A)||8||
59628752|NCT01128270|75742246|FG000|COMPLETED|Therapeutic Chloral Hydrate and DCA (2A)||8||
59628753|NCT01128270|75742246|FG000|NOT COMPLETED|Therapeutic Chloral Hydrate and DCA (2A)||0||
59628754|NCT01128270|75742246|FG000|STARTED|Therapeutic Chloral Hydrate (2B)||8||
59628755|NCT01128270|75742246|FG000|COMPLETED|Therapeutic Chloral Hydrate (2B)||8||
59628756|NCT01128270|75742246|FG000|NOT COMPLETED|Therapeutic Chloral Hydrate (2B)||0||
59628757|NCT01128426|75742258|FG000|STARTED|Overall Study||53902||
59628758|NCT01128426|75742258|FG000|COMPLETED|Overall Study||53902||
59628759|NCT01128426|75742258|FG000|NOT COMPLETED|Overall Study||0||
59628760|NCT01128972|75742264|FG000|STARTED|Period I||7||
59628761|NCT01128972|75742265|FG001|STARTED|Period I||7||
59628762|NCT01128972|75742266|FG002|STARTED|Period I||7||
59628763|NCT01128972|75742267|FG003|STARTED|Period I||7||
59628764|NCT01128972|75742268|FG004|STARTED|Period I||8||
59628765|NCT01128972|75742264|FG000|COMPLETED|Period I||7||
59628766|NCT01128972|75742265|FG001|COMPLETED|Period I||7||
59628767|NCT01128972|75742266|FG002|COMPLETED|Period I||7||
59628768|NCT01128972|75742267|FG003|COMPLETED|Period I||7||
59628769|NCT01128972|75742268|FG004|COMPLETED|Period I||8||
59628770|NCT01128972|75742264|FG000|NOT COMPLETED|Period I||0||
59628771|NCT01128972|75742265|FG001|NOT COMPLETED|Period I||0||
59628772|NCT01128972|75742266|FG002|NOT COMPLETED|Period I||0||
59628773|NCT01128972|75742267|FG003|NOT COMPLETED|Period I||0||
59628774|NCT01128972|75742268|FG004|NOT COMPLETED|Period I||0||
59628775|NCT01128972|75742264|FG000|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|7||
59628776|NCT01128972|75742265|FG001|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|7||
59628777|NCT01128972|75742266|FG002|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|7||
59628778|NCT01128972|75742267|FG003|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|8||
59628779|NCT01128972|75742268|FG004|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|7||
59628780|NCT01128972|75742264|FG000|COMPLETED|Period II||7||
59628781|NCT01128972|75742265|FG001|COMPLETED|Period II||7||
59628782|NCT01128972|75742266|FG002|COMPLETED|Period II||7||
59628783|NCT01128972|75742267|FG003|COMPLETED|Period II||8||
59628784|NCT01128972|75742268|FG004|COMPLETED|Period II||7||
59628785|NCT01128972|75742264|FG000|NOT COMPLETED|Period II||0||
59628786|NCT01128972|75742265|FG001|NOT COMPLETED|Period II||0||
59628787|NCT01128972|75742266|FG002|NOT COMPLETED|Period II||0||
59628788|NCT01128972|75742267|FG003|NOT COMPLETED|Period II||0||
59628789|NCT01128972|75742268|FG004|NOT COMPLETED|Period II||0||
59628790|NCT01128972|75742264|FG000|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|7||
59628791|NCT01128972|75742265|FG001|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|7||
59628792|NCT01128972|75742266|FG002|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|8||
59628793|NCT01128972|75742267|FG003|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|7||
59628794|NCT01128972|75742268|FG004|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|7||
59628795|NCT01128972|75742264|FG000|COMPLETED|Period III||7||
59628796|NCT01128972|75742265|FG001|COMPLETED|Period III||7||
59628797|NCT01128972|75742266|FG002|COMPLETED|Period III||8||
59628798|NCT01128972|75742267|FG003|COMPLETED|Period III||7||
59628799|NCT01128972|75742268|FG004|COMPLETED|Period III||7||
59628800|NCT01128972|75742264|FG000|NOT COMPLETED|Period III||0||
59628801|NCT01128972|75742265|FG001|NOT COMPLETED|Period III||0||
59628802|NCT01128972|75742266|FG002|NOT COMPLETED|Period III||0||
59628803|NCT01128972|75742267|FG003|NOT COMPLETED|Period III||0||
59628804|NCT01128972|75742268|FG004|NOT COMPLETED|Period III||0||
59628805|NCT01128972|75742264|FG000|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|7||
59628806|NCT01128972|75742265|FG001|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|8||
59628807|NCT01128972|75742266|FG002|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|7||
59628808|NCT01128972|75742267|FG003|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|7||
59628809|NCT01128972|75742268|FG004|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|7||
59628810|NCT01128972|75742264|FG000|COMPLETED|Period IV||7||
59628811|NCT01128972|75742265|FG001|COMPLETED|Period IV||8||
59628812|NCT01128972|75742266|FG002|COMPLETED|Period IV||7||
59628813|NCT01128972|75742267|FG003|COMPLETED|Period IV||7||
59628814|NCT01128972|75742268|FG004|COMPLETED|Period IV||7||
59628815|NCT01128972|75742264|FG000|NOT COMPLETED|Period IV||0||
59628816|NCT01128972|75742265|FG001|NOT COMPLETED|Period IV||0||
59628817|NCT01128972|75742266|FG002|NOT COMPLETED|Period IV||0||
59628818|NCT01128972|75742267|FG003|NOT COMPLETED|Period IV||0||
59628819|NCT01128972|75742268|FG004|NOT COMPLETED|Period IV||0||
59628820|NCT01128972|75742264|FG000|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|8||
59628821|NCT01128972|75742265|FG001|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|7||
59628822|NCT01128972|75742266|FG002|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|7||
59628823|NCT01128972|75742267|FG003|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|7||
59628824|NCT01128972|75742268|FG004|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|7||
59628825|NCT01128972|75742264|FG000|COMPLETED|Period V||8||
59628826|NCT01128972|75742265|FG001|COMPLETED|Period V||7||
59628827|NCT01128972|75742266|FG002|COMPLETED|Period V||7||
59628828|NCT01128972|75742267|FG003|COMPLETED|Period V||7||
59628829|NCT01128972|75742268|FG004|COMPLETED|Period V||7||
59628830|NCT01128972|75742264|FG000|NOT COMPLETED|Period V||0||
59628831|NCT01128972|75742265|FG001|NOT COMPLETED|Period V||0||
59628832|NCT01128972|75742266|FG002|NOT COMPLETED|Period V||0||
59628833|NCT01128972|75742267|FG003|NOT COMPLETED|Period V||0||
59628834|NCT01128972|75742268|FG004|NOT COMPLETED|Period V||0||
59628835|NCT01129206|75742286|FG000|STARTED|Overall Study||6||
59628836|NCT01129206|75742286|FG000|COMPLETED|Overall Study||6||
59628837|NCT01129206|75742286|FG000|NOT COMPLETED|Overall Study||0||
59628838|NCT01129440|75742295|FG000|STARTED|Overall Study||297||
59628839|NCT01129440|75742296|FG001|STARTED|Overall Study||300||
59628840|NCT01129440|75742295|FG000|12 Month Follow-up|Overall Study||249||
59628841|NCT01129440|75742296|FG001|12 Month Follow-up|Overall Study||256||
59628842|NCT01129440|75742295|FG000|24 Month Follow-up|Overall Study||239||
59628843|NCT01129440|75742296|FG001|24 Month Follow-up|Overall Study||258||
59628844|NCT01129440|75742295|FG000|COMPLETED|Overall Study||246||
59628845|NCT01129440|75742296|FG001|COMPLETED|Overall Study||258||
59628846|NCT01129440|75742295|FG000|NOT COMPLETED|Overall Study||51||
59628847|NCT01129440|75742296|FG001|NOT COMPLETED|Overall Study||42||
59628848|NCT01130844|75742306|FG000|STARTED|Overall Study||21||
59628849|NCT01130844|75742307|FG001|STARTED|Overall Study||22||
59628850|NCT01130844|75742308|FG002|STARTED|Overall Study||9||
59628851|NCT01130844|75742306|FG000|COMPLETED|Overall Study||21||
59628852|NCT01130844|75742307|FG001|COMPLETED|Overall Study||22||
59628853|NCT01130844|75742308|FG002|COMPLETED|Overall Study||9||
59628854|NCT01130844|75742306|FG000|NOT COMPLETED|Overall Study||0||
59628855|NCT01130844|75742307|FG001|NOT COMPLETED|Overall Study||0||
59628856|NCT01130844|75742308|FG002|NOT COMPLETED|Overall Study||0||
59628857|NCT01134198|75742321|FG000|STARTED|Phase 1||16|randomized in phase 1, inpatient stay|
59628858|NCT01134198|75742322|FG001|STARTED|Phase 1||13|randomized in phase 1, inpatient stay|
59628859|NCT01134198|75742321|FG000|COMPLETED|Phase 1||9|started phase 2, outpatient treatment|
59628860|NCT01134198|75742322|FG001|COMPLETED|Phase 1||11|started phase 2, outpatient treatment|
59628861|NCT01134198|75742321|FG000|NOT COMPLETED|Phase 1||7||
59628862|NCT01134198|75742322|FG001|NOT COMPLETED|Phase 1||2||
59628863|NCT01134198|75742321|FG000|STARTED|Phase 2||9||
59628864|NCT01134198|75742322|FG001|STARTED|Phase 2||11||
59628865|NCT01134198|75742321|FG000|COMPLETED|Phase 2||9|completed phase 2|
59628866|NCT01134198|75742322|FG001|COMPLETED|Phase 2||7|completed phase 2|
59628867|NCT01134198|75742321|FG000|NOT COMPLETED|Phase 2||0||
59628868|NCT01134198|75742322|FG001|NOT COMPLETED|Phase 2||4||
59628869|NCT01134276|75742330|FG000|STARTED|Overall Study||104||
59628870|NCT01134276|75742331|FG001|STARTED|Overall Study||107||
59628871|NCT01134276|75742330|FG000|COMPLETED|Overall Study||104||
59628872|NCT01134276|75742331|FG001|COMPLETED|Overall Study||107||
59628873|NCT01134276|75742330|FG000|NOT COMPLETED|Overall Study||0||
59628874|NCT01134276|75742331|FG001|NOT COMPLETED|Overall Study||0||
59628875|NCT01134900|75742342|FG000|STARTED|Overall Study||200||
59628876|NCT01134900|75742343|FG001|STARTED|Overall Study||196||
59628877|NCT01134900|75742342|FG000|COMPLETED|Overall Study||200||
59628878|NCT01134900|75742343|FG001|COMPLETED|Overall Study||196||
59628879|NCT01134900|75742342|FG000|NOT COMPLETED|Overall Study||0||
59628880|NCT01134900|75742343|FG001|NOT COMPLETED|Overall Study||0||
59628881|NCT01135368|75742349|FG000|STARTED|Overall Study||506||
59628882|NCT01135368|75742349|FG000|COMPLETED|Overall Study||255||
59628883|NCT01135368|75742349|FG000|NOT COMPLETED|Overall Study||251||
59628884|NCT01136226|75742387|FG000|STARTED|Overall Study||42||
59628885|NCT01136226|75742387|FG000|COMPLETED|Overall Study||29||
59628886|NCT01136226|75742387|FG000|NOT COMPLETED|Overall Study||13||
59628887|NCT01137006|75742399|FG000|STARTED|Overall Study||3||
59628888|NCT01137006|75742400|FG001|STARTED|Overall Study||3||
59628889|NCT01137006|75742401|FG002|STARTED|Overall Study||8||
59628890|NCT01137006|75742402|FG003|STARTED|Overall Study||3||
59628891|NCT01137006|75742403|FG004|STARTED|Overall Study||3||
59628892|NCT01137006|75742404|FG005|STARTED|Overall Study||4||
59815664|NCT03659136|75938117|FG000|NOT COMPLETED|Overall Study||52||
59815665|NCT03659136|75938118|FG001|NOT COMPLETED|Overall Study||51||
59628893|NCT01137006|75742405|FG006|STARTED|Overall Study||3||
59628894|NCT01137006|75742399|FG000|Completed at Least 1 Treatment Cycle|Overall Study||3||
59628895|NCT01137006|75742400|FG001|Completed at Least 1 Treatment Cycle|Overall Study||3||
59628896|NCT01137006|75742401|FG002|Completed at Least 1 Treatment Cycle|Overall Study||8||
59628897|NCT01137006|75742402|FG003|Completed at Least 1 Treatment Cycle|Overall Study||3||
59628898|NCT01137006|75742403|FG004|Completed at Least 1 Treatment Cycle|Overall Study||3||
59628899|NCT01137006|75742404|FG005|Completed at Least 1 Treatment Cycle|Overall Study||4||
59628900|NCT01137006|75742405|FG006|Completed at Least 1 Treatment Cycle|Overall Study||3||
59628901|NCT01137006|75742399|FG000|COMPLETED|Overall Study||3||
59628902|NCT01137006|75742400|FG001|COMPLETED|Overall Study||3||
59628903|NCT01137006|75742401|FG002|COMPLETED|Overall Study||8||
59628904|NCT01137006|75742402|FG003|COMPLETED|Overall Study||3||
59628905|NCT01137006|75742403|FG004|COMPLETED|Overall Study||3||
59628906|NCT01137006|75742404|FG005|COMPLETED|Overall Study||4||
59628907|NCT01137006|75742405|FG006|COMPLETED|Overall Study||3||
59628908|NCT01137006|75742399|FG000|NOT COMPLETED|Overall Study||0||
59628909|NCT01137006|75742400|FG001|NOT COMPLETED|Overall Study||0||
59628910|NCT01137006|75742401|FG002|NOT COMPLETED|Overall Study||0||
59628911|NCT01137006|75742402|FG003|NOT COMPLETED|Overall Study||0||
59628912|NCT01137006|75742403|FG004|NOT COMPLETED|Overall Study||0||
59628913|NCT01137006|75742404|FG005|NOT COMPLETED|Overall Study||0||
59628914|NCT01137006|75742405|FG006|NOT COMPLETED|Overall Study||0||
59628915|NCT01137396|75742424|FG000|STARTED|Overall Study||30||
59628916|NCT01137396|75742425|FG001|STARTED|Overall Study||27||
59628917|NCT01137396|75742424|FG000|COMPLETED|Overall Study||22||
59628918|NCT01137396|75742425|FG001|COMPLETED|Overall Study||25||
59628919|NCT01137396|75742424|FG000|NOT COMPLETED|Overall Study||8||
59628920|NCT01137396|75742425|FG001|NOT COMPLETED|Overall Study||2||
59628921|NCT01138098|75742433|FG000|STARTED|Overall Study||95||
59628922|NCT01138098|75742434|FG001|STARTED|Overall Study||90||
59628923|NCT01138098|75742433|FG000|COMPLETED|Overall Study||95||
59628924|NCT01138098|75742434|FG001|COMPLETED|Overall Study||90||
59628925|NCT01138098|75742433|FG000|NOT COMPLETED|Overall Study||0||
59628926|NCT01138098|75742434|FG001|NOT COMPLETED|Overall Study||0||
59628927|NCT01139190|75742442|FG000|STARTED|Overall Study||38||
59628928|NCT01139190|75742443|FG001|STARTED|Overall Study||39||
59628929|NCT01139190|75742442|FG000|COMPLETED|Overall Study||38||
59628930|NCT01139190|75742443|FG001|COMPLETED|Overall Study||38||
59628931|NCT01139190|75742442|FG000|NOT COMPLETED|Overall Study||0||
59628932|NCT01139190|75742443|FG001|NOT COMPLETED|Overall Study||1||
59628933|NCT01139814|75742449|FG000|STARTED|Overall Study||181||
59628934|NCT01139814|75742449|FG000|COMPLETED|Overall Study||181||
59628935|NCT01139814|75742449|FG000|NOT COMPLETED|Overall Study||0||
59628936|NCT01140360|75742454|FG000|STARTED|Overall Study||21||
59628937|NCT01140360|75742454|FG000|COMPLETED|Overall Study||15||
59628938|NCT01140360|75742454|FG000|NOT COMPLETED|Overall Study||6||
59628939|NCT01141374|75742461|FG000|STARTED|Overall Study||26||
59628940|NCT01141374|75742462|FG001|STARTED|Overall Study||27||
59628941|NCT01141374|75742463|FG002|STARTED|Overall Study||22||
59628942|NCT01141374|75742461|FG000|COMPLETED|Overall Study||26||
59628943|NCT01141374|75742462|FG001|COMPLETED|Overall Study||27||
59628944|NCT01141374|75742463|FG002|COMPLETED|Overall Study||22||
59628945|NCT01141374|75742461|FG000|NOT COMPLETED|Overall Study||0||
59628946|NCT01141374|75742462|FG001|NOT COMPLETED|Overall Study||0||
59628947|NCT01141374|75742463|FG002|NOT COMPLETED|Overall Study||0||
59628948|NCT01141608|75742475|FG000|STARTED|Overall Study||152||
59628949|NCT01141608|75742476|FG001|STARTED|Overall Study||150||
59628950|NCT01141608|75742475|FG000|COMPLETED|Overall Study||152||
59628951|NCT01141608|75742476|FG001|COMPLETED|Overall Study||150||
59628952|NCT01141608|75742475|FG000|NOT COMPLETED|Overall Study||0||
59628953|NCT01141608|75742476|FG001|NOT COMPLETED|Overall Study||0||
59628954|NCT01142310|75742484|FG000|STARTED|Overall Study||26||
59628955|NCT01142310|75742485|FG001|STARTED|Overall Study||28||
59628956|NCT01142310|75742484|FG000|COMPLETED|Overall Study||17||
59628957|NCT01142310|75742485|FG001|COMPLETED|Overall Study||16||
59628958|NCT01142310|75742484|FG000|NOT COMPLETED|Overall Study||9||
59628959|NCT01142310|75742485|FG001|NOT COMPLETED|Overall Study||12||
59628960|NCT01143636|75742494|FG000|STARTED|Overall Study||6||
59628961|NCT01143636|75742495|FG001|STARTED|Overall Study||5||
59628962|NCT01143636|75742496|FG002|STARTED|Overall Study||8||
59628963|NCT01143636|75742497|FG003|STARTED|Overall Study||7||
59628964|NCT01143636|75742494|FG000|COMPLETED|Overall Study||5||
59628965|NCT01143636|75742495|FG001|COMPLETED|Overall Study||4||
59628966|NCT01143636|75742496|FG002|COMPLETED|Overall Study||8||
59628967|NCT01143636|75742497|FG003|COMPLETED|Overall Study||7||
59628968|NCT01143636|75742494|FG000|NOT COMPLETED|Overall Study||1||
59628969|NCT01143636|75742495|FG001|NOT COMPLETED|Overall Study||1||
59628970|NCT01143636|75742496|FG002|NOT COMPLETED|Overall Study||0||
59628971|NCT01143636|75742497|FG003|NOT COMPLETED|Overall Study||0||
59628972|NCT01143792|75742510|FG000|STARTED|Overall Study||93||
59628973|NCT01143792|75742511|FG001|STARTED|Overall Study||86||
59628974|NCT01143792|75742512|FG002|STARTED|Overall Study||91||
59628975|NCT01143792|75742510|FG000|COMPLETED|Overall Study||93||
59628976|NCT01143792|75742511|FG001|COMPLETED|Overall Study||86||
59628977|NCT01143792|75742512|FG002|COMPLETED|Overall Study||91||
59628978|NCT01143792|75742510|FG000|NOT COMPLETED|Overall Study||0||
59628979|NCT01143792|75742511|FG001|NOT COMPLETED|Overall Study||0||
59815666|NCT03615469|75938126|FG000|STARTED|Overall Study||7||
59628980|NCT01143792|75742512|FG002|NOT COMPLETED|Overall Study||0||
59628981|NCT01143870|75742534|FG000|STARTED|Overall Study||58||
59628982|NCT01143870|75742535|FG001|STARTED|Overall Study||58||
59628983|NCT01143870|75742536|FG002|STARTED|Overall Study||61||
59628984|NCT01143870|75742534|FG000|Post-intervention Survey|Overall Study||53||
59628985|NCT01143870|75742535|FG001|Post-intervention Survey|Overall Study||50||
59628986|NCT01143870|75742536|FG002|Post-intervention Survey|Overall Study||61||
59628987|NCT01143870|75742534|FG000|Had Available 6-month A1C|Overall Study||27||
59628988|NCT01143870|75742535|FG001|Had Available 6-month A1C|Overall Study||29||
59628989|NCT01143870|75742536|FG002|Had Available 6-month A1C|Overall Study||31||
59628990|NCT01143870|75742534|FG000|A1C Imputed|Overall Study||31||
59628991|NCT01143870|75742535|FG001|A1C Imputed|Overall Study||29||
59628992|NCT01143870|75742536|FG002|A1C Imputed|Overall Study||30||
59628993|NCT01143870|75742534|FG000|COMPLETED|Overall Study||58||
59628994|NCT01143870|75742535|FG001|COMPLETED|Overall Study||58||
59628995|NCT01143870|75742536|FG002|COMPLETED|Overall Study||61||
59628996|NCT01143870|75742534|FG000|NOT COMPLETED|Overall Study||0||
60076297|NCT01904773|76191367|FG003|STARTED|Placebo Washout Fourth Intervention||2||
60076298|NCT01904773|76191368|FG004|STARTED|Placebo Washout Fourth Intervention||3||
60076299|NCT01904773|76191369|FG005|STARTED|Placebo Washout Fourth Intervention||4||
60076300|NCT01904773|76191370|FG006|STARTED|Placebo Washout Fourth Intervention||3||
60076301|NCT01904773|76191371|FG007|STARTED|Placebo Washout Fourth Intervention||3||
60076302|NCT01904773|76191372|FG008|STARTED|Placebo Washout Fourth Intervention||4||
59628997|NCT01143870|75742535|FG001|NOT COMPLETED|Overall Study||0||
59628998|NCT01143870|75742536|FG002|NOT COMPLETED|Overall Study||0||
59628999|NCT01144026|75742546|FG000|STARTED|Overall Study||10||
59629000|NCT01144026|75742547|FG001|STARTED|Overall Study||5||
59629001|NCT01144026|75742546|FG000|COMPLETED|Overall Study||10||
59629002|NCT01144026|75742547|FG001|COMPLETED|Overall Study||5||
59629003|NCT01144026|75742546|FG000|NOT COMPLETED|Overall Study||0||
59629004|NCT01144026|75742547|FG001|NOT COMPLETED|Overall Study||0||
59629005|NCT01144338|75742555|FG000|STARTED|Overall Study||7396||
59629006|NCT01144338|75742556|FG001|STARTED|Overall Study||7356||
59629007|NCT01144338|75742555|FG000|COMPLETED|Overall Study||7093||
59629008|NCT01144338|75742556|FG001|COMPLETED|Overall Study||7094||
59629009|NCT01144338|75742555|FG000|NOT COMPLETED|Overall Study||303||
59629010|NCT01144338|75742556|FG001|NOT COMPLETED|Overall Study||262||
59629011|NCT01146600|75742564|FG000|STARTED|Period 1 (Weeks 1 & 2)||13||
59629012|NCT01146600|75742565|FG001|STARTED|Period 1 (Weeks 1 & 2)||10||
59629013|NCT01146600|75742564|FG000|COMPLETED|Period 1 (Weeks 1 & 2)||10||
59629014|NCT01146600|75742565|FG001|COMPLETED|Period 1 (Weeks 1 & 2)||10||
59629015|NCT01146600|75742564|FG000|NOT COMPLETED|Period 1 (Weeks 1 & 2)||3||
59629016|NCT01146600|75742565|FG001|NOT COMPLETED|Period 1 (Weeks 1 & 2)||0||
59629017|NCT01146600|75742564|FG000|STARTED|Washout (Week 3)||10||
59629018|NCT01146600|75742565|FG001|STARTED|Washout (Week 3)||10||
59629019|NCT01146600|75742564|FG000|COMPLETED|Washout (Week 3)||10||
59629020|NCT01146600|75742565|FG001|COMPLETED|Washout (Week 3)||10||
59629021|NCT01146600|75742564|FG000|NOT COMPLETED|Washout (Week 3)||0||
59629022|NCT01146600|75742565|FG001|NOT COMPLETED|Washout (Week 3)||0||
59629023|NCT01146600|75742564|FG000|STARTED|Period 2 (Weeks 4 & 5)||10||
59629024|NCT01146600|75742565|FG001|STARTED|Period 2 (Weeks 4 & 5)||10||
59629025|NCT01146600|75742564|FG000|COMPLETED|Period 2 (Weeks 4 & 5)||10||
59629026|NCT01146600|75742565|FG001|COMPLETED|Period 2 (Weeks 4 & 5)||10||
59629027|NCT01146600|75742564|FG000|NOT COMPLETED|Period 2 (Weeks 4 & 5)||0||
59629028|NCT01146600|75742565|FG001|NOT COMPLETED|Period 2 (Weeks 4 & 5)||0||
59629029|NCT01146834|75742577|FG000|STARTED|Overall Study||20||
59629030|NCT01146834|75742578|FG001|STARTED|Overall Study||4||
59629031|NCT01146834|75742579|FG002|STARTED|Overall Study||23||
59629032|NCT01146834|75742580|FG003|STARTED|Overall Study||0||
59629033|NCT01146834|75742581|FG004|STARTED|Overall Study||0||
59629034|NCT01146834|75742577|FG000|COMPLETED|Overall Study||17||
59629035|NCT01146834|75742578|FG001|COMPLETED|Overall Study||4||
59629036|NCT01146834|75742579|FG002|COMPLETED|Overall Study||21||
59629037|NCT01146834|75742580|FG003|COMPLETED|Overall Study||0||
59629038|NCT01146834|75742581|FG004|COMPLETED|Overall Study||0||
59629039|NCT01146834|75742577|FG000|NOT COMPLETED|Overall Study||3||
59629040|NCT01146834|75742578|FG001|NOT COMPLETED|Overall Study||0||
60076303|NCT01904773|76191364|FG000|COMPLETED|Placebo Washout Fourth Intervention||0||
60076304|NCT01904773|76191365|FG001|COMPLETED|Placebo Washout Fourth Intervention||1||
60076305|NCT01904773|76191366|FG002|COMPLETED|Placebo Washout Fourth Intervention||1||
60076306|NCT01904773|76191367|FG003|COMPLETED|Placebo Washout Fourth Intervention||2||
60076307|NCT01904773|76191368|FG004|COMPLETED|Placebo Washout Fourth Intervention||3||
60076308|NCT01904773|76191369|FG005|COMPLETED|Placebo Washout Fourth Intervention||4||
60076309|NCT01904773|76191370|FG006|COMPLETED|Placebo Washout Fourth Intervention||3||
60076310|NCT01904773|76191371|FG007|COMPLETED|Placebo Washout Fourth Intervention||3||
60076311|NCT01904773|76191372|FG008|COMPLETED|Placebo Washout Fourth Intervention||4||
60076312|NCT01904773|76191364|FG000|NOT COMPLETED|Placebo Washout Fourth Intervention||0||
60076313|NCT01904773|76191365|FG001|NOT COMPLETED|Placebo Washout Fourth Intervention||0||
60076314|NCT01904773|76191366|FG002|NOT COMPLETED|Placebo Washout Fourth Intervention||0||
60076315|NCT01904773|76191367|FG003|NOT COMPLETED|Placebo Washout Fourth Intervention||0||
60076316|NCT01904773|76191368|FG004|NOT COMPLETED|Placebo Washout Fourth Intervention||0||
60076317|NCT01904773|76191369|FG005|NOT COMPLETED|Placebo Washout Fourth Intervention||0||
59629041|NCT01146834|75742579|FG002|NOT COMPLETED|Overall Study||2||
59629042|NCT01146834|75742580|FG003|NOT COMPLETED|Overall Study||0||
59629043|NCT01146834|75742581|FG004|NOT COMPLETED|Overall Study||0||
59629044|NCT01147302|75742595|FG000|STARTED|Overall Study||9||
59629045|NCT01147302|75742596|FG001|STARTED|Overall Study||9||
59629046|NCT01147302|75742595|FG000|COMPLETED|Overall Study||9||
59629047|NCT01147302|75742596|FG001|COMPLETED|Overall Study||9||
59629048|NCT01147302|75742595|FG000|NOT COMPLETED|Overall Study||0||
59629049|NCT01147302|75742596|FG001|NOT COMPLETED|Overall Study||0||
59629050|NCT01147380|75742604|FG000|STARTED|Overall Study||6||
59629051|NCT01147380|75742605|FG001|STARTED|Overall Study||12||
59629052|NCT01147380|75742604|FG000|COMPLETED|Overall Study||6||
59629053|NCT01147380|75742605|FG001|COMPLETED|Overall Study||12||
59629054|NCT01147380|75742604|FG000|NOT COMPLETED|Overall Study||0||
59629055|NCT01147380|75742605|FG001|NOT COMPLETED|Overall Study||0||
59629056|NCT01148940|75742615|FG000|STARTED|Overall Study||7||
59629057|NCT01148940|75742616|FG001|STARTED|Overall Study||27||
59629058|NCT01148940|75742617|FG002|STARTED|Overall Study||0||
59629059|NCT01148940|75742615|FG000|COMPLETED|Overall Study||7||
59629060|NCT01148940|75742616|FG001|COMPLETED|Overall Study||27||
59629061|NCT01148940|75742617|FG002|COMPLETED|Overall Study||0||
59629062|NCT01148940|75742615|FG000|NOT COMPLETED|Overall Study||0||
59629063|NCT01148940|75742616|FG001|NOT COMPLETED|Overall Study||0||
59629064|NCT01148940|75742617|FG002|NOT COMPLETED|Overall Study||0||
59629065|NCT01149876|75742629|FG000|STARTED|Overall Study||21||
59629066|NCT01149876|75742630|FG001|STARTED|Overall Study||20||
59629067|NCT01149876|75742631|FG002|STARTED|Overall Study||21||
59629068|NCT01149876|75742632|FG003|STARTED|Overall Study||18||
59629069|NCT01149876|75742629|FG000|COMPLETED|Overall Study||20||
59629070|NCT01149876|75742630|FG001|COMPLETED|Overall Study||20||
59629071|NCT01149876|75742631|FG002|COMPLETED|Overall Study||20||
59629072|NCT01149876|75742632|FG003|COMPLETED|Overall Study||18||
59629073|NCT01149876|75742629|FG000|NOT COMPLETED|Overall Study||1||
59629074|NCT01149876|75742630|FG001|NOT COMPLETED|Overall Study||0||
59629075|NCT01149876|75742631|FG002|NOT COMPLETED|Overall Study||1||
59629076|NCT01149876|75742632|FG003|NOT COMPLETED|Overall Study||0||
59629077|NCT01150500|75742643|FG000|STARTED|Overall Study||65||
59629078|NCT01150500|75742643|FG000|COMPLETED|Overall Study||0||
59629079|NCT01150500|75742643|FG000|NOT COMPLETED|Overall Study||65||
59629080|NCT01151046|75742649|FG000|STARTED|Overall Study||59||
59629081|NCT01151046|75742650|FG001|STARTED|Overall Study||59||
59629082|NCT01151046|75742649|FG000|COMPLETED|Overall Study||56||
59629083|NCT01151046|75742650|FG001|COMPLETED|Overall Study||59||
59629084|NCT01151046|75742649|FG000|NOT COMPLETED|Overall Study||3||
59629085|NCT01151046|75742650|FG001|NOT COMPLETED|Overall Study||0||
59629086|NCT01151436|75742660|FG000|STARTED|Overall Study||77||
59629087|NCT01151436|75742660|FG000|COMPLETED|Overall Study||76||
59629088|NCT01151436|75742660|FG000|NOT COMPLETED|Overall Study||1||
59629089|NCT01152294|75742666|FG000|STARTED|Overall Study||213||
59629090|NCT01152294|75742667|FG001|STARTED|Overall Study||188||
59629091|NCT01152294|75742666|FG000|COMPLETED|Overall Study||213||
59629092|NCT01152294|75742667|FG001|COMPLETED|Overall Study||188||
59629093|NCT01152294|75742666|FG000|NOT COMPLETED|Overall Study||0||
59629094|NCT01152294|75742667|FG001|NOT COMPLETED|Overall Study||0||
59629095|NCT01153620|75742675|FG000|STARTED|Overall Study||30||
59629096|NCT01153620|75742676|FG001|STARTED|Overall Study|30 patients (31 wounds)|30||
59629097|NCT01153620|75742675|FG000|COMPLETED|Overall Study||30||
59629098|NCT01153620|75742676|FG001|COMPLETED|Overall Study|30 patients (31 wounds)|30||
59629099|NCT01153620|75742675|FG000|NOT COMPLETED|Overall Study||0||
59629100|NCT01153620|75742676|FG001|NOT COMPLETED|Overall Study||0||
59629101|NCT01154322|75742682|FG000|STARTED|Overall Study||16||
59629102|NCT01154322|75742682|FG000|COMPLETED|Overall Study||14||
59629103|NCT01154322|75742682|FG000|NOT COMPLETED|Overall Study||2||
59629104|NCT01154634|75742691|FG000|STARTED|Period 1 - First Intervention||4||
59629105|NCT01154634|75742692|FG001|STARTED|Period 1 - First Intervention||7||
59629106|NCT01154634|75742693|FG002|STARTED|Period 1 - First Intervention||4||
59629107|NCT01154634|75742694|FG003|STARTED|Period 1 - First Intervention||5||
59629108|NCT01154634|75742691|FG000|COMPLETED|Period 1 - First Intervention||4||
59629109|NCT01154634|75742692|FG001|COMPLETED|Period 1 - First Intervention||7||
59629110|NCT01154634|75742693|FG002|COMPLETED|Period 1 - First Intervention||4||
59629111|NCT01154634|75742694|FG003|COMPLETED|Period 1 - First Intervention||5||
59629112|NCT01154634|75742691|FG000|NOT COMPLETED|Period 1 - First Intervention||0||
59629113|NCT01154634|75742692|FG001|NOT COMPLETED|Period 1 - First Intervention||0||
59629114|NCT01154634|75742693|FG002|NOT COMPLETED|Period 1 - First Intervention||0||
59629115|NCT01154634|75742694|FG003|NOT COMPLETED|Period 1 - First Intervention||0||
59629116|NCT01154634|75742691|FG000|STARTED|Period 2 - Washout||4||
59629117|NCT01154634|75742692|FG001|STARTED|Period 2 - Washout||7||
59629118|NCT01154634|75742693|FG002|STARTED|Period 2 - Washout||4||
59629119|NCT01154634|75742694|FG003|STARTED|Period 2 - Washout||5||
59629120|NCT01154634|75742691|FG000|COMPLETED|Period 2 - Washout||4||
59629121|NCT01154634|75742692|FG001|COMPLETED|Period 2 - Washout||7||
59629122|NCT01154634|75742693|FG002|COMPLETED|Period 2 - Washout||4||
59629123|NCT01154634|75742694|FG003|COMPLETED|Period 2 - Washout||5||
59629124|NCT01154634|75742691|FG000|NOT COMPLETED|Period 2 - Washout||0||
59629125|NCT01154634|75742692|FG001|NOT COMPLETED|Period 2 - Washout||0||
59629126|NCT01154634|75742693|FG002|NOT COMPLETED|Period 2 - Washout||0||
59629127|NCT01154634|75742694|FG003|NOT COMPLETED|Period 2 - Washout||0||
59629128|NCT01154634|75742691|FG000|STARTED|Period 3- Second Intervention||4||
59629129|NCT01154634|75742692|FG001|STARTED|Period 3- Second Intervention||7||
59629130|NCT01154634|75742693|FG002|STARTED|Period 3- Second Intervention||4||
59629131|NCT01154634|75742694|FG003|STARTED|Period 3- Second Intervention||5||
59629132|NCT01154634|75742691|FG000|COMPLETED|Period 3- Second Intervention||4||
59629133|NCT01154634|75742692|FG001|COMPLETED|Period 3- Second Intervention||7||
59629134|NCT01154634|75742693|FG002|COMPLETED|Period 3- Second Intervention||4||
59629135|NCT01154634|75742694|FG003|COMPLETED|Period 3- Second Intervention||5||
59629136|NCT01154634|75742691|FG000|NOT COMPLETED|Period 3- Second Intervention||0||
59629137|NCT01154634|75742692|FG001|NOT COMPLETED|Period 3- Second Intervention||0||
59629138|NCT01154634|75742693|FG002|NOT COMPLETED|Period 3- Second Intervention||0||
59629139|NCT01154634|75742694|FG003|NOT COMPLETED|Period 3- Second Intervention||0||
59629140|NCT01154634|75742691|FG000|STARTED|Period 4 - Washout||4||
59629141|NCT01154634|75742692|FG001|STARTED|Period 4 - Washout||7||
59629142|NCT01154634|75742693|FG002|STARTED|Period 4 - Washout||4||
59629143|NCT01154634|75742694|FG003|STARTED|Period 4 - Washout||5||
59629144|NCT01154634|75742691|FG000|COMPLETED|Period 4 - Washout||4||
59629145|NCT01154634|75742692|FG001|COMPLETED|Period 4 - Washout||7||
59629146|NCT01154634|75742693|FG002|COMPLETED|Period 4 - Washout||4||
59629147|NCT01154634|75742694|FG003|COMPLETED|Period 4 - Washout||5||
59629148|NCT01154634|75742691|FG000|NOT COMPLETED|Period 4 - Washout||0||
59629149|NCT01154634|75742692|FG001|NOT COMPLETED|Period 4 - Washout||0||
59629150|NCT01154634|75742693|FG002|NOT COMPLETED|Period 4 - Washout||0||
59629151|NCT01154634|75742694|FG003|NOT COMPLETED|Period 4 - Washout||0||
59629152|NCT01154634|75742691|FG000|STARTED|Period 5 - Third Intervention||4||
59629153|NCT01154634|75742692|FG001|STARTED|Period 5 - Third Intervention||7||
59629154|NCT01154634|75742693|FG002|STARTED|Period 5 - Third Intervention||4||
59629155|NCT01154634|75742694|FG003|STARTED|Period 5 - Third Intervention||5||
59629156|NCT01154634|75742691|FG000|COMPLETED|Period 5 - Third Intervention||4||
59629157|NCT01154634|75742692|FG001|COMPLETED|Period 5 - Third Intervention||7||
59629158|NCT01154634|75742693|FG002|COMPLETED|Period 5 - Third Intervention||4||
59629159|NCT01154634|75742694|FG003|COMPLETED|Period 5 - Third Intervention||5||
59629160|NCT01154634|75742691|FG000|NOT COMPLETED|Period 5 - Third Intervention||0||
59629161|NCT01154634|75742692|FG001|NOT COMPLETED|Period 5 - Third Intervention||0||
59629162|NCT01154634|75742693|FG002|NOT COMPLETED|Period 5 - Third Intervention||0||
59629163|NCT01154634|75742694|FG003|NOT COMPLETED|Period 5 - Third Intervention||0||
59629164|NCT01154634|75742691|FG000|STARTED|Period 6 - Washout||4||
59629165|NCT01154634|75742692|FG001|STARTED|Period 6 - Washout||7||
59629166|NCT01154634|75742693|FG002|STARTED|Period 6 - Washout||4||
59629167|NCT01154634|75742694|FG003|STARTED|Period 6 - Washout||5||
59629168|NCT01154634|75742691|FG000|COMPLETED|Period 6 - Washout||4||
59629169|NCT01154634|75742692|FG001|COMPLETED|Period 6 - Washout||7||
59629170|NCT01154634|75742693|FG002|COMPLETED|Period 6 - Washout||4||
59629171|NCT01154634|75742694|FG003|COMPLETED|Period 6 - Washout||5||
59629172|NCT01154634|75742691|FG000|NOT COMPLETED|Period 6 - Washout||0||
59629173|NCT01154634|75742692|FG001|NOT COMPLETED|Period 6 - Washout||0||
59629174|NCT01154634|75742693|FG002|NOT COMPLETED|Period 6 - Washout||0||
59629175|NCT01154634|75742694|FG003|NOT COMPLETED|Period 6 - Washout||0||
59629176|NCT01154634|75742691|FG000|STARTED|Period 7 - Fourth Intervention||4||
59629177|NCT01154634|75742692|FG001|STARTED|Period 7 - Fourth Intervention||7||
59629178|NCT01154634|75742693|FG002|STARTED|Period 7 - Fourth Intervention||4||
59629179|NCT01154634|75742694|FG003|STARTED|Period 7 - Fourth Intervention||5||
59629180|NCT01154634|75742691|FG000|COMPLETED|Period 7 - Fourth Intervention||4||
59629181|NCT01154634|75742692|FG001|COMPLETED|Period 7 - Fourth Intervention||7||
59629182|NCT01154634|75742693|FG002|COMPLETED|Period 7 - Fourth Intervention||4||
59629183|NCT01154634|75742694|FG003|COMPLETED|Period 7 - Fourth Intervention||5||
59629184|NCT01154634|75742691|FG000|NOT COMPLETED|Period 7 - Fourth Intervention||0||
59629185|NCT01154634|75742692|FG001|NOT COMPLETED|Period 7 - Fourth Intervention||0||
59629186|NCT01154634|75742693|FG002|NOT COMPLETED|Period 7 - Fourth Intervention||0||
59629187|NCT01154634|75742694|FG003|NOT COMPLETED|Period 7 - Fourth Intervention||0||
59629188|NCT01155180|75742706|FG000|STARTED|Overall Study||18||
59629189|NCT01155180|75742707|FG001|STARTED|Overall Study||6||
59629190|NCT01155180|75742706|FG000|COMPLETED|Overall Study||18||
59629191|NCT01155180|75742707|FG001|COMPLETED|Overall Study||6||
59629192|NCT01155180|75742706|FG000|NOT COMPLETED|Overall Study||0||
59629193|NCT01155180|75742707|FG001|NOT COMPLETED|Overall Study||0||
59629194|NCT01155336|75742715|FG000|STARTED|Overall Study|We did not complete the study.|0||
59629195|NCT01155336|75742716|FG001|STARTED|Overall Study|We did not complete the study.|4||
59629196|NCT01155336|75742715|FG000|COMPLETED|Overall Study|We did not complete the study.|0||
59629197|NCT01155336|75742716|FG001|COMPLETED|Overall Study|We did not complete the study.|4||
59629198|NCT01155336|75742715|FG000|NOT COMPLETED|Overall Study||0||
59629199|NCT01155336|75742716|FG001|NOT COMPLETED|Overall Study||0||
59629200|NCT01161420|75742722|FG000|STARTED|Inspire Therapy||126||
59629201|NCT01161420|75742722|FG000|COMPLETED|Inspire Therapy||124||
59629202|NCT01161420|75742722|FG000|NOT COMPLETED|Inspire Therapy||2||
59629203|NCT01161420|75742722|FG000|STARTED|Withdrawal Study - Maintenance||23||
59629204|NCT01161420|75742722|FG000|COMPLETED|Withdrawal Study - Maintenance||23||
59629205|NCT01161420|75742722|FG000|NOT COMPLETED|Withdrawal Study - Maintenance||0||
59629206|NCT01161420|75742722|FG000|STARTED|Withdrawal Study - Withdrawal||23||
59629207|NCT01161420|75742722|FG000|COMPLETED|Withdrawal Study - Withdrawal||23||
59629208|NCT01161420|75742722|FG000|NOT COMPLETED|Withdrawal Study - Withdrawal||0||
59629209|NCT01163214|75742734|FG000|STARTED|Overall Study||79||
59629210|NCT01163214|75742735|FG001|STARTED|Overall Study||81||
59629211|NCT01163214|75742734|FG000|COMPLETED|Overall Study||79||
59629212|NCT01163214|75742735|FG001|COMPLETED|Overall Study||81||
59629213|NCT01163214|75742734|FG000|NOT COMPLETED|Overall Study||0||
59629214|NCT01163214|75742735|FG001|NOT COMPLETED|Overall Study||0||
59629215|NCT01163604|75742743|FG000|STARTED|Overall Study|August 2010|58||
59629216|NCT01163604|75742744|FG001|STARTED|Overall Study|August 2010|56||
59629217|NCT01163604|75742743|FG000|COMPLETED|Overall Study|August 2011|58||
59629218|NCT01163604|75742744|FG001|COMPLETED|Overall Study|August 2011|56||
59629219|NCT01163604|75742743|FG000|NOT COMPLETED|Overall Study||0||
59629220|NCT01163604|75742744|FG001|NOT COMPLETED|Overall Study||0||
59629221|NCT01163760|75742750|FG000|STARTED|Period 1 (Fit)||12||
59629222|NCT01163760|75742751|FG001|STARTED|Period 1 (Fit)||13||
59629223|NCT01163760|75742752|FG002|STARTED|Period 1 (Fit)||13||
59629224|NCT01163760|75742753|FG003|STARTED|Period 1 (Fit)||12||
59629225|NCT01163760|75742750|FG000|COMPLETED|Period 1 (Fit)||12||
59629226|NCT01163760|75742751|FG001|COMPLETED|Period 1 (Fit)||13||
59629227|NCT01163760|75742752|FG002|COMPLETED|Period 1 (Fit)||13||
59629228|NCT01163760|75742753|FG003|COMPLETED|Period 1 (Fit)||12||
59629229|NCT01163760|75742750|FG000|NOT COMPLETED|Period 1 (Fit)||0||
59629230|NCT01163760|75742751|FG001|NOT COMPLETED|Period 1 (Fit)||0||
59629231|NCT01163760|75742752|FG002|NOT COMPLETED|Period 1 (Fit)||0||
59629232|NCT01163760|75742753|FG003|NOT COMPLETED|Period 1 (Fit)||0||
59629233|NCT01163760|75742750|FG000|STARTED|Period 2 (Follow-up)||12||
59629234|NCT01163760|75742751|FG001|STARTED|Period 2 (Follow-up)||13||
59629235|NCT01163760|75742752|FG002|STARTED|Period 2 (Follow-up)||13||
59629236|NCT01163760|75742753|FG003|STARTED|Period 2 (Follow-up)||12||
59629237|NCT01163760|75742750|FG000|COMPLETED|Period 2 (Follow-up)||12||
59629238|NCT01163760|75742751|FG001|COMPLETED|Period 2 (Follow-up)||13||
59629239|NCT01163760|75742752|FG002|COMPLETED|Period 2 (Follow-up)||13||
59629240|NCT01163760|75742753|FG003|COMPLETED|Period 2 (Follow-up)||12||
59629241|NCT01163760|75742750|FG000|NOT COMPLETED|Period 2 (Follow-up)||0||
59629242|NCT01163760|75742751|FG001|NOT COMPLETED|Period 2 (Follow-up)||0||
59629243|NCT01163760|75742752|FG002|NOT COMPLETED|Period 2 (Follow-up)||0||
59629244|NCT01163760|75742753|FG003|NOT COMPLETED|Period 2 (Follow-up)||0||
59629245|NCT01163760|75742750|FG000|STARTED|Period 3 (Fit)||12||
59629246|NCT01163760|75742751|FG001|STARTED|Period 3 (Fit)||13||
59629247|NCT01163760|75742752|FG002|STARTED|Period 3 (Fit)||13||
59629248|NCT01163760|75742753|FG003|STARTED|Period 3 (Fit)||12||
59629249|NCT01163760|75742750|FG000|COMPLETED|Period 3 (Fit)||12||
59629250|NCT01163760|75742751|FG001|COMPLETED|Period 3 (Fit)||13||
59629251|NCT01163760|75742752|FG002|COMPLETED|Period 3 (Fit)||13||
59629252|NCT01163760|75742753|FG003|COMPLETED|Period 3 (Fit)||12||
59629253|NCT01163760|75742750|FG000|NOT COMPLETED|Period 3 (Fit)||0||
59629254|NCT01163760|75742751|FG001|NOT COMPLETED|Period 3 (Fit)||0||
59629255|NCT01163760|75742752|FG002|NOT COMPLETED|Period 3 (Fit)||0||
59629256|NCT01163760|75742753|FG003|NOT COMPLETED|Period 3 (Fit)||0||
59629257|NCT01163760|75742750|FG000|STARTED|Period 4 (Follow-up)||12||
59629258|NCT01163760|75742751|FG001|STARTED|Period 4 (Follow-up)||13||
59629259|NCT01163760|75742752|FG002|STARTED|Period 4 (Follow-up)||13||
59629260|NCT01163760|75742753|FG003|STARTED|Period 4 (Follow-up)||12||
59629261|NCT01163760|75742750|FG000|COMPLETED|Period 4 (Follow-up)||12||
59629262|NCT01163760|75742751|FG001|COMPLETED|Period 4 (Follow-up)||13||
59629263|NCT01163760|75742752|FG002|COMPLETED|Period 4 (Follow-up)||13||
59629264|NCT01163760|75742753|FG003|COMPLETED|Period 4 (Follow-up)||12||
59629265|NCT01163760|75742750|FG000|NOT COMPLETED|Period 4 (Follow-up)||0||
59629266|NCT01163760|75742751|FG001|NOT COMPLETED|Period 4 (Follow-up)||0||
59629267|NCT01163760|75742752|FG002|NOT COMPLETED|Period 4 (Follow-up)||0||
59629268|NCT01163760|75742753|FG003|NOT COMPLETED|Period 4 (Follow-up)||0||
59629269|NCT01167504|75742761|FG000|STARTED|Overall Study||15||
59629270|NCT01167504|75742761|FG000|COMPLETED|Overall Study||12||
59629271|NCT01167504|75742761|FG000|NOT COMPLETED|Overall Study||3||
59988253|NCT02271880|76103377|FG001|STARTED|Overall Study||4||
59629272|NCT01168674|75742765|FG000|STARTED|Overall Study||25||
59629273|NCT01168674|75742766|FG001|STARTED|Overall Study||24||
59629274|NCT01168674|75742765|FG000|COMPLETED|Overall Study||25||
59629275|NCT01168674|75742766|FG001|COMPLETED|Overall Study||24||
59629276|NCT01168674|75742765|FG000|NOT COMPLETED|Overall Study||0||
59629277|NCT01168674|75742766|FG001|NOT COMPLETED|Overall Study||0||
59629278|NCT01168908|75742775|FG000|STARTED|Double Blind, Placebo Controlled||10||
59629279|NCT01168908|75742776|FG001|STARTED|Double Blind, Placebo Controlled||10||
59629280|NCT01168908|75742775|FG000|COMPLETED|Double Blind, Placebo Controlled||7||
59629281|NCT01168908|75742776|FG001|COMPLETED|Double Blind, Placebo Controlled||8||
59629282|NCT01168908|75742775|FG000|NOT COMPLETED|Double Blind, Placebo Controlled||3||
59629283|NCT01168908|75742776|FG001|NOT COMPLETED|Double Blind, Placebo Controlled||2||
59629284|NCT01168908|75742775|FG000|STARTED|Open Label||7||
59629285|NCT01168908|75742776|FG001|STARTED|Open Label||8||
59629286|NCT01168908|75742775|FG000|COMPLETED|Open Label||6||
59629287|NCT01168908|75742776|FG001|COMPLETED|Open Label||7||
59629288|NCT01168908|75742775|FG000|NOT COMPLETED|Open Label||1||
59629289|NCT01168908|75742776|FG001|NOT COMPLETED|Open Label||1||
59629290|NCT01168986|75742785|FG000|STARTED|Overall Study||20||
59629291|NCT01168986|75742786|FG001|STARTED|Overall Study||21||
59629292|NCT01168986|75742787|FG002|STARTED|Overall Study||21||
59629293|NCT01168986|75742785|FG000|COMPLETED|Overall Study||18||
59629294|NCT01168986|75742786|FG001|COMPLETED|Overall Study||20||
59629295|NCT01168986|75742787|FG002|COMPLETED|Overall Study||21||
59629296|NCT01168986|75742785|FG000|NOT COMPLETED|Overall Study||2||
59629297|NCT01168986|75742786|FG001|NOT COMPLETED|Overall Study||1||
59629298|NCT01168986|75742787|FG002|NOT COMPLETED|Overall Study||0||
59629299|NCT01169064|75742797|FG000|STARTED|Overall Study||239||
59629300|NCT01169064|75742798|FG001|STARTED|Overall Study||236||
59629301|NCT01169064|75742797|FG000|COMPLETED|Overall Study||239||
59629302|NCT01169064|75742798|FG001|COMPLETED|Overall Study||236||
59629303|NCT01169064|75742797|FG000|NOT COMPLETED|Overall Study||0||
59629304|NCT01169064|75742798|FG001|NOT COMPLETED|Overall Study||0||
59629305|NCT01170390|75742808|FG000|STARTED|Oral Contraceptives||32||
59629306|NCT01170390|75742809|FG001|STARTED|Oral Contraceptives||0||
59629307|NCT01170390|75742810|FG002|STARTED|Oral Contraceptives||0||
59629308|NCT01170390|75742808|FG000|COMPLETED|Oral Contraceptives||31||
59629309|NCT01170390|75742809|FG001|COMPLETED|Oral Contraceptives||0||
59629310|NCT01170390|75742810|FG002|COMPLETED|Oral Contraceptives||0||
59629311|NCT01170390|75742808|FG000|NOT COMPLETED|Oral Contraceptives||1||
59629312|NCT01170390|75742809|FG001|NOT COMPLETED|Oral Contraceptives||0||
59629313|NCT01170390|75742810|FG002|NOT COMPLETED|Oral Contraceptives||0||
59629314|NCT01170390|75742808|FG000|STARTED|Randomized Treatment||0||
59629315|NCT01170390|75742809|FG001|STARTED|Randomized Treatment||17||
59629316|NCT01170390|75742810|FG002|STARTED|Randomized Treatment||15||
59629317|NCT01170390|75742808|FG000|COMPLETED|Randomized Treatment||0||
59629318|NCT01170390|75742809|FG001|COMPLETED|Randomized Treatment||16||
59629319|NCT01170390|75742810|FG002|COMPLETED|Randomized Treatment||15||
60076318|NCT01904773|76191370|FG006|NOT COMPLETED|Placebo Washout Fourth Intervention||0||
60076319|NCT01904773|76191371|FG007|NOT COMPLETED|Placebo Washout Fourth Intervention||0||
59629320|NCT01170390|75742808|FG000|NOT COMPLETED|Randomized Treatment||0||
59629321|NCT01170390|75742809|FG001|NOT COMPLETED|Randomized Treatment||1||
59629322|NCT01170390|75742810|FG002|NOT COMPLETED|Randomized Treatment||0||
59629323|NCT01170546|75742822|FG000|STARTED|Overall Study||7||
59629324|NCT01170546|75742823|FG001|STARTED|Overall Study||7||
59629325|NCT01170546|75742824|FG002|STARTED|Overall Study||6||
59629326|NCT01170546|75742825|FG003|STARTED|Overall Study||8||
59629327|NCT01170546|75742822|FG000|COMPLETED|Overall Study||7||
59629328|NCT01170546|75742823|FG001|COMPLETED|Overall Study||7||
59629329|NCT01170546|75742824|FG002|COMPLETED|Overall Study||6||
59629330|NCT01170546|75742825|FG003|COMPLETED|Overall Study||8||
59629331|NCT01170546|75742822|FG000|NOT COMPLETED|Overall Study||0||
59629332|NCT01170546|75742823|FG001|NOT COMPLETED|Overall Study||0||
59629333|NCT01170546|75742824|FG002|NOT COMPLETED|Overall Study||0||
59629334|NCT01170546|75742825|FG003|NOT COMPLETED|Overall Study||0||
59629335|NCT01134510|75742837|FG000|STARTED|Overall Study|Transplant Day; Infusion #1 C1 esterase inhibitor vs Placebo|10||
59629336|NCT01134510|75742838|FG001|STARTED|Overall Study|Transplant Day; Infusion #1 C1 esterase inhibitor vs Placebo|10||
59629337|NCT01134510|75742837|FG000|Day 2|Overall Study|Infusion #2 C1 esterase inhibitor vs Placebo|10||
59629338|NCT01134510|75742838|FG001|Day 2|Overall Study|Infusion #2 C1 esterase inhibitor vs Placebo|10||
59629339|NCT01134510|75742837|FG000|Week 2|Overall Study|Infusion #3 C1 esterase inhibitor vs Placebo|10||
60076320|NCT01904773|76191372|FG008|NOT COMPLETED|Placebo Washout Fourth Intervention||0||
60076321|NCT01904773|76191364|FG000|STARTED|Fifth Intervention||0||
60076322|NCT01904773|76191365|FG001|STARTED|Fifth Intervention||1||
60076323|NCT01904773|76191366|FG002|STARTED|Fifth Intervention||1||
60076324|NCT01904773|76191367|FG003|STARTED|Fifth Intervention||2||
60076325|NCT01904773|76191368|FG004|STARTED|Fifth Intervention||3||
60076326|NCT01904773|76191369|FG005|STARTED|Fifth Intervention||4||
60076327|NCT01904773|76191370|FG006|STARTED|Fifth Intervention||3||
59629340|NCT01134510|75742838|FG001|Week 2|Overall Study|Infusion #3 C1 esterase inhibitor vs Placebo|10||
59629341|NCT01134510|75742837|FG000|Week 2|Overall Study|Infusion #4 C1 esterase inhibitor vs Placebo|10||
59629342|NCT01134510|75742838|FG001|Week 2|Overall Study|Infusion #4 C1 esterase inhibitor vs Placebo|10||
59629343|NCT01134510|75742837|FG000|Week 3|Overall Study|Infusion #5 C1 esterase inhibitor vs Placebo|10||
59629344|NCT01134510|75742838|FG001|Week 3|Overall Study|Infusion #5 C1 esterase inhibitor vs Placebo|10||
59629345|NCT01134510|75742837|FG000|Week 3|Overall Study|Infusion #6 C1 esterase inhibitor vs Placebo|10||
59629346|NCT01134510|75742838|FG001|Week 3|Overall Study|Infusion #6 C1 esterase inhibitor vs Placebo|10||
59629347|NCT01134510|75742837|FG000|Week 4|Overall Study|Infusion #7 C1 esterase inhibitor vs Placebo|10||
59629348|NCT01134510|75742838|FG001|Week 4|Overall Study|Infusion #7 C1 esterase inhibitor vs Placebo|10||
59629349|NCT01134510|75742837|FG000|Week 4|Overall Study|Infusion #8 C1 esterase inhibitor vs Placebo|10||
59629350|NCT01134510|75742838|FG001|Week 4|Overall Study|Infusion #8 C1 esterase inhibitor vs Placebo|10||
59629351|NCT01134510|75742837|FG000|Month 1|Overall Study||10||
59629352|NCT01134510|75742838|FG001|Month 1|Overall Study||10||
59629353|NCT01134510|75742837|FG000|Month 3|Overall Study||10||
60076328|NCT01904773|76191371|FG007|STARTED|Fifth Intervention||3||
59629354|NCT01134510|75742838|FG001|Month 3|Overall Study||9||
59629355|NCT01134510|75742837|FG000|COMPLETED|Overall Study||10||
59629356|NCT01134510|75742838|FG001|COMPLETED|Overall Study||9||
59629357|NCT01134510|75742837|FG000|NOT COMPLETED|Overall Study||0||
60076329|NCT01904773|76191372|FG008|STARTED|Fifth Intervention||4||
59629358|NCT01134510|75742838|FG001|NOT COMPLETED|Overall Study||1||
59629359|NCT01171794|75742849|FG000|STARTED|Overall Study||47||
59629360|NCT01171794|75742850|FG001|STARTED|Overall Study||42||
59629361|NCT01171794|75742849|FG000|COMPLETED|Overall Study||44||
59629362|NCT01171794|75742850|FG001|COMPLETED|Overall Study||42||
59629363|NCT01171794|75742849|FG000|NOT COMPLETED|Overall Study||3||
59629364|NCT01171794|75742850|FG001|NOT COMPLETED|Overall Study||0||
59629365|NCT01172184|75742856|FG000|STARTED|Overall Study||111||
59629366|NCT01172184|75742856|FG000|COMPLETED|Overall Study||111||
59629367|NCT01172184|75742856|FG000|NOT COMPLETED|Overall Study||0||
59629368|NCT01175148|75742862|FG000|STARTED|Overall Study||30||
59629369|NCT01175148|75742863|FG001|STARTED|Overall Study||30||
59629370|NCT01175148|75742862|FG000|COMPLETED|Overall Study||30||
59629371|NCT01175148|75742863|FG001|COMPLETED|Overall Study||30||
59629372|NCT01175148|75742862|FG000|NOT COMPLETED|Overall Study||0||
59629373|NCT01175148|75742863|FG001|NOT COMPLETED|Overall Study||0||
59629374|NCT01175226|75742870|FG000|STARTED|Overall Study||155||
59629375|NCT01175226|75742871|FG001|STARTED|Overall Study||145||
59629376|NCT01175226|75742870|FG000|COMPLETED|Overall Study||144||
59629377|NCT01175226|75742871|FG001|COMPLETED|Overall Study||140||
59629378|NCT01175226|75742870|FG000|NOT COMPLETED|Overall Study||11||
59629379|NCT01175226|75742871|FG001|NOT COMPLETED|Overall Study||5||
59629380|NCT01175850|75742879|FG000|STARTED|IN.PACT SFA I Phase||99||
59629381|NCT01175850|75742880|FG001|STARTED|IN.PACT SFA I Phase||51||
59629382|NCT01175850|75742879|FG000|COMPLETED|IN.PACT SFA I Phase||88||
59629383|NCT01175850|75742880|FG001|COMPLETED|IN.PACT SFA I Phase||49||
59629384|NCT01175850|75742879|FG000|NOT COMPLETED|IN.PACT SFA I Phase||11||
59629385|NCT01175850|75742880|FG001|NOT COMPLETED|IN.PACT SFA I Phase||2||
59629386|NCT01175850|75742879|FG000|STARTED|IN.PACT SFA II Phase||121||
59629387|NCT01175850|75742880|FG001|STARTED|IN.PACT SFA II Phase||60||
59629388|NCT01175850|75742879|FG000|COMPLETED|IN.PACT SFA II Phase||109||
59629389|NCT01175850|75742880|FG001|COMPLETED|IN.PACT SFA II Phase||55||
59629390|NCT01175850|75742879|FG000|NOT COMPLETED|IN.PACT SFA II Phase||12||
59629391|NCT01175850|75742880|FG001|NOT COMPLETED|IN.PACT SFA II Phase||5||
59629392|NCT01177098|75742889|FG000|STARTED|Overall Study||278||
59629393|NCT01177098|75742890|FG001|STARTED|Overall Study||283||
59629394|NCT01177098|75742889|FG000|COMPLETED|Overall Study||269||
59629395|NCT01177098|75742890|FG001|COMPLETED|Overall Study||271||
59629396|NCT01177098|75742889|FG000|NOT COMPLETED|Overall Study||9||
59629397|NCT01177098|75742890|FG001|NOT COMPLETED|Overall Study||12||
59629398|NCT01177956|75742896|FG000|STARTED|Overall Study||68||
59629399|NCT01177956|75742896|FG000|COMPLETED|Overall Study||68||
59629400|NCT01177956|75742896|FG000|NOT COMPLETED|Overall Study||0||
59629401|NCT01178268|75742903|FG000|STARTED|Overall Study||367||
59629402|NCT01178268|75742904|FG001|STARTED|Overall Study||121||
59629403|NCT01178268|75742903|FG000|COMPLETED|Overall Study||360||
59629404|NCT01178268|75742904|FG001|COMPLETED|Overall Study||120||
59629405|NCT01178268|75742903|FG000|NOT COMPLETED|Overall Study||7||
59629406|NCT01178268|75742904|FG001|NOT COMPLETED|Overall Study||1||
59629407|NCT01179984|75742910|FG000|STARTED|Overall Study||76||
59629408|NCT01179984|75742910|FG000|COMPLETED|Overall Study||58||
59629409|NCT01179984|75742910|FG000|NOT COMPLETED|Overall Study||18||
59629410|NCT01181076|75742917|FG000|STARTED|Overall Study||59||
59629411|NCT01181076|75742918|FG001|STARTED|Overall Study||60||
59629412|NCT01181076|75742917|FG000|COMPLETED|Overall Study||40||
59629413|NCT01181076|75742918|FG001|COMPLETED|Overall Study|As determined|48||
59629414|NCT01181076|75742917|FG000|NOT COMPLETED|Overall Study||19||
59629415|NCT01181076|75742918|FG001|NOT COMPLETED|Overall Study||12||
59629416|NCT01182480|75742924|FG000|STARTED|Overall Study||47||
59629417|NCT01182480|75742924|FG000|COMPLETED|Overall Study||47||
59629418|NCT01182480|75742924|FG000|NOT COMPLETED|Overall Study||0||
59629419|NCT01183650|75742930|FG000|STARTED|Overall Study||12||
59629420|NCT01183650|75742931|FG001|STARTED|Overall Study||12||
59629421|NCT01183650|75742930|FG000|COMPLETED|Overall Study||12||
59629422|NCT01183650|75742931|FG001|COMPLETED|Overall Study||12||
59629423|NCT01183650|75742930|FG000|NOT COMPLETED|Overall Study||0||
59629424|NCT01183650|75742931|FG001|NOT COMPLETED|Overall Study||0||
59629425|NCT01183728|75742937|FG000|STARTED|Overall Study||12||
59629426|NCT01183728|75742937|FG000|COMPLETED|Overall Study||12||
59629427|NCT01183728|75742937|FG000|NOT COMPLETED|Overall Study||0||
59629428|NCT01184898|75742941|FG000|STARTED|Overall Study||36||
59629429|NCT01184898|75742941|FG000|COMPLETED|Overall Study||36||
59629430|NCT01184898|75742941|FG000|NOT COMPLETED|Overall Study||0||
59629431|NCT01187004|75742947|FG000|STARTED|Overall Study||20||
59629432|NCT01187004|75742948|FG001|STARTED|Overall Study||144||
59629433|NCT01187004|75742947|FG000|COMPLETED|Overall Study||20||
59629434|NCT01187004|75742948|FG001|COMPLETED|Overall Study||144||
59629435|NCT01187004|75742947|FG000|NOT COMPLETED|Overall Study||0||
59629436|NCT01187004|75742948|FG001|NOT COMPLETED|Overall Study||0||
59629437|NCT01188876|75742955|FG000|STARTED|Overall Study||50||
59629438|NCT01188876|75742955|FG000|COMPLETED|Overall Study||50||
59629439|NCT01188876|75742955|FG000|NOT COMPLETED|Overall Study||0||
59629440|NCT01189110|75742961|FG000|STARTED|Overall Study|September, 2010|64||
59629441|NCT01189110|75742962|FG001|STARTED|Overall Study||61||
59815667|NCT03615469|75938127|FG001|STARTED|Overall Study||8||
59629442|NCT01189110|75742961|FG000|COMPLETED|Overall Study|February, 2011|64||
59629443|NCT01189110|75742962|FG001|COMPLETED|Overall Study||61||
59629444|NCT01189110|75742961|FG000|NOT COMPLETED|Overall Study||0||
59629445|NCT01189110|75742962|FG001|NOT COMPLETED|Overall Study||0||
59629446|NCT01192542|75742968|FG000|STARTED|Period 1||18||
59629447|NCT01192542|75742969|FG001|STARTED|Period 1||20||
59629448|NCT01192542|75742968|FG000|COMPLETED|Period 1||18||
59629449|NCT01192542|75742969|FG001|COMPLETED|Period 1||20||
59629450|NCT01192542|75742968|FG000|NOT COMPLETED|Period 1||0||
59629451|NCT01192542|75742969|FG001|NOT COMPLETED|Period 1||0||
59629452|NCT01192542|75742968|FG000|STARTED|Period 2||18||
59629453|NCT01192542|75742969|FG001|STARTED|Period 2||20||
59629454|NCT01192542|75742968|FG000|COMPLETED|Period 2||18||
59629455|NCT01192542|75742969|FG001|COMPLETED|Period 2||20||
59629456|NCT01192542|75742968|FG000|NOT COMPLETED|Period 2||0||
59629457|NCT01192542|75742969|FG001|NOT COMPLETED|Period 2||0||
59629458|NCT01193010|75742979|FG000|STARTED|Overall Study||20||
59629459|NCT01193010|75742980|FG001|STARTED|Overall Study||20||
59629460|NCT01193010|75742979|FG000|COMPLETED|Overall Study||17||
59629461|NCT01193010|75742980|FG001|COMPLETED|Overall Study||20||
59629462|NCT01193010|75742979|FG000|NOT COMPLETED|Overall Study||3||
59629463|NCT01193010|75742980|FG001|NOT COMPLETED|Overall Study||0||
59629464|NCT01193868|75742986|FG000|STARTED|Overall Study||6||
59629465|NCT01193868|75742986|FG000|COMPLETED|Overall Study||6||
59629466|NCT01193868|75742986|FG000|NOT COMPLETED|Overall Study||0||
59629467|NCT01195116|75742992|FG000|STARTED|Overall Study||21||
59629468|NCT01195116|75742993|FG001|STARTED|Overall Study||20||
59629469|NCT01195116|75742992|FG000|COMPLETED|Overall Study||21||
59629470|NCT01195116|75742993|FG001|COMPLETED|Overall Study||20||
59629471|NCT01195116|75742992|FG000|NOT COMPLETED|Overall Study||0||
59629472|NCT01195116|75742993|FG001|NOT COMPLETED|Overall Study||0||
59629473|NCT01195584|75743002|FG000|STARTED|Overall Study||20||
59629474|NCT01195584|75743003|FG001|STARTED|Overall Study||25||
59629475|NCT01195584|75743004|FG002|STARTED|Overall Study||27||
59629476|NCT01195584|75743002|FG000|COMPLETED|Overall Study||20||
59629477|NCT01195584|75743003|FG001|COMPLETED|Overall Study||25||
59629478|NCT01195584|75743004|FG002|COMPLETED|Overall Study||27||
59629479|NCT01195584|75743002|FG000|NOT COMPLETED|Overall Study||0||
59629480|NCT01195584|75743003|FG001|NOT COMPLETED|Overall Study||0||
59629481|NCT01195584|75743004|FG002|NOT COMPLETED|Overall Study||0||
59629482|NCT01196442|75743014|FG000|STARTED|Overall Study||39||
59629483|NCT01196442|75743014|FG000|COMPLETED|Overall Study||39||
59629484|NCT01196442|75743014|FG000|NOT COMPLETED|Overall Study||0||
59629485|NCT01197456|75743021|FG000|STARTED|Overall Study||171||
59629486|NCT01197456|75743022|FG001|STARTED|Overall Study||61||
59629487|NCT01197456|75743021|FG000|COMPLETED|Overall Study||171||
59629488|NCT01197456|75743022|FG001|COMPLETED|Overall Study||61||
59629489|NCT01197456|75743021|FG000|NOT COMPLETED|Overall Study||0||
59629490|NCT01197456|75743022|FG001|NOT COMPLETED|Overall Study||0||
59629491|NCT01197612|75743028|FG000|STARTED|Overall Study||18||
59629492|NCT01197612|75743028|FG000|Week 3|Overall Study||16||
59629493|NCT01197612|75743028|FG000|Returned for Week 24|Overall Study||6||
59629494|NCT01197612|75743028|FG000|COMPLETED|Overall Study||6||
59629495|NCT01197612|75743028|FG000|NOT COMPLETED|Overall Study||12||
59629496|NCT01198158|75743037|FG000|STARTED|Overall Study||41||
59629497|NCT01198158|75743038|FG001|STARTED|Overall Study||36||
59629498|NCT01198158|75743037|FG000|COMPLETED|Overall Study||41||
59629499|NCT01198158|75743038|FG001|COMPLETED|Overall Study||36||
59629500|NCT01198158|75743037|FG000|NOT COMPLETED|Overall Study||0||
59629501|NCT01198158|75743038|FG001|NOT COMPLETED|Overall Study||0||
59629502|NCT01199952|75743046|FG000|STARTED|Overall Study||103||
59629503|NCT01199952|75743047|FG001|STARTED|Overall Study||104||
59629504|NCT01199952|75743046|FG000|COMPLETED|Overall Study||51||
59629505|NCT01199952|75743047|FG001|COMPLETED|Overall Study||59||
59629506|NCT01199952|75743046|FG000|NOT COMPLETED|Overall Study||52||
59629507|NCT01199952|75743047|FG001|NOT COMPLETED|Overall Study||45||
59629508|NCT01200030|75743057|FG000|STARTED|Overall Study||12||
59629509|NCT01200030|75743058|FG001|STARTED|Overall Study||13||
59629510|NCT01200030|75743059|FG002|STARTED|Overall Study||12||
59629511|NCT01200030|75743057|FG000|COMPLETED|Overall Study||12||
59629512|NCT01200030|75743058|FG001|COMPLETED|Overall Study||13||
59629513|NCT01200030|75743059|FG002|COMPLETED|Overall Study||12||
59629514|NCT01200030|75743057|FG000|NOT COMPLETED|Overall Study||0||
59629515|NCT01200030|75743058|FG001|NOT COMPLETED|Overall Study||0||
59629516|NCT01200030|75743059|FG002|NOT COMPLETED|Overall Study||0||
59629517|NCT01200498|75743067|FG000|STARTED|Overall Study||22||
59629518|NCT01200498|75743067|FG000|COMPLETED|Overall Study||22||
59629519|NCT01200498|75743067|FG000|NOT COMPLETED|Overall Study||0||
59629520|NCT01203774|75743071|FG000|STARTED|Overall Study||21||
59629521|NCT01203774|75743072|FG001|STARTED|Overall Study||10||
59629522|NCT01203774|75743071|FG000|COMPLETED|Overall Study||21||
59629523|NCT01203774|75743072|FG001|COMPLETED|Overall Study||10||
59629524|NCT01203774|75743071|FG000|NOT COMPLETED|Overall Study||0||
59629525|NCT01203774|75743072|FG001|NOT COMPLETED|Overall Study||0||
59629526|NCT01205568|75743078|FG000|STARTED|Overall Study|26 patients received only CB therapy, 39 patients received both CB and HPB therapy.|65||107
59629527|NCT01205568|75743079|FG001|STARTED|Overall Study|8 patients received only HPB therapy, 39 patients received both CB and HPB therapy.|47||66
59629528|NCT01205568|75743078|FG000|COMPLETED|Overall Study||65||106
59629529|NCT01205568|75743079|FG001|COMPLETED|Overall Study||47||65
59629530|NCT01205568|75743078|FG000|NOT COMPLETED|Overall Study||0||1
59629531|NCT01205568|75743079|FG001|NOT COMPLETED|Overall Study||0||1
59629532|NCT01205646|75743083|FG000|STARTED|Overall Study||11||
59629533|NCT01205646|75743083|FG000|COMPLETED|Overall Study||11||
59629534|NCT01205646|75743083|FG000|NOT COMPLETED|Overall Study||0||
59629535|NCT01206660|75743089|FG000|STARTED|Overall Study||60||
59629536|NCT01206660|75743090|FG001|STARTED|Overall Study||60||
59629537|NCT01206660|75743089|FG000|COMPLETED|Overall Study||60||
59629538|NCT01206660|75743090|FG001|COMPLETED|Overall Study||60||
59629539|NCT01206660|75743089|FG000|NOT COMPLETED|Overall Study||0||
59629540|NCT01206660|75743090|FG001|NOT COMPLETED|Overall Study||0||
59629541|NCT01206738|75743099|FG000|STARTED|Overall Study||63||
59629542|NCT01206738|75743100|FG001|STARTED|Overall Study||74||
59629543|NCT01206738|75743101|FG002|STARTED|Overall Study||61||
59629544|NCT01206738|75743099|FG000|COMPLETED|Overall Study||40||
59629545|NCT01206738|75743100|FG001|COMPLETED|Overall Study||49||
59629546|NCT01206738|75743101|FG002|COMPLETED|Overall Study||42||
59629547|NCT01206738|75743099|FG000|NOT COMPLETED|Overall Study||23||
59629548|NCT01206738|75743100|FG001|NOT COMPLETED|Overall Study||25||
59629549|NCT01206738|75743101|FG002|NOT COMPLETED|Overall Study||19||
59629550|NCT01207752|75743113|FG000|STARTED|Overall Study||35||
59629551|NCT01207752|75743114|FG001|STARTED|Overall Study||34||
59629552|NCT01207752|75743113|FG000|COMPLETED|Overall Study||33||
59629553|NCT01207752|75743114|FG001|COMPLETED|Overall Study||27||
59629554|NCT01207752|75743113|FG000|NOT COMPLETED|Overall Study||2||
59629555|NCT01207752|75743114|FG001|NOT COMPLETED|Overall Study||7||
59629556|NCT01207908|75743122|FG000|STARTED|Overall Study||22||
59629557|NCT01207908|75743123|FG001|STARTED|Overall Study||22||
59629558|NCT01207908|75743122|FG000|COMPLETED|Overall Study||17||
59629559|NCT01207908|75743123|FG001|COMPLETED|Overall Study||21||
59629560|NCT01207908|75743122|FG000|NOT COMPLETED|Overall Study||5||
59629561|NCT01207908|75743123|FG001|NOT COMPLETED|Overall Study||1||
59629562|NCT01208220|75743131|FG000|STARTED|Overall Study||1||
59629563|NCT01208220|75743132|FG001|STARTED|Overall Study||1||
59629564|NCT01208220|75743131|FG000|COMPLETED|Overall Study||1||
59629565|NCT01208220|75743132|FG001|COMPLETED|Overall Study||1||
59629566|NCT01208220|75743131|FG000|NOT COMPLETED|Overall Study||0||
59629567|NCT01208220|75743132|FG001|NOT COMPLETED|Overall Study||0||
59629568|NCT01208922|75743140|FG000|STARTED|Overall Study||420||
59629569|NCT01208922|75743141|FG001|STARTED|Overall Study||415||
59629570|NCT01208922|75743140|FG000|COMPLETED|Overall Study||409||
59629571|NCT01208922|75743141|FG001|COMPLETED|Overall Study||405||
59629572|NCT01208922|75743140|FG000|NOT COMPLETED|Overall Study||11||
59629573|NCT01208922|75743141|FG001|NOT COMPLETED|Overall Study||10||
59629574|NCT01209702|75743149|FG000|STARTED|Overall Study||51||
59629575|NCT01209702|75743150|FG001|STARTED|Overall Study||51||
59629576|NCT01209702|75743151|FG002|STARTED|Overall Study||51||
59629577|NCT01209702|75743152|FG003|STARTED|Overall Study||153||
59629578|NCT01209702|75743149|FG000|Treated|Overall Study||51||
59629579|NCT01209702|75743150|FG001|Treated|Overall Study||51||
59629580|NCT01209702|75743151|FG002|Treated|Overall Study||51||
59629581|NCT01209702|75743152|FG003|Treated|Overall Study||152||
59629582|NCT01209702|75743149|FG000|Escape or Switched to Tocilizumab|Overall Study||51||
59629583|NCT01209702|75743150|FG001|Escape or Switched to Tocilizumab|Overall Study||0||
59629584|NCT01209702|75743151|FG002|Escape or Switched to Tocilizumab|Overall Study||6||
59629585|NCT01209702|75743152|FG003|Escape or Switched to Tocilizumab|Overall Study||0||
59629586|NCT01209702|75743149|FG000|Completed 12 Weeks Treatment|Overall Study||50||
59629587|NCT01209702|75743150|FG001|Completed 12 Weeks Treatment|Overall Study||48||
59815668|NCT03615469|75938126|FG000|COMPLETED|Overall Study||4||
59629588|NCT01209702|75743151|FG002|Completed 12 Weeks Treatment|Overall Study||12||
59629589|NCT01209702|75743152|FG003|Completed 12 Weeks Treatment|Overall Study||59||
59629590|NCT01209702|75743149|FG000|Completed 24 Weeks Treatment|Overall Study||19||
59629591|NCT01209702|75743150|FG001|Completed 24 Weeks Treatment|Overall Study||28||
59815669|NCT03615469|75938127|FG001|COMPLETED|Overall Study||7||
59629592|NCT01209702|75743151|FG002|Completed 24 Weeks Treatment|Overall Study||3||
59629593|NCT01209702|75743152|FG003|Completed 24 Weeks Treatment|Overall Study||10||
59629594|NCT01209702|75743149|FG000|COMPLETED|Overall Study||0||
59629595|NCT01209702|75743150|FG001|COMPLETED|Overall Study||0||
59629596|NCT01209702|75743151|FG002|COMPLETED|Overall Study||0||
59629597|NCT01209702|75743152|FG003|COMPLETED|Overall Study||0||
59629598|NCT01209702|75743149|FG000|NOT COMPLETED|Overall Study||51||
59629599|NCT01209702|75743150|FG001|NOT COMPLETED|Overall Study||51||
59629600|NCT01209702|75743151|FG002|NOT COMPLETED|Overall Study||51||
59629601|NCT01209702|75743152|FG003|NOT COMPLETED|Overall Study||153||
59629602|NCT01210170|75743171|FG000|STARTED|Overall Study||22||
59629603|NCT01210170|75743171|FG000|COMPLETED|Overall Study||15||
59629604|NCT01210170|75743171|FG000|NOT COMPLETED|Overall Study||7||
59629605|NCT01210560|75743194|FG000|STARTED|Intervention 1 (7 Days)||2||
59629606|NCT01210560|75743195|FG001|STARTED|Intervention 1 (7 Days)||2||
59629607|NCT01210560|75743196|FG002|STARTED|Intervention 1 (7 Days)||2||
59629608|NCT01210560|75743197|FG003|STARTED|Intervention 1 (7 Days)||2||
59629609|NCT01210560|75743198|FG004|STARTED|Intervention 1 (7 Days)||2||
59629610|NCT01210560|75743199|FG005|STARTED|Intervention 1 (7 Days)||2||
59629611|NCT01210560|75743200|FG006|STARTED|Intervention 1 (7 Days)||4||
59629612|NCT01210560|75743201|FG007|STARTED|Intervention 1 (7 Days)||4||
59629613|NCT01210560|75743202|FG008|STARTED|Intervention 1 (7 Days)||5||
59629614|NCT01210560|75743194|FG000|COMPLETED|Intervention 1 (7 Days)||2||
59629615|NCT01210560|75743195|FG001|COMPLETED|Intervention 1 (7 Days)||2||
59629616|NCT01210560|75743196|FG002|COMPLETED|Intervention 1 (7 Days)||2||
59629617|NCT01210560|75743197|FG003|COMPLETED|Intervention 1 (7 Days)||2||
59629618|NCT01210560|75743198|FG004|COMPLETED|Intervention 1 (7 Days)||2||
59629619|NCT01210560|75743199|FG005|COMPLETED|Intervention 1 (7 Days)||2||
59629620|NCT01210560|75743200|FG006|COMPLETED|Intervention 1 (7 Days)||4||
59629621|NCT01210560|75743201|FG007|COMPLETED|Intervention 1 (7 Days)||4||
59629622|NCT01210560|75743202|FG008|COMPLETED|Intervention 1 (7 Days)||5||
59629623|NCT01210560|75743194|FG000|NOT COMPLETED|Intervention 1 (7 Days)||0||
59629624|NCT01210560|75743195|FG001|NOT COMPLETED|Intervention 1 (7 Days)||0||
59629625|NCT01210560|75743196|FG002|NOT COMPLETED|Intervention 1 (7 Days)||0||
59629626|NCT01210560|75743197|FG003|NOT COMPLETED|Intervention 1 (7 Days)||0||
59629627|NCT01210560|75743198|FG004|NOT COMPLETED|Intervention 1 (7 Days)||0||
59629628|NCT01210560|75743199|FG005|NOT COMPLETED|Intervention 1 (7 Days)||0||
59629629|NCT01210560|75743200|FG006|NOT COMPLETED|Intervention 1 (7 Days)||0||
59629630|NCT01210560|75743201|FG007|NOT COMPLETED|Intervention 1 (7 Days)||0||
59629631|NCT01210560|75743202|FG008|NOT COMPLETED|Intervention 1 (7 Days)||0||
59629632|NCT01210560|75743194|FG000|STARTED|Intervention 2 (7 Days)||2||
59629633|NCT01210560|75743195|FG001|STARTED|Intervention 2 (7 Days)||2||
59629634|NCT01210560|75743196|FG002|STARTED|Intervention 2 (7 Days)||2||
59629635|NCT01210560|75743197|FG003|STARTED|Intervention 2 (7 Days)||2||
59629636|NCT01210560|75743198|FG004|STARTED|Intervention 2 (7 Days)||2||
59629637|NCT01210560|75743199|FG005|STARTED|Intervention 2 (7 Days)||2||
59629638|NCT01210560|75743200|FG006|STARTED|Intervention 2 (7 Days)||4||
59629639|NCT01210560|75743201|FG007|STARTED|Intervention 2 (7 Days)||4||
59629640|NCT01210560|75743202|FG008|STARTED|Intervention 2 (7 Days)||5||
59629641|NCT01210560|75743194|FG000|COMPLETED|Intervention 2 (7 Days)||2||
59629642|NCT01210560|75743195|FG001|COMPLETED|Intervention 2 (7 Days)||2||
59629643|NCT01210560|75743196|FG002|COMPLETED|Intervention 2 (7 Days)||2||
59629644|NCT01210560|75743197|FG003|COMPLETED|Intervention 2 (7 Days)||2||
59629645|NCT01210560|75743198|FG004|COMPLETED|Intervention 2 (7 Days)||2||
59629646|NCT01210560|75743199|FG005|COMPLETED|Intervention 2 (7 Days)||2||
59629647|NCT01210560|75743200|FG006|COMPLETED|Intervention 2 (7 Days)||4||
59629648|NCT01210560|75743201|FG007|COMPLETED|Intervention 2 (7 Days)||4||
59629649|NCT01210560|75743202|FG008|COMPLETED|Intervention 2 (7 Days)||5||
59629650|NCT01210560|75743194|FG000|NOT COMPLETED|Intervention 2 (7 Days)||0||
59629651|NCT01210560|75743195|FG001|NOT COMPLETED|Intervention 2 (7 Days)||0||
59629652|NCT01210560|75743196|FG002|NOT COMPLETED|Intervention 2 (7 Days)||0||
59629653|NCT01210560|75743197|FG003|NOT COMPLETED|Intervention 2 (7 Days)||0||
59629654|NCT01210560|75743198|FG004|NOT COMPLETED|Intervention 2 (7 Days)||0||
59629655|NCT01210560|75743199|FG005|NOT COMPLETED|Intervention 2 (7 Days)||0||
59629656|NCT01210560|75743200|FG006|NOT COMPLETED|Intervention 2 (7 Days)||0||
59629657|NCT01210560|75743201|FG007|NOT COMPLETED|Intervention 2 (7 Days)||0||
59629658|NCT01210560|75743202|FG008|NOT COMPLETED|Intervention 2 (7 Days)||0||
59629659|NCT01210560|75743194|FG000|STARTED|Intervention 3 (7 Days)||2||
59629660|NCT01210560|75743195|FG001|STARTED|Intervention 3 (7 Days)||2||
59629661|NCT01210560|75743196|FG002|STARTED|Intervention 3 (7 Days)||2||
59629662|NCT01210560|75743197|FG003|STARTED|Intervention 3 (7 Days)||2||
59629663|NCT01210560|75743198|FG004|STARTED|Intervention 3 (7 Days)||2||
59629664|NCT01210560|75743199|FG005|STARTED|Intervention 3 (7 Days)||2||
59629665|NCT01210560|75743200|FG006|STARTED|Intervention 3 (7 Days)||4||
59629666|NCT01210560|75743201|FG007|STARTED|Intervention 3 (7 Days)||4||
59629667|NCT01210560|75743202|FG008|STARTED|Intervention 3 (7 Days)||5||
59629668|NCT01210560|75743194|FG000|COMPLETED|Intervention 3 (7 Days)||2||
59629669|NCT01210560|75743195|FG001|COMPLETED|Intervention 3 (7 Days)||2||
59629670|NCT01210560|75743196|FG002|COMPLETED|Intervention 3 (7 Days)||2||
59629671|NCT01210560|75743197|FG003|COMPLETED|Intervention 3 (7 Days)||2||
59629672|NCT01210560|75743198|FG004|COMPLETED|Intervention 3 (7 Days)||2||
59629673|NCT01210560|75743199|FG005|COMPLETED|Intervention 3 (7 Days)||2||
59629674|NCT01210560|75743200|FG006|COMPLETED|Intervention 3 (7 Days)||4||
59629675|NCT01210560|75743201|FG007|COMPLETED|Intervention 3 (7 Days)||4||
59629676|NCT01210560|75743202|FG008|COMPLETED|Intervention 3 (7 Days)||5||
59629677|NCT01210560|75743194|FG000|NOT COMPLETED|Intervention 3 (7 Days)||0||
59629678|NCT01210560|75743195|FG001|NOT COMPLETED|Intervention 3 (7 Days)||0||
59629679|NCT01210560|75743196|FG002|NOT COMPLETED|Intervention 3 (7 Days)||0||
59629680|NCT01210560|75743197|FG003|NOT COMPLETED|Intervention 3 (7 Days)||0||
59629681|NCT01210560|75743198|FG004|NOT COMPLETED|Intervention 3 (7 Days)||0||
59629682|NCT01210560|75743199|FG005|NOT COMPLETED|Intervention 3 (7 Days)||0||
59629683|NCT01210560|75743200|FG006|NOT COMPLETED|Intervention 3 (7 Days)||0||
59629684|NCT01210560|75743201|FG007|NOT COMPLETED|Intervention 3 (7 Days)||0||
59629685|NCT01210560|75743202|FG008|NOT COMPLETED|Intervention 3 (7 Days)||0||
59629686|NCT01210716|75743215|FG000|STARTED|First TPE Procedure||20||
59629687|NCT01210716|75743216|FG001|STARTED|First TPE Procedure||17||
59629688|NCT01210716|75743215|FG000|COMPLETED|First TPE Procedure||18||
59629689|NCT01210716|75743216|FG001|COMPLETED|First TPE Procedure||15||
59629690|NCT01210716|75743215|FG000|NOT COMPLETED|First TPE Procedure||2||
59629691|NCT01210716|75743216|FG001|NOT COMPLETED|First TPE Procedure||2||
59629692|NCT01210716|75743215|FG000|STARTED|Second TPE Procedure||18||
59629693|NCT01210716|75743216|FG001|STARTED|Second TPE Procedure||15||
59629694|NCT01210716|75743215|FG000|COMPLETED|Second TPE Procedure||15||
59629695|NCT01210716|75743216|FG001|COMPLETED|Second TPE Procedure||15||
59629696|NCT01210716|75743215|FG000|NOT COMPLETED|Second TPE Procedure||3||
59629697|NCT01210716|75743216|FG001|NOT COMPLETED|Second TPE Procedure||0||
59629698|NCT01211106|75743224|FG000|STARTED|Overall Study||95||
59629699|NCT01211106|75743225|FG001|STARTED|Overall Study||88||
59629700|NCT01211106|75743224|FG000|COMPLETED|Overall Study||82||
59629701|NCT01211106|75743225|FG001|COMPLETED|Overall Study||77||
59629702|NCT01211106|75743224|FG000|NOT COMPLETED|Overall Study||13||
59629703|NCT01211106|75743225|FG001|NOT COMPLETED|Overall Study||11||
59629704|NCT01211340|75743235|FG000|STARTED|Overall Study||223||
59629705|NCT01211340|75743236|FG001|STARTED|Overall Study||223||
59629706|NCT01211340|75743235|FG000|COMPLETED|Overall Study||223||
59629707|NCT01211340|75743236|FG001|COMPLETED|Overall Study||223||
59629708|NCT01211340|75743235|FG000|NOT COMPLETED|Overall Study||0||
59629709|NCT01211340|75743236|FG001|NOT COMPLETED|Overall Study||0||
59629710|NCT01211730|75743244|FG000|STARTED|Overall Study||82||
59629711|NCT01211730|75743245|FG001|STARTED|Overall Study||82||
59629712|NCT01211730|75743244|FG000|COMPLETED|Overall Study||82||
59629713|NCT01211730|75743245|FG001|COMPLETED|Overall Study||82||
59629714|NCT01211730|75743244|FG000|NOT COMPLETED|Overall Study||0||
59629715|NCT01211730|75743245|FG001|NOT COMPLETED|Overall Study||0||
59629716|NCT01212900|75743253|FG000|STARTED|Overall Study||116||
59629717|NCT01212900|75743254|FG001|STARTED|Overall Study||114||
59629718|NCT01212900|75743253|FG000|COMPLETED|Overall Study||104||
59629719|NCT01212900|75743254|FG001|COMPLETED|Overall Study||107||
59629720|NCT01212900|75743253|FG000|NOT COMPLETED|Overall Study||12||
59629721|NCT01212900|75743254|FG001|NOT COMPLETED|Overall Study||7||
59629722|NCT01215240|75743262|FG000|STARTED|Overall Study||10||
59629723|NCT01215240|75743263|FG001|STARTED|Overall Study||12||
59629724|NCT01215240|75743262|FG000|COMPLETED|Overall Study||10||
59629725|NCT01215240|75743263|FG001|COMPLETED|Overall Study||12||
59629726|NCT01215240|75743262|FG000|NOT COMPLETED|Overall Study||0||
59988254|NCT02271880|76103376|FG000|COMPLETED|Overall Study||0|This study was prematurely discontinued due to low enrollment.|
59988255|NCT02271880|76103377|FG001|COMPLETED|Overall Study||0|This study was prematurely discontinued due to low enrollment.|
59988256|NCT02271880|76103376|FG000|NOT COMPLETED|Overall Study||3||
59988257|NCT02271880|76103377|FG001|NOT COMPLETED|Overall Study||4||
59988258|NCT02367352|76103385|FG000|STARTED|Overall Study||9||
59988259|NCT02367352|76103386|FG001|STARTED|Overall Study||0||
59988260|NCT02367352|76103387|FG002|STARTED|Overall Study||0||
59988261|NCT02367352|76103385|FG000|COMPLETED|Overall Study||0||
59988262|NCT02367352|76103386|FG001|COMPLETED|Overall Study||0||
59988263|NCT02367352|76103387|FG002|COMPLETED|Overall Study||0||
59988264|NCT02367352|76103385|FG000|NOT COMPLETED|Overall Study||9||
59629727|NCT01215240|75743263|FG001|NOT COMPLETED|Overall Study||0||
59629728|NCT01215318|75743271|FG000|STARTED|Overall Study||20||
59629729|NCT01215318|75743272|FG001|STARTED|Overall Study||24||
59629730|NCT01215318|75743271|FG000|COMPLETED|Overall Study||20||
59629731|NCT01215318|75743272|FG001|COMPLETED|Overall Study||24||
59629732|NCT01215318|75743271|FG000|NOT COMPLETED|Overall Study||0||
59629733|NCT01215318|75743272|FG001|NOT COMPLETED|Overall Study||0||
59629734|NCT01215786|75743283|FG000|STARTED|Overall Study||21||
59629735|NCT01215786|75743284|FG001|STARTED|Overall Study||19||
59629736|NCT01215786|75743285|FG002|STARTED|Overall Study||10||
59629737|NCT01215786|75743283|FG000|COMPLETED|Overall Study||21||
59629738|NCT01215786|75743284|FG001|COMPLETED|Overall Study||19||
59629739|NCT01215786|75743285|FG002|COMPLETED|Overall Study||10||
59629740|NCT01215786|75743283|FG000|NOT COMPLETED|Overall Study||0||
59629741|NCT01215786|75743284|FG001|NOT COMPLETED|Overall Study||0||
59629742|NCT01215786|75743285|FG002|NOT COMPLETED|Overall Study||0||
59629743|NCT01216410|75743296|FG000|STARTED|Overall Study||103||
59629744|NCT01216410|75743297|FG001|STARTED|Overall Study||100||
59629745|NCT01216410|75743298|FG002|STARTED|Overall Study||103||
59629746|NCT01216410|75743296|FG000|COMPLETED|Overall Study||101||
59629747|NCT01216410|75743297|FG001|COMPLETED|Overall Study||99||
59629748|NCT01216410|75743298|FG002|COMPLETED|Overall Study||100||
59629749|NCT01216410|75743296|FG000|NOT COMPLETED|Overall Study||2||
59629750|NCT01216410|75743297|FG001|NOT COMPLETED|Overall Study||1||
59629751|NCT01216410|75743298|FG002|NOT COMPLETED|Overall Study||3||
59629752|NCT01218048|75743306|FG000|STARTED|Overall Study||40||
59629753|NCT01218048|75743306|FG000|COMPLETED|Overall Study||40||
59629754|NCT01218048|75743306|FG000|NOT COMPLETED|Overall Study||0||
59629755|NCT01218672|75743313|FG000|STARTED|Overall Study||139||
59629756|NCT01218672|75743314|FG001|STARTED|Overall Study||142||
59629757|NCT01218672|75743313|FG000|Treated|Overall Study||136||
59629758|NCT01218672|75743314|FG001|Treated|Overall Study||133||
59629759|NCT01218672|75743313|FG000|COMPLETED|Overall Study||128||
59629760|NCT01218672|75743314|FG001|COMPLETED|Overall Study||121||
59629761|NCT01218672|75743313|FG000|NOT COMPLETED|Overall Study||11||
59629762|NCT01218672|75743314|FG001|NOT COMPLETED|Overall Study||21||
59629763|NCT01218984|75743325|FG000|STARTED|Overall Study||9||
59629764|NCT01218984|75743326|FG001|STARTED|Overall Study||8||
59629765|NCT01218984|75743327|FG002|STARTED|Overall Study||10||
59629766|NCT01218984|75743325|FG000|COMPLETED|Overall Study||8||
59629767|NCT01218984|75743326|FG001|COMPLETED|Overall Study||6||
59629768|NCT01218984|75743327|FG002|COMPLETED|Overall Study||7||
59629769|NCT01218984|75743325|FG000|NOT COMPLETED|Overall Study||1||
59629770|NCT01218984|75743326|FG001|NOT COMPLETED|Overall Study||2||
59629771|NCT01218984|75743327|FG002|NOT COMPLETED|Overall Study||3||
59629772|NCT01220466|75743338|FG000|STARTED|Overall Study|19 eyes|11||
59629773|NCT01220466|75743339|FG001|STARTED|Overall Study|108 eyes|56||
59629774|NCT01220466|75743340|FG002|STARTED|Overall Study|16 eyes|10||
59629775|NCT01220466|75743338|FG000|COMPLETED|Overall Study|19 eyes|11||
59629776|NCT01220466|75743339|FG001|COMPLETED|Overall Study|108 eyes|56||
59629777|NCT01220466|75743340|FG002|COMPLETED|Overall Study|16 eyes|10||
59629778|NCT01220466|75743338|FG000|NOT COMPLETED|Overall Study||0||
59629779|NCT01220466|75743339|FG001|NOT COMPLETED|Overall Study||0||
59629780|NCT01220466|75743340|FG002|NOT COMPLETED|Overall Study||0||
59629781|NCT01222260|75743348|FG000|STARTED|Overall Study||31||
59629782|NCT01222260|75743348|FG000|COMPLETED|Overall Study||29||
59629783|NCT01222260|75743348|FG000|NOT COMPLETED|Overall Study||2||
59629784|NCT01222494|75743355|FG000|STARTED|Overall Study||7||
59629785|NCT01222494|75743356|FG001|STARTED|Overall Study||19||
59629786|NCT01222494|75743357|FG002|STARTED|Overall Study||21||
59629787|NCT01222494|75743355|FG000|COMPLETED|Overall Study||6||
59629788|NCT01222494|75743356|FG001|COMPLETED|Overall Study||15||
59629789|NCT01222494|75743357|FG002|COMPLETED|Overall Study||17||
59629790|NCT01222494|75743355|FG000|NOT COMPLETED|Overall Study||1||
59629791|NCT01222494|75743356|FG001|NOT COMPLETED|Overall Study||4||
59629792|NCT01222494|75743357|FG002|NOT COMPLETED|Overall Study||4||
59629793|NCT01222572|75743365|FG000|STARTED|Overall Study||1||
59629794|NCT01222572|75743366|FG001|STARTED|Overall Study||0||
59629795|NCT01222572|75743367|FG002|STARTED|Overall Study||0||
59629796|NCT01222572|75743365|FG000|COMPLETED|Overall Study||1||
59629797|NCT01222572|75743366|FG001|COMPLETED|Overall Study||0||
59629798|NCT01222572|75743367|FG002|COMPLETED|Overall Study||0||
59629799|NCT01222572|75743365|FG000|NOT COMPLETED|Overall Study||0||
59629800|NCT01222572|75743366|FG001|NOT COMPLETED|Overall Study||0||
59629801|NCT01222572|75743367|FG002|NOT COMPLETED|Overall Study||0||
59629802|NCT01222884|75743373|FG000|STARTED|Overall Study||234||
59629803|NCT01222884|75743374|FG001|STARTED|Overall Study||117||
59629804|NCT01222884|75743373|FG000|COMPLETED|Overall Study||210||
59629805|NCT01222884|75743374|FG001|COMPLETED|Overall Study||113||
59629806|NCT01222884|75743373|FG000|NOT COMPLETED|Overall Study||24||
59629807|NCT01222884|75743374|FG001|NOT COMPLETED|Overall Study||4||
59629808|NCT01223352|75743382|FG000|STARTED|Overall Study||31||
59629809|NCT01223352|75743383|FG001|STARTED|Overall Study||33||
59629810|NCT01223352|75743382|FG000|COMPLETED|Overall Study||31||
59629811|NCT01223352|75743383|FG001|COMPLETED|Overall Study||33||
59629812|NCT01223352|75743382|FG000|NOT COMPLETED|Overall Study||0||
59629813|NCT01223352|75743383|FG001|NOT COMPLETED|Overall Study||0||
59629814|NCT01224210|75743395|FG000|STARTED|Overall Study||30||
59629815|NCT01224210|75743395|FG000|COMPLETED|Overall Study||23||
59629816|NCT01224210|75743395|FG000|NOT COMPLETED|Overall Study||7||
59629817|NCT01224444|75743400|FG000|STARTED|Overall Study||269||
59629818|NCT01224444|75743400|FG000|COMPLETED|Overall Study||269||
59629819|NCT01224444|75743400|FG000|NOT COMPLETED|Overall Study||0||
59629820|NCT01224678|75743406|FG000|STARTED|Overall Study||150||
59629821|NCT01224678|75743407|FG001|STARTED|Overall Study||150||
59629822|NCT01224678|75743406|FG000|COMPLETED|Overall Study||150||
59629823|NCT01224678|75743407|FG001|COMPLETED|Overall Study||150||
59629824|NCT01224678|75743406|FG000|NOT COMPLETED|Overall Study||0||
59629825|NCT01224678|75743407|FG001|NOT COMPLETED|Overall Study||0||
59629826|NCT01225068|75743415|FG000|STARTED|Overall Study||20||
59629827|NCT01225068|75743416|FG001|STARTED|Overall Study||20||
59629828|NCT01225068|75743415|FG000|COMPLETED|Overall Study||16||
59629829|NCT01225068|75743416|FG001|COMPLETED|Overall Study||19||
59629830|NCT01225068|75743415|FG000|NOT COMPLETED|Overall Study||4||
59629831|NCT01225068|75743416|FG001|NOT COMPLETED|Overall Study||1||
59629832|NCT01225926|75743424|FG000|STARTED|Overall Study||12||
59629833|NCT01225926|75743425|FG001|STARTED|Overall Study||12||
59629834|NCT01225926|75743424|FG000|COMPLETED|Overall Study||12||
59629835|NCT01225926|75743425|FG001|COMPLETED|Overall Study||12||
59629836|NCT01225926|75743424|FG000|NOT COMPLETED|Overall Study||0||
59629837|NCT01225926|75743425|FG001|NOT COMPLETED|Overall Study||0||
59629838|NCT01226706|75743433|FG000|STARTED|Overall Study||10||
59629839|NCT01226706|75743434|FG001|STARTED|Overall Study||11||
59629840|NCT01226706|75743433|FG000|COMPLETED|Overall Study||10||
59629841|NCT01226706|75743434|FG001|COMPLETED|Overall Study||11||
59629842|NCT01226706|75743433|FG000|NOT COMPLETED|Overall Study||0||
59629843|NCT01226706|75743434|FG001|NOT COMPLETED|Overall Study||0||
59629844|NCT01228968|75743442|FG000|STARTED|Overall Study||9||
59629845|NCT01228968|75743442|FG000|COMPLETED|Overall Study||9||
59629846|NCT01228968|75743442|FG000|NOT COMPLETED|Overall Study||0||
59629847|NCT01231230|75743446|FG000|STARTED|Overall Study||14||
59629848|NCT01231230|75743446|FG000|Fluticasone|Overall Study||14||
59629849|NCT01231230|75743446|FG000|Salmeterol|Overall Study||14||
59629850|NCT01231230|75743446|FG000|Fluticasone/Salmeterol|Overall Study||14||
59629851|NCT01231230|75743446|FG000|Placebo|Overall Study||14||
59629852|NCT01231230|75743446|FG000|COMPLETED|Overall Study||14||
59629853|NCT01231230|75743446|FG000|NOT COMPLETED|Overall Study||0||
59629854|NCT01232946|75743459|FG000|STARTED|Overall Study||9||
59629855|NCT01232946|75743460|FG001|STARTED|Overall Study||10||
59629856|NCT01232946|75743461|FG002|STARTED|Overall Study||11||
59629857|NCT01232946|75743459|FG000|COMPLETED|Overall Study||9||
59629858|NCT01232946|75743460|FG001|COMPLETED|Overall Study|1 participant died unrelated to study|9||
59629859|NCT01232946|75743461|FG002|COMPLETED|Overall Study|2 withdrew after baseline measurements|9||
59629860|NCT01232946|75743459|FG000|NOT COMPLETED|Overall Study||0||
59629861|NCT01232946|75743460|FG001|NOT COMPLETED|Overall Study||1||
59629862|NCT01232946|75743461|FG002|NOT COMPLETED|Overall Study||2||
59629863|NCT01233726|75743472|FG000|STARTED|Overall Study||53||
59629864|NCT01233726|75743473|FG001|STARTED|Overall Study||53||
59629865|NCT01233726|75743474|FG002|STARTED|Overall Study||53||
59629866|NCT01233726|75743472|FG000|COMPLETED|Overall Study||52||
59629867|NCT01233726|75743473|FG001|COMPLETED|Overall Study||53||
59629868|NCT01233726|75743474|FG002|COMPLETED|Overall Study||52||
59629869|NCT01233726|75743472|FG000|NOT COMPLETED|Overall Study||1||
59629870|NCT01233726|75743473|FG001|NOT COMPLETED|Overall Study||0||
59629871|NCT01233726|75743474|FG002|NOT COMPLETED|Overall Study||1||
59629872|NCT01235910|75743485|FG000|STARTED|Overall Study||1||
59629873|NCT01235910|75743485|FG000|COMPLETED|Overall Study||1||
59629874|NCT01235910|75743485|FG000|NOT COMPLETED|Overall Study||0||
59629875|NCT01236300|75743489|FG000|STARTED|Overall Study||66||
59629876|NCT01236300|75743489|FG000|COMPLETED|Overall Study||66||
59629877|NCT01236300|75743489|FG000|NOT COMPLETED|Overall Study||0||
59629878|NCT01236378|75743494|FG000|STARTED|Overall Study||24||
59629879|NCT01236378|75743494|FG000|COMPLETED|Overall Study||24||
59629880|NCT01236378|75743494|FG000|NOT COMPLETED|Overall Study||0||
59629881|NCT01236768|75743500|FG000|STARTED|Overall Study||201||
59629882|NCT01236768|75743501|FG001|STARTED|Overall Study||206||
59629883|NCT01236768|75743500|FG000|COMPLETED|Overall Study||112||
59629884|NCT01236768|75743501|FG001|COMPLETED|Overall Study||145||
59629885|NCT01236768|75743500|FG000|NOT COMPLETED|Overall Study||89||
59629886|NCT01236768|75743501|FG001|NOT COMPLETED|Overall Study||61||
59629887|NCT01237080|75743510|FG000|STARTED|Overall Study||50||
59629888|NCT01237080|75743511|FG001|STARTED|Overall Study||50||
59629889|NCT01237080|75743510|FG000|COMPLETED|Overall Study||50||
59629890|NCT01237080|75743511|FG001|COMPLETED|Overall Study||50||
59629891|NCT01237080|75743510|FG000|NOT COMPLETED|Overall Study||0||
59629892|NCT01237080|75743511|FG001|NOT COMPLETED|Overall Study||0||
59629893|NCT01238640|75743517|FG000|STARTED|Overall Study||84||
59629894|NCT01238640|75743517|FG000|COMPLETED|Overall Study||84||
59629895|NCT01238640|75743517|FG000|NOT COMPLETED|Overall Study||0||
59629896|NCT01240122|75743525|FG000|STARTED|Overall Study||29||
59629897|NCT01240122|75743525|FG000|COMPLETED|Overall Study||29||
59629898|NCT01240122|75743525|FG000|NOT COMPLETED|Overall Study||0||
59629899|NCT01241916|75743536|FG000|STARTED|Overall Study||35||
59629900|NCT01241916|75743537|FG001|STARTED|Overall Study||31||
59629901|NCT01241916|75743536|FG000|COMPLETED|Overall Study||28||
59629902|NCT01241916|75743537|FG001|COMPLETED|Overall Study||21||
59629903|NCT01241916|75743536|FG000|NOT COMPLETED|Overall Study||7||
59629904|NCT01241916|75743537|FG001|NOT COMPLETED|Overall Study||10||
59629905|NCT01243320|75743543|FG000|STARTED|10ppm Oral Silver (3 Days)||36||
59629906|NCT01243320|75743543|FG000|COMPLETED|10ppm Oral Silver (3 Days)||36||
59629907|NCT01243320|75743543|FG000|NOT COMPLETED|10ppm Oral Silver (3 Days)||0||
59629908|NCT01243320|75743543|FG000|STARTED|10ppm Oral Silver (7 Days)||36||
59629909|NCT01243320|75743543|FG000|COMPLETED|10ppm Oral Silver (7 Days)||36||
59629910|NCT01243320|75743543|FG000|NOT COMPLETED|10ppm Oral Silver (7 Days)||0||
59629911|NCT01243320|75743543|FG000|STARTED|10ppm Oral Silver (14 Days)||36||
59629912|NCT01243320|75743543|FG000|COMPLETED|10ppm Oral Silver (14 Days)||36||
59629913|NCT01243320|75743543|FG000|NOT COMPLETED|10ppm Oral Silver (14 Days)||0||
59629914|NCT01243320|75743543|FG000|STARTED|Washout (3 Days)||36||
59629915|NCT01243320|75743543|FG000|COMPLETED|Washout (3 Days)||36||
59629916|NCT01243320|75743543|FG000|NOT COMPLETED|Washout (3 Days)||0||
59629917|NCT01243320|75743543|FG000|STARTED|32ppm Oral Silver (14 Days)||24||
59629918|NCT01243320|75743543|FG000|COMPLETED|32ppm Oral Silver (14 Days)||24||
59629919|NCT01243320|75743543|FG000|NOT COMPLETED|32ppm Oral Silver (14 Days)||0||
59629920|NCT01244412|75743549|FG000|STARTED|Overall Study||1||
59629921|NCT01244412|75743549|FG000|COMPLETED|Overall Study||1||
59629922|NCT01244412|75743549|FG000|NOT COMPLETED|Overall Study||0||
59629923|NCT01245270|75743555|FG000|STARTED|Overall Study|In a cross-over design, volunteers (n=8) were randomised and double blinded into two groups (n=4)|4||
59629924|NCT01245270|75743556|FG001|STARTED|Overall Study|In a cross-over design, volunteers (n=8) were randomised and double blinded into two groups (n=4)|4||
59629925|NCT01245270|75743555|FG000|COMPLETED|Overall Study|In a cross-over design, volunteers (n=8) were randomised and double blinded into two groups (n=4)|4||
59629926|NCT01245270|75743556|FG001|COMPLETED|Overall Study|In a cross-over design, volunteers (n=8) were randomised and double blinded into two groups (n=4)|4||
59629927|NCT01245270|75743555|FG000|NOT COMPLETED|Overall Study||0||
59629928|NCT01245270|75743556|FG001|NOT COMPLETED|Overall Study||0||
59629929|NCT01245738|75743564|FG000|STARTED|Overall Study||514||
59629930|NCT01245738|75743564|FG000|COMPLETED|Overall Study||474||
59629931|NCT01245738|75743564|FG000|NOT COMPLETED|Overall Study||40||
59629932|NCT01245972|75743571|FG000|STARTED|Overall Study||7||
59629933|NCT01245972|75743572|FG001|STARTED|Overall Study||8||
59629934|NCT01245972|75743573|FG002|STARTED|Overall Study||8||
59629935|NCT01245972|75743571|FG000|COMPLETED|Overall Study||7||
59629936|NCT01245972|75743572|FG001|COMPLETED|Overall Study||8||
59629937|NCT01245972|75743573|FG002|COMPLETED|Overall Study||8||
59629938|NCT01245972|75743571|FG000|NOT COMPLETED|Overall Study||0||
59629939|NCT01245972|75743572|FG001|NOT COMPLETED|Overall Study||0||
59629940|NCT01245972|75743573|FG002|NOT COMPLETED|Overall Study||0||
59629941|NCT01246050|75743583|FG000|STARTED|Overall Study||6||
59629942|NCT01246050|75743584|FG001|STARTED|Overall Study|Control providers were other providers in the same Primary Care Clinic, not enrolled in the study|6||
59629943|NCT01246050|75743583|FG000|COMPLETED|Overall Study||6||
59629944|NCT01246050|75743584|FG001|COMPLETED|Overall Study|Control providers were other providers in the same Primary Care Clinic, not enrolled in the study|6||
59629945|NCT01246050|75743583|FG000|NOT COMPLETED|Overall Study||0||
59629946|NCT01246050|75743584|FG001|NOT COMPLETED|Overall Study||0||
59629947|NCT01247064|75743592|FG000|STARTED|Overall Study||31||
59629948|NCT01247064|75743593|FG001|STARTED|Overall Study||31||
59629949|NCT01247064|75743592|FG000|COMPLETED|Overall Study||31||
59629950|NCT01247064|75743593|FG001|COMPLETED|Overall Study||31||
59629951|NCT01247064|75743592|FG000|NOT COMPLETED|Overall Study||0||
59629952|NCT01247064|75743593|FG001|NOT COMPLETED|Overall Study||0||
59629953|NCT01247220|75743601|FG000|STARTED|Overall Study||6||
59629954|NCT01247220|75743602|FG001|STARTED|Overall Study||6||
59629955|NCT01247220|75743601|FG000|COMPLETED|Overall Study||6||
59629956|NCT01247220|75743602|FG001|COMPLETED|Overall Study||6||
59629957|NCT01247220|75743601|FG000|NOT COMPLETED|Overall Study||0||
59629958|NCT01247220|75743602|FG001|NOT COMPLETED|Overall Study||0||
59629959|NCT01247298|75743608|FG000|STARTED|Overall Study||17||
59629960|NCT01247298|75743608|FG000|COMPLETED|Overall Study||17||
59629961|NCT01247298|75743608|FG000|NOT COMPLETED|Overall Study||0||
59629962|NCT01249872|75743619|FG000|STARTED|Overall Study||16||
59629963|NCT01249872|75743620|FG001|STARTED|Overall Study||16||
59629964|NCT01249872|75743621|FG002|STARTED|Overall Study||16||
59629965|NCT01249872|75743622|FG003|STARTED|Overall Study||16||
59629966|NCT01249872|75743623|FG004|STARTED|Overall Study||16||
59539848|NCT02512302|75638165|FG007|COMPLETED|Period 4||3||
59539849|NCT02512302|75638166|FG008|COMPLETED|Period 4||3||
59539850|NCT02512302|75638167|FG009|COMPLETED|Period 4||2||
59539851|NCT02512302|75638158|FG000|NOT COMPLETED|Period 4||0||
59539852|NCT02512302|75638159|FG001|NOT COMPLETED|Period 4||0||
59539853|NCT02512302|75638160|FG002|NOT COMPLETED|Period 4||0||
59539854|NCT02512302|75638161|FG003|NOT COMPLETED|Period 4||0||
59539855|NCT02512302|75638162|FG004|NOT COMPLETED|Period 4||0||
59539856|NCT02512302|75638163|FG005|NOT COMPLETED|Period 4||0||
59539857|NCT02512302|75638164|FG006|NOT COMPLETED|Period 4||1||
59539858|NCT02512302|75638165|FG007|NOT COMPLETED|Period 4||0||
59539859|NCT02512302|75638166|FG008|NOT COMPLETED|Period 4||0||
59629967|NCT01249872|75743624|FG005|STARTED|Overall Study||16||
59539860|NCT02512302|75638167|FG009|NOT COMPLETED|Period 4||0||
59539861|NCT02512302|75638158|FG000|STARTED|Period 5||3||
59629968|NCT01249872|75743619|FG000|COMPLETED|Overall Study||16||
59539862|NCT02512302|75638159|FG001|STARTED|Period 5||2||
59539863|NCT02512302|75638160|FG002|STARTED|Period 5||3||
59539864|NCT02512302|75638161|FG003|STARTED|Period 5||3||
59539865|NCT02512302|75638162|FG004|STARTED|Period 5||3||
59539866|NCT02512302|75638163|FG005|STARTED|Period 5||3||
59539867|NCT02512302|75638164|FG006|STARTED|Period 5||1||
59539868|NCT02512302|75638165|FG007|STARTED|Period 5||3||
59539869|NCT02512302|75638166|FG008|STARTED|Period 5||3||
59539870|NCT02512302|75638167|FG009|STARTED|Period 5||2||
59539871|NCT02512302|75638158|FG000|COMPLETED|Period 5||3||
59539872|NCT02512302|75638159|FG001|COMPLETED|Period 5||2||
59539873|NCT02512302|75638160|FG002|COMPLETED|Period 5||3||
59539874|NCT02512302|75638161|FG003|COMPLETED|Period 5||3||
59539875|NCT02512302|75638162|FG004|COMPLETED|Period 5||3||
59539876|NCT02512302|75638163|FG005|COMPLETED|Period 5||3||
59539877|NCT02512302|75638164|FG006|COMPLETED|Period 5||1||
59539878|NCT02512302|75638165|FG007|COMPLETED|Period 5||3||
59539879|NCT02512302|75638166|FG008|COMPLETED|Period 5||3||
59539880|NCT02512302|75638167|FG009|COMPLETED|Period 5||2||
59539881|NCT02512302|75638158|FG000|NOT COMPLETED|Period 5||0||
59539882|NCT02512302|75638159|FG001|NOT COMPLETED|Period 5||0||
59539883|NCT02512302|75638160|FG002|NOT COMPLETED|Period 5||0||
59539884|NCT02512302|75638161|FG003|NOT COMPLETED|Period 5||0||
59539885|NCT02512302|75638162|FG004|NOT COMPLETED|Period 5||0||
59539886|NCT02512302|75638163|FG005|NOT COMPLETED|Period 5||0||
59539887|NCT02512302|75638164|FG006|NOT COMPLETED|Period 5||0||
59539888|NCT02512302|75638165|FG007|NOT COMPLETED|Period 5||0||
59539889|NCT02512302|75638166|FG008|NOT COMPLETED|Period 5||0||
59539890|NCT02512302|75638167|FG009|NOT COMPLETED|Period 5||0||
59539891|NCT01507181|75638182|FG000|STARTED|Overall Study||12||
59539892|NCT01507181|75638183|FG001|STARTED|Overall Study||12||
59539893|NCT01507181|75638182|FG000|COMPLETED|Overall Study||12||
59539894|NCT01507181|75638183|FG001|COMPLETED|Overall Study||12||
59539895|NCT01507181|75638182|FG000|NOT COMPLETED|Overall Study||0||
59539896|NCT01507181|75638183|FG001|NOT COMPLETED|Overall Study||0||
59539897|NCT00877058|75638192|FG000|STARTED|Overall Study||174||
59539898|NCT00877058|75638193|FG001|STARTED|Overall Study||171||
59539899|NCT00877058|75638194|FG002|STARTED|Overall Study||114||
59539900|NCT00877058|75638192|FG000|COMPLETED|Overall Study||137||
59539901|NCT00877058|75638193|FG001|COMPLETED|Overall Study||131||
59539902|NCT00877058|75638194|FG002|COMPLETED|Overall Study||75||
59539903|NCT00877058|75638192|FG000|NOT COMPLETED|Overall Study||37||
59539904|NCT00877058|75638193|FG001|NOT COMPLETED|Overall Study||40||
59539905|NCT00877058|75638194|FG002|NOT COMPLETED|Overall Study||39||
59539906|NCT01428245|75638202|FG000|STARTED|Overall Study||1||
59539907|NCT01428245|75638202|FG000|COMPLETED|Overall Study||1||
59539908|NCT01428245|75638202|FG000|NOT COMPLETED|Overall Study||0||
59539909|NCT00877370|75638206|FG000|STARTED|Overall Study||8||
59539910|NCT00877370|75638206|FG000|COMPLETED|Overall Study||8||
59539911|NCT00877370|75638206|FG000|NOT COMPLETED|Overall Study||0||
59539912|NCT02210039|75638210|FG000|STARTED|Overall Study||6||
59539913|NCT02210039|75638210|FG000|COMPLETED|Overall Study||6||
59539914|NCT02210039|75638210|FG000|NOT COMPLETED|Overall Study||0||
59539915|NCT00877604|75638216|FG000|STARTED|Overall Study||17||
59539916|NCT00877604|75638217|FG001|STARTED|Overall Study||17||
59539917|NCT00877604|75638216|FG000|COMPLETED|Overall Study||15||
59539918|NCT00877604|75638217|FG001|COMPLETED|Overall Study||14||
59539919|NCT00877604|75638216|FG000|NOT COMPLETED|Overall Study||2||
59539920|NCT00877604|75638217|FG001|NOT COMPLETED|Overall Study||3||
59539921|NCT01507493|75638225|FG000|STARTED|Overall Study||22||
59539922|NCT01507493|75638226|FG001|STARTED|Overall Study||178||
59539923|NCT01507493|75638225|FG000|COMPLETED|Overall Study||22||
59539924|NCT01507493|75638226|FG001|COMPLETED|Overall Study||178||
59539925|NCT01507493|75638225|FG000|NOT COMPLETED|Overall Study||0||
59539926|NCT01507493|75638226|FG001|NOT COMPLETED|Overall Study||0||
59539927|NCT01508117|75638232|FG000|STARTED|Overall Study||1||
59539928|NCT01508117|75638232|FG000|COMPLETED|Overall Study||1||
59539929|NCT01508117|75638232|FG000|NOT COMPLETED|Overall Study||0||
59539930|NCT00878228|75638238|FG000|STARTED|Overall Study||49||
59539931|NCT00878228|75638239|FG001|STARTED|Overall Study||49||
59539932|NCT00878228|75638238|FG000|COMPLETED|Overall Study||39||
59539933|NCT00878228|75638239|FG001|COMPLETED|Overall Study||37||
59539934|NCT00878228|75638238|FG000|NOT COMPLETED|Overall Study||10||
59539935|NCT00878228|75638239|FG001|NOT COMPLETED|Overall Study||12||
59539936|NCT01390259|75638245|FG000|STARTED|Overall Study||5||
59539937|NCT01390259|75638246|FG001|STARTED|Overall Study||6||
59539938|NCT01390259|75638245|FG000|COMPLETED|Overall Study||5||
59539939|NCT01390259|75638246|FG001|COMPLETED|Overall Study||6||
59539940|NCT01390259|75638245|FG000|NOT COMPLETED|Overall Study||0||
59539941|NCT01390259|75638246|FG001|NOT COMPLETED|Overall Study||0||
59539942|NCT01391273|75638253|FG000|STARTED|Overall Study||88||
59539943|NCT01391273|75638254|FG001|STARTED|Overall Study||85||
59539944|NCT01391273|75638253|FG000|COMPLETED|Overall Study||84||
59539945|NCT01391273|75638254|FG001|COMPLETED|Overall Study||83||
59539946|NCT01391273|75638253|FG000|NOT COMPLETED|Overall Study||4||
59539947|NCT01391273|75638254|FG001|NOT COMPLETED|Overall Study||2||
59539948|NCT01429259|75638260|FG000|STARTED|Overall Study||30||
59629969|NCT01249872|75743620|FG001|COMPLETED|Overall Study||16||
59629970|NCT01249872|75743621|FG002|COMPLETED|Overall Study||16||
59629971|NCT01249872|75743622|FG003|COMPLETED|Overall Study||16||
59629972|NCT01249872|75743623|FG004|COMPLETED|Overall Study||16||
59629973|NCT01249872|75743624|FG005|COMPLETED|Overall Study||16||
59629974|NCT01249872|75743619|FG000|NOT COMPLETED|Overall Study||0||
59629975|NCT01249872|75743620|FG001|NOT COMPLETED|Overall Study||0||
59539949|NCT01429259|75638260|FG000|COMPLETED|Overall Study||30||
59539950|NCT01429259|75638260|FG000|NOT COMPLETED|Overall Study||0||
59629976|NCT01249872|75743621|FG002|NOT COMPLETED|Overall Study||0||
59629977|NCT01249872|75743622|FG003|NOT COMPLETED|Overall Study||0||
59629978|NCT01249872|75743623|FG004|NOT COMPLETED|Overall Study||0||
59629979|NCT01249872|75743624|FG005|NOT COMPLETED|Overall Study||0||
59629980|NCT01250184|75743649|FG000|STARTED|Overall Study||43||
59629981|NCT01250184|75743650|FG001|STARTED|Overall Study||41||
59629982|NCT01250184|75743651|FG002|STARTED|Overall Study||43||
59629983|NCT01250184|75743649|FG000|COMPLETED|Overall Study||43||
59629984|NCT01250184|75743650|FG001|COMPLETED|Overall Study||41||
59629985|NCT01250184|75743651|FG002|COMPLETED|Overall Study||43||
59629986|NCT01250184|75743649|FG000|NOT COMPLETED|Overall Study||0||
59629987|NCT01250184|75743650|FG001|NOT COMPLETED|Overall Study||0||
59629988|NCT01250184|75743651|FG002|NOT COMPLETED|Overall Study||0||
59629989|NCT01250730|75743662|FG000|STARTED|Overall Study||6||
59629990|NCT01250730|75743663|FG001|STARTED|Overall Study||6||
59629991|NCT01250730|75743664|FG002|STARTED|Overall Study||6||
59629992|NCT01250730|75743662|FG000|COMPLETED|Overall Study||6||
59629993|NCT01250730|75743663|FG001|COMPLETED|Overall Study||6||
59629994|NCT01250730|75743664|FG002|COMPLETED|Overall Study||6||
59629995|NCT01250730|75743662|FG000|NOT COMPLETED|Overall Study||0||
59629996|NCT01250730|75743663|FG001|NOT COMPLETED|Overall Study||0||
59629997|NCT01250730|75743664|FG002|NOT COMPLETED|Overall Study||0||
59629998|NCT01251042|75743674|FG000|STARTED|Overall Study||26||
59629999|NCT01251042|75743675|FG001|STARTED|Overall Study||23||
59630000|NCT01251042|75743674|FG000|COMPLETED|Overall Study||26||
59630001|NCT01251042|75743675|FG001|COMPLETED|Overall Study||23||
59630002|NCT01251042|75743674|FG000|NOT COMPLETED|Overall Study||0||
59630003|NCT01251042|75743675|FG001|NOT COMPLETED|Overall Study||0||
59539951|NCT01392053|75638266|FG000|STARTED|Overall Study||23||
59539952|NCT01392053|75638267|FG001|STARTED|Overall Study||23||
59539953|NCT01392053|75638266|FG000|COMPLETED|Overall Study||23||
59539954|NCT01392053|75638267|FG001|COMPLETED|Overall Study||23||
59539955|NCT01392053|75638266|FG000|NOT COMPLETED|Overall Study||0||
59539956|NCT01392053|75638267|FG001|NOT COMPLETED|Overall Study||0||
59539957|NCT02204657|75638275|FG000|STARTED|Overall Study||32||
59539958|NCT02204657|75638276|FG001|STARTED|Overall Study||25||
59539959|NCT02204657|75638275|FG000|COMPLETED|Overall Study||25||
59539960|NCT02204657|75638276|FG001|COMPLETED|Overall Study||25||
59539961|NCT02204657|75638275|FG000|NOT COMPLETED|Overall Study||7||
59539962|NCT02204657|75638276|FG001|NOT COMPLETED|Overall Study||0||
59539963|NCT02511678|75638282|FG000|STARTED|Overall Study||73||
59539964|NCT02511678|75638282|FG000|Intent-to-Treat (ITT) Population|Overall Study|Participants for whom cryoablation via Galil Medical cryoablation system was attempted or performed.|66||
59539965|NCT02511678|75638282|FG000|Participants Discontinued Pre-Treatment|Overall Study||7||
59539966|NCT02511678|75638282|FG000|Safety Population|Overall Study|Participants for whom received the complete study cryoablation procedure.|65||
59539967|NCT02511678|75638282|FG000|COMPLETED|Overall Study||37||
59539968|NCT02511678|75638282|FG000|NOT COMPLETED|Overall Study||36||
59539969|NCT01392989|75638287|FG000|STARTED|Total Lymphoid Irradiation (TLI)||44||
59539970|NCT01392989|75638287|FG000|COMPLETED|Total Lymphoid Irradiation (TLI)||44||
59539971|NCT01392989|75638287|FG000|NOT COMPLETED|Total Lymphoid Irradiation (TLI)||0||
59539972|NCT01392989|75638287|FG000|STARTED|CIK Cell Infusion||31||
59539973|NCT01392989|75638287|FG000|COMPLETED|CIK Cell Infusion||31||
59539974|NCT01392989|75638287|FG000|NOT COMPLETED|CIK Cell Infusion||0||
59539975|NCT01393457|75638296|FG000|STARTED|Overall Study||26||
59539976|NCT01393457|75638297|FG001|STARTED|Overall Study||26||
59539977|NCT01393457|75638298|FG002|STARTED|Overall Study||31||
59539978|NCT01393457|75638299|FG003|STARTED|Overall Study||27||
59630004|NCT01251588|75743683|FG000|STARTED|Overall Study||65||
59630005|NCT01251588|75743684|FG001|STARTED|Overall Study||63||
59630006|NCT01251588|75743683|FG000|COMPLETED|Overall Study||65||
59630007|NCT01251588|75743684|FG001|COMPLETED|Overall Study||59||
59630008|NCT01251588|75743683|FG000|NOT COMPLETED|Overall Study||0||
59630009|NCT01251588|75743684|FG001|NOT COMPLETED|Overall Study||4||
59630010|NCT01251978|75743694|FG000|STARTED|Overall Study||5||
59630011|NCT01251978|75743695|FG001|STARTED|Overall Study||3||
59630012|NCT01251978|75743694|FG000|COMPLETED|Overall Study||5||
59630013|NCT01251978|75743695|FG001|COMPLETED|Overall Study||3||
59630014|NCT01251978|75743694|FG000|NOT COMPLETED|Overall Study||0||
59630015|NCT01251978|75743695|FG001|NOT COMPLETED|Overall Study||0||
59630016|NCT01253148|75743701|FG000|STARTED|Overall Study||25||
59630017|NCT01253148|75743701|FG000|COMPLETED|Overall Study||25||
59630018|NCT01253148|75743701|FG000|NOT COMPLETED|Overall Study||0||
59630019|NCT01253460|75743705|FG000|STARTED|Overall Study||18||
59630020|NCT01253460|75743705|FG000|COMPLETED|Overall Study||18||
59630021|NCT01253460|75743705|FG000|NOT COMPLETED|Overall Study||0||
59630022|NCT01254396|75743709|FG000|STARTED|First Intervention Period||6||
59630023|NCT01254396|75743710|FG001|STARTED|First Intervention Period||6||
59630024|NCT01254396|75743709|FG000|COMPLETED|First Intervention Period||6||
59630025|NCT01254396|75743710|FG001|COMPLETED|First Intervention Period||6||
59630026|NCT01254396|75743709|FG000|NOT COMPLETED|First Intervention Period||0||
59630027|NCT01254396|75743710|FG001|NOT COMPLETED|First Intervention Period||0||
59630028|NCT01254396|75743709|FG000|STARTED|Washout Period (at Least 1 Day)||6||
59630029|NCT01254396|75743710|FG001|STARTED|Washout Period (at Least 1 Day)||6||
59630030|NCT01254396|75743709|FG000|COMPLETED|Washout Period (at Least 1 Day)||6||
59630031|NCT01254396|75743710|FG001|COMPLETED|Washout Period (at Least 1 Day)||6||
59630032|NCT01254396|75743709|FG000|NOT COMPLETED|Washout Period (at Least 1 Day)||0||
59630033|NCT01254396|75743710|FG001|NOT COMPLETED|Washout Period (at Least 1 Day)||0||
59630034|NCT01254396|75743709|FG000|STARTED|Second Intervention Period||6||
59630035|NCT01254396|75743710|FG001|STARTED|Second Intervention Period||6||
59630036|NCT01254396|75743709|FG000|COMPLETED|Second Intervention Period||6||
59630037|NCT01254396|75743710|FG001|COMPLETED|Second Intervention Period||6||
59630038|NCT01254396|75743709|FG000|NOT COMPLETED|Second Intervention Period||0||
59630039|NCT01254396|75743710|FG001|NOT COMPLETED|Second Intervention Period||0||
59630040|NCT01254552|75743716|FG000|STARTED|Screening Visit||351||
59630041|NCT01254552|75743716|FG000|COMPLETED|Screening Visit||348||
59630042|NCT01254552|75743716|FG000|NOT COMPLETED|Screening Visit||3||
59630043|NCT01254552|75743716|FG000|STARTED|Delayed-enhanced MRI With Dotarem||348||
59630044|NCT01254552|75743716|FG000|COMPLETED|Delayed-enhanced MRI With Dotarem||328||
59630045|NCT01254552|75743716|FG000|NOT COMPLETED|Delayed-enhanced MRI With Dotarem||20||
59630046|NCT01254552|75743716|FG000|STARTED|CCTA With Xenetix 350||328||
59630047|NCT01254552|75743716|FG000|COMPLETED|CCTA With Xenetix 350||322||
59630048|NCT01254552|75743716|FG000|NOT COMPLETED|CCTA With Xenetix 350||6||
59630049|NCT01256034|75743726|FG000|STARTED|Overall Study||25||
59630050|NCT01256034|75743727|FG001|STARTED|Overall Study||25||
59630051|NCT01256034|75743726|FG000|COMPLETED|Overall Study||0||
59630052|NCT01256034|75743727|FG001|COMPLETED|Overall Study||0||
59630053|NCT01256034|75743726|FG000|NOT COMPLETED|Overall Study||25||
59630054|NCT01256034|75743727|FG001|NOT COMPLETED|Overall Study||25||
59630055|NCT01244724|75743733|FG000|STARTED|Overall Study|Of these 15 returned for a week 2 visit and are included in the efficacy analysis.|17||
59630056|NCT01244724|75743733|FG000|Week 2 Visit|Overall Study||15||
59630057|NCT01244724|75743733|FG000|COMPLETED|Overall Study||9||
59630058|NCT01244724|75743733|FG000|NOT COMPLETED|Overall Study||8||
59630059|NCT01256424|75743741|FG000|STARTED|Overall Study||65||
59630060|NCT01256424|75743742|FG001|STARTED|Overall Study||67||
59630061|NCT01256424|75743743|FG002|STARTED|Overall Study||62||
59630062|NCT01256424|75743744|FG003|STARTED|Overall Study||68||
59630063|NCT01256424|75743741|FG000|COMPLETED|Overall Study||56||
59630064|NCT01256424|75743742|FG001|COMPLETED|Overall Study||59||
59630065|NCT01256424|75743743|FG002|COMPLETED|Overall Study||55||
59630066|NCT01256424|75743744|FG003|COMPLETED|Overall Study||61||
59630067|NCT01256424|75743741|FG000|NOT COMPLETED|Overall Study||9||
59630068|NCT01256424|75743742|FG001|NOT COMPLETED|Overall Study||8||
59630069|NCT01256424|75743743|FG002|NOT COMPLETED|Overall Study||7||
59630070|NCT01256424|75743744|FG003|NOT COMPLETED|Overall Study||7||
59630071|NCT01257750|75743755|FG000|STARTED|Overall Study||20||
59630072|NCT01257750|75743755|FG000|COMPLETED|Overall Study||20||
59630073|NCT01257750|75743755|FG000|NOT COMPLETED|Overall Study||0||
59630074|NCT01258374|75743760|FG000|STARTED|Overall Study||15||
59630075|NCT01258374|75743760|FG000|COMPLETED|Overall Study||15||
59630076|NCT01258374|75743760|FG000|NOT COMPLETED|Overall Study||0||
59630077|NCT01260324|75743767|FG000|STARTED|Overall Study||1283||
59630078|NCT01260324|75743768|FG001|STARTED|Overall Study||20000||
59630079|NCT01260324|75743767|FG000|COMPLETED|Overall Study||1283||
59630080|NCT01260324|75743768|FG001|COMPLETED|Overall Study||20000||
59630081|NCT01260324|75743767|FG000|NOT COMPLETED|Overall Study||0||
59630082|NCT01260324|75743768|FG001|NOT COMPLETED|Overall Study||0||
59630083|NCT01262118|75743776|FG000|STARTED|Baseline Assessment Period (3 Days)||36||
59630084|NCT01262118|75743777|FG001|STARTED|Baseline Assessment Period (3 Days)||33||
59630085|NCT01262118|75743776|FG000|COMPLETED|Baseline Assessment Period (3 Days)||36||
59630086|NCT01262118|75743777|FG001|COMPLETED|Baseline Assessment Period (3 Days)||33||
59630087|NCT01262118|75743776|FG000|NOT COMPLETED|Baseline Assessment Period (3 Days)||0||
59630088|NCT01262118|75743777|FG001|NOT COMPLETED|Baseline Assessment Period (3 Days)||0||
59630089|NCT01262118|75743776|FG000|STARTED|Treatment Period (6 Weeks)||36||
59630090|NCT01262118|75743777|FG001|STARTED|Treatment Period (6 Weeks)||0||
59630091|NCT01262118|75743776|FG000|COMPLETED|Treatment Period (6 Weeks)||36||
59630092|NCT01262118|75743777|FG001|COMPLETED|Treatment Period (6 Weeks)||0||
59630093|NCT01262118|75743776|FG000|NOT COMPLETED|Treatment Period (6 Weeks)||0||
59630094|NCT01262118|75743777|FG001|NOT COMPLETED|Treatment Period (6 Weeks)||0||
59630095|NCT01263132|75743785|FG000|STARTED|Overall Study||38||
59630096|NCT01263132|75743786|FG001|STARTED|Overall Study||37||
59630097|NCT01263132|75743785|FG000|COMPLETED|Overall Study||38||
59630098|NCT01263132|75743786|FG001|COMPLETED|Overall Study||37||
59630099|NCT01263132|75743785|FG000|NOT COMPLETED|Overall Study||0||
59630100|NCT01263132|75743786|FG001|NOT COMPLETED|Overall Study||0||
59630101|NCT01264614|75743794|FG000|STARTED|Overall Study||13||
59630102|NCT01264614|75743795|FG001|STARTED|Overall Study||9||
59630103|NCT01264614|75743794|FG000|COMPLETED|Overall Study||12||
59630104|NCT01264614|75743795|FG001|COMPLETED|Overall Study||7||
59630105|NCT01264614|75743794|FG000|NOT COMPLETED|Overall Study||1||
59630106|NCT01264614|75743795|FG001|NOT COMPLETED|Overall Study||2||
59630107|NCT01267422|75743801|FG000|STARTED|Intravitreal rAAV2-ND4 Injection||5||
59630108|NCT01267422|75743802|FG001|STARTED|Intravitreal rAAV2-ND4 Injection||4||
59630109|NCT01267422|75743801|FG000|COMPLETED|Intravitreal rAAV2-ND4 Injection||5||
59630110|NCT01267422|75743802|FG001|COMPLETED|Intravitreal rAAV2-ND4 Injection||4||
59630111|NCT01267422|75743801|FG000|NOT COMPLETED|Intravitreal rAAV2-ND4 Injection||0||
59630112|NCT01267422|75743802|FG001|NOT COMPLETED|Intravitreal rAAV2-ND4 Injection||0||
59630113|NCT01267422|75743801|FG000|STARTED|Safety and Efficacy Study||5||
59630114|NCT01267422|75743802|FG001|STARTED|Safety and Efficacy Study||4||
59630115|NCT01267422|75743801|FG000|COMPLETED|Safety and Efficacy Study||5||
59630116|NCT01267422|75743802|FG001|COMPLETED|Safety and Efficacy Study||4||
59630117|NCT01267422|75743801|FG000|NOT COMPLETED|Safety and Efficacy Study||0||
59630118|NCT01267422|75743802|FG001|NOT COMPLETED|Safety and Efficacy Study||0||
59630119|NCT01267656|75743820|FG000|STARTED|Overall Study||83||
59630120|NCT01267656|75743821|FG001|STARTED|Overall Study||83||
59630121|NCT01267656|75743820|FG000|COMPLETED|Overall Study||82||
59630122|NCT01267656|75743821|FG001|COMPLETED|Overall Study||82||
59630123|NCT01267656|75743820|FG000|NOT COMPLETED|Overall Study||1||
59630124|NCT01267656|75743821|FG001|NOT COMPLETED|Overall Study||1||
59630125|NCT01269372|75743827|FG000|STARTED|Overall Study||30||
59630126|NCT01269372|75743827|FG000|COMPLETED|Overall Study||30||
59630127|NCT01269372|75743827|FG000|NOT COMPLETED|Overall Study||0||
59630128|NCT01270542|75743838|FG000|STARTED|Overall Study||10||10
59630129|NCT01270542|75743839|FG001|STARTED|Overall Study||9||10
59630130|NCT01270542|75743838|FG000|COMPLETED|Overall Study||9||9
59630131|NCT01270542|75743839|FG001|COMPLETED|Overall Study||8||9
59630132|NCT01270542|75743838|FG000|NOT COMPLETED|Overall Study||1||1
59630133|NCT01270542|75743839|FG001|NOT COMPLETED|Overall Study||1||1
59630134|NCT01271244|75743847|FG000|STARTED|Overall Study||18||
59630135|NCT01271244|75743848|FG001|STARTED|Overall Study||8||
59630136|NCT01271244|75743847|FG000|COMPLETED|Overall Study||11||
59630137|NCT01271244|75743848|FG001|COMPLETED|Overall Study||5||
59630138|NCT01271244|75743847|FG000|NOT COMPLETED|Overall Study||7||
59630139|NCT01271244|75743848|FG001|NOT COMPLETED|Overall Study||3||
59630140|NCT01271868|75743854|FG000|STARTED|Pharmacokinetic Study||9||
59630141|NCT01271868|75743854|FG000|COMPLETED|Pharmacokinetic Study||9||
59630142|NCT01271868|75743854|FG000|NOT COMPLETED|Pharmacokinetic Study||0||
59630143|NCT01271868|75743854|FG000|STARTED|Treatment Study||9||
59630144|NCT01271868|75743854|FG000|COMPLETED|Treatment Study||9||
59630145|NCT01271868|75743854|FG000|NOT COMPLETED|Treatment Study||0||
59630146|NCT01271946|75743862|FG000|STARTED|Overall Study||346||
59630147|NCT01271946|75743863|FG001|STARTED|Overall Study||5||
59630148|NCT01271946|75743862|FG000|COMPLETED|Overall Study||346||
59630149|NCT01271946|75743863|FG001|COMPLETED|Overall Study||5||
59630150|NCT01271946|75743862|FG000|NOT COMPLETED|Overall Study||0||
59630151|NCT01271946|75743863|FG001|NOT COMPLETED|Overall Study||0||
59630152|NCT01272882|75743883|FG000|STARTED|Overall Study||13||
59630153|NCT01272882|75743883|FG000|COMPLETED|Overall Study||13||
59630154|NCT01272882|75743883|FG000|NOT COMPLETED|Overall Study||0||
59815670|NCT03615469|75938126|FG000|NOT COMPLETED|Overall Study||3||
59815671|NCT03615469|75938127|FG001|NOT COMPLETED|Overall Study||1||
59630155|NCT01272960|75743889|FG000|STARTED|Overall Study||14||
59630156|NCT01272960|75743890|FG001|STARTED|Overall Study||15||
59630157|NCT01272960|75743889|FG000|COMPLETED|Overall Study||14||
59630158|NCT01272960|75743890|FG001|COMPLETED|Overall Study||15||
59630159|NCT01272960|75743889|FG000|NOT COMPLETED|Overall Study||0||
59630160|NCT01272960|75743890|FG001|NOT COMPLETED|Overall Study||0||
59630161|NCT01273896|75743899|FG000|STARTED|Overall Study||22||
59630162|NCT01273896|75743899|FG000|COMPLETED|Overall Study||22||
59630163|NCT01273896|75743899|FG000|NOT COMPLETED|Overall Study||0||
59630164|NCT01274520|75743905|FG000|STARTED|Overall Study||25||
59630165|NCT01274520|75743906|FG001|STARTED|Overall Study||24||
59630166|NCT01274520|75743905|FG000|COMPLETED|Overall Study||25||
59630167|NCT01274520|75743906|FG001|COMPLETED|Overall Study||24||
59630168|NCT01274520|75743905|FG000|NOT COMPLETED|Overall Study||0||
59630169|NCT01274520|75743906|FG001|NOT COMPLETED|Overall Study||0||
59630170|NCT01275300|75743915|FG000|STARTED|1st Intervention (5 Days)||5||
59630171|NCT01275300|75743916|FG001|STARTED|1st Intervention (5 Days)||4||
59815672|NCT03606213|75938137|FG000|STARTED|Overall Study||15||
59630172|NCT01275300|75743915|FG000|COMPLETED|1st Intervention (5 Days)||5||
59630173|NCT01275300|75743916|FG001|COMPLETED|1st Intervention (5 Days)||4||
59630174|NCT01275300|75743915|FG000|NOT COMPLETED|1st Intervention (5 Days)||0||
59630175|NCT01275300|75743916|FG001|NOT COMPLETED|1st Intervention (5 Days)||0||
59630176|NCT01275300|75743915|FG000|STARTED|Washout (14 Days)||5||
59630177|NCT01275300|75743916|FG001|STARTED|Washout (14 Days)||4||
59630178|NCT01275300|75743915|FG000|COMPLETED|Washout (14 Days)||5||
59630179|NCT01275300|75743916|FG001|COMPLETED|Washout (14 Days)||4||
59630180|NCT01275300|75743915|FG000|NOT COMPLETED|Washout (14 Days)||0||
59630181|NCT01275300|75743916|FG001|NOT COMPLETED|Washout (14 Days)||0||
59630182|NCT01275300|75743915|FG000|STARTED|2nd Intervention(5 Days)||5||
59630183|NCT01275300|75743916|FG001|STARTED|2nd Intervention(5 Days)||4||
59630184|NCT01275300|75743915|FG000|COMPLETED|2nd Intervention(5 Days)||5||
59630185|NCT01275300|75743916|FG001|COMPLETED|2nd Intervention(5 Days)||4||
59630186|NCT01275300|75743915|FG000|NOT COMPLETED|2nd Intervention(5 Days)||0||
59630187|NCT01275300|75743916|FG001|NOT COMPLETED|2nd Intervention(5 Days)||0||
59630188|NCT01275300|75743915|FG000|STARTED|Washout (14 Days)||5||
59630189|NCT01275300|75743916|FG001|STARTED|Washout (14 Days)||4||
59630190|NCT01275300|75743915|FG000|COMPLETED|Washout (14 Days)||5||
59630191|NCT01275300|75743916|FG001|COMPLETED|Washout (14 Days)||4||
59630192|NCT01275300|75743915|FG000|NOT COMPLETED|Washout (14 Days)||0||
59630193|NCT01275300|75743916|FG001|NOT COMPLETED|Washout (14 Days)||0||
59630194|NCT01275300|75743915|FG000|STARTED|Phase 2: Open-label 6days)||5||
59630195|NCT01275300|75743916|FG001|STARTED|Phase 2: Open-label 6days)||4||
59630196|NCT01275300|75743915|FG000|COMPLETED|Phase 2: Open-label 6days)||5||
59630197|NCT01275300|75743916|FG001|COMPLETED|Phase 2: Open-label 6days)||4||
59630198|NCT01275300|75743915|FG000|NOT COMPLETED|Phase 2: Open-label 6days)||0||
59630199|NCT01275300|75743916|FG001|NOT COMPLETED|Phase 2: Open-label 6days)||0||
59630200|NCT01276314|75743926|FG000|STARTED|Overall Study||48||
59630201|NCT01276314|75743927|FG001|STARTED|Overall Study||43||
59630202|NCT01276314|75743928|FG002|STARTED|Overall Study||22||
59630203|NCT01276314|75743929|FG003|STARTED|Overall Study||22||
59630204|NCT01276314|75743926|FG000|COMPLETED|Overall Study||38||
59630205|NCT01276314|75743927|FG001|COMPLETED|Overall Study||33||
59630206|NCT01276314|75743928|FG002|COMPLETED|Overall Study||18||
59630207|NCT01276314|75743929|FG003|COMPLETED|Overall Study||17||
59630208|NCT01276314|75743926|FG000|NOT COMPLETED|Overall Study||10||
59630209|NCT01276314|75743927|FG001|NOT COMPLETED|Overall Study||10||
59630210|NCT01276314|75743928|FG002|NOT COMPLETED|Overall Study||4||
59630211|NCT01276314|75743929|FG003|NOT COMPLETED|Overall Study||5||
59630212|NCT01276860|75743941|FG000|STARTED|Overall Study||5||
59630213|NCT01276860|75743942|FG001|STARTED|Overall Study||2||
59630214|NCT01276860|75743941|FG000|COMPLETED|Overall Study||5||
59630215|NCT01276860|75743942|FG001|COMPLETED|Overall Study||2||
59630216|NCT01276860|75743941|FG000|NOT COMPLETED|Overall Study||0||
59630217|NCT01276860|75743942|FG001|NOT COMPLETED|Overall Study||0||
59630218|NCT01280058|75743950|FG000|STARTED|Overall Study||36||
59630219|NCT01280058|75743951|FG001|STARTED|Overall Study||37||
59630220|NCT01280058|75743950|FG000|COMPLETED|Overall Study||36||
59630221|NCT01280058|75743951|FG001|COMPLETED|Overall Study||37||
59630222|NCT01280058|75743950|FG000|NOT COMPLETED|Overall Study||0||
59630223|NCT01280058|75743951|FG001|NOT COMPLETED|Overall Study||0||
59630224|NCT01280604|75743961|FG000|STARTED|Overall Study||33||
59630225|NCT01280604|75743962|FG001|STARTED|Overall Study||33||
59630226|NCT01280604|75743961|FG000|Subjects Meeting All Inclusion Criteria|Overall Study||25||
59630227|NCT01280604|75743962|FG001|Subjects Meeting All Inclusion Criteria|Overall Study||29||
59630228|NCT01280604|75743961|FG000|COMPLETED|Overall Study||24||
59630229|NCT01280604|75743962|FG001|COMPLETED|Overall Study||28||
59630230|NCT01280604|75743961|FG000|NOT COMPLETED|Overall Study||9||
59630231|NCT01280604|75743962|FG001|NOT COMPLETED|Overall Study||5||
59630232|NCT01282086|75743968|FG000|STARTED|Overall Study||1365||
59630233|NCT01282086|75743968|FG000|COMPLETED|Overall Study||1365||
59630234|NCT01282086|75743968|FG000|NOT COMPLETED|Overall Study||0||
59630235|NCT01282242|75743975|FG000|STARTED|Overall Study||80||
59630236|NCT01282242|75743976|FG001|STARTED|Overall Study||8||
59630237|NCT01282242|75743975|FG000|COMPLETED|Overall Study||80||
59630238|NCT01282242|75743976|FG001|COMPLETED|Overall Study||8||
59630239|NCT01282242|75743975|FG000|NOT COMPLETED|Overall Study||0||
59630240|NCT01282242|75743976|FG001|NOT COMPLETED|Overall Study||0||
59630241|NCT01282710|75743982|FG000|STARTED|Overall Study||20||
59630242|NCT01282710|75743982|FG000|COMPLETED|Overall Study||20||
59630243|NCT01282710|75743982|FG000|NOT COMPLETED|Overall Study||0||
59630244|NCT01283022|75743986|FG000|STARTED|Overall Study||24||
59630245|NCT01283022|75743986|FG000|COMPLETED|Overall Study||24||
59630246|NCT01283022|75743986|FG000|NOT COMPLETED|Overall Study||0||
59630247|NCT01284426|75743991|FG000|STARTED|Overall Study||94||
59630248|NCT01284426|75743991|FG000|COMPLETED|Overall Study||92||
59630249|NCT01284426|75743991|FG000|NOT COMPLETED|Overall Study||2||
59630250|NCT01285050|75743995|FG000|STARTED|Overall Study||20||
59630251|NCT01285050|75743995|FG000|COMPLETED|Overall Study||19||
59630252|NCT01285050|75743995|FG000|NOT COMPLETED|Overall Study||1||
59630253|NCT01286454|75744000|FG000|STARTED|Part I- First Intervention Period||2||
59815673|NCT03606213|75938138|FG001|STARTED|Overall Study||16||
59630254|NCT01286454|75744001|FG001|STARTED|Part I- First Intervention Period||2||
59630255|NCT01286454|75744002|FG002|STARTED|Part I- First Intervention Period||2||
59630256|NCT01286454|75744003|FG003|STARTED|Part I- First Intervention Period||2||
59630257|NCT01286454|75744004|FG004|STARTED|Part I- First Intervention Period||2||
59630258|NCT01286454|75744005|FG005|STARTED|Part I- First Intervention Period||2||
59630259|NCT01286454|75744006|FG006|STARTED|Part I- First Intervention Period||2||
59630260|NCT01286454|75744007|FG007|STARTED|Part I- First Intervention Period||2||
59630261|NCT01286454|75744008|FG008|STARTED|Part I- First Intervention Period||2||
59630262|NCT01286454|75744009|FG009|STARTED|Part I- First Intervention Period||2||
59630263|NCT01286454|75744010|FG010|STARTED|Part I- First Intervention Period||0||
59630264|NCT01286454|75744000|FG000|COMPLETED|Part I- First Intervention Period||2||
59630265|NCT01286454|75744001|FG001|COMPLETED|Part I- First Intervention Period||2||
59630266|NCT01286454|75744002|FG002|COMPLETED|Part I- First Intervention Period||2||
59630267|NCT01286454|75744003|FG003|COMPLETED|Part I- First Intervention Period||2||
59630268|NCT01286454|75744004|FG004|COMPLETED|Part I- First Intervention Period||2||
59630269|NCT01286454|75744005|FG005|COMPLETED|Part I- First Intervention Period||2||
59630270|NCT01286454|75744006|FG006|COMPLETED|Part I- First Intervention Period||2||
59630271|NCT01286454|75744007|FG007|COMPLETED|Part I- First Intervention Period||2||
59630272|NCT01286454|75744008|FG008|COMPLETED|Part I- First Intervention Period||2||
59630273|NCT01286454|75744009|FG009|COMPLETED|Part I- First Intervention Period||2||
59630274|NCT01286454|75744010|FG010|COMPLETED|Part I- First Intervention Period||0||
59630275|NCT01286454|75744000|FG000|NOT COMPLETED|Part I- First Intervention Period||0||
59630276|NCT01286454|75744001|FG001|NOT COMPLETED|Part I- First Intervention Period||0||
59630277|NCT01286454|75744002|FG002|NOT COMPLETED|Part I- First Intervention Period||0||
59630278|NCT01286454|75744003|FG003|NOT COMPLETED|Part I- First Intervention Period||0||
59630279|NCT01286454|75744004|FG004|NOT COMPLETED|Part I- First Intervention Period||0||
59630280|NCT01286454|75744005|FG005|NOT COMPLETED|Part I- First Intervention Period||0||
59630281|NCT01286454|75744006|FG006|NOT COMPLETED|Part I- First Intervention Period||0||
59630282|NCT01286454|75744007|FG007|NOT COMPLETED|Part I- First Intervention Period||0||
59630283|NCT01286454|75744008|FG008|NOT COMPLETED|Part I- First Intervention Period||0||
59630284|NCT01286454|75744009|FG009|NOT COMPLETED|Part I- First Intervention Period||0||
59630285|NCT01286454|75744010|FG010|NOT COMPLETED|Part I- First Intervention Period||0||
59630286|NCT01286454|75744000|FG000|STARTED|Washout Period (At Least 3 Days)||2||
59630287|NCT01286454|75744001|FG001|STARTED|Washout Period (At Least 3 Days)||2||
59630288|NCT01286454|75744002|FG002|STARTED|Washout Period (At Least 3 Days)||2||
59630289|NCT01286454|75744003|FG003|STARTED|Washout Period (At Least 3 Days)||2||
59630290|NCT01286454|75744004|FG004|STARTED|Washout Period (At Least 3 Days)||2||
59630291|NCT01286454|75744005|FG005|STARTED|Washout Period (At Least 3 Days)||2||
59630292|NCT01286454|75744006|FG006|STARTED|Washout Period (At Least 3 Days)||2||
59630293|NCT01286454|75744007|FG007|STARTED|Washout Period (At Least 3 Days)||2||
59630294|NCT01286454|75744008|FG008|STARTED|Washout Period (At Least 3 Days)||2||
59630295|NCT01286454|75744009|FG009|STARTED|Washout Period (At Least 3 Days)||2||
59630296|NCT01286454|75744010|FG010|STARTED|Washout Period (At Least 3 Days)||0||
59630297|NCT01286454|75744000|FG000|COMPLETED|Washout Period (At Least 3 Days)||2||
59630298|NCT01286454|75744001|FG001|COMPLETED|Washout Period (At Least 3 Days)||2||
59630299|NCT01286454|75744002|FG002|COMPLETED|Washout Period (At Least 3 Days)||2||
59630300|NCT01286454|75744003|FG003|COMPLETED|Washout Period (At Least 3 Days)||2||
59630301|NCT01286454|75744004|FG004|COMPLETED|Washout Period (At Least 3 Days)||2||
59630302|NCT01286454|75744005|FG005|COMPLETED|Washout Period (At Least 3 Days)||2||
59630303|NCT01286454|75744006|FG006|COMPLETED|Washout Period (At Least 3 Days)||2||
59630304|NCT01286454|75744007|FG007|COMPLETED|Washout Period (At Least 3 Days)||2||
59630305|NCT01286454|75744008|FG008|COMPLETED|Washout Period (At Least 3 Days)||2||
59630306|NCT01286454|75744009|FG009|COMPLETED|Washout Period (At Least 3 Days)||2||
59630307|NCT01286454|75744010|FG010|COMPLETED|Washout Period (At Least 3 Days)||0||
59630308|NCT01286454|75744000|FG000|NOT COMPLETED|Washout Period (At Least 3 Days)||0||
59630309|NCT01286454|75744001|FG001|NOT COMPLETED|Washout Period (At Least 3 Days)||0||
59630310|NCT01286454|75744002|FG002|NOT COMPLETED|Washout Period (At Least 3 Days)||0||
59630311|NCT01286454|75744003|FG003|NOT COMPLETED|Washout Period (At Least 3 Days)||0||
59630312|NCT01286454|75744004|FG004|NOT COMPLETED|Washout Period (At Least 3 Days)||0||
59630313|NCT01286454|75744005|FG005|NOT COMPLETED|Washout Period (At Least 3 Days)||0||
59630314|NCT01286454|75744006|FG006|NOT COMPLETED|Washout Period (At Least 3 Days)||0||
59630315|NCT01286454|75744007|FG007|NOT COMPLETED|Washout Period (At Least 3 Days)||0||
59630316|NCT01286454|75744008|FG008|NOT COMPLETED|Washout Period (At Least 3 Days)||0||
59630317|NCT01286454|75744009|FG009|NOT COMPLETED|Washout Period (At Least 3 Days)||0||
59630318|NCT01286454|75744010|FG010|NOT COMPLETED|Washout Period (At Least 3 Days)||0||
59630319|NCT01286454|75744000|FG000|STARTED|Second Intervention Period||2||
59630320|NCT01286454|75744001|FG001|STARTED|Second Intervention Period||2||
59630321|NCT01286454|75744002|FG002|STARTED|Second Intervention Period||2||
59630322|NCT01286454|75744003|FG003|STARTED|Second Intervention Period||2||
59630323|NCT01286454|75744004|FG004|STARTED|Second Intervention Period||2||
59630324|NCT01286454|75744005|FG005|STARTED|Second Intervention Period||2||
59630325|NCT01286454|75744006|FG006|STARTED|Second Intervention Period||2||
59630326|NCT01286454|75744007|FG007|STARTED|Second Intervention Period||2||
59630327|NCT01286454|75744008|FG008|STARTED|Second Intervention Period||2||
59630328|NCT01286454|75744009|FG009|STARTED|Second Intervention Period||2||
59630329|NCT01286454|75744010|FG010|STARTED|Second Intervention Period||0||
59630330|NCT01286454|75744000|FG000|COMPLETED|Second Intervention Period||2||
59630331|NCT01286454|75744001|FG001|COMPLETED|Second Intervention Period||2||
59630332|NCT01286454|75744002|FG002|COMPLETED|Second Intervention Period||2||
59630333|NCT01286454|75744003|FG003|COMPLETED|Second Intervention Period||2||
59630334|NCT01286454|75744004|FG004|COMPLETED|Second Intervention Period||2||
59630335|NCT01286454|75744005|FG005|COMPLETED|Second Intervention Period||2||
59630336|NCT01286454|75744006|FG006|COMPLETED|Second Intervention Period||2||
59630337|NCT01286454|75744007|FG007|COMPLETED|Second Intervention Period||2||
59630338|NCT01286454|75744008|FG008|COMPLETED|Second Intervention Period||2||
59630339|NCT01286454|75744009|FG009|COMPLETED|Second Intervention Period||2||
59630340|NCT01286454|75744010|FG010|COMPLETED|Second Intervention Period||0||
59630341|NCT01286454|75744000|FG000|NOT COMPLETED|Second Intervention Period||0||
59630342|NCT01286454|75744001|FG001|NOT COMPLETED|Second Intervention Period||0||
59630343|NCT01286454|75744002|FG002|NOT COMPLETED|Second Intervention Period||0||
59630344|NCT01286454|75744003|FG003|NOT COMPLETED|Second Intervention Period||0||
59630345|NCT01286454|75744004|FG004|NOT COMPLETED|Second Intervention Period||0||
59630346|NCT01286454|75744005|FG005|NOT COMPLETED|Second Intervention Period||0||
59630347|NCT01286454|75744006|FG006|NOT COMPLETED|Second Intervention Period||0||
59630348|NCT01286454|75744007|FG007|NOT COMPLETED|Second Intervention Period||0||
59630349|NCT01286454|75744008|FG008|NOT COMPLETED|Second Intervention Period||0||
59630350|NCT01286454|75744009|FG009|NOT COMPLETED|Second Intervention Period||0||
59630351|NCT01286454|75744010|FG010|NOT COMPLETED|Second Intervention Period||0||
59630352|NCT01286454|75744000|FG000|STARTED|Washout Period (At Least 3 Days)||2||
59630353|NCT01286454|75744001|FG001|STARTED|Washout Period (At Least 3 Days)||2||
59630354|NCT01286454|75744002|FG002|STARTED|Washout Period (At Least 3 Days)||2||
59630355|NCT01286454|75744003|FG003|STARTED|Washout Period (At Least 3 Days)||2||
59630356|NCT01286454|75744004|FG004|STARTED|Washout Period (At Least 3 Days)||2||
59630357|NCT01286454|75744005|FG005|STARTED|Washout Period (At Least 3 Days)||2||
59630358|NCT01286454|75744006|FG006|STARTED|Washout Period (At Least 3 Days)||2||
59630359|NCT01286454|75744007|FG007|STARTED|Washout Period (At Least 3 Days)||2||
59630360|NCT01286454|75744008|FG008|STARTED|Washout Period (At Least 3 Days)||2||
59630361|NCT01286454|75744009|FG009|STARTED|Washout Period (At Least 3 Days)||2||
59630362|NCT01286454|75744010|FG010|STARTED|Washout Period (At Least 3 Days)||0||
59630363|NCT01286454|75744000|FG000|COMPLETED|Washout Period (At Least 3 Days)||2||
59630364|NCT01286454|75744001|FG001|COMPLETED|Washout Period (At Least 3 Days)||2||
59630365|NCT01286454|75744002|FG002|COMPLETED|Washout Period (At Least 3 Days)||2||
59630366|NCT01286454|75744003|FG003|COMPLETED|Washout Period (At Least 3 Days)||2||
59630367|NCT01286454|75744004|FG004|COMPLETED|Washout Period (At Least 3 Days)||2||
59630368|NCT01286454|75744005|FG005|COMPLETED|Washout Period (At Least 3 Days)||2||
59630369|NCT01286454|75744006|FG006|COMPLETED|Washout Period (At Least 3 Days)||2||
59630370|NCT01286454|75744007|FG007|COMPLETED|Washout Period (At Least 3 Days)||2||
59630371|NCT01286454|75744008|FG008|COMPLETED|Washout Period (At Least 3 Days)||2||
59630372|NCT01286454|75744009|FG009|COMPLETED|Washout Period (At Least 3 Days)||2||
59630373|NCT01286454|75744010|FG010|COMPLETED|Washout Period (At Least 3 Days)||0||
59630374|NCT01286454|75744000|FG000|NOT COMPLETED|Washout Period (At Least 3 Days)||0||
59630375|NCT01286454|75744001|FG001|NOT COMPLETED|Washout Period (At Least 3 Days)||0||
59630376|NCT01286454|75744002|FG002|NOT COMPLETED|Washout Period (At Least 3 Days)||0||
59630377|NCT01286454|75744003|FG003|NOT COMPLETED|Washout Period (At Least 3 Days)||0||
59630378|NCT01286454|75744004|FG004|NOT COMPLETED|Washout Period (At Least 3 Days)||0||
59630379|NCT01286454|75744005|FG005|NOT COMPLETED|Washout Period (At Least 3 Days)||0||
59630380|NCT01286454|75744006|FG006|NOT COMPLETED|Washout Period (At Least 3 Days)||0||
59630381|NCT01286454|75744007|FG007|NOT COMPLETED|Washout Period (At Least 3 Days)||0||
59630382|NCT01286454|75744008|FG008|NOT COMPLETED|Washout Period (At Least 3 Days)||0||
59630383|NCT01286454|75744009|FG009|NOT COMPLETED|Washout Period (At Least 3 Days)||0||
59630384|NCT01286454|75744010|FG010|NOT COMPLETED|Washout Period (At Least 3 Days)||0||
59630385|NCT01286454|75744000|FG000|STARTED|Third Intervention Period||2||
59630386|NCT01286454|75744001|FG001|STARTED|Third Intervention Period||2||
59630387|NCT01286454|75744002|FG002|STARTED|Third Intervention Period||2||
59630388|NCT01286454|75744003|FG003|STARTED|Third Intervention Period||2||
59630389|NCT01286454|75744004|FG004|STARTED|Third Intervention Period||2||
59630390|NCT01286454|75744005|FG005|STARTED|Third Intervention Period||2||
59630391|NCT01286454|75744006|FG006|STARTED|Third Intervention Period||2||
59630392|NCT01286454|75744007|FG007|STARTED|Third Intervention Period||2||
59630393|NCT01286454|75744008|FG008|STARTED|Third Intervention Period||2||
59630394|NCT01286454|75744009|FG009|STARTED|Third Intervention Period||2||
59630395|NCT01286454|75744010|FG010|STARTED|Third Intervention Period||0||
59630396|NCT01286454|75744000|FG000|COMPLETED|Third Intervention Period||2||
59630397|NCT01286454|75744001|FG001|COMPLETED|Third Intervention Period||2||
59630398|NCT01286454|75744002|FG002|COMPLETED|Third Intervention Period||2||
59630399|NCT01286454|75744003|FG003|COMPLETED|Third Intervention Period||2||
59630400|NCT01286454|75744004|FG004|COMPLETED|Third Intervention Period||2||
59630401|NCT01286454|75744005|FG005|COMPLETED|Third Intervention Period||2||
59630402|NCT01286454|75744006|FG006|COMPLETED|Third Intervention Period||2||
59630403|NCT01286454|75744007|FG007|COMPLETED|Third Intervention Period||2||
59630404|NCT01286454|75744008|FG008|COMPLETED|Third Intervention Period||2||
59630405|NCT01286454|75744009|FG009|COMPLETED|Third Intervention Period||2||
59630406|NCT01286454|75744010|FG010|COMPLETED|Third Intervention Period||0||
59630407|NCT01286454|75744000|FG000|NOT COMPLETED|Third Intervention Period||0||
59630408|NCT01286454|75744001|FG001|NOT COMPLETED|Third Intervention Period||0||
59630409|NCT01286454|75744002|FG002|NOT COMPLETED|Third Intervention Period||0||
59630410|NCT01286454|75744003|FG003|NOT COMPLETED|Third Intervention Period||0||
59630411|NCT01286454|75744004|FG004|NOT COMPLETED|Third Intervention Period||0||
59630412|NCT01286454|75744005|FG005|NOT COMPLETED|Third Intervention Period||0||
59630413|NCT01286454|75744006|FG006|NOT COMPLETED|Third Intervention Period||0||
59630414|NCT01286454|75744007|FG007|NOT COMPLETED|Third Intervention Period||0||
59630415|NCT01286454|75744008|FG008|NOT COMPLETED|Third Intervention Period||0||
59630416|NCT01286454|75744009|FG009|NOT COMPLETED|Third Intervention Period||0||
59630417|NCT01286454|75744010|FG010|NOT COMPLETED|Third Intervention Period||0||
59630418|NCT01286454|75744000|FG000|STARTED|Washout Period (At Least 3 Days)||2||
59630419|NCT01286454|75744001|FG001|STARTED|Washout Period (At Least 3 Days)||2||
59630420|NCT01286454|75744002|FG002|STARTED|Washout Period (At Least 3 Days)||2||
59630421|NCT01286454|75744003|FG003|STARTED|Washout Period (At Least 3 Days)||2||
59630422|NCT01286454|75744004|FG004|STARTED|Washout Period (At Least 3 Days)||2||
59630423|NCT01286454|75744005|FG005|STARTED|Washout Period (At Least 3 Days)||2||
59630424|NCT01286454|75744006|FG006|STARTED|Washout Period (At Least 3 Days)||2||
59630425|NCT01286454|75744007|FG007|STARTED|Washout Period (At Least 3 Days)||2||
59630426|NCT01286454|75744008|FG008|STARTED|Washout Period (At Least 3 Days)||2||
59630427|NCT01286454|75744009|FG009|STARTED|Washout Period (At Least 3 Days)||2||
59630428|NCT01286454|75744010|FG010|STARTED|Washout Period (At Least 3 Days)||0||
59630429|NCT01286454|75744000|FG000|COMPLETED|Washout Period (At Least 3 Days)||2||
59630430|NCT01286454|75744001|FG001|COMPLETED|Washout Period (At Least 3 Days)||2||
59630431|NCT01286454|75744002|FG002|COMPLETED|Washout Period (At Least 3 Days)||2||
59630432|NCT01286454|75744003|FG003|COMPLETED|Washout Period (At Least 3 Days)||2||
59630433|NCT01286454|75744004|FG004|COMPLETED|Washout Period (At Least 3 Days)||2||
59630434|NCT01286454|75744005|FG005|COMPLETED|Washout Period (At Least 3 Days)||2||
59630435|NCT01286454|75744006|FG006|COMPLETED|Washout Period (At Least 3 Days)||2||
59630436|NCT01286454|75744007|FG007|COMPLETED|Washout Period (At Least 3 Days)||2||
59630437|NCT01286454|75744008|FG008|COMPLETED|Washout Period (At Least 3 Days)||2||
59630438|NCT01286454|75744009|FG009|COMPLETED|Washout Period (At Least 3 Days)||2||
59630439|NCT01286454|75744010|FG010|COMPLETED|Washout Period (At Least 3 Days)||0||
59630440|NCT01286454|75744000|FG000|NOT COMPLETED|Washout Period (At Least 3 Days)||0||
59630441|NCT01286454|75744001|FG001|NOT COMPLETED|Washout Period (At Least 3 Days)||0||
59630442|NCT01286454|75744002|FG002|NOT COMPLETED|Washout Period (At Least 3 Days)||0||
59630443|NCT01286454|75744003|FG003|NOT COMPLETED|Washout Period (At Least 3 Days)||0||
59630444|NCT01286454|75744004|FG004|NOT COMPLETED|Washout Period (At Least 3 Days)||0||
59630445|NCT01286454|75744005|FG005|NOT COMPLETED|Washout Period (At Least 3 Days)||0||
59630446|NCT01286454|75744006|FG006|NOT COMPLETED|Washout Period (At Least 3 Days)||0||
59630447|NCT01286454|75744007|FG007|NOT COMPLETED|Washout Period (At Least 3 Days)||0||
59630448|NCT01286454|75744008|FG008|NOT COMPLETED|Washout Period (At Least 3 Days)||0||
59630449|NCT01286454|75744009|FG009|NOT COMPLETED|Washout Period (At Least 3 Days)||0||
59630450|NCT01286454|75744010|FG010|NOT COMPLETED|Washout Period (At Least 3 Days)||0||
59630451|NCT01286454|75744000|FG000|STARTED|Fourth Intervention Period||2||
59630452|NCT01286454|75744001|FG001|STARTED|Fourth Intervention Period||2||
59630453|NCT01286454|75744002|FG002|STARTED|Fourth Intervention Period||2||
59630454|NCT01286454|75744003|FG003|STARTED|Fourth Intervention Period||2||
59630455|NCT01286454|75744004|FG004|STARTED|Fourth Intervention Period||2||
59630456|NCT01286454|75744005|FG005|STARTED|Fourth Intervention Period||2||
59630457|NCT01286454|75744006|FG006|STARTED|Fourth Intervention Period||2||
59630458|NCT01286454|75744007|FG007|STARTED|Fourth Intervention Period||2||
59630459|NCT01286454|75744008|FG008|STARTED|Fourth Intervention Period||2||
59630460|NCT01286454|75744009|FG009|STARTED|Fourth Intervention Period||2||
59630461|NCT01286454|75744010|FG010|STARTED|Fourth Intervention Period||0||
59630462|NCT01286454|75744000|FG000|COMPLETED|Fourth Intervention Period||2||
59630463|NCT01286454|75744001|FG001|COMPLETED|Fourth Intervention Period||2||
59630464|NCT01286454|75744002|FG002|COMPLETED|Fourth Intervention Period||2||
59630465|NCT01286454|75744003|FG003|COMPLETED|Fourth Intervention Period||2||
59630466|NCT01286454|75744004|FG004|COMPLETED|Fourth Intervention Period||2||
59630467|NCT01286454|75744005|FG005|COMPLETED|Fourth Intervention Period||2||
59630468|NCT01286454|75744006|FG006|COMPLETED|Fourth Intervention Period||2||
59630469|NCT01286454|75744007|FG007|COMPLETED|Fourth Intervention Period||2||
59988265|NCT02367352|76103386|FG001|NOT COMPLETED|Overall Study||0||
59630470|NCT01286454|75744008|FG008|COMPLETED|Fourth Intervention Period||2||
59630471|NCT01286454|75744009|FG009|COMPLETED|Fourth Intervention Period||2||
59630472|NCT01286454|75744010|FG010|COMPLETED|Fourth Intervention Period||0||
59539979|NCT01393457|75638296|FG000|COMPLETED|Overall Study||14||
59539980|NCT01393457|75638297|FG001|COMPLETED|Overall Study||14||
59539981|NCT01393457|75638298|FG002|COMPLETED|Overall Study||16||
59539982|NCT01393457|75638299|FG003|COMPLETED|Overall Study||15||
59539983|NCT01393457|75638296|FG000|NOT COMPLETED|Overall Study||12||
59539984|NCT01393457|75638297|FG001|NOT COMPLETED|Overall Study||12||
59630473|NCT01286454|75744000|FG000|NOT COMPLETED|Fourth Intervention Period||0||
59539985|NCT01393457|75638298|FG002|NOT COMPLETED|Overall Study||15||
59539986|NCT01393457|75638299|FG003|NOT COMPLETED|Overall Study||12||
59539987|NCT02518464|75638309|FG000|STARTED|Overall Study||40||
59539988|NCT02518464|75638309|FG000|COMPLETED|Overall Study||38||
59539989|NCT02518464|75638309|FG000|NOT COMPLETED|Overall Study||2||
59539990|NCT02510820|75638313|FG000|STARTED|First Intervention (4 Weeks)||21||
59539991|NCT02510820|75638314|FG001|STARTED|First Intervention (4 Weeks)||27||
59539992|NCT02510820|75638313|FG000|COMPLETED|First Intervention (4 Weeks)||21||
59539993|NCT02510820|75638314|FG001|COMPLETED|First Intervention (4 Weeks)||26||
59539994|NCT02510820|75638313|FG000|NOT COMPLETED|First Intervention (4 Weeks)||0||
59539995|NCT02510820|75638314|FG001|NOT COMPLETED|First Intervention (4 Weeks)||1||
59539996|NCT02510820|75638313|FG000|STARTED|Washout (1 Week)||21||
59539997|NCT02510820|75638314|FG001|STARTED|Washout (1 Week)||26||
59539998|NCT02510820|75638313|FG000|COMPLETED|Washout (1 Week)||21||
59539999|NCT02510820|75638314|FG001|COMPLETED|Washout (1 Week)||26||
59540000|NCT02510820|75638313|FG000|NOT COMPLETED|Washout (1 Week)||0||
59540001|NCT02510820|75638314|FG001|NOT COMPLETED|Washout (1 Week)||0||
59540002|NCT02510820|75638313|FG000|STARTED|Second Intervention (4 Weeks)||21||
59540003|NCT02510820|75638314|FG001|STARTED|Second Intervention (4 Weeks)||26||
59540004|NCT02510820|75638313|FG000|COMPLETED|Second Intervention (4 Weeks)||20||
59540005|NCT02510820|75638314|FG001|COMPLETED|Second Intervention (4 Weeks)||26||
59540006|NCT02510820|75638313|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||1||
59540007|NCT02510820|75638314|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||0||
59540008|NCT02510664|75638324|FG000|STARTED|Overall Study||84|of 84 consented, n=20 did not receive any intervention (see description in Pre-assignment details)|
59540009|NCT02510664|75638325|FG001|STARTED|Overall Study||84|of 84 consented, n=20 did not receive any intervention (see description in Pre-assignment details)|
59540010|NCT02510664|75638326|FG002|STARTED|Overall Study||4|of 84 consented, n=20 did not receive any intervention (see description in Pre-assignment details)|
59540011|NCT02510664|75638324|FG000|COMPLETED|Overall Study||64||
59540012|NCT02510664|75638325|FG001|COMPLETED|Overall Study||64||
59540013|NCT02510664|75638326|FG002|COMPLETED|Overall Study||4||
59540014|NCT02510664|75638324|FG000|NOT COMPLETED|Overall Study||20||
59540015|NCT02510664|75638325|FG001|NOT COMPLETED|Overall Study||20||
59540016|NCT02510664|75638326|FG002|NOT COMPLETED|Overall Study||0||
59540017|NCT01509677|75638341|FG000|STARTED|Overall Study||79||
59540018|NCT01509677|75638342|FG001|STARTED|Overall Study||79||
59540019|NCT01509677|75638341|FG000|COMPLETED|Overall Study||76||
59540020|NCT01509677|75638342|FG001|COMPLETED|Overall Study||73||
59540021|NCT01509677|75638341|FG000|NOT COMPLETED|Overall Study||3||
59540022|NCT01509677|75638342|FG001|NOT COMPLETED|Overall Study||6||
59540023|NCT01510379|75638350|FG000|STARTED|Overall Study||49||
59540024|NCT01510379|75638351|FG001|STARTED|Overall Study||51||
59540025|NCT01510379|75638350|FG000|COMPLETED|Overall Study||49||
59540026|NCT01510379|75638351|FG001|COMPLETED|Overall Study||51||
59540027|NCT01510379|75638350|FG000|NOT COMPLETED|Overall Study||0||
59540028|NCT01510379|75638351|FG001|NOT COMPLETED|Overall Study||0||
59540029|NCT01363986|75638357|FG000|STARTED|Overall Study||3||
59540030|NCT01363986|75638357|FG000|COMPLETED|Overall Study||2||
59540031|NCT01363986|75638357|FG000|NOT COMPLETED|Overall Study||1||
59540032|NCT01510457|75638363|FG000|STARTED|Overall Study||17||
59540033|NCT01510457|75638364|FG001|STARTED|Overall Study||29||
59540034|NCT01510457|75638363|FG000|COMPLETED|Overall Study||12||
59540035|NCT01510457|75638364|FG001|COMPLETED|Overall Study||26||
59540036|NCT01510457|75638363|FG000|NOT COMPLETED|Overall Study||5||
59540037|NCT01510457|75638364|FG001|NOT COMPLETED|Overall Study||3||
59540038|NCT01430741|75638376|FG000|STARTED|Overall Study||22||
59540039|NCT01430741|75638377|FG001|STARTED|Overall Study||87||
59540040|NCT01430741|75638378|FG002|STARTED|Overall Study||47||
59540041|NCT01430741|75638379|FG003|STARTED|Overall Study||81||
59540042|NCT01430741|75638376|FG000|COMPLETED|Overall Study||22||
59540043|NCT01430741|75638377|FG001|COMPLETED|Overall Study||87||
59540044|NCT01430741|75638378|FG002|COMPLETED|Overall Study||37||
59540045|NCT01430741|75638379|FG003|COMPLETED|Overall Study||81||
59540046|NCT01430741|75638376|FG000|NOT COMPLETED|Overall Study||0||
59540047|NCT01430741|75638377|FG001|NOT COMPLETED|Overall Study||0||
59540048|NCT01430741|75638378|FG002|NOT COMPLETED|Overall Study||10||
59540049|NCT01430741|75638379|FG003|NOT COMPLETED|Overall Study||0||
59540050|NCT02478372|75638391|FG000|STARTED|Overall Study||121||
59540051|NCT02478372|75638392|FG001|STARTED|Overall Study||121||
59540052|NCT02478372|75638391|FG000|Recieved Allocation Intervention|Overall Study||109||
59540053|NCT02478372|75638392|FG001|Recieved Allocation Intervention|Overall Study||113||
59540054|NCT02478372|75638391|FG000|Reviewed at Six Weeks|Overall Study|Routine follow up at six weeks - one patient refused to attend|108||
59540055|NCT02478372|75638392|FG001|Reviewed at Six Weeks|Overall Study|Routine follow up at six weeks|113||
59815674|NCT03606213|75938139|FG002|STARTED|Overall Study||14||
59630474|NCT01286454|75744001|FG001|NOT COMPLETED|Fourth Intervention Period||0||
59630475|NCT01286454|75744002|FG002|NOT COMPLETED|Fourth Intervention Period||0||
59630476|NCT01286454|75744003|FG003|NOT COMPLETED|Fourth Intervention Period||0||
59630477|NCT01286454|75744004|FG004|NOT COMPLETED|Fourth Intervention Period||0||
59630478|NCT01286454|75744005|FG005|NOT COMPLETED|Fourth Intervention Period||0||
59630479|NCT01286454|75744006|FG006|NOT COMPLETED|Fourth Intervention Period||0||
59630480|NCT01286454|75744007|FG007|NOT COMPLETED|Fourth Intervention Period||0||
59630481|NCT01286454|75744008|FG008|NOT COMPLETED|Fourth Intervention Period||0||
59630482|NCT01286454|75744009|FG009|NOT COMPLETED|Fourth Intervention Period||0||
59630483|NCT01286454|75744010|FG010|NOT COMPLETED|Fourth Intervention Period||0||
59630484|NCT01286454|75744000|FG000|STARTED|Washout Period (At Least 3 Days)||2||
59630485|NCT01286454|75744001|FG001|STARTED|Washout Period (At Least 3 Days)||2||
59630486|NCT01286454|75744002|FG002|STARTED|Washout Period (At Least 3 Days)||2||
59630487|NCT01286454|75744003|FG003|STARTED|Washout Period (At Least 3 Days)||2||
59630488|NCT01286454|75744004|FG004|STARTED|Washout Period (At Least 3 Days)||2||
59630489|NCT01286454|75744005|FG005|STARTED|Washout Period (At Least 3 Days)||2||
59630490|NCT01286454|75744006|FG006|STARTED|Washout Period (At Least 3 Days)||2||
59630491|NCT01286454|75744007|FG007|STARTED|Washout Period (At Least 3 Days)||2||
59630492|NCT01286454|75744008|FG008|STARTED|Washout Period (At Least 3 Days)||2||
59630493|NCT01286454|75744009|FG009|STARTED|Washout Period (At Least 3 Days)||2||
59630494|NCT01286454|75744010|FG010|STARTED|Washout Period (At Least 3 Days)||0||
59630495|NCT01286454|75744000|FG000|COMPLETED|Washout Period (At Least 3 Days)||2||
59630496|NCT01286454|75744001|FG001|COMPLETED|Washout Period (At Least 3 Days)||2||
59630497|NCT01286454|75744002|FG002|COMPLETED|Washout Period (At Least 3 Days)||2||
59630498|NCT01286454|75744003|FG003|COMPLETED|Washout Period (At Least 3 Days)||2||
59630499|NCT01286454|75744004|FG004|COMPLETED|Washout Period (At Least 3 Days)||2||
59630500|NCT01286454|75744005|FG005|COMPLETED|Washout Period (At Least 3 Days)||2||
59630501|NCT01286454|75744006|FG006|COMPLETED|Washout Period (At Least 3 Days)||2||
59630502|NCT01286454|75744007|FG007|COMPLETED|Washout Period (At Least 3 Days)||2||
59630503|NCT01286454|75744008|FG008|COMPLETED|Washout Period (At Least 3 Days)||2||
59630504|NCT01286454|75744009|FG009|COMPLETED|Washout Period (At Least 3 Days)||2||
59630505|NCT01286454|75744010|FG010|COMPLETED|Washout Period (At Least 3 Days)||0||
59630506|NCT01286454|75744000|FG000|NOT COMPLETED|Washout Period (At Least 3 Days)||0||
59630507|NCT01286454|75744001|FG001|NOT COMPLETED|Washout Period (At Least 3 Days)||0||
59630508|NCT01286454|75744002|FG002|NOT COMPLETED|Washout Period (At Least 3 Days)||0||
59630509|NCT01286454|75744003|FG003|NOT COMPLETED|Washout Period (At Least 3 Days)||0||
59630510|NCT01286454|75744004|FG004|NOT COMPLETED|Washout Period (At Least 3 Days)||0||
59630511|NCT01286454|75744005|FG005|NOT COMPLETED|Washout Period (At Least 3 Days)||0||
59630512|NCT01286454|75744006|FG006|NOT COMPLETED|Washout Period (At Least 3 Days)||0||
59630513|NCT01286454|75744007|FG007|NOT COMPLETED|Washout Period (At Least 3 Days)||0||
59630514|NCT01286454|75744008|FG008|NOT COMPLETED|Washout Period (At Least 3 Days)||0||
59630515|NCT01286454|75744009|FG009|NOT COMPLETED|Washout Period (At Least 3 Days)||0||
59630516|NCT01286454|75744010|FG010|NOT COMPLETED|Washout Period (At Least 3 Days)||0||
59630517|NCT01286454|75744000|FG000|STARTED|Fifth Intervention Period||2||
59630518|NCT01286454|75744001|FG001|STARTED|Fifth Intervention Period||2||
59630519|NCT01286454|75744002|FG002|STARTED|Fifth Intervention Period||2||
59630520|NCT01286454|75744003|FG003|STARTED|Fifth Intervention Period||2||
59630521|NCT01286454|75744004|FG004|STARTED|Fifth Intervention Period||2||
59630522|NCT01286454|75744005|FG005|STARTED|Fifth Intervention Period||2||
59630523|NCT01286454|75744006|FG006|STARTED|Fifth Intervention Period||2||
59630524|NCT01286454|75744007|FG007|STARTED|Fifth Intervention Period||2||
59630525|NCT01286454|75744008|FG008|STARTED|Fifth Intervention Period||2||
59630526|NCT01286454|75744009|FG009|STARTED|Fifth Intervention Period||2||
59630527|NCT01286454|75744010|FG010|STARTED|Fifth Intervention Period||0||
59630528|NCT01286454|75744000|FG000|COMPLETED|Fifth Intervention Period||2||
59630529|NCT01286454|75744001|FG001|COMPLETED|Fifth Intervention Period||2||
59630530|NCT01286454|75744002|FG002|COMPLETED|Fifth Intervention Period||2||
59815675|NCT03606213|75938140|FG003|STARTED|Overall Study||11||
59815676|NCT03606213|75938137|FG000|COMPLETED|Overall Study||15||
59630531|NCT01286454|75744003|FG003|COMPLETED|Fifth Intervention Period||2||
59630532|NCT01286454|75744004|FG004|COMPLETED|Fifth Intervention Period||2||
59630533|NCT01286454|75744005|FG005|COMPLETED|Fifth Intervention Period||2||
59630534|NCT01286454|75744006|FG006|COMPLETED|Fifth Intervention Period||2||
59815677|NCT03606213|75938138|FG001|COMPLETED|Overall Study||16||
59630535|NCT01286454|75744007|FG007|COMPLETED|Fifth Intervention Period||2||
59630536|NCT01286454|75744008|FG008|COMPLETED|Fifth Intervention Period||2||
59630537|NCT01286454|75744009|FG009|COMPLETED|Fifth Intervention Period||2||
59630538|NCT01286454|75744010|FG010|COMPLETED|Fifth Intervention Period||0||
59630539|NCT01286454|75744000|FG000|NOT COMPLETED|Fifth Intervention Period||0||
59630540|NCT01286454|75744001|FG001|NOT COMPLETED|Fifth Intervention Period||0||
59630541|NCT01286454|75744002|FG002|NOT COMPLETED|Fifth Intervention Period||0||
59630542|NCT01286454|75744003|FG003|NOT COMPLETED|Fifth Intervention Period||0||
59630543|NCT01286454|75744004|FG004|NOT COMPLETED|Fifth Intervention Period||0||
59630544|NCT01286454|75744005|FG005|NOT COMPLETED|Fifth Intervention Period||0||
59815678|NCT03606213|75938139|FG002|COMPLETED|Overall Study||14||
59630545|NCT01286454|75744006|FG006|NOT COMPLETED|Fifth Intervention Period||0||
59630546|NCT01286454|75744007|FG007|NOT COMPLETED|Fifth Intervention Period||0||
59630547|NCT01286454|75744008|FG008|NOT COMPLETED|Fifth Intervention Period||0||
59630548|NCT01286454|75744009|FG009|NOT COMPLETED|Fifth Intervention Period||0||
59630549|NCT01286454|75744010|FG010|NOT COMPLETED|Fifth Intervention Period||0||
59630550|NCT01286454|75744000|FG000|STARTED|Washout Period (Approximately 2 Weeks)||2||
59630551|NCT01286454|75744001|FG001|STARTED|Washout Period (Approximately 2 Weeks)||2||
59630552|NCT01286454|75744002|FG002|STARTED|Washout Period (Approximately 2 Weeks)||2||
59630553|NCT01286454|75744003|FG003|STARTED|Washout Period (Approximately 2 Weeks)||2||
59630554|NCT01286454|75744004|FG004|STARTED|Washout Period (Approximately 2 Weeks)||2||
59630555|NCT01286454|75744005|FG005|STARTED|Washout Period (Approximately 2 Weeks)||2||
59630556|NCT01286454|75744006|FG006|STARTED|Washout Period (Approximately 2 Weeks)||2||
59630557|NCT01286454|75744007|FG007|STARTED|Washout Period (Approximately 2 Weeks)||2||
59630558|NCT01286454|75744008|FG008|STARTED|Washout Period (Approximately 2 Weeks)||2||
59630559|NCT01286454|75744009|FG009|STARTED|Washout Period (Approximately 2 Weeks)||2||
59630560|NCT01286454|75744010|FG010|STARTED|Washout Period (Approximately 2 Weeks)||0||
59630561|NCT01286454|75744000|FG000|COMPLETED|Washout Period (Approximately 2 Weeks)||2||
59630562|NCT01286454|75744001|FG001|COMPLETED|Washout Period (Approximately 2 Weeks)||2||
59630563|NCT01286454|75744002|FG002|COMPLETED|Washout Period (Approximately 2 Weeks)||2||
59630564|NCT01286454|75744003|FG003|COMPLETED|Washout Period (Approximately 2 Weeks)||2||
59630565|NCT01286454|75744004|FG004|COMPLETED|Washout Period (Approximately 2 Weeks)||2||
59630566|NCT01286454|75744005|FG005|COMPLETED|Washout Period (Approximately 2 Weeks)||2||
59630567|NCT01286454|75744006|FG006|COMPLETED|Washout Period (Approximately 2 Weeks)||2||
59630568|NCT01286454|75744007|FG007|COMPLETED|Washout Period (Approximately 2 Weeks)||2||
59630569|NCT01286454|75744008|FG008|COMPLETED|Washout Period (Approximately 2 Weeks)||2||
59630570|NCT01286454|75744009|FG009|COMPLETED|Washout Period (Approximately 2 Weeks)||2||
59630571|NCT01286454|75744010|FG010|COMPLETED|Washout Period (Approximately 2 Weeks)||0||
59630572|NCT01286454|75744000|FG000|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0||
59630573|NCT01286454|75744001|FG001|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0||
59630574|NCT01286454|75744002|FG002|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0||
59630575|NCT01286454|75744003|FG003|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0||
59630576|NCT01286454|75744004|FG004|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0||
59630577|NCT01286454|75744005|FG005|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0||
59630578|NCT01286454|75744006|FG006|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0||
59630579|NCT01286454|75744007|FG007|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0||
59630580|NCT01286454|75744008|FG008|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0||
59630581|NCT01286454|75744009|FG009|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0||
59630582|NCT01286454|75744010|FG010|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0||
59630583|NCT01286454|75744000|FG000|STARTED|Part II- Sixth Intervention Period||0||
59630584|NCT01286454|75744001|FG001|STARTED|Part II- Sixth Intervention Period||0||
59630585|NCT01286454|75744002|FG002|STARTED|Part II- Sixth Intervention Period||0||
59630586|NCT01286454|75744003|FG003|STARTED|Part II- Sixth Intervention Period||0||
59630587|NCT01286454|75744004|FG004|STARTED|Part II- Sixth Intervention Period||0||
59630588|NCT01286454|75744005|FG005|STARTED|Part II- Sixth Intervention Period||0||
59630589|NCT01286454|75744006|FG006|STARTED|Part II- Sixth Intervention Period||0||
59630590|NCT01286454|75744007|FG007|STARTED|Part II- Sixth Intervention Period||0||
59630591|NCT01286454|75744008|FG008|STARTED|Part II- Sixth Intervention Period||0||
59630592|NCT01286454|75744009|FG009|STARTED|Part II- Sixth Intervention Period||0||
59630593|NCT01286454|75744010|FG010|STARTED|Part II- Sixth Intervention Period||20||
59630594|NCT01286454|75744000|FG000|COMPLETED|Part II- Sixth Intervention Period||0||
59630595|NCT01286454|75744001|FG001|COMPLETED|Part II- Sixth Intervention Period||0||
59630596|NCT01286454|75744002|FG002|COMPLETED|Part II- Sixth Intervention Period||0||
59630597|NCT01286454|75744003|FG003|COMPLETED|Part II- Sixth Intervention Period||0||
59630598|NCT01286454|75744004|FG004|COMPLETED|Part II- Sixth Intervention Period||0||
59988266|NCT02367352|76103387|FG002|NOT COMPLETED|Overall Study||0||
59630599|NCT01286454|75744005|FG005|COMPLETED|Part II- Sixth Intervention Period||0||
59988267|NCT02365636|76103396|FG000|STARTED|Overall Study||100||
59988268|NCT02365636|76103397|FG001|STARTED|Overall Study||100||
59988269|NCT02365636|76103398|FG002|STARTED|Overall Study||100||
59988270|NCT02365636|76103396|FG000|Safety Population|Overall Study||100||
59988271|NCT02365636|76103397|FG001|Safety Population|Overall Study|2 terminated prior to treatment due to 1) prohibited concomitant medication 2) exclusion criteria|98||
59988272|NCT02365636|76103398|FG002|Safety Population|Overall Study||100||
59988273|NCT02365636|76103396|FG000|Full Analysis Set|Overall Study||100||
59988274|NCT02365636|76103397|FG001|Full Analysis Set|Overall Study||98||
59988275|NCT02365636|76103398|FG002|Full Analysis Set|Overall Study||100||
59988276|NCT02365636|76103396|FG000|COMPLETED|Overall Study||94||
59988277|NCT02365636|76103397|FG001|COMPLETED|Overall Study||93||
59988278|NCT02365636|76103398|FG002|COMPLETED|Overall Study||97||
59630600|NCT01286454|75744006|FG006|COMPLETED|Part II- Sixth Intervention Period||0||
59630601|NCT01286454|75744007|FG007|COMPLETED|Part II- Sixth Intervention Period||0||
59988279|NCT02365636|76103396|FG000|NOT COMPLETED|Overall Study||6||
59630602|NCT01286454|75744008|FG008|COMPLETED|Part II- Sixth Intervention Period||0||
59630603|NCT01286454|75744009|FG009|COMPLETED|Part II- Sixth Intervention Period||0||
59630604|NCT01286454|75744010|FG010|COMPLETED|Part II- Sixth Intervention Period||20||
59630605|NCT01286454|75744000|FG000|NOT COMPLETED|Part II- Sixth Intervention Period||0||
59630606|NCT01286454|75744001|FG001|NOT COMPLETED|Part II- Sixth Intervention Period||0||
59630607|NCT01286454|75744002|FG002|NOT COMPLETED|Part II- Sixth Intervention Period||0||
59630608|NCT01286454|75744003|FG003|NOT COMPLETED|Part II- Sixth Intervention Period||0||
59630609|NCT01286454|75744004|FG004|NOT COMPLETED|Part II- Sixth Intervention Period||0||
59630610|NCT01286454|75744005|FG005|NOT COMPLETED|Part II- Sixth Intervention Period||0||
59630611|NCT01286454|75744006|FG006|NOT COMPLETED|Part II- Sixth Intervention Period||0||
59630612|NCT01286454|75744007|FG007|NOT COMPLETED|Part II- Sixth Intervention Period||0||
59630613|NCT01286454|75744008|FG008|NOT COMPLETED|Part II- Sixth Intervention Period||0||
59630614|NCT01286454|75744009|FG009|NOT COMPLETED|Part II- Sixth Intervention Period||0||
59630615|NCT01286454|75744010|FG010|NOT COMPLETED|Part II- Sixth Intervention Period||0||
59630616|NCT01287078|75744026|FG000|STARTED|Overall Study||20||
59630617|NCT01287078|75744027|FG001|STARTED|Overall Study||3||
59630618|NCT01287078|75744026|FG000|COMPLETED|Overall Study||10||
59630619|NCT01287078|75744027|FG001|COMPLETED|Overall Study||1||
59630620|NCT01287078|75744026|FG000|NOT COMPLETED|Overall Study||10||
59630621|NCT01287078|75744027|FG001|NOT COMPLETED|Overall Study||2||
59630622|NCT01290978|75744033|FG000|STARTED|Overall Study||22||
59630623|NCT01290978|75744033|FG000|COMPLETED|Overall Study||22||
59630624|NCT01290978|75744033|FG000|NOT COMPLETED|Overall Study||0||
59630625|NCT01291056|75744040|FG000|STARTED|Intervention One (Menstraution Day 3-7)||10||
59630626|NCT01291056|75744041|FG001|STARTED|Intervention One (Menstraution Day 3-7)||10||
59630627|NCT01291056|75744040|FG000|COMPLETED|Intervention One (Menstraution Day 3-7)||10||
59630628|NCT01291056|75744041|FG001|COMPLETED|Intervention One (Menstraution Day 3-7)||10||
59630629|NCT01291056|75744040|FG000|NOT COMPLETED|Intervention One (Menstraution Day 3-7)||0||
59630630|NCT01291056|75744041|FG001|NOT COMPLETED|Intervention One (Menstraution Day 3-7)||0||
59630631|NCT01291056|75744040|FG000|STARTED|Washout||10||
59630632|NCT01291056|75744041|FG001|STARTED|Washout||10||
59630633|NCT01291056|75744040|FG000|COMPLETED|Washout||10||
59630634|NCT01291056|75744041|FG001|COMPLETED|Washout||10||
59630635|NCT01291056|75744040|FG000|NOT COMPLETED|Washout||0||
59630636|NCT01291056|75744041|FG001|NOT COMPLETED|Washout||0||
59630637|NCT01291056|75744040|FG000|STARTED|Intervention Two (Menstration Days 3-7)||10||
59630638|NCT01291056|75744041|FG001|STARTED|Intervention Two (Menstration Days 3-7)||10||
59630639|NCT01291056|75744040|FG000|COMPLETED|Intervention Two (Menstration Days 3-7)||10||
59630640|NCT01291056|75744041|FG001|COMPLETED|Intervention Two (Menstration Days 3-7)||10||
59630641|NCT01291056|75744040|FG000|NOT COMPLETED|Intervention Two (Menstration Days 3-7)||0||
59630642|NCT01291056|75744041|FG001|NOT COMPLETED|Intervention Two (Menstration Days 3-7)||0||
59630643|NCT01292304|75744047|FG000|STARTED|Overall Study||10||
59630644|NCT01292304|75744047|FG000|COMPLETED|Overall Study||10||
59630645|NCT01292304|75744047|FG000|NOT COMPLETED|Overall Study||0||
59630646|NCT01292538|75744053|FG000|STARTED|Overall Study||35||
59630647|NCT01292538|75744054|FG001|STARTED|Overall Study||32||
59630648|NCT01292538|75744053|FG000|COMPLETED|Overall Study||35||
59630649|NCT01292538|75744054|FG001|COMPLETED|Overall Study||32||
59630650|NCT01292538|75744053|FG000|NOT COMPLETED|Overall Study||0||
59630651|NCT01292538|75744054|FG001|NOT COMPLETED|Overall Study||0||
59630652|NCT01293396|75744060|FG000|STARTED|First Intervention||6||
59630653|NCT01293396|75744061|FG001|STARTED|First Intervention||7||
59630654|NCT01293396|75744062|FG002|STARTED|First Intervention||7||
59630655|NCT01293396|75744060|FG000|COMPLETED|First Intervention||6||
59630656|NCT01293396|75744061|FG001|COMPLETED|First Intervention||7||
59630657|NCT01293396|75744062|FG002|COMPLETED|First Intervention||7||
59630658|NCT01293396|75744060|FG000|NOT COMPLETED|First Intervention||0||
59630659|NCT01293396|75744061|FG001|NOT COMPLETED|First Intervention||0||
59630660|NCT01293396|75744062|FG002|NOT COMPLETED|First Intervention||0||
59630661|NCT01293396|75744060|FG000|STARTED|Wash Out Period 1 (3 Days)||6||
59630662|NCT01293396|75744061|FG001|STARTED|Wash Out Period 1 (3 Days)||7||
59630663|NCT01293396|75744062|FG002|STARTED|Wash Out Period 1 (3 Days)||7||
59630664|NCT01293396|75744060|FG000|COMPLETED|Wash Out Period 1 (3 Days)||6||
59630665|NCT01293396|75744061|FG001|COMPLETED|Wash Out Period 1 (3 Days)||7||
59630666|NCT01293396|75744062|FG002|COMPLETED|Wash Out Period 1 (3 Days)||7||
59630667|NCT01293396|75744060|FG000|NOT COMPLETED|Wash Out Period 1 (3 Days)||0||
59630668|NCT01293396|75744061|FG001|NOT COMPLETED|Wash Out Period 1 (3 Days)||0||
59630669|NCT01293396|75744062|FG002|NOT COMPLETED|Wash Out Period 1 (3 Days)||0||
59630670|NCT01293396|75744060|FG000|STARTED|Second Intervention||5|"20 participants finished washout-period 1 and were randomized to the 3 interventions (BiAsp30, BiAsp70 and IAsp).~In this cross over design the participants first received BiAsp30, then e.g. switched to BiAsp70 and then to IAsp. Therefore, the number of participants could not be the same to participants who completed previous period. However, the total number of partcipants who finished the washout period is equal to the number of particpants who started this intervention sequence."|
59709637|NCT01235741|75828429|FG000|NOT COMPLETED|Non-Randomized Low Calorie Diet Lead-In||141||
59709638|NCT01235741|75828430|FG001|NOT COMPLETED|Non-Randomized Low Calorie Diet Lead-In||0||
59709639|NCT01235741|75828431|FG002|NOT COMPLETED|Non-Randomized Low Calorie Diet Lead-In||0||
59630671|NCT01293396|75744061|FG001|STARTED|Second Intervention||5|"20 participants finished washout-period 1 and were randomized to the 3 interventions (BiAsp30, BiAsp70 and IAsp).~In this cross over design the participants first received BiAsp30, then e.g. switched to BiAsp70 and then to IAsp. Therefore, the number of participants could not be the same to participants who completed previous period. However, the total number of partcipants who finished the washout period is equal to the number of particpants who started this intervention sequence."|
59630672|NCT01293396|75744062|FG002|STARTED|Second Intervention||10|"20 participants finished washout-period 1 and were randomized to the 3 interventions (BiAsp30, BiAsp70 and IAsp).~In this cross over design the participants first received BiAsp30, then e.g. switched to BiAsp70 and then to IAsp. Therefore, the number of participants could not be the same to participants who completed previous period. However, the total number of partcipants who finished the washout period is equal to the number of particpants who started this intervention sequence."|
59630673|NCT01293396|75744060|FG000|COMPLETED|Second Intervention||5||
59630674|NCT01293396|75744061|FG001|COMPLETED|Second Intervention||5||
59630675|NCT01293396|75744062|FG002|COMPLETED|Second Intervention||10||
59630676|NCT01293396|75744060|FG000|NOT COMPLETED|Second Intervention||0||
59630677|NCT01293396|75744061|FG001|NOT COMPLETED|Second Intervention||0||
59630678|NCT01293396|75744062|FG002|NOT COMPLETED|Second Intervention||0||
59630679|NCT01293396|75744060|FG000|STARTED|Wash Out Period 2 (3 Days)||5||
59630680|NCT01293396|75744061|FG001|STARTED|Wash Out Period 2 (3 Days)||5||
59630681|NCT01293396|75744062|FG002|STARTED|Wash Out Period 2 (3 Days)||10||
59630682|NCT01293396|75744060|FG000|COMPLETED|Wash Out Period 2 (3 Days)||5||
59630683|NCT01293396|75744061|FG001|COMPLETED|Wash Out Period 2 (3 Days)||5||
59630684|NCT01293396|75744062|FG002|COMPLETED|Wash Out Period 2 (3 Days)||10||
59630685|NCT01293396|75744060|FG000|NOT COMPLETED|Wash Out Period 2 (3 Days)||0||
59630686|NCT01293396|75744061|FG001|NOT COMPLETED|Wash Out Period 2 (3 Days)||0||
59630687|NCT01293396|75744062|FG002|NOT COMPLETED|Wash Out Period 2 (3 Days)||0||
59630688|NCT01293396|75744060|FG000|STARTED|Third Intervention||9|20 participants finished washout-period 2 and were randomized to the 3 interventions (BiAsp30, BiAsp70 and IAsp).|
59630689|NCT01293396|75744061|FG001|STARTED|Third Intervention||8|20 participants finished washout-period 2 and were randomized to the 3 interventions (BiAsp30, BiAsp70 and IAsp).|
59630690|NCT01293396|75744062|FG002|STARTED|Third Intervention||3|20 participants finished washout-period 2 and were randomized to the 3 interventions (BiAsp30, BiAsp70 and IAsp).|
59630691|NCT01293396|75744060|FG000|COMPLETED|Third Intervention||9||
59630692|NCT01293396|75744061|FG001|COMPLETED|Third Intervention||8||
59630693|NCT01293396|75744062|FG002|COMPLETED|Third Intervention||3||
59630694|NCT01293396|75744060|FG000|NOT COMPLETED|Third Intervention||0||
59630695|NCT01293396|75744061|FG001|NOT COMPLETED|Third Intervention||0||
59630696|NCT01293396|75744062|FG002|NOT COMPLETED|Third Intervention||0||
59630697|NCT01294098|75744073|FG000|STARTED|Overall Study||0||
60076330|NCT01904773|76191364|FG000|COMPLETED|Fifth Intervention||0||
60076331|NCT01904773|76191365|FG001|COMPLETED|Fifth Intervention||1||
60076332|NCT01904773|76191366|FG002|COMPLETED|Fifth Intervention||1||
60076333|NCT01904773|76191367|FG003|COMPLETED|Fifth Intervention||2||
60076334|NCT01904773|76191368|FG004|COMPLETED|Fifth Intervention||3||
60076335|NCT01904773|76191369|FG005|COMPLETED|Fifth Intervention||4||
60076336|NCT01904773|76191370|FG006|COMPLETED|Fifth Intervention||3||
60076337|NCT01904773|76191371|FG007|COMPLETED|Fifth Intervention||2||
60076338|NCT01904773|76191372|FG008|COMPLETED|Fifth Intervention||4||
59630698|NCT01294098|75744074|FG001|STARTED|Overall Study||1||
59630699|NCT01294098|75744075|FG002|STARTED|Overall Study||1||
59630700|NCT01294098|75744073|FG000|COMPLETED|Overall Study||0||
59630701|NCT01294098|75744074|FG001|COMPLETED|Overall Study||0||
59630702|NCT01294098|75744075|FG002|COMPLETED|Overall Study||0||
59630703|NCT01294098|75744073|FG000|NOT COMPLETED|Overall Study||0||
59630704|NCT01294098|75744074|FG001|NOT COMPLETED|Overall Study||1||
59630705|NCT01294098|75744075|FG002|NOT COMPLETED|Overall Study||1||
59630706|NCT01295112|75744085|FG000|STARTED|Overall Study||35||
59630707|NCT01295112|75744086|FG001|STARTED|Overall Study||33||
59630708|NCT01295112|75744085|FG000|COMPLETED|Overall Study||35||
59630709|NCT01295112|75744086|FG001|COMPLETED|Overall Study||33||
59630710|NCT01295112|75744085|FG000|NOT COMPLETED|Overall Study||0||
59630711|NCT01295112|75744086|FG001|NOT COMPLETED|Overall Study||0||
59630712|NCT01296360|75744094|FG000|STARTED|Overall Study||150||
59630713|NCT01296360|75744095|FG001|STARTED|Overall Study||150||
59630714|NCT01296360|75744094|FG000|Visit 2 (Month 12)|Overall Study|booster was administered|148||
59630715|NCT01296360|75744095|FG001|Visit 2 (Month 12)|Overall Study||149||
59630716|NCT01296360|75744094|FG000|Visit 2a (Month 13)|Overall Study|visit in Booster Group only: ~13 months after immunization in IC51-323 (i.e., 1 month post booster)|148||
59630717|NCT01296360|75744095|FG001|Visit 2a (Month 13)|Overall Study||0||
59630718|NCT01296360|75744094|FG000|COMPLETED|Overall Study||144||
59630719|NCT01296360|75744095|FG001|COMPLETED|Overall Study||142||
59630720|NCT01296360|75744094|FG000|NOT COMPLETED|Overall Study||6||
59630721|NCT01296360|75744095|FG001|NOT COMPLETED|Overall Study||8||
59630722|NCT01298544|75744101|FG000|STARTED|Overall Study||335||
59630723|NCT01298544|75744101|FG000|COMPLETED|Overall Study||335||
60076339|NCT01904773|76191364|FG000|NOT COMPLETED|Fifth Intervention||0||
60076340|NCT01904773|76191365|FG001|NOT COMPLETED|Fifth Intervention||0||
60076341|NCT01904773|76191366|FG002|NOT COMPLETED|Fifth Intervention||0||
60076342|NCT01904773|76191367|FG003|NOT COMPLETED|Fifth Intervention||0||
60076343|NCT01904773|76191368|FG004|NOT COMPLETED|Fifth Intervention||0||
59630724|NCT01298544|75744101|FG000|NOT COMPLETED|Overall Study||0||
59630725|NCT01299090|75744107|FG000|STARTED|Overall Study||49||
59630726|NCT01299090|75744107|FG000|COMPLETED|Overall Study||49||
59630727|NCT01299090|75744107|FG000|NOT COMPLETED|Overall Study||0||
59630728|NCT01301742|75744111|FG000|STARTED|First Intervention||9||
59630729|NCT01301742|75744112|FG001|STARTED|First Intervention||9||
59630730|NCT01301742|75744111|FG000|COMPLETED|First Intervention||9||
59630731|NCT01301742|75744112|FG001|COMPLETED|First Intervention||9||
59630732|NCT01301742|75744111|FG000|NOT COMPLETED|First Intervention||0||
59630733|NCT01301742|75744112|FG001|NOT COMPLETED|First Intervention||0||
59630734|NCT01301742|75744111|FG000|STARTED|Washout Period of at Least 7 Days||9||
59630735|NCT01301742|75744112|FG001|STARTED|Washout Period of at Least 7 Days||9||
59630736|NCT01301742|75744111|FG000|COMPLETED|Washout Period of at Least 7 Days||9||
59630737|NCT01301742|75744112|FG001|COMPLETED|Washout Period of at Least 7 Days||9||
59630738|NCT01301742|75744111|FG000|NOT COMPLETED|Washout Period of at Least 7 Days||0||
59630739|NCT01301742|75744112|FG001|NOT COMPLETED|Washout Period of at Least 7 Days||0||
59630740|NCT01301742|75744111|FG000|STARTED|Second Intervention||9||
59630741|NCT01301742|75744112|FG001|STARTED|Second Intervention||9||
59630742|NCT01301742|75744111|FG000|COMPLETED|Second Intervention||9||
59630743|NCT01301742|75744112|FG001|COMPLETED|Second Intervention||9||
59630744|NCT01301742|75744111|FG000|NOT COMPLETED|Second Intervention||0||
59630745|NCT01301742|75744112|FG001|NOT COMPLETED|Second Intervention||0||
59630752|NCT01303224|75744132|FG000|STARTED|Overall Study|randomised, safety population, >= 1 dose of study medication|141||
59630753|NCT01303224|75744133|FG001|STARTED|Overall Study|randomised, safety population, >= 1 dose of study medication|142||
59630754|NCT01303224|75744134|FG002|STARTED|Overall Study|randomised, safety population, >= 1 dose of study medication|139||
59630755|NCT01303224|75744135|FG003|STARTED|Overall Study|randomised, safety population, >= 1 dose of study medication|143||
59630756|NCT01303224|75744132|FG000|Intention To Treat|Overall Study|subjects with at least 1 primary endpoint evaluation post randomisation|140||
59630757|NCT01303224|75744133|FG001|Intention To Treat|Overall Study|subjects with at least 1 primary endpoint evaluation post randomisation|138||
59630758|NCT01303224|75744134|FG002|Intention To Treat|Overall Study|subjects with at least 1 primary endpoint evaluation post randomisation|139||
59630759|NCT01303224|75744135|FG003|Intention To Treat|Overall Study|subjects with at least 1 primary endpoint evaluation post randomisation|142||
59630760|NCT01303224|75744132|FG000|COMPLETED|Overall Study||130||
59630761|NCT01303224|75744133|FG001|COMPLETED|Overall Study||131||
59630762|NCT01303224|75744134|FG002|COMPLETED|Overall Study||133||
59630763|NCT01303224|75744135|FG003|COMPLETED|Overall Study||133||
59630764|NCT01303224|75744132|FG000|NOT COMPLETED|Overall Study||11||
59630765|NCT01303224|75744133|FG001|NOT COMPLETED|Overall Study||11||
59630766|NCT01303224|75744134|FG002|NOT COMPLETED|Overall Study||6||
59630767|NCT01303224|75744135|FG003|NOT COMPLETED|Overall Study||10||
59630768|NCT01304082|75744145|FG000|STARTED|Overall Study||3||
59630769|NCT01304082|75744146|FG001|STARTED|Overall Study||2||
59630770|NCT01304082|75744147|FG002|STARTED|Overall Study||11||
59630771|NCT01304082|75744148|FG003|STARTED|Overall Study||8||
59630772|NCT01304082|75744149|FG004|STARTED|Overall Study||5||
59630773|NCT01304082|75744145|FG000|First Intervention|Overall Study||3||
59630774|NCT01304082|75744146|FG001|First Intervention|Overall Study||2||
59630775|NCT01304082|75744147|FG002|First Intervention|Overall Study||11||
59630776|NCT01304082|75744148|FG003|First Intervention|Overall Study||8||
59630777|NCT01304082|75744149|FG004|First Intervention|Overall Study||5||
59630778|NCT01304082|75744145|FG000|Second Intervention|Overall Study||3||
59630779|NCT01304082|75744146|FG001|Second Intervention|Overall Study||2||
59630780|NCT01304082|75744147|FG002|Second Intervention|Overall Study||11||
59630781|NCT01304082|75744148|FG003|Second Intervention|Overall Study||8||
59630782|NCT01304082|75744149|FG004|Second Intervention|Overall Study||5||
59630783|NCT01304082|75744145|FG000|Third Intervention|Overall Study||3||
59630784|NCT01304082|75744146|FG001|Third Intervention|Overall Study||2||
59630785|NCT01304082|75744147|FG002|Third Intervention|Overall Study||11||
59630786|NCT01304082|75744148|FG003|Third Intervention|Overall Study||8||
59630787|NCT01304082|75744149|FG004|Third Intervention|Overall Study||5||
59630788|NCT01304082|75744145|FG000|COMPLETED|Overall Study||3||
59630789|NCT01304082|75744146|FG001|COMPLETED|Overall Study||2||
59630790|NCT01304082|75744147|FG002|COMPLETED|Overall Study||11||
59630791|NCT01304082|75744148|FG003|COMPLETED|Overall Study||8||
59630792|NCT01304082|75744149|FG004|COMPLETED|Overall Study||5||
59630793|NCT01304082|75744145|FG000|NOT COMPLETED|Overall Study||0||
59630794|NCT01304082|75744146|FG001|NOT COMPLETED|Overall Study||0||
59630795|NCT01304082|75744147|FG002|NOT COMPLETED|Overall Study||0||
59630796|NCT01304082|75744148|FG003|NOT COMPLETED|Overall Study||0||
59630797|NCT01304082|75744149|FG004|NOT COMPLETED|Overall Study||0||
59630798|NCT01304238|75744167|FG000|STARTED|Overall Study||32||
59630799|NCT01304238|75744168|FG001|STARTED|Overall Study||4||
59988280|NCT02365636|76103397|FG001|NOT COMPLETED|Overall Study||7||
59630800|NCT01304238|75744169|FG002|STARTED|Overall Study||46||
59630801|NCT01304238|75744170|FG003|STARTED|Overall Study||78||
59630802|NCT01304238|75744171|FG004|STARTED|Overall Study||11||
59630803|NCT01304238|75744172|FG005|STARTED|Overall Study||11||
59630804|NCT01304238|75744173|FG006|STARTED|Overall Study||5||
59630805|NCT01304238|75744174|FG007|STARTED|Overall Study||4||
59630806|NCT01304238|75744175|FG008|STARTED|Overall Study||1||
59630807|NCT01304238|75744176|FG009|STARTED|Overall Study||3||
59630808|NCT01304238|75744167|FG000|COMPLETED|Overall Study||32||
59630809|NCT01304238|75744168|FG001|COMPLETED|Overall Study||4||
59630810|NCT01304238|75744169|FG002|COMPLETED|Overall Study||46||
59630811|NCT01304238|75744170|FG003|COMPLETED|Overall Study||78||
59630812|NCT01304238|75744171|FG004|COMPLETED|Overall Study||11||
59630813|NCT01304238|75744172|FG005|COMPLETED|Overall Study||11||
59630814|NCT01304238|75744173|FG006|COMPLETED|Overall Study||5||
59630815|NCT01304238|75744174|FG007|COMPLETED|Overall Study||4||
59630816|NCT01304238|75744175|FG008|COMPLETED|Overall Study||1||
59630817|NCT01304238|75744176|FG009|COMPLETED|Overall Study||3||
59630818|NCT01304238|75744167|FG000|NOT COMPLETED|Overall Study||0||
59630819|NCT01304238|75744168|FG001|NOT COMPLETED|Overall Study||0||
59630820|NCT01304238|75744169|FG002|NOT COMPLETED|Overall Study||0||
59630821|NCT01304238|75744170|FG003|NOT COMPLETED|Overall Study||0||
59630822|NCT01304238|75744171|FG004|NOT COMPLETED|Overall Study||0||
59630823|NCT01304238|75744172|FG005|NOT COMPLETED|Overall Study||0||
59630824|NCT01304238|75744173|FG006|NOT COMPLETED|Overall Study||0||
59630825|NCT01304238|75744174|FG007|NOT COMPLETED|Overall Study||0||
59630826|NCT01304238|75744175|FG008|NOT COMPLETED|Overall Study||0||
59630827|NCT01304238|75744176|FG009|NOT COMPLETED|Overall Study||0||
59630828|NCT01305252|75744200|FG000|STARTED|Overall Study||10||
59630829|NCT01305252|75744201|FG001|STARTED|Overall Study||11||
59630830|NCT01305252|75744200|FG000|COMPLETED|Overall Study||9||
59630831|NCT01305252|75744201|FG001|COMPLETED|Overall Study||11||
59630832|NCT01305252|75744200|FG000|NOT COMPLETED|Overall Study||1||
59630833|NCT01305252|75744201|FG001|NOT COMPLETED|Overall Study||0||
59630834|NCT01307748|75744214|FG000|STARTED|Overall Study||31||
59630835|NCT01307748|75744215|FG001|STARTED|Overall Study||31||
59630836|NCT01307748|75744216|FG002|STARTED|Overall Study||30||
59630837|NCT01307748|75744214|FG000|COMPLETED|Overall Study||31||
59630838|NCT01307748|75744215|FG001|COMPLETED|Overall Study||31||
59630839|NCT01307748|75744216|FG002|COMPLETED|Overall Study||30||
59630840|NCT01307748|75744214|FG000|NOT COMPLETED|Overall Study||0||
59630841|NCT01307748|75744215|FG001|NOT COMPLETED|Overall Study||0||
59630842|NCT01307748|75744216|FG002|NOT COMPLETED|Overall Study||0||
59630843|NCT01308060|75744232|FG000|STARTED|Part A||252||
59630844|NCT01308060|75744233|FG001|STARTED|Part A||83||
59630845|NCT01308060|75744232|FG000|COMPLETED|Part A||238||
59630846|NCT01308060|75744233|FG001|COMPLETED|Part A||77||
59630847|NCT01308060|75744232|FG000|NOT COMPLETED|Part A||14||
59630848|NCT01308060|75744233|FG001|NOT COMPLETED|Part A||6||
59630849|NCT01308060|75744232|FG000|STARTED|Part B||238||
59630850|NCT01308060|75744233|FG001|STARTED|Part B||77||
59630851|NCT01308060|75744232|FG000|COMPLETED|Part B||219||
59630852|NCT01308060|75744233|FG001|COMPLETED|Part B||69||
59630853|NCT01308060|75744232|FG000|NOT COMPLETED|Part B||19||
59630854|NCT01308060|75744233|FG001|NOT COMPLETED|Part B||8||
59630855|NCT01308294|75744243|FG000|STARTED|Cycle 1||10||
59630856|NCT01308294|75744244|FG001|STARTED|Cycle 1||6||
59630857|NCT01308294|75744245|FG002|STARTED|Cycle 1||0||
59630858|NCT01308294|75744243|FG000|COMPLETED|Cycle 1||10||
59630859|NCT01308294|75744244|FG001|COMPLETED|Cycle 1||6||
59630860|NCT01308294|75744245|FG002|COMPLETED|Cycle 1||0||
59630861|NCT01308294|75744243|FG000|NOT COMPLETED|Cycle 1||0||
59630862|NCT01308294|75744244|FG001|NOT COMPLETED|Cycle 1||0||
59630863|NCT01308294|75744245|FG002|NOT COMPLETED|Cycle 1||0||
59630864|NCT01308294|75744243|FG000|STARTED|Cycle 2||10||
59630865|NCT01308294|75744244|FG001|STARTED|Cycle 2||6||
59630866|NCT01308294|75744245|FG002|STARTED|Cycle 2||0||
59630867|NCT01308294|75744243|FG000|COMPLETED|Cycle 2||10||
59630868|NCT01308294|75744244|FG001|COMPLETED|Cycle 2||5||
59630869|NCT01308294|75744245|FG002|COMPLETED|Cycle 2||0||
59630870|NCT01308294|75744243|FG000|NOT COMPLETED|Cycle 2||0||
59630871|NCT01308294|75744244|FG001|NOT COMPLETED|Cycle 2||1||
59630872|NCT01308294|75744245|FG002|NOT COMPLETED|Cycle 2||0||
59630873|NCT01308294|75744243|FG000|STARTED|Cycle 3||10||
59630874|NCT01308294|75744244|FG001|STARTED|Cycle 3||5||
59630875|NCT01308294|75744245|FG002|STARTED|Cycle 3||0||
59630876|NCT01308294|75744243|FG000|COMPLETED|Cycle 3||10||
59630877|NCT01308294|75744244|FG001|COMPLETED|Cycle 3||4||
59630878|NCT01308294|75744245|FG002|COMPLETED|Cycle 3||0||
59630879|NCT01308294|75744243|FG000|NOT COMPLETED|Cycle 3||0||
59630880|NCT01308294|75744244|FG001|NOT COMPLETED|Cycle 3||1||
59630881|NCT01308294|75744245|FG002|NOT COMPLETED|Cycle 3||0||
59630882|NCT01308450|75744256|FG000|STARTED|Overall Study|302 subjects were screen. 300 subjects were enrolled in this one site, one visit study.|302||
59630883|NCT01308450|75744256|FG000|COMPLETED|Overall Study|Last subject was enrolled 06/28/2011|300||
59630884|NCT01308450|75744256|FG000|NOT COMPLETED|Overall Study||2||
59630885|NCT01308840|75744260|FG000|STARTED|Overall Study||31||
59630886|NCT01308840|75744260|FG000|COMPLETED|Overall Study||31||
59630887|NCT01308840|75744260|FG000|NOT COMPLETED|Overall Study||0||
59630888|NCT01308918|75744264|FG000|STARTED|Overall Study||50||
59630889|NCT01308918|75744264|FG000|COMPLETED|Overall Study||50||
59630890|NCT01308918|75744264|FG000|NOT COMPLETED|Overall Study||0||
59630891|NCT01310400|75744271|FG000|STARTED|Overall Study||452||
59630892|NCT01310400|75744272|FG001|STARTED|Overall Study||452||
59630893|NCT01310400|75744273|FG002|STARTED|Overall Study||452||
59630894|NCT01310400|75744271|FG000|COMPLETED|Overall Study||424||
59630895|NCT01310400|75744272|FG001|COMPLETED|Overall Study||420||
59630896|NCT01310400|75744273|FG002|COMPLETED|Overall Study||422||
59630897|NCT01310400|75744271|FG000|NOT COMPLETED|Overall Study||28||
59630898|NCT01310400|75744272|FG001|NOT COMPLETED|Overall Study||32||
59630899|NCT01310400|75744273|FG002|NOT COMPLETED|Overall Study||30||
59630900|NCT01311102|75744286|FG000|STARTED|Overall Study||20||
59630901|NCT01311102|75744287|FG001|STARTED|Overall Study||20||
59630902|NCT01311102|75744286|FG000|COMPLETED|Overall Study||20||
59630903|NCT01311102|75744287|FG001|COMPLETED|Overall Study||20||
59630904|NCT01311102|75744286|FG000|NOT COMPLETED|Overall Study||0||
59630905|NCT01311102|75744287|FG001|NOT COMPLETED|Overall Study||0||
59630906|NCT01312038|75744297|FG000|STARTED|Overall Study||13||
59630907|NCT01312038|75744298|FG001|STARTED|Overall Study||12||
59630908|NCT01312038|75744297|FG000|COMPLETED|Overall Study||13||
59630909|NCT01312038|75744298|FG001|COMPLETED|Overall Study||12||
59630910|NCT01312038|75744297|FG000|NOT COMPLETED|Overall Study||0||
59630911|NCT01312038|75744298|FG001|NOT COMPLETED|Overall Study||0||
59630912|NCT01312272|75744306|FG000|STARTED|Overall Study||12||
59630913|NCT01312272|75744307|FG001|STARTED|Overall Study||12||
59630914|NCT01312272|75744306|FG000|COMPLETED|Overall Study||12||
59630915|NCT01312272|75744307|FG001|COMPLETED|Overall Study||11||
59630916|NCT01312272|75744306|FG000|NOT COMPLETED|Overall Study||0||
59630917|NCT01312272|75744307|FG001|NOT COMPLETED|Overall Study||1||
59630918|NCT01312818|75744313|FG000|STARTED|Overall Study||2||
59630919|NCT01312818|75744313|FG000|COMPLETED|Overall Study||2||
59630920|NCT01312818|75744313|FG000|NOT COMPLETED|Overall Study||0||
59630921|NCT01313520|75744321|FG000|STARTED|Overall Study||30||
59630922|NCT01313520|75744322|FG001|STARTED|Overall Study||31||
59630923|NCT01313520|75744321|FG000|COMPLETED|Overall Study||30||
59630924|NCT01313520|75744322|FG001|COMPLETED|Overall Study||31||
59630925|NCT01313520|75744321|FG000|NOT COMPLETED|Overall Study||0||
59630926|NCT01313520|75744322|FG001|NOT COMPLETED|Overall Study||0||
59630927|NCT01313910|75744330|FG000|STARTED|Overall Study||8||
59630928|NCT01313910|75744330|FG000|COMPLETED|Overall Study||8||
59630929|NCT01313910|75744330|FG000|NOT COMPLETED|Overall Study||0||
59630930|NCT01315002|75744334|FG000|STARTED|Overall Study||61||
59630931|NCT01315002|75744335|FG001|STARTED|Overall Study||60||
59630932|NCT01315002|75744334|FG000|COMPLETED|Overall Study||56||
59630933|NCT01315002|75744335|FG001|COMPLETED|Overall Study||55||
59630934|NCT01315002|75744334|FG000|NOT COMPLETED|Overall Study||5||
59630935|NCT01315002|75744335|FG001|NOT COMPLETED|Overall Study||5||
59630936|NCT01315158|75744343|FG000|STARTED|Overall Study||17||
59630937|NCT01315158|75744344|FG001|STARTED|Overall Study||19||
59630938|NCT01315158|75744343|FG000|COMPLETED|Overall Study||17||
59630939|NCT01315158|75744344|FG001|COMPLETED|Overall Study||19||
59630940|NCT01315158|75744343|FG000|NOT COMPLETED|Overall Study||0||
59630941|NCT01315158|75744344|FG001|NOT COMPLETED|Overall Study||0||
59630942|NCT01317030|75744352|FG000|STARTED|Overall Study||12||
59630943|NCT01317030|75744353|FG001|STARTED|Overall Study||13||
59630944|NCT01317030|75744352|FG000|COMPLETED|Overall Study||12||
59630945|NCT01317030|75744353|FG001|COMPLETED|Overall Study||13||
59630946|NCT01317030|75744352|FG000|NOT COMPLETED|Overall Study||0||
59630947|NCT01317030|75744353|FG001|NOT COMPLETED|Overall Study||0||
59630948|NCT01318278|75744362|FG000|STARTED|Overall Study||10||
59630949|NCT01318278|75744363|FG001|STARTED|Overall Study||10||
59630950|NCT01318278|75744364|FG002|STARTED|Overall Study||50||
59630951|NCT01318278|75744362|FG000|COMPLETED|Overall Study||10||
59630952|NCT01318278|75744363|FG001|COMPLETED|Overall Study||10||
59630953|NCT01318278|75744364|FG002|COMPLETED|Overall Study||50||
59630954|NCT01318278|75744362|FG000|NOT COMPLETED|Overall Study||0||
59630955|NCT01318278|75744363|FG001|NOT COMPLETED|Overall Study||0||
59630956|NCT01318278|75744364|FG002|NOT COMPLETED|Overall Study||0||
59630957|NCT01318356|75744376|FG000|STARTED|Overall Study||51||
59630958|NCT01318356|75744377|FG001|STARTED|Overall Study||52||
59630959|NCT01318356|75744378|FG002|STARTED|Overall Study||52||
59630960|NCT01318356|75744376|FG000|COMPLETED|Overall Study||43||
59630961|NCT01318356|75744377|FG001|COMPLETED|Overall Study||49||
59630962|NCT01318356|75744378|FG002|COMPLETED|Overall Study||50||
59630963|NCT01318356|75744376|FG000|NOT COMPLETED|Overall Study||8||
59630964|NCT01318356|75744377|FG001|NOT COMPLETED|Overall Study||3||
59630965|NCT01318356|75744378|FG002|NOT COMPLETED|Overall Study||2||
59630966|NCT01322022|75744388|FG000|STARTED|Overall Study||20||
59630967|NCT01322022|75744389|FG001|STARTED|Overall Study||20||
59630968|NCT01322022|75744388|FG000|Week 4|Overall Study||15||
59630969|NCT01322022|75744389|FG001|Week 4|Overall Study||18||
59630970|NCT01322022|75744388|FG000|COMPLETED|Overall Study||15||
59630971|NCT01322022|75744389|FG001|COMPLETED|Overall Study||18||
59630972|NCT01322022|75744388|FG000|NOT COMPLETED|Overall Study||5||
59630973|NCT01322022|75744389|FG001|NOT COMPLETED|Overall Study||2||
59540056|NCT02478372|75638391|FG000|Reviewed at One Year|Overall Study|Routine follow up at one year|108||
59540057|NCT02478372|75638392|FG001|Reviewed at One Year|Overall Study|Routine folow up at one year - four patients did not attend, two patients died|107||
59540058|NCT02478372|75638391|FG000|COMPLETED|Overall Study||108||
59540059|NCT02478372|75638392|FG001|COMPLETED|Overall Study||107||
59540060|NCT02478372|75638391|FG000|NOT COMPLETED|Overall Study||13||
59540061|NCT02478372|75638392|FG001|NOT COMPLETED|Overall Study||14||
59540062|NCT01511315|75638398|FG000|STARTED|Overall Study||36||
59540063|NCT01511315|75638398|FG000|COMPLETED|Overall Study||32||
59540064|NCT01511315|75638398|FG000|NOT COMPLETED|Overall Study||4||
59540065|NCT01654536|75638404|FG000|STARTED|Overall Study||368||
59540066|NCT01654536|75638405|FG001|STARTED|Overall Study||369||
59540067|NCT01654536|75638404|FG000|COMPLETED|Overall Study||324||
59540068|NCT01654536|75638405|FG001|COMPLETED|Overall Study||331||
59540069|NCT01654536|75638404|FG000|NOT COMPLETED|Overall Study||44||
59540070|NCT01654536|75638405|FG001|NOT COMPLETED|Overall Study||38||
59540071|NCT01654380|75638414|FG000|STARTED|Part A, Period 1||4||
59540072|NCT01654380|75638415|FG001|STARTED|Part A, Period 1||4||
59540073|NCT01654380|75638416|FG002|STARTED|Part A, Period 1||0||
59540074|NCT01654380|75638417|FG003|STARTED|Part A, Period 1||0||
59540075|NCT01654380|75638414|FG000|Received at Least 1 Dose of Study Drug|Part A, Period 1||4||
59540076|NCT01654380|75638415|FG001|Received at Least 1 Dose of Study Drug|Part A, Period 1||4||
59540077|NCT01654380|75638416|FG002|Received at Least 1 Dose of Study Drug|Part A, Period 1||0||
59540078|NCT01654380|75638417|FG003|Received at Least 1 Dose of Study Drug|Part A, Period 1||0||
59540079|NCT01654380|75638414|FG000|COMPLETED|Part A, Period 1||4||
59540080|NCT01654380|75638415|FG001|COMPLETED|Part A, Period 1||4||
59540081|NCT01654380|75638416|FG002|COMPLETED|Part A, Period 1||0||
59540082|NCT01654380|75638417|FG003|COMPLETED|Part A, Period 1||0||
59540083|NCT01654380|75638414|FG000|NOT COMPLETED|Part A, Period 1||0||
59540084|NCT01654380|75638415|FG001|NOT COMPLETED|Part A, Period 1||0||
59540085|NCT01654380|75638416|FG002|NOT COMPLETED|Part A, Period 1||0||
59540086|NCT01654380|75638417|FG003|NOT COMPLETED|Part A, Period 1||0||
59540087|NCT01654380|75638414|FG000|STARTED|Part A, Washout of at Least 6 Days||4||
59540088|NCT01654380|75638415|FG001|STARTED|Part A, Washout of at Least 6 Days||4||
59540089|NCT01654380|75638416|FG002|STARTED|Part A, Washout of at Least 6 Days||0||
59540090|NCT01654380|75638417|FG003|STARTED|Part A, Washout of at Least 6 Days||0||
59540091|NCT01654380|75638414|FG000|COMPLETED|Part A, Washout of at Least 6 Days||4||
59540092|NCT01654380|75638415|FG001|COMPLETED|Part A, Washout of at Least 6 Days||4||
59540093|NCT01654380|75638416|FG002|COMPLETED|Part A, Washout of at Least 6 Days||0||
59540094|NCT01654380|75638417|FG003|COMPLETED|Part A, Washout of at Least 6 Days||0||
59540095|NCT01654380|75638414|FG000|NOT COMPLETED|Part A, Washout of at Least 6 Days||0||
59540096|NCT01654380|75638415|FG001|NOT COMPLETED|Part A, Washout of at Least 6 Days||0||
59540097|NCT01654380|75638416|FG002|NOT COMPLETED|Part A, Washout of at Least 6 Days||0||
59540098|NCT01654380|75638417|FG003|NOT COMPLETED|Part A, Washout of at Least 6 Days||0||
59540099|NCT01654380|75638414|FG000|STARTED|Part A, Period 2||4||
59540100|NCT01654380|75638415|FG001|STARTED|Part A, Period 2||4||
59540101|NCT01654380|75638416|FG002|STARTED|Part A, Period 2||0||
59540102|NCT01654380|75638417|FG003|STARTED|Part A, Period 2||0||
59540103|NCT01654380|75638414|FG000|COMPLETED|Part A, Period 2||4||
59540104|NCT01654380|75638415|FG001|COMPLETED|Part A, Period 2||4||
59540105|NCT01654380|75638416|FG002|COMPLETED|Part A, Period 2||0||
59540106|NCT01654380|75638417|FG003|COMPLETED|Part A, Period 2||0||
59540107|NCT01654380|75638414|FG000|NOT COMPLETED|Part A, Period 2||0||
59540108|NCT01654380|75638415|FG001|NOT COMPLETED|Part A, Period 2||0||
59540109|NCT01654380|75638416|FG002|NOT COMPLETED|Part A, Period 2||0||
59540110|NCT01654380|75638417|FG003|NOT COMPLETED|Part A, Period 2||0||
59540111|NCT01654380|75638414|FG000|STARTED|Part A, Washout of at Least 6 Days||4||
59540112|NCT01654380|75638415|FG001|STARTED|Part A, Washout of at Least 6 Days||4||
59540113|NCT01654380|75638416|FG002|STARTED|Part A, Washout of at Least 6 Days||0||
59540114|NCT01654380|75638417|FG003|STARTED|Part A, Washout of at Least 6 Days||0||
59540115|NCT01654380|75638414|FG000|COMPLETED|Part A, Washout of at Least 6 Days||4||
59540116|NCT01654380|75638415|FG001|COMPLETED|Part A, Washout of at Least 6 Days||4||
59540117|NCT01654380|75638416|FG002|COMPLETED|Part A, Washout of at Least 6 Days||0||
59540118|NCT01654380|75638417|FG003|COMPLETED|Part A, Washout of at Least 6 Days||0||
59540119|NCT01654380|75638414|FG000|NOT COMPLETED|Part A, Washout of at Least 6 Days||0||
59540120|NCT01654380|75638415|FG001|NOT COMPLETED|Part A, Washout of at Least 6 Days||0||
59540121|NCT01654380|75638416|FG002|NOT COMPLETED|Part A, Washout of at Least 6 Days||0||
59540122|NCT01654380|75638417|FG003|NOT COMPLETED|Part A, Washout of at Least 6 Days||0||
59630974|NCT01324128|75744397|FG000|STARTED|Stage 1||710||
59540123|NCT01654380|75638414|FG000|STARTED|Part A, Period 3||4||
59540124|NCT01654380|75638415|FG001|STARTED|Part A, Period 3||4||
59540125|NCT01654380|75638416|FG002|STARTED|Part A, Period 3||0||
59540126|NCT01654380|75638417|FG003|STARTED|Part A, Period 3||0||
59540127|NCT01654380|75638414|FG000|COMPLETED|Part A, Period 3||4||
59540128|NCT01654380|75638415|FG001|COMPLETED|Part A, Period 3||4||
59540129|NCT01654380|75638416|FG002|COMPLETED|Part A, Period 3||0||
59540130|NCT01654380|75638417|FG003|COMPLETED|Part A, Period 3||0||
59540131|NCT01654380|75638414|FG000|NOT COMPLETED|Part A, Period 3||0||
59630975|NCT01324128|75744398|FG001|STARTED|Stage 1||349||
59630976|NCT01324128|75744399|FG002|STARTED|Stage 1||0||
59630977|NCT01324128|75744400|FG003|STARTED|Stage 1||0||
59630978|NCT01324128|75744397|FG000|COMPLETED|Stage 1||515||
59630979|NCT01324128|75744398|FG001|COMPLETED|Stage 1||293||
59630980|NCT01324128|75744399|FG002|COMPLETED|Stage 1||0||
59630981|NCT01324128|75744400|FG003|COMPLETED|Stage 1||0||
59630982|NCT01324128|75744397|FG000|NOT COMPLETED|Stage 1||195||
59630983|NCT01324128|75744398|FG001|NOT COMPLETED|Stage 1||56||
59630984|NCT01324128|75744399|FG002|NOT COMPLETED|Stage 1||0||
59630985|NCT01324128|75744400|FG003|NOT COMPLETED|Stage 1||0||
59630986|NCT01324128|75744397|FG000|STARTED|Stage 2||0||
59630987|NCT01324128|75744398|FG001|STARTED|Stage 2||0||
59630988|NCT01324128|75744399|FG002|STARTED|Stage 2||50||
59630989|NCT01324128|75744400|FG003|STARTED|Stage 2||49||
59630990|NCT01324128|75744397|FG000|COMPLETED|Stage 2||0||
59630991|NCT01324128|75744398|FG001|COMPLETED|Stage 2||0||
59630992|NCT01324128|75744399|FG002|COMPLETED|Stage 2||42||
59630993|NCT01324128|75744400|FG003|COMPLETED|Stage 2||46||
59630994|NCT01324128|75744397|FG000|NOT COMPLETED|Stage 2||0||
59630995|NCT01324128|75744398|FG001|NOT COMPLETED|Stage 2||0||
59630996|NCT01324128|75744399|FG002|NOT COMPLETED|Stage 2||8||
59630997|NCT01324128|75744400|FG003|NOT COMPLETED|Stage 2||3||
59630998|NCT01324518|75744413|FG000|STARTED|Overall Study||33||
59630999|NCT01324518|75744414|FG001|STARTED|Overall Study||33||
59631000|NCT01324518|75744415|FG002|STARTED|Overall Study||34||
59631001|NCT01324518|75744413|FG000|COMPLETED|Overall Study||28||
59631002|NCT01324518|75744414|FG001|COMPLETED|Overall Study||30||
59631003|NCT01324518|75744415|FG002|COMPLETED|Overall Study||33||
59631004|NCT01324518|75744413|FG000|NOT COMPLETED|Overall Study||5||
59631005|NCT01324518|75744414|FG001|NOT COMPLETED|Overall Study||3||
59631006|NCT01324518|75744415|FG002|NOT COMPLETED|Overall Study||1||
59631007|NCT01326780|75744427|FG000|STARTED|Overall Study||106||
59631008|NCT01326780|75744428|FG001|STARTED|Overall Study||109||
59631009|NCT01326780|75744429|FG002|STARTED|Overall Study||109||
59631010|NCT01326780|75744430|FG003|STARTED|Overall Study||107||
59631011|NCT01326780|75744427|FG000|COMPLETED|Overall Study||93||
59631012|NCT01326780|75744428|FG001|COMPLETED|Overall Study||100||
59988281|NCT02365636|76103398|FG002|NOT COMPLETED|Overall Study||3||
59631013|NCT01326780|75744429|FG002|COMPLETED|Overall Study||103||
59631014|NCT01326780|75744430|FG003|COMPLETED|Overall Study||94||
59631015|NCT01326780|75744427|FG000|NOT COMPLETED|Overall Study||13||
59631016|NCT01326780|75744428|FG001|NOT COMPLETED|Overall Study||9||
59631017|NCT01326780|75744429|FG002|NOT COMPLETED|Overall Study||6||
59631018|NCT01326780|75744430|FG003|NOT COMPLETED|Overall Study||13||
59631019|NCT01328184|75744440|FG000|STARTED|Overall Study||18||
59631020|NCT01328184|75744440|FG000|COMPLETED|Overall Study||18||
59631021|NCT01328184|75744440|FG000|NOT COMPLETED|Overall Study||0||
59631022|NCT01328964|75744449|FG000|STARTED|Overall Study||2212||
59631023|NCT01328964|75744450|FG001|STARTED|Overall Study||3270||
59631024|NCT01328964|75744451|FG002|STARTED|Overall Study||4424||
59631025|NCT01328964|75744449|FG000|COMPLETED|Overall Study||2212||
59631026|NCT01328964|75744450|FG001|COMPLETED|Overall Study||3270||
59631027|NCT01328964|75744451|FG002|COMPLETED|Overall Study||4424||
59631028|NCT01328964|75744449|FG000|NOT COMPLETED|Overall Study||0||
59631029|NCT01328964|75744450|FG001|NOT COMPLETED|Overall Study||0||
59631030|NCT01328964|75744451|FG002|NOT COMPLETED|Overall Study||0||
59988282|NCT01655498|76103406|FG000|STARTED|Overall Study||61||
59631031|NCT01329198|75744461|FG000|STARTED|Overall Study||3||
59631032|NCT01329198|75744462|FG001|STARTED|Overall Study||2||
59631033|NCT01329198|75744461|FG000|COMPLETED|Overall Study||3||
59631034|NCT01329198|75744462|FG001|COMPLETED|Overall Study||2||
59631035|NCT01329198|75744461|FG000|NOT COMPLETED|Overall Study||0||
59631036|NCT01329198|75744462|FG001|NOT COMPLETED|Overall Study||0||
59631037|NCT01330134|75744475|FG000|STARTED|Overall Study||244||
59631038|NCT01330134|75744476|FG001|STARTED|Overall Study||237||
59631039|NCT01330134|75744475|FG000|COMPLETED|Overall Study||244||
59631040|NCT01330134|75744476|FG001|COMPLETED|Overall Study||237||
59631041|NCT01330134|75744475|FG000|NOT COMPLETED|Overall Study||0||
59631042|NCT01330134|75744476|FG001|NOT COMPLETED|Overall Study||0||
59631043|NCT01330290|75744482|FG000|STARTED|Overall Study||148||
59631044|NCT01330290|75744482|FG000|COMPLETED|Overall Study|As this is a cross-sectional study, the terms completed/not completed are not applicable.|148||
59631045|NCT01330290|75744482|FG000|NOT COMPLETED|Overall Study||0||
59631046|NCT01331304|75744488|FG000|STARTED|Overall Study||240||
59631047|NCT01331304|75744489|FG001|STARTED|Overall Study||242||
59631048|NCT01331304|75744488|FG000|COMPLETED|Overall Study||182||
59631049|NCT01331304|75744489|FG001|COMPLETED|Overall Study||182||
59631050|NCT01331304|75744488|FG000|NOT COMPLETED|Overall Study||58||
59631051|NCT01331304|75744489|FG001|NOT COMPLETED|Overall Study||60||
59631052|NCT01331694|75744502|FG000|STARTED|Overall Study||16684||
59631053|NCT01331694|75744503|FG001|STARTED|Overall Study||14449||
59631054|NCT01331694|75744504|FG002|STARTED|Overall Study||12659||
59631055|NCT01331694|75744505|FG003|STARTED|Overall Study||12595||
59631056|NCT01331694|75744506|FG004|STARTED|Overall Study||10617||
59631057|NCT01331694|75744507|FG005|STARTED|Overall Study||9126||
59631058|NCT01331694|75744502|FG000|COMPLETED|Overall Study||16684||
59631059|NCT01331694|75744503|FG001|COMPLETED|Overall Study||14449||
59631060|NCT01331694|75744504|FG002|COMPLETED|Overall Study||12659||
59631061|NCT01331694|75744505|FG003|COMPLETED|Overall Study||12595||
59631062|NCT01331694|75744506|FG004|COMPLETED|Overall Study||10617||
59631063|NCT01331694|75744507|FG005|COMPLETED|Overall Study||9126||
59631064|NCT01331694|75744502|FG000|NOT COMPLETED|Overall Study||0||
59631065|NCT01331694|75744503|FG001|NOT COMPLETED|Overall Study||0||
59631066|NCT01331694|75744504|FG002|NOT COMPLETED|Overall Study||0||
59631067|NCT01331694|75744505|FG003|NOT COMPLETED|Overall Study||0||
59631068|NCT01331694|75744506|FG004|NOT COMPLETED|Overall Study||0||
59631069|NCT01331694|75744507|FG005|NOT COMPLETED|Overall Study||0||
59631070|NCT01333098|75744521|FG000|STARTED|Overall Study||15||
59631071|NCT01333098|75744521|FG000|COMPLETED|Overall Study||12||
59631072|NCT01333098|75744521|FG000|NOT COMPLETED|Overall Study||3||
59631073|NCT01333488|75744530|FG000|STARTED|Overall Study||2||
59631074|NCT01333488|75744531|FG001|STARTED|Overall Study||1||
59631075|NCT01333488|75744532|FG002|STARTED|Overall Study||3||
59631076|NCT01333488|75744530|FG000|COMPLETED|Overall Study||2||
59631077|NCT01333488|75744531|FG001|COMPLETED|Overall Study||1||
59631078|NCT01333488|75744532|FG002|COMPLETED|Overall Study||3||
59631079|NCT01333488|75744530|FG000|NOT COMPLETED|Overall Study||0||
59631080|NCT01333488|75744531|FG001|NOT COMPLETED|Overall Study||0||
59631081|NCT01333488|75744532|FG002|NOT COMPLETED|Overall Study||0||
59631082|NCT01335204|75744541|FG000|STARTED|Overall Study||4||
59631083|NCT01335204|75744541|FG000|COMPLETED|Overall Study||4||
59631084|NCT01335204|75744541|FG000|NOT COMPLETED|Overall Study||0||
59631085|NCT01335750|75744545|FG000|STARTED|Overall Study||32||
59631086|NCT01335750|75744545|FG000|COMPLETED|Overall Study||32||
59631087|NCT01335750|75744545|FG000|NOT COMPLETED|Overall Study||0||
59631088|NCT01336296|75744559|FG000|STARTED|Overall Study||40||
59631089|NCT01336296|75744560|FG001|STARTED|Overall Study||21||
59631090|NCT01336296|75744559|FG000|COMPLETED|Overall Study||35||
59631091|NCT01336296|75744560|FG001|COMPLETED|Overall Study||17||
59631092|NCT01336296|75744559|FG000|NOT COMPLETED|Overall Study||5||
59631093|NCT01336296|75744560|FG001|NOT COMPLETED|Overall Study||4||
59631094|NCT01337076|75744566|FG000|STARTED|Overall Study|subjects implanted|21||
59631095|NCT01337076|75744566|FG000|COMPLETED|Overall Study|subjects met the primary endpoint of 6 months postimplant activation|19||
59631096|NCT01337076|75744566|FG000|NOT COMPLETED|Overall Study||2||
59631097|NCT01337700|75744572|FG000|STARTED|Overall Study||5||
59631098|NCT01337700|75744573|FG001|STARTED|Overall Study||5||
59631099|NCT01337700|75744572|FG000|COMPLETED|Overall Study||5||
59631100|NCT01337700|75744573|FG001|COMPLETED|Overall Study||5||
59631101|NCT01337700|75744572|FG000|NOT COMPLETED|Overall Study||0||
59631102|NCT01337700|75744573|FG001|NOT COMPLETED|Overall Study||0||
59631103|NCT01339260|75744581|FG000|STARTED|Cycle 1|Intent-To-Treat: randomized patients|726||
59631104|NCT01339260|75744582|FG001|STARTED|Cycle 1|Intent-To-Treat: randomized patients|729||
59631105|NCT01339260|75744581|FG000|Safety Population|Cycle 1|Patients receiving netupitant/palonosetron combination|725||
59631106|NCT01339260|75744582|FG001|Safety Population|Cycle 1|Patients receiving palonosetron|725||
59631107|NCT01339260|75744581|FG000|Full Analysis Set|Cycle 1|Patients receiving chemotherapy and randomized to netupitant/palonosetron combination|724||
59631108|NCT01339260|75744582|FG001|Full Analysis Set|Cycle 1|Patients receiving chemotherapy and randomized to palonosetron|725||
59631109|NCT01339260|75744581|FG000|COMPLETED|Cycle 1||719||
59631110|NCT01339260|75744582|FG001|COMPLETED|Cycle 1||719||
59631111|NCT01339260|75744581|FG000|NOT COMPLETED|Cycle 1||7||
59631112|NCT01339260|75744582|FG001|NOT COMPLETED|Cycle 1||10||
59631113|NCT01339260|75744581|FG000|STARTED|Multi-cycle Extension|Patients scheduled to netupitant/palonosetron combination|635||
59631114|NCT01339260|75744582|FG001|STARTED|Multi-cycle Extension|Patients scheduled to palonosetron|651||
59631115|NCT01339260|75744581|FG000|Safety Population|Multi-cycle Extension|Patients receiving netupitant/palonosetron combination|635||
59631116|NCT01339260|75744582|FG001|Safety Population|Multi-cycle Extension|Patients receiving palonosetron|651||
59988283|NCT01655498|76103406|FG000|COMPLETED|Overall Study||56||
59988284|NCT01655498|76103406|FG000|NOT COMPLETED|Overall Study||5||
59988285|NCT02270944|76103415|FG000|STARTED|Overall Study||529||
59631117|NCT01339260|75744581|FG000|COMPLETED|Multi-cycle Extension|Patients completing at least number of cycles they were scheduled to|449||
59631118|NCT01339260|75744582|FG001|COMPLETED|Multi-cycle Extension|Patients completing at least number of cycles they were scheduled to|458||
59631119|NCT01339260|75744581|FG000|NOT COMPLETED|Multi-cycle Extension||186||
59631120|NCT01339260|75744582|FG001|NOT COMPLETED|Multi-cycle Extension||193||
59631121|NCT01339416|75744590|FG000|STARTED|Overall Study||8202||
59631122|NCT01339416|75744590|FG000|COMPLETED|Overall Study||8202||
59631123|NCT01339416|75744590|FG000|NOT COMPLETED|Overall Study||0||
59988286|NCT02270944|76103416|FG001|STARTED|Overall Study||521||
59988287|NCT02270944|76103415|FG000|COMPLETED|Overall Study||518||
59631124|NCT01340586|75744596|FG000|STARTED|Overall Study||8||
59631125|NCT01340586|75744597|FG001|STARTED|Overall Study||8||
59631126|NCT01340586|75744596|FG000|COMPLETED|Overall Study||8||
59631127|NCT01340586|75744597|FG001|COMPLETED|Overall Study||8||
59631128|NCT01340586|75744596|FG000|NOT COMPLETED|Overall Study||0||
59631129|NCT01340586|75744597|FG001|NOT COMPLETED|Overall Study||0||
59988288|NCT02270944|76103416|FG001|COMPLETED|Overall Study||516||
59631130|NCT01341912|75744608|FG000|STARTED|Overall Study||3||
59631131|NCT01341912|75744608|FG000|COMPLETED|Overall Study||3||
59631132|NCT01341912|75744608|FG000|NOT COMPLETED|Overall Study||0||
59631133|NCT01342458|75744614|FG000|STARTED|Overall Study||28||
59631134|NCT01342458|75744615|FG001|STARTED|Overall Study||28||
59631135|NCT01342458|75744614|FG000|COMPLETED|Overall Study||26||
59631136|NCT01342458|75744615|FG001|COMPLETED|Overall Study||24||
59631137|NCT01342458|75744614|FG000|NOT COMPLETED|Overall Study||2||
59631138|NCT01342458|75744615|FG001|NOT COMPLETED|Overall Study||4||
59631139|NCT01342770|75744635|FG000|STARTED|Overall Study||6||
59631140|NCT01342770|75744635|FG000|COMPLETED|Overall Study||6||
59631141|NCT01342770|75744635|FG000|NOT COMPLETED|Overall Study||0||
59631142|NCT01343004|75744642|FG000|STARTED|Overall Study||821||
59631143|NCT01343004|75744643|FG001|STARTED|Overall Study||824||
59631144|NCT01343004|75744644|FG002|STARTED|Overall Study||818||
59631145|NCT01343004|75744642|FG000|COMPLETED|Overall Study||637||
59631146|NCT01343004|75744643|FG001|COMPLETED|Overall Study||606||
59631147|NCT01343004|75744644|FG002|COMPLETED|Overall Study||658||
59631148|NCT01343004|75744642|FG000|NOT COMPLETED|Overall Study||184||
59631149|NCT01343004|75744643|FG001|NOT COMPLETED|Overall Study||218||
59631150|NCT01343004|75744644|FG002|NOT COMPLETED|Overall Study||160||
59631151|NCT01343160|75744652|FG000|STARTED|Overall Study||36||
59631152|NCT01343160|75744652|FG000|COMPLETED|Overall Study||31||
59631153|NCT01343160|75744652|FG000|NOT COMPLETED|Overall Study||5||
59631154|NCT01347060|75744659|FG000|STARTED|Overall Study||9868||
59631155|NCT01347060|75744660|FG001|STARTED|Overall Study||7580||
59631156|NCT01347060|75744659|FG000|COMPLETED|Overall Study||9868||
59631157|NCT01347060|75744660|FG001|COMPLETED|Overall Study||7580||
59631158|NCT01347060|75744659|FG000|NOT COMPLETED|Overall Study||0||
59631159|NCT01347060|75744660|FG001|NOT COMPLETED|Overall Study||0||
59631160|NCT01351506|75744668|FG000|STARTED|Overall Study||602||
59631161|NCT01351506|75744668|FG000|COMPLETED|Overall Study||465||
59631162|NCT01351506|75744668|FG000|NOT COMPLETED|Overall Study||137||
59631163|NCT01351740|75744676|FG000|STARTED|Overall Study||25||
59631164|NCT01351740|75744677|FG001|STARTED|Overall Study||25||
59631165|NCT01351740|75744676|FG000|COMPLETED|Overall Study||23||
59631166|NCT01351740|75744677|FG001|COMPLETED|Overall Study||19||
59631167|NCT01351740|75744676|FG000|NOT COMPLETED|Overall Study||2||
59631168|NCT01351740|75744677|FG001|NOT COMPLETED|Overall Study||6||
59631169|NCT01352286|75744684|FG000|STARTED|Overall Study||25||
59631170|NCT01352286|75744684|FG000|Received T-cells|Overall Study||25||
59631171|NCT01352286|75744684|FG000|COMPLETED|Overall Study||25||
59631172|NCT01352286|75744684|FG000|NOT COMPLETED|Overall Study||0||
59631173|NCT01352442|75744689|FG000|STARTED|Overall Study||151||
59631174|NCT01352442|75744689|FG000|COMPLETED|Overall Study||139||
59631175|NCT01352442|75744689|FG000|NOT COMPLETED|Overall Study||12||
59631176|NCT01352598|75744693|FG000|STARTED|Overall Study||84||
59631177|NCT01352598|75744693|FG000|COMPLETED|Overall Study||72||
59631178|NCT01352598|75744693|FG000|NOT COMPLETED|Overall Study||12||
59631179|NCT01257438|75744699|FG000|STARTED|Overall Study||132||
59631180|NCT01257438|75744700|FG001|STARTED|Overall Study||143||
59631181|NCT01257438|75744699|FG000|COMPLETED|Overall Study||102||
59631182|NCT01257438|75744700|FG001|COMPLETED|Overall Study||97||
59631183|NCT01257438|75744699|FG000|NOT COMPLETED|Overall Study||30||
59631184|NCT01257438|75744700|FG001|NOT COMPLETED|Overall Study||46||
59631185|NCT01353144|75744708|FG000|STARTED|Overall Study||89||
59631186|NCT01353144|75744709|FG001|STARTED|Overall Study||89||
59631187|NCT01353144|75744708|FG000|COMPLETED|Overall Study||80||
59631188|NCT01353144|75744709|FG001|COMPLETED|Overall Study||81||
59631189|NCT01353144|75744708|FG000|NOT COMPLETED|Overall Study||9||
59631190|NCT01353144|75744709|FG001|NOT COMPLETED|Overall Study||8||
59631191|NCT01355484|75744719|FG000|STARTED|Overall Study||160||
59631192|NCT01355484|75744720|FG001|STARTED|Overall Study||161||
59631193|NCT01355484|75744719|FG000|COMPLETED|Overall Study||109||
59631194|NCT01355484|75744720|FG001|COMPLETED|Overall Study||107||
59631195|NCT01355484|75744719|FG000|NOT COMPLETED|Overall Study||51||
59631196|NCT01355484|75744720|FG001|NOT COMPLETED|Overall Study||54||
59631197|NCT01355796|75744726|FG000|STARTED|Overall Study||15||
59631198|NCT01355796|75744727|FG001|STARTED|Overall Study||15||
59631199|NCT01355796|75744726|FG000|First Intervention for 14 Days|Overall Study||15||
59631200|NCT01355796|75744727|FG001|First Intervention for 14 Days|Overall Study||15||
59631201|NCT01355796|75744726|FG000|Washout Period for 7 Days|Overall Study||15||
59631202|NCT01355796|75744727|FG001|Washout Period for 7 Days|Overall Study||15||
59631203|NCT01355796|75744726|FG000|Second Intervention for 14 Days|Overall Study||15||
59815679|NCT03606213|75938140|FG003|COMPLETED|Overall Study||11||
59631204|NCT01355796|75744727|FG001|Second Intervention for 14 Days|Overall Study||15||
59631205|NCT01355796|75744726|FG000|COMPLETED|Overall Study||15||
59631206|NCT01355796|75744727|FG001|COMPLETED|Overall Study||15||
59631207|NCT01355796|75744726|FG000|NOT COMPLETED|Overall Study||0||
59631208|NCT01355796|75744727|FG001|NOT COMPLETED|Overall Study||0||
59631209|NCT01356498|75744739|FG000|STARTED|Overall Study||35||
59631210|NCT01356498|75744740|FG001|STARTED|Overall Study|2 other patients received no investigational drug in C0407 but elected to be followed in Observation|25||
59631211|NCT01356498|75744741|FG002|STARTED|Overall Study||23||
59631212|NCT01356498|75744742|FG003|STARTED|Overall Study||22||
59631213|NCT01356498|75744743|FG004|STARTED|Overall Study||28||
59815680|NCT03606213|75938137|FG000|NOT COMPLETED|Overall Study||0||
59631214|NCT01356498|75744744|FG005|STARTED|Overall Study||16||
59631215|NCT01356498|75744739|FG000|COMPLETED|Overall Study||24||
59631216|NCT01356498|75744740|FG001|COMPLETED|Overall Study||17||
59631217|NCT01356498|75744741|FG002|COMPLETED|Overall Study||11||
59631218|NCT01356498|75744742|FG003|COMPLETED|Overall Study||8||
59631219|NCT01356498|75744743|FG004|COMPLETED|Overall Study||8||
59631220|NCT01356498|75744744|FG005|COMPLETED|Overall Study||2||
59631221|NCT01356498|75744739|FG000|NOT COMPLETED|Overall Study||11||
59631222|NCT01356498|75744740|FG001|NOT COMPLETED|Overall Study||8||
59631223|NCT01356498|75744741|FG002|NOT COMPLETED|Overall Study||12||
59631224|NCT01356498|75744742|FG003|NOT COMPLETED|Overall Study||14||
59631225|NCT01356498|75744743|FG004|NOT COMPLETED|Overall Study||20||
59631226|NCT01356498|75744744|FG005|NOT COMPLETED|Overall Study||14||
59631227|NCT01357356|75744768|FG000|STARTED|Overall Study||188||
59631228|NCT01357356|75744769|FG001|STARTED|Overall Study||188||
59631229|NCT01357356|75744770|FG002|STARTED|Overall Study||186||
59631230|NCT01357356|75744771|FG003|STARTED|Overall Study||188||
59631231|NCT01357356|75744768|FG000|COMPLETED|Overall Study||166||
59631232|NCT01357356|75744769|FG001|COMPLETED|Overall Study||163||
59631233|NCT01357356|75744770|FG002|COMPLETED|Overall Study||158||
59631234|NCT01357356|75744771|FG003|COMPLETED|Overall Study||171||
59631235|NCT01357356|75744768|FG000|NOT COMPLETED|Overall Study||22||
59631236|NCT01357356|75744769|FG001|NOT COMPLETED|Overall Study||25||
59631237|NCT01357356|75744770|FG002|NOT COMPLETED|Overall Study||28||
59631238|NCT01357356|75744771|FG003|NOT COMPLETED|Overall Study||17||
59631239|NCT01357512|75744785|FG000|STARTED|Overall Study||65||
59631240|NCT01357512|75744786|FG001|STARTED|Overall Study||65||
59631241|NCT01357512|75744785|FG000|COMPLETED|Overall Study||53||
59631242|NCT01357512|75744786|FG001|COMPLETED|Overall Study||60||
59631243|NCT01357512|75744785|FG000|NOT COMPLETED|Overall Study||12||
59631244|NCT01357512|75744786|FG001|NOT COMPLETED|Overall Study||5||
59631245|NCT01362192|75744792|FG000|STARTED|Overall Study||20||
59631246|NCT01362192|75744792|FG000|COMPLETED|Overall Study||16||
59631247|NCT01362192|75744792|FG000|NOT COMPLETED|Overall Study||4||
59631248|NCT01362894|75744796|FG000|STARTED|Period One, 1 Week|One participant was not dispensed lenses until Period 2.|119||
59631249|NCT01362894|75744797|FG001|STARTED|Period One, 1 Week|One participant was not dispensed lenses until Period 2.|117||
59631250|NCT01362894|75744796|FG000|COMPLETED|Period One, 1 Week||119||
59631251|NCT01362894|75744797|FG001|COMPLETED|Period One, 1 Week||117||
59631252|NCT01362894|75744796|FG000|NOT COMPLETED|Period One, 1 Week||0||
59631253|NCT01362894|75744797|FG001|NOT COMPLETED|Period One, 1 Week||0||
60076344|NCT01904773|76191369|FG005|NOT COMPLETED|Fifth Intervention||0||
60076345|NCT01904773|76191370|FG006|NOT COMPLETED|Fifth Intervention||0||
60076346|NCT01904773|76191371|FG007|NOT COMPLETED|Fifth Intervention||1||
60076347|NCT01904773|76191372|FG008|NOT COMPLETED|Fifth Intervention||0||
60076348|NCT01904773|76191364|FG000|STARTED|Placebo Washout Fifth Intervention||0||
60076349|NCT01904773|76191365|FG001|STARTED|Placebo Washout Fifth Intervention||1||
60076350|NCT01904773|76191366|FG002|STARTED|Placebo Washout Fifth Intervention||1||
60076351|NCT01904773|76191367|FG003|STARTED|Placebo Washout Fifth Intervention||2||
60076352|NCT01904773|76191368|FG004|STARTED|Placebo Washout Fifth Intervention||3||
60076353|NCT01904773|76191369|FG005|STARTED|Placebo Washout Fifth Intervention||4||
60076354|NCT01904773|76191370|FG006|STARTED|Placebo Washout Fifth Intervention||3||
60076355|NCT01904773|76191371|FG007|STARTED|Placebo Washout Fifth Intervention||2||
60076356|NCT01904773|76191372|FG008|STARTED|Placebo Washout Fifth Intervention||4||
60076357|NCT01904773|76191364|FG000|COMPLETED|Placebo Washout Fifth Intervention||0||
60076358|NCT01904773|76191365|FG001|COMPLETED|Placebo Washout Fifth Intervention||0||
59631254|NCT01362894|75744796|FG000|STARTED|Period Two, 1 Week|Two participants discontinued between Periods 1 and 2 due to discomfort (1) and poor fit (1).|118||
59631255|NCT01362894|75744797|FG001|STARTED|Period Two, 1 Week|Three participants discontinued between Periods 1 and 2 due to unacceptable vision.|115||
59631256|NCT01362894|75744796|FG000|COMPLETED|Period Two, 1 Week||118||
59631257|NCT01362894|75744797|FG001|COMPLETED|Period Two, 1 Week||115||
59631258|NCT01362894|75744796|FG000|NOT COMPLETED|Period Two, 1 Week||0||
59631259|NCT01362894|75744797|FG001|NOT COMPLETED|Period Two, 1 Week||0||
59631260|NCT01363050|75744803|FG000|STARTED|Overall Study||15||
59631261|NCT01363050|75744803|FG000|COMPLETED|Overall Study||15||
59631262|NCT01363050|75744803|FG000|NOT COMPLETED|Overall Study||0||
59631263|NCT01363128|75744809|FG000|STARTED|Overall Study||69||
59631264|NCT01363128|75744809|FG000|COMPLETED|Overall Study||69||
59631265|NCT01363128|75744809|FG000|NOT COMPLETED|Overall Study||0||
59631266|NCT01365624|75744815|FG000|STARTED|Overall Study||15||
59631267|NCT01365624|75744816|FG001|STARTED|Overall Study||15||
59631268|NCT01365624|75744815|FG000|COMPLETED|Overall Study||15||
59631269|NCT01365624|75744816|FG001|COMPLETED|Overall Study||15||
59631270|NCT01365624|75744815|FG000|NOT COMPLETED|Overall Study||0||
59631271|NCT01365624|75744816|FG001|NOT COMPLETED|Overall Study||0||
60076359|NCT01904773|76191366|FG002|COMPLETED|Placebo Washout Fifth Intervention||1||
60076360|NCT01904773|76191367|FG003|COMPLETED|Placebo Washout Fifth Intervention||2||
60076361|NCT01904773|76191368|FG004|COMPLETED|Placebo Washout Fifth Intervention||3||
59631272|NCT01366872|75744822|FG000|STARTED|Overall Study||50||
59631273|NCT01366872|75744822|FG000|COMPLETED|Overall Study||50||
59631274|NCT01366872|75744822|FG000|NOT COMPLETED|Overall Study||0||
59631275|NCT01367262|75744826|FG000|STARTED|Overall Study||6||
59631276|NCT01367262|75744826|FG000|COMPLETED|Overall Study||6||
59631277|NCT01367262|75744826|FG000|NOT COMPLETED|Overall Study||0||
59631278|NCT01369758|75744830|FG000|STARTED|Overall Study||290||
59631279|NCT01369758|75744830|FG000|COMPLETED|Overall Study||290||
59631280|NCT01369758|75744830|FG000|NOT COMPLETED|Overall Study||0||
59631281|NCT01371786|75744836|FG000|STARTED|Overall Study||7||
59631282|NCT01371786|75744837|FG001|STARTED|Overall Study||7||
59631283|NCT01371786|75744836|FG000|COMPLETED|Overall Study||7||
59631284|NCT01371786|75744837|FG001|COMPLETED|Overall Study||7||
59631285|NCT01371786|75744836|FG000|NOT COMPLETED|Overall Study||0||
59631286|NCT01371786|75744837|FG001|NOT COMPLETED|Overall Study||0||
59631287|NCT01373580|75744843|FG000|STARTED|Overall Study||373||
59631288|NCT01373580|75744843|FG000|COMPLETED|Overall Study||317||
59631289|NCT01373580|75744843|FG000|NOT COMPLETED|Overall Study||56||
59631290|NCT01374438|75744849|FG000|STARTED|Overall Study||16||
59631291|NCT01374438|75744850|FG001|STARTED|Overall Study||13||
59631292|NCT01374438|75744849|FG000|COMPLETED|Overall Study||16||
59631293|NCT01374438|75744850|FG001|COMPLETED|Overall Study||13||
59631294|NCT01374438|75744849|FG000|NOT COMPLETED|Overall Study||0||
59631295|NCT01374438|75744850|FG001|NOT COMPLETED|Overall Study||0||
59631296|NCT01377402|75744856|FG000|STARTED|Overall Study||982||
59631297|NCT01377402|75744856|FG000|COMPLETED|Overall Study||982||
59631298|NCT01377402|75744856|FG000|NOT COMPLETED|Overall Study||0||
59631299|NCT01377636|75744862|FG000|STARTED|Overall Study||20||
59631300|NCT01377636|75744862|FG000|COMPLETED|Overall Study||20||
59631301|NCT01377636|75744862|FG000|NOT COMPLETED|Overall Study||0||
59631302|NCT01378416|75744868|FG000|STARTED|Overall Study||16||
59631303|NCT01378416|75744868|FG000|COMPLETED|Overall Study||16||
59631304|NCT01378416|75744868|FG000|NOT COMPLETED|Overall Study||0||
59631305|NCT01379664|75744874|FG000|STARTED|Overall Study||714||
59631306|NCT01379664|75744875|FG001|STARTED|Overall Study||870||
59631307|NCT01379664|75744874|FG000|COMPLETED|Overall Study||714||
59815681|NCT03606213|75938138|FG001|NOT COMPLETED|Overall Study||0||
59815682|NCT03606213|75938139|FG002|NOT COMPLETED|Overall Study||0||
59815683|NCT03606213|75938140|FG003|NOT COMPLETED|Overall Study||0||
59631308|NCT01379664|75744875|FG001|COMPLETED|Overall Study||870||
59631309|NCT01379664|75744874|FG000|NOT COMPLETED|Overall Study||0||
59631310|NCT01379664|75744875|FG001|NOT COMPLETED|Overall Study||0||
59631311|NCT01380366|75744881|FG000|STARTED|Overall Study||15||
59631312|NCT01380366|75744881|FG000|COMPLETED|Overall Study||15||
59631313|NCT01380366|75744881|FG000|NOT COMPLETED|Overall Study||0||
59631314|NCT01383720|75744886|FG000|STARTED|Overall Study||11||
59631315|NCT01383720|75744886|FG000|Primary Endpoint (Discharge/7 Days)|Overall Study||11||
59631316|NCT01383720|75744886|FG000|COMPLETED|Overall Study|Study is continuing to 5 years. All patients are still in the study.|11||
59631317|NCT01383720|75744886|FG000|NOT COMPLETED|Overall Study||0||
59631318|NCT01386528|75744890|FG000|STARTED|Overall Study||13||
59631319|NCT01386528|75744890|FG000|COMPLETED|Overall Study||13||
59631320|NCT01386528|75744890|FG000|NOT COMPLETED|Overall Study||0||
59631321|NCT01387464|75744896|FG000|STARTED|Overall Study||30||
59631322|NCT01387464|75744897|FG001|STARTED|Overall Study||30||
59815684|NCT03390036|75938153|FG000|STARTED|Overall Study||233|Safety Population and ITT Population|
59815685|NCT03390036|75938154|FG001|STARTED|Overall Study||230|Safety Population and ITT Population|
59631323|NCT01387464|75744896|FG000|Safety Population|Overall Study||30||
59631324|NCT01387464|75744897|FG001|Safety Population|Overall Study||29||
59631325|NCT01387464|75744896|FG000|Per-Protocol Population|Overall Study|Safety subjects who completed surgery|29||
59815686|NCT03390036|75938155|FG002|STARTED|Overall Study||63|Safety Population and ITT Population|
59815687|NCT03390036|75938153|FG000|COMPLETED|Overall Study||231||
59631326|NCT01387464|75744897|FG001|Per-Protocol Population|Overall Study||29||
59631327|NCT01387464|75744896|FG000|COMPLETED|Overall Study||29||
59631328|NCT01387464|75744897|FG001|COMPLETED|Overall Study||29||
59631329|NCT01387464|75744896|FG000|NOT COMPLETED|Overall Study||1||
59631330|NCT01387464|75744897|FG001|NOT COMPLETED|Overall Study||1||
59631331|NCT01388946|75744905|FG000|STARTED|Overall Study||55||
59631332|NCT01388946|75744906|FG001|STARTED|Overall Study||55||
59815688|NCT03390036|75938154|FG001|COMPLETED|Overall Study||230||
59631333|NCT01388946|75744905|FG000|COMPLETED|Overall Study||49||
59631334|NCT01388946|75744906|FG001|COMPLETED|Overall Study||52||
59631335|NCT01388946|75744905|FG000|NOT COMPLETED|Overall Study||6||
59631336|NCT01388946|75744906|FG001|NOT COMPLETED|Overall Study||3||
59631337|NCT01390818|75744927|FG000|STARTED|Overall Study||3||
59631338|NCT01390818|75744928|FG001|STARTED|Overall Study||3||
59631339|NCT01390818|75744929|FG002|STARTED|Overall Study||3||
59815689|NCT03390036|75938155|FG002|COMPLETED|Overall Study||63||
59815690|NCT03390036|75938153|FG000|NOT COMPLETED|Overall Study||2||
59631340|NCT01390818|75744930|FG003|STARTED|Overall Study||4||
59631341|NCT01390818|75744931|FG004|STARTED|Overall Study||4||
59631342|NCT01390818|75744932|FG005|STARTED|Overall Study||3||
59631343|NCT01390818|75744933|FG006|STARTED|Overall Study||19||
59631344|NCT01390818|75744934|FG007|STARTED|Overall Study||14||
59631345|NCT01390818|75744935|FG008|STARTED|Overall Study||3||
59631346|NCT01390818|75744936|FG009|STARTED|Overall Study||3||
59631347|NCT01390818|75744937|FG010|STARTED|Overall Study||4||
59631348|NCT01390818|75744938|FG011|STARTED|Overall Study||26||
59631349|NCT01390818|75744939|FG012|STARTED|Overall Study||24||
59631350|NCT01390818|75744940|FG013|STARTED|Overall Study||18||
59631351|NCT01390818|75744941|FG014|STARTED|Overall Study||15||
59631352|NCT01390818|75744927|FG000|COMPLETED|Overall Study||3||
59631353|NCT01390818|75744928|FG001|COMPLETED|Overall Study||3||
59631354|NCT01390818|75744929|FG002|COMPLETED|Overall Study||3||
59631355|NCT01390818|75744930|FG003|COMPLETED|Overall Study||4||
59631356|NCT01390818|75744931|FG004|COMPLETED|Overall Study||4||
59631357|NCT01390818|75744932|FG005|COMPLETED|Overall Study||3||
59631358|NCT01390818|75744933|FG006|COMPLETED|Overall Study||19||
59631359|NCT01390818|75744934|FG007|COMPLETED|Overall Study||14||
59631360|NCT01390818|75744935|FG008|COMPLETED|Overall Study||3||
59631361|NCT01390818|75744936|FG009|COMPLETED|Overall Study||3||
59631362|NCT01390818|75744937|FG010|COMPLETED|Overall Study||4||
59631363|NCT01390818|75744938|FG011|COMPLETED|Overall Study||26||
59631364|NCT01390818|75744939|FG012|COMPLETED|Overall Study||24||
59631365|NCT01390818|75744940|FG013|COMPLETED|Overall Study||18||
59631366|NCT01390818|75744941|FG014|COMPLETED|Overall Study||15||
59631367|NCT01390818|75744927|FG000|NOT COMPLETED|Overall Study||0||
59631368|NCT01390818|75744928|FG001|NOT COMPLETED|Overall Study||0||
59631369|NCT01390818|75744929|FG002|NOT COMPLETED|Overall Study||0||
59631370|NCT01390818|75744930|FG003|NOT COMPLETED|Overall Study||0||
59631371|NCT01390818|75744931|FG004|NOT COMPLETED|Overall Study||0||
59631372|NCT01390818|75744932|FG005|NOT COMPLETED|Overall Study||0||
59631373|NCT01390818|75744933|FG006|NOT COMPLETED|Overall Study||0||
59631374|NCT01390818|75744934|FG007|NOT COMPLETED|Overall Study||0||
59631375|NCT01390818|75744935|FG008|NOT COMPLETED|Overall Study||0||
59631376|NCT01390818|75744936|FG009|NOT COMPLETED|Overall Study||0||
59631377|NCT01390818|75744937|FG010|NOT COMPLETED|Overall Study||0||
59631378|NCT01390818|75744938|FG011|NOT COMPLETED|Overall Study||0||
59631379|NCT01390818|75744939|FG012|NOT COMPLETED|Overall Study||0||
59631380|NCT01390818|75744940|FG013|NOT COMPLETED|Overall Study||0||
59631381|NCT01390818|75744941|FG014|NOT COMPLETED|Overall Study||0||
59631382|NCT01391286|75745043|FG000|STARTED|Overall Study||18||
59631383|NCT01391286|75745044|FG001|STARTED|Overall Study||18||
59631384|NCT01391286|75745043|FG000|COMPLETED|Overall Study||18||
59631385|NCT01391286|75745044|FG001|COMPLETED|Overall Study||18||
59631386|NCT01391286|75745043|FG000|NOT COMPLETED|Overall Study||0||
59631387|NCT01391286|75745044|FG001|NOT COMPLETED|Overall Study||0||
59631388|NCT01391364|75745052|FG000|STARTED|Overall Study||222||
59631389|NCT01391364|75745053|FG001|STARTED|Overall Study||216||
59631390|NCT01391364|75745052|FG000|COMPLETED|Overall Study||217||
59631391|NCT01391364|75745053|FG001|COMPLETED|Overall Study||214||
59631392|NCT01391364|75745052|FG000|NOT COMPLETED|Overall Study||5||
59631393|NCT01391364|75745053|FG001|NOT COMPLETED|Overall Study||2||
59631394|NCT01393392|75745061|FG000|STARTED|Overall Study||44||
59631395|NCT01393392|75745062|FG001|STARTED|Overall Study||43||
59631396|NCT01393392|75745061|FG000|COMPLETED|Overall Study||33||
59631397|NCT01393392|75745062|FG001|COMPLETED|Overall Study||24||
59988289|NCT02270944|76103415|FG000|NOT COMPLETED|Overall Study||11||
59631398|NCT01393392|75745061|FG000|NOT COMPLETED|Overall Study||11||
59631399|NCT01393392|75745062|FG001|NOT COMPLETED|Overall Study||19||
59631400|NCT01393704|75745070|FG000|STARTED|Overall Study||76||
59631401|NCT01393704|75745071|FG001|STARTED|Overall Study||76||
59631402|NCT01393704|75745070|FG000|COMPLETED|Overall Study||76||
59631403|NCT01393704|75745071|FG001|COMPLETED|Overall Study||76||
59631404|NCT01393704|75745070|FG000|NOT COMPLETED|Overall Study||0||
59631405|NCT01393704|75745071|FG001|NOT COMPLETED|Overall Study||0||
59631406|NCT01395966|75745080|FG000|STARTED|Overall Study||109||
59988290|NCT02270944|76103416|FG001|NOT COMPLETED|Overall Study||5||
59988291|NCT02365558|76103423|FG000|STARTED|Period 1 (Day 1 Through Day 7)||34||
59631407|NCT01395966|75745081|FG001|STARTED|Overall Study||110||
59631408|NCT01395966|75745082|FG002|STARTED|Overall Study||112||
59631409|NCT01395966|75745080|FG000|COMPLETED|Overall Study||99||
59631410|NCT01395966|75745081|FG001|COMPLETED|Overall Study||91||
59631411|NCT01395966|75745082|FG002|COMPLETED|Overall Study||104||
59631412|NCT01395966|75745080|FG000|NOT COMPLETED|Overall Study||10||
59988292|NCT02365558|76103424|FG001|STARTED|Period 1 (Day 1 Through Day 7)||0||
59988293|NCT02365558|76103423|FG000|Received at Least One Dose of Study Drug|Period 1 (Day 1 Through Day 7)||34||
59631413|NCT01395966|75745081|FG001|NOT COMPLETED|Overall Study||19||
59631414|NCT01395966|75745082|FG002|NOT COMPLETED|Overall Study||8||
59631415|NCT01396044|75745092|FG000|STARTED|Overall Study||125||
59631416|NCT01396044|75745093|FG001|STARTED|Overall Study||171||
59631417|NCT01396044|75745092|FG000|COMPLETED|Overall Study||125||
59631418|NCT01396044|75745093|FG001|COMPLETED|Overall Study||171||
59631419|NCT01396044|75745092|FG000|NOT COMPLETED|Overall Study||0||
59631420|NCT01396044|75745093|FG001|NOT COMPLETED|Overall Study||0||
59631421|NCT01399008|75745102|FG000|STARTED|Overall Study||35||
59631422|NCT01399008|75745103|FG001|STARTED|Overall Study||32||
59631423|NCT01399008|75745104|FG002|STARTED|Overall Study||33||
59631424|NCT01399008|75745102|FG000|COMPLETED|Overall Study||32||
59631425|NCT01399008|75745103|FG001|COMPLETED|Overall Study||27||
59631426|NCT01399008|75745104|FG002|COMPLETED|Overall Study||31||
59631427|NCT01399008|75745102|FG000|NOT COMPLETED|Overall Study||3||
59631428|NCT01399008|75745103|FG001|NOT COMPLETED|Overall Study||5||
59631429|NCT01399008|75745104|FG002|NOT COMPLETED|Overall Study||2||
59631430|NCT01399866|75745114|FG000|STARTED|Overall Study||32||
59631431|NCT01399866|75745115|FG001|STARTED|Overall Study||30||
59631432|NCT01399866|75745114|FG000|COMPLETED|Overall Study||28||
59631433|NCT01399866|75745115|FG001|COMPLETED|Overall Study||28||
59631434|NCT01399866|75745114|FG000|NOT COMPLETED|Overall Study||4||
59631435|NCT01399866|75745115|FG001|NOT COMPLETED|Overall Study||2||
59631436|NCT01400880|75745121|FG000|STARTED|Overall Study|patients were added throughout the study. There was not a set number of patients that we began with|103||
59631437|NCT01400880|75745121|FG000|COMPLETED|Overall Study|patients were added throughout the study. There was not a set number of patients that we began with|101||
59631438|NCT01400880|75745121|FG000|NOT COMPLETED|Overall Study||2||
59631439|NCT01401582|75745127|FG000|STARTED|Overall Study||226||
59631440|NCT01401582|75745128|FG001|STARTED|Overall Study||408||
59631441|NCT01401582|75745127|FG000|Baseline Completed|Overall Study||168||
59631442|NCT01401582|75745128|FG001|Baseline Completed|Overall Study||348||
59631443|NCT01401582|75745127|FG000|COMPLETED|Overall Study||116||
59631444|NCT01401582|75745128|FG001|COMPLETED|Overall Study||291||
59631445|NCT01401582|75745127|FG000|NOT COMPLETED|Overall Study||110||
59631446|NCT01401582|75745128|FG001|NOT COMPLETED|Overall Study||117||
59631447|NCT01402050|75745139|FG000|STARTED|Overall Study||185||
59631448|NCT01402050|75745140|FG001|STARTED|Overall Study||191||
59631449|NCT01402050|75745139|FG000|COMPLETED|Overall Study||185||
59631450|NCT01402050|75745140|FG001|COMPLETED|Overall Study||191||
59631451|NCT01402050|75745139|FG000|NOT COMPLETED|Overall Study||0||
59631452|NCT01402050|75745140|FG001|NOT COMPLETED|Overall Study||0||
59631453|NCT01402128|75745148|FG000|STARTED|Overall Study||40||
59631454|NCT01402128|75745149|FG001|STARTED|Overall Study||40||
59631455|NCT01402128|75745148|FG000|COMPLETED|Overall Study||39||
59631456|NCT01402128|75745149|FG001|COMPLETED|Overall Study||40||
59631457|NCT01402128|75745148|FG000|NOT COMPLETED|Overall Study||1||
59631458|NCT01402128|75745149|FG001|NOT COMPLETED|Overall Study||0||
59631459|NCT01403376|75745158|FG000|STARTED|Overall Study||41||
59631460|NCT01403376|75745159|FG001|STARTED|Overall Study||41||
59631461|NCT01403376|75745160|FG002|STARTED|Overall Study||46||
59631462|NCT01403376|75745158|FG000|COMPLETED|Overall Study||41||
59631463|NCT01403376|75745159|FG001|COMPLETED|Overall Study||41||
59631464|NCT01403376|75745160|FG002|COMPLETED|Overall Study||46||
59631465|NCT01403376|75745158|FG000|NOT COMPLETED|Overall Study||0||
59631466|NCT01403376|75745159|FG001|NOT COMPLETED|Overall Study||0||
59631467|NCT01403376|75745160|FG002|NOT COMPLETED|Overall Study||0||
59631468|NCT01404078|75745170|FG000|STARTED|Overall Study|725 Started on Phase 1 run in low dose polycap 645 started on phase 2 run in full dose polycap|261||
59631469|NCT01404078|75745171|FG001|STARTED|Overall Study|725 Started on Phase 1 run in low dose polycap 645 started on phase 2 run in full dose polycap|257||
59631470|NCT01404078|75745170|FG000|COMPLETED|Overall Study||243||
59631471|NCT01404078|75745171|FG001|COMPLETED|Overall Study||237||
59631472|NCT01404078|75745170|FG000|NOT COMPLETED|Overall Study||18||
59631473|NCT01404078|75745171|FG001|NOT COMPLETED|Overall Study||20||
59631474|NCT01404936|75745177|FG000|STARTED|Overall Study||30||
59631475|NCT01404936|75745177|FG000|COMPLETED|Overall Study||30||
59631476|NCT01404936|75745177|FG000|NOT COMPLETED|Overall Study||0||
59631477|NCT01405794|75745181|FG000|STARTED|First Dose Placebo (14 Days)||12||
59631478|NCT01405794|75745181|FG000|COMPLETED|First Dose Placebo (14 Days)||12||
59631479|NCT01405794|75745181|FG000|NOT COMPLETED|First Dose Placebo (14 Days)||0||
59631480|NCT01405794|75745181|FG000|STARTED|72 hr Washout||12||
59631481|NCT01405794|75745181|FG000|COMPLETED|72 hr Washout||12||
59631482|NCT01405794|75745181|FG000|NOT COMPLETED|72 hr Washout||0||
59631483|NCT01405794|75745181|FG000|STARTED|Second Dose 32ppm Oral Silver (14 Days)||12||
59631484|NCT01405794|75745181|FG000|COMPLETED|Second Dose 32ppm Oral Silver (14 Days)||12||
59631485|NCT01405794|75745181|FG000|NOT COMPLETED|Second Dose 32ppm Oral Silver (14 Days)||0||
59631486|NCT01408992|75745187|FG000|STARTED|Overall Study||558||
59631487|NCT01408992|75745187|FG000|COMPLETED|Overall Study||558||
59631488|NCT01408992|75745187|FG000|NOT COMPLETED|Overall Study||0||
59631489|NCT01410084|75745201|FG000|STARTED|Overall Study||38||
59631490|NCT01410084|75745202|FG001|STARTED|Overall Study||30||
59631491|NCT01410084|75745201|FG000|COMPLETED|Overall Study||37||
59631492|NCT01410084|75745202|FG001|COMPLETED|Overall Study||27||
59631493|NCT01410084|75745201|FG000|NOT COMPLETED|Overall Study||1||
59631494|NCT01410084|75745202|FG001|NOT COMPLETED|Overall Study||3||
59631495|NCT01410552|75745208|FG000|STARTED|Overall Study||1013||
59631496|NCT01410552|75745208|FG000|COMPLETED|Overall Study||877||
59631497|NCT01410552|75745208|FG000|NOT COMPLETED|Overall Study||136||
59631498|NCT01411488|75745214|FG000|STARTED|Overall Study||41||
59631499|NCT01411488|75745215|FG001|STARTED|Overall Study||38||
59631500|NCT01411488|75745214|FG000|COMPLETED|Overall Study||41||
59631501|NCT01411488|75745215|FG001|COMPLETED|Overall Study||38||
59631502|NCT01411488|75745214|FG000|NOT COMPLETED|Overall Study||0||
59631503|NCT01411488|75745215|FG001|NOT COMPLETED|Overall Study||0||
59631504|NCT01413750|75745225|FG000|STARTED|Overall Study||6||
59631505|NCT01413750|75745226|FG001|STARTED|Overall Study||6||
59631506|NCT01413750|75745227|FG002|STARTED|Overall Study||4||
59631507|NCT01413750|75745228|FG003|STARTED|Overall Study||7||
59631508|NCT01413750|75745225|FG000|COMPLETED|Overall Study||6||
59631509|NCT01413750|75745226|FG001|COMPLETED|Overall Study||6||
59631510|NCT01413750|75745227|FG002|COMPLETED|Overall Study||4||
59631511|NCT01413750|75745228|FG003|COMPLETED|Overall Study||7||
59631512|NCT01413750|75745225|FG000|NOT COMPLETED|Overall Study||0||
59631513|NCT01413750|75745226|FG001|NOT COMPLETED|Overall Study||0||
59631514|NCT01413750|75745227|FG002|NOT COMPLETED|Overall Study||0||
59631515|NCT01413750|75745228|FG003|NOT COMPLETED|Overall Study||0||
59631516|NCT01415232|75745239|FG000|STARTED|Overall Study||160||
59631517|NCT01415232|75745239|FG000|COMPLETED|Overall Study||160||
59631518|NCT01415232|75745239|FG000|NOT COMPLETED|Overall Study||0||
59631519|NCT01415934|75745245|FG000|STARTED|Overall Study||192||
59631520|NCT01415934|75745246|FG001|STARTED|Overall Study||189||
59631521|NCT01415934|75745245|FG000|COMPLETED|Overall Study||189||
59631522|NCT01415934|75745246|FG001|COMPLETED|Overall Study||182||
59631523|NCT01415934|75745245|FG000|NOT COMPLETED|Overall Study||3||
59631524|NCT01415934|75745246|FG001|NOT COMPLETED|Overall Study||7||
59631525|NCT01417026|75745254|FG000|STARTED|Overall Study||16||
59631526|NCT01417026|75745255|FG001|STARTED|Overall Study||13||
59631527|NCT01417026|75745254|FG000|COMPLETED|Overall Study||14||
59631528|NCT01417026|75745255|FG001|COMPLETED|Overall Study||13||
59631529|NCT01417026|75745254|FG000|NOT COMPLETED|Overall Study||2||
59540132|NCT01654380|75638415|FG001|NOT COMPLETED|Part A, Period 3||0||
59540133|NCT01654380|75638416|FG002|NOT COMPLETED|Part A, Period 3||0||
59540134|NCT01654380|75638417|FG003|NOT COMPLETED|Part A, Period 3||0||
59540135|NCT01654380|75638414|FG000|STARTED|Part A, Washout of at Least 6 Days||4||
59540136|NCT01654380|75638415|FG001|STARTED|Part A, Washout of at Least 6 Days||4||
59540137|NCT01654380|75638416|FG002|STARTED|Part A, Washout of at Least 6 Days||0||
59540138|NCT01654380|75638417|FG003|STARTED|Part A, Washout of at Least 6 Days||0||
59540139|NCT01654380|75638414|FG000|COMPLETED|Part A, Washout of at Least 6 Days||4||
59540140|NCT01654380|75638415|FG001|COMPLETED|Part A, Washout of at Least 6 Days||4||
59540141|NCT01654380|75638416|FG002|COMPLETED|Part A, Washout of at Least 6 Days||0||
59540142|NCT01654380|75638417|FG003|COMPLETED|Part A, Washout of at Least 6 Days||0||
59540143|NCT01654380|75638414|FG000|NOT COMPLETED|Part A, Washout of at Least 6 Days||0||
59540144|NCT01654380|75638415|FG001|NOT COMPLETED|Part A, Washout of at Least 6 Days||0||
59540145|NCT01654380|75638416|FG002|NOT COMPLETED|Part A, Washout of at Least 6 Days||0||
59540146|NCT01654380|75638417|FG003|NOT COMPLETED|Part A, Washout of at Least 6 Days||0||
59540147|NCT01654380|75638414|FG000|STARTED|Part A, Period 4||4||
59540148|NCT01654380|75638415|FG001|STARTED|Part A, Period 4||4||
59540149|NCT01654380|75638416|FG002|STARTED|Part A, Period 4||0||
59540150|NCT01654380|75638417|FG003|STARTED|Part A, Period 4||0||
59540151|NCT01654380|75638414|FG000|COMPLETED|Part A, Period 4||4||
59540152|NCT01654380|75638415|FG001|COMPLETED|Part A, Period 4||4||
59540153|NCT01654380|75638416|FG002|COMPLETED|Part A, Period 4||0||
59540154|NCT01654380|75638417|FG003|COMPLETED|Part A, Period 4||0||
59540155|NCT01654380|75638414|FG000|NOT COMPLETED|Part A, Period 4||0||
59540156|NCT01654380|75638415|FG001|NOT COMPLETED|Part A, Period 4||0||
59540157|NCT01654380|75638416|FG002|NOT COMPLETED|Part A, Period 4||0||
59540158|NCT01654380|75638417|FG003|NOT COMPLETED|Part A, Period 4||0||
59540159|NCT01654380|75638414|FG000|STARTED|Part B, Period 1|Participants in Part A were not included in Part B.|0||
59540160|NCT01654380|75638415|FG001|STARTED|Part B, Period 1|Participants in Part A were not included in Part B.|0||
59540161|NCT01654380|75638416|FG002|STARTED|Part B, Period 1|Participants in Part B were not included in Part A.|7||
59540162|NCT01654380|75638417|FG003|STARTED|Part B, Period 1|Participants in Part B were not included in Part A.|7||
59540163|NCT01654380|75638414|FG000|Received at Least 1 Dose of Study Drug|Part B, Period 1||0||
59540164|NCT01654380|75638415|FG001|Received at Least 1 Dose of Study Drug|Part B, Period 1||0||
59540165|NCT01654380|75638416|FG002|Received at Least 1 Dose of Study Drug|Part B, Period 1||7||
59540166|NCT01654380|75638417|FG003|Received at Least 1 Dose of Study Drug|Part B, Period 1||7||
59540167|NCT01654380|75638414|FG000|COMPLETED|Part B, Period 1||0||
59540168|NCT01654380|75638415|FG001|COMPLETED|Part B, Period 1||0||
59540169|NCT01654380|75638416|FG002|COMPLETED|Part B, Period 1|Participant who did not complete received only 1 dose of LY2605541 74.1 mU/min IV for 8 hours|6||
59540170|NCT01654380|75638417|FG003|COMPLETED|Part B, Period 1||7||
59540171|NCT01654380|75638414|FG000|NOT COMPLETED|Part B, Period 1||0||
59540172|NCT01654380|75638415|FG001|NOT COMPLETED|Part B, Period 1||0||
59540173|NCT01654380|75638416|FG002|NOT COMPLETED|Part B, Period 1||1||
59540174|NCT01654380|75638417|FG003|NOT COMPLETED|Part B, Period 1||0||
59540175|NCT01654380|75638414|FG000|STARTED|Part B, Washout of at Least 6 Days||0||
59540176|NCT01654380|75638415|FG001|STARTED|Part B, Washout of at Least 6 Days||0||
59540177|NCT01654380|75638416|FG002|STARTED|Part B, Washout of at Least 6 Days||6||
59540178|NCT01654380|75638417|FG003|STARTED|Part B, Washout of at Least 6 Days||7||
59540179|NCT01654380|75638414|FG000|COMPLETED|Part B, Washout of at Least 6 Days||0||
59540180|NCT01654380|75638415|FG001|COMPLETED|Part B, Washout of at Least 6 Days||0||
59540181|NCT01654380|75638416|FG002|COMPLETED|Part B, Washout of at Least 6 Days||6||
59540182|NCT01654380|75638417|FG003|COMPLETED|Part B, Washout of at Least 6 Days||7||
59540183|NCT01654380|75638414|FG000|NOT COMPLETED|Part B, Washout of at Least 6 Days||0||
59540184|NCT01654380|75638415|FG001|NOT COMPLETED|Part B, Washout of at Least 6 Days||0||
59540185|NCT01654380|75638416|FG002|NOT COMPLETED|Part B, Washout of at Least 6 Days||0||
59540186|NCT01654380|75638417|FG003|NOT COMPLETED|Part B, Washout of at Least 6 Days||0||
59540187|NCT01654380|75638414|FG000|STARTED|Part B, Period 2||0||
59540188|NCT01654380|75638415|FG001|STARTED|Part B, Period 2||0||
59540189|NCT01654380|75638416|FG002|STARTED|Part B, Period 2||6||
59815691|NCT03390036|75938154|FG001|NOT COMPLETED|Overall Study||0||
59815692|NCT03390036|75938155|FG002|NOT COMPLETED|Overall Study||0||
59815693|NCT03379506|75938167|FG000|STARTED|Overall Study||22||
59815694|NCT03379506|75938168|FG001|STARTED|Overall Study||17||
59988294|NCT02365558|76103424|FG001|Received at Least One Dose of Study Drug|Period 1 (Day 1 Through Day 7)||0||
59988295|NCT02365558|76103423|FG000|COMPLETED|Period 1 (Day 1 Through Day 7)||33||
59988296|NCT02365558|76103424|FG001|COMPLETED|Period 1 (Day 1 Through Day 7)||0||
59988297|NCT02365558|76103423|FG000|NOT COMPLETED|Period 1 (Day 1 Through Day 7)||1||
59540190|NCT01654380|75638417|FG003|STARTED|Part B, Period 2||7||
59540191|NCT01654380|75638414|FG000|COMPLETED|Part B, Period 2||0||
59540192|NCT01654380|75638415|FG001|COMPLETED|Part B, Period 2||0||
59988298|NCT02365558|76103424|FG001|NOT COMPLETED|Period 1 (Day 1 Through Day 7)||0||
59540193|NCT01654380|75638416|FG002|COMPLETED|Part B, Period 2||6||
59815695|NCT03379506|75938169|FG002|STARTED|Overall Study||7||
59988299|NCT02365558|76103423|FG000|STARTED|Period 2 (Day 8 Through Day 20)|Participants move to Evacetrapib + Omeprazole for Period 2.|0||
59631530|NCT01417026|75745255|FG001|NOT COMPLETED|Overall Study||0||
59631531|NCT01420146|75745261|FG000|STARTED|Overall Study||20||
59631532|NCT01420146|75745261|FG000|COMPLETED|Overall Study||20||
59631533|NCT01420146|75745261|FG000|NOT COMPLETED|Overall Study||0||
59631534|NCT01420848|75745268|FG000|STARTED|Overall Study||24||
59631535|NCT01420848|75745269|FG001|STARTED|Overall Study||25||
59631536|NCT01420848|75745270|FG002|STARTED|Overall Study||22||
59631537|NCT01420848|75745268|FG000|COMPLETED|Overall Study||24||
59631538|NCT01420848|75745269|FG001|COMPLETED|Overall Study||25||
59631539|NCT01420848|75745270|FG002|COMPLETED|Overall Study||22||
59631540|NCT01420848|75745268|FG000|NOT COMPLETED|Overall Study||0||
59631541|NCT01420848|75745269|FG001|NOT COMPLETED|Overall Study||0||
59631542|NCT01420848|75745270|FG002|NOT COMPLETED|Overall Study||0||
59631543|NCT01421472|75745282|FG000|STARTED|Overall Study||67||
59631544|NCT01421472|75745283|FG001|STARTED|Overall Study||33||
59631545|NCT01421472|75745284|FG002|STARTED|Overall Study||64||
59631546|NCT01421472|75745285|FG003|STARTED|Overall Study||32||
59631547|NCT01421472|75745282|FG000|COMPLETED|Overall Study||67||
59631548|NCT01421472|75745283|FG001|COMPLETED|Overall Study||33||
59631549|NCT01421472|75745284|FG002|COMPLETED|Overall Study||64||
59631550|NCT01421472|75745285|FG003|COMPLETED|Overall Study||32||
59631551|NCT01421472|75745282|FG000|NOT COMPLETED|Overall Study||0||
59631552|NCT01421472|75745283|FG001|NOT COMPLETED|Overall Study||0||
59631553|NCT01421472|75745284|FG002|NOT COMPLETED|Overall Study||0||
59631554|NCT01421472|75745285|FG003|NOT COMPLETED|Overall Study||0||
59631555|NCT01426230|75745297|FG000|STARTED|Overall Study|90 patients were enrolled, but only 86 received study treatment.|86||
59631556|NCT01426230|75745298|FG001|STARTED|Overall Study||111||
59631557|NCT01426230|75745297|FG000|COMPLETED|Overall Study||55||
59631558|NCT01426230|75745298|FG001|COMPLETED|Overall Study||84||
59631559|NCT01426230|75745297|FG000|NOT COMPLETED|Overall Study||31||
59631560|NCT01426230|75745298|FG001|NOT COMPLETED|Overall Study||27||
59631561|NCT01428336|75745305|FG000|STARTED|Overall Study||10||
59631562|NCT01428336|75745306|FG001|STARTED|Overall Study||12||
59631563|NCT01428336|75745305|FG000|COMPLETED|Overall Study||10||
59631564|NCT01428336|75745306|FG001|COMPLETED|Overall Study||12||
59631565|NCT01428336|75745305|FG000|NOT COMPLETED|Overall Study||0||
59631566|NCT01428336|75745306|FG001|NOT COMPLETED|Overall Study||0||
59631567|NCT01429272|75745319|FG000|STARTED|Overall Study||30||
59631568|NCT01429272|75745320|FG001|STARTED|Overall Study||31||
59631569|NCT01429272|75745321|FG002|STARTED|Overall Study||19||
59631570|NCT01429272|75745322|FG003|STARTED|Overall Study||19||
59631571|NCT01429272|75745319|FG000|COMPLETED|Overall Study||24||
59631572|NCT01429272|75745320|FG001|COMPLETED|Overall Study||22||
59631573|NCT01429272|75745321|FG002|COMPLETED|Overall Study||15||
59631574|NCT01429272|75745322|FG003|COMPLETED|Overall Study||14||
59631575|NCT01429272|75745319|FG000|NOT COMPLETED|Overall Study||6||
59631576|NCT01429272|75745320|FG001|NOT COMPLETED|Overall Study||9||
59631577|NCT01429272|75745321|FG002|NOT COMPLETED|Overall Study||4||
59631578|NCT01429272|75745322|FG003|NOT COMPLETED|Overall Study||5||
59631579|NCT01429350|75745334|FG000|STARTED|Overall Study||53||
59631580|NCT01429350|75745335|FG001|STARTED|Overall Study||55||
59631581|NCT01429350|75745334|FG000|As-Treated|Overall Study||62||
59631582|NCT01429350|75745335|FG001|As-Treated|Overall Study||43||
59631583|NCT01429350|75745334|FG000|Per Protocol|Overall Study||41||
59631584|NCT01429350|75745335|FG001|Per Protocol|Overall Study||37||
59631585|NCT01429350|75745334|FG000|90 Day|Overall Study||46||
59631586|NCT01429350|75745335|FG001|90 Day|Overall Study||50||
59631587|NCT01429350|75745334|FG000|COMPLETED|Overall Study||46||
59631588|NCT01429350|75745335|FG001|COMPLETED|Overall Study||50||
59631589|NCT01429350|75745334|FG000|NOT COMPLETED|Overall Study||7||
59631590|NCT01429350|75745335|FG001|NOT COMPLETED|Overall Study||5||
59631591|NCT01431300|75745344|FG000|STARTED|Overall Study|One subject with indeterminate pregnancy test, subject declined to proceed|11||
59631592|NCT01431300|75745345|FG001|STARTED|Overall Study||10||
59631593|NCT01431300|75745346|FG002|STARTED|Overall Study||10||
59631594|NCT01431300|75745344|FG000|COMPLETED|Overall Study||10||
59631595|NCT01431300|75745345|FG001|COMPLETED|Overall Study||10||
59631596|NCT01431300|75745346|FG002|COMPLETED|Overall Study||10||
59631597|NCT01431300|75745344|FG000|NOT COMPLETED|Overall Study||1||
59631598|NCT01431300|75745345|FG001|NOT COMPLETED|Overall Study||0||
59631599|NCT01431300|75745346|FG002|NOT COMPLETED|Overall Study||0||
59631600|NCT01431846|75745357|FG000|STARTED|Overall Study||8||
59631601|NCT01431846|75745358|FG001|STARTED|Overall Study||3||
59631602|NCT01431846|75745359|FG002|STARTED|Overall Study||8||
59631603|NCT01431846|75745357|FG000|COMPLETED|Overall Study||8||
59631604|NCT01431846|75745358|FG001|COMPLETED|Overall Study||3||
59631605|NCT01431846|75745359|FG002|COMPLETED|Overall Study||8||
59631606|NCT01431846|75745357|FG000|NOT COMPLETED|Overall Study||0||
59631607|NCT01431846|75745358|FG001|NOT COMPLETED|Overall Study||0||
59631608|NCT01431846|75745359|FG002|NOT COMPLETED|Overall Study||0||
59631609|NCT01432236|75745369|FG000|STARTED|Overall Study||96||
59631610|NCT01432236|75745370|FG001|STARTED|Overall Study||97||
59631611|NCT01432236|75745369|FG000|COMPLETED|Overall Study||70||
59631612|NCT01432236|75745370|FG001|COMPLETED|Overall Study||79||
59631613|NCT01432236|75745369|FG000|NOT COMPLETED|Overall Study||26||
59631614|NCT01432236|75745370|FG001|NOT COMPLETED|Overall Study||18||
59631615|NCT01434030|75745383|FG000|STARTED|Overall Study||57||
59631616|NCT01434030|75745383|FG000|COMPLETED|Overall Study||56||
59631617|NCT01434030|75745383|FG000|NOT COMPLETED|Overall Study||1||
59631618|NCT01434186|75745390|FG000|STARTED|Overall Study||2||
59631619|NCT01434186|75745391|FG001|STARTED|Overall Study||4||
59631620|NCT01434186|75745390|FG000|COMPLETED|Overall Study||2||
59631621|NCT01434186|75745391|FG001|COMPLETED|Overall Study||4||
59631622|NCT01434186|75745390|FG000|NOT COMPLETED|Overall Study||0||
59631623|NCT01434186|75745391|FG001|NOT COMPLETED|Overall Study||0||
59631624|NCT01434342|75745399|FG000|STARTED|Overall Study||98||
59631625|NCT01434342|75745400|FG001|STARTED|Overall Study||48||
59631626|NCT01434342|75745399|FG000|COMPLETED|Overall Study||50||
59631627|NCT01434342|75745400|FG001|COMPLETED|Overall Study||31||
59631628|NCT01434342|75745399|FG000|NOT COMPLETED|Overall Study||48||
59631629|NCT01434342|75745400|FG001|NOT COMPLETED|Overall Study||17||
59631630|NCT01435512|75745408|FG000|STARTED|Overall Study||67||
59631631|NCT01435512|75745409|FG001|STARTED|Overall Study||68||
59631632|NCT01435512|75745408|FG000|COMPLETED|Overall Study||67||
59631633|NCT01435512|75745409|FG001|COMPLETED|Overall Study||68||
59631634|NCT01435512|75745408|FG000|NOT COMPLETED|Overall Study||0||
59631635|NCT01435512|75745409|FG001|NOT COMPLETED|Overall Study||0||
59631636|NCT01435824|75745415|FG000|STARTED|First Intervention||8||
59631637|NCT01435824|75745416|FG001|STARTED|First Intervention||8||
59631638|NCT01435824|75745415|FG000|COMPLETED|First Intervention||8||
59631639|NCT01435824|75745416|FG001|COMPLETED|First Intervention||8||
59631640|NCT01435824|75745415|FG000|NOT COMPLETED|First Intervention||0||
59631641|NCT01435824|75745416|FG001|NOT COMPLETED|First Intervention||0||
59631642|NCT01435824|75745415|FG000|STARTED|Washout of 1-2 Weeks||8||
59631643|NCT01435824|75745416|FG001|STARTED|Washout of 1-2 Weeks||8||
59631644|NCT01435824|75745415|FG000|COMPLETED|Washout of 1-2 Weeks||8||
59631645|NCT01435824|75745416|FG001|COMPLETED|Washout of 1-2 Weeks||8||
59631646|NCT01435824|75745415|FG000|NOT COMPLETED|Washout of 1-2 Weeks||0||
59631647|NCT01435824|75745416|FG001|NOT COMPLETED|Washout of 1-2 Weeks||0||
59631648|NCT01435824|75745415|FG000|STARTED|Second Intervention||8||
59631649|NCT01435824|75745416|FG001|STARTED|Second Intervention||8||
59631650|NCT01435824|75745415|FG000|COMPLETED|Second Intervention||8||
59631651|NCT01435824|75745416|FG001|COMPLETED|Second Intervention||8||
59631652|NCT01435824|75745415|FG000|NOT COMPLETED|Second Intervention||0||
59631653|NCT01435824|75745416|FG001|NOT COMPLETED|Second Intervention||0||
59631654|NCT01436526|75745424|FG000|STARTED|Period 1||14||
59631655|NCT01436526|75745425|FG001|STARTED|Period 1||14||
59631656|NCT01436526|75745424|FG000|Participants Received Treatment|Period 1||14||
59631657|NCT01436526|75745425|FG001|Participants Received Treatment|Period 1||14||
59631658|NCT01436526|75745424|FG000|COMPLETED|Period 1||14||
59631659|NCT01436526|75745425|FG001|COMPLETED|Period 1||14||
59631660|NCT01436526|75745424|FG000|NOT COMPLETED|Period 1||0||
59631661|NCT01436526|75745425|FG001|NOT COMPLETED|Period 1||0||
59631662|NCT01436526|75745424|FG000|STARTED|Period 2|1 participant withdrew his consent after completing the first period.|13||
59631663|NCT01436526|75745425|FG001|STARTED|Period 2|1 participant withdrew his consent after completing the first period.|13||
59631664|NCT01436526|75745424|FG000|Participants Received Treatment|Period 2||13||
59631665|NCT01436526|75745425|FG001|Participants Received Treatment|Period 2||13||
59631666|NCT01436526|75745424|FG000|COMPLETED|Period 2||13||
59631667|NCT01436526|75745425|FG001|COMPLETED|Period 2||13||
59631668|NCT01436526|75745424|FG000|NOT COMPLETED|Period 2||0||
59631669|NCT01436526|75745425|FG001|NOT COMPLETED|Period 2||0||
59631670|NCT01437852|75745431|FG000|STARTED|Overall Study||30||
59631671|NCT01437852|75745431|FG000|Received StrataGraft Skin Tissue|Overall Study||30||
59631672|NCT01437852|75745431|FG000|Received Autograft|Overall Study||30||
59631673|NCT01437852|75745431|FG000|COMPLETED|Overall Study||30||
59631674|NCT01437852|75745431|FG000|NOT COMPLETED|Overall Study||0||
59631675|NCT01438008|75745438|FG000|STARTED|Overall Study||4||
59631676|NCT01438008|75745439|FG001|STARTED|Overall Study||5||
59631677|NCT01438008|75745438|FG000|COMPLETED|Overall Study||4||
59631678|NCT01438008|75745439|FG001|COMPLETED|Overall Study||5||
59631679|NCT01438008|75745438|FG000|NOT COMPLETED|Overall Study||0||
59631680|NCT01438008|75745439|FG001|NOT COMPLETED|Overall Study||0||
59631681|NCT01438710|75745445|FG000|STARTED|First Week of Treatment|Patients are only treated with Prograf/generic Tacrolimus during the first week.|0||
59631682|NCT01438710|75745446|FG001|STARTED|First Week of Treatment||44||
59631683|NCT01438710|75745445|FG000|COMPLETED|First Week of Treatment|Patients are only treated with Prograf/generic Tacrolimus during the first week.|0||
59631684|NCT01438710|75745446|FG001|COMPLETED|First Week of Treatment||41||
59631685|NCT01438710|75745445|FG000|NOT COMPLETED|First Week of Treatment||0||
59631686|NCT01438710|75745446|FG001|NOT COMPLETED|First Week of Treatment||3||
59631687|NCT01438710|75745445|FG000|STARTED|Second Week of Treatment|Patients completing the first week will continue on LCP-Tacro treatment during the second week.|41||
59631688|NCT01438710|75745446|FG001|STARTED|Second Week of Treatment|Patients are only treated with LCP-Tacro during the second week.|0||
59631689|NCT01438710|75745445|FG000|COMPLETED|Second Week of Treatment||40||
59631690|NCT01438710|75745446|FG001|COMPLETED|Second Week of Treatment|Patients are only treated with LCP-Tacro during the second week.|0||
59631691|NCT01438710|75745445|FG000|NOT COMPLETED|Second Week of Treatment||1||
59540194|NCT01654380|75638417|FG003|COMPLETED|Part B, Period 2||7||
59540195|NCT01654380|75638414|FG000|NOT COMPLETED|Part B, Period 2||0||
59540196|NCT01654380|75638415|FG001|NOT COMPLETED|Part B, Period 2||0||
59540197|NCT01654380|75638416|FG002|NOT COMPLETED|Part B, Period 2||0||
59540198|NCT01654380|75638417|FG003|NOT COMPLETED|Part B, Period 2||0||
59540199|NCT01654380|75638414|FG000|STARTED|Part B, Washout of at Least 6 Days||0||
59540200|NCT01654380|75638415|FG001|STARTED|Part B, Washout of at Least 6 Days||0||
59631692|NCT01438710|75745446|FG001|NOT COMPLETED|Second Week of Treatment||0||
59631693|NCT01442844|75745453|FG000|STARTED|Overall Study||1||
59631694|NCT01442844|75745454|FG001|STARTED|Overall Study||2||
59631695|NCT01442844|75745453|FG000|COMPLETED|Overall Study||1||
59631696|NCT01442844|75745454|FG001|COMPLETED|Overall Study||2||
59631697|NCT01442844|75745453|FG000|NOT COMPLETED|Overall Study||0||
59631698|NCT01442844|75745454|FG001|NOT COMPLETED|Overall Study||0||
59631699|NCT01443546|75745463|FG000|STARTED|Overall Study||9||
59631700|NCT01443546|75745464|FG001|STARTED|Overall Study||9||
59631701|NCT01443546|75745465|FG002|STARTED|Overall Study||8||
59631702|NCT01443546|75745463|FG000|COMPLETED|Overall Study||9||
59631703|NCT01443546|75745464|FG001|COMPLETED|Overall Study||9||
59631704|NCT01443546|75745465|FG002|COMPLETED|Overall Study||8||
59631705|NCT01443546|75745463|FG000|NOT COMPLETED|Overall Study||0||
59631706|NCT01443546|75745464|FG001|NOT COMPLETED|Overall Study||0||
59631707|NCT01443546|75745465|FG002|NOT COMPLETED|Overall Study||0||
59631708|NCT01444716|75745475|FG000|STARTED|Overall Study||34||
59631709|NCT01444716|75745475|FG000|COMPLETED|Overall Study||34||
59631710|NCT01444716|75745475|FG000|NOT COMPLETED|Overall Study||0||
59631711|NCT01445028|75745481|FG000|STARTED|Overall Study||58||
59631712|NCT01445028|75745482|FG001|STARTED|Overall Study||54||
59631713|NCT01445028|75745481|FG000|COMPLETED|Overall Study||58||
59631714|NCT01445028|75745482|FG001|COMPLETED|Overall Study||51||
59631715|NCT01445028|75745481|FG000|NOT COMPLETED|Overall Study||0||
59631716|NCT01445028|75745482|FG001|NOT COMPLETED|Overall Study||3||
59631717|NCT01446666|75745488|FG000|STARTED|Overall Study|Among the 423 participants who consented, 15 withdrew the consent and one died.|407||
59631718|NCT01446666|75745488|FG000|COMPLETED|Overall Study||326||
59631719|NCT01446666|75745488|FG000|NOT COMPLETED|Overall Study||81||
59631720|NCT01447914|75745493|FG000|STARTED|Overall Study||16||
59631721|NCT01447914|75745493|FG000|COMPLETED|Overall Study||16||
59631722|NCT01447914|75745493|FG000|NOT COMPLETED|Overall Study||0||
59631723|NCT01449240|75745497|FG000|STARTED|Overall Study||10||
59540201|NCT01654380|75638416|FG002|STARTED|Part B, Washout of at Least 6 Days||6||
59540202|NCT01654380|75638417|FG003|STARTED|Part B, Washout of at Least 6 Days||7||
59631724|NCT01449240|75745497|FG000|COMPLETED|Overall Study||10||
59631725|NCT01449240|75745497|FG000|NOT COMPLETED|Overall Study||0||
59631726|NCT01449864|75745501|FG000|STARTED|Overall Study||22||
59631727|NCT01449864|75745501|FG000|COMPLETED|Overall Study||17||
59631728|NCT01449864|75745501|FG000|NOT COMPLETED|Overall Study||5||
59631729|NCT01452126|75745505|FG000|STARTED|Overall Study||49||
59631730|NCT01452126|75745505|FG000|COMPLETED|Overall Study||49||
59540203|NCT01654380|75638414|FG000|COMPLETED|Part B, Washout of at Least 6 Days||0||
59540204|NCT01654380|75638415|FG001|COMPLETED|Part B, Washout of at Least 6 Days||0||
59540205|NCT01654380|75638416|FG002|COMPLETED|Part B, Washout of at Least 6 Days||6||
59540206|NCT01654380|75638417|FG003|COMPLETED|Part B, Washout of at Least 6 Days||7||
59540207|NCT01654380|75638414|FG000|NOT COMPLETED|Part B, Washout of at Least 6 Days||0||
59540208|NCT01654380|75638415|FG001|NOT COMPLETED|Part B, Washout of at Least 6 Days||0||
59631731|NCT01452126|75745505|FG000|NOT COMPLETED|Overall Study||0||
59631732|NCT01456494|75745515|FG000|STARTED|Initial Inpatient Visit||24||
59631733|NCT01456494|75745516|FG001|STARTED|Initial Inpatient Visit||26||
59631734|NCT01456494|75745515|FG000|COMPLETED|Initial Inpatient Visit||24||
59631735|NCT01456494|75745516|FG001|COMPLETED|Initial Inpatient Visit||26||
59631736|NCT01456494|75745515|FG000|NOT COMPLETED|Initial Inpatient Visit||0||
59540209|NCT01654380|75638416|FG002|NOT COMPLETED|Part B, Washout of at Least 6 Days||0||
59540210|NCT01654380|75638417|FG003|NOT COMPLETED|Part B, Washout of at Least 6 Days||0||
59540211|NCT01654380|75638414|FG000|STARTED|Part B, Period 3||0||
59631737|NCT01456494|75745516|FG001|NOT COMPLETED|Initial Inpatient Visit||0||
59631738|NCT01456494|75745515|FG000|STARTED|Follow-Up Visit (Post 30-day Discharge)||24||
59631739|NCT01456494|75745516|FG001|STARTED|Follow-Up Visit (Post 30-day Discharge)||26||
59631740|NCT01456494|75745515|FG000|COMPLETED|Follow-Up Visit (Post 30-day Discharge)||19||
59631741|NCT01456494|75745516|FG001|COMPLETED|Follow-Up Visit (Post 30-day Discharge)||20||
59631742|NCT01456494|75745515|FG000|NOT COMPLETED|Follow-Up Visit (Post 30-day Discharge)||5||
59631743|NCT01456494|75745516|FG001|NOT COMPLETED|Follow-Up Visit (Post 30-day Discharge)||6||
59631744|NCT01457196|75745522|FG000|STARTED|Overall Study||2074||
59631745|NCT01457196|75745522|FG000|COMPLETED|Overall Study||2074||
59631746|NCT01457196|75745522|FG000|NOT COMPLETED|Overall Study||0||
59631747|NCT01457430|75745528|FG000|STARTED|Overall Study||19||
59631748|NCT01457430|75745528|FG000|COMPLETED|Overall Study||19||
59631749|NCT01457430|75745528|FG000|NOT COMPLETED|Overall Study||0||
59631750|NCT01458288|75745533|FG000|STARTED|Overall Study||12||
59631751|NCT01458288|75745533|FG000|COMPLETED|Overall Study||12||
59631752|NCT01458288|75745533|FG000|NOT COMPLETED|Overall Study||0||
59631753|NCT01458990|75745540|FG000|STARTED|Overall Study||45||
59631754|NCT01458990|75745541|FG001|STARTED|Overall Study||15||
59631755|NCT01458990|75745540|FG000|COMPLETED|Overall Study||45||
59631756|NCT01458990|75745541|FG001|COMPLETED|Overall Study||15||
59631757|NCT01458990|75745540|FG000|NOT COMPLETED|Overall Study||0||
59631758|NCT01458990|75745541|FG001|NOT COMPLETED|Overall Study||0||
59631759|NCT01460940|75745549|FG000|STARTED|Overall Study||24||
59631760|NCT01460940|75745549|FG000|COMPLETED|Overall Study||24||
59631761|NCT01460940|75745549|FG000|NOT COMPLETED|Overall Study||0||
59631762|NCT01462812|75745555|FG000|STARTED|Overall Study||111||
59631763|NCT01462812|75745556|FG001|STARTED|Overall Study||112||
59631764|NCT01462812|75745555|FG000|COMPLETED|Overall Study||111||
59631765|NCT01462812|75745556|FG001|COMPLETED|Overall Study||111||
59631766|NCT01462812|75745555|FG000|NOT COMPLETED|Overall Study||0||
59631767|NCT01462812|75745556|FG001|NOT COMPLETED|Overall Study||1||
59631768|NCT01463202|75745564|FG000|STARTED|Overall Study||79|27 ineligible postpartum (26 no longer eligible, 1 withdrew consent)|
59631769|NCT01463202|75745565|FG001|STARTED|Overall Study||78|27 ineligible postpartum (26 no longer eligible, 1 withdrew consent)|
59631770|NCT01463202|75745564|FG000|COMPLETED|Overall Study||79||
59631771|NCT01463202|75745565|FG001|COMPLETED|Overall Study||78||
59631772|NCT01463202|75745564|FG000|NOT COMPLETED|Overall Study||0||
59631773|NCT01463202|75745565|FG001|NOT COMPLETED|Overall Study||0||
59631774|NCT01463358|75745573|FG000|STARTED|Overall Study||49||
59631775|NCT01463358|75745574|FG001|STARTED|Overall Study||52||
59631776|NCT01463358|75745573|FG000|COMPLETED|Overall Study||46||
59631777|NCT01463358|75745574|FG001|COMPLETED|Overall Study||47||
59631778|NCT01463358|75745573|FG000|NOT COMPLETED|Overall Study||3||
59631779|NCT01463358|75745574|FG001|NOT COMPLETED|Overall Study||5||
59631780|NCT01467882|75745580|FG000|STARTED|Overall Study||44||
59631781|NCT01467882|75745580|FG000|COMPLETED|Overall Study||44||
59631782|NCT01467882|75745580|FG000|NOT COMPLETED|Overall Study||0||
59631783|NCT01468350|75745595|FG000|STARTED|(PART A) Day 1, Day 3||6||
59631784|NCT01468350|75745596|FG001|STARTED|(PART A) Day 1, Day 3||5||
59631785|NCT01468350|75745597|FG002|STARTED|(PART A) Day 1, Day 3||0||
59540212|NCT01654380|75638415|FG001|STARTED|Part B, Period 3||0||
59540213|NCT01654380|75638416|FG002|STARTED|Part B, Period 3||6||
59631786|NCT01468350|75745598|FG003|STARTED|(PART A) Day 1, Day 3||0||
59631787|NCT01468350|75745595|FG000|COMPLETED|(PART A) Day 1, Day 3||6||
59631788|NCT01468350|75745596|FG001|COMPLETED|(PART A) Day 1, Day 3||5||
59631789|NCT01468350|75745597|FG002|COMPLETED|(PART A) Day 1, Day 3||0||
59631790|NCT01468350|75745598|FG003|COMPLETED|(PART A) Day 1, Day 3||0||
59631791|NCT01468350|75745595|FG000|NOT COMPLETED|(PART A) Day 1, Day 3||0||
59631792|NCT01468350|75745596|FG001|NOT COMPLETED|(PART A) Day 1, Day 3||0||
59631793|NCT01468350|75745597|FG002|NOT COMPLETED|(PART A) Day 1, Day 3||0||
59631794|NCT01468350|75745598|FG003|NOT COMPLETED|(PART A) Day 1, Day 3||0||
59540214|NCT01654380|75638417|FG003|STARTED|Part B, Period 3||7||
59631795|NCT01468350|75745595|FG000|STARTED|(PART B) Day 1, Day 15||0||
59631796|NCT01468350|75745596|FG001|STARTED|(PART B) Day 1, Day 15||0||
59631797|NCT01468350|75745597|FG002|STARTED|(PART B) Day 1, Day 15||12||
59631798|NCT01468350|75745598|FG003|STARTED|(PART B) Day 1, Day 15||12||
59631799|NCT01468350|75745595|FG000|COMPLETED|(PART B) Day 1, Day 15||0||
59631800|NCT01468350|75745596|FG001|COMPLETED|(PART B) Day 1, Day 15||0||
59631801|NCT01468350|75745597|FG002|COMPLETED|(PART B) Day 1, Day 15||12||
59631802|NCT01468350|75745598|FG003|COMPLETED|(PART B) Day 1, Day 15||12||
59631803|NCT01468350|75745595|FG000|NOT COMPLETED|(PART B) Day 1, Day 15||0||
59631804|NCT01468350|75745596|FG001|NOT COMPLETED|(PART B) Day 1, Day 15||0||
59631805|NCT01468350|75745597|FG002|NOT COMPLETED|(PART B) Day 1, Day 15||0||
59631806|NCT01468350|75745598|FG003|NOT COMPLETED|(PART B) Day 1, Day 15||0||
59631807|NCT01468584|75745608|FG000|STARTED|Overall Study||10||
59631808|NCT01468584|75745608|FG000|COMPLETED|Overall Study||10||
59631809|NCT01468584|75745608|FG000|NOT COMPLETED|Overall Study||0||
59631810|NCT01468974|75745612|FG000|STARTED|1 Month Follow-up|Intent-to-treat (ITT) population|35||
59631811|NCT01468974|75745612|FG000|COMPLETED|1 Month Follow-up||34||
59631812|NCT01468974|75745612|FG000|NOT COMPLETED|1 Month Follow-up||1||
59631813|NCT01468974|75745612|FG000|STARTED|6 Months Follow-up||34||
59631814|NCT01468974|75745612|FG000|COMPLETED|6 Months Follow-up||34||
59631815|NCT01468974|75745612|FG000|NOT COMPLETED|6 Months Follow-up||0||
59631816|NCT01468974|75745612|FG000|STARTED|1 Year Follow-up||34||
59631817|NCT01468974|75745612|FG000|COMPLETED|1 Year Follow-up||34||
59631818|NCT01468974|75745612|FG000|NOT COMPLETED|1 Year Follow-up||0||
59631819|NCT01468974|75745612|FG000|STARTED|2 Years Follow-up||34||
59631820|NCT01468974|75745612|FG000|COMPLETED|2 Years Follow-up||32||
59631821|NCT01468974|75745612|FG000|NOT COMPLETED|2 Years Follow-up||2||
59631822|NCT01468974|75745612|FG000|STARTED|3 Years Follow-up||32||
59631823|NCT01468974|75745612|FG000|COMPLETED|3 Years Follow-up||26||
59631824|NCT01468974|75745612|FG000|NOT COMPLETED|3 Years Follow-up||6||
59631825|NCT01471626|75745616|FG000|STARTED|Overall Study||21||
59631826|NCT01471626|75745616|FG000|COMPLETED|Overall Study||21||
59631827|NCT01471626|75745616|FG000|NOT COMPLETED|Overall Study||0||
59631828|NCT01472718|75745622|FG000|STARTED|Overall Study||104||
59631829|NCT01472718|75745623|FG001|STARTED|Overall Study||104||
59631830|NCT01472718|75745622|FG000|COMPLETED|Overall Study||98||
59631831|NCT01472718|75745623|FG001|COMPLETED|Overall Study||97||
59631832|NCT01472718|75745622|FG000|NOT COMPLETED|Overall Study||6||
59631833|NCT01472718|75745623|FG001|NOT COMPLETED|Overall Study||7||
59631834|NCT01472874|75745629|FG000|STARTED|Overall Study||8||
59631835|NCT01472874|75745629|FG000|COMPLETED|Overall Study||8||
59631836|NCT01472874|75745629|FG000|NOT COMPLETED|Overall Study||0||
59631837|NCT01474122|75745636|FG000|STARTED|Period 1: Baseline to Week 16||88||
59631838|NCT01474122|75745637|FG001|STARTED|Period 1: Baseline to Week 16|One patient was randomised but did not receive study treatment|88||
59631839|NCT01474122|75745638|FG002|STARTED|Period 1: Baseline to Week 16||89||
59631840|NCT01474122|75745636|FG000|COMPLETED|Period 1: Baseline to Week 16||87||
59631841|NCT01474122|75745637|FG001|COMPLETED|Period 1: Baseline to Week 16||86||
59631842|NCT01474122|75745638|FG002|COMPLETED|Period 1: Baseline to Week 16||88||
59631843|NCT01474122|75745636|FG000|NOT COMPLETED|Period 1: Baseline to Week 16||1||
59631844|NCT01474122|75745637|FG001|NOT COMPLETED|Period 1: Baseline to Week 16||2||
59631845|NCT01474122|75745638|FG002|NOT COMPLETED|Period 1: Baseline to Week 16||1||
59631846|NCT01474122|75745636|FG000|STARTED|Period 2: Week 16 to End of Study||87||
59631847|NCT01474122|75745637|FG001|STARTED|Period 2: Week 16 to End of Study||86||
59631848|NCT01474122|75745638|FG002|STARTED|Period 2: Week 16 to End of Study||88||
59631849|NCT01474122|75745636|FG000|COMPLETED|Period 2: Week 16 to End of Study|Patients on treatment at the time of study termination|70||
59631850|NCT01474122|75745637|FG001|COMPLETED|Period 2: Week 16 to End of Study|Patients on treatment at the time of study termination|73||
59631851|NCT01474122|75745638|FG002|COMPLETED|Period 2: Week 16 to End of Study|Patients on treatment at the time of study termination|73||
59631852|NCT01474122|75745636|FG000|NOT COMPLETED|Period 2: Week 16 to End of Study||17||
59631853|NCT01474122|75745637|FG001|NOT COMPLETED|Period 2: Week 16 to End of Study||13||
59631854|NCT01474122|75745638|FG002|NOT COMPLETED|Period 2: Week 16 to End of Study||15||
59631855|NCT01474590|75745650|FG000|STARTED|Overall Study||133||
59631856|NCT01474590|75745651|FG001|STARTED|Overall Study||133||
59631857|NCT01474590|75745650|FG000|COMPLETED|Overall Study||105||
59631858|NCT01474590|75745651|FG001|COMPLETED|Overall Study||116||
59631859|NCT01474590|75745650|FG000|NOT COMPLETED|Overall Study||28||
59631860|NCT01474590|75745651|FG001|NOT COMPLETED|Overall Study||17||
59631861|NCT01477320|75745659|FG000|STARTED|Overall Study||62||
59631862|NCT01477320|75745660|FG001|STARTED|Overall Study||62||
59631863|NCT01477320|75745659|FG000|COMPLETED|Overall Study||55||
59631864|NCT01477320|75745660|FG001|COMPLETED|Overall Study||47||
59631865|NCT01477320|75745659|FG000|NOT COMPLETED|Overall Study||7||
59631866|NCT01477320|75745660|FG001|NOT COMPLETED|Overall Study||15||
59631867|NCT01477710|75745666|FG000|STARTED|Overall Study||30||
59631868|NCT01477710|75745666|FG000|COMPLETED|Overall Study||30||
59631869|NCT01477710|75745666|FG000|NOT COMPLETED|Overall Study||0||
59631870|NCT01478256|75745676|FG000|STARTED|Overall Study||15||
59631871|NCT01478256|75745677|FG001|STARTED|Overall Study||15||
59631872|NCT01478256|75745676|FG000|COMPLETED|Overall Study||15||
59631873|NCT01478256|75745677|FG001|COMPLETED|Overall Study||15||
59631874|NCT01478256|75745676|FG000|NOT COMPLETED|Overall Study||0||
59631875|NCT01478256|75745677|FG001|NOT COMPLETED|Overall Study||0||
59631876|NCT01479270|75745687|FG000|STARTED|Overall Study||28||
59631877|NCT01479270|75745688|FG001|STARTED|Overall Study||28||
59631878|NCT01479270|75745687|FG000|COMPLETED|Overall Study||28||
59631879|NCT01479270|75745688|FG001|COMPLETED|Overall Study||28||
59631880|NCT01479270|75745687|FG000|NOT COMPLETED|Overall Study||0||
59631881|NCT01479270|75745688|FG001|NOT COMPLETED|Overall Study||0||
59631882|NCT01479348|75745697|FG000|STARTED|Overall Study||5||
59631883|NCT01479348|75745698|FG001|STARTED|Overall Study||0||
59631884|NCT01479348|75745697|FG000|COMPLETED|Overall Study||5||
59631885|NCT01479348|75745698|FG001|COMPLETED|Overall Study||0||
59631886|NCT01479348|75745697|FG000|NOT COMPLETED|Overall Study||0||
59631887|NCT01479348|75745698|FG001|NOT COMPLETED|Overall Study||0||
59631888|NCT01479426|75745704|FG000|STARTED|Overall Study||40||
59631889|NCT01479426|75745705|FG001|STARTED|Overall Study||40||
59631890|NCT01479426|75745704|FG000|COMPLETED|Overall Study||36||
59631891|NCT01479426|75745705|FG001|COMPLETED|Overall Study||37||
59631892|NCT01479426|75745704|FG000|NOT COMPLETED|Overall Study||4||
59631893|NCT01479426|75745705|FG001|NOT COMPLETED|Overall Study||3||
59631894|NCT01481376|75745711|FG000|STARTED|Overall Study||200||
59631895|NCT01481376|75745711|FG000|COMPLETED|Overall Study||169||
59631896|NCT01481376|75745711|FG000|NOT COMPLETED|Overall Study||31||
59631897|NCT01483560|75745717|FG000|STARTED|Overall Study||219||
59631898|NCT01483560|75745718|FG001|STARTED|Overall Study||209||
59631899|NCT01483560|75745717|FG000|COMPLETED|Overall Study||193||
59631900|NCT01483560|75745718|FG001|COMPLETED|Overall Study||194||
59631901|NCT01483560|75745717|FG000|NOT COMPLETED|Overall Study||26||
59631902|NCT01483560|75745718|FG001|NOT COMPLETED|Overall Study||15||
59631903|NCT01484340|75745726|FG000|STARTED|Overall Study||281||
59631904|NCT01484340|75745727|FG001|STARTED|Overall Study||279||
59631905|NCT01484340|75745726|FG000|COMPLETED|Overall Study||281||
59631906|NCT01484340|75745727|FG001|COMPLETED|Overall Study||279||
59631907|NCT01484340|75745726|FG000|NOT COMPLETED|Overall Study||0||
59631908|NCT01484340|75745727|FG001|NOT COMPLETED|Overall Study||0||
59631909|NCT01484652|75745735|FG000|STARTED|Overall Study||166||
59631910|NCT01484652|75745736|FG001|STARTED|Overall Study||163||
59631911|NCT01484652|75745735|FG000|COMPLETED|Overall Study||151||
59631912|NCT01484652|75745736|FG001|COMPLETED|Overall Study||142||
59631913|NCT01484652|75745735|FG000|NOT COMPLETED|Overall Study||15||
59631914|NCT01484652|75745736|FG001|NOT COMPLETED|Overall Study||21||
59631915|NCT01485588|75745745|FG000|STARTED|Overall Study||6||
59631916|NCT01485588|75745746|FG001|STARTED|Overall Study||6||
59631917|NCT01485588|75745747|FG002|STARTED|Overall Study||6||
59631918|NCT01485588|75745745|FG000|COMPLETED|Overall Study||6||
59631919|NCT01485588|75745746|FG001|COMPLETED|Overall Study||6||
60076362|NCT01904773|76191369|FG005|COMPLETED|Placebo Washout Fifth Intervention||4||
60076363|NCT01904773|76191370|FG006|COMPLETED|Placebo Washout Fifth Intervention||3||
60076364|NCT01904773|76191371|FG007|COMPLETED|Placebo Washout Fifth Intervention||2||
60076365|NCT01904773|76191372|FG008|COMPLETED|Placebo Washout Fifth Intervention||4||
60076366|NCT01904773|76191364|FG000|NOT COMPLETED|Placebo Washout Fifth Intervention||0||
60076367|NCT01904773|76191365|FG001|NOT COMPLETED|Placebo Washout Fifth Intervention||1||
59540215|NCT01654380|75638414|FG000|COMPLETED|Part B, Period 3||0||
59540216|NCT01654380|75638415|FG001|COMPLETED|Part B, Period 3||0||
59540217|NCT01654380|75638416|FG002|COMPLETED|Part B, Period 3||6||
59540218|NCT01654380|75638417|FG003|COMPLETED|Part B, Period 3||7||
59540219|NCT01654380|75638414|FG000|NOT COMPLETED|Part B, Period 3||0||
59540220|NCT01654380|75638415|FG001|NOT COMPLETED|Part B, Period 3||0||
59540221|NCT01654380|75638416|FG002|NOT COMPLETED|Part B, Period 3||0||
59540222|NCT01654380|75638417|FG003|NOT COMPLETED|Part B, Period 3||0||
59540223|NCT01654380|75638414|FG000|STARTED|Part B, Washout of at Least 6 Days||0||
59540224|NCT01654380|75638415|FG001|STARTED|Part B, Washout of at Least 6 Days||0||
59540225|NCT01654380|75638416|FG002|STARTED|Part B, Washout of at Least 6 Days||6||
59540226|NCT01654380|75638417|FG003|STARTED|Part B, Washout of at Least 6 Days||7||
59540227|NCT01654380|75638414|FG000|COMPLETED|Part B, Washout of at Least 6 Days||0||
59540228|NCT01654380|75638415|FG001|COMPLETED|Part B, Washout of at Least 6 Days||0||
59631920|NCT01485588|75745747|FG002|COMPLETED|Overall Study||6||
59631921|NCT01485588|75745745|FG000|NOT COMPLETED|Overall Study||0||
59631922|NCT01485588|75745746|FG001|NOT COMPLETED|Overall Study||0||
59631923|NCT01485588|75745747|FG002|NOT COMPLETED|Overall Study||0||
59631924|NCT01488318|75745757|FG000|STARTED|Overall Study||14||
59631925|NCT01488318|75745757|FG000|COMPLETED|Overall Study||14||
59631926|NCT01488318|75745757|FG000|NOT COMPLETED|Overall Study||0||
59631927|NCT01488708|75745763|FG000|STARTED|Overall Study||940||
59631928|NCT01488708|75745764|FG001|STARTED|Overall Study||578||
59631929|NCT01488708|75745763|FG000|Received at Least 1 Dose of Study Drug|Overall Study||937||
59631930|NCT01488708|75745764|FG001|Received at Least 1 Dose of Study Drug|Overall Study||578||
60076368|NCT01904773|76191366|FG002|NOT COMPLETED|Placebo Washout Fifth Intervention||0||
60076369|NCT01904773|76191367|FG003|NOT COMPLETED|Placebo Washout Fifth Intervention||0||
60076370|NCT01904773|76191368|FG004|NOT COMPLETED|Placebo Washout Fifth Intervention||0||
59631931|NCT01488708|75745763|FG000|Participated in Follow Up|Overall Study||810||
59631932|NCT01488708|75745764|FG001|Participated in Follow Up|Overall Study||526||
59631933|NCT01488708|75745763|FG000|COMPLETED|Overall Study||0||
59631934|NCT01488708|75745764|FG001|COMPLETED|Overall Study||0||
59631935|NCT01488708|75745763|FG000|NOT COMPLETED|Overall Study||940||
59631936|NCT01488708|75745764|FG001|NOT COMPLETED|Overall Study||578||
59631937|NCT01490892|75745772|FG000|STARTED|Overall Study||219||
59631938|NCT01490892|75745772|FG000|COMPLETED|Overall Study||219||
59631939|NCT01490892|75745772|FG000|NOT COMPLETED|Overall Study||0||
59631940|NCT01491984|75745778|FG000|STARTED|Overall Study||49||
59631941|NCT01491984|75745779|FG001|STARTED|Overall Study||45||
59631942|NCT01491984|75745778|FG000|COMPLETED|Overall Study||47||
59631943|NCT01491984|75745779|FG001|COMPLETED|Overall Study||44||
59631944|NCT01491984|75745778|FG000|NOT COMPLETED|Overall Study||2||
59631945|NCT01491984|75745779|FG001|NOT COMPLETED|Overall Study||1||
59631946|NCT01495572|75745787|FG000|STARTED|Overall Study||0||
59631947|NCT01495572|75745788|FG001|STARTED|Overall Study||5||
59631948|NCT01495572|75745787|FG000|COMPLETED|Overall Study||0||
59631949|NCT01495572|75745788|FG001|COMPLETED|Overall Study||5||
59631950|NCT01495572|75745787|FG000|NOT COMPLETED|Overall Study||0||
59631951|NCT01495572|75745788|FG001|NOT COMPLETED|Overall Study||0||
59631952|NCT01496352|75745797|FG000|STARTED|Overall Study||24||
59631953|NCT01496352|75745798|FG001|STARTED|Overall Study||6||
59631954|NCT01496352|75745797|FG000|COMPLETED|Overall Study||24||
59631955|NCT01496352|75745798|FG001|COMPLETED|Overall Study||6||
59631956|NCT01496352|75745797|FG000|NOT COMPLETED|Overall Study||0||
59631957|NCT01496352|75745798|FG001|NOT COMPLETED|Overall Study||0||
59631958|NCT01497756|75745813|FG000|STARTED|Overall Study||10||
59631959|NCT01497756|75745813|FG000|COMPLETED|Overall Study||10||
59631960|NCT01497756|75745813|FG000|NOT COMPLETED|Overall Study||0||
59631961|NCT01499862|75745817|FG000|STARTED|Overall Study||3||
59631962|NCT01499862|75745817|FG000|COMPLETED|Overall Study||3||
59631963|NCT01499862|75745817|FG000|NOT COMPLETED|Overall Study||0||
59631964|NCT01504854|75745837|FG000|STARTED|Overall Study||64||
59631965|NCT01504854|75745838|FG001|STARTED|Overall Study||55||
59631966|NCT01504854|75745837|FG000|COMPLETED|Overall Study||56||
59631967|NCT01504854|75745838|FG001|COMPLETED|Overall Study||48||
59631968|NCT01504854|75745837|FG000|NOT COMPLETED|Overall Study||8||
59631969|NCT01504854|75745838|FG001|NOT COMPLETED|Overall Study||7||
59631970|NCT01505166|75745847|FG000|STARTED|Overall Study||3||
59631971|NCT01505166|75745848|FG001|STARTED|Overall Study||0||
59631972|NCT01505166|75745849|FG002|STARTED|Overall Study||0||
59631973|NCT01505166|75745847|FG000|COMPLETED|Overall Study|"Completed means subject had successful Vigil manufacturing and had been given all the doses."|3||
59631974|NCT01505166|75745848|FG001|COMPLETED|Overall Study||0||
59631975|NCT01505166|75745849|FG002|COMPLETED|Overall Study||0||
59631976|NCT01505166|75745847|FG000|NOT COMPLETED|Overall Study||0||
59631977|NCT01505166|75745848|FG001|NOT COMPLETED|Overall Study||0||
59631978|NCT01505166|75745849|FG002|NOT COMPLETED|Overall Study||0||
59631979|NCT01507350|75745859|FG000|STARTED|Overall Study||9||
59631980|NCT01507350|75745859|FG000|COMPLETED|Overall Study||9||
59631981|NCT01507350|75745859|FG000|NOT COMPLETED|Overall Study||0||
59631982|NCT01508052|75745865|FG000|STARTED|Overall Study||20||
59631983|NCT01508052|75745866|FG001|STARTED|Overall Study||20||
59631984|NCT01508052|75745865|FG000|COMPLETED|Overall Study||20||
59631985|NCT01508052|75745866|FG001|COMPLETED|Overall Study||20||
59631986|NCT01508052|75745865|FG000|NOT COMPLETED|Overall Study||0||
59631987|NCT01508052|75745866|FG001|NOT COMPLETED|Overall Study||0||
59631988|NCT01508832|75745874|FG000|STARTED|Overall Study||6||
59631989|NCT01508832|75745875|FG001|STARTED|Overall Study||6||
59631990|NCT01508832|75745874|FG000|COMPLETED|Overall Study||6||
59631991|NCT01508832|75745875|FG001|COMPLETED|Overall Study||6||
59631992|NCT01508832|75745874|FG000|NOT COMPLETED|Overall Study||0||
59631993|NCT01508832|75745875|FG001|NOT COMPLETED|Overall Study||0||
59631994|NCT01509612|75745884|FG000|STARTED|Overall Study||47||
59631995|NCT01509612|75745885|FG001|STARTED|Overall Study||51||
59631996|NCT01509612|75745886|FG002|STARTED|Overall Study||52||
59631997|NCT01509612|75745884|FG000|COMPLETED|Overall Study||47||
59631998|NCT01509612|75745885|FG001|COMPLETED|Overall Study||51||
59631999|NCT01509612|75745886|FG002|COMPLETED|Overall Study||52||
59632000|NCT01509612|75745884|FG000|NOT COMPLETED|Overall Study||0||
59632001|NCT01509612|75745885|FG001|NOT COMPLETED|Overall Study||0||
59632002|NCT01509612|75745886|FG002|NOT COMPLETED|Overall Study||0||
59632003|NCT01510704|75745901|FG000|STARTED|Overall Study||54||
59632004|NCT01510704|75745902|FG001|STARTED|Overall Study||58||
59632005|NCT01510704|75745903|FG002|STARTED|Overall Study||50||
59632006|NCT01510704|75745904|FG003|STARTED|Overall Study||53||
59632007|NCT01510704|75745901|FG000|COMPLETED|Overall Study||54||
59632008|NCT01510704|75745902|FG001|COMPLETED|Overall Study||58||
59632009|NCT01510704|75745903|FG002|COMPLETED|Overall Study||50||
59632010|NCT01510704|75745904|FG003|COMPLETED|Overall Study||53||
59632011|NCT01510704|75745901|FG000|NOT COMPLETED|Overall Study||0||
59632012|NCT01510704|75745902|FG001|NOT COMPLETED|Overall Study||0||
59632013|NCT01510704|75745903|FG002|NOT COMPLETED|Overall Study||0||
59632014|NCT01510704|75745904|FG003|NOT COMPLETED|Overall Study||0||
59632015|NCT01511016|75745916|FG000|STARTED|Overall Study||8||
59632016|NCT01511016|75745917|FG001|STARTED|Overall Study||9||
59632017|NCT01511016|75745916|FG000|COMPLETED|Overall Study||6||
59632018|NCT01511016|75745917|FG001|COMPLETED|Overall Study||7||
59632019|NCT01511016|75745916|FG000|NOT COMPLETED|Overall Study||2||
59632020|NCT01511016|75745917|FG001|NOT COMPLETED|Overall Study||2||
59632021|NCT01511640|75745928|FG000|STARTED|First Intervention (11-15 Days)||7||
59632022|NCT01511640|75745929|FG001|STARTED|First Intervention (11-15 Days)||8||
59632023|NCT01511640|75745930|FG002|STARTED|First Intervention (11-15 Days)||7||
59632024|NCT01511640|75745931|FG003|STARTED|First Intervention (11-15 Days)||8||
59632025|NCT01511640|75745928|FG000|COMPLETED|First Intervention (11-15 Days)||5||
59632026|NCT01511640|75745929|FG001|COMPLETED|First Intervention (11-15 Days)||8||
59632027|NCT01511640|75745930|FG002|COMPLETED|First Intervention (11-15 Days)||7||
59632028|NCT01511640|75745931|FG003|COMPLETED|First Intervention (11-15 Days)||7||
59632029|NCT01511640|75745928|FG000|NOT COMPLETED|First Intervention (11-15 Days)||2||
59632030|NCT01511640|75745929|FG001|NOT COMPLETED|First Intervention (11-15 Days)||0||
59632031|NCT01511640|75745930|FG002|NOT COMPLETED|First Intervention (11-15 Days)||0||
59632032|NCT01511640|75745931|FG003|NOT COMPLETED|First Intervention (11-15 Days)||1||
59632033|NCT01511640|75745928|FG000|STARTED|Washout (6-10 Days)||5||
59632034|NCT01511640|75745929|FG001|STARTED|Washout (6-10 Days)||8||
59632035|NCT01511640|75745930|FG002|STARTED|Washout (6-10 Days)||7||
59632036|NCT01511640|75745931|FG003|STARTED|Washout (6-10 Days)||7||
59632037|NCT01511640|75745928|FG000|COMPLETED|Washout (6-10 Days)||5||
59632038|NCT01511640|75745929|FG001|COMPLETED|Washout (6-10 Days)||8||
59632039|NCT01511640|75745930|FG002|COMPLETED|Washout (6-10 Days)||7||
59632040|NCT01511640|75745931|FG003|COMPLETED|Washout (6-10 Days)||6||
59632041|NCT01511640|75745928|FG000|NOT COMPLETED|Washout (6-10 Days)||0||
59632042|NCT01511640|75745929|FG001|NOT COMPLETED|Washout (6-10 Days)||0||
59632043|NCT01511640|75745930|FG002|NOT COMPLETED|Washout (6-10 Days)||0||
59632044|NCT01511640|75745931|FG003|NOT COMPLETED|Washout (6-10 Days)||1||
59632045|NCT01511640|75745928|FG000|STARTED|Third Intervention (11-15 Days)||5||
59632046|NCT01511640|75745929|FG001|STARTED|Third Intervention (11-15 Days)||8||
59632047|NCT01511640|75745930|FG002|STARTED|Third Intervention (11-15 Days)||7||
59632048|NCT01511640|75745931|FG003|STARTED|Third Intervention (11-15 Days)||6||
59632049|NCT01511640|75745928|FG000|COMPLETED|Third Intervention (11-15 Days)||4||
59632050|NCT01511640|75745929|FG001|COMPLETED|Third Intervention (11-15 Days)||7||
59632051|NCT01511640|75745930|FG002|COMPLETED|Third Intervention (11-15 Days)||7||
59632052|NCT01511640|75745931|FG003|COMPLETED|Third Intervention (11-15 Days)||6||
59632053|NCT01511640|75745928|FG000|NOT COMPLETED|Third Intervention (11-15 Days)||1||
59632054|NCT01511640|75745929|FG001|NOT COMPLETED|Third Intervention (11-15 Days)||1||
59632055|NCT01511640|75745930|FG002|NOT COMPLETED|Third Intervention (11-15 Days)||0||
59632056|NCT01511640|75745931|FG003|NOT COMPLETED|Third Intervention (11-15 Days)||0||
59632057|NCT01513122|75745943|FG000|STARTED|Overall Study||102||
59632058|NCT01513122|75745944|FG001|STARTED|Overall Study||108||
59632059|NCT01513122|75745943|FG000|COMPLETED|Overall Study||91||
59632060|NCT01513122|75745944|FG001|COMPLETED|Overall Study||105||
59632061|NCT01513122|75745943|FG000|NOT COMPLETED|Overall Study||11||
59632062|NCT01513122|75745944|FG001|NOT COMPLETED|Overall Study||3||
59632063|NCT01513902|75745953|FG000|STARTED|Overall Study||8||
59632064|NCT01513902|75745954|FG001|STARTED|Overall Study||9||
59632065|NCT01513902|75745955|FG002|STARTED|Overall Study||9||
59632066|NCT01513902|75745953|FG000|COMPLETED|Overall Study||8||
59632067|NCT01513902|75745954|FG001|COMPLETED|Overall Study||9||
59632068|NCT01513902|75745955|FG002|COMPLETED|Overall Study||9||
59632069|NCT01513902|75745953|FG000|NOT COMPLETED|Overall Study||0||
59632070|NCT01513902|75745954|FG001|NOT COMPLETED|Overall Study||0||
59632071|NCT01513902|75745955|FG002|NOT COMPLETED|Overall Study||0||
59632072|NCT01514292|75745963|FG000|STARTED|Overall Study||72||
59632073|NCT01514292|75745963|FG000|COMPLETED|Overall Study||72||
59632074|NCT01514292|75745963|FG000|NOT COMPLETED|Overall Study||0||
59632075|NCT01515072|75745969|FG000|STARTED|Overall Study||166||
59632076|NCT01515072|75745970|FG001|STARTED|Overall Study||155||
59632077|NCT01515072|75745969|FG000|COMPLETED|Overall Study|There were 566 total organs transplanted and 248 kidneys transplanted in the No RIPC group.|166||
59632078|NCT01515072|75745970|FG001|COMPLETED|Overall Study|There were 513 total organs transplanted and 235 kidneys transplanted in the RIPC group|155||
59632079|NCT01515072|75745969|FG000|NOT COMPLETED|Overall Study||0||
59632080|NCT01515072|75745970|FG001|NOT COMPLETED|Overall Study||0||
59632081|NCT01515540|75745992|FG000|STARTED|Overall Study||20||
59632082|NCT01515540|75745993|FG001|STARTED|Overall Study||18||
59632083|NCT01515540|75745992|FG000|COMPLETED|Overall Study||15||
59632084|NCT01515540|75745993|FG001|COMPLETED|Overall Study||15||
59632085|NCT01515540|75745992|FG000|NOT COMPLETED|Overall Study||5||
59632086|NCT01515540|75745993|FG001|NOT COMPLETED|Overall Study||3||
59632087|NCT01515696|75746001|FG000|STARTED|Overall Study||47||
59632088|NCT01515696|75746002|FG001|STARTED|Overall Study||49||
59632089|NCT01515696|75746001|FG000|COMPLETED|Overall Study||39||
59632090|NCT01515696|75746002|FG001|COMPLETED|Overall Study||39||
59632091|NCT01515696|75746001|FG000|NOT COMPLETED|Overall Study||8||
59632092|NCT01515696|75746002|FG001|NOT COMPLETED|Overall Study||10||
59632093|NCT01516632|75746010|FG000|STARTED|Overall Study||101||
59632094|NCT01516632|75746011|FG001|STARTED|Overall Study||63||
59632095|NCT01516632|75746010|FG000|COMPLETED|Overall Study||77||
59632096|NCT01516632|75746011|FG001|COMPLETED|Overall Study||48||
59632097|NCT01516632|75746010|FG000|NOT COMPLETED|Overall Study||24||
59632098|NCT01516632|75746011|FG001|NOT COMPLETED|Overall Study||15||
59632099|NCT01518270|75746019|FG000|STARTED|Overall Study||179||
59632100|NCT01518270|75746019|FG000|COMPLETED|Overall Study||179||
59632101|NCT01518270|75746019|FG000|NOT COMPLETED|Overall Study||0||
59632102|NCT01519284|75746028|FG000|STARTED|Overall Study||16||
59632103|NCT01519284|75746029|FG001|STARTED|Overall Study||16||
59632104|NCT01519284|75746030|FG002|STARTED|Overall Study||18||
59632105|NCT01519284|75746031|FG003|STARTED|Overall Study||16||
59632106|NCT01519284|75746032|FG004|STARTED|Overall Study||16||
59632107|NCT01519284|75746028|FG000|COMPLETED|Overall Study||16||
59632108|NCT01519284|75746029|FG001|COMPLETED|Overall Study||16||
59632109|NCT01519284|75746030|FG002|COMPLETED|Overall Study||16||
59632110|NCT01519284|75746031|FG003|COMPLETED|Overall Study||16||
59632111|NCT01519284|75746032|FG004|COMPLETED|Overall Study||16||
59632112|NCT01519284|75746028|FG000|NOT COMPLETED|Overall Study||0||
59632113|NCT01519284|75746029|FG001|NOT COMPLETED|Overall Study||0||
59632114|NCT01519284|75746030|FG002|NOT COMPLETED|Overall Study||2||
59632115|NCT01519284|75746031|FG003|NOT COMPLETED|Overall Study||0||
59632116|NCT01519284|75746032|FG004|NOT COMPLETED|Overall Study||0||
59632117|NCT01520454|75746048|FG000|STARTED|Overall Study||9||
59632118|NCT01520454|75746049|FG001|STARTED|Overall Study||6||
59632119|NCT01520454|75746050|FG002|STARTED|Overall Study||5||
59632120|NCT01520454|75746051|FG003|STARTED|Overall Study||6||
59632121|NCT01520454|75746048|FG000|COMPLETED|Overall Study||9||
59632122|NCT01520454|75746049|FG001|COMPLETED|Overall Study||6||
59632123|NCT01520454|75746050|FG002|COMPLETED|Overall Study||5||
59632124|NCT01520454|75746051|FG003|COMPLETED|Overall Study||6||
59632125|NCT01520454|75746048|FG000|NOT COMPLETED|Overall Study||0||
59632126|NCT01520454|75746049|FG001|NOT COMPLETED|Overall Study||0||
59632127|NCT01520454|75746050|FG002|NOT COMPLETED|Overall Study||0||
59632128|NCT01520454|75746051|FG003|NOT COMPLETED|Overall Study||0||
59632129|NCT01520532|75746064|FG000|STARTED|Overall Study|Subjects who underwent an ablation and had post-procedure MRI|60||
59632130|NCT01520532|75746064|FG000|COMPLETED|Overall Study||60||
59632131|NCT01520532|75746064|FG000|NOT COMPLETED|Overall Study||0||
59632132|NCT01520688|75746068|FG000|STARTED|Overall Study||4||
59632133|NCT01520688|75746069|FG001|STARTED|Overall Study||4||
59632134|NCT01520688|75746070|FG002|STARTED|Overall Study||4||
59632135|NCT01520688|75746071|FG003|STARTED|Overall Study||5||
59632136|NCT01520688|75746072|FG004|STARTED|Overall Study||5||
59632137|NCT01520688|75746073|FG005|STARTED|Overall Study||5||
59632138|NCT01520688|75746074|FG006|STARTED|Overall Study||5||
59632139|NCT01520688|75746068|FG000|COMPLETED|Overall Study||4||
59632140|NCT01520688|75746069|FG001|COMPLETED|Overall Study||2||
59632141|NCT01520688|75746070|FG002|COMPLETED|Overall Study||4||
59632142|NCT01520688|75746071|FG003|COMPLETED|Overall Study||4||
59632143|NCT01520688|75746072|FG004|COMPLETED|Overall Study||4||
59632144|NCT01520688|75746073|FG005|COMPLETED|Overall Study||5||
59632145|NCT01520688|75746074|FG006|COMPLETED|Overall Study||0||
59632146|NCT01520688|75746068|FG000|NOT COMPLETED|Overall Study||0||
59632147|NCT01520688|75746069|FG001|NOT COMPLETED|Overall Study||2||
59632148|NCT01520688|75746070|FG002|NOT COMPLETED|Overall Study||0||
59632149|NCT01520688|75746071|FG003|NOT COMPLETED|Overall Study||1||
59632150|NCT01520688|75746072|FG004|NOT COMPLETED|Overall Study||1||
59632151|NCT01520688|75746073|FG005|NOT COMPLETED|Overall Study||0||
59632152|NCT01520688|75746074|FG006|NOT COMPLETED|Overall Study||5||
59632153|NCT01521546|75746084|FG000|STARTED|Overall Study||22||
59632154|NCT01521546|75746085|FG001|STARTED|Overall Study||20||
59632155|NCT01521546|75746084|FG000|COMPLETED|Overall Study||20||
59632156|NCT01521546|75746085|FG001|COMPLETED|Overall Study||20||
59632157|NCT01521546|75746084|FG000|NOT COMPLETED|Overall Study||2||
59632158|NCT01521546|75746085|FG001|NOT COMPLETED|Overall Study||0||
59632159|NCT01521780|75746091|FG000|STARTED|Overall Study||9||
59632160|NCT01521780|75746092|FG001|STARTED|Overall Study||1||
59632161|NCT01521780|75746093|FG002|STARTED|Overall Study||2||
59632162|NCT01521780|75746091|FG000|COMPLETED|Overall Study||9||
59632163|NCT01521780|75746092|FG001|COMPLETED|Overall Study||1||
59632164|NCT01521780|75746093|FG002|COMPLETED|Overall Study||2||
59632165|NCT01521780|75746091|FG000|NOT COMPLETED|Overall Study||0||
59632166|NCT01521780|75746092|FG001|NOT COMPLETED|Overall Study||0||
59632167|NCT01521780|75746093|FG002|NOT COMPLETED|Overall Study||0||
59632168|NCT01523496|75746106|FG000|STARTED|Overall Study|The supplementation group includes medium and high dose vitamin D supplementation|66||
59632169|NCT01523496|75746107|FG001|STARTED|Overall Study||36||
59632170|NCT01523496|75746108|FG002|STARTED|Overall Study|The supplementation group includes medium and high dose vitamin D supplementation|58||
59632171|NCT01523496|75746109|FG003|STARTED|Overall Study||30||
59632172|NCT01523496|75746106|FG000|COMPLETED|Overall Study||56||
59632173|NCT01523496|75746107|FG001|COMPLETED|Overall Study||32||
59632174|NCT01523496|75746108|FG002|COMPLETED|Overall Study||46||
59632175|NCT01523496|75746109|FG003|COMPLETED|Overall Study||27||
59632176|NCT01523496|75746106|FG000|NOT COMPLETED|Overall Study||10||
59632177|NCT01523496|75746107|FG001|NOT COMPLETED|Overall Study||4||
59632178|NCT01523496|75746108|FG002|NOT COMPLETED|Overall Study||12||
59632179|NCT01523496|75746109|FG003|NOT COMPLETED|Overall Study||3||
59632180|NCT01523808|75746127|FG000|STARTED|Overall Study||3||
59632181|NCT01523808|75746128|FG001|STARTED|Overall Study||3||
59632182|NCT01523808|75746129|FG002|STARTED|Overall Study||3||
59632183|NCT01523808|75746130|FG003|STARTED|Overall Study||3||
59632184|NCT01523808|75746127|FG000|COMPLETED|Overall Study||0||
59632185|NCT01523808|75746128|FG001|COMPLETED|Overall Study||3||
59632186|NCT01523808|75746129|FG002|COMPLETED|Overall Study||1||
59632187|NCT01523808|75746130|FG003|COMPLETED|Overall Study||0||
59632188|NCT01523808|75746127|FG000|NOT COMPLETED|Overall Study||3||
59632189|NCT01523808|75746128|FG001|NOT COMPLETED|Overall Study||0||
59632190|NCT01523808|75746129|FG002|NOT COMPLETED|Overall Study||2||
59632191|NCT01523808|75746130|FG003|NOT COMPLETED|Overall Study||3||
59632192|NCT01523964|75746153|FG000|STARTED|Overall Study||31||
59632193|NCT01523964|75746154|FG001|STARTED|Overall Study||30||
59632194|NCT01523964|75746155|FG002|STARTED|Overall Study||16||
59632195|NCT01523964|75746156|FG003|STARTED|Overall Study||15||
59632196|NCT01523964|75746153|FG000|COMPLETED|Overall Study||31||
59632197|NCT01523964|75746154|FG001|COMPLETED|Overall Study||30||
59632198|NCT01523964|75746155|FG002|COMPLETED|Overall Study||16||
59632199|NCT01523964|75746156|FG003|COMPLETED|Overall Study||15||
59632200|NCT01523964|75746153|FG000|NOT COMPLETED|Overall Study||0||
59632201|NCT01523964|75746154|FG001|NOT COMPLETED|Overall Study||0||
59632202|NCT01523964|75746155|FG002|NOT COMPLETED|Overall Study||0||
59632203|NCT01523964|75746156|FG003|NOT COMPLETED|Overall Study||0||
59632204|NCT01526538|75746168|FG000|STARTED|Overall Study||30||
59632205|NCT01526538|75746169|FG001|STARTED|Overall Study||22||
59632206|NCT01526538|75746168|FG000|COMPLETED|Overall Study||21||
59632207|NCT01526538|75746169|FG001|COMPLETED|Overall Study||18||
59632208|NCT01526538|75746168|FG000|NOT COMPLETED|Overall Study||9||
59632209|NCT01526538|75746169|FG001|NOT COMPLETED|Overall Study||4||
59632210|NCT01527162|75746177|FG000|STARTED|Overall Study||6||
59632211|NCT01527162|75746178|FG001|STARTED|Overall Study||5||
59632212|NCT01527162|75746177|FG000|COMPLETED|Overall Study||6||
59632213|NCT01527162|75746178|FG001|COMPLETED|Overall Study||5||
59632214|NCT01527162|75746177|FG000|NOT COMPLETED|Overall Study||0||
59632215|NCT01527162|75746178|FG001|NOT COMPLETED|Overall Study||0||
59632216|NCT01528332|75746188|FG000|STARTED|Overall Study||85||
59632217|NCT01528332|75746189|FG001|STARTED|Overall Study||86||
59632218|NCT01528332|75746188|FG000|COMPLETED|Overall Study||81||
59632219|NCT01528332|75746189|FG001|COMPLETED|Overall Study||84||
59632220|NCT01528332|75746188|FG000|NOT COMPLETED|Overall Study||4||
59632221|NCT01528332|75746189|FG001|NOT COMPLETED|Overall Study||2||
59632222|NCT01528878|75746195|FG000|STARTED|Overall Study||30||
59632223|NCT01528878|75746195|FG000|COMPLETED|Overall Study||30||
59632224|NCT01528878|75746195|FG000|NOT COMPLETED|Overall Study||0||
59632225|NCT01529502|75746207|FG000|STARTED|Overall Study||2||
59632226|NCT01529502|75746208|FG001|STARTED|Overall Study||3||
59632227|NCT01529502|75746209|FG002|STARTED|Overall Study||2||
59632228|NCT01529502|75746210|FG003|STARTED|Overall Study||3||
59632229|NCT01529502|75746211|FG004|STARTED|Overall Study||2||
59632230|NCT01529502|75746212|FG005|STARTED|Overall Study||2||
59632231|NCT01529502|75746207|FG000|COMPLETED|Overall Study||2||
59632232|NCT01529502|75746208|FG001|COMPLETED|Overall Study||3||
59632233|NCT01529502|75746209|FG002|COMPLETED|Overall Study||2||
59632234|NCT01529502|75746210|FG003|COMPLETED|Overall Study||1||
59632235|NCT01529502|75746211|FG004|COMPLETED|Overall Study||2||
59632236|NCT01529502|75746212|FG005|COMPLETED|Overall Study||2||
59632237|NCT01529502|75746207|FG000|NOT COMPLETED|Overall Study||0||
59632238|NCT01529502|75746208|FG001|NOT COMPLETED|Overall Study||0||
59632239|NCT01529502|75746209|FG002|NOT COMPLETED|Overall Study||0||
59632240|NCT01529502|75746210|FG003|NOT COMPLETED|Overall Study||2||
59632241|NCT01529502|75746211|FG004|NOT COMPLETED|Overall Study||0||
59632242|NCT01529502|75746212|FG005|NOT COMPLETED|Overall Study||0||
59632243|NCT01532700|75746220|FG000|STARTED|Overall Study||28||
59632244|NCT01532700|75746220|FG000|COMPLETED|Overall Study||28||
59632245|NCT01532700|75746220|FG000|NOT COMPLETED|Overall Study||0||
59632246|NCT01533948|75746224|FG000|STARTED|Overall Study||25||
59632247|NCT01533948|75746224|FG000|COMPLETED|Overall Study||25||
59632248|NCT01533948|75746224|FG000|NOT COMPLETED|Overall Study||0||
59632249|NCT01534416|75746230|FG000|STARTED|Overall Study||68||
59632250|NCT01534416|75746231|FG001|STARTED|Overall Study||64||
59632251|NCT01534416|75746230|FG000|COMPLETED|Overall Study||68||
59632252|NCT01534416|75746231|FG001|COMPLETED|Overall Study||64||
59632253|NCT01534416|75746230|FG000|NOT COMPLETED|Overall Study||0||
59632254|NCT01534416|75746231|FG001|NOT COMPLETED|Overall Study||0||
59632255|NCT01535118|75746247|FG000|STARTED|Overall Study||2765||
59632256|NCT01535118|75746247|FG000|COMPLETED|Overall Study||2765||
59632257|NCT01535118|75746247|FG000|NOT COMPLETED|Overall Study||0||
59632258|NCT01535664|75746251|FG000|STARTED|Overall Study||20||
59632259|NCT01535664|75746251|FG000|COMPLETED|Overall Study||20||
59632260|NCT01535664|75746251|FG000|NOT COMPLETED|Overall Study||0||
59632261|NCT01535976|75746261|FG000|STARTED|Overall Study||27||
59632262|NCT01535976|75746262|FG001|STARTED|Overall Study||27||
59632263|NCT01535976|75746261|FG000|COMPLETED|Overall Study||26||
59632264|NCT01535976|75746262|FG001|COMPLETED|Overall Study||26||
59632265|NCT01535976|75746261|FG000|NOT COMPLETED|Overall Study||1||
59632266|NCT01535976|75746262|FG001|NOT COMPLETED|Overall Study||1||
59632267|NCT01536366|75746270|FG000|STARTED|Overall Study||14||
59632268|NCT01536366|75746271|FG001|STARTED|Overall Study||13||
59632269|NCT01536366|75746270|FG000|BIA 9-1067 + Repaglinide|Overall Study||14||
59632270|NCT01536366|75746271|FG001|BIA 9-1067 + Repaglinide|Overall Study||10||
59632271|NCT01536366|75746270|FG000|Repaglinide|Overall Study||14||
59632272|NCT01536366|75746271|FG001|Repaglinide|Overall Study||13||
59632273|NCT01536366|75746270|FG000|Follow-up|Overall Study||13||
59632274|NCT01536366|75746271|FG001|Follow-up|Overall Study||9||
59632275|NCT01536366|75746270|FG000|COMPLETED|Overall Study||1||
59632276|NCT01536366|75746271|FG001|COMPLETED|Overall Study||9||
59632277|NCT01536366|75746270|FG000|NOT COMPLETED|Overall Study||13||
59632278|NCT01536366|75746271|FG001|NOT COMPLETED|Overall Study||4||
59632279|NCT05483127|75746279|FG000|STARTED|First Wear Period, 8 (-0/+3) Days||77||
59632280|NCT05483127|75746280|FG001|STARTED|First Wear Period, 8 (-0/+3) Days||75||
59632281|NCT05483127|75746279|FG000|COMPLETED|First Wear Period, 8 (-0/+3) Days||77||
59632282|NCT05483127|75746280|FG001|COMPLETED|First Wear Period, 8 (-0/+3) Days||75||
59632283|NCT05483127|75746279|FG000|NOT COMPLETED|First Wear Period, 8 (-0/+3) Days||0||
59632284|NCT05483127|75746280|FG001|NOT COMPLETED|First Wear Period, 8 (-0/+3) Days||0||
59632285|NCT05483127|75746279|FG000|STARTED|Second Wear Period, 8 (-0/+3) Days||76|One participant discontinued between First Wear Period and Second Wear Period due to an adverse event.|
59632286|NCT05483127|75746280|FG001|STARTED|Second Wear Period, 8 (-0/+3) Days||75|One participant discontinued between First Wear Period and Second Wear Period due to an adverse event.|
59632287|NCT05483127|75746279|FG000|COMPLETED|Second Wear Period, 8 (-0/+3) Days||76||
59632288|NCT05483127|75746280|FG001|COMPLETED|Second Wear Period, 8 (-0/+3) Days||75||
59632289|NCT05483127|75746279|FG000|NOT COMPLETED|Second Wear Period, 8 (-0/+3) Days||0||
59632290|NCT05483127|75746280|FG001|NOT COMPLETED|Second Wear Period, 8 (-0/+3) Days||0||
59632291|NCT05131451|75746291|FG000|STARTED|Overall Study||83||
59632292|NCT05131451|75746292|FG001|STARTED|Overall Study||81||
59632293|NCT05131451|75746291|FG000|COMPLETED|Overall Study|One patient in the usual care arm was inadvertently enrolled in another eye screening study.|82||
59632294|NCT05131451|75746292|FG001|COMPLETED|Overall Study||81||
59632295|NCT05131451|75746291|FG000|NOT COMPLETED|Overall Study||1||
59632296|NCT05131451|75746292|FG001|NOT COMPLETED|Overall Study||0||
59632297|NCT05108922|75746300|FG000|STARTED|Overall Study||74||
59632298|NCT05108922|75746301|FG001|STARTED|Overall Study||74||
59632299|NCT05108922|75746300|FG000|Received at Least One Dose of Study Drug|Overall Study||69||
59632300|NCT05108922|75746301|FG001|Received at Least One Dose of Study Drug|Overall Study||71||
59632301|NCT05108922|75746300|FG000|Intermediate Tau Analysis Set|Overall Study||28||
59632302|NCT05108922|75746301|FG001|Intermediate Tau Analysis Set|Overall Study||27||
59632303|NCT05108922|75746300|FG000|COMPLETED|Overall Study||65||
59632304|NCT05108922|75746301|FG001|COMPLETED|Overall Study||67||
59632305|NCT05108922|75746300|FG000|NOT COMPLETED|Overall Study||9||
59632306|NCT05108922|75746301|FG001|NOT COMPLETED|Overall Study||7||
59632307|NCT04982874|75746307|FG000|STARTED|1st Intervention||12||
59632308|NCT04982874|75746308|FG001|STARTED|1st Intervention||12||
59632309|NCT04982874|75746307|FG000|COMPLETED|1st Intervention||12||
59632310|NCT04982874|75746308|FG001|COMPLETED|1st Intervention||12||
59632311|NCT04982874|75746307|FG000|NOT COMPLETED|1st Intervention||0||
59632312|NCT04982874|75746308|FG001|NOT COMPLETED|1st Intervention||0||
59632313|NCT04982874|75746307|FG000|STARTED|Washout Periods >= One Week||12||
59632314|NCT04982874|75746308|FG001|STARTED|Washout Periods >= One Week||12||
59632315|NCT04982874|75746307|FG000|COMPLETED|Washout Periods >= One Week||12||
59632316|NCT04982874|75746308|FG001|COMPLETED|Washout Periods >= One Week||12||
59632317|NCT04982874|75746307|FG000|NOT COMPLETED|Washout Periods >= One Week||0||
59632318|NCT04982874|75746308|FG001|NOT COMPLETED|Washout Periods >= One Week||0||
59632319|NCT04982874|75746307|FG000|STARTED|2nd Intervention||12||
59632320|NCT04982874|75746308|FG001|STARTED|2nd Intervention||12||
59632321|NCT04982874|75746307|FG000|COMPLETED|2nd Intervention||12||
59632322|NCT04982874|75746308|FG001|COMPLETED|2nd Intervention||12||
59632323|NCT04982874|75746307|FG000|NOT COMPLETED|2nd Intervention||0||
59632324|NCT04982874|75746308|FG001|NOT COMPLETED|2nd Intervention||0||
59632325|NCT04874636|75746317|FG000|STARTED|Overall Study||102||
59632326|NCT04874636|75746318|FG001|STARTED|Overall Study||51||
59632327|NCT04874636|75746317|FG000|Received at Least One Dose of Study Drug|Overall Study||102||
59632328|NCT04874636|75746318|FG001|Received at Least One Dose of Study Drug|Overall Study||50||
60076371|NCT01904773|76191369|FG005|NOT COMPLETED|Placebo Washout Fifth Intervention||0||
59632329|NCT04874636|75746317|FG000|COMPLETED|Overall Study||75||
59632330|NCT04874636|75746318|FG001|COMPLETED|Overall Study||39||
59632331|NCT04874636|75746317|FG000|NOT COMPLETED|Overall Study||27||
60076372|NCT01904773|76191370|FG006|NOT COMPLETED|Placebo Washout Fifth Intervention||0||
60076373|NCT01904773|76191371|FG007|NOT COMPLETED|Placebo Washout Fifth Intervention||0||
59632332|NCT04874636|75746318|FG001|NOT COMPLETED|Overall Study||12||
59632333|NCT04840849|75746326|FG000|STARTED|Overall Study||18||
59632334|NCT04840849|75746327|FG001|STARTED|Overall Study||6||
59632335|NCT04840849|75746326|FG000|COMPLETED|Overall Study||18||
59632336|NCT04840849|75746327|FG001|COMPLETED|Overall Study||6||
59632337|NCT04840849|75746326|FG000|NOT COMPLETED|Overall Study||0||
59632338|NCT04840849|75746327|FG001|NOT COMPLETED|Overall Study||0||
59632339|NCT04707157|75746334|FG000|STARTED|Overall Study||45||
59632340|NCT04707157|75746335|FG001|STARTED|Overall Study||23||
59632341|NCT04707157|75746334|FG000|Received at Least One Dose of Study Drug|Overall Study||45||
59632342|NCT04707157|75746335|FG001|Received at Least One Dose of Study Drug|Overall Study||23||
59632343|NCT04707157|75746334|FG000|COMPLETED|Overall Study||20||
59632344|NCT04707157|75746335|FG001|COMPLETED|Overall Study||14||
59632345|NCT04707157|75746334|FG000|NOT COMPLETED|Overall Study||25||
59632346|NCT04707157|75746335|FG001|NOT COMPLETED|Overall Study||9||
59632347|NCT04700449|75746344|FG000|STARTED|Stage 1: Double-Blind Period||39||
59632348|NCT04700449|75746345|FG001|STARTED|Stage 1: Double-Blind Period||53||
59632349|NCT04700449|75746346|FG002|STARTED|Stage 1: Double-Blind Period||52||
59632350|NCT04700449|75746347|FG003|STARTED|Stage 1: Double-Blind Period||0||
59632351|NCT04700449|75746344|FG000|COMPLETED|Stage 1: Double-Blind Period||28||
59632352|NCT04700449|75746345|FG001|COMPLETED|Stage 1: Double-Blind Period||50||
59632353|NCT04700449|75746346|FG002|COMPLETED|Stage 1: Double-Blind Period||47||
59632354|NCT04700449|75746347|FG003|COMPLETED|Stage 1: Double-Blind Period||0||
59632355|NCT04700449|75746344|FG000|NOT COMPLETED|Stage 1: Double-Blind Period||11||
59632356|NCT04700449|75746345|FG001|NOT COMPLETED|Stage 1: Double-Blind Period||3||
59632357|NCT04700449|75746346|FG002|NOT COMPLETED|Stage 1: Double-Blind Period||5||
59632358|NCT04700449|75746347|FG003|NOT COMPLETED|Stage 1: Double-Blind Period||0||
59632359|NCT04700449|75746344|FG000|STARTED|Stage 2 Sub-study 1||12||
59632360|NCT04700449|75746345|FG001|STARTED|Stage 2 Sub-study 1||21||
59632361|NCT04700449|75746346|FG002|STARTED|Stage 2 Sub-study 1||13||
59632362|NCT04700449|75746347|FG003|STARTED|Stage 2 Sub-study 1||0||
59632363|NCT04700449|75746344|FG000|COMPLETED|Stage 2 Sub-study 1||10||
59632364|NCT04700449|75746345|FG001|COMPLETED|Stage 2 Sub-study 1||17||
59632365|NCT04700449|75746346|FG002|COMPLETED|Stage 2 Sub-study 1||9||
59632366|NCT04700449|75746347|FG003|COMPLETED|Stage 2 Sub-study 1||0||
59632367|NCT04700449|75746344|FG000|NOT COMPLETED|Stage 2 Sub-study 1||2||
59632368|NCT04700449|75746345|FG001|NOT COMPLETED|Stage 2 Sub-study 1||4||
59632369|NCT04700449|75746346|FG002|NOT COMPLETED|Stage 2 Sub-study 1||4||
59632370|NCT04700449|75746347|FG003|NOT COMPLETED|Stage 2 Sub-study 1||0||
59632371|NCT04700449|75746344|FG000|STARTED|Stage 2 Sub-study 2||0||
59632372|NCT04700449|75746345|FG001|STARTED|Stage 2 Sub-study 2||0||
59632373|NCT04700449|75746346|FG002|STARTED|Stage 2 Sub-study 2||0||
59632374|NCT04700449|75746347|FG003|STARTED|Stage 2 Sub-study 2||40||
59632375|NCT04700449|75746344|FG000|COMPLETED|Stage 2 Sub-study 2||0||
59632376|NCT04700449|75746345|FG001|COMPLETED|Stage 2 Sub-study 2||0||
59632377|NCT04700449|75746346|FG002|COMPLETED|Stage 2 Sub-study 2||0||
59632378|NCT04700449|75746347|FG003|COMPLETED|Stage 2 Sub-study 2||17||
59632379|NCT04700449|75746344|FG000|NOT COMPLETED|Stage 2 Sub-study 2||0||
59632380|NCT04700449|75746345|FG001|NOT COMPLETED|Stage 2 Sub-study 2||0||
59632381|NCT04700449|75746346|FG002|NOT COMPLETED|Stage 2 Sub-study 2||0||
59632382|NCT04700449|75746347|FG003|NOT COMPLETED|Stage 2 Sub-study 2||23||
59632383|NCT04695691|75746362|FG000|STARTED|Overall Study||104||
59632384|NCT04695691|75746362|FG000|COMPLETED|Overall Study||76||
59632385|NCT04695691|75746362|FG000|NOT COMPLETED|Overall Study||28||
59632386|NCT04667377|75746371|FG000|STARTED|Dose Escalation Period||78|Randomised|
59632387|NCT04667377|75746372|FG001|STARTED|Dose Escalation Period||78|Randomised|
59632388|NCT04667377|75746373|FG002|STARTED|Dose Escalation Period||77|Randomised|
59632389|NCT04667377|75746374|FG003|STARTED|Dose Escalation Period||77|Randomised|
59632390|NCT04667377|75746375|FG004|STARTED|Dose Escalation Period||77|Randomised|
59632391|NCT04667377|75746371|FG000|Treated During Dose Escalation Period|Dose Escalation Period||77||
59632392|NCT04667377|75746372|FG001|Treated During Dose Escalation Period|Dose Escalation Period||78||
59632393|NCT04667377|75746373|FG002|Treated During Dose Escalation Period|Dose Escalation Period||77||
59632394|NCT04667377|75746374|FG003|Treated During Dose Escalation Period|Dose Escalation Period||77||
59632395|NCT04667377|75746375|FG004|Treated During Dose Escalation Period|Dose Escalation Period||77||
59632396|NCT04667377|75746371|FG000|COMPLETED|Dose Escalation Period||55|Completed = Completed trial medication|
59632397|NCT04667377|75746372|FG001|COMPLETED|Dose Escalation Period||60|Completed = Completed trial medication|
59632398|NCT04667377|75746373|FG002|COMPLETED|Dose Escalation Period||59|Completed = Completed trial medication|
59632399|NCT04667377|75746374|FG003|COMPLETED|Dose Escalation Period||55|Completed = Completed trial medication|
59632400|NCT04667377|75746375|FG004|COMPLETED|Dose Escalation Period||57|Completed = Completed trial medication|
59632401|NCT04667377|75746371|FG000|NOT COMPLETED|Dose Escalation Period||23||
59632402|NCT04667377|75746372|FG001|NOT COMPLETED|Dose Escalation Period||18||
59632403|NCT04667377|75746373|FG002|NOT COMPLETED|Dose Escalation Period||18||
59632404|NCT04667377|75746374|FG003|NOT COMPLETED|Dose Escalation Period||22||
59632405|NCT04667377|75746375|FG004|NOT COMPLETED|Dose Escalation Period||20||
59632406|NCT04667377|75746371|FG000|STARTED|Maintenance Period||55||
59632407|NCT04667377|75746372|FG001|STARTED|Maintenance Period||60||
59632408|NCT04667377|75746373|FG002|STARTED|Maintenance Period||59||
59632409|NCT04667377|75746374|FG003|STARTED|Maintenance Period||55||
59815696|NCT03379506|75938170|FG003|STARTED|Overall Study||11||
59815697|NCT03379506|75938167|FG000|COMPLETED|Overall Study||22||
59632410|NCT04667377|75746375|FG004|STARTED|Maintenance Period||57||
59632411|NCT04667377|75746371|FG000|COMPLETED|Maintenance Period||47|Completed = Completed trial medication|
59632412|NCT04667377|75746372|FG001|COMPLETED|Maintenance Period||45|Completed = Completed trial medication|
59632413|NCT04667377|75746373|FG002|COMPLETED|Maintenance Period||48|Completed = Completed trial medication|
59632414|NCT04667377|75746374|FG003|COMPLETED|Maintenance Period||47|Completed = Completed trial medication|
59632415|NCT04667377|75746375|FG004|COMPLETED|Maintenance Period||46|Completed = Completed trial medication|
59632416|NCT04667377|75746371|FG000|NOT COMPLETED|Maintenance Period||8||
59632417|NCT04667377|75746372|FG001|NOT COMPLETED|Maintenance Period||15||
59632418|NCT04667377|75746373|FG002|NOT COMPLETED|Maintenance Period||11||
59632419|NCT04667377|75746374|FG003|NOT COMPLETED|Maintenance Period||8||
59632420|NCT04667377|75746375|FG004|NOT COMPLETED|Maintenance Period||11||
59632421|NCT04569799|75746387|FG000|STARTED|Overall Study||26||33
59632422|NCT04569799|75746387|FG000|COMPLETED|Overall Study||26||30
59632423|NCT04569799|75746387|FG000|NOT COMPLETED|Overall Study||0||3
59632424|NCT04537923|75746395|FG000|STARTED|Overall Study||243||
59632425|NCT04537923|75746396|FG001|STARTED|Overall Study||238||
59632426|NCT04537923|75746397|FG002|STARTED|Overall Study||236||
59632427|NCT04537923|75746398|FG003|STARTED|Overall Study||711||
59632428|NCT04537923|75746395|FG000|Received at Least One Dose of Study Drug|Overall Study||243||
59632429|NCT04537923|75746396|FG001|Received at Least One Dose of Study Drug|Overall Study||238||
59632430|NCT04537923|75746397|FG002|Received at Least One Dose of Study Drug|Overall Study||236||
59632431|NCT04537923|75746398|FG003|Received at Least One Dose of Study Drug|Overall Study||708||
59632432|NCT04537923|75746395|FG000|COMPLETED|Overall Study||228||
59632433|NCT04537923|75746396|FG001|COMPLETED|Overall Study||228||
59632434|NCT04537923|75746397|FG002|COMPLETED|Overall Study||225||
59632435|NCT04537923|75746398|FG003|COMPLETED|Overall Study||623||
59632436|NCT04537923|75746395|FG000|NOT COMPLETED|Overall Study||15||
59632437|NCT04537923|75746396|FG001|NOT COMPLETED|Overall Study||10||
59632438|NCT04537923|75746397|FG002|NOT COMPLETED|Overall Study||11||
59632439|NCT04537923|75746398|FG003|NOT COMPLETED|Overall Study||88||
59632440|NCT04437485|75746412|FG000|STARTED|Overall Study||24||
59632441|NCT04437485|75746413|FG001|STARTED|Overall Study||22||
59632442|NCT04437485|75746412|FG000|COMPLETED|Overall Study||21||
59632443|NCT04437485|75746413|FG001|COMPLETED|Overall Study||18||
59632444|NCT04437485|75746412|FG000|NOT COMPLETED|Overall Study||3||
59632445|NCT04437485|75746413|FG001|NOT COMPLETED|Overall Study||4||
59632446|NCT04428333|75746421|FG000|STARTED|Overall Study||57||
59632447|NCT04428333|75746422|FG001|STARTED|Overall Study||59||
59632448|NCT04428333|75746421|FG000|Modified Intent-to-Treat (mITT) Population|Overall Study||52|5 participants initially randomized to feladilimab + chemotherapy arm and 4 participants initially randomized to placebo + chemotherapy arm were dosed only after DIL date requesting immediate discontinuation of feladilimab/placebo and were not included in the mITT population.|
59632449|NCT04428333|75746422|FG001|Modified Intent-to-Treat (mITT) Population|Overall Study||55|5 participants initially randomized to feladilimab + chemotherapy arm and 4 participants initially randomized to placebo + chemotherapy arm were dosed only after DIL date requesting immediate discontinuation of feladilimab/placebo and were not included in the mITT population.|
59632450|NCT04428333|75746421|FG000|Safety Population|Overall Study||50|"6 participants initially randomized to feladilimab + pembrolizumab + 5-FU-platinum chemotherapy arm were never dosed with feladilimab, among them 5 participants received first dose after the DIL date and were re-assigned to placebo + pembrolizumab + 5-FU-platinum chemotherapy arm.~1 participant was initially randomized to feladilimab + pembrolizumab + 5-FU-platinum chemotherapy arm but was never dosed and was excluded from the safety population."|
59632451|NCT04428333|75746422|FG001|Safety Population|Overall Study||65|"6 participants initially randomized to feladilimab + pembrolizumab + 5-FU-platinum chemotherapy arm were never dosed with feladilimab, among them 5 participants received first dose after the DIL date and were re-assigned to placebo + pembrolizumab + 5-FU-platinum chemotherapy arm.~1 participant was initially randomized to feladilimab + pembrolizumab + 5-FU-platinum chemotherapy arm but was never dosed and was excluded from the safety population."|
59632452|NCT04428333|75746421|FG000|COMPLETED|Overall Study||3||
59632453|NCT04428333|75746422|FG001|COMPLETED|Overall Study||1||
59632454|NCT04428333|75746421|FG000|NOT COMPLETED|Overall Study||54||
59632455|NCT04428333|75746422|FG001|NOT COMPLETED|Overall Study||58||
59632456|NCT04160468|75746430|FG000|STARTED|Overall Study||173||
59632457|NCT04160468|75746431|FG001|STARTED|Overall Study||86||
59632458|NCT04160468|75746430|FG000|COMPLETED|Overall Study||142||
59632459|NCT04160468|75746431|FG001|COMPLETED|Overall Study||81||
59632460|NCT04160468|75746430|FG000|NOT COMPLETED|Overall Study||31||
59632461|NCT04160468|75746431|FG001|NOT COMPLETED|Overall Study||5||
59632462|NCT03987841|75746437|FG000|STARTED|Overall Study||5||
59632463|NCT03987841|75746437|FG000|COMPLETED|Overall Study||5||
59632464|NCT03987841|75746437|FG000|NOT COMPLETED|Overall Study||0||
59632465|NCT03834766|75746443|FG000|STARTED|Overall Study||62||
59632466|NCT03834766|75746444|FG001|STARTED|Overall Study||65||
59632467|NCT03834766|75746443|FG000|COMPLETED|Overall Study||45||
59632468|NCT03834766|75746444|FG001|COMPLETED|Overall Study||46||
59632469|NCT03834766|75746443|FG000|NOT COMPLETED|Overall Study||17||
59632470|NCT03834766|75746444|FG001|NOT COMPLETED|Overall Study||19||
59632471|NCT03761056|75746450|FG000|STARTED|Overall Study||42||
59632472|NCT03761056|75746450|FG000|COMPLETED|Overall Study||0||
59632473|NCT03761056|75746450|FG000|NOT COMPLETED|Overall Study||42||
59632474|NCT03508921|75746458|FG000|STARTED|Overall Study||10||
59632475|NCT03508921|75746459|FG001|STARTED|Overall Study||12||
59632476|NCT03508921|75746458|FG000|COMPLETED|Overall Study||6||
59632477|NCT03508921|75746459|FG001|COMPLETED|Overall Study||11||
59632478|NCT03508921|75746458|FG000|NOT COMPLETED|Overall Study||4||
59632479|NCT03508921|75746459|FG001|NOT COMPLETED|Overall Study||1||
59632480|NCT03276572|75746472|FG000|STARTED|Overall Study||1||
59632481|NCT03276572|75746473|FG001|STARTED|Overall Study||1||
59632482|NCT03276572|75746474|FG002|STARTED|Overall Study||1||
59632483|NCT03276572|75746475|FG003|STARTED|Overall Study||1||
59632484|NCT03276572|75746476|FG004|STARTED|Overall Study||6||
59632485|NCT03276572|75746477|FG005|STARTED|Overall Study||6||
59632486|NCT03276572|75746478|FG006|STARTED|Overall Study||16||
59632487|NCT03276572|75746472|FG000|COMPLETED|Overall Study||1||
59632488|NCT03276572|75746473|FG001|COMPLETED|Overall Study||1||
59632489|NCT03276572|75746474|FG002|COMPLETED|Overall Study||1||
59632490|NCT03276572|75746475|FG003|COMPLETED|Overall Study||1||
59632491|NCT03276572|75746476|FG004|COMPLETED|Overall Study||6||
59632492|NCT03276572|75746477|FG005|COMPLETED|Overall Study||5||
59632493|NCT03276572|75746478|FG006|COMPLETED|Overall Study||14||
59632494|NCT03276572|75746472|FG000|NOT COMPLETED|Overall Study||0||
59632495|NCT03276572|75746473|FG001|NOT COMPLETED|Overall Study||0||
59632496|NCT03276572|75746474|FG002|NOT COMPLETED|Overall Study||0||
59632497|NCT03276572|75746475|FG003|NOT COMPLETED|Overall Study||0||
59632498|NCT03276572|75746476|FG004|NOT COMPLETED|Overall Study||0||
59632499|NCT03276572|75746477|FG005|NOT COMPLETED|Overall Study||1||
59632500|NCT03276572|75746478|FG006|NOT COMPLETED|Overall Study||2||
59632501|NCT02925195|75746497|FG000|STARTED|Overall Study||499||
59632502|NCT02925195|75746498|FG001|STARTED|Overall Study||167||
59632503|NCT02925195|75746497|FG000|COMPLETED|Overall Study||453||
59632504|NCT02925195|75746498|FG001|COMPLETED|Overall Study||158||
59632505|NCT02925195|75746497|FG000|NOT COMPLETED|Overall Study||46||
59632506|NCT02925195|75746498|FG001|NOT COMPLETED|Overall Study||9||
59632507|NCT02840877|75746504|FG000|STARTED|Baseline to 12 Weeks||303||
59632508|NCT02840877|75746504|FG000|COMPLETED|Baseline to 12 Weeks||282||
59632509|NCT02840877|75746504|FG000|NOT COMPLETED|Baseline to 12 Weeks||21||
59632510|NCT02840877|75746504|FG000|STARTED|12 Weeks to 6 Months||282||
59632511|NCT02840877|75746504|FG000|COMPLETED|12 Weeks to 6 Months||271||
59632512|NCT02840877|75746504|FG000|NOT COMPLETED|12 Weeks to 6 Months||11||
59632513|NCT02840877|75746504|FG000|STARTED|6 Months to 18 Months||271||
59632514|NCT02840877|75746504|FG000|COMPLETED|6 Months to 18 Months||205||
59632515|NCT02840877|75746504|FG000|NOT COMPLETED|6 Months to 18 Months||66||
59632516|NCT02694185|75746510|FG000|STARTED|Overall Study||476||
59632517|NCT02694185|75746511|FG001|STARTED|Overall Study||4793||
59632518|NCT02694185|75746510|FG000|COMPLETED|Overall Study||431||
59632519|NCT02694185|75746511|FG001|COMPLETED|Overall Study||4793||
59632520|NCT02694185|75746510|FG000|NOT COMPLETED|Overall Study||45||
59632521|NCT02694185|75746511|FG001|NOT COMPLETED|Overall Study||0||
59632522|NCT02684903|75746519|FG000|STARTED|Overall Study|(84 parents and 84 children)|168||
59632523|NCT02684903|75746520|FG001|STARTED|Overall Study|(120 parents and 120 children)|240||
59632524|NCT02684903|75746519|FG000|COMPLETED|Overall Study|(68 parents and 65 children)|133||
59632525|NCT02684903|75746520|FG001|COMPLETED|Overall Study|(100 parents and 93 children)|193||
59632526|NCT02684903|75746519|FG000|NOT COMPLETED|Overall Study||35||
59632527|NCT02684903|75746520|FG001|NOT COMPLETED|Overall Study||47||
59632528|NCT02621424|75746535|FG000|STARTED|Overall Study||14||
59632529|NCT02621424|75746536|FG001|STARTED|Overall Study||18||
59632530|NCT02621424|75746535|FG000|COMPLETED|Overall Study||13||
59632531|NCT02621424|75746536|FG001|COMPLETED|Overall Study||16||
59632532|NCT02621424|75746535|FG000|NOT COMPLETED|Overall Study||1||
59632533|NCT02621424|75746536|FG001|NOT COMPLETED|Overall Study||2||
59632534|NCT02616185|75746551|FG000|STARTED|Overall Study||3||
59632535|NCT02616185|75746552|FG001|STARTED|Overall Study||4||
59632536|NCT02616185|75746553|FG002|STARTED|Overall Study||6||
59632537|NCT02616185|75746554|FG003|STARTED|Overall Study||8||
59632538|NCT02616185|75746555|FG004|STARTED|Overall Study||14||
59632539|NCT02616185|75746556|FG005|STARTED|Overall Study||3||
59632540|NCT02616185|75746557|FG006|STARTED|Overall Study||20||
59632541|NCT02616185|75746558|FG007|STARTED|Overall Study||18||
59632542|NCT02616185|75746559|FG008|STARTED|Overall Study||15||
59632543|NCT02616185|75746551|FG000|COMPLETED|Overall Study||2||
59632544|NCT02616185|75746552|FG001|COMPLETED|Overall Study||3||
59632545|NCT02616185|75746553|FG002|COMPLETED|Overall Study||3||
59632546|NCT02616185|75746554|FG003|COMPLETED|Overall Study||3||
59632547|NCT02616185|75746555|FG004|COMPLETED|Overall Study||5||
59632548|NCT02616185|75746556|FG005|COMPLETED|Overall Study||2||
59632549|NCT02616185|75746557|FG006|COMPLETED|Overall Study||12||
59632550|NCT02616185|75746558|FG007|COMPLETED|Overall Study||5||
59632551|NCT02616185|75746559|FG008|COMPLETED|Overall Study||9||
59632552|NCT02616185|75746551|FG000|NOT COMPLETED|Overall Study||1||
59632553|NCT02616185|75746552|FG001|NOT COMPLETED|Overall Study||1||
59632554|NCT02616185|75746553|FG002|NOT COMPLETED|Overall Study||3||
59632555|NCT02616185|75746554|FG003|NOT COMPLETED|Overall Study||5||
59632556|NCT02616185|75746555|FG004|NOT COMPLETED|Overall Study||9||
59632557|NCT02616185|75746556|FG005|NOT COMPLETED|Overall Study||1||
59632558|NCT02616185|75746557|FG006|NOT COMPLETED|Overall Study||8||
59632559|NCT02616185|75746558|FG007|NOT COMPLETED|Overall Study||13||
59632560|NCT02616185|75746559|FG008|NOT COMPLETED|Overall Study||6||
59632561|NCT02453737|75746613|FG000|STARTED|Overall Study||56||
59632562|NCT02453737|75746614|FG001|STARTED|Overall Study||58||
59632563|NCT02453737|75746615|FG002|STARTED|Overall Study||52||
59632564|NCT02453737|75746613|FG000|COMPLETED|Overall Study||56||
59632565|NCT02453737|75746614|FG001|COMPLETED|Overall Study||56||
59632566|NCT02453737|75746615|FG002|COMPLETED|Overall Study||49||
59632567|NCT02453737|75746613|FG000|NOT COMPLETED|Overall Study||0||
59632568|NCT02453737|75746614|FG001|NOT COMPLETED|Overall Study||2||
59632569|NCT02453737|75746615|FG002|NOT COMPLETED|Overall Study||3||
59632570|NCT01967888|75746625|FG000|STARTED|Overall Study||52||
59632571|NCT01967888|75746626|FG001|STARTED|Overall Study||52||
59632572|NCT01967888|75746625|FG000|COMPLETED|Overall Study||42||
59632573|NCT01967888|75746626|FG001|COMPLETED|Overall Study||45||
59632574|NCT01967888|75746625|FG000|NOT COMPLETED|Overall Study||10||
59632575|NCT01967888|75746626|FG001|NOT COMPLETED|Overall Study||7||
59632576|NCT00687453|75746634|FG000|STARTED|Overall Study||11||
59632577|NCT00687453|75746635|FG001|STARTED|Overall Study||13||
59632578|NCT00687453|75746634|FG000|COMPLETED|Overall Study||8||
59632579|NCT00687453|75746635|FG001|COMPLETED|Overall Study||7||
59632580|NCT00687453|75746634|FG000|NOT COMPLETED|Overall Study||3||
59632581|NCT00687453|75746635|FG001|NOT COMPLETED|Overall Study||6||
59632582|NCT00653068|75746649|FG000|STARTED|Overall Study||70||
59815698|NCT03379506|75938168|FG001|COMPLETED|Overall Study||17||
59815699|NCT03379506|75938169|FG002|COMPLETED|Overall Study||7||
60076374|NCT01904773|76191372|FG008|NOT COMPLETED|Placebo Washout Fifth Intervention||0||
59632583|NCT00653068|75746649|FG000|COMPLETED|Overall Study||20||
59632584|NCT00653068|75746649|FG000|NOT COMPLETED|Overall Study||50||
59632585|NCT00414648|75746658|FG000|STARTED|Overall Study|46 participants were randomized to the sirolimus treatment arm.|46||
59632586|NCT00414648|75746659|FG001|STARTED|Overall Study|43 participants were randomized to the placebo treatment arm.|43||
59632587|NCT00414648|75746658|FG000|COMPLETED|Overall Study|41 participants in the sirolimus treatment arm had 12 month data available for analysis.|41||
59632588|NCT00414648|75746659|FG001|COMPLETED|Overall Study|34 participants in the placebo treatment arm had 12 month data available for analysis.|34||
59632589|NCT00414648|75746658|FG000|NOT COMPLETED|Overall Study||5||
59632590|NCT00414648|75746659|FG001|NOT COMPLETED|Overall Study||9||
59632591|NCT01537302|75746671|FG000|STARTED|Overall Study||100||
59632592|NCT01537302|75746671|FG000|COMPLETED|Overall Study||100||
59632593|NCT01537302|75746671|FG000|NOT COMPLETED|Overall Study||0||
59632594|NCT01537926|75746677|FG000|STARTED|Overall Study||29||
59632595|NCT01537926|75746678|FG001|STARTED|Overall Study||13||
59632596|NCT01537926|75746677|FG000|COMPLETED|Overall Study||24||
59632597|NCT01537926|75746678|FG001|COMPLETED|Overall Study||11||
59632598|NCT01537926|75746677|FG000|NOT COMPLETED|Overall Study||5||
59632599|NCT01537926|75746678|FG001|NOT COMPLETED|Overall Study||2||
59632600|NCT01538862|75746685|FG000|STARTED|Overall Study||7||
59632601|NCT01538862|75746685|FG000|COMPLETED|Overall Study||7||
59632602|NCT01538862|75746685|FG000|NOT COMPLETED|Overall Study||0||
59632603|NCT01540266|75746696|FG000|STARTED|Overall Study||63||
60076375|NCT01904773|76191364|FG000|STARTED|Sixth Intervention||0||
60076376|NCT01904773|76191365|FG001|STARTED|Sixth Intervention||0||
60076377|NCT01904773|76191366|FG002|STARTED|Sixth Intervention||1||
60076378|NCT01904773|76191367|FG003|STARTED|Sixth Intervention||2||
60076379|NCT01904773|76191368|FG004|STARTED|Sixth Intervention||3||
60076380|NCT01904773|76191369|FG005|STARTED|Sixth Intervention||4||
60076381|NCT01904773|76191370|FG006|STARTED|Sixth Intervention||3||
59632604|NCT01540266|75746697|FG001|STARTED|Overall Study||42||
59632605|NCT01540266|75746698|FG002|STARTED|Overall Study||60||
59632606|NCT01540266|75746699|FG003|STARTED|Overall Study||38||
59632607|NCT01540266|75746700|FG004|STARTED|Overall Study||20||
59632608|NCT01540266|75746701|FG005|STARTED|Overall Study||19||
59632609|NCT01540266|75746696|FG000|COMPLETED|Overall Study||57||
59632610|NCT01540266|75746697|FG001|COMPLETED|Overall Study||41||
59632611|NCT01540266|75746698|FG002|COMPLETED|Overall Study||59||
59632612|NCT01540266|75746699|FG003|COMPLETED|Overall Study||38||
59632613|NCT01540266|75746700|FG004|COMPLETED|Overall Study||20||
59632614|NCT01540266|75746701|FG005|COMPLETED|Overall Study||19||
59632615|NCT01540266|75746696|FG000|NOT COMPLETED|Overall Study||6||
59632616|NCT01540266|75746697|FG001|NOT COMPLETED|Overall Study||1||
59632617|NCT01540266|75746698|FG002|NOT COMPLETED|Overall Study||1||
59632618|NCT01540266|75746699|FG003|NOT COMPLETED|Overall Study||0||
59632619|NCT01540266|75746700|FG004|NOT COMPLETED|Overall Study||0||
59632620|NCT01540266|75746701|FG005|NOT COMPLETED|Overall Study||0||
59632621|NCT01541358|75746715|FG000|STARTED|Overall Study||2||
59632622|NCT01541358|75746715|FG000|COMPLETED|Overall Study||2||
59632623|NCT01541358|75746715|FG000|NOT COMPLETED|Overall Study||0||
59632624|NCT01542372|75746720|FG000|STARTED|Overall Study||11||
59632625|NCT01542372|75746721|FG001|STARTED|Overall Study||11||
59632626|NCT01542372|75746720|FG000|COMPLETED|Overall Study||11||
59815700|NCT03379506|75938170|FG003|COMPLETED|Overall Study||11||
60076382|NCT01904773|76191371|FG007|STARTED|Sixth Intervention||2||
60076383|NCT01904773|76191372|FG008|STARTED|Sixth Intervention||4||
59632627|NCT01542372|75746721|FG001|COMPLETED|Overall Study||11||
59632628|NCT01542372|75746720|FG000|NOT COMPLETED|Overall Study||0||
59632629|NCT01542372|75746721|FG001|NOT COMPLETED|Overall Study||0||
59632630|NCT01542684|75746726|FG000|STARTED|Overall Study||8||
60076384|NCT01904773|76191364|FG000|COMPLETED|Sixth Intervention||0||
59632631|NCT01542684|75746726|FG000|COMPLETED|Overall Study||8||
59632632|NCT01542684|75746726|FG000|NOT COMPLETED|Overall Study||0||
59632633|NCT01543074|75746734|FG000|STARTED|Overall Study||5||
59632634|NCT01543074|75746735|FG001|STARTED|Overall Study||7||
59632635|NCT01543074|75746736|FG002|STARTED|Overall Study||5||
59632636|NCT01543074|75746737|FG003|STARTED|Overall Study||6||
59632637|NCT01543074|75746734|FG000|COMPLETED|Overall Study||5||
59632638|NCT01543074|75746735|FG001|COMPLETED|Overall Study||7||
59632639|NCT01543074|75746736|FG002|COMPLETED|Overall Study||5||
59632640|NCT01543074|75746737|FG003|COMPLETED|Overall Study||6||
59632641|NCT01543074|75746734|FG000|NOT COMPLETED|Overall Study||0||
59632642|NCT01543074|75746735|FG001|NOT COMPLETED|Overall Study||0||
59632643|NCT01543074|75746736|FG002|NOT COMPLETED|Overall Study||0||
59632644|NCT01543074|75746737|FG003|NOT COMPLETED|Overall Study||0||
59632645|NCT01544088|75746753|FG000|STARTED|Overall Study||98||
59632646|NCT01544088|75746754|FG001|STARTED|Overall Study||100||
59632647|NCT01544088|75746753|FG000|COMPLETED|Overall Study||61||
59632648|NCT01544088|75746754|FG001|COMPLETED|Overall Study||79||
59632649|NCT01544088|75746753|FG000|NOT COMPLETED|Overall Study||37||
59632650|NCT01544088|75746754|FG001|NOT COMPLETED|Overall Study||21||
59632651|NCT01544166|75746760|FG000|STARTED|Overall Study||44||
59632652|NCT01544166|75746760|FG000|COMPLETED|Overall Study||44||
59632653|NCT01544166|75746760|FG000|NOT COMPLETED|Overall Study||0||
59632654|NCT01545336|75746769|FG000|STARTED|Overall Study||12||
59632655|NCT01545336|75746770|FG001|STARTED|Overall Study||6||
59632656|NCT01545336|75746769|FG000|COMPLETED|Overall Study||12||
59632657|NCT01545336|75746770|FG001|COMPLETED|Overall Study||6||
59632658|NCT01545336|75746769|FG000|NOT COMPLETED|Overall Study||0||
59632659|NCT01545336|75746770|FG001|NOT COMPLETED|Overall Study||0||
59632660|NCT01546194|75746780|FG000|STARTED|Overall Study||100||
59632661|NCT01546194|75746781|FG001|STARTED|Overall Study||100||
59632662|NCT01546194|75746780|FG000|COMPLETED|Overall Study||64||
59632663|NCT01546194|75746781|FG001|COMPLETED|Overall Study||65||
59632664|NCT01546194|75746780|FG000|NOT COMPLETED|Overall Study||36||
59632665|NCT01546194|75746781|FG001|NOT COMPLETED|Overall Study||35||
59632666|NCT01548690|75746791|FG000|STARTED|Overall Study||9||
59632667|NCT01548690|75746792|FG001|STARTED|Overall Study||10||
59632668|NCT01548690|75746793|FG002|STARTED|Overall Study||13||
59632669|NCT01548690|75746794|FG003|STARTED|Overall Study||15||
59632670|NCT01548690|75746791|FG000|Evaluable (72 Hours on Infusion)|Overall Study||6||
59632671|NCT01548690|75746792|FG001|Evaluable (72 Hours on Infusion)|Overall Study||6||
59632672|NCT01548690|75746793|FG002|Evaluable (72 Hours on Infusion)|Overall Study||12||
59632673|NCT01548690|75746794|FG003|Evaluable (72 Hours on Infusion)|Overall Study||12||
59632674|NCT01548690|75746791|FG000|COMPLETED|Overall Study||9||
59632675|NCT01548690|75746792|FG001|COMPLETED|Overall Study||7||
59632676|NCT01548690|75746793|FG002|COMPLETED|Overall Study||8||
59632677|NCT01548690|75746794|FG003|COMPLETED|Overall Study||10||
59632678|NCT01548690|75746791|FG000|NOT COMPLETED|Overall Study||0||
59632679|NCT01548690|75746792|FG001|NOT COMPLETED|Overall Study||3||
59632680|NCT01548690|75746793|FG002|NOT COMPLETED|Overall Study||5||
59632681|NCT01548690|75746794|FG003|NOT COMPLETED|Overall Study||5||
59632682|NCT01549314|75746810|FG000|STARTED|Overall Study|1 subject signed the consent form but dropped out prior to any study procedures or data collection.|27||
59632683|NCT01549314|75746811|FG001|STARTED|Overall Study||26||
59632684|NCT01549314|75746812|FG002|STARTED|Overall Study||26||
59632685|NCT01549314|75746810|FG000|COMPLETED|Overall Study||23||
59632686|NCT01549314|75746811|FG001|COMPLETED|Overall Study||21||
59632687|NCT01549314|75746812|FG002|COMPLETED|Overall Study||24||
59632688|NCT01549314|75746810|FG000|NOT COMPLETED|Overall Study||4||
59632689|NCT01549314|75746811|FG001|NOT COMPLETED|Overall Study||5||
59632690|NCT01549314|75746812|FG002|NOT COMPLETED|Overall Study||2||
59632691|NCT01550952|75746820|FG000|STARTED|Overall Study||10||
59632692|NCT01550952|75746820|FG000|COMPLETED|Overall Study||10||
59632693|NCT01550952|75746820|FG000|NOT COMPLETED|Overall Study||0||
59632694|NCT01551030|75746824|FG000|STARTED|Overall Study||19||
60076385|NCT01904773|76191365|FG001|COMPLETED|Sixth Intervention||0||
60076386|NCT01904773|76191366|FG002|COMPLETED|Sixth Intervention||1||
59632695|NCT01551030|75746824|FG000|COMPLETED|Overall Study||19||
59632696|NCT01551030|75746824|FG000|NOT COMPLETED|Overall Study||0||
59632697|NCT01551186|75746830|FG000|STARTED|Overall Study||50||
59632698|NCT01551186|75746831|FG001|STARTED|Overall Study||53||
59632699|NCT01551186|75746830|FG000|COMPLETED|Overall Study||30||
59632700|NCT01551186|75746831|FG001|COMPLETED|Overall Study||40||
59632701|NCT01551186|75746830|FG000|NOT COMPLETED|Overall Study||20||
59632702|NCT01551186|75746831|FG001|NOT COMPLETED|Overall Study||13||
59632703|NCT01551264|75746839|FG000|STARTED|Overall Study||70|Enrolled and Randomized|
59632704|NCT01551264|75746840|FG001|STARTED|Overall Study||69|Enrolled and Randomized|
59632705|NCT01551264|75746839|FG000|Started Bracing|Overall Study||69||
59632706|NCT01551264|75746840|FG001|Started Bracing|Overall Study||67||
59632707|NCT01551264|75746839|FG000|Data for at Least One Follow-up After Brace Discontinuation Ascertained|Overall Study|Attended at least one visit within one year after discontinuing bracing|44||
59632708|NCT01551264|75746840|FG001|Data for at Least One Follow-up After Brace Discontinuation Ascertained|Overall Study|Attended at least one visit within one year after discontinuing bracing|55||
59632709|NCT01551264|75746839|FG000|COMPLETED|Overall Study|Attended 60 month follow-up visit|38|One year follow-up after brace discontinuation ascertained|
59632710|NCT01551264|75746840|FG001|COMPLETED|Overall Study|Attended 36 month follow-up visit|41|One year follow-up after brace discontinuation ascertained|
59632711|NCT01551264|75746839|FG000|NOT COMPLETED|Overall Study||32||
59632712|NCT01551264|75746840|FG001|NOT COMPLETED|Overall Study||28||
59632713|NCT01551888|75746846|FG000|STARTED|Period 1||12||
59632714|NCT01551888|75746847|FG001|STARTED|Period 1||12||
59632715|NCT01551888|75746846|FG000|COMPLETED|Period 1||12||
59632716|NCT01551888|75746847|FG001|COMPLETED|Period 1||12||
59632717|NCT01551888|75746846|FG000|NOT COMPLETED|Period 1||0||
59632718|NCT01551888|75746847|FG001|NOT COMPLETED|Period 1||0||
59632719|NCT01551888|75746846|FG000|STARTED|Period 2||12||
59632720|NCT01551888|75746847|FG001|STARTED|Period 2||12||
59632721|NCT01551888|75746846|FG000|COMPLETED|Period 2||12||
59632722|NCT01551888|75746847|FG001|COMPLETED|Period 2||12||
59632723|NCT01551888|75746846|FG000|NOT COMPLETED|Period 2||0||
59632724|NCT01551888|75746847|FG001|NOT COMPLETED|Period 2||0||
59632725|NCT01553058|75746856|FG000|STARTED|Overall Study||33||
59632726|NCT01553058|75746857|FG001|STARTED|Overall Study||31||
59632727|NCT01553058|75746858|FG002|STARTED|Overall Study||33||
59632728|NCT01553058|75746856|FG000|COMPLETED|Overall Study||32||
59632729|NCT01553058|75746857|FG001|COMPLETED|Overall Study||30||
59632730|NCT01553058|75746858|FG002|COMPLETED|Overall Study||30||
59632731|NCT01553058|75746856|FG000|NOT COMPLETED|Overall Study||1||
59632732|NCT01553058|75746857|FG001|NOT COMPLETED|Overall Study||1||
59632733|NCT01553058|75746858|FG002|NOT COMPLETED|Overall Study||3||
59632734|NCT01553292|75746870|FG000|STARTED|Overall Study||21||
59632735|NCT01553292|75746870|FG000|COMPLETED|Overall Study||21||
59632736|NCT01553292|75746870|FG000|NOT COMPLETED|Overall Study||0||
59632737|NCT01556100|75746876|FG000|STARTED|Overall Study||40||
59632738|NCT01556100|75746876|FG000|COMPLETED|Overall Study||34||
59632739|NCT01556100|75746876|FG000|NOT COMPLETED|Overall Study||6||
59632740|NCT01556724|75746882|FG000|STARTED|Overall Study||16||
59632741|NCT01556724|75746883|FG001|STARTED|Overall Study||14||
59632742|NCT01556724|75746882|FG000|COMPLETED|Overall Study||16||
59632743|NCT01556724|75746883|FG001|COMPLETED|Overall Study||14||
59632744|NCT01556724|75746882|FG000|NOT COMPLETED|Overall Study||0||
59632745|NCT01556724|75746883|FG001|NOT COMPLETED|Overall Study||0||
59632746|NCT01557894|75746894|FG000|STARTED|Overall Study||38||
59632747|NCT01557894|75746895|FG001|STARTED|Overall Study||38||
59632748|NCT01557894|75746894|FG000|COMPLETED|Overall Study||35||
59632749|NCT01557894|75746895|FG001|COMPLETED|Overall Study||33||
59632750|NCT01557894|75746894|FG000|NOT COMPLETED|Overall Study||3||
59632751|NCT01557894|75746895|FG001|NOT COMPLETED|Overall Study||5||
59632752|NCT01558128|75746902|FG000|STARTED|Overall Study||1||
59632753|NCT01558128|75746902|FG000|COMPLETED|Overall Study||1||
59632754|NCT01558128|75746902|FG000|NOT COMPLETED|Overall Study||0||
59632755|NCT01559064|75746909|FG000|STARTED|Overall Study||16||
59632756|NCT01559064|75746910|FG001|STARTED|Overall Study||40||
59632757|NCT01559064|75746911|FG002|STARTED|Overall Study||59||
59632758|NCT01559064|75746909|FG000|COMPLETED|Overall Study||15||
59632759|NCT01559064|75746910|FG001|COMPLETED|Overall Study||39||
59632760|NCT01559064|75746911|FG002|COMPLETED|Overall Study||57||
59632761|NCT01559064|75746909|FG000|NOT COMPLETED|Overall Study||1||
59632762|NCT01559064|75746910|FG001|NOT COMPLETED|Overall Study||1||
59632763|NCT01559064|75746911|FG002|NOT COMPLETED|Overall Study||2||
59632764|NCT01559922|75746921|FG000|STARTED|Overall Study||50||
59632765|NCT01559922|75746922|FG001|STARTED|Overall Study||97||
59632766|NCT01559922|75746921|FG000|COMPLETED|Overall Study||46||
59632767|NCT01559922|75746922|FG001|COMPLETED|Overall Study||87||
59632768|NCT01559922|75746921|FG000|NOT COMPLETED|Overall Study||4||
59632769|NCT01559922|75746922|FG001|NOT COMPLETED|Overall Study||10||
59632770|NCT01560624|75746930|FG000|STARTED|Overall Study||346||
59632771|NCT01560624|75746931|FG001|STARTED|Overall Study||344||
59632772|NCT01560624|75746930|FG000|Clinical Worsening Event|Overall Study||91|Including death|
59632773|NCT01560624|75746931|FG001|Clinical Worsening Event|Overall Study||133|Including death|
59632774|NCT01560624|75746930|FG000|Early Discontinuation From Treatment|Overall Study||107|Due to progressive disease, AE, withdrawal by subject, protocol violation, lost to follow-up|
59632775|NCT01560624|75746931|FG001|Early Discontinuation From Treatment|Overall Study||56|Due to progressive disease, AE, withdrawal by subject, protocol violation, lost to follow-up|
59632776|NCT01560624|75746930|FG000|COMPLETED|Overall Study||148|Completed the study without clinical worsening or early discontinuation|
59632777|NCT01560624|75746931|FG001|COMPLETED|Overall Study||155|Completed the study without clinical worsening or early discontinuation|
59632778|NCT01560624|75746930|FG000|NOT COMPLETED|Overall Study||198||
59632779|NCT01560624|75746931|FG001|NOT COMPLETED|Overall Study||189||
59632780|NCT01561716|75746943|FG000|STARTED|Overall Study||5||
59632781|NCT01561716|75746944|FG001|STARTED|Overall Study||5||
59632782|NCT01561716|75746945|FG002|STARTED|Overall Study||5||
59632783|NCT01561716|75746946|FG003|STARTED|Overall Study||5||
59632784|NCT01561716|75746947|FG004|STARTED|Overall Study||5||
59632785|NCT01561716|75746948|FG005|STARTED|Overall Study||5||
59632786|NCT01561716|75746943|FG000|COMPLETED|Overall Study||5||
59632787|NCT01561716|75746944|FG001|COMPLETED|Overall Study||5||
59632788|NCT01561716|75746945|FG002|COMPLETED|Overall Study||5||
59632789|NCT01561716|75746946|FG003|COMPLETED|Overall Study||5||
59632790|NCT01561716|75746947|FG004|COMPLETED|Overall Study||5||
59632791|NCT01561716|75746948|FG005|COMPLETED|Overall Study||5||
59632792|NCT01561716|75746943|FG000|NOT COMPLETED|Overall Study||0||
59632793|NCT01561716|75746944|FG001|NOT COMPLETED|Overall Study||0||
59632794|NCT01561716|75746945|FG002|NOT COMPLETED|Overall Study||0||
59632795|NCT01561716|75746946|FG003|NOT COMPLETED|Overall Study||0||
59632796|NCT01561716|75746947|FG004|NOT COMPLETED|Overall Study||0||
59632797|NCT01561716|75746948|FG005|NOT COMPLETED|Overall Study||0||
59632798|NCT01562886|75746962|FG000|STARTED|Overall Study||14||
59632799|NCT01562886|75746962|FG000|COMPLETED|Overall Study||13||
59632800|NCT01562886|75746962|FG000|NOT COMPLETED|Overall Study||1||
59632801|NCT01563198|75746966|FG000|STARTED|Baseline||49733||3
59632802|NCT01563198|75746966|FG000|COMPLETED|Baseline||49733||3
59632803|NCT01563198|75746966|FG000|NOT COMPLETED|Baseline||0||0
59632804|NCT01563198|75746966|FG000|STARTED|After Training||47979||3
59632805|NCT01563198|75746966|FG000|COMPLETED|After Training||47979||3
59632806|NCT01563198|75746966|FG000|NOT COMPLETED|After Training||0||0
59632807|NCT01564914|75746972|FG000|STARTED|Overall Study||16||
59632808|NCT01564914|75746973|FG001|STARTED|Overall Study||6||
59632809|NCT01564914|75746972|FG000|COMPLETED|Overall Study||16||
59632810|NCT01564914|75746973|FG001|COMPLETED|Overall Study||6||
59988300|NCT02365558|76103424|FG001|STARTED|Period 2 (Day 8 Through Day 20)|Participants completed Period 1 and entered Evacetrapib + Omeprazole for Period 2.|33||
59632811|NCT01564914|75746972|FG000|NOT COMPLETED|Overall Study||0||
59632812|NCT01564914|75746973|FG001|NOT COMPLETED|Overall Study||0||
59632813|NCT01565538|75746984|FG000|STARTED|Overall Study||61||
59632814|NCT01565538|75746985|FG001|STARTED|Overall Study||62||
59632815|NCT01565538|75746984|FG000|COMPLETED|Overall Study||61||
59632816|NCT01565538|75746985|FG001|COMPLETED|Overall Study||62||
59632817|NCT01565538|75746984|FG000|NOT COMPLETED|Overall Study||0||
59632818|NCT01565538|75746985|FG001|NOT COMPLETED|Overall Study||0||
59632819|NCT01565616|75746991|FG000|STARTED|Overall Study||22||
59632820|NCT01565616|75746991|FG000|First Component: 5 Related Donors|Overall Study||5|The first component was restricted to patients having an HLA-identical sibling donor.|
59632821|NCT01565616|75746991|FG000|Second Component: Related or Unrelated|Overall Study||17|The second component included patients having a related or unrelated HLA matched donor.|
59632822|NCT01565616|75746991|FG000|COMPLETED|Overall Study||22||
59632823|NCT01565616|75746991|FG000|NOT COMPLETED|Overall Study||0||
59632824|NCT01566084|75746997|FG000|STARTED|Overall Study||7||
59632825|NCT01566084|75746998|FG001|STARTED|Overall Study||10||
59632826|NCT01566084|75746997|FG000|COMPLETED|Overall Study||7||
59632827|NCT01566084|75746998|FG001|COMPLETED|Overall Study||10||
59632828|NCT01566084|75746997|FG000|NOT COMPLETED|Overall Study||0||
59632829|NCT01566084|75746998|FG001|NOT COMPLETED|Overall Study||0||
59632830|NCT01566162|75747012|FG000|STARTED|Overall Study||191||
59632831|NCT01566162|75747012|FG000|COMPLETED|Overall Study||155||
59632832|NCT01566162|75747012|FG000|NOT COMPLETED|Overall Study||36||
59632833|NCT01566630|75747018|FG000|STARTED|Overall Study||2||
59632834|NCT01566630|75747019|FG001|STARTED|Overall Study||1||
59632835|NCT01566630|75747018|FG000|COMPLETED|Overall Study||2||
59632836|NCT01566630|75747019|FG001|COMPLETED|Overall Study||1||
59632837|NCT01566630|75747018|FG000|NOT COMPLETED|Overall Study||0||
59632838|NCT01566630|75747019|FG001|NOT COMPLETED|Overall Study||0||
59632839|NCT01567020|75747035|FG000|STARTED|Overall Study||28||
59632840|NCT01567020|75747036|FG001|STARTED|Overall Study||46||
59632841|NCT01567020|75747037|FG002|STARTED|Overall Study||20||
59632842|NCT01567020|75747038|FG003|STARTED|Overall Study||11||
59988301|NCT02365558|76103423|FG000|COMPLETED|Period 2 (Day 8 Through Day 20)||0||
59988302|NCT02365558|76103424|FG001|COMPLETED|Period 2 (Day 8 Through Day 20)||32||
59988303|NCT02365558|76103423|FG000|NOT COMPLETED|Period 2 (Day 8 Through Day 20)||0||
59988304|NCT02365558|76103424|FG001|NOT COMPLETED|Period 2 (Day 8 Through Day 20)||1||
59988305|NCT02365480|76103435|FG000|STARTED|Overall Study||14||
59632843|NCT01567020|75747035|FG000|COMPLETED|Overall Study||21||
59632844|NCT01567020|75747036|FG001|COMPLETED|Overall Study||41||
59632845|NCT01567020|75747037|FG002|COMPLETED|Overall Study||18||
59632846|NCT01567020|75747038|FG003|COMPLETED|Overall Study||10||
59632847|NCT01567020|75747035|FG000|NOT COMPLETED|Overall Study||7||
59632848|NCT01567020|75747036|FG001|NOT COMPLETED|Overall Study||5||
59632849|NCT01567020|75747037|FG002|NOT COMPLETED|Overall Study||2||
59632850|NCT01567020|75747038|FG003|NOT COMPLETED|Overall Study||1||
59632851|NCT01569126|75747054|FG000|STARTED|Overall Study||8||
59632852|NCT01569126|75747055|FG001|STARTED|Overall Study||8||
59632853|NCT01569126|75747056|FG002|STARTED|Overall Study||8||
59632854|NCT01569126|75747057|FG003|STARTED|Overall Study||8||
59632855|NCT01569126|75747058|FG004|STARTED|Overall Study||12||
59632856|NCT01569126|75747059|FG005|STARTED|Overall Study||12||
59988306|NCT02365480|76103436|FG001|STARTED|Overall Study||4||
59988307|NCT02365480|76103435|FG000|COMPLETED|Overall Study||12||
59632857|NCT01569126|75747054|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8||
59632858|NCT01569126|75747055|FG001|Received at Least 1 Dose of Study Drug|Overall Study||8||
59632859|NCT01569126|75747056|FG002|Received at Least 1 Dose of Study Drug|Overall Study||8||
59632860|NCT01569126|75747057|FG003|Received at Least 1 Dose of Study Drug|Overall Study||8||
59632861|NCT01569126|75747058|FG004|Received at Least 1 Dose of Study Drug|Overall Study||12||
59632862|NCT01569126|75747059|FG005|Received at Least 1 Dose of Study Drug|Overall Study||12||
59632863|NCT01569126|75747054|FG000|COMPLETED|Overall Study||8||
59632864|NCT01569126|75747055|FG001|COMPLETED|Overall Study||8||
59632865|NCT01569126|75747056|FG002|COMPLETED|Overall Study||8||
59632866|NCT01569126|75747057|FG003|COMPLETED|Overall Study||8||
59632867|NCT01569126|75747058|FG004|COMPLETED|Overall Study||12||
59632868|NCT01569126|75747059|FG005|COMPLETED|Overall Study||12||
59632869|NCT01569126|75747054|FG000|NOT COMPLETED|Overall Study||0||
59632870|NCT01569126|75747055|FG001|NOT COMPLETED|Overall Study||0||
59632871|NCT01569126|75747056|FG002|NOT COMPLETED|Overall Study||0||
59632872|NCT01569126|75747057|FG003|NOT COMPLETED|Overall Study||0||
59632873|NCT01569126|75747058|FG004|NOT COMPLETED|Overall Study||0||
59632874|NCT01569126|75747059|FG005|NOT COMPLETED|Overall Study||0||
59632875|NCT01569828|75747080|FG000|STARTED|Overall Study||6||
59632876|NCT01569828|75747081|FG001|STARTED|Overall Study||6||
59632877|NCT01569828|75747080|FG000|COMPLETED|Overall Study||6||
59632878|NCT01569828|75747081|FG001|COMPLETED|Overall Study||6||
59632879|NCT01569828|75747080|FG000|NOT COMPLETED|Overall Study||0||
59632880|NCT01569828|75747081|FG001|NOT COMPLETED|Overall Study||0||
59632881|NCT01573260|75747090|FG000|STARTED|Overall Study||18||
59632882|NCT01573260|75747091|FG001|STARTED|Overall Study||15||
59632883|NCT01573260|75747090|FG000|COMPLETED|Overall Study||18||
59632884|NCT01573260|75747091|FG001|COMPLETED|Overall Study||15||
59632885|NCT01573260|75747090|FG000|NOT COMPLETED|Overall Study||0||
59632886|NCT01573260|75747091|FG001|NOT COMPLETED|Overall Study||0||
59632887|NCT01573572|75747099|FG000|STARTED|Overall Study||131||
59632888|NCT01573572|75747099|FG000|COMPLETED|Overall Study||103||
59632889|NCT01573572|75747099|FG000|NOT COMPLETED|Overall Study||28||
59632890|NCT01575522|75747103|FG000|STARTED|Overall Study||22||
59632891|NCT01575522|75747103|FG000|COMPLETED|Overall Study||22||
59632892|NCT01575522|75747103|FG000|NOT COMPLETED|Overall Study||0||
59632893|NCT01575756|75747110|FG000|STARTED|Treatment Period 1||11||
59632894|NCT01575756|75747111|FG001|STARTED|Treatment Period 1||11||
59632895|NCT01575756|75747110|FG000|COMPLETED|Treatment Period 1||11||
59632896|NCT01575756|75747111|FG001|COMPLETED|Treatment Period 1||11||
59632897|NCT01575756|75747110|FG000|NOT COMPLETED|Treatment Period 1||0||
59632898|NCT01575756|75747111|FG001|NOT COMPLETED|Treatment Period 1||0||
59632899|NCT01575756|75747110|FG000|STARTED|Treatment Period 2||11||
59632900|NCT01575756|75747111|FG001|STARTED|Treatment Period 2||11||
59632901|NCT01575756|75747110|FG000|COMPLETED|Treatment Period 2||11||
59632902|NCT01575756|75747111|FG001|COMPLETED|Treatment Period 2||11||
59632903|NCT01575756|75747110|FG000|NOT COMPLETED|Treatment Period 2||0||
59632904|NCT01575756|75747111|FG001|NOT COMPLETED|Treatment Period 2||0||
59632905|NCT01575912|75747121|FG000|STARTED|Overall Study||30||
59632906|NCT01575912|75747122|FG001|STARTED|Overall Study||32||
59632907|NCT01575912|75747123|FG002|STARTED|Overall Study||30||
59632908|NCT01575912|75747121|FG000|COMPLETED|Overall Study||30||
59632909|NCT01575912|75747122|FG001|COMPLETED|Overall Study||32||
59632910|NCT01575912|75747123|FG002|COMPLETED|Overall Study||30||
59632911|NCT01575912|75747121|FG000|NOT COMPLETED|Overall Study||0||
59632912|NCT01575912|75747122|FG001|NOT COMPLETED|Overall Study||0||
59632913|NCT01575912|75747123|FG002|NOT COMPLETED|Overall Study||0||
59632914|NCT01576536|75747131|FG000|STARTED|Overall Study||117||
59632915|NCT01576536|75747131|FG000|COMPLETED|Overall Study||117||
59632916|NCT01576536|75747131|FG000|NOT COMPLETED|Overall Study||0||
59632917|NCT01577238|75747137|FG000|STARTED|Overall Study||127||
59632918|NCT01577238|75747138|FG001|STARTED|Overall Study||123||
59632919|NCT01577238|75747137|FG000|COMPLETED|Overall Study||117||
59632920|NCT01577238|75747138|FG001|COMPLETED|Overall Study||111||
59632921|NCT01577238|75747137|FG000|NOT COMPLETED|Overall Study||10||
59632922|NCT01577238|75747138|FG001|NOT COMPLETED|Overall Study||12||
59632923|NCT01577706|75747144|FG000|STARTED|First Intervention (1 Day)||3||
59632924|NCT01577706|75747145|FG001|STARTED|First Intervention (1 Day)||1||
59632925|NCT01577706|75747146|FG002|STARTED|First Intervention (1 Day)||3||
59632926|NCT01577706|75747144|FG000|COMPLETED|First Intervention (1 Day)||3||
59632927|NCT01577706|75747145|FG001|COMPLETED|First Intervention (1 Day)||1||
59632928|NCT01577706|75747146|FG002|COMPLETED|First Intervention (1 Day)||3||
59632929|NCT01577706|75747144|FG000|NOT COMPLETED|First Intervention (1 Day)||0||
59632930|NCT01577706|75747145|FG001|NOT COMPLETED|First Intervention (1 Day)||0||
59632931|NCT01577706|75747146|FG002|NOT COMPLETED|First Intervention (1 Day)||0||
59632932|NCT01577706|75747144|FG000|STARTED|Washout (at Least 1 Week)||3||
59632933|NCT01577706|75747145|FG001|STARTED|Washout (at Least 1 Week)||1||
59632934|NCT01577706|75747146|FG002|STARTED|Washout (at Least 1 Week)||3||
59632935|NCT01577706|75747144|FG000|COMPLETED|Washout (at Least 1 Week)||3||
59632936|NCT01577706|75747145|FG001|COMPLETED|Washout (at Least 1 Week)||1||
59632937|NCT01577706|75747146|FG002|COMPLETED|Washout (at Least 1 Week)||3||
59632938|NCT01577706|75747144|FG000|NOT COMPLETED|Washout (at Least 1 Week)||0||
59632939|NCT01577706|75747145|FG001|NOT COMPLETED|Washout (at Least 1 Week)||0||
59632940|NCT01577706|75747146|FG002|NOT COMPLETED|Washout (at Least 1 Week)||0||
59632941|NCT01577706|75747144|FG000|STARTED|Second Intervention (1 Day)||3||
59632942|NCT01577706|75747145|FG001|STARTED|Second Intervention (1 Day)||1||
59632943|NCT01577706|75747146|FG002|STARTED|Second Intervention (1 Day)||3||
59632944|NCT01577706|75747144|FG000|COMPLETED|Second Intervention (1 Day)||3||
59632945|NCT01577706|75747145|FG001|COMPLETED|Second Intervention (1 Day)||1||
59632946|NCT01577706|75747146|FG002|COMPLETED|Second Intervention (1 Day)||3||
59632947|NCT01577706|75747144|FG000|NOT COMPLETED|Second Intervention (1 Day)||0||
59632948|NCT01577706|75747145|FG001|NOT COMPLETED|Second Intervention (1 Day)||0||
59632949|NCT01577706|75747146|FG002|NOT COMPLETED|Second Intervention (1 Day)||0||
59632950|NCT01577706|75747144|FG000|STARTED|Washout (at Least 1 Week)||3||
59632951|NCT01577706|75747145|FG001|STARTED|Washout (at Least 1 Week)||1||
59632952|NCT01577706|75747146|FG002|STARTED|Washout (at Least 1 Week)||3||
59632953|NCT01577706|75747144|FG000|COMPLETED|Washout (at Least 1 Week)||3||
59632954|NCT01577706|75747145|FG001|COMPLETED|Washout (at Least 1 Week)||1||
59632955|NCT01577706|75747146|FG002|COMPLETED|Washout (at Least 1 Week)||3||
59632956|NCT01577706|75747144|FG000|NOT COMPLETED|Washout (at Least 1 Week)||0||
59632957|NCT01577706|75747145|FG001|NOT COMPLETED|Washout (at Least 1 Week)||0||
59632958|NCT01577706|75747146|FG002|NOT COMPLETED|Washout (at Least 1 Week)||0||
59632959|NCT01577706|75747144|FG000|STARTED|Third Intervention (1 Day)||3||
59632960|NCT01577706|75747145|FG001|STARTED|Third Intervention (1 Day)||1||
59632961|NCT01577706|75747146|FG002|STARTED|Third Intervention (1 Day)||3||
59632962|NCT01577706|75747144|FG000|COMPLETED|Third Intervention (1 Day)||3||
59632963|NCT01577706|75747145|FG001|COMPLETED|Third Intervention (1 Day)||1||
59632964|NCT01577706|75747146|FG002|COMPLETED|Third Intervention (1 Day)||3||
59632965|NCT01577706|75747144|FG000|NOT COMPLETED|Third Intervention (1 Day)||0||
59632966|NCT01577706|75747145|FG001|NOT COMPLETED|Third Intervention (1 Day)||0||
59632967|NCT01577706|75747146|FG002|NOT COMPLETED|Third Intervention (1 Day)||0||
59632968|NCT01580592|75747157|FG000|STARTED|Overall Study||10||
59632969|NCT01580592|75747158|FG001|STARTED|Overall Study||9||
59632970|NCT01580592|75747159|FG002|STARTED|Overall Study||12||
59632971|NCT01580592|75747157|FG000|COMPLETED|Overall Study||10||
59632972|NCT01580592|75747158|FG001|COMPLETED|Overall Study||9||
59632973|NCT01580592|75747159|FG002|COMPLETED|Overall Study||12||
59632974|NCT01580592|75747157|FG000|NOT COMPLETED|Overall Study||0||
59632975|NCT01580592|75747158|FG001|NOT COMPLETED|Overall Study||0||
59632976|NCT01580592|75747159|FG002|NOT COMPLETED|Overall Study||0||
59632977|NCT01580904|75747169|FG000|STARTED|Overall Study||51||
59632978|NCT01580904|75747170|FG001|STARTED|Overall Study||49||
59632979|NCT01580904|75747169|FG000|COMPLETED|Overall Study||47||
59632980|NCT01580904|75747170|FG001|COMPLETED|Overall Study||42||
59632981|NCT01580904|75747169|FG000|NOT COMPLETED|Overall Study||4||
59632982|NCT01580904|75747170|FG001|NOT COMPLETED|Overall Study||7||
59632983|NCT01583868|75747179|FG000|STARTED|Overall Study||108||
59632984|NCT01583868|75747180|FG001|STARTED|Overall Study||108||
59632985|NCT01583868|75747179|FG000|COMPLETED|Overall Study||104||
59632986|NCT01583868|75747180|FG001|COMPLETED|Overall Study||104||
59632987|NCT01583868|75747179|FG000|NOT COMPLETED|Overall Study||4||
59632988|NCT01583868|75747180|FG001|NOT COMPLETED|Overall Study||4||
59632989|NCT01588158|75747192|FG000|STARTED|Overall Study||4||
59632990|NCT01588158|75747193|FG001|STARTED|Overall Study||3||
59632991|NCT01588158|75747192|FG000|COMPLETED|Overall Study||4||
59632992|NCT01588158|75747193|FG001|COMPLETED|Overall Study||3||
59632993|NCT01588158|75747192|FG000|NOT COMPLETED|Overall Study||0||
59632994|NCT01588158|75747193|FG001|NOT COMPLETED|Overall Study||0||
59632995|NCT01588236|75747202|FG000|STARTED|Overall Study||92||
59632996|NCT01588236|75747203|FG001|STARTED|Overall Study||94||
59632997|NCT01588236|75747204|FG002|STARTED|Overall Study||94||
59632998|NCT01588236|75747202|FG000|COMPLETED|Overall Study||76||
59632999|NCT01588236|75747203|FG001|COMPLETED|Overall Study||66||
59633000|NCT01588236|75747204|FG002|COMPLETED|Overall Study||69||
59633001|NCT01588236|75747202|FG000|NOT COMPLETED|Overall Study||16||
59633002|NCT01588236|75747203|FG001|NOT COMPLETED|Overall Study||28||
59633003|NCT01588236|75747204|FG002|NOT COMPLETED|Overall Study||25||
59633004|NCT01588470|75747212|FG000|STARTED|Overall Study|First enrolled April 2007|130||
59633005|NCT01588470|75747212|FG000|COMPLETED|Overall Study|Completed Dec. 2011|50||
59633006|NCT01588470|75747212|FG000|NOT COMPLETED|Overall Study||80||
59633007|NCT01589484|75747221|FG000|STARTED|Overall Study||104||
59633008|NCT01589484|75747221|FG000|COMPLETED|Overall Study||100||
59633009|NCT01589484|75747221|FG000|NOT COMPLETED|Overall Study||4||
59633010|NCT01590264|75747226|FG000|STARTED|Overall Study||5||
59633011|NCT01590264|75747226|FG000|COMPLETED|Overall Study||5||
59633012|NCT01590264|75747226|FG000|NOT COMPLETED|Overall Study||0||
59633013|NCT01591044|75747233|FG000|STARTED|Overall Study||101||
59633014|NCT01591044|75747234|FG001|STARTED|Overall Study||100||
59633015|NCT01591044|75747235|FG002|STARTED|Overall Study||100||
59633016|NCT01591044|75747233|FG000|COMPLETED|Overall Study||94||
59633017|NCT01591044|75747234|FG001|COMPLETED|Overall Study||91||
59633018|NCT01591044|75747235|FG002|COMPLETED|Overall Study||96||
59633019|NCT01591044|75747233|FG000|NOT COMPLETED|Overall Study||7||
59633020|NCT01591044|75747234|FG001|NOT COMPLETED|Overall Study||9||
59633021|NCT01591044|75747235|FG002|NOT COMPLETED|Overall Study||4||
59633022|NCT01591746|75747245|FG000|STARTED|Overall Study||68||
59633023|NCT01591746|75747246|FG001|STARTED|Overall Study||63||
59633024|NCT01591746|75747245|FG000|COMPLETED|Overall Study||68||
59633025|NCT01591746|75747246|FG001|COMPLETED|Overall Study||63||
59633026|NCT01591746|75747245|FG000|NOT COMPLETED|Overall Study||0||
59633027|NCT01591746|75747246|FG001|NOT COMPLETED|Overall Study||0||
59633028|NCT01597128|75747254|FG000|STARTED|Overall Study||18||
59633029|NCT01597128|75747255|FG001|STARTED|Overall Study||17||
59633030|NCT01597128|75747254|FG000|COMPLETED|Overall Study||18||
59633031|NCT01597128|75747255|FG001|COMPLETED|Overall Study||17||
59633032|NCT01597128|75747254|FG000|NOT COMPLETED|Overall Study||0||
59633033|NCT01597128|75747255|FG001|NOT COMPLETED|Overall Study||0||
59633034|NCT02538666|75747264|FG000|STARTED|Pre-Treatment||300|Started = Randomized|
59633035|NCT02538666|75747265|FG001|STARTED|Pre-Treatment||304|Started = Randomized|
59633036|NCT02538666|75747266|FG002|STARTED|Pre-Treatment||303|Started = Randomized|
59633037|NCT02538666|75747264|FG000|Global|Pre-Treatment||275||
59633038|NCT02538666|75747265|FG001|Global|Pre-Treatment||280||
59633039|NCT02538666|75747266|FG002|Global|Pre-Treatment||279||
59633040|NCT02538666|75747264|FG000|China|Pre-Treatment||26||
59633041|NCT02538666|75747265|FG001|China|Pre-Treatment||25||
59633042|NCT02538666|75747266|FG002|China|Pre-Treatment||24||
59633043|NCT02538666|75747264|FG000|COMPLETED|Pre-Treatment||298|Completed = Treated|
59633044|NCT02538666|75747265|FG001|COMPLETED|Pre-Treatment||303|Completed = Treated|
59633045|NCT02538666|75747266|FG002|COMPLETED|Pre-Treatment||302|Completed = Treated|
59633046|NCT02538666|75747264|FG000|NOT COMPLETED|Pre-Treatment||2||
59633047|NCT02538666|75747265|FG001|NOT COMPLETED|Pre-Treatment||1||
59633048|NCT02538666|75747266|FG002|NOT COMPLETED|Pre-Treatment||1||
59633049|NCT02538666|75747264|FG000|STARTED|Treatment||298|Started = Started Treatment|
59633050|NCT02538666|75747265|FG001|STARTED|Treatment||303|Started = Started Treatment|
59633051|NCT02538666|75747266|FG002|STARTED|Treatment||302|Started = Started Treatment|
59633052|NCT02538666|75747264|FG000|Global|Treatment||273||
59633053|NCT02538666|75747265|FG001|Global|Treatment||279||
59633054|NCT02538666|75747266|FG002|Global|Treatment||278||
59633055|NCT02538666|75747264|FG000|China|Treatment||26||
59633056|NCT02538666|75747265|FG001|China|Treatment||25||
59633057|NCT02538666|75747266|FG002|China|Treatment||24||
59633058|NCT02538666|75747264|FG000|COMPLETED|Treatment||0|Completed = Continuing in treatment period|
59633059|NCT02538666|75747265|FG001|COMPLETED|Treatment||0|Completed = Continuing in treatment period|
59633060|NCT02538666|75747266|FG002|COMPLETED|Treatment||0|Completed = Continuing in treatment period|
59633061|NCT02538666|75747264|FG000|NOT COMPLETED|Treatment||298||
59633062|NCT02538666|75747265|FG001|NOT COMPLETED|Treatment||303||
59633063|NCT02538666|75747266|FG002|NOT COMPLETED|Treatment||302||
59633064|NCT02438358|75747290|FG000|STARTED|Overall Study||5||
59633065|NCT02438358|75747291|FG001|STARTED|Overall Study||5||
59633066|NCT02438358|75747292|FG002|STARTED|Overall Study||5||
59633067|NCT02438358|75747293|FG003|STARTED|Overall Study||45||
59633068|NCT02438358|75747290|FG000|COMPLETED|Overall Study||5||
59633069|NCT02438358|75747291|FG001|COMPLETED|Overall Study||5||
59633070|NCT02438358|75747292|FG002|COMPLETED|Overall Study||5||
59633071|NCT02438358|75747293|FG003|COMPLETED|Overall Study||44||
59633072|NCT02438358|75747290|FG000|NOT COMPLETED|Overall Study||0||
59633073|NCT02438358|75747291|FG001|NOT COMPLETED|Overall Study||0||
59633074|NCT02438358|75747292|FG002|NOT COMPLETED|Overall Study||0||
59633075|NCT02438358|75747293|FG003|NOT COMPLETED|Overall Study||1||
59633076|NCT02407236|75747320|FG000|STARTED|Induction Study (8 Weeks)||319||
59633077|NCT02407236|75747321|FG001|STARTED|Induction Study (8 Weeks)||320||
59633078|NCT02407236|75747322|FG002|STARTED|Induction Study (8 Weeks)||322||
59633079|NCT02407236|75747323|FG003|STARTED|Induction Study (8 Weeks)||0||
59633080|NCT02407236|75747324|FG004|STARTED|Induction Study (8 Weeks)||0||
59633081|NCT02407236|75747325|FG005|STARTED|Induction Study (8 Weeks)||0||
59633082|NCT02407236|75747326|FG006|STARTED|Induction Study (8 Weeks)||0||
59633083|NCT02407236|75747327|FG007|STARTED|Induction Study (8 Weeks)||0||
59633084|NCT02407236|75747328|FG008|STARTED|Induction Study (8 Weeks)||0||
59633085|NCT02407236|75747329|FG009|STARTED|Induction Study (8 Weeks)||0||
59633086|NCT02407236|75747330|FG010|STARTED|Induction Study (8 Weeks)||0||
59633087|NCT02407236|75747331|FG011|STARTED|Induction Study (8 Weeks)||0||
59633088|NCT02407236|75747332|FG012|STARTED|Induction Study (8 Weeks)||0||
59633089|NCT02407236|75747320|FG000|COMPLETED|Induction Study (8 Weeks)||296||
59633090|NCT02407236|75747321|FG001|COMPLETED|Induction Study (8 Weeks)||309||
59633091|NCT02407236|75747322|FG002|COMPLETED|Induction Study (8 Weeks)||307||
59633092|NCT02407236|75747323|FG003|COMPLETED|Induction Study (8 Weeks)||0||
59633093|NCT02407236|75747324|FG004|COMPLETED|Induction Study (8 Weeks)||0||
59633094|NCT02407236|75747325|FG005|COMPLETED|Induction Study (8 Weeks)||0||
59633095|NCT02407236|75747326|FG006|COMPLETED|Induction Study (8 Weeks)||0||
59633096|NCT02407236|75747327|FG007|COMPLETED|Induction Study (8 Weeks)||0||
59633097|NCT02407236|75747328|FG008|COMPLETED|Induction Study (8 Weeks)||0||
59633098|NCT02407236|75747329|FG009|COMPLETED|Induction Study (8 Weeks)||0||
59633099|NCT02407236|75747330|FG010|COMPLETED|Induction Study (8 Weeks)||0||
59633100|NCT02407236|75747331|FG011|COMPLETED|Induction Study (8 Weeks)||0||
59633101|NCT02407236|75747332|FG012|COMPLETED|Induction Study (8 Weeks)||0||
59633102|NCT02407236|75747320|FG000|NOT COMPLETED|Induction Study (8 Weeks)||23||
59633103|NCT02407236|75747321|FG001|NOT COMPLETED|Induction Study (8 Weeks)||11||
59633104|NCT02407236|75747322|FG002|NOT COMPLETED|Induction Study (8 Weeks)||15||
59633105|NCT02407236|75747323|FG003|NOT COMPLETED|Induction Study (8 Weeks)||0||
59633106|NCT02407236|75747324|FG004|NOT COMPLETED|Induction Study (8 Weeks)||0||
59633107|NCT02407236|75747325|FG005|NOT COMPLETED|Induction Study (8 Weeks)||0||
59633108|NCT02407236|75747326|FG006|NOT COMPLETED|Induction Study (8 Weeks)||0||
59633109|NCT02407236|75747327|FG007|NOT COMPLETED|Induction Study (8 Weeks)||0||
59633110|NCT02407236|75747328|FG008|NOT COMPLETED|Induction Study (8 Weeks)||0||
59633111|NCT02407236|75747329|FG009|NOT COMPLETED|Induction Study (8 Weeks)||0||
59633112|NCT02407236|75747330|FG010|NOT COMPLETED|Induction Study (8 Weeks)||0||
59633113|NCT02407236|75747331|FG011|NOT COMPLETED|Induction Study (8 Weeks)||0||
59633114|NCT02407236|75747332|FG012|NOT COMPLETED|Induction Study (8 Weeks)||0||
59633115|NCT02407236|75747320|FG000|STARTED|Maintenance Study (44 Weeks)||0||
59633116|NCT02407236|75747321|FG001|STARTED|Maintenance Study (44 Weeks)||0||
59633117|NCT02407236|75747322|FG002|STARTED|Maintenance Study (44 Weeks)||0||
59633118|NCT02407236|75747323|FG003|STARTED|Maintenance Study (44 Weeks)||175||
59633119|NCT02407236|75747324|FG004|STARTED|Maintenance Study (44 Weeks)||172||
59633120|NCT02407236|75747325|FG005|STARTED|Maintenance Study (44 Weeks)||176||
59633121|NCT02407236|75747326|FG006|STARTED|Maintenance Study (44 Weeks)||103||
59633122|NCT02407236|75747327|FG007|STARTED|Maintenance Study (44 Weeks)||157||
59633123|NCT02407236|75747328|FG008|STARTED|Maintenance Study (44 Weeks)||0||
59633124|NCT02407236|75747329|FG009|STARTED|Maintenance Study (44 Weeks)||0||
59633125|NCT02407236|75747330|FG010|STARTED|Maintenance Study (44 Weeks)||0||
59633126|NCT02407236|75747331|FG011|STARTED|Maintenance Study (44 Weeks)||0||
59633127|NCT02407236|75747332|FG012|STARTED|Maintenance Study (44 Weeks)||0||
59633128|NCT02407236|75747320|FG000|COMPLETED|Maintenance Study (44 Weeks)||0||
59633129|NCT02407236|75747321|FG001|COMPLETED|Maintenance Study (44 Weeks)||0||
59633130|NCT02407236|75747322|FG002|COMPLETED|Maintenance Study (44 Weeks)||0||
59633131|NCT02407236|75747323|FG003|COMPLETED|Maintenance Study (44 Weeks)||132||
59633132|NCT02407236|75747324|FG004|COMPLETED|Maintenance Study (44 Weeks)||148||
59633133|NCT02407236|75747325|FG005|COMPLETED|Maintenance Study (44 Weeks)||158||
59633134|NCT02407236|75747326|FG006|COMPLETED|Maintenance Study (44 Weeks)||76||
59633135|NCT02407236|75747327|FG007|COMPLETED|Maintenance Study (44 Weeks)||128||
59633136|NCT02407236|75747328|FG008|COMPLETED|Maintenance Study (44 Weeks)||0||
59633137|NCT02407236|75747329|FG009|COMPLETED|Maintenance Study (44 Weeks)||0||
59633138|NCT02407236|75747330|FG010|COMPLETED|Maintenance Study (44 Weeks)||0||
59633139|NCT02407236|75747331|FG011|COMPLETED|Maintenance Study (44 Weeks)||0||
59633140|NCT02407236|75747332|FG012|COMPLETED|Maintenance Study (44 Weeks)||0||
59633141|NCT02407236|75747320|FG000|NOT COMPLETED|Maintenance Study (44 Weeks)||0||
59633142|NCT02407236|75747321|FG001|NOT COMPLETED|Maintenance Study (44 Weeks)||0||
59633143|NCT02407236|75747322|FG002|NOT COMPLETED|Maintenance Study (44 Weeks)||0||
59633144|NCT02407236|75747323|FG003|NOT COMPLETED|Maintenance Study (44 Weeks)||43||
59633145|NCT02407236|75747324|FG004|NOT COMPLETED|Maintenance Study (44 Weeks)||24||
59633146|NCT02407236|75747325|FG005|NOT COMPLETED|Maintenance Study (44 Weeks)||18||
59633147|NCT02407236|75747326|FG006|NOT COMPLETED|Maintenance Study (44 Weeks)||27||
59633148|NCT02407236|75747327|FG007|NOT COMPLETED|Maintenance Study (44 Weeks)||29||
59633149|NCT02407236|75747328|FG008|NOT COMPLETED|Maintenance Study (44 Weeks)||0||
59633150|NCT02407236|75747329|FG009|NOT COMPLETED|Maintenance Study (44 Weeks)||0||
59633151|NCT02407236|75747330|FG010|NOT COMPLETED|Maintenance Study (44 Weeks)||0||
59633152|NCT02407236|75747331|FG011|NOT COMPLETED|Maintenance Study (44 Weeks)||0||
59633153|NCT02407236|75747332|FG012|NOT COMPLETED|Maintenance Study (44 Weeks)||0||
59633154|NCT02407236|75747320|FG000|STARTED|Long-term Extension Period (176 Weeks)||0||
59633155|NCT02407236|75747321|FG001|STARTED|Long-term Extension Period (176 Weeks)||0||
59633156|NCT02407236|75747322|FG002|STARTED|Long-term Extension Period (176 Weeks)||0||
59633157|NCT02407236|75747323|FG003|STARTED|Long-term Extension Period (176 Weeks)||0||
59633158|NCT02407236|75747324|FG004|STARTED|Long-term Extension Period (176 Weeks)||0||
59633159|NCT02407236|75747325|FG005|STARTED|Long-term Extension Period (176 Weeks)||0||
59633160|NCT02407236|75747326|FG006|STARTED|Long-term Extension Period (176 Weeks)||0||
59633161|NCT02407236|75747327|FG007|STARTED|Long-term Extension Period (176 Weeks)||0||
59633162|NCT02407236|75747328|FG008|STARTED|Long-term Extension Period (176 Weeks)||115||
59709640|NCT01235741|75828429|FG000|STARTED|Randomized to Treatment||0||
59633163|NCT02407236|75747329|FG009|STARTED|Long-term Extension Period (176 Weeks)||141||
59633164|NCT02407236|75747330|FG010|STARTED|Long-term Extension Period (176 Weeks)||143||
59633165|NCT02407236|75747331|FG011|STARTED|Long-term Extension Period (176 Weeks)||73||
59633166|NCT02407236|75747332|FG012|STARTED|Long-term Extension Period (176 Weeks)||116||
59633167|NCT02407236|75747320|FG000|COMPLETED|Long-term Extension Period (176 Weeks)||0||
59633168|NCT02407236|75747321|FG001|COMPLETED|Long-term Extension Period (176 Weeks)||0||
59633169|NCT02407236|75747322|FG002|COMPLETED|Long-term Extension Period (176 Weeks)||0||
59633170|NCT02407236|75747323|FG003|COMPLETED|Long-term Extension Period (176 Weeks)||0||
59633171|NCT02407236|75747324|FG004|COMPLETED|Long-term Extension Period (176 Weeks)||0||
59633172|NCT02407236|75747325|FG005|COMPLETED|Long-term Extension Period (176 Weeks)||0||
59633173|NCT02407236|75747326|FG006|COMPLETED|Long-term Extension Period (176 Weeks)||0||
59633174|NCT02407236|75747327|FG007|COMPLETED|Long-term Extension Period (176 Weeks)||0||
59633175|NCT02407236|75747328|FG008|COMPLETED|Long-term Extension Period (176 Weeks)||34||
59633176|NCT02407236|75747329|FG009|COMPLETED|Long-term Extension Period (176 Weeks)||99||
59633177|NCT02407236|75747330|FG010|COMPLETED|Long-term Extension Period (176 Weeks)||101||
59633178|NCT02407236|75747331|FG011|COMPLETED|Long-term Extension Period (176 Weeks)||0||
59633179|NCT02407236|75747332|FG012|COMPLETED|Long-term Extension Period (176 Weeks)||95||
59633180|NCT02407236|75747320|FG000|NOT COMPLETED|Long-term Extension Period (176 Weeks)||0||
59633181|NCT02407236|75747321|FG001|NOT COMPLETED|Long-term Extension Period (176 Weeks)||0||
59633182|NCT02407236|75747322|FG002|NOT COMPLETED|Long-term Extension Period (176 Weeks)||0||
59633183|NCT02407236|75747323|FG003|NOT COMPLETED|Long-term Extension Period (176 Weeks)||0||
59633184|NCT02407236|75747324|FG004|NOT COMPLETED|Long-term Extension Period (176 Weeks)||0||
59633185|NCT02407236|75747325|FG005|NOT COMPLETED|Long-term Extension Period (176 Weeks)||0||
59633186|NCT02407236|75747326|FG006|NOT COMPLETED|Long-term Extension Period (176 Weeks)||0||
59633187|NCT02407236|75747327|FG007|NOT COMPLETED|Long-term Extension Period (176 Weeks)||0||
59633188|NCT02407236|75747328|FG008|NOT COMPLETED|Long-term Extension Period (176 Weeks)||81||
59633189|NCT02407236|75747329|FG009|NOT COMPLETED|Long-term Extension Period (176 Weeks)||42||
59633190|NCT02407236|75747330|FG010|NOT COMPLETED|Long-term Extension Period (176 Weeks)||42||
59633191|NCT02407236|75747331|FG011|NOT COMPLETED|Long-term Extension Period (176 Weeks)||73||
59633192|NCT02407236|75747332|FG012|NOT COMPLETED|Long-term Extension Period (176 Weeks)||21||
59633193|NCT01893138|75747360|FG000|STARTED|Double-Blind Period||199||
59633194|NCT01893138|75747361|FG001|STARTED|Double-Blind Period||98||
59633195|NCT01893138|75747360|FG000|Injection|Double-Blind Period||199||
59633196|NCT01893138|75747361|FG001|Injection|Double-Blind Period||98||
59633197|NCT01893138|75747360|FG000|1 Month Follow-Up|Double-Blind Period||199||
59633198|NCT01893138|75747361|FG001|1 Month Follow-Up|Double-Blind Period||97||
59633199|NCT01893138|75747360|FG000|3 Month Follow-Up|Double-Blind Period||199||
59633200|NCT01893138|75747361|FG001|3 Month Follow-Up|Double-Blind Period||97||
59633201|NCT01893138|75747360|FG000|6 Month Follow-Up|Double-Blind Period||198||
59633202|NCT01893138|75747361|FG001|6 Month Follow-Up|Double-Blind Period||97||
59633203|NCT01893138|75747360|FG000|12 Month Follow-Up|Double-Blind Period||198||
59633204|NCT01893138|75747361|FG001|12 Month Follow-Up|Double-Blind Period||97||
59633205|NCT01893138|75747360|FG000|COMPLETED|Double-Blind Period||198||
59633206|NCT01893138|75747361|FG001|COMPLETED|Double-Blind Period||97||
59633207|NCT01893138|75747360|FG000|NOT COMPLETED|Double-Blind Period||1||
59633208|NCT01893138|75747361|FG001|NOT COMPLETED|Double-Blind Period||1||
59633209|NCT01893138|75747360|FG000|STARTED|Open Label - Unblinded Period||198||
59633210|NCT01893138|75747361|FG001|STARTED|Open Label - Unblinded Period||97||
59633211|NCT01893138|75747360|FG000|Open Label Period|Open Label - Unblinded Period||166||
59633212|NCT01893138|75747361|FG001|Open Label Period|Open Label - Unblinded Period||97||
59633213|NCT01893138|75747360|FG000|Iltamiocel Injection|Open Label - Unblinded Period||0|"No additional treatment for iltamiocel arm.~Subjects originally randomized to placebo received single, open-label iltamiocel injection."|
59633214|NCT01893138|75747361|FG001|Iltamiocel Injection|Open Label - Unblinded Period||92|"No additional treatment for iltamiocel arm.~Subjects originally randomized to placebo received single, open-label iltamiocel injection."|
59633215|NCT01893138|75747360|FG000|2 Year Follow-Up|Open Label - Unblinded Period||166||
59633216|NCT01893138|75747361|FG001|2 Year Follow-Up|Open Label - Unblinded Period||87||
59633217|NCT01893138|75747360|FG000|COMPLETED|Open Label - Unblinded Period||166||
59633218|NCT01893138|75747361|FG001|COMPLETED|Open Label - Unblinded Period||87||
59633219|NCT01893138|75747360|FG000|NOT COMPLETED|Open Label - Unblinded Period||32||
59633220|NCT01893138|75747361|FG001|NOT COMPLETED|Open Label - Unblinded Period||10||
59633221|NCT04309500|75747373|FG000|STARTED|Overall Study||5||
59633222|NCT04309500|75747374|FG001|STARTED|Overall Study||5||
59633223|NCT04309500|75747375|FG002|STARTED|Overall Study||5||
59633224|NCT04309500|75747376|FG003|STARTED|Overall Study||5||
59633225|NCT04309500|75747373|FG000|Immediate|Overall Study||5||
59633226|NCT04309500|75747374|FG001|Immediate|Overall Study||5||
59633227|NCT04309500|75747375|FG002|Immediate|Overall Study||5||
59633228|NCT04309500|75747376|FG003|Immediate|Overall Study||5||
59633229|NCT04309500|75747373|FG000|1 Week Later|Overall Study||5||
59633230|NCT04309500|75747374|FG001|1 Week Later|Overall Study||5||
59633231|NCT04309500|75747375|FG002|1 Week Later|Overall Study||5||
59633232|NCT04309500|75747376|FG003|1 Week Later|Overall Study||5||
59633233|NCT04309500|75747373|FG000|6 Weeks Later|Overall Study||4||
59633234|NCT04309500|75747374|FG001|6 Weeks Later|Overall Study||5||
59633235|NCT04309500|75747375|FG002|6 Weeks Later|Overall Study||4||
59633236|NCT04309500|75747376|FG003|6 Weeks Later|Overall Study||5||
59633237|NCT04309500|75747373|FG000|COMPLETED|Overall Study||4||
59633238|NCT04309500|75747374|FG001|COMPLETED|Overall Study||5||
59633239|NCT04309500|75747375|FG002|COMPLETED|Overall Study||5||
59633240|NCT04309500|75747376|FG003|COMPLETED|Overall Study||5||
59633241|NCT04309500|75747373|FG000|NOT COMPLETED|Overall Study||1||
59633242|NCT04309500|75747374|FG001|NOT COMPLETED|Overall Study||0||
59633243|NCT04309500|75747375|FG002|NOT COMPLETED|Overall Study||0||
59633244|NCT04309500|75747376|FG003|NOT COMPLETED|Overall Study||0||
59633245|NCT03678402|75747387|FG000|STARTED|Overall Study||521||
59633246|NCT03678402|75747387|FG000|COMPLETED|Overall Study||521||
59633247|NCT03678402|75747387|FG000|NOT COMPLETED|Overall Study||0||
59633248|NCT01597440|75747393|FG000|STARTED|Overall Study||1||
59633249|NCT01597440|75747394|FG001|STARTED|Overall Study||0||
59633250|NCT01597440|75747393|FG000|COMPLETED|Overall Study||1||
59633251|NCT01597440|75747394|FG001|COMPLETED|Overall Study||0||
59633252|NCT01597440|75747393|FG000|NOT COMPLETED|Overall Study||0||
59633253|NCT01597440|75747394|FG001|NOT COMPLETED|Overall Study||0||
59633254|NCT01598064|75747404|FG000|STARTED|Overall Study||25||
59633255|NCT01598064|75747405|FG001|STARTED|Overall Study||24||
59633256|NCT01598064|75747404|FG000|COMPLETED|Overall Study||25||
59633257|NCT01598064|75747405|FG001|COMPLETED|Overall Study||24||
59633258|NCT01598064|75747404|FG000|NOT COMPLETED|Overall Study||0||
59633259|NCT01598064|75747405|FG001|NOT COMPLETED|Overall Study||0||
59633260|NCT01600170|75747415|FG000|STARTED|Period 1|Participants were assigned atorvastatin for 12 wks followed by a washout and then placebo.|6||
59633261|NCT01600170|75747416|FG001|STARTED|Period 1|Participants were assigned placebo for 12 wks followed by a washout and then atorvastatin.|5||
59633262|NCT01600170|75747415|FG000|COMPLETED|Period 1||6||
59633263|NCT01600170|75747416|FG001|COMPLETED|Period 1||5||
59633264|NCT01600170|75747415|FG000|NOT COMPLETED|Period 1||0||
59633265|NCT01600170|75747416|FG001|NOT COMPLETED|Period 1||0||
59633266|NCT01600170|75747415|FG000|STARTED|Period 2|These 6 were on atorvastatin in period 1 and on placebo in Period 2.|6||
59633267|NCT01600170|75747416|FG001|STARTED|Period 2|These 5 were on placebo in Period 1 and on Atorvastatin in Period 2.|5||
59633268|NCT01600170|75747415|FG000|COMPLETED|Period 2|One subject moved away from the area due to job responsibilities and dropped out of study.|5||
59633269|NCT01600170|75747416|FG001|COMPLETED|Period 2||5||
59633270|NCT01600170|75747415|FG000|NOT COMPLETED|Period 2||1||
59633271|NCT01600170|75747416|FG001|NOT COMPLETED|Period 2||0||
59633272|NCT01600482|75747426|FG000|STARTED|Overall Study||148||
59633273|NCT01600482|75747427|FG001|STARTED|Overall Study|Last 26 patients allocated to CELT ACD|59||
59633274|NCT01600482|75747426|FG000|COMPLETED|Overall Study|Last 26 patients allocated to CELT ACD|148||
59633275|NCT01600482|75747427|FG001|COMPLETED|Overall Study||59||
59633276|NCT01600482|75747426|FG000|NOT COMPLETED|Overall Study||0||
59633277|NCT01600482|75747427|FG001|NOT COMPLETED|Overall Study||0||
59633278|NCT01600638|75747433|FG000|STARTED|Overall Study||25||
59633279|NCT01600638|75747433|FG000|COMPLETED|Overall Study||25||
59633280|NCT01600638|75747433|FG000|NOT COMPLETED|Overall Study||0||
59633281|NCT01600950|75747437|FG000|STARTED|Period 1||10||
59633282|NCT01600950|75747438|FG001|STARTED|Period 1||10||
59633283|NCT01600950|75747437|FG000|COMPLETED|Period 1||10||
59633284|NCT01600950|75747438|FG001|COMPLETED|Period 1||10||
59633285|NCT01600950|75747437|FG000|NOT COMPLETED|Period 1||0||
59633286|NCT01600950|75747438|FG001|NOT COMPLETED|Period 1||0||
59633287|NCT01600950|75747437|FG000|STARTED|Period 2||10||
59633288|NCT01600950|75747438|FG001|STARTED|Period 2||10||
59633289|NCT01600950|75747437|FG000|COMPLETED|Period 2||10||
59633290|NCT01600950|75747438|FG001|COMPLETED|Period 2||10||
59633291|NCT01600950|75747437|FG000|NOT COMPLETED|Period 2||0||
59633292|NCT01600950|75747438|FG001|NOT COMPLETED|Period 2||0||
59633293|NCT01603056|75747446|FG000|STARTED|Overall Study||413||
59633294|NCT01603056|75747447|FG001|STARTED|Overall Study||204||
59633295|NCT01603056|75747446|FG000|COMPLETED|Overall Study||379||
59633296|NCT01603056|75747447|FG001|COMPLETED|Overall Study||190||
59633297|NCT01603056|75747446|FG000|NOT COMPLETED|Overall Study||34||
59633298|NCT01603056|75747447|FG001|NOT COMPLETED|Overall Study||14||
59633299|NCT01604772|75747453|FG000|STARTED|Overall Study||16||
59633300|NCT01604772|75747453|FG000|COMPLETED|Overall Study||16||
59633301|NCT01604772|75747453|FG000|NOT COMPLETED|Overall Study||0||
59633302|NCT01605942|75747460|FG000|STARTED|Overall Study||6||
59633303|NCT01605942|75747461|FG001|STARTED|Overall Study||2||
59633304|NCT01605942|75747460|FG000|COMPLETED|Overall Study||6||
59633305|NCT01605942|75747461|FG001|COMPLETED|Overall Study||2||
59633306|NCT01605942|75747460|FG000|NOT COMPLETED|Overall Study||0||
59633307|NCT01605942|75747461|FG001|NOT COMPLETED|Overall Study||0||
59633308|NCT01607112|75747469|FG000|STARTED|Overall Study||60||
59633309|NCT01607112|75747470|FG001|STARTED|Overall Study||59||
59633310|NCT01607112|75747469|FG000|COMPLETED|Overall Study||60||
59633311|NCT01607112|75747470|FG001|COMPLETED|Overall Study||59||
59633312|NCT01607112|75747469|FG000|NOT COMPLETED|Overall Study||0||
59633313|NCT01607112|75747470|FG001|NOT COMPLETED|Overall Study||0||
59633314|NCT01607658|75747484|FG000|STARTED|Overall Study||65||
59540229|NCT01654380|75638416|FG002|COMPLETED|Part B, Washout of at Least 6 Days||6||
59540230|NCT01654380|75638417|FG003|COMPLETED|Part B, Washout of at Least 6 Days||7||
59540231|NCT01654380|75638414|FG000|NOT COMPLETED|Part B, Washout of at Least 6 Days||0||
59540232|NCT01654380|75638415|FG001|NOT COMPLETED|Part B, Washout of at Least 6 Days||0||
59540233|NCT01654380|75638416|FG002|NOT COMPLETED|Part B, Washout of at Least 6 Days||0||
59540234|NCT01654380|75638417|FG003|NOT COMPLETED|Part B, Washout of at Least 6 Days||0||
59540235|NCT01654380|75638414|FG000|STARTED|Part B, Period 4||0||
59540236|NCT01654380|75638415|FG001|STARTED|Part B, Period 4||0||
59540237|NCT01654380|75638416|FG002|STARTED|Part B, Period 4||6||
59540238|NCT01654380|75638417|FG003|STARTED|Part B, Period 4||7||
59540239|NCT01654380|75638414|FG000|COMPLETED|Part B, Period 4||0||
59540240|NCT01654380|75638415|FG001|COMPLETED|Part B, Period 4||0||
59540241|NCT01654380|75638416|FG002|COMPLETED|Part B, Period 4||6||
59540242|NCT01654380|75638417|FG003|COMPLETED|Part B, Period 4||7||
59540243|NCT01654380|75638414|FG000|NOT COMPLETED|Part B, Period 4||0||
59540244|NCT01654380|75638415|FG001|NOT COMPLETED|Part B, Period 4||0||
59540245|NCT01654380|75638416|FG002|NOT COMPLETED|Part B, Period 4||0||
59540246|NCT01654380|75638417|FG003|NOT COMPLETED|Part B, Period 4||0||
59540247|NCT02477670|75638436|FG000|STARTED|Stage 1||47||
59540248|NCT02477670|75638437|FG001|STARTED|Stage 1||80||
59540249|NCT02477670|75638438|FG002|STARTED|Stage 1||0||
59540250|NCT02477670|75638439|FG003|STARTED|Stage 1||0||
59540251|NCT02477670|75638440|FG004|STARTED|Stage 1||0||
59540252|NCT02477670|75638441|FG005|STARTED|Stage 1||0||
59540253|NCT02477670|75638442|FG006|STARTED|Stage 1||0||
59540254|NCT02477670|75638436|FG000|COMPLETED|Stage 1||43||
59540255|NCT02477670|75638437|FG001|COMPLETED|Stage 1||67||
59540256|NCT02477670|75638438|FG002|COMPLETED|Stage 1||0||
59540257|NCT02477670|75638439|FG003|COMPLETED|Stage 1||0||
59540258|NCT02477670|75638440|FG004|COMPLETED|Stage 1||0||
59540259|NCT02477670|75638441|FG005|COMPLETED|Stage 1||0||
59540260|NCT02477670|75638442|FG006|COMPLETED|Stage 1||0||
59540261|NCT02477670|75638436|FG000|NOT COMPLETED|Stage 1||4||
59540262|NCT02477670|75638437|FG001|NOT COMPLETED|Stage 1||13||
59540263|NCT02477670|75638438|FG002|NOT COMPLETED|Stage 1||0||
59540264|NCT02477670|75638439|FG003|NOT COMPLETED|Stage 1||0||
59540265|NCT02477670|75638440|FG004|NOT COMPLETED|Stage 1||0||
59540266|NCT02477670|75638441|FG005|NOT COMPLETED|Stage 1||0||
59540267|NCT02477670|75638442|FG006|NOT COMPLETED|Stage 1||0||
59540268|NCT02477670|75638436|FG000|STARTED|Stage 2||0||
59540269|NCT02477670|75638437|FG001|STARTED|Stage 2||0||
59540270|NCT02477670|75638438|FG002|STARTED|Stage 2||30||
59540271|NCT02477670|75638439|FG003|STARTED|Stage 2||33||
59540272|NCT02477670|75638440|FG004|STARTED|Stage 2||2||
59540273|NCT02477670|75638441|FG005|STARTED|Stage 2||1||
59540274|NCT02477670|75638442|FG006|STARTED|Stage 2||42||
59540275|NCT02477670|75638436|FG000|COMPLETED|Stage 2||0||
59540276|NCT02477670|75638437|FG001|COMPLETED|Stage 2||0||
59540277|NCT02477670|75638438|FG002|COMPLETED|Stage 2||28||
59540278|NCT02477670|75638439|FG003|COMPLETED|Stage 2||32||
59540279|NCT02477670|75638440|FG004|COMPLETED|Stage 2||2||
59540280|NCT02477670|75638441|FG005|COMPLETED|Stage 2||1||
59540281|NCT02477670|75638442|FG006|COMPLETED|Stage 2||42||
59540282|NCT02477670|75638436|FG000|NOT COMPLETED|Stage 2||0||
59540283|NCT02477670|75638437|FG001|NOT COMPLETED|Stage 2||0||
59540284|NCT02477670|75638438|FG002|NOT COMPLETED|Stage 2||2||
59540285|NCT02477670|75638439|FG003|NOT COMPLETED|Stage 2||1||
59540286|NCT02477670|75638440|FG004|NOT COMPLETED|Stage 2||0||
59540287|NCT02477670|75638441|FG005|NOT COMPLETED|Stage 2||0||
59540288|NCT02477670|75638442|FG006|NOT COMPLETED|Stage 2||0||
59540289|NCT02509026|75638453|FG000|STARTED|Induction Period (24 Weeks)||210||
59540290|NCT02509026|75638453|FG000|Treated|Induction Period (24 Weeks)||209||
59540291|NCT02509026|75638453|FG000|COMPLETED|Induction Period (24 Weeks)||188||
59540292|NCT02509026|75638453|FG000|NOT COMPLETED|Induction Period (24 Weeks)||22||
59540293|NCT02509026|75638453|FG000|STARTED|Withdrawal Period (40 Weeks)|Participants who completed Period 1 and achieved ASDAS-CRP<1.3 were eligible to enter into Period 2|119||
59540294|NCT02509026|75638453|FG000|COMPLETED|Withdrawal Period (40 Weeks)||112||
59633315|NCT01607658|75747485|FG001|STARTED|Overall Study||67||
59633316|NCT01607658|75747486|FG002|STARTED|Overall Study||58||
59633317|NCT01607658|75747487|FG003|STARTED|Overall Study||63||
59633318|NCT01607658|75747484|FG000|COMPLETED|Overall Study||56||
59633319|NCT01607658|75747485|FG001|COMPLETED|Overall Study||56||
59633320|NCT01607658|75747486|FG002|COMPLETED|Overall Study||47||
59633321|NCT01607658|75747487|FG003|COMPLETED|Overall Study||52||
59633322|NCT01607658|75747484|FG000|NOT COMPLETED|Overall Study||9||
59633323|NCT01607658|75747485|FG001|NOT COMPLETED|Overall Study||11||
59633324|NCT01607658|75747486|FG002|NOT COMPLETED|Overall Study||11||
59633325|NCT01607658|75747487|FG003|NOT COMPLETED|Overall Study||11||
59633326|NCT01608672|75747497|FG000|STARTED|Overall Study||207||
59633327|NCT01608672|75747497|FG000|COMPLETED|Overall Study||207||
59633328|NCT01608672|75747497|FG000|NOT COMPLETED|Overall Study||0||
59633329|NCT01610154|75747501|FG000|STARTED|Overall Study||85||
59633330|NCT01610154|75747501|FG000|COMPLETED|Overall Study||84||
59633331|NCT01610154|75747501|FG000|NOT COMPLETED|Overall Study||1||
59633332|NCT01611948|75747509|FG000|STARTED|Overall Study||32||
59633333|NCT01611948|75747510|FG001|STARTED|Overall Study||38||
59633334|NCT01611948|75747509|FG000|COMPLETED|Overall Study||18||
59633335|NCT01611948|75747510|FG001|COMPLETED|Overall Study||26||
59633336|NCT01611948|75747509|FG000|NOT COMPLETED|Overall Study||14||
59633337|NCT01611948|75747510|FG001|NOT COMPLETED|Overall Study||12||
59633338|NCT01612494|75747518|FG000|STARTED|Overall Study||21||
59633339|NCT01612494|75747519|FG001|STARTED|Overall Study||23||
59633340|NCT01612494|75747518|FG000|COMPLETED|Overall Study||21||
59633341|NCT01612494|75747519|FG001|COMPLETED|Overall Study||23||
59633342|NCT01612494|75747518|FG000|NOT COMPLETED|Overall Study||0||
59633343|NCT01612494|75747519|FG001|NOT COMPLETED|Overall Study||0||
59633344|NCT01612884|75747527|FG000|STARTED|Overall Study||19||
59633345|NCT01612884|75747528|FG001|STARTED|Overall Study||18||
59633346|NCT01612884|75747527|FG000|COMPLETED|Overall Study||19||
59633347|NCT01612884|75747528|FG001|COMPLETED|Overall Study||18||
59633348|NCT01612884|75747527|FG000|NOT COMPLETED|Overall Study||0||
59633349|NCT01612884|75747528|FG001|NOT COMPLETED|Overall Study||0||
59633350|NCT01614210|75747534|FG000|STARTED|Overall Study||52||
59633351|NCT01614210|75747534|FG000|COMPLETED|Overall Study||52||
59633352|NCT01614210|75747534|FG000|NOT COMPLETED|Overall Study||0||
59633353|NCT01616082|75747540|FG000|STARTED|Overall Study||19||
59633354|NCT01616082|75747541|FG001|STARTED|Overall Study||20||
59633355|NCT01616082|75747540|FG000|COMPLETED|Overall Study||19||
59633356|NCT01616082|75747541|FG001|COMPLETED|Overall Study||18||
59633357|NCT01616082|75747540|FG000|NOT COMPLETED|Overall Study||0||
59633358|NCT01616082|75747541|FG001|NOT COMPLETED|Overall Study||2||
59633359|NCT01616160|75747548|FG000|STARTED|Overall Study||11||
59633360|NCT01616160|75747548|FG000|COMPLETED|Overall Study||9||
59633361|NCT01616160|75747548|FG000|NOT COMPLETED|Overall Study||2||
59633362|NCT01618344|75747552|FG000|STARTED|Overall Study||32||
59633363|NCT01618344|75747552|FG000|COMPLETED|Overall Study||23||
59633364|NCT01618344|75747552|FG000|NOT COMPLETED|Overall Study||9||
59633365|NCT01618422|75747558|FG000|STARTED|Overall Study||114||
59633366|NCT01618422|75747559|FG001|STARTED|Overall Study||111||
59633367|NCT01618422|75747558|FG000|COMPLETED|Overall Study||114||
59633368|NCT01618422|75747559|FG001|COMPLETED|Overall Study||111||
59633369|NCT01618422|75747558|FG000|NOT COMPLETED|Overall Study||0||
59633370|NCT01618422|75747559|FG001|NOT COMPLETED|Overall Study||0||
59633371|NCT01619982|75747567|FG000|STARTED|Overall Study||20||
59633372|NCT01619982|75747568|FG001|STARTED|Overall Study||12||
59633373|NCT01619982|75747567|FG000|COMPLETED|Overall Study||20||
59633374|NCT01619982|75747568|FG001|COMPLETED|Overall Study||12||
59633375|NCT01619982|75747567|FG000|NOT COMPLETED|Overall Study||0||
59633376|NCT01619982|75747568|FG001|NOT COMPLETED|Overall Study||0||
59633377|NCT01620216|75747585|FG000|STARTED|Overall Study||4||
59633378|NCT01620216|75747586|FG001|STARTED|Overall Study||2||
59633379|NCT01620216|75747587|FG002|STARTED|Overall Study||6||
59633380|NCT01620216|75747588|FG003|STARTED|Overall Study||0||
59633381|NCT01620216|75747589|FG004|STARTED|Overall Study||0||
59633382|NCT01620216|75747590|FG005|STARTED|Overall Study||0||
59633383|NCT01620216|75747591|FG006|STARTED|Overall Study||0||
59633384|NCT01620216|75747585|FG000|COMPLETED|Overall Study||4||
59633385|NCT01620216|75747586|FG001|COMPLETED|Overall Study||2||
59633386|NCT01620216|75747587|FG002|COMPLETED|Overall Study||6||
59633387|NCT01620216|75747588|FG003|COMPLETED|Overall Study||0||
59633388|NCT01620216|75747589|FG004|COMPLETED|Overall Study||0||
59633389|NCT01620216|75747590|FG005|COMPLETED|Overall Study||0||
59633390|NCT01620216|75747591|FG006|COMPLETED|Overall Study||0||
59633391|NCT01620216|75747585|FG000|NOT COMPLETED|Overall Study||0||
59633392|NCT01620216|75747586|FG001|NOT COMPLETED|Overall Study||0||
59633393|NCT01620216|75747587|FG002|NOT COMPLETED|Overall Study||0||
59633394|NCT01620216|75747588|FG003|NOT COMPLETED|Overall Study||0||
59633395|NCT01620216|75747589|FG004|NOT COMPLETED|Overall Study||0||
59633396|NCT01620216|75747590|FG005|NOT COMPLETED|Overall Study||0||
59633397|NCT01620216|75747591|FG006|NOT COMPLETED|Overall Study||0||
59633398|NCT01621230|75747609|FG000|STARTED|Overall Study||154||
59633399|NCT01621230|75747610|FG001|STARTED|Overall Study||156||
59633400|NCT01621230|75747609|FG000|COMPLETED|Overall Study||154||
59633401|NCT01621230|75747610|FG001|COMPLETED|Overall Study||156||
59633402|NCT01621230|75747609|FG000|NOT COMPLETED|Overall Study||0||
59633403|NCT01621230|75747610|FG001|NOT COMPLETED|Overall Study||0||
59633404|NCT01621776|75747622|FG000|STARTED|Overall Study||41||
59633405|NCT01621776|75747623|FG001|STARTED|Overall Study||40||
59633406|NCT01621776|75747624|FG002|STARTED|Overall Study||18||
59633407|NCT01621776|75747622|FG000|COMPLETED|Overall Study||41||
59633408|NCT01621776|75747623|FG001|COMPLETED|Overall Study||40||
59633409|NCT01621776|75747624|FG002|COMPLETED|Overall Study||18||
59633410|NCT01621776|75747622|FG000|NOT COMPLETED|Overall Study||0||
59633411|NCT01621776|75747623|FG001|NOT COMPLETED|Overall Study||0||
59633412|NCT01621776|75747624|FG002|NOT COMPLETED|Overall Study||0||
59633413|NCT01622010|75747634|FG000|STARTED|Overall Study||18||
59633414|NCT01622010|75747635|FG001|STARTED|Overall Study||12||
59633415|NCT01622010|75747634|FG000|COMPLETED|Overall Study||12||
59633416|NCT01622010|75747635|FG001|COMPLETED|Overall Study||8||
59633417|NCT01622010|75747634|FG000|NOT COMPLETED|Overall Study||6||
59633418|NCT01622010|75747635|FG001|NOT COMPLETED|Overall Study||4||
59633419|NCT01624350|75747643|FG000|STARTED|Overall Study||100||
59633420|NCT01624350|75747643|FG000|COMPLETED|Overall Study||75||
59633421|NCT01624350|75747643|FG000|NOT COMPLETED|Overall Study||25||
59633422|NCT01624740|75747665|FG000|STARTED|First Intervention (3-4 Days)||9||
59633423|NCT01624740|75747666|FG001|STARTED|First Intervention (3-4 Days)||9||
59633424|NCT01624740|75747665|FG000|COMPLETED|First Intervention (3-4 Days)||9||
59633425|NCT01624740|75747666|FG001|COMPLETED|First Intervention (3-4 Days)||9||
59633426|NCT01624740|75747665|FG000|NOT COMPLETED|First Intervention (3-4 Days)||0||
59633427|NCT01624740|75747666|FG001|NOT COMPLETED|First Intervention (3-4 Days)||0||
59633428|NCT01624740|75747665|FG000|STARTED|Washout (1 Hour)||9||
59633429|NCT01624740|75747666|FG001|STARTED|Washout (1 Hour)||9||
59633430|NCT01624740|75747665|FG000|COMPLETED|Washout (1 Hour)||9||
59633431|NCT01624740|75747666|FG001|COMPLETED|Washout (1 Hour)||9||
59633432|NCT01624740|75747665|FG000|NOT COMPLETED|Washout (1 Hour)||0||
59633433|NCT01624740|75747666|FG001|NOT COMPLETED|Washout (1 Hour)||0||
59633434|NCT01624740|75747665|FG000|STARTED|Second Intervention (3-4 Days)||9||
59633435|NCT01624740|75747666|FG001|STARTED|Second Intervention (3-4 Days)||9||
59633436|NCT01624740|75747665|FG000|COMPLETED|Second Intervention (3-4 Days)||8||
59633437|NCT01624740|75747666|FG001|COMPLETED|Second Intervention (3-4 Days)||9||
59633438|NCT01624740|75747665|FG000|NOT COMPLETED|Second Intervention (3-4 Days)||1||
59633439|NCT01624740|75747666|FG001|NOT COMPLETED|Second Intervention (3-4 Days)||0||
59633440|NCT01627002|75747675|FG000|STARTED|Overall Study||4||
59633441|NCT01627002|75747676|FG001|STARTED|Overall Study||4||
59633442|NCT01627002|75747677|FG002|STARTED|Overall Study||4||
59633443|NCT01627002|75747678|FG003|STARTED|Overall Study||4||
59633444|NCT01627002|75747679|FG004|STARTED|Overall Study||2||
59633445|NCT01627002|75747680|FG005|STARTED|Overall Study||9||
59633446|NCT01627002|75747681|FG006|STARTED|Overall Study||10||
59633447|NCT01627002|75747682|FG007|STARTED|Overall Study||5||
59633448|NCT01627002|75747683|FG008|STARTED|Overall Study||7||
59633449|NCT01627002|75747675|FG000|COMPLETED|Overall Study||4||
59633450|NCT01627002|75747676|FG001|COMPLETED|Overall Study||4||
59633451|NCT01627002|75747677|FG002|COMPLETED|Overall Study||4||
59633452|NCT01627002|75747678|FG003|COMPLETED|Overall Study||4||
59633453|NCT01627002|75747679|FG004|COMPLETED|Overall Study||2||
59633454|NCT01627002|75747680|FG005|COMPLETED|Overall Study||9||
59633455|NCT01627002|75747681|FG006|COMPLETED|Overall Study||10||
59633456|NCT01627002|75747682|FG007|COMPLETED|Overall Study||5||
59633457|NCT01627002|75747683|FG008|COMPLETED|Overall Study||7||
59633458|NCT01627002|75747675|FG000|NOT COMPLETED|Overall Study||0||
59633459|NCT01627002|75747676|FG001|NOT COMPLETED|Overall Study||0||
59633460|NCT01627002|75747677|FG002|NOT COMPLETED|Overall Study||0||
59633461|NCT01627002|75747678|FG003|NOT COMPLETED|Overall Study||0||
59633462|NCT01627002|75747679|FG004|NOT COMPLETED|Overall Study||0||
59633463|NCT01627002|75747680|FG005|NOT COMPLETED|Overall Study||0||
59633464|NCT01627002|75747681|FG006|NOT COMPLETED|Overall Study||0||
59633465|NCT01627002|75747682|FG007|NOT COMPLETED|Overall Study||0||
59633466|NCT01627002|75747683|FG008|NOT COMPLETED|Overall Study||0||
59633467|NCT01628016|75747713|FG000|STARTED|Pretraining to Posttraining||27||
59633468|NCT01628016|75747714|FG001|STARTED|Pretraining to Posttraining||27||
59633469|NCT01628016|75747715|FG002|STARTED|Pretraining to Posttraining||23||
59633470|NCT01628016|75747713|FG000|COMPLETED|Pretraining to Posttraining||27||
59633471|NCT01628016|75747714|FG001|COMPLETED|Pretraining to Posttraining||27||
59633472|NCT01628016|75747715|FG002|COMPLETED|Pretraining to Posttraining||23||
59633473|NCT01628016|75747713|FG000|NOT COMPLETED|Pretraining to Posttraining||0||
59633474|NCT01628016|75747714|FG001|NOT COMPLETED|Pretraining to Posttraining||0||
59633475|NCT01628016|75747715|FG002|NOT COMPLETED|Pretraining to Posttraining||0||
59633476|NCT01628016|75747713|FG000|STARTED|Posttraining to 5 Follow-ups||27||
59633477|NCT01628016|75747714|FG001|STARTED|Posttraining to 5 Follow-ups||27||
59633478|NCT01628016|75747715|FG002|STARTED|Posttraining to 5 Follow-ups||23||
59633479|NCT01628016|75747713|FG000|COMPLETED|Posttraining to 5 Follow-ups||23||
59633480|NCT01628016|75747714|FG001|COMPLETED|Posttraining to 5 Follow-ups||20||
59633481|NCT01628016|75747715|FG002|COMPLETED|Posttraining to 5 Follow-ups||18||
59633482|NCT01628016|75747713|FG000|NOT COMPLETED|Posttraining to 5 Follow-ups||4||
59633483|NCT01628016|75747714|FG001|NOT COMPLETED|Posttraining to 5 Follow-ups||7||
59633484|NCT01628016|75747715|FG002|NOT COMPLETED|Posttraining to 5 Follow-ups||5||
59633485|NCT01628718|75747727|FG000|STARTED|Overall Study||60||
59633486|NCT01628718|75747728|FG001|STARTED|Overall Study||62||
59633487|NCT01628718|75747727|FG000|COMPLETED|Overall Study||33||
59633488|NCT01628718|75747728|FG001|COMPLETED|Overall Study||37||
59633489|NCT01628718|75747727|FG000|NOT COMPLETED|Overall Study||27||
59633490|NCT01628718|75747728|FG001|NOT COMPLETED|Overall Study||25||
59633491|NCT01630200|75747736|FG000|STARTED|Overall Study||40||
59633492|NCT01630200|75747737|FG001|STARTED|Overall Study||40||
59633493|NCT01630200|75747736|FG000|COMPLETED|Overall Study||33||
59633494|NCT01630200|75747737|FG001|COMPLETED|Overall Study||34||
59633495|NCT01630200|75747736|FG000|NOT COMPLETED|Overall Study||7||
59633496|NCT01630200|75747737|FG001|NOT COMPLETED|Overall Study||6||
59633497|NCT01631682|75747747|FG000|STARTED|Overall Study||55||
59633498|NCT01631682|75747748|FG001|STARTED|Overall Study||66||
59633499|NCT01631682|75747749|FG002|STARTED|Overall Study||44||
59633500|NCT01631682|75747750|FG003|STARTED|Overall Study||7||
59633501|NCT01631682|75747747|FG000|COMPLETED|Overall Study||24||
59633502|NCT01631682|75747748|FG001|COMPLETED|Overall Study||21||
59633503|NCT01631682|75747749|FG002|COMPLETED|Overall Study||13||
59633504|NCT01631682|75747750|FG003|COMPLETED|Overall Study||5||
59633505|NCT01631682|75747747|FG000|NOT COMPLETED|Overall Study||31||
59633506|NCT01631682|75747748|FG001|NOT COMPLETED|Overall Study||45||
59633507|NCT01631682|75747749|FG002|NOT COMPLETED|Overall Study||31||
59633508|NCT01631682|75747750|FG003|NOT COMPLETED|Overall Study||2||
59633509|NCT01633320|75747762|FG000|STARTED|Overall Study||132||
59633510|NCT01633320|75747763|FG001|STARTED|Overall Study||68||
59633511|NCT01633320|75747762|FG000|COMPLETED|Overall Study||132||
59633512|NCT01633320|75747763|FG001|COMPLETED|Overall Study||68||
59633513|NCT01633320|75747762|FG000|NOT COMPLETED|Overall Study||0||
59633514|NCT01633320|75747763|FG001|NOT COMPLETED|Overall Study||0||
59633515|NCT01633398|75747771|FG000|STARTED|Overall Study||4779||
59633516|NCT01633398|75747772|FG001|STARTED|Overall Study||1550||
59633517|NCT01633398|75747771|FG000|COMPLETED|Overall Study||4779||
59633518|NCT01633398|75747772|FG001|COMPLETED|Overall Study||1550||
59633519|NCT01633398|75747771|FG000|NOT COMPLETED|Overall Study||0||
59633520|NCT01633398|75747772|FG001|NOT COMPLETED|Overall Study||0||
59633521|NCT01634256|75747780|FG000|STARTED|Overall Study||30||
59633522|NCT01634256|75747781|FG001|STARTED|Overall Study||30||
59633523|NCT01634256|75747780|FG000|COMPLETED|Overall Study||26||
59633524|NCT01634256|75747781|FG001|COMPLETED|Overall Study||22||
59633525|NCT01634256|75747780|FG000|NOT COMPLETED|Overall Study||4||
59633526|NCT01634256|75747781|FG001|NOT COMPLETED|Overall Study||8||
59633527|NCT01635504|75747787|FG000|STARTED|Overall Study||5||
59633528|NCT01635504|75747787|FG000|COMPLETED|Overall Study||5||
59633529|NCT01635504|75747787|FG000|NOT COMPLETED|Overall Study||0||
59633530|NCT01636206|75747793|FG000|STARTED|Overall Study||111||
59633531|NCT01636206|75747794|FG001|STARTED|Overall Study||221||
59633532|NCT01636206|75747793|FG000|COMPLETED|Overall Study||92||
59633533|NCT01636206|75747794|FG001|COMPLETED|Overall Study||170||
59633534|NCT01636206|75747793|FG000|NOT COMPLETED|Overall Study||19||
59633535|NCT01636206|75747794|FG001|NOT COMPLETED|Overall Study||51||
59633536|NCT01636284|75747800|FG000|STARTED|Overall Study||16||
59633537|NCT01636284|75747800|FG000|COMPLETED|Overall Study||16||
59633538|NCT01636284|75747800|FG000|NOT COMPLETED|Overall Study||0||
59633539|NCT01638312|75747806|FG000|STARTED|Overall Study||20||
59633540|NCT01638312|75747807|FG001|STARTED|Overall Study||30||
59633541|NCT01638312|75747806|FG000|COMPLETED|Overall Study||20||
59633542|NCT01638312|75747807|FG001|COMPLETED|Overall Study||30||
59633543|NCT01638312|75747806|FG000|NOT COMPLETED|Overall Study||0||
59633544|NCT01638312|75747807|FG001|NOT COMPLETED|Overall Study||0||
59633545|NCT01638468|75747813|FG000|STARTED|Overall Study||7||
59633546|NCT01638468|75747813|FG000|COMPLETED|Overall Study||7||
59633547|NCT01638468|75747813|FG000|NOT COMPLETED|Overall Study||0||
59633548|NCT01639872|75747819|FG000|STARTED|Overall Study||24||
59633549|NCT01639872|75747820|FG001|STARTED|Overall Study||25||
59633550|NCT01639872|75747819|FG000|COMPLETED|Overall Study||14||
59633551|NCT01639872|75747820|FG001|COMPLETED|Overall Study||20||
59633552|NCT01639872|75747819|FG000|NOT COMPLETED|Overall Study||10||
59633553|NCT01639872|75747820|FG001|NOT COMPLETED|Overall Study||5||
59633554|NCT01640340|75747828|FG000|STARTED|Overall Study||20||
59633555|NCT01640340|75747829|FG001|STARTED|Overall Study||20||
59633556|NCT01640340|75747828|FG000|Overall Complete Response Rate|Overall Study||20||
59633557|NCT01640340|75747829|FG001|Overall Complete Response Rate|Overall Study||20||
59633558|NCT01640340|75747828|FG000|COMPLETED|Overall Study||20||
59633559|NCT01640340|75747829|FG001|COMPLETED|Overall Study||20||
59633560|NCT01640340|75747828|FG000|NOT COMPLETED|Overall Study||0||
59633561|NCT01640340|75747829|FG001|NOT COMPLETED|Overall Study||0||
59633562|NCT01641042|75747837|FG000|STARTED|Overall Study||43||
59633563|NCT01641042|75747838|FG001|STARTED|Overall Study||43||
59633564|NCT01641042|75747837|FG000|COMPLETED|Overall Study||43||
59633565|NCT01641042|75747838|FG001|COMPLETED|Overall Study||43||
59633566|NCT01641042|75747837|FG000|NOT COMPLETED|Overall Study||0||
59633567|NCT01641042|75747838|FG001|NOT COMPLETED|Overall Study||0||
59633568|NCT01641120|75747844|FG000|STARTED|25 Gauge Needle Weeks 1, 4, 5||20||
59633569|NCT01641120|75747844|FG000|COMPLETED|25 Gauge Needle Weeks 1, 4, 5||20||
59633570|NCT01641120|75747844|FG000|NOT COMPLETED|25 Gauge Needle Weeks 1, 4, 5||0||
59633571|NCT01641120|75747844|FG000|STARTED|30 Gauge Needle Weeks 2 and 3||20||
59633572|NCT01641120|75747844|FG000|COMPLETED|30 Gauge Needle Weeks 2 and 3||20||
59633573|NCT01641120|75747844|FG000|NOT COMPLETED|30 Gauge Needle Weeks 2 and 3||0||
59633574|NCT01641978|75747851|FG000|STARTED|Overall Study||125||
59633575|NCT01641978|75747851|FG000|COMPLETED|Overall Study||125||
59633576|NCT01641978|75747851|FG000|NOT COMPLETED|Overall Study||0||
59633577|NCT01642056|75747861|FG000|STARTED|First Intervention||10||
59633578|NCT01642056|75747862|FG001|STARTED|First Intervention||10||
59633579|NCT01642056|75747861|FG000|COMPLETED|First Intervention||9||
59633580|NCT01642056|75747862|FG001|COMPLETED|First Intervention||10||
59633581|NCT01642056|75747861|FG000|NOT COMPLETED|First Intervention||1||
59633582|NCT01642056|75747862|FG001|NOT COMPLETED|First Intervention||0||
59633583|NCT01642056|75747861|FG000|STARTED|Second Intervention||9||
59633584|NCT01642056|75747862|FG001|STARTED|Second Intervention||10||
59633585|NCT01642056|75747861|FG000|COMPLETED|Second Intervention||8||
59633586|NCT01642056|75747862|FG001|COMPLETED|Second Intervention||8||
59633587|NCT01642056|75747861|FG000|NOT COMPLETED|Second Intervention||1||
59633588|NCT01642056|75747862|FG001|NOT COMPLETED|Second Intervention||2||
59633589|NCT01643382|75747870|FG000|STARTED|Overall Study||30||
59633590|NCT01643382|75747871|FG001|STARTED|Overall Study||30||
59633591|NCT01643382|75747870|FG000|COMPLETED|Overall Study||30||
59633592|NCT01643382|75747871|FG001|COMPLETED|Overall Study||30||
59633593|NCT01643382|75747870|FG000|NOT COMPLETED|Overall Study||0||
59633594|NCT01643382|75747871|FG001|NOT COMPLETED|Overall Study||0||
59633595|NCT01643616|75747879|FG000|STARTED|Overall Study||125||
59633596|NCT01643616|75747880|FG001|STARTED|Overall Study||125||
59633597|NCT01643616|75747879|FG000|COMPLETED|Overall Study||125||
59633598|NCT01643616|75747880|FG001|COMPLETED|Overall Study||125||
59633599|NCT01643616|75747879|FG000|NOT COMPLETED|Overall Study||0||
59633600|NCT01643616|75747880|FG001|NOT COMPLETED|Overall Study||0||
59633601|NCT01644240|75747889|FG000|STARTED|Overall Study||6||
59633602|NCT01644240|75747890|FG001|STARTED|Overall Study||4||
59633603|NCT01644240|75747891|FG002|STARTED|Overall Study||6||
59633604|NCT01644240|75747889|FG000|COMPLETED|Overall Study||6||
59633605|NCT01644240|75747890|FG001|COMPLETED|Overall Study||4||
59633606|NCT01644240|75747891|FG002|COMPLETED|Overall Study||6||
59633607|NCT01644240|75747889|FG000|NOT COMPLETED|Overall Study||0||
59633608|NCT01644240|75747890|FG001|NOT COMPLETED|Overall Study||0||
59633609|NCT01644240|75747891|FG002|NOT COMPLETED|Overall Study||0||
59633610|NCT01644396|75747899|FG000|STARTED|Overall Study||50||
59633611|NCT01644396|75747899|FG000|COMPLETED|Overall Study||50||
59633612|NCT01644396|75747899|FG000|NOT COMPLETED|Overall Study||0||
59633613|NCT01645098|75747906|FG000|STARTED|Overall Study||24||
59633614|NCT01645098|75747907|FG001|STARTED|Overall Study||29||
59633615|NCT01645098|75747906|FG000|COMPLETED|Overall Study||24||
59633616|NCT01645098|75747907|FG001|COMPLETED|Overall Study||29||
59633617|NCT01645098|75747906|FG000|NOT COMPLETED|Overall Study||0||
59633618|NCT01645098|75747907|FG001|NOT COMPLETED|Overall Study||0||
59633619|NCT01646346|75747913|FG000|STARTED|Overall Study||46||
59633620|NCT01646346|75747913|FG000|COMPLETED|Overall Study||46||
59633621|NCT01646346|75747913|FG000|NOT COMPLETED|Overall Study||0||
59633622|NCT01647438|75747919|FG000|STARTED|Overall Study||32||
59633623|NCT01647438|75747920|FG001|STARTED|Overall Study||31||
59633624|NCT01647438|75747919|FG000|COMPLETED|Overall Study||32||
59633625|NCT01647438|75747920|FG001|COMPLETED|Overall Study||31||
59633626|NCT01647438|75747919|FG000|NOT COMPLETED|Overall Study||0||
59633627|NCT01647438|75747920|FG001|NOT COMPLETED|Overall Study||0||
59633628|NCT01648452|75747926|FG000|STARTED|Overall Study||5||
59633629|NCT01648452|75747926|FG000|COMPLETED|Overall Study|One participant was explanted due to an adverse event. Remainder kept implant at study completion.|5||
59633630|NCT01648452|75747926|FG000|NOT COMPLETED|Overall Study||0||
59633631|NCT01648530|75747932|FG000|STARTED|Overall Study||16789||
59633632|NCT01648530|75747932|FG000|COMPLETED|Overall Study||5915||
59633633|NCT01648530|75747932|FG000|NOT COMPLETED|Overall Study||10874||
59633634|NCT01648920|75747938|FG000|STARTED|Overall Study||50||
59633635|NCT01648920|75747938|FG000|COMPLETED|Overall Study||50||
59633636|NCT01648920|75747938|FG000|NOT COMPLETED|Overall Study||0||
59633637|NCT01650324|75747947|FG000|STARTED|Overall Study||8||
59633638|NCT01650324|75747948|FG001|STARTED|Overall Study||6||
59633639|NCT01650324|75747949|FG002|STARTED|Overall Study||6||
59633640|NCT01650324|75747950|FG003|STARTED|Overall Study||6||
59633641|NCT01650324|75747951|FG004|STARTED|Overall Study||6||
59633642|NCT01650324|75747947|FG000|COMPLETED|Overall Study||8||
59633643|NCT01650324|75747948|FG001|COMPLETED|Overall Study||6||
59633644|NCT01650324|75747949|FG002|COMPLETED|Overall Study||6||
59633645|NCT01650324|75747950|FG003|COMPLETED|Overall Study||6||
59633646|NCT01650324|75747951|FG004|COMPLETED|Overall Study||6||
59633647|NCT01650324|75747947|FG000|NOT COMPLETED|Overall Study||0||
59633648|NCT01650324|75747948|FG001|NOT COMPLETED|Overall Study||0||
59633649|NCT01650324|75747949|FG002|NOT COMPLETED|Overall Study||0||
59633650|NCT01650324|75747950|FG003|NOT COMPLETED|Overall Study||0||
59633651|NCT01650324|75747951|FG004|NOT COMPLETED|Overall Study||0||
59633652|NCT01650402|75747970|FG000|STARTED|Overall Study||99||
59633653|NCT01650402|75747971|FG001|STARTED|Overall Study||100||
59633654|NCT01650402|75747970|FG000|COMPLETED|Overall Study||79||
59633655|NCT01650402|75747971|FG001|COMPLETED|Overall Study||86||
59633656|NCT01650402|75747970|FG000|NOT COMPLETED|Overall Study||20||
59633657|NCT01650402|75747971|FG001|NOT COMPLETED|Overall Study||14||
59633658|NCT01651104|75747977|FG000|STARTED|Overall Study||63||
59633659|NCT01651104|75747977|FG000|COMPLETED|Overall Study||63||
59633660|NCT01651104|75747977|FG000|NOT COMPLETED|Overall Study||0||
59633661|NCT01651806|75747986|FG000|STARTED|Overall Study||13||
59633662|NCT01651806|75747987|FG001|STARTED|Overall Study||12||
59633663|NCT01651806|75747988|FG002|STARTED|Overall Study||25||
59633664|NCT01651806|75747989|FG003|STARTED|Overall Study||7||
59633665|NCT01651806|75747990|FG004|STARTED|Overall Study||8||
59633666|NCT01651806|75747986|FG000|COMPLETED|Overall Study||13||
59633667|NCT01651806|75747987|FG001|COMPLETED|Overall Study||12||
59633668|NCT01651806|75747988|FG002|COMPLETED|Overall Study||25||
60076387|NCT01904773|76191367|FG003|COMPLETED|Sixth Intervention||2||
60076388|NCT01904773|76191368|FG004|COMPLETED|Sixth Intervention||3||
60076389|NCT01904773|76191369|FG005|COMPLETED|Sixth Intervention||4||
59540295|NCT02509026|75638453|FG000|NOT COMPLETED|Withdrawal Period (40 Weeks)||7||
59540296|NCT02509026|75638453|FG000|STARTED|Retreatment Period (12 Weeks)|Participants who completed Period 2 and achieved ASDAS-ESR>=2.1 were eligible to enter into Period 3|88||
59540297|NCT02509026|75638453|FG000|Treated|Retreatment Period (12 Weeks)||87||
59540298|NCT02509026|75638453|FG000|COMPLETED|Retreatment Period (12 Weeks)||84||
59540299|NCT02509026|75638453|FG000|NOT COMPLETED|Retreatment Period (12 Weeks)||4||
59540300|NCT03439280|75638468|FG000|STARTED|Overall Study||4||
59540301|NCT03439280|75638469|FG001|STARTED|Overall Study||3||
59540302|NCT03439280|75638470|FG002|STARTED|Overall Study||12||
60076390|NCT01904773|76191370|FG006|COMPLETED|Sixth Intervention||3||
60076391|NCT01904773|76191371|FG007|COMPLETED|Sixth Intervention||2||
60076392|NCT01904773|76191372|FG008|COMPLETED|Sixth Intervention||4||
59540303|NCT03439280|75638471|FG003|STARTED|Overall Study||22||
59540304|NCT03439280|75638472|FG004|STARTED|Overall Study||3||
59540305|NCT03439280|75638473|FG005|STARTED|Overall Study||6||
59540306|NCT03439280|75638474|FG006|STARTED|Overall Study||0||
59633669|NCT01651806|75747989|FG003|COMPLETED|Overall Study||7||
59633670|NCT01651806|75747990|FG004|COMPLETED|Overall Study||8||
59633671|NCT01651806|75747986|FG000|NOT COMPLETED|Overall Study||0||
59633672|NCT01651806|75747987|FG001|NOT COMPLETED|Overall Study||0||
60076393|NCT01904773|76191364|FG000|NOT COMPLETED|Sixth Intervention||0||
60076394|NCT01904773|76191365|FG001|NOT COMPLETED|Sixth Intervention||0||
60076395|NCT01904773|76191366|FG002|NOT COMPLETED|Sixth Intervention||0||
60076396|NCT01904773|76191367|FG003|NOT COMPLETED|Sixth Intervention||0||
60076397|NCT01904773|76191368|FG004|NOT COMPLETED|Sixth Intervention||0||
59633673|NCT01651806|75747988|FG002|NOT COMPLETED|Overall Study||0||
59633674|NCT01651806|75747989|FG003|NOT COMPLETED|Overall Study||0||
60076398|NCT01904773|76191369|FG005|NOT COMPLETED|Sixth Intervention||0||
60076399|NCT01904773|76191370|FG006|NOT COMPLETED|Sixth Intervention||0||
60076400|NCT01904773|76191371|FG007|NOT COMPLETED|Sixth Intervention||0||
59540307|NCT03439280|75638468|FG000|COMPLETED|Overall Study||4||
59633675|NCT01651806|75747990|FG004|NOT COMPLETED|Overall Study||0||
59633676|NCT01652040|75748005|FG000|STARTED|Overall Study||13||
60076401|NCT01904773|76191372|FG008|NOT COMPLETED|Sixth Intervention||0||
60076402|NCT01928719|76191386|FG000|STARTED|Overall Study||122||
60076403|NCT01928719|76191387|FG001|STARTED|Overall Study||123||
59540308|NCT03439280|75638469|FG001|COMPLETED|Overall Study||3||
59633677|NCT01652040|75748006|FG001|STARTED|Overall Study||13||
59633678|NCT01652040|75748005|FG000|COMPLETED|Overall Study||11||
59633679|NCT01652040|75748006|FG001|COMPLETED|Overall Study||11||
59540309|NCT03439280|75638470|FG002|COMPLETED|Overall Study||12||
59633680|NCT01652040|75748005|FG000|NOT COMPLETED|Overall Study||2||
59633681|NCT01652040|75748006|FG001|NOT COMPLETED|Overall Study||2||
59633682|NCT01652976|75748013|FG000|STARTED|Overall Study||44||
59633683|NCT01652976|75748013|FG000|COMPLETED|Overall Study||44||
59633684|NCT01652976|75748013|FG000|NOT COMPLETED|Overall Study||0||
59633685|NCT01653210|75748017|FG000|STARTED|Overall Study||15||
60076404|NCT01928719|76191386|FG000|COMPLETED|Overall Study||70||
60076405|NCT01928719|76191387|FG001|COMPLETED|Overall Study||104||
59540310|NCT03439280|75638471|FG003|COMPLETED|Overall Study||22||
59633686|NCT01653210|75748017|FG000|COMPLETED|Overall Study||12||
59633687|NCT01653210|75748017|FG000|NOT COMPLETED|Overall Study||3||
59633688|NCT01653288|75748023|FG000|STARTED|Overall Study||36||
59633689|NCT01653288|75748024|FG001|STARTED|Overall Study||36||
59633690|NCT01653288|75748023|FG000|COMPLETED|Overall Study||26||
59633691|NCT01653288|75748024|FG001|COMPLETED|Overall Study||35||
59633692|NCT01653288|75748023|FG000|NOT COMPLETED|Overall Study||10||
59633693|NCT01653288|75748024|FG001|NOT COMPLETED|Overall Study||1||
59633694|NCT01654068|75748032|FG000|STARTED|Overall Study||14||
59633695|NCT01654068|75748032|FG000|COMPLETED|Overall Study||14||
59633696|NCT01654068|75748032|FG000|NOT COMPLETED|Overall Study||0||
59633697|NCT01598922|75748038|FG000|STARTED|Overall Study||37||
59633698|NCT01598922|75748039|FG001|STARTED|Overall Study||40||
59633699|NCT01598922|75748038|FG000|COMPLETED|Overall Study||34||
59633700|NCT01598922|75748039|FG001|COMPLETED|Overall Study||30||
59633701|NCT01598922|75748038|FG000|NOT COMPLETED|Overall Study||3||
59633702|NCT01598922|75748039|FG001|NOT COMPLETED|Overall Study||10||
59633703|NCT01656252|75748045|FG000|STARTED|Phase I||14||
59633704|NCT01656252|75748045|FG000|COMPLETED|Phase I||14||
59633705|NCT01656252|75748045|FG000|NOT COMPLETED|Phase I||0||
59633706|NCT01656252|75748045|FG000|STARTED|Phase II||0||
59633707|NCT01656252|75748045|FG000|COMPLETED|Phase II||0||
59633708|NCT01656252|75748045|FG000|NOT COMPLETED|Phase II||0||
59633709|NCT01657344|75748051|FG000|STARTED|Overall Study||421622||
59633710|NCT01657344|75748052|FG001|STARTED|Overall Study||409967||
59633711|NCT01657344|75748053|FG002|STARTED|Overall Study||196300||
59633712|NCT01657344|75748054|FG003|STARTED|Overall Study||376517||
59633713|NCT01657344|75748055|FG004|STARTED|Overall Study||157802||
59633714|NCT01657344|75748056|FG005|STARTED|Overall Study||316477||
59633715|NCT01657344|75748057|FG006|STARTED|Overall Study||140776||
59633716|NCT01657344|75748051|FG000|COMPLETED|Overall Study||421622||
59633717|NCT01657344|75748052|FG001|COMPLETED|Overall Study||409967||
59633718|NCT01657344|75748053|FG002|COMPLETED|Overall Study||196300||
59633719|NCT01657344|75748054|FG003|COMPLETED|Overall Study||376517||
59633720|NCT01657344|75748055|FG004|COMPLETED|Overall Study||157802||
59633721|NCT01657344|75748056|FG005|COMPLETED|Overall Study||316477||
59633722|NCT01657344|75748057|FG006|COMPLETED|Overall Study||140776||
59633723|NCT01657344|75748051|FG000|NOT COMPLETED|Overall Study||0||
59633724|NCT01657344|75748052|FG001|NOT COMPLETED|Overall Study||0||
59633725|NCT01657344|75748053|FG002|NOT COMPLETED|Overall Study||0||
59633726|NCT01657344|75748054|FG003|NOT COMPLETED|Overall Study||0||
59633727|NCT01657344|75748055|FG004|NOT COMPLETED|Overall Study||0||
59633728|NCT01657344|75748056|FG005|NOT COMPLETED|Overall Study||0||
59633729|NCT01657344|75748057|FG006|NOT COMPLETED|Overall Study||0||
59633730|NCT01660230|75748079|FG000|STARTED|Overall Study||4||
59633731|NCT01660230|75748080|FG001|STARTED|Overall Study||4||
59633732|NCT01660230|75748081|FG002|STARTED|Overall Study||4||
59633733|NCT01660230|75748082|FG003|STARTED|Overall Study||4||
59633734|NCT01660230|75748083|FG004|STARTED|Overall Study||4||
59633735|NCT01660230|75748084|FG005|STARTED|Overall Study||2||
59633736|NCT01660230|75748085|FG006|STARTED|Overall Study||4||
59633737|NCT01660230|75748086|FG007|STARTED|Overall Study||6||
59633738|NCT01660230|75748087|FG008|STARTED|Overall Study||6||
59633739|NCT01660230|75748088|FG009|STARTED|Overall Study||6||
59988308|NCT02365480|76103436|FG001|COMPLETED|Overall Study||4||
59988309|NCT02365480|76103435|FG000|NOT COMPLETED|Overall Study||2||
59988310|NCT02365480|76103436|FG001|NOT COMPLETED|Overall Study||0||
59633740|NCT01660230|75748089|FG010|STARTED|Overall Study||6||
59633741|NCT01660230|75748090|FG011|STARTED|Overall Study||14||
59633742|NCT01660230|75748079|FG000|COMPLETED|Overall Study||4||
59633743|NCT01660230|75748080|FG001|COMPLETED|Overall Study||4||
59988311|NCT02270242|76103444|FG000|STARTED|Overall Study||3555||
59633744|NCT01660230|75748081|FG002|COMPLETED|Overall Study||4||
59633745|NCT01660230|75748082|FG003|COMPLETED|Overall Study||4||
59633746|NCT01660230|75748083|FG004|COMPLETED|Overall Study||4||
59633747|NCT01660230|75748084|FG005|COMPLETED|Overall Study||2||
59633748|NCT01660230|75748085|FG006|COMPLETED|Overall Study||4||
59633749|NCT01660230|75748086|FG007|COMPLETED|Overall Study||6||
59633750|NCT01660230|75748087|FG008|COMPLETED|Overall Study||6||
59633751|NCT01660230|75748088|FG009|COMPLETED|Overall Study||6||
59988312|NCT02270242|76103445|FG001|STARTED|Overall Study||3564||
59988313|NCT02270242|76103444|FG000|COMPLETED|Overall Study||3496||
59633752|NCT01660230|75748089|FG010|COMPLETED|Overall Study||6||
59633753|NCT01660230|75748090|FG011|COMPLETED|Overall Study||14||
59633754|NCT01660230|75748079|FG000|NOT COMPLETED|Overall Study||0||
59633755|NCT01660230|75748080|FG001|NOT COMPLETED|Overall Study||0||
59633756|NCT01660230|75748081|FG002|NOT COMPLETED|Overall Study||0||
59633757|NCT01660230|75748082|FG003|NOT COMPLETED|Overall Study||0||
59633758|NCT01660230|75748083|FG004|NOT COMPLETED|Overall Study||0||
59633759|NCT01660230|75748084|FG005|NOT COMPLETED|Overall Study||0||
59633760|NCT01660230|75748085|FG006|NOT COMPLETED|Overall Study||0||
59633761|NCT01660230|75748086|FG007|NOT COMPLETED|Overall Study||0||
59633762|NCT01660230|75748087|FG008|NOT COMPLETED|Overall Study||0||
59633763|NCT01660230|75748088|FG009|NOT COMPLETED|Overall Study||0||
59988314|NCT02270242|76103445|FG001|COMPLETED|Overall Study||3511||
59988315|NCT02270242|76103444|FG000|NOT COMPLETED|Overall Study||59||
59815701|NCT03379506|75938167|FG000|NOT COMPLETED|Overall Study||0||
59815702|NCT03379506|75938168|FG001|NOT COMPLETED|Overall Study||0||
59815703|NCT03379506|75938169|FG002|NOT COMPLETED|Overall Study||0||
59815704|NCT03379506|75938170|FG003|NOT COMPLETED|Overall Study||0||
59815705|NCT03341936|75938180|FG000|STARTED|Overall Study||29||
59815706|NCT03341936|75938180|FG000|Treated|Overall Study||28||
59815707|NCT03341936|75938180|FG000|COMPLETED|Overall Study||18||
59815708|NCT03341936|75938180|FG000|NOT COMPLETED|Overall Study||11||
59815709|NCT03284203|75938184|FG000|STARTED|Overall Study||8||
59815710|NCT03284203|75938184|FG000|COMPLETED|Overall Study||5||
59815711|NCT03284203|75938184|FG000|NOT COMPLETED|Overall Study||3||
59815712|NCT03233724|75938193|FG000|STARTED|Phase I Dose Escalation||2||
59815713|NCT03233724|75938194|FG001|STARTED|Phase I Dose Escalation||2||
59815714|NCT03233724|75938195|FG002|STARTED|Phase I Dose Escalation||4||
59815715|NCT03233724|75938196|FG003|STARTED|Phase I Dose Escalation|No participants were enrolled in this Arm/Group.|0||
59815716|NCT03233724|75938197|FG004|STARTED|Phase I Dose Escalation||1||
59633764|NCT01660230|75748089|FG010|NOT COMPLETED|Overall Study||0||
59633765|NCT01660230|75748090|FG011|NOT COMPLETED|Overall Study||0||
59633766|NCT01660698|75748119|FG000|STARTED|Overall Study||10||
59633767|NCT01660698|75748120|FG001|STARTED|Overall Study||10||
59633768|NCT01660698|75748119|FG000|COMPLETED|Overall Study||10||
59633769|NCT01660698|75748120|FG001|COMPLETED|Overall Study||10||
59633770|NCT01660698|75748119|FG000|NOT COMPLETED|Overall Study||0||
59633771|NCT01660698|75748120|FG001|NOT COMPLETED|Overall Study||0||
59633772|NCT01661088|75748126|FG000|STARTED|FOLFIRINOX||25||
59633773|NCT01661088|75748126|FG000|COMPLETED|FOLFIRINOX||21||
59633774|NCT01661088|75748126|FG000|NOT COMPLETED|FOLFIRINOX||4||
59633775|NCT01661088|75748126|FG000|STARTED|IMRT With FDR Gemcitabine||21||
59633776|NCT01661088|75748126|FG000|COMPLETED|IMRT With FDR Gemcitabine||19||
59633777|NCT01661088|75748126|FG000|NOT COMPLETED|IMRT With FDR Gemcitabine||2||
59633778|NCT01661712|75748132|FG000|STARTED|Overall Study|initial sham stimulation night|18|1st night, patients completed intervention/sham arm in randomised assigned order, cross-over design.|
59633779|NCT01661712|75748133|FG001|STARTED|Overall Study|initial night on transcutaneous electrical stimulation|18|1st night, patients completed intervention/sham arm in randomised assigned order, cross-over design.|
59633780|NCT01661712|75748132|FG000|Washout Period|Overall Study|>Three nights of no stimulation/sham stimulation|18|Washout period of >3 nights.|
59633781|NCT01661712|75748133|FG001|Washout Period|Overall Study|>Three nights of no stimulation/sham stimulation|18|Washout period of >3 nights.|
59633782|NCT01661712|75748132|FG000|COMPLETED|Overall Study|night on transcutaneous electrical stimulation|18|2nd night, patients completed intervention/sham arm in randomised assigned order, cross-over design.|
59633783|NCT01661712|75748133|FG001|COMPLETED|Overall Study|sham stimulation night|18|2nd night, patients completed intervention/sham arm in randomised assigned order, cross-over design.|
59633784|NCT01661712|75748132|FG000|NOT COMPLETED|Overall Study||0||
59633785|NCT01661712|75748133|FG001|NOT COMPLETED|Overall Study||0||
59633786|NCT01661946|75748147|FG000|STARTED|Overall Study||5||
59633787|NCT01661946|75748148|FG001|STARTED|Overall Study||5||
59633788|NCT01661946|75748147|FG000|COMPLETED|Overall Study||5||
59633789|NCT01661946|75748148|FG001|COMPLETED|Overall Study||5||
59633790|NCT01661946|75748147|FG000|NOT COMPLETED|Overall Study||0||
59633791|NCT01661946|75748148|FG001|NOT COMPLETED|Overall Study||0||
59633792|NCT01662882|75748157|FG000|STARTED|Overall Study||15||
59633793|NCT01662882|75748158|FG001|STARTED|Overall Study||18||
59815717|NCT03233724|75938193|FG000|COMPLETED|Phase I Dose Escalation||1||
59815718|NCT03233724|75938194|FG001|COMPLETED|Phase I Dose Escalation||1||
59633794|NCT01662882|75748159|FG002|STARTED|Overall Study||15||
59633795|NCT01662882|75748157|FG000|COMPLETED|Overall Study||15||
59633796|NCT01662882|75748158|FG001|COMPLETED|Overall Study||18||
59633797|NCT01662882|75748159|FG002|COMPLETED|Overall Study||15||
59633798|NCT01662882|75748157|FG000|NOT COMPLETED|Overall Study||0||
59633799|NCT01662882|75748158|FG001|NOT COMPLETED|Overall Study||0||
59633800|NCT01662882|75748159|FG002|NOT COMPLETED|Overall Study||0||
59633801|NCT01662960|75748171|FG000|STARTED|End of 4 Week Treatment Period||25||
59633802|NCT01662960|75748172|FG001|STARTED|End of 4 Week Treatment Period||23||
59633803|NCT01662960|75748173|FG002|STARTED|End of 4 Week Treatment Period||9||
59633804|NCT01662960|75748174|FG003|STARTED|End of 4 Week Treatment Period||15||
59633805|NCT01662960|75748171|FG000|COMPLETED|End of 4 Week Treatment Period||24||
59633806|NCT01662960|75748172|FG001|COMPLETED|End of 4 Week Treatment Period||19||
59633807|NCT01662960|75748173|FG002|COMPLETED|End of 4 Week Treatment Period||8||
59633808|NCT01662960|75748174|FG003|COMPLETED|End of 4 Week Treatment Period||15||
59633809|NCT01662960|75748171|FG000|NOT COMPLETED|End of 4 Week Treatment Period||1||
59633810|NCT01662960|75748172|FG001|NOT COMPLETED|End of 4 Week Treatment Period||4||
59633811|NCT01662960|75748173|FG002|NOT COMPLETED|End of 4 Week Treatment Period||1||
59633812|NCT01662960|75748174|FG003|NOT COMPLETED|End of 4 Week Treatment Period||0||
59815719|NCT03233724|75938195|FG002|COMPLETED|Phase I Dose Escalation||1||
59815720|NCT03233724|75938196|FG003|COMPLETED|Phase I Dose Escalation||0||
59815721|NCT03233724|75938197|FG004|COMPLETED|Phase I Dose Escalation||0||
59815722|NCT03233724|75938193|FG000|NOT COMPLETED|Phase I Dose Escalation||1||
59815723|NCT03233724|75938194|FG001|NOT COMPLETED|Phase I Dose Escalation||1||
59815724|NCT03233724|75938195|FG002|NOT COMPLETED|Phase I Dose Escalation||3||
59815725|NCT03233724|75938196|FG003|NOT COMPLETED|Phase I Dose Escalation||0||
59540311|NCT03439280|75638472|FG004|COMPLETED|Overall Study||3||
59540312|NCT03439280|75638473|FG005|COMPLETED|Overall Study||6||
59540313|NCT03439280|75638474|FG006|COMPLETED|Overall Study||0||
59540314|NCT03439280|75638468|FG000|NOT COMPLETED|Overall Study||0||
59540315|NCT03439280|75638469|FG001|NOT COMPLETED|Overall Study||0||
59540316|NCT03439280|75638470|FG002|NOT COMPLETED|Overall Study||0||
59540317|NCT03439280|75638471|FG003|NOT COMPLETED|Overall Study||0||
59540318|NCT03439280|75638472|FG004|NOT COMPLETED|Overall Study||0||
59540319|NCT03439280|75638473|FG005|NOT COMPLETED|Overall Study||0||
59540320|NCT03439280|75638474|FG006|NOT COMPLETED|Overall Study||0||
59540321|NCT00828074|75638493|FG000|STARTED|Overall Study||6||
59540322|NCT00828074|75638494|FG001|STARTED|Overall Study||5||
59540323|NCT00828074|75638495|FG002|STARTED|Overall Study||35||
59540324|NCT00828074|75638493|FG000|COMPLETED|Overall Study||6||
59540325|NCT00828074|75638494|FG001|COMPLETED|Overall Study||5||
59540326|NCT00828074|75638495|FG002|COMPLETED|Overall Study||35||
59540327|NCT00828074|75638493|FG000|NOT COMPLETED|Overall Study||0||
59540328|NCT00828074|75638494|FG001|NOT COMPLETED|Overall Study||0||
59540329|NCT00828074|75638495|FG002|NOT COMPLETED|Overall Study||0||
59540330|NCT01394003|75638513|FG000|STARTED|Overall Study||3||
59540331|NCT01394003|75638514|FG001|STARTED|Overall Study||8||
59540332|NCT01394003|75638515|FG002|STARTED|Overall Study||3||
59540333|NCT01394003|75638516|FG003|STARTED|Overall Study||6||
59540334|NCT01394003|75638517|FG004|STARTED|Overall Study||3||
59540335|NCT01394003|75638518|FG005|STARTED|Overall Study||3||
59540336|NCT01394003|75638519|FG006|STARTED|Overall Study||6||
59540337|NCT01394003|75638520|FG007|STARTED|Overall Study||2||
59540338|NCT01394003|75638513|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3||
59540339|NCT01394003|75638514|FG001|Received at Least 1 Dose of Study Drug|Overall Study||8||
59540340|NCT01394003|75638515|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3||
59540341|NCT01394003|75638516|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6||
59540342|NCT01394003|75638517|FG004|Received at Least 1 Dose of Study Drug|Overall Study||3||
59540343|NCT01394003|75638518|FG005|Received at Least 1 Dose of Study Drug|Overall Study||3||
59540344|NCT01394003|75638519|FG006|Received at Least 1 Dose of Study Drug|Overall Study||6||
59540345|NCT01394003|75638520|FG007|Received at Least 1 Dose of Study Drug|Overall Study||2||
59540346|NCT01394003|75638513|FG000|COMPLETED|Overall Study||3||
59540347|NCT01394003|75638514|FG001|COMPLETED|Overall Study||8||
59540348|NCT01394003|75638515|FG002|COMPLETED|Overall Study||3||
59540349|NCT01394003|75638516|FG003|COMPLETED|Overall Study||6||
59540350|NCT01394003|75638517|FG004|COMPLETED|Overall Study||3||
59540351|NCT01394003|75638518|FG005|COMPLETED|Overall Study||3||
59540352|NCT01394003|75638519|FG006|COMPLETED|Overall Study||6||
59540353|NCT01394003|75638520|FG007|COMPLETED|Overall Study||2||
59540354|NCT01394003|75638513|FG000|NOT COMPLETED|Overall Study||0||
59540355|NCT01394003|75638514|FG001|NOT COMPLETED|Overall Study||0||
59540356|NCT01394003|75638515|FG002|NOT COMPLETED|Overall Study||0||
59540357|NCT01394003|75638516|FG003|NOT COMPLETED|Overall Study||0||
59540358|NCT01394003|75638517|FG004|NOT COMPLETED|Overall Study||0||
59540359|NCT01394003|75638518|FG005|NOT COMPLETED|Overall Study||0||
59540360|NCT01394003|75638519|FG006|NOT COMPLETED|Overall Study||0||
59540361|NCT01394003|75638520|FG007|NOT COMPLETED|Overall Study||0||
59540362|NCT01394081|75638546|FG000|STARTED|Overall Study||101||
59540363|NCT01394081|75638547|FG001|STARTED|Overall Study||102||
59540364|NCT01394081|75638546|FG000|COMPLETED|Overall Study||101||
59540365|NCT01394081|75638547|FG001|COMPLETED|Overall Study||102||
59540366|NCT01394081|75638546|FG000|NOT COMPLETED|Overall Study||0||
59540367|NCT01394081|75638547|FG001|NOT COMPLETED|Overall Study||0||
59540368|NCT00880022|75638557|FG000|STARTED|Overall Study||23||
59540369|NCT00880022|75638558|FG001|STARTED|Overall Study||24||
59540370|NCT00880022|75638557|FG000|COMPLETED|Overall Study||21||
59540371|NCT00880022|75638558|FG001|COMPLETED|Overall Study||21||
59540372|NCT00880022|75638557|FG000|NOT COMPLETED|Overall Study||2||
59540373|NCT00880022|75638558|FG001|NOT COMPLETED|Overall Study||3||
59540374|NCT01430819|75638568|FG000|STARTED|Overall Study||150||
59540375|NCT01430819|75638569|FG001|STARTED|Overall Study||150||
59540376|NCT01430819|75638568|FG000|COMPLETED|Overall Study||150||
59540377|NCT01430819|75638569|FG001|COMPLETED|Overall Study||150||
59540378|NCT01430819|75638568|FG000|NOT COMPLETED|Overall Study||0||
59540379|NCT01430819|75638569|FG001|NOT COMPLETED|Overall Study||0||
59540380|NCT00828542|75638577|FG000|STARTED|Overall Study||23||
59540381|NCT00828542|75638578|FG001|STARTED|Overall Study||23||
59540382|NCT00828542|75638577|FG000|COMPLETED|Overall Study||20||
59540383|NCT00828542|75638578|FG001|COMPLETED|Overall Study||20||
59540384|NCT00828542|75638577|FG000|NOT COMPLETED|Overall Study||3||
59540385|NCT00828542|75638578|FG001|NOT COMPLETED|Overall Study||3||
59540386|NCT01394159|75638586|FG000|STARTED|Overall Study||28||
59540387|NCT01394159|75638587|FG001|STARTED|Overall Study||28||
59540388|NCT01394159|75638586|FG000|COMPLETED|Overall Study||28||
59540389|NCT01394159|75638587|FG001|COMPLETED|Overall Study||28||
59540390|NCT01394159|75638586|FG000|NOT COMPLETED|Overall Study||0||
59540391|NCT01394159|75638587|FG001|NOT COMPLETED|Overall Study||0||
59540392|NCT01394705|75638595|FG000|STARTED|Overall Study||21||
59540393|NCT01394705|75638596|FG001|STARTED|Overall Study||21||
59540394|NCT01394705|75638595|FG000|COMPLETED|Overall Study||19||
59540395|NCT01394705|75638596|FG001|COMPLETED|Overall Study||19||
59540396|NCT01394705|75638595|FG000|NOT COMPLETED|Overall Study||2||
59540397|NCT01394705|75638596|FG001|NOT COMPLETED|Overall Study||2||
59540398|NCT01395329|75638606|FG000|STARTED|Overall Study||14||
59540399|NCT01395329|75638607|FG001|STARTED|Overall Study||14||
59540400|NCT01395329|75638608|FG002|STARTED|Overall Study||14||
59540401|NCT01395329|75638606|FG000|COMPLETED|Overall Study||14||
59540402|NCT01395329|75638607|FG001|COMPLETED|Overall Study||14||
59540403|NCT01395329|75638608|FG002|COMPLETED|Overall Study||14||
59540404|NCT01395329|75638606|FG000|NOT COMPLETED|Overall Study||0||
59540405|NCT01395329|75638607|FG001|NOT COMPLETED|Overall Study||0||
59540406|NCT01395329|75638608|FG002|NOT COMPLETED|Overall Study||0||
59540407|NCT00882206|75638619|FG000|STARTED|Overall Study||13||
59540408|NCT00882206|75638619|FG000|COMPLETED|Overall Study||13||
59540409|NCT00882206|75638619|FG000|NOT COMPLETED|Overall Study||0||
59540410|NCT00831272|75638628|FG000|STARTED|Overall Study||38||
59540411|NCT00831272|75638629|FG001|STARTED|Overall Study||44||
59540412|NCT00831272|75638630|FG002|STARTED|Overall Study||73||
59540413|NCT00831272|75638631|FG003|STARTED|Overall Study||66||
59633813|NCT01662960|75748171|FG000|STARTED|3 Month Follow-up||24||
59540414|NCT00831272|75638628|FG000|COMPLETED|Overall Study||30||
59540415|NCT00831272|75638629|FG001|COMPLETED|Overall Study||37||
59540416|NCT00831272|75638630|FG002|COMPLETED|Overall Study||63||
59540417|NCT00831272|75638631|FG003|COMPLETED|Overall Study||56||
59540418|NCT00831272|75638628|FG000|NOT COMPLETED|Overall Study||8||
59540419|NCT00831272|75638629|FG001|NOT COMPLETED|Overall Study||7||
59540420|NCT00831272|75638630|FG002|NOT COMPLETED|Overall Study||10||
59540421|NCT00831272|75638631|FG003|NOT COMPLETED|Overall Study||10||
59540422|NCT00831428|75638641|FG000|STARTED|Overall Study||97||
59540423|NCT00831428|75638641|FG000|COMPLETED|Overall Study||97||
59540424|NCT00831428|75638641|FG000|NOT COMPLETED|Overall Study||0||
59540425|NCT00832130|75638647|FG000|STARTED|Overall Study||69||
59540426|NCT00832130|75638648|FG001|STARTED|Overall Study||70||
59540427|NCT00832130|75638647|FG000|COMPLETED|Overall Study||69||
59540428|NCT00832130|75638648|FG001|COMPLETED|Overall Study||70||
59540429|NCT00832130|75638647|FG000|NOT COMPLETED|Overall Study||0||
59540430|NCT00832130|75638648|FG001|NOT COMPLETED|Overall Study||0||
59540431|NCT00885092|75638656|FG000|STARTED|Period 1, 7 Days||20||
59540432|NCT00885092|75638657|FG001|STARTED|Period 1, 7 Days||20||
59540433|NCT00885092|75638656|FG000|COMPLETED|Period 1, 7 Days||20||
59540434|NCT00885092|75638657|FG001|COMPLETED|Period 1, 7 Days||20||
59540435|NCT00885092|75638656|FG000|NOT COMPLETED|Period 1, 7 Days||0||
59540436|NCT00885092|75638657|FG001|NOT COMPLETED|Period 1, 7 Days||0||
59540437|NCT00885092|75638656|FG000|STARTED|Period 2, 7 Days||20||
59540438|NCT00885092|75638657|FG001|STARTED|Period 2, 7 Days||20||
59540439|NCT00885092|75638656|FG000|COMPLETED|Period 2, 7 Days||20||
59540440|NCT00885092|75638657|FG001|COMPLETED|Period 2, 7 Days||20||
59540441|NCT00885092|75638656|FG000|NOT COMPLETED|Period 2, 7 Days||0||
59540442|NCT00885092|75638657|FG001|NOT COMPLETED|Period 2, 7 Days||0||
59540443|NCT01512251|75638665|FG000|STARTED|Dose Level -1||3||
59540444|NCT01512251|75638666|FG001|STARTED|Dose Level -1||5||
59540445|NCT01512251|75638665|FG000|COMPLETED|Dose Level -1||3||
59540446|NCT01512251|75638666|FG001|COMPLETED|Dose Level -1||5||
59540447|NCT01512251|75638665|FG000|NOT COMPLETED|Dose Level -1||0||
59540448|NCT01512251|75638666|FG001|NOT COMPLETED|Dose Level -1||0||
59540449|NCT01512251|75638665|FG000|STARTED|Phase I, Dose 1||3||
59540450|NCT01512251|75638666|FG001|STARTED|Phase I, Dose 1||5||
59540451|NCT01512251|75638665|FG000|COMPLETED|Phase I, Dose 1||0||
59540452|NCT01512251|75638666|FG001|COMPLETED|Phase I, Dose 1||0||
59540453|NCT01512251|75638665|FG000|NOT COMPLETED|Phase I, Dose 1||3||
59540454|NCT01512251|75638666|FG001|NOT COMPLETED|Phase I, Dose 1||5||
59633814|NCT01662960|75748172|FG001|STARTED|3 Month Follow-up||19||
59633815|NCT01662960|75748173|FG002|STARTED|3 Month Follow-up||8||
59540455|NCT01512251|75638665|FG000|STARTED|Phase I, Dose 2||0||
59540456|NCT01512251|75638666|FG001|STARTED|Phase I, Dose 2||0||
59540457|NCT01512251|75638665|FG000|COMPLETED|Phase I, Dose 2||0||
59540458|NCT01512251|75638666|FG001|COMPLETED|Phase I, Dose 2||0||
59540459|NCT01512251|75638665|FG000|NOT COMPLETED|Phase I, Dose 2||0||
59540460|NCT01512251|75638666|FG001|NOT COMPLETED|Phase I, Dose 2||0||
59540461|NCT01512251|75638665|FG000|STARTED|Phase I, Dose 3||0||
59540462|NCT01512251|75638666|FG001|STARTED|Phase I, Dose 3||0||
59540463|NCT01512251|75638665|FG000|COMPLETED|Phase I, Dose 3||0||
59540464|NCT01512251|75638666|FG001|COMPLETED|Phase I, Dose 3||0||
59633816|NCT01662960|75748174|FG003|STARTED|3 Month Follow-up||15||
59540465|NCT01512251|75638665|FG000|NOT COMPLETED|Phase I, Dose 3||0||
59540466|NCT01512251|75638666|FG001|NOT COMPLETED|Phase I, Dose 3||0||
59540467|NCT01512251|75638665|FG000|STARTED|Phase I, Dose 4||0||
59540468|NCT01512251|75638666|FG001|STARTED|Phase I, Dose 4||0||
59540469|NCT01512251|75638665|FG000|COMPLETED|Phase I, Dose 4||0||
59540470|NCT01512251|75638666|FG001|COMPLETED|Phase I, Dose 4||0||
59540471|NCT01512251|75638665|FG000|NOT COMPLETED|Phase I, Dose 4||0||
59540472|NCT01512251|75638666|FG001|NOT COMPLETED|Phase I, Dose 4||0||
59540473|NCT01512251|75638665|FG000|STARTED|Phase II||0||
59540474|NCT01512251|75638666|FG001|STARTED|Phase II||0||
59633817|NCT01662960|75748171|FG000|COMPLETED|3 Month Follow-up||21||
59633818|NCT01662960|75748172|FG001|COMPLETED|3 Month Follow-up||16||
59633819|NCT01662960|75748173|FG002|COMPLETED|3 Month Follow-up||5||
59633820|NCT01662960|75748174|FG003|COMPLETED|3 Month Follow-up||13||
59633821|NCT01662960|75748171|FG000|NOT COMPLETED|3 Month Follow-up||3||
59633822|NCT01662960|75748172|FG001|NOT COMPLETED|3 Month Follow-up||3||
59633823|NCT01662960|75748173|FG002|NOT COMPLETED|3 Month Follow-up||3||
59633824|NCT01662960|75748174|FG003|NOT COMPLETED|3 Month Follow-up||2||
59633825|NCT01663272|75748184|FG000|STARTED|Overall Study||5||
59633826|NCT01663272|75748185|FG001|STARTED|Overall Study||6||
59633827|NCT01663272|75748186|FG002|STARTED|Overall Study||1||
59633828|NCT01663272|75748184|FG000|COMPLETED|Overall Study||5||
59633829|NCT01663272|75748185|FG001|COMPLETED|Overall Study||6||
59633830|NCT01663272|75748186|FG002|COMPLETED|Overall Study||1||
59633831|NCT01663272|75748184|FG000|NOT COMPLETED|Overall Study||0||
59633832|NCT01663272|75748185|FG001|NOT COMPLETED|Overall Study||0||
59633833|NCT01663272|75748186|FG002|NOT COMPLETED|Overall Study||0||
59633834|NCT01667250|75748192|FG000|STARTED|Run-in (no Treatment)||0||
59633835|NCT01667250|75748193|FG001|STARTED|Run-in (no Treatment)||0||
59633836|NCT01667250|75748194|FG002|STARTED|Run-in (no Treatment)||73||
59633837|NCT01667250|75748192|FG000|COMPLETED|Run-in (no Treatment)||0||
59633838|NCT01667250|75748193|FG001|COMPLETED|Run-in (no Treatment)||0||
59633839|NCT01667250|75748194|FG002|COMPLETED|Run-in (no Treatment)||59||
59633840|NCT01667250|75748192|FG000|NOT COMPLETED|Run-in (no Treatment)||0||
59633841|NCT01667250|75748193|FG001|NOT COMPLETED|Run-in (no Treatment)||0||
59633842|NCT01667250|75748194|FG002|NOT COMPLETED|Run-in (no Treatment)||14||
59633843|NCT01667250|75748192|FG000|STARTED|Randomised Period||30||
59633844|NCT01667250|75748193|FG001|STARTED|Randomised Period||29||
59633845|NCT01667250|75748194|FG002|STARTED|Randomised Period||0||
59633846|NCT01667250|75748192|FG000|COMPLETED|Randomised Period||29||
59633847|NCT01667250|75748193|FG001|COMPLETED|Randomised Period||28||
59633848|NCT01667250|75748194|FG002|COMPLETED|Randomised Period||0||
59633849|NCT01667250|75748192|FG000|NOT COMPLETED|Randomised Period||1||
59633850|NCT01667250|75748193|FG001|NOT COMPLETED|Randomised Period||1||
59633851|NCT01667250|75748194|FG002|NOT COMPLETED|Randomised Period||0||
59633852|NCT01667406|75748211|FG000|STARTED|Overall Study||2||
59633853|NCT01667406|75748212|FG001|STARTED|Overall Study||3||
59633854|NCT01667406|75748213|FG002|STARTED|Overall Study||24||
59633855|NCT01667406|75748214|FG003|STARTED|Overall Study||24||
59633856|NCT01667406|75748215|FG004|STARTED|Overall Study||5||
59633857|NCT01667406|75748216|FG005|STARTED|Overall Study||20||
59633858|NCT01667406|75748217|FG006|STARTED|Overall Study||15||
59633859|NCT01667406|75748218|FG007|STARTED|Overall Study||20||
59633860|NCT01667406|75748219|FG008|STARTED|Overall Study||31||
59633861|NCT01667406|75748220|FG009|STARTED|Overall Study||31||
59633862|NCT01667406|75748211|FG000|COMPLETED|Overall Study||2||
59633863|NCT01667406|75748212|FG001|COMPLETED|Overall Study||3||
59633864|NCT01667406|75748213|FG002|COMPLETED|Overall Study||24||
59633865|NCT01667406|75748214|FG003|COMPLETED|Overall Study||24||
59633866|NCT01667406|75748215|FG004|COMPLETED|Overall Study||5||
59633867|NCT01667406|75748216|FG005|COMPLETED|Overall Study||20||
59633868|NCT01667406|75748217|FG006|COMPLETED|Overall Study||15||
59633869|NCT01667406|75748218|FG007|COMPLETED|Overall Study||20||
59633870|NCT01667406|75748219|FG008|COMPLETED|Overall Study||31||
59633871|NCT01667406|75748220|FG009|COMPLETED|Overall Study||31||
59633872|NCT01667406|75748211|FG000|NOT COMPLETED|Overall Study||0||
59633873|NCT01667406|75748212|FG001|NOT COMPLETED|Overall Study||0||
59633874|NCT01667406|75748213|FG002|NOT COMPLETED|Overall Study||0||
59633875|NCT01667406|75748214|FG003|NOT COMPLETED|Overall Study||0||
59633876|NCT01667406|75748215|FG004|NOT COMPLETED|Overall Study||0||
59633877|NCT01667406|75748216|FG005|NOT COMPLETED|Overall Study||0||
59633878|NCT01667406|75748217|FG006|NOT COMPLETED|Overall Study||0||
59633879|NCT01667406|75748218|FG007|NOT COMPLETED|Overall Study||0||
59633880|NCT01667406|75748219|FG008|NOT COMPLETED|Overall Study||0||
59633881|NCT01667406|75748220|FG009|NOT COMPLETED|Overall Study||0||
59633882|NCT01667796|75748274|FG000|STARTED|Overall Study||27||
59633883|NCT01667796|75748275|FG001|STARTED|Overall Study||30||
59633884|NCT01667796|75748274|FG000|COMPLETED|Overall Study||24||
59633885|NCT01667796|75748275|FG001|COMPLETED|Overall Study||29||
59633886|NCT01667796|75748274|FG000|NOT COMPLETED|Overall Study||3||
59633887|NCT01667796|75748275|FG001|NOT COMPLETED|Overall Study||1||
59633888|NCT01668030|75748285|FG000|STARTED|Overall Study||10||10
59633889|NCT01668030|75748286|FG001|STARTED|Overall Study||10||10
59633890|NCT01668030|75748285|FG000|COMPLETED|Overall Study||10||10
59633891|NCT01668030|75748286|FG001|COMPLETED|Overall Study||10||10
59633892|NCT01668030|75748285|FG000|NOT COMPLETED|Overall Study||0||0
59633893|NCT01668030|75748286|FG001|NOT COMPLETED|Overall Study||0||0
59633894|NCT01669434|75748293|FG000|STARTED|Overall Study||146||
59633895|NCT01669434|75748294|FG001|STARTED|Overall Study||145||
59633896|NCT01669434|75748293|FG000|COMPLETED|Overall Study||137||
59633897|NCT01669434|75748294|FG001|COMPLETED|Overall Study||138||
59633898|NCT01669434|75748293|FG000|NOT COMPLETED|Overall Study||9||
59633899|NCT01669434|75748294|FG001|NOT COMPLETED|Overall Study||7||
59633900|NCT01670760|75748300|FG000|STARTED|Overall Study||20||
59633901|NCT01670760|75748300|FG000|COMPLETED|Overall Study||20||
59540475|NCT01512251|75638665|FG000|COMPLETED|Phase II||0||
59540476|NCT01512251|75638666|FG001|COMPLETED|Phase II||0||
59540477|NCT01512251|75638665|FG000|NOT COMPLETED|Phase II||0||
59540478|NCT01512251|75638666|FG001|NOT COMPLETED|Phase II||0||
59540479|NCT00885638|75638673|FG000|STARTED|Overall Study||6||
59540480|NCT00885638|75638674|FG001|STARTED|Overall Study||6||
59540481|NCT00885638|75638673|FG000|COMPLETED|Overall Study||6||
59540482|NCT00885638|75638674|FG001|COMPLETED|Overall Study||6||
59540483|NCT00885638|75638673|FG000|NOT COMPLETED|Overall Study||0||
59540484|NCT00885638|75638674|FG001|NOT COMPLETED|Overall Study||0||
59540485|NCT01512797|75638683|FG000|STARTED|Overall Study||16||
59540486|NCT01512797|75638684|FG001|STARTED|Overall Study||16||
59540487|NCT01512797|75638683|FG000|COMPLETED|Overall Study||16||
59540488|NCT01512797|75638684|FG001|COMPLETED|Overall Study||16||
59540489|NCT01512797|75638683|FG000|NOT COMPLETED|Overall Study||0||
59540490|NCT01512797|75638684|FG001|NOT COMPLETED|Overall Study||0||
59540491|NCT01395797|75638696|FG000|STARTED|Overall Study||19||
59540492|NCT01395797|75638697|FG001|STARTED|Overall Study||4||
59540493|NCT01395797|75638698|FG002|STARTED|Overall Study||18||
59540494|NCT01395797|75638699|FG003|STARTED|Overall Study||15||
59540495|NCT01395797|75638700|FG004|STARTED|Overall Study||9||
59540496|NCT01395797|75638701|FG005|STARTED|Overall Study||17||
59540497|NCT01395797|75638696|FG000|COMPLETED|Overall Study||16||
59540498|NCT01395797|75638697|FG001|COMPLETED|Overall Study||3||
59540499|NCT01395797|75638698|FG002|COMPLETED|Overall Study||14||
59540500|NCT01395797|75638699|FG003|COMPLETED|Overall Study||13||
59540501|NCT01395797|75638700|FG004|COMPLETED|Overall Study||7||
59540502|NCT01395797|75638701|FG005|COMPLETED|Overall Study||14||
59540503|NCT01395797|75638696|FG000|NOT COMPLETED|Overall Study||3||
59540504|NCT01395797|75638697|FG001|NOT COMPLETED|Overall Study||1||
59540505|NCT01395797|75638698|FG002|NOT COMPLETED|Overall Study||4||
59540506|NCT01395797|75638699|FG003|NOT COMPLETED|Overall Study||2||
59540507|NCT01395797|75638700|FG004|NOT COMPLETED|Overall Study||2||
59540508|NCT01395797|75638701|FG005|NOT COMPLETED|Overall Study||3||
59540509|NCT00834236|75638723|FG000|STARTED|Overall Study||29||
59540510|NCT00834236|75638724|FG001|STARTED|Overall Study||47||
59540511|NCT00834236|75638723|FG000|COMPLETED|Overall Study||29||
59540512|NCT00834236|75638724|FG001|COMPLETED|Overall Study||47||
59540513|NCT00834236|75638723|FG000|NOT COMPLETED|Overall Study||0||
59540514|NCT00834236|75638724|FG001|NOT COMPLETED|Overall Study||0||
59540515|NCT01431131|75638732|FG000|STARTED|Overall Study||12||
59540516|NCT01431131|75638733|FG001|STARTED|Overall Study||12||
59540517|NCT01431131|75638732|FG000|COMPLETED|Overall Study||12||
59540518|NCT01431131|75638733|FG001|COMPLETED|Overall Study||12||
59540519|NCT01431131|75638732|FG000|NOT COMPLETED|Overall Study||0||
59540520|NCT01431131|75638733|FG001|NOT COMPLETED|Overall Study||0||
59540521|NCT02203019|75638741|FG000|STARTED|Overall Study||19|Duration of mechanical ventilation|
59540522|NCT02203019|75638742|FG001|STARTED|Overall Study||17|Duration of mechanical ventilation|
59540523|NCT02203019|75638741|FG000|COMPLETED|Overall Study||19||
59540524|NCT02203019|75638742|FG001|COMPLETED|Overall Study||17||
59540525|NCT02203019|75638741|FG000|NOT COMPLETED|Overall Study||0||
59540526|NCT02203019|75638742|FG001|NOT COMPLETED|Overall Study||0||
59540527|NCT00886262|75638750|FG000|STARTED|Overall Study||8||
59540528|NCT00886262|75638751|FG001|STARTED|Overall Study||10||
59540529|NCT00886262|75638750|FG000|COMPLETED|Overall Study||8||
59540530|NCT00886262|75638751|FG001|COMPLETED|Overall Study||7||
59540531|NCT00886262|75638750|FG000|NOT COMPLETED|Overall Study||0||
59540532|NCT00886262|75638751|FG001|NOT COMPLETED|Overall Study||3||
59540533|NCT00887510|75638759|FG000|STARTED|Overall Study||12||
59540534|NCT00887510|75638760|FG001|STARTED|Overall Study||12||
59633902|NCT01670760|75748300|FG000|NOT COMPLETED|Overall Study||0||
59633903|NCT01673022|75748304|FG000|STARTED|Overall Study||430||
59633904|NCT01673022|75748304|FG000|COMPLETED|Overall Study||422||
59633905|NCT01673022|75748304|FG000|NOT COMPLETED|Overall Study||8||
59633906|NCT01673256|75748308|FG000|STARTED|Overall Study||90||
59633907|NCT01673256|75748308|FG000|COMPLETED|Overall Study||90||
59633908|NCT01673256|75748308|FG000|NOT COMPLETED|Overall Study||0||
59633909|NCT01673568|75748314|FG000|STARTED|Overall Study||28||
59633910|NCT01673568|75748315|FG001|STARTED|Overall Study||28||
59633911|NCT01673568|75748314|FG000|COMPLETED|Overall Study||28||
59633912|NCT01673568|75748315|FG001|COMPLETED|Overall Study||28||
59633913|NCT01673568|75748314|FG000|NOT COMPLETED|Overall Study||0||
59633914|NCT01673568|75748315|FG001|NOT COMPLETED|Overall Study||0||
59633915|NCT01673802|75748321|FG000|STARTED|Gadoxetate Standard Dose 0.025 mmol/kg||8||
59633916|NCT01673802|75748321|FG000|COMPLETED|Gadoxetate Standard Dose 0.025 mmol/kg||8||
59633917|NCT01673802|75748321|FG000|NOT COMPLETED|Gadoxetate Standard Dose 0.025 mmol/kg||0||
59633918|NCT01673802|75748321|FG000|STARTED|Gadoxetate Double Dose 0.050 mmol/kg||10||
59633919|NCT01673802|75748321|FG000|COMPLETED|Gadoxetate Double Dose 0.050 mmol/kg||10||
59633920|NCT01673802|75748321|FG000|NOT COMPLETED|Gadoxetate Double Dose 0.050 mmol/kg||0||
59633921|NCT01675830|75748325|FG000|STARTED|Overall Study||10||
59633922|NCT01675830|75748325|FG000|COMPLETED|Overall Study||10||
59633923|NCT01675830|75748325|FG000|NOT COMPLETED|Overall Study||0||
59633924|NCT01676298|75748337|FG000|STARTED|Overall Study||1||
59633925|NCT01676298|75748338|FG001|STARTED|Overall Study||1||
59633926|NCT01676298|75748339|FG002|STARTED|Overall Study||1||
59633927|NCT01676298|75748340|FG003|STARTED|Overall Study||1||
59633928|NCT01676298|75748341|FG004|STARTED|Overall Study||1||
59633929|NCT01676298|75748342|FG005|STARTED|Overall Study||1||
59633930|NCT01676298|75748343|FG006|STARTED|Overall Study||1||
59633931|NCT01676298|75748344|FG007|STARTED|Overall Study||1||
59633932|NCT01676298|75748337|FG000|All Genotypes Confirmed With Reference|Overall Study||1||
59633933|NCT01676298|75748338|FG001|All Genotypes Confirmed With Reference|Overall Study||1||
59633934|NCT01676298|75748339|FG002|All Genotypes Confirmed With Reference|Overall Study||1||
59633935|NCT01676298|75748340|FG003|All Genotypes Confirmed With Reference|Overall Study||1||
59633936|NCT01676298|75748341|FG004|All Genotypes Confirmed With Reference|Overall Study||1||
59633937|NCT01676298|75748342|FG005|All Genotypes Confirmed With Reference|Overall Study||1||
59633938|NCT01676298|75748343|FG006|All Genotypes Confirmed With Reference|Overall Study||1||
59633939|NCT01676298|75748344|FG007|All Genotypes Confirmed With Reference|Overall Study||1||
59633940|NCT01676298|75748337|FG000|Participated in All Tests|Overall Study||1||
59633941|NCT01676298|75748338|FG001|Participated in All Tests|Overall Study||1||
59633942|NCT01676298|75748339|FG002|Participated in All Tests|Overall Study||1||
59633943|NCT01676298|75748340|FG003|Participated in All Tests|Overall Study||1||
59633944|NCT01676298|75748341|FG004|Participated in All Tests|Overall Study||1||
59633945|NCT01676298|75748342|FG005|Participated in All Tests|Overall Study||1||
59633946|NCT01676298|75748343|FG006|Participated in All Tests|Overall Study||1||
59633947|NCT01676298|75748344|FG007|Participated in All Tests|Overall Study||1||
59633948|NCT01676298|75748337|FG000|COMPLETED|Overall Study||1||
59633949|NCT01676298|75748338|FG001|COMPLETED|Overall Study||1||
59633950|NCT01676298|75748339|FG002|COMPLETED|Overall Study||1||
59633951|NCT01676298|75748340|FG003|COMPLETED|Overall Study||1||
59633952|NCT01676298|75748341|FG004|COMPLETED|Overall Study||1||
59633953|NCT01676298|75748342|FG005|COMPLETED|Overall Study||1||
59633954|NCT01676298|75748343|FG006|COMPLETED|Overall Study||1||
59633955|NCT01676298|75748344|FG007|COMPLETED|Overall Study||1||
59633956|NCT01676298|75748337|FG000|NOT COMPLETED|Overall Study||0||
59633957|NCT01676298|75748338|FG001|NOT COMPLETED|Overall Study||0||
59633958|NCT01676298|75748339|FG002|NOT COMPLETED|Overall Study||0||
59633959|NCT01676298|75748340|FG003|NOT COMPLETED|Overall Study||0||
59633960|NCT01676298|75748341|FG004|NOT COMPLETED|Overall Study||0||
59633961|NCT01676298|75748342|FG005|NOT COMPLETED|Overall Study||0||
59633962|NCT01676298|75748343|FG006|NOT COMPLETED|Overall Study||0||
59633963|NCT01676298|75748344|FG007|NOT COMPLETED|Overall Study||0||
59633964|NCT01676532|75748362|FG000|STARTED|Overall Study||127||
59633965|NCT01676532|75748362|FG000|COMPLETED|Overall Study||127||
59633966|NCT01676532|75748362|FG000|NOT COMPLETED|Overall Study||0||
59633967|NCT01677312|75748373|FG000|STARTED|Overall Study||36||
59633968|NCT01677312|75748374|FG001|STARTED|Overall Study||36||
59633969|NCT01677312|75748373|FG000|COMPLETED|Overall Study||36||
59633970|NCT01677312|75748374|FG001|COMPLETED|Overall Study||36||
59633971|NCT01677312|75748373|FG000|NOT COMPLETED|Overall Study||0||
59633972|NCT01677312|75748374|FG001|NOT COMPLETED|Overall Study||0||
59633973|NCT01678794|75748382|FG000|STARTED|Overall Study||16||
59633974|NCT01678794|75748383|FG001|STARTED|Overall Study||17||
59633975|NCT01678794|75748382|FG000|COMPLETED|Overall Study||16||
59633976|NCT01678794|75748383|FG001|COMPLETED|Overall Study||17||
59633977|NCT01678794|75748382|FG000|NOT COMPLETED|Overall Study||0||
59633978|NCT01678794|75748383|FG001|NOT COMPLETED|Overall Study||0||
59633979|NCT01679028|75748395|FG000|STARTED|Overall Study||2||
59633980|NCT01679028|75748396|FG001|STARTED|Overall Study||4||
59633981|NCT01679028|75748397|FG002|STARTED|Overall Study||2||
59633982|NCT01679028|75748398|FG003|STARTED|Overall Study||4||
59633983|NCT01679028|75748399|FG004|STARTED|Overall Study||2||
59633984|NCT01679028|75748400|FG005|STARTED|Overall Study||6||
59633985|NCT01679028|75748395|FG000|COMPLETED|Overall Study||2||
59633986|NCT01679028|75748396|FG001|COMPLETED|Overall Study||4||
59633987|NCT01679028|75748397|FG002|COMPLETED|Overall Study||2||
59633988|NCT01679028|75748398|FG003|COMPLETED|Overall Study||4||
59633989|NCT01679028|75748399|FG004|COMPLETED|Overall Study||2||
59633990|NCT01679028|75748400|FG005|COMPLETED|Overall Study||6||
59633991|NCT01679028|75748395|FG000|NOT COMPLETED|Overall Study||0||
59633992|NCT01679028|75748396|FG001|NOT COMPLETED|Overall Study||0||
59633993|NCT01679028|75748397|FG002|NOT COMPLETED|Overall Study||0||
59633994|NCT01679028|75748398|FG003|NOT COMPLETED|Overall Study||0||
59633995|NCT01679028|75748399|FG004|NOT COMPLETED|Overall Study||0||
59633996|NCT01679028|75748400|FG005|NOT COMPLETED|Overall Study||0||
59633997|NCT01680666|75748416|FG000|STARTED|Overall Study||84||
59633998|NCT01680666|75748417|FG001|STARTED|Overall Study||66||
59633999|NCT01680666|75748416|FG000|COMPLETED|Overall Study||84||
59634000|NCT01680666|75748417|FG001|COMPLETED|Overall Study||66||
59634001|NCT01680666|75748416|FG000|NOT COMPLETED|Overall Study||0||
59634002|NCT01680666|75748417|FG001|NOT COMPLETED|Overall Study||0||
59634003|NCT01680900|75748426|FG000|STARTED|Overall Study||24||
59634004|NCT01680900|75748427|FG001|STARTED|Overall Study||12||
59634005|NCT01680900|75748426|FG000|COMPLETED|Overall Study||20||
59634006|NCT01680900|75748427|FG001|COMPLETED|Overall Study||11||
59634007|NCT01680900|75748426|FG000|NOT COMPLETED|Overall Study||4||
59634008|NCT01680900|75748427|FG001|NOT COMPLETED|Overall Study||1||
59634009|NCT01682538|75748433|FG000|STARTED|Overall Study||12||
59634010|NCT01682538|75748433|FG000|COMPLETED|Overall Study||12||
59634011|NCT01682538|75748433|FG000|NOT COMPLETED|Overall Study||0||
59634012|NCT01683630|75748450|FG000|STARTED|Overall Study||1404||
59634013|NCT01683630|75748451|FG001|STARTED|Overall Study||445||
59634014|NCT01683630|75748450|FG000|COMPLETED|Overall Study||1404||
59634015|NCT01683630|75748451|FG001|COMPLETED|Overall Study||445||
59634016|NCT01683630|75748450|FG000|NOT COMPLETED|Overall Study||0||
59634017|NCT01683630|75748451|FG001|NOT COMPLETED|Overall Study||0||
59634018|NCT01684020|75748459|FG000|STARTED|Overall Study||5||
59634019|NCT01684020|75748460|FG001|STARTED|Overall Study||5||
59634020|NCT01684020|75748459|FG000|COMPLETED|Overall Study||4||
59634021|NCT01684020|75748460|FG001|COMPLETED|Overall Study||5||
59634022|NCT01684020|75748459|FG000|NOT COMPLETED|Overall Study||1||
59634023|NCT01684020|75748460|FG001|NOT COMPLETED|Overall Study||0||
59634024|NCT01684410|75748469|FG000|STARTED|Overall Study||10||
59634025|NCT01684410|75748470|FG001|STARTED|Overall Study||10||
59634026|NCT01684410|75748471|FG002|STARTED|Overall Study||10||
59634027|NCT01684410|75748469|FG000|COMPLETED|Overall Study||10||
59634028|NCT01684410|75748470|FG001|COMPLETED|Overall Study||10||
59634029|NCT01684410|75748471|FG002|COMPLETED|Overall Study||10||
59634030|NCT01684410|75748469|FG000|NOT COMPLETED|Overall Study||0||
59634031|NCT01684410|75748470|FG001|NOT COMPLETED|Overall Study||0||
59634032|NCT01684410|75748471|FG002|NOT COMPLETED|Overall Study||0||
59634033|NCT01684566|75748481|FG000|STARTED|Overall Study||60||
59634034|NCT01684566|75748482|FG001|STARTED|Overall Study||56||
59634035|NCT01684566|75748481|FG000|Treated (ITT)|Overall Study||57||
59634036|NCT01684566|75748482|FG001|Treated (ITT)|Overall Study||52||
59634037|NCT01684566|75748481|FG000|COMPLETED|Overall Study||44||
59634038|NCT01684566|75748482|FG001|COMPLETED|Overall Study||49||
59634039|NCT01684566|75748481|FG000|NOT COMPLETED|Overall Study||16||
59634040|NCT01684566|75748482|FG001|NOT COMPLETED|Overall Study||7||
59634041|NCT01686750|75748490|FG000|STARTED|Overall Study||11001||11
59634042|NCT01686750|75748491|FG001|STARTED|Overall Study||10725||11
59634043|NCT01686750|75748490|FG000|COMPLETED|Overall Study||11001||11
59634044|NCT01686750|75748491|FG001|COMPLETED|Overall Study||10725||11
59634045|NCT01686750|75748490|FG000|NOT COMPLETED|Overall Study||0||0
60076406|NCT01928719|76191386|FG000|NOT COMPLETED|Overall Study||52||
59634046|NCT01686750|75748491|FG001|NOT COMPLETED|Overall Study||0||0
59634047|NCT01688310|75748501|FG000|STARTED|Overall Study||100||
59634048|NCT01688310|75748502|FG001|STARTED|Overall Study||100||
59634049|NCT01688310|75748501|FG000|COMPLETED|Overall Study||100||
59634050|NCT01688310|75748502|FG001|COMPLETED|Overall Study||100||
60076407|NCT01928719|76191387|FG001|NOT COMPLETED|Overall Study||19||
59634051|NCT01688310|75748501|FG000|NOT COMPLETED|Overall Study||0||
59634052|NCT01688310|75748502|FG001|NOT COMPLETED|Overall Study||0||
59634053|NCT01688856|75748513|FG000|STARTED|Overall Study||28||
59634054|NCT01688856|75748514|FG001|STARTED|Overall Study||28||
59634055|NCT01688856|75748515|FG002|STARTED|Overall Study||11||
59634056|NCT01688856|75748513|FG000|COMPLETED|Overall Study||21||
59634057|NCT01688856|75748514|FG001|COMPLETED|Overall Study||24||
59634058|NCT01688856|75748515|FG002|COMPLETED|Overall Study||8||
59634059|NCT01688856|75748513|FG000|NOT COMPLETED|Overall Study||7||
59634060|NCT01688856|75748514|FG001|NOT COMPLETED|Overall Study||4||
59634061|NCT01688856|75748515|FG002|NOT COMPLETED|Overall Study||3||
59634062|NCT01689324|75748523|FG000|STARTED|Overall Study||43||
59634063|NCT01689324|75748523|FG000|COMPLETED|Overall Study||43||
59634064|NCT01689324|75748523|FG000|NOT COMPLETED|Overall Study||0||
59634065|NCT01692756|75748531|FG000|STARTED|Overall Study||12||
59634066|NCT01692756|75748532|FG001|STARTED|Overall Study||12||
59634067|NCT01692756|75748533|FG002|STARTED|Overall Study||13||
59634068|NCT01692756|75748534|FG003|STARTED|Overall Study||12||
59634069|NCT01692756|75748531|FG000|COMPLETED|Overall Study||11||
59634070|NCT01692756|75748532|FG001|COMPLETED|Overall Study||11||
59634071|NCT01692756|75748533|FG002|COMPLETED|Overall Study||11||
59634072|NCT01692756|75748534|FG003|COMPLETED|Overall Study||12||
59634073|NCT01692756|75748531|FG000|NOT COMPLETED|Overall Study||1||
59634074|NCT01692756|75748532|FG001|NOT COMPLETED|Overall Study||1||
59634075|NCT01692756|75748533|FG002|NOT COMPLETED|Overall Study||2||
59634076|NCT01692756|75748534|FG003|NOT COMPLETED|Overall Study||0||
59634077|NCT01695330|75748544|FG000|STARTED|Overall Study||52||
59634078|NCT01695330|75748545|FG001|STARTED|Overall Study||0||
59634079|NCT01695330|75748544|FG000|COMPLETED|Overall Study||5||
59634080|NCT01695330|75748545|FG001|COMPLETED|Overall Study||0||
59634081|NCT01695330|75748544|FG000|NOT COMPLETED|Overall Study||47||
59634082|NCT01695330|75748545|FG001|NOT COMPLETED|Overall Study||0||
59634083|NCT01698528|75748551|FG000|STARTED|Overall Study||20||
59634084|NCT01698528|75748552|FG001|STARTED|Overall Study||20||
59634085|NCT01698528|75748551|FG000|COMPLETED|Overall Study||19||
59634086|NCT01698528|75748552|FG001|COMPLETED|Overall Study||16||
59634087|NCT01698528|75748551|FG000|NOT COMPLETED|Overall Study||1||
59634088|NCT01698528|75748552|FG001|NOT COMPLETED|Overall Study||4||
59634089|NCT01698684|75748561|FG000|STARTED|Overall Study||145||
59634090|NCT01698684|75748562|FG001|STARTED|Overall Study||147||
59634091|NCT01698684|75748563|FG002|STARTED|Overall Study||148||
59634092|NCT01698684|75748561|FG000|ITT Population|Overall Study||136||
59634093|NCT01698684|75748562|FG001|ITT Population|Overall Study||139||
59634094|NCT01698684|75748563|FG002|ITT Population|Overall Study||139||
59634095|NCT01698684|75748561|FG000|Safety Population|Overall Study||143||
59634096|NCT01698684|75748562|FG001|Safety Population|Overall Study||146||
59634097|NCT01698684|75748563|FG002|Safety Population|Overall Study||146||
59634098|NCT01698684|75748561|FG000|COMPLETED|Overall Study||116||
59634099|NCT01698684|75748562|FG001|COMPLETED|Overall Study||124||
59634100|NCT01698684|75748563|FG002|COMPLETED|Overall Study||127||
59634101|NCT01698684|75748561|FG000|NOT COMPLETED|Overall Study||29||
59634102|NCT01698684|75748562|FG001|NOT COMPLETED|Overall Study||23||
59634103|NCT01698684|75748563|FG002|NOT COMPLETED|Overall Study||21||
59634104|NCT01699542|75748573|FG000|STARTED|Overall Study||9||
59634105|NCT01699542|75748574|FG001|STARTED|Overall Study||9||
59634106|NCT01699542|75748573|FG000|COMPLETED|Overall Study||9||
59634107|NCT01699542|75748574|FG001|COMPLETED|Overall Study||9||
59634108|NCT01699542|75748573|FG000|NOT COMPLETED|Overall Study||0||
59634109|NCT01699542|75748574|FG001|NOT COMPLETED|Overall Study||0||
59634110|NCT01699698|75748582|FG000|STARTED|Overall Study||44||
59634111|NCT01699698|75748583|FG001|STARTED|Overall Study||61||
59634112|NCT01699698|75748582|FG000|COMPLETED|Overall Study||42||
59634113|NCT01699698|75748583|FG001|COMPLETED|Overall Study||56||
59634114|NCT01699698|75748582|FG000|NOT COMPLETED|Overall Study||2||
59634115|NCT01699698|75748583|FG001|NOT COMPLETED|Overall Study||5||
59634116|NCT01701024|75748592|FG000|STARTED|Overall Study||253||
59634117|NCT01701024|75748593|FG001|STARTED|Overall Study||245||
59634118|NCT01701024|75748592|FG000|COMPLETED|Overall Study||243||
59634119|NCT01701024|75748593|FG001|COMPLETED|Overall Study||236||
59634120|NCT01701024|75748592|FG000|NOT COMPLETED|Overall Study||10||
59634121|NCT01701024|75748593|FG001|NOT COMPLETED|Overall Study||9||
59634122|NCT01701102|75748603|FG000|STARTED|Overall Study||22||
59634123|NCT01701102|75748604|FG001|STARTED|Overall Study||6||
59634124|NCT01701102|75748605|FG002|STARTED|Overall Study||10||
59634125|NCT01701102|75748606|FG003|STARTED|Overall Study||18||
59634126|NCT01701102|75748603|FG000|COMPLETED|Overall Study||22||
59634127|NCT01701102|75748604|FG001|COMPLETED|Overall Study||6||
59634128|NCT01701102|75748605|FG002|COMPLETED|Overall Study||10||
59634129|NCT01701102|75748606|FG003|COMPLETED|Overall Study||18||
59634130|NCT01701102|75748603|FG000|NOT COMPLETED|Overall Study||0||
59634131|NCT01701102|75748604|FG001|NOT COMPLETED|Overall Study||0||
59634132|NCT01701102|75748605|FG002|NOT COMPLETED|Overall Study||0||
59634133|NCT01701102|75748606|FG003|NOT COMPLETED|Overall Study||0||
59634134|NCT01701414|75748618|FG000|STARTED|Overall Study||19||
59634135|NCT01701414|75748619|FG001|STARTED|Overall Study||19||
59634136|NCT01701414|75748618|FG000|COMPLETED|Overall Study||18||
59634137|NCT01701414|75748619|FG001|COMPLETED|Overall Study||18||
59634138|NCT01701414|75748618|FG000|NOT COMPLETED|Overall Study||1||
59634139|NCT01701414|75748619|FG001|NOT COMPLETED|Overall Study||1||
59634140|NCT01703598|75748625|FG000|STARTED|Overall Study||69||
59634141|NCT01703598|75748625|FG000|COMPLETED|Overall Study||69||
59634142|NCT01703598|75748625|FG000|NOT COMPLETED|Overall Study||0||
59634143|NCT01706952|75748629|FG000|STARTED|Overall Study||45||
59634144|NCT01706952|75748629|FG000|COMPLETED|Overall Study||37||
59634145|NCT01706952|75748629|FG000|NOT COMPLETED|Overall Study||8||
59634146|NCT01707108|75748635|FG000|STARTED|Overall Study||60||117
59634147|NCT01707108|75748635|FG000|1 Year|Overall Study||60||117
59634148|NCT01707108|75748635|FG000|COMPLETED|Overall Study||60||117
59634149|NCT01707108|75748635|FG000|NOT COMPLETED|Overall Study||0||0
59634150|NCT01707420|75748642|FG000|STARTED|Overall Study||18||
59634151|NCT01707420|75748643|FG001|STARTED|Overall Study||18||
59634152|NCT01707420|75748642|FG000|COMPLETED|Overall Study||18||
59634153|NCT01707420|75748643|FG001|COMPLETED|Overall Study||18||
59634154|NCT01707420|75748642|FG000|NOT COMPLETED|Overall Study||0||
59634155|NCT01707420|75748643|FG001|NOT COMPLETED|Overall Study||0||
59634156|NCT01707654|75748651|FG000|STARTED|Overall Study||9||
59634157|NCT01707654|75748651|FG000|COMPLETED|Overall Study||9||
59634158|NCT01707654|75748651|FG000|NOT COMPLETED|Overall Study||0||
59634159|NCT01708122|75748657|FG000|STARTED|Overall Study||27||
59634160|NCT01708122|75748658|FG001|STARTED|Overall Study||26||
59634161|NCT01708122|75748657|FG000|COMPLETED|Overall Study||27||
59634162|NCT01708122|75748658|FG001|COMPLETED|Overall Study||26||
59634163|NCT01708122|75748657|FG000|NOT COMPLETED|Overall Study||0||
59634164|NCT01708122|75748658|FG001|NOT COMPLETED|Overall Study||0||
59634165|NCT01708278|75748670|FG000|STARTED|Overall Study||1||
59634166|NCT01708278|75748671|FG001|STARTED|Overall Study||2||
59634167|NCT01708278|75748672|FG002|STARTED|Overall Study||2||
59634168|NCT01708278|75748673|FG003|STARTED|Overall Study||2||
59634169|NCT01708278|75748674|FG004|STARTED|Overall Study||1||
59634170|NCT01708278|75748675|FG005|STARTED|Overall Study||1||
59634171|NCT01708278|75748670|FG000|COMPLETED|Overall Study||1||
59634172|NCT01708278|75748671|FG001|COMPLETED|Overall Study||2||
59634173|NCT01708278|75748672|FG002|COMPLETED|Overall Study||2||
59634174|NCT01708278|75748673|FG003|COMPLETED|Overall Study||2||
59634175|NCT01708278|75748674|FG004|COMPLETED|Overall Study||1||
59634176|NCT01708278|75748675|FG005|COMPLETED|Overall Study||1||
59634177|NCT01708278|75748670|FG000|NOT COMPLETED|Overall Study||0||
59634178|NCT01708278|75748671|FG001|NOT COMPLETED|Overall Study||0||
59634179|NCT01708278|75748672|FG002|NOT COMPLETED|Overall Study||0||
59634180|NCT01708278|75748673|FG003|NOT COMPLETED|Overall Study||0||
59634181|NCT01708278|75748674|FG004|NOT COMPLETED|Overall Study||0||
59634182|NCT01708278|75748675|FG005|NOT COMPLETED|Overall Study||0||
59634183|NCT01708590|75748692|FG000|STARTED|Induction Phase||222||
59634184|NCT01708590|75748693|FG001|STARTED|Induction Phase||219||
59634185|NCT01708590|75748694|FG002|STARTED|Induction Phase||220||
59634186|NCT01708590|75748695|FG003|STARTED|Induction Phase||0||
59634187|NCT01708590|75748696|FG004|STARTED|Induction Phase||0||
59634188|NCT01708590|75748697|FG005|STARTED|Induction Phase||0||
59634189|NCT01708590|75748698|FG006|STARTED|Induction Phase||0||
59634190|NCT01708590|75748692|FG000|COMPLETED|Induction Phase||212||
59634191|NCT01708590|75748693|FG001|COMPLETED|Induction Phase||212||
59634192|NCT01708590|75748694|FG002|COMPLETED|Induction Phase||209||
59634193|NCT01708590|75748695|FG003|COMPLETED|Induction Phase||0||
59634194|NCT01708590|75748696|FG004|COMPLETED|Induction Phase||0||
59634195|NCT01708590|75748697|FG005|COMPLETED|Induction Phase||0||
59634196|NCT01708590|75748698|FG006|COMPLETED|Induction Phase||0||
59634197|NCT01708590|75748692|FG000|NOT COMPLETED|Induction Phase||10||
59634198|NCT01708590|75748693|FG001|NOT COMPLETED|Induction Phase||7||
59634199|NCT01708590|75748694|FG002|NOT COMPLETED|Induction Phase||11||
59634200|NCT01708590|75748695|FG003|NOT COMPLETED|Induction Phase||0||
59634201|NCT01708590|75748696|FG004|NOT COMPLETED|Induction Phase||0||
59634202|NCT01708590|75748697|FG005|NOT COMPLETED|Induction Phase||0||
59634203|NCT01708590|75748698|FG006|NOT COMPLETED|Induction Phase||0||
59634204|NCT01708590|75748692|FG000|STARTED|Withdrawal Phase||0|A subset of 283 subjects were rerandomized to Placebo or Brodalumab in the Withdrawal Phase.|
59634205|NCT01708590|75748693|FG001|STARTED|Withdrawal Phase||0|A subset of 283 subjects were rerandomized to Placebo or Brodalumab in the Withdrawal Phase.|
60076408|NCT00986674|76191398|FG000|STARTED|Overall Study||47||
60076409|NCT00986674|76191399|FG001|STARTED|Overall Study||45||
60076410|NCT00986674|76191400|FG002|STARTED|Overall Study||48||
60076411|NCT00986674|76191398|FG000|Treated|Overall Study||43||
60076412|NCT00986674|76191399|FG001|Treated|Overall Study||42||
60076413|NCT00986674|76191400|FG002|Treated|Overall Study||47||
59634206|NCT01708590|75748694|FG002|STARTED|Withdrawal Phase||0|A subset of 283 subjects were rerandomized to Placebo or Brodalumab in the Withdrawal Phase.|
59634207|NCT01708590|75748695|FG003|STARTED|Withdrawal Phase||59|A subset of 283 subjects were rerandomized to Placebo or Brodalumab in the Withdrawal Phase.|
59634208|NCT01708590|75748696|FG004|STARTED|Withdrawal Phase||57|A subset of 283 subjects were rerandomized to Placebo or Brodalumab in the Withdrawal Phase.|
59634209|NCT01708590|75748697|FG005|STARTED|Withdrawal Phase||84|A subset of 283 subjects were rerandomized to Placebo or Brodalumab in the Withdrawal Phase.|
59634210|NCT01708590|75748698|FG006|STARTED|Withdrawal Phase||83|A subset of 283 subjects were rerandomized to Placebo or Brodalumab in the Withdrawal Phase.|
59634211|NCT01708590|75748692|FG000|COMPLETED|Withdrawal Phase||0||
59634212|NCT01708590|75748693|FG001|COMPLETED|Withdrawal Phase||0||
60076414|NCT00986674|76191398|FG000|Eligible and Treated|Overall Study||39||
60076415|NCT00986674|76191399|FG001|Eligible and Treated|Overall Study||41||
60076416|NCT00986674|76191400|FG002|Eligible and Treated|Overall Study||47||
60076417|NCT00986674|76191398|FG000|COMPLETED|Overall Study||0||
59634213|NCT01708590|75748694|FG002|COMPLETED|Withdrawal Phase||0||
59634214|NCT01708590|75748695|FG003|COMPLETED|Withdrawal Phase||6||
59634215|NCT01708590|75748696|FG004|COMPLETED|Withdrawal Phase||45||
59634216|NCT01708590|75748697|FG005|COMPLETED|Withdrawal Phase||2||
59634217|NCT01708590|75748698|FG006|COMPLETED|Withdrawal Phase||74||
59634218|NCT01708590|75748692|FG000|NOT COMPLETED|Withdrawal Phase||0||
59634219|NCT01708590|75748693|FG001|NOT COMPLETED|Withdrawal Phase||0||
59634220|NCT01708590|75748694|FG002|NOT COMPLETED|Withdrawal Phase||0||
59634221|NCT01708590|75748695|FG003|NOT COMPLETED|Withdrawal Phase||53||
59634222|NCT01708590|75748696|FG004|NOT COMPLETED|Withdrawal Phase||12||
59634223|NCT01708590|75748697|FG005|NOT COMPLETED|Withdrawal Phase||82||
59634224|NCT01708590|75748698|FG006|NOT COMPLETED|Withdrawal Phase||9||
59634225|NCT03671304|75748711|FG000|STARTED|Overall Study||8||
59634226|NCT03671304|75748711|FG000|COMPLETED|Overall Study||1||
59634227|NCT03671304|75748711|FG000|NOT COMPLETED|Overall Study||7||
59634228|NCT03447990|75748722|FG000|STARTED|Overall Study||8|Started = Randomized and treated|
59634229|NCT03447990|75748723|FG001|STARTED|Overall Study||4|Started = Randomized and treated|
59634230|NCT03447990|75748724|FG002|STARTED|Overall Study||6|Started = Randomized and treated|
59634231|NCT03447990|75748725|FG003|STARTED|Overall Study||9|Started = Randomized and treated|
59634232|NCT03447990|75748726|FG004|STARTED|Overall Study||9|Started = Randomized and treated|
59634233|NCT03447990|75748727|FG005|STARTED|Overall Study||6|Started = Randomized and treated|
59634234|NCT03447990|75748728|FG006|STARTED|Overall Study||10|Started = Randomized and treated|
59634235|NCT03447990|75748722|FG000|Completed Blinded Treatment Period A|Overall Study||8|Blinded treatment period A planned in SAD Cohort 1 and 2|
59634236|NCT03447990|75748723|FG001|Completed Blinded Treatment Period A|Overall Study||4|Blinded treatment period A planned in SAD Cohort 1 and 2|
59634237|NCT03447990|75748724|FG002|Completed Blinded Treatment Period A|Overall Study||0|Blinded treatment period A planned in SAD Cohort 1 and 2|
59634238|NCT03447990|75748725|FG003|Completed Blinded Treatment Period A|Overall Study||0|Blinded treatment period A planned in SAD Cohort 1 and 2|
59634239|NCT03447990|75748726|FG004|Completed Blinded Treatment Period A|Overall Study||0|Blinded treatment period A planned in SAD Cohort 1 and 2|
59634240|NCT03447990|75748727|FG005|Completed Blinded Treatment Period A|Overall Study||0|Blinded treatment period A planned in SAD Cohort 1 and 2|
59634241|NCT03447990|75748728|FG006|Completed Blinded Treatment Period A|Overall Study||0|Blinded treatment period A planned in SAD Cohort 1 and 2|
59634242|NCT03447990|75748722|FG000|Completed Blinded Treatment Period B|Overall Study||8|Blinded treatment period B planned in SAD Cohort 1 and 2|
59634243|NCT03447990|75748723|FG001|Completed Blinded Treatment Period B|Overall Study||4|Blinded treatment period B planned in SAD Cohort 1 and 2|
59634244|NCT03447990|75748724|FG002|Completed Blinded Treatment Period B|Overall Study||0|Blinded treatment period B planned in SAD Cohort 1 and 2|
59634245|NCT03447990|75748725|FG003|Completed Blinded Treatment Period B|Overall Study||0|Blinded treatment period B planned in SAD Cohort 1 and 2|
59634246|NCT03447990|75748726|FG004|Completed Blinded Treatment Period B|Overall Study||0|Blinded treatment period B planned in SAD Cohort 1 and 2|
59634247|NCT03447990|75748727|FG005|Completed Blinded Treatment Period B|Overall Study||0|Blinded treatment period B planned in SAD Cohort 1 and 2|
59634248|NCT03447990|75748728|FG006|Completed Blinded Treatment Period B|Overall Study||0|Blinded treatment period B planned in SAD Cohort 1 and 2|
59634249|NCT03447990|75748722|FG000|Completed Blinded Treatment Period C|Overall Study||8|Blinded treatment period C planned in SAD Cohort 1 and 2|
59634250|NCT03447990|75748723|FG001|Completed Blinded Treatment Period C|Overall Study||4|Blinded treatment period C planned in SAD Cohort 1 and 2|
59634251|NCT03447990|75748724|FG002|Completed Blinded Treatment Period C|Overall Study||0|Blinded treatment period C planned in SAD Cohort 1 and 2|
59634252|NCT03447990|75748725|FG003|Completed Blinded Treatment Period C|Overall Study||0|Blinded treatment period C planned in SAD Cohort 1 and 2|
59634253|NCT03447990|75748726|FG004|Completed Blinded Treatment Period C|Overall Study||0|Blinded treatment period C planned in SAD Cohort 1 and 2|
59634254|NCT03447990|75748727|FG005|Completed Blinded Treatment Period C|Overall Study||0|Blinded treatment period C planned in SAD Cohort 1 and 2|
59634255|NCT03447990|75748728|FG006|Completed Blinded Treatment Period C|Overall Study||0|Blinded treatment period C planned in SAD Cohort 1 and 2|
59634256|NCT03447990|75748722|FG000|Completed Optional Open-Label Treatment Period D|Overall Study||6|Optional open-label treatment period D planned in SAD Cohort 1|
59634257|NCT03447990|75748723|FG001|Completed Optional Open-Label Treatment Period D|Overall Study||0|Optional open-label treatment period D planned in SAD Cohort 1|
59634258|NCT03447990|75748724|FG002|Completed Optional Open-Label Treatment Period D|Overall Study||0|Optional open-label treatment period D planned in SAD Cohort 1|
59634259|NCT03447990|75748725|FG003|Completed Optional Open-Label Treatment Period D|Overall Study||0|Optional open-label treatment period D planned in SAD Cohort 1|
59634260|NCT03447990|75748726|FG004|Completed Optional Open-Label Treatment Period D|Overall Study||0|Optional open-label treatment period D planned in SAD Cohort 1|
59634261|NCT03447990|75748727|FG005|Completed Optional Open-Label Treatment Period D|Overall Study||0|Optional open-label treatment period D planned in SAD Cohort 1|
59634262|NCT03447990|75748728|FG006|Completed Optional Open-Label Treatment Period D|Overall Study||0|Optional open-label treatment period D planned in SAD Cohort 1|
59634263|NCT03447990|75748722|FG000|COMPLETED|Overall Study||8|Completed = completed treatment|
59634264|NCT03447990|75748723|FG001|COMPLETED|Overall Study||4|Completed = completed treatment|
59634265|NCT03447990|75748724|FG002|COMPLETED|Overall Study||6|Completed = completed treatment|
59634266|NCT03447990|75748725|FG003|COMPLETED|Overall Study||9|Completed = completed treatment|
59634267|NCT03447990|75748726|FG004|COMPLETED|Overall Study||9|Completed = completed treatment|
59634268|NCT03447990|75748727|FG005|COMPLETED|Overall Study||6|Completed = completed treatment|
59634269|NCT03447990|75748728|FG006|COMPLETED|Overall Study||9|Completed = completed treatment|
59634270|NCT03447990|75748722|FG000|NOT COMPLETED|Overall Study||0||
59634271|NCT03447990|75748723|FG001|NOT COMPLETED|Overall Study||0||
59634272|NCT03447990|75748724|FG002|NOT COMPLETED|Overall Study||0||
59634273|NCT03447990|75748725|FG003|NOT COMPLETED|Overall Study||0||
59634274|NCT03447990|75748726|FG004|NOT COMPLETED|Overall Study||0||
59634275|NCT03447990|75748727|FG005|NOT COMPLETED|Overall Study||0||
59634276|NCT03447990|75748728|FG006|NOT COMPLETED|Overall Study||1||
59634277|NCT01376778|75748780|FG000|STARTED|Overall Study||206||
59634278|NCT01376778|75748781|FG001|STARTED|Overall Study||193||
59634279|NCT01376778|75748780|FG000|COMPLETED|Overall Study||203||
59634280|NCT01376778|75748781|FG001|COMPLETED|Overall Study||191||
59634281|NCT01376778|75748780|FG000|NOT COMPLETED|Overall Study||3||
59634282|NCT01376778|75748781|FG001|NOT COMPLETED|Overall Study||2||
59634283|NCT01074294|75748790|FG000|STARTED|Phase A (Day 1 to Week 5)||740||
59634284|NCT01074294|75748791|FG001|STARTED|Phase A (Day 1 to Week 5)||0||
59634285|NCT01074294|75748792|FG002|STARTED|Phase A (Day 1 to Week 5)||0||
59634286|NCT01074294|75748793|FG003|STARTED|Phase A (Day 1 to Week 5)||0||
59634287|NCT01074294|75748790|FG000|Analyzed for Safety|Phase A (Day 1 to Week 5)||733|Safety Sample consisted of randomized participants who received at least one dose of double-blind investigational medicinal product (IMP) as indicated on the dosing record.|
59634288|NCT01074294|75748791|FG001|Analyzed for Safety|Phase A (Day 1 to Week 5)||0|Safety Sample consisted of randomized participants who received at least one dose of double-blind investigational medicinal product (IMP) as indicated on the dosing record.|
59634289|NCT01074294|75748792|FG002|Analyzed for Safety|Phase A (Day 1 to Week 5)||0|Safety Sample consisted of randomized participants who received at least one dose of double-blind investigational medicinal product (IMP) as indicated on the dosing record.|
59634290|NCT01074294|75748793|FG003|Analyzed for Safety|Phase A (Day 1 to Week 5)||0|Safety Sample consisted of randomized participants who received at least one dose of double-blind investigational medicinal product (IMP) as indicated on the dosing record.|
59634291|NCT01074294|75748790|FG000|COMPLETED|Phase A (Day 1 to Week 5)||574||
59634292|NCT01074294|75748791|FG001|COMPLETED|Phase A (Day 1 to Week 5)||0||
59634293|NCT01074294|75748792|FG002|COMPLETED|Phase A (Day 1 to Week 5)||0||
59634294|NCT01074294|75748793|FG003|COMPLETED|Phase A (Day 1 to Week 5)||0||
59634295|NCT01074294|75748790|FG000|NOT COMPLETED|Phase A (Day 1 to Week 5)||166||
59634296|NCT01074294|75748791|FG001|NOT COMPLETED|Phase A (Day 1 to Week 5)||0||
59634297|NCT01074294|75748792|FG002|NOT COMPLETED|Phase A (Day 1 to Week 5)||0||
59634298|NCT01074294|75748793|FG003|NOT COMPLETED|Phase A (Day 1 to Week 5)||0||
59634299|NCT01074294|75748790|FG000|STARTED|Phase B and Phase A+ (Week 6 to Week 11)||0||
59634300|NCT01074294|75748791|FG001|STARTED|Phase B and Phase A+ (Week 6 to Week 11)||155||
59634301|NCT01074294|75748792|FG002|STARTED|Phase B and Phase A+ (Week 6 to Week 11)||80||
59634302|NCT01074294|75748793|FG003|STARTED|Phase B and Phase A+ (Week 6 to Week 11)||339||
59634303|NCT01074294|75748790|FG000|Analyzed for Safety|Phase B and Phase A+ (Week 6 to Week 11)||0|Safety Sample consisted of randomized participants who received at least one dose of double-blind IMP as indicated on the dosing record.|
59634304|NCT01074294|75748791|FG001|Analyzed for Safety|Phase B and Phase A+ (Week 6 to Week 11)||155|Safety Sample consisted of randomized participants who received at least one dose of double-blind IMP as indicated on the dosing record.|
59634305|NCT01074294|75748792|FG002|Analyzed for Safety|Phase B and Phase A+ (Week 6 to Week 11)||80|Safety Sample consisted of randomized participants who received at least one dose of double-blind IMP as indicated on the dosing record.|
59634306|NCT01074294|75748793|FG003|Analyzed for Safety|Phase B and Phase A+ (Week 6 to Week 11)||235|Safety Sample consisted of randomized participants who received at least one dose of double-blind IMP as indicated on the dosing record.|
59634307|NCT01074294|75748790|FG000|COMPLETED|Phase B and Phase A+ (Week 6 to Week 11)||0||
59634308|NCT01074294|75748791|FG001|COMPLETED|Phase B and Phase A+ (Week 6 to Week 11)||146||
59634309|NCT01074294|75748792|FG002|COMPLETED|Phase B and Phase A+ (Week 6 to Week 11)||70||
59634310|NCT01074294|75748793|FG003|COMPLETED|Phase B and Phase A+ (Week 6 to Week 11)||314||
59634311|NCT01074294|75748790|FG000|NOT COMPLETED|Phase B and Phase A+ (Week 6 to Week 11)||0||
59634312|NCT01074294|75748791|FG001|NOT COMPLETED|Phase B and Phase A+ (Week 6 to Week 11)||9||
59634313|NCT01074294|75748792|FG002|NOT COMPLETED|Phase B and Phase A+ (Week 6 to Week 11)||10||
59634314|NCT01074294|75748793|FG003|NOT COMPLETED|Phase B and Phase A+ (Week 6 to Week 11)||25||
59634315|NCT01710306|75748803|FG000|STARTED|Overall Study||86||
59634316|NCT01710306|75748804|FG001|STARTED|Overall Study||85||
59634317|NCT01710306|75748803|FG000|COMPLETED|Overall Study||68||
59634318|NCT01710306|75748804|FG001|COMPLETED|Overall Study||55||
59634319|NCT01710306|75748803|FG000|NOT COMPLETED|Overall Study||18||
59634320|NCT01710306|75748804|FG001|NOT COMPLETED|Overall Study||30||
59634321|NCT01713660|75748811|FG000|STARTED|Overall Study||37||
59634322|NCT01713660|75748811|FG000|COMPLETED|Overall Study||37||
59634323|NCT01713660|75748811|FG000|NOT COMPLETED|Overall Study||0||
59634324|NCT01715064|75748817|FG000|STARTED|Overall Study||18||
59634325|NCT01715064|75748818|FG001|STARTED|Overall Study||18||
59634326|NCT01715064|75748817|FG000|COMPLETED|Overall Study||18||
59634327|NCT01715064|75748818|FG001|COMPLETED|Overall Study||18||
59634328|NCT01715064|75748817|FG000|NOT COMPLETED|Overall Study||0||
59634329|NCT01715064|75748818|FG001|NOT COMPLETED|Overall Study||0||
59634330|NCT01716468|75748824|FG000|STARTED|Overall Study||17||
59634331|NCT01716468|75748824|FG000|COMPLETED|Overall Study||11||
59634332|NCT01716468|75748824|FG000|NOT COMPLETED|Overall Study||6||
59634333|NCT01717014|75748828|FG000|STARTED|Overall Study||8||
59634334|NCT01717014|75748828|FG000|COMPLETED|Overall Study||8||
59634335|NCT01717014|75748828|FG000|NOT COMPLETED|Overall Study||0||
59634336|NCT01717872|75748834|FG000|STARTED|Overall Study||25||
59634337|NCT01717872|75748835|FG001|STARTED|Overall Study||25||
59634338|NCT01717872|75748834|FG000|COMPLETED|Overall Study||25||
59634339|NCT01717872|75748835|FG001|COMPLETED|Overall Study||25||
59540535|NCT00887510|75638759|FG000|COMPLETED|Overall Study||12||
59634340|NCT01717872|75748834|FG000|NOT COMPLETED|Overall Study||0||
59634341|NCT01717872|75748835|FG001|NOT COMPLETED|Overall Study||0||
59540536|NCT00887510|75638760|FG001|COMPLETED|Overall Study||12||
59540537|NCT00887510|75638759|FG000|NOT COMPLETED|Overall Study||0||
59540538|NCT00887510|75638760|FG001|NOT COMPLETED|Overall Study||0||
59540539|NCT00834626|75638766|FG000|STARTED|Overall Study||30||
59540540|NCT00834626|75638766|FG000|1 Year Follow-up|Overall Study||30||
60076418|NCT00986674|76191399|FG001|COMPLETED|Overall Study||0||
59634342|NCT01718028|75748847|FG000|STARTED|Overall Study||25||
60076419|NCT00986674|76191400|FG002|COMPLETED|Overall Study||0||
60076420|NCT00986674|76191398|FG000|NOT COMPLETED|Overall Study||47||
60076421|NCT00986674|76191399|FG001|NOT COMPLETED|Overall Study||45||
60076422|NCT00986674|76191400|FG002|NOT COMPLETED|Overall Study||48||
60076423|NCT00986440|76191410|FG000|STARTED|Overall Study||41||
60076424|NCT00986440|76191411|FG001|STARTED|Overall Study||43||
60076425|NCT00986440|76191410|FG000|Randomized, But Not Dosed|Overall Study||0||
60076426|NCT00986440|76191411|FG001|Randomized, But Not Dosed|Overall Study||1||
59540541|NCT00834626|75638766|FG000|COMPLETED|Overall Study||30||
59540542|NCT00834626|75638766|FG000|NOT COMPLETED|Overall Study||0||
59540543|NCT00836342|75638774|FG000|STARTED|Overall Study||22||
59540544|NCT00836342|75638775|FG001|STARTED|Overall Study||23||
59540545|NCT00836342|75638776|FG002|STARTED|Overall Study||36||
59540546|NCT00836342|75638774|FG000|COMPLETED|Overall Study||22||
59540547|NCT00836342|75638775|FG001|COMPLETED|Overall Study||23||
59540548|NCT00836342|75638776|FG002|COMPLETED|Overall Study||36||
59540549|NCT00836342|75638774|FG000|NOT COMPLETED|Overall Study||0||
59540550|NCT00836342|75638775|FG001|NOT COMPLETED|Overall Study||0||
59540551|NCT00836342|75638776|FG002|NOT COMPLETED|Overall Study||0||
59540552|NCT01431989|75638786|FG000|STARTED|Period 1||14||
59540553|NCT01431989|75638787|FG001|STARTED|Period 1||14||
59540554|NCT01431989|75638786|FG000|COMPLETED|Period 1||14||
59540555|NCT01431989|75638787|FG001|COMPLETED|Period 1||14||
59540556|NCT01431989|75638786|FG000|NOT COMPLETED|Period 1||0||
59540557|NCT01431989|75638787|FG001|NOT COMPLETED|Period 1||0||
59540558|NCT01431989|75638786|FG000|STARTED|14-Day Washout Period||14||
59540559|NCT01431989|75638787|FG001|STARTED|14-Day Washout Period||14||
59540560|NCT01431989|75638786|FG000|COMPLETED|14-Day Washout Period||14||
59540561|NCT01431989|75638787|FG001|COMPLETED|14-Day Washout Period||14||
59540562|NCT01431989|75638786|FG000|NOT COMPLETED|14-Day Washout Period||0||
59540563|NCT01431989|75638787|FG001|NOT COMPLETED|14-Day Washout Period||0||
59540564|NCT01431989|75638786|FG000|STARTED|Period 2||14||
59540565|NCT01431989|75638787|FG001|STARTED|Period 2||14||
59540566|NCT01431989|75638786|FG000|COMPLETED|Period 2||14||
59540567|NCT01431989|75638787|FG001|COMPLETED|Period 2||14||
59540568|NCT01431989|75638786|FG000|NOT COMPLETED|Period 2||0||
59540569|NCT01431989|75638787|FG001|NOT COMPLETED|Period 2||0||
59540570|NCT01397591|75638793|FG000|STARTED|Overall Study||2||
59540571|NCT01397591|75638793|FG000|COMPLETED|Overall Study||2||
59540572|NCT01397591|75638793|FG000|NOT COMPLETED|Overall Study||0||
59540573|NCT01398059|75638798|FG000|STARTED|Overall Study||4||
59540574|NCT01398059|75638799|FG001|STARTED|Overall Study||3||
59540575|NCT01398059|75638800|FG002|STARTED|Overall Study||4||
59540576|NCT01398059|75638801|FG003|STARTED|Overall Study||2||
59540577|NCT01398059|75638802|FG004|STARTED|Overall Study||4||
59540578|NCT01398059|75638803|FG005|STARTED|Overall Study||2||
59540579|NCT01398059|75638798|FG000|COMPLETED|Overall Study||4||
60076427|NCT00986440|76191410|FG000|COMPLETED|Overall Study||0||
60076428|NCT00986440|76191411|FG001|COMPLETED|Overall Study||0||
60076429|NCT00986440|76191410|FG000|NOT COMPLETED|Overall Study||41||
60076430|NCT00986440|76191411|FG001|NOT COMPLETED|Overall Study||43||
60076431|NCT01904383|76191417|FG000|STARTED|Overall Study||4057|Started are registered|
59540580|NCT01398059|75638799|FG001|COMPLETED|Overall Study||3||
59634343|NCT01718028|75748848|FG001|STARTED|Overall Study||24||
59634344|NCT01718028|75748847|FG000|COMPLETED|Overall Study||25||
59634345|NCT01718028|75748848|FG001|COMPLETED|Overall Study||24||
59634346|NCT01718028|75748847|FG000|NOT COMPLETED|Overall Study||0||
59634347|NCT01718028|75748848|FG001|NOT COMPLETED|Overall Study||0||
59634348|NCT01719900|75748856|FG000|STARTED|Overall Study||29||
59634349|NCT01719900|75748857|FG001|STARTED|Overall Study||24||
59634350|NCT01719900|75748856|FG000|COMPLETED|Overall Study||22||
59634351|NCT01719900|75748857|FG001|COMPLETED|Overall Study||22||
60076432|NCT01904383|76191417|FG000|Treated|Overall Study||3940||
59540581|NCT01398059|75638800|FG002|COMPLETED|Overall Study||4||
59540582|NCT01398059|75638801|FG003|COMPLETED|Overall Study||2||
59540583|NCT01398059|75638802|FG004|COMPLETED|Overall Study||4||
59540584|NCT01398059|75638803|FG005|COMPLETED|Overall Study||2||
59540585|NCT01398059|75638798|FG000|NOT COMPLETED|Overall Study||0||
59540586|NCT01398059|75638799|FG001|NOT COMPLETED|Overall Study||0||
59540587|NCT01398059|75638800|FG002|NOT COMPLETED|Overall Study||0||
59540588|NCT01398059|75638801|FG003|NOT COMPLETED|Overall Study||0||
59540589|NCT01398059|75638802|FG004|NOT COMPLETED|Overall Study||0||
59540590|NCT01398059|75638803|FG005|NOT COMPLETED|Overall Study||0||
59540591|NCT01514279|75638814|FG000|STARTED|Overall Study||118||
59540592|NCT01514279|75638815|FG001|STARTED|Overall Study||123||
59540593|NCT01514279|75638816|FG002|STARTED|Overall Study||119||
59540594|NCT01514279|75638814|FG000|COMPLETED|Overall Study||107||
59540595|NCT01514279|75638815|FG001|COMPLETED|Overall Study||110||
59540596|NCT01514279|75638816|FG002|COMPLETED|Overall Study||114||
59540597|NCT01514279|75638814|FG000|NOT COMPLETED|Overall Study||11||
59540598|NCT01514279|75638815|FG001|NOT COMPLETED|Overall Study||13||
59540599|NCT01514279|75638816|FG002|NOT COMPLETED|Overall Study||5||
59540600|NCT02476968|75638827|FG000|STARTED|Overall Study||145|Enrolled and included in the full analysis set (FAS)|
59540601|NCT02476968|75638828|FG001|STARTED|Overall Study||33|Enrolled and included in the full analysis set (FAS)|
59540602|NCT02476968|75638829|FG002|STARTED|Overall Study||3|Enrolled and included in the full analysis set (FAS)|
59540603|NCT02476968|75638827|FG000|Received Treatment|Overall Study||143||
59540604|NCT02476968|75638828|FG001|Received Treatment|Overall Study||32||
59540605|NCT02476968|75638829|FG002|Received Treatment|Overall Study||2||
59540606|NCT02476968|75638827|FG000|COMPLETED|Overall Study||50||
59540607|NCT02476968|75638828|FG001|COMPLETED|Overall Study||15||
59540608|NCT02476968|75638829|FG002|COMPLETED|Overall Study||0||
59540609|NCT02476968|75638827|FG000|NOT COMPLETED|Overall Study||95||
59540610|NCT02476968|75638828|FG001|NOT COMPLETED|Overall Study||18||
59540611|NCT02476968|75638829|FG002|NOT COMPLETED|Overall Study||3||
59540612|NCT01514513|75638841|FG000|STARTED|Overall Study||21||
59540613|NCT01514513|75638842|FG001|STARTED|Overall Study||21||
59540614|NCT01514513|75638841|FG000|COMPLETED|Overall Study||20||
59540615|NCT01514513|75638842|FG001|COMPLETED|Overall Study||20||
59540616|NCT01514513|75638841|FG000|NOT COMPLETED|Overall Study||1||
59540617|NCT01514513|75638842|FG001|NOT COMPLETED|Overall Study||1||
59540618|NCT02476578|75638850|FG000|STARTED|Overall Study||4310||
59540619|NCT02476578|75638851|FG001|STARTED|Overall Study||4274||
59540620|NCT02476578|75638850|FG000|Died Before Email Was Sent|Overall Study||35|Died before 9.11.2015|
59540621|NCT02476578|75638851|FG001|Died Before Email Was Sent|Overall Study||43|Died before 9.11.2015|
59540622|NCT02476578|75638850|FG000|Left Before End of Trial|Overall Study||6|Left district before 9.11.2016|
59540623|NCT02476578|75638851|FG001|Left Before End of Trial|Overall Study||13|Left district before 9.11.2016|
59540624|NCT02476578|75638850|FG000|COMPLETED|Overall Study||4269|Included in final analysis|
59540625|NCT02476578|75638851|FG001|COMPLETED|Overall Study||4218|Included in final analysis|
59540626|NCT02476578|75638850|FG000|NOT COMPLETED|Overall Study||41||
59540627|NCT02476578|75638851|FG001|NOT COMPLETED|Overall Study||56||
59540628|NCT01432145|75638857|FG000|STARTED|Overall Study|Corrected from 75. 75 was entered in error|74||
59540629|NCT01432145|75638857|FG000|COMPLETED|Overall Study||67||
59540630|NCT01432145|75638857|FG000|NOT COMPLETED|Overall Study||7||
59540631|NCT00889928|75638861|FG000|STARTED|Overall Study||7||
59540632|NCT00889928|75638861|FG000|COMPLETED|Overall Study||7||
59540633|NCT00889928|75638861|FG000|NOT COMPLETED|Overall Study||0||
59540634|NCT01432379|75638865|FG000|STARTED|Overall Study||1168||
59540635|NCT01432379|75638865|FG000|COMPLETED|Overall Study||783||
59540636|NCT01432379|75638865|FG000|NOT COMPLETED|Overall Study||385||
59540637|NCT02504892|75638869|FG000|STARTED|Overall Study||3||
59540638|NCT02504892|75638869|FG000|COMPLETED|Overall Study||1||
59540639|NCT02504892|75638869|FG000|NOT COMPLETED|Overall Study||2||
59540640|NCT02504502|75638875|FG000|STARTED|Routine Care vs. Enhanced Report||24||
59540641|NCT02504502|75638876|FG001|STARTED|Routine Care vs. Enhanced Report||28||
59540642|NCT02504502|75638875|FG000|COMPLETED|Routine Care vs. Enhanced Report||20||
59540643|NCT02504502|75638876|FG001|COMPLETED|Routine Care vs. Enhanced Report||21||
59540644|NCT02504502|75638875|FG000|NOT COMPLETED|Routine Care vs. Enhanced Report||4||
59540645|NCT02504502|75638876|FG001|NOT COMPLETED|Routine Care vs. Enhanced Report||7||
59540646|NCT02504502|75638875|FG000|STARTED|Crossover to Enhanced Report||20||
59540647|NCT02504502|75638876|FG001|STARTED|Crossover to Enhanced Report|The enhanced report arm was completed in first period and does not carry forward to period 2.|0||
59540648|NCT02504502|75638875|FG000|COMPLETED|Crossover to Enhanced Report||15||
59540649|NCT02504502|75638876|FG001|COMPLETED|Crossover to Enhanced Report|the enhanced report arm was completed in first period and does not carry forward to period 2|0||
59540650|NCT02504502|75638875|FG000|NOT COMPLETED|Crossover to Enhanced Report||5||
59540651|NCT02504502|75638876|FG001|NOT COMPLETED|Crossover to Enhanced Report||0||
59540652|NCT01432535|75638885|FG000|STARTED|Overall Study||12||
59540653|NCT01432535|75638886|FG001|STARTED|Overall Study|One participant later determined ineligible is not included in baseline/efficacy analyses.|7||
59540654|NCT01432535|75638887|FG002|STARTED|Overall Study||6||
59540655|NCT01432535|75638885|FG000|COMPLETED|Overall Study||12||
59540656|NCT01432535|75638886|FG001|COMPLETED|Overall Study||7||
59540657|NCT01432535|75638887|FG002|COMPLETED|Overall Study||6||
59540658|NCT01432535|75638885|FG000|NOT COMPLETED|Overall Study||0||
59634352|NCT01719900|75748856|FG000|NOT COMPLETED|Overall Study||7||
59634353|NCT01719900|75748857|FG001|NOT COMPLETED|Overall Study||2||
59634354|NCT01721226|75748865|FG000|STARTED|Overall Study||55||
59634355|NCT01721226|75748866|FG001|STARTED|Overall Study||57||
59634356|NCT01721226|75748865|FG000|Baseline|Overall Study||53||
59634357|NCT01721226|75748866|FG001|Baseline|Overall Study||57||
59634358|NCT01721226|75748865|FG000|Week 12|Overall Study||48||
59634359|NCT01721226|75748866|FG001|Week 12|Overall Study||53||
59634360|NCT01721226|75748865|FG000|Week 24|Overall Study||50||
59634361|NCT01721226|75748866|FG001|Week 24|Overall Study||50||
59634362|NCT01721226|75748865|FG000|COMPLETED|Overall Study||50||
59634363|NCT01721226|75748866|FG001|COMPLETED|Overall Study||50||
59634364|NCT01721226|75748865|FG000|NOT COMPLETED|Overall Study||5||
59634365|NCT01721226|75748866|FG001|NOT COMPLETED|Overall Study||7||
59634366|NCT01721460|75748872|FG000|STARTED|Overall Study||6||
59634367|NCT01721460|75748872|FG000|COMPLETED|Overall Study||5||
59634368|NCT01721460|75748872|FG000|NOT COMPLETED|Overall Study||1||
59634369|NCT01722318|75748883|FG000|STARTED|Overall Study||86||
59634370|NCT01722318|75748884|FG001|STARTED|Overall Study||85||
59634371|NCT01722318|75748885|FG002|STARTED|Overall Study||86||
59634372|NCT01722318|75748886|FG003|STARTED|Overall Study||85||
59634373|NCT01722318|75748887|FG004|STARTED|Overall Study||86||
59634374|NCT01722318|75748883|FG000|COMPLETED|Overall Study||72||
59634375|NCT01722318|75748884|FG001|COMPLETED|Overall Study||65||
59634376|NCT01722318|75748885|FG002|COMPLETED|Overall Study||66||
59634377|NCT01722318|75748886|FG003|COMPLETED|Overall Study||65||
59634378|NCT01722318|75748887|FG004|COMPLETED|Overall Study||68||
59634379|NCT01722318|75748883|FG000|NOT COMPLETED|Overall Study||14||
59634380|NCT01722318|75748884|FG001|NOT COMPLETED|Overall Study||20||
59634381|NCT01722318|75748885|FG002|NOT COMPLETED|Overall Study||20||
59634382|NCT01722318|75748886|FG003|NOT COMPLETED|Overall Study||20||
59634383|NCT01722318|75748887|FG004|NOT COMPLETED|Overall Study||18||
59634384|NCT01722552|75748899|FG000|STARTED|Overall Study|Number of subjects enrolled|120||
59634385|NCT01722552|75748899|FG000|COMPLETED|Overall Study|Number of subjects who completed the intervention|116||
59634386|NCT01722552|75748899|FG000|NOT COMPLETED|Overall Study||4||
59634387|NCT01723722|75748907|FG000|STARTED|Overall Study||20||
59634388|NCT01723722|75748908|FG001|STARTED|Overall Study||20||
59634389|NCT01723722|75748907|FG000|COMPLETED|Overall Study||20||
59634390|NCT01723722|75748908|FG001|COMPLETED|Overall Study||20||
59634391|NCT01723722|75748907|FG000|NOT COMPLETED|Overall Study||0||
59634392|NCT01723722|75748908|FG001|NOT COMPLETED|Overall Study||0||
59634393|NCT01725984|75748916|FG000|STARTED|Overall Study||39||
59634394|NCT01725984|75748917|FG001|STARTED|Overall Study||41||
59634395|NCT01725984|75748916|FG000|COMPLETED|Overall Study||39||
59634396|NCT01725984|75748917|FG001|COMPLETED|Overall Study||41||
59634397|NCT01725984|75748916|FG000|NOT COMPLETED|Overall Study||0||
59634398|NCT01725984|75748917|FG001|NOT COMPLETED|Overall Study||0||
59634399|NCT01728636|75748925|FG000|STARTED|Overall Study||31||
59634400|NCT01728636|75748926|FG001|STARTED|Overall Study||30||
59634401|NCT01728636|75748925|FG000|COMPLETED|Overall Study||31||
59634402|NCT01728636|75748926|FG001|COMPLETED|Overall Study||30||
59634403|NCT01728636|75748925|FG000|NOT COMPLETED|Overall Study||0||
59634404|NCT01728636|75748926|FG001|NOT COMPLETED|Overall Study||0||
59634405|NCT01729338|75748932|FG000|STARTED|Overall Study||16||
59634406|NCT01729338|75748932|FG000|COMPLETED|Overall Study||14||
59634407|NCT01729338|75748932|FG000|NOT COMPLETED|Overall Study||2||
59634408|NCT01729494|75748939|FG000|STARTED|Overall Study||107||
59634409|NCT01729494|75748940|FG001|STARTED|Overall Study||104||
59634410|NCT01729494|75748941|FG002|STARTED|Overall Study||105||
59634411|NCT01729494|75748939|FG000|COMPLETED|Overall Study||97||
59634412|NCT01729494|75748940|FG001|COMPLETED|Overall Study||93||
59634413|NCT01729494|75748941|FG002|COMPLETED|Overall Study||94||
59634414|NCT01729494|75748939|FG000|NOT COMPLETED|Overall Study||10||
59634415|NCT01729494|75748940|FG001|NOT COMPLETED|Overall Study||11||
59634416|NCT01729494|75748941|FG002|NOT COMPLETED|Overall Study||11||
59634417|NCT03245580|75748951|FG000|STARTED|Overall Study||75||
59634418|NCT03245580|75748952|FG001|STARTED|Overall Study||78||
59634419|NCT03245580|75748951|FG000|COMPLETED|Overall Study||75||
59634420|NCT03245580|75748952|FG001|COMPLETED|Overall Study||78||
59634421|NCT03245580|75748951|FG000|NOT COMPLETED|Overall Study||0||
59634422|NCT03245580|75748952|FG001|NOT COMPLETED|Overall Study||0||
59634423|NCT01733472|75748960|FG000|STARTED|Overall Study||60||
59634424|NCT01733472|75748961|FG001|STARTED|Overall Study||60||
59634425|NCT01733472|75748960|FG000|COMPLETED|Overall Study||60||
59634426|NCT01733472|75748961|FG001|COMPLETED|Overall Study||60||
59634427|NCT01733472|75748960|FG000|NOT COMPLETED|Overall Study||0||
59634428|NCT01733472|75748961|FG001|NOT COMPLETED|Overall Study||0||
59634429|NCT01733628|75748968|FG000|STARTED|Overall Study||143||
59634430|NCT01733628|75748968|FG000|COMPLETED|Overall Study||143||
59634431|NCT01733628|75748968|FG000|NOT COMPLETED|Overall Study||0||
59634432|NCT01736358|75748974|FG000|STARTED|Overall Study||25||
59634433|NCT01736358|75748975|FG001|STARTED|Overall Study||25||
59634434|NCT01736358|75748974|FG000|COMPLETED|Overall Study||20||
59634435|NCT01736358|75748975|FG001|COMPLETED|Overall Study||23||
59634436|NCT01736358|75748974|FG000|NOT COMPLETED|Overall Study||5||
59634437|NCT01736358|75748975|FG001|NOT COMPLETED|Overall Study||2||
59634438|NCT01737684|75748983|FG000|STARTED|Overall Study||8||
59634439|NCT01737684|75748984|FG001|STARTED|Overall Study||8||
59634440|NCT01737684|75748985|FG002|STARTED|Overall Study|Participants with mild hepatic insufficiency were not enrolled in study.|0||
59634441|NCT01737684|75748983|FG000|COMPLETED|Overall Study||8||
59634442|NCT01737684|75748984|FG001|COMPLETED|Overall Study||8||
59634443|NCT01737684|75748985|FG002|COMPLETED|Overall Study|Participants with mild hepatic insufficiency were not enrolled in study.|0||
59634444|NCT01737684|75748983|FG000|NOT COMPLETED|Overall Study||0||
59634445|NCT01737684|75748984|FG001|NOT COMPLETED|Overall Study||0||
59634446|NCT01737684|75748985|FG002|NOT COMPLETED|Overall Study||0||
59634447|NCT01740258|75748991|FG000|STARTED|Overall Study||68||
59634448|NCT01740258|75748991|FG000|Entered Part A|Overall Study||68||
59634449|NCT01740258|75748991|FG000|Entered Part B|Overall Study||62||
59634450|NCT01740258|75748991|FG000|Entered Part C|Overall Study||20||
59634451|NCT01740258|75748991|FG000|Entered Part D|Overall Study||42||
59634452|NCT01740258|75748991|FG000|COMPLETED|Overall Study||68||
59634453|NCT01740258|75748991|FG000|NOT COMPLETED|Overall Study||0||
59634454|NCT01740414|75748997|FG000|STARTED|Overall Study||12||
59634455|NCT01740414|75748998|FG001|STARTED|Overall Study||16||
59634456|NCT01740414|75748997|FG000|COMPLETED|Overall Study||3|This study employed a within-subjects design. Participants completed both MN-166 and Placebo phases.|
59634457|NCT01740414|75748998|FG001|COMPLETED|Overall Study||8|This study employed a within-subjects design. Participants completed both MN-166 and Placebo phases.|
59634458|NCT01740414|75748997|FG000|NOT COMPLETED|Overall Study||9||
59634459|NCT01740414|75748998|FG001|NOT COMPLETED|Overall Study||8||
59634460|NCT01740726|75749011|FG000|STARTED|Overall Study||0||
59634461|NCT01740726|75749012|FG001|STARTED|Overall Study||1||
59634462|NCT01740726|75749011|FG000|COMPLETED|Overall Study||0||
59634463|NCT01740726|75749012|FG001|COMPLETED|Overall Study||1||
59634464|NCT01740726|75749011|FG000|NOT COMPLETED|Overall Study||0||
59634465|NCT01740726|75749012|FG001|NOT COMPLETED|Overall Study||0||
59634466|NCT01741350|75749020|FG000|STARTED|Study Intervention||149||
59634467|NCT01741350|75749021|FG001|STARTED|Study Intervention||155||
59634468|NCT01741350|75749020|FG000|COMPLETED|Study Intervention||149||
59634469|NCT01741350|75749021|FG001|COMPLETED|Study Intervention||155||
59634470|NCT01741350|75749020|FG000|NOT COMPLETED|Study Intervention||0||
59634471|NCT01741350|75749021|FG001|NOT COMPLETED|Study Intervention||0||
59634472|NCT01741350|75749020|FG000|STARTED|Post Intervention Assessment (at Week 4)||149||
59634473|NCT01741350|75749021|FG001|STARTED|Post Intervention Assessment (at Week 4)||155||
59634474|NCT01741350|75749020|FG000|COMPLETED|Post Intervention Assessment (at Week 4)||135||
59634475|NCT01741350|75749021|FG001|COMPLETED|Post Intervention Assessment (at Week 4)||141||
59634476|NCT01741350|75749020|FG000|NOT COMPLETED|Post Intervention Assessment (at Week 4)||14||
59634477|NCT01741350|75749021|FG001|NOT COMPLETED|Post Intervention Assessment (at Week 4)||14||
59634478|NCT01741350|75749020|FG000|STARTED|3-Month Follow-up Assessment||135||
59634479|NCT01741350|75749021|FG001|STARTED|3-Month Follow-up Assessment||141||
59634480|NCT01741350|75749020|FG000|COMPLETED|3-Month Follow-up Assessment||129||
59634481|NCT01741350|75749021|FG001|COMPLETED|3-Month Follow-up Assessment||119||
59634482|NCT01741350|75749020|FG000|NOT COMPLETED|3-Month Follow-up Assessment||6||
59634483|NCT01741350|75749021|FG001|NOT COMPLETED|3-Month Follow-up Assessment||22||
59634484|NCT01741350|75749020|FG000|STARTED|6-Month Follow-up Assessment||129||
59634485|NCT01741350|75749021|FG001|STARTED|6-Month Follow-up Assessment||119||
59634486|NCT01741350|75749020|FG000|COMPLETED|6-Month Follow-up Assessment||114||
59634487|NCT01741350|75749021|FG001|COMPLETED|6-Month Follow-up Assessment||111||
59634488|NCT01741350|75749020|FG000|NOT COMPLETED|6-Month Follow-up Assessment||15||
59634489|NCT01741350|75749021|FG001|NOT COMPLETED|6-Month Follow-up Assessment||8||
59634490|NCT01741350|75749020|FG000|STARTED|12-Month Follow-up Assessment||114||
59634491|NCT01741350|75749021|FG001|STARTED|12-Month Follow-up Assessment||111||
59634492|NCT01741350|75749020|FG000|COMPLETED|12-Month Follow-up Assessment||111||
59634493|NCT01741350|75749021|FG001|COMPLETED|12-Month Follow-up Assessment||109||
59634494|NCT01741350|75749020|FG000|NOT COMPLETED|12-Month Follow-up Assessment||3||
59634495|NCT01741350|75749021|FG001|NOT COMPLETED|12-Month Follow-up Assessment||2||
59634496|NCT01741272|75749029|FG000|STARTED|Overall Study||92||
59634497|NCT01741272|75749030|FG001|STARTED|Overall Study||97||
59634498|NCT01741272|75749029|FG000|COMPLETED|Overall Study||92||
59988316|NCT02270242|76103445|FG001|NOT COMPLETED|Overall Study||53||
59634499|NCT01741272|75749030|FG001|COMPLETED|Overall Study||97||
59634500|NCT01741272|75749029|FG000|NOT COMPLETED|Overall Study||0||
59634501|NCT01741272|75749030|FG001|NOT COMPLETED|Overall Study||0||
59634502|NCT01742208|75749039|FG000|STARTED|Overall Study||3||
59634503|NCT01742208|75749040|FG001|STARTED|Overall Study||17||
59988317|NCT02364388|76103451|FG000|STARTED|Overall Study||217||
59634504|NCT01742208|75749041|FG002|STARTED|Overall Study||16||
59634505|NCT01742208|75749039|FG000|COMPLETED|Overall Study||3||
59634506|NCT01742208|75749040|FG001|COMPLETED|Overall Study||17||
59634507|NCT01742208|75749041|FG002|COMPLETED|Overall Study||16||
59634508|NCT01742208|75749039|FG000|NOT COMPLETED|Overall Study||0||
59634509|NCT01742208|75749040|FG001|NOT COMPLETED|Overall Study||0||
59634510|NCT01742208|75749041|FG002|NOT COMPLETED|Overall Study||0||
59988318|NCT02364388|76103451|FG000|Biopsied|Overall Study||209||
59634511|NCT01742364|75749055|FG000|STARTED|Overall Study||33||
59634512|NCT01742364|75749056|FG001|STARTED|Overall Study||33||
59634513|NCT01742364|75749057|FG002|STARTED|Overall Study||15||
59634514|NCT01742364|75749058|FG003|STARTED|Overall Study||15||
59634515|NCT01742364|75749055|FG000|COMPLETED|Overall Study||33||
59634516|NCT01742364|75749056|FG001|COMPLETED|Overall Study||33||
59634517|NCT01742364|75749057|FG002|COMPLETED|Overall Study||15||
59634518|NCT01742364|75749058|FG003|COMPLETED|Overall Study||15||
59634519|NCT01742364|75749055|FG000|NOT COMPLETED|Overall Study||0||
59634520|NCT01742364|75749056|FG001|NOT COMPLETED|Overall Study||0||
59634521|NCT01742364|75749057|FG002|NOT COMPLETED|Overall Study||0||
59634522|NCT01742364|75749058|FG003|NOT COMPLETED|Overall Study||0||
59634523|NCT01744860|75749069|FG000|STARTED|Overall Study||420||
59634524|NCT01744860|75749069|FG000|COMPLETED|Overall Study||420||
59634525|NCT01744860|75749069|FG000|NOT COMPLETED|Overall Study||0||
59634526|NCT01745952|75749081|FG000|STARTED|Overall Study||4||
59634527|NCT01745952|75749082|FG001|STARTED|Overall Study||4||
59634528|NCT01745952|75749083|FG002|STARTED|Overall Study||3||
59634529|NCT01745952|75749081|FG000|COMPLETED|Overall Study||3||
59634530|NCT01745952|75749082|FG001|COMPLETED|Overall Study|data of one patient not used due to no seizure diary entries on multiple occasions|3||
59634531|NCT01745952|75749083|FG002|COMPLETED|Overall Study||3||
59634532|NCT01745952|75749081|FG000|NOT COMPLETED|Overall Study||1||
59634533|NCT01745952|75749082|FG001|NOT COMPLETED|Overall Study||1||
59634534|NCT01745952|75749083|FG002|NOT COMPLETED|Overall Study||0||
59634535|NCT01746264|75749097|FG000|STARTED|Overall Study||19||
59634536|NCT01746264|75749097|FG000|COMPLETED|Overall Study||19||
59634537|NCT01746264|75749097|FG000|NOT COMPLETED|Overall Study||0||
59634538|NCT01746420|75749106|FG000|STARTED|Overall Study||20||
59634539|NCT01746420|75749107|FG001|STARTED|Overall Study||20||
59634540|NCT01746420|75749108|FG002|STARTED|Overall Study||20||
59634541|NCT01746420|75749109|FG003|STARTED|Overall Study||20||
59634542|NCT01746420|75749110|FG004|STARTED|Overall Study||20||
59634543|NCT01746420|75749106|FG000|COMPLETED|Overall Study||17||
59634544|NCT01746420|75749107|FG001|COMPLETED|Overall Study||18||
59634545|NCT01746420|75749108|FG002|COMPLETED|Overall Study||17||
59634546|NCT01746420|75749109|FG003|COMPLETED|Overall Study||20||
59634547|NCT01746420|75749110|FG004|COMPLETED|Overall Study||20||
59634548|NCT01746420|75749106|FG000|NOT COMPLETED|Overall Study||3||
59634549|NCT01746420|75749107|FG001|NOT COMPLETED|Overall Study||2||
59634550|NCT01746420|75749108|FG002|NOT COMPLETED|Overall Study||3||
59634551|NCT01746420|75749109|FG003|NOT COMPLETED|Overall Study||0||
59634552|NCT01746420|75749110|FG004|NOT COMPLETED|Overall Study||0||
59634553|NCT01748916|75749123|FG000|STARTED|Overall Study||2||
59634554|NCT01748916|75749124|FG001|STARTED|Overall Study||3||
59634555|NCT01748916|75749125|FG002|STARTED|Overall Study||2||
59634556|NCT01748916|75749126|FG003|STARTED|Overall Study||3||
59634557|NCT01748916|75749127|FG004|STARTED|Overall Study||3||
59634558|NCT01748916|75749128|FG005|STARTED|Overall Study||3||
59634559|NCT01748916|75749123|FG000|COMPLETED|Overall Study||2||
59634560|NCT01748916|75749124|FG001|COMPLETED|Overall Study||3||
59634561|NCT01748916|75749125|FG002|COMPLETED|Overall Study||2||
59634562|NCT01748916|75749126|FG003|COMPLETED|Overall Study||3||
59634563|NCT01748916|75749127|FG004|COMPLETED|Overall Study||3||
59634564|NCT01748916|75749128|FG005|COMPLETED|Overall Study||3||
59634565|NCT01748916|75749123|FG000|NOT COMPLETED|Overall Study||0||
59634566|NCT01748916|75749124|FG001|NOT COMPLETED|Overall Study||0||
59634567|NCT01748916|75749125|FG002|NOT COMPLETED|Overall Study||0||
59634568|NCT01748916|75749126|FG003|NOT COMPLETED|Overall Study||0||
59634569|NCT01748916|75749127|FG004|NOT COMPLETED|Overall Study||0||
59634570|NCT01748916|75749128|FG005|NOT COMPLETED|Overall Study||0||
59634571|NCT01749930|75749138|FG000|STARTED|Overall Study|randomized population|283||
59634572|NCT01749930|75749139|FG001|STARTED|Overall Study|randomized population|137||
59634573|NCT01749930|75749138|FG000|COMPLETED|Overall Study|randomized population|253||
59634574|NCT01749930|75749139|FG001|COMPLETED|Overall Study|randomized population|125||
59634575|NCT01749930|75749138|FG000|NOT COMPLETED|Overall Study||30||
59634576|NCT01749930|75749139|FG001|NOT COMPLETED|Overall Study||12||
59634577|NCT01750086|75749151|FG000|STARTED|Overall Study||13||
59634578|NCT01750086|75749152|FG001|STARTED|Overall Study||14||
59634579|NCT01750086|75749151|FG000|COMPLETED|Overall Study||12||
59634580|NCT01750086|75749152|FG001|COMPLETED|Overall Study||13||
59634581|NCT01750086|75749151|FG000|NOT COMPLETED|Overall Study||1||
59634582|NCT01750086|75749152|FG001|NOT COMPLETED|Overall Study||1||
59634583|NCT01750398|75749158|FG000|STARTED|ADT Lead In Phase||33||
59634584|NCT01750398|75749158|FG000|COMPLETED|ADT Lead In Phase||29||
59634585|NCT01750398|75749158|FG000|NOT COMPLETED|ADT Lead In Phase||4||
59634586|NCT01750398|75749158|FG000|STARTED|Bipolar Androgen Thearpy Phase||29||
59634587|NCT01750398|75749158|FG000|COMPLETED|Bipolar Androgen Thearpy Phase||26||
59634588|NCT01750398|75749158|FG000|NOT COMPLETED|Bipolar Androgen Thearpy Phase||3||
59634589|NCT01751022|75749165|FG000|STARTED|Overall Study||499||
59634590|NCT01751022|75749166|FG001|STARTED|Overall Study||326||
59634591|NCT01751022|75749167|FG002|STARTED|Overall Study||300||
59634592|NCT01751022|75749165|FG000|COMPLETED|Overall Study|6 month visit|443||
59634593|NCT01751022|75749166|FG001|COMPLETED|Overall Study|6 month visit|282||
59634594|NCT01751022|75749167|FG002|COMPLETED|Overall Study|6 month visit|273||
59634595|NCT01751022|75749165|FG000|NOT COMPLETED|Overall Study||56||
59634596|NCT01751022|75749166|FG001|NOT COMPLETED|Overall Study||44||
59634597|NCT01751022|75749167|FG002|NOT COMPLETED|Overall Study||27||
59634598|NCT01752426|75749194|FG000|STARTED|Overall Study||30||
59634599|NCT01752426|75749194|FG000|COMPLETED|Overall Study||30||
59634600|NCT01752426|75749194|FG000|NOT COMPLETED|Overall Study||0||
59634601|NCT01753362|75749200|FG000|STARTED|Overall Study||36||
59634602|NCT01753362|75749201|FG001|STARTED|Overall Study||48||
59634603|NCT01753362|75749200|FG000|COMPLETED|Overall Study||26||
59634604|NCT01753362|75749201|FG001|COMPLETED|Overall Study||40||
59634605|NCT01753362|75749200|FG000|NOT COMPLETED|Overall Study||10||
59634606|NCT01753362|75749201|FG001|NOT COMPLETED|Overall Study||8||
59634607|NCT01754688|75749207|FG000|STARTED|Overall Study||624||
59634608|NCT01754688|75749207|FG000|COMPLETED|Overall Study||624||
59634609|NCT01754688|75749207|FG000|NOT COMPLETED|Overall Study||0||
59634610|NCT01757964|75749214|FG000|STARTED|Overall Study||9||
59634611|NCT01757964|75749215|FG001|STARTED|Overall Study||4||
59634612|NCT01757964|75749214|FG000|COMPLETED|Overall Study||9||
59634613|NCT01757964|75749215|FG001|COMPLETED|Overall Study||4||
59634614|NCT01757964|75749214|FG000|NOT COMPLETED|Overall Study||0||
59634615|NCT01757964|75749215|FG001|NOT COMPLETED|Overall Study||0||
59634616|NCT01758588|75749221|FG000|STARTED|Overall Study||5||
59634617|NCT01758588|75749222|FG001|STARTED|Overall Study||3||
59634618|NCT01758588|75749221|FG000|COMPLETED|Overall Study||5||
59634619|NCT01758588|75749222|FG001|COMPLETED|Overall Study||3||
59634620|NCT01758588|75749221|FG000|NOT COMPLETED|Overall Study||0||
59634621|NCT01758588|75749222|FG001|NOT COMPLETED|Overall Study||0||
59634622|NCT01759602|75749230|FG000|STARTED|Overall Study||10||
59634623|NCT01759602|75749230|FG000|COMPLETED|Overall Study||10||
59634624|NCT01759602|75749230|FG000|NOT COMPLETED|Overall Study||0||
59634625|NCT01760304|75749236|FG000|STARTED|Overall Study||2|This is a double crossover study design, therefore each patient use intervention and placebo|
59634626|NCT01760304|75749237|FG001|STARTED|Overall Study||3|This is a double crossover study design, therefore each patient use intervention and placebo|
59634627|NCT01760304|75749236|FG000|COMPLETED|Overall Study||2||
59634628|NCT01760304|75749237|FG001|COMPLETED|Overall Study||3||
59634629|NCT01760304|75749236|FG000|NOT COMPLETED|Overall Study||0||
59634630|NCT01760304|75749237|FG001|NOT COMPLETED|Overall Study||0||
59634631|NCT01761084|75749249|FG000|STARTED|Overall Study||71||
59634632|NCT01761084|75749250|FG001|STARTED|Overall Study||70||
59634633|NCT01761084|75749249|FG000|COMPLETED|Overall Study||66||
59634634|NCT01761084|75749250|FG001|COMPLETED|Overall Study||64||
59634635|NCT01761084|75749249|FG000|NOT COMPLETED|Overall Study||5||
59634636|NCT01761084|75749250|FG001|NOT COMPLETED|Overall Study||6||
59634637|NCT01762722|75749259|FG000|STARTED|Overall Study||12||
59634638|NCT01762722|75749260|FG001|STARTED|Overall Study||11||
59634639|NCT01762722|75749259|FG000|COMPLETED|Overall Study||12||
59634640|NCT01762722|75749260|FG001|COMPLETED|Overall Study||11||
59634641|NCT01762722|75749259|FG000|NOT COMPLETED|Overall Study||0||
59634642|NCT01762722|75749260|FG001|NOT COMPLETED|Overall Study||0||
59634643|NCT01763346|75749268|FG000|STARTED|Overall Study|"Five subjects who enrolled in the study refused to initiate metformin therapy, thus did not start"|44||
59634644|NCT01763346|75749269|FG001|STARTED|Overall Study|"Six subjects randomized to gastric banding refused the banding surgery and, thus, did not start"|44||
59634645|NCT01763346|75749268|FG000|Received Intervention|Overall Study||39||
59634646|NCT01763346|75749269|FG001|Received Intervention|Overall Study||38||
59634647|NCT01763346|75749268|FG000|COMPLETED|Overall Study||34||
59634648|NCT01763346|75749269|FG001|COMPLETED|Overall Study||36||
59634649|NCT01763346|75749268|FG000|NOT COMPLETED|Overall Study||10||
59634650|NCT01763346|75749269|FG001|NOT COMPLETED|Overall Study||8||
59634651|NCT01763970|75749275|FG000|STARTED|Overall Study||14||
59634652|NCT01763970|75749275|FG000|COMPLETED|Overall Study||14||
59634653|NCT01763970|75749275|FG000|NOT COMPLETED|Overall Study||0||
59634654|NCT01765530|75749284|FG000|STARTED|Overall Study||37||
59634655|NCT01765530|75749285|FG001|STARTED|Overall Study||37||
59634656|NCT01765530|75749284|FG000|COMPLETED|Overall Study||36||
59634657|NCT01765530|75749285|FG001|COMPLETED|Overall Study||36||
59634658|NCT01765530|75749284|FG000|NOT COMPLETED|Overall Study||1||
59634659|NCT01765530|75749285|FG001|NOT COMPLETED|Overall Study||1||
59634660|NCT01766466|75749293|FG000|STARTED|Day 1||6||
59634661|NCT01766466|75749294|FG001|STARTED|Day 1||0||
59634662|NCT01766466|75749295|FG002|STARTED|Day 1||6||
59634663|NCT01766466|75749296|FG003|STARTED|Day 1||0||
59634664|NCT01766466|75749293|FG000|COMPLETED|Day 1||6||
59634665|NCT01766466|75749294|FG001|COMPLETED|Day 1||0||
59634666|NCT01766466|75749295|FG002|COMPLETED|Day 1||6||
59634667|NCT01766466|75749296|FG003|COMPLETED|Day 1||0||
59634668|NCT01766466|75749293|FG000|NOT COMPLETED|Day 1||0||
59634669|NCT01766466|75749294|FG001|NOT COMPLETED|Day 1||0||
59634670|NCT01766466|75749295|FG002|NOT COMPLETED|Day 1||0||
59634671|NCT01766466|75749296|FG003|NOT COMPLETED|Day 1||0||
59634672|NCT01766466|75749293|FG000|STARTED|Day 5||0||
59634673|NCT01766466|75749294|FG001|STARTED|Day 5||6||
59634674|NCT01766466|75749295|FG002|STARTED|Day 5||0||
59634675|NCT01766466|75749296|FG003|STARTED|Day 5||6||
59634676|NCT01766466|75749293|FG000|COMPLETED|Day 5||0||
59634677|NCT01766466|75749294|FG001|COMPLETED|Day 5||6||
59634678|NCT01766466|75749295|FG002|COMPLETED|Day 5||0||
59634679|NCT01766466|75749296|FG003|COMPLETED|Day 5||6||
59634680|NCT01766466|75749293|FG000|NOT COMPLETED|Day 5||0||
59634681|NCT01766466|75749294|FG001|NOT COMPLETED|Day 5||0||
59634682|NCT01766466|75749295|FG002|NOT COMPLETED|Day 5||0||
59634683|NCT01766466|75749296|FG003|NOT COMPLETED|Day 5||0||
59634684|NCT01767636|75749305|FG000|STARTED|Overall Study||38||
59634685|NCT01767636|75749305|FG000|COMPLETED|Overall Study||35||
59634686|NCT01767636|75749305|FG000|NOT COMPLETED|Overall Study||3||
59634687|NCT01769274|75749309|FG000|STARTED|Part A||5||
59634688|NCT01769274|75749310|FG001|STARTED|Part A||0||
59634689|NCT01769274|75749311|FG002|STARTED|Part A||0||
59634690|NCT01769274|75749309|FG000|COMPLETED|Part A||5||
59634691|NCT01769274|75749310|FG001|COMPLETED|Part A||0||
59634692|NCT01769274|75749311|FG002|COMPLETED|Part A||0||
59634693|NCT01769274|75749309|FG000|NOT COMPLETED|Part A||0||
59634694|NCT01769274|75749310|FG001|NOT COMPLETED|Part A||0||
59634695|NCT01769274|75749311|FG002|NOT COMPLETED|Part A||0||
59634696|NCT01769274|75749309|FG000|STARTED|Part B:Treatment Session1-Period1||0||
59634697|NCT01769274|75749310|FG001|STARTED|Part B:Treatment Session1-Period1||2||
59634698|NCT01769274|75749311|FG002|STARTED|Part B:Treatment Session1-Period1||3||
59634699|NCT01769274|75749309|FG000|COMPLETED|Part B:Treatment Session1-Period1||0||
59634700|NCT01769274|75749310|FG001|COMPLETED|Part B:Treatment Session1-Period1||2||
59634701|NCT01769274|75749311|FG002|COMPLETED|Part B:Treatment Session1-Period1||3||
59634702|NCT01769274|75749309|FG000|NOT COMPLETED|Part B:Treatment Session1-Period1||0||
59634703|NCT01769274|75749310|FG001|NOT COMPLETED|Part B:Treatment Session1-Period1||0||
59634704|NCT01769274|75749311|FG002|NOT COMPLETED|Part B:Treatment Session1-Period1||0||
59634705|NCT01769274|75749309|FG000|STARTED|Washout Period||0||
59634706|NCT01769274|75749310|FG001|STARTED|Washout Period||2||
59634707|NCT01769274|75749311|FG002|STARTED|Washout Period||3||
59634708|NCT01769274|75749309|FG000|COMPLETED|Washout Period||0||
59634709|NCT01769274|75749310|FG001|COMPLETED|Washout Period||2||
59634710|NCT01769274|75749311|FG002|COMPLETED|Washout Period||3||
59634711|NCT01769274|75749309|FG000|NOT COMPLETED|Washout Period||0||
59634712|NCT01769274|75749310|FG001|NOT COMPLETED|Washout Period||0||
59634713|NCT01769274|75749311|FG002|NOT COMPLETED|Washout Period||0||
59634714|NCT01769274|75749309|FG000|STARTED|Part B:Treatment Session1-Period2||0||
59634715|NCT01769274|75749310|FG001|STARTED|Part B:Treatment Session1-Period2||2||
59634716|NCT01769274|75749311|FG002|STARTED|Part B:Treatment Session1-Period2||3||
59634717|NCT01769274|75749309|FG000|COMPLETED|Part B:Treatment Session1-Period2||0||
59634718|NCT01769274|75749310|FG001|COMPLETED|Part B:Treatment Session1-Period2||2||
59634719|NCT01769274|75749311|FG002|COMPLETED|Part B:Treatment Session1-Period2||3||
59634720|NCT01769274|75749309|FG000|NOT COMPLETED|Part B:Treatment Session1-Period2||0||
59634721|NCT01769274|75749310|FG001|NOT COMPLETED|Part B:Treatment Session1-Period2||0||
59634722|NCT01769274|75749311|FG002|NOT COMPLETED|Part B:Treatment Session1-Period2||0||
59634723|NCT01769274|75749309|FG000|STARTED|Washout Period||0||
59634724|NCT01769274|75749310|FG001|STARTED|Washout Period||2||
59634725|NCT01769274|75749311|FG002|STARTED|Washout Period||3||
59634726|NCT01769274|75749309|FG000|COMPLETED|Washout Period||0||
59634727|NCT01769274|75749310|FG001|COMPLETED|Washout Period||2||
59634728|NCT01769274|75749311|FG002|COMPLETED|Washout Period||3||
59634729|NCT01769274|75749309|FG000|NOT COMPLETED|Washout Period||0||
59634730|NCT01769274|75749310|FG001|NOT COMPLETED|Washout Period||0||
59634731|NCT01769274|75749311|FG002|NOT COMPLETED|Washout Period||0||
59634732|NCT01769274|75749309|FG000|STARTED|Part B:Treatment Session2-Period3||0||
59634733|NCT01769274|75749310|FG001|STARTED|Part B:Treatment Session2-Period3||2||
60076433|NCT01904383|76191417|FG000|COMPLETED|Overall Study||2283||
60076434|NCT01904383|76191417|FG000|NOT COMPLETED|Overall Study||1774||
60076435|NCT01904149|76191427|FG000|STARTED|Overall Study||152||
60076436|NCT01904149|76191428|FG001|STARTED|Overall Study||151||
60076437|NCT01904149|76191429|FG002|STARTED|Overall Study||150||
60076438|NCT01904149|76191430|FG003|STARTED|Overall Study||51||
60076439|NCT01904149|76191431|FG004|STARTED|Overall Study||51||
59634734|NCT01769274|75749311|FG002|STARTED|Part B:Treatment Session2-Period3||3||
59634735|NCT01769274|75749309|FG000|COMPLETED|Part B:Treatment Session2-Period3||0||
59634736|NCT01769274|75749310|FG001|COMPLETED|Part B:Treatment Session2-Period3||2||
59634737|NCT01769274|75749311|FG002|COMPLETED|Part B:Treatment Session2-Period3||3||
59634738|NCT01769274|75749309|FG000|NOT COMPLETED|Part B:Treatment Session2-Period3||0||
59634739|NCT01769274|75749310|FG001|NOT COMPLETED|Part B:Treatment Session2-Period3||0||
59634740|NCT01769274|75749311|FG002|NOT COMPLETED|Part B:Treatment Session2-Period3||0||
59634741|NCT01769274|75749309|FG000|STARTED|Washout Period||0||
59634742|NCT01769274|75749310|FG001|STARTED|Washout Period||2||
59634743|NCT01769274|75749311|FG002|STARTED|Washout Period||3||
60076440|NCT01904149|76191432|FG005|STARTED|Overall Study||51||
59634744|NCT01769274|75749309|FG000|COMPLETED|Washout Period||0||
59634745|NCT01769274|75749310|FG001|COMPLETED|Washout Period||2||
59634746|NCT01769274|75749311|FG002|COMPLETED|Washout Period||3||
59634747|NCT01769274|75749309|FG000|NOT COMPLETED|Washout Period||0||
59634748|NCT01769274|75749310|FG001|NOT COMPLETED|Washout Period||0||
59634749|NCT01769274|75749311|FG002|NOT COMPLETED|Washout Period||0||
60076441|NCT01904149|76191427|FG000|Single-dose Phase|Overall Study||152||
59540659|NCT01432535|75638886|FG001|NOT COMPLETED|Overall Study||0||
59540660|NCT01432535|75638887|FG002|NOT COMPLETED|Overall Study||0||
59540661|NCT04184622|75638899|FG000|STARTED|Overall Study||643||
59540662|NCT04184622|75638900|FG001|STARTED|Overall Study||630||
59540663|NCT04184622|75638901|FG002|STARTED|Overall Study||636||
59540664|NCT04184622|75638902|FG003|STARTED|Overall Study||630||
59540665|NCT04184622|75638899|FG000|COMPLETED|Overall Study||495||
59540666|NCT04184622|75638900|FG001|COMPLETED|Overall Study||561||
59540667|NCT04184622|75638901|FG002|COMPLETED|Overall Study||562||
59540668|NCT04184622|75638902|FG003|COMPLETED|Overall Study||566||
59540669|NCT04184622|75638899|FG000|NOT COMPLETED|Overall Study||148||
59540670|NCT04184622|75638900|FG001|NOT COMPLETED|Overall Study||69||
59540671|NCT04184622|75638901|FG002|NOT COMPLETED|Overall Study||74||
59540672|NCT04184622|75638902|FG003|NOT COMPLETED|Overall Study||64||
59540673|NCT03861091|75638919|FG000|STARTED|Overall Study||41||
59540674|NCT03861091|75638920|FG001|STARTED|Overall Study||43||
59540675|NCT03861091|75638919|FG000|COMPLETED|Overall Study||41||
59540676|NCT03861091|75638920|FG001|COMPLETED|Overall Study||43||
59540677|NCT03861091|75638919|FG000|NOT COMPLETED|Overall Study||0||
59540678|NCT03861091|75638920|FG001|NOT COMPLETED|Overall Study||0||
59540679|NCT03854916|75638928|FG000|STARTED|Overall Study||38||
59540680|NCT03854916|75638929|FG001|STARTED|Overall Study||40||
59540681|NCT03854916|75638928|FG000|COMPLETED|Overall Study||38||
59540682|NCT03854916|75638929|FG001|COMPLETED|Overall Study||40||
59540683|NCT03854916|75638928|FG000|NOT COMPLETED|Overall Study||0||
59540684|NCT03854916|75638929|FG001|NOT COMPLETED|Overall Study||0||
59540685|NCT03772717|75638935|FG000|STARTED|Overall Study||2||
59540686|NCT03772717|75638935|FG000|COMPLETED|Overall Study||0||
59540687|NCT03772717|75638935|FG000|NOT COMPLETED|Overall Study||2||
59540688|NCT03770403|75638939|FG000|STARTED|Overall Study||145||
59540689|NCT03770403|75638939|FG000|COMPLETED|Overall Study||28||
59540690|NCT03770403|75638939|FG000|NOT COMPLETED|Overall Study||117||
59540691|NCT03740100|75638943|FG000|STARTED|Overall Study|Note: Ten patients were consented, but two died before starting therapy.|8||
59540692|NCT03740100|75638943|FG000|Confirmed Partial Response|Overall Study|"Using a Simon's optimal two-stage design, we planned to enroll up to 10 evaluable patients in the first stage.~Two of eight treated patients were not evaluable for response based on toxicity.~We did not reach this milestone."|1||
59540693|NCT03740100|75638943|FG000|COMPLETED|Overall Study||6||
59540694|NCT03740100|75638943|FG000|NOT COMPLETED|Overall Study||2||
59540695|NCT03499795|75638947|FG000|STARTED|Overall Study||23||
59540696|NCT03499795|75638947|FG000|Safety Population|Overall Study||23|Safety population included all participants who received at least 1 dose of VGX-3100+EP.|
59540697|NCT03499795|75638947|FG000|Modified Intent-to-treat (mITT) Population|Overall Study||23|mITT population included all participants who received at least 1 dose of VGX-3100+EP.|
59540698|NCT03499795|75638947|FG000|COMPLETED|Overall Study||21||
59540699|NCT03499795|75638947|FG000|NOT COMPLETED|Overall Study||2||
59540700|NCT03496987|75638953|FG000|STARTED|Overall Study||49||
59540701|NCT03496987|75638954|FG001|STARTED|Overall Study||51||
59540702|NCT03496987|75638953|FG000|COMPLETED|Overall Study||49||
59540703|NCT03496987|75638954|FG001|COMPLETED|Overall Study||51||
59540704|NCT03496987|75638953|FG000|NOT COMPLETED|Overall Study||0||
59540705|NCT03496987|75638954|FG001|NOT COMPLETED|Overall Study||0||
59540706|NCT03456804|75638960|FG000|STARTED|Overall Study||13||
59540707|NCT03456804|75638960|FG000|COMPLETED|Overall Study||13||
59540708|NCT03456804|75638960|FG000|NOT COMPLETED|Overall Study||0||
59540709|NCT03456700|75638964|FG000|STARTED|Overall Study||22||
59540710|NCT03456700|75638964|FG000|COMPLETED|Overall Study||21||
59540711|NCT03456700|75638964|FG000|NOT COMPLETED|Overall Study||1||
59540712|NCT03401450|75638970|FG000|STARTED|Overall Study||33||
59540713|NCT03401450|75638971|FG001|STARTED|Overall Study||36||
59540714|NCT03401450|75638970|FG000|COMPLETED|Overall Study||21||
59540715|NCT03401450|75638971|FG001|COMPLETED|Overall Study||23||
59540716|NCT03401450|75638970|FG000|NOT COMPLETED|Overall Study||12||
59540717|NCT03401450|75638971|FG001|NOT COMPLETED|Overall Study||13||
59540718|NCT03326063|75638979|FG000|STARTED|Overall Study||18||
59540719|NCT03326063|75638980|FG001|STARTED|Overall Study||18||
59540720|NCT03326063|75638979|FG000|COMPLETED|Overall Study||17||
59540721|NCT03326063|75638980|FG001|COMPLETED|Overall Study||18||
59540722|NCT03326063|75638979|FG000|NOT COMPLETED|Overall Study||1||
59540723|NCT03326063|75638980|FG001|NOT COMPLETED|Overall Study||0||
59540724|NCT03267810|75638990|FG000|STARTED|Overall Study||13||
59540725|NCT03267810|75638991|FG001|STARTED|Overall Study||13||
59540726|NCT03267810|75638990|FG000|COMPLETED|Overall Study||10||
59540727|NCT03267810|75638991|FG001|COMPLETED|Overall Study||12||
59540728|NCT03267810|75638990|FG000|NOT COMPLETED|Overall Study||3||
59540729|NCT03267810|75638991|FG001|NOT COMPLETED|Overall Study||1||
59540730|NCT03155997|75639001|FG000|STARTED|Overall Study||2808||
59540731|NCT03155997|75639002|FG001|STARTED|Overall Study||2829||
59540732|NCT03155997|75639001|FG000|Received at Least One Dose of Study Drug|Overall Study||2791||
59540733|NCT03155997|75639002|FG001|Received at Least One Dose of Study Drug|Overall Study||2800||
59540734|NCT03155997|75639001|FG000|COMPLETED|Overall Study||650||
59540735|NCT03155997|75639002|FG001|COMPLETED|Overall Study||607||
59540736|NCT03155997|75639001|FG000|NOT COMPLETED|Overall Study||2158||
59540737|NCT03155997|75639002|FG001|NOT COMPLETED|Overall Study||2222||
59634750|NCT01769274|75749309|FG000|STARTED|Part B:Treatment Session2-Period4||0||
59634751|NCT01769274|75749310|FG001|STARTED|Part B:Treatment Session2-Period4||2||
59634752|NCT01769274|75749311|FG002|STARTED|Part B:Treatment Session2-Period4||3||
59634753|NCT01769274|75749309|FG000|COMPLETED|Part B:Treatment Session2-Period4||0||
59634754|NCT01769274|75749310|FG001|COMPLETED|Part B:Treatment Session2-Period4||2||
59634755|NCT01769274|75749311|FG002|COMPLETED|Part B:Treatment Session2-Period4||3||
59634756|NCT01769274|75749309|FG000|NOT COMPLETED|Part B:Treatment Session2-Period4||0||
59634757|NCT01769274|75749310|FG001|NOT COMPLETED|Part B:Treatment Session2-Period4||0||
59634758|NCT01769274|75749311|FG002|NOT COMPLETED|Part B:Treatment Session2-Period4||0||
59634759|NCT01769586|75749324|FG000|STARTED|Overall Study||100||
59634760|NCT01769586|75749325|FG001|STARTED|Overall Study||100||
59634761|NCT01769586|75749324|FG000|COMPLETED|Overall Study||100||
59634762|NCT01769586|75749325|FG001|COMPLETED|Overall Study||100||
59634763|NCT01769586|75749324|FG000|NOT COMPLETED|Overall Study||0||
59634764|NCT01769586|75749325|FG001|NOT COMPLETED|Overall Study||0||
59634765|NCT01770366|75749333|FG000|STARTED|Overall Study||4||
59634766|NCT01770366|75749334|FG001|STARTED|Overall Study||6||
59634767|NCT01770366|75749333|FG000|COMPLETED|Overall Study||2||
59634768|NCT01770366|75749334|FG001|COMPLETED|Overall Study||4||
59634769|NCT01770366|75749333|FG000|NOT COMPLETED|Overall Study||2||
59634770|NCT01770366|75749334|FG001|NOT COMPLETED|Overall Study||2||
59634771|NCT01773954|75749340|FG000|STARTED|Overall Study||40||
59634772|NCT01773954|75749340|FG000|COMPLETED|Overall Study||31||
59634773|NCT01773954|75749340|FG000|NOT COMPLETED|Overall Study||9||
59634774|NCT01778634|75749346|FG000|STARTED|Overall Study||61||
59634775|NCT01778634|75749347|FG001|STARTED|Overall Study||60||
59634776|NCT01778634|75749346|FG000|COMPLETED|Overall Study||61||
59634777|NCT01778634|75749347|FG001|COMPLETED|Overall Study||60||
59634778|NCT01778634|75749346|FG000|NOT COMPLETED|Overall Study||0||
59634779|NCT01778634|75749347|FG001|NOT COMPLETED|Overall Study||0||
59634780|NCT01779024|75749354|FG000|STARTED|1st Visit - Alcohol Self-Administration||8||
59634781|NCT01779024|75749355|FG001|STARTED|1st Visit - Alcohol Self-Administration||9||
59634782|NCT01779024|75749354|FG000|COMPLETED|1st Visit - Alcohol Self-Administration||8||
59634783|NCT01779024|75749355|FG001|COMPLETED|1st Visit - Alcohol Self-Administration||9||
59634784|NCT01779024|75749354|FG000|NOT COMPLETED|1st Visit - Alcohol Self-Administration||0||
59634785|NCT01779024|75749355|FG001|NOT COMPLETED|1st Visit - Alcohol Self-Administration||0||
59634786|NCT01779024|75749354|FG000|STARTED|2nd Visit - Alcohol Self-Administration||8||
59634787|NCT01779024|75749355|FG001|STARTED|2nd Visit - Alcohol Self-Administration||9||
59634788|NCT01779024|75749354|FG000|COMPLETED|2nd Visit - Alcohol Self-Administration||6||
59634789|NCT01779024|75749355|FG001|COMPLETED|2nd Visit - Alcohol Self-Administration||9||
59634790|NCT01779024|75749354|FG000|NOT COMPLETED|2nd Visit - Alcohol Self-Administration||2||
59634791|NCT01779024|75749355|FG001|NOT COMPLETED|2nd Visit - Alcohol Self-Administration||0||
59634792|NCT01779024|75749354|FG000|STARTED|1st Visit - Functional MRI||6||
59634793|NCT01779024|75749355|FG001|STARTED|1st Visit - Functional MRI||7||
59634794|NCT01779024|75749354|FG000|COMPLETED|1st Visit - Functional MRI||4||
59634795|NCT01779024|75749355|FG001|COMPLETED|1st Visit - Functional MRI||5||
59634796|NCT01779024|75749354|FG000|NOT COMPLETED|1st Visit - Functional MRI||2||
59634797|NCT01779024|75749355|FG001|NOT COMPLETED|1st Visit - Functional MRI||2||
59634798|NCT01779024|75749354|FG000|STARTED|2nd Visit - Functional MRI||5||
59634799|NCT01779024|75749355|FG001|STARTED|2nd Visit - Functional MRI||6||
59634800|NCT01779024|75749354|FG000|COMPLETED|2nd Visit - Functional MRI||5||
59634801|NCT01779024|75749355|FG001|COMPLETED|2nd Visit - Functional MRI||6||
59634802|NCT01779024|75749354|FG000|NOT COMPLETED|2nd Visit - Functional MRI||0||
59815726|NCT03233724|75938197|FG004|NOT COMPLETED|Phase I Dose Escalation||1||
59988319|NCT02364388|76103451|FG000|Excluded|Overall Study||8||
59988320|NCT02364388|76103451|FG000|COMPLETED|Overall Study||209||
59988321|NCT02364388|76103451|FG000|NOT COMPLETED|Overall Study||8||
59988322|NCT02363686|76103455|FG000|STARTED|Overall Study||248||
59988323|NCT02363686|76103455|FG000|COMPLETED|Overall Study||213||
59988324|NCT02363686|76103455|FG000|NOT COMPLETED|Overall Study||35||
59988325|NCT02268916|76103461|FG000|STARTED|Overall Study||52||
59634803|NCT01779024|75749355|FG001|NOT COMPLETED|2nd Visit - Functional MRI||0||
59634804|NCT01780350|75749361|FG000|STARTED|Overall Study||200||
59634805|NCT01780350|75749361|FG000|COMPLETED|Overall Study||200||
59634806|NCT01780350|75749361|FG000|NOT COMPLETED|Overall Study||0||
59634807|NCT01781208|75749365|FG000|STARTED|Overall Study||62||
59634808|NCT01781208|75749365|FG000|Overall Study|Overall Study||62||
59634809|NCT01781208|75749365|FG000|COMPLETED|Overall Study||62||
59634810|NCT01781208|75749365|FG000|NOT COMPLETED|Overall Study||0||
59634811|NCT01783080|75749370|FG000|STARTED|Overall Study||16||
59634812|NCT01783080|75749370|FG000|COMPLETED|Overall Study||16||
59634813|NCT01783080|75749370|FG000|NOT COMPLETED|Overall Study||0||
59988326|NCT02268916|76103462|FG001|STARTED|Overall Study||52||
59988327|NCT02268916|76103461|FG000|COMPLETED|Overall Study||35||
59634814|NCT01783236|75749376|FG000|STARTED|Overall Study||8||
59634815|NCT01783236|75749377|FG001|STARTED|Overall Study||8||
59988328|NCT02268916|76103462|FG001|COMPLETED|Overall Study||42||
59988329|NCT02268916|76103461|FG000|NOT COMPLETED|Overall Study||17||
59988330|NCT02268916|76103462|FG001|NOT COMPLETED|Overall Study||10||
59988331|NCT02518490|76103469|FG000|STARTED|Overall Study||18||18
59988332|NCT02518490|76103470|FG001|STARTED|Overall Study||18||18
59988333|NCT02518490|76103469|FG000|COMPLETED|Overall Study||17||17
59988334|NCT02518490|76103470|FG001|COMPLETED|Overall Study||17||17
59634816|NCT01783236|75749376|FG000|COMPLETED|Overall Study||6||
59634817|NCT01783236|75749377|FG001|COMPLETED|Overall Study||8||
59634818|NCT01783236|75749376|FG000|NOT COMPLETED|Overall Study||2||
59634819|NCT01783236|75749377|FG001|NOT COMPLETED|Overall Study||0||
59634820|NCT01783470|75749383|FG000|STARTED|Overall Study||6||
59634821|NCT01783470|75749384|FG001|STARTED|Overall Study|Single-dose|6||
59634822|NCT01783470|75749383|FG000|COMPLETED|Overall Study||6||
59634823|NCT01783470|75749384|FG001|COMPLETED|Overall Study||6||
59634824|NCT01783470|75749383|FG000|NOT COMPLETED|Overall Study||0||
59634825|NCT01783470|75749384|FG001|NOT COMPLETED|Overall Study||0||
59634826|NCT01783860|75749393|FG000|STARTED|Overall Study||50||
59634827|NCT01783860|75749394|FG001|STARTED|Overall Study||50||
59634828|NCT01783860|75749393|FG000|COMPLETED|Overall Study||50||
59634829|NCT01783860|75749394|FG001|COMPLETED|Overall Study||50||
59634830|NCT01783860|75749393|FG000|NOT COMPLETED|Overall Study||0||
59634831|NCT01783860|75749394|FG001|NOT COMPLETED|Overall Study||0||
59634832|NCT01784796|75749402|FG000|STARTED|Overall Study|These are participants who provided informed consent|87||
59634833|NCT01784796|75749403|FG001|STARTED|Overall Study|These are participants who provided informed consent|77||
59634834|NCT01784796|75749402|FG000|Baseline Data Collected|Overall Study||75||
59634835|NCT01784796|75749403|FG001|Baseline Data Collected|Overall Study||61||
59634836|NCT01784796|75749402|FG000|4 Week Data Collection|Overall Study||48||
59634837|NCT01784796|75749403|FG001|4 Week Data Collection|Overall Study||41||
59634838|NCT01784796|75749402|FG000|8 wk Data Collection|Overall Study||50||
59634839|NCT01784796|75749403|FG001|8 wk Data Collection|Overall Study||46||
59634840|NCT01784796|75749402|FG000|COMPLETED|Overall Study||39|This is data collected 6 months after end of intervention|
59634841|NCT01784796|75749403|FG001|COMPLETED|Overall Study||34|This is data collected 6 months after end of intervention|
59634842|NCT01784796|75749402|FG000|NOT COMPLETED|Overall Study||48||
59634843|NCT01784796|75749403|FG001|NOT COMPLETED|Overall Study||43||
59634844|NCT01785186|75749415|FG000|STARTED|Overall Study||59||
59634845|NCT01785186|75749416|FG001|STARTED|Overall Study||63||
59634846|NCT01785186|75749417|FG002|STARTED|Overall Study||57||
59634847|NCT01785186|75749418|FG003|STARTED|Overall Study||63||
59634848|NCT01785186|75749419|FG004|STARTED|Overall Study||123||
59634849|NCT01785186|75749415|FG000|COMPLETED|Overall Study||53||
59634850|NCT01785186|75749416|FG001|COMPLETED|Overall Study||57||
59634851|NCT01785186|75749417|FG002|COMPLETED|Overall Study||52||
59634852|NCT01785186|75749418|FG003|COMPLETED|Overall Study||58||
59634853|NCT01785186|75749419|FG004|COMPLETED|Overall Study||117||
59634854|NCT01785186|75749415|FG000|NOT COMPLETED|Overall Study||6||
59634855|NCT01785186|75749416|FG001|NOT COMPLETED|Overall Study||6||
59634856|NCT01785186|75749417|FG002|NOT COMPLETED|Overall Study||5||
59634857|NCT01785186|75749418|FG003|NOT COMPLETED|Overall Study||5||
59634858|NCT01785186|75749419|FG004|NOT COMPLETED|Overall Study||6||
59634859|NCT01785810|75749433|FG000|STARTED|Overall Study||37||
59634860|NCT01785810|75749433|FG000|COMPLETED|Overall Study||29||
59634861|NCT01785810|75749433|FG000|NOT COMPLETED|Overall Study||8||
59634862|NCT01786902|75749439|FG000|STARTED|Overall Study||36||
59634863|NCT01786902|75749440|FG001|STARTED|Overall Study||34||
59634864|NCT01786902|75749439|FG000|COMPLETED|Overall Study||32||
59634865|NCT01786902|75749440|FG001|COMPLETED|Overall Study||31||
59634866|NCT01786902|75749439|FG000|NOT COMPLETED|Overall Study||4||
59634867|NCT01786902|75749440|FG001|NOT COMPLETED|Overall Study||3||
59634868|NCT01787604|75749448|FG000|STARTED|Overall Study||32||
59634869|NCT01787604|75749449|FG001|STARTED|Overall Study||32||
59634870|NCT01787604|75749448|FG000|COMPLETED|Overall Study||28||
59634871|NCT01787604|75749449|FG001|COMPLETED|Overall Study||28||
59634872|NCT01787604|75749448|FG000|NOT COMPLETED|Overall Study||4||
59634873|NCT01787604|75749449|FG001|NOT COMPLETED|Overall Study||4||
59634874|NCT01787916|75749455|FG000|STARTED|First Intervention (24 Weeks)||8||
59634875|NCT01787916|75749456|FG001|STARTED|First Intervention (24 Weeks)||7||
59634876|NCT01787916|75749455|FG000|COMPLETED|First Intervention (24 Weeks)||8||
59634877|NCT01787916|75749456|FG001|COMPLETED|First Intervention (24 Weeks)||7||
59634878|NCT01787916|75749455|FG000|NOT COMPLETED|First Intervention (24 Weeks)||0||
59634879|NCT01787916|75749456|FG001|NOT COMPLETED|First Intervention (24 Weeks)||0||
59634880|NCT01787916|75749455|FG000|STARTED|Washout (4 Weeks)||8||
59634881|NCT01787916|75749456|FG001|STARTED|Washout (4 Weeks)||7||
59634882|NCT01787916|75749455|FG000|COMPLETED|Washout (4 Weeks)||8||
59634883|NCT01787916|75749456|FG001|COMPLETED|Washout (4 Weeks)||7||
59634884|NCT01787916|75749455|FG000|NOT COMPLETED|Washout (4 Weeks)||0||
59634885|NCT01787916|75749456|FG001|NOT COMPLETED|Washout (4 Weeks)||0||
59988335|NCT02518490|76103469|FG000|NOT COMPLETED|Overall Study||1||1
59634886|NCT01787916|75749455|FG000|STARTED|Second Intervention (24 Weeks)||8||
59634887|NCT01787916|75749456|FG001|STARTED|Second Intervention (24 Weeks)||7||
59988336|NCT02518490|76103470|FG001|NOT COMPLETED|Overall Study||1||1
59988337|NCT01364870|76103480|FG000|STARTED|Overall Study||122||
59988338|NCT01364870|76103481|FG001|STARTED|Overall Study||123||
59709641|NCT01235741|75828430|FG001|STARTED|Randomized to Treatment||36||
59634888|NCT01787916|75749455|FG000|COMPLETED|Second Intervention (24 Weeks)||8||
59634889|NCT01787916|75749456|FG001|COMPLETED|Second Intervention (24 Weeks)||7||
59634890|NCT01787916|75749455|FG000|NOT COMPLETED|Second Intervention (24 Weeks)||0||
59634891|NCT01787916|75749456|FG001|NOT COMPLETED|Second Intervention (24 Weeks)||0||
59634892|NCT01788150|75749464|FG000|STARTED|Overall Study||108||
59634893|NCT01788150|75749465|FG001|STARTED|Overall Study||51||
59634894|NCT01788150|75749464|FG000|COMPLETED|Overall Study||95||
59634895|NCT01788150|75749465|FG001|COMPLETED|Overall Study||48||
59634896|NCT01788150|75749464|FG000|NOT COMPLETED|Overall Study||13||
59634897|NCT01788150|75749465|FG001|NOT COMPLETED|Overall Study||3||
59634898|NCT01790178|75749473|FG000|STARTED|Overall Study||16||
59634899|NCT01790178|75749474|FG001|STARTED|Overall Study||24||
59634900|NCT01790178|75749473|FG000|COMPLETED|Overall Study||16||
59634901|NCT01790178|75749474|FG001|COMPLETED|Overall Study||24||
59634902|NCT01790178|75749473|FG000|NOT COMPLETED|Overall Study||0||
59634903|NCT01790178|75749474|FG001|NOT COMPLETED|Overall Study||0||
59634904|NCT01790490|75749483|FG000|STARTED|Overall Study||3||
59634905|NCT01790490|75749484|FG001|STARTED|Overall Study||3||
59634906|NCT01790490|75749485|FG002|STARTED|Overall Study||2||
59634907|NCT01790490|75749483|FG000|COMPLETED|Overall Study||3||
59634908|NCT01790490|75749484|FG001|COMPLETED|Overall Study||3||
59634909|NCT01790490|75749485|FG002|COMPLETED|Overall Study||2||
59634910|NCT01790490|75749483|FG000|NOT COMPLETED|Overall Study||0||
59634911|NCT01790490|75749484|FG001|NOT COMPLETED|Overall Study||0||
59634912|NCT01790490|75749485|FG002|NOT COMPLETED|Overall Study||0||
59634913|NCT01791972|75749498|FG000|STARTED|Overall Study||19||
59634914|NCT01791972|75749499|FG001|STARTED|Overall Study||19||
59634915|NCT01791972|75749498|FG000|COMPLETED|Overall Study||19||
59634916|NCT01791972|75749499|FG001|COMPLETED|Overall Study||19||
59634917|NCT01791972|75749498|FG000|NOT COMPLETED|Overall Study||0||
59634918|NCT01791972|75749499|FG001|NOT COMPLETED|Overall Study||0||
59634919|NCT01792986|75749505|FG000|STARTED|Overall Study||12||
59634920|NCT01792986|75749505|FG000|COMPLETED|Overall Study||12||
59634921|NCT01792986|75749505|FG000|NOT COMPLETED|Overall Study||0||
59634922|NCT01794702|75749512|FG000|STARTED|Overall Study||18||
59634923|NCT01794702|75749513|FG001|STARTED|Overall Study||0||
59634924|NCT01794702|75749514|FG002|STARTED|Overall Study||47||
59634925|NCT01794702|75749512|FG000|COMPLETED|Overall Study||18||
59634926|NCT01794702|75749513|FG001|COMPLETED|Overall Study||0||
59634927|NCT01794702|75749514|FG002|COMPLETED|Overall Study||47||
59634928|NCT01794702|75749512|FG000|NOT COMPLETED|Overall Study||0||
59634929|NCT01794702|75749513|FG001|NOT COMPLETED|Overall Study||0||
59634930|NCT01794702|75749514|FG002|NOT COMPLETED|Overall Study||0||
59634931|NCT01795716|75749524|FG000|STARTED|First Intervention (13 Days)||10||
59634932|NCT01795716|75749525|FG001|STARTED|First Intervention (13 Days)||11||
59634933|NCT01795716|75749524|FG000|COMPLETED|First Intervention (13 Days)||10||
59634934|NCT01795716|75749525|FG001|COMPLETED|First Intervention (13 Days)||11||
59634935|NCT01795716|75749524|FG000|NOT COMPLETED|First Intervention (13 Days)||0||
59634936|NCT01795716|75749525|FG001|NOT COMPLETED|First Intervention (13 Days)||0||
59634937|NCT01795716|75749524|FG000|STARTED|Washout (10 Days)||10||
59634938|NCT01795716|75749525|FG001|STARTED|Washout (10 Days)||11||
59634939|NCT01795716|75749524|FG000|COMPLETED|Washout (10 Days)||10||
59634940|NCT01795716|75749525|FG001|COMPLETED|Washout (10 Days)||11||
59634941|NCT01795716|75749524|FG000|NOT COMPLETED|Washout (10 Days)||0||
59634942|NCT01795716|75749525|FG001|NOT COMPLETED|Washout (10 Days)||0||
59634943|NCT01795716|75749524|FG000|STARTED|Second Intervention (13 Days)||10||
59634944|NCT01795716|75749525|FG001|STARTED|Second Intervention (13 Days)||11||
59634945|NCT01795716|75749524|FG000|COMPLETED|Second Intervention (13 Days)||10||
59634946|NCT01795716|75749525|FG001|COMPLETED|Second Intervention (13 Days)||11||
59634947|NCT01795716|75749524|FG000|NOT COMPLETED|Second Intervention (13 Days)||0||
59634948|NCT01795716|75749525|FG001|NOT COMPLETED|Second Intervention (13 Days)||0||
59634949|NCT01800318|75749535|FG000|STARTED|Overall Study||39||
59634950|NCT01800318|75749536|FG001|STARTED|Overall Study||42||
59634951|NCT01800318|75749537|FG002|STARTED|Overall Study||41||
59634952|NCT01800318|75749538|FG003|STARTED|Overall Study||40||
59634953|NCT01800318|75749535|FG000|COMPLETED|Overall Study||37||
59634954|NCT01800318|75749536|FG001|COMPLETED|Overall Study||37||
59634955|NCT01800318|75749537|FG002|COMPLETED|Overall Study||40||
59634956|NCT01800318|75749538|FG003|COMPLETED|Overall Study||39||
59634957|NCT01800318|75749535|FG000|NOT COMPLETED|Overall Study||2||
59634958|NCT01800318|75749536|FG001|NOT COMPLETED|Overall Study||5||
59634959|NCT01800318|75749537|FG002|NOT COMPLETED|Overall Study||1||
59634960|NCT01800318|75749538|FG003|NOT COMPLETED|Overall Study||1||
59634961|NCT01800786|75749554|FG000|STARTED|Overall Study||17||
59634962|NCT01800786|75749555|FG001|STARTED|Overall Study||16||
59634963|NCT01800786|75749554|FG000|COMPLETED|Overall Study||15||
59634964|NCT01800786|75749555|FG001|COMPLETED|Overall Study||15||
59634965|NCT01800786|75749554|FG000|NOT COMPLETED|Overall Study||2||
59634966|NCT01800786|75749555|FG001|NOT COMPLETED|Overall Study||1||
59634967|NCT01803204|75749563|FG000|STARTED|Overall Study||20||
59634968|NCT01803204|75749564|FG001|STARTED|Overall Study||20||
59634969|NCT01803204|75749563|FG000|COMPLETED|Overall Study||20||
59634970|NCT01803204|75749564|FG001|COMPLETED|Overall Study||20||
59634971|NCT01803204|75749563|FG000|NOT COMPLETED|Overall Study||0||
59634972|NCT01803204|75749564|FG001|NOT COMPLETED|Overall Study||0||
59634973|NCT01804062|75749570|FG000|STARTED|Overall Study||30||
59634974|NCT01804062|75749570|FG000|COMPLETED|Overall Study||30||
59634975|NCT01804062|75749570|FG000|NOT COMPLETED|Overall Study||0||
59634976|NCT01805154|75749574|FG000|STARTED|Overall Study||1529||
59634977|NCT01805154|75749574|FG000|COMPLETED|Overall Study||1175||
59634978|NCT01805154|75749574|FG000|NOT COMPLETED|Overall Study||354||
59634979|NCT01809834|75749581|FG000|STARTED|Overall Study||44||
59634980|NCT01809834|75749581|FG000|COMPLETED|Overall Study||44||
59634981|NCT01809834|75749581|FG000|NOT COMPLETED|Overall Study||0||
59634982|NCT01769352|75749591|FG000|STARTED|Overall Study||13||
59634983|NCT01769352|75749592|FG001|STARTED|Overall Study||12||
59634984|NCT01769352|75749593|FG002|STARTED|Overall Study||9||
59634985|NCT01769352|75749594|FG003|STARTED|Overall Study||8||
59634986|NCT01769352|75749591|FG000|COMPLETED|Overall Study||13||
59634987|NCT01769352|75749592|FG001|COMPLETED|Overall Study||12||
59634988|NCT01769352|75749593|FG002|COMPLETED|Overall Study||9||
59634989|NCT01769352|75749594|FG003|COMPLETED|Overall Study||8||
59634990|NCT01769352|75749591|FG000|NOT COMPLETED|Overall Study||0||
59634991|NCT01769352|75749592|FG001|NOT COMPLETED|Overall Study||0||
59634992|NCT01769352|75749593|FG002|NOT COMPLETED|Overall Study||0||
59634993|NCT01769352|75749594|FG003|NOT COMPLETED|Overall Study||0||
59634994|NCT01810692|75749607|FG000|STARTED|Overall Study||77||
59634995|NCT01810692|75749608|FG001|STARTED|Overall Study||77||
59634996|NCT01810692|75749607|FG000|COMPLETED|Overall Study||77||
59634997|NCT01810692|75749608|FG001|COMPLETED|Overall Study||77||
59634998|NCT01810692|75749607|FG000|NOT COMPLETED|Overall Study||0||
59634999|NCT01810692|75749608|FG001|NOT COMPLETED|Overall Study||0||
59635000|NCT01811004|75749616|FG000|STARTED|Overall Study||9||
59635001|NCT01811004|75749617|FG001|STARTED|Overall Study||8||
59635002|NCT01811004|75749616|FG000|COMPLETED|Overall Study||8||
59635003|NCT01811004|75749617|FG001|COMPLETED|Overall Study||5||
59635004|NCT01811004|75749616|FG000|NOT COMPLETED|Overall Study||1||
59988339|NCT01364870|76103482|FG002|STARTED|Overall Study||72||
59988340|NCT01364870|76103480|FG000|COMPLETED|Overall Study||100||
59988341|NCT01364870|76103481|FG001|COMPLETED|Overall Study||93||
59988342|NCT01364870|76103482|FG002|COMPLETED|Overall Study||58||
59635005|NCT01811004|75749617|FG001|NOT COMPLETED|Overall Study||3||
59635006|NCT01811316|75749628|FG000|STARTED|Overall Study||21||
59635007|NCT01811316|75749629|FG001|STARTED|Overall Study||22||
59635008|NCT01811316|75749630|FG002|STARTED|Overall Study||19||
59635009|NCT01811316|75749628|FG000|Visit 4 Weeks|Overall Study||19||
59635010|NCT01811316|75749629|FG001|Visit 4 Weeks|Overall Study||22||
59635011|NCT01811316|75749630|FG002|Visit 4 Weeks|Overall Study||19||
59635012|NCT01811316|75749628|FG000|Visit 12 Weeks|Overall Study||18||
59635013|NCT01811316|75749629|FG001|Visit 12 Weeks|Overall Study||22||
59635014|NCT01811316|75749630|FG002|Visit 12 Weeks|Overall Study||19||
59635015|NCT01811316|75749628|FG000|COMPLETED|Overall Study||18||
59635016|NCT01811316|75749629|FG001|COMPLETED|Overall Study||22||
59635017|NCT01811316|75749630|FG002|COMPLETED|Overall Study||19||
59635018|NCT01811316|75749628|FG000|NOT COMPLETED|Overall Study||3||
59635019|NCT01811316|75749629|FG001|NOT COMPLETED|Overall Study||0||
59635020|NCT01811316|75749630|FG002|NOT COMPLETED|Overall Study||0||
59635021|NCT01811940|75749640|FG000|STARTED|Overall Study||64||
59635022|NCT01811940|75749641|FG001|STARTED|Overall Study||63||
59635023|NCT01811940|75749640|FG000|COMPLETED|Overall Study||42||
59635024|NCT01811940|75749641|FG001|COMPLETED|Overall Study||37||
59635025|NCT01811940|75749640|FG000|NOT COMPLETED|Overall Study||22||
59635026|NCT01811940|75749641|FG001|NOT COMPLETED|Overall Study||26||
59635027|NCT01813110|75749647|FG000|STARTED|Overall Study||10||
59635028|NCT01813110|75749648|FG001|STARTED|Overall Study||11||
59635029|NCT01813110|75749647|FG000|COMPLETED|Overall Study||10||
59635030|NCT01813110|75749648|FG001|COMPLETED|Overall Study||10||
59635031|NCT01813110|75749647|FG000|NOT COMPLETED|Overall Study||0||
59635032|NCT01813110|75749648|FG001|NOT COMPLETED|Overall Study||1||
59988343|NCT01364870|76103480|FG000|NOT COMPLETED|Overall Study||22||
59988344|NCT01364870|76103481|FG001|NOT COMPLETED|Overall Study||30||
59635033|NCT01813734|75749654|FG000|STARTED|Overall Study||9||
59635034|NCT01813734|75749654|FG000|COMPLETED|Overall Study||9||
59635035|NCT01813734|75749654|FG000|NOT COMPLETED|Overall Study||0||
59635036|NCT01816230|75749658|FG000|STARTED|Overall Study||36||
59635037|NCT01816230|75749658|FG000|COMPLETED|Overall Study||36||
59635038|NCT01816230|75749658|FG000|NOT COMPLETED|Overall Study||0||
59635039|NCT01816776|75749664|FG000|STARTED|Overall Study||73|Randomized|
59635040|NCT01816776|75749665|FG001|STARTED|Overall Study||78|Randomized|
59635041|NCT01816776|75749664|FG000|6 Month Primary Effectiveness Assessed|Overall Study||68||
59635042|NCT01816776|75749665|FG001|6 Month Primary Effectiveness Assessed|Overall Study||73||
59635043|NCT01816776|75749664|FG000|COMPLETED|Overall Study||60|Primary safety assessed through 12 months|
59635044|NCT01816776|75749665|FG001|COMPLETED|Overall Study||70|Primary safety assessed through 12 months|
59635045|NCT01816776|75749664|FG000|NOT COMPLETED|Overall Study||13||
59635046|NCT01816776|75749665|FG001|NOT COMPLETED|Overall Study||8||
59635047|NCT01817712|75749673|FG000|STARTED|Overall Study||271||
59988345|NCT01364870|76103482|FG002|NOT COMPLETED|Overall Study||14||
59635048|NCT01817712|75749674|FG001|STARTED|Overall Study||270||
59635049|NCT01817712|75749673|FG000|COMPLETED|Overall Study|Primary Outcome Assessed over 18 months|250||
59635050|NCT01817712|75749674|FG001|COMPLETED|Overall Study|Primary Outcome assessed over 18 months|240||
59635051|NCT01817712|75749673|FG000|NOT COMPLETED|Overall Study||21||
59635052|NCT01817712|75749674|FG001|NOT COMPLETED|Overall Study||30||
59635053|NCT01818414|75749682|FG000|STARTED|Overall Study||14||
59635054|NCT01818414|75749683|FG001|STARTED|Overall Study||15||
59635055|NCT01818414|75749682|FG000|COMPLETED|Overall Study||14||
59635056|NCT01818414|75749683|FG001|COMPLETED|Overall Study||15||
59635057|NCT01818414|75749682|FG000|NOT COMPLETED|Overall Study||0||
59635058|NCT01818414|75749683|FG001|NOT COMPLETED|Overall Study||0||
59635059|NCT04939727|75749693|FG000|STARTED|Overall Study||69||8
59635060|NCT04939727|75749694|FG001|STARTED|Overall Study||46||7
59635061|NCT04939727|75749693|FG000|COMPLETED|Overall Study||69||8
59635062|NCT04939727|75749694|FG001|COMPLETED|Overall Study||46||7
59635063|NCT04939727|75749693|FG000|NOT COMPLETED|Overall Study||0||0
59635064|NCT04939727|75749694|FG001|NOT COMPLETED|Overall Study||0||0
59635065|NCT04811573|75749710|FG000|STARTED|Overall Study||2||
59635066|NCT04811573|75749711|FG001|STARTED|Overall Study||2||
59635067|NCT04811573|75749712|FG002|STARTED|Overall Study||2||
59635068|NCT04811573|75749713|FG003|STARTED|Overall Study||2||
59635069|NCT04811573|75749714|FG004|STARTED|Overall Study||2||
59635070|NCT04811573|75749715|FG005|STARTED|Overall Study||2||
59635071|NCT04811573|75749716|FG006|STARTED|Overall Study||2||
59635072|NCT04811573|75749717|FG007|STARTED|Overall Study||2||
59635073|NCT04811573|75749718|FG008|STARTED|Overall Study||2||
59635074|NCT04811573|75749719|FG009|STARTED|Overall Study||2||
59635075|NCT04811573|75749710|FG000|COMPLETED|Overall Study||2||
59635076|NCT04811573|75749711|FG001|COMPLETED|Overall Study||2||
59635077|NCT04811573|75749712|FG002|COMPLETED|Overall Study||2||
59635078|NCT04811573|75749713|FG003|COMPLETED|Overall Study||2||
59635079|NCT04811573|75749714|FG004|COMPLETED|Overall Study||2||
59635080|NCT04811573|75749715|FG005|COMPLETED|Overall Study||2||
59635081|NCT04811573|75749716|FG006|COMPLETED|Overall Study||2||
59635082|NCT04811573|75749717|FG007|COMPLETED|Overall Study||2||
59635083|NCT04811573|75749718|FG008|COMPLETED|Overall Study||2||
59635084|NCT04811573|75749719|FG009|COMPLETED|Overall Study||2||
59635085|NCT04811573|75749710|FG000|NOT COMPLETED|Overall Study||0||
59635086|NCT04811573|75749711|FG001|NOT COMPLETED|Overall Study||0||
59635087|NCT04811573|75749712|FG002|NOT COMPLETED|Overall Study||0||
59635088|NCT04811573|75749713|FG003|NOT COMPLETED|Overall Study||0||
59635089|NCT04811573|75749714|FG004|NOT COMPLETED|Overall Study||0||
59635090|NCT04811573|75749715|FG005|NOT COMPLETED|Overall Study||0||
59635091|NCT04811573|75749716|FG006|NOT COMPLETED|Overall Study||0||
59635092|NCT04811573|75749717|FG007|NOT COMPLETED|Overall Study||0||
59635093|NCT04811573|75749718|FG008|NOT COMPLETED|Overall Study||0||
59635094|NCT04811573|75749719|FG009|NOT COMPLETED|Overall Study||0||
59635095|NCT04753437|75749733|FG000|STARTED|Overall Study||22||
59635096|NCT04753437|75749734|FG001|STARTED|Overall Study||22||
59635097|NCT04753437|75749733|FG000|COMPLETED|Overall Study||20||
59635098|NCT04753437|75749734|FG001|COMPLETED|Overall Study||17||
59635099|NCT04753437|75749733|FG000|NOT COMPLETED|Overall Study||2||
59635100|NCT04753437|75749734|FG001|NOT COMPLETED|Overall Study||5||
59635101|NCT04605094|75749742|FG000|STARTED|Overall Study||96||
59635102|NCT04605094|75749743|FG001|STARTED|Overall Study||98||
59635103|NCT04605094|75749742|FG000|COMPLETED|Overall Study||37||
59635104|NCT04605094|75749743|FG001|COMPLETED|Overall Study||37||
59635105|NCT04605094|75749742|FG000|NOT COMPLETED|Overall Study||59||
59635106|NCT04605094|75749743|FG001|NOT COMPLETED|Overall Study||61||
59635107|NCT04526210|75749752|FG000|STARTED|Overall Study||27||
59635108|NCT04526210|75749753|FG001|STARTED|Overall Study||27||
59635109|NCT04526210|75749752|FG000|Received at Least 1 Dose of Stud Drug|Overall Study|4 participants received Treatment A only.|27||
59635110|NCT04526210|75749753|FG001|Received at Least 1 Dose of Stud Drug|Overall Study|4 participants received Treatment B only.|27||
59988346|NCT02268526|76103493|FG000|STARTED|Overall Study||6||
59988347|NCT02268526|76103494|FG001|STARTED|Overall Study||59||
59635111|NCT04526210|75749752|FG000|COMPLETED|Overall Study||17||
59815727|NCT03233724|75938193|FG000|STARTED|Phase II Dose Expansion||0||
59988348|NCT02268526|76103495|FG002|STARTED|Overall Study||21||
59635112|NCT04526210|75749753|FG001|COMPLETED|Overall Study||20||
59635113|NCT04526210|75749752|FG000|NOT COMPLETED|Overall Study||10||
59635114|NCT04526210|75749753|FG001|NOT COMPLETED|Overall Study||7||
59635115|NCT04190056|75749762|FG000|STARTED|Overall Study||0||
59635116|NCT04190056|75749763|FG001|STARTED|Overall Study||1||
59635117|NCT04190056|75749762|FG000|COMPLETED|Overall Study||0||
59635118|NCT04190056|75749763|FG001|COMPLETED|Overall Study||1||
59635119|NCT04190056|75749762|FG000|NOT COMPLETED|Overall Study||0||
59635120|NCT04190056|75749763|FG001|NOT COMPLETED|Overall Study||0||
59635121|NCT04149964|75749771|FG000|STARTED|Overall Study||34||
59635122|NCT04149964|75749772|FG001|STARTED|Overall Study||31||
59635123|NCT04149964|75749771|FG000|COMPLETED|Overall Study||15||
59635124|NCT04149964|75749772|FG001|COMPLETED|Overall Study||13||
59635125|NCT04149964|75749771|FG000|NOT COMPLETED|Overall Study||19||
59815728|NCT03233724|75938194|FG001|STARTED|Phase II Dose Expansion||0||
59815729|NCT03233724|75938195|FG002|STARTED|Phase II Dose Expansion||0||
59815730|NCT03233724|75938196|FG003|STARTED|Phase II Dose Expansion||0||
59815731|NCT03233724|75938197|FG004|STARTED|Phase II Dose Expansion||0||
59815732|NCT03233724|75938193|FG000|COMPLETED|Phase II Dose Expansion||0||
59815733|NCT03233724|75938194|FG001|COMPLETED|Phase II Dose Expansion||0||
59815734|NCT03233724|75938195|FG002|COMPLETED|Phase II Dose Expansion||0||
59815735|NCT03233724|75938196|FG003|COMPLETED|Phase II Dose Expansion||0||
60076442|NCT01904149|76191428|FG001|Single-dose Phase|Overall Study||151||
60076443|NCT01904149|76191429|FG002|Single-dose Phase|Overall Study||150||
60076444|NCT01904149|76191430|FG003|Single-dose Phase|Overall Study||51||
60076445|NCT01904149|76191431|FG004|Single-dose Phase|Overall Study||51||
60076446|NCT01904149|76191432|FG005|Single-dose Phase|Overall Study||51||
60076447|NCT01904149|76191427|FG000|Multiple-dose Phase|Overall Study||150||
60076448|NCT01904149|76191428|FG001|Multiple-dose Phase|Overall Study||146||
59540738|NCT02764762|75639008|FG000|STARTED|Overall Study||55||
60076449|NCT01904149|76191429|FG002|Multiple-dose Phase|Overall Study||149||
60076450|NCT01904149|76191430|FG003|Multiple-dose Phase|Overall Study||48||
60076451|NCT01904149|76191431|FG004|Multiple-dose Phase|Overall Study||48||
60076452|NCT01904149|76191432|FG005|Multiple-dose Phase|Overall Study||49||
60076453|NCT01904149|76191427|FG000|COMPLETED|Overall Study||147||
60076454|NCT01904149|76191428|FG001|COMPLETED|Overall Study||140||
60076455|NCT01904149|76191429|FG002|COMPLETED|Overall Study||148||
60076456|NCT01904149|76191430|FG003|COMPLETED|Overall Study||47||
60076457|NCT01904149|76191431|FG004|COMPLETED|Overall Study||46||
60076458|NCT01904149|76191432|FG005|COMPLETED|Overall Study||48||
60076459|NCT01904149|76191427|FG000|NOT COMPLETED|Overall Study||5||
60076460|NCT01904149|76191428|FG001|NOT COMPLETED|Overall Study||11||
59540739|NCT02764762|75639008|FG000|Triple Combination Therapy|Overall Study||55|Participants who received triple combination therapy of vedolizumab 300 mg, IV infusion, adalimumab 160-80-40 mg SC and Methotrexate 15 mg tablets orally.|
59540740|NCT02764762|75639008|FG000|Monotherapy|Overall Study||45|Participants who received vedolizumab 300 mg IV infusion as monotherapy or have any visit data after Week 26 and before the safety follow up.|
59540741|NCT02764762|75639008|FG000|Safety Follow-up|Overall Study||53|Participants who completed the study treatment or were terminated early from the study were followed-up for safety up to 18 weeks after receiving the last dose of study drug.|
59540742|NCT02764762|75639008|FG000|COMPLETED|Overall Study||16||
59540743|NCT02764762|75639008|FG000|NOT COMPLETED|Overall Study||39||
59540744|NCT02340962|75639018|FG000|STARTED|Overall Study||13||
59540745|NCT02340962|75639019|FG001|STARTED|Overall Study||12||
59540746|NCT02340962|75639018|FG000|COMPLETED|Overall Study||12||
59540747|NCT02340962|75639019|FG001|COMPLETED|Overall Study||12||
59540748|NCT02340962|75639018|FG000|NOT COMPLETED|Overall Study||1||
59540749|NCT02340962|75639019|FG001|NOT COMPLETED|Overall Study||0||
59540750|NCT02309645|75639029|FG000|STARTED|Overall Study||26||
59540751|NCT02309645|75639030|FG001|STARTED|Overall Study||14||
59540752|NCT02309645|75639029|FG000|Full Analysis Set (FAS)|Overall Study||25||
59540753|NCT02309645|75639030|FG001|Full Analysis Set (FAS)|Overall Study||15||
59540754|NCT02309645|75639029|FG000|COMPLETED|Overall Study||26||
59540755|NCT02309645|75639030|FG001|COMPLETED|Overall Study||14||
60076461|NCT01904149|76191429|FG002|NOT COMPLETED|Overall Study||2||
60076462|NCT01904149|76191430|FG003|NOT COMPLETED|Overall Study||4||
59540756|NCT02309645|75639029|FG000|NOT COMPLETED|Overall Study||0||
59540757|NCT02309645|75639030|FG001|NOT COMPLETED|Overall Study||0||
59540758|NCT02272634|75639039|FG000|STARTED|Overall Study||20||
59540759|NCT02272634|75639040|FG001|STARTED|Overall Study||21||
59540760|NCT02272634|75639041|FG002|STARTED|Overall Study||20||
59540761|NCT02272634|75639039|FG000|COMPLETED|Overall Study||19||
59540762|NCT02272634|75639040|FG001|COMPLETED|Overall Study||20||
59540763|NCT02272634|75639041|FG002|COMPLETED|Overall Study||19||
59540764|NCT02272634|75639039|FG000|NOT COMPLETED|Overall Study||1||
59540765|NCT02272634|75639040|FG001|NOT COMPLETED|Overall Study||1||
59540766|NCT02272634|75639041|FG002|NOT COMPLETED|Overall Study||1||
59540767|NCT00788125|75639052|FG000|STARTED|Overall Study||7||
59540768|NCT00788125|75639052|FG000|COMPLETED|Overall Study||1||
59540769|NCT00788125|75639052|FG000|NOT COMPLETED|Overall Study||6||
59540770|NCT00890162|75639058|FG000|STARTED|Overall Study||8||
59540771|NCT00890162|75639059|FG001|STARTED|Overall Study||8||
59540772|NCT00890162|75639058|FG000|COMPLETED|Overall Study||6||
59540773|NCT00890162|75639059|FG001|COMPLETED|Overall Study||7||
59540774|NCT00890162|75639058|FG000|NOT COMPLETED|Overall Study||2||
59540775|NCT00890162|75639059|FG001|NOT COMPLETED|Overall Study||1||
59540776|NCT02504424|75639065|FG000|STARTED|Overall Study||50||
59540777|NCT02504424|75639065|FG000|COMPLETED|Overall Study||48||
59540778|NCT02504424|75639065|FG000|NOT COMPLETED|Overall Study||2||
59540779|NCT01433081|75639072|FG000|STARTED|Overall Study||25||
59540780|NCT01433081|75639073|FG001|STARTED|Overall Study||25||
59540781|NCT01433081|75639072|FG000|COMPLETED|Overall Study||23||
59540782|NCT01433081|75639073|FG001|COMPLETED|Overall Study||23||
59540783|NCT01433081|75639072|FG000|NOT COMPLETED|Overall Study||2||
59540784|NCT01433081|75639073|FG001|NOT COMPLETED|Overall Study||2||
59815736|NCT03233724|75938197|FG004|COMPLETED|Phase II Dose Expansion||0||
60076463|NCT01904149|76191431|FG004|NOT COMPLETED|Overall Study||5||
60076464|NCT01904149|76191432|FG005|NOT COMPLETED|Overall Study||3||
59635126|NCT04149964|75749772|FG001|NOT COMPLETED|Overall Study||18||
59635127|NCT03974932|75749782|FG000|STARTED|Overall Study||66||
59635128|NCT03974932|75749783|FG001|STARTED|Overall Study||14||
59635129|NCT03974932|75749784|FG002|STARTED|Overall Study||16||
59635130|NCT03974932|75749785|FG003|STARTED|Overall Study||20||
59635131|NCT03974932|75749782|FG000|COMPLETED|Overall Study||66||
59635132|NCT03974932|75749783|FG001|COMPLETED|Overall Study||14||
59635133|NCT03974932|75749784|FG002|COMPLETED|Overall Study||16||
59635134|NCT03974932|75749785|FG003|COMPLETED|Overall Study||20||
59635135|NCT03974932|75749782|FG000|NOT COMPLETED|Overall Study||0||
59635136|NCT03974932|75749783|FG001|NOT COMPLETED|Overall Study||0||
59635137|NCT03974932|75749784|FG002|NOT COMPLETED|Overall Study||0||
59635138|NCT03974932|75749785|FG003|NOT COMPLETED|Overall Study||0||
59635139|NCT03842969|75749798|FG000|STARTED|Overall Study||17||
59635140|NCT03842969|75749799|FG001|STARTED|Overall Study||138||
59635141|NCT03842969|75749800|FG002|STARTED|Overall Study||81||
59635142|NCT03842969|75749798|FG000|Period 1|Overall Study||17|Period 1 has only 1 arm with 17 participants of which 15 were transferred to two Arms of Period 2 (8 and 7 participants, see below)|
59635143|NCT03842969|75749799|FG001|Period 1|Overall Study||0|Period 1 has only 1 arm with 17 participants of which 15 were transferred to two Arms of Period 2 (8 and 7 participants, see below)|
59635144|NCT03842969|75749800|FG002|Period 1|Overall Study||0|Period 1 has only 1 arm with 17 participants of which 15 were transferred to two Arms of Period 2 (8 and 7 participants, see below)|
59635145|NCT03842969|75749798|FG000|Period 2|Overall Study|8 and 7 Participants from Arm Tominersen 120mg Q4W (Period 1) joined newly enrolled 138 participants in this Arm of Period 2.|0|Period 2 has 2 arms: Tominersen 120mg Q8W (8 participants from Period 1 and 138 new participants enrolled) and Tominersen 120mg Q16W (7 participants from Period 1 and 81 new enrolled). There were no participants in arm Tominersen 120mg Q4W.|
59635146|NCT03842969|75749799|FG001|Period 2|Overall Study|8 Participants from Arm Tominersen 120mg Q4W (Period 1) joined newly enrolled 138 participants in this Arm of Period 2.|146|Period 2 has 2 arms: Tominersen 120mg Q8W (8 participants from Period 1 and 138 new participants enrolled) and Tominersen 120mg Q16W (7 participants from Period 1 and 81 new enrolled). There were no participants in arm Tominersen 120mg Q4W.|
59635147|NCT03842969|75749800|FG002|Period 2|Overall Study|7 Participants from Arm Tominersen 120mg Q4W (Period 2) joined newly enrolled 81 participants in this Arm of Period 2|88|Period 2 has 2 arms: Tominersen 120mg Q8W (8 participants from Period 1 and 138 new participants enrolled) and Tominersen 120mg Q16W (7 participants from Period 1 and 81 new enrolled). There were no participants in arm Tominersen 120mg Q4W.|
59635148|NCT03842969|75749798|FG000|COMPLETED|Overall Study||0|None of the participants completed the study|
59635149|NCT03842969|75749799|FG001|COMPLETED|Overall Study||0|None of the participants completed the study|
59635150|NCT03842969|75749800|FG002|COMPLETED|Overall Study||0|None of the participants completed the study|
59635151|NCT03842969|75749798|FG000|NOT COMPLETED|Overall Study||17||
59635152|NCT03842969|75749799|FG001|NOT COMPLETED|Overall Study||138||
59635153|NCT03842969|75749800|FG002|NOT COMPLETED|Overall Study||81||
59635154|NCT02996994|75749817|FG000|STARTED|Overall Study||364||
59635155|NCT02996994|75749817|FG000|COMPLETED|Overall Study||364||
59635156|NCT02996994|75749817|FG000|NOT COMPLETED|Overall Study||0||
59635157|NCT02938520|75749823|FG000|STARTED|Overall Study||283||
59635158|NCT02938520|75749824|FG001|STARTED|Overall Study||283||
59635159|NCT02938520|75749823|FG000|COMPLETED|Overall Study||0||
59635160|NCT02938520|75749824|FG001|COMPLETED|Overall Study||0||
59635161|NCT02938520|75749823|FG000|NOT COMPLETED|Overall Study||283||
59635162|NCT02938520|75749824|FG001|NOT COMPLETED|Overall Study||283||
59635163|NCT02764541|75749841|FG000|STARTED|Overall Study||36||
59635164|NCT02764541|75749842|FG001|STARTED|Overall Study||21||
59635165|NCT02764541|75749843|FG002|STARTED|Overall Study||37||
59635166|NCT02764541|75749844|FG003|STARTED|Overall Study||19||
59635167|NCT02764541|75749845|FG004|STARTED|Overall Study||1||
59635168|NCT02764541|75749846|FG005|STARTED|Overall Study||2||
59635169|NCT02764541|75749847|FG006|STARTED|Overall Study||55||
59635170|NCT02764541|75749848|FG007|STARTED|Overall Study||21||
59635171|NCT02764541|75749841|FG000|COMPLETED|Overall Study||33||
59635172|NCT02764541|75749842|FG001|COMPLETED|Overall Study||20||
59635173|NCT02764541|75749843|FG002|COMPLETED|Overall Study||36||
59635174|NCT02764541|75749844|FG003|COMPLETED|Overall Study||16||
59635175|NCT02764541|75749845|FG004|COMPLETED|Overall Study||0||
59635176|NCT02764541|75749846|FG005|COMPLETED|Overall Study||0||
59635177|NCT02764541|75749847|FG006|COMPLETED|Overall Study||52||
59635178|NCT02764541|75749848|FG007|COMPLETED|Overall Study||18||
59635179|NCT02764541|75749841|FG000|NOT COMPLETED|Overall Study||3||
59635180|NCT02764541|75749842|FG001|NOT COMPLETED|Overall Study||1||
59635181|NCT02764541|75749843|FG002|NOT COMPLETED|Overall Study||1||
59635182|NCT02764541|75749844|FG003|NOT COMPLETED|Overall Study||3||
59635183|NCT02764541|75749845|FG004|NOT COMPLETED|Overall Study||1||
59988349|NCT02268526|76103493|FG000|PD Analysis Set (Cohort 2)|Overall Study||0||
59988350|NCT02268526|76103494|FG001|PD Analysis Set (Cohort 2)|Overall Study||42||
59988351|NCT02268526|76103495|FG002|PD Analysis Set (Cohort 2)|Overall Study||17||
59988352|NCT02268526|76103493|FG000|COMPLETED|Overall Study||5||
59988353|NCT02268526|76103494|FG001|COMPLETED|Overall Study||38||
59988354|NCT02268526|76103495|FG002|COMPLETED|Overall Study||16||
59988355|NCT02268526|76103493|FG000|NOT COMPLETED|Overall Study||1||
59988356|NCT02268526|76103494|FG001|NOT COMPLETED|Overall Study||21||
60103774|NCT04102098|76222036|FG001|NOT COMPLETED|Crossover: AS Who Crossed Over||0||
59988357|NCT02268526|76103495|FG002|NOT COMPLETED|Overall Study||5||
59635184|NCT02764541|75749846|FG005|NOT COMPLETED|Overall Study||2||
59635185|NCT02764541|75749847|FG006|NOT COMPLETED|Overall Study||3||
59635186|NCT02764541|75749848|FG007|NOT COMPLETED|Overall Study||3||
59635187|NCT02587065|75749868|FG000|STARTED|Overall Study||193||
59635188|NCT02587065|75749868|FG000|COMPLETED|Overall Study||166||
59635189|NCT02587065|75749868|FG000|NOT COMPLETED|Overall Study||27||
59635190|NCT02572856|75749872|FG000|STARTED|Overall Study||10||
59635191|NCT02572856|75749872|FG000|COMPLETED|Overall Study||10||
59635192|NCT02572856|75749872|FG000|NOT COMPLETED|Overall Study||0||
59635193|NCT02544503|75749878|FG000|STARTED|Overall Study||66||
59635194|NCT02544503|75749879|FG001|STARTED|Overall Study||34||
59635195|NCT02544503|75749878|FG000|Completed First Study Assessment|Overall Study||42|For stroke patients, the first study visit occurred one month after their stroke.|
59635196|NCT02544503|75749879|FG001|Completed First Study Assessment|Overall Study||31|For stroke patients, the first study visit occurred one month after their stroke.|
59635197|NCT02544503|75749878|FG000|Stroke Patients Who Completed the 6 Month Post-stroke Assessment|Overall Study||32||
59635198|NCT02544503|75749879|FG001|Stroke Patients Who Completed the 6 Month Post-stroke Assessment|Overall Study|Healthy control participants were not assessed at the 6 month time point.|0||
59635199|NCT02544503|75749878|FG000|COMPLETED|Overall Study||32||
59635200|NCT02544503|75749879|FG001|COMPLETED|Overall Study||31||
59635201|NCT02544503|75749878|FG000|NOT COMPLETED|Overall Study||34||
59635202|NCT02544503|75749879|FG001|NOT COMPLETED|Overall Study||3||
59635203|NCT01705977|75749887|FG000|STARTED|Treatment Period (Year 1)|Randomized|2009||
59635204|NCT01705977|75749888|FG001|STARTED|Treatment Period (Year 1)|Randomized|2010||
59635205|NCT01705977|75749887|FG000|Intent-to-Treat Population|Treatment Period (Year 1)||2002||
59635206|NCT01705977|75749888|FG001|Intent-to-Treat Population|Treatment Period (Year 1)||2001||
59635207|NCT01705977|75749887|FG000|COMPLETED|Treatment Period (Year 1)||1729||
59635208|NCT01705977|75749888|FG001|COMPLETED|Treatment Period (Year 1)||1741||
59635209|NCT01705977|75749887|FG000|NOT COMPLETED|Treatment Period (Year 1)||280||
59635210|NCT01705977|75749888|FG001|NOT COMPLETED|Treatment Period (Year 1)||269||
59635211|NCT01705977|75749887|FG000|STARTED|Follow-up Period (Years 2 to 5)|1670 participants from the Year 1 - treatment period entered in the Year 2 to 5 follow-up period|1670||
59635212|NCT01705977|75749888|FG001|STARTED|Follow-up Period (Years 2 to 5)|1695 participants from the Year 1 - treatment period entered in the Year 2 to 5 follow-up period|1695||
59635213|NCT01705977|75749887|FG000|COMPLETED|Follow-up Period (Years 2 to 5)||1474||
59635214|NCT01705977|75749888|FG001|COMPLETED|Follow-up Period (Years 2 to 5)||1514||
59635215|NCT01705977|75749887|FG000|NOT COMPLETED|Follow-up Period (Years 2 to 5)||196||
59635216|NCT01705977|75749888|FG001|NOT COMPLETED|Follow-up Period (Years 2 to 5)||181||
59635217|NCT01474889|75749897|FG000|STARTED|Overall Study||13||
59635218|NCT01474889|75749898|FG001|STARTED|Overall Study||12||
59635219|NCT01474889|75749899|FG002|STARTED|Overall Study||12||
59635220|NCT01474889|75749897|FG000|COMPLETED|Overall Study||11||
59635221|NCT01474889|75749898|FG001|COMPLETED|Overall Study||11||
59635222|NCT01474889|75749899|FG002|COMPLETED|Overall Study||12||
59635223|NCT01474889|75749897|FG000|NOT COMPLETED|Overall Study||2||
59635224|NCT01474889|75749898|FG001|NOT COMPLETED|Overall Study||1||
59635225|NCT01474889|75749899|FG002|NOT COMPLETED|Overall Study||0||
59635226|NCT01231906|75749907|FG000|STARTED|Overall Study||319|Eligible and began receiving protocol therapy|
59635227|NCT01231906|75749908|FG001|STARTED|Overall Study||323|Eligible and began receiving protocol therapy|
59635228|NCT01231906|75749907|FG000|Received Therapy|Overall Study||308||
59635229|NCT01231906|75749908|FG001|Received Therapy|Overall Study||318||
59635230|NCT01231906|75749907|FG000|COMPLETED|Overall Study||198|Completion of planned therapy with no event observed: disease progression, second malignant neoplasm (SMN), death regardless of cause|
59635231|NCT01231906|75749908|FG001|COMPLETED|Overall Study||222|Completion of planned therapy with no event observed: disease progression, second malignant neoplasm (SMN), death regardless of cause|
59635232|NCT01231906|75749907|FG000|NOT COMPLETED|Overall Study||121||
59635233|NCT01231906|75749908|FG001|NOT COMPLETED|Overall Study||101||
59635234|NCT00724048|75749918|FG000|STARTED|Overall Study||58||
59635235|NCT00724048|75749919|FG001|STARTED|Overall Study||56||
59635236|NCT00724048|75749920|FG002|STARTED|Overall Study||55||
59635237|NCT00724048|75749921|FG003|STARTED|Overall Study||58||
59635238|NCT00724048|75749918|FG000|Received at Least 1 Dose of Study Drug|Overall Study||58||
59635239|NCT00724048|75749919|FG001|Received at Least 1 Dose of Study Drug|Overall Study||56||
59635240|NCT00724048|75749920|FG002|Received at Least 1 Dose of Study Drug|Overall Study||55||
59635241|NCT00724048|75749921|FG003|Received at Least 1 Dose of Study Drug|Overall Study||58||
59635242|NCT00724048|75749918|FG000|Full Analysis Set|Overall Study||58|All randomized participants who received at least 1 dose of study drug and had undergone at least 1 clinical assessment post randomization.|
59635243|NCT00724048|75749919|FG001|Full Analysis Set|Overall Study||55|All randomized participants who received at least 1 dose of study drug and had undergone at least 1 clinical assessment post randomization.|
59635244|NCT00724048|75749920|FG002|Full Analysis Set|Overall Study||55|All randomized participants who received at least 1 dose of study drug and had undergone at least 1 clinical assessment post randomization.|
59635245|NCT00724048|75749921|FG003|Full Analysis Set|Overall Study||58|All randomized participants who received at least 1 dose of study drug and had undergone at least 1 clinical assessment post randomization.|
59635246|NCT00724048|75749918|FG000|COMPLETED|Overall Study||55||
59635247|NCT00724048|75749919|FG001|COMPLETED|Overall Study||51||
59635248|NCT00724048|75749920|FG002|COMPLETED|Overall Study||52||
59635249|NCT00724048|75749921|FG003|COMPLETED|Overall Study||55||
59635250|NCT00724048|75749918|FG000|NOT COMPLETED|Overall Study||3||
59635251|NCT00724048|75749919|FG001|NOT COMPLETED|Overall Study||5||
59635252|NCT00724048|75749920|FG002|NOT COMPLETED|Overall Study||3||
59635253|NCT00724048|75749921|FG003|NOT COMPLETED|Overall Study||3||
59635254|NCT00304070|75749934|FG000|STARTED|Overall Study||24||
59635255|NCT00304070|75749935|FG001|STARTED|Overall Study||15||
59635256|NCT00304070|75749936|FG002|STARTED|Overall Study||39||
59635257|NCT00304070|75749934|FG000|COMPLETED|Overall Study||21||
59635258|NCT00304070|75749935|FG001|COMPLETED|Overall Study||8||
59635259|NCT00304070|75749936|FG002|COMPLETED|Overall Study||27||
59635260|NCT00304070|75749934|FG000|NOT COMPLETED|Overall Study||3||
59635261|NCT00304070|75749935|FG001|NOT COMPLETED|Overall Study||7||
59635262|NCT00304070|75749936|FG002|NOT COMPLETED|Overall Study||12||
59635263|NCT00160680|75749950|FG000|STARTED|Overall Study||31||
59635264|NCT00160680|75749951|FG001|STARTED|Overall Study||31||
59635265|NCT00160680|75749950|FG000|COMPLETED|Overall Study||22||
59635266|NCT00160680|75749951|FG001|COMPLETED|Overall Study||18||
59635267|NCT00160680|75749950|FG000|NOT COMPLETED|Overall Study||9||
59635268|NCT00160680|75749951|FG001|NOT COMPLETED|Overall Study||13||
59635269|NCT01818804|75749959|FG000|STARTED|Overall Study||73||
59635270|NCT01818804|75749960|FG001|STARTED|Overall Study||72||
59635271|NCT01818804|75749959|FG000|COMPLETED|Overall Study||68||
59635272|NCT01818804|75749960|FG001|COMPLETED|Overall Study||65||
59635273|NCT01818804|75749959|FG000|NOT COMPLETED|Overall Study||5||
59635274|NCT01818804|75749960|FG001|NOT COMPLETED|Overall Study||7||
59635275|NCT01820754|75749966|FG000|STARTED|Overall Study||24||
59635276|NCT01820754|75749966|FG000|COMPLETED|Overall Study||24||
59635277|NCT01820754|75749966|FG000|NOT COMPLETED|Overall Study||0||
59635278|NCT01821300|75749972|FG000|STARTED|Overall Study||154||
59635279|NCT01821300|75749973|FG001|STARTED|Overall Study||103||
59635280|NCT01821300|75749972|FG000|COMPLETED|Overall Study||154||
59635281|NCT01821300|75749973|FG001|COMPLETED|Overall Study||103||
59635282|NCT01821300|75749972|FG000|NOT COMPLETED|Overall Study||0||
59635283|NCT01821300|75749973|FG001|NOT COMPLETED|Overall Study||0||
59635284|NCT01821378|75749988|FG000|STARTED|Overall Study||101||
59635285|NCT01821378|75749989|FG001|STARTED|Overall Study||199||
59635286|NCT01821378|75749990|FG002|STARTED|Overall Study||112||
59635287|NCT01821378|75749988|FG000|COMPLETED|Overall Study||74||
59635288|NCT01821378|75749989|FG001|COMPLETED|Overall Study||145||
59635289|NCT01821378|75749990|FG002|COMPLETED|Overall Study||70||
59635290|NCT01821378|75749988|FG000|NOT COMPLETED|Overall Study||27||
59635291|NCT01821378|75749989|FG001|NOT COMPLETED|Overall Study||54||
59635292|NCT01821378|75749990|FG002|NOT COMPLETED|Overall Study||42||
59635293|NCT01821534|75750003|FG000|STARTED|Overall Study||201||
59635294|NCT01821534|75750003|FG000|COMPLETED|Overall Study||201||
59635295|NCT01821534|75750003|FG000|NOT COMPLETED|Overall Study||0||
59635296|NCT01822548|75750009|FG000|STARTED|Overall Study|Received allocated intervention n=38 Did not receive allocated intervention (only metformin) n=2|40||
59635297|NCT01822548|75750010|FG001|STARTED|Overall Study||24||
59635298|NCT01822548|75750009|FG000|Discontinued Intervention|Overall Study||0||
59635299|NCT01822548|75750010|FG001|Discontinued Intervention|Overall Study||5||
59635300|NCT01822548|75750009|FG000|COMPLETED|Overall Study||40||
59635301|NCT01822548|75750010|FG001|COMPLETED|Overall Study||24||
59635302|NCT01822548|75750009|FG000|NOT COMPLETED|Overall Study||0||
59635303|NCT01822548|75750010|FG001|NOT COMPLETED|Overall Study||0||
59635304|NCT01825122|75750018|FG000|STARTED|Overall Study||77||
59635305|NCT01825122|75750019|FG001|STARTED|Overall Study||78||
59635306|NCT01825122|75750018|FG000|COMPLETED|Overall Study||67||
59635307|NCT01825122|75750019|FG001|COMPLETED|Overall Study||59||
59635308|NCT01825122|75750018|FG000|NOT COMPLETED|Overall Study||10||
59635309|NCT01825122|75750019|FG001|NOT COMPLETED|Overall Study||19||
59635310|NCT01825512|75750027|FG000|STARTED|Baseline||194||
59635311|NCT01825512|75750028|FG001|STARTED|Baseline||199||
59635312|NCT01825512|75750027|FG000|COMPLETED|Baseline||193||
59635313|NCT01825512|75750028|FG001|COMPLETED|Baseline||197||
59635314|NCT01825512|75750027|FG000|NOT COMPLETED|Baseline||1||
59635315|NCT01825512|75750028|FG001|NOT COMPLETED|Baseline||2||
59635316|NCT01825512|75750027|FG000|STARTED|Treatment||193||
59635317|NCT01825512|75750028|FG001|STARTED|Treatment||197||
59635318|NCT01825512|75750027|FG000|COMPLETED|Treatment||140||
59635319|NCT01825512|75750028|FG001|COMPLETED|Treatment||170||
59635320|NCT01825512|75750027|FG000|NOT COMPLETED|Treatment||53||
59635321|NCT01825512|75750028|FG001|NOT COMPLETED|Treatment||27||
59635322|NCT01827462|75750037|FG000|STARTED|Overall Study||59||
59635323|NCT01827462|75750038|FG001|STARTED|Overall Study||37||
59635324|NCT01827462|75750039|FG002|STARTED|Overall Study||40||
59635325|NCT01827462|75750037|FG000|COMPLETED|Overall Study||18||
59635326|NCT01827462|75750038|FG001|COMPLETED|Overall Study||19||
59635327|NCT01827462|75750039|FG002|COMPLETED|Overall Study||12||
59635328|NCT01827462|75750037|FG000|NOT COMPLETED|Overall Study||41||
59635329|NCT01827462|75750038|FG001|NOT COMPLETED|Overall Study||18||
59635330|NCT01827462|75750039|FG002|NOT COMPLETED|Overall Study||28||
59635331|NCT01827930|75750053|FG000|STARTED|Overall Study||24||
59635332|NCT01827930|75750054|FG001|STARTED|Overall Study||25||
59635333|NCT01827930|75750055|FG002|STARTED|Overall Study||19||
59635334|NCT01827930|75750053|FG000|COMPLETED|Overall Study||24||
59635335|NCT01827930|75750054|FG001|COMPLETED|Overall Study||25||
59635336|NCT01827930|75750055|FG002|COMPLETED|Overall Study||19||
59635337|NCT01827930|75750053|FG000|NOT COMPLETED|Overall Study||0||
59635338|NCT01827930|75750054|FG001|NOT COMPLETED|Overall Study||0||
59635339|NCT01827930|75750055|FG002|NOT COMPLETED|Overall Study||0||
59635340|NCT01828164|75750063|FG000|STARTED|Overall Study|11 out of 60 subjects did not meet inclusion criteria after enrollment.|49||
59635341|NCT01828164|75750063|FG000|COMPLETED|Overall Study||32||
59635342|NCT01828164|75750063|FG000|NOT COMPLETED|Overall Study||17||
59635343|NCT01828476|75750073|FG000|STARTED|Overall Study||13||
59635344|NCT01828476|75750074|FG001|STARTED|Overall Study||0||
59635345|NCT01828476|75750073|FG000|COMPLETED|Overall Study||13||
59635346|NCT01828476|75750074|FG001|COMPLETED|Overall Study||0||
59635347|NCT01828476|75750073|FG000|NOT COMPLETED|Overall Study||0||
59635348|NCT01828476|75750074|FG001|NOT COMPLETED|Overall Study||0||
59635349|NCT01828554|75750082|FG000|STARTED|Overall Study||8||
59635350|NCT01828554|75750082|FG000|COMPLETED|Overall Study||8||
59635351|NCT01828554|75750082|FG000|NOT COMPLETED|Overall Study||0||
59635352|NCT01832610|75750086|FG000|STARTED|Overall Study||101||
59635353|NCT01832610|75750086|FG000|COMPLETED|Overall Study||97||
59635354|NCT01832610|75750086|FG000|NOT COMPLETED|Overall Study||4||
59635355|NCT01833078|75750090|FG000|STARTED|Overall Study||5||
59635356|NCT01833078|75750090|FG000|COMPLETED|Overall Study||5||
59635357|NCT01833078|75750090|FG000|NOT COMPLETED|Overall Study||0||
59635358|NCT01833936|75750096|FG000|STARTED|Overall Study||20||
59635359|NCT01833936|75750097|FG001|STARTED|Overall Study||20||
59635360|NCT01833936|75750096|FG000|COMPLETED|Overall Study||16||
59635361|NCT01833936|75750097|FG001|COMPLETED|Overall Study||18||
59635362|NCT01833936|75750096|FG000|NOT COMPLETED|Overall Study||4||
59635363|NCT01833936|75750097|FG001|NOT COMPLETED|Overall Study||2||
59635364|NCT01834326|75750105|FG000|STARTED|Overall Study||10||
59635365|NCT01834326|75750106|FG001|STARTED|Overall Study||8||
59635366|NCT01834326|75750105|FG000|COMPLETED|Overall Study||8||
59635367|NCT01834326|75750106|FG001|COMPLETED|Overall Study||2||
59635368|NCT01834326|75750105|FG000|NOT COMPLETED|Overall Study||2||
59635369|NCT01834326|75750106|FG001|NOT COMPLETED|Overall Study||6||
59635370|NCT01834404|75750114|FG000|STARTED|Overall Study||12||
59635371|NCT01834404|75750115|FG001|STARTED|Overall Study||12||
59635372|NCT01834404|75750114|FG000|COMPLETED|Overall Study||12||
59635373|NCT01834404|75750115|FG001|COMPLETED|Overall Study||12||
59635374|NCT01834404|75750114|FG000|NOT COMPLETED|Overall Study||0||
59635375|NCT01834404|75750115|FG001|NOT COMPLETED|Overall Study||0||
59635376|NCT01834716|75750123|FG000|STARTED|Overall Study||4||
59635377|NCT01834716|75750124|FG001|STARTED|Overall Study||12||
59635378|NCT01834716|75750123|FG000|COMPLETED|Overall Study||4||
59635379|NCT01834716|75750124|FG001|COMPLETED|Overall Study||11||
59635380|NCT01834716|75750123|FG000|NOT COMPLETED|Overall Study||0||
59635381|NCT01834716|75750124|FG001|NOT COMPLETED|Overall Study||1||
59635382|NCT01835262|75750132|FG000|STARTED|Overall Study||45||
59635383|NCT01835262|75750133|FG001|STARTED|Overall Study||45||
59635384|NCT01835262|75750132|FG000|COMPLETED|Overall Study||45||
59635385|NCT01835262|75750133|FG001|COMPLETED|Overall Study||45||
59635386|NCT01835262|75750132|FG000|NOT COMPLETED|Overall Study||0||
59635387|NCT01835262|75750133|FG001|NOT COMPLETED|Overall Study||0||
59635388|NCT01835496|75750139|FG000|STARTED|Overall Study||8||
59635389|NCT01835496|75750139|FG000|COMPLETED|Overall Study||8||
59635390|NCT01835496|75750139|FG000|NOT COMPLETED|Overall Study||0||
59635391|NCT01836042|75750146|FG000|STARTED|Overall Study||51||
59635392|NCT01836042|75750147|FG001|STARTED|Overall Study||35||
59635393|NCT01836042|75750148|FG002|STARTED|Overall Study||22||
59635394|NCT01836042|75750146|FG000|COMPLETED|Overall Study||51||
59635395|NCT01836042|75750147|FG001|COMPLETED|Overall Study||35||
59635396|NCT01836042|75750148|FG002|COMPLETED|Overall Study||22||
59635397|NCT01836042|75750146|FG000|NOT COMPLETED|Overall Study||0||
59635398|NCT01836042|75750147|FG001|NOT COMPLETED|Overall Study||0||
59635399|NCT01836042|75750148|FG002|NOT COMPLETED|Overall Study||0||
59635400|NCT01766076|75750158|FG000|STARTED|Overall Study||15||
59635401|NCT01766076|75750159|FG001|STARTED|Overall Study||15||
59635402|NCT01766076|75750158|FG000|COMPLETED|Overall Study||15||
59635403|NCT01766076|75750159|FG001|COMPLETED|Overall Study||15||
59635404|NCT01766076|75750158|FG000|NOT COMPLETED|Overall Study||0||
59635405|NCT01766076|75750159|FG001|NOT COMPLETED|Overall Study||0||
59635406|NCT01767792|75750165|FG000|STARTED|Overall Study||22||
59635407|NCT01767792|75750165|FG000|COMPLETED|Overall Study||20||
59635408|NCT01767792|75750165|FG000|NOT COMPLETED|Overall Study||2||
59635409|NCT01794312|75750172|FG000|STARTED|Overall Study||74||
59635410|NCT01794312|75750173|FG001|STARTED|Overall Study||78||
59635411|NCT01794312|75750172|FG000|COMPLETED|Overall Study||68||
59635412|NCT01794312|75750173|FG001|COMPLETED|Overall Study||67||
59635413|NCT01794312|75750172|FG000|NOT COMPLETED|Overall Study||6||
59635414|NCT01794312|75750173|FG001|NOT COMPLETED|Overall Study||11||
59635415|NCT01797822|75750179|FG000|STARTED|Overall Study||20||
59635416|NCT01797822|75750179|FG000|COMPLETED|Overall Study|The protocol is now closed.|20||
59635417|NCT01797822|75750179|FG000|NOT COMPLETED|Overall Study||0||
59635418|NCT01809054|75750187|FG000|STARTED|Overall Study||27||
59635419|NCT01809054|75750188|FG001|STARTED|Overall Study||22||
59635420|NCT01809054|75750187|FG000|COMPLETED|Overall Study||27||
59635421|NCT01809054|75750188|FG001|COMPLETED|Overall Study||22||
59635422|NCT01809054|75750187|FG000|NOT COMPLETED|Overall Study||0||
59635423|NCT01809054|75750188|FG001|NOT COMPLETED|Overall Study||0||
59635424|NCT01827306|75750196|FG000|STARTED|Overall Study||21||
59635425|NCT01827306|75750197|FG001|STARTED|Overall Study||13||
59635426|NCT01827306|75750196|FG000|COMPLETED|Overall Study||10||
59635427|NCT01827306|75750197|FG001|COMPLETED|Overall Study||8||
59635428|NCT01827306|75750196|FG000|NOT COMPLETED|Overall Study||11||
59635429|NCT01827306|75750197|FG001|NOT COMPLETED|Overall Study||5||
59635430|NCT01833546|75750207|FG000|STARTED|Overall Study||3||
59635431|NCT01833546|75750208|FG001|STARTED|Overall Study||3||
59635432|NCT01833546|75750209|FG002|STARTED|Overall Study||8||
59635433|NCT01833546|75750210|FG003|STARTED|Overall Study||6||
59635434|NCT01833546|75750207|FG000|COMPLETED|Overall Study||3||
59635435|NCT01833546|75750208|FG001|COMPLETED|Overall Study||3||
59635436|NCT01833546|75750209|FG002|COMPLETED|Overall Study||8||
59635437|NCT01833546|75750210|FG003|COMPLETED|Overall Study||6||
59635438|NCT01833546|75750207|FG000|NOT COMPLETED|Overall Study||0||
59635439|NCT01833546|75750208|FG001|NOT COMPLETED|Overall Study||0||
59635440|NCT01833546|75750209|FG002|NOT COMPLETED|Overall Study||0||
59635441|NCT01833546|75750210|FG003|NOT COMPLETED|Overall Study||0||
59635442|NCT01837524|75750223|FG000|STARTED|Overall Study||28||
59635443|NCT01837524|75750224|FG001|STARTED|Overall Study||27||
59635444|NCT01837524|75750223|FG000|COMPLETED|Overall Study||25||
59635445|NCT01837524|75750224|FG001|COMPLETED|Overall Study||25||
59635446|NCT01837524|75750223|FG000|NOT COMPLETED|Overall Study||3||
59635447|NCT01837524|75750224|FG001|NOT COMPLETED|Overall Study||2||
59635448|NCT01838226|75750232|FG000|STARTED|Overall Study||202||
59635449|NCT01838226|75750233|FG001|STARTED|Overall Study||199||
59635450|NCT01838226|75750232|FG000|COMPLETED|Overall Study||126||
59635451|NCT01838226|75750233|FG001|COMPLETED|Overall Study||128||
59635452|NCT01838226|75750232|FG000|NOT COMPLETED|Overall Study||76||
59635453|NCT01838226|75750233|FG001|NOT COMPLETED|Overall Study||71||
59635454|NCT01838304|75750241|FG000|STARTED|Overall Study||20||
59635455|NCT01838304|75750242|FG001|STARTED|Overall Study||20||
59635456|NCT01838304|75750241|FG000|COMPLETED|Overall Study||19||
59635457|NCT01838304|75750242|FG001|COMPLETED|Overall Study||20||
59635458|NCT01838304|75750241|FG000|NOT COMPLETED|Overall Study||1||
59635459|NCT01838304|75750242|FG001|NOT COMPLETED|Overall Study||0||
59635460|NCT01839318|75750248|FG000|STARTED|Period 1, First Day of Wear||4||
59635461|NCT01839318|75750249|FG001|STARTED|Period 1, First Day of Wear||4||
59635462|NCT01839318|75750250|FG002|STARTED|Period 1, First Day of Wear||5||
59635463|NCT01839318|75750251|FG003|STARTED|Period 1, First Day of Wear||6||
59635464|NCT01839318|75750252|FG004|STARTED|Period 1, First Day of Wear||7||
59635465|NCT01839318|75750253|FG005|STARTED|Period 1, First Day of Wear||2||
59635466|NCT01839318|75750248|FG000|COMPLETED|Period 1, First Day of Wear||4||
59635467|NCT01839318|75750249|FG001|COMPLETED|Period 1, First Day of Wear||4||
59635468|NCT01839318|75750250|FG002|COMPLETED|Period 1, First Day of Wear||5||
59635469|NCT01839318|75750251|FG003|COMPLETED|Period 1, First Day of Wear||6||
59635470|NCT01839318|75750252|FG004|COMPLETED|Period 1, First Day of Wear||7||
59635471|NCT01839318|75750253|FG005|COMPLETED|Period 1, First Day of Wear||2||
59635472|NCT01839318|75750248|FG000|NOT COMPLETED|Period 1, First Day of Wear||0||
59635473|NCT01839318|75750249|FG001|NOT COMPLETED|Period 1, First Day of Wear||0||
59635474|NCT01839318|75750250|FG002|NOT COMPLETED|Period 1, First Day of Wear||0||
59635475|NCT01839318|75750251|FG003|NOT COMPLETED|Period 1, First Day of Wear||0||
59635476|NCT01839318|75750252|FG004|NOT COMPLETED|Period 1, First Day of Wear||0||
59635477|NCT01839318|75750253|FG005|NOT COMPLETED|Period 1, First Day of Wear||0||
59635478|NCT01839318|75750248|FG000|STARTED|Period 2, Second Day of Wear||4||
59635479|NCT01839318|75750249|FG001|STARTED|Period 2, Second Day of Wear||4||
59635480|NCT01839318|75750250|FG002|STARTED|Period 2, Second Day of Wear||5||
59635481|NCT01839318|75750251|FG003|STARTED|Period 2, Second Day of Wear||6||
59635482|NCT01839318|75750252|FG004|STARTED|Period 2, Second Day of Wear||7||
59635483|NCT01839318|75750253|FG005|STARTED|Period 2, Second Day of Wear||2||
59635484|NCT01839318|75750248|FG000|COMPLETED|Period 2, Second Day of Wear||4||
59635485|NCT01839318|75750249|FG001|COMPLETED|Period 2, Second Day of Wear||4||
59635486|NCT01839318|75750250|FG002|COMPLETED|Period 2, Second Day of Wear||5||
59635487|NCT01839318|75750251|FG003|COMPLETED|Period 2, Second Day of Wear||6||
59635488|NCT01839318|75750252|FG004|COMPLETED|Period 2, Second Day of Wear||7||
59635489|NCT01839318|75750253|FG005|COMPLETED|Period 2, Second Day of Wear||2||
59635490|NCT01839318|75750248|FG000|NOT COMPLETED|Period 2, Second Day of Wear||0||
59635491|NCT01839318|75750249|FG001|NOT COMPLETED|Period 2, Second Day of Wear||0||
59635492|NCT01839318|75750250|FG002|NOT COMPLETED|Period 2, Second Day of Wear||0||
59635493|NCT01839318|75750251|FG003|NOT COMPLETED|Period 2, Second Day of Wear||0||
59635494|NCT01839318|75750252|FG004|NOT COMPLETED|Period 2, Second Day of Wear||0||
59635495|NCT01839318|75750253|FG005|NOT COMPLETED|Period 2, Second Day of Wear||0||
59635496|NCT01839318|75750248|FG000|STARTED|Period 3, Third Day of Wear||4||
59635497|NCT01839318|75750249|FG001|STARTED|Period 3, Third Day of Wear||4||
59635498|NCT01839318|75750250|FG002|STARTED|Period 3, Third Day of Wear||5||
59540785|NCT00890396|75639082|FG000|STARTED|Overall Study||127||
59540786|NCT00890396|75639083|FG001|STARTED|Overall Study||36||
59540787|NCT00890396|75639082|FG000|COMPLETED|Overall Study||122||
59540788|NCT00890396|75639083|FG001|COMPLETED|Overall Study||34||
59540789|NCT00890396|75639082|FG000|NOT COMPLETED|Overall Study||5||
59540790|NCT00890396|75639083|FG001|NOT COMPLETED|Overall Study||2||
59540791|NCT01399229|75639092|FG000|STARTED|Overall Study||20||
59540792|NCT01399229|75639093|FG001|STARTED|Overall Study||5||
59540793|NCT01399229|75639094|FG002|STARTED|Overall Study||5||
59540794|NCT01399229|75639092|FG000|COMPLETED|Overall Study||20||
59540795|NCT01399229|75639093|FG001|COMPLETED|Overall Study||5||
59540796|NCT01399229|75639094|FG002|COMPLETED|Overall Study||5||
59540797|NCT01399229|75639092|FG000|NOT COMPLETED|Overall Study||0||
59540798|NCT01399229|75639093|FG001|NOT COMPLETED|Overall Study||0||
59540799|NCT01399229|75639094|FG002|NOT COMPLETED|Overall Study||0||
59540800|NCT01434641|75639098|FG000|STARTED|Overall Study||102||
59540801|NCT01434641|75639098|FG000|COMPLETED|Overall Study||102||
59540802|NCT01434641|75639098|FG000|NOT COMPLETED|Overall Study||0||
59540803|NCT01400477|75639104|FG000|STARTED|Overall Study||40||
59540804|NCT01400477|75639105|FG001|STARTED|Overall Study||40||
59540805|NCT01400477|75639104|FG000|COMPLETED|Overall Study||38||
59540806|NCT01400477|75639105|FG001|COMPLETED|Overall Study||40||
59540807|NCT01400477|75639104|FG000|NOT COMPLETED|Overall Study||2||
59540808|NCT01400477|75639105|FG001|NOT COMPLETED|Overall Study||0||
59540809|NCT01401023|75639111|FG000|STARTED|Overall Study||10||
59540810|NCT01401023|75639111|FG000|COMPLETED|Overall Study||10||
59540811|NCT01401023|75639111|FG000|NOT COMPLETED|Overall Study||0||
59540812|NCT01401101|75639119|FG000|STARTED|Overall Study||206||
59540813|NCT01401101|75639120|FG001|STARTED|Overall Study||198||
59540814|NCT01401101|75639119|FG000|COMPLETED|Overall Study||184||
59540815|NCT01401101|75639120|FG001|COMPLETED|Overall Study||171||
59540816|NCT01401101|75639119|FG000|NOT COMPLETED|Overall Study||22||
59540817|NCT01401101|75639120|FG001|NOT COMPLETED|Overall Study||27||
59540818|NCT01515995|75639128|FG000|STARTED|Overall Study||25||
59540819|NCT01515995|75639129|FG001|STARTED|Overall Study||25||
59540820|NCT01515995|75639128|FG000|COMPLETED|Overall Study||22||
59540821|NCT01515995|75639129|FG001|COMPLETED|Overall Study||21||
59540822|NCT01515995|75639128|FG000|NOT COMPLETED|Overall Study||3||
59540823|NCT01515995|75639129|FG001|NOT COMPLETED|Overall Study||4||
59540824|NCT01436045|75639135|FG000|STARTED|Overall Study||6||
59540825|NCT01436045|75639136|FG001|STARTED|Overall Study||6||
59540826|NCT01436045|75639135|FG000|COMPLETED|Overall Study||6||
59540827|NCT01436045|75639136|FG001|COMPLETED|Overall Study||6||
59540828|NCT01436045|75639135|FG000|NOT COMPLETED|Overall Study||0||
59540829|NCT01436045|75639136|FG001|NOT COMPLETED|Overall Study||0||
59540830|NCT01519271|75639144|FG000|STARTED|Phase 1||14||
59540831|NCT01519271|75639145|FG001|STARTED|Phase 1||14||
59540832|NCT01519271|75639144|FG000|COMPLETED|Phase 1||14||
59540833|NCT01519271|75639145|FG001|COMPLETED|Phase 1|1 participant discontinued participation in the middle of phase 1.|13||
59540834|NCT01519271|75639144|FG000|NOT COMPLETED|Phase 1||0||
59540835|NCT01519271|75639145|FG001|NOT COMPLETED|Phase 1||1||
59540836|NCT01519271|75639144|FG000|STARTED|Phase 2|2 participants discontinued after Phase 1|12||
59540837|NCT01519271|75639145|FG001|STARTED|Phase 2||14||
59540838|NCT01519271|75639144|FG000|COMPLETED|Phase 2||12||
59540839|NCT01519271|75639145|FG001|COMPLETED|Phase 2||14||
59540840|NCT01519271|75639144|FG000|NOT COMPLETED|Phase 2||0||
59540841|NCT01519271|75639145|FG001|NOT COMPLETED|Phase 2||0||
59540842|NCT01401257|75639157|FG000|STARTED|Overall Study||21||
59540843|NCT01401257|75639158|FG001|STARTED|Overall Study||21||
59540844|NCT01401257|75639159|FG002|STARTED|Overall Study||19||
59540845|NCT01401257|75639160|FG003|STARTED|Overall Study||19||
59540846|NCT01401257|75639157|FG000|COMPLETED|Overall Study||21||
59540847|NCT01401257|75639158|FG001|COMPLETED|Overall Study||19||
59540848|NCT01401257|75639159|FG002|COMPLETED|Overall Study||16||
59540849|NCT01401257|75639160|FG003|COMPLETED|Overall Study||17||
59540850|NCT01401257|75639157|FG000|NOT COMPLETED|Overall Study||0||
59540851|NCT01401257|75639158|FG001|NOT COMPLETED|Overall Study||2||
59540852|NCT01401257|75639159|FG002|NOT COMPLETED|Overall Study||3||
59540853|NCT01401257|75639160|FG003|NOT COMPLETED|Overall Study||2||
59540854|NCT01402115|75639172|FG000|STARTED|Overall Study||30||
59540855|NCT01402115|75639173|FG001|STARTED|Overall Study||30||
59540856|NCT01402115|75639172|FG000|COMPLETED|Overall Study||29||
59540857|NCT01402115|75639173|FG001|COMPLETED|Overall Study||29||
59540858|NCT01402115|75639172|FG000|NOT COMPLETED|Overall Study||1||
59540859|NCT01402115|75639173|FG001|NOT COMPLETED|Overall Study||1||
59540860|NCT01436279|75639181|FG000|STARTED|Overall Study||30||
59540861|NCT01436279|75639182|FG001|STARTED|Overall Study||20||
59540862|NCT01436279|75639181|FG000|COMPLETED|Overall Study||30||
59540863|NCT01436279|75639182|FG001|COMPLETED|Overall Study||20||
59540864|NCT01436279|75639181|FG000|NOT COMPLETED|Overall Study||0||
59540865|NCT01436279|75639182|FG001|NOT COMPLETED|Overall Study||0||
59540866|NCT02210195|75639192|FG000|STARTED|Overall Study||10||
59540867|NCT02210195|75639193|FG001|STARTED|Overall Study||10||
59540868|NCT02210195|75639192|FG000|COMPLETED|Overall Study||6||
59540869|NCT02210195|75639193|FG001|COMPLETED|Overall Study||10||
59540870|NCT02210195|75639192|FG000|NOT COMPLETED|Overall Study||4||
59635499|NCT01839318|75750251|FG003|STARTED|Period 3, Third Day of Wear||6||
59635500|NCT01839318|75750252|FG004|STARTED|Period 3, Third Day of Wear||7||
59635501|NCT01839318|75750253|FG005|STARTED|Period 3, Third Day of Wear||2||
59635502|NCT01839318|75750248|FG000|COMPLETED|Period 3, Third Day of Wear||4||
59635503|NCT01839318|75750249|FG001|COMPLETED|Period 3, Third Day of Wear||4||
59635504|NCT01839318|75750250|FG002|COMPLETED|Period 3, Third Day of Wear||5||
59635505|NCT01839318|75750251|FG003|COMPLETED|Period 3, Third Day of Wear||6||
59635506|NCT01839318|75750252|FG004|COMPLETED|Period 3, Third Day of Wear||7||
59635507|NCT01839318|75750253|FG005|COMPLETED|Period 3, Third Day of Wear||2||
59635508|NCT01839318|75750248|FG000|NOT COMPLETED|Period 3, Third Day of Wear||0||
59635509|NCT01839318|75750249|FG001|NOT COMPLETED|Period 3, Third Day of Wear||0||
59635510|NCT01839318|75750250|FG002|NOT COMPLETED|Period 3, Third Day of Wear||0||
59635511|NCT01839318|75750251|FG003|NOT COMPLETED|Period 3, Third Day of Wear||0||
59635512|NCT01839318|75750252|FG004|NOT COMPLETED|Period 3, Third Day of Wear||0||
59635513|NCT01839318|75750253|FG005|NOT COMPLETED|Period 3, Third Day of Wear||0||
59635514|NCT01839708|75750263|FG000|STARTED|Overall Study||387||
59635515|NCT01839708|75750264|FG001|STARTED|Overall Study||182||
59635516|NCT01839708|75750263|FG000|COMPLETED|Overall Study||311||
59635517|NCT01839708|75750264|FG001|COMPLETED|Overall Study||115||
59635518|NCT01839708|75750263|FG000|NOT COMPLETED|Overall Study||76||
59635519|NCT01839708|75750264|FG001|NOT COMPLETED|Overall Study||67||
59635520|NCT01840722|75750272|FG000|STARTED|Overall Study||201||
59635521|NCT01840722|75750273|FG001|STARTED|Overall Study||199||
59635522|NCT01840722|75750272|FG000|COMPLETED|Overall Study||201||
59635523|NCT01840722|75750273|FG001|COMPLETED|Overall Study||130||
59635524|NCT01840722|75750272|FG000|NOT COMPLETED|Overall Study||0||
59635525|NCT01840722|75750273|FG001|NOT COMPLETED|Overall Study||69||
59635526|NCT01842594|75750279|FG000|STARTED|Overall Study||13||
59635527|NCT01842594|75750279|FG000|COMPLETED|Overall Study||10||
59635528|NCT01842594|75750279|FG000|NOT COMPLETED|Overall Study||3||
59635529|NCT01842906|75750285|FG000|STARTED|Overall Study||115||
59635530|NCT01842906|75750286|FG001|STARTED|Overall Study||104||
59635531|NCT01842906|75750285|FG000|COMPLETED|Overall Study||115||
59635532|NCT01842906|75750286|FG001|COMPLETED|Overall Study||104||
59635533|NCT01842906|75750285|FG000|NOT COMPLETED|Overall Study||0||
59635534|NCT01842906|75750286|FG001|NOT COMPLETED|Overall Study||0||
59635535|NCT01843920|75750294|FG000|STARTED|Overall Study||12||
59635536|NCT01843920|75750295|FG001|STARTED|Overall Study||9||
59635537|NCT01843920|75750294|FG000|COMPLETED|Overall Study||12||
59635538|NCT01843920|75750295|FG001|COMPLETED|Overall Study||9||
59635539|NCT01843920|75750294|FG000|NOT COMPLETED|Overall Study||0||
59635540|NCT01843920|75750295|FG001|NOT COMPLETED|Overall Study||0||
59635541|NCT01844388|75750303|FG000|STARTED|Overall Study||244||
59635542|NCT01844388|75750304|FG001|STARTED|Overall Study||121||
59635543|NCT01844388|75750303|FG000|COMPLETED|Overall Study||236||
59635544|NCT01844388|75750304|FG001|COMPLETED|Overall Study||114||
59635545|NCT01844388|75750303|FG000|NOT COMPLETED|Overall Study||8||
59635546|NCT01844388|75750304|FG001|NOT COMPLETED|Overall Study||7||
59635547|NCT01845636|75750310|FG000|STARTED|Overall Study||41||
59635548|NCT01845636|75750310|FG000|COMPLETED|Overall Study||37||
59635549|NCT01845636|75750310|FG000|NOT COMPLETED|Overall Study||4||
59635550|NCT01845792|75750316|FG000|STARTED|Overall Study||5||
59635551|NCT01845792|75750317|FG001|STARTED|Overall Study||2||
59635552|NCT01845792|75750316|FG000|COMPLETED|Overall Study||5||
59635553|NCT01845792|75750317|FG001|COMPLETED|Overall Study||2||
59635554|NCT01845792|75750316|FG000|NOT COMPLETED|Overall Study||0||
59635555|NCT01845792|75750317|FG001|NOT COMPLETED|Overall Study||0||
59635556|NCT01846494|75750325|FG000|STARTED|Overall Study||50||
59635557|NCT01846494|75750326|FG001|STARTED|Overall Study||63||
59635558|NCT01846494|75750325|FG000|COMPLETED|Overall Study||20||
59635559|NCT01846494|75750326|FG001|COMPLETED|Overall Study||25||
59635560|NCT01846494|75750325|FG000|NOT COMPLETED|Overall Study||30||
59635561|NCT01846494|75750326|FG001|NOT COMPLETED|Overall Study||38||
59635562|NCT01846728|75750332|FG000|STARTED|Overall Study||6||
59635563|NCT01846728|75750332|FG000|COMPLETED|Overall Study||6||
59635564|NCT01846728|75750332|FG000|NOT COMPLETED|Overall Study||0||
59635565|NCT01847196|75750336|FG000|STARTED|Overall Study|Includes all subjects in which Angel Catheter placement was attempted.|5||
59635566|NCT01847196|75750336|FG000|COMPLETED|Overall Study||5||
59635567|NCT01847196|75750336|FG000|NOT COMPLETED|Overall Study||0||
59635568|NCT01847430|75750340|FG000|STARTED|Overall Study||302||
59635569|NCT01847430|75750340|FG000|COMPLETED|Overall Study||302||
59635570|NCT01847430|75750340|FG000|NOT COMPLETED|Overall Study||0||
59635571|NCT01848054|75750346|FG000|STARTED|Induction Phase||155||
59635572|NCT01848054|75750347|FG001|STARTED|Induction Phase||155||
59635573|NCT01848054|75750346|FG000|COMPLETED|Induction Phase||132||
59635574|NCT01848054|75750347|FG001|COMPLETED|Induction Phase||147||
59635575|NCT01848054|75750346|FG000|NOT COMPLETED|Induction Phase||23||
59635576|NCT01848054|75750347|FG001|NOT COMPLETED|Induction Phase||8||
59635577|NCT01848054|75750346|FG000|STARTED|Stabilization/Maintenance||132||
59635578|NCT01848054|75750347|FG001|STARTED|Stabilization/Maintenance||147||
59635579|NCT01848054|75750346|FG000|COMPLETED|Stabilization/Maintenance||92||
59635580|NCT01848054|75750347|FG001|COMPLETED|Stabilization/Maintenance||107||
59540871|NCT02210195|75639193|FG001|NOT COMPLETED|Overall Study||0||
59540872|NCT01436435|75639199|FG000|STARTED|Overall Study||241||
59540873|NCT01436435|75639199|FG000|COMPLETED|Overall Study||177||
59540874|NCT01436435|75639199|FG000|NOT COMPLETED|Overall Study||64||
59540878|NCT00836888|75639211|FG000|STARTED|Overall Study||3||
59540879|NCT00836888|75639212|FG001|STARTED|Overall Study||5||
59540880|NCT00836888|75639213|FG002|STARTED|Overall Study||6||
59540881|NCT00836888|75639214|FG003|STARTED|Overall Study||3||
59540882|NCT00836888|75639211|FG000|COMPLETED|Overall Study||0||
59540883|NCT00836888|75639212|FG001|COMPLETED|Overall Study||2||
59540884|NCT00836888|75639213|FG002|COMPLETED|Overall Study||0||
59540885|NCT00836888|75639214|FG003|COMPLETED|Overall Study||0||
59540886|NCT00836888|75639211|FG000|NOT COMPLETED|Overall Study||3||
59540887|NCT00836888|75639212|FG001|NOT COMPLETED|Overall Study||3||
59540888|NCT00836888|75639213|FG002|NOT COMPLETED|Overall Study||6||
59540889|NCT00836888|75639214|FG003|NOT COMPLETED|Overall Study||3||
59540890|NCT00889226|75639226|FG000|STARTED|Overall Study||83||
59540891|NCT00889226|75639227|FG001|STARTED|Overall Study||78||
59540892|NCT00889226|75639226|FG000|COMPLETED|Overall Study||58||
59540893|NCT00889226|75639227|FG001|COMPLETED|Overall Study||43||
59540894|NCT00889226|75639226|FG000|NOT COMPLETED|Overall Study||25||
59540895|NCT00889226|75639227|FG001|NOT COMPLETED|Overall Study||35||
59540896|NCT00837200|75639233|FG000|STARTED|Overall Study||13||
59540897|NCT00837200|75639233|FG000|COMPLETED|Overall Study||13||
59540898|NCT00837200|75639233|FG000|NOT COMPLETED|Overall Study||0||
59540899|NCT00837512|75639237|FG000|STARTED|First Intervention (6hrs) - RANDOMIZED||8||
59540900|NCT00837512|75639238|FG001|STARTED|First Intervention (6hrs) - RANDOMIZED||8||
59540901|NCT00837512|75639237|FG000|COMPLETED|First Intervention (6hrs) - RANDOMIZED||8||
59540902|NCT00837512|75639238|FG001|COMPLETED|First Intervention (6hrs) - RANDOMIZED||8||
59540903|NCT00837512|75639237|FG000|NOT COMPLETED|First Intervention (6hrs) - RANDOMIZED||0||
59540904|NCT00837512|75639238|FG001|NOT COMPLETED|First Intervention (6hrs) - RANDOMIZED||0||
59540905|NCT00837512|75639237|FG000|STARTED|Both Arms: Washout (7-28 Days)||8||
59540906|NCT00837512|75639238|FG001|STARTED|Both Arms: Washout (7-28 Days)||8||
59540907|NCT00837512|75639237|FG000|COMPLETED|Both Arms: Washout (7-28 Days)||8||
59540908|NCT00837512|75639238|FG001|COMPLETED|Both Arms: Washout (7-28 Days)||8||
59540909|NCT00837512|75639237|FG000|NOT COMPLETED|Both Arms: Washout (7-28 Days)||0||
59540910|NCT00837512|75639238|FG001|NOT COMPLETED|Both Arms: Washout (7-28 Days)||0||
59540911|NCT00837512|75639237|FG000|STARTED|2nd Intervention (6 Hrs) - RANDOMIZED||8||
59540912|NCT00837512|75639238|FG001|STARTED|2nd Intervention (6 Hrs) - RANDOMIZED||8||
59540913|NCT00837512|75639237|FG000|COMPLETED|2nd Intervention (6 Hrs) - RANDOMIZED||8||
59540914|NCT00837512|75639238|FG001|COMPLETED|2nd Intervention (6 Hrs) - RANDOMIZED||8||
59540915|NCT00837512|75639237|FG000|NOT COMPLETED|2nd Intervention (6 Hrs) - RANDOMIZED||0||
59540916|NCT00837512|75639238|FG001|NOT COMPLETED|2nd Intervention (6 Hrs) - RANDOMIZED||0||
59540917|NCT00837590|75639247|FG000|STARTED|Overall Study||6||
59540918|NCT00837590|75639248|FG001|STARTED|Overall Study||5||
59540919|NCT00837590|75639249|FG002|STARTED|Overall Study||5||
59540920|NCT00837590|75639247|FG000|COMPLETED|Overall Study||6||
59540921|NCT00837590|75639248|FG001|COMPLETED|Overall Study||4||
59540922|NCT00837590|75639249|FG002|COMPLETED|Overall Study||4||
59540923|NCT00837590|75639247|FG000|NOT COMPLETED|Overall Study||0||
59540924|NCT00837590|75639248|FG001|NOT COMPLETED|Overall Study||1||
59540925|NCT00837590|75639249|FG002|NOT COMPLETED|Overall Study||1||
59540926|NCT00837824|75639259|FG000|STARTED|Overall Study||11||
59540927|NCT00837824|75639260|FG001|STARTED|Overall Study||9||
59540928|NCT00837824|75639259|FG000|COMPLETED|Overall Study||11||
59540929|NCT00837824|75639260|FG001|COMPLETED|Overall Study||9||
59540930|NCT00837824|75639259|FG000|NOT COMPLETED|Overall Study||0||
59540931|NCT00837824|75639260|FG001|NOT COMPLETED|Overall Study||0||
59540932|NCT01540409|75639269|FG000|STARTED|Overall Study||6||
59540933|NCT01540409|75639270|FG001|STARTED|Overall Study||6||
59540934|NCT01540409|75639269|FG000|COMPLETED|Overall Study||6||
59540935|NCT01540409|75639270|FG001|COMPLETED|Overall Study||6||
59540936|NCT01540409|75639269|FG000|NOT COMPLETED|Overall Study||0||
59540937|NCT01540409|75639270|FG001|NOT COMPLETED|Overall Study||0||
59540938|NCT00891176|75639283|FG000|STARTED|At 3 Years of Age||144||
59540939|NCT00891176|75639284|FG001|STARTED|At 3 Years of Age||147||
59540940|NCT00891176|75639285|FG002|STARTED|At 3 Years of Age||149||
59540941|NCT00891176|75639286|FG003|STARTED|At 3 Years of Age||141||
59540942|NCT00891176|75639283|FG000|COMPLETED|At 3 Years of Age||144||
59540943|NCT00891176|75639284|FG001|COMPLETED|At 3 Years of Age||147||
59540944|NCT00891176|75639285|FG002|COMPLETED|At 3 Years of Age||149||
59540945|NCT00891176|75639286|FG003|COMPLETED|At 3 Years of Age||141||
59540946|NCT00891176|75639283|FG000|NOT COMPLETED|At 3 Years of Age||0||
59540947|NCT00891176|75639284|FG001|NOT COMPLETED|At 3 Years of Age||0||
59540948|NCT00891176|75639285|FG002|NOT COMPLETED|At 3 Years of Age||0||
59540949|NCT00891176|75639286|FG003|NOT COMPLETED|At 3 Years of Age||0||
59540950|NCT00891176|75639283|FG000|STARTED|At 4 Years of Age||140||
59540951|NCT00891176|75639284|FG001|STARTED|At 4 Years of Age||142||
59635581|NCT01848054|75750346|FG000|NOT COMPLETED|Stabilization/Maintenance||40||
59635582|NCT01848054|75750347|FG001|NOT COMPLETED|Stabilization/Maintenance||40||
59635583|NCT01848366|75750357|FG000|STARTED|Overall Study||8||
59635584|NCT01848366|75750357|FG000|COMPLETED|Overall Study||8||
59635585|NCT01848366|75750357|FG000|NOT COMPLETED|Overall Study||0||
59635586|NCT01849068|75750363|FG000|STARTED|Overall Study||10||
59635587|NCT01849068|75750364|FG001|STARTED|Overall Study||10||
59635588|NCT01849068|75750363|FG000|COMPLETED|Overall Study||10||
59635589|NCT01849068|75750364|FG001|COMPLETED|Overall Study||10||
59635590|NCT01849068|75750363|FG000|NOT COMPLETED|Overall Study||0||
59635591|NCT01849068|75750364|FG001|NOT COMPLETED|Overall Study||0||
59635592|NCT01849692|75750372|FG000|STARTED|Overall Study||10||
59635593|NCT01849692|75750373|FG001|STARTED|Overall Study||3||
59635594|NCT01849692|75750374|FG002|STARTED|Overall Study||10||
59635595|NCT01849692|75750375|FG003|STARTED|Overall Study||3||
59635596|NCT01849692|75750376|FG004|STARTED|Overall Study||10||
59635597|NCT01849692|75750377|FG005|STARTED|Overall Study||3||
59635598|NCT01849692|75750378|FG006|STARTED|Overall Study||10||
59635599|NCT01849692|75750379|FG007|STARTED|Overall Study||3||
59635600|NCT01849692|75750372|FG000|COMPLETED|Overall Study||10||
59635601|NCT01849692|75750373|FG001|COMPLETED|Overall Study||3||
59635602|NCT01849692|75750374|FG002|COMPLETED|Overall Study||10||
59635603|NCT01849692|75750375|FG003|COMPLETED|Overall Study||3||
59635604|NCT01849692|75750376|FG004|COMPLETED|Overall Study||10||
59635605|NCT01849692|75750377|FG005|COMPLETED|Overall Study||3||
59635606|NCT01849692|75750378|FG006|COMPLETED|Overall Study||10||
59635607|NCT01849692|75750379|FG007|COMPLETED|Overall Study||3||
59635608|NCT01849692|75750372|FG000|NOT COMPLETED|Overall Study||0||
59635609|NCT01849692|75750373|FG001|NOT COMPLETED|Overall Study||0||
59635610|NCT01849692|75750374|FG002|NOT COMPLETED|Overall Study||0||
59635611|NCT01849692|75750375|FG003|NOT COMPLETED|Overall Study||0||
59635612|NCT01849692|75750376|FG004|NOT COMPLETED|Overall Study||0||
59635613|NCT01849692|75750377|FG005|NOT COMPLETED|Overall Study||0||
59635614|NCT01849692|75750378|FG006|NOT COMPLETED|Overall Study||0||
59635615|NCT01849692|75750379|FG007|NOT COMPLETED|Overall Study||0||
59635616|NCT01849770|75750403|FG000|STARTED|Overall Study||20||
59635617|NCT01849770|75750404|FG001|STARTED|Overall Study||19||
59635618|NCT01849770|75750405|FG002|STARTED|Overall Study||20||
59635619|NCT01849770|75750403|FG000|COMPLETED|Overall Study||20||
59635620|NCT01849770|75750404|FG001|COMPLETED|Overall Study||15||
59635621|NCT01849770|75750405|FG002|COMPLETED|Overall Study||19||
59635622|NCT01849770|75750403|FG000|NOT COMPLETED|Overall Study||0||
59635623|NCT01849770|75750404|FG001|NOT COMPLETED|Overall Study||4||
59635624|NCT01849770|75750405|FG002|NOT COMPLETED|Overall Study||1||
59635625|NCT01850394|75750418|FG000|STARTED|Overall Study||45||
59635626|NCT01850394|75750419|FG001|STARTED|Overall Study||45||
59635627|NCT01850394|75750420|FG002|STARTED|Overall Study||45||
59635628|NCT01850394|75750418|FG000|COMPLETED|Overall Study||45||
59635629|NCT01850394|75750419|FG001|COMPLETED|Overall Study||45||
59635630|NCT01850394|75750420|FG002|COMPLETED|Overall Study||45||
59635631|NCT01850394|75750418|FG000|NOT COMPLETED|Overall Study||0||
59635632|NCT01850394|75750419|FG001|NOT COMPLETED|Overall Study||0||
59635633|NCT01850394|75750420|FG002|NOT COMPLETED|Overall Study||0||
59635634|NCT01850550|75750430|FG000|STARTED|Overall Study||40||
59635635|NCT01850550|75750431|FG001|STARTED|Overall Study||40||
59635636|NCT01850550|75750430|FG000|COMPLETED|Overall Study||40||
59635637|NCT01850550|75750431|FG001|COMPLETED|Overall Study||37||
59635638|NCT01850550|75750430|FG000|NOT COMPLETED|Overall Study||0||
59635639|NCT01850550|75750431|FG001|NOT COMPLETED|Overall Study||3||
59635640|NCT01851876|75750439|FG000|STARTED|Overall Study||56||
59635641|NCT01851876|75750440|FG001|STARTED|Overall Study||62||
59635642|NCT01851876|75750439|FG000|COMPLETED|Overall Study||56||
59635643|NCT01851876|75750440|FG001|COMPLETED|Overall Study||62||
59635644|NCT01851876|75750439|FG000|NOT COMPLETED|Overall Study||0||
59540952|NCT00891176|75639285|FG002|STARTED|At 4 Years of Age||142||
59540953|NCT00891176|75639286|FG003|STARTED|At 4 Years of Age||137||
59540954|NCT00891176|75639283|FG000|COMPLETED|At 4 Years of Age||140||
59540955|NCT00891176|75639284|FG001|COMPLETED|At 4 Years of Age||142||
59540956|NCT00891176|75639285|FG002|COMPLETED|At 4 Years of Age||142||
59540957|NCT00891176|75639286|FG003|COMPLETED|At 4 Years of Age||137||
59540958|NCT00891176|75639283|FG000|NOT COMPLETED|At 4 Years of Age||0||
59540959|NCT00891176|75639284|FG001|NOT COMPLETED|At 4 Years of Age||0||
59540960|NCT00891176|75639285|FG002|NOT COMPLETED|At 4 Years of Age||0||
59635645|NCT01851876|75750440|FG001|NOT COMPLETED|Overall Study||0||
59635646|NCT01852032|75750446|FG000|STARTED|Overall Study||23||
59635647|NCT01852032|75750446|FG000|COMPLETED|Overall Study||23||
59635648|NCT01852032|75750446|FG000|NOT COMPLETED|Overall Study||0||
59635649|NCT01852344|75750454|FG000|STARTED|Overall Study||27||
59635650|NCT01852344|75750455|FG001|STARTED|Overall Study||27||
59635651|NCT01852344|75750456|FG002|STARTED|Overall Study||27||
59635652|NCT01852344|75750457|FG003|STARTED|Overall Study||27||
59635653|NCT01852344|75750454|FG000|Actual Participation in First Assignment|Overall Study||27||
59635654|NCT01852344|75750455|FG001|Actual Participation in First Assignment|Overall Study||27||
59635655|NCT01852344|75750456|FG002|Actual Participation in First Assignment|Overall Study||27||
59635656|NCT01852344|75750457|FG003|Actual Participation in First Assignment|Overall Study||27||
59635657|NCT01852344|75750454|FG000|COMPLETED|Overall Study||27||
59635658|NCT01852344|75750455|FG001|COMPLETED|Overall Study||27||
59635659|NCT01852344|75750456|FG002|COMPLETED|Overall Study||27||
59635660|NCT01852344|75750457|FG003|COMPLETED|Overall Study||27||
59635661|NCT01852344|75750454|FG000|NOT COMPLETED|Overall Study||0||
59635662|NCT01852344|75750455|FG001|NOT COMPLETED|Overall Study||0||
59635663|NCT01852344|75750456|FG002|NOT COMPLETED|Overall Study||0||
59635664|NCT01852344|75750457|FG003|NOT COMPLETED|Overall Study||0||
59635665|NCT01854138|75750470|FG000|STARTED|Overall Study|historical control with waiver of authorization; no informed consent signed|400||
59635666|NCT01854138|75750471|FG001|STARTED|Overall Study||248||
59635667|NCT01854138|75750470|FG000|COMPLETED|Overall Study||400||
59635668|NCT01854138|75750471|FG001|COMPLETED|Overall Study||196||
59635669|NCT01854138|75750470|FG000|NOT COMPLETED|Overall Study||0||
59635670|NCT01854138|75750471|FG001|NOT COMPLETED|Overall Study||52||
59635671|NCT01856712|75750480|FG000|STARTED|Overall Study||23||
59635672|NCT01856712|75750481|FG001|STARTED|Overall Study|1 received oral in error thus randomized.|22||
59635673|NCT01856712|75750480|FG000|Lost to 14 Day Follow up|Overall Study||6||
59635674|NCT01856712|75750481|FG001|Lost to 14 Day Follow up|Overall Study||2||
59635675|NCT01856712|75750480|FG000|Lost to 45 Day Follow up|Overall Study||1||
59635676|NCT01856712|75750481|FG001|Lost to 45 Day Follow up|Overall Study||1||
59635677|NCT01856712|75750480|FG000|COMPLETED|Overall Study||16||
59635678|NCT01856712|75750481|FG001|COMPLETED|Overall Study||19||
59635679|NCT01856712|75750480|FG000|NOT COMPLETED|Overall Study||7||
59635680|NCT01856712|75750481|FG001|NOT COMPLETED|Overall Study||3||
59635681|NCT01857258|75750491|FG000|STARTED|First Intervention (3 h Postprandially)||8||
59635682|NCT01857258|75750492|FG001|STARTED|First Intervention (3 h Postprandially)||7||
59635683|NCT01857258|75750491|FG000|COMPLETED|First Intervention (3 h Postprandially)||8||
59635684|NCT01857258|75750492|FG001|COMPLETED|First Intervention (3 h Postprandially)||7||
59635685|NCT01857258|75750491|FG000|NOT COMPLETED|First Intervention (3 h Postprandially)||0||
59635686|NCT01857258|75750492|FG001|NOT COMPLETED|First Intervention (3 h Postprandially)||0||
59635687|NCT01857258|75750491|FG000|STARTED|Wash-out Period (7 Days)||8||
59635688|NCT01857258|75750492|FG001|STARTED|Wash-out Period (7 Days)||7||
59635689|NCT01857258|75750491|FG000|COMPLETED|Wash-out Period (7 Days)||8||
59635690|NCT01857258|75750492|FG001|COMPLETED|Wash-out Period (7 Days)||7||
59635691|NCT01857258|75750491|FG000|NOT COMPLETED|Wash-out Period (7 Days)||0||
59635692|NCT01857258|75750492|FG001|NOT COMPLETED|Wash-out Period (7 Days)||0||
59635693|NCT01857258|75750491|FG000|STARTED|Second Intervention (3 h Postprandially)||8||
59635694|NCT01857258|75750492|FG001|STARTED|Second Intervention (3 h Postprandially)||7||
59635695|NCT01857258|75750491|FG000|COMPLETED|Second Intervention (3 h Postprandially)||8||
59635696|NCT01857258|75750492|FG001|COMPLETED|Second Intervention (3 h Postprandially)||7||
59635697|NCT01857258|75750491|FG000|NOT COMPLETED|Second Intervention (3 h Postprandially)||0||
59635698|NCT01857258|75750492|FG001|NOT COMPLETED|Second Intervention (3 h Postprandially)||0||
59635699|NCT01857882|75750502|FG000|STARTED|Overall Study||21||
59635700|NCT01857882|75750503|FG001|STARTED|Overall Study||20||
59635701|NCT01857882|75750502|FG000|COMPLETED|Overall Study||21||
59635702|NCT01857882|75750503|FG001|COMPLETED|Overall Study||20||
59635703|NCT01857882|75750502|FG000|NOT COMPLETED|Overall Study||0||
59635704|NCT01857882|75750503|FG001|NOT COMPLETED|Overall Study||0||
59635705|NCT01858428|75750511|FG000|STARTED|Overall Study|EverCross™ Balloon Catheter now a product of Medtronic|100||
59635706|NCT01858428|75750512|FG001|STARTED|Overall Study||200||
59635707|NCT01858428|75750511|FG000|COMPLETED|Overall Study||99||
59635708|NCT01858428|75750512|FG001|COMPLETED|Overall Study||190||
59635709|NCT01858428|75750511|FG000|NOT COMPLETED|Overall Study||1||
59635710|NCT01858428|75750512|FG001|NOT COMPLETED|Overall Study||10||
59635711|NCT01861002|75750518|FG000|STARTED|Overall Study||15||
59635712|NCT01861002|75750518|FG000|COMPLETED|Overall Study||14||
59635713|NCT01861002|75750518|FG000|NOT COMPLETED|Overall Study||1||
59635714|NCT01861704|75750528|FG000|STARTED|Overall Study||70||
59635715|NCT01861704|75750529|FG001|STARTED|Overall Study||107||
59635716|NCT01861704|75750528|FG000|COMPLETED|Overall Study||67||
59635717|NCT01861704|75750529|FG001|COMPLETED|Overall Study||104||
59635718|NCT01861704|75750528|FG000|NOT COMPLETED|Overall Study||3||
59635719|NCT01861704|75750529|FG001|NOT COMPLETED|Overall Study||3||
59635720|NCT01863030|75750535|FG000|STARTED|Baseline||31||
59988358|NCT02268214|76103508|FG000|STARTED|Overall Study||277||
59988359|NCT02268214|76103509|FG001|STARTED|Overall Study||296||
59988360|NCT02268214|76103510|FG002|STARTED|Overall Study||260||
59635721|NCT01863030|75750535|FG000|COMPLETED|Baseline||31||
59635722|NCT01863030|75750535|FG000|NOT COMPLETED|Baseline||0||
59635723|NCT01863030|75750535|FG000|STARTED|Follow up||31||
59635724|NCT01863030|75750535|FG000|2 Weeks|Follow up||31||
59635725|NCT01863030|75750535|FG000|3 Months|Follow up||28||
59635726|NCT01863030|75750535|FG000|6 Months|Follow up||29||
59635727|NCT01863030|75750535|FG000|12 Months|Follow up||26||
59635728|NCT01863030|75750535|FG000|24 Months|Follow up||13||
59635729|NCT01863030|75750535|FG000|COMPLETED|Follow up||13||
59635730|NCT01863030|75750535|FG000|NOT COMPLETED|Follow up||18||
59635731|NCT01863498|75750542|FG000|STARTED|Overall Study||33||
59988361|NCT02268214|76103508|FG000|COMPLETED 24 WEEK PERIOD|Overall Study||252||
59635732|NCT01863498|75750543|FG001|STARTED|Overall Study||32||
59635733|NCT01863498|75750542|FG000|COMPLETED|Overall Study||33||
59635734|NCT01863498|75750543|FG001|COMPLETED|Overall Study||32||
59635735|NCT01863498|75750542|FG000|NOT COMPLETED|Overall Study||0||
59635736|NCT01863498|75750543|FG001|NOT COMPLETED|Overall Study||0||
59635737|NCT01864434|75750551|FG000|STARTED|Overall Study||25||
59635738|NCT01864434|75750552|FG001|STARTED|Overall Study||25||
59635739|NCT01864434|75750551|FG000|COMPLETED|Overall Study||25||
59635740|NCT01864434|75750552|FG001|COMPLETED|Overall Study||25||
59635741|NCT01864434|75750551|FG000|NOT COMPLETED|Overall Study||0||
59635742|NCT01864434|75750552|FG001|NOT COMPLETED|Overall Study||0||
59635743|NCT01866150|75750558|FG000|STARTED|Overall Study||450||
59635744|NCT01866150|75750558|FG000|COMPLETED|Overall Study||450||
59635745|NCT01866150|75750558|FG000|NOT COMPLETED|Overall Study||0||
59635746|NCT01866306|75750572|FG000|STARTED|Overall Study||6||
59635747|NCT01866306|75750573|FG001|STARTED|Overall Study||6||
59635748|NCT01866306|75750574|FG002|STARTED|Overall Study||6||
59635749|NCT01866306|75750575|FG003|STARTED|Overall Study||6||
59635750|NCT01866306|75750576|FG004|STARTED|Overall Study||6||
59635751|NCT01866306|75750577|FG005|STARTED|Overall Study||6||
59635752|NCT01866306|75750578|FG006|STARTED|Overall Study||23||
59635753|NCT01866306|75750572|FG000|COMPLETED|Overall Study||6||
59635754|NCT01866306|75750573|FG001|COMPLETED|Overall Study||6||
59635755|NCT01866306|75750574|FG002|COMPLETED|Overall Study||6||
59635756|NCT01866306|75750575|FG003|COMPLETED|Overall Study||6||
59635757|NCT01866306|75750576|FG004|COMPLETED|Overall Study||6||
59635758|NCT01866306|75750577|FG005|COMPLETED|Overall Study||6||
59635759|NCT01866306|75750578|FG006|COMPLETED|Overall Study||23||
59635760|NCT01866306|75750572|FG000|NOT COMPLETED|Overall Study||0||
59635761|NCT01866306|75750573|FG001|NOT COMPLETED|Overall Study||0||
59635762|NCT01866306|75750574|FG002|NOT COMPLETED|Overall Study||0||
59635763|NCT01866306|75750575|FG003|NOT COMPLETED|Overall Study||0||
59635764|NCT01866306|75750576|FG004|NOT COMPLETED|Overall Study||0||
59635765|NCT01866306|75750577|FG005|NOT COMPLETED|Overall Study||0||
59635766|NCT01866306|75750578|FG006|NOT COMPLETED|Overall Study||0||
59635767|NCT01867164|75750596|FG000|STARTED|Overall Study||81||
59635768|NCT01867164|75750597|FG001|STARTED|Overall Study||79||
59635769|NCT01867164|75750596|FG000|COMPLETED|Overall Study||81||
59635770|NCT01867164|75750597|FG001|COMPLETED|Overall Study||79||
59635771|NCT01867164|75750596|FG000|NOT COMPLETED|Overall Study||0||
59635772|NCT01867164|75750597|FG001|NOT COMPLETED|Overall Study||0||
59635773|NCT01867632|75750605|FG000|STARTED|Overall Study||65||
59635774|NCT01867632|75750606|FG001|STARTED|Overall Study||66||
59635775|NCT01867632|75750605|FG000|COMPLETED|Overall Study||65||
59635776|NCT01867632|75750606|FG001|COMPLETED|Overall Study||66||
59635777|NCT01867632|75750605|FG000|NOT COMPLETED|Overall Study||0||
59635778|NCT01867632|75750606|FG001|NOT COMPLETED|Overall Study||0||
59635779|NCT01868334|75750616|FG000|STARTED|Year 1 RCCT Study||13186||10
59635780|NCT01868334|75750617|FG001|STARTED|Year 1 RCCT Study||17185||8
59635781|NCT01868334|75750618|FG002|STARTED|Year 1 RCCT Study||19274||3
59635782|NCT01868334|75750619|FG003|STARTED|Year 1 RCCT Study||20904||3
59635783|NCT01868334|75750616|FG000|COMPLETED|Year 1 RCCT Study||13186||10
59635784|NCT01868334|75750617|FG001|COMPLETED|Year 1 RCCT Study||17185||8
59635785|NCT01868334|75750618|FG002|COMPLETED|Year 1 RCCT Study||19274||3
59635786|NCT01868334|75750619|FG003|COMPLETED|Year 1 RCCT Study||20904||3
59635787|NCT01868334|75750616|FG000|NOT COMPLETED|Year 1 RCCT Study||0||0
59635788|NCT01868334|75750617|FG001|NOT COMPLETED|Year 1 RCCT Study||0||0
59635789|NCT01868334|75750618|FG002|NOT COMPLETED|Year 1 RCCT Study||0||0
59635790|NCT01868334|75750619|FG003|NOT COMPLETED|Year 1 RCCT Study||0||0
59635791|NCT01868334|75750616|FG000|STARTED|Year 2 Pre-post Study|Reflects: control sites from Year 1 (N=8) and Year 1 Intervention sites who continued in Y2 (N=4)|22324||12
59635792|NCT01868334|75750617|FG001|STARTED|Year 2 Pre-post Study|Reflects: the six Year 1 Intervention sites who chose not to actively engage Year 2|8047||6
59635793|NCT01868334|75750618|FG002|STARTED|Year 2 Pre-post Study|Reflects: Year 1 Control sites who became active in the intervention during Year 2|20904||3
59635794|NCT01868334|75750619|FG003|STARTED|Year 2 Pre-post Study|Reflects: Year 1 Intervention sites who chose not to actively engage Year 2|19274||3
59635795|NCT01868334|75750616|FG000|COMPLETED|Year 2 Pre-post Study||22324||12
59635796|NCT01868334|75750617|FG001|COMPLETED|Year 2 Pre-post Study||8047||6
59635797|NCT01868334|75750618|FG002|COMPLETED|Year 2 Pre-post Study||20904||3
59635798|NCT01868334|75750619|FG003|COMPLETED|Year 2 Pre-post Study||19274||3
59635799|NCT01868334|75750616|FG000|NOT COMPLETED|Year 2 Pre-post Study||0||0
59635800|NCT01868334|75750617|FG001|NOT COMPLETED|Year 2 Pre-post Study||0||0
59635801|NCT01868334|75750618|FG002|NOT COMPLETED|Year 2 Pre-post Study||0||0
59635802|NCT01868334|75750619|FG003|NOT COMPLETED|Year 2 Pre-post Study||0||0
59635803|NCT01870596|75750659|FG000|STARTED|Overall Study||14||
59635804|NCT01870596|75750660|FG001|STARTED|Overall Study||18||
59635805|NCT01870596|75750659|FG000|COMPLETED|Overall Study||14||
59635806|NCT01870596|75750660|FG001|COMPLETED|Overall Study||18||
59635807|NCT01870596|75750659|FG000|NOT COMPLETED|Overall Study||0||
59635808|NCT01870596|75750660|FG001|NOT COMPLETED|Overall Study||0||
59635809|NCT01874262|75750668|FG000|STARTED|Overall Study||91||
59635810|NCT01874262|75750669|FG001|STARTED|Overall Study||83||
59995440|NCT02911792|76111263|FG002|STARTED|Overall Study||18||
59988362|NCT02268214|76103509|FG001|COMPLETED 24 WEEK PERIOD|Overall Study||273||
59988363|NCT02268214|76103510|FG002|COMPLETED 24 WEEK PERIOD|Overall Study||232||
59988364|NCT02268214|76103508|FG000|COMPLETED|Overall Study||235||
59540961|NCT00891176|75639286|FG003|NOT COMPLETED|At 4 Years of Age||0||
59540962|NCT00891176|75639283|FG000|STARTED|At 6 Years of Age||131||
59540963|NCT00891176|75639284|FG001|STARTED|At 6 Years of Age||138||
59540964|NCT00891176|75639285|FG002|STARTED|At 6 Years of Age||135||
59540965|NCT00891176|75639286|FG003|STARTED|At 6 Years of Age||135||
59540966|NCT00891176|75639283|FG000|COMPLETED|At 6 Years of Age||131||
59540967|NCT00891176|75639284|FG001|COMPLETED|At 6 Years of Age||138||
59540968|NCT00891176|75639285|FG002|COMPLETED|At 6 Years of Age||135||
59540969|NCT00891176|75639286|FG003|COMPLETED|At 6 Years of Age||135||
59540970|NCT00891176|75639283|FG000|NOT COMPLETED|At 6 Years of Age||0||
59540971|NCT00891176|75639284|FG001|NOT COMPLETED|At 6 Years of Age||0||
59540972|NCT00891176|75639285|FG002|NOT COMPLETED|At 6 Years of Age||0||
59540973|NCT00891176|75639286|FG003|NOT COMPLETED|At 6 Years of Age||0||
59540974|NCT00839540|75639305|FG000|STARTED|Overall Study||8||
59540975|NCT00839540|75639306|FG001|STARTED|Overall Study||8||
59540976|NCT00839540|75639307|FG002|STARTED|Overall Study||5||
59540977|NCT00839540|75639305|FG000|COMPLETED|Overall Study||8||
59540978|NCT00839540|75639306|FG001|COMPLETED|Overall Study||8||
59540979|NCT00839540|75639307|FG002|COMPLETED|Overall Study||5||
59540980|NCT00839540|75639305|FG000|NOT COMPLETED|Overall Study||0||
59540981|NCT00839540|75639306|FG001|NOT COMPLETED|Overall Study||0||
59540982|NCT00839540|75639307|FG002|NOT COMPLETED|Overall Study||0||
59540983|NCT01437605|75639317|FG000|STARTED|Overall Study||9||
59540984|NCT01437605|75639318|FG001|STARTED|Overall Study||5||
59540985|NCT01437605|75639317|FG000|COMPLETED|Overall Study||9||
59540986|NCT01437605|75639318|FG001|COMPLETED|Overall Study||5||
59540987|NCT01437605|75639317|FG000|NOT COMPLETED|Overall Study||0||
59540988|NCT01437605|75639318|FG001|NOT COMPLETED|Overall Study||0||
59540989|NCT00841412|75639324|FG000|STARTED|Overall Study|200 of 222 consented residents completed baseline assessments across both groups.|120||
59540990|NCT00841412|75639325|FG001|STARTED|Overall Study|80 residents were in the delayed intervention group, but all residents received intervention.|80||
59540991|NCT00841412|75639324|FG000|COMPLETED|Overall Study|130 residents completed all study phases across both groups, including follow-up.|80||
59540992|NCT00841412|75639325|FG001|COMPLETED|Overall Study||50||
59540993|NCT00841412|75639324|FG000|NOT COMPLETED|Overall Study||40||
59540994|NCT00841412|75639325|FG001|NOT COMPLETED|Overall Study||30||
59540995|NCT02154386|75639331|FG000|STARTED|Overall Study||23||
59540996|NCT02154386|75639332|FG001|STARTED|Overall Study||23||
59540997|NCT02154386|75639331|FG000|COMPLETED|Overall Study||22||
59540998|NCT02154386|75639332|FG001|COMPLETED|Overall Study||21||
59540999|NCT02154386|75639331|FG000|NOT COMPLETED|Overall Study||1||
59541000|NCT02154386|75639332|FG001|NOT COMPLETED|Overall Study||2||
59541001|NCT01438229|75639338|FG000|STARTED|Overall Study||47||
59541002|NCT01438229|75639338|FG000|Excluded Due to Renal Artery Anatomy|Overall Study||1||
59541003|NCT01438229|75639338|FG000|Underwent Procedure|Overall Study||46||
59541004|NCT01438229|75639338|FG000|COMPLETED|Overall Study||44||
59541005|NCT01438229|75639338|FG000|NOT COMPLETED|Overall Study||3||
59541006|NCT01541735|75639344|FG000|STARTED|Overall Study||7||
59541007|NCT01541735|75639345|FG001|STARTED|Overall Study||7||
59541008|NCT01541735|75639344|FG000|COMPLETED|Overall Study||7||
59541009|NCT01541735|75639345|FG001|COMPLETED|Overall Study||7||
59541010|NCT01541735|75639344|FG000|NOT COMPLETED|Overall Study||0||
59541011|NCT01541735|75639345|FG001|NOT COMPLETED|Overall Study||0||
59541012|NCT01541891|75639353|FG000|STARTED|Overall Study||15||
59541013|NCT01541891|75639354|FG001|STARTED|Overall Study||15||
59541014|NCT01541891|75639353|FG000|COMPLETED|Overall Study||14||
59541015|NCT01541891|75639354|FG001|COMPLETED|Overall Study||14||
59541016|NCT01541891|75639353|FG000|NOT COMPLETED|Overall Study||1||
59988365|NCT02268214|76103509|FG001|COMPLETED|Overall Study||255||
59541017|NCT01541891|75639354|FG001|NOT COMPLETED|Overall Study||1||
59541018|NCT01520207|75639364|FG000|STARTED|Overall Study||27||
59541019|NCT01520207|75639365|FG001|STARTED|Overall Study||25||
59541020|NCT01520207|75639364|FG000|COMPLETED|Overall Study||25||
59541021|NCT01520207|75639365|FG001|COMPLETED|Overall Study||25||
59541022|NCT01520207|75639364|FG000|NOT COMPLETED|Overall Study||2||
59541023|NCT01520207|75639365|FG001|NOT COMPLETED|Overall Study||0||
59541024|NCT01520519|75639371|FG000|STARTED|Overall Study||40||
59541025|NCT01520519|75639371|FG000|COMPLETED|Overall Study||40||
59541026|NCT01520519|75639371|FG000|NOT COMPLETED|Overall Study||0||
59541027|NCT01542125|75639377|FG000|STARTED|Overall Study||140||
59541028|NCT01542125|75639378|FG001|STARTED|Overall Study||141||
59541029|NCT01542125|75639377|FG000|COMPLETED|Overall Study||140||
59541030|NCT01542125|75639378|FG001|COMPLETED|Overall Study||141||
59541031|NCT01542125|75639377|FG000|NOT COMPLETED|Overall Study||0||
59541032|NCT01542125|75639378|FG001|NOT COMPLETED|Overall Study||0||
59541033|NCT01439087|75639384|FG000|STARTED|Overall Study||2||
59541034|NCT01439087|75639384|FG000|COMPLETED|Overall Study||2||
59541035|NCT01439087|75639384|FG000|NOT COMPLETED|Overall Study||0||
59541036|NCT01439633|75639388|FG000|STARTED|Overall Study||22||
59541037|NCT01439633|75639388|FG000|COMPLETED|Overall Study||22||
59988366|NCT02268214|76103510|FG002|COMPLETED|Overall Study||218||
59541038|NCT01439633|75639388|FG000|NOT COMPLETED|Overall Study||0||
59541039|NCT02548832|75639395|FG000|STARTED|Overall Study||12||
59541040|NCT02548832|75639396|FG001|STARTED|Overall Study||12||
59541041|NCT02548832|75639397|FG002|STARTED|Overall Study||12||
59541042|NCT02548832|75639395|FG000|COMPLETED|Overall Study||10||
59541043|NCT02548832|75639396|FG001|COMPLETED|Overall Study||10||
59541044|NCT02548832|75639397|FG002|COMPLETED|Overall Study||10||
59541045|NCT02548832|75639395|FG000|NOT COMPLETED|Overall Study||2||
59541046|NCT02548832|75639396|FG001|NOT COMPLETED|Overall Study||2||
59541047|NCT02548832|75639397|FG002|NOT COMPLETED|Overall Study||2||
59541048|NCT01440959|75639406|FG000|STARTED|Overall Study||30||
59541049|NCT01440959|75639406|FG000|COMPLETED|Overall Study||30||
59541050|NCT01440959|75639406|FG000|NOT COMPLETED|Overall Study||0||
59541051|NCT01543607|75639410|FG000|STARTED|Overall Study||1||
59541052|NCT01543607|75639410|FG000|COMPLETED|Overall Study||1||
59541053|NCT01543607|75639410|FG000|NOT COMPLETED|Overall Study||0||
59541054|NCT01521845|75639416|FG000|STARTED|Overall Study||52||
59541055|NCT01521845|75639417|FG001|STARTED|Overall Study||52||
59541056|NCT01521845|75639416|FG000|COMPLETED|Overall Study||43||
59541057|NCT01521845|75639417|FG001|COMPLETED|Overall Study||47||
59541058|NCT01521845|75639416|FG000|NOT COMPLETED|Overall Study||9||
59541059|NCT01521845|75639417|FG001|NOT COMPLETED|Overall Study||5||
59541060|NCT01522391|75639425|FG000|STARTED|Overall Study||20||
59541061|NCT01522391|75639426|FG001|STARTED|Overall Study||21||
59541062|NCT01522391|75639425|FG000|COMPLETED|Overall Study||19||
59541063|NCT01522391|75639426|FG001|COMPLETED|Overall Study||20||
59541064|NCT01522391|75639425|FG000|NOT COMPLETED|Overall Study||1||
59541065|NCT01522391|75639426|FG001|NOT COMPLETED|Overall Study||1||
59541066|NCT00837902|75639434|FG000|STARTED|Overall Study||85||
59541067|NCT00837902|75639435|FG001|STARTED|Overall Study||69||
59541068|NCT00837902|75639434|FG000|COMPLETED|Overall Study||85||
59541069|NCT00837902|75639435|FG001|COMPLETED|Overall Study||69||
59541070|NCT00837902|75639434|FG000|NOT COMPLETED|Overall Study||0||
59541071|NCT00837902|75639435|FG001|NOT COMPLETED|Overall Study||0||
59541072|NCT01522703|75639444|FG000|STARTED|Overall Study||25||
59541073|NCT01522703|75639445|FG001|STARTED|Overall Study||26||
59541074|NCT01522703|75639444|FG000|COMPLETED|Overall Study||20||
59541075|NCT01522703|75639445|FG001|COMPLETED|Overall Study||20||
59541076|NCT01522703|75639444|FG000|NOT COMPLETED|Overall Study||5||
59541077|NCT01522703|75639445|FG001|NOT COMPLETED|Overall Study||6||
59541078|NCT01522937|75639451|FG000|STARTED|Overall Study||146||
59541079|NCT01522937|75639451|FG000|COMPLETED|Overall Study||146||
59541080|NCT01522937|75639451|FG000|NOT COMPLETED|Overall Study||0||
59541081|NCT01441037|75639455|FG000|STARTED|Overall Study||27||
59541082|NCT01441037|75639455|FG000|COMPLETED|Overall Study||27||
59541083|NCT01441037|75639455|FG000|NOT COMPLETED|Overall Study||0||
59541084|NCT00891878|75639461|FG000|STARTED|Overall Study||6||
59541085|NCT00891878|75639462|FG001|STARTED|Overall Study||6||
59541086|NCT00891878|75639461|FG000|COMPLETED|Overall Study||6||
59541087|NCT00891878|75639462|FG001|COMPLETED|Overall Study||6||
59541088|NCT00891878|75639461|FG000|NOT COMPLETED|Overall Study||0||
59541089|NCT00891878|75639462|FG001|NOT COMPLETED|Overall Study||0||
59541090|NCT01442129|75639470|FG000|STARTED|Overall Study||20||
59541091|NCT01442129|75639471|FG001|STARTED|Overall Study||10||
59541092|NCT01442129|75639470|FG000|COMPLETED|Overall Study|Treatment withheld from 1 patient randomized before results of screening PRA known|20||
59541093|NCT01442129|75639471|FG001|COMPLETED|Overall Study||10||
59541094|NCT01442129|75639470|FG000|NOT COMPLETED|Overall Study||0||
59541095|NCT01442129|75639471|FG001|NOT COMPLETED|Overall Study||0||
59541096|NCT01445873|75639477|FG000|STARTED|Overall Study||36||
59541097|NCT01445873|75639477|FG000|COMPLETED|Overall Study||36||
59541098|NCT01445873|75639477|FG000|NOT COMPLETED|Overall Study||0||
59541099|NCT01525667|75639484|FG000|STARTED|Overall Study||7||
59541100|NCT01525667|75639485|FG001|STARTED|Overall Study||6||
59541101|NCT01525667|75639486|FG002|STARTED|Overall Study||7||
59541102|NCT01525667|75639484|FG000|COMPLETED|Overall Study||7||
59541103|NCT01525667|75639485|FG001|COMPLETED|Overall Study||6||
59541104|NCT01525667|75639486|FG002|COMPLETED|Overall Study||7||
59541105|NCT01525667|75639484|FG000|NOT COMPLETED|Overall Study||0||
59541106|NCT01525667|75639485|FG001|NOT COMPLETED|Overall Study||0||
59541107|NCT01525667|75639486|FG002|NOT COMPLETED|Overall Study||0||
59541108|NCT01526213|75639502|FG000|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3||
59541109|NCT01526213|75639503|FG001|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3||
59541110|NCT01526213|75639504|FG002|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3||
59541111|NCT01526213|75639505|FG003|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3||
59541112|NCT01526213|75639506|FG004|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3||
59541113|NCT01526213|75639507|FG005|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to (and completed) one of six sequences.|3||
59541114|NCT01526213|75639502|FG000|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3||
59541115|NCT01526213|75639503|FG001|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3||
59635811|NCT01874262|75750668|FG000|Not Correctly Randomised|Overall Study||2||
59635812|NCT01874262|75750669|FG001|Not Correctly Randomised|Overall Study||0||
59635813|NCT01874262|75750668|FG000|Not Included Due to Tehnical Issues|Overall Study||3||
59635814|NCT01874262|75750669|FG001|Not Included Due to Tehnical Issues|Overall Study||3||
59635815|NCT01874262|75750668|FG000|COMPLETED|Overall Study||86||
59635816|NCT01874262|75750669|FG001|COMPLETED|Overall Study||80||
59635817|NCT01874262|75750668|FG000|NOT COMPLETED|Overall Study||5||
59635818|NCT01874262|75750669|FG001|NOT COMPLETED|Overall Study||3||
59635819|NCT01875510|75750677|FG000|STARTED|Overall Study||40||
59635820|NCT01875510|75750678|FG001|STARTED|Overall Study||40||
59635821|NCT01875510|75750677|FG000|COMPLETED|Overall Study||40||
59635822|NCT01875510|75750678|FG001|COMPLETED|Overall Study||40||
59635823|NCT01875510|75750677|FG000|NOT COMPLETED|Overall Study||0||
59635824|NCT01875510|75750678|FG001|NOT COMPLETED|Overall Study||0||
59635825|NCT01875978|75750686|FG000|STARTED|Study 4weeks||20||
59635826|NCT01875978|75750687|FG001|STARTED|Study 4weeks||20||
59635827|NCT01875978|75750686|FG000|COMPLETED|Study 4weeks||20||
59635828|NCT01875978|75750687|FG001|COMPLETED|Study 4weeks||20||
59635829|NCT01875978|75750686|FG000|NOT COMPLETED|Study 4weeks||0||
59635830|NCT01875978|75750687|FG001|NOT COMPLETED|Study 4weeks||0||
59635831|NCT01875978|75750686|FG000|STARTED|Washout 2 Weeks ,Crossover Study 4 Weeks||20||
59635832|NCT01875978|75750687|FG001|STARTED|Washout 2 Weeks ,Crossover Study 4 Weeks||20||
59635833|NCT01875978|75750686|FG000|COMPLETED|Washout 2 Weeks ,Crossover Study 4 Weeks||20||
59635834|NCT01875978|75750687|FG001|COMPLETED|Washout 2 Weeks ,Crossover Study 4 Weeks||20||
59635835|NCT01875978|75750686|FG000|NOT COMPLETED|Washout 2 Weeks ,Crossover Study 4 Weeks||0||
59635836|NCT01875978|75750687|FG001|NOT COMPLETED|Washout 2 Weeks ,Crossover Study 4 Weeks||0||
59635837|NCT01876212|75750697|FG000|STARTED|Overall Study||9||
59635838|NCT01876212|75750698|FG001|STARTED|Overall Study||6||
59635839|NCT01876212|75750697|FG000|COMPLETED|Overall Study||9||
59635840|NCT01876212|75750698|FG001|COMPLETED|Overall Study||6||
59635841|NCT01876212|75750697|FG000|NOT COMPLETED|Overall Study||0||
59635842|NCT01876212|75750698|FG001|NOT COMPLETED|Overall Study||0||
59635843|NCT01876992|75750706|FG000|STARTED|Overall Study||5||
59635844|NCT01876992|75750707|FG001|STARTED|Overall Study||5||
59635845|NCT01876992|75750706|FG000|COMPLETED|Overall Study||5||
59635846|NCT01876992|75750707|FG001|COMPLETED|Overall Study||5||
59635847|NCT01876992|75750706|FG000|NOT COMPLETED|Overall Study||0||
59635848|NCT01876992|75750707|FG001|NOT COMPLETED|Overall Study||0||
59635849|NCT01877148|75750716|FG000|STARTED|Overall Study||6||
59635850|NCT01877148|75750717|FG001|STARTED|Overall Study||6||
59635851|NCT01877148|75750716|FG000|COMPLETED|Overall Study||5||
59635852|NCT01877148|75750717|FG001|COMPLETED|Overall Study||5||
59635853|NCT01877148|75750716|FG000|NOT COMPLETED|Overall Study||1||
59635854|NCT01877148|75750717|FG001|NOT COMPLETED|Overall Study||1||
59635855|NCT01877538|75750723|FG000|STARTED|Overall Study||7||
59635856|NCT01877538|75750723|FG000|COMPLETED|Overall Study||7||
59635857|NCT01877538|75750723|FG000|NOT COMPLETED|Overall Study||0||
59635858|NCT01878006|75750727|FG000|STARTED|Study Session 1||5||
59635859|NCT01878006|75750728|FG001|STARTED|Study Session 1||5||
59635860|NCT01878006|75750727|FG000|COMPLETED|Study Session 1||5||
59635861|NCT01878006|75750728|FG001|COMPLETED|Study Session 1||5||
59635862|NCT01878006|75750727|FG000|NOT COMPLETED|Study Session 1||0||
59635863|NCT01878006|75750728|FG001|NOT COMPLETED|Study Session 1||0||
59635864|NCT01878006|75750727|FG000|STARTED|Study Session 2||5||
59635865|NCT01878006|75750728|FG001|STARTED|Study Session 2||5||
59635866|NCT01878006|75750727|FG000|COMPLETED|Study Session 2||5||
59635867|NCT01878006|75750728|FG001|COMPLETED|Study Session 2||5||
59635868|NCT01878006|75750727|FG000|NOT COMPLETED|Study Session 2||0||
59635869|NCT01878006|75750728|FG001|NOT COMPLETED|Study Session 2||0||
59635870|NCT01879176|75750736|FG000|STARTED|Overall Study||24||
59635871|NCT01879176|75750737|FG001|STARTED|Overall Study||22||
59635872|NCT01879176|75750736|FG000|COMPLETED|Overall Study||16||
59635873|NCT01879176|75750737|FG001|COMPLETED|Overall Study||16||
59635874|NCT01879176|75750736|FG000|NOT COMPLETED|Overall Study||8||
59635875|NCT01879176|75750737|FG001|NOT COMPLETED|Overall Study||6||
59635876|NCT01879332|75750746|FG000|STARTED|Overall Study||6||
59635877|NCT01879332|75750747|FG001|STARTED|Overall Study||6||
59635878|NCT01879332|75750748|FG002|STARTED|Overall Study||4||
59635879|NCT01879332|75750746|FG000|COMPLETED|Overall Study||0||
59635880|NCT01879332|75750747|FG001|COMPLETED|Overall Study||0||
59635881|NCT01879332|75750748|FG002|COMPLETED|Overall Study||0||
59635882|NCT01879332|75750746|FG000|NOT COMPLETED|Overall Study||6||
59635883|NCT01879332|75750747|FG001|NOT COMPLETED|Overall Study||6||
59635884|NCT01879332|75750748|FG002|NOT COMPLETED|Overall Study||4||
59635885|NCT03362112|75750756|FG000|STARTED|Overall Study||1713||
59635886|NCT03362112|75750756|FG000|COMPLETED|Overall Study||1622||
59635887|NCT03362112|75750756|FG000|NOT COMPLETED|Overall Study||91||
59635888|NCT03158298|75750760|FG000|STARTED|Overall Study||82||
59635889|NCT03158298|75750760|FG000|COMPLETED|Overall Study||82||
59635890|NCT03158298|75750760|FG000|NOT COMPLETED|Overall Study||0||
59635891|NCT02232282|75750766|FG000|STARTED|Overall Study||10||
59635892|NCT02232282|75750767|FG001|STARTED|Overall Study||12||
59635893|NCT02232282|75750766|FG000|COMPLETED|Overall Study||10||
59635894|NCT02232282|75750767|FG001|COMPLETED|Overall Study||11||
59635895|NCT02232282|75750766|FG000|NOT COMPLETED|Overall Study||0||
59635896|NCT02232282|75750767|FG001|NOT COMPLETED|Overall Study||1||
59635897|NCT01879800|75750779|FG000|STARTED|Overall Study||14||
59635898|NCT01879800|75750780|FG001|STARTED|Overall Study||30||
59635899|NCT01879800|75750779|FG000|COMPLETED|Overall Study||14||
59635900|NCT01879800|75750780|FG001|COMPLETED|Overall Study||26||
59635901|NCT01879800|75750779|FG000|NOT COMPLETED|Overall Study||0||
59635902|NCT01879800|75750780|FG001|NOT COMPLETED|Overall Study||4||
59635903|NCT04921332|75750786|FG000|STARTED|Overall Study||4||
59635904|NCT04921332|75750786|FG000|COMPLETED|Overall Study||4||
59635905|NCT04921332|75750786|FG000|NOT COMPLETED|Overall Study||0||
59635906|NCT04336332|75750794|FG000|STARTED|Overall Study||16||
59635907|NCT04336332|75750795|FG001|STARTED|Overall Study||30||
59635908|NCT04336332|75750796|FG002|STARTED|Overall Study||29||
59635909|NCT04336332|75750794|FG000|COMPLETED|Overall Study||16||
59635910|NCT04336332|75750795|FG001|COMPLETED|Overall Study||30||
59635911|NCT04336332|75750796|FG002|COMPLETED|Overall Study||29||
59635912|NCT04336332|75750794|FG000|NOT COMPLETED|Overall Study||0||
59635913|NCT04336332|75750795|FG001|NOT COMPLETED|Overall Study||0||
59635914|NCT04336332|75750796|FG002|NOT COMPLETED|Overall Study||0||
59635915|NCT03671148|75750806|FG000|STARTED|Overall Study||220||
59635916|NCT03671148|75750807|FG001|STARTED|Overall Study||224||
59635917|NCT03671148|75750806|FG000|Received Study Drug|Overall Study||219||
59635918|NCT03671148|75750807|FG001|Received Study Drug|Overall Study||224||
59635919|NCT03671148|75750806|FG000|COMPLETED|Overall Study||199|Completed Period 1 Study Participation|
59635920|NCT03671148|75750807|FG001|COMPLETED|Overall Study||215|Completed Period 1 Study Participation|
59635921|NCT03671148|75750806|FG000|NOT COMPLETED|Overall Study||21||
59635922|NCT03671148|75750807|FG001|NOT COMPLETED|Overall Study||9||
59635923|NCT01430442|75750821|FG000|STARTED|Overall Study||85||
59635924|NCT01430442|75750822|FG001|STARTED|Overall Study||68||
59635925|NCT01430442|75750823|FG002|STARTED|Overall Study||91||
59635926|NCT01430442|75750824|FG003|STARTED|Overall Study||90||
59635927|NCT01430442|75750825|FG004|STARTED|Overall Study||121||
59635928|NCT01430442|75750826|FG005|STARTED|Overall Study||92||
59635929|NCT01430442|75750827|FG006|STARTED|Overall Study||229||
59635930|NCT01430442|75750828|FG007|STARTED|Overall Study||109||
59635931|NCT01430442|75750821|FG000|COMPLETED|Overall Study||72||
59635932|NCT01430442|75750822|FG001|COMPLETED|Overall Study||62||
59635933|NCT01430442|75750823|FG002|COMPLETED|Overall Study||86||
59635934|NCT01430442|75750824|FG003|COMPLETED|Overall Study||86||
59635935|NCT01430442|75750825|FG004|COMPLETED|Overall Study||112||
59635936|NCT01430442|75750826|FG005|COMPLETED|Overall Study||84||
59635937|NCT01430442|75750827|FG006|COMPLETED|Overall Study||210||
59635938|NCT01430442|75750828|FG007|COMPLETED|Overall Study||100||
59635939|NCT01430442|75750821|FG000|NOT COMPLETED|Overall Study||13||
59541116|NCT01526213|75639504|FG002|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3||
59541117|NCT01526213|75639505|FG003|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3||
59541118|NCT01526213|75639506|FG004|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3||
59541119|NCT01526213|75639507|FG005|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3||
59541120|NCT01526213|75639502|FG000|NOT COMPLETED|Period 1 (5 Days)||0||
59541121|NCT01526213|75639503|FG001|NOT COMPLETED|Period 1 (5 Days)||0||
59635940|NCT01430442|75750822|FG001|NOT COMPLETED|Overall Study||6||
59635941|NCT01430442|75750823|FG002|NOT COMPLETED|Overall Study||5||
59635942|NCT01430442|75750824|FG003|NOT COMPLETED|Overall Study||4||
59635943|NCT01430442|75750825|FG004|NOT COMPLETED|Overall Study||9||
59635944|NCT01430442|75750826|FG005|NOT COMPLETED|Overall Study||8||
59541122|NCT01526213|75639504|FG002|NOT COMPLETED|Period 1 (5 Days)||0||
59541123|NCT01526213|75639505|FG003|NOT COMPLETED|Period 1 (5 Days)||0||
59541124|NCT01526213|75639506|FG004|NOT COMPLETED|Period 1 (5 Days)||0||
59541125|NCT01526213|75639507|FG005|NOT COMPLETED|Period 1 (5 Days)||0||
59541126|NCT01526213|75639502|FG000|STARTED|Washout 1 (10 Days)||3||
59541127|NCT01526213|75639503|FG001|STARTED|Washout 1 (10 Days)||3||
59541128|NCT01526213|75639504|FG002|STARTED|Washout 1 (10 Days)||3||
59541129|NCT01526213|75639505|FG003|STARTED|Washout 1 (10 Days)||3||
59541130|NCT01526213|75639506|FG004|STARTED|Washout 1 (10 Days)||3||
59541131|NCT01526213|75639507|FG005|STARTED|Washout 1 (10 Days)||3||
59541132|NCT01526213|75639502|FG000|COMPLETED|Washout 1 (10 Days)||3||
59635945|NCT01430442|75750827|FG006|NOT COMPLETED|Overall Study||19||
59635946|NCT01430442|75750828|FG007|NOT COMPLETED|Overall Study||9||
59635947|NCT01420926|75750848|FG000|STARTED|Overall Study||82||
59635948|NCT01420926|75750849|FG001|STARTED|Overall Study||81||
59635949|NCT01420926|75750848|FG000|COMPLETED|Overall Study||22||
59988367|NCT02268214|76103508|FG000|NOT COMPLETED|Overall Study||42||
59635950|NCT01420926|75750849|FG001|COMPLETED|Overall Study||18||
59635951|NCT01420926|75750848|FG000|NOT COMPLETED|Overall Study||60||
59635952|NCT01420926|75750849|FG001|NOT COMPLETED|Overall Study||63||
59635953|NCT01881828|75750857|FG000|STARTED|Overall Study|23 excluded at randomization from enrollment|71||
59635954|NCT01881828|75750858|FG001|STARTED|Overall Study|23 excluded from randomization from enrollment|69||
59635955|NCT01881828|75750857|FG000|COMPLETED|Overall Study||71||
59635956|NCT01881828|75750858|FG001|COMPLETED|Overall Study||69||
59635957|NCT01881828|75750857|FG000|NOT COMPLETED|Overall Study||0||
59635958|NCT01881828|75750858|FG001|NOT COMPLETED|Overall Study||0||
59635959|NCT01882062|75750864|FG000|STARTED|Overall Study|16th of may 2013|10||
59635960|NCT01882062|75750864|FG000|COMPLETED|Overall Study|18th of july 2013|10||
59635961|NCT01882062|75750864|FG000|NOT COMPLETED|Overall Study||0||
59635962|NCT01882764|75750870|FG000|STARTED|Overall Study||47||
59635963|NCT01882764|75750871|FG001|STARTED|Overall Study||19||
59635964|NCT01882764|75750870|FG000|COMPLETED|Overall Study||0||
59635965|NCT01882764|75750871|FG001|COMPLETED|Overall Study||1||
59635966|NCT01882764|75750870|FG000|NOT COMPLETED|Overall Study||47||
59635967|NCT01882764|75750871|FG001|NOT COMPLETED|Overall Study||18||
59635968|NCT01883856|75750879|FG000|STARTED|Overall Study||26||
59635969|NCT01883856|75750880|FG001|STARTED|Overall Study||26||
59635970|NCT01883856|75750879|FG000|COMPLETED|Overall Study||26||
59635971|NCT01883856|75750880|FG001|COMPLETED|Overall Study||26||
59635972|NCT01883856|75750879|FG000|NOT COMPLETED|Overall Study||0||
59635973|NCT01883856|75750880|FG001|NOT COMPLETED|Overall Study||0||
59635974|NCT01887132|75750886|FG000|STARTED|Overall Study||4||
59635975|NCT01887132|75750886|FG000|COMPLETED|Overall Study||4||
59635976|NCT01887132|75750886|FG000|NOT COMPLETED|Overall Study||0||
59635977|NCT01887990|75750894|FG000|STARTED|Overall Study||7||
59635978|NCT01887990|75750895|FG001|STARTED|Overall Study||7||
59635979|NCT01887990|75750896|FG002|STARTED|Overall Study||2||
59635980|NCT01887990|75750897|FG003|STARTED|Overall Study||2||
59635981|NCT01887990|75750894|FG000|COMPLETED|Overall Study||7||
59635982|NCT01887990|75750895|FG001|COMPLETED|Overall Study||7||
59635983|NCT01887990|75750896|FG002|COMPLETED|Overall Study||2||
59635984|NCT01887990|75750897|FG003|COMPLETED|Overall Study||2||
59635985|NCT01887990|75750894|FG000|NOT COMPLETED|Overall Study||0||
59635986|NCT01887990|75750895|FG001|NOT COMPLETED|Overall Study||0||
59635987|NCT01887990|75750896|FG002|NOT COMPLETED|Overall Study||0||
59635988|NCT01887990|75750897|FG003|NOT COMPLETED|Overall Study||0||
59635989|NCT01890642|75750912|FG000|STARTED|Overall Study||56||
59635990|NCT01890642|75750913|FG001|STARTED|Overall Study||53||
59635991|NCT01890642|75750914|FG002|STARTED|Overall Study||96||
59635992|NCT01890642|75750912|FG000|COMPLETED|Overall Study||56||
59635993|NCT01890642|75750913|FG001|COMPLETED|Overall Study||53||
59635994|NCT01890642|75750914|FG002|COMPLETED|Overall Study||96||
59635995|NCT01890642|75750912|FG000|NOT COMPLETED|Overall Study||0||
59635996|NCT01890642|75750913|FG001|NOT COMPLETED|Overall Study||0||
59635997|NCT01890642|75750914|FG002|NOT COMPLETED|Overall Study||0||
59635998|NCT01891734|75750924|FG000|STARTED|Overall Study||17||
59635999|NCT01891734|75750925|FG001|STARTED|Overall Study||16||
59636000|NCT01891734|75750924|FG000|COMPLETED|Overall Study||14||
59636001|NCT01891734|75750925|FG001|COMPLETED|Overall Study||13||
59636002|NCT01891734|75750924|FG000|NOT COMPLETED|Overall Study||3||
59636003|NCT01891734|75750925|FG001|NOT COMPLETED|Overall Study||3||
59636004|NCT01891968|75750933|FG000|STARTED|Overall Study||15||
59636005|NCT01891968|75750933|FG000|COMPLETED|Overall Study||15||
59636006|NCT01891968|75750933|FG000|NOT COMPLETED|Overall Study||0||
59636007|NCT01893372|75750939|FG000|STARTED|Overall Study||7||
59636008|NCT01893372|75750940|FG001|STARTED|Overall Study||22||
59636009|NCT01893372|75750939|FG000|COMPLETED|Overall Study||7||
59636010|NCT01893372|75750940|FG001|COMPLETED|Overall Study||22||
59636011|NCT01893372|75750939|FG000|NOT COMPLETED|Overall Study||0||
59636012|NCT01893372|75750940|FG001|NOT COMPLETED|Overall Study||0||
59636013|NCT01895088|75750946|FG000|STARTED|Overall Study|1 subject consented for monitoring after device removal (not included in cohort), per FDA request.|271||
59636014|NCT01895088|75750946|FG000|COMPLETED|Overall Study||253||
59636015|NCT01895088|75750946|FG000|NOT COMPLETED|Overall Study||18||
59636016|NCT01895634|75750950|FG000|STARTED|Overall Study||49||
59636017|NCT01895634|75750950|FG000|COMPLETED|Overall Study||46||
59636018|NCT01895634|75750950|FG000|NOT COMPLETED|Overall Study||3||
59636019|NCT01895946|75750956|FG000|STARTED|Overall Study||18||
59636020|NCT01895946|75750957|FG001|STARTED|Overall Study||12||
59636021|NCT01895946|75750956|FG000|COMPLETED|Overall Study||18||
59636022|NCT01895946|75750957|FG001|COMPLETED|Overall Study||12||
59636023|NCT01895946|75750956|FG000|NOT COMPLETED|Overall Study||0||
59636024|NCT01895946|75750957|FG001|NOT COMPLETED|Overall Study||0||
59636025|NCT01898754|75750965|FG000|STARTED|Overall Study||494||
59636026|NCT01898754|75750966|FG001|STARTED|Overall Study||497||
59636027|NCT01898754|75750965|FG000|COMPLETED|Overall Study||400||
59636028|NCT01898754|75750966|FG001|COMPLETED|Overall Study||403||
59636029|NCT01898754|75750965|FG000|NOT COMPLETED|Overall Study||94||
59636030|NCT01898754|75750966|FG001|NOT COMPLETED|Overall Study||94||
59636031|NCT01899300|75750972|FG000|STARTED|Overall Study||1|Patients 1-10, stent indwell for 8 weeks +/- 7 days.|
59636032|NCT01899300|75750973|FG001|STARTED|Overall Study||0|Patients 1-10, stent indwell for 8 weeks +/- 7 days.|
59636033|NCT01899300|75750972|FG000|COMPLETED|Overall Study||1||
59636034|NCT01899300|75750973|FG001|COMPLETED|Overall Study||0||
59636035|NCT01899300|75750972|FG000|NOT COMPLETED|Overall Study||0||
59636036|NCT01899300|75750973|FG001|NOT COMPLETED|Overall Study||0||
59636037|NCT01900392|75750982|FG000|STARTED|Overall Study||39||
59636038|NCT01900392|75750983|FG001|STARTED|Overall Study||75||
59541133|NCT01526213|75639503|FG001|COMPLETED|Washout 1 (10 Days)||3||
59541134|NCT01526213|75639504|FG002|COMPLETED|Washout 1 (10 Days)||3||
59541135|NCT01526213|75639505|FG003|COMPLETED|Washout 1 (10 Days)||3||
59541136|NCT01526213|75639506|FG004|COMPLETED|Washout 1 (10 Days)||3||
59541137|NCT01526213|75639507|FG005|COMPLETED|Washout 1 (10 Days)||3||
59541138|NCT01526213|75639502|FG000|NOT COMPLETED|Washout 1 (10 Days)||0||
59541139|NCT01526213|75639503|FG001|NOT COMPLETED|Washout 1 (10 Days)||0||
59541140|NCT01526213|75639504|FG002|NOT COMPLETED|Washout 1 (10 Days)||0||
59541141|NCT01526213|75639505|FG003|NOT COMPLETED|Washout 1 (10 Days)||0||
59541142|NCT01526213|75639506|FG004|NOT COMPLETED|Washout 1 (10 Days)||0||
59541143|NCT01526213|75639507|FG005|NOT COMPLETED|Washout 1 (10 Days)||0||
59541144|NCT01526213|75639502|FG000|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3||
59541145|NCT01526213|75639503|FG001|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3||
59541146|NCT01526213|75639504|FG002|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3||
59541147|NCT01526213|75639505|FG003|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3||
59541148|NCT01526213|75639506|FG004|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3||
59541149|NCT01526213|75639507|FG005|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3||
59541150|NCT01526213|75639502|FG000|COMPLETED|Period 2 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3||
59541151|NCT01526213|75639503|FG001|COMPLETED|Period 2 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3||
59541152|NCT01526213|75639504|FG002|COMPLETED|Period 2 (5 Days)|3-way crossover study. Each subject was his/her own control and underwent all 3 treatments.|3||
59541153|NCT01526213|75639505|FG003|COMPLETED|Period 2 (5 Days)|3-way crossover study. Each subject was his/her own control and underwent all 3 treatments.|3||
59541154|NCT01526213|75639506|FG004|COMPLETED|Period 2 (5 Days)|3-way crossover study. Each subject was his/her own control and underwent all 3 treatments.|3||
59541155|NCT01526213|75639507|FG005|COMPLETED|Period 2 (5 Days)|3-way crossover study. Each subject was his/her own control and underwent all 3 treatments.|3||
59541156|NCT01526213|75639502|FG000|NOT COMPLETED|Period 2 (5 Days)||0||
59541157|NCT01526213|75639503|FG001|NOT COMPLETED|Period 2 (5 Days)||0||
59541158|NCT01526213|75639504|FG002|NOT COMPLETED|Period 2 (5 Days)||0||
59541159|NCT01526213|75639505|FG003|NOT COMPLETED|Period 2 (5 Days)||0||
59541160|NCT01526213|75639506|FG004|NOT COMPLETED|Period 2 (5 Days)||0||
59541161|NCT01526213|75639507|FG005|NOT COMPLETED|Period 2 (5 Days)||0||
59541162|NCT01526213|75639502|FG000|STARTED|Washout 2 (10 Days)||3||
59541163|NCT01526213|75639503|FG001|STARTED|Washout 2 (10 Days)||3||
59541164|NCT01526213|75639504|FG002|STARTED|Washout 2 (10 Days)||3||
59541165|NCT01526213|75639505|FG003|STARTED|Washout 2 (10 Days)||3||
59541166|NCT01526213|75639506|FG004|STARTED|Washout 2 (10 Days)||3||
59541167|NCT01526213|75639507|FG005|STARTED|Washout 2 (10 Days)||3||
59541168|NCT01526213|75639502|FG000|COMPLETED|Washout 2 (10 Days)||3||
59541169|NCT01526213|75639503|FG001|COMPLETED|Washout 2 (10 Days)||3||
59541170|NCT01526213|75639504|FG002|COMPLETED|Washout 2 (10 Days)||3||
59541171|NCT01526213|75639505|FG003|COMPLETED|Washout 2 (10 Days)||3||
59541172|NCT01526213|75639506|FG004|COMPLETED|Washout 2 (10 Days)||3||
59541173|NCT01526213|75639507|FG005|COMPLETED|Washout 2 (10 Days)||3||
59541174|NCT01526213|75639502|FG000|NOT COMPLETED|Washout 2 (10 Days)||0||
59541175|NCT01526213|75639503|FG001|NOT COMPLETED|Washout 2 (10 Days)||0||
59541176|NCT01526213|75639504|FG002|NOT COMPLETED|Washout 2 (10 Days)||0||
59541177|NCT01526213|75639505|FG003|NOT COMPLETED|Washout 2 (10 Days)||0||
59541178|NCT01526213|75639506|FG004|NOT COMPLETED|Washout 2 (10 Days)||0||
59541179|NCT01526213|75639507|FG005|NOT COMPLETED|Washout 2 (10 Days)||0||
59541180|NCT01526213|75639502|FG000|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3||
59541181|NCT01526213|75639503|FG001|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3||
59541182|NCT01526213|75639504|FG002|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3||
59541183|NCT01526213|75639505|FG003|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3||
59541184|NCT01526213|75639506|FG004|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3||
59541185|NCT01526213|75639507|FG005|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3||
59541186|NCT01526213|75639502|FG000|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3||
59541187|NCT01526213|75639503|FG001|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3||
59541188|NCT01526213|75639504|FG002|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3||
59541189|NCT01526213|75639505|FG003|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3||
59541190|NCT01526213|75639506|FG004|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3||
59541191|NCT01526213|75639507|FG005|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3||
59541192|NCT01526213|75639502|FG000|NOT COMPLETED|Period 3 (5 Days)||0||
59541193|NCT01526213|75639503|FG001|NOT COMPLETED|Period 3 (5 Days)||0||
59541194|NCT01526213|75639504|FG002|NOT COMPLETED|Period 3 (5 Days)||0||
59541195|NCT01526213|75639505|FG003|NOT COMPLETED|Period 3 (5 Days)||0||
59636039|NCT01900392|75750984|FG002|STARTED|Overall Study||77||
59636040|NCT01900392|75750982|FG000|COMPLETED|Overall Study||38||
59636041|NCT01900392|75750983|FG001|COMPLETED|Overall Study||74||
59636042|NCT01900392|75750984|FG002|COMPLETED|Overall Study||77||
59636043|NCT01900392|75750982|FG000|NOT COMPLETED|Overall Study||1||
59636044|NCT01900392|75750983|FG001|NOT COMPLETED|Overall Study||1||
59636045|NCT01900392|75750984|FG002|NOT COMPLETED|Overall Study||0||
59636046|NCT01900704|75750995|FG000|STARTED|Overall Study||270||
59636047|NCT01900704|75750996|FG001|STARTED|Overall Study||270||
59636048|NCT01900704|75750997|FG002|STARTED|Overall Study||270||
59636049|NCT01900704|75750995|FG000|COMPLETED|Overall Study||229||
59636050|NCT01900704|75750996|FG001|COMPLETED|Overall Study||235||
59636051|NCT01900704|75750997|FG002|COMPLETED|Overall Study||237||
59636052|NCT01900704|75750995|FG000|NOT COMPLETED|Overall Study||41||
59636053|NCT01900704|75750996|FG001|NOT COMPLETED|Overall Study||35||
59636054|NCT01900704|75750997|FG002|NOT COMPLETED|Overall Study||33||
59636055|NCT01901250|75751008|FG000|STARTED|Overall Study||260||
59636056|NCT01901250|75751009|FG001|STARTED|Overall Study||265||
59636057|NCT01901250|75751008|FG000|End of Kidergarten|Overall Study||215||
59636058|NCT01901250|75751009|FG001|End of Kidergarten|Overall Study||212||
59636059|NCT01901250|75751008|FG000|Start of 1st Grade|Overall Study||173||
59636060|NCT01901250|75751009|FG001|Start of 1st Grade|Overall Study||176||
59636061|NCT01901250|75751008|FG000|End of 1st Grade|Overall Study||143||
59636062|NCT01901250|75751009|FG001|End of 1st Grade|Overall Study||151||
59636063|NCT01901250|75751008|FG000|COMPLETED|Overall Study||122||
59636064|NCT01901250|75751009|FG001|COMPLETED|Overall Study||139||
59636065|NCT01901250|75751008|FG000|NOT COMPLETED|Overall Study||138||
59636066|NCT01901250|75751009|FG001|NOT COMPLETED|Overall Study||126||
59636067|NCT01904448|75751015|FG000|STARTED|Overall Study||5||
59636068|NCT01904448|75751015|FG000|COMPLETED|Overall Study||5||
59636069|NCT01904448|75751015|FG000|NOT COMPLETED|Overall Study||0||
59636070|NCT01904526|75751020|FG000|STARTED|Overall Study||5||
59636071|NCT01904526|75751020|FG000|COMPLETED|Overall Study||5||
59636072|NCT01904526|75751020|FG000|NOT COMPLETED|Overall Study||0||
59636073|NCT01906866|75751030|FG000|STARTED|Overall Study||60||
59636074|NCT01906866|75751031|FG001|STARTED|Overall Study||65||
59636075|NCT01906866|75751030|FG000|COMPLETED|Overall Study||51||
59636076|NCT01906866|75751031|FG001|COMPLETED|Overall Study||44||
59636077|NCT01906866|75751030|FG000|NOT COMPLETED|Overall Study||9||
59636078|NCT01906866|75751031|FG001|NOT COMPLETED|Overall Study||21||
59636079|NCT01907334|75751040|FG000|STARTED|Overall Study||6||
59636080|NCT01907334|75751041|FG001|STARTED|Overall Study||4||
59636081|NCT01907334|75751040|FG000|COMPLETED|Overall Study||6||
59636082|NCT01907334|75751041|FG001|COMPLETED|Overall Study||4||
59636083|NCT01907334|75751040|FG000|NOT COMPLETED|Overall Study||0||
59636084|NCT01907334|75751041|FG001|NOT COMPLETED|Overall Study||0||
59636085|NCT01907490|75751046|FG000|STARTED|Overall Study||38||
59636086|NCT01907490|75751046|FG000|COMPLETED|Overall Study||38||
59636087|NCT01907490|75751046|FG000|NOT COMPLETED|Overall Study||0||
59636088|NCT01908972|75751053|FG000|STARTED|Overall Study||17||
59636089|NCT01908972|75751054|FG001|STARTED|Overall Study||17||
59636090|NCT01908972|75751053|FG000|COMPLETED|Overall Study||15||
59636091|NCT01908972|75751054|FG001|COMPLETED|Overall Study||17||
59636092|NCT01908972|75751053|FG000|NOT COMPLETED|Overall Study||2||
59636093|NCT01908972|75751054|FG001|NOT COMPLETED|Overall Study||0||
59636094|NCT01910064|75751060|FG000|STARTED|Overall Study||436||
59636095|NCT01910064|75751060|FG000|COMPLETED|Overall Study||391||
59636096|NCT01910064|75751060|FG000|NOT COMPLETED|Overall Study||45||
59636097|NCT01910688|75751064|FG000|STARTED|Overall Study||25||
59636098|NCT01910688|75751064|FG000|3.5month|Overall Study||25||
59636099|NCT01910688|75751064|FG000|2nd RFA Treatment|Overall Study||22||
59636100|NCT01910688|75751064|FG000|7.5months|Overall Study||24||
59636101|NCT01910688|75751064|FG000|3rd RFA Treatment|Overall Study||18||
59636102|NCT01910688|75751064|FG000|12months|Overall Study||22||
59636103|NCT01910688|75751064|FG000|COMPLETED|Overall Study||20||
59636104|NCT01910688|75751064|FG000|NOT COMPLETED|Overall Study||5||
59636105|NCT01911390|75751072|FG000|STARTED|Overall Study||10||
59636106|NCT01911390|75751073|FG001|STARTED|Overall Study||10||
59636107|NCT01911390|75751074|FG002|STARTED|Overall Study||10||
59636108|NCT01911390|75751075|FG003|STARTED|Overall Study||11||
59636109|NCT01911390|75751072|FG000|COMPLETED|Overall Study||9||
59636110|NCT01911390|75751073|FG001|COMPLETED|Overall Study||10||
59636111|NCT01911390|75751074|FG002|COMPLETED|Overall Study||9||
59636112|NCT01911390|75751075|FG003|COMPLETED|Overall Study||10||
59636113|NCT01911390|75751072|FG000|NOT COMPLETED|Overall Study||1||
59636114|NCT01911390|75751073|FG001|NOT COMPLETED|Overall Study||0||
59636115|NCT01911390|75751074|FG002|NOT COMPLETED|Overall Study||1||
59636116|NCT01911390|75751075|FG003|NOT COMPLETED|Overall Study||1||
59636117|NCT01912716|75751087|FG000|STARTED|Overall Study|receipt of 1st dose of indomethacin|522||
59636118|NCT01912716|75751088|FG001|STARTED|Overall Study||515||
59636119|NCT01912716|75751087|FG000|Receipt of 2nd Dose|Overall Study||511||
59636120|NCT01912716|75751088|FG001|Receipt of 2nd Dose|Overall Study||503||
59636121|NCT01912716|75751087|FG000|5-day Follow-up|Overall Study||522||
59636122|NCT01912716|75751088|FG001|5-day Follow-up|Overall Study||515||
59636123|NCT01912716|75751087|FG000|3-day Follow-up|Overall Study||521||
59636124|NCT01912716|75751088|FG001|3-day Follow-up|Overall Study||513||
59636125|NCT01912716|75751087|FG000|COMPLETED|Overall Study||522||
59636126|NCT01912716|75751088|FG001|COMPLETED|Overall Study||515||
59636127|NCT01912716|75751087|FG000|NOT COMPLETED|Overall Study||0||
59636128|NCT01912716|75751088|FG001|NOT COMPLETED|Overall Study||0||
59636129|NCT01914510|75751096|FG000|STARTED|Overall Study||40||
59636130|NCT01914510|75751096|FG000|COMPLETED|Overall Study||38||
59636131|NCT01914510|75751096|FG000|NOT COMPLETED|Overall Study||2||
59636132|NCT01916928|75751101|FG000|STARTED|Overall Study||50||
59636133|NCT01916928|75751101|FG000|COMPLETED|Overall Study||50||
59636134|NCT01916928|75751101|FG000|NOT COMPLETED|Overall Study||0||
59636135|NCT01918800|75751107|FG000|STARTED|Overall Study||109||
59636136|NCT01918800|75751108|FG001|STARTED|Overall Study||109||
59636137|NCT01918800|75751107|FG000|COMPLETED|Overall Study||100||
59636138|NCT01918800|75751108|FG001|COMPLETED|Overall Study||104||
59636139|NCT01918800|75751107|FG000|NOT COMPLETED|Overall Study||9||
59636140|NCT01918800|75751108|FG001|NOT COMPLETED|Overall Study||5||
59636141|NCT01920282|75751117|FG000|STARTED|Overall Study||15||
59636142|NCT01920282|75751118|FG001|STARTED|Overall Study||15||
59636143|NCT01920282|75751119|FG002|STARTED|Overall Study||15||
59636144|NCT01920282|75751117|FG000|COMPLETED|Overall Study||15||
59636145|NCT01920282|75751118|FG001|COMPLETED|Overall Study||15||
59636146|NCT01920282|75751119|FG002|COMPLETED|Overall Study||15||
59636147|NCT01920282|75751117|FG000|NOT COMPLETED|Overall Study||0||
59636148|NCT01920282|75751118|FG001|NOT COMPLETED|Overall Study||0||
59636149|NCT01920282|75751119|FG002|NOT COMPLETED|Overall Study||0||
59636150|NCT01921296|75751127|FG000|STARTED|Overall Study||2||
59636151|NCT01921296|75751127|FG000|COMPLETED|Overall Study||2||
59636152|NCT01921296|75751127|FG000|NOT COMPLETED|Overall Study||0||
59636153|NCT01921452|75751131|FG000|STARTED|Overall Study||283||
59636154|NCT01921452|75751131|FG000|COMPLETED|Overall Study||283||
59636155|NCT01921452|75751131|FG000|NOT COMPLETED|Overall Study||0||
59636156|NCT01929642|75751136|FG000|STARTED|Overall Study||3||
59636157|NCT01929642|75751136|FG000|COMPLETED|Overall Study||1||
59636158|NCT01929642|75751136|FG000|NOT COMPLETED|Overall Study||2||
59636159|NCT01932060|75751144|FG000|STARTED|Overall Study||27||
59636160|NCT01932060|75751145|FG001|STARTED|Overall Study||24||
59636161|NCT01932060|75751144|FG000|COMPLETED|Overall Study||27||
59636162|NCT01932060|75751145|FG001|COMPLETED|Overall Study||24||
59636163|NCT01932060|75751144|FG000|NOT COMPLETED|Overall Study||0||
59636164|NCT01932060|75751145|FG001|NOT COMPLETED|Overall Study||0||
59636165|NCT01932606|75751153|FG000|STARTED|Overall Study||14||
59636166|NCT01932606|75751154|FG001|STARTED|Overall Study||14||
59636167|NCT01932606|75751153|FG000|COMPLETED|Overall Study||14||
59636168|NCT01932606|75751154|FG001|COMPLETED|Overall Study||14||
59636169|NCT01932606|75751153|FG000|NOT COMPLETED|Overall Study||0||
59636170|NCT01932606|75751154|FG001|NOT COMPLETED|Overall Study||0||
59636171|NCT01933230|75751160|FG000|STARTED|Overall Study||2||
59636172|NCT01933230|75751160|FG000|COMPLETED|Overall Study||2||
59636173|NCT01933230|75751160|FG000|NOT COMPLETED|Overall Study||0||
59636174|NCT01933464|75751166|FG000|STARTED|Overall Study||5||
59636175|NCT01933464|75751167|FG001|STARTED|Overall Study||5||
59636176|NCT01933464|75751166|FG000|COMPLETED|Overall Study||5||
59636177|NCT01933464|75751167|FG001|COMPLETED|Overall Study||5||
59636178|NCT01933464|75751166|FG000|NOT COMPLETED|Overall Study||0||
59636179|NCT01933464|75751167|FG001|NOT COMPLETED|Overall Study||0||
59636180|NCT01933776|75751175|FG000|STARTED|Overall Study||20||
59636181|NCT01933776|75751176|FG001|STARTED|Overall Study||20||
59636182|NCT01933776|75751175|FG000|COMPLETED|Overall Study||20||
59636183|NCT01933776|75751176|FG001|COMPLETED|Overall Study||20||
59636184|NCT01933776|75751175|FG000|NOT COMPLETED|Overall Study||0||
59636185|NCT01933776|75751176|FG001|NOT COMPLETED|Overall Study||0||
59636186|NCT01935180|75751184|FG000|STARTED|Overall Study||573||
59636187|NCT01935180|75751185|FG001|STARTED|Overall Study||575||
59636188|NCT01935180|75751184|FG000|COMPLETED|Overall Study||552||
59636189|NCT01935180|75751185|FG001|COMPLETED|Overall Study||561||
59636190|NCT01935180|75751184|FG000|NOT COMPLETED|Overall Study||21||
59636191|NCT01935180|75751185|FG001|NOT COMPLETED|Overall Study||14||
59636192|NCT01936662|75751193|FG000|STARTED|Overall Study||42||
59636193|NCT01936662|75751194|FG001|STARTED|Overall Study||42||
59636194|NCT01936662|75751193|FG000|COMPLETED|Overall Study||42||
59636195|NCT01936662|75751194|FG001|COMPLETED|Overall Study||42||
59636196|NCT01936662|75751193|FG000|NOT COMPLETED|Overall Study||0||
59636197|NCT01936662|75751194|FG001|NOT COMPLETED|Overall Study||0||
59636198|NCT01936896|75751202|FG000|STARTED|Overall Study||10||
59636199|NCT01936896|75751202|FG000|COMPLETED|Overall Study||10||
59636200|NCT01936896|75751202|FG000|NOT COMPLETED|Overall Study||0||
59636201|NCT01937520|75751208|FG000|STARTED|Overall Study||11||
59636202|NCT01937520|75751209|FG001|STARTED|Overall Study||9||
59636203|NCT01937520|75751208|FG000|COMPLETED|Overall Study||11||
59636204|NCT01937520|75751209|FG001|COMPLETED|Overall Study||9||
59636205|NCT01937520|75751208|FG000|NOT COMPLETED|Overall Study||0||
59636206|NCT01937520|75751209|FG001|NOT COMPLETED|Overall Study||0||
59636207|NCT01937598|75751216|FG000|STARTED|Overall Study||8||
59636208|NCT01937598|75751217|FG001|STARTED|Overall Study||8||
59636209|NCT01937598|75751216|FG000|COMPLETED|Overall Study||8||
59636210|NCT01937598|75751217|FG001|COMPLETED|Overall Study||8||
59636211|NCT01937598|75751216|FG000|NOT COMPLETED|Overall Study||0||
59636212|NCT01937598|75751217|FG001|NOT COMPLETED|Overall Study||0||
59636213|NCT01938066|75751225|FG000|STARTED|Overall Study||15||
59636214|NCT01938066|75751226|FG001|STARTED|Overall Study||15||
59636215|NCT01938066|75751225|FG000|COMPLETED|Overall Study||14||
59636216|NCT01938066|75751226|FG001|COMPLETED|Overall Study||13||
59636217|NCT01938066|75751225|FG000|NOT COMPLETED|Overall Study||1||
59636218|NCT01938066|75751226|FG001|NOT COMPLETED|Overall Study||2||
59636219|NCT01938378|75751235|FG000|STARTED|Overall Study||41||
59636220|NCT01938378|75751235|FG000|COMPLETED|Overall Study||41||
59636221|NCT01938378|75751235|FG000|NOT COMPLETED|Overall Study||0||
59636222|NCT01939938|75751253|FG000|STARTED|Overall Study||10||
59636223|NCT01939938|75751253|FG000|COMPLETED|Overall Study||10||
59636224|NCT01939938|75751253|FG000|NOT COMPLETED|Overall Study||0||
59636225|NCT01942668|75751264|FG000|STARTED|Overall Study||418|Number of subjects started reflects total number of subjects randomized per arm.|
59636226|NCT01942668|75751265|FG001|STARTED|Overall Study||426|Number of subjects started reflects total number of subjects randomized per arm.|
59636227|NCT01942668|75751266|FG002|STARTED|Overall Study||422|Number of subjects started reflects total number of subjects randomized per arm.|
59636228|NCT01942668|75751267|FG003|STARTED|Overall Study||427|Number of subjects started reflects total number of subjects randomized per arm.|
59636229|NCT01942668|75751268|FG004|STARTED|Overall Study||152|Number of subjects started reflects total number of subjects randomized per arm.|
59636230|NCT01942668|75751264|FG000|COMPLETED|Overall Study||284||
59636231|NCT01942668|75751265|FG001|COMPLETED|Overall Study||305||
59636232|NCT01942668|75751266|FG002|COMPLETED|Overall Study||312||
59636233|NCT01942668|75751267|FG003|COMPLETED|Overall Study||281||
59636234|NCT01942668|75751268|FG004|COMPLETED|Overall Study||93||
59636235|NCT01942668|75751264|FG000|NOT COMPLETED|Overall Study||134||
59636236|NCT01942668|75751265|FG001|NOT COMPLETED|Overall Study||121||
59636237|NCT01942668|75751266|FG002|NOT COMPLETED|Overall Study||110||
59636238|NCT01942668|75751267|FG003|NOT COMPLETED|Overall Study||146||
59636239|NCT01942668|75751268|FG004|NOT COMPLETED|Overall Study||59||
59636240|NCT01944930|75751287|FG000|STARTED|Overall Study||12||
59636241|NCT01944930|75751288|FG001|STARTED|Overall Study||11||
59636242|NCT01944930|75751287|FG000|COMPLETED|Overall Study||10||
59636243|NCT01944930|75751288|FG001|COMPLETED|Overall Study||10||
59636244|NCT01944930|75751287|FG000|NOT COMPLETED|Overall Study||2||
59636245|NCT01944930|75751288|FG001|NOT COMPLETED|Overall Study||1||
59636246|NCT01947816|75751294|FG000|STARTED|Overall Study||1593|Number of participants with CRFs attained|
59636247|NCT01947816|75751294|FG000|COMPLETED|Overall Study||1523|Number of participants not excluded from the safety and/or efficacy analysis sets|
59636248|NCT01947816|75751294|FG000|NOT COMPLETED|Overall Study||70||
59636249|NCT01948518|75751298|FG000|STARTED|Overall Study||15||
59636250|NCT01948518|75751298|FG000|COMPLETED|Overall Study||15||
59636251|NCT01948518|75751298|FG000|NOT COMPLETED|Overall Study||0||
59636252|NCT01948986|75751307|FG000|STARTED|Overall Study||6||
59636253|NCT01948986|75751308|FG001|STARTED|Overall Study||8||
59636254|NCT01948986|75751309|FG002|STARTED|Overall Study||8||
59636255|NCT01948986|75751310|FG003|STARTED|Overall Study||6||
59636256|NCT01948986|75751311|FG004|STARTED|Overall Study||8||
59636257|NCT01948986|75751307|FG000|COMPLETED|Overall Study||6||
59636258|NCT01948986|75751308|FG001|COMPLETED|Overall Study||8||
59636259|NCT01948986|75751309|FG002|COMPLETED|Overall Study||8||
59636260|NCT01948986|75751310|FG003|COMPLETED|Overall Study||6||
59636261|NCT01948986|75751311|FG004|COMPLETED|Overall Study||8||
59636262|NCT01948986|75751307|FG000|NOT COMPLETED|Overall Study||0||
59636263|NCT01948986|75751308|FG001|NOT COMPLETED|Overall Study||0||
59636264|NCT01948986|75751309|FG002|NOT COMPLETED|Overall Study||0||
59636265|NCT01948986|75751310|FG003|NOT COMPLETED|Overall Study||0||
59636266|NCT01948986|75751311|FG004|NOT COMPLETED|Overall Study||0||
59636267|NCT01949844|75751323|FG000|STARTED|Overall Study||44||
59636268|NCT01949844|75751323|FG000|COMPLETED|Overall Study||44||
59636269|NCT01949844|75751323|FG000|NOT COMPLETED|Overall Study||0||
59636270|NCT01950078|75751329|FG000|STARTED|Overall Study||1025||
59636271|NCT01950078|75751330|FG001|STARTED|Overall Study||508||
59636272|NCT01950078|75751329|FG000|COMPLETED|Overall Study||1005||
59636273|NCT01950078|75751330|FG001|COMPLETED|Overall Study||496||
59636274|NCT01950078|75751329|FG000|NOT COMPLETED|Overall Study||20||
59636275|NCT01950078|75751330|FG001|NOT COMPLETED|Overall Study||12||
59636276|NCT01950780|75751336|FG000|STARTED|Overall Study||12||
59636277|NCT01950780|75751336|FG000|COMPLETED|Overall Study||12||
59636278|NCT01950780|75751336|FG000|NOT COMPLETED|Overall Study||0||
59636279|NCT01951326|75751343|FG000|STARTED|Overall Study||166||
59636280|NCT01951326|75751344|FG001|STARTED|Overall Study||165||
59636281|NCT01951326|75751343|FG000|COMPLETED|Overall Study||87||
59636282|NCT01951326|75751344|FG001|COMPLETED|Overall Study||87||
59636283|NCT01951326|75751343|FG000|NOT COMPLETED|Overall Study||79||
59636284|NCT01951326|75751344|FG001|NOT COMPLETED|Overall Study||78||
59636285|NCT01951950|75751353|FG000|STARTED|Overall Study||26||
59636286|NCT01951950|75751354|FG001|STARTED|Overall Study||26||
59636287|NCT01951950|75751353|FG000|COMPLETED|Overall Study||20||
59636288|NCT01951950|75751354|FG001|COMPLETED|Overall Study||20||
59636289|NCT01951950|75751353|FG000|NOT COMPLETED|Overall Study||6||
59636290|NCT01951950|75751354|FG001|NOT COMPLETED|Overall Study||6||
59636291|NCT01952418|75751362|FG000|STARTED|Overall Study||910||
59636292|NCT01952418|75751363|FG001|STARTED|Overall Study||895||
59636293|NCT01952418|75751362|FG000|COMPLETED|Overall Study||910||
59636294|NCT01952418|75751363|FG001|COMPLETED|Overall Study||895||
59636295|NCT01952418|75751362|FG000|NOT COMPLETED|Overall Study||0||
59636296|NCT01952418|75751363|FG001|NOT COMPLETED|Overall Study||0||
59636297|NCT01953432|75751371|FG000|STARTED|Overall Study||22||
59636298|NCT01953432|75751372|FG001|STARTED|Overall Study||21||
59636299|NCT01953432|75751371|FG000|COMPLETED|Overall Study||8||
59636300|NCT01953432|75751372|FG001|COMPLETED|Overall Study||6||
59636301|NCT01953432|75751371|FG000|NOT COMPLETED|Overall Study||14||
59636302|NCT01953432|75751372|FG001|NOT COMPLETED|Overall Study||15||
59636303|NCT01955382|75751380|FG000|STARTED|Overall Study||35||
59636304|NCT01955382|75751381|FG001|STARTED|Overall Study||35||
59636305|NCT01955382|75751380|FG000|COMPLETED|Overall Study||35||
59636306|NCT01955382|75751381|FG001|COMPLETED|Overall Study||35||
59636307|NCT01955382|75751380|FG000|NOT COMPLETED|Overall Study||0||
59636308|NCT01955382|75751381|FG001|NOT COMPLETED|Overall Study||0||
59636309|NCT01957410|75751388|FG000|STARTED|Open Label||13||
59636310|NCT01957410|75751388|FG000|COMPLETED|Open Label||13||
59636311|NCT01957410|75751388|FG000|NOT COMPLETED|Open Label||0||
59636312|NCT01957410|75751388|FG000|STARTED|Optional Open Label||13||
59636313|NCT01957410|75751388|FG000|COMPLETED|Optional Open Label||13||
59636314|NCT01957410|75751388|FG000|NOT COMPLETED|Optional Open Label||0||
59636315|NCT01958112|75751392|FG000|STARTED|Overall Study||14||
59636316|NCT01958112|75751392|FG000|COMPLETED|Overall Study||14||
59636317|NCT01958112|75751392|FG000|NOT COMPLETED|Overall Study||0||
59636318|NCT01958346|75751398|FG000|STARTED|Overall Study||39||
59636319|NCT01958346|75751399|FG001|STARTED|Overall Study||39||
59636320|NCT01958346|75751398|FG000|COMPLETED|Overall Study||39||
59636321|NCT01958346|75751399|FG001|COMPLETED|Overall Study||39||
59636322|NCT01958346|75751398|FG000|NOT COMPLETED|Overall Study||0||
59636323|NCT01958346|75751399|FG001|NOT COMPLETED|Overall Study||0||
59636324|NCT04303572|75751405|FG000|STARTED|Overall Study||1||
59636325|NCT04303572|75751405|FG000|COMPLETED|Overall Study||0||
59636326|NCT04303572|75751405|FG000|NOT COMPLETED|Overall Study||1||
59636327|NCT03849066|75751409|FG000|STARTED|Overall Study||136||
59636328|NCT03849066|75751409|FG000|COMPLETED|Overall Study||123||
59636329|NCT03849066|75751409|FG000|NOT COMPLETED|Overall Study||13||
59636330|NCT03834168|75751415|FG000|STARTED|Overall Study||19|42 participants started the study; 19 Lean and 23 Obese|
59636331|NCT03834168|75751416|FG001|STARTED|Overall Study||23|42 participants started the study; 19 Lean and 23 Obese|
59636332|NCT03834168|75751415|FG000|Total Participant Screened for the Purpose of Eligibility|Overall Study||22|52 Participants were screened for the eligibilty|
59636333|NCT03834168|75751416|FG001|Total Participant Screened for the Purpose of Eligibility|Overall Study||30|52 Participants were screened for the eligibilty|
59636334|NCT03834168|75751415|FG000|Ineligible Participants|Overall Study||3|10 participants determined ineligible by screening labs|
59636335|NCT03834168|75751416|FG001|Ineligible Participants|Overall Study||7|10 participants determined ineligible by screening labs|
59636336|NCT03834168|75751415|FG000|Unable to Complete the Protocol|Overall Study||0||
59636337|NCT03834168|75751416|FG001|Unable to Complete the Protocol|Overall Study||1||
59636338|NCT03834168|75751415|FG000|Study Dropouts|Overall Study||1||
59636339|NCT03834168|75751416|FG001|Study Dropouts|Overall Study||0||
59636340|NCT03834168|75751415|FG000|Participants Received 5 Days of Standardized Meals|Overall Study||19|42 participants received 5 days of standardized meals to control the salt intake|
59636341|NCT03834168|75751416|FG001|Participants Received 5 Days of Standardized Meals|Overall Study||23|42 participants received 5 days of standardized meals to control the salt intake|
59636342|NCT03834168|75751415|FG000|Participants Returned for the 24-h Inpatient Protocol|Overall Study||18|41 participants returned for the 24-h inpatient protocol|
59636343|NCT03834168|75751416|FG001|Participants Returned for the 24-h Inpatient Protocol|Overall Study||23|41 participants returned for the 24-h inpatient protocol|
59636344|NCT03834168|75751415|FG000|COMPLETED|Overall Study||18|40 participants completed the study; 18 Lean and 22 Obese|
59636345|NCT03834168|75751416|FG001|COMPLETED|Overall Study||22|40 participants completed the study; 18 Lean and 22 Obese|
59636346|NCT03834168|75751415|FG000|NOT COMPLETED|Overall Study||1||
59636347|NCT03834168|75751416|FG001|NOT COMPLETED|Overall Study||1||
59636348|NCT03692208|75751424|FG000|STARTED|Overall Study|randomized to arm|57||
59636349|NCT03692208|75751425|FG001|STARTED|Overall Study|randomized to arm|53||
59636350|NCT03692208|75751424|FG000|Received Allocated Intervention|Overall Study||42|Received Allocated Intervention|
59636351|NCT03692208|75751425|FG001|Received Allocated Intervention|Overall Study||33|Received Allocated Intervention|
59636352|NCT03692208|75751424|FG000|Follow-Up Survey|Overall Study||41||
59636353|NCT03692208|75751425|FG001|Follow-Up Survey|Overall Study||25||
59636354|NCT03692208|75751424|FG000|COMPLETED|Overall Study|3 participants excluded from final analysis|50|Excluded from final analysis: withdrawn participants|
59636355|NCT03692208|75751425|FG001|COMPLETED|Overall Study|7 participants excluded from final analysis|50|Excluded from final analysis: withdrawn participants|
59636356|NCT03692208|75751424|FG000|NOT COMPLETED|Overall Study||7||
59636357|NCT03692208|75751425|FG001|NOT COMPLETED|Overall Study||3||
59636358|NCT03551730|75751437|FG000|STARTED|Overall Study||9||
59636359|NCT03551730|75751438|FG001|STARTED|Overall Study||6||
60076465|NCT00986362|76191450|FG000|STARTED|Overall Study|16 eyes randomized and treated (in 15 subjects).|16||
59636360|NCT03551730|75751439|FG002|STARTED|Overall Study||6||
59541196|NCT01526213|75639506|FG004|NOT COMPLETED|Period 3 (5 Days)||0||
59541197|NCT01526213|75639507|FG005|NOT COMPLETED|Period 3 (5 Days)||0||
59541198|NCT01548833|75639518|FG000|STARTED|Overall Study||39||
59541199|NCT01548833|75639518|FG000|COMPLETED|Overall Study||39||
59541200|NCT01548833|75639518|FG000|NOT COMPLETED|Overall Study||0||
59541201|NCT01549223|75639528|FG000|STARTED|Overall Study||30||
59541202|NCT01549223|75639529|FG001|STARTED|Overall Study||30||
59541203|NCT01549223|75639528|FG000|COMPLETED|Overall Study||30||
59541204|NCT01549223|75639529|FG001|COMPLETED|Overall Study||30||
59541205|NCT01549223|75639528|FG000|NOT COMPLETED|Overall Study||0||
59541206|NCT01549223|75639529|FG001|NOT COMPLETED|Overall Study||0||
59541207|NCT01549925|75639537|FG000|STARTED|Overall Study||25||
59541208|NCT01549925|75639538|FG001|STARTED|Overall Study||25||
59541209|NCT01549925|75639537|FG000|COMPLETED|Overall Study||25||
59541210|NCT01549925|75639538|FG001|COMPLETED|Overall Study||25||
59541211|NCT01549925|75639537|FG000|NOT COMPLETED|Overall Study||0||
59636361|NCT03551730|75751440|FG003|STARTED|Overall Study||6||
59636362|NCT03551730|75751437|FG000|COMPLETED|Overall Study||8||
59636363|NCT03551730|75751438|FG001|COMPLETED|Overall Study||6||
59636364|NCT03551730|75751439|FG002|COMPLETED|Overall Study||6||
59636365|NCT03551730|75751440|FG003|COMPLETED|Overall Study||6||
60076466|NCT00986362|76191451|FG001|STARTED|Overall Study|8 eyes randomized and treated (in 8 subjects).|8||
60076467|NCT00986362|76191450|FG000|COMPLETED|Overall Study|14 eyes completed the study (in 14 subjects).|14||
60076468|NCT00986362|76191451|FG001|COMPLETED|Overall Study|7 eyes completed the study (in 7 subjects).|7||
60076469|NCT00986362|76191450|FG000|NOT COMPLETED|Overall Study||2||
60076470|NCT00986362|76191451|FG001|NOT COMPLETED|Overall Study||1||
60076471|NCT01890421|76191457|FG000|STARTED|Overall Study||426||
60076472|NCT01890421|76191457|FG000|COMPLETED|Overall Study||415||
60076473|NCT01890421|76191457|FG000|NOT COMPLETED|Overall Study||11||
60076474|NCT00985738|76191463|FG000|STARTED|Overall Study||8||
60076475|NCT00985738|76191464|FG001|STARTED|Overall Study||8||
60076476|NCT00985738|76191463|FG000|COMPLETED|Overall Study||0||
60076477|NCT00985738|76191464|FG001|COMPLETED|Overall Study||0||
60076478|NCT00985738|76191463|FG000|NOT COMPLETED|Overall Study||8||
60076479|NCT00985738|76191464|FG001|NOT COMPLETED|Overall Study||8||
60076480|NCT01928485|76191472|FG000|STARTED|Overall Study||4||
60076481|NCT01928485|76191473|FG001|STARTED|Overall Study||2||
60076482|NCT01928485|76191472|FG000|COMPLETED|Overall Study||4||
60076483|NCT01928485|76191473|FG001|COMPLETED|Overall Study||1||
60076484|NCT01928485|76191472|FG000|NOT COMPLETED|Overall Study||0||
60076485|NCT01928485|76191473|FG001|NOT COMPLETED|Overall Study||1||
60076486|NCT00985504|76191481|FG000|STARTED|Acute Treatment Period||244||
60076487|NCT00985504|76191482|FG001|STARTED|Acute Treatment Period||239||
59636366|NCT03551730|75751437|FG000|NOT COMPLETED|Overall Study||1||
59541212|NCT01549925|75639538|FG001|NOT COMPLETED|Overall Study||0||
59541213|NCT00895934|75639546|FG000|STARTED|Dose Escalation||3||
59541214|NCT00895934|75639547|FG001|STARTED|Dose Escalation||3||
59541215|NCT00895934|75639548|FG002|STARTED|Dose Escalation||3||
59541216|NCT00895934|75639549|FG003|STARTED|Dose Escalation||6||
59541217|NCT00895934|75639546|FG000|COMPLETED|Dose Escalation||3||
59541218|NCT00895934|75639547|FG001|COMPLETED|Dose Escalation||3||
59541219|NCT00895934|75639548|FG002|COMPLETED|Dose Escalation||3||
59636367|NCT03551730|75751438|FG001|NOT COMPLETED|Overall Study||0||
59636368|NCT03551730|75751439|FG002|NOT COMPLETED|Overall Study||0||
59636369|NCT03551730|75751440|FG003|NOT COMPLETED|Overall Study||0||
59636370|NCT02534844|75751452|FG000|STARTED|Part A||3||
59636371|NCT02534844|75751453|FG001|STARTED|Part A||3||
59636372|NCT02534844|75751454|FG002|STARTED|Part A||3||
59636373|NCT02534844|75751455|FG003|STARTED|Part A||3||
59636374|NCT02534844|75751456|FG004|STARTED|Part A||0||
59636375|NCT02534844|75751457|FG005|STARTED|Part A||0||
59636376|NCT02534844|75751452|FG000|Received at Least One Dose of Study Drug|Part A||3||
59636377|NCT02534844|75751453|FG001|Received at Least One Dose of Study Drug|Part A||3||
59636378|NCT02534844|75751454|FG002|Received at Least One Dose of Study Drug|Part A||3||
59636379|NCT02534844|75751455|FG003|Received at Least One Dose of Study Drug|Part A||3||
59636380|NCT02534844|75751456|FG004|Received at Least One Dose of Study Drug|Part A||0||
59636381|NCT02534844|75751457|FG005|Received at Least One Dose of Study Drug|Part A||0||
59636382|NCT02534844|75751452|FG000|COMPLETED|Part A||3||
59636383|NCT02534844|75751453|FG001|COMPLETED|Part A||3||
59636384|NCT02534844|75751454|FG002|COMPLETED|Part A||3||
59636385|NCT02534844|75751455|FG003|COMPLETED|Part A||3||
59636386|NCT02534844|75751456|FG004|COMPLETED|Part A||0||
59636387|NCT02534844|75751457|FG005|COMPLETED|Part A||0||
59636388|NCT02534844|75751452|FG000|NOT COMPLETED|Part A||0||
59636389|NCT02534844|75751453|FG001|NOT COMPLETED|Part A||0||
59636390|NCT02534844|75751454|FG002|NOT COMPLETED|Part A||0||
59636391|NCT02534844|75751455|FG003|NOT COMPLETED|Part A||0||
59636392|NCT02534844|75751456|FG004|NOT COMPLETED|Part A||0||
59636393|NCT02534844|75751457|FG005|NOT COMPLETED|Part A||0||
59636394|NCT02534844|75751452|FG000|STARTED|Part B||0||
59636395|NCT02534844|75751453|FG001|STARTED|Part B||0||
59636396|NCT02534844|75751454|FG002|STARTED|Part B||0||
59636397|NCT02534844|75751455|FG003|STARTED|Part B||0||
59636398|NCT02534844|75751456|FG004|STARTED|Part B||29||
59636399|NCT02534844|75751457|FG005|STARTED|Part B||15||
59636400|NCT02534844|75751452|FG000|Received at Least One Dose of Study Drug|Part B||0||
59636401|NCT02534844|75751453|FG001|Received at Least One Dose of Study Drug|Part B||0||
59636402|NCT02534844|75751454|FG002|Received at Least One Dose of Study Drug|Part B||0||
59636403|NCT02534844|75751455|FG003|Received at Least One Dose of Study Drug|Part B||0||
59636404|NCT02534844|75751456|FG004|Received at Least One Dose of Study Drug|Part B||29||
59636405|NCT02534844|75751457|FG005|Received at Least One Dose of Study Drug|Part B||15||
59636406|NCT02534844|75751452|FG000|COMPLETED|Part B||0||
59636407|NCT02534844|75751453|FG001|COMPLETED|Part B||0||
59636408|NCT02534844|75751454|FG002|COMPLETED|Part B||0||
59636409|NCT02534844|75751455|FG003|COMPLETED|Part B||0||
59636410|NCT02534844|75751456|FG004|COMPLETED|Part B||27||
59636411|NCT02534844|75751457|FG005|COMPLETED|Part B||14||
59636412|NCT02534844|75751452|FG000|NOT COMPLETED|Part B||0||
59636413|NCT02534844|75751453|FG001|NOT COMPLETED|Part B||0||
59636414|NCT02534844|75751454|FG002|NOT COMPLETED|Part B||0||
59636415|NCT02534844|75751455|FG003|NOT COMPLETED|Part B||0||
59636416|NCT02534844|75751456|FG004|NOT COMPLETED|Part B||2||
59636417|NCT02534844|75751457|FG005|NOT COMPLETED|Part B||1||
59636418|NCT01818492|75751474|FG000|STARTED|Overall Study||45||
59636419|NCT01818492|75751474|FG000|COMPLETED|Overall Study||35||
59636420|NCT01818492|75751474|FG000|NOT COMPLETED|Overall Study||10||
59636421|NCT01239030|75751484|FG000|STARTED|Double Blind||49||
59636422|NCT01239030|75751485|FG001|STARTED|Double Blind||44||
59636423|NCT01239030|75751486|FG002|STARTED|Double Blind||45||
59636424|NCT01239030|75751487|FG003|STARTED|Double Blind||45||
59636425|NCT01239030|75751488|FG004|STARTED|Double Blind||47||
59636426|NCT01239030|75751484|FG000|COMPLETED|Double Blind||48||
59636427|NCT01239030|75751485|FG001|COMPLETED|Double Blind||40||
59636428|NCT01239030|75751486|FG002|COMPLETED|Double Blind||44||
59636429|NCT01239030|75751487|FG003|COMPLETED|Double Blind||43||
59636430|NCT01239030|75751488|FG004|COMPLETED|Double Blind||46||
59636431|NCT01239030|75751484|FG000|NOT COMPLETED|Double Blind||1||
59636432|NCT01239030|75751485|FG001|NOT COMPLETED|Double Blind||4||
59636433|NCT01239030|75751486|FG002|NOT COMPLETED|Double Blind||1||
59636434|NCT01239030|75751487|FG003|NOT COMPLETED|Double Blind||2||
59636435|NCT01239030|75751488|FG004|NOT COMPLETED|Double Blind||1||
59636436|NCT01239030|75751484|FG000|STARTED|Dose Optimization (Open Label)||48||
59636437|NCT01239030|75751485|FG001|STARTED|Dose Optimization (Open Label)||40||
59636438|NCT01239030|75751486|FG002|STARTED|Dose Optimization (Open Label)||44||
59636439|NCT01239030|75751487|FG003|STARTED|Dose Optimization (Open Label)||43||
59636440|NCT01239030|75751488|FG004|STARTED|Dose Optimization (Open Label)||46||
59636441|NCT01239030|75751484|FG000|COMPLETED|Dose Optimization (Open Label)||41||
59636442|NCT01239030|75751485|FG001|COMPLETED|Dose Optimization (Open Label)||38||
59636443|NCT01239030|75751486|FG002|COMPLETED|Dose Optimization (Open Label)||42||
59636444|NCT01239030|75751487|FG003|COMPLETED|Dose Optimization (Open Label)||40||
59636445|NCT01239030|75751488|FG004|COMPLETED|Dose Optimization (Open Label)||39||
59636446|NCT01239030|75751484|FG000|NOT COMPLETED|Dose Optimization (Open Label)||7||
59636447|NCT01239030|75751485|FG001|NOT COMPLETED|Dose Optimization (Open Label)||2||
59636448|NCT01239030|75751486|FG002|NOT COMPLETED|Dose Optimization (Open Label)||2||
59636449|NCT01239030|75751487|FG003|NOT COMPLETED|Dose Optimization (Open Label)||3||
59709642|NCT01235741|75828431|FG002|STARTED|Randomized to Treatment||36||
59636450|NCT01239030|75751488|FG004|NOT COMPLETED|Dose Optimization (Open Label)||7||
59636451|NCT01086540|75751503|FG000|STARTED|Overall Study||29||
59636452|NCT01086540|75751504|FG001|STARTED|Overall Study||28||
59636453|NCT01086540|75751503|FG000|COMPLETED|Overall Study||23||
59636454|NCT01086540|75751504|FG001|COMPLETED|Overall Study||26||
59636455|NCT01086540|75751503|FG000|NOT COMPLETED|Overall Study||6||
59636456|NCT01086540|75751504|FG001|NOT COMPLETED|Overall Study||2||
59636457|NCT01959048|75751510|FG000|STARTED|Overall Study||3||
59636458|NCT01959048|75751510|FG000|COMPLETED|Overall Study||3||
59636459|NCT01959048|75751510|FG000|NOT COMPLETED|Overall Study||0||
59636460|NCT01962558|75751516|FG000|STARTED|Overall Study||16||
59636461|NCT01962558|75751517|FG001|STARTED|Overall Study||14||
59636462|NCT01962558|75751516|FG000|Acute Study|Overall Study||16||
59636463|NCT01962558|75751517|FG001|Acute Study|Overall Study||14||
59636464|NCT01962558|75751516|FG000|12-Weeks|Overall Study||16||
59636465|NCT01962558|75751517|FG001|12-Weeks|Overall Study||14||
59636466|NCT01962558|75751516|FG000|COMPLETED|Overall Study||16||
59636467|NCT01962558|75751517|FG001|COMPLETED|Overall Study||14||
59636468|NCT01962558|75751516|FG000|NOT COMPLETED|Overall Study||0||
59636469|NCT01962558|75751517|FG001|NOT COMPLETED|Overall Study||0||
59636470|NCT01962714|75751525|FG000|STARTED|Overall Study||91||
59636471|NCT01962714|75751526|FG001|STARTED|Overall Study||93||
59636472|NCT01962714|75751525|FG000|Immediate Post-treatment Assessment|Overall Study||63||
59636473|NCT01962714|75751526|FG001|Immediate Post-treatment Assessment|Overall Study||57||
59636474|NCT01962714|75751525|FG000|3-month Follow-up|Overall Study||58||
59636475|NCT01962714|75751526|FG001|3-month Follow-up|Overall Study||56||
59636476|NCT01962714|75751525|FG000|COMPLETED|Overall Study||61||
59636477|NCT01962714|75751526|FG001|COMPLETED|Overall Study||60||
59636478|NCT01962714|75751525|FG000|NOT COMPLETED|Overall Study||30||
59636479|NCT01962714|75751526|FG001|NOT COMPLETED|Overall Study||33||
59636480|NCT01962870|75751534|FG000|STARTED|Overall Study||13||
59636481|NCT01962870|75751535|FG001|STARTED|Overall Study||17||
59636482|NCT01962870|75751534|FG000|COMPLETED|Overall Study||13||
59636483|NCT01962870|75751535|FG001|COMPLETED|Overall Study||17||
59636484|NCT01962870|75751534|FG000|NOT COMPLETED|Overall Study||0||
59636485|NCT01962870|75751535|FG001|NOT COMPLETED|Overall Study||0||
59636486|NCT01965288|75751543|FG000|STARTED|Overall Study||30||
59636487|NCT01965288|75751544|FG001|STARTED|Overall Study||30||
59636488|NCT01965288|75751543|FG000|COMPLETED|Overall Study||30||
59636489|NCT01965288|75751544|FG001|COMPLETED|Overall Study||30||
59636490|NCT01965288|75751543|FG000|NOT COMPLETED|Overall Study||0||
59636491|NCT01965288|75751544|FG001|NOT COMPLETED|Overall Study||0||
59636492|NCT01965366|75751564|FG000|STARTED|Overall Study||13||
59636493|NCT01965366|75751565|FG001|STARTED|Overall Study||14||
59636494|NCT01965366|75751564|FG000|COMPLETED|Overall Study||3||
59636495|NCT01965366|75751565|FG001|COMPLETED|Overall Study||9||
59636496|NCT01965366|75751564|FG000|NOT COMPLETED|Overall Study||10||
59636497|NCT01965366|75751565|FG001|NOT COMPLETED|Overall Study||5||
59636498|NCT01965756|75751573|FG000|STARTED|Overall Study||10||
59636499|NCT01965756|75751574|FG001|STARTED|Overall Study||10||
59636500|NCT01965756|75751573|FG000|COMPLETED|Overall Study||10||
59636501|NCT01965756|75751574|FG001|COMPLETED|Overall Study||10||
59636502|NCT01965756|75751573|FG000|NOT COMPLETED|Overall Study||0||
59636503|NCT01965756|75751574|FG001|NOT COMPLETED|Overall Study||0||
60076488|NCT00985504|76191481|FG000|COMPLETED|Acute Treatment Period||229||
59636504|NCT01966380|75751584|FG000|STARTED|Overall Study||3||
59636505|NCT01966380|75751585|FG001|STARTED|Overall Study||3||
59636506|NCT01966380|75751584|FG000|COMPLETED|Overall Study||3||
59636507|NCT01966380|75751585|FG001|COMPLETED|Overall Study||2||
60076489|NCT00985504|76191482|FG001|COMPLETED|Acute Treatment Period||227||
60076490|NCT00985504|76191481|FG000|NOT COMPLETED|Acute Treatment Period||15||
60076491|NCT00985504|76191482|FG001|NOT COMPLETED|Acute Treatment Period||12||
59636508|NCT01966380|75751584|FG000|NOT COMPLETED|Overall Study||0||
59636509|NCT01966380|75751585|FG001|NOT COMPLETED|Overall Study||1||
59636510|NCT01966458|75751593|FG000|STARTED|Overall Study||308||
59636511|NCT01966458|75751594|FG001|STARTED|Overall Study||157||
59636512|NCT01966458|75751593|FG000|COMPLETED|Overall Study||304||
59636513|NCT01966458|75751594|FG001|COMPLETED|Overall Study||155||
59636514|NCT01966458|75751593|FG000|NOT COMPLETED|Overall Study||4||
59636515|NCT01966458|75751594|FG001|NOT COMPLETED|Overall Study||2||
59636516|NCT01966770|75751600|FG000|STARTED|Overall Study||20||
59636517|NCT01966770|75751600|FG000|COMPLETED|Overall Study||20||
59636518|NCT01966770|75751600|FG000|NOT COMPLETED|Overall Study||0||
59636519|NCT01966926|75751636|FG000|STARTED|Overall Study||15||
59636520|NCT01966926|75751637|FG001|STARTED|Overall Study||15||
59636521|NCT01966926|75751636|FG000|COMPLETED|Overall Study||15||
59636522|NCT01966926|75751637|FG001|COMPLETED|Overall Study||15||
59636523|NCT01966926|75751636|FG000|NOT COMPLETED|Overall Study||0||
59636524|NCT01966926|75751637|FG001|NOT COMPLETED|Overall Study||0||
59636525|NCT01967784|75751643|FG000|STARTED|Overall Study||100||
60076492|NCT00985504|76191481|FG000|STARTED|Optimization Period||229||
59636526|NCT01967784|75751643|FG000|COMPLETED|Overall Study||100||
59636527|NCT01967784|75751643|FG000|NOT COMPLETED|Overall Study||0||
59636528|NCT01967862|75751647|FG000|STARTED|Overall Study||54||
59636529|NCT01967862|75751647|FG000|COMPLETED|Overall Study||54||
59636530|NCT01967862|75751647|FG000|NOT COMPLETED|Overall Study||0||
59636531|NCT01974102|75751653|FG000|STARTED|Overall Study||22||
59636532|NCT01974102|75751654|FG001|STARTED|Overall Study||20||
59636533|NCT01974102|75751653|FG000|COMPLETED|Overall Study||15||
60076493|NCT00985504|76191482|FG001|STARTED|Optimization Period||227||
60076494|NCT00985504|76191481|FG000|COMPLETED|Optimization Period||203||
60076495|NCT00985504|76191482|FG001|COMPLETED|Optimization Period||204||
60076496|NCT00985504|76191481|FG000|NOT COMPLETED|Optimization Period||26||
60076497|NCT00985504|76191482|FG001|NOT COMPLETED|Optimization Period||23||
60076498|NCT00985426|76191490|FG000|STARTED|Overall Study||258||
60076499|NCT00985426|76191491|FG001|STARTED|Overall Study||263||
60076500|NCT00985426|76191490|FG000|COMPLETED|Overall Study||215||
60076501|NCT00985426|76191491|FG001|COMPLETED|Overall Study||219||
60076502|NCT00985426|76191490|FG000|NOT COMPLETED|Overall Study||43||
60076503|NCT00985426|76191491|FG001|NOT COMPLETED|Overall Study||44||
60076504|NCT00985192|76191497|FG000|STARTED|Overall Study||49||
60076505|NCT00985192|76191497|FG000|COMPLETED|Overall Study||45||
60076506|NCT00985192|76191497|FG000|NOT COMPLETED|Overall Study||4||
60076507|NCT00985114|76191503|FG000|STARTED|Overall Study|38 randomized, 34 received the device|34||
60076508|NCT00985114|76191504|FG001|STARTED|Overall Study||39||
60076509|NCT00985114|76191503|FG000|Diet + Lifestyle Counseling Cross-over|Overall Study||0||
60076510|NCT00985114|76191504|FG001|Diet + Lifestyle Counseling Cross-over|Overall Study|Received device for intended period of 12 months with 6 months follow up|28||
60076511|NCT00985114|76191503|FG000|COMPLETED|Overall Study||33||
60076512|NCT00985114|76191504|FG001|COMPLETED|Overall Study||37||
59541220|NCT00895934|75639549|FG003|COMPLETED|Dose Escalation||6||
59541221|NCT00895934|75639546|FG000|NOT COMPLETED|Dose Escalation||0||
59541222|NCT00895934|75639547|FG001|NOT COMPLETED|Dose Escalation||0||
59541223|NCT00895934|75639548|FG002|NOT COMPLETED|Dose Escalation||0||
59541224|NCT00895934|75639549|FG003|NOT COMPLETED|Dose Escalation||0||
59541225|NCT00895934|75639546|FG000|STARTED|Efficacy of Most Tolerated Dose||0||
59541226|NCT00895934|75639547|FG001|STARTED|Efficacy of Most Tolerated Dose||0||
59541227|NCT00895934|75639548|FG002|STARTED|Efficacy of Most Tolerated Dose||0||
59541228|NCT00895934|75639549|FG003|STARTED|Efficacy of Most Tolerated Dose||37||
59541229|NCT00895934|75639546|FG000|COMPLETED|Efficacy of Most Tolerated Dose||0||
59541230|NCT00895934|75639547|FG001|COMPLETED|Efficacy of Most Tolerated Dose||0||
59541231|NCT00895934|75639548|FG002|COMPLETED|Efficacy of Most Tolerated Dose||0||
59541232|NCT00895934|75639549|FG003|COMPLETED|Efficacy of Most Tolerated Dose||37||
59541233|NCT00895934|75639546|FG000|NOT COMPLETED|Efficacy of Most Tolerated Dose||0||
59541234|NCT00895934|75639547|FG001|NOT COMPLETED|Efficacy of Most Tolerated Dose||0||
59541235|NCT00895934|75639548|FG002|NOT COMPLETED|Efficacy of Most Tolerated Dose||0||
59541236|NCT00895934|75639549|FG003|NOT COMPLETED|Efficacy of Most Tolerated Dose||0||
59541237|NCT01447121|75639560|FG000|STARTED|Overall Study||118||
59541238|NCT01447121|75639560|FG000|COMPLETED|Overall Study||118||
59541239|NCT01447121|75639560|FG000|NOT COMPLETED|Overall Study||0||
59541240|NCT01550471|75639565|FG000|STARTED|Run-In Period (3 Weeks)||3||
59541241|NCT01550471|75639566|FG001|STARTED|Run-In Period (3 Weeks)||4||
59541242|NCT01550471|75639567|FG002|STARTED|Run-In Period (3 Weeks)||3||
59541243|NCT01550471|75639568|FG003|STARTED|Run-In Period (3 Weeks)||4||
59541244|NCT01550471|75639569|FG004|STARTED|Run-In Period (3 Weeks)||4||
59541245|NCT01550471|75639570|FG005|STARTED|Run-In Period (3 Weeks)||4||
59541246|NCT01550471|75639565|FG000|COMPLETED|Run-In Period (3 Weeks)||3||
59636534|NCT01974102|75751654|FG001|COMPLETED|Overall Study||19||
59636535|NCT01974102|75751653|FG000|NOT COMPLETED|Overall Study||7||
59636536|NCT01974102|75751654|FG001|NOT COMPLETED|Overall Study||1||
60076513|NCT00985114|76191503|FG000|NOT COMPLETED|Overall Study||1||
60076514|NCT00985114|76191504|FG001|NOT COMPLETED|Overall Study||2||
60076515|NCT00984568|76191512|FG000|STARTED|Overall Study||15||
60076516|NCT00984568|76191513|FG001|STARTED|Overall Study||13||
60076517|NCT00984568|76191512|FG000|COMPLETED|Overall Study||7||
60076518|NCT00984568|76191513|FG001|COMPLETED|Overall Study||7||
60076519|NCT00984568|76191512|FG000|NOT COMPLETED|Overall Study||8||
60076520|NCT00984568|76191513|FG001|NOT COMPLETED|Overall Study||6||
60076521|NCT00984256|76191521|FG000|STARTED|Overall Study||6||
60076522|NCT00984256|76191522|FG001|STARTED|Overall Study||30||
60076523|NCT00984256|76191521|FG000|COMPLETED|Overall Study||6||
60076524|NCT00984256|76191522|FG001|COMPLETED|Overall Study||29||
59541247|NCT01550471|75639566|FG001|COMPLETED|Run-In Period (3 Weeks)||4||
59541248|NCT01550471|75639567|FG002|COMPLETED|Run-In Period (3 Weeks)||3||
59541249|NCT01550471|75639568|FG003|COMPLETED|Run-In Period (3 Weeks)||4||
59541250|NCT01550471|75639569|FG004|COMPLETED|Run-In Period (3 Weeks)||4||
59541251|NCT01550471|75639570|FG005|COMPLETED|Run-In Period (3 Weeks)||4||
59541252|NCT01550471|75639565|FG000|NOT COMPLETED|Run-In Period (3 Weeks)||0||
59541253|NCT01550471|75639566|FG001|NOT COMPLETED|Run-In Period (3 Weeks)||0||
59541254|NCT01550471|75639567|FG002|NOT COMPLETED|Run-In Period (3 Weeks)||0||
59636537|NCT01975974|75751662|FG000|STARTED|Overall Study||100||
60076525|NCT00984256|76191521|FG000|NOT COMPLETED|Overall Study||0||
60076526|NCT00984256|76191522|FG001|NOT COMPLETED|Overall Study||1||
60076527|NCT00984022|76191539|FG000|STARTED|Overall Study||43||
60076528|NCT00984022|76191540|FG001|STARTED|Overall Study||49||
60076529|NCT00984022|76191539|FG000|COMPLETED|Overall Study||33||
60076530|NCT00984022|76191540|FG001|COMPLETED|Overall Study||35||
59636538|NCT01975974|75751662|FG000|COMPLETED|Overall Study||100||
59636539|NCT01975974|75751662|FG000|NOT COMPLETED|Overall Study||0||
59636540|NCT01976442|75751668|FG000|STARTED|Overall Study||69||
59636541|NCT01976442|75751669|FG001|STARTED|Overall Study||31||
59636542|NCT01976442|75751668|FG000|COMPLETED|Overall Study||69||
59636543|NCT01976442|75751669|FG001|COMPLETED|Overall Study||31||
59636544|NCT01976442|75751668|FG000|NOT COMPLETED|Overall Study||0||
59636545|NCT01976442|75751669|FG001|NOT COMPLETED|Overall Study||0||
59636546|NCT01976988|75751677|FG000|STARTED|Overall Study||208||
59636547|NCT01976988|75751678|FG001|STARTED|Overall Study||202||
59636548|NCT01976988|75751677|FG000|COMPLETED|Overall Study||192||
59636549|NCT01976988|75751678|FG001|COMPLETED|Overall Study||184||
59636550|NCT01976988|75751677|FG000|NOT COMPLETED|Overall Study||16||
59636551|NCT01976988|75751678|FG001|NOT COMPLETED|Overall Study||18||
59636552|NCT01978314|75751691|FG000|STARTED|Overall Study||8||
59636553|NCT01978314|75751692|FG001|STARTED|Overall Study||8||
59636554|NCT01978314|75751693|FG002|STARTED|Overall Study||8||
59636555|NCT01978314|75751694|FG003|STARTED|Overall Study||1||
59636556|NCT01978314|75751695|FG004|STARTED|Overall Study||8||
59636557|NCT01978314|75751691|FG000|COMPLETED|Overall Study||8||
59636558|NCT01978314|75751692|FG001|COMPLETED|Overall Study||8||
59636559|NCT01978314|75751693|FG002|COMPLETED|Overall Study||8||
59636560|NCT01978314|75751694|FG003|COMPLETED|Overall Study||1||
59636561|NCT01978314|75751695|FG004|COMPLETED|Overall Study||8||
59636562|NCT01978314|75751691|FG000|NOT COMPLETED|Overall Study||0||
59636563|NCT01978314|75751692|FG001|NOT COMPLETED|Overall Study||0||
59636564|NCT01978314|75751693|FG002|NOT COMPLETED|Overall Study||0||
59636565|NCT01978314|75751694|FG003|NOT COMPLETED|Overall Study||0||
59636566|NCT01978314|75751695|FG004|NOT COMPLETED|Overall Study||0||
59636567|NCT01980654|75751720|FG000|STARTED|Overall Study||60||
59636568|NCT01980654|75751721|FG001|STARTED|Overall Study||20||
59636569|NCT01980654|75751720|FG000|COMPLETED|Overall Study||60||
59636570|NCT01980654|75751721|FG001|COMPLETED|Overall Study||20||
59636571|NCT01980654|75751720|FG000|NOT COMPLETED|Overall Study||0||
59636572|NCT01980654|75751721|FG001|NOT COMPLETED|Overall Study||0||
59636573|NCT01981590|75751727|FG000|STARTED|Overall Study||15||
59636574|NCT01981590|75751727|FG000|COMPLETED|Overall Study||15||
59636575|NCT01981590|75751727|FG000|NOT COMPLETED|Overall Study||0||
59636576|NCT01983228|75751734|FG000|STARTED|Overall Study||249||
59636577|NCT01983228|75751735|FG001|STARTED|Overall Study||251||
59636578|NCT01983228|75751734|FG000|COMPLETED|Overall Study||211||
59636579|NCT01983228|75751735|FG001|COMPLETED|Overall Study||189||
59636580|NCT01983228|75751734|FG000|NOT COMPLETED|Overall Study||38||
59636581|NCT01983228|75751735|FG001|NOT COMPLETED|Overall Study||62||
59636582|NCT01984398|75751745|FG000|STARTED|Treatment Period 1||4||
59636583|NCT01984398|75751746|FG001|STARTED|Treatment Period 1||4||
59636584|NCT01984398|75751747|FG002|STARTED|Treatment Period 1||4||
59636585|NCT01984398|75751748|FG003|STARTED|Treatment Period 1||4||
59636586|NCT01984398|75751745|FG000|COMPLETED|Treatment Period 1||4||
59636587|NCT01984398|75751746|FG001|COMPLETED|Treatment Period 1||4||
59636588|NCT01984398|75751747|FG002|COMPLETED|Treatment Period 1||4||
59636589|NCT01984398|75751748|FG003|COMPLETED|Treatment Period 1||4||
59636590|NCT01984398|75751745|FG000|NOT COMPLETED|Treatment Period 1||0||
59636591|NCT01984398|75751746|FG001|NOT COMPLETED|Treatment Period 1||0||
60076531|NCT00984022|76191539|FG000|NOT COMPLETED|Overall Study||10||
60076532|NCT00984022|76191540|FG001|NOT COMPLETED|Overall Study||14||
60076533|NCT01890265|76191552|FG000|STARTED|Overall Study||50||
60076534|NCT01890265|76191553|FG001|STARTED|Overall Study||53||
60076535|NCT01890265|76191554|FG002|STARTED|Overall Study||24||
60076536|NCT01890265|76191555|FG003|STARTED|Overall Study||12||
60076537|NCT01890265|76191556|FG004|STARTED|Overall Study||15||
60076538|NCT01890265|76191557|FG005|STARTED|Overall Study||6||
60076539|NCT01890265|76191552|FG000|Safety Population|Overall Study||50|Population included randomized participants who received any amount of study medication.|
59636592|NCT01984398|75751747|FG002|NOT COMPLETED|Treatment Period 1||0||
59636593|NCT01984398|75751748|FG003|NOT COMPLETED|Treatment Period 1||0||
59636594|NCT01984398|75751745|FG000|STARTED|Washout Period of 5 to 7 Days||4||
59636595|NCT01984398|75751746|FG001|STARTED|Washout Period of 5 to 7 Days||4||
59636596|NCT01984398|75751747|FG002|STARTED|Washout Period of 5 to 7 Days||4||
59636597|NCT01984398|75751748|FG003|STARTED|Washout Period of 5 to 7 Days||4||
59636598|NCT01984398|75751745|FG000|COMPLETED|Washout Period of 5 to 7 Days||4||
59636599|NCT01984398|75751746|FG001|COMPLETED|Washout Period of 5 to 7 Days||4||
59636600|NCT01984398|75751747|FG002|COMPLETED|Washout Period of 5 to 7 Days||4||
59636601|NCT01984398|75751748|FG003|COMPLETED|Washout Period of 5 to 7 Days||4||
60076540|NCT01890265|76191553|FG001|Safety Population|Overall Study||53|Population included randomized participants who received any amount of study medication.|
60076541|NCT01890265|76191554|FG002|Safety Population|Overall Study||24|Population included randomized participants who received any amount of study medication.|
60076542|NCT01890265|76191555|FG003|Safety Population|Overall Study||12|Population included randomized participants who received any amount of study medication.|
60076543|NCT01890265|76191556|FG004|Safety Population|Overall Study||15|Population included randomized participants who received any amount of study medication.|
60103775|NCT03964493|76222046|FG000|STARTED|Overall Study||80||
59636602|NCT01984398|75751745|FG000|NOT COMPLETED|Washout Period of 5 to 7 Days||0||
59636603|NCT01984398|75751746|FG001|NOT COMPLETED|Washout Period of 5 to 7 Days||0||
59636604|NCT01984398|75751747|FG002|NOT COMPLETED|Washout Period of 5 to 7 Days||0||
59636605|NCT01984398|75751748|FG003|NOT COMPLETED|Washout Period of 5 to 7 Days||0||
59636606|NCT01984398|75751745|FG000|STARTED|Treatment Period 2||4||
59636607|NCT01984398|75751746|FG001|STARTED|Treatment Period 2||4||
59636608|NCT01984398|75751747|FG002|STARTED|Treatment Period 2||4||
59636609|NCT01984398|75751748|FG003|STARTED|Treatment Period 2||4||
59636610|NCT01984398|75751745|FG000|COMPLETED|Treatment Period 2||4||
59636611|NCT01984398|75751746|FG001|COMPLETED|Treatment Period 2||4||
59636612|NCT01984398|75751747|FG002|COMPLETED|Treatment Period 2||4||
59636613|NCT01984398|75751748|FG003|COMPLETED|Treatment Period 2||4||
59636614|NCT01984398|75751745|FG000|NOT COMPLETED|Treatment Period 2||0||
59636615|NCT01984398|75751746|FG001|NOT COMPLETED|Treatment Period 2||0||
59636616|NCT01984398|75751747|FG002|NOT COMPLETED|Treatment Period 2||0||
59636617|NCT01984398|75751748|FG003|NOT COMPLETED|Treatment Period 2||0||
59636618|NCT01985958|75751758|FG000|STARTED|Overall Study||4||
59636619|NCT01985958|75751758|FG000|COMPLETED|Overall Study||3||
59636620|NCT01985958|75751758|FG000|NOT COMPLETED|Overall Study||1||
59636621|NCT01987752|75751762|FG000|STARTED|Overall Study||732||
59636622|NCT01987752|75751762|FG000|COMPLETED|Overall Study||732||
59636623|NCT01987752|75751762|FG000|NOT COMPLETED|Overall Study||0||
59636624|NCT01988376|75751768|FG000|STARTED|Overall Study||129||
59636625|NCT01988376|75751769|FG001|STARTED|Overall Study||129||
59636626|NCT01988376|75751768|FG000|COMPLETED|Overall Study||129||
59636627|NCT01988376|75751769|FG001|COMPLETED|Overall Study||129||
59636628|NCT01988376|75751768|FG000|NOT COMPLETED|Overall Study||0||
59636629|NCT01988376|75751769|FG001|NOT COMPLETED|Overall Study||0||
59636630|NCT01988922|75751778|FG000|STARTED|Overall Study||10||
59636631|NCT01988922|75751779|FG001|STARTED|Overall Study||10||
59636632|NCT01988922|75751780|FG002|STARTED|Overall Study||10||
59636633|NCT01988922|75751778|FG000|COMPLETED|Overall Study||10||
59636634|NCT01988922|75751779|FG001|COMPLETED|Overall Study||10||
59636635|NCT01988922|75751780|FG002|COMPLETED|Overall Study||10||
59636636|NCT01988922|75751778|FG000|NOT COMPLETED|Overall Study||0||
59636637|NCT01988922|75751779|FG001|NOT COMPLETED|Overall Study||0||
59636638|NCT01988922|75751780|FG002|NOT COMPLETED|Overall Study||0||
59636639|NCT01990794|75751791|FG000|STARTED|Overall Study||13||
59636640|NCT01990794|75751791|FG000|One Month Into Study|Overall Study||10||
59636641|NCT01990794|75751791|FG000|COMPLETED|Overall Study||10||
59636642|NCT01990794|75751791|FG000|NOT COMPLETED|Overall Study||3||
59636643|NCT01991808|75751878|FG000|STARTED|Overall Study||16||
59636644|NCT01991808|75751878|FG000|COMPLETED|Overall Study||16||
59636645|NCT01991808|75751878|FG000|NOT COMPLETED|Overall Study||0||
59636646|NCT01992354|75751882|FG000|STARTED|Overall Study||4||
59636647|NCT01992354|75751882|FG000|COMPLETED|Overall Study||4||
59636648|NCT01992354|75751882|FG000|NOT COMPLETED|Overall Study||0||
59636649|NCT01994538|75751889|FG000|STARTED|Overall Study||136|One subject consented but was not randomized due to a miscommunication with the research pharmacy|
59636650|NCT01994538|75751890|FG001|STARTED|Overall Study||136|One subject consented but was not randomized due to a miscommunication with the research pharmacy|
59636651|NCT01994538|75751889|FG000|COMPLETED|Overall Study||136|A second site (Houston VA) was added mid-study, and began enrolling 1/2018|
59636652|NCT01994538|75751890|FG001|COMPLETED|Overall Study||136|A second site (Houston VA) was added mid-study, and began enrolling 1/2018|
59636653|NCT01994538|75751889|FG000|NOT COMPLETED|Overall Study||0||
59636654|NCT01994538|75751890|FG001|NOT COMPLETED|Overall Study||0||
59636655|NCT01996644|75751898|FG000|STARTED|Overall Study||20||
59636656|NCT01996644|75751899|FG001|STARTED|Overall Study||16||
59636657|NCT01996644|75751898|FG000|COMPLETED|Overall Study||20||
59636658|NCT01996644|75751899|FG001|COMPLETED|Overall Study||16||
59636659|NCT01996644|75751898|FG000|NOT COMPLETED|Overall Study||0||
59636660|NCT01996644|75751899|FG001|NOT COMPLETED|Overall Study||0||
59636661|NCT01998360|75751910|FG000|STARTED|Overall Study||50||
59636662|NCT01998360|75751911|FG001|STARTED|Overall Study||50||
59636663|NCT01998360|75751910|FG000|COMPLETED|Overall Study||50||
59636664|NCT01998360|75751911|FG001|COMPLETED|Overall Study||50||
59636665|NCT01998360|75751910|FG000|NOT COMPLETED|Overall Study||0||
59636666|NCT01998360|75751911|FG001|NOT COMPLETED|Overall Study||0||
59636667|NCT01998438|75751920|FG000|STARTED|Overall Study||319||
59636668|NCT01998438|75751921|FG001|STARTED|Overall Study||318||
59636669|NCT01998438|75751922|FG002|STARTED|Overall Study||318||
59636670|NCT01998438|75751920|FG000|COMPLETED|Overall Study||319||
59636671|NCT01998438|75751921|FG001|COMPLETED|Overall Study||318||
59636672|NCT01998438|75751922|FG002|COMPLETED|Overall Study||318||
59636673|NCT01998438|75751920|FG000|NOT COMPLETED|Overall Study||0||
59636674|NCT01998438|75751921|FG001|NOT COMPLETED|Overall Study||0||
59636675|NCT01998438|75751922|FG002|NOT COMPLETED|Overall Study||0||
59636676|NCT01999530|75751930|FG000|STARTED|Overall Study||20||
59636677|NCT01999530|75751930|FG000|COMPLETED|Overall Study||7||
59636678|NCT01999530|75751930|FG000|NOT COMPLETED|Overall Study||13||
59636679|NCT01999920|75751936|FG000|STARTED|Overall Study||13||
59636680|NCT01999920|75751937|FG001|STARTED|Overall Study||11||
59636681|NCT01999920|75751936|FG000|COMPLETED|Overall Study||7||
59988368|NCT02268214|76103509|FG001|NOT COMPLETED|Overall Study||41||
59988369|NCT02268214|76103510|FG002|NOT COMPLETED|Overall Study||42||
59988370|NCT02521376|76103522|FG000|STARTED|Overall Study||8||
59988371|NCT02521376|76103523|FG001|STARTED|Overall Study||18||
59988372|NCT02521376|76103524|FG002|STARTED|Overall Study||10||
59988373|NCT02521376|76103525|FG003|STARTED|Overall Study||20||
59988374|NCT02521376|76103522|FG000|COMPLETED|Overall Study||7||
59988375|NCT02521376|76103523|FG001|COMPLETED|Overall Study||18||
59988376|NCT02521376|76103524|FG002|COMPLETED|Overall Study||10||
59988377|NCT02521376|76103525|FG003|COMPLETED|Overall Study||20||
59988378|NCT02521376|76103522|FG000|NOT COMPLETED|Overall Study||1||
59988379|NCT02521376|76103523|FG001|NOT COMPLETED|Overall Study||0||
59988380|NCT02521376|76103524|FG002|NOT COMPLETED|Overall Study||0||
59988381|NCT02521376|76103525|FG003|NOT COMPLETED|Overall Study||0||
59988382|NCT02268058|76103547|FG000|STARTED|Overall Study||20||
59988383|NCT02268058|76103548|FG001|STARTED|Overall Study||20||
59988384|NCT02268058|76103549|FG002|STARTED|Overall Study||20||
59988385|NCT02268058|76103550|FG003|STARTED|Overall Study||20||
59988386|NCT02268058|76103547|FG000|COMPLETED|Overall Study||19||
59988387|NCT02268058|76103548|FG001|COMPLETED|Overall Study||20||
59988388|NCT02268058|76103549|FG002|COMPLETED|Overall Study||20||
59988389|NCT02268058|76103550|FG003|COMPLETED|Overall Study||20||
59988390|NCT02268058|76103547|FG000|NOT COMPLETED|Overall Study||1||
59988391|NCT02268058|76103548|FG001|NOT COMPLETED|Overall Study||0||
59988392|NCT02268058|76103549|FG002|NOT COMPLETED|Overall Study||0||
59988393|NCT02268058|76103550|FG003|NOT COMPLETED|Overall Study||0||
59988394|NCT02267824|76103562|FG000|STARTED|Overall Study||83||
59636682|NCT01999920|75751937|FG001|COMPLETED|Overall Study||9||
59988395|NCT02267824|76103563|FG001|STARTED|Overall Study||18||
59988396|NCT02267824|76103562|FG000|COMPLETED|Overall Study||73||
59988397|NCT02267824|76103563|FG001|COMPLETED|Overall Study||17||
59988398|NCT02267824|76103562|FG000|NOT COMPLETED|Overall Study||10||
59988399|NCT02267824|76103563|FG001|NOT COMPLETED|Overall Study||1||
59636683|NCT01999920|75751936|FG000|NOT COMPLETED|Overall Study||6||
59636684|NCT01999920|75751937|FG001|NOT COMPLETED|Overall Study||2||
59636685|NCT02000154|75751943|FG000|STARTED|Overall Study||1||
59636686|NCT02000154|75751943|FG000|COMPLETED|Overall Study||1||
59636687|NCT02000154|75751943|FG000|NOT COMPLETED|Overall Study||0||
59636688|NCT02001714|75751949|FG000|STARTED|Overall Study||232||
59636689|NCT02001714|75751950|FG001|STARTED|Overall Study||231||
59636690|NCT02001714|75751949|FG000|COMPLETED|Overall Study||210||
59636691|NCT02001714|75751950|FG001|COMPLETED|Overall Study||219||
59636692|NCT02001714|75751949|FG000|NOT COMPLETED|Overall Study||22||
59636693|NCT02001714|75751950|FG001|NOT COMPLETED|Overall Study||12||
59636694|NCT02002494|75751956|FG000|STARTED|Overall Study||27||
59636695|NCT02002494|75751956|FG000|COMPLETED|Overall Study||27||
59636696|NCT02002494|75751956|FG000|NOT COMPLETED|Overall Study||0||
59636697|NCT02002650|75751973|FG000|STARTED|Overall Study||1297||
59636698|NCT02002650|75751974|FG001|STARTED|Overall Study||1303||
59636699|NCT02002650|75751973|FG000|COMPLETED|Overall Study||1297||
59636700|NCT02002650|75751974|FG001|COMPLETED|Overall Study||1303||
59636701|NCT02002650|75751973|FG000|NOT COMPLETED|Overall Study||0||
59636702|NCT02002650|75751974|FG001|NOT COMPLETED|Overall Study||0||
59636703|NCT02003352|75751981|FG000|STARTED|Overall Study||98||
59636704|NCT02003352|75751981|FG000|COMPLETED|Overall Study||98||
59636705|NCT02003352|75751981|FG000|NOT COMPLETED|Overall Study||0||
59636706|NCT02003508|75751987|FG000|STARTED|Overall Study||179||
59636707|NCT02003508|75751988|FG001|STARTED|Overall Study||166||
59636708|NCT02003508|75751987|FG000|COMPLETED|Overall Study||179||
59636709|NCT02003508|75751988|FG001|COMPLETED|Overall Study||166||
59636710|NCT02003508|75751987|FG000|NOT COMPLETED|Overall Study||0||
59636711|NCT02003508|75751988|FG001|NOT COMPLETED|Overall Study||0||
59636712|NCT02004132|75751994|FG000|STARTED|Overall Study||12||
59636713|NCT02004132|75751994|FG000|Received Study Drug|Overall Study||12||
59636714|NCT02004132|75751994|FG000|COMPLETED|Overall Study||12||
59636715|NCT02004132|75751994|FG000|NOT COMPLETED|Overall Study||0||
60076544|NCT01890265|76191557|FG005|Safety Population|Overall Study||6|Population included randomized participants who received any amount of study medication.|
60076545|NCT01890265|76191552|FG000|Intent-to-Treat (ITT) Population|Overall Study||50|Population included participants who were randomized and met all protocol eligibility criteria.|
59636716|NCT02004288|75752000|FG000|STARTED|Overall Study||15||
59636717|NCT02004288|75752001|FG001|STARTED|Overall Study||16||
59636718|NCT02004288|75752000|FG000|COMPLETED|Overall Study||14||
59636719|NCT02004288|75752001|FG001|COMPLETED|Overall Study||15||
59636720|NCT02004288|75752000|FG000|NOT COMPLETED|Overall Study||1||
59636721|NCT02004288|75752001|FG001|NOT COMPLETED|Overall Study||1||
59636722|NCT02004366|75752012|FG000|STARTED|In-hospital||128||
59636723|NCT02004366|75752013|FG001|STARTED|In-hospital||122||
59636724|NCT02004366|75752014|FG002|STARTED|In-hospital||0||
59636725|NCT02004366|75752015|FG003|STARTED|In-hospital||0||
59636726|NCT02004366|75752016|FG004|STARTED|In-hospital||0||
59636727|NCT02004366|75752012|FG000|COMPLETED|In-hospital||128||
59636728|NCT02004366|75752013|FG001|COMPLETED|In-hospital||122||
59636729|NCT02004366|75752014|FG002|COMPLETED|In-hospital||0||
59636730|NCT02004366|75752015|FG003|COMPLETED|In-hospital||0||
59636731|NCT02004366|75752016|FG004|COMPLETED|In-hospital||0||
59636732|NCT02004366|75752012|FG000|NOT COMPLETED|In-hospital||0||
59636733|NCT02004366|75752013|FG001|NOT COMPLETED|In-hospital||0||
59636734|NCT02004366|75752014|FG002|NOT COMPLETED|In-hospital||0||
59636735|NCT02004366|75752015|FG003|NOT COMPLETED|In-hospital||0||
59636736|NCT02004366|75752016|FG004|NOT COMPLETED|In-hospital||0||
59636737|NCT02004366|75752012|FG000|STARTED|On Discharge||0||
59636738|NCT02004366|75752013|FG001|STARTED|On Discharge||0||
59636739|NCT02004366|75752014|FG002|STARTED|On Discharge||92||
59636740|NCT02004366|75752015|FG003|STARTED|On Discharge||93||
59636741|NCT02004366|75752016|FG004|STARTED|On Discharge||39||
59636742|NCT02004366|75752012|FG000|COMPLETED|On Discharge||0||
59636743|NCT02004366|75752013|FG001|COMPLETED|On Discharge||0||
59636744|NCT02004366|75752014|FG002|COMPLETED|On Discharge||92||
59636745|NCT02004366|75752015|FG003|COMPLETED|On Discharge||93||
59636746|NCT02004366|75752016|FG004|COMPLETED|On Discharge||39||
59636747|NCT02004366|75752012|FG000|NOT COMPLETED|On Discharge||0||
59636748|NCT02004366|75752013|FG001|NOT COMPLETED|On Discharge||0||
59636749|NCT02004366|75752014|FG002|NOT COMPLETED|On Discharge||0||
59636750|NCT02004366|75752015|FG003|NOT COMPLETED|On Discharge||0||
59636751|NCT02004366|75752016|FG004|NOT COMPLETED|On Discharge||0||
59636752|NCT02004990|75752029|FG000|STARTED|Overall Study||12||
59636753|NCT02004990|75752029|FG000|COMPLETED|Overall Study||12||
59636754|NCT02004990|75752029|FG000|NOT COMPLETED|Overall Study||0||
59636755|NCT02005536|75752033|FG000|STARTED|Overall Study||60||
59636756|NCT02005536|75752033|FG000|COMPLETED|Overall Study||60||
59636757|NCT02005536|75752033|FG000|NOT COMPLETED|Overall Study||0||
59636758|NCT02006160|75752039|FG000|STARTED|Overall Study||45||
59636759|NCT02006160|75752040|FG001|STARTED|Overall Study||16||
59636760|NCT02006160|75752039|FG000|COMPLETED|Overall Study||41||
59636761|NCT02006160|75752040|FG001|COMPLETED|Overall Study||16||
59636762|NCT02006160|75752039|FG000|NOT COMPLETED|Overall Study||4||
59636763|NCT02006160|75752040|FG001|NOT COMPLETED|Overall Study||0||
59636764|NCT02010216|75752046|FG000|STARTED|Overall Study||23||
59636765|NCT02010216|75752046|FG000|COMPLETED|Overall Study||23||
59636766|NCT02010216|75752046|FG000|NOT COMPLETED|Overall Study||0||
59636767|NCT02010996|75752052|FG000|STARTED|Overall Study||36||
59636768|NCT02010996|75752053|FG001|STARTED|Overall Study||36||
59636769|NCT02010996|75752052|FG000|COMPLETED|Overall Study||36||
59636770|NCT02010996|75752053|FG001|COMPLETED|Overall Study||36||
59636771|NCT02010996|75752052|FG000|NOT COMPLETED|Overall Study||0||
59636772|NCT02010996|75752053|FG001|NOT COMPLETED|Overall Study||0||
59636773|NCT02011464|75752065|FG000|STARTED|Overall Study||10||
59636774|NCT02011464|75752066|FG001|STARTED|Overall Study||10||
59636775|NCT02011464|75752065|FG000|COMPLETED|Overall Study||10||
59636776|NCT02011464|75752066|FG001|COMPLETED|Overall Study||10||
59636777|NCT02011464|75752065|FG000|NOT COMPLETED|Overall Study||0||
59636778|NCT02011464|75752066|FG001|NOT COMPLETED|Overall Study||0||
59636779|NCT02013180|75752086|FG000|STARTED|Overall Study||119||
59636780|NCT02013180|75752087|FG001|STARTED|Overall Study||361||
59636781|NCT02013180|75752086|FG000|COMPLETED|Overall Study||119||
59636782|NCT02013180|75752087|FG001|COMPLETED|Overall Study||361||
59636783|NCT02013180|75752086|FG000|NOT COMPLETED|Overall Study||0||
59636784|NCT02013180|75752087|FG001|NOT COMPLETED|Overall Study||0||
59636785|NCT02015442|75752093|FG000|STARTED|First Intervention (7 Days)||5||
59636786|NCT02015442|75752094|FG001|STARTED|First Intervention (7 Days)||4||
59636787|NCT02015442|75752093|FG000|COMPLETED|First Intervention (7 Days)||5||
59636788|NCT02015442|75752094|FG001|COMPLETED|First Intervention (7 Days)||4||
59636789|NCT02015442|75752093|FG000|NOT COMPLETED|First Intervention (7 Days)||0||
59636790|NCT02015442|75752094|FG001|NOT COMPLETED|First Intervention (7 Days)||0||
59636791|NCT02015442|75752093|FG000|STARTED|Wash-out (4 Weeks)||5||
59636792|NCT02015442|75752094|FG001|STARTED|Wash-out (4 Weeks)||4||
59636793|NCT02015442|75752093|FG000|COMPLETED|Wash-out (4 Weeks)||5||
59636794|NCT02015442|75752094|FG001|COMPLETED|Wash-out (4 Weeks)||4||
59636795|NCT02015442|75752093|FG000|NOT COMPLETED|Wash-out (4 Weeks)||0||
59636796|NCT02015442|75752094|FG001|NOT COMPLETED|Wash-out (4 Weeks)||0||
59636797|NCT02015442|75752093|FG000|STARTED|Second Intervention (7 Days)||5||
59636798|NCT02015442|75752094|FG001|STARTED|Second Intervention (7 Days)||4||
59636799|NCT02015442|75752093|FG000|COMPLETED|Second Intervention (7 Days)||5||
59636800|NCT02015442|75752094|FG001|COMPLETED|Second Intervention (7 Days)||4||
59636801|NCT02015442|75752093|FG000|NOT COMPLETED|Second Intervention (7 Days)||0||
59636802|NCT02015442|75752094|FG001|NOT COMPLETED|Second Intervention (7 Days)||0||
59636803|NCT02016612|75752104|FG000|STARTED|Overall Study||25||
59636804|NCT02016612|75752105|FG001|STARTED|Overall Study||25||
59636805|NCT02016612|75752106|FG002|STARTED|Overall Study||26||
59636806|NCT02016612|75752107|FG003|STARTED|Overall Study||61||
59636807|NCT02016612|75752104|FG000|COMPLETED|Overall Study||25||
59636808|NCT02016612|75752105|FG001|COMPLETED|Overall Study||25||
59636809|NCT02016612|75752106|FG002|COMPLETED|Overall Study||26||
59636810|NCT02016612|75752107|FG003|COMPLETED|Overall Study||61||
59636811|NCT02016612|75752104|FG000|NOT COMPLETED|Overall Study||0||
59636812|NCT02016612|75752105|FG001|NOT COMPLETED|Overall Study||0||
59636813|NCT02016612|75752106|FG002|NOT COMPLETED|Overall Study||0||
60076546|NCT01890265|76191553|FG001|Intent-to-Treat (ITT) Population|Overall Study||51|Population included participants who were randomized and met all protocol eligibility criteria.|
60076547|NCT01890265|76191554|FG002|Intent-to-Treat (ITT) Population|Overall Study||24|Population included participants who were randomized and met all protocol eligibility criteria.|
59636814|NCT02016612|75752107|FG003|NOT COMPLETED|Overall Study||0||
59636815|NCT02019888|75752120|FG000|STARTED|Overall Study||148||
59636816|NCT02019888|75752121|FG001|STARTED|Overall Study||113||
59636817|NCT02019888|75752122|FG002|STARTED|Overall Study||59||
59636818|NCT02019888|75752120|FG000|COMPLETED|Overall Study||108||
59636819|NCT02019888|75752121|FG001|COMPLETED|Overall Study||83||
59636820|NCT02019888|75752122|FG002|COMPLETED|Overall Study||54||
59636821|NCT02019888|75752120|FG000|NOT COMPLETED|Overall Study||40||
59636822|NCT02019888|75752121|FG001|NOT COMPLETED|Overall Study||30||
59636823|NCT02019888|75752122|FG002|NOT COMPLETED|Overall Study||5||
59636824|NCT02020278|75752130|FG000|STARTED|Core Safety Follow-up Component||3||
59636825|NCT02020278|75752130|FG000|COMPLETED|Core Safety Follow-up Component||3||
59636826|NCT02020278|75752130|FG000|NOT COMPLETED|Core Safety Follow-up Component||0||
59636827|NCT02020278|75752130|FG000|STARTED|Optional Tolvaptan Treatment Component||0||
59636828|NCT02020278|75752130|FG000|COMPLETED|Optional Tolvaptan Treatment Component||0||
59636829|NCT02020278|75752130|FG000|NOT COMPLETED|Optional Tolvaptan Treatment Component||0||
59636830|NCT02020590|75752136|FG000|STARTED|Overall Study||22||
59636831|NCT02020590|75752136|FG000|COMPLETED|Overall Study||22||
59636832|NCT02020590|75752136|FG000|NOT COMPLETED|Overall Study||0||
59636833|NCT02023944|75752142|FG000|STARTED|Overall Study||25||
59636834|NCT02023944|75752143|FG001|STARTED|Overall Study||25||
59636835|NCT02023944|75752142|FG000|COMPLETED|Overall Study||25||
59636836|NCT02023944|75752143|FG001|COMPLETED|Overall Study||24||
59636837|NCT02023944|75752142|FG000|NOT COMPLETED|Overall Study||0||
59636838|NCT02023944|75752143|FG001|NOT COMPLETED|Overall Study||1||
59636839|NCT02024646|75752153|FG000|STARTED|Overall Study||163||
59636840|NCT02024646|75752154|FG001|STARTED|Overall Study||160||
59636841|NCT02024646|75752155|FG002|STARTED|Overall Study||161||
59636842|NCT02024646|75752153|FG000|COMPLETED|Overall Study||131||
59636843|NCT02024646|75752154|FG001|COMPLETED|Overall Study||135||
59636844|NCT02024646|75752155|FG002|COMPLETED|Overall Study||133||
59636845|NCT02024646|75752153|FG000|NOT COMPLETED|Overall Study||32||
59636846|NCT02024646|75752154|FG001|NOT COMPLETED|Overall Study||25||
59636847|NCT02024646|75752155|FG002|NOT COMPLETED|Overall Study||28||
59636848|NCT02024724|75752165|FG000|STARTED|Overall Study||30||
59636849|NCT02024724|75752166|FG001|STARTED|Overall Study||30||
59636850|NCT02024724|75752165|FG000|COMPLETED|Overall Study||29||
59636851|NCT02024724|75752166|FG001|COMPLETED|Overall Study||30||
59636852|NCT02024724|75752165|FG000|NOT COMPLETED|Overall Study||1||
59636853|NCT02024724|75752166|FG001|NOT COMPLETED|Overall Study||0||
59636854|NCT02025426|75752174|FG000|STARTED|Overall Study||9||
59636855|NCT02025426|75752175|FG001|STARTED|Overall Study||4||
59636856|NCT02025426|75752174|FG000|COMPLETED|Overall Study||9||
59636857|NCT02025426|75752175|FG001|COMPLETED|Overall Study||4||
59636858|NCT02025426|75752174|FG000|NOT COMPLETED|Overall Study||0||
59636859|NCT02025426|75752175|FG001|NOT COMPLETED|Overall Study||0||
59636860|NCT02026206|75752183|FG000|STARTED|Overall Study||44||
59636861|NCT02026206|75752184|FG001|STARTED|Overall Study||44||
59636862|NCT02026206|75752183|FG000|COMPLETED|Overall Study||40||
59636863|NCT02026206|75752184|FG001|COMPLETED|Overall Study||36||
59636864|NCT02026206|75752183|FG000|NOT COMPLETED|Overall Study||4||
59636865|NCT02026206|75752184|FG001|NOT COMPLETED|Overall Study||8||
59636866|NCT02028780|75752202|FG000|STARTED|Observation Phase||6||
59636867|NCT02028780|75752203|FG001|STARTED|Observation Phase||2||
59636868|NCT02028780|75752204|FG002|STARTED|Observation Phase||6||
59636869|NCT02028780|75752205|FG003|STARTED|Observation Phase||6||
59636870|NCT02028780|75752206|FG004|STARTED|Observation Phase||6||
59636871|NCT02028780|75752207|FG005|STARTED|Observation Phase||6||
59636872|NCT02028780|75752208|FG006|STARTED|Observation Phase||9||
59636873|NCT02028780|75752209|FG007|STARTED|Observation Phase||3||
59636874|NCT02028780|75752210|FG008|STARTED|Observation Phase||9||
59636875|NCT02028780|75752211|FG009|STARTED|Observation Phase||9||
59636876|NCT02028780|75752212|FG010|STARTED|Observation Phase||9||
59636877|NCT02028780|75752213|FG011|STARTED|Observation Phase||9||
59636878|NCT02028780|75752202|FG000|COMPLETED|Observation Phase||6||
59541255|NCT01550471|75639568|FG003|NOT COMPLETED|Run-In Period (3 Weeks)||0||
59541256|NCT01550471|75639569|FG004|NOT COMPLETED|Run-In Period (3 Weeks)||0||
59541257|NCT01550471|75639570|FG005|NOT COMPLETED|Run-In Period (3 Weeks)||0||
59541258|NCT01550471|75639565|FG000|STARTED|First Treatment Period (3 Weeks)||3||
59541259|NCT01550471|75639566|FG001|STARTED|First Treatment Period (3 Weeks)||4||
59541260|NCT01550471|75639567|FG002|STARTED|First Treatment Period (3 Weeks)||3||
59541261|NCT01550471|75639568|FG003|STARTED|First Treatment Period (3 Weeks)||4||
59541262|NCT01550471|75639569|FG004|STARTED|First Treatment Period (3 Weeks)||4||
59541263|NCT01550471|75639570|FG005|STARTED|First Treatment Period (3 Weeks)||4||
59541264|NCT01550471|75639565|FG000|COMPLETED|First Treatment Period (3 Weeks)||3||
59541265|NCT01550471|75639566|FG001|COMPLETED|First Treatment Period (3 Weeks)||4||
59541266|NCT01550471|75639567|FG002|COMPLETED|First Treatment Period (3 Weeks)||3||
59541267|NCT01550471|75639568|FG003|COMPLETED|First Treatment Period (3 Weeks)||4||
59636879|NCT02028780|75752203|FG001|COMPLETED|Observation Phase||2||
59636880|NCT02028780|75752204|FG002|COMPLETED|Observation Phase||6||
59636881|NCT02028780|75752205|FG003|COMPLETED|Observation Phase||6||
59636882|NCT02028780|75752206|FG004|COMPLETED|Observation Phase||6||
59636883|NCT02028780|75752207|FG005|COMPLETED|Observation Phase||6||
59636884|NCT02028780|75752208|FG006|COMPLETED|Observation Phase||9||
59636885|NCT02028780|75752209|FG007|COMPLETED|Observation Phase||3||
59636886|NCT02028780|75752210|FG008|COMPLETED|Observation Phase||9||
59636887|NCT02028780|75752211|FG009|COMPLETED|Observation Phase||9||
59636888|NCT02028780|75752212|FG010|COMPLETED|Observation Phase||9||
59636889|NCT02028780|75752213|FG011|COMPLETED|Observation Phase||9||
59636890|NCT02028780|75752202|FG000|NOT COMPLETED|Observation Phase||0||
59636891|NCT02028780|75752203|FG001|NOT COMPLETED|Observation Phase||0||
59636892|NCT02028780|75752204|FG002|NOT COMPLETED|Observation Phase||0||
59541268|NCT01550471|75639569|FG004|COMPLETED|First Treatment Period (3 Weeks)||4||
59541269|NCT01550471|75639570|FG005|COMPLETED|First Treatment Period (3 Weeks)||4||
59541270|NCT01550471|75639565|FG000|NOT COMPLETED|First Treatment Period (3 Weeks)||0||
59636893|NCT02028780|75752205|FG003|NOT COMPLETED|Observation Phase||0||
59636894|NCT02028780|75752206|FG004|NOT COMPLETED|Observation Phase||0||
59636895|NCT02028780|75752207|FG005|NOT COMPLETED|Observation Phase||0||
59636896|NCT02028780|75752208|FG006|NOT COMPLETED|Observation Phase||0||
59636897|NCT02028780|75752209|FG007|NOT COMPLETED|Observation Phase||0||
59636898|NCT02028780|75752210|FG008|NOT COMPLETED|Observation Phase||0||
59636899|NCT02028780|75752211|FG009|NOT COMPLETED|Observation Phase||0||
59636900|NCT02028780|75752212|FG010|NOT COMPLETED|Observation Phase||0||
59636901|NCT02028780|75752213|FG011|NOT COMPLETED|Observation Phase||0||
59636902|NCT02028780|75752202|FG000|STARTED|Follow up Phase||6||
59636903|NCT02028780|75752203|FG001|STARTED|Follow up Phase||2||
59636904|NCT02028780|75752204|FG002|STARTED|Follow up Phase||6||
59636905|NCT02028780|75752205|FG003|STARTED|Follow up Phase||6||
59636906|NCT02028780|75752206|FG004|STARTED|Follow up Phase||6||
59636907|NCT02028780|75752207|FG005|STARTED|Follow up Phase||6||
59636908|NCT02028780|75752208|FG006|STARTED|Follow up Phase||9||
59636909|NCT02028780|75752209|FG007|STARTED|Follow up Phase||3||
59636910|NCT02028780|75752210|FG008|STARTED|Follow up Phase||9||
59636911|NCT02028780|75752211|FG009|STARTED|Follow up Phase||9||
59636912|NCT02028780|75752212|FG010|STARTED|Follow up Phase||9||
59636913|NCT02028780|75752213|FG011|STARTED|Follow up Phase||9||
59636914|NCT02028780|75752202|FG000|COMPLETED|Follow up Phase||6||
59636915|NCT02028780|75752203|FG001|COMPLETED|Follow up Phase||2||
59636916|NCT02028780|75752204|FG002|COMPLETED|Follow up Phase||6||
59636917|NCT02028780|75752205|FG003|COMPLETED|Follow up Phase||6||
59636918|NCT02028780|75752206|FG004|COMPLETED|Follow up Phase||6||
59636919|NCT02028780|75752207|FG005|COMPLETED|Follow up Phase||6||
59636920|NCT02028780|75752208|FG006|COMPLETED|Follow up Phase||9||
59636921|NCT02028780|75752209|FG007|COMPLETED|Follow up Phase||3||
59636922|NCT02028780|75752210|FG008|COMPLETED|Follow up Phase||9||
59636923|NCT02028780|75752211|FG009|COMPLETED|Follow up Phase||9||
59636924|NCT02028780|75752212|FG010|COMPLETED|Follow up Phase||9||
59636925|NCT02028780|75752213|FG011|COMPLETED|Follow up Phase||9||
59636926|NCT02028780|75752202|FG000|NOT COMPLETED|Follow up Phase||0||
59636927|NCT02028780|75752203|FG001|NOT COMPLETED|Follow up Phase||0||
59636928|NCT02028780|75752204|FG002|NOT COMPLETED|Follow up Phase||0||
59636929|NCT02028780|75752205|FG003|NOT COMPLETED|Follow up Phase||0||
59636930|NCT02028780|75752206|FG004|NOT COMPLETED|Follow up Phase||0||
59636931|NCT02028780|75752207|FG005|NOT COMPLETED|Follow up Phase||0||
59636932|NCT02028780|75752208|FG006|NOT COMPLETED|Follow up Phase||0||
59636933|NCT02028780|75752209|FG007|NOT COMPLETED|Follow up Phase||0||
59636934|NCT02028780|75752210|FG008|NOT COMPLETED|Follow up Phase||0||
59636935|NCT02028780|75752211|FG009|NOT COMPLETED|Follow up Phase||0||
59636936|NCT02028780|75752212|FG010|NOT COMPLETED|Follow up Phase||0||
59636937|NCT02028780|75752213|FG011|NOT COMPLETED|Follow up Phase||0||
59636938|NCT02029872|75752259|FG000|STARTED|Overall Study||9||
59636939|NCT02029872|75752260|FG001|STARTED|Overall Study||9||
59636940|NCT02029872|75752259|FG000|COMPLETED|Overall Study||7||
59636941|NCT02029872|75752260|FG001|COMPLETED|Overall Study||6||
59636942|NCT02029872|75752259|FG000|NOT COMPLETED|Overall Study||2||
59636943|NCT02029872|75752260|FG001|NOT COMPLETED|Overall Study||3||
59636944|NCT02030574|75752266|FG000|STARTED|Overall Study||2||
59636945|NCT02030574|75752266|FG000|COMPLETED|Overall Study||2||
59636946|NCT02030574|75752266|FG000|NOT COMPLETED|Overall Study||0||
59636947|NCT02030886|75752272|FG000|STARTED|Overall Study||14||
59636948|NCT02030886|75752273|FG001|STARTED|Overall Study||6||
59636949|NCT02030886|75752272|FG000|COMPLETED|Overall Study||14||
59636950|NCT02030886|75752273|FG001|COMPLETED|Overall Study||6||
59636951|NCT02030886|75752272|FG000|NOT COMPLETED|Overall Study||0||
59636952|NCT02030886|75752273|FG001|NOT COMPLETED|Overall Study||0||
59636953|NCT02032212|75752285|FG000|STARTED|Overall Study||3||
59636954|NCT02032212|75752286|FG001|STARTED|Overall Study||3||
59636955|NCT02032212|75752287|FG002|STARTED|Overall Study||3||
59636956|NCT02032212|75752288|FG003|STARTED|Overall Study||3||
59636957|NCT02032212|75752285|FG000|COMPLETED|Overall Study||3||
59636958|NCT02032212|75752286|FG001|COMPLETED|Overall Study||3||
59636959|NCT02032212|75752287|FG002|COMPLETED|Overall Study||3||
59636960|NCT02032212|75752288|FG003|COMPLETED|Overall Study||3||
59636961|NCT02032212|75752285|FG000|NOT COMPLETED|Overall Study||0||
59636962|NCT02032212|75752286|FG001|NOT COMPLETED|Overall Study||0||
59636963|NCT02032212|75752287|FG002|NOT COMPLETED|Overall Study||0||
59636964|NCT02032212|75752288|FG003|NOT COMPLETED|Overall Study||0||
59636965|NCT02032680|75752300|FG000|STARTED|Overall Study||22||
59636966|NCT02032680|75752301|FG001|STARTED|Overall Study||8||
59636967|NCT02032680|75752300|FG000|COMPLETED|Overall Study||16||
59636968|NCT02032680|75752301|FG001|COMPLETED|Overall Study||7||
59636969|NCT02032680|75752300|FG000|NOT COMPLETED|Overall Study||6||
59636970|NCT02032680|75752301|FG001|NOT COMPLETED|Overall Study||1||
59636971|NCT02032758|75752309|FG000|STARTED|Overall Study||27||
59636972|NCT02032758|75752310|FG001|STARTED|Overall Study||11||
59636973|NCT02032758|75752309|FG000|COMPLETED|Overall Study||27||
59636974|NCT02032758|75752310|FG001|COMPLETED|Overall Study||11||
59636975|NCT02032758|75752309|FG000|NOT COMPLETED|Overall Study||0||
59636976|NCT02032758|75752310|FG001|NOT COMPLETED|Overall Study||0||
59636977|NCT02033382|75752318|FG000|STARTED|Overall Study||83||
59636978|NCT02033382|75752319|FG001|STARTED|Overall Study||82||
59636979|NCT02033382|75752318|FG000|COMPLETED|Overall Study||32||
59636980|NCT02033382|75752319|FG001|COMPLETED|Overall Study||36||
59636981|NCT02033382|75752318|FG000|NOT COMPLETED|Overall Study||51||
59636982|NCT02033382|75752319|FG001|NOT COMPLETED|Overall Study||46||
59636983|NCT02033694|75752329|FG000|STARTED|Overall Study||1271||
59636984|NCT02033694|75752329|FG000|COMPLETED|Overall Study||1271||
59636985|NCT02033694|75752329|FG000|NOT COMPLETED|Overall Study||0||
59541271|NCT01550471|75639566|FG001|NOT COMPLETED|First Treatment Period (3 Weeks)||0||
59541272|NCT01550471|75639567|FG002|NOT COMPLETED|First Treatment Period (3 Weeks)||0||
59541273|NCT01550471|75639568|FG003|NOT COMPLETED|First Treatment Period (3 Weeks)||0||
59541274|NCT01550471|75639569|FG004|NOT COMPLETED|First Treatment Period (3 Weeks)||0||
59541275|NCT01550471|75639570|FG005|NOT COMPLETED|First Treatment Period (3 Weeks)||0||
59541276|NCT01550471|75639565|FG000|STARTED|First Wash Out Period (3 Weeks)||3||
59636986|NCT02036424|75752336|FG000|STARTED|Overall Study|23 study eyes, not number of subjects|23||
59636987|NCT02036424|75752337|FG001|STARTED|Overall Study|27 study eyes, not number of subjects|27||
59636988|NCT02036424|75752336|FG000|COMPLETED|Overall Study|23 study eyes, not number of subjects|23||
59636989|NCT02036424|75752337|FG001|COMPLETED|Overall Study|27 study eyes, not number of subjects|27||
59636990|NCT02036424|75752336|FG000|NOT COMPLETED|Overall Study||0||
59636991|NCT02036424|75752337|FG001|NOT COMPLETED|Overall Study||0||
59636992|NCT02037204|75752343|FG000|STARTED|Overall Study||35||
59636993|NCT02037204|75752343|FG000|COMPLETED|Overall Study||35||
59636994|NCT02037204|75752343|FG000|NOT COMPLETED|Overall Study||0||
59636995|NCT02037438|75752350|FG000|STARTED|Overall Study||920||
59636996|NCT02037438|75752351|FG001|STARTED|Overall Study||916||
59636997|NCT02037438|75752350|FG000|COMPLETED|Overall Study||574||
59636998|NCT02037438|75752351|FG001|COMPLETED|Overall Study||561||
59636999|NCT02037438|75752350|FG000|NOT COMPLETED|Overall Study||346||
59637000|NCT02037438|75752351|FG001|NOT COMPLETED|Overall Study||355||
59637001|NCT02038218|75752359|FG000|STARTED|Overall Study|Drug tolerated - Arm 1: No liver disease - 98.7 mg/m2. No alterations of liver functions.|22|The aim of the project was that the drug was acceptable in patients with liver disease.|
59637002|NCT02038218|75752360|FG001|STARTED|Overall Study|Drug tolerated - Arm 2: liver involvement - 85.5 mg/m2. No alterations of liver functions.|7|The aim of the project was that the drug was acceptable in patients with liver disease.|
59637003|NCT02038218|75752359|FG000|COMPLETED|Overall Study|22 patients are included in a publication in progress|22|22 patients were treated|
59637004|NCT02038218|75752360|FG001|COMPLETED|Overall Study|5 patients are included in a publication in progress|7|22 patients were treated|
59637005|NCT02038218|75752359|FG000|NOT COMPLETED|Overall Study||0||
59637006|NCT02038218|75752360|FG001|NOT COMPLETED|Overall Study||0||
59637007|NCT02042274|75752366|FG000|STARTED|Overall Study||12||
59637008|NCT02042274|75752366|FG000|COMPLETED|Overall Study||12||
59637009|NCT02042274|75752366|FG000|NOT COMPLETED|Overall Study||0||
59637010|NCT02044380|75752370|FG000|STARTED|Overall Study|Started are the treated patients|14||
59637011|NCT02044380|75752370|FG000|COMPLETED|Overall Study||14||
59637012|NCT02044380|75752370|FG000|NOT COMPLETED|Overall Study||0||
59637013|NCT02045238|75752376|FG000|STARTED|Overall Study||16||
59637014|NCT02045238|75752377|FG001|STARTED|Overall Study||15||
59637015|NCT02045238|75752376|FG000|COMPLETED|Overall Study||9||
59637016|NCT02045238|75752377|FG001|COMPLETED|Overall Study||14||
59637017|NCT02045238|75752376|FG000|NOT COMPLETED|Overall Study||7||
59637018|NCT02045238|75752377|FG001|NOT COMPLETED|Overall Study||1||
59637019|NCT02047032|75752385|FG000|STARTED|Overall Study||250||
59637020|NCT02047032|75752386|FG001|STARTED|Overall Study||250||
59637021|NCT02047032|75752385|FG000|COMPLETED|Overall Study||245||
59637022|NCT02047032|75752386|FG001|COMPLETED|Overall Study||235||
59637023|NCT02047032|75752385|FG000|NOT COMPLETED|Overall Study||5||
59637024|NCT02047032|75752386|FG001|NOT COMPLETED|Overall Study||15||
59637025|NCT02047344|75752396|FG000|STARTED|Overall Study|one patient is not evaluable in process. however, evaluable to safety report.|16||
59637026|NCT02047344|75752397|FG001|STARTED|Overall Study||15||
59637027|NCT02047344|75752396|FG000|COMPLETED|Overall Study||16||
59637028|NCT02047344|75752397|FG001|COMPLETED|Overall Study||15||
59637029|NCT02047344|75752396|FG000|NOT COMPLETED|Overall Study||0||
59988400|NCT02267746|76103572|FG000|STARTED|Overall Study||298||
59988401|NCT02267746|76103573|FG001|STARTED|Overall Study||296||
59988402|NCT02267746|76103574|FG002|STARTED|Overall Study||299||
59988403|NCT02267746|76103572|FG000|COMPLETED|Overall Study||277||
59988404|NCT02267746|76103573|FG001|COMPLETED|Overall Study||274||
59988405|NCT02267746|76103574|FG002|COMPLETED|Overall Study||278||
59988406|NCT02267746|76103572|FG000|NOT COMPLETED|Overall Study||21||
59988407|NCT02267746|76103573|FG001|NOT COMPLETED|Overall Study||22||
59988408|NCT02267746|76103574|FG002|NOT COMPLETED|Overall Study||21||
59988409|NCT02362360|76103584|FG000|STARTED|Period 1||26||
59988410|NCT02362360|76103585|FG001|STARTED|Period 1||26||
59988411|NCT02362360|76103584|FG000|COMPLETED|Period 1||23||
59988412|NCT02362360|76103585|FG001|COMPLETED|Period 1||25||
59988413|NCT02362360|76103584|FG000|NOT COMPLETED|Period 1||3||
59988414|NCT02362360|76103585|FG001|NOT COMPLETED|Period 1||1||
59988415|NCT02362360|76103584|FG000|STARTED|Period 2||23||
59541277|NCT01550471|75639566|FG001|STARTED|First Wash Out Period (3 Weeks)||4||
59541278|NCT01550471|75639567|FG002|STARTED|First Wash Out Period (3 Weeks)||3||
59541279|NCT01550471|75639568|FG003|STARTED|First Wash Out Period (3 Weeks)||4||
59988416|NCT02362360|76103585|FG001|STARTED|Period 2||25||
59988417|NCT02362360|76103584|FG000|COMPLETED|Period 2||23||
59637030|NCT02047344|75752397|FG001|NOT COMPLETED|Overall Study||0||
59637031|NCT02047500|75752409|FG000|STARTED|Overall Study||19||
59637032|NCT02047500|75752409|FG000|COMPLETED|Overall Study||0||
59637033|NCT02047500|75752409|FG000|NOT COMPLETED|Overall Study||19||
59637034|NCT02048670|75752415|FG000|STARTED|Overall Study||6||
59637035|NCT02048670|75752416|FG001|STARTED|Overall Study||6||
59637036|NCT02048670|75752415|FG000|COMPLETED|Overall Study||6||
59637037|NCT02048670|75752416|FG001|COMPLETED|Overall Study||6||
59637038|NCT02048670|75752415|FG000|NOT COMPLETED|Overall Study||0||
59637039|NCT02048670|75752416|FG001|NOT COMPLETED|Overall Study||0||
59637040|NCT02051790|75752422|FG000|STARTED|Overall Study||241||
59637041|NCT02051790|75752422|FG000|COMPLETED|Overall Study||241||
59637042|NCT02051790|75752422|FG000|NOT COMPLETED|Overall Study||0||
59637043|NCT02054754|75752428|FG000|STARTED|Overall Study||6||
59637044|NCT02054754|75752429|FG001|STARTED|Overall Study||6||
59637045|NCT02054754|75752430|FG002|STARTED|Overall Study||6||
59637046|NCT02054754|75752431|FG003|STARTED|Overall Study||6||
59637047|NCT02054754|75752432|FG004|STARTED|Overall Study||6||
59637048|NCT02054754|75752433|FG005|STARTED|Overall Study||10||
59637049|NCT02054754|75752428|FG000|COMPLETED|Overall Study||6||
59637050|NCT02054754|75752429|FG001|COMPLETED|Overall Study||6||
59637051|NCT02054754|75752430|FG002|COMPLETED|Overall Study||6||
59637052|NCT02054754|75752431|FG003|COMPLETED|Overall Study||6||
59637053|NCT02054754|75752432|FG004|COMPLETED|Overall Study||6||
59637054|NCT02054754|75752433|FG005|COMPLETED|Overall Study||10||
59637055|NCT02054754|75752428|FG000|NOT COMPLETED|Overall Study||0||
59637056|NCT02054754|75752429|FG001|NOT COMPLETED|Overall Study||0||
59637057|NCT02054754|75752430|FG002|NOT COMPLETED|Overall Study||0||
59637058|NCT02054754|75752431|FG003|NOT COMPLETED|Overall Study||0||
59637059|NCT02054754|75752432|FG004|NOT COMPLETED|Overall Study||0||
59988418|NCT02362360|76103585|FG001|COMPLETED|Period 2||25||
59988419|NCT02362360|76103584|FG000|NOT COMPLETED|Period 2||0||
59988420|NCT02362360|76103585|FG001|NOT COMPLETED|Period 2||0||
59637060|NCT02054754|75752433|FG005|NOT COMPLETED|Overall Study||0||
59637061|NCT02057640|75752450|FG000|STARTED|Weeks 1-4|1 extra participant accidentally treated at DL1 (in addition to initial 3).|4||
59637062|NCT02057640|75752451|FG001|STARTED|Weeks 1-4||3||
59637063|NCT02057640|75752450|FG000|COMPLETED|Weeks 1-4||4||
59637064|NCT02057640|75752451|FG001|COMPLETED|Weeks 1-4||3||
59637065|NCT02057640|75752450|FG000|NOT COMPLETED|Weeks 1-4||0||
59637066|NCT02057640|75752451|FG001|NOT COMPLETED|Weeks 1-4||0||
59637067|NCT02057640|75752450|FG000|STARTED|Phase II Portion of Study at DL2||0||
59637068|NCT02057640|75752451|FG001|STARTED|Phase II Portion of Study at DL2||9||
59637069|NCT02057640|75752450|FG000|COMPLETED|Phase II Portion of Study at DL2||0||
59637070|NCT02057640|75752451|FG001|COMPLETED|Phase II Portion of Study at DL2||9||
59637071|NCT02057640|75752450|FG000|NOT COMPLETED|Phase II Portion of Study at DL2||0||
59637072|NCT02057640|75752451|FG001|NOT COMPLETED|Phase II Portion of Study at DL2||0||
59637073|NCT02057952|75752461|FG000|STARTED|Overall Study||51||
59637074|NCT02057952|75752462|FG001|STARTED|Overall Study||49||
59637075|NCT02057952|75752463|FG002|STARTED|Overall Study||50||
59637076|NCT02057952|75752461|FG000|COMPLETED|Overall Study||43||
59637077|NCT02057952|75752462|FG001|COMPLETED|Overall Study||39||
59637078|NCT02057952|75752463|FG002|COMPLETED|Overall Study||28||
59637079|NCT02057952|75752461|FG000|NOT COMPLETED|Overall Study||8||
59637080|NCT02057952|75752462|FG001|NOT COMPLETED|Overall Study||10||
59637081|NCT02057952|75752463|FG002|NOT COMPLETED|Overall Study||22||
59637082|NCT02059512|75752474|FG000|STARTED|Overall Study||46||
59637083|NCT02059512|75752475|FG001|STARTED|Overall Study||34||
59637084|NCT02059512|75752476|FG002|STARTED|Overall Study||37||
59637085|NCT02059512|75752474|FG000|COMPLETED|Overall Study||37||
59637086|NCT02059512|75752475|FG001|COMPLETED|Overall Study||25||
59637087|NCT02059512|75752476|FG002|COMPLETED|Overall Study||23||
59637088|NCT02059512|75752474|FG000|NOT COMPLETED|Overall Study||9||
59637089|NCT02059512|75752475|FG001|NOT COMPLETED|Overall Study||9||
59637090|NCT02059512|75752476|FG002|NOT COMPLETED|Overall Study||14||
59637091|NCT02059902|75752502|FG000|STARTED|Overall Study||18||
59637092|NCT02059902|75752503|FG001|STARTED|Overall Study||18||
59637093|NCT02059902|75752502|FG000|COMPLETED|Overall Study||14||
59988421|NCT02362282|76103593|FG000|STARTED|Overall Study||5||
59988422|NCT02362282|76103594|FG001|STARTED|Overall Study||7||
59988423|NCT02362282|76103593|FG000|COMPLETED|Overall Study||4||
59988424|NCT02362282|76103594|FG001|COMPLETED|Overall Study||7||
59988425|NCT02362282|76103593|FG000|NOT COMPLETED|Overall Study||1||
59637094|NCT02059902|75752503|FG001|COMPLETED|Overall Study||14||
59637095|NCT02059902|75752502|FG000|NOT COMPLETED|Overall Study||4||
59637096|NCT02059902|75752503|FG001|NOT COMPLETED|Overall Study||4||
59637097|NCT02060058|75752512|FG000|STARTED|Overall Study||4||
59637098|NCT02060058|75752513|FG001|STARTED|Overall Study||0||
59637099|NCT02060058|75752514|FG002|STARTED|Overall Study||8||
59637100|NCT02060058|75752512|FG000|COMPLETED|Overall Study||4||
59637101|NCT02060058|75752513|FG001|COMPLETED|Overall Study||0||
59637102|NCT02060058|75752514|FG002|COMPLETED|Overall Study||8||
59637103|NCT02060058|75752512|FG000|NOT COMPLETED|Overall Study||0||
59988426|NCT02362282|76103594|FG001|NOT COMPLETED|Overall Study||0||
59988427|NCT02361580|76103602|FG000|STARTED|Overall Study||6||
59637104|NCT02060058|75752513|FG001|NOT COMPLETED|Overall Study||0||
59637105|NCT02060058|75752514|FG002|NOT COMPLETED|Overall Study||0||
59637106|NCT02060526|75752526|FG000|STARTED|Overall Study||7||
59637107|NCT02060526|75752527|FG001|STARTED|Overall Study||7||
59637108|NCT02060526|75752528|FG002|STARTED|Overall Study||7||
59637109|NCT02060526|75752526|FG000|COMPLETED|Overall Study||7||
59637110|NCT02060526|75752527|FG001|COMPLETED|Overall Study||7||
59637111|NCT02060526|75752528|FG002|COMPLETED|Overall Study||7||
59637112|NCT02060526|75752526|FG000|NOT COMPLETED|Overall Study||0||
59637113|NCT02060526|75752527|FG001|NOT COMPLETED|Overall Study||0||
59637114|NCT02060526|75752528|FG002|NOT COMPLETED|Overall Study||0||
59637115|NCT02060838|75752540|FG000|STARTED|Overall Study||28||
59637116|NCT02060838|75752541|FG001|STARTED|Overall Study||22||
59637117|NCT02060838|75752540|FG000|COMPLETED|Overall Study||28||
59637118|NCT02060838|75752541|FG001|COMPLETED|Overall Study||22||
59637119|NCT02060838|75752540|FG000|NOT COMPLETED|Overall Study||0||
59637120|NCT02060838|75752541|FG001|NOT COMPLETED|Overall Study||0||
59637121|NCT02061384|75752549|FG000|STARTED|Overall Study||10||
59637122|NCT02061384|75752550|FG001|STARTED|Overall Study||10||
59637123|NCT02061384|75752549|FG000|COMPLETED|Overall Study||10||
59637124|NCT02061384|75752550|FG001|COMPLETED|Overall Study||10||
59637125|NCT02061384|75752549|FG000|NOT COMPLETED|Overall Study||0||
59637126|NCT02061384|75752550|FG001|NOT COMPLETED|Overall Study||0||
59637127|NCT02061696|75752558|FG000|STARTED|Overall Study||17||
59637128|NCT02061696|75752559|FG001|STARTED|Overall Study||22||
59637129|NCT02061696|75752558|FG000|COMPLETED|Overall Study||17||
59637130|NCT02061696|75752559|FG001|COMPLETED|Overall Study||22||
59637131|NCT02061696|75752558|FG000|NOT COMPLETED|Overall Study||0||
59637132|NCT02061696|75752559|FG001|NOT COMPLETED|Overall Study||0||
59637133|NCT02061774|75752567|FG000|STARTED|Overall Study||10||
59637134|NCT02061774|75752568|FG001|STARTED|Overall Study||11||
59637135|NCT02061774|75752567|FG000|COMPLETED|Overall Study||10||
59637136|NCT02061774|75752568|FG001|COMPLETED|Overall Study||11||
59637137|NCT02061774|75752567|FG000|NOT COMPLETED|Overall Study||0||
59637138|NCT02061774|75752568|FG001|NOT COMPLETED|Overall Study||0||
59637139|NCT02062008|75752574|FG000|STARTED|Overall Study||2||
59637140|NCT02062008|75752574|FG000|COMPLETED|Overall Study||2||
59637141|NCT02062008|75752574|FG000|NOT COMPLETED|Overall Study||0||
59637142|NCT02062710|75752578|FG000|STARTED|Overall Study|3 of total 22 subjects randomized to receive the 3 study drugs in this particular sequence|3||
59637143|NCT02062710|75752579|FG001|STARTED|Overall Study|4 of the total 22 subjects randomized to receive the 3 study drugs in this particular sequence|4||
59637144|NCT02062710|75752580|FG002|STARTED|Overall Study|5 of total of 22 subjects randomized to receive the 3 study drugs in this particular sequence|5||
59637145|NCT02062710|75752581|FG003|STARTED|Overall Study|3 of 22 subjects randomized to receive the 3 study drugs in this particular sequence|3||
59637146|NCT02062710|75752582|FG004|STARTED|Overall Study|3 of 22 subjects randomized to receive the 3 study drugs in this aprticular sequence|3||
59637147|NCT02062710|75752583|FG005|STARTED|Overall Study|4 of 22 subjects randomized to receive the 3 study drugs in this particular sequence|4||
59637148|NCT02062710|75752578|FG000|COMPLETED|Overall Study||3||
59637149|NCT02062710|75752579|FG001|COMPLETED|Overall Study||4||
59637150|NCT02062710|75752580|FG002|COMPLETED|Overall Study||5||
59637151|NCT02062710|75752581|FG003|COMPLETED|Overall Study||3||
59637152|NCT02062710|75752582|FG004|COMPLETED|Overall Study||3||
60076548|NCT01890265|76191555|FG003|Intent-to-Treat (ITT) Population|Overall Study||12|Population included participants who were randomized and met all protocol eligibility criteria.|
60076549|NCT01890265|76191556|FG004|Intent-to-Treat (ITT) Population|Overall Study||15|Population included participants who were randomized and met all protocol eligibility criteria.|
60076550|NCT01890265|76191557|FG005|Intent-to-Treat (ITT) Population|Overall Study||6|Population included participants who were randomized and met all protocol eligibility criteria.|
60076551|NCT01890265|76191552|FG000|COMPLETED|Overall Study||40||
60076552|NCT01890265|76191553|FG001|COMPLETED|Overall Study||40||
60076553|NCT01890265|76191554|FG002|COMPLETED|Overall Study||20||
60076554|NCT01890265|76191555|FG003|COMPLETED|Overall Study||12||
60076555|NCT01890265|76191556|FG004|COMPLETED|Overall Study||13||
60076556|NCT01890265|76191557|FG005|COMPLETED|Overall Study||6||
59637153|NCT02062710|75752583|FG005|COMPLETED|Overall Study||4||
59637154|NCT02062710|75752578|FG000|NOT COMPLETED|Overall Study||0||
59637155|NCT02062710|75752579|FG001|NOT COMPLETED|Overall Study||0||
59637156|NCT02062710|75752580|FG002|NOT COMPLETED|Overall Study||0||
59637157|NCT02062710|75752581|FG003|NOT COMPLETED|Overall Study||0||
59637158|NCT02062710|75752582|FG004|NOT COMPLETED|Overall Study||0||
59637159|NCT02062710|75752583|FG005|NOT COMPLETED|Overall Study||0||
59637160|NCT02063178|75752593|FG000|STARTED|Overall Study||124||
59637161|NCT02063178|75752594|FG001|STARTED|Overall Study||124||
59637162|NCT02063178|75752593|FG000|COMPLETED|Overall Study||95||
59637163|NCT02063178|75752594|FG001|COMPLETED|Overall Study||77||
59637164|NCT02063178|75752593|FG000|NOT COMPLETED|Overall Study||29||
59637165|NCT02063178|75752594|FG001|NOT COMPLETED|Overall Study||47||
59637166|NCT02064270|75752606|FG000|STARTED|Overall Study||263||
59637167|NCT02064270|75752607|FG001|STARTED|Overall Study||263||
59637168|NCT02064270|75752606|FG000|COMPLETED|Overall Study||201||
59637169|NCT02064270|75752607|FG001|COMPLETED|Overall Study||231||
59637170|NCT02064270|75752606|FG000|NOT COMPLETED|Overall Study||62||
59637171|NCT02064270|75752607|FG001|NOT COMPLETED|Overall Study||32||
59637172|NCT02064582|75752613|FG000|STARTED|Overall Study||7||
59637173|NCT02064582|75752613|FG000|COMPLETED|Overall Study||7||
59637174|NCT02064582|75752613|FG000|NOT COMPLETED|Overall Study||0||
59637175|NCT02067000|75752617|FG000|STARTED|Overall Study||217||
59637176|NCT02067000|75752617|FG000|COMPLETED|Overall Study||167||
59637177|NCT02067000|75752617|FG000|NOT COMPLETED|Overall Study||50||
59637178|NCT02067468|75752624|FG000|STARTED|Overall Study||882||
59637179|NCT02067468|75752625|FG001|STARTED|Overall Study||890||
59637180|NCT02067468|75752626|FG002|STARTED|Overall Study||889||
59637181|NCT02067468|75752624|FG000|Followed-up Through Medical Records|Overall Study||882|All included women followed through databases and medical records manually ascertained from HMOs|
59637182|NCT02067468|75752625|FG001|Followed-up Through Medical Records|Overall Study||890|All included women followed through databases and medical records manually ascertained from HMOs|
59637183|NCT02067468|75752626|FG002|Followed-up Through Medical Records|Overall Study||889|All included women followed through databases and medical records manually ascertained from HMOs|
59637184|NCT02067468|75752624|FG000|Had at Least One Routine Colposcopy|Overall Study||772|Referred to colposcopy: 100% for COLPOSCOPY, abnormal Pap for CYTOLOGY (31%), and HPV+ for HPV (41%)|
59637185|NCT02067468|75752625|FG001|Had at Least One Routine Colposcopy|Overall Study||372|Referred to colposcopy: 100% for COLPOSCOPY, abnormal Pap for CYTOLOGY (31%), and HPV+ for HPV (41%)|
59637186|NCT02067468|75752626|FG002|Had at Least One Routine Colposcopy|Overall Study||462|Referred to colposcopy: 100% for COLPOSCOPY, abnormal Pap for CYTOLOGY (31%), and HPV+ for HPV (41%)|
59637187|NCT02067468|75752624|FG000|COMPLETED|Overall Study||882||
59637188|NCT02067468|75752625|FG001|COMPLETED|Overall Study||890||
59637189|NCT02067468|75752626|FG002|COMPLETED|Overall Study||889||
59637190|NCT02067468|75752624|FG000|NOT COMPLETED|Overall Study||0||
59637191|NCT02067468|75752625|FG001|NOT COMPLETED|Overall Study||0||
59637192|NCT02067468|75752626|FG002|NOT COMPLETED|Overall Study||0||
59637193|NCT02067858|75752634|FG000|STARTED|Overall Study||6||
59637194|NCT02067858|75752634|FG000|COMPLETED|Overall Study||6||
59637195|NCT02067858|75752634|FG000|NOT COMPLETED|Overall Study||0||
59637196|NCT02069184|75752640|FG000|STARTED|Overall Study||33||
59637197|NCT02069184|75752641|FG001|STARTED|Overall Study||33||
59637198|NCT02069184|75752640|FG000|COMPLETED|Overall Study||27||
59637199|NCT02069184|75752641|FG001|COMPLETED|Overall Study||31||
59637200|NCT02069184|75752640|FG000|NOT COMPLETED|Overall Study||6||
59637201|NCT02069184|75752641|FG001|NOT COMPLETED|Overall Study||2||
59637202|NCT02070276|75752650|FG000|STARTED|Overall Study||149||
59637203|NCT02070276|75752651|FG001|STARTED|Overall Study||132||
59637204|NCT02070276|75752652|FG002|STARTED|Overall Study||148||
59637205|NCT02070276|75752650|FG000|COMPLETED|Overall Study||149||
59637206|NCT02070276|75752651|FG001|COMPLETED|Overall Study||132||
59637207|NCT02070276|75752652|FG002|COMPLETED|Overall Study||148||
59637208|NCT02070276|75752650|FG000|NOT COMPLETED|Overall Study||0||
59637209|NCT02070276|75752651|FG001|NOT COMPLETED|Overall Study||0||
59637210|NCT02070276|75752652|FG002|NOT COMPLETED|Overall Study||0||
59637211|NCT02134314|75752662|FG000|STARTED|Overall Study||35||
59637212|NCT02134314|75752663|FG001|STARTED|Overall Study||35||
59637213|NCT02134314|75752662|FG000|COMPLETED|Overall Study||34||
59637214|NCT02134314|75752663|FG001|COMPLETED|Overall Study||34||
59637215|NCT02134314|75752662|FG000|NOT COMPLETED|Overall Study||1||
59637216|NCT02134314|75752663|FG001|NOT COMPLETED|Overall Study||1||
59637217|NCT02135016|75752673|FG000|STARTED|Overall Study||15||
59637218|NCT02135016|75752674|FG001|STARTED|Overall Study||15||
59637219|NCT02135016|75752675|FG002|STARTED|Overall Study||15||
59637220|NCT02135016|75752673|FG000|COMPLETED|Overall Study||15||
59637221|NCT02135016|75752674|FG001|COMPLETED|Overall Study||15||
59637222|NCT02135016|75752675|FG002|COMPLETED|Overall Study||15||
59637223|NCT02135016|75752673|FG000|NOT COMPLETED|Overall Study||0||
59637224|NCT02135016|75752674|FG001|NOT COMPLETED|Overall Study||0||
59637225|NCT02135016|75752675|FG002|NOT COMPLETED|Overall Study||0||
59637226|NCT02135094|75752685|FG000|STARTED|Overall Study||25||
59637227|NCT02135094|75752686|FG001|STARTED|Overall Study||8||
59637228|NCT02135094|75752685|FG000|Week 2|Overall Study||25||
59637229|NCT02135094|75752686|FG001|Week 2|Overall Study||8||
59637230|NCT02135094|75752685|FG000|Week 3|Overall Study||25||
59637231|NCT02135094|75752686|FG001|Week 3|Overall Study||8||
59637232|NCT02135094|75752685|FG000|Week 4|Overall Study||25||
59988428|NCT02361580|76103603|FG001|STARTED|Overall Study||3||
59988429|NCT02361580|76103602|FG000|COMPLETED|Overall Study||0||
59988430|NCT02361580|76103603|FG001|COMPLETED|Overall Study||0||
59988431|NCT02361580|76103602|FG000|NOT COMPLETED|Overall Study||6||
59637233|NCT02135094|75752686|FG001|Week 4|Overall Study||8||
59637234|NCT02135094|75752685|FG000|COMPLETED|Overall Study||25||
59637235|NCT02135094|75752686|FG001|COMPLETED|Overall Study||8||
59637236|NCT02135094|75752685|FG000|NOT COMPLETED|Overall Study||0||
59637237|NCT02135094|75752686|FG001|NOT COMPLETED|Overall Study||0||
59988432|NCT02361580|76103603|FG001|NOT COMPLETED|Overall Study||3||
59988433|NCT02520284|76103612|FG000|STARTED|Blinded Induction Phase: Up to Week 8||54||
59988434|NCT02520284|76103613|FG001|STARTED|Blinded Induction Phase: Up to Week 8||56||
59637238|NCT02137512|75752692|FG000|STARTED|2-Week Baseline Sensor-Augmented Pump||30||
59637239|NCT02137512|75752692|FG000|COMPLETED|2-Week Baseline Sensor-Augmented Pump||30||
59709643|NCT01235741|75828429|FG000|COMPLETED|Randomized to Treatment||0||
59637240|NCT02137512|75752692|FG000|NOT COMPLETED|2-Week Baseline Sensor-Augmented Pump||0||
59637241|NCT02137512|75752692|FG000|STARTED|2-Week Overnight-Only Closed-Loop||30||
59637242|NCT02137512|75752692|FG000|COMPLETED|2-Week Overnight-Only Closed-Loop||30||
59637243|NCT02137512|75752692|FG000|NOT COMPLETED|2-Week Overnight-Only Closed-Loop||0||
59637244|NCT02137512|75752692|FG000|STARTED|2-Week 24/7 Closed-Loop||30||
59637245|NCT02137512|75752692|FG000|COMPLETED|2-Week 24/7 Closed-Loop||30||
59637246|NCT02137512|75752692|FG000|NOT COMPLETED|2-Week 24/7 Closed-Loop||0||
59637247|NCT02137512|75752692|FG000|STARTED|5-Month 24/7 Closed-Loop||14||
59637248|NCT02137512|75752692|FG000|COMPLETED|5-Month 24/7 Closed-Loop||14||
59637249|NCT02137512|75752692|FG000|NOT COMPLETED|5-Month 24/7 Closed-Loop||0||
59637250|NCT02139228|75752702|FG000|STARTED|Overall Study||215||
59637251|NCT02139228|75752703|FG001|STARTED|Overall Study||211||
59637252|NCT02139228|75752702|FG000|COMPLETED|Overall Study||215||
59637253|NCT02139228|75752703|FG001|COMPLETED|Overall Study||211||
59637254|NCT02139228|75752702|FG000|NOT COMPLETED|Overall Study||0||
59637255|NCT02139228|75752703|FG001|NOT COMPLETED|Overall Study||0||
59637256|NCT02139540|75752711|FG000|STARTED|Overall Study||11||
59637257|NCT02139540|75752712|FG001|STARTED|Overall Study||10||
59637258|NCT02139540|75752711|FG000|COMPLETED|Overall Study||10||
59637259|NCT02139540|75752712|FG001|COMPLETED|Overall Study||10||
59637260|NCT02139540|75752711|FG000|NOT COMPLETED|Overall Study||1||
59637261|NCT02139540|75752712|FG001|NOT COMPLETED|Overall Study||0||
59637262|NCT02146482|75752720|FG000|STARTED|Overall Study|11 participants total enrolled in study but withdrew prior to randomization|21||
59637263|NCT02146482|75752721|FG001|STARTED|Overall Study|11 participants total enrolled in study but withdrew prior to randomization|25||
59637264|NCT02146482|75752720|FG000|COMPLETED|Overall Study||21||
59637265|NCT02146482|75752721|FG001|COMPLETED|Overall Study||25||
59637266|NCT02146482|75752720|FG000|NOT COMPLETED|Overall Study||0||
59637267|NCT02146482|75752721|FG001|NOT COMPLETED|Overall Study||0||
59637268|NCT02148588|75752727|FG000|STARTED|Overall Study||8||
59637269|NCT02148588|75752727|FG000|COMPLETED|Overall Study||8||
59637270|NCT02148588|75752727|FG000|NOT COMPLETED|Overall Study||0||
59637271|NCT02149290|75752731|FG000|STARTED|Overall Study||198||
59637272|NCT02149290|75752731|FG000|COMPLETED|Overall Study||198||
59637273|NCT02149290|75752731|FG000|NOT COMPLETED|Overall Study||0||
59637274|NCT02149524|75752739|FG000|STARTED|Overall Study||438||
59637275|NCT02149524|75752740|FG001|STARTED|Overall Study||437||
59637276|NCT02149524|75752739|FG000|COMPLETED|Overall Study||384||
59637277|NCT02149524|75752740|FG001|COMPLETED|Overall Study||380||
59637278|NCT02149524|75752739|FG000|NOT COMPLETED|Overall Study||54||
59637279|NCT02149524|75752740|FG001|NOT COMPLETED|Overall Study||57||
59637280|NCT02150460|75752748|FG000|STARTED|Overall Study||50||
59637281|NCT02150460|75752749|FG001|STARTED|Overall Study||50||
59637282|NCT02150460|75752748|FG000|COMPLETED|Overall Study||50||
59637283|NCT02150460|75752749|FG001|COMPLETED|Overall Study||50||
59637284|NCT02150460|75752748|FG000|NOT COMPLETED|Overall Study||0||
59637285|NCT02150460|75752749|FG001|NOT COMPLETED|Overall Study||0||
59637286|NCT02154048|75752758|FG000|STARTED|Overall Study||2||
59637287|NCT02154048|75752759|FG001|STARTED|Overall Study||2||
59637288|NCT02154048|75752760|FG002|STARTED|Overall Study||1||
59637289|NCT02154048|75752758|FG000|COMPLETED|Overall Study||2||
59637290|NCT02154048|75752759|FG001|COMPLETED|Overall Study||2||
59637291|NCT02154048|75752760|FG002|COMPLETED|Overall Study||1||
59637292|NCT02154048|75752758|FG000|NOT COMPLETED|Overall Study||0||
59637293|NCT02154048|75752759|FG001|NOT COMPLETED|Overall Study||0||
59637294|NCT02154048|75752760|FG002|NOT COMPLETED|Overall Study||0||
59637295|NCT02154672|75752768|FG000|STARTED|Overall Study||1||
59637296|NCT02154672|75752768|FG000|COMPLETED|Overall Study||1||
59637297|NCT02154672|75752768|FG000|NOT COMPLETED|Overall Study||0||
59637298|NCT02154906|75752774|FG000|STARTED|Overall Study||21||
59637299|NCT02154906|75752775|FG001|STARTED|Overall Study||20||
59637300|NCT02154906|75752774|FG000|COMPLETED|Overall Study||19||
59637301|NCT02154906|75752775|FG001|COMPLETED|Overall Study||17||
59637302|NCT02154906|75752774|FG000|NOT COMPLETED|Overall Study||2||
59637303|NCT02154906|75752775|FG001|NOT COMPLETED|Overall Study||3||
59637304|NCT02156154|75752783|FG000|STARTED|Overall Study||291||
59637305|NCT02156154|75752784|FG001|STARTED|Overall Study||289||
59637306|NCT02156154|75752783|FG000|COMPLETED|Overall Study||287||
59637307|NCT02156154|75752784|FG001|COMPLETED|Overall Study||283||
59637308|NCT02156154|75752783|FG000|NOT COMPLETED|Overall Study||4||
59637309|NCT02156154|75752784|FG001|NOT COMPLETED|Overall Study||6||
59637310|NCT02157168|75752793|FG000|STARTED|Overall Study||746||
59637311|NCT02157168|75752794|FG001|STARTED|Overall Study||159||
59637312|NCT02157168|75752795|FG002|STARTED|Overall Study||1362||
59637313|NCT02157168|75752793|FG000|COMPLETED|Overall Study||746||
59637314|NCT02157168|75752794|FG001|COMPLETED|Overall Study||159||
59637315|NCT02157168|75752795|FG002|COMPLETED|Overall Study||1362||
59637316|NCT02157168|75752793|FG000|NOT COMPLETED|Overall Study||0||
59637317|NCT02157168|75752794|FG001|NOT COMPLETED|Overall Study||0||
59637318|NCT02157168|75752795|FG002|NOT COMPLETED|Overall Study||0||
59637319|NCT02158494|75752808|FG000|STARTED|Overall Study||22||
59637320|NCT02158494|75752809|FG001|STARTED|Overall Study||22||
59637321|NCT02158494|75752808|FG000|COMPLETED|Overall Study||22||
59637322|NCT02158494|75752809|FG001|COMPLETED|Overall Study||21||
59637323|NCT02158494|75752808|FG000|NOT COMPLETED|Overall Study||0||
59637324|NCT02158494|75752809|FG001|NOT COMPLETED|Overall Study||1||
59637325|NCT02158572|75752820|FG000|STARTED|Overall Study||2032||
59637326|NCT02158572|75752820|FG000|COMPLETED|Overall Study||989||
59637327|NCT02158572|75752820|FG000|NOT COMPLETED|Overall Study||1043||
59637328|NCT02159118|75752826|FG000|STARTED|Overall Study||22||
59637329|NCT02159118|75752827|FG001|STARTED|Overall Study||22||
59637330|NCT02159118|75752826|FG000|COMPLETED|Overall Study||22||
59637331|NCT02159118|75752827|FG001|COMPLETED|Overall Study||22||
59637332|NCT02159118|75752826|FG000|NOT COMPLETED|Overall Study||0||
59637333|NCT02159118|75752827|FG001|NOT COMPLETED|Overall Study||0||
59637334|NCT02159898|75752835|FG000|STARTED|Overall Study||30||
59637335|NCT02159898|75752836|FG001|STARTED|Overall Study||30||
59637336|NCT02159898|75752835|FG000|COMPLETED|Overall Study||29||
59637337|NCT02159898|75752836|FG001|COMPLETED|Overall Study||30||
59637338|NCT02159898|75752835|FG000|NOT COMPLETED|Overall Study||1||
59637339|NCT02159898|75752836|FG001|NOT COMPLETED|Overall Study||0||
59637340|NCT02159976|75752846|FG000|STARTED|Overall Study||195||
59637341|NCT02159976|75752847|FG001|STARTED|Overall Study||195||
59637342|NCT02159976|75752846|FG000|COMPLETED|Overall Study||165||
59637343|NCT02159976|75752847|FG001|COMPLETED|Overall Study||170||
59637344|NCT02159976|75752846|FG000|NOT COMPLETED|Overall Study||30||
59637345|NCT02159976|75752847|FG001|NOT COMPLETED|Overall Study||25||
59637346|NCT02160288|75752857|FG000|STARTED|Overall Study||1||
59637347|NCT02160288|75752858|FG001|STARTED|Overall Study||0||
59637348|NCT02160288|75752857|FG000|COMPLETED|Overall Study||1||
59637349|NCT02160288|75752858|FG001|COMPLETED|Overall Study||0||
59637350|NCT02160288|75752857|FG000|NOT COMPLETED|Overall Study||0||
59637351|NCT02160288|75752858|FG001|NOT COMPLETED|Overall Study||0||
59637352|NCT02160990|75752866|FG000|STARTED|Overall Study||10||
59637353|NCT02160990|75752867|FG001|STARTED|Overall Study||10||
59637354|NCT02160990|75752866|FG000|COMPLETED|Overall Study||10||
59637355|NCT02160990|75752867|FG001|COMPLETED|Overall Study||10||
59637356|NCT02160990|75752866|FG000|NOT COMPLETED|Overall Study||0||
59637357|NCT02160990|75752867|FG001|NOT COMPLETED|Overall Study||0||
59637358|NCT02161536|75752876|FG000|STARTED|Overall Study||6||
59637359|NCT02161536|75752877|FG001|STARTED|Overall Study||21||
59637360|NCT02161536|75752878|FG002|STARTED|Overall Study||20||
59637361|NCT02161536|75752876|FG000|COMPLETED|Overall Study||6||
59637362|NCT02161536|75752877|FG001|COMPLETED|Overall Study||21||
59637363|NCT02161536|75752878|FG002|COMPLETED|Overall Study||20||
59637364|NCT02161536|75752876|FG000|NOT COMPLETED|Overall Study||0||
59637365|NCT02161536|75752877|FG001|NOT COMPLETED|Overall Study||0||
59637366|NCT02161536|75752878|FG002|NOT COMPLETED|Overall Study||0||
59637367|NCT02163486|75752888|FG000|STARTED|Overall Study||51||
59637368|NCT02163486|75752889|FG001|STARTED|Overall Study||52||
59637369|NCT02163486|75752888|FG000|COMPLETED|Overall Study||50||
59637370|NCT02163486|75752889|FG001|COMPLETED|Overall Study||50||
59637371|NCT02163486|75752888|FG000|NOT COMPLETED|Overall Study||1||
59637372|NCT02163486|75752889|FG001|NOT COMPLETED|Overall Study||2||
59637373|NCT02164422|75752898|FG000|STARTED|Overall Study||25||
59637374|NCT02164422|75752899|FG001|STARTED|Overall Study||22||
59637375|NCT02164422|75752900|FG002|STARTED|Overall Study||23||
59637376|NCT02164422|75752898|FG000|COMPLETED|Overall Study||24||
59637377|NCT02164422|75752899|FG001|COMPLETED|Overall Study||20||
59637378|NCT02164422|75752900|FG002|COMPLETED|Overall Study||23||
59637379|NCT02164422|75752898|FG000|NOT COMPLETED|Overall Study||1||
59637380|NCT02164422|75752899|FG001|NOT COMPLETED|Overall Study||2||
59637381|NCT02164422|75752900|FG002|NOT COMPLETED|Overall Study||0||
59637382|NCT02165124|75752908|FG000|STARTED|Overall Study||20||
59637383|NCT02165124|75752908|FG000|COMPLETED|Overall Study||15||
59637384|NCT02165124|75752908|FG000|NOT COMPLETED|Overall Study||5||
59637385|NCT02165904|75752912|FG000|STARTED|Overall Study||10||
59637386|NCT02165904|75752912|FG000|COMPLETED|Overall Study||10||
59637387|NCT02165904|75752912|FG000|NOT COMPLETED|Overall Study||0||
59637388|NCT02167074|75752918|FG000|STARTED|Overall Study||306||
59637389|NCT02167074|75752919|FG001|STARTED|Overall Study||302||
59637390|NCT02167074|75752918|FG000|COMPLETED|Overall Study||306||
59637391|NCT02167074|75752919|FG001|COMPLETED|Overall Study||302||
59637392|NCT02167074|75752918|FG000|NOT COMPLETED|Overall Study||0||
59637393|NCT02167074|75752919|FG001|NOT COMPLETED|Overall Study||0||
59637394|NCT02170662|75752927|FG000|STARTED|Overall Study||3||
59637395|NCT02170662|75752928|FG001|STARTED|Overall Study||6||
59637396|NCT02170662|75752927|FG000|COMPLETED|Overall Study||3||
59637397|NCT02170662|75752928|FG001|COMPLETED|Overall Study||6||
59637398|NCT02170662|75752927|FG000|NOT COMPLETED|Overall Study||0||
59637399|NCT02170662|75752928|FG001|NOT COMPLETED|Overall Study||0||
59637400|NCT02173392|75752936|FG000|STARTED|Overall Study||73||
59637401|NCT02173392|75752937|FG001|STARTED|Overall Study||72||
59637402|NCT02173392|75752936|FG000|COMPLETED|Overall Study||59||
59637403|NCT02173392|75752937|FG001|COMPLETED|Overall Study||68||
59637404|NCT02173392|75752936|FG000|NOT COMPLETED|Overall Study||14||
59637405|NCT02173392|75752937|FG001|NOT COMPLETED|Overall Study||4||
59637406|NCT02178540|75752945|FG000|STARTED|Overall Study||45||
59637407|NCT02178540|75752945|FG000|COMPLETED|Overall Study||45||
59637408|NCT02178540|75752945|FG000|NOT COMPLETED|Overall Study||0||
59637409|NCT02178696|75752952|FG000|STARTED|First Assignment and Washout||20||
59637410|NCT02178696|75752953|FG001|STARTED|First Assignment and Washout||20||
59637411|NCT02178696|75752952|FG000|COMPLETED|First Assignment and Washout||20||
59637412|NCT02178696|75752953|FG001|COMPLETED|First Assignment and Washout||20||
59637413|NCT02178696|75752952|FG000|NOT COMPLETED|First Assignment and Washout||0||
59637414|NCT02178696|75752953|FG001|NOT COMPLETED|First Assignment and Washout||0||
59637415|NCT02178696|75752952|FG000|STARTED|Second Assignment After Crossover||20||
59637416|NCT02178696|75752953|FG001|STARTED|Second Assignment After Crossover||20||
59637417|NCT02178696|75752952|FG000|COMPLETED|Second Assignment After Crossover||20||
59637418|NCT02178696|75752953|FG001|COMPLETED|Second Assignment After Crossover||20||
59637419|NCT02178696|75752952|FG000|NOT COMPLETED|Second Assignment After Crossover||0||
59637420|NCT02178696|75752953|FG001|NOT COMPLETED|Second Assignment After Crossover||0||
59637421|NCT02178696|75752952|FG000|STARTED|Open-label Antidepressant||20||
59637422|NCT02178696|75752953|FG001|STARTED|Open-label Antidepressant||20||
59637423|NCT02178696|75752952|FG000|COMPLETED|Open-label Antidepressant||14||
59637424|NCT02178696|75752953|FG001|COMPLETED|Open-label Antidepressant||13||
59637425|NCT02178696|75752952|FG000|NOT COMPLETED|Open-label Antidepressant||6||
59637426|NCT02178696|75752953|FG001|NOT COMPLETED|Open-label Antidepressant||7||
59637427|NCT02179788|75752966|FG000|STARTED|Overall Study||10||
59637428|NCT02179788|75752967|FG001|STARTED|Overall Study||5||
59637429|NCT02179788|75752966|FG000|COMPLETED|Overall Study||10||
59637430|NCT02179788|75752967|FG001|COMPLETED|Overall Study||5||
59637431|NCT02179788|75752966|FG000|NOT COMPLETED|Overall Study||0||
59637432|NCT02179788|75752967|FG001|NOT COMPLETED|Overall Study||0||
59637433|NCT02180100|75752975|FG000|STARTED|Overall Study||70||
59637434|NCT02180100|75752976|FG001|STARTED|Overall Study||70||
59637435|NCT02180100|75752975|FG000|COMPLETED|Overall Study||58||
59637436|NCT02180100|75752976|FG001|COMPLETED|Overall Study||66||
59637437|NCT02180100|75752975|FG000|NOT COMPLETED|Overall Study||12||
59637438|NCT02180100|75752976|FG001|NOT COMPLETED|Overall Study||4||
59637439|NCT02180646|75752984|FG000|STARTED|First Intervention (7 Days)||6||
59637440|NCT02180646|75752985|FG001|STARTED|First Intervention (7 Days)||6||
59637441|NCT02180646|75752984|FG000|COMPLETED|First Intervention (7 Days)||6||
59637442|NCT02180646|75752985|FG001|COMPLETED|First Intervention (7 Days)||6||
59637443|NCT02180646|75752984|FG000|NOT COMPLETED|First Intervention (7 Days)||0||
59637444|NCT02180646|75752985|FG001|NOT COMPLETED|First Intervention (7 Days)||0||
59637445|NCT02180646|75752984|FG000|STARTED|Washout (7 Days)||6||
59637446|NCT02180646|75752985|FG001|STARTED|Washout (7 Days)||6||
59637447|NCT02180646|75752984|FG000|COMPLETED|Washout (7 Days)||6||
59637448|NCT02180646|75752985|FG001|COMPLETED|Washout (7 Days)||6||
59637449|NCT02180646|75752984|FG000|NOT COMPLETED|Washout (7 Days)||0||
59637450|NCT02180646|75752985|FG001|NOT COMPLETED|Washout (7 Days)||0||
59637451|NCT02180646|75752984|FG000|STARTED|Second Intervention (7 Days)||6||
59637452|NCT02180646|75752985|FG001|STARTED|Second Intervention (7 Days)||6||
59637453|NCT02180646|75752984|FG000|COMPLETED|Second Intervention (7 Days)||6||
59637454|NCT02180646|75752985|FG001|COMPLETED|Second Intervention (7 Days)||6||
59637455|NCT02180646|75752984|FG000|NOT COMPLETED|Second Intervention (7 Days)||0||
59637456|NCT02180646|75752985|FG001|NOT COMPLETED|Second Intervention (7 Days)||0||
59637457|NCT02181426|75752997|FG000|STARTED|Overall Study||28||
59637458|NCT02181426|75752998|FG001|STARTED|Overall Study||28||
59637459|NCT02181426|75752999|FG002|STARTED|Overall Study||28||
59637460|NCT02181426|75753000|FG003|STARTED|Overall Study||28||
59637461|NCT02181426|75752997|FG000|COMPLETED|Overall Study||28||
59637462|NCT02181426|75752998|FG001|COMPLETED|Overall Study||28||
59815737|NCT03233724|75938193|FG000|NOT COMPLETED|Phase II Dose Expansion||0||
59637463|NCT02181426|75752999|FG002|COMPLETED|Overall Study||28||
59637464|NCT02181426|75753000|FG003|COMPLETED|Overall Study||28||
59637465|NCT02181426|75752997|FG000|NOT COMPLETED|Overall Study||0||
59637466|NCT02181426|75752998|FG001|NOT COMPLETED|Overall Study||0||
59637467|NCT02181426|75752999|FG002|NOT COMPLETED|Overall Study||0||
59637468|NCT02181426|75753000|FG003|NOT COMPLETED|Overall Study||0||
59637469|NCT02184624|75753015|FG000|STARTED|Overall Study||171||
59637470|NCT02184624|75753016|FG001|STARTED|Overall Study||80||
59637471|NCT02184624|75753017|FG002|STARTED|Overall Study||100||
59637472|NCT02184624|75753018|FG003|STARTED|Overall Study||118||
59637473|NCT02184624|75753019|FG004|STARTED|Overall Study||98||
59637474|NCT02184624|75753015|FG000|COMPLETED|Overall Study||171||
59637475|NCT02184624|75753016|FG001|COMPLETED|Overall Study||80||
59637476|NCT02184624|75753017|FG002|COMPLETED|Overall Study||100||
59637477|NCT02184624|75753018|FG003|COMPLETED|Overall Study||118||
59637478|NCT02184624|75753019|FG004|COMPLETED|Overall Study||98||
59637479|NCT02184624|75753015|FG000|NOT COMPLETED|Overall Study||0||
59637480|NCT02184624|75753016|FG001|NOT COMPLETED|Overall Study||0||
59637481|NCT02184624|75753017|FG002|NOT COMPLETED|Overall Study||0||
59637482|NCT02184624|75753018|FG003|NOT COMPLETED|Overall Study||0||
59637483|NCT02184624|75753019|FG004|NOT COMPLETED|Overall Study||0||
59637484|NCT02185404|75753031|FG000|STARTED|Overall Study||6||
59637485|NCT02185404|75753031|FG000|COMPLETED|Overall Study||6||
59637486|NCT02185404|75753031|FG000|NOT COMPLETED|Overall Study||0||
59637487|NCT02186808|75753035|FG000|STARTED|Overall Study||80||
59637488|NCT02186808|75753035|FG000|COMPLETED|Overall Study||67||
59637489|NCT02186808|75753035|FG000|NOT COMPLETED|Overall Study||13||
59637490|NCT02189382|75753041|FG000|STARTED|Overall Study||35||
59637491|NCT02189382|75753042|FG001|STARTED|Overall Study||35||
59637492|NCT02189382|75753041|FG000|COMPLETED|Overall Study||35||
59637493|NCT02189382|75753042|FG001|COMPLETED|Overall Study||35||
59637494|NCT02189382|75753041|FG000|NOT COMPLETED|Overall Study||0||
59637495|NCT02189382|75753042|FG001|NOT COMPLETED|Overall Study||0||
59637496|NCT02189850|75753050|FG000|STARTED|Overall Study||16|Safety population - all subjects that took preparation.|
59637497|NCT02189850|75753051|FG001|STARTED|Overall Study||13|Safety population - all subjects that took preparation.|
59637498|NCT02189850|75753050|FG000|COMPLETED|Overall Study||14||
59637499|NCT02189850|75753051|FG001|COMPLETED|Overall Study||11||
59637500|NCT02189850|75753050|FG000|NOT COMPLETED|Overall Study||2||
59637501|NCT02189850|75753051|FG001|NOT COMPLETED|Overall Study||2||
59637502|NCT02190552|75753057|FG000|STARTED|Overall Study||40||
59637503|NCT02190552|75753057|FG000|COMPLETED|Overall Study||36||
59637504|NCT02190552|75753057|FG000|NOT COMPLETED|Overall Study||4||
59637505|NCT02192814|75753062|FG000|STARTED|Overall Study||9||
59637506|NCT02192814|75753062|FG000|COMPLETED|Overall Study||9||
59637507|NCT02192814|75753062|FG000|NOT COMPLETED|Overall Study||0||
59637508|NCT02195232|75753068|FG000|STARTED|Overall Study|patients consented|32||
59637509|NCT02195232|75753069|FG001|STARTED|Overall Study|patients consented|32||
59637510|NCT02195232|75753068|FG000|COMPLETED|Overall Study|Evaluated for VTE and safety|28||
59637511|NCT02195232|75753069|FG001|COMPLETED|Overall Study|Evaluated for VTE and safety|29||
59637512|NCT02195232|75753068|FG000|NOT COMPLETED|Overall Study||4||
59637513|NCT02195232|75753069|FG001|NOT COMPLETED|Overall Study||3||
59637514|NCT02195622|75753081|FG000|STARTED|Overall Study||37||
59637515|NCT02195622|75753082|FG001|STARTED|Overall Study||37||
59637516|NCT02195622|75753081|FG000|COMPLETED|Overall Study||37||
59637517|NCT02195622|75753082|FG001|COMPLETED|Overall Study||37||
59637518|NCT02195622|75753081|FG000|NOT COMPLETED|Overall Study||0||
59637519|NCT02195622|75753082|FG001|NOT COMPLETED|Overall Study||0||
59637520|NCT02196168|75753090|FG000|STARTED|Overall Study||6||
59637521|NCT02196168|75753091|FG001|STARTED|Overall Study||0||
59637522|NCT02196168|75753090|FG000|COMPLETED|Overall Study||6||
60076557|NCT01890265|76191552|FG000|NOT COMPLETED|Overall Study||10||
60076558|NCT01890265|76191553|FG001|NOT COMPLETED|Overall Study||13||
59541280|NCT01550471|75639569|FG004|STARTED|First Wash Out Period (3 Weeks)||4||
59541281|NCT01550471|75639570|FG005|STARTED|First Wash Out Period (3 Weeks)||4||
59541282|NCT01550471|75639565|FG000|COMPLETED|First Wash Out Period (3 Weeks)||3||
59541283|NCT01550471|75639566|FG001|COMPLETED|First Wash Out Period (3 Weeks)||4||
59541284|NCT01550471|75639567|FG002|COMPLETED|First Wash Out Period (3 Weeks)||3||
59541285|NCT01550471|75639568|FG003|COMPLETED|First Wash Out Period (3 Weeks)||4||
59541286|NCT01550471|75639569|FG004|COMPLETED|First Wash Out Period (3 Weeks)||4||
59541287|NCT01550471|75639570|FG005|COMPLETED|First Wash Out Period (3 Weeks)||4||
59541288|NCT01550471|75639565|FG000|NOT COMPLETED|First Wash Out Period (3 Weeks)||0||
59541289|NCT01550471|75639566|FG001|NOT COMPLETED|First Wash Out Period (3 Weeks)||0||
59541290|NCT01550471|75639567|FG002|NOT COMPLETED|First Wash Out Period (3 Weeks)||0||
59637523|NCT02196168|75753091|FG001|COMPLETED|Overall Study||0||
59637524|NCT02196168|75753090|FG000|NOT COMPLETED|Overall Study||0||
59637525|NCT02196168|75753091|FG001|NOT COMPLETED|Overall Study||0||
59637526|NCT02198430|75753099|FG000|STARTED|Overall Study||53||
59637527|NCT02198430|75753100|FG001|STARTED|Overall Study||51||
59637528|NCT02198430|75753099|FG000|COMPLETED|Overall Study||53||
59637529|NCT02198430|75753100|FG001|COMPLETED|Overall Study||51||
59637530|NCT02198430|75753099|FG000|NOT COMPLETED|Overall Study||0||
59637531|NCT02198430|75753100|FG001|NOT COMPLETED|Overall Study||0||
59637532|NCT02200458|75753106|FG000|STARTED|Overall Study||62||
59637533|NCT02200458|75753106|FG000|COMPLETED|Overall Study||62||
59637534|NCT02200458|75753106|FG000|NOT COMPLETED|Overall Study||0||
59637535|NCT02200536|75753113|FG000|STARTED|Overall Study||32||
59637536|NCT02200536|75753114|FG001|STARTED|Overall Study||30||
59637537|NCT02200536|75753115|FG002|STARTED|Overall Study||30||
59637538|NCT02200536|75753113|FG000|COMPLETED|Overall Study||32||
59637539|NCT02200536|75753114|FG001|COMPLETED|Overall Study||30||
59637540|NCT02200536|75753115|FG002|COMPLETED|Overall Study||30||
59637541|NCT02200536|75753113|FG000|NOT COMPLETED|Overall Study||0||
59637542|NCT02200536|75753114|FG001|NOT COMPLETED|Overall Study||0||
59637543|NCT02200536|75753115|FG002|NOT COMPLETED|Overall Study||0||
59637544|NCT02201394|75753123|FG000|STARTED|Loading Dose||20||
59637545|NCT02201394|75753123|FG000|COMPLETED|Loading Dose||20||
59637546|NCT02201394|75753123|FG000|NOT COMPLETED|Loading Dose||0||
59637547|NCT02201394|75753123|FG000|STARTED|Maintenance Dose||20||
59637548|NCT02201394|75753123|FG000|COMPLETED|Maintenance Dose||20||
59637549|NCT02201394|75753123|FG000|NOT COMPLETED|Maintenance Dose||0||
60076559|NCT01890265|76191554|FG002|NOT COMPLETED|Overall Study||4||
60076560|NCT01890265|76191555|FG003|NOT COMPLETED|Overall Study||0||
60076561|NCT01890265|76191556|FG004|NOT COMPLETED|Overall Study||2||
60076562|NCT01890265|76191557|FG005|NOT COMPLETED|Overall Study||0||
60076563|NCT03070444|76191569|FG000|STARTED|Overall Study||52||
60076564|NCT03070444|76191570|FG001|STARTED|Overall Study||52||
60076565|NCT03070444|76191569|FG000|COMPLETED|Overall Study||39||
59637550|NCT02202252|75753130|FG000|STARTED|Overall Study||30||
59637551|NCT02202252|75753131|FG001|STARTED|Overall Study||30||
59637552|NCT02202252|75753130|FG000|COMPLETED|Overall Study||30||
59637553|NCT02202252|75753131|FG001|COMPLETED|Overall Study||30||
59637554|NCT02202252|75753130|FG000|NOT COMPLETED|Overall Study||0||
59637555|NCT02202252|75753131|FG001|NOT COMPLETED|Overall Study||0||
59637556|NCT02203578|75753137|FG000|STARTED|Overall Study||1||
59637557|NCT02203578|75753137|FG000|COMPLETED|Overall Study||1||
59637558|NCT02203578|75753137|FG000|NOT COMPLETED|Overall Study||0||
59637559|NCT02204124|75753143|FG000|STARTED|Overall Study||13||
59637560|NCT02204124|75753144|FG001|STARTED|Overall Study||19||
59637561|NCT02204124|75753143|FG000|COMPLETED|Overall Study||13||
59637562|NCT02204124|75753144|FG001|COMPLETED|Overall Study||19||
59637563|NCT02204124|75753143|FG000|NOT COMPLETED|Overall Study||0||
59637564|NCT02204124|75753144|FG001|NOT COMPLETED|Overall Study||0||
59637565|NCT02204748|75753150|FG000|STARTED|Overall Study||5||
59637566|NCT02204748|75753150|FG000|COMPLETED|Overall Study||5||
59637567|NCT02204748|75753150|FG000|NOT COMPLETED|Overall Study||0||
59637568|NCT02206776|75753156|FG000|STARTED|Overall Study||1||
59637569|NCT02206776|75753157|FG001|STARTED|Overall Study||1||
59637570|NCT02206776|75753156|FG000|COMPLETED|Overall Study||1||
59637571|NCT02206776|75753157|FG001|COMPLETED|Overall Study||1||
59637572|NCT02206776|75753156|FG000|NOT COMPLETED|Overall Study||0||
59637573|NCT02206776|75753157|FG001|NOT COMPLETED|Overall Study||0||
59988435|NCT02520284|76103614|FG002|STARTED|Blinded Induction Phase: Up to Week 8||55||
59988436|NCT02520284|76103612|FG000|COMPLETED|Blinded Induction Phase: Up to Week 8||52||
59988437|NCT02520284|76103613|FG001|COMPLETED|Blinded Induction Phase: Up to Week 8|1 Participant completed Blinded Induction Phase but did not continue further in study.|52||
59988438|NCT02520284|76103614|FG002|COMPLETED|Blinded Induction Phase: Up to Week 8|1 Participant completed Blinded Induction Phase but did not continue further in study.|53||
59988439|NCT02520284|76103612|FG000|NOT COMPLETED|Blinded Induction Phase: Up to Week 8||2||
59988440|NCT02520284|76103613|FG001|NOT COMPLETED|Blinded Induction Phase: Up to Week 8||4||
59988441|NCT02520284|76103614|FG002|NOT COMPLETED|Blinded Induction Phase: Up to Week 8||2||
59988442|NCT02520284|76103612|FG000|STARTED|Blinded Maintenance Phase: Up to Week 51|Participants achieving EBS remission and/or MCS response continued in Blinded Maintenance Phase.|20||
59988443|NCT02520284|76103613|FG001|STARTED|Blinded Maintenance Phase: Up to Week 51|Participants achieving EBS remission and/or MCS response continued in Blinded Maintenance Phase.|16||
59637574|NCT02207322|75753165|FG000|STARTED|Overall Study||79||
59637575|NCT02207322|75753166|FG001|STARTED|Overall Study||81||
59637576|NCT02207322|75753165|FG000|Week-2|Overall Study||77||
59637577|NCT02207322|75753166|FG001|Week-2|Overall Study||80||
59637578|NCT02207322|75753165|FG000|3-month|Overall Study||74||
59637579|NCT02207322|75753166|FG001|3-month|Overall Study||75||
59637580|NCT02207322|75753165|FG000|COMPLETED|Overall Study|6-month|70|6-month|
59637581|NCT02207322|75753166|FG001|COMPLETED|Overall Study|6-month|71|6-month|
59637582|NCT02207322|75753165|FG000|NOT COMPLETED|Overall Study||9||
59637583|NCT02207322|75753166|FG001|NOT COMPLETED|Overall Study||10||
59637584|NCT02207478|75753174|FG000|STARTED|Overall Study||40||
59637585|NCT02207478|75753175|FG001|STARTED|Overall Study||46||
59637586|NCT02207478|75753174|FG000|COMPLETED|Overall Study||40||
59637587|NCT02207478|75753175|FG001|COMPLETED|Overall Study||46||
59995441|NCT02911792|76111264|FG003|STARTED|Overall Study||18||
59995442|NCT02911792|76111261|FG000|COMPLETED|Overall Study||15||
59995443|NCT02911792|76111262|FG001|COMPLETED|Overall Study||15||
59995444|NCT02911792|76111263|FG002|COMPLETED|Overall Study||15||
59995445|NCT02911792|76111264|FG003|COMPLETED|Overall Study||15||
59995446|NCT02911792|76111261|FG000|NOT COMPLETED|Overall Study||3||
59637588|NCT02207478|75753174|FG000|NOT COMPLETED|Overall Study||0||
59637589|NCT02207478|75753175|FG001|NOT COMPLETED|Overall Study||0||
59637590|NCT02209272|75753183|FG000|STARTED|Overall Study||32||
59637591|NCT02209272|75753184|FG001|STARTED|Overall Study||36||
59637592|NCT02209272|75753183|FG000|COMPLETED|Overall Study||32||
59637593|NCT02209272|75753184|FG001|COMPLETED|Overall Study||36||
59637594|NCT02209272|75753183|FG000|NOT COMPLETED|Overall Study||0||
59637595|NCT02209272|75753184|FG001|NOT COMPLETED|Overall Study||0||
59637596|NCT02210052|75753190|FG000|STARTED|Overall Study||6||
59637597|NCT02210052|75753190|FG000|COMPLETED|Overall Study||6||
59637598|NCT02210052|75753190|FG000|NOT COMPLETED|Overall Study||0||
59637599|NCT02210286|75753194|FG000|STARTED|Overall Study||17||
59637600|NCT02210286|75753194|FG000|COMPLETED|Overall Study||15||
59637601|NCT02210286|75753194|FG000|NOT COMPLETED|Overall Study||2||
59637602|NCT02211456|75753202|FG000|STARTED|Overall Study||15||
59637603|NCT02211456|75753202|FG000|COMPLETED|Overall Study||15||
59637604|NCT02211456|75753202|FG000|NOT COMPLETED|Overall Study||0||
59637605|NCT02211534|75753208|FG000|STARTED|Overall Study||24||
59637606|NCT02211534|75753209|FG001|STARTED|Overall Study||11||
59637607|NCT02211534|75753208|FG000|COMPLETED|Overall Study||11||
59637608|NCT02211534|75753209|FG001|COMPLETED|Overall Study||6||
59995447|NCT02911792|76111262|FG001|NOT COMPLETED|Overall Study||3||
59995448|NCT02911792|76111263|FG002|NOT COMPLETED|Overall Study||3||
59637609|NCT02211534|75753208|FG000|NOT COMPLETED|Overall Study||13||
59637610|NCT02211534|75753209|FG001|NOT COMPLETED|Overall Study||5||
59995449|NCT02911792|76111264|FG003|NOT COMPLETED|Overall Study||3||
59637611|NCT02213250|75753215|FG000|STARTED|Overall Study||4||
59637612|NCT02213250|75753216|FG001|STARTED|Overall Study||8||
59637613|NCT02213250|75753215|FG000|COMPLETED|Overall Study||4||
59637614|NCT02213250|75753216|FG001|COMPLETED|Overall Study||8||
59637615|NCT02213250|75753215|FG000|NOT COMPLETED|Overall Study||0||
59637616|NCT02213250|75753216|FG001|NOT COMPLETED|Overall Study||0||
59637617|NCT02214420|75753225|FG000|STARTED|Overall Study||14||
59637618|NCT02214420|75753226|FG001|STARTED|Overall Study||10||
59637619|NCT02214420|75753225|FG000|COMPLETED|Overall Study||13||
59637620|NCT02214420|75753226|FG001|COMPLETED|Overall Study||10||
59637621|NCT02214420|75753225|FG000|NOT COMPLETED|Overall Study||1||
59637622|NCT02214420|75753226|FG001|NOT COMPLETED|Overall Study||0||
59637623|NCT02215200|75753235|FG000|STARTED|Overall Study||29||
59637624|NCT02215200|75753236|FG001|STARTED|Overall Study||29||
59637625|NCT02215200|75753237|FG002|STARTED|Overall Study||31||
59637626|NCT02215200|75753235|FG000|COMPLETED|Overall Study||29||
59637627|NCT02215200|75753236|FG001|COMPLETED|Overall Study||28||
59637628|NCT02215200|75753237|FG002|COMPLETED|Overall Study||30||
59637629|NCT02215200|75753235|FG000|NOT COMPLETED|Overall Study||0||
59637630|NCT02215200|75753236|FG001|NOT COMPLETED|Overall Study||1||
59637631|NCT02215200|75753237|FG002|NOT COMPLETED|Overall Study||1||
59637632|NCT02216136|75753248|FG000|STARTED|Overall Study||72||
59637633|NCT02216136|75753249|FG001|STARTED|Overall Study||90||
59637634|NCT02216136|75753250|FG002|STARTED|Overall Study||0||
59637635|NCT02216136|75753248|FG000|COMPLETED|Overall Study||72||
59637636|NCT02216136|75753249|FG001|COMPLETED|Overall Study||90||
59637637|NCT02216136|75753250|FG002|COMPLETED|Overall Study||0||
59637638|NCT02216136|75753248|FG000|NOT COMPLETED|Overall Study||0||
59637639|NCT02216136|75753249|FG001|NOT COMPLETED|Overall Study||0||
59637640|NCT02216136|75753250|FG002|NOT COMPLETED|Overall Study||0||
59637641|NCT02217618|75753258|FG000|STARTED|Overall Study||16||
59541291|NCT01550471|75639568|FG003|NOT COMPLETED|First Wash Out Period (3 Weeks)||0||
59541292|NCT01550471|75639569|FG004|NOT COMPLETED|First Wash Out Period (3 Weeks)||0||
59541293|NCT01550471|75639570|FG005|NOT COMPLETED|First Wash Out Period (3 Weeks)||0||
59541294|NCT01550471|75639565|FG000|STARTED|Second Treatment Period (3 Weeks)||3||
59541295|NCT01550471|75639566|FG001|STARTED|Second Treatment Period (3 Weeks)||4||
59541296|NCT01550471|75639567|FG002|STARTED|Second Treatment Period (3 Weeks)||3||
59637642|NCT02217618|75753258|FG000|Received Study Drug|Overall Study||16||
59637643|NCT02217618|75753258|FG000|COMPLETED|Overall Study||16||
59637644|NCT02217618|75753258|FG000|NOT COMPLETED|Overall Study||0||
59637645|NCT02218242|75753262|FG000|STARTED|Overall Study||9||
59637646|NCT02218242|75753262|FG000|COMPLETED|Overall Study||9||
59637647|NCT02218242|75753262|FG000|NOT COMPLETED|Overall Study||0||
59637648|NCT02218320|75753268|FG000|STARTED|Overall Study|First participant visit on this arm Dec 2014|10||
59637649|NCT02218320|75753269|FG001|STARTED|Overall Study|First participant contact on this arm was December 2014|10||
59637650|NCT02218320|75753268|FG000|COMPLETED|Overall Study|Last participant contact on this arm was June 2015|10||
59637651|NCT02218320|75753269|FG001|COMPLETED|Overall Study|Last participant contact on this arm was October 2015|10||
59541297|NCT01550471|75639568|FG003|STARTED|Second Treatment Period (3 Weeks)||4||
59541298|NCT01550471|75639569|FG004|STARTED|Second Treatment Period (3 Weeks)||4||
59541299|NCT01550471|75639570|FG005|STARTED|Second Treatment Period (3 Weeks)||4||
59541300|NCT01550471|75639565|FG000|COMPLETED|Second Treatment Period (3 Weeks)||3||
59541301|NCT01550471|75639566|FG001|COMPLETED|Second Treatment Period (3 Weeks)||4||
59541302|NCT01550471|75639567|FG002|COMPLETED|Second Treatment Period (3 Weeks)||3||
59541303|NCT01550471|75639568|FG003|COMPLETED|Second Treatment Period (3 Weeks)||4||
59541304|NCT01550471|75639569|FG004|COMPLETED|Second Treatment Period (3 Weeks)||4||
59541305|NCT01550471|75639570|FG005|COMPLETED|Second Treatment Period (3 Weeks)||4||
59541306|NCT01550471|75639565|FG000|NOT COMPLETED|Second Treatment Period (3 Weeks)||0||
59541307|NCT01550471|75639566|FG001|NOT COMPLETED|Second Treatment Period (3 Weeks)||0||
59637652|NCT02218320|75753268|FG000|NOT COMPLETED|Overall Study||0||
59637653|NCT02218320|75753269|FG001|NOT COMPLETED|Overall Study||0||
59637654|NCT02219256|75753287|FG000|STARTED|Overall Study||12||
59637655|NCT02219256|75753288|FG001|STARTED|Overall Study||4||
59637656|NCT02219256|75753289|FG002|STARTED|Overall Study||4||
59637657|NCT02219256|75753290|FG003|STARTED|Overall Study||4||
59637658|NCT02219256|75753291|FG004|STARTED|Overall Study||6||
59637659|NCT02219256|75753292|FG005|STARTED|Overall Study||6||
59637660|NCT02219256|75753293|FG006|STARTED|Overall Study||6||
59637661|NCT02219256|75753294|FG007|STARTED|Overall Study||8||
59637662|NCT02219256|75753295|FG008|STARTED|Overall Study||6||
59637663|NCT02219256|75753296|FG009|STARTED|Overall Study||6||
59637664|NCT02219256|75753297|FG010|STARTED|Overall Study||6||
59637665|NCT02219256|75753298|FG011|STARTED|Overall Study||6||
59637666|NCT02219256|75753287|FG000|COMPLETED|Overall Study||12||
59637667|NCT02219256|75753288|FG001|COMPLETED|Overall Study||4||
59637668|NCT02219256|75753289|FG002|COMPLETED|Overall Study||4||
59637669|NCT02219256|75753290|FG003|COMPLETED|Overall Study||4||
59637670|NCT02219256|75753291|FG004|COMPLETED|Overall Study||6||
59637671|NCT02219256|75753292|FG005|COMPLETED|Overall Study||6||
59637672|NCT02219256|75753293|FG006|COMPLETED|Overall Study||6||
59637673|NCT02219256|75753294|FG007|COMPLETED|Overall Study||8||
59637674|NCT02219256|75753295|FG008|COMPLETED|Overall Study||6||
59637675|NCT02219256|75753296|FG009|COMPLETED|Overall Study||6||
59637676|NCT02219256|75753297|FG010|COMPLETED|Overall Study||6||
59637677|NCT02219256|75753298|FG011|COMPLETED|Overall Study||6||
59637678|NCT02219256|75753287|FG000|NOT COMPLETED|Overall Study||0||
59637679|NCT02219256|75753288|FG001|NOT COMPLETED|Overall Study||0||
59637680|NCT02219256|75753289|FG002|NOT COMPLETED|Overall Study||0||
59637681|NCT02219256|75753290|FG003|NOT COMPLETED|Overall Study||0||
59637682|NCT02219256|75753291|FG004|NOT COMPLETED|Overall Study||0||
59637683|NCT02219256|75753292|FG005|NOT COMPLETED|Overall Study||0||
59637684|NCT02219256|75753293|FG006|NOT COMPLETED|Overall Study||0||
59637685|NCT02219256|75753294|FG007|NOT COMPLETED|Overall Study||0||
59637686|NCT02219256|75753295|FG008|NOT COMPLETED|Overall Study||0||
59637687|NCT02219256|75753296|FG009|NOT COMPLETED|Overall Study||0||
59637688|NCT02219256|75753297|FG010|NOT COMPLETED|Overall Study||0||
59637689|NCT02219256|75753298|FG011|NOT COMPLETED|Overall Study||0||
59637690|NCT02222610|75753327|FG000|STARTED|Baseline to W48||8||8
59637691|NCT02222610|75753328|FG001|STARTED|Baseline to W48||16||16
59637692|NCT02222610|75753329|FG002|STARTED|Baseline to W48||16||16
59637693|NCT02222610|75753327|FG000|COMPLETED|Baseline to W48||8||8
59637694|NCT02222610|75753328|FG001|COMPLETED|Baseline to W48||14||14
59637695|NCT02222610|75753329|FG002|COMPLETED|Baseline to W48||15||15
59637696|NCT02222610|75753327|FG000|NOT COMPLETED|Baseline to W48||0||0
59637697|NCT02222610|75753328|FG001|NOT COMPLETED|Baseline to W48||2||2
59637698|NCT02222610|75753329|FG002|NOT COMPLETED|Baseline to W48||1||1
59637699|NCT02222610|75753327|FG000|STARTED|Baseline to W104||8||8
59637700|NCT02222610|75753328|FG001|STARTED|Baseline to W104||16||16
59637701|NCT02222610|75753329|FG002|STARTED|Baseline to W104||16||16
59637702|NCT02222610|75753327|FG000|COMPLETED|Baseline to W104||8||8
59637703|NCT02222610|75753328|FG001|COMPLETED|Baseline to W104||11||11
59637704|NCT02222610|75753329|FG002|COMPLETED|Baseline to W104||10||10
59637705|NCT02222610|75753327|FG000|NOT COMPLETED|Baseline to W104||0||0
59637706|NCT02222610|75753328|FG001|NOT COMPLETED|Baseline to W104||5||5
59637707|NCT02222610|75753329|FG002|NOT COMPLETED|Baseline to W104||6||6
59637708|NCT02223546|75753337|FG000|STARTED|Overall Study||15||
59637709|NCT02223546|75753337|FG000|COMPLETED|Overall Study||15||
59637710|NCT02223546|75753337|FG000|NOT COMPLETED|Overall Study||0||
59637711|NCT02223702|75753343|FG000|STARTED|Overall Study||20||
59637712|NCT02223702|75753344|FG001|STARTED|Overall Study||19||
59637713|NCT02223702|75753343|FG000|COMPLETED|Overall Study||19||
59637714|NCT02223702|75753344|FG001|COMPLETED|Overall Study||15||
59637715|NCT02223702|75753343|FG000|NOT COMPLETED|Overall Study||1||
59637716|NCT02223702|75753344|FG001|NOT COMPLETED|Overall Study||4||
59541308|NCT01550471|75639567|FG002|NOT COMPLETED|Second Treatment Period (3 Weeks)||0||
59541309|NCT01550471|75639568|FG003|NOT COMPLETED|Second Treatment Period (3 Weeks)||0||
59541310|NCT01550471|75639569|FG004|NOT COMPLETED|Second Treatment Period (3 Weeks)||0||
59541311|NCT01550471|75639570|FG005|NOT COMPLETED|Second Treatment Period (3 Weeks)||0||
59541312|NCT01550471|75639565|FG000|STARTED|Second Wash Out Period (3 Weeks)||3||
59541313|NCT01550471|75639566|FG001|STARTED|Second Wash Out Period (3 Weeks)||4||
59541314|NCT01550471|75639567|FG002|STARTED|Second Wash Out Period (3 Weeks)||3||
59541315|NCT01550471|75639568|FG003|STARTED|Second Wash Out Period (3 Weeks)||4||
59541316|NCT01550471|75639569|FG004|STARTED|Second Wash Out Period (3 Weeks)||4||
59541317|NCT01550471|75639570|FG005|STARTED|Second Wash Out Period (3 Weeks)||4||
59541318|NCT01550471|75639565|FG000|COMPLETED|Second Wash Out Period (3 Weeks)||3||
59541319|NCT01550471|75639566|FG001|COMPLETED|Second Wash Out Period (3 Weeks)||4||
59541320|NCT01550471|75639567|FG002|COMPLETED|Second Wash Out Period (3 Weeks)||3||
59541321|NCT01550471|75639568|FG003|COMPLETED|Second Wash Out Period (3 Weeks)||4||
59541322|NCT01550471|75639569|FG004|COMPLETED|Second Wash Out Period (3 Weeks)||4||
59637717|NCT02224404|75753350|FG000|STARTED|Overall Study||21||
59637718|NCT02224404|75753350|FG000|COMPLETED|Overall Study||21||
59637719|NCT02224404|75753350|FG000|NOT COMPLETED|Overall Study||0||
59637720|NCT02224482|75753356|FG000|STARTED|Overall Study||214||
59637721|NCT02224482|75753357|FG001|STARTED|Overall Study||217||
59637722|NCT02224482|75753356|FG000|COMPLETED|Overall Study||63||
59637723|NCT02224482|75753357|FG001|COMPLETED|Overall Study||57||
59637724|NCT02224482|75753356|FG000|NOT COMPLETED|Overall Study||151||
59637725|NCT02224482|75753357|FG001|NOT COMPLETED|Overall Study||160||
59637726|NCT02225106|75753363|FG000|STARTED|Overall Study||11||
59637727|NCT02225106|75753363|FG000|COMPLETED|Overall Study||11||
59637728|NCT02225106|75753363|FG000|NOT COMPLETED|Overall Study||0||
59637729|NCT02227758|75753367|FG000|STARTED|Overall Study||112||
59637730|NCT02227758|75753367|FG000|COMPLETED|Overall Study||45||
59637731|NCT02227758|75753367|FG000|NOT COMPLETED|Overall Study||67||
59637732|NCT02227836|75753373|FG000|STARTED|Overall Study||8||
59637733|NCT02227836|75753373|FG000|COMPLETED|Overall Study||8||
59637734|NCT02227836|75753373|FG000|NOT COMPLETED|Overall Study||0||
59637735|NCT02229318|75753377|FG000|STARTED|Overall Study|September 6th 2014 11 enrolled|11||
59637736|NCT02229318|75753377|FG000|COMPLETED|Overall Study|September 15th 2014 11 completed|11||
59637737|NCT02229318|75753377|FG000|NOT COMPLETED|Overall Study||0||
59637738|NCT02229474|75753384|FG000|STARTED|Overall Study||16||
59637739|NCT02229474|75753385|FG001|STARTED|Overall Study||18||
59637740|NCT02229474|75753384|FG000|COMPLETED|Overall Study||16||
59637741|NCT02229474|75753385|FG001|COMPLETED|Overall Study||15||
59637742|NCT02229474|75753384|FG000|NOT COMPLETED|Overall Study||0||
59637743|NCT02229474|75753385|FG001|NOT COMPLETED|Overall Study||3||
59637744|NCT02230566|75753396|FG000|STARTED|Overall Study||3||
59637745|NCT02230566|75753397|FG001|STARTED|Overall Study||3||
59637746|NCT02230566|75753398|FG002|STARTED|Overall Study||3||
59637747|NCT02230566|75753399|FG003|STARTED|Overall Study||3||
59637748|NCT02230566|75753396|FG000|COMPLETED|Overall Study||3||
59637749|NCT02230566|75753397|FG001|COMPLETED|Overall Study||3||
59637750|NCT02230566|75753398|FG002|COMPLETED|Overall Study||3||
59637751|NCT02230566|75753399|FG003|COMPLETED|Overall Study||3||
59637752|NCT02230566|75753396|FG000|NOT COMPLETED|Overall Study||0||
59637753|NCT02230566|75753397|FG001|NOT COMPLETED|Overall Study||0||
59637754|NCT02230566|75753398|FG002|NOT COMPLETED|Overall Study||0||
59637755|NCT02230566|75753399|FG003|NOT COMPLETED|Overall Study||0||
59637756|NCT02233296|75753406|FG000|STARTED|Overall Study||16||
59637757|NCT02233296|75753407|FG001|STARTED|Overall Study||14||
59637758|NCT02233296|75753406|FG000|COMPLETED|Overall Study||16||
59637759|NCT02233296|75753407|FG001|COMPLETED|Overall Study||14||
59637760|NCT02233296|75753406|FG000|NOT COMPLETED|Overall Study||0||
59637761|NCT02233296|75753407|FG001|NOT COMPLETED|Overall Study||0||
59637762|NCT02233530|75753417|FG000|STARTED|Overall Study||8||
59637763|NCT02233530|75753417|FG000|COMPLETED|Overall Study||8||
59637764|NCT02233530|75753417|FG000|NOT COMPLETED|Overall Study||0||
59637765|NCT02233842|75753421|FG000|STARTED|Questionnaire 1 Version 1||5||
59637766|NCT02233842|75753421|FG000|COMPLETED|Questionnaire 1 Version 1||5||
59637767|NCT02233842|75753421|FG000|NOT COMPLETED|Questionnaire 1 Version 1||0||
59637768|NCT02233842|75753421|FG000|STARTED|Questionnaire 1 Version 2||5||
59637769|NCT02233842|75753421|FG000|COMPLETED|Questionnaire 1 Version 2||5||
59637770|NCT02233842|75753421|FG000|NOT COMPLETED|Questionnaire 1 Version 2||0||
59637771|NCT02233842|75753421|FG000|STARTED|Questionnaire 2 Version 1||5||
59637772|NCT02233842|75753421|FG000|COMPLETED|Questionnaire 2 Version 1||5||
59637773|NCT02233842|75753421|FG000|NOT COMPLETED|Questionnaire 2 Version 1||0||
59637774|NCT02233842|75753421|FG000|STARTED|Questionnaire 2 Version 2||5||
59637775|NCT02233842|75753421|FG000|COMPLETED|Questionnaire 2 Version 2||5||
59637776|NCT02233842|75753421|FG000|NOT COMPLETED|Questionnaire 2 Version 2||0||
59637777|NCT02233842|75753421|FG000|STARTED|Questionnaire 3 Version 1||5||
59637778|NCT02233842|75753421|FG000|COMPLETED|Questionnaire 3 Version 1||5||
59637779|NCT02233842|75753421|FG000|NOT COMPLETED|Questionnaire 3 Version 1||0||
59637780|NCT02233842|75753421|FG000|STARTED|Questionnaire 3 Version 2||5||
59637781|NCT02233842|75753421|FG000|COMPLETED|Questionnaire 3 Version 2||5||
59637782|NCT02233842|75753421|FG000|NOT COMPLETED|Questionnaire 3 Version 2||0||
59637783|NCT02233998|75753429|FG000|STARTED|Overall Study||53||
59637784|NCT02233998|75753430|FG001|STARTED|Overall Study||52||
59637785|NCT02233998|75753431|FG002|STARTED|Overall Study||53||
59637786|NCT02233998|75753429|FG000|COMPLETED|Overall Study||53||
59637787|NCT02233998|75753430|FG001|COMPLETED|Overall Study||52||
59637788|NCT02233998|75753431|FG002|COMPLETED|Overall Study||53||
59637789|NCT02233998|75753429|FG000|NOT COMPLETED|Overall Study||0||
59637790|NCT02233998|75753430|FG001|NOT COMPLETED|Overall Study||0||
59637791|NCT02233998|75753431|FG002|NOT COMPLETED|Overall Study||0||
59637792|NCT02235870|75753441|FG000|STARTED|Overall Study||198|Subjects, Registered Dietitians and Adverse Event Assessors were blinded of device assignment|
59637793|NCT02235870|75753442|FG001|STARTED|Overall Study||189|Subjects, Registered Dietitians and Adverse Event Assessors were blinded of device assignment|
59637794|NCT02235870|75753441|FG000|Completed Phase I (Week 24)|Overall Study||182|Device assignment unblinding and Obalon Balloon removal for Treatment Group|
59637795|NCT02235870|75753442|FG001|Completed Phase I (Week 24)|Overall Study||179|Device assignment unblinding and Obalon Balloon removal for Treatment Group|
59637796|NCT02235870|75753441|FG000|Crossover (Week 24)|Overall Study||170|Sham Group received Obalon Balloon & Treatment Group followed after balloon removal (WLBM for both)|
59637797|NCT02235870|75753442|FG001|Crossover (Week 24)|Overall Study||138|Sham Group received Obalon Balloon & Treatment Group followed after balloon removal (WLBM for both)|
59637798|NCT02235870|75753441|FG000|COMPLETED|Overall Study||160|Completed Phase II (Week 48), Obalon Balloon removal for Sham Group|
59637799|NCT02235870|75753442|FG001|COMPLETED|Overall Study||128|Completed Phase II (Week 48), Obalon Balloon removal for Sham Group|
59637800|NCT02235870|75753441|FG000|NOT COMPLETED|Overall Study||38||
59637801|NCT02235870|75753442|FG001|NOT COMPLETED|Overall Study||61||
59637802|NCT02236338|75753451|FG000|STARTED|Overall Study||100||
59637803|NCT02236338|75753452|FG001|STARTED|Overall Study||100||
59637804|NCT02236338|75753451|FG000|COMPLETED|Overall Study||100||
59637805|NCT02236338|75753452|FG001|COMPLETED|Overall Study||100||
59637806|NCT02236338|75753451|FG000|NOT COMPLETED|Overall Study||0||
59637807|NCT02236338|75753452|FG001|NOT COMPLETED|Overall Study||0||
59637808|NCT02237898|75753460|FG000|STARTED|Overall Study||12||
59637809|NCT02237898|75753461|FG001|STARTED|Overall Study||14||
59637810|NCT02237898|75753460|FG000|Completed 12 Weeks of CM|Overall Study||7||
59637811|NCT02237898|75753461|FG001|Completed 12 Weeks of CM|Overall Study||2||
59637812|NCT02237898|75753460|FG000|Completed 3 Month Follow-up|Overall Study||6||
59637813|NCT02237898|75753461|FG001|Completed 3 Month Follow-up|Overall Study||6||
59637814|NCT02237898|75753460|FG000|Completed 9 Month Follow-up|Overall Study||6||
59637815|NCT02237898|75753461|FG001|Completed 9 Month Follow-up|Overall Study||7||
59637816|NCT02237898|75753460|FG000|Completed 15 Month Follow-up|Overall Study||8||
59637817|NCT02237898|75753461|FG001|Completed 15 Month Follow-up|Overall Study||8||
59637818|NCT02237898|75753460|FG000|COMPLETED|Overall Study||5||
59637819|NCT02237898|75753461|FG001|COMPLETED|Overall Study||2||
59637820|NCT02237898|75753460|FG000|NOT COMPLETED|Overall Study||7||
59637821|NCT02237898|75753461|FG001|NOT COMPLETED|Overall Study||12||
59637822|NCT02239380|75753469|FG000|STARTED|Overall Study||26||
59637823|NCT02239380|75753469|FG000|COMPLETED|Overall Study||26||
59637824|NCT02239380|75753469|FG000|NOT COMPLETED|Overall Study||0||
59637825|NCT02239770|75753479|FG000|STARTED|Part 1||4||
59637826|NCT02239770|75753480|FG001|STARTED|Part 1||4||
59637827|NCT02239770|75753481|FG002|STARTED|Part 1||4||
59637828|NCT02239770|75753482|FG003|STARTED|Part 1||0||
59637829|NCT02239770|75753483|FG004|STARTED|Part 1||0||
59637830|NCT02239770|75753484|FG005|STARTED|Part 1||0||
59637831|NCT02239770|75753479|FG000|COMPLETED|Part 1||4||
59637832|NCT02239770|75753480|FG001|COMPLETED|Part 1||4||
59637833|NCT02239770|75753481|FG002|COMPLETED|Part 1||4||
59637834|NCT02239770|75753482|FG003|COMPLETED|Part 1||0||
59637835|NCT02239770|75753483|FG004|COMPLETED|Part 1||0||
59637836|NCT02239770|75753484|FG005|COMPLETED|Part 1||0||
59637837|NCT02239770|75753479|FG000|NOT COMPLETED|Part 1||0||
59637838|NCT02239770|75753480|FG001|NOT COMPLETED|Part 1||0||
59637839|NCT02239770|75753481|FG002|NOT COMPLETED|Part 1||0||
59637840|NCT02239770|75753482|FG003|NOT COMPLETED|Part 1||0||
59637841|NCT02239770|75753483|FG004|NOT COMPLETED|Part 1||0||
59637842|NCT02239770|75753484|FG005|NOT COMPLETED|Part 1||0||
59637843|NCT02239770|75753479|FG000|STARTED|Part 2||0||
59637844|NCT02239770|75753480|FG001|STARTED|Part 2||0||
59637845|NCT02239770|75753481|FG002|STARTED|Part 2||0||
59637846|NCT02239770|75753482|FG003|STARTED|Part 2||4||
59637847|NCT02239770|75753483|FG004|STARTED|Part 2||4||
59637848|NCT02239770|75753484|FG005|STARTED|Part 2||4||
59637849|NCT02239770|75753479|FG000|COMPLETED|Part 2||0||
59637850|NCT02239770|75753480|FG001|COMPLETED|Part 2||0||
59637851|NCT02239770|75753481|FG002|COMPLETED|Part 2||0||
59637852|NCT02239770|75753482|FG003|COMPLETED|Part 2||4||
59637853|NCT02239770|75753483|FG004|COMPLETED|Part 2||4||
59637854|NCT02239770|75753484|FG005|COMPLETED|Part 2||4||
59637855|NCT02239770|75753479|FG000|NOT COMPLETED|Part 2||0||
59637856|NCT02239770|75753480|FG001|NOT COMPLETED|Part 2||0||
59637857|NCT02239770|75753481|FG002|NOT COMPLETED|Part 2||0||
59637858|NCT02239770|75753482|FG003|NOT COMPLETED|Part 2||0||
59637859|NCT02239770|75753483|FG004|NOT COMPLETED|Part 2||0||
59637860|NCT02239770|75753484|FG005|NOT COMPLETED|Part 2||0||
59637861|NCT02241486|75753506|FG000|STARTED|Overall Study||2||
59637862|NCT02241486|75753506|FG000|COMPLETED|Overall Study||2||
59637863|NCT02241486|75753506|FG000|NOT COMPLETED|Overall Study||0||
59637864|NCT02241720|75753510|FG000|STARTED|Overall Study||5||
59637865|NCT02241720|75753510|FG000|COMPLETED|Overall Study||1||
59637866|NCT02241720|75753510|FG000|NOT COMPLETED|Overall Study||4||
59637867|NCT02244840|75753514|FG000|STARTED|Overall Study||40||
59637868|NCT02244840|75753514|FG000|COMPLETED|Overall Study||40||
59637869|NCT02244840|75753514|FG000|NOT COMPLETED|Overall Study||0||
59637870|NCT02244918|75753520|FG000|STARTED|Overall Study||185||
59637871|NCT02244918|75753521|FG001|STARTED|Overall Study||93||
60076566|NCT03070444|76191570|FG001|COMPLETED|Overall Study||35||
60076567|NCT03070444|76191569|FG000|NOT COMPLETED|Overall Study||13||
60076568|NCT03070444|76191570|FG001|NOT COMPLETED|Overall Study||17||
59637872|NCT02244918|75753520|FG000|Week 12|Overall Study||160|End of Treatment|
59637873|NCT02244918|75753521|FG001|Week 12|Overall Study||83|End of Treatment|
59637874|NCT02244918|75753520|FG000|COMPLETED|Overall Study||185||
59637875|NCT02244918|75753521|FG001|COMPLETED|Overall Study||93||
59637876|NCT02244918|75753520|FG000|NOT COMPLETED|Overall Study||0||
60076569|NCT01928329|76191578|FG000|STARTED|Overall Study||40||
60076570|NCT01928329|76191579|FG001|STARTED|Overall Study||39||
59637877|NCT02244918|75753521|FG001|NOT COMPLETED|Overall Study||0||
59637878|NCT02246010|75753530|FG000|STARTED|Overall Study||4||
59637879|NCT02246010|75753531|FG001|STARTED|Overall Study||2||
59637880|NCT02246010|75753530|FG000|COMPLETED|Overall Study||4||
59637881|NCT02246010|75753531|FG001|COMPLETED|Overall Study||2||
59637882|NCT02246010|75753530|FG000|NOT COMPLETED|Overall Study||0||
59637883|NCT02246010|75753531|FG001|NOT COMPLETED|Overall Study||0||
59637884|NCT02247336|75753539|FG000|STARTED|Overall Study||252||
59637885|NCT02247336|75753540|FG001|STARTED|Overall Study||253||
59637886|NCT02247336|75753539|FG000|COMPLETED|Overall Study||252||
59637887|NCT02247336|75753540|FG001|COMPLETED|Overall Study||253||
59637888|NCT02247336|75753539|FG000|NOT COMPLETED|Overall Study||0||
59637889|NCT02247336|75753540|FG001|NOT COMPLETED|Overall Study||0||
59637890|NCT02248662|75753548|FG000|STARTED|Overall Study||5320||
59637891|NCT02248662|75753549|FG001|STARTED|Overall Study||33194||
59637892|NCT02248662|75753548|FG000|COMPLETED|Overall Study||757||
59637893|NCT02248662|75753549|FG001|COMPLETED|Overall Study||2679||
59637894|NCT02248662|75753548|FG000|NOT COMPLETED|Overall Study||4563||
59637895|NCT02248662|75753549|FG001|NOT COMPLETED|Overall Study||30515||
59637896|NCT02249052|75753559|FG000|STARTED|Overall Study||19||
59637897|NCT02249052|75753559|FG000|COMPLETED|Overall Study||19||
59637898|NCT02249052|75753559|FG000|NOT COMPLETED|Overall Study||0||
59637899|NCT02250612|75753572|FG000|STARTED|Overall Study||37||
59637900|NCT02250612|75753573|FG001|STARTED|Overall Study||40||
59637901|NCT02250612|75753574|FG002|STARTED|Overall Study||37||
59637902|NCT02250612|75753575|FG003|STARTED|Overall Study||33||
59637903|NCT02250612|75753576|FG004|STARTED|Overall Study||37||
59637904|NCT02250612|75753572|FG000|COMPLETED|Overall Study||36||
59637905|NCT02250612|75753573|FG001|COMPLETED|Overall Study||38||
59637906|NCT02250612|75753574|FG002|COMPLETED|Overall Study||35||
59637907|NCT02250612|75753575|FG003|COMPLETED|Overall Study||33||
59637908|NCT02250612|75753576|FG004|COMPLETED|Overall Study||36||
59637909|NCT02250612|75753572|FG000|NOT COMPLETED|Overall Study||1||
59637910|NCT02250612|75753573|FG001|NOT COMPLETED|Overall Study||2||
59637911|NCT02250612|75753574|FG002|NOT COMPLETED|Overall Study||2||
59637912|NCT02250612|75753575|FG003|NOT COMPLETED|Overall Study||0||
59637913|NCT02250612|75753576|FG004|NOT COMPLETED|Overall Study||1||
59637914|NCT02251236|75753598|FG000|STARTED|Overall Study||9||
59637915|NCT02251236|75753599|FG001|STARTED|Overall Study||5||
59637916|NCT02251236|75753600|FG002|STARTED|Overall Study||0||
59637917|NCT02251236|75753598|FG000|COMPLETED|Overall Study||9||
59637918|NCT02251236|75753599|FG001|COMPLETED|Overall Study||5||
59637919|NCT02251236|75753600|FG002|COMPLETED|Overall Study||0||
59637920|NCT02251236|75753598|FG000|NOT COMPLETED|Overall Study||0||
59637921|NCT02251236|75753599|FG001|NOT COMPLETED|Overall Study||0||
59637922|NCT02251236|75753600|FG002|NOT COMPLETED|Overall Study||0||
59637923|NCT02251938|75753608|FG000|STARTED|Overall Study||60||
59637924|NCT02251938|75753608|FG000|COMPLETED|Overall Study||43||
59637925|NCT02251938|75753608|FG000|NOT COMPLETED|Overall Study||17||
59637926|NCT02252562|75753614|FG000|STARTED|Overall Study||1620|Operating rooms|1620
59637927|NCT02252562|75753615|FG001|STARTED|Overall Study||1636|Operating rooms|1636
59637928|NCT02252562|75753614|FG000|COMPLETED|Overall Study||1620|Operating rooms|1620
59637929|NCT02252562|75753615|FG001|COMPLETED|Overall Study||1636|Operating rooms|1636
59637930|NCT02252562|75753614|FG000|NOT COMPLETED|Overall Study||0||0
59637931|NCT02252562|75753615|FG001|NOT COMPLETED|Overall Study||0||0
59637932|NCT02252718|75753622|FG000|STARTED|Overall Study||100||
59637933|NCT02252718|75753622|FG000|COMPLETED|Overall Study||100||
59988444|NCT02520284|76103614|FG002|STARTED|Blinded Maintenance Phase: Up to Week 51|Participants achieving EBS remission and/or MCS response continued in Blinded Maintenance Phase.|18||
59637934|NCT02252718|75753622|FG000|NOT COMPLETED|Overall Study||0||
59637935|NCT02255604|75753629|FG000|STARTED|Overall Study||12||
59637936|NCT02255604|75753630|FG001|STARTED|Overall Study||12||
59637937|NCT02255604|75753631|FG002|STARTED|Overall Study||12||
59637938|NCT02255604|75753629|FG000|COMPLETED|Overall Study||10||
59637939|NCT02255604|75753630|FG001|COMPLETED|Overall Study||11||
59637940|NCT02255604|75753631|FG002|COMPLETED|Overall Study||9||
59637941|NCT02255604|75753629|FG000|NOT COMPLETED|Overall Study||2||
59637942|NCT02255604|75753630|FG001|NOT COMPLETED|Overall Study||1||
59637943|NCT02255604|75753631|FG002|NOT COMPLETED|Overall Study||3||
59637944|NCT02256072|75753641|FG000|STARTED|Overall Study||194||
59637945|NCT02256072|75753642|FG001|STARTED|Overall Study||191||
59637946|NCT02256072|75753641|FG000|Completed 1 Month Follow-Up|Overall Study|Completed the 1-month follow-up|167||
59541323|NCT01550471|75639570|FG005|COMPLETED|Second Wash Out Period (3 Weeks)||3||
59541324|NCT01550471|75639565|FG000|NOT COMPLETED|Second Wash Out Period (3 Weeks)||0||
59541325|NCT01550471|75639566|FG001|NOT COMPLETED|Second Wash Out Period (3 Weeks)||0||
59541326|NCT01550471|75639567|FG002|NOT COMPLETED|Second Wash Out Period (3 Weeks)||0||
59541327|NCT01550471|75639568|FG003|NOT COMPLETED|Second Wash Out Period (3 Weeks)||0||
59541328|NCT01550471|75639569|FG004|NOT COMPLETED|Second Wash Out Period (3 Weeks)||0||
59541329|NCT01550471|75639570|FG005|NOT COMPLETED|Second Wash Out Period (3 Weeks)||1||
59541330|NCT01550471|75639565|FG000|STARTED|Third Treatment Period (3 Weeks)||3||
59637947|NCT02256072|75753642|FG001|Completed 1 Month Follow-Up|Overall Study||179||
59637948|NCT02256072|75753641|FG000|COMPLETED|Overall Study|Completed the 3-month follow-up|152||
59637949|NCT02256072|75753642|FG001|COMPLETED|Overall Study||162||
59637950|NCT02256072|75753641|FG000|NOT COMPLETED|Overall Study||42||
59637951|NCT02256072|75753642|FG001|NOT COMPLETED|Overall Study||29||
59637952|NCT02258256|75753649|FG000|STARTED|Overall Study||11||
59637953|NCT02258256|75753649|FG000|COMPLETED|Overall Study||11||
59637954|NCT02258256|75753649|FG000|NOT COMPLETED|Overall Study||0||
59637955|NCT02258412|75753656|FG000|STARTED|Overall Study||26||
59988445|NCT02520284|76103612|FG000|COMPLETED|Blinded Maintenance Phase: Up to Week 51||0||
59988446|NCT02520284|76103613|FG001|COMPLETED|Blinded Maintenance Phase: Up to Week 51||0||
59637956|NCT02258412|75753657|FG001|STARTED|Overall Study||25||
59637957|NCT02258412|75753658|FG002|STARTED|Overall Study||61||
59637958|NCT02258412|75753656|FG000|COMPLETED|Overall Study||26||
59637959|NCT02258412|75753657|FG001|COMPLETED|Overall Study||25||
59637960|NCT02258412|75753658|FG002|COMPLETED|Overall Study||61||
59637961|NCT02258412|75753656|FG000|NOT COMPLETED|Overall Study||0||
59637962|NCT02258412|75753657|FG001|NOT COMPLETED|Overall Study||0||
59637963|NCT02258412|75753658|FG002|NOT COMPLETED|Overall Study||0||
59637964|NCT02260440|75753665|FG000|STARTED|Overall Study||31||
59541331|NCT01550471|75639566|FG001|STARTED|Third Treatment Period (3 Weeks)||4||
59541332|NCT01550471|75639567|FG002|STARTED|Third Treatment Period (3 Weeks)||3||
59637965|NCT02260440|75753665|FG000|COMPLETED|Overall Study||31||
59637966|NCT02260440|75753665|FG000|NOT COMPLETED|Overall Study||0||
59637967|NCT02262078|75753671|FG000|STARTED|Overall Study||13||
59637968|NCT02262078|75753672|FG001|STARTED|Overall Study||13||
59637969|NCT02262078|75753671|FG000|COMPLETED|Overall Study||13||
59637970|NCT02262078|75753672|FG001|COMPLETED|Overall Study||13||
59637971|NCT02262078|75753671|FG000|NOT COMPLETED|Overall Study||0||
59637972|NCT02262078|75753672|FG001|NOT COMPLETED|Overall Study||0||
59637973|NCT02267226|75753678|FG000|STARTED|Overall Study||25||
59637974|NCT02267226|75753678|FG000|SAFETY Population|Overall Study||25|25 patients received at least one administration of Octafibrin.|
59637975|NCT02267226|75753678|FG000|FAS-Bleeding Population|Overall Study||24|Patients received Octafibrin for treatment of bleeding.|
59637976|NCT02267226|75753678|FG000|Surgical Prophylaxis Population|Overall Study||9|Patients received Octafibrin for surgical procedures.|
59637977|NCT02267226|75753678|FG000|COMPLETED|Overall Study||18||
59637978|NCT02267226|75753678|FG000|NOT COMPLETED|Overall Study||7||
59637979|NCT02267382|75753702|FG000|STARTED|Overall Study||42||
59637980|NCT02267382|75753703|FG001|STARTED|Overall Study||43||
59637981|NCT02267382|75753704|FG002|STARTED|Overall Study||43||
59637982|NCT02267382|75753705|FG003|STARTED|Overall Study||41||
59637983|NCT02267382|75753706|FG004|STARTED|Overall Study||46||
59637984|NCT02267382|75753702|FG000|COMPLETED|Overall Study||35||
59637985|NCT02267382|75753703|FG001|COMPLETED|Overall Study||33||
59637986|NCT02267382|75753704|FG002|COMPLETED|Overall Study||34||
59637987|NCT02267382|75753705|FG003|COMPLETED|Overall Study||35||
59637988|NCT02267382|75753706|FG004|COMPLETED|Overall Study||39||
59637989|NCT02267382|75753702|FG000|NOT COMPLETED|Overall Study||7||
59637990|NCT02267382|75753703|FG001|NOT COMPLETED|Overall Study||10||
59637991|NCT02267382|75753704|FG002|NOT COMPLETED|Overall Study||9||
59637992|NCT02267382|75753705|FG003|NOT COMPLETED|Overall Study||6||
59637993|NCT02267382|75753706|FG004|NOT COMPLETED|Overall Study||7||
59637994|NCT02267538|75753720|FG000|STARTED|Overall Study||142||
59637995|NCT02267538|75753721|FG001|STARTED|Overall Study||143||
59637996|NCT02267538|75753720|FG000|COMPLETED|Overall Study||142||
59637997|NCT02267538|75753721|FG001|COMPLETED|Overall Study||143||
59637998|NCT02267538|75753720|FG000|NOT COMPLETED|Overall Study||0||
59637999|NCT02267538|75753721|FG001|NOT COMPLETED|Overall Study||0||
59638000|NCT02267772|75753729|FG000|STARTED|Overall Study||50||
59638001|NCT02267772|75753730|FG001|STARTED|Overall Study||52||
59638002|NCT02267772|75753729|FG000|Randomized|Overall Study||50||
59638003|NCT02267772|75753730|FG001|Randomized|Overall Study||52||
59638004|NCT02267772|75753729|FG000|Received Study Drug|Overall Study||48||
59638005|NCT02267772|75753730|FG001|Received Study Drug|Overall Study||52||
59638006|NCT02267772|75753729|FG000|COMPLETED|Overall Study||48||
59638007|NCT02267772|75753730|FG001|COMPLETED|Overall Study||52||
59638008|NCT02267772|75753729|FG000|NOT COMPLETED|Overall Study||2||
59638009|NCT02267772|75753730|FG001|NOT COMPLETED|Overall Study||0||
59988447|NCT02520284|76103614|FG002|COMPLETED|Blinded Maintenance Phase: Up to Week 51||0||
59988448|NCT02520284|76103612|FG000|NOT COMPLETED|Blinded Maintenance Phase: Up to Week 51||20||
59988449|NCT02520284|76103613|FG001|NOT COMPLETED|Blinded Maintenance Phase: Up to Week 51||16||
59988450|NCT02520284|76103614|FG002|NOT COMPLETED|Blinded Maintenance Phase: Up to Week 51||18||
59988451|NCT02520284|76103612|FG000|STARTED|Open-Label MaintenancePhase: Upto Week51|Participants achieving neither EBS remission nor MCS response entered Open-Label Maintenance Phase.|32||
59541333|NCT01550471|75639568|FG003|STARTED|Third Treatment Period (3 Weeks)||4||
59541334|NCT01550471|75639569|FG004|STARTED|Third Treatment Period (3 Weeks)||4||
59541335|NCT01550471|75639570|FG005|STARTED|Third Treatment Period (3 Weeks)||3||
59541336|NCT01550471|75639565|FG000|COMPLETED|Third Treatment Period (3 Weeks)||3||
59541337|NCT01550471|75639566|FG001|COMPLETED|Third Treatment Period (3 Weeks)||4||
59541338|NCT01550471|75639567|FG002|COMPLETED|Third Treatment Period (3 Weeks)||3||
59541339|NCT01550471|75639568|FG003|COMPLETED|Third Treatment Period (3 Weeks)||4||
59541340|NCT01550471|75639569|FG004|COMPLETED|Third Treatment Period (3 Weeks)||4||
59541341|NCT01550471|75639570|FG005|COMPLETED|Third Treatment Period (3 Weeks)||3||
59541342|NCT01550471|75639565|FG000|NOT COMPLETED|Third Treatment Period (3 Weeks)||0||
59541343|NCT01550471|75639566|FG001|NOT COMPLETED|Third Treatment Period (3 Weeks)||0||
59541344|NCT01550471|75639567|FG002|NOT COMPLETED|Third Treatment Period (3 Weeks)||0||
59541345|NCT01550471|75639568|FG003|NOT COMPLETED|Third Treatment Period (3 Weeks)||0||
59541346|NCT01550471|75639569|FG004|NOT COMPLETED|Third Treatment Period (3 Weeks)||0||
59541347|NCT01550471|75639570|FG005|NOT COMPLETED|Third Treatment Period (3 Weeks)||0||
59541348|NCT01550471|75639565|FG000|STARTED|Third Wash Out Period (3 Weeks)||3||
59541349|NCT01550471|75639566|FG001|STARTED|Third Wash Out Period (3 Weeks)||4||
59541350|NCT01550471|75639567|FG002|STARTED|Third Wash Out Period (3 Weeks)||3||
59541351|NCT01550471|75639568|FG003|STARTED|Third Wash Out Period (3 Weeks)||4||
59541352|NCT01550471|75639569|FG004|STARTED|Third Wash Out Period (3 Weeks)||4||
59541353|NCT01550471|75639570|FG005|STARTED|Third Wash Out Period (3 Weeks)||3||
59541354|NCT01550471|75639565|FG000|COMPLETED|Third Wash Out Period (3 Weeks)||3||
59541355|NCT01550471|75639566|FG001|COMPLETED|Third Wash Out Period (3 Weeks)||4||
59638010|NCT02267850|75753738|FG000|STARTED|Overall Study||15||
59638011|NCT02267850|75753739|FG001|STARTED|Overall Study||14||
59638012|NCT02267850|75753738|FG000|COMPLETED|Overall Study||14||
59638013|NCT02267850|75753739|FG001|COMPLETED|Overall Study||12||
59638014|NCT02267850|75753738|FG000|NOT COMPLETED|Overall Study||1||
59638015|NCT02267850|75753739|FG001|NOT COMPLETED|Overall Study||2||
59638016|NCT02268942|75753745|FG000|STARTED|Overall Study||144||
59638017|NCT02268942|75753745|FG000|COMPLETED|Overall Study||144||
59638018|NCT02268942|75753745|FG000|NOT COMPLETED|Overall Study||0||
59638019|NCT02269488|75753749|FG000|STARTED|Overall Study||100||
59638020|NCT02269488|75753749|FG000|COMPLETED|Overall Study||100||
59638021|NCT02269488|75753749|FG000|NOT COMPLETED|Overall Study||0||
59638022|NCT02271906|75753753|FG000|STARTED|Overall Study||2||
59638023|NCT02271906|75753753|FG000|COMPLETED|Overall Study||2||
59638024|NCT02271906|75753753|FG000|NOT COMPLETED|Overall Study||0||
59638025|NCT02272686|75753757|FG000|STARTED|Overall Study||1||
59638026|NCT02272686|75753757|FG000|COMPLETED|Overall Study||1||
59638027|NCT02272686|75753757|FG000|NOT COMPLETED|Overall Study||0||
59638028|NCT02273310|75753763|FG000|STARTED|Overall Study||42||
59638029|NCT02273310|75753764|FG001|STARTED|Overall Study||41||
59638030|NCT02273310|75753763|FG000|COMPLETED|Overall Study||24||
59638031|NCT02273310|75753764|FG001|COMPLETED|Overall Study||38||
59638032|NCT02273310|75753763|FG000|NOT COMPLETED|Overall Study||18||
59638033|NCT02273310|75753764|FG001|NOT COMPLETED|Overall Study||3||
59638034|NCT02274870|75753773|FG000|STARTED|Overall Study||32||
59638035|NCT02274870|75753774|FG001|STARTED|Overall Study||33||
59638036|NCT02274870|75753773|FG000|COMPLETED|Overall Study||32||
59638037|NCT02274870|75753774|FG001|COMPLETED|Overall Study||33||
59638038|NCT02274870|75753773|FG000|NOT COMPLETED|Overall Study||0||
59638039|NCT02274870|75753774|FG001|NOT COMPLETED|Overall Study||0||
59638040|NCT02277054|75753783|FG000|STARTED|Overall Study||5||
59638041|NCT02277054|75753783|FG000|COMPLETED|Overall Study||5||
59638042|NCT02277054|75753783|FG000|NOT COMPLETED|Overall Study||0||
59638043|NCT02278146|75753790|FG000|STARTED|Overall Study||6||
59638044|NCT02278146|75753791|FG001|STARTED|Overall Study||10||
59638045|NCT02278146|75753790|FG000|COMPLETED|Overall Study||6||
59638046|NCT02278146|75753791|FG001|COMPLETED|Overall Study||8||
59638047|NCT02278146|75753790|FG000|NOT COMPLETED|Overall Study||0||
59638048|NCT02278146|75753791|FG001|NOT COMPLETED|Overall Study||2||
59638049|NCT02279082|75753797|FG000|STARTED|Overall Study|Intentions were to have 173 participants, but only 167 participants received study drug.|167||
59638050|NCT02279082|75753797|FG000|COMPLETED|Overall Study||134||
59638051|NCT02279082|75753797|FG000|NOT COMPLETED|Overall Study||33||
59638052|NCT02279160|75753803|FG000|STARTED|Overall Study||40||
59638053|NCT02279160|75753804|FG001|STARTED|Overall Study||21||
59638054|NCT02279160|75753803|FG000|COMPLETED|Overall Study||34||
59638055|NCT02279160|75753804|FG001|COMPLETED|Overall Study||19||
59638056|NCT02279160|75753803|FG000|NOT COMPLETED|Overall Study||6||
59638057|NCT02279160|75753804|FG001|NOT COMPLETED|Overall Study||2||
59638058|NCT02281344|75753810|FG000|STARTED|Overall Study||6||
59638059|NCT02281344|75753810|FG000|COMPLETED|Overall Study||6||
59638060|NCT02281344|75753810|FG000|NOT COMPLETED|Overall Study||0||
59638061|NCT02281422|75753819|FG000|STARTED|Overall Study||8||
59638062|NCT02281422|75753820|FG001|STARTED|Overall Study||8||
59638063|NCT02281422|75753821|FG002|STARTED|Overall Study||8||
59638064|NCT02281422|75753822|FG003|STARTED|Overall Study||8||
59638065|NCT02281422|75753823|FG004|STARTED|Overall Study||8||
59638066|NCT02281422|75753819|FG000|COMPLETED|Overall Study||8||
59638067|NCT02281422|75753820|FG001|COMPLETED|Overall Study||8||
59638068|NCT02281422|75753821|FG002|COMPLETED|Overall Study||8||
59638069|NCT02281422|75753822|FG003|COMPLETED|Overall Study||8||
59638070|NCT02281422|75753823|FG004|COMPLETED|Overall Study||8||
59638071|NCT02281422|75753819|FG000|NOT COMPLETED|Overall Study||0||
59638072|NCT02281422|75753820|FG001|NOT COMPLETED|Overall Study||0||
59638073|NCT02281422|75753821|FG002|NOT COMPLETED|Overall Study||0||
59638074|NCT02281422|75753822|FG003|NOT COMPLETED|Overall Study||0||
59638075|NCT02281422|75753823|FG004|NOT COMPLETED|Overall Study||0||
59638076|NCT02282514|75753835|FG000|STARTED|Overall Study||23||
59638077|NCT02282514|75753835|FG000|COMPLETED|Overall Study||23|Conditioning Regimen|
59638078|NCT02282514|75753835|FG000|NOT COMPLETED|Overall Study||0||
59638079|NCT02282904|75753839|FG000|STARTED|Overall Study||7||
59638080|NCT02282904|75753839|FG000|COMPLETED|Overall Study|Patient accrual was stopped early, and the protocol closed after completing followup|7||
59638081|NCT02282904|75753839|FG000|NOT COMPLETED|Overall Study||0||
59638082|NCT02283528|75753845|FG000|STARTED|Overall Study||26||
59638083|NCT02283528|75753846|FG001|STARTED|Overall Study||24||
59638084|NCT02283528|75753845|FG000|COMPLETED|Overall Study||26||
59638085|NCT02283528|75753846|FG001|COMPLETED|Overall Study||24||
59638086|NCT02283528|75753845|FG000|NOT COMPLETED|Overall Study||0||
59638087|NCT02283528|75753846|FG001|NOT COMPLETED|Overall Study||0||
59638088|NCT02283840|75753855|FG000|STARTED|Overall Study||20||
59638089|NCT02283840|75753856|FG001|STARTED|Overall Study||20||
59638090|NCT02283840|75753857|FG002|STARTED|Overall Study||20||
59638091|NCT02283840|75753855|FG000|COMPLETED|Overall Study||20||
59638092|NCT02283840|75753856|FG001|COMPLETED|Overall Study||19||
59638093|NCT02283840|75753857|FG002|COMPLETED|Overall Study||20||
59638094|NCT02283840|75753855|FG000|NOT COMPLETED|Overall Study||0||
59638095|NCT02283840|75753856|FG001|NOT COMPLETED|Overall Study||1||
59638096|NCT02283840|75753857|FG002|NOT COMPLETED|Overall Study||0||
59638097|NCT02284386|75753868|FG000|STARTED|Overall Study||15||
60076571|NCT01928329|76191578|FG000|COMPLETED|Overall Study||28||
60076572|NCT01928329|76191579|FG001|COMPLETED|Overall Study||25||
60076573|NCT01928329|76191578|FG000|NOT COMPLETED|Overall Study||12||
60076574|NCT01928329|76191579|FG001|NOT COMPLETED|Overall Study||14||
60076575|NCT01890109|76191587|FG000|STARTED|Overall Study||52||
60076576|NCT01890109|76191588|FG001|STARTED|Overall Study||51||
60076577|NCT01890109|76191587|FG000|Received Study Treatment|Overall Study||52||
60076578|NCT01890109|76191588|FG001|Received Study Treatment|Overall Study||50||
60076579|NCT01890109|76191587|FG000|COMPLETED|Overall Study||51||
60076580|NCT01890109|76191588|FG001|COMPLETED|Overall Study||46||
60076581|NCT01890109|76191587|FG000|NOT COMPLETED|Overall Study||1||
60076582|NCT01890109|76191588|FG001|NOT COMPLETED|Overall Study||5||
60076583|NCT00982930|76191595|FG000|STARTED|Overall Study||55||
60076584|NCT00982930|76191595|FG000|COMPLETED|Overall Study||51||
60076585|NCT00982930|76191595|FG000|NOT COMPLETED|Overall Study||4||
60076586|NCT00981682|76191599|FG000|STARTED|Overall Study||376||
60076587|NCT00981682|76191599|FG000|COMPLETED|Overall Study||234||
60076588|NCT00981682|76191599|FG000|NOT COMPLETED|Overall Study||142||
60076589|NCT01903993|76191605|FG000|STARTED|Overall Study||143||
60076590|NCT01903993|76191606|FG001|STARTED|Overall Study||144||
60076591|NCT01903993|76191605|FG000|Received Treatment|Overall Study||135|Two patients in the docetaxel arm crossed over to receive atezolizumab treatment.|
60076592|NCT01903993|76191606|FG001|Received Treatment|Overall Study||142|Two patients in the docetaxel arm crossed over to receive atezolizumab treatment.|
60076593|NCT01903993|76191605|FG000|COMPLETED|Overall Study||0|Study terminated by Sponsor participants either discontinued or enrolled in extension study|
60076594|NCT01903993|76191606|FG001|COMPLETED|Overall Study||0|Study terminated by Sponsor participants either discontinued or enrolled in extension study|
60076595|NCT01903993|76191605|FG000|NOT COMPLETED|Overall Study||143||
60076596|NCT01903993|76191606|FG001|NOT COMPLETED|Overall Study||144||
60076597|NCT00981292|76191619|FG000|STARTED|Day 1||7||
60076598|NCT00981292|76191620|FG001|STARTED|Day 1||4||
60076599|NCT00981292|76191621|FG002|STARTED|Day 1||6||
60076600|NCT00981292|76191622|FG003|STARTED|Day 1||4||
60076601|NCT00981292|76191623|FG004|STARTED|Day 1||4||
60076602|NCT00981292|76191624|FG005|STARTED|Day 1||7||
60076603|NCT00981292|76191619|FG000|COMPLETED|Day 1||6||
60076604|NCT00981292|76191620|FG001|COMPLETED|Day 1||4||
60076605|NCT00981292|76191621|FG002|COMPLETED|Day 1||6||
60076606|NCT00981292|76191622|FG003|COMPLETED|Day 1||4||
60076607|NCT00981292|76191623|FG004|COMPLETED|Day 1||4||
60076608|NCT00981292|76191624|FG005|COMPLETED|Day 1||5||
60076609|NCT00981292|76191619|FG000|NOT COMPLETED|Day 1||1||
60076610|NCT00981292|76191620|FG001|NOT COMPLETED|Day 1||0||
60076611|NCT00981292|76191621|FG002|NOT COMPLETED|Day 1||0||
60076612|NCT00981292|76191622|FG003|NOT COMPLETED|Day 1||0||
60076613|NCT00981292|76191623|FG004|NOT COMPLETED|Day 1||0||
60076614|NCT00981292|76191624|FG005|NOT COMPLETED|Day 1||2||
60076615|NCT00981292|76191619|FG000|STARTED|Day 2||6||
60076616|NCT00981292|76191620|FG001|STARTED|Day 2||4||
60076617|NCT00981292|76191621|FG002|STARTED|Day 2||6||
60076618|NCT00981292|76191622|FG003|STARTED|Day 2||4||
60076619|NCT00981292|76191623|FG004|STARTED|Day 2||4||
60076620|NCT00981292|76191624|FG005|STARTED|Day 2||5||
60076621|NCT00981292|76191619|FG000|COMPLETED|Day 2||4||
60076622|NCT00981292|76191620|FG001|COMPLETED|Day 2||4||
60076623|NCT00981292|76191621|FG002|COMPLETED|Day 2||6||
60076624|NCT00981292|76191622|FG003|COMPLETED|Day 2||4||
59541356|NCT01550471|75639567|FG002|COMPLETED|Third Wash Out Period (3 Weeks)||3||
60076625|NCT00981292|76191623|FG004|COMPLETED|Day 2||4||
59541357|NCT01550471|75639568|FG003|COMPLETED|Third Wash Out Period (3 Weeks)||4||
59541358|NCT01550471|75639569|FG004|COMPLETED|Third Wash Out Period (3 Weeks)||4||
59541359|NCT01550471|75639570|FG005|COMPLETED|Third Wash Out Period (3 Weeks)||3||
59541360|NCT01550471|75639565|FG000|NOT COMPLETED|Third Wash Out Period (3 Weeks)||0||
60076626|NCT00981292|76191624|FG005|COMPLETED|Day 2||5||
60076627|NCT00981292|76191619|FG000|NOT COMPLETED|Day 2||2||
60076628|NCT00981292|76191620|FG001|NOT COMPLETED|Day 2||0||
60076629|NCT00981292|76191621|FG002|NOT COMPLETED|Day 2||0||
60076630|NCT00981292|76191622|FG003|NOT COMPLETED|Day 2||0||
60076631|NCT00981292|76191623|FG004|NOT COMPLETED|Day 2||0||
60076632|NCT00981292|76191624|FG005|NOT COMPLETED|Day 2||0||
60076633|NCT00981292|76191619|FG000|STARTED|Day 3||4||
60076634|NCT00981292|76191620|FG001|STARTED|Day 3||4||
60076635|NCT00981292|76191621|FG002|STARTED|Day 3||6||
60076636|NCT00981292|76191622|FG003|STARTED|Day 3||4||
60076637|NCT00981292|76191623|FG004|STARTED|Day 3||4||
60076638|NCT00981292|76191624|FG005|STARTED|Day 3||5||
60076639|NCT00981292|76191619|FG000|COMPLETED|Day 3||4||
60076640|NCT00981292|76191620|FG001|COMPLETED|Day 3||4||
60076641|NCT00981292|76191621|FG002|COMPLETED|Day 3||6||
60076642|NCT00981292|76191622|FG003|COMPLETED|Day 3||4||
60076643|NCT00981292|76191623|FG004|COMPLETED|Day 3||4||
60076644|NCT00981292|76191624|FG005|COMPLETED|Day 3||4||
60076645|NCT00981292|76191619|FG000|NOT COMPLETED|Day 3||0||
60076646|NCT00981292|76191620|FG001|NOT COMPLETED|Day 3||0||
60076647|NCT00981292|76191621|FG002|NOT COMPLETED|Day 3||0||
60076648|NCT00981292|76191622|FG003|NOT COMPLETED|Day 3||0||
60076649|NCT00981292|76191623|FG004|NOT COMPLETED|Day 3||0||
60076650|NCT00981292|76191624|FG005|NOT COMPLETED|Day 3||1||
60076651|NCT00980044|76191639|FG000|STARTED|Overall Study||17||
60076652|NCT00980044|76191640|FG001|STARTED|Overall Study||19||
60076653|NCT00980044|76191641|FG002|STARTED|Overall Study||17||
60076654|NCT00980044|76191639|FG000|COMPLETED|Overall Study||12||
60076655|NCT00980044|76191640|FG001|COMPLETED|Overall Study||12||
60076656|NCT00980044|76191641|FG002|COMPLETED|Overall Study||12||
60076657|NCT00980044|76191639|FG000|NOT COMPLETED|Overall Study||5||
60076658|NCT00980044|76191640|FG001|NOT COMPLETED|Overall Study||7||
60076659|NCT00980044|76191641|FG002|NOT COMPLETED|Overall Study||5||
60076660|NCT01903837|76191656|FG000|STARTED|Part A||75||
60076661|NCT01903837|76191657|FG001|STARTED|Part A||80||
60076662|NCT01903837|76191658|FG002|STARTED|Part A||86||
59638098|NCT02284386|75753868|FG000|COMPLETED|Overall Study||15||
59638099|NCT02284386|75753868|FG000|NOT COMPLETED|Overall Study||0||
59638100|NCT02284464|75753874|FG000|STARTED|Overall Study||52||
59638101|NCT02284464|75753875|FG001|STARTED|Overall Study||53||
59638102|NCT02284464|75753874|FG000|COMPLETED|Overall Study||39||
59638103|NCT02284464|75753875|FG001|COMPLETED|Overall Study||36||
59638104|NCT02284464|75753874|FG000|NOT COMPLETED|Overall Study||13||
59638105|NCT02284464|75753875|FG001|NOT COMPLETED|Overall Study||17||
59638106|NCT02284854|75753883|FG000|STARTED|Overall Study||23||
59638107|NCT02284854|75753884|FG001|STARTED|Overall Study||20||
60076663|NCT01903837|76191659|FG003|STARTED|Part A||68||
60076664|NCT01903837|76191656|FG000|COMPLETED|Part A||56||
60076665|NCT01903837|76191657|FG001|COMPLETED|Part A||52||
59541361|NCT01550471|75639566|FG001|NOT COMPLETED|Third Wash Out Period (3 Weeks)||0||
59541362|NCT01550471|75639567|FG002|NOT COMPLETED|Third Wash Out Period (3 Weeks)||0||
59541363|NCT01550471|75639568|FG003|NOT COMPLETED|Third Wash Out Period (3 Weeks)||0||
59541364|NCT01550471|75639569|FG004|NOT COMPLETED|Third Wash Out Period (3 Weeks)||0||
59541365|NCT01550471|75639570|FG005|NOT COMPLETED|Third Wash Out Period (3 Weeks)||0||
59541366|NCT01528319|75639579|FG000|STARTED|Overall Study||24||
59541367|NCT01528319|75639579|FG000|12 Weeks After Surgery|Overall Study||24||
59541368|NCT01528319|75639579|FG000|COMPLETED|Overall Study||23||
59541369|NCT01528319|75639579|FG000|NOT COMPLETED|Overall Study||1||
59541370|NCT03215264|75639586|FG000|STARTED|Dose Level 1||6||
59541371|NCT03215264|75639587|FG001|STARTED|Dose Level 1||0||
59541372|NCT03215264|75639588|FG002|STARTED|Dose Level 1||0||
59541373|NCT03215264|75639586|FG000|COMPLETED|Dose Level 1||6||
59541374|NCT03215264|75639587|FG001|COMPLETED|Dose Level 1||0||
59541375|NCT03215264|75639588|FG002|COMPLETED|Dose Level 1||0||
59541376|NCT03215264|75639586|FG000|NOT COMPLETED|Dose Level 1||0||
59541377|NCT03215264|75639587|FG001|NOT COMPLETED|Dose Level 1||0||
59541378|NCT03215264|75639588|FG002|NOT COMPLETED|Dose Level 1||0||
59541379|NCT03215264|75639586|FG000|STARTED|Dose Level 2||0||
59541380|NCT03215264|75639587|FG001|STARTED|Dose Level 2||7||
59541381|NCT03215264|75639588|FG002|STARTED|Dose Level 2||0||
59541382|NCT03215264|75639586|FG000|COMPLETED|Dose Level 2||0||
59541383|NCT03215264|75639587|FG001|COMPLETED|Dose Level 2||6||
59541384|NCT03215264|75639588|FG002|COMPLETED|Dose Level 2||0||
59541385|NCT03215264|75639586|FG000|NOT COMPLETED|Dose Level 2||0||
59541386|NCT03215264|75639587|FG001|NOT COMPLETED|Dose Level 2||1||
59638108|NCT02284854|75753883|FG000|COMPLETED|Overall Study||18||
59638109|NCT02284854|75753884|FG001|COMPLETED|Overall Study||20||
59638110|NCT02284854|75753883|FG000|NOT COMPLETED|Overall Study||5||
59638111|NCT02284854|75753884|FG001|NOT COMPLETED|Overall Study||0||
59638112|NCT02285634|75753901|FG000|STARTED|Overall Study||15||
59638113|NCT02285634|75753902|FG001|STARTED|Overall Study||20||
59638114|NCT02285634|75753903|FG002|STARTED|Overall Study||15||
59638115|NCT02285634|75753904|FG003|STARTED|Overall Study||18||
59638116|NCT02285634|75753901|FG000|COMPLETED|Overall Study||15||
59638117|NCT02285634|75753902|FG001|COMPLETED|Overall Study||20||
59638118|NCT02285634|75753903|FG002|COMPLETED|Overall Study||11||
59638119|NCT02285634|75753904|FG003|COMPLETED|Overall Study||17||
59638120|NCT02285634|75753901|FG000|NOT COMPLETED|Overall Study||0||
59638121|NCT02285634|75753902|FG001|NOT COMPLETED|Overall Study||0||
59638122|NCT02285634|75753903|FG002|NOT COMPLETED|Overall Study||4||
59638123|NCT02285634|75753904|FG003|NOT COMPLETED|Overall Study||1||
59638124|NCT02287350|75753915|FG000|STARTED|Overall Study||51||
60076666|NCT01903837|76191658|FG002|COMPLETED|Part A||58||
60076667|NCT01903837|76191659|FG003|COMPLETED|Part A||55||
60076668|NCT01903837|76191656|FG000|NOT COMPLETED|Part A||19||
59541387|NCT03215264|75639588|FG002|NOT COMPLETED|Dose Level 2||0||
59638125|NCT02287350|75753915|FG000|COMPLETED|Overall Study||48||
60076669|NCT01903837|76191657|FG001|NOT COMPLETED|Part A||28||
60076670|NCT01903837|76191658|FG002|NOT COMPLETED|Part A||28||
60076671|NCT01903837|76191659|FG003|NOT COMPLETED|Part A||13||
60103606|NCT01291108|76221863|FG000|COMPLETED|Month 1 (Monotherapy)|All patients who completed Month 1 were randomized to adjunctive therapy for Month 2.|64||
60103607|NCT01291108|76221864|FG001|COMPLETED|Month 1 (Monotherapy)||0||
60103608|NCT01291108|76221865|FG002|COMPLETED|Month 1 (Monotherapy)||0||
59638126|NCT02287350|75753915|FG000|NOT COMPLETED|Overall Study||3||
59638127|NCT02288364|75753921|FG000|STARTED|Overall Study||42||
59638128|NCT02288364|75753922|FG001|STARTED|Overall Study||44||
59638129|NCT02288364|75753921|FG000|COMPLETED|Overall Study||42||
59638130|NCT02288364|75753922|FG001|COMPLETED|Overall Study||44||
59638131|NCT02288364|75753921|FG000|NOT COMPLETED|Overall Study||0||
59638132|NCT02288364|75753922|FG001|NOT COMPLETED|Overall Study||0||
59638133|NCT02289222|75753928|FG000|STARTED|Overall Study||48||
59638134|NCT02289222|75753928|FG000|COMPLETED|Overall Study||48||
59638135|NCT02289222|75753928|FG000|NOT COMPLETED|Overall Study||0||
59638136|NCT02291016|75753934|FG000|STARTED|Visit 1||2||
59638137|NCT02291016|75753935|FG001|STARTED|Visit 1||5||
59638138|NCT02291016|75753934|FG000|COMPLETED|Visit 1||2||
59638139|NCT02291016|75753935|FG001|COMPLETED|Visit 1||5||
59638140|NCT02291016|75753934|FG000|NOT COMPLETED|Visit 1||0||
59638141|NCT02291016|75753935|FG001|NOT COMPLETED|Visit 1||0||
59638142|NCT02291016|75753934|FG000|STARTED|Visit 2||2||
59638143|NCT02291016|75753935|FG001|STARTED|Visit 2||5||
59638144|NCT02291016|75753934|FG000|COMPLETED|Visit 2|Patients did not meet visit 2 FEV1 criteria ( 15% or closer to value at visit 1)|1||
59638145|NCT02291016|75753935|FG001|COMPLETED|Visit 2||5||
59638146|NCT02291016|75753934|FG000|NOT COMPLETED|Visit 2||1||
59638147|NCT02291016|75753935|FG001|NOT COMPLETED|Visit 2||0||
59638148|NCT02291718|75753945|FG000|STARTED|Overall Study||50||
59638149|NCT02291718|75753946|FG001|STARTED|Overall Study||50||
59638150|NCT02291718|75753947|FG002|STARTED|Overall Study||50||
59638151|NCT02291718|75753945|FG000|COMPLETED|Overall Study||50||
59638152|NCT02291718|75753946|FG001|COMPLETED|Overall Study||50||
59638153|NCT02291718|75753947|FG002|COMPLETED|Overall Study||50||
59638154|NCT02291718|75753945|FG000|NOT COMPLETED|Overall Study||0||
59638155|NCT02291718|75753946|FG001|NOT COMPLETED|Overall Study||0||
59638156|NCT02291718|75753947|FG002|NOT COMPLETED|Overall Study||0||
59638157|NCT02292186|75753955|FG000|STARTED|Overall Study||25||
59638158|NCT02292186|75753955|FG000|COMPLETED|Overall Study||7||
59638159|NCT02292186|75753955|FG000|NOT COMPLETED|Overall Study||18||
59638160|NCT02293044|75753959|FG000|STARTED|Overall Study||15||
59638161|NCT02293044|75753959|FG000|COMPLETED|Overall Study||15||
59638162|NCT02293044|75753959|FG000|NOT COMPLETED|Overall Study||0||
59638163|NCT02293512|75753967|FG000|STARTED|Overall Study||10||
59638164|NCT02293512|75753968|FG001|STARTED|Overall Study||10||
59638165|NCT02293512|75753969|FG002|STARTED|Overall Study||10||
59638166|NCT02293512|75753970|FG003|STARTED|Overall Study||10||
59638167|NCT02293512|75753967|FG000|COMPLETED|Overall Study||6||
59638168|NCT02293512|75753968|FG001|COMPLETED|Overall Study||4||
59638169|NCT02293512|75753969|FG002|COMPLETED|Overall Study||7||
59638170|NCT02293512|75753970|FG003|COMPLETED|Overall Study||8||
59638171|NCT02293512|75753967|FG000|NOT COMPLETED|Overall Study||4||
59638172|NCT02293512|75753968|FG001|NOT COMPLETED|Overall Study||6||
59638173|NCT02293512|75753969|FG002|NOT COMPLETED|Overall Study||3||
59638174|NCT02293512|75753970|FG003|NOT COMPLETED|Overall Study||2||
59638175|NCT02296164|75753980|FG000|STARTED|Overall Study|2 patients not eligible as were not on Valchlor at time of study start|298|Registered: 301; Only registered/not enrolled:1; Enrolled: 300|
59638176|NCT02296164|75753980|FG000|COMPLETED|Overall Study||188||
59638177|NCT02296164|75753980|FG000|NOT COMPLETED|Overall Study||110||
59638178|NCT02297100|75753986|FG000|STARTED|Overall Study||13||
59638179|NCT02297100|75753987|FG001|STARTED|Overall Study||14||
59638180|NCT02297100|75753986|FG000|COMPLETED|Overall Study||13||
59638181|NCT02297100|75753987|FG001|COMPLETED|Overall Study||14||
59638182|NCT02297100|75753986|FG000|NOT COMPLETED|Overall Study||0||
59638183|NCT02297100|75753987|FG001|NOT COMPLETED|Overall Study||0||
59638184|NCT02299050|75753993|FG000|STARTED|Overall Study||23||
59638185|NCT02299050|75753993|FG000|COMPLETED|Overall Study||15||
59638186|NCT02299050|75753993|FG000|NOT COMPLETED|Overall Study||8||
59638187|NCT02302092|75753999|FG000|STARTED|Overall Study||6||
59638188|NCT02302092|75754000|FG001|STARTED|Overall Study||7||
59638189|NCT02302092|75753999|FG000|COMPLETED|Overall Study||6||
59638190|NCT02302092|75754000|FG001|COMPLETED|Overall Study||7||
59638191|NCT02302092|75753999|FG000|NOT COMPLETED|Overall Study||0||
59638192|NCT02302092|75754000|FG001|NOT COMPLETED|Overall Study||0||
59638193|NCT02303184|75754008|FG000|STARTED|Overall Study||23||
59638194|NCT02303184|75754009|FG001|STARTED|Overall Study||23||
59638195|NCT02303184|75754008|FG000|COMPLETED|Overall Study||23||
59638196|NCT02303184|75754009|FG001|COMPLETED|Overall Study||23||
59638197|NCT02303184|75754008|FG000|NOT COMPLETED|Overall Study||0||
59638198|NCT02303184|75754009|FG001|NOT COMPLETED|Overall Study||0||
59638199|NCT02304432|75754015|FG000|STARTED|Open Label DCS||2||
59638200|NCT02304432|75754016|FG001|STARTED|Open Label DCS||0||
59638201|NCT02304432|75754017|FG002|STARTED|Open Label DCS||0||
59638202|NCT02304432|75754018|FG003|STARTED|Open Label DCS||0||
59638203|NCT02304432|75754015|FG000|COMPLETED|Open Label DCS||2||
59638204|NCT02304432|75754016|FG001|COMPLETED|Open Label DCS||0||
59638205|NCT02304432|75754017|FG002|COMPLETED|Open Label DCS||0||
59638206|NCT02304432|75754018|FG003|COMPLETED|Open Label DCS||0||
59638207|NCT02304432|75754015|FG000|NOT COMPLETED|Open Label DCS||0||
59638208|NCT02304432|75754016|FG001|NOT COMPLETED|Open Label DCS||0||
59638209|NCT02304432|75754017|FG002|NOT COMPLETED|Open Label DCS||0||
59638210|NCT02304432|75754018|FG003|NOT COMPLETED|Open Label DCS||0||
59638211|NCT02304432|75754015|FG000|STARTED|Double-Blind DCS Placebo Crossover||0||
59638212|NCT02304432|75754016|FG001|STARTED|Double-Blind DCS Placebo Crossover||1||
59638213|NCT02304432|75754017|FG002|STARTED|Double-Blind DCS Placebo Crossover||1||
59638214|NCT02304432|75754018|FG003|STARTED|Double-Blind DCS Placebo Crossover||0||
59638215|NCT02304432|75754015|FG000|COMPLETED|Double-Blind DCS Placebo Crossover||0||
59638216|NCT02304432|75754016|FG001|COMPLETED|Double-Blind DCS Placebo Crossover||1||
59638217|NCT02304432|75754017|FG002|COMPLETED|Double-Blind DCS Placebo Crossover||1||
59638218|NCT02304432|75754018|FG003|COMPLETED|Double-Blind DCS Placebo Crossover||0||
59638219|NCT02304432|75754015|FG000|NOT COMPLETED|Double-Blind DCS Placebo Crossover||0||
59638220|NCT02304432|75754016|FG001|NOT COMPLETED|Double-Blind DCS Placebo Crossover||0||
59638221|NCT02304432|75754017|FG002|NOT COMPLETED|Double-Blind DCS Placebo Crossover||0||
59638222|NCT02304432|75754018|FG003|NOT COMPLETED|Double-Blind DCS Placebo Crossover||0||
59638223|NCT02304432|75754015|FG000|STARTED|Second Open Label DCS||0||
59638224|NCT02304432|75754016|FG001|STARTED|Second Open Label DCS||0||
59638225|NCT02304432|75754017|FG002|STARTED|Second Open Label DCS||0||
59638226|NCT02304432|75754018|FG003|STARTED|Second Open Label DCS||2||
59638227|NCT02304432|75754015|FG000|COMPLETED|Second Open Label DCS||0||
59638228|NCT02304432|75754016|FG001|COMPLETED|Second Open Label DCS||0||
59638229|NCT02304432|75754017|FG002|COMPLETED|Second Open Label DCS||0||
59988452|NCT02520284|76103613|FG001|STARTED|Open-Label MaintenancePhase: Upto Week51|Participants achieving neither EBS remission nor MCS response entered Open-Label Maintenance Phase.|35||
59988453|NCT02520284|76103614|FG002|STARTED|Open-Label MaintenancePhase: Upto Week51|Participants achieving neither EBS remission nor MCS response entered Open-Label Maintenance Phase.|34||
59988454|NCT02520284|76103612|FG000|COMPLETED|Open-Label MaintenancePhase: Upto Week51||0||
59988455|NCT02520284|76103613|FG001|COMPLETED|Open-Label MaintenancePhase: Upto Week51||0||
59638230|NCT02304432|75754018|FG003|COMPLETED|Second Open Label DCS||2||
59638231|NCT02304432|75754015|FG000|NOT COMPLETED|Second Open Label DCS||0||
59638232|NCT02304432|75754016|FG001|NOT COMPLETED|Second Open Label DCS||0||
59638233|NCT02304432|75754017|FG002|NOT COMPLETED|Second Open Label DCS||0||
59638234|NCT02304432|75754018|FG003|NOT COMPLETED|Second Open Label DCS||0||
59638235|NCT02306928|75754033|FG000|STARTED|Overall Study||15||
59638236|NCT02306928|75754033|FG000|COMPLETED|Overall Study||15||
59638237|NCT02306928|75754033|FG000|NOT COMPLETED|Overall Study||0||
59638238|NCT02307318|75754037|FG000|STARTED|Overall Study||51||
59638239|NCT02307318|75754037|FG000|COMPLETED|Overall Study||51||
59638240|NCT02307318|75754037|FG000|NOT COMPLETED|Overall Study||0||
59988456|NCT02520284|76103614|FG002|COMPLETED|Open-Label MaintenancePhase: Upto Week51||0||
59638241|NCT02307552|75754041|FG000|STARTED|Overall Study||1||
59638242|NCT02307552|75754041|FG000|COMPLETED|Overall Study||1||
59638243|NCT02307552|75754041|FG000|NOT COMPLETED|Overall Study||0||
59638244|NCT02312154|75754045|FG000|STARTED|Overall Study||25||
59638245|NCT02312154|75754045|FG000|COMPLETED|Overall Study||24||
59638246|NCT02312154|75754045|FG000|NOT COMPLETED|Overall Study||1||
59638247|NCT02312310|75754054|FG000|STARTED|Overall Study||53||
59638248|NCT02312310|75754055|FG001|STARTED|Overall Study||53||
59638249|NCT02312310|75754056|FG002|STARTED|Overall Study||53||
59638250|NCT02312310|75754057|FG003|STARTED|Overall Study||52||
59638251|NCT02312310|75754054|FG000|COMPLETED|Overall Study||51||
59638252|NCT02312310|75754055|FG001|COMPLETED|Overall Study||51||
59638253|NCT02312310|75754056|FG002|COMPLETED|Overall Study||50||
59638254|NCT02312310|75754057|FG003|COMPLETED|Overall Study||52||
59638255|NCT02312310|75754054|FG000|NOT COMPLETED|Overall Study||2||
59638256|NCT02312310|75754055|FG001|NOT COMPLETED|Overall Study||2||
59638257|NCT02312310|75754056|FG002|NOT COMPLETED|Overall Study||3||
59638258|NCT02312310|75754057|FG003|NOT COMPLETED|Overall Study||0||
59638259|NCT02314104|75754074|FG000|STARTED|Overall Study||71||
59638260|NCT02314104|75754075|FG001|STARTED|Overall Study||78||
59638261|NCT02314104|75754076|FG002|STARTED|Overall Study||71||
59638262|NCT02314104|75754074|FG000|COMPLETED|Overall Study||57||
59638263|NCT02314104|75754075|FG001|COMPLETED|Overall Study||58||
59638264|NCT02314104|75754076|FG002|COMPLETED|Overall Study||53||
59638265|NCT02314104|75754074|FG000|NOT COMPLETED|Overall Study||14||
59638266|NCT02314104|75754075|FG001|NOT COMPLETED|Overall Study||20||
59638267|NCT02314104|75754076|FG002|NOT COMPLETED|Overall Study||18||
59638268|NCT02314260|75754084|FG000|STARTED|Overall Study||80||
59638269|NCT02314260|75754084|FG000|COMPLETED|Overall Study||80||
59638270|NCT02314260|75754084|FG000|NOT COMPLETED|Overall Study||0||
59638271|NCT02320812|75754088|FG000|STARTED|Overall Study||28||
59638272|NCT02320812|75754088|FG000|COMPLETED|Overall Study||28||
59638273|NCT02320812|75754088|FG000|NOT COMPLETED|Overall Study||0||
59638274|NCT02321748|75754098|FG000|STARTED|Overall Study||12||
59988457|NCT02520284|76103612|FG000|NOT COMPLETED|Open-Label MaintenancePhase: Upto Week51||32||
59988458|NCT02520284|76103613|FG001|NOT COMPLETED|Open-Label MaintenancePhase: Upto Week51||35||
59638275|NCT02321748|75754099|FG001|STARTED|Overall Study||12||
59638276|NCT02321748|75754098|FG000|First Intervention (4 Days)|Overall Study||12||
59638277|NCT02321748|75754099|FG001|First Intervention (4 Days)|Overall Study||12||
59638278|NCT02321748|75754098|FG000|Wasout (2weeks)|Overall Study||12||
59638279|NCT02321748|75754099|FG001|Wasout (2weeks)|Overall Study||12||
59638280|NCT02321748|75754098|FG000|Second Intervention (4 Days)|Overall Study||12||
59638281|NCT02321748|75754099|FG001|Second Intervention (4 Days)|Overall Study||12||
59638282|NCT02321748|75754098|FG000|COMPLETED|Overall Study||12||
59638283|NCT02321748|75754099|FG001|COMPLETED|Overall Study||12||
59638284|NCT02321748|75754098|FG000|NOT COMPLETED|Overall Study||0||
59638285|NCT02321748|75754099|FG001|NOT COMPLETED|Overall Study||0||
59638286|NCT02322528|75754108|FG000|STARTED|Overall Study||10||
59638287|NCT02322528|75754108|FG000|COMPLETED|Overall Study||10||
59638288|NCT02322528|75754108|FG000|NOT COMPLETED|Overall Study||0||
59638289|NCT02323854|75754112|FG000|STARTED|Overall Study||15||
59638290|NCT02323854|75754112|FG000|COMPLETED|Overall Study||15||
59638291|NCT02323854|75754112|FG000|NOT COMPLETED|Overall Study||0||
59638292|NCT02327052|75754116|FG000|STARTED|Overall Study||58||
59638293|NCT02327052|75754116|FG000|COMPLETED|Overall Study||58||
59638294|NCT02327052|75754116|FG000|NOT COMPLETED|Overall Study||0||
59638295|NCT02330094|75754122|FG000|STARTED|Overall Study||8||
59638296|NCT02330094|75754123|FG001|STARTED|Overall Study||8||
59638297|NCT02330094|75754122|FG000|COMPLETED|Overall Study||8||
59638298|NCT02330094|75754123|FG001|COMPLETED|Overall Study||8||
59638299|NCT02330094|75754122|FG000|NOT COMPLETED|Overall Study||0||
59638300|NCT02330094|75754123|FG001|NOT COMPLETED|Overall Study||0||
59638301|NCT02330172|75754131|FG000|STARTED|Overall Study||22||
59638302|NCT02330172|75754132|FG001|STARTED|Overall Study||22||
59638303|NCT02330172|75754131|FG000|COMPLETED|Overall Study||19||
59638304|NCT02330172|75754132|FG001|COMPLETED|Overall Study||21||
59638305|NCT02330172|75754131|FG000|NOT COMPLETED|Overall Study||3||
59638306|NCT02330172|75754132|FG001|NOT COMPLETED|Overall Study||1||
59638307|NCT02331108|75754144|FG000|STARTED|Overall Study||51||
59638308|NCT02331108|75754145|FG001|STARTED|Overall Study||52||
59638309|NCT02331108|75754146|FG002|STARTED|Overall Study||51||
59638310|NCT02331108|75754147|FG003|STARTED|Overall Study||51||
59638311|NCT02331108|75754148|FG004|STARTED|Overall Study||52||
59638312|NCT02331108|75754149|FG005|STARTED|Overall Study||52||
59638313|NCT02331108|75754144|FG000|COMPLETED|Overall Study||50||
59638314|NCT02331108|75754145|FG001|COMPLETED|Overall Study||50||
59638315|NCT02331108|75754146|FG002|COMPLETED|Overall Study||50||
59638316|NCT02331108|75754147|FG003|COMPLETED|Overall Study||50||
59638317|NCT02331108|75754148|FG004|COMPLETED|Overall Study||50||
59638318|NCT02331108|75754149|FG005|COMPLETED|Overall Study||50||
59638319|NCT02331108|75754144|FG000|NOT COMPLETED|Overall Study||1||
59638320|NCT02331108|75754145|FG001|NOT COMPLETED|Overall Study||2||
59638321|NCT02331108|75754146|FG002|NOT COMPLETED|Overall Study||1||
59638322|NCT02331108|75754147|FG003|NOT COMPLETED|Overall Study||1||
59638323|NCT02331108|75754148|FG004|NOT COMPLETED|Overall Study||2||
59638324|NCT02331108|75754149|FG005|NOT COMPLETED|Overall Study||2||
59638325|NCT02340156|75754165|FG000|STARTED|Overall Study||1||
59638326|NCT02340156|75754165|FG000|COMPLETED|Overall Study||1||
59638327|NCT02340156|75754165|FG000|NOT COMPLETED|Overall Study||0||
59638328|NCT02343276|75754171|FG000|STARTED|Overall Study||164||
59638329|NCT02343276|75754172|FG001|STARTED|Overall Study||164||
59638330|NCT02343276|75754171|FG000|COMPLETED|Overall Study||164||
59638331|NCT02343276|75754172|FG001|COMPLETED|Overall Study||164||
59638332|NCT02343276|75754171|FG000|NOT COMPLETED|Overall Study||0||
59638333|NCT02343276|75754172|FG001|NOT COMPLETED|Overall Study||0||
59638334|NCT02347410|75754178|FG000|STARTED|Overall Study||102||
59638335|NCT02347410|75754178|FG000|COMPLETED|Overall Study||98||
59638336|NCT02347410|75754178|FG000|NOT COMPLETED|Overall Study||4||
59638337|NCT02347488|75754188|FG000|STARTED|Overall Study||30||
59638338|NCT02347488|75754188|FG000|COMPLETED|Overall Study||30||
59638339|NCT02347488|75754188|FG000|NOT COMPLETED|Overall Study||0||
59638340|NCT02348658|75754194|FG000|STARTED|Period 1 (7 Days)||6||
59638341|NCT02348658|75754195|FG001|STARTED|Period 1 (7 Days)||6||
59638342|NCT02348658|75754194|FG000|COMPLETED|Period 1 (7 Days)||6||
59638343|NCT02348658|75754195|FG001|COMPLETED|Period 1 (7 Days)||6||
59638344|NCT02348658|75754194|FG000|NOT COMPLETED|Period 1 (7 Days)||0||
59638345|NCT02348658|75754195|FG001|NOT COMPLETED|Period 1 (7 Days)||0||
59638346|NCT02348658|75754194|FG000|STARTED|Washout Period (22 Days)||6||
59638347|NCT02348658|75754195|FG001|STARTED|Washout Period (22 Days)||6||
59638348|NCT02348658|75754194|FG000|COMPLETED|Washout Period (22 Days)||6||
59638349|NCT02348658|75754195|FG001|COMPLETED|Washout Period (22 Days)||6||
59638350|NCT02348658|75754194|FG000|NOT COMPLETED|Washout Period (22 Days)||0||
59638351|NCT02348658|75754195|FG001|NOT COMPLETED|Washout Period (22 Days)||0||
59638352|NCT02348658|75754194|FG000|STARTED|Period 2 (7 Days)||6||
59638353|NCT02348658|75754195|FG001|STARTED|Period 2 (7 Days)||6||
59638354|NCT02348658|75754194|FG000|COMPLETED|Period 2 (7 Days)||6||
59638355|NCT02348658|75754195|FG001|COMPLETED|Period 2 (7 Days)||6||
59638356|NCT02348658|75754194|FG000|NOT COMPLETED|Period 2 (7 Days)||0||
59638357|NCT02348658|75754195|FG001|NOT COMPLETED|Period 2 (7 Days)||0||
59638358|NCT02349438|75754201|FG000|STARTED|Period 1||11||
59638359|NCT02349438|75754202|FG001|STARTED|Period 1||10||
59638360|NCT02349438|75754201|FG000|COMPLETED|Period 1||11||
59638361|NCT02349438|75754202|FG001|COMPLETED|Period 1||10||
59638362|NCT02349438|75754201|FG000|NOT COMPLETED|Period 1||0||
59638363|NCT02349438|75754202|FG001|NOT COMPLETED|Period 1||0||
59638364|NCT02349438|75754201|FG000|STARTED|Period 2||11||
59638365|NCT02349438|75754202|FG001|STARTED|Period 2||10||
59638366|NCT02349438|75754201|FG000|COMPLETED|Period 2||11||
59638367|NCT02349438|75754202|FG001|COMPLETED|Period 2||10||
59638368|NCT02349438|75754201|FG000|NOT COMPLETED|Period 2||0||
59638369|NCT02349438|75754202|FG001|NOT COMPLETED|Period 2||0||
59638370|NCT02350998|75754208|FG000|STARTED|Overall Study||33||
59638371|NCT02350998|75754208|FG000|COMPLETED|Overall Study||33||
59638372|NCT02350998|75754208|FG000|NOT COMPLETED|Overall Study||0||
59638373|NCT02351700|75754216|FG000|STARTED|Overall Study||28||
59638374|NCT02351700|75754217|FG001|STARTED|Overall Study||34||
59638375|NCT02351700|75754216|FG000|COMPLETED|Overall Study||28||
59638376|NCT02351700|75754217|FG001|COMPLETED|Overall Study||34||
59638377|NCT02351700|75754216|FG000|NOT COMPLETED|Overall Study||0||
59638378|NCT02351700|75754217|FG001|NOT COMPLETED|Overall Study||0||
59638379|NCT02353806|75754225|FG000|STARTED|Overall Study||16||
59638380|NCT02353806|75754225|FG000|COMPLETED|Overall Study||6||
59638381|NCT02353806|75754225|FG000|NOT COMPLETED|Overall Study||10||
59638382|NCT02354352|75754233|FG000|STARTED|Overall Study||26||
59638383|NCT02354352|75754234|FG001|STARTED|Overall Study||26||
59638384|NCT02354352|75754233|FG000|2 Weeks|Overall Study||26||
59638385|NCT02354352|75754234|FG001|2 Weeks|Overall Study||25||
59638386|NCT02354352|75754233|FG000|1 Month|Overall Study||24||
59638387|NCT02354352|75754234|FG001|1 Month|Overall Study||23||
59638388|NCT02354352|75754233|FG000|2 Months|Overall Study||24||
59638389|NCT02354352|75754234|FG001|2 Months|Overall Study||22||
59638390|NCT02354352|75754233|FG000|3 Months|Overall Study||25||
59638391|NCT02354352|75754234|FG001|3 Months|Overall Study||23||
59638392|NCT02354352|75754233|FG000|6 Months|Overall Study||25||
59638393|NCT02354352|75754234|FG001|6 Months|Overall Study||23||
59638394|NCT02354352|75754233|FG000|9 Months|Overall Study||25||
59638395|NCT02354352|75754234|FG001|9 Months|Overall Study||23||
59638396|NCT02354352|75754233|FG000|COMPLETED|Overall Study||23||
59638397|NCT02354352|75754234|FG001|COMPLETED|Overall Study||23||
59638398|NCT02354352|75754233|FG000|NOT COMPLETED|Overall Study||3||
59638399|NCT02354352|75754234|FG001|NOT COMPLETED|Overall Study||3||
59638400|NCT02355210|75754246|FG000|STARTED|Overall Study||19||
59638401|NCT02355210|75754247|FG001|STARTED|Overall Study||18||
59638402|NCT02355210|75754248|FG002|STARTED|Overall Study||16||
59638403|NCT02355210|75754249|FG003|STARTED|Overall Study||17||
59638404|NCT02355210|75754250|FG004|STARTED|Overall Study||19||
59638405|NCT02355210|75754251|FG005|STARTED|Overall Study||18||
59638406|NCT02355210|75754246|FG000|COMPLETED|Overall Study||19||
59638407|NCT02355210|75754247|FG001|COMPLETED|Overall Study||18||
59638408|NCT02355210|75754248|FG002|COMPLETED|Overall Study||16||
59638409|NCT02355210|75754249|FG003|COMPLETED|Overall Study||17||
59638410|NCT02355210|75754250|FG004|COMPLETED|Overall Study||19||
59638411|NCT02355210|75754251|FG005|COMPLETED|Overall Study||18||
59638412|NCT02355210|75754246|FG000|NOT COMPLETED|Overall Study||0||
59638413|NCT02355210|75754247|FG001|NOT COMPLETED|Overall Study||0||
59638414|NCT02355210|75754248|FG002|NOT COMPLETED|Overall Study||0||
59638415|NCT02355210|75754249|FG003|NOT COMPLETED|Overall Study||0||
59638416|NCT02355210|75754250|FG004|NOT COMPLETED|Overall Study||0||
59638417|NCT02355210|75754251|FG005|NOT COMPLETED|Overall Study||0||
59638418|NCT02356692|75754265|FG000|STARTED|Overall Study||60||60
59638419|NCT02356692|75754266|FG001|STARTED|Overall Study||60||60
59638420|NCT02356692|75754265|FG000|COMPLETED|Overall Study||60||60
59638421|NCT02356692|75754266|FG001|COMPLETED|Overall Study||60||60
59638422|NCT02356692|75754265|FG000|NOT COMPLETED|Overall Study||0||0
59638423|NCT02356692|75754266|FG001|NOT COMPLETED|Overall Study||0||0
59638424|NCT02357394|75754276|FG000|STARTED|Overall Study||4||
59638425|NCT02357394|75754277|FG001|STARTED|Overall Study||3||
59638426|NCT02357394|75754276|FG000|COMPLETED|Overall Study||4||
59638427|NCT02357394|75754277|FG001|COMPLETED|Overall Study||3||
59638428|NCT02357394|75754276|FG000|NOT COMPLETED|Overall Study||0||
59638429|NCT02357394|75754277|FG001|NOT COMPLETED|Overall Study||0||
59638430|NCT02357706|75754283|FG000|STARTED|Overall Study||10||
59638431|NCT02357706|75754284|FG001|STARTED|Overall Study||10||
59638432|NCT02357706|75754283|FG000|COMPLETED|Overall Study||10||
59638433|NCT02357706|75754284|FG001|COMPLETED|Overall Study||10||
59638434|NCT02357706|75754283|FG000|NOT COMPLETED|Overall Study||0||
59638435|NCT02357706|75754284|FG001|NOT COMPLETED|Overall Study||0||
59638436|NCT02358876|75754293|FG000|STARTED|Overall Study||32||
59638437|NCT02358876|75754293|FG000|COMPLETED|Overall Study|All 32 participants completed the in-clinic portion and 30 out of the 32 completed the home portion.|30||
59638438|NCT02358876|75754293|FG000|NOT COMPLETED|Overall Study||2||
59638439|NCT02359110|75754299|FG000|STARTED|Overall Study||55||
59638440|NCT02359110|75754300|FG001|STARTED|Overall Study||54||
59638441|NCT02359110|75754299|FG000|COMPLETED|Overall Study||55||
59638442|NCT02359110|75754300|FG001|COMPLETED|Overall Study||54||
59638443|NCT02359110|75754299|FG000|NOT COMPLETED|Overall Study||0||
59638444|NCT02359110|75754300|FG001|NOT COMPLETED|Overall Study||0||
59638445|NCT02360124|75754309|FG000|STARTED|Overall Study||108||
59638446|NCT02360124|75754310|FG001|STARTED|Overall Study||107||
59638447|NCT02360124|75754311|FG002|STARTED|Overall Study||108||
59638448|NCT02360124|75754309|FG000|COMPLETED|Overall Study||80||
59638449|NCT02360124|75754310|FG001|COMPLETED|Overall Study||95||
59638450|NCT02360124|75754311|FG002|COMPLETED|Overall Study||82||
59638451|NCT02360124|75754309|FG000|NOT COMPLETED|Overall Study||28||
59638452|NCT02360124|75754310|FG001|NOT COMPLETED|Overall Study||12||
59638453|NCT02360124|75754311|FG002|NOT COMPLETED|Overall Study||26||
59638454|NCT02364570|75754321|FG000|STARTED|Overall Study||1||
59638455|NCT02364570|75754322|FG001|STARTED|Overall Study||1||
59638456|NCT02364570|75754323|FG002|STARTED|Overall Study||2||
59638457|NCT02364570|75754324|FG003|STARTED|Overall Study||1||
59638458|NCT02364570|75754325|FG004|STARTED|Overall Study||1||
59638459|NCT02364570|75754326|FG005|STARTED|Overall Study||1||
59638460|NCT02364570|75754327|FG006|STARTED|Overall Study||2||
59638461|NCT02364570|75754328|FG007|STARTED|Overall Study||1||
59638462|NCT02364570|75754329|FG008|STARTED|Overall Study||2||
59638463|NCT02364570|75754330|FG009|STARTED|Overall Study||1||
59638464|NCT02364570|75754331|FG010|STARTED|Overall Study||1||
59638465|NCT02364570|75754332|FG011|STARTED|Overall Study||1||
59638466|NCT02364570|75754333|FG012|STARTED|Overall Study||1||
59638467|NCT02364570|75754334|FG013|STARTED|Overall Study||2||
59638468|NCT02364570|75754335|FG014|STARTED|Overall Study||1||
59638469|NCT02364570|75754336|FG015|STARTED|Overall Study||1||
59638470|NCT02364570|75754321|FG000|COMPLETED|Overall Study||1||
59638471|NCT02364570|75754322|FG001|COMPLETED|Overall Study||1||
59638472|NCT02364570|75754323|FG002|COMPLETED|Overall Study||2||
59638473|NCT02364570|75754324|FG003|COMPLETED|Overall Study||1||
59638474|NCT02364570|75754325|FG004|COMPLETED|Overall Study||1||
59638475|NCT02364570|75754326|FG005|COMPLETED|Overall Study||1||
59638476|NCT02364570|75754327|FG006|COMPLETED|Overall Study||2||
59638477|NCT02364570|75754328|FG007|COMPLETED|Overall Study||1||
59638478|NCT02364570|75754329|FG008|COMPLETED|Overall Study||2||
59638479|NCT02364570|75754330|FG009|COMPLETED|Overall Study||1||
59638480|NCT02364570|75754331|FG010|COMPLETED|Overall Study||1||
59638481|NCT02364570|75754332|FG011|COMPLETED|Overall Study||1||
59638482|NCT02364570|75754333|FG012|COMPLETED|Overall Study||1||
59638483|NCT02364570|75754334|FG013|COMPLETED|Overall Study||2||
59638484|NCT02364570|75754335|FG014|COMPLETED|Overall Study||1||
59638485|NCT02364570|75754336|FG015|COMPLETED|Overall Study||1||
59638486|NCT02364570|75754321|FG000|NOT COMPLETED|Overall Study||0||
59638487|NCT02364570|75754322|FG001|NOT COMPLETED|Overall Study||0||
59638488|NCT02364570|75754323|FG002|NOT COMPLETED|Overall Study||0||
59638489|NCT02364570|75754324|FG003|NOT COMPLETED|Overall Study||0||
59638490|NCT02364570|75754325|FG004|NOT COMPLETED|Overall Study||0||
59638491|NCT02364570|75754326|FG005|NOT COMPLETED|Overall Study||0||
59638492|NCT02364570|75754327|FG006|NOT COMPLETED|Overall Study||0||
59638493|NCT02364570|75754328|FG007|NOT COMPLETED|Overall Study||0||
59638494|NCT02364570|75754329|FG008|NOT COMPLETED|Overall Study||0||
59638495|NCT02364570|75754330|FG009|NOT COMPLETED|Overall Study||0||
59638496|NCT02364570|75754331|FG010|NOT COMPLETED|Overall Study||0||
59638497|NCT02364570|75754332|FG011|NOT COMPLETED|Overall Study||0||
59638498|NCT02364570|75754333|FG012|NOT COMPLETED|Overall Study||0||
59638499|NCT02364570|75754334|FG013|NOT COMPLETED|Overall Study||0||
59638500|NCT02364570|75754335|FG014|NOT COMPLETED|Overall Study||0||
59638501|NCT02364570|75754336|FG015|NOT COMPLETED|Overall Study||0||
59638502|NCT02367066|75754348|FG000|STARTED|Overall Study||10||
59638503|NCT02367066|75754349|FG001|STARTED|Overall Study||10||
59638504|NCT02367066|75754348|FG000|COMPLETED|Overall Study||10||
59638505|NCT02367066|75754349|FG001|COMPLETED|Overall Study||10||
59638506|NCT02367066|75754348|FG000|NOT COMPLETED|Overall Study||0||
59638507|NCT02367066|75754349|FG001|NOT COMPLETED|Overall Study||0||
59638508|NCT02369172|75754360|FG000|STARTED|Overall Study||24||
59638509|NCT02369172|75754360|FG000|COMPLETED|Overall Study||24||
59638510|NCT02369172|75754360|FG000|NOT COMPLETED|Overall Study||0||
59638511|NCT02369796|75754387|FG000|STARTED|Overall Study||3||
59638512|NCT02369796|75754388|FG001|STARTED|Overall Study||3||
59638513|NCT02369796|75754389|FG002|STARTED|Overall Study||3||
59638514|NCT02369796|75754390|FG003|STARTED|Overall Study||3||
59638515|NCT02369796|75754391|FG004|STARTED|Overall Study||3||
59638516|NCT02369796|75754387|FG000|COMPLETED|Overall Study||3||
59638517|NCT02369796|75754388|FG001|COMPLETED|Overall Study||3||
59638518|NCT02369796|75754389|FG002|COMPLETED|Overall Study||3||
59638519|NCT02369796|75754390|FG003|COMPLETED|Overall Study||3||
59638520|NCT02369796|75754391|FG004|COMPLETED|Overall Study||3||
59638521|NCT02369796|75754387|FG000|NOT COMPLETED|Overall Study||0||
59638522|NCT02369796|75754388|FG001|NOT COMPLETED|Overall Study||0||
59638523|NCT02369796|75754389|FG002|NOT COMPLETED|Overall Study||0||
59638524|NCT02369796|75754390|FG003|NOT COMPLETED|Overall Study||0||
59638525|NCT02369796|75754391|FG004|NOT COMPLETED|Overall Study||0||
59638526|NCT02370810|75754405|FG000|STARTED|Overall Study||73||
59638527|NCT02370810|75754406|FG001|STARTED|Overall Study||73||
59638528|NCT02370810|75754405|FG000|COMPLETED|Overall Study||50||
59638529|NCT02370810|75754406|FG001|COMPLETED|Overall Study||54||
59638530|NCT02370810|75754405|FG000|NOT COMPLETED|Overall Study||23||
59638531|NCT02370810|75754406|FG001|NOT COMPLETED|Overall Study||19||
59638532|NCT02371356|75754419|FG000|STARTED|Overall Study||1320||
59638533|NCT02371356|75754420|FG001|STARTED|Overall Study||7354||
59638534|NCT02371356|75754421|FG002|STARTED|Overall Study||2804||
59638535|NCT02371356|75754422|FG003|STARTED|Overall Study||7423||
59638536|NCT02371356|75754423|FG004|STARTED|Overall Study||72183||
59638537|NCT02371356|75754419|FG000|COMPLETED|Overall Study||1320||
59638538|NCT02371356|75754420|FG001|COMPLETED|Overall Study||7354||
59638539|NCT02371356|75754421|FG002|COMPLETED|Overall Study||2804||
59638540|NCT02371356|75754422|FG003|COMPLETED|Overall Study||7423||
59638541|NCT02371356|75754423|FG004|COMPLETED|Overall Study||72183||
59638542|NCT02371356|75754419|FG000|NOT COMPLETED|Overall Study||0||
59638543|NCT02371356|75754420|FG001|NOT COMPLETED|Overall Study||0||
59638544|NCT02371356|75754421|FG002|NOT COMPLETED|Overall Study||0||
59638545|NCT02371356|75754422|FG003|NOT COMPLETED|Overall Study||0||
59638546|NCT02371356|75754423|FG004|NOT COMPLETED|Overall Study||0||
59638547|NCT02371668|75754437|FG000|STARTED|Overall Study||49||
59638548|NCT02371668|75754438|FG001|STARTED|Overall Study||42||
59638549|NCT02371668|75754437|FG000|COMPLETED|Overall Study||49||
59638550|NCT02371668|75754438|FG001|COMPLETED|Overall Study||42||
59638551|NCT02371668|75754437|FG000|NOT COMPLETED|Overall Study||0||
59638552|NCT02371668|75754438|FG001|NOT COMPLETED|Overall Study||0||
59638553|NCT02372682|75754446|FG000|STARTED|Overall Study||78||
59638554|NCT02372682|75754447|FG001|STARTED|Overall Study||93||
59638555|NCT02372682|75754446|FG000|COMPLETED|Overall Study||70||
59638556|NCT02372682|75754447|FG001|COMPLETED|Overall Study||79||
59638557|NCT02372682|75754446|FG000|NOT COMPLETED|Overall Study||8||
59638558|NCT02372682|75754447|FG001|NOT COMPLETED|Overall Study||14||
59638559|NCT02373852|75754460|FG000|STARTED|Overall Study|Includes patients from a previous retrospective study NCT01042444|12||
59638560|NCT02373852|75754460|FG000|COMPLETED|Overall Study||11||
59638561|NCT02373852|75754460|FG000|NOT COMPLETED|Overall Study||1||
59638562|NCT02374164|75754467|FG000|STARTED|Treatment Period 1||12||
59638563|NCT02374164|75754468|FG001|STARTED|Treatment Period 1||12||
59638564|NCT02374164|75754469|FG002|STARTED|Treatment Period 1||12||
59638565|NCT02374164|75754467|FG000|COMPLETED|Treatment Period 1||12||
59638566|NCT02374164|75754468|FG001|COMPLETED|Treatment Period 1||12||
59638567|NCT02374164|75754469|FG002|COMPLETED|Treatment Period 1||12||
59638568|NCT02374164|75754467|FG000|NOT COMPLETED|Treatment Period 1||0||
59638569|NCT02374164|75754468|FG001|NOT COMPLETED|Treatment Period 1||0||
59638570|NCT02374164|75754469|FG002|NOT COMPLETED|Treatment Period 1||0||
59638571|NCT02374164|75754467|FG000|STARTED|Treatment Period 2||12||
59638572|NCT02374164|75754468|FG001|STARTED|Treatment Period 2||12||
59638573|NCT02374164|75754469|FG002|STARTED|Treatment Period 2||12||
59638574|NCT02374164|75754467|FG000|COMPLETED|Treatment Period 2||12||
59638575|NCT02374164|75754468|FG001|COMPLETED|Treatment Period 2||12||
59638576|NCT02374164|75754469|FG002|COMPLETED|Treatment Period 2||12||
59638577|NCT02374164|75754467|FG000|NOT COMPLETED|Treatment Period 2||0||
59638578|NCT02374164|75754468|FG001|NOT COMPLETED|Treatment Period 2||0||
59638579|NCT02374164|75754469|FG002|NOT COMPLETED|Treatment Period 2||0||
59638580|NCT02374164|75754467|FG000|STARTED|Treatment Period 3||12||
59638581|NCT02374164|75754468|FG001|STARTED|Treatment Period 3|One participant was Lost-to-Follow-Up prior to treatment A.|11||
59638582|NCT02374164|75754469|FG002|STARTED|Treatment Period 3||12||
59638583|NCT02374164|75754467|FG000|COMPLETED|Treatment Period 3||12||
59638584|NCT02374164|75754468|FG001|COMPLETED|Treatment Period 3||11||
59638585|NCT02374164|75754469|FG002|COMPLETED|Treatment Period 3||12||
59638586|NCT02374164|75754467|FG000|NOT COMPLETED|Treatment Period 3||0||
59638587|NCT02374164|75754468|FG001|NOT COMPLETED|Treatment Period 3||0||
59638588|NCT02374164|75754469|FG002|NOT COMPLETED|Treatment Period 3||0||
59638589|NCT02374398|75754481|FG000|STARTED|Overall Study||31||
59638590|NCT02374398|75754482|FG001|STARTED|Overall Study||32||
59638591|NCT02374398|75754483|FG002|STARTED|Overall Study||32||
59638592|NCT02374398|75754484|FG003|STARTED|Overall Study||32||
59638593|NCT02374398|75754481|FG000|COMPLETED|Overall Study||29||
59638594|NCT02374398|75754482|FG001|COMPLETED|Overall Study||31||
59638595|NCT02374398|75754483|FG002|COMPLETED|Overall Study||29||
59638596|NCT02374398|75754484|FG003|COMPLETED|Overall Study||32||
59638597|NCT02374398|75754481|FG000|NOT COMPLETED|Overall Study||2||
59638598|NCT02374398|75754482|FG001|NOT COMPLETED|Overall Study||1||
59638599|NCT02374398|75754483|FG002|NOT COMPLETED|Overall Study||3||
59638600|NCT02374398|75754484|FG003|NOT COMPLETED|Overall Study||0||
59995450|NCT02675114|76111276|FG000|STARTED|Overall Study||497||
59638601|NCT02377752|75754499|FG000|STARTED|Overall Study||7||
59638602|NCT02377752|75754500|FG001|STARTED|Overall Study||6||
59638603|NCT02377752|75754501|FG002|STARTED|Overall Study||6||
59638604|NCT02377752|75754502|FG003|STARTED|Overall Study||6||
59638605|NCT02377752|75754499|FG000|Received at Least 1 Dose of Study Drug|Overall Study||7||
59638606|NCT02377752|75754500|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6||
59638607|NCT02377752|75754501|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6||
59638608|NCT02377752|75754502|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6||
59638609|NCT02377752|75754499|FG000|COMPLETED|Overall Study||7||
59638610|NCT02377752|75754500|FG001|COMPLETED|Overall Study||6||
59638611|NCT02377752|75754501|FG002|COMPLETED|Overall Study||6||
59638612|NCT02377752|75754502|FG003|COMPLETED|Overall Study||6||
59638613|NCT02377752|75754499|FG000|NOT COMPLETED|Overall Study||0||
59638614|NCT02377752|75754500|FG001|NOT COMPLETED|Overall Study||0||
59638615|NCT02377752|75754501|FG002|NOT COMPLETED|Overall Study||0||
59638616|NCT02377752|75754502|FG003|NOT COMPLETED|Overall Study||0||
59638617|NCT02377986|75754515|FG000|STARTED|Overall Study||5||
59638618|NCT02377986|75754515|FG000|COMPLETED|Overall Study||5||
59638619|NCT02377986|75754515|FG000|NOT COMPLETED|Overall Study||0||
59638620|NCT02377674|75754519|FG000|STARTED|Overall Study||5||
59638621|NCT02377674|75754519|FG000|COMPLETED|Overall Study||5||
59638622|NCT02377674|75754519|FG000|NOT COMPLETED|Overall Study||0||
59638623|NCT02378844|75754525|FG000|STARTED|Run-in Period||169||
59638624|NCT02378844|75754526|FG001|STARTED|Run-in Period||172||
59638625|NCT02378844|75754527|FG002|STARTED|Run-in Period||136||
59638626|NCT02378844|75754525|FG000|COMPLETED|Run-in Period||165||
59638627|NCT02378844|75754526|FG001|COMPLETED|Run-in Period||167||
59638628|NCT02378844|75754527|FG002|COMPLETED|Run-in Period||0||
59638629|NCT02378844|75754525|FG000|NOT COMPLETED|Run-in Period||4||
59638630|NCT02378844|75754526|FG001|NOT COMPLETED|Run-in Period||5||
59638631|NCT02378844|75754527|FG002|NOT COMPLETED|Run-in Period||136||
59638632|NCT02378844|75754525|FG000|STARTED|Randomized Period (Double Blind)||165||
59638633|NCT02378844|75754526|FG001|STARTED|Randomized Period (Double Blind)||167||
59638634|NCT02378844|75754527|FG002|STARTED|Randomized Period (Double Blind)||0||
59638635|NCT02378844|75754525|FG000|COMPLETED|Randomized Period (Double Blind)||142||
59638636|NCT02378844|75754526|FG001|COMPLETED|Randomized Period (Double Blind)||135||
59638637|NCT02378844|75754527|FG002|COMPLETED|Randomized Period (Double Blind)||0||
59638638|NCT02378844|75754525|FG000|NOT COMPLETED|Randomized Period (Double Blind)||23||
59638639|NCT02378844|75754526|FG001|NOT COMPLETED|Randomized Period (Double Blind)||32||
59638640|NCT02378844|75754527|FG002|NOT COMPLETED|Randomized Period (Double Blind)||0||
59638641|NCT02378844|75754525|FG000|STARTED|Open Label Period||142||
59638642|NCT02378844|75754526|FG001|STARTED|Open Label Period||135||
59638643|NCT02378844|75754527|FG002|STARTED|Open Label Period||0||
59638644|NCT02378844|75754525|FG000|COMPLETED|Open Label Period||99||
59638645|NCT02378844|75754526|FG001|COMPLETED|Open Label Period||87||
59638646|NCT02378844|75754527|FG002|COMPLETED|Open Label Period||0||
59638647|NCT02378844|75754525|FG000|NOT COMPLETED|Open Label Period||43||
59638648|NCT02378844|75754526|FG001|NOT COMPLETED|Open Label Period||48||
59638649|NCT02378844|75754527|FG002|NOT COMPLETED|Open Label Period||0||
59638650|NCT02379858|75754539|FG000|STARTED|Overall Study||6||
59638651|NCT02379858|75754540|FG001|STARTED|Overall Study||4||
59638652|NCT02379858|75754539|FG000|COMPLETED|Overall Study||6||
59638653|NCT02379858|75754540|FG001|COMPLETED|Overall Study||4||
59638654|NCT02379858|75754539|FG000|NOT COMPLETED|Overall Study||0||
59638655|NCT02379858|75754540|FG001|NOT COMPLETED|Overall Study||0||
59638656|NCT02381418|75754546|FG000|STARTED|Overall Study||120||
59638657|NCT02381418|75754546|FG000|COMPLETED|Overall Study||120||
59638658|NCT02381418|75754546|FG000|NOT COMPLETED|Overall Study||0||
59638659|NCT02382744|75754553|FG000|STARTED|Overall Study||40||
59638660|NCT02382744|75754554|FG001|STARTED|Overall Study||40||
59638661|NCT02382744|75754553|FG000|Allocated|Overall Study||40||
59638662|NCT02382744|75754554|FG001|Allocated|Overall Study||40||
59638663|NCT02382744|75754553|FG000|Analyzed|Overall Study||40||
59638664|NCT02382744|75754554|FG001|Analyzed|Overall Study||40||
59638665|NCT02382744|75754553|FG000|COMPLETED|Overall Study||40||
59638666|NCT02382744|75754554|FG001|COMPLETED|Overall Study||40||
59638667|NCT02382744|75754553|FG000|NOT COMPLETED|Overall Study||0||
59638668|NCT02382744|75754554|FG001|NOT COMPLETED|Overall Study||0||
59638669|NCT02384070|75754567|FG000|STARTED|Overall Study||100||
59638670|NCT02384070|75754568|FG001|STARTED|Overall Study||100||
59638671|NCT02384070|75754569|FG002|STARTED|Overall Study||100||
59638672|NCT02384070|75754567|FG000|COMPLETED|Overall Study||100||
59638673|NCT02384070|75754568|FG001|COMPLETED|Overall Study||100||
59638674|NCT02384070|75754569|FG002|COMPLETED|Overall Study||100||
59638675|NCT02384070|75754567|FG000|NOT COMPLETED|Overall Study||0||
59638676|NCT02384070|75754568|FG001|NOT COMPLETED|Overall Study||0||
59638677|NCT02384070|75754569|FG002|NOT COMPLETED|Overall Study||0||
59638678|NCT02385240|75754580|FG000|STARTED|Overall Study||183||
59638679|NCT02385240|75754581|FG001|STARTED|Overall Study||184||
59638680|NCT02385240|75754582|FG002|STARTED|Overall Study||185||
59638681|NCT02385240|75754580|FG000|COMPLETED|Overall Study||182||
59638682|NCT02385240|75754581|FG001|COMPLETED|Overall Study||178||
59638683|NCT02385240|75754582|FG002|COMPLETED|Overall Study||184||
59638684|NCT02385240|75754580|FG000|NOT COMPLETED|Overall Study||1||
59638685|NCT02385240|75754581|FG001|NOT COMPLETED|Overall Study||6||
59638686|NCT02385240|75754582|FG002|NOT COMPLETED|Overall Study||1||
59638687|NCT02385318|75754593|FG000|STARTED|Overall Study||204||
59638688|NCT02385318|75754594|FG001|STARTED|Overall Study||210||
59638689|NCT02385318|75754595|FG002|STARTED|Overall Study||105||
59638690|NCT02385318|75754593|FG000|COMPLETED|Overall Study||200||
59638691|NCT02385318|75754594|FG001|COMPLETED|Overall Study||203||
59638692|NCT02385318|75754595|FG002|COMPLETED|Overall Study||99||
59638693|NCT02385318|75754593|FG000|NOT COMPLETED|Overall Study||4||
59638694|NCT02385318|75754594|FG001|NOT COMPLETED|Overall Study||7||
59638695|NCT02385318|75754595|FG002|NOT COMPLETED|Overall Study||6||
59638696|NCT02387268|75754603|FG000|STARTED|Overall Study||10||
59638697|NCT02387268|75754603|FG000|COMPLETED|Overall Study||9||
59638698|NCT02387268|75754603|FG000|NOT COMPLETED|Overall Study||1||
59638699|NCT02387502|75754610|FG000|STARTED|Overall Study||40||
59638700|NCT02387502|75754611|FG001|STARTED|Overall Study||40||
59638701|NCT02387502|75754612|FG002|STARTED|Overall Study||40||
59638702|NCT02387502|75754610|FG000|COMPLETED|Overall Study||40||
59638703|NCT02387502|75754611|FG001|COMPLETED|Overall Study||40||
59638704|NCT02387502|75754612|FG002|COMPLETED|Overall Study||40||
59638705|NCT02387502|75754610|FG000|NOT COMPLETED|Overall Study||0||
59638706|NCT02387502|75754611|FG001|NOT COMPLETED|Overall Study||0||
59638707|NCT02387502|75754612|FG002|NOT COMPLETED|Overall Study||0||
59638708|NCT02387814|75754624|FG000|STARTED|Overall Study||10||
59638709|NCT02387814|75754625|FG001|STARTED|Overall Study||9||
59638710|NCT02387814|75754626|FG002|STARTED|Overall Study||10||
59638711|NCT02387814|75754627|FG003|STARTED|Overall Study||6||
59638712|NCT02387814|75754624|FG000|Received Abemaciclib|Overall Study||10||
59638713|NCT02387814|75754625|FG001|Received Abemaciclib|Overall Study||9||
59638714|NCT02387814|75754626|FG002|Received Abemaciclib|Overall Study||10||
59638715|NCT02387814|75754627|FG003|Received Abemaciclib|Overall Study||6||
59638716|NCT02387814|75754624|FG000|COMPLETED|Overall Study||10||
59638717|NCT02387814|75754625|FG001|COMPLETED|Overall Study||9||
59638718|NCT02387814|75754626|FG002|COMPLETED|Overall Study||10||
59638719|NCT02387814|75754627|FG003|COMPLETED|Overall Study||6||
59638720|NCT02387814|75754624|FG000|NOT COMPLETED|Overall Study||0||
59638721|NCT02387814|75754625|FG001|NOT COMPLETED|Overall Study||0||
59638722|NCT02387814|75754626|FG002|NOT COMPLETED|Overall Study||0||
59638723|NCT02387814|75754627|FG003|NOT COMPLETED|Overall Study||0||
59638724|NCT02391714|75754639|FG000|STARTED|Overall Study||40||
59638725|NCT02391714|75754640|FG001|STARTED|Overall Study||40||
59638726|NCT02391714|75754639|FG000|COMPLETED|Overall Study||40||
59638727|NCT02391714|75754640|FG001|COMPLETED|Overall Study||40||
59638728|NCT02391714|75754639|FG000|NOT COMPLETED|Overall Study||0||
59638729|NCT02391714|75754640|FG001|NOT COMPLETED|Overall Study||0||
59638730|NCT02392494|75754651|FG000|STARTED|Overall Study||3||
59638731|NCT02392494|75754652|FG001|STARTED|Overall Study||3||
59638732|NCT02392494|75754653|FG002|STARTED|Overall Study||3||
59638733|NCT02392494|75754654|FG003|STARTED|Overall Study||0||
59638734|NCT02392494|75754651|FG000|COMPLETED|Overall Study||3||
59638735|NCT02392494|75754652|FG001|COMPLETED|Overall Study||3||
59638736|NCT02392494|75754653|FG002|COMPLETED|Overall Study||3||
59638737|NCT02392494|75754654|FG003|COMPLETED|Overall Study||0||
59638738|NCT02392494|75754651|FG000|NOT COMPLETED|Overall Study||0||
59638739|NCT02392494|75754652|FG001|NOT COMPLETED|Overall Study||0||
59638740|NCT02392494|75754653|FG002|NOT COMPLETED|Overall Study||0||
59638741|NCT02392494|75754654|FG003|NOT COMPLETED|Overall Study||0||
59638742|NCT02392806|75754664|FG000|STARTED|Overall Study||22||
59638743|NCT02392806|75754665|FG001|STARTED|Overall Study||21||
59638744|NCT02392806|75754664|FG000|COMPLETED|Overall Study||22||
59638745|NCT02392806|75754665|FG001|COMPLETED|Overall Study||21||
59638746|NCT02392806|75754664|FG000|NOT COMPLETED|Overall Study||0||
59638747|NCT02392806|75754665|FG001|NOT COMPLETED|Overall Study||0||
59638748|NCT02394912|75754671|FG000|STARTED|Overall Study||21||
59638749|NCT02394912|75754671|FG000|COMPLETED|Overall Study||21||
59638750|NCT02394912|75754671|FG000|NOT COMPLETED|Overall Study||0||
59638751|NCT02395692|75754677|FG000|STARTED|Overall Study||19||
59638752|NCT02395692|75754678|FG001|STARTED|Overall Study||0||
59638753|NCT02395692|75754677|FG000|COMPLETED|Overall Study||19||
59638754|NCT02395692|75754678|FG001|COMPLETED|Overall Study||0||
59638755|NCT02395692|75754677|FG000|NOT COMPLETED|Overall Study||0||
59638756|NCT02395692|75754678|FG001|NOT COMPLETED|Overall Study||0||
59638757|NCT02396160|75754687|FG000|STARTED|Overall Study||75||
59638758|NCT02396160|75754688|FG001|STARTED|Overall Study||75||
59638759|NCT02396160|75754687|FG000|COMPLETED|Overall Study||69||
59638760|NCT02396160|75754688|FG001|COMPLETED|Overall Study||73||
59638761|NCT02396160|75754687|FG000|NOT COMPLETED|Overall Study||6||
59988459|NCT02520284|76103614|FG002|NOT COMPLETED|Open-Label MaintenancePhase: Upto Week51||34||
59988460|NCT02517866|76103628|FG000|STARTED|Overall Study||289||
59988461|NCT02517866|76103629|FG001|STARTED|Overall Study||90||
59988462|NCT02517866|76103630|FG002|STARTED|Overall Study||1||
59988463|NCT02517866|76103628|FG000|COMPLETED|Overall Study||269||
59988464|NCT02517866|76103629|FG001|COMPLETED|Overall Study||84||
59988465|NCT02517866|76103630|FG002|COMPLETED|Overall Study||1||
59988466|NCT02517866|76103628|FG000|NOT COMPLETED|Overall Study||20||
59638762|NCT02396160|75754688|FG001|NOT COMPLETED|Overall Study||2||
59638763|NCT02397564|75754694|FG000|STARTED|Overall Study||20||
59638764|NCT02397564|75754694|FG000|COMPLETED|Overall Study||16||
59638765|NCT02397564|75754694|FG000|NOT COMPLETED|Overall Study||4||
59638766|NCT02397954|75754699|FG000|STARTED|Overall Study||4||
59638767|NCT02397954|75754699|FG000|COMPLETED|Overall Study||4||
59638768|NCT02397954|75754699|FG000|NOT COMPLETED|Overall Study||0||
59638769|NCT02400996|75754703|FG000|STARTED|Overall Study||40||
59638770|NCT02400996|75754703|FG000|COMPLETED|Overall Study||40||
59638771|NCT02400996|75754703|FG000|NOT COMPLETED|Overall Study||0||
59638772|NCT02401464|75754711|FG000|STARTED|Intervention Period 1 (6 Days)||13||
59638773|NCT02401464|75754712|FG001|STARTED|Intervention Period 1 (6 Days)||13||
59638774|NCT02401464|75754713|FG002|STARTED|Intervention Period 1 (6 Days)||13||
59638775|NCT02401464|75754714|FG003|STARTED|Intervention Period 1 (6 Days)||13||
59638776|NCT02401464|75754711|FG000|COMPLETED|Intervention Period 1 (6 Days)||13||
59638777|NCT02401464|75754712|FG001|COMPLETED|Intervention Period 1 (6 Days)||13||
59638778|NCT02401464|75754713|FG002|COMPLETED|Intervention Period 1 (6 Days)||13||
59638779|NCT02401464|75754714|FG003|COMPLETED|Intervention Period 1 (6 Days)||13||
59638780|NCT02401464|75754711|FG000|NOT COMPLETED|Intervention Period 1 (6 Days)||0||
59638781|NCT02401464|75754712|FG001|NOT COMPLETED|Intervention Period 1 (6 Days)||0||
59638782|NCT02401464|75754713|FG002|NOT COMPLETED|Intervention Period 1 (6 Days)||0||
59638783|NCT02401464|75754714|FG003|NOT COMPLETED|Intervention Period 1 (6 Days)||0||
59638784|NCT02401464|75754711|FG000|STARTED|Washout Period (At Least 6 Days)||13||
59638785|NCT02401464|75754712|FG001|STARTED|Washout Period (At Least 6 Days)||13||
59638786|NCT02401464|75754713|FG002|STARTED|Washout Period (At Least 6 Days)||13||
59638787|NCT02401464|75754714|FG003|STARTED|Washout Period (At Least 6 Days)||13||
59638788|NCT02401464|75754711|FG000|COMPLETED|Washout Period (At Least 6 Days)||13||
59638789|NCT02401464|75754712|FG001|COMPLETED|Washout Period (At Least 6 Days)||13||
59638790|NCT02401464|75754713|FG002|COMPLETED|Washout Period (At Least 6 Days)||13||
59638791|NCT02401464|75754714|FG003|COMPLETED|Washout Period (At Least 6 Days)||13||
59638792|NCT02401464|75754711|FG000|NOT COMPLETED|Washout Period (At Least 6 Days)||0||
59638793|NCT02401464|75754712|FG001|NOT COMPLETED|Washout Period (At Least 6 Days)||0||
59638794|NCT02401464|75754713|FG002|NOT COMPLETED|Washout Period (At Least 6 Days)||0||
59638795|NCT02401464|75754714|FG003|NOT COMPLETED|Washout Period (At Least 6 Days)||0||
59638796|NCT02401464|75754711|FG000|STARTED|Intervention Period 2 (6 Days)||13||
59638797|NCT02401464|75754712|FG001|STARTED|Intervention Period 2 (6 Days)||13||
59638798|NCT02401464|75754713|FG002|STARTED|Intervention Period 2 (6 Days)||13||
59638799|NCT02401464|75754714|FG003|STARTED|Intervention Period 2 (6 Days)||13||
59638800|NCT02401464|75754711|FG000|COMPLETED|Intervention Period 2 (6 Days)||13||
59638801|NCT02401464|75754712|FG001|COMPLETED|Intervention Period 2 (6 Days)||13||
59638802|NCT02401464|75754713|FG002|COMPLETED|Intervention Period 2 (6 Days)||13||
59638803|NCT02401464|75754714|FG003|COMPLETED|Intervention Period 2 (6 Days)||13||
59638804|NCT02401464|75754711|FG000|NOT COMPLETED|Intervention Period 2 (6 Days)||0||
59638805|NCT02401464|75754712|FG001|NOT COMPLETED|Intervention Period 2 (6 Days)||0||
59638806|NCT02401464|75754713|FG002|NOT COMPLETED|Intervention Period 2 (6 Days)||0||
59638807|NCT02401464|75754714|FG003|NOT COMPLETED|Intervention Period 2 (6 Days)||0||
59638808|NCT02401542|75754729|FG000|STARTED|Overall Study||41||
59638809|NCT02401542|75754730|FG001|STARTED|Overall Study||30||
59638810|NCT02401542|75754731|FG002|STARTED|Overall Study||0||
59638811|NCT02401542|75754729|FG000|COMPLETED|Overall Study||40||
59638812|NCT02401542|75754730|FG001|COMPLETED|Overall Study||30||
59638813|NCT02401542|75754731|FG002|COMPLETED|Overall Study||0||
59638814|NCT02401542|75754729|FG000|NOT COMPLETED|Overall Study||1||
59638815|NCT02401542|75754730|FG001|NOT COMPLETED|Overall Study||0||
59638816|NCT02401542|75754731|FG002|NOT COMPLETED|Overall Study||0||
59638817|NCT02408796|75754741|FG000|STARTED|Overall Study||39||
59638818|NCT02408796|75754741|FG000|COMPLETED|Overall Study||39||
59638819|NCT02408796|75754741|FG000|NOT COMPLETED|Overall Study||0||
59638820|NCT02411916|75754747|FG000|STARTED|Overall Study||73||
59638821|NCT02411916|75754748|FG001|STARTED|Overall Study||70||
59638822|NCT02411916|75754747|FG000|COMPLETED|Overall Study||73||
59638823|NCT02411916|75754748|FG001|COMPLETED|Overall Study||70||
59638824|NCT02411916|75754747|FG000|NOT COMPLETED|Overall Study||0||
59638825|NCT02411916|75754748|FG001|NOT COMPLETED|Overall Study||0||
59638826|NCT02413008|75754756|FG000|STARTED|Overall Study||50||
59638827|NCT02413008|75754757|FG001|STARTED|Overall Study||11||
59638828|NCT02413008|75754756|FG000|COMPLETED|Overall Study||43||
59638829|NCT02413008|75754757|FG001|COMPLETED|Overall Study||9||
59638830|NCT02413008|75754756|FG000|NOT COMPLETED|Overall Study||7||
59638831|NCT02413008|75754757|FG001|NOT COMPLETED|Overall Study||2||
59638832|NCT02413320|75754768|FG000|STARTED|Overall Study||49||
59638833|NCT02413320|75754769|FG001|STARTED|Overall Study||52||
59638834|NCT02413320|75754768|FG000|COMPLETED|Overall Study||48||
59638835|NCT02413320|75754769|FG001|COMPLETED|Overall Study||52||
59638836|NCT02413320|75754768|FG000|NOT COMPLETED|Overall Study||1||
59638837|NCT02413320|75754769|FG001|NOT COMPLETED|Overall Study||0||
59638838|NCT04567524|75754779|FG000|STARTED|Overall Study||12||
59638839|NCT04567524|75754780|FG001|STARTED|Overall Study||12||
59638840|NCT04567524|75754781|FG002|STARTED|Overall Study||4||
59638841|NCT04567524|75754782|FG003|STARTED|Overall Study||4||
59638842|NCT04567524|75754779|FG000|COMPLETED|Overall Study||9||
59638843|NCT04567524|75754780|FG001|COMPLETED|Overall Study||11||
59638844|NCT04567524|75754781|FG002|COMPLETED|Overall Study||4||
59638845|NCT04567524|75754782|FG003|COMPLETED|Overall Study||3||
59638846|NCT04567524|75754779|FG000|NOT COMPLETED|Overall Study||3||
59638847|NCT04567524|75754780|FG001|NOT COMPLETED|Overall Study||1||
59638848|NCT04567524|75754781|FG002|NOT COMPLETED|Overall Study||0||
59638849|NCT04567524|75754782|FG003|NOT COMPLETED|Overall Study||1||
59638850|NCT04475718|75754807|FG000|STARTED|Overall Study||87||
59638851|NCT04475718|75754807|FG000|COMPLETED|Overall Study||79||
59638852|NCT04475718|75754807|FG000|NOT COMPLETED|Overall Study||8||
59638853|NCT03370302|75754818|FG000|STARTED|Dose Escalation Phase||3||
59638854|NCT03370302|75754819|FG001|STARTED|Dose Escalation Phase||6||
59638855|NCT03370302|75754820|FG002|STARTED|Dose Escalation Phase||7||
59638856|NCT03370302|75754821|FG003|STARTED|Dose Escalation Phase||0||
59638857|NCT03370302|75754822|FG004|STARTED|Dose Escalation Phase||3||
59638858|NCT03370302|75754823|FG005|STARTED|Dose Escalation Phase||3||
59638859|NCT03370302|75754818|FG000|COMPLETED|Dose Escalation Phase||0||
59638860|NCT03370302|75754819|FG001|COMPLETED|Dose Escalation Phase||0||
59638861|NCT03370302|75754820|FG002|COMPLETED|Dose Escalation Phase||0||
59638862|NCT03370302|75754821|FG003|COMPLETED|Dose Escalation Phase||0||
59638863|NCT03370302|75754822|FG004|COMPLETED|Dose Escalation Phase||0||
59638864|NCT03370302|75754823|FG005|COMPLETED|Dose Escalation Phase||0||
59638865|NCT03370302|75754818|FG000|NOT COMPLETED|Dose Escalation Phase||3||
59638866|NCT03370302|75754819|FG001|NOT COMPLETED|Dose Escalation Phase||6||
59638867|NCT03370302|75754820|FG002|NOT COMPLETED|Dose Escalation Phase||7||
59638868|NCT03370302|75754821|FG003|NOT COMPLETED|Dose Escalation Phase||0||
59638869|NCT03370302|75754822|FG004|NOT COMPLETED|Dose Escalation Phase||3||
59638870|NCT03370302|75754823|FG005|NOT COMPLETED|Dose Escalation Phase||3||
59638871|NCT03370302|75754818|FG000|STARTED|Dose Expansion Phase||0||
59638872|NCT03370302|75754819|FG001|STARTED|Dose Expansion Phase||0||
59638873|NCT03370302|75754820|FG002|STARTED|Dose Expansion Phase||0||
59638874|NCT03370302|75754821|FG003|STARTED|Dose Expansion Phase||6||
59638875|NCT03370302|75754822|FG004|STARTED|Dose Expansion Phase||0||
59638876|NCT03370302|75754823|FG005|STARTED|Dose Expansion Phase||0||
59638877|NCT03370302|75754818|FG000|COMPLETED|Dose Expansion Phase||0||
59638878|NCT03370302|75754819|FG001|COMPLETED|Dose Expansion Phase||0||
59638879|NCT03370302|75754820|FG002|COMPLETED|Dose Expansion Phase||0||
59638880|NCT03370302|75754821|FG003|COMPLETED|Dose Expansion Phase||0||
59638881|NCT03370302|75754822|FG004|COMPLETED|Dose Expansion Phase||0||
59638882|NCT03370302|75754823|FG005|COMPLETED|Dose Expansion Phase||0||
59638883|NCT03370302|75754818|FG000|NOT COMPLETED|Dose Expansion Phase||0||
59638884|NCT03370302|75754819|FG001|NOT COMPLETED|Dose Expansion Phase||0||
59638885|NCT03370302|75754820|FG002|NOT COMPLETED|Dose Expansion Phase||0||
59638886|NCT03370302|75754821|FG003|NOT COMPLETED|Dose Expansion Phase||6||
59638887|NCT03370302|75754822|FG004|NOT COMPLETED|Dose Expansion Phase||0||
59638888|NCT03370302|75754823|FG005|NOT COMPLETED|Dose Expansion Phase||0||
59638889|NCT03327324|75754847|FG000|STARTED|Baseline (Month 0-Month 3)||18||
59638890|NCT03327324|75754848|FG001|STARTED|Baseline (Month 0-Month 3)||20||
59638891|NCT03327324|75754849|FG002|STARTED|Baseline (Month 0-Month 3)||9||
59638892|NCT03327324|75754850|FG003|STARTED|Baseline (Month 0-Month 3)||10||
59638893|NCT03327324|75754851|FG004|STARTED|Baseline (Month 0-Month 3)||15||
59638894|NCT03327324|75754852|FG005|STARTED|Baseline (Month 0-Month 3)||20||
59988467|NCT02517866|76103629|FG001|NOT COMPLETED|Overall Study||6||
59988468|NCT02517866|76103630|FG002|NOT COMPLETED|Overall Study||0||
59638895|NCT03327324|75754847|FG000|COMPLETED|Baseline (Month 0-Month 3)||18||
59638896|NCT03327324|75754848|FG001|COMPLETED|Baseline (Month 0-Month 3)||17||
59638897|NCT03327324|75754849|FG002|COMPLETED|Baseline (Month 0-Month 3)||9||
59638898|NCT03327324|75754850|FG003|COMPLETED|Baseline (Month 0-Month 3)||9||
59638899|NCT03327324|75754851|FG004|COMPLETED|Baseline (Month 0-Month 3)||13||
59638900|NCT03327324|75754852|FG005|COMPLETED|Baseline (Month 0-Month 3)||14||
59638901|NCT03327324|75754847|FG000|NOT COMPLETED|Baseline (Month 0-Month 3)||0||
59638902|NCT03327324|75754848|FG001|NOT COMPLETED|Baseline (Month 0-Month 3)||3||
59638903|NCT03327324|75754849|FG002|NOT COMPLETED|Baseline (Month 0-Month 3)||0||
59638904|NCT03327324|75754850|FG003|NOT COMPLETED|Baseline (Month 0-Month 3)||1||
59638905|NCT03327324|75754851|FG004|NOT COMPLETED|Baseline (Month 0-Month 3)||2||
59638906|NCT03327324|75754852|FG005|NOT COMPLETED|Baseline (Month 0-Month 3)||6||
59988469|NCT02515994|76103642|FG000|STARTED|Overall Study||109||
59988470|NCT02515994|76103643|FG001|STARTED|Overall Study||112||
60103776|NCT03964493|76222047|FG001|STARTED|Overall Study||40||
59638907|NCT03327324|75754847|FG000|STARTED|Intervention (Month 3-Month 6)||18||
59638908|NCT03327324|75754848|FG001|STARTED|Intervention (Month 3-Month 6)||17||
59638909|NCT03327324|75754849|FG002|STARTED|Intervention (Month 3-Month 6)||9||
59638910|NCT03327324|75754850|FG003|STARTED|Intervention (Month 3-Month 6)||9||
59638911|NCT03327324|75754851|FG004|STARTED|Intervention (Month 3-Month 6)||13||
59638912|NCT03327324|75754852|FG005|STARTED|Intervention (Month 3-Month 6)||14||
59638913|NCT03327324|75754847|FG000|COMPLETED|Intervention (Month 3-Month 6)||13||
59638914|NCT03327324|75754848|FG001|COMPLETED|Intervention (Month 3-Month 6)||16||
59988471|NCT02515994|76103642|FG000|COMPLETED|Overall Study||99||
60103777|NCT03964493|76222046|FG000|COMPLETED|Overall Study||63||
60103778|NCT03964493|76222047|FG001|COMPLETED|Overall Study||35||
60103779|NCT03964493|76222046|FG000|NOT COMPLETED|Overall Study||17||
60103780|NCT03964493|76222047|FG001|NOT COMPLETED|Overall Study||5||
60103781|NCT03915574|76222055|FG000|STARTED|Overall Study|70 mother-infant dyads (total participants = 140 per arm)|70||
60103782|NCT03915574|76222056|FG001|STARTED|Overall Study|70 mother-infant dyads (total participants = 140 per arm)|70||
59638915|NCT03327324|75754849|FG002|COMPLETED|Intervention (Month 3-Month 6)||6||
59638916|NCT03327324|75754850|FG003|COMPLETED|Intervention (Month 3-Month 6)||8||
59638917|NCT03327324|75754851|FG004|COMPLETED|Intervention (Month 3-Month 6)||11||
59638918|NCT03327324|75754852|FG005|COMPLETED|Intervention (Month 3-Month 6)||0||
59638919|NCT03327324|75754847|FG000|NOT COMPLETED|Intervention (Month 3-Month 6)||5||
59638920|NCT03327324|75754848|FG001|NOT COMPLETED|Intervention (Month 3-Month 6)||1||
59638921|NCT03327324|75754849|FG002|NOT COMPLETED|Intervention (Month 3-Month 6)||3||
59638922|NCT03327324|75754850|FG003|NOT COMPLETED|Intervention (Month 3-Month 6)||1||
59638923|NCT03327324|75754851|FG004|NOT COMPLETED|Intervention (Month 3-Month 6)||2||
59638924|NCT03327324|75754852|FG005|NOT COMPLETED|Intervention (Month 3-Month 6)||14||
59638925|NCT03327324|75754847|FG000|STARTED|Sustainability Follow-Up 1 (Month 6-9)||13||
59638926|NCT03327324|75754848|FG001|STARTED|Sustainability Follow-Up 1 (Month 6-9)||16||
59638927|NCT03327324|75754849|FG002|STARTED|Sustainability Follow-Up 1 (Month 6-9)||6||
59638928|NCT03327324|75754850|FG003|STARTED|Sustainability Follow-Up 1 (Month 6-9)||8||
59638929|NCT03327324|75754851|FG004|STARTED|Sustainability Follow-Up 1 (Month 6-9)||11||
59638930|NCT03327324|75754852|FG005|STARTED|Sustainability Follow-Up 1 (Month 6-9)||0||
59638931|NCT03327324|75754847|FG000|COMPLETED|Sustainability Follow-Up 1 (Month 6-9)||9||
59638932|NCT03327324|75754848|FG001|COMPLETED|Sustainability Follow-Up 1 (Month 6-9)||14||
59638933|NCT03327324|75754849|FG002|COMPLETED|Sustainability Follow-Up 1 (Month 6-9)||5||
59638934|NCT03327324|75754850|FG003|COMPLETED|Sustainability Follow-Up 1 (Month 6-9)||5||
59638935|NCT03327324|75754851|FG004|COMPLETED|Sustainability Follow-Up 1 (Month 6-9)||6||
59638936|NCT03327324|75754852|FG005|COMPLETED|Sustainability Follow-Up 1 (Month 6-9)||0||
59638937|NCT03327324|75754847|FG000|NOT COMPLETED|Sustainability Follow-Up 1 (Month 6-9)||4||
59638938|NCT03327324|75754848|FG001|NOT COMPLETED|Sustainability Follow-Up 1 (Month 6-9)||2||
59638939|NCT03327324|75754849|FG002|NOT COMPLETED|Sustainability Follow-Up 1 (Month 6-9)||1||
59638940|NCT03327324|75754850|FG003|NOT COMPLETED|Sustainability Follow-Up 1 (Month 6-9)||3||
59638941|NCT03327324|75754851|FG004|NOT COMPLETED|Sustainability Follow-Up 1 (Month 6-9)||5||
59638942|NCT03327324|75754852|FG005|NOT COMPLETED|Sustainability Follow-Up 1 (Month 6-9)||0||
59638943|NCT03327324|75754847|FG000|STARTED|Sustainability Follow-Up 2 (Month 9-12)||9||
59638944|NCT03327324|75754848|FG001|STARTED|Sustainability Follow-Up 2 (Month 9-12)||14||
59638945|NCT03327324|75754849|FG002|STARTED|Sustainability Follow-Up 2 (Month 9-12)||2||
59638946|NCT03327324|75754850|FG003|STARTED|Sustainability Follow-Up 2 (Month 9-12)||0||
59638947|NCT03327324|75754851|FG004|STARTED|Sustainability Follow-Up 2 (Month 9-12)||0||
59638948|NCT03327324|75754852|FG005|STARTED|Sustainability Follow-Up 2 (Month 9-12)||0||
59638949|NCT03327324|75754847|FG000|COMPLETED|Sustainability Follow-Up 2 (Month 9-12)||7||
59638950|NCT03327324|75754848|FG001|COMPLETED|Sustainability Follow-Up 2 (Month 9-12)||14||
59638951|NCT03327324|75754849|FG002|COMPLETED|Sustainability Follow-Up 2 (Month 9-12)||2||
59638952|NCT03327324|75754850|FG003|COMPLETED|Sustainability Follow-Up 2 (Month 9-12)||0||
59638953|NCT03327324|75754851|FG004|COMPLETED|Sustainability Follow-Up 2 (Month 9-12)||0||
59638954|NCT03327324|75754852|FG005|COMPLETED|Sustainability Follow-Up 2 (Month 9-12)||0||
59638955|NCT03327324|75754847|FG000|NOT COMPLETED|Sustainability Follow-Up 2 (Month 9-12)||2||
59638956|NCT03327324|75754848|FG001|NOT COMPLETED|Sustainability Follow-Up 2 (Month 9-12)||0||
59638957|NCT03327324|75754849|FG002|NOT COMPLETED|Sustainability Follow-Up 2 (Month 9-12)||0||
59638958|NCT03327324|75754850|FG003|NOT COMPLETED|Sustainability Follow-Up 2 (Month 9-12)||0||
59638959|NCT03327324|75754851|FG004|NOT COMPLETED|Sustainability Follow-Up 2 (Month 9-12)||0||
59638960|NCT03327324|75754852|FG005|NOT COMPLETED|Sustainability Follow-Up 2 (Month 9-12)||0||
59638961|NCT03252522|75754858|FG000|STARTED|Phase 1: Intervention & Placebo||78||
59638962|NCT03252522|75754859|FG001|STARTED|Phase 1: Intervention & Placebo||57||
59638963|NCT03252522|75754860|FG002|STARTED|Phase 1: Intervention & Placebo||0||
59638964|NCT03252522|75754858|FG000|COMPLETED|Phase 1: Intervention & Placebo||69||
59638965|NCT03252522|75754859|FG001|COMPLETED|Phase 1: Intervention & Placebo||54||
59638966|NCT03252522|75754860|FG002|COMPLETED|Phase 1: Intervention & Placebo||0||
59638967|NCT03252522|75754858|FG000|NOT COMPLETED|Phase 1: Intervention & Placebo||9||
59638968|NCT03252522|75754859|FG001|NOT COMPLETED|Phase 1: Intervention & Placebo||3||
59638969|NCT03252522|75754860|FG002|NOT COMPLETED|Phase 1: Intervention & Placebo||0||
59638970|NCT03252522|75754858|FG000|STARTED|Phase 2: Open Label||0||
59638971|NCT03252522|75754859|FG001|STARTED|Phase 2: Open Label||0||
59638972|NCT03252522|75754860|FG002|STARTED|Phase 2: Open Label||123||
59638973|NCT03252522|75754858|FG000|COMPLETED|Phase 2: Open Label||0||
59638974|NCT03252522|75754859|FG001|COMPLETED|Phase 2: Open Label||0||
59638975|NCT03252522|75754860|FG002|COMPLETED|Phase 2: Open Label||99||
59638976|NCT03252522|75754858|FG000|NOT COMPLETED|Phase 2: Open Label||0||
59638977|NCT03252522|75754859|FG001|NOT COMPLETED|Phase 2: Open Label||0||
59638978|NCT03252522|75754860|FG002|NOT COMPLETED|Phase 2: Open Label||24||
59638979|NCT02756364|75754875|FG000|STARTED|Overall Study||46|Full Analysis Set (FAS) - Randomized Participants|
59638980|NCT02756364|75754876|FG001|STARTED|Overall Study||47|Full Analysis Set (FAS) - Randomized Participants|
59638981|NCT02756364|75754877|FG002|STARTED|Overall Study||48|Full Analysis Set (FAS) - Randomized Participants|
59638982|NCT02756364|75754875|FG000|Treated Participants|Overall Study||46|Safety Analysis Set|
59638983|NCT02756364|75754876|FG001|Treated Participants|Overall Study||47|Safety Analysis Set|
59638984|NCT02756364|75754877|FG002|Treated Participants|Overall Study||47|Safety Analysis Set|
59638985|NCT02756364|75754875|FG000|COMPLETED|Overall Study||0||
59638986|NCT02756364|75754876|FG001|COMPLETED|Overall Study||0||
59638987|NCT02756364|75754877|FG002|COMPLETED|Overall Study||0||
59638988|NCT02756364|75754875|FG000|NOT COMPLETED|Overall Study||46||
59638989|NCT02756364|75754876|FG001|NOT COMPLETED|Overall Study||47||
59638990|NCT02756364|75754877|FG002|NOT COMPLETED|Overall Study||48||
59638991|NCT01906476|75754887|FG000|STARTED|Overall Study||157||
59638992|NCT01906476|75754888|FG001|STARTED|Overall Study||155||
59638993|NCT01906476|75754887|FG000|COMPLETED|Overall Study||140||
59638994|NCT01906476|75754888|FG001|COMPLETED|Overall Study||139||
59638995|NCT01906476|75754887|FG000|NOT COMPLETED|Overall Study||17||
59638996|NCT01906476|75754888|FG001|NOT COMPLETED|Overall Study||16||
59638997|NCT05343624|75754894|FG000|STARTED|Overall Study||9||
59638998|NCT05343624|75754894|FG000|COMPLETED|Overall Study||8||
59638999|NCT05343624|75754894|FG000|NOT COMPLETED|Overall Study||1||
59639000|NCT04988646|75754900|FG000|STARTED|1st Intervention||14||
59639001|NCT04988646|75754901|FG001|STARTED|1st Intervention||14||
59639002|NCT04988646|75754902|FG002|STARTED|1st Intervention||14||
59639003|NCT04988646|75754903|FG003|STARTED|1st Intervention||14||
59639004|NCT04988646|75754900|FG000|COMPLETED|1st Intervention||14||
59639005|NCT04988646|75754901|FG001|COMPLETED|1st Intervention||14||
59639006|NCT04988646|75754902|FG002|COMPLETED|1st Intervention||14||
59639007|NCT04988646|75754903|FG003|COMPLETED|1st Intervention||14||
59639008|NCT04988646|75754900|FG000|NOT COMPLETED|1st Intervention||0||
59639009|NCT04988646|75754901|FG001|NOT COMPLETED|1st Intervention||0||
59639010|NCT04988646|75754902|FG002|NOT COMPLETED|1st Intervention||0||
59639011|NCT04988646|75754903|FG003|NOT COMPLETED|1st Intervention||0||
59639012|NCT04988646|75754900|FG000|STARTED|Washout >= One Week||14||
59639013|NCT04988646|75754901|FG001|STARTED|Washout >= One Week||14||
59639014|NCT04988646|75754902|FG002|STARTED|Washout >= One Week||14||
59639015|NCT04988646|75754903|FG003|STARTED|Washout >= One Week||14||
59639016|NCT04988646|75754900|FG000|COMPLETED|Washout >= One Week||14||
59639017|NCT04988646|75754901|FG001|COMPLETED|Washout >= One Week||14||
59639018|NCT04988646|75754902|FG002|COMPLETED|Washout >= One Week||14||
59639019|NCT04988646|75754903|FG003|COMPLETED|Washout >= One Week||14||
59639020|NCT04988646|75754900|FG000|NOT COMPLETED|Washout >= One Week||0||
59639021|NCT04988646|75754901|FG001|NOT COMPLETED|Washout >= One Week||0||
59541388|NCT03215264|75639586|FG000|STARTED|Dose Level 3||0||
59541389|NCT03215264|75639587|FG001|STARTED|Dose Level 3||0||
59541390|NCT03215264|75639588|FG002|STARTED|Dose Level 3||7||
59541391|NCT03215264|75639586|FG000|COMPLETED|Dose Level 3||0||
59541392|NCT03215264|75639587|FG001|COMPLETED|Dose Level 3||0||
59541393|NCT03215264|75639588|FG002|COMPLETED|Dose Level 3||6||
59541394|NCT03215264|75639586|FG000|NOT COMPLETED|Dose Level 3||0||
59541395|NCT03215264|75639587|FG001|NOT COMPLETED|Dose Level 3||0||
59541396|NCT03215264|75639588|FG002|NOT COMPLETED|Dose Level 3||1||
59541397|NCT01447511|75639599|FG000|STARTED|Control Period||8||
59541398|NCT01447511|75639600|FG001|STARTED|Control Period||5||
59541399|NCT01447511|75639601|FG002|STARTED|Control Period||9||
59541400|NCT01447511|75639602|FG003|STARTED|Control Period||3||
59541401|NCT01447511|75639603|FG004|STARTED|Control Period||4||
59541402|NCT01447511|75639599|FG000|COMPLETED|Control Period||8||
59541403|NCT01447511|75639600|FG001|COMPLETED|Control Period||5||
59541404|NCT01447511|75639601|FG002|COMPLETED|Control Period||9||
59541405|NCT01447511|75639602|FG003|COMPLETED|Control Period||3||
59541406|NCT01447511|75639603|FG004|COMPLETED|Control Period||4||
59541407|NCT01447511|75639599|FG000|NOT COMPLETED|Control Period||0||
59541408|NCT01447511|75639600|FG001|NOT COMPLETED|Control Period||0||
59541409|NCT01447511|75639601|FG002|NOT COMPLETED|Control Period||0||
59541410|NCT01447511|75639602|FG003|NOT COMPLETED|Control Period||0||
59541411|NCT01447511|75639603|FG004|NOT COMPLETED|Control Period||0||
59541412|NCT01447511|75639599|FG000|STARTED|Fluconazole Period||8||
59541413|NCT01447511|75639600|FG001|STARTED|Fluconazole Period||0||
59541414|NCT01447511|75639601|FG002|STARTED|Fluconazole Period||9||
59541415|NCT01447511|75639602|FG003|STARTED|Fluconazole Period||3||
59541416|NCT01447511|75639603|FG004|STARTED|Fluconazole Period||4||
59541417|NCT01447511|75639599|FG000|COMPLETED|Fluconazole Period||8||
59541418|NCT01447511|75639600|FG001|COMPLETED|Fluconazole Period||0||
59541419|NCT01447511|75639601|FG002|COMPLETED|Fluconazole Period||8||
59541420|NCT01447511|75639602|FG003|COMPLETED|Fluconazole Period||3||
59541421|NCT01447511|75639603|FG004|COMPLETED|Fluconazole Period||4||
59541422|NCT01447511|75639599|FG000|NOT COMPLETED|Fluconazole Period||0||
59541423|NCT01447511|75639600|FG001|NOT COMPLETED|Fluconazole Period||0||
59541424|NCT01447511|75639601|FG002|NOT COMPLETED|Fluconazole Period||1||
59639022|NCT04988646|75754902|FG002|NOT COMPLETED|Washout >= One Week||0||
59639023|NCT04988646|75754903|FG003|NOT COMPLETED|Washout >= One Week||0||
59639024|NCT04988646|75754900|FG000|STARTED|2nd Intervention||14||
59639025|NCT04988646|75754901|FG001|STARTED|2nd Intervention||14||
59639026|NCT04988646|75754902|FG002|STARTED|2nd Intervention||14||
59639027|NCT04988646|75754903|FG003|STARTED|2nd Intervention||14||
59639028|NCT04988646|75754900|FG000|COMPLETED|2nd Intervention||13||
59639029|NCT04988646|75754901|FG001|COMPLETED|2nd Intervention||13||
59639030|NCT04988646|75754902|FG002|COMPLETED|2nd Intervention||14||
59639031|NCT04988646|75754903|FG003|COMPLETED|2nd Intervention||14||
59639032|NCT04988646|75754900|FG000|NOT COMPLETED|2nd Intervention||1||
59639033|NCT04988646|75754901|FG001|NOT COMPLETED|2nd Intervention||1||
59639034|NCT04988646|75754902|FG002|NOT COMPLETED|2nd Intervention||0||
59639035|NCT04988646|75754903|FG003|NOT COMPLETED|2nd Intervention||0||
59639036|NCT04707846|75754915|FG000|STARTED|Overall Study||28||
59639037|NCT04707846|75754916|FG001|STARTED|Overall Study||32||
59639038|NCT04707846|75754915|FG000|COMPLETED|Overall Study||28||
59639039|NCT04707846|75754916|FG001|COMPLETED|Overall Study||32||
59639040|NCT04707846|75754915|FG000|NOT COMPLETED|Overall Study||0||
59639041|NCT04707846|75754916|FG001|NOT COMPLETED|Overall Study||0||
59639042|NCT04535310|75754921|FG000|STARTED|Overall Study||35||
59639043|NCT04535310|75754921|FG000|COMPLETED|Overall Study||35||
59639044|NCT04535310|75754921|FG000|NOT COMPLETED|Overall Study||0||
59639045|NCT04208412|75754927|FG000|STARTED|Overall Study||34||
59639046|NCT04208412|75754928|FG001|STARTED|Overall Study||34||
59639047|NCT04208412|75754927|FG000|COMPLETED|Overall Study||25||
59639048|NCT04208412|75754928|FG001|COMPLETED|Overall Study||28||
59639049|NCT04208412|75754927|FG000|NOT COMPLETED|Overall Study||9||
59639050|NCT04208412|75754928|FG001|NOT COMPLETED|Overall Study||6||
59639051|NCT04095858|75754938|FG000|STARTED|Overall Study||3||
59639052|NCT04095858|75754939|FG001|STARTED|Overall Study||4||
59639053|NCT04095858|75754938|FG000|COMPLETED|Overall Study||0||
59639054|NCT04095858|75754939|FG001|COMPLETED|Overall Study||0||
59639055|NCT04095858|75754938|FG000|NOT COMPLETED|Overall Study||3||
59639056|NCT04095858|75754939|FG001|NOT COMPLETED|Overall Study||4||
59639057|NCT03937986|75754945|FG000|STARTED|Overall Study||8||
59639058|NCT03937986|75754945|FG000|COMPLETED|Overall Study||7||
59639059|NCT03937986|75754945|FG000|NOT COMPLETED|Overall Study||1||
59639060|NCT03738150|75754960|FG000|STARTED|Base Study||21||
59639061|NCT03738150|75754960|FG000|COMPLETED|Base Study||20||
59639062|NCT03738150|75754960|FG000|NOT COMPLETED|Base Study||1||
59639063|NCT03738150|75754960|FG000|STARTED|Extension Study||20||
59639064|NCT03738150|75754960|FG000|COMPLETED|Extension Study||19||
59639065|NCT03738150|75754960|FG000|NOT COMPLETED|Extension Study||1||
59639066|NCT03607500|75754967|FG000|STARTED|Overall Study||1||
59639067|NCT03607500|75754968|FG001|STARTED|Overall Study||0||
59639068|NCT03607500|75754967|FG000|COMPLETED|Overall Study||1||
59639069|NCT03607500|75754968|FG001|COMPLETED|Overall Study||0||
59639070|NCT03607500|75754967|FG000|NOT COMPLETED|Overall Study||0||
59639071|NCT03607500|75754968|FG001|NOT COMPLETED|Overall Study||0||
59639072|NCT03567174|75754976|FG000|STARTED|Overall Study||360||6
59639073|NCT03567174|75754977|FG001|STARTED|Overall Study||360||6
59639074|NCT03567174|75754976|FG000|V7 Follow-up|Overall Study||268||6
59639075|NCT03567174|75754977|FG001|V7 Follow-up|Overall Study||243||6
59639076|NCT03567174|75754976|FG000|V14 Follow-up (Pre-COVID)|Overall Study||79||2
59639077|NCT03567174|75754977|FG001|V14 Follow-up (Pre-COVID)|Overall Study||70||2
59639078|NCT03567174|75754976|FG000|COVID Phone Surveys|Overall Study||164||6
59639079|NCT03567174|75754977|FG001|COVID Phone Surveys|Overall Study||155||6
59639080|NCT03567174|75754976|FG000|V14 Follow-up (Post-COVID)|Overall Study||92||4
59639081|NCT03567174|75754977|FG001|V14 Follow-up (Post-COVID)|Overall Study||85||4
59639082|NCT03567174|75754976|FG000|COMPLETED|Overall Study||171||6
59639083|NCT03567174|75754977|FG001|COMPLETED|Overall Study||155||6
59639084|NCT03567174|75754976|FG000|NOT COMPLETED|Overall Study||189||0
59639085|NCT03567174|75754977|FG001|NOT COMPLETED|Overall Study||205||0
59639086|NCT03445650|75754988|FG000|STARTED|Overall Study||7||
59639087|NCT03445650|75754989|FG001|STARTED|Overall Study||4||
59639088|NCT03445650|75754988|FG000|COMPLETED|Overall Study||6||
59639089|NCT03445650|75754989|FG001|COMPLETED|Overall Study||3||
59639090|NCT03445650|75754988|FG000|NOT COMPLETED|Overall Study||1||
59639091|NCT03445650|75754989|FG001|NOT COMPLETED|Overall Study||1||
59639092|NCT03042546|75754997|FG000|STARTED|Overall Study||0||
59639093|NCT03042546|75754998|FG001|STARTED|Overall Study||0||
59639094|NCT03042546|75754999|FG002|STARTED|Overall Study||0||
59639095|NCT03042546|75754997|FG000|COMPLETED|Overall Study||0||
59639096|NCT03042546|75754998|FG001|COMPLETED|Overall Study||0||
59639097|NCT03042546|75754999|FG002|COMPLETED|Overall Study||0||
59639098|NCT03042546|75754997|FG000|NOT COMPLETED|Overall Study||0||
59639099|NCT03042546|75754998|FG001|NOT COMPLETED|Overall Study||0||
59639100|NCT03042546|75754999|FG002|NOT COMPLETED|Overall Study||0||
59639101|NCT02561754|75755010|FG000|STARTED|Overall Study||36||
59639102|NCT02561754|75755011|FG001|STARTED|Overall Study||39||
59639103|NCT02561754|75755012|FG002|STARTED|Overall Study||35||
59639104|NCT02561754|75755010|FG000|6 Months|Overall Study||35||
59639105|NCT02561754|75755011|FG001|6 Months|Overall Study||39||
59639106|NCT02561754|75755012|FG002|6 Months|Overall Study||30||
59639107|NCT02561754|75755010|FG000|12 Months|Overall Study||32||
59639108|NCT02561754|75755011|FG001|12 Months|Overall Study||34||
59639109|NCT02561754|75755012|FG002|12 Months|Overall Study||26||
59639110|NCT02561754|75755010|FG000|COMPLETED|Overall Study||30||
59639111|NCT02561754|75755011|FG001|COMPLETED|Overall Study||33||
59639112|NCT02561754|75755012|FG002|COMPLETED|Overall Study||26||
59639113|NCT02561754|75755010|FG000|NOT COMPLETED|Overall Study||6||
59639114|NCT02561754|75755011|FG001|NOT COMPLETED|Overall Study||6||
59639115|NCT02561754|75755012|FG002|NOT COMPLETED|Overall Study||9||
59639116|NCT02545998|75755022|FG000|STARTED|Overall Study||44||
59639117|NCT02545998|75755023|FG001|STARTED|Overall Study||44||
59639118|NCT02545998|75755022|FG000|Received the Intervention|Overall Study||33||
59639119|NCT02545998|75755023|FG001|Received the Intervention|Overall Study||42||
59639120|NCT02545998|75755022|FG000|COMPLETED|Overall Study||29||
59639121|NCT02545998|75755023|FG001|COMPLETED|Overall Study||39||
59639122|NCT02545998|75755022|FG000|NOT COMPLETED|Overall Study||15||
59639123|NCT02545998|75755023|FG001|NOT COMPLETED|Overall Study||5||
59639124|NCT02420652|75755031|FG000|STARTED|Overall Study||18||
59639125|NCT02420652|75755032|FG001|STARTED|Overall Study||9||
59639126|NCT02420652|75755031|FG000|COMPLETED|Overall Study||8||
59639127|NCT02420652|75755032|FG001|COMPLETED|Overall Study||5||
59541425|NCT01447511|75639602|FG003|NOT COMPLETED|Fluconazole Period||0||
59541426|NCT01447511|75639603|FG004|NOT COMPLETED|Fluconazole Period||0||
59541427|NCT01447511|75639599|FG000|STARTED|Rifampin Period||8||
59541428|NCT01447511|75639600|FG001|STARTED|Rifampin Period||5||
59639128|NCT02420652|75755031|FG000|NOT COMPLETED|Overall Study||10||
59639129|NCT02420652|75755032|FG001|NOT COMPLETED|Overall Study||4||
59639130|NCT02257242|75755047|FG000|STARTED|Overall Study||2||
59639131|NCT02257242|75755048|FG001|STARTED|Overall Study||1||
59639132|NCT02257242|75755049|FG002|STARTED|Overall Study||1||
59639133|NCT02257242|75755050|FG003|STARTED|Overall Study||2||
59639134|NCT02257242|75755051|FG004|STARTED|Overall Study||1||
59639135|NCT02257242|75755052|FG005|STARTED|Overall Study||1||
59639136|NCT02257242|75755053|FG006|STARTED|Overall Study||1||
59639137|NCT02257242|75755054|FG007|STARTED|Overall Study||1||
59639138|NCT02257242|75755055|FG008|STARTED|Overall Study||1||
59639139|NCT02257242|75755047|FG000|COMPLETED|Overall Study||1||
59639140|NCT02257242|75755048|FG001|COMPLETED|Overall Study||1||
59639141|NCT02257242|75755049|FG002|COMPLETED|Overall Study||1||
59639142|NCT02257242|75755050|FG003|COMPLETED|Overall Study||2||
59639143|NCT02257242|75755051|FG004|COMPLETED|Overall Study||1||
59639144|NCT02257242|75755052|FG005|COMPLETED|Overall Study||1||
59639145|NCT02257242|75755053|FG006|COMPLETED|Overall Study||1||
59639146|NCT02257242|75755054|FG007|COMPLETED|Overall Study||1||
59639147|NCT02257242|75755055|FG008|COMPLETED|Overall Study||1||
59639148|NCT02257242|75755047|FG000|NOT COMPLETED|Overall Study||1||
59639149|NCT02257242|75755048|FG001|NOT COMPLETED|Overall Study||0||
59639150|NCT02257242|75755049|FG002|NOT COMPLETED|Overall Study||0||
59639151|NCT02257242|75755050|FG003|NOT COMPLETED|Overall Study||0||
59639152|NCT02257242|75755051|FG004|NOT COMPLETED|Overall Study||0||
59639153|NCT02257242|75755052|FG005|NOT COMPLETED|Overall Study||0||
59639154|NCT02257242|75755053|FG006|NOT COMPLETED|Overall Study||0||
59639155|NCT02257242|75755054|FG007|NOT COMPLETED|Overall Study||0||
59639156|NCT02257242|75755055|FG008|NOT COMPLETED|Overall Study||0||
59639157|NCT01943916|75755085|FG000|STARTED|Overall Study||2105||
59639158|NCT01943916|75755085|FG000|COMPLETED|Overall Study||1739||
59639159|NCT01943916|75755085|FG000|NOT COMPLETED|Overall Study||366||
59639160|NCT01564368|75755094|FG000|STARTED|Overall Study||406||
59639161|NCT01564368|75755094|FG000|Randomized in Parent Study|Overall Study||272||
59815738|NCT03233724|75938194|FG001|NOT COMPLETED|Phase II Dose Expansion||0||
59988472|NCT02515994|76103643|FG001|COMPLETED|Overall Study||105||
59988473|NCT02515994|76103642|FG000|NOT COMPLETED|Overall Study||10||
59541429|NCT01447511|75639601|FG002|STARTED|Rifampin Period||8||
59541430|NCT01447511|75639602|FG003|STARTED|Rifampin Period||3||
59541431|NCT01447511|75639603|FG004|STARTED|Rifampin Period||4||
59541432|NCT01447511|75639599|FG000|COMPLETED|Rifampin Period||8||
59541433|NCT01447511|75639600|FG001|COMPLETED|Rifampin Period||5||
59541434|NCT01447511|75639601|FG002|COMPLETED|Rifampin Period||8||
59541435|NCT01447511|75639602|FG003|COMPLETED|Rifampin Period||2||
59541436|NCT01447511|75639603|FG004|COMPLETED|Rifampin Period||4||
59541437|NCT01447511|75639599|FG000|NOT COMPLETED|Rifampin Period||0||
59541438|NCT01447511|75639600|FG001|NOT COMPLETED|Rifampin Period||0||
59541439|NCT01447511|75639601|FG002|NOT COMPLETED|Rifampin Period||0||
59639162|NCT01564368|75755094|FG000|Acceptable Baseline Imaging|Overall Study||263||
59639163|NCT01564368|75755094|FG000|Acceptable Post Baseline Image|Overall Study||242||
59639164|NCT01564368|75755094|FG000|Baseline and Early Treatment Usable|Overall Study||227||
59639165|NCT01564368|75755094|FG000|Baseline and Mid-treatment Usable|Overall Study||210||
59639166|NCT01564368|75755094|FG000|Baseline and Post-Treatment Usable|Overall Study||186||
59541440|NCT01447511|75639602|FG003|NOT COMPLETED|Rifampin Period||1||
59541441|NCT01447511|75639603|FG004|NOT COMPLETED|Rifampin Period||0||
59541442|NCT01550549|75639615|FG000|STARTED|Overall Study||151||
59639167|NCT01564368|75755094|FG000|Usable Re-test Scan|Overall Study||71||
59639168|NCT01564368|75755094|FG000|COMPLETED|Overall Study||242||
59639169|NCT01564368|75755094|FG000|NOT COMPLETED|Overall Study||164||
59639170|NCT00281658|75755102|FG000|STARTED|Randomized Phase||222|All randomized subjects were included in the Intent-to-Treat (ITT) Population|
59639171|NCT00281658|75755103|FG001|STARTED|Randomized Phase||222|All randomized subjects were included in the Intent-to-Treat (ITT) Population|
59639172|NCT00281658|75755104|FG002|STARTED|Randomized Phase||0|All randomized subjects were included in the Intent-to-Treat (ITT) Population|
59988474|NCT02515994|76103643|FG001|NOT COMPLETED|Overall Study||7||
59639173|NCT00281658|75755105|FG003|STARTED|Randomized Phase||0|All randomized subjects were included in the Intent-to-Treat (ITT) Population|
59639174|NCT00281658|75755102|FG000|Safety Population|Randomized Phase||222|All randomized subjects who received at least one dose of study medication|
59639175|NCT00281658|75755103|FG001|Safety Population|Randomized Phase||221|All randomized subjects who received at least one dose of study medication|
59639176|NCT00281658|75755104|FG002|Safety Population|Randomized Phase||0|All randomized subjects who received at least one dose of study medication|
59639177|NCT00281658|75755105|FG003|Safety Population|Randomized Phase||0|All randomized subjects who received at least one dose of study medication|
59639178|NCT00281658|75755102|FG000|COMPLETED|Randomized Phase||133||
59639179|NCT00281658|75755103|FG001|COMPLETED|Randomized Phase||149||
59639180|NCT00281658|75755104|FG002|COMPLETED|Randomized Phase||0||
59639181|NCT00281658|75755105|FG003|COMPLETED|Randomized Phase||0||
59639182|NCT00281658|75755102|FG000|NOT COMPLETED|Randomized Phase||89||
59639183|NCT00281658|75755103|FG001|NOT COMPLETED|Randomized Phase||73||
59639184|NCT00281658|75755104|FG002|NOT COMPLETED|Randomized Phase||0||
59639185|NCT00281658|75755105|FG003|NOT COMPLETED|Randomized Phase||0||
59639186|NCT00281658|75755102|FG000|STARTED|Open Label Phase||0||
59639187|NCT00281658|75755103|FG001|STARTED|Open Label Phase||0||
59639188|NCT00281658|75755104|FG002|STARTED|Open Label Phase||149||
59639189|NCT00281658|75755105|FG003|STARTED|Open Label Phase||4||
59639190|NCT00281658|75755102|FG000|COMPLETED|Open Label Phase||0||
59639191|NCT00281658|75755103|FG001|COMPLETED|Open Label Phase||0||
59639192|NCT00281658|75755104|FG002|COMPLETED|Open Label Phase||104||
59639193|NCT00281658|75755105|FG003|COMPLETED|Open Label Phase||0||
59639194|NCT00281658|75755102|FG000|NOT COMPLETED|Open Label Phase||0||
59639195|NCT00281658|75755103|FG001|NOT COMPLETED|Open Label Phase||0||
59639196|NCT00281658|75755104|FG002|NOT COMPLETED|Open Label Phase||45||
59639197|NCT00281658|75755105|FG003|NOT COMPLETED|Open Label Phase||4||
59639198|NCT02417376|75755115|FG000|STARTED|Overall Study||35||
59639199|NCT02417376|75755116|FG001|STARTED|Overall Study||35||
59639200|NCT02417376|75755115|FG000|COMPLETED|Overall Study||30||
59639201|NCT02417376|75755116|FG001|COMPLETED|Overall Study||25||
59639202|NCT02417376|75755115|FG000|NOT COMPLETED|Overall Study||5||
59639203|NCT02417376|75755116|FG001|NOT COMPLETED|Overall Study||10||
59639204|NCT02417532|75755122|FG000|STARTED|Overall Study||56||
59639205|NCT02417532|75755122|FG000|COMPLETED|Overall Study||56||
59639206|NCT02417532|75755122|FG000|NOT COMPLETED|Overall Study||0||
59639207|NCT02417844|75755128|FG000|STARTED|Overall Study||17||
59639208|NCT02417844|75755129|FG001|STARTED|Overall Study||17||
59639209|NCT02417844|75755128|FG000|COMPLETED|Overall Study||17||
59639210|NCT02417844|75755129|FG001|COMPLETED|Overall Study||17||
59639211|NCT02417844|75755128|FG000|NOT COMPLETED|Overall Study||0||
59639212|NCT02417844|75755129|FG001|NOT COMPLETED|Overall Study||0||
59639213|NCT02418234|75755135|FG000|STARTED|Overall Study||314||
59639214|NCT02418234|75755135|FG000|COMPLETED|Overall Study||314||
59639215|NCT02418234|75755135|FG000|NOT COMPLETED|Overall Study||0||
59639216|NCT02418312|75755145|FG000|STARTED|Overall Study||114||
59639217|NCT02418312|75755146|FG001|STARTED|Overall Study||114||
59639218|NCT02418312|75755145|FG000|COMPLETED|Overall Study||114||
59639219|NCT02418312|75755146|FG001|COMPLETED|Overall Study||114||
59639220|NCT02418312|75755145|FG000|NOT COMPLETED|Overall Study||0||
59639221|NCT02418312|75755146|FG001|NOT COMPLETED|Overall Study||0||
59639222|NCT02418546|75755155|FG000|STARTED|Overall Study||26||
59639223|NCT02418546|75755156|FG001|STARTED|Overall Study||26||
59639224|NCT02418546|75755157|FG002|STARTED|Overall Study||26||
59639225|NCT02418546|75755155|FG000|COMPLETED|Overall Study||19||
59639226|NCT02418546|75755156|FG001|COMPLETED|Overall Study||20||
59639227|NCT02418546|75755157|FG002|COMPLETED|Overall Study||23||
59639228|NCT02418546|75755155|FG000|NOT COMPLETED|Overall Study||7||
59639229|NCT02418546|75755156|FG001|NOT COMPLETED|Overall Study||6||
59639230|NCT02418546|75755157|FG002|NOT COMPLETED|Overall Study||3||
59639231|NCT02421354|75755165|FG000|STARTED|Overall Study||8||
59639232|NCT02421354|75755165|FG000|COMPLETED|Overall Study||8||
59639233|NCT02421354|75755165|FG000|NOT COMPLETED|Overall Study||0||
59639234|NCT02422290|75755169|FG000|STARTED|Overall Study||5||
59639235|NCT02422290|75755169|FG000|COMPLETED|Overall Study||5||
59639236|NCT02422290|75755169|FG000|NOT COMPLETED|Overall Study||0||
59639237|NCT02425956|75755173|FG000|STARTED|Overall Study||21||
59639238|NCT02425956|75755173|FG000|COMPLETED|Overall Study||21||
59639239|NCT02425956|75755173|FG000|NOT COMPLETED|Overall Study||0||
59639240|NCT02427672|75755179|FG000|STARTED|Overall Study||40||
59639241|NCT02427672|75755180|FG001|STARTED|Overall Study||44||
59639242|NCT02427672|75755179|FG000|COMPLETED|Overall Study||39||
59639243|NCT02427672|75755180|FG001|COMPLETED|Overall Study||42||
59639244|NCT02427672|75755179|FG000|NOT COMPLETED|Overall Study||1||
59639245|NCT02427672|75755180|FG001|NOT COMPLETED|Overall Study||2||
59639246|NCT02427750|75755188|FG000|STARTED|Overall Study||63||
59639247|NCT02427750|75755189|FG001|STARTED|Overall Study||63||
59639248|NCT02427750|75755188|FG000|COMPLETED|Overall Study||63||
59639249|NCT02427750|75755189|FG001|COMPLETED|Overall Study||63||
59639250|NCT02427750|75755188|FG000|NOT COMPLETED|Overall Study||0||
59639251|NCT02427750|75755189|FG001|NOT COMPLETED|Overall Study||0||
59639252|NCT02430090|75755199|FG000|STARTED|Overall Study||15||
59639253|NCT02430090|75755200|FG001|STARTED|Overall Study||15||
59639254|NCT02430090|75755201|FG002|STARTED|Overall Study||15||
59639255|NCT02430090|75755199|FG000|COMPLETED|Overall Study||15||
59639256|NCT02430090|75755200|FG001|COMPLETED|Overall Study||15||
59639257|NCT02430090|75755201|FG002|COMPLETED|Overall Study||15||
59639258|NCT02430090|75755199|FG000|NOT COMPLETED|Overall Study||0||
59639259|NCT02430090|75755200|FG001|NOT COMPLETED|Overall Study||0||
59639260|NCT02430090|75755201|FG002|NOT COMPLETED|Overall Study||0||
59639261|NCT02431572|75755212|FG000|STARTED|Overall Study||1||
59639262|NCT02431572|75755213|FG001|STARTED|Overall Study||1||
59639263|NCT02431572|75755214|FG002|STARTED|Overall Study||9||
59639264|NCT02431572|75755212|FG000|COMPLETED|Overall Study||0||
59639265|NCT02431572|75755213|FG001|COMPLETED|Overall Study||1||
59639266|NCT02431572|75755214|FG002|COMPLETED|Overall Study||9||
59639267|NCT02431572|75755212|FG000|NOT COMPLETED|Overall Study||1||
59639268|NCT02431572|75755213|FG001|NOT COMPLETED|Overall Study||0||
59639269|NCT02431572|75755214|FG002|NOT COMPLETED|Overall Study||0||
59639270|NCT02431650|75755224|FG000|STARTED|Overall Study||5||
59639271|NCT02431650|75755225|FG001|STARTED|Overall Study||6||
59639272|NCT02431650|75755224|FG000|COMPLETED|Overall Study||5||
59639273|NCT02431650|75755225|FG001|COMPLETED|Overall Study||6||
59639274|NCT02431650|75755224|FG000|NOT COMPLETED|Overall Study||0||
59639275|NCT02431650|75755225|FG001|NOT COMPLETED|Overall Study||0||
59639276|NCT02433366|75755233|FG000|STARTED|Overall Study||411||
59639277|NCT02433366|75755234|FG001|STARTED|Overall Study||802||
59639278|NCT02433366|75755233|FG000|COMPLETED|Overall Study||411||
59639279|NCT02433366|75755234|FG001|COMPLETED|Overall Study||802||
59639280|NCT02433366|75755233|FG000|NOT COMPLETED|Overall Study||0||
59639281|NCT02433366|75755234|FG001|NOT COMPLETED|Overall Study||0||
59639282|NCT02435706|75755242|FG000|STARTED|Overall Study||18||
59639283|NCT02435706|75755243|FG001|STARTED|Overall Study||21||
59639284|NCT02435706|75755242|FG000|COMPLETED|Overall Study||16||
59639285|NCT02435706|75755243|FG001|COMPLETED|Overall Study||20||
59639286|NCT02435706|75755242|FG000|NOT COMPLETED|Overall Study||2||
59639287|NCT02435706|75755243|FG001|NOT COMPLETED|Overall Study||1||
59639288|NCT02437344|75755249|FG000|STARTED|Overall Study||16||
59639289|NCT02437344|75755249|FG000|COMPLETED|Overall Study||15||
59639290|NCT02437344|75755249|FG000|NOT COMPLETED|Overall Study||1||
59639291|NCT02440308|75755253|FG000|STARTED|Overall Study||10||
59639292|NCT02440308|75755253|FG000|COMPLETED|Overall Study||10||
59639293|NCT02440308|75755253|FG000|NOT COMPLETED|Overall Study||0||
59639294|NCT02444988|75755259|FG000|STARTED|Overall Study||2646||
59639295|NCT02444988|75755260|FG001|STARTED|Overall Study||2735||
59639296|NCT02444988|75755259|FG000|COMPLETED|Overall Study||2646||
59639297|NCT02444988|75755260|FG001|COMPLETED|Overall Study||2735||
59639298|NCT02444988|75755259|FG000|NOT COMPLETED|Overall Study||0||
59639299|NCT02444988|75755260|FG001|NOT COMPLETED|Overall Study||0||
59639300|NCT02446314|75755270|FG000|STARTED|Zero to Twelve Weeks.||30||
59639301|NCT02446314|75755271|FG001|STARTED|Zero to Twelve Weeks.||30||
59639302|NCT02446314|75755272|FG002|STARTED|Zero to Twelve Weeks.||31||
59639303|NCT02446314|75755273|FG003|STARTED|Zero to Twelve Weeks.||31||
59639304|NCT02446314|75755270|FG000|COMPLETED|Zero to Twelve Weeks.||27||
59639305|NCT02446314|75755271|FG001|COMPLETED|Zero to Twelve Weeks.||29||
59639306|NCT02446314|75755272|FG002|COMPLETED|Zero to Twelve Weeks.||31||
59639307|NCT02446314|75755273|FG003|COMPLETED|Zero to Twelve Weeks.||29||
59639308|NCT02446314|75755270|FG000|NOT COMPLETED|Zero to Twelve Weeks.||3||
59639309|NCT02446314|75755271|FG001|NOT COMPLETED|Zero to Twelve Weeks.||1||
59639310|NCT02446314|75755272|FG002|NOT COMPLETED|Zero to Twelve Weeks.||0||
59639311|NCT02446314|75755273|FG003|NOT COMPLETED|Zero to Twelve Weeks.||2||
59639312|NCT02446314|75755270|FG000|STARTED|Thirteen to Twenty Four Weeks||27||
59639313|NCT02446314|75755271|FG001|STARTED|Thirteen to Twenty Four Weeks||29||
59639314|NCT02446314|75755272|FG002|STARTED|Thirteen to Twenty Four Weeks||31||
59639315|NCT02446314|75755273|FG003|STARTED|Thirteen to Twenty Four Weeks||29||
59639316|NCT02446314|75755270|FG000|COMPLETED|Thirteen to Twenty Four Weeks||27||
59988475|NCT02516306|76103651|FG000|STARTED|Period 1: Day 1 - 7||50||
59639317|NCT02446314|75755271|FG001|COMPLETED|Thirteen to Twenty Four Weeks||28||
59639318|NCT02446314|75755272|FG002|COMPLETED|Thirteen to Twenty Four Weeks||29||
59639319|NCT02446314|75755273|FG003|COMPLETED|Thirteen to Twenty Four Weeks||28||
59639320|NCT02446314|75755270|FG000|NOT COMPLETED|Thirteen to Twenty Four Weeks||0||
59639321|NCT02446314|75755271|FG001|NOT COMPLETED|Thirteen to Twenty Four Weeks||1||
59639322|NCT02446314|75755272|FG002|NOT COMPLETED|Thirteen to Twenty Four Weeks||2||
59639323|NCT02446314|75755273|FG003|NOT COMPLETED|Thirteen to Twenty Four Weeks||1||
59639324|NCT02448654|75755289|FG000|STARTED|Overall Study||19|Were eligible and completed the baseline assessments.|
59639325|NCT02448654|75755290|FG001|STARTED|Overall Study||17|Were eligible and completed the baseline assessments.|
59639326|NCT02448654|75755289|FG000|Started Pills (Tolcapone or Placebo)|Overall Study||17|Started the medication (tolcapone or placebo) portion of the trial.|
59639327|NCT02448654|75755290|FG001|Started Pills (Tolcapone or Placebo)|Overall Study||15|Started the medication (tolcapone or placebo) portion of the trial.|
59639328|NCT02448654|75755289|FG000|COMPLETED|Overall Study||16|Completed the medication (tolcapone or placebo) trial.|
59639329|NCT02448654|75755290|FG001|COMPLETED|Overall Study||13|Completed the medication (tolcapone or placebo) trial.|
59639330|NCT02448654|75755289|FG000|NOT COMPLETED|Overall Study||3||
59639331|NCT02448654|75755290|FG001|NOT COMPLETED|Overall Study||4||
59639332|NCT02449356|75755298|FG000|STARTED|Overall Study||30||
59639333|NCT02449356|75755299|FG001|STARTED|Overall Study||30||
59639334|NCT02449356|75755298|FG000|COMPLETED|Overall Study||30||
59639335|NCT02449356|75755299|FG001|COMPLETED|Overall Study||30||
59639336|NCT02449356|75755298|FG000|NOT COMPLETED|Overall Study||0||
59639337|NCT02449356|75755299|FG001|NOT COMPLETED|Overall Study||0||
59639338|NCT02449434|75755309|FG000|STARTED|Overall Study||300||
59639339|NCT02449434|75755310|FG001|STARTED|Overall Study||300||
59639340|NCT02449434|75755309|FG000|COMPLETED|Overall Study||300||
59639341|NCT02449434|75755310|FG001|COMPLETED|Overall Study||300||
59639342|NCT02449434|75755309|FG000|NOT COMPLETED|Overall Study||0||
59639343|NCT02449434|75755310|FG001|NOT COMPLETED|Overall Study||0||
59639344|NCT02451150|75755318|FG000|STARTED|Overall Study||3||
59639345|NCT02451150|75755319|FG001|STARTED|Overall Study||3||
59639346|NCT02451150|75755318|FG000|COMPLETED|Overall Study||3||
59639347|NCT02451150|75755319|FG001|COMPLETED|Overall Study||3||
59639348|NCT02451150|75755318|FG000|NOT COMPLETED|Overall Study||0||
59639349|NCT02451150|75755319|FG001|NOT COMPLETED|Overall Study||0||
59639350|NCT02452866|75755325|FG000|STARTED|Overall Study||325||
59639351|NCT02452866|75755325|FG000|COMPLETED|Overall Study||321||
59639352|NCT02452866|75755325|FG000|NOT COMPLETED|Overall Study||4||
59639353|NCT02452944|75755331|FG000|STARTED|Overall Study||31||
59639354|NCT02452944|75755332|FG001|STARTED|Overall Study||31||
59639355|NCT02452944|75755331|FG000|COMPLETED|Overall Study||31||
59639356|NCT02452944|75755332|FG001|COMPLETED|Overall Study||31||
59639357|NCT02452944|75755331|FG000|NOT COMPLETED|Overall Study||0||
59639358|NCT02452944|75755332|FG001|NOT COMPLETED|Overall Study||0||
59639359|NCT02460666|75755342|FG000|STARTED|Overall Study||89||
59639360|NCT02460666|75755343|FG001|STARTED|Overall Study||89||
59639361|NCT02460666|75755342|FG000|COMPLETED|Overall Study||62||
59639362|NCT02460666|75755343|FG001|COMPLETED|Overall Study||63||
59639363|NCT02460666|75755342|FG000|NOT COMPLETED|Overall Study||27||
59639364|NCT02460666|75755343|FG001|NOT COMPLETED|Overall Study||26||
59639365|NCT02461992|75755349|FG000|STARTED|Overall Study||13||
59639366|NCT02461992|75755349|FG000|COMPLETED|Overall Study||13||
59639367|NCT02461992|75755349|FG000|NOT COMPLETED|Overall Study||0||
59639368|NCT02462070|75755355|FG000|STARTED|Overall Study||135||
59639369|NCT02462070|75755356|FG001|STARTED|Overall Study||68||
59639370|NCT02462070|75755355|FG000|COMPLETED|Overall Study||112||
59639371|NCT02462070|75755356|FG001|COMPLETED|Overall Study||57||
59639372|NCT02462070|75755355|FG000|NOT COMPLETED|Overall Study||23||
59639373|NCT02462070|75755356|FG001|NOT COMPLETED|Overall Study||11||
59639374|NCT02462148|75755365|FG000|STARTED|Overall Study||37||
59639375|NCT02462148|75755366|FG001|STARTED|Overall Study||36||
59639376|NCT02462148|75755367|FG002|STARTED|Overall Study||12||
59639377|NCT02462148|75755365|FG000|COMPLETED|Overall Study||36||
59639378|NCT02462148|75755366|FG001|COMPLETED|Overall Study||36||
59639379|NCT02462148|75755367|FG002|COMPLETED|Overall Study||12||
59639380|NCT02462148|75755365|FG000|NOT COMPLETED|Overall Study||1||
59639381|NCT02462148|75755366|FG001|NOT COMPLETED|Overall Study||0||
59639382|NCT02462148|75755367|FG002|NOT COMPLETED|Overall Study||0||
59639383|NCT02462382|75755380|FG000|STARTED|Overall Study||24||
59639384|NCT02462382|75755381|FG001|STARTED|Overall Study||27||
59639385|NCT02462382|75755380|FG000|COMPLETED|Overall Study||24||
59639386|NCT02462382|75755381|FG001|COMPLETED|Overall Study||27||
59639387|NCT02462382|75755380|FG000|NOT COMPLETED|Overall Study||0||
59639388|NCT02462382|75755381|FG001|NOT COMPLETED|Overall Study||0||
59639389|NCT02464176|75755390|FG000|STARTED|Overall Study||50||
59639390|NCT02464176|75755391|FG001|STARTED|Overall Study||50||
59639391|NCT02464176|75755392|FG002|STARTED|Overall Study||15||
59639392|NCT02464176|75755390|FG000|COMPLETED|Overall Study||50||
59639393|NCT02464176|75755391|FG001|COMPLETED|Overall Study||50||
59639394|NCT02464176|75755392|FG002|COMPLETED|Overall Study||15||
59639395|NCT02464176|75755390|FG000|NOT COMPLETED|Overall Study||0||
59639396|NCT02464176|75755391|FG001|NOT COMPLETED|Overall Study||0||
59639397|NCT02464176|75755392|FG002|NOT COMPLETED|Overall Study||0||
59639398|NCT02466126|75755402|FG000|STARTED|Baseline||109||
59639399|NCT02466126|75755403|FG001|STARTED|Baseline||80||
59639400|NCT02466126|75755402|FG000|COMPLETED|Baseline||109||
59639401|NCT02466126|75755403|FG001|COMPLETED|Baseline||80||
59639402|NCT02466126|75755402|FG000|NOT COMPLETED|Baseline||0||
59639403|NCT02466126|75755403|FG001|NOT COMPLETED|Baseline||0||
59639404|NCT02466126|75755402|FG000|STARTED|4 Month Assessment||109||
59639405|NCT02466126|75755403|FG001|STARTED|4 Month Assessment||80||
59639406|NCT02466126|75755402|FG000|COMPLETED|4 Month Assessment||93||
59639407|NCT02466126|75755403|FG001|COMPLETED|4 Month Assessment||71||
59639408|NCT02466126|75755402|FG000|NOT COMPLETED|4 Month Assessment||16||
59639409|NCT02466126|75755403|FG001|NOT COMPLETED|4 Month Assessment||9||
59639410|NCT02466126|75755402|FG000|STARTED|8 Month Assessment||93||
59639411|NCT02466126|75755403|FG001|STARTED|8 Month Assessment||71||
59639412|NCT02466126|75755402|FG000|COMPLETED|8 Month Assessment||86||
59639413|NCT02466126|75755403|FG001|COMPLETED|8 Month Assessment||68||
59639414|NCT02466126|75755402|FG000|NOT COMPLETED|8 Month Assessment||7||
59639415|NCT02466126|75755403|FG001|NOT COMPLETED|8 Month Assessment||3||
59639416|NCT02466126|75755402|FG000|STARTED|12 Month Assessment||86||
59639417|NCT02466126|75755403|FG001|STARTED|12 Month Assessment||68||
59639418|NCT02466126|75755402|FG000|COMPLETED|12 Month Assessment||85||
59639419|NCT02466126|75755403|FG001|COMPLETED|12 Month Assessment||66||
59639420|NCT02466126|75755402|FG000|NOT COMPLETED|12 Month Assessment||1||
59639421|NCT02466126|75755403|FG001|NOT COMPLETED|12 Month Assessment||2||
59639422|NCT02467842|75755412|FG000|STARTED|Overall Study||752||
59639423|NCT02467842|75755413|FG001|STARTED|Overall Study||373||
59639424|NCT02467842|75755414|FG002|STARTED|Overall Study||378||
59639425|NCT02467842|75755412|FG000|COMPLETED|Overall Study||752||
59639426|NCT02467842|75755413|FG001|COMPLETED|Overall Study||373||
59639427|NCT02467842|75755414|FG002|COMPLETED|Overall Study||378||
59639428|NCT02467842|75755412|FG000|NOT COMPLETED|Overall Study||0||
59639429|NCT02467842|75755413|FG001|NOT COMPLETED|Overall Study||0||
59639430|NCT02467842|75755414|FG002|NOT COMPLETED|Overall Study||0||
59639431|NCT02468154|75755426|FG000|STARTED|Overall Study||29||
59639432|NCT02468154|75755427|FG001|STARTED|Overall Study||28||
59639433|NCT02468154|75755426|FG000|COMPLETED|Overall Study||29||
59639434|NCT02468154|75755427|FG001|COMPLETED|Overall Study||28||
59639435|NCT02468154|75755426|FG000|NOT COMPLETED|Overall Study||0||
59639436|NCT02468154|75755427|FG001|NOT COMPLETED|Overall Study||0||
59639437|NCT02468700|75755435|FG000|STARTED|Overall Study||22||
59639438|NCT02468700|75755436|FG001|STARTED|Overall Study||21||
59639439|NCT02468700|75755435|FG000|COMPLETED|Overall Study||20||
59639440|NCT02468700|75755436|FG001|COMPLETED|Overall Study||19||
59639441|NCT02468700|75755435|FG000|NOT COMPLETED|Overall Study||2||
59639442|NCT02468700|75755436|FG001|NOT COMPLETED|Overall Study||2||
59639443|NCT02469714|75755444|FG000|STARTED|Overall Study||55|Baseline|
59639444|NCT02469714|75755445|FG001|STARTED|Overall Study||55|Baseline|
59639445|NCT02469714|75755444|FG000|4 Month Follow-Up|Overall Study||50||
59639446|NCT02469714|75755445|FG001|4 Month Follow-Up|Overall Study||51||
59639447|NCT02469714|75755444|FG000|8 Month Follow-Up|Overall Study||49||
59639448|NCT02469714|75755445|FG001|8 Month Follow-Up|Overall Study||50||
59639449|NCT02469714|75755444|FG000|COMPLETED|Overall Study||47|12 Month Follow-Up|
59639450|NCT02469714|75755445|FG001|COMPLETED|Overall Study||50|12 Month Follow-Up|
59639451|NCT02469714|75755444|FG000|NOT COMPLETED|Overall Study||8||
59639452|NCT02469714|75755445|FG001|NOT COMPLETED|Overall Study||5||
59639453|NCT02469870|75755453|FG000|STARTED|Overall Study||77||
59639454|NCT02469870|75755454|FG001|STARTED|Overall Study||79||
59639455|NCT02469870|75755453|FG000|COMPLETED|Overall Study||73||
59639456|NCT02469870|75755454|FG001|COMPLETED|Overall Study||72||
59639457|NCT02469870|75755453|FG000|NOT COMPLETED|Overall Study||4||
59639458|NCT02469870|75755454|FG001|NOT COMPLETED|Overall Study||7||
59639459|NCT02470494|75755463|FG000|STARTED|Overall Study||46||
59639460|NCT02470494|75755463|FG000|COMPLETED|Overall Study||41||
59639461|NCT02470494|75755463|FG000|NOT COMPLETED|Overall Study||5||
59639462|NCT02472522|75755469|FG000|STARTED|Overall Study||50||
59639463|NCT02472522|75755470|FG001|STARTED|Overall Study||50||
59639464|NCT02472522|75755469|FG000|COMPLETED|Overall Study||50||
59639465|NCT02472522|75755470|FG001|COMPLETED|Overall Study||50||
59639466|NCT02472522|75755469|FG000|NOT COMPLETED|Overall Study||0||
59639467|NCT02472522|75755470|FG001|NOT COMPLETED|Overall Study||0||
59639468|NCT02476032|75755481|FG000|STARTED|Overall Study||20||
59639469|NCT02476032|75755482|FG001|STARTED|Overall Study||20||
59639470|NCT02476032|75755483|FG002|STARTED|Overall Study||20||
59639471|NCT02476032|75755481|FG000|COMPLETED|Overall Study||20||
59639472|NCT02476032|75755482|FG001|COMPLETED|Overall Study||19||
59639473|NCT02476032|75755483|FG002|COMPLETED|Overall Study||19||
59639474|NCT02476032|75755481|FG000|NOT COMPLETED|Overall Study||0||
59639475|NCT02476032|75755482|FG001|NOT COMPLETED|Overall Study||1||
59639476|NCT02476032|75755483|FG002|NOT COMPLETED|Overall Study||1||
59639477|NCT02476890|75755498|FG000|STARTED|Overall Study|Crossover study|6||
59639478|NCT02476890|75755499|FG001|STARTED|Overall Study|Crossover study|6||
59639479|NCT02476890|75755500|FG002|STARTED|Overall Study|Crossover study|12||
59639480|NCT02476890|75755501|FG003|STARTED|Overall Study|Crossover study|12||
59639481|NCT02476890|75755498|FG000|Washout|Overall Study||6||
59639482|NCT02476890|75755499|FG001|Washout|Overall Study||6||
59639483|NCT02476890|75755500|FG002|Washout|Overall Study||12||
59639484|NCT02476890|75755501|FG003|Washout|Overall Study||12||
59639485|NCT02476890|75755498|FG000|COMPLETED|Overall Study||6||
59639486|NCT02476890|75755499|FG001|COMPLETED|Overall Study||6||
59639487|NCT02476890|75755500|FG002|COMPLETED|Overall Study||12||
59639488|NCT02476890|75755501|FG003|COMPLETED|Overall Study||12||
59639489|NCT02476890|75755498|FG000|NOT COMPLETED|Overall Study||0||
59639490|NCT02476890|75755499|FG001|NOT COMPLETED|Overall Study||0||
59639491|NCT02476890|75755500|FG002|NOT COMPLETED|Overall Study||0||
59639492|NCT02476890|75755501|FG003|NOT COMPLETED|Overall Study||0||
59639493|NCT02480166|75755516|FG000|STARTED|Overall Study||20||
59639494|NCT02480166|75755517|FG001|STARTED|Overall Study||36||
59639495|NCT02480166|75755518|FG002|STARTED|Overall Study||4||
59639496|NCT02480166|75755516|FG000|COMPLETED|Overall Study||20||
59639497|NCT02480166|75755517|FG001|COMPLETED|Overall Study||36||
59639498|NCT02480166|75755518|FG002|COMPLETED|Overall Study||4||
59639499|NCT02480166|75755516|FG000|NOT COMPLETED|Overall Study||0||
59639500|NCT02480166|75755517|FG001|NOT COMPLETED|Overall Study||0||
59639501|NCT02480166|75755518|FG002|NOT COMPLETED|Overall Study||0||
59639502|NCT02481258|75755529|FG000|STARTED|Overall Study||12||
59639503|NCT02481258|75755530|FG001|STARTED|Overall Study||11||
59639504|NCT02481258|75755529|FG000|COMPLETED|Overall Study||12||
59639505|NCT02481258|75755530|FG001|COMPLETED|Overall Study||11||
59639506|NCT02481258|75755529|FG000|NOT COMPLETED|Overall Study||0||
59639507|NCT02481258|75755530|FG001|NOT COMPLETED|Overall Study||0||
59639508|NCT02483676|75755540|FG000|STARTED|Overall Study||23||
59639509|NCT02483676|75755541|FG001|STARTED|Overall Study||22||
59639510|NCT02483676|75755540|FG000|COMPLETED|Overall Study||17||
59639511|NCT02483676|75755541|FG001|COMPLETED|Overall Study||17||
59639512|NCT02483676|75755540|FG000|NOT COMPLETED|Overall Study||6||
59639513|NCT02483676|75755541|FG001|NOT COMPLETED|Overall Study||5||
59639514|NCT02484222|75755547|FG000|STARTED|Overall Study||80||
59639515|NCT02484222|75755547|FG000|COMPLETED|Overall Study||77||
59639516|NCT02484222|75755547|FG000|NOT COMPLETED|Overall Study||3||
59639517|NCT02486016|75755553|FG000|STARTED|Overall Study|Same 10 volunteers completed Apotex, Duragesic and Mylan arms of the study; crossover study.|10||
59639518|NCT02486016|75755553|FG000|COMPLETED|Overall Study||10||
59639519|NCT02486016|75755553|FG000|NOT COMPLETED|Overall Study||0||
59639520|NCT02486328|75755563|FG000|STARTED|Overall Study||52||
59639521|NCT02486328|75755564|FG001|STARTED|Overall Study||51||
59639522|NCT02486328|75755563|FG000|COMPLETED|Overall Study||50||
59639523|NCT02486328|75755564|FG001|COMPLETED|Overall Study||50||
59639524|NCT02486328|75755563|FG000|NOT COMPLETED|Overall Study||2||
59639525|NCT02486328|75755564|FG001|NOT COMPLETED|Overall Study||1||
59639526|NCT02491788|75755572|FG000|STARTED|Overall Study||8||
59639527|NCT02491788|75755573|FG001|STARTED|Overall Study||11||
59639528|NCT02491788|75755572|FG000|COMPLETED|Overall Study||8||
59988476|NCT02516306|76103652|FG001|STARTED|Period 1: Day 1 - 7||25||
59988477|NCT02516306|76103651|FG000|COMPLETED|Period 1: Day 1 - 7||50||
59639529|NCT02491788|75755573|FG001|COMPLETED|Overall Study||11||
59639530|NCT02491788|75755572|FG000|NOT COMPLETED|Overall Study||0||
59639531|NCT02491788|75755573|FG001|NOT COMPLETED|Overall Study||0||
59639532|NCT02491944|75755579|FG000|STARTED|Overall Study||10||
59639533|NCT02491944|75755579|FG000|COMPLETED|Overall Study||10||
59639534|NCT02491944|75755579|FG000|NOT COMPLETED|Overall Study||0||
59639535|NCT02492802|75755583|FG000|STARTED|Overall Study||64||
59639536|NCT02492802|75755583|FG000|COMPLETED|Overall Study||64||
59639537|NCT02492802|75755583|FG000|NOT COMPLETED|Overall Study||0||
59639538|NCT02493036|75755590|FG000|STARTED|Overall Study||17||
59639539|NCT02493036|75755591|FG001|STARTED|Overall Study||20||
59639540|NCT02493036|75755592|FG002|STARTED|Overall Study||17||
59639541|NCT02493036|75755590|FG000|COMPLETED|Overall Study||16||
59639542|NCT02493036|75755591|FG001|COMPLETED|Overall Study||18||
59988478|NCT02516306|76103652|FG001|COMPLETED|Period 1: Day 1 - 7||25||
59988479|NCT02516306|76103651|FG000|NOT COMPLETED|Period 1: Day 1 - 7||0||
59639543|NCT02493036|75755592|FG002|COMPLETED|Overall Study||15||
59639544|NCT02493036|75755590|FG000|NOT COMPLETED|Overall Study||1||
59639545|NCT02493036|75755591|FG001|NOT COMPLETED|Overall Study||2||
59639546|NCT02493036|75755592|FG002|NOT COMPLETED|Overall Study||2||
59639547|NCT02494440|75755600|FG000|STARTED|Overall Study||90||
59639548|NCT02494440|75755600|FG000|COMPLETED|Overall Study||90||
59639549|NCT02494440|75755600|FG000|NOT COMPLETED|Overall Study||0||
59639550|NCT02494518|75755607|FG000|STARTED|Overall Study||11||
59639551|NCT02494518|75755608|FG001|STARTED|Overall Study||12||
59639552|NCT02494518|75755609|FG002|STARTED|Overall Study||11||
59639553|NCT02494518|75755607|FG000|COMPLETED|Overall Study||10||
59639554|NCT02494518|75755608|FG001|COMPLETED|Overall Study||10||
59639555|NCT02494518|75755609|FG002|COMPLETED|Overall Study||8||
59639556|NCT02494518|75755607|FG000|NOT COMPLETED|Overall Study||1||
59639557|NCT02494518|75755608|FG001|NOT COMPLETED|Overall Study||2||
59639558|NCT02494518|75755609|FG002|NOT COMPLETED|Overall Study||3||
59639559|NCT02495454|75755617|FG000|STARTED|Overall Study||34||
59988480|NCT02516306|76103652|FG001|NOT COMPLETED|Period 1: Day 1 - 7||0||
59639560|NCT02495454|75755617|FG000|COMPLETED|Overall Study|One case excluded for violation of inclusion criteria (transformed lymphoma)|33||
59639561|NCT02495454|75755617|FG000|NOT COMPLETED|Overall Study||1||
59639562|NCT02500368|75755622|FG000|STARTED|First Intervention (1 Week)||20||
59639563|NCT02500368|75755623|FG001|STARTED|First Intervention (1 Week)||20||
59639564|NCT02500368|75755622|FG000|COMPLETED|First Intervention (1 Week)||20||
59639565|NCT02500368|75755623|FG001|COMPLETED|First Intervention (1 Week)||20||
59639566|NCT02500368|75755622|FG000|NOT COMPLETED|First Intervention (1 Week)||0||
59639567|NCT02500368|75755623|FG001|NOT COMPLETED|First Intervention (1 Week)||0||
59639568|NCT02500368|75755622|FG000|STARTED|Second Intervention (1 Week)||20||
59639569|NCT02500368|75755623|FG001|STARTED|Second Intervention (1 Week)||20||
59639570|NCT02500368|75755622|FG000|COMPLETED|Second Intervention (1 Week)||20||
59639571|NCT02500368|75755623|FG001|COMPLETED|Second Intervention (1 Week)||20||
59639572|NCT02500368|75755622|FG000|NOT COMPLETED|Second Intervention (1 Week)||0||
59639573|NCT02500368|75755623|FG001|NOT COMPLETED|Second Intervention (1 Week)||0||
59639574|NCT02500602|75755631|FG000|STARTED|Treatment Phase||74||
59639575|NCT02500602|75755632|FG001|STARTED|Treatment Phase||70||
59639576|NCT02500602|75755631|FG000|COMPLETED|Treatment Phase||68||
59639577|NCT02500602|75755632|FG001|COMPLETED|Treatment Phase||69||
59639578|NCT02500602|75755631|FG000|NOT COMPLETED|Treatment Phase||6||
59639579|NCT02500602|75755632|FG001|NOT COMPLETED|Treatment Phase||1||
59639580|NCT02500602|75755631|FG000|STARTED|Follow Up Phase||68||
59639581|NCT02500602|75755632|FG001|STARTED|Follow Up Phase||69||
59639582|NCT02500602|75755631|FG000|COMPLETED|Follow Up Phase||53||
59639583|NCT02500602|75755632|FG001|COMPLETED|Follow Up Phase||47||
59639584|NCT02500602|75755631|FG000|NOT COMPLETED|Follow Up Phase||15||
59639585|NCT02500602|75755632|FG001|NOT COMPLETED|Follow Up Phase||22||
59639586|NCT02500836|75755643|FG000|STARTED|Overall Study||259||
59639587|NCT02500836|75755644|FG001|STARTED|Overall Study||259||
59639588|NCT02500836|75755645|FG002|STARTED|Overall Study||128||
59639589|NCT02500836|75755643|FG000|COMPLETED|Overall Study||256||
59639590|NCT02500836|75755644|FG001|COMPLETED|Overall Study||254||
59639591|NCT02500836|75755645|FG002|COMPLETED|Overall Study||127||
59639592|NCT02500836|75755643|FG000|NOT COMPLETED|Overall Study||3||
59639593|NCT02500836|75755644|FG001|NOT COMPLETED|Overall Study||5||
59639594|NCT02500836|75755645|FG002|NOT COMPLETED|Overall Study||1||
59639595|NCT02503410|75755655|FG000|STARTED|Overall Study||4||
59639596|NCT02503410|75755656|FG001|STARTED|Overall Study||3||
59639597|NCT02503410|75755655|FG000|COMPLETED|Overall Study||4||
59639598|NCT02503410|75755656|FG001|COMPLETED|Overall Study||3||
59639599|NCT02503410|75755655|FG000|NOT COMPLETED|Overall Study||0||
59639600|NCT02503410|75755656|FG001|NOT COMPLETED|Overall Study||0||
59639601|NCT02507388|75755669|FG000|STARTED|Overall Study||25||
59639602|NCT02507388|75755670|FG001|STARTED|Overall Study||25||
59639603|NCT02507388|75755669|FG000|COMPLETED|Overall Study||25||
59639604|NCT02507388|75755670|FG001|COMPLETED|Overall Study||25||
59639605|NCT02507388|75755669|FG000|NOT COMPLETED|Overall Study||0||
59988481|NCT02516306|76103651|FG000|STARTED|Period 2: Day 8 - 91||50||
59988482|NCT02516306|76103652|FG001|STARTED|Period 2: Day 8 - 91||25||
59988483|NCT02516306|76103651|FG000|COMPLETED|Period 2: Day 8 - 91||49||
59988484|NCT02516306|76103652|FG001|COMPLETED|Period 2: Day 8 - 91||23||
59639606|NCT02507388|75755670|FG001|NOT COMPLETED|Overall Study||0||
59639607|NCT02508480|75755679|FG000|STARTED|Overall Study||95||
59639608|NCT02508480|75755680|FG001|STARTED|Overall Study||97||
59639609|NCT02508480|75755679|FG000|Post-Treatment Assessment|Overall Study||87|Participants who completed assessment after the 10-week photovoice intervention|
59639610|NCT02508480|75755680|FG001|Post-Treatment Assessment|Overall Study||89|Participants who completed assessment after the 10-week photovoice intervention|
59639611|NCT02508480|75755679|FG000|Three Month Follow-up|Overall Study||84|Participants who completed the 3-month post-intervention follow-up|
59639612|NCT02508480|75755680|FG001|Three Month Follow-up|Overall Study||86|Participants who completed the 3-month post-intervention follow-up|
59639613|NCT02508480|75755679|FG000|Six-Month Follow-Up|Overall Study||84|Participants who completed the 6-month post-intervention follow-up|
59639614|NCT02508480|75755680|FG001|Six-Month Follow-Up|Overall Study||86|Participants who completed the 6-month post-intervention follow-up|
59639615|NCT02508480|75755679|FG000|COMPLETED|Overall Study||90|Participants who completed at least one post-baseline assessment over the study period.|
59639616|NCT02508480|75755680|FG001|COMPLETED|Overall Study||93|Participants who completed at least one post-baseline assessment over the study period.|
59639617|NCT02508480|75755679|FG000|NOT COMPLETED|Overall Study||5||
59639618|NCT02508480|75755680|FG001|NOT COMPLETED|Overall Study||4||
59639619|NCT02508636|75755686|FG000|STARTED|Overall Study||11||
59639620|NCT02508636|75755686|FG000|COMPLETED|Overall Study||11||
59639621|NCT02508636|75755686|FG000|NOT COMPLETED|Overall Study||0||
59639622|NCT02512224|75755692|FG000|STARTED|Overall Study||2912||
59639623|NCT02512224|75755693|FG001|STARTED|Overall Study||2912||
59988485|NCT02516306|76103651|FG000|NOT COMPLETED|Period 2: Day 8 - 91||1||
59639624|NCT02512224|75755692|FG000|COMPLETED|Overall Study||2912||
59639625|NCT02512224|75755693|FG001|COMPLETED|Overall Study||2912||
59639626|NCT02512224|75755692|FG000|NOT COMPLETED|Overall Study||0||
59639627|NCT02512224|75755693|FG001|NOT COMPLETED|Overall Study||0||
59639628|NCT02513940|75755699|FG000|STARTED|Overall Study|This was a crossover study, with a total n=14. All 14 subjects completed each phase of the study|2||
59639629|NCT02513940|75755700|FG001|STARTED|Overall Study||3||
59639630|NCT02513940|75755701|FG002|STARTED|Overall Study||2||
59639631|NCT02513940|75755702|FG003|STARTED|Overall Study||2||
59639632|NCT02513940|75755703|FG004|STARTED|Overall Study||2||
59639633|NCT02513940|75755704|FG005|STARTED|Overall Study||3||
59639634|NCT02513940|75755699|FG000|COMPLETED|Overall Study||2||
59639635|NCT02513940|75755700|FG001|COMPLETED|Overall Study||3||
59639636|NCT02513940|75755701|FG002|COMPLETED|Overall Study||2||
59639637|NCT02513940|75755702|FG003|COMPLETED|Overall Study||2||
59639638|NCT02513940|75755703|FG004|COMPLETED|Overall Study||2||
59639639|NCT02513940|75755704|FG005|COMPLETED|Overall Study||3||
59639640|NCT02513940|75755699|FG000|NOT COMPLETED|Overall Study||0||
59639641|NCT02513940|75755700|FG001|NOT COMPLETED|Overall Study||0||
59639642|NCT02513940|75755701|FG002|NOT COMPLETED|Overall Study||0||
59639643|NCT02513940|75755702|FG003|NOT COMPLETED|Overall Study||0||
59639644|NCT02513940|75755703|FG004|NOT COMPLETED|Overall Study||0||
59639645|NCT02513940|75755704|FG005|NOT COMPLETED|Overall Study||0||
59639646|NCT02515656|75755716|FG000|STARTED|Overall Study||326||
59639647|NCT02515656|75755717|FG001|STARTED|Overall Study||332||
59639648|NCT02515656|75755716|FG000|Full Analysis Set (FAS)|Overall Study||302||
59639649|NCT02515656|75755717|FG001|Full Analysis Set (FAS)|Overall Study||309||
59639650|NCT02515656|75755716|FG000|Per Protocol Set (PPS)|Overall Study||277||
59639651|NCT02515656|75755717|FG001|Per Protocol Set (PPS)|Overall Study||275||
59639652|NCT02515656|75755716|FG000|Safety Population|Overall Study||325||
59639653|NCT02515656|75755717|FG001|Safety Population|Overall Study||328||
59639654|NCT02515656|75755716|FG000|COMPLETED|Overall Study||270||
59639655|NCT02515656|75755717|FG001|COMPLETED|Overall Study||261||
59639656|NCT02515656|75755716|FG000|NOT COMPLETED|Overall Study||56||
59639657|NCT02515656|75755717|FG001|NOT COMPLETED|Overall Study||71||
59639658|NCT02515890|75755728|FG000|STARTED|Overall Study||7||
59639659|NCT02515890|75755729|FG001|STARTED|Overall Study||4||
59639660|NCT02515890|75755730|FG002|STARTED|Overall Study||5||
59639661|NCT02515890|75755731|FG003|STARTED|Overall Study||8||
59639662|NCT02515890|75755732|FG004|STARTED|Overall Study||8||
59639663|NCT02515890|75755728|FG000|COMPLETED|Overall Study||7||
59639664|NCT02515890|75755729|FG001|COMPLETED|Overall Study||4||
59639665|NCT02515890|75755730|FG002|COMPLETED|Overall Study||5||
59639666|NCT02515890|75755731|FG003|COMPLETED|Overall Study||8||
59639667|NCT02515890|75755732|FG004|COMPLETED|Overall Study||8||
59639668|NCT02515890|75755728|FG000|NOT COMPLETED|Overall Study||0||
59639669|NCT02515890|75755729|FG001|NOT COMPLETED|Overall Study||0||
59639670|NCT02515890|75755730|FG002|NOT COMPLETED|Overall Study||0||
59639671|NCT02515890|75755731|FG003|NOT COMPLETED|Overall Study||0||
59639672|NCT02515890|75755732|FG004|NOT COMPLETED|Overall Study||0||
59639673|NCT02516046|75755743|FG000|STARTED|Overall Study|Total number of subjects scanned|156||
59639674|NCT02516046|75755743|FG000|Died While on Study|Overall Study||73||
59639675|NCT02516046|75755743|FG000|Valid Autopsy Results and PET Scan|Overall Study|includes 3 front-runners|67||
59639676|NCT02516046|75755743|FG000|COMPLETED|Overall Study|Completed = included in autopsy cohort|64||
59639677|NCT02516046|75755743|FG000|NOT COMPLETED|Overall Study||92||
59639678|NCT02517996|75755759|FG000|STARTED|Overall Study||8||
59639679|NCT02517996|75755760|FG001|STARTED|Overall Study||9||
59639680|NCT02517996|75755759|FG000|COMPLETED|Overall Study||8||
59639681|NCT02517996|75755760|FG001|COMPLETED|Overall Study||9||
59639682|NCT02517996|75755759|FG000|NOT COMPLETED|Overall Study||0||
59639683|NCT02517996|75755760|FG001|NOT COMPLETED|Overall Study||0||
59639684|NCT02518230|75755768|FG000|STARTED|Overall Study||11||
59639685|NCT02518230|75755769|FG001|STARTED|Overall Study||11||
59639686|NCT02518230|75755768|FG000|COMPLETED|Overall Study||11||
59639687|NCT02518230|75755769|FG001|COMPLETED|Overall Study||11||
59639688|NCT02518230|75755768|FG000|NOT COMPLETED|Overall Study||0||
59815739|NCT03233724|75938195|FG002|NOT COMPLETED|Phase II Dose Expansion||0||
59815740|NCT03233724|75938196|FG003|NOT COMPLETED|Phase II Dose Expansion||0||
59815741|NCT03233724|75938197|FG004|NOT COMPLETED|Phase II Dose Expansion||0||
59639689|NCT02518230|75755769|FG001|NOT COMPLETED|Overall Study||0||
59639690|NCT02519244|75755776|FG000|STARTED|Overall Study||10||
59639691|NCT02519244|75755776|FG000|COMPLETED|Overall Study||10||
59988486|NCT02516306|76103652|FG001|NOT COMPLETED|Period 2: Day 8 - 91||2||
59988487|NCT02516228|76103658|FG000|STARTED|Overall Study||6||
59639692|NCT02519244|75755776|FG000|NOT COMPLETED|Overall Study||0||
59639693|NCT02520414|75755780|FG000|STARTED|Overall Study||10||
59639694|NCT02520414|75755780|FG000|COMPLETED|Overall Study||10||
59639695|NCT02520414|75755780|FG000|NOT COMPLETED|Overall Study||0||
59639696|NCT02521974|75755786|FG000|STARTED|Overall Study||50||
59639697|NCT02521974|75755787|FG001|STARTED|Overall Study||114||
59639698|NCT02521974|75755786|FG000|COMPLETED|Overall Study||47||
59639699|NCT02521974|75755787|FG001|COMPLETED|Overall Study||110||
59639700|NCT02521974|75755786|FG000|NOT COMPLETED|Overall Study||3||
59639701|NCT02521974|75755787|FG001|NOT COMPLETED|Overall Study||4||
59639702|NCT02522442|75755796|FG000|STARTED|Overall Study||26||
59639703|NCT02522442|75755797|FG001|STARTED|Overall Study||22||
59639704|NCT02522442|75755796|FG000|COMPLETED|Overall Study||26||
59639705|NCT02522442|75755797|FG001|COMPLETED|Overall Study||22||
59639706|NCT02522442|75755796|FG000|NOT COMPLETED|Overall Study||0||
59639707|NCT02522442|75755797|FG001|NOT COMPLETED|Overall Study||0||
59639708|NCT02523690|75755805|FG000|STARTED|Overall Study||3||
59639709|NCT02523690|75755806|FG001|STARTED|Overall Study||2||
59639710|NCT02523690|75755805|FG000|COMPLETED|Overall Study||3||
59639711|NCT02523690|75755806|FG001|COMPLETED|Overall Study||2||
59639712|NCT02523690|75755805|FG000|NOT COMPLETED|Overall Study||0||
59639713|NCT02523690|75755806|FG001|NOT COMPLETED|Overall Study||0||
59639714|NCT02523924|75755812|FG000|STARTED|Overall Study||31||
59639715|NCT02523924|75755812|FG000|COMPLETED|Overall Study||31||
59639716|NCT02523924|75755812|FG000|NOT COMPLETED|Overall Study||0||
59639717|NCT02525718|75755818|FG000|STARTED|Overall Study||23||
59639718|NCT02525718|75755819|FG001|STARTED|Overall Study||24||
59639719|NCT02525718|75755818|FG000|COMPLETED|Overall Study||22||
59639720|NCT02525718|75755819|FG001|COMPLETED|Overall Study||23||
59639721|NCT02525718|75755818|FG000|NOT COMPLETED|Overall Study||1||
59639722|NCT02525718|75755819|FG001|NOT COMPLETED|Overall Study||1||
59639723|NCT02526654|75755827|FG000|STARTED|Overall Study||79||
59639724|NCT02526654|75755828|FG001|STARTED|Overall Study||36||
59639725|NCT02526654|75755827|FG000|COMPLETED|Overall Study||79||
59639726|NCT02526654|75755828|FG001|COMPLETED|Overall Study||36||
59639727|NCT02526654|75755827|FG000|NOT COMPLETED|Overall Study||0||
59639728|NCT02526654|75755828|FG001|NOT COMPLETED|Overall Study||0||
59639729|NCT02527512|75755839|FG000|STARTED|Overall Study||85||
59639730|NCT02527512|75755840|FG001|STARTED|Overall Study||82||
59639731|NCT02527512|75755839|FG000|COMPLETED|Overall Study||77||
59639732|NCT02527512|75755840|FG001|COMPLETED|Overall Study||76||
59639733|NCT02527512|75755839|FG000|NOT COMPLETED|Overall Study||8||
59639734|NCT02527512|75755840|FG001|NOT COMPLETED|Overall Study||6||
59639735|NCT02528370|75755852|FG000|STARTED|Overall Study||119||
59639736|NCT02528370|75755853|FG001|STARTED|Overall Study||78||
59639737|NCT02528370|75755852|FG000|COMPLETED|Overall Study||102||
59639738|NCT02528370|75755853|FG001|COMPLETED|Overall Study||77||
59639739|NCT02528370|75755852|FG000|NOT COMPLETED|Overall Study||17||
59639740|NCT02528370|75755853|FG001|NOT COMPLETED|Overall Study||1||
59639741|NCT02529072|75755861|FG000|STARTED|Overall Study||3||
59639742|NCT02529072|75755862|FG001|STARTED|Overall Study||3||
59639743|NCT02529072|75755861|FG000|COMPLETED|Overall Study||3||
59639744|NCT02529072|75755862|FG001|COMPLETED|Overall Study||3||
59639745|NCT02529072|75755861|FG000|NOT COMPLETED|Overall Study||0||
59639746|NCT02529072|75755862|FG001|NOT COMPLETED|Overall Study||0||
59639747|NCT02530476|75755872|FG000|STARTED|Overall Study||4||
59639748|NCT02530476|75755873|FG001|STARTED|Overall Study||3||
59639749|NCT02530476|75755874|FG002|STARTED|Overall Study||7||
59639750|NCT02530476|75755875|FG003|STARTED|Overall Study||3||
59639751|NCT02530476|75755872|FG000|COMPLETED|Overall Study||4||
59639752|NCT02530476|75755873|FG001|COMPLETED|Overall Study||3||
60076672|NCT01903837|76191656|FG000|STARTED|Part B||54|The number of subjects starting the period is not consistent with the number completing the preceding period. It is expected the number of subjects starting the subsequent period will be the same as the number completing the preceding period. This is because 3 subjects discontinued the study after completing Part A, and did not participate in Part B.|
60103609|NCT01291108|76221866|FG003|COMPLETED|Month 1 (Monotherapy)|All patients who completed Month 1 were randomized to adjunctive therapy for Month 2.|60||
60103610|NCT01291108|76221867|FG004|COMPLETED|Month 1 (Monotherapy)||0||
59639753|NCT02530476|75755874|FG002|COMPLETED|Overall Study||7||
59639754|NCT02530476|75755875|FG003|COMPLETED|Overall Study||3||
59639755|NCT02530476|75755872|FG000|NOT COMPLETED|Overall Study||0||
59639756|NCT02530476|75755873|FG001|NOT COMPLETED|Overall Study||0||
59639757|NCT02530476|75755874|FG002|NOT COMPLETED|Overall Study||0||
59639758|NCT02530476|75755875|FG003|NOT COMPLETED|Overall Study||0||
59639759|NCT02530554|75755885|FG000|STARTED|Overall Study||12|14 total participants,12 treated on all 4 sites & 2 treated on 2 sites with both interventions.|12
59639760|NCT02530554|75755886|FG001|STARTED|Overall Study||14|14 total participants,12 treated on all 4 sites & 2 treated on 2 sites with both interventions.|14
59639761|NCT02530554|75755887|FG002|STARTED|Overall Study||12|14 total participants,12 treated on all 4 sites & 2 treated on 2 sites with both interventions.|12
59639762|NCT02530554|75755888|FG003|STARTED|Overall Study||14|14 total participants,12 treated on all 4 sites & 2 treated on 2 sites with both interventions.|14
60103611|NCT01291108|76221868|FG005|COMPLETED|Month 1 (Monotherapy)||0||
59639763|NCT02530554|75755885|FG000|COMPLETED|Overall Study||12||12
59639764|NCT02530554|75755886|FG001|COMPLETED|Overall Study||14||14
59639765|NCT02530554|75755887|FG002|COMPLETED|Overall Study||12||12
59639766|NCT02530554|75755888|FG003|COMPLETED|Overall Study||14||14
59639767|NCT02530554|75755885|FG000|NOT COMPLETED|Overall Study||0||0
59639768|NCT02530554|75755886|FG001|NOT COMPLETED|Overall Study||0||0
59639769|NCT02530554|75755887|FG002|NOT COMPLETED|Overall Study||0||0
59639770|NCT02530554|75755888|FG003|NOT COMPLETED|Overall Study||0||0
59639771|NCT02531022|75755897|FG000|STARTED|Overall Study||55||
59639772|NCT02531022|75755898|FG001|STARTED|Overall Study||50||
59639773|NCT02531022|75755897|FG000|COMPLETED|Overall Study||55||
59639774|NCT02531022|75755898|FG001|COMPLETED|Overall Study||48||
59639775|NCT02531022|75755897|FG000|NOT COMPLETED|Overall Study||0||
59639776|NCT02531022|75755898|FG001|NOT COMPLETED|Overall Study||2||
59639777|NCT02532036|75755904|FG000|STARTED|Overall Study||2||
59639778|NCT02532036|75755905|FG001|STARTED|Overall Study||0||
59639779|NCT02532036|75755904|FG000|COMPLETED|Overall Study||2||
59639780|NCT02532036|75755905|FG001|COMPLETED|Overall Study||0||
59639781|NCT02532036|75755904|FG000|NOT COMPLETED|Overall Study||0||
59639782|NCT02532036|75755905|FG001|NOT COMPLETED|Overall Study||0||
59639783|NCT02536248|75755911|FG000|STARTED|First Intervention (6 Weeks)||10||
59639784|NCT02536248|75755912|FG001|STARTED|First Intervention (6 Weeks)||10||
59639785|NCT02536248|75755911|FG000|COMPLETED|First Intervention (6 Weeks)||10||
59639786|NCT02536248|75755912|FG001|COMPLETED|First Intervention (6 Weeks)||10||
59639787|NCT02536248|75755911|FG000|NOT COMPLETED|First Intervention (6 Weeks)||0||
59639788|NCT02536248|75755912|FG001|NOT COMPLETED|First Intervention (6 Weeks)||0||
59639789|NCT02536248|75755911|FG000|STARTED|Wash-out (14 Days)||10||
59639790|NCT02536248|75755912|FG001|STARTED|Wash-out (14 Days)||10||
59639791|NCT02536248|75755911|FG000|COMPLETED|Wash-out (14 Days)||10||
59639792|NCT02536248|75755912|FG001|COMPLETED|Wash-out (14 Days)||10||
59639793|NCT02536248|75755911|FG000|NOT COMPLETED|Wash-out (14 Days)||0||
59639794|NCT02536248|75755912|FG001|NOT COMPLETED|Wash-out (14 Days)||0||
59639795|NCT02536248|75755911|FG000|STARTED|Second Intervention (6 Weeks)||10||
59541443|NCT01550549|75639615|FG000|COMPLETED|Overall Study||151||
59541444|NCT01550549|75639615|FG000|NOT COMPLETED|Overall Study||0||
59541445|NCT01448447|75639627|FG000|STARTED|Overall Study||20||
59541446|NCT01448447|75639628|FG001|STARTED|Overall Study||0||
59541447|NCT01448447|75639627|FG000|COMPLETED|Overall Study||20||
59639796|NCT02536248|75755912|FG001|STARTED|Second Intervention (6 Weeks)||10||
59639797|NCT02536248|75755911|FG000|COMPLETED|Second Intervention (6 Weeks)||10||
59639798|NCT02536248|75755912|FG001|COMPLETED|Second Intervention (6 Weeks)||10||
59639799|NCT02536248|75755911|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0||
59639800|NCT02536248|75755912|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||0||
59639801|NCT02537730|75755918|FG000|STARTED|First Intervention (7 Days)||17||
59639802|NCT02537730|75755919|FG001|STARTED|First Intervention (7 Days)||16||
59639803|NCT02537730|75755918|FG000|COMPLETED|First Intervention (7 Days)||17||
59639804|NCT02537730|75755919|FG001|COMPLETED|First Intervention (7 Days)||16||
59639805|NCT02537730|75755918|FG000|NOT COMPLETED|First Intervention (7 Days)||0||
59639806|NCT02537730|75755919|FG001|NOT COMPLETED|First Intervention (7 Days)||0||
59639807|NCT02537730|75755918|FG000|STARTED|Second Intervention (7 Days)||17||
59639808|NCT02537730|75755919|FG001|STARTED|Second Intervention (7 Days)||16||
59639809|NCT02537730|75755918|FG000|COMPLETED|Second Intervention (7 Days)||17||
59639810|NCT02537730|75755919|FG001|COMPLETED|Second Intervention (7 Days)||16||
59639811|NCT02537730|75755918|FG000|NOT COMPLETED|Second Intervention (7 Days)||0||
59639812|NCT02537730|75755919|FG001|NOT COMPLETED|Second Intervention (7 Days)||0||
59639813|NCT02538042|75755927|FG000|STARTED|Overall Study||17||
59639814|NCT02538042|75755928|FG001|STARTED|Overall Study||17||
59639815|NCT02538042|75755927|FG000|Completed All MCE Sessions|Overall Study||15||
59639816|NCT02538042|75755928|FG001|Completed All MCE Sessions|Overall Study||15||
59639817|NCT02538042|75755927|FG000|Attended Post-Quit Visit|Overall Study||15||
59639818|NCT02538042|75755928|FG001|Attended Post-Quit Visit|Overall Study||14||
59639819|NCT02538042|75755927|FG000|Completed All Post-Quit Visits|Overall Study||12||
59639820|NCT02538042|75755928|FG001|Completed All Post-Quit Visits|Overall Study||12||
59639821|NCT02538042|75755927|FG000|COMPLETED|Overall Study||6||
59639822|NCT02538042|75755928|FG001|COMPLETED|Overall Study||6||
59639823|NCT02538042|75755927|FG000|NOT COMPLETED|Overall Study||11||
59639824|NCT02538042|75755928|FG001|NOT COMPLETED|Overall Study||11||
59639825|NCT02538354|75755938|FG000|STARTED|Overall Study||40||
59639826|NCT02538354|75755939|FG001|STARTED|Overall Study||30||
59639827|NCT02538354|75755938|FG000|COMPLETED|Overall Study||40||
59541448|NCT01448447|75639628|FG001|COMPLETED|Overall Study||0||
59541449|NCT01448447|75639627|FG000|NOT COMPLETED|Overall Study||0||
59541450|NCT01448447|75639628|FG001|NOT COMPLETED|Overall Study||0||
59541451|NCT02214017|75639636|FG000|STARTED|Overall Study||22||
59541452|NCT02214017|75639637|FG001|STARTED|Overall Study||18||
59541453|NCT02214017|75639636|FG000|COMPLETED|Overall Study||22||
59541454|NCT02214017|75639637|FG001|COMPLETED|Overall Study||18||
59541455|NCT02214017|75639636|FG000|NOT COMPLETED|Overall Study||0||
59541456|NCT02214017|75639637|FG001|NOT COMPLETED|Overall Study||0||
59541457|NCT01550705|75639643|FG000|STARTED|Overall Study||11||
59541458|NCT01550705|75639643|FG000|COMPLETED|Overall Study||10||
59541459|NCT01550705|75639643|FG000|NOT COMPLETED|Overall Study||1||
59541460|NCT01531439|75639649|FG000|STARTED|Overall Study||41||
59541461|NCT01531439|75639650|FG001|STARTED|Overall Study||43||
59639828|NCT02538354|75755939|FG001|COMPLETED|Overall Study||30||
59639829|NCT02538354|75755938|FG000|NOT COMPLETED|Overall Study||0||
59639830|NCT02538354|75755939|FG001|NOT COMPLETED|Overall Study||0||
59639831|NCT02539992|75755948|FG000|STARTED|Overall Study||15||
59639832|NCT02539992|75755949|FG001|STARTED|Overall Study||11||
59639833|NCT02539992|75755950|FG002|STARTED|Overall Study||18||
59639834|NCT02539992|75755948|FG000|COMPLETED|Overall Study||15||
59639835|NCT02539992|75755949|FG001|COMPLETED|Overall Study||7||
59639836|NCT02539992|75755950|FG002|COMPLETED|Overall Study||14||
59639837|NCT02539992|75755948|FG000|NOT COMPLETED|Overall Study||0||
59639838|NCT02539992|75755949|FG001|NOT COMPLETED|Overall Study||4||
59639839|NCT02539992|75755950|FG002|NOT COMPLETED|Overall Study||4||
59639840|NCT02540226|75755962|FG000|STARTED|Overall Study||33||
59639841|NCT02540226|75755963|FG001|STARTED|Overall Study||33||
59639842|NCT02540226|75755962|FG000|COMPLETED|Overall Study||31||
59639843|NCT02540226|75755963|FG001|COMPLETED|Overall Study||32||
59639844|NCT02540226|75755962|FG000|NOT COMPLETED|Overall Study||2||
59639845|NCT02540226|75755963|FG001|NOT COMPLETED|Overall Study||1||
59639846|NCT02540772|75755971|FG000|STARTED|Overall Study||10||
59639847|NCT02540772|75755972|FG001|STARTED|Overall Study||10||
59639848|NCT02540772|75755971|FG000|COMPLETED|Overall Study||10||
59639849|NCT02540772|75755972|FG001|COMPLETED|Overall Study||10||
59639850|NCT02540772|75755971|FG000|NOT COMPLETED|Overall Study||0||
59639851|NCT02540772|75755972|FG001|NOT COMPLETED|Overall Study||0||
59639852|NCT02541864|75755980|FG000|STARTED|Overall Study||164||
59639853|NCT02541864|75755981|FG001|STARTED|Overall Study||166||
59639854|NCT02541864|75755980|FG000|COMPLETED|Overall Study||164||
59639855|NCT02541864|75755981|FG001|COMPLETED|Overall Study||166||
59639856|NCT02541864|75755980|FG000|NOT COMPLETED|Overall Study||0||
59639857|NCT02541864|75755981|FG001|NOT COMPLETED|Overall Study||0||
59639858|NCT02541942|75755987|FG000|STARTED|Overall Study||19||
59639859|NCT02541942|75755987|FG000|COMPLETED|Overall Study||19||
59639860|NCT02541942|75755987|FG000|NOT COMPLETED|Overall Study||0||
59639861|NCT02542410|75755993|FG000|STARTED|Overall Study||5||
59639862|NCT02542410|75755994|FG001|STARTED|Overall Study||5||
59639863|NCT02542410|75755993|FG000|COMPLETED|Overall Study||3||
59639864|NCT02542410|75755994|FG001|COMPLETED|Overall Study||4||
59639865|NCT02542410|75755993|FG000|NOT COMPLETED|Overall Study||2||
59639866|NCT02542410|75755994|FG001|NOT COMPLETED|Overall Study||1||
59639867|NCT02544984|75756002|FG000|STARTED|Overall Study||30||
59639868|NCT02544984|75756003|FG001|STARTED|Overall Study||30||
59639869|NCT02544984|75756002|FG000|COMPLETED|Overall Study||28||
59639870|NCT02544984|75756003|FG001|COMPLETED|Overall Study||28||
59639871|NCT02544984|75756002|FG000|NOT COMPLETED|Overall Study||2||
59639872|NCT02544984|75756003|FG001|NOT COMPLETED|Overall Study||2||
59639873|NCT02546388|75756011|FG000|STARTED|Overall Study||4||
59639874|NCT02546388|75756012|FG001|STARTED|Overall Study||13||
59639875|NCT02546388|75756011|FG000|COMPLETED|Overall Study||4||
59639876|NCT02546388|75756012|FG001|COMPLETED|Overall Study||13||
59639877|NCT02546388|75756011|FG000|NOT COMPLETED|Overall Study||0||
59639878|NCT02546388|75756012|FG001|NOT COMPLETED|Overall Study||0||
59639879|NCT02547012|75756021|FG000|STARTED|Overall Study||24||
59639880|NCT02547012|75756022|FG001|STARTED|Overall Study||27||
59639881|NCT02547012|75756021|FG000|COMPLETED|Overall Study||24||
59639882|NCT02547012|75756022|FG001|COMPLETED|Overall Study||27||
59639883|NCT02547012|75756021|FG000|NOT COMPLETED|Overall Study||0||
59639884|NCT02547012|75756022|FG001|NOT COMPLETED|Overall Study||0||
59639885|NCT02547714|75756028|FG000|STARTED|Overall Study||34||
59639886|NCT02547714|75756028|FG000|COMPLETED|Overall Study||34||
59639887|NCT02547714|75756028|FG000|NOT COMPLETED|Overall Study||0||
59639888|NCT02548728|75756035|FG000|STARTED|Overall Study||6||
59639889|NCT02548728|75756036|FG001|STARTED|Overall Study||6||
59639890|NCT02548728|75756035|FG000|COMPLETED|Overall Study||6||
59639891|NCT02548728|75756036|FG001|COMPLETED|Overall Study||6||
59639892|NCT02548728|75756035|FG000|NOT COMPLETED|Overall Study||0||
59639893|NCT02548728|75756036|FG001|NOT COMPLETED|Overall Study||0||
59639894|NCT02549040|75756042|FG000|STARTED|Period 1||16||
59639895|NCT02549040|75756042|FG000|COMPLETED|Period 1||16||
59639896|NCT02549040|75756042|FG000|NOT COMPLETED|Period 1||0||
59639897|NCT02549040|75756042|FG000|STARTED|Period 2||16||
59639898|NCT02549040|75756042|FG000|COMPLETED|Period 2||16||
59639899|NCT02549040|75756042|FG000|NOT COMPLETED|Period 2||0||
59639900|NCT02549040|75756042|FG000|STARTED|Period 3||16||
59639901|NCT02549040|75756042|FG000|COMPLETED|Period 3||16||
59639902|NCT02549040|75756042|FG000|NOT COMPLETED|Period 3||0||
59639903|NCT02549040|75756042|FG000|STARTED|Period 4||16||
59639904|NCT02549040|75756042|FG000|COMPLETED|Period 4||16||
59639905|NCT02549040|75756042|FG000|NOT COMPLETED|Period 4||0||
59639906|NCT02549040|75756042|FG000|STARTED|Period 5||16||
59639907|NCT02549040|75756042|FG000|COMPLETED|Period 5||16||
59639908|NCT02549040|75756042|FG000|NOT COMPLETED|Period 5||0||
59639909|NCT02549508|75756056|FG000|STARTED|Overall Study||47||
59639910|NCT02549508|75756057|FG001|STARTED|Overall Study||38||
59639911|NCT02549508|75756056|FG000|COMPLETED|Overall Study||33||
59639912|NCT02549508|75756057|FG001|COMPLETED|Overall Study||21||
59639913|NCT02549508|75756056|FG000|NOT COMPLETED|Overall Study||14||
59639914|NCT02549508|75756057|FG001|NOT COMPLETED|Overall Study||17||
59639915|NCT02550132|75756065|FG000|STARTED|Overall Study||25||
59639916|NCT02550132|75756065|FG000|COMPLETED|Overall Study||25||
59639917|NCT02550132|75756065|FG000|NOT COMPLETED|Overall Study||0||
59639918|NCT02550210|75756069|FG000|STARTED|Overall Study||23||
59639919|NCT02550210|75756069|FG000|COMPLETED|Overall Study||19||
59639920|NCT02550210|75756069|FG000|NOT COMPLETED|Overall Study||4||
59639921|NCT02551224|75756073|FG000|STARTED|First Intervention||50||
59639922|NCT02551224|75756074|FG001|STARTED|First Intervention||50||
59639923|NCT02551224|75756073|FG000|COMPLETED|First Intervention||50||
59639924|NCT02551224|75756074|FG001|COMPLETED|First Intervention||50||
59639925|NCT02551224|75756073|FG000|NOT COMPLETED|First Intervention||0||
59639926|NCT02551224|75756074|FG001|NOT COMPLETED|First Intervention||0||
59639927|NCT02551224|75756073|FG000|STARTED|Second Intervention (5 Min After First )||50||
59639928|NCT02551224|75756074|FG001|STARTED|Second Intervention (5 Min After First )||50||
59639929|NCT02551224|75756073|FG000|COMPLETED|Second Intervention (5 Min After First )||50||
59639930|NCT02551224|75756074|FG001|COMPLETED|Second Intervention (5 Min After First )||50||
59639931|NCT02551224|75756073|FG000|NOT COMPLETED|Second Intervention (5 Min After First )||0||
59639932|NCT02551224|75756074|FG001|NOT COMPLETED|Second Intervention (5 Min After First )||0||
59639933|NCT02551770|75756080|FG000|STARTED|Overall Study||51||167
59639934|NCT02551770|75756081|FG001|STARTED|Overall Study||51||170
59639935|NCT02551770|75756080|FG000|COMPLETED|Overall Study||48||162
59639936|NCT02551770|75756081|FG001|COMPLETED|Overall Study||48||162
59639937|NCT02551770|75756080|FG000|NOT COMPLETED|Overall Study||3||5
59639938|NCT02551770|75756081|FG001|NOT COMPLETED|Overall Study||3||8
59639939|NCT02553798|75756086|FG000|STARTED|Overall Study||564||
59639940|NCT02553798|75756086|FG000|COMPLETED|Overall Study||226||
59639941|NCT02553798|75756086|FG000|NOT COMPLETED|Overall Study||338||
59639942|NCT02557698|75756092|FG000|STARTED|Overall Study||30||
59639943|NCT02557698|75756093|FG001|STARTED|Overall Study||30||
59639944|NCT02557698|75756092|FG000|COMPLETED|Overall Study||30||
59639945|NCT02557698|75756093|FG001|COMPLETED|Overall Study||30||
59639946|NCT02557698|75756092|FG000|NOT COMPLETED|Overall Study||0||
59639947|NCT02557698|75756093|FG001|NOT COMPLETED|Overall Study||0||
59639948|NCT02560038|75756099|FG000|STARTED|Overall Study||3||
59639949|NCT02560038|75756099|FG000|COMPLETED|Overall Study||1||
59639950|NCT02560038|75756099|FG000|NOT COMPLETED|Overall Study||2||
59639951|NCT02560584|75756103|FG000|STARTED|Overall Study||304||
59639952|NCT02560584|75756103|FG000|COMPLETED|Overall Study||304||
59639953|NCT02560584|75756103|FG000|NOT COMPLETED|Overall Study||0||
59639954|NCT02561130|75756111|FG000|STARTED|Overall Study||77||
59639955|NCT02561130|75756112|FG001|STARTED|Overall Study||77||
59639956|NCT02561130|75756111|FG000|COMPLETED|Overall Study||76||
59639957|NCT02561130|75756112|FG001|COMPLETED|Overall Study||76||
59639958|NCT02561130|75756111|FG000|NOT COMPLETED|Overall Study||1||
59639959|NCT02561130|75756112|FG001|NOT COMPLETED|Overall Study||1||
59639960|NCT02562066|75756120|FG000|STARTED|Overall Study||8||
59639961|NCT02562066|75756121|FG001|STARTED|Overall Study||8||
59639962|NCT02562066|75756122|FG002|STARTED|Overall Study||4||
59639963|NCT02562066|75756120|FG000|COMPLETED|Overall Study||7||
59639964|NCT02562066|75756121|FG001|COMPLETED|Overall Study||7||
59639965|NCT02562066|75756122|FG002|COMPLETED|Overall Study||0||
59639966|NCT02562066|75756120|FG000|NOT COMPLETED|Overall Study||1||
59639967|NCT02562066|75756121|FG001|NOT COMPLETED|Overall Study||1||
59639968|NCT02562066|75756122|FG002|NOT COMPLETED|Overall Study||4||
59639969|NCT02562924|75756131|FG000|STARTED|Overall Study||13||
59639970|NCT02562924|75756132|FG001|STARTED|Overall Study||12||
59639971|NCT02562924|75756133|FG002|STARTED|Overall Study||12||
59639972|NCT02562924|75756131|FG000|COMPLETED|Overall Study||12||
59639973|NCT02562924|75756132|FG001|COMPLETED|Overall Study||1||
59639974|NCT02562924|75756133|FG002|COMPLETED|Overall Study||8||
59639975|NCT02562924|75756131|FG000|NOT COMPLETED|Overall Study||1||
59639976|NCT02562924|75756132|FG001|NOT COMPLETED|Overall Study||11||
59639977|NCT02562924|75756133|FG002|NOT COMPLETED|Overall Study||4||
59639978|NCT02563860|75756144|FG000|STARTED|Overall Study||20||
59639979|NCT02563860|75756144|FG000|COMPLETED|Overall Study||19||
59639980|NCT02563860|75756144|FG000|NOT COMPLETED|Overall Study||1||
59639981|NCT02564016|75756150|FG000|STARTED|Overall Study||22||
59639982|NCT02564016|75756151|FG001|STARTED|Overall Study||14||
59639983|NCT02564016|75756150|FG000|COMPLETED|Overall Study||4||
59639984|NCT02564016|75756151|FG001|COMPLETED|Overall Study||4||
59639985|NCT02564016|75756150|FG000|NOT COMPLETED|Overall Study||18||
59639986|NCT02564016|75756151|FG001|NOT COMPLETED|Overall Study||10||
59639987|NCT02566044|75756160|FG000|STARTED|Overall Study||6||
59639988|NCT02566044|75756161|FG001|STARTED|Overall Study||6||
59639989|NCT02566044|75756162|FG002|STARTED|Overall Study||4||
59639990|NCT02566044|75756160|FG000|COMPLETED|Overall Study||6||
59639991|NCT02566044|75756161|FG001|COMPLETED|Overall Study||6||
59639992|NCT02566044|75756162|FG002|COMPLETED|Overall Study||4||
59639993|NCT02566044|75756160|FG000|NOT COMPLETED|Overall Study||0||
59639994|NCT02566044|75756161|FG001|NOT COMPLETED|Overall Study||0||
59639995|NCT02566044|75756162|FG002|NOT COMPLETED|Overall Study||0||
59639996|NCT02566590|75756177|FG000|STARTED|Overall Study||10||
59639997|NCT02566590|75756178|FG001|STARTED|Overall Study||10||
59639998|NCT02566590|75756177|FG000|COMPLETED|Overall Study||10||
59639999|NCT02566590|75756178|FG001|COMPLETED|Overall Study||10||
59640000|NCT02566590|75756177|FG000|NOT COMPLETED|Overall Study||0||
59640001|NCT02566590|75756178|FG001|NOT COMPLETED|Overall Study||0||
59640002|NCT02568852|75756186|FG000|STARTED|Overall Study||25||
59640003|NCT02568852|75756187|FG001|STARTED|Overall Study||25||
59640004|NCT02568852|75756186|FG000|COMPLETED|Overall Study||25||
59640005|NCT02568852|75756187|FG001|COMPLETED|Overall Study||25||
59640006|NCT02568852|75756186|FG000|NOT COMPLETED|Overall Study||0||
59640007|NCT02568852|75756187|FG001|NOT COMPLETED|Overall Study||0||
59640008|NCT02569086|75756193|FG000|STARTED|Overall Study||22||
59640009|NCT02569086|75756193|FG000|COMPLETED|Overall Study||22||
59640010|NCT02569086|75756193|FG000|NOT COMPLETED|Overall Study||0||
59640011|NCT02569632|75756197|FG000|STARTED|Overall Study||18||
59640012|NCT02569632|75756197|FG000|COMPLETED|Overall Study||17||
59640013|NCT02569632|75756197|FG000|NOT COMPLETED|Overall Study||1||
59640014|NCT02570022|75756203|FG000|STARTED|Overall Study||26||
59640015|NCT02570022|75756204|FG001|STARTED|Overall Study||31||
59640016|NCT02570022|75756203|FG000|COMPLETED|Overall Study||26||
59640017|NCT02570022|75756204|FG001|COMPLETED|Overall Study||31||
59640018|NCT02570022|75756203|FG000|NOT COMPLETED|Overall Study||0||
59640019|NCT02570022|75756204|FG001|NOT COMPLETED|Overall Study||0||
59640020|NCT02572752|75756213|FG000|STARTED|Period 1 Including Washout||23||
59640021|NCT02572752|75756214|FG001|STARTED|Period 1 Including Washout||23||
59640022|NCT02572752|75756215|FG002|STARTED|Period 1 Including Washout||24||
59640023|NCT02572752|75756213|FG000|COMPLETED|Period 1 Including Washout||23||
59640024|NCT02572752|75756214|FG001|COMPLETED|Period 1 Including Washout||23||
59640025|NCT02572752|75756215|FG002|COMPLETED|Period 1 Including Washout||24||
59640026|NCT02572752|75756213|FG000|NOT COMPLETED|Period 1 Including Washout||0||
59640027|NCT02572752|75756214|FG001|NOT COMPLETED|Period 1 Including Washout||0||
59640028|NCT02572752|75756215|FG002|NOT COMPLETED|Period 1 Including Washout||0||
59640029|NCT02572752|75756213|FG000|STARTED|Period 2 Including Washout||23||
59640030|NCT02572752|75756214|FG001|STARTED|Period 2 Including Washout||23||
59640031|NCT02572752|75756215|FG002|STARTED|Period 2 Including Washout||24||
59640032|NCT02572752|75756213|FG000|COMPLETED|Period 2 Including Washout||23||
59640033|NCT02572752|75756214|FG001|COMPLETED|Period 2 Including Washout||23||
59640034|NCT02572752|75756215|FG002|COMPLETED|Period 2 Including Washout||24||
59640035|NCT02572752|75756213|FG000|NOT COMPLETED|Period 2 Including Washout||0||
59640036|NCT02572752|75756214|FG001|NOT COMPLETED|Period 2 Including Washout||0||
59640037|NCT02572752|75756215|FG002|NOT COMPLETED|Period 2 Including Washout||0||
59640038|NCT02572752|75756213|FG000|STARTED|Period 3 Including Washout||23||
59640039|NCT02572752|75756214|FG001|STARTED|Period 3 Including Washout||23||
59640040|NCT02572752|75756215|FG002|STARTED|Period 3 Including Washout||24||
59640041|NCT02572752|75756213|FG000|COMPLETED|Period 3 Including Washout||23||
59640042|NCT02572752|75756214|FG001|COMPLETED|Period 3 Including Washout||23||
59640043|NCT02572752|75756215|FG002|COMPLETED|Period 3 Including Washout||24||
59640044|NCT02572752|75756213|FG000|NOT COMPLETED|Period 3 Including Washout||0||
59640045|NCT02572752|75756214|FG001|NOT COMPLETED|Period 3 Including Washout||0||
59640046|NCT02572752|75756215|FG002|NOT COMPLETED|Period 3 Including Washout||0||
59640047|NCT02574858|75756222|FG000|STARTED|Overall Study||25||
59640048|NCT02574858|75756222|FG000|COMPLETED|Overall Study||25||
59640049|NCT02574858|75756222|FG000|NOT COMPLETED|Overall Study||0||
59640050|NCT02577042|75756228|FG000|STARTED|Overall Study||20||
59640051|NCT02577042|75756229|FG001|STARTED|Overall Study||22||
59640052|NCT02577042|75756228|FG000|COMPLETED|Overall Study||15||
59640053|NCT02577042|75756229|FG001|COMPLETED|Overall Study||19||
59640054|NCT02577042|75756228|FG000|NOT COMPLETED|Overall Study||5||
59640055|NCT02577042|75756229|FG001|NOT COMPLETED|Overall Study||3||
59640056|NCT02577510|75756236|FG000|STARTED|Overall Study||21||21
59640057|NCT02577510|75756237|FG001|STARTED|Overall Study||21||21
59640058|NCT02577510|75756236|FG000|COMPLETED|Overall Study||21||21
59640059|NCT02577510|75756237|FG001|COMPLETED|Overall Study||21||21
59640060|NCT02577510|75756236|FG000|NOT COMPLETED|Overall Study||0||0
59640061|NCT02577510|75756237|FG001|NOT COMPLETED|Overall Study||0||0
59640062|NCT02577822|75756248|FG000|STARTED|Overall Study||27||
59640063|NCT02577822|75756249|FG001|STARTED|Overall Study||33||
59640064|NCT02577822|75756248|FG000|COMPLETED|Overall Study||21||
59640065|NCT02577822|75756249|FG001|COMPLETED|Overall Study||20||
59988488|NCT02516228|76103658|FG000|COMPLETED|Overall Study||3||
59988489|NCT02516228|76103658|FG000|NOT COMPLETED|Overall Study||3||
59640066|NCT02577822|75756248|FG000|NOT COMPLETED|Overall Study||6||
59640067|NCT02577822|75756249|FG001|NOT COMPLETED|Overall Study||13||
59640068|NCT02577900|75756258|FG000|STARTED|Overall Study||11||
59640069|NCT02577900|75756259|FG001|STARTED|Overall Study||10||
59640070|NCT02577900|75756260|FG002|STARTED|Overall Study||10||
59995451|NCT02675114|76111277|FG001|STARTED|Overall Study||503||
59640071|NCT02577900|75756258|FG000|COMPLETED|Overall Study||11||
59640072|NCT02577900|75756259|FG001|COMPLETED|Overall Study||10||
59640073|NCT02577900|75756260|FG002|COMPLETED|Overall Study||10||
59640074|NCT02577900|75756258|FG000|NOT COMPLETED|Overall Study||0||
59640075|NCT02577900|75756259|FG001|NOT COMPLETED|Overall Study||0||
59640076|NCT02577900|75756260|FG002|NOT COMPLETED|Overall Study||0||
59640077|NCT02580318|75756268|FG000|STARTED|Overall Study||54||
59640078|NCT02580318|75756268|FG000|Poor Effort|Overall Study||53||
59640079|NCT02580318|75756268|FG000|Hyperventilation (Immediate)|Overall Study||54||
59640080|NCT02580318|75756268|FG000|Hyperventilation (5 Minutes)|Overall Study||54||
59640081|NCT02580318|75756268|FG000|Hyperventilation (10 Minutes)|Overall Study||54||
59640082|NCT02580318|75756268|FG000|Drinking Water (Immediate)|Overall Study||51||
59640083|NCT02580318|75756268|FG000|Drinking Water (5 Minutes)|Overall Study||54||
59640084|NCT02580318|75756268|FG000|COMPLETED|Overall Study||54||
59640085|NCT02580318|75756268|FG000|NOT COMPLETED|Overall Study||0||
59988490|NCT02519504|76103664|FG000|STARTED|Overall Study||319|Completed the initial online survey|
59988491|NCT02519504|76103665|FG001|STARTED|Overall Study||247|Completed the initial online survey|
59640086|NCT02582970|75756272|FG000|STARTED|Overall Study||40||
59640087|NCT02582970|75756272|FG000|COMPLETED|Overall Study||40||
59640088|NCT02582970|75756272|FG000|NOT COMPLETED|Overall Study||0||
59640089|NCT02583360|75756278|FG000|STARTED|Overall Study||60||
59640090|NCT02583360|75756279|FG001|STARTED|Overall Study||49||
59640091|NCT02583360|75756278|FG000|COMPLETED|Overall Study||60||
59640092|NCT02583360|75756279|FG001|COMPLETED|Overall Study||49||
59640093|NCT02583360|75756278|FG000|NOT COMPLETED|Overall Study||0||
59640094|NCT02583360|75756279|FG001|NOT COMPLETED|Overall Study||0||
59640095|NCT02584140|75756285|FG000|STARTED|Overall Study||136||
59640096|NCT02584140|75756285|FG000|COMPLETED|Overall Study||83||
59640097|NCT02584140|75756285|FG000|NOT COMPLETED|Overall Study||53||
59640098|NCT02584608|75756289|FG000|STARTED|Overall Study||12||
59640099|NCT02584608|75756289|FG000|COMPLETED|Overall Study||12||
59640100|NCT02584608|75756289|FG000|NOT COMPLETED|Overall Study||0||
59640101|NCT02584686|75756295|FG000|STARTED|Overall Study||12||
59640102|NCT02584686|75756296|FG001|STARTED|Overall Study||12||
59640103|NCT02584686|75756295|FG000|COMPLETED|Overall Study||12||
59640104|NCT02584686|75756296|FG001|COMPLETED|Overall Study||12||
59640105|NCT02584686|75756295|FG000|NOT COMPLETED|Overall Study||0||
59640106|NCT02584686|75756296|FG001|NOT COMPLETED|Overall Study||0||
59640107|NCT02584998|75756306|FG000|STARTED|Overall Study||260||
59640108|NCT02584998|75756307|FG001|STARTED|Overall Study||261||
59640109|NCT02584998|75756308|FG002|STARTED|Overall Study||261||
59640110|NCT02584998|75756306|FG000|COMPLETED|Overall Study||260||
59640111|NCT02584998|75756307|FG001|COMPLETED|Overall Study||261||
59640112|NCT02584998|75756308|FG002|COMPLETED|Overall Study||261||
59640113|NCT02584998|75756306|FG000|NOT COMPLETED|Overall Study||0||
59640114|NCT02584998|75756307|FG001|NOT COMPLETED|Overall Study||0||
59640115|NCT02584998|75756308|FG002|NOT COMPLETED|Overall Study||0||
59640116|NCT02585700|75756318|FG000|STARTED|Overall Study||30||
59640117|NCT02585700|75756319|FG001|STARTED|Overall Study||30||
59640118|NCT02585700|75756318|FG000|COMPLETED|Overall Study||30||
59640119|NCT02585700|75756319|FG001|COMPLETED|Overall Study||30||
59640120|NCT02585700|75756318|FG000|NOT COMPLETED|Overall Study||0||
59640121|NCT02585700|75756319|FG001|NOT COMPLETED|Overall Study||0||
59640122|NCT02588586|75756325|FG000|STARTED|Overall Study||17||
59640123|NCT02588586|75756325|FG000|COMPLETED|Overall Study||15||
59640124|NCT02588586|75756325|FG000|NOT COMPLETED|Overall Study||2||
59640125|NCT02588976|75756329|FG000|STARTED|Overall Study||30||
59640126|NCT02588976|75756329|FG000|COMPLETED|Overall Study||30||
59640127|NCT02588976|75756329|FG000|NOT COMPLETED|Overall Study||0||
59640128|NCT02592486|75756336|FG000|STARTED|Overall Study||81||
59640129|NCT02592486|75756337|FG001|STARTED|Overall Study||81||
59640130|NCT02592486|75756336|FG000|COMPLETED|Overall Study||81||
59640131|NCT02592486|75756337|FG001|COMPLETED|Overall Study||76||
59640132|NCT02592486|75756336|FG000|NOT COMPLETED|Overall Study||0||
59640133|NCT02592486|75756337|FG001|NOT COMPLETED|Overall Study||5||
59640134|NCT02593032|75756345|FG000|STARTED|Overall Study||17||
59640135|NCT02593032|75756346|FG001|STARTED|Overall Study||33||
59640136|NCT02593032|75756345|FG000|COMPLETED|Overall Study||17||
59640137|NCT02593032|75756346|FG001|COMPLETED|Overall Study||33||
59640138|NCT02593032|75756345|FG000|NOT COMPLETED|Overall Study||0||
59640139|NCT02593032|75756346|FG001|NOT COMPLETED|Overall Study||0||
59640140|NCT04087122|75756352|FG000|STARTED|Overall Study||20||
59640141|NCT04087122|75756352|FG000|COMPLETED|Overall Study||20||
59640142|NCT04087122|75756352|FG000|NOT COMPLETED|Overall Study||0||
59640143|NCT03084666|75756360|FG000|STARTED|Overall Study||20||
59640144|NCT03084666|75756361|FG001|STARTED|Overall Study||20||
59640145|NCT03084666|75756360|FG000|COMPLETED|Overall Study||20||
59988492|NCT02519504|76103664|FG000|Attended Direct Testing|Overall Study||212||
59640146|NCT03084666|75756361|FG001|COMPLETED|Overall Study||20||
59640147|NCT03084666|75756360|FG000|NOT COMPLETED|Overall Study||0||
59640148|NCT03084666|75756361|FG001|NOT COMPLETED|Overall Study||0||
59640149|NCT02594826|75756369|FG000|STARTED|Overall Study||347||
59988493|NCT02519504|76103665|FG001|Attended Direct Testing|Overall Study||149||
59988494|NCT02519504|76103664|FG000|COMPLETED|Overall Study||206|Had complete information from the direct testing visit.|
59640150|NCT02594826|75756370|FG001|STARTED|Overall Study||358||
59640151|NCT02594826|75756369|FG000|COMPLETED|Overall Study||290||
59640152|NCT02594826|75756370|FG001|COMPLETED|Overall Study||298||
59640153|NCT02594826|75756369|FG000|NOT COMPLETED|Overall Study||57||
59640154|NCT02594826|75756370|FG001|NOT COMPLETED|Overall Study||60||
59815742|NCT03209050|75938206|FG000|STARTED|Overall Study||30||
59640155|NCT02595684|75756378|FG000|STARTED|Overall Study||9||
59640156|NCT02595684|75756379|FG001|STARTED|Overall Study||9||
59640157|NCT02595684|75756378|FG000|COMPLETED|Overall Study||9||
59640158|NCT02595684|75756379|FG001|COMPLETED|Overall Study||9||
59640159|NCT02595684|75756378|FG000|NOT COMPLETED|Overall Study||0||
59640160|NCT02595684|75756379|FG001|NOT COMPLETED|Overall Study||0||
59640161|NCT02599194|75756385|FG000|STARTED|Overall Study||7||
59640162|NCT02599194|75756385|FG000|COMPLETED|Overall Study||7||
59640163|NCT02599194|75756385|FG000|NOT COMPLETED|Overall Study||0||
59640164|NCT02604810|75756391|FG000|STARTED|IGIV-C 10%, 4-5 Weeks||52||
59640165|NCT02604810|75756391|FG000|COMPLETED|IGIV-C 10%, 4-5 Weeks||49||
59640166|NCT02604810|75756391|FG000|NOT COMPLETED|IGIV-C 10%, 4-5 Weeks||3||
59640167|NCT02604810|75756391|FG000|STARTED|IGSC 20%, 24 Weeks||49||
59640168|NCT02604810|75756391|FG000|COMPLETED|IGSC 20%, 24 Weeks||42||
59640169|NCT02604810|75756391|FG000|NOT COMPLETED|IGSC 20%, 24 Weeks||7||
59640170|NCT02606604|75756399|FG000|STARTED|Overall Study||8||
59640171|NCT02606604|75756400|FG001|STARTED|Overall Study||7||
59640172|NCT02606604|75756399|FG000|COMPLETED|Overall Study||7||
59640173|NCT02606604|75756400|FG001|COMPLETED|Overall Study||7||
59640174|NCT02606604|75756399|FG000|NOT COMPLETED|Overall Study||1||
59640175|NCT02606604|75756400|FG001|NOT COMPLETED|Overall Study||0||
59640176|NCT02606838|75756408|FG000|STARTED|Overall Study||119||
59640177|NCT02606838|75756408|FG000|COMPLETED|Overall Study||119||
59640178|NCT02606838|75756408|FG000|NOT COMPLETED|Overall Study||0||
59640179|NCT02607618|75756418|FG000|STARTED|Overall Study||306||
59640180|NCT02607618|75756419|FG001|STARTED|Overall Study||307||
59640181|NCT02607618|75756418|FG000|COMPLETED|Overall Study||295||
59640182|NCT02607618|75756419|FG001|COMPLETED|Overall Study||305||
59640183|NCT02607618|75756418|FG000|NOT COMPLETED|Overall Study||11||
59640184|NCT02607618|75756419|FG001|NOT COMPLETED|Overall Study||2||
59640185|NCT02609100|75756427|FG000|STARTED|Overall Study||2||
59640186|NCT02609100|75756428|FG001|STARTED|Overall Study||2||
59640187|NCT02609100|75756427|FG000|COMPLETED|Overall Study||2||
59640188|NCT02609100|75756428|FG001|COMPLETED|Overall Study||2||
59640189|NCT02609100|75756427|FG000|NOT COMPLETED|Overall Study||0||
59640190|NCT02609100|75756428|FG001|NOT COMPLETED|Overall Study||0||
59640191|NCT02610972|75756438|FG000|STARTED|Overall Study||100||
59640192|NCT02610972|75756439|FG001|STARTED|Overall Study||50||
59640193|NCT02610972|75756438|FG000|COMPLETED|Overall Study||100||
59640194|NCT02610972|75756439|FG001|COMPLETED|Overall Study||50||
59640195|NCT02610972|75756438|FG000|NOT COMPLETED|Overall Study||0||
59640196|NCT02610972|75756439|FG001|NOT COMPLETED|Overall Study||0||
59640197|NCT02612688|75756447|FG000|STARTED|Overall Study||33035||
59640198|NCT02612688|75756448|FG001|STARTED|Overall Study||70013||
59640199|NCT02612688|75756447|FG000|COMPLETED|Overall Study||33035||
59640200|NCT02612688|75756448|FG001|COMPLETED|Overall Study||70013||
59640201|NCT02612688|75756447|FG000|NOT COMPLETED|Overall Study||0||
59640202|NCT02612688|75756448|FG001|NOT COMPLETED|Overall Study||0||
59640203|NCT03712410|75756460|FG000|STARTED|Overall Study||154||
59640204|NCT03712410|75756461|FG001|STARTED|Overall Study||152||
59640205|NCT03712410|75756462|FG002|STARTED|Overall Study||154||
59640206|NCT03712410|75756463|FG003|STARTED|Overall Study||63||
59640207|NCT03712410|75756460|FG000|COMPLETED|Overall Study||115||
59640208|NCT03712410|75756461|FG001|COMPLETED|Overall Study||106||
59640209|NCT03712410|75756462|FG002|COMPLETED|Overall Study||101||
59640210|NCT03712410|75756463|FG003|COMPLETED|Overall Study||46||
59640211|NCT03712410|75756460|FG000|NOT COMPLETED|Overall Study||39||
59640212|NCT03712410|75756461|FG001|NOT COMPLETED|Overall Study||46||
59640213|NCT03712410|75756462|FG002|NOT COMPLETED|Overall Study||53||
59640214|NCT03712410|75756463|FG003|NOT COMPLETED|Overall Study||17||
59640215|NCT03139344|75756480|FG000|STARTED|Overall Study||28||
59640216|NCT03139344|75756481|FG001|STARTED|Overall Study||12||
59640217|NCT03139344|75756482|FG002|STARTED|Overall Study||21||
59640218|NCT03139344|75756483|FG003|STARTED|Overall Study||10||
59640219|NCT03139344|75756484|FG004|STARTED|Overall Study||18||
59640220|NCT03139344|75756480|FG000|COMPLETED|Overall Study||28||
59640221|NCT03139344|75756481|FG001|COMPLETED|Overall Study||12||
59640222|NCT03139344|75756482|FG002|COMPLETED|Overall Study||21||
59640223|NCT03139344|75756483|FG003|COMPLETED|Overall Study||10||
59640224|NCT03139344|75756484|FG004|COMPLETED|Overall Study||18||
59640225|NCT03139344|75756480|FG000|NOT COMPLETED|Overall Study||0||
59640226|NCT03139344|75756481|FG001|NOT COMPLETED|Overall Study||0||
59640227|NCT03139344|75756482|FG002|NOT COMPLETED|Overall Study||0||
59640228|NCT03139344|75756483|FG003|NOT COMPLETED|Overall Study||0||
59640229|NCT03139344|75756484|FG004|NOT COMPLETED|Overall Study||0||
59640230|NCT02758626|75756498|FG000|STARTED|Double-Blind Phase (Week 0 - Week 28)||9||
59640231|NCT02758626|75756499|FG001|STARTED|Double-Blind Phase (Week 0 - Week 28)||6||
59640232|NCT02758626|75756498|FG000|COMPLETED|Double-Blind Phase (Week 0 - Week 28)||8||
59640233|NCT02758626|75756499|FG001|COMPLETED|Double-Blind Phase (Week 0 - Week 28)||6||
59640234|NCT02758626|75756498|FG000|NOT COMPLETED|Double-Blind Phase (Week 0 - Week 28)||1||
59640235|NCT02758626|75756499|FG001|NOT COMPLETED|Double-Blind Phase (Week 0 - Week 28)||0||
59640236|NCT02758626|75756498|FG000|STARTED|Open-Label Extension (Week 28-Week 124)||8||
59640237|NCT02758626|75756499|FG001|STARTED|Open-Label Extension (Week 28-Week 124)||6||
59640238|NCT02758626|75756498|FG000|COMPLETED|Open-Label Extension (Week 28-Week 124)||6||
59640239|NCT02758626|75756499|FG001|COMPLETED|Open-Label Extension (Week 28-Week 124)||3||
59640240|NCT02758626|75756498|FG000|NOT COMPLETED|Open-Label Extension (Week 28-Week 124)||2||
59640241|NCT02758626|75756499|FG001|NOT COMPLETED|Open-Label Extension (Week 28-Week 124)||3||
59640242|NCT02357784|75756505|FG000|STARTED|Overall Study||1||
59640243|NCT02357784|75756505|FG000|COMPLETED|Overall Study||0||
59640244|NCT02357784|75756505|FG000|NOT COMPLETED|Overall Study||1||
59640245|NCT01448616|75756512|FG000|STARTED|Lead-In (Observational Phase)||73||
59640246|NCT01448616|75756513|FG001|STARTED|Lead-In (Observational Phase)|N/A during observational phase as participants randomized subsequently|0||
59640247|NCT01448616|75756514|FG002|STARTED|Lead-In (Observational Phase)|N/A during observational phase as participants randomized subsequently|0||
59640248|NCT01448616|75756515|FG003|STARTED|Lead-In (Observational Phase)|N/A during observational phase as participants randomized subsequently|0||
59640249|NCT01448616|75756512|FG000|COMPLETED|Lead-In (Observational Phase)|Participants who swabbed >90% completed this phase and were randomized to treatment 2:2:1.|64||
59640250|NCT01448616|75756513|FG001|COMPLETED|Lead-In (Observational Phase)|completed >90% of sample collection to qualify for randomization for next phase|0||
59640251|NCT01448616|75756514|FG002|COMPLETED|Lead-In (Observational Phase)||0||
59640252|NCT01448616|75756515|FG003|COMPLETED|Lead-In (Observational Phase)||0||
59640253|NCT01448616|75756512|FG000|NOT COMPLETED|Lead-In (Observational Phase)||9||
59640254|NCT01448616|75756513|FG001|NOT COMPLETED|Lead-In (Observational Phase)||0||
59640255|NCT01448616|75756514|FG002|NOT COMPLETED|Lead-In (Observational Phase)||0||
59640256|NCT01448616|75756515|FG003|NOT COMPLETED|Lead-In (Observational Phase)||0||
59640257|NCT01448616|75756512|FG000|STARTED|Study Drug (Treatment Phase)|All qualifying participants from this group moved to treatment group.|0||
59640258|NCT01448616|75756513|FG001|STARTED|Study Drug (Treatment Phase)||24||
59640259|NCT01448616|75756514|FG002|STARTED|Study Drug (Treatment Phase)||27||
59640260|NCT01448616|75756515|FG003|STARTED|Study Drug (Treatment Phase)||13||
59640261|NCT01448616|75756512|FG000|COMPLETED|Study Drug (Treatment Phase)||0||
59640262|NCT01448616|75756513|FG001|COMPLETED|Study Drug (Treatment Phase)||22||
59640263|NCT01448616|75756514|FG002|COMPLETED|Study Drug (Treatment Phase)||23||
59640264|NCT01448616|75756515|FG003|COMPLETED|Study Drug (Treatment Phase)||9||
59640265|NCT01448616|75756512|FG000|NOT COMPLETED|Study Drug (Treatment Phase)||0||
59640266|NCT01448616|75756513|FG001|NOT COMPLETED|Study Drug (Treatment Phase)||2||
59640267|NCT01448616|75756514|FG002|NOT COMPLETED|Study Drug (Treatment Phase)||4||
59640268|NCT01448616|75756515|FG003|NOT COMPLETED|Study Drug (Treatment Phase)||4||
59640269|NCT01320696|75756533|FG000|STARTED|Overall Study||56||
59640270|NCT01320696|75756534|FG001|STARTED|Overall Study||55||
59640271|NCT01320696|75756535|FG002|STARTED|Overall Study||54||
59640272|NCT01320696|75756536|FG003|STARTED|Overall Study||55||
59640273|NCT01320696|75756537|FG004|STARTED|Overall Study||55||
59640274|NCT01320696|75756533|FG000|Vaccinated Vacc. 1|Overall Study||56||
59640275|NCT01320696|75756534|FG001|Vaccinated Vacc. 1|Overall Study||55||
59640276|NCT01320696|75756535|FG002|Vaccinated Vacc. 1|Overall Study||54||
59640277|NCT01320696|75756536|FG003|Vaccinated Vacc. 1|Overall Study||55||
59640278|NCT01320696|75756537|FG004|Vaccinated Vacc. 1|Overall Study||55||
59640279|NCT01320696|75756533|FG000|Vaccinated Vacc. 2|Overall Study||53||
59640280|NCT01320696|75756534|FG001|Vaccinated Vacc. 2|Overall Study||53||
59640281|NCT01320696|75756535|FG002|Vaccinated Vacc. 2|Overall Study||54||
59640282|NCT01320696|75756536|FG003|Vaccinated Vacc. 2|Overall Study||55||
59640283|NCT01320696|75756537|FG004|Vaccinated Vacc. 2|Overall Study||54||
59640284|NCT01320696|75756533|FG000|COMPLETED|Overall Study||51||
59640285|NCT01320696|75756534|FG001|COMPLETED|Overall Study||51||
59640286|NCT01320696|75756535|FG002|COMPLETED|Overall Study||51||
59640287|NCT01320696|75756536|FG003|COMPLETED|Overall Study||50||
59640288|NCT01320696|75756537|FG004|COMPLETED|Overall Study||52||
59640289|NCT01320696|75756533|FG000|NOT COMPLETED|Overall Study||5||
59640290|NCT01320696|75756534|FG001|NOT COMPLETED|Overall Study||4||
59640291|NCT01320696|75756535|FG002|NOT COMPLETED|Overall Study||3||
59640292|NCT01320696|75756536|FG003|NOT COMPLETED|Overall Study||5||
59640293|NCT01320696|75756537|FG004|NOT COMPLETED|Overall Study||3||
59640294|NCT00074412|75756552|FG000|STARTED|Overall Study|Number of infants randomized at 6 weeks.|763||
59640295|NCT00074412|75756553|FG001|STARTED|Overall Study|Number of infants randomized at 6 weeks.|759||
59640296|NCT00074412|75756552|FG000|Week 8 Visit|Overall Study||759||
59640297|NCT00074412|75756553|FG001|Week 8 Visit|Overall Study||759||
59640298|NCT00074412|75756552|FG000|Month 3 Visit|Overall Study||759||
59640299|NCT00074412|75756553|FG001|Month 3 Visit|Overall Study||755||
59640300|NCT00074412|75756552|FG000|Month 4 Visit|Overall Study||758||
59640301|NCT00074412|75756553|FG001|Month 4 Visit|Overall Study||752||
59640302|NCT00074412|75756552|FG000|Month 5 Visit|Overall Study||756||
59640303|NCT00074412|75756553|FG001|Month 5 Visit|Overall Study||750||
59640304|NCT00074412|75756552|FG000|Month 6 Visit|Overall Study||748||
59640305|NCT00074412|75756553|FG001|Month 6 Visit|Overall Study||748||
59640306|NCT00074412|75756552|FG000|Month 9 Visit|Overall Study||741||
59640307|NCT00074412|75756553|FG001|Month 9 Visit|Overall Study||741||
59640308|NCT00074412|75756552|FG000|Month 12 Visit|Overall Study||733||
59640309|NCT00074412|75756553|FG001|Month 12 Visit|Overall Study||735||
59640310|NCT00074412|75756552|FG000|COMPLETED|Overall Study|Number of infants who completed final 18 month visit: out of 733 infants who were expected.|681||
59640311|NCT00074412|75756553|FG001|COMPLETED|Overall Study|Number of infants who completed final 18 month visit: out of 733 infants who were expected.|675||
59640312|NCT00074412|75756552|FG000|NOT COMPLETED|Overall Study||82||
59640313|NCT00074412|75756553|FG001|NOT COMPLETED|Overall Study||84||
59640314|NCT02618772|75756562|FG000|STARTED|Overall Study||39||
59640315|NCT02618772|75756563|FG001|STARTED|Overall Study||40||
59815743|NCT03209050|75938206|FG000|COMPLETED|Overall Study||27||
59640316|NCT02618772|75756562|FG000|Withdrawal by Subject|Overall Study|The participant's family withdrew from the study after administration of the trial intervention.|1||
59640317|NCT02618772|75756563|FG001|Withdrawal by Subject|Overall Study||0||
59640318|NCT02618772|75756562|FG000|COMPLETED|Overall Study||38||
59640319|NCT02618772|75756563|FG001|COMPLETED|Overall Study||40||
59640320|NCT02618772|75756562|FG000|NOT COMPLETED|Overall Study||1||
59640321|NCT02618772|75756563|FG001|NOT COMPLETED|Overall Study||0||
59640322|NCT02619396|75756573|FG000|STARTED|Overall Study||20||
59640323|NCT02619396|75756574|FG001|STARTED|Overall Study||20||
59640324|NCT02619396|75756575|FG002|STARTED|Overall Study||20||
59640325|NCT02619396|75756576|FG003|STARTED|Overall Study||20||
59640326|NCT02619396|75756573|FG000|COMPLETED|Overall Study||20||
59640327|NCT02619396|75756574|FG001|COMPLETED|Overall Study||20||
59640328|NCT02619396|75756575|FG002|COMPLETED|Overall Study||20||
59640329|NCT02619396|75756576|FG003|COMPLETED|Overall Study||20||
59640330|NCT02619396|75756573|FG000|NOT COMPLETED|Overall Study||0||
59640331|NCT02619396|75756574|FG001|NOT COMPLETED|Overall Study||0||
59640332|NCT02619396|75756575|FG002|NOT COMPLETED|Overall Study||0||
59640333|NCT02619396|75756576|FG003|NOT COMPLETED|Overall Study||0||
59640334|NCT02620878|75756587|FG000|STARTED|Overall Study||16|"participants in CLOSED LOOP First are also being counted in the OPEN LOOP Second"|
59640335|NCT02620878|75756588|FG001|STARTED|Overall Study||16|"participants in CLOSED LOOP First are also being counted in the OPEN LOOP Second"|
59640336|NCT02620878|75756587|FG000|COMPLETED|Overall Study||16||
59640337|NCT02620878|75756588|FG001|COMPLETED|Overall Study||16||
59640338|NCT02620878|75756587|FG000|NOT COMPLETED|Overall Study||0||
59640339|NCT02620878|75756588|FG001|NOT COMPLETED|Overall Study||0||
59640340|NCT02621892|75756596|FG000|STARTED|Treatment Period||307||
59640341|NCT02621892|75756597|FG001|STARTED|Treatment Period||299||
59640342|NCT02621892|75756596|FG000|COMPLETED|Treatment Period||261||
59640343|NCT02621892|75756597|FG001|COMPLETED|Treatment Period||272||
59640344|NCT02621892|75756596|FG000|NOT COMPLETED|Treatment Period||46||
59640345|NCT02621892|75756597|FG001|NOT COMPLETED|Treatment Period||27||
59640346|NCT02621892|75756596|FG000|STARTED|Randomized Withdrawal Period||261||
59640347|NCT02621892|75756597|FG001|STARTED|Randomized Withdrawal Period||272||
59640348|NCT02621892|75756596|FG000|COMPLETED|Randomized Withdrawal Period||250||
59640349|NCT02621892|75756597|FG001|COMPLETED|Randomized Withdrawal Period||260||
59640350|NCT02621892|75756596|FG000|NOT COMPLETED|Randomized Withdrawal Period||11||
59640351|NCT02621892|75756597|FG001|NOT COMPLETED|Randomized Withdrawal Period||12||
59640352|NCT02624700|75756605|FG000|STARTED|Overall Study||9||
59640353|NCT02624700|75756606|FG001|STARTED|Overall Study||4||
59640354|NCT02624700|75756605|FG000|COMPLETED|Overall Study||9||
59640355|NCT02624700|75756606|FG001|COMPLETED|Overall Study||4||
59640356|NCT02624700|75756605|FG000|NOT COMPLETED|Overall Study||0||
59640357|NCT02624700|75756606|FG001|NOT COMPLETED|Overall Study||0||
59988495|NCT02519504|76103665|FG001|COMPLETED|Overall Study||144|Had complete information from the direct testing visit.|
59988496|NCT02519504|76103664|FG000|NOT COMPLETED|Overall Study||113||
59988497|NCT02519504|76103665|FG001|NOT COMPLETED|Overall Study||103||
59640358|NCT02625402|75756616|FG000|STARTED|Overall Study||42||
59640359|NCT02625402|75756617|FG001|STARTED|Overall Study||37||
59640360|NCT02625402|75756616|FG000|COMPLETED|Overall Study||33||
59640361|NCT02625402|75756617|FG001|COMPLETED|Overall Study||25||
59640362|NCT02625402|75756616|FG000|NOT COMPLETED|Overall Study||9||
59640363|NCT02625402|75756617|FG001|NOT COMPLETED|Overall Study||12||
59640364|NCT02627118|75756623|FG000|STARTED|Overall Study||10||
59640365|NCT02627118|75756623|FG000|COMPLETED|Overall Study||10||
59640366|NCT02627118|75756623|FG000|NOT COMPLETED|Overall Study||0||
59640367|NCT02631954|75756630|FG000|STARTED|Overall Study||12||
59640368|NCT02631954|75756631|FG001|STARTED|Overall Study||12||
59640369|NCT02631954|75756630|FG000|COMPLETED|Overall Study||12||
59640370|NCT02631954|75756631|FG001|COMPLETED|Overall Study||12||
59640371|NCT02631954|75756630|FG000|NOT COMPLETED|Overall Study||0||
59640372|NCT02631954|75756631|FG001|NOT COMPLETED|Overall Study||0||
59640373|NCT02632812|75756639|FG000|STARTED|Overall Study||12||
59640374|NCT02632812|75756640|FG001|STARTED|Overall Study||12||
59640375|NCT02632812|75756639|FG000|COMPLETED|Overall Study||12||
59640376|NCT02632812|75756640|FG001|COMPLETED|Overall Study||12||
59640377|NCT02632812|75756639|FG000|NOT COMPLETED|Overall Study||0||
59640378|NCT02632812|75756640|FG001|NOT COMPLETED|Overall Study||0||
59640379|NCT02633358|75756648|FG000|STARTED|Overall Study||87||
59640380|NCT02633358|75756649|FG001|STARTED|Overall Study||54||
59640381|NCT02633358|75756648|FG000|COMPLETED|Overall Study||87||
59640382|NCT02633358|75756649|FG001|COMPLETED|Overall Study||54||
59640383|NCT02633358|75756648|FG000|NOT COMPLETED|Overall Study||0||
59640384|NCT02633358|75756649|FG001|NOT COMPLETED|Overall Study||0||
59640385|NCT02634684|75756660|FG000|STARTED|Overall Study||19||
59640386|NCT02634684|75756661|FG001|STARTED|Overall Study||19||
59640387|NCT02634684|75756662|FG002|STARTED|Overall Study||21||
59640388|NCT02634684|75756663|FG003|STARTED|Overall Study||23||
59640389|NCT02634684|75756660|FG000|COMPLETED|Overall Study||19||
59640390|NCT02634684|75756661|FG001|COMPLETED|Overall Study||19||
59640391|NCT02634684|75756662|FG002|COMPLETED|Overall Study||21||
59640392|NCT02634684|75756663|FG003|COMPLETED|Overall Study||23||
59640393|NCT02634684|75756660|FG000|NOT COMPLETED|Overall Study||0||
59640394|NCT02634684|75756661|FG001|NOT COMPLETED|Overall Study||0||
59640395|NCT02634684|75756662|FG002|NOT COMPLETED|Overall Study||0||
59640396|NCT02634684|75756663|FG003|NOT COMPLETED|Overall Study||0||
59640397|NCT02635542|75756675|FG000|STARTED|Overall Study||50||
59640398|NCT02635542|75756676|FG001|STARTED|Overall Study||50||
59640399|NCT02635542|75756675|FG000|COMPLETED|Overall Study||50||
59640400|NCT02635542|75756676|FG001|COMPLETED|Overall Study||50||
59640401|NCT02635542|75756675|FG000|NOT COMPLETED|Overall Study||0||
59640402|NCT02635542|75756676|FG001|NOT COMPLETED|Overall Study||0||
59640403|NCT02636712|75756682|FG000|STARTED|Overall Study||10||
59640404|NCT02636712|75756682|FG000|COMPLETED|Overall Study||10||
59640405|NCT02636712|75756682|FG000|NOT COMPLETED|Overall Study||0||
59640406|NCT02637804|75756689|FG000|STARTED|First Intervention (1 Week)||27||
59640407|NCT02637804|75756690|FG001|STARTED|First Intervention (1 Week)||28||
59640408|NCT02637804|75756691|FG002|STARTED|First Intervention (1 Week)||25||
59640409|NCT02637804|75756692|FG003|STARTED|First Intervention (1 Week)||26||
59640410|NCT02637804|75756689|FG000|COMPLETED|First Intervention (1 Week)||27||
59640411|NCT02637804|75756690|FG001|COMPLETED|First Intervention (1 Week)||28||
59640412|NCT02637804|75756691|FG002|COMPLETED|First Intervention (1 Week)||25||
59640413|NCT02637804|75756692|FG003|COMPLETED|First Intervention (1 Week)||26||
59640414|NCT02637804|75756689|FG000|NOT COMPLETED|First Intervention (1 Week)||0||
60076673|NCT01903837|76191657|FG001|STARTED|Part B||52|The number of subjects starting the period is not consistent with the number completing the preceding period. It is expected the number of subjects starting the subsequent period will be the same as the number completing the preceding period. This is because 3 subjects discontinued the study after completing Part A, and did not participate in Part B.|
60076674|NCT01903837|76191658|FG002|STARTED|Part B||57|The number of subjects starting the period is not consistent with the number completing the preceding period. It is expected the number of subjects starting the subsequent period will be the same as the number completing the preceding period. This is because 3 subjects discontinued the study after completing Part A, and did not participate in Part B.|
60103612|NCT01291108|76221863|FG000|NOT COMPLETED|Month 1 (Monotherapy)||1||
60103613|NCT01291108|76221864|FG001|NOT COMPLETED|Month 1 (Monotherapy)||0||
60103614|NCT01291108|76221865|FG002|NOT COMPLETED|Month 1 (Monotherapy)||0||
59640415|NCT02637804|75756690|FG001|NOT COMPLETED|First Intervention (1 Week)||0||
59640416|NCT02637804|75756691|FG002|NOT COMPLETED|First Intervention (1 Week)||0||
59640417|NCT02637804|75756692|FG003|NOT COMPLETED|First Intervention (1 Week)||0||
59640418|NCT02637804|75756689|FG000|STARTED|Second Intervention (1 Week)||27||
59640419|NCT02637804|75756690|FG001|STARTED|Second Intervention (1 Week)||28||
59640420|NCT02637804|75756691|FG002|STARTED|Second Intervention (1 Week)||25||
59640421|NCT02637804|75756692|FG003|STARTED|Second Intervention (1 Week)||26||
59640422|NCT02637804|75756689|FG000|COMPLETED|Second Intervention (1 Week)||27||
59640423|NCT02637804|75756690|FG001|COMPLETED|Second Intervention (1 Week)||28||
59640424|NCT02637804|75756691|FG002|COMPLETED|Second Intervention (1 Week)||25||
59640425|NCT02637804|75756692|FG003|COMPLETED|Second Intervention (1 Week)||26||
59640426|NCT02637804|75756689|FG000|NOT COMPLETED|Second Intervention (1 Week)||0||
59988498|NCT02514824|76103673|FG000|STARTED|Overall Study||4||
59988499|NCT02514824|76103674|FG001|STARTED|Overall Study||5||
59988500|NCT02514824|76103675|FG002|STARTED|Overall Study||0||
59988501|NCT02514824|76103676|FG003|STARTED|Overall Study||0||
59988502|NCT02514824|76103673|FG000|Evaluable for Dose-limiting Toxicity|Overall Study||3||
59988503|NCT02514824|76103674|FG001|Evaluable for Dose-limiting Toxicity|Overall Study||5||
59988504|NCT02514824|76103675|FG002|Evaluable for Dose-limiting Toxicity|Overall Study||0||
59988505|NCT02514824|76103676|FG003|Evaluable for Dose-limiting Toxicity|Overall Study||0||
59988506|NCT02514824|76103673|FG000|COMPLETED|Overall Study||3||
59640427|NCT02637804|75756690|FG001|NOT COMPLETED|Second Intervention (1 Week)||0||
59640428|NCT02637804|75756691|FG002|NOT COMPLETED|Second Intervention (1 Week)||0||
59640429|NCT02637804|75756692|FG003|NOT COMPLETED|Second Intervention (1 Week)||0||
59640430|NCT02638974|75756711|FG000|STARTED|Overall Study||26||
59640431|NCT02638974|75756712|FG001|STARTED|Overall Study||25||
59640432|NCT02638974|75756711|FG000|COMPLETED|Overall Study||23||
59640433|NCT02638974|75756712|FG001|COMPLETED|Overall Study||22||
59640434|NCT02638974|75756711|FG000|NOT COMPLETED|Overall Study||3||
59640435|NCT02638974|75756712|FG001|NOT COMPLETED|Overall Study||3||
59640436|NCT02639286|75756720|FG000|STARTED|Overall Study||3||
59640437|NCT02639286|75756721|FG001|STARTED|Overall Study||2||
59640438|NCT02639286|75756720|FG000|COMPLETED|Overall Study||3||
59640439|NCT02639286|75756721|FG001|COMPLETED|Overall Study||2||
59640440|NCT02639286|75756720|FG000|NOT COMPLETED|Overall Study||0||
59640441|NCT02639286|75756721|FG001|NOT COMPLETED|Overall Study||0||
59640442|NCT02642952|75756729|FG000|STARTED|Overall Study||21||
59640443|NCT02642952|75756730|FG001|STARTED|Overall Study||30||
59640444|NCT02642952|75756729|FG000|COMPLETED|Overall Study||19||
59640445|NCT02642952|75756730|FG001|COMPLETED|Overall Study||25||
59640446|NCT02642952|75756729|FG000|NOT COMPLETED|Overall Study||2||
59988507|NCT02514824|76103674|FG001|COMPLETED|Overall Study||4||
59988508|NCT02514824|76103675|FG002|COMPLETED|Overall Study||0||
59988509|NCT02514824|76103676|FG003|COMPLETED|Overall Study||0||
59988510|NCT02514824|76103673|FG000|NOT COMPLETED|Overall Study||1||
59988511|NCT02514824|76103674|FG001|NOT COMPLETED|Overall Study||1||
59988512|NCT02514824|76103675|FG002|NOT COMPLETED|Overall Study||0||
59988513|NCT02514824|76103676|FG003|NOT COMPLETED|Overall Study||0||
59988514|NCT02514746|76103685|FG000|STARTED|Overall Study||437|All enrolled participants|
60076675|NCT01903837|76191659|FG003|STARTED|Part B||55|The number of subjects starting the period is not consistent with the number completing the preceding period. It is expected the number of subjects starting the subsequent period will be the same as the number completing the preceding period. This is because 3 subjects discontinued the study after completing Part A, and did not participate in Part B.|
60076676|NCT01903837|76191656|FG000|COMPLETED|Part B||45||
60076677|NCT01903837|76191657|FG001|COMPLETED|Part B||46||
60076678|NCT01903837|76191658|FG002|COMPLETED|Part B||52||
60076679|NCT01903837|76191659|FG003|COMPLETED|Part B||44||
60076680|NCT01903837|76191656|FG000|NOT COMPLETED|Part B||9||
59640447|NCT02642952|75756730|FG001|NOT COMPLETED|Overall Study||5||
59640448|NCT03693846|75756736|FG000|STARTED|Overall Study||11||
59640449|NCT03693846|75756736|FG000|COMPLETED|Overall Study||11||
59640450|NCT03693846|75756736|FG000|NOT COMPLETED|Overall Study||0||
59640451|NCT02703480|75756741|FG000|STARTED|Overall Study||11||11
59640452|NCT02703480|75756742|FG001|STARTED|Overall Study||11||11
59640453|NCT02703480|75756741|FG000|COMPLETED|Overall Study||10||10
59640454|NCT02703480|75756742|FG001|COMPLETED|Overall Study||10||10
59640455|NCT02703480|75756741|FG000|NOT COMPLETED|Overall Study||1||1
59640456|NCT02703480|75756742|FG001|NOT COMPLETED|Overall Study||1||1
59640457|NCT02644278|75756752|FG000|STARTED|Overall Study||3||
59640458|NCT02644278|75756753|FG001|STARTED|Overall Study||3||
59640459|NCT02644278|75756754|FG002|STARTED|Overall Study||6||
59640460|NCT02644278|75756755|FG003|STARTED|Overall Study||3||
59640461|NCT02644278|75756752|FG000|COMPLETED|Overall Study||3||
59640462|NCT02644278|75756753|FG001|COMPLETED|Overall Study||3||
59640463|NCT02644278|75756754|FG002|COMPLETED|Overall Study||6||
59640464|NCT02644278|75756755|FG003|COMPLETED|Overall Study||3||
59640465|NCT02644278|75756752|FG000|NOT COMPLETED|Overall Study||0||
59640466|NCT02644278|75756753|FG001|NOT COMPLETED|Overall Study||0||
59640467|NCT02644278|75756754|FG002|NOT COMPLETED|Overall Study||0||
59640468|NCT02644278|75756755|FG003|NOT COMPLETED|Overall Study||0||
59640469|NCT02645760|75756767|FG000|STARTED|Overall Study||19||
59640470|NCT02645760|75756768|FG001|STARTED|Overall Study||19||
59640471|NCT02645760|75756767|FG000|COMPLETED|Overall Study||19||
59640472|NCT02645760|75756768|FG001|COMPLETED|Overall Study||19||
59640473|NCT02645760|75756767|FG000|NOT COMPLETED|Overall Study||0||
59640474|NCT02645760|75756768|FG001|NOT COMPLETED|Overall Study||0||
59640475|NCT02648022|75756777|FG000|STARTED|Overall Study||40||
59640476|NCT02648022|75756778|FG001|STARTED|Overall Study||39||
59640477|NCT02648022|75756777|FG000|COMPLETED|Overall Study||40||
59640478|NCT02648022|75756778|FG001|COMPLETED|Overall Study||39||
60076681|NCT01903837|76191657|FG001|NOT COMPLETED|Part B||6||
60076682|NCT01903837|76191658|FG002|NOT COMPLETED|Part B||5||
59640479|NCT02648022|75756777|FG000|NOT COMPLETED|Overall Study||0||
59640480|NCT02648022|75756778|FG001|NOT COMPLETED|Overall Study||0||
59640481|NCT02648178|75756784|FG000|STARTED|Overall Study||19||
59640482|NCT02648178|75756784|FG000|COMPLETED|Overall Study||10||
59640483|NCT02648178|75756784|FG000|NOT COMPLETED|Overall Study||9||
60076683|NCT01903837|76191659|FG003|NOT COMPLETED|Part B||11||
59640484|NCT02648646|75756788|FG000|STARTED|Overall Study||10||
59640485|NCT02648646|75756788|FG000|COMPLETED|Overall Study||8||
59640486|NCT02648646|75756788|FG000|NOT COMPLETED|Overall Study||2||
59640487|NCT02648880|75756792|FG000|STARTED|Overall Study|Recruitment was significantly limited, only 3 participants were eligible, all enrolled. All three were assigned to the exercise arm, per protocol. No participants were recruited into the control arm and it was eliminated.|3||
59640488|NCT02648880|75756792|FG000|COMPLETED|Overall Study||3||
59640489|NCT02648880|75756792|FG000|NOT COMPLETED|Overall Study||0||
59640490|NCT02649192|75756802|FG000|STARTED|Overall Study||5||
59640491|NCT02649192|75756803|FG001|STARTED|Overall Study||4||
59640492|NCT02649192|75756804|FG002|STARTED|Overall Study||22||
59640493|NCT02649192|75756805|FG003|STARTED|Overall Study||22||
59640494|NCT02649192|75756806|FG004|STARTED|Overall Study||12||
59640495|NCT02649192|75756807|FG005|STARTED|Overall Study||14||
59640496|NCT02649192|75756802|FG000|Vitamin A Sufficiency (RBP≥22,000 ng/ml)|Overall Study||2||
59640497|NCT02649192|75756803|FG001|Vitamin A Sufficiency (RBP≥22,000 ng/ml)|Overall Study||2||
59640498|NCT02649192|75756804|FG002|Vitamin A Sufficiency (RBP≥22,000 ng/ml)|Overall Study||11||
59988515|NCT02514746|76103686|FG001|STARTED|Overall Study||124|All enrolled participants|
59988516|NCT02514746|76103685|FG000|Valid Serology 3 Years Post Primary Dose|Overall Study||437||
59988517|NCT02514746|76103686|FG001|Valid Serology 3 Years Post Primary Dose|Overall Study||123||
59640499|NCT02649192|75756805|FG003|Vitamin A Sufficiency (RBP≥22,000 ng/ml)|Overall Study||12||
59640500|NCT02649192|75756806|FG004|Vitamin A Sufficiency (RBP≥22,000 ng/ml)|Overall Study||7||
59815744|NCT03209050|75938206|FG000|NOT COMPLETED|Overall Study||3||
59988518|NCT02514746|76103685|FG000|Valid Serology 4 Years Post Primary Dose|Overall Study||424||
60076684|NCT01903525|76191692|FG000|STARTED|Overall Study||20||
59640501|NCT02649192|75756807|FG005|Vitamin A Sufficiency (RBP≥22,000 ng/ml)|Overall Study||8||
59640502|NCT02649192|75756802|FG000|Vitamin A Insufficiency (RBP<22,000 ng/m|Overall Study||3||
59640503|NCT02649192|75756803|FG001|Vitamin A Insufficiency (RBP<22,000 ng/m|Overall Study||2||
59640504|NCT02649192|75756804|FG002|Vitamin A Insufficiency (RBP<22,000 ng/m|Overall Study||11||
59640505|NCT02649192|75756805|FG003|Vitamin A Insufficiency (RBP<22,000 ng/m|Overall Study||10||
59640506|NCT02649192|75756806|FG004|Vitamin A Insufficiency (RBP<22,000 ng/m|Overall Study||5||
59640507|NCT02649192|75756807|FG005|Vitamin A Insufficiency (RBP<22,000 ng/m|Overall Study||6||
59640508|NCT02649192|75756802|FG000|COMPLETED|Overall Study||5||
59640509|NCT02649192|75756803|FG001|COMPLETED|Overall Study||4||
59640510|NCT02649192|75756804|FG002|COMPLETED|Overall Study||21||
59640511|NCT02649192|75756805|FG003|COMPLETED|Overall Study||20||
59640512|NCT02649192|75756806|FG004|COMPLETED|Overall Study||11||
59640513|NCT02649192|75756807|FG005|COMPLETED|Overall Study||14||
59640514|NCT02649192|75756802|FG000|NOT COMPLETED|Overall Study||0||
59640515|NCT02649192|75756803|FG001|NOT COMPLETED|Overall Study||0||
59640516|NCT02649192|75756804|FG002|NOT COMPLETED|Overall Study||1||
59640517|NCT02649192|75756805|FG003|NOT COMPLETED|Overall Study||2||
59640518|NCT02649192|75756806|FG004|NOT COMPLETED|Overall Study||1||
59640519|NCT02649192|75756807|FG005|NOT COMPLETED|Overall Study||0||
59640520|NCT02650440|75756836|FG000|STARTED|Overall Study||10||
59640521|NCT02650440|75756837|FG001|STARTED|Overall Study||10||
59640522|NCT02650440|75756836|FG000|COMPLETED|Overall Study||10||
59640523|NCT02650440|75756837|FG001|COMPLETED|Overall Study||8||
59640524|NCT02650440|75756836|FG000|NOT COMPLETED|Overall Study||0||
59640525|NCT02650440|75756837|FG001|NOT COMPLETED|Overall Study||2||
59640526|NCT02652390|75756846|FG000|STARTED|Overall Study||37||
59640527|NCT02652390|75756847|FG001|STARTED|Overall Study||37||
59640528|NCT02652390|75756848|FG002|STARTED|Overall Study||37||
59640529|NCT02652390|75756846|FG000|COMPLETED|Overall Study||37||
59640530|NCT02652390|75756847|FG001|COMPLETED|Overall Study||37||
59640531|NCT02652390|75756848|FG002|COMPLETED|Overall Study||37||
59640532|NCT02652390|75756846|FG000|NOT COMPLETED|Overall Study||0||
59640533|NCT02652390|75756847|FG001|NOT COMPLETED|Overall Study||0||
59640534|NCT02652390|75756848|FG002|NOT COMPLETED|Overall Study||0||
59640535|NCT02652780|75756858|FG000|STARTED|Overall Study||37||
59640536|NCT02652780|75756858|FG000|COMPLETED|Overall Study||37||
59640537|NCT02652780|75756858|FG000|NOT COMPLETED|Overall Study||0||
59640538|NCT02653560|75756865|FG000|STARTED|KMgCit Phase||30||
59640539|NCT02653560|75756866|FG001|STARTED|KMgCit Phase||0||
59640540|NCT02653560|75756867|FG002|STARTED|KMgCit Phase||0||
59640541|NCT02653560|75756868|FG003|STARTED|KMgCit Phase||0||
59640542|NCT02653560|75756865|FG000|COMPLETED|KMgCit Phase||30||
59640543|NCT02653560|75756866|FG001|COMPLETED|KMgCit Phase||0||
59640544|NCT02653560|75756867|FG002|COMPLETED|KMgCit Phase||0||
59640545|NCT02653560|75756868|FG003|COMPLETED|KMgCit Phase||0||
59640546|NCT02653560|75756865|FG000|NOT COMPLETED|KMgCit Phase||0||
59640547|NCT02653560|75756866|FG001|NOT COMPLETED|KMgCit Phase||0||
59640548|NCT02653560|75756867|FG002|NOT COMPLETED|KMgCit Phase||0||
59640549|NCT02653560|75756868|FG003|NOT COMPLETED|KMgCit Phase||0||
59640550|NCT02653560|75756865|FG000|STARTED|K Citrate Phase||0||
59640551|NCT02653560|75756866|FG001|STARTED|K Citrate Phase||30||
59640552|NCT02653560|75756867|FG002|STARTED|K Citrate Phase||0||
59640553|NCT02653560|75756868|FG003|STARTED|K Citrate Phase||0||
59640554|NCT02653560|75756865|FG000|COMPLETED|K Citrate Phase||0||
59640555|NCT02653560|75756866|FG001|COMPLETED|K Citrate Phase||30||
59640556|NCT02653560|75756867|FG002|COMPLETED|K Citrate Phase||0||
59640557|NCT02653560|75756868|FG003|COMPLETED|K Citrate Phase||0||
59640558|NCT02653560|75756865|FG000|NOT COMPLETED|K Citrate Phase||0||
59640559|NCT02653560|75756866|FG001|NOT COMPLETED|K Citrate Phase||0||
59640560|NCT02653560|75756867|FG002|NOT COMPLETED|K Citrate Phase||0||
59640561|NCT02653560|75756868|FG003|NOT COMPLETED|K Citrate Phase||0||
59640562|NCT02653560|75756865|FG000|STARTED|KCl Phase||0||
59640563|NCT02653560|75756866|FG001|STARTED|KCl Phase||0||
59640564|NCT02653560|75756867|FG002|STARTED|KCl Phase||30||
59640565|NCT02653560|75756868|FG003|STARTED|KCl Phase||0||
59640566|NCT02653560|75756865|FG000|COMPLETED|KCl Phase||0||
59640567|NCT02653560|75756866|FG001|COMPLETED|KCl Phase||0||
59640568|NCT02653560|75756867|FG002|COMPLETED|KCl Phase||30||
59640569|NCT02653560|75756868|FG003|COMPLETED|KCl Phase||0||
59640570|NCT02653560|75756865|FG000|NOT COMPLETED|KCl Phase||0||
59640571|NCT02653560|75756866|FG001|NOT COMPLETED|KCl Phase||0||
59640572|NCT02653560|75756867|FG002|NOT COMPLETED|KCl Phase||0||
59640573|NCT02653560|75756868|FG003|NOT COMPLETED|KCl Phase||0||
59640574|NCT02653560|75756865|FG000|STARTED|Placebo Phase||0||
59640575|NCT02653560|75756866|FG001|STARTED|Placebo Phase||0||
59640576|NCT02653560|75756867|FG002|STARTED|Placebo Phase||0||
59640577|NCT02653560|75756868|FG003|STARTED|Placebo Phase||30||
59640578|NCT02653560|75756865|FG000|COMPLETED|Placebo Phase||0||
59640579|NCT02653560|75756866|FG001|COMPLETED|Placebo Phase||0||
59640580|NCT02653560|75756867|FG002|COMPLETED|Placebo Phase||0||
59640581|NCT02653560|75756868|FG003|COMPLETED|Placebo Phase||30||
59640582|NCT02653560|75756865|FG000|NOT COMPLETED|Placebo Phase||0||
59640583|NCT02653560|75756866|FG001|NOT COMPLETED|Placebo Phase||0||
59640584|NCT02653560|75756867|FG002|NOT COMPLETED|Placebo Phase||0||
59640585|NCT02653560|75756868|FG003|NOT COMPLETED|Placebo Phase||0||
59640586|NCT02653872|75756878|FG000|STARTED|Overall Study||15||
59640587|NCT02653872|75756878|FG000|Treatment Period 1:|Overall Study|Participants received single AZD7986 (25 mg).|15||
59640588|NCT02653872|75756878|FG000|Treatment Period 2:|Overall Study|Participants received Verapamil (240 mg; extended release formulation) + AZD7986 (25 mg).|15||
59640589|NCT02653872|75756878|FG000|Treatment Period 3:|Overall Study|Participants received: itraconazole 200 mg + AZD7986.|15||
59640590|NCT02653872|75756878|FG000|COMPLETED|Overall Study||15||
59640591|NCT02653872|75756878|FG000|NOT COMPLETED|Overall Study||0||
59640592|NCT02654652|75756894|FG000|STARTED|Overall Study||19||
59640593|NCT02654652|75756895|FG001|STARTED|Overall Study||21||
59640594|NCT02654652|75756894|FG000|COMPLETED|Overall Study||18||
59640595|NCT02654652|75756895|FG001|COMPLETED|Overall Study||18||
59640596|NCT02654652|75756894|FG000|NOT COMPLETED|Overall Study||1||
59640597|NCT02654652|75756895|FG001|NOT COMPLETED|Overall Study||3||
59640598|NCT02654808|75756905|FG000|STARTED|Overall Study||33||
59640599|NCT02654808|75756906|FG001|STARTED|Overall Study||33||
59640600|NCT02654808|75756907|FG002|STARTED|Overall Study||33||
59640601|NCT02654808|75756908|FG003|STARTED|Overall Study||33||
59640602|NCT02654808|75756905|FG000|COMPLETED|Overall Study||33||
59640603|NCT02654808|75756906|FG001|COMPLETED|Overall Study||33||
59640604|NCT02654808|75756907|FG002|COMPLETED|Overall Study||33||
59640605|NCT02654808|75756908|FG003|COMPLETED|Overall Study||33||
59640606|NCT02654808|75756905|FG000|NOT COMPLETED|Overall Study||0||
59640607|NCT02654808|75756906|FG001|NOT COMPLETED|Overall Study||0||
59640608|NCT02654808|75756907|FG002|NOT COMPLETED|Overall Study||0||
59640609|NCT02654808|75756908|FG003|NOT COMPLETED|Overall Study||0||
59640610|NCT02655354|75756924|FG000|STARTED|Overall Study||265||
59640611|NCT02655354|75756925|FG001|STARTED|Overall Study||370||
59640612|NCT02655354|75756924|FG000|COMPLETED|Overall Study||188||
59640613|NCT02655354|75756925|FG001|COMPLETED|Overall Study||289||
59640614|NCT02655354|75756924|FG000|NOT COMPLETED|Overall Study||77||
59640615|NCT02655354|75756925|FG001|NOT COMPLETED|Overall Study||81||
59640616|NCT02655510|75756934|FG000|STARTED|Overall Study||6||
59640617|NCT02655510|75756935|FG001|STARTED|Overall Study||6||
59640618|NCT02655510|75756936|FG002|STARTED|Overall Study||6||
59640619|NCT02655510|75756934|FG000|COMPLETED|Overall Study||6||
59640620|NCT02655510|75756935|FG001|COMPLETED|Overall Study||6||
59640621|NCT02655510|75756936|FG002|COMPLETED|Overall Study||6||
59640622|NCT02655510|75756934|FG000|NOT COMPLETED|Overall Study||0||
59640623|NCT02655510|75756935|FG001|NOT COMPLETED|Overall Study||0||
59640624|NCT02655510|75756936|FG002|NOT COMPLETED|Overall Study||0||
59640625|NCT02656836|75756944|FG000|STARTED|Overall Study||9||
59640626|NCT02656836|75756944|FG000|COMPLETED|Overall Study||6||
59640627|NCT02656836|75756944|FG000|NOT COMPLETED|Overall Study||3||
59640628|NCT02657538|75756948|FG000|STARTED|Overall Study||35||
59640629|NCT02657538|75756948|FG000|Received Near Infrared Transillumination|Overall Study||35||
59640630|NCT02657538|75756948|FG000|Received Visual Caries Detection + Bite|Overall Study||35||
59640631|NCT02657538|75756948|FG000|COMPLETED|Overall Study||31||
59640632|NCT02657538|75756948|FG000|NOT COMPLETED|Overall Study||4||
59640633|NCT02657928|75756957|FG000|STARTED|Overall Study||20||
59640634|NCT02657928|75756958|FG001|STARTED|Overall Study||20||
59640635|NCT02657928|75756957|FG000|COMPLETED|Overall Study||20||
59640636|NCT02657928|75756958|FG001|COMPLETED|Overall Study||20||
59640637|NCT02657928|75756957|FG000|NOT COMPLETED|Overall Study||0||
59640638|NCT02657928|75756958|FG001|NOT COMPLETED|Overall Study||0||
59640639|NCT02658240|75756967|FG000|STARTED|Overall Study||30||
59640640|NCT02658240|75756968|FG001|STARTED|Overall Study||30||
59640641|NCT02658240|75756967|FG000|COMPLETED|Overall Study||30||
59640642|NCT02658240|75756968|FG001|COMPLETED|Overall Study||30||
59640643|NCT02658240|75756967|FG000|NOT COMPLETED|Overall Study||0||
59640644|NCT02658240|75756968|FG001|NOT COMPLETED|Overall Study||0||
59640645|NCT02660112|75756974|FG000|STARTED|Overall Study||10||
59640646|NCT02660112|75756974|FG000|COMPLETED|Overall Study||10||
59640647|NCT02660112|75756974|FG000|NOT COMPLETED|Overall Study||0||
59640648|NCT02661126|75756980|FG000|STARTED|Overall Study||8||
59640649|NCT02661126|75756981|FG001|STARTED|Overall Study||8||
59640650|NCT02661126|75756980|FG000|COMPLETED|Overall Study||8||
59640651|NCT02661126|75756981|FG001|COMPLETED|Overall Study||8||
59640652|NCT02661126|75756980|FG000|NOT COMPLETED|Overall Study||0||
59640653|NCT02661126|75756981|FG001|NOT COMPLETED|Overall Study||0||
59640654|NCT02661828|75756989|FG000|STARTED|Overall Study||1||
59640655|NCT02661828|75756990|FG001|STARTED|Overall Study||0||
59640656|NCT02661828|75756989|FG000|COMPLETED|Overall Study||1||
59640657|NCT02661828|75756990|FG001|COMPLETED|Overall Study||0||
59640658|NCT02661828|75756989|FG000|NOT COMPLETED|Overall Study||0||
59640659|NCT02661828|75756990|FG001|NOT COMPLETED|Overall Study||0||
59640660|NCT02662608|75756995|FG000|STARTED|Overall Study||1||
59640661|NCT02662608|75756995|FG000|COMPLETED|Overall Study||1||
59640662|NCT02662608|75756995|FG000|NOT COMPLETED|Overall Study||0||
59640663|NCT02665260|75757003|FG000|STARTED|Overall Study||24||
59640664|NCT02665260|75757004|FG001|STARTED|Overall Study||23||
59640665|NCT02665260|75757005|FG002|STARTED|Overall Study||25||
59640666|NCT02665260|75757006|FG003|STARTED|Overall Study||22||
59640667|NCT02665260|75757003|FG000|COMPLETED|Overall Study||22||
59640668|NCT02665260|75757004|FG001|COMPLETED|Overall Study||22||
59640669|NCT02665260|75757005|FG002|COMPLETED|Overall Study||21||
59640670|NCT02665260|75757006|FG003|COMPLETED|Overall Study||21||
59640671|NCT02665260|75757003|FG000|NOT COMPLETED|Overall Study||2||
59640672|NCT02665260|75757004|FG001|NOT COMPLETED|Overall Study||1||
59640673|NCT02665260|75757005|FG002|NOT COMPLETED|Overall Study||4||
59640674|NCT02665260|75757006|FG003|NOT COMPLETED|Overall Study||1||
59640675|NCT02665728|75757020|FG000|STARTED|Overall Study||33||
59640676|NCT02665728|75757020|FG000|COMPLETED|Overall Study||33||
59640677|NCT02665728|75757020|FG000|NOT COMPLETED|Overall Study||0||
59640678|NCT02666352|75757027|FG000|STARTED|Overall Study||8||
59640679|NCT02666352|75757028|FG001|STARTED|Overall Study||8||
59640680|NCT02666352|75757029|FG002|STARTED|Overall Study||8||
59640681|NCT02666352|75757027|FG000|COMPLETED|Overall Study||8||
59640682|NCT02666352|75757028|FG001|COMPLETED|Overall Study||8||
59640683|NCT02666352|75757029|FG002|COMPLETED|Overall Study||8||
59640684|NCT02666352|75757027|FG000|NOT COMPLETED|Overall Study||0||
59640685|NCT02666352|75757028|FG001|NOT COMPLETED|Overall Study||0||
59640686|NCT02666352|75757029|FG002|NOT COMPLETED|Overall Study||0||
59640687|NCT02666508|75757039|FG000|STARTED|Overall Study||31||
59640688|NCT02666508|75757040|FG001|STARTED|Overall Study||30||
59640689|NCT02666508|75757039|FG000|COMPLETED|Overall Study||31||
59640690|NCT02666508|75757040|FG001|COMPLETED|Overall Study||30||
59640691|NCT02666508|75757039|FG000|NOT COMPLETED|Overall Study||0||
59640692|NCT02666508|75757040|FG001|NOT COMPLETED|Overall Study||0||
59640693|NCT02669784|75757052|FG000|STARTED|Overall Study||18||
59640694|NCT02669784|75757053|FG001|STARTED|Overall Study||16||
59640695|NCT02669784|75757052|FG000|COMPLETED|Overall Study||18||
59640696|NCT02669784|75757053|FG001|COMPLETED|Overall Study||16||
59640697|NCT02669784|75757052|FG000|NOT COMPLETED|Overall Study||0||
59640698|NCT02669784|75757053|FG001|NOT COMPLETED|Overall Study||0||
59640699|NCT02671032|75757059|FG000|STARTED|Overall Study||12||
59640700|NCT02671032|75757059|FG000|COMPLETED|Overall Study||12||
59640701|NCT02671032|75757059|FG000|NOT COMPLETED|Overall Study||0||
59640702|NCT02672514|75757065|FG000|STARTED|Overall Study||53||
59640703|NCT02672514|75757066|FG001|STARTED|Overall Study||51||
59640704|NCT02672514|75757065|FG000|COMPLETED|Overall Study||53||
59640705|NCT02672514|75757066|FG001|COMPLETED|Overall Study||51||
59640706|NCT02672514|75757065|FG000|NOT COMPLETED|Overall Study||0||
59640707|NCT02672514|75757066|FG001|NOT COMPLETED|Overall Study||0||
59640708|NCT02673138|75757072|FG000|STARTED|Overall Study||10||
59640709|NCT02673138|75757072|FG000|Started Day 1|Overall Study||10||
59640710|NCT02673138|75757072|FG000|Ended Day 1|Overall Study||10||
59640711|NCT02673138|75757072|FG000|Started Day 2|Overall Study||10||
59640712|NCT02673138|75757072|FG000|Ended Day 2|Overall Study||10||
59640713|NCT02673138|75757072|FG000|COMPLETED|Overall Study||10||
59640714|NCT02673138|75757072|FG000|NOT COMPLETED|Overall Study||0||
59640715|NCT02673372|75757080|FG000|STARTED|Overall Study||30||
59640716|NCT02673372|75757081|FG001|STARTED|Overall Study||30||
59640717|NCT02673372|75757080|FG000|COMPLETED|Overall Study||30||
59640718|NCT02673372|75757081|FG001|COMPLETED|Overall Study||30||
59640719|NCT02673372|75757080|FG000|NOT COMPLETED|Overall Study||0||
59640720|NCT02673372|75757081|FG001|NOT COMPLETED|Overall Study||0||
59640721|NCT02673918|75757089|FG000|STARTED|Overall Study||35||
59640722|NCT02673918|75757090|FG001|STARTED|Overall Study||24||
59640723|NCT02673918|75757089|FG000|COMPLETED|Overall Study||29||
59640724|NCT02673918|75757090|FG001|COMPLETED|Overall Study||20||
59640725|NCT02673918|75757089|FG000|NOT COMPLETED|Overall Study||6||
59640726|NCT02673918|75757090|FG001|NOT COMPLETED|Overall Study||4||
59640727|NCT02677428|75757100|FG000|STARTED|Overall Study||63||
59640728|NCT02677428|75757101|FG001|STARTED|Overall Study||55||
59640729|NCT02677428|75757100|FG000|COMPLETED|Overall Study||63||
59640730|NCT02677428|75757101|FG001|COMPLETED|Overall Study||55||
59640731|NCT02677428|75757100|FG000|NOT COMPLETED|Overall Study||0||
59640732|NCT02677428|75757101|FG001|NOT COMPLETED|Overall Study||0||
59640733|NCT02677740|75757109|FG000|STARTED|Overall Study||7||
59640734|NCT02677740|75757110|FG001|STARTED|Overall Study||1||
59640735|NCT02677740|75757109|FG000|COMPLETED|Overall Study||7||
59640736|NCT02677740|75757110|FG001|COMPLETED|Overall Study||1||
59640737|NCT02677740|75757109|FG000|NOT COMPLETED|Overall Study||0||
59640738|NCT02677740|75757110|FG001|NOT COMPLETED|Overall Study||0||
59640739|NCT02678442|75757118|FG000|STARTED|First Intervention||25||
59640740|NCT02678442|75757119|FG001|STARTED|First Intervention||25||
59640741|NCT02678442|75757118|FG000|COMPLETED|First Intervention||25||
59640742|NCT02678442|75757119|FG001|COMPLETED|First Intervention||25||
59640743|NCT02678442|75757118|FG000|NOT COMPLETED|First Intervention||0||
59640744|NCT02678442|75757119|FG001|NOT COMPLETED|First Intervention||0||
59640745|NCT02678442|75757118|FG000|STARTED|Second Intervention||25||
59640746|NCT02678442|75757119|FG001|STARTED|Second Intervention||25||
59640747|NCT02678442|75757118|FG000|COMPLETED|Second Intervention||23||
59640748|NCT02678442|75757119|FG001|COMPLETED|Second Intervention||23||
59640749|NCT02678442|75757118|FG000|NOT COMPLETED|Second Intervention||2||
59640750|NCT02678442|75757119|FG001|NOT COMPLETED|Second Intervention||2||
59640751|NCT02679690|75757125|FG000|STARTED|Overall Study||10||
59640752|NCT02679690|75757125|FG000|COMPLETED|Overall Study||9||
59640753|NCT02679690|75757125|FG000|NOT COMPLETED|Overall Study||1||
59640754|NCT02680158|75757131|FG000|STARTED|Overall Study||8||8
59640755|NCT02680158|75757132|FG001|STARTED|Overall Study||8||8
59640756|NCT02680158|75757133|FG002|STARTED|Overall Study||8||8
59640757|NCT02680158|75757134|FG003|STARTED|Overall Study||8||8
59640758|NCT02680158|75757135|FG004|STARTED|Overall Study||8||8
59640759|NCT02680158|75757136|FG005|STARTED|Overall Study||8||8
59640760|NCT02680158|75757131|FG000|COMPLETED|Overall Study||8||8
59640761|NCT02680158|75757132|FG001|COMPLETED|Overall Study||8||8
59640762|NCT02680158|75757133|FG002|COMPLETED|Overall Study||8||8
59640763|NCT02680158|75757134|FG003|COMPLETED|Overall Study||8||8
59640764|NCT02680158|75757135|FG004|COMPLETED|Overall Study||8||8
59640765|NCT02680158|75757136|FG005|COMPLETED|Overall Study||8||8
59640766|NCT02680158|75757131|FG000|NOT COMPLETED|Overall Study||0||0
59640767|NCT02680158|75757132|FG001|NOT COMPLETED|Overall Study||0||0
59640768|NCT02680158|75757133|FG002|NOT COMPLETED|Overall Study||0||0
59640769|NCT02680158|75757134|FG003|NOT COMPLETED|Overall Study||0||0
59640770|NCT02680158|75757135|FG004|NOT COMPLETED|Overall Study||0||0
59640771|NCT02680158|75757136|FG005|NOT COMPLETED|Overall Study||0||0
59640772|NCT02681172|75757144|FG000|STARTED|Overall Study||218||
59640773|NCT02681172|75757144|FG000|Safety Analysis Set|Overall Study||205||
59640774|NCT02681172|75757144|FG000|Full Analysis Set|Overall Study||205||
59640775|NCT02681172|75757144|FG000|Per Protocol Set|Overall Study||205||
59640776|NCT02681172|75757144|FG000|COMPLETED|Overall Study||205||
59640777|NCT02681172|75757144|FG000|NOT COMPLETED|Overall Study||13||
59640778|NCT02682030|75757150|FG000|STARTED|Overall Study||1||
59640779|NCT02682030|75757151|FG001|STARTED|Overall Study||4||
59640780|NCT02682030|75757150|FG000|COMPLETED|Overall Study||0||
59640781|NCT02682030|75757151|FG001|COMPLETED|Overall Study||2||
59640782|NCT02682030|75757150|FG000|NOT COMPLETED|Overall Study||1||
59640783|NCT02682030|75757151|FG001|NOT COMPLETED|Overall Study||2||
59640784|NCT02682420|75757158|FG000|STARTED|Overall Study||100||
59640785|NCT02682420|75757158|FG000|COMPLETED|Overall Study|Note: 63 participants completed the 6-month visit. The study was discontinued prematurely due to company acquisition and therefore, many participants did not complete their 12-month visit.|63||
59640786|NCT02682420|75757158|FG000|NOT COMPLETED|Overall Study||37||
59640787|NCT02682498|75757171|FG000|STARTED|Overall Study||18||
59640788|NCT02682498|75757172|FG001|STARTED|Overall Study||20||
59640789|NCT02682498|75757171|FG000|COMPLETED|Overall Study||18||
59640790|NCT02682498|75757172|FG001|COMPLETED|Overall Study||20||
59640791|NCT02682498|75757171|FG000|NOT COMPLETED|Overall Study||0||
59640792|NCT02682498|75757172|FG001|NOT COMPLETED|Overall Study||0||
59640793|NCT02684136|75757179|FG000|STARTED|First Intervention (9 Nights)||5||
59640794|NCT02684136|75757180|FG001|STARTED|First Intervention (9 Nights)||5||
59640795|NCT02684136|75757179|FG000|COMPLETED|First Intervention (9 Nights)||5||
59640796|NCT02684136|75757180|FG001|COMPLETED|First Intervention (9 Nights)||5||
59640797|NCT02684136|75757179|FG000|NOT COMPLETED|First Intervention (9 Nights)||0||
59640798|NCT02684136|75757180|FG001|NOT COMPLETED|First Intervention (9 Nights)||0||
59640799|NCT02684136|75757179|FG000|STARTED|Washout (7 Days)||5||
59640800|NCT02684136|75757180|FG001|STARTED|Washout (7 Days)||5||
59640801|NCT02684136|75757179|FG000|COMPLETED|Washout (7 Days)||5||
59640802|NCT02684136|75757180|FG001|COMPLETED|Washout (7 Days)||5||
59640803|NCT02684136|75757179|FG000|NOT COMPLETED|Washout (7 Days)||0||
59640804|NCT02684136|75757180|FG001|NOT COMPLETED|Washout (7 Days)||0||
59640805|NCT02684136|75757179|FG000|STARTED|Second Intervention (9 Nights)||5||
59640806|NCT02684136|75757180|FG001|STARTED|Second Intervention (9 Nights)||5||
59640807|NCT02684136|75757179|FG000|COMPLETED|Second Intervention (9 Nights)||5||
59640808|NCT02684136|75757180|FG001|COMPLETED|Second Intervention (9 Nights)||5||
59640809|NCT02684136|75757179|FG000|NOT COMPLETED|Second Intervention (9 Nights)||0||
59640810|NCT02684136|75757180|FG001|NOT COMPLETED|Second Intervention (9 Nights)||0||
59640811|NCT02684604|75757188|FG000|STARTED|Overall Study||44||
59640812|NCT02684604|75757189|FG001|STARTED|Overall Study||44||
59640813|NCT02684604|75757188|FG000|COMPLETED|Overall Study||44||
59640814|NCT02684604|75757189|FG001|COMPLETED|Overall Study||44||
59640815|NCT02684604|75757188|FG000|NOT COMPLETED|Overall Study||0||
59640816|NCT02684604|75757189|FG001|NOT COMPLETED|Overall Study||0||
59640817|NCT02687412|75757197|FG000|STARTED|Overall Study||50||
59640818|NCT02687412|75757198|FG001|STARTED|Overall Study||57||
59640819|NCT02687412|75757197|FG000|COMPLETED|Overall Study||50||
59640820|NCT02687412|75757198|FG001|COMPLETED|Overall Study||57||
59640821|NCT02687412|75757197|FG000|NOT COMPLETED|Overall Study||0||
59640822|NCT02687412|75757198|FG001|NOT COMPLETED|Overall Study||0||
59640823|NCT02693262|75757204|FG000|STARTED|Overall Study||4||
59640824|NCT02693262|75757205|FG001|STARTED|Overall Study||5||
59640825|NCT02693262|75757204|FG000|COMPLETED|Overall Study||4||
59640826|NCT02693262|75757205|FG001|COMPLETED|Overall Study||5||
59640827|NCT02693262|75757204|FG000|NOT COMPLETED|Overall Study||0||
59640828|NCT02693262|75757205|FG001|NOT COMPLETED|Overall Study||0||
59640829|NCT02694198|75757211|FG000|STARTED|Overall Study||135||
59640830|NCT02694198|75757211|FG000|COMPLETED|Overall Study||135||
59640831|NCT02694198|75757211|FG000|NOT COMPLETED|Overall Study||0||
59640832|NCT02695290|75757215|FG000|STARTED|Overall Study||1||
59640833|NCT02695290|75757215|FG000|COMPLETED|Overall Study||1||
59640834|NCT02695290|75757215|FG000|NOT COMPLETED|Overall Study||0||
59640835|NCT02695446|75757219|FG000|STARTED|Overall Study||12||
59640836|NCT02695446|75757219|FG000|COMPLETED|Overall Study||12||
59640837|NCT02695446|75757219|FG000|NOT COMPLETED|Overall Study||0||
59640838|NCT02696070|75757225|FG000|STARTED|Overall Study||8||
59640839|NCT02696070|75757226|FG001|STARTED|Overall Study||14||
59640840|NCT02696070|75757225|FG000|COMPLETED|Overall Study||7||
59640841|NCT02696070|75757226|FG001|COMPLETED|Overall Study||12||
59640842|NCT02696070|75757225|FG000|NOT COMPLETED|Overall Study||1||
59640843|NCT02696070|75757226|FG001|NOT COMPLETED|Overall Study||2||
59640844|NCT02697240|75757232|FG000|STARTED|Overall Study||4||
59640845|NCT02697240|75757232|FG000|COMPLETED|Overall Study||4||
59640846|NCT02697240|75757232|FG000|NOT COMPLETED|Overall Study||0||
59640847|NCT02698566|75757236|FG000|STARTED|Overall Study||35||
59640848|NCT02698566|75757237|FG001|STARTED|Overall Study||3||
59640849|NCT02698566|75757236|FG000|COMPLETED|Overall Study||35||
59640850|NCT02698566|75757237|FG001|COMPLETED|Overall Study||3||
59640851|NCT02698566|75757236|FG000|NOT COMPLETED|Overall Study||0||
59640852|NCT02698566|75757237|FG001|NOT COMPLETED|Overall Study||0||
59640853|NCT02698800|75757241|FG000|STARTED|Overall Study||7||
59640854|NCT02698800|75757242|FG001|STARTED|Overall Study||8||
59640855|NCT02698800|75757241|FG000|COMPLETED|Overall Study||6||
59640856|NCT02698800|75757242|FG001|COMPLETED|Overall Study||8||
59640857|NCT02698800|75757241|FG000|NOT COMPLETED|Overall Study||1||
59640858|NCT02698800|75757242|FG001|NOT COMPLETED|Overall Study||0||
59640859|NCT02699970|75757248|FG000|STARTED|Overall Study||399||420
59640860|NCT02699970|75757248|FG000|Intra-system|Overall Study||399||420
59640861|NCT02699970|75757248|FG000|Inter-system|Overall Study||399||420
59640862|NCT02699970|75757248|FG000|COMPLETED|Overall Study||399||420
59640863|NCT02699970|75757248|FG000|NOT COMPLETED|Overall Study||0||0
59640864|NCT02657226|75757253|FG000|STARTED|Overall Study||15724||
59640865|NCT02657226|75757253|FG000|COMPLETED|Overall Study||15724|Total study population 15724.Patients were observed using different criteria of monitoring.|
59640866|NCT02657226|75757253|FG000|NOT COMPLETED|Overall Study||0||
59640867|NCT02701062|75757262|FG000|STARTED|Baseline||376||
59640868|NCT02701062|75757263|FG001|STARTED|Baseline||186||
59640869|NCT02701062|75757262|FG000|COMPLETED|Baseline||376||
59640870|NCT02701062|75757263|FG001|COMPLETED|Baseline||186||
59541462|NCT01531439|75639649|FG000|COMPLETED|Overall Study||37||
59541463|NCT01531439|75639650|FG001|COMPLETED|Overall Study||42||
59541464|NCT01531439|75639649|FG000|NOT COMPLETED|Overall Study||4||
59541465|NCT01531439|75639650|FG001|NOT COMPLETED|Overall Study||1||
59541466|NCT02504268|75639659|FG000|STARTED|Overall Study||451|= Started the Induction Period|
59541467|NCT02504268|75639660|FG001|STARTED|Overall Study||301|= Started the Induction Period|
59541468|NCT02504268|75639661|FG002|STARTED|Overall Study||242|= Started the Induction Period|
59541469|NCT02504268|75639662|FG003|STARTED|Overall Study||0|= Started the Induction Period|
59541470|NCT02504268|75639663|FG004|STARTED|Overall Study||0|= Started the Induction Period|
59541471|NCT02504268|75639664|FG005|STARTED|Overall Study||0|= Started the Induction Period|
59541472|NCT02504268|75639665|FG006|STARTED|Overall Study||0|= Started the Induction Period|
59541473|NCT02504268|75639666|FG007|STARTED|Overall Study||0|= Started the Induction Period|
59541474|NCT02504268|75639667|FG008|STARTED|Overall Study||0|= Started the Induction Period|
59541475|NCT02504268|75639659|FG000|Induction to Open Label|Overall Study||289|Number of participants who completed induction period and treated in Open Label Period|
59541476|NCT02504268|75639660|FG001|Induction to Open Label|Overall Study||196|Number of participants who completed induction period and treated in Open Label Period|
59640871|NCT02701062|75757262|FG000|NOT COMPLETED|Baseline||0||
59640872|NCT02701062|75757263|FG001|NOT COMPLETED|Baseline||0||
59640873|NCT02701062|75757262|FG000|STARTED|Index Procedure||376||
59640874|NCT02701062|75757263|FG001|STARTED|Index Procedure||186||
59640875|NCT02701062|75757262|FG000|COMPLETED|Index Procedure||376||
59640876|NCT02701062|75757263|FG001|COMPLETED|Index Procedure||186||
59640877|NCT02701062|75757262|FG000|NOT COMPLETED|Index Procedure||0||
59541477|NCT02504268|75639661|FG002|Induction to Open Label|Overall Study||147|Number of participants who completed induction period and treated in Open Label Period|
59541478|NCT02504268|75639662|FG003|Induction to Open Label|Overall Study||0|Number of participants who completed induction period and treated in Open Label Period|
59541479|NCT02504268|75639663|FG004|Induction to Open Label|Overall Study||0|Number of participants who completed induction period and treated in Open Label Period|
59640878|NCT02701062|75757263|FG001|NOT COMPLETED|Index Procedure||0||
59640879|NCT02701062|75757262|FG000|STARTED|Discharge||376||
59640880|NCT02701062|75757263|FG001|STARTED|Discharge||186||
59640881|NCT02701062|75757262|FG000|COMPLETED|Discharge||376||
59640882|NCT02701062|75757263|FG001|COMPLETED|Discharge||186||
59640883|NCT02701062|75757262|FG000|NOT COMPLETED|Discharge||0||
59640884|NCT02701062|75757263|FG001|NOT COMPLETED|Discharge||0||
59640885|NCT02701062|75757262|FG000|STARTED|30 Day Follow-up||376||
59640886|NCT02701062|75757263|FG001|STARTED|30 Day Follow-up||186||
59640887|NCT02701062|75757262|FG000|COMPLETED|30 Day Follow-up||366||
59640888|NCT02701062|75757263|FG001|COMPLETED|30 Day Follow-up||183||
59640889|NCT02701062|75757262|FG000|NOT COMPLETED|30 Day Follow-up||10||
59640890|NCT02701062|75757263|FG001|NOT COMPLETED|30 Day Follow-up||3||
59640891|NCT02701062|75757262|FG000|STARTED|90 Day Follow-up||366||
59640892|NCT02701062|75757263|FG001|STARTED|90 Day Follow-up||183||
59640893|NCT02701062|75757262|FG000|COMPLETED|90 Day Follow-up||308||
59640894|NCT02701062|75757263|FG001|COMPLETED|90 Day Follow-up||72||
59640895|NCT02701062|75757262|FG000|NOT COMPLETED|90 Day Follow-up||58||
59640896|NCT02701062|75757263|FG001|NOT COMPLETED|90 Day Follow-up||111||
59640897|NCT02701062|75757262|FG000|STARTED|365 Day Follow-up||308||
59640898|NCT02701062|75757263|FG001|STARTED|365 Day Follow-up||72||
59640899|NCT02701062|75757262|FG000|COMPLETED|365 Day Follow-up||294||
59640900|NCT02701062|75757263|FG001|COMPLETED|365 Day Follow-up||69||
59640901|NCT02701062|75757262|FG000|NOT COMPLETED|365 Day Follow-up||14||
59640902|NCT02701062|75757263|FG001|NOT COMPLETED|365 Day Follow-up||3||
59640903|NCT02704104|75757277|FG000|STARTED|Overall Study||46||
59640904|NCT02704104|75757277|FG000|COMPLETED|Overall Study||46||
59640905|NCT02704104|75757277|FG000|NOT COMPLETED|Overall Study||0||
59640906|NCT02705352|75757287|FG000|STARTED|Overall Study||1||
59640907|NCT02705352|75757288|FG001|STARTED|Overall Study||0||
59640908|NCT02705352|75757287|FG000|COMPLETED|Overall Study||1||
59640909|NCT02705352|75757288|FG001|COMPLETED|Overall Study||0||
59640910|NCT02705352|75757287|FG000|NOT COMPLETED|Overall Study||0||
59640911|NCT02705352|75757288|FG001|NOT COMPLETED|Overall Study||0||
59640912|NCT02707146|75757296|FG000|STARTED|Overall Study||359||
59640913|NCT02707146|75757297|FG001|STARTED|Overall Study||391||
59640914|NCT02707146|75757296|FG000|COMPLETED|Overall Study||359||
59640915|NCT02707146|75757297|FG001|COMPLETED|Overall Study||388||
59640916|NCT02707146|75757296|FG000|NOT COMPLETED|Overall Study||0||
59640917|NCT02707146|75757297|FG001|NOT COMPLETED|Overall Study||3||
59640918|NCT02707770|75757305|FG000|STARTED|Overall Study||10||
59640919|NCT02707770|75757306|FG001|STARTED|Overall Study||10||
59640920|NCT02707770|75757305|FG000|COMPLETED|Overall Study|One patient withdrew from the study following consent, initial assessment and randomisation|9||
59640921|NCT02707770|75757306|FG001|COMPLETED|Overall Study||10||
59640922|NCT02707770|75757305|FG000|NOT COMPLETED|Overall Study||1||
59640923|NCT02707770|75757306|FG001|NOT COMPLETED|Overall Study||0||
59640924|NCT02708238|75757317|FG000|STARTED|Overall Study||60||
59640925|NCT02708238|75757318|FG001|STARTED|Overall Study||60||
59640926|NCT02708238|75757319|FG002|STARTED|Overall Study||60||
59640927|NCT02708238|75757317|FG000|COMPLETED|Overall Study||60||
59640928|NCT02708238|75757318|FG001|COMPLETED|Overall Study||59||
59640929|NCT02708238|75757319|FG002|COMPLETED|Overall Study||57||
59640930|NCT02708238|75757317|FG000|NOT COMPLETED|Overall Study||0||
59640931|NCT02708238|75757318|FG001|NOT COMPLETED|Overall Study||1||
59640932|NCT02708238|75757319|FG002|NOT COMPLETED|Overall Study||3||
59640933|NCT02708862|75757327|FG000|STARTED|Overall Study||26||
59640934|NCT02708862|75757327|FG000|COMPLETED|Overall Study||26||
59640935|NCT02708862|75757327|FG000|NOT COMPLETED|Overall Study||0||
59640936|NCT02709018|75757336|FG000|STARTED|Overall Study||75||
59640937|NCT02709018|75757337|FG001|STARTED|Overall Study||74||
59640938|NCT02709018|75757336|FG000|COMPLETED|Overall Study||59||
59640939|NCT02709018|75757337|FG001|COMPLETED|Overall Study||58||
59640940|NCT02709018|75757336|FG000|NOT COMPLETED|Overall Study||16||
59640941|NCT02709018|75757337|FG001|NOT COMPLETED|Overall Study||16||
59640942|NCT02713230|75757348|FG000|STARTED|Overall Study||69||
59640943|NCT02713230|75757349|FG001|STARTED|Overall Study||15||
59640944|NCT02713230|75757350|FG002|STARTED|Overall Study||71||
59640945|NCT02713230|75757348|FG000|COMPLETED|Overall Study||68||
59640946|NCT02713230|75757349|FG001|COMPLETED|Overall Study||15||
59640947|NCT02713230|75757350|FG002|COMPLETED|Overall Study||71||
59640948|NCT02713230|75757348|FG000|NOT COMPLETED|Overall Study||1||
59640949|NCT02713230|75757349|FG001|NOT COMPLETED|Overall Study||0||
59640950|NCT02713230|75757350|FG002|NOT COMPLETED|Overall Study||0||
59640951|NCT02713698|75757360|FG000|STARTED|Overall Study||20||
59640952|NCT02713698|75757361|FG001|STARTED|Overall Study||20||
59640953|NCT02713698|75757362|FG002|STARTED|Overall Study||20||
59640954|NCT02713698|75757360|FG000|COMPLETED|Overall Study||20||
59640955|NCT02713698|75757361|FG001|COMPLETED|Overall Study||20||
59640956|NCT02713698|75757362|FG002|COMPLETED|Overall Study||20||
59640957|NCT02713698|75757360|FG000|NOT COMPLETED|Overall Study||0||
59640958|NCT02713698|75757361|FG001|NOT COMPLETED|Overall Study||0||
59640959|NCT02713698|75757362|FG002|NOT COMPLETED|Overall Study||0||
59640960|NCT02714400|75757370|FG000|STARTED|First Intervention (1 Day)||12||
59640961|NCT02714400|75757371|FG001|STARTED|First Intervention (1 Day)||8||
59640962|NCT02714400|75757370|FG000|COMPLETED|First Intervention (1 Day)||12||
59640963|NCT02714400|75757371|FG001|COMPLETED|First Intervention (1 Day)||8||
59640964|NCT02714400|75757370|FG000|NOT COMPLETED|First Intervention (1 Day)||0||
59640965|NCT02714400|75757371|FG001|NOT COMPLETED|First Intervention (1 Day)||0||
59640966|NCT02714400|75757370|FG000|STARTED|Washout (>4 Days)||12||
59640967|NCT02714400|75757371|FG001|STARTED|Washout (>4 Days)||8||
59640968|NCT02714400|75757370|FG000|COMPLETED|Washout (>4 Days)||12||
59640969|NCT02714400|75757371|FG001|COMPLETED|Washout (>4 Days)||8||
59640970|NCT02714400|75757370|FG000|NOT COMPLETED|Washout (>4 Days)||0||
59640971|NCT02714400|75757371|FG001|NOT COMPLETED|Washout (>4 Days)||0||
59640972|NCT02714400|75757370|FG000|STARTED|Second Intervention (1 Day)||12||
59640973|NCT02714400|75757371|FG001|STARTED|Second Intervention (1 Day)||8||
59640974|NCT02714400|75757370|FG000|COMPLETED|Second Intervention (1 Day)||12||
59640975|NCT02714400|75757371|FG001|COMPLETED|Second Intervention (1 Day)||8||
60076685|NCT01903525|76191693|FG001|STARTED|Overall Study||20||
60076686|NCT01903525|76191692|FG000|COMPLETED|Overall Study||15||
60076687|NCT01903525|76191693|FG001|COMPLETED|Overall Study||10||
60076688|NCT01903525|76191692|FG000|NOT COMPLETED|Overall Study||5||
60076689|NCT01903525|76191693|FG001|NOT COMPLETED|Overall Study||10||
60076690|NCT00981526|76191701|FG000|STARTED|Overall Study||26||
60076691|NCT00981526|76191702|FG001|STARTED|Overall Study||28||
60076692|NCT00981526|76191701|FG000|COMPLETED|Overall Study||22||
60076693|NCT00981526|76191702|FG001|COMPLETED|Overall Study||22||
60076694|NCT00981526|76191701|FG000|NOT COMPLETED|Overall Study||4||
60076695|NCT00981526|76191702|FG001|NOT COMPLETED|Overall Study||6||
60076696|NCT01927861|76191712|FG000|STARTED|Pivotal Phase (104 Weeks)||25||
59541480|NCT02504268|75639664|FG005|Induction to Open Label|Overall Study||0|Number of participants who completed induction period and treated in Open Label Period|
59541481|NCT02504268|75639665|FG006|Induction to Open Label|Overall Study||0|Number of participants who completed induction period and treated in Open Label Period|
59541482|NCT02504268|75639666|FG007|Induction to Open Label|Overall Study||0|Number of participants who completed induction period and treated in Open Label Period|
59541483|NCT02504268|75639667|FG008|Induction to Open Label|Overall Study||0|Number of participants who completed induction period and treated in Open Label Period|
59541484|NCT02504268|75639659|FG000|Early Escaped to Open Label|Overall Study||10|Number of participants who early escaped and treated in open label period|
59541485|NCT02504268|75639660|FG001|Early Escaped to Open Label|Overall Study||21|Number of participants who early escaped and treated in open label period|
59541486|NCT02504268|75639661|FG002|Early Escaped to Open Label|Overall Study||8|Number of participants who early escaped and treated in open label period|
59541487|NCT02504268|75639662|FG003|Early Escaped to Open Label|Overall Study||0|Number of participants who early escaped and treated in open label period|
59541488|NCT02504268|75639663|FG004|Early Escaped to Open Label|Overall Study||0|Number of participants who early escaped and treated in open label period|
59541489|NCT02504268|75639664|FG005|Early Escaped to Open Label|Overall Study||0|Number of participants who early escaped and treated in open label period|
59541490|NCT02504268|75639665|FG006|Early Escaped to Open Label|Overall Study||0|Number of participants who early escaped and treated in open label period|
59541491|NCT02504268|75639666|FG007|Early Escaped to Open Label|Overall Study||0|Number of participants who early escaped and treated in open label period|
59541492|NCT02504268|75639667|FG008|Early Escaped to Open Label|Overall Study||0|Number of participants who early escaped and treated in open label period|
59541493|NCT02504268|75639659|FG000|Induction to De-Escalation|Overall Study||94|Number of participants who completed induction period and treated in de-escalation period|
59541494|NCT02504268|75639660|FG001|Induction to De-Escalation|Overall Study||37|Number of participants who completed induction period and treated in de-escalation period|
59541495|NCT02504268|75639661|FG002|Induction to De-Escalation|Overall Study||53|Number of participants who completed induction period and treated in de-escalation period|
59541496|NCT02504268|75639662|FG003|Induction to De-Escalation|Overall Study||0|Number of participants who completed induction period and treated in de-escalation period|
59541497|NCT02504268|75639663|FG004|Induction to De-Escalation|Overall Study||0|Number of participants who completed induction period and treated in de-escalation period|
59541498|NCT02504268|75639664|FG005|Induction to De-Escalation|Overall Study||0|Number of participants who completed induction period and treated in de-escalation period|
59541499|NCT02504268|75639665|FG006|Induction to De-Escalation|Overall Study||0|Number of participants who completed induction period and treated in de-escalation period|
59541500|NCT02504268|75639666|FG007|Induction to De-Escalation|Overall Study||0|Number of participants who completed induction period and treated in de-escalation period|
59541501|NCT02504268|75639667|FG008|Induction to De-Escalation|Overall Study||0|Number of participants who completed induction period and treated in de-escalation period|
59541502|NCT02504268|75639659|FG000|Randomized in De-Escalation Period|Overall Study||0|Participants after induction period randomized into De-Escalation|
59541503|NCT02504268|75639660|FG001|Randomized in De-Escalation Period|Overall Study||0|Participants after induction period randomized into De-Escalation|
59541504|NCT02504268|75639661|FG002|Randomized in De-Escalation Period|Overall Study||0|Participants after induction period randomized into De-Escalation|
59541505|NCT02504268|75639662|FG003|Randomized in De-Escalation Period|Overall Study||50|Participants after induction period randomized into De-Escalation|
59541506|NCT02504268|75639663|FG004|Randomized in De-Escalation Period|Overall Study||50|Participants after induction period randomized into De-Escalation|
59541507|NCT02504268|75639664|FG005|Randomized in De-Escalation Period|Overall Study||47|Participants after induction period randomized into De-Escalation|
59565813|NCT02335242|75668229|FG000|NOT COMPLETED|Open-label Phase (20 Weeks)||0||
60076697|NCT01927861|76191713|FG001|STARTED|Pivotal Phase (104 Weeks)||26||
60076698|NCT01927861|76191712|FG000|COMPLETED|Pivotal Phase (104 Weeks)||25||
59640976|NCT02714400|75757370|FG000|NOT COMPLETED|Second Intervention (1 Day)||0||
59640977|NCT02714400|75757371|FG001|NOT COMPLETED|Second Intervention (1 Day)||0||
59640978|NCT02716506|75757377|FG000|STARTED|Overall Study||3515||
59640979|NCT02716506|75757377|FG000|6 Months|Overall Study|Patients that completed the questionnaires six months after the operation.|2528||
59640980|NCT02716506|75757377|FG000|2 Years|Overall Study|Patients that completed the questionnaires two years after the operation.|2351||
59640981|NCT02716506|75757377|FG000|COMPLETED|Overall Study||2351||
59640982|NCT02716506|75757377|FG000|NOT COMPLETED|Overall Study||1164||
59640983|NCT02716818|75757383|FG000|STARTED|Overall Study||61||
59640984|NCT02716818|75757384|FG001|STARTED|Overall Study||61||
59640985|NCT02716818|75757383|FG000|COMPLETED|Overall Study||58||
59640986|NCT02716818|75757384|FG001|COMPLETED|Overall Study||59||
59640987|NCT02716818|75757383|FG000|NOT COMPLETED|Overall Study||3||
59640988|NCT02716818|75757384|FG001|NOT COMPLETED|Overall Study||2||
59640989|NCT02719158|75757415|FG000|STARTED|Overall Study||38||
59640990|NCT02719158|75757416|FG001|STARTED|Overall Study||38||
59640991|NCT02719158|75757417|FG002|STARTED|Overall Study||19||
59640992|NCT02719158|75757415|FG000|COMPLETED|Overall Study||38||
59640993|NCT02719158|75757416|FG001|COMPLETED|Overall Study||38||
59640994|NCT02719158|75757417|FG002|COMPLETED|Overall Study||18||
59640995|NCT02719158|75757415|FG000|NOT COMPLETED|Overall Study||0||
59640996|NCT02719158|75757416|FG001|NOT COMPLETED|Overall Study||0||
59640997|NCT02719158|75757417|FG002|NOT COMPLETED|Overall Study||1||
59640998|NCT02719938|75757427|FG000|STARTED|Overall Study||30||
59640999|NCT02719938|75757428|FG001|STARTED|Overall Study||32||
59641000|NCT02719938|75757427|FG000|COMPLETED|Overall Study||26||
59641001|NCT02719938|75757428|FG001|COMPLETED|Overall Study||31||
59641002|NCT02719938|75757427|FG000|NOT COMPLETED|Overall Study||4||
59641003|NCT02719938|75757428|FG001|NOT COMPLETED|Overall Study||1||
59641004|NCT02723916|75757436|FG000|STARTED|Overall Study||144||
59641005|NCT02723916|75757437|FG001|STARTED|Overall Study||143||
59641006|NCT02723916|75757436|FG000|COMPLETED|Overall Study||135||
59641007|NCT02723916|75757437|FG001|COMPLETED|Overall Study||137||
59641008|NCT02723916|75757436|FG000|NOT COMPLETED|Overall Study||9||
59641009|NCT02723916|75757437|FG001|NOT COMPLETED|Overall Study||6||
59641010|NCT02726178|75757445|FG000|STARTED|Overall Study||28||
59641011|NCT02726178|75757446|FG001|STARTED|Overall Study||28||
59641012|NCT02726178|75757445|FG000|COMPLETED|Overall Study||28||
59641013|NCT02726178|75757446|FG001|COMPLETED|Overall Study||28||
59641014|NCT02726178|75757445|FG000|NOT COMPLETED|Overall Study||0||
59641015|NCT02726178|75757446|FG001|NOT COMPLETED|Overall Study||0||
59641016|NCT02727816|75757454|FG000|STARTED|Overall Study||35||
59641017|NCT02727816|75757454|FG000|COMPLETED|Overall Study||35||
59641018|NCT02727816|75757454|FG000|NOT COMPLETED|Overall Study||0||
59641019|NCT02727894|75757476|FG000|STARTED|Overall Study|March 2013|73||
59641020|NCT02727894|75757477|FG001|STARTED|Overall Study|March 2013|192||
59641021|NCT02727894|75757476|FG000|COMPLETED|Overall Study|September 2015|73||
59641022|NCT02727894|75757477|FG001|COMPLETED|Overall Study|September 2015|192||
59641023|NCT02727894|75757476|FG000|NOT COMPLETED|Overall Study||0||
59641024|NCT02727894|75757477|FG001|NOT COMPLETED|Overall Study||0||
59641025|NCT02730234|75757486|FG000|STARTED|Overall Study||60||
59641026|NCT02730234|75757486|FG000|COMPLETED|Overall Study|8 Deaths|52||
59641027|NCT02730234|75757486|FG000|NOT COMPLETED|Overall Study||8||
59641028|NCT02733588|75757490|FG000|STARTED|Overall Study||7||
59641029|NCT02733588|75757490|FG000|COMPLETED|Overall Study||7||
59641030|NCT02733588|75757490|FG000|NOT COMPLETED|Overall Study||0||
59641031|NCT02734056|75757496|FG000|STARTED|Overall Study||50||
59641032|NCT02734056|75757497|FG001|STARTED|Overall Study||50||
59641033|NCT02734056|75757496|FG000|COMPLETED|Overall Study||50||
59641034|NCT02734056|75757497|FG001|COMPLETED|Overall Study||49||
59641035|NCT02734056|75757496|FG000|NOT COMPLETED|Overall Study||0||
59641036|NCT02734056|75757497|FG001|NOT COMPLETED|Overall Study||1||
59641037|NCT02735382|75757507|FG000|STARTED|Overall Study||7481||
59641038|NCT02735382|75757508|FG001|STARTED|Overall Study||7155||
59641039|NCT02735382|75757509|FG002|STARTED|Overall Study||184||
59641040|NCT02735382|75757510|FG003|STARTED|Overall Study||110||
59641041|NCT02735382|75757507|FG000|COMPLETED|Overall Study||7481||
59641042|NCT02735382|75757508|FG001|COMPLETED|Overall Study||7155||
59641043|NCT02735382|75757509|FG002|COMPLETED|Overall Study||184||
59641044|NCT02735382|75757510|FG003|COMPLETED|Overall Study||110||
59641045|NCT02735382|75757507|FG000|NOT COMPLETED|Overall Study||0||
59641046|NCT02735382|75757508|FG001|NOT COMPLETED|Overall Study||0||
59641047|NCT02735382|75757509|FG002|NOT COMPLETED|Overall Study||0||
59641048|NCT02735382|75757510|FG003|NOT COMPLETED|Overall Study||0||
59641049|NCT02737332|75757522|FG000|STARTED|Overall Study||29||
59641050|NCT02737332|75757523|FG001|STARTED|Overall Study||24||
59641051|NCT02737332|75757522|FG000|COMPLETED|Overall Study||28||
59641052|NCT02737332|75757523|FG001|COMPLETED|Overall Study||23||
59541508|NCT02504268|75639665|FG006|Randomized in De-Escalation Period|Overall Study||37|Participants after induction period randomized into De-Escalation|
59541509|NCT02504268|75639666|FG007|Randomized in De-Escalation Period|Overall Study||0|Participants after induction period randomized into De-Escalation|
59541510|NCT02504268|75639667|FG008|Randomized in De-Escalation Period|Overall Study||0|Participants after induction period randomized into De-Escalation|
59541511|NCT02504268|75639659|FG000|De-Escalation to Open Label Extension|Overall Study||0|Number of participants who completed De-escalation period and treated in Open Label Extension Period|
59541512|NCT02504268|75639660|FG001|De-Escalation to Open Label Extension|Overall Study||0|Number of participants who completed De-escalation period and treated in Open Label Extension Period|
59541513|NCT02504268|75639661|FG002|De-Escalation to Open Label Extension|Overall Study||0|Number of participants who completed De-escalation period and treated in Open Label Extension Period|
59541514|NCT02504268|75639662|FG003|De-Escalation to Open Label Extension|Overall Study||36|Number of participants who completed De-escalation period and treated in Open Label Extension Period|
59541515|NCT02504268|75639663|FG004|De-Escalation to Open Label Extension|Overall Study||30|Number of participants who completed De-escalation period and treated in Open Label Extension Period|
59541516|NCT02504268|75639664|FG005|De-Escalation to Open Label Extension|Overall Study||32|Number of participants who completed De-escalation period and treated in Open Label Extension Period|
59541517|NCT02504268|75639665|FG006|De-Escalation to Open Label Extension|Overall Study||22|Number of participants who completed De-escalation period and treated in Open Label Extension Period|
59541518|NCT02504268|75639666|FG007|De-Escalation to Open Label Extension|Overall Study||0|Number of participants who completed De-escalation period and treated in Open Label Extension Period|
59541519|NCT02504268|75639667|FG008|De-Escalation to Open Label Extension|Overall Study||0|Number of participants who completed De-escalation period and treated in Open Label Extension Period|
59541520|NCT02504268|75639659|FG000|Early Escaped De-Escalation to Open Label Period|Overall Study||0|Number of participants who early escaped the De-Escalation Period and treated in the Open Label Period|
59541521|NCT02504268|75639660|FG001|Early Escaped De-Escalation to Open Label Period|Overall Study||0|Number of participants who early escaped the De-Escalation Period and treated in the Open Label Period|
59541522|NCT02504268|75639661|FG002|Early Escaped De-Escalation to Open Label Period|Overall Study||0|Number of participants who early escaped the De-Escalation Period and treated in the Open Label Period|
59541523|NCT02504268|75639662|FG003|Early Escaped De-Escalation to Open Label Period|Overall Study||2|Number of participants who early escaped the De-Escalation Period and treated in the Open Label Period|
59541524|NCT02504268|75639663|FG004|Early Escaped De-Escalation to Open Label Period|Overall Study||5|Number of participants who early escaped the De-Escalation Period and treated in the Open Label Period|
59541525|NCT02504268|75639664|FG005|Early Escaped De-Escalation to Open Label Period|Overall Study||4|Number of participants who early escaped the De-Escalation Period and treated in the Open Label Period|
59541526|NCT02504268|75639665|FG006|Early Escaped De-Escalation to Open Label Period|Overall Study||3|Number of participants who early escaped the De-Escalation Period and treated in the Open Label Period|
59541527|NCT02504268|75639666|FG007|Early Escaped De-Escalation to Open Label Period|Overall Study||0|Number of participants who early escaped the De-Escalation Period and treated in the Open Label Period|
59541528|NCT02504268|75639667|FG008|Early Escaped De-Escalation to Open Label Period|Overall Study||0|Number of participants who early escaped the De-Escalation Period and treated in the Open Label Period|
59541529|NCT02504268|75639659|FG000|Open Label and Open Label Extension Period|Overall Study||0|Participants who entered Open Label and Open Label Extension Periods|
59541530|NCT02504268|75639660|FG001|Open Label and Open Label Extension Period|Overall Study||0|Participants who entered Open Label and Open Label Extension Periods|
59541531|NCT02504268|75639661|FG002|Open Label and Open Label Extension Period|Overall Study||0|Participants who entered Open Label and Open Label Extension Periods|
59541532|NCT02504268|75639662|FG003|Open Label and Open Label Extension Period|Overall Study||0|Participants who entered Open Label and Open Label Extension Periods|
59541533|NCT02504268|75639663|FG004|Open Label and Open Label Extension Period|Overall Study||0|Participants who entered Open Label and Open Label Extension Periods|
59541534|NCT02504268|75639664|FG005|Open Label and Open Label Extension Period|Overall Study||0|Participants who entered Open Label and Open Label Extension Periods|
59541535|NCT02504268|75639665|FG006|Open Label and Open Label Extension Period|Overall Study||0|Participants who entered Open Label and Open Label Extension Periods|
59541536|NCT02504268|75639666|FG007|Open Label and Open Label Extension Period|Overall Study||685|Participants who entered Open Label and Open Label Extension Periods|
59541537|NCT02504268|75639667|FG008|Open Label and Open Label Extension Period|Overall Study||120|Participants who entered Open Label and Open Label Extension Periods|
59541538|NCT02504268|75639659|FG000|COMPLETED|Overall Study||388|Completed = Completed Induction Period|
59541539|NCT02504268|75639660|FG001|COMPLETED|Overall Study||233|Completed = Completed Induction Period|
59541540|NCT02504268|75639661|FG002|COMPLETED|Overall Study||201|Completed = Completed Induction Period|
59541541|NCT02504268|75639662|FG003|COMPLETED|Overall Study||0|Completed = Completed Induction Period|
59541542|NCT02504268|75639663|FG004|COMPLETED|Overall Study||0|Completed = Completed Induction Period|
59541543|NCT02504268|75639664|FG005|COMPLETED|Overall Study||0|Completed = Completed Induction Period|
59541544|NCT02504268|75639665|FG006|COMPLETED|Overall Study||0|Completed = Completed Induction Period|
59541545|NCT02504268|75639666|FG007|COMPLETED|Overall Study||0|Completed = Completed Induction Period|
59541546|NCT02504268|75639667|FG008|COMPLETED|Overall Study||0|Completed = Completed Induction Period|
59541547|NCT02504268|75639659|FG000|NOT COMPLETED|Overall Study||63||
59541548|NCT02504268|75639660|FG001|NOT COMPLETED|Overall Study||68||
59541549|NCT02504268|75639661|FG002|NOT COMPLETED|Overall Study||41||
59541550|NCT02504268|75639662|FG003|NOT COMPLETED|Overall Study||0||
59541551|NCT02504268|75639663|FG004|NOT COMPLETED|Overall Study||0||
59541552|NCT02504268|75639664|FG005|NOT COMPLETED|Overall Study||0||
59541553|NCT02504268|75639665|FG006|NOT COMPLETED|Overall Study||0||
59541554|NCT02504268|75639666|FG007|NOT COMPLETED|Overall Study||0||
59541555|NCT02504268|75639667|FG008|NOT COMPLETED|Overall Study||0||
59641053|NCT02737332|75757522|FG000|NOT COMPLETED|Overall Study||1||
59641054|NCT02737332|75757523|FG001|NOT COMPLETED|Overall Study||1||
59641055|NCT02445456|75757533|FG000|STARTED|Overall Study||13||
59641056|NCT02445456|75757534|FG001|STARTED|Overall Study||2||
59641057|NCT02445456|75757533|FG000|COMPLETED|Overall Study||13||
59641058|NCT02445456|75757534|FG001|COMPLETED|Overall Study||2||
59641059|NCT02445456|75757533|FG000|NOT COMPLETED|Overall Study||0||
59641060|NCT02445456|75757534|FG001|NOT COMPLETED|Overall Study||0||
59641061|NCT05028426|75757543|FG000|STARTED|Overall Study||214||
59641062|NCT05028426|75757544|FG001|STARTED|Overall Study||132||
59641063|NCT05028426|75757545|FG002|STARTED|Overall Study||109||
59641064|NCT05028426|75757543|FG000|COMPLETED|Overall Study||214||
59641065|NCT05028426|75757544|FG001|COMPLETED|Overall Study||132||
59641066|NCT05028426|75757545|FG002|COMPLETED|Overall Study||109||
59641067|NCT05028426|75757543|FG000|NOT COMPLETED|Overall Study||0||
59641068|NCT05028426|75757544|FG001|NOT COMPLETED|Overall Study||0||
59641069|NCT05028426|75757545|FG002|NOT COMPLETED|Overall Study||0||
59641070|NCT04522206|75757553|FG000|STARTED|Overall Study||44||
59641071|NCT04522206|75757553|FG000|COMPLETED|Overall Study||44||
59641072|NCT04522206|75757553|FG000|NOT COMPLETED|Overall Study||0||
59641073|NCT04505592|75757559|FG000|STARTED|Overall Study||8||
59641074|NCT04505592|75757560|FG001|STARTED|Overall Study||5||
59641075|NCT04505592|75757559|FG000|COMPLETED|Overall Study||6||
59641076|NCT04505592|75757560|FG001|COMPLETED|Overall Study||4||
59641077|NCT04505592|75757559|FG000|NOT COMPLETED|Overall Study||2||
59641078|NCT04505592|75757560|FG001|NOT COMPLETED|Overall Study||1||
59641079|NCT03745716|75757568|FG000|STARTED|Overall Study||78||
59641080|NCT03745716|75757569|FG001|STARTED|Overall Study||76||
59641081|NCT03745716|75757568|FG000|COMPLETED|Overall Study||75||
59641082|NCT03745716|75757569|FG001|COMPLETED|Overall Study||74||
59641083|NCT03745716|75757568|FG000|NOT COMPLETED|Overall Study||3||
59641084|NCT03745716|75757569|FG001|NOT COMPLETED|Overall Study||2||
59641085|NCT03395340|75757575|FG000|STARTED|Overall Study||1||
59641086|NCT03395340|75757575|FG000|COMPLETED|Overall Study||1||
59641087|NCT03395340|75757575|FG000|NOT COMPLETED|Overall Study||0||
59641088|NCT00553800|75757581|FG000|STARTED|Overall Study||32||
59641089|NCT00553800|75757581|FG000|COMPLETED|Overall Study||32||
59641090|NCT00553800|75757581|FG000|NOT COMPLETED|Overall Study||0||
59641091|NCT02747628|75757588|FG000|STARTED|Overall Study||20||
59641092|NCT02747628|75757589|FG001|STARTED|Overall Study||20||
59641093|NCT02747628|75757590|FG002|STARTED|Overall Study||20||
59641094|NCT02747628|75757588|FG000|COMPLETED|Overall Study||20||
59641095|NCT02747628|75757589|FG001|COMPLETED|Overall Study||20||
59641096|NCT02747628|75757590|FG002|COMPLETED|Overall Study||20||
59641097|NCT02747628|75757588|FG000|NOT COMPLETED|Overall Study||0||
59641098|NCT02747628|75757589|FG001|NOT COMPLETED|Overall Study||0||
59641099|NCT02747628|75757590|FG002|NOT COMPLETED|Overall Study||0||
59641100|NCT02748096|75757600|FG000|STARTED|Overall Study||23||
59988519|NCT02514746|76103686|FG001|Valid Serology 4 Years Post Primary Dose|Overall Study||109||
59988520|NCT02514746|76103685|FG000|Received CD-JEV Booster Vaccine|Overall Study||424||
59988521|NCT02514746|76103686|FG001|Received CD-JEV Booster Vaccine|Overall Study||109||
59988522|NCT02514746|76103685|FG000|COMPLETED|Overall Study||415|Completed all study visits through 28 days post booster vaccination.|
59988523|NCT02514746|76103686|FG001|COMPLETED|Overall Study||109|Completed all study visits through 28 days post booster vaccination.|
59988524|NCT02514746|76103685|FG000|NOT COMPLETED|Overall Study||22||
59541556|NCT00904826|75639687|FG000|STARTED|Overall Study||14||
59541557|NCT00904826|75639687|FG000|COMPLETED|Overall Study||14||
59541558|NCT00904826|75639687|FG000|NOT COMPLETED|Overall Study||0||
59641101|NCT02748096|75757601|FG001|STARTED|Overall Study||22||
59641102|NCT02748096|75757600|FG000|COMPLETED|Overall Study||23||
59641103|NCT02748096|75757601|FG001|COMPLETED|Overall Study||22||
59641104|NCT02748096|75757600|FG000|NOT COMPLETED|Overall Study||0||
59641105|NCT02748096|75757601|FG001|NOT COMPLETED|Overall Study||0||
59641106|NCT02754570|75757607|FG000|STARTED|Overall Study||27||
59641107|NCT02754570|75757607|FG000|Visits 1 and 2 (PGA Only)|Overall Study||27||
59641108|NCT02754570|75757607|FG000|Visit 3 (PGA + Pilocarpine)|Overall Study||27||
59641109|NCT02754570|75757607|FG000|COMPLETED|Overall Study||27||
59641110|NCT02754570|75757607|FG000|NOT COMPLETED|Overall Study||0||
59641111|NCT02756910|75757613|FG000|STARTED|Overall Study||80||
59541559|NCT01532453|75639693|FG000|STARTED|Overall Study||81||
59541560|NCT01532453|75639694|FG001|STARTED|Overall Study||160||
59541561|NCT01532453|75639693|FG000|COMPLETED|Overall Study||54||
59541562|NCT01532453|75639694|FG001|COMPLETED|Overall Study||90||
59541563|NCT01532453|75639693|FG000|NOT COMPLETED|Overall Study||27||
59541564|NCT01532453|75639694|FG001|NOT COMPLETED|Overall Study||70||
59541565|NCT01448525|75639702|FG000|STARTED|Overall Study||44||
59641112|NCT02756910|75757613|FG000|COMPLETED|Overall Study||80||
59641113|NCT02756910|75757613|FG000|NOT COMPLETED|Overall Study||0||
59641114|NCT02760264|75757621|FG000|STARTED|0.25 mg/kg/Day||12||
59641115|NCT02760264|75757622|FG001|STARTED|0.25 mg/kg/Day||0||
59641116|NCT02760264|75757623|FG002|STARTED|0.25 mg/kg/Day||0||
59641117|NCT02760264|75757624|FG003|STARTED|0.25 mg/kg/Day||0||
59641118|NCT02760264|75757621|FG000|COMPLETED|0.25 mg/kg/Day||12||
59641119|NCT02760264|75757622|FG001|COMPLETED|0.25 mg/kg/Day||0||
59641120|NCT02760264|75757623|FG002|COMPLETED|0.25 mg/kg/Day||0||
59641121|NCT02760264|75757624|FG003|COMPLETED|0.25 mg/kg/Day||0||
59641122|NCT02760264|75757621|FG000|NOT COMPLETED|0.25 mg/kg/Day||0||
59541566|NCT01448525|75639703|FG001|STARTED|Overall Study||44||
59541567|NCT01448525|75639702|FG000|COMPLETED|Overall Study||43||
59541568|NCT01448525|75639703|FG001|COMPLETED|Overall Study||42||
59541569|NCT01448525|75639702|FG000|NOT COMPLETED|Overall Study||1||
59541570|NCT01448525|75639703|FG001|NOT COMPLETED|Overall Study||2||
59541571|NCT01654302|75639711|FG000|STARTED|First Intervention (Day 1)||20||
59541572|NCT01654302|75639712|FG001|STARTED|First Intervention (Day 1)||20||
59541573|NCT01654302|75639711|FG000|COMPLETED|First Intervention (Day 1)||20||
59541574|NCT01654302|75639712|FG001|COMPLETED|First Intervention (Day 1)||20||
59541575|NCT01654302|75639711|FG000|NOT COMPLETED|First Intervention (Day 1)||0||
59541576|NCT01654302|75639712|FG001|NOT COMPLETED|First Intervention (Day 1)||0||
59541577|NCT01654302|75639711|FG000|STARTED|Second Intervention (Day 7)||20||
59541578|NCT01654302|75639712|FG001|STARTED|Second Intervention (Day 7)||20||
59541579|NCT01654302|75639711|FG000|COMPLETED|Second Intervention (Day 7)||19||
59541580|NCT01654302|75639712|FG001|COMPLETED|Second Intervention (Day 7)||19||
59541581|NCT01654302|75639711|FG000|NOT COMPLETED|Second Intervention (Day 7)||1||
59541582|NCT01654302|75639712|FG001|NOT COMPLETED|Second Intervention (Day 7)||1||
59541583|NCT01551095|75639718|FG000|STARTED|Overall Study||7||
59541584|NCT01551095|75639718|FG000|COMPLETED|Overall Study||7||
59541585|NCT01551095|75639718|FG000|NOT COMPLETED|Overall Study||0||
59541586|NCT01449305|75639722|FG000|STARTED|Overall Study||44||
59541587|NCT01449305|75639722|FG000|COMPLETED|Overall Study||42||
59541588|NCT01449305|75639722|FG000|NOT COMPLETED|Overall Study||2||
59541589|NCT02476422|75639728|FG000|STARTED|Overall Study|"started = Randomized Set/Full analysis set/Safety set"|166||
59541590|NCT02476422|75639729|FG001|STARTED|Overall Study||162||
59541591|NCT02476422|75639728|FG000|COMPLETED|Overall Study||166||
59541592|NCT02476422|75639729|FG001|COMPLETED|Overall Study||161||
59541593|NCT02476422|75639728|FG000|NOT COMPLETED|Overall Study||0||
59541594|NCT02476422|75639729|FG001|NOT COMPLETED|Overall Study||1||
59541595|NCT01450319|75639735|FG000|STARTED|Overall Study||70||
59541596|NCT01450319|75639735|FG000|COMPLETED|Overall Study||70||
59541597|NCT01450319|75639735|FG000|NOT COMPLETED|Overall Study||0||
59541598|NCT01552343|75639741|FG000|STARTED|Overall Study||29||
59641123|NCT02760264|75757622|FG001|NOT COMPLETED|0.25 mg/kg/Day||0||
59641124|NCT02760264|75757623|FG002|NOT COMPLETED|0.25 mg/kg/Day||0||
59815745|NCT03026283|75938211|FG000|STARTED|CCTA Diagnosis||586||
59541599|NCT01552343|75639742|FG001|STARTED|Overall Study||27||
59541600|NCT01552343|75639741|FG000|COMPLETED|Overall Study||29||
59541601|NCT01552343|75639742|FG001|COMPLETED|Overall Study||27||
59541602|NCT01552343|75639741|FG000|NOT COMPLETED|Overall Study||0||
59541603|NCT01552343|75639742|FG001|NOT COMPLETED|Overall Study||0||
59541604|NCT02475564|75639759|FG000|STARTED|Overall Study||22||
59541605|NCT02475564|75639760|FG001|STARTED|Overall Study||22||
59541606|NCT02475564|75639759|FG000|COMPLETED|Overall Study||18||
59541607|NCT02475564|75639760|FG001|COMPLETED|Overall Study||21||
59541608|NCT02475564|75639759|FG000|NOT COMPLETED|Overall Study||4||
59541609|NCT02475564|75639760|FG001|NOT COMPLETED|Overall Study||1||
59541610|NCT00893984|75639766|FG000|STARTED|Overall Study||6||
59641125|NCT02760264|75757624|FG003|NOT COMPLETED|0.25 mg/kg/Day||0||
59641126|NCT02760264|75757621|FG000|STARTED|0.75 mg/kg/Day||0||
59641127|NCT02760264|75757622|FG001|STARTED|0.75 mg/kg/Day||12||
59641128|NCT02760264|75757623|FG002|STARTED|0.75 mg/kg/Day||0||
59541611|NCT00893984|75639766|FG000|COMPLETED|Overall Study||0||
59541612|NCT00893984|75639766|FG000|NOT COMPLETED|Overall Study||6||
59541613|NCT01552889|75639772|FG000|STARTED|Overall Study||101||
59541614|NCT01552889|75639773|FG001|STARTED|Overall Study||100||
59541615|NCT01552889|75639772|FG000|COMPLETED|Overall Study||90||
59541616|NCT01552889|75639773|FG001|COMPLETED|Overall Study||95||
59541617|NCT01552889|75639772|FG000|NOT COMPLETED|Overall Study||11||
59541618|NCT01552889|75639773|FG001|NOT COMPLETED|Overall Study||5||
59541619|NCT01553201|75639783|FG000|STARTED|Overall Study||15||
59641129|NCT02760264|75757624|FG003|STARTED|0.75 mg/kg/Day||0||
59641130|NCT02760264|75757621|FG000|COMPLETED|0.75 mg/kg/Day||0||
59641131|NCT02760264|75757622|FG001|COMPLETED|0.75 mg/kg/Day||12||
59641132|NCT02760264|75757623|FG002|COMPLETED|0.75 mg/kg/Day||0||
59641133|NCT02760264|75757624|FG003|COMPLETED|0.75 mg/kg/Day||0||
59641134|NCT02760264|75757621|FG000|NOT COMPLETED|0.75 mg/kg/Day||0||
59641135|NCT02760264|75757622|FG001|NOT COMPLETED|0.75 mg/kg/Day||0||
59541620|NCT01553201|75639784|FG001|STARTED|Overall Study||15||
59541621|NCT01553201|75639783|FG000|COMPLETED|Overall Study||15||
59541622|NCT01553201|75639784|FG001|COMPLETED|Overall Study||15||
59541623|NCT01553201|75639783|FG000|NOT COMPLETED|Overall Study||0||
59541624|NCT01553201|75639784|FG001|NOT COMPLETED|Overall Study||0||
59541625|NCT01533077|75639794|FG000|STARTED|Overall Study||5||
59541626|NCT01533077|75639795|FG001|STARTED|Overall Study||5||
59541627|NCT01533077|75639796|FG002|STARTED|Overall Study||4||
59541628|NCT01533077|75639797|FG003|STARTED|Overall Study||4||
59541629|NCT01533077|75639794|FG000|BIA 9-1067 50 mg|Overall Study||5||
59541630|NCT01533077|75639795|FG001|BIA 9-1067 50 mg|Overall Study||5||
59541631|NCT01533077|75639796|FG002|BIA 9-1067 50 mg|Overall Study||4||
59541632|NCT01533077|75639797|FG003|BIA 9-1067 50 mg|Overall Study||4||
59541633|NCT01533077|75639794|FG000|Sinemet® 100/25|Overall Study||4||
59541634|NCT01533077|75639795|FG001|Sinemet® 100/25|Overall Study||5||
59541635|NCT01533077|75639796|FG002|Sinemet® 100/25|Overall Study||4||
59541636|NCT01533077|75639797|FG003|Sinemet® 100/25|Overall Study||4||
59541637|NCT01533077|75639794|FG000|BIA 9-1067 50 mg + Sinemet® 100/25|Overall Study||4||
59541638|NCT01533077|75639795|FG001|BIA 9-1067 50 mg + Sinemet® 100/25|Overall Study||4||
59541639|NCT01533077|75639796|FG002|BIA 9-1067 50 mg + Sinemet® 100/25|Overall Study||4||
59541640|NCT01533077|75639797|FG003|BIA 9-1067 50 mg + Sinemet® 100/25|Overall Study||4||
59541641|NCT01533077|75639794|FG000|Sinemet® 100/25 1 h After the BIA 9-1067|Overall Study||5||
59541642|NCT01533077|75639795|FG001|Sinemet® 100/25 1 h After the BIA 9-1067|Overall Study||5||
59541643|NCT01533077|75639796|FG002|Sinemet® 100/25 1 h After the BIA 9-1067|Overall Study||4||
59541644|NCT01533077|75639797|FG003|Sinemet® 100/25 1 h After the BIA 9-1067|Overall Study||4||
59541645|NCT01533077|75639794|FG000|COMPLETED|Overall Study||4||
59541646|NCT01533077|75639795|FG001|COMPLETED|Overall Study||4||
59541647|NCT01533077|75639796|FG002|COMPLETED|Overall Study||4||
59541648|NCT01533077|75639797|FG003|COMPLETED|Overall Study||4||
59541649|NCT01533077|75639794|FG000|NOT COMPLETED|Overall Study||1||
59541650|NCT01533077|75639795|FG001|NOT COMPLETED|Overall Study||1||
59541651|NCT01533077|75639796|FG002|NOT COMPLETED|Overall Study||0||
59541652|NCT01533077|75639797|FG003|NOT COMPLETED|Overall Study||0||
59541653|NCT01534013|75639809|FG000|STARTED|Overall Study||8||
59541654|NCT01534013|75639810|FG001|STARTED|Overall Study||6||
59541655|NCT01534013|75639809|FG000|COMPLETED|Overall Study||6||
59541656|NCT01534013|75639810|FG001|COMPLETED|Overall Study||6||
59541657|NCT01534013|75639809|FG000|NOT COMPLETED|Overall Study||2||
59541658|NCT01534013|75639810|FG001|NOT COMPLETED|Overall Study||0||
59541659|NCT01450397|75639816|FG000|STARTED|Overall Study||5||
59541660|NCT01450397|75639816|FG000|COMPLETED|Overall Study||5||
59541661|NCT01450397|75639816|FG000|NOT COMPLETED|Overall Study||0||
59541662|NCT01532141|75639823|FG000|STARTED|Overall Study||9||
59541663|NCT01532141|75639824|FG001|STARTED|Overall Study||8||
59541664|NCT01532141|75639825|FG002|STARTED|Overall Study||8||
59541665|NCT01532141|75639823|FG000|Period 1|Overall Study||9||
59541666|NCT01532141|75639824|FG001|Period 1|Overall Study||8||
59541667|NCT01532141|75639825|FG002|Period 1|Overall Study||8||
59541668|NCT01532141|75639823|FG000|Period 2|Overall Study||8||
59541669|NCT01532141|75639824|FG001|Period 2|Overall Study||8||
59541670|NCT01532141|75639825|FG002|Period 2|Overall Study||8||
59541671|NCT01532141|75639823|FG000|Period 3|Overall Study||8||
59541672|NCT01532141|75639824|FG001|Period 3|Overall Study||8||
59541673|NCT01532141|75639825|FG002|Period 3|Overall Study||8||
59541674|NCT01532141|75639823|FG000|COMPLETED|Overall Study||8||
59541675|NCT01532141|75639824|FG001|COMPLETED|Overall Study||8||
59541676|NCT01532141|75639825|FG002|COMPLETED|Overall Study||8||
59541677|NCT01532141|75639823|FG000|NOT COMPLETED|Overall Study||1||
59541678|NCT01532141|75639824|FG001|NOT COMPLETED|Overall Study||0||
59541679|NCT01532141|75639825|FG002|NOT COMPLETED|Overall Study||0||
59541680|NCT00899600|75639836|FG000|STARTED|Overall Study||50||
59541681|NCT00899600|75639837|FG001|STARTED|Overall Study||52||
59541682|NCT00899600|75639836|FG000|COMPLETED|Overall Study||50||
59541683|NCT00899600|75639837|FG001|COMPLETED|Overall Study||52||
59541684|NCT00899600|75639836|FG000|NOT COMPLETED|Overall Study||0||
59541685|NCT00899600|75639837|FG001|NOT COMPLETED|Overall Study||0||
59541686|NCT01554371|75639846|FG000|STARTED|Overall Study||3||
59541687|NCT01554371|75639847|FG001|STARTED|Overall Study||3||
59541688|NCT01554371|75639848|FG002|STARTED|Overall Study||38||
59541689|NCT01554371|75639846|FG000|COMPLETED|Overall Study||3||
59541690|NCT01554371|75639847|FG001|COMPLETED|Overall Study||3||
59541691|NCT01554371|75639848|FG002|COMPLETED|Overall Study||38||
59541692|NCT01554371|75639846|FG000|NOT COMPLETED|Overall Study||0||
59541693|NCT01554371|75639847|FG001|NOT COMPLETED|Overall Study||0||
59541694|NCT01554371|75639848|FG002|NOT COMPLETED|Overall Study||0||
59541695|NCT01450787|75639861|FG000|STARTED|Overall Study||38||
59541696|NCT01450787|75639862|FG001|STARTED|Overall Study||25||
59541697|NCT01450787|75639861|FG000|COMPLETED|Overall Study||38||
59541698|NCT01450787|75639862|FG001|COMPLETED|Overall Study||25||
59541699|NCT01450787|75639861|FG000|NOT COMPLETED|Overall Study||0||
59541700|NCT01450787|75639862|FG001|NOT COMPLETED|Overall Study||0||
59541701|NCT01451411|75639870|FG000|STARTED|Overall Study||3||
59541702|NCT01451411|75639871|FG001|STARTED|Overall Study||1||
59541703|NCT01451411|75639870|FG000|COMPLETED|Overall Study||3||
59541704|NCT01451411|75639871|FG001|COMPLETED|Overall Study||1||
59541705|NCT01451411|75639870|FG000|NOT COMPLETED|Overall Study||0||
59541706|NCT01451411|75639871|FG001|NOT COMPLETED|Overall Study||0||
59541707|NCT01554683|75639877|FG000|STARTED|Overall Study||2||
59541708|NCT01554683|75639878|FG001|STARTED|Overall Study||1||
59541709|NCT01554683|75639879|FG002|STARTED|Overall Study||3||
59541710|NCT01554683|75639880|FG003|STARTED|Overall Study||2||
59541711|NCT01554683|75639881|FG004|STARTED|Overall Study||1||
59641136|NCT02760264|75757623|FG002|NOT COMPLETED|0.75 mg/kg/Day||0||
59641137|NCT02760264|75757624|FG003|NOT COMPLETED|0.75 mg/kg/Day||0||
59641138|NCT02760264|75757621|FG000|STARTED|2.0 mg/kg/Day||0||
59641139|NCT02760264|75757622|FG001|STARTED|2.0 mg/kg/Day||0||
59641140|NCT02760264|75757623|FG002|STARTED|2.0 mg/kg/Day||12||
59641141|NCT02760264|75757624|FG003|STARTED|2.0 mg/kg/Day||0||
59641142|NCT02760264|75757621|FG000|COMPLETED|2.0 mg/kg/Day||0||
59641143|NCT02760264|75757622|FG001|COMPLETED|2.0 mg/kg/Day||0||
59641144|NCT02760264|75757623|FG002|COMPLETED|2.0 mg/kg/Day||12||
59641145|NCT02760264|75757624|FG003|COMPLETED|2.0 mg/kg/Day||0||
59641146|NCT02760264|75757621|FG000|NOT COMPLETED|2.0 mg/kg/Day||0||
59641147|NCT02760264|75757622|FG001|NOT COMPLETED|2.0 mg/kg/Day||0||
59641148|NCT02760264|75757623|FG002|NOT COMPLETED|2.0 mg/kg/Day||0||
59641149|NCT02760264|75757624|FG003|NOT COMPLETED|2.0 mg/kg/Day||0||
59641150|NCT02760264|75757621|FG000|STARTED|6.0 mg/kg/Day||0||
59641151|NCT02760264|75757622|FG001|STARTED|6.0 mg/kg/Day||0||
59641152|NCT02760264|75757623|FG002|STARTED|6.0 mg/kg/Day||0||
59641153|NCT02760264|75757624|FG003|STARTED|6.0 mg/kg/Day||12||
59641154|NCT02760264|75757621|FG000|COMPLETED|6.0 mg/kg/Day||0||
59641155|NCT02760264|75757622|FG001|COMPLETED|6.0 mg/kg/Day||0||
59641156|NCT02760264|75757623|FG002|COMPLETED|6.0 mg/kg/Day||0||
59641157|NCT02760264|75757624|FG003|COMPLETED|6.0 mg/kg/Day||12||
59641158|NCT02760264|75757621|FG000|NOT COMPLETED|6.0 mg/kg/Day||0||
59641159|NCT02760264|75757622|FG001|NOT COMPLETED|6.0 mg/kg/Day||0||
59641160|NCT02760264|75757623|FG002|NOT COMPLETED|6.0 mg/kg/Day||0||
59641161|NCT02760264|75757624|FG003|NOT COMPLETED|6.0 mg/kg/Day||0||
59641162|NCT02764164|75757635|FG000|STARTED|Overall Study||1||
59641163|NCT02764164|75757635|FG000|COMPLETED|Overall Study|Duration flexible up to 12mo, ended early (funding), 2 week time point achieved|1||
59641164|NCT02764164|75757635|FG000|NOT COMPLETED|Overall Study||0||
59641165|NCT02765256|75757641|FG000|STARTED|Overall Study||4||
59641166|NCT02765256|75757642|FG001|STARTED|Overall Study||4||
59641167|NCT02765256|75757641|FG000|COMPLETED|Overall Study||4||
59641168|NCT02765256|75757642|FG001|COMPLETED|Overall Study||4||
59641169|NCT02765256|75757641|FG000|NOT COMPLETED|Overall Study||0||
59641170|NCT02765256|75757642|FG001|NOT COMPLETED|Overall Study||0||
59641171|NCT02767128|75757648|FG000|STARTED|Overall Study||14||
59641172|NCT02767128|75757648|FG000|Baseline|Overall Study||14||
59641173|NCT02767128|75757648|FG000|Fer-In-Sol|Overall Study||14||
59641174|NCT02767128|75757648|FG000|Shohl's + Fer-In-Sol|Overall Study||14||
59641175|NCT02767128|75757648|FG000|Triferic|Overall Study||14||
59641176|NCT02767128|75757648|FG000|Shohl's + Triferic After 10 Min|Overall Study||14||
59641177|NCT02767128|75757648|FG000|Shohl's + Triferic Immediately|Overall Study||14||
59641178|NCT02767128|75757648|FG000|COMPLETED|Overall Study||14||
59641179|NCT02767128|75757648|FG000|NOT COMPLETED|Overall Study||0||
59641180|NCT02769702|75757662|FG000|STARTED|Overall Study||2||
59541712|NCT01554683|75639882|FG005|STARTED|Overall Study||0||
59541713|NCT01554683|75639877|FG000|COMPLETED|Overall Study||2||
59541714|NCT01554683|75639878|FG001|COMPLETED|Overall Study||1||
59541715|NCT01554683|75639879|FG002|COMPLETED|Overall Study||3||
59541716|NCT01554683|75639880|FG003|COMPLETED|Overall Study||2||
59541717|NCT01554683|75639881|FG004|COMPLETED|Overall Study||1||
59541718|NCT01554683|75639882|FG005|COMPLETED|Overall Study||0||
59541719|NCT01554683|75639877|FG000|NOT COMPLETED|Overall Study||0||
59541720|NCT01554683|75639878|FG001|NOT COMPLETED|Overall Study||0||
59641181|NCT02769702|75757662|FG000|COMPLETED|Overall Study||2||
59641182|NCT02769702|75757662|FG000|NOT COMPLETED|Overall Study||0||
59641183|NCT02770014|75757666|FG000|STARTED|Plasma Genotyping||43||
59641184|NCT02770014|75757666|FG000|COMPLETED|Plasma Genotyping||43||
59641185|NCT02770014|75757666|FG000|NOT COMPLETED|Plasma Genotyping||0||
59641186|NCT02770014|75757666|FG000|STARTED|EGFR Exon 19 Pos, Treated With Erlotinib|A total of 11 participants were found to have an activating EGFR mutation (exon 19 del or L858R).|11||
59641187|NCT02770014|75757666|FG000|COMPLETED|EGFR Exon 19 Pos, Treated With Erlotinib|Of the 11 participants that had an activating EGFR mutation, 6 started erlotinib treatment.|6||
59641188|NCT02770014|75757666|FG000|NOT COMPLETED|EGFR Exon 19 Pos, Treated With Erlotinib||5||
59641189|NCT02771340|75757674|FG000|STARTED|Overall Study||2||
59641190|NCT02771340|75757675|FG001|STARTED|Overall Study||3||
59641191|NCT02771340|75757676|FG002|STARTED|Overall Study||5||
59641192|NCT02771340|75757674|FG000|COMPLETED|Overall Study||2||
59641193|NCT02771340|75757675|FG001|COMPLETED|Overall Study||3||
59641194|NCT02771340|75757676|FG002|COMPLETED|Overall Study||5||
59641195|NCT02771340|75757674|FG000|NOT COMPLETED|Overall Study||0||
59641196|NCT02771340|75757675|FG001|NOT COMPLETED|Overall Study||0||
59641197|NCT02771340|75757676|FG002|NOT COMPLETED|Overall Study||0||
59641198|NCT02771574|75757689|FG000|STARTED|Lyo Avexitide Dose Level 1 (3 Days)||3||
59641199|NCT02771574|75757690|FG001|STARTED|Lyo Avexitide Dose Level 1 (3 Days)||0||
59541721|NCT01554683|75639879|FG002|NOT COMPLETED|Overall Study||0||
59541722|NCT01554683|75639880|FG003|NOT COMPLETED|Overall Study||0||
59541723|NCT01554683|75639881|FG004|NOT COMPLETED|Overall Study||0||
59541724|NCT01554683|75639882|FG005|NOT COMPLETED|Overall Study||0||
59815746|NCT03026283|75938212|FG001|STARTED|CCTA Diagnosis||0||
59541725|NCT01452191|75639893|FG000|STARTED|Overall Study||373||12
59541726|NCT01452191|75639894|FG001|STARTED|Overall Study||369||12
59541727|NCT01452191|75639895|FG002|STARTED|Overall Study||370||12
59641200|NCT02771574|75757691|FG002|STARTED|Lyo Avexitide Dose Level 1 (3 Days)||0||
59641201|NCT02771574|75757692|FG003|STARTED|Lyo Avexitide Dose Level 1 (3 Days)||0||
59641202|NCT02771574|75757693|FG004|STARTED|Lyo Avexitide Dose Level 1 (3 Days)||0||
59641203|NCT02771574|75757689|FG000|COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||3||
59641204|NCT02771574|75757690|FG001|COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0||
59641205|NCT02771574|75757691|FG002|COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0||
59641206|NCT02771574|75757692|FG003|COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0||
59641207|NCT02771574|75757693|FG004|COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0||
59641208|NCT02771574|75757689|FG000|NOT COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0||
59641209|NCT02771574|75757690|FG001|NOT COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0||
59641210|NCT02771574|75757691|FG002|NOT COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0||
59641211|NCT02771574|75757692|FG003|NOT COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0||
59641212|NCT02771574|75757693|FG004|NOT COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0||
59641213|NCT02771574|75757689|FG000|STARTED|Lyo Avexitide Dose Level 2 (3 Days)||0||
59641214|NCT02771574|75757690|FG001|STARTED|Lyo Avexitide Dose Level 2 (3 Days)||5||
59641215|NCT02771574|75757691|FG002|STARTED|Lyo Avexitide Dose Level 2 (3 Days)||0||
59641216|NCT02771574|75757692|FG003|STARTED|Lyo Avexitide Dose Level 2 (3 Days)||0||
59641217|NCT02771574|75757693|FG004|STARTED|Lyo Avexitide Dose Level 2 (3 Days)||0||
59641218|NCT02771574|75757689|FG000|COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0||
59641219|NCT02771574|75757690|FG001|COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||5||
59641220|NCT02771574|75757691|FG002|COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0||
59641221|NCT02771574|75757692|FG003|COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0||
59641222|NCT02771574|75757693|FG004|COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0||
59641223|NCT02771574|75757689|FG000|NOT COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0||
59641224|NCT02771574|75757690|FG001|NOT COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0||
59641225|NCT02771574|75757691|FG002|NOT COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0||
59641226|NCT02771574|75757692|FG003|NOT COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0||
59641227|NCT02771574|75757693|FG004|NOT COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0||
59641228|NCT02771574|75757689|FG000|STARTED|Lyo Avexitide Dose Level 3 (3 Days)||0||
59641229|NCT02771574|75757690|FG001|STARTED|Lyo Avexitide Dose Level 3 (3 Days)||0||
59641230|NCT02771574|75757691|FG002|STARTED|Lyo Avexitide Dose Level 3 (3 Days)||3||
59641231|NCT02771574|75757692|FG003|STARTED|Lyo Avexitide Dose Level 3 (3 Days)||0||
59641232|NCT02771574|75757693|FG004|STARTED|Lyo Avexitide Dose Level 3 (3 Days)||0||
59641233|NCT02771574|75757689|FG000|COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0||
59641234|NCT02771574|75757690|FG001|COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0||
59641235|NCT02771574|75757691|FG002|COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||3||
59641236|NCT02771574|75757692|FG003|COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0||
59641237|NCT02771574|75757693|FG004|COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0||
59641238|NCT02771574|75757689|FG000|NOT COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0||
59641239|NCT02771574|75757690|FG001|NOT COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0||
59641240|NCT02771574|75757691|FG002|NOT COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0||
59641241|NCT02771574|75757692|FG003|NOT COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0||
59641242|NCT02771574|75757693|FG004|NOT COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0||
59641243|NCT02771574|75757689|FG000|STARTED|Lyo Avexitide Dose Level 4 (3 Days)||0||
59641244|NCT02771574|75757690|FG001|STARTED|Lyo Avexitide Dose Level 4 (3 Days)||0||
59641245|NCT02771574|75757691|FG002|STARTED|Lyo Avexitide Dose Level 4 (3 Days)||0||
59641246|NCT02771574|75757692|FG003|STARTED|Lyo Avexitide Dose Level 4 (3 Days)||3||
59641247|NCT02771574|75757693|FG004|STARTED|Lyo Avexitide Dose Level 4 (3 Days)||0||
59641248|NCT02771574|75757689|FG000|COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0||
59641249|NCT02771574|75757690|FG001|COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0||
59641250|NCT02771574|75757691|FG002|COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0||
59641251|NCT02771574|75757692|FG003|COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||3||
59641252|NCT02771574|75757693|FG004|COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0||
59641253|NCT02771574|75757689|FG000|NOT COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0||
59641254|NCT02771574|75757690|FG001|NOT COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0||
59641255|NCT02771574|75757691|FG002|NOT COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0||
59641256|NCT02771574|75757692|FG003|NOT COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0||
59641257|NCT02771574|75757693|FG004|NOT COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0||
59641258|NCT02771574|75757689|FG000|STARTED|Liq Avexitide (3 Days)||0||
59641259|NCT02771574|75757690|FG001|STARTED|Liq Avexitide (3 Days)||0||
59641260|NCT02771574|75757691|FG002|STARTED|Liq Avexitide (3 Days)||0||
59641261|NCT02771574|75757692|FG003|STARTED|Liq Avexitide (3 Days)||0||
59641262|NCT02771574|75757693|FG004|STARTED|Liq Avexitide (3 Days)||5||
59641263|NCT02771574|75757689|FG000|COMPLETED|Liq Avexitide (3 Days)||0||
59641264|NCT02771574|75757690|FG001|COMPLETED|Liq Avexitide (3 Days)||0||
59641265|NCT02771574|75757691|FG002|COMPLETED|Liq Avexitide (3 Days)||0||
59641266|NCT02771574|75757692|FG003|COMPLETED|Liq Avexitide (3 Days)||0||
59641267|NCT02771574|75757693|FG004|COMPLETED|Liq Avexitide (3 Days)||5||
59641268|NCT02771574|75757689|FG000|NOT COMPLETED|Liq Avexitide (3 Days)||0||
59641269|NCT02771574|75757690|FG001|NOT COMPLETED|Liq Avexitide (3 Days)||0||
59641270|NCT02771574|75757691|FG002|NOT COMPLETED|Liq Avexitide (3 Days)||0||
59641271|NCT02771574|75757692|FG003|NOT COMPLETED|Liq Avexitide (3 Days)||0||
59641272|NCT02771574|75757693|FG004|NOT COMPLETED|Liq Avexitide (3 Days)||0||
59641273|NCT02772432|75757710|FG000|STARTED|Overall Study||31||
59641274|NCT02772432|75757711|FG001|STARTED|Overall Study||22||
59641275|NCT02772432|75757710|FG000|COMPLETED|Overall Study||19||
59641276|NCT02772432|75757711|FG001|COMPLETED|Overall Study||21||
59641277|NCT02772432|75757710|FG000|NOT COMPLETED|Overall Study||12||
59641278|NCT02772432|75757711|FG001|NOT COMPLETED|Overall Study||1||
59641279|NCT02772666|75757717|FG000|STARTED|O-Glas Then SFT||44||
59641280|NCT02772666|75757717|FG000|COMPLETED|O-Glas Then SFT||44||
59641281|NCT02772666|75757717|FG000|NOT COMPLETED|O-Glas Then SFT||0||
59641282|NCT02772666|75757717|FG000|STARTED|SFT Then O-Glass||44||
59641283|NCT02772666|75757717|FG000|COMPLETED|SFT Then O-Glass||44||
59641284|NCT02772666|75757717|FG000|NOT COMPLETED|SFT Then O-Glass||0||
59641285|NCT02773758|75757724|FG000|STARTED|Overall Study||71||
59641286|NCT02773758|75757725|FG001|STARTED|Overall Study||70||
59641287|NCT02773758|75757724|FG000|COMPLETED|Overall Study||71||
59641288|NCT02773758|75757725|FG001|COMPLETED|Overall Study||70||
59641289|NCT02773758|75757724|FG000|NOT COMPLETED|Overall Study||0||
59641290|NCT02773758|75757725|FG001|NOT COMPLETED|Overall Study||0||
59641291|NCT02773836|75757737|FG000|STARTED|Wave 1- Pre-TPD Implementation||1000||
59641292|NCT02773836|75757738|FG001|STARTED|Wave 1- Pre-TPD Implementation||1003||
59641293|NCT02773836|75757739|FG002|STARTED|Wave 1- Pre-TPD Implementation||1001||
59641294|NCT02773836|75757740|FG003|STARTED|Wave 1- Pre-TPD Implementation||1001||
59641295|NCT02773836|75757741|FG004|STARTED|Wave 1- Pre-TPD Implementation||1000||
59641296|NCT02773836|75757742|FG005|STARTED|Wave 1- Pre-TPD Implementation||1006||
59641297|NCT02773836|75757737|FG000|COMPLETED|Wave 1- Pre-TPD Implementation||1000||
59641298|NCT02773836|75757738|FG001|COMPLETED|Wave 1- Pre-TPD Implementation||1003||
59641299|NCT02773836|75757739|FG002|COMPLETED|Wave 1- Pre-TPD Implementation||1001||
59641300|NCT02773836|75757740|FG003|COMPLETED|Wave 1- Pre-TPD Implementation||1001||
59641301|NCT02773836|75757741|FG004|COMPLETED|Wave 1- Pre-TPD Implementation||1000||
59641302|NCT02773836|75757742|FG005|COMPLETED|Wave 1- Pre-TPD Implementation||1006||
59641303|NCT02773836|75757737|FG000|NOT COMPLETED|Wave 1- Pre-TPD Implementation||0||
59641304|NCT02773836|75757738|FG001|NOT COMPLETED|Wave 1- Pre-TPD Implementation||0||
59641305|NCT02773836|75757739|FG002|NOT COMPLETED|Wave 1- Pre-TPD Implementation||0||
59641306|NCT02773836|75757740|FG003|NOT COMPLETED|Wave 1- Pre-TPD Implementation||0||
59641307|NCT02773836|75757741|FG004|NOT COMPLETED|Wave 1- Pre-TPD Implementation||0||
59641308|NCT02773836|75757742|FG005|NOT COMPLETED|Wave 1- Pre-TPD Implementation||0||
59641309|NCT02773836|75757737|FG000|STARTED|Wave 2- Post-TPD Implementation||1010|The reason there are more participants in Period 2 is because a replenishment sample was also used|
59641310|NCT02773836|75757738|FG001|STARTED|Wave 2- Post-TPD Implementation||1013|The reason there are more participants in Period 2 is because a replenishment sample was also used|
59641311|NCT02773836|75757739|FG002|STARTED|Wave 2- Post-TPD Implementation||1003|The reason there are more participants in Period 2 is because a replenishment sample was also used|
59641312|NCT02773836|75757740|FG003|STARTED|Wave 2- Post-TPD Implementation||1010|The reason there are more participants in Period 2 is because a replenishment sample was also used|
59641313|NCT02773836|75757741|FG004|STARTED|Wave 2- Post-TPD Implementation||1002|The reason there are more participants in Period 2 is because a replenishment sample was also used|
59641314|NCT02773836|75757742|FG005|STARTED|Wave 2- Post-TPD Implementation||998|The reason there are more participants in Period 2 is because a replenishment sample was also used|
59641315|NCT02773836|75757737|FG000|COMPLETED|Wave 2- Post-TPD Implementation||1010||
59641316|NCT02773836|75757738|FG001|COMPLETED|Wave 2- Post-TPD Implementation||1013||
59641317|NCT02773836|75757739|FG002|COMPLETED|Wave 2- Post-TPD Implementation||1003||
59641318|NCT02773836|75757740|FG003|COMPLETED|Wave 2- Post-TPD Implementation||1010||
59641319|NCT02773836|75757741|FG004|COMPLETED|Wave 2- Post-TPD Implementation||1002||
59641320|NCT02773836|75757742|FG005|COMPLETED|Wave 2- Post-TPD Implementation||998||
59641321|NCT02773836|75757737|FG000|NOT COMPLETED|Wave 2- Post-TPD Implementation||0||
59641322|NCT02773836|75757738|FG001|NOT COMPLETED|Wave 2- Post-TPD Implementation||0||
59641323|NCT02773836|75757739|FG002|NOT COMPLETED|Wave 2- Post-TPD Implementation||0||
59641324|NCT02773836|75757740|FG003|NOT COMPLETED|Wave 2- Post-TPD Implementation||0||
59641325|NCT02773836|75757741|FG004|NOT COMPLETED|Wave 2- Post-TPD Implementation||0||
59641326|NCT02773836|75757742|FG005|NOT COMPLETED|Wave 2- Post-TPD Implementation||0||
60076699|NCT01927861|76191713|FG001|COMPLETED|Pivotal Phase (104 Weeks)||26||
60076700|NCT01927861|76191712|FG000|NOT COMPLETED|Pivotal Phase (104 Weeks)||0||
60076701|NCT01927861|76191713|FG001|NOT COMPLETED|Pivotal Phase (104 Weeks)||0||
60076702|NCT01927861|76191712|FG000|STARTED|Extension Phase (104 Weeks)||25||
60076703|NCT01927861|76191713|FG001|STARTED|Extension Phase (104 Weeks)||26||
60076704|NCT01927861|76191712|FG000|COMPLETED|Extension Phase (104 Weeks)||25||
60076705|NCT01927861|76191713|FG001|COMPLETED|Extension Phase (104 Weeks)||23||
60076706|NCT01927861|76191712|FG000|NOT COMPLETED|Extension Phase (104 Weeks)||0||
60076707|NCT01927861|76191713|FG001|NOT COMPLETED|Extension Phase (104 Weeks)||3||
60076708|NCT01927861|76191712|FG000|STARTED|Extended Treatment Phase (26 Weeks)|15 participants agreed to continue the treatment for 26 weeks in the extended treatment phase.|15||
59641327|NCT02774226|75757764|FG000|STARTED|Overall Study||8||
59641328|NCT02774226|75757765|FG001|STARTED|Overall Study||7||
60076709|NCT01927861|76191713|FG001|STARTED|Extended Treatment Phase (26 Weeks)|14 participants agreed to continue the treatment for 26 weeks in the extended treatment phase.|14||
59641329|NCT02774226|75757764|FG000|COMPLETED|Overall Study||8||
59641330|NCT02774226|75757765|FG001|COMPLETED|Overall Study||7||
59641331|NCT02774226|75757764|FG000|NOT COMPLETED|Overall Study||0||
59641332|NCT02774226|75757765|FG001|NOT COMPLETED|Overall Study||0||
59641333|NCT02774616|75757774|FG000|STARTED|Overall Study||95||
59641334|NCT02774616|75757775|FG001|STARTED|Overall Study||167||
59641335|NCT02774616|75757776|FG002|STARTED|Overall Study||16||
59641336|NCT02774616|75757774|FG000|Died|Overall Study||6||
59641337|NCT02774616|75757775|FG001|Died|Overall Study||3||
59641338|NCT02774616|75757776|FG002|Died|Overall Study||1||
59641339|NCT02774616|75757774|FG000|Withdrew Consent|Overall Study||3||
59641340|NCT02774616|75757775|FG001|Withdrew Consent|Overall Study||3||
59641341|NCT02774616|75757776|FG002|Withdrew Consent|Overall Study||0||
59641342|NCT02774616|75757774|FG000|Lost to FU|Overall Study||2||
59641343|NCT02774616|75757775|FG001|Lost to FU|Overall Study||0||
59641344|NCT02774616|75757776|FG002|Lost to FU|Overall Study||0||
59641345|NCT02774616|75757774|FG000|Device Explanted|Overall Study||2||
59641346|NCT02774616|75757775|FG001|Device Explanted|Overall Study||1||
59641347|NCT02774616|75757776|FG002|Device Explanted|Overall Study||1||
59641348|NCT02774616|75757774|FG000|Other|Overall Study||2||
59641349|NCT02774616|75757775|FG001|Other|Overall Study||4||
59641350|NCT02774616|75757776|FG002|Other|Overall Study||1||
59641351|NCT02774616|75757774|FG000|COMPLETED|Overall Study||80||
59641352|NCT02774616|75757775|FG001|COMPLETED|Overall Study||156||
59641353|NCT02774616|75757776|FG002|COMPLETED|Overall Study||13||
59641354|NCT02774616|75757774|FG000|NOT COMPLETED|Overall Study||15||
59641355|NCT02774616|75757775|FG001|NOT COMPLETED|Overall Study||11||
59641356|NCT02774616|75757776|FG002|NOT COMPLETED|Overall Study||3||
59641357|NCT02774850|75757788|FG000|STARTED|Overall Study||610||
59641358|NCT02774850|75757788|FG000|Induction I|Overall Study||585|Patients whose Induction I course was included in chart abstractions.|
59641359|NCT02774850|75757788|FG000|Early Discharge Eligible at Induction I|Overall Study|24 of these patients were managed as outpatients. 252 were managed as inpatients.|276|Study population after early discharge criteria were applied at Induction I.|
59641360|NCT02774850|75757788|FG000|Induction II|Overall Study||564|Patients whose Induction II course was included in chart abstractions.|
59641361|NCT02774850|75757788|FG000|Early Discharge Eligible at Induction II|Overall Study|114 of these patients were managed as outpatients. 379 were managed as inpatients.|493|Study population after early discharge criteria were applied at Induction II.|
59641362|NCT02774850|75757788|FG000|Intensification I|Overall Study||476|Patients whose Intensification I course was included in chart abstractions.|
59641363|NCT02774850|75757788|FG000|Early Discharge Eligible at Int I|Overall Study|104 of these patients were managed as outpatients. 270 were managed as inpatients.|374|Study population after early discharge criteria were applied at Intensification I.|
59641364|NCT02774850|75757788|FG000|Intensification II|Overall Study||342|Patients whose Intensification II course was included in chart abstractions.|
59641365|NCT02774850|75757788|FG000|Early Discharge Eligible at Int II|Overall Study|56 of these patients were managed as outpatients. 229 were managed as inpatients.|285|Study population after early discharge criteria were applied at Intensification II.|
59641366|NCT02774850|75757788|FG000|Intensification III|Overall Study||48|Patients whose Intensification III course was included in chart abstractions.|
59641367|NCT02774850|75757788|FG000|Early Discharge Eligible at Int III|Overall Study|7 of these patients were managed as outpatients. 37 were managed as inpatients.|44|Study population after early discharge criteria were applied at Intensification III.|
59641368|NCT02774850|75757788|FG000|COMPLETED|Overall Study||575|This milestone reflects the total early discharge-eligible study population in the overall study.|
59641369|NCT02774850|75757788|FG000|NOT COMPLETED|Overall Study||35||
59641370|NCT02775240|75757794|FG000|STARTED|Overall Study||18||
59641371|NCT02775240|75757794|FG000|Started Treatment A|Overall Study||18||
59641372|NCT02775240|75757794|FG000|Started Treatment B|Overall Study||17||
59641373|NCT02775240|75757794|FG000|COMPLETED|Overall Study||17||
59641374|NCT02775240|75757794|FG000|NOT COMPLETED|Overall Study||1||
59641375|NCT02777268|75757801|FG000|STARTED|Overall Study||16||
59641376|NCT02777268|75757801|FG000|COMPLETED|Overall Study||16||
59641377|NCT02777268|75757801|FG000|NOT COMPLETED|Overall Study||0||
59641378|NCT03686514|75757825|FG000|STARTED|Overall Study||20||
59641379|NCT03686514|75757826|FG001|STARTED|Overall Study||19||
59641380|NCT03686514|75757825|FG000|Started 2018-2019 Vaccine Year|Overall Study||10||
59641381|NCT03686514|75757826|FG001|Started 2018-2019 Vaccine Year|Overall Study||10||
59641382|NCT03686514|75757825|FG000|Completed 2018-2019 Vaccine Follow up|Overall Study||10||
59641383|NCT03686514|75757826|FG001|Completed 2018-2019 Vaccine Follow up|Overall Study||10||
59541728|NCT01452191|75639893|FG000|COMPLETED|Overall Study||241||12
59541729|NCT01452191|75639894|FG001|COMPLETED|Overall Study||252||12
59541730|NCT01452191|75639895|FG002|COMPLETED|Overall Study||258||12
59541731|NCT01452191|75639893|FG000|NOT COMPLETED|Overall Study||132||0
59541732|NCT01452191|75639894|FG001|NOT COMPLETED|Overall Study||117||0
59641384|NCT03686514|75757825|FG000|Started 2019-2020 Vaccine Year|Overall Study||10||
59641385|NCT03686514|75757826|FG001|Started 2019-2020 Vaccine Year|Overall Study||10||
59641386|NCT03686514|75757825|FG000|Completed 2019-2020 Vaccine Follow up|Overall Study||10||
59641387|NCT03686514|75757826|FG001|Completed 2019-2020 Vaccine Follow up|Overall Study||10||
59541733|NCT01452191|75639895|FG002|NOT COMPLETED|Overall Study||112||0
59541734|NCT00905060|75639903|FG000|STARTED|Surgical Resection||70|All patients underwent aggressive resection with intra-operative collection of tissue to generate autologous vaccine. Forty-six patients met all pre- and postoperative criteria for enrollment and constitute the intention-to-treat population|
59541735|NCT00905060|75639903|FG000|COMPLETED|Surgical Resection||46||
59541736|NCT00905060|75639903|FG000|NOT COMPLETED|Surgical Resection||24||
59541737|NCT00905060|75639903|FG000|STARTED|Vaccination Treatment Period||46||
59541738|NCT00905060|75639903|FG000|COMPLETED|Vaccination Treatment Period||46||
59541739|NCT00905060|75639903|FG000|NOT COMPLETED|Vaccination Treatment Period||0||
59541740|NCT01535573|75639910|FG000|STARTED|Overall Study||21||
59541741|NCT01535573|75639911|FG001|STARTED|Overall Study||44||
59541742|NCT01535573|75639912|FG002|STARTED|Overall Study||43||
59541743|NCT01535573|75639910|FG000|COMPLETED|Overall Study||13||
59541744|NCT01535573|75639911|FG001|COMPLETED|Overall Study||23||
59541745|NCT01535573|75639912|FG002|COMPLETED|Overall Study||24||
59541746|NCT01535573|75639910|FG000|NOT COMPLETED|Overall Study||8||
59541747|NCT01535573|75639911|FG001|NOT COMPLETED|Overall Study||21||
59541748|NCT01535573|75639912|FG002|NOT COMPLETED|Overall Study||19||
59541749|NCT01452425|75639920|FG000|STARTED|Overall Study||10||
59541750|NCT01452425|75639920|FG000|COMPLETED|Overall Study||10||
59541751|NCT01452425|75639920|FG000|NOT COMPLETED|Overall Study||0||
59541752|NCT01455545|75639925|FG000|STARTED|Overall Study||55||
59541753|NCT01455545|75639926|FG001|STARTED|Overall Study||45||
59541754|NCT01455545|75639925|FG000|COMPLETED|Overall Study||55||
59541755|NCT01455545|75639926|FG001|COMPLETED|Overall Study||45||
59541756|NCT01455545|75639925|FG000|NOT COMPLETED|Overall Study||0||
59541757|NCT01455545|75639926|FG001|NOT COMPLETED|Overall Study||0||
59541758|NCT00905450|75639949|FG000|STARTED|Overall Study||60||
59541759|NCT00905450|75639950|FG001|STARTED|Overall Study||28||
59541760|NCT00905450|75639951|FG002|STARTED|Overall Study||28||
59541761|NCT00905450|75639952|FG003|STARTED|Overall Study||60||
59541762|NCT00905450|75639953|FG004|STARTED|Overall Study||59||
59541763|NCT00905450|75639954|FG005|STARTED|Overall Study||60||
59541764|NCT00905450|75639955|FG006|STARTED|Overall Study||60||
59541765|NCT00905450|75639956|FG007|STARTED|Overall Study||60||
59541766|NCT00905450|75639949|FG000|COMPLETED|Overall Study||59||
59541767|NCT00905450|75639950|FG001|COMPLETED|Overall Study||27||
59541768|NCT00905450|75639951|FG002|COMPLETED|Overall Study||28||
59541769|NCT00905450|75639952|FG003|COMPLETED|Overall Study||60||
59541770|NCT00905450|75639953|FG004|COMPLETED|Overall Study||59||
59541771|NCT00905450|75639954|FG005|COMPLETED|Overall Study||58||
59541772|NCT00905450|75639955|FG006|COMPLETED|Overall Study||58||
59541773|NCT00905450|75639956|FG007|COMPLETED|Overall Study||59||
59541774|NCT00905450|75639949|FG000|NOT COMPLETED|Overall Study||1||
59541775|NCT00905450|75639950|FG001|NOT COMPLETED|Overall Study||1||
59541776|NCT00905450|75639951|FG002|NOT COMPLETED|Overall Study||0||
59541777|NCT00905450|75639952|FG003|NOT COMPLETED|Overall Study||0||
59541778|NCT00905450|75639953|FG004|NOT COMPLETED|Overall Study||0||
59541779|NCT00905450|75639954|FG005|NOT COMPLETED|Overall Study||2||
59541780|NCT00905450|75639955|FG006|NOT COMPLETED|Overall Study||2||
59541781|NCT00905450|75639956|FG007|NOT COMPLETED|Overall Study||1||
59541782|NCT01536197|75639976|FG000|STARTED|Overall Study||23||
59541783|NCT01536197|75639977|FG001|STARTED|Overall Study||10||
59541784|NCT01536197|75639976|FG000|COMPLETED|Overall Study||23||
59541785|NCT01536197|75639977|FG001|COMPLETED|Overall Study||10||
59541786|NCT01536197|75639976|FG000|NOT COMPLETED|Overall Study||0||
59541787|NCT01536197|75639977|FG001|NOT COMPLETED|Overall Study||0||
59541788|NCT01537367|75639986|FG000|STARTED|Overall Study||615||
59541789|NCT01537367|75639987|FG001|STARTED|Overall Study||610||
59541790|NCT01537367|75639988|FG002|STARTED|Overall Study||613||
59541791|NCT01537367|75639986|FG000|COMPLETED|Overall Study|All participants who were enrolled were followed for routine HIV clinic attendance via clinic EMR.|615||
59541792|NCT01537367|75639987|FG001|COMPLETED|Overall Study|All participants who were enrolled were followed for routine HIV clinic attendance via clinic EMR.|610||
59541793|NCT01537367|75639988|FG002|COMPLETED|Overall Study|All participants who were enrolled were followed for routine HIV clinic attendance via clinic EMR.|613||
59541794|NCT01537367|75639986|FG000|NOT COMPLETED|Overall Study||0||
59541795|NCT01537367|75639987|FG001|NOT COMPLETED|Overall Study||0||
59541796|NCT01537367|75639988|FG002|NOT COMPLETED|Overall Study||0||
59541797|NCT01537835|75639999|FG000|STARTED|Overall Study||37||
59541798|NCT01537835|75640000|FG001|STARTED|Overall Study||37||
59541799|NCT01537835|75640001|FG002|STARTED|Overall Study||35||
59541800|NCT01537835|75639999|FG000|COMPLETED|Overall Study||37||
59541801|NCT01537835|75640000|FG001|COMPLETED|Overall Study||37||
59541802|NCT01537835|75640001|FG002|COMPLETED|Overall Study||35||
59541803|NCT01537835|75639999|FG000|NOT COMPLETED|Overall Study||0||
59541804|NCT01537835|75640000|FG001|NOT COMPLETED|Overall Study||0||
59541805|NCT01537835|75640001|FG002|NOT COMPLETED|Overall Study||0||
59541806|NCT00906074|75640011|FG000|STARTED|Overall Study||90||
59541807|NCT00906074|75640012|FG001|STARTED|Overall Study||90||
59541808|NCT00906074|75640011|FG000|COMPLETED|Overall Study||90||
59541809|NCT00906074|75640012|FG001|COMPLETED|Overall Study||90||
59541810|NCT00906074|75640011|FG000|NOT COMPLETED|Overall Study||0||
59541811|NCT00906074|75640012|FG001|NOT COMPLETED|Overall Study||0||
59541812|NCT01538615|75640020|FG000|STARTED|Overall Study||162||
59541813|NCT01538615|75640021|FG001|STARTED|Overall Study||158||
59541814|NCT01538615|75640020|FG000|COMPLETED|Overall Study||140||
59541815|NCT01538615|75640021|FG001|COMPLETED|Overall Study||146||
59541816|NCT01538615|75640020|FG000|NOT COMPLETED|Overall Study||22||
59541817|NCT01538615|75640021|FG001|NOT COMPLETED|Overall Study||12||
59541818|NCT01556633|75640029|FG000|STARTED|Overall Study||10||
59541819|NCT01556633|75640030|FG001|STARTED|Overall Study||6||
59541820|NCT01556633|75640029|FG000|COMPLETED|Overall Study||10||
59541821|NCT01556633|75640030|FG001|COMPLETED|Overall Study||6||
59541822|NCT01556633|75640029|FG000|NOT COMPLETED|Overall Study||0||
59541823|NCT01556633|75640030|FG001|NOT COMPLETED|Overall Study||0||
59541824|NCT01557959|75640039|FG000|STARTED|Overall Study||45||
59541825|NCT01557959|75640039|FG000|COMPLETED|Overall Study||45||
59541826|NCT01557959|75640039|FG000|NOT COMPLETED|Overall Study||0||
59541827|NCT02503332|75640048|FG000|STARTED|Overall Study||86||
59541828|NCT02503332|75640049|FG001|STARTED|Overall Study||79||
59541829|NCT02503332|75640050|FG002|STARTED|Overall Study||41||
59541830|NCT02503332|75640051|FG003|STARTED|Overall Study||40||
59541831|NCT02503332|75640048|FG000|COMPLETED|Overall Study||52|Completed treatment.|
59541832|NCT02503332|75640049|FG001|COMPLETED|Overall Study||60|Completed treatment.|
59541833|NCT02503332|75640050|FG002|COMPLETED|Overall Study||33|Completed treatment.|
59541834|NCT02503332|75640051|FG003|COMPLETED|Overall Study||36|Completed treatment.|
59541835|NCT02503332|75640048|FG000|NOT COMPLETED|Overall Study||34||
59541836|NCT02503332|75640049|FG001|NOT COMPLETED|Overall Study||19||
59541837|NCT02503332|75640050|FG002|NOT COMPLETED|Overall Study||8||
59541838|NCT02503332|75640051|FG003|NOT COMPLETED|Overall Study||4||
59541839|NCT01558661|75640065|FG000|STARTED|Overall Study||33||
59541840|NCT01558661|75640065|FG000|First Stage|Overall Study||18||
59541841|NCT01558661|75640065|FG000|Second Stage|Overall Study||15||
59541842|NCT01558661|75640065|FG000|COMPLETED|Overall Study||33||
59541843|NCT01558661|75640065|FG000|NOT COMPLETED|Overall Study||0||
59541844|NCT02502864|75640069|FG000|STARTED|Overall Study||9||
59541845|NCT02502864|75640069|FG000|COMPLETED|Overall Study||8||
59541846|NCT02502864|75640069|FG000|NOT COMPLETED|Overall Study||1||
59541847|NCT01457417|75640078|FG000|STARTED|Overall Study||3||
59541848|NCT01457417|75640079|FG001|STARTED|Overall Study||3||
59541849|NCT01457417|75640080|FG002|STARTED|Overall Study||4||
59541850|NCT01457417|75640081|FG003|STARTED|Overall Study||3||
59541851|NCT01457417|75640082|FG004|STARTED|Overall Study||19||
59541852|NCT01457417|75640078|FG000|COMPLETED|Overall Study||3||
59541853|NCT01457417|75640079|FG001|COMPLETED|Overall Study||3||
59641388|NCT03686514|75757825|FG000|COMPLETED|Overall Study||20||
59641389|NCT03686514|75757826|FG001|COMPLETED|Overall Study||19||
59641390|NCT03686514|75757825|FG000|NOT COMPLETED|Overall Study||0||
59641391|NCT03686514|75757826|FG001|NOT COMPLETED|Overall Study||0||
59641392|NCT03004248|75757832|FG000|STARTED|Overall Study||2691||
59641393|NCT03004248|75757832|FG000|Received a Single Treatment|Overall Study||1809||
59641394|NCT03004248|75757832|FG000|Received Two Treatments|Overall Study||314||
59641395|NCT03004248|75757832|FG000|Received Three Treatments|Overall Study||568||
59641396|NCT03004248|75757832|FG000|COMPLETED|Overall Study||2314||
59641397|NCT03004248|75757832|FG000|NOT COMPLETED|Overall Study||377||
59541854|NCT01457417|75640080|FG002|COMPLETED|Overall Study||4||
59541855|NCT01457417|75640081|FG003|COMPLETED|Overall Study||3||
59541856|NCT01457417|75640082|FG004|COMPLETED|Overall Study||19||
59541857|NCT01457417|75640078|FG000|NOT COMPLETED|Overall Study||0||
59541858|NCT01457417|75640079|FG001|NOT COMPLETED|Overall Study||0||
59541859|NCT01457417|75640080|FG002|NOT COMPLETED|Overall Study||0||
59541860|NCT01457417|75640081|FG003|NOT COMPLETED|Overall Study||0||
59541861|NCT01457417|75640082|FG004|NOT COMPLETED|Overall Study||0||
59541862|NCT01457573|75640096|FG000|STARTED|Overall Study||10||
59541863|NCT01457573|75640096|FG000|COMPLETED|Overall Study||10||
59541864|NCT01457573|75640096|FG000|NOT COMPLETED|Overall Study||0||
59541865|NCT02474082|75640103|FG000|STARTED|Overall Study||105||
59541866|NCT02474082|75640104|FG001|STARTED|Overall Study||97||
59541867|NCT02474082|75640103|FG000|Full Analysis Set (FAS)|Overall Study||105||
59541868|NCT02474082|75640104|FG001|Full Analysis Set (FAS)|Overall Study||95||
59541869|NCT02474082|75640103|FG000|COMPLETED|Overall Study||99||
59541870|NCT02474082|75640104|FG001|COMPLETED|Overall Study||43||
59541871|NCT02474082|75640103|FG000|NOT COMPLETED|Overall Study||6||
59541872|NCT02474082|75640104|FG001|NOT COMPLETED|Overall Study||54||
59541873|NCT01560143|75640110|FG000|STARTED|Overall Study||12||
59541874|NCT01560143|75640110|FG000|COMPLETED|Overall Study||12||
59641398|NCT04977479|75757840|FG000|STARTED|First Period of Crossover||8||
59641399|NCT04977479|75757841|FG001|STARTED|First Period of Crossover||8||
59641400|NCT04977479|75757842|FG002|STARTED|First Period of Crossover||0||
59641401|NCT04977479|75757840|FG000|COMPLETED|First Period of Crossover||8||
59641402|NCT04977479|75757841|FG001|COMPLETED|First Period of Crossover||8||
59641403|NCT04977479|75757842|FG002|COMPLETED|First Period of Crossover||0||
59641404|NCT04977479|75757840|FG000|NOT COMPLETED|First Period of Crossover||0||
59641405|NCT04977479|75757841|FG001|NOT COMPLETED|First Period of Crossover||0||
59641406|NCT04977479|75757842|FG002|NOT COMPLETED|First Period of Crossover||0||
59641407|NCT04977479|75757840|FG000|STARTED|Washout Period||8||
59641408|NCT04977479|75757841|FG001|STARTED|Washout Period||8||
59641409|NCT04977479|75757842|FG002|STARTED|Washout Period||0||
59641410|NCT04977479|75757840|FG000|COMPLETED|Washout Period||8||
59641411|NCT04977479|75757841|FG001|COMPLETED|Washout Period||8||
59641412|NCT04977479|75757842|FG002|COMPLETED|Washout Period||0||
59641413|NCT04977479|75757840|FG000|NOT COMPLETED|Washout Period||0||
59641414|NCT04977479|75757841|FG001|NOT COMPLETED|Washout Period||0||
59641415|NCT04977479|75757842|FG002|NOT COMPLETED|Washout Period||0||
59641416|NCT04977479|75757840|FG000|STARTED|Second Period of Crossover||8||
59641417|NCT04977479|75757841|FG001|STARTED|Second Period of Crossover||8||
59641418|NCT04977479|75757842|FG002|STARTED|Second Period of Crossover||0||
59641419|NCT04977479|75757840|FG000|COMPLETED|Second Period of Crossover||8||
59641420|NCT04977479|75757841|FG001|COMPLETED|Second Period of Crossover||8||
59641421|NCT04977479|75757842|FG002|COMPLETED|Second Period of Crossover||0||
59641422|NCT04977479|75757840|FG000|NOT COMPLETED|Second Period of Crossover||0||
59641423|NCT04977479|75757841|FG001|NOT COMPLETED|Second Period of Crossover||0||
59641424|NCT04977479|75757842|FG002|NOT COMPLETED|Second Period of Crossover||0||
59641425|NCT04977479|75757840|FG000|STARTED|Open Label||0||
59641426|NCT04977479|75757841|FG001|STARTED|Open Label||0||
59641427|NCT04977479|75757842|FG002|STARTED|Open Label||16||
59641428|NCT04977479|75757840|FG000|COMPLETED|Open Label||0||
59641429|NCT04977479|75757841|FG001|COMPLETED|Open Label||0||
59641430|NCT04977479|75757842|FG002|COMPLETED|Open Label||16||
59641431|NCT04977479|75757840|FG000|NOT COMPLETED|Open Label||0||
59641432|NCT04977479|75757841|FG001|NOT COMPLETED|Open Label||0||
59641433|NCT04977479|75757842|FG002|NOT COMPLETED|Open Label||0||
59641434|NCT04974515|75757854|FG000|STARTED|Overall Study||19||
59641435|NCT04974515|75757855|FG001|STARTED|Overall Study||21||
59641436|NCT04974515|75757854|FG000|COMPLETED|Overall Study||19||
59641437|NCT04974515|75757855|FG001|COMPLETED|Overall Study||21||
59641438|NCT04974515|75757854|FG000|NOT COMPLETED|Overall Study||0||
59641439|NCT04974515|75757855|FG001|NOT COMPLETED|Overall Study||0||
59641440|NCT04706793|75757863|FG000|STARTED|Treatment||14||
59641441|NCT04706793|75757864|FG001|STARTED|Treatment||28||
59641442|NCT04706793|75757863|FG000|COMPLETED|Treatment||4||
59641443|NCT04706793|75757864|FG001|COMPLETED|Treatment||18||
59641444|NCT04706793|75757863|FG000|NOT COMPLETED|Treatment||10||
59641445|NCT04706793|75757864|FG001|NOT COMPLETED|Treatment||10||
59641446|NCT04706793|75757863|FG000|STARTED|Follow-up||14||
59641447|NCT04706793|75757864|FG001|STARTED|Follow-up||28||
59641448|NCT04706793|75757863|FG000|COMPLETED|Follow-up||4||
59641449|NCT04706793|75757864|FG001|COMPLETED|Follow-up||18||
59641450|NCT04706793|75757863|FG000|NOT COMPLETED|Follow-up||10||
59641451|NCT04706793|75757864|FG001|NOT COMPLETED|Follow-up||10||
59641452|NCT04607148|75757874|FG000|STARTED|Overall Study||14||
59641453|NCT04607148|75757875|FG001|STARTED|Overall Study||70||
59641454|NCT04607148|75757876|FG002|STARTED|Overall Study||12||
59641455|NCT04607148|75757877|FG003|STARTED|Overall Study||48||
59641456|NCT04607148|75757874|FG000|COMPLETED|Overall Study||0||
59641457|NCT04607148|75757875|FG001|COMPLETED|Overall Study||0||
59641458|NCT04607148|75757876|FG002|COMPLETED|Overall Study||0||
59641459|NCT04607148|75757877|FG003|COMPLETED|Overall Study||0||
59641460|NCT04607148|75757874|FG000|NOT COMPLETED|Overall Study||14||
59641461|NCT04607148|75757875|FG001|NOT COMPLETED|Overall Study||70||
59641462|NCT04607148|75757876|FG002|NOT COMPLETED|Overall Study||12||
59641463|NCT04607148|75757877|FG003|NOT COMPLETED|Overall Study||48||
59641464|NCT04542057|75757889|FG000|STARTED|Overall Study||499||
59641465|NCT04542057|75757890|FG001|STARTED|Overall Study||291||
59641466|NCT04542057|75757889|FG000|Received Treatment|Overall Study||498||
59641467|NCT04542057|75757890|FG001|Received Treatment|Overall Study||291||
59641468|NCT04542057|75757889|FG000|COMPLETED|Overall Study||393||
59641469|NCT04542057|75757890|FG001|COMPLETED|Overall Study||218||
59641470|NCT04542057|75757889|FG000|NOT COMPLETED|Overall Study||106||
59641471|NCT04542057|75757890|FG001|NOT COMPLETED|Overall Study||73||
59641472|NCT04422951|75757896|FG000|STARTED|Overall Study||0||
59641473|NCT04422951|75757897|FG001|STARTED|Overall Study||2||
59641474|NCT04422951|75757896|FG000|COMPLETED|Overall Study||0||
59641475|NCT04422951|75757897|FG001|COMPLETED|Overall Study||0||
59641476|NCT04422951|75757896|FG000|NOT COMPLETED|Overall Study||0||
59641477|NCT04422951|75757897|FG001|NOT COMPLETED|Overall Study||2||
59641478|NCT04193527|75757904|FG000|STARTED|Overall Study||75||
59641479|NCT04193527|75757905|FG001|STARTED|Overall Study||75||
59641480|NCT04193527|75757906|FG002|STARTED|Overall Study||22||
59641481|NCT04193527|75757904|FG000|COMPLETED|Overall Study||74||
59641482|NCT04193527|75757905|FG001|COMPLETED|Overall Study||74||
59641483|NCT04193527|75757906|FG002|COMPLETED|Overall Study||22||
59641484|NCT04193527|75757904|FG000|NOT COMPLETED|Overall Study||1||
59641485|NCT04193527|75757905|FG001|NOT COMPLETED|Overall Study||1||
59641486|NCT04193527|75757906|FG002|NOT COMPLETED|Overall Study||0||
59641487|NCT03915470|75757919|FG000|STARTED|Overall Study||63||
59641488|NCT03915470|75757920|FG001|STARTED|Overall Study||61||
59641489|NCT03915470|75757919|FG000|COMPLETED|Overall Study|63 - 6 (discontinued intervention)|57||
59641490|NCT03915470|75757920|FG001|COMPLETED|Overall Study|61-2 (discontinued intervention)|59||
59641491|NCT03915470|75757919|FG000|NOT COMPLETED|Overall Study||6||
59641492|NCT03915470|75757920|FG001|NOT COMPLETED|Overall Study||2||
59641493|NCT03575468|75757928|FG000|STARTED|Overall Study||56||
59641494|NCT03575468|75757929|FG001|STARTED|Overall Study||54||
59641495|NCT03575468|75757928|FG000|COMPLETED|Overall Study||30||
59641496|NCT03575468|75757929|FG001|COMPLETED|Overall Study||33||
59641497|NCT03575468|75757928|FG000|NOT COMPLETED|Overall Study||26||
59641498|NCT03575468|75757929|FG001|NOT COMPLETED|Overall Study||21||
59641499|NCT03555981|75757937|FG000|STARTED|Overall Study||138||
59641500|NCT03555981|75757938|FG001|STARTED|Overall Study||141||
59641501|NCT03555981|75757937|FG000|COMPLETED|Overall Study||138||
59641502|NCT03555981|75757938|FG001|COMPLETED|Overall Study||139||
59641503|NCT03555981|75757937|FG000|NOT COMPLETED|Overall Study||0||
59641504|NCT03555981|75757938|FG001|NOT COMPLETED|Overall Study||2||
59641505|NCT03488225|75757944|FG000|STARTED|Overall Study||4||
59641506|NCT03488225|75757944|FG000|COMPLETED|Overall Study||0||
59641507|NCT03488225|75757944|FG000|NOT COMPLETED|Overall Study||4||
59641508|NCT03382834|75757950|FG000|STARTED|Overall Study||21||
59641509|NCT03382834|75757951|FG001|STARTED|Overall Study||10||
59641510|NCT03382834|75757950|FG000|COMPLETED|Overall Study||20|Completed Step 1 of the study.|
59641511|NCT03382834|75757951|FG001|COMPLETED|Overall Study||9|Completed Step 1 of the study.|
59641512|NCT03382834|75757950|FG000|NOT COMPLETED|Overall Study||1||
59641513|NCT03382834|75757951|FG001|NOT COMPLETED|Overall Study||1||
59641514|NCT03308942|75757962|FG000|STARTED|Stage 1 (Up to a Maximum of 45 Months)||17||
59641515|NCT03308942|75757963|FG001|STARTED|Stage 1 (Up to a Maximum of 45 Months)||21||
59641516|NCT03308942|75757964|FG002|STARTED|Stage 1 (Up to a Maximum of 45 Months)||3||
59641517|NCT03308942|75757965|FG003|STARTED|Stage 1 (Up to a Maximum of 45 Months)||0||
59641518|NCT03308942|75757966|FG004|STARTED|Stage 1 (Up to a Maximum of 45 Months)||0||
59641519|NCT03308942|75757962|FG000|COMPLETED|Stage 1 (Up to a Maximum of 45 Months)||0||
59641520|NCT03308942|75757963|FG001|COMPLETED|Stage 1 (Up to a Maximum of 45 Months)||0||
59641521|NCT03308942|75757964|FG002|COMPLETED|Stage 1 (Up to a Maximum of 45 Months)||0||
59641522|NCT03308942|75757965|FG003|COMPLETED|Stage 1 (Up to a Maximum of 45 Months)||0||
59641523|NCT03308942|75757966|FG004|COMPLETED|Stage 1 (Up to a Maximum of 45 Months)||0||
59641524|NCT03308942|75757962|FG000|NOT COMPLETED|Stage 1 (Up to a Maximum of 45 Months)||17||
59641525|NCT03308942|75757963|FG001|NOT COMPLETED|Stage 1 (Up to a Maximum of 45 Months)||21||
59641526|NCT03308942|75757964|FG002|NOT COMPLETED|Stage 1 (Up to a Maximum of 45 Months)||3||
59641527|NCT03308942|75757965|FG003|NOT COMPLETED|Stage 1 (Up to a Maximum of 45 Months)||0||
59641528|NCT03308942|75757966|FG004|NOT COMPLETED|Stage 1 (Up to a Maximum of 45 Months)||0||
59641529|NCT03308942|75757962|FG000|STARTED|Stage 2 (Up to a Maximum of 29 Months)||0||
59641530|NCT03308942|75757963|FG001|STARTED|Stage 2 (Up to a Maximum of 29 Months)||0||
59641531|NCT03308942|75757964|FG002|STARTED|Stage 2 (Up to a Maximum of 29 Months)||0||
59641532|NCT03308942|75757965|FG003|STARTED|Stage 2 (Up to a Maximum of 29 Months)||12||
59641533|NCT03308942|75757966|FG004|STARTED|Stage 2 (Up to a Maximum of 29 Months)||0||
59641534|NCT03308942|75757962|FG000|COMPLETED|Stage 2 (Up to a Maximum of 29 Months)||0||
59641535|NCT03308942|75757963|FG001|COMPLETED|Stage 2 (Up to a Maximum of 29 Months)||0||
59641536|NCT03308942|75757964|FG002|COMPLETED|Stage 2 (Up to a Maximum of 29 Months)||0||
59641537|NCT03308942|75757965|FG003|COMPLETED|Stage 2 (Up to a Maximum of 29 Months)||0||
59641538|NCT03308942|75757966|FG004|COMPLETED|Stage 2 (Up to a Maximum of 29 Months)||0||
59641539|NCT03308942|75757962|FG000|NOT COMPLETED|Stage 2 (Up to a Maximum of 29 Months)||0||
59641540|NCT03308942|75757963|FG001|NOT COMPLETED|Stage 2 (Up to a Maximum of 29 Months)||0||
59641541|NCT03308942|75757964|FG002|NOT COMPLETED|Stage 2 (Up to a Maximum of 29 Months)||0||
59641542|NCT03308942|75757965|FG003|NOT COMPLETED|Stage 2 (Up to a Maximum of 29 Months)||12||
59641543|NCT03308942|75757966|FG004|NOT COMPLETED|Stage 2 (Up to a Maximum of 29 Months)||0||
59641544|NCT03291431|75757981|FG000|STARTED|Overall Study||8||
59641545|NCT03291431|75757982|FG001|STARTED|Overall Study||9||
59641546|NCT03291431|75757981|FG000|COMPLETED|Overall Study||5||
59641547|NCT03291431|75757982|FG001|COMPLETED|Overall Study||7||
59641548|NCT03291431|75757981|FG000|NOT COMPLETED|Overall Study||3||
59641549|NCT03291431|75757982|FG001|NOT COMPLETED|Overall Study||2||
59641550|NCT03261401|75758001|FG000|STARTED|Overall Study||17||
59641551|NCT03261401|75758002|FG001|STARTED|Overall Study||6||
59641552|NCT03261401|75758003|FG002|STARTED|Overall Study||6||
59641553|NCT03261401|75758004|FG003|STARTED|Overall Study||6||
59641554|NCT03261401|75758005|FG004|STARTED|Overall Study||6||
59641555|NCT03261401|75758006|FG005|STARTED|Overall Study||6||
59641556|NCT03261401|75758007|FG006|STARTED|Overall Study||6||
59641557|NCT03261401|75758008|FG007|STARTED|Overall Study||6||
59641558|NCT03261401|75758009|FG008|STARTED|Overall Study||6||
59641559|NCT03261401|75758010|FG009|STARTED|Overall Study||1||
59641560|NCT03261401|75758011|FG010|STARTED|Overall Study||6||
59641561|NCT03261401|75758012|FG011|STARTED|Overall Study||8||
59641562|NCT03261401|75758013|FG012|STARTED|Overall Study||8||
59641563|NCT03261401|75758001|FG000|COMPLETED|Overall Study||17||
59641564|NCT03261401|75758002|FG001|COMPLETED|Overall Study||6||
59641565|NCT03261401|75758003|FG002|COMPLETED|Overall Study||6||
59641566|NCT03261401|75758004|FG003|COMPLETED|Overall Study||6||
59641567|NCT03261401|75758005|FG004|COMPLETED|Overall Study||6||
59641568|NCT03261401|75758006|FG005|COMPLETED|Overall Study||5||
59641569|NCT03261401|75758007|FG006|COMPLETED|Overall Study||6||
59641570|NCT03261401|75758008|FG007|COMPLETED|Overall Study||6||
59641571|NCT03261401|75758009|FG008|COMPLETED|Overall Study||6||
59641572|NCT03261401|75758010|FG009|COMPLETED|Overall Study||1||
59641573|NCT03261401|75758011|FG010|COMPLETED|Overall Study||6||
59641574|NCT03261401|75758012|FG011|COMPLETED|Overall Study||8||
59641575|NCT03261401|75758013|FG012|COMPLETED|Overall Study||7||
59641576|NCT03261401|75758001|FG000|NOT COMPLETED|Overall Study||0||
59641577|NCT03261401|75758002|FG001|NOT COMPLETED|Overall Study||0||
59641578|NCT03261401|75758003|FG002|NOT COMPLETED|Overall Study||0||
59641579|NCT03261401|75758004|FG003|NOT COMPLETED|Overall Study||0||
59641580|NCT03261401|75758005|FG004|NOT COMPLETED|Overall Study||0||
59641581|NCT03261401|75758006|FG005|NOT COMPLETED|Overall Study||1||
59641582|NCT03261401|75758007|FG006|NOT COMPLETED|Overall Study||0||
59641583|NCT03261401|75758008|FG007|NOT COMPLETED|Overall Study||0||
59641584|NCT03261401|75758009|FG008|NOT COMPLETED|Overall Study||0||
59641585|NCT03261401|75758010|FG009|NOT COMPLETED|Overall Study||0||
59641586|NCT03261401|75758011|FG010|NOT COMPLETED|Overall Study||0||
59641587|NCT03261401|75758012|FG011|NOT COMPLETED|Overall Study||0||
59641588|NCT03261401|75758013|FG012|NOT COMPLETED|Overall Study||1||
59641589|NCT02998528|75758053|FG000|STARTED|Randomization Period||113||
59641590|NCT02998528|75758054|FG001|STARTED|Randomization Period||213||
59641591|NCT02998528|75758055|FG002|STARTED|Randomization Period||179||
59641592|NCT02998528|75758053|FG000|All Concurrently Randomized Participants in Arms B and C|Randomization Period||0|The primary population for efficacy analyses|
59641593|NCT02998528|75758054|FG001|All Concurrently Randomized Participants in Arms B and C|Randomization Period||179|The primary population for efficacy analyses|
59641594|NCT02998528|75758055|FG002|All Concurrently Randomized Participants in Arms B and C|Randomization Period||179|The primary population for efficacy analyses|
59641595|NCT02998528|75758053|FG000|COMPLETED|Randomization Period||112||
59641596|NCT02998528|75758054|FG001|COMPLETED|Randomization Period||207||
59641597|NCT02998528|75758055|FG002|COMPLETED|Randomization Period||176||
59641598|NCT02998528|75758053|FG000|NOT COMPLETED|Randomization Period||1||
59641599|NCT02998528|75758054|FG001|NOT COMPLETED|Randomization Period||6||
59641600|NCT02998528|75758055|FG002|NOT COMPLETED|Randomization Period||3||
59641601|NCT02998528|75758053|FG000|STARTED|Neoadjuvant Treatment Period||111||
59641602|NCT02998528|75758054|FG001|STARTED|Neoadjuvant Treatment Period||208||
59641603|NCT02998528|75758055|FG002|STARTED|Neoadjuvant Treatment Period||176||
59641604|NCT02998528|75758053|FG000|All Treated Participants From Concurrently Randomized Arms B and C|Neoadjuvant Treatment Period||0|The primary population for safety analyses|
59641605|NCT02998528|75758054|FG001|All Treated Participants From Concurrently Randomized Arms B and C|Neoadjuvant Treatment Period||176|The primary population for safety analyses|
59641606|NCT02998528|75758055|FG002|All Treated Participants From Concurrently Randomized Arms B and C|Neoadjuvant Treatment Period||176|The primary population for safety analyses|
59641607|NCT02998528|75758053|FG000|COMPLETED|Neoadjuvant Treatment Period||101||
59641608|NCT02998528|75758054|FG001|COMPLETED|Neoadjuvant Treatment Period||177||
59641609|NCT02998528|75758055|FG002|COMPLETED|Neoadjuvant Treatment Period||165||
59641610|NCT02998528|75758053|FG000|NOT COMPLETED|Neoadjuvant Treatment Period||10||
59641611|NCT02998528|75758054|FG001|NOT COMPLETED|Neoadjuvant Treatment Period||31||
59641612|NCT02998528|75758055|FG002|NOT COMPLETED|Neoadjuvant Treatment Period||11||
59641613|NCT02998528|75758053|FG000|STARTED|Systemic Adjuvant Treatment Period||37||
59641614|NCT02998528|75758054|FG001|STARTED|Systemic Adjuvant Treatment Period||47||
59641615|NCT02998528|75758055|FG002|STARTED|Systemic Adjuvant Treatment Period||26||
59641616|NCT02998528|75758053|FG000|COMPLETED|Systemic Adjuvant Treatment Period||28||
59641617|NCT02998528|75758054|FG001|COMPLETED|Systemic Adjuvant Treatment Period||41||
59641618|NCT02998528|75758055|FG002|COMPLETED|Systemic Adjuvant Treatment Period||22||
59641619|NCT02998528|75758053|FG000|NOT COMPLETED|Systemic Adjuvant Treatment Period||9||
59641620|NCT02998528|75758054|FG001|NOT COMPLETED|Systemic Adjuvant Treatment Period||6||
59641621|NCT02998528|75758055|FG002|NOT COMPLETED|Systemic Adjuvant Treatment Period||4||
59641622|NCT02828917|75758062|FG000|STARTED|Overall Study||104||
59641623|NCT02828917|75758062|FG000|COMPLETED|Overall Study||104||
59641624|NCT02828917|75758062|FG000|NOT COMPLETED|Overall Study||0||
59641625|NCT02718911|75758076|FG000|STARTED|Overall Study||4||
59641626|NCT02718911|75758077|FG001|STARTED|Overall Study||3||
59641627|NCT02718911|75758078|FG002|STARTED|Overall Study||3||
59641628|NCT02718911|75758079|FG003|STARTED|Overall Study||5||
59641629|NCT02718911|75758080|FG004|STARTED|Overall Study||3||
59641630|NCT02718911|75758081|FG005|STARTED|Overall Study||5||
59641631|NCT02718911|75758082|FG006|STARTED|Overall Study||5||
59641632|NCT02718911|75758083|FG007|STARTED|Overall Study||5||
59641633|NCT02718911|75758084|FG008|STARTED|Overall Study||19||
59641634|NCT02718911|75758085|FG009|STARTED|Overall Study||20||
59641635|NCT02718911|75758076|FG000|Received at Least One Dose of Study Drug|Overall Study||4||
59641636|NCT02718911|75758077|FG001|Received at Least One Dose of Study Drug|Overall Study||3||
59641637|NCT02718911|75758078|FG002|Received at Least One Dose of Study Drug|Overall Study||3||
59641638|NCT02718911|75758079|FG003|Received at Least One Dose of Study Drug|Overall Study||5||
59641639|NCT02718911|75758080|FG004|Received at Least One Dose of Study Drug|Overall Study||3||
59641640|NCT02718911|75758081|FG005|Received at Least One Dose of Study Drug|Overall Study||5||
59641641|NCT02718911|75758082|FG006|Received at Least One Dose of Study Drug|Overall Study||5||
59641642|NCT02718911|75758083|FG007|Received at Least One Dose of Study Drug|Overall Study||5||
59641643|NCT02718911|75758084|FG008|Received at Least One Dose of Study Drug|Overall Study||19||
59641644|NCT02718911|75758085|FG009|Received at Least One Dose of Study Drug|Overall Study||20||
59641645|NCT02718911|75758076|FG000|COMPLETED|Overall Study||0||
59641646|NCT02718911|75758077|FG001|COMPLETED|Overall Study||0||
59641647|NCT02718911|75758078|FG002|COMPLETED|Overall Study||0||
59641648|NCT02718911|75758079|FG003|COMPLETED|Overall Study||4||
59641649|NCT02718911|75758080|FG004|COMPLETED|Overall Study||1||
59641650|NCT02718911|75758081|FG005|COMPLETED|Overall Study||2||
59641651|NCT02718911|75758082|FG006|COMPLETED|Overall Study||2||
59641652|NCT02718911|75758083|FG007|COMPLETED|Overall Study||2||
59641653|NCT02718911|75758084|FG008|COMPLETED|Overall Study||7||
59641654|NCT02718911|75758085|FG009|COMPLETED|Overall Study||1||
59641655|NCT02718911|75758076|FG000|NOT COMPLETED|Overall Study||4||
59641656|NCT02718911|75758077|FG001|NOT COMPLETED|Overall Study||3||
59641657|NCT02718911|75758078|FG002|NOT COMPLETED|Overall Study||3||
59641658|NCT02718911|75758079|FG003|NOT COMPLETED|Overall Study||1||
59641659|NCT02718911|75758080|FG004|NOT COMPLETED|Overall Study||2||
59641660|NCT02718911|75758081|FG005|NOT COMPLETED|Overall Study||3||
59641661|NCT02718911|75758082|FG006|NOT COMPLETED|Overall Study||3||
59641662|NCT02718911|75758083|FG007|NOT COMPLETED|Overall Study||3||
59641663|NCT02718911|75758084|FG008|NOT COMPLETED|Overall Study||12||
59641664|NCT02718911|75758085|FG009|NOT COMPLETED|Overall Study||19||
59641665|NCT02542267|75758109|FG000|STARTED|Overall Study||108||
59641666|NCT02542267|75758109|FG000|COMPLETED|Overall Study||53||
59641667|NCT02542267|75758109|FG000|NOT COMPLETED|Overall Study||55||
59641668|NCT02477202|75758113|FG000|STARTED|Overall Study||7||
59641669|NCT02477202|75758113|FG000|COMPLETED|Overall Study||7||
59641670|NCT02477202|75758113|FG000|NOT COMPLETED|Overall Study||0||
59641671|NCT02330653|75758119|FG000|STARTED|Overall Study||10||
59641672|NCT02330653|75758120|FG001|STARTED|Overall Study||5||
59641673|NCT02330653|75758119|FG000|COMPLETED|Overall Study||7||
59641674|NCT02330653|75758120|FG001|COMPLETED|Overall Study||4||
59641675|NCT02330653|75758119|FG000|NOT COMPLETED|Overall Study||3||
59641676|NCT02330653|75758120|FG001|NOT COMPLETED|Overall Study||1||
59641677|NCT02096055|75758139|FG000|STARTED|Overall Study||13||
59641678|NCT02096055|75758140|FG001|STARTED|Overall Study||9||
59641679|NCT02096055|75758141|FG002|STARTED|Overall Study||13||
59641680|NCT02096055|75758142|FG003|STARTED|Overall Study||9||
59641681|NCT02096055|75758139|FG000|COMPLETED|Overall Study||13||
59641682|NCT02096055|75758140|FG001|COMPLETED|Overall Study||9||
59641683|NCT02096055|75758141|FG002|COMPLETED|Overall Study||13||
59641684|NCT02096055|75758142|FG003|COMPLETED|Overall Study||9||
59641685|NCT02096055|75758139|FG000|NOT COMPLETED|Overall Study||0||
59641686|NCT02096055|75758140|FG001|NOT COMPLETED|Overall Study||0||
59641687|NCT02096055|75758141|FG002|NOT COMPLETED|Overall Study||0||
59641688|NCT02096055|75758142|FG003|NOT COMPLETED|Overall Study||0||
59641689|NCT02017717|75758161|FG000|STARTED|Before Treatment Period||10||
59641690|NCT02017717|75758162|FG001|STARTED|Before Treatment Period||10||
59641691|NCT02017717|75758163|FG002|STARTED|Before Treatment Period||20||
59641692|NCT02017717|75758164|FG003|STARTED|Before Treatment Period||184||
59641693|NCT02017717|75758165|FG004|STARTED|Before Treatment Period||185||
59641694|NCT02017717|75758166|FG005|STARTED|Before Treatment Period||31||
59641695|NCT02017717|75758167|FG006|STARTED|Before Treatment Period||30||
59641696|NCT02017717|75758168|FG007|STARTED|Before Treatment Period||29||
59641697|NCT02017717|75758169|FG008|STARTED|Before Treatment Period||30||
59641698|NCT02017717|75758161|FG000|Randomized|Before Treatment Period||10||
59641699|NCT02017717|75758162|FG001|Randomized|Before Treatment Period||10||
59641700|NCT02017717|75758163|FG002|Randomized|Before Treatment Period||0||
59641701|NCT02017717|75758164|FG003|Randomized|Before Treatment Period||184||
59641702|NCT02017717|75758165|FG004|Randomized|Before Treatment Period||185||
59641703|NCT02017717|75758166|FG005|Randomized|Before Treatment Period||0||
59641704|NCT02017717|75758167|FG006|Randomized|Before Treatment Period||0||
59641705|NCT02017717|75758168|FG007|Randomized|Before Treatment Period||29||
59641706|NCT02017717|75758169|FG008|Randomized|Before Treatment Period||30||
59641707|NCT02017717|75758161|FG000|COMPLETED|Before Treatment Period||10|Completed = Moved to treatment period|
59641708|NCT02017717|75758162|FG001|COMPLETED|Before Treatment Period||10|Completed = Moved to treatment period|
59641709|NCT02017717|75758163|FG002|COMPLETED|Before Treatment Period||20|Completed = Moved to treatment period|
59641710|NCT02017717|75758164|FG003|COMPLETED|Before Treatment Period||182|Completed = Moved to treatment period|
59815747|NCT03026283|75938213|FG002|STARTED|CCTA Diagnosis||0||
59641711|NCT02017717|75758165|FG004|COMPLETED|Before Treatment Period||165|Completed = Moved to treatment period|
59641712|NCT02017717|75758166|FG005|COMPLETED|Before Treatment Period||31|Completed = Moved to treatment period|
59641713|NCT02017717|75758167|FG006|COMPLETED|Before Treatment Period||30|Completed = Moved to treatment period|
59541875|NCT01560143|75640110|FG000|NOT COMPLETED|Overall Study||0||
59541876|NCT01560377|75640114|FG000|STARTED|Overall Study||147||
59541877|NCT01560377|75640114|FG000|Eligible for Analysis|Overall Study||139||
59541878|NCT01560377|75640114|FG000|COMPLETED|Overall Study||147||
59541879|NCT01560377|75640114|FG000|NOT COMPLETED|Overall Study||0||
59541880|NCT00895232|75640121|FG000|STARTED|Overall Study||7||
59541881|NCT00895232|75640122|FG001|STARTED|Overall Study||6||
59541882|NCT00895232|75640123|FG002|STARTED|Overall Study||8||
59541883|NCT00895232|75640121|FG000|COMPLETED|Overall Study||4||
59541884|NCT00895232|75640122|FG001|COMPLETED|Overall Study||2||
59541885|NCT00895232|75640123|FG002|COMPLETED|Overall Study||3||
59541886|NCT00895232|75640121|FG000|NOT COMPLETED|Overall Study||3||
59541887|NCT00895232|75640122|FG001|NOT COMPLETED|Overall Study||4||
59541888|NCT00895232|75640123|FG002|NOT COMPLETED|Overall Study||5||
59541889|NCT01560923|75640133|FG000|STARTED|Overall Study||24||
59541890|NCT01560923|75640134|FG001|STARTED|Overall Study||22||
59641714|NCT02017717|75758168|FG007|COMPLETED|Before Treatment Period||28|Completed = Moved to treatment period|
59641715|NCT02017717|75758169|FG008|COMPLETED|Before Treatment Period||28|Completed = Moved to treatment period|
59641716|NCT02017717|75758161|FG000|NOT COMPLETED|Before Treatment Period||0||
59641717|NCT02017717|75758162|FG001|NOT COMPLETED|Before Treatment Period||0||
59641718|NCT02017717|75758163|FG002|NOT COMPLETED|Before Treatment Period||0||
59641719|NCT02017717|75758164|FG003|NOT COMPLETED|Before Treatment Period||2||
59641720|NCT02017717|75758165|FG004|NOT COMPLETED|Before Treatment Period||20||
59641721|NCT02017717|75758166|FG005|NOT COMPLETED|Before Treatment Period||0||
59641722|NCT02017717|75758167|FG006|NOT COMPLETED|Before Treatment Period||0||
59641723|NCT02017717|75758168|FG007|NOT COMPLETED|Before Treatment Period||1||
59641724|NCT02017717|75758169|FG008|NOT COMPLETED|Before Treatment Period||2||
59641725|NCT02017717|75758161|FG000|STARTED|Treatment Period||10|Started = Treated|
59641726|NCT02017717|75758162|FG001|STARTED|Treatment Period||10|Started = Treated|
59641727|NCT02017717|75758163|FG002|STARTED|Treatment Period||20|Started = Treated|
59641728|NCT02017717|75758164|FG003|STARTED|Treatment Period||182|Started = Treated|
59641729|NCT02017717|75758165|FG004|STARTED|Treatment Period||165|Started = Treated|
59641730|NCT02017717|75758166|FG005|STARTED|Treatment Period||31|Started = Treated|
59641731|NCT02017717|75758167|FG006|STARTED|Treatment Period||30|Started = Treated|
59641732|NCT02017717|75758168|FG007|STARTED|Treatment Period||28|Started = Treated|
59641733|NCT02017717|75758169|FG008|STARTED|Treatment Period||28|Started = Treated|
59641734|NCT02017717|75758161|FG000|COMPLETED|Treatment Period||0|Completed = Continuing in the treatment period|
59641735|NCT02017717|75758162|FG001|COMPLETED|Treatment Period||1|Completed = Continuing in the treatment period|
59641736|NCT02017717|75758163|FG002|COMPLETED|Treatment Period||0|Completed = Continuing in the treatment period|
59641737|NCT02017717|75758164|FG003|COMPLETED|Treatment Period||1|Completed = Continuing in the treatment period|
59641738|NCT02017717|75758165|FG004|COMPLETED|Treatment Period||1|Completed = Continuing in the treatment period|
59641739|NCT02017717|75758166|FG005|COMPLETED|Treatment Period||2|Completed = Continuing in the treatment period|
59641740|NCT02017717|75758167|FG006|COMPLETED|Treatment Period||0|Completed = Continuing in the treatment period|
59641741|NCT02017717|75758168|FG007|COMPLETED|Treatment Period||0|Completed = Continuing in the treatment period|
59641742|NCT02017717|75758169|FG008|COMPLETED|Treatment Period||0|Completed = Continuing in the treatment period|
59641743|NCT02017717|75758161|FG000|NOT COMPLETED|Treatment Period||10||
59641744|NCT02017717|75758162|FG001|NOT COMPLETED|Treatment Period||9||
59641745|NCT02017717|75758163|FG002|NOT COMPLETED|Treatment Period||20||
59641746|NCT02017717|75758164|FG003|NOT COMPLETED|Treatment Period||181||
59641747|NCT02017717|75758165|FG004|NOT COMPLETED|Treatment Period||164||
59641748|NCT02017717|75758166|FG005|NOT COMPLETED|Treatment Period||29||
59641749|NCT02017717|75758167|FG006|NOT COMPLETED|Treatment Period||30||
59641750|NCT02017717|75758168|FG007|NOT COMPLETED|Treatment Period||28||
59641751|NCT02017717|75758169|FG008|NOT COMPLETED|Treatment Period||28||
59641752|NCT01539863|75758195|FG000|STARTED|Overall Study||166||
59641753|NCT01539863|75758196|FG001|STARTED|Overall Study||162||
59641754|NCT01539863|75758195|FG000|COMPLETED|Overall Study||161||
59641755|NCT01539863|75758196|FG001|COMPLETED|Overall Study||158||
59641756|NCT01539863|75758195|FG000|NOT COMPLETED|Overall Study||5||
59641757|NCT01539863|75758196|FG001|NOT COMPLETED|Overall Study||4||
59641758|NCT00942331|75758204|FG000|STARTED|Overall Study||252||
59641759|NCT00942331|75758205|FG001|STARTED|Overall Study||254||
59641760|NCT00942331|75758204|FG000|COMPLETED|Overall Study||237|Started treatment|
59641761|NCT00942331|75758205|FG001|COMPLETED|Overall Study||232|Started treatment|
59641762|NCT00942331|75758204|FG000|NOT COMPLETED|Overall Study||15||
59641763|NCT00942331|75758205|FG001|NOT COMPLETED|Overall Study||22||
59641764|NCT00827372|75758211|FG000|STARTED|Overall Study||10||
59541891|NCT01560923|75640133|FG000|COMPLETED|Overall Study||24||
59541892|NCT01560923|75640134|FG001|COMPLETED|Overall Study||22||
59541893|NCT01560923|75640133|FG000|NOT COMPLETED|Overall Study||0||
59541894|NCT01560923|75640134|FG001|NOT COMPLETED|Overall Study||0||
59641765|NCT00827372|75758211|FG000|COMPLETED|Overall Study||2||
59641766|NCT00827372|75758211|FG000|NOT COMPLETED|Overall Study||8||
59641767|NCT00687856|75758216|FG000|STARTED|Overall Study||211||
59641768|NCT00687856|75758216|FG000|COMPLETED|Overall Study||211||
59641769|NCT00687856|75758216|FG000|NOT COMPLETED|Overall Study||0||
59641770|NCT00590902|75758220|FG000|STARTED|Overall Study||81||
59641771|NCT00590902|75758220|FG000|COMPLETED|Overall Study||80||
59641772|NCT00590902|75758220|FG000|NOT COMPLETED|Overall Study||1||
59641773|NCT00577122|75758226|FG000|STARTED|Overall Study||14||
59641774|NCT00577122|75758227|FG001|STARTED|Overall Study||16||
59641775|NCT00577122|75758226|FG000|COMPLETED|Overall Study||0||
59641776|NCT00577122|75758227|FG001|COMPLETED|Overall Study||0||
59641777|NCT00577122|75758226|FG000|NOT COMPLETED|Overall Study||14||
59641778|NCT00577122|75758227|FG001|NOT COMPLETED|Overall Study||16||
59641779|NCT00419770|75758236|FG000|STARTED|Overall Study||11||
59641780|NCT00419770|75758237|FG001|STARTED|Overall Study||9||
59641781|NCT00419770|75758236|FG000|COMPLETED|Overall Study||6||
59641782|NCT00419770|75758237|FG001|COMPLETED|Overall Study||8||
59641783|NCT00419770|75758236|FG000|NOT COMPLETED|Overall Study||5||
59641784|NCT00419770|75758237|FG001|NOT COMPLETED|Overall Study||1||
59641785|NCT00129701|75758243|FG000|STARTED|Overall Study||104||
59641786|NCT00129701|75758243|FG000|COMPLETED|Overall Study||71||
59641787|NCT00129701|75758243|FG000|NOT COMPLETED|Overall Study||33||
59641788|NCT04350606|75758250|FG000|STARTED|Overall Study||3||
59641789|NCT04350606|75758250|FG000|Treated|Overall Study||3||
59641790|NCT04350606|75758250|FG000|Follow-up|Overall Study||3||
59641791|NCT04350606|75758250|FG000|COMPLETED|Overall Study||3||
59641792|NCT04350606|75758250|FG000|NOT COMPLETED|Overall Study||0||
59641793|NCT02780622|75758254|FG000|STARTED|Treatment Period 1||10||
59641794|NCT02780622|75758255|FG001|STARTED|Treatment Period 1||10||
59641795|NCT02780622|75758254|FG000|COMPLETED|Treatment Period 1||10||
59641796|NCT02780622|75758255|FG001|COMPLETED|Treatment Period 1||10||
59641797|NCT02780622|75758254|FG000|NOT COMPLETED|Treatment Period 1||0||
59641798|NCT02780622|75758255|FG001|NOT COMPLETED|Treatment Period 1||0||
59641799|NCT02780622|75758254|FG000|STARTED|Treatment Period 2||10||
59641800|NCT02780622|75758255|FG001|STARTED|Treatment Period 2||10||
59641801|NCT02780622|75758254|FG000|COMPLETED|Treatment Period 2||10||
59641802|NCT02780622|75758255|FG001|COMPLETED|Treatment Period 2||10||
59641803|NCT02780622|75758254|FG000|NOT COMPLETED|Treatment Period 2||0||
59641804|NCT02780622|75758255|FG001|NOT COMPLETED|Treatment Period 2||0||
59641805|NCT02781480|75758265|FG000|STARTED|Overall Study||9||
59641806|NCT02781480|75758266|FG001|STARTED|Overall Study||3||
59641807|NCT02781480|75758267|FG002|STARTED|Overall Study||3||
59641808|NCT02781480|75758265|FG000|COMPLETED|Overall Study||9||
59641809|NCT02781480|75758266|FG001|COMPLETED|Overall Study||3||
59641810|NCT02781480|75758267|FG002|COMPLETED|Overall Study||3||
59641811|NCT02781480|75758265|FG000|NOT COMPLETED|Overall Study||0||
59641812|NCT02781480|75758266|FG001|NOT COMPLETED|Overall Study||0||
59641813|NCT02781480|75758267|FG002|NOT COMPLETED|Overall Study||0||
59641814|NCT02783820|75758279|FG000|STARTED|Overall Study||6||
59641815|NCT02783820|75758280|FG001|STARTED|Overall Study||6||
59641816|NCT02783820|75758281|FG002|STARTED|Overall Study||6||
59641817|NCT02783820|75758282|FG003|STARTED|Overall Study||6||
59641818|NCT02783820|75758279|FG000|COMPLETED|Overall Study||6||
59641819|NCT02783820|75758280|FG001|COMPLETED|Overall Study||6||
59641820|NCT02783820|75758281|FG002|COMPLETED|Overall Study||6||
59641821|NCT02783820|75758282|FG003|COMPLETED|Overall Study||6||
59641822|NCT02783820|75758279|FG000|NOT COMPLETED|Overall Study||0||
59641823|NCT02783820|75758280|FG001|NOT COMPLETED|Overall Study||0||
59641824|NCT02783820|75758281|FG002|NOT COMPLETED|Overall Study||0||
59641825|NCT02783820|75758282|FG003|NOT COMPLETED|Overall Study||0||
59641826|NCT02783898|75758294|FG000|STARTED|Overall Study||125||
59641827|NCT02783898|75758295|FG001|STARTED|Overall Study||117||
59641828|NCT02783898|75758294|FG000|COMPLETED|Overall Study||124||
59641829|NCT02783898|75758295|FG001|COMPLETED|Overall Study||116||
59641830|NCT02783898|75758294|FG000|NOT COMPLETED|Overall Study||1||
59641831|NCT02783898|75758295|FG001|NOT COMPLETED|Overall Study||1||
59641832|NCT02784444|75758307|FG000|STARTED|Overall Study||94||
59641833|NCT02784444|75758308|FG001|STARTED|Overall Study||99||
59641834|NCT02784444|75758309|FG002|STARTED|Overall Study||98||
59641835|NCT02784444|75758310|FG003|STARTED|Overall Study||101||
59641836|NCT02784444|75758307|FG000|COMPLETED|Overall Study||78||
59641837|NCT02784444|75758308|FG001|COMPLETED|Overall Study||90||
59641838|NCT02784444|75758309|FG002|COMPLETED|Overall Study||86||
59641839|NCT02784444|75758310|FG003|COMPLETED|Overall Study||88||
59641840|NCT02784444|75758307|FG000|NOT COMPLETED|Overall Study||16||
59641841|NCT02784444|75758308|FG001|NOT COMPLETED|Overall Study||9||
59641842|NCT02784444|75758309|FG002|NOT COMPLETED|Overall Study||12||
59641843|NCT02784444|75758310|FG003|NOT COMPLETED|Overall Study||13||
59641844|NCT02787564|75758322|FG000|STARTED|Overall Study||32||
59641845|NCT02787564|75758323|FG001|STARTED|Overall Study||29||
59641846|NCT02787564|75758322|FG000|COMPLETED|Overall Study|n=12 food bank users; n=13 non-food bank users|25||
59641847|NCT02787564|75758323|FG001|COMPLETED|Overall Study|n=12 food bank users; n=15 non-food bank users|27||
59641848|NCT02787564|75758322|FG000|NOT COMPLETED|Overall Study||7||
59641849|NCT02787564|75758323|FG001|NOT COMPLETED|Overall Study||2||
59641850|NCT02788188|75758336|FG000|STARTED|Overall Study||2||
59641851|NCT02788188|75758337|FG001|STARTED|Overall Study||2||
59641852|NCT02788188|75758338|FG002|STARTED|Overall Study||4||
59641853|NCT02788188|75758339|FG003|STARTED|Overall Study||4||
59641854|NCT02788188|75758340|FG004|STARTED|Overall Study||8||
59641855|NCT02788188|75758341|FG005|STARTED|Overall Study||8||
59641856|NCT02788188|75758342|FG006|STARTED|Overall Study||10||
59641857|NCT02788188|75758336|FG000|COMPLETED|Overall Study||2||
59641858|NCT02788188|75758337|FG001|COMPLETED|Overall Study||2||
59641859|NCT02788188|75758338|FG002|COMPLETED|Overall Study||4||
59641860|NCT02788188|75758339|FG003|COMPLETED|Overall Study||4||
59641861|NCT02788188|75758340|FG004|COMPLETED|Overall Study||8||
59641862|NCT02788188|75758341|FG005|COMPLETED|Overall Study||8||
59641863|NCT02788188|75758342|FG006|COMPLETED|Overall Study||10||
59641864|NCT02788188|75758336|FG000|NOT COMPLETED|Overall Study||0||
59641865|NCT02788188|75758337|FG001|NOT COMPLETED|Overall Study||0||
59641866|NCT02788188|75758338|FG002|NOT COMPLETED|Overall Study||0||
59641867|NCT02788188|75758339|FG003|NOT COMPLETED|Overall Study||0||
59641868|NCT02788188|75758340|FG004|NOT COMPLETED|Overall Study||0||
59641869|NCT02788188|75758341|FG005|NOT COMPLETED|Overall Study||0||
59641870|NCT02788188|75758342|FG006|NOT COMPLETED|Overall Study||0||
59641871|NCT02791308|75758361|FG000|STARTED|Overall Study||195||
59641872|NCT02791308|75758362|FG001|STARTED|Overall Study||196||
59641873|NCT02791308|75758363|FG002|STARTED|Overall Study||196||
59641874|NCT02791308|75758361|FG000|COMPLETED|Overall Study||185||
59641875|NCT02791308|75758362|FG001|COMPLETED|Overall Study||187||
59641876|NCT02791308|75758363|FG002|COMPLETED|Overall Study||179||
59641877|NCT02791308|75758361|FG000|NOT COMPLETED|Overall Study||10||
59641878|NCT02791308|75758362|FG001|NOT COMPLETED|Overall Study||9||
59641879|NCT02791308|75758363|FG002|NOT COMPLETED|Overall Study||17||
59641880|NCT02796144|75758374|FG000|STARTED|Overall Study||23||
59641881|NCT02796144|75758375|FG001|STARTED|Overall Study||24||
59641882|NCT02796144|75758376|FG002|STARTED|Overall Study||24||
59641883|NCT02796144|75758374|FG000|COMPLETED|Overall Study||18||
59641884|NCT02796144|75758375|FG001|COMPLETED|Overall Study||21||
59641885|NCT02796144|75758376|FG002|COMPLETED|Overall Study||18||
59641886|NCT02796144|75758374|FG000|NOT COMPLETED|Overall Study||5||
59641887|NCT02796144|75758375|FG001|NOT COMPLETED|Overall Study||3||
59641888|NCT02796144|75758376|FG002|NOT COMPLETED|Overall Study||6||
59641889|NCT02796300|75758388|FG000|STARTED|Overall Study||10||
59641890|NCT02796300|75758389|FG001|STARTED|Overall Study||22||
59641891|NCT02796300|75758388|FG000|COMPLETED|Overall Study||10||
59641892|NCT02796300|75758389|FG001|COMPLETED|Overall Study||22||
59641893|NCT02796300|75758388|FG000|NOT COMPLETED|Overall Study||0||
59641894|NCT02796300|75758389|FG001|NOT COMPLETED|Overall Study||0||
59641895|NCT02796924|75758395|FG000|STARTED|Overall Study||10||
59641896|NCT02796924|75758395|FG000|COMPLETED|Overall Study||10||
59641897|NCT02796924|75758395|FG000|NOT COMPLETED|Overall Study||0||
59641898|NCT02798952|75758399|FG000|STARTED|Overall Study||302||
59641899|NCT02798952|75758399|FG000|COMPLETED|Overall Study||302||
59641900|NCT02798952|75758399|FG000|NOT COMPLETED|Overall Study||0||
59641901|NCT02800356|75758403|FG000|STARTED|Overall Study||20||
59641902|NCT02800356|75758403|FG000|COMPLETED|Overall Study||20||
59641903|NCT02800356|75758403|FG000|NOT COMPLETED|Overall Study||0||
59641904|NCT02801370|75758409|FG000|STARTED|Overall Study||130||
59641905|NCT02801370|75758410|FG001|STARTED|Overall Study||132||
59641906|NCT02801370|75758409|FG000|COMPLETED|Overall Study||123||
59641907|NCT02801370|75758410|FG001|COMPLETED|Overall Study||132||
59641908|NCT02801370|75758409|FG000|NOT COMPLETED|Overall Study||7||
59641909|NCT02801370|75758410|FG001|NOT COMPLETED|Overall Study||0||
59641910|NCT02803164|75758419|FG000|STARTED|Overall Study||10||
59641911|NCT02803164|75758420|FG001|STARTED|Overall Study||11||
59641912|NCT02803164|75758419|FG000|COMPLETED|Overall Study||10||
59641913|NCT02803164|75758420|FG001|COMPLETED|Overall Study||11||
59641914|NCT02803164|75758419|FG000|NOT COMPLETED|Overall Study||0||
59641915|NCT02803164|75758420|FG001|NOT COMPLETED|Overall Study||0||
59641916|NCT02806908|75758430|FG000|STARTED|Overall Study||11||
59641917|NCT02806908|75758431|FG001|STARTED|Overall Study||13||
59641918|NCT02806908|75758430|FG000|COMPLETED|Overall Study||10||
59641919|NCT02806908|75758431|FG001|COMPLETED|Overall Study||12||
59641920|NCT02806908|75758430|FG000|NOT COMPLETED|Overall Study||1||
59641921|NCT02806908|75758431|FG001|NOT COMPLETED|Overall Study||1||
59641922|NCT02813070|75758441|FG000|STARTED|Overall Study||28|Screened participants|
59641923|NCT02813070|75758442|FG001|STARTED|Overall Study||23|Screened participants|
59641924|NCT02813070|75758443|FG002|STARTED|Overall Study||36|Screened participants|
59641925|NCT02813070|75758441|FG000|Treated (Safety Population)|Overall Study||25||
59641926|NCT02813070|75758442|FG001|Treated (Safety Population)|Overall Study||20||
59641927|NCT02813070|75758443|FG002|Treated (Safety Population)|Overall Study||25||
59641928|NCT02813070|75758441|FG000|COMPLETED|Overall Study||25||
59641929|NCT02813070|75758442|FG001|COMPLETED|Overall Study||20||
59641930|NCT02813070|75758443|FG002|COMPLETED|Overall Study||25||
59641931|NCT02813070|75758441|FG000|NOT COMPLETED|Overall Study||3||
59641932|NCT02813070|75758442|FG001|NOT COMPLETED|Overall Study||3||
59641933|NCT02813070|75758443|FG002|NOT COMPLETED|Overall Study||11||
59641934|NCT02815644|75758452|FG000|STARTED|Treatment Period 1 + Washout||11||
59641935|NCT02815644|75758453|FG001|STARTED|Treatment Period 1 + Washout||11||
59641936|NCT02815644|75758452|FG000|COMPLETED|Treatment Period 1 + Washout||11||
59641937|NCT02815644|75758453|FG001|COMPLETED|Treatment Period 1 + Washout||11||
59641938|NCT02815644|75758452|FG000|NOT COMPLETED|Treatment Period 1 + Washout||0||
59641939|NCT02815644|75758453|FG001|NOT COMPLETED|Treatment Period 1 + Washout||0||
59641940|NCT02815644|75758452|FG000|STARTED|Treatment Period 2||11||
59641941|NCT02815644|75758453|FG001|STARTED|Treatment Period 2||11||
59641942|NCT02815644|75758452|FG000|COMPLETED|Treatment Period 2||11||
59641943|NCT02815644|75758453|FG001|COMPLETED|Treatment Period 2||11||
59641944|NCT02815644|75758452|FG000|NOT COMPLETED|Treatment Period 2||0||
59641945|NCT02815644|75758453|FG001|NOT COMPLETED|Treatment Period 2||0||
59641946|NCT02816346|75758464|FG000|STARTED|Overall Study||10||
59641947|NCT02816346|75758465|FG001|STARTED|Overall Study||10||
59641948|NCT02816346|75758466|FG002|STARTED|Overall Study||10||
59641949|NCT02816346|75758467|FG003|STARTED|Overall Study||10||
59641950|NCT02816346|75758468|FG004|STARTED|Overall Study||16||
59641951|NCT02816346|75758464|FG000|COMPLETED|Overall Study||10||
59641952|NCT02816346|75758465|FG001|COMPLETED|Overall Study||10||
60076710|NCT01927861|76191712|FG000|COMPLETED|Extended Treatment Phase (26 Weeks)||15||
60076711|NCT01927861|76191713|FG001|COMPLETED|Extended Treatment Phase (26 Weeks)||14||
60076712|NCT01927861|76191712|FG000|NOT COMPLETED|Extended Treatment Phase (26 Weeks)||0||
60076713|NCT01927861|76191713|FG001|NOT COMPLETED|Extended Treatment Phase (26 Weeks)||0||
59641953|NCT02816346|75758466|FG002|COMPLETED|Overall Study||10||
59641954|NCT02816346|75758467|FG003|COMPLETED|Overall Study||10||
59641955|NCT02816346|75758468|FG004|COMPLETED|Overall Study||16||
59641956|NCT02816346|75758464|FG000|NOT COMPLETED|Overall Study||0||
59641957|NCT02816346|75758465|FG001|NOT COMPLETED|Overall Study||0||
59641958|NCT02816346|75758466|FG002|NOT COMPLETED|Overall Study||0||
59641959|NCT02816346|75758467|FG003|NOT COMPLETED|Overall Study||0||
59641960|NCT02816346|75758468|FG004|NOT COMPLETED|Overall Study||0||
59641961|NCT02820324|75758485|FG000|STARTED|Overall Study||78||
59641962|NCT02820324|75758486|FG001|STARTED|Overall Study||82||
59641963|NCT02820324|75758487|FG002|STARTED|Overall Study||82||
59641964|NCT02820324|75758488|FG003|STARTED|Overall Study||82||
59641965|NCT02820324|75758489|FG004|STARTED|Overall Study||83||
59641966|NCT02820324|75758485|FG000|Treated With Study Medication|Overall Study||77||
59641967|NCT02820324|75758486|FG001|Treated With Study Medication|Overall Study||80||
59641968|NCT02820324|75758487|FG002|Treated With Study Medication|Overall Study||80||
59641969|NCT02820324|75758488|FG003|Treated With Study Medication|Overall Study||81||
59641970|NCT02820324|75758489|FG004|Treated With Study Medication|Overall Study||83||
59641971|NCT02820324|75758485|FG000|COMPLETED|Overall Study||76||
59641972|NCT02820324|75758486|FG001|COMPLETED|Overall Study||79||
59641973|NCT02820324|75758487|FG002|COMPLETED|Overall Study||79||
59641974|NCT02820324|75758488|FG003|COMPLETED|Overall Study||79||
59641975|NCT02820324|75758489|FG004|COMPLETED|Overall Study||80||
59641976|NCT02820324|75758485|FG000|NOT COMPLETED|Overall Study||2||
59641977|NCT02820324|75758486|FG001|NOT COMPLETED|Overall Study||3||
59641978|NCT02820324|75758487|FG002|NOT COMPLETED|Overall Study||3||
59641979|NCT02820324|75758488|FG003|NOT COMPLETED|Overall Study||3||
59641980|NCT02820324|75758489|FG004|NOT COMPLETED|Overall Study||3||
59641981|NCT02820870|75758503|FG000|STARTED|Before Intervention|These are a separate set of visits from the intervention period and have different visit numbers.|15|Care received prior to the intervention and intended to adjust for confounding due to chance.|538
59641982|NCT02820870|75758504|FG001|STARTED|Before Intervention|These are a separate set of visits from the intervention period and have different visit numbers.|28|Care received prior to the intervention and intended to adjust for confounding due to chance.|672
59641983|NCT02820870|75758503|FG000|COMPLETED|Before Intervention||15||538
59641984|NCT02820870|75758504|FG001|COMPLETED|Before Intervention||28||672
59641985|NCT02820870|75758503|FG000|NOT COMPLETED|Before Intervention||0||0
59641986|NCT02820870|75758504|FG001|NOT COMPLETED|Before Intervention||0||0
59641987|NCT02820870|75758503|FG000|STARTED|Intervention||15||573
59641988|NCT02820870|75758504|FG001|STARTED|Intervention||28||673
59641989|NCT02820870|75758503|FG000|COMPLETED|Intervention||15||573
59641990|NCT02820870|75758504|FG001|COMPLETED|Intervention||28||673
59641991|NCT02820870|75758503|FG000|NOT COMPLETED|Intervention||0||0
59641992|NCT02820870|75758504|FG001|NOT COMPLETED|Intervention||0||0
59641993|NCT02820870|75758503|FG000|STARTED|Post Intervention|These are a separate set of visits from the intervention period and have different visit numbers.|15|These are visits after the intervention was done. It tested the effects' persistence.|603
59641994|NCT02820870|75758504|FG001|STARTED|Post Intervention|These are a separate set of visits from the intervention period and have different visit numbers.|28|These are visits after the intervention was done. It tested the effects' persistence.|728
59641995|NCT02820870|75758503|FG000|COMPLETED|Post Intervention||15||603
59641996|NCT02820870|75758504|FG001|COMPLETED|Post Intervention||28||728
59641997|NCT02820870|75758503|FG000|NOT COMPLETED|Post Intervention||0||0
59641998|NCT02820870|75758504|FG001|NOT COMPLETED|Post Intervention||0||0
59641999|NCT02821104|75758512|FG000|STARTED|Overall Study||77||
59642000|NCT02821104|75758512|FG000|COMPLETED|Overall Study||77||
59642001|NCT02821104|75758512|FG000|NOT COMPLETED|Overall Study||0||
59642002|NCT02821338|75758519|FG000|STARTED|Overall Study||15|All completed subjects received two rounds of Lamictal and Lamotrigine.|
59642003|NCT02821338|75758520|FG001|STARTED|Overall Study||15|All completed subjects received two rounds of Lamictal and Lamotrigine.|
60076714|NCT01927627|76191719|FG000|STARTED|Overall Study||42||
60076715|NCT01927627|76191719|FG000|COMPLETED|Overall Study||37||
59642004|NCT02821338|75758519|FG000|COMPLETED|Overall Study|12 out of 15 subjects assigned to Sequence 1 completed the study, and provided two data points.|12||
59642005|NCT02821338|75758520|FG001|COMPLETED|Overall Study|13 out of 15 subjects assigned to Sequence 2 completed the study, and provided two data points.|13||
59642006|NCT02821338|75758519|FG000|NOT COMPLETED|Overall Study||3||
59642007|NCT02821338|75758520|FG001|NOT COMPLETED|Overall Study||2||
59642008|NCT02823600|75758526|FG000|STARTED|Overall Study||68||
59642009|NCT02823600|75758526|FG000|COMPLETED|Overall Study||68||
59642010|NCT02823600|75758526|FG000|NOT COMPLETED|Overall Study||0||
59642011|NCT02829294|75758532|FG000|STARTED|Overall Study||19||
59642012|NCT02829294|75758532|FG000|COMPLETED|Overall Study||19||
59642013|NCT02829294|75758532|FG000|NOT COMPLETED|Overall Study||0||
59642014|NCT02830074|75758540|FG000|STARTED|Overall Study||32||
59642015|NCT02830074|75758541|FG001|STARTED|Overall Study||31||
59642016|NCT02830074|75758540|FG000|COMPLETED|Overall Study||32||
59642017|NCT02830074|75758541|FG001|COMPLETED|Overall Study||31||
59642018|NCT02830074|75758540|FG000|NOT COMPLETED|Overall Study||0||
59642019|NCT02830074|75758541|FG001|NOT COMPLETED|Overall Study||0||
59642020|NCT02835846|75758548|FG000|STARTED|Overall Study||35||
59642021|NCT02835846|75758548|FG000|COMPLETED|Overall Study||24||
59642022|NCT02835846|75758548|FG000|NOT COMPLETED|Overall Study||11||
59642023|NCT02837328|75758554|FG000|STARTED|Overall Study||29||
59642024|NCT02837328|75758555|FG001|STARTED|Overall Study||30||
59642025|NCT02837328|75758554|FG000|COMPLETED|Overall Study||29||
59642026|NCT02837328|75758555|FG001|COMPLETED|Overall Study||30||
59642027|NCT02837328|75758554|FG000|NOT COMPLETED|Overall Study||0||
59642028|NCT02837328|75758555|FG001|NOT COMPLETED|Overall Study||0||
59642029|NCT02839902|75758563|FG000|STARTED|Overall Study||24||
59642030|NCT02839902|75758564|FG001|STARTED|Overall Study||29||
59642031|NCT02839902|75758563|FG000|COMPLETED|Overall Study||24||
59642032|NCT02839902|75758564|FG001|COMPLETED|Overall Study||29||
59642033|NCT02839902|75758563|FG000|NOT COMPLETED|Overall Study||0||
59642034|NCT02839902|75758564|FG001|NOT COMPLETED|Overall Study||0||
59642035|NCT02840916|75758572|FG000|STARTED|Overall Study||33||
59642036|NCT02840916|75758573|FG001|STARTED|Overall Study||33||
59541895|NCT00906776|75640142|FG000|STARTED|Overall Study||11||
59541896|NCT00906776|75640143|FG001|STARTED|Overall Study||8||
59541897|NCT00906776|75640142|FG000|COMPLETED|Overall Study||11||
59541898|NCT00906776|75640143|FG001|COMPLETED|Overall Study||8||
59541899|NCT00906776|75640142|FG000|NOT COMPLETED|Overall Study||0||
59541900|NCT00906776|75640143|FG001|NOT COMPLETED|Overall Study||0||
59642037|NCT02840916|75758572|FG000|COMPLETED|Overall Study||32||
59642038|NCT02840916|75758573|FG001|COMPLETED|Overall Study||30||
59642039|NCT02840916|75758572|FG000|NOT COMPLETED|Overall Study||1||
59642040|NCT02840916|75758573|FG001|NOT COMPLETED|Overall Study||3||
59642041|NCT02842242|75758581|FG000|STARTED|Overall Study||11||
59642042|NCT02842242|75758582|FG001|STARTED|Overall Study||10||
59642043|NCT02842242|75758581|FG000|COMPLETED|Overall Study||10||
59642044|NCT02842242|75758582|FG001|COMPLETED|Overall Study||10||
59642045|NCT02842242|75758581|FG000|NOT COMPLETED|Overall Study||1||
59642046|NCT02842242|75758582|FG001|NOT COMPLETED|Overall Study||0||
59642047|NCT02844582|75758588|FG000|STARTED|Overall Study||2||
59642048|NCT02844582|75758588|FG000|COMPLETED|Overall Study||2||
59642049|NCT02844582|75758588|FG000|NOT COMPLETED|Overall Study||0||
59541901|NCT01457885|75640149|FG000|STARTED|Overall Study||74||
59541902|NCT01457885|75640149|FG000|COMPLETED|Overall Study||74||
59541903|NCT01457885|75640149|FG000|NOT COMPLETED|Overall Study||0||
59642050|NCT02845674|75758594|FG000|STARTED|Overall Study||129||
59642051|NCT02845674|75758595|FG001|STARTED|Overall Study||129||
59642052|NCT02845674|75758594|FG000|COMPLETED|Overall Study||111||
59642053|NCT02845674|75758595|FG001|COMPLETED|Overall Study||79||
59642054|NCT02845674|75758594|FG000|NOT COMPLETED|Overall Study||18||
59642055|NCT02845674|75758595|FG001|NOT COMPLETED|Overall Study||50||
59642056|NCT02845752|75758603|FG000|STARTED|First Intervention (7 Days)||7||
59642057|NCT02845752|75758604|FG001|STARTED|First Intervention (7 Days)||7||
59642058|NCT02845752|75758603|FG000|COMPLETED|First Intervention (7 Days)||7||
59642059|NCT02845752|75758604|FG001|COMPLETED|First Intervention (7 Days)||7||
59642060|NCT02845752|75758603|FG000|NOT COMPLETED|First Intervention (7 Days)||0||
59642061|NCT02845752|75758604|FG001|NOT COMPLETED|First Intervention (7 Days)||0||
59642062|NCT02845752|75758603|FG000|STARTED|Washout (14 Days)||7||
59642063|NCT02845752|75758604|FG001|STARTED|Washout (14 Days)||7||
59642064|NCT02845752|75758603|FG000|COMPLETED|Washout (14 Days)||7||
59642065|NCT02845752|75758604|FG001|COMPLETED|Washout (14 Days)||7||
59642066|NCT02845752|75758603|FG000|NOT COMPLETED|Washout (14 Days)||0||
59642067|NCT02845752|75758604|FG001|NOT COMPLETED|Washout (14 Days)||0||
59541904|NCT01460225|75640153|FG000|STARTED|Overall Study|January 2009.|19||
59642068|NCT02845752|75758603|FG000|STARTED|Second Intervention (7 Days)||7||
59642069|NCT02845752|75758604|FG001|STARTED|Second Intervention (7 Days)||7||
59642070|NCT02845752|75758603|FG000|COMPLETED|Second Intervention (7 Days)||7||
59642071|NCT02845752|75758604|FG001|COMPLETED|Second Intervention (7 Days)||7||
59642072|NCT02845752|75758603|FG000|NOT COMPLETED|Second Intervention (7 Days)||0||
59642073|NCT02845752|75758604|FG001|NOT COMPLETED|Second Intervention (7 Days)||0||
59642074|NCT02849184|75758612|FG000|STARTED|Overall Study||40||
59642075|NCT02849184|75758613|FG001|STARTED|Overall Study||42||
59541905|NCT01460225|75640153|FG000|COMPLETED|Overall Study|November 2010|19||
59541906|NCT01460225|75640153|FG000|NOT COMPLETED|Overall Study||0||
59541907|NCT01561469|75640160|FG000|STARTED|Overall Study||101||
59541908|NCT01561469|75640161|FG001|STARTED|Overall Study||87||
59541909|NCT01561469|75640160|FG000|COMPLETED|Overall Study||101||
59541910|NCT01561469|75640161|FG001|COMPLETED|Overall Study||87||
59541911|NCT01561469|75640160|FG000|NOT COMPLETED|Overall Study||0||
59541912|NCT01561469|75640161|FG001|NOT COMPLETED|Overall Study||0||
59541913|NCT01561703|75640169|FG000|STARTED|Overall Study||28||
59541914|NCT01561703|75640170|FG001|STARTED|Overall Study||30||
59541915|NCT01561703|75640169|FG000|COMPLETED|Overall Study||20||
59541916|NCT01561703|75640170|FG001|COMPLETED|Overall Study||24||
59541917|NCT01561703|75640169|FG000|NOT COMPLETED|Overall Study||8||
59541918|NCT01561703|75640170|FG001|NOT COMPLETED|Overall Study||6||
59541919|NCT01460303|75640178|FG000|STARTED|Overall Study||25||
59541920|NCT01460303|75640179|FG001|STARTED|Overall Study||24||
59541921|NCT01460303|75640178|FG000|COMPLETED|Overall Study||25||
59541922|NCT01460303|75640179|FG001|COMPLETED|Overall Study||24||
59541923|NCT01460303|75640178|FG000|NOT COMPLETED|Overall Study||0||
59541924|NCT01460303|75640179|FG001|NOT COMPLETED|Overall Study||0||
59541925|NCT01460927|75640185|FG000|STARTED|Overall Study||25||
59541926|NCT01460927|75640185|FG000|COMPLETED|Overall Study||25||
59541927|NCT01460927|75640185|FG000|NOT COMPLETED|Overall Study||0||
59541928|NCT01461473|75640195|FG000|STARTED|Overall Study||72||
59541929|NCT01461473|75640196|FG001|STARTED|Overall Study||59||
59541930|NCT01461473|75640195|FG000|COMPLETED|Overall Study||67||
59541931|NCT01461473|75640196|FG001|COMPLETED|Overall Study||55||
59541932|NCT01461473|75640195|FG000|NOT COMPLETED|Overall Study||5||
59541933|NCT01461473|75640196|FG001|NOT COMPLETED|Overall Study||4||
59541934|NCT00901316|75640204|FG000|STARTED|Overall Study||492||
59541935|NCT00901316|75640205|FG001|STARTED|Overall Study||495||
59541936|NCT00901316|75640204|FG000|COMPLETED|Overall Study||492||
59541937|NCT00901316|75640205|FG001|COMPLETED|Overall Study||495||
59541938|NCT00901316|75640204|FG000|NOT COMPLETED|Overall Study||0||
59541939|NCT00901316|75640205|FG001|NOT COMPLETED|Overall Study||0||
59541940|NCT02501928|75640214|FG000|STARTED|Overall Study|No participant was assigned to this arm, in this LTE study.|0||
59541941|NCT02501928|75640215|FG001|STARTED|Overall Study||2||
59541942|NCT02501928|75640216|FG002|STARTED|Overall Study|No participant was assigned to this arm, in this LTE study.|0||
59541943|NCT02501928|75640217|FG003|STARTED|Overall Study|No participant was assigned to this arm, in this LTE study.|0||
59541944|NCT02501928|75640218|FG004|STARTED|Overall Study||7||
59541945|NCT02501928|75640219|FG005|STARTED|Overall Study||3||
59541946|NCT02501928|75640214|FG000|COMPLETED|Overall Study||0||
59541947|NCT02501928|75640215|FG001|COMPLETED|Overall Study||2||
59541948|NCT02501928|75640216|FG002|COMPLETED|Overall Study||0||
59541949|NCT02501928|75640217|FG003|COMPLETED|Overall Study||0||
59541950|NCT02501928|75640218|FG004|COMPLETED|Overall Study||6||
59541951|NCT02501928|75640219|FG005|COMPLETED|Overall Study||3||
59541952|NCT02501928|75640214|FG000|NOT COMPLETED|Overall Study||0||
59541953|NCT02501928|75640215|FG001|NOT COMPLETED|Overall Study||0||
59541954|NCT02501928|75640216|FG002|NOT COMPLETED|Overall Study||0||
59541955|NCT02501928|75640217|FG003|NOT COMPLETED|Overall Study||0||
59541956|NCT02501928|75640218|FG004|NOT COMPLETED|Overall Study||1||
59541957|NCT02501928|75640219|FG005|NOT COMPLETED|Overall Study||0||
59541958|NCT01461863|75640238|FG000|STARTED|Overall Study||48||
59541959|NCT01461863|75640239|FG001|STARTED|Overall Study||48||
59541960|NCT01461863|75640238|FG000|COMPLETED|Overall Study||48||
59541961|NCT01461863|75640239|FG001|COMPLETED|Overall Study||48||
59541962|NCT01461863|75640238|FG000|NOT COMPLETED|Overall Study||0||
59541963|NCT01461863|75640239|FG001|NOT COMPLETED|Overall Study||0||
59541964|NCT00907088|75640249|FG000|STARTED|Overall Study||122||
59541965|NCT00907088|75640250|FG001|STARTED|Overall Study||129||
59541966|NCT00907088|75640249|FG000|COMPLETED|Overall Study||102||
59541967|NCT00907088|75640250|FG001|COMPLETED|Overall Study||99||
59541968|NCT00907088|75640249|FG000|NOT COMPLETED|Overall Study||20||
59541969|NCT00907088|75640250|FG001|NOT COMPLETED|Overall Study||30||
59541970|NCT01462253|75640256|FG000|STARTED|Overall Study||35||
59541971|NCT01462253|75640256|FG000|COMPLETED|Overall Study||27||
59541972|NCT01462253|75640256|FG000|NOT COMPLETED|Overall Study||8||
59541973|NCT00902018|75640263|FG000|STARTED|Overall Study||7||
59541974|NCT00902018|75640264|FG001|STARTED|Overall Study||3||
59541975|NCT00902018|75640265|FG002|STARTED|Overall Study||10||
59541976|NCT00902018|75640263|FG000|COMPLETED|Overall Study||7||
59541977|NCT00902018|75640264|FG001|COMPLETED|Overall Study||3||
59541978|NCT00902018|75640265|FG002|COMPLETED|Overall Study||10||
59541979|NCT00902018|75640263|FG000|NOT COMPLETED|Overall Study||0||
59541980|NCT00902018|75640264|FG001|NOT COMPLETED|Overall Study||0||
59541981|NCT00902018|75640265|FG002|NOT COMPLETED|Overall Study||0||
59541982|NCT01462565|75640279|FG000|STARTED|Overall Study||16||
59541983|NCT01462565|75640279|FG000|COMPLETED|Overall Study||16||
59541984|NCT01462565|75640279|FG000|NOT COMPLETED|Overall Study||0||
59541985|NCT02473614|75640283|FG000|STARTED|First Intervention (3 Weeks)||6||
59541986|NCT02473614|75640284|FG001|STARTED|First Intervention (3 Weeks)||5||
59541987|NCT02473614|75640283|FG000|COMPLETED|First Intervention (3 Weeks)||5||
59642076|NCT02849184|75758612|FG000|COMPLETED|Overall Study||40||
59642077|NCT02849184|75758613|FG001|COMPLETED|Overall Study||42||
59642078|NCT02849184|75758612|FG000|NOT COMPLETED|Overall Study||0||
59642079|NCT02849184|75758613|FG001|NOT COMPLETED|Overall Study||0||
59642080|NCT02849418|75758621|FG000|STARTED|Double-blinded (Up to 48 Weeks)||10||
59642081|NCT02849418|75758622|FG001|STARTED|Double-blinded (Up to 48 Weeks)||11||
59642082|NCT02849418|75758623|FG002|STARTED|Double-blinded (Up to 48 Weeks)||0||
59642083|NCT02849418|75758624|FG003|STARTED|Double-blinded (Up to 48 Weeks)||0||
59642084|NCT02849418|75758625|FG004|STARTED|Double-blinded (Up to 48 Weeks)||0||
59642085|NCT02849418|75758626|FG005|STARTED|Double-blinded (Up to 48 Weeks)||0||
59642086|NCT02849418|75758621|FG000|COMPLETED|Double-blinded (Up to 48 Weeks)||10||
59642087|NCT02849418|75758622|FG001|COMPLETED|Double-blinded (Up to 48 Weeks)||11||
59642088|NCT02849418|75758623|FG002|COMPLETED|Double-blinded (Up to 48 Weeks)||0||
59642089|NCT02849418|75758624|FG003|COMPLETED|Double-blinded (Up to 48 Weeks)||0||
59642090|NCT02849418|75758625|FG004|COMPLETED|Double-blinded (Up to 48 Weeks)||0||
59642091|NCT02849418|75758626|FG005|COMPLETED|Double-blinded (Up to 48 Weeks)||0||
59642092|NCT02849418|75758621|FG000|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0||
59642093|NCT02849418|75758622|FG001|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0||
59642094|NCT02849418|75758623|FG002|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0||
59642095|NCT02849418|75758624|FG003|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0||
59642096|NCT02849418|75758625|FG004|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0||
59642097|NCT02849418|75758626|FG005|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0||
59642098|NCT02849418|75758621|FG000|STARTED|Open-label(2nd Treatment-Week 12 to 48)||0||
59642099|NCT02849418|75758622|FG001|STARTED|Open-label(2nd Treatment-Week 12 to 48)||0||
59642100|NCT02849418|75758623|FG002|STARTED|Open-label(2nd Treatment-Week 12 to 48)||10||
59642101|NCT02849418|75758624|FG003|STARTED|Open-label(2nd Treatment-Week 12 to 48)||6||
59642102|NCT02849418|75758625|FG004|STARTED|Open-label(2nd Treatment-Week 12 to 48)||0||
59642103|NCT02849418|75758626|FG005|STARTED|Open-label(2nd Treatment-Week 12 to 48)||0||
59642104|NCT02849418|75758621|FG000|COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0||
59642105|NCT02849418|75758622|FG001|COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0||
59642106|NCT02849418|75758623|FG002|COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||10||
59642107|NCT02849418|75758624|FG003|COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||6||
59642108|NCT02849418|75758625|FG004|COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0||
59642109|NCT02849418|75758626|FG005|COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0||
59642110|NCT02849418|75758621|FG000|NOT COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0||
59642111|NCT02849418|75758622|FG001|NOT COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0||
59642112|NCT02849418|75758623|FG002|NOT COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0||
59642113|NCT02849418|75758624|FG003|NOT COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0||
59642114|NCT02849418|75758625|FG004|NOT COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0||
59642115|NCT02849418|75758626|FG005|NOT COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0||
59642116|NCT02849418|75758621|FG000|STARTED|Open-label(3rd Treatment-Week 12 to 48)||0||
59642117|NCT02849418|75758622|FG001|STARTED|Open-label(3rd Treatment-Week 12 to 48)||0||
59642118|NCT02849418|75758623|FG002|STARTED|Open-label(3rd Treatment-Week 12 to 48)||0||
59642119|NCT02849418|75758624|FG003|STARTED|Open-label(3rd Treatment-Week 12 to 48)||0||
59642120|NCT02849418|75758625|FG004|STARTED|Open-label(3rd Treatment-Week 12 to 48)||5||
59642121|NCT02849418|75758626|FG005|STARTED|Open-label(3rd Treatment-Week 12 to 48)||3||
59642122|NCT02849418|75758621|FG000|COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0||
59642123|NCT02849418|75758622|FG001|COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0||
59642124|NCT02849418|75758623|FG002|COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0||
59642125|NCT02849418|75758624|FG003|COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0||
59642126|NCT02849418|75758625|FG004|COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||5||
59541988|NCT02473614|75640284|FG001|COMPLETED|First Intervention (3 Weeks)||5||
59541989|NCT02473614|75640283|FG000|NOT COMPLETED|First Intervention (3 Weeks)||1||
59541990|NCT02473614|75640284|FG001|NOT COMPLETED|First Intervention (3 Weeks)||0||
59541991|NCT02473614|75640283|FG000|STARTED|Wash Out Period (3 Weeks)||5||
59541992|NCT02473614|75640284|FG001|STARTED|Wash Out Period (3 Weeks)||5||
59541993|NCT02473614|75640283|FG000|COMPLETED|Wash Out Period (3 Weeks)||5||
59541994|NCT02473614|75640284|FG001|COMPLETED|Wash Out Period (3 Weeks)||5||
59541995|NCT02473614|75640283|FG000|NOT COMPLETED|Wash Out Period (3 Weeks)||0||
59541996|NCT02473614|75640284|FG001|NOT COMPLETED|Wash Out Period (3 Weeks)||0||
59541997|NCT02473614|75640283|FG000|STARTED|Second Intervention (3 Weeks)||5||
59541998|NCT02473614|75640284|FG001|STARTED|Second Intervention (3 Weeks)||5||
59541999|NCT02473614|75640283|FG000|COMPLETED|Second Intervention (3 Weeks)||5||
59542000|NCT02473614|75640284|FG001|COMPLETED|Second Intervention (3 Weeks)||5||
59642127|NCT02849418|75758626|FG005|COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||3||
59642128|NCT02849418|75758621|FG000|NOT COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0||
59642129|NCT02849418|75758622|FG001|NOT COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0||
59642130|NCT02849418|75758623|FG002|NOT COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0||
59642131|NCT02849418|75758624|FG003|NOT COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0||
59642132|NCT02849418|75758625|FG004|NOT COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0||
59542001|NCT02473614|75640283|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||0||
59542002|NCT02473614|75640284|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0||
59642133|NCT02849418|75758626|FG005|NOT COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0||
59642134|NCT02856828|75758644|FG000|STARTED|Overall Study||2||
59642135|NCT02856828|75758645|FG001|STARTED|Overall Study||3||
59642136|NCT02856828|75758644|FG000|COMPLETED|Overall Study||2||
59642137|NCT02856828|75758645|FG001|COMPLETED|Overall Study||3||
59642138|NCT02856828|75758644|FG000|NOT COMPLETED|Overall Study||0||
59642139|NCT02856828|75758645|FG001|NOT COMPLETED|Overall Study||0||
59642140|NCT02861118|75758661|FG000|STARTED|Overall Study||194||
59642141|NCT02861118|75758662|FG001|STARTED|Overall Study||116||
59642142|NCT02861118|75758661|FG000|COMPLETED|Overall Study||194||
59642143|NCT02861118|75758662|FG001|COMPLETED|Overall Study||116||
59642144|NCT02861118|75758661|FG000|NOT COMPLETED|Overall Study||0||
59642145|NCT02861118|75758662|FG001|NOT COMPLETED|Overall Study||0||
59642146|NCT02862912|75758672|FG000|STARTED|Overall Study||23||
59642147|NCT02862912|75758673|FG001|STARTED|Overall Study||20||
59642148|NCT02862912|75758672|FG000|COMPLETED|Overall Study||22||
59642149|NCT02862912|75758673|FG001|COMPLETED|Overall Study||20||
59642150|NCT02862912|75758672|FG000|NOT COMPLETED|Overall Study||1||
59642151|NCT02862912|75758673|FG001|NOT COMPLETED|Overall Study||0||
59642152|NCT02864706|75758683|FG000|STARTED|Overall Study||48||
59642153|NCT02864706|75758684|FG001|STARTED|Overall Study||47||
59642154|NCT02864706|75758683|FG000|Safety Set|Overall Study||48||
59642155|NCT02864706|75758684|FG001|Safety Set|Overall Study||47||
59642156|NCT02864706|75758683|FG000|Intent to Treat|Overall Study||46||
59642157|NCT02864706|75758684|FG001|Intent to Treat|Overall Study||47||
59642158|NCT02864706|75758683|FG000|COMPLETED|Overall Study||48||
59642159|NCT02864706|75758684|FG001|COMPLETED|Overall Study||47||
59642160|NCT02864706|75758683|FG000|NOT COMPLETED|Overall Study||0||
59642161|NCT02864706|75758684|FG001|NOT COMPLETED|Overall Study||0||
59642162|NCT02865720|75758692|FG000|STARTED|Overall Study||0||
59642163|NCT02865720|75758693|FG001|STARTED|Overall Study||8||
59642164|NCT02865720|75758692|FG000|COMPLETED|Overall Study||0||
59642165|NCT02865720|75758693|FG001|COMPLETED|Overall Study||8||
59642166|NCT02865720|75758692|FG000|NOT COMPLETED|Overall Study||0||
59642167|NCT02865720|75758693|FG001|NOT COMPLETED|Overall Study||0||
59642168|NCT02867202|75758700|FG000|STARTED|Overall Study||83||
59642169|NCT02867202|75758701|FG001|STARTED|Overall Study||88||
59642170|NCT02867202|75758700|FG000|COMPLETED|Overall Study||62||
59642171|NCT02867202|75758701|FG001|COMPLETED|Overall Study||56||
59642172|NCT02867202|75758700|FG000|NOT COMPLETED|Overall Study||21||
59642173|NCT02867202|75758701|FG001|NOT COMPLETED|Overall Study||32||
59642174|NCT02871570|75758709|FG000|STARTED|Overall Study||8||
59642175|NCT02871570|75758710|FG001|STARTED|Overall Study||8||
59642176|NCT02871570|75758709|FG000|COMPLETED|Overall Study||8||
59642177|NCT02871570|75758710|FG001|COMPLETED|Overall Study||8||
59642178|NCT02871570|75758709|FG000|NOT COMPLETED|Overall Study||0||
59642179|NCT02871570|75758710|FG001|NOT COMPLETED|Overall Study||0||
59642180|NCT02873286|75758721|FG000|STARTED|Main Study||78|Received first vaccination|
59642181|NCT02873286|75758722|FG001|STARTED|Main Study||89|Received first vaccination|
59642182|NCT02873286|75758723|FG002|STARTED|Main Study||80|Received first vaccination|
59642183|NCT02873286|75758724|FG003|STARTED|Main Study||90|Received first vaccination|
59642184|NCT02873286|75758725|FG004|STARTED|Main Study||83|Received first vaccination|
60076716|NCT01927627|76191719|FG000|NOT COMPLETED|Overall Study||5||
59642185|NCT02873286|75758721|FG000|COMPLETED|Main Study||76|Completed active trial phase|
59642186|NCT02873286|75758722|FG001|COMPLETED|Main Study||84|Completed active trial phase|
59642187|NCT02873286|75758723|FG002|COMPLETED|Main Study||78|Completed active trial phase|
59642188|NCT02873286|75758724|FG003|COMPLETED|Main Study||89|Completed active trial phase|
59642189|NCT02873286|75758725|FG004|COMPLETED|Main Study||81|Completed active trial phase|
59642190|NCT02873286|75758721|FG000|NOT COMPLETED|Main Study||2||
59642191|NCT02873286|75758722|FG001|NOT COMPLETED|Main Study||5||
59642192|NCT02873286|75758723|FG002|NOT COMPLETED|Main Study||2||
59642193|NCT02873286|75758724|FG003|NOT COMPLETED|Main Study||1||
60076717|NCT01889251|76191725|FG000|STARTED|Overall Study||115||
60076718|NCT01889251|76191726|FG001|STARTED|Overall Study||57||
59642194|NCT02873286|75758725|FG004|NOT COMPLETED|Main Study||2||
59642195|NCT02873286|75758721|FG000|STARTED|Booster Substudy||43|Entered substudy and received booster vaccination|
59642196|NCT02873286|75758722|FG001|STARTED|Booster Substudy||0|Entered substudy and received booster vaccination|
59642197|NCT02873286|75758723|FG002|STARTED|Booster Substudy||45|Entered substudy and received booster vaccination|
59642198|NCT02873286|75758724|FG003|STARTED|Booster Substudy||0|Entered substudy and received booster vaccination|
59642199|NCT02873286|75758725|FG004|STARTED|Booster Substudy||0|Entered substudy and received booster vaccination|
59642200|NCT02873286|75758721|FG000|COMPLETED|Booster Substudy||43|Completed substudy active trial phase|
59642201|NCT02873286|75758722|FG001|COMPLETED|Booster Substudy||0|Completed substudy active trial phase|
59642202|NCT02873286|75758723|FG002|COMPLETED|Booster Substudy||45|Completed substudy active trial phase|
59642203|NCT02873286|75758724|FG003|COMPLETED|Booster Substudy||0|Completed substudy active trial phase|
59642204|NCT02873286|75758725|FG004|COMPLETED|Booster Substudy||0|Completed substudy active trial phase|
60076719|NCT01889251|76191725|FG000|COMPLETED|Overall Study||114||
60076720|NCT01889251|76191726|FG001|COMPLETED|Overall Study||57||
60076721|NCT01889251|76191725|FG000|NOT COMPLETED|Overall Study||1||
59642205|NCT02873286|75758721|FG000|NOT COMPLETED|Booster Substudy||0||
59642206|NCT02873286|75758722|FG001|NOT COMPLETED|Booster Substudy||0||
59642207|NCT02873286|75758723|FG002|NOT COMPLETED|Booster Substudy||0||
59642208|NCT02873286|75758724|FG003|NOT COMPLETED|Booster Substudy||0||
59642209|NCT02873286|75758725|FG004|NOT COMPLETED|Booster Substudy||0||
59642210|NCT02874066|75758737|FG000|STARTED|Overall Study||46||
59642211|NCT02874066|75758737|FG000|COMPLETED|Overall Study||46||
59642212|NCT02874066|75758737|FG000|NOT COMPLETED|Overall Study||0||
59642213|NCT02874846|75758743|FG000|STARTED|Overall Study||8||
59642214|NCT02874846|75758744|FG001|STARTED|Overall Study||4||
59642215|NCT02874846|75758743|FG000|COMPLETED|Overall Study||8||
59642216|NCT02874846|75758744|FG001|COMPLETED|Overall Study||4||
59642217|NCT02874846|75758743|FG000|NOT COMPLETED|Overall Study||0||
59642218|NCT02874846|75758744|FG001|NOT COMPLETED|Overall Study||0||
59642219|NCT02880228|75758751|FG000|STARTED|Overall Study||11||
59642220|NCT02880228|75758751|FG000|COMPLETED|Overall Study||11||
59642221|NCT02880228|75758751|FG000|NOT COMPLETED|Overall Study||0||
59642222|NCT02880852|75758755|FG000|STARTED|Overall Study||20||
59642223|NCT02880852|75758755|FG000|COMPLETED|Overall Study||20||
59642224|NCT02880852|75758755|FG000|NOT COMPLETED|Overall Study||0||
59642225|NCT02882178|75758759|FG000|STARTED|Overall Study||18||
59642226|NCT02882178|75758759|FG000|COMPLETED|Overall Study||18||
59642227|NCT02882178|75758759|FG000|NOT COMPLETED|Overall Study||0||
59642228|NCT02886234|75758765|FG000|STARTED|Overall Study||20||
59642229|NCT02886234|75758766|FG001|STARTED|Overall Study||24||
59642230|NCT02886234|75758765|FG000|COMPLETED|Overall Study||20||
59642231|NCT02886234|75758766|FG001|COMPLETED|Overall Study||22||
59642232|NCT02886234|75758765|FG000|NOT COMPLETED|Overall Study||0||
59642233|NCT02886234|75758766|FG001|NOT COMPLETED|Overall Study||2||
59642234|NCT02887404|75758774|FG000|STARTED|Overall Study||150||
59642235|NCT02887404|75758775|FG001|STARTED|Overall Study||149||
59642236|NCT02887404|75758774|FG000|COMPLETED|Overall Study||150||
59642237|NCT02887404|75758775|FG001|COMPLETED|Overall Study||149||
59642238|NCT02887404|75758774|FG000|NOT COMPLETED|Overall Study||0||
59642239|NCT02887404|75758775|FG001|NOT COMPLETED|Overall Study||0||
59642240|NCT02889510|75758782|FG000|STARTED|Overall Study||35||
59642241|NCT02889510|75758783|FG001|STARTED|Overall Study||37||
59642242|NCT02889510|75758782|FG000|COMPLETED|Overall Study||27||
59642243|NCT02889510|75758783|FG001|COMPLETED|Overall Study||32||
59642244|NCT02889510|75758782|FG000|NOT COMPLETED|Overall Study||8||
59642245|NCT02889510|75758783|FG001|NOT COMPLETED|Overall Study||5||
59642246|NCT02893878|75758792|FG000|STARTED|Overall Study||13861||
59642247|NCT02893878|75758793|FG001|STARTED|Overall Study||2295||
59642248|NCT02893878|75758794|FG002|STARTED|Overall Study||3178||
59642249|NCT02893878|75758792|FG000|COMPLETED|Overall Study||13861||
59642250|NCT02893878|75758793|FG001|COMPLETED|Overall Study||2295||
59642251|NCT02893878|75758794|FG002|COMPLETED|Overall Study||3178||
59642252|NCT02893878|75758792|FG000|NOT COMPLETED|Overall Study||0||
59642253|NCT02893878|75758793|FG001|NOT COMPLETED|Overall Study||0||
59642254|NCT02893878|75758794|FG002|NOT COMPLETED|Overall Study||0||
59642255|NCT02899650|75758808|FG000|STARTED|Overall Study||15||
59642256|NCT02899650|75758809|FG001|STARTED|Overall Study||10||
59642257|NCT02899650|75758810|FG002|STARTED|Overall Study||14||
59642258|NCT02899650|75758811|FG003|STARTED|Overall Study|We were not able to recruit older unfit adults so this group was dropped from the study.|0||
59642259|NCT02899650|75758808|FG000|COMPLETED|Overall Study||15||
59642260|NCT02899650|75758809|FG001|COMPLETED|Overall Study||10||
59642261|NCT02899650|75758810|FG002|COMPLETED|Overall Study||14||
59642262|NCT02899650|75758811|FG003|COMPLETED|Overall Study||0||
59642263|NCT02899650|75758808|FG000|NOT COMPLETED|Overall Study||0||
59642264|NCT02899650|75758809|FG001|NOT COMPLETED|Overall Study||0||
59642265|NCT02899650|75758810|FG002|NOT COMPLETED|Overall Study||0||
59642266|NCT02899650|75758811|FG003|NOT COMPLETED|Overall Study||0||
59642267|NCT02899884|75758820|FG000|STARTED|Overall Study||3765||
59642268|NCT02899884|75758820|FG000|COMPLETED|Overall Study||3765||
59642269|NCT02899884|75758820|FG000|NOT COMPLETED|Overall Study||0||
59642270|NCT02902146|75758826|FG000|STARTED|Overall Study||381||
59642271|NCT02902146|75758827|FG001|STARTED|Overall Study||376||
59642272|NCT02902146|75758826|FG000|COMPLETED|Overall Study||381||
59642273|NCT02902146|75758827|FG001|COMPLETED|Overall Study||376||
59642274|NCT02902146|75758826|FG000|NOT COMPLETED|Overall Study||0||
59642275|NCT02902146|75758827|FG001|NOT COMPLETED|Overall Study||0||
59642276|NCT02902770|75758836|FG000|STARTED|Overall Study||50||
59642277|NCT02902770|75758837|FG001|STARTED|Overall Study||50||
59642278|NCT02902770|75758838|FG002|STARTED|Overall Study||50||
59642279|NCT02902770|75758836|FG000|COMPLETED|Overall Study||50||
59642280|NCT02902770|75758837|FG001|COMPLETED|Overall Study||50||
59642281|NCT02902770|75758838|FG002|COMPLETED|Overall Study||50||
59642282|NCT02902770|75758836|FG000|NOT COMPLETED|Overall Study||0||
59642283|NCT02902770|75758837|FG001|NOT COMPLETED|Overall Study||0||
59642284|NCT02902770|75758838|FG002|NOT COMPLETED|Overall Study||0||
59642285|NCT02903394|75758848|FG000|STARTED|Overall Study||5||
59642286|NCT02903394|75758849|FG001|STARTED|Overall Study||50||
59642287|NCT02903394|75758848|FG000|COMPLETED|Overall Study||5||
59642288|NCT02903394|75758849|FG001|COMPLETED|Overall Study||50||
59642289|NCT02903394|75758848|FG000|NOT COMPLETED|Overall Study||0||
59642290|NCT02903394|75758849|FG001|NOT COMPLETED|Overall Study||0||
59642291|NCT02907918|75758856|FG000|STARTED|Overall Study||26||
59642292|NCT02907918|75758856|FG000|COMPLETED|Overall Study||26||
59642293|NCT02907918|75758856|FG000|NOT COMPLETED|Overall Study||0||
59642294|NCT02908620|75758867|FG000|STARTED|Overall Study||10||
59642295|NCT02908620|75758868|FG001|STARTED|Overall Study||10||
59642296|NCT02908620|75758869|FG002|STARTED|Overall Study||10||
59642297|NCT02908620|75758870|FG003|STARTED|Overall Study||10||
59642298|NCT02908620|75758867|FG000|COMPLETED|Overall Study||10||
59642299|NCT02908620|75758868|FG001|COMPLETED|Overall Study||10||
59642300|NCT02908620|75758869|FG002|COMPLETED|Overall Study||10||
59642301|NCT02908620|75758870|FG003|COMPLETED|Overall Study||10||
59642302|NCT02908620|75758867|FG000|NOT COMPLETED|Overall Study||0||
59642303|NCT02908620|75758868|FG001|NOT COMPLETED|Overall Study||0||
59642304|NCT02908620|75758869|FG002|NOT COMPLETED|Overall Study||0||
59642305|NCT02908620|75758870|FG003|NOT COMPLETED|Overall Study||0||
59642306|NCT02910102|75758886|FG000|STARTED|Overall Study||21||
59642307|NCT02910102|75758887|FG001|STARTED|Overall Study||17||
59642308|NCT02910102|75758886|FG000|Safety Population|Overall Study||21|The Safety population included subjects who took at least 1 dose of double-blind study drug|
59642309|NCT02910102|75758887|FG001|Safety Population|Overall Study||17|The Safety population included subjects who took at least 1 dose of double-blind study drug|
59642310|NCT02910102|75758886|FG000|Intent to Treat (ITT) Population|Overall Study||21|Subjects took at least 1 dose of DB study drug and had at least 1 post-baseline assessment|
59642311|NCT02910102|75758887|FG001|Intent to Treat (ITT) Population|Overall Study||17|Subjects took at least 1 dose of DB study drug and had at least 1 post-baseline assessment|
59642312|NCT02910102|75758886|FG000|Per-Protocol Population|Overall Study||20|Subjects in the ITT population who had no major protocol violations|
59642313|NCT02910102|75758887|FG001|Per-Protocol Population|Overall Study||17|Subjects in the ITT population who had no major protocol violations|
59642314|NCT02910102|75758886|FG000|COMPLETED|Overall Study||21|Subjects in the ITT population who completed the study|
59642315|NCT02910102|75758887|FG001|COMPLETED|Overall Study||17|Subjects in the ITT population who completed the study|
59642316|NCT02910102|75758886|FG000|NOT COMPLETED|Overall Study||0||
59642317|NCT02910102|75758887|FG001|NOT COMPLETED|Overall Study||0||
59642318|NCT02911818|75758901|FG000|STARTED|52 Week Study||50||
59642319|NCT02911818|75758902|FG001|STARTED|52 Week Study||50||
59642320|NCT02911818|75758903|FG002|STARTED|52 Week Study||50||
59642321|NCT02911818|75758904|FG003|STARTED|52 Week Study||0||
59642322|NCT02911818|75758905|FG004|STARTED|52 Week Study||0||
59642323|NCT02911818|75758901|FG000|COMPLETED|52 Week Study||46||
59642324|NCT02911818|75758902|FG001|COMPLETED|52 Week Study||45||
59642325|NCT02911818|75758903|FG002|COMPLETED|52 Week Study||46||
59642326|NCT02911818|75758904|FG003|COMPLETED|52 Week Study||0||
59642327|NCT02911818|75758905|FG004|COMPLETED|52 Week Study||0||
59642328|NCT02911818|75758901|FG000|NOT COMPLETED|52 Week Study||4||
59642329|NCT02911818|75758902|FG001|NOT COMPLETED|52 Week Study||5||
59642330|NCT02911818|75758903|FG002|NOT COMPLETED|52 Week Study||4||
59642331|NCT02911818|75758904|FG003|NOT COMPLETED|52 Week Study||0||
59642332|NCT02911818|75758905|FG004|NOT COMPLETED|52 Week Study||0||
59642333|NCT02911818|75758901|FG000|STARTED|12 Week Extension Study||0||
59642334|NCT02911818|75758902|FG001|STARTED|12 Week Extension Study||0||
59642335|NCT02911818|75758903|FG002|STARTED|12 Week Extension Study||0||
59642336|NCT02911818|75758904|FG003|STARTED|12 Week Extension Study||22||
59642337|NCT02911818|75758905|FG004|STARTED|12 Week Extension Study||23||
59642338|NCT02911818|75758901|FG000|COMPLETED|12 Week Extension Study||0||
59642339|NCT02911818|75758902|FG001|COMPLETED|12 Week Extension Study||0||
59642340|NCT02911818|75758903|FG002|COMPLETED|12 Week Extension Study||0||
59642341|NCT02911818|75758904|FG003|COMPLETED|12 Week Extension Study||22||
59642342|NCT02911818|75758905|FG004|COMPLETED|12 Week Extension Study||22||
59642343|NCT02911818|75758901|FG000|NOT COMPLETED|12 Week Extension Study||0||
59642344|NCT02911818|75758902|FG001|NOT COMPLETED|12 Week Extension Study||0||
59642345|NCT02911818|75758903|FG002|NOT COMPLETED|12 Week Extension Study||0||
59642346|NCT02911818|75758904|FG003|NOT COMPLETED|12 Week Extension Study||0||
59642347|NCT02911818|75758905|FG004|NOT COMPLETED|12 Week Extension Study||1||
59642348|NCT02912364|75758919|FG000|STARTED|Treatment 1||23||
59642349|NCT02912364|75758920|FG001|STARTED|Treatment 1||23||
59642350|NCT02912364|75758919|FG000|Received Intervention|Treatment 1||18||
59642351|NCT02912364|75758920|FG001|Received Intervention|Treatment 1||18||
59642352|NCT02912364|75758919|FG000|COMPLETED|Treatment 1||13||
59642353|NCT02912364|75758920|FG001|COMPLETED|Treatment 1||11||
59642354|NCT02912364|75758919|FG000|NOT COMPLETED|Treatment 1||10||
59642355|NCT02912364|75758920|FG001|NOT COMPLETED|Treatment 1||12||
59988525|NCT02514746|76103686|FG001|NOT COMPLETED|Overall Study||15||
59988526|NCT02483078|76103696|FG000|STARTED|Part 1 One-week Randomized||25||
59642356|NCT02912364|75758919|FG000|STARTED|Washout Period||13||
59642357|NCT02912364|75758920|FG001|STARTED|Washout Period||11||
59642358|NCT02912364|75758919|FG000|COMPLETED|Washout Period||13||
59642359|NCT02912364|75758920|FG001|COMPLETED|Washout Period||11||
59642360|NCT02912364|75758919|FG000|NOT COMPLETED|Washout Period||0||
59988527|NCT02483078|76103697|FG001|STARTED|Part 1 One-week Randomized||27||
59988528|NCT02483078|76103696|FG000|COMPLETED|Part 1 One-week Randomized||25||
59642361|NCT02912364|75758920|FG001|NOT COMPLETED|Washout Period||0||
59995452|NCT02675114|76111276|FG000|As Treated|Overall Study||454||
59642362|NCT02912364|75758919|FG000|STARTED|Treatment 2||13||
59642363|NCT02912364|75758920|FG001|STARTED|Treatment 2||11||
59642364|NCT02912364|75758919|FG000|Received Intervention|Treatment 2||12||
59642365|NCT02912364|75758920|FG001|Received Intervention|Treatment 2||11||
59642366|NCT02912364|75758919|FG000|COMPLETED|Treatment 2||12||
59642367|NCT02912364|75758920|FG001|COMPLETED|Treatment 2||11||
59642368|NCT02912364|75758919|FG000|NOT COMPLETED|Treatment 2||1||
59642369|NCT02912364|75758920|FG001|NOT COMPLETED|Treatment 2||0||
59642370|NCT02913924|75758931|FG000|STARTED|Overall Study||34||
59642371|NCT02913924|75758932|FG001|STARTED|Overall Study||34||
59642372|NCT02913924|75758931|FG000|COMPLETED|Overall Study||21||
59642373|NCT02913924|75758932|FG001|COMPLETED|Overall Study||21||
59642374|NCT02913924|75758931|FG000|NOT COMPLETED|Overall Study||13||
59642375|NCT02913924|75758932|FG001|NOT COMPLETED|Overall Study||13||
59642376|NCT02916498|75758940|FG000|STARTED|First Intervention, 21 Days||2||
59642377|NCT02916498|75758941|FG001|STARTED|First Intervention, 21 Days||4||
59642378|NCT02916498|75758940|FG000|COMPLETED|First Intervention, 21 Days||2||
59642379|NCT02916498|75758941|FG001|COMPLETED|First Intervention, 21 Days||4||
59642380|NCT02916498|75758940|FG000|NOT COMPLETED|First Intervention, 21 Days||0||
59642381|NCT02916498|75758941|FG001|NOT COMPLETED|First Intervention, 21 Days||0||
59642382|NCT02916498|75758940|FG000|STARTED|Second Intervention, 21 Days||2||
59642383|NCT02916498|75758941|FG001|STARTED|Second Intervention, 21 Days||4||
59642384|NCT02916498|75758940|FG000|COMPLETED|Second Intervention, 21 Days||2||
59642385|NCT02916498|75758941|FG001|COMPLETED|Second Intervention, 21 Days||4||
59642386|NCT02916498|75758940|FG000|NOT COMPLETED|Second Intervention, 21 Days||0||
59642387|NCT02916498|75758941|FG001|NOT COMPLETED|Second Intervention, 21 Days||0||
59642388|NCT02917122|75758949|FG000|STARTED|Overall Study||8||
59642389|NCT02917122|75758950|FG001|STARTED|Overall Study||7||
59642390|NCT02917122|75758949|FG000|COMPLETED|Overall Study||8||
59642391|NCT02917122|75758950|FG001|COMPLETED|Overall Study||7||
59642392|NCT02917122|75758949|FG000|NOT COMPLETED|Overall Study||0||
59642393|NCT02917122|75758950|FG001|NOT COMPLETED|Overall Study||0||
59642394|NCT02917278|75758958|FG000|STARTED|Overall Study||10||
59542003|NCT00908882|75640293|FG000|STARTED|Overall Study||89||
59542004|NCT00908882|75640294|FG001|STARTED|Overall Study||89||
59542005|NCT00908882|75640293|FG000|COMPLETED|Overall Study||61||
59542006|NCT00908882|75640294|FG001|COMPLETED|Overall Study||59||
59542007|NCT00908882|75640293|FG000|NOT COMPLETED|Overall Study||28||
59542008|NCT00908882|75640294|FG001|NOT COMPLETED|Overall Study||30||
59542009|NCT01462877|75640300|FG000|STARTED|Overall Study||506||
59542010|NCT01462877|75640300|FG000|Safety Set|Overall Study||492||
59542011|NCT01462877|75640300|FG000|Full Analysis Set|Overall Study||468||
59542012|NCT01462877|75640300|FG000|Per-protocol Set|Overall Study||364||
59542013|NCT01462877|75640300|FG000|COMPLETED|Overall Study||435||
59542014|NCT01462877|75640300|FG000|NOT COMPLETED|Overall Study||71||
59542015|NCT02500758|75640306|FG000|STARTED|First Intervention (2 Minutes)||15||
59542016|NCT02500758|75640307|FG001|STARTED|First Intervention (2 Minutes)||15||
59542017|NCT02500758|75640306|FG000|COMPLETED|First Intervention (2 Minutes)||15||
59542018|NCT02500758|75640307|FG001|COMPLETED|First Intervention (2 Minutes)||14||
59542019|NCT02500758|75640306|FG000|NOT COMPLETED|First Intervention (2 Minutes)||0||
59542020|NCT02500758|75640307|FG001|NOT COMPLETED|First Intervention (2 Minutes)||1||
59542021|NCT02500758|75640306|FG000|STARTED|Washout (1 Week)||15||
59542022|NCT02500758|75640307|FG001|STARTED|Washout (1 Week)||14||
59542023|NCT02500758|75640306|FG000|COMPLETED|Washout (1 Week)||13||
59542024|NCT02500758|75640307|FG001|COMPLETED|Washout (1 Week)||12||
59542025|NCT02500758|75640306|FG000|NOT COMPLETED|Washout (1 Week)||2||
59542026|NCT02500758|75640307|FG001|NOT COMPLETED|Washout (1 Week)||2||
59542027|NCT02500758|75640306|FG000|STARTED|Second Intervention (2 Minutes)||13||
59542028|NCT02500758|75640307|FG001|STARTED|Second Intervention (2 Minutes)||12||
59542029|NCT02500758|75640306|FG000|COMPLETED|Second Intervention (2 Minutes)||10||
59642395|NCT02917278|75758959|FG001|STARTED|Overall Study||9||
59642396|NCT02917278|75758958|FG000|COMPLETED|Overall Study||9||
59642397|NCT02917278|75758959|FG001|COMPLETED|Overall Study||9||
59642398|NCT02917278|75758958|FG000|NOT COMPLETED|Overall Study||1||
59642399|NCT02917278|75758959|FG001|NOT COMPLETED|Overall Study||0||
59642400|NCT02921412|75758965|FG000|STARTED|Overall Study||36||
59642401|NCT02921412|75758965|FG000|COMPLETED|Overall Study||36||
59542030|NCT02500758|75640307|FG001|COMPLETED|Second Intervention (2 Minutes)||10||
59642402|NCT02921412|75758965|FG000|NOT COMPLETED|Overall Study||0||
59642403|NCT02921490|75758976|FG000|STARTED|Overall Study||10||
59642404|NCT02921490|75758976|FG000|COMPLETED|Overall Study||10||
59642405|NCT02921490|75758976|FG000|NOT COMPLETED|Overall Study||0||
59642406|NCT02922582|75758984|FG000|STARTED|Overall Study||4||
59642407|NCT02922582|75758985|FG001|STARTED|Overall Study||4||
59642408|NCT02922582|75758986|FG002|STARTED|Overall Study||4||
59642409|NCT02922582|75758987|FG003|STARTED|Overall Study||4||
59642410|NCT02922582|75758984|FG000|COMPLETED|Overall Study||4||
59642411|NCT02922582|75758985|FG001|COMPLETED|Overall Study||3||
59642412|NCT02922582|75758986|FG002|COMPLETED|Overall Study||4||
59642413|NCT02922582|75758987|FG003|COMPLETED|Overall Study||4||
59642414|NCT02922582|75758984|FG000|NOT COMPLETED|Overall Study||0||
59642415|NCT02922582|75758985|FG001|NOT COMPLETED|Overall Study||1||
59642416|NCT02922582|75758986|FG002|NOT COMPLETED|Overall Study||0||
59642417|NCT02922582|75758987|FG003|NOT COMPLETED|Overall Study||0||
59642418|NCT02922738|75758999|FG000|STARTED|Overall Study|158 patients and 17 providers|175||
59642419|NCT02922738|75759000|FG001|STARTED|Overall Study|275 patients and 15 providers|290||
59642420|NCT02922738|75758999|FG000|COMPLETED|Overall Study||175||
59642421|NCT02922738|75759000|FG001|COMPLETED|Overall Study||290||
59642422|NCT02922738|75758999|FG000|NOT COMPLETED|Overall Study||0||
59642423|NCT02922738|75759000|FG001|NOT COMPLETED|Overall Study||0||
59642424|NCT02925078|75759010|FG000|STARTED|Overall Study||14||
59642425|NCT02925078|75759011|FG001|STARTED|Overall Study||16||
59642426|NCT02925078|75759010|FG000|COMPLETED|Overall Study||13||
59642427|NCT02925078|75759011|FG001|COMPLETED|Overall Study||13||
59642428|NCT02925078|75759010|FG000|NOT COMPLETED|Overall Study||1||
59642429|NCT02925078|75759011|FG001|NOT COMPLETED|Overall Study||3||
59642430|NCT02925858|75759019|FG000|STARTED|Overall Study||42||
59642431|NCT02925858|75759020|FG001|STARTED|Overall Study||38||
59642432|NCT02925858|75759019|FG000|COMPLETED|Overall Study||42||
59642433|NCT02925858|75759020|FG001|COMPLETED|Overall Study||38||
59642434|NCT02925858|75759019|FG000|NOT COMPLETED|Overall Study||0||
59642435|NCT02925858|75759020|FG001|NOT COMPLETED|Overall Study||0||
59642436|NCT02933034|75759026|FG000|STARTED|Overall Study||33||
59642437|NCT02933034|75759026|FG000|Received Both MEMRI and DEMRI Scans|Overall Study||24||
59642438|NCT02933034|75759026|FG000|COMPLETED|Overall Study||24||
59642439|NCT02933034|75759026|FG000|NOT COMPLETED|Overall Study||9||
59642440|NCT02933502|75759030|FG000|STARTED|Overall Study||3||
59642441|NCT02933502|75759030|FG000|COMPLETED|Overall Study||3||
59642442|NCT02933502|75759030|FG000|NOT COMPLETED|Overall Study||0||
59642443|NCT02935062|75759037|FG000|STARTED|Overall Study||8||
59642444|NCT02935062|75759038|FG001|STARTED|Overall Study||8||
59642445|NCT02935062|75759039|FG002|STARTED|Overall Study||8||
59642446|NCT02935062|75759037|FG000|COMPLETED|Overall Study||8||
59642447|NCT02935062|75759038|FG001|COMPLETED|Overall Study||8||
59642448|NCT02935062|75759039|FG002|COMPLETED|Overall Study||8||
59642449|NCT02935062|75759037|FG000|NOT COMPLETED|Overall Study||0||
59642450|NCT02935062|75759038|FG001|NOT COMPLETED|Overall Study||0||
59642451|NCT02935062|75759039|FG002|NOT COMPLETED|Overall Study||0||
59642452|NCT02936076|75759049|FG000|STARTED|Overall Study||25||
59642453|NCT02936076|75759050|FG001|STARTED|Overall Study||24||
59642454|NCT02936076|75759049|FG000|COMPLETED|Overall Study||19||
59642455|NCT02936076|75759050|FG001|COMPLETED|Overall Study||20||
59642456|NCT02936076|75759049|FG000|NOT COMPLETED|Overall Study||6||
59642457|NCT02936076|75759050|FG001|NOT COMPLETED|Overall Study||4||
59642458|NCT02937168|75759056|FG000|STARTED|PET/CT Screening Period (21 Days)||5||
59642459|NCT02937168|75759057|FG001|STARTED|PET/CT Screening Period (21 Days)||0||
59642460|NCT02937168|75759058|FG002|STARTED|PET/CT Screening Period (21 Days)||0||
59642461|NCT02937168|75759056|FG000|COMPLETED|PET/CT Screening Period (21 Days)||5||
59642462|NCT02937168|75759057|FG001|COMPLETED|PET/CT Screening Period (21 Days)||0||
59642463|NCT02937168|75759058|FG002|COMPLETED|PET/CT Screening Period (21 Days)||0||
59642464|NCT02937168|75759056|FG000|NOT COMPLETED|PET/CT Screening Period (21 Days)||0||
59642465|NCT02937168|75759057|FG001|NOT COMPLETED|PET/CT Screening Period (21 Days)||0||
59642466|NCT02937168|75759058|FG002|NOT COMPLETED|PET/CT Screening Period (21 Days)||0||
59642467|NCT02937168|75759056|FG000|STARTED|Double-Blind Treatment Period (6 Weeks)||0|No participants were recruited for Part 2.|
59642468|NCT02937168|75759057|FG001|STARTED|Double-Blind Treatment Period (6 Weeks)||0|No participants were recruited for Part 2.|
59642469|NCT02937168|75759058|FG002|STARTED|Double-Blind Treatment Period (6 Weeks)||0|No participants were recruited for Part 2.|
59642470|NCT02937168|75759056|FG000|COMPLETED|Double-Blind Treatment Period (6 Weeks)||0||
59642471|NCT02937168|75759057|FG001|COMPLETED|Double-Blind Treatment Period (6 Weeks)||0||
59642472|NCT02937168|75759058|FG002|COMPLETED|Double-Blind Treatment Period (6 Weeks)||0||
59642473|NCT02937168|75759056|FG000|NOT COMPLETED|Double-Blind Treatment Period (6 Weeks)||0||
59642474|NCT02937168|75759057|FG001|NOT COMPLETED|Double-Blind Treatment Period (6 Weeks)||0||
59642475|NCT02937168|75759058|FG002|NOT COMPLETED|Double-Blind Treatment Period (6 Weeks)||0||
59642476|NCT02937558|75759066|FG000|STARTED|Double-blind Phase||3||
59815748|NCT03026283|75938214|FG003|STARTED|CCTA Diagnosis||0||
59642477|NCT02937558|75759067|FG001|STARTED|Double-blind Phase||2||
59642478|NCT02937558|75759066|FG000|COMPLETED|Double-blind Phase||3||
59642479|NCT02937558|75759067|FG001|COMPLETED|Double-blind Phase||2||
59542031|NCT02500758|75640306|FG000|NOT COMPLETED|Second Intervention (2 Minutes)||3||
59542032|NCT02500758|75640307|FG001|NOT COMPLETED|Second Intervention (2 Minutes)||2||
59542033|NCT01565369|75640314|FG000|STARTED|Overall Study||35||
59542034|NCT01565369|75640314|FG000|COMPLETED|Overall Study||35||
59542035|NCT01565369|75640314|FG000|NOT COMPLETED|Overall Study||0||
59542036|NCT02500056|75640321|FG000|STARTED|Overall Study||70||
59542037|NCT02500056|75640322|FG001|STARTED|Overall Study||73||
59542038|NCT02500056|75640321|FG000|COMPLETED|Overall Study||63||
59542039|NCT02500056|75640322|FG001|COMPLETED|Overall Study||65||
59542040|NCT02500056|75640321|FG000|NOT COMPLETED|Overall Study||7||
59542041|NCT02500056|75640322|FG001|NOT COMPLETED|Overall Study||8||
59542042|NCT01463267|75640332|FG000|STARTED|Overall Study||15||
59542043|NCT01463267|75640333|FG001|STARTED|Overall Study||15||
59542044|NCT01463267|75640334|FG002|STARTED|Overall Study||15||
59542045|NCT01463267|75640335|FG003|STARTED|Overall Study||15||
59542046|NCT01463267|75640332|FG000|COMPLETED|Overall Study||14||
59542047|NCT01463267|75640333|FG001|COMPLETED|Overall Study||15||
59542048|NCT01463267|75640334|FG002|COMPLETED|Overall Study||13||
59542049|NCT01463267|75640335|FG003|COMPLETED|Overall Study||13||
59542050|NCT01463267|75640332|FG000|NOT COMPLETED|Overall Study||1||
59542051|NCT01463267|75640333|FG001|NOT COMPLETED|Overall Study||0||
59542052|NCT01463267|75640334|FG002|NOT COMPLETED|Overall Study||2||
59542053|NCT01463267|75640335|FG003|NOT COMPLETED|Overall Study||2||
59542054|NCT02205983|75640349|FG000|STARTED|Overall Study||12||
59542055|NCT02205983|75640350|FG001|STARTED|Overall Study||12||
59542056|NCT02205983|75640351|FG002|STARTED|Overall Study||13||
59542057|NCT02205983|75640352|FG003|STARTED|Overall Study||13||
59542058|NCT02205983|75640349|FG000|COMPLETED|Overall Study||12||
59542059|NCT02205983|75640350|FG001|COMPLETED|Overall Study||12||
59542060|NCT02205983|75640351|FG002|COMPLETED|Overall Study||13||
59542061|NCT02205983|75640352|FG003|COMPLETED|Overall Study||13||
59542062|NCT02205983|75640349|FG000|NOT COMPLETED|Overall Study||0||
59542063|NCT02205983|75640350|FG001|NOT COMPLETED|Overall Study||0||
59542064|NCT02205983|75640351|FG002|NOT COMPLETED|Overall Study||0||
59542065|NCT02205983|75640352|FG003|NOT COMPLETED|Overall Study||0||
59542066|NCT02206217|75640364|FG000|STARTED|Overall Study||90||
59542067|NCT02206217|75640365|FG001|STARTED|Overall Study||93||
59542068|NCT02206217|75640364|FG000|COMPLETED|Overall Study||81||
59542069|NCT02206217|75640365|FG001|COMPLETED|Overall Study||79||
59542070|NCT02206217|75640364|FG000|NOT COMPLETED|Overall Study||9||
59542071|NCT02206217|75640365|FG001|NOT COMPLETED|Overall Study||14||
59542072|NCT02472756|75640371|FG000|STARTED|Induction (Approximately 6 Months)||41||
59542073|NCT02472756|75640371|FG000|Treated|Induction (Approximately 6 Months)||40||
59542074|NCT02472756|75640371|FG000|COMPLETED|Induction (Approximately 6 Months)||39||
59542075|NCT02472756|75640371|FG000|NOT COMPLETED|Induction (Approximately 6 Months)||2||
59542076|NCT02472756|75640371|FG000|STARTED|Maintenance (Approximately 2 Years)|Out of 39 participants who completed induction period, 19 did not continue in maintenance period.|20||
59542077|NCT02472756|75640371|FG000|COMPLETED|Maintenance (Approximately 2 Years)||10||
59542078|NCT02472756|75640371|FG000|NOT COMPLETED|Maintenance (Approximately 2 Years)||10||
59542079|NCT01464359|75640375|FG000|STARTED|Overall Study||3||
59542080|NCT01464359|75640375|FG000|COMPLETED|Overall Study||3||
59542081|NCT01464359|75640375|FG000|NOT COMPLETED|Overall Study||0||
59542082|NCT02498652|75640381|FG000|STARTED|Overall Study||20||
59642480|NCT02937558|75759066|FG000|NOT COMPLETED|Double-blind Phase||0||
59642481|NCT02937558|75759067|FG001|NOT COMPLETED|Double-blind Phase||0||
59642482|NCT02937558|75759066|FG000|STARTED|Open-label Phase||5||
59642483|NCT02937558|75759067|FG001|STARTED|Open-label Phase||0||
59642484|NCT02937558|75759066|FG000|COMPLETED|Open-label Phase||5||
59642485|NCT02937558|75759067|FG001|COMPLETED|Open-label Phase||0||
59642486|NCT02937558|75759066|FG000|NOT COMPLETED|Open-label Phase||0||
59642487|NCT02937558|75759067|FG001|NOT COMPLETED|Open-label Phase||0||
59642488|NCT02938494|75759078|FG000|STARTED|Overall Study||69||
59642489|NCT02938494|75759079|FG001|STARTED|Overall Study||72||
59642490|NCT02938494|75759080|FG002|STARTED|Overall Study||34||
59642491|NCT02938494|75759081|FG003|STARTED|Overall Study||35||
59642492|NCT02938494|75759078|FG000|COMPLETED|Overall Study||65||
59642493|NCT02938494|75759079|FG001|COMPLETED|Overall Study||63||
59642494|NCT02938494|75759080|FG002|COMPLETED|Overall Study||30||
59642495|NCT02938494|75759081|FG003|COMPLETED|Overall Study||31||
59642496|NCT02938494|75759078|FG000|NOT COMPLETED|Overall Study||4||
59642497|NCT02938494|75759079|FG001|NOT COMPLETED|Overall Study||9||
59642498|NCT02938494|75759080|FG002|NOT COMPLETED|Overall Study||4||
59642499|NCT02938494|75759081|FG003|NOT COMPLETED|Overall Study||4||
59642500|NCT02941614|75759092|FG000|STARTED|Overall Study||744||
59642501|NCT02941614|75759093|FG001|STARTED|Overall Study||692||
59642502|NCT02941614|75759092|FG000|COMPLETED|Overall Study||603||
59642503|NCT02941614|75759093|FG001|COMPLETED|Overall Study||446||
59642504|NCT02941614|75759092|FG000|NOT COMPLETED|Overall Study||141||
59642505|NCT02941614|75759093|FG001|NOT COMPLETED|Overall Study||246||
59642506|NCT02941692|75759103|FG000|STARTED|Overall Study||32||
59642507|NCT02941692|75759104|FG001|STARTED|Overall Study||34||
59642508|NCT02941692|75759103|FG000|COMPLETED|Overall Study||32||
59642509|NCT02941692|75759104|FG001|COMPLETED|Overall Study||34||
59642510|NCT02941692|75759103|FG000|NOT COMPLETED|Overall Study||0||
59642511|NCT02941692|75759104|FG001|NOT COMPLETED|Overall Study||0||
59642512|NCT02942160|75759110|FG000|STARTED|Overall Study|Observation Phase prior to open-label treatment phase|259||
59642513|NCT02942160|75759110|FG000|EN3835-202 Participants|Overall Study|Observation Phase Completed|222||
59642514|NCT02942160|75759110|FG000|EN3835 Treated Subjects in EN3835-202|Overall Study|EN3835 Treated Participants in EN3835-202 Started|200||
59642515|NCT02942160|75759110|FG000|COMPLETED|Overall Study|EN3835 Treated Participants in EN3835-202 Completed|156||
59642516|NCT02942160|75759110|FG000|NOT COMPLETED|Overall Study||103||
59642517|NCT02953860|75759118|FG000|STARTED|Overall Study||32||
59642518|NCT02953860|75759118|FG000|COMPLETED|Overall Study||32||
59642519|NCT02953860|75759118|FG000|NOT COMPLETED|Overall Study||0||
59642520|NCT02956044|75759125|FG000|STARTED|Overall Study||18||
59642521|NCT02956044|75759126|FG001|STARTED|Overall Study||18||
59642522|NCT02956044|75759127|FG002|STARTED|Overall Study||18||
59642523|NCT02956044|75759125|FG000|COMPLETED|Overall Study||18||
59642524|NCT02956044|75759126|FG001|COMPLETED|Overall Study||18||
59642525|NCT02956044|75759127|FG002|COMPLETED|Overall Study||18||
59642526|NCT02956044|75759125|FG000|NOT COMPLETED|Overall Study||0||
59642527|NCT02956044|75759126|FG001|NOT COMPLETED|Overall Study||0||
59642528|NCT02956044|75759127|FG002|NOT COMPLETED|Overall Study||0||
59642529|NCT02956122|75759149|FG000|STARTED|Overall Study||1||
59642530|NCT02956122|75759149|FG000|COMPLETED|Overall Study||1||
59642531|NCT02956122|75759149|FG000|NOT COMPLETED|Overall Study||0||
59642532|NCT02956746|75759164|FG000|STARTED|Overall Study||40||
59642533|NCT02956746|75759165|FG001|STARTED|Overall Study||40||
59642534|NCT02956746|75759166|FG002|STARTED|Overall Study||42||
59642535|NCT02956746|75759167|FG003|STARTED|Overall Study||42||
59642536|NCT02956746|75759164|FG000|COMPLETED|Overall Study||38||
59642537|NCT02956746|75759165|FG001|COMPLETED|Overall Study||37||
59642538|NCT02956746|75759166|FG002|COMPLETED|Overall Study||36||
59642539|NCT02956746|75759167|FG003|COMPLETED|Overall Study||38||
59642540|NCT02956746|75759164|FG000|NOT COMPLETED|Overall Study||2||
59642541|NCT02956746|75759165|FG001|NOT COMPLETED|Overall Study||3||
59642542|NCT02956746|75759166|FG002|NOT COMPLETED|Overall Study||6||
59642543|NCT02956746|75759167|FG003|NOT COMPLETED|Overall Study||4||
59642544|NCT02961894|75759178|FG000|STARTED|Overall Study||121||
59642545|NCT02961894|75759178|FG000|COMPLETED|Overall Study||121||
59642546|NCT02961894|75759178|FG000|NOT COMPLETED|Overall Study||0||
59642547|NCT02963376|75759186|FG000|STARTED|Overall Study||6||
59642548|NCT02963376|75759187|FG001|STARTED|Overall Study||2||
59642549|NCT02963376|75759188|FG002|STARTED|Overall Study||6||
59642550|NCT02963376|75759189|FG003|STARTED|Overall Study||2||
59642551|NCT02963376|75759190|FG004|STARTED|Overall Study||6||
59642552|NCT02963376|75759191|FG005|STARTED|Overall Study||2||
59642553|NCT02963376|75759186|FG000|COMPLETED|Overall Study||6||
59642554|NCT02963376|75759187|FG001|COMPLETED|Overall Study||2||
59642555|NCT02963376|75759188|FG002|COMPLETED|Overall Study||6||
59642556|NCT02963376|75759189|FG003|COMPLETED|Overall Study||2||
59642557|NCT02963376|75759190|FG004|COMPLETED|Overall Study||6||
59642558|NCT02963376|75759191|FG005|COMPLETED|Overall Study||2||
59642559|NCT02963376|75759186|FG000|NOT COMPLETED|Overall Study||0||
59642560|NCT02963376|75759187|FG001|NOT COMPLETED|Overall Study||0||
59642561|NCT02963376|75759188|FG002|NOT COMPLETED|Overall Study||0||
59642562|NCT02963376|75759189|FG003|NOT COMPLETED|Overall Study||0||
59642563|NCT02963376|75759190|FG004|NOT COMPLETED|Overall Study||0||
59642564|NCT02963376|75759191|FG005|NOT COMPLETED|Overall Study||0||
59642565|NCT02967354|75759218|FG000|STARTED|Overall Study||8||
59642566|NCT02967354|75759219|FG001|STARTED|Overall Study||7||
59642567|NCT02967354|75759220|FG002|STARTED|Overall Study||9||
59642568|NCT02967354|75759221|FG003|STARTED|Overall Study||7||
59642569|NCT02967354|75759222|FG004|STARTED|Overall Study||8||
59642570|NCT02967354|75759218|FG000|COMPLETED|Overall Study||8||
59642571|NCT02967354|75759219|FG001|COMPLETED|Overall Study||7||
59642572|NCT02967354|75759220|FG002|COMPLETED|Overall Study||9||
59642573|NCT02967354|75759221|FG003|COMPLETED|Overall Study||7||
59642574|NCT02967354|75759222|FG004|COMPLETED|Overall Study||8||
59642575|NCT02967354|75759218|FG000|NOT COMPLETED|Overall Study||0||
59642576|NCT02967354|75759219|FG001|NOT COMPLETED|Overall Study||0||
59642577|NCT02967354|75759220|FG002|NOT COMPLETED|Overall Study||0||
59642578|NCT02967354|75759221|FG003|NOT COMPLETED|Overall Study||0||
59642579|NCT02967354|75759222|FG004|NOT COMPLETED|Overall Study||0||
59642580|NCT02967510|75759243|FG000|STARTED|Overall Study||70||
59542083|NCT02498652|75640382|FG001|STARTED|Overall Study||21||
59542084|NCT02498652|75640381|FG000|COMPLETED|Overall Study||20||
59542085|NCT02498652|75640382|FG001|COMPLETED|Overall Study|One subject was withdrawn due to noncompliance/protocol violation|20||
59542086|NCT02498652|75640381|FG000|NOT COMPLETED|Overall Study||0||
59542087|NCT02498652|75640382|FG001|NOT COMPLETED|Overall Study||1||
59542088|NCT03213158|75640406|FG000|STARTED|Overall Study||10||
59542089|NCT03213158|75640406|FG000|COMPLETED|Overall Study||7||
59542090|NCT03213158|75640406|FG000|NOT COMPLETED|Overall Study||3||
59542091|NCT02498418|75640413|FG000|STARTED|Overall Study||247||
59542092|NCT02498418|75640414|FG001|STARTED|Overall Study||248||
59542093|NCT02498418|75640415|FG002|STARTED|Overall Study||244||
59542094|NCT02498418|75640413|FG000|Safety Population|Overall Study||246|Received at least 1 dose of study drug.|
59542095|NCT02498418|75640414|FG001|Safety Population|Overall Study||247|Received at least 1 dose of study drug.|
59542096|NCT02498418|75640415|FG002|Safety Population|Overall Study||244|Received at least 1 dose of study drug.|
59542097|NCT02498418|75640413|FG000|Modified Intent-to-treat Population|Overall Study||183|Met inclusion/exclusion criteria, took ≥1 dose of study drug, provided efficacy and safety data.|
59542098|NCT02498418|75640414|FG001|Modified Intent-to-treat Population|Overall Study||186|Met inclusion/exclusion criteria, took ≥1 dose of study drug, provided efficacy and safety data.|
59542099|NCT02498418|75640415|FG002|Modified Intent-to-treat Population|Overall Study||180|Met inclusion/exclusion criteria, took ≥1 dose of study drug, provided efficacy and safety data.|
59542100|NCT02498418|75640413|FG000|Per-protocol Analysis Set|Overall Study||182|Met study criteria, completed Visit 3 within 24-72 hrs of last dose, had no major protocol violation|
59542101|NCT02498418|75640414|FG001|Per-protocol Analysis Set|Overall Study||181|Met study criteria, completed Visit 3 within 24-72 hrs of last dose, had no major protocol violation|
59542102|NCT02498418|75640415|FG002|Per-protocol Analysis Set|Overall Study||176|Met study criteria, completed Visit 3 within 24-72 hrs of last dose, had no major protocol violation|
59542103|NCT02498418|75640413|FG000|COMPLETED|Overall Study||245||
59542104|NCT02498418|75640414|FG001|COMPLETED|Overall Study||246||
59542105|NCT02498418|75640415|FG002|COMPLETED|Overall Study||238||
59542106|NCT02498418|75640413|FG000|NOT COMPLETED|Overall Study||2||
59642581|NCT02967510|75759244|FG001|STARTED|Overall Study||70||
59642582|NCT02967510|75759245|FG002|STARTED|Overall Study||72||
59642583|NCT02967510|75759246|FG003|STARTED|Overall Study||71||
59542107|NCT02498418|75640414|FG001|NOT COMPLETED|Overall Study||2||
59542108|NCT02498418|75640415|FG002|NOT COMPLETED|Overall Study||6||
59542109|NCT03219476|75640423|FG000|STARTED|Overall Study||37||
59542110|NCT03219476|75640423|FG000|COMPLETED|Overall Study||37||
59542111|NCT03219476|75640423|FG000|NOT COMPLETED|Overall Study||0||
59542112|NCT02472366|75640433|FG000|STARTED|Overall Study|6 subjects receiving ILUVIEN, 7 eyes receiving ILUVIEN|6||
59542113|NCT02472366|75640434|FG001|STARTED|Overall Study||10||
59542114|NCT02472366|75640433|FG000|COMPLETED|Overall Study||5||
59542115|NCT02472366|75640434|FG001|COMPLETED|Overall Study||10||
59542116|NCT02472366|75640433|FG000|NOT COMPLETED|Overall Study||1||
59542117|NCT02472366|75640434|FG001|NOT COMPLETED|Overall Study||0||
59542118|NCT03219164|75640442|FG000|STARTED|Overall Study||74||
59542119|NCT03219164|75640443|FG001|STARTED|Overall Study||75||
59542120|NCT03219164|75640442|FG000|COMPLETED|Overall Study||49||
59542121|NCT03219164|75640443|FG001|COMPLETED|Overall Study||57||
59542122|NCT03219164|75640442|FG000|NOT COMPLETED|Overall Study||25||
59542123|NCT03219164|75640443|FG001|NOT COMPLETED|Overall Study||18||
59542124|NCT01566461|75640451|FG000|STARTED|IN.PACT SFA I Phase||99||
59642584|NCT02967510|75759243|FG000|COMPLETED|Overall Study||66||
59642585|NCT02967510|75759244|FG001|COMPLETED|Overall Study||67||
59642586|NCT02967510|75759245|FG002|COMPLETED|Overall Study||65||
59542125|NCT01566461|75640452|FG001|STARTED|IN.PACT SFA I Phase||51||
59542126|NCT01566461|75640451|FG000|COMPLETED|IN.PACT SFA I Phase||88||
59542127|NCT01566461|75640452|FG001|COMPLETED|IN.PACT SFA I Phase||49||
59542128|NCT01566461|75640451|FG000|NOT COMPLETED|IN.PACT SFA I Phase||11||
59642587|NCT02967510|75759246|FG003|COMPLETED|Overall Study||63||
59642588|NCT02967510|75759243|FG000|NOT COMPLETED|Overall Study||4||
59642589|NCT02967510|75759244|FG001|NOT COMPLETED|Overall Study||3||
59642590|NCT02967510|75759245|FG002|NOT COMPLETED|Overall Study||7||
59642591|NCT02967510|75759246|FG003|NOT COMPLETED|Overall Study||8||
59642592|NCT02968134|75759256|FG000|STARTED|Overall Study||8||
59642593|NCT02968134|75759256|FG000|COMPLETED|Overall Study||8||
59642594|NCT02968134|75759256|FG000|NOT COMPLETED|Overall Study||0||
59642595|NCT02968368|75759262|FG000|STARTED|Double Blind Phase||111||
59642596|NCT02968368|75759263|FG001|STARTED|Double Blind Phase||56||
59642597|NCT02968368|75759262|FG000|COMPLETED|Double Blind Phase||90||
59642598|NCT02968368|75759263|FG001|COMPLETED|Double Blind Phase||39||
59642599|NCT02968368|75759262|FG000|NOT COMPLETED|Double Blind Phase||21||
59642600|NCT02968368|75759263|FG001|NOT COMPLETED|Double Blind Phase||17||
59642601|NCT02968368|75759262|FG000|STARTED|Open Label Phase||86||
59642602|NCT02968368|75759263|FG001|STARTED|Open Label Phase||39||
59642603|NCT02968368|75759262|FG000|COMPLETED|Open Label Phase||67||
59642604|NCT02968368|75759263|FG001|COMPLETED|Open Label Phase||25||
59642605|NCT02968368|75759262|FG000|NOT COMPLETED|Open Label Phase||19||
59642606|NCT02968368|75759263|FG001|NOT COMPLETED|Open Label Phase||14||
59642607|NCT02968758|75759273|FG000|STARTED|Overall Study||797||
59642608|NCT02968758|75759274|FG001|STARTED|Overall Study||1664||
59642609|NCT02968758|75759273|FG000|COMPLETED|Overall Study||797||
59642610|NCT02968758|75759274|FG001|COMPLETED|Overall Study||1664||
59642611|NCT02968758|75759273|FG000|NOT COMPLETED|Overall Study||0||
59642612|NCT02968758|75759274|FG001|NOT COMPLETED|Overall Study||0||
59642613|NCT02968914|75759281|FG000|STARTED|Overall Study||90||
59642614|NCT02968914|75759282|FG001|STARTED|Overall Study||90||
59642615|NCT02968914|75759281|FG000|COMPLETED|Overall Study||90||
59988529|NCT02483078|76103697|FG001|COMPLETED|Part 1 One-week Randomized||26||
59988530|NCT02483078|76103696|FG000|NOT COMPLETED|Part 1 One-week Randomized||0||
59988531|NCT02483078|76103697|FG001|NOT COMPLETED|Part 1 One-week Randomized||1||
59988532|NCT02483078|76103696|FG000|STARTED|Part 2 Open Label Treatment Period|In Open Label Treatment Period, all study participants received PRO140|25||
59988533|NCT02483078|76103697|FG001|STARTED|Part 2 Open Label Treatment Period|In Open Label Treatment Period, all study participants received PRO140|26||
59988534|NCT02483078|76103696|FG000|COMPLETED|Part 2 Open Label Treatment Period||25||
59988535|NCT02483078|76103697|FG001|COMPLETED|Part 2 Open Label Treatment Period||21||
59988536|NCT02483078|76103696|FG000|NOT COMPLETED|Part 2 Open Label Treatment Period||0||
59988537|NCT02483078|76103697|FG001|NOT COMPLETED|Part 2 Open Label Treatment Period||5||
59988538|NCT02452190|76103711|FG000|STARTED|Overall Study||232||
59988539|NCT02452190|76103712|FG001|STARTED|Overall Study||236||
59988540|NCT02452190|76103711|FG000|Intent to Treat (ITT) Population|Overall Study||230|All randomized participants, excluding 4 from a terminated study site.|
59988541|NCT02452190|76103712|FG001|Intent to Treat (ITT) Population|Overall Study||234|All randomized participants, excluding 4 from a terminated study site.|
59988542|NCT02452190|76103711|FG000|Safety Population|Overall Study||231|Placebo participant treated with reslizumab at 1 visit is counted in reslizumab arm for Safety.|
59988543|NCT02452190|76103712|FG001|Safety Population|Overall Study||237|Placebo participant treated with reslizumab at 1 visit is counted in reslizumab arm for Safety.|
59988544|NCT02452190|76103711|FG000|COMPLETED|Overall Study||197||
59988545|NCT02452190|76103712|FG001|COMPLETED|Overall Study||212||
59642616|NCT02968914|75759282|FG001|COMPLETED|Overall Study||90||
59988546|NCT02452190|76103711|FG000|NOT COMPLETED|Overall Study||35||
59642617|NCT02968914|75759281|FG000|NOT COMPLETED|Overall Study||0||
59642618|NCT02968914|75759282|FG001|NOT COMPLETED|Overall Study||0||
59642619|NCT02970006|75759288|FG000|STARTED|Overall Study||15||
59988547|NCT02452190|76103712|FG001|NOT COMPLETED|Overall Study||24||
59988548|NCT02514122|76103720|FG000|STARTED|Overall Study||32||
59988549|NCT02514122|76103721|FG001|STARTED|Overall Study||29||
59642620|NCT02970006|75759288|FG000|COMPLETED|Overall Study||14||
59642621|NCT02970006|75759288|FG000|NOT COMPLETED|Overall Study||1||
59642622|NCT02970162|75759294|FG000|STARTED|Overall Study||13||
59642623|NCT02970162|75759295|FG001|STARTED|Overall Study||13||
59642624|NCT02970162|75759294|FG000|COMPLETED|Overall Study||13||
59642625|NCT02970162|75759295|FG001|COMPLETED|Overall Study||13||
59642626|NCT02970162|75759294|FG000|NOT COMPLETED|Overall Study||0||
59642627|NCT02970162|75759295|FG001|NOT COMPLETED|Overall Study||0||
59642628|NCT02970552|75759303|FG000|STARTED|Overall Study||70||
59642629|NCT02970552|75759304|FG001|STARTED|Overall Study||70||
59642630|NCT02970552|75759303|FG000|COMPLETED|Overall Study||67||
59642631|NCT02970552|75759304|FG001|COMPLETED|Overall Study||67||
59642632|NCT02970552|75759303|FG000|NOT COMPLETED|Overall Study||3||
59642633|NCT02970552|75759304|FG001|NOT COMPLETED|Overall Study||3||
59642634|NCT02971488|75759314|FG000|STARTED|Overall Study||529||
59642635|NCT02971488|75759314|FG000|COMPLETED|Overall Study||529||
59642636|NCT02971488|75759314|FG000|NOT COMPLETED|Overall Study||0||
59642637|NCT02973438|75759325|FG000|STARTED|First Treatment Session (4 Days)||2||
59642638|NCT02973438|75759326|FG001|STARTED|First Treatment Session (4 Days)||1||
59642639|NCT02973438|75759327|FG002|STARTED|First Treatment Session (4 Days)||2||
59642640|NCT02973438|75759328|FG003|STARTED|First Treatment Session (4 Days)||1||
59642641|NCT02973438|75759325|FG000|COMPLETED|First Treatment Session (4 Days)||2||
59642642|NCT02973438|75759326|FG001|COMPLETED|First Treatment Session (4 Days)||1||
59642643|NCT02973438|75759327|FG002|COMPLETED|First Treatment Session (4 Days)||2||
59642644|NCT02973438|75759328|FG003|COMPLETED|First Treatment Session (4 Days)||1||
59642645|NCT02973438|75759325|FG000|NOT COMPLETED|First Treatment Session (4 Days)||0||
59642646|NCT02973438|75759326|FG001|NOT COMPLETED|First Treatment Session (4 Days)||0||
59642647|NCT02973438|75759327|FG002|NOT COMPLETED|First Treatment Session (4 Days)||0||
59642648|NCT02973438|75759328|FG003|NOT COMPLETED|First Treatment Session (4 Days)||0||
59642649|NCT02973438|75759325|FG000|STARTED|Washout (Three Weeks)||2||
59642650|NCT02973438|75759326|FG001|STARTED|Washout (Three Weeks)||1||
59642651|NCT02973438|75759327|FG002|STARTED|Washout (Three Weeks)||2||
59642652|NCT02973438|75759328|FG003|STARTED|Washout (Three Weeks)||1||
59642653|NCT02973438|75759325|FG000|COMPLETED|Washout (Three Weeks)||2||
59642654|NCT02973438|75759326|FG001|COMPLETED|Washout (Three Weeks)||1||
59642655|NCT02973438|75759327|FG002|COMPLETED|Washout (Three Weeks)||2||
59642656|NCT02973438|75759328|FG003|COMPLETED|Washout (Three Weeks)||1||
59642657|NCT02973438|75759325|FG000|NOT COMPLETED|Washout (Three Weeks)||0||
59642658|NCT02973438|75759326|FG001|NOT COMPLETED|Washout (Three Weeks)||0||
59642659|NCT02973438|75759327|FG002|NOT COMPLETED|Washout (Three Weeks)||0||
59642660|NCT02973438|75759328|FG003|NOT COMPLETED|Washout (Three Weeks)||0||
59642661|NCT02973438|75759325|FG000|STARTED|Second Treatment Session (4 Days)||2||
59642662|NCT02973438|75759326|FG001|STARTED|Second Treatment Session (4 Days)||1||
59642663|NCT02973438|75759327|FG002|STARTED|Second Treatment Session (4 Days)||2||
59642664|NCT02973438|75759328|FG003|STARTED|Second Treatment Session (4 Days)||1||
59642665|NCT02973438|75759325|FG000|COMPLETED|Second Treatment Session (4 Days)||2||
59642666|NCT02973438|75759326|FG001|COMPLETED|Second Treatment Session (4 Days)||1||
59642667|NCT02973438|75759327|FG002|COMPLETED|Second Treatment Session (4 Days)||2||
59642668|NCT02973438|75759328|FG003|COMPLETED|Second Treatment Session (4 Days)||1||
59642669|NCT02973438|75759325|FG000|NOT COMPLETED|Second Treatment Session (4 Days)||0||
59642670|NCT02973438|75759326|FG001|NOT COMPLETED|Second Treatment Session (4 Days)||0||
59642671|NCT02973438|75759327|FG002|NOT COMPLETED|Second Treatment Session (4 Days)||0||
59642672|NCT02973438|75759328|FG003|NOT COMPLETED|Second Treatment Session (4 Days)||0||
59642673|NCT02973516|75759341|FG000|STARTED|Overall Study||30||
59642674|NCT02973516|75759342|FG001|STARTED|Overall Study||10||
59642675|NCT02973516|75759341|FG000|COMPLETED|Overall Study||30||
59642676|NCT02973516|75759342|FG001|COMPLETED|Overall Study||10||
59642677|NCT02973516|75759341|FG000|NOT COMPLETED|Overall Study||0||
59642678|NCT02973516|75759342|FG001|NOT COMPLETED|Overall Study||0||
59642679|NCT02974296|75759350|FG000|STARTED|Overall Study||10||
59642680|NCT02974296|75759351|FG001|STARTED|Overall Study||23||
59642681|NCT02974296|75759350|FG000|COMPLETED|Overall Study||10||
59642682|NCT02974296|75759351|FG001|COMPLETED|Overall Study||22||
59642683|NCT02974296|75759350|FG000|NOT COMPLETED|Overall Study||0||
59642684|NCT02974296|75759351|FG001|NOT COMPLETED|Overall Study||1||
59642685|NCT02978508|75759359|FG000|STARTED|Overall Study||70||
59642686|NCT02978508|75759360|FG001|STARTED|Overall Study||70||
59642687|NCT02978508|75759359|FG000|COMPLETED|Overall Study||70||
59988550|NCT02514122|76103720|FG000|COMPLETED|Overall Study|one participant dropped out for religious reasons; one for needle phobia|30||
59642688|NCT02978508|75759360|FG001|COMPLETED|Overall Study||70||
59642689|NCT02978508|75759359|FG000|NOT COMPLETED|Overall Study||0||
59642690|NCT02978508|75759360|FG001|NOT COMPLETED|Overall Study||0||
59642691|NCT02979054|75759368|FG000|STARTED|Overall Study||71||
59642692|NCT02979054|75759369|FG001|STARTED|Overall Study||64||
59642693|NCT02979054|75759368|FG000|COMPLETED|Overall Study||71||
59642694|NCT02979054|75759369|FG001|COMPLETED|Overall Study||64||
59642695|NCT02979054|75759368|FG000|NOT COMPLETED|Overall Study||0||
59642696|NCT02979054|75759369|FG001|NOT COMPLETED|Overall Study||0||
59642697|NCT02979444|75759378|FG000|STARTED|Overall Study||405||
59642698|NCT02979444|75759379|FG001|STARTED|Overall Study||310||
59642699|NCT02979444|75759380|FG002|STARTED|Overall Study||159||
59642700|NCT02979444|75759378|FG000|COMPLETED|Overall Study||382||
59642701|NCT02979444|75759379|FG001|COMPLETED|Overall Study||293||
59642702|NCT02979444|75759380|FG002|COMPLETED|Overall Study||149||
59642703|NCT02979444|75759378|FG000|NOT COMPLETED|Overall Study||23||
59642704|NCT02979444|75759379|FG001|NOT COMPLETED|Overall Study||17||
59642705|NCT02979444|75759380|FG002|NOT COMPLETED|Overall Study||10||
59642706|NCT02881008|75759394|FG000|STARTED|Overall Study||8||
59642707|NCT02881008|75759395|FG001|STARTED|Overall Study||8||
59642708|NCT02881008|75759396|FG002|STARTED|Overall Study||8||
59642709|NCT02881008|75759397|FG003|STARTED|Overall Study||8||
59642710|NCT02881008|75759398|FG004|STARTED|Overall Study||8||
59642711|NCT02881008|75759399|FG005|STARTED|Overall Study||8||
59642712|NCT02881008|75759394|FG000|COMPLETED|Overall Study||8||
59642713|NCT02881008|75759395|FG001|COMPLETED|Overall Study||8||
59642714|NCT02881008|75759396|FG002|COMPLETED|Overall Study||8||
59642715|NCT02881008|75759397|FG003|COMPLETED|Overall Study||8||
59642716|NCT02881008|75759398|FG004|COMPLETED|Overall Study||8||
59642717|NCT02881008|75759399|FG005|COMPLETED|Overall Study||8||
59642718|NCT02881008|75759394|FG000|NOT COMPLETED|Overall Study||0||
59642719|NCT02881008|75759395|FG001|NOT COMPLETED|Overall Study||0||
59642720|NCT02881008|75759396|FG002|NOT COMPLETED|Overall Study||0||
59642721|NCT02881008|75759397|FG003|NOT COMPLETED|Overall Study||0||
59642722|NCT02881008|75759398|FG004|NOT COMPLETED|Overall Study||0||
59642723|NCT02881008|75759399|FG005|NOT COMPLETED|Overall Study||0||
59642724|NCT02987868|75759416|FG000|STARTED|First Intervention||8||
59642725|NCT02987868|75759417|FG001|STARTED|First Intervention||8||
59642726|NCT02987868|75759416|FG000|COMPLETED|First Intervention||8||
59642727|NCT02987868|75759417|FG001|COMPLETED|First Intervention||8||
59642728|NCT02987868|75759416|FG000|NOT COMPLETED|First Intervention||0||
59642729|NCT02987868|75759417|FG001|NOT COMPLETED|First Intervention||0||
59642730|NCT02987868|75759416|FG000|STARTED|Wash Out Period 1 Week||8||
59642731|NCT02987868|75759417|FG001|STARTED|Wash Out Period 1 Week||8||
59642732|NCT02987868|75759416|FG000|COMPLETED|Wash Out Period 1 Week||8||
59642733|NCT02987868|75759417|FG001|COMPLETED|Wash Out Period 1 Week||8||
59642734|NCT02987868|75759416|FG000|NOT COMPLETED|Wash Out Period 1 Week||0||
59642735|NCT02987868|75759417|FG001|NOT COMPLETED|Wash Out Period 1 Week||0||
59642736|NCT02987868|75759416|FG000|STARTED|Second Intervention||8||
59642737|NCT02987868|75759417|FG001|STARTED|Second Intervention||8||
59642738|NCT02987868|75759416|FG000|COMPLETED|Second Intervention||8||
59642739|NCT02987868|75759417|FG001|COMPLETED|Second Intervention||8||
59642740|NCT02987868|75759416|FG000|NOT COMPLETED|Second Intervention||0||
59642741|NCT02987868|75759417|FG001|NOT COMPLETED|Second Intervention||0||
59642742|NCT02988882|75759425|FG000|STARTED|Overall Study||44||
59642743|NCT02988882|75759426|FG001|STARTED|Overall Study||42||
59642744|NCT02988882|75759425|FG000|COMPLETED|Overall Study||41||
59642745|NCT02988882|75759426|FG001|COMPLETED|Overall Study||40||
59642746|NCT02988882|75759425|FG000|NOT COMPLETED|Overall Study||3||
59642747|NCT02988882|75759426|FG001|NOT COMPLETED|Overall Study||2||
59642748|NCT02992236|75759434|FG000|STARTED|Overall Study||8||
59642749|NCT02992236|75759435|FG001|STARTED|Overall Study||8||
59642750|NCT02992236|75759434|FG000|COMPLETED|Overall Study||8||
59642751|NCT02992236|75759435|FG001|COMPLETED|Overall Study||8||
59642752|NCT02992236|75759434|FG000|NOT COMPLETED|Overall Study||0||
59642753|NCT02992236|75759435|FG001|NOT COMPLETED|Overall Study||0||
59642754|NCT02994732|75759443|FG000|STARTED|Overall Study|All subjects entered clinic on January 11, 2017|6||
59642755|NCT02994732|75759443|FG000|COMPLETED|Overall Study|All subjects were discharged from the clinic by Jan 24, 2017|6||
59642756|NCT02994732|75759443|FG000|NOT COMPLETED|Overall Study||0||
59642757|NCT03001674|75759450|FG000|STARTED|Overall Study||10||
59642758|NCT03001674|75759451|FG001|STARTED|Overall Study||5||
59642759|NCT03001674|75759450|FG000|COMPLETED|Overall Study||10||
59642760|NCT03001674|75759451|FG001|COMPLETED|Overall Study||5||
59642761|NCT03001674|75759450|FG000|NOT COMPLETED|Overall Study||0||
59642762|NCT03001674|75759451|FG001|NOT COMPLETED|Overall Study||0||
59642763|NCT03002454|75759457|FG000|STARTED|Overall Study||4||
59642764|NCT03002454|75759457|FG000|COMPLETED|Overall Study||4||
59642765|NCT03002454|75759457|FG000|NOT COMPLETED|Overall Study||0||
59642766|NCT03004638|75759468|FG000|STARTED|Overall Study||6||
59642767|NCT03004638|75759469|FG001|STARTED|Overall Study||6||
59642768|NCT03004638|75759470|FG002|STARTED|Overall Study||6||
59642769|NCT03004638|75759471|FG003|STARTED|Overall Study||6||
59642770|NCT03004638|75759472|FG004|STARTED|Overall Study||1||
59642771|NCT03004638|75759473|FG005|STARTED|Overall Study||7||
59642772|NCT03004638|75759468|FG000|COMPLETED|Overall Study||6||
59642773|NCT03004638|75759469|FG001|COMPLETED|Overall Study||6||
59642774|NCT03004638|75759470|FG002|COMPLETED|Overall Study||6||
59642775|NCT03004638|75759471|FG003|COMPLETED|Overall Study||6||
59642776|NCT03004638|75759472|FG004|COMPLETED|Overall Study||1||
59642777|NCT03004638|75759473|FG005|COMPLETED|Overall Study||7||
59642778|NCT03004638|75759468|FG000|NOT COMPLETED|Overall Study||0||
59642779|NCT03004638|75759469|FG001|NOT COMPLETED|Overall Study||0||
59642780|NCT03004638|75759470|FG002|NOT COMPLETED|Overall Study||0||
59642781|NCT03004638|75759471|FG003|NOT COMPLETED|Overall Study||0||
59642782|NCT03004638|75759472|FG004|NOT COMPLETED|Overall Study||0||
59642783|NCT03004638|75759473|FG005|NOT COMPLETED|Overall Study||0||
59642784|NCT03009162|75759493|FG000|STARTED|Overall Study||8||
59642785|NCT03009162|75759494|FG001|STARTED|Overall Study||8||
59642786|NCT03009162|75759493|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8||
59642787|NCT03009162|75759494|FG001|Received at Least 1 Dose of Study Drug|Overall Study||8||
59642788|NCT03009162|75759493|FG000|COMPLETED|Overall Study||8||
59642789|NCT03009162|75759494|FG001|COMPLETED|Overall Study||8||
59642790|NCT03009162|75759493|FG000|NOT COMPLETED|Overall Study||0||
59642791|NCT03009162|75759494|FG001|NOT COMPLETED|Overall Study||0||
59642792|NCT03009396|75759500|FG000|STARTED|Overall Study||16||
59642793|NCT03009396|75759501|FG001|STARTED|Overall Study||38||
59642794|NCT03009396|75759500|FG000|COMPLETED|Overall Study||9||
59642795|NCT03009396|75759501|FG001|COMPLETED|Overall Study||21||
59642796|NCT03009396|75759500|FG000|NOT COMPLETED|Overall Study||7||
59642797|NCT03009396|75759501|FG001|NOT COMPLETED|Overall Study||17||
59642798|NCT03010488|75759510|FG000|STARTED|Overall Study||22||
59642799|NCT03010488|75759511|FG001|STARTED|Overall Study||22||
59642800|NCT03010488|75759510|FG000|COMPLETED|Overall Study||17||
59642801|NCT03010488|75759511|FG001|COMPLETED|Overall Study||15||
59642802|NCT03010488|75759510|FG000|NOT COMPLETED|Overall Study||5||
59642803|NCT03010488|75759511|FG001|NOT COMPLETED|Overall Study||7||
59642804|NCT03010800|75759519|FG000|STARTED|Initial Assignment||4||
59642805|NCT03010800|75759520|FG001|STARTED|Initial Assignment||4||
59642806|NCT03010800|75759519|FG000|COMPLETED|Initial Assignment||4||
59642807|NCT03010800|75759520|FG001|COMPLETED|Initial Assignment||4||
59642808|NCT03010800|75759519|FG000|NOT COMPLETED|Initial Assignment||0||
59642809|NCT03010800|75759520|FG001|NOT COMPLETED|Initial Assignment||0||
59642810|NCT03010800|75759519|FG000|STARTED|Cross Over||4||
59642811|NCT03010800|75759520|FG001|STARTED|Cross Over||4||
59642812|NCT03010800|75759519|FG000|COMPLETED|Cross Over||4||
59642813|NCT03010800|75759520|FG001|COMPLETED|Cross Over||4||
59642814|NCT03010800|75759519|FG000|NOT COMPLETED|Cross Over||0||
59642815|NCT03010800|75759520|FG001|NOT COMPLETED|Cross Over||0||
59642816|NCT03012594|75759526|FG000|STARTED|Overall Study||12||
59642817|NCT03012594|75759526|FG000|COMPLETED|Overall Study||9||
59642818|NCT03012594|75759526|FG000|NOT COMPLETED|Overall Study||3||
59642819|NCT03014700|75759532|FG000|STARTED|Overall Study||30||
59642820|NCT03014700|75759533|FG001|STARTED|Overall Study||30||
59642821|NCT03014700|75759532|FG000|COMPLETED|Overall Study||25||
59642822|NCT03014700|75759533|FG001|COMPLETED|Overall Study||29||
59642823|NCT03014700|75759532|FG000|NOT COMPLETED|Overall Study||5||
59642824|NCT03014700|75759533|FG001|NOT COMPLETED|Overall Study||1||
59642825|NCT03017508|75759541|FG000|STARTED|Overall Study||12||
59642826|NCT03017508|75759542|FG001|STARTED|Overall Study||10||
59642827|NCT03017508|75759541|FG000|First Intervention (1 Day)|Overall Study||12||
59642828|NCT03017508|75759542|FG001|First Intervention (1 Day)|Overall Study||10||
59642829|NCT03017508|75759541|FG000|Washout (2-10 Days)|Overall Study||12||
59642830|NCT03017508|75759542|FG001|Washout (2-10 Days)|Overall Study||10||
59642831|NCT03017508|75759541|FG000|Second Intervention (1 Day)|Overall Study||12||
59642832|NCT03017508|75759542|FG001|Second Intervention (1 Day)|Overall Study||10||
59642833|NCT03017508|75759541|FG000|COMPLETED|Overall Study||12||
59642834|NCT03017508|75759542|FG001|COMPLETED|Overall Study||10||
59642835|NCT03017508|75759541|FG000|NOT COMPLETED|Overall Study||0||
59642836|NCT03017508|75759542|FG001|NOT COMPLETED|Overall Study||0||
59642837|NCT03020004|75759548|FG000|STARTED|Overall Study||70||
59642838|NCT03020004|75759548|FG000|COMPLETED|Overall Study||69||
59642839|NCT03020004|75759548|FG000|NOT COMPLETED|Overall Study||1||
59642840|NCT03020082|75759552|FG000|STARTED|Overall Study||141||
59642841|NCT03020082|75759552|FG000|COMPLETED|Overall Study||138||
59642842|NCT03020082|75759552|FG000|NOT COMPLETED|Overall Study||3||
59642843|NCT03020472|75759556|FG000|STARTED|Overall Study||6||
59642844|NCT03020472|75759556|FG000|COMPLETED|Overall Study||6||
59988551|NCT02514122|76103721|FG001|COMPLETED|Overall Study||29||
59988552|NCT02514122|76103720|FG000|NOT COMPLETED|Overall Study||2||
59642845|NCT03020472|75759556|FG000|NOT COMPLETED|Overall Study||0||
59642846|NCT03020550|75759562|FG000|STARTED|Overall Study||8||
59988553|NCT02514122|76103721|FG001|NOT COMPLETED|Overall Study||0||
59642847|NCT03020550|75759563|FG001|STARTED|Overall Study||16||
59642848|NCT03020550|75759562|FG000|COMPLETED|Overall Study||8||
59642849|NCT03020550|75759563|FG001|COMPLETED|Overall Study||16||
59642850|NCT03020550|75759562|FG000|NOT COMPLETED|Overall Study||0||
59642851|NCT03020550|75759563|FG001|NOT COMPLETED|Overall Study||0||
59642852|NCT03026556|75759572|FG000|STARTED|Overall Study||12763||
59642853|NCT03026556|75759573|FG001|STARTED|Overall Study||17177||
59642854|NCT03026556|75759574|FG002|STARTED|Overall Study||12594||
59642855|NCT03026556|75759572|FG000|COMPLETED|Overall Study||12763||
59642856|NCT03026556|75759573|FG001|COMPLETED|Overall Study||17177||
59642857|NCT03026556|75759574|FG002|COMPLETED|Overall Study||12594||
59642858|NCT03026556|75759572|FG000|NOT COMPLETED|Overall Study||0||
59642859|NCT03026556|75759573|FG001|NOT COMPLETED|Overall Study||0||
59642860|NCT03026556|75759574|FG002|NOT COMPLETED|Overall Study||0||
59642861|NCT03028974|75759588|FG000|STARTED|2014-2015||1|LAIV was not recommended in Group B and C age groups starting in 2014-2015.|
59815749|NCT03026283|75938215|FG004|STARTED|CCTA Diagnosis||0||
59988554|NCT00730639|76103732|FG000|STARTED|Overall Study||17||
59642862|NCT03028974|75759589|FG001|STARTED|2014-2015||0|LAIV was not recommended in Group B and C age groups starting in 2014-2015.|
59642863|NCT03028974|75759590|FG002|STARTED|2014-2015||0|LAIV was not recommended in Group B and C age groups starting in 2014-2015.|
59642864|NCT03028974|75759591|FG003|STARTED|2014-2015||3|LAIV was not recommended in Group B and C age groups starting in 2014-2015.|
59642865|NCT03028974|75759592|FG004|STARTED|2014-2015||0|LAIV was not recommended in Group B and C age groups starting in 2014-2015.|
59642866|NCT03028974|75759593|FG005|STARTED|2014-2015||11|LAIV was not recommended in Group B and C age groups starting in 2014-2015.|
59642867|NCT03028974|75759594|FG006|STARTED|2014-2015||13|LAIV was not recommended in Group B and C age groups starting in 2014-2015.|
59642868|NCT03028974|75759588|FG000|COMPLETED|2014-2015||1||
59642869|NCT03028974|75759589|FG001|COMPLETED|2014-2015||0||
59642870|NCT03028974|75759590|FG002|COMPLETED|2014-2015||0||
59642871|NCT03028974|75759591|FG003|COMPLETED|2014-2015||3||
59642872|NCT03028974|75759592|FG004|COMPLETED|2014-2015||0||
59642873|NCT03028974|75759593|FG005|COMPLETED|2014-2015|2 participants did not continue to the next period.|11||
59642874|NCT03028974|75759594|FG006|COMPLETED|2014-2015|13 participants did not continue to the next period.|13||
59542129|NCT01566461|75640452|FG001|NOT COMPLETED|IN.PACT SFA I Phase||2||
59542130|NCT01566461|75640451|FG000|STARTED|IN.PACT SFA II Phase||121||
59542131|NCT01566461|75640452|FG001|STARTED|IN.PACT SFA II Phase||60||
59542132|NCT01566461|75640451|FG000|COMPLETED|IN.PACT SFA II Phase||109||
59542133|NCT01566461|75640452|FG001|COMPLETED|IN.PACT SFA II Phase||55||
59542134|NCT01566461|75640451|FG000|NOT COMPLETED|IN.PACT SFA II Phase||12||
59542135|NCT01566461|75640452|FG001|NOT COMPLETED|IN.PACT SFA II Phase||5||
59542136|NCT02471586|75640461|FG000|STARTED|Overall Study||158||
59642875|NCT03028974|75759588|FG000|NOT COMPLETED|2014-2015||0||
59642876|NCT03028974|75759589|FG001|NOT COMPLETED|2014-2015||0||
59642877|NCT03028974|75759590|FG002|NOT COMPLETED|2014-2015||0||
59642878|NCT03028974|75759591|FG003|NOT COMPLETED|2014-2015||0||
59642879|NCT03028974|75759592|FG004|NOT COMPLETED|2014-2015||0||
59642880|NCT03028974|75759593|FG005|NOT COMPLETED|2014-2015||0||
59642881|NCT03028974|75759594|FG006|NOT COMPLETED|2014-2015||0||
59642882|NCT03028974|75759588|FG000|STARTED|2015-2016||0|LAIV was not recommended in Groups A, B, C and F in 2015-2016.|
59642883|NCT03028974|75759589|FG001|STARTED|2015-2016||0|LAIV was not recommended in Groups A, B, C and F in 2015-2016.|
59642884|NCT03028974|75759590|FG002|STARTED|2015-2016||0|LAIV was not recommended in Groups A, B, C and F in 2015-2016.|
59642885|NCT03028974|75759591|FG003|STARTED|2015-2016|One participant joined from Group A, 2 new were enrolled.|6|LAIV was not recommended in Groups A, B, C and F in 2015-2016.|
59642886|NCT03028974|75759592|FG004|STARTED|2015-2016||0|LAIV was not recommended in Groups A, B, C and F in 2015-2016.|
59642887|NCT03028974|75759593|FG005|STARTED|2015-2016|10 new participants were enrolled; 4 subjects switched from Group G.|14|LAIV was not recommended in Groups A, B, C and F in 2015-2016.|
59642888|NCT03028974|75759594|FG006|STARTED|2015-2016|11 new participants were enrolled; 9 subjects switched from Group F.|20|LAIV was not recommended in Groups A, B, C and F in 2015-2016.|
59642889|NCT03028974|75759588|FG000|COMPLETED|2015-2016||0||
59642890|NCT03028974|75759589|FG001|COMPLETED|2015-2016||0||
59642891|NCT03028974|75759590|FG002|COMPLETED|2015-2016||0||
59642892|NCT03028974|75759591|FG003|COMPLETED|2015-2016|3 participants did not continue to the next period. 1 Participant returned in period 4 (2017-2018).|6||
59642893|NCT03028974|75759592|FG004|COMPLETED|2015-2016||0||
59642894|NCT03028974|75759593|FG005|COMPLETED|2015-2016|14 participants did not continue to the next period.|14||
59642895|NCT03028974|75759594|FG006|COMPLETED|2015-2016|20 participants did not continue to the next period.|20||
59642896|NCT03028974|75759588|FG000|NOT COMPLETED|2015-2016||0||
59642897|NCT03028974|75759589|FG001|NOT COMPLETED|2015-2016||0||
59642898|NCT03028974|75759590|FG002|NOT COMPLETED|2015-2016||0||
59642899|NCT03028974|75759591|FG003|NOT COMPLETED|2015-2016||0||
59642900|NCT03028974|75759592|FG004|NOT COMPLETED|2015-2016||0||
59642901|NCT03028974|75759593|FG005|NOT COMPLETED|2015-2016||0||
59642902|NCT03028974|75759594|FG006|NOT COMPLETED|2015-2016||0||
59642903|NCT03028974|75759588|FG000|STARTED|2016-2017||0|Groups A, B, C and F closed to enrollment. LAIV4 not recommended.|
59642904|NCT03028974|75759589|FG001|STARTED|2016-2017||0|Groups A, B, C and F closed to enrollment. LAIV4 not recommended.|
59642905|NCT03028974|75759590|FG002|STARTED|2016-2017||0|Groups A, B, C and F closed to enrollment. LAIV4 not recommended.|
59642906|NCT03028974|75759591|FG003|STARTED|2016-2017|1 new participant was enrolled.|4|Groups A, B, C and F closed to enrollment. LAIV4 not recommended.|
59642907|NCT03028974|75759592|FG004|STARTED|2016-2017|2 new participants were enrolled.|2|Groups A, B, C and F closed to enrollment. LAIV4 not recommended.|
59642908|NCT03028974|75759593|FG005|STARTED|2016-2017||0|Groups A, B, C and F closed to enrollment. LAIV4 not recommended.|
59642909|NCT03028974|75759594|FG006|STARTED|2016-2017|18 new participants were enrolled.|18|Groups A, B, C and F closed to enrollment. LAIV4 not recommended.|
59642910|NCT03028974|75759588|FG000|COMPLETED|2016-2017||0||
59642911|NCT03028974|75759589|FG001|COMPLETED|2016-2017||0||
59542137|NCT02471586|75640462|FG001|STARTED|Overall Study||146||
59542138|NCT02471586|75640463|FG002|STARTED|Overall Study||146||
59542139|NCT02471586|75640461|FG000|COMPLETED|Overall Study||153||
59542140|NCT02471586|75640462|FG001|COMPLETED|Overall Study||136||
59542141|NCT02471586|75640463|FG002|COMPLETED|Overall Study||142||
59542142|NCT02471586|75640461|FG000|NOT COMPLETED|Overall Study||5||
59542143|NCT02471586|75640462|FG001|NOT COMPLETED|Overall Study||10||
59542144|NCT02471586|75640463|FG002|NOT COMPLETED|Overall Study||4||
59642912|NCT03028974|75759590|FG002|COMPLETED|2016-2017||0||
59642913|NCT03028974|75759591|FG003|COMPLETED|2016-2017||4||
59642914|NCT03028974|75759592|FG004|COMPLETED|2016-2017|2 participants did not continue to the next period|2||
59642915|NCT03028974|75759593|FG005|COMPLETED|2016-2017||0||
59642916|NCT03028974|75759594|FG006|COMPLETED|2016-2017|18 participants did not continue to the next period.|18||
59642917|NCT03028974|75759588|FG000|NOT COMPLETED|2016-2017||0||
59642918|NCT03028974|75759589|FG001|NOT COMPLETED|2016-2017||0||
59642919|NCT03028974|75759590|FG002|NOT COMPLETED|2016-2017||0||
59642920|NCT03028974|75759591|FG003|NOT COMPLETED|2016-2017||0||
59642921|NCT03028974|75759592|FG004|NOT COMPLETED|2016-2017||0||
59642922|NCT03028974|75759593|FG005|NOT COMPLETED|2016-2017||0||
59642923|NCT03028974|75759594|FG006|NOT COMPLETED|2016-2017||0||
59642924|NCT03028974|75759588|FG000|STARTED|2017-2018||0||
59642925|NCT03028974|75759589|FG001|STARTED|2017-2018||0||
59642926|NCT03028974|75759590|FG002|STARTED|2017-2018||0||
59642927|NCT03028974|75759591|FG003|STARTED|2017-2018||5||
59642928|NCT03028974|75759592|FG004|STARTED|2017-2018||0||
59642929|NCT03028974|75759593|FG005|STARTED|2017-2018||0||
59642930|NCT03028974|75759594|FG006|STARTED|2017-2018|5 new participants were enrolled.|5||
59642931|NCT03028974|75759588|FG000|COMPLETED|2017-2018||0||
59642932|NCT03028974|75759589|FG001|COMPLETED|2017-2018||0||
59642933|NCT03028974|75759590|FG002|COMPLETED|2017-2018||0||
59642934|NCT03028974|75759591|FG003|COMPLETED|2017-2018||5||
59642935|NCT03028974|75759592|FG004|COMPLETED|2017-2018||0||
59642936|NCT03028974|75759593|FG005|COMPLETED|2017-2018||0||
59642937|NCT03028974|75759594|FG006|COMPLETED|2017-2018||5||
59642938|NCT03028974|75759588|FG000|NOT COMPLETED|2017-2018||0||
59642939|NCT03028974|75759589|FG001|NOT COMPLETED|2017-2018||0||
59642940|NCT03028974|75759590|FG002|NOT COMPLETED|2017-2018||0||
59642941|NCT03028974|75759591|FG003|NOT COMPLETED|2017-2018||0||
59642942|NCT03028974|75759592|FG004|NOT COMPLETED|2017-2018||0||
59642943|NCT03028974|75759593|FG005|NOT COMPLETED|2017-2018||0||
59815750|NCT03026283|75938216|FG005|STARTED|CCTA Diagnosis||0||
59542145|NCT00910208|75640476|FG000|STARTED|Overall Study||69||
59542146|NCT00910208|75640477|FG001|STARTED|Overall Study||72||
59542147|NCT00910208|75640478|FG002|STARTED|Overall Study||70||
59542148|NCT00910208|75640476|FG000|COMPLETED|Overall Study||67||
59542149|NCT00910208|75640477|FG001|COMPLETED|Overall Study||70||
59542150|NCT00910208|75640478|FG002|COMPLETED|Overall Study||69||
59542151|NCT00910208|75640476|FG000|NOT COMPLETED|Overall Study||2||
59542152|NCT00910208|75640477|FG001|NOT COMPLETED|Overall Study||2||
59542153|NCT00910208|75640478|FG002|NOT COMPLETED|Overall Study||1||
59542154|NCT01566539|75640494|FG000|STARTED|Main Study Period||101||
59542155|NCT01566539|75640495|FG001|STARTED|Main Study Period||100||
59542156|NCT01566539|75640496|FG002|STARTED|Main Study Period||104||
59542157|NCT01566539|75640497|FG003|STARTED|Main Study Period||0||
59542158|NCT01566539|75640498|FG004|STARTED|Main Study Period||40||
59542159|NCT01566539|75640499|FG005|STARTED|Main Study Period||43||
59542160|NCT01566539|75640500|FG006|STARTED|Main Study Period||30||
59542161|NCT01566539|75640501|FG007|STARTED|Main Study Period||30||
59542162|NCT01566539|75640502|FG008|STARTED|Main Study Period||1||
59542163|NCT01566539|75640494|FG000|COMPLETED|Main Study Period||100||
59542164|NCT01566539|75640495|FG001|COMPLETED|Main Study Period||100||
59542165|NCT01566539|75640496|FG002|COMPLETED|Main Study Period||104||
59542166|NCT01566539|75640497|FG003|COMPLETED|Main Study Period||0||
59542167|NCT01566539|75640498|FG004|COMPLETED|Main Study Period||40||
59542168|NCT01566539|75640499|FG005|COMPLETED|Main Study Period||40||
59542169|NCT01566539|75640500|FG006|COMPLETED|Main Study Period||30||
59542170|NCT01566539|75640501|FG007|COMPLETED|Main Study Period||30||
59542171|NCT01566539|75640502|FG008|COMPLETED|Main Study Period||1||
59542172|NCT01566539|75640494|FG000|NOT COMPLETED|Main Study Period||1||
59542173|NCT01566539|75640495|FG001|NOT COMPLETED|Main Study Period||0||
59542174|NCT01566539|75640496|FG002|NOT COMPLETED|Main Study Period||0||
59542175|NCT01566539|75640497|FG003|NOT COMPLETED|Main Study Period||0||
59542176|NCT01566539|75640498|FG004|NOT COMPLETED|Main Study Period||0||
59542177|NCT01566539|75640499|FG005|NOT COMPLETED|Main Study Period||3||
59542178|NCT01566539|75640500|FG006|NOT COMPLETED|Main Study Period||0||
59542179|NCT01566539|75640501|FG007|NOT COMPLETED|Main Study Period||0||
59642944|NCT03028974|75759594|FG006|NOT COMPLETED|2017-2018||0||
59642945|NCT03029988|75759607|FG000|STARTED|Overall Study||3||
59642946|NCT03029988|75759607|FG000|COMPLETED|Overall Study||3||
59642947|NCT03029988|75759607|FG000|NOT COMPLETED|Overall Study||0||
59642948|NCT03033108|75759615|FG000|STARTED|Overall Study||7||
59642949|NCT03033108|75759616|FG001|STARTED|Overall Study||9||
59642950|NCT03033108|75759617|FG002|STARTED|Overall Study||7||
59642951|NCT03033108|75759615|FG000|COMPLETED|Overall Study||7||
59642952|NCT03033108|75759616|FG001|COMPLETED|Overall Study||8||
59642953|NCT03033108|75759617|FG002|COMPLETED|Overall Study||7||
59642954|NCT03033108|75759615|FG000|NOT COMPLETED|Overall Study||0||
59642955|NCT03033108|75759616|FG001|NOT COMPLETED|Overall Study||1||
59642956|NCT03033108|75759617|FG002|NOT COMPLETED|Overall Study||0||
59642957|NCT03035760|75759630|FG000|STARTED|First Intervention - 10/7 Days Follow-up||8||
59642958|NCT03035760|75759631|FG001|STARTED|First Intervention - 10/7 Days Follow-up||8||
59642959|NCT03035760|75759632|FG002|STARTED|First Intervention - 10/7 Days Follow-up||8||
59642960|NCT03035760|75759633|FG003|STARTED|First Intervention - 10/7 Days Follow-up||6||
59642961|NCT03035760|75759634|FG004|STARTED|First Intervention - 10/7 Days Follow-up||6||
59642962|NCT03035760|75759630|FG000|COMPLETED|First Intervention - 10/7 Days Follow-up||8||
59642963|NCT03035760|75759631|FG001|COMPLETED|First Intervention - 10/7 Days Follow-up||8||
59642964|NCT03035760|75759632|FG002|COMPLETED|First Intervention - 10/7 Days Follow-up||8||
59642965|NCT03035760|75759633|FG003|COMPLETED|First Intervention - 10/7 Days Follow-up||6||
59642966|NCT03035760|75759634|FG004|COMPLETED|First Intervention - 10/7 Days Follow-up||6||
59642967|NCT03035760|75759630|FG000|NOT COMPLETED|First Intervention - 10/7 Days Follow-up||0||
59642968|NCT03035760|75759631|FG001|NOT COMPLETED|First Intervention - 10/7 Days Follow-up||0||
59642969|NCT03035760|75759632|FG002|NOT COMPLETED|First Intervention - 10/7 Days Follow-up||0||
59642970|NCT03035760|75759633|FG003|NOT COMPLETED|First Intervention - 10/7 Days Follow-up||0||
59642971|NCT03035760|75759634|FG004|NOT COMPLETED|First Intervention - 10/7 Days Follow-up||0||
59642972|NCT03035760|75759630|FG000|STARTED|Second Intervention - 7 Days Follow-up||0||
59642973|NCT03035760|75759631|FG001|STARTED|Second Intervention - 7 Days Follow-up||0||
59642974|NCT03035760|75759632|FG002|STARTED|Second Intervention - 7 Days Follow-up||0||
59642975|NCT03035760|75759633|FG003|STARTED|Second Intervention - 7 Days Follow-up||6||
59642976|NCT03035760|75759634|FG004|STARTED|Second Intervention - 7 Days Follow-up||6||
59642977|NCT03035760|75759630|FG000|COMPLETED|Second Intervention - 7 Days Follow-up||0||
59642978|NCT03035760|75759631|FG001|COMPLETED|Second Intervention - 7 Days Follow-up||0||
59642979|NCT03035760|75759632|FG002|COMPLETED|Second Intervention - 7 Days Follow-up||0||
59642980|NCT03035760|75759633|FG003|COMPLETED|Second Intervention - 7 Days Follow-up||6||
59642981|NCT03035760|75759634|FG004|COMPLETED|Second Intervention - 7 Days Follow-up||6||
59642982|NCT03035760|75759630|FG000|NOT COMPLETED|Second Intervention - 7 Days Follow-up||0||
59642983|NCT03035760|75759631|FG001|NOT COMPLETED|Second Intervention - 7 Days Follow-up||0||
59642984|NCT03035760|75759632|FG002|NOT COMPLETED|Second Intervention - 7 Days Follow-up||0||
59642985|NCT03035760|75759633|FG003|NOT COMPLETED|Second Intervention - 7 Days Follow-up||0||
59642986|NCT03035760|75759634|FG004|NOT COMPLETED|Second Intervention - 7 Days Follow-up||0||
59642987|NCT03036384|75759651|FG000|STARTED|Overall Study||4||
59642988|NCT03036384|75759652|FG001|STARTED|Overall Study||4||
59642989|NCT03036384|75759653|FG002|STARTED|Overall Study||4||
59642990|NCT03036384|75759654|FG003|STARTED|Overall Study||4||
59642991|NCT03036384|75759655|FG004|STARTED|Overall Study||4||
59642992|NCT03036384|75759656|FG005|STARTED|Overall Study||4||
59642993|NCT03036384|75759657|FG006|STARTED|Overall Study||4||
59642994|NCT03036384|75759658|FG007|STARTED|Overall Study||4||
59642995|NCT03036384|75759659|FG008|STARTED|Overall Study||4||
59642996|NCT03036384|75759660|FG009|STARTED|Overall Study||4||
59642997|NCT03036384|75759651|FG000|COMPLETED|Overall Study||4||
59642998|NCT03036384|75759652|FG001|COMPLETED|Overall Study||4||
59642999|NCT03036384|75759653|FG002|COMPLETED|Overall Study||4||
59643000|NCT03036384|75759654|FG003|COMPLETED|Overall Study||4||
59643001|NCT03036384|75759655|FG004|COMPLETED|Overall Study||4||
59643002|NCT03036384|75759656|FG005|COMPLETED|Overall Study||4||
59643003|NCT03036384|75759657|FG006|COMPLETED|Overall Study||4||
59643004|NCT03036384|75759658|FG007|COMPLETED|Overall Study||4||
59643005|NCT03036384|75759659|FG008|COMPLETED|Overall Study||4||
59643006|NCT03036384|75759660|FG009|COMPLETED|Overall Study||4||
59643007|NCT03036384|75759651|FG000|NOT COMPLETED|Overall Study||0||
59643008|NCT03036384|75759652|FG001|NOT COMPLETED|Overall Study||0||
59643009|NCT03036384|75759653|FG002|NOT COMPLETED|Overall Study||0||
59643010|NCT03036384|75759654|FG003|NOT COMPLETED|Overall Study||0||
59643011|NCT03036384|75759655|FG004|NOT COMPLETED|Overall Study||0||
59542180|NCT01566539|75640502|FG008|NOT COMPLETED|Main Study Period||0||
59542181|NCT01566539|75640494|FG000|STARTED|Within Subject Group||0||
59542182|NCT01566539|75640495|FG001|STARTED|Within Subject Group||0||
59542183|NCT01566539|75640496|FG002|STARTED|Within Subject Group||0||
59542184|NCT01566539|75640497|FG003|STARTED|Within Subject Group|Participants can move from Healthy Volunteers-AVP, OT and Placebo groups to the within subject group|156||
59542185|NCT01566539|75640498|FG004|STARTED|Within Subject Group||0||
59542186|NCT01566539|75640499|FG005|STARTED|Within Subject Group||0||
59542187|NCT01566539|75640500|FG006|STARTED|Within Subject Group||0||
59542188|NCT01566539|75640501|FG007|STARTED|Within Subject Group||0||
59542189|NCT01566539|75640502|FG008|STARTED|Within Subject Group||0||
59542190|NCT01566539|75640494|FG000|COMPLETED|Within Subject Group||0||
59542191|NCT01566539|75640495|FG001|COMPLETED|Within Subject Group||0||
59542192|NCT01566539|75640496|FG002|COMPLETED|Within Subject Group||0||
59542193|NCT01566539|75640497|FG003|COMPLETED|Within Subject Group|Participants can move from Healthy Volunteers-AVP, OT and Placebo groups to the within subject group|153||
59542194|NCT01566539|75640498|FG004|COMPLETED|Within Subject Group||0||
59542195|NCT01566539|75640499|FG005|COMPLETED|Within Subject Group||0||
59542196|NCT01566539|75640500|FG006|COMPLETED|Within Subject Group||0||
59542197|NCT01566539|75640501|FG007|COMPLETED|Within Subject Group||0||
59542198|NCT01566539|75640502|FG008|COMPLETED|Within Subject Group||0||
59542199|NCT01566539|75640494|FG000|NOT COMPLETED|Within Subject Group||0||
59542200|NCT01566539|75640495|FG001|NOT COMPLETED|Within Subject Group||0||
59542201|NCT01566539|75640496|FG002|NOT COMPLETED|Within Subject Group||0||
59542202|NCT01566539|75640497|FG003|NOT COMPLETED|Within Subject Group||3||
59542203|NCT01566539|75640498|FG004|NOT COMPLETED|Within Subject Group||0||
59542204|NCT01566539|75640499|FG005|NOT COMPLETED|Within Subject Group||0||
59542205|NCT01566539|75640500|FG006|NOT COMPLETED|Within Subject Group||0||
59542206|NCT01566539|75640501|FG007|NOT COMPLETED|Within Subject Group||0||
59542207|NCT01566539|75640502|FG008|NOT COMPLETED|Within Subject Group||0||
59542208|NCT01567943|75640526|FG000|STARTED|Overall Study||40||
59542209|NCT01567943|75640527|FG001|STARTED|Overall Study||39||
59542210|NCT01567943|75640528|FG002|STARTED|Overall Study||44||
59542211|NCT01567943|75640526|FG000|COMPLETED|Overall Study||26||
59542212|NCT01567943|75640527|FG001|COMPLETED|Overall Study||29||
59542213|NCT01567943|75640528|FG002|COMPLETED|Overall Study||44||
59542214|NCT01567943|75640526|FG000|NOT COMPLETED|Overall Study||14||
59542215|NCT01567943|75640527|FG001|NOT COMPLETED|Overall Study||10||
59542216|NCT01567943|75640528|FG002|NOT COMPLETED|Overall Study||0||
59542217|NCT01467557|75640536|FG000|STARTED|Overall Study||601||
59542218|NCT01467557|75640537|FG001|STARTED|Overall Study||570||
59542219|NCT01467557|75640536|FG000|2 Week Survey Completed|Overall Study||551||
59542220|NCT01467557|75640537|FG001|2 Week Survey Completed|Overall Study||522||
59542221|NCT01467557|75640536|FG000|4 Month Survey Completed|Overall Study||533||
59542222|NCT01467557|75640537|FG001|4 Month Survey Completed|Overall Study||493||
59542223|NCT01467557|75640536|FG000|12 Month Survey Completed|Overall Study||502||
59542224|NCT01467557|75640537|FG001|12 Month Survey Completed|Overall Study||463||
59542225|NCT01467557|75640536|FG000|COMPLETED|Overall Study||502||
59542226|NCT01467557|75640537|FG001|COMPLETED|Overall Study||463||
59542227|NCT01467557|75640536|FG000|NOT COMPLETED|Overall Study||99||
59542228|NCT01467557|75640537|FG001|NOT COMPLETED|Overall Study||107||
59542229|NCT01467947|75640543|FG000|STARTED|Overall Study||46||
59542230|NCT01467947|75640543|FG000|COMPLETED|Overall Study||46||
59542231|NCT01467947|75640543|FG000|NOT COMPLETED|Overall Study||0||
59542232|NCT01568021|75640547|FG000|STARTED|Overall Study||99||
59542233|NCT01568021|75640547|FG000|COMPLETED|Overall Study||83||
59542234|NCT01568021|75640547|FG000|NOT COMPLETED|Overall Study||16||
59542235|NCT00910520|75640553|FG000|STARTED|Treatment Cycle 1||277||
59542236|NCT00910520|75640554|FG001|STARTED|Treatment Cycle 1||271||
59542237|NCT00910520|75640553|FG000|COMPLETED|Treatment Cycle 1||257||
59542238|NCT00910520|75640554|FG001|COMPLETED|Treatment Cycle 1||247||
59542239|NCT00910520|75640553|FG000|NOT COMPLETED|Treatment Cycle 1||20||
59542240|NCT00910520|75640554|FG001|NOT COMPLETED|Treatment Cycle 1||24||
59542241|NCT00910520|75640553|FG000|STARTED|Treatment Cycle 2|Not all participants who completed Treatment Cycle 1 went onto Treatment Cycle 2|163||
59542242|NCT00910520|75640554|FG001|STARTED|Treatment Cycle 2|Not all participants who completed Treatment Cycle 1 went onto Treatment Cycle 2|223||
59542243|NCT00910520|75640553|FG000|COMPLETED|Treatment Cycle 2||156||
59542244|NCT00910520|75640554|FG001|COMPLETED|Treatment Cycle 2||215||
59542245|NCT00910520|75640553|FG000|NOT COMPLETED|Treatment Cycle 2||7||
59542246|NCT00910520|75640554|FG001|NOT COMPLETED|Treatment Cycle 2||8||
59542247|NCT01568255|75640562|FG000|STARTED|Overall Study||5||
59542248|NCT01568255|75640563|FG001|STARTED|Overall Study||6||
59542249|NCT01568255|75640562|FG000|COMPLETED|Overall Study||5||
59542250|NCT01568255|75640563|FG001|COMPLETED|Overall Study||6||
59542251|NCT01568255|75640562|FG000|NOT COMPLETED|Overall Study||0||
59542252|NCT01568255|75640563|FG001|NOT COMPLETED|Overall Study||0||
59542253|NCT01569191|75640571|FG000|STARTED|Overall Study||11||
59542254|NCT01569191|75640572|FG001|STARTED|Overall Study||7||
59542255|NCT01569191|75640571|FG000|COMPLETED|Overall Study||11||
59542256|NCT01569191|75640572|FG001|COMPLETED|Overall Study||7||
59542257|NCT01569191|75640571|FG000|NOT COMPLETED|Overall Study||0||
59643012|NCT03036384|75759656|FG005|NOT COMPLETED|Overall Study||0||
59643013|NCT03036384|75759657|FG006|NOT COMPLETED|Overall Study||0||
59643014|NCT03036384|75759658|FG007|NOT COMPLETED|Overall Study||0||
59643015|NCT03036384|75759659|FG008|NOT COMPLETED|Overall Study||0||
59643016|NCT03036384|75759660|FG009|NOT COMPLETED|Overall Study||0||
59643017|NCT03040362|75759678|FG000|STARTED|Overall Study||8||
59643018|NCT03040362|75759678|FG000|Received at Least 1dose of Study Drug|Overall Study||8||
59643019|NCT03040362|75759678|FG000|COMPLETED|Overall Study||8||
59643020|NCT03040362|75759678|FG000|NOT COMPLETED|Overall Study||0||
59643021|NCT03041298|75759682|FG000|STARTED|Overall Study||1537||
59643022|NCT03041298|75759682|FG000|COMPLETED|Overall Study||1537||
59643023|NCT03041298|75759682|FG000|NOT COMPLETED|Overall Study||0||
59643024|NCT03042702|75759686|FG000|STARTED|Overall Study||2||
59643025|NCT03042702|75759686|FG000|COMPLETED|Overall Study||2||
59643026|NCT03042702|75759686|FG000|NOT COMPLETED|Overall Study||0||
59643027|NCT03044028|75759694|FG000|STARTED|Overall Study||22||
59643028|NCT03044028|75759695|FG001|STARTED|Overall Study||22||
59643029|NCT03044028|75759696|FG002|STARTED|Overall Study||22||
59643030|NCT03044028|75759694|FG000|COMPLETED|Overall Study||12||
59643031|NCT03044028|75759695|FG001|COMPLETED|Overall Study||12||
59643032|NCT03044028|75759696|FG002|COMPLETED|Overall Study||22||
59643033|NCT03044028|75759694|FG000|NOT COMPLETED|Overall Study||10||
59643034|NCT03044028|75759695|FG001|NOT COMPLETED|Overall Study||10||
59643035|NCT03044028|75759696|FG002|NOT COMPLETED|Overall Study||0||
59643036|NCT03044418|75759705|FG000|STARTED|Overall Study||30||
59643037|NCT03044418|75759705|FG000|COMPLETED|Overall Study||30||
59643038|NCT03044418|75759705|FG000|NOT COMPLETED|Overall Study||0||
59643039|NCT03046212|75759711|FG000|STARTED|Overall Study||15||
59643040|NCT03046212|75759712|FG001|STARTED|Overall Study||15||
59643041|NCT03046212|75759711|FG000|COMPLETED|Overall Study||15||
59643042|NCT03046212|75759712|FG001|COMPLETED|Overall Study||15||
59643043|NCT03046212|75759711|FG000|NOT COMPLETED|Overall Study||0||
59643044|NCT03046212|75759712|FG001|NOT COMPLETED|Overall Study||0||
59643045|NCT03048006|75759718|FG000|STARTED|Overall Study||44456||
59643046|NCT03048006|75759718|FG000|COMPLETED|Overall Study||44456||
59643047|NCT03048006|75759718|FG000|NOT COMPLETED|Overall Study||0||
59643048|NCT03051672|75759722|FG000|STARTED|Overall Study||8||
59643049|NCT03051672|75759722|FG000|Began Treatment|Overall Study||8||
59643050|NCT03051672|75759722|FG000|COMPLETED|Overall Study||8||
59643051|NCT03051672|75759722|FG000|NOT COMPLETED|Overall Study||0||
59643052|NCT03052530|75759727|FG000|STARTED|Overall Study||61||
59643053|NCT03052530|75759727|FG000|COMPLETED|Overall Study||61||
59643054|NCT03052530|75759727|FG000|NOT COMPLETED|Overall Study||0||
59643055|NCT03055650|75759731|FG000|STARTED|Overall Study||30||
59643056|NCT03055650|75759731|FG000|COMPLETED|Overall Study||30||
59643057|NCT03055650|75759731|FG000|NOT COMPLETED|Overall Study||0||
59643058|NCT03057132|75759735|FG000|STARTED|Overall Study||1||
59643059|NCT03057132|75759735|FG000|COMPLETED|Overall Study||1||
59643060|NCT03057132|75759735|FG000|NOT COMPLETED|Overall Study||0||
59643061|NCT03057366|75759740|FG000|STARTED|Part A||8||
59643062|NCT03057366|75759741|FG001|STARTED|Part A||0||
59643063|NCT03057366|75759742|FG002|STARTED|Part A||0||
59643064|NCT03057366|75759740|FG000|COMPLETED|Part A||8||
59643065|NCT03057366|75759741|FG001|COMPLETED|Part A||0||
59643066|NCT03057366|75759742|FG002|COMPLETED|Part A||0||
59643067|NCT03057366|75759740|FG000|NOT COMPLETED|Part A||0||
59643068|NCT03057366|75759741|FG001|NOT COMPLETED|Part A||0||
59643069|NCT03057366|75759742|FG002|NOT COMPLETED|Part A||0||
59643070|NCT03057366|75759740|FG000|STARTED|Part B||0||
59643071|NCT03057366|75759741|FG001|STARTED|Part B|Participants completed Part A, met eligibility criteria, and provided consent for Part B.|5||
59643072|NCT03057366|75759742|FG002|STARTED|Part B|Participants completed Part A, met eligibility criteria, and provided consent for Part B.|2||
59643073|NCT03057366|75759740|FG000|COMPLETED|Part B||0||
59643074|NCT03057366|75759741|FG001|COMPLETED|Part B||5||
59643075|NCT03057366|75759742|FG002|COMPLETED|Part B||2||
59643076|NCT03057366|75759740|FG000|NOT COMPLETED|Part B||0||
59643077|NCT03057366|75759741|FG001|NOT COMPLETED|Part B||0||
59643078|NCT03057366|75759742|FG002|NOT COMPLETED|Part B||0||
59643079|NCT03060486|75759752|FG000|STARTED|Overall Study||15||15
59643080|NCT03060486|75759752|FG000|COMPLETED|Overall Study||15||15
59815751|NCT03026283|75938217|FG006|STARTED|CCTA Diagnosis||0||
59643081|NCT03060486|75759752|FG000|NOT COMPLETED|Overall Study||0||0
59643082|NCT03061812|75759758|FG000|STARTED|Overall Study||148||
59643083|NCT03061812|75759759|FG001|STARTED|Overall Study||296||
59643084|NCT03061812|75759758|FG000|COMPLETED|Overall Study||148|Participants who were off study as of 04 December 2019.|
59643085|NCT03061812|75759759|FG001|COMPLETED|Overall Study||296|Participants who were off study as of 04 December 2019.|
59643086|NCT03061812|75759758|FG000|NOT COMPLETED|Overall Study||0||
59643087|NCT03061812|75759759|FG001|NOT COMPLETED|Overall Study||0||
59709644|NCT01235741|75828430|FG001|COMPLETED|Randomized to Treatment|Study terminated by Sponsor. Maximum exposure to study drug was 30 days.|0||
59709645|NCT01235741|75828431|FG002|COMPLETED|Randomized to Treatment|Study terminated by Sponsor. Maximum exposure to study drug was 30 days.|0||
59709646|NCT01235741|75828429|FG000|NOT COMPLETED|Randomized to Treatment||0||
59709647|NCT01235741|75828430|FG001|NOT COMPLETED|Randomized to Treatment||36||
59815752|NCT03026283|75938218|FG007|STARTED|CCTA Diagnosis||0||
59643088|NCT03063294|75759767|FG000|STARTED|Overall Study|2463 equals the sum of 1241 cross-sectional survey respondents at baseline and 1222 at follow-up.|2463|"The terminology of started applies only to primary care clinics here (only clinics were followed longitudinally). At each clinic, a cross-sectional survey of participants took place at baseline (N=2484), and then a separate cross-sectional survey with a new sample of participants took place at follow-up (N=2481). Since it is incorrect to use the terminology of started with respect to participants, we provide the total (baseline plus follow-up) participant sample size (2484+2481=4965)."|6
59643089|NCT03063294|75759768|FG001|STARTED|Overall Study|2502 equals the sum of 1243 cross-sectional survey respondents at baseline and 1259 at follow-up.|2502|"The terminology of started applies only to primary care clinics here (only clinics were followed longitudinally). At each clinic, a cross-sectional survey of participants took place at baseline (N=2484), and then a separate cross-sectional survey with a new sample of participants took place at follow-up (N=2481). Since it is incorrect to use the terminology of started with respect to participants, we provide the total (baseline plus follow-up) participant sample size (2484+2481=4965)."|6
59643090|NCT03063294|75759767|FG000|COMPLETED|Overall Study|2463 equals the sum of 1241 cross-sectional survey respondents at baseline and 1222 at follow-up.|2463|"The terminology of completed applies only to primary care clinics here (only clinics were followed longitudinally). At each clinic, a cross-sectional survey of participants took place at baseline (N=2484), and then a separate cross-sectional survey with a new sample of participants took place at follow-up (N=2481). Since it is incorrect to use the terminology of completed with respect to participants, we provide the total (baseline plus follow-up) participant sample size (2484+2481=4965)."|6
59643091|NCT03063294|75759768|FG001|COMPLETED|Overall Study|2502 equals the sum of 1243 cross-sectional survey respondents at baseline and 1259 at follow-up.|2502|"The terminology of completed applies only to primary care clinics here (only clinics were followed longitudinally). At each clinic, a cross-sectional survey of participants took place at baseline (N=2484), and then a separate cross-sectional survey with a new sample of participants took place at follow-up (N=2481). Since it is incorrect to use the terminology of completed with respect to participants, we provide the total (baseline plus follow-up) participant sample size (2484+2481=4965)."|6
59643092|NCT03063294|75759767|FG000|NOT COMPLETED|Overall Study||0||0
59643093|NCT03063294|75759768|FG001|NOT COMPLETED|Overall Study||0||0
59643094|NCT03064152|75759776|FG000|STARTED|Overall Study||26||
59643095|NCT03064152|75759777|FG001|STARTED|Overall Study||23||
59643096|NCT03064152|75759776|FG000|COMPLETED|Overall Study||26||
59643097|NCT03064152|75759777|FG001|COMPLETED|Overall Study||23||
59643098|NCT03064152|75759776|FG000|NOT COMPLETED|Overall Study||0||
59643099|NCT03064152|75759777|FG001|NOT COMPLETED|Overall Study||0||
59643100|NCT03066102|75759783|FG000|STARTED|Overall Study||30||
59643101|NCT03066102|75759783|FG000|COMPLETED|Overall Study||30||
59643102|NCT03066102|75759783|FG000|NOT COMPLETED|Overall Study||0||
59643103|NCT03067506|75759787|FG000|STARTED|Overall Study||30||
59643104|NCT03067506|75759787|FG000|COMPLETED|Overall Study||30||
59643105|NCT03067506|75759787|FG000|NOT COMPLETED|Overall Study||0||
59643106|NCT03070470|75759797|FG000|STARTED|Overall Study||10||
59643107|NCT03070470|75759798|FG001|STARTED|Overall Study||10||
59643108|NCT03070470|75759799|FG002|STARTED|Overall Study||10||
59643109|NCT03070470|75759800|FG003|STARTED|Overall Study||10||
59643110|NCT03070470|75759801|FG004|STARTED|Overall Study||10||
59643111|NCT03070470|75759802|FG005|STARTED|Overall Study||10||
59643112|NCT03070470|75759797|FG000|COMPLETED|Overall Study||10||
59643113|NCT03070470|75759798|FG001|COMPLETED|Overall Study||9||
59643114|NCT03070470|75759799|FG002|COMPLETED|Overall Study||10||
59643115|NCT03070470|75759800|FG003|COMPLETED|Overall Study||10||
59643116|NCT03070470|75759801|FG004|COMPLETED|Overall Study||10||
59643117|NCT03070470|75759802|FG005|COMPLETED|Overall Study||8||
59643118|NCT03070470|75759797|FG000|NOT COMPLETED|Overall Study||0||
59643119|NCT03070470|75759798|FG001|NOT COMPLETED|Overall Study||1||
59643120|NCT03070470|75759799|FG002|NOT COMPLETED|Overall Study||0||
59643121|NCT03070470|75759800|FG003|NOT COMPLETED|Overall Study||0||
59643122|NCT03070470|75759801|FG004|NOT COMPLETED|Overall Study||0||
59643123|NCT03070470|75759802|FG005|NOT COMPLETED|Overall Study||2||
59643124|NCT03070548|75759818|FG000|STARTED|Overall Study||6||
59643125|NCT03070548|75759818|FG000|COMPLETED|Overall Study||6||
59643126|NCT03070548|75759818|FG000|NOT COMPLETED|Overall Study||0||
59643127|NCT03072186|75759822|FG000|STARTED|Overall Study||23||
59643128|NCT03072186|75759822|FG000|COMPLETED|Overall Study||17||
59643129|NCT03072186|75759822|FG000|NOT COMPLETED|Overall Study||6||
59643130|NCT03072732|75759828|FG000|STARTED|Overall Study||20||
59643131|NCT03072732|75759829|FG001|STARTED|Overall Study||20||
59643132|NCT03072732|75759828|FG000|COMPLETED|Overall Study||20||
59643133|NCT03072732|75759829|FG001|COMPLETED|Overall Study||20||
59643134|NCT03072732|75759828|FG000|NOT COMPLETED|Overall Study||0||
59643135|NCT03072732|75759829|FG001|NOT COMPLETED|Overall Study||0||
59643136|NCT03074682|75759838|FG000|STARTED|Overall Study||18||
59643137|NCT03074682|75759839|FG001|STARTED|Overall Study||18||
59643138|NCT03074682|75759840|FG002|STARTED|Overall Study||18||
59643139|NCT03074682|75759838|FG000|COMPLETED|Overall Study||18||
59643140|NCT03074682|75759839|FG001|COMPLETED|Overall Study||18||
59643141|NCT03074682|75759840|FG002|COMPLETED|Overall Study||18||
59643142|NCT03074682|75759838|FG000|NOT COMPLETED|Overall Study||0||
59643143|NCT03074682|75759839|FG001|NOT COMPLETED|Overall Study||0||
59643144|NCT03074682|75759840|FG002|NOT COMPLETED|Overall Study||0||
59643145|NCT03078504|75759848|FG000|STARTED|Overall Study||6||
59643146|NCT03078504|75759848|FG000|COMPLETED|Overall Study||6||
59643147|NCT03078504|75759848|FG000|NOT COMPLETED|Overall Study||0||
59643148|NCT03080142|75759854|FG000|STARTED|Overall Study||42||
59542258|NCT01569191|75640572|FG001|NOT COMPLETED|Overall Study||0||
59643149|NCT03080142|75759855|FG001|STARTED|Overall Study||44||
59643150|NCT03080142|75759854|FG000|COMPLETED|Overall Study||42||
59643151|NCT03080142|75759855|FG001|COMPLETED|Overall Study||44||
59643152|NCT03080142|75759854|FG000|NOT COMPLETED|Overall Study||0||
59643153|NCT03080142|75759855|FG001|NOT COMPLETED|Overall Study||0||
59643154|NCT03085836|75759864|FG000|STARTED|Overall Study||12||
59643155|NCT03085836|75759865|FG001|STARTED|Overall Study||11||
59643156|NCT03085836|75759866|FG002|STARTED|Overall Study||10||
59643157|NCT03085836|75759864|FG000|COMPLETED|Overall Study||12||
59643158|NCT03085836|75759865|FG001|COMPLETED|Overall Study||11||
59643159|NCT03085836|75759866|FG002|COMPLETED|Overall Study||10||
59643160|NCT03085836|75759864|FG000|NOT COMPLETED|Overall Study||0||
59643161|NCT03085836|75759865|FG001|NOT COMPLETED|Overall Study||0||
59643162|NCT03085836|75759866|FG002|NOT COMPLETED|Overall Study||0||
59643163|NCT03088800|75759877|FG000|STARTED|Overall Study||30||
59643164|NCT03088800|75759878|FG001|STARTED|Overall Study||30||
59643165|NCT03088800|75759879|FG002|STARTED|Overall Study||30||
59643166|NCT03088800|75759877|FG000|COMPLETED|Overall Study||30||
59643167|NCT03088800|75759878|FG001|COMPLETED|Overall Study||30||
59643168|NCT03088800|75759879|FG002|COMPLETED|Overall Study||30||
59643169|NCT03088800|75759877|FG000|NOT COMPLETED|Overall Study||0||
59643170|NCT03088800|75759878|FG001|NOT COMPLETED|Overall Study||0||
59643171|NCT03088800|75759879|FG002|NOT COMPLETED|Overall Study||0||
59643172|NCT03092934|75759891|FG000|STARTED|Overall Study||8||
59643173|NCT03092934|75759892|FG001|STARTED|Overall Study||2||
59643174|NCT03092934|75759893|FG002|STARTED|Overall Study||2||
59643175|NCT03092934|75759894|FG003|STARTED|Overall Study||1||
59643176|NCT03092934|75759891|FG000|Received at Least One Dose of Study Drug|Overall Study||8||
59643177|NCT03092934|75759892|FG001|Received at Least One Dose of Study Drug|Overall Study||2||
59643178|NCT03092934|75759893|FG002|Received at Least One Dose of Study Drug|Overall Study||2||
59643179|NCT03092934|75759894|FG003|Received at Least One Dose of Study Drug|Overall Study||1||
59643180|NCT03092934|75759891|FG000|COMPLETED|Overall Study||8||
59643181|NCT03092934|75759892|FG001|COMPLETED|Overall Study||2||
59643182|NCT03092934|75759893|FG002|COMPLETED|Overall Study||2||
59643183|NCT03092934|75759894|FG003|COMPLETED|Overall Study||1||
59643184|NCT03092934|75759891|FG000|NOT COMPLETED|Overall Study||0||
59643185|NCT03092934|75759892|FG001|NOT COMPLETED|Overall Study||0||
59643186|NCT03092934|75759893|FG002|NOT COMPLETED|Overall Study||0||
59643187|NCT03092934|75759894|FG003|NOT COMPLETED|Overall Study||0||
59643188|NCT03094806|75759906|FG000|STARTED|Overall Study||44||
59643189|NCT03094806|75759907|FG001|STARTED|Overall Study||47||
59643190|NCT03094806|75759906|FG000|COMPLETED|Overall Study||44||
59643191|NCT03094806|75759907|FG001|COMPLETED|Overall Study||47||
59643192|NCT03094806|75759906|FG000|NOT COMPLETED|Overall Study||0||
59643193|NCT03094806|75759907|FG001|NOT COMPLETED|Overall Study||0||
59542266|NCT00911612|75640588|FG000|STARTED|Overall Study||12||
59542267|NCT00911612|75640589|FG001|STARTED|Overall Study||12||
59542268|NCT00911612|75640588|FG000|COMPLETED|Overall Study||12||
59542269|NCT00911612|75640589|FG001|COMPLETED|Overall Study||12||
59542270|NCT00911612|75640588|FG000|NOT COMPLETED|Overall Study||0||
59542271|NCT00911612|75640589|FG001|NOT COMPLETED|Overall Study||0||
59542272|NCT01469039|75640598|FG000|STARTED|Overall Study||207||
59542273|NCT01469039|75640599|FG001|STARTED|Overall Study||208||
59542274|NCT01469039|75640600|FG002|STARTED|Overall Study||208||
59542275|NCT01469039|75640598|FG000|COMPLETED|Overall Study||130||
59542276|NCT01469039|75640599|FG001|COMPLETED|Overall Study||135||
59542277|NCT01469039|75640600|FG002|COMPLETED|Overall Study||95||
59542278|NCT01469039|75640598|FG000|NOT COMPLETED|Overall Study||77||
59542279|NCT01469039|75640599|FG001|NOT COMPLETED|Overall Study||73||
59542280|NCT01469039|75640600|FG002|NOT COMPLETED|Overall Study||113||
59542281|NCT01569737|75640608|FG000|STARTED|Overall Study||98||
59542282|NCT01569737|75640608|FG000|COMPLETED|Overall Study||95||
59542283|NCT01569737|75640608|FG000|NOT COMPLETED|Overall Study||3||
59542284|NCT02470806|75640614|FG000|STARTED|Overall Study||80||
59565814|NCT02335242|75668230|FG001|NOT COMPLETED|Open-label Phase (20 Weeks)||0||
59643194|NCT03095976|75759913|FG000|STARTED|Overall Study||4||
59643195|NCT03095976|75759913|FG000|COMPLETED|Overall Study||4||
59643196|NCT03095976|75759913|FG000|NOT COMPLETED|Overall Study||0||
59643197|NCT03096444|75759917|FG000|STARTED|Overall Study||13||65
59643198|NCT03096444|75759917|FG000|COMPLETED|Overall Study||13||65
59643199|NCT03096444|75759917|FG000|NOT COMPLETED|Overall Study||0||0
59643200|NCT03100500|75759929|FG000|STARTED|Overall Study||51||
59643201|NCT03100500|75759929|FG000|COMPLETED|Overall Study||51||
59643202|NCT03100500|75759929|FG000|NOT COMPLETED|Overall Study||0||
59643203|NCT03100968|75759935|FG000|STARTED|Overall Study||75||
59643204|NCT03100968|75759936|FG001|STARTED|Overall Study||75||
59643205|NCT03100968|75759935|FG000|COMPLETED|Overall Study||75||
59643206|NCT03100968|75759936|FG001|COMPLETED|Overall Study||75||
59643207|NCT03100968|75759935|FG000|NOT COMPLETED|Overall Study||0||
59643208|NCT03100968|75759936|FG001|NOT COMPLETED|Overall Study||0||
59643209|NCT03104322|75759942|FG000|STARTED|Overall Study||7||
59643210|NCT03104322|75759942|FG000|COMPLETED|Overall Study||6||
59643211|NCT03104322|75759942|FG000|NOT COMPLETED|Overall Study||1||
59643212|NCT03107754|75759948|FG000|STARTED|Overall Study||48||
59643213|NCT03107754|75759949|FG001|STARTED|Overall Study||50||
59643214|NCT03107754|75759948|FG000|COMPLETED|Overall Study||48||
59643215|NCT03107754|75759949|FG001|COMPLETED|Overall Study||50||
59643216|NCT03107754|75759948|FG000|NOT COMPLETED|Overall Study||0||
59643217|NCT03107754|75759949|FG001|NOT COMPLETED|Overall Study||0||
59643218|NCT03118596|75759957|FG000|STARTED|Overall Study||90||
59643219|NCT03118596|75759958|FG001|STARTED|Overall Study||90||
59643220|NCT03118596|75759957|FG000|Treated|Overall Study||2||
59643221|NCT03118596|75759958|FG001|Treated|Overall Study||0||
59643222|NCT03118596|75759957|FG000|Failed|Overall Study||0||
59643223|NCT03118596|75759958|FG001|Failed|Overall Study||4||
59643224|NCT03118596|75759957|FG000|COMPLETED|Overall Study||90||
59643225|NCT03118596|75759958|FG001|COMPLETED|Overall Study||86||
59643226|NCT03118596|75759957|FG000|NOT COMPLETED|Overall Study||0||
59643227|NCT03118596|75759958|FG001|NOT COMPLETED|Overall Study||4||
59643228|NCT03124368|75759966|FG000|STARTED|Overall Study||2||
59643229|NCT03124368|75759967|FG001|STARTED|Overall Study||4||
59643230|NCT03124368|75759966|FG000|Received at Least 1 Dose of Study Drug|Overall Study||2||
59643231|NCT03124368|75759967|FG001|Received at Least 1 Dose of Study Drug|Overall Study||4||
59643232|NCT03124368|75759966|FG000|COMPLETED|Overall Study||2||
59643233|NCT03124368|75759967|FG001|COMPLETED|Overall Study||4||
59643234|NCT03124368|75759966|FG000|NOT COMPLETED|Overall Study||0||
59643235|NCT03124368|75759967|FG001|NOT COMPLETED|Overall Study||0||
59643236|NCT03124602|75759978|FG000|STARTED|Overall Study||35||
59643237|NCT03124602|75759978|FG000|COMPLETED|Overall Study||25||
59643238|NCT03124602|75759978|FG000|NOT COMPLETED|Overall Study||10||
59643239|NCT03124758|75759982|FG000|STARTED|Overall Study||354||
59643240|NCT03124758|75759982|FG000|COMPLETED|Overall Study||354||
59643241|NCT03124758|75759982|FG000|NOT COMPLETED|Overall Study||0||
59643242|NCT03124836|75759986|FG000|STARTED|Overall Study||28||
59643243|NCT03124836|75759986|FG000|COMPLETED|Overall Study||28||
59643244|NCT03124836|75759986|FG000|NOT COMPLETED|Overall Study||0||
59643245|NCT03125226|75759990|FG000|STARTED|Overall Study||12||
59643246|NCT03125226|75759990|FG000|COMPLETED|Overall Study||12||
59643247|NCT03125226|75759990|FG000|NOT COMPLETED|Overall Study||0||
59643248|NCT03127956|75759994|FG000|STARTED|Overall Study||748||
59643249|NCT03127956|75759994|FG000|COMPLETED|Overall Study||431||
59643250|NCT03127956|75759994|FG000|NOT COMPLETED|Overall Study||317||
59643251|NCT03132246|75760000|FG000|STARTED|Overall Study||260||
59643252|NCT03132246|75760000|FG000|COMPLETED|Overall Study||156||
59643253|NCT03132246|75760000|FG000|NOT COMPLETED|Overall Study||104||
59643254|NCT03138330|75760007|FG000|STARTED|Overall Study||95||
59643255|NCT03138330|75760007|FG000|COMPLETED|Overall Study||91||
59643256|NCT03138330|75760007|FG000|NOT COMPLETED|Overall Study||4||
59643257|NCT03138798|75760013|FG000|STARTED|Overall Study||173||
59643258|NCT03138798|75760014|FG001|STARTED|Overall Study||175||
59643259|NCT03138798|75760013|FG000|Randomized But Did Not Meet Eligibility|Overall Study||6||
59643260|NCT03138798|75760014|FG001|Randomized But Did Not Meet Eligibility|Overall Study||4||
59643261|NCT03138798|75760013|FG000|COMPLETED|Overall Study||167||
59643262|NCT03138798|75760014|FG001|COMPLETED|Overall Study||171||
59643263|NCT03138798|75760013|FG000|NOT COMPLETED|Overall Study||6||
59643264|NCT03138798|75760014|FG001|NOT COMPLETED|Overall Study||4||
59643265|NCT03138876|75760021|FG000|STARTED|Overall Study||20||
59643266|NCT03138876|75760021|FG000|COMPLETED|Overall Study||20||
59643267|NCT03138876|75760021|FG000|NOT COMPLETED|Overall Study||0||
59643268|NCT03139032|75760025|FG000|STARTED|Overall Study||1||
59643269|NCT03139032|75760025|FG000|COMPLETED|Overall Study||1||
59643270|NCT03139032|75760025|FG000|NOT COMPLETED|Overall Study||0||
59643271|NCT03139578|75760030|FG000|STARTED|Period 1||12||
59643272|NCT03139578|75760031|FG001|STARTED|Period 1||13||
59643273|NCT03139578|75760032|FG002|STARTED|Period 1||12||
59643274|NCT03139578|75760033|FG003|STARTED|Period 1||13||
59643275|NCT03139578|75760030|FG000|Discontinued|Period 1||0||
59643276|NCT03139578|75760031|FG001|Discontinued|Period 1||0||
59643277|NCT03139578|75760032|FG002|Discontinued|Period 1||0||
59643278|NCT03139578|75760033|FG003|Discontinued|Period 1||0||
59643279|NCT03139578|75760030|FG000|COMPLETED|Period 1||12||
59643280|NCT03139578|75760031|FG001|COMPLETED|Period 1||13||
59643281|NCT03139578|75760032|FG002|COMPLETED|Period 1||12||
59643282|NCT03139578|75760033|FG003|COMPLETED|Period 1||13||
59643283|NCT03139578|75760030|FG000|NOT COMPLETED|Period 1||0||
59643284|NCT03139578|75760031|FG001|NOT COMPLETED|Period 1||0||
59643285|NCT03139578|75760032|FG002|NOT COMPLETED|Period 1||0||
59643286|NCT03139578|75760033|FG003|NOT COMPLETED|Period 1||0||
59643287|NCT03139578|75760030|FG000|STARTED|Period 2||12||
59643288|NCT03139578|75760031|FG001|STARTED|Period 2||13||
59643289|NCT03139578|75760032|FG002|STARTED|Period 2||12||
59643290|NCT03139578|75760033|FG003|STARTED|Period 2||13||
59643291|NCT03139578|75760030|FG000|Discontinued|Period 2||0||
59643292|NCT03139578|75760031|FG001|Discontinued|Period 2||0||
59643293|NCT03139578|75760032|FG002|Discontinued|Period 2||0||
59643294|NCT03139578|75760033|FG003|Discontinued|Period 2||0||
59643295|NCT03139578|75760030|FG000|COMPLETED|Period 2||12||
59643296|NCT03139578|75760031|FG001|COMPLETED|Period 2||13||
59643297|NCT03139578|75760032|FG002|COMPLETED|Period 2||12||
59643298|NCT03139578|75760033|FG003|COMPLETED|Period 2||13||
59643299|NCT03139578|75760030|FG000|NOT COMPLETED|Period 2||0||
59643300|NCT03139578|75760031|FG001|NOT COMPLETED|Period 2||0||
59643301|NCT03139578|75760032|FG002|NOT COMPLETED|Period 2||0||
59643302|NCT03139578|75760033|FG003|NOT COMPLETED|Period 2||0||
59643303|NCT03141372|75760045|FG000|STARTED|Overall Study||42||
59643304|NCT03141372|75760046|FG001|STARTED|Overall Study||42||
59643305|NCT03141372|75760045|FG000|COMPLETED|Overall Study||42||
59643306|NCT03141372|75760046|FG001|COMPLETED|Overall Study||40||
59643307|NCT03141372|75760045|FG000|NOT COMPLETED|Overall Study||0||
59643308|NCT03141372|75760046|FG001|NOT COMPLETED|Overall Study||2||
59643309|NCT03141528|75760056|FG000|STARTED|Overall Study||122||
59643310|NCT03141528|75760057|FG001|STARTED|Overall Study||118||
59643311|NCT03141528|75760056|FG000|COMPLETED|Overall Study||75||
59643312|NCT03141528|75760057|FG001|COMPLETED|Overall Study||77||
59643313|NCT03141528|75760056|FG000|NOT COMPLETED|Overall Study||47||
59643314|NCT03141528|75760057|FG001|NOT COMPLETED|Overall Study||41||
59643315|NCT03145818|75760067|FG000|STARTED|Overall Study||99||
59643316|NCT03145818|75760068|FG001|STARTED|Overall Study||8||
59643317|NCT03145818|75760069|FG002|STARTED|Overall Study||10||
59643318|NCT03145818|75760070|FG003|STARTED|Overall Study||9||
59643319|NCT03145818|75760067|FG000|COMPLETED|Overall Study||8||
59643320|NCT03145818|75760068|FG001|COMPLETED|Overall Study||0||
59643321|NCT03145818|75760069|FG002|COMPLETED|Overall Study||10||
59643322|NCT03145818|75760070|FG003|COMPLETED|Overall Study||9||
59643323|NCT03145818|75760067|FG000|NOT COMPLETED|Overall Study||91||
59643324|NCT03145818|75760068|FG001|NOT COMPLETED|Overall Study||8||
59643325|NCT03145818|75760069|FG002|NOT COMPLETED|Overall Study||0||
59643326|NCT03145818|75760070|FG003|NOT COMPLETED|Overall Study||0||
59643327|NCT03147690|75760078|FG000|STARTED|Overall Study||74||
59643328|NCT03147690|75760078|FG000|COMPLETED|Overall Study||71||
59643329|NCT03147690|75760078|FG000|NOT COMPLETED|Overall Study||3||
59643330|NCT03148236|75760097|FG000|STARTED|Overall Study||10||
59643331|NCT03148236|75760098|FG001|STARTED|Overall Study||10||
59643332|NCT03148236|75760097|FG000|COMPLETED|Overall Study||10||
59643333|NCT03148236|75760098|FG001|COMPLETED|Overall Study||10||
59643334|NCT03148236|75760097|FG000|NOT COMPLETED|Overall Study||0||
59643335|NCT03148236|75760098|FG001|NOT COMPLETED|Overall Study||0||
59643336|NCT03148470|75760106|FG000|STARTED|Overall Study|21 Participants completed the Tasks following Sham-stimulation|21||
59815753|NCT03026283|75938211|FG000|COMPLETED|CCTA Diagnosis||572||
59815754|NCT03026283|75938212|FG001|COMPLETED|CCTA Diagnosis||0||
59643337|NCT03148470|75760107|FG001|STARTED|Overall Study|20 Participants completed the Tasks following Sham-stimulation|20||
59643338|NCT03148470|75760106|FG000|COMPLETED|Overall Study|20 Participants completed the Tasks following iTBS-stimulation|20||
59643339|NCT03148470|75760107|FG001|COMPLETED|Overall Study|20 Participants completed the Tasks following cTBS-stimulation|20||
59643340|NCT03148470|75760106|FG000|NOT COMPLETED|Overall Study||1||
59643341|NCT03148470|75760107|FG001|NOT COMPLETED|Overall Study||0||
59643342|NCT03149172|75760124|FG000|STARTED|Overall Study||8||
59643343|NCT03149172|75760125|FG001|STARTED|Overall Study||6||
59643344|NCT03149172|75760126|FG002|STARTED|Overall Study||7||
59815755|NCT03026283|75938213|FG002|COMPLETED|CCTA Diagnosis||0||
59815756|NCT03026283|75938214|FG003|COMPLETED|CCTA Diagnosis||0||
59815757|NCT03026283|75938215|FG004|COMPLETED|CCTA Diagnosis||0||
59643345|NCT03149172|75760124|FG000|COMPLETED|Overall Study||6||
59643346|NCT03149172|75760125|FG001|COMPLETED|Overall Study||5||
59643347|NCT03149172|75760126|FG002|COMPLETED|Overall Study||5||
59643348|NCT03149172|75760124|FG000|NOT COMPLETED|Overall Study||2||
59643349|NCT03149172|75760125|FG001|NOT COMPLETED|Overall Study||1||
59643350|NCT03149172|75760126|FG002|NOT COMPLETED|Overall Study||2||
59643351|NCT03150108|75760136|FG000|STARTED|Overall Study||12||
59643352|NCT03150108|75760137|FG001|STARTED|Overall Study||12||
59643353|NCT03150108|75760136|FG000|COMPLETED|Overall Study||12||
59643354|NCT03150108|75760137|FG001|COMPLETED|Overall Study||12||
59643355|NCT03150108|75760136|FG000|NOT COMPLETED|Overall Study||0||
59643356|NCT03150108|75760137|FG001|NOT COMPLETED|Overall Study||0||
59643357|NCT03154710|75760154|FG000|STARTED|Overall Study||27||
59643358|NCT03154710|75760155|FG001|STARTED|Overall Study||25||
59643359|NCT03154710|75760154|FG000|COMPLETED|Overall Study||20||
59643360|NCT03154710|75760155|FG001|COMPLETED|Overall Study||20||
59643361|NCT03154710|75760154|FG000|NOT COMPLETED|Overall Study||7||
59643362|NCT03154710|75760155|FG001|NOT COMPLETED|Overall Study||5||
59643363|NCT03160170|75760163|FG000|STARTED|Overall Study||10||
59643364|NCT03160170|75760164|FG001|STARTED|Overall Study||10||
59643365|NCT03160170|75760163|FG000|COMPLETED|Overall Study||10||
59643366|NCT03160170|75760164|FG001|COMPLETED|Overall Study||10||
59643367|NCT03160170|75760163|FG000|NOT COMPLETED|Overall Study||0||
59643368|NCT03160170|75760164|FG001|NOT COMPLETED|Overall Study||0||
59643369|NCT03162354|75760172|FG000|STARTED|Overall Study||183||4
59643370|NCT03162354|75760173|FG001|STARTED|Overall Study||237||4
59643371|NCT03162354|75760172|FG000|COMPLETED|Overall Study||183||4
59643372|NCT03162354|75760173|FG001|COMPLETED|Overall Study||237||4
59643373|NCT03162354|75760172|FG000|NOT COMPLETED|Overall Study||0||0
59643374|NCT03162354|75760173|FG001|NOT COMPLETED|Overall Study||0||0
59643375|NCT03163134|75760186|FG000|STARTED|Overall Study||85||
59643376|NCT03163134|75760187|FG001|STARTED|Overall Study||85||
59643377|NCT03163134|75760186|FG000|COMPLETED|Overall Study||85||
59643378|NCT03163134|75760187|FG001|COMPLETED|Overall Study||85||
59643379|NCT03163134|75760186|FG000|NOT COMPLETED|Overall Study||0||
59643380|NCT03163134|75760187|FG001|NOT COMPLETED|Overall Study||0||
59643381|NCT03163758|75760195|FG000|STARTED|Overall Study||21||
59643382|NCT03163758|75760196|FG001|STARTED|Overall Study||21||
59643383|NCT03163758|75760195|FG000|COMPLETED|Overall Study||13||
59643384|NCT03163758|75760196|FG001|COMPLETED|Overall Study||14||
59643385|NCT03163758|75760195|FG000|NOT COMPLETED|Overall Study||8||
59643386|NCT03163758|75760196|FG001|NOT COMPLETED|Overall Study||7||
59643387|NCT03164538|75760204|FG000|STARTED|Overall Study||35||
59643388|NCT03164538|75760205|FG001|STARTED|Overall Study||35||
59643389|NCT03164538|75760204|FG000|COMPLETED|Overall Study||28||
59643390|NCT03164538|75760205|FG001|COMPLETED|Overall Study||29||
59643391|NCT03164538|75760204|FG000|NOT COMPLETED|Overall Study||7||
59643392|NCT03164538|75760205|FG001|NOT COMPLETED|Overall Study||6||
59643393|NCT03169062|75760211|FG000|STARTED|Overall Study||10||
59643394|NCT03169062|75760211|FG000|COMPLETED|Overall Study||10||
59643395|NCT03169062|75760211|FG000|NOT COMPLETED|Overall Study||0||
59643396|NCT03170388|75760220|FG000|STARTED|Overall Study||147||
59643397|NCT03170388|75760221|FG001|STARTED|Overall Study||150||
59643398|NCT03170388|75760222|FG002|STARTED|Overall Study||146||
59643399|NCT03170388|75760223|FG003|STARTED|Overall Study||150||
59643400|NCT03170388|75760224|FG004|STARTED|Overall Study||148||
59643401|NCT03170388|75760220|FG000|COMPLETED|Overall Study||125||
59643402|NCT03170388|75760221|FG001|COMPLETED|Overall Study||132||
59643403|NCT03170388|75760222|FG002|COMPLETED|Overall Study||133||
59643404|NCT03170388|75760223|FG003|COMPLETED|Overall Study||132||
59643405|NCT03170388|75760224|FG004|COMPLETED|Overall Study||127||
59643406|NCT03170388|75760220|FG000|NOT COMPLETED|Overall Study||22||
59643407|NCT03170388|75760221|FG001|NOT COMPLETED|Overall Study||18||
59643408|NCT03170388|75760222|FG002|NOT COMPLETED|Overall Study||13||
59643409|NCT03170388|75760223|FG003|NOT COMPLETED|Overall Study||18||
59643410|NCT03170388|75760224|FG004|NOT COMPLETED|Overall Study||21||
59643411|NCT03172884|75760240|FG000|STARTED|Overall Study||8||
59643412|NCT03172884|75760241|FG001|STARTED|Overall Study||6||
59643413|NCT03172884|75760242|FG002|STARTED|Overall Study||8||
59643414|NCT03172884|75760243|FG003|STARTED|Overall Study||8||
59643415|NCT03172884|75760240|FG000|COMPLETED|Overall Study||8||
59643416|NCT03172884|75760241|FG001|COMPLETED|Overall Study||6||
59643417|NCT03172884|75760242|FG002|COMPLETED|Overall Study||8||
59643418|NCT03172884|75760243|FG003|COMPLETED|Overall Study||8||
59643419|NCT03172884|75760240|FG000|NOT COMPLETED|Overall Study||0||
59643420|NCT03172884|75760241|FG001|NOT COMPLETED|Overall Study||0||
59643421|NCT03172884|75760242|FG002|NOT COMPLETED|Overall Study||0||
59643422|NCT03172884|75760243|FG003|NOT COMPLETED|Overall Study||0||
59643423|NCT03174366|75760253|FG000|STARTED|Overall Study||7||
59643424|NCT03174366|75760253|FG000|COMPLETED|Overall Study||7||
59643425|NCT03174366|75760253|FG000|NOT COMPLETED|Overall Study||0||
59643426|NCT03177798|75760259|FG000|STARTED|Overall Study||5||
59643427|NCT03177798|75760260|FG001|STARTED|Overall Study||6||
59643428|NCT03177798|75760259|FG000|Intervention 1|Overall Study||5||
59643429|NCT03177798|75760260|FG001|Intervention 1|Overall Study||6||
59643430|NCT03177798|75760259|FG000|Washout|Overall Study||5||
59643431|NCT03177798|75760260|FG001|Washout|Overall Study||6||
59643432|NCT03177798|75760259|FG000|Intervention 2|Overall Study||5||
59643433|NCT03177798|75760260|FG001|Intervention 2|Overall Study||6||
59643434|NCT03177798|75760259|FG000|COMPLETED|Overall Study||5||
59643435|NCT03177798|75760260|FG001|COMPLETED|Overall Study||6||
59643436|NCT03177798|75760259|FG000|NOT COMPLETED|Overall Study||0||
59643437|NCT03177798|75760260|FG001|NOT COMPLETED|Overall Study||0||
59643438|NCT03178344|75760268|FG000|STARTED|First Session||10||
59643439|NCT03178344|75760269|FG001|STARTED|First Session||10||
59643440|NCT03178344|75760268|FG000|COMPLETED|First Session||10||
59643441|NCT03178344|75760269|FG001|COMPLETED|First Session||10||
59643442|NCT03178344|75760268|FG000|NOT COMPLETED|First Session||0||
59643443|NCT03178344|75760269|FG001|NOT COMPLETED|First Session||0||
59643444|NCT03178344|75760268|FG000|STARTED|Washout Period (5-9 Days)||10||
59643445|NCT03178344|75760269|FG001|STARTED|Washout Period (5-9 Days)||10||
59643446|NCT03178344|75760268|FG000|COMPLETED|Washout Period (5-9 Days)||10||
59643447|NCT03178344|75760269|FG001|COMPLETED|Washout Period (5-9 Days)||10||
59643448|NCT03178344|75760268|FG000|NOT COMPLETED|Washout Period (5-9 Days)||0||
59643449|NCT03178344|75760269|FG001|NOT COMPLETED|Washout Period (5-9 Days)||0||
59643450|NCT03178344|75760268|FG000|STARTED|Second Session||10||
59643451|NCT03178344|75760269|FG001|STARTED|Second Session||10||
59643452|NCT03178344|75760268|FG000|COMPLETED|Second Session||10||
59643453|NCT03178344|75760269|FG001|COMPLETED|Second Session||10||
59643454|NCT03178344|75760268|FG000|NOT COMPLETED|Second Session||0||
59643455|NCT03178344|75760269|FG001|NOT COMPLETED|Second Session||0||
59643456|NCT03137160|75760275|FG000|STARTED|Overall Study||4|One screen failed due to infection and never enrolled or received drug|
59643457|NCT03137160|75760275|FG000|COMPLETED|Overall Study||2||
59643458|NCT03137160|75760275|FG000|NOT COMPLETED|Overall Study||2||
59643459|NCT04426500|75760282|FG000|STARTED|Overall Study||28||
59643460|NCT04426500|75760283|FG001|STARTED|Overall Study||64||
59643461|NCT04426500|75760284|FG002|STARTED|Overall Study||56||
59643462|NCT04426500|75760282|FG000|COMPLETED|Overall Study||28||
59643463|NCT04426500|75760283|FG001|COMPLETED|Overall Study||64||
59643464|NCT04426500|75760284|FG002|COMPLETED|Overall Study||56||
59643465|NCT04426500|75760282|FG000|NOT COMPLETED|Overall Study||0||
59643466|NCT04426500|75760283|FG001|NOT COMPLETED|Overall Study||0||
59643467|NCT04426500|75760284|FG002|NOT COMPLETED|Overall Study||0||
59643468|NCT01463670|75760292|FG000|STARTED|Overall Study||11||
59643469|NCT01463670|75760292|FG000|COMPLETED|Overall Study||11||
59643470|NCT01463670|75760292|FG000|NOT COMPLETED|Overall Study||0||
59643471|NCT03181308|75760298|FG000|STARTED|Overall Study||3||
59643472|NCT03181308|75760299|FG001|STARTED|Overall Study||8||
59643473|NCT03181308|75760298|FG000|COMPLETED|Overall Study||3||
59643474|NCT03181308|75760299|FG001|COMPLETED|Overall Study||8||
59643475|NCT03181308|75760298|FG000|NOT COMPLETED|Overall Study||0||
59643476|NCT03181308|75760299|FG001|NOT COMPLETED|Overall Study||0||
59643477|NCT03184428|75760305|FG000|STARTED|Overall Study||3785||5549
59643478|NCT03184428|75760305|FG000|COMPLETED|Overall Study||2963||4388
59643479|NCT03184428|75760305|FG000|NOT COMPLETED|Overall Study||822||1161
59643480|NCT03187002|75760323|FG000|STARTED|Overall Study||55||
59643481|NCT03187002|75760324|FG001|STARTED|Overall Study||54||
59643482|NCT03187002|75760323|FG000|COMPLETED|Overall Study||55||
59643483|NCT03187002|75760324|FG001|COMPLETED|Overall Study||54||
59643484|NCT03187002|75760323|FG000|NOT COMPLETED|Overall Study||0||
59643485|NCT03187002|75760324|FG001|NOT COMPLETED|Overall Study||0||
59643486|NCT03193398|75760332|FG000|STARTED|Overall Study||53||
59643487|NCT03193398|75760333|FG001|STARTED|Overall Study||51||
59643488|NCT03193398|75760332|FG000|COMPLETED|Overall Study||38||
59643489|NCT03193398|75760333|FG001|COMPLETED|Overall Study||35||
59643490|NCT03193398|75760332|FG000|NOT COMPLETED|Overall Study||15||
59643491|NCT03193398|75760333|FG001|NOT COMPLETED|Overall Study||16||
59643492|NCT03194334|75760342|FG000|STARTED|0-3 Months||10||
59643493|NCT03194334|75760343|FG001|STARTED|0-3 Months||15||
59643494|NCT03194334|75760344|FG002|STARTED|0-3 Months||15||
59643495|NCT03194334|75760342|FG000|COMPLETED|0-3 Months||10||
59643496|NCT03194334|75760343|FG001|COMPLETED|0-3 Months||15||
59643497|NCT03194334|75760344|FG002|COMPLETED|0-3 Months||14||
59643498|NCT03194334|75760342|FG000|NOT COMPLETED|0-3 Months||0||
59643499|NCT03194334|75760343|FG001|NOT COMPLETED|0-3 Months||0||
59643500|NCT03194334|75760344|FG002|NOT COMPLETED|0-3 Months||1||
59643501|NCT03194334|75760342|FG000|STARTED|3-6 Months||10||
59643502|NCT03194334|75760343|FG001|STARTED|3-6 Months||15||
59643503|NCT03194334|75760344|FG002|STARTED|3-6 Months||14||
59643504|NCT03194334|75760342|FG000|COMPLETED|3-6 Months||10||
59643505|NCT03194334|75760343|FG001|COMPLETED|3-6 Months||15||
59643506|NCT03194334|75760344|FG002|COMPLETED|3-6 Months||14||
59815758|NCT03026283|75938216|FG005|COMPLETED|CCTA Diagnosis||0||
59643507|NCT03194334|75760342|FG000|NOT COMPLETED|3-6 Months||0||
59643508|NCT03194334|75760343|FG001|NOT COMPLETED|3-6 Months||0||
59643509|NCT03194334|75760344|FG002|NOT COMPLETED|3-6 Months||0||
59643510|NCT03199872|75760353|FG000|STARTED|Overall Study||22||
59643511|NCT03199872|75760353|FG000|COMPLETED|Overall Study||22||
59643512|NCT03199872|75760353|FG000|NOT COMPLETED|Overall Study||0||
59643513|NCT03202134|75760359|FG000|STARTED|Overall Study||55||
59643514|NCT03202134|75760360|FG001|STARTED|Overall Study||149||
59643515|NCT03202134|75760359|FG000|COMPLETED|Overall Study||55||
59643516|NCT03202134|75760360|FG001|COMPLETED|Overall Study||149||
59643517|NCT03202134|75760359|FG000|NOT COMPLETED|Overall Study||0||
59643518|NCT03202134|75760360|FG001|NOT COMPLETED|Overall Study||0||
59643519|NCT03204942|75760371|FG000|STARTED|Overall Study||23||
59643520|NCT03204942|75760372|FG001|STARTED|Overall Study||23||
59643521|NCT03204942|75760373|FG002|STARTED|Overall Study||23||
59643522|NCT03204942|75760371|FG000|COMPLETED|Overall Study||23||
59643523|NCT03204942|75760372|FG001|COMPLETED|Overall Study||23||
59643524|NCT03204942|75760373|FG002|COMPLETED|Overall Study||23||
59643525|NCT03204942|75760371|FG000|NOT COMPLETED|Overall Study||0||
59643526|NCT03204942|75760372|FG001|NOT COMPLETED|Overall Study||0||
59643527|NCT03204942|75760373|FG002|NOT COMPLETED|Overall Study||0||
59643528|NCT03207438|75760390|FG000|STARTED|Overall Study||167||
59643529|NCT03207438|75760391|FG001|STARTED|Overall Study||166||
59643530|NCT03207438|75760392|FG002|STARTED|Overall Study||875||
59643531|NCT03207438|75760393|FG003|STARTED|Overall Study||582||
59643532|NCT03207438|75760390|FG000|COMPLETED|Overall Study||148||
59643533|NCT03207438|75760391|FG001|COMPLETED|Overall Study||145||
59643534|NCT03207438|75760392|FG002|COMPLETED|Overall Study||643||
59643535|NCT03207438|75760393|FG003|COMPLETED|Overall Study||470||
59643536|NCT03207438|75760390|FG000|NOT COMPLETED|Overall Study||19||
59643537|NCT03207438|75760391|FG001|NOT COMPLETED|Overall Study||21||
59643538|NCT03207438|75760392|FG002|NOT COMPLETED|Overall Study||232||
59643539|NCT03207438|75760393|FG003|NOT COMPLETED|Overall Study||112||
59643540|NCT03218592|75760409|FG000|STARTED|Phase 1: 1 Dose||12||
59643541|NCT03218592|75760410|FG001|STARTED|Phase 1: 1 Dose||12||
59643542|NCT03218592|75760411|FG002|STARTED|Phase 1: 1 Dose||12||
59643543|NCT03218592|75760409|FG000|COMPLETED|Phase 1: 1 Dose||12||
59643544|NCT03218592|75760410|FG001|COMPLETED|Phase 1: 1 Dose||12||
59643545|NCT03218592|75760411|FG002|COMPLETED|Phase 1: 1 Dose||12||
59643546|NCT03218592|75760409|FG000|NOT COMPLETED|Phase 1: 1 Dose||0||
59643547|NCT03218592|75760410|FG001|NOT COMPLETED|Phase 1: 1 Dose||0||
59643548|NCT03218592|75760411|FG002|NOT COMPLETED|Phase 1: 1 Dose||0||
59643549|NCT03218592|75760409|FG000|STARTED|Phase 2: Daily Doses x 28 Days||12||
59643550|NCT03218592|75760410|FG001|STARTED|Phase 2: Daily Doses x 28 Days||12||
59643551|NCT03218592|75760411|FG002|STARTED|Phase 2: Daily Doses x 28 Days||12||
59643552|NCT03218592|75760409|FG000|COMPLETED|Phase 2: Daily Doses x 28 Days||12||
59643553|NCT03218592|75760410|FG001|COMPLETED|Phase 2: Daily Doses x 28 Days||12||
59643554|NCT03218592|75760411|FG002|COMPLETED|Phase 2: Daily Doses x 28 Days||12||
59643555|NCT03218592|75760409|FG000|NOT COMPLETED|Phase 2: Daily Doses x 28 Days||0||
59643556|NCT03218592|75760410|FG001|NOT COMPLETED|Phase 2: Daily Doses x 28 Days||0||
59643557|NCT03218592|75760411|FG002|NOT COMPLETED|Phase 2: Daily Doses x 28 Days||0||
59643558|NCT03218592|75760409|FG000|STARTED|Phase 3: 0 Doses Per Week||4||
59643559|NCT03218592|75760410|FG001|STARTED|Phase 3: 0 Doses Per Week||4||
59643560|NCT03218592|75760411|FG002|STARTED|Phase 3: 0 Doses Per Week||4||
59643561|NCT03218592|75760409|FG000|4 Patients Per Group|Phase 3: 0 Doses Per Week||4||
59643562|NCT03218592|75760410|FG001|4 Patients Per Group|Phase 3: 0 Doses Per Week||4||
59643563|NCT03218592|75760411|FG002|4 Patients Per Group|Phase 3: 0 Doses Per Week||4||
59643564|NCT03218592|75760409|FG000|COMPLETED|Phase 3: 0 Doses Per Week||4||
59643565|NCT03218592|75760410|FG001|COMPLETED|Phase 3: 0 Doses Per Week||4||
59643566|NCT03218592|75760411|FG002|COMPLETED|Phase 3: 0 Doses Per Week||4||
59643567|NCT03218592|75760409|FG000|NOT COMPLETED|Phase 3: 0 Doses Per Week||0||
59643568|NCT03218592|75760410|FG001|NOT COMPLETED|Phase 3: 0 Doses Per Week||0||
59643569|NCT03218592|75760411|FG002|NOT COMPLETED|Phase 3: 0 Doses Per Week||0||
59643570|NCT03218592|75760409|FG000|STARTED|Phase 3: 1 Dose Per Period||4||
59643571|NCT03218592|75760410|FG001|STARTED|Phase 3: 1 Dose Per Period||4||
59643572|NCT03218592|75760411|FG002|STARTED|Phase 3: 1 Dose Per Period||4||
59643573|NCT03218592|75760409|FG000|4 Patients Per Group|Phase 3: 1 Dose Per Period||4||
59643574|NCT03218592|75760410|FG001|4 Patients Per Group|Phase 3: 1 Dose Per Period||4||
59643575|NCT03218592|75760411|FG002|4 Patients Per Group|Phase 3: 1 Dose Per Period||4||
59643576|NCT03218592|75760409|FG000|COMPLETED|Phase 3: 1 Dose Per Period||4||
59643577|NCT03218592|75760410|FG001|COMPLETED|Phase 3: 1 Dose Per Period||4||
59643578|NCT03218592|75760411|FG002|COMPLETED|Phase 3: 1 Dose Per Period||4||
59643579|NCT03218592|75760409|FG000|NOT COMPLETED|Phase 3: 1 Dose Per Period||0||
59643580|NCT03218592|75760410|FG001|NOT COMPLETED|Phase 3: 1 Dose Per Period||0||
59643581|NCT03218592|75760411|FG002|NOT COMPLETED|Phase 3: 1 Dose Per Period||0||
59643582|NCT03218592|75760409|FG000|STARTED|Phase 3: 3 Doses Per Week||4||
59643583|NCT03218592|75760410|FG001|STARTED|Phase 3: 3 Doses Per Week||4||
59643584|NCT03218592|75760411|FG002|STARTED|Phase 3: 3 Doses Per Week||4||
59643585|NCT03218592|75760409|FG000|4 Patients Per Group|Phase 3: 3 Doses Per Week||4||
59643586|NCT03218592|75760410|FG001|4 Patients Per Group|Phase 3: 3 Doses Per Week||4||
59643587|NCT03218592|75760411|FG002|4 Patients Per Group|Phase 3: 3 Doses Per Week||4||
59643588|NCT03218592|75760409|FG000|COMPLETED|Phase 3: 3 Doses Per Week||4||
59643589|NCT03218592|75760410|FG001|COMPLETED|Phase 3: 3 Doses Per Week||4||
59643590|NCT03218592|75760411|FG002|COMPLETED|Phase 3: 3 Doses Per Week||4||
59643591|NCT03218592|75760409|FG000|NOT COMPLETED|Phase 3: 3 Doses Per Week||0||
59643592|NCT03218592|75760410|FG001|NOT COMPLETED|Phase 3: 3 Doses Per Week||0||
59643593|NCT03218592|75760411|FG002|NOT COMPLETED|Phase 3: 3 Doses Per Week||0||
59643594|NCT03219294|75760426|FG000|STARTED|Overall Study||58||
59643595|NCT03219294|75760427|FG001|STARTED|Overall Study||58||
59643596|NCT03219294|75760426|FG000|COMPLETED|Overall Study||58||
59643597|NCT03219294|75760427|FG001|COMPLETED|Overall Study||58||
59643598|NCT03219294|75760426|FG000|NOT COMPLETED|Overall Study||0||
59643599|NCT03219294|75760427|FG001|NOT COMPLETED|Overall Study||0||
59643600|NCT03219840|75760433|FG000|STARTED|Overall Study||38||
59643601|NCT03219840|75760434|FG001|STARTED|Overall Study||31||
59643602|NCT03219840|75760433|FG000|Day 1 Visit for 1st Period|Overall Study||37||
59643603|NCT03219840|75760434|FG001|Day 1 Visit for 1st Period|Overall Study||31||
59815759|NCT03026283|75938217|FG006|COMPLETED|CCTA Diagnosis||0||
59542285|NCT02470806|75640615|FG001|STARTED|Overall Study|The Safety analysis included 164, ITT was 161, and Per Protocol was 115 subjects (total both arms).|84||
59542286|NCT02470806|75640614|FG000|COMPLETED|Overall Study||62||
59542287|NCT02470806|75640615|FG001|COMPLETED|Overall Study||42||
59542288|NCT02470806|75640614|FG000|NOT COMPLETED|Overall Study||18||
59542289|NCT02470806|75640615|FG001|NOT COMPLETED|Overall Study||42||
59542290|NCT00912002|75640621|FG000|STARTED|Overall Study||6||
59542291|NCT00912002|75640621|FG000|COMPLETED|Overall Study||6||
59542292|NCT00912002|75640621|FG000|NOT COMPLETED|Overall Study||0||
59542293|NCT01569815|75640630|FG000|STARTED|Overall Study||8||
59542294|NCT01569815|75640631|FG001|STARTED|Overall Study||8||
59542295|NCT01569815|75640632|FG002|STARTED|Overall Study||8||
59542296|NCT01569815|75640633|FG003|STARTED|Overall Study||8||
59542297|NCT01569815|75640630|FG000|COMPLETED|Overall Study||8||
59542298|NCT01569815|75640631|FG001|COMPLETED|Overall Study||8||
59542299|NCT01569815|75640632|FG002|COMPLETED|Overall Study||8||
59542300|NCT01569815|75640633|FG003|COMPLETED|Overall Study||8||
59542301|NCT01569815|75640630|FG000|NOT COMPLETED|Overall Study||0||
59542302|NCT01569815|75640631|FG001|NOT COMPLETED|Overall Study||0||
59542303|NCT01569815|75640632|FG002|NOT COMPLETED|Overall Study||0||
59542304|NCT01569815|75640633|FG003|NOT COMPLETED|Overall Study||0||
59542305|NCT01469585|75640646|FG000|STARTED|Overall Study||11||
59542306|NCT01469585|75640647|FG001|STARTED|Overall Study||9||
59542307|NCT01469585|75640646|FG000|COMPLETED|Overall Study||4||
59542308|NCT01469585|75640647|FG001|COMPLETED|Overall Study||6||
59542309|NCT01469585|75640646|FG000|NOT COMPLETED|Overall Study||7||
59542310|NCT01469585|75640647|FG001|NOT COMPLETED|Overall Study||3||
59542311|NCT01363908|75640657|FG000|STARTED|Screening/Enrollment||14||
59542312|NCT01363908|75640658|FG001|STARTED|Screening/Enrollment||16||
59542313|NCT01363908|75640657|FG000|COMPLETED|Screening/Enrollment|One participant did not receive investigational product.|13||
59542314|NCT01363908|75640658|FG001|COMPLETED|Screening/Enrollment||16||
59542315|NCT01363908|75640657|FG000|NOT COMPLETED|Screening/Enrollment||1||
59542316|NCT01363908|75640658|FG001|NOT COMPLETED|Screening/Enrollment||0||
59542317|NCT01363908|75640657|FG000|STARTED|Pharmacokinetic (PK) Phase|Per study design, at least 8 participants in each age cohort participated in the PK phase.|8||
59542318|NCT01363908|75640658|FG001|STARTED|Pharmacokinetic (PK) Phase|Per study design, at least 8 participants in each age cohort participated in the PK phase.|8||
59542319|NCT01363908|75640657|FG000|COMPLETED|Pharmacokinetic (PK) Phase||8||
59542320|NCT01363908|75640658|FG001|COMPLETED|Pharmacokinetic (PK) Phase||8||
59542321|NCT01363908|75640657|FG000|NOT COMPLETED|Pharmacokinetic (PK) Phase||0||
59542322|NCT01363908|75640658|FG001|NOT COMPLETED|Pharmacokinetic (PK) Phase||0||
59542323|NCT01363908|75640657|FG000|STARTED|Chronic Dosing (CD) Phase|The CD phase enrolled willing participants who completed the PK phase plus additional participants.|13||
59542324|NCT01363908|75640658|FG001|STARTED|Chronic Dosing (CD) Phase|The CD phase enrolled willing participants who completed the PK phase plus additional participants.|16||
59542325|NCT01363908|75640657|FG000|COMPLETED|Chronic Dosing (CD) Phase||3||
59542326|NCT01363908|75640658|FG001|COMPLETED|Chronic Dosing (CD) Phase||10||
59542327|NCT01363908|75640657|FG000|NOT COMPLETED|Chronic Dosing (CD) Phase||10||
59542328|NCT01363908|75640658|FG001|NOT COMPLETED|Chronic Dosing (CD) Phase||6||
59542329|NCT00915590|75640666|FG000|STARTED|Overall Study||5||
59542330|NCT00915590|75640667|FG001|STARTED|Overall Study||5||
59542331|NCT00915590|75640666|FG000|COMPLETED|Overall Study||3||
59542332|NCT00915590|75640667|FG001|COMPLETED|Overall Study||4||
59542333|NCT00915590|75640666|FG000|NOT COMPLETED|Overall Study||2||
59542334|NCT00915590|75640667|FG001|NOT COMPLETED|Overall Study||1||
59542335|NCT01570829|75640680|FG000|STARTED|Overall Study||164||
59542336|NCT01570829|75640681|FG001|STARTED|Overall Study||167||
59542337|NCT01570829|75640680|FG000|COMPLETED|Overall Study||164||
59542338|NCT01570829|75640681|FG001|COMPLETED|Overall Study||167||
59542339|NCT01570829|75640680|FG000|NOT COMPLETED|Overall Study||0||
59542340|NCT01570829|75640681|FG001|NOT COMPLETED|Overall Study||0||
59542341|NCT01471457|75640689|FG000|STARTED|Overall Study||92||
59542342|NCT01471457|75640690|FG001|STARTED|Overall Study||92||
59542343|NCT01471457|75640689|FG000|COMPLETED|Overall Study||73||
59542344|NCT01471457|75640690|FG001|COMPLETED|Overall Study||74||
59542345|NCT01471457|75640689|FG000|NOT COMPLETED|Overall Study||19||
59542346|NCT01471457|75640690|FG001|NOT COMPLETED|Overall Study||18||
59542347|NCT02497404|75640696|FG000|STARTED|Overall Study||40||
59542348|NCT02497404|75640696|FG000|COMPLETED|Overall Study||39||
59542349|NCT02497404|75640696|FG000|NOT COMPLETED|Overall Study||1||
59542350|NCT01573169|75640702|FG000|STARTED|Overall Study||38||
59542351|NCT01573169|75640703|FG001|STARTED|Overall Study||35||
59542352|NCT01573169|75640702|FG000|COMPLETED|Overall Study||38||
59542353|NCT01573169|75640703|FG001|COMPLETED|Overall Study||35||
59542354|NCT01573169|75640702|FG000|NOT COMPLETED|Overall Study||0||
59542355|NCT01573169|75640703|FG001|NOT COMPLETED|Overall Study||0||
59542356|NCT02218307|75640711|FG000|STARTED|Overall Study||34||
59542357|NCT02218307|75640712|FG001|STARTED|Overall Study||34||
59542358|NCT02218307|75640711|FG000|COMPLETED|Overall Study||25||
59542359|NCT02218307|75640712|FG001|COMPLETED|Overall Study||33||
59542360|NCT02218307|75640711|FG000|NOT COMPLETED|Overall Study||9||
59542361|NCT02218307|75640712|FG001|NOT COMPLETED|Overall Study||1||
59542362|NCT01573325|75640718|FG000|STARTED|Overall Study||50||
59643604|NCT03219840|75760433|FG000|1st Intervention Period of 21 Days|Overall Study||34||
59643605|NCT03219840|75760434|FG001|1st Intervention Period of 21 Days|Overall Study||31||
59643606|NCT03219840|75760433|FG000|Day 22 Visit for 1st Period|Overall Study||34||
59643607|NCT03219840|75760434|FG001|Day 22 Visit for 1st Period|Overall Study||31||
59643608|NCT03219840|75760433|FG000|Washout Period of 21 Days|Overall Study||34||
59643609|NCT03219840|75760434|FG001|Washout Period of 21 Days|Overall Study||31||
59643610|NCT03219840|75760433|FG000|Day 1 Visit for 2nd Period|Overall Study||34||
59643611|NCT03219840|75760434|FG001|Day 1 Visit for 2nd Period|Overall Study||31||
59643612|NCT03219840|75760433|FG000|2nd Intervention Period of 21 Days|Overall Study||34||
59643613|NCT03219840|75760434|FG001|2nd Intervention Period of 21 Days|Overall Study||31||
59643614|NCT03219840|75760433|FG000|Day 22 Visit for 2nd Period|Overall Study||34||
59643615|NCT03219840|75760434|FG001|Day 22 Visit for 2nd Period|Overall Study||31||
59643616|NCT03219840|75760433|FG000|COMPLETED|Overall Study||34||
59643617|NCT03219840|75760434|FG001|COMPLETED|Overall Study||31||
59643618|NCT03219840|75760433|FG000|NOT COMPLETED|Overall Study||4||
59643619|NCT03219840|75760434|FG001|NOT COMPLETED|Overall Study||0||
59643620|NCT03220230|75760440|FG000|STARTED|Overall Study||4240||
59643621|NCT03220230|75760440|FG000|COMPLETED|Overall Study||4240||
59988555|NCT00730639|76103733|FG001|STARTED|Overall Study||18||
59988556|NCT00730639|76103734|FG002|STARTED|Overall Study||86||
59988557|NCT00730639|76103735|FG003|STARTED|Overall Study||54||
59988558|NCT00730639|76103736|FG004|STARTED|Overall Study||131||
59988559|NCT00730639|76103732|FG000|COMPLETED|Overall Study||0||
59988560|NCT00730639|76103733|FG001|COMPLETED|Overall Study||0||
59988561|NCT00730639|76103734|FG002|COMPLETED|Overall Study||0||
59988562|NCT00730639|76103735|FG003|COMPLETED|Overall Study||0||
59988563|NCT00730639|76103736|FG004|COMPLETED|Overall Study||0||
59988564|NCT00730639|76103732|FG000|NOT COMPLETED|Overall Study||17||
59988565|NCT00730639|76103733|FG001|NOT COMPLETED|Overall Study||18||
59988566|NCT00730639|76103734|FG002|NOT COMPLETED|Overall Study||86||
59988567|NCT00730639|76103735|FG003|NOT COMPLETED|Overall Study||54||
59643622|NCT03220230|75760440|FG000|NOT COMPLETED|Overall Study||0||
59643623|NCT03222414|75760446|FG000|STARTED|Overall Study||0||
59643624|NCT03222414|75760447|FG001|STARTED|Overall Study||1||
59643625|NCT03222414|75760446|FG000|COMPLETED|Overall Study||0||
59643626|NCT03222414|75760447|FG001|COMPLETED|Overall Study||1||
59643627|NCT03222414|75760446|FG000|NOT COMPLETED|Overall Study||0||
59643628|NCT03222414|75760447|FG001|NOT COMPLETED|Overall Study||0||
59643629|NCT03223272|75760453|FG000|STARTED|Overall Study||7||
59643630|NCT03223272|75760453|FG000|COMPLETED|Overall Study||6||
59643631|NCT03223272|75760453|FG000|NOT COMPLETED|Overall Study||1||
59643632|NCT03224520|75760461|FG000|STARTED|Overall Study||371||
59643633|NCT03224520|75760462|FG001|STARTED|Overall Study||370||
59643634|NCT03224520|75760463|FG002|STARTED|Overall Study||374||
59643635|NCT03224520|75760464|FG003|STARTED|Overall Study||372||
59643636|NCT03224520|75760461|FG000|COMPLETED|Overall Study||205||
59643637|NCT03224520|75760462|FG001|COMPLETED|Overall Study||207||
59643638|NCT03224520|75760463|FG002|COMPLETED|Overall Study||190||
59643639|NCT03224520|75760464|FG003|COMPLETED|Overall Study||199||
59643640|NCT03224520|75760461|FG000|NOT COMPLETED|Overall Study||166||
59643641|NCT03224520|75760462|FG001|NOT COMPLETED|Overall Study||163||
59643642|NCT03224520|75760463|FG002|NOT COMPLETED|Overall Study||184||
59643643|NCT03224520|75760464|FG003|NOT COMPLETED|Overall Study||173||
59643644|NCT03237156|75760478|FG000|STARTED|Overall Study||6||
59643645|NCT03237156|75760479|FG001|STARTED|Overall Study||6||
59643646|NCT03237156|75760480|FG002|STARTED|Overall Study||6||
59643647|NCT03237156|75760481|FG003|STARTED|Overall Study||6||
59643648|NCT03237156|75760478|FG000|COMPLETED|Overall Study||6||
59643649|NCT03237156|75760479|FG001|COMPLETED|Overall Study||6||
59643650|NCT03237156|75760480|FG002|COMPLETED|Overall Study||6||
59643651|NCT03237156|75760481|FG003|COMPLETED|Overall Study||6||
59643652|NCT03237156|75760478|FG000|NOT COMPLETED|Overall Study||0||
59643653|NCT03237156|75760479|FG001|NOT COMPLETED|Overall Study||0||
59643654|NCT03237156|75760480|FG002|NOT COMPLETED|Overall Study||0||
59643655|NCT03237156|75760481|FG003|NOT COMPLETED|Overall Study||0||
59643656|NCT03239106|75760494|FG000|STARTED|Overall Study||10||
59643657|NCT03239106|75760494|FG000|COMPLETED|Overall Study||3||
59643658|NCT03239106|75760494|FG000|NOT COMPLETED|Overall Study||7||
59988568|NCT00730639|76103736|FG004|NOT COMPLETED|Overall Study||131||
59988569|NCT02536339|76103759|FG000|STARTED|Overall Study||40|Intention-to-Treat (ITT) Population|
59643659|NCT03239574|75760499|FG000|STARTED|Overall Study||34||
59988570|NCT02536339|76103759|FG000|Received at Least One Dose of Study Drug|Overall Study||39|Safety Population|
59988571|NCT02536339|76103759|FG000|Efficacy-Evaluable Population|Overall Study|2 participants did not have post-baseline assessments and were not evaluable for efficacy.|37||
59988572|NCT02536339|76103759|FG000|COMPLETED|Overall Study||12||
59988573|NCT02536339|76103759|FG000|NOT COMPLETED|Overall Study||28||
59988574|NCT01578967|76103763|FG000|STARTED|Overall Study||41||
59988575|NCT01578967|76103763|FG000|COMPLETED|Overall Study||41||
59643660|NCT03239574|75760499|FG000|COMPLETED|Overall Study||34||
59643661|NCT03239574|75760499|FG000|NOT COMPLETED|Overall Study||0||
59643662|NCT03242148|75760503|FG000|STARTED|Overall Study||38||
59643663|NCT03242148|75760503|FG000|COMPLETED|Overall Study||38||
59643664|NCT03242148|75760503|FG000|NOT COMPLETED|Overall Study||0||
59643665|NCT03257202|75760507|FG000|STARTED|Overall Study||12||
59643666|NCT03257202|75760507|FG000|COMPLETED|Overall Study||12||
59643667|NCT03257202|75760507|FG000|NOT COMPLETED|Overall Study||0||
59643668|NCT03260790|75760519|FG000|STARTED|Overall Study||8||
59643669|NCT03260790|75760520|FG001|STARTED|Overall Study||9||
59643670|NCT03260790|75760519|FG000|COMPLETED|Overall Study||8||
59643671|NCT03260790|75760520|FG001|COMPLETED|Overall Study||9||
59643672|NCT03260790|75760519|FG000|NOT COMPLETED|Overall Study||0||
59643673|NCT03260790|75760520|FG001|NOT COMPLETED|Overall Study||0||
59542363|NCT01573325|75640718|FG000|COMPLETED|Overall Study||50||
59643674|NCT03261960|75760528|FG000|STARTED|Overall Study||190|Safety population - all patients that took preparation.|
59643675|NCT03261960|75760529|FG001|STARTED|Overall Study||199|Safety population - all patients that took preparation.|
59643676|NCT03261960|75760528|FG000|COMPLETED|Overall Study||176||
59643677|NCT03261960|75760529|FG001|COMPLETED|Overall Study||185||
59542364|NCT01573325|75640718|FG000|NOT COMPLETED|Overall Study||0||
59542365|NCT01573949|75640723|FG000|STARTED|Overall Study||7||
59542366|NCT01573949|75640723|FG000|COMPLETED|Overall Study||7||
59542367|NCT01573949|75640723|FG000|NOT COMPLETED|Overall Study||0||
59542368|NCT02496702|75640729|FG000|STARTED|Overall Study||30||
59542369|NCT02496702|75640730|FG001|STARTED|Overall Study||30||
59542370|NCT02496702|75640729|FG000|Received Allocated Intervention|Overall Study||21||
59542371|NCT02496702|75640730|FG001|Received Allocated Intervention|Overall Study||0||
59643678|NCT03261960|75760528|FG000|NOT COMPLETED|Overall Study||14||
59643679|NCT03261960|75760529|FG001|NOT COMPLETED|Overall Study||14||
59643680|NCT03273270|75760537|FG000|STARTED|Overall Study||12||
59643681|NCT03273270|75760538|FG001|STARTED|Overall Study||8||
59643682|NCT03273270|75760537|FG000|COMPLETED|Overall Study||12||
59643683|NCT03273270|75760538|FG001|COMPLETED|Overall Study||8||
59643684|NCT03273270|75760537|FG000|NOT COMPLETED|Overall Study||0||
59643685|NCT03273270|75760538|FG001|NOT COMPLETED|Overall Study||0||
59643686|NCT03273426|75760546|FG000|STARTED|Overall Study||20||
59643687|NCT03273426|75760547|FG001|STARTED|Overall Study||20||
59643688|NCT03273426|75760546|FG000|COMPLETED|Overall Study||20||
59643689|NCT03273426|75760547|FG001|COMPLETED|Overall Study||20||
59643690|NCT03273426|75760546|FG000|NOT COMPLETED|Overall Study||0||
59643691|NCT03273426|75760547|FG001|NOT COMPLETED|Overall Study||0||
59643692|NCT03274518|75760556|FG000|STARTED|First Intervention||8|First intervention: online hemodiafiltration, for 30 days|
59643693|NCT03274518|75760557|FG001|STARTED|First Intervention|First intervention: expanded hemodialysis, for 30 days.|8|First intervention: online hemodiafiltration, for 30 days|
59643694|NCT03274518|75760556|FG000|COMPLETED|First Intervention||8||
59643695|NCT03274518|75760557|FG001|COMPLETED|First Intervention||8||
59643696|NCT03274518|75760556|FG000|NOT COMPLETED|First Intervention||0||
59643697|NCT03274518|75760557|FG001|NOT COMPLETED|First Intervention||0||
59643698|NCT03274518|75760556|FG000|STARTED|Washout Period||8|Patients returned from online Hemodiafiltration to conventional hemodialysis for 15 days.|
59643699|NCT03274518|75760557|FG001|STARTED|Washout Period|Patients returned from expanded hemodialysis to conventional hemodialysis for 15 days.|8|Patients returned from online Hemodiafiltration to conventional hemodialysis for 15 days.|
59643700|NCT03274518|75760556|FG000|COMPLETED|Washout Period||8||
59643701|NCT03274518|75760557|FG001|COMPLETED|Washout Period||8||
59643702|NCT03274518|75760556|FG000|NOT COMPLETED|Washout Period||0||
59643703|NCT03274518|75760557|FG001|NOT COMPLETED|Washout Period||0||
59542372|NCT02496702|75640729|FG000|Did Not Receive Allocated Intervention|Overall Study||9||
59542373|NCT02496702|75640730|FG001|Did Not Receive Allocated Intervention|Overall Study||0||
59542374|NCT02496702|75640729|FG000|COMPLETED|Overall Study||22||
59542375|NCT02496702|75640730|FG001|COMPLETED|Overall Study||22||
59542376|NCT02496702|75640729|FG000|NOT COMPLETED|Overall Study||8||
59542377|NCT02496702|75640730|FG001|NOT COMPLETED|Overall Study||8||
59542378|NCT01574105|75640738|FG000|STARTED|Overall Study||29||
59542379|NCT01574105|75640739|FG001|STARTED|Overall Study||37||
59542380|NCT01574105|75640738|FG000|COMPLETED|Overall Study||29||
59542381|NCT01574105|75640739|FG001|COMPLETED|Overall Study||37||
59643704|NCT03274518|75760556|FG000|STARTED|Second Intervention||8|Second intervention: patients from this group underwent expanded hemodialysis for 30 days.|
59643705|NCT03274518|75760557|FG001|STARTED|Second Intervention|Second intervention: patients from this group underwent online hemodiafiltration for 30 days.|8|Second intervention: patients from this group underwent expanded hemodialysis for 30 days.|
59643706|NCT03274518|75760556|FG000|COMPLETED|Second Intervention||8||
59643707|NCT03274518|75760557|FG001|COMPLETED|Second Intervention||8||
59643708|NCT03274518|75760556|FG000|NOT COMPLETED|Second Intervention||0||
59643709|NCT03274518|75760557|FG001|NOT COMPLETED|Second Intervention||0||
59643710|NCT03275766|75760567|FG000|STARTED|Overall Study||12||
59643711|NCT03275766|75760568|FG001|STARTED|Overall Study||12||
59643712|NCT03275766|75760569|FG002|STARTED|Overall Study||11||
59643713|NCT03275766|75760570|FG003|STARTED|Overall Study||10||
59643714|NCT03275766|75760567|FG000|Received Intervention|Overall Study||9||
59643715|NCT03275766|75760568|FG001|Received Intervention|Overall Study||11||
59643716|NCT03275766|75760569|FG002|Received Intervention|Overall Study||10||
59643717|NCT03275766|75760570|FG003|Received Intervention|Overall Study||9||
59643718|NCT03275766|75760567|FG000|COMPLETED|Overall Study||7||
59643719|NCT03275766|75760568|FG001|COMPLETED|Overall Study||5||
59643720|NCT03275766|75760569|FG002|COMPLETED|Overall Study||7||
59643721|NCT03275766|75760570|FG003|COMPLETED|Overall Study||4||
59643722|NCT03275766|75760567|FG000|NOT COMPLETED|Overall Study||5||
59643723|NCT03275766|75760568|FG001|NOT COMPLETED|Overall Study||7||
59643724|NCT03275766|75760569|FG002|NOT COMPLETED|Overall Study||4||
59643725|NCT03275766|75760570|FG003|NOT COMPLETED|Overall Study||6||
59643726|NCT03278886|75760582|FG000|STARTED|Overall Study||8||
59643727|NCT03278886|75760583|FG001|STARTED|Overall Study||3||
59643728|NCT03278886|75760582|FG000|COMPLETED|Overall Study||8||
59643729|NCT03278886|75760583|FG001|COMPLETED|Overall Study||2||
59643730|NCT03278886|75760582|FG000|NOT COMPLETED|Overall Study||0||
59643731|NCT03278886|75760583|FG001|NOT COMPLETED|Overall Study||1||
59643732|NCT03281538|75760589|FG000|STARTED|Overall Study||288||
59643733|NCT03281538|75760589|FG000|COMPLETED|Overall Study||133||
59643734|NCT03281538|75760589|FG000|NOT COMPLETED|Overall Study||155||
59643735|NCT03285984|75760593|FG000|STARTED|Overall Study||56||
59643736|NCT03285984|75760593|FG000|Received Test Product 1|Overall Study||56||
59643737|NCT03285984|75760593|FG000|Received Test Product 2|Overall Study||56||
59643738|NCT03285984|75760593|FG000|Received Test Product 3|Overall Study||56||
59643739|NCT03285984|75760593|FG000|Received Test Product 4|Overall Study||56||
59643740|NCT03285984|75760593|FG000|COMPLETED|Overall Study||56||
59643741|NCT03285984|75760593|FG000|NOT COMPLETED|Overall Study||0||
59643742|NCT03287310|75760611|FG000|STARTED|Overall Study||12||
59643743|NCT03287310|75760612|FG001|STARTED|Overall Study||6||
59643744|NCT03287310|75760613|FG002|STARTED|Overall Study||6||
59643745|NCT03287310|75760614|FG003|STARTED|Overall Study||9||
59643746|NCT03287310|75760615|FG004|STARTED|Overall Study||9||
59643747|NCT03287310|75760616|FG005|STARTED|Overall Study||6||
59643748|NCT03287310|75760611|FG000|COMPLETED|Overall Study||12||
59643749|NCT03287310|75760612|FG001|COMPLETED|Overall Study||6||
59643750|NCT03287310|75760613|FG002|COMPLETED|Overall Study||6||
59643751|NCT03287310|75760614|FG003|COMPLETED|Overall Study||9||
59643752|NCT03287310|75760615|FG004|COMPLETED|Overall Study||9||
59643753|NCT03287310|75760616|FG005|COMPLETED|Overall Study||6||
59643754|NCT03287310|75760611|FG000|NOT COMPLETED|Overall Study||0||
59643755|NCT03287310|75760612|FG001|NOT COMPLETED|Overall Study||0||
59643756|NCT03287310|75760613|FG002|NOT COMPLETED|Overall Study||0||
59643757|NCT03287310|75760614|FG003|NOT COMPLETED|Overall Study||0||
59643758|NCT03287310|75760615|FG004|NOT COMPLETED|Overall Study||0||
59643759|NCT03287310|75760616|FG005|NOT COMPLETED|Overall Study||0||
59643760|NCT03292614|75760638|FG000|STARTED|Overall Study||25||
59643761|NCT03292614|75760638|FG000|COMPLETED|Overall Study||25||
59643762|NCT03292614|75760638|FG000|NOT COMPLETED|Overall Study||0||
59643763|NCT03292692|75760644|FG000|STARTED|Overall Study||302||
59643764|NCT03292692|75760645|FG001|STARTED|Overall Study||298||
59643765|NCT03292692|75760644|FG000|COMPLETED|Overall Study||264||
59643766|NCT03292692|75760645|FG001|COMPLETED|Overall Study||260||
59643767|NCT03292692|75760644|FG000|NOT COMPLETED|Overall Study||38||
59643768|NCT03292692|75760645|FG001|NOT COMPLETED|Overall Study||38||
59643769|NCT03295266|75760653|FG000|STARTED|Overall Study||5||
59643770|NCT03295266|75760654|FG001|STARTED|Overall Study||4||
59643771|NCT03295266|75760653|FG000|COMPLETED|Overall Study||5||
59643772|NCT03295266|75760654|FG001|COMPLETED|Overall Study||4||
59643773|NCT03295266|75760653|FG000|NOT COMPLETED|Overall Study||0||
59643774|NCT03295266|75760654|FG001|NOT COMPLETED|Overall Study||0||
59643775|NCT03296280|75760662|FG000|STARTED|Overall Study||73||
59643776|NCT03296280|75760663|FG001|STARTED|Overall Study||43||
59643777|NCT03296280|75760662|FG000|COMPLETED|Overall Study||67||
59643778|NCT03296280|75760663|FG001|COMPLETED|Overall Study||36||
59643779|NCT03296280|75760662|FG000|NOT COMPLETED|Overall Study||6||
59643780|NCT03296280|75760663|FG001|NOT COMPLETED|Overall Study||7||
59643781|NCT03301272|75760671|FG000|STARTED|First Intervention (30 Days)||7||
59643782|NCT03301272|75760672|FG001|STARTED|First Intervention (30 Days)||9||
59643783|NCT03301272|75760671|FG000|COMPLETED|First Intervention (30 Days)||7||
59643784|NCT03301272|75760672|FG001|COMPLETED|First Intervention (30 Days)||9||
59643785|NCT03301272|75760671|FG000|NOT COMPLETED|First Intervention (30 Days)||0||
59643786|NCT03301272|75760672|FG001|NOT COMPLETED|First Intervention (30 Days)||0||
59643787|NCT03301272|75760671|FG000|STARTED|Washout (90 Days From 1st Intervention)||7||
59643788|NCT03301272|75760672|FG001|STARTED|Washout (90 Days From 1st Intervention)||9||
59643789|NCT03301272|75760671|FG000|COMPLETED|Washout (90 Days From 1st Intervention)||7||
59643790|NCT03301272|75760672|FG001|COMPLETED|Washout (90 Days From 1st Intervention)||9||
59643791|NCT03301272|75760671|FG000|NOT COMPLETED|Washout (90 Days From 1st Intervention)||0||
59643792|NCT03301272|75760672|FG001|NOT COMPLETED|Washout (90 Days From 1st Intervention)||0||
59643793|NCT03301272|75760671|FG000|STARTED|Second Intervention (30 Days)||7||
59643794|NCT03301272|75760672|FG001|STARTED|Second Intervention (30 Days)||9||
59643795|NCT03301272|75760671|FG000|COMPLETED|Second Intervention (30 Days)||7||
59643796|NCT03301272|75760672|FG001|COMPLETED|Second Intervention (30 Days)||9||
59643797|NCT03301272|75760671|FG000|NOT COMPLETED|Second Intervention (30 Days)||0||
59643798|NCT03301272|75760672|FG001|NOT COMPLETED|Second Intervention (30 Days)||0||
59643799|NCT03303144|75760678|FG000|STARTED|Triferic Via Hemodialysate (Day 3)||26||
59643800|NCT03303144|75760679|FG001|STARTED|Triferic Via Hemodialysate (Day 3)||0||
59643801|NCT03303144|75760680|FG002|STARTED|Triferic Via Hemodialysate (Day 3)||0||
59643802|NCT03303144|75760678|FG000|COMPLETED|Triferic Via Hemodialysate (Day 3)||26||
59643803|NCT03303144|75760679|FG001|COMPLETED|Triferic Via Hemodialysate (Day 3)||0||
59643804|NCT03303144|75760680|FG002|COMPLETED|Triferic Via Hemodialysate (Day 3)||0||
59643805|NCT03303144|75760678|FG000|NOT COMPLETED|Triferic Via Hemodialysate (Day 3)||0||
59643806|NCT03303144|75760679|FG001|NOT COMPLETED|Triferic Via Hemodialysate (Day 3)||0||
59643807|NCT03303144|75760680|FG002|NOT COMPLETED|Triferic Via Hemodialysate (Day 3)||0||
59643808|NCT03303144|75760678|FG000|STARTED|Triferic Via IV Infusion (Day 8)||0||
59643809|NCT03303144|75760679|FG001|STARTED|Triferic Via IV Infusion (Day 8)||26||
59643810|NCT03303144|75760680|FG002|STARTED|Triferic Via IV Infusion (Day 8)||0||
59643811|NCT03303144|75760678|FG000|COMPLETED|Triferic Via IV Infusion (Day 8)||0||
59643812|NCT03303144|75760679|FG001|COMPLETED|Triferic Via IV Infusion (Day 8)||25||
59643813|NCT03303144|75760680|FG002|COMPLETED|Triferic Via IV Infusion (Day 8)||0||
59643814|NCT03303144|75760678|FG000|NOT COMPLETED|Triferic Via IV Infusion (Day 8)||0||
59643815|NCT03303144|75760679|FG001|NOT COMPLETED|Triferic Via IV Infusion (Day 8)||1||
59643816|NCT03303144|75760680|FG002|NOT COMPLETED|Triferic Via IV Infusion (Day 8)||0||
59643817|NCT03303144|75760678|FG000|STARTED|Triferic Via IV Infusion (Day 10)||0||
59643818|NCT03303144|75760679|FG001|STARTED|Triferic Via IV Infusion (Day 10)||0||
59643819|NCT03303144|75760680|FG002|STARTED|Triferic Via IV Infusion (Day 10)||26||
59643820|NCT03303144|75760678|FG000|COMPLETED|Triferic Via IV Infusion (Day 10)||0||
59643821|NCT03303144|75760679|FG001|COMPLETED|Triferic Via IV Infusion (Day 10)||0||
59643822|NCT03303144|75760680|FG002|COMPLETED|Triferic Via IV Infusion (Day 10)||25||
60076722|NCT01889251|76191726|FG001|NOT COMPLETED|Overall Study||0||
60076723|NCT01616563|76191732|FG000|STARTED|Overall Study||293||
60076724|NCT01616563|76191732|FG000|COMPLETED|Overall Study||253||
60076725|NCT01616563|76191732|FG000|NOT COMPLETED|Overall Study||40||
60076726|NCT01616173|76191740|FG000|STARTED|Overall Study||27||
60076727|NCT01616173|76191741|FG001|STARTED|Overall Study||26||
59643823|NCT03303144|75760678|FG000|NOT COMPLETED|Triferic Via IV Infusion (Day 10)||0||
59643824|NCT03303144|75760679|FG001|NOT COMPLETED|Triferic Via IV Infusion (Day 10)||0||
59643825|NCT03303144|75760680|FG002|NOT COMPLETED|Triferic Via IV Infusion (Day 10)||1||
59643826|NCT03306420|75760696|FG000|STARTED|Overall Study||3||
59643827|NCT03306420|75760697|FG001|STARTED|Overall Study||3||
59643828|NCT03306420|75760698|FG002|STARTED|Overall Study||3||
59643829|NCT03306420|75760699|FG003|STARTED|Overall Study||3||
59643830|NCT03306420|75760700|FG004|STARTED|Overall Study||3||
59643831|NCT03306420|75760696|FG000|COMPLETED|Overall Study||3||
60076728|NCT01616173|76191742|FG002|STARTED|Overall Study||27||
60076729|NCT01616173|76191740|FG000|COMPLETED|Overall Study||27||
60076730|NCT01616173|76191741|FG001|COMPLETED|Overall Study||24||
60076731|NCT01616173|76191742|FG002|COMPLETED|Overall Study||27||
60076732|NCT01616173|76191740|FG000|NOT COMPLETED|Overall Study||0||
59643832|NCT03306420|75760697|FG001|COMPLETED|Overall Study||3||
59643833|NCT03306420|75760698|FG002|COMPLETED|Overall Study||3||
59643834|NCT03306420|75760699|FG003|COMPLETED|Overall Study||3||
59643835|NCT03306420|75760700|FG004|COMPLETED|Overall Study||3||
59643836|NCT03306420|75760696|FG000|NOT COMPLETED|Overall Study||0||
59643837|NCT03306420|75760697|FG001|NOT COMPLETED|Overall Study||0||
59643838|NCT03306420|75760698|FG002|NOT COMPLETED|Overall Study||0||
59643839|NCT03306420|75760699|FG003|NOT COMPLETED|Overall Study||0||
59643840|NCT03306420|75760700|FG004|NOT COMPLETED|Overall Study||0||
59643841|NCT03312348|75760712|FG000|STARTED|Overall Study||30||
59643842|NCT03312348|75760712|FG000|COMPLETED|Overall Study||30||
59643843|NCT03312348|75760712|FG000|NOT COMPLETED|Overall Study||0||
59643844|NCT03315702|75760716|FG000|STARTED|Overall Study||52||
59643845|NCT03315702|75760716|FG000|COMPLETED|Overall Study||52||
59643846|NCT03315702|75760716|FG000|NOT COMPLETED|Overall Study||0||
59643847|NCT03315780|75760721|FG000|STARTED|Period 1||6||
59643848|NCT03315780|75760722|FG001|STARTED|Period 1||6||
59643849|NCT03315780|75760721|FG000|Received One Dose of Study Drug|Period 1||6||
59643850|NCT03315780|75760722|FG001|Received One Dose of Study Drug|Period 1||6||
59643851|NCT03315780|75760721|FG000|COMPLETED|Period 1||6||
59643852|NCT03315780|75760722|FG001|COMPLETED|Period 1||6||
59643853|NCT03315780|75760721|FG000|NOT COMPLETED|Period 1||0||
59643854|NCT03315780|75760722|FG001|NOT COMPLETED|Period 1||0||
59643855|NCT03315780|75760721|FG000|STARTED|Period 2||6||
59643856|NCT03315780|75760722|FG001|STARTED|Period 2||6||
59643857|NCT03315780|75760721|FG000|COMPLETED|Period 2||6||
59643858|NCT03315780|75760722|FG001|COMPLETED|Period 2||6||
59643859|NCT03315780|75760721|FG000|NOT COMPLETED|Period 2||0||
59643860|NCT03315780|75760722|FG001|NOT COMPLETED|Period 2||0||
59643861|NCT03319134|75760731|FG000|STARTED|Overall Study||15||
59643862|NCT03319134|75760732|FG001|STARTED|Overall Study||15||
59643863|NCT03319134|75760733|FG002|STARTED|Overall Study||15||
59643864|NCT03319134|75760731|FG000|COMPLETED|Overall Study||15||
59643865|NCT03319134|75760732|FG001|COMPLETED|Overall Study||15||
59643866|NCT03319134|75760733|FG002|COMPLETED|Overall Study||15||
59643867|NCT03319134|75760731|FG000|NOT COMPLETED|Overall Study||0||
59643868|NCT03319134|75760732|FG001|NOT COMPLETED|Overall Study||0||
59643869|NCT03319134|75760733|FG002|NOT COMPLETED|Overall Study||0||
59643870|NCT03329352|75760741|FG000|STARTED|F&P Toffee Full Face Mask Validation||44||
59643871|NCT03329352|75760741|FG000|COMPLETED|F&P Toffee Full Face Mask Validation||42||
59643872|NCT03329352|75760741|FG000|NOT COMPLETED|F&P Toffee Full Face Mask Validation||2||
59643873|NCT03329352|75760741|FG000|STARTED|Extension||29||
59643874|NCT03329352|75760741|FG000|COMPLETED|Extension||22||
59643875|NCT03329352|75760741|FG000|NOT COMPLETED|Extension||7||
59643876|NCT03330834|75760747|FG000|STARTED|Overall Study||1||
59643877|NCT03330834|75760747|FG000|COMPLETED|Overall Study||1||
59643878|NCT03330834|75760747|FG000|NOT COMPLETED|Overall Study||0||
59643879|NCT03334734|75760755|FG000|STARTED|Overall Study||4||
59643880|NCT03334734|75760756|FG001|STARTED|Overall Study||4||
59643881|NCT03334734|75760757|FG002|STARTED|Overall Study||7||
59643882|NCT03334734|75760758|FG003|STARTED|Overall Study||1||
59643883|NCT03334734|75760755|FG000|COMPLETED|Overall Study||4||
59643884|NCT03334734|75760756|FG001|COMPLETED|Overall Study||4||
59643885|NCT03334734|75760757|FG002|COMPLETED|Overall Study||5||
59643886|NCT03334734|75760758|FG003|COMPLETED|Overall Study||1||
59643887|NCT03334734|75760755|FG000|NOT COMPLETED|Overall Study||0||
59643888|NCT03334734|75760756|FG001|NOT COMPLETED|Overall Study||0||
59643889|NCT03334734|75760757|FG002|NOT COMPLETED|Overall Study||2||
59643890|NCT03334734|75760758|FG003|NOT COMPLETED|Overall Study||0||
59643891|NCT03334812|75760770|FG000|STARTED|Overall Study||9||
59643892|NCT03334812|75760771|FG001|STARTED|Overall Study||5||
60076733|NCT01616173|76191741|FG001|NOT COMPLETED|Overall Study||2||
60076734|NCT01616173|76191742|FG002|NOT COMPLETED|Overall Study||0||
59643893|NCT03334812|75760772|FG002|STARTED|Overall Study||0||
59643894|NCT03334812|75760773|FG003|STARTED|Overall Study||0||
59643895|NCT03334812|75760770|FG000|COMPLETED|Overall Study||9||
59643896|NCT03334812|75760771|FG001|COMPLETED|Overall Study||5||
59643897|NCT03334812|75760772|FG002|COMPLETED|Overall Study||0||
59643898|NCT03334812|75760773|FG003|COMPLETED|Overall Study||0||
60076735|NCT01544595|76191756|FG000|STARTED|Status at Week 68||301||
59643899|NCT03334812|75760770|FG000|NOT COMPLETED|Overall Study||0||
59643900|NCT03334812|75760771|FG001|NOT COMPLETED|Overall Study||0||
59815760|NCT03026283|75938218|FG007|COMPLETED|CCTA Diagnosis||0||
60076736|NCT01544595|76191757|FG001|STARTED|Status at Week 68||363||
59643901|NCT03334812|75760772|FG002|NOT COMPLETED|Overall Study||0||
59643902|NCT03334812|75760773|FG003|NOT COMPLETED|Overall Study||0||
59643903|NCT03336450|75760779|FG000|STARTED|Overall Study||3||
59643904|NCT03336450|75760779|FG000|COMPLETED|Overall Study||3||
59643905|NCT03336450|75760779|FG000|NOT COMPLETED|Overall Study||0||
59643906|NCT03338556|75760787|FG000|STARTED|Overall Study||25||
60076737|NCT01544595|76191758|FG002|STARTED|Status at Week 68||150||
59643907|NCT03338556|75760788|FG001|STARTED|Overall Study||27||
59643908|NCT03338556|75760789|FG002|STARTED|Overall Study||24||
59643909|NCT03338556|75760790|FG003|STARTED|Overall Study||26||
59643910|NCT03338556|75760787|FG000|COMPLETED|Overall Study||23||
60076738|NCT01544595|76191759|FG003|STARTED|Status at Week 68||181||
59643911|NCT03338556|75760788|FG001|COMPLETED|Overall Study||23||
59643912|NCT03338556|75760789|FG002|COMPLETED|Overall Study||22||
59643913|NCT03338556|75760790|FG003|COMPLETED|Overall Study||24||
59643914|NCT03338556|75760787|FG000|NOT COMPLETED|Overall Study||2||
59643915|NCT03338556|75760788|FG001|NOT COMPLETED|Overall Study||4||
59643916|NCT03338556|75760789|FG002|NOT COMPLETED|Overall Study||2||
59643917|NCT03338556|75760790|FG003|NOT COMPLETED|Overall Study||2||
59643918|NCT03256968|75760800|FG000|STARTED|Overall Study||1||
59643919|NCT03256968|75760800|FG000|COMPLETED|Overall Study||1||
59643920|NCT03256968|75760800|FG000|NOT COMPLETED|Overall Study||0||
59643921|NCT03339570|75760804|FG000|STARTED|Overall Study||20||
59643922|NCT03339570|75760804|FG000|COMPLETED|Overall Study||16||
59643923|NCT03339570|75760804|FG000|NOT COMPLETED|Overall Study||4||
59643924|NCT03340350|75760817|FG000|STARTED|Overall Study||10||
59643925|NCT03340350|75760817|FG000|COMPLETED|Overall Study||4||
59643926|NCT03340350|75760817|FG000|NOT COMPLETED|Overall Study||6||
59643927|NCT03340428|75760824|FG000|STARTED|Overall Study||117||
59643928|NCT03340428|75760825|FG001|STARTED|Overall Study||59||
59643929|NCT03340428|75760824|FG000|COMPLETED|Overall Study||116||
59643930|NCT03340428|75760825|FG001|COMPLETED|Overall Study||59||
59643931|NCT03340428|75760824|FG000|NOT COMPLETED|Overall Study||1||
59643932|NCT03340428|75760825|FG001|NOT COMPLETED|Overall Study||0||
60076739|NCT01544595|76191760|FG004|STARTED|Status at Week 68|These patients were not in the study arms at this time point.|0||
60076740|NCT01544595|76191761|FG005|STARTED|Status at Week 68|These patients were not in the study arms at this time point.|0||
60076741|NCT01544595|76191756|FG000|COMPLETED|Status at Week 68||262|Week 68|
59542382|NCT01574105|75640738|FG000|NOT COMPLETED|Overall Study||0||
59542383|NCT01574105|75640739|FG001|NOT COMPLETED|Overall Study||0||
59542384|NCT01574183|75640747|FG000|STARTED|Overall Study||41||
59542385|NCT01574183|75640748|FG001|STARTED|Overall Study||35||
59542386|NCT01574183|75640747|FG000|COMPLETED|Overall Study||14||
59542387|NCT01574183|75640748|FG001|COMPLETED|Overall Study||17||
59542388|NCT01574183|75640747|FG000|NOT COMPLETED|Overall Study||27||
59542389|NCT01574183|75640748|FG001|NOT COMPLETED|Overall Study||18||
59542390|NCT01574807|75640756|FG000|STARTED|First Appointment||50||
59542391|NCT01574807|75640757|FG001|STARTED|First Appointment||50||
59542392|NCT01574807|75640756|FG000|COMPLETED|First Appointment||50||
59542393|NCT01574807|75640757|FG001|COMPLETED|First Appointment||50||
59542394|NCT01574807|75640756|FG000|NOT COMPLETED|First Appointment||0||
59542395|NCT01574807|75640757|FG001|NOT COMPLETED|First Appointment||0||
59542396|NCT01574807|75640756|FG000|STARTED|Wash Out Period 2 Weeks||50||
59542397|NCT01574807|75640757|FG001|STARTED|Wash Out Period 2 Weeks||50||
59542398|NCT01574807|75640756|FG000|COMPLETED|Wash Out Period 2 Weeks||50||
59542399|NCT01574807|75640757|FG001|COMPLETED|Wash Out Period 2 Weeks||50||
59542400|NCT01574807|75640756|FG000|NOT COMPLETED|Wash Out Period 2 Weeks||0||
59542401|NCT01574807|75640757|FG001|NOT COMPLETED|Wash Out Period 2 Weeks||0||
59542402|NCT01574807|75640756|FG000|STARTED|Second Appointment||50||
59542403|NCT01574807|75640757|FG001|STARTED|Second Appointment||50||
59542404|NCT01574807|75640756|FG000|COMPLETED|Second Appointment||50||
59542405|NCT01574807|75640757|FG001|COMPLETED|Second Appointment||50||
59542406|NCT01574807|75640756|FG000|NOT COMPLETED|Second Appointment||0||
59542407|NCT01574807|75640757|FG001|NOT COMPLETED|Second Appointment||0||
59542408|NCT01575275|75640762|FG000|STARTED|Overall Study||8||
59542409|NCT01575275|75640762|FG000|COMPLETED|Overall Study||8||
59542410|NCT01575275|75640762|FG000|NOT COMPLETED|Overall Study||0||
59542411|NCT01576055|75640768|FG000|STARTED|Overall Study||197||
59542412|NCT01576055|75640769|FG001|STARTED|Overall Study||70||
59542413|NCT01576055|75640768|FG000|COMPLETED|Overall Study||178||
59542414|NCT01576055|75640769|FG001|COMPLETED|Overall Study||64||
59542415|NCT01576055|75640768|FG000|NOT COMPLETED|Overall Study||19||
59542416|NCT01576055|75640769|FG001|NOT COMPLETED|Overall Study||6||
59542417|NCT01576523|75640781|FG000|STARTED|Dosing Period 1||3||
59542418|NCT01576523|75640782|FG001|STARTED|Dosing Period 1||3||
59542419|NCT01576523|75640783|FG002|STARTED|Dosing Period 1||3||
59542420|NCT01576523|75640784|FG003|STARTED|Dosing Period 1||3||
59542421|NCT01576523|75640785|FG004|STARTED|Dosing Period 1||3||
59542422|NCT01576523|75640786|FG005|STARTED|Dosing Period 1||3||
59542423|NCT01576523|75640781|FG000|COMPLETED|Dosing Period 1||3||
59542424|NCT01576523|75640782|FG001|COMPLETED|Dosing Period 1||3||
59542425|NCT01576523|75640783|FG002|COMPLETED|Dosing Period 1||3||
59643933|NCT03341910|75760835|FG000|STARTED|Overall Study||54||
60076742|NCT01544595|76191757|FG001|COMPLETED|Status at Week 68||346|Week 68|
59542426|NCT01576523|75640784|FG003|COMPLETED|Dosing Period 1||3||
59542427|NCT01576523|75640785|FG004|COMPLETED|Dosing Period 1||3||
59643934|NCT03341910|75760836|FG001|STARTED|Overall Study||49||
59643935|NCT03341910|75760837|FG002|STARTED|Overall Study||26||
59643936|NCT03341910|75760838|FG003|STARTED|Overall Study||26||
59643937|NCT03341910|75760835|FG000|COMPLETED|Overall Study||54||
59643938|NCT03341910|75760836|FG001|COMPLETED|Overall Study||49||
59643939|NCT03341910|75760837|FG002|COMPLETED|Overall Study||26||
59643940|NCT03341910|75760838|FG003|COMPLETED|Overall Study||26||
59643941|NCT03341910|75760835|FG000|NOT COMPLETED|Overall Study||0||
59643942|NCT03341910|75760836|FG001|NOT COMPLETED|Overall Study||0||
59643943|NCT03341910|75760837|FG002|NOT COMPLETED|Overall Study||0||
59643944|NCT03341910|75760838|FG003|NOT COMPLETED|Overall Study||0||
59643945|NCT03343080|75760850|FG000|STARTED|Overall Study||14||
59643946|NCT03343080|75760851|FG001|STARTED|Overall Study||18||
59643947|NCT03343080|75760850|FG000|COMPLETED|Overall Study||14||
59643948|NCT03343080|75760851|FG001|COMPLETED|Overall Study||18||
59643949|NCT03343080|75760850|FG000|NOT COMPLETED|Overall Study||0||
59643950|NCT03343080|75760851|FG001|NOT COMPLETED|Overall Study||0||
59643951|NCT03345108|75760857|FG000|STARTED|Period-1||8||
59643952|NCT03345108|75760858|FG001|STARTED|Period-1||8||
59643953|NCT03345108|75760859|FG002|STARTED|Period-1||8||
59643954|NCT03345108|75760860|FG003|STARTED|Period-1||8||
59643955|NCT03345108|75760861|FG004|STARTED|Period-1||8||
59643956|NCT03345108|75760862|FG005|STARTED|Period-1||8||
59643957|NCT03345108|75760857|FG000|COMPLETED|Period-1||8||
59643958|NCT03345108|75760858|FG001|COMPLETED|Period-1||8||
59643959|NCT03345108|75760859|FG002|COMPLETED|Period-1||8||
59643960|NCT03345108|75760860|FG003|COMPLETED|Period-1||8||
59643961|NCT03345108|75760861|FG004|COMPLETED|Period-1||8||
59643962|NCT03345108|75760862|FG005|COMPLETED|Period-1||8||
59643963|NCT03345108|75760857|FG000|NOT COMPLETED|Period-1||0||
59643964|NCT03345108|75760858|FG001|NOT COMPLETED|Period-1||0||
59643965|NCT03345108|75760859|FG002|NOT COMPLETED|Period-1||0||
59643966|NCT03345108|75760860|FG003|NOT COMPLETED|Period-1||0||
59643967|NCT03345108|75760861|FG004|NOT COMPLETED|Period-1||0||
59643968|NCT03345108|75760862|FG005|NOT COMPLETED|Period-1||0||
59643969|NCT03345108|75760857|FG000|STARTED|Period-2||8||
59643970|NCT03345108|75760858|FG001|STARTED|Period-2||8||
59643971|NCT03345108|75760859|FG002|STARTED|Period-2||8||
59643972|NCT03345108|75760860|FG003|STARTED|Period-2||8||
59643973|NCT03345108|75760861|FG004|STARTED|Period-2||8||
59643974|NCT03345108|75760862|FG005|STARTED|Period-2||8||
59643975|NCT03345108|75760857|FG000|COMPLETED|Period-2||8||
59643976|NCT03345108|75760858|FG001|COMPLETED|Period-2||8||
59643977|NCT03345108|75760859|FG002|COMPLETED|Period-2||8||
59643978|NCT03345108|75760860|FG003|COMPLETED|Period-2||8||
59643979|NCT03345108|75760861|FG004|COMPLETED|Period-2||8||
59643980|NCT03345108|75760862|FG005|COMPLETED|Period-2||8||
59643981|NCT03345108|75760857|FG000|NOT COMPLETED|Period-2||0||
59643982|NCT03345108|75760858|FG001|NOT COMPLETED|Period-2||0||
59643983|NCT03345108|75760859|FG002|NOT COMPLETED|Period-2||0||
59643984|NCT03345108|75760860|FG003|NOT COMPLETED|Period-2||0||
59643985|NCT03345108|75760861|FG004|NOT COMPLETED|Period-2||0||
59643986|NCT03345108|75760862|FG005|NOT COMPLETED|Period-2||0||
59643987|NCT03345108|75760857|FG000|STARTED|Period-3||7||
59643988|NCT03345108|75760858|FG001|STARTED|Period-3||8||
59643989|NCT03345108|75760859|FG002|STARTED|Period-3||8||
59643990|NCT03345108|75760860|FG003|STARTED|Period-3||8||
59643991|NCT03345108|75760861|FG004|STARTED|Period-3||8||
59643992|NCT03345108|75760862|FG005|STARTED|Period-3||8||
59643993|NCT03345108|75760857|FG000|COMPLETED|Period-3||7||
59643994|NCT03345108|75760858|FG001|COMPLETED|Period-3||8||
59643995|NCT03345108|75760859|FG002|COMPLETED|Period-3||8||
59643996|NCT03345108|75760860|FG003|COMPLETED|Period-3||8||
59643997|NCT03345108|75760861|FG004|COMPLETED|Period-3||8||
60076743|NCT01544595|76191758|FG002|COMPLETED|Status at Week 68||87|Week 68|
59643998|NCT03345108|75760862|FG005|COMPLETED|Period-3||8||
59643999|NCT03345108|75760857|FG000|NOT COMPLETED|Period-3||0||
59644000|NCT03345108|75760858|FG001|NOT COMPLETED|Period-3||0||
59644001|NCT03345108|75760859|FG002|NOT COMPLETED|Period-3||0||
59644002|NCT03345108|75760860|FG003|NOT COMPLETED|Period-3||0||
59644003|NCT03345108|75760861|FG004|NOT COMPLETED|Period-3||0||
59644004|NCT03345108|75760862|FG005|NOT COMPLETED|Period-3||0||
59644005|NCT03346902|75760872|FG000|STARTED|Overall Study||4||
59644006|NCT03346902|75760873|FG001|STARTED|Overall Study||8||
59644007|NCT03346902|75760872|FG000|COMPLETED|Overall Study||4||
59644008|NCT03346902|75760873|FG001|COMPLETED|Overall Study||8||
59644009|NCT03346902|75760872|FG000|NOT COMPLETED|Overall Study||0||
59644010|NCT03346902|75760873|FG001|NOT COMPLETED|Overall Study||0||
59644011|NCT03349632|75760879|FG000|STARTED|Period 1, First Week of Wear||11||
59644012|NCT03349632|75760880|FG001|STARTED|Period 1, First Week of Wear||11||
59644013|NCT03349632|75760881|FG002|STARTED|Period 1, First Week of Wear||11||
59644014|NCT03349632|75760882|FG003|STARTED|Period 1, First Week of Wear||11||
59644015|NCT03349632|75760883|FG004|STARTED|Period 1, First Week of Wear||11||
59644016|NCT03349632|75760884|FG005|STARTED|Period 1, First Week of Wear||11||
59644017|NCT03349632|75760879|FG000|COMPLETED|Period 1, First Week of Wear||11||
59644018|NCT03349632|75760880|FG001|COMPLETED|Period 1, First Week of Wear||11||
59644019|NCT03349632|75760881|FG002|COMPLETED|Period 1, First Week of Wear||11||
59644020|NCT03349632|75760882|FG003|COMPLETED|Period 1, First Week of Wear||11||
59644021|NCT03349632|75760883|FG004|COMPLETED|Period 1, First Week of Wear||11||
59644022|NCT03349632|75760884|FG005|COMPLETED|Period 1, First Week of Wear||11||
59644023|NCT03349632|75760879|FG000|NOT COMPLETED|Period 1, First Week of Wear||0||
59644024|NCT03349632|75760880|FG001|NOT COMPLETED|Period 1, First Week of Wear||0||
59644025|NCT03349632|75760881|FG002|NOT COMPLETED|Period 1, First Week of Wear||0||
59644026|NCT03349632|75760882|FG003|NOT COMPLETED|Period 1, First Week of Wear||0||
59644027|NCT03349632|75760883|FG004|NOT COMPLETED|Period 1, First Week of Wear||0||
59644028|NCT03349632|75760884|FG005|NOT COMPLETED|Period 1, First Week of Wear||0||
59644029|NCT03349632|75760879|FG000|STARTED|Period 2, Second Week of Wear||11||
59644030|NCT03349632|75760880|FG001|STARTED|Period 2, Second Week of Wear||11||
59644031|NCT03349632|75760881|FG002|STARTED|Period 2, Second Week of Wear||11||
59644032|NCT03349632|75760882|FG003|STARTED|Period 2, Second Week of Wear||11||
59644033|NCT03349632|75760883|FG004|STARTED|Period 2, Second Week of Wear||11||
59644034|NCT03349632|75760884|FG005|STARTED|Period 2, Second Week of Wear||11||
59644035|NCT03349632|75760879|FG000|COMPLETED|Period 2, Second Week of Wear||11||
59644036|NCT03349632|75760880|FG001|COMPLETED|Period 2, Second Week of Wear||11||
59644037|NCT03349632|75760881|FG002|COMPLETED|Period 2, Second Week of Wear||11||
59644038|NCT03349632|75760882|FG003|COMPLETED|Period 2, Second Week of Wear||11||
59644039|NCT03349632|75760883|FG004|COMPLETED|Period 2, Second Week of Wear||11||
59644040|NCT03349632|75760884|FG005|COMPLETED|Period 2, Second Week of Wear||11||
59644041|NCT03349632|75760879|FG000|NOT COMPLETED|Period 2, Second Week of Wear||0||
59644042|NCT03349632|75760880|FG001|NOT COMPLETED|Period 2, Second Week of Wear||0||
59644043|NCT03349632|75760881|FG002|NOT COMPLETED|Period 2, Second Week of Wear||0||
59644044|NCT03349632|75760882|FG003|NOT COMPLETED|Period 2, Second Week of Wear||0||
59644045|NCT03349632|75760883|FG004|NOT COMPLETED|Period 2, Second Week of Wear||0||
59644046|NCT03349632|75760884|FG005|NOT COMPLETED|Period 2, Second Week of Wear||0||
59644047|NCT03350724|75760900|FG000|STARTED|Overall Study||17||
59644048|NCT03350724|75760901|FG001|STARTED|Overall Study||17||
59644049|NCT03350724|75760900|FG000|COMPLETED|Overall Study||17||
59644050|NCT03350724|75760901|FG001|COMPLETED|Overall Study||17||
59644051|NCT03350724|75760900|FG000|NOT COMPLETED|Overall Study||0||
59644052|NCT03350724|75760901|FG001|NOT COMPLETED|Overall Study||0||
59644053|NCT03365154|75760907|FG000|STARTED|Overall Study||10||
59644054|NCT03365154|75760907|FG000|COMPLETED|Overall Study||10||
59644055|NCT03365154|75760907|FG000|NOT COMPLETED|Overall Study||0||
59644056|NCT03365778|75760914|FG000|STARTED|Overall Study||16||
59644057|NCT03365778|75760915|FG001|STARTED|Overall Study||17||
59644058|NCT03365778|75760916|FG002|STARTED|Overall Study||53||
59644059|NCT03365778|75760914|FG000|COMPLETED|Overall Study||16||
59644060|NCT03365778|75760915|FG001|COMPLETED|Overall Study||17||
59644061|NCT03365778|75760916|FG002|COMPLETED|Overall Study||53||
59644062|NCT03365778|75760914|FG000|NOT COMPLETED|Overall Study||0||
59644063|NCT03365778|75760915|FG001|NOT COMPLETED|Overall Study||0||
59644064|NCT03365778|75760916|FG002|NOT COMPLETED|Overall Study||0||
59644065|NCT03368898|75760927|FG000|STARTED|Overall Study||37||
59644066|NCT03368898|75760928|FG001|STARTED|Overall Study||33||
59644067|NCT03368898|75760929|FG002|STARTED|Overall Study||34||
59644068|NCT03368898|75760927|FG000|COMPLETED|Overall Study||37||
59644069|NCT03368898|75760928|FG001|COMPLETED|Overall Study||33||
59644070|NCT03368898|75760929|FG002|COMPLETED|Overall Study||34||
59644071|NCT03368898|75760927|FG000|NOT COMPLETED|Overall Study||0||
59644072|NCT03368898|75760928|FG001|NOT COMPLETED|Overall Study||0||
59644073|NCT03368898|75760929|FG002|NOT COMPLETED|Overall Study||0||
59644074|NCT03369756|75760937|FG000|STARTED|Overall Study||43||
59644075|NCT03369756|75760937|FG000|COMPLETED|Overall Study|36 completed 4 weeks of treatment; 40 were considered statistical completers|36||
59644076|NCT03369756|75760937|FG000|NOT COMPLETED|Overall Study||7||
59644077|NCT03373890|75760943|FG000|STARTED|Overall Study||6||
59644078|NCT03373890|75760944|FG001|STARTED|Overall Study||6||
59644079|NCT03373890|75760943|FG000|COMPLETED|Overall Study||6||
59644080|NCT03373890|75760944|FG001|COMPLETED|Overall Study||6||
59644081|NCT03373890|75760943|FG000|NOT COMPLETED|Overall Study||0||
59644082|NCT03373890|75760944|FG001|NOT COMPLETED|Overall Study||0||
59644083|NCT03375294|75760952|FG000|STARTED|Overall Study||3||
59644084|NCT03375294|75760952|FG000|COMPLETED|Overall Study||3||
59644085|NCT03375294|75760952|FG000|NOT COMPLETED|Overall Study||0||
59644086|NCT03377244|75760959|FG000|STARTED|Baseline||19||
59644087|NCT03377244|75760960|FG001|STARTED|Baseline||14||
59644088|NCT03377244|75760961|FG002|STARTED|Baseline||69||
59644089|NCT03377244|75760959|FG000|COMPLETED|Baseline||19||
59644090|NCT03377244|75760960|FG001|COMPLETED|Baseline||14||
59644091|NCT03377244|75760961|FG002|COMPLETED|Baseline||69||
59644092|NCT03377244|75760959|FG000|NOT COMPLETED|Baseline||0||
59644093|NCT03377244|75760960|FG001|NOT COMPLETED|Baseline||0||
59644094|NCT03377244|75760961|FG002|NOT COMPLETED|Baseline||0||
59644095|NCT03377244|75760959|FG000|STARTED|6 Months Post-intervention||19||
59644096|NCT03377244|75760960|FG001|STARTED|6 Months Post-intervention||14||
59644097|NCT03377244|75760961|FG002|STARTED|6 Months Post-intervention||69||
59644098|NCT03377244|75760959|FG000|COMPLETED|6 Months Post-intervention||13||
59644099|NCT03377244|75760960|FG001|COMPLETED|6 Months Post-intervention||7||
59644100|NCT03377244|75760961|FG002|COMPLETED|6 Months Post-intervention||55||
59644101|NCT03377244|75760959|FG000|NOT COMPLETED|6 Months Post-intervention||6||
59644102|NCT03377244|75760960|FG001|NOT COMPLETED|6 Months Post-intervention||7||
59644103|NCT03377244|75760961|FG002|NOT COMPLETED|6 Months Post-intervention||14||
59644104|NCT03379662|75760971|FG000|STARTED|Overall Study||21||
59644105|NCT03379662|75760972|FG001|STARTED|Overall Study||19||
59644106|NCT03379662|75760971|FG000|COMPLETED|Overall Study||21||
59644107|NCT03379662|75760972|FG001|COMPLETED|Overall Study||19||
59644108|NCT03379662|75760971|FG000|NOT COMPLETED|Overall Study||0||
59644109|NCT03379662|75760972|FG001|NOT COMPLETED|Overall Study||0||
59644110|NCT03379740|75760980|FG000|STARTED|Overall Study||8||
59644111|NCT03379740|75760981|FG001|STARTED|Overall Study||7||
59644112|NCT03379740|75760980|FG000|COMPLETED|Overall Study||8||
59644113|NCT03379740|75760981|FG001|COMPLETED|Overall Study||7||
59644114|NCT03379740|75760980|FG000|NOT COMPLETED|Overall Study||0||
59644115|NCT03379740|75760981|FG001|NOT COMPLETED|Overall Study||0||
59644116|NCT03390114|75760996|FG000|STARTED|Overall Study||10||
59644117|NCT03390114|75760997|FG001|STARTED|Overall Study||10||
59644118|NCT03390114|75760996|FG000|COMPLETED|Overall Study||6||
59644119|NCT03390114|75760997|FG001|COMPLETED|Overall Study||8||
59644120|NCT03390114|75760996|FG000|NOT COMPLETED|Overall Study||4||
59644121|NCT03390114|75760997|FG001|NOT COMPLETED|Overall Study||2||
59644122|NCT03391986|75761006|FG000|STARTED|Overall Study||53||
59644123|NCT03391986|75761007|FG001|STARTED|Overall Study||50||
59644124|NCT03391986|75761008|FG002|STARTED|Overall Study||50||
59644125|NCT03391986|75761006|FG000|COMPLETED|Overall Study||53||
59644126|NCT03391986|75761007|FG001|COMPLETED|Overall Study||50||
59644127|NCT03391986|75761008|FG002|COMPLETED|Overall Study||50||
59644128|NCT03391986|75761006|FG000|NOT COMPLETED|Overall Study||0||
59644129|NCT03391986|75761007|FG001|NOT COMPLETED|Overall Study||0||
59644130|NCT03391986|75761008|FG002|NOT COMPLETED|Overall Study||0||
59644131|NCT03392532|75761016|FG000|STARTED|Period 1, FIrst 30 Minutes of Wear||18|As randomized|
59644132|NCT03392532|75761017|FG001|STARTED|Period 1, FIrst 30 Minutes of Wear||18|As randomized|
59644133|NCT03392532|75761016|FG000|COMPLETED|Period 1, FIrst 30 Minutes of Wear||18||
59644134|NCT03392532|75761017|FG001|COMPLETED|Period 1, FIrst 30 Minutes of Wear||18||
59644135|NCT03392532|75761016|FG000|NOT COMPLETED|Period 1, FIrst 30 Minutes of Wear||0||
59644136|NCT03392532|75761017|FG001|NOT COMPLETED|Period 1, FIrst 30 Minutes of Wear||0||
59644137|NCT03392532|75761016|FG000|STARTED|Period 2, Second 30 Minutes of Wear||18|As randomized|
59644138|NCT03392532|75761017|FG001|STARTED|Period 2, Second 30 Minutes of Wear||18|As randomized|
59644139|NCT03392532|75761016|FG000|COMPLETED|Period 2, Second 30 Minutes of Wear||18||
59644140|NCT03392532|75761017|FG001|COMPLETED|Period 2, Second 30 Minutes of Wear||18||
59644141|NCT03392532|75761016|FG000|NOT COMPLETED|Period 2, Second 30 Minutes of Wear||0||
59644142|NCT03392532|75761017|FG001|NOT COMPLETED|Period 2, Second 30 Minutes of Wear||0||
59644143|NCT03395808|75761023|FG000|STARTED|Overall Study||251||
59644144|NCT03395808|75761023|FG000|COMPLETED|Overall Study||251||
59644145|NCT03395808|75761023|FG000|NOT COMPLETED|Overall Study||0||
59644146|NCT03395886|75761029|FG000|STARTED|Overall Study||52||
59644147|NCT03395886|75761030|FG001|STARTED|Overall Study||38||
59644148|NCT03395886|75761029|FG000|COMPLETED|Overall Study||0||
59644149|NCT03395886|75761030|FG001|COMPLETED|Overall Study||0||
59644150|NCT03395886|75761029|FG000|NOT COMPLETED|Overall Study||52||
59644151|NCT03395886|75761030|FG001|NOT COMPLETED|Overall Study||38||
59644152|NCT03396432|75761038|FG000|STARTED|Overall Study||283||
59644153|NCT03396432|75761039|FG001|STARTED|Overall Study||283||
59644154|NCT03396432|75761038|FG000|COMPLETED|Overall Study||274||
59644155|NCT03396432|75761039|FG001|COMPLETED|Overall Study||277||
59644156|NCT03396432|75761038|FG000|NOT COMPLETED|Overall Study||9||
59644157|NCT03396432|75761039|FG001|NOT COMPLETED|Overall Study||6||
59644158|NCT03398928|75761049|FG000|STARTED|Overall Study||50||
59644159|NCT03398928|75761050|FG001|STARTED|Overall Study||31||
59644160|NCT03398928|75761049|FG000|COMPLETED|Overall Study||50||
59644161|NCT03398928|75761050|FG001|COMPLETED|Overall Study||31||
59644162|NCT03398928|75761049|FG000|NOT COMPLETED|Overall Study||0||
59644163|NCT03398928|75761050|FG001|NOT COMPLETED|Overall Study||0||
59644164|NCT03400800|75761058|FG000|STARTED|Overall Study||810||
59644165|NCT03400800|75761059|FG001|STARTED|Overall Study||807||
59644166|NCT03400800|75761058|FG000|COMPLETED|Overall Study||772||
59644167|NCT03400800|75761059|FG001|COMPLETED|Overall Study||770||
59644168|NCT03400800|75761058|FG000|NOT COMPLETED|Overall Study||38||
59644169|NCT03400800|75761059|FG001|NOT COMPLETED|Overall Study||37||
59644170|NCT03410628|75761065|FG000|STARTED|Overall Study||21||
59644171|NCT03410628|75761065|FG000|COMPLETED|Overall Study||15||
59644172|NCT03410628|75761065|FG000|NOT COMPLETED|Overall Study||6||
59644173|NCT03410862|75761071|FG000|STARTED|Overall Study||43||
59644174|NCT03410862|75761072|FG001|STARTED|Overall Study||44||
59644175|NCT03410862|75761071|FG000|COMPLETED|Overall Study||41||
59644176|NCT03410862|75761072|FG001|COMPLETED|Overall Study||42||
59644177|NCT03410862|75761071|FG000|NOT COMPLETED|Overall Study||2||
59644178|NCT03410862|75761072|FG001|NOT COMPLETED|Overall Study||2||
59644179|NCT03415152|75761078|FG000|STARTED|Overall Study||3000||
59644180|NCT03415152|75761078|FG000|COMPLETED|Overall Study||1975||
59644181|NCT03415152|75761078|FG000|NOT COMPLETED|Overall Study||1025||
59644182|NCT03416946|75761087|FG000|STARTED|Overall Study||25||
59644183|NCT03416946|75761088|FG001|STARTED|Overall Study||29||
59644184|NCT03416946|75761087|FG000|COMPLETED|Overall Study||25||
59644185|NCT03416946|75761088|FG001|COMPLETED|Overall Study||29||
59644186|NCT03416946|75761087|FG000|NOT COMPLETED|Overall Study||0||
59644187|NCT03416946|75761088|FG001|NOT COMPLETED|Overall Study||0||
59644188|NCT03417804|75761094|FG000|STARTED|Overall Study|at least 360 patients|366||
59644189|NCT03417804|75761094|FG000|COMPLETED|Overall Study||366||
59644190|NCT03417804|75761094|FG000|NOT COMPLETED|Overall Study||0||
59644191|NCT03418662|75761101|FG000|STARTED|Overall Study||287||
59644192|NCT03418662|75761102|FG001|STARTED|Overall Study||282||
59644193|NCT03418662|75761101|FG000|COMPLETED|Overall Study||284||
59644194|NCT03418662|75761102|FG001|COMPLETED|Overall Study||278||
59644195|NCT03418662|75761101|FG000|NOT COMPLETED|Overall Study||3||
59644196|NCT03418662|75761102|FG001|NOT COMPLETED|Overall Study||4||
59644197|NCT03423186|75761110|FG000|STARTED|Overall Study||3||
59542428|NCT01576523|75640786|FG005|COMPLETED|Dosing Period 1||3||
59542429|NCT01576523|75640781|FG000|NOT COMPLETED|Dosing Period 1||0||
59542430|NCT01576523|75640782|FG001|NOT COMPLETED|Dosing Period 1||0||
59542431|NCT01576523|75640783|FG002|NOT COMPLETED|Dosing Period 1||0||
59542432|NCT01576523|75640784|FG003|NOT COMPLETED|Dosing Period 1||0||
59644198|NCT03423186|75761111|FG001|STARTED|Overall Study||3||
59644199|NCT03423186|75761110|FG000|COMPLETED|Overall Study||3||
59644200|NCT03423186|75761111|FG001|COMPLETED|Overall Study||3||
59644201|NCT03423186|75761110|FG000|NOT COMPLETED|Overall Study||0||
59644202|NCT03423186|75761111|FG001|NOT COMPLETED|Overall Study||0||
59644203|NCT03426228|75761119|FG000|STARTED|Overall Study||158||
59644204|NCT03426228|75761120|FG001|STARTED|Overall Study||191||
59644205|NCT03426228|75761119|FG000|COMPLETED|Overall Study||117||
59644206|NCT03426228|75761120|FG001|COMPLETED|Overall Study||158||
59644207|NCT03426228|75761119|FG000|NOT COMPLETED|Overall Study||41||
59644208|NCT03426228|75761120|FG001|NOT COMPLETED|Overall Study||33||
59644209|NCT03429270|75761128|FG000|STARTED|Overall Study||28||
59644210|NCT03429270|75761128|FG000|COMPLETED|Overall Study||28||
59644211|NCT03429270|75761128|FG000|NOT COMPLETED|Overall Study||0||
59644212|NCT03429348|75761134|FG000|STARTED|Overall Study|4 participants had no additional rehab & had no corresponding sauna rehab participant to compare to.|12||
59644213|NCT03429348|75761135|FG001|STARTED|Overall Study||12||
59644214|NCT03429348|75761134|FG000|COMPLETED|Overall Study||12||
59644215|NCT03429348|75761135|FG001|COMPLETED|Overall Study||12||
59644216|NCT03429348|75761134|FG000|NOT COMPLETED|Overall Study||0||
60076744|NCT01544595|76191759|FG003|COMPLETED|Status at Week 68||130|Week 68|
60076745|NCT01544595|76191760|FG004|COMPLETED|Status at Week 68|These patients were not in the study arms at this time point.|0|Week 68|
60076746|NCT01544595|76191761|FG005|COMPLETED|Status at Week 68|These patients were not in the study arms at this time point.|0|Week 68|
60076747|NCT01544595|76191756|FG000|NOT COMPLETED|Status at Week 68||39||
60076748|NCT01544595|76191757|FG001|NOT COMPLETED|Status at Week 68||17||
60076749|NCT01544595|76191758|FG002|NOT COMPLETED|Status at Week 68||63||
60076750|NCT01544595|76191759|FG003|NOT COMPLETED|Status at Week 68||51||
60076751|NCT01544595|76191760|FG004|NOT COMPLETED|Status at Week 68||0||
60076752|NCT01544595|76191761|FG005|NOT COMPLETED|Status at Week 68||0||
60076753|NCT01544595|76191756|FG000|STARTED|Status at Week 156||301||
60076754|NCT01544595|76191757|FG001|STARTED|Status at Week 156||363||
60076755|NCT01544595|76191758|FG002|STARTED|Status at Week 156||150||
60076756|NCT01544595|76191759|FG003|STARTED|Status at Week 156||181||
60076757|NCT01544595|76191760|FG004|STARTED|Status at Week 156||98||
59542433|NCT01576523|75640785|FG004|NOT COMPLETED|Dosing Period 1||0||
59542434|NCT01576523|75640786|FG005|NOT COMPLETED|Dosing Period 1||0||
59542435|NCT01576523|75640781|FG000|STARTED|Dosing Period 2||3||
59542436|NCT01576523|75640782|FG001|STARTED|Dosing Period 2||3||
59542437|NCT01576523|75640783|FG002|STARTED|Dosing Period 2||3||
59542438|NCT01576523|75640784|FG003|STARTED|Dosing Period 2||3||
59542439|NCT01576523|75640785|FG004|STARTED|Dosing Period 2||3||
59542440|NCT01576523|75640786|FG005|STARTED|Dosing Period 2||3||
59542441|NCT01576523|75640781|FG000|COMPLETED|Dosing Period 2||3||
59542442|NCT01576523|75640782|FG001|COMPLETED|Dosing Period 2||3||
59542443|NCT01576523|75640783|FG002|COMPLETED|Dosing Period 2||3||
59644217|NCT03429348|75761135|FG001|NOT COMPLETED|Overall Study||0||
60076758|NCT01544595|76191761|FG005|STARTED|Status at Week 156||53||
60076759|NCT01544595|76191756|FG000|COMPLETED|Status at Week 156||184|Week 156|
59644218|NCT03430050|75761145|FG000|STARTED|Overall Study||3||
59644219|NCT03430050|75761146|FG001|STARTED|Overall Study||5||
59644220|NCT03430050|75761145|FG000|COMPLETED|Overall Study||3||
59644221|NCT03430050|75761146|FG001|COMPLETED|Overall Study||5||
59644222|NCT03430050|75761145|FG000|NOT COMPLETED|Overall Study||0||
59644223|NCT03430050|75761146|FG001|NOT COMPLETED|Overall Study||0||
59644224|NCT03430206|75761154|FG000|STARTED|Overall Study||40||
59644225|NCT03430206|75761155|FG001|STARTED|Overall Study||38||
59644226|NCT03430206|75761154|FG000|COMPLETED|Overall Study||18||
59644227|NCT03430206|75761155|FG001|COMPLETED|Overall Study||21||
59644228|NCT03430206|75761154|FG000|NOT COMPLETED|Overall Study||22||
60076760|NCT01544595|76191757|FG001|COMPLETED|Status at Week 156||285|Week 156|
60076761|NCT01544595|76191758|FG002|COMPLETED|Status at Week 156||10|Week 156|
60076762|NCT01544595|76191759|FG003|COMPLETED|Status at Week 156||15|Week 156|
59644229|NCT03430206|75761155|FG001|NOT COMPLETED|Overall Study||17||
59644230|NCT03433794|75761164|FG000|STARTED|Baseline||183||
59644231|NCT03433794|75761165|FG001|STARTED|Baseline||173||
59644232|NCT03433794|75761166|FG002|STARTED|Baseline||181||
59644233|NCT03433794|75761164|FG000|COMPLETED|Baseline||183||
59644234|NCT03433794|75761165|FG001|COMPLETED|Baseline||173||
59644235|NCT03433794|75761166|FG002|COMPLETED|Baseline||181||
59644236|NCT03433794|75761164|FG000|NOT COMPLETED|Baseline||0||
59644237|NCT03433794|75761165|FG001|NOT COMPLETED|Baseline||0||
59644238|NCT03433794|75761166|FG002|NOT COMPLETED|Baseline||0||
59644239|NCT03433794|75761164|FG000|STARTED|2-Week Assessment||183||
59644240|NCT03433794|75761165|FG001|STARTED|2-Week Assessment||173||
59644241|NCT03433794|75761166|FG002|STARTED|2-Week Assessment||181||
59644242|NCT03433794|75761164|FG000|COMPLETED|2-Week Assessment||117||
59644243|NCT03433794|75761165|FG001|COMPLETED|2-Week Assessment||112||
59644244|NCT03433794|75761166|FG002|COMPLETED|2-Week Assessment||109||
59644245|NCT03433794|75761164|FG000|NOT COMPLETED|2-Week Assessment||66||
59644246|NCT03433794|75761165|FG001|NOT COMPLETED|2-Week Assessment||61||
59644247|NCT03433794|75761166|FG002|NOT COMPLETED|2-Week Assessment||72||
59644248|NCT03433794|75761164|FG000|STARTED|4-Week Assessment||183||
59644249|NCT03433794|75761165|FG001|STARTED|4-Week Assessment||173||
59644250|NCT03433794|75761166|FG002|STARTED|4-Week Assessment||181||
59644251|NCT03433794|75761164|FG000|COMPLETED|4-Week Assessment||98||
59644252|NCT03433794|75761165|FG001|COMPLETED|4-Week Assessment||95||
59644253|NCT03433794|75761166|FG002|COMPLETED|4-Week Assessment||91||
59644254|NCT03433794|75761164|FG000|NOT COMPLETED|4-Week Assessment||85||
59644255|NCT03433794|75761165|FG001|NOT COMPLETED|4-Week Assessment||78||
59644256|NCT03433794|75761166|FG002|NOT COMPLETED|4-Week Assessment||90||
59644257|NCT03433794|75761164|FG000|STARTED|6-Week Assessment||183||
59644258|NCT03433794|75761165|FG001|STARTED|6-Week Assessment||173||
59644259|NCT03433794|75761166|FG002|STARTED|6-Week Assessment||181||
59644260|NCT03433794|75761164|FG000|COMPLETED|6-Week Assessment||94||
59644261|NCT03433794|75761165|FG001|COMPLETED|6-Week Assessment||85||
59644262|NCT03433794|75761166|FG002|COMPLETED|6-Week Assessment||80||
59644263|NCT03433794|75761164|FG000|NOT COMPLETED|6-Week Assessment||89||
59644264|NCT03433794|75761165|FG001|NOT COMPLETED|6-Week Assessment||88||
59644265|NCT03433794|75761166|FG002|NOT COMPLETED|6-Week Assessment||101||
59644266|NCT03433794|75761164|FG000|STARTED|3-Month Assessment||183||
59644267|NCT03433794|75761165|FG001|STARTED|3-Month Assessment||173||
59644268|NCT03433794|75761166|FG002|STARTED|3-Month Assessment||181||
59644269|NCT03433794|75761164|FG000|COMPLETED|3-Month Assessment||69||
59644270|NCT03433794|75761165|FG001|COMPLETED|3-Month Assessment||73||
59644271|NCT03433794|75761166|FG002|COMPLETED|3-Month Assessment||71||
59644272|NCT03433794|75761164|FG000|NOT COMPLETED|3-Month Assessment||114||
59644273|NCT03433794|75761165|FG001|NOT COMPLETED|3-Month Assessment||100||
59644274|NCT03433794|75761166|FG002|NOT COMPLETED|3-Month Assessment||110||
59644275|NCT03433794|75761164|FG000|STARTED|6-Month Assessment||183||
59644276|NCT03433794|75761165|FG001|STARTED|6-Month Assessment||173||
59644277|NCT03433794|75761166|FG002|STARTED|6-Month Assessment||181||
59644278|NCT03433794|75761164|FG000|COMPLETED|6-Month Assessment||65||
59644279|NCT03433794|75761165|FG001|COMPLETED|6-Month Assessment||58||
59644280|NCT03433794|75761166|FG002|COMPLETED|6-Month Assessment||50||
59644281|NCT03433794|75761164|FG000|NOT COMPLETED|6-Month Assessment||118||
59644282|NCT03433794|75761165|FG001|NOT COMPLETED|6-Month Assessment||115||
59644283|NCT03433794|75761166|FG002|NOT COMPLETED|6-Month Assessment||131||
59644284|NCT03433794|75761164|FG000|STARTED|9-Month Assessment||183||
59644285|NCT03433794|75761165|FG001|STARTED|9-Month Assessment||173||
59644286|NCT03433794|75761166|FG002|STARTED|9-Month Assessment||181||
59644287|NCT03433794|75761164|FG000|COMPLETED|9-Month Assessment||49||
59644288|NCT03433794|75761165|FG001|COMPLETED|9-Month Assessment||52||
59644289|NCT03433794|75761166|FG002|COMPLETED|9-Month Assessment||39||
59644290|NCT03433794|75761164|FG000|NOT COMPLETED|9-Month Assessment||134||
59644291|NCT03433794|75761165|FG001|NOT COMPLETED|9-Month Assessment||121||
59644292|NCT03433794|75761166|FG002|NOT COMPLETED|9-Month Assessment||142||
59644293|NCT03440424|75761177|FG000|STARTED|Overall Study||8||
59644294|NCT03440424|75761178|FG001|STARTED|Overall Study||8||
59644295|NCT03440424|75761179|FG002|STARTED|Overall Study||8||
59644296|NCT03440424|75761177|FG000|COMPLETED|Overall Study||8||
59644297|NCT03440424|75761178|FG001|COMPLETED|Overall Study||8||
59644298|NCT03440424|75761179|FG002|COMPLETED|Overall Study||8||
59644299|NCT03440424|75761177|FG000|NOT COMPLETED|Overall Study||0||
59644300|NCT03440424|75761178|FG001|NOT COMPLETED|Overall Study||0||
59644301|NCT03440424|75761179|FG002|NOT COMPLETED|Overall Study||0||
59644302|NCT03441594|75761187|FG000|STARTED|Overall Study||56||
59644303|NCT03441594|75761187|FG000|COMPLETED|Overall Study||56||
59644304|NCT03441594|75761187|FG000|NOT COMPLETED|Overall Study||0||
59644305|NCT03444090|75761193|FG000|STARTED|Overall Study||214||
59644306|NCT03444090|75761194|FG001|STARTED|Overall Study||214||
59644307|NCT03444090|75761193|FG000|COMPLETED|Overall Study||211||
59644308|NCT03444090|75761194|FG001|COMPLETED|Overall Study||210||
59644309|NCT03444090|75761193|FG000|NOT COMPLETED|Overall Study||3||
59644310|NCT03444090|75761194|FG001|NOT COMPLETED|Overall Study||4||
59644311|NCT03448068|75761202|FG000|STARTED|Overall Study||17||
59644312|NCT03448068|75761203|FG001|STARTED|Overall Study||17||
59644313|NCT03448068|75761202|FG000|COMPLETED|Overall Study||17||
59644314|NCT03448068|75761203|FG001|COMPLETED|Overall Study||17||
59644315|NCT03448068|75761202|FG000|NOT COMPLETED|Overall Study||0||
59644316|NCT03448068|75761203|FG001|NOT COMPLETED|Overall Study||0||
59644317|NCT03453060|75761214|FG000|STARTED|Overall Study||4||
59644318|NCT03453060|75761215|FG001|STARTED|Overall Study||4||
59644319|NCT03453060|75761216|FG002|STARTED|Overall Study||4||
59644320|NCT03453060|75761217|FG003|STARTED|Overall Study||4||
59644321|NCT03453060|75761218|FG004|STARTED|Overall Study||5||
59644322|NCT03453060|75761214|FG000|COMPLETED|Overall Study||4||
59644323|NCT03453060|75761215|FG001|COMPLETED|Overall Study||4||
59644324|NCT03453060|75761216|FG002|COMPLETED|Overall Study||4||
59644325|NCT03453060|75761217|FG003|COMPLETED|Overall Study||4||
59644326|NCT03453060|75761218|FG004|COMPLETED|Overall Study||5||
59644327|NCT03453060|75761214|FG000|NOT COMPLETED|Overall Study||0||
59644328|NCT03453060|75761215|FG001|NOT COMPLETED|Overall Study||0||
59644329|NCT03453060|75761216|FG002|NOT COMPLETED|Overall Study||0||
59644330|NCT03453060|75761217|FG003|NOT COMPLETED|Overall Study||0||
59644331|NCT03453060|75761218|FG004|NOT COMPLETED|Overall Study||0||
59644332|NCT03457116|75761232|FG000|STARTED|Overall Study||41||
59644333|NCT03457116|75761233|FG001|STARTED|Overall Study||29||
59644334|NCT03457116|75761232|FG000|COMPLETED|Overall Study||41||
59644335|NCT03457116|75761233|FG001|COMPLETED|Overall Study||29||
59644336|NCT03457116|75761232|FG000|NOT COMPLETED|Overall Study||0||
59644337|NCT03457116|75761233|FG001|NOT COMPLETED|Overall Study||0||
59644338|NCT03459612|75761243|FG000|STARTED|Period 1||17||
59644339|NCT03459612|75761244|FG001|STARTED|Period 1||17||
59644340|NCT03459612|75761245|FG002|STARTED|Period 1||17||
59644341|NCT03459612|75761246|FG003|STARTED|Period 1||17||
59644342|NCT03459612|75761243|FG000|Received at Least 1 Dose of Study Drug|Period 1||17||
59644343|NCT03459612|75761244|FG001|Received at Least 1 Dose of Study Drug|Period 1||17||
59644344|NCT03459612|75761245|FG002|Received at Least 1 Dose of Study Drug|Period 1||17||
59644345|NCT03459612|75761246|FG003|Received at Least 1 Dose of Study Drug|Period 1||17||
59644346|NCT03459612|75761243|FG000|COMPLETED|Period 1||17||
59644347|NCT03459612|75761244|FG001|COMPLETED|Period 1||17||
59644348|NCT03459612|75761245|FG002|COMPLETED|Period 1||17||
59644349|NCT03459612|75761246|FG003|COMPLETED|Period 1||17||
59644350|NCT03459612|75761243|FG000|NOT COMPLETED|Period 1||0||
59644351|NCT03459612|75761244|FG001|NOT COMPLETED|Period 1||0||
59644352|NCT03459612|75761245|FG002|NOT COMPLETED|Period 1||0||
59644353|NCT03459612|75761246|FG003|NOT COMPLETED|Period 1||0||
59644354|NCT03459612|75761243|FG000|STARTED|Period 2||17||
59644355|NCT03459612|75761244|FG001|STARTED|Period 2||17||
59644356|NCT03459612|75761245|FG002|STARTED|Period 2||17||
59644357|NCT03459612|75761246|FG003|STARTED|Period 2||17||
59644358|NCT03459612|75761243|FG000|Received at Least 1 Dose of Study Drug|Period 2||17||
59644359|NCT03459612|75761244|FG001|Received at Least 1 Dose of Study Drug|Period 2||17||
59644360|NCT03459612|75761245|FG002|Received at Least 1 Dose of Study Drug|Period 2||17||
59644361|NCT03459612|75761246|FG003|Received at Least 1 Dose of Study Drug|Period 2||17||
59644362|NCT03459612|75761243|FG000|COMPLETED|Period 2||17||
59644363|NCT03459612|75761244|FG001|COMPLETED|Period 2||17||
59644364|NCT03459612|75761245|FG002|COMPLETED|Period 2||17||
59644365|NCT03459612|75761246|FG003|COMPLETED|Period 2||17||
59644366|NCT03459612|75761243|FG000|NOT COMPLETED|Period 2||0||
59644367|NCT03459612|75761244|FG001|NOT COMPLETED|Period 2||0||
59644368|NCT03459612|75761245|FG002|NOT COMPLETED|Period 2||0||
59644369|NCT03459612|75761246|FG003|NOT COMPLETED|Period 2||0||
59644370|NCT03459612|75761243|FG000|STARTED|Period 3||17||
59644371|NCT03459612|75761244|FG001|STARTED|Period 3||17||
59644372|NCT03459612|75761245|FG002|STARTED|Period 3||17||
59815761|NCT03026283|75938211|FG000|NOT COMPLETED|CCTA Diagnosis||14||
59644373|NCT03459612|75761246|FG003|STARTED|Period 3||17||
59815762|NCT03026283|75938212|FG001|NOT COMPLETED|CCTA Diagnosis||0||
59644374|NCT03459612|75761243|FG000|Received at Least 1 Dose of Study Drug|Period 3||17||
59644375|NCT03459612|75761244|FG001|Received at Least 1 Dose of Study Drug|Period 3||17||
59644376|NCT03459612|75761245|FG002|Received at Least 1 Dose of Study Drug|Period 3||17||
59644377|NCT03459612|75761246|FG003|Received at Least 1 Dose of Study Drug|Period 3||17||
59644378|NCT03459612|75761243|FG000|COMPLETED|Period 3||17||
59644379|NCT03459612|75761244|FG001|COMPLETED|Period 3||17||
59644380|NCT03459612|75761245|FG002|COMPLETED|Period 3||17||
59644381|NCT03459612|75761246|FG003|COMPLETED|Period 3||17||
59644382|NCT03459612|75761243|FG000|NOT COMPLETED|Period 3||0||
59644383|NCT03459612|75761244|FG001|NOT COMPLETED|Period 3||0||
59644384|NCT03459612|75761245|FG002|NOT COMPLETED|Period 3||0||
59644385|NCT03459612|75761246|FG003|NOT COMPLETED|Period 3||0||
59644386|NCT03459612|75761243|FG000|STARTED|Period 4||17||
59644387|NCT03459612|75761244|FG001|STARTED|Period 4||17||
59644388|NCT03459612|75761245|FG002|STARTED|Period 4|One participant completed period 3 and withdrew for personal reasons prior to Period 4.|16||
59644389|NCT03459612|75761246|FG003|STARTED|Period 4||17||
59644390|NCT03459612|75761243|FG000|Received at Least 1 Dose of Study Drug|Period 4||17||
59644391|NCT03459612|75761244|FG001|Received at Least 1 Dose of Study Drug|Period 4||17||
59644392|NCT03459612|75761245|FG002|Received at Least 1 Dose of Study Drug|Period 4||16||
59644393|NCT03459612|75761246|FG003|Received at Least 1 Dose of Study Drug|Period 4||17||
59644394|NCT03459612|75761243|FG000|COMPLETED|Period 4||17||
59644395|NCT03459612|75761244|FG001|COMPLETED|Period 4||17||
59644396|NCT03459612|75761245|FG002|COMPLETED|Period 4||16||
59644397|NCT03459612|75761246|FG003|COMPLETED|Period 4||17||
59644398|NCT03459612|75761243|FG000|NOT COMPLETED|Period 4||0||
59644399|NCT03459612|75761244|FG001|NOT COMPLETED|Period 4||0||
59644400|NCT03459612|75761245|FG002|NOT COMPLETED|Period 4||0||
59644401|NCT03459612|75761246|FG003|NOT COMPLETED|Period 4||0||
59644402|NCT03463512|75761261|FG000|STARTED|Overall Study||62||
59644403|NCT03463512|75761262|FG001|STARTED|Overall Study||62||
59644404|NCT03463512|75761261|FG000|COMPLETED|Overall Study||62||
59644405|NCT03463512|75761262|FG001|COMPLETED|Overall Study||62||
59644406|NCT03463512|75761261|FG000|NOT COMPLETED|Overall Study||0||
59644407|NCT03463512|75761262|FG001|NOT COMPLETED|Overall Study||0||
59644408|NCT03467412|75761268|FG000|STARTED|Overall Study|Each unique subject will appear in 2 arms. Total sum of subjects is therefore120/2=60.|25||25
59644409|NCT03467412|75761269|FG001|STARTED|Overall Study|Each unique subject will appear in 2 arms. Total sum of subjects is therefore120/2=60.|25||25
59644410|NCT03467412|75761270|FG002|STARTED|Overall Study|Each unique subject will appear in 2 arms. Total sum of subjects is therefore120/2=60.|25||25
59644411|NCT03467412|75761271|FG003|STARTED|Overall Study|Each unique subject will appear in 2 arms. Total sum of subjects is therefore120/2=60.|25||25
59644412|NCT03467412|75761272|FG004|STARTED|Overall Study|Each unique subject will appear in 2 arms. Total sum of subjects is therefore120/2=60.|20||20
59644413|NCT03467412|75761268|FG000|COMPLETED|Overall Study||22||22
59644414|NCT03467412|75761269|FG001|COMPLETED|Overall Study||24||24
59644415|NCT03467412|75761270|FG002|COMPLETED|Overall Study||20||20
59644416|NCT03467412|75761271|FG003|COMPLETED|Overall Study||23||23
59644417|NCT03467412|75761272|FG004|COMPLETED|Overall Study||17||17
59644418|NCT03467412|75761268|FG000|NOT COMPLETED|Overall Study||3||3
59644419|NCT03467412|75761269|FG001|NOT COMPLETED|Overall Study||1||1
59644420|NCT03467412|75761270|FG002|NOT COMPLETED|Overall Study||5||5
59644421|NCT03467412|75761271|FG003|NOT COMPLETED|Overall Study||2||2
59644422|NCT03467412|75761272|FG004|NOT COMPLETED|Overall Study||3||3
59644423|NCT03468816|75761293|FG000|STARTED|Overall Study||2||
59644424|NCT03468816|75761294|FG001|STARTED|Overall Study||3||
59644425|NCT03468816|75761293|FG000|COMPLETED|Overall Study||2||
59644426|NCT03468816|75761294|FG001|COMPLETED|Overall Study||3||
59644427|NCT03468816|75761293|FG000|NOT COMPLETED|Overall Study||0||
59644428|NCT03468816|75761294|FG001|NOT COMPLETED|Overall Study||0||
59644429|NCT03473184|75761302|FG000|STARTED|Overall Study||34||170
59644430|NCT03473184|75761302|FG000|Diacerein 1% Ointment Irradiated|Overall Study||34||34
59644431|NCT03473184|75761302|FG000|Vehicle Ointment Irradiated|Overall Study||34||34
59644432|NCT03473184|75761302|FG000|Diacerein 1% Ointment Non-irradiated|Overall Study||34||34
59644433|NCT03473184|75761302|FG000|Vehicle Ointment Non-irradiated|Overall Study||34||34
59644434|NCT03473184|75761302|FG000|Untreated Irradiated|Overall Study||34||34
59644435|NCT03473184|75761302|FG000|COMPLETED|Overall Study||34||170
59644436|NCT03473184|75761302|FG000|NOT COMPLETED|Overall Study||0||0
59644437|NCT03473886|75761306|FG000|STARTED|Overall Study||8||
59644438|NCT03473886|75761306|FG000|COMPLETED|Overall Study||7||
59644439|NCT03473886|75761306|FG000|NOT COMPLETED|Overall Study||1||
59644440|NCT03475992|75761313|FG000|STARTED|Overall Study||11||
59644441|NCT03475992|75761314|FG001|STARTED|Overall Study||9||
59644442|NCT03475992|75761315|FG002|STARTED|Overall Study||5||
59644443|NCT03475992|75761313|FG000|COMPLETED|Overall Study||11||
59644444|NCT03475992|75761314|FG001|COMPLETED|Overall Study||9||
59644445|NCT03475992|75761315|FG002|COMPLETED|Overall Study||5||
59644446|NCT03475992|75761313|FG000|NOT COMPLETED|Overall Study||0||
59644447|NCT03475992|75761314|FG001|NOT COMPLETED|Overall Study||0||
59644448|NCT03475992|75761315|FG002|NOT COMPLETED|Overall Study||0||
59644449|NCT03476850|75761325|FG000|STARTED|Overall Study||24||
59644450|NCT03476850|75761326|FG001|STARTED|Overall Study||24||
59644451|NCT03476850|75761325|FG000|COMPLETED|Overall Study||24||
59644452|NCT03476850|75761326|FG001|COMPLETED|Overall Study||24||
59644453|NCT03476850|75761325|FG000|NOT COMPLETED|Overall Study||0||
59644454|NCT03476850|75761326|FG001|NOT COMPLETED|Overall Study||0||
59644455|NCT03477006|75761334|FG000|STARTED|Overall Study||40||
59644456|NCT03477006|75761335|FG001|STARTED|Overall Study||46||
59644457|NCT03477006|75761334|FG000|COMPLETED|Overall Study||40||
59644458|NCT03477006|75761335|FG001|COMPLETED|Overall Study||46||
59644459|NCT03477006|75761334|FG000|NOT COMPLETED|Overall Study||0||
59644460|NCT03477006|75761335|FG001|NOT COMPLETED|Overall Study||0||
59644461|NCT03478254|75761341|FG000|STARTED|Overall Study||300||
59644462|NCT03478254|75761341|FG000|COMPLETED|Overall Study||300||
59815763|NCT03026283|75938213|FG002|NOT COMPLETED|CCTA Diagnosis||0||
60076763|NCT01544595|76191760|FG004|COMPLETED|Status at Week 156||60|Week 156|
59644463|NCT03478254|75761341|FG000|NOT COMPLETED|Overall Study||0||
59644464|NCT03480048|75761348|FG000|STARTED|Overall Study||28||
59644465|NCT03480048|75761349|FG001|STARTED|Overall Study||25||
59644466|NCT03480048|75761348|FG000|COMPLETED|Overall Study||18||
59644467|NCT03480048|75761349|FG001|COMPLETED|Overall Study||17||
59644468|NCT03480048|75761348|FG000|NOT COMPLETED|Overall Study||10||
59644469|NCT03480048|75761349|FG001|NOT COMPLETED|Overall Study||8||
59644470|NCT03485976|75761355|FG000|STARTED|Overall Study||12||
59644471|NCT03485976|75761355|FG000|COMPLETED|Overall Study||11||
59542444|NCT01576523|75640784|FG003|COMPLETED|Dosing Period 2||3||
59542445|NCT01576523|75640785|FG004|COMPLETED|Dosing Period 2||3||
59542446|NCT01576523|75640786|FG005|COMPLETED|Dosing Period 2||3||
59542447|NCT01576523|75640781|FG000|NOT COMPLETED|Dosing Period 2||0||
59542448|NCT01576523|75640782|FG001|NOT COMPLETED|Dosing Period 2||0||
59542449|NCT01576523|75640783|FG002|NOT COMPLETED|Dosing Period 2||0||
59542450|NCT01576523|75640784|FG003|NOT COMPLETED|Dosing Period 2||0||
59542451|NCT01576523|75640785|FG004|NOT COMPLETED|Dosing Period 2||0||
59542452|NCT01576523|75640786|FG005|NOT COMPLETED|Dosing Period 2||0||
59542453|NCT01577537|75640797|FG000|STARTED|Overall Study||128||
59542454|NCT01577537|75640798|FG001|STARTED|Overall Study||123||
59542455|NCT01577537|75640797|FG000|COMPLETED|Overall Study||120||
59542456|NCT01577537|75640798|FG001|COMPLETED|Overall Study||116||
59542457|NCT01577537|75640797|FG000|NOT COMPLETED|Overall Study||8||
59542458|NCT01577537|75640798|FG001|NOT COMPLETED|Overall Study||7||
59542459|NCT02469246|75640806|FG000|STARTED|Double-Blind Phase||285||
59542460|NCT02469246|75640807|FG001|STARTED|Double-Blind Phase||282||
59542461|NCT02469246|75640806|FG000|COMPLETED|Double-Blind Phase||218||
59542462|NCT02469246|75640807|FG001|COMPLETED|Double-Blind Phase||226||
59542463|NCT02469246|75640806|FG000|NOT COMPLETED|Double-Blind Phase||67||
59542464|NCT02469246|75640807|FG001|NOT COMPLETED|Double-Blind Phase||56||
59542465|NCT02469246|75640806|FG000|STARTED|Open-Label Extension (OLE)|Only participants in countries where F/TAF was not commercially available were eligible for the OLE.|6||
59542466|NCT02469246|75640807|FG001|STARTED|Open-Label Extension (OLE)|Only participants in countries where F/TAF was not commercially available were eligible for the OLE.|5||
59542467|NCT02469246|75640806|FG000|COMPLETED|Open-Label Extension (OLE)||6||
59542468|NCT02469246|75640807|FG001|COMPLETED|Open-Label Extension (OLE)||5||
59542469|NCT02469246|75640806|FG000|NOT COMPLETED|Open-Label Extension (OLE)||0||
59542470|NCT02469246|75640807|FG001|NOT COMPLETED|Open-Label Extension (OLE)||0||
59542471|NCT01578317|75640817|FG000|STARTED|Overall Study||22||
59542472|NCT01578317|75640818|FG001|STARTED|Overall Study||21||
59542473|NCT01578317|75640817|FG000|Analysis Population|Overall Study||22||
59542474|NCT01578317|75640818|FG001|Analysis Population|Overall Study||20||
59542475|NCT01578317|75640817|FG000|COMPLETED|Overall Study||22||
59542476|NCT01578317|75640818|FG001|COMPLETED|Overall Study||20||
59542477|NCT01578317|75640817|FG000|NOT COMPLETED|Overall Study||0||
59542478|NCT01578317|75640818|FG001|NOT COMPLETED|Overall Study||1||
59542479|NCT02469168|75640826|FG000|STARTED|Overall Study||1||
59542480|NCT02469168|75640827|FG001|STARTED|Overall Study||0||
59542481|NCT02469168|75640826|FG000|COMPLETED|Overall Study||0||
59542482|NCT02469168|75640827|FG001|COMPLETED|Overall Study||0||
59542483|NCT02469168|75640826|FG000|NOT COMPLETED|Overall Study||1||
59644472|NCT03485976|75761355|FG000|NOT COMPLETED|Overall Study||1||
59644473|NCT03486990|75761368|FG000|STARTED|Overall Study||2||
59644474|NCT03486990|75761369|FG001|STARTED|Overall Study||2||
59644475|NCT03486990|75761370|FG002|STARTED|Overall Study||3||
59644476|NCT03486990|75761371|FG003|STARTED|Overall Study||3||
59644477|NCT03486990|75761372|FG004|STARTED|Overall Study||3||
59644478|NCT03486990|75761373|FG005|STARTED|Overall Study||4||
59644479|NCT03486990|75761374|FG006|STARTED|Overall Study||2||
59644480|NCT03486990|75761375|FG007|STARTED|Overall Study||2||
59644481|NCT03486990|75761376|FG008|STARTED|Overall Study||2||
59644482|NCT03486990|75761368|FG000|COMPLETED|Overall Study||2||
59644483|NCT03486990|75761369|FG001|COMPLETED|Overall Study||2||
59644484|NCT03486990|75761370|FG002|COMPLETED|Overall Study||3||
59644485|NCT03486990|75761371|FG003|COMPLETED|Overall Study||3||
59644486|NCT03486990|75761372|FG004|COMPLETED|Overall Study||3||
59644487|NCT03486990|75761373|FG005|COMPLETED|Overall Study||4||
59644488|NCT03486990|75761374|FG006|COMPLETED|Overall Study||2||
59644489|NCT03486990|75761375|FG007|COMPLETED|Overall Study||2||
59644490|NCT03486990|75761376|FG008|COMPLETED|Overall Study||2||
59644491|NCT03486990|75761368|FG000|NOT COMPLETED|Overall Study||0||
59644492|NCT03486990|75761369|FG001|NOT COMPLETED|Overall Study||0||
59644493|NCT03486990|75761370|FG002|NOT COMPLETED|Overall Study||0||
59644494|NCT03486990|75761371|FG003|NOT COMPLETED|Overall Study||0||
59644495|NCT03486990|75761372|FG004|NOT COMPLETED|Overall Study||0||
59644496|NCT03486990|75761373|FG005|NOT COMPLETED|Overall Study||0||
59644497|NCT03486990|75761374|FG006|NOT COMPLETED|Overall Study||0||
59644498|NCT03486990|75761375|FG007|NOT COMPLETED|Overall Study||0||
59644499|NCT03486990|75761376|FG008|NOT COMPLETED|Overall Study||0||
59644500|NCT03490110|75761414|FG000|STARTED|Overall Study||9||
59644501|NCT03490110|75761415|FG001|STARTED|Overall Study||9||
59644502|NCT03490110|75761414|FG000|COMPLETED|Overall Study||6||
59644503|NCT03490110|75761415|FG001|COMPLETED|Overall Study||6||
59644504|NCT03490110|75761414|FG000|NOT COMPLETED|Overall Study||3||
59644505|NCT03490110|75761415|FG001|NOT COMPLETED|Overall Study||3||
59644506|NCT03495648|75761423|FG000|STARTED|Overall Study||60||
59644507|NCT03495648|75761424|FG001|STARTED|Overall Study||61||
59644508|NCT03495648|75761423|FG000|COMPLETED|Overall Study||60||
59644509|NCT03495648|75761424|FG001|COMPLETED|Overall Study||61||
59644510|NCT03495648|75761423|FG000|NOT COMPLETED|Overall Study||0||
59644511|NCT03495648|75761424|FG001|NOT COMPLETED|Overall Study||0||
59644512|NCT03496428|75761430|FG000|STARTED|Overall Study|304 locations distributed for the analyzed teeth 108 locations distributed for the implant spots|6||412
59644513|NCT03496428|75761430|FG000|COMPLETED|Overall Study|304 locations distributed for the analyzed teeth 108 locations distributed for the implant spots|6||412
59644514|NCT03496428|75761430|FG000|NOT COMPLETED|Overall Study||0||0
59644515|NCT03496974|75761436|FG000|STARTED|Overall Study||10||
59644516|NCT03496974|75761437|FG001|STARTED|Overall Study||28||
59644517|NCT03496974|75761436|FG000|COMPLETED|Overall Study||9||
59644518|NCT03496974|75761437|FG001|COMPLETED|Overall Study||20||
59644519|NCT03496974|75761436|FG000|NOT COMPLETED|Overall Study||1||
59644520|NCT03496974|75761437|FG001|NOT COMPLETED|Overall Study||8||
59644521|NCT03498300|75761445|FG000|STARTED|Overall Study||21||
59644522|NCT03498300|75761446|FG001|STARTED|Overall Study||21||
59644523|NCT03498300|75761445|FG000|COMPLETED|Overall Study||18||
59644524|NCT03498300|75761446|FG001|COMPLETED|Overall Study||13||
59644525|NCT03498300|75761445|FG000|NOT COMPLETED|Overall Study||3||
59644526|NCT03498300|75761446|FG001|NOT COMPLETED|Overall Study||8||
59644527|NCT03501264|75761455|FG000|STARTED|Overall Study||120||
59644528|NCT03501264|75761456|FG001|STARTED|Overall Study||120||
59644529|NCT03501264|75761455|FG000|COMPLETED|Overall Study||120||
59644530|NCT03501264|75761456|FG001|COMPLETED|Overall Study||120||
59644531|NCT03501264|75761455|FG000|NOT COMPLETED|Overall Study||0||
59644532|NCT03501264|75761456|FG001|NOT COMPLETED|Overall Study||0||
59644533|NCT03503292|75761464|FG000|STARTED|Overall Study||2||
59644534|NCT03503292|75761465|FG001|STARTED|Overall Study||90||
59644535|NCT03503292|75761464|FG000|COMPLETED|Overall Study||2||
59644536|NCT03503292|75761465|FG001|COMPLETED|Overall Study||90||
59644537|NCT03503292|75761464|FG000|NOT COMPLETED|Overall Study||0||
59644538|NCT03503292|75761465|FG001|NOT COMPLETED|Overall Study||0||
59644539|NCT03506724|75761473|FG000|STARTED|Overall Study||54||
59644540|NCT03506724|75761474|FG001|STARTED|Overall Study||55||
59644541|NCT03506724|75761473|FG000|COMPLETED|Overall Study||54||
59644542|NCT03506724|75761474|FG001|COMPLETED|Overall Study||55||
59644543|NCT03506724|75761473|FG000|NOT COMPLETED|Overall Study||0||
59644544|NCT03506724|75761474|FG001|NOT COMPLETED|Overall Study||0||
59644545|NCT03507036|75761480|FG000|STARTED|Overall Study||20||
59644546|NCT03507036|75761480|FG000|COMPLETED|Overall Study||15||
59644547|NCT03507036|75761480|FG000|NOT COMPLETED|Overall Study||5||
59644548|NCT03509766|75761487|FG000|STARTED|Overall Study||24||
59644549|NCT03509766|75761487|FG000|COMPLETED|Overall Study||24||
59644550|NCT03509766|75761487|FG000|NOT COMPLETED|Overall Study||0||
59644551|NCT03511638|75761494|FG000|STARTED|Overall Study||184||
59644552|NCT03511638|75761495|FG001|STARTED|Overall Study||188||
59644553|NCT03511638|75761494|FG000|COMPLETED|Overall Study||182||
59644554|NCT03511638|75761495|FG001|COMPLETED|Overall Study||187||
59644555|NCT03511638|75761494|FG000|NOT COMPLETED|Overall Study||2||
59644556|NCT03511638|75761495|FG001|NOT COMPLETED|Overall Study||1||
59644557|NCT03519282|75761501|FG000|STARTED|First Intervention||5||
59644558|NCT03519282|75761502|FG001|STARTED|First Intervention||5||
59644559|NCT03519282|75761501|FG000|COMPLETED|First Intervention||5||
59644560|NCT03519282|75761502|FG001|COMPLETED|First Intervention||5||
59644561|NCT03519282|75761501|FG000|NOT COMPLETED|First Intervention||0||
59644562|NCT03519282|75761502|FG001|NOT COMPLETED|First Intervention||0||
59644563|NCT03519282|75761501|FG000|STARTED|Second Intervention||5||
59644564|NCT03519282|75761502|FG001|STARTED|Second Intervention||5||
59644565|NCT03519282|75761501|FG000|COMPLETED|Second Intervention||5||
59644566|NCT03519282|75761502|FG001|COMPLETED|Second Intervention||5||
59644567|NCT03519282|75761501|FG000|NOT COMPLETED|Second Intervention||0||
59644568|NCT03519282|75761502|FG001|NOT COMPLETED|Second Intervention||0||
59644569|NCT03520998|75761510|FG000|STARTED|Overall Study||24||
59644570|NCT03520998|75761511|FG001|STARTED|Overall Study||23||
59644571|NCT03520998|75761510|FG000|COMPLETED|Overall Study||18||
59644572|NCT03520998|75761511|FG001|COMPLETED|Overall Study||21||
59644573|NCT03520998|75761510|FG000|NOT COMPLETED|Overall Study||6||
59644574|NCT03520998|75761511|FG001|NOT COMPLETED|Overall Study||2||
59644575|NCT03525210|75761519|FG000|STARTED|Overall Study||100||
59644576|NCT03525210|75761520|FG001|STARTED|Overall Study||171||
59644577|NCT03525210|75761519|FG000|COMPLETED|Overall Study||96||
59644578|NCT03525210|75761520|FG001|COMPLETED|Overall Study||169||
59644579|NCT03525210|75761519|FG000|NOT COMPLETED|Overall Study||4||
59644580|NCT03525210|75761520|FG001|NOT COMPLETED|Overall Study||2||
59644581|NCT03532308|75761530|FG000|STARTED|Overall Study||10||
59644582|NCT03532308|75761531|FG001|STARTED|Overall Study||9||
59644583|NCT03532308|75761530|FG000|Completed Assessments|Overall Study||9||
59644584|NCT03532308|75761531|FG001|Completed Assessments|Overall Study||7||
59644585|NCT03532308|75761530|FG000|COMPLETED|Overall Study||10||
59644586|NCT03532308|75761531|FG001|COMPLETED|Overall Study||8||
59644587|NCT03532308|75761530|FG000|NOT COMPLETED|Overall Study||0||
59644588|NCT03532308|75761531|FG001|NOT COMPLETED|Overall Study||1||
59644589|NCT03532776|75761540|FG000|STARTED|Overall Study||201||
59644590|NCT03532776|75761541|FG001|STARTED|Overall Study||198||
59644591|NCT03532776|75761542|FG002|STARTED|Overall Study||67||
59644592|NCT03532776|75761540|FG000|COMPLETED|Overall Study||196||
59644593|NCT03532776|75761541|FG001|COMPLETED|Overall Study||194||
59644594|NCT03532776|75761542|FG002|COMPLETED|Overall Study||63||
59644595|NCT03532776|75761540|FG000|NOT COMPLETED|Overall Study||5||
59644596|NCT03532776|75761541|FG001|NOT COMPLETED|Overall Study||4||
59644597|NCT03532776|75761542|FG002|NOT COMPLETED|Overall Study||4||
59644598|NCT03533244|75761554|FG000|STARTED|Overall Study||20||
59644599|NCT03533244|75761555|FG001|STARTED|Overall Study||22||
59644600|NCT03533244|75761556|FG002|STARTED|Overall Study||22||
59644601|NCT03533244|75761554|FG000|COMPLETED|Overall Study||18||
59644602|NCT03533244|75761555|FG001|COMPLETED|Overall Study||21||
59644603|NCT03533244|75761556|FG002|COMPLETED|Overall Study||22||
59644604|NCT03533244|75761554|FG000|NOT COMPLETED|Overall Study||2||
59644605|NCT03533244|75761555|FG001|NOT COMPLETED|Overall Study||1||
59644606|NCT03533244|75761556|FG002|NOT COMPLETED|Overall Study||0||
59644607|NCT03541356|75761569|FG000|STARTED|Overall Study||8||
59644608|NCT03541356|75761570|FG001|STARTED|Overall Study||6||
59644609|NCT03541356|75761571|FG002|STARTED|Overall Study||6||
59644610|NCT03541356|75761572|FG003|STARTED|Overall Study||6||
59644611|NCT03541356|75761573|FG004|STARTED|Overall Study||6||
59644612|NCT03541356|75761569|FG000|COMPLETED|Overall Study||8||
59644613|NCT03541356|75761570|FG001|COMPLETED|Overall Study||6||
59644614|NCT03541356|75761571|FG002|COMPLETED|Overall Study||6||
59644615|NCT03541356|75761572|FG003|COMPLETED|Overall Study||6||
59644616|NCT03541356|75761573|FG004|COMPLETED|Overall Study||6||
59644617|NCT03541356|75761569|FG000|NOT COMPLETED|Overall Study||0||
59644618|NCT03541356|75761570|FG001|NOT COMPLETED|Overall Study||0||
59644619|NCT03541356|75761571|FG002|NOT COMPLETED|Overall Study||0||
59644620|NCT03541356|75761572|FG003|NOT COMPLETED|Overall Study||0||
59644621|NCT03541356|75761573|FG004|NOT COMPLETED|Overall Study||0||
59644622|NCT03545412|75761590|FG000|STARTED|Overall Study||25||
59644623|NCT03545412|75761590|FG000|COMPLETED|Overall Study||25||
59644624|NCT03545412|75761590|FG000|NOT COMPLETED|Overall Study||0||
59644625|NCT03546270|75761596|FG000|STARTED|Overall Study||52||
59644626|NCT03546270|75761597|FG001|STARTED|Overall Study||48||
59644627|NCT03546270|75761596|FG000|COMPLETED|Overall Study||52||
59644628|NCT03546270|75761597|FG001|COMPLETED|Overall Study||48||
59644629|NCT03546270|75761596|FG000|NOT COMPLETED|Overall Study||0||
59644630|NCT03546270|75761597|FG001|NOT COMPLETED|Overall Study||0||
59644631|NCT03549234|75761605|FG000|STARTED|Overall Study||50||
59644632|NCT03549234|75761606|FG001|STARTED|Overall Study||50||
59644633|NCT03549234|75761605|FG000|COMPLETED|Overall Study||50||
59644634|NCT03549234|75761606|FG001|COMPLETED|Overall Study||50||
59644635|NCT03549234|75761605|FG000|NOT COMPLETED|Overall Study||0||
59644636|NCT03549234|75761606|FG001|NOT COMPLETED|Overall Study||0||
59644637|NCT03557658|75761614|FG000|STARTED|Overall Study||8||
59644638|NCT03557658|75761615|FG001|STARTED|Overall Study||8||
59644639|NCT03557658|75761614|FG000|COMPLETED|Overall Study||8||
59644640|NCT03557658|75761615|FG001|COMPLETED|Overall Study||8||
59644641|NCT03557658|75761614|FG000|NOT COMPLETED|Overall Study||0||
59644642|NCT03557658|75761615|FG001|NOT COMPLETED|Overall Study||0||
59644643|NCT03564444|75761623|FG000|STARTED|Overall Study||60||
59644644|NCT03564444|75761624|FG001|STARTED|Overall Study||240||
59644645|NCT03564444|75761623|FG000|COMPLETED|Overall Study||60||
59644646|NCT03564444|75761624|FG001|COMPLETED|Overall Study||240||
59644647|NCT03564444|75761623|FG000|NOT COMPLETED|Overall Study||0||
59644648|NCT03564444|75761624|FG001|NOT COMPLETED|Overall Study||0||
59644649|NCT03567252|75761632|FG000|STARTED|Overall Study||48||
59644650|NCT03567252|75761633|FG001|STARTED|Overall Study||19||
59644651|NCT03567252|75761632|FG000|COMPLETED|Overall Study||48||
59644652|NCT03567252|75761633|FG001|COMPLETED|Overall Study||19||
59644653|NCT03567252|75761632|FG000|NOT COMPLETED|Overall Study||0||
59644654|NCT03567252|75761633|FG001|NOT COMPLETED|Overall Study||0||
59644655|NCT03569748|75761641|FG000|STARTED|Overall Study||110||
59644656|NCT03569748|75761642|FG001|STARTED|Overall Study||110||
59644657|NCT03569748|75761641|FG000|COMPLETED|Overall Study||110||
59644658|NCT03569748|75761642|FG001|COMPLETED|Overall Study||101||
59644659|NCT03569748|75761641|FG000|NOT COMPLETED|Overall Study||0||
59644660|NCT03569748|75761642|FG001|NOT COMPLETED|Overall Study||9||
59644661|NCT03572478|75761654|FG000|STARTED|Overall Study||12||
59644662|NCT03572478|75761654|FG000|COMPLETED|Overall Study||12||
59644663|NCT03572478|75761654|FG000|NOT COMPLETED|Overall Study||0||
59644664|NCT03574818|75761658|FG000|STARTED|Overall Study||1||
59644665|NCT03574818|75761658|FG000|COMPLETED|Overall Study||1||
59644666|NCT03574818|75761658|FG000|NOT COMPLETED|Overall Study||0||
59644667|NCT03575754|75761664|FG000|STARTED|Overall Study||25||
59644668|NCT03575754|75761665|FG001|STARTED|Overall Study||25||
59644669|NCT03575754|75761664|FG000|COMPLETED|Overall Study||25||
59644670|NCT03575754|75761665|FG001|COMPLETED|Overall Study||25||
59644671|NCT03575754|75761664|FG000|NOT COMPLETED|Overall Study||0||
59644672|NCT03575754|75761665|FG001|NOT COMPLETED|Overall Study||0||
59644673|NCT03593538|75761674|FG000|STARTED|Overall Study||26||
59644674|NCT03593538|75761675|FG001|STARTED|Overall Study||21||
59644675|NCT03593538|75761676|FG002|STARTED|Overall Study||22||
59644676|NCT03593538|75761674|FG000|COMPLETED|Overall Study||15||
59644677|NCT03593538|75761675|FG001|COMPLETED|Overall Study||15||
59644678|NCT03593538|75761676|FG002|COMPLETED|Overall Study||11||
59644679|NCT03593538|75761674|FG000|NOT COMPLETED|Overall Study||11||
59644680|NCT03593538|75761675|FG001|NOT COMPLETED|Overall Study||6||
59644681|NCT03593538|75761676|FG002|NOT COMPLETED|Overall Study||11||
59644682|NCT03610464|75761684|FG000|STARTED|Overall Study||5||
59644683|NCT03610464|75761684|FG000|COMPLETED|Overall Study||5||
59644684|NCT03610464|75761684|FG000|NOT COMPLETED|Overall Study||0||
59644685|NCT03613818|75761691|FG000|STARTED|Overall Study||174||
59644686|NCT03613818|75761692|FG001|STARTED|Overall Study||137||
59644687|NCT03613818|75761691|FG000|COMPLETED|Overall Study||137||
59644688|NCT03613818|75761692|FG001|COMPLETED|Overall Study||110||
59644689|NCT03613818|75761691|FG000|NOT COMPLETED|Overall Study||37||
59644690|NCT03613818|75761692|FG001|NOT COMPLETED|Overall Study||27||
59644691|NCT03614130|75761700|FG000|STARTED|Overall Study||10||20
59644692|NCT03614130|75761701|FG001|STARTED|Overall Study||12||24
59644693|NCT03614130|75761700|FG000|COMPLETED|Overall Study||10||20
59644694|NCT03614130|75761701|FG001|COMPLETED|Overall Study||12||24
59644695|NCT03614130|75761700|FG000|NOT COMPLETED|Overall Study||0||0
59644696|NCT03614130|75761701|FG001|NOT COMPLETED|Overall Study||0||0
59644697|NCT03618030|75761711|FG000|STARTED|Overall Study||15|Randomized Treatment (in double-blind period) or Last Dose Administered (dose-optimization period)|
59644698|NCT03618030|75761712|FG001|STARTED|Overall Study||14|Randomized Treatment (in double-blind period) or Last Dose Administered (dose-optimization period)|
59644699|NCT03618030|75761713|FG002|STARTED|Overall Study||21|Randomized Treatment (in double-blind period) or Last Dose Administered (dose-optimization period)|
59644700|NCT03618030|75761714|FG003|STARTED|Overall Study||39|Randomized Treatment (in double-blind period) or Last Dose Administered (dose-optimization period)|
59644701|NCT03618030|75761715|FG004|STARTED|Overall Study||36|Randomized Treatment (in double-blind period) or Last Dose Administered (dose-optimization period)|
59644702|NCT03618030|75761716|FG005|STARTED|Overall Study||27|Randomized Treatment (in double-blind period) or Last Dose Administered (dose-optimization period)|
59644703|NCT03618030|75761717|FG006|STARTED|Overall Study||18|Randomized Treatment (in double-blind period) or Last Dose Administered (dose-optimization period)|
59644704|NCT03618030|75761718|FG007|STARTED|Overall Study||118|Randomized Treatment (in double-blind period) or Last Dose Administered (dose-optimization period)|
59644705|NCT03618030|75761711|FG000|COMPLETED|Overall Study||3||
59644706|NCT03618030|75761712|FG001|COMPLETED|Overall Study||3||
59644707|NCT03618030|75761713|FG002|COMPLETED|Overall Study||13||
59644708|NCT03618030|75761714|FG003|COMPLETED|Overall Study||30||
59644709|NCT03618030|75761715|FG004|COMPLETED|Overall Study||29||
59644710|NCT03618030|75761716|FG005|COMPLETED|Overall Study||21||
59644711|NCT03618030|75761717|FG006|COMPLETED|Overall Study||14||
59644712|NCT03618030|75761718|FG007|COMPLETED|Overall Study||108||
59644713|NCT03618030|75761711|FG000|NOT COMPLETED|Overall Study||12||
59644714|NCT03618030|75761712|FG001|NOT COMPLETED|Overall Study||11||
59644715|NCT03618030|75761713|FG002|NOT COMPLETED|Overall Study||8||
59644716|NCT03618030|75761714|FG003|NOT COMPLETED|Overall Study||9||
59644717|NCT03618030|75761715|FG004|NOT COMPLETED|Overall Study||7||
59644718|NCT03618030|75761716|FG005|NOT COMPLETED|Overall Study||6||
59644719|NCT03618030|75761717|FG006|NOT COMPLETED|Overall Study||4||
59644720|NCT03618030|75761718|FG007|NOT COMPLETED|Overall Study||10||
59644721|NCT03619590|75761731|FG000|STARTED|Overall Study||103||
59644722|NCT03619590|75761731|FG000|COMPLETED|Overall Study||103||
59644723|NCT03619590|75761731|FG000|NOT COMPLETED|Overall Study||0||
59644724|NCT03623334|75761738|FG000|STARTED|Overall Study||15||
59644725|NCT03623334|75761739|FG001|STARTED|Overall Study||21||
59644726|NCT03623334|75761740|FG002|STARTED|Overall Study||19||
59644727|NCT03623334|75761738|FG000|COMPLETED|Overall Study||15||
59644728|NCT03623334|75761739|FG001|COMPLETED|Overall Study||21||
59644729|NCT03623334|75761740|FG002|COMPLETED|Overall Study||19||
59644730|NCT03623334|75761738|FG000|NOT COMPLETED|Overall Study||0||
59644731|NCT03623334|75761739|FG001|NOT COMPLETED|Overall Study||0||
59644732|NCT03623334|75761740|FG002|NOT COMPLETED|Overall Study||0||
59644733|NCT03630198|75761750|FG000|STARTED|Overall Study||13||
59644734|NCT03630198|75761751|FG001|STARTED|Overall Study||18||
59644735|NCT03630198|75761750|FG000|COMPLETED|Overall Study||13||
59644736|NCT03630198|75761751|FG001|COMPLETED|Overall Study||18||
59644737|NCT03630198|75761750|FG000|NOT COMPLETED|Overall Study||0||
59644738|NCT03630198|75761751|FG001|NOT COMPLETED|Overall Study||0||
59644739|NCT03633084|75761760|FG000|STARTED|Overall Study||3||
59644740|NCT03633084|75761761|FG001|STARTED|Overall Study||3||
59644741|NCT03633084|75761762|FG002|STARTED|Overall Study||3||
59644742|NCT03633084|75761760|FG000|COMPLETED|Overall Study||3||
59644743|NCT03633084|75761761|FG001|COMPLETED|Overall Study||3||
59644744|NCT03633084|75761762|FG002|COMPLETED|Overall Study||3||
59644745|NCT03633084|75761760|FG000|NOT COMPLETED|Overall Study||0||
59644746|NCT03633084|75761761|FG001|NOT COMPLETED|Overall Study||0||
59644747|NCT03633084|75761762|FG002|NOT COMPLETED|Overall Study||0||
59644748|NCT03637296|75761773|FG000|STARTED|Overall Study||10||
59644749|NCT03637296|75761774|FG001|STARTED|Overall Study||5||
59644750|NCT03637296|75761773|FG000|COMPLETED|Overall Study||10||
59644751|NCT03637296|75761774|FG001|COMPLETED|Overall Study||5||
59644752|NCT03637296|75761773|FG000|NOT COMPLETED|Overall Study||0||
59644753|NCT03637296|75761774|FG001|NOT COMPLETED|Overall Study||0||
59644754|NCT03637842|75761782|FG000|STARTED|Overall Study||2||
59644755|NCT03637842|75761783|FG001|STARTED|Overall Study||2||
59644756|NCT03637842|75761782|FG000|COMPLETED|Overall Study||2||
59644757|NCT03637842|75761783|FG001|COMPLETED|Overall Study||2||
59644758|NCT03637842|75761782|FG000|NOT COMPLETED|Overall Study||0||
59644759|NCT03637842|75761783|FG001|NOT COMPLETED|Overall Study||0||
59644760|NCT03638622|75761789|FG000|STARTED|Overall Study||30||
59644761|NCT03638622|75761789|FG000|COMPLETED|Overall Study||29||
59644762|NCT03638622|75761789|FG000|NOT COMPLETED|Overall Study||1||
59644763|NCT03643692|75761793|FG000|STARTED|Overall Study||12||
59644764|NCT03643692|75761793|FG000|COMPLETED|Overall Study||12||
59644765|NCT03643692|75761793|FG000|NOT COMPLETED|Overall Study||0||
59644766|NCT03645954|75761799|FG000|STARTED|Overall Study||40||
59644767|NCT03645954|75761800|FG001|STARTED|Overall Study||40||
59644768|NCT03645954|75761799|FG000|COMPLETED|Overall Study||37||
59644769|NCT03645954|75761800|FG001|COMPLETED|Overall Study||40||
59644770|NCT03645954|75761799|FG000|NOT COMPLETED|Overall Study||3||
59644771|NCT03645954|75761800|FG001|NOT COMPLETED|Overall Study||0||
59815764|NCT03026283|75938214|FG003|NOT COMPLETED|CCTA Diagnosis||0||
59815765|NCT03026283|75938215|FG004|NOT COMPLETED|CCTA Diagnosis||0||
59988576|NCT01578967|76103763|FG000|NOT COMPLETED|Overall Study||0||
59644772|NCT03647046|75761806|FG000|STARTED|Overall Study||12||
59644773|NCT03647046|75761806|FG000|COMPLETED|Overall Study||8||
59644774|NCT03647046|75761806|FG000|NOT COMPLETED|Overall Study||4||
59644775|NCT03649932|75761813|FG000|STARTED|Overall Study||14||
59644776|NCT03649932|75761814|FG001|STARTED|Overall Study||14||
59644777|NCT03649932|75761815|FG002|STARTED|Overall Study||14||
59644778|NCT03649932|75761813|FG000|COMPLETED|Overall Study||14||
59644779|NCT03649932|75761814|FG001|COMPLETED|Overall Study||13||
59644780|NCT03649932|75761815|FG002|COMPLETED|Overall Study||13||
59815766|NCT03026283|75938216|FG005|NOT COMPLETED|CCTA Diagnosis||0||
59815767|NCT03026283|75938217|FG006|NOT COMPLETED|CCTA Diagnosis||0||
59988577|NCT01186003|76103772|FG000|STARTED|Overall Study||14||
59988578|NCT01186003|76103773|FG001|STARTED|Overall Study||16||
59988579|NCT01186003|76103772|FG000|COMPLETED|Overall Study||14||
59644781|NCT03649932|75761813|FG000|NOT COMPLETED|Overall Study||0||
59644782|NCT03649932|75761814|FG001|NOT COMPLETED|Overall Study||1||
59644783|NCT03649932|75761815|FG002|NOT COMPLETED|Overall Study||1||
59644784|NCT03655080|75761823|FG000|STARTED|Overall Study||2||
59815768|NCT03026283|75938218|FG007|NOT COMPLETED|CCTA Diagnosis||0||
59644785|NCT03655080|75761823|FG000|COMPLETED|Overall Study||2||
59988580|NCT01186003|76103773|FG001|COMPLETED|Overall Study||16||
59644786|NCT03655080|75761823|FG000|NOT COMPLETED|Overall Study||0||
59644787|NCT03663816|75761827|FG000|STARTED|Overall Study||15||
59644788|NCT03663816|75761827|FG000|COMPLETED|Overall Study||15||
59644789|NCT03663816|75761827|FG000|NOT COMPLETED|Overall Study||0||
59644790|NCT03669354|75761835|FG000|STARTED|Overall Study||73||
59644791|NCT03669354|75761836|FG001|STARTED|Overall Study||22||
59644792|NCT03669354|75761837|FG002|STARTED|Overall Study||47||
59644793|NCT03669354|75761838|FG003|STARTED|Overall Study||53||
59988581|NCT01186003|76103772|FG000|NOT COMPLETED|Overall Study||0||
59644794|NCT03669354|75761835|FG000|COMPLETED|Overall Study||73||
59644795|NCT03669354|75761836|FG001|COMPLETED|Overall Study||22||
59644796|NCT03669354|75761837|FG002|COMPLETED|Overall Study||47||
59644797|NCT03669354|75761838|FG003|COMPLETED|Overall Study||53||
59644798|NCT03669354|75761835|FG000|NOT COMPLETED|Overall Study||0||
59644799|NCT03669354|75761836|FG001|NOT COMPLETED|Overall Study||0||
59644800|NCT03669354|75761837|FG002|NOT COMPLETED|Overall Study||0||
59644801|NCT03669354|75761838|FG003|NOT COMPLETED|Overall Study||0||
59644802|NCT03674970|75761852|FG000|STARTED|Overall Study||15||
59644803|NCT03674970|75761853|FG001|STARTED|Overall Study||15||
59644804|NCT03674970|75761854|FG002|STARTED|Overall Study||15||
59644805|NCT03674970|75761852|FG000|COMPLETED|Overall Study||12||
59644806|NCT03674970|75761853|FG001|COMPLETED|Overall Study||8||
59644807|NCT03674970|75761854|FG002|COMPLETED|Overall Study||12||
59644808|NCT03674970|75761852|FG000|NOT COMPLETED|Overall Study||3||
59644809|NCT03674970|75761853|FG001|NOT COMPLETED|Overall Study||7||
59644810|NCT03674970|75761854|FG002|NOT COMPLETED|Overall Study||3||
59644811|NCT03679494|75761864|FG000|STARTED|Overall Study||67||
59644812|NCT03679494|75761865|FG001|STARTED|Overall Study||63||
59644813|NCT03679494|75761864|FG000|COMPLETED|Overall Study||67||
59644814|NCT03679494|75761865|FG001|COMPLETED|Overall Study||63||
59644815|NCT03679494|75761864|FG000|NOT COMPLETED|Overall Study||0||
59644816|NCT03679494|75761865|FG001|NOT COMPLETED|Overall Study||0||
59644817|NCT03685968|75761874|FG000|STARTED|Overall Study||75||
59644818|NCT03685968|75761875|FG001|STARTED|Overall Study||75||
59644819|NCT03685968|75761876|FG002|STARTED|Overall Study||75||
59644820|NCT03685968|75761874|FG000|COMPLETED|Overall Study||75||
59644821|NCT03685968|75761875|FG001|COMPLETED|Overall Study||75||
59644822|NCT03685968|75761876|FG002|COMPLETED|Overall Study||75||
59644823|NCT03685968|75761874|FG000|NOT COMPLETED|Overall Study||0||
59644824|NCT03685968|75761875|FG001|NOT COMPLETED|Overall Study||0||
59644825|NCT03685968|75761876|FG002|NOT COMPLETED|Overall Study||0||
59644826|NCT03687450|75761886|FG000|STARTED|Overall Study||38||
59644827|NCT03687450|75761887|FG001|STARTED|Overall Study||18||
59644828|NCT03687450|75761886|FG000|Post-Program Follow-Up|Overall Study|1 withdrew, 9 lost to follow-up|28||
59644829|NCT03687450|75761887|FG001|Post-Program Follow-Up|Overall Study|3 lost to follow-up|15||
59644830|NCT03687450|75761886|FG000|Two-month Follow-up|Overall Study|2 lost to follow-up|26||
59644831|NCT03687450|75761887|FG001|Two-month Follow-up|Overall Study|2 lost to follow-up (N.B. 1 participant completed 2-month follow-up but not post-program follow-up)|16||
59644832|NCT03687450|75761886|FG000|COMPLETED|Overall Study||26||
59644833|NCT03687450|75761887|FG001|COMPLETED|Overall Study||16||
59644834|NCT03687450|75761886|FG000|NOT COMPLETED|Overall Study||12||
59644835|NCT03687450|75761887|FG001|NOT COMPLETED|Overall Study||2||
59644836|NCT03687684|75761902|FG000|STARTED|Overall Study||4||
59644837|NCT03687684|75761903|FG001|STARTED|Overall Study||2||
59644838|NCT03687684|75761904|FG002|STARTED|Overall Study||2||
59644839|NCT03687684|75761905|FG003|STARTED|Overall Study||6||
59644840|NCT03687684|75761906|FG004|STARTED|Overall Study||6||
59644841|NCT03687684|75761907|FG005|STARTED|Overall Study||6||
59644842|NCT03687684|75761908|FG006|STARTED|Overall Study||6||
59644843|NCT03687684|75761909|FG007|STARTED|Overall Study||2||
59644844|NCT03687684|75761910|FG008|STARTED|Overall Study||6||
59644845|NCT03687684|75761902|FG000|COMPLETED|Overall Study||4||
59644846|NCT03687684|75761903|FG001|COMPLETED|Overall Study||2||
59644847|NCT03687684|75761904|FG002|COMPLETED|Overall Study||2||
59644848|NCT03687684|75761905|FG003|COMPLETED|Overall Study||6||
59644849|NCT03687684|75761906|FG004|COMPLETED|Overall Study||6||
59644850|NCT03687684|75761907|FG005|COMPLETED|Overall Study||6||
59644851|NCT03687684|75761908|FG006|COMPLETED|Overall Study||6||
59644852|NCT03687684|75761909|FG007|COMPLETED|Overall Study||2||
59644853|NCT03687684|75761910|FG008|COMPLETED|Overall Study||6||
59644854|NCT03687684|75761902|FG000|NOT COMPLETED|Overall Study||0||
59644855|NCT03687684|75761903|FG001|NOT COMPLETED|Overall Study||0||
59644856|NCT03687684|75761904|FG002|NOT COMPLETED|Overall Study||0||
59644857|NCT03687684|75761905|FG003|NOT COMPLETED|Overall Study||0||
59644858|NCT03687684|75761906|FG004|NOT COMPLETED|Overall Study||0||
59644859|NCT03687684|75761907|FG005|NOT COMPLETED|Overall Study||0||
59644860|NCT03687684|75761908|FG006|NOT COMPLETED|Overall Study||0||
59644861|NCT03687684|75761909|FG007|NOT COMPLETED|Overall Study||0||
59644862|NCT03687684|75761910|FG008|NOT COMPLETED|Overall Study||0||
59644863|NCT03688542|75761942|FG000|STARTED|Overall Study|No individual participants were recruited, only nursing homes.|||27
59644864|NCT03688542|75761943|FG001|STARTED|Overall Study|No individual participants were recruited, only nursing homes.|||29
59644865|NCT03688542|75761942|FG000|COMPLETED|Overall Study|No individual participants were recruited, only nursing homes.|||27
59644866|NCT03688542|75761943|FG001|COMPLETED|Overall Study|"1 nursing home withdrew from the study.~No individual participants were recruited, only nursing homes."|||28
59644867|NCT03688542|75761942|FG000|NOT COMPLETED|Overall Study||||0
59644868|NCT03688542|75761943|FG001|NOT COMPLETED|Overall Study||||1
59644869|NCT03697122|75761949|FG000|STARTED|Overall Study||14||
59644870|NCT03697122|75761949|FG000|COMPLETED|Overall Study||14||
59644871|NCT03697122|75761949|FG000|NOT COMPLETED|Overall Study||0||
59644872|NCT03704376|75761955|FG000|STARTED|Overall Study||42||
59644873|NCT03704376|75761956|FG001|STARTED|Overall Study||44||
59644874|NCT03704376|75761955|FG000|COMPLETED|Overall Study||38||
59644875|NCT03704376|75761956|FG001|COMPLETED|Overall Study||40||
59644876|NCT03704376|75761955|FG000|NOT COMPLETED|Overall Study||4||
59644877|NCT03704376|75761956|FG001|NOT COMPLETED|Overall Study||4||
59644878|NCT03709602|75761965|FG000|STARTED|Overall Study|Adolescents recruited for qualitative interviews.|16||
59644879|NCT03709602|75761966|FG001|STARTED|Overall Study|Parents recruited for qualitative interviews.|16||
59644880|NCT03709602|75761967|FG002|STARTED|Overall Study|Cohort of adolescents created from the EHR data for the quantitative portion of the study.|3044||
59644881|NCT03709602|75761965|FG000|COMPLETED|Overall Study|Adolescents recruited for qualitative interviews.|16||
59644882|NCT03709602|75761966|FG001|COMPLETED|Overall Study|Parents recruited for qualitative interviews.|16||
59644883|NCT03709602|75761967|FG002|COMPLETED|Overall Study|Cohort of adolescents created from the EHR data for the quantitative portion of the study.|3044||
59644884|NCT03709602|75761965|FG000|NOT COMPLETED|Overall Study||0||
59644885|NCT03709602|75761966|FG001|NOT COMPLETED|Overall Study||0||
59644886|NCT03709602|75761967|FG002|NOT COMPLETED|Overall Study||0||
59644887|NCT03711396|75761973|FG000|STARTED|Overall Study||13||
59644888|NCT03711396|75761974|FG001|STARTED|Overall Study||13||
59644889|NCT03711396|75761973|FG000|COMPLETED|Overall Study||13||
59644890|NCT03711396|75761974|FG001|COMPLETED|Overall Study||13||
59644891|NCT03711396|75761973|FG000|NOT COMPLETED|Overall Study||0||
59644892|NCT03711396|75761974|FG001|NOT COMPLETED|Overall Study||0||
59644893|NCT03715452|75761981|FG000|STARTED|Overall Study||114||
59644894|NCT03715452|75761981|FG000|COMPLETED|Overall Study||114||
59644895|NCT03715452|75761981|FG000|NOT COMPLETED|Overall Study||0||
59644896|NCT03716076|75761987|FG000|STARTED|Overall Study||25||
59644897|NCT03716076|75761988|FG001|STARTED|Overall Study||25||
59644898|NCT03716076|75761987|FG000|COMPLETED|Overall Study||22||
59644899|NCT03716076|75761988|FG001|COMPLETED|Overall Study||19||
59644900|NCT03716076|75761987|FG000|NOT COMPLETED|Overall Study||3||
59644901|NCT03716076|75761988|FG001|NOT COMPLETED|Overall Study||6||
59644902|NCT03801408|75761994|FG000|STARTED|Overall Study||145||
59644903|NCT03801408|75761994|FG000|COMPLETED|Overall Study||145||
59644904|NCT03801408|75761994|FG000|NOT COMPLETED|Overall Study||0||
59644905|NCT03835728|75762000|FG000|STARTED|Overall Study||2||
59644906|NCT03835728|75762001|FG001|STARTED|Overall Study||1||
59644907|NCT03835728|75762000|FG000|COMPLETED|Overall Study||2|Completed is defined as completing study procedures according to protocol even if the participant met primary endpoint and discontinued prior to 12 months.|
59644908|NCT03835728|75762001|FG001|COMPLETED|Overall Study||1|Completed is defined as completing study procedures according to protocol even if the participant met primary endpoint and discontinued prior to 12 months.|
59644909|NCT03835728|75762000|FG000|NOT COMPLETED|Overall Study||0||
59644910|NCT03835728|75762001|FG001|NOT COMPLETED|Overall Study||0||
59644911|NCT03848910|75762007|FG000|STARTED|Overall Study||11||
59644912|NCT03848910|75762007|FG000|COMPLETED|Overall Study||11||
59644913|NCT03848910|75762007|FG000|NOT COMPLETED|Overall Study||0||
59644914|NCT03861780|75762015|FG000|STARTED|Overall Study||51||
59644915|NCT03861780|75762016|FG001|STARTED|Overall Study||50||
59644916|NCT03861780|75762017|FG002|STARTED|Overall Study||51||
59644917|NCT03861780|75762015|FG000|COMPLETED|Overall Study||51||
59644918|NCT03861780|75762016|FG001|COMPLETED|Overall Study||50||
59644919|NCT03861780|75762017|FG002|COMPLETED|Overall Study||51||
59644920|NCT03861780|75762015|FG000|NOT COMPLETED|Overall Study||0||
59644921|NCT03861780|75762016|FG001|NOT COMPLETED|Overall Study||0||
59644922|NCT03861780|75762017|FG002|NOT COMPLETED|Overall Study||0||
59644923|NCT03889158|75762027|FG000|STARTED|Overall Study||20||
59644924|NCT03889158|75762028|FG001|STARTED|Overall Study||15||
59644925|NCT03889158|75762027|FG000|COMPLETED|Overall Study||16||
59644926|NCT03889158|75762028|FG001|COMPLETED|Overall Study||9||
59644927|NCT03889158|75762027|FG000|NOT COMPLETED|Overall Study||4||
59644928|NCT03889158|75762028|FG001|NOT COMPLETED|Overall Study||6||
59644929|NCT04018794|75762035|FG000|STARTED|Overall Study|N=15 students participants completed the open trial of usability/feasibility of the intervention and completed quantitative ratings of usability before and after using the program.|15||
59644930|NCT04018794|75762035|FG000|COMPLETED|Overall Study|N=15 students participants completed the open trial of usability/feasibility of the intervention and completed quantitative ratings of usability before and after using the program.|15||
59644931|NCT04018794|75762035|FG000|NOT COMPLETED|Overall Study||0||
59644932|NCT04096482|75762039|FG000|STARTED|Overall Study||6||
59644933|NCT04096482|75762039|FG000|COMPLETED|Overall Study||6||
59644934|NCT04096482|75762039|FG000|NOT COMPLETED|Overall Study||0||
59644935|NCT04138758|75762047|FG000|STARTED|Overall Study||2600||
59644936|NCT04138758|75762048|FG001|STARTED|Overall Study||40353||
59644937|NCT04138758|75762047|FG000|COMPLETED|Overall Study||2600||
59644938|NCT04138758|75762048|FG001|COMPLETED|Overall Study||40353||
59644939|NCT04138758|75762047|FG000|NOT COMPLETED|Overall Study||0||
59644940|NCT04138758|75762048|FG001|NOT COMPLETED|Overall Study||0||
59644941|NCT04323852|75762056|FG000|STARTED|Overall Study||35||
59644942|NCT04323852|75762057|FG001|STARTED|Overall Study||35||
59644943|NCT04323852|75762056|FG000|COMPLETED|Overall Study||35||
59644944|NCT04323852|75762057|FG001|COMPLETED|Overall Study||35||
59644945|NCT04323852|75762056|FG000|NOT COMPLETED|Overall Study||0||
59644946|NCT04323852|75762057|FG001|NOT COMPLETED|Overall Study||0||
59644947|NCT04381728|75762063|FG000|STARTED|Overall Study||23||
59644948|NCT04381728|75762063|FG000|COMPLETED|Overall Study||23||
59644949|NCT04381728|75762063|FG000|NOT COMPLETED|Overall Study||0||
59644950|NCT04420572|75762069|FG000|STARTED|Overall Study||33||
59644951|NCT04420572|75762070|FG001|STARTED|Overall Study||30||
59644952|NCT04420572|75762069|FG000|COMPLETED|Overall Study||33||
59644953|NCT04420572|75762070|FG001|COMPLETED|Overall Study||30||
59644954|NCT04420572|75762069|FG000|NOT COMPLETED|Overall Study||0||
59644955|NCT04420572|75762070|FG001|NOT COMPLETED|Overall Study||0||
59644956|NCT04709484|75762078|FG000|STARTED|Overall Study||34||
59644957|NCT04709484|75762079|FG001|STARTED|Overall Study||32||
59644958|NCT04709484|75762078|FG000|COMPLETED|Overall Study||34||
59644959|NCT04709484|75762079|FG001|COMPLETED|Overall Study||32||
59644960|NCT04709484|75762078|FG000|NOT COMPLETED|Overall Study||0||
59644961|NCT04709484|75762079|FG001|NOT COMPLETED|Overall Study||0||
59644962|NCT03541980|75762087|FG000|STARTED|Overall Study||35||
59644963|NCT03541980|75762088|FG001|STARTED|Overall Study||36||
59644964|NCT03541980|75762087|FG000|COMPLETED|Overall Study||35||
59644965|NCT03541980|75762088|FG001|COMPLETED|Overall Study||36||
59644966|NCT03541980|75762087|FG000|NOT COMPLETED|Overall Study||0||
59644967|NCT03541980|75762088|FG001|NOT COMPLETED|Overall Study||0||
59644968|NCT04898166|75762102|FG000|STARTED|Overall Study||220||
59644969|NCT04898166|75762103|FG001|STARTED|Overall Study||80||
59644970|NCT04898166|75762102|FG000|COMPLETED|Overall Study||220||
59644971|NCT04898166|75762103|FG001|COMPLETED|Overall Study||80||
59644972|NCT04898166|75762102|FG000|NOT COMPLETED|Overall Study||0||
59644973|NCT04898166|75762103|FG001|NOT COMPLETED|Overall Study||0||
59644974|NCT04511520|75762124|FG000|STARTED|Overall Study||24||
59644975|NCT04511520|75762125|FG001|STARTED|Overall Study||24||
59644976|NCT04511520|75762126|FG002|STARTED|Overall Study||24||
59644977|NCT04511520|75762124|FG000|COMPLETED|Overall Study||24||
59644978|NCT04511520|75762125|FG001|COMPLETED|Overall Study||24||
59644979|NCT04511520|75762126|FG002|COMPLETED|Overall Study||24||
59644980|NCT04511520|75762124|FG000|NOT COMPLETED|Overall Study||0||
59644981|NCT04511520|75762125|FG001|NOT COMPLETED|Overall Study||0||
59644982|NCT04511520|75762126|FG002|NOT COMPLETED|Overall Study||0||
59644983|NCT04491240|75762138|FG000|STARTED|Overall Study||10||
59815769|NCT03026283|75938211|FG000|STARTED|Optimal Medical Care/FFR-CT Diagnosis||0|Note: Number of participants to start period is not equal to number who completed previous period.|
59817896|NCT04488770|75940335|FG009|COMPLETED|Part 1-Cohort 2: Period 1 (Up to 5 Days)||0||
59644984|NCT04491240|75762139|FG001|STARTED|Overall Study||10||
59644985|NCT04491240|75762140|FG002|STARTED|Overall Study||10||
59644986|NCT04491240|75762138|FG000|COMPLETED|Overall Study||10||
59644987|NCT04491240|75762139|FG001|COMPLETED|Overall Study||10||
59644988|NCT04491240|75762140|FG002|COMPLETED|Overall Study||10||
59644989|NCT04491240|75762138|FG000|NOT COMPLETED|Overall Study||0||
59644990|NCT04491240|75762139|FG001|NOT COMPLETED|Overall Study||0||
59644991|NCT04491240|75762140|FG002|NOT COMPLETED|Overall Study||0||
59644992|NCT04463004|75762150|FG000|STARTED|Overall Study||1||
59644993|NCT04463004|75762151|FG001|STARTED|Overall Study||1||
59644994|NCT04463004|75762150|FG000|COMPLETED|Overall Study||1||
59644995|NCT04463004|75762151|FG001|COMPLETED|Overall Study||1||
59644996|NCT04463004|75762150|FG000|NOT COMPLETED|Overall Study||0||
59644997|NCT04463004|75762151|FG001|NOT COMPLETED|Overall Study||0||
59644998|NCT04430634|75762165|FG000|STARTED|Overall Study||5||
59644999|NCT04430634|75762166|FG001|STARTED|Overall Study||5||
59645000|NCT04430634|75762167|FG002|STARTED|Overall Study||5||
59645001|NCT04430634|75762168|FG003|STARTED|Overall Study||5||
59645002|NCT04430634|75762169|FG004|STARTED|Overall Study||5||
59645003|NCT04430634|75762170|FG005|STARTED|Overall Study||5||
59645004|NCT04430634|75762171|FG006|STARTED|Overall Study||5||
59645005|NCT04430634|75762172|FG007|STARTED|Overall Study||5||
59645006|NCT04430634|75762165|FG000|COMPLETED|Overall Study||5||
59645007|NCT04430634|75762166|FG001|COMPLETED|Overall Study||5||
59645008|NCT04430634|75762167|FG002|COMPLETED|Overall Study||5||
59645009|NCT04430634|75762168|FG003|COMPLETED|Overall Study||4||
59645010|NCT04430634|75762169|FG004|COMPLETED|Overall Study||5||
59645011|NCT04430634|75762170|FG005|COMPLETED|Overall Study||5||
59645012|NCT04430634|75762171|FG006|COMPLETED|Overall Study||4||
59645013|NCT04430634|75762172|FG007|COMPLETED|Overall Study||5||
59645014|NCT04430634|75762165|FG000|NOT COMPLETED|Overall Study||0||
59645015|NCT04430634|75762166|FG001|NOT COMPLETED|Overall Study||0||
59645016|NCT04430634|75762167|FG002|NOT COMPLETED|Overall Study||0||
59645017|NCT04430634|75762168|FG003|NOT COMPLETED|Overall Study||1||
59645018|NCT04430634|75762169|FG004|NOT COMPLETED|Overall Study||0||
59645019|NCT04430634|75762170|FG005|NOT COMPLETED|Overall Study||0||
59645020|NCT04430634|75762171|FG006|NOT COMPLETED|Overall Study||1||
59645021|NCT04430634|75762172|FG007|NOT COMPLETED|Overall Study||0||
59645022|NCT04429932|75762199|FG000|STARTED|Overall Study||4||
59645023|NCT04429932|75762200|FG001|STARTED|Overall Study||5||
59645024|NCT04429932|75762201|FG002|STARTED|Overall Study||5||
59645025|NCT04429932|75762202|FG003|STARTED|Overall Study||5||
59645026|NCT04429932|75762203|FG004|STARTED|Overall Study||5||
59645027|NCT04429932|75762204|FG005|STARTED|Overall Study||5||
59645028|NCT04429932|75762205|FG006|STARTED|Overall Study||5||
59645029|NCT04429932|75762206|FG007|STARTED|Overall Study||5||
59645030|NCT04429932|75762199|FG000|COMPLETED|Overall Study||3||
59645031|NCT04429932|75762200|FG001|COMPLETED|Overall Study||5||
59645032|NCT04429932|75762201|FG002|COMPLETED|Overall Study||5||
59645033|NCT04429932|75762202|FG003|COMPLETED|Overall Study||2||
59645034|NCT04429932|75762203|FG004|COMPLETED|Overall Study||5||
59645035|NCT04429932|75762204|FG005|COMPLETED|Overall Study||5||
59645036|NCT04429932|75762205|FG006|COMPLETED|Overall Study||5||
59645037|NCT04429932|75762206|FG007|COMPLETED|Overall Study||5||
59645038|NCT04429932|75762199|FG000|NOT COMPLETED|Overall Study||1||
59645039|NCT04429932|75762200|FG001|NOT COMPLETED|Overall Study||0||
59645040|NCT04429932|75762201|FG002|NOT COMPLETED|Overall Study||0||
59645041|NCT04429932|75762202|FG003|NOT COMPLETED|Overall Study||3||
59645042|NCT04429932|75762203|FG004|NOT COMPLETED|Overall Study||0||
59645043|NCT04429932|75762204|FG005|NOT COMPLETED|Overall Study||0||
59645044|NCT04429932|75762205|FG006|NOT COMPLETED|Overall Study||0||
59645045|NCT04429932|75762206|FG007|NOT COMPLETED|Overall Study||0||
59645046|NCT04409886|75762225|FG000|STARTED|Overall Study||1||
59645047|NCT04409886|75762225|FG000|COMPLETED|Overall Study||1||
59645048|NCT04409886|75762225|FG000|NOT COMPLETED|Overall Study||0||
59645049|NCT04399980|75762231|FG000|STARTED|Overall Study||21||
59645050|NCT04399980|75762232|FG001|STARTED|Overall Study||19||
59645051|NCT04399980|75762231|FG000|COMPLETED|Overall Study||21||
59645052|NCT04399980|75762232|FG001|COMPLETED|Overall Study||19||
59645053|NCT04399980|75762231|FG000|NOT COMPLETED|Overall Study||0||
59645054|NCT04399980|75762232|FG001|NOT COMPLETED|Overall Study||0||
59645055|NCT04397094|75762240|FG000|STARTED|Overall Study||30||
59645056|NCT04397094|75762241|FG001|STARTED|Overall Study||30||
59645057|NCT04397094|75762240|FG000|COMPLETED|Overall Study||30||
59645058|NCT04397094|75762241|FG001|COMPLETED|Overall Study||30||
59645059|NCT04397094|75762240|FG000|NOT COMPLETED|Overall Study||0||
59645060|NCT04397094|75762241|FG001|NOT COMPLETED|Overall Study||0||
59645061|NCT04385238|75762251|FG000|STARTED|Overall Study||5712||
59645062|NCT04385238|75762252|FG001|STARTED|Overall Study||1182||
59645063|NCT04385238|75762251|FG000|COMPLETED|Overall Study||5712||
59645064|NCT04385238|75762252|FG001|COMPLETED|Overall Study||1182||
59645065|NCT04385238|75762251|FG000|NOT COMPLETED|Overall Study||0||
59645066|NCT04385238|75762252|FG001|NOT COMPLETED|Overall Study||0||
59645067|NCT04383132|75762260|FG000|STARTED|Overall Study||173||
59645068|NCT04383132|75762261|FG001|STARTED|Overall Study||173||
59645069|NCT04383132|75762260|FG000|COMPLETED|Overall Study||173||
59645070|NCT04383132|75762261|FG001|COMPLETED|Overall Study||173||
59645071|NCT04383132|75762260|FG000|NOT COMPLETED|Overall Study||0||
59645072|NCT04383132|75762261|FG001|NOT COMPLETED|Overall Study||0||
59645073|NCT04335552|75762271|FG000|STARTED|Overall Study||2||
59645074|NCT04335552|75762272|FG001|STARTED|Overall Study||4||
59645075|NCT04335552|75762273|FG002|STARTED|Overall Study||3||
59645076|NCT04335552|75762274|FG003|STARTED|Overall Study||2||
59645077|NCT04335552|75762271|FG000|COMPLETED|Overall Study||1||
59645078|NCT04335552|75762272|FG001|COMPLETED|Overall Study||4||
59645079|NCT04335552|75762273|FG002|COMPLETED|Overall Study||3||
59645080|NCT04335552|75762274|FG003|COMPLETED|Overall Study||2||
59645081|NCT04335552|75762271|FG000|NOT COMPLETED|Overall Study||1||
59645082|NCT04335552|75762272|FG001|NOT COMPLETED|Overall Study||0||
59645083|NCT04335552|75762273|FG002|NOT COMPLETED|Overall Study||0||
59645084|NCT04335552|75762274|FG003|NOT COMPLETED|Overall Study||0||
59645085|NCT04321980|75762286|FG000|STARTED|Overall Study||4||
59645086|NCT04321980|75762287|FG001|STARTED|Overall Study||4||
59645087|NCT04321980|75762286|FG000|COMPLETED|Overall Study||4||
59645088|NCT04321980|75762287|FG001|COMPLETED|Overall Study||4||
59645089|NCT04321980|75762286|FG000|NOT COMPLETED|Overall Study||0||
59645090|NCT04321980|75762287|FG001|NOT COMPLETED|Overall Study||0||
59645091|NCT04288752|75762295|FG000|STARTED|Overall Study|88 Participants were randomized to the VR101 group. However, one randomized participant (AR33) was unable to place the device and was immediately terminated from the study, prior to any post-randomization data collection. Therefore, 87 participants assigned to the VR101 group entered the treatment phase.|87||
59645092|NCT04288752|75762296|FG001|STARTED|Overall Study||88||
59645093|NCT04288752|75762295|FG000|COMPLETED|Overall Study||81||
59645094|NCT04288752|75762296|FG001|COMPLETED|Overall Study||85||
59645095|NCT04288752|75762295|FG000|NOT COMPLETED|Overall Study||6||
59645096|NCT04288752|75762296|FG001|NOT COMPLETED|Overall Study||3||
59645097|NCT04287036|75762302|FG000|STARTED|Period 1||13||
59645098|NCT04287036|75762303|FG001|STARTED|Period 1||12||
59645099|NCT04287036|75762302|FG000|COMPLETED|Period 1||13||
59645100|NCT04287036|75762303|FG001|COMPLETED|Period 1||12||
59645101|NCT04287036|75762302|FG000|NOT COMPLETED|Period 1||0||
59645102|NCT04287036|75762303|FG001|NOT COMPLETED|Period 1||0||
59645103|NCT04287036|75762302|FG000|STARTED|Period 2||13||
59645104|NCT04287036|75762303|FG001|STARTED|Period 2||12||
59645105|NCT04287036|75762302|FG000|COMPLETED|Period 2||13||
59645106|NCT04287036|75762303|FG001|COMPLETED|Period 2||12||
59645107|NCT04287036|75762302|FG000|NOT COMPLETED|Period 2||0||
59645108|NCT04287036|75762303|FG001|NOT COMPLETED|Period 2||0||
59645109|NCT04284930|75762312|FG000|STARTED|Overall Study||8||
59645110|NCT04284930|75762313|FG001|STARTED|Overall Study||5||
59645111|NCT04284930|75762314|FG002|STARTED|Overall Study||8||
59645112|NCT04284930|75762312|FG000|COMPLETED|Overall Study||8||
59645113|NCT04284930|75762313|FG001|COMPLETED|Overall Study||5||
59645114|NCT04284930|75762314|FG002|COMPLETED|Overall Study||8||
59645115|NCT04284930|75762312|FG000|NOT COMPLETED|Overall Study||0||
59645116|NCT04284930|75762313|FG001|NOT COMPLETED|Overall Study||0||
59645117|NCT04284930|75762314|FG002|NOT COMPLETED|Overall Study||0||
59645118|NCT04267770|75762324|FG000|STARTED|Overall Study||9||
59645119|NCT04267770|75762325|FG001|STARTED|Overall Study||8||
59645120|NCT04267770|75762324|FG000|COMPLETED|Overall Study||9||
59645121|NCT04267770|75762325|FG001|COMPLETED|Overall Study||8||
59645122|NCT04267770|75762324|FG000|NOT COMPLETED|Overall Study||0||
59645123|NCT04267770|75762325|FG001|NOT COMPLETED|Overall Study||0||
59645124|NCT04252092|75762333|FG000|STARTED|Overall Study||15||
59645125|NCT04252092|75762334|FG001|STARTED|Overall Study||15||
59645126|NCT04252092|75762333|FG000|COMPLETED|Overall Study||15||
59645127|NCT04252092|75762334|FG001|COMPLETED|Overall Study||15||
59645128|NCT04252092|75762333|FG000|NOT COMPLETED|Overall Study||0||
59645129|NCT04252092|75762334|FG001|NOT COMPLETED|Overall Study||0||
59645130|NCT04204200|75762343|FG000|STARTED|Overall Study||22||
59645131|NCT04204200|75762344|FG001|STARTED|Overall Study||22||
59645132|NCT04204200|75762345|FG002|STARTED|Overall Study||22||
59645133|NCT04204200|75762343|FG000|COMPLETED|Overall Study||22||
59645134|NCT04204200|75762344|FG001|COMPLETED|Overall Study||22||
59645135|NCT04204200|75762345|FG002|COMPLETED|Overall Study||22||
59645136|NCT04204200|75762343|FG000|NOT COMPLETED|Overall Study||0||
59645137|NCT04204200|75762344|FG001|NOT COMPLETED|Overall Study||0||
59645138|NCT04204200|75762345|FG002|NOT COMPLETED|Overall Study||0||
59645139|NCT04179474|75762355|FG000|STARTED|Treatment Period 1 (First Intervention)||20||
59645140|NCT04179474|75762356|FG001|STARTED|Treatment Period 1 (First Intervention)||20||
59645141|NCT04179474|75762355|FG000|COMPLETED|Treatment Period 1 (First Intervention)||20||
59645142|NCT04179474|75762356|FG001|COMPLETED|Treatment Period 1 (First Intervention)||20||
59645143|NCT04179474|75762355|FG000|NOT COMPLETED|Treatment Period 1 (First Intervention)||0||
59645144|NCT04179474|75762356|FG001|NOT COMPLETED|Treatment Period 1 (First Intervention)||0||
59645145|NCT04179474|75762355|FG000|STARTED|Treatment Period 2 (Second Intervention)|1 participant did not receive Intervention B.|19||
59645146|NCT04179474|75762356|FG001|STARTED|Treatment Period 2 (Second Intervention)||20||
59645147|NCT04179474|75762355|FG000|COMPLETED|Treatment Period 2 (Second Intervention)||19||
59645148|NCT04179474|75762356|FG001|COMPLETED|Treatment Period 2 (Second Intervention)||20||
59645149|NCT04179474|75762355|FG000|NOT COMPLETED|Treatment Period 2 (Second Intervention)||0||
59645150|NCT04179474|75762356|FG001|NOT COMPLETED|Treatment Period 2 (Second Intervention)||0||
59645151|NCT04179474|75762355|FG000|STARTED|Treatment Period 3 (Third Intervention)||19||
59645152|NCT04179474|75762356|FG001|STARTED|Treatment Period 3 (Third Intervention)|1 participant did not receive Intervention D.|19||
59645153|NCT04179474|75762355|FG000|COMPLETED|Treatment Period 3 (Third Intervention)||19||
59645154|NCT04179474|75762356|FG001|COMPLETED|Treatment Period 3 (Third Intervention)||19||
59645155|NCT04179474|75762355|FG000|NOT COMPLETED|Treatment Period 3 (Third Intervention)||0||
59645156|NCT04179474|75762356|FG001|NOT COMPLETED|Treatment Period 3 (Third Intervention)||0||
59645157|NCT04174638|75762379|FG000|STARTED|Overall Study||32||
59645158|NCT04174638|75762380|FG001|STARTED|Overall Study||28||
59645159|NCT04174638|75762379|FG000|COMPLETED|Overall Study||32||
59645160|NCT04174638|75762380|FG001|COMPLETED|Overall Study||28||
59645161|NCT04174638|75762379|FG000|NOT COMPLETED|Overall Study||0||
59645162|NCT04174638|75762380|FG001|NOT COMPLETED|Overall Study||0||
59645163|NCT04152642|75762389|FG000|STARTED|Overall Study||22||
59645164|NCT04152642|75762389|FG000|C (Water/Negative) Control|Overall Study||20|This was a 3-treatment, 3-period, cross-over design. Each subject was assigned to receive each treatment. Each period lasted 4 days.|
59645165|NCT04152642|75762389|FG000|A (Marketed Rinse)|Overall Study||19|This was a 3-treatment, 3-period, cross-over design. Each subject was assigned to receive each treatment. Each period lasted 4 days.|
59645166|NCT04152642|75762389|FG000|B (Experimental Rinse)|Overall Study||19|This was a 3-treatment, 3-period, cross-over design. Each subject was assigned to receive each treatment. Each period lasted 4 days.|
59645167|NCT04152642|75762389|FG000|COMPLETED|Overall Study||15|15 subjects received all 3 treatment products|
59645168|NCT04152642|75762389|FG000|NOT COMPLETED|Overall Study||7||
59645169|NCT04150224|75762403|FG000|STARTED|Overall Study|10 healthy volunteers receiving PBTZ169 + 1 backup volunteer|10||
59645170|NCT04150224|75762404|FG001|STARTED|Overall Study|10 healthy volunteers receiving PBTZ169 + 1 backup volunteer|10||
59645171|NCT04150224|75762405|FG002|STARTED|Overall Study|10 healthy volunteers receiving PBTZ169 + 1 backup volunteer|10||
59645172|NCT04150224|75762406|FG003|STARTED|Overall Study|10 healthy volunteers receiving PBTZ169 + 1 backup volunteer|10||
59645173|NCT04150224|75762407|FG004|STARTED|Overall Study|10 healthy volunteers receiving PBTZ169 + 1 backup volunteer|10||
59645174|NCT04150224|75762408|FG005|STARTED|Overall Study|Period 2: Multple Dosing|10||
59645175|NCT04150224|75762403|FG000|COMPLETED|Overall Study||10||
59645176|NCT04150224|75762404|FG001|COMPLETED|Overall Study||10||
59645177|NCT04150224|75762405|FG002|COMPLETED|Overall Study||10||
59645178|NCT04150224|75762406|FG003|COMPLETED|Overall Study||10||
59645179|NCT04150224|75762407|FG004|COMPLETED|Overall Study||10||
59645180|NCT04150224|75762408|FG005|COMPLETED|Overall Study|Period 2: Multple Dosing|10||
59645181|NCT04150224|75762403|FG000|NOT COMPLETED|Overall Study||0||
59645182|NCT04150224|75762404|FG001|NOT COMPLETED|Overall Study||0||
59645183|NCT04150224|75762405|FG002|NOT COMPLETED|Overall Study||0||
59645184|NCT04150224|75762406|FG003|NOT COMPLETED|Overall Study||0||
59645185|NCT04150224|75762407|FG004|NOT COMPLETED|Overall Study||0||
59645186|NCT04150224|75762408|FG005|NOT COMPLETED|Overall Study||0||
59645187|NCT04116684|75762433|FG000|STARTED|Overall Study||3||
59645188|NCT04116684|75762434|FG001|STARTED|Overall Study||1||
59645189|NCT04116684|75762433|FG000|COMPLETED|Overall Study||1||
59645190|NCT04116684|75762434|FG001|COMPLETED|Overall Study||1||
59645191|NCT04116684|75762433|FG000|NOT COMPLETED|Overall Study||2||
59645192|NCT04116684|75762434|FG001|NOT COMPLETED|Overall Study||0||
59645193|NCT04102956|75762442|FG000|STARTED|Overall Study||42||
59645194|NCT04102956|75762443|FG001|STARTED|Overall Study||38||
59645195|NCT04102956|75762442|FG000|COMPLETED|Overall Study||42||
59645196|NCT04102956|75762443|FG001|COMPLETED|Overall Study||38||
59645197|NCT04102956|75762442|FG000|NOT COMPLETED|Overall Study||0||
59645198|NCT04102956|75762443|FG001|NOT COMPLETED|Overall Study||0||
59645199|NCT04086576|75762451|FG000|STARTED|Overall Study||10||
59645200|NCT04086576|75762452|FG001|STARTED|Overall Study||10||
59645201|NCT04086576|75762451|FG000|COMPLETED|Overall Study||10||
59645202|NCT04086576|75762452|FG001|COMPLETED|Overall Study||10||
59645203|NCT04086576|75762451|FG000|NOT COMPLETED|Overall Study||0||
59645204|NCT04086576|75762452|FG001|NOT COMPLETED|Overall Study||0||
59645205|NCT04075812|75762468|FG000|STARTED|Overall Study||2||
59645206|NCT04075812|75762468|FG000|COMPLETED|Overall Study||2||
59645207|NCT04075812|75762468|FG000|NOT COMPLETED|Overall Study||0||
59645208|NCT04061694|75762474|FG000|STARTED|Overall Study||21||
59645209|NCT04061694|75762475|FG001|STARTED|Overall Study||25||
59645210|NCT04061694|75762474|FG000|COMPLETED|Overall Study||19||
59645211|NCT04061694|75762475|FG001|COMPLETED|Overall Study||25||
59645212|NCT04061694|75762474|FG000|NOT COMPLETED|Overall Study||2||
59645213|NCT04061694|75762475|FG001|NOT COMPLETED|Overall Study||0||
59645214|NCT04057248|75762481|FG000|STARTED|Overall Study||14||
59645215|NCT04057248|75762481|FG000|COMPLETED|Overall Study||12||
59645216|NCT04057248|75762481|FG000|NOT COMPLETED|Overall Study||2||
59645217|NCT04053270|75762487|FG000|STARTED|Overall Study||49||
59645218|NCT04053270|75762488|FG001|STARTED|Overall Study||51||
59645219|NCT04053270|75762487|FG000|COMPLETED|Overall Study||47||
59645220|NCT04053270|75762488|FG001|COMPLETED|Overall Study||46||
59645221|NCT04053270|75762487|FG000|NOT COMPLETED|Overall Study||2||
59645222|NCT04053270|75762488|FG001|NOT COMPLETED|Overall Study||5||
59645223|NCT04051710|75762501|FG000|STARTED|Overall Study||620||
59645224|NCT04051710|75762502|FG001|STARTED|Overall Study||620||
59645225|NCT04051710|75762503|FG002|STARTED|Overall Study||310||
59645226|NCT04051710|75762501|FG000|COMPLETED|Overall Study||616||
59645227|NCT04051710|75762502|FG001|COMPLETED|Overall Study||612||
59645228|NCT04051710|75762503|FG002|COMPLETED|Overall Study||306||
59645229|NCT04051710|75762501|FG000|NOT COMPLETED|Overall Study||4||
59645230|NCT04051710|75762502|FG001|NOT COMPLETED|Overall Study||8||
59645231|NCT04051710|75762503|FG002|NOT COMPLETED|Overall Study||4||
59645232|NCT04047342|75762513|FG000|STARTED|Overall Study||409||
59645233|NCT04047342|75762514|FG001|STARTED|Overall Study||415||
59645234|NCT04047342|75762513|FG000|COMPLETED|Overall Study||409|We did not receive information on bounced emails, so we assumed that all participants in the data set started and completed the study.|
59645235|NCT04047342|75762514|FG001|COMPLETED|Overall Study||415|We did not receive information on bounced emails, so we assumed that all participants in the data set started and completed the study.|
59645236|NCT04047342|75762513|FG000|NOT COMPLETED|Overall Study||0||
59645237|NCT04047342|75762514|FG001|NOT COMPLETED|Overall Study||0||
59645238|NCT04022694|75762522|FG000|STARTED|Overall Study||167||
59645239|NCT04022694|75762523|FG001|STARTED|Overall Study||145||
59645240|NCT04022694|75762524|FG002|STARTED|Overall Study|This was a cross-sectional study, so participants at baseline -- were not the same as exposure.|143||
59645241|NCT04022694|75762525|FG003|STARTED|Overall Study|This was a cross-sectional study, so participants at baseline -- were not the same as exposure.|173||
59645242|NCT04022694|75762522|FG000|COMPLETED|Overall Study||167||
59645243|NCT04022694|75762523|FG001|COMPLETED|Overall Study||145||
59645244|NCT04022694|75762524|FG002|COMPLETED|Overall Study||143||
59645245|NCT04022694|75762525|FG003|COMPLETED|Overall Study||173||
59645246|NCT04022694|75762522|FG000|NOT COMPLETED|Overall Study||0||
59645247|NCT04022694|75762523|FG001|NOT COMPLETED|Overall Study||0||
59645248|NCT04022694|75762524|FG002|NOT COMPLETED|Overall Study||0||
59645249|NCT04022694|75762525|FG003|NOT COMPLETED|Overall Study||0||
59645250|NCT04015440|75762539|FG000|STARTED|Overall Study||117||
59645251|NCT04015440|75762540|FG001|STARTED|Overall Study||112||
59645252|NCT04015440|75762539|FG000|COMPLETED|Overall Study||109||
59645253|NCT04015440|75762540|FG001|COMPLETED|Overall Study||108||
59645254|NCT04015440|75762539|FG000|NOT COMPLETED|Overall Study||8||
59645255|NCT04015440|75762540|FG001|NOT COMPLETED|Overall Study||4||
59645256|NCT04030104|75762546|FG000|STARTED|Overall Study||480||
59645257|NCT04030104|75762546|FG000|COMPLETED|Overall Study||480||
59645258|NCT04030104|75762546|FG000|NOT COMPLETED|Overall Study||0||
59645259|NCT04027218|75762559|FG000|STARTED|Overall Study||10||
59645260|NCT04027218|75762560|FG001|STARTED|Overall Study||11||
59645261|NCT04027218|75762561|FG002|STARTED|Overall Study||9||
59645262|NCT04027218|75762562|FG003|STARTED|Overall Study||11||
59645263|NCT04027218|75762563|FG004|STARTED|Overall Study||10||
59645264|NCT04027218|75762564|FG005|STARTED|Overall Study||11||
59645265|NCT04027218|75762559|FG000|COMPLETED|Overall Study||10||
59645266|NCT04027218|75762560|FG001|COMPLETED|Overall Study||8||
59645267|NCT04027218|75762561|FG002|COMPLETED|Overall Study||9||
59645268|NCT04027218|75762562|FG003|COMPLETED|Overall Study||11||
59645269|NCT04027218|75762563|FG004|COMPLETED|Overall Study||10||
59645270|NCT04027218|75762564|FG005|COMPLETED|Overall Study||11||
59645271|NCT04027218|75762559|FG000|NOT COMPLETED|Overall Study||0||
59645272|NCT04027218|75762560|FG001|NOT COMPLETED|Overall Study||3||
59645273|NCT04027218|75762561|FG002|NOT COMPLETED|Overall Study||0||
59645274|NCT04027218|75762562|FG003|NOT COMPLETED|Overall Study||0||
59645275|NCT04027218|75762563|FG004|NOT COMPLETED|Overall Study||0||
59645276|NCT04027218|75762564|FG005|NOT COMPLETED|Overall Study||0||
59645277|NCT04026750|75762576|FG000|STARTED|Overall Study||3||
59645278|NCT04026750|75762577|FG001|STARTED|Overall Study||2||
59645279|NCT04026750|75762576|FG000|COMPLETED|Overall Study||3||
59645280|NCT04026750|75762577|FG001|COMPLETED|Overall Study||2||
59645281|NCT04026750|75762576|FG000|NOT COMPLETED|Overall Study||0||
59645282|NCT04026750|75762577|FG001|NOT COMPLETED|Overall Study||0||
59645283|NCT04020822|75762584|FG000|STARTED|Overall Study||19||
59645284|NCT04020822|75762584|FG000|COMPLETED|Overall Study||19||
59645285|NCT04020822|75762584|FG000|NOT COMPLETED|Overall Study||0||
59645286|NCT03979872|75762592|FG000|STARTED|Overall Study||22||
59645287|NCT03979872|75762593|FG001|STARTED|Overall Study||23||
59645288|NCT03979872|75762594|FG002|STARTED|Overall Study||24||
59645289|NCT03979872|75762595|FG003|STARTED|Overall Study||23||
59645290|NCT03979872|75762592|FG000|COMPLETED|Overall Study||19||
59645291|NCT03979872|75762593|FG001|COMPLETED|Overall Study||15||
59645292|NCT03979872|75762594|FG002|COMPLETED|Overall Study||18||
59645293|NCT03979872|75762595|FG003|COMPLETED|Overall Study||19||
59645294|NCT03979872|75762592|FG000|NOT COMPLETED|Overall Study||3||
59645295|NCT03979872|75762593|FG001|NOT COMPLETED|Overall Study||8||
59645296|NCT03979872|75762594|FG002|NOT COMPLETED|Overall Study||6||
59645297|NCT03979872|75762595|FG003|NOT COMPLETED|Overall Study||4||
59645298|NCT03993210|75762607|FG000|STARTED|Overall Study||1||
59645299|NCT03993210|75762608|FG001|STARTED|Overall Study||0||
59645300|NCT03993210|75762607|FG000|COMPLETED|Overall Study||1||
59645301|NCT03993210|75762608|FG001|COMPLETED|Overall Study||0||
59645302|NCT03993210|75762607|FG000|NOT COMPLETED|Overall Study||0||
59645303|NCT03993210|75762608|FG001|NOT COMPLETED|Overall Study||0||
59645304|NCT03988374|75762621|FG000|STARTED|Overall Study||104||
59645305|NCT03988374|75762622|FG001|STARTED|Overall Study||107||
59645306|NCT03988374|75762623|FG002|STARTED|Overall Study||108||
59645307|NCT03988374|75762621|FG000|COMPLETED|Overall Study||103||
59645308|NCT03988374|75762622|FG001|COMPLETED|Overall Study||105||
59645309|NCT03988374|75762623|FG002|COMPLETED|Overall Study||107||
59645310|NCT03988374|75762621|FG000|NOT COMPLETED|Overall Study||1||
59645311|NCT03988374|75762622|FG001|NOT COMPLETED|Overall Study||2||
59645312|NCT03988374|75762623|FG002|NOT COMPLETED|Overall Study||1||
59645313|NCT03976752|75762633|FG000|STARTED|Overall Study||4||
59645314|NCT03976752|75762634|FG001|STARTED|Overall Study||37||
59645315|NCT03976752|75762633|FG000|Started Study Arm A|Overall Study||0||
59645316|NCT03976752|75762634|FG001|Started Study Arm A|Overall Study||14||
59645317|NCT03976752|75762633|FG000|Completed Study Arm A|Overall Study||0||
59645318|NCT03976752|75762634|FG001|Completed Study Arm A|Overall Study||8||
59645319|NCT03976752|75762633|FG000|Started Study Arm B|Overall Study||0||
60076764|NCT01544595|76191761|FG005|COMPLETED|Status at Week 156||38|Week 156|
60076765|NCT01544595|76191756|FG000|NOT COMPLETED|Status at Week 156||117||
60076766|NCT01544595|76191757|FG001|NOT COMPLETED|Status at Week 156||78||
60076767|NCT01544595|76191758|FG002|NOT COMPLETED|Status at Week 156||140||
60076768|NCT01544595|76191759|FG003|NOT COMPLETED|Status at Week 156||166||
60076769|NCT01544595|76191760|FG004|NOT COMPLETED|Status at Week 156||38||
59645320|NCT03976752|75762634|FG001|Started Study Arm B|Overall Study||8||
59645321|NCT03976752|75762633|FG000|Completed Study Arm B|Overall Study||0||
59645322|NCT03976752|75762634|FG001|Completed Study Arm B|Overall Study||8||
59817897|NCT04488770|75940336|FG010|COMPLETED|Part 1-Cohort 2: Period 1 (Up to 5 Days)||0||
59645323|NCT03976752|75762633|FG000|Started Study Arm C|Overall Study||0||
59645324|NCT03976752|75762634|FG001|Started Study Arm C|Overall Study||11||
59645325|NCT03976752|75762633|FG000|Completed Study Arm C|Overall Study||0||
59645326|NCT03976752|75762634|FG001|Completed Study Arm C|Overall Study||8||
60076770|NCT01544595|76191761|FG005|NOT COMPLETED|Status at Week 156||15||
60076771|NCT01539525|76191782|FG000|STARTED|Overall Study||145||
59645327|NCT03976752|75762633|FG000|Started Study Arm D|Overall Study||0||
59645328|NCT03976752|75762634|FG001|Started Study Arm D|Overall Study||6||
59645329|NCT03976752|75762633|FG000|Completed Study Arm D|Overall Study||0||
59645330|NCT03976752|75762634|FG001|Completed Study Arm D|Overall Study||4||
59645331|NCT03976752|75762633|FG000|COMPLETED|Overall Study||3||
59645332|NCT03976752|75762634|FG001|COMPLETED|Overall Study||28||
59645333|NCT03976752|75762633|FG000|NOT COMPLETED|Overall Study||1||
59645334|NCT03976752|75762634|FG001|NOT COMPLETED|Overall Study||9||
59645335|NCT03974802|75762645|FG000|STARTED|Overall Study||41||
59645336|NCT03974802|75762645|FG000|COMPLETED|Overall Study||41||
59645337|NCT03974802|75762645|FG000|NOT COMPLETED|Overall Study||0||
59645338|NCT03966924|75762654|FG000|STARTED|Overall Study||2||
59645339|NCT03966924|75762654|FG000|COMPLETED|Overall Study||2||
59542484|NCT02469168|75640827|FG001|NOT COMPLETED|Overall Study||0||
59542485|NCT02469090|75640835|FG000|STARTED|Period 1: Dose Titration Phase||141||
59542486|NCT02469090|75640836|FG001|STARTED|Period 1: Dose Titration Phase||0||
59542487|NCT02469090|75640837|FG002|STARTED|Period 1: Dose Titration Phase||0||
59542488|NCT02469090|75640835|FG000|COMPLETED|Period 1: Dose Titration Phase||109||
59542489|NCT02469090|75640836|FG001|COMPLETED|Period 1: Dose Titration Phase||0||
59542490|NCT02469090|75640837|FG002|COMPLETED|Period 1: Dose Titration Phase||0||
59542491|NCT02469090|75640835|FG000|NOT COMPLETED|Period 1: Dose Titration Phase||32||
59542492|NCT02469090|75640836|FG001|NOT COMPLETED|Period 1: Dose Titration Phase||0||
59542493|NCT02469090|75640837|FG002|NOT COMPLETED|Period 1: Dose Titration Phase||0||
59542494|NCT02469090|75640835|FG000|STARTED|Period 2: Maintenance Treatment Phase|Subjects who completed the Titration Phase were eligible to proceed to Maintenance Treatment Phase|0||
59542495|NCT02469090|75640836|FG001|STARTED|Period 2: Maintenance Treatment Phase|subjects who completed the Titration Phase and were randomized to Placebo in the Maintenance Phase|55||
59542496|NCT02469090|75640837|FG002|STARTED|Period 2: Maintenance Treatment Phase|subjects who completed the Titration Phase and were randomized to APL-130277 Maintenance Phase|54||
59542497|NCT02469090|75640835|FG000|COMPLETED|Period 2: Maintenance Treatment Phase||0||
59542498|NCT02469090|75640836|FG001|COMPLETED|Period 2: Maintenance Treatment Phase||46||
59542499|NCT02469090|75640837|FG002|COMPLETED|Period 2: Maintenance Treatment Phase||34||
59542500|NCT02469090|75640835|FG000|NOT COMPLETED|Period 2: Maintenance Treatment Phase||0||
59542501|NCT02469090|75640836|FG001|NOT COMPLETED|Period 2: Maintenance Treatment Phase||9||
59542502|NCT02469090|75640837|FG002|NOT COMPLETED|Period 2: Maintenance Treatment Phase||20||
59542503|NCT02496000|75640847|FG000|STARTED|Overall Study||64||
59542504|NCT02496000|75640848|FG001|STARTED|Overall Study||61||
59542505|NCT02496000|75640849|FG002|STARTED|Overall Study||63||
59542506|NCT02496000|75640847|FG000|COMPLETED|Overall Study||62||
59542507|NCT02496000|75640848|FG001|COMPLETED|Overall Study||56||
59542508|NCT02496000|75640849|FG002|COMPLETED|Overall Study||61||
59542509|NCT02496000|75640847|FG000|NOT COMPLETED|Overall Study||2||
59542510|NCT02496000|75640848|FG001|NOT COMPLETED|Overall Study||5||
59542511|NCT02496000|75640849|FG002|NOT COMPLETED|Overall Study||2||
59542512|NCT02468934|75640858|FG000|STARTED|Overall Study||27||
59542513|NCT02468934|75640858|FG000|Enrolled/Received Leads|Overall Study||24|Subjects consented, met eligibility criteria, and continued with SPRINT Lead placement.|
59542514|NCT02468934|75640858|FG000|Underwent Total Knee Arthroplasty|Overall Study||20|Subjects consented, met eligibility criteria, received Leads, and underwent total knee arthroplasty.|
59542515|NCT02468934|75640858|FG000|COMPLETED|Overall Study||20||
59542516|NCT02468934|75640858|FG000|NOT COMPLETED|Overall Study||7||
59542517|NCT02517528|75640864|FG000|STARTED|Overall Study||104||
59542518|NCT02517528|75640864|FG000|COMPLETED|Overall Study||103||
59542519|NCT02517528|75640864|FG000|NOT COMPLETED|Overall Study||1||
59542520|NCT02495844|75640870|FG000|STARTED|Overall Study||27||
59542521|NCT02495844|75640871|FG001|STARTED|Overall Study||28||
59542522|NCT02495844|75640870|FG000|COMPLETED|Overall Study||26||
59542523|NCT02495844|75640871|FG001|COMPLETED|Overall Study||24||
59542524|NCT02495844|75640870|FG000|NOT COMPLETED|Overall Study||1||
59542525|NCT02495844|75640871|FG001|NOT COMPLETED|Overall Study||4||
59542526|NCT02468778|75640882|FG000|STARTED|Overall Study||18||
59542527|NCT02468778|75640883|FG001|STARTED|Overall Study||26||
59542528|NCT02468778|75640884|FG002|STARTED|Overall Study||10||
59542529|NCT02468778|75640882|FG000|COMPLETED|Overall Study||15||
59542530|NCT02468778|75640883|FG001|COMPLETED|Overall Study||22||
59542531|NCT02468778|75640884|FG002|COMPLETED|Overall Study||7||
59542532|NCT02468778|75640882|FG000|NOT COMPLETED|Overall Study||3||
59542533|NCT02468778|75640883|FG001|NOT COMPLETED|Overall Study||4||
59542534|NCT02468778|75640884|FG002|NOT COMPLETED|Overall Study||3||
59542535|NCT01727336|75640898|FG000|STARTED|Part 1 Dalantercept Dose Escalation||6||
59542536|NCT01727336|75640899|FG001|STARTED|Part 1 Dalantercept Dose Escalation||9||
59645340|NCT03966924|75762654|FG000|NOT COMPLETED|Overall Study||0||
59645341|NCT03965754|75762662|FG000|STARTED|Overall Study||1422|No email bounce information was available, so this number includes all people emailed.|
59645342|NCT03965754|75762663|FG001|STARTED|Overall Study||1425|No email bounce information was available, so this number includes all people emailed.|
59645343|NCT03965754|75762664|FG002|STARTED|Overall Study||1425|No email bounce information was available, so this number includes all people emailed.|
59645344|NCT03965754|75762665|FG003|STARTED|Overall Study||1425|No email bounce information was available, so this number includes all people emailed.|
59645345|NCT03965754|75762662|FG000|COMPLETED|Overall Study||1422|Given no bounce information, all emails were considered received, which we counted as completion.|
59645346|NCT03965754|75762663|FG001|COMPLETED|Overall Study||1425|Given no bounce information, all emails were considered received, which we counted as completion.|
59645347|NCT03965754|75762664|FG002|COMPLETED|Overall Study||1425|Given no bounce information, all emails were considered received, which we counted as completion.|
59645348|NCT03965754|75762665|FG003|COMPLETED|Overall Study||1425|Given no bounce information, all emails were considered received, which we counted as completion.|
59645349|NCT03965754|75762662|FG000|NOT COMPLETED|Overall Study||0||
59645350|NCT03965754|75762663|FG001|NOT COMPLETED|Overall Study||0||
59645351|NCT03965754|75762664|FG002|NOT COMPLETED|Overall Study||0||
59645352|NCT03965754|75762665|FG003|NOT COMPLETED|Overall Study||0||
59645353|NCT03962634|75762677|FG000|STARTED|Overall Study||1||
59645354|NCT03962634|75762678|FG001|STARTED|Overall Study||2||
59645355|NCT03962634|75762677|FG000|COMPLETED|Overall Study||1||
59645356|NCT03962634|75762678|FG001|COMPLETED|Overall Study||2||
59645357|NCT03962634|75762677|FG000|NOT COMPLETED|Overall Study||0||
59645358|NCT03962634|75762678|FG001|NOT COMPLETED|Overall Study||0||
59645359|NCT03933774|75762686|FG000|STARTED|Overall Study||12||
59645360|NCT03933774|75762687|FG001|STARTED|Overall Study||13||
59645361|NCT03933774|75762686|FG000|COMPLETED|Overall Study||10||
59645362|NCT03933774|75762687|FG001|COMPLETED|Overall Study||11||
59645363|NCT03933774|75762686|FG000|NOT COMPLETED|Overall Study||2||
59645364|NCT03933774|75762687|FG001|NOT COMPLETED|Overall Study||2||
59645365|NCT03933618|75762699|FG000|STARTED|Baseline||4||
59645366|NCT03933618|75762700|FG001|STARTED|Baseline||4||
59645367|NCT03933618|75762701|FG002|STARTED|Baseline||4||
59645368|NCT03933618|75762702|FG003|STARTED|Baseline||4||
59645369|NCT03933618|75762703|FG004|STARTED|Baseline||4||
59645370|NCT03933618|75762704|FG005|STARTED|Baseline||4||
59645371|NCT03933618|75762699|FG000|COMPLETED|Baseline||4||
59645372|NCT03933618|75762700|FG001|COMPLETED|Baseline||4||
59645373|NCT03933618|75762701|FG002|COMPLETED|Baseline||4||
59645374|NCT03933618|75762702|FG003|COMPLETED|Baseline||4||
59645375|NCT03933618|75762703|FG004|COMPLETED|Baseline||4||
59645376|NCT03933618|75762704|FG005|COMPLETED|Baseline||4||
59645377|NCT03933618|75762699|FG000|NOT COMPLETED|Baseline||0||
59645378|NCT03933618|75762700|FG001|NOT COMPLETED|Baseline||0||
59645379|NCT03933618|75762701|FG002|NOT COMPLETED|Baseline||0||
59645380|NCT03933618|75762702|FG003|NOT COMPLETED|Baseline||0||
59645381|NCT03933618|75762703|FG004|NOT COMPLETED|Baseline||0||
59645382|NCT03933618|75762704|FG005|NOT COMPLETED|Baseline||0||
59645383|NCT03933618|75762699|FG000|STARTED|Baseline to Week 8||4||
59645384|NCT03933618|75762700|FG001|STARTED|Baseline to Week 8||4||
59645385|NCT03933618|75762701|FG002|STARTED|Baseline to Week 8||4||
59645386|NCT03933618|75762702|FG003|STARTED|Baseline to Week 8||4||
59645387|NCT03933618|75762703|FG004|STARTED|Baseline to Week 8||4||
59645388|NCT03933618|75762704|FG005|STARTED|Baseline to Week 8||4||
59645389|NCT03933618|75762699|FG000|COMPLETED|Baseline to Week 8||4||
59645390|NCT03933618|75762700|FG001|COMPLETED|Baseline to Week 8||4||
59645391|NCT03933618|75762701|FG002|COMPLETED|Baseline to Week 8||4||
59645392|NCT03933618|75762702|FG003|COMPLETED|Baseline to Week 8||4||
59645393|NCT03933618|75762703|FG004|COMPLETED|Baseline to Week 8||4||
59645394|NCT03933618|75762704|FG005|COMPLETED|Baseline to Week 8||4||
59645395|NCT03933618|75762699|FG000|NOT COMPLETED|Baseline to Week 8||0||
59645396|NCT03933618|75762700|FG001|NOT COMPLETED|Baseline to Week 8||0||
59645397|NCT03933618|75762701|FG002|NOT COMPLETED|Baseline to Week 8||0||
59645398|NCT03933618|75762702|FG003|NOT COMPLETED|Baseline to Week 8||0||
59645399|NCT03933618|75762703|FG004|NOT COMPLETED|Baseline to Week 8||0||
59645400|NCT03933618|75762704|FG005|NOT COMPLETED|Baseline to Week 8||0||
59645401|NCT03933618|75762699|FG000|STARTED|Week 8 to Week 16||4||
59645402|NCT03933618|75762700|FG001|STARTED|Week 8 to Week 16||4||
59645403|NCT03933618|75762701|FG002|STARTED|Week 8 to Week 16||4||
59645404|NCT03933618|75762702|FG003|STARTED|Week 8 to Week 16||4||
59645405|NCT03933618|75762703|FG004|STARTED|Week 8 to Week 16||4||
59645406|NCT03933618|75762704|FG005|STARTED|Week 8 to Week 16||4||
59645407|NCT03933618|75762699|FG000|COMPLETED|Week 8 to Week 16||4||
59645408|NCT03933618|75762700|FG001|COMPLETED|Week 8 to Week 16||4||
59645409|NCT03933618|75762701|FG002|COMPLETED|Week 8 to Week 16||4||
59645410|NCT03933618|75762702|FG003|COMPLETED|Week 8 to Week 16||4||
59645411|NCT03933618|75762703|FG004|COMPLETED|Week 8 to Week 16||4||
59645412|NCT03933618|75762704|FG005|COMPLETED|Week 8 to Week 16||4||
59645413|NCT03933618|75762699|FG000|NOT COMPLETED|Week 8 to Week 16||0||
59645414|NCT03933618|75762700|FG001|NOT COMPLETED|Week 8 to Week 16||0||
59645415|NCT03933618|75762701|FG002|NOT COMPLETED|Week 8 to Week 16||0||
59645416|NCT03933618|75762702|FG003|NOT COMPLETED|Week 8 to Week 16||0||
59645417|NCT03933618|75762703|FG004|NOT COMPLETED|Week 8 to Week 16||0||
59645418|NCT03933618|75762704|FG005|NOT COMPLETED|Week 8 to Week 16||0||
59645419|NCT03933618|75762699|FG000|STARTED|Week 16 to Week 24||4||
59645420|NCT03933618|75762700|FG001|STARTED|Week 16 to Week 24||4||
59645421|NCT03933618|75762701|FG002|STARTED|Week 16 to Week 24||4||
59645422|NCT03933618|75762702|FG003|STARTED|Week 16 to Week 24||4||
59645423|NCT03933618|75762703|FG004|STARTED|Week 16 to Week 24||4||
59645424|NCT03933618|75762704|FG005|STARTED|Week 16 to Week 24||4||
59645425|NCT03933618|75762699|FG000|COMPLETED|Week 16 to Week 24||4||
59645426|NCT03933618|75762700|FG001|COMPLETED|Week 16 to Week 24||4||
59645427|NCT03933618|75762701|FG002|COMPLETED|Week 16 to Week 24||4||
59645428|NCT03933618|75762702|FG003|COMPLETED|Week 16 to Week 24||4||
59645429|NCT03933618|75762703|FG004|COMPLETED|Week 16 to Week 24||4||
59645430|NCT03933618|75762704|FG005|COMPLETED|Week 16 to Week 24||4||
59645431|NCT03933618|75762699|FG000|NOT COMPLETED|Week 16 to Week 24||0||
59645432|NCT03933618|75762700|FG001|NOT COMPLETED|Week 16 to Week 24||0||
59645433|NCT03933618|75762701|FG002|NOT COMPLETED|Week 16 to Week 24||0||
59645434|NCT03933618|75762702|FG003|NOT COMPLETED|Week 16 to Week 24||0||
59645435|NCT03933618|75762703|FG004|NOT COMPLETED|Week 16 to Week 24||0||
59645436|NCT03933618|75762704|FG005|NOT COMPLETED|Week 16 to Week 24||0||
59645437|NCT03930264|75762720|FG000|STARTED|Overall Study||15||
59645438|NCT03930264|75762721|FG001|STARTED|Overall Study||15||
59645439|NCT03930264|75762720|FG000|COMPLETED|Overall Study||15||
59645440|NCT03930264|75762721|FG001|COMPLETED|Overall Study||14||
59645441|NCT03930264|75762720|FG000|NOT COMPLETED|Overall Study||0||
59645442|NCT03930264|75762721|FG001|NOT COMPLETED|Overall Study||1||
59645443|NCT03919422|75762729|FG000|STARTED|Overall Study||40||
59645444|NCT03919422|75762730|FG001|STARTED|Overall Study||40||
59645445|NCT03919422|75762729|FG000|COMPLETED|Overall Study||40||
59645446|NCT03919422|75762730|FG001|COMPLETED|Overall Study||40||
59645447|NCT03919422|75762729|FG000|NOT COMPLETED|Overall Study||0||
59645448|NCT03919422|75762730|FG001|NOT COMPLETED|Overall Study||0||
59645449|NCT03926208|75762738|FG000|STARTED|Overall Study||119||
59645450|NCT03926208|75762739|FG001|STARTED|Overall Study||123||
59645451|NCT03926208|75762738|FG000|COMPLETED|Overall Study||119||
59645452|NCT03926208|75762739|FG001|COMPLETED|Overall Study||123||
59645453|NCT03926208|75762738|FG000|NOT COMPLETED|Overall Study||0||
59645454|NCT03926208|75762739|FG001|NOT COMPLETED|Overall Study||0||
59645455|NCT03901092|75762745|FG000|STARTED|Overall Study||83||
59645456|NCT03901092|75762746|FG001|STARTED|Overall Study||159||
59645457|NCT03901092|75762745|FG000|COMPLETED|Overall Study||83||
59645458|NCT03901092|75762746|FG001|COMPLETED|Overall Study||159||
59645459|NCT03901092|75762745|FG000|NOT COMPLETED|Overall Study||0||
59645460|NCT03901092|75762746|FG001|NOT COMPLETED|Overall Study||0||
59645461|NCT03887286|75762760|FG000|STARTED|Overall Study||47||
59645462|NCT03887286|75762760|FG000|COMPLETED|Overall Study||47||
59645463|NCT03887286|75762760|FG000|NOT COMPLETED|Overall Study||0||
59645464|NCT03882528|75762765|FG000|STARTED|Overall Study||12||
59645465|NCT03882528|75762765|FG000|COMPLETED|Overall Study||12||
59645466|NCT03882528|75762765|FG000|NOT COMPLETED|Overall Study||0||
59645467|NCT03881670|75762771|FG000|STARTED|Overall Study||12||
59645468|NCT03881670|75762772|FG001|STARTED|Overall Study||12||
59645469|NCT03881670|75762771|FG000|Completed First Intervention|Overall Study||12||
59645470|NCT03881670|75762772|FG001|Completed First Intervention|Overall Study||12||
59645471|NCT03881670|75762771|FG000|Completed Second Intervetion|Overall Study||12||
59645472|NCT03881670|75762772|FG001|Completed Second Intervetion|Overall Study||12||
59645473|NCT03881670|75762771|FG000|COMPLETED|Overall Study||12||
59645474|NCT03881670|75762772|FG001|COMPLETED|Overall Study||12||
59645475|NCT03881670|75762771|FG000|NOT COMPLETED|Overall Study||0||
59645476|NCT03881670|75762772|FG001|NOT COMPLETED|Overall Study||0||
59645477|NCT03861000|75762782|FG000|STARTED|Overall Study||2||
59645478|NCT03861000|75762783|FG001|STARTED|Overall Study||1||
59645479|NCT03861000|75762782|FG000|COMPLETED|Overall Study||2||
59645480|NCT03861000|75762783|FG001|COMPLETED|Overall Study||1||
59645481|NCT03861000|75762782|FG000|NOT COMPLETED|Overall Study||0||
59645482|NCT03861000|75762783|FG001|NOT COMPLETED|Overall Study||0||
59645483|NCT03863496|75762788|FG000|STARTED|Overall Study||71||
59645484|NCT03863496|75762788|FG000|COMPLETED|Overall Study||71||
59645485|NCT03863496|75762788|FG000|NOT COMPLETED|Overall Study||0||
59645486|NCT03856944|75762794|FG000|STARTED|Overall Study||29||
59645487|NCT03856944|75762794|FG000|COMPLETED|Overall Study||29||
59645488|NCT03856944|75762794|FG000|NOT COMPLETED|Overall Study||0||
59645489|NCT03865446|75762800|FG000|STARTED|Overall Study||8||
59645490|NCT03865446|75762801|FG001|STARTED|Overall Study||8||
59645491|NCT03865446|75762800|FG000|COMPLETED|Overall Study||8||
59645492|NCT03865446|75762801|FG001|COMPLETED|Overall Study||8||
59645493|NCT03865446|75762800|FG000|NOT COMPLETED|Overall Study||0||
59645494|NCT03865446|75762801|FG001|NOT COMPLETED|Overall Study||0||
59645495|NCT03868254|75762809|FG000|STARTED|Overall Study||98||116
59645496|NCT03868254|75762810|FG001|STARTED|Overall Study||76||96
59645497|NCT03868254|75762809|FG000|COMPLETED|Overall Study||98||116
59645498|NCT03868254|75762810|FG001|COMPLETED|Overall Study||76||96
59645499|NCT03868254|75762809|FG000|NOT COMPLETED|Overall Study||0||0
59645500|NCT03868254|75762810|FG001|NOT COMPLETED|Overall Study||0||0
59988582|NCT01186003|76103773|FG001|NOT COMPLETED|Overall Study||0||
59815770|NCT03026283|75938212|FG001|STARTED|Optimal Medical Care/FFR-CT Diagnosis||289|Note: Number of participants to start period is not equal to number who completed previous period.|
59817898|NCT04488770|75940337|FG011|COMPLETED|Part 1-Cohort 2: Period 1 (Up to 5 Days)||0||
59542537|NCT01727336|75640900|FG002|STARTED|Part 1 Dalantercept Dose Escalation||14||
59542538|NCT01727336|75640901|FG003|STARTED|Part 1 Dalantercept Dose Escalation||0||
59542539|NCT01727336|75640902|FG004|STARTED|Part 1 Dalantercept Dose Escalation||0||
59542540|NCT01727336|75640903|FG005|STARTED|Part 1 Dalantercept Dose Escalation||0||
59542541|NCT01727336|75640898|FG000|COMPLETED|Part 1 Dalantercept Dose Escalation||3||
59542542|NCT01727336|75640899|FG001|COMPLETED|Part 1 Dalantercept Dose Escalation||7||
59542543|NCT01727336|75640900|FG002|COMPLETED|Part 1 Dalantercept Dose Escalation||6||
59542544|NCT01727336|75640901|FG003|COMPLETED|Part 1 Dalantercept Dose Escalation||0||
59542545|NCT01727336|75640902|FG004|COMPLETED|Part 1 Dalantercept Dose Escalation||0||
59542546|NCT01727336|75640903|FG005|COMPLETED|Part 1 Dalantercept Dose Escalation||0||
59542547|NCT01727336|75640898|FG000|NOT COMPLETED|Part 1 Dalantercept Dose Escalation||3||
59542548|NCT01727336|75640899|FG001|NOT COMPLETED|Part 1 Dalantercept Dose Escalation||2||
59542549|NCT01727336|75640900|FG002|NOT COMPLETED|Part 1 Dalantercept Dose Escalation||8||
59542550|NCT01727336|75640901|FG003|NOT COMPLETED|Part 1 Dalantercept Dose Escalation||0||
59542551|NCT01727336|75640902|FG004|NOT COMPLETED|Part 1 Dalantercept Dose Escalation||0||
59542552|NCT01727336|75640903|FG005|NOT COMPLETED|Part 1 Dalantercept Dose Escalation||0||
59542553|NCT01727336|75640898|FG000|STARTED|Part 2 Blinded||0||
59542554|NCT01727336|75640899|FG001|STARTED|Part 2 Blinded||0||
59542555|NCT01727336|75640900|FG002|STARTED|Part 2 Blinded||0||
59542556|NCT01727336|75640901|FG003|STARTED|Part 2 Blinded||0||
59542557|NCT01727336|75640902|FG004|STARTED|Part 2 Blinded||63||
59542558|NCT01727336|75640903|FG005|STARTED|Part 2 Blinded||68||
59542559|NCT01727336|75640898|FG000|COMPLETED|Part 2 Blinded||0||
59542560|NCT01727336|75640899|FG001|COMPLETED|Part 2 Blinded||0||
59542561|NCT01727336|75640900|FG002|COMPLETED|Part 2 Blinded||0||
59542562|NCT01727336|75640901|FG003|COMPLETED|Part 2 Blinded||0||
59542563|NCT01727336|75640902|FG004|COMPLETED|Part 2 Blinded||0||
59542564|NCT01727336|75640903|FG005|COMPLETED|Part 2 Blinded||0||
59542565|NCT01727336|75640898|FG000|NOT COMPLETED|Part 2 Blinded||0||
59542566|NCT01727336|75640899|FG001|NOT COMPLETED|Part 2 Blinded||0||
59542567|NCT01727336|75640900|FG002|NOT COMPLETED|Part 2 Blinded||0||
59542568|NCT01727336|75640901|FG003|NOT COMPLETED|Part 2 Blinded||0||
59542569|NCT01727336|75640902|FG004|NOT COMPLETED|Part 2 Blinded||63||
59542570|NCT01727336|75640903|FG005|NOT COMPLETED|Part 2 Blinded||68||
59542571|NCT01578707|75640925|FG000|STARTED|Overall Study||196||
59542572|NCT01578707|75640926|FG001|STARTED|Overall Study||195||
59542573|NCT01578707|75640925|FG000|COMPLETED|Overall Study||196||
59542574|NCT01578707|75640926|FG001|COMPLETED|Overall Study||195||
59542575|NCT01578707|75640925|FG000|NOT COMPLETED|Overall Study||0||
59542576|NCT01578707|75640926|FG001|NOT COMPLETED|Overall Study||0||
59542577|NCT02466516|75640937|FG000|STARTED|Overall Study||20||
59542578|NCT02466516|75640938|FG001|STARTED|Overall Study||22||
59542579|NCT02466516|75640939|FG002|STARTED|Overall Study||10||
59542580|NCT02466516|75640940|FG003|STARTED|Overall Study||10||
59542581|NCT02466516|75640941|FG004|STARTED|Overall Study||10||
59542582|NCT02466516|75640937|FG000|COMPLETED|Overall Study||16||
59542583|NCT02466516|75640938|FG001|COMPLETED|Overall Study||21||
59542584|NCT02466516|75640939|FG002|COMPLETED|Overall Study||9||
59542585|NCT02466516|75640940|FG003|COMPLETED|Overall Study||10||
59542586|NCT02466516|75640941|FG004|COMPLETED|Overall Study||10||
59542587|NCT02466516|75640937|FG000|NOT COMPLETED|Overall Study||4||
59542588|NCT02466516|75640938|FG001|NOT COMPLETED|Overall Study||1||
59542589|NCT02466516|75640939|FG002|NOT COMPLETED|Overall Study||1||
59542590|NCT02466516|75640940|FG003|NOT COMPLETED|Overall Study||0||
59542591|NCT02466516|75640941|FG004|NOT COMPLETED|Overall Study||0||
59542592|NCT01725152|75640955|FG000|STARTED|Treatment Period 1 (Week 1 to Week 6)||30||
59542593|NCT01725152|75640956|FG001|STARTED|Treatment Period 1 (Week 1 to Week 6)||29||
59542594|NCT01725152|75640955|FG000|COMPLETED|Treatment Period 1 (Week 1 to Week 6)||26||
59542595|NCT01725152|75640956|FG001|COMPLETED|Treatment Period 1 (Week 1 to Week 6)||29||
59542596|NCT01725152|75640955|FG000|NOT COMPLETED|Treatment Period 1 (Week 1 to Week 6)||4||
59542597|NCT01725152|75640956|FG001|NOT COMPLETED|Treatment Period 1 (Week 1 to Week 6)||0||
59542598|NCT01725152|75640955|FG000|STARTED|Washout Period (2 Weeks)||26||
59542599|NCT01725152|75640956|FG001|STARTED|Washout Period (2 Weeks)||29||
59542600|NCT01725152|75640955|FG000|COMPLETED|Washout Period (2 Weeks)||26||
59542601|NCT01725152|75640956|FG001|COMPLETED|Washout Period (2 Weeks)||29||
59542602|NCT01725152|75640955|FG000|NOT COMPLETED|Washout Period (2 Weeks)||0||
59542603|NCT01725152|75640956|FG001|NOT COMPLETED|Washout Period (2 Weeks)||0||
59542604|NCT01725152|75640955|FG000|STARTED|Treatment Period 2 (Week 8 to Week 14)||26||
59542605|NCT01725152|75640956|FG001|STARTED|Treatment Period 2 (Week 8 to Week 14)||29||
59542606|NCT01725152|75640955|FG000|COMPLETED|Treatment Period 2 (Week 8 to Week 14)||25||
59542607|NCT01725152|75640956|FG001|COMPLETED|Treatment Period 2 (Week 8 to Week 14)||26||
59542608|NCT01725152|75640955|FG000|NOT COMPLETED|Treatment Period 2 (Week 8 to Week 14)||1||
59542609|NCT01725152|75640956|FG001|NOT COMPLETED|Treatment Period 2 (Week 8 to Week 14)||3||
59542610|NCT01580423|75640962|FG000|STARTED|First Intervention||8||
59542611|NCT01580423|75640963|FG001|STARTED|First Intervention||8||
59645501|NCT03862482|75762819|FG000|STARTED|Overall Study|Eight participants (forty implant units) were randomly allocated to Configuration 1 by study coordinator. Each participant was also randomly assigned one of the three implant units (B or SW or SC) on a rotating basis to one of five sites between mental foramen. As a result, an equal number of each implant unit type was placed at each the five sites|8||40
59645502|NCT03862482|75762820|FG001|STARTED|Overall Study|Eight participants (forty implant units) were randomly allocated to Configuration 2 by study coordinator. Each participant was also randomly assigned one of the three implant units (B or SW or SC) on a rotating basis to one of five sites between mental foramen. As a result, an equal number of each implant unit type was placed at each the five sites|8||40
59645503|NCT03862482|75762821|FG002|STARTED|Overall Study|Six participants (thirty implant units) were randomly allocated to Configuration 3 by study coordinator. Each participant was also randomly assigned one of the three implant units (B or SW or SC) on a rotating basis to one of five sites between mental foramen. As a result, an equal number of each implant unit type was placed at each the five sites|6||30
59645504|NCT03862482|75762819|FG000|COMPLETED|Overall Study|Sixteen B, 16 SW, and eight SC implant units were placed on a rotating basis at the five sites for a total of 40 implant units. Of these, one implant unit (SW) had fractured and was subsequently excluded from all future analyses|8||39
59645505|NCT03862482|75762820|FG001|COMPLETED|Overall Study|Eight B, 16 SW, and 16 SC implant units were placed on a rotating basis at the five sites for a total of 40 implant units. Of these, two implant units (one B, one SW) were removed from all future analyses due to technical issues with radiographs|8||38
59645506|NCT03862482|75762821|FG002|COMPLETED|Overall Study|Twelve B, six SW, and 12 SC implant units were placed on a rotating basis at the five sites for a total of 30 implant units|6||30
59645507|NCT03862482|75762819|FG000|NOT COMPLETED|Overall Study||0||1
59645508|NCT03862482|75762820|FG001|NOT COMPLETED|Overall Study||0||2
59645509|NCT03862482|75762821|FG002|NOT COMPLETED|Overall Study||0||0
59645510|NCT03848208|75762837|FG000|STARTED|Overall Study||18|randomized and treated|
59645511|NCT03848208|75762838|FG001|STARTED|Overall Study||6|randomized and treated|
59645512|NCT03848208|75762839|FG002|STARTED|Overall Study||6|randomized and treated|
59645513|NCT03848208|75762840|FG003|STARTED|Overall Study||6|randomized and treated|
59645514|NCT03848208|75762841|FG004|STARTED|Overall Study||6|randomized and treated|
59645515|NCT03848208|75762842|FG005|STARTED|Overall Study||6|randomized and treated|
59645516|NCT03848208|75762843|FG006|STARTED|Overall Study||6|randomized and treated|
59645517|NCT03848208|75762844|FG007|STARTED|Overall Study||6|randomized and treated|
59645518|NCT03848208|75762845|FG008|STARTED|Overall Study||6|randomized and treated|
59645519|NCT03848208|75762846|FG009|STARTED|Overall Study||6|randomized and treated|
59645520|NCT03848208|75762837|FG000|COMPLETED|Overall Study||18||
59645521|NCT03848208|75762838|FG001|COMPLETED|Overall Study||6||
59645522|NCT03848208|75762839|FG002|COMPLETED|Overall Study||6||
59645523|NCT03848208|75762840|FG003|COMPLETED|Overall Study||6||
59645524|NCT03848208|75762841|FG004|COMPLETED|Overall Study||6||
59645525|NCT03848208|75762842|FG005|COMPLETED|Overall Study||6||
59542612|NCT01580423|75640962|FG000|COMPLETED|First Intervention||8||
59542613|NCT01580423|75640963|FG001|COMPLETED|First Intervention||8||
59542614|NCT01580423|75640962|FG000|NOT COMPLETED|First Intervention||0||
59542615|NCT01580423|75640963|FG001|NOT COMPLETED|First Intervention||0||
59542616|NCT01580423|75640962|FG000|STARTED|Second Intervention||8||
59542617|NCT01580423|75640963|FG001|STARTED|Second Intervention||8||
59542618|NCT01580423|75640962|FG000|COMPLETED|Second Intervention||8||
59542619|NCT01580423|75640963|FG001|COMPLETED|Second Intervention||8||
59542620|NCT01580423|75640962|FG000|NOT COMPLETED|Second Intervention||0||
59542621|NCT01580423|75640963|FG001|NOT COMPLETED|Second Intervention||0||
59542622|NCT01049984|75640972|FG000|STARTED|Overall Study||163||
59542623|NCT01049984|75640973|FG001|STARTED|Overall Study||165||
59542624|NCT01049984|75640972|FG000|Safety Population|Overall Study|One patient was randomized but not dosed; omitted from safety population|162||
59542625|NCT01049984|75640973|FG001|Safety Population|Overall Study|One patient was randomized but not dosed; omitted from safety population|164||
59542626|NCT01049984|75640972|FG000|Modified Intent-to-treat Pop|Overall Study|Took >= 1 dose of study drug and had both baseline and at least 1 post-baseline efficacy assessment|159||
59542627|NCT01049984|75640973|FG001|Modified Intent-to-treat Pop|Overall Study|Took >= 1 dose of study drug and had both baseline and at least 1 post-baseline efficacy assessment|162||
59542628|NCT01049984|75640972|FG000|COMPLETED|Overall Study||144||
59542629|NCT01049984|75640973|FG001|COMPLETED|Overall Study||146||
59542630|NCT01049984|75640972|FG000|NOT COMPLETED|Overall Study||19||
59542631|NCT01049984|75640973|FG001|NOT COMPLETED|Overall Study||19||
59542632|NCT01049360|75640979|FG000|STARTED|Period 1||6||
59542633|NCT01049360|75640980|FG001|STARTED|Period 1||6||
59542634|NCT01049360|75640981|FG002|STARTED|Period 1||7||
59542635|NCT01049360|75640982|FG003|STARTED|Period 1||7||
59542636|NCT01049360|75640983|FG004|STARTED|Period 1||7||
59542637|NCT01049360|75640984|FG005|STARTED|Period 1||6||
59542638|NCT01049360|75640985|FG006|STARTED|Period 1||6||
59542639|NCT01049360|75640986|FG007|STARTED|Period 1||6||
59542640|NCT01049360|75640987|FG008|STARTED|Period 1||7||
59542641|NCT01049360|75640988|FG009|STARTED|Period 1||6||
59542642|NCT01049360|75640989|FG010|STARTED|Period 1||6||
59542643|NCT01049360|75640990|FG011|STARTED|Period 1||6||
59542644|NCT01049360|75640991|FG012|STARTED|Period 1||6||
59542645|NCT01049360|75640992|FG013|STARTED|Period 1||7||
59542646|NCT01049360|75640993|FG014|STARTED|Period 1||7||
59542647|NCT01049360|75640994|FG015|STARTED|Period 1||7||
59542648|NCT01049360|75640995|FG016|STARTED|Period 1||6||
59645526|NCT03848208|75762843|FG006|COMPLETED|Overall Study||6||
59645527|NCT03848208|75762844|FG007|COMPLETED|Overall Study||6||
59645528|NCT03848208|75762845|FG008|COMPLETED|Overall Study||6||
59645529|NCT03848208|75762846|FG009|COMPLETED|Overall Study||6||
59645530|NCT03848208|75762837|FG000|NOT COMPLETED|Overall Study||0||
59645531|NCT03848208|75762838|FG001|NOT COMPLETED|Overall Study||0||
59645532|NCT03848208|75762839|FG002|NOT COMPLETED|Overall Study||0||
59645533|NCT03848208|75762840|FG003|NOT COMPLETED|Overall Study||0||
59645534|NCT03848208|75762841|FG004|NOT COMPLETED|Overall Study||0||
59645535|NCT03848208|75762842|FG005|NOT COMPLETED|Overall Study||0||
59645536|NCT03848208|75762843|FG006|NOT COMPLETED|Overall Study||0||
59645537|NCT03848208|75762844|FG007|NOT COMPLETED|Overall Study||0||
59645538|NCT03848208|75762845|FG008|NOT COMPLETED|Overall Study||0||
59645539|NCT03848208|75762846|FG009|NOT COMPLETED|Overall Study||0||
59645540|NCT03858894|75762879|FG000|STARTED|Overall Study||48||
59645541|NCT03858894|75762880|FG001|STARTED|Overall Study||50||
59645542|NCT03858894|75762879|FG000|COMPLETED|Overall Study||44||
59645543|NCT03858894|75762880|FG001|COMPLETED|Overall Study||50||
59645544|NCT03858894|75762879|FG000|NOT COMPLETED|Overall Study||4||
59645545|NCT03858894|75762880|FG001|NOT COMPLETED|Overall Study||0||
59645546|NCT03856164|75762888|FG000|STARTED|Overall Study||55||
59645547|NCT03856164|75762889|FG001|STARTED|Overall Study||55||
59645548|NCT03856164|75762888|FG000|COMPLETED|Overall Study||55||
59645549|NCT03856164|75762889|FG001|COMPLETED|Overall Study||55||
59645550|NCT03856164|75762888|FG000|NOT COMPLETED|Overall Study||0||
59645551|NCT03856164|75762889|FG001|NOT COMPLETED|Overall Study||0||
59645552|NCT03849690|75762897|FG000|STARTED|Period 1 (3 Days)||12||
59645553|NCT03849690|75762897|FG000|COMPLETED|Period 1 (3 Days)||12||
59645554|NCT03849690|75762897|FG000|NOT COMPLETED|Period 1 (3 Days)||0||
59645555|NCT03849690|75762897|FG000|STARTED|Washout Period (at Least 4 Days)||12||
59645556|NCT03849690|75762897|FG000|COMPLETED|Washout Period (at Least 4 Days)||12||
59645557|NCT03849690|75762897|FG000|NOT COMPLETED|Washout Period (at Least 4 Days)||0||
59645558|NCT03849690|75762897|FG000|STARTED|Period 2 (6 Days)||12||
59645559|NCT03849690|75762897|FG000|COMPLETED|Period 2 (6 Days)||12||
59645560|NCT03849690|75762897|FG000|NOT COMPLETED|Period 2 (6 Days)||0||
59645561|NCT03843372|75762908|FG000|STARTED|Overall Study||14||
59645562|NCT03843372|75762909|FG001|STARTED|Overall Study||18||
59645563|NCT03843372|75762908|FG000|COMPLETED|Overall Study||12||
59645564|NCT03843372|75762909|FG001|COMPLETED|Overall Study||16||
59645565|NCT03843372|75762908|FG000|NOT COMPLETED|Overall Study||2||
59645566|NCT03843372|75762909|FG001|NOT COMPLETED|Overall Study||2||
59645567|NCT03822078|75762921|FG000|STARTED|Overall Study||12||
59645568|NCT03822078|75762922|FG001|STARTED|Overall Study||6||
59645569|NCT03822078|75762923|FG002|STARTED|Overall Study||6||
59645570|NCT03822078|75762924|FG003|STARTED|Overall Study||8||
59645571|NCT03822078|75762925|FG004|STARTED|Overall Study||7||
59645572|NCT03822078|75762926|FG005|STARTED|Overall Study||6||
59645573|NCT03822078|75762921|FG000|Received Study Drug|Overall Study||10||
59645574|NCT03822078|75762922|FG001|Received Study Drug|Overall Study||6||
59645575|NCT03822078|75762923|FG002|Received Study Drug|Overall Study||6||
59645576|NCT03822078|75762924|FG003|Received Study Drug|Overall Study||6||
59645577|NCT03822078|75762925|FG004|Received Study Drug|Overall Study||6||
59645578|NCT03822078|75762926|FG005|Received Study Drug|Overall Study||6||
59645579|NCT03822078|75762921|FG000|COMPLETED|Overall Study||10||
59645580|NCT03822078|75762922|FG001|COMPLETED|Overall Study||6||
59645581|NCT03822078|75762923|FG002|COMPLETED|Overall Study||6||
59645582|NCT03822078|75762924|FG003|COMPLETED|Overall Study||6||
59645583|NCT03822078|75762925|FG004|COMPLETED|Overall Study||6||
59645584|NCT03822078|75762926|FG005|COMPLETED|Overall Study||6||
59645585|NCT03822078|75762921|FG000|NOT COMPLETED|Overall Study||2||
59645586|NCT03822078|75762922|FG001|NOT COMPLETED|Overall Study||0||
59645587|NCT03822078|75762923|FG002|NOT COMPLETED|Overall Study||0||
59645588|NCT03822078|75762924|FG003|NOT COMPLETED|Overall Study||2||
59645589|NCT03822078|75762925|FG004|NOT COMPLETED|Overall Study||1||
59645590|NCT03822078|75762926|FG005|NOT COMPLETED|Overall Study||0||
59815771|NCT03026283|75938213|FG002|STARTED|Optimal Medical Care/FFR-CT Diagnosis||280|Note: Number of participants to start period is not equal to number who completed previous period.|
59815772|NCT03026283|75938214|FG003|STARTED|Optimal Medical Care/FFR-CT Diagnosis||0|Note: Number of participants to start period is not equal to number who completed previous period.|
59645591|NCT03806556|75762948|FG000|STARTED|Overall Study||6||
59645592|NCT03806556|75762949|FG001|STARTED|Overall Study||5||
59645593|NCT03806556|75762948|FG000|COMPLETED|Overall Study||6||
59645594|NCT03806556|75762949|FG001|COMPLETED|Overall Study||5||
59645595|NCT03806556|75762948|FG000|NOT COMPLETED|Overall Study||0||
59645596|NCT03806556|75762949|FG001|NOT COMPLETED|Overall Study||0||
59645597|NCT03809052|75762967|FG000|STARTED|Overall Study||6||
59645598|NCT03809052|75762968|FG001|STARTED|Overall Study||6||
59645599|NCT03809052|75762969|FG002|STARTED|Overall Study||6||
59645600|NCT03809052|75762970|FG003|STARTED|Overall Study||6||
59645601|NCT03809052|75762971|FG004|STARTED|Overall Study||6||
59645602|NCT03809052|75762972|FG005|STARTED|Overall Study||6||
59645603|NCT03809052|75762973|FG006|STARTED|Overall Study||6||
59645604|NCT03809052|75762974|FG007|STARTED|Overall Study||14||
59645605|NCT03809052|75762975|FG008|STARTED|Overall Study||8||
59645606|NCT03809052|75762976|FG009|STARTED|Overall Study||8||
59645607|NCT03809052|75762977|FG010|STARTED|Overall Study||6||
59645608|NCT03809052|75762967|FG000|COMPLETED|Overall Study||6||
59645609|NCT03809052|75762968|FG001|COMPLETED|Overall Study||6||
59645610|NCT03809052|75762969|FG002|COMPLETED|Overall Study||6||
59645611|NCT03809052|75762970|FG003|COMPLETED|Overall Study||6||
59645612|NCT03809052|75762971|FG004|COMPLETED|Overall Study||6||
59645613|NCT03809052|75762972|FG005|COMPLETED|Overall Study||6||
59645614|NCT03809052|75762973|FG006|COMPLETED|Overall Study||6||
59645615|NCT03809052|75762974|FG007|COMPLETED|Overall Study||14||
59645616|NCT03809052|75762975|FG008|COMPLETED|Overall Study||8||
59645617|NCT03809052|75762976|FG009|COMPLETED|Overall Study||8||
59645618|NCT03809052|75762977|FG010|COMPLETED|Overall Study||6||
59645619|NCT03809052|75762967|FG000|NOT COMPLETED|Overall Study||0||
59645620|NCT03809052|75762968|FG001|NOT COMPLETED|Overall Study||0||
59645621|NCT03809052|75762969|FG002|NOT COMPLETED|Overall Study||0||
59645622|NCT03809052|75762970|FG003|NOT COMPLETED|Overall Study||0||
59645623|NCT03809052|75762971|FG004|NOT COMPLETED|Overall Study||0||
59645624|NCT03809052|75762972|FG005|NOT COMPLETED|Overall Study||0||
59645625|NCT03809052|75762973|FG006|NOT COMPLETED|Overall Study||0||
59645626|NCT03809052|75762974|FG007|NOT COMPLETED|Overall Study||0||
59645627|NCT03809052|75762975|FG008|NOT COMPLETED|Overall Study||0||
59645628|NCT03809052|75762976|FG009|NOT COMPLETED|Overall Study||0||
59645629|NCT03809052|75762977|FG010|NOT COMPLETED|Overall Study||0||
59645630|NCT03812328|75763006|FG000|STARTED|Overall Study||55||
59645631|NCT03812328|75763007|FG001|STARTED|Overall Study||63||
59645632|NCT03812328|75763008|FG002|STARTED|Overall Study||89||
59645633|NCT03812328|75763006|FG000|Modified Intent-to-Treat (mITT) Population|Overall Study||48||
59645634|NCT03812328|75763007|FG001|Modified Intent-to-Treat (mITT) Population|Overall Study||61||
59645635|NCT03812328|75763008|FG002|Modified Intent-to-Treat (mITT) Population|Overall Study||84||
59645636|NCT03812328|75763006|FG000|Safety Population|Overall Study||55||
59645637|NCT03812328|75763007|FG001|Safety Population|Overall Study||63||
59645638|NCT03812328|75763008|FG002|Safety Population|Overall Study||88||
59645639|NCT03812328|75763006|FG000|COMPLETED|Overall Study||55||
59645640|NCT03812328|75763007|FG001|COMPLETED|Overall Study||60||
59645641|NCT03812328|75763008|FG002|COMPLETED|Overall Study||88||
59645642|NCT03812328|75763006|FG000|NOT COMPLETED|Overall Study||0||
59645643|NCT03812328|75763007|FG001|NOT COMPLETED|Overall Study||3||
59645644|NCT03812328|75763008|FG002|NOT COMPLETED|Overall Study||1||
59645645|NCT03816696|75763016|FG000|STARTED|Period 1 (Up to Day 5)||16||
59645646|NCT03816696|75763016|FG000|COMPLETED|Period 1 (Up to Day 5)||16||
59645647|NCT03816696|75763016|FG000|NOT COMPLETED|Period 1 (Up to Day 5)||0||
59645648|NCT03816696|75763016|FG000|STARTED|Wash Out Period (Days 6 to 9)||16||
59645649|NCT03816696|75763016|FG000|COMPLETED|Wash Out Period (Days 6 to 9)||16||
59645650|NCT03816696|75763016|FG000|NOT COMPLETED|Wash Out Period (Days 6 to 9)||0||
59645651|NCT03816696|75763016|FG000|STARTED|Period 2 (Up to Day 7)||16||
59645652|NCT03816696|75763016|FG000|COMPLETED|Period 2 (Up to Day 7)||16||
59645653|NCT03816696|75763016|FG000|NOT COMPLETED|Period 2 (Up to Day 7)||0||
59645654|NCT03816696|75763016|FG000|STARTED|Period 3 (Up to Day 11)||16||
59645655|NCT03816696|75763016|FG000|COMPLETED|Period 3 (Up to Day 11)||16||
59645656|NCT03816696|75763016|FG000|NOT COMPLETED|Period 3 (Up to Day 11)||0||
59645657|NCT03815292|75763028|FG000|STARTED|Overall Study||135||
59645658|NCT03815292|75763029|FG001|STARTED|Overall Study||140||
59645659|NCT03815292|75763028|FG000|COMPLETED|Overall Study||135||
59645660|NCT03815292|75763029|FG001|COMPLETED|Overall Study||140||
59645661|NCT03815292|75763028|FG000|NOT COMPLETED|Overall Study||0||
59645662|NCT03815292|75763029|FG001|NOT COMPLETED|Overall Study||0||
59645663|NCT03809910|75763035|FG000|STARTED|Period 1 (Visit 2)||20||
59645664|NCT03809910|75763036|FG001|STARTED|Period 1 (Visit 2)||19||
59645665|NCT03809910|75763035|FG000|COMPLETED|Period 1 (Visit 2)||20||
59645666|NCT03809910|75763036|FG001|COMPLETED|Period 1 (Visit 2)||19||
59645667|NCT03809910|75763035|FG000|NOT COMPLETED|Period 1 (Visit 2)||0||
59645668|NCT03809910|75763036|FG001|NOT COMPLETED|Period 1 (Visit 2)||0||
59645669|NCT03809910|75763035|FG000|STARTED|Washout Period 1 (3 Days)||20||
59645670|NCT03809910|75763036|FG001|STARTED|Washout Period 1 (3 Days)||19||
59645671|NCT03809910|75763035|FG000|COMPLETED|Washout Period 1 (3 Days)||20||
59645672|NCT03809910|75763036|FG001|COMPLETED|Washout Period 1 (3 Days)||19||
59645673|NCT03809910|75763035|FG000|NOT COMPLETED|Washout Period 1 (3 Days)||0||
59645674|NCT03809910|75763036|FG001|NOT COMPLETED|Washout Period 1 (3 Days)||0||
59645675|NCT03809910|75763035|FG000|STARTED|Period 2 (Visit 3)||20||
59645676|NCT03809910|75763036|FG001|STARTED|Period 2 (Visit 3)||19||
59645677|NCT03809910|75763035|FG000|COMPLETED|Period 2 (Visit 3)||20||
59645678|NCT03809910|75763036|FG001|COMPLETED|Period 2 (Visit 3)||19||
59645679|NCT03809910|75763035|FG000|NOT COMPLETED|Period 2 (Visit 3)||0||
59645680|NCT03809910|75763036|FG001|NOT COMPLETED|Period 2 (Visit 3)||0||
59645681|NCT03809910|75763035|FG000|STARTED|Washout Period 2 (3 Days)||20||
59645682|NCT03809910|75763036|FG001|STARTED|Washout Period 2 (3 Days)||19||
59645683|NCT03809910|75763035|FG000|COMPLETED|Washout Period 2 (3 Days)||20||
59645684|NCT03809910|75763036|FG001|COMPLETED|Washout Period 2 (3 Days)||19||
59645685|NCT03809910|75763035|FG000|NOT COMPLETED|Washout Period 2 (3 Days)||0||
59645686|NCT03809910|75763036|FG001|NOT COMPLETED|Washout Period 2 (3 Days)||0||
59645687|NCT03809910|75763035|FG000|STARTED|Period 3 (Visit 4)||20||
59645688|NCT03809910|75763036|FG001|STARTED|Period 3 (Visit 4)||19||
59645689|NCT03809910|75763035|FG000|COMPLETED|Period 3 (Visit 4)||20||
59645690|NCT03809910|75763036|FG001|COMPLETED|Period 3 (Visit 4)||19||
59645691|NCT03809910|75763035|FG000|NOT COMPLETED|Period 3 (Visit 4)||0||
59645692|NCT03809910|75763036|FG001|NOT COMPLETED|Period 3 (Visit 4)||0||
59645693|NCT03806790|75763048|FG000|STARTED|Overall Study||87||
59645694|NCT03806790|75763049|FG001|STARTED|Overall Study||95||
59645695|NCT03806790|75763048|FG000|COMPLETED|Overall Study||87||
59645696|NCT03806790|75763049|FG001|COMPLETED|Overall Study||95||
59645697|NCT03806790|75763048|FG000|NOT COMPLETED|Overall Study||0||
59645698|NCT03806790|75763049|FG001|NOT COMPLETED|Overall Study||0||
59645699|NCT03805386|75763057|FG000|STARTED|Overall Study||32||
59645700|NCT03805386|75763058|FG001|STARTED|Overall Study||33||
59645701|NCT03805386|75763057|FG000|COMPLETED|Overall Study||32||
59645702|NCT03805386|75763058|FG001|COMPLETED|Overall Study||33||
59645703|NCT03805386|75763057|FG000|NOT COMPLETED|Overall Study||0||
59645704|NCT03805386|75763058|FG001|NOT COMPLETED|Overall Study||0||
59645705|NCT03802344|75763070|FG000|STARTED|Overall Study||213||
59645706|NCT03802344|75763071|FG001|STARTED|Overall Study||209||
59645707|NCT03802344|75763072|FG002|STARTED|Overall Study||68||
59645708|NCT03802344|75763070|FG000|COMPLETED|Overall Study||205||
59645709|NCT03802344|75763071|FG001|COMPLETED|Overall Study||203||
59645710|NCT03802344|75763072|FG002|COMPLETED|Overall Study||55||
59645711|NCT03802344|75763070|FG000|NOT COMPLETED|Overall Study||8||
59645712|NCT03802344|75763071|FG001|NOT COMPLETED|Overall Study||6||
59645713|NCT03802344|75763072|FG002|NOT COMPLETED|Overall Study||13||
59645714|NCT03799614|75763083|FG000|STARTED|Overall Study||15||
59645715|NCT03799614|75763084|FG001|STARTED|Overall Study||15||
59645716|NCT03799614|75763083|FG000|COMPLETED|Overall Study||15||
59645717|NCT03799614|75763084|FG001|COMPLETED|Overall Study||15||
59645718|NCT03799614|75763083|FG000|NOT COMPLETED|Overall Study||0||
59645719|NCT03799614|75763084|FG001|NOT COMPLETED|Overall Study||0||
59645720|NCT03796260|75763095|FG000|STARTED|Period 1||7||
59645721|NCT03796260|75763096|FG001|STARTED|Period 1||7||
59645722|NCT03796260|75763095|FG000|COMPLETED|Period 1||7||
59645723|NCT03796260|75763096|FG001|COMPLETED|Period 1||7||
59645724|NCT03796260|75763095|FG000|NOT COMPLETED|Period 1||0||
59645725|NCT03796260|75763096|FG001|NOT COMPLETED|Period 1||0||
59645726|NCT03796260|75763095|FG000|STARTED|Period 2||7||
59645727|NCT03796260|75763096|FG001|STARTED|Period 2||7||
59645728|NCT03796260|75763095|FG000|COMPLETED|Period 2||7||
59645729|NCT03796260|75763096|FG001|COMPLETED|Period 2||7||
59645730|NCT03796260|75763095|FG000|NOT COMPLETED|Period 2||0||
59645731|NCT03796260|75763096|FG001|NOT COMPLETED|Period 2||0||
59645732|NCT03796182|75763102|FG000|STARTED|Period 1||6||
59645733|NCT03796182|75763103|FG001|STARTED|Period 1||6||
59645734|NCT03796182|75763102|FG000|COMPLETED|Period 1||6||
59645735|NCT03796182|75763103|FG001|COMPLETED|Period 1||6||
59988583|NCT02743871|76103793|FG000|STARTED|Overall Study||6||
59645736|NCT03796182|75763102|FG000|NOT COMPLETED|Period 1||0||
59645737|NCT03796182|75763103|FG001|NOT COMPLETED|Period 1||0||
59645738|NCT03796182|75763102|FG000|STARTED|Washout Period||6||
59645739|NCT03796182|75763103|FG001|STARTED|Washout Period||6||
59645740|NCT03796182|75763102|FG000|COMPLETED|Washout Period||6||
59645741|NCT03796182|75763103|FG001|COMPLETED|Washout Period||6||
59645742|NCT03796182|75763102|FG000|NOT COMPLETED|Washout Period||0||
59645743|NCT03796182|75763103|FG001|NOT COMPLETED|Washout Period||0||
59645744|NCT03796182|75763102|FG000|STARTED|Period 2||6||
59645745|NCT03796182|75763103|FG001|STARTED|Period 2||6||
59988584|NCT02743871|76103794|FG001|STARTED|Overall Study||6||
59645746|NCT03796182|75763102|FG000|COMPLETED|Period 2||6||
59645747|NCT03796182|75763103|FG001|COMPLETED|Period 2||6||
59645748|NCT03796182|75763102|FG000|NOT COMPLETED|Period 2||0||
59645749|NCT03796182|75763103|FG001|NOT COMPLETED|Period 2||0||
59645750|NCT03779724|75763111|FG000|STARTED|Overall Study||25||
59645751|NCT03779724|75763112|FG001|STARTED|Overall Study||25||
59645752|NCT03779724|75763111|FG000|COMPLETED|Overall Study||19||
59645753|NCT03779724|75763112|FG001|COMPLETED|Overall Study||21||
59645754|NCT03779724|75763111|FG000|NOT COMPLETED|Overall Study||6||
59645755|NCT03779724|75763112|FG001|NOT COMPLETED|Overall Study||4||
59645756|NCT03786744|75763122|FG000|STARTED|Overall Study||10||
59645757|NCT03786744|75763123|FG001|STARTED|Overall Study||10||
59988585|NCT02743871|76103795|FG002|STARTED|Overall Study||6||
59645758|NCT03786744|75763122|FG000|COMPLETED|Overall Study||10||
59645759|NCT03786744|75763123|FG001|COMPLETED|Overall Study||10||
59645760|NCT03786744|75763122|FG000|NOT COMPLETED|Overall Study||0||
59645761|NCT03786744|75763123|FG001|NOT COMPLETED|Overall Study||0||
59645762|NCT03790878|75763133|FG000|STARTED|Overall Study||26||
59645763|NCT03790878|75763134|FG001|STARTED|Overall Study||27||
59645764|NCT03790878|75763135|FG002|STARTED|Overall Study||27||
59645765|NCT03790878|75763133|FG000|COMPLETED|Overall Study||26||
59645766|NCT03790878|75763134|FG001|COMPLETED|Overall Study||27||
59645767|NCT03790878|75763135|FG002|COMPLETED|Overall Study||27||
59645768|NCT03790878|75763133|FG000|NOT COMPLETED|Overall Study||0||
59645769|NCT03790878|75763134|FG001|NOT COMPLETED|Overall Study||0||
59645770|NCT03790878|75763135|FG002|NOT COMPLETED|Overall Study||0||
59645771|NCT03789474|75763145|FG000|STARTED|Overall Study||30||
59645772|NCT03789474|75763146|FG001|STARTED|Overall Study||30||
59645773|NCT03789474|75763145|FG000|COMPLETED|Overall Study||30||
59645774|NCT03789474|75763146|FG001|COMPLETED|Overall Study||30||
59645775|NCT03789474|75763145|FG000|NOT COMPLETED|Overall Study||0||
59645776|NCT03789474|75763146|FG001|NOT COMPLETED|Overall Study||0||
59645777|NCT03765996|75763154|FG000|STARTED|Overall Study||18||
59645778|NCT03765996|75763155|FG001|STARTED|Overall Study||18||
59645779|NCT03765996|75763154|FG000|COMPLETED|Overall Study||14||
59645780|NCT03765996|75763155|FG001|COMPLETED|Overall Study||18||
59645781|NCT03765996|75763154|FG000|NOT COMPLETED|Overall Study||4||
59645782|NCT03765996|75763155|FG001|NOT COMPLETED|Overall Study||0||
59645783|NCT03765762|75763163|FG000|STARTED|Overall Study||18||
59645784|NCT03765762|75763164|FG001|STARTED|Overall Study||8||
59645785|NCT03765762|75763163|FG000|COMPLETED|Overall Study||18||
59645786|NCT03765762|75763164|FG001|COMPLETED|Overall Study||8||
59645787|NCT03765762|75763163|FG000|NOT COMPLETED|Overall Study||0||
59645788|NCT03765762|75763164|FG001|NOT COMPLETED|Overall Study||0||
59645789|NCT03756012|75763170|FG000|STARTED|Overall Study||15||
59645790|NCT03756012|75763170|FG000|COMPLETED|Overall Study||15||
59645791|NCT03756012|75763170|FG000|NOT COMPLETED|Overall Study||0||
59645792|NCT03748992|75763175|FG000|STARTED|Overall Study||10||
59645793|NCT03748992|75763175|FG000|COMPLETED|Overall Study||10||
59645794|NCT03748992|75763175|FG000|NOT COMPLETED|Overall Study||0||
59645795|NCT03748758|75763182|FG000|STARTED|Overall Study||12||
59645796|NCT03748758|75763183|FG001|STARTED|Overall Study||12||
59645797|NCT03748758|75763184|FG002|STARTED|Overall Study||6||
59645798|NCT03748758|75763182|FG000|COMPLETED|Overall Study||12||
59645799|NCT03748758|75763183|FG001|COMPLETED|Overall Study||12||
59645800|NCT03748758|75763184|FG002|COMPLETED|Overall Study||5||
59645801|NCT03748758|75763182|FG000|NOT COMPLETED|Overall Study||0||
59645802|NCT03748758|75763183|FG001|NOT COMPLETED|Overall Study||0||
59645803|NCT03748758|75763184|FG002|NOT COMPLETED|Overall Study||1||
59645804|NCT03745092|75763216|FG000|STARTED|Overall Study||26||
59645805|NCT03745092|75763217|FG001|STARTED|Overall Study||23||
59645806|NCT03745092|75763216|FG000|COMPLETED|Overall Study||26||
59645807|NCT03745092|75763217|FG001|COMPLETED|Overall Study||23||
59645808|NCT03745092|75763216|FG000|NOT COMPLETED|Overall Study||0||
59645809|NCT03745092|75763217|FG001|NOT COMPLETED|Overall Study||0||
59645810|NCT03744780|75763223|FG000|STARTED|Overall Study||32||
59645811|NCT03744780|75763223|FG000|COMPLETED|Overall Study||32||
59645812|NCT03744780|75763223|FG000|NOT COMPLETED|Overall Study||0||
59645813|NCT03730116|75763227|FG000|STARTED|Inclusion|Planned to include 1920 pts, included 1909|1909||
59645814|NCT03730116|75763227|FG000|FVFP|Inclusion||1909||
59645815|NCT03730116|75763227|FG000|COMPLETED|Inclusion||1909||
59645816|NCT03730116|75763227|FG000|NOT COMPLETED|Inclusion||0||
59645817|NCT03730116|75763227|FG000|STARTED|1 Month After Inclusion||1909||
59645818|NCT03730116|75763227|FG000|1 Month After Inclusion|1 Month After Inclusion||1909||
59645819|NCT03730116|75763227|FG000|COMPLETED|1 Month After Inclusion||1909||
59645820|NCT03730116|75763227|FG000|NOT COMPLETED|1 Month After Inclusion||0||
59645821|NCT03730116|75763227|FG000|STARTED|3 Month After Inclusion||1909||
59645822|NCT03730116|75763227|FG000|3 Month After Inclusion|3 Month After Inclusion||1909||
59645823|NCT03730116|75763227|FG000|COMPLETED|3 Month After Inclusion||1892||
59645824|NCT03730116|75763227|FG000|NOT COMPLETED|3 Month After Inclusion||17||
59645825|NCT03729960|75763235|FG000|STARTED|Overall Study||20||
59645826|NCT03729960|75763235|FG000|COMPLETED|Overall Study||20||
59645827|NCT03729960|75763235|FG000|NOT COMPLETED|Overall Study||0||
59645828|NCT03729024|75763240|FG000|STARTED|Overall Study||21||42
59645829|NCT03729024|75763240|FG000|COMPLETED|Overall Study||21||42
59645830|NCT03729024|75763240|FG000|NOT COMPLETED|Overall Study||0||0
59645831|NCT03728790|75763246|FG000|STARTED|Overall Study||112||
59645832|NCT03728790|75763247|FG001|STARTED|Overall Study||101||
59645833|NCT03728790|75763246|FG000|COMPLETED|Overall Study||112||
59645834|NCT03728790|75763247|FG001|COMPLETED|Overall Study||101||
59645835|NCT03728790|75763246|FG000|NOT COMPLETED|Overall Study||0||
59645836|NCT03728790|75763247|FG001|NOT COMPLETED|Overall Study||0||
59645837|NCT03727854|75763255|FG000|STARTED|Overall Study||20||
59645838|NCT03727854|75763256|FG001|STARTED|Overall Study||20||
59645839|NCT03727854|75763255|FG000|COMPLETED|Overall Study||20||
59645840|NCT03727854|75763256|FG001|COMPLETED|Overall Study||20||
59645841|NCT03727854|75763255|FG000|NOT COMPLETED|Overall Study||0||
59645842|NCT03727854|75763256|FG001|NOT COMPLETED|Overall Study||0||
59645843|NCT03544242|75763265|FG000|STARTED|Overall Study||1||
59645844|NCT03544242|75763266|FG001|STARTED|Overall Study||1||
59645845|NCT03544242|75763267|FG002|STARTED|Overall Study||2||
59645846|NCT03544242|75763265|FG000|COMPLETED|Overall Study||1||
59645847|NCT03544242|75763266|FG001|COMPLETED|Overall Study||1||
59645848|NCT03544242|75763267|FG002|COMPLETED|Overall Study||2||
59645849|NCT03544242|75763265|FG000|NOT COMPLETED|Overall Study||0||
59645850|NCT03544242|75763266|FG001|NOT COMPLETED|Overall Study||0||
59645851|NCT03544242|75763267|FG002|NOT COMPLETED|Overall Study||0||
59645852|NCT03500406|75763277|FG000|STARTED|Overall Study||4||
59645853|NCT03500406|75763278|FG001|STARTED|Overall Study||20||
59645854|NCT03500406|75763277|FG000|COMPLETED|Overall Study||4||
59645855|NCT03500406|75763278|FG001|COMPLETED|Overall Study||20||
59645856|NCT03500406|75763277|FG000|NOT COMPLETED|Overall Study||0||
59645857|NCT03500406|75763278|FG001|NOT COMPLETED|Overall Study||0||
59645858|NCT03423654|75763286|FG000|STARTED|Overall Study||3||
59645859|NCT03423654|75763287|FG001|STARTED|Overall Study||3||
59645860|NCT03423654|75763286|FG000|COMPLETED|Overall Study||3||
59645861|NCT03423654|75763287|FG001|COMPLETED|Overall Study||3||
59645862|NCT03423654|75763286|FG000|NOT COMPLETED|Overall Study||0||
59645863|NCT03423654|75763287|FG001|NOT COMPLETED|Overall Study||0||
59645864|NCT03370536|75763293|FG000|STARTED|Overall Study||1||
59645865|NCT03370536|75763293|FG000|COMPLETED|Overall Study||0||
59645866|NCT03370536|75763293|FG000|NOT COMPLETED|Overall Study||1||
59645867|NCT03161964|75763299|FG000|STARTED|Overall Study||1||
59645868|NCT03161964|75763300|FG001|STARTED|Overall Study||1||
59645869|NCT03161964|75763299|FG000|COMPLETED|Overall Study||1||
59645870|NCT03161964|75763300|FG001|COMPLETED|Overall Study||0||
59645871|NCT03161964|75763299|FG000|NOT COMPLETED|Overall Study||0||
59645872|NCT03161964|75763300|FG001|NOT COMPLETED|Overall Study||1||
59645873|NCT03078270|75763308|FG000|STARTED|Overall Study||4||
59645874|NCT03078270|75763309|FG001|STARTED|Overall Study||0||
59645875|NCT03078270|75763308|FG000|COMPLETED|Overall Study||0||
59645876|NCT03078270|75763309|FG001|COMPLETED|Overall Study||0||
59645877|NCT03078270|75763308|FG000|NOT COMPLETED|Overall Study||4||
59645878|NCT03078270|75763309|FG001|NOT COMPLETED|Overall Study||0||
59645879|NCT03042780|75763315|FG000|STARTED|Overall Study||2||
59645880|NCT03042780|75763315|FG000|COMPLETED|Overall Study||2||
59645881|NCT03042780|75763315|FG000|NOT COMPLETED|Overall Study||0||
59645882|NCT03017040|75763319|FG000|STARTED|Overall Study|Participants enroll one wrist into each group,thus, one participant flows into both groups.|1||1
59645883|NCT03017040|75763320|FG001|STARTED|Overall Study|Participants enroll one wrist into each group,thus, one participant flows into both groups.|1||1
59645884|NCT03017040|75763319|FG000|COMPLETED|Overall Study||0||0
59645885|NCT03017040|75763320|FG001|COMPLETED|Overall Study||0||0
59645886|NCT03017040|75763319|FG000|NOT COMPLETED|Overall Study||1||1
59645887|NCT03017040|75763320|FG001|NOT COMPLETED|Overall Study||1||1
59645888|NCT02985840|75763328|FG000|STARTED|Overall Study||64||
59645889|NCT02985840|75763329|FG001|STARTED|Overall Study||63||
59645890|NCT02985840|75763328|FG000|COMPLETED|Overall Study||64||
59645891|NCT02985840|75763329|FG001|COMPLETED|Overall Study||63||
59645892|NCT02985840|75763328|FG000|NOT COMPLETED|Overall Study||0||
59645893|NCT02985840|75763329|FG001|NOT COMPLETED|Overall Study||0||
59645894|NCT02974686|75763337|FG000|STARTED|Overall Study||0||
59645895|NCT02974686|75763338|FG001|STARTED|Overall Study||0||
59645896|NCT02974686|75763337|FG000|COMPLETED|Overall Study||0||
59645897|NCT02974686|75763338|FG001|COMPLETED|Overall Study||0||
59645898|NCT02974686|75763337|FG000|NOT COMPLETED|Overall Study||0||
59645899|NCT02974686|75763338|FG001|NOT COMPLETED|Overall Study||0||
59645900|NCT02966184|75763348|FG000|STARTED|Overall Study||0||
59645901|NCT02966184|75763349|FG001|STARTED|Overall Study||8||
59645902|NCT02966184|75763348|FG000|COMPLETED|Overall Study||0||
59645903|NCT02966184|75763349|FG001|COMPLETED|Overall Study||0||
59645904|NCT02966184|75763348|FG000|NOT COMPLETED|Overall Study||0||
59645905|NCT02966184|75763349|FG001|NOT COMPLETED|Overall Study||8||
59645906|NCT02950896|75763355|FG000|STARTED|Overall Study||4||
59645907|NCT02950896|75763355|FG000|COMPLETED|Overall Study||4||
59645908|NCT02950896|75763355|FG000|NOT COMPLETED|Overall Study||0||
59645909|NCT02877732|75763361|FG000|STARTED|Overall Study||6||
59645910|NCT02877732|75763362|FG001|STARTED|Overall Study||6||
59645911|NCT02877732|75763361|FG000|COMPLETED|Overall Study||0||
59645912|NCT02877732|75763362|FG001|COMPLETED|Overall Study||0||
59645913|NCT02877732|75763361|FG000|NOT COMPLETED|Overall Study||6||
59645914|NCT02877732|75763362|FG001|NOT COMPLETED|Overall Study||6||
59645915|NCT02808390|75763371|FG000|STARTED|Overall Study||4||
59645916|NCT02808390|75763372|FG001|STARTED|Overall Study||8||
59645917|NCT02808390|75763373|FG002|STARTED|Overall Study||7||
59645918|NCT02808390|75763371|FG000|COMPLETED|Overall Study||2||
59645919|NCT02808390|75763372|FG001|COMPLETED|Overall Study||2||
59645920|NCT02808390|75763373|FG002|COMPLETED|Overall Study||4||
59645921|NCT02808390|75763371|FG000|NOT COMPLETED|Overall Study||2||
59645922|NCT02808390|75763372|FG001|NOT COMPLETED|Overall Study||6||
59645923|NCT02808390|75763373|FG002|NOT COMPLETED|Overall Study||3||
59645924|NCT02744352|75763383|FG000|STARTED|Overall Study||4||
59645925|NCT02744352|75763384|FG001|STARTED|Overall Study||4||
59645926|NCT02744352|75763383|FG000|COMPLETED|Overall Study||4||
59645927|NCT02744352|75763384|FG001|COMPLETED|Overall Study||4||
59645928|NCT02744352|75763383|FG000|NOT COMPLETED|Overall Study||0||
59645929|NCT02744352|75763384|FG001|NOT COMPLETED|Overall Study||0||
59645930|NCT02745210|75763392|FG000|STARTED|Overall Study||0||
59645931|NCT02745210|75763393|FG001|STARTED|Overall Study||9||
59645932|NCT02745210|75763392|FG000|COMPLETED|Overall Study||0||
59645933|NCT02745210|75763393|FG001|COMPLETED|Overall Study||9||
59645934|NCT02745210|75763392|FG000|NOT COMPLETED|Overall Study||0||
59645935|NCT02745210|75763393|FG001|NOT COMPLETED|Overall Study||0||
59645936|NCT02679066|75763399|FG000|STARTED|Overall Study||100||
59645937|NCT02679066|75763400|FG001|STARTED|Overall Study||100||
59645938|NCT02679066|75763399|FG000|COMPLETED|Overall Study||100||
59645939|NCT02679066|75763400|FG001|COMPLETED|Overall Study||100||
59645940|NCT02679066|75763399|FG000|NOT COMPLETED|Overall Study||0||
59645941|NCT02679066|75763400|FG001|NOT COMPLETED|Overall Study||0||
59645942|NCT02590068|75763408|FG000|STARTED|Overall Study||0||
59645943|NCT02590068|75763409|FG001|STARTED|Overall Study||14||
59645944|NCT02590068|75763408|FG000|COMPLETED|Overall Study||0||
59645945|NCT02590068|75763409|FG001|COMPLETED|Overall Study||14||
59645946|NCT02590068|75763408|FG000|NOT COMPLETED|Overall Study||0||
59645947|NCT02590068|75763409|FG001|NOT COMPLETED|Overall Study||0||
59645948|NCT02587650|75763415|FG000|STARTED|Overall Study||0||
59645949|NCT02587650|75763416|FG001|STARTED|Overall Study||0||
59645950|NCT02587650|75763417|FG002|STARTED|Overall Study||1||
59645951|NCT02587650|75763418|FG003|STARTED|Overall Study||0||
59645952|NCT02587650|75763415|FG000|COMPLETED|Overall Study||0||
59645953|NCT02587650|75763416|FG001|COMPLETED|Overall Study||0||
59645954|NCT02587650|75763417|FG002|COMPLETED|Overall Study||1||
59645955|NCT02587650|75763418|FG003|COMPLETED|Overall Study||0||
59645956|NCT02587650|75763415|FG000|NOT COMPLETED|Overall Study||0||
59645957|NCT02587650|75763416|FG001|NOT COMPLETED|Overall Study||0||
59645958|NCT02587650|75763417|FG002|NOT COMPLETED|Overall Study||0||
59645959|NCT02587650|75763418|FG003|NOT COMPLETED|Overall Study||0||
59645960|NCT02514252|75763422|FG000|STARTED|Overall Study||6||
59645961|NCT02514252|75763422|FG000|COMPLETED|Overall Study||6||
59645962|NCT02514252|75763422|FG000|NOT COMPLETED|Overall Study||0||
59645963|NCT02434146|75763426|FG000|STARTED|Overall Study||3||
59645964|NCT02434146|75763426|FG000|COMPLETED|Overall Study||3||
59645965|NCT02434146|75763426|FG000|NOT COMPLETED|Overall Study||0||
59645966|NCT02431494|75763433|FG000|STARTED|Overall Study|The results cannot be evaluated because the sample size was so small. He had trouble recruiting|0||
59645967|NCT02431494|75763434|FG001|STARTED|Overall Study|The results cannot be evaluated because the sample size was so small. He had trouble recruiting|0||
59645968|NCT02431494|75763435|FG002|STARTED|Overall Study|The results cannot be evaluated because the sample size was so small. He had trouble recruiting|0||
59645969|NCT02431494|75763433|FG000|COMPLETED|Overall Study||0||
59645970|NCT02431494|75763434|FG001|COMPLETED|Overall Study||0||
59645971|NCT02431494|75763435|FG002|COMPLETED|Overall Study||0||
59645972|NCT02431494|75763433|FG000|NOT COMPLETED|Overall Study||0||
59645973|NCT02431494|75763434|FG001|NOT COMPLETED|Overall Study||0||
59645974|NCT02431494|75763435|FG002|NOT COMPLETED|Overall Study||0||
59645975|NCT02382588|75763447|FG000|STARTED|Overall Study||4||
59645976|NCT02382588|75763448|FG001|STARTED|Overall Study||4||
59645977|NCT02382588|75763447|FG000|COMPLETED|Overall Study||4||
59645978|NCT02382588|75763448|FG001|COMPLETED|Overall Study||4||
59645979|NCT02382588|75763447|FG000|NOT COMPLETED|Overall Study||0||
59645980|NCT02382588|75763448|FG001|NOT COMPLETED|Overall Study||0||
59645981|NCT02345460|75763454|FG000|STARTED|Overall Study||1||
59645982|NCT02345460|75763454|FG000|COMPLETED|Overall Study||1||
59645983|NCT02345460|75763454|FG000|NOT COMPLETED|Overall Study||0||
59645984|NCT02345772|75763458|FG000|STARTED|Overall Study||4||
59645985|NCT02345772|75763458|FG000|COMPLETED|Overall Study||0||
59645986|NCT02345772|75763458|FG000|NOT COMPLETED|Overall Study||4||
59645987|NCT02280252|75763462|FG000|STARTED|Overall Study||0||
59645988|NCT02280252|75763462|FG000|COMPLETED|Overall Study||0||
59645989|NCT02280252|75763462|FG000|NOT COMPLETED|Overall Study||0||
59645990|NCT02266914|75763466|FG000|STARTED|Overall Study||9||
59645991|NCT02266914|75763466|FG000|COMPLETED|Overall Study||0||
59645992|NCT02266914|75763466|FG000|NOT COMPLETED|Overall Study||9||
59645993|NCT02262000|75763472|FG000|STARTED|Overall Study||3||
59645994|NCT02262000|75763473|FG001|STARTED|Overall Study||0||
59645995|NCT02262000|75763472|FG000|COMPLETED|Overall Study||3||
59645996|NCT02262000|75763473|FG001|COMPLETED|Overall Study||0||
59645997|NCT02262000|75763472|FG000|NOT COMPLETED|Overall Study||0||
59645998|NCT02262000|75763473|FG001|NOT COMPLETED|Overall Study||0||
59645999|NCT02248740|75763481|FG000|STARTED|Overall Study||18||
59646000|NCT02248740|75763482|FG001|STARTED|Overall Study||18||
59646001|NCT02248740|75763481|FG000|COMPLETED|Overall Study||0||
59646002|NCT02248740|75763482|FG001|COMPLETED|Overall Study||0||
59646003|NCT02248740|75763481|FG000|NOT COMPLETED|Overall Study||18||
59646004|NCT02248740|75763482|FG001|NOT COMPLETED|Overall Study||18||
59646005|NCT02242578|75763490|FG000|STARTED|Overall Study||0||
59646006|NCT02242578|75763491|FG001|STARTED|Overall Study||0||
59646007|NCT02242578|75763490|FG000|COMPLETED|Overall Study||0||
59646008|NCT02242578|75763491|FG001|COMPLETED|Overall Study||0||
59646009|NCT02242578|75763490|FG000|NOT COMPLETED|Overall Study||0||
59646010|NCT02242578|75763491|FG001|NOT COMPLETED|Overall Study||0||
59646011|NCT02133534|75763497|FG000|STARTED|Overall Study||1||
59646012|NCT02133534|75763497|FG000|COMPLETED|Overall Study||1||
59646013|NCT02133534|75763497|FG000|NOT COMPLETED|Overall Study||0||
59646014|NCT02009982|75763503|FG000|STARTED|Overall Study||1||
59646015|NCT02009982|75763504|FG001|STARTED|Overall Study||2||
59646016|NCT02009982|75763503|FG000|COMPLETED|Overall Study||1||
59646017|NCT02009982|75763504|FG001|COMPLETED|Overall Study||2||
59646018|NCT02009982|75763503|FG000|NOT COMPLETED|Overall Study||0||
59646019|NCT02009982|75763504|FG001|NOT COMPLETED|Overall Study||0||
59646020|NCT02013414|75763510|FG000|STARTED|Overall Study||9||
59646021|NCT02013414|75763510|FG000|COMPLETED|Overall Study||9||
59646022|NCT02013414|75763510|FG000|NOT COMPLETED|Overall Study||0||
59646023|NCT02015910|75763518|FG000|STARTED|Overall Study||0||
59646024|NCT02015910|75763519|FG001|STARTED|Overall Study||1||
59646025|NCT02015910|75763518|FG000|COMPLETED|Overall Study||0||
59646026|NCT02015910|75763519|FG001|COMPLETED|Overall Study||1||
59646027|NCT02015910|75763518|FG000|NOT COMPLETED|Overall Study||0||
59646028|NCT02015910|75763519|FG001|NOT COMPLETED|Overall Study||0||
59646029|NCT01996410|75763533|FG000|STARTED|Overall Study||3||
59646030|NCT01996410|75763534|FG001|STARTED|Overall Study||3||
59646031|NCT01996410|75763535|FG002|STARTED|Overall Study||0||
59646032|NCT01996410|75763536|FG003|STARTED|Overall Study||0||
59646033|NCT01996410|75763537|FG004|STARTED|Overall Study||2||
59646034|NCT01996410|75763538|FG005|STARTED|Overall Study||2||
59646035|NCT01996410|75763539|FG006|STARTED|Overall Study||0||
59646036|NCT01996410|75763540|FG007|STARTED|Overall Study||0||
59646037|NCT01996410|75763533|FG000|COMPLETED|Overall Study||3||
59646038|NCT01996410|75763534|FG001|COMPLETED|Overall Study||3||
59646039|NCT01996410|75763535|FG002|COMPLETED|Overall Study||0||
59646040|NCT01996410|75763536|FG003|COMPLETED|Overall Study||0||
59646041|NCT01996410|75763537|FG004|COMPLETED|Overall Study||2||
59646042|NCT01996410|75763538|FG005|COMPLETED|Overall Study||2||
59646043|NCT01996410|75763539|FG006|COMPLETED|Overall Study||0||
59646044|NCT01996410|75763540|FG007|COMPLETED|Overall Study||0||
59646045|NCT01996410|75763533|FG000|NOT COMPLETED|Overall Study||0||
59646046|NCT01996410|75763534|FG001|NOT COMPLETED|Overall Study||0||
59646047|NCT01996410|75763535|FG002|NOT COMPLETED|Overall Study||0||
59646048|NCT01996410|75763536|FG003|NOT COMPLETED|Overall Study||0||
59646049|NCT01996410|75763537|FG004|NOT COMPLETED|Overall Study||0||
59646050|NCT01996410|75763538|FG005|NOT COMPLETED|Overall Study||0||
59646051|NCT01996410|75763539|FG006|NOT COMPLETED|Overall Study||0||
59646052|NCT01996410|75763540|FG007|NOT COMPLETED|Overall Study||0||
59646053|NCT01980342|75763552|FG000|STARTED|Overall Study||1||
59646054|NCT01980342|75763552|FG000|COMPLETED|Overall Study||0||
59646055|NCT01980342|75763552|FG000|NOT COMPLETED|Overall Study||1||
59646056|NCT01881984|75763556|FG000|STARTED|Overall Study||4||
59646057|NCT01881984|75763556|FG000|COMPLETED|Overall Study||4||
59646058|NCT01881984|75763556|FG000|NOT COMPLETED|Overall Study||0||
59646059|NCT01878786|75763563|FG000|STARTED|Overall Study||9||
59646060|NCT01878786|75763564|FG001|STARTED|Overall Study||9||
59646061|NCT01878786|75763565|FG002|STARTED|Overall Study||7||
59646062|NCT01878786|75763563|FG000|COMPLETED|Overall Study|Study closed prematurely|0||
59646063|NCT01878786|75763564|FG001|COMPLETED|Overall Study|Study closed prematurely|0||
59646064|NCT01878786|75763565|FG002|COMPLETED|Overall Study|Study closed prematurely; 1 patient was a screen fail|0||
59646065|NCT01878786|75763563|FG000|NOT COMPLETED|Overall Study||9||
59646066|NCT01878786|75763564|FG001|NOT COMPLETED|Overall Study||9||
59646067|NCT01878786|75763565|FG002|NOT COMPLETED|Overall Study||7||
59646068|NCT01851174|75763573|FG000|STARTED|Overall Study||15||
59646069|NCT01851174|75763573|FG000|COMPLETED|Overall Study||15||
59646070|NCT01851174|75763573|FG000|NOT COMPLETED|Overall Study||0||
59646071|NCT01846182|75763580|FG000|STARTED|Overall Study|Unclear due to assignment records.|0||
59646072|NCT01846182|75763581|FG001|STARTED|Overall Study|Unclear due to assignment records.|0||
59646073|NCT01846182|75763582|FG002|STARTED|Overall Study|Unclear due to assignment records.|0||
59646074|NCT01846182|75763580|FG000|COMPLETED|Overall Study|The data on completion subjects is corrupted and not reliable for interpretation.|0||
59646075|NCT01846182|75763581|FG001|COMPLETED|Overall Study|The data on completion subjects is corrupted and not reliable for interpretation.|0||
59646076|NCT01846182|75763582|FG002|COMPLETED|Overall Study|The data on completion subjects is corrupted and not reliable for interpretation.|0||
59646077|NCT01846182|75763580|FG000|NOT COMPLETED|Overall Study||0||
59646078|NCT01846182|75763581|FG001|NOT COMPLETED|Overall Study||0||
59646079|NCT01846182|75763582|FG002|NOT COMPLETED|Overall Study||0||
59646080|NCT01800162|75763595|FG000|STARTED|Overall Study|1 subject was randomized to uterine evacuation on 6/26/2013.|1|Study ended early only 1 subject randomized to uterine evacuation.|
59646081|NCT01800162|75763596|FG001|STARTED|Overall Study||0|Study ended early only 1 subject randomized to uterine evacuation.|
59646082|NCT01800162|75763597|FG002|STARTED|Overall Study|1 subject randomized to expectant management on 11/1/2013.|1|Study ended early only 1 subject randomized to uterine evacuation.|
59646083|NCT01800162|75763595|FG000|COMPLETED|Overall Study||1||
59646084|NCT01800162|75763596|FG001|COMPLETED|Overall Study||0||
59646085|NCT01800162|75763597|FG002|COMPLETED|Overall Study||1||
59646086|NCT01800162|75763595|FG000|NOT COMPLETED|Overall Study||0||
59646087|NCT01800162|75763596|FG001|NOT COMPLETED|Overall Study||0||
59646088|NCT01800162|75763597|FG002|NOT COMPLETED|Overall Study||0||
59646089|NCT01794936|75763605|FG000|STARTED|Overall Study||9||
59646090|NCT01794936|75763605|FG000|COMPLETED|Overall Study||9||
59646091|NCT01794936|75763605|FG000|NOT COMPLETED|Overall Study||0||
59646092|NCT01756560|75763611|FG000|STARTED|Overall Study||2||
59646093|NCT01756560|75763612|FG001|STARTED|Overall Study||0||
59646094|NCT01756560|75763611|FG000|COMPLETED|Overall Study||0||
59646095|NCT01756560|75763612|FG001|COMPLETED|Overall Study||0||
59646096|NCT01756560|75763611|FG000|NOT COMPLETED|Overall Study||2||
59646097|NCT01756560|75763612|FG001|NOT COMPLETED|Overall Study||0||
59646098|NCT01738698|75763622|FG000|STARTED|Overall Study||0||
59646099|NCT01738698|75763623|FG001|STARTED|Overall Study||0||
59646100|NCT01738698|75763624|FG002|STARTED|Overall Study||0||
59646101|NCT01738698|75763625|FG003|STARTED|Overall Study||0||
59646102|NCT01738698|75763622|FG000|COMPLETED|Overall Study||0||
59646103|NCT01738698|75763623|FG001|COMPLETED|Overall Study||0||
59646104|NCT01738698|75763624|FG002|COMPLETED|Overall Study||0||
59646105|NCT01738698|75763625|FG003|COMPLETED|Overall Study||0||
59646106|NCT01738698|75763622|FG000|NOT COMPLETED|Overall Study||0||
59646107|NCT01738698|75763623|FG001|NOT COMPLETED|Overall Study||0||
59646108|NCT01738698|75763624|FG002|NOT COMPLETED|Overall Study||0||
59646109|NCT01738698|75763625|FG003|NOT COMPLETED|Overall Study||0||
59646110|NCT01717482|75763637|FG000|STARTED|Overall Study||4||
59646111|NCT01717482|75763638|FG001|STARTED|Overall Study||2||
59646112|NCT01717482|75763637|FG000|COMPLETED|Overall Study||0||
59646113|NCT01717482|75763638|FG001|COMPLETED|Overall Study||2||
59646114|NCT01717482|75763637|FG000|NOT COMPLETED|Overall Study||4||
59646115|NCT01717482|75763638|FG001|NOT COMPLETED|Overall Study||0||
59646116|NCT01702896|75763645|FG000|STARTED|Overall Study||8||
59646117|NCT01702896|75763645|FG000|COMPLETED|Overall Study||0||
59646118|NCT01702896|75763645|FG000|NOT COMPLETED|Overall Study||8||
59646119|NCT01682928|75763653|FG000|STARTED|Overall Study|2 subjects in this Arm|2||
59646120|NCT01682928|75763654|FG001|STARTED|Overall Study|2 subjects in this Arm|2||
59646121|NCT01682928|75763653|FG000|COMPLETED|Overall Study||2||
59646122|NCT01682928|75763654|FG001|COMPLETED|Overall Study||2||
59815773|NCT03026283|75938215|FG004|STARTED|Optimal Medical Care/FFR-CT Diagnosis||0|Note: Number of participants to start period is not equal to number who completed previous period.|
59646123|NCT01682928|75763653|FG000|NOT COMPLETED|Overall Study||0||
59646124|NCT01682928|75763654|FG001|NOT COMPLETED|Overall Study||0||
59646125|NCT01683864|75763665|FG000|STARTED|Overall Study||0||
59646126|NCT01683864|75763666|FG001|STARTED|Overall Study||0||
59646127|NCT01683864|75763667|FG002|STARTED|Overall Study||0||
59646128|NCT01683864|75763665|FG000|COMPLETED|Overall Study||0||
59646129|NCT01683864|75763666|FG001|COMPLETED|Overall Study||0||
59646130|NCT01683864|75763667|FG002|COMPLETED|Overall Study||0||
59646131|NCT01683864|75763665|FG000|NOT COMPLETED|Overall Study||0||
59646132|NCT01683864|75763666|FG001|NOT COMPLETED|Overall Study||0||
59646133|NCT01683864|75763667|FG002|NOT COMPLETED|Overall Study||0||
59646134|NCT01648296|75763677|FG000|STARTED|Overall Study||11||
59646135|NCT01648296|75763678|FG001|STARTED|Overall Study||17||
59646136|NCT01648296|75763677|FG000|COMPLETED|Overall Study||11||
59646137|NCT01648296|75763678|FG001|COMPLETED|Overall Study||17||
59646138|NCT01648296|75763677|FG000|NOT COMPLETED|Overall Study||0||
59646139|NCT01648296|75763678|FG001|NOT COMPLETED|Overall Study||0||
59646140|NCT01608906|75763686|FG000|STARTED|Overall Study||152||
59646141|NCT01608906|75763686|FG000|COMPLETED|Overall Study||113||
59646142|NCT01608906|75763686|FG000|NOT COMPLETED|Overall Study||39||
59646143|NCT01602198|75763693|FG000|STARTED|Overall Study||0||
59646144|NCT01602198|75763694|FG001|STARTED|Overall Study||1||
59646145|NCT01602198|75763693|FG000|COMPLETED|Overall Study||0||
59646146|NCT01602198|75763694|FG001|COMPLETED|Overall Study||1||
59646147|NCT01602198|75763693|FG000|NOT COMPLETED|Overall Study||0||
59646148|NCT01602198|75763694|FG001|NOT COMPLETED|Overall Study||0||
59646149|NCT01577628|75763702|FG000|STARTED|Overall Study||0||
59646150|NCT01577628|75763703|FG001|STARTED|Overall Study||0||
59646151|NCT01577628|75763704|FG002|STARTED|Overall Study||2||
59646152|NCT01577628|75763702|FG000|COMPLETED|Overall Study||0||
59646153|NCT01577628|75763703|FG001|COMPLETED|Overall Study||0||
59646154|NCT01577628|75763704|FG002|COMPLETED|Overall Study||0||
59646155|NCT01577628|75763702|FG000|NOT COMPLETED|Overall Study||0||
59646156|NCT01577628|75763703|FG001|NOT COMPLETED|Overall Study||0||
59646157|NCT01577628|75763704|FG002|NOT COMPLETED|Overall Study||2||
59646158|NCT01550562|75763710|FG000|STARTED|First Intervention, 4 - 5 Days||1||
59646159|NCT01550562|75763710|FG000|COMPLETED|First Intervention, 4 - 5 Days||1||
59646160|NCT01550562|75763710|FG000|NOT COMPLETED|First Intervention, 4 - 5 Days||0||
59646161|NCT01550562|75763710|FG000|STARTED|Second Intervention, 4 - 5 Days||1||
59646162|NCT01550562|75763710|FG000|COMPLETED|Second Intervention, 4 - 5 Days||1||
59646163|NCT01550562|75763710|FG000|NOT COMPLETED|Second Intervention, 4 - 5 Days||0||
59646164|NCT01550562|75763710|FG000|STARTED|Third Intervention, 4 - 5 Days||1||
59646165|NCT01550562|75763710|FG000|COMPLETED|Third Intervention, 4 - 5 Days||1||
59646166|NCT01550562|75763710|FG000|NOT COMPLETED|Third Intervention, 4 - 5 Days||0||
59646167|NCT01545648|75763714|FG000|STARTED|Overall Study||4||
59646168|NCT01545648|75763714|FG000|6 Months of Treatment|Overall Study||4||
59646169|NCT01545648|75763714|FG000|COMPLETED|Overall Study||4|12 months of treatment|
59646170|NCT01545648|75763714|FG000|NOT COMPLETED|Overall Study||0||
59646171|NCT01527942|75763720|FG000|STARTED|Overall Study||16||
59646172|NCT01527942|75763721|FG001|STARTED|Overall Study||18||
59646173|NCT01527942|75763720|FG000|COMPLETED|Overall Study||16||
59646174|NCT01527942|75763721|FG001|COMPLETED|Overall Study||18||
59646175|NCT01527942|75763720|FG000|NOT COMPLETED|Overall Study||0||
59646176|NCT01527942|75763721|FG001|NOT COMPLETED|Overall Study||0||
59646177|NCT01507584|75763727|FG000|STARTED|Overall Study||0||
59646178|NCT01507584|75763727|FG000|COMPLETED|Overall Study||0||
59646179|NCT01507584|75763727|FG000|NOT COMPLETED|Overall Study||0||
59646180|NCT01483872|75763731|FG000|STARTED|Overall Study||0||
59646181|NCT01483872|75763732|FG001|STARTED|Overall Study||1||
59646182|NCT01483872|75763731|FG000|COMPLETED|Overall Study||0||
59646183|NCT01483872|75763732|FG001|COMPLETED|Overall Study||1||
59646184|NCT01483872|75763731|FG000|NOT COMPLETED|Overall Study||0||
59646185|NCT01483872|75763732|FG001|NOT COMPLETED|Overall Study||0||
59646186|NCT01385280|75763736|FG000|STARTED|Overall Study||13||
59646187|NCT01385280|75763736|FG000|COMPLETED|Overall Study||13||
59646188|NCT01385280|75763736|FG000|NOT COMPLETED|Overall Study||0||
59646189|NCT01365156|75763742|FG000|STARTED|Overall Study||14||
59646190|NCT01365156|75763743|FG001|STARTED|Overall Study||14||
59646191|NCT01365156|75763742|FG000|COMPLETED|Overall Study||14||
59646192|NCT01365156|75763743|FG001|COMPLETED|Overall Study||14||
59646193|NCT01365156|75763742|FG000|NOT COMPLETED|Overall Study||0||
59646194|NCT01365156|75763743|FG001|NOT COMPLETED|Overall Study||0||
59646195|NCT01350258|75763749|FG000|STARTED|Overall Study||8||
59646196|NCT01350258|75763749|FG000|COMPLETED|Overall Study||8||
59646197|NCT01350258|75763749|FG000|NOT COMPLETED|Overall Study||0||
59646198|NCT01319760|75763755|FG000|STARTED|Overall Study|The study experienced a very low enrollment rate. the sponsor decided to stop the study.|0||
59646199|NCT01319760|75763756|FG001|STARTED|Overall Study||5||
59646200|NCT01319760|75763755|FG000|COMPLETED|Overall Study|The study experienced a very low enrollment rate. the sponsor decided to stop the study.|0||
59646201|NCT01319760|75763756|FG001|COMPLETED|Overall Study||5||
59646202|NCT01319760|75763755|FG000|NOT COMPLETED|Overall Study||0||
59646203|NCT01319760|75763756|FG001|NOT COMPLETED|Overall Study||0||
59646204|NCT01302444|75763764|FG000|STARTED|Overall Study||1||
59646205|NCT01302444|75763765|FG001|STARTED|Overall Study||0||
59646206|NCT01302444|75763764|FG000|COMPLETED|Overall Study||1||
59646207|NCT01302444|75763765|FG001|COMPLETED|Overall Study||0||
59646208|NCT01302444|75763764|FG000|NOT COMPLETED|Overall Study||0||
59646209|NCT01302444|75763765|FG001|NOT COMPLETED|Overall Study||0||
59646210|NCT01292070|75763771|FG000|STARTED|Overall Study||4||
59646211|NCT01292070|75763771|FG000|COMPLETED|Overall Study||4||
59646212|NCT01292070|75763771|FG000|NOT COMPLETED|Overall Study||0||
59646213|NCT01284504|75763777|FG000|STARTED|Overall Study||0||
59646214|NCT01284504|75763778|FG001|STARTED|Overall Study||0||
59646215|NCT01284504|75763777|FG000|COMPLETED|Overall Study||0||
59646216|NCT01284504|75763778|FG001|COMPLETED|Overall Study||0||
59646217|NCT01284504|75763777|FG000|NOT COMPLETED|Overall Study||0||
59646218|NCT01284504|75763778|FG001|NOT COMPLETED|Overall Study||0||
59646219|NCT01204788|75763786|FG000|STARTED|Overall Study||1||
59646220|NCT01204788|75763787|FG001|STARTED|Overall Study||3||
59646221|NCT01204788|75763786|FG000|COMPLETED|Overall Study||0||
59646222|NCT01204788|75763787|FG001|COMPLETED|Overall Study||0||
59646223|NCT01204788|75763786|FG000|NOT COMPLETED|Overall Study||1||
59646224|NCT01204788|75763787|FG001|NOT COMPLETED|Overall Study||3||
59646225|NCT01183416|75763793|FG000|STARTED|Overall Study||4||
59646226|NCT01183416|75763793|FG000|COMPLETED|Overall Study||4||
59646227|NCT01183416|75763793|FG000|NOT COMPLETED|Overall Study||0||
59646228|NCT01169610|75763797|FG000|STARTED|Overall Study||1||
59646229|NCT01169610|75763797|FG000|COMPLETED|Overall Study||1||
59646230|NCT01169610|75763797|FG000|NOT COMPLETED|Overall Study||0||
59646231|NCT01166724|75763803|FG000|STARTED|Overall Study||7||
59646232|NCT01166724|75763804|FG001|STARTED|Overall Study||5||
59646233|NCT01166724|75763803|FG000|COMPLETED|Overall Study||0||
59646234|NCT01166724|75763804|FG001|COMPLETED|Overall Study||0||
59646235|NCT01166724|75763803|FG000|NOT COMPLETED|Overall Study||7||
59646236|NCT01166724|75763804|FG001|NOT COMPLETED|Overall Study||5||
59646237|NCT01151904|75763810|FG000|STARTED|Overall Study||17||
59646238|NCT01151904|75763810|FG000|COMPLETED|Overall Study||17||
59646239|NCT01151904|75763810|FG000|NOT COMPLETED|Overall Study||0||
59646240|NCT01110174|75763814|FG000|STARTED|Overall Study||8||
59646241|NCT01110174|75763814|FG000|COMPLETED|Overall Study||8||
59646242|NCT01110174|75763814|FG000|NOT COMPLETED|Overall Study||0||
59646243|NCT01115244|75763820|FG000|STARTED|Overall Study||0||
59646244|NCT01115244|75763821|FG001|STARTED|Overall Study||0||
59646245|NCT01115244|75763820|FG000|COMPLETED|Overall Study||0||
59646246|NCT01115244|75763821|FG001|COMPLETED|Overall Study||0||
59646247|NCT01115244|75763820|FG000|NOT COMPLETED|Overall Study||0||
59646248|NCT01115244|75763821|FG001|NOT COMPLETED|Overall Study||0||
59646249|NCT01079598|75763827|FG000|STARTED|Overall Study||8||
59646250|NCT01079598|75763827|FG000|COMPLETED|Overall Study||8||
59646251|NCT01079598|75763827|FG000|NOT COMPLETED|Overall Study||0||
59646252|NCT01031550|75763833|FG000|STARTED|Overall Study||5||
59646253|NCT01031550|75763834|FG001|STARTED|Overall Study||3||
59646254|NCT01031550|75763833|FG000|COMPLETED|Overall Study||5||
59646255|NCT01031550|75763834|FG001|COMPLETED|Overall Study||3||
59646256|NCT01031550|75763833|FG000|NOT COMPLETED|Overall Study||0||
59646257|NCT01031550|75763834|FG001|NOT COMPLETED|Overall Study||0||
59646258|NCT00986310|75763844|FG000|STARTED|Overall Study||0||
59646259|NCT00986310|75763845|FG001|STARTED|Overall Study||0||
59646260|NCT00986310|75763844|FG000|COMPLETED|Overall Study||0||
59646261|NCT00986310|75763845|FG001|COMPLETED|Overall Study||0||
59646262|NCT00986310|75763844|FG000|NOT COMPLETED|Overall Study||0||
59646263|NCT00986310|75763845|FG001|NOT COMPLETED|Overall Study||0||
59646264|NCT00907218|75763851|FG000|STARTED|Overall Study||2||
59646265|NCT00907218|75763851|FG000|COMPLETED|Overall Study||2||
59646266|NCT00907218|75763851|FG000|NOT COMPLETED|Overall Study||0||
59646267|NCT00895284|75763857|FG000|STARTED|Overall Study||3||
59646268|NCT00895284|75763858|FG001|STARTED|Overall Study||0||
59646269|NCT00895284|75763857|FG000|COMPLETED|Overall Study||3||
59646270|NCT00895284|75763858|FG001|COMPLETED|Overall Study||0||
59646271|NCT00895284|75763857|FG000|NOT COMPLETED|Overall Study||0||
59646272|NCT00895284|75763858|FG001|NOT COMPLETED|Overall Study||0||
59646273|NCT00903396|75763868|FG000|STARTED|Overall Study||2||
59646274|NCT00903396|75763869|FG001|STARTED|Overall Study||1||
59646275|NCT00903396|75763870|FG002|STARTED|Overall Study||3||
59646276|NCT00903396|75763871|FG003|STARTED|Overall Study||1||
59646277|NCT00903396|75763868|FG000|COMPLETED|Overall Study||2||
59646278|NCT00903396|75763869|FG001|COMPLETED|Overall Study||1||
59646279|NCT00903396|75763870|FG002|COMPLETED|Overall Study||3||
59646280|NCT00903396|75763871|FG003|COMPLETED|Overall Study||1||
59646281|NCT00903396|75763868|FG000|NOT COMPLETED|Overall Study||0||
59646282|NCT00903396|75763869|FG001|NOT COMPLETED|Overall Study||0||
59646283|NCT00903396|75763870|FG002|NOT COMPLETED|Overall Study||0||
59646284|NCT00903396|75763871|FG003|NOT COMPLETED|Overall Study||0||
59646285|NCT00875394|75763884|FG000|STARTED|Overall Study||36||
59646286|NCT00875394|75763885|FG001|STARTED|Overall Study||23||
59646287|NCT00875394|75763886|FG002|STARTED|Overall Study||9||
59646288|NCT00875394|75763884|FG000|COMPLETED|Overall Study||36||
59646289|NCT00875394|75763885|FG001|COMPLETED|Overall Study||23||
59646290|NCT00875394|75763886|FG002|COMPLETED|Overall Study||9||
59646291|NCT00875394|75763884|FG000|NOT COMPLETED|Overall Study||0||
59646292|NCT00875394|75763885|FG001|NOT COMPLETED|Overall Study||0||
59646293|NCT00875394|75763886|FG002|NOT COMPLETED|Overall Study||0||
59646294|NCT00832572|75763896|FG000|STARTED|Period 1||3||
59646295|NCT00832572|75763897|FG001|STARTED|Period 1||2||
59646296|NCT00832572|75763896|FG000|COMPLETED|Period 1||3||
59646297|NCT00832572|75763897|FG001|COMPLETED|Period 1||2||
59646298|NCT00832572|75763896|FG000|NOT COMPLETED|Period 1||0||
59646299|NCT00832572|75763897|FG001|NOT COMPLETED|Period 1||0||
59646300|NCT00832572|75763896|FG000|STARTED|Period 2||3||
59646301|NCT00832572|75763897|FG001|STARTED|Period 2||2||
59646302|NCT00832572|75763896|FG000|COMPLETED|Period 2||3||
59646303|NCT00832572|75763897|FG001|COMPLETED|Period 2||2||
59646304|NCT00832572|75763896|FG000|NOT COMPLETED|Period 2||0||
59646305|NCT00832572|75763897|FG001|NOT COMPLETED|Period 2||0||
59646306|NCT00811590|75763905|FG000|STARTED|Overall Study||3||
59646307|NCT00811590|75763905|FG000|COMPLETED|Overall Study||3||
59646308|NCT00811590|75763905|FG000|NOT COMPLETED|Overall Study||0||
59646309|NCT00749658|75763911|FG000|STARTED|Overall Study||60||
59646310|NCT00749658|75763912|FG001|STARTED|Overall Study||61||
59646311|NCT00749658|75763911|FG000|COMPLETED|Overall Study||60||
59646312|NCT00749658|75763912|FG001|COMPLETED|Overall Study||61||
59646313|NCT00749658|75763911|FG000|NOT COMPLETED|Overall Study||0||
59646314|NCT00749658|75763912|FG001|NOT COMPLETED|Overall Study||0||
59646315|NCT00738972|75763922|FG000|STARTED|Overall Study||3||
59646316|NCT00738972|75763923|FG001|STARTED|Overall Study||3||
59646317|NCT00738972|75763924|FG002|STARTED|Overall Study||3||
59646318|NCT00738972|75763925|FG003|STARTED|Overall Study||3||
59646319|NCT00738972|75763922|FG000|COMPLETED|Overall Study||3||
59646320|NCT00738972|75763923|FG001|COMPLETED|Overall Study||3||
59646321|NCT00738972|75763924|FG002|COMPLETED|Overall Study||3||
59646322|NCT00738972|75763925|FG003|COMPLETED|Overall Study||2||
59646323|NCT00738972|75763922|FG000|NOT COMPLETED|Overall Study||0||
59646324|NCT00738972|75763923|FG001|NOT COMPLETED|Overall Study||0||
59646325|NCT00738972|75763924|FG002|NOT COMPLETED|Overall Study||0||
59646326|NCT00738972|75763925|FG003|NOT COMPLETED|Overall Study||1||
59646327|NCT00726180|75763935|FG000|STARTED|Overall Study||1||
59646328|NCT00726180|75763935|FG000|COMPLETED|Overall Study||1||
59646329|NCT00726180|75763935|FG000|NOT COMPLETED|Overall Study||0||
59646330|NCT00704496|75763941|FG000|STARTED|Overall Study||0||
59646331|NCT00704496|75763942|FG001|STARTED|Overall Study||0||
59646332|NCT00704496|75763941|FG000|COMPLETED|Overall Study||0||
59646333|NCT00704496|75763942|FG001|COMPLETED|Overall Study||0||
59646334|NCT00704496|75763941|FG000|NOT COMPLETED|Overall Study||0||
59646335|NCT00704496|75763942|FG001|NOT COMPLETED|Overall Study||0||
59646336|NCT00692094|75763952|FG000|STARTED|Overall Study||0||
59646337|NCT00692094|75763953|FG001|STARTED|Overall Study||0||
59646338|NCT00692094|75763954|FG002|STARTED|Overall Study||0||
59646339|NCT00692094|75763955|FG003|STARTED|Overall Study||0||
59646340|NCT00692094|75763952|FG000|COMPLETED|Overall Study||0||
59646341|NCT00692094|75763953|FG001|COMPLETED|Overall Study||0||
59646342|NCT00692094|75763954|FG002|COMPLETED|Overall Study||0||
59646343|NCT00692094|75763955|FG003|COMPLETED|Overall Study||0||
59646344|NCT00692094|75763952|FG000|NOT COMPLETED|Overall Study||0||
59646345|NCT00692094|75763953|FG001|NOT COMPLETED|Overall Study||0||
59646346|NCT00692094|75763954|FG002|NOT COMPLETED|Overall Study||0||
59646347|NCT00692094|75763955|FG003|NOT COMPLETED|Overall Study||0||
59646348|NCT00676026|75763965|FG000|STARTED|Overall Study||8||
59646349|NCT00676026|75763965|FG000|COMPLETED|Overall Study||8||
59646350|NCT00676026|75763965|FG000|NOT COMPLETED|Overall Study||0||
59646351|NCT00679926|75763969|FG000|STARTED|Overall Study||15||
59646352|NCT00679926|75763969|FG000|COMPLETED|Overall Study||2||
59646353|NCT00679926|75763969|FG000|NOT COMPLETED|Overall Study||13||
59646354|NCT00680316|75763976|FG000|STARTED|Overall Study||1||
59646355|NCT00680316|75763977|FG001|STARTED|Overall Study||2||
59646356|NCT00680316|75763976|FG000|COMPLETED|Overall Study||1||
59646357|NCT00680316|75763977|FG001|COMPLETED|Overall Study||2||
59646358|NCT00680316|75763976|FG000|NOT COMPLETED|Overall Study||0||
59646359|NCT00680316|75763977|FG001|NOT COMPLETED|Overall Study||0||
59646360|NCT00656916|75763985|FG000|STARTED|Overall Study||1||
59646361|NCT00656916|75763986|FG001|STARTED|Overall Study||0||
59646362|NCT00656916|75763985|FG000|COMPLETED|Overall Study||1||
59646363|NCT00656916|75763986|FG001|COMPLETED|Overall Study||0||
59646364|NCT00656916|75763985|FG000|NOT COMPLETED|Overall Study||0||
59646365|NCT00656916|75763986|FG001|NOT COMPLETED|Overall Study||0||
59646366|NCT00629850|75763994|FG000|STARTED|Overall Study||1||
59646367|NCT00629850|75763995|FG001|STARTED|Overall Study||0||
59646368|NCT00629850|75763994|FG000|COMPLETED|Overall Study||1||
59646369|NCT00629850|75763995|FG001|COMPLETED|Overall Study||0||
59646370|NCT00629850|75763994|FG000|NOT COMPLETED|Overall Study||0||
59646371|NCT00629850|75763995|FG001|NOT COMPLETED|Overall Study||0||
59646372|NCT00619242|75764001|FG000|STARTED|Overall Study||3||
59646373|NCT00619242|75764001|FG000|COMPLETED|Overall Study||3||
59646374|NCT00619242|75764001|FG000|NOT COMPLETED|Overall Study||0||
59646375|NCT00601848|75764005|FG000|STARTED|Overall Study||9||
59646376|NCT00601848|75764005|FG000|COMPLETED|Overall Study||0||
59646377|NCT00601848|75764005|FG000|NOT COMPLETED|Overall Study||9||
59646378|NCT00586716|75764011|FG000|STARTED|Overall Study||14||
59646379|NCT00586716|75764012|FG001|STARTED|Overall Study||8||
59646380|NCT00586716|75764011|FG000|COMPLETED|Overall Study||14||
59646381|NCT00586716|75764012|FG001|COMPLETED|Overall Study||8||
59646382|NCT00586716|75764011|FG000|NOT COMPLETED|Overall Study||0||
59646383|NCT00586716|75764012|FG001|NOT COMPLETED|Overall Study||0||
59646384|NCT00571194|75764019|FG000|STARTED|Overall Study||7||
59646385|NCT00571194|75764019|FG000|COMPLETED|Overall Study||7||
59646386|NCT00571194|75764019|FG000|NOT COMPLETED|Overall Study||0||
59646387|NCT00570258|75764025|FG000|STARTED|Overall Study||12||
59646388|NCT00570258|75764026|FG001|STARTED|Overall Study||15||
59646389|NCT00570258|75764025|FG000|COMPLETED|Overall Study|Early termination due to a change in drug FDA approval.|0||
59646390|NCT00570258|75764026|FG001|COMPLETED|Overall Study|Early termination due to a change in drug FDA approval.|0||
59646391|NCT00570258|75764025|FG000|NOT COMPLETED|Overall Study||12||
59646392|NCT00570258|75764026|FG001|NOT COMPLETED|Overall Study||15||
59646393|NCT00568698|75764034|FG000|STARTED|Overall Study||29||
59646394|NCT00568698|75764034|FG000|COMPLETED|Overall Study||18||
59646395|NCT00568698|75764034|FG000|NOT COMPLETED|Overall Study||11||
59646396|NCT00577356|75764040|FG000|STARTED|Overall Study||6||
59646397|NCT00577356|75764040|FG000|COMPLETED|Overall Study||6||
59646398|NCT00577356|75764040|FG000|NOT COMPLETED|Overall Study||0||
59646399|NCT00569868|75764044|FG000|STARTED|Overall Study||11||
59646400|NCT00569868|75764044|FG000|COMPLETED|Overall Study||11||
59646401|NCT00569868|75764044|FG000|NOT COMPLETED|Overall Study||0||
59646402|NCT04575090|75764051|FG000|STARTED|Overall Study||0||
59646403|NCT04575090|75764052|FG001|STARTED|Overall Study||7||
59646404|NCT04575090|75764053|FG002|STARTED|Overall Study||1||
59646405|NCT04575090|75764051|FG000|COMPLETED|Overall Study||0||
59646406|NCT04575090|75764052|FG001|COMPLETED|Overall Study||5||
59646407|NCT04575090|75764053|FG002|COMPLETED|Overall Study||1||
59646408|NCT04575090|75764051|FG000|NOT COMPLETED|Overall Study||0||
59646409|NCT04575090|75764052|FG001|NOT COMPLETED|Overall Study||2||
59646410|NCT04575090|75764053|FG002|NOT COMPLETED|Overall Study||0||
59646411|NCT00564876|75764061|FG000|STARTED|Overall Study||2||
59646412|NCT00564876|75764061|FG000|COMPLETED|Overall Study||2||
59646413|NCT00564876|75764061|FG000|NOT COMPLETED|Overall Study||0||
59988586|NCT02743871|76103796|FG003|STARTED|Overall Study||3||
59646414|NCT00558870|75764067|FG000|STARTED|Overall Study||2||
59646415|NCT00558870|75764068|FG001|STARTED|Overall Study||2||
59646416|NCT00558870|75764067|FG000|COMPLETED|Overall Study||2||
59646417|NCT00558870|75764068|FG001|COMPLETED|Overall Study||2||
59646418|NCT00558870|75764067|FG000|NOT COMPLETED|Overall Study||0||
59646419|NCT00558870|75764068|FG001|NOT COMPLETED|Overall Study||0||
59988587|NCT02743871|76103797|FG004|STARTED|Overall Study||4||
59988588|NCT02743871|76103798|FG005|STARTED|Overall Study||6||
59646420|NCT00548886|75764074|FG000|STARTED|Overall Study||7||
59646421|NCT00548886|75764074|FG000|COMPLETED|Overall Study||7||
59817899|NCT04488770|75940338|FG012|COMPLETED|Part 1-Cohort 2: Period 1 (Up to 5 Days)||0||
59646422|NCT00548886|75764074|FG000|NOT COMPLETED|Overall Study||0||
59646423|NCT00538980|75764078|FG000|STARTED|Overall Study||10||
59646424|NCT00538980|75764078|FG000|COMPLETED|Overall Study||0||
59988589|NCT02743871|76103799|FG006|STARTED|Overall Study||6||
59646425|NCT00538980|75764078|FG000|NOT COMPLETED|Overall Study||10||
59646426|NCT00529464|75764085|FG000|STARTED|Overall Study||0||
59646427|NCT00529464|75764086|FG001|STARTED|Overall Study||0||
59646428|NCT00529464|75764087|FG002|STARTED|Overall Study||0||
59646429|NCT00529464|75764085|FG000|COMPLETED|Overall Study||0||
59646430|NCT00529464|75764086|FG001|COMPLETED|Overall Study||0||
59988590|NCT02743871|76103800|FG007|STARTED|Overall Study||8||
59646431|NCT00529464|75764087|FG002|COMPLETED|Overall Study||0||
59646432|NCT00529464|75764085|FG000|NOT COMPLETED|Overall Study||0||
59646433|NCT00529464|75764086|FG001|NOT COMPLETED|Overall Study||0||
59646434|NCT00529464|75764087|FG002|NOT COMPLETED|Overall Study||0||
59646435|NCT00519090|75764097|FG000|STARTED|Overall Study||2||
59646436|NCT00519090|75764098|FG001|STARTED|Overall Study||4||
59646437|NCT00519090|75764097|FG000|COMPLETED|Overall Study||2||
59646438|NCT00519090|75764098|FG001|COMPLETED|Overall Study||4||
59646439|NCT00519090|75764097|FG000|NOT COMPLETED|Overall Study||0||
59646440|NCT00519090|75764098|FG001|NOT COMPLETED|Overall Study||0||
59646441|NCT00524394|75764104|FG000|STARTED|Overall Study||2||
59646442|NCT00524394|75764104|FG000|COMPLETED|Overall Study||1||
59646443|NCT00524394|75764104|FG000|NOT COMPLETED|Overall Study||1||
59646444|NCT00506064|75764110|FG000|STARTED|Overall Study||1||
59646445|NCT00506064|75764111|FG001|STARTED|Overall Study||0||
59646446|NCT00506064|75764110|FG000|COMPLETED|Overall Study||1||
59646447|NCT00506064|75764111|FG001|COMPLETED|Overall Study||0||
59646448|NCT00506064|75764110|FG000|NOT COMPLETED|Overall Study||0||
59646449|NCT00506064|75764111|FG001|NOT COMPLETED|Overall Study||0||
59646450|NCT00475332|75764117|FG000|STARTED|Overall Study||2||
59646451|NCT00475332|75764117|FG000|COMPLETED|Overall Study||2||
59646452|NCT00475332|75764117|FG000|NOT COMPLETED|Overall Study||0||
59646453|NCT00478062|75764122|FG000|STARTED|Overall Study||1||
59646454|NCT00478062|75764122|FG000|COMPLETED|Overall Study||1||
59646455|NCT00478062|75764122|FG000|NOT COMPLETED|Overall Study||0||
59646456|NCT00470574|75764126|FG000|STARTED|Overall Study||7||
59646457|NCT00470574|75764126|FG000|COMPLETED|Overall Study||7||
59646458|NCT00470574|75764126|FG000|NOT COMPLETED|Overall Study||0||
59646459|NCT00442260|75764130|FG000|STARTED|Overall Study||2||
59646460|NCT00442260|75764130|FG000|COMPLETED|Overall Study||2||
59646461|NCT00442260|75764130|FG000|NOT COMPLETED|Overall Study||0||
59646462|NCT00386724|75764134|FG000|STARTED|Overall Study||8||
59646463|NCT00386724|75764134|FG000|3 Months Post-activation|Overall Study||4||
59646464|NCT00386724|75764134|FG000|COMPLETED|Overall Study||3||
59646465|NCT00386724|75764134|FG000|NOT COMPLETED|Overall Study||5||
59646466|NCT00325572|75764140|FG000|STARTED|PHASE I||45||
59646467|NCT00325572|75764141|FG001|STARTED|PHASE I||44||
60076772|NCT01539525|76191783|FG001|STARTED|Overall Study||143||
59646468|NCT00325572|75764140|FG000|COMPLETED|PHASE I||45||
59646469|NCT00325572|75764141|FG001|COMPLETED|PHASE I||44||
59646470|NCT00325572|75764140|FG000|NOT COMPLETED|PHASE I||0||
59646471|NCT00325572|75764141|FG001|NOT COMPLETED|PHASE I||0||
59646472|NCT00325572|75764140|FG000|STARTED|PHASE ii||0||
59646473|NCT00325572|75764141|FG001|STARTED|PHASE ii||0||
59646474|NCT00325572|75764140|FG000|COMPLETED|PHASE ii||0||
59646475|NCT00325572|75764141|FG001|COMPLETED|PHASE ii||0||
59646476|NCT00325572|75764140|FG000|NOT COMPLETED|PHASE ii||0||
59646477|NCT00325572|75764141|FG001|NOT COMPLETED|PHASE ii||0||
59646478|NCT00333762|75764147|FG000|STARTED|Overall Study||4||
59646479|NCT00333762|75764147|FG000|COMPLETED|Overall Study||0||
59646480|NCT00333762|75764147|FG000|NOT COMPLETED|Overall Study||4||
59646481|NCT00145704|75764153|FG000|STARTED|Overall Study||3||
59646482|NCT00145704|75764154|FG001|STARTED|Overall Study||3||
59646483|NCT00145704|75764153|FG000|COMPLETED|Overall Study||0||
59646484|NCT00145704|75764154|FG001|COMPLETED|Overall Study||0||
59646485|NCT00145704|75764153|FG000|NOT COMPLETED|Overall Study||3||
59646486|NCT00145704|75764154|FG001|NOT COMPLETED|Overall Study||3||
59646487|NCT00108342|75764162|FG000|STARTED|Overall Study||8||
59646488|NCT00108342|75764163|FG001|STARTED|Overall Study||9||
59646489|NCT00108342|75764162|FG000|COMPLETED|Overall Study||7||
59646490|NCT00108342|75764163|FG001|COMPLETED|Overall Study||9||
59646491|NCT00108342|75764162|FG000|NOT COMPLETED|Overall Study||1||
59646492|NCT00108342|75764163|FG001|NOT COMPLETED|Overall Study||0||
59646493|NCT00090870|75764169|FG000|STARTED|Overall Study||10||
59646494|NCT00090870|75764169|FG000|COMPLETED|Overall Study||10||
59646495|NCT00090870|75764169|FG000|NOT COMPLETED|Overall Study||0||
59988591|NCT02743871|76103801|FG008|STARTED|Overall Study||2||
59988592|NCT02743871|76103802|FG009|STARTED|Overall Study||2||
59988593|NCT02743871|76103803|FG010|STARTED|Overall Study||11||
59988594|NCT02743871|76103804|FG011|STARTED|Overall Study||9||
59988595|NCT02743871|76103805|FG012|STARTED|Overall Study||20||
59988596|NCT02743871|76103806|FG013|STARTED|Overall Study||8||
59988597|NCT02743871|76103793|FG000|COMPLETED|Overall Study||5||
59646496|NCT00074724|75764175|FG000|STARTED|Overall Study|The PI has left the institution and no results data is available. Efforts were made to contact the PI/study team members, as well as to review data on shared drives, IRB historical records and published resources, but were unsuccessful. No study data are available|0||
59646497|NCT00074724|75764176|FG001|STARTED|Overall Study|The PI has left the institution and no results data is available. Efforts were made to contact the PI/study team members, as well as to review data on shared drives, IRB historical records and published resources, but were unsuccessful. No study data are available|0||
59646498|NCT00074724|75764175|FG000|COMPLETED|Overall Study|The PI has left the institution and no results data is available. Efforts were made to contact the PI/study team members, as well as to review data on shared drives, IRB historical records and published resources, but were unsuccessful. No study data are available|0||
59646499|NCT00074724|75764176|FG001|COMPLETED|Overall Study|The PI has left the institution and no results data is available. Efforts were made to contact the PI/study team members, as well as to review data on shared drives, IRB historical records and published resources, but were unsuccessful. No study data are available|0||
59646500|NCT00074724|75764175|FG000|NOT COMPLETED|Overall Study||0||
59646501|NCT00074724|75764176|FG001|NOT COMPLETED|Overall Study||0||
59646502|NCT00058188|75764184|FG000|STARTED|Overall Study||0||
59646503|NCT00058188|75764185|FG001|STARTED|Overall Study||0||
59646504|NCT00058188|75764184|FG000|COMPLETED|Overall Study||0||
59646505|NCT00058188|75764185|FG001|COMPLETED|Overall Study||0||
59646506|NCT00058188|75764184|FG000|NOT COMPLETED|Overall Study||0||
59646507|NCT00058188|75764185|FG001|NOT COMPLETED|Overall Study||0||
59646508|NCT00003726|75764191|FG000|STARTED|Overall Study||1||
59646509|NCT00003726|75764191|FG000|COMPLETED|Overall Study|Funding was pulled on the trial and therefore no other participants were enrolled|0||
59646510|NCT00003726|75764191|FG000|NOT COMPLETED|Overall Study||1||
59646511|NCT02595996|75764195|FG000|STARTED|Overall Study||1||
59646512|NCT02595996|75764195|FG000|COMPLETED|Overall Study||1||
59646513|NCT02595996|75764195|FG000|NOT COMPLETED|Overall Study||0||
59646514|NCT03198156|75764201|FG000|STARTED|Overall Study||19||
59646515|NCT03198156|75764202|FG001|STARTED|Overall Study||19||
59646516|NCT03198156|75764201|FG000|COMPLETED|Overall Study||19||
59646517|NCT03198156|75764202|FG001|COMPLETED|Overall Study||19||
59646518|NCT03198156|75764201|FG000|NOT COMPLETED|Overall Study||0||
59646519|NCT03198156|75764202|FG001|NOT COMPLETED|Overall Study||0||
59646520|NCT04422210|75764216|FG000|STARTED|Overall Study||0||
59646521|NCT04422210|75764217|FG001|STARTED|Overall Study||0||
59646522|NCT04422210|75764218|FG002|STARTED|Overall Study||0||
59646523|NCT04422210|75764219|FG003|STARTED|Overall Study||0||
59646524|NCT04422210|75764220|FG004|STARTED|Overall Study||0||
59646525|NCT04422210|75764221|FG005|STARTED|Overall Study||0||
59646526|NCT04422210|75764222|FG006|STARTED|Overall Study||0||
59646527|NCT04422210|75764223|FG007|STARTED|Overall Study||0||
59646528|NCT04422210|75764216|FG000|COMPLETED|Overall Study||0||
59646529|NCT04422210|75764217|FG001|COMPLETED|Overall Study||0||
59646530|NCT04422210|75764218|FG002|COMPLETED|Overall Study||0||
59646531|NCT04422210|75764219|FG003|COMPLETED|Overall Study||0||
59646532|NCT04422210|75764220|FG004|COMPLETED|Overall Study||0||
59646533|NCT04422210|75764221|FG005|COMPLETED|Overall Study||0||
59646534|NCT04422210|75764222|FG006|COMPLETED|Overall Study||0||
59646535|NCT04422210|75764223|FG007|COMPLETED|Overall Study||0||
59646536|NCT04422210|75764216|FG000|NOT COMPLETED|Overall Study||0||
59646537|NCT04422210|75764217|FG001|NOT COMPLETED|Overall Study||0||
59646538|NCT04422210|75764218|FG002|NOT COMPLETED|Overall Study||0||
59646539|NCT04422210|75764219|FG003|NOT COMPLETED|Overall Study||0||
59646540|NCT04422210|75764220|FG004|NOT COMPLETED|Overall Study||0||
59646541|NCT04422210|75764221|FG005|NOT COMPLETED|Overall Study||0||
59646542|NCT04422210|75764222|FG006|NOT COMPLETED|Overall Study||0||
59646543|NCT04422210|75764223|FG007|NOT COMPLETED|Overall Study||0||
59646544|NCT04010370|75764242|FG000|STARTED|Overall Study||25||
59646545|NCT04010370|75764242|FG000|COMPLETED|Overall Study||25||
59646546|NCT04010370|75764242|FG000|NOT COMPLETED|Overall Study||0||
59646547|NCT04521114|75764249|FG000|STARTED|Overall Study||30||
59646548|NCT04521114|75764250|FG001|STARTED|Overall Study||27||
59646549|NCT04521114|75764251|FG002|STARTED|Overall Study||30||
59646550|NCT04521114|75764249|FG000|COMPLETED|Overall Study||24||
59646551|NCT04521114|75764250|FG001|COMPLETED|Overall Study||21||
59646552|NCT04521114|75764251|FG002|COMPLETED|Overall Study||28||
59646553|NCT04521114|75764249|FG000|NOT COMPLETED|Overall Study||6||
59646554|NCT04521114|75764250|FG001|NOT COMPLETED|Overall Study||6||
59646555|NCT04521114|75764251|FG002|NOT COMPLETED|Overall Study||2||
59646556|NCT04360824|75764273|FG000|STARTED|Overall Study||88||
59646557|NCT04360824|75764274|FG001|STARTED|Overall Study||88||
59646558|NCT04360824|75764273|FG000|COMPLETED|Overall Study||85||
59646559|NCT04360824|75764274|FG001|COMPLETED|Overall Study||84||
59646560|NCT04360824|75764273|FG000|NOT COMPLETED|Overall Study||3||
59646561|NCT04360824|75764274|FG001|NOT COMPLETED|Overall Study||4||
59646562|NCT03711786|75764283|FG000|STARTED|Period 1: Recruited in Study Months 1-5||168||5
59646563|NCT03711786|75764284|FG001|STARTED|Period 1: Recruited in Study Months 1-5||189||5
59646564|NCT03711786|75764283|FG000|3-month Assessment|Period 1: Recruited in Study Months 1-5||162||5
59646565|NCT03711786|75764284|FG001|3-month Assessment|Period 1: Recruited in Study Months 1-5||186||5
59646566|NCT03711786|75764283|FG000|6-month Assessment|Period 1: Recruited in Study Months 1-5||156||5
59988598|NCT02743871|76103794|FG001|COMPLETED|Overall Study||6||
59646567|NCT03711786|75764284|FG001|6-month Assessment|Period 1: Recruited in Study Months 1-5||179||5
59646568|NCT03711786|75764283|FG000|12-month Assessment|Period 1: Recruited in Study Months 1-5||148||5
59646569|NCT03711786|75764284|FG001|12-month Assessment|Period 1: Recruited in Study Months 1-5||183||5
59646570|NCT03711786|75764283|FG000|COMPLETED|Period 1: Recruited in Study Months 1-5||148||5
59646571|NCT03711786|75764284|FG001|COMPLETED|Period 1: Recruited in Study Months 1-5||183||5
59646572|NCT03711786|75764283|FG000|NOT COMPLETED|Period 1: Recruited in Study Months 1-5||20||0
59646573|NCT03711786|75764284|FG001|NOT COMPLETED|Period 1: Recruited in Study Months 1-5||6||0
59646574|NCT03711786|75764283|FG000|STARTED|Period 1: Recruited in Study Months 6-32||301||5
59646575|NCT03711786|75764284|FG001|STARTED|Period 1: Recruited in Study Months 6-32||288||5
59646576|NCT03711786|75764283|FG000|3-month Assessment|Period 1: Recruited in Study Months 6-32||275||5
59646577|NCT03711786|75764284|FG001|3-month Assessment|Period 1: Recruited in Study Months 6-32||264||5
59646578|NCT03711786|75764283|FG000|6-month Assessment|Period 1: Recruited in Study Months 6-32||277||5
59646579|NCT03711786|75764284|FG001|6-month Assessment|Period 1: Recruited in Study Months 6-32||267||5
59646580|NCT03711786|75764283|FG000|12-month Assessment|Period 1: Recruited in Study Months 6-32||237||5
59646581|NCT03711786|75764284|FG001|12-month Assessment|Period 1: Recruited in Study Months 6-32||220||5
59646582|NCT03711786|75764283|FG000|COMPLETED|Period 1: Recruited in Study Months 6-32||279||5
59646583|NCT03711786|75764284|FG001|COMPLETED|Period 1: Recruited in Study Months 6-32||258||5
59646584|NCT03711786|75764283|FG000|NOT COMPLETED|Period 1: Recruited in Study Months 6-32||22||0
59646585|NCT03711786|75764284|FG001|NOT COMPLETED|Period 1: Recruited in Study Months 6-32||30||0
59646586|NCT03691974|75764294|FG000|STARTED|Overall Study||89||
59646587|NCT03691974|75764295|FG001|STARTED|Overall Study||91||
59646588|NCT03691974|75764294|FG000|COMPLETED|Overall Study||67||
59646589|NCT03691974|75764295|FG001|COMPLETED|Overall Study||75||
59646590|NCT03691974|75764294|FG000|NOT COMPLETED|Overall Study||22||
59646591|NCT03691974|75764295|FG001|NOT COMPLETED|Overall Study||16||
59646592|NCT03675360|75764306|FG000|STARTED|Overall Study||75||
59646593|NCT03675360|75764307|FG001|STARTED|Overall Study||75||
59646594|NCT03675360|75764306|FG000|COMPLETED|Overall Study||73||
59646595|NCT03675360|75764307|FG001|COMPLETED|Overall Study||69||
59646596|NCT03675360|75764306|FG000|NOT COMPLETED|Overall Study||2||
59542649|NCT01049360|75640996|FG017|STARTED|Period 1||6||
59542650|NCT01049360|75640997|FG018|STARTED|Period 1||6||
59542651|NCT01049360|75640998|FG019|STARTED|Period 1||7||
59542652|NCT01049360|75640979|FG000|COMPLETED|Period 1||6||
59542653|NCT01049360|75640980|FG001|COMPLETED|Period 1||5||
59542654|NCT01049360|75640981|FG002|COMPLETED|Period 1||7||
59542655|NCT01049360|75640982|FG003|COMPLETED|Period 1||6||
59815774|NCT03026283|75938216|FG005|STARTED|Optimal Medical Care/FFR-CT Diagnosis||0|Note: Number of participants to start period is not equal to number who completed previous period.|
59817900|NCT04488770|75940326|FG000|NOT COMPLETED|Part 1-Cohort 2: Period 1 (Up to 5 Days)||0||
59542656|NCT01049360|75640983|FG004|COMPLETED|Period 1||7||
59542657|NCT01049360|75640984|FG005|COMPLETED|Period 1||6||
59542658|NCT01049360|75640985|FG006|COMPLETED|Period 1||6||
59542659|NCT01049360|75640986|FG007|COMPLETED|Period 1||4||
59542660|NCT01049360|75640987|FG008|COMPLETED|Period 1||5||
59542661|NCT01049360|75640988|FG009|COMPLETED|Period 1||6||
59542662|NCT01049360|75640989|FG010|COMPLETED|Period 1||5||
59646597|NCT03675360|75764307|FG001|NOT COMPLETED|Overall Study||6||
59646598|NCT02454972|75764322|FG000|STARTED|Overall Study||19||
59646599|NCT02454972|75764323|FG001|STARTED|Overall Study||19||
59646600|NCT02454972|75764324|FG002|STARTED|Overall Study||76||
59646601|NCT02454972|75764325|FG003|STARTED|Overall Study||29||
59646602|NCT02454972|75764326|FG004|STARTED|Overall Study||24||
59646603|NCT02454972|75764327|FG005|STARTED|Overall Study||15||
59646604|NCT02454972|75764328|FG006|STARTED|Overall Study||21||
59646605|NCT02454972|75764329|FG007|STARTED|Overall Study||32||
59646606|NCT02454972|75764330|FG008|STARTED|Overall Study||110||
59646607|NCT02454972|75764322|FG000|Treated|Overall Study||19||
59646608|NCT02454972|75764323|FG001|Treated|Overall Study||19||
59646609|NCT02454972|75764324|FG002|Treated|Overall Study||73||
59646610|NCT02454972|75764325|FG003|Treated|Overall Study||28||
59646611|NCT02454972|75764326|FG004|Treated|Overall Study||23||
59646612|NCT02454972|75764327|FG005|Treated|Overall Study||15||
59646613|NCT02454972|75764328|FG006|Treated|Overall Study||21||
59646614|NCT02454972|75764329|FG007|Treated|Overall Study||32||
59646615|NCT02454972|75764330|FG008|Treated|Overall Study||105||
59646616|NCT02454972|75764322|FG000|COMPLETED|Overall Study||0||
59646617|NCT02454972|75764323|FG001|COMPLETED|Overall Study||0||
59646618|NCT02454972|75764324|FG002|COMPLETED|Overall Study||0||
59646619|NCT02454972|75764325|FG003|COMPLETED|Overall Study||0||
59646620|NCT02454972|75764326|FG004|COMPLETED|Overall Study||0||
59646621|NCT02454972|75764327|FG005|COMPLETED|Overall Study||0||
59646622|NCT02454972|75764328|FG006|COMPLETED|Overall Study||0||
59646623|NCT02454972|75764329|FG007|COMPLETED|Overall Study||0||
59646624|NCT02454972|75764330|FG008|COMPLETED|Overall Study||0||
59646625|NCT02454972|75764322|FG000|NOT COMPLETED|Overall Study||19||
59646626|NCT02454972|75764323|FG001|NOT COMPLETED|Overall Study||19||
59646627|NCT02454972|75764324|FG002|NOT COMPLETED|Overall Study||76||
59542663|NCT01049360|75640990|FG011|COMPLETED|Period 1||6||
59646628|NCT02454972|75764325|FG003|NOT COMPLETED|Overall Study||29||
59646629|NCT02454972|75764326|FG004|NOT COMPLETED|Overall Study||24||
59646630|NCT02454972|75764327|FG005|NOT COMPLETED|Overall Study||15||
59646631|NCT02454972|75764328|FG006|NOT COMPLETED|Overall Study||21||
59646632|NCT02454972|75764329|FG007|NOT COMPLETED|Overall Study||32||
59646633|NCT02454972|75764330|FG008|NOT COMPLETED|Overall Study||110||
59646634|NCT00978822|75764342|FG000|STARTED|Overall Study||5||
59646635|NCT00978822|75764342|FG000|COMPLETED|Overall Study||5||
59646636|NCT00978822|75764342|FG000|NOT COMPLETED|Overall Study||0||
59646637|NCT00063882|75764348|FG000|STARTED|Overall Study||292||
59646638|NCT00063882|75764349|FG001|STARTED|Overall Study||296||
59646639|NCT00063882|75764348|FG000|Eligible Patients|Overall Study||287||
59646640|NCT00063882|75764349|FG001|Eligible Patients|Overall Study||292||
59646641|NCT00063882|75764348|FG000|Has Acute Adverse Event Data|Overall Study||282|Eligible patients who started study treatment|
59646642|NCT00063882|75764349|FG001|Has Acute Adverse Event Data|Overall Study||288|Eligible patients who started study treatment|
59646643|NCT00063882|75764348|FG000|Has Late Adverse Event Data|Overall Study||282|Eligible patients who started study treatment and are alive 181 days after start of radiation|
59646644|NCT00063882|75764349|FG001|Has Late Adverse Event Data|Overall Study||287|Eligible patients who started study treatment and are alive 181 days after start of radiation|
59646645|NCT00063882|75764348|FG000|COMPLETED|Overall Study||287|Subjects contributing any data to analysis are considered to have completed the study.|
59646646|NCT00063882|75764349|FG001|COMPLETED|Overall Study||292|Subjects contributing any data to analysis are considered to have completed the study.|
59646647|NCT00063882|75764348|FG000|NOT COMPLETED|Overall Study||5||
59646648|NCT00063882|75764349|FG001|NOT COMPLETED|Overall Study||4||
59646649|NCT01279044|75764358|FG000|STARTED|PHASE 1 - Formative||59||
59646650|NCT01279044|75764359|FG001|STARTED|PHASE 1 - Formative|Participants who participated in the formative phase did not participate in the RCT.|0||
59646651|NCT01279044|75764360|FG002|STARTED|PHASE 1 - Formative|Participants who participated in the formative phase did not participate in the RCT.|0||
59646652|NCT01279044|75764358|FG000|COMPLETED|PHASE 1 - Formative||59||
59646653|NCT01279044|75764359|FG001|COMPLETED|PHASE 1 - Formative|Participants who participated in the formative phase did not participate in the RCT.|0||
59646654|NCT01279044|75764360|FG002|COMPLETED|PHASE 1 - Formative|Participants who participated in the formative phase did not participate in the RCT.|0||
59646655|NCT01279044|75764358|FG000|NOT COMPLETED|PHASE 1 - Formative||0||
59646656|NCT01279044|75764359|FG001|NOT COMPLETED|PHASE 1 - Formative||0||
59646657|NCT01279044|75764360|FG002|NOT COMPLETED|PHASE 1 - Formative||0||
59646658|NCT01279044|75764358|FG000|STARTED|PHASE 2 - Randmonized Controlled Trial|Participants who participated in the RCT did not participate in the formative phase.|0||
59646659|NCT01279044|75764359|FG001|STARTED|PHASE 2 - Randmonized Controlled Trial||162||
59646660|NCT01279044|75764360|FG002|STARTED|PHASE 2 - Randmonized Controlled Trial||164||
59646661|NCT01279044|75764358|FG000|COMPLETED|PHASE 2 - Randmonized Controlled Trial|Participants who participated in the RCT did not participate in the formative phase.|0||
59646662|NCT01279044|75764359|FG001|COMPLETED|PHASE 2 - Randmonized Controlled Trial||151||
59646663|NCT01279044|75764360|FG002|COMPLETED|PHASE 2 - Randmonized Controlled Trial||161||
59646664|NCT01279044|75764358|FG000|NOT COMPLETED|PHASE 2 - Randmonized Controlled Trial||0||
59646665|NCT01279044|75764359|FG001|NOT COMPLETED|PHASE 2 - Randmonized Controlled Trial||11||
59646666|NCT01279044|75764360|FG002|NOT COMPLETED|PHASE 2 - Randmonized Controlled Trial||3||
59646667|NCT01278342|75764369|FG000|STARTED|Overall Study||7||
59646668|NCT01278342|75764370|FG001|STARTED|Overall Study||31||
59646669|NCT01278342|75764371|FG002|STARTED|Overall Study||32||
59646670|NCT01278342|75764369|FG000|COMPLETED|Overall Study||3||
59646671|NCT01278342|75764370|FG001|COMPLETED|Overall Study||30||
59646672|NCT01278342|75764371|FG002|COMPLETED|Overall Study||32||
59646673|NCT01278342|75764369|FG000|NOT COMPLETED|Overall Study||4||
59646674|NCT01278342|75764370|FG001|NOT COMPLETED|Overall Study||1||
59646675|NCT01278342|75764371|FG002|NOT COMPLETED|Overall Study||0||
59646676|NCT01278030|75764381|FG000|STARTED|Overall Study||43||
59646677|NCT01278030|75764382|FG001|STARTED|Overall Study||35||
59646678|NCT01278030|75764381|FG000|COMPLETED|Overall Study||35||
59646679|NCT01278030|75764382|FG001|COMPLETED|Overall Study||31||
59646680|NCT01278030|75764381|FG000|NOT COMPLETED|Overall Study||8||
59646681|NCT01278030|75764382|FG001|NOT COMPLETED|Overall Study||4||
59646682|NCT01277718|75764388|FG000|STARTED|Period 1 - First Intervention||10||
59646683|NCT01277718|75764389|FG001|STARTED|Period 1 - First Intervention||10||
59646684|NCT01277718|75764388|FG000|COMPLETED|Period 1 - First Intervention||10||
59646685|NCT01277718|75764389|FG001|COMPLETED|Period 1 - First Intervention||10||
59646686|NCT01277718|75764388|FG000|NOT COMPLETED|Period 1 - First Intervention||0||
59646687|NCT01277718|75764389|FG001|NOT COMPLETED|Period 1 - First Intervention||0||
59646688|NCT01277718|75764388|FG000|STARTED|Washout Period of 13 Days||10||
59646689|NCT01277718|75764389|FG001|STARTED|Washout Period of 13 Days||10||
59646690|NCT01277718|75764388|FG000|COMPLETED|Washout Period of 13 Days||10||
59646691|NCT01277718|75764389|FG001|COMPLETED|Washout Period of 13 Days||10||
59646692|NCT01277718|75764388|FG000|NOT COMPLETED|Washout Period of 13 Days||0||
59646693|NCT01277718|75764389|FG001|NOT COMPLETED|Washout Period of 13 Days||0||
59646694|NCT01277718|75764388|FG000|STARTED|Period 2 - Second Intervention||10||
59646695|NCT01277718|75764389|FG001|STARTED|Period 2 - Second Intervention||10||
59646696|NCT01277718|75764388|FG000|COMPLETED|Period 2 - Second Intervention||10||
59646697|NCT01277718|75764389|FG001|COMPLETED|Period 2 - Second Intervention||7||
59646698|NCT01277718|75764388|FG000|NOT COMPLETED|Period 2 - Second Intervention||0||
59646699|NCT01277718|75764389|FG001|NOT COMPLETED|Period 2 - Second Intervention||3||
59646700|NCT01277718|75764388|FG000|STARTED|Washout Period of 13 Days||10||
59646701|NCT01277718|75764389|FG001|STARTED|Washout Period of 13 Days||7||
59646702|NCT01277718|75764388|FG000|COMPLETED|Washout Period of 13 Days||10||
59646703|NCT01277718|75764389|FG001|COMPLETED|Washout Period of 13 Days||7||
59646704|NCT01277718|75764388|FG000|NOT COMPLETED|Washout Period of 13 Days||0||
59646705|NCT01277718|75764389|FG001|NOT COMPLETED|Washout Period of 13 Days||0||
59646706|NCT01277718|75764388|FG000|STARTED|Period 3 - Third Intervention||10||
59646707|NCT01277718|75764389|FG001|STARTED|Period 3 - Third Intervention||7||
59646708|NCT01277718|75764388|FG000|COMPLETED|Period 3 - Third Intervention||10||
59646709|NCT01277718|75764389|FG001|COMPLETED|Period 3 - Third Intervention||7||
59646710|NCT01277718|75764388|FG000|NOT COMPLETED|Period 3 - Third Intervention||0||
59646711|NCT01277718|75764389|FG001|NOT COMPLETED|Period 3 - Third Intervention||0||
59542664|NCT01049360|75640991|FG012|COMPLETED|Period 1||4||
59542665|NCT01049360|75640992|FG013|COMPLETED|Period 1||6||
59542666|NCT01049360|75640993|FG014|COMPLETED|Period 1||7||
59542667|NCT01049360|75640994|FG015|COMPLETED|Period 1||7||
59542668|NCT01049360|75640995|FG016|COMPLETED|Period 1||5||
59646712|NCT01276236|75764397|FG000|STARTED|Overall Study||13||
59646713|NCT01276236|75764397|FG000|Week 36 Visit|Overall Study||13||
59646714|NCT01276236|75764397|FG000|Week 56 Visit|Overall Study||9||
59646715|NCT01276236|75764397|FG000|Week 76 Visit|Overall Study||8||
59646716|NCT01276236|75764397|FG000|COMPLETED|Overall Study||7||
59646717|NCT01276236|75764397|FG000|NOT COMPLETED|Overall Study||6||
59646718|NCT01275222|75764407|FG000|STARTED|Phase l by Treatment||13||
59646719|NCT01275222|75764408|FG001|STARTED|Phase l by Treatment||13||
59646720|NCT01275222|75764409|FG002|STARTED|Phase l by Treatment||5||
59646721|NCT01275222|75764410|FG003|STARTED|Phase l by Treatment||11||
59646722|NCT01275222|75764411|FG004|STARTED|Phase l by Treatment||0||
59646723|NCT01275222|75764412|FG005|STARTED|Phase l by Treatment||0||
59646724|NCT01275222|75764407|FG000|COMPLETED|Phase l by Treatment||0||
59646725|NCT01275222|75764408|FG001|COMPLETED|Phase l by Treatment||0||
59646726|NCT01275222|75764409|FG002|COMPLETED|Phase l by Treatment||0||
59646727|NCT01275222|75764410|FG003|COMPLETED|Phase l by Treatment||0||
59646728|NCT01275222|75764411|FG004|COMPLETED|Phase l by Treatment||0||
59646729|NCT01275222|75764412|FG005|COMPLETED|Phase l by Treatment||0||
59646730|NCT01275222|75764407|FG000|NOT COMPLETED|Phase l by Treatment||13||
59646731|NCT01275222|75764408|FG001|NOT COMPLETED|Phase l by Treatment||13||
59646732|NCT01275222|75764409|FG002|NOT COMPLETED|Phase l by Treatment||5||
59646733|NCT01275222|75764410|FG003|NOT COMPLETED|Phase l by Treatment||11||
59646734|NCT01275222|75764411|FG004|NOT COMPLETED|Phase l by Treatment||0||
59646735|NCT01275222|75764412|FG005|NOT COMPLETED|Phase l by Treatment||0||
59646736|NCT01275222|75764407|FG000|STARTED|Phase ll by Stratum||0||
59646737|NCT01275222|75764408|FG001|STARTED|Phase ll by Stratum||0||
59646738|NCT01275222|75764409|FG002|STARTED|Phase ll by Stratum||0||
59646739|NCT01275222|75764410|FG003|STARTED|Phase ll by Stratum||0||
59646740|NCT01275222|75764411|FG004|STARTED|Phase ll by Stratum||28||
59646741|NCT01275222|75764412|FG005|STARTED|Phase ll by Stratum||47||
59646742|NCT01275222|75764407|FG000|COMPLETED|Phase ll by Stratum||0||
59646743|NCT01275222|75764408|FG001|COMPLETED|Phase ll by Stratum||0||
59646744|NCT01275222|75764409|FG002|COMPLETED|Phase ll by Stratum||0||
59646745|NCT01275222|75764410|FG003|COMPLETED|Phase ll by Stratum||0||
59646746|NCT01275222|75764411|FG004|COMPLETED|Phase ll by Stratum||0||
59646747|NCT01275222|75764412|FG005|COMPLETED|Phase ll by Stratum||1||
59646748|NCT01275222|75764407|FG000|NOT COMPLETED|Phase ll by Stratum||0||
59646749|NCT01275222|75764408|FG001|NOT COMPLETED|Phase ll by Stratum||0||
59646750|NCT01275222|75764409|FG002|NOT COMPLETED|Phase ll by Stratum||0||
59646751|NCT01275222|75764410|FG003|NOT COMPLETED|Phase ll by Stratum||0||
59646752|NCT01275222|75764411|FG004|NOT COMPLETED|Phase ll by Stratum||28||
59646753|NCT01275222|75764412|FG005|NOT COMPLETED|Phase ll by Stratum||46||
59646754|NCT01275144|75764430|FG000|STARTED|First Intervention (6 Days)||14||
59646755|NCT01275144|75764431|FG001|STARTED|First Intervention (6 Days)||14||
59646756|NCT01275144|75764430|FG000|Received at Least 1 Dose of Study Drug|First Intervention (6 Days)||14||
59646757|NCT01275144|75764431|FG001|Received at Least 1 Dose of Study Drug|First Intervention (6 Days)||14||
59646758|NCT01275144|75764430|FG000|COMPLETED|First Intervention (6 Days)||14||
59646759|NCT01275144|75764431|FG001|COMPLETED|First Intervention (6 Days)||14||
59646760|NCT01275144|75764430|FG000|NOT COMPLETED|First Intervention (6 Days)||0||
59646761|NCT01275144|75764431|FG001|NOT COMPLETED|First Intervention (6 Days)||0||
59646762|NCT01275144|75764430|FG000|STARTED|Washout (7 Days)||14||
59646763|NCT01275144|75764431|FG001|STARTED|Washout (7 Days)||14||
59542669|NCT01049360|75640996|FG017|COMPLETED|Period 1||6||
59542670|NCT01049360|75640997|FG018|COMPLETED|Period 1||5||
59542671|NCT01049360|75640998|FG019|COMPLETED|Period 1||7||
59542672|NCT01049360|75640979|FG000|NOT COMPLETED|Period 1||0||
59542673|NCT01049360|75640980|FG001|NOT COMPLETED|Period 1||1||
59542674|NCT01049360|75640981|FG002|NOT COMPLETED|Period 1||0||
59542675|NCT01049360|75640982|FG003|NOT COMPLETED|Period 1||1||
59646764|NCT01275144|75764430|FG000|COMPLETED|Washout (7 Days)||14||
59646765|NCT01275144|75764431|FG001|COMPLETED|Washout (7 Days)||14||
59646766|NCT01275144|75764430|FG000|NOT COMPLETED|Washout (7 Days)||0||
59646767|NCT01275144|75764431|FG001|NOT COMPLETED|Washout (7 Days)||0||
59646768|NCT01275144|75764430|FG000|STARTED|Second Intervention (6 Days)||14||
59646769|NCT01275144|75764431|FG001|STARTED|Second Intervention (6 Days)||14||
59646770|NCT01275144|75764430|FG000|COMPLETED|Second Intervention (6 Days)||13||
59646771|NCT01275144|75764431|FG001|COMPLETED|Second Intervention (6 Days)||14||
59646772|NCT01275144|75764430|FG000|NOT COMPLETED|Second Intervention (6 Days)||1||
59646773|NCT01275144|75764431|FG001|NOT COMPLETED|Second Intervention (6 Days)||0||
59646774|NCT01275066|75764442|FG000|STARTED|Overall Study||60||
59646775|NCT01275066|75764443|FG001|STARTED|Overall Study||59||
59646776|NCT01275066|75764444|FG002|STARTED|Overall Study||58||
59646777|NCT01275066|75764442|FG000|Treated|Overall Study||59||
59646778|NCT01275066|75764443|FG001|Treated|Overall Study||59||
59646779|NCT01275066|75764444|FG002|Treated|Overall Study||58||
59646780|NCT01275066|75764442|FG000|COMPLETED|Overall Study||59||
59646781|NCT01275066|75764443|FG001|COMPLETED|Overall Study||59||
59646782|NCT01275066|75764444|FG002|COMPLETED|Overall Study||57||
59646783|NCT01275066|75764442|FG000|NOT COMPLETED|Overall Study||1||
59646784|NCT01275066|75764443|FG001|NOT COMPLETED|Overall Study||0||
59646785|NCT01275066|75764444|FG002|NOT COMPLETED|Overall Study||1||
59646786|NCT01273038|75764454|FG000|STARTED|First Intervention (14 Days)||10||
59646787|NCT01273038|75764455|FG001|STARTED|First Intervention (14 Days)||10||
59646788|NCT01273038|75764454|FG000|COMPLETED|First Intervention (14 Days)||10||
59646789|NCT01273038|75764455|FG001|COMPLETED|First Intervention (14 Days)||10||
59646790|NCT01273038|75764454|FG000|NOT COMPLETED|First Intervention (14 Days)||0||
59646791|NCT01273038|75764455|FG001|NOT COMPLETED|First Intervention (14 Days)||0||
59646792|NCT01273038|75764454|FG000|STARTED|Second Intervention (14 Days)||10||
59646793|NCT01273038|75764455|FG001|STARTED|Second Intervention (14 Days)||10||
59646794|NCT01273038|75764454|FG000|COMPLETED|Second Intervention (14 Days)||10||
59646795|NCT01273038|75764455|FG001|COMPLETED|Second Intervention (14 Days)||8||
59646796|NCT01273038|75764454|FG000|NOT COMPLETED|Second Intervention (14 Days)||0||
59646797|NCT01273038|75764455|FG001|NOT COMPLETED|Second Intervention (14 Days)||2||
59646798|NCT01272180|75764465|FG000|STARTED|Overall Study||120||
59646799|NCT01272180|75764466|FG001|STARTED|Overall Study||121||
59646800|NCT01272180|75764467|FG002|STARTED|Overall Study||122||
59646801|NCT01272180|75764468|FG003|STARTED|Overall Study||121||
59646802|NCT01272180|75764465|FG000|COMPLETED|Overall Study||103||
59646803|NCT01272180|75764466|FG001|COMPLETED|Overall Study||100||
59646804|NCT01272180|75764467|FG002|COMPLETED|Overall Study||109||
59646805|NCT01272180|75764468|FG003|COMPLETED|Overall Study||107||
59646806|NCT01272180|75764465|FG000|NOT COMPLETED|Overall Study||17||
59646807|NCT01272180|75764466|FG001|NOT COMPLETED|Overall Study||21||
59646808|NCT01272180|75764467|FG002|NOT COMPLETED|Overall Study||13||
59646809|NCT01272180|75764468|FG003|NOT COMPLETED|Overall Study||14||
59646810|NCT01271712|75764484|FG000|STARTED|Double Blind Treatment||133||
59646811|NCT01271712|75764485|FG001|STARTED|Double Blind Treatment||66||
59646812|NCT01271712|75764484|FG000|Participants Received Treatment|Double Blind Treatment||132||
59646813|NCT01271712|75764485|FG001|Participants Received Treatment|Double Blind Treatment||66||
59646814|NCT01271712|75764484|FG000|COMPLETED|Double Blind Treatment|91 participants started open-label treatment with regorafenib|91||
59646815|NCT01271712|75764485|FG001|COMPLETED|Double Blind Treatment|58 participants started open-label treatment with regorafenib|58||
59646816|NCT01271712|75764484|FG000|NOT COMPLETED|Double Blind Treatment||42||
59646817|NCT01271712|75764485|FG001|NOT COMPLETED|Double Blind Treatment||8||
59646818|NCT01271712|75764484|FG000|STARTED|Open Label Treatment||91||
59646819|NCT01271712|75764485|FG001|STARTED|Open Label Treatment||58||
59646820|NCT01271712|75764484|FG000|COMPLETED|Open Label Treatment||0||
59646821|NCT01271712|75764485|FG001|COMPLETED|Open Label Treatment||0||
59646822|NCT01271712|75764484|FG000|NOT COMPLETED|Open Label Treatment||91||
59646823|NCT01271712|75764485|FG001|NOT COMPLETED|Open Label Treatment||58||
59646824|NCT01271712|75764484|FG000|STARTED|Safety Follow-up|All participants who discontinued study drug entered 30-day Safety Follow-up|118||
59646825|NCT01271712|75764485|FG001|STARTED|Safety Follow-up|All participants who discontinued study drug entered 30-day Safety Follow-up|52||
59646826|NCT01271712|75764484|FG000|COMPLETED|Safety Follow-up||97||
59646827|NCT01271712|75764485|FG001|COMPLETED|Safety Follow-up||37||
59646828|NCT01271712|75764484|FG000|NOT COMPLETED|Safety Follow-up||21||
59646829|NCT01271712|75764485|FG001|NOT COMPLETED|Safety Follow-up||15||
59646830|NCT01271712|75764484|FG000|STARTED|Survival Follow-up|All participants entered Survival Follow-up immediately after safety follow-up|100||
59646831|NCT01271712|75764485|FG001|STARTED|Survival Follow-up|All participants entered Survival Follow-up immediately after safety follow-up|39||
59646832|NCT01271712|75764484|FG000|COMPLETED|Survival Follow-up|85 participants died and completed survival follow-up.|85||
59646833|NCT01271712|75764485|FG001|COMPLETED|Survival Follow-up|33 participants died and completed survival follow-up.|33||
59646834|NCT01271712|75764484|FG000|NOT COMPLETED|Survival Follow-up||15||
59646835|NCT01271712|75764485|FG001|NOT COMPLETED|Survival Follow-up||6||
59646836|NCT01271010|75764494|FG000|STARTED|Overall Study||89||
59646837|NCT01271010|75764494|FG000|COMPLETED|Overall Study||28||
59646838|NCT01271010|75764494|FG000|NOT COMPLETED|Overall Study||61||
59646839|NCT01270620|75764500|FG000|STARTED|Overall Study||50||
59646840|NCT01270620|75764501|FG001|STARTED|Overall Study||50||
59646841|NCT01270620|75764500|FG000|COMPLETED|Overall Study||49||
59646842|NCT01270620|75764501|FG001|COMPLETED|Overall Study||47||
59646843|NCT01270620|75764500|FG000|NOT COMPLETED|Overall Study||1||
59646844|NCT01270620|75764501|FG001|NOT COMPLETED|Overall Study||3||
59646845|NCT01270464|75764516|FG000|STARTED|Overall Study||105||
59646846|NCT01270464|75764517|FG001|STARTED|Overall Study||104||
59646847|NCT01270464|75764518|FG002|STARTED|Overall Study||106||
59646848|NCT01270464|75764516|FG000|Safety Analysis Set|Overall Study||105||
59646849|NCT01270464|75764517|FG001|Safety Analysis Set|Overall Study||103||
59646850|NCT01270464|75764518|FG002|Safety Analysis Set|Overall Study||103||
59646851|NCT01270464|75764516|FG000|Full Analysis Set|Overall Study||105||
59646852|NCT01270464|75764517|FG001|Full Analysis Set|Overall Study||103||
59646853|NCT01270464|75764518|FG002|Full Analysis Set|Overall Study||103||
59646854|NCT01270464|75764516|FG000|Pharmacokinetic Analysis Set|Overall Study||105||
59646855|NCT01270464|75764517|FG001|Pharmacokinetic Analysis Set|Overall Study||103||
59646856|NCT01270464|75764518|FG002|Pharmacokinetic Analysis Set|Overall Study||103||
59646857|NCT01270464|75764516|FG000|COMPLETED|Overall Study||85||
59646858|NCT01270464|75764517|FG001|COMPLETED|Overall Study||92||
59646859|NCT01270464|75764518|FG002|COMPLETED|Overall Study||88||
59646860|NCT01270464|75764516|FG000|NOT COMPLETED|Overall Study||20||
59646861|NCT01270464|75764517|FG001|NOT COMPLETED|Overall Study||12||
59646862|NCT01270464|75764518|FG002|NOT COMPLETED|Overall Study||18||
59646863|NCT00249834|75764534|FG000|STARTED|Overall Study||1||
59646864|NCT00249834|75764535|FG001|STARTED|Overall Study||48||
59646865|NCT00249834|75764536|FG002|STARTED|Overall Study||45||
59646866|NCT00249834|75764537|FG003|STARTED|Overall Study||34||
59646867|NCT00249834|75764538|FG004|STARTED|Overall Study||24||
59646868|NCT00249834|75764539|FG005|STARTED|Overall Study||10||
59646869|NCT00249834|75764540|FG006|STARTED|Overall Study||2||
59646870|NCT00249834|75764541|FG007|STARTED|Overall Study||2||
59646871|NCT00249834|75764534|FG000|COMPLETED|Overall Study||0||
59646872|NCT00249834|75764535|FG001|COMPLETED|Overall Study||29||
59646873|NCT00249834|75764536|FG002|COMPLETED|Overall Study||31||
59646874|NCT00249834|75764537|FG003|COMPLETED|Overall Study||26||
59646875|NCT00249834|75764538|FG004|COMPLETED|Overall Study||19||
59646876|NCT00249834|75764539|FG005|COMPLETED|Overall Study||8||
59646877|NCT00249834|75764540|FG006|COMPLETED|Overall Study||1||
59646878|NCT00249834|75764541|FG007|COMPLETED|Overall Study||2||
59646879|NCT00249834|75764534|FG000|NOT COMPLETED|Overall Study||1||
59646880|NCT00249834|75764535|FG001|NOT COMPLETED|Overall Study||19||
59646881|NCT00249834|75764536|FG002|NOT COMPLETED|Overall Study||14||
59646882|NCT00249834|75764537|FG003|NOT COMPLETED|Overall Study||8||
59646883|NCT00249834|75764538|FG004|NOT COMPLETED|Overall Study||5||
59646884|NCT00249834|75764539|FG005|NOT COMPLETED|Overall Study||2||
59646885|NCT00249834|75764540|FG006|NOT COMPLETED|Overall Study||1||
59646886|NCT00249834|75764541|FG007|NOT COMPLETED|Overall Study||0||
59646887|NCT00249444|75764555|FG000|STARTED|Overall Study||42||
59646888|NCT00249444|75764556|FG001|STARTED|Overall Study||44||
59646889|NCT00249444|75764555|FG000|COMPLETED|Overall Study||30||
59646890|NCT00249444|75764556|FG001|COMPLETED|Overall Study||29||
59646891|NCT00249444|75764555|FG000|NOT COMPLETED|Overall Study||12||
59646892|NCT00249444|75764556|FG001|NOT COMPLETED|Overall Study||15||
59646893|NCT00249288|75764564|FG000|STARTED|Overall Study||19||
59646894|NCT00249288|75764565|FG001|STARTED|Overall Study||19||
59646895|NCT00249288|75764564|FG000|Initiated Treatment|Overall Study||17||
59646896|NCT00249288|75764565|FG001|Initiated Treatment|Overall Study||15||
59646897|NCT00249288|75764564|FG000|COMPLETED|Overall Study||14||
59646898|NCT00249288|75764565|FG001|COMPLETED|Overall Study||14||
59646899|NCT00249288|75764564|FG000|NOT COMPLETED|Overall Study||5||
59646900|NCT00249288|75764565|FG001|NOT COMPLETED|Overall Study||5||
59646901|NCT00247962|75764581|FG000|STARTED|Overall Study||379||
60076773|NCT01539525|76191784|FG002|STARTED|Overall Study||151||
60076774|NCT01539525|76191782|FG000|COMPLETED|Overall Study||125||
60076775|NCT01539525|76191783|FG001|COMPLETED|Overall Study||127||
60076776|NCT01539525|76191784|FG002|COMPLETED|Overall Study||134||
59646902|NCT00247962|75764582|FG001|STARTED|Overall Study||187||
60076777|NCT01539525|76191782|FG000|NOT COMPLETED|Overall Study||20||
60076778|NCT01539525|76191783|FG001|NOT COMPLETED|Overall Study||16||
59646903|NCT00247962|75764581|FG000|COMPLETED|Overall Study||353||
59646904|NCT00247962|75764582|FG001|COMPLETED|Overall Study||168||
59646905|NCT00247962|75764581|FG000|NOT COMPLETED|Overall Study||26||
59646906|NCT00247962|75764582|FG001|NOT COMPLETED|Overall Study||19||
59646907|NCT00247416|75764590|FG000|STARTED|Overall Study||26||
59646908|NCT00247416|75764591|FG001|STARTED|Overall Study||33||
59646909|NCT00247416|75764590|FG000|COMPLETED|Overall Study||25||
59646910|NCT00247416|75764591|FG001|COMPLETED|Overall Study||31||
59646911|NCT00247416|75764590|FG000|NOT COMPLETED|Overall Study||1||
59646912|NCT00247416|75764591|FG001|NOT COMPLETED|Overall Study||2||
59646913|NCT00246090|75764599|FG000|STARTED|Overall Study||298||
59646914|NCT00246090|75764599|FG000|COMPLETED|Overall Study||3||
59646915|NCT00246090|75764599|FG000|NOT COMPLETED|Overall Study||295||
59646916|NCT00246012|75764612|FG000|STARTED|Overall Study||3||
60076779|NCT01539525|76191784|FG002|NOT COMPLETED|Overall Study||17||
59646917|NCT00246012|75764613|FG001|STARTED|Overall Study||3||
59646918|NCT00246012|75764614|FG002|STARTED|Overall Study||3||
59646919|NCT00246012|75764615|FG003|STARTED|Overall Study||3||
59646920|NCT00246012|75764616|FG004|STARTED|Overall Study||3||
59646921|NCT00246012|75764617|FG005|STARTED|Overall Study||32||
59646922|NCT00246012|75764618|FG006|STARTED|Overall Study||32||
59646923|NCT00246012|75764619|FG007|STARTED|Overall Study||33||
59646924|NCT00246012|75764620|FG008|STARTED|Overall Study||32||
59646925|NCT00246012|75764612|FG000|Treated|Overall Study||3||
59646926|NCT00246012|75764613|FG001|Treated|Overall Study||3||
59646927|NCT00246012|75764614|FG002|Treated|Overall Study||3||
59646928|NCT00246012|75764615|FG003|Treated|Overall Study||3||
59646929|NCT00246012|75764616|FG004|Treated|Overall Study||3||
59646930|NCT00246012|75764617|FG005|Treated|Overall Study||31||
59646931|NCT00246012|75764618|FG006|Treated|Overall Study||31||
59646932|NCT00246012|75764619|FG007|Treated|Overall Study||33||
59646933|NCT00246012|75764620|FG008|Treated|Overall Study||32||
59646934|NCT00246012|75764612|FG000|COMPLETED|Overall Study||0||
59646935|NCT00246012|75764613|FG001|COMPLETED|Overall Study||2||
59646936|NCT00246012|75764614|FG002|COMPLETED|Overall Study||1||
59646937|NCT00246012|75764615|FG003|COMPLETED|Overall Study||0||
59646938|NCT00246012|75764616|FG004|COMPLETED|Overall Study||0||
59646939|NCT00246012|75764617|FG005|COMPLETED|Overall Study||4||
59646940|NCT00246012|75764618|FG006|COMPLETED|Overall Study||1||
59646941|NCT00246012|75764619|FG007|COMPLETED|Overall Study||5||
59646942|NCT00246012|75764620|FG008|COMPLETED|Overall Study||4||
59646943|NCT00246012|75764612|FG000|NOT COMPLETED|Overall Study||3||
59646944|NCT00246012|75764613|FG001|NOT COMPLETED|Overall Study||1||
59646945|NCT00246012|75764614|FG002|NOT COMPLETED|Overall Study||2||
59646946|NCT00246012|75764615|FG003|NOT COMPLETED|Overall Study||3||
59646947|NCT00246012|75764616|FG004|NOT COMPLETED|Overall Study||3||
59646948|NCT00246012|75764617|FG005|NOT COMPLETED|Overall Study||28||
59646949|NCT00246012|75764618|FG006|NOT COMPLETED|Overall Study||31||
59646950|NCT00246012|75764619|FG007|NOT COMPLETED|Overall Study||28||
59646951|NCT00246012|75764620|FG008|NOT COMPLETED|Overall Study||28||
59646952|NCT00245856|75764642|FG000|STARTED|Period One||28||
59646953|NCT00245856|75764643|FG001|STARTED|Period One||0||
59646954|NCT00245856|75764642|FG000|COMPLETED|Period One||28||
59646955|NCT00245856|75764643|FG001|COMPLETED|Period One||0||
59646956|NCT00245856|75764642|FG000|NOT COMPLETED|Period One||0||
59646957|NCT00245856|75764643|FG001|NOT COMPLETED|Period One||0||
59646958|NCT00245856|75764642|FG000|STARTED|Period Two||0||
59646959|NCT00245856|75764643|FG001|STARTED|Period Two||39||
59646960|NCT00245856|75764642|FG000|COMPLETED|Period Two||0||
59646961|NCT00245856|75764643|FG001|COMPLETED|Period Two||38||
59646962|NCT00245856|75764642|FG000|NOT COMPLETED|Period Two||0||
59646963|NCT00245856|75764643|FG001|NOT COMPLETED|Period Two||1||
59646964|NCT00245466|75764653|FG000|STARTED|Overall Study||43||
59646965|NCT00245466|75764654|FG001|STARTED|Overall Study||46||
59646966|NCT00245466|75764655|FG002|STARTED|Overall Study||40||
59646967|NCT00245466|75764653|FG000|Started FE200486 CS02A|Overall Study||32||
59646968|NCT00245466|75764654|FG001|Started FE200486 CS02A|Overall Study||30||
59646969|NCT00245466|75764655|FG002|Started FE200486 CS02A|Overall Study||26||
59646970|NCT00245466|75764653|FG000|COMPLETED|Overall Study|Defined as those participants ongoing when the extension study was terminated|7||
59646971|NCT00245466|75764654|FG001|COMPLETED|Overall Study||2||
59646972|NCT00245466|75764655|FG002|COMPLETED|Overall Study||3||
59646973|NCT00245466|75764653|FG000|NOT COMPLETED|Overall Study||36||
59646974|NCT00245466|75764654|FG001|NOT COMPLETED|Overall Study||44||
59646975|NCT00245466|75764655|FG002|NOT COMPLETED|Overall Study||37||
59646976|NCT00244764|75764663|FG000|STARTED|Overall Study||225||
59646977|NCT00244764|75764663|FG000|COMPLETED|Overall Study||129||
59646978|NCT00244764|75764663|FG000|NOT COMPLETED|Overall Study||96||
59646979|NCT00244374|75764668|FG000|STARTED|Pre-Randomization Cross-sectional Study||546||
59646980|NCT00244374|75764669|FG001|STARTED|Pre-Randomization Cross-sectional Study||0||
59646981|NCT00244374|75764670|FG002|STARTED|Pre-Randomization Cross-sectional Study||0||
59646982|NCT00244374|75764671|FG003|STARTED|Pre-Randomization Cross-sectional Study||0||
59646983|NCT00244374|75764672|FG004|STARTED|Pre-Randomization Cross-sectional Study||0||
59646984|NCT00244374|75764668|FG000|COMPLETED|Pre-Randomization Cross-sectional Study||409||
59646985|NCT00244374|75764669|FG001|COMPLETED|Pre-Randomization Cross-sectional Study||0||
59646986|NCT00244374|75764670|FG002|COMPLETED|Pre-Randomization Cross-sectional Study||0||
59646987|NCT00244374|75764671|FG003|COMPLETED|Pre-Randomization Cross-sectional Study||0||
59646988|NCT00244374|75764672|FG004|COMPLETED|Pre-Randomization Cross-sectional Study||0||
59646989|NCT00244374|75764668|FG000|NOT COMPLETED|Pre-Randomization Cross-sectional Study||137||
59646990|NCT00244374|75764669|FG001|NOT COMPLETED|Pre-Randomization Cross-sectional Study||0||
59646991|NCT00244374|75764670|FG002|NOT COMPLETED|Pre-Randomization Cross-sectional Study||0||
59646992|NCT00244374|75764671|FG003|NOT COMPLETED|Pre-Randomization Cross-sectional Study||0||
59646993|NCT00244374|75764672|FG004|NOT COMPLETED|Pre-Randomization Cross-sectional Study||0||
59646994|NCT00244374|75764668|FG000|STARTED|Evaluation for Vaccine Adherence Cohort|440 study participants enrolled prior to 3/31/2007 were evaluated for vaccine adherence cohort|440||
59646995|NCT00244374|75764669|FG001|STARTED|Evaluation for Vaccine Adherence Cohort||0||
59646996|NCT00244374|75764670|FG002|STARTED|Evaluation for Vaccine Adherence Cohort||0||
59646997|NCT00244374|75764671|FG003|STARTED|Evaluation for Vaccine Adherence Cohort||0||
59646998|NCT00244374|75764672|FG004|STARTED|Evaluation for Vaccine Adherence Cohort||0||
59646999|NCT00244374|75764668|FG000|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||217||
59647000|NCT00244374|75764669|FG001|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||0||
59647001|NCT00244374|75764670|FG002|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||0||
59647002|NCT00244374|75764671|FG003|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||0||
59647003|NCT00244374|75764672|FG004|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||0||
59647004|NCT00244374|75764668|FG000|COMPLETED|Evaluation for Vaccine Adherence Cohort||167||
59647005|NCT00244374|75764669|FG001|COMPLETED|Evaluation for Vaccine Adherence Cohort||0||
59647006|NCT00244374|75764670|FG002|COMPLETED|Evaluation for Vaccine Adherence Cohort||0||
59647007|NCT00244374|75764671|FG003|COMPLETED|Evaluation for Vaccine Adherence Cohort||0||
59647008|NCT00244374|75764672|FG004|COMPLETED|Evaluation for Vaccine Adherence Cohort||0||
59647009|NCT00244374|75764668|FG000|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||273||
59647010|NCT00244374|75764669|FG001|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||0||
59647011|NCT00244374|75764670|FG002|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||0||
59647012|NCT00244374|75764671|FG003|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||0||
59647013|NCT00244374|75764672|FG004|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||0||
59647014|NCT00244374|75764668|FG000|STARTED|Vaccine Adherence Cohort|Eligible and willing cross-sectional study participants progressed to adherence cohort randomization|0||
59647015|NCT00244374|75764669|FG001|STARTED|Vaccine Adherence Cohort||47||
59647016|NCT00244374|75764670|FG002|STARTED|Vaccine Adherence Cohort||43||
59647017|NCT00244374|75764671|FG003|STARTED|Vaccine Adherence Cohort||36||
59647018|NCT00244374|75764672|FG004|STARTED|Vaccine Adherence Cohort||41||
59647019|NCT00244374|75764668|FG000|COMPLETED|Vaccine Adherence Cohort||0||
59647020|NCT00244374|75764669|FG001|COMPLETED|Vaccine Adherence Cohort||47||
59647021|NCT00244374|75764670|FG002|COMPLETED|Vaccine Adherence Cohort||43||
59647022|NCT00244374|75764671|FG003|COMPLETED|Vaccine Adherence Cohort||36||
59647023|NCT00244374|75764672|FG004|COMPLETED|Vaccine Adherence Cohort||41||
59647024|NCT00244374|75764668|FG000|NOT COMPLETED|Vaccine Adherence Cohort||0||
59647025|NCT00244374|75764669|FG001|NOT COMPLETED|Vaccine Adherence Cohort||0||
59647026|NCT00244374|75764670|FG002|NOT COMPLETED|Vaccine Adherence Cohort||0||
59647027|NCT00244374|75764671|FG003|NOT COMPLETED|Vaccine Adherence Cohort||0||
59647028|NCT00244374|75764672|FG004|NOT COMPLETED|Vaccine Adherence Cohort||0||
59647029|NCT00242658|75764690|FG000|STARTED|Overall Study||187||
59647030|NCT00242658|75764691|FG001|STARTED|Overall Study||207||
59647031|NCT00242658|75764690|FG000|COMPLETED|Overall Study||165||
59647032|NCT00242658|75764691|FG001|COMPLETED|Overall Study||188||
59647033|NCT00242658|75764690|FG000|NOT COMPLETED|Overall Study||22||
59647034|NCT00242658|75764691|FG001|NOT COMPLETED|Overall Study||19||
59647035|NCT00242580|75764700|FG000|STARTED|Overall Study||32||
59647036|NCT00242580|75764701|FG001|STARTED|Overall Study||41||
59647037|NCT00242580|75764702|FG002|STARTED|Overall Study||38||
59647038|NCT00242580|75764700|FG000|COMPLETED|Overall Study|"Completed indicates 12 month data."|22||
59647039|NCT00242580|75764701|FG001|COMPLETED|Overall Study||29||
59647040|NCT00242580|75764702|FG002|COMPLETED|Overall Study||24||
59647041|NCT00242580|75764700|FG000|NOT COMPLETED|Overall Study||10||
59647042|NCT00242580|75764701|FG001|NOT COMPLETED|Overall Study||12||
59647043|NCT00242580|75764702|FG002|NOT COMPLETED|Overall Study||14||
59647044|NCT00241644|75764714|FG000|STARTED|First Efficacy Period (Year 1)||1647||
59647045|NCT00241644|75764715|FG001|STARTED|First Efficacy Period (Year 1)||1651||
59647046|NCT00241644|75764716|FG002|STARTED|First Efficacy Period (Year 1)||1641||
59647047|NCT00241644|75764717|FG003|STARTED|First Efficacy Period (Year 1)||3298||
59647048|NCT00241644|75764714|FG000|COMPLETED|First Efficacy Period (Year 1)||1420||
59647049|NCT00241644|75764715|FG001|COMPLETED|First Efficacy Period (Year 1)||1383||
59647050|NCT00241644|75764716|FG002|COMPLETED|First Efficacy Period (Year 1)||1392||
59647051|NCT00241644|75764717|FG003|COMPLETED|First Efficacy Period (Year 1)||2803||
59647052|NCT00241644|75764714|FG000|NOT COMPLETED|First Efficacy Period (Year 1)||227||
59647053|NCT00241644|75764715|FG001|NOT COMPLETED|First Efficacy Period (Year 1)||268||
59647054|NCT00241644|75764716|FG002|NOT COMPLETED|First Efficacy Period (Year 1)||249||
59647055|NCT00241644|75764717|FG003|NOT COMPLETED|First Efficacy Period (Year 1)||495||
59647056|NCT00241644|75764714|FG000|STARTED|Second Efficacy Period (Year 2)||771||
59647057|NCT00241644|75764715|FG001|STARTED|Second Efficacy Period (Year 2)||754||
59647058|NCT00241644|75764716|FG002|STARTED|Second Efficacy Period (Year 2)||746||
59647059|NCT00241644|75764717|FG003|STARTED|Second Efficacy Period (Year 2)||1525||
59647060|NCT00241644|75764714|FG000|COMPLETED|Second Efficacy Period (Year 2)||710||
59647061|NCT00241644|75764715|FG001|COMPLETED|Second Efficacy Period (Year 2)||697||
59647062|NCT00241644|75764716|FG002|COMPLETED|Second Efficacy Period (Year 2)||682||
59647063|NCT00241644|75764717|FG003|COMPLETED|Second Efficacy Period (Year 2)||1407||
59647064|NCT00241644|75764714|FG000|NOT COMPLETED|Second Efficacy Period (Year 2)||61||
59647065|NCT00241644|75764715|FG001|NOT COMPLETED|Second Efficacy Period (Year 2)||57||
59647066|NCT00241644|75764716|FG002|NOT COMPLETED|Second Efficacy Period (Year 2)||64||
59647067|NCT00241644|75764717|FG003|NOT COMPLETED|Second Efficacy Period (Year 2)||118||
59647068|NCT03805698|75764729|FG000|STARTED|Overall Study||10||
59647069|NCT03805698|75764730|FG001|STARTED|Overall Study||0||
59647070|NCT03805698|75764729|FG000|COMPLETED|Overall Study||10||
59647071|NCT03805698|75764730|FG001|COMPLETED|Overall Study||0||
59647072|NCT03805698|75764729|FG000|NOT COMPLETED|Overall Study||0||
59647073|NCT03805698|75764730|FG001|NOT COMPLETED|Overall Study||0||
59647074|NCT03804684|75764738|FG000|STARTED|Overall Study||28||
59647075|NCT03804684|75764739|FG001|STARTED|Overall Study||44||
59647076|NCT03804684|75764738|FG000|COMPLETED|Overall Study||25||
59647077|NCT03804684|75764739|FG001|COMPLETED|Overall Study||26||
59647078|NCT03804684|75764738|FG000|NOT COMPLETED|Overall Study||3||
59647079|NCT03804684|75764739|FG001|NOT COMPLETED|Overall Study||18||
59647080|NCT04601454|75764747|FG000|STARTED|Overall Study|Total subjects|57||
59647081|NCT04601454|75764747|FG000|Completed Per Protocol at the 12 Month Visit|Overall Study|Programmed to Differential Target Multiplex - Low Energy (DTM-LE) per protocol through the 12 month visit (secondary objective)|27||
59647082|NCT04601454|75764747|FG000|COMPLETED|Overall Study|Programmed to Differential Target Multiplex - Low Energy (DTM-LE) per protocol through the 3 month visit (primary objective)|32||
59647083|NCT04601454|75764747|FG000|NOT COMPLETED|Overall Study||25||
59647084|NCT04295772|75764754|FG000|STARTED|Overall Study||39||
59647085|NCT04295772|75764755|FG001|STARTED|Overall Study||3||
59647086|NCT04295772|75764754|FG000|COMPLETED|Overall Study||22||
59647087|NCT04295772|75764755|FG001|COMPLETED|Overall Study||2||
59647088|NCT04295772|75764754|FG000|NOT COMPLETED|Overall Study||17||
59647089|NCT04295772|75764755|FG001|NOT COMPLETED|Overall Study||1||
59647090|NCT03888066|75764764|FG000|STARTED|Run-in Phase||1195||
59647091|NCT03888066|75764765|FG001|STARTED|Run-in Phase||0||
59647092|NCT03888066|75764764|FG000|COMPLETED|Run-in Phase||878||
59647093|NCT03888066|75764765|FG001|COMPLETED|Run-in Phase||0||
59647094|NCT03888066|75764764|FG000|NOT COMPLETED|Run-in Phase||317||
59647095|NCT03888066|75764765|FG001|NOT COMPLETED|Run-in Phase||0||
59647096|NCT03888066|75764764|FG000|STARTED|Treatment Phase (Overall Study)||439||
59647097|NCT03888066|75764765|FG001|STARTED|Treatment Phase (Overall Study)||439||
59647098|NCT03888066|75764764|FG000|COMPLETED|Treatment Phase (Overall Study)||360||
59647099|NCT03888066|75764765|FG001|COMPLETED|Treatment Phase (Overall Study)||367||
59647100|NCT03888066|75764764|FG000|NOT COMPLETED|Treatment Phase (Overall Study)||79||
59647101|NCT03888066|75764765|FG001|NOT COMPLETED|Treatment Phase (Overall Study)||72||
59647102|NCT01049334|75764774|FG000|STARTED|Overall Study||102||
59647103|NCT01049334|75764775|FG001|STARTED|Overall Study||102||
59647104|NCT01049334|75764774|FG000|COMPLETED|Overall Study||93||
59647105|NCT01049334|75764775|FG001|COMPLETED|Overall Study||95||
59647106|NCT01049334|75764774|FG000|NOT COMPLETED|Overall Study||9||
59647107|NCT01049334|75764775|FG001|NOT COMPLETED|Overall Study||7||
59647108|NCT01048944|75764785|FG000|STARTED|Overall Study||32||
59647109|NCT01048944|75764786|FG001|STARTED|Overall Study||38||
59647110|NCT01048944|75764787|FG002|STARTED|Overall Study||35||
59647111|NCT01048944|75764788|FG003|STARTED|Overall Study||21||
59647112|NCT01048944|75764785|FG000|COMPLETED|Overall Study||24||
59647113|NCT01048944|75764786|FG001|COMPLETED|Overall Study||28||
59647114|NCT01048944|75764787|FG002|COMPLETED|Overall Study||25||
59647115|NCT01048944|75764788|FG003|COMPLETED|Overall Study||19||
59647116|NCT01048944|75764785|FG000|NOT COMPLETED|Overall Study||8||
59647117|NCT01048944|75764786|FG001|NOT COMPLETED|Overall Study||10||
59647118|NCT01048944|75764787|FG002|NOT COMPLETED|Overall Study||10||
59647119|NCT01048944|75764788|FG003|NOT COMPLETED|Overall Study||2||
59647120|NCT01048866|75764800|FG000|STARTED|Overall Study||101||
59647121|NCT01048866|75764801|FG001|STARTED|Overall Study||97||
59647122|NCT01048866|75764800|FG000|COMPLETED|Overall Study||97||
59647123|NCT01048866|75764801|FG001|COMPLETED|Overall Study||92||
59647124|NCT01048866|75764800|FG000|NOT COMPLETED|Overall Study||4||
59647125|NCT01048866|75764801|FG001|NOT COMPLETED|Overall Study||5||
59647126|NCT01048788|75764810|FG000|STARTED|Overall Study||8||
59647127|NCT01048788|75764811|FG001|STARTED|Overall Study||30||
59647128|NCT01048788|75764812|FG002|STARTED|Overall Study||13||
59647129|NCT01048788|75764810|FG000|COMPLETED|Overall Study||3||
59647130|NCT01048788|75764811|FG001|COMPLETED|Overall Study||28||
59647131|NCT01048788|75764812|FG002|COMPLETED|Overall Study||11||
59647132|NCT01048788|75764810|FG000|NOT COMPLETED|Overall Study||5||
59647133|NCT01048788|75764811|FG001|NOT COMPLETED|Overall Study||2||
59647134|NCT01048788|75764812|FG002|NOT COMPLETED|Overall Study||2||
59647135|NCT01048242|75764822|FG000|STARTED|Overall Study||12||
59647136|NCT01048242|75764823|FG001|STARTED|Overall Study||15||
59647137|NCT01048242|75764822|FG000|COMPLETED|Overall Study||8||
59647138|NCT01048242|75764823|FG001|COMPLETED|Overall Study||13||
59647139|NCT01048242|75764822|FG000|NOT COMPLETED|Overall Study||4||
59647140|NCT01048242|75764823|FG001|NOT COMPLETED|Overall Study||2||
59647141|NCT01047306|75764831|FG000|STARTED|Overall Study||19||
59647142|NCT01047306|75764832|FG001|STARTED|Overall Study||6||
59647143|NCT01047306|75764831|FG000|Discontinued From the Study|Overall Study||3||
59647144|NCT01047306|75764832|FG001|Discontinued From the Study|Overall Study||0||
59647145|NCT01047306|75764831|FG000|COMPLETED|Overall Study||16||
59647146|NCT01047306|75764832|FG001|COMPLETED|Overall Study||6||
59647147|NCT01047306|75764831|FG000|NOT COMPLETED|Overall Study||3||
59647148|NCT01047306|75764832|FG001|NOT COMPLETED|Overall Study||0||
59647149|NCT01046682|75764842|FG000|STARTED|Overall Study||20||
59647150|NCT01046682|75764843|FG001|STARTED|Overall Study||20||
59647151|NCT01046682|75764842|FG000|COMPLETED|Overall Study||18||
59647152|NCT01046682|75764843|FG001|COMPLETED|Overall Study||20||
59647153|NCT01046682|75764842|FG000|NOT COMPLETED|Overall Study||2||
59647154|NCT01046682|75764843|FG001|NOT COMPLETED|Overall Study||0||
59647155|NCT01044732|75764851|FG000|STARTED|Overall Study||222||
59647156|NCT01044732|75764852|FG001|STARTED|Overall Study||226||
59647157|NCT01044732|75764851|FG000|COMPLETED|Overall Study||173||
59647158|NCT01044732|75764852|FG001|COMPLETED|Overall Study||176||
59647159|NCT01044732|75764851|FG000|NOT COMPLETED|Overall Study||49||
59647160|NCT01044732|75764852|FG001|NOT COMPLETED|Overall Study||50||
59647161|NCT01044498|75764862|FG000|STARTED|Overall Study||23||
59647162|NCT01044498|75764863|FG001|STARTED|Overall Study||23||
59647163|NCT01044498|75764862|FG000|COMPLETED|Overall Study||20||
59647164|NCT01044498|75764863|FG001|COMPLETED|Overall Study||21||
59647165|NCT01044498|75764862|FG000|NOT COMPLETED|Overall Study||3||
59647166|NCT01044498|75764863|FG001|NOT COMPLETED|Overall Study||2||
59647167|NCT01043874|75764869|FG000|STARTED|Overall Study||45||
59647168|NCT01043874|75764869|FG000|COMPLETED|Overall Study||39||
59647169|NCT01043874|75764869|FG000|NOT COMPLETED|Overall Study||6||
59647170|NCT01042938|75764875|FG000|STARTED|Overall Study|1 withdrew before radiation; 1 ineligible due to other clinical trial; 1 non-compliance.|17||
59647171|NCT01042938|75764876|FG001|STARTED|Overall Study|1 withdrew before radiation; 1 non-compliance.|18||
59647172|NCT01042938|75764875|FG000|COMPLETED|Overall Study||14||
59647173|NCT01042938|75764876|FG001|COMPLETED|Overall Study||16||
59647174|NCT01042938|75764875|FG000|NOT COMPLETED|Overall Study||3||
59647175|NCT01042938|75764876|FG001|NOT COMPLETED|Overall Study||2||
59647176|NCT01042158|75764884|FG000|STARTED|Overall Study||25||
59647177|NCT01042158|75764884|FG000|COMPLETED|Overall Study||24||
59647178|NCT01042158|75764884|FG000|NOT COMPLETED|Overall Study||1||
59647179|NCT03408444|75764892|FG000|STARTED|Overall Study||50||
59647180|NCT03408444|75764893|FG001|STARTED|Overall Study||48||
59647181|NCT03408444|75764894|FG002|STARTED|Overall Study||50||
59647182|NCT03408444|75764895|FG003|STARTED|Overall Study||51||
59647183|NCT03408444|75764892|FG000|COMPLETED|Overall Study||49||
59647184|NCT03408444|75764893|FG001|COMPLETED|Overall Study||45||
59647185|NCT03408444|75764894|FG002|COMPLETED|Overall Study||44||
59647186|NCT03408444|75764895|FG003|COMPLETED|Overall Study||47||
59647187|NCT03408444|75764892|FG000|NOT COMPLETED|Overall Study||1||
59647188|NCT03408444|75764893|FG001|NOT COMPLETED|Overall Study||3||
59647189|NCT03408444|75764894|FG002|NOT COMPLETED|Overall Study||6||
59647190|NCT03408444|75764895|FG003|NOT COMPLETED|Overall Study||4||
59647191|NCT03401190|75764908|FG000|STARTED|Overall Study||8||
59647192|NCT03401190|75764909|FG001|STARTED|Overall Study||6||
59647193|NCT03401190|75764910|FG002|STARTED|Overall Study||7||
59647194|NCT03401190|75764908|FG000|COMPLETED|Overall Study||8||
59647195|NCT03401190|75764909|FG001|COMPLETED|Overall Study||4||
59647196|NCT03401190|75764910|FG002|COMPLETED|Overall Study||7||
59647197|NCT03401190|75764908|FG000|NOT COMPLETED|Overall Study||0||
59647198|NCT03401190|75764909|FG001|NOT COMPLETED|Overall Study||2||
59647199|NCT03401190|75764910|FG002|NOT COMPLETED|Overall Study||0||
59647200|NCT03400956|75764925|FG000|STARTED|Treatment Period 1||35|Allocated|
59647201|NCT03400956|75764926|FG001|STARTED|Treatment Period 1||34|Allocated|
59647202|NCT03400956|75764927|FG002|STARTED|Treatment Period 1||34|Allocated|
59647203|NCT03400956|75764925|FG000|Treated|Treatment Period 1||31||
59647204|NCT03400956|75764926|FG001|Treated|Treatment Period 1||30||
59647205|NCT03400956|75764927|FG002|Treated|Treatment Period 1||30||
59647206|NCT03400956|75764925|FG000|FAS|Treatment Period 1||32|Full analysis set|
59647207|NCT03400956|75764926|FG001|FAS|Treatment Period 1||33|Full analysis set|
59647208|NCT03400956|75764927|FG002|FAS|Treatment Period 1||31|Full analysis set|
59647209|NCT03400956|75764925|FG000|COMPLETED|Treatment Period 1||31||
59647210|NCT03400956|75764926|FG001|COMPLETED|Treatment Period 1||26||
59647211|NCT03400956|75764927|FG002|COMPLETED|Treatment Period 1||25||
59647212|NCT03400956|75764925|FG000|NOT COMPLETED|Treatment Period 1||4||
59647213|NCT03400956|75764926|FG001|NOT COMPLETED|Treatment Period 1||8||
59647214|NCT03400956|75764927|FG002|NOT COMPLETED|Treatment Period 1||9||
59647215|NCT03400956|75764925|FG000|STARTED|Post-treatment Period 1||31||
59647216|NCT03400956|75764926|FG001|STARTED|Post-treatment Period 1||26||
59647217|NCT03400956|75764927|FG002|STARTED|Post-treatment Period 1||25||
59647218|NCT03400956|75764925|FG000|COMPLETED|Post-treatment Period 1||9||
59647219|NCT03400956|75764926|FG001|COMPLETED|Post-treatment Period 1||10||
59647220|NCT03400956|75764927|FG002|COMPLETED|Post-treatment Period 1||9||
59647221|NCT03400956|75764925|FG000|NOT COMPLETED|Post-treatment Period 1||22||
59647222|NCT03400956|75764926|FG001|NOT COMPLETED|Post-treatment Period 1||16||
59647223|NCT03400956|75764927|FG002|NOT COMPLETED|Post-treatment Period 1||16||
59647224|NCT03400956|75764925|FG000|STARTED|Treatment Period 2||9|Treatment started|
59647225|NCT03400956|75764926|FG001|STARTED|Treatment Period 2||10|Treatment started|
59647226|NCT03400956|75764927|FG002|STARTED|Treatment Period 2||9|Treatment started|
59647227|NCT03400956|75764925|FG000|COMPLETED|Treatment Period 2||5||
59647228|NCT03400956|75764926|FG001|COMPLETED|Treatment Period 2||7||
59647229|NCT03400956|75764927|FG002|COMPLETED|Treatment Period 2||5||
59647230|NCT03400956|75764925|FG000|NOT COMPLETED|Treatment Period 2||4||
59647231|NCT03400956|75764926|FG001|NOT COMPLETED|Treatment Period 2||3||
59647232|NCT03400956|75764927|FG002|NOT COMPLETED|Treatment Period 2||4||
59647233|NCT03400956|75764925|FG000|STARTED|Follow-up Period||6||
59647234|NCT03400956|75764926|FG001|STARTED|Follow-up Period||9||
59647235|NCT03400956|75764927|FG002|STARTED|Follow-up Period||7||
59647236|NCT03400956|75764925|FG000|COMPLETED|Follow-up Period||6||
59647237|NCT03400956|75764926|FG001|COMPLETED|Follow-up Period||9||
59647238|NCT03400956|75764927|FG002|COMPLETED|Follow-up Period||5||
59647239|NCT03400956|75764925|FG000|NOT COMPLETED|Follow-up Period||0||
59647240|NCT03400956|75764926|FG001|NOT COMPLETED|Follow-up Period||0||
59647241|NCT03400956|75764927|FG002|NOT COMPLETED|Follow-up Period||2||
59647242|NCT00012012|75764940|FG000|STARTED|Overall Study||27||
59647243|NCT00012012|75764941|FG001|STARTED|Overall Study||18||
59647244|NCT00012012|75764940|FG000|COMPLETED|Overall Study||26||
59647245|NCT00012012|75764941|FG001|COMPLETED|Overall Study||15||
59647246|NCT00012012|75764940|FG000|NOT COMPLETED|Overall Study||1||
59647247|NCT00012012|75764941|FG001|NOT COMPLETED|Overall Study||3||
59647248|NCT00010374|75764947|FG000|STARTED|Overall Study||54||
59647249|NCT00010374|75764947|FG000|COMPLETED|Overall Study|One compassionate use participant was withheld from analysis per FDA instructions|53||
59647250|NCT00010374|75764947|FG000|NOT COMPLETED|Overall Study||1||
59647251|NCT02245308|75764954|FG000|STARTED|Overall Study||63||
59647252|NCT02245308|75764955|FG001|STARTED|Overall Study||64||
59647253|NCT02245308|75764954|FG000|COMPLETED|Overall Study|Using intent-to-treat analyses, i.e., missing=smoking|63||
59647254|NCT02245308|75764955|FG001|COMPLETED|Overall Study|Using intent-to-treat analyses, i.e., missing=smoking|64||
59647255|NCT02245308|75764954|FG000|NOT COMPLETED|Overall Study||0||
59647256|NCT02245308|75764955|FG001|NOT COMPLETED|Overall Study||0||
59647257|NCT02243358|75764961|FG000|STARTED|Overall Study||24||
59647258|NCT02243358|75764961|FG000|COMPLETED|Overall Study||24||
59647259|NCT02243358|75764961|FG000|NOT COMPLETED|Overall Study||0||
59647260|NCT00559962|75764973|FG000|STARTED|Overall Study||33||
59647261|NCT00559962|75764974|FG001|STARTED|Overall Study||34||
59647262|NCT00559962|75764975|FG002|STARTED|Overall Study||34||
59647263|NCT00559962|75764976|FG003|STARTED|Overall Study||34||
59647264|NCT00559962|75764977|FG004|STARTED|Overall Study||35||
59647265|NCT00559962|75764978|FG005|STARTED|Overall Study||28||
59647266|NCT00559962|75764979|FG006|STARTED|Overall Study||33||
59647267|NCT00559962|75764980|FG007|STARTED|Overall Study||29||
59647268|NCT00559962|75764973|FG000|COMPLETED|Overall Study||31||
59647269|NCT00559962|75764974|FG001|COMPLETED|Overall Study||25||
59647270|NCT00559962|75764975|FG002|COMPLETED|Overall Study||24||
59647271|NCT00559962|75764976|FG003|COMPLETED|Overall Study||29||
59647272|NCT00559962|75764977|FG004|COMPLETED|Overall Study||21||
59647273|NCT00559962|75764978|FG005|COMPLETED|Overall Study||23||
59647274|NCT00559962|75764979|FG006|COMPLETED|Overall Study||28||
59647275|NCT00559962|75764980|FG007|COMPLETED|Overall Study||25||
59647276|NCT00559962|75764973|FG000|NOT COMPLETED|Overall Study||2||
59647277|NCT00559962|75764974|FG001|NOT COMPLETED|Overall Study||9||
59647278|NCT00559962|75764975|FG002|NOT COMPLETED|Overall Study||10||
59647279|NCT00559962|75764976|FG003|NOT COMPLETED|Overall Study||5||
59647280|NCT00559962|75764977|FG004|NOT COMPLETED|Overall Study||14||
59647281|NCT00559962|75764978|FG005|NOT COMPLETED|Overall Study||5||
59647282|NCT00559962|75764979|FG006|NOT COMPLETED|Overall Study||5||
59647283|NCT00559962|75764980|FG007|NOT COMPLETED|Overall Study||4||
59647284|NCT00559104|75765001|FG000|STARTED|Overall Study||55||
59647285|NCT00559104|75765002|FG001|STARTED|Overall Study||5||
59988599|NCT02743871|76103795|FG002|COMPLETED|Overall Study||6||
59647286|NCT00559104|75765001|FG000|COMPLETED|Overall Study|Progression was the reason for off-treatment for 9 of 9 patients who went off of treatment.|46||
59647287|NCT00559104|75765002|FG001|COMPLETED|Overall Study||5||
59647288|NCT00559104|75765001|FG000|NOT COMPLETED|Overall Study||9||
59647289|NCT00559104|75765002|FG001|NOT COMPLETED|Overall Study||0||
59647290|NCT00558636|75765010|FG000|STARTED|Treatment|up to 6 cycles of combination therapy|47||
59647291|NCT00558636|75765011|FG001|STARTED|Treatment||44||
59647292|NCT00558636|75765010|FG000|Start of Maintenance Monotherapy|Treatment|Sorafenib taken as the single agent in the Maintenance Phase|2||
59647293|NCT00558636|75765011|FG001|Start of Maintenance Monotherapy|Treatment|Placebo taken as the single agent in the Maintenance Phase|2||
59647294|NCT00558636|75765010|FG000|COMPLETED|Treatment|Patients still on treatment did not enter follow-up because the study was prematurely terminated|0||
59647295|NCT00558636|75765011|FG001|COMPLETED|Treatment|Patients still on treatment did not enter follow-up because the study was prematurely terminated|0||
59647296|NCT00558636|75765010|FG000|NOT COMPLETED|Treatment||47||
59647297|NCT00558636|75765011|FG001|NOT COMPLETED|Treatment||44||
59647298|NCT00558636|75765010|FG000|STARTED|Follow-up|12 subjects entered Follow-up phase before they completed the treatment phase|12||
59647299|NCT00558636|75765011|FG001|STARTED|Follow-up|7 subjects entered Follow-up phase before they completed the treatment phase|7||
59647300|NCT00558636|75765010|FG000|COMPLETED|Follow-up|Study was prematurely terminated|0||
59647301|NCT00558636|75765011|FG001|COMPLETED|Follow-up|Study was prematurely terminated|0||
59988600|NCT02743871|76103796|FG003|COMPLETED|Overall Study||2||
59988601|NCT02743871|76103797|FG004|COMPLETED|Overall Study||4||
59988602|NCT02743871|76103798|FG005|COMPLETED|Overall Study||6||
59647302|NCT00558636|75765010|FG000|NOT COMPLETED|Follow-up||12||
59647303|NCT00558636|75765011|FG001|NOT COMPLETED|Follow-up||7||
59988603|NCT02743871|76103799|FG006|COMPLETED|Overall Study||5||
59542676|NCT01049360|75640983|FG004|NOT COMPLETED|Period 1||0||
59542677|NCT01049360|75640984|FG005|NOT COMPLETED|Period 1||0||
59542678|NCT01049360|75640985|FG006|NOT COMPLETED|Period 1||0||
59542679|NCT01049360|75640986|FG007|NOT COMPLETED|Period 1||2||
59542680|NCT01049360|75640987|FG008|NOT COMPLETED|Period 1||2||
59542681|NCT01049360|75640988|FG009|NOT COMPLETED|Period 1||0||
59542682|NCT01049360|75640989|FG010|NOT COMPLETED|Period 1||1||
59542683|NCT01049360|75640990|FG011|NOT COMPLETED|Period 1||0||
59542684|NCT01049360|75640991|FG012|NOT COMPLETED|Period 1||2||
59542685|NCT01049360|75640992|FG013|NOT COMPLETED|Period 1||1||
59542686|NCT01049360|75640993|FG014|NOT COMPLETED|Period 1||0||
59542687|NCT01049360|75640994|FG015|NOT COMPLETED|Period 1||0||
59542688|NCT01049360|75640995|FG016|NOT COMPLETED|Period 1||1||
59542689|NCT01049360|75640996|FG017|NOT COMPLETED|Period 1||0||
59542690|NCT01049360|75640997|FG018|NOT COMPLETED|Period 1||1||
59542691|NCT01049360|75640998|FG019|NOT COMPLETED|Period 1||0||
59542692|NCT01049360|75640979|FG000|STARTED|Period 2||6||
59542693|NCT01049360|75640980|FG001|STARTED|Period 2||5||
59542694|NCT01049360|75640981|FG002|STARTED|Period 2||7||
59542695|NCT01049360|75640982|FG003|STARTED|Period 2||6||
59542696|NCT01049360|75640983|FG004|STARTED|Period 2||7||
59542697|NCT01049360|75640984|FG005|STARTED|Period 2||6||
59542698|NCT01049360|75640985|FG006|STARTED|Period 2||6||
59542699|NCT01049360|75640986|FG007|STARTED|Period 2||4||
59542700|NCT01049360|75640987|FG008|STARTED|Period 2||5||
59542701|NCT01049360|75640988|FG009|STARTED|Period 2||6||
59542702|NCT01049360|75640989|FG010|STARTED|Period 2||5||
59542703|NCT01049360|75640990|FG011|STARTED|Period 2||6||
59542704|NCT01049360|75640991|FG012|STARTED|Period 2||4||
59542705|NCT01049360|75640992|FG013|STARTED|Period 2||6||
59542706|NCT01049360|75640993|FG014|STARTED|Period 2||7||
59542707|NCT01049360|75640994|FG015|STARTED|Period 2||7||
59542708|NCT01049360|75640995|FG016|STARTED|Period 2||5||
59542709|NCT01049360|75640996|FG017|STARTED|Period 2||6||
59542710|NCT01049360|75640997|FG018|STARTED|Period 2||5||
59542711|NCT01049360|75640998|FG019|STARTED|Period 2||7||
59542712|NCT01049360|75640979|FG000|COMPLETED|Period 2||6||
59542713|NCT01049360|75640980|FG001|COMPLETED|Period 2||4||
59542714|NCT01049360|75640981|FG002|COMPLETED|Period 2||7||
59542715|NCT01049360|75640982|FG003|COMPLETED|Period 2||4||
59542716|NCT01049360|75640983|FG004|COMPLETED|Period 2||7||
59542717|NCT01049360|75640984|FG005|COMPLETED|Period 2||5||
59542718|NCT01049360|75640985|FG006|COMPLETED|Period 2||6||
59542719|NCT01049360|75640986|FG007|COMPLETED|Period 2||4||
59542720|NCT01049360|75640987|FG008|COMPLETED|Period 2||4||
59542721|NCT01049360|75640988|FG009|COMPLETED|Period 2||6||
59542722|NCT01049360|75640989|FG010|COMPLETED|Period 2||5||
59542723|NCT01049360|75640990|FG011|COMPLETED|Period 2||6||
59542724|NCT01049360|75640991|FG012|COMPLETED|Period 2||4||
59542725|NCT01049360|75640992|FG013|COMPLETED|Period 2||6||
59542726|NCT01049360|75640993|FG014|COMPLETED|Period 2||5||
59542727|NCT01049360|75640994|FG015|COMPLETED|Period 2||6||
59542728|NCT01049360|75640995|FG016|COMPLETED|Period 2||5||
59542729|NCT01049360|75640996|FG017|COMPLETED|Period 2||6||
59542730|NCT01049360|75640997|FG018|COMPLETED|Period 2||5||
59542731|NCT01049360|75640998|FG019|COMPLETED|Period 2||5||
59542732|NCT01049360|75640979|FG000|NOT COMPLETED|Period 2||0||
59542733|NCT01049360|75640980|FG001|NOT COMPLETED|Period 2||1||
59542734|NCT01049360|75640981|FG002|NOT COMPLETED|Period 2||0||
59542735|NCT01049360|75640982|FG003|NOT COMPLETED|Period 2||2||
59542736|NCT01049360|75640983|FG004|NOT COMPLETED|Period 2||0||
59542737|NCT01049360|75640984|FG005|NOT COMPLETED|Period 2||1||
59542738|NCT01049360|75640985|FG006|NOT COMPLETED|Period 2||0||
59542739|NCT01049360|75640986|FG007|NOT COMPLETED|Period 2||0||
59542740|NCT01049360|75640987|FG008|NOT COMPLETED|Period 2||1||
59542741|NCT01049360|75640988|FG009|NOT COMPLETED|Period 2||0||
59542742|NCT01049360|75640989|FG010|NOT COMPLETED|Period 2||0||
59542743|NCT01049360|75640990|FG011|NOT COMPLETED|Period 2||0||
59542744|NCT01049360|75640991|FG012|NOT COMPLETED|Period 2||0||
59542745|NCT01049360|75640992|FG013|NOT COMPLETED|Period 2||0||
59542746|NCT01049360|75640993|FG014|NOT COMPLETED|Period 2||2||
59542747|NCT01049360|75640994|FG015|NOT COMPLETED|Period 2||1||
59542748|NCT01049360|75640995|FG016|NOT COMPLETED|Period 2||0||
59542749|NCT01049360|75640996|FG017|NOT COMPLETED|Period 2||0||
59542750|NCT01049360|75640997|FG018|NOT COMPLETED|Period 2||0||
59542751|NCT01049360|75640998|FG019|NOT COMPLETED|Period 2||2||
59542752|NCT01049360|75640979|FG000|STARTED|Period 3||6||
59542753|NCT01049360|75640980|FG001|STARTED|Period 3||4||
59542754|NCT01049360|75640981|FG002|STARTED|Period 3||7||
59542755|NCT01049360|75640982|FG003|STARTED|Period 3||4||
59542756|NCT01049360|75640983|FG004|STARTED|Period 3||7||
59542757|NCT01049360|75640984|FG005|STARTED|Period 3||5||
59542758|NCT01049360|75640985|FG006|STARTED|Period 3||6||
59542759|NCT01049360|75640986|FG007|STARTED|Period 3||4||
59542760|NCT01049360|75640987|FG008|STARTED|Period 3||4||
59542761|NCT01049360|75640988|FG009|STARTED|Period 3||6||
59542762|NCT01049360|75640989|FG010|STARTED|Period 3||5||
59542763|NCT01049360|75640990|FG011|STARTED|Period 3||6||
59542764|NCT01049360|75640991|FG012|STARTED|Period 3||4||
59542765|NCT01049360|75640992|FG013|STARTED|Period 3||6||
59542766|NCT01049360|75640993|FG014|STARTED|Period 3||5||
59647304|NCT00558558|75765017|FG000|STARTED|Overall Study||6||
59647305|NCT00558558|75765017|FG000|COMPLETED|Overall Study||0||
59647306|NCT00558558|75765017|FG000|NOT COMPLETED|Overall Study||6||
59647307|NCT00557622|75765023|FG000|STARTED|4-Week Run-in Phase||5||
59647308|NCT00557622|75765024|FG001|STARTED|4-Week Run-in Phase||0||
59647309|NCT00557622|75765023|FG000|COMPLETED|4-Week Run-in Phase||3||
59647310|NCT00557622|75765024|FG001|COMPLETED|4-Week Run-in Phase||0||
59647311|NCT00557622|75765023|FG000|NOT COMPLETED|4-Week Run-in Phase||2||
59647312|NCT00557622|75765024|FG001|NOT COMPLETED|4-Week Run-in Phase||0||
59647313|NCT00557622|75765023|FG000|STARTED|12-Week Treatment Phase||1||
59647314|NCT00557622|75765024|FG001|STARTED|12-Week Treatment Phase||2||
59647315|NCT00557622|75765023|FG000|COMPLETED|12-Week Treatment Phase||1||
59647316|NCT00557622|75765024|FG001|COMPLETED|12-Week Treatment Phase||1||
59647317|NCT00557622|75765023|FG000|NOT COMPLETED|12-Week Treatment Phase||0||
59647318|NCT00557622|75765024|FG001|NOT COMPLETED|12-Week Treatment Phase||1||
59647319|NCT00557466|75765036|FG000|STARTED|Overall Study||98||
59647320|NCT00557466|75765037|FG001|STARTED|Overall Study||92||
59542767|NCT01049360|75640994|FG015|STARTED|Period 3||6||
59647321|NCT00557466|75765038|FG002|STARTED|Overall Study||101||
59647322|NCT00557466|75765039|FG003|STARTED|Overall Study||96||
59647323|NCT00557466|75765040|FG004|STARTED|Overall Study||90||
59647324|NCT00557466|75765041|FG005|STARTED|Overall Study||91||
59647325|NCT00557466|75765036|FG000|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|98||
59647326|NCT00557466|75765037|FG001|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|92||
59647327|NCT00557466|75765038|FG002|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|101||
59647328|NCT00557466|75765039|FG003|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|96||
59647329|NCT00557466|75765040|FG004|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|90||
59647330|NCT00557466|75765041|FG005|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|91||
59647331|NCT00557466|75765036|FG000|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|98||
59647332|NCT00557466|75765037|FG001|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|91||
59647333|NCT00557466|75765038|FG002|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|98||
59647334|NCT00557466|75765039|FG003|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|93||
59647335|NCT00557466|75765040|FG004|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|87||
59647336|NCT00557466|75765041|FG005|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|89||
59647337|NCT00557466|75765036|FG000|COMPLETED|Overall Study||94||
59647338|NCT00557466|75765037|FG001|COMPLETED|Overall Study||87||
59647339|NCT00557466|75765038|FG002|COMPLETED|Overall Study||95||
59647340|NCT00557466|75765039|FG003|COMPLETED|Overall Study||92||
59647341|NCT00557466|75765040|FG004|COMPLETED|Overall Study||87||
59542768|NCT01049360|75640995|FG016|STARTED|Period 3||5||
59542769|NCT01049360|75640996|FG017|STARTED|Period 3||6||
59542770|NCT01049360|75640997|FG018|STARTED|Period 3||5||
59542771|NCT01049360|75640998|FG019|STARTED|Period 3||5||
59542772|NCT01049360|75640979|FG000|COMPLETED|Period 3||6||
59542773|NCT01049360|75640980|FG001|COMPLETED|Period 3||4||
59542774|NCT01049360|75640981|FG002|COMPLETED|Period 3||7||
59542775|NCT01049360|75640982|FG003|COMPLETED|Period 3||4||
59542776|NCT01049360|75640983|FG004|COMPLETED|Period 3||7||
59542777|NCT01049360|75640984|FG005|COMPLETED|Period 3||5||
59542778|NCT01049360|75640985|FG006|COMPLETED|Period 3||6||
59542779|NCT01049360|75640986|FG007|COMPLETED|Period 3||4||
59542780|NCT01049360|75640987|FG008|COMPLETED|Period 3||4||
59542781|NCT01049360|75640988|FG009|COMPLETED|Period 3||6||
59542782|NCT01049360|75640989|FG010|COMPLETED|Period 3||5||
59542783|NCT01049360|75640990|FG011|COMPLETED|Period 3||6||
59542784|NCT01049360|75640991|FG012|COMPLETED|Period 3||4||
59542785|NCT01049360|75640992|FG013|COMPLETED|Period 3||6||
59542786|NCT01049360|75640993|FG014|COMPLETED|Period 3||5||
59542787|NCT01049360|75640994|FG015|COMPLETED|Period 3||6||
59542788|NCT01049360|75640995|FG016|COMPLETED|Period 3||5||
59542789|NCT01049360|75640996|FG017|COMPLETED|Period 3||6||
59542790|NCT01049360|75640997|FG018|COMPLETED|Period 3||5||
59542791|NCT01049360|75640998|FG019|COMPLETED|Period 3||5||
59542792|NCT01049360|75640979|FG000|NOT COMPLETED|Period 3||0||
59542793|NCT01049360|75640980|FG001|NOT COMPLETED|Period 3||0||
59542794|NCT01049360|75640981|FG002|NOT COMPLETED|Period 3||0||
59542795|NCT01049360|75640982|FG003|NOT COMPLETED|Period 3||0||
59542796|NCT01049360|75640983|FG004|NOT COMPLETED|Period 3||0||
59542797|NCT01049360|75640984|FG005|NOT COMPLETED|Period 3||0||
59542798|NCT01049360|75640985|FG006|NOT COMPLETED|Period 3||0||
59542799|NCT01049360|75640986|FG007|NOT COMPLETED|Period 3||0||
59542800|NCT01049360|75640987|FG008|NOT COMPLETED|Period 3||0||
59542801|NCT01049360|75640988|FG009|NOT COMPLETED|Period 3||0||
59542802|NCT01049360|75640989|FG010|NOT COMPLETED|Period 3||0||
59542803|NCT01049360|75640990|FG011|NOT COMPLETED|Period 3||0||
59647342|NCT00557466|75765041|FG005|COMPLETED|Overall Study||85||
59647343|NCT00557466|75765036|FG000|NOT COMPLETED|Overall Study||4||
59647344|NCT00557466|75765037|FG001|NOT COMPLETED|Overall Study||5||
59647345|NCT00557466|75765038|FG002|NOT COMPLETED|Overall Study||6||
59647346|NCT00557466|75765039|FG003|NOT COMPLETED|Overall Study||4||
59647347|NCT00557466|75765040|FG004|NOT COMPLETED|Overall Study||3||
59647348|NCT00557466|75765041|FG005|NOT COMPLETED|Overall Study||6||
59647349|NCT00557310|75765055|FG000|STARTED|Main Study (0 - 18 Months)||35||
59647350|NCT00557310|75765055|FG000|COMPLETED|Main Study (0 - 18 Months)|One had a metal hip implant, a protocol violation, and was excluded from efficacy analyses.|30||
59647351|NCT00557310|75765055|FG000|NOT COMPLETED|Main Study (0 - 18 Months)||5||
59647352|NCT00557310|75765055|FG000|STARTED|Extension Phase (18 - 24 Months)||30||
59647353|NCT00557310|75765055|FG000|COMPLETED|Extension Phase (18 - 24 Months)|One had a metal hip implant, a protocol violation, and was excluded from efficacy analyses.|25||
59647354|NCT00557310|75765055|FG000|NOT COMPLETED|Extension Phase (18 - 24 Months)||5||
59647355|NCT00555438|75765059|FG000|STARTED|10 Days Post-operative||442||
59647356|NCT00555438|75765059|FG000|COMPLETED|10 Days Post-operative|438 patients attended the day 10 visit (four patients died during hospitalization)|438||
59647357|NCT00555438|75765059|FG000|NOT COMPLETED|10 Days Post-operative||4||
59647358|NCT00555438|75765059|FG000|STARTED|Between 10 Days and 30 Days Postoperativ||438||
59647359|NCT00555438|75765059|FG000|COMPLETED|Between 10 Days and 30 Days Postoperativ||433||
59647360|NCT00555438|75765059|FG000|NOT COMPLETED|Between 10 Days and 30 Days Postoperativ||5||
59647361|NCT00553644|75765063|FG000|STARTED|Overall Study||53||
59647362|NCT00553644|75765063|FG000|COMPLETED|Overall Study||25||
59647363|NCT00553644|75765063|FG000|NOT COMPLETED|Overall Study||28||
59647364|NCT00553332|75765067|FG000|STARTED|Overall Study||29||
59647365|NCT00553332|75765067|FG000|COMPLETED|Overall Study|evaluable for response|28||
59647366|NCT00553332|75765067|FG000|NOT COMPLETED|Overall Study||1||
59647367|NCT00552396|75765078|FG000|STARTED|Overall Study||4||
59647368|NCT00552396|75765079|FG001|STARTED|Overall Study||3||
59647369|NCT00552396|75765080|FG002|STARTED|Overall Study||3||
59647370|NCT00552396|75765081|FG003|STARTED|Overall Study||6||
59647371|NCT00552396|75765082|FG004|STARTED|Overall Study||3||
59647372|NCT00552396|75765083|FG005|STARTED|Overall Study||3||
59647373|NCT00552396|75765084|FG006|STARTED|Overall Study||10||
59647374|NCT00552396|75765078|FG000|COMPLETED|Overall Study||1||
59647375|NCT00552396|75765079|FG001|COMPLETED|Overall Study||0||
59647376|NCT00552396|75765080|FG002|COMPLETED|Overall Study||0||
59647377|NCT00552396|75765081|FG003|COMPLETED|Overall Study||0||
59647378|NCT00552396|75765082|FG004|COMPLETED|Overall Study||0||
59647379|NCT00552396|75765083|FG005|COMPLETED|Overall Study||0||
59647380|NCT00552396|75765084|FG006|COMPLETED|Overall Study||1||
59647381|NCT00552396|75765078|FG000|NOT COMPLETED|Overall Study||3||
59647382|NCT00552396|75765079|FG001|NOT COMPLETED|Overall Study||3||
59647383|NCT00552396|75765080|FG002|NOT COMPLETED|Overall Study||3||
59988604|NCT02743871|76103800|FG007|COMPLETED|Overall Study||8||
59988605|NCT02743871|76103801|FG008|COMPLETED|Overall Study||2||
59988606|NCT02743871|76103802|FG009|COMPLETED|Overall Study||2||
59988607|NCT02743871|76103803|FG010|COMPLETED|Overall Study||10||
59988608|NCT02743871|76103804|FG011|COMPLETED|Overall Study||6||
59647384|NCT00552396|75765081|FG003|NOT COMPLETED|Overall Study||6||
59647385|NCT00552396|75765082|FG004|NOT COMPLETED|Overall Study||3||
59647386|NCT00552396|75765083|FG005|NOT COMPLETED|Overall Study||3||
59988609|NCT02743871|76103805|FG012|COMPLETED|Overall Study||5||
59988610|NCT02743871|76103806|FG013|COMPLETED|Overall Study||1||
59988611|NCT02743871|76103793|FG000|NOT COMPLETED|Overall Study||1||
59647387|NCT00552396|75765084|FG006|NOT COMPLETED|Overall Study||9||
59647388|NCT00552240|75765120|FG000|STARTED|Overall Study|Number in Full Analysis Set (FAS)|75||
59647389|NCT00552240|75765121|FG001|STARTED|Overall Study|Number in Full Analysis Set (FAS)|77||
59647390|NCT00552240|75765120|FG000|COMPLETED|Overall Study||51||
59647391|NCT00552240|75765121|FG001|COMPLETED|Overall Study||59||
59647392|NCT00552240|75765120|FG000|NOT COMPLETED|Overall Study||24||
59647393|NCT00552240|75765121|FG001|NOT COMPLETED|Overall Study||18||
59647394|NCT00552084|75765129|FG000|STARTED|Overall Study||126||
59647395|NCT00552084|75765130|FG001|STARTED|Overall Study||64||
59647396|NCT00552084|75765129|FG000|COMPLETED|Overall Study||118||
59647397|NCT00552084|75765130|FG001|COMPLETED|Overall Study||55||
59647398|NCT00552084|75765129|FG000|NOT COMPLETED|Overall Study||8||
59647399|NCT00552084|75765130|FG001|NOT COMPLETED|Overall Study||9||
59647400|NCT00550836|75765138|FG000|STARTED|Overall Study||49||
59988612|NCT02743871|76103794|FG001|NOT COMPLETED|Overall Study||0||
59988613|NCT02743871|76103795|FG002|NOT COMPLETED|Overall Study||0||
59988614|NCT02743871|76103796|FG003|NOT COMPLETED|Overall Study||1||
59988615|NCT02743871|76103797|FG004|NOT COMPLETED|Overall Study||0||
59988616|NCT02743871|76103798|FG005|NOT COMPLETED|Overall Study||0||
59988617|NCT02743871|76103799|FG006|NOT COMPLETED|Overall Study||1||
59647401|NCT00550836|75765139|FG001|STARTED|Overall Study||55||
59647402|NCT00550836|75765138|FG000|COMPLETED|Overall Study||46||
59647403|NCT00550836|75765139|FG001|COMPLETED|Overall Study||46||
59647404|NCT00550836|75765138|FG000|NOT COMPLETED|Overall Study||3||
59647405|NCT00550836|75765139|FG001|NOT COMPLETED|Overall Study||9||
59647406|NCT00550680|75765145|FG000|STARTED|Overall Study||208||
59647407|NCT00550680|75765145|FG000|COMPLETED|Overall Study||152||
59647408|NCT00550680|75765145|FG000|NOT COMPLETED|Overall Study||56||
59647409|NCT00554190|75765149|FG000|STARTED|Overall Study|29 subjects treated.|29||
59647410|NCT00554190|75765149|FG000|COMPLETED|Overall Study|10 subjects did not complete the Termination Study Forms|19||
59647411|NCT00554190|75765149|FG000|NOT COMPLETED|Overall Study||10||
59647412|NCT00556374|75765155|FG000|STARTED|Overall Study||1709||
59647413|NCT00556374|75765156|FG001|STARTED|Overall Study||1711||
59647414|NCT00556374|75765155|FG000|Received Study Drug in the Double-blind Phase|Overall Study||1699||
59647415|NCT00556374|75765156|FG001|Received Study Drug in the Double-blind Phase|Overall Study||1700||
59647416|NCT00556374|75765155|FG000|Continued Into the Open-Label Phase|Overall Study||268||
59647417|NCT00556374|75765156|FG001|Continued Into the Open-Label Phase|Overall Study||3||
59647418|NCT00556374|75765155|FG000|Safety Analysis Set|Overall Study|The safety analysis set was summarized based on the actual treatment received in the double-blind phase. Participants who received at least 1 dose of denosumab in the double-blind phase were summarized in the denosumab group regardless of the randomized treatment.|1690||
59647419|NCT00556374|75765156|FG001|Safety Analysis Set|Overall Study|The safety analysis set was summarized based on the actual treatment received in the double-blind phase. Participants who received at least 1 dose of denosumab in the double-blind phase were summarized in the denosumab group regardless of the randomized treatment.|1709||
59647420|NCT00556374|75765155|FG000|COMPLETED|Overall Study||1242||
59647421|NCT00556374|75765156|FG001|COMPLETED|Overall Study||1362||
59647422|NCT00556374|75765155|FG000|NOT COMPLETED|Overall Study||467||
59647423|NCT00556374|75765156|FG001|NOT COMPLETED|Overall Study||349||
59647424|NCT04278846|75765166|FG000|STARTED|Overall Study|No longer patients to study|25||
59647425|NCT04278846|75765167|FG001|STARTED|Overall Study||25||
59647426|NCT04278846|75765166|FG000|COMPLETED|Overall Study||25||
59647427|NCT04278846|75765167|FG001|COMPLETED|Overall Study||25||
59647428|NCT04278846|75765166|FG000|NOT COMPLETED|Overall Study||0||
59647429|NCT04278846|75765167|FG001|NOT COMPLETED|Overall Study||0||
59647430|NCT03831360|75765178|FG000|STARTED|Overall Study||15||
59647431|NCT03831360|75765179|FG001|STARTED|Overall Study||15||
59647432|NCT03831360|75765178|FG000|COMPLETED|Overall Study||12||
59647433|NCT03831360|75765179|FG001|COMPLETED|Overall Study||14||
59647434|NCT03831360|75765178|FG000|NOT COMPLETED|Overall Study||3||
59647435|NCT03831360|75765179|FG001|NOT COMPLETED|Overall Study||1||
59647436|NCT04677959|75765187|FG000|STARTED|Overall Study||185||
59647437|NCT04677959|75765188|FG001|STARTED|Overall Study||242||
59647438|NCT04677959|75765187|FG000|Safety Analysis Set|Overall Study||185|All participants in the DS group who received at least 1 dose of IMP and all participants in the SoC group.|
59647439|NCT04677959|75765188|FG001|Safety Analysis Set|Overall Study||224|All participants in the DS group who received at least 1 dose of IMP and all participants in the SoC group.|
59647440|NCT04677959|75765187|FG000|COMPLETED|Overall Study||173||
59647441|NCT04677959|75765188|FG001|COMPLETED|Overall Study||183||
59647442|NCT04677959|75765187|FG000|NOT COMPLETED|Overall Study||12||
59647443|NCT04677959|75765188|FG001|NOT COMPLETED|Overall Study||59||
59647444|NCT04656899|75765197|FG000|STARTED|Overall Study||19||
59647445|NCT04656899|75765198|FG001|STARTED|Overall Study||22||
59647446|NCT04656899|75765197|FG000|COMPLETED|Overall Study||16||
59647447|NCT04656899|75765198|FG001|COMPLETED|Overall Study||13||
59647448|NCT04656899|75765197|FG000|NOT COMPLETED|Overall Study||3||
59647449|NCT04656899|75765198|FG001|NOT COMPLETED|Overall Study||9||
59647450|NCT04645342|75765206|FG000|STARTED|Overall Study||36||
59647451|NCT04645342|75765207|FG001|STARTED|Overall Study||39||
59647452|NCT04645342|75765206|FG000|COMPLETED|Overall Study||36||
59647453|NCT04645342|75765207|FG001|COMPLETED|Overall Study||39||
59647454|NCT04645342|75765206|FG000|NOT COMPLETED|Overall Study||0||
59647455|NCT04645342|75765207|FG001|NOT COMPLETED|Overall Study||0||
59647456|NCT04330638|75765215|FG000|STARTED|Overall Study||74||
59647457|NCT04330638|75765216|FG001|STARTED|Overall Study||44||
59647458|NCT04330638|75765217|FG002|STARTED|Overall Study||75||
59647459|NCT04330638|75765218|FG003|STARTED|Overall Study||36||
59647460|NCT04330638|75765219|FG004|STARTED|Overall Study||81||
59647461|NCT04330638|75765220|FG005|STARTED|Overall Study||32||
59647462|NCT04330638|75765215|FG000|Randomization 1: No IL-1 Blockade|Overall Study||74||
59647463|NCT04330638|75765216|FG001|Randomization 1: No IL-1 Blockade|Overall Study||0||
59647464|NCT04330638|75765217|FG002|Randomization 1: No IL-1 Blockade|Overall Study||75||
59647465|NCT04330638|75765218|FG003|Randomization 1: No IL-1 Blockade|Overall Study||0||
59647466|NCT04330638|75765219|FG004|Randomization 1: No IL-1 Blockade|Overall Study||81||
59647467|NCT04330638|75765220|FG005|Randomization 1: No IL-1 Blockade|Overall Study||0||
59647468|NCT04330638|75765215|FG000|Randomization 1: IL-1 Blockade|Overall Study||0||
59647469|NCT04330638|75765216|FG001|Randomization 1: IL-1 Blockade|Overall Study||44||
59647470|NCT04330638|75765217|FG002|Randomization 1: IL-1 Blockade|Overall Study||0||
59647471|NCT04330638|75765218|FG003|Randomization 1: IL-1 Blockade|Overall Study||36||
59647472|NCT04330638|75765219|FG004|Randomization 1: IL-1 Blockade|Overall Study||0||
59647473|NCT04330638|75765220|FG005|Randomization 1: IL-1 Blockade|Overall Study||32||
59647474|NCT04330638|75765215|FG000|Randomization 2: No IL-6 Blockade|Overall Study||74||
59647475|NCT04330638|75765216|FG001|Randomization 2: No IL-6 Blockade|Overall Study||41||
59647476|NCT04330638|75765217|FG002|Randomization 2: No IL-6 Blockade|Overall Study||0||
59647477|NCT04330638|75765218|FG003|Randomization 2: No IL-6 Blockade|Overall Study||0||
59647478|NCT04330638|75765219|FG004|Randomization 2: No IL-6 Blockade|Overall Study||0||
59647479|NCT04330638|75765220|FG005|Randomization 2: No IL-6 Blockade|Overall Study||0||
59647480|NCT04330638|75765215|FG000|Randomization 2: IL-6 Blockade|Overall Study||0||
59647481|NCT04330638|75765216|FG001|Randomization 2: IL-6 Blockade|Overall Study||0||
59647482|NCT04330638|75765217|FG002|Randomization 2: IL-6 Blockade|Overall Study||75||
59647483|NCT04330638|75765218|FG003|Randomization 2: IL-6 Blockade|Overall Study||36||
59647484|NCT04330638|75765219|FG004|Randomization 2: IL-6 Blockade|Overall Study||81||
59647485|NCT04330638|75765220|FG005|Randomization 2: IL-6 Blockade|Overall Study||32||
59647486|NCT04330638|75765215|FG000|COMPLETED|Overall Study||56||
59647487|NCT04330638|75765216|FG001|COMPLETED|Overall Study||30||
59647488|NCT04330638|75765217|FG002|COMPLETED|Overall Study||52||
59647489|NCT04330638|75765218|FG003|COMPLETED|Overall Study||27||
59647490|NCT04330638|75765219|FG004|COMPLETED|Overall Study||65||
59647491|NCT04330638|75765220|FG005|COMPLETED|Overall Study||25||
59647492|NCT04330638|75765215|FG000|NOT COMPLETED|Overall Study||18||
59647493|NCT04330638|75765216|FG001|NOT COMPLETED|Overall Study||14||
59647494|NCT04330638|75765217|FG002|NOT COMPLETED|Overall Study||23||
59647495|NCT04330638|75765218|FG003|NOT COMPLETED|Overall Study||9||
59647496|NCT04330638|75765219|FG004|NOT COMPLETED|Overall Study||16||
59647497|NCT04330638|75765220|FG005|NOT COMPLETED|Overall Study||7||
59647498|NCT04231669|75765234|FG000|STARTED|Overall Study||100||5
59647499|NCT04231669|75765235|FG001|STARTED|Overall Study||100||5
59647500|NCT04231669|75765234|FG000|COMPLETED|Overall Study||100||5
59647501|NCT04231669|75765235|FG001|COMPLETED|Overall Study||94||5
59647502|NCT04231669|75765234|FG000|NOT COMPLETED|Overall Study||0||0
59647503|NCT04231669|75765235|FG001|NOT COMPLETED|Overall Study||6||0
59647504|NCT04194541|75765241|FG000|STARTED|Visit 0 (Baseline)||28||
59647505|NCT04194541|75765241|FG000|COMPLETED|Visit 0 (Baseline)||28||
59647506|NCT04194541|75765241|FG000|NOT COMPLETED|Visit 0 (Baseline)||0||
59647507|NCT04194541|75765241|FG000|STARTED|Day 1 Through 13||28||
59647508|NCT04194541|75765241|FG000|COMPLETED|Day 1 Through 13||19||
59647509|NCT04194541|75765241|FG000|NOT COMPLETED|Day 1 Through 13||9||
59647510|NCT04194541|75765241|FG000|STARTED|Visit 1 (Day 14)||19||
59647511|NCT04194541|75765241|FG000|COMPLETED|Visit 1 (Day 14)||19||
59647512|NCT04194541|75765241|FG000|NOT COMPLETED|Visit 1 (Day 14)||0||
59647513|NCT04194541|75765241|FG000|STARTED|Day 15 Through Week 6||19||
59647514|NCT04194541|75765241|FG000|COMPLETED|Day 15 Through Week 6||14||
59647515|NCT04194541|75765241|FG000|NOT COMPLETED|Day 15 Through Week 6||5||
59647516|NCT04194541|75765241|FG000|STARTED|Visit 2 (6 Weeks)||14||
59647517|NCT04194541|75765241|FG000|COMPLETED|Visit 2 (6 Weeks)||14||
59647518|NCT04194541|75765241|FG000|NOT COMPLETED|Visit 2 (6 Weeks)||0||
59647519|NCT04148521|75765250|FG000|STARTED|Overall Study||534||
59647520|NCT04148521|75765251|FG001|STARTED|Overall Study||555||
59647521|NCT04148521|75765250|FG000|COMPLETED|Overall Study||534||
59647522|NCT04148521|75765251|FG001|COMPLETED|Overall Study||555||
59647523|NCT04148521|75765250|FG000|NOT COMPLETED|Overall Study||0||
59647524|NCT04148521|75765251|FG001|NOT COMPLETED|Overall Study||0||
59647525|NCT04006392|75765259|FG000|STARTED|Overall Study||11||
59647526|NCT04006392|75765260|FG001|STARTED|Overall Study||7||
59647527|NCT04006392|75765259|FG000|COMPLETED|Overall Study||11||
59647528|NCT04006392|75765260|FG001|COMPLETED|Overall Study||6||
59647529|NCT04006392|75765259|FG000|NOT COMPLETED|Overall Study||0||
59647530|NCT04006392|75765260|FG001|NOT COMPLETED|Overall Study||1||
59647531|NCT03959423|75765268|FG000|STARTED|Overall Study||160||
59647532|NCT03959423|75765269|FG001|STARTED|Overall Study||128||
59647533|NCT03959423|75765268|FG000|COMPLETED|Overall Study||151||
59647534|NCT03959423|75765269|FG001|COMPLETED|Overall Study||124||
59647535|NCT03959423|75765268|FG000|NOT COMPLETED|Overall Study||9||
59647536|NCT03959423|75765269|FG001|NOT COMPLETED|Overall Study||4||
59647537|NCT03786783|75765275|FG000|STARTED|Overall Study||42||
59647538|NCT03786783|75765275|FG000|COMPLETED|Overall Study||22||
59647539|NCT03786783|75765275|FG000|NOT COMPLETED|Overall Study||20||
59647540|NCT03785587|75765279|FG000|STARTED|Overall Study||21||
59647541|NCT03785587|75765279|FG000|COMPLETED|Overall Study||16||
59647542|NCT03785587|75765279|FG000|NOT COMPLETED|Overall Study||5||
59647543|NCT03432494|75765289|FG000|STARTED|Overall Study||12||
59647544|NCT03432494|75765289|FG000|COMPLETED|Overall Study||10||
59647545|NCT03432494|75765289|FG000|NOT COMPLETED|Overall Study||2||
59647546|NCT03287830|75765295|FG000|STARTED|Overall Study||1050||
59647547|NCT03287830|75765296|FG001|STARTED|Overall Study||1055||
59815775|NCT03026283|75938217|FG006|STARTED|Optimal Medical Care/FFR-CT Diagnosis||0|Note: Number of participants to start period is not equal to number who completed previous period.|
59817901|NCT04488770|75940327|FG001|NOT COMPLETED|Part 1-Cohort 2: Period 1 (Up to 5 Days)||0||
59647548|NCT03287830|75765295|FG000|COMPLETED|Overall Study||1044||
59647549|NCT03287830|75765296|FG001|COMPLETED|Overall Study||1042||
59647550|NCT03287830|75765295|FG000|NOT COMPLETED|Overall Study||6||
59647551|NCT03287830|75765296|FG001|NOT COMPLETED|Overall Study||13||
59647552|NCT03242824|75765302|FG000|STARTED|Overall Study||20||
59647553|NCT03242824|75765302|FG000|COMPLETED|Overall Study||20||
59647554|NCT03242824|75765302|FG000|NOT COMPLETED|Overall Study||0||
59647555|NCT03181633|75765306|FG000|STARTED|Overall Study||8||
59647556|NCT03181633|75765306|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8||
59647557|NCT03181633|75765306|FG000|COMPLETED|Overall Study||6||
59647558|NCT03181633|75765306|FG000|NOT COMPLETED|Overall Study||2||
59647559|NCT03141983|75765312|FG000|STARTED|Overall Study||38||
59647560|NCT03141983|75765313|FG001|STARTED|Overall Study||42||
59647561|NCT03141983|75765312|FG000|COMPLETED|Overall Study||30||
59647562|NCT03141983|75765313|FG001|COMPLETED|Overall Study||34||
59647563|NCT03141983|75765312|FG000|NOT COMPLETED|Overall Study||8||
59647564|NCT03141983|75765313|FG001|NOT COMPLETED|Overall Study||8||
59647565|NCT03122223|75765323|FG000|STARTED|Overall Study||50||
59647566|NCT03122223|75765324|FG001|STARTED|Overall Study||50||
59647567|NCT03122223|75765325|FG002|STARTED|Overall Study||50||
59647568|NCT03122223|75765326|FG003|STARTED|Overall Study||10||
59647569|NCT03122223|75765323|FG000|Month 6.5 Immunogenicity Cohort|Overall Study||49||
59647570|NCT03122223|75765324|FG001|Month 6.5 Immunogenicity Cohort|Overall Study||48||
59647571|NCT03122223|75765325|FG002|Month 6.5 Immunogenicity Cohort|Overall Study||47||
59647572|NCT03122223|75765326|FG003|Month 6.5 Immunogenicity Cohort|Overall Study||8||
59647573|NCT03122223|75765323|FG000|Month 12 Immunogenicity Cohort|Overall Study||47||
59647574|NCT03122223|75765324|FG001|Month 12 Immunogenicity Cohort|Overall Study||45||
59647575|NCT03122223|75765325|FG002|Month 12 Immunogenicity Cohort|Overall Study||46||
59647576|NCT03122223|75765326|FG003|Month 12 Immunogenicity Cohort|Overall Study||10||
59647577|NCT03122223|75765323|FG000|COMPLETED|Overall Study||47||
59647578|NCT03122223|75765324|FG001|COMPLETED|Overall Study||45||
59647579|NCT03122223|75765325|FG002|COMPLETED|Overall Study||46||
59647580|NCT03122223|75765326|FG003|COMPLETED|Overall Study||10||
59647581|NCT03122223|75765323|FG000|NOT COMPLETED|Overall Study||3||
59647582|NCT03122223|75765324|FG001|NOT COMPLETED|Overall Study||5||
59647583|NCT03122223|75765325|FG002|NOT COMPLETED|Overall Study||4||
59647584|NCT03122223|75765326|FG003|NOT COMPLETED|Overall Study||0||
59647585|NCT03077087|75765336|FG000|STARTED|Overall Study||2||
59647586|NCT03077087|75765336|FG000|COMPLETED|Overall Study||0||
59647587|NCT03077087|75765336|FG000|NOT COMPLETED|Overall Study||2||
59647588|NCT02853604|75765342|FG000|STARTED|Overall Study||37||
59647589|NCT02853604|75765343|FG001|STARTED|Overall Study||73||
59647590|NCT02853604|75765342|FG000|Treated|Overall Study||37||
59647591|NCT02853604|75765343|FG001|Treated|Overall Study||72||
59647592|NCT02853604|75765342|FG000|COMPLETED|Overall Study||9||
59647593|NCT02853604|75765343|FG001|COMPLETED|Overall Study||21||
59647594|NCT02853604|75765342|FG000|NOT COMPLETED|Overall Study||28||
59647595|NCT02853604|75765343|FG001|NOT COMPLETED|Overall Study||52||
59647596|NCT02759458|75765351|FG000|STARTED|Overall Study||20||
59647597|NCT02759458|75765352|FG001|STARTED|Overall Study||20||
59647598|NCT02759458|75765351|FG000|COMPLETED|Overall Study||20||
59647599|NCT02759458|75765352|FG001|COMPLETED|Overall Study||20||
59647600|NCT02759458|75765351|FG000|NOT COMPLETED|Overall Study||0||
59647601|NCT02759458|75765352|FG001|NOT COMPLETED|Overall Study||0||
59647602|NCT02678377|75765360|FG000|STARTED|Overall Study||45||
59647603|NCT02678377|75765361|FG001|STARTED|Overall Study||43||
59647604|NCT02678377|75765360|FG000|COMPLETED|Overall Study||41||
59647605|NCT02678377|75765361|FG001|COMPLETED|Overall Study||37||
59647606|NCT02678377|75765360|FG000|NOT COMPLETED|Overall Study||4||
59647607|NCT02678377|75765361|FG001|NOT COMPLETED|Overall Study||6||
59647608|NCT02632552|75765369|FG000|STARTED|Overall Study||80||
59647609|NCT02632552|75765370|FG001|STARTED|Overall Study||60||
59647610|NCT02632552|75765369|FG000|COMPLETED|Overall Study||57||
59647611|NCT02632552|75765370|FG001|COMPLETED|Overall Study||50||
59647612|NCT02632552|75765369|FG000|NOT COMPLETED|Overall Study||23||
59647613|NCT02632552|75765370|FG001|NOT COMPLETED|Overall Study||10||
59647614|NCT02591147|75765379|FG000|STARTED|Overall Study||20||
59647615|NCT02591147|75765380|FG001|STARTED|Overall Study||21||
59647616|NCT02591147|75765379|FG000|COMPLETED|Overall Study||18||
59647617|NCT02591147|75765380|FG001|COMPLETED|Overall Study||16||
59647618|NCT02591147|75765379|FG000|NOT COMPLETED|Overall Study||2||
59647619|NCT02591147|75765380|FG001|NOT COMPLETED|Overall Study||5||
59647620|NCT02588872|75765388|FG000|STARTED|Overall Study||59||
59647621|NCT02588872|75765389|FG001|STARTED|Overall Study||52||
59647622|NCT02588872|75765388|FG000|COMPLETED|Overall Study||59||
59647623|NCT02588872|75765389|FG001|COMPLETED|Overall Study||52||
59988618|NCT02743871|76103800|FG007|NOT COMPLETED|Overall Study||0||
59988619|NCT02743871|76103801|FG008|NOT COMPLETED|Overall Study||0||
59647624|NCT02588872|75765388|FG000|NOT COMPLETED|Overall Study||0||
59988620|NCT02743871|76103802|FG009|NOT COMPLETED|Overall Study||0||
59988621|NCT02743871|76103803|FG010|NOT COMPLETED|Overall Study||1||
59647625|NCT02588872|75765389|FG001|NOT COMPLETED|Overall Study||0||
59647626|NCT02525562|75765395|FG000|STARTED|Overall Study||223||
59647627|NCT02525562|75765396|FG001|STARTED|Overall Study||0||
59647628|NCT02525562|75765397|FG002|STARTED|Overall Study||0||
59647629|NCT02525562|75765395|FG000|COMPLETED|Overall Study||0||
59647630|NCT02525562|75765396|FG001|COMPLETED|Overall Study||0||
59647631|NCT02525562|75765397|FG002|COMPLETED|Overall Study||0||
59647632|NCT02525562|75765395|FG000|NOT COMPLETED|Overall Study||223||
59647633|NCT02525562|75765396|FG001|NOT COMPLETED|Overall Study||0||
59647634|NCT02525562|75765397|FG002|NOT COMPLETED|Overall Study||0||
59647635|NCT01992653|75765410|FG000|STARTED|Overall Study||3||
59647636|NCT01992653|75765411|FG001|STARTED|Overall Study||3||
59647637|NCT01992653|75765412|FG002|STARTED|Overall Study||6||
59647638|NCT01992653|75765413|FG003|STARTED|Overall Study||1||
59647639|NCT01992653|75765414|FG004|STARTED|Overall Study||6||
59647640|NCT01992653|75765415|FG005|STARTED|Overall Study||6||
59647641|NCT01992653|75765416|FG006|STARTED|Overall Study||40||
59647642|NCT01992653|75765417|FG007|STARTED|Overall Study||17||
59647643|NCT01992653|75765410|FG000|COMPLETED|Overall Study||3||
59647644|NCT01992653|75765411|FG001|COMPLETED|Overall Study||3||
59647645|NCT01992653|75765412|FG002|COMPLETED|Overall Study||5||
59647646|NCT01992653|75765413|FG003|COMPLETED|Overall Study||1||
59647647|NCT01992653|75765414|FG004|COMPLETED|Overall Study||5||
59647648|NCT01992653|75765415|FG005|COMPLETED|Overall Study||6||
59647649|NCT01992653|75765416|FG006|COMPLETED|Overall Study||32||
59647650|NCT01992653|75765417|FG007|COMPLETED|Overall Study||13||
59647651|NCT01992653|75765410|FG000|NOT COMPLETED|Overall Study||0||
59647652|NCT01992653|75765411|FG001|NOT COMPLETED|Overall Study||0||
59647653|NCT01992653|75765412|FG002|NOT COMPLETED|Overall Study||1||
59647654|NCT01992653|75765413|FG003|NOT COMPLETED|Overall Study||0||
59647655|NCT01992653|75765414|FG004|NOT COMPLETED|Overall Study||1||
59647656|NCT01992653|75765415|FG005|NOT COMPLETED|Overall Study||0||
59647657|NCT01992653|75765416|FG006|NOT COMPLETED|Overall Study||8||
59647658|NCT01992653|75765417|FG007|NOT COMPLETED|Overall Study||4||
59647659|NCT01696435|75765439|FG000|STARTED|Overall Study||4573||
59647660|NCT01696435|75765440|FG001|STARTED|Overall Study||4563||
59647661|NCT01696435|75765441|FG002|STARTED|Overall Study||4609||
59647662|NCT01696435|75765442|FG003|STARTED|Overall Study||4608||
59647663|NCT01696435|75765439|FG000|COMPLETED|Overall Study||4573||
59647664|NCT01696435|75765440|FG001|COMPLETED|Overall Study||4563||
59647665|NCT01696435|75765441|FG002|COMPLETED|Overall Study||4609||
59647666|NCT01696435|75765442|FG003|COMPLETED|Overall Study||4608||
59647667|NCT01696435|75765439|FG000|NOT COMPLETED|Overall Study||0||
59647668|NCT01696435|75765440|FG001|NOT COMPLETED|Overall Study||0||
59542804|NCT01049360|75640991|FG012|NOT COMPLETED|Period 3||0||
59542805|NCT01049360|75640992|FG013|NOT COMPLETED|Period 3||0||
59542806|NCT01049360|75640993|FG014|NOT COMPLETED|Period 3||0||
59542807|NCT01049360|75640994|FG015|NOT COMPLETED|Period 3||0||
59542808|NCT01049360|75640995|FG016|NOT COMPLETED|Period 3||0||
59542809|NCT01049360|75640996|FG017|NOT COMPLETED|Period 3||0||
59542810|NCT01049360|75640997|FG018|NOT COMPLETED|Period 3||0||
59542811|NCT01049360|75640998|FG019|NOT COMPLETED|Period 3||0||
59542812|NCT01049360|75640979|FG000|STARTED|Period 4||6||
59542813|NCT01049360|75640980|FG001|STARTED|Period 4||4||
59542814|NCT01049360|75640981|FG002|STARTED|Period 4||7||
59542815|NCT01049360|75640982|FG003|STARTED|Period 4||4||
59542816|NCT01049360|75640983|FG004|STARTED|Period 4||7||
59542817|NCT01049360|75640984|FG005|STARTED|Period 4||5||
59542818|NCT01049360|75640985|FG006|STARTED|Period 4||6||
59542819|NCT01049360|75640986|FG007|STARTED|Period 4||4||
59542820|NCT01049360|75640987|FG008|STARTED|Period 4||4||
59542821|NCT01049360|75640988|FG009|STARTED|Period 4||6||
59542822|NCT01049360|75640989|FG010|STARTED|Period 4||5||
59542823|NCT01049360|75640990|FG011|STARTED|Period 4||6||
59647669|NCT01696435|75765441|FG002|NOT COMPLETED|Overall Study||0||
59647670|NCT01696435|75765442|FG003|NOT COMPLETED|Overall Study||0||
59647671|NCT01654276|75765452|FG000|STARTED|Overall Study||24||
59647672|NCT01654276|75765452|FG000|Visit 2 (2 Months)|Overall Study||19||
59647673|NCT01654276|75765452|FG000|Visit 3 (4 Months)|Overall Study||18||
59647674|NCT01654276|75765452|FG000|Visit 4 (6months)|Overall Study||18||
59647675|NCT01654276|75765452|FG000|COMPLETED|Overall Study||18||
59647676|NCT01654276|75765452|FG000|NOT COMPLETED|Overall Study||6||
59647677|NCT01399658|75765456|FG000|STARTED|Overall Study||93||
59647678|NCT01399658|75765456|FG000|COMPLETED|Overall Study||87||
59647679|NCT01399658|75765456|FG000|NOT COMPLETED|Overall Study||6||
59647680|NCT00590122|75765462|FG000|STARTED|Overall Study||10||
59647681|NCT00590122|75765463|FG001|STARTED|Overall Study||10||
59542824|NCT01049360|75640991|FG012|STARTED|Period 4||4||
59542825|NCT01049360|75640992|FG013|STARTED|Period 4||6||
59542826|NCT01049360|75640993|FG014|STARTED|Period 4||5||
59542827|NCT01049360|75640994|FG015|STARTED|Period 4||6||
59542828|NCT01049360|75640995|FG016|STARTED|Period 4||5||
59542829|NCT01049360|75640996|FG017|STARTED|Period 4||6||
59542830|NCT01049360|75640997|FG018|STARTED|Period 4||5||
59542831|NCT01049360|75640998|FG019|STARTED|Period 4||5||
59647682|NCT00590122|75765462|FG000|COMPLETED|Overall Study||9||
59647683|NCT00590122|75765463|FG001|COMPLETED|Overall Study||10||
59647684|NCT00590122|75765462|FG000|NOT COMPLETED|Overall Study||1||
59647685|NCT00590122|75765463|FG001|NOT COMPLETED|Overall Study||0||
59647686|NCT00110591|75765474|FG000|STARTED|Overall Study||4||
59647687|NCT00110591|75765475|FG001|STARTED|Overall Study||4||
59647688|NCT00110591|75765476|FG002|STARTED|Overall Study||4||
59647689|NCT00110591|75765477|FG003|STARTED|Overall Study||4||
59647690|NCT00110591|75765478|FG004|STARTED|Overall Study||4||
59647691|NCT00110591|75765474|FG000|COMPLETED|Overall Study||4||
59647692|NCT00110591|75765475|FG001|COMPLETED|Overall Study||4||
59647693|NCT00110591|75765476|FG002|COMPLETED|Overall Study||4||
59647694|NCT00110591|75765477|FG003|COMPLETED|Overall Study||4||
59647695|NCT00110591|75765478|FG004|COMPLETED|Overall Study||4||
59647696|NCT00110591|75765474|FG000|NOT COMPLETED|Overall Study||0||
59647697|NCT00110591|75765475|FG001|NOT COMPLETED|Overall Study||0||
59647698|NCT00110591|75765476|FG002|NOT COMPLETED|Overall Study||0||
59647699|NCT00110591|75765477|FG003|NOT COMPLETED|Overall Study||0||
59647700|NCT00110591|75765478|FG004|NOT COMPLETED|Overall Study||0||
59647701|NCT01386658|75765492|FG000|STARTED|Initial Icatibant Exposure||11||
59647702|NCT01386658|75765493|FG001|STARTED|Initial Icatibant Exposure||21||
59647703|NCT01386658|75765492|FG000|COMPLETED|Initial Icatibant Exposure||11||
59647704|NCT01386658|75765493|FG001|COMPLETED|Initial Icatibant Exposure||9||
59647705|NCT01386658|75765492|FG000|NOT COMPLETED|Initial Icatibant Exposure||0||
59647706|NCT01386658|75765493|FG001|NOT COMPLETED|Initial Icatibant Exposure||12||
59647707|NCT01386658|75765492|FG000|STARTED|Icatibant Exposure 2||0||
59647708|NCT01386658|75765493|FG001|STARTED|Icatibant Exposure 2||9||
59647709|NCT01386658|75765492|FG000|COMPLETED|Icatibant Exposure 2||0||
59647710|NCT01386658|75765493|FG001|COMPLETED|Icatibant Exposure 2||9||
59647711|NCT01386658|75765492|FG000|NOT COMPLETED|Icatibant Exposure 2||0||
59647712|NCT01386658|75765493|FG001|NOT COMPLETED|Icatibant Exposure 2||0||
59647713|NCT01386658|75765492|FG000|STARTED|Icatibant Exposure 3||0||
59647714|NCT01386658|75765493|FG001|STARTED|Icatibant Exposure 3||9||
59647715|NCT01386658|75765492|FG000|COMPLETED|Icatibant Exposure 3||0||
59647716|NCT01386658|75765493|FG001|COMPLETED|Icatibant Exposure 3||9||
59647717|NCT01386658|75765492|FG000|NOT COMPLETED|Icatibant Exposure 3||0||
59647718|NCT01386658|75765493|FG001|NOT COMPLETED|Icatibant Exposure 3||0||
59647719|NCT01386684|75765503|FG000|STARTED|Overall Study||552||
59647720|NCT01386684|75765503|FG000|COMPLETED|Overall Study||259||
59647721|NCT01386684|75765503|FG000|NOT COMPLETED|Overall Study||293||
59647722|NCT01386879|75765510|FG000|STARTED|Overall Study||17||
59647723|NCT01386879|75765511|FG001|STARTED|Overall Study||17||
59647724|NCT01386879|75765512|FG002|STARTED|Overall Study||16||
59647725|NCT01386879|75765510|FG000|COMPLETED|Overall Study||17||
59647726|NCT01386879|75765511|FG001|COMPLETED|Overall Study||17||
59647727|NCT01386879|75765512|FG002|COMPLETED|Overall Study||16||
59647728|NCT01386879|75765510|FG000|NOT COMPLETED|Overall Study||0||
59647729|NCT01386879|75765511|FG001|NOT COMPLETED|Overall Study||0||
59647730|NCT01386879|75765512|FG002|NOT COMPLETED|Overall Study||0||
59647731|NCT04980014|75765520|FG000|STARTED|Overall Study||730||
59647732|NCT04980014|75765520|FG000|Safety Analysis Set|Overall Study||655||
59647733|NCT04980014|75765520|FG000|Effectiveness Analysis Set|Overall Study||482||
59647734|NCT04980014|75765520|FG000|COMPLETED|Overall Study||655||
59647735|NCT04980014|75765520|FG000|NOT COMPLETED|Overall Study||75||
59647736|NCT04503603|75765526|FG000|STARTED|Overall Study||9||
59647737|NCT04503603|75765527|FG001|STARTED|Overall Study||3||
59647738|NCT04503603|75765526|FG000|COMPLETED|Overall Study||9||
59647739|NCT04503603|75765527|FG001|COMPLETED|Overall Study||3||
59647740|NCT04503603|75765526|FG000|NOT COMPLETED|Overall Study||0||
59647741|NCT04503603|75765527|FG001|NOT COMPLETED|Overall Study||0||
59647742|NCT04454918|75765533|FG000|STARTED|Treatment Period 1 (Day 1)||6||
59647743|NCT04454918|75765533|FG000|COMPLETED|Treatment Period 1 (Day 1)||6||
59647744|NCT04454918|75765533|FG000|NOT COMPLETED|Treatment Period 1 (Day 1)||0||
59647745|NCT04454918|75765533|FG000|STARTED|Washout Period (Day 2 to 8)||6||
59647746|NCT04454918|75765533|FG000|COMPLETED|Washout Period (Day 2 to 8)||6||
59647747|NCT04454918|75765533|FG000|NOT COMPLETED|Washout Period (Day 2 to 8)||0||
59647748|NCT04454918|75765533|FG000|STARTED|Treatment Period 2(Day9[Day1of Period2])||6||
59647749|NCT04454918|75765533|FG000|COMPLETED|Treatment Period 2(Day9[Day1of Period2])||6||
59647750|NCT04454918|75765533|FG000|NOT COMPLETED|Treatment Period 2(Day9[Day1of Period2])||0||
59647751|NCT05301322|75765543|FG000|STARTED|Overall Study||705||
59647752|NCT05301322|75765544|FG001|STARTED|Overall Study|1 participant received SIIV but was discontinued prior to receiving placebo at Vaccination 1 (as randomized) and is thus not included in the safety tables.|698||
59647753|NCT05301322|75765543|FG000|Not Vaccinated|Overall Study|Participants were counted as not completed study due to the following reasons: protocol violation (2 participants) and other unspecified (1 participant).|3||
59647754|NCT05301322|75765544|FG001|Not Vaccinated|Overall Study|Participant was counted as not completed study due to protocol violation.|1||
59647755|NCT05301322|75765543|FG000|Vaccination 1|Overall Study||702||
59647756|NCT05301322|75765544|FG001|Vaccination 1|Overall Study||697||
59647757|NCT05301322|75765543|FG000|Vaccination 2|Overall Study||688||
59647758|NCT05301322|75765544|FG001|Vaccination 2|Overall Study||693||
59647759|NCT05301322|75765543|FG000|COMPLETED|Overall Study||686||
59647760|NCT05301322|75765544|FG001|COMPLETED|Overall Study||692||
59647761|NCT05301322|75765543|FG000|NOT COMPLETED|Overall Study||19||
59647762|NCT05301322|75765544|FG001|NOT COMPLETED|Overall Study||6||
59647763|NCT05286528|75765556|FG000|STARTED|Overall Study||1484||
59647764|NCT05286528|75765556|FG000|COMPLETED|Overall Study||1484||
59647765|NCT05286528|75765556|FG000|NOT COMPLETED|Overall Study||0||
59647766|NCT05062343|75765563|FG000|STARTED|Overall Study||40||
59647767|NCT05062343|75765564|FG001|STARTED|Overall Study||40||
59647768|NCT05062343|75765563|FG000|COMPLETED|Overall Study||40||
59647769|NCT05062343|75765564|FG001|COMPLETED|Overall Study||40||
59647770|NCT05062343|75765563|FG000|NOT COMPLETED|Overall Study||0||
59647771|NCT05062343|75765564|FG001|NOT COMPLETED|Overall Study||0||
59647772|NCT04956575|75765582|FG000|STARTED|Overall Study||45||
59647773|NCT04956575|75765583|FG001|STARTED|Overall Study||45||
59647774|NCT04956575|75765584|FG002|STARTED|Overall Study||45||
59647775|NCT04956575|75765585|FG003|STARTED|Overall Study||45||
59647776|NCT04956575|75765586|FG004|STARTED|Overall Study||53||
59647777|NCT04956575|75765587|FG005|STARTED|Overall Study||153||
59647778|NCT04956575|75765588|FG006|STARTED|Overall Study||149||
59647779|NCT04956575|75765589|FG007|STARTED|Overall Study||148||
59647780|NCT04956575|75765590|FG008|STARTED|Overall Study||51||
59647781|NCT04956575|75765591|FG009|STARTED|Overall Study||50||
59647782|NCT04956575|75765592|FG010|STARTED|Overall Study||51||
59647783|NCT04956575|75765593|FG011|STARTED|Overall Study||50||
59647784|NCT04956575|75765582|FG000|Received at Least 1 Dose of Investigational Product|Overall Study||45|Numbers are based on planned vaccination group.|
59647785|NCT04956575|75765583|FG001|Received at Least 1 Dose of Investigational Product|Overall Study||45|Numbers are based on planned vaccination group.|
59647786|NCT04956575|75765584|FG002|Received at Least 1 Dose of Investigational Product|Overall Study||45|Numbers are based on planned vaccination group.|
59647787|NCT04956575|75765585|FG003|Received at Least 1 Dose of Investigational Product|Overall Study||45|Numbers are based on planned vaccination group.|
59647788|NCT04956575|75765586|FG004|Received at Least 1 Dose of Investigational Product|Overall Study||53|Numbers are based on planned vaccination group.|
59647789|NCT04956575|75765587|FG005|Received at Least 1 Dose of Investigational Product|Overall Study||151|Numbers are based on planned vaccination group.|
59647790|NCT04956575|75765588|FG006|Received at Least 1 Dose of Investigational Product|Overall Study||147|Numbers are based on planned vaccination group.|
59647791|NCT04956575|75765589|FG007|Received at Least 1 Dose of Investigational Product|Overall Study||147|Numbers are based on planned vaccination group.|
59647792|NCT04956575|75765590|FG008|Received at Least 1 Dose of Investigational Product|Overall Study||51|Numbers are based on planned vaccination group.|
59647793|NCT04956575|75765591|FG009|Received at Least 1 Dose of Investigational Product|Overall Study||50|Numbers are based on planned vaccination group.|
59647794|NCT04956575|75765592|FG010|Received at Least 1 Dose of Investigational Product|Overall Study||50|Numbers are based on planned vaccination group.|
59647795|NCT04956575|75765593|FG011|Received at Least 1 Dose of Investigational Product|Overall Study||49|Numbers are based on planned vaccination group.|
59647796|NCT04956575|75765582|FG000|Safety Analysis Set|Overall Study||45|Safety Analysis Set consisted of all randomly assigned participants who received the investigational product. The Safety Set was used for analysis of safety except for the solicited adverse reactions (ARs). Participants were included in the vaccination group corresponding to the study injection they actually received.|
59647797|NCT04956575|75765583|FG001|Safety Analysis Set|Overall Study||45|Safety Analysis Set consisted of all randomly assigned participants who received the investigational product. The Safety Set was used for analysis of safety except for the solicited adverse reactions (ARs). Participants were included in the vaccination group corresponding to the study injection they actually received.|
59647798|NCT04956575|75765584|FG002|Safety Analysis Set|Overall Study||46|Safety Analysis Set consisted of all randomly assigned participants who received the investigational product. The Safety Set was used for analysis of safety except for the solicited adverse reactions (ARs). Participants were included in the vaccination group corresponding to the study injection they actually received.|
59647799|NCT04956575|75765585|FG003|Safety Analysis Set|Overall Study||44|Safety Analysis Set consisted of all randomly assigned participants who received the investigational product. The Safety Set was used for analysis of safety except for the solicited adverse reactions (ARs). Participants were included in the vaccination group corresponding to the study injection they actually received.|
59647800|NCT04956575|75765586|FG004|Safety Analysis Set|Overall Study||54|Safety Analysis Set consisted of all randomly assigned participants who received the investigational product. The Safety Set was used for analysis of safety except for the solicited adverse reactions (ARs). Participants were included in the vaccination group corresponding to the study injection they actually received.|
59647801|NCT04956575|75765587|FG005|Safety Analysis Set|Overall Study||150|Safety Analysis Set consisted of all randomly assigned participants who received the investigational product. The Safety Set was used for analysis of safety except for the solicited adverse reactions (ARs). Participants were included in the vaccination group corresponding to the study injection they actually received.|
59647802|NCT04956575|75765588|FG006|Safety Analysis Set|Overall Study||147|Safety Analysis Set consisted of all randomly assigned participants who received the investigational product. The Safety Set was used for analysis of safety except for the solicited adverse reactions (ARs). Participants were included in the vaccination group corresponding to the study injection they actually received.|
59647803|NCT04956575|75765589|FG007|Safety Analysis Set|Overall Study||147|Safety Analysis Set consisted of all randomly assigned participants who received the investigational product. The Safety Set was used for analysis of safety except for the solicited adverse reactions (ARs). Participants were included in the vaccination group corresponding to the study injection they actually received.|
59647804|NCT04956575|75765590|FG008|Safety Analysis Set|Overall Study||51|Safety Analysis Set consisted of all randomly assigned participants who received the investigational product. The Safety Set was used for analysis of safety except for the solicited adverse reactions (ARs). Participants were included in the vaccination group corresponding to the study injection they actually received.|
59647805|NCT04956575|75765591|FG009|Safety Analysis Set|Overall Study||50|Safety Analysis Set consisted of all randomly assigned participants who received the investigational product. The Safety Set was used for analysis of safety except for the solicited adverse reactions (ARs). Participants were included in the vaccination group corresponding to the study injection they actually received.|
59647806|NCT04956575|75765592|FG010|Safety Analysis Set|Overall Study||50|Safety Analysis Set consisted of all randomly assigned participants who received the investigational product. The Safety Set was used for analysis of safety except for the solicited adverse reactions (ARs). Participants were included in the vaccination group corresponding to the study injection they actually received.|
59647807|NCT04956575|75765593|FG011|Safety Analysis Set|Overall Study||49|Safety Analysis Set consisted of all randomly assigned participants who received the investigational product. The Safety Set was used for analysis of safety except for the solicited adverse reactions (ARs). Participants were included in the vaccination group corresponding to the study injection they actually received.|
59647808|NCT04956575|75765582|FG000|Solicited Safety Set|Overall Study||44|Solicited Safety Set consisted of all participants in the Safety Set who contributed any solicited AR data. Participants were included in the vaccination group corresponding to the study injection they actually received.|
59647809|NCT04956575|75765583|FG001|Solicited Safety Set|Overall Study||45|Solicited Safety Set consisted of all participants in the Safety Set who contributed any solicited AR data. Participants were included in the vaccination group corresponding to the study injection they actually received.|
59647810|NCT04956575|75765584|FG002|Solicited Safety Set|Overall Study||46|Solicited Safety Set consisted of all participants in the Safety Set who contributed any solicited AR data. Participants were included in the vaccination group corresponding to the study injection they actually received.|
59647811|NCT04956575|75765585|FG003|Solicited Safety Set|Overall Study||44|Solicited Safety Set consisted of all participants in the Safety Set who contributed any solicited AR data. Participants were included in the vaccination group corresponding to the study injection they actually received.|
59647812|NCT04956575|75765586|FG004|Solicited Safety Set|Overall Study||53|Solicited Safety Set consisted of all participants in the Safety Set who contributed any solicited AR data. Participants were included in the vaccination group corresponding to the study injection they actually received.|
59647813|NCT04956575|75765587|FG005|Solicited Safety Set|Overall Study||149|Solicited Safety Set consisted of all participants in the Safety Set who contributed any solicited AR data. Participants were included in the vaccination group corresponding to the study injection they actually received.|
59647814|NCT04956575|75765588|FG006|Solicited Safety Set|Overall Study||146|Solicited Safety Set consisted of all participants in the Safety Set who contributed any solicited AR data. Participants were included in the vaccination group corresponding to the study injection they actually received.|
59647815|NCT04956575|75765589|FG007|Solicited Safety Set|Overall Study||145|Solicited Safety Set consisted of all participants in the Safety Set who contributed any solicited AR data. Participants were included in the vaccination group corresponding to the study injection they actually received.|
59647816|NCT04956575|75765590|FG008|Solicited Safety Set|Overall Study||51|Solicited Safety Set consisted of all participants in the Safety Set who contributed any solicited AR data. Participants were included in the vaccination group corresponding to the study injection they actually received.|
59647817|NCT04956575|75765591|FG009|Solicited Safety Set|Overall Study||50|Solicited Safety Set consisted of all participants in the Safety Set who contributed any solicited AR data. Participants were included in the vaccination group corresponding to the study injection they actually received.|
59647818|NCT04956575|75765592|FG010|Solicited Safety Set|Overall Study||50|Solicited Safety Set consisted of all participants in the Safety Set who contributed any solicited AR data. Participants were included in the vaccination group corresponding to the study injection they actually received.|
59647819|NCT04956575|75765593|FG011|Solicited Safety Set|Overall Study||49|Solicited Safety Set consisted of all participants in the Safety Set who contributed any solicited AR data. Participants were included in the vaccination group corresponding to the study injection they actually received.|
59647820|NCT04956575|75765582|FG000|Per-Protocol (PP) Set|Overall Study||41|PP Set consisted of all participants who received the investigational product and who complied with the injection schedule and timing of immunogenicity blood sampling, did not have influenza infection at baseline through Day 29, and had no major protocol deviations that impacted the immune response.|
59647821|NCT04956575|75765583|FG001|Per-Protocol (PP) Set|Overall Study||43|PP Set consisted of all participants who received the investigational product and who complied with the injection schedule and timing of immunogenicity blood sampling, did not have influenza infection at baseline through Day 29, and had no major protocol deviations that impacted the immune response.|
59647822|NCT04956575|75765584|FG002|Per-Protocol (PP) Set|Overall Study||44|PP Set consisted of all participants who received the investigational product and who complied with the injection schedule and timing of immunogenicity blood sampling, did not have influenza infection at baseline through Day 29, and had no major protocol deviations that impacted the immune response.|
59647823|NCT04956575|75765585|FG003|Per-Protocol (PP) Set|Overall Study||41|PP Set consisted of all participants who received the investigational product and who complied with the injection schedule and timing of immunogenicity blood sampling, did not have influenza infection at baseline through Day 29, and had no major protocol deviations that impacted the immune response.|
59647824|NCT04956575|75765586|FG004|Per-Protocol (PP) Set|Overall Study||52|PP Set consisted of all participants who received the investigational product and who complied with the injection schedule and timing of immunogenicity blood sampling, did not have influenza infection at baseline through Day 29, and had no major protocol deviations that impacted the immune response.|
59647825|NCT04956575|75765587|FG005|Per-Protocol (PP) Set|Overall Study||144|PP Set consisted of all participants who received the investigational product and who complied with the injection schedule and timing of immunogenicity blood sampling, did not have influenza infection at baseline through Day 29, and had no major protocol deviations that impacted the immune response.|
59647826|NCT04956575|75765588|FG006|Per-Protocol (PP) Set|Overall Study||138|PP Set consisted of all participants who received the investigational product and who complied with the injection schedule and timing of immunogenicity blood sampling, did not have influenza infection at baseline through Day 29, and had no major protocol deviations that impacted the immune response.|
59647827|NCT04956575|75765589|FG007|Per-Protocol (PP) Set|Overall Study||141|PP Set consisted of all participants who received the investigational product and who complied with the injection schedule and timing of immunogenicity blood sampling, did not have influenza infection at baseline through Day 29, and had no major protocol deviations that impacted the immune response.|
59647828|NCT04956575|75765590|FG008|Per-Protocol (PP) Set|Overall Study||48|PP Set consisted of all participants who received the investigational product and who complied with the injection schedule and timing of immunogenicity blood sampling, did not have influenza infection at baseline through Day 29, and had no major protocol deviations that impacted the immune response.|
59647829|NCT04956575|75765591|FG009|Per-Protocol (PP) Set|Overall Study||49|PP Set consisted of all participants who received the investigational product and who complied with the injection schedule and timing of immunogenicity blood sampling, did not have influenza infection at baseline through Day 29, and had no major protocol deviations that impacted the immune response.|
59647830|NCT04956575|75765592|FG010|Per-Protocol (PP) Set|Overall Study||47|PP Set consisted of all participants who received the investigational product and who complied with the injection schedule and timing of immunogenicity blood sampling, did not have influenza infection at baseline through Day 29, and had no major protocol deviations that impacted the immune response.|
59647831|NCT04956575|75765593|FG011|Per-Protocol (PP) Set|Overall Study||46|PP Set consisted of all participants who received the investigational product and who complied with the injection schedule and timing of immunogenicity blood sampling, did not have influenza infection at baseline through Day 29, and had no major protocol deviations that impacted the immune response.|
59647832|NCT04956575|75765582|FG000|COMPLETED|Overall Study||40|Participants were considered to have completed the study if they completed the final visit on Day 181 (Month 6), 6 months after the investigational product administration on Day 1|
59647833|NCT04956575|75765583|FG001|COMPLETED|Overall Study||39|Participants were considered to have completed the study if they completed the final visit on Day 181 (Month 6), 6 months after the investigational product administration on Day 1|
59647834|NCT04956575|75765584|FG002|COMPLETED|Overall Study||42|Participants were considered to have completed the study if they completed the final visit on Day 181 (Month 6), 6 months after the investigational product administration on Day 1|
59647835|NCT04956575|75765585|FG003|COMPLETED|Overall Study||38|Participants were considered to have completed the study if they completed the final visit on Day 181 (Month 6), 6 months after the investigational product administration on Day 1|
59647836|NCT04956575|75765586|FG004|COMPLETED|Overall Study||50|Participants were considered to have completed the study if they completed the final visit on Day 181 (Month 6), 6 months after the investigational product administration on Day 1|
59647837|NCT04956575|75765587|FG005|COMPLETED|Overall Study||135|Participants were considered to have completed the study if they completed the final visit on Day 181 (Month 6), 6 months after the investigational product administration on Day 1|
59647838|NCT04956575|75765588|FG006|COMPLETED|Overall Study||133|Participants were considered to have completed the study if they completed the final visit on Day 181 (Month 6), 6 months after the investigational product administration on Day 1|
59647839|NCT04956575|75765589|FG007|COMPLETED|Overall Study||139|Participants were considered to have completed the study if they completed the final visit on Day 181 (Month 6), 6 months after the investigational product administration on Day 1|
59647840|NCT04956575|75765590|FG008|COMPLETED|Overall Study||46|Participants were considered to have completed the study if they completed the final visit on Day 181 (Month 6), 6 months after the investigational product administration on Day 1|
59647841|NCT04956575|75765591|FG009|COMPLETED|Overall Study||47|Participants were considered to have completed the study if they completed the final visit on Day 181 (Month 6), 6 months after the investigational product administration on Day 1|
59647842|NCT04956575|75765592|FG010|COMPLETED|Overall Study||45|Participants were considered to have completed the study if they completed the final visit on Day 181 (Month 6), 6 months after the investigational product administration on Day 1|
59647843|NCT04956575|75765593|FG011|COMPLETED|Overall Study||41|Participants were considered to have completed the study if they completed the final visit on Day 181 (Month 6), 6 months after the investigational product administration on Day 1|
59647844|NCT04956575|75765582|FG000|NOT COMPLETED|Overall Study||5||
59647845|NCT04956575|75765583|FG001|NOT COMPLETED|Overall Study||6||
59647846|NCT04956575|75765584|FG002|NOT COMPLETED|Overall Study||3||
59647847|NCT04956575|75765585|FG003|NOT COMPLETED|Overall Study||7||
59647848|NCT04956575|75765586|FG004|NOT COMPLETED|Overall Study||3||
59647849|NCT04956575|75765587|FG005|NOT COMPLETED|Overall Study||18||
59647850|NCT04956575|75765588|FG006|NOT COMPLETED|Overall Study||16||
59647851|NCT04956575|75765589|FG007|NOT COMPLETED|Overall Study||9||
59647852|NCT04956575|75765590|FG008|NOT COMPLETED|Overall Study||5||
59647853|NCT04956575|75765591|FG009|NOT COMPLETED|Overall Study||3||
59647854|NCT04956575|75765592|FG010|NOT COMPLETED|Overall Study||6||
59647855|NCT04956575|75765593|FG011|NOT COMPLETED|Overall Study||9||
59647856|NCT04720105|75765644|FG000|STARTED|Overall Study||22||
59647857|NCT04720105|75765644|FG000|COMPLETED|Overall Study||17||
59647858|NCT04720105|75765644|FG000|NOT COMPLETED|Overall Study||5||
59647859|NCT04649177|75765648|FG000|STARTED|Overall Study||11||
59647860|NCT04649177|75765648|FG000|COMPLETED|Overall Study||10||
59647861|NCT04649177|75765648|FG000|NOT COMPLETED|Overall Study||1||
59647862|NCT04573309|75765654|FG000|STARTED|Overall Study||8||
59647863|NCT04573309|75765655|FG001|STARTED|Overall Study||1||
59647864|NCT04573309|75765654|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8||
59647865|NCT04573309|75765655|FG001|Received at Least 1 Dose of Study Drug|Overall Study||1||
59988622|NCT02743871|76103804|FG011|NOT COMPLETED|Overall Study||3||
59988623|NCT02743871|76103805|FG012|NOT COMPLETED|Overall Study||15||
59988624|NCT02743871|76103806|FG013|NOT COMPLETED|Overall Study||7||
59988625|NCT01704547|76103848|FG000|STARTED|Overall Study||25||
59988626|NCT01704547|76103848|FG000|COMPLETED|Overall Study||20||
59988627|NCT01704547|76103848|FG000|NOT COMPLETED|Overall Study||5||
59647866|NCT04573309|75765654|FG000|COMPLETED|Overall Study||7||
59647867|NCT04573309|75765655|FG001|COMPLETED|Overall Study||1||
59647868|NCT04573309|75765654|FG000|NOT COMPLETED|Overall Study||1||
59647869|NCT04573309|75765655|FG001|NOT COMPLETED|Overall Study||0||
59647870|NCT04446312|75765663|FG000|STARTED|Overall Study||250||
59647871|NCT04446312|75765664|FG001|STARTED|Overall Study||250||
59647872|NCT04446312|75765663|FG000|COMPLETED|Overall Study||212||
59647873|NCT04446312|75765664|FG001|COMPLETED|Overall Study||206||
59647874|NCT04446312|75765663|FG000|NOT COMPLETED|Overall Study||38||
59647875|NCT04446312|75765664|FG001|NOT COMPLETED|Overall Study||44||
59647876|NCT04220866|75765672|FG000|STARTED|Overall Study||8|Randomized|
59647877|NCT04220866|75765673|FG001|STARTED|Overall Study||10|Randomized|
59647878|NCT04220866|75765672|FG000|COMPLETED|Overall Study||0||
59647879|NCT04220866|75765673|FG001|COMPLETED|Overall Study||0||
59647880|NCT04220866|75765672|FG000|NOT COMPLETED|Overall Study||8||
59647881|NCT04220866|75765673|FG001|NOT COMPLETED|Overall Study||10||
59647882|NCT04115384|75765679|FG000|STARTED|Overall Study||3||
59647883|NCT04115384|75765679|FG000|COMPLETED|Overall Study||3||
59647884|NCT04115384|75765679|FG000|NOT COMPLETED|Overall Study||0||
59647885|NCT04004611|75765686|FG000|STARTED|OL Induction Period (Wk 0-12)||10||
59647886|NCT04004611|75765687|FG001|STARTED|OL Induction Period (Wk 0-12)||5||
59647887|NCT04004611|75765688|FG002|STARTED|OL Induction Period (Wk 0-12)||11||
59647888|NCT04004611|75765689|FG003|STARTED|OL Induction Period (Wk 0-12)||0||
59647889|NCT04004611|75765690|FG004|STARTED|OL Induction Period (Wk 0-12)||0||
59647890|NCT04004611|75765691|FG005|STARTED|OL Induction Period (Wk 0-12)||0||
59647891|NCT04004611|75765692|FG006|STARTED|OL Induction Period (Wk 0-12)||0||
59647892|NCT04004611|75765693|FG007|STARTED|OL Induction Period (Wk 0-12)||0||
59647893|NCT04004611|75765694|FG008|STARTED|OL Induction Period (Wk 0-12)||0||
59647894|NCT04004611|75765686|FG000|COMPLETED|OL Induction Period (Wk 0-12)||10||
59647895|NCT04004611|75765687|FG001|COMPLETED|OL Induction Period (Wk 0-12)||5||
59647896|NCT04004611|75765688|FG002|COMPLETED|OL Induction Period (Wk 0-12)||11||
59647897|NCT04004611|75765689|FG003|COMPLETED|OL Induction Period (Wk 0-12)||0||
59647898|NCT04004611|75765690|FG004|COMPLETED|OL Induction Period (Wk 0-12)||0||
59647899|NCT04004611|75765691|FG005|COMPLETED|OL Induction Period (Wk 0-12)||0||
59647900|NCT04004611|75765692|FG006|COMPLETED|OL Induction Period (Wk 0-12)||0||
59647901|NCT04004611|75765693|FG007|COMPLETED|OL Induction Period (Wk 0-12)||0||
59647902|NCT04004611|75765694|FG008|COMPLETED|OL Induction Period (Wk 0-12)||0||
59647903|NCT04004611|75765686|FG000|NOT COMPLETED|OL Induction Period (Wk 0-12)||0||
59647904|NCT04004611|75765687|FG001|NOT COMPLETED|OL Induction Period (Wk 0-12)||0||
59647905|NCT04004611|75765688|FG002|NOT COMPLETED|OL Induction Period (Wk 0-12)||0||
59647906|NCT04004611|75765689|FG003|NOT COMPLETED|OL Induction Period (Wk 0-12)||0||
59647907|NCT04004611|75765690|FG004|NOT COMPLETED|OL Induction Period (Wk 0-12)||0||
59647908|NCT04004611|75765691|FG005|NOT COMPLETED|OL Induction Period (Wk 0-12)||0||
59647909|NCT04004611|75765692|FG006|NOT COMPLETED|OL Induction Period (Wk 0-12)||0||
59647910|NCT04004611|75765693|FG007|NOT COMPLETED|OL Induction Period (Wk 0-12)||0||
59647911|NCT04004611|75765694|FG008|NOT COMPLETED|OL Induction Period (Wk 0-12)||0||
59647912|NCT04004611|75765686|FG000|STARTED|OL Maintenance Period (Wk 12-52)|Participants were assigned to this arm only during open label induction period.|0||
59647913|NCT04004611|75765687|FG001|STARTED|OL Maintenance Period (Wk 12-52)|Participants were assigned to this arm only during open label induction period.|0||
59647914|NCT04004611|75765688|FG002|STARTED|OL Maintenance Period (Wk 12-52)|Participants were assigned to this arm only during open label induction period.|0||
59647915|NCT04004611|75765689|FG003|STARTED|OL Maintenance Period (Wk 12-52)|Included only participants who entered open label maintenance period.|1||
59647916|NCT04004611|75765690|FG004|STARTED|OL Maintenance Period (Wk 12-52)|Included only participants who entered open label maintenance period.|8||
59647917|NCT04004611|75765691|FG005|STARTED|OL Maintenance Period (Wk 12-52)|Included only participants who entered open label maintenance period.|9||
59647918|NCT04004611|75765692|FG006|STARTED|OL Maintenance Period (Wk 12-52)|Included only participants who entered open label maintenance period.|1||
59647919|NCT04004611|75765693|FG007|STARTED|OL Maintenance Period (Wk 12-52)|Included only participants who entered open label maintenance period.|1||
59647920|NCT04004611|75765694|FG008|STARTED|OL Maintenance Period (Wk 12-52)|Included only participants who entered open label maintenance period.|6||
59647921|NCT04004611|75765686|FG000|COMPLETED|OL Maintenance Period (Wk 12-52)||0||
59647922|NCT04004611|75765687|FG001|COMPLETED|OL Maintenance Period (Wk 12-52)||0||
59647923|NCT04004611|75765688|FG002|COMPLETED|OL Maintenance Period (Wk 12-52)||0||
59647924|NCT04004611|75765689|FG003|COMPLETED|OL Maintenance Period (Wk 12-52)||1||
59647925|NCT04004611|75765690|FG004|COMPLETED|OL Maintenance Period (Wk 12-52)||7||
59647926|NCT04004611|75765691|FG005|COMPLETED|OL Maintenance Period (Wk 12-52)||8||
59647927|NCT04004611|75765692|FG006|COMPLETED|OL Maintenance Period (Wk 12-52)||0||
59647928|NCT04004611|75765693|FG007|COMPLETED|OL Maintenance Period (Wk 12-52)||1||
59647929|NCT04004611|75765694|FG008|COMPLETED|OL Maintenance Period (Wk 12-52)||2||
59647930|NCT04004611|75765686|FG000|NOT COMPLETED|OL Maintenance Period (Wk 12-52)||0||
59647931|NCT04004611|75765687|FG001|NOT COMPLETED|OL Maintenance Period (Wk 12-52)||0||
59647932|NCT04004611|75765688|FG002|NOT COMPLETED|OL Maintenance Period (Wk 12-52)||0||
59647933|NCT04004611|75765689|FG003|NOT COMPLETED|OL Maintenance Period (Wk 12-52)||0||
59647934|NCT04004611|75765690|FG004|NOT COMPLETED|OL Maintenance Period (Wk 12-52)||1||
59647935|NCT04004611|75765691|FG005|NOT COMPLETED|OL Maintenance Period (Wk 12-52)||1||
59647936|NCT04004611|75765692|FG006|NOT COMPLETED|OL Maintenance Period (Wk 12-52)||1||
59647937|NCT04004611|75765693|FG007|NOT COMPLETED|OL Maintenance Period (Wk 12-52)||0||
59647938|NCT04004611|75765694|FG008|NOT COMPLETED|OL Maintenance Period (Wk 12-52)||4||
59647939|NCT04004611|75765686|FG000|STARTED|OL Induction and Maintenance Period|Included only participants who entered open label induction and maintenance period.|10||
59647940|NCT04004611|75765687|FG001|STARTED|OL Induction and Maintenance Period|Included only participants who entered open label induction and maintenance period.|5||
59647941|NCT04004611|75765688|FG002|STARTED|OL Induction and Maintenance Period|Included only participants who entered open label induction and maintenance period.|11||
59647942|NCT04004611|75765689|FG003|STARTED|OL Induction and Maintenance Period|Participants were assigned to this arm only during open label maintenance period.|0||
59647943|NCT04004611|75765690|FG004|STARTED|OL Induction and Maintenance Period|Participants were assigned to this arm only during open label maintenance period.|0||
59647944|NCT04004611|75765691|FG005|STARTED|OL Induction and Maintenance Period|Participants were assigned to this arm only during open label maintenance period.|0||
59647945|NCT04004611|75765692|FG006|STARTED|OL Induction and Maintenance Period|Participants were assigned to this arm only during open label maintenance period.|0||
59647946|NCT04004611|75765693|FG007|STARTED|OL Induction and Maintenance Period|Participants were assigned to this arm only during open label maintenance period.|0||
59647947|NCT04004611|75765694|FG008|STARTED|OL Induction and Maintenance Period|Participants were assigned to this arm only during open label maintenance period.|0||
59647948|NCT04004611|75765686|FG000|COMPLETED|OL Induction and Maintenance Period||9||
59647949|NCT04004611|75765687|FG001|COMPLETED|OL Induction and Maintenance Period||4||
59647950|NCT04004611|75765688|FG002|COMPLETED|OL Induction and Maintenance Period||6||
59647951|NCT04004611|75765689|FG003|COMPLETED|OL Induction and Maintenance Period||0||
59647952|NCT04004611|75765690|FG004|COMPLETED|OL Induction and Maintenance Period||0||
59647953|NCT04004611|75765691|FG005|COMPLETED|OL Induction and Maintenance Period||0||
59647954|NCT04004611|75765692|FG006|COMPLETED|OL Induction and Maintenance Period||0||
59647955|NCT04004611|75765693|FG007|COMPLETED|OL Induction and Maintenance Period||0||
59647956|NCT04004611|75765694|FG008|COMPLETED|OL Induction and Maintenance Period||0||
59647957|NCT04004611|75765686|FG000|NOT COMPLETED|OL Induction and Maintenance Period||1||
59647958|NCT04004611|75765687|FG001|NOT COMPLETED|OL Induction and Maintenance Period||1||
59647959|NCT04004611|75765688|FG002|NOT COMPLETED|OL Induction and Maintenance Period||5||
59647960|NCT04004611|75765689|FG003|NOT COMPLETED|OL Induction and Maintenance Period||0||
59647961|NCT04004611|75765690|FG004|NOT COMPLETED|OL Induction and Maintenance Period||0||
59647962|NCT04004611|75765691|FG005|NOT COMPLETED|OL Induction and Maintenance Period||0||
59647963|NCT04004611|75765692|FG006|NOT COMPLETED|OL Induction and Maintenance Period||0||
59647964|NCT04004611|75765693|FG007|NOT COMPLETED|OL Induction and Maintenance Period||0||
59647965|NCT04004611|75765694|FG008|NOT COMPLETED|OL Induction and Maintenance Period||0||
59647966|NCT03824938|75765724|FG000|STARTED|Overall Study||7||
59647967|NCT03824938|75765725|FG001|STARTED|Overall Study||8||
59647968|NCT03824938|75765726|FG002|STARTED|Overall Study||7||
59647969|NCT03824938|75765727|FG003|STARTED|Overall Study||5||
59647970|NCT03824938|75765728|FG004|STARTED|Overall Study||7||
59647971|NCT03824938|75765729|FG005|STARTED|Overall Study||3||
59647972|NCT03824938|75765724|FG000|COMPLETED|Overall Study||5||
59647973|NCT03824938|75765725|FG001|COMPLETED|Overall Study||6||
59647974|NCT03824938|75765726|FG002|COMPLETED|Overall Study||7||
59647975|NCT03824938|75765727|FG003|COMPLETED|Overall Study||3||
59647976|NCT03824938|75765728|FG004|COMPLETED|Overall Study||6||
59647977|NCT03824938|75765729|FG005|COMPLETED|Overall Study||2||
59647978|NCT03824938|75765724|FG000|NOT COMPLETED|Overall Study||2||
59647979|NCT03824938|75765725|FG001|NOT COMPLETED|Overall Study||2||
59647980|NCT03824938|75765726|FG002|NOT COMPLETED|Overall Study||0||
59647981|NCT03824938|75765727|FG003|NOT COMPLETED|Overall Study||2||
59647982|NCT03824938|75765728|FG004|NOT COMPLETED|Overall Study||1||
59647983|NCT03824938|75765729|FG005|NOT COMPLETED|Overall Study||1||
59647984|NCT03636373|75765739|FG000|STARTED|Overall Study||3||
59647985|NCT03636373|75765740|FG001|STARTED|Overall Study||2||
59647986|NCT03636373|75765739|FG000|COMPLETED|Overall Study||2||
59647987|NCT03636373|75765740|FG001|COMPLETED|Overall Study||2||
59647988|NCT03636373|75765739|FG000|NOT COMPLETED|Overall Study||1||
59647989|NCT03636373|75765740|FG001|NOT COMPLETED|Overall Study||0||
59647990|NCT03631706|75765754|FG000|STARTED|Overall Study||152||
59647991|NCT03631706|75765755|FG001|STARTED|Overall Study||152||
59647992|NCT03631706|75765754|FG000|Treated|Overall Study||151||
59647993|NCT03631706|75765755|FG001|Treated|Overall Study||152||
59647994|NCT03631706|75765754|FG000|COMPLETED|Overall Study||60||
59647995|NCT03631706|75765755|FG001|COMPLETED|Overall Study||54||
59647996|NCT03631706|75765754|FG000|NOT COMPLETED|Overall Study||92||
59647997|NCT03631706|75765755|FG001|NOT COMPLETED|Overall Study||98||
59647998|NCT03004443|75765763|FG000|STARTED|Overall Study||11||
59647999|NCT03004443|75765764|FG001|STARTED|Overall Study||11||
59648000|NCT03004443|75765763|FG000|COMPLETED|Overall Study||11||
59648001|NCT03004443|75765764|FG001|COMPLETED|Overall Study||10||
59648002|NCT03004443|75765763|FG000|NOT COMPLETED|Overall Study||0||
59648003|NCT03004443|75765764|FG001|NOT COMPLETED|Overall Study||1||
59648004|NCT02277028|75765772|FG000|STARTED|Overall Study||8||
59648005|NCT02277028|75765773|FG001|STARTED|Overall Study||8||
59648006|NCT02277028|75765772|FG000|COMPLETED|Overall Study||7||
59648007|NCT02277028|75765773|FG001|COMPLETED|Overall Study||7||
59648008|NCT02277028|75765772|FG000|NOT COMPLETED|Overall Study||1||
59648009|NCT02277028|75765773|FG001|NOT COMPLETED|Overall Study||1||
59648010|NCT01781468|75765782|FG000|STARTED|Overall Study||109||
59648011|NCT01781468|75765783|FG001|STARTED|Overall Study||110||
59648012|NCT01781468|75765784|FG002|STARTED|Overall Study||109||
59648013|NCT01781468|75765782|FG000|COMPLETED|Overall Study||103|Evaluable for the Primary Endpoint|
59648014|NCT01781468|75765783|FG001|COMPLETED|Overall Study||97|Evaluable for the Primary Endpoint|
59648015|NCT01781468|75765784|FG002|COMPLETED|Overall Study||97|Evaluable for the Primary Endpoint|
59648016|NCT01781468|75765782|FG000|NOT COMPLETED|Overall Study||6||
59648017|NCT01781468|75765783|FG001|NOT COMPLETED|Overall Study||13||
59648018|NCT01781468|75765784|FG002|NOT COMPLETED|Overall Study||12||
59648019|NCT01545141|75765797|FG000|STARTED|Overall Study||2|9 patients in Phase I. 6 patients randomized in Phase II (2 to surgery alone and 4 to 20 MU/m2)|
59648020|NCT01545141|75765798|FG001|STARTED|Overall Study||3|9 patients in Phase I. 6 patients randomized in Phase II (2 to surgery alone and 4 to 20 MU/m2)|
59648021|NCT01545141|75765799|FG002|STARTED|Overall Study||3|9 patients in Phase I. 6 patients randomized in Phase II (2 to surgery alone and 4 to 20 MU/m2)|
59648022|NCT01545141|75765800|FG003|STARTED|Overall Study||7|9 patients in Phase I. 6 patients randomized in Phase II (2 to surgery alone and 4 to 20 MU/m2)|
59648023|NCT01545141|75765797|FG000|COMPLETED|Overall Study||2||
59648024|NCT01545141|75765798|FG001|COMPLETED|Overall Study||3||
59648025|NCT01545141|75765799|FG002|COMPLETED|Overall Study||3||
59648026|NCT01545141|75765800|FG003|COMPLETED|Overall Study||7||
59648027|NCT01545141|75765797|FG000|NOT COMPLETED|Overall Study||0||
59648028|NCT01545141|75765798|FG001|NOT COMPLETED|Overall Study||0||
59648029|NCT01545141|75765799|FG002|NOT COMPLETED|Overall Study||0||
59648030|NCT01545141|75765800|FG003|NOT COMPLETED|Overall Study||0||
59648031|NCT00944528|75765811|FG000|STARTED|Overall Study||9||
59648032|NCT00944528|75765812|FG001|STARTED|Overall Study||10||
59648033|NCT00944528|75765813|FG002|STARTED|Overall Study||16||
59648034|NCT00944528|75765811|FG000|COMPLETED|Overall Study||8||
59648035|NCT00944528|75765812|FG001|COMPLETED|Overall Study||8||
59648036|NCT00944528|75765813|FG002|COMPLETED|Overall Study||16||
59648037|NCT00944528|75765811|FG000|NOT COMPLETED|Overall Study||1||
59648038|NCT00944528|75765812|FG001|NOT COMPLETED|Overall Study||2||
59648039|NCT00944528|75765813|FG002|NOT COMPLETED|Overall Study||0||
59648040|NCT03735849|75765825|FG000|STARTED|Overall Study||11||
59648041|NCT03735849|75765826|FG001|STARTED|Overall Study||13||
59648042|NCT03735849|75765827|FG002|STARTED|Overall Study||4||
59648043|NCT03735849|75765825|FG000|Safety Population|Overall Study||11||
59648044|NCT03735849|75765826|FG001|Safety Population|Overall Study||13||
59648045|NCT03735849|75765827|FG002|Safety Population|Overall Study||4||
59648046|NCT03735849|75765825|FG000|COMPLETED|Overall Study||9||
59648047|NCT03735849|75765826|FG001|COMPLETED|Overall Study||13||
59648048|NCT03735849|75765827|FG002|COMPLETED|Overall Study||0||
60076780|NCT01513551|76191798|FG000|STARTED|Overall Study||230||
60076781|NCT01513551|76191799|FG001|STARTED|Overall Study||231||
59648049|NCT03735849|75765825|FG000|NOT COMPLETED|Overall Study||2||
59648050|NCT03735849|75765826|FG001|NOT COMPLETED|Overall Study||0||
59648051|NCT03735849|75765827|FG002|NOT COMPLETED|Overall Study||4||
59648052|NCT03552393|75765834|FG000|STARTED|Core Period||40||
59648053|NCT03552393|75765834|FG000|COMPLETED|Core Period||38||
59648054|NCT03552393|75765834|FG000|NOT COMPLETED|Core Period||2||
59648055|NCT03552393|75765834|FG000|STARTED|Safety Extension Period||25||
59648056|NCT03552393|75765834|FG000|COMPLETED|Safety Extension Period||21||
59648057|NCT03552393|75765834|FG000|NOT COMPLETED|Safety Extension Period||4||
59648058|NCT03333382|75765840|FG000|STARTED|Overall Study||1||
59648059|NCT03333382|75765841|FG001|STARTED|Overall Study||0||
59648060|NCT03333382|75765840|FG000|COMPLETED|Overall Study||0||
59648061|NCT03333382|75765841|FG001|COMPLETED|Overall Study||0||
59648062|NCT03333382|75765840|FG000|NOT COMPLETED|Overall Study||1||
59648063|NCT03333382|75765841|FG001|NOT COMPLETED|Overall Study||0||
59648064|NCT03245827|75765851|FG000|STARTED|Overall Study||1||
59648065|NCT03245827|75765852|FG001|STARTED|Overall Study||0||
59648066|NCT03245827|75765853|FG002|STARTED|Overall Study||3||
59648067|NCT03245827|75765854|FG003|STARTED|Overall Study||5||
59648068|NCT03245827|75765851|FG000|COMPLETED|Overall Study||1||
60076782|NCT01513551|76191800|FG002|STARTED|Overall Study||231||
60076783|NCT01513551|76191798|FG000|Vaccinated|Overall Study||230||
60076784|NCT01513551|76191799|FG001|Vaccinated|Overall Study||231||
59648069|NCT03245827|75765852|FG001|COMPLETED|Overall Study||0||
59648070|NCT03245827|75765853|FG002|COMPLETED|Overall Study||3||
59648071|NCT03245827|75765854|FG003|COMPLETED|Overall Study||5||
59648072|NCT03245827|75765851|FG000|NOT COMPLETED|Overall Study||0||
59648073|NCT03245827|75765852|FG001|NOT COMPLETED|Overall Study||0||
59648074|NCT03245827|75765853|FG002|NOT COMPLETED|Overall Study||0||
59648075|NCT03245827|75765854|FG003|NOT COMPLETED|Overall Study||0||
59648076|NCT03129321|75765865|FG000|STARTED|Overall Study||351||
59648077|NCT03129321|75765866|FG001|STARTED|Overall Study||350||
59648078|NCT03129321|75765867|FG002|STARTED|Overall Study||175||
59648079|NCT03129321|75765865|FG000|COMPLETED|Overall Study||253||
59648080|NCT03129321|75765866|FG001|COMPLETED|Overall Study||241||
59648081|NCT03129321|75765867|FG002|COMPLETED|Overall Study||120||
59648082|NCT03129321|75765865|FG000|NOT COMPLETED|Overall Study||98||
59648083|NCT03129321|75765866|FG001|NOT COMPLETED|Overall Study||109||
59648084|NCT03129321|75765867|FG002|NOT COMPLETED|Overall Study||55||
59648085|NCT03107611|75765880|FG000|STARTED|Overall Study||217||
59648086|NCT03107611|75765881|FG001|STARTED|Overall Study||216||
59648087|NCT03107611|75765882|FG002|STARTED|Overall Study||221||
59648088|NCT03107611|75765880|FG000|Dosed|Overall Study||215|2 Test, 2 Reference, and 1 Placebo Subjects are not known to have dosed|
59648089|NCT03107611|75765881|FG001|Dosed|Overall Study||214|2 Test, 2 Reference, and 1 Placebo Subjects are not known to have dosed|
59648090|NCT03107611|75765882|FG002|Dosed|Overall Study||220|2 Test, 2 Reference, and 1 Placebo Subjects are not known to have dosed|
59648091|NCT03107611|75765880|FG000|COMPLETED|Overall Study||210||
59648092|NCT03107611|75765881|FG001|COMPLETED|Overall Study||212||
59648093|NCT03107611|75765882|FG002|COMPLETED|Overall Study||212||
59648094|NCT03107611|75765880|FG000|NOT COMPLETED|Overall Study||7||
59648095|NCT03107611|75765881|FG001|NOT COMPLETED|Overall Study||4||
59648096|NCT03107611|75765882|FG002|NOT COMPLETED|Overall Study||9||
59648097|NCT02720016|75765893|FG000|STARTED|Overall Study||92||
59648098|NCT02720016|75765894|FG001|STARTED|Overall Study||92||
59648099|NCT02720016|75765895|FG002|STARTED|Overall Study||90||
59648100|NCT02720016|75765893|FG000|Y1|Overall Study||26|Number of enrollment in Year 1 of study (March 2017-December 2017)|
59648101|NCT02720016|75765894|FG001|Y1|Overall Study||26|Number of enrollment in Year 1 of study (March 2017-December 2017)|
59648102|NCT02720016|75765895|FG002|Y1|Overall Study||28|Number of enrollment in Year 1 of study (March 2017-December 2017)|
59648103|NCT02720016|75765893|FG000|Y2|Overall Study||34|Number of enrollment in Year 2 of study (2018)|
59648104|NCT02720016|75765894|FG001|Y2|Overall Study||32|Number of enrollment in Year 2 of study (2018)|
59648105|NCT02720016|75765895|FG002|Y2|Overall Study||34|Number of enrollment in Year 2 of study (2018)|
59648106|NCT02720016|75765893|FG000|Y3|Overall Study||28|Number of enrollment in Year 3 of study (2019)|
59648107|NCT02720016|75765894|FG001|Y3|Overall Study||30|Number of enrollment in Year 3 of study (2019)|
59648108|NCT02720016|75765895|FG002|Y3|Overall Study||24|Number of enrollment in Year 3 of study (2019)|
59648109|NCT02720016|75765893|FG000|Y4|Overall Study||4|Number of enrollment in Year 4 of study (January 2020-March 2020)|
59648110|NCT02720016|75765894|FG001|Y4|Overall Study||4|Number of enrollment in Year 4 of study (January 2020-March 2020)|
59648111|NCT02720016|75765895|FG002|Y4|Overall Study||4|Number of enrollment in Year 4 of study (January 2020-March 2020)|
59648112|NCT02720016|75765893|FG000|Veteran Total|Overall Study||46|Total number of veteran participants|
59648113|NCT02720016|75765894|FG001|Veteran Total|Overall Study||46|Total number of veteran participants|
59648114|NCT02720016|75765895|FG002|Veteran Total|Overall Study||45|Total number of veteran participants|
59648115|NCT02720016|75765893|FG000|Intimate Partner Total|Overall Study||46|Total number of intimate partners of veterans|
59648116|NCT02720016|75765894|FG001|Intimate Partner Total|Overall Study||46|Total number of intimate partners of veterans|
59648117|NCT02720016|75765895|FG002|Intimate Partner Total|Overall Study||45|Total number of intimate partners of veterans|
59648118|NCT02720016|75765893|FG000|COMPLETED|Overall Study||72||
59648119|NCT02720016|75765894|FG001|COMPLETED|Overall Study||72||
59648120|NCT02720016|75765895|FG002|COMPLETED|Overall Study||70||
59648121|NCT02720016|75765893|FG000|NOT COMPLETED|Overall Study||20||
59648122|NCT02720016|75765894|FG001|NOT COMPLETED|Overall Study||20||
59648123|NCT02720016|75765895|FG002|NOT COMPLETED|Overall Study||20||
59648124|NCT02607956|75765906|FG000|STARTED|Double-Blinded Phase||327||
59648125|NCT02607956|75765907|FG001|STARTED|Double-Blinded Phase||330||
59648126|NCT02607956|75765908|FG002|STARTED|Double-Blinded Phase||0||
59648127|NCT02607956|75765909|FG003|STARTED|Double-Blinded Phase||0||
59648128|NCT02607956|75765906|FG000|COMPLETED|Double-Blinded Phase||266||
59648129|NCT02607956|75765907|FG001|COMPLETED|Double-Blinded Phase||277||
59648130|NCT02607956|75765908|FG002|COMPLETED|Double-Blinded Phase||0||
59648131|NCT02607956|75765909|FG003|COMPLETED|Double-Blinded Phase||0||
59648132|NCT02607956|75765906|FG000|NOT COMPLETED|Double-Blinded Phase||61||
59648133|NCT02607956|75765907|FG001|NOT COMPLETED|Double-Blinded Phase||53||
59648134|NCT02607956|75765908|FG002|NOT COMPLETED|Double-Blinded Phase||0||
59648135|NCT02607956|75765909|FG003|NOT COMPLETED|Double-Blinded Phase||0||
59648136|NCT02607956|75765906|FG000|STARTED|Open-Label Extension Phase|At the End of Blinded Treatment Visit, participants were given the option to receive B/F/TAF FDC in an OL extension phase for up to 96 weeks.|0||
59648137|NCT02607956|75765907|FG001|STARTED|Open-Label Extension Phase|At the End of Blinded Treatment Visit, participants were given the option to receive B/F/TAF FDC in an OL extension phase for up to 96 weeks.|0||
59648138|NCT02607956|75765908|FG002|STARTED|Open-Label Extension Phase|66 participants from the Double-Blinded Phase did not enter the Open-Label Extension Phase.|254||
59648139|NCT02607956|75765909|FG003|STARTED|Open-Label Extension Phase|60 participants from the Double-Blinded Phase did not enter the Open-Label Extension Phase.|265||
59648140|NCT02607956|75765906|FG000|COMPLETED|Open-Label Extension Phase||0||
59648141|NCT02607956|75765907|FG001|COMPLETED|Open-Label Extension Phase||0||
59648142|NCT02607956|75765908|FG002|COMPLETED|Open-Label Extension Phase||225||
59648143|NCT02607956|75765909|FG003|COMPLETED|Open-Label Extension Phase||235||
59648144|NCT02607956|75765906|FG000|NOT COMPLETED|Open-Label Extension Phase||0||
59648145|NCT02607956|75765907|FG001|NOT COMPLETED|Open-Label Extension Phase||0||
59648146|NCT02607956|75765908|FG002|NOT COMPLETED|Open-Label Extension Phase||29||
59648147|NCT02607956|75765909|FG003|NOT COMPLETED|Open-Label Extension Phase||30||
59988628|NCT03471065|76103853|FG000|STARTED|Overall Study||100||
59988629|NCT03471065|76103853|FG000|COMPLETED|Overall Study||100||
59988630|NCT03471065|76103853|FG000|NOT COMPLETED|Overall Study||0||
59988631|NCT03382925|76103859|FG000|STARTED|Overall Study||10||
59988632|NCT03382925|76103860|FG001|STARTED|Overall Study||6||
59988633|NCT03382925|76103859|FG000|COMPLETED|Overall Study||10||
59542832|NCT01049360|75640979|FG000|COMPLETED|Period 4||6||
59542833|NCT01049360|75640980|FG001|COMPLETED|Period 4||4||
59542834|NCT01049360|75640981|FG002|COMPLETED|Period 4||7||
59542835|NCT01049360|75640982|FG003|COMPLETED|Period 4||3||
59542836|NCT01049360|75640983|FG004|COMPLETED|Period 4||7||
59542837|NCT01049360|75640984|FG005|COMPLETED|Period 4||5||
59542838|NCT01049360|75640985|FG006|COMPLETED|Period 4||6||
59542839|NCT01049360|75640986|FG007|COMPLETED|Period 4||4||
59542840|NCT01049360|75640987|FG008|COMPLETED|Period 4||4||
59542841|NCT01049360|75640988|FG009|COMPLETED|Period 4||6||
59542842|NCT01049360|75640989|FG010|COMPLETED|Period 4||5||
59542843|NCT01049360|75640990|FG011|COMPLETED|Period 4||6||
59542844|NCT01049360|75640991|FG012|COMPLETED|Period 4||4||
59542845|NCT01049360|75640992|FG013|COMPLETED|Period 4||6||
59542846|NCT01049360|75640993|FG014|COMPLETED|Period 4||5||
59542847|NCT01049360|75640994|FG015|COMPLETED|Period 4||6||
59542848|NCT01049360|75640995|FG016|COMPLETED|Period 4||5||
59542849|NCT01049360|75640996|FG017|COMPLETED|Period 4||5||
59542850|NCT01049360|75640997|FG018|COMPLETED|Period 4||5||
59542851|NCT01049360|75640998|FG019|COMPLETED|Period 4||5||
59542852|NCT01049360|75640979|FG000|NOT COMPLETED|Period 4||0||
59542853|NCT01049360|75640980|FG001|NOT COMPLETED|Period 4||0||
59542854|NCT01049360|75640981|FG002|NOT COMPLETED|Period 4||0||
59542855|NCT01049360|75640982|FG003|NOT COMPLETED|Period 4||1||
59542856|NCT01049360|75640983|FG004|NOT COMPLETED|Period 4||0||
59542857|NCT01049360|75640984|FG005|NOT COMPLETED|Period 4||0||
59542858|NCT01049360|75640985|FG006|NOT COMPLETED|Period 4||0||
59542859|NCT01049360|75640986|FG007|NOT COMPLETED|Period 4||0||
59542860|NCT01049360|75640987|FG008|NOT COMPLETED|Period 4||0||
59542861|NCT01049360|75640988|FG009|NOT COMPLETED|Period 4||0||
59542862|NCT01049360|75640989|FG010|NOT COMPLETED|Period 4||0||
59542863|NCT01049360|75640990|FG011|NOT COMPLETED|Period 4||0||
59542864|NCT01049360|75640991|FG012|NOT COMPLETED|Period 4||0||
59542865|NCT01049360|75640992|FG013|NOT COMPLETED|Period 4||0||
59542866|NCT01049360|75640993|FG014|NOT COMPLETED|Period 4||0||
59542867|NCT01049360|75640994|FG015|NOT COMPLETED|Period 4||0||
59542868|NCT01049360|75640995|FG016|NOT COMPLETED|Period 4||0||
59542869|NCT01049360|75640996|FG017|NOT COMPLETED|Period 4||1||
59542870|NCT01049360|75640997|FG018|NOT COMPLETED|Period 4||0||
59542871|NCT01049360|75640998|FG019|NOT COMPLETED|Period 4||0||
59542872|NCT02494596|75641010|FG000|STARTED|Overall Study||5||
59542873|NCT02494596|75641011|FG001|STARTED|Overall Study||7||
59542874|NCT02494596|75641012|FG002|STARTED|Overall Study||7||
59542875|NCT02494596|75641010|FG000|COMPLETED|Overall Study||2||
59542876|NCT02494596|75641011|FG001|COMPLETED|Overall Study||2||
59542877|NCT02494596|75641012|FG002|COMPLETED|Overall Study||6||
59542878|NCT02494596|75641010|FG000|NOT COMPLETED|Overall Study||3||
59542879|NCT02494596|75641011|FG001|NOT COMPLETED|Overall Study||5||
59542880|NCT02494596|75641012|FG002|NOT COMPLETED|Overall Study||1||
59542881|NCT01581437|75641023|FG000|STARTED|Overall Study||78||
59542882|NCT01581437|75641023|FG000|COMPLETED|Overall Study||78||
59542883|NCT01581437|75641023|FG000|NOT COMPLETED|Overall Study||0||
59542884|NCT02494206|75641031|FG000|STARTED|Overall Study||9||
59542885|NCT02494206|75641031|FG000|COMPLETED|Overall Study||7||
59542886|NCT02494206|75641031|FG000|NOT COMPLETED|Overall Study||2||
59542887|NCT01582139|75641037|FG000|STARTED|Overall Study||6||
59542888|NCT01582139|75641038|FG001|STARTED|Overall Study||6||
59542889|NCT01582139|75641037|FG000|COMPLETED|Overall Study||6||
59542890|NCT01582139|75641038|FG001|COMPLETED|Overall Study||6||
59648148|NCT02564523|75765939|FG000|STARTED|Overall Study||225||
59988634|NCT03382925|76103860|FG001|COMPLETED|Overall Study||6||
59648149|NCT02564523|75765940|FG001|STARTED|Overall Study||43||
59648150|NCT02564523|75765941|FG002|STARTED|Overall Study||224||
59648151|NCT02564523|75765942|FG003|STARTED|Overall Study||44||
59648152|NCT02564523|75765943|FG004|STARTED|Overall Study||110||
59648153|NCT02564523|75765944|FG005|STARTED|Overall Study||22||
59648154|NCT02564523|75765945|FG006|STARTED|Overall Study||59||
59648155|NCT02564523|75765946|FG007|STARTED|Overall Study||12||
59648156|NCT02564523|75765947|FG008|STARTED|Overall Study||59||
59648157|NCT02564523|75765948|FG009|STARTED|Overall Study||12||
59648158|NCT02564523|75765949|FG010|STARTED|Overall Study||55||
59648159|NCT02564523|75765950|FG011|STARTED|Overall Study||11||
59648160|NCT02564523|75765951|FG012|STARTED|Overall Study||55||
59648161|NCT02564523|75765952|FG013|STARTED|Overall Study||10||
59648162|NCT02564523|75765953|FG014|STARTED|Overall Study||54||
59648163|NCT02564523|75765954|FG015|STARTED|Overall Study||12||
59648164|NCT02564523|75765955|FG016|STARTED|Overall Study||54||
59648165|NCT02564523|75765956|FG017|STARTED|Overall Study||12||
59648166|NCT02564523|75765939|FG000|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||34||
59648167|NCT02564523|75765940|FG001|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||8||
59648168|NCT02564523|75765941|FG002|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||39||
59648169|NCT02564523|75765942|FG003|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||9||
59648170|NCT02564523|75765943|FG004|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0||
59648171|NCT02564523|75765944|FG005|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0||
59648172|NCT02564523|75765945|FG006|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0||
59648173|NCT02564523|75765946|FG007|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0||
59648174|NCT02564523|75765947|FG008|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0||
59648175|NCT02564523|75765948|FG009|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0||
59648176|NCT02564523|75765949|FG010|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0||
59648177|NCT02564523|75765950|FG011|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0||
59648178|NCT02564523|75765951|FG012|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0||
59648179|NCT02564523|75765952|FG013|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0||
59648180|NCT02564523|75765953|FG014|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0||
59648181|NCT02564523|75765954|FG015|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0||
59648182|NCT02564523|75765955|FG016|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0||
59648183|NCT02564523|75765956|FG017|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0||
59648184|NCT02564523|75765939|FG000|COMPLETED|Overall Study||215||
59648185|NCT02564523|75765940|FG001|COMPLETED|Overall Study||40||
59648186|NCT02564523|75765941|FG002|COMPLETED|Overall Study||214||
59648187|NCT02564523|75765942|FG003|COMPLETED|Overall Study||43||
59648188|NCT02564523|75765943|FG004|COMPLETED|Overall Study||106||
59648189|NCT02564523|75765944|FG005|COMPLETED|Overall Study||22||
59648190|NCT02564523|75765945|FG006|COMPLETED|Overall Study||56||
59648191|NCT02564523|75765946|FG007|COMPLETED|Overall Study||12||
59648192|NCT02564523|75765947|FG008|COMPLETED|Overall Study||59||
59648193|NCT02564523|75765948|FG009|COMPLETED|Overall Study||12||
59648194|NCT02564523|75765949|FG010|COMPLETED|Overall Study||52||
59648195|NCT02564523|75765950|FG011|COMPLETED|Overall Study||10||
59648196|NCT02564523|75765951|FG012|COMPLETED|Overall Study||53||
59648197|NCT02564523|75765952|FG013|COMPLETED|Overall Study||10||
59648198|NCT02564523|75765953|FG014|COMPLETED|Overall Study||54||
59648199|NCT02564523|75765954|FG015|COMPLETED|Overall Study||12||
59648200|NCT02564523|75765955|FG016|COMPLETED|Overall Study||54||
59648201|NCT02564523|75765956|FG017|COMPLETED|Overall Study||11||
59648202|NCT02564523|75765939|FG000|NOT COMPLETED|Overall Study||10||
59648203|NCT02564523|75765940|FG001|NOT COMPLETED|Overall Study||3||
59648204|NCT02564523|75765941|FG002|NOT COMPLETED|Overall Study||10||
59648205|NCT02564523|75765942|FG003|NOT COMPLETED|Overall Study||1||
59648206|NCT02564523|75765943|FG004|NOT COMPLETED|Overall Study||4||
59648207|NCT02564523|75765944|FG005|NOT COMPLETED|Overall Study||0||
59648208|NCT02564523|75765945|FG006|NOT COMPLETED|Overall Study||3||
59648209|NCT02564523|75765946|FG007|NOT COMPLETED|Overall Study||0||
59648210|NCT02564523|75765947|FG008|NOT COMPLETED|Overall Study||0||
59648211|NCT02564523|75765948|FG009|NOT COMPLETED|Overall Study||0||
59648212|NCT02564523|75765949|FG010|NOT COMPLETED|Overall Study||3||
59648213|NCT02564523|75765950|FG011|NOT COMPLETED|Overall Study||1||
59648214|NCT02564523|75765951|FG012|NOT COMPLETED|Overall Study||2||
59648215|NCT02564523|75765952|FG013|NOT COMPLETED|Overall Study||0||
59648216|NCT02564523|75765953|FG014|NOT COMPLETED|Overall Study||0||
59648217|NCT02564523|75765954|FG015|NOT COMPLETED|Overall Study||0||
59648218|NCT02564523|75765955|FG016|NOT COMPLETED|Overall Study||0||
59648219|NCT02564523|75765956|FG017|NOT COMPLETED|Overall Study||1||
59648220|NCT02094716|75766013|FG000|STARTED|Overall Study||43||
59648221|NCT02094716|75766014|FG001|STARTED|Overall Study||43||
59648222|NCT02094716|75766015|FG002|STARTED|Overall Study||44||
59648223|NCT02094716|75766013|FG000|Received Second Dose at Day 14|Overall Study||15|Of 44 subjects who had a first dose of vehicle, 8 received a second treatment with 4% and 9 with 5%.|
59648224|NCT02094716|75766014|FG001|Received Second Dose at Day 14|Overall Study||10|Of 44 subjects who had a first dose of vehicle, 8 received a second treatment with 4% and 9 with 5%.|
59648225|NCT02094716|75766015|FG002|Received Second Dose at Day 14|Overall Study||17|Of 44 subjects who had a first dose of vehicle, 8 received a second treatment with 4% and 9 with 5%.|
59648226|NCT02094716|75766013|FG000|COMPLETED|Overall Study||41||
59648227|NCT02094716|75766014|FG001|COMPLETED|Overall Study||36||
59648228|NCT02094716|75766015|FG002|COMPLETED|Overall Study||40||
59648229|NCT02094716|75766013|FG000|NOT COMPLETED|Overall Study||2||
59648230|NCT02094716|75766014|FG001|NOT COMPLETED|Overall Study||7||
59648231|NCT02094716|75766015|FG002|NOT COMPLETED|Overall Study||4||
59648232|NCT01868139|75766035|FG000|STARTED|Overall Study||1||
59648233|NCT01868139|75766035|FG000|COMPLETED|Overall Study||0||
59648234|NCT01868139|75766035|FG000|NOT COMPLETED|Overall Study||1||
59648235|NCT01620658|75766043|FG000|STARTED|Overall Study||59||
59648236|NCT01620658|75766044|FG001|STARTED|Overall Study||74||
59648237|NCT01620658|75766045|FG002|STARTED|Overall Study||64||
59648238|NCT01620658|75766043|FG000|COMPLETED|Overall Study||35||
59648239|NCT01620658|75766044|FG001|COMPLETED|Overall Study||45||
59648240|NCT01620658|75766045|FG002|COMPLETED|Overall Study||44||
59648241|NCT01620658|75766043|FG000|NOT COMPLETED|Overall Study||24||
59542891|NCT01582139|75641037|FG000|NOT COMPLETED|Overall Study||0||
59542892|NCT01582139|75641038|FG001|NOT COMPLETED|Overall Study||0||
59542893|NCT01048502|75641048|FG000|STARTED|Overall Study||24||
59542894|NCT01048502|75641049|FG001|STARTED|Overall Study||23||
59542895|NCT01048502|75641050|FG002|STARTED|Overall Study||28||
59542896|NCT01048502|75641051|FG003|STARTED|Overall Study||25||
59648242|NCT01620658|75766044|FG001|NOT COMPLETED|Overall Study||29||
59648243|NCT01620658|75766045|FG002|NOT COMPLETED|Overall Study||20||
59648244|NCT01447628|75766063|FG000|STARTED|Week 0 to Week 12 (1st Intervention)||19||
59648245|NCT01447628|75766064|FG001|STARTED|Week 0 to Week 12 (1st Intervention)||20||
59648246|NCT01447628|75766065|FG002|STARTED|Week 0 to Week 12 (1st Intervention)|Randomisation error meant the arms were not balanced- refer to protocol description for full details|12||
59648247|NCT01447628|75766066|FG003|STARTED|Week 0 to Week 12 (1st Intervention)|Randomisation error meant the arms were not balanced- refer to protocol description for full details|5||
59648248|NCT01447628|75766063|FG000|COMPLETED|Week 0 to Week 12 (1st Intervention)||19||
59648249|NCT01447628|75766064|FG001|COMPLETED|Week 0 to Week 12 (1st Intervention)||20||
59648250|NCT01447628|75766065|FG002|COMPLETED|Week 0 to Week 12 (1st Intervention)||12||
59648251|NCT01447628|75766066|FG003|COMPLETED|Week 0 to Week 12 (1st Intervention)||4||
59648252|NCT01447628|75766063|FG000|NOT COMPLETED|Week 0 to Week 12 (1st Intervention)||0||
59648253|NCT01447628|75766064|FG001|NOT COMPLETED|Week 0 to Week 12 (1st Intervention)||0||
59648254|NCT01447628|75766065|FG002|NOT COMPLETED|Week 0 to Week 12 (1st Intervention)||0||
59648255|NCT01447628|75766066|FG003|NOT COMPLETED|Week 0 to Week 12 (1st Intervention)||1||
59648256|NCT01447628|75766063|FG000|STARTED|Week 12 to Week 24 (2nd Intervention)||19||
59648257|NCT01447628|75766064|FG001|STARTED|Week 12 to Week 24 (2nd Intervention)||20||
59648258|NCT01447628|75766065|FG002|STARTED|Week 12 to Week 24 (2nd Intervention)||12||
59648259|NCT01447628|75766066|FG003|STARTED|Week 12 to Week 24 (2nd Intervention)||4||
59648260|NCT01447628|75766063|FG000|COMPLETED|Week 12 to Week 24 (2nd Intervention)||19||
59648261|NCT01447628|75766064|FG001|COMPLETED|Week 12 to Week 24 (2nd Intervention)||20||
59648262|NCT01447628|75766065|FG002|COMPLETED|Week 12 to Week 24 (2nd Intervention)||12||
59648263|NCT01447628|75766066|FG003|COMPLETED|Week 12 to Week 24 (2nd Intervention)||4||
59648264|NCT01447628|75766063|FG000|NOT COMPLETED|Week 12 to Week 24 (2nd Intervention)||0||
59648265|NCT01447628|75766064|FG001|NOT COMPLETED|Week 12 to Week 24 (2nd Intervention)||0||
59648266|NCT01447628|75766065|FG002|NOT COMPLETED|Week 12 to Week 24 (2nd Intervention)||0||
59648267|NCT01447628|75766066|FG003|NOT COMPLETED|Week 12 to Week 24 (2nd Intervention)||0||
59648268|NCT00515853|75766088|FG000|STARTED|Overall Study||61||
59648269|NCT00515853|75766089|FG001|STARTED|Overall Study||60||
59648270|NCT00515853|75766088|FG000|COMPLETED|Overall Study||46||
59648271|NCT00515853|75766089|FG001|COMPLETED|Overall Study||43||
59648272|NCT00515853|75766088|FG000|NOT COMPLETED|Overall Study||15||
59648273|NCT00515853|75766089|FG001|NOT COMPLETED|Overall Study||17||
59648274|NCT00003458|75766095|FG000|STARTED|Overall Study||34||
59648275|NCT00003458|75766095|FG000|COMPLETED|Overall Study||30||
59648276|NCT00003458|75766095|FG000|NOT COMPLETED|Overall Study||4||
59542897|NCT01048502|75641048|FG000|COMPLETED|Overall Study||20||
59542898|NCT01048502|75641049|FG001|COMPLETED|Overall Study||16||
59648277|NCT05032872|75766102|FG000|STARTED|Overall Study||38|enrolled in the study|
59542899|NCT01048502|75641050|FG002|COMPLETED|Overall Study||23||
59648278|NCT05032872|75766103|FG001|STARTED|Overall Study||42|enrolled in the study|
59648279|NCT05032872|75766102|FG000|Completed Pretest|Overall Study||38||
59648280|NCT05032872|75766103|FG001|Completed Pretest|Overall Study||38||
59648281|NCT05032872|75766102|FG000|COMPLETED|Overall Study||31|completed posttest|
59648282|NCT05032872|75766103|FG001|COMPLETED|Overall Study||35|completed posttest|
59648283|NCT05032872|75766102|FG000|NOT COMPLETED|Overall Study||7||
59648284|NCT05032872|75766103|FG001|NOT COMPLETED|Overall Study||7||
59648285|NCT04871815|75766109|FG000|STARTED|Baseline Day 1-7||22||
59648286|NCT04871815|75766109|FG000|COMPLETED|Baseline Day 1-7||22||
59648287|NCT04871815|75766109|FG000|NOT COMPLETED|Baseline Day 1-7||0||
59648288|NCT04871815|75766109|FG000|STARTED|N115 Treatment Day 8-14||22||
59648289|NCT04871815|75766109|FG000|COMPLETED|N115 Treatment Day 8-14||22||
59648290|NCT04871815|75766109|FG000|NOT COMPLETED|N115 Treatment Day 8-14||0||
59648291|NCT04772560|75766121|FG000|STARTED|Overall Study||11||
59648292|NCT04772560|75766122|FG001|STARTED|Overall Study||12||
59648293|NCT04772560|75766121|FG000|COMPLETED|Overall Study||11||
59648294|NCT04772560|75766122|FG001|COMPLETED|Overall Study||12||
59648295|NCT04772560|75766121|FG000|NOT COMPLETED|Overall Study||0||
59648296|NCT04772560|75766122|FG001|NOT COMPLETED|Overall Study||0||
59648297|NCT04613739|75766129|FG000|STARTED|Overall Study||19||
59648298|NCT04613739|75766130|FG001|STARTED|Overall Study||37||
59648299|NCT04613739|75766129|FG000|COMPLETED|Overall Study||12|Completed four-month survey|
59648300|NCT04613739|75766130|FG001|COMPLETED|Overall Study||25|Completed four-month survey|
59648301|NCT04613739|75766129|FG000|NOT COMPLETED|Overall Study||7||
59648302|NCT04613739|75766130|FG001|NOT COMPLETED|Overall Study||12||
59648303|NCT04526925|75766138|FG000|STARTED|First Intervention||4||
59648304|NCT04526925|75766139|FG001|STARTED|First Intervention||6||
59648305|NCT04526925|75766138|FG000|COMPLETED|First Intervention||4||
59648306|NCT04526925|75766139|FG001|COMPLETED|First Intervention||6||
59648307|NCT04526925|75766138|FG000|NOT COMPLETED|First Intervention||0||
59648308|NCT04526925|75766139|FG001|NOT COMPLETED|First Intervention||0||
59648309|NCT04526925|75766138|FG000|STARTED|Second Intervention||4||
59648310|NCT04526925|75766139|FG001|STARTED|Second Intervention||6||
59648311|NCT04526925|75766138|FG000|COMPLETED|Second Intervention||4||
59648312|NCT04526925|75766139|FG001|COMPLETED|Second Intervention||6||
59648313|NCT04526925|75766138|FG000|NOT COMPLETED|Second Intervention||0||
59648314|NCT04526925|75766139|FG001|NOT COMPLETED|Second Intervention||0||
59648315|NCT04432272|75766147|FG000|STARTED|Overall Study||43||
59648316|NCT04432272|75766148|FG001|STARTED|Overall Study||28||
59648317|NCT04432272|75766147|FG000|COMPLETED|Overall Study||43||
59648318|NCT04432272|75766148|FG001|COMPLETED|Overall Study||28||
59648319|NCT04432272|75766147|FG000|NOT COMPLETED|Overall Study||0||
59648320|NCT04432272|75766148|FG001|NOT COMPLETED|Overall Study||0||
59648321|NCT04407806|75766157|FG000|STARTED|Overall Study||3||
59648322|NCT04407806|75766158|FG001|STARTED|Overall Study||3||
59648323|NCT04407806|75766157|FG000|COMPLETED|Overall Study||2||
59648324|NCT04407806|75766158|FG001|COMPLETED|Overall Study||1||
59648325|NCT04407806|75766157|FG000|NOT COMPLETED|Overall Study||1||
59648326|NCT04407806|75766158|FG001|NOT COMPLETED|Overall Study||2||
59648327|NCT04324021|75766167|FG000|STARTED|Overall Study||5||
59648328|NCT04324021|75766168|FG001|STARTED|Overall Study||5||
59648329|NCT04324021|75766169|FG002|STARTED|Overall Study||6||
59648330|NCT04324021|75766167|FG000|COMPLETED|Overall Study||3||
59648331|NCT04324021|75766168|FG001|COMPLETED|Overall Study||4||
59648332|NCT04324021|75766169|FG002|COMPLETED|Overall Study||5||
59648333|NCT04324021|75766167|FG000|NOT COMPLETED|Overall Study||2||
59648334|NCT04324021|75766168|FG001|NOT COMPLETED|Overall Study||1||
59648335|NCT04324021|75766169|FG002|NOT COMPLETED|Overall Study||1||
59648336|NCT04209621|75766180|FG000|STARTED|Overall Study||3||
59648337|NCT04209621|75766180|FG000|Dose Level 1|Overall Study||3||
59648338|NCT04209621|75766180|FG000|COMPLETED|Overall Study||0||
59648339|NCT04209621|75766180|FG000|NOT COMPLETED|Overall Study||3||
59648340|NCT04186663|75766185|FG000|STARTED|Overall Study||59||
59648341|NCT04186663|75766185|FG000|COMPLETED|Overall Study||55||
59648342|NCT04186663|75766185|FG000|NOT COMPLETED|Overall Study||4||
59648343|NCT04158219|75766189|FG000|STARTED|Overall Study||8||
59648344|NCT04158219|75766189|FG000|COMPLETED|Overall Study||7||
59648345|NCT04158219|75766189|FG000|NOT COMPLETED|Overall Study||1||
59648346|NCT04131959|75766193|FG000|STARTED|Overall Study||5||
59648347|NCT04131959|75766193|FG000|COMPLETED|Overall Study||5||
59648348|NCT04131959|75766193|FG000|NOT COMPLETED|Overall Study||0||
59648349|NCT04084990|75766200|FG000|STARTED|Overall Study||2||
59648350|NCT04084990|75766201|FG001|STARTED|Overall Study||1||
59648351|NCT04084990|75766200|FG000|COMPLETED|Overall Study||2||
59648352|NCT04084990|75766201|FG001|COMPLETED|Overall Study||1||
59648353|NCT04084990|75766200|FG000|NOT COMPLETED|Overall Study||0||
59648354|NCT04084990|75766201|FG001|NOT COMPLETED|Overall Study||0||
59648355|NCT03970109|75766210|FG000|STARTED|Overall Study||15||
59648356|NCT03970109|75766211|FG001|STARTED|Overall Study||13||
59648357|NCT03970109|75766212|FG002|STARTED|Overall Study||15||
59648358|NCT03970109|75766210|FG000|COMPLETED|Overall Study||14||
59648359|NCT03970109|75766211|FG001|COMPLETED|Overall Study||10||
59648360|NCT03970109|75766212|FG002|COMPLETED|Overall Study||15||
59648361|NCT03970109|75766210|FG000|NOT COMPLETED|Overall Study||1||
59648362|NCT03970109|75766211|FG001|NOT COMPLETED|Overall Study||3||
59648363|NCT03970109|75766212|FG002|NOT COMPLETED|Overall Study||0||
59648364|NCT03954743|75766222|FG000|STARTED|Overall Study||677||
59648365|NCT03954743|75766223|FG001|STARTED|Overall Study||674||
59648366|NCT03954743|75766222|FG000|COMPLETED|Overall Study||653||
59648367|NCT03954743|75766223|FG001|COMPLETED|Overall Study||657||
59648368|NCT03954743|75766222|FG000|NOT COMPLETED|Overall Study||24||
59648369|NCT03954743|75766223|FG001|NOT COMPLETED|Overall Study||17||
59648370|NCT03954223|75766232|FG000|STARTED|Overall Study||15||
59648371|NCT03954223|75766233|FG001|STARTED|Overall Study||19||
59648372|NCT03954223|75766234|FG002|STARTED|Overall Study||16||
59648373|NCT03954223|75766232|FG000|COMPLETED|Overall Study||15||
59648374|NCT03954223|75766233|FG001|COMPLETED|Overall Study||19||
59648375|NCT03954223|75766234|FG002|COMPLETED|Overall Study||16||
59648376|NCT03954223|75766232|FG000|NOT COMPLETED|Overall Study||0||
59648377|NCT03954223|75766233|FG001|NOT COMPLETED|Overall Study||0||
59648378|NCT03954223|75766234|FG002|NOT COMPLETED|Overall Study||0||
59648379|NCT03880565|75766244|FG000|STARTED|Overall Study||15||
59648380|NCT03880565|75766245|FG001|STARTED|Overall Study||15||
59648381|NCT03880565|75766244|FG000|COMPLETED|Overall Study||14||
59648382|NCT03880565|75766245|FG001|COMPLETED|Overall Study||15||
59648383|NCT03880565|75766244|FG000|NOT COMPLETED|Overall Study||1||
59648384|NCT03880565|75766245|FG001|NOT COMPLETED|Overall Study||0||
59648385|NCT03782792|75766253|FG000|STARTED|Overall Study||18||
59648386|NCT03782792|75766254|FG001|STARTED|Overall Study||35||
59648387|NCT03782792|75766253|FG000|Received Open Label Treatment With Spesolimab at Wk1/D8|Overall Study||15|In addition to the randomized treatment, patients received also an i.v. dose of 900 mg spesolimab at Wk1/D8.|
59648388|NCT03782792|75766254|FG001|Received Open Label Treatment With Spesolimab at Wk1/D8|Overall Study||12|In addition to the randomized treatment, patients received also an i.v. dose of 900 mg spesolimab at Wk1/D8.|
59648389|NCT03782792|75766253|FG000|Received Rescue Treatment With Spesolimab After Wk1|Overall Study||2|In addition to the randomized treatment, Patients received also one single rescue i.v. dose of 900 mg spesolimab between Wk1 to Wk 12.|
59648390|NCT03782792|75766254|FG001|Received Rescue Treatment With Spesolimab After Wk1|Overall Study||4|In addition to the randomized treatment, Patients received also one single rescue i.v. dose of 900 mg spesolimab between Wk1 to Wk 12.|
59648391|NCT03782792|75766253|FG000|COMPLETED|Overall Study||17|Completed planned observation period.|
59648392|NCT03782792|75766254|FG001|COMPLETED|Overall Study||32|Completed planned observation period.|
59648393|NCT03782792|75766253|FG000|NOT COMPLETED|Overall Study||1||
59648394|NCT03782792|75766254|FG001|NOT COMPLETED|Overall Study||3||
59648395|NCT03733119|75766264|FG000|STARTED|Overall Study||2||
59648396|NCT03733119|75766265|FG001|STARTED|Overall Study||2||
59648397|NCT03733119|75766264|FG000|Treated|Overall Study||2||
59648398|NCT03733119|75766265|FG001|Treated|Overall Study||1||
59648399|NCT03733119|75766264|FG000|Stopped Treatment After 1 Dose|Overall Study||1|removed by physician for disease progression 2 days after first dose|
59648400|NCT03733119|75766265|FG001|Stopped Treatment After 1 Dose|Overall Study||0|removed by physician for disease progression 2 days after first dose|
59648401|NCT03733119|75766264|FG000|Stopped Treatment After 3 Cycles|Overall Study||1|removed by physician for disease progression after the first planned time point for disease evaluation|
59648402|NCT03733119|75766265|FG001|Stopped Treatment After 3 Cycles|Overall Study||1|removed by physician for disease progression after the first planned time point for disease evaluation|
59648403|NCT03733119|75766264|FG000|COMPLETED|Overall Study||0||
59648404|NCT03733119|75766265|FG001|COMPLETED|Overall Study||0||
59648405|NCT03733119|75766264|FG000|NOT COMPLETED|Overall Study||2||
59648406|NCT03733119|75766265|FG001|NOT COMPLETED|Overall Study||2||
59648407|NCT03661996|75766276|FG000|STARTED|Overall Study||162||
59648408|NCT03661996|75766277|FG001|STARTED|Overall Study||180||
59648409|NCT03661996|75766278|FG002|STARTED|Overall Study||176||
59648410|NCT03661996|75766279|FG003|STARTED|Overall Study||163||
59648411|NCT03661996|75766280|FG004|STARTED|Overall Study||173||
59648412|NCT03661996|75766276|FG000|Treated|Overall Study||162||
59648413|NCT03661996|75766277|FG001|Treated|Overall Study||179||
59648414|NCT03661996|75766278|FG002|Treated|Overall Study||175||
59648415|NCT03661996|75766279|FG003|Treated|Overall Study||160||
59648416|NCT03661996|75766280|FG004|Treated|Overall Study||172||
59648417|NCT03661996|75766276|FG000|COMPLETED|Overall Study||150||
59648418|NCT03661996|75766277|FG001|COMPLETED|Overall Study||172||
59648419|NCT03661996|75766278|FG002|COMPLETED|Overall Study||170||
59648420|NCT03661996|75766279|FG003|COMPLETED|Overall Study||150||
59648421|NCT03661996|75766280|FG004|COMPLETED|Overall Study||159||
59648422|NCT03661996|75766276|FG000|NOT COMPLETED|Overall Study||12||
59648423|NCT03661996|75766277|FG001|NOT COMPLETED|Overall Study||8||
59648424|NCT03661996|75766278|FG002|NOT COMPLETED|Overall Study||6||
59648425|NCT03661996|75766279|FG003|NOT COMPLETED|Overall Study||13||
59648426|NCT03661996|75766280|FG004|NOT COMPLETED|Overall Study||14||
59988635|NCT03382925|76103859|FG000|NOT COMPLETED|Overall Study||0||
59988636|NCT03382925|76103860|FG001|NOT COMPLETED|Overall Study||0||
59988637|NCT00796523|76103868|FG000|STARTED|Overall Study||27||
59648427|NCT03633461|75766297|FG000|STARTED|Overall Study||34||
59648428|NCT03633461|75766298|FG001|STARTED|Overall Study||19||
59648429|NCT03633461|75766297|FG000|COMPLETED|Overall Study||34||
59648430|NCT03633461|75766298|FG001|COMPLETED|Overall Study||18||
59648431|NCT03633461|75766297|FG000|NOT COMPLETED|Overall Study||0||
59648432|NCT03633461|75766298|FG001|NOT COMPLETED|Overall Study||1||
59648433|NCT03622658|75766306|FG000|STARTED|Overall Study||6||
59648434|NCT03622658|75766307|FG001|STARTED|Overall Study||36||
59648435|NCT03622658|75766306|FG000|COMPLETED|Overall Study||3||
59648436|NCT03622658|75766307|FG001|COMPLETED|Overall Study||32||
59648437|NCT03622658|75766306|FG000|NOT COMPLETED|Overall Study||3||
59648438|NCT03622658|75766307|FG001|NOT COMPLETED|Overall Study||4||
59648439|NCT03600142|75766315|FG000|STARTED|Overall Study||777||
59648440|NCT03600142|75766316|FG001|STARTED|Overall Study||762||
59542900|NCT01048502|75641051|FG003|COMPLETED|Overall Study||21||
59542901|NCT01048502|75641048|FG000|NOT COMPLETED|Overall Study||4||
59542902|NCT01048502|75641049|FG001|NOT COMPLETED|Overall Study||7||
59542903|NCT01048502|75641050|FG002|NOT COMPLETED|Overall Study||5||
59542904|NCT01048502|75641051|FG003|NOT COMPLETED|Overall Study||4||
59542905|NCT02465034|75641064|FG000|STARTED|Overall Study||19||
59542906|NCT02465034|75641065|FG001|STARTED|Overall Study||26||
59542907|NCT02465034|75641064|FG000|Started PAS|Overall Study||12||
59542908|NCT02465034|75641065|FG001|Started PAS|Overall Study||21||
59542909|NCT02465034|75641064|FG000|Completed PAS|Overall Study||9||
59542910|NCT02465034|75641065|FG001|Completed PAS|Overall Study||20||
59542911|NCT02465034|75641064|FG000|Started CC-PAS|Overall Study||16||
59542912|NCT02465034|75641065|FG001|Started CC-PAS|Overall Study||0||
59542913|NCT02465034|75641064|FG000|Completed CC-PAS|Overall Study||16||
59542914|NCT02465034|75641065|FG001|Completed CC-PAS|Overall Study||0||
59542915|NCT02465034|75641064|FG000|COMPLETED|Overall Study||16||
59542916|NCT02465034|75641065|FG001|COMPLETED|Overall Study||20||
59542917|NCT02465034|75641064|FG000|NOT COMPLETED|Overall Study||3||
59542918|NCT02465034|75641065|FG001|NOT COMPLETED|Overall Study||6||
59542919|NCT00918866|75641081|FG000|STARTED|Overall Study||16||
59542920|NCT00918866|75641082|FG001|STARTED|Overall Study||16||
59542921|NCT00918866|75641081|FG000|COMPLETED|Overall Study||16||
59542922|NCT00918866|75641082|FG001|COMPLETED|Overall Study||16||
59542923|NCT00918866|75641081|FG000|NOT COMPLETED|Overall Study||0||
59542924|NCT00918866|75641082|FG001|NOT COMPLETED|Overall Study||0||
59542925|NCT02516982|75641092|FG000|STARTED|Overall Study||305||
59542926|NCT02516982|75641093|FG001|STARTED|Overall Study||292||
59542927|NCT02516982|75641094|FG002|STARTED|Overall Study||174||
59542928|NCT02516982|75641095|FG003|STARTED|Overall Study||175||
59542929|NCT02516982|75641092|FG000|COMPLETED|Overall Study||273||
59542930|NCT02516982|75641093|FG001|COMPLETED|Overall Study||257||
59542931|NCT02516982|75641094|FG002|COMPLETED|Overall Study||126||
59542932|NCT02516982|75641095|FG003|COMPLETED|Overall Study||125||
59542933|NCT02516982|75641092|FG000|NOT COMPLETED|Overall Study||32||
59542934|NCT02516982|75641093|FG001|NOT COMPLETED|Overall Study||35||
59542935|NCT02516982|75641094|FG002|NOT COMPLETED|Overall Study||48||
59542936|NCT02516982|75641095|FG003|NOT COMPLETED|Overall Study||50||
59542937|NCT01583543|75641105|FG000|STARTED|Overall Study||12||
59542938|NCT01583543|75641105|FG000|COMPLETED|Overall Study||12||
59542939|NCT01583543|75641105|FG000|NOT COMPLETED|Overall Study||0||
59542940|NCT00919100|75641114|FG000|STARTED|Overall Study||40||
59542941|NCT00919100|75641115|FG001|STARTED|Overall Study||41||
59542942|NCT00919100|75641114|FG000|COMPLETED|Overall Study||40||
59542943|NCT00919100|75641115|FG001|COMPLETED|Overall Study||41||
59542944|NCT00919100|75641114|FG000|NOT COMPLETED|Overall Study||0||
59542945|NCT00919100|75641115|FG001|NOT COMPLETED|Overall Study||0||
59542946|NCT01584479|75641125|FG000|STARTED|Overall Study||732||
59542947|NCT01584479|75641126|FG001|STARTED|Overall Study||1686||
59542948|NCT01584479|75641127|FG002|STARTED|Overall Study||852||
59542949|NCT01584479|75641128|FG003|STARTED|Overall Study||1847||
59542950|NCT01584479|75641125|FG000|COMPLETED|Overall Study||732||
59542951|NCT01584479|75641126|FG001|COMPLETED|Overall Study||1686||
59542952|NCT01584479|75641127|FG002|COMPLETED|Overall Study||852||
59542953|NCT01584479|75641128|FG003|COMPLETED|Overall Study||1847||
59542954|NCT01584479|75641125|FG000|NOT COMPLETED|Overall Study||0||
59542955|NCT01584479|75641126|FG001|NOT COMPLETED|Overall Study||0||
59542956|NCT01584479|75641127|FG002|NOT COMPLETED|Overall Study||0||
59542957|NCT01584479|75641128|FG003|NOT COMPLETED|Overall Study||0||
59542958|NCT02464410|75641140|FG000|STARTED|Overall Study||147||
59542959|NCT02464410|75641141|FG001|STARTED|Overall Study||152||
59542960|NCT02464410|75641140|FG000|3-month Follow-up|Overall Study||137||
59542961|NCT02464410|75641141|FG001|3-month Follow-up|Overall Study||138||
59542962|NCT02464410|75641140|FG000|6-month Follow-up|Overall Study||132||
59542963|NCT02464410|75641141|FG001|6-month Follow-up|Overall Study||140||
59542964|NCT02464410|75641140|FG000|12-month Follow-up|Overall Study||125||
59542965|NCT02464410|75641141|FG001|12-month Follow-up|Overall Study||136||
59542966|NCT02464410|75641140|FG000|COMPLETED|Overall Study||125||
59542967|NCT02464410|75641141|FG001|COMPLETED|Overall Study||136||
59542968|NCT02464410|75641140|FG000|NOT COMPLETED|Overall Study||22||
59542969|NCT02464410|75641141|FG001|NOT COMPLETED|Overall Study||16||
59542970|NCT01047332|75641149|FG000|STARTED|Overall Study||61||
59542971|NCT01047332|75641150|FG001|STARTED|Overall Study||68||
59542972|NCT01047332|75641149|FG000|COMPLETED|Overall Study|Alive at final follow-up|4||
59542973|NCT01047332|75641150|FG001|COMPLETED|Overall Study|Alive at final follow-up|4||
59542974|NCT01047332|75641149|FG000|NOT COMPLETED|Overall Study||57||
59542975|NCT01047332|75641150|FG001|NOT COMPLETED|Overall Study||64||
59542976|NCT01046396|75641156|FG000|STARTED|Overall Study||69||
59542977|NCT01046396|75641156|FG000|COMPLETED|Overall Study||64||
59542978|NCT01046396|75641156|FG000|NOT COMPLETED|Overall Study||5||
59542979|NCT01586039|75641167|FG000|STARTED|Overall Study||8||
59542980|NCT01586039|75641168|FG001|STARTED|Overall Study||9||
59542981|NCT01586039|75641169|FG002|STARTED|Overall Study||8||
59542982|NCT01586039|75641170|FG003|STARTED|Overall Study||8||
59542983|NCT01586039|75641167|FG000|COMPLETED|Overall Study||8||
59542984|NCT01586039|75641168|FG001|COMPLETED|Overall Study||8||
59648441|NCT03600142|75766315|FG000|COMPLETED|Overall Study||773||
59648442|NCT03600142|75766316|FG001|COMPLETED|Overall Study||758||
59648443|NCT03600142|75766315|FG000|NOT COMPLETED|Overall Study||4||
59648444|NCT03600142|75766316|FG001|NOT COMPLETED|Overall Study||4||
59648445|NCT03499314|75766326|FG000|STARTED|Overall Study||33||
59648446|NCT03499314|75766327|FG001|STARTED|Overall Study||32||
59648447|NCT03499314|75766326|FG000|COMPLETED|Overall Study||31||
59648448|NCT03499314|75766327|FG001|COMPLETED|Overall Study||29||
59648449|NCT03499314|75766326|FG000|NOT COMPLETED|Overall Study||2||
59648450|NCT03499314|75766327|FG001|NOT COMPLETED|Overall Study||3||
59648451|NCT03369431|75766335|FG000|STARTED|Overall Study||35||
59648452|NCT03369431|75766336|FG001|STARTED|Overall Study||34||
59648453|NCT03369431|75766335|FG000|Taste Test (1 Week)|Overall Study||35||
59648454|NCT03369431|75766336|FG001|Taste Test (1 Week)|Overall Study||34||
59648455|NCT03369431|75766335|FG000|Part 1 Treatment (12 Weeks)|Overall Study||34||
59648456|NCT03369431|75766336|FG001|Part 1 Treatment (12 Weeks)|Overall Study||34||
59648457|NCT03369431|75766335|FG000|Washout (4 Weeks)|Overall Study||34||
59648458|NCT03369431|75766336|FG001|Washout (4 Weeks)|Overall Study||32||
59648459|NCT03369431|75766335|FG000|Part 2 Treatment (12 Weeks)|Overall Study||34||
59648460|NCT03369431|75766336|FG001|Part 2 Treatment (12 Weeks)|Overall Study||32||
59648461|NCT03369431|75766335|FG000|COMPLETED|Overall Study||31||
59648462|NCT03369431|75766336|FG001|COMPLETED|Overall Study||27||
59648463|NCT03369431|75766335|FG000|NOT COMPLETED|Overall Study||4||
59648464|NCT03369431|75766336|FG001|NOT COMPLETED|Overall Study||7||
59648465|NCT03336866|75766345|FG000|STARTED|Overall Study||20||
59648466|NCT03336866|75766346|FG001|STARTED|Overall Study||18||
59648467|NCT03336866|75766347|FG002|STARTED|Overall Study||18||
59648468|NCT03336866|75766345|FG000|COMPLETED|Overall Study||17||
59648469|NCT03336866|75766346|FG001|COMPLETED|Overall Study||17||
59648470|NCT03336866|75766347|FG002|COMPLETED|Overall Study||14||
59648471|NCT03336866|75766345|FG000|NOT COMPLETED|Overall Study||3||
59648472|NCT03336866|75766346|FG001|NOT COMPLETED|Overall Study||1||
59648473|NCT03336866|75766347|FG002|NOT COMPLETED|Overall Study||4||
59648474|NCT03332173|75766360|FG000|STARTED|Overall Study||44||
59648475|NCT03332173|75766360|FG000|COMPLETED|Overall Study||0||
59648476|NCT03332173|75766360|FG000|NOT COMPLETED|Overall Study||44||
59648477|NCT03322293|75766367|FG000|STARTED|Overall Study||8||
59648478|NCT03322293|75766368|FG001|STARTED|Overall Study||8||
59648479|NCT03322293|75766369|FG002|STARTED|Overall Study||8||
59648480|NCT03322293|75766367|FG000|COMPLETED|Overall Study||8||
59648481|NCT03322293|75766368|FG001|COMPLETED|Overall Study||8||
59648482|NCT03322293|75766369|FG002|COMPLETED|Overall Study||7||
59648483|NCT03322293|75766367|FG000|NOT COMPLETED|Overall Study||0||
59648484|NCT03322293|75766368|FG001|NOT COMPLETED|Overall Study||0||
59648485|NCT03322293|75766369|FG002|NOT COMPLETED|Overall Study||1||
59648486|NCT03315039|75766379|FG000|STARTED|Overall Study||4||
59648487|NCT03315039|75766380|FG001|STARTED|Overall Study||3||
59648488|NCT03315039|75766379|FG000|COMPLETED|Overall Study||4||
59648489|NCT03315039|75766380|FG001|COMPLETED|Overall Study||3||
59648490|NCT03315039|75766379|FG000|NOT COMPLETED|Overall Study||0||
59648491|NCT03315039|75766380|FG001|NOT COMPLETED|Overall Study||0||
59648492|NCT03254394|75766391|FG000|STARTED|Overall Study||12||
59648493|NCT03254394|75766392|FG001|STARTED|Overall Study||14||
59648494|NCT03254394|75766391|FG000|COMPLETED|Overall Study||12||
59648495|NCT03254394|75766392|FG001|COMPLETED|Overall Study||12||
59648496|NCT03254394|75766391|FG000|NOT COMPLETED|Overall Study||0||
59648497|NCT03254394|75766392|FG001|NOT COMPLETED|Overall Study||2||
59648498|NCT03253809|75766398|FG000|STARTED|Overall Study||14||
59648499|NCT03253809|75766398|FG000|COMPLETED|Overall Study||0||
59648500|NCT03253809|75766398|FG000|NOT COMPLETED|Overall Study||14||
59648501|NCT03180294|75766405|FG000|STARTED|Overall Study||79||
59648502|NCT03180294|75766406|FG001|STARTED|Overall Study||74||
59648503|NCT03180294|75766407|FG002|STARTED|Overall Study||77||
59648504|NCT03180294|75766405|FG000|Eligible Population|Overall Study||79||
59648505|NCT03180294|75766406|FG001|Eligible Population|Overall Study||74||
59648506|NCT03180294|75766407|FG002|Eligible Population|Overall Study||77||
59648507|NCT03180294|75766405|FG000|Adverse Event Population|Overall Study||77|Eligible participants with adverse event data who started study treatment.|
59648508|NCT03180294|75766406|FG001|Adverse Event Population|Overall Study||73|Eligible participants with adverse event data who started study treatment.|
59648509|NCT03180294|75766407|FG002|Adverse Event Population|Overall Study||76|Eligible participants with adverse event data who started study treatment.|
59648510|NCT03180294|75766405|FG000|COMPLETED|Overall Study||79|Participants contributing data to results are considered to have completed the study.|
59648511|NCT03180294|75766406|FG001|COMPLETED|Overall Study||74|Participants contributing data to results are considered to have completed the study.|
59648512|NCT03180294|75766407|FG002|COMPLETED|Overall Study||77|Participants contributing data to results are considered to have completed the study.|
59648513|NCT03180294|75766405|FG000|NOT COMPLETED|Overall Study||0||
59648514|NCT03180294|75766406|FG001|NOT COMPLETED|Overall Study||0||
59648515|NCT03180294|75766407|FG002|NOT COMPLETED|Overall Study||0||
59648516|NCT03111030|75766418|FG000|STARTED|Overall Study||14||
59648517|NCT03111030|75766419|FG001|STARTED|Overall Study||14||
59648518|NCT03111030|75766418|FG000|COMPLETED|Overall Study||14||
59648519|NCT03111030|75766419|FG001|COMPLETED|Overall Study||14||
59648520|NCT03111030|75766418|FG000|NOT COMPLETED|Overall Study||0||
59648521|NCT03111030|75766419|FG001|NOT COMPLETED|Overall Study||0||
59648522|NCT03061903|75766427|FG000|STARTED|Overall Study||61||
59648523|NCT03061903|75766428|FG001|STARTED|Overall Study||61||
59648524|NCT03061903|75766427|FG000|COMPLETED|Overall Study||60||
59648525|NCT03061903|75766428|FG001|COMPLETED|Overall Study||60||
59648526|NCT03061903|75766427|FG000|NOT COMPLETED|Overall Study||1||
59648527|NCT03061903|75766428|FG001|NOT COMPLETED|Overall Study||1||
59648528|NCT03015142|75766434|FG000|STARTED|Overall Study||21||
59648529|NCT03015142|75766434|FG000|COMPLETED|Overall Study||20||
59648530|NCT03015142|75766434|FG000|NOT COMPLETED|Overall Study||1||
59648531|NCT03012672|75766442|FG000|STARTED|Overall Study||20||
59648532|NCT03012672|75766443|FG001|STARTED|Overall Study||30||
59648533|NCT03012672|75766442|FG000|COMPLETED|Overall Study||20||
59648534|NCT03012672|75766443|FG001|COMPLETED|Overall Study||30||
59648535|NCT03012672|75766442|FG000|NOT COMPLETED|Overall Study||0||
59648536|NCT03012672|75766443|FG001|NOT COMPLETED|Overall Study||0||
59648537|NCT03011775|75766450|FG000|STARTED|Overall Study||20||
59648538|NCT03011775|75766451|FG001|STARTED|Overall Study||23||
59648539|NCT03011775|75766450|FG000|COMPLETED|Overall Study||20||
59648540|NCT03011775|75766451|FG001|COMPLETED|Overall Study||23||
59648541|NCT03011775|75766450|FG000|NOT COMPLETED|Overall Study||0||
59648542|NCT03011775|75766451|FG001|NOT COMPLETED|Overall Study||0||
59648543|NCT03007485|75766463|FG000|STARTED|Overall Study||98||
59648544|NCT03007485|75766464|FG001|STARTED|Overall Study||111||
59648545|NCT03007485|75766463|FG000|COMPLETED|Overall Study||28||
59648546|NCT03007485|75766464|FG001|COMPLETED|Overall Study||57||
59648547|NCT03007485|75766463|FG000|NOT COMPLETED|Overall Study||70||
59648548|NCT03007485|75766464|FG001|NOT COMPLETED|Overall Study||54||
59648549|NCT02998476|75766477|FG000|STARTED|Overall Study||55|60|
59648550|NCT02998476|75766478|FG001|STARTED|Overall Study||5|60|
59648551|NCT02998476|75766477|FG000|COMPLETED|Overall Study||0|0|
59648552|NCT02998476|75766478|FG001|COMPLETED|Overall Study||0|0|
59648553|NCT02998476|75766477|FG000|NOT COMPLETED|Overall Study||55||
59648554|NCT02998476|75766478|FG001|NOT COMPLETED|Overall Study||5||
59648555|NCT02960997|75766487|FG000|STARTED|First Intervention, 12 Weeks||4||
59648556|NCT02960997|75766488|FG001|STARTED|First Intervention, 12 Weeks||4||
59648557|NCT02960997|75766487|FG000|COMPLETED|First Intervention, 12 Weeks||4||
59648558|NCT02960997|75766488|FG001|COMPLETED|First Intervention, 12 Weeks||4||
59648559|NCT02960997|75766487|FG000|NOT COMPLETED|First Intervention, 12 Weeks||0||
59648560|NCT02960997|75766488|FG001|NOT COMPLETED|First Intervention, 12 Weeks||0||
59648561|NCT02960997|75766487|FG000|STARTED|Washout Period, 4 Weeks||4||
59648562|NCT02960997|75766488|FG001|STARTED|Washout Period, 4 Weeks||4||
59648563|NCT02960997|75766487|FG000|COMPLETED|Washout Period, 4 Weeks||4||
59648564|NCT02960997|75766488|FG001|COMPLETED|Washout Period, 4 Weeks||4||
59648565|NCT02960997|75766487|FG000|NOT COMPLETED|Washout Period, 4 Weeks||0||
59648566|NCT02960997|75766488|FG001|NOT COMPLETED|Washout Period, 4 Weeks||0||
59648567|NCT02960997|75766487|FG000|STARTED|Second Treatment, 12 Weeks||4||
59648568|NCT02960997|75766488|FG001|STARTED|Second Treatment, 12 Weeks||4||
59648569|NCT02960997|75766487|FG000|COMPLETED|Second Treatment, 12 Weeks||4||
59648570|NCT02960997|75766488|FG001|COMPLETED|Second Treatment, 12 Weeks||4||
59648571|NCT02960997|75766487|FG000|NOT COMPLETED|Second Treatment, 12 Weeks||0||
59648572|NCT02960997|75766488|FG001|NOT COMPLETED|Second Treatment, 12 Weeks||0||
59648573|NCT02960997|75766487|FG000|STARTED|Follow-up Period, 4 Weeks||4||
59542985|NCT01586039|75641169|FG002|COMPLETED|Overall Study||8||
59542986|NCT01586039|75641170|FG003|COMPLETED|Overall Study||8||
59542987|NCT01586039|75641167|FG000|NOT COMPLETED|Overall Study||0||
59648574|NCT02960997|75766488|FG001|STARTED|Follow-up Period, 4 Weeks||4||
59648575|NCT02960997|75766487|FG000|COMPLETED|Follow-up Period, 4 Weeks||4||
59648576|NCT02960997|75766488|FG001|COMPLETED|Follow-up Period, 4 Weeks||4||
59648577|NCT02960997|75766487|FG000|NOT COMPLETED|Follow-up Period, 4 Weeks||0||
59648578|NCT02960997|75766488|FG001|NOT COMPLETED|Follow-up Period, 4 Weeks||0||
59542988|NCT01586039|75641168|FG001|NOT COMPLETED|Overall Study||1||
59542989|NCT01586039|75641169|FG002|NOT COMPLETED|Overall Study||0||
59542990|NCT01586039|75641170|FG003|NOT COMPLETED|Overall Study||0||
59542991|NCT01046084|75641182|FG000|STARTED|First Intervention||25||
59542992|NCT01046084|75641183|FG001|STARTED|First Intervention||25||
59648579|NCT02924064|75766496|FG000|STARTED|Overall Study||123||
59648580|NCT02924064|75766497|FG001|STARTED|Overall Study||124||
59648581|NCT02924064|75766496|FG000|FAS|Overall Study||122||
59648582|NCT02924064|75766497|FG001|FAS|Overall Study||124||
59648583|NCT02924064|75766496|FG000|COMPLETED|Overall Study||99||
59648584|NCT02924064|75766497|FG001|COMPLETED|Overall Study||81||
59648585|NCT02924064|75766496|FG000|NOT COMPLETED|Overall Study||24||
59648586|NCT02924064|75766497|FG001|NOT COMPLETED|Overall Study||43||
59648587|NCT02916706|75766505|FG000|STARTED|Overall Study||127||
59648588|NCT02916706|75766506|FG001|STARTED|Overall Study||127||
59542993|NCT01046084|75641182|FG000|COMPLETED|First Intervention||25||
59542994|NCT01046084|75641183|FG001|COMPLETED|First Intervention||25||
59542995|NCT01046084|75641182|FG000|NOT COMPLETED|First Intervention||0||
59542996|NCT01046084|75641183|FG001|NOT COMPLETED|First Intervention||0||
59542997|NCT01046084|75641182|FG000|STARTED|First Washout of 7 Days||25||
59648589|NCT02916706|75766505|FG000|FAS|Overall Study||125||
59648590|NCT02916706|75766506|FG001|FAS|Overall Study||126||
59648591|NCT02916706|75766505|FG000|COMPLETED|Overall Study||112||
59648592|NCT02916706|75766506|FG001|COMPLETED|Overall Study||96||
59648593|NCT02916706|75766505|FG000|NOT COMPLETED|Overall Study||15||
59648594|NCT02916706|75766506|FG001|NOT COMPLETED|Overall Study||31||
59648595|NCT02889900|75766512|FG000|STARTED|Overall Study||62||
59648596|NCT02889900|75766512|FG000|Received Treatment|Overall Study||60||
59648597|NCT02889900|75766512|FG000|COMPLETED|Overall Study|Patients ongoing in study at primary analysis data cut off (DCO)|5||
59648598|NCT02889900|75766512|FG000|NOT COMPLETED|Overall Study||57||
59648599|NCT02866695|75766516|FG000|STARTED|Overall Study||20||
59648600|NCT02866695|75766516|FG000|COMPLETED|Overall Study||18||
59648601|NCT02866695|75766516|FG000|NOT COMPLETED|Overall Study||2||
59648602|NCT02834793|75766522|FG000|STARTED|Core Study (Up to 18 Weeks)||36||
59648603|NCT02834793|75766523|FG001|STARTED|Core Study (Up to 18 Weeks)||34||
59648604|NCT02834793|75766524|FG002|STARTED|Core Study (Up to 18 Weeks)||0||
59648605|NCT02834793|75766525|FG003|STARTED|Core Study (Up to 18 Weeks)||0||
59648606|NCT02834793|75766522|FG000|COMPLETED|Core Study (Up to 18 Weeks)||32||
59648607|NCT02834793|75766523|FG001|COMPLETED|Core Study (Up to 18 Weeks)||29||
59648608|NCT02834793|75766524|FG002|COMPLETED|Core Study (Up to 18 Weeks)||0||
59648609|NCT02834793|75766525|FG003|COMPLETED|Core Study (Up to 18 Weeks)||0||
59648610|NCT02834793|75766522|FG000|NOT COMPLETED|Core Study (Up to 18 Weeks)||4||
59648611|NCT02834793|75766523|FG001|NOT COMPLETED|Core Study (Up to 18 Weeks)||5||
59648612|NCT02834793|75766524|FG002|NOT COMPLETED|Core Study (Up to 18 Weeks)||0||
59648613|NCT02834793|75766525|FG003|NOT COMPLETED|Core Study (Up to 18 Weeks)||0||
59648614|NCT02834793|75766522|FG000|STARTED|Extension Phase A (up to 52 Weeks)||0||
59648615|NCT02834793|75766523|FG001|STARTED|Extension Phase A (up to 52 Weeks)||0||
59648616|NCT02834793|75766524|FG002|STARTED|Extension Phase A (up to 52 Weeks)|Only eligible participants who completed Core Study entered into Extension Phase A.|58||
59648617|NCT02834793|75766525|FG003|STARTED|Extension Phase A (up to 52 Weeks)||0||
59648618|NCT02834793|75766522|FG000|COMPLETED|Extension Phase A (up to 52 Weeks)||0||
59648619|NCT02834793|75766523|FG001|COMPLETED|Extension Phase A (up to 52 Weeks)||0||
59648620|NCT02834793|75766524|FG002|COMPLETED|Extension Phase A (up to 52 Weeks)||32||
59648621|NCT02834793|75766525|FG003|COMPLETED|Extension Phase A (up to 52 Weeks)||0||
59648622|NCT02834793|75766522|FG000|NOT COMPLETED|Extension Phase A (up to 52 Weeks)||0||
59648623|NCT02834793|75766523|FG001|NOT COMPLETED|Extension Phase A (up to 52 Weeks)||0||
59648624|NCT02834793|75766524|FG002|NOT COMPLETED|Extension Phase A (up to 52 Weeks)||26||
59648625|NCT02834793|75766525|FG003|NOT COMPLETED|Extension Phase A (up to 52 Weeks)||0||
59648626|NCT02834793|75766522|FG000|STARTED|Extension Phase B (up to 188 Weeks)||0||
59648627|NCT02834793|75766523|FG001|STARTED|Extension Phase B (up to 188 Weeks)||0||
59648628|NCT02834793|75766524|FG002|STARTED|Extension Phase B (up to 188 Weeks)||0||
59648629|NCT02834793|75766525|FG003|STARTED|Extension Phase B (up to 188 Weeks)|Only eligible participants who completed Extension Phase A entered into Extension Phase B.|13||
59648630|NCT02834793|75766522|FG000|COMPLETED|Extension Phase B (up to 188 Weeks)||0||
59648631|NCT02834793|75766523|FG001|COMPLETED|Extension Phase B (up to 188 Weeks)||0||
59648632|NCT02834793|75766524|FG002|COMPLETED|Extension Phase B (up to 188 Weeks)||0||
59648633|NCT02834793|75766525|FG003|COMPLETED|Extension Phase B (up to 188 Weeks)||1||
59648634|NCT02834793|75766522|FG000|NOT COMPLETED|Extension Phase B (up to 188 Weeks)||0||
59648635|NCT02834793|75766523|FG001|NOT COMPLETED|Extension Phase B (up to 188 Weeks)||0||
59648636|NCT02834793|75766524|FG002|NOT COMPLETED|Extension Phase B (up to 188 Weeks)||0||
59648637|NCT02834793|75766525|FG003|NOT COMPLETED|Extension Phase B (up to 188 Weeks)||12||
59648638|NCT02810457|75766535|FG000|STARTED|Overall Study|362 patients received study treatment|364||
59648639|NCT02810457|75766536|FG001|STARTED|Overall Study|366 patients received study treatment|367||
59648640|NCT02810457|75766535|FG000|COMPLETED|Overall Study||37|Patients still in the study at DCO|
59648641|NCT02810457|75766536|FG001|COMPLETED|Overall Study||38|Patients still in the study at DCO|
59648642|NCT02810457|75766535|FG000|NOT COMPLETED|Overall Study||327||
59648643|NCT02810457|75766536|FG001|NOT COMPLETED|Overall Study||329||
59648644|NCT02745535|75766542|FG000|STARTED|Overall Study||77||
59648645|NCT02745535|75766542|FG000|Sustained Virologic Repsonse|Overall Study|Sustained Virologic response measured 24 weeks after completing study medication|70||
59648646|NCT02745535|75766542|FG000|COMPLETED|Overall Study|Completed 12 weeks of study medication per protocol|71||
59648647|NCT02745535|75766542|FG000|NOT COMPLETED|Overall Study||6||
59648648|NCT02729701|75766546|FG000|STARTED|Overall Study||28||
59648649|NCT02729701|75766546|FG000|COMPLETED|Overall Study||28||
59815776|NCT03026283|75938218|FG007|STARTED|Optimal Medical Care/FFR-CT Diagnosis||0|Note: Number of participants to start period is not equal to number who completed previous period.|
59815777|NCT03026283|75938211|FG000|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0||
59648650|NCT02729701|75766546|FG000|NOT COMPLETED|Overall Study||0||
59648651|NCT02684253|75766552|FG000|STARTED|Overall Study||32||
59648652|NCT02684253|75766553|FG001|STARTED|Overall Study||33||
59648653|NCT02684253|75766552|FG000|COMPLETED|Overall Study||32||
59648654|NCT02684253|75766553|FG001|COMPLETED|Overall Study||33||
59648655|NCT02684253|75766552|FG000|NOT COMPLETED|Overall Study||0||
59648656|NCT02684253|75766553|FG001|NOT COMPLETED|Overall Study||0||
59815778|NCT03026283|75938212|FG001|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||286||
59648657|NCT02681406|75766563|FG000|STARTED|Overall Study||65||
59648658|NCT02681406|75766564|FG001|STARTED|Overall Study||59||
59648659|NCT02681406|75766565|FG002|STARTED|Overall Study||68||
59648660|NCT02681406|75766566|FG003|STARTED|Overall Study||70||
59648661|NCT02681406|75766563|FG000|COMPLETED|Overall Study||49||
59648662|NCT02681406|75766564|FG001|COMPLETED|Overall Study||35||
59648663|NCT02681406|75766565|FG002|COMPLETED|Overall Study||42||
59648664|NCT02681406|75766566|FG003|COMPLETED|Overall Study||58||
59648665|NCT02681406|75766563|FG000|NOT COMPLETED|Overall Study||16||
59648666|NCT02681406|75766564|FG001|NOT COMPLETED|Overall Study||24||
59648667|NCT02681406|75766565|FG002|NOT COMPLETED|Overall Study||26||
59648668|NCT02681406|75766566|FG003|NOT COMPLETED|Overall Study||12||
59648669|NCT02625090|75766576|FG000|STARTED|Overall Study||42||
59648670|NCT02625090|75766576|FG000|COMPLETED|Overall Study||0||
59648671|NCT02625090|75766576|FG000|NOT COMPLETED|Overall Study||42||
59648672|NCT02539225|75766583|FG000|STARTED|Part A||97||
59648673|NCT02539225|75766584|FG001|STARTED|Part A||94||
59648674|NCT02539225|75766583|FG000|Received Any Quantity of Study Drug|Part A||96||
59648675|NCT02539225|75766584|FG001|Received Any Quantity of Study Drug|Part A||93||
59648676|NCT02539225|75766583|FG000|COMPLETED|Part A||77||
59648677|NCT02539225|75766584|FG001|COMPLETED|Part A||78||
59648678|NCT02539225|75766583|FG000|NOT COMPLETED|Part A||20||
59648679|NCT02539225|75766584|FG001|NOT COMPLETED|Part A||16||
59648680|NCT02539225|75766583|FG000|STARTED|Pre Treatment for Part B|Participants who met initiation criteria of Part B were allowed to pretreatment for part B.|63||
59648681|NCT02539225|75766584|FG001|STARTED|Pre Treatment for Part B|Participants who met initiation criteria of Part B were allowed to pretreatment for part B.|66||
59648682|NCT02539225|75766583|FG000|COMPLETED|Pre Treatment for Part B||58||
59648683|NCT02539225|75766584|FG001|COMPLETED|Pre Treatment for Part B||64||
59648684|NCT02539225|75766583|FG000|NOT COMPLETED|Pre Treatment for Part B||5||
59648685|NCT02539225|75766584|FG001|NOT COMPLETED|Pre Treatment for Part B||2||
59648686|NCT02539225|75766583|FG000|STARTED|Part B||58||
59648687|NCT02539225|75766584|FG001|STARTED|Part B||64||
59648688|NCT02539225|75766583|FG000|COMPLETED|Part B||54||
59648689|NCT02539225|75766584|FG001|COMPLETED|Part B||48||
59648690|NCT02539225|75766583|FG000|NOT COMPLETED|Part B||4||
59648691|NCT02539225|75766584|FG001|NOT COMPLETED|Part B||16||
59648692|NCT02526017|75766604|FG000|STARTED|Overall Study||3||
59648693|NCT02526017|75766605|FG001|STARTED|Overall Study||10||
59648694|NCT02526017|75766606|FG002|STARTED|Overall Study||11||
59648695|NCT02526017|75766607|FG003|STARTED|Overall Study||4||
59648696|NCT02526017|75766608|FG004|STARTED|Overall Study||4||
59648697|NCT02526017|75766609|FG005|STARTED|Overall Study||3||
59648698|NCT02526017|75766610|FG006|STARTED|Overall Study||6||
59648699|NCT02526017|75766611|FG007|STARTED|Overall Study||10||
59648700|NCT02526017|75766612|FG008|STARTED|Overall Study||262||
59648701|NCT02526017|75766604|FG000|Received Study Treatment|Overall Study||3||
59648702|NCT02526017|75766605|FG001|Received Study Treatment|Overall Study||10||
59648703|NCT02526017|75766606|FG002|Received Study Treatment|Overall Study||11||
59648704|NCT02526017|75766607|FG003|Received Study Treatment|Overall Study||4||
59648705|NCT02526017|75766608|FG004|Received Study Treatment|Overall Study||3||
59648706|NCT02526017|75766609|FG005|Received Study Treatment|Overall Study||3||
59648707|NCT02526017|75766610|FG006|Received Study Treatment|Overall Study||6||
59648708|NCT02526017|75766611|FG007|Received Study Treatment|Overall Study||10||
59648709|NCT02526017|75766612|FG008|Received Study Treatment|Overall Study||262||
59648710|NCT02526017|75766604|FG000|COMPLETED|Overall Study||3||
59648711|NCT02526017|75766605|FG001|COMPLETED|Overall Study||10||
59648712|NCT02526017|75766606|FG002|COMPLETED|Overall Study||11||
59648713|NCT02526017|75766607|FG003|COMPLETED|Overall Study||4||
59648714|NCT02526017|75766608|FG004|COMPLETED|Overall Study||3||
59648715|NCT02526017|75766609|FG005|COMPLETED|Overall Study||3||
59648716|NCT02526017|75766610|FG006|COMPLETED|Overall Study||6||
59648717|NCT02526017|75766611|FG007|COMPLETED|Overall Study||10||
59648718|NCT02526017|75766612|FG008|COMPLETED|Overall Study||262||
59648719|NCT02526017|75766604|FG000|NOT COMPLETED|Overall Study||0||
59648720|NCT02526017|75766605|FG001|NOT COMPLETED|Overall Study||0||
59648721|NCT02526017|75766606|FG002|NOT COMPLETED|Overall Study||0||
59648722|NCT02526017|75766607|FG003|NOT COMPLETED|Overall Study||0||
59648723|NCT02526017|75766608|FG004|NOT COMPLETED|Overall Study||1||
59648724|NCT02526017|75766609|FG005|NOT COMPLETED|Overall Study||0||
59648725|NCT02526017|75766610|FG006|NOT COMPLETED|Overall Study||0||
59648726|NCT02526017|75766611|FG007|NOT COMPLETED|Overall Study||0||
59648727|NCT02526017|75766612|FG008|NOT COMPLETED|Overall Study||0||
59648728|NCT02417415|75766672|FG000|STARTED|Overall Study||13||
59648729|NCT02417415|75766673|FG001|STARTED|Overall Study||9||
59648730|NCT02417415|75766672|FG000|COMPLETED|Overall Study||13||
59648731|NCT02417415|75766673|FG001|COMPLETED|Overall Study||9||
59648732|NCT02417415|75766672|FG000|NOT COMPLETED|Overall Study||0||
59648733|NCT02417415|75766673|FG001|NOT COMPLETED|Overall Study||0||
59648734|NCT02369653|75766681|FG000|STARTED|Overall Study||256||
59648735|NCT02369653|75766682|FG001|STARTED|Overall Study||256||
59648736|NCT02369653|75766681|FG000|Adverse Event Analysis Population|Overall Study|Out of the 256 participants randomized to Apixaban only 250 participants received an apixaban dose.|250||
59709648|NCT01235741|75828431|FG002|NOT COMPLETED|Randomized to Treatment||36||
59648737|NCT02369653|75766682|FG001|Adverse Event Analysis Population|Overall Study|The 6 subjects who were randomized to apixaban but received no dose were analyzed in Standard of Care.|262||
59648738|NCT02369653|75766681|FG000|COMPLETED|Overall Study||242||
59648739|NCT02369653|75766682|FG001|COMPLETED|Overall Study||249||
59648740|NCT02369653|75766681|FG000|NOT COMPLETED|Overall Study||14||
59648741|NCT02369653|75766682|FG001|NOT COMPLETED|Overall Study||7||
59648742|NCT02284568|75766695|FG000|STARTED|Overall Study|Intent to treat (ITT) population|140||
59648743|NCT02284568|75766696|FG001|STARTED|Overall Study|Intent to treat (ITT) population|139||
59648744|NCT02284568|75766697|FG002|STARTED|Overall Study|Intent to treat (ITT) population|95||
59648745|NCT02284568|75766695|FG000|Safety Population|Overall Study||140||
59648746|NCT02284568|75766696|FG001|Safety Population|Overall Study||138||
59648747|NCT02284568|75766697|FG002|Safety Population|Overall Study||95||
59648748|NCT02284568|75766695|FG000|Completed Week 48 MRI - on Treatment|Overall Study||113||
59648749|NCT02284568|75766696|FG001|Completed Week 48 MRI - on Treatment|Overall Study||107||
59648750|NCT02284568|75766697|FG002|Completed Week 48 MRI - on Treatment|Overall Study||0||
59648751|NCT02284568|75766695|FG000|COMPLETED|Overall Study||109||
59648752|NCT02284568|75766696|FG001|COMPLETED|Overall Study||93||
59648753|NCT02284568|75766697|FG002|COMPLETED|Overall Study||0||
59648754|NCT02284568|75766695|FG000|NOT COMPLETED|Overall Study||31||
59648755|NCT02284568|75766696|FG001|NOT COMPLETED|Overall Study||46||
59648756|NCT02284568|75766697|FG002|NOT COMPLETED|Overall Study||95||
59648757|NCT02228525|75766705|FG000|STARTED|Overall Study||25||
59648758|NCT02228525|75766705|FG000|COMPLETED|Overall Study||25||
59648759|NCT02228525|75766705|FG000|NOT COMPLETED|Overall Study||0||
59648760|NCT02195986|75766712|FG000|STARTED|Overall Study||146||
59648761|NCT02195986|75766713|FG001|STARTED|Overall Study||147||
59648762|NCT02195986|75766714|FG002|STARTED|Overall Study||73||
59648763|NCT02195986|75766712|FG000|COMPLETED|Overall Study||143||
59648764|NCT02195986|75766713|FG001|COMPLETED|Overall Study||142||
59648765|NCT02195986|75766714|FG002|COMPLETED|Overall Study||71||
59648766|NCT02195986|75766712|FG000|NOT COMPLETED|Overall Study||3||
59648767|NCT02195986|75766713|FG001|NOT COMPLETED|Overall Study||5||
59648768|NCT02195986|75766714|FG002|NOT COMPLETED|Overall Study||2||
59648769|NCT01982630|75766730|FG000|STARTED|Overall Study||10||
59648770|NCT01982630|75766731|FG001|STARTED|Overall Study||8||
59648771|NCT01982630|75766732|FG002|STARTED|Overall Study||13||
59648772|NCT01982630|75766733|FG003|STARTED|Overall Study||9||
59648773|NCT01982630|75766734|FG004|STARTED|Overall Study||19||
59648774|NCT01982630|75766735|FG005|STARTED|Overall Study||14||
59648775|NCT01982630|75766736|FG006|STARTED|Overall Study||6||
59648776|NCT01982630|75766737|FG007|STARTED|Overall Study||8||
59648777|NCT01982630|75766730|FG000|Treated|Overall Study||9||
59648778|NCT01982630|75766731|FG001|Treated|Overall Study||8||
59648779|NCT01982630|75766732|FG002|Treated|Overall Study||11||
59648780|NCT01982630|75766733|FG003|Treated|Overall Study||9||
59648781|NCT01982630|75766734|FG004|Treated|Overall Study||18||
59542998|NCT01046084|75641183|FG001|STARTED|First Washout of 7 Days||25||
59542999|NCT01046084|75641182|FG000|COMPLETED|First Washout of 7 Days||25||
59543000|NCT01046084|75641183|FG001|COMPLETED|First Washout of 7 Days||25||
59543001|NCT01046084|75641182|FG000|NOT COMPLETED|First Washout of 7 Days||0||
59543002|NCT01046084|75641183|FG001|NOT COMPLETED|First Washout of 7 Days||0||
59543003|NCT01046084|75641182|FG000|STARTED|Second Intervention||25||
59648782|NCT01982630|75766735|FG005|Treated|Overall Study||14||
59648783|NCT01982630|75766736|FG006|Treated|Overall Study||6||
59648784|NCT01982630|75766737|FG007|Treated|Overall Study||8||
59648785|NCT01982630|75766730|FG000|COMPLETED|Overall Study||7||
59648786|NCT01982630|75766731|FG001|COMPLETED|Overall Study||8||
59648787|NCT01982630|75766732|FG002|COMPLETED|Overall Study||8||
59648788|NCT01982630|75766733|FG003|COMPLETED|Overall Study||8||
59648789|NCT01982630|75766734|FG004|COMPLETED|Overall Study||16||
59648790|NCT01982630|75766735|FG005|COMPLETED|Overall Study||11||
59648791|NCT01982630|75766736|FG006|COMPLETED|Overall Study||5||
59648792|NCT01982630|75766737|FG007|COMPLETED|Overall Study||8||
59648793|NCT01982630|75766730|FG000|NOT COMPLETED|Overall Study||3||
59648794|NCT01982630|75766731|FG001|NOT COMPLETED|Overall Study||0||
59648795|NCT01982630|75766732|FG002|NOT COMPLETED|Overall Study||5||
59648796|NCT01982630|75766733|FG003|NOT COMPLETED|Overall Study||1||
59648797|NCT01982630|75766734|FG004|NOT COMPLETED|Overall Study||3||
59543004|NCT01046084|75641183|FG001|STARTED|Second Intervention||25||
59543005|NCT01046084|75641182|FG000|COMPLETED|Second Intervention||25||
59543006|NCT01046084|75641183|FG001|COMPLETED|Second Intervention||25||
59543007|NCT01046084|75641182|FG000|NOT COMPLETED|Second Intervention||0||
59543008|NCT01046084|75641183|FG001|NOT COMPLETED|Second Intervention||0||
59543009|NCT01046084|75641182|FG000|STARTED|Second Washout of 7 Days||25||
59543010|NCT01046084|75641183|FG001|STARTED|Second Washout of 7 Days||25||
59543011|NCT01046084|75641182|FG000|COMPLETED|Second Washout of 7 Days||25||
59543012|NCT01046084|75641183|FG001|COMPLETED|Second Washout of 7 Days||25||
59648798|NCT01982630|75766735|FG005|NOT COMPLETED|Overall Study||3||
59648799|NCT01982630|75766736|FG006|NOT COMPLETED|Overall Study||1||
59648800|NCT01982630|75766737|FG007|NOT COMPLETED|Overall Study||0||
59648801|NCT01879228|75766792|FG000|STARTED|Overall Study||13||
59648802|NCT01879228|75766793|FG001|STARTED|Overall Study||13||
59543013|NCT01046084|75641182|FG000|NOT COMPLETED|Second Washout of 7 Days||0||
59543014|NCT01046084|75641183|FG001|NOT COMPLETED|Second Washout of 7 Days||0||
59543015|NCT01046084|75641182|FG000|STARTED|Third Intervention||25||
59543016|NCT01046084|75641183|FG001|STARTED|Third Intervention||25||
59543017|NCT01046084|75641182|FG000|COMPLETED|Third Intervention||25||
59543018|NCT01046084|75641183|FG001|COMPLETED|Third Intervention||25||
59543019|NCT01046084|75641182|FG000|NOT COMPLETED|Third Intervention||0||
59543020|NCT01046084|75641183|FG001|NOT COMPLETED|Third Intervention||0||
59543021|NCT01046084|75641182|FG000|STARTED|Third Washout of 7 Days||25||
59543022|NCT01046084|75641183|FG001|STARTED|Third Washout of 7 Days||25||
59543023|NCT01046084|75641182|FG000|COMPLETED|Third Washout of 7 Days||23||
59543024|NCT01046084|75641183|FG001|COMPLETED|Third Washout of 7 Days||25||
60076785|NCT01513551|76191800|FG002|Vaccinated|Overall Study||230||
60076786|NCT01513551|76191798|FG000|COMPLETED|Overall Study||226||
60076787|NCT01513551|76191799|FG001|COMPLETED|Overall Study||225||
60076788|NCT01513551|76191800|FG002|COMPLETED|Overall Study||226||
60076789|NCT01513551|76191798|FG000|NOT COMPLETED|Overall Study||4||
60076790|NCT01513551|76191799|FG001|NOT COMPLETED|Overall Study||6||
60076791|NCT01513551|76191800|FG002|NOT COMPLETED|Overall Study||5||
60076792|NCT01513473|76191810|FG000|STARTED|Main Trial (26 Weeks)||174||
60076793|NCT01513473|76191811|FG001|STARTED|Main Trial (26 Weeks)|1 subject was randomised but withdrew before the drug exposure.|176||
59543025|NCT01046084|75641182|FG000|NOT COMPLETED|Third Washout of 7 Days||2||
59543026|NCT01046084|75641183|FG001|NOT COMPLETED|Third Washout of 7 Days||0||
59543027|NCT01046084|75641182|FG000|STARTED|Fourth Intervention||23||
59543028|NCT01046084|75641183|FG001|STARTED|Fourth Intervention||25||
59543029|NCT01046084|75641182|FG000|COMPLETED|Fourth Intervention||23||
59543030|NCT01046084|75641183|FG001|COMPLETED|Fourth Intervention||25||
59543031|NCT01046084|75641182|FG000|NOT COMPLETED|Fourth Intervention||0||
59543032|NCT01046084|75641183|FG001|NOT COMPLETED|Fourth Intervention||0||
59543033|NCT01586741|75641192|FG000|STARTED|Overall Study||28||
59543034|NCT01586741|75641193|FG001|STARTED|Overall Study||29||
59543035|NCT01586741|75641194|FG002|STARTED|Overall Study||32||
59543036|NCT01586741|75641192|FG000|COMPLETED|Overall Study||27||
59543037|NCT01586741|75641193|FG001|COMPLETED|Overall Study||29||
59543038|NCT01586741|75641194|FG002|COMPLETED|Overall Study||30||
59543039|NCT01586741|75641192|FG000|NOT COMPLETED|Overall Study||1||
59543040|NCT01586741|75641193|FG001|NOT COMPLETED|Overall Study||0||
59543041|NCT01586741|75641194|FG002|NOT COMPLETED|Overall Study||2||
59543042|NCT01045694|75641202|FG000|STARTED|Overall Study||8||
59543043|NCT01045694|75641202|FG000|COMPLETED|Overall Study||6||
59543044|NCT01045694|75641202|FG000|NOT COMPLETED|Overall Study||2||
59543045|NCT01586897|75641208|FG000|STARTED|Overall Study||26||
59543046|NCT01586897|75641209|FG001|STARTED|Overall Study||26||
59543047|NCT01586897|75641208|FG000|COMPLETED|Overall Study||26||
59543048|NCT01586897|75641209|FG001|COMPLETED|Overall Study||26||
59543049|NCT01586897|75641208|FG000|NOT COMPLETED|Overall Study||0||
59543050|NCT01586897|75641209|FG001|NOT COMPLETED|Overall Study||0||
59543051|NCT01586975|75641220|FG000|STARTED|Overall Study||15||
59543052|NCT01586975|75641221|FG001|STARTED|Overall Study||32||
59543053|NCT01586975|75641222|FG002|STARTED|Overall Study||46||
59543054|NCT01586975|75641220|FG000|COMPLETED|Overall Study||15||
59543055|NCT01586975|75641221|FG001|COMPLETED|Overall Study||32||
59543056|NCT01586975|75641222|FG002|COMPLETED|Overall Study||46||
59543057|NCT01586975|75641220|FG000|NOT COMPLETED|Overall Study||0||
59543058|NCT01586975|75641221|FG001|NOT COMPLETED|Overall Study||0||
59543059|NCT01586975|75641222|FG002|NOT COMPLETED|Overall Study||0||
59543060|NCT01588457|75641232|FG000|STARTED|Randomization 1||53|Not all subjects were eligible to progress to from Randomization 1 to 2 based on depression symptoms|
59543061|NCT01588457|75641233|FG001|STARTED|Randomization 1||59|Not all subjects were eligible to progress to from Randomization 1 to 2 based on depression symptoms|
59543062|NCT01588457|75641234|FG002|STARTED|Randomization 1|No subject assigned during first randomization to monotherapy|0|Not all subjects were eligible to progress to from Randomization 1 to 2 based on depression symptoms|
59543063|NCT01588457|75641235|FG003|STARTED|Randomization 1|No subject assigned during first randomization to monotherapy|0|Not all subjects were eligible to progress to from Randomization 1 to 2 based on depression symptoms|
59543064|NCT01588457|75641232|FG000|COMPLETED|Randomization 1||30||
59543065|NCT01588457|75641233|FG001|COMPLETED|Randomization 1||43||
59543066|NCT01588457|75641234|FG002|COMPLETED|Randomization 1||0||
59543067|NCT01588457|75641235|FG003|COMPLETED|Randomization 1||0||
59543068|NCT01588457|75641232|FG000|NOT COMPLETED|Randomization 1||23||
59543069|NCT01588457|75641233|FG001|NOT COMPLETED|Randomization 1||16||
59543070|NCT01588457|75641234|FG002|NOT COMPLETED|Randomization 1||0||
59543071|NCT01588457|75641235|FG003|NOT COMPLETED|Randomization 1||0||
59543072|NCT01588457|75641232|FG000|STARTED|Randomization 2|Some subjects who completed the first randomization had QTP or LTG added to regimen|21|Some subjects completed at the end of Randomization 1 and did not progress to randomization 2|
59543073|NCT01588457|75641233|FG001|STARTED|Randomization 2|Some subjects who completed the first randomization had QTP or LTG added to regimen|31|Some subjects completed at the end of Randomization 1 and did not progress to randomization 2|
59543074|NCT01588457|75641234|FG002|STARTED|Randomization 2|Assignment of Quetiapine plus monotherapy for symptoms of depression|17|Some subjects completed at the end of Randomization 1 and did not progress to randomization 2|
60076794|NCT01513473|76191810|FG000|Exposed|Main Trial (26 Weeks)||174||
59648803|NCT01879228|75766792|FG000|COMPLETED|Overall Study||12||
59648804|NCT01879228|75766793|FG001|COMPLETED|Overall Study||12||
59648805|NCT01879228|75766792|FG000|NOT COMPLETED|Overall Study||1||
59648806|NCT01879228|75766793|FG001|NOT COMPLETED|Overall Study||1||
59648807|NCT01740297|75766802|FG000|STARTED|Overall Study||19||
59648808|NCT01740297|75766803|FG001|STARTED|Overall Study||100||
59648809|NCT01740297|75766804|FG002|STARTED|Overall Study||98||
59648810|NCT01740297|75766802|FG000|Received Talimogene Laherparepvec|Overall Study||19||
59648811|NCT01740297|75766803|FG001|Received Talimogene Laherparepvec|Overall Study||0||
59648812|NCT01740297|75766804|FG002|Received Talimogene Laherparepvec|Overall Study||95||
59648813|NCT01740297|75766802|FG000|Received Ipilimumab|Overall Study||18||
59648814|NCT01740297|75766803|FG001|Received Ipilimumab|Overall Study||95||
59648815|NCT01740297|75766804|FG002|Received Ipilimumab|Overall Study||92||
59648816|NCT01740297|75766802|FG000|COMPLETED|Overall Study||6|Completed study|
59648817|NCT01740297|75766803|FG001|COMPLETED|Overall Study||36|Completed study|
59648818|NCT01740297|75766804|FG002|COMPLETED|Overall Study||37|Completed study|
59648819|NCT01740297|75766802|FG000|NOT COMPLETED|Overall Study||13||
59648820|NCT01740297|75766803|FG001|NOT COMPLETED|Overall Study||64||
59648821|NCT01740297|75766804|FG002|NOT COMPLETED|Overall Study||61||
59648822|NCT01729754|75766818|FG000|STARTED|Part 1||20||
59648823|NCT01729754|75766819|FG001|STARTED|Part 1||184||
59648824|NCT01729754|75766820|FG002|STARTED|Part 1||110||
59648825|NCT01729754|75766821|FG003|STARTED|Part 1||18||
59648826|NCT01729754|75766822|FG004|STARTED|Part 1||21||
59648827|NCT01729754|75766823|FG005|STARTED|Part 1||268||
59648828|NCT01729754|75766824|FG006|STARTED|Part 1||14||
59648829|NCT01729754|75766825|FG007|STARTED|Part 1||72||
59648830|NCT01729754|75766826|FG008|STARTED|Part 1||70||
59648831|NCT01729754|75766827|FG009|STARTED|Part 1||313||
59648832|NCT01729754|75766818|FG000|COMPLETED|Part 1||6||
59648833|NCT01729754|75766819|FG001|COMPLETED|Part 1||184||
59648834|NCT01729754|75766820|FG002|COMPLETED|Part 1||110||
59648835|NCT01729754|75766821|FG003|COMPLETED|Part 1||6||
59648836|NCT01729754|75766822|FG004|COMPLETED|Part 1||21||
59648837|NCT01729754|75766823|FG005|COMPLETED|Part 1||268||
59648838|NCT01729754|75766824|FG006|COMPLETED|Part 1||0||
59648839|NCT01729754|75766825|FG007|COMPLETED|Part 1||72||
59648840|NCT01729754|75766826|FG008|COMPLETED|Part 1||70||
59648841|NCT01729754|75766827|FG009|COMPLETED|Part 1||289||
59648842|NCT01729754|75766818|FG000|NOT COMPLETED|Part 1||14||
59648843|NCT01729754|75766819|FG001|NOT COMPLETED|Part 1||0||
59648844|NCT01729754|75766820|FG002|NOT COMPLETED|Part 1||0||
59648845|NCT01729754|75766821|FG003|NOT COMPLETED|Part 1||12||
59648846|NCT01729754|75766822|FG004|NOT COMPLETED|Part 1||0||
59648847|NCT01729754|75766823|FG005|NOT COMPLETED|Part 1||0||
59648848|NCT01729754|75766824|FG006|NOT COMPLETED|Part 1||14||
59648849|NCT01729754|75766825|FG007|NOT COMPLETED|Part 1||0||
59648850|NCT01729754|75766826|FG008|NOT COMPLETED|Part 1||0||
59648851|NCT01729754|75766827|FG009|NOT COMPLETED|Part 1||24||
59648852|NCT01729754|75766818|FG000|STARTED|Part 2||6||
59648853|NCT01729754|75766819|FG001|STARTED|Part 2||184||
59648854|NCT01729754|75766820|FG002|STARTED|Part 2||110||
60076795|NCT01513473|76191811|FG001|Exposed|Main Trial (26 Weeks)||175||
60076796|NCT01513473|76191810|FG000|COMPLETED|Main Trial (26 Weeks)||170||
60076797|NCT01513473|76191811|FG001|COMPLETED|Main Trial (26 Weeks)||165||
60076798|NCT01513473|76191810|FG000|NOT COMPLETED|Main Trial (26 Weeks)||4||
60076799|NCT01513473|76191811|FG001|NOT COMPLETED|Main Trial (26 Weeks)||11||
59543075|NCT01588457|75641235|FG003|STARTED|Randomization 2|Assignment of Lamotrigine plus monotherapy for symptoms of depression|18|Some subjects completed at the end of Randomization 1 and did not progress to randomization 2|
59543076|NCT01588457|75641232|FG000|COMPLETED|Randomization 2||1||
59543077|NCT01588457|75641233|FG001|COMPLETED|Randomization 2||3||
59543078|NCT01588457|75641234|FG002|COMPLETED|Randomization 2||12||
59543079|NCT01588457|75641235|FG003|COMPLETED|Randomization 2||13||
59543080|NCT01588457|75641232|FG000|NOT COMPLETED|Randomization 2||20||
59543081|NCT01588457|75641233|FG001|NOT COMPLETED|Randomization 2||28||
59543082|NCT01588457|75641234|FG002|NOT COMPLETED|Randomization 2||5||
59543083|NCT01588457|75641235|FG003|NOT COMPLETED|Randomization 2||5||
59543084|NCT01589315|75641255|FG000|STARTED|Overall Study||17||
59543085|NCT01589315|75641255|FG000|COMPLETED|Overall Study||16||
59543086|NCT01589315|75641255|FG000|NOT COMPLETED|Overall Study||1||
59543087|NCT01044290|75641262|FG000|STARTED|Randomization||75||
59543088|NCT01044290|75641263|FG001|STARTED|Randomization||74||
59543089|NCT01044290|75641264|FG002|STARTED|Randomization||72||
59543090|NCT01044290|75641262|FG000|Randomized|Randomization||75||
59543091|NCT01044290|75641263|FG001|Randomized|Randomization||74||
59543092|NCT01044290|75641264|FG002|Randomized|Randomization||72||
59543093|NCT01044290|75641262|FG000|COMPLETED|Randomization||75||
59648855|NCT01729754|75766821|FG003|STARTED|Part 2|1 participant completed Part 1 but did not enter Part 2|5||
59648856|NCT01729754|75766822|FG004|STARTED|Part 2||21||
59648857|NCT01729754|75766823|FG005|STARTED|Part 2||268||
59648858|NCT01729754|75766824|FG006|STARTED|Part 2||0||
59648859|NCT01729754|75766825|FG007|STARTED|Part 2||72||
59648860|NCT01729754|75766826|FG008|STARTED|Part 2||70||
59648861|NCT01729754|75766827|FG009|STARTED|Part 2||289||
59648862|NCT01729754|75766818|FG000|COMPLETED|Part 2||0||
59648863|NCT01729754|75766819|FG001|COMPLETED|Part 2||184||
60076800|NCT01513473|76191810|FG000|STARTED|Extension Trial (26 Weeks)|18 subjects did not consent to participate in the extension trial.|152||
59543094|NCT01044290|75641263|FG001|COMPLETED|Randomization||74||
59543095|NCT01044290|75641264|FG002|COMPLETED|Randomization||72||
59543096|NCT01044290|75641262|FG000|NOT COMPLETED|Randomization||0||
59543097|NCT01044290|75641263|FG001|NOT COMPLETED|Randomization||0||
59543098|NCT01044290|75641264|FG002|NOT COMPLETED|Randomization||0||
59543099|NCT01044290|75641262|FG000|STARTED|Follow-up 1||75||
59543100|NCT01044290|75641263|FG001|STARTED|Follow-up 1||74||
59543101|NCT01044290|75641264|FG002|STARTED|Follow-up 1||72||
59543102|NCT01044290|75641262|FG000|Completed F1 Interview|Follow-up 1||61||
59543103|NCT01044290|75641263|FG001|Completed F1 Interview|Follow-up 1||60||
59543104|NCT01044290|75641264|FG002|Completed F1 Interview|Follow-up 1||61||
59543105|NCT01044290|75641262|FG000|COMPLETED|Follow-up 1||70||
59543106|NCT01044290|75641263|FG001|COMPLETED|Follow-up 1||69||
59543107|NCT01044290|75641264|FG002|COMPLETED|Follow-up 1||71||
59543108|NCT01044290|75641262|FG000|NOT COMPLETED|Follow-up 1||5||
59543109|NCT01044290|75641263|FG001|NOT COMPLETED|Follow-up 1||5||
59543110|NCT01044290|75641264|FG002|NOT COMPLETED|Follow-up 1||1||
59543111|NCT01044290|75641262|FG000|STARTED|Follow-Up 2||70||
59543112|NCT01044290|75641263|FG001|STARTED|Follow-Up 2||69||
59543113|NCT01044290|75641264|FG002|STARTED|Follow-Up 2||71||
59543114|NCT01044290|75641262|FG000|Completed F2 Interview|Follow-Up 2||64||
59543115|NCT01044290|75641263|FG001|Completed F2 Interview|Follow-Up 2||57||
59543116|NCT01044290|75641264|FG002|Completed F2 Interview|Follow-Up 2||64||
59543117|NCT01044290|75641262|FG000|COMPLETED|Follow-Up 2||70||
59543118|NCT01044290|75641263|FG001|COMPLETED|Follow-Up 2||67||
59543119|NCT01044290|75641264|FG002|COMPLETED|Follow-Up 2||69||
59543120|NCT01044290|75641262|FG000|NOT COMPLETED|Follow-Up 2||0||
59543121|NCT01044290|75641263|FG001|NOT COMPLETED|Follow-Up 2||2||
59543122|NCT01044290|75641264|FG002|NOT COMPLETED|Follow-Up 2||2||
59543123|NCT01590875|75641284|FG000|STARTED|Overall Study||10||
59543124|NCT01590875|75641285|FG001|STARTED|Overall Study||10||
59543125|NCT01590875|75641284|FG000|COMPLETED|Overall Study||10||
60076801|NCT01513473|76191811|FG001|STARTED|Extension Trial (26 Weeks)|37 subjects did not consent to participate in the extension trial.|128||
60076802|NCT01513473|76191810|FG000|COMPLETED|Extension Trial (26 Weeks)||151||
60076803|NCT01513473|76191811|FG001|COMPLETED|Extension Trial (26 Weeks)||122||
60076804|NCT01513473|76191810|FG000|NOT COMPLETED|Extension Trial (26 Weeks)||1||
59543126|NCT01590875|75641285|FG001|COMPLETED|Overall Study||10||
59543127|NCT01590875|75641284|FG000|NOT COMPLETED|Overall Study||0||
59543128|NCT01590875|75641285|FG001|NOT COMPLETED|Overall Study||0||
59543129|NCT01591655|75641295|FG000|STARTED|Overall Study||240||
59543130|NCT01591655|75641296|FG001|STARTED|Overall Study||120||
59543131|NCT01591655|75641295|FG000|COMPLETED|Overall Study||168||
59543132|NCT01591655|75641296|FG001|COMPLETED|Overall Study||57||
59543133|NCT01591655|75641295|FG000|NOT COMPLETED|Overall Study||72||
59543134|NCT01591655|75641296|FG001|NOT COMPLETED|Overall Study||63||
59543135|NCT00916136|75641304|FG000|STARTED|Overall Study||37||
60076805|NCT01513473|76191811|FG001|NOT COMPLETED|Extension Trial (26 Weeks)||6||
60076806|NCT01513317|76191819|FG000|STARTED|Overall Study||50||
60076807|NCT01513317|76191820|FG001|STARTED|Overall Study||26||
60076808|NCT01513317|76191819|FG000|COMPLETED|Overall Study||16||
60076809|NCT01513317|76191820|FG001|COMPLETED|Overall Study||2||
59543136|NCT00916136|75641305|FG001|STARTED|Overall Study||29||
59543137|NCT00916136|75641304|FG000|COMPLETED|Overall Study||37||
59543138|NCT00916136|75641305|FG001|COMPLETED|Overall Study||29||
59543139|NCT00916136|75641304|FG000|NOT COMPLETED|Overall Study||0||
59543140|NCT00916136|75641305|FG001|NOT COMPLETED|Overall Study||0||
59543141|NCT01591733|75641311|FG000|STARTED|Overall Study||48||
59543142|NCT01591733|75641311|FG000|COMPLETED|Overall Study||48||
59543143|NCT01591733|75641311|FG000|NOT COMPLETED|Overall Study||0||
59543144|NCT01592435|75641317|FG000|STARTED|Overall Study||76||
59543145|NCT01592435|75641317|FG000|COMPLETED|Overall Study||76||
59543146|NCT01592435|75641317|FG000|NOT COMPLETED|Overall Study||0||
59543147|NCT01593215|75641325|FG000|STARTED|Overall Study||25||
59543148|NCT01593215|75641326|FG001|STARTED|Overall Study||25||
59543149|NCT01593215|75641325|FG000|COMPLETED|Overall Study||24||
59543150|NCT01593215|75641326|FG001|COMPLETED|Overall Study||25||
59543151|NCT01593215|75641325|FG000|NOT COMPLETED|Overall Study||1||
59543152|NCT01593215|75641326|FG001|NOT COMPLETED|Overall Study||0||
59543153|NCT01594385|75641334|FG000|STARTED|Overall Study||17||
59648864|NCT01729754|75766820|FG002|COMPLETED|Part 2||110||
59648865|NCT01729754|75766821|FG003|COMPLETED|Part 2||0||
59648866|NCT01729754|75766822|FG004|COMPLETED|Part 2||21||
59648867|NCT01729754|75766823|FG005|COMPLETED|Part 2||268||
59648868|NCT01729754|75766824|FG006|COMPLETED|Part 2||0||
59648869|NCT01729754|75766825|FG007|COMPLETED|Part 2||69||
59648870|NCT01729754|75766826|FG008|COMPLETED|Part 2||66||
59648871|NCT01729754|75766827|FG009|COMPLETED|Part 2||277||
59648872|NCT01729754|75766818|FG000|NOT COMPLETED|Part 2||6||
59648873|NCT01729754|75766819|FG001|NOT COMPLETED|Part 2||0||
59648874|NCT01729754|75766820|FG002|NOT COMPLETED|Part 2||0||
59648875|NCT01729754|75766821|FG003|NOT COMPLETED|Part 2||5||
59648876|NCT01729754|75766822|FG004|NOT COMPLETED|Part 2||0||
59648877|NCT01729754|75766823|FG005|NOT COMPLETED|Part 2||0||
59648878|NCT01729754|75766824|FG006|NOT COMPLETED|Part 2||0||
59648879|NCT01729754|75766825|FG007|NOT COMPLETED|Part 2||3||
59648880|NCT01729754|75766826|FG008|NOT COMPLETED|Part 2||4||
59648881|NCT01729754|75766827|FG009|NOT COMPLETED|Part 2||12||
59648882|NCT01729754|75766818|FG000|STARTED|Part 3||0||
59648883|NCT01729754|75766819|FG001|STARTED|Part 3|14 participants completed Part 2 but did not enter Part 3|170||
59648884|NCT01729754|75766820|FG002|STARTED|Part 3||110||
59648885|NCT01729754|75766821|FG003|STARTED|Part 3||0||
59648886|NCT01729754|75766822|FG004|STARTED|Part 3||21||
59648887|NCT01729754|75766823|FG005|STARTED|Part 3|31 participants completed Part 2 but did not enter Part 3|237||
59648888|NCT01729754|75766824|FG006|STARTED|Part 3||0||
59648889|NCT01729754|75766825|FG007|STARTED|Part 3||69||
59648890|NCT01729754|75766826|FG008|STARTED|Part 3||66||
59648891|NCT01729754|75766827|FG009|STARTED|Part 3|156 participants completed Part 2 but did not enter Part 3|121||
59648892|NCT01729754|75766818|FG000|COMPLETED|Part 3||0||
59648893|NCT01729754|75766819|FG001|COMPLETED|Part 3||165||
59648894|NCT01729754|75766820|FG002|COMPLETED|Part 3||105||
59648895|NCT01729754|75766821|FG003|COMPLETED|Part 3||0||
59648896|NCT01729754|75766822|FG004|COMPLETED|Part 3||17||
59648897|NCT01729754|75766823|FG005|COMPLETED|Part 3||224||
59648898|NCT01729754|75766824|FG006|COMPLETED|Part 3||0||
59648899|NCT01729754|75766825|FG007|COMPLETED|Part 3||66||
59648900|NCT01729754|75766826|FG008|COMPLETED|Part 3||65||
59648901|NCT01729754|75766827|FG009|COMPLETED|Part 3||114||
59648902|NCT01729754|75766818|FG000|NOT COMPLETED|Part 3||0||
59648903|NCT01729754|75766819|FG001|NOT COMPLETED|Part 3||5||
59648904|NCT01729754|75766820|FG002|NOT COMPLETED|Part 3||5||
59648905|NCT01729754|75766821|FG003|NOT COMPLETED|Part 3||0||
59648906|NCT01729754|75766822|FG004|NOT COMPLETED|Part 3||4||
59648907|NCT01729754|75766823|FG005|NOT COMPLETED|Part 3||13||
59648908|NCT01729754|75766824|FG006|NOT COMPLETED|Part 3||0||
59648909|NCT01729754|75766825|FG007|NOT COMPLETED|Part 3||3||
59648910|NCT01729754|75766826|FG008|NOT COMPLETED|Part 3||1||
59648911|NCT01729754|75766827|FG009|NOT COMPLETED|Part 3||7||
59648912|NCT01599741|75766857|FG000|STARTED|Overall Study||51||
59648913|NCT01599741|75766857|FG000|Collected Dose and Image Information|Overall Study||48||
59648914|NCT01599741|75766857|FG000|COMPLETED|Overall Study||48||
59648915|NCT01599741|75766857|FG000|NOT COMPLETED|Overall Study||3||
59648916|NCT01593852|75766863|FG000|STARTED|Overall Study||68||
59648917|NCT01593852|75766864|FG001|STARTED|Overall Study||68||
59648918|NCT01593852|75766863|FG000|COMPLETED|Overall Study||68||
59648919|NCT01593852|75766864|FG001|COMPLETED|Overall Study||68||
59648920|NCT01593852|75766863|FG000|NOT COMPLETED|Overall Study||0||
59648921|NCT01593852|75766864|FG001|NOT COMPLETED|Overall Study||0||
59648922|NCT01515306|75766872|FG000|STARTED|Overall Study||24||
59648923|NCT01515306|75766873|FG001|STARTED|Overall Study||16||
59648924|NCT01515306|75766872|FG000|Received at Least 1 Dose of Study Drug|Overall Study||24||
59648925|NCT01515306|75766873|FG001|Received at Least 1 Dose of Study Drug|Overall Study||16||
59648926|NCT01515306|75766872|FG000|Cycle 1|Overall Study||24||
59988638|NCT00796523|76103869|FG001|STARTED|Overall Study||24||
59648927|NCT01515306|75766873|FG001|Cycle 1|Overall Study||16||
59648928|NCT01515306|75766872|FG000|Cycle 2|Overall Study||21||
59648929|NCT01515306|75766873|FG001|Cycle 2|Overall Study||15||
59648930|NCT01515306|75766872|FG000|Drug-Drug Interaction Population|Overall Study|Completed Cycle 1 Day 1 and Cycle 2 Day 1 treatment.|21||
59988639|NCT00796523|76103868|FG000|COMPLETED|Overall Study||18||
59988640|NCT00796523|76103869|FG001|COMPLETED|Overall Study||17||
59988641|NCT00796523|76103868|FG000|NOT COMPLETED|Overall Study||9||
59648931|NCT01515306|75766873|FG001|Drug-Drug Interaction Population|Overall Study|Drug-drug interaction was only assessed in Part A.|0||
59648932|NCT01515306|75766872|FG000|COMPLETED|Overall Study||0||
59648933|NCT01515306|75766873|FG001|COMPLETED|Overall Study||2||
59648934|NCT01515306|75766872|FG000|NOT COMPLETED|Overall Study||24||
59648935|NCT01515306|75766873|FG001|NOT COMPLETED|Overall Study||14||
59648936|NCT01423851|75766894|FG000|STARTED|Whole Study||3||
59648937|NCT01423851|75766895|FG001|STARTED|Whole Study||3||
59648938|NCT01423851|75766896|FG002|STARTED|Whole Study||3||
59648939|NCT01423851|75766897|FG003|STARTED|Whole Study||6||
59648940|NCT01423851|75766898|FG004|STARTED|Whole Study||3||
59648941|NCT01423851|75766899|FG005|STARTED|Whole Study||3||
59648942|NCT01423851|75766900|FG006|STARTED|Whole Study||3||
59648943|NCT01423851|75766901|FG007|STARTED|Whole Study||8||
59648944|NCT01423851|75766902|FG008|STARTED|Whole Study||8||
59988642|NCT00796523|76103869|FG001|NOT COMPLETED|Overall Study||7||
59648945|NCT01423851|75766903|FG009|STARTED|Whole Study||8||
59648946|NCT01423851|75766904|FG010|STARTED|Whole Study||29||
59648947|NCT01423851|75766894|FG000|COMPLETED|Whole Study||0||
59648948|NCT01423851|75766895|FG001|COMPLETED|Whole Study||0||
59648949|NCT01423851|75766896|FG002|COMPLETED|Whole Study||0||
59648950|NCT01423851|75766897|FG003|COMPLETED|Whole Study||0||
59648951|NCT01423851|75766898|FG004|COMPLETED|Whole Study||0||
59648952|NCT01423851|75766899|FG005|COMPLETED|Whole Study||0||
59648953|NCT01423851|75766900|FG006|COMPLETED|Whole Study||0||
59648954|NCT01423851|75766901|FG007|COMPLETED|Whole Study||0||
59648955|NCT01423851|75766902|FG008|COMPLETED|Whole Study||0||
59648956|NCT01423851|75766903|FG009|COMPLETED|Whole Study||0||
59648957|NCT01423851|75766904|FG010|COMPLETED|Whole Study||0||
59648958|NCT01423851|75766894|FG000|NOT COMPLETED|Whole Study||3||
59648959|NCT01423851|75766895|FG001|NOT COMPLETED|Whole Study||3||
59648960|NCT01423851|75766896|FG002|NOT COMPLETED|Whole Study||3||
59648961|NCT01423851|75766897|FG003|NOT COMPLETED|Whole Study||6||
59648962|NCT01423851|75766898|FG004|NOT COMPLETED|Whole Study||3||
59648963|NCT01423851|75766899|FG005|NOT COMPLETED|Whole Study||3||
59648964|NCT01423851|75766900|FG006|NOT COMPLETED|Whole Study||3||
59648965|NCT01423851|75766901|FG007|NOT COMPLETED|Whole Study||8||
59648966|NCT01423851|75766902|FG008|NOT COMPLETED|Whole Study||8||
59648967|NCT01423851|75766903|FG009|NOT COMPLETED|Whole Study||8||
59648968|NCT01423851|75766904|FG010|NOT COMPLETED|Whole Study||29||
59648969|NCT01423851|75766894|FG000|STARTED|Dose Finding Period - Escalation||0||
59648970|NCT01423851|75766895|FG001|STARTED|Dose Finding Period - Escalation||1||
59648971|NCT01423851|75766896|FG002|STARTED|Dose Finding Period - Escalation||4||
59648972|NCT01423851|75766897|FG003|STARTED|Dose Finding Period - Escalation||4||
59648973|NCT01423851|75766898|FG004|STARTED|Dose Finding Period - Escalation||0||
59648974|NCT01423851|75766899|FG005|STARTED|Dose Finding Period - Escalation||0||
59648975|NCT01423851|75766900|FG006|STARTED|Dose Finding Period - Escalation||2||
59648976|NCT01423851|75766901|FG007|STARTED|Dose Finding Period - Escalation||0||
59648977|NCT01423851|75766902|FG008|STARTED|Dose Finding Period - Escalation||1||
59648978|NCT01423851|75766903|FG009|STARTED|Dose Finding Period - Escalation||0||
59648979|NCT01423851|75766904|FG010|STARTED|Dose Finding Period - Escalation||0||
59648980|NCT01423851|75766894|FG000|COMPLETED|Dose Finding Period - Escalation||0||
59648981|NCT01423851|75766895|FG001|COMPLETED|Dose Finding Period - Escalation||0||
59648982|NCT01423851|75766896|FG002|COMPLETED|Dose Finding Period - Escalation||0||
59648983|NCT01423851|75766897|FG003|COMPLETED|Dose Finding Period - Escalation||0||
59648984|NCT01423851|75766898|FG004|COMPLETED|Dose Finding Period - Escalation||0||
59648985|NCT01423851|75766899|FG005|COMPLETED|Dose Finding Period - Escalation||0||
59648986|NCT01423851|75766900|FG006|COMPLETED|Dose Finding Period - Escalation||0||
59648987|NCT01423851|75766901|FG007|COMPLETED|Dose Finding Period - Escalation||0||
59648988|NCT01423851|75766902|FG008|COMPLETED|Dose Finding Period - Escalation||0||
59648989|NCT01423851|75766903|FG009|COMPLETED|Dose Finding Period - Escalation||0||
59648990|NCT01423851|75766904|FG010|COMPLETED|Dose Finding Period - Escalation||0||
59648991|NCT01423851|75766894|FG000|NOT COMPLETED|Dose Finding Period - Escalation||0||
59648992|NCT01423851|75766895|FG001|NOT COMPLETED|Dose Finding Period - Escalation||1||
59648993|NCT01423851|75766896|FG002|NOT COMPLETED|Dose Finding Period - Escalation||4||
59648994|NCT01423851|75766897|FG003|NOT COMPLETED|Dose Finding Period - Escalation||4||
59648995|NCT01423851|75766898|FG004|NOT COMPLETED|Dose Finding Period - Escalation||0||
59648996|NCT01423851|75766899|FG005|NOT COMPLETED|Dose Finding Period - Escalation||0||
59648997|NCT01423851|75766900|FG006|NOT COMPLETED|Dose Finding Period - Escalation||2||
59648998|NCT01423851|75766901|FG007|NOT COMPLETED|Dose Finding Period - Escalation||0||
59648999|NCT01423851|75766902|FG008|NOT COMPLETED|Dose Finding Period - Escalation||1||
59649000|NCT01423851|75766903|FG009|NOT COMPLETED|Dose Finding Period - Escalation||0||
59649001|NCT01423851|75766904|FG010|NOT COMPLETED|Dose Finding Period - Escalation||0||
59649002|NCT01423851|75766894|FG000|STARTED|Dose Finding Period - Reduction||0||
59649003|NCT01423851|75766895|FG001|STARTED|Dose Finding Period - Reduction||0||
59649004|NCT01423851|75766896|FG002|STARTED|Dose Finding Period - Reduction||3||
59649005|NCT01423851|75766897|FG003|STARTED|Dose Finding Period - Reduction||5||
59649006|NCT01423851|75766898|FG004|STARTED|Dose Finding Period - Reduction||1||
59649007|NCT01423851|75766899|FG005|STARTED|Dose Finding Period - Reduction||2||
59649008|NCT01423851|75766900|FG006|STARTED|Dose Finding Period - Reduction||8||
59649009|NCT01423851|75766901|FG007|STARTED|Dose Finding Period - Reduction||0||
59649010|NCT01423851|75766902|FG008|STARTED|Dose Finding Period - Reduction||3||
59649011|NCT01423851|75766903|FG009|STARTED|Dose Finding Period - Reduction||0||
59649012|NCT01423851|75766904|FG010|STARTED|Dose Finding Period - Reduction||0||
59649013|NCT01423851|75766894|FG000|COMPLETED|Dose Finding Period - Reduction||0||
59649014|NCT01423851|75766895|FG001|COMPLETED|Dose Finding Period - Reduction||0||
59649015|NCT01423851|75766896|FG002|COMPLETED|Dose Finding Period - Reduction||0||
59649016|NCT01423851|75766897|FG003|COMPLETED|Dose Finding Period - Reduction||0||
59649017|NCT01423851|75766898|FG004|COMPLETED|Dose Finding Period - Reduction||0||
59649018|NCT01423851|75766899|FG005|COMPLETED|Dose Finding Period - Reduction||0||
59649019|NCT01423851|75766900|FG006|COMPLETED|Dose Finding Period - Reduction||0||
59649020|NCT01423851|75766901|FG007|COMPLETED|Dose Finding Period - Reduction||0||
59649021|NCT01423851|75766902|FG008|COMPLETED|Dose Finding Period - Reduction||0||
59649022|NCT01423851|75766903|FG009|COMPLETED|Dose Finding Period - Reduction||0||
59649023|NCT01423851|75766904|FG010|COMPLETED|Dose Finding Period - Reduction||0||
59649024|NCT01423851|75766894|FG000|NOT COMPLETED|Dose Finding Period - Reduction||0||
59649025|NCT01423851|75766895|FG001|NOT COMPLETED|Dose Finding Period - Reduction||0||
59649026|NCT01423851|75766896|FG002|NOT COMPLETED|Dose Finding Period - Reduction||3||
59649027|NCT01423851|75766897|FG003|NOT COMPLETED|Dose Finding Period - Reduction||5||
59649028|NCT01423851|75766898|FG004|NOT COMPLETED|Dose Finding Period - Reduction||1||
59649029|NCT01423851|75766899|FG005|NOT COMPLETED|Dose Finding Period - Reduction||2||
59649030|NCT01423851|75766900|FG006|NOT COMPLETED|Dose Finding Period - Reduction||8||
59649031|NCT01423851|75766901|FG007|NOT COMPLETED|Dose Finding Period - Reduction||0||
59649032|NCT01423851|75766902|FG008|NOT COMPLETED|Dose Finding Period - Reduction||3||
59649033|NCT01423851|75766903|FG009|NOT COMPLETED|Dose Finding Period - Reduction||0||
59649034|NCT01423851|75766904|FG010|NOT COMPLETED|Dose Finding Period - Reduction||0||
59649035|NCT01360593|75766933|FG000|STARTED|Overall Study||35||
59649036|NCT01360593|75766933|FG000|COMPLETED|Overall Study||35||
59649037|NCT01360593|75766933|FG000|NOT COMPLETED|Overall Study||0||
59649038|NCT01354977|75766939|FG000|STARTED|Overall Study||12||
59649039|NCT01354977|75766940|FG001|STARTED|Overall Study||8||
59649040|NCT01354977|75766939|FG000|COMPLETED|Overall Study||12||
59649041|NCT01354977|75766940|FG001|COMPLETED|Overall Study||8||
59649042|NCT01354977|75766939|FG000|NOT COMPLETED|Overall Study||0||
59649043|NCT01354977|75766940|FG001|NOT COMPLETED|Overall Study||0||
59649044|NCT01334606|75766946|FG000|STARTED|Overall Study||21||
59649045|NCT01334606|75766946|FG000|COMPLETED|Overall Study||3||
59649046|NCT01334606|75766946|FG000|NOT COMPLETED|Overall Study||18||
59649047|NCT01317875|75766962|FG000|STARTED|Overall Study||5||
59649048|NCT01317875|75766963|FG001|STARTED|Overall Study||3||
59649049|NCT01317875|75766964|FG002|STARTED|Overall Study||20||
59649050|NCT01317875|75766965|FG003|STARTED|Overall Study||4||
59649051|NCT01317875|75766966|FG004|STARTED|Overall Study||12||
59649052|NCT01317875|75766967|FG005|STARTED|Overall Study||3||
59649053|NCT01317875|75766968|FG006|STARTED|Overall Study||4||
59649054|NCT01317875|75766969|FG007|STARTED|Overall Study||18||
59649055|NCT01317875|75766970|FG008|STARTED|Overall Study|No participants enrolled in Stratum 2 : Cohort 4|0||
59649056|NCT01317875|75766971|FG009|STARTED|Overall Study|No participants enrolled in Stratum 2 : Cohort 5|0||
59649057|NCT01317875|75766962|FG000|COMPLETED|Overall Study||2||
59649058|NCT01317875|75766963|FG001|COMPLETED|Overall Study||1||
59649059|NCT01317875|75766964|FG002|COMPLETED|Overall Study||11||
59649060|NCT01317875|75766965|FG003|COMPLETED|Overall Study||2||
59649061|NCT01317875|75766966|FG004|COMPLETED|Overall Study||3||
59649062|NCT01317875|75766967|FG005|COMPLETED|Overall Study||1||
59649063|NCT01317875|75766968|FG006|COMPLETED|Overall Study||2||
59649064|NCT01317875|75766969|FG007|COMPLETED|Overall Study||3||
59649065|NCT01317875|75766970|FG008|COMPLETED|Overall Study||0||
59649066|NCT01317875|75766971|FG009|COMPLETED|Overall Study||0||
59649067|NCT01317875|75766962|FG000|NOT COMPLETED|Overall Study||3||
59649068|NCT01317875|75766963|FG001|NOT COMPLETED|Overall Study||2||
59649069|NCT01317875|75766964|FG002|NOT COMPLETED|Overall Study||9||
59649070|NCT01317875|75766965|FG003|NOT COMPLETED|Overall Study||2||
59649071|NCT01317875|75766966|FG004|NOT COMPLETED|Overall Study||9||
60076810|NCT01513317|76191819|FG000|NOT COMPLETED|Overall Study||34||
59543154|NCT01594385|75641335|FG001|STARTED|Overall Study||13||
59543155|NCT01594385|75641334|FG000|COMPLETED|Overall Study||17||
59543156|NCT01594385|75641335|FG001|COMPLETED|Overall Study||13||
59543157|NCT01594385|75641334|FG000|NOT COMPLETED|Overall Study||0||
59543158|NCT01594385|75641335|FG001|NOT COMPLETED|Overall Study||0||
59543159|NCT01041638|75641345|FG000|STARTED|Overall Study||105||
59543160|NCT01041638|75641345|FG000|COMPLETED|Overall Study||78||
59543161|NCT01041638|75641345|FG000|NOT COMPLETED|Overall Study||27||
59543162|NCT00914186|75641353|FG000|STARTED|Overall Study||31||
59543163|NCT00914186|75641354|FG001|STARTED|Overall Study||30||
59543164|NCT00914186|75641355|FG002|STARTED|Overall Study||31||
59543165|NCT00914186|75641356|FG003|STARTED|Overall Study||30||
59543166|NCT00914186|75641353|FG000|COMPLETED|Overall Study||28||
59543167|NCT00914186|75641354|FG001|COMPLETED|Overall Study||28||
59543168|NCT00914186|75641355|FG002|COMPLETED|Overall Study||29||
59543169|NCT00914186|75641356|FG003|COMPLETED|Overall Study||20||
59543170|NCT00914186|75641353|FG000|NOT COMPLETED|Overall Study||3||
59543171|NCT00914186|75641354|FG001|NOT COMPLETED|Overall Study||2||
59543172|NCT00914186|75641355|FG002|NOT COMPLETED|Overall Study||2||
59543173|NCT00914186|75641356|FG003|NOT COMPLETED|Overall Study||10||
59649072|NCT01317875|75766967|FG005|NOT COMPLETED|Overall Study||2||
59649073|NCT01317875|75766968|FG006|NOT COMPLETED|Overall Study||2||
59543174|NCT01045460|75641369|FG000|STARTED|Overall Study||17||
59543175|NCT01045460|75641370|FG001|STARTED|Overall Study||18||
59649074|NCT01317875|75766969|FG007|NOT COMPLETED|Overall Study||15||
59649075|NCT01317875|75766970|FG008|NOT COMPLETED|Overall Study||0||
59649076|NCT01317875|75766971|FG009|NOT COMPLETED|Overall Study||0||
59649077|NCT01226732|75767007|FG000|STARTED|Overall Study||3||
59649078|NCT01226732|75767008|FG001|STARTED|Overall Study||3||
59649079|NCT01226732|75767009|FG002|STARTED|Overall Study||3||
59649080|NCT01226732|75767010|FG003|STARTED|Overall Study||5||
59543176|NCT01045460|75641369|FG000|COMPLETED|Overall Study||11||
59543177|NCT01045460|75641370|FG001|COMPLETED|Overall Study||15||
59543178|NCT01045460|75641369|FG000|NOT COMPLETED|Overall Study||6||
59543179|NCT01045460|75641370|FG001|NOT COMPLETED|Overall Study||3||
59543180|NCT05014919|75641381|FG000|STARTED|Open-Label (12 Weeks)|24 de novo and 9 rollover participants|33||
59543181|NCT05014919|75641382|FG001|STARTED|Open-Label (12 Weeks)||0||
59543182|NCT05014919|75641383|FG002|STARTED|Open-Label (12 Weeks)||0||
59543183|NCT05014919|75641381|FG000|Received at Least 1 Dose of Study Drug|Open-Label (12 Weeks)||33||
59543184|NCT05014919|75641382|FG001|Received at Least 1 Dose of Study Drug|Open-Label (12 Weeks)||0||
59543185|NCT05014919|75641383|FG002|Received at Least 1 Dose of Study Drug|Open-Label (12 Weeks)||0||
59543186|NCT05014919|75641381|FG000|COMPLETED|Open-Label (12 Weeks)||5||
59543187|NCT05014919|75641382|FG001|COMPLETED|Open-Label (12 Weeks)||0||
59543188|NCT05014919|75641383|FG002|COMPLETED|Open-Label (12 Weeks)||0||
59543189|NCT05014919|75641381|FG000|NOT COMPLETED|Open-Label (12 Weeks)||28||
59543190|NCT05014919|75641382|FG001|NOT COMPLETED|Open-Label (12 Weeks)||0||
59543191|NCT05014919|75641383|FG002|NOT COMPLETED|Open-Label (12 Weeks)||0||
59543192|NCT05014919|75641381|FG000|STARTED|Double-Blind (26 Weeks)||0||
59543193|NCT05014919|75641382|FG001|STARTED|Double-Blind (26 Weeks)|1 from open-label period and 1 from study 12712A|2||
59543194|NCT05014919|75641383|FG002|STARTED|Double-Blind (26 Weeks)|1 from open-label period and 1 from study 12712A|2||
59543195|NCT05014919|75641381|FG000|Received at Least 1 Dose of Study Drug|Double-Blind (26 Weeks)||0||
59543196|NCT05014919|75641382|FG001|Received at Least 1 Dose of Study Drug|Double-Blind (26 Weeks)||2||
59543197|NCT05014919|75641383|FG002|Received at Least 1 Dose of Study Drug|Double-Blind (26 Weeks)||2||
59543198|NCT05014919|75641381|FG000|COMPLETED|Double-Blind (26 Weeks)||0||
59543199|NCT05014919|75641382|FG001|COMPLETED|Double-Blind (26 Weeks)||1||
59543200|NCT05014919|75641383|FG002|COMPLETED|Double-Blind (26 Weeks)||0||
59543201|NCT05014919|75641381|FG000|NOT COMPLETED|Double-Blind (26 Weeks)||0||
59543202|NCT05014919|75641382|FG001|NOT COMPLETED|Double-Blind (26 Weeks)||1||
59543203|NCT05014919|75641383|FG002|NOT COMPLETED|Double-Blind (26 Weeks)||2||
59543204|NCT02218463|75641392|FG000|STARTED|Overall Study||21||
59543205|NCT02218463|75641393|FG001|STARTED|Overall Study||22||
59543206|NCT02218463|75641392|FG000|COMPLETED|Overall Study||18||
59543207|NCT02218463|75641393|FG001|COMPLETED|Overall Study||19||
59543208|NCT02218463|75641392|FG000|NOT COMPLETED|Overall Study||3||
59543209|NCT02218463|75641393|FG001|NOT COMPLETED|Overall Study||3||
59543210|NCT00919724|75641401|FG000|STARTED|Overall Study||45||
59543211|NCT00919724|75641402|FG001|STARTED|Overall Study||44||
59543212|NCT00919724|75641401|FG000|COMPLETED|Overall Study||45||
59543213|NCT00919724|75641402|FG001|COMPLETED|Overall Study||44||
59543214|NCT00919724|75641401|FG000|NOT COMPLETED|Overall Study||0||
59543215|NCT00919724|75641402|FG001|NOT COMPLETED|Overall Study||0||
59543216|NCT00919802|75641408|FG000|STARTED|First Intervention - (24 Hours)||12||
59543217|NCT00919802|75641409|FG001|STARTED|First Intervention - (24 Hours)||13||
59543218|NCT00919802|75641408|FG000|COMPLETED|First Intervention - (24 Hours)||12||
59543219|NCT00919802|75641409|FG001|COMPLETED|First Intervention - (24 Hours)||13||
59543220|NCT00919802|75641408|FG000|NOT COMPLETED|First Intervention - (24 Hours)||0||
59543221|NCT00919802|75641409|FG001|NOT COMPLETED|First Intervention - (24 Hours)||0||
59543222|NCT00919802|75641408|FG000|STARTED|Second Intervention - (24 Hours)||12||
59543223|NCT00919802|75641409|FG001|STARTED|Second Intervention - (24 Hours)||13||
59543224|NCT00919802|75641408|FG000|COMPLETED|Second Intervention - (24 Hours)||12||
59543225|NCT00919802|75641409|FG001|COMPLETED|Second Intervention - (24 Hours)||13||
59543226|NCT00919802|75641408|FG000|NOT COMPLETED|Second Intervention - (24 Hours)||0||
59543227|NCT00919802|75641409|FG001|NOT COMPLETED|Second Intervention - (24 Hours)||0||
59543228|NCT02222129|75641417|FG000|STARTED|Overall Study||100||
59543229|NCT02222129|75641418|FG001|STARTED|Overall Study||106||
59543230|NCT02222129|75641417|FG000|COMPLETED|Overall Study||100||
59543231|NCT02222129|75641418|FG001|COMPLETED|Overall Study||106||
59543232|NCT02222129|75641417|FG000|NOT COMPLETED|Overall Study||0||
59543233|NCT02222129|75641418|FG001|NOT COMPLETED|Overall Study||0||
59543234|NCT03409796|75641426|FG000|STARTED|Overall Study||9||
59543235|NCT03409796|75641427|FG001|STARTED|Overall Study||7||
59543236|NCT03409796|75641426|FG000|COMPLETED|Overall Study||7||
59543237|NCT03409796|75641427|FG001|COMPLETED|Overall Study||6||
59543238|NCT03409796|75641426|FG000|NOT COMPLETED|Overall Study||2||
59649081|NCT01226732|75767011|FG004|STARTED|Overall Study||3||
59649082|NCT01226732|75767012|FG005|STARTED|Overall Study||6||
59649083|NCT01226732|75767007|FG000|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0||
59988643|NCT03335033|76103875|FG000|STARTED|Overall Study||17||
59649084|NCT01226732|75767008|FG001|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0||
59649085|NCT01226732|75767009|FG002|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0||
59649086|NCT01226732|75767010|FG003|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0||
59649087|NCT01226732|75767011|FG004|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0||
59649088|NCT01226732|75767012|FG005|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0||
59649089|NCT01226732|75767007|FG000|NOT COMPLETED|Overall Study||3||
59649090|NCT01226732|75767008|FG001|NOT COMPLETED|Overall Study||3||
59649091|NCT01226732|75767009|FG002|NOT COMPLETED|Overall Study||3||
59649092|NCT01226732|75767010|FG003|NOT COMPLETED|Overall Study||5||
59649093|NCT01226732|75767011|FG004|NOT COMPLETED|Overall Study||3||
59649094|NCT01226732|75767012|FG005|NOT COMPLETED|Overall Study||6||
59649095|NCT00828308|75767033|FG000|STARTED|Overall Study||16||
59649096|NCT00828308|75767033|FG000|COMPLETED|Overall Study||16||
59649097|NCT00828308|75767033|FG000|NOT COMPLETED|Overall Study||0||
59649098|NCT00600015|75767039|FG000|STARTED|Overall Study||111||
59649099|NCT00600015|75767040|FG001|STARTED|Overall Study||55||
59649100|NCT00600015|75767039|FG000|COMPLETED|Overall Study|Completed >=2 cycles|51||
59649101|NCT00600015|75767040|FG001|COMPLETED|Overall Study|Completed >=2 cycles|20||
59649102|NCT00600015|75767039|FG000|NOT COMPLETED|Overall Study||60||
59649103|NCT00600015|75767040|FG001|NOT COMPLETED|Overall Study||35||
59649104|NCT00500071|75767047|FG000|STARTED|Screening and Washout Phase||318||
59649105|NCT00500071|75767047|FG000|COMPLETED|Screening and Washout Phase||317||
59649106|NCT00500071|75767047|FG000|NOT COMPLETED|Screening and Washout Phase||1||
59649107|NCT00500071|75767047|FG000|STARTED|Dose-optimization and Maintenance Phase|Safety population (i.e., received at least one dose of study medication)|317||
59649108|NCT00500071|75767047|FG000|COMPLETED|Dose-optimization and Maintenance Phase||295||
59649109|NCT00500071|75767047|FG000|NOT COMPLETED|Dose-optimization and Maintenance Phase||22||
59649110|NCT00500071|75767047|FG000|STARTED|30-day Safety Follow-up||295||
59649111|NCT00500071|75767047|FG000|COMPLETED|30-day Safety Follow-up||278||
59649112|NCT00500071|75767047|FG000|NOT COMPLETED|30-day Safety Follow-up||17||
59649113|NCT00447122|75767055|FG000|STARTED|Overall Study||3||
59649114|NCT00447122|75767056|FG001|STARTED|Overall Study||11||
59649115|NCT00447122|75767057|FG002|STARTED|Overall Study||6||
59649116|NCT00447122|75767058|FG003|STARTED|Overall Study||5||
59649117|NCT00447122|75767055|FG000|COMPLETED|Overall Study||3||
59649118|NCT00447122|75767056|FG001|COMPLETED|Overall Study||10||
59649119|NCT00447122|75767057|FG002|COMPLETED|Overall Study||6||
59649120|NCT00447122|75767058|FG003|COMPLETED|Overall Study||5||
59649121|NCT00447122|75767055|FG000|NOT COMPLETED|Overall Study||0||
59649122|NCT00447122|75767056|FG001|NOT COMPLETED|Overall Study||1||
59649123|NCT00447122|75767057|FG002|NOT COMPLETED|Overall Study||0||
59649124|NCT00447122|75767058|FG003|NOT COMPLETED|Overall Study||0||
59649125|NCT00382252|75767068|FG000|STARTED|Overall Study||89||
59649126|NCT00382252|75767068|FG000|COMPLETED|Overall Study||76||
59649127|NCT00382252|75767068|FG000|NOT COMPLETED|Overall Study||13||
59649128|NCT00290251|75767075|FG000|STARTED|Baseline (Month 1)||14||
59649129|NCT00290251|75767076|FG001|STARTED|Baseline (Month 1)||14||
59649130|NCT00290251|75767077|FG002|STARTED|Baseline (Month 1)||14||
59649131|NCT00290251|75767078|FG003|STARTED|Baseline (Month 1)||0||
59649132|NCT00290251|75767079|FG004|STARTED|Baseline (Month 1)||0||
59649133|NCT00290251|75767080|FG005|STARTED|Baseline (Month 1)||0||
59649134|NCT00290251|75767075|FG000|COMPLETED|Baseline (Month 1)||14||
59649135|NCT00290251|75767076|FG001|COMPLETED|Baseline (Month 1)||14||
59649136|NCT00290251|75767077|FG002|COMPLETED|Baseline (Month 1)||14||
59649137|NCT00290251|75767078|FG003|COMPLETED|Baseline (Month 1)||0||
59649138|NCT00290251|75767079|FG004|COMPLETED|Baseline (Month 1)||0||
59649139|NCT00290251|75767080|FG005|COMPLETED|Baseline (Month 1)||0||
59649140|NCT00290251|75767075|FG000|NOT COMPLETED|Baseline (Month 1)||0||
59649141|NCT00290251|75767076|FG001|NOT COMPLETED|Baseline (Month 1)||0||
59649142|NCT00290251|75767077|FG002|NOT COMPLETED|Baseline (Month 1)||0||
59649143|NCT00290251|75767078|FG003|NOT COMPLETED|Baseline (Month 1)||0||
59649144|NCT00290251|75767079|FG004|NOT COMPLETED|Baseline (Month 1)||0||
59649145|NCT00290251|75767080|FG005|NOT COMPLETED|Baseline (Month 1)||0||
59649146|NCT00290251|75767075|FG000|STARTED|Treatment 1 (Months 2-4)|Subjects crossed over from no intervention baseline to treatment assignment|0||
59649147|NCT00290251|75767076|FG001|STARTED|Treatment 1 (Months 2-4)|Subjects crossed over from no intervention baseline to treatment assignment|0||
59649148|NCT00290251|75767077|FG002|STARTED|Treatment 1 (Months 2-4)|Subjects crossed over from no intervention baseline to treatment assignment|0||
59649149|NCT00290251|75767078|FG003|STARTED|Treatment 1 (Months 2-4)|Subjects crossed over from no intervention baseline to treatment assignment|14||
59649150|NCT00290251|75767079|FG004|STARTED|Treatment 1 (Months 2-4)|Subjects crossed over from no intervention baseline to treatment assignment|14||
59649151|NCT00290251|75767080|FG005|STARTED|Treatment 1 (Months 2-4)|Subjects crossed over from no intervention baseline to treatment assignment|14||
59649152|NCT00290251|75767075|FG000|COMPLETED|Treatment 1 (Months 2-4)||0||
59649153|NCT00290251|75767076|FG001|COMPLETED|Treatment 1 (Months 2-4)||0||
59649154|NCT00290251|75767077|FG002|COMPLETED|Treatment 1 (Months 2-4)||0||
59649155|NCT00290251|75767078|FG003|COMPLETED|Treatment 1 (Months 2-4)||13||
59649156|NCT00290251|75767079|FG004|COMPLETED|Treatment 1 (Months 2-4)||13||
59649157|NCT00290251|75767080|FG005|COMPLETED|Treatment 1 (Months 2-4)||12||
59649158|NCT00290251|75767075|FG000|NOT COMPLETED|Treatment 1 (Months 2-4)||0||
59649159|NCT00290251|75767076|FG001|NOT COMPLETED|Treatment 1 (Months 2-4)||0||
59649160|NCT00290251|75767077|FG002|NOT COMPLETED|Treatment 1 (Months 2-4)||0||
59649161|NCT00290251|75767078|FG003|NOT COMPLETED|Treatment 1 (Months 2-4)||1||
59649162|NCT00290251|75767079|FG004|NOT COMPLETED|Treatment 1 (Months 2-4)||1||
59649163|NCT00290251|75767080|FG005|NOT COMPLETED|Treatment 1 (Months 2-4)||2||
59649164|NCT00066963|75767096|FG000|STARTED|Overall Study||126||
59649165|NCT00066963|75767097|FG001|STARTED|Overall Study||124||
59649166|NCT00066963|75767098|FG002|STARTED|Overall Study||126||
59649167|NCT00066963|75767096|FG000|COMPLETED|Overall Study|any follow-up|100||
59649168|NCT00066963|75767097|FG001|COMPLETED|Overall Study||93||
59649169|NCT00066963|75767098|FG002|COMPLETED|Overall Study||87||
59649170|NCT00066963|75767096|FG000|NOT COMPLETED|Overall Study||26||
59649171|NCT00066963|75767097|FG001|NOT COMPLETED|Overall Study||31||
59649172|NCT00066963|75767098|FG002|NOT COMPLETED|Overall Study||39||
59649173|NCT01403948|75767116|FG000|STARTED|Overall Study||1||
59649174|NCT01403948|75767117|FG001|STARTED|Overall Study||4||
59649175|NCT01403948|75767118|FG002|STARTED|Overall Study||3||
59649176|NCT01403948|75767119|FG003|STARTED|Overall Study||4||
59649177|NCT01403948|75767120|FG004|STARTED|Overall Study||6||
59649178|NCT01403948|75767121|FG005|STARTED|Overall Study||7||
59649179|NCT01403948|75767122|FG006|STARTED|Overall Study||6||
59649180|NCT01403948|75767123|FG007|STARTED|Overall Study||4||
59649181|NCT01403948|75767124|FG008|STARTED|Overall Study||6||
59649182|NCT01403948|75767125|FG009|STARTED|Overall Study||7||
59649183|NCT01403948|75767116|FG000|COMPLETED|Overall Study||0||
59649184|NCT01403948|75767117|FG001|COMPLETED|Overall Study||0||
59649185|NCT01403948|75767118|FG002|COMPLETED|Overall Study||0||
59649186|NCT01403948|75767119|FG003|COMPLETED|Overall Study||0||
59649187|NCT01403948|75767120|FG004|COMPLETED|Overall Study||0||
59649188|NCT01403948|75767121|FG005|COMPLETED|Overall Study||0||
59649189|NCT01403948|75767122|FG006|COMPLETED|Overall Study||0||
59649190|NCT01403948|75767123|FG007|COMPLETED|Overall Study||0||
59649191|NCT01403948|75767124|FG008|COMPLETED|Overall Study||0||
59649192|NCT01403948|75767125|FG009|COMPLETED|Overall Study||0||
59649193|NCT01403948|75767116|FG000|NOT COMPLETED|Overall Study||1||
59649194|NCT01403948|75767117|FG001|NOT COMPLETED|Overall Study||4||
59649195|NCT01403948|75767118|FG002|NOT COMPLETED|Overall Study||3||
59649196|NCT01403948|75767119|FG003|NOT COMPLETED|Overall Study||4||
59649197|NCT01403948|75767120|FG004|NOT COMPLETED|Overall Study||6||
59649198|NCT01403948|75767121|FG005|NOT COMPLETED|Overall Study||7||
59649199|NCT01403948|75767122|FG006|NOT COMPLETED|Overall Study||6||
59649200|NCT01403948|75767123|FG007|NOT COMPLETED|Overall Study||4||
59649201|NCT01403948|75767124|FG008|NOT COMPLETED|Overall Study||6||
59649202|NCT01403948|75767125|FG009|NOT COMPLETED|Overall Study||7||
59649203|NCT01404312|75767153|FG000|STARTED|Overall Study||1496||
59649204|NCT01404312|75767154|FG001|STARTED|Overall Study||1504||
59649205|NCT01404312|75767153|FG000|COMPLETED|Overall Study||1198||
59649206|NCT01404312|75767154|FG001|COMPLETED|Overall Study||1193||
59649207|NCT01404312|75767153|FG000|NOT COMPLETED|Overall Study||298||
59649208|NCT01404312|75767154|FG001|NOT COMPLETED|Overall Study||311||
59649209|NCT01414608|75767163|FG000|STARTED|Overall Study||461||
59649210|NCT01414608|75767164|FG001|STARTED|Overall Study||465||
59649211|NCT01414608|75767163|FG000|COMPLETED|Overall Study||456||
59649212|NCT01414608|75767164|FG001|COMPLETED|Overall Study||463||
59649213|NCT01414608|75767163|FG000|NOT COMPLETED|Overall Study||5||
59649214|NCT01414608|75767164|FG001|NOT COMPLETED|Overall Study||2||
59649215|NCT01420861|75767174|FG000|STARTED|Overall Study||18||
59649216|NCT01420861|75767174|FG000|Randomized|Overall Study||11||
59649217|NCT01420861|75767174|FG000|Treated|Overall Study||9||
59815779|NCT03026283|75938213|FG002|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||265||
59649218|NCT01420861|75767174|FG000|COMPLETED|Overall Study||0||
59649219|NCT01420861|75767174|FG000|NOT COMPLETED|Overall Study||18||
59649220|NCT01425008|75767197|FG000|STARTED|Dose Escalation Phase||4||
59649221|NCT01425008|75767198|FG001|STARTED|Dose Escalation Phase||3||
59649222|NCT01425008|75767199|FG002|STARTED|Dose Escalation Phase||3||
59649223|NCT01425008|75767200|FG003|STARTED|Dose Escalation Phase||3||
59649224|NCT01425008|75767201|FG004|STARTED|Dose Escalation Phase||7||
59649225|NCT01425008|75767202|FG005|STARTED|Dose Escalation Phase||7||
59649226|NCT01425008|75767203|FG006|STARTED|Dose Escalation Phase||3||
59649227|NCT01425008|75767204|FG007|STARTED|Dose Escalation Phase||3||
59649228|NCT01425008|75767205|FG008|STARTED|Dose Escalation Phase||13||
59649229|NCT01425008|75767206|FG009|STARTED|Dose Escalation Phase||4||
59649230|NCT01425008|75767207|FG010|STARTED|Dose Escalation Phase||0||
59649231|NCT01425008|75767208|FG011|STARTED|Dose Escalation Phase||0||
59649232|NCT01425008|75767209|FG012|STARTED|Dose Escalation Phase||0||
59649233|NCT01425008|75767210|FG013|STARTED|Dose Escalation Phase||0||
59649234|NCT01425008|75767211|FG014|STARTED|Dose Escalation Phase||0||
59649235|NCT01425008|75767212|FG015|STARTED|Dose Escalation Phase||0||
59649236|NCT01425008|75767213|FG016|STARTED|Dose Escalation Phase||0||
59649237|NCT01425008|75767214|FG017|STARTED|Dose Escalation Phase||0||
59649238|NCT01425008|75767215|FG018|STARTED|Dose Escalation Phase||0||
59649239|NCT01425008|75767197|FG000|COMPLETED|Dose Escalation Phase||0||
59649240|NCT01425008|75767198|FG001|COMPLETED|Dose Escalation Phase||0||
59649241|NCT01425008|75767199|FG002|COMPLETED|Dose Escalation Phase||0||
59649242|NCT01425008|75767200|FG003|COMPLETED|Dose Escalation Phase||0||
59649243|NCT01425008|75767201|FG004|COMPLETED|Dose Escalation Phase||0||
59649244|NCT01425008|75767202|FG005|COMPLETED|Dose Escalation Phase||0||
59649245|NCT01425008|75767203|FG006|COMPLETED|Dose Escalation Phase||0||
59649246|NCT01425008|75767204|FG007|COMPLETED|Dose Escalation Phase||0||
59649247|NCT01425008|75767205|FG008|COMPLETED|Dose Escalation Phase||0||
59649248|NCT01425008|75767206|FG009|COMPLETED|Dose Escalation Phase||0||
59649249|NCT01425008|75767207|FG010|COMPLETED|Dose Escalation Phase||0||
59649250|NCT01425008|75767208|FG011|COMPLETED|Dose Escalation Phase||0||
59649251|NCT01425008|75767209|FG012|COMPLETED|Dose Escalation Phase||0||
59649252|NCT01425008|75767210|FG013|COMPLETED|Dose Escalation Phase||0||
59649253|NCT01425008|75767211|FG014|COMPLETED|Dose Escalation Phase||0||
59649254|NCT01425008|75767212|FG015|COMPLETED|Dose Escalation Phase||0||
59649255|NCT01425008|75767213|FG016|COMPLETED|Dose Escalation Phase||0||
59649256|NCT01425008|75767214|FG017|COMPLETED|Dose Escalation Phase||0||
59649257|NCT01425008|75767215|FG018|COMPLETED|Dose Escalation Phase||0||
59649258|NCT01425008|75767197|FG000|NOT COMPLETED|Dose Escalation Phase||4||
59649259|NCT01425008|75767198|FG001|NOT COMPLETED|Dose Escalation Phase||3||
59649260|NCT01425008|75767199|FG002|NOT COMPLETED|Dose Escalation Phase||3||
59649261|NCT01425008|75767200|FG003|NOT COMPLETED|Dose Escalation Phase||3||
59649262|NCT01425008|75767201|FG004|NOT COMPLETED|Dose Escalation Phase||7||
59649263|NCT01425008|75767202|FG005|NOT COMPLETED|Dose Escalation Phase||7||
59649264|NCT01425008|75767203|FG006|NOT COMPLETED|Dose Escalation Phase||3||
59649265|NCT01425008|75767204|FG007|NOT COMPLETED|Dose Escalation Phase||3||
59649266|NCT01425008|75767205|FG008|NOT COMPLETED|Dose Escalation Phase||13||
59649267|NCT01425008|75767206|FG009|NOT COMPLETED|Dose Escalation Phase||4||
59649268|NCT01425008|75767207|FG010|NOT COMPLETED|Dose Escalation Phase||0||
59649269|NCT01425008|75767208|FG011|NOT COMPLETED|Dose Escalation Phase||0||
59649270|NCT01425008|75767209|FG012|NOT COMPLETED|Dose Escalation Phase||0||
59649271|NCT01425008|75767210|FG013|NOT COMPLETED|Dose Escalation Phase||0||
59649272|NCT01425008|75767211|FG014|NOT COMPLETED|Dose Escalation Phase||0||
59649273|NCT01425008|75767212|FG015|NOT COMPLETED|Dose Escalation Phase||0||
59649274|NCT01425008|75767213|FG016|NOT COMPLETED|Dose Escalation Phase||0||
59649275|NCT01425008|75767214|FG017|NOT COMPLETED|Dose Escalation Phase||0||
59649276|NCT01425008|75767215|FG018|NOT COMPLETED|Dose Escalation Phase||0||
59649277|NCT01425008|75767197|FG000|STARTED|Dose Expansion Phase||0||
59649278|NCT01425008|75767198|FG001|STARTED|Dose Expansion Phase||0||
59649279|NCT01425008|75767199|FG002|STARTED|Dose Expansion Phase||0||
59649280|NCT01425008|75767200|FG003|STARTED|Dose Expansion Phase||0||
59649281|NCT01425008|75767201|FG004|STARTED|Dose Expansion Phase||0||
59649282|NCT01425008|75767202|FG005|STARTED|Dose Expansion Phase||0||
59649283|NCT01425008|75767203|FG006|STARTED|Dose Expansion Phase||0||
59649284|NCT01425008|75767204|FG007|STARTED|Dose Expansion Phase||0||
59649285|NCT01425008|75767205|FG008|STARTED|Dose Expansion Phase||0||
59649286|NCT01425008|75767206|FG009|STARTED|Dose Expansion Phase||0||
59649287|NCT01425008|75767207|FG010|STARTED|Dose Expansion Phase||16||
59649288|NCT01425008|75767208|FG011|STARTED|Dose Expansion Phase||8||
59649289|NCT01425008|75767209|FG012|STARTED|Dose Expansion Phase||16||
59649290|NCT01425008|75767210|FG013|STARTED|Dose Expansion Phase||1||
59649291|NCT01425008|75767211|FG014|STARTED|Dose Expansion Phase||6||
59649292|NCT01425008|75767212|FG015|STARTED|Dose Expansion Phase||11||
59649293|NCT01425008|75767213|FG016|STARTED|Dose Expansion Phase||20||
59649294|NCT01425008|75767214|FG017|STARTED|Dose Expansion Phase||2||
59649295|NCT01425008|75767215|FG018|STARTED|Dose Expansion Phase||19||
59649296|NCT01425008|75767197|FG000|COMPLETED|Dose Expansion Phase||0||
59649297|NCT01425008|75767198|FG001|COMPLETED|Dose Expansion Phase||0||
59649298|NCT01425008|75767199|FG002|COMPLETED|Dose Expansion Phase||0||
59649299|NCT01425008|75767200|FG003|COMPLETED|Dose Expansion Phase||0||
59649300|NCT01425008|75767201|FG004|COMPLETED|Dose Expansion Phase||0||
59649301|NCT01425008|75767202|FG005|COMPLETED|Dose Expansion Phase||0||
59649302|NCT01425008|75767203|FG006|COMPLETED|Dose Expansion Phase||0||
59649303|NCT01425008|75767204|FG007|COMPLETED|Dose Expansion Phase||0||
59649304|NCT01425008|75767205|FG008|COMPLETED|Dose Expansion Phase||0||
59649305|NCT01425008|75767206|FG009|COMPLETED|Dose Expansion Phase||0||
59649306|NCT01425008|75767207|FG010|COMPLETED|Dose Expansion Phase||1||
59649307|NCT01425008|75767208|FG011|COMPLETED|Dose Expansion Phase||0||
59649308|NCT01425008|75767209|FG012|COMPLETED|Dose Expansion Phase||0||
59649309|NCT01425008|75767210|FG013|COMPLETED|Dose Expansion Phase||0||
59649310|NCT01425008|75767211|FG014|COMPLETED|Dose Expansion Phase||0||
59649311|NCT01425008|75767212|FG015|COMPLETED|Dose Expansion Phase||0||
59649312|NCT01425008|75767213|FG016|COMPLETED|Dose Expansion Phase||0||
59649313|NCT01425008|75767214|FG017|COMPLETED|Dose Expansion Phase||0||
59649314|NCT01425008|75767215|FG018|COMPLETED|Dose Expansion Phase||0||
59649315|NCT01425008|75767197|FG000|NOT COMPLETED|Dose Expansion Phase||0||
59649316|NCT01425008|75767198|FG001|NOT COMPLETED|Dose Expansion Phase||0||
59988644|NCT03335033|76103876|FG001|STARTED|Overall Study||37||
59649317|NCT01425008|75767199|FG002|NOT COMPLETED|Dose Expansion Phase||0||
59649318|NCT01425008|75767200|FG003|NOT COMPLETED|Dose Expansion Phase||0||
59649319|NCT01425008|75767201|FG004|NOT COMPLETED|Dose Expansion Phase||0||
59649320|NCT01425008|75767202|FG005|NOT COMPLETED|Dose Expansion Phase||0||
59649321|NCT01425008|75767203|FG006|NOT COMPLETED|Dose Expansion Phase||0||
59649322|NCT01425008|75767204|FG007|NOT COMPLETED|Dose Expansion Phase||0||
59649323|NCT01425008|75767205|FG008|NOT COMPLETED|Dose Expansion Phase||0||
59649324|NCT01425008|75767206|FG009|NOT COMPLETED|Dose Expansion Phase||0||
59649325|NCT01425008|75767207|FG010|NOT COMPLETED|Dose Expansion Phase||15||
59649326|NCT01425008|75767208|FG011|NOT COMPLETED|Dose Expansion Phase||8||
59649327|NCT01425008|75767209|FG012|NOT COMPLETED|Dose Expansion Phase||16||
59649328|NCT01425008|75767210|FG013|NOT COMPLETED|Dose Expansion Phase||1||
59649329|NCT01425008|75767211|FG014|NOT COMPLETED|Dose Expansion Phase||6||
59649330|NCT01425008|75767212|FG015|NOT COMPLETED|Dose Expansion Phase||11||
59649331|NCT01425008|75767213|FG016|NOT COMPLETED|Dose Expansion Phase||20||
59649332|NCT01425008|75767214|FG017|NOT COMPLETED|Dose Expansion Phase||2||
59649333|NCT01425008|75767215|FG018|NOT COMPLETED|Dose Expansion Phase||19||
59649334|NCT04072146|75767270|FG000|STARTED|Overall Study||11||
59649335|NCT04072146|75767271|FG001|STARTED|Overall Study||11||
59649336|NCT04072146|75767270|FG000|COMPLETED|Overall Study||11||
59649337|NCT04072146|75767271|FG001|COMPLETED|Overall Study||10||
59649338|NCT04072146|75767270|FG000|NOT COMPLETED|Overall Study||0||
59649339|NCT04072146|75767271|FG001|NOT COMPLETED|Overall Study||1||
59649340|NCT03861481|75767285|FG000|STARTED|Overall Study||17||
59649341|NCT03861481|75767286|FG001|STARTED|Overall Study||17||
59649342|NCT03861481|75767285|FG000|COMPLETED|Overall Study||11||
59649343|NCT03861481|75767286|FG001|COMPLETED|Overall Study||10||
59649344|NCT03861481|75767285|FG000|NOT COMPLETED|Overall Study||6||
59649345|NCT03861481|75767286|FG001|NOT COMPLETED|Overall Study||7||
59649346|NCT03708198|75767292|FG000|STARTED|Overall Study||15||
59649347|NCT03708198|75767292|FG000|COMPLETED|Overall Study||15||
59649348|NCT03708198|75767292|FG000|NOT COMPLETED|Overall Study||0||
59649349|NCT03648476|75767298|FG000|STARTED|Overall Study||10||
59649350|NCT03648476|75767299|FG001|STARTED|Overall Study||14||
59649351|NCT03648476|75767298|FG000|COMPLETED|Overall Study||8||
59649352|NCT03648476|75767299|FG001|COMPLETED|Overall Study||13||
60076811|NCT01513317|76191820|FG001|NOT COMPLETED|Overall Study||24||
60076812|NCT03824392|76191830|FG000|STARTED|Overall Study||12||
60076813|NCT03824392|76191831|FG001|STARTED|Overall Study||8||
60076814|NCT03824392|76191832|FG002|STARTED|Overall Study||8||
60076815|NCT03824392|76191833|FG003|STARTED|Overall Study||9||
60076816|NCT03824392|76191830|FG000|Received at Least 1 Dose of Study Drug|Overall Study||12||
60076817|NCT03824392|76191831|FG001|Received at Least 1 Dose of Study Drug|Overall Study||8||
60076818|NCT03824392|76191832|FG002|Received at Least 1 Dose of Study Drug|Overall Study||8||
60076819|NCT03824392|76191833|FG003|Received at Least 1 Dose of Study Drug|Overall Study||9||
60076820|NCT03824392|76191830|FG000|COMPLETED|Overall Study||9||
59543239|NCT03409796|75641427|FG001|NOT COMPLETED|Overall Study||1||
60076821|NCT03824392|76191831|FG001|COMPLETED|Overall Study||6||
60076822|NCT03824392|76191832|FG002|COMPLETED|Overall Study||5||
60076823|NCT03824392|76191833|FG003|COMPLETED|Overall Study||8||
60076824|NCT03824392|76191830|FG000|NOT COMPLETED|Overall Study||3||
59543240|NCT02462928|75641436|FG000|STARTED|Overall Study||314||
59543241|NCT02462928|75641437|FG001|STARTED|Overall Study||313||
59543242|NCT02462928|75641438|FG002|STARTED|Overall Study||312||
59543243|NCT02462928|75641436|FG000|COMPLETED|Overall Study||224||
59543244|NCT02462928|75641437|FG001|COMPLETED|Overall Study||221||
59543245|NCT02462928|75641438|FG002|COMPLETED|Overall Study||255||
59543246|NCT02462928|75641436|FG000|NOT COMPLETED|Overall Study||90||
59543247|NCT02462928|75641437|FG001|NOT COMPLETED|Overall Study||92||
59543248|NCT02462928|75641438|FG002|NOT COMPLETED|Overall Study||57||
59543249|NCT03408860|75641448|FG000|STARTED|Overall Study||4||
59543250|NCT03408860|75641449|FG001|STARTED|Overall Study||4||
59543251|NCT03408860|75641448|FG000|COMPLETED|Overall Study||4||
59649353|NCT03648476|75767298|FG000|NOT COMPLETED|Overall Study||2||
59649354|NCT03648476|75767299|FG001|NOT COMPLETED|Overall Study||1||
59649355|NCT03537937|75767309|FG000|STARTED|Overall Study||808||
59649356|NCT03537937|75767310|FG001|STARTED|Overall Study||859||
59649357|NCT03537937|75767311|FG002|STARTED|Overall Study||874||
59649358|NCT03537937|75767309|FG000|COMPLETED|Overall Study||808||
59649359|NCT03537937|75767310|FG001|COMPLETED|Overall Study||859||
59649360|NCT03537937|75767311|FG002|COMPLETED|Overall Study||874||
59649361|NCT03537937|75767309|FG000|NOT COMPLETED|Overall Study||0||
59649362|NCT03537937|75767310|FG001|NOT COMPLETED|Overall Study||0||
59543252|NCT03408860|75641449|FG001|COMPLETED|Overall Study||4||
59543253|NCT03408860|75641448|FG000|NOT COMPLETED|Overall Study||0||
59649363|NCT03537937|75767311|FG002|NOT COMPLETED|Overall Study||0||
59649364|NCT05384041|75767321|FG000|STARTED|Overall Study||126||
59649365|NCT05384041|75767322|FG001|STARTED|Overall Study||129||
59543254|NCT03408860|75641449|FG001|NOT COMPLETED|Overall Study||0||
59649366|NCT05384041|75767321|FG000|COMPLETED|Overall Study||121||
59649367|NCT05384041|75767322|FG001|COMPLETED|Overall Study||125||
60076825|NCT03824392|76191831|FG001|NOT COMPLETED|Overall Study||2||
59649368|NCT05384041|75767321|FG000|NOT COMPLETED|Overall Study||5||
59649369|NCT05384041|75767322|FG001|NOT COMPLETED|Overall Study||4||
59649370|NCT04545060|75767330|FG000|STARTED|Overall Study||528||
59649371|NCT04545060|75767331|FG001|STARTED|Overall Study||529||
59649372|NCT04545060|75767330|FG000|COMPLETED|Overall Study||498||
59649373|NCT04545060|75767331|FG001|COMPLETED|Overall Study||488||
59649374|NCT04545060|75767330|FG000|NOT COMPLETED|Overall Study||30||
59649375|NCT04545060|75767331|FG001|NOT COMPLETED|Overall Study||41||
59649376|NCT04323137|75767344|FG000|STARTED|Overall Study||11667||
59649377|NCT04323137|75767345|FG001|STARTED|Overall Study||11639||
59649378|NCT04323137|75767346|FG002|STARTED|Overall Study||11652||
59649379|NCT04323137|75767347|FG003|STARTED|Overall Study||11644||
59649380|NCT04323137|75767348|FG004|STARTED|Overall Study||46898||
59649381|NCT04323137|75767349|FG005|STARTED|Overall Study||24149||
59649382|NCT04323137|75767344|FG000|COMPLETED|Overall Study||11667||
59649383|NCT04323137|75767345|FG001|COMPLETED|Overall Study||11639||
59649384|NCT04323137|75767346|FG002|COMPLETED|Overall Study||11652||
59649385|NCT04323137|75767347|FG003|COMPLETED|Overall Study||11644||
59649386|NCT04323137|75767348|FG004|COMPLETED|Overall Study||46898||
59649387|NCT04323137|75767349|FG005|COMPLETED|Overall Study||24149||
59649388|NCT04323137|75767344|FG000|NOT COMPLETED|Overall Study||0||
59649389|NCT04323137|75767345|FG001|NOT COMPLETED|Overall Study||0||
59649390|NCT04323137|75767346|FG002|NOT COMPLETED|Overall Study||0||
59649391|NCT04323137|75767347|FG003|NOT COMPLETED|Overall Study||0||
59649392|NCT04323137|75767348|FG004|NOT COMPLETED|Overall Study||0||
59649393|NCT04323137|75767349|FG005|NOT COMPLETED|Overall Study||0||
59649394|NCT04316104|75767364|FG000|STARTED|Overall Study||24||
59649395|NCT04316104|75767364|FG000|COMPLETED|Overall Study||21||
59649396|NCT04316104|75767364|FG000|NOT COMPLETED|Overall Study||3||
59649397|NCT04189848|75767368|FG000|STARTED|Treatment Period 1 (Day 1)||26||
59649398|NCT04189848|75767369|FG001|STARTED|Treatment Period 1 (Day 1)||26||
59649399|NCT04189848|75767370|FG002|STARTED|Treatment Period 1 (Day 1)||25||
59649400|NCT04189848|75767371|FG003|STARTED|Treatment Period 1 (Day 1)||27||
59649401|NCT04189848|75767368|FG000|COMPLETED|Treatment Period 1 (Day 1)||26||
59649402|NCT04189848|75767369|FG001|COMPLETED|Treatment Period 1 (Day 1)||26||
59649403|NCT04189848|75767370|FG002|COMPLETED|Treatment Period 1 (Day 1)||25||
59649404|NCT04189848|75767371|FG003|COMPLETED|Treatment Period 1 (Day 1)||27||
59649405|NCT04189848|75767368|FG000|NOT COMPLETED|Treatment Period 1 (Day 1)||0||
59649406|NCT04189848|75767369|FG001|NOT COMPLETED|Treatment Period 1 (Day 1)||0||
59649407|NCT04189848|75767370|FG002|NOT COMPLETED|Treatment Period 1 (Day 1)||0||
59649408|NCT04189848|75767371|FG003|NOT COMPLETED|Treatment Period 1 (Day 1)||0||
59649409|NCT04189848|75767368|FG000|STARTED|Treatment Period 2 (Day 1)||26||
59649410|NCT04189848|75767369|FG001|STARTED|Treatment Period 2 (Day 1)||26||
59649411|NCT04189848|75767370|FG002|STARTED|Treatment Period 2 (Day 1)||25||
59649412|NCT04189848|75767371|FG003|STARTED|Treatment Period 2 (Day 1)||27||
59649413|NCT04189848|75767368|FG000|COMPLETED|Treatment Period 2 (Day 1)||26||
59649414|NCT04189848|75767369|FG001|COMPLETED|Treatment Period 2 (Day 1)||26||
59649415|NCT04189848|75767370|FG002|COMPLETED|Treatment Period 2 (Day 1)||25||
59649416|NCT04189848|75767371|FG003|COMPLETED|Treatment Period 2 (Day 1)||27||
59649417|NCT04189848|75767368|FG000|NOT COMPLETED|Treatment Period 2 (Day 1)||0||
59649418|NCT04189848|75767369|FG001|NOT COMPLETED|Treatment Period 2 (Day 1)||0||
59649419|NCT04189848|75767370|FG002|NOT COMPLETED|Treatment Period 2 (Day 1)||0||
59649420|NCT04189848|75767371|FG003|NOT COMPLETED|Treatment Period 2 (Day 1)||0||
59988645|NCT03335033|76103875|FG000|COMPLETED|Overall Study||17||
59649421|NCT04036968|75767376|FG000|STARTED|Overall Study||31||
59649422|NCT04036968|75767376|FG000|Placebo + Placebo|Overall Study||31||
59649423|NCT04036968|75767376|FG000|Hydromorphoe 4mg + Placebo|Overall Study||31||
59988646|NCT03335033|76103876|FG001|COMPLETED|Overall Study||37||
59649424|NCT04036968|75767376|FG000|Hydromorphone 4mg + Cannabidiol 50mg|Overall Study||31||
59649425|NCT04036968|75767376|FG000|Hydromorphone 4mg + Cannabidiol 100mg|Overall Study||31||
59988647|NCT03335033|76103875|FG000|NOT COMPLETED|Overall Study||0||
59649426|NCT04036968|75767376|FG000|Hydromorphone 4mg + Cannabidiol 200mg|Overall Study||31||
59649427|NCT04036968|75767376|FG000|COMPLETED|Overall Study||31||
59649428|NCT04036968|75767376|FG000|NOT COMPLETED|Overall Study||0||
59649429|NCT03860077|75767390|FG000|STARTED|Overall Study||25||
59649430|NCT03860077|75767391|FG001|STARTED|Overall Study||24||
59649431|NCT03860077|75767390|FG000|COMPLETED|Overall Study||21||
59649432|NCT03860077|75767391|FG001|COMPLETED|Overall Study||17||
59988648|NCT03335033|76103876|FG001|NOT COMPLETED|Overall Study||0||
59988649|NCT01352585|76103884|FG000|STARTED|Overall Study||23||
59649433|NCT03860077|75767390|FG000|NOT COMPLETED|Overall Study||4||
59649434|NCT03860077|75767391|FG001|NOT COMPLETED|Overall Study||7||
59649435|NCT03670004|75767399|FG000|STARTED|Overall Study||13||
59649436|NCT03670004|75767400|FG001|STARTED|Overall Study||10||
59649437|NCT03670004|75767399|FG000|COMPLETED|Overall Study||13||
59649438|NCT03670004|75767400|FG001|COMPLETED|Overall Study||10||
59649439|NCT03670004|75767399|FG000|NOT COMPLETED|Overall Study||0||
59649440|NCT03670004|75767400|FG001|NOT COMPLETED|Overall Study||0||
59649441|NCT03533660|75767408|FG000|STARTED|Overall Study||15||
59649442|NCT03533660|75767409|FG001|STARTED|Overall Study||18||
59649443|NCT03533660|75767408|FG000|COMPLETED|Overall Study||11||
59649444|NCT03533660|75767409|FG001|COMPLETED|Overall Study||10||
59649445|NCT03533660|75767408|FG000|NOT COMPLETED|Overall Study||4||
59649446|NCT03533660|75767409|FG001|NOT COMPLETED|Overall Study||8||
59649447|NCT03416127|75767423|FG000|STARTED|Overall Study||12||
59649448|NCT03416127|75767424|FG001|STARTED|Overall Study||12||
59649449|NCT03416127|75767425|FG002|STARTED|Overall Study||12||
59649450|NCT03416127|75767423|FG000|COMPLETED|Overall Study||12||
59649451|NCT03416127|75767424|FG001|COMPLETED|Overall Study||11||
59649452|NCT03416127|75767425|FG002|COMPLETED|Overall Study||11||
59649453|NCT03416127|75767423|FG000|NOT COMPLETED|Overall Study||0||
59649454|NCT03416127|75767424|FG001|NOT COMPLETED|Overall Study||1||
59649455|NCT03416127|75767425|FG002|NOT COMPLETED|Overall Study||1||
59649456|NCT03232346|75767436|FG000|STARTED|Overall Study||6||
59649457|NCT03232346|75767437|FG001|STARTED|Overall Study||5||
59649458|NCT03232346|75767436|FG000|COMPLETED|Overall Study||2||
59649459|NCT03232346|75767437|FG001|COMPLETED|Overall Study||3||
59649460|NCT03232346|75767436|FG000|NOT COMPLETED|Overall Study||4||
59649461|NCT03232346|75767437|FG001|NOT COMPLETED|Overall Study||2||
59649462|NCT03203512|75767445|FG000|STARTED|First Intervention (12 Weeks)||20||
59649463|NCT03203512|75767446|FG001|STARTED|First Intervention (12 Weeks)||20||
59649464|NCT03203512|75767445|FG000|COMPLETED|First Intervention (12 Weeks)||20||
59649465|NCT03203512|75767446|FG001|COMPLETED|First Intervention (12 Weeks)||20||
59649466|NCT03203512|75767445|FG000|NOT COMPLETED|First Intervention (12 Weeks)||0||
59649467|NCT03203512|75767446|FG001|NOT COMPLETED|First Intervention (12 Weeks)||0||
59649468|NCT03203512|75767445|FG000|STARTED|Washout (12 Weeks)||20||
59649469|NCT03203512|75767446|FG001|STARTED|Washout (12 Weeks)||20||
59649470|NCT03203512|75767445|FG000|COMPLETED|Washout (12 Weeks)||20||
59649471|NCT03203512|75767446|FG001|COMPLETED|Washout (12 Weeks)||20||
59649472|NCT03203512|75767445|FG000|NOT COMPLETED|Washout (12 Weeks)||0||
59649473|NCT03203512|75767446|FG001|NOT COMPLETED|Washout (12 Weeks)||0||
59649474|NCT03203512|75767445|FG000|STARTED|Second Intervention (12 Weeks)||20||
59649475|NCT03203512|75767446|FG001|STARTED|Second Intervention (12 Weeks)||20||
59649476|NCT03203512|75767445|FG000|COMPLETED|Second Intervention (12 Weeks)||20||
59649477|NCT03203512|75767446|FG001|COMPLETED|Second Intervention (12 Weeks)||20||
59649478|NCT03203512|75767445|FG000|NOT COMPLETED|Second Intervention (12 Weeks)||0||
59649479|NCT03203512|75767446|FG001|NOT COMPLETED|Second Intervention (12 Weeks)||0||
59649480|NCT02986334|75767459|FG000|STARTED|Overall Study||14||
59649481|NCT02986334|75767460|FG001|STARTED|Overall Study||40||
59649482|NCT02986334|75767461|FG002|STARTED|Overall Study||40||
59649483|NCT02986334|75767459|FG000|COMPLETED|Overall Study||11||
59649484|NCT02986334|75767460|FG001|COMPLETED|Overall Study||33||
59649485|NCT02986334|75767461|FG002|COMPLETED|Overall Study||33||
59649486|NCT02986334|75767459|FG000|NOT COMPLETED|Overall Study||3||
59649487|NCT02986334|75767460|FG001|NOT COMPLETED|Overall Study||7||
59649488|NCT02986334|75767461|FG002|NOT COMPLETED|Overall Study||7||
59649489|NCT02275156|75767472|FG000|STARTED|Overall Study||6||
59649490|NCT02275156|75767473|FG001|STARTED|Overall Study||6||
59649491|NCT02275156|75767474|FG002|STARTED|Overall Study||6||
59649492|NCT02275156|75767472|FG000|COMPLETED|Overall Study||6||
59649493|NCT02275156|75767473|FG001|COMPLETED|Overall Study||6||
59543255|NCT00019604|75641455|FG000|STARTED|Overall Study||44||
59649494|NCT02275156|75767474|FG002|COMPLETED|Overall Study||6||
59649495|NCT02275156|75767472|FG000|NOT COMPLETED|Overall Study||0||
59649496|NCT02275156|75767473|FG001|NOT COMPLETED|Overall Study||0||
59649497|NCT02275156|75767474|FG002|NOT COMPLETED|Overall Study||0||
59543256|NCT00019604|75641455|FG000|COMPLETED|Overall Study||5||
59543257|NCT00019604|75641455|FG000|NOT COMPLETED|Overall Study||39||
59543258|NCT02226965|75641459|FG000|STARTED|Overall Study||45||
59543259|NCT02226965|75641459|FG000|COMPLETED|Overall Study||4|4 subjects completed the Induction Phase and 3 subjects started the Continuation Phase|
59543260|NCT02226965|75641459|FG000|NOT COMPLETED|Overall Study||41||
59543261|NCT02227121|75641463|FG000|STARTED|Overall Study||16|Subject underwent attempted VF induction during surgery procedure|
59543262|NCT02227121|75641463|FG000|COMPLETED|Overall Study||16||
59543263|NCT02227121|75641463|FG000|NOT COMPLETED|Overall Study||0||
59649498|NCT02210221|75767483|FG000|STARTED|Overall Study||4559||
59649499|NCT02210221|75767483|FG000|COMPLETED|Overall Study||4509||
59543264|NCT02492958|75641471|FG000|STARTED|Overall Study||34||
59543265|NCT02492958|75641472|FG001|STARTED|Overall Study||34||
59543266|NCT02492958|75641473|FG002|STARTED|Overall Study||34||
59543267|NCT02492958|75641474|FG003|STARTED|Overall Study||34||
59543268|NCT02492958|75641471|FG000|COMPLETED|Overall Study||33||
59649500|NCT02210221|75767483|FG000|NOT COMPLETED|Overall Study||50||
59649501|NCT02124902|75767496|FG000|STARTED|Overall Study||123|Completion is considered receiving 6 cycles of treatment.|
59649502|NCT02124902|75767497|FG001|STARTED|Overall Study||25|Completion is considered receiving 6 cycles of treatment.|
59649503|NCT02124902|75767496|FG000|COMPLETED|Overall Study||106||
59649504|NCT02124902|75767497|FG001|COMPLETED|Overall Study||19||
59649505|NCT02124902|75767496|FG000|NOT COMPLETED|Overall Study||17||
59649506|NCT02124902|75767497|FG001|NOT COMPLETED|Overall Study||6||
59649507|NCT01940341|75767505|FG000|STARTED|Period 1: Double-blind Phase||285||
59649508|NCT01940341|75767506|FG001|STARTED|Period 1: Double-blind Phase||141||
59649509|NCT01940341|75767507|FG002|STARTED|Period 1: Double-blind Phase||0||
59649510|NCT01940341|75767508|FG003|STARTED|Period 1: Double-blind Phase||0||
59649511|NCT01940341|75767505|FG000|COMPLETED|Period 1: Double-blind Phase||261||
59649512|NCT01940341|75767506|FG001|COMPLETED|Period 1: Double-blind Phase||129||
59649513|NCT01940341|75767507|FG002|COMPLETED|Period 1: Double-blind Phase||0||
59649514|NCT01940341|75767508|FG003|COMPLETED|Period 1: Double-blind Phase||0||
59649515|NCT01940341|75767505|FG000|NOT COMPLETED|Period 1: Double-blind Phase||24||
59649516|NCT01940341|75767506|FG001|NOT COMPLETED|Period 1: Double-blind Phase||12||
59649517|NCT01940341|75767507|FG002|NOT COMPLETED|Period 1: Double-blind Phase||0||
59649518|NCT01940341|75767508|FG003|NOT COMPLETED|Period 1: Double-blind Phase||0||
59649519|NCT01940341|75767505|FG000|STARTED|Period 2: Open-Label TAF Extension Phase||0|At the end of Double-blind Phase, participants were given the option to receive TAF in an OL TAF Extension Phase for up to 240 or 288 weeks.|
59649520|NCT01940341|75767506|FG001|STARTED|Period 2: Open-Label TAF Extension Phase||0|At the end of Double-blind Phase, participants were given the option to receive TAF in an OL TAF Extension Phase for up to 240 or 288 weeks.|
59649521|NCT01940341|75767507|FG002|STARTED|Period 2: Open-Label TAF Extension Phase|24 participants from TAF arm did not enter the OL TAF Extension Phase.|261|At the end of Double-blind Phase, participants were given the option to receive TAF in an OL TAF Extension Phase for up to 240 or 288 weeks.|
59649522|NCT01940341|75767508|FG003|STARTED|Period 2: Open-Label TAF Extension Phase|12 participants from TDF arm did not enter the OL TAF Extension Phase.|129|At the end of Double-blind Phase, participants were given the option to receive TAF in an OL TAF Extension Phase for up to 240 or 288 weeks.|
59649523|NCT01940341|75767505|FG000|COMPLETED|Period 2: Open-Label TAF Extension Phase||0||
60076826|NCT03824392|76191832|FG002|NOT COMPLETED|Overall Study||3||
60076827|NCT03824392|76191833|FG003|NOT COMPLETED|Overall Study||1||
60076828|NCT01901653|76191856|FG000|STARTED|Overall Study||3||
60076829|NCT01901653|76191857|FG001|STARTED|Overall Study||1||
60076830|NCT01901653|76191858|FG002|STARTED|Overall Study||11||
60076831|NCT01901653|76191859|FG003|STARTED|Overall Study||3||
60076832|NCT01901653|76191860|FG004|STARTED|Overall Study||2||
60076833|NCT01901653|76191861|FG005|STARTED|Overall Study||3||
60076834|NCT01901653|76191862|FG006|STARTED|Overall Study||7||
60076835|NCT01901653|76191863|FG007|STARTED|Overall Study||10||
60076836|NCT01901653|76191864|FG008|STARTED|Overall Study||1||
60076837|NCT01901653|76191865|FG009|STARTED|Overall Study||18||
60076838|NCT01901653|76191866|FG010|STARTED|Overall Study||2||
60076839|NCT01901653|76191867|FG011|STARTED|Overall Study||16||
59543269|NCT02492958|75641472|FG001|COMPLETED|Overall Study||34||
59543270|NCT02492958|75641473|FG002|COMPLETED|Overall Study||32||
59543271|NCT02492958|75641474|FG003|COMPLETED|Overall Study||34||
59543272|NCT02492958|75641471|FG000|NOT COMPLETED|Overall Study||1||
59543273|NCT02492958|75641472|FG001|NOT COMPLETED|Overall Study||0||
59543274|NCT02492958|75641473|FG002|NOT COMPLETED|Overall Study||2||
59543275|NCT02492958|75641474|FG003|NOT COMPLETED|Overall Study||0||
59543276|NCT02492880|75641484|FG000|STARTED|Overall Study||15||
59543277|NCT02492880|75641484|FG000|COMPLETED|Overall Study||13||
59543278|NCT02492880|75641484|FG000|NOT COMPLETED|Overall Study||2||
59543279|NCT02516592|75641490|FG000|STARTED|Overall Study||251||
59543280|NCT02516592|75641491|FG001|STARTED|Overall Study||251||
59543281|NCT02516592|75641490|FG000|Full Analysis Set|Overall Study||248||
59543282|NCT02516592|75641491|FG001|Full Analysis Set|Overall Study||250||
59543283|NCT02516592|75641490|FG000|COMPLETED|Overall Study||235||
59543284|NCT02516592|75641491|FG001|COMPLETED|Overall Study||238||
59543285|NCT02516592|75641490|FG000|NOT COMPLETED|Overall Study||16||
59543286|NCT02516592|75641491|FG001|NOT COMPLETED|Overall Study||13||
59543287|NCT02219321|75641499|FG000|STARTED|Overall Study||1||
59543288|NCT02219321|75641500|FG001|STARTED|Overall Study||2||
59543289|NCT02219321|75641499|FG000|COMPLETED|Overall Study||1||
59543290|NCT02219321|75641500|FG001|COMPLETED|Overall Study||2||
59543291|NCT02219321|75641499|FG000|NOT COMPLETED|Overall Study||0||
60076840|NCT01901653|76191868|FG012|STARTED|Overall Study||5||
60076841|NCT01901653|76191856|FG000|COMPLETED|Overall Study||0||
60076842|NCT01901653|76191857|FG001|COMPLETED|Overall Study||0||
59543292|NCT02219321|75641500|FG001|NOT COMPLETED|Overall Study||0||
59649524|NCT01940341|75767506|FG001|COMPLETED|Period 2: Open-Label TAF Extension Phase||0||
59649525|NCT01940341|75767507|FG002|COMPLETED|Period 2: Open-Label TAF Extension Phase||227||
59649526|NCT01940341|75767508|FG003|COMPLETED|Period 2: Open-Label TAF Extension Phase||118||
59988650|NCT01352585|76103885|FG001|STARTED|Overall Study||24||
60076843|NCT01901653|76191858|FG002|COMPLETED|Overall Study||0||
60076844|NCT01901653|76191859|FG003|COMPLETED|Overall Study||0||
60076845|NCT01901653|76191860|FG004|COMPLETED|Overall Study||0||
60076846|NCT01901653|76191861|FG005|COMPLETED|Overall Study||0||
60076847|NCT01901653|76191862|FG006|COMPLETED|Overall Study||0||
60076848|NCT01901653|76191863|FG007|COMPLETED|Overall Study||0||
60076849|NCT01901653|76191864|FG008|COMPLETED|Overall Study||0||
59543293|NCT02156258|75641509|FG000|STARTED|Overall Study||674||
59543294|NCT02156258|75641510|FG001|STARTED|Overall Study||203||
60076850|NCT01901653|76191865|FG009|COMPLETED|Overall Study||0||
60076851|NCT01901653|76191866|FG010|COMPLETED|Overall Study||0||
59543295|NCT02156258|75641511|FG002|STARTED|Overall Study||355||
59543296|NCT02156258|75641509|FG000|COMPLETED|Overall Study||642||
59543297|NCT02156258|75641510|FG001|COMPLETED|Overall Study||124||
59543298|NCT02156258|75641511|FG002|COMPLETED|Overall Study||244||
59543299|NCT02156258|75641509|FG000|NOT COMPLETED|Overall Study||32||
59649527|NCT01940341|75767505|FG000|NOT COMPLETED|Period 2: Open-Label TAF Extension Phase||0||
59649528|NCT01940341|75767506|FG001|NOT COMPLETED|Period 2: Open-Label TAF Extension Phase||0||
59649529|NCT01940341|75767507|FG002|NOT COMPLETED|Period 2: Open-Label TAF Extension Phase||34||
59649530|NCT01940341|75767508|FG003|NOT COMPLETED|Period 2: Open-Label TAF Extension Phase||11||
59649531|NCT01877837|75767516|FG000|STARTED|Overall Study||30||
59649532|NCT01877837|75767516|FG000|COMPLETED|Overall Study||25||
59649533|NCT01877837|75767516|FG000|NOT COMPLETED|Overall Study||5||
59649534|NCT01624142|75767522|FG000|STARTED|Overall Study||106||
59649535|NCT01624142|75767523|FG001|STARTED|Overall Study||194||
59649536|NCT01624142|75767522|FG000|COMPLETED|Overall Study||74||
59649537|NCT01624142|75767523|FG001|COMPLETED|Overall Study||178||
59649538|NCT01624142|75767522|FG000|NOT COMPLETED|Overall Study||32||
59649539|NCT01624142|75767523|FG001|NOT COMPLETED|Overall Study||16||
59649540|NCT01535807|75767532|FG000|STARTED|Overall Study||22||
59649541|NCT01535807|75767533|FG001|STARTED|Overall Study||22||
59649542|NCT01535807|75767532|FG000|COMPLETED|Overall Study||20||
59649543|NCT01535807|75767533|FG001|COMPLETED|Overall Study||20||
59649544|NCT01535807|75767532|FG000|NOT COMPLETED|Overall Study||2||
59649545|NCT01535807|75767533|FG001|NOT COMPLETED|Overall Study||2||
59649546|NCT01375764|75767545|FG000|STARTED|Overall Study||33||
59649547|NCT01375764|75767546|FG001|STARTED|Overall Study||31||
59649548|NCT01375764|75767547|FG002|STARTED|Overall Study||32||
59649549|NCT01375764|75767548|FG003|STARTED|Overall Study||32||
59649550|NCT01375764|75767549|FG004|STARTED|Overall Study||32||
59649551|NCT01375764|75767545|FG000|Received Treatment|Overall Study||32||
59649552|NCT01375764|75767546|FG001|Received Treatment|Overall Study||30||
59649553|NCT01375764|75767547|FG002|Received Treatment|Overall Study||32||
59649554|NCT01375764|75767548|FG003|Received Treatment|Overall Study||31||
59649555|NCT01375764|75767549|FG004|Received Treatment|Overall Study||32||
59649556|NCT01375764|75767545|FG000|COMPLETED|Overall Study||31||
59649557|NCT01375764|75767546|FG001|COMPLETED|Overall Study||30||
59649558|NCT01375764|75767547|FG002|COMPLETED|Overall Study||32||
59649559|NCT01375764|75767548|FG003|COMPLETED|Overall Study||31||
59649560|NCT01375764|75767549|FG004|COMPLETED|Overall Study||31||
59649561|NCT01375764|75767545|FG000|NOT COMPLETED|Overall Study||2||
59649562|NCT01375764|75767546|FG001|NOT COMPLETED|Overall Study||1||
59649563|NCT01375764|75767547|FG002|NOT COMPLETED|Overall Study||0||
59649564|NCT01375764|75767548|FG003|NOT COMPLETED|Overall Study||1||
59649565|NCT01375764|75767549|FG004|NOT COMPLETED|Overall Study||1||
59649566|NCT00722046|75767568|FG000|STARTED|Overall Study||26||
59649567|NCT00722046|75767569|FG001|STARTED|Overall Study||26||
59649568|NCT00722046|75767570|FG002|STARTED|Overall Study||25||
59649569|NCT00722046|75767571|FG003|STARTED|Overall Study||26||
59649570|NCT00722046|75767572|FG004|STARTED|Overall Study||32||
59649571|NCT00722046|75767573|FG005|STARTED|Overall Study||31||
59649572|NCT00722046|75767574|FG006|STARTED|Overall Study||32||
59649573|NCT00722046|75767568|FG000|Treated|Overall Study||25||
59649574|NCT00722046|75767569|FG001|Treated|Overall Study||25||
59649575|NCT00722046|75767570|FG002|Treated|Overall Study||25||
59649576|NCT00722046|75767571|FG003|Treated|Overall Study||24||
59649577|NCT00722046|75767572|FG004|Treated|Overall Study||32||
59649578|NCT00722046|75767573|FG005|Treated|Overall Study||31||
59649579|NCT00722046|75767574|FG006|Treated|Overall Study||32||
59649580|NCT00722046|75767568|FG000|COMPLETED|Overall Study||21||
59649581|NCT00722046|75767569|FG001|COMPLETED|Overall Study||20||
59649582|NCT00722046|75767570|FG002|COMPLETED|Overall Study||18||
59649583|NCT00722046|75767571|FG003|COMPLETED|Overall Study||18||
59649584|NCT00722046|75767572|FG004|COMPLETED|Overall Study||23||
59649585|NCT00722046|75767573|FG005|COMPLETED|Overall Study||20||
59649586|NCT00722046|75767574|FG006|COMPLETED|Overall Study||26||
59649587|NCT00722046|75767568|FG000|NOT COMPLETED|Overall Study||5||
59649588|NCT00722046|75767569|FG001|NOT COMPLETED|Overall Study||6||
59649589|NCT00722046|75767570|FG002|NOT COMPLETED|Overall Study||7||
59649590|NCT00722046|75767571|FG003|NOT COMPLETED|Overall Study||8||
59649591|NCT00722046|75767572|FG004|NOT COMPLETED|Overall Study||9||
59649592|NCT00722046|75767573|FG005|NOT COMPLETED|Overall Study||11||
59649593|NCT00722046|75767574|FG006|NOT COMPLETED|Overall Study||6||
59649594|NCT00614523|75767594|FG000|STARTED|Overall Study||83||
59649595|NCT00614523|75767595|FG001|STARTED|Overall Study||167||
59649596|NCT00614523|75767594|FG000|COMPLETED|Overall Study||20||
59649597|NCT00614523|75767595|FG001|COMPLETED|Overall Study||36||
59649598|NCT00614523|75767594|FG000|NOT COMPLETED|Overall Study||63||
59649599|NCT00614523|75767595|FG001|NOT COMPLETED|Overall Study||131||
59649600|NCT00523341|75767603|FG000|STARTED|Overall Study||2207||
59649601|NCT00523341|75767604|FG001|STARTED|Overall Study||2343||
59649602|NCT00523341|75767603|FG000|Received Treatment|Overall Study||2206||
59649603|NCT00523341|75767604|FG001|Received Treatment|Overall Study||2343||
59649604|NCT00523341|75767603|FG000|COMPLETED|Overall Study||1283||
59649605|NCT00523341|75767604|FG001|COMPLETED|Overall Study||1343||
59649606|NCT00523341|75767603|FG000|NOT COMPLETED|Overall Study||924||
59649607|NCT00523341|75767604|FG001|NOT COMPLETED|Overall Study||1000||
59649608|NCT00364013|75767612|FG000|STARTED|Overall Study||593||
59649609|NCT00364013|75767613|FG001|STARTED|Overall Study||590||
59649610|NCT00364013|75767612|FG000|Received Study Drug|Overall Study|One participant randomized to this group did not receive any panitumumab|586||
59649611|NCT00364013|75767613|FG001|Received Study Drug|Overall Study||583||
59649612|NCT00364013|75767612|FG000|COMPLETED|Overall Study|Indicates participants who had completed the safety visit 30 days after last dose or had died|492||
59649613|NCT00364013|75767613|FG001|COMPLETED|Overall Study|Indicates participants who had completed the safety visit 30 days after last dose or had died|495||
59649614|NCT00364013|75767612|FG000|NOT COMPLETED|Overall Study||101||
59649615|NCT00364013|75767613|FG001|NOT COMPLETED|Overall Study||95||
59649616|NCT00345839|75767625|FG000|STARTED|Overall Study|Randomized to cinacalcet|1948||
59649617|NCT00345839|75767626|FG001|STARTED|Overall Study|Randomized to placebo|1935||
59649618|NCT00345839|75767625|FG000|COMPLETED|Overall Study|Participants who completed study includes those with ended study due to death.|1799||
59649619|NCT00345839|75767626|FG001|COMPLETED|Overall Study|Participants who completed study includes those with ended study due to death.|1776||
59649620|NCT00345839|75767625|FG000|NOT COMPLETED|Overall Study||149||
59649621|NCT00345839|75767626|FG001|NOT COMPLETED|Overall Study||159||
59649622|NCT00330759|75767634|FG000|STARTED|Overall Study||890||
59649623|NCT00330759|75767635|FG001|STARTED|Overall Study||886||
59649624|NCT00330759|75767634|FG000|Received Investigational Product|Overall Study||878||
59649625|NCT00330759|75767635|FG001|Received Investigational Product|Overall Study||878||
59649626|NCT00330759|75767634|FG000|COMPLETED|Overall Study||178||
59649627|NCT00330759|75767635|FG001|COMPLETED|Overall Study||180||
59649628|NCT00330759|75767634|FG000|NOT COMPLETED|Overall Study||712||
59649629|NCT00330759|75767635|FG001|NOT COMPLETED|Overall Study||706||
59649630|NCT00113763|75767643|FG000|STARTED|Overall Study||231||
59649631|NCT00113763|75767644|FG001|STARTED|Overall Study||232||
59649632|NCT00113763|75767643|FG000|Received Study Drug|Overall Study||229||
59649633|NCT00113763|75767644|FG001|Received Study Drug|Overall Study||0||
59649634|NCT00113763|75767643|FG000|COMPLETED|Overall Study|Defined as participants who completed safety follow-up visit or who died.|158||
59649635|NCT00113763|75767644|FG001|COMPLETED|Overall Study|Defined as participants who completed safety follow-up visit or who died.|206||
59649636|NCT00113763|75767643|FG000|NOT COMPLETED|Overall Study||73||
59649637|NCT00113763|75767644|FG001|NOT COMPLETED|Overall Study||26||
59649638|NCT05433571|75767651|FG000|STARTED|Period 1||53||
59649639|NCT05433571|75767652|FG001|STARTED|Period 1||49||
59649640|NCT05433571|75767651|FG000|COMPLETED|Period 1||53||
59649641|NCT05433571|75767652|FG001|COMPLETED|Period 1||49||
59649642|NCT05433571|75767651|FG000|NOT COMPLETED|Period 1||0||
59649643|NCT05433571|75767652|FG001|NOT COMPLETED|Period 1||0||
59649644|NCT05433571|75767651|FG000|STARTED|Period 2||53||
59649645|NCT05433571|75767652|FG001|STARTED|Period 2||49||
59649646|NCT05433571|75767651|FG000|COMPLETED|Period 2||53||
59649647|NCT05433571|75767652|FG001|COMPLETED|Period 2||49||
59649648|NCT05433571|75767651|FG000|NOT COMPLETED|Period 2||0||
59649649|NCT05433571|75767652|FG001|NOT COMPLETED|Period 2||0||
59649650|NCT05166902|75767658|FG000|STARTED|First Intervention||34||
59649651|NCT05166902|75767659|FG001|STARTED|First Intervention||33||
59649652|NCT05166902|75767658|FG000|COMPLETED|First Intervention||34||
59649653|NCT05166902|75767659|FG001|COMPLETED|First Intervention||32||
59649654|NCT05166902|75767658|FG000|NOT COMPLETED|First Intervention||0||
59649655|NCT05166902|75767659|FG001|NOT COMPLETED|First Intervention||1||
59649656|NCT05166902|75767658|FG000|STARTED|Second Intervention||34||
59649657|NCT05166902|75767659|FG001|STARTED|Second Intervention||32||
59649658|NCT05166902|75767658|FG000|COMPLETED|Second Intervention||34||
59649659|NCT05166902|75767659|FG001|COMPLETED|Second Intervention||32||
59649660|NCT05166902|75767658|FG000|NOT COMPLETED|Second Intervention||0||
59649661|NCT05166902|75767659|FG001|NOT COMPLETED|Second Intervention||0||
59649662|NCT05142566|75767665|FG000|STARTED|Overall Study||18||
59649663|NCT05142566|75767665|FG000|COMPLETED|Overall Study||17||
59649664|NCT05142566|75767665|FG000|NOT COMPLETED|Overall Study||1||
59649665|NCT05083949|75767671|FG000|STARTED|Period 1||16||
59649666|NCT05083949|75767672|FG001|STARTED|Period 1||16||
59649667|NCT05083949|75767671|FG000|COMPLETED|Period 1||13||
59649668|NCT05083949|75767672|FG001|COMPLETED|Period 1||14||
59649669|NCT05083949|75767671|FG000|NOT COMPLETED|Period 1||3||
59649670|NCT05083949|75767672|FG001|NOT COMPLETED|Period 1||2||
59649671|NCT05083949|75767671|FG000|STARTED|Wash-out||13||
59649672|NCT05083949|75767672|FG001|STARTED|Wash-out||14||
59649673|NCT05083949|75767671|FG000|COMPLETED|Wash-out||13||
59649674|NCT05083949|75767672|FG001|COMPLETED|Wash-out||14||
59649675|NCT05083949|75767671|FG000|NOT COMPLETED|Wash-out||0||
59649676|NCT05083949|75767672|FG001|NOT COMPLETED|Wash-out||0||
59649677|NCT05083949|75767671|FG000|STARTED|Period 2||13||
59649678|NCT05083949|75767672|FG001|STARTED|Period 2||14||
59649679|NCT05083949|75767671|FG000|COMPLETED|Period 2||12||
59649680|NCT05083949|75767672|FG001|COMPLETED|Period 2||12||
59649681|NCT05083949|75767671|FG000|NOT COMPLETED|Period 2||1||
59649682|NCT05083949|75767672|FG001|NOT COMPLETED|Period 2||2||
59649683|NCT04982575|75767684|FG000|STARTED|Overall Study||31||
59649684|NCT04982575|75767685|FG001|STARTED|Overall Study||30||
59649685|NCT04982575|75767686|FG002|STARTED|Overall Study||31||
59649686|NCT04982575|75767684|FG000|COMPLETED|Overall Study||29||
59649687|NCT04982575|75767685|FG001|COMPLETED|Overall Study||30||
59649688|NCT04982575|75767686|FG002|COMPLETED|Overall Study||29||
59649689|NCT04982575|75767684|FG000|NOT COMPLETED|Overall Study||2||
59649690|NCT04982575|75767685|FG001|NOT COMPLETED|Overall Study||0||
59649691|NCT04982575|75767686|FG002|NOT COMPLETED|Overall Study||2||
59649692|NCT04903249|75767696|FG000|STARTED|Overall Study||37||
59649693|NCT04903249|75767696|FG000|Received Intervention|Overall Study||30||
59649694|NCT04903249|75767696|FG000|Week 2 Follow-up|Overall Study||30||
59649695|NCT04903249|75767696|FG000|Week 6 Follow-up|Overall Study||30||
59649696|NCT04903249|75767696|FG000|Week 12 Follow-up|Overall Study||30||
59649697|NCT04903249|75767696|FG000|COMPLETED|Overall Study||30||
59649698|NCT04903249|75767696|FG000|NOT COMPLETED|Overall Study||7||
59649699|NCT04902014|75767704|FG000|STARTED|Overall Study||10||
59649700|NCT04902014|75767705|FG001|STARTED|Overall Study||10||
59649701|NCT04902014|75767706|FG002|STARTED|Overall Study||10||
59649702|NCT04902014|75767707|FG003|STARTED|Overall Study||10||
59649703|NCT04902014|75767704|FG000|COMPLETED|Overall Study||10||
59649704|NCT04902014|75767705|FG001|COMPLETED|Overall Study||10||
59649705|NCT04902014|75767706|FG002|COMPLETED|Overall Study||10||
59649706|NCT04902014|75767707|FG003|COMPLETED|Overall Study||10||
59649707|NCT04902014|75767704|FG000|NOT COMPLETED|Overall Study||0||
59649708|NCT04902014|75767705|FG001|NOT COMPLETED|Overall Study||0||
59649709|NCT04902014|75767706|FG002|NOT COMPLETED|Overall Study||0||
59649710|NCT04902014|75767707|FG003|NOT COMPLETED|Overall Study||0||
59649711|NCT05776901|75767717|FG000|STARTED|Overall Study||3|Milestone 1 (Week 1): Completion of the C-STRESS app orientation session and the SUS questionnaire at the baseline.|
59649712|NCT05776901|75767717|FG000|Week 3|Overall Study||3|Milestone 2 (Week 3): Completion of the SUS questionnaire at week 3|
59649713|NCT05776901|75767717|FG000|Week 6|Overall Study||0|Milestone 3: Completion of the SUS questionnaire at week 6. The collection of data was not completed due to grant termination.|
59649714|NCT05776901|75767717|FG000|COMPLETED|Overall Study||0||
59649715|NCT05776901|75767717|FG000|NOT COMPLETED|Overall Study||3||
59649716|NCT05344560|75767721|FG000|STARTED|Period 1||63||
59649717|NCT05344560|75767722|FG001|STARTED|Period 1||63||
59649718|NCT05344560|75767721|FG000|COMPLETED|Period 1||62||
59649719|NCT05344560|75767722|FG001|COMPLETED|Period 1||62||
59649720|NCT05344560|75767721|FG000|NOT COMPLETED|Period 1||1||
59649721|NCT05344560|75767722|FG001|NOT COMPLETED|Period 1||1||
59649722|NCT05344560|75767721|FG000|STARTED|Period 2||62||
59649723|NCT05344560|75767722|FG001|STARTED|Period 2||62||
59649724|NCT05344560|75767721|FG000|COMPLETED|Period 2||59||
59649725|NCT05344560|75767722|FG001|COMPLETED|Period 2||61||
59649726|NCT05344560|75767721|FG000|NOT COMPLETED|Period 2||3||
59649727|NCT05344560|75767722|FG001|NOT COMPLETED|Period 2||1||
59649728|NCT05344560|75767721|FG000|STARTED|Period 3||59||
59649729|NCT05344560|75767722|FG001|STARTED|Period 3||61||
59649730|NCT05344560|75767721|FG000|COMPLETED|Period 3||58||
59649731|NCT05344560|75767722|FG001|COMPLETED|Period 3||61||
59649732|NCT05344560|75767721|FG000|NOT COMPLETED|Period 3||1||
59649733|NCT05344560|75767722|FG001|NOT COMPLETED|Period 3||0||
59649734|NCT05209191|75767728|FG000|STARTED|Overall Study||102||
59649735|NCT05209191|75767728|FG000|COMPLETED|Overall Study||102||
59649736|NCT05209191|75767728|FG000|NOT COMPLETED|Overall Study||0||
59649737|NCT05024058|75767742|FG000|STARTED|Treatment||5||
59649738|NCT05024058|75767743|FG001|STARTED|Treatment||6||
59649739|NCT05024058|75767744|FG002|STARTED|Treatment||4||
59649740|NCT05024058|75767745|FG003|STARTED|Treatment||2||
59649741|NCT05024058|75767746|FG004|STARTED|Treatment||3||
59649742|NCT05024058|75767747|FG005|STARTED|Treatment||3||
59649743|NCT05024058|75767748|FG006|STARTED|Treatment||1||
59649744|NCT05024058|75767749|FG007|STARTED|Treatment||3||
59649745|NCT05024058|75767750|FG008|STARTED|Treatment||6||
59649746|NCT05024058|75767751|FG009|STARTED|Treatment||6||
59649747|NCT05024058|75767742|FG000|COMPLETED|Treatment||0||
59649748|NCT05024058|75767743|FG001|COMPLETED|Treatment||0||
59649749|NCT05024058|75767744|FG002|COMPLETED|Treatment||0||
59649750|NCT05024058|75767745|FG003|COMPLETED|Treatment||0||
59649751|NCT05024058|75767746|FG004|COMPLETED|Treatment||0||
59649752|NCT05024058|75767747|FG005|COMPLETED|Treatment||0||
59649753|NCT05024058|75767748|FG006|COMPLETED|Treatment||0||
59649754|NCT05024058|75767749|FG007|COMPLETED|Treatment||0||
59649755|NCT05024058|75767750|FG008|COMPLETED|Treatment||0||
59649756|NCT05024058|75767751|FG009|COMPLETED|Treatment||0||
59649757|NCT05024058|75767742|FG000|NOT COMPLETED|Treatment||5||
59649758|NCT05024058|75767743|FG001|NOT COMPLETED|Treatment||6||
59649759|NCT05024058|75767744|FG002|NOT COMPLETED|Treatment||4||
59649760|NCT05024058|75767745|FG003|NOT COMPLETED|Treatment||2||
59649761|NCT05024058|75767746|FG004|NOT COMPLETED|Treatment||3||
59649762|NCT05024058|75767747|FG005|NOT COMPLETED|Treatment||3||
59649763|NCT05024058|75767748|FG006|NOT COMPLETED|Treatment||1||
59649764|NCT05024058|75767749|FG007|NOT COMPLETED|Treatment||3||
59649765|NCT05024058|75767750|FG008|NOT COMPLETED|Treatment||6||
59649766|NCT05024058|75767751|FG009|NOT COMPLETED|Treatment||6||
59649767|NCT05024058|75767742|FG000|STARTED|Follow-up||2||
59649768|NCT05024058|75767743|FG001|STARTED|Follow-up||5||
59649769|NCT05024058|75767744|FG002|STARTED|Follow-up||4||
59649770|NCT05024058|75767745|FG003|STARTED|Follow-up||0||
59649771|NCT05024058|75767746|FG004|STARTED|Follow-up||3||
59649772|NCT05024058|75767747|FG005|STARTED|Follow-up||2||
59649773|NCT05024058|75767748|FG006|STARTED|Follow-up||0||
59649774|NCT05024058|75767749|FG007|STARTED|Follow-up||2||
59649775|NCT05024058|75767750|FG008|STARTED|Follow-up||5||
59649776|NCT05024058|75767751|FG009|STARTED|Follow-up||6||
59649777|NCT05024058|75767742|FG000|COMPLETED|Follow-up||1||
59649778|NCT05024058|75767743|FG001|COMPLETED|Follow-up||5||
59649779|NCT05024058|75767744|FG002|COMPLETED|Follow-up||3||
59649780|NCT05024058|75767745|FG003|COMPLETED|Follow-up||0||
59649781|NCT05024058|75767746|FG004|COMPLETED|Follow-up||3||
59649782|NCT05024058|75767747|FG005|COMPLETED|Follow-up||2||
59649783|NCT05024058|75767748|FG006|COMPLETED|Follow-up||0||
59649784|NCT05024058|75767749|FG007|COMPLETED|Follow-up||1||
59649785|NCT05024058|75767750|FG008|COMPLETED|Follow-up||5||
59649786|NCT05024058|75767751|FG009|COMPLETED|Follow-up||5||
59649787|NCT05024058|75767742|FG000|NOT COMPLETED|Follow-up||1||
59649788|NCT05024058|75767743|FG001|NOT COMPLETED|Follow-up||0||
59649789|NCT05024058|75767744|FG002|NOT COMPLETED|Follow-up||1||
59649790|NCT05024058|75767745|FG003|NOT COMPLETED|Follow-up||0||
59649791|NCT05024058|75767746|FG004|NOT COMPLETED|Follow-up||0||
59649792|NCT05024058|75767747|FG005|NOT COMPLETED|Follow-up||0||
59649793|NCT05024058|75767748|FG006|NOT COMPLETED|Follow-up||0||
59649794|NCT05024058|75767749|FG007|NOT COMPLETED|Follow-up||1||
59649795|NCT05024058|75767750|FG008|NOT COMPLETED|Follow-up||0||
59649796|NCT05024058|75767751|FG009|NOT COMPLETED|Follow-up||1||
59649797|NCT05013008|75767774|FG000|STARTED|Overall Study||483||
59649798|NCT05013008|75767775|FG001|STARTED|Overall Study||468||
59649799|NCT05013008|75767774|FG000|mBFAS|Overall Study||478|Modified biomarker full analysis set (mBFAS)|
59649800|NCT05013008|75767775|FG001|mBFAS|Overall Study||443|Modified biomarker full analysis set (mBFAS)|
59649801|NCT05013008|75767774|FG000|COMPLETED|Overall Study||478||
59649802|NCT05013008|75767775|FG001|COMPLETED|Overall Study||443||
59649803|NCT05013008|75767774|FG000|NOT COMPLETED|Overall Study||5||
59649804|NCT05013008|75767775|FG001|NOT COMPLETED|Overall Study||25||
59649805|NCT04826900|75767783|FG000|STARTED|Overall Study||15||
59649806|NCT04826900|75767784|FG001|STARTED|Overall Study||16||
59649807|NCT04826900|75767783|FG000|COMPLETED|Overall Study||14||
59649808|NCT04826900|75767784|FG001|COMPLETED|Overall Study||15||
59649809|NCT04826900|75767783|FG000|NOT COMPLETED|Overall Study||1||
59649810|NCT04826900|75767784|FG001|NOT COMPLETED|Overall Study||1||
59649811|NCT04721158|75767790|FG000|STARTED|Overall Study||41||
59649812|NCT04721158|75767790|FG000|COMPLETED|Overall Study||36||
59649813|NCT04721158|75767790|FG000|NOT COMPLETED|Overall Study||5||
59649814|NCT04263766|75767797|FG000|STARTED|Overall Study||50||
59649815|NCT04263766|75767798|FG001|STARTED|Overall Study||26||
59649816|NCT04263766|75767797|FG000|COMPLETED|Overall Study||43||
59649817|NCT04263766|75767798|FG001|COMPLETED|Overall Study||19||
59649818|NCT04263766|75767797|FG000|NOT COMPLETED|Overall Study||7||
59649819|NCT04263766|75767798|FG001|NOT COMPLETED|Overall Study||7||
59649820|NCT04203199|75767820|FG000|STARTED|First Intervention Period||15||
59649821|NCT04203199|75767821|FG001|STARTED|First Intervention Period||16||
59649822|NCT04203199|75767820|FG000|COMPLETED|First Intervention Period||15||
59649823|NCT04203199|75767821|FG001|COMPLETED|First Intervention Period||15||
59649824|NCT04203199|75767820|FG000|NOT COMPLETED|First Intervention Period||0||
59649825|NCT04203199|75767821|FG001|NOT COMPLETED|First Intervention Period||1||
59649826|NCT04203199|75767820|FG000|STARTED|Second Intervention Period||15||
59649827|NCT04203199|75767821|FG001|STARTED|Second Intervention Period||15||
59649828|NCT04203199|75767820|FG000|COMPLETED|Second Intervention Period||14||
59649829|NCT04203199|75767821|FG001|COMPLETED|Second Intervention Period||15||
59649830|NCT04203199|75767820|FG000|NOT COMPLETED|Second Intervention Period||1||
59649831|NCT04203199|75767821|FG001|NOT COMPLETED|Second Intervention Period||0||
59649832|NCT04191733|75767829|FG000|STARTED|Overall Study||122|Enrolled participants|
59649833|NCT04191733|75767830|FG001|STARTED|Overall Study||121|Enrolled participants|
59649834|NCT04191733|75767829|FG000|Enrolled But Not Treated|Overall Study||5||
59649835|NCT04191733|75767830|FG001|Enrolled But Not Treated|Overall Study||10||
59649836|NCT04191733|75767829|FG000|Safety Population|Overall Study||117|The safety population set consisted of all enrolled participants who signed the informed consent document and attempted treatment according to the actual treatment received.|
59649837|NCT04191733|75767830|FG001|Safety Population|Overall Study||111|The safety population set consisted of all enrolled participants who signed the informed consent document and attempted treatment according to the actual treatment received.|
59649838|NCT04191733|75767829|FG000|COMPLETED|Overall Study||101||
59649839|NCT04191733|75767830|FG001|COMPLETED|Overall Study||95||
59649840|NCT04191733|75767829|FG000|NOT COMPLETED|Overall Study||21||
59649841|NCT04191733|75767830|FG001|NOT COMPLETED|Overall Study||26||
59649842|NCT04049097|75767836|FG000|STARTED|Overall Study||121||
59649843|NCT04049097|75767836|FG000|COMPLETED|Overall Study||0||
59649844|NCT04049097|75767836|FG000|NOT COMPLETED|Overall Study||121||
59649845|NCT04002310|75767845|FG000|STARTED|Overall Study||3||
59649846|NCT04002310|75767846|FG001|STARTED|Overall Study||3||
59649847|NCT04002310|75767847|FG002|STARTED|Overall Study||3||
59649848|NCT04002310|75767848|FG003|STARTED|Overall Study||6||
59649849|NCT04002310|75767849|FG004|STARTED|Overall Study||3||
59649850|NCT04002310|75767845|FG000|Treated|Overall Study||3||
59649851|NCT04002310|75767846|FG001|Treated|Overall Study||3||
59649852|NCT04002310|75767847|FG002|Treated|Overall Study||3||
59649853|NCT04002310|75767848|FG003|Treated|Overall Study||6||
59649854|NCT04002310|75767849|FG004|Treated|Overall Study||3||
59649855|NCT04002310|75767845|FG000|COMPLETED|Overall Study||3|Completed=Not prematurely discontinued from trial medication.|
59649856|NCT04002310|75767846|FG001|COMPLETED|Overall Study||3|Completed=Not prematurely discontinued from trial medication.|
59649857|NCT04002310|75767847|FG002|COMPLETED|Overall Study||3|Completed=Not prematurely discontinued from trial medication.|
59649858|NCT04002310|75767848|FG003|COMPLETED|Overall Study||6|Completed=Not prematurely discontinued from trial medication.|
59649859|NCT04002310|75767849|FG004|COMPLETED|Overall Study||2|Completed=Not prematurely discontinued from trial medication.|
59649860|NCT04002310|75767845|FG000|NOT COMPLETED|Overall Study||0||
59649861|NCT04002310|75767846|FG001|NOT COMPLETED|Overall Study||0||
59649862|NCT04002310|75767847|FG002|NOT COMPLETED|Overall Study||0||
59649863|NCT04002310|75767848|FG003|NOT COMPLETED|Overall Study||0||
59649864|NCT04002310|75767849|FG004|NOT COMPLETED|Overall Study||1||
59649865|NCT03982511|75767863|FG000|STARTED|Overall Study|27 caregivers and 14 children (from 14 families)|41||
59649866|NCT03982511|75767864|FG001|STARTED|Overall Study|11 caregivers and 7 children (from 7 families)|18||
59988651|NCT01352585|76103884|FG000|COMPLETED|Overall Study||15||
59988652|NCT01352585|76103885|FG001|COMPLETED|Overall Study||21||
59649867|NCT03982511|75767863|FG000|COMPLETED|Overall Study|20 caregivers and 10 children (from 10 families)|30||
59649868|NCT03982511|75767864|FG001|COMPLETED|Overall Study|9 caregivers and 6 children (from 6 families)|15||
59649869|NCT03982511|75767863|FG000|NOT COMPLETED|Overall Study||11||
59649870|NCT03982511|75767864|FG001|NOT COMPLETED|Overall Study||3||
59649871|NCT03887650|75767872|FG000|STARTED|Preoperative-48 Hours Postoperative||45||
59649872|NCT03887650|75767873|FG001|STARTED|Preoperative-48 Hours Postoperative||45||
59649873|NCT03887650|75767872|FG000|COMPLETED|Preoperative-48 Hours Postoperative||45||
59649874|NCT03887650|75767873|FG001|COMPLETED|Preoperative-48 Hours Postoperative||44||
59649875|NCT03887650|75767872|FG000|NOT COMPLETED|Preoperative-48 Hours Postoperative||0||
59649876|NCT03887650|75767873|FG001|NOT COMPLETED|Preoperative-48 Hours Postoperative||1||
59649877|NCT03887650|75767872|FG000|STARTED|48-96 Hours Postoperative|A patient who was lost to follow-up from the previous period came back for this period of the study|45||
59649878|NCT03887650|75767873|FG001|STARTED|48-96 Hours Postoperative||44||
59649879|NCT03887650|75767872|FG000|COMPLETED|48-96 Hours Postoperative||45||
59649880|NCT03887650|75767873|FG001|COMPLETED|48-96 Hours Postoperative||42||
59988653|NCT01352585|76103884|FG000|NOT COMPLETED|Overall Study||8||
59988654|NCT01352585|76103885|FG001|NOT COMPLETED|Overall Study||3||
59543300|NCT02156258|75641510|FG001|NOT COMPLETED|Overall Study||79||
59543301|NCT02156258|75641511|FG002|NOT COMPLETED|Overall Study||111||
59649881|NCT03887650|75767872|FG000|NOT COMPLETED|48-96 Hours Postoperative||0||
59649882|NCT03887650|75767873|FG001|NOT COMPLETED|48-96 Hours Postoperative||2||
59649883|NCT03887650|75767872|FG000|STARTED|60 Postoperative Days||45||
59649884|NCT03887650|75767873|FG001|STARTED|60 Postoperative Days||42||
59649885|NCT03887650|75767872|FG000|COMPLETED|60 Postoperative Days||44||
59649886|NCT03887650|75767873|FG001|COMPLETED|60 Postoperative Days||42||
59649887|NCT03887650|75767872|FG000|NOT COMPLETED|60 Postoperative Days||1||
59649888|NCT03887650|75767873|FG001|NOT COMPLETED|60 Postoperative Days||0||
59649889|NCT03513328|75767883|FG000|STARTED|Overall Study||6||
59649890|NCT03513328|75767884|FG001|STARTED|Overall Study||0||
59649891|NCT03513328|75767885|FG002|STARTED|Overall Study||0||
59649892|NCT03513328|75767886|FG003|STARTED|Overall Study||0||
59649893|NCT03513328|75767883|FG000|COMPLETED|Overall Study||6||
59649894|NCT03513328|75767884|FG001|COMPLETED|Overall Study||0||
59649895|NCT03513328|75767885|FG002|COMPLETED|Overall Study||0||
59649896|NCT03513328|75767886|FG003|COMPLETED|Overall Study||0||
59988655|NCT01352507|76103894|FG000|STARTED|Treatment Period 1||190||
59988656|NCT01352507|76103895|FG001|STARTED|Treatment Period 1||193||
59988657|NCT01352507|76103894|FG000|Received Treatment|Treatment Period 1||182||
59543302|NCT02492100|75641519|FG000|STARTED|Overall Study||47||
59543303|NCT02492100|75641519|FG000|COMPLETED|Overall Study||46||
59543304|NCT02492100|75641519|FG000|NOT COMPLETED|Overall Study||1||
59543305|NCT02221349|75641526|FG000|STARTED|Overall Study||15||
59543306|NCT02221349|75641527|FG001|STARTED|Overall Study||15||
59543307|NCT02221349|75641526|FG000|COMPLETED|Overall Study||14||
59543308|NCT02221349|75641527|FG001|COMPLETED|Overall Study||15||
59543309|NCT02221349|75641526|FG000|NOT COMPLETED|Overall Study||1||
59543310|NCT02221349|75641527|FG001|NOT COMPLETED|Overall Study||0||
59649897|NCT03513328|75767883|FG000|NOT COMPLETED|Overall Study||0||
59649898|NCT03513328|75767884|FG001|NOT COMPLETED|Overall Study||0||
59649899|NCT03513328|75767885|FG002|NOT COMPLETED|Overall Study||0||
59649900|NCT03513328|75767886|FG003|NOT COMPLETED|Overall Study||0||
59649901|NCT03424161|75767896|FG000|STARTED|Overall Study||27||
59649902|NCT03424161|75767896|FG000|COMPLETED|Overall Study||10||
59543311|NCT02461758|75641537|FG000|STARTED|Overall Study||20||
59543312|NCT02461758|75641538|FG001|STARTED|Overall Study||20||
59543313|NCT02461758|75641539|FG002|STARTED|Overall Study||26||
59649903|NCT03424161|75767896|FG000|NOT COMPLETED|Overall Study||17||
59649904|NCT03373201|75767902|FG000|STARTED|Overall Study||160||
59649905|NCT03373201|75767903|FG001|STARTED|Overall Study||160||
59988658|NCT01352507|76103895|FG001|Received Treatment|Treatment Period 1||188||
59988659|NCT01352507|76103894|FG000|COMPLETED|Treatment Period 1||176||
59543314|NCT02461758|75641540|FG003|STARTED|Overall Study||15||
59543315|NCT02461758|75641537|FG000|COMPLETED|Overall Study||20||
59649906|NCT03373201|75767902|FG000|COMPLETED|Overall Study||159||
59649907|NCT03373201|75767903|FG001|COMPLETED|Overall Study||159||
59649908|NCT03373201|75767902|FG000|NOT COMPLETED|Overall Study||1||
59649909|NCT03373201|75767903|FG001|NOT COMPLETED|Overall Study||1||
59649910|NCT03345342|75767911|FG000|STARTED|Open-Label Phase||838||
59649911|NCT03345342|75767912|FG001|STARTED|Open-Label Phase||0||
59649912|NCT03345342|75767913|FG002|STARTED|Open-Label Phase||0||
59649913|NCT03345342|75767914|FG003|STARTED|Open-Label Phase||0||
59649914|NCT03345342|75767915|FG004|STARTED|Open-Label Phase||0||
59649915|NCT03345342|75767911|FG000|COMPLETED|Open-Label Phase||702||
59649916|NCT03345342|75767912|FG001|COMPLETED|Open-Label Phase||0||
59649917|NCT03345342|75767913|FG002|COMPLETED|Open-Label Phase||0||
59649918|NCT03345342|75767914|FG003|COMPLETED|Open-Label Phase||0||
59649919|NCT03345342|75767915|FG004|COMPLETED|Open-Label Phase||0||
59649920|NCT03345342|75767911|FG000|NOT COMPLETED|Open-Label Phase||136||
59649921|NCT03345342|75767912|FG001|NOT COMPLETED|Open-Label Phase||0||
59649922|NCT03345342|75767913|FG002|NOT COMPLETED|Open-Label Phase||0||
59649923|NCT03345342|75767914|FG003|NOT COMPLETED|Open-Label Phase||0||
59649924|NCT03345342|75767915|FG004|NOT COMPLETED|Open-Label Phase||0||
59649925|NCT03345342|75767911|FG000|STARTED|Double-Blind Phase||0||
59649926|NCT03345342|75767912|FG001|STARTED|Double-Blind Phase|Participants from the OL phase have continued in the DB phase.|224||
59649927|NCT03345342|75767913|FG002|STARTED|Double-Blind Phase|Participants from the OL phase have continued in the DB phase.|478||
59649928|NCT03345342|75767914|FG003|STARTED|Double-Blind Phase||0||
59649929|NCT03345342|75767915|FG004|STARTED|Double-Blind Phase||0||
59649930|NCT03345342|75767911|FG000|COMPLETED|Double-Blind Phase||0||
59649931|NCT03345342|75767912|FG001|COMPLETED|Double-Blind Phase||202||
59649932|NCT03345342|75767913|FG002|COMPLETED|Double-Blind Phase||416||
59649933|NCT03345342|75767914|FG003|COMPLETED|Double-Blind Phase||0||
59649934|NCT03345342|75767915|FG004|COMPLETED|Double-Blind Phase||0||
59649935|NCT03345342|75767911|FG000|NOT COMPLETED|Double-Blind Phase||0||
59649936|NCT03345342|75767912|FG001|NOT COMPLETED|Double-Blind Phase||22||
59649937|NCT03345342|75767913|FG002|NOT COMPLETED|Double-Blind Phase||62||
59649938|NCT03345342|75767914|FG003|NOT COMPLETED|Double-Blind Phase||0||
59649939|NCT03345342|75767915|FG004|NOT COMPLETED|Double-Blind Phase||0||
59649940|NCT03345342|75767911|FG000|STARTED|Follow-Up Phase||0||
59649941|NCT03345342|75767912|FG001|STARTED|Follow-Up Phase||0||
59649942|NCT03345342|75767913|FG002|STARTED|Follow-Up Phase||0||
59649943|NCT03345342|75767914|FG003|STARTED|Follow-Up Phase|Participants from the DB phase have continued in the FU phase.|42||
59649944|NCT03345342|75767915|FG004|STARTED|Follow-Up Phase|Participants from the DB phase have continued in the FU phase.|109||
59649945|NCT03345342|75767911|FG000|COMPLETED|Follow-Up Phase||0||
59649946|NCT03345342|75767912|FG001|COMPLETED|Follow-Up Phase||0||
59649947|NCT03345342|75767913|FG002|COMPLETED|Follow-Up Phase||0||
59649948|NCT03345342|75767914|FG003|COMPLETED|Follow-Up Phase||34||
59649949|NCT03345342|75767915|FG004|COMPLETED|Follow-Up Phase||78||
59649950|NCT03345342|75767911|FG000|NOT COMPLETED|Follow-Up Phase||0||
59649951|NCT03345342|75767912|FG001|NOT COMPLETED|Follow-Up Phase||0||
59649952|NCT03345342|75767913|FG002|NOT COMPLETED|Follow-Up Phase||0||
59649953|NCT03345342|75767914|FG003|NOT COMPLETED|Follow-Up Phase||8||
59649954|NCT03345342|75767915|FG004|NOT COMPLETED|Follow-Up Phase||31||
59649955|NCT03290547|75767927|FG000|STARTED|Overall Study||22||
59649956|NCT03290547|75767927|FG000|COMPLETED|Overall Study||6||
59649957|NCT03290547|75767927|FG000|NOT COMPLETED|Overall Study||16||
59649958|NCT03192176|75767939|FG000|STARTED|Overall Study||44||
59649959|NCT03192176|75767940|FG001|STARTED|Overall Study||45||
59649960|NCT03192176|75767941|FG002|STARTED|Overall Study||44||
59649961|NCT03192176|75767942|FG003|STARTED|Overall Study||45||
59649962|NCT03192176|75767943|FG004|STARTED|Overall Study||44||
59649963|NCT03192176|75767944|FG005|STARTED|Overall Study||45||
59649964|NCT03192176|75767945|FG006|STARTED|Overall Study||45||
59649965|NCT03192176|75767946|FG007|STARTED|Overall Study||44||
59649966|NCT03192176|75767939|FG000|Treated|Overall Study||43||
59649967|NCT03192176|75767940|FG001|Treated|Overall Study||45||
59649968|NCT03192176|75767941|FG002|Treated|Overall Study||43||
59649969|NCT03192176|75767942|FG003|Treated|Overall Study||45||
59649970|NCT03192176|75767943|FG004|Treated|Overall Study||44||
59649971|NCT03192176|75767944|FG005|Treated|Overall Study||43||
59649972|NCT03192176|75767945|FG006|Treated|Overall Study||45||
59649973|NCT03192176|75767946|FG007|Treated|Overall Study||44||
59649974|NCT03192176|75767939|FG000|COMPLETED|Overall Study||37||
59649975|NCT03192176|75767940|FG001|COMPLETED|Overall Study||40||
59649976|NCT03192176|75767941|FG002|COMPLETED|Overall Study||38||
59649977|NCT03192176|75767942|FG003|COMPLETED|Overall Study||33||
59649978|NCT03192176|75767943|FG004|COMPLETED|Overall Study||32||
59649979|NCT03192176|75767944|FG005|COMPLETED|Overall Study||34||
59649980|NCT03192176|75767945|FG006|COMPLETED|Overall Study||36||
59649981|NCT03192176|75767946|FG007|COMPLETED|Overall Study||37||
59649982|NCT03192176|75767939|FG000|NOT COMPLETED|Overall Study||7||
59649983|NCT03192176|75767940|FG001|NOT COMPLETED|Overall Study||5||
59649984|NCT03192176|75767941|FG002|NOT COMPLETED|Overall Study||6||
59649985|NCT03192176|75767942|FG003|NOT COMPLETED|Overall Study||12||
59649986|NCT03192176|75767943|FG004|NOT COMPLETED|Overall Study||12||
59649987|NCT03192176|75767944|FG005|NOT COMPLETED|Overall Study||11||
59649988|NCT03192176|75767945|FG006|NOT COMPLETED|Overall Study||9||
59649989|NCT03192176|75767946|FG007|NOT COMPLETED|Overall Study||7||
59649990|NCT02910492|75767965|FG000|STARTED|Overall Study||10||
59649991|NCT02910492|75767965|FG000|COMPLETED|Overall Study||4||
59649992|NCT02910492|75767965|FG000|NOT COMPLETED|Overall Study||6||
59649993|NCT02603835|75767969|FG000|STARTED|Overall Study||100||
59649994|NCT02603835|75767969|FG000|COMPLETED|Overall Study||93||
59649995|NCT02603835|75767969|FG000|NOT COMPLETED|Overall Study||7||
59649996|NCT02531594|75767975|FG000|STARTED|Overall Study|This represents a dyad (child participant/caregiver participant).|384||
59649997|NCT02531594|75767976|FG001|STARTED|Overall Study|This represents a dyad (child participant/caregiver participant).|381||
59649998|NCT02531594|75767975|FG000|COMPLETED|Overall Study|This represents a dyad (child participant/caregiver participant).|377||
59649999|NCT02531594|75767976|FG001|COMPLETED|Overall Study|This represents a dyad (child participant/caregiver participant).|373||
59650000|NCT02531594|75767975|FG000|NOT COMPLETED|Overall Study||7||
59650001|NCT02531594|75767976|FG001|NOT COMPLETED|Overall Study||8||
59650002|NCT02370875|75767984|FG000|STARTED|Overall Study||6||6
59650003|NCT02370875|75767985|FG001|STARTED|Overall Study||6||6
59650004|NCT02370875|75767984|FG000|COMPLETED|Overall Study||6||6
59650005|NCT02370875|75767985|FG001|COMPLETED|Overall Study||6||6
59650006|NCT02370875|75767984|FG000|NOT COMPLETED|Overall Study||0||0
59650007|NCT02370875|75767985|FG001|NOT COMPLETED|Overall Study||0||0
59650008|NCT02365467|75767991|FG000|STARTED|Overall Study||32||
59650009|NCT02365467|75767991|FG000|Implanted|Overall Study||30||
59650010|NCT02365467|75767991|FG000|COMPLETED|Overall Study||29||
59650011|NCT02365467|75767991|FG000|NOT COMPLETED|Overall Study||3||
59650012|NCT01612351|75767995|FG000|STARTED|Chemotherapy||40||
59650013|NCT01612351|75767995|FG000|COMPLETED|Chemotherapy||40||
59650014|NCT01612351|75767995|FG000|NOT COMPLETED|Chemotherapy||0||
59650015|NCT01612351|75767995|FG000|STARTED|Transoral Surgery|One patient completed chemotherapy then withdrew before surgery.|39||
59650016|NCT01612351|75767995|FG000|COMPLETED|Transoral Surgery||39||
59650017|NCT01612351|75767995|FG000|NOT COMPLETED|Transoral Surgery||0||
59650018|NCT01612351|75767995|FG000|STARTED|Post-Operative Treatment||39||
59650019|NCT01612351|75767995|FG000|COMPLETED|Post-Operative Treatment|One patient completed chemotherapy then withdrew before surgery.|39||
59650020|NCT01612351|75767995|FG000|NOT COMPLETED|Post-Operative Treatment||0||
59650021|NCT01256593|75768004|FG000|STARTED|Overall Study||3827||
59650022|NCT01256593|75768004|FG000|COMPLETED|Overall Study|Number of participants whose survey form were collected and included in analyses is shown.|3613||
59650023|NCT01256593|75768004|FG000|NOT COMPLETED|Overall Study||214||
59650024|NCT01179009|75768010|FG000|STARTED|Overall Study||10||
59650025|NCT01179009|75768011|FG001|STARTED|Overall Study||10||
59650026|NCT01179009|75768010|FG000|COMPLETED|Overall Study||10||
59650027|NCT01179009|75768011|FG001|COMPLETED|Overall Study||10||
59650028|NCT01179009|75768010|FG000|NOT COMPLETED|Overall Study||0||
59650029|NCT01179009|75768011|FG001|NOT COMPLETED|Overall Study||0||
59650030|NCT00562640|75768022|FG000|STARTED|Overall Study||3||
59650031|NCT00562640|75768023|FG001|STARTED|Overall Study||3||
59650032|NCT00562640|75768024|FG002|STARTED|Overall Study||4||
59650033|NCT00562640|75768025|FG003|STARTED|Overall Study||2||
59650034|NCT00562640|75768022|FG000|COMPLETED|Overall Study||3||
59650035|NCT00562640|75768023|FG001|COMPLETED|Overall Study||2||
59650036|NCT00562640|75768024|FG002|COMPLETED|Overall Study||3||
59650037|NCT00562640|75768025|FG003|COMPLETED|Overall Study||2||
59650038|NCT00562640|75768022|FG000|NOT COMPLETED|Overall Study||0||
59650039|NCT00562640|75768023|FG001|NOT COMPLETED|Overall Study||1||
59650040|NCT00562640|75768024|FG002|NOT COMPLETED|Overall Study||1||
59650041|NCT00562640|75768025|FG003|NOT COMPLETED|Overall Study||0||
59650042|NCT04791917|75768037|FG000|STARTED|Overall Study||26||
59650043|NCT04791917|75768038|FG001|STARTED|Overall Study||25||
59650044|NCT04791917|75768037|FG000|COMPLETED|Overall Study||26||
59650045|NCT04791917|75768038|FG001|COMPLETED|Overall Study||25||
59650046|NCT04791917|75768037|FG000|NOT COMPLETED|Overall Study||0||
59650047|NCT04791917|75768038|FG001|NOT COMPLETED|Overall Study||0||
59650048|NCT04646499|75768046|FG000|STARTED|Overall Study||14||
59650049|NCT04646499|75768046|FG000|COMPLETED|Overall Study||13||
59650050|NCT04646499|75768046|FG000|NOT COMPLETED|Overall Study||1||
59650051|NCT04554394|75768050|FG000|STARTED|Overall Study||62||195
59650052|NCT04554394|75768051|FG001|STARTED|Overall Study|A total of 62 participants were enrolled and 1 randomized control wart per participant was enrolled in the control arm|62||62
59650053|NCT04554394|75768050|FG000|COMPLETED|Overall Study||53||136
59650054|NCT04554394|75768051|FG001|COMPLETED|Overall Study||53||53
59650055|NCT04554394|75768050|FG000|NOT COMPLETED|Overall Study||9||59
59650056|NCT04554394|75768051|FG001|NOT COMPLETED|Overall Study||9||9
59650057|NCT04518410|75768081|FG000|STARTED|Overall Study||48|"Total enrolled = Started (Randomized) + Screen Fail (Randomized) + Excluded from Analysis at NIH Request (suspected scientific misconduct at site level) + Dual Enrolled Subject = 3923+2+118+1=4044~A* = Subjects Treated and then not completed for reported reason and not excluded from analyses = 0+323+208+35+31+37+2=636~Not completed=A*+Ongoing+Randomized not Treated+Screen failed but randomized+Excluded from Analyses (suspected scientific misconduct at site level) =636+481+58+2+118+1=1296"|
59709649|NCT01235741|75828429|FG000|STARTED|Follow-Up Post Treatment up to Month 6||0||
59709650|NCT01235741|75828430|FG001|STARTED|Follow-Up Post Treatment up to Month 6|No treatment; those who had been treated with placebo (36) were followed up 6 Months post treatment.|36||
59650058|NCT04518410|75768082|FG001|STARTED|Overall Study||46|"Total enrolled = Started (Randomized) + Screen Fail (Randomized) + Excluded from Analysis at NIH Request (suspected scientific misconduct at site level) + Dual Enrolled Subject = 3923+2+118+1=4044~A* = Subjects Treated and then not completed for reported reason and not excluded from analyses = 0+323+208+35+31+37+2=636~Not completed=A*+Ongoing+Randomized not Treated+Screen failed but randomized+Excluded from Analyses (suspected scientific misconduct at site level) =636+481+58+2+118+1=1296"|
59650059|NCT04518410|75768083|FG002|STARTED|Overall Study||111|"Total enrolled = Started (Randomized) + Screen Fail (Randomized) + Excluded from Analysis at NIH Request (suspected scientific misconduct at site level) + Dual Enrolled Subject = 3923+2+118+1=4044~A* = Subjects Treated and then not completed for reported reason and not excluded from analyses = 0+323+208+35+31+37+2=636~Not completed=A*+Ongoing+Randomized not Treated+Screen failed but randomized+Excluded from Analyses (suspected scientific misconduct at site level) =636+481+58+2+118+1=1296"|
59650060|NCT04518410|75768084|FG003|STARTED|Overall Study||114|"Total enrolled = Started (Randomized) + Screen Fail (Randomized) + Excluded from Analysis at NIH Request (suspected scientific misconduct at site level) + Dual Enrolled Subject = 3923+2+118+1=4044~A* = Subjects Treated and then not completed for reported reason and not excluded from analyses = 0+323+208+35+31+37+2=636~Not completed=A*+Ongoing+Randomized not Treated+Screen failed but randomized+Excluded from Analyses (suspected scientific misconduct at site level) =636+481+58+2+118+1=1296"|
59650061|NCT04518410|75768085|FG004|STARTED|Overall Study||1079|"Total enrolled = Started (Randomized) + Screen Fail (Randomized) + Excluded from Analysis at NIH Request (suspected scientific misconduct at site level) + Dual Enrolled Subject = 3923+2+118+1=4044~A* = Subjects Treated and then not completed for reported reason and not excluded from analyses = 0+323+208+35+31+37+2=636~Not completed=A*+Ongoing+Randomized not Treated+Screen failed but randomized+Excluded from Analyses (suspected scientific misconduct at site level) =636+481+58+2+118+1=1296"|
59650062|NCT04518410|75768086|FG005|STARTED|Overall Study||424|"Total enrolled = Started (Randomized) + Screen Fail (Randomized) + Excluded from Analysis at NIH Request (suspected scientific misconduct at site level) + Dual Enrolled Subject = 3923+2+118+1=4044~A* = Subjects Treated and then not completed for reported reason and not excluded from analyses = 0+323+208+35+31+37+2=636~Not completed=A*+Ongoing+Randomized not Treated+Screen failed but randomized+Excluded from Analyses (suspected scientific misconduct at site level) =636+481+58+2+118+1=1296"|
59650063|NCT04518410|75768087|FG006|STARTED|Overall Study||422|"Total enrolled = Started (Randomized) + Screen Fail (Randomized) + Excluded from Analysis at NIH Request (suspected scientific misconduct at site level) + Dual Enrolled Subject = 3923+2+118+1=4044~A* = Subjects Treated and then not completed for reported reason and not excluded from analyses = 0+323+208+35+31+37+2=636~Not completed=A*+Ongoing+Randomized not Treated+Screen failed but randomized+Excluded from Analyses (suspected scientific misconduct at site level) =636+481+58+2+118+1=1296"|
59650064|NCT04518410|75768088|FG007|STARTED|Overall Study||61|"Total enrolled = Started (Randomized) + Screen Fail (Randomized) + Excluded from Analysis at NIH Request (suspected scientific misconduct at site level) + Dual Enrolled Subject = 3923+2+118+1=4044~A* = Subjects Treated and then not completed for reported reason and not excluded from analyses = 0+323+208+35+31+37+2=636~Not completed=A*+Ongoing+Randomized not Treated+Screen failed but randomized+Excluded from Analyses (suspected scientific misconduct at site level) =636+481+58+2+118+1=1296"|
59650065|NCT04518410|75768089|FG008|STARTED|Overall Study||33|"Total enrolled = Started (Randomized) + Screen Fail (Randomized) + Excluded from Analysis at NIH Request (suspected scientific misconduct at site level) + Dual Enrolled Subject = 3923+2+118+1=4044~A* = Subjects Treated and then not completed for reported reason and not excluded from analyses = 0+323+208+35+31+37+2=636~Not completed=A*+Ongoing+Randomized not Treated+Screen failed but randomized+Excluded from Analyses (suspected scientific misconduct at site level) =636+481+58+2+118+1=1296"|
59650066|NCT04518410|75768090|FG009|STARTED|Overall Study||110|"Total enrolled = Started (Randomized) + Screen Fail (Randomized) + Excluded from Analysis at NIH Request (suspected scientific misconduct at site level) + Dual Enrolled Subject = 3923+2+118+1=4044~A* = Subjects Treated and then not completed for reported reason and not excluded from analyses = 0+323+208+35+31+37+2=636~Not completed=A*+Ongoing+Randomized not Treated+Screen failed but randomized+Excluded from Analyses (suspected scientific misconduct at site level) =636+481+58+2+118+1=1296"|
59650067|NCT04518410|75768091|FG010|STARTED|Overall Study||54|"Total enrolled = Started (Randomized) + Screen Fail (Randomized) + Excluded from Analysis at NIH Request (suspected scientific misconduct at site level) + Dual Enrolled Subject = 3923+2+118+1=4044~A* = Subjects Treated and then not completed for reported reason and not excluded from analyses = 0+323+208+35+31+37+2=636~Not completed=A*+Ongoing+Randomized not Treated+Screen failed but randomized+Excluded from Analyses (suspected scientific misconduct at site level) =636+481+58+2+118+1=1296"|
59650068|NCT04518410|75768092|FG011|STARTED|Overall Study||110|"Total enrolled = Started (Randomized) + Screen Fail (Randomized) + Excluded from Analysis at NIH Request (suspected scientific misconduct at site level) + Dual Enrolled Subject = 3923+2+118+1=4044~A* = Subjects Treated and then not completed for reported reason and not excluded from analyses = 0+323+208+35+31+37+2=636~Not completed=A*+Ongoing+Randomized not Treated+Screen failed but randomized+Excluded from Analyses (suspected scientific misconduct at site level) =636+481+58+2+118+1=1296"|
59650069|NCT04518410|75768093|FG012|STARTED|Overall Study||53|"Total enrolled = Started (Randomized) + Screen Fail (Randomized) + Excluded from Analysis at NIH Request (suspected scientific misconduct at site level) + Dual Enrolled Subject = 3923+2+118+1=4044~A* = Subjects Treated and then not completed for reported reason and not excluded from analyses = 0+323+208+35+31+37+2=636~Not completed=A*+Ongoing+Randomized not Treated+Screen failed but randomized+Excluded from Analyses (suspected scientific misconduct at site level) =636+481+58+2+118+1=1296"|
59650070|NCT04518410|75768094|FG013|STARTED|Overall Study||113|"Total enrolled = Started (Randomized) + Screen Fail (Randomized) + Excluded from Analysis at NIH Request (suspected scientific misconduct at site level) + Dual Enrolled Subject = 3923+2+118+1=4044~A* = Subjects Treated and then not completed for reported reason and not excluded from analyses = 0+323+208+35+31+37+2=636~Not completed=A*+Ongoing+Randomized not Treated+Screen failed but randomized+Excluded from Analyses (suspected scientific misconduct at site level) =636+481+58+2+118+1=1296"|
59709651|NCT01235741|75828431|FG002|STARTED|Follow-Up Post Treatment up to Month 6|No treatment; those who had been treated with drug (36) were followed up 6 months post treatment.|36||
59709652|NCT01235741|75828429|FG000|COMPLETED|Follow-Up Post Treatment up to Month 6||0||
59709653|NCT01235741|75828430|FG001|COMPLETED|Follow-Up Post Treatment up to Month 6|9 participants did not complete the 6 month follow up period|27||
59650071|NCT04518410|75768095|FG014|STARTED|Overall Study||54|"Total enrolled = Started (Randomized) + Screen Fail (Randomized) + Excluded from Analysis at NIH Request (suspected scientific misconduct at site level) + Dual Enrolled Subject = 3923+2+118+1=4044~A* = Subjects Treated and then not completed for reported reason and not excluded from analyses = 0+323+208+35+31+37+2=636~Not completed=A*+Ongoing+Randomized not Treated+Screen failed but randomized+Excluded from Analyses (suspected scientific misconduct at site level) =636+481+58+2+118+1=1296"|
59650072|NCT04518410|75768096|FG015|STARTED|Overall Study||110|"Total enrolled = Started (Randomized) + Screen Fail (Randomized) + Excluded from Analysis at NIH Request (suspected scientific misconduct at site level) + Dual Enrolled Subject = 3923+2+118+1=4044~A* = Subjects Treated and then not completed for reported reason and not excluded from analyses = 0+323+208+35+31+37+2=636~Not completed=A*+Ongoing+Randomized not Treated+Screen failed but randomized+Excluded from Analyses (suspected scientific misconduct at site level) =636+481+58+2+118+1=1296"|
59650073|NCT04518410|75768097|FG016|STARTED|Overall Study||39|"Total enrolled = Started (Randomized) + Screen Fail (Randomized) + Excluded from Analysis at NIH Request (suspected scientific misconduct at site level) + Dual Enrolled Subject = 3923+2+118+1=4044~A* = Subjects Treated and then not completed for reported reason and not excluded from analyses = 0+323+208+35+31+37+2=636~Not completed=A*+Ongoing+Randomized not Treated+Screen failed but randomized+Excluded from Analyses (suspected scientific misconduct at site level) =636+481+58+2+118+1=1296"|
59650074|NCT04518410|75768098|FG017|STARTED|Overall Study||225|"Total enrolled = Started (Randomized) + Screen Fail (Randomized) + Excluded from Analysis at NIH Request (suspected scientific misconduct at site level) + Dual Enrolled Subject = 3923+2+118+1=4044~A* = Subjects Treated and then not completed for reported reason and not excluded from analyses = 0+323+208+35+31+37+2=636~Not completed=A*+Ongoing+Randomized not Treated+Screen failed but randomized+Excluded from Analyses (suspected scientific misconduct at site level) =636+481+58+2+118+1=1296"|
59650075|NCT04518410|75768099|FG018|STARTED|Overall Study||214|"Total enrolled = Started (Randomized) + Screen Fail (Randomized) + Excluded from Analysis at NIH Request (suspected scientific misconduct at site level) + Dual Enrolled Subject = 3923+2+118+1=4044~A* = Subjects Treated and then not completed for reported reason and not excluded from analyses = 0+323+208+35+31+37+2=636~Not completed=A*+Ongoing+Randomized not Treated+Screen failed but randomized+Excluded from Analyses (suspected scientific misconduct at site level) =636+481+58+2+118+1=1296"|
59650076|NCT04518410|75768100|FG019|STARTED|Overall Study||142|"Total enrolled = Started (Randomized) + Screen Fail (Randomized) + Excluded from Analysis at NIH Request (suspected scientific misconduct at site level) + Dual Enrolled Subject = 3923+2+118+1=4044~A* = Subjects Treated and then not completed for reported reason and not excluded from analyses = 0+323+208+35+31+37+2=636~Not completed=A*+Ongoing+Randomized not Treated+Screen failed but randomized+Excluded from Analyses (suspected scientific misconduct at site level) =636+481+58+2+118+1=1296"|
59650077|NCT04518410|75768101|FG020|STARTED|Overall Study||153|"Total enrolled = Started (Randomized) + Screen Fail (Randomized) + Excluded from Analysis at NIH Request (suspected scientific misconduct at site level) + Dual Enrolled Subject = 3923+2+118+1=4044~A* = Subjects Treated and then not completed for reported reason and not excluded from analyses = 0+323+208+35+31+37+2=636~Not completed=A*+Ongoing+Randomized not Treated+Screen failed but randomized+Excluded from Analyses (suspected scientific misconduct at site level) =636+481+58+2+118+1=1296"|
59650078|NCT04518410|75768102|FG021|STARTED|Overall Study||115|"Total enrolled = Started (Randomized) + Screen Fail (Randomized) + Excluded from Analysis at NIH Request (suspected scientific misconduct at site level) + Dual Enrolled Subject = 3923+2+118+1=4044~A* = Subjects Treated and then not completed for reported reason and not excluded from analyses = 0+323+208+35+31+37+2=636~Not completed=A*+Ongoing+Randomized not Treated+Screen failed but randomized+Excluded from Analyses (suspected scientific misconduct at site level) =636+481+58+2+118+1=1296"|
59650079|NCT04518410|75768103|FG022|STARTED|Overall Study||41|"Total enrolled = Started (Randomized) + Screen Fail (Randomized) + Excluded from Analysis at NIH Request (suspected scientific misconduct at site level) + Dual Enrolled Subject = 3923+2+118+1=4044~A* = Subjects Treated and then not completed for reported reason and not excluded from analyses = 0+323+208+35+31+37+2=636~Not completed=A*+Ongoing+Randomized not Treated+Screen failed but randomized+Excluded from Analyses (suspected scientific misconduct at site level) =636+481+58+2+118+1=1296"|
59650080|NCT04518410|75768104|FG023|STARTED|Overall Study||112|"Total enrolled = Started (Randomized) + Screen Fail (Randomized) + Excluded from Analysis at NIH Request (suspected scientific misconduct at site level) + Dual Enrolled Subject = 3923+2+118+1=4044~A* = Subjects Treated and then not completed for reported reason and not excluded from analyses = 0+323+208+35+31+37+2=636~Not completed=A*+Ongoing+Randomized not Treated+Screen failed but randomized+Excluded from Analyses (suspected scientific misconduct at site level) =636+481+58+2+118+1=1296"|
59650081|NCT04518410|75768105|FG024|STARTED|Overall Study||61|"Total enrolled = Started (Randomized) + Screen Fail (Randomized) + Excluded from Analysis at NIH Request (suspected scientific misconduct at site level) + Dual Enrolled Subject = 3923+2+118+1=4044~A* = Subjects Treated and then not completed for reported reason and not excluded from analyses = 0+323+208+35+31+37+2=636~Not completed=A*+Ongoing+Randomized not Treated+Screen failed but randomized+Excluded from Analyses (suspected scientific misconduct at site level) =636+481+58+2+118+1=1296"|
59650082|NCT04518410|75768081|FG000|COMPLETED|Overall Study||45||
59650083|NCT04518410|75768082|FG001|COMPLETED|Overall Study||43||
59650084|NCT04518410|75768083|FG002|COMPLETED|Overall Study||100||
59650085|NCT04518410|75768084|FG003|COMPLETED|Overall Study||101||
59650086|NCT04518410|75768085|FG004|COMPLETED|Overall Study||843||
59650087|NCT04518410|75768086|FG005|COMPLETED|Overall Study||340||
59650088|NCT04518410|75768087|FG006|COMPLETED|Overall Study||339||
59650089|NCT04518410|75768088|FG007|COMPLETED|Overall Study||46||
59650090|NCT04518410|75768089|FG008|COMPLETED|Overall Study||27||
59988660|NCT01352507|76103895|FG001|COMPLETED|Treatment Period 1||184||
59988661|NCT01352507|76103894|FG000|NOT COMPLETED|Treatment Period 1||14||
59988662|NCT01352507|76103895|FG001|NOT COMPLETED|Treatment Period 1||9||
59988663|NCT01352507|76103894|FG000|STARTED|Washout Period||176||
59988664|NCT01352507|76103895|FG001|STARTED|Washout Period||184||
59988665|NCT01352507|76103894|FG000|COMPLETED|Washout Period||176||
59988666|NCT01352507|76103895|FG001|COMPLETED|Washout Period||183||
59988667|NCT01352507|76103894|FG000|NOT COMPLETED|Washout Period||0||
59988668|NCT01352507|76103895|FG001|NOT COMPLETED|Washout Period||1||
59650091|NCT04518410|75768090|FG009|COMPLETED|Overall Study||78||
59650092|NCT04518410|75768091|FG010|COMPLETED|Overall Study||39||
59650093|NCT04518410|75768092|FG011|COMPLETED|Overall Study||88||
59650094|NCT04518410|75768093|FG012|COMPLETED|Overall Study||41||
59650095|NCT04518410|75768094|FG013|COMPLETED|Overall Study||81||
59650096|NCT04518410|75768095|FG014|COMPLETED|Overall Study||38||
59650097|NCT04518410|75768096|FG015|COMPLETED|Overall Study||85||
59650098|NCT04518410|75768097|FG016|COMPLETED|Overall Study||27||
59650099|NCT04518410|75768098|FG017|COMPLETED|Overall Study||0||
59650100|NCT04518410|75768099|FG018|COMPLETED|Overall Study||0||
59650101|NCT04518410|75768100|FG019|COMPLETED|Overall Study||73||
59650102|NCT04518410|75768101|FG020|COMPLETED|Overall Study||69||
59650103|NCT04518410|75768102|FG021|COMPLETED|Overall Study||83||
59650104|NCT04518410|75768103|FG022|COMPLETED|Overall Study||36||
59650105|NCT04518410|75768104|FG023|COMPLETED|Overall Study||84||
59650106|NCT04518410|75768105|FG024|COMPLETED|Overall Study||42||
59650107|NCT04518410|75768081|FG000|NOT COMPLETED|Overall Study||3||
59650108|NCT04518410|75768082|FG001|NOT COMPLETED|Overall Study||3||
59650109|NCT04518410|75768083|FG002|NOT COMPLETED|Overall Study||11||
59650110|NCT04518410|75768084|FG003|NOT COMPLETED|Overall Study||13||
59650111|NCT04518410|75768085|FG004|NOT COMPLETED|Overall Study||236||
59650112|NCT04518410|75768086|FG005|NOT COMPLETED|Overall Study||84||
59650113|NCT04518410|75768087|FG006|NOT COMPLETED|Overall Study||83||
59650114|NCT04518410|75768088|FG007|NOT COMPLETED|Overall Study||15||
59650115|NCT04518410|75768089|FG008|NOT COMPLETED|Overall Study||6||
59650116|NCT04518410|75768090|FG009|NOT COMPLETED|Overall Study||32||
59650117|NCT04518410|75768091|FG010|NOT COMPLETED|Overall Study||15||
59650118|NCT04518410|75768092|FG011|NOT COMPLETED|Overall Study||22||
59650119|NCT04518410|75768093|FG012|NOT COMPLETED|Overall Study||12||
59650120|NCT04518410|75768094|FG013|NOT COMPLETED|Overall Study||32||
59650121|NCT04518410|75768095|FG014|NOT COMPLETED|Overall Study||16||
59650122|NCT04518410|75768096|FG015|NOT COMPLETED|Overall Study||25||
59650123|NCT04518410|75768097|FG016|NOT COMPLETED|Overall Study||12||
59650124|NCT04518410|75768098|FG017|NOT COMPLETED|Overall Study||225||
59650125|NCT04518410|75768099|FG018|NOT COMPLETED|Overall Study||214||
59650126|NCT04518410|75768100|FG019|NOT COMPLETED|Overall Study||69||
59650127|NCT04518410|75768101|FG020|NOT COMPLETED|Overall Study||84||
59650128|NCT04518410|75768102|FG021|NOT COMPLETED|Overall Study||32||
59650129|NCT04518410|75768103|FG022|NOT COMPLETED|Overall Study||5||
59650130|NCT04518410|75768104|FG023|NOT COMPLETED|Overall Study||28||
59650131|NCT04518410|75768105|FG024|NOT COMPLETED|Overall Study||19||
59650132|NCT04517864|75768165|FG000|STARTED|Placebo-Controlled Phase||36||
59650133|NCT04517864|75768166|FG001|STARTED|Placebo-Controlled Phase||35||
59650134|NCT04517864|75768165|FG000|COMPLETED|Placebo-Controlled Phase||32||
59650135|NCT04517864|75768166|FG001|COMPLETED|Placebo-Controlled Phase||33||
59650136|NCT04517864|75768165|FG000|NOT COMPLETED|Placebo-Controlled Phase||4||
59650137|NCT04517864|75768166|FG001|NOT COMPLETED|Placebo-Controlled Phase||2||
59650138|NCT04517864|75768165|FG000|STARTED|Active Therapy Extension Phase||32||
59650139|NCT04517864|75768166|FG001|STARTED|Active Therapy Extension Phase|2 participants had completed Placebo-Controlled Phase and not yet entered Active Therapy Extension Phase at the time of the PCD data-cut.|31||
59543316|NCT02461758|75641538|FG001|COMPLETED|Overall Study||19||
59543317|NCT02461758|75641539|FG002|COMPLETED|Overall Study||25||
59543318|NCT02461758|75641540|FG003|COMPLETED|Overall Study||15||
59543319|NCT02461758|75641537|FG000|NOT COMPLETED|Overall Study||0||
59543320|NCT02461758|75641538|FG001|NOT COMPLETED|Overall Study||1||
59543321|NCT02461758|75641539|FG002|NOT COMPLETED|Overall Study||1||
59543322|NCT02461758|75641540|FG003|NOT COMPLETED|Overall Study||0||
59543323|NCT00921518|75641555|FG000|STARTED|Overall Study||48||
59650140|NCT04517864|75768165|FG000|COMPLETED|Active Therapy Extension Phase|This 31 participants remained ongoing in the study.|31|At the time of the Primary Completion Date (PCD) data-cut, 62 participants in this row remained ongoing in the study.|
59650141|NCT04517864|75768166|FG001|COMPLETED|Active Therapy Extension Phase|This 31 participants remained ongoing in the study.|31|At the time of the Primary Completion Date (PCD) data-cut, 62 participants in this row remained ongoing in the study.|
59650142|NCT04517864|75768165|FG000|NOT COMPLETED|Active Therapy Extension Phase||1||
59650143|NCT04517864|75768166|FG001|NOT COMPLETED|Active Therapy Extension Phase||0||
59650144|NCT04507204|75768187|FG000|STARTED|Overall Study||133||
59650145|NCT04507204|75768188|FG001|STARTED|Overall Study||134||
59650146|NCT04507204|75768187|FG000|COMPLETED|Overall Study||83||
59650147|NCT04507204|75768188|FG001|COMPLETED|Overall Study||86||
59650148|NCT04507204|75768187|FG000|NOT COMPLETED|Overall Study||50||
59650149|NCT04507204|75768188|FG001|NOT COMPLETED|Overall Study||48||
59650150|NCT04500457|75768196|FG000|STARTED|Overall Study||39||
59650151|NCT04500457|75768197|FG001|STARTED|Overall Study||37||
59650152|NCT04500457|75768196|FG000|COMPLETED|Overall Study||36||
59650153|NCT04500457|75768197|FG001|COMPLETED|Overall Study||35||
59650154|NCT04500457|75768196|FG000|NOT COMPLETED|Overall Study||3||
59543324|NCT00921518|75641556|FG001|STARTED|Overall Study||44||
59543325|NCT00921518|75641555|FG000|COMPLETED|Overall Study||48||
59543326|NCT00921518|75641556|FG001|COMPLETED|Overall Study||44||
59543327|NCT00921518|75641555|FG000|NOT COMPLETED|Overall Study||0||
59543328|NCT00921518|75641556|FG001|NOT COMPLETED|Overall Study||0||
59543329|NCT02461290|75641562|FG000|STARTED|Overall Study||99||
59650155|NCT04500457|75768197|FG001|NOT COMPLETED|Overall Study||2||
59650156|NCT04331002|75768205|FG000|STARTED|Overall Study||1||
59650157|NCT04331002|75768206|FG001|STARTED|Overall Study||0||
59650158|NCT04331002|75768205|FG000|COMPLETED|Overall Study||1||
59650159|NCT04331002|75768206|FG001|COMPLETED|Overall Study||0||
59650160|NCT04331002|75768205|FG000|NOT COMPLETED|Overall Study||0||
59650161|NCT04331002|75768206|FG001|NOT COMPLETED|Overall Study||0||
59650162|NCT04135937|75768212|FG000|STARTED|Overall Study||12||
59650163|NCT04135937|75768212|FG000|COMPLETED|Overall Study||9||
59650164|NCT04135937|75768212|FG000|NOT COMPLETED|Overall Study||3||
59650165|NCT04060147|75768216|FG000|STARTED|Overall Study||11||
59650166|NCT04060147|75768216|FG000|COMPLETED|Overall Study||10||
59650167|NCT04060147|75768216|FG000|NOT COMPLETED|Overall Study||1||
59650168|NCT04019093|75768222|FG000|STARTED|Overall Study||9||
59650169|NCT04019093|75768223|FG001|STARTED|Overall Study||16||
59650170|NCT04019093|75768224|FG002|STARTED|Overall Study||10||
59650171|NCT04019093|75768225|FG003|STARTED|Overall Study||13||
59650172|NCT04019093|75768222|FG000|COMPLETED|Overall Study||9||
59650173|NCT04019093|75768223|FG001|COMPLETED|Overall Study||16||
59650174|NCT04019093|75768224|FG002|COMPLETED|Overall Study||10||
59650175|NCT04019093|75768225|FG003|COMPLETED|Overall Study||13||
59650176|NCT04019093|75768222|FG000|NOT COMPLETED|Overall Study||0||
59650177|NCT04019093|75768223|FG001|NOT COMPLETED|Overall Study||0||
59650178|NCT04019093|75768224|FG002|NOT COMPLETED|Overall Study||0||
59650179|NCT04019093|75768225|FG003|NOT COMPLETED|Overall Study||0||
59650180|NCT04019041|75768250|FG000|STARTED|Placebo Controlled Period (Weeks 0-16)||52||
59650181|NCT04019041|75768251|FG001|STARTED|Placebo Controlled Period (Weeks 0-16)||50||
59650182|NCT04019041|75768252|FG002|STARTED|Placebo Controlled Period (Weeks 0-16)||51||
59650183|NCT04019041|75768253|FG003|STARTED|Placebo Controlled Period (Weeks 0-16)||0||
59650184|NCT04019041|75768254|FG004|STARTED|Placebo Controlled Period (Weeks 0-16)||0||
59650185|NCT04019041|75768255|FG005|STARTED|Placebo Controlled Period (Weeks 0-16)||0||
59650186|NCT04019041|75768250|FG000|COMPLETED|Placebo Controlled Period (Weeks 0-16)||48||
59650187|NCT04019041|75768251|FG001|COMPLETED|Placebo Controlled Period (Weeks 0-16)||43||
59650188|NCT04019041|75768252|FG002|COMPLETED|Placebo Controlled Period (Weeks 0-16)||43||
60076852|NCT01901653|76191867|FG011|COMPLETED|Overall Study||0||
60076853|NCT01901653|76191868|FG012|COMPLETED|Overall Study||0||
60076854|NCT01901653|76191856|FG000|NOT COMPLETED|Overall Study||3||
60076855|NCT01901653|76191857|FG001|NOT COMPLETED|Overall Study||1||
60076856|NCT01901653|76191858|FG002|NOT COMPLETED|Overall Study||11||
60076857|NCT01901653|76191859|FG003|NOT COMPLETED|Overall Study||3||
60076858|NCT01901653|76191860|FG004|NOT COMPLETED|Overall Study||2||
60076859|NCT01901653|76191861|FG005|NOT COMPLETED|Overall Study||3||
60076860|NCT01901653|76191862|FG006|NOT COMPLETED|Overall Study||7||
60076861|NCT01901653|76191863|FG007|NOT COMPLETED|Overall Study||10||
60076862|NCT01901653|76191864|FG008|NOT COMPLETED|Overall Study||1||
60076863|NCT01901653|76191865|FG009|NOT COMPLETED|Overall Study||18||
59650189|NCT04019041|75768253|FG003|COMPLETED|Placebo Controlled Period (Weeks 0-16)||0||
59650190|NCT04019041|75768254|FG004|COMPLETED|Placebo Controlled Period (Weeks 0-16)||0||
59650191|NCT04019041|75768255|FG005|COMPLETED|Placebo Controlled Period (Weeks 0-16)||0||
59650192|NCT04019041|75768250|FG000|NOT COMPLETED|Placebo Controlled Period (Weeks 0-16)||4||
60076864|NCT01901653|76191866|FG010|NOT COMPLETED|Overall Study||2||
59650193|NCT04019041|75768251|FG001|NOT COMPLETED|Placebo Controlled Period (Weeks 0-16)||7||
59650194|NCT04019041|75768252|FG002|NOT COMPLETED|Placebo Controlled Period (Weeks 0-16)||8||
59650195|NCT04019041|75768253|FG003|NOT COMPLETED|Placebo Controlled Period (Weeks 0-16)||0||
59650196|NCT04019041|75768254|FG004|NOT COMPLETED|Placebo Controlled Period (Weeks 0-16)||0||
59650197|NCT04019041|75768255|FG005|NOT COMPLETED|Placebo Controlled Period (Weeks 0-16)||0||
59650198|NCT04019041|75768250|FG000|STARTED|Active Treatment+Safety F-U (Week 17-36)||0||
59650199|NCT04019041|75768251|FG001|STARTED|Active Treatment+Safety F-U (Week 17-36)||0||
59650200|NCT04019041|75768252|FG002|STARTED|Active Treatment+Safety F-U (Week 17-36)||0||
59650201|NCT04019041|75768253|FG003|STARTED|Active Treatment+Safety F-U (Week 17-36)||48||
59650202|NCT04019041|75768254|FG004|STARTED|Active Treatment+Safety F-U (Week 17-36)||43||
59650203|NCT04019041|75768255|FG005|STARTED|Active Treatment+Safety F-U (Week 17-36)||43||
59650204|NCT04019041|75768250|FG000|COMPLETED|Active Treatment+Safety F-U (Week 17-36)||0||
59650205|NCT04019041|75768251|FG001|COMPLETED|Active Treatment+Safety F-U (Week 17-36)||0||
59650206|NCT04019041|75768252|FG002|COMPLETED|Active Treatment+Safety F-U (Week 17-36)||0||
59650207|NCT04019041|75768253|FG003|COMPLETED|Active Treatment+Safety F-U (Week 17-36)||42||
59650208|NCT04019041|75768254|FG004|COMPLETED|Active Treatment+Safety F-U (Week 17-36)||35||
59650209|NCT04019041|75768255|FG005|COMPLETED|Active Treatment+Safety F-U (Week 17-36)||38||
59650210|NCT04019041|75768250|FG000|NOT COMPLETED|Active Treatment+Safety F-U (Week 17-36)||0||
59650211|NCT04019041|75768251|FG001|NOT COMPLETED|Active Treatment+Safety F-U (Week 17-36)||0||
59650212|NCT04019041|75768252|FG002|NOT COMPLETED|Active Treatment+Safety F-U (Week 17-36)||0||
59650213|NCT04019041|75768253|FG003|NOT COMPLETED|Active Treatment+Safety F-U (Week 17-36)||6||
59650214|NCT04019041|75768254|FG004|NOT COMPLETED|Active Treatment+Safety F-U (Week 17-36)||8||
59650215|NCT04019041|75768255|FG005|NOT COMPLETED|Active Treatment+Safety F-U (Week 17-36)||5||
59650216|NCT03930849|75768271|FG000|STARTED|Overall Study||17||
59650217|NCT03930849|75768272|FG001|STARTED|Overall Study||18||
59650218|NCT03930849|75768273|FG002|STARTED|Overall Study||18||
59650219|NCT03930849|75768271|FG000|COMPLETED|Overall Study||13||
59650220|NCT03930849|75768272|FG001|COMPLETED|Overall Study||18||
59650221|NCT03930849|75768273|FG002|COMPLETED|Overall Study||14||
59650222|NCT03930849|75768271|FG000|NOT COMPLETED|Overall Study||4||
59650223|NCT03930849|75768272|FG001|NOT COMPLETED|Overall Study||0||
60076865|NCT01901653|76191867|FG011|NOT COMPLETED|Overall Study||16||
60076866|NCT01901653|76191868|FG012|NOT COMPLETED|Overall Study||5||
60076867|NCT01925989|76191896|FG000|STARTED|Period 1||7||
60076868|NCT01925989|76191897|FG001|STARTED|Period 1||8||
59650224|NCT03930849|75768273|FG002|NOT COMPLETED|Overall Study||4||
59650225|NCT03919448|75768284|FG000|STARTED|Overall Study||30||
59650226|NCT03919448|75768285|FG001|STARTED|Overall Study||30||
59650227|NCT03919448|75768286|FG002|STARTED|Overall Study||30||
59650228|NCT03919448|75768284|FG000|COMPLETED|Overall Study||29||
59650229|NCT03919448|75768285|FG001|COMPLETED|Overall Study||30||
59650230|NCT03919448|75768286|FG002|COMPLETED|Overall Study||30||
59650231|NCT03919448|75768284|FG000|NOT COMPLETED|Overall Study||1||
59650232|NCT03919448|75768285|FG001|NOT COMPLETED|Overall Study||0||
59650233|NCT03919448|75768286|FG002|NOT COMPLETED|Overall Study||0||
59650234|NCT03818737|75768298|FG000|STARTED|Overall Study||118|Intent to treat population|
60076869|NCT01925989|76191898|FG002|STARTED|Period 1||12||
60076870|NCT01925989|76191896|FG000|Received at Least 1 Dose of Study Drug|Period 1||7||
60076871|NCT01925989|76191897|FG001|Received at Least 1 Dose of Study Drug|Period 1||8||
60076872|NCT01925989|76191898|FG002|Received at Least 1 Dose of Study Drug|Period 1||0||
59650235|NCT03818737|75768299|FG001|STARTED|Overall Study||119|Intent to treat population|
59650236|NCT03818737|75768300|FG002|STARTED|Overall Study||118|Intent to treat population|
59650237|NCT03818737|75768301|FG003|STARTED|Overall Study||120|Intent to treat population|
59650238|NCT03818737|75768298|FG000|Received Study Intervention|Overall Study||107||
59650239|NCT03818737|75768299|FG001|Received Study Intervention|Overall Study||109||
59650240|NCT03818737|75768300|FG002|Received Study Intervention|Overall Study||116||
59650241|NCT03818737|75768301|FG003|Received Study Intervention|Overall Study||108||
59650242|NCT03818737|75768298|FG000|COMPLETED|Overall Study||97||
59650243|NCT03818737|75768299|FG001|COMPLETED|Overall Study||93||
59650244|NCT03818737|75768300|FG002|COMPLETED|Overall Study||103||
59650245|NCT03818737|75768301|FG003|COMPLETED|Overall Study||97||
59650246|NCT03818737|75768298|FG000|NOT COMPLETED|Overall Study||21||
59650247|NCT03818737|75768299|FG001|NOT COMPLETED|Overall Study||26||
59650248|NCT03818737|75768300|FG002|NOT COMPLETED|Overall Study||15||
59650249|NCT03818737|75768301|FG003|NOT COMPLETED|Overall Study||23||
59650250|NCT03795922|75768313|FG000|STARTED|Overall Study||80||
59650251|NCT03795922|75768314|FG001|STARTED|Overall Study||154||
59650252|NCT03795922|75768313|FG000|COMPLETED|Overall Study||67||
59650253|NCT03795922|75768314|FG001|COMPLETED|Overall Study||129||
59650254|NCT03795922|75768313|FG000|NOT COMPLETED|Overall Study||13||
59650255|NCT03795922|75768314|FG001|NOT COMPLETED|Overall Study||25||
59650256|NCT03794089|75768324|FG000|STARTED|Overall Study||17||
59650257|NCT03794089|75768325|FG001|STARTED|Overall Study||18||
59650258|NCT03794089|75768324|FG000|Completed 4-week Assessment|Overall Study||16||
59650259|NCT03794089|75768325|FG001|Completed 4-week Assessment|Overall Study||18||
59650260|NCT03794089|75768324|FG000|Completed 8-week Assessment|Overall Study||14||
59650261|NCT03794089|75768325|FG001|Completed 8-week Assessment|Overall Study||18||
59650262|NCT03794089|75768324|FG000|Completed 12-week Assessment|Overall Study||13||
59650263|NCT03794089|75768325|FG001|Completed 12-week Assessment|Overall Study||17||
59650264|NCT03794089|75768324|FG000|COMPLETED|Overall Study||11||
59650265|NCT03794089|75768325|FG001|COMPLETED|Overall Study||17||
59650266|NCT03794089|75768324|FG000|NOT COMPLETED|Overall Study||6||
59650267|NCT03794089|75768325|FG001|NOT COMPLETED|Overall Study||1||
59650268|NCT03769025|75768333|FG000|STARTED|Overall Study||8||
59650269|NCT03769025|75768334|FG001|STARTED|Overall Study||8||
59650270|NCT03769025|75768333|FG000|COMPLETED|Overall Study||3||
59650271|NCT03769025|75768334|FG001|COMPLETED|Overall Study||4||
59650272|NCT03769025|75768333|FG000|NOT COMPLETED|Overall Study||5||
59650273|NCT03769025|75768334|FG001|NOT COMPLETED|Overall Study||4||
59650274|NCT03762473|75768342|FG000|STARTED|Overall Study||44||
59650275|NCT03762473|75768343|FG001|STARTED|Overall Study||45||
59650276|NCT03762473|75768342|FG000|COMPLETED|Overall Study||43||
59650277|NCT03762473|75768343|FG001|COMPLETED|Overall Study||45||
59650278|NCT03762473|75768342|FG000|NOT COMPLETED|Overall Study||1||
59650279|NCT03762473|75768343|FG001|NOT COMPLETED|Overall Study||0||
59650280|NCT03745989|75768352|FG000|STARTED|Overall Study||3||
59650281|NCT03745989|75768353|FG001|STARTED|Overall Study||12||
59650282|NCT03745989|75768354|FG002|STARTED|Overall Study||15||
59650283|NCT03745989|75768352|FG000|COMPLETED|Overall Study||0||
59988669|NCT01352507|76103894|FG000|STARTED|Treatment Period 2||176||
59988670|NCT01352507|76103895|FG001|STARTED|Treatment Period 2||183||
59988671|NCT01352507|76103894|FG000|Received Treatment|Treatment Period 2||173||
59988672|NCT01352507|76103895|FG001|Received Treatment|Treatment Period 2||181||
59988673|NCT01352507|76103894|FG000|COMPLETED|Treatment Period 2|Six participants who completed Treatment Period 2 chose not to enter the Extension Phase.|170||
59650284|NCT03745989|75768353|FG001|COMPLETED|Overall Study||0||
59650285|NCT03745989|75768354|FG002|COMPLETED|Overall Study||0||
59650286|NCT03745989|75768352|FG000|NOT COMPLETED|Overall Study||3||
59650287|NCT03745989|75768353|FG001|NOT COMPLETED|Overall Study||12||
59650288|NCT03745989|75768354|FG002|NOT COMPLETED|Overall Study||15||
59650289|NCT03724552|75768364|FG000|STARTED|Overall Study||0||
59650290|NCT03724552|75768365|FG001|STARTED|Overall Study||12||
59650291|NCT03724552|75768364|FG000|COMPLETED|Overall Study||0||
59650292|NCT03724552|75768365|FG001|COMPLETED|Overall Study||10||
59650293|NCT03724552|75768364|FG000|NOT COMPLETED|Overall Study||0||
59650294|NCT03724552|75768365|FG001|NOT COMPLETED|Overall Study||2||
59650295|NCT03665688|75768375|FG000|STARTED|Overall Study||167||
59650296|NCT03665688|75768376|FG001|STARTED|Overall Study||171||
59650297|NCT03665688|75768375|FG000|COMPLETED|Overall Study||167||
59650298|NCT03665688|75768376|FG001|COMPLETED|Overall Study||171||
59650299|NCT03665688|75768375|FG000|NOT COMPLETED|Overall Study||0||
59650300|NCT03665688|75768376|FG001|NOT COMPLETED|Overall Study||0||
59650301|NCT03646656|75768384|FG000|STARTED|Overall Study||12||
59650302|NCT03646656|75768385|FG001|STARTED|Overall Study||3||
59650303|NCT03646656|75768384|FG000|Attended 1st Group Session|Overall Study||10||
59650304|NCT03646656|75768385|FG001|Attended 1st Group Session|Overall Study||3||
59650305|NCT03646656|75768384|FG000|COMPLETED|Overall Study||9||
59650306|NCT03646656|75768385|FG001|COMPLETED|Overall Study||3||
59650307|NCT03646656|75768384|FG000|NOT COMPLETED|Overall Study||3||
59650308|NCT03646656|75768385|FG001|NOT COMPLETED|Overall Study||0||
59988674|NCT01352507|76103895|FG001|COMPLETED|Treatment Period 2|Seven participants who completed Treatment Period 2 chose not to enter the Extension Phase.|180||
59988675|NCT01352507|76103894|FG000|NOT COMPLETED|Treatment Period 2||6||
59650309|NCT03555435|75768398|FG000|STARTED|Overall Study||28||
59650310|NCT03555435|75768399|FG001|STARTED|Overall Study||27||
59650311|NCT03555435|75768400|FG002|STARTED|Overall Study||26||
59650312|NCT03555435|75768398|FG000|COMPLETED|Overall Study||11||
59650313|NCT03555435|75768399|FG001|COMPLETED|Overall Study||8||
59650314|NCT03555435|75768400|FG002|COMPLETED|Overall Study||18||
59650315|NCT03555435|75768398|FG000|NOT COMPLETED|Overall Study||17||
59650316|NCT03555435|75768399|FG001|NOT COMPLETED|Overall Study||19||
59650317|NCT03555435|75768400|FG002|NOT COMPLETED|Overall Study||8||
59650318|NCT03521115|75768410|FG000|STARTED|Time 0 Baseline Surveys||206||
59650319|NCT03521115|75768411|FG001|STARTED|Time 0 Baseline Surveys||205||
59650320|NCT03521115|75768410|FG000|COMPLETED|Time 0 Baseline Surveys||206||
59650321|NCT03521115|75768411|FG001|COMPLETED|Time 0 Baseline Surveys||205||
59650322|NCT03521115|75768410|FG000|NOT COMPLETED|Time 0 Baseline Surveys||0||
59650323|NCT03521115|75768411|FG001|NOT COMPLETED|Time 0 Baseline Surveys||0||
59650324|NCT03521115|75768410|FG000|STARTED|Time 1 Survey (6 Months Post Baseline)||206|Failure to complete program did not preclude completing surveys.|
59650325|NCT03521115|75768411|FG001|STARTED|Time 1 Survey (6 Months Post Baseline)||205|Failure to complete program did not preclude completing surveys.|
59650326|NCT03521115|75768410|FG000|COMPLETED|Time 1 Survey (6 Months Post Baseline)||150||
59650327|NCT03521115|75768411|FG001|COMPLETED|Time 1 Survey (6 Months Post Baseline)||165||
59650328|NCT03521115|75768410|FG000|NOT COMPLETED|Time 1 Survey (6 Months Post Baseline)||56||
59650329|NCT03521115|75768411|FG001|NOT COMPLETED|Time 1 Survey (6 Months Post Baseline)||40||
59650330|NCT03521115|75768410|FG000|STARTED|Time 2 Survey (12 Months Post Baseline)||150||
59650331|NCT03521115|75768411|FG001|STARTED|Time 2 Survey (12 Months Post Baseline)||165||
59650332|NCT03521115|75768410|FG000|COMPLETED|Time 2 Survey (12 Months Post Baseline)||147||
59650333|NCT03521115|75768411|FG001|COMPLETED|Time 2 Survey (12 Months Post Baseline)||164||
59650334|NCT03521115|75768410|FG000|NOT COMPLETED|Time 2 Survey (12 Months Post Baseline)||3||
59650335|NCT03521115|75768411|FG001|NOT COMPLETED|Time 2 Survey (12 Months Post Baseline)||1||
59650336|NCT03521115|75768410|FG000|STARTED|Time 3 Survey (18 Months Post Baseline)||147||
59650337|NCT03521115|75768411|FG001|STARTED|Time 3 Survey (18 Months Post Baseline)||164||
59650338|NCT03521115|75768410|FG000|COMPLETED|Time 3 Survey (18 Months Post Baseline)||145||
59650339|NCT03521115|75768411|FG001|COMPLETED|Time 3 Survey (18 Months Post Baseline)||164||
59650340|NCT03521115|75768410|FG000|NOT COMPLETED|Time 3 Survey (18 Months Post Baseline)||2||
59650341|NCT03521115|75768411|FG001|NOT COMPLETED|Time 3 Survey (18 Months Post Baseline)||0||
59650342|NCT03520413|75768425|FG000|STARTED|Overall Study||101||
59650343|NCT03520413|75768426|FG001|STARTED|Overall Study||99||
59650344|NCT03520413|75768425|FG000|COMPLETED|Overall Study|Completed defined as Hemoglobin A1c collected at 12months|77||
59650345|NCT03520413|75768426|FG001|COMPLETED|Overall Study|Completed defined as Hemoglobin A1c collected at 12months|73||
59650346|NCT03520413|75768425|FG000|NOT COMPLETED|Overall Study||24||
59650347|NCT03520413|75768426|FG001|NOT COMPLETED|Overall Study||26||
59650348|NCT03419897|75768433|FG000|STARTED|Overall Study||249||
59650349|NCT03419897|75768433|FG000|COMPLETED|Overall Study||0||
59650350|NCT03419897|75768433|FG000|NOT COMPLETED|Overall Study||249||
59650351|NCT03418129|75768440|FG000|STARTED|Overall Study||84||
59650352|NCT03418129|75768441|FG001|STARTED|Overall Study||85||
59650353|NCT03418129|75768442|FG002|STARTED|Overall Study||85||
59650354|NCT03418129|75768440|FG000|COMPLETED|Overall Study||70||
59650355|NCT03418129|75768441|FG001|COMPLETED|Overall Study||59||
59650356|NCT03418129|75768442|FG002|COMPLETED|Overall Study||66||
59650357|NCT03418129|75768440|FG000|NOT COMPLETED|Overall Study||14||
59650358|NCT03418129|75768441|FG001|NOT COMPLETED|Overall Study||26||
59650359|NCT03418129|75768442|FG002|NOT COMPLETED|Overall Study||19||
59650360|NCT03377049|75768450|FG000|STARTED|Overall Study||11||
59650361|NCT03377049|75768450|FG000|COMPLETED|Overall Study||11||
59650362|NCT03377049|75768450|FG000|NOT COMPLETED|Overall Study||0||
59650363|NCT03344796|75768460|FG000|STARTED|Overall Study||32||
59650364|NCT03344796|75768461|FG001|STARTED|Overall Study||10||
59650365|NCT03344796|75768462|FG002|STARTED|Overall Study||31||
59650366|NCT03344796|75768463|FG003|STARTED|Overall Study||29||
59650367|NCT03344796|75768464|FG004|STARTED|Overall Study||20||
59650368|NCT03344796|75768465|FG005|STARTED|Overall Study||42||
59650369|NCT03344796|75768460|FG000|COMPLETED|Overall Study||32||
59650370|NCT03344796|75768461|FG001|COMPLETED|Overall Study||10||
59650371|NCT03344796|75768462|FG002|COMPLETED|Overall Study||31||
59650372|NCT03344796|75768463|FG003|COMPLETED|Overall Study||29||
59650373|NCT03344796|75768464|FG004|COMPLETED|Overall Study||20||
59650374|NCT03344796|75768465|FG005|COMPLETED|Overall Study|Daily online survey data was not completed by 2 participants.|40||
59650375|NCT03344796|75768460|FG000|NOT COMPLETED|Overall Study||0||
59650376|NCT03344796|75768461|FG001|NOT COMPLETED|Overall Study||0||
59650377|NCT03344796|75768462|FG002|NOT COMPLETED|Overall Study||0||
59650378|NCT03344796|75768463|FG003|NOT COMPLETED|Overall Study||0||
59650379|NCT03344796|75768464|FG004|NOT COMPLETED|Overall Study||0||
59650380|NCT03344796|75768465|FG005|NOT COMPLETED|Overall Study||2||
59650381|NCT03335488|75768488|FG000|STARTED|Initial Treatment Period||11||
59650382|NCT03335488|75768489|FG001|STARTED|Initial Treatment Period||5||
59650383|NCT03335488|75768488|FG000|COMPLETED|Initial Treatment Period||11||
59650384|NCT03335488|75768489|FG001|COMPLETED|Initial Treatment Period||5||
59650385|NCT03335488|75768488|FG000|NOT COMPLETED|Initial Treatment Period||0||
59650386|NCT03335488|75768489|FG001|NOT COMPLETED|Initial Treatment Period||0||
59650387|NCT03335488|75768488|FG000|STARTED|Transition Period||0||
59650388|NCT03335488|75768489|FG001|STARTED|Transition Period||5||
59650389|NCT03335488|75768488|FG000|COMPLETED|Transition Period||0||
59650390|NCT03335488|75768489|FG001|COMPLETED|Transition Period||5||
59650391|NCT03335488|75768488|FG000|NOT COMPLETED|Transition Period||0||
59650392|NCT03335488|75768489|FG001|NOT COMPLETED|Transition Period||0||
59650393|NCT03335488|75768488|FG000|STARTED|Maintenance Period||11||
59650394|NCT03335488|75768489|FG001|STARTED|Maintenance Period||5||
59650395|NCT03335488|75768488|FG000|COMPLETED|Maintenance Period||10||
59650396|NCT03335488|75768489|FG001|COMPLETED|Maintenance Period||5||
59650397|NCT03335488|75768488|FG000|NOT COMPLETED|Maintenance Period||1||
59650398|NCT03335488|75768489|FG001|NOT COMPLETED|Maintenance Period||0||
59650399|NCT03335488|75768488|FG000|STARTED|Safety Extension Period||10||
59650400|NCT03335488|75768489|FG001|STARTED|Safety Extension Period||5||
59650401|NCT03335488|75768488|FG000|COMPLETED|Safety Extension Period||8||
59650402|NCT03335488|75768489|FG001|COMPLETED|Safety Extension Period||5||
59650403|NCT03335488|75768488|FG000|NOT COMPLETED|Safety Extension Period||2||
59650404|NCT03335488|75768489|FG001|NOT COMPLETED|Safety Extension Period||0||
59650405|NCT03324802|75768499|FG000|STARTED|Overall Study||54||
59650406|NCT03324802|75768500|FG001|STARTED|Overall Study||53||
59650407|NCT03324802|75768499|FG000|COMPLETED|Overall Study||54||
59650408|NCT03324802|75768500|FG001|COMPLETED|Overall Study||53||
59650409|NCT03324802|75768499|FG000|NOT COMPLETED|Overall Study||0||
59650410|NCT03324802|75768500|FG001|NOT COMPLETED|Overall Study||0||
59650411|NCT03261700|75768508|FG000|STARTED|Overall Study||30||
59650412|NCT03261700|75768509|FG001|STARTED|Overall Study||30||
59650413|NCT03261700|75768508|FG000|COMPLETED|Overall Study|1 participant did not attend either the 10 or 14 week follow-up assessment and thus is not included in primary intent-to-treat (ITT) analyses. The participant was not able to participate due to COVID-19 related stressors.|29||
59650414|NCT03261700|75768509|FG001|COMPLETED|Overall Study||30||
59650415|NCT03261700|75768508|FG000|NOT COMPLETED|Overall Study||1||
59650416|NCT03261700|75768509|FG001|NOT COMPLETED|Overall Study||0||
59650417|NCT03238417|75768520|FG000|STARTED|Overall||1330||7
59650418|NCT03238417|75768521|FG001|STARTED|Overall||2632||14
59650419|NCT03238417|75768520|FG000|COMPLETED|Overall||327||7
59650420|NCT03238417|75768521|FG001|COMPLETED|Overall||644||14
59650421|NCT03238417|75768520|FG000|NOT COMPLETED|Overall||1003||0
59650422|NCT03238417|75768521|FG001|NOT COMPLETED|Overall||1988||0
59650423|NCT03238417|75768520|FG000|STARTED|Baseline||513||7
59650424|NCT03238417|75768521|FG001|STARTED|Baseline||934||14
59650425|NCT03238417|75768520|FG000|COMPLETED|Baseline||124||7
59650426|NCT03238417|75768521|FG001|COMPLETED|Baseline||217||14
59650427|NCT03238417|75768520|FG000|NOT COMPLETED|Baseline||389||0
59650428|NCT03238417|75768521|FG001|NOT COMPLETED|Baseline||717||0
59650429|NCT03238417|75768520|FG000|STARTED|12-month||400||7
59650430|NCT03238417|75768521|FG001|STARTED|12-month||911||14
59650431|NCT03238417|75768520|FG000|COMPLETED|12-month||81||7
59650432|NCT03238417|75768521|FG001|COMPLETED|12-month||205||14
59650433|NCT03238417|75768520|FG000|NOT COMPLETED|12-month||319||0
59650434|NCT03238417|75768521|FG001|NOT COMPLETED|12-month||706||0
59650435|NCT03238417|75768520|FG000|STARTED|24-month||417||7
59988676|NCT01352507|76103895|FG001|NOT COMPLETED|Treatment Period 2||3||
59650436|NCT03238417|75768521|FG001|STARTED|24-month||847||14
59650437|NCT03238417|75768520|FG000|COMPLETED|24-month||122||7
59650438|NCT03238417|75768521|FG001|COMPLETED|24-month||222||14
59650439|NCT03238417|75768520|FG000|NOT COMPLETED|24-month||295||0
59650440|NCT03238417|75768521|FG001|NOT COMPLETED|24-month||625||0
59650441|NCT03215277|75768529|FG000|STARTED|Overall Study||25||
59650442|NCT03215277|75768530|FG001|STARTED|Overall Study||51||
59650443|NCT03215277|75768529|FG000|COMPLETED|Overall Study||22||
59650444|NCT03215277|75768530|FG001|COMPLETED|Overall Study||46||
59650445|NCT03215277|75768529|FG000|NOT COMPLETED|Overall Study||3||
59650446|NCT03215277|75768530|FG001|NOT COMPLETED|Overall Study||5||
59650447|NCT03185013|75768540|FG000|STARTED|Overall Study||138||
59650448|NCT03185013|75768541|FG001|STARTED|Overall Study||63||
59988677|NCT01352507|76103894|FG000|STARTED|Extension Phase||164||
59988678|NCT01352507|76103895|FG001|STARTED|Extension Phase||173||
59650449|NCT03185013|75768540|FG000|Intent-to-Treat (ITT) Population|Overall Study||138|ITT population included all participants who were randomized.|
59650450|NCT03185013|75768541|FG001|Intent-to-Treat (ITT) Population|Overall Study||63|ITT population included all participants who were randomized.|
59650451|NCT03185013|75768540|FG000|Modified ITT (mITT) Population|Overall Study||134|mITT population included all participants who received at least one dose of clinical trial treatment and who had the analysis endpoint of interest.|
59650452|NCT03185013|75768541|FG001|Modified ITT (mITT) Population|Overall Study||63|mITT population included all participants who received at least one dose of clinical trial treatment and who had the analysis endpoint of interest.|
59650453|NCT03185013|75768540|FG000|Safety Population|Overall Study||136|Safety set included all participants who received at least one dose of clinical trial treatment.|
59650454|NCT03185013|75768541|FG001|Safety Population|Overall Study||63|Safety set included all participants who received at least one dose of clinical trial treatment.|
59988679|NCT01352507|76103894|FG000|COMPLETED|Extension Phase||164||
59988680|NCT01352507|76103895|FG001|COMPLETED|Extension Phase||173||
59988681|NCT01352507|76103894|FG000|NOT COMPLETED|Extension Phase||0||
59650455|NCT03185013|75768540|FG000|COMPLETED|Overall Study||116||
59650456|NCT03185013|75768541|FG001|COMPLETED|Overall Study||56||
59650457|NCT03185013|75768540|FG000|NOT COMPLETED|Overall Study||22||
59650458|NCT03185013|75768541|FG001|NOT COMPLETED|Overall Study||7||
59650459|NCT03182907|75768549|FG000|STARTED|Overall Study||111||
59650460|NCT03182907|75768550|FG001|STARTED|Overall Study||37||
59650461|NCT03182907|75768549|FG000|Treated|Overall Study||107||
59650462|NCT03182907|75768550|FG001|Treated|Overall Study||36||
59650463|NCT03182907|75768549|FG000|COMPLETED|Overall Study||103||
59650464|NCT03182907|75768550|FG001|COMPLETED|Overall Study||35||
59650465|NCT03182907|75768549|FG000|NOT COMPLETED|Overall Study||8||
59650466|NCT03182907|75768550|FG001|NOT COMPLETED|Overall Study||2||
59650467|NCT03036813|75768562|FG000|STARTED|Overall Study||92||
59650468|NCT03036813|75768563|FG001|STARTED|Overall Study||90||
59650469|NCT03036813|75768564|FG002|STARTED|Overall Study||92||
59650470|NCT03036813|75768562|FG000|COMPLETED|Overall Study||70||
59650471|NCT03036813|75768563|FG001|COMPLETED|Overall Study||63||
59650472|NCT03036813|75768564|FG002|COMPLETED|Overall Study||66||
59650473|NCT03036813|75768562|FG000|NOT COMPLETED|Overall Study||22||
59650474|NCT03036813|75768563|FG001|NOT COMPLETED|Overall Study||27||
59650475|NCT03036813|75768564|FG002|NOT COMPLETED|Overall Study||26||
59650476|NCT03007953|75768577|FG000|STARTED|Overall Study||73||
59650477|NCT03007953|75768578|FG001|STARTED|Overall Study||78||
59650478|NCT03007953|75768577|FG000|COMPLETED|Overall Study||57||
59650479|NCT03007953|75768578|FG001|COMPLETED|Overall Study||65||
59650480|NCT03007953|75768577|FG000|NOT COMPLETED|Overall Study||16||
59650481|NCT03007953|75768578|FG001|NOT COMPLETED|Overall Study||13||
59650482|NCT02920021|75768586|FG000|STARTED|Overall Study||15||
59650483|NCT02920021|75768587|FG001|STARTED|Overall Study||5||
59650484|NCT02920021|75768586|FG000|COMPLETED|Overall Study||15||
59650485|NCT02920021|75768587|FG001|COMPLETED|Overall Study||5||
59650486|NCT02920021|75768586|FG000|NOT COMPLETED|Overall Study||0||
59650487|NCT02920021|75768587|FG001|NOT COMPLETED|Overall Study||0||
59650488|NCT02919618|75768593|FG000|STARTED|Overall Study||19||
59650489|NCT02919618|75768593|FG000|Primary Safety Endpoint (</=90 Days)|Overall Study||19|Phase 1 - Defined by a </=20% rate of SAEs using CTCAE v4.0 criteria.|
59650490|NCT02919618|75768593|FG000|Primary Efficacy Endpoint (6 Months)|Overall Study||18|Phase 2 - Number of subjects with a reduction in ICD therapies 6mo before and 6mo post-SBRT.|
59650491|NCT02919618|75768593|FG000|COMPLETED|Overall Study||18||
59650492|NCT02919618|75768593|FG000|NOT COMPLETED|Overall Study||1||
59650493|NCT02911701|75768610|FG000|STARTED|Overall Study||50||
59650494|NCT02911701|75768611|FG001|STARTED|Overall Study||50||
59650495|NCT02911701|75768610|FG000|COMPLETED|Overall Study||47||
59650496|NCT02911701|75768611|FG001|COMPLETED|Overall Study||46||
59650497|NCT02911701|75768610|FG000|NOT COMPLETED|Overall Study||3||
59650498|NCT02911701|75768611|FG001|NOT COMPLETED|Overall Study||4||
59650499|NCT02896257|75768621|FG000|STARTED|Providers||88||111
59650500|NCT02896257|75768622|FG001|STARTED|Providers||93||109
59650501|NCT02896257|75768621|FG000|PCPs Assigned to 1 Primary Care Team|Providers||68||68
59650502|NCT02896257|75768622|FG001|PCPs Assigned to 1 Primary Care Team|Providers||79||79
59650503|NCT02896257|75768621|FG000|PCPs Assigned to Two Primary Care Teams|Providers||18||36
59650504|NCT02896257|75768622|FG001|PCPs Assigned to Two Primary Care Teams|Providers||12||24
59988682|NCT01352507|76103895|FG001|NOT COMPLETED|Extension Phase||0||
59650505|NCT02896257|75768621|FG000|PCPs Assigned to 3 Primary Care Teams|Providers||1||3
59650506|NCT02896257|75768622|FG001|PCPs Assigned to 3 Primary Care Teams|Providers||2||6
59650507|NCT02896257|75768621|FG000|PCPs Assigned to Four Primary Care Teams|Providers||1||4
59650508|NCT02896257|75768622|FG001|PCPs Assigned to Four Primary Care Teams|Providers||0||0
59650509|NCT02896257|75768621|FG000|COMPLETED|Providers||67||76
59650510|NCT02896257|75768622|FG001|COMPLETED|Providers||65||72
59650511|NCT02896257|75768621|FG000|NOT COMPLETED|Providers||21||35
59650512|NCT02896257|75768622|FG001|NOT COMPLETED|Providers||28||37
59650513|NCT02896257|75768621|FG000|STARTED|Patients|Eligible patient participants assigned to a usual care PCP=344|344||111
59650514|NCT02896257|75768622|FG001|STARTED|Patients|Eligible patient participants assigned to an intervention PCP=342|342||109
59650515|NCT02896257|75768621|FG000|COMPLETED|Patients|Patients with an eligible primary care appointment with a usual care PCP who were assigned an index date=281|281||76
59650516|NCT02896257|75768622|FG001|COMPLETED|Patients|Patients with an eligible primary care appointment with an intervention PCP who were assigned an index date=269|269||72
59650517|NCT02896257|75768621|FG000|NOT COMPLETED|Patients||63||35
59650518|NCT02896257|75768622|FG001|NOT COMPLETED|Patients||73||37
59650519|NCT02874742|75768632|FG000|STARTED|Overall Study||103||
59650520|NCT02874742|75768633|FG001|STARTED|Overall Study||104||
59650521|NCT02874742|75768634|FG002|STARTED|Overall Study||16||
59650522|NCT02874742|75768632|FG000|Treated (Safety Analysis Set)|Overall Study||101||
59650523|NCT02874742|75768633|FG001|Treated (Safety Analysis Set)|Overall Study||100||
59650524|NCT02874742|75768634|FG002|Treated (Safety Analysis Set)|Overall Study||16||
59650525|NCT02874742|75768632|FG000|COMPLETED|Overall Study||76||
59650526|NCT02874742|75768633|FG001|COMPLETED|Overall Study||88||
59650527|NCT02874742|75768634|FG002|COMPLETED|Overall Study||15||
59650528|NCT02874742|75768632|FG000|NOT COMPLETED|Overall Study||27||
59988683|NCT02361346|76103916|FG000|STARTED|Part 1 and 2 ( Up to Day 112)||3||
59650529|NCT02874742|75768633|FG001|NOT COMPLETED|Overall Study||16||
59650530|NCT02874742|75768634|FG002|NOT COMPLETED|Overall Study||1||
59650531|NCT02749292|75768644|FG000|STARTED|Overall Study||58||
59650532|NCT02749292|75768645|FG001|STARTED|Overall Study||57||
59650533|NCT02749292|75768644|FG000|COMPLETED|Overall Study||36|Subjects who were not withdrawn from the study and reached to common close out of the study.|
59650534|NCT02749292|75768645|FG001|COMPLETED|Overall Study||31|Subjects who were not withdrawn from the study and reached to common close out of the study.|
59650535|NCT02749292|75768644|FG000|NOT COMPLETED|Overall Study||22||
59650536|NCT02749292|75768645|FG001|NOT COMPLETED|Overall Study||26||
59650537|NCT02707744|75768654|FG000|STARTED|Overall Study||50||
59650538|NCT02707744|75768655|FG001|STARTED|Overall Study||50||
59650539|NCT02707744|75768654|FG000|COMPLETED|Overall Study||47||
59650540|NCT02707744|75768655|FG001|COMPLETED|Overall Study||50||
59650541|NCT02707744|75768654|FG000|NOT COMPLETED|Overall Study||3||
59650542|NCT02707744|75768655|FG001|NOT COMPLETED|Overall Study||0||
59650543|NCT02689076|75768664|FG000|STARTED|Overall Study||268||
59650544|NCT02689076|75768665|FG001|STARTED|Overall Study||337||
59650545|NCT02689076|75768666|FG002|STARTED|Overall Study||191||
59650546|NCT02689076|75768664|FG000|COMPLETED|Overall Study||87||
59650547|NCT02689076|75768665|FG001|COMPLETED|Overall Study||115||
59650548|NCT02689076|75768666|FG002|COMPLETED|Overall Study||191||
59650549|NCT02689076|75768664|FG000|NOT COMPLETED|Overall Study||181||
59650550|NCT02689076|75768665|FG001|NOT COMPLETED|Overall Study||222||
59650551|NCT02689076|75768666|FG002|NOT COMPLETED|Overall Study||0||
59650552|NCT02576990|75768676|FG000|STARTED|Overall Study||56||
59650553|NCT02576990|75768677|FG001|STARTED|Overall Study||24||
59650554|NCT02576990|75768676|FG000|Treated|Overall Study||53||
59650555|NCT02576990|75768677|FG001|Treated|Overall Study||23||
59650556|NCT02576990|75768676|FG000|COMPLETED|Overall Study||0||
59650557|NCT02576990|75768677|FG001|COMPLETED|Overall Study||0||
59650558|NCT02576990|75768676|FG000|NOT COMPLETED|Overall Study||56||
59650559|NCT02576990|75768677|FG001|NOT COMPLETED|Overall Study||24||
59650560|NCT02550561|75768683|FG000|STARTED|Overall Study||16||
59650561|NCT02550561|75768683|FG000|COMPLETED|Overall Study||10||
59650562|NCT02550561|75768683|FG000|NOT COMPLETED|Overall Study||6||
59650563|NCT02524171|75768693|FG000|STARTED|6-month Follow-up||172||
59650564|NCT02524171|75768694|FG001|STARTED|6-month Follow-up||169||
59650565|NCT02524171|75768693|FG000|COMPLETED|6-month Follow-up||119||
59650566|NCT02524171|75768694|FG001|COMPLETED|6-month Follow-up||124||
59650567|NCT02524171|75768693|FG000|NOT COMPLETED|6-month Follow-up||53||
59650568|NCT02524171|75768694|FG001|NOT COMPLETED|6-month Follow-up||45||
59650569|NCT02524171|75768693|FG000|STARTED|12-month Follow-up Interview||172||
59650570|NCT02524171|75768694|FG001|STARTED|12-month Follow-up Interview||169||
59650571|NCT02524171|75768693|FG000|COMPLETED|12-month Follow-up Interview||127||
59650572|NCT02524171|75768694|FG001|COMPLETED|12-month Follow-up Interview||128||
59650573|NCT02524171|75768693|FG000|NOT COMPLETED|12-month Follow-up Interview||45||
59650574|NCT02524171|75768694|FG001|NOT COMPLETED|12-month Follow-up Interview||41||
59650575|NCT02511106|75768702|FG000|STARTED|Overall Study||339||
59650576|NCT02511106|75768703|FG001|STARTED|Overall Study||343||
59650577|NCT02511106|75768702|FG000|Received Treatment|Overall Study||337||
59650578|NCT02511106|75768703|FG001|Received Treatment|Overall Study||343||
59650579|NCT02511106|75768702|FG000|COMPLETED|Overall Study||8||
59650580|NCT02511106|75768703|FG001|COMPLETED|Overall Study||20||
59650581|NCT02511106|75768702|FG000|NOT COMPLETED|Overall Study||331||
59650582|NCT02511106|75768703|FG001|NOT COMPLETED|Overall Study||323||
59650583|NCT02500589|75768713|FG000|STARTED|Overall Study||175||
59650584|NCT02500589|75768714|FG001|STARTED|Overall Study||175||
59650585|NCT02500589|75768713|FG000|COMPLETED|Overall Study||147||
59650586|NCT02500589|75768714|FG001|COMPLETED|Overall Study||143||
59650587|NCT02500589|75768713|FG000|NOT COMPLETED|Overall Study||28||
59650588|NCT02500589|75768714|FG001|NOT COMPLETED|Overall Study||32||
59650589|NCT02481830|75768726|FG000|STARTED|Pre-treatment||284|Randomized|
59650590|NCT02481830|75768727|FG001|STARTED|Pre-treatment||285|Randomized|
59650591|NCT02481830|75768726|FG000|COMPLETED|Pre-treatment||282|Treated|
59650592|NCT02481830|75768727|FG001|COMPLETED|Pre-treatment||265|Treated|
59650593|NCT02481830|75768726|FG000|NOT COMPLETED|Pre-treatment||2||
59650594|NCT02481830|75768727|FG001|NOT COMPLETED|Pre-treatment||20||
59650595|NCT02481830|75768726|FG000|STARTED|Treatment||282|Treated|
59815780|NCT03026283|75938214|FG003|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0||
59815781|NCT03026283|75938215|FG004|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0||
59815782|NCT03026283|75938216|FG005|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0||
59815783|NCT03026283|75938217|FG006|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0||
59650596|NCT02481830|75768727|FG001|STARTED|Treatment||265|Treated|
59650597|NCT02481830|75768726|FG000|COMPLETED|Treatment||0||
59650598|NCT02481830|75768727|FG001|COMPLETED|Treatment||0||
59650599|NCT02481830|75768726|FG000|NOT COMPLETED|Treatment||282||
59650600|NCT02481830|75768727|FG001|NOT COMPLETED|Treatment||265||
59650601|NCT02477111|75768733|FG000|STARTED|Overall Study||150||
59650602|NCT02477111|75768733|FG000|COMPLETED|Overall Study|All participants who were assessed for one year|139||
59650603|NCT02477111|75768733|FG000|NOT COMPLETED|Overall Study||11||
59650604|NCT02425943|75768741|FG000|STARTED|Overall Study||557||
59650605|NCT02425943|75768742|FG001|STARTED|Overall Study||310||
59650606|NCT02425943|75768741|FG000|COMPLETED|Overall Study||421||
59650607|NCT02425943|75768742|FG001|COMPLETED|Overall Study||240||
59650608|NCT02425943|75768741|FG000|NOT COMPLETED|Overall Study||136||
59650609|NCT02425943|75768742|FG001|NOT COMPLETED|Overall Study||70||
59650610|NCT02383173|75768752|FG000|STARTED|Overall Study||88||23
59650611|NCT02383173|75768753|FG001|STARTED|Overall Study||46||24
59650612|NCT02383173|75768752|FG000|COMPLETED|Overall Study||88||23
59650613|NCT02383173|75768753|FG001|COMPLETED|Overall Study||44||23
59650614|NCT02383173|75768752|FG000|NOT COMPLETED|Overall Study||0||0
59650615|NCT02383173|75768753|FG001|NOT COMPLETED|Overall Study||2||1
59650616|NCT02380690|75768761|FG000|STARTED|Overall Study||119||
59650617|NCT02380690|75768762|FG001|STARTED|Overall Study||94||
59650618|NCT02380690|75768761|FG000|COMPLETED|Overall Study||85||
59650619|NCT02380690|75768762|FG001|COMPLETED|Overall Study||82||
59650620|NCT02380690|75768761|FG000|NOT COMPLETED|Overall Study||34||
59650621|NCT02380690|75768762|FG001|NOT COMPLETED|Overall Study||12||
59650622|NCT02368132|75768771|FG000|STARTED|Overall Study||112||
59650623|NCT02368132|75768772|FG001|STARTED|Overall Study||122||
59650624|NCT02368132|75768773|FG002|STARTED|Overall Study||85||
59650625|NCT02368132|75768771|FG000|COMPLETED|Overall Study||32|3 Month Follow-Up Completed|
59650626|NCT02368132|75768772|FG001|COMPLETED|Overall Study||71|3 Month Follow-Up Completed|
59650627|NCT02368132|75768773|FG002|COMPLETED|Overall Study||50|3 Month Follow-Up Completed|
59650628|NCT02368132|75768771|FG000|NOT COMPLETED|Overall Study||80||
59650629|NCT02368132|75768772|FG001|NOT COMPLETED|Overall Study||51||
59650630|NCT02368132|75768773|FG002|NOT COMPLETED|Overall Study||35||
59650631|NCT02362997|75768784|FG000|STARTED|Overall Study||31||
59650632|NCT02362997|75768785|FG001|STARTED|Overall Study||30||
59650633|NCT02362997|75768786|FG002|STARTED|Overall Study||21||
59650634|NCT02362997|75768784|FG000|COMPLETED|Overall Study||31||
59650635|NCT02362997|75768785|FG001|COMPLETED|Overall Study||30||
59650636|NCT02362997|75768786|FG002|COMPLETED|Overall Study||21||
59650637|NCT02362997|75768784|FG000|NOT COMPLETED|Overall Study||0||
59650638|NCT02362997|75768785|FG001|NOT COMPLETED|Overall Study||0||
59650639|NCT02362997|75768786|FG002|NOT COMPLETED|Overall Study||0||
59650640|NCT02311673|75768804|FG000|STARTED|Placebo Run-in Period 1 (2 Weeks)||0||
59650641|NCT02311673|75768805|FG001|STARTED|Placebo Run-in Period 1 (2 Weeks)||0||
59650642|NCT02311673|75768806|FG002|STARTED|Placebo Run-in Period 1 (2 Weeks)||0||
59650643|NCT02311673|75768807|FG003|STARTED|Placebo Run-in Period 1 (2 Weeks)||40||
59650644|NCT02311673|75768804|FG000|COMPLETED|Placebo Run-in Period 1 (2 Weeks)||0||
59650645|NCT02311673|75768805|FG001|COMPLETED|Placebo Run-in Period 1 (2 Weeks)||0||
59650646|NCT02311673|75768806|FG002|COMPLETED|Placebo Run-in Period 1 (2 Weeks)||0||
59650647|NCT02311673|75768807|FG003|COMPLETED|Placebo Run-in Period 1 (2 Weeks)||40||
59650648|NCT02311673|75768804|FG000|NOT COMPLETED|Placebo Run-in Period 1 (2 Weeks)||0||
59650649|NCT02311673|75768805|FG001|NOT COMPLETED|Placebo Run-in Period 1 (2 Weeks)||0||
59650650|NCT02311673|75768806|FG002|NOT COMPLETED|Placebo Run-in Period 1 (2 Weeks)||0||
59650651|NCT02311673|75768807|FG003|NOT COMPLETED|Placebo Run-in Period 1 (2 Weeks)||0||
59650652|NCT02311673|75768804|FG000|STARTED|Double-blind Randomized Period 2 (4 Wks)||4|Forty participants who completed placebo single-blind run-in period entered the double-blind randomized treatment period. Fifteen participants continued placebo and 25 participants were randomized to other treatment groups in the double-blind randomized treatment period.|
59650653|NCT02311673|75768805|FG001|STARTED|Double-blind Randomized Period 2 (4 Wks)|One participant was randomized to setmelanotide 2.5 mg treatment group and treated with setmelanotide 1.5 mg group.|13|Forty participants who completed placebo single-blind run-in period entered the double-blind randomized treatment period. Fifteen participants continued placebo and 25 participants were randomized to other treatment groups in the double-blind randomized treatment period.|
59650654|NCT02311673|75768806|FG002|STARTED|Double-blind Randomized Period 2 (4 Wks)||8|Forty participants who completed placebo single-blind run-in period entered the double-blind randomized treatment period. Fifteen participants continued placebo and 25 participants were randomized to other treatment groups in the double-blind randomized treatment period.|
59650655|NCT02311673|75768807|FG003|STARTED|Double-blind Randomized Period 2 (4 Wks)|One participant was randomized to setmelanotide 2.5 mg treatment group and treated with placebo.|15|Forty participants who completed placebo single-blind run-in period entered the double-blind randomized treatment period. Fifteen participants continued placebo and 25 participants were randomized to other treatment groups in the double-blind randomized treatment period.|
59650656|NCT02311673|75768804|FG000|COMPLETED|Double-blind Randomized Period 2 (4 Wks)||4||
59650657|NCT02311673|75768805|FG001|COMPLETED|Double-blind Randomized Period 2 (4 Wks)||13||
59650658|NCT02311673|75768806|FG002|COMPLETED|Double-blind Randomized Period 2 (4 Wks)||7||
59650659|NCT02311673|75768807|FG003|COMPLETED|Double-blind Randomized Period 2 (4 Wks)||15||
59650660|NCT02311673|75768804|FG000|NOT COMPLETED|Double-blind Randomized Period 2 (4 Wks)||0||
59650661|NCT02311673|75768805|FG001|NOT COMPLETED|Double-blind Randomized Period 2 (4 Wks)||0||
59650662|NCT02311673|75768806|FG002|NOT COMPLETED|Double-blind Randomized Period 2 (4 Wks)||1||
59650663|NCT02311673|75768807|FG003|NOT COMPLETED|Double-blind Randomized Period 2 (4 Wks)||0||
59650664|NCT02311673|75768804|FG000|STARTED|Randomized Withdrawal Period 3 (2 Weeks)||3|After completion of Period 2, a randomized withdrawal (Period 3) was initiated; participants within each of the setmelanotide groups were randomized 1:1; participants who had received setmelanotide were either continued at the current active dose, or switched to placebo treatment. Participants administered placebo during Period 2 were randomized 1:1 in Period 3 and either continued to receive placebo or began to receive setmelanotide.|
59650665|NCT02311673|75768805|FG001|STARTED|Randomized Withdrawal Period 3 (2 Weeks)||10|After completion of Period 2, a randomized withdrawal (Period 3) was initiated; participants within each of the setmelanotide groups were randomized 1:1; participants who had received setmelanotide were either continued at the current active dose, or switched to placebo treatment. Participants administered placebo during Period 2 were randomized 1:1 in Period 3 and either continued to receive placebo or began to receive setmelanotide.|
59650666|NCT02311673|75768806|FG002|STARTED|Randomized Withdrawal Period 3 (2 Weeks)||5|After completion of Period 2, a randomized withdrawal (Period 3) was initiated; participants within each of the setmelanotide groups were randomized 1:1; participants who had received setmelanotide were either continued at the current active dose, or switched to placebo treatment. Participants administered placebo during Period 2 were randomized 1:1 in Period 3 and either continued to receive placebo or began to receive setmelanotide.|
59650667|NCT02311673|75768807|FG003|STARTED|Randomized Withdrawal Period 3 (2 Weeks)||20|After completion of Period 2, a randomized withdrawal (Period 3) was initiated; participants within each of the setmelanotide groups were randomized 1:1; participants who had received setmelanotide were either continued at the current active dose, or switched to placebo treatment. Participants administered placebo during Period 2 were randomized 1:1 in Period 3 and either continued to receive placebo or began to receive setmelanotide.|
59650668|NCT02311673|75768804|FG000|COMPLETED|Randomized Withdrawal Period 3 (2 Weeks)||3||
59650669|NCT02311673|75768805|FG001|COMPLETED|Randomized Withdrawal Period 3 (2 Weeks)||10||
59650670|NCT02311673|75768806|FG002|COMPLETED|Randomized Withdrawal Period 3 (2 Weeks)||5||
59650671|NCT02311673|75768807|FG003|COMPLETED|Randomized Withdrawal Period 3 (2 Weeks)||20||
59650672|NCT02311673|75768804|FG000|NOT COMPLETED|Randomized Withdrawal Period 3 (2 Weeks)||0||
59650673|NCT02311673|75768805|FG001|NOT COMPLETED|Randomized Withdrawal Period 3 (2 Weeks)||0||
59650674|NCT02311673|75768806|FG002|NOT COMPLETED|Randomized Withdrawal Period 3 (2 Weeks)||0||
59650675|NCT02311673|75768807|FG003|NOT COMPLETED|Randomized Withdrawal Period 3 (2 Weeks)||0||
59650676|NCT02311673|75768804|FG000|STARTED|Open-label Extension Period 4 (2 Weeks)||0|Period 4 was a follow-up, open-label extension available to participants who completed the first 3 periods and wanted to continue treatment. In Period 4, all participants were to receive either setmelanotide 1.5 mg or setmelanotide 2.5 mg.|
59650677|NCT02311673|75768805|FG001|STARTED|Open-label Extension Period 4 (2 Weeks)|Three participants were randomized to setmelanotide 2.5 mg treatment group and treated with setmelanotide 1.5 mg.|22|Period 4 was a follow-up, open-label extension available to participants who completed the first 3 periods and wanted to continue treatment. In Period 4, all participants were to receive either setmelanotide 1.5 mg or setmelanotide 2.5 mg.|
59650678|NCT02311673|75768806|FG002|STARTED|Open-label Extension Period 4 (2 Weeks)||16|Period 4 was a follow-up, open-label extension available to participants who completed the first 3 periods and wanted to continue treatment. In Period 4, all participants were to receive either setmelanotide 1.5 mg or setmelanotide 2.5 mg.|
59650679|NCT02311673|75768807|FG003|STARTED|Open-label Extension Period 4 (2 Weeks)|"One participant advanced from the Double-blind Randomized Treatment Period (Period 2) to the Open-Label Extension Period (Period 4) due to an error in the interactive voice response system (IVRS); therefore, results are presented for 38 participants in Randomized Withdrawal Period (Period 3) but 39 participants in the Open-Label Extension Period (Period 4).~The participant was randomized to setmelanotide 2.5 mg treatment group and treated with placebo."|1|Period 4 was a follow-up, open-label extension available to participants who completed the first 3 periods and wanted to continue treatment. In Period 4, all participants were to receive either setmelanotide 1.5 mg or setmelanotide 2.5 mg.|
59650680|NCT02311673|75768804|FG000|COMPLETED|Open-label Extension Period 4 (2 Weeks)||0||
59650681|NCT02311673|75768805|FG001|COMPLETED|Open-label Extension Period 4 (2 Weeks)||22||
59650682|NCT02311673|75768806|FG002|COMPLETED|Open-label Extension Period 4 (2 Weeks)||16||
59650683|NCT02311673|75768807|FG003|COMPLETED|Open-label Extension Period 4 (2 Weeks)||1||
59650684|NCT02311673|75768804|FG000|NOT COMPLETED|Open-label Extension Period 4 (2 Weeks)||0||
59650685|NCT02311673|75768805|FG001|NOT COMPLETED|Open-label Extension Period 4 (2 Weeks)||0||
59650686|NCT02311673|75768806|FG002|NOT COMPLETED|Open-label Extension Period 4 (2 Weeks)||0||
59650687|NCT02311673|75768807|FG003|NOT COMPLETED|Open-label Extension Period 4 (2 Weeks)||0||
59650688|NCT02233738|75768841|FG000|STARTED|Overall Study||93||
59650689|NCT02233738|75768842|FG001|STARTED|Overall Study||91||
59650690|NCT02233738|75768841|FG000|1 Month Follow-Up|Overall Study||89||
59650691|NCT02233738|75768842|FG001|1 Month Follow-Up|Overall Study||82||
59650692|NCT02233738|75768841|FG000|3 Month Follow-Up|Overall Study||87||
59650693|NCT02233738|75768842|FG001|3 Month Follow-Up|Overall Study||77||
59650694|NCT02233738|75768841|FG000|6 Month Follow-Up|Overall Study||85||
59650695|NCT02233738|75768842|FG001|6 Month Follow-Up|Overall Study||75||
59650696|NCT02233738|75768841|FG000|COMPLETED|Overall Study||85||
59650697|NCT02233738|75768842|FG001|COMPLETED|Overall Study||75||
59650698|NCT02233738|75768841|FG000|NOT COMPLETED|Overall Study||8||
59650699|NCT02233738|75768842|FG001|NOT COMPLETED|Overall Study||16||
59650700|NCT02123121|75769013|FG000|STARTED|Overall Study||20||
59650701|NCT02123121|75769014|FG001|STARTED|Overall Study||21||
59650702|NCT02123121|75769015|FG002|STARTED|Overall Study||19||
59650703|NCT02123121|75769013|FG000|COMPLETED|Overall Study||18||
59650704|NCT02123121|75769014|FG001|COMPLETED|Overall Study||20||
59650705|NCT02123121|75769015|FG002|COMPLETED|Overall Study||16||
59650706|NCT02123121|75769013|FG000|NOT COMPLETED|Overall Study||2||
59650707|NCT02123121|75769014|FG001|NOT COMPLETED|Overall Study||1||
59650708|NCT02123121|75769015|FG002|NOT COMPLETED|Overall Study||3||
59650709|NCT01959698|75769030|FG000|STARTED|Overall Study||3||
59650710|NCT01959698|75769031|FG001|STARTED|Overall Study||3||
59650711|NCT01959698|75769032|FG002|STARTED|Overall Study||3||
59650712|NCT01959698|75769033|FG003|STARTED|Overall Study||3||
59650713|NCT01959698|75769034|FG004|STARTED|Overall Study||3||
59650714|NCT01959698|75769035|FG005|STARTED|Overall Study||6||
59650715|NCT01959698|75769036|FG006|STARTED|Overall Study||8||
59650716|NCT01959698|75769030|FG000|COMPLETED|Overall Study||2||
59650717|NCT01959698|75769031|FG001|COMPLETED|Overall Study||3||
59650718|NCT01959698|75769032|FG002|COMPLETED|Overall Study||2||
59650719|NCT01959698|75769033|FG003|COMPLETED|Overall Study||1||
59650720|NCT01959698|75769034|FG004|COMPLETED|Overall Study||3||
59650721|NCT01959698|75769035|FG005|COMPLETED|Overall Study||3||
59650722|NCT01959698|75769036|FG006|COMPLETED|Overall Study||4||
59650723|NCT01959698|75769030|FG000|NOT COMPLETED|Overall Study||1||
59650724|NCT01959698|75769031|FG001|NOT COMPLETED|Overall Study||0||
59650725|NCT01959698|75769032|FG002|NOT COMPLETED|Overall Study||1||
59650726|NCT01959698|75769033|FG003|NOT COMPLETED|Overall Study||2||
59650727|NCT01959698|75769034|FG004|NOT COMPLETED|Overall Study||0||
59650728|NCT01959698|75769035|FG005|NOT COMPLETED|Overall Study||3||
59650729|NCT01959698|75769036|FG006|NOT COMPLETED|Overall Study||4||
59650730|NCT01910402|75769055|FG000|STARTED|Randomized Phase (Up to 48 Weeks)||250|Randomized|
59650731|NCT01910402|75769056|FG001|STARTED|Randomized Phase (Up to 48 Weeks)||249|Randomized|
59650732|NCT01910402|75769057|FG002|STARTED|Randomized Phase (Up to 48 Weeks)||0|Randomized|
59650733|NCT01910402|75769055|FG000|ITT-E Population|Randomized Phase (Up to 48 Weeks)||248||
59650734|NCT01910402|75769056|FG001|ITT-E Population|Randomized Phase (Up to 48 Weeks)||247||
59650735|NCT01910402|75769057|FG002|ITT-E Population|Randomized Phase (Up to 48 Weeks)||0||
59650736|NCT01910402|75769055|FG000|COMPLETED|Randomized Phase (Up to 48 Weeks)||206||
59650737|NCT01910402|75769056|FG001|COMPLETED|Randomized Phase (Up to 48 Weeks)||192||
59650738|NCT01910402|75769057|FG002|COMPLETED|Randomized Phase (Up to 48 Weeks)||0||
59650739|NCT01910402|75769055|FG000|NOT COMPLETED|Randomized Phase (Up to 48 Weeks)||44||
59650740|NCT01910402|75769056|FG001|NOT COMPLETED|Randomized Phase (Up to 48 Weeks)||57||
59650741|NCT01910402|75769057|FG002|NOT COMPLETED|Randomized Phase (Up to 48 Weeks)||0||
59650742|NCT01910402|75769055|FG000|STARTED|Continuation Phase(From Weeks 48 to 432)||0||
59650743|NCT01910402|75769056|FG001|STARTED|Continuation Phase(From Weeks 48 to 432)||0||
59650744|NCT01910402|75769057|FG002|STARTED|Continuation Phase(From Weeks 48 to 432)|149 participants from the Randomized Phase entered in the Continuation Phase|149||
59650745|NCT01910402|75769055|FG000|COMPLETED|Continuation Phase(From Weeks 48 to 432)||0||
59650746|NCT01910402|75769056|FG001|COMPLETED|Continuation Phase(From Weeks 48 to 432)||0||
59650747|NCT01910402|75769057|FG002|COMPLETED|Continuation Phase(From Weeks 48 to 432)||113||
59650748|NCT01910402|75769055|FG000|NOT COMPLETED|Continuation Phase(From Weeks 48 to 432)||0||
59650749|NCT01910402|75769056|FG001|NOT COMPLETED|Continuation Phase(From Weeks 48 to 432)||0||
59650750|NCT01910402|75769057|FG002|NOT COMPLETED|Continuation Phase(From Weeks 48 to 432)||36||
59650751|NCT01772420|75769071|FG000|STARTED|Overall Study||16||
60076873|NCT01925989|76191896|FG000|COMPLETED|Period 1||6||
60076874|NCT01925989|76191897|FG001|COMPLETED|Period 1||6||
60076875|NCT01925989|76191898|FG002|COMPLETED|Period 1||12||
60076876|NCT01925989|76191896|FG000|NOT COMPLETED|Period 1||1||
60076877|NCT01925989|76191897|FG001|NOT COMPLETED|Period 1||2||
59650752|NCT01772420|75769072|FG001|STARTED|Overall Study||15||
59650753|NCT01772420|75769073|FG002|STARTED|Overall Study||21||
59650754|NCT01772420|75769071|FG000|COMPLETED|Overall Study||16||
59650755|NCT01772420|75769072|FG001|COMPLETED|Overall Study||15||
59650756|NCT01772420|75769073|FG002|COMPLETED|Overall Study||21||
59650757|NCT01772420|75769071|FG000|NOT COMPLETED|Overall Study||0||
60076878|NCT01925989|76191898|FG002|NOT COMPLETED|Period 1||0||
60076879|NCT01925989|76191896|FG000|STARTED|Period 2||6||
60076880|NCT01925989|76191897|FG001|STARTED|Period 2||6||
59650758|NCT01772420|75769072|FG001|NOT COMPLETED|Overall Study||0||
59650759|NCT01772420|75769073|FG002|NOT COMPLETED|Overall Study||0||
59650760|NCT01614197|75769086|FG000|STARTED|Overall Study||3||
60076881|NCT01925989|76191898|FG002|STARTED|Period 2||12||
60076882|NCT01925989|76191896|FG000|COMPLETED|Period 2||6||
59650761|NCT01614197|75769087|FG001|STARTED|Overall Study||4||
59650762|NCT01614197|75769088|FG002|STARTED|Overall Study||6||
59650763|NCT01614197|75769089|FG003|STARTED|Overall Study||3||
59650764|NCT01614197|75769086|FG000|COMPLETED|Overall Study||3||
59650765|NCT01614197|75769087|FG001|COMPLETED|Overall Study||3||
59650766|NCT01614197|75769088|FG002|COMPLETED|Overall Study||6||
59650767|NCT01614197|75769089|FG003|COMPLETED|Overall Study||3||
59650768|NCT01614197|75769086|FG000|NOT COMPLETED|Overall Study||0||
59650769|NCT01614197|75769087|FG001|NOT COMPLETED|Overall Study||1||
59650770|NCT01614197|75769088|FG002|NOT COMPLETED|Overall Study||0||
59650771|NCT01614197|75769089|FG003|NOT COMPLETED|Overall Study||0||
59650772|NCT01341964|75769101|FG000|STARTED|Overall Study||152||
59650773|NCT01341964|75769102|FG001|STARTED|Overall Study||150||
59650774|NCT01341964|75769101|FG000|COMPLETED|Overall Study||152||
59650775|NCT01341964|75769102|FG001|COMPLETED|Overall Study||150||
59650776|NCT01341964|75769101|FG000|NOT COMPLETED|Overall Study||0||
59650777|NCT01341964|75769102|FG001|NOT COMPLETED|Overall Study||0||
59650778|NCT01267812|75769108|FG000|STARTED|Overall Study||23||
59650779|NCT01267812|75769108|FG000|COMPLETED|Overall Study||23||
59650780|NCT01267812|75769108|FG000|NOT COMPLETED|Overall Study||0||
59650781|NCT01247974|75769114|FG000|STARTED|Overall Study||217||
59650782|NCT01247974|75769115|FG001|STARTED|Overall Study||222||
59650783|NCT01247974|75769114|FG000|COMPLETED|Overall Study||191||
59650784|NCT01247974|75769115|FG001|COMPLETED|Overall Study||203||
59650785|NCT01247974|75769114|FG000|NOT COMPLETED|Overall Study||26||
59650786|NCT01247974|75769115|FG001|NOT COMPLETED|Overall Study||19||
59650787|NCT01236521|75769123|FG000|STARTED|Overall Study||131||
59650788|NCT01236521|75769124|FG001|STARTED|Overall Study||130||
59650789|NCT01236521|75769123|FG000|3-month Completed|Overall Study||122||
59650790|NCT01236521|75769124|FG001|3-month Completed|Overall Study||118||
59650791|NCT01236521|75769123|FG000|6-month Completed|Overall Study||121||
59650792|NCT01236521|75769124|FG001|6-month Completed|Overall Study||114||
59650793|NCT01236521|75769123|FG000|9-month Completed|Overall Study||105||
59650794|NCT01236521|75769124|FG001|9-month Completed|Overall Study||98||
59650795|NCT01236521|75769123|FG000|12-moth Completed|Overall Study||108||
59650796|NCT01236521|75769124|FG001|12-moth Completed|Overall Study||105||
59650797|NCT01236521|75769123|FG000|COMPLETED|Overall Study||108||
59650798|NCT01236521|75769124|FG001|COMPLETED|Overall Study||105||
59650799|NCT01236521|75769123|FG000|NOT COMPLETED|Overall Study||23||
59650800|NCT01236521|75769124|FG001|NOT COMPLETED|Overall Study||25||
59650801|NCT01226797|75769132|FG000|STARTED|Overall Study||12||
59650802|NCT01226797|75769133|FG001|STARTED|Overall Study||12||
59650803|NCT01226797|75769132|FG000|COMPLETED|Overall Study||10||
59650804|NCT01226797|75769133|FG001|COMPLETED|Overall Study||11||
59650805|NCT01226797|75769132|FG000|NOT COMPLETED|Overall Study||2||
59650806|NCT01226797|75769133|FG001|NOT COMPLETED|Overall Study||1||
59650807|NCT01142908|75769141|FG000|STARTED|Overall Study||215||
59650808|NCT01142908|75769142|FG001|STARTED|Overall Study||213||
59650809|NCT01142908|75769141|FG000|6 Month f/u|Overall Study||188||
59650810|NCT01142908|75769142|FG001|6 Month f/u|Overall Study||196||
59650811|NCT01142908|75769141|FG000|COMPLETED|Overall Study||183||
59650812|NCT01142908|75769142|FG001|COMPLETED|Overall Study||191||
59650813|NCT01142908|75769141|FG000|NOT COMPLETED|Overall Study||32||
59650814|NCT01142908|75769142|FG001|NOT COMPLETED|Overall Study||22||
59650815|NCT00544115|75769154|FG000|STARTED|Overall Study||62||
59650816|NCT00544115|75769155|FG001|STARTED|Overall Study||17||
59650817|NCT00544115|75769156|FG002|STARTED|Overall Study||130||
59650818|NCT00544115|75769157|FG003|STARTED|Overall Study||4||
59650819|NCT00544115|75769158|FG004|STARTED|Overall Study||40||
59650820|NCT00544115|75769159|FG005|STARTED|Overall Study||2||
59650821|NCT00544115|75769154|FG000|COMPLETED|Overall Study||62||
59650822|NCT00544115|75769155|FG001|COMPLETED|Overall Study||17||
59650823|NCT00544115|75769156|FG002|COMPLETED|Overall Study||130||
59650824|NCT00544115|75769157|FG003|COMPLETED|Overall Study||4||
59650825|NCT00544115|75769158|FG004|COMPLETED|Overall Study||40||
59815784|NCT03026283|75938218|FG007|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0||
59650826|NCT00544115|75769159|FG005|COMPLETED|Overall Study||2||
59650827|NCT00544115|75769154|FG000|NOT COMPLETED|Overall Study||0||
59650828|NCT00544115|75769155|FG001|NOT COMPLETED|Overall Study||0||
59650829|NCT00544115|75769156|FG002|NOT COMPLETED|Overall Study||0||
59650830|NCT00544115|75769157|FG003|NOT COMPLETED|Overall Study||0||
59650831|NCT00544115|75769158|FG004|NOT COMPLETED|Overall Study||0||
59650832|NCT00544115|75769159|FG005|NOT COMPLETED|Overall Study||0||
59650833|NCT00150488|75769173|FG000|STARTED|Overall Study||53||
59650834|NCT00150488|75769173|FG000|COMPLETED|Overall Study||53||
59650835|NCT00150488|75769173|FG000|NOT COMPLETED|Overall Study||0||
59650836|NCT05569148|75769178|FG000|STARTED|Overall Study||35||
59650837|NCT05569148|75769178|FG000|COMPLETED|Overall Study||35||
59650838|NCT05569148|75769178|FG000|NOT COMPLETED|Overall Study||0||
59650839|NCT05286450|75769182|FG000|STARTED|Overall Study||153||
59650840|NCT05286450|75769182|FG000|COMPLETED|Overall Study||153||
59650841|NCT05286450|75769182|FG000|NOT COMPLETED|Overall Study||0||
59650842|NCT05011890|75769187|FG000|STARTED|Overall Study||41||
59650843|NCT05011890|75769187|FG000|COMPLETED|Overall Study||41|Forty-one participants completed the baseline assessment and thirty- three subjects completed the six-month evaluation.|
59650844|NCT05011890|75769187|FG000|NOT COMPLETED|Overall Study||0||
59650845|NCT04962230|75769191|FG000|STARTED|PF-07321332 300 mg/Ritonavir 100 mg||12||
59650846|NCT04962230|75769191|FG000|COMPLETED|PF-07321332 300 mg/Ritonavir 100 mg||12||
59650847|NCT04962230|75769191|FG000|NOT COMPLETED|PF-07321332 300 mg/Ritonavir 100 mg||0||
59650848|NCT04962230|75769191|FG000|STARTED|Carbamazepine+PF-07321332/Ritonavir||12||
59650849|NCT04962230|75769191|FG000|COMPLETED|Carbamazepine+PF-07321332/Ritonavir||10||
59650850|NCT04962230|75769191|FG000|NOT COMPLETED|Carbamazepine+PF-07321332/Ritonavir||2||
59650851|NCT04947150|75769215|FG000|STARTED|Overall Study||4||
59650852|NCT04947150|75769216|FG001|STARTED|Overall Study||7||
59650853|NCT04947150|75769217|FG002|STARTED|Overall Study||2||
59650854|NCT04947150|75769218|FG003|STARTED|Overall Study||2||
59650855|NCT04947150|75769219|FG004|STARTED|Overall Study||7||
59650856|NCT04947150|75769220|FG005|STARTED|Overall Study||2||
59650857|NCT04947150|75769221|FG006|STARTED|Overall Study||5||
59650858|NCT04947150|75769222|FG007|STARTED|Overall Study||2||
59650859|NCT04947150|75769223|FG008|STARTED|Overall Study||3||
59650860|NCT04947150|75769224|FG009|STARTED|Overall Study||5||
59650861|NCT04947150|75769225|FG010|STARTED|Overall Study||6||
59650862|NCT04947150|75769226|FG011|STARTED|Overall Study||2||
59650863|NCT04947150|75769227|FG012|STARTED|Overall Study||5||
59650864|NCT04947150|75769228|FG013|STARTED|Overall Study||2||
59650865|NCT04947150|75769229|FG014|STARTED|Overall Study||4||
59650866|NCT04947150|75769230|FG015|STARTED|Overall Study||4||
59650867|NCT04947150|75769215|FG000|Wave 1|Overall Study||2||
59650868|NCT04947150|75769216|FG001|Wave 1|Overall Study||2||
59650869|NCT04947150|75769217|FG002|Wave 1|Overall Study||1||
59650870|NCT04947150|75769218|FG003|Wave 1|Overall Study||2||
59650871|NCT04947150|75769219|FG004|Wave 1|Overall Study||2||
59650872|NCT04947150|75769220|FG005|Wave 1|Overall Study||2||
59650873|NCT04947150|75769221|FG006|Wave 1|Overall Study||2||
59650874|NCT04947150|75769222|FG007|Wave 1|Overall Study||1||
59650875|NCT04947150|75769223|FG008|Wave 1|Overall Study||2||
59650876|NCT04947150|75769224|FG009|Wave 1|Overall Study||2||
59650877|NCT04947150|75769225|FG010|Wave 1|Overall Study||2||
59650878|NCT04947150|75769226|FG011|Wave 1|Overall Study||1||
59650879|NCT04947150|75769227|FG012|Wave 1|Overall Study||2||
59650880|NCT04947150|75769228|FG013|Wave 1|Overall Study||1||
59650881|NCT04947150|75769229|FG014|Wave 1|Overall Study||2||
59650882|NCT04947150|75769230|FG015|Wave 1|Overall Study||2||
59650883|NCT04947150|75769215|FG000|Wave 2|Overall Study||2||
59650884|NCT04947150|75769216|FG001|Wave 2|Overall Study||5||
59650885|NCT04947150|75769217|FG002|Wave 2|Overall Study||1||
59650886|NCT04947150|75769218|FG003|Wave 2|Overall Study||0||
59650887|NCT04947150|75769219|FG004|Wave 2|Overall Study||5||
59650888|NCT04947150|75769220|FG005|Wave 2|Overall Study||0||
59650889|NCT04947150|75769221|FG006|Wave 2|Overall Study||3||
59650890|NCT04947150|75769222|FG007|Wave 2|Overall Study||1||
59650891|NCT04947150|75769223|FG008|Wave 2|Overall Study||1||
59650892|NCT04947150|75769224|FG009|Wave 2|Overall Study||3||
59650893|NCT04947150|75769225|FG010|Wave 2|Overall Study||4||
59650894|NCT04947150|75769226|FG011|Wave 2|Overall Study||1||
59650895|NCT04947150|75769227|FG012|Wave 2|Overall Study||3||
59650896|NCT04947150|75769228|FG013|Wave 2|Overall Study||1||
59650897|NCT04947150|75769229|FG014|Wave 2|Overall Study||2||
59650898|NCT04947150|75769230|FG015|Wave 2|Overall Study||2||
59650899|NCT04947150|75769215|FG000|COMPLETED|Overall Study||4||
59650900|NCT04947150|75769216|FG001|COMPLETED|Overall Study||7||
59650901|NCT04947150|75769217|FG002|COMPLETED|Overall Study||1||
59650902|NCT04947150|75769218|FG003|COMPLETED|Overall Study||2||
59650903|NCT04947150|75769219|FG004|COMPLETED|Overall Study||7||
59650904|NCT04947150|75769220|FG005|COMPLETED|Overall Study||0||
59650905|NCT04947150|75769221|FG006|COMPLETED|Overall Study||4||
59650906|NCT04947150|75769222|FG007|COMPLETED|Overall Study||2||
59650907|NCT04947150|75769223|FG008|COMPLETED|Overall Study||3||
59650908|NCT04947150|75769224|FG009|COMPLETED|Overall Study||5||
59650909|NCT04947150|75769225|FG010|COMPLETED|Overall Study||5||
59650910|NCT04947150|75769226|FG011|COMPLETED|Overall Study||1||
59650911|NCT04947150|75769227|FG012|COMPLETED|Overall Study||5||
59650912|NCT04947150|75769228|FG013|COMPLETED|Overall Study||1||
59650913|NCT04947150|75769229|FG014|COMPLETED|Overall Study||4||
59650914|NCT04947150|75769230|FG015|COMPLETED|Overall Study||4||
59650915|NCT04947150|75769215|FG000|NOT COMPLETED|Overall Study||0||
59650916|NCT04947150|75769216|FG001|NOT COMPLETED|Overall Study||0||
59650917|NCT04947150|75769217|FG002|NOT COMPLETED|Overall Study||1||
59650918|NCT04947150|75769218|FG003|NOT COMPLETED|Overall Study||0||
59650919|NCT04947150|75769219|FG004|NOT COMPLETED|Overall Study||0||
59650920|NCT04947150|75769220|FG005|NOT COMPLETED|Overall Study||2||
59650921|NCT04947150|75769221|FG006|NOT COMPLETED|Overall Study||1||
59650922|NCT04947150|75769222|FG007|NOT COMPLETED|Overall Study||0||
59650923|NCT04947150|75769223|FG008|NOT COMPLETED|Overall Study||0||
59650924|NCT04947150|75769224|FG009|NOT COMPLETED|Overall Study||0||
59650925|NCT04947150|75769225|FG010|NOT COMPLETED|Overall Study||1||
59650926|NCT04947150|75769226|FG011|NOT COMPLETED|Overall Study||1||
59650927|NCT04947150|75769227|FG012|NOT COMPLETED|Overall Study||0||
59650928|NCT04947150|75769228|FG013|NOT COMPLETED|Overall Study||1||
59650929|NCT04947150|75769229|FG014|NOT COMPLETED|Overall Study||0||
59650930|NCT04947150|75769230|FG015|NOT COMPLETED|Overall Study||0||
59650931|NCT04919317|75769272|FG000|STARTED|Hospitalization and Wound Follow-up||26||
59650932|NCT04919317|75769273|FG001|STARTED|Hospitalization and Wound Follow-up||30||
59650933|NCT04919317|75769272|FG000|COMPLETED|Hospitalization and Wound Follow-up||26||
59650934|NCT04919317|75769273|FG001|COMPLETED|Hospitalization and Wound Follow-up|5 patients completed the study but should not have been enrolled as they met pre-study exclusion criteria (chronic pain due to fibromyalgia)|25||
59650935|NCT04919317|75769272|FG000|NOT COMPLETED|Hospitalization and Wound Follow-up||0||
59650936|NCT04919317|75769273|FG001|NOT COMPLETED|Hospitalization and Wound Follow-up||5||
59650937|NCT04919317|75769272|FG000|STARTED|SF-36 Quality of Life Survey Completion||26||
59650938|NCT04919317|75769273|FG001|STARTED|SF-36 Quality of Life Survey Completion||25||
59650939|NCT04919317|75769272|FG000|COMPLETED|SF-36 Quality of Life Survey Completion||14||
59650940|NCT04919317|75769273|FG001|COMPLETED|SF-36 Quality of Life Survey Completion||19||
59650941|NCT04919317|75769272|FG000|NOT COMPLETED|SF-36 Quality of Life Survey Completion||12||
59650942|NCT04919317|75769273|FG001|NOT COMPLETED|SF-36 Quality of Life Survey Completion||6||
59650943|NCT04806165|75769295|FG000|STARTED|Overall Study||13||
59650944|NCT04806165|75769296|FG001|STARTED|Overall Study||12||
59650945|NCT04806165|75769297|FG002|STARTED|Overall Study||11||
59650946|NCT04806165|75769298|FG003|STARTED|Overall Study||14||
59650947|NCT04806165|75769299|FG004|STARTED|Overall Study||13||
59650948|NCT04806165|75769300|FG005|STARTED|Overall Study||13||
59650949|NCT04806165|75769301|FG006|STARTED|Overall Study||14||
59650950|NCT04806165|75769302|FG007|STARTED|Overall Study||13||
59650951|NCT04806165|75769303|FG008|STARTED|Overall Study||13||
59650952|NCT04806165|75769304|FG009|STARTED|Overall Study||12||
59650953|NCT04806165|75769305|FG010|STARTED|Overall Study||13||
59650954|NCT04806165|75769306|FG011|STARTED|Overall Study||13||
59650955|NCT04806165|75769307|FG012|STARTED|Overall Study||13||
59650956|NCT04806165|75769308|FG013|STARTED|Overall Study||13||
59650957|NCT04806165|75769309|FG014|STARTED|Overall Study||12||
59650958|NCT04806165|75769310|FG015|STARTED|Overall Study||13||
59650959|NCT04806165|75769295|FG000|Completed 2-Week Follow-Up Assessment|Overall Study||10||
59650960|NCT04806165|75769296|FG001|Completed 2-Week Follow-Up Assessment|Overall Study||9||
59650961|NCT04806165|75769297|FG002|Completed 2-Week Follow-Up Assessment|Overall Study||10||
59650962|NCT04806165|75769298|FG003|Completed 2-Week Follow-Up Assessment|Overall Study||12||
59650963|NCT04806165|75769299|FG004|Completed 2-Week Follow-Up Assessment|Overall Study||11||
59650964|NCT04806165|75769300|FG005|Completed 2-Week Follow-Up Assessment|Overall Study||8||
59650965|NCT04806165|75769301|FG006|Completed 2-Week Follow-Up Assessment|Overall Study||10||
59650966|NCT04806165|75769302|FG007|Completed 2-Week Follow-Up Assessment|Overall Study||9||
59650967|NCT04806165|75769303|FG008|Completed 2-Week Follow-Up Assessment|Overall Study||10||
59650968|NCT04806165|75769304|FG009|Completed 2-Week Follow-Up Assessment|Overall Study||10||
59650969|NCT04806165|75769305|FG010|Completed 2-Week Follow-Up Assessment|Overall Study||10||
59650970|NCT04806165|75769306|FG011|Completed 2-Week Follow-Up Assessment|Overall Study||8||
59650971|NCT04806165|75769307|FG012|Completed 2-Week Follow-Up Assessment|Overall Study||10||
59650972|NCT04806165|75769308|FG013|Completed 2-Week Follow-Up Assessment|Overall Study||9||
59650973|NCT04806165|75769309|FG014|Completed 2-Week Follow-Up Assessment|Overall Study||9||
59650974|NCT04806165|75769310|FG015|Completed 2-Week Follow-Up Assessment|Overall Study||11||
59650975|NCT04806165|75769295|FG000|Completed 6-Week Follow-Up Assessment|Overall Study||9||
59650976|NCT04806165|75769296|FG001|Completed 6-Week Follow-Up Assessment|Overall Study||8||
59650977|NCT04806165|75769297|FG002|Completed 6-Week Follow-Up Assessment|Overall Study||9||
59650978|NCT04806165|75769298|FG003|Completed 6-Week Follow-Up Assessment|Overall Study||10||
59650979|NCT04806165|75769299|FG004|Completed 6-Week Follow-Up Assessment|Overall Study||9||
59650980|NCT04806165|75769300|FG005|Completed 6-Week Follow-Up Assessment|Overall Study||7||
59650981|NCT04806165|75769301|FG006|Completed 6-Week Follow-Up Assessment|Overall Study||8||
59650982|NCT04806165|75769302|FG007|Completed 6-Week Follow-Up Assessment|Overall Study||9||
59650983|NCT04806165|75769303|FG008|Completed 6-Week Follow-Up Assessment|Overall Study||9||
59650984|NCT04806165|75769304|FG009|Completed 6-Week Follow-Up Assessment|Overall Study||11||
59650985|NCT04806165|75769305|FG010|Completed 6-Week Follow-Up Assessment|Overall Study||9||
59650986|NCT04806165|75769306|FG011|Completed 6-Week Follow-Up Assessment|Overall Study||8||
59650987|NCT04806165|75769307|FG012|Completed 6-Week Follow-Up Assessment|Overall Study||10||
59650988|NCT04806165|75769308|FG013|Completed 6-Week Follow-Up Assessment|Overall Study||9||
59650989|NCT04806165|75769309|FG014|Completed 6-Week Follow-Up Assessment|Overall Study||9||
59650990|NCT04806165|75769310|FG015|Completed 6-Week Follow-Up Assessment|Overall Study||10||
59988684|NCT02361346|76103917|FG001|STARTED|Part 1 and 2 ( Up to Day 112)||3||
59988685|NCT02361346|76103918|FG002|STARTED|Part 1 and 2 ( Up to Day 112)||3||
59650991|NCT04806165|75769295|FG000|Completed 14-Week Follow-Up Assessment|Overall Study||9||
59650992|NCT04806165|75769296|FG001|Completed 14-Week Follow-Up Assessment|Overall Study||10||
59988686|NCT02361346|76103919|FG003|STARTED|Part 1 and 2 ( Up to Day 112)||4||
59988687|NCT02361346|76103920|FG004|STARTED|Part 1 and 2 ( Up to Day 112)||2||
59988688|NCT02361346|76103921|FG005|STARTED|Part 1 and 2 ( Up to Day 112)||6||
59988689|NCT02361346|76103922|FG006|STARTED|Part 1 and 2 ( Up to Day 112)||6||
59650993|NCT04806165|75769297|FG002|Completed 14-Week Follow-Up Assessment|Overall Study||9||
59650994|NCT04806165|75769298|FG003|Completed 14-Week Follow-Up Assessment|Overall Study||10||
59650995|NCT04806165|75769299|FG004|Completed 14-Week Follow-Up Assessment|Overall Study||10||
59650996|NCT04806165|75769300|FG005|Completed 14-Week Follow-Up Assessment|Overall Study||6||
59650997|NCT04806165|75769301|FG006|Completed 14-Week Follow-Up Assessment|Overall Study||10||
59650998|NCT04806165|75769302|FG007|Completed 14-Week Follow-Up Assessment|Overall Study||9||
59650999|NCT04806165|75769303|FG008|Completed 14-Week Follow-Up Assessment|Overall Study||9||
59651000|NCT04806165|75769304|FG009|Completed 14-Week Follow-Up Assessment|Overall Study||11||
59651001|NCT04806165|75769305|FG010|Completed 14-Week Follow-Up Assessment|Overall Study||10||
59651002|NCT04806165|75769306|FG011|Completed 14-Week Follow-Up Assessment|Overall Study||8||
59651003|NCT04806165|75769307|FG012|Completed 14-Week Follow-Up Assessment|Overall Study||9||
59651004|NCT04806165|75769308|FG013|Completed 14-Week Follow-Up Assessment|Overall Study||8||
59651005|NCT04806165|75769309|FG014|Completed 14-Week Follow-Up Assessment|Overall Study||6||
59651006|NCT04806165|75769310|FG015|Completed 14-Week Follow-Up Assessment|Overall Study||11||
59651007|NCT04806165|75769295|FG000|COMPLETED|Overall Study||13||
59651008|NCT04806165|75769296|FG001|COMPLETED|Overall Study||12||
59651009|NCT04806165|75769297|FG002|COMPLETED|Overall Study||11||
59651010|NCT04806165|75769298|FG003|COMPLETED|Overall Study||14||
59651011|NCT04806165|75769299|FG004|COMPLETED|Overall Study||13||
59651012|NCT04806165|75769300|FG005|COMPLETED|Overall Study||13||
59651013|NCT04806165|75769301|FG006|COMPLETED|Overall Study||14||
59651014|NCT04806165|75769302|FG007|COMPLETED|Overall Study||13||
59651015|NCT04806165|75769303|FG008|COMPLETED|Overall Study||13||
59543330|NCT02461290|75641562|FG000|COMPLETED|Overall Study||89||
59543331|NCT02461290|75641562|FG000|NOT COMPLETED|Overall Study||10||
59543332|NCT02461134|75641566|FG000|STARTED|Overall Study||1||
59543333|NCT02461134|75641566|FG000|COMPLETED|Overall Study||0||
59543334|NCT02461134|75641566|FG000|NOT COMPLETED|Overall Study||1||
59651016|NCT04806165|75769304|FG009|COMPLETED|Overall Study||12||
59651017|NCT04806165|75769305|FG010|COMPLETED|Overall Study||13||
59651018|NCT04806165|75769306|FG011|COMPLETED|Overall Study||13||
59651019|NCT04806165|75769307|FG012|COMPLETED|Overall Study||13||
59651020|NCT04806165|75769308|FG013|COMPLETED|Overall Study||13||
59651021|NCT04806165|75769309|FG014|COMPLETED|Overall Study||12||
59651022|NCT04806165|75769310|FG015|COMPLETED|Overall Study||13||
59651023|NCT04806165|75769295|FG000|NOT COMPLETED|Overall Study||0||
59651024|NCT04806165|75769296|FG001|NOT COMPLETED|Overall Study||0||
59651025|NCT04806165|75769297|FG002|NOT COMPLETED|Overall Study||0||
59651026|NCT04806165|75769298|FG003|NOT COMPLETED|Overall Study||0||
59651027|NCT04806165|75769299|FG004|NOT COMPLETED|Overall Study||0||
59651028|NCT04806165|75769300|FG005|NOT COMPLETED|Overall Study||0||
59651029|NCT04806165|75769301|FG006|NOT COMPLETED|Overall Study||0||
59651030|NCT04806165|75769302|FG007|NOT COMPLETED|Overall Study||0||
59651031|NCT04806165|75769303|FG008|NOT COMPLETED|Overall Study||0||
59651032|NCT04806165|75769304|FG009|NOT COMPLETED|Overall Study||0||
59651033|NCT04806165|75769305|FG010|NOT COMPLETED|Overall Study||0||
59651034|NCT04806165|75769306|FG011|NOT COMPLETED|Overall Study||0||
59651035|NCT04806165|75769307|FG012|NOT COMPLETED|Overall Study||0||
59651036|NCT04806165|75769308|FG013|NOT COMPLETED|Overall Study||0||
59651037|NCT04806165|75769309|FG014|NOT COMPLETED|Overall Study||0||
59651038|NCT04806165|75769310|FG015|NOT COMPLETED|Overall Study||0||
59651039|NCT04789577|75769343|FG000|STARTED|Overall Study||121||
59651040|NCT04789577|75769344|FG001|STARTED|Overall Study||116||
59651041|NCT04789577|75769345|FG002|STARTED|Overall Study||119||
59651042|NCT04789577|75769346|FG003|STARTED|Overall Study||119||
59651043|NCT04789577|75769347|FG004|STARTED|Overall Study||117||
59651044|NCT04789577|75769348|FG005|STARTED|Overall Study||121||
59651045|NCT04789577|75769349|FG006|STARTED|Overall Study||120||
59651046|NCT04789577|75769343|FG000|COMPLETED|Overall Study||113||
59651047|NCT04789577|75769344|FG001|COMPLETED|Overall Study||103||
59651048|NCT04789577|75769345|FG002|COMPLETED|Overall Study||111||
59651049|NCT04789577|75769346|FG003|COMPLETED|Overall Study||105||
59651050|NCT04789577|75769347|FG004|COMPLETED|Overall Study||108||
59651051|NCT04789577|75769348|FG005|COMPLETED|Overall Study||107||
59651052|NCT04789577|75769349|FG006|COMPLETED|Overall Study||109||
59651053|NCT04789577|75769343|FG000|NOT COMPLETED|Overall Study||8||
59543335|NCT02223065|75641572|FG000|STARTED|Overall Study||18||
59543336|NCT02223065|75641573|FG001|STARTED|Overall Study||18||
59543337|NCT02223065|75641572|FG000|COMPLETED|Overall Study||18||
59543338|NCT02223065|75641573|FG001|COMPLETED|Overall Study||18||
59651054|NCT04789577|75769344|FG001|NOT COMPLETED|Overall Study||13||
59651055|NCT04789577|75769345|FG002|NOT COMPLETED|Overall Study||8||
59651056|NCT04789577|75769346|FG003|NOT COMPLETED|Overall Study||14||
59651057|NCT04789577|75769347|FG004|NOT COMPLETED|Overall Study||9||
59651058|NCT04789577|75769348|FG005|NOT COMPLETED|Overall Study||14||
59651059|NCT04789577|75769349|FG006|NOT COMPLETED|Overall Study||11||
59651060|NCT04732624|75769367|FG000|STARTED|Overall Study||15||
59651061|NCT04732624|75769368|FG001|STARTED|Overall Study||15||
59651062|NCT04732624|75769367|FG000|COMPLETED|Overall Study||15||
59651063|NCT04732624|75769368|FG001|COMPLETED|Overall Study||15||
59543339|NCT02223065|75641572|FG000|NOT COMPLETED|Overall Study||0||
59651064|NCT04732624|75769367|FG000|NOT COMPLETED|Overall Study||0||
59651065|NCT04732624|75769368|FG001|NOT COMPLETED|Overall Study||0||
59651066|NCT04585243|75769374|FG000|STARTED|Overall Study||22||
59651067|NCT04585243|75769374|FG000|COMPLETED|Overall Study||12||
59651068|NCT04585243|75769374|FG000|NOT COMPLETED|Overall Study||10||
59651069|NCT04555694|75769381|FG000|STARTED|Overall Study||10||20
59651070|NCT04555694|75769382|FG001|STARTED|Overall Study||10||20
59651071|NCT04555694|75769383|FG002|STARTED|Overall Study||10||20
59651072|NCT04555694|75769381|FG000|COMPLETED|Overall Study||10||20
59651073|NCT04555694|75769382|FG001|COMPLETED|Overall Study||10||20
59651074|NCT04555694|75769383|FG002|COMPLETED|Overall Study||10||20
59651075|NCT04555694|75769381|FG000|NOT COMPLETED|Overall Study||0||0
59651076|NCT04555694|75769382|FG001|NOT COMPLETED|Overall Study||0||0
59651077|NCT04555694|75769383|FG002|NOT COMPLETED|Overall Study||0||0
59651078|NCT04541667|75769393|FG000|STARTED|Overall Study||98||98
59651079|NCT04541667|75769394|FG001|STARTED|Overall Study||102||102
59651080|NCT04541667|75769393|FG000|COMPLETED|Overall Study||98||98
59651081|NCT04541667|75769394|FG001|COMPLETED|Overall Study||102||102
59651082|NCT04541667|75769393|FG000|NOT COMPLETED|Overall Study||0||0
59651083|NCT04541667|75769394|FG001|NOT COMPLETED|Overall Study||0||0
59651084|NCT04511026|75769402|FG000|STARTED|Overall Study||6||
59651085|NCT04511026|75769402|FG000|COMPLETED|Overall Study||6||
59651086|NCT04511026|75769402|FG000|NOT COMPLETED|Overall Study||0||
59651087|NCT04480463|75769410|FG000|STARTED|Overall Study||288||
59651088|NCT04480463|75769411|FG001|STARTED|Overall Study||288||
59651089|NCT04480463|75769410|FG000|COMPLETED|Overall Study||259||
59651090|NCT04480463|75769411|FG001|COMPLETED|Overall Study||256||
59651091|NCT04480463|75769410|FG000|NOT COMPLETED|Overall Study||29||
59651092|NCT04480463|75769411|FG001|NOT COMPLETED|Overall Study||32||
59651093|NCT04285853|75769419|FG000|STARTED|Overall Study||49||
59651094|NCT04285853|75769420|FG001|STARTED|Overall Study||49||
59651095|NCT04285853|75769419|FG000|COMPLETED|Overall Study||39||
59651096|NCT04285853|75769420|FG001|COMPLETED|Overall Study||44||
59651097|NCT04285853|75769419|FG000|NOT COMPLETED|Overall Study||10||
59651098|NCT04285853|75769420|FG001|NOT COMPLETED|Overall Study||5||
59651099|NCT04128696|75769428|FG000|STARTED|Overall Study||158|Enrolled population|
59651100|NCT04128696|75769429|FG001|STARTED|Overall Study||157|Enrolled population|
59651101|NCT04128696|75769428|FG000|Modified Intent to Treat (mITT) Population|Overall Study||157|2 participants (1 from each arm) were dosed after the date of DIL requesting immediate discontinuation of feladilimab/placebo and were not included in the mITT population.|
59651102|NCT04128696|75769429|FG001|Modified Intent to Treat (mITT) Population|Overall Study||156|2 participants (1 from each arm) were dosed after the date of DIL requesting immediate discontinuation of feladilimab/placebo and were not included in the mITT population.|
59651103|NCT04128696|75769428|FG000|Safety Population|Overall Study||159|"Two participants were initially randomized to placebo+pembrolizumab arm but were dosed with feladilimab. Therefore, they were included in the in the feladilimab+pembrolizumab arm of the safety population.~The 2 participants enrolled but excluded from the mITT population (one from each arm) were both included in the placebo+pembrolizumab arm for the safety population, as both participants were only dosed with pembrolizumab."|
59651104|NCT04128696|75769429|FG001|Safety Population|Overall Study||156|"Two participants were initially randomized to placebo+pembrolizumab arm but were dosed with feladilimab. Therefore, they were included in the in the feladilimab+pembrolizumab arm of the safety population.~The 2 participants enrolled but excluded from the mITT population (one from each arm) were both included in the placebo+pembrolizumab arm for the safety population, as both participants were only dosed with pembrolizumab."|
59651105|NCT04128696|75769428|FG000|COMPLETED|Overall Study||51||
59651106|NCT04128696|75769429|FG001|COMPLETED|Overall Study||38||
59651107|NCT04128696|75769428|FG000|NOT COMPLETED|Overall Study||107||
59651108|NCT04128696|75769429|FG001|NOT COMPLETED|Overall Study||119||
59651109|NCT04102579|75769437|FG000|STARTED|Overall Study||64||
59651110|NCT04102579|75769438|FG001|STARTED|Overall Study||64||
59651111|NCT04102579|75769437|FG000|Received at Least 1 Dose of Study Drug|Overall Study||64||
59651112|NCT04102579|75769438|FG001|Received at Least 1 Dose of Study Drug|Overall Study||63||
59651113|NCT04102579|75769437|FG000|COMPLETED|Overall Study||57||
59651114|NCT04102579|75769438|FG001|COMPLETED|Overall Study||54||
59651115|NCT04102579|75769437|FG000|NOT COMPLETED|Overall Study||7||
59651116|NCT04102579|75769438|FG001|NOT COMPLETED|Overall Study||10||
59651117|NCT04036227|75769455|FG000|STARTED|Part I (SAD): 1 mg||6||
59651118|NCT04036227|75769456|FG001|STARTED|Part I (SAD): 1 mg||0||
59651119|NCT04036227|75769457|FG002|STARTED|Part I (SAD): 1 mg||0||
59651120|NCT04036227|75769458|FG003|STARTED|Part I (SAD): 1 mg||0||
59651121|NCT04036227|75769459|FG004|STARTED|Part I (SAD): 1 mg||0||
59651122|NCT04036227|75769460|FG005|STARTED|Part I (SAD): 1 mg||0||
59651123|NCT04036227|75769461|FG006|STARTED|Part I (SAD): 1 mg||0||
59651124|NCT04036227|75769462|FG007|STARTED|Part I (SAD): 1 mg||0||
59651125|NCT04036227|75769463|FG008|STARTED|Part I (SAD): 1 mg||0||
59651126|NCT04036227|75769464|FG009|STARTED|Part I (SAD): 1 mg||0||
59651127|NCT04036227|75769465|FG010|STARTED|Part I (SAD): 1 mg||0||
59651128|NCT04036227|75769455|FG000|COMPLETED|Part I (SAD): 1 mg||6||
59651129|NCT04036227|75769456|FG001|COMPLETED|Part I (SAD): 1 mg||0||
59651130|NCT04036227|75769457|FG002|COMPLETED|Part I (SAD): 1 mg||0||
59651131|NCT04036227|75769458|FG003|COMPLETED|Part I (SAD): 1 mg||0||
59651132|NCT04036227|75769459|FG004|COMPLETED|Part I (SAD): 1 mg||0||
59651133|NCT04036227|75769460|FG005|COMPLETED|Part I (SAD): 1 mg||0||
59651134|NCT04036227|75769461|FG006|COMPLETED|Part I (SAD): 1 mg||0||
59651135|NCT04036227|75769462|FG007|COMPLETED|Part I (SAD): 1 mg||0||
59651136|NCT04036227|75769463|FG008|COMPLETED|Part I (SAD): 1 mg||0||
59651137|NCT04036227|75769464|FG009|COMPLETED|Part I (SAD): 1 mg||0||
59651138|NCT04036227|75769465|FG010|COMPLETED|Part I (SAD): 1 mg||0||
59651139|NCT04036227|75769455|FG000|NOT COMPLETED|Part I (SAD): 1 mg||0||
59651140|NCT04036227|75769456|FG001|NOT COMPLETED|Part I (SAD): 1 mg||0||
59651141|NCT04036227|75769457|FG002|NOT COMPLETED|Part I (SAD): 1 mg||0||
59651142|NCT04036227|75769458|FG003|NOT COMPLETED|Part I (SAD): 1 mg||0||
59651143|NCT04036227|75769459|FG004|NOT COMPLETED|Part I (SAD): 1 mg||0||
59651144|NCT04036227|75769460|FG005|NOT COMPLETED|Part I (SAD): 1 mg||0||
59651145|NCT04036227|75769461|FG006|NOT COMPLETED|Part I (SAD): 1 mg||0||
59651146|NCT04036227|75769462|FG007|NOT COMPLETED|Part I (SAD): 1 mg||0||
59651147|NCT04036227|75769463|FG008|NOT COMPLETED|Part I (SAD): 1 mg||0||
59651148|NCT04036227|75769464|FG009|NOT COMPLETED|Part I (SAD): 1 mg||0||
59651149|NCT04036227|75769465|FG010|NOT COMPLETED|Part I (SAD): 1 mg||0||
59651150|NCT04036227|75769455|FG000|STARTED|Part I (SAD): 5 mg||0||
59651151|NCT04036227|75769456|FG001|STARTED|Part I (SAD): 5 mg||6||
59651152|NCT04036227|75769457|FG002|STARTED|Part I (SAD): 5 mg||0||
59651153|NCT04036227|75769458|FG003|STARTED|Part I (SAD): 5 mg||0||
59651154|NCT04036227|75769459|FG004|STARTED|Part I (SAD): 5 mg||0||
59651155|NCT04036227|75769460|FG005|STARTED|Part I (SAD): 5 mg||0||
59651156|NCT04036227|75769461|FG006|STARTED|Part I (SAD): 5 mg||0||
59651157|NCT04036227|75769462|FG007|STARTED|Part I (SAD): 5 mg||0||
59651158|NCT04036227|75769463|FG008|STARTED|Part I (SAD): 5 mg||0||
59651159|NCT04036227|75769464|FG009|STARTED|Part I (SAD): 5 mg||0||
59651160|NCT04036227|75769465|FG010|STARTED|Part I (SAD): 5 mg||0||
59651161|NCT04036227|75769455|FG000|COMPLETED|Part I (SAD): 5 mg||0||
59651162|NCT04036227|75769456|FG001|COMPLETED|Part I (SAD): 5 mg||6||
59651163|NCT04036227|75769457|FG002|COMPLETED|Part I (SAD): 5 mg||0||
59651164|NCT04036227|75769458|FG003|COMPLETED|Part I (SAD): 5 mg||0||
59651165|NCT04036227|75769459|FG004|COMPLETED|Part I (SAD): 5 mg||0||
59651166|NCT04036227|75769460|FG005|COMPLETED|Part I (SAD): 5 mg||0||
59651167|NCT04036227|75769461|FG006|COMPLETED|Part I (SAD): 5 mg||0||
59651168|NCT04036227|75769462|FG007|COMPLETED|Part I (SAD): 5 mg||0||
59651169|NCT04036227|75769463|FG008|COMPLETED|Part I (SAD): 5 mg||0||
59651170|NCT04036227|75769464|FG009|COMPLETED|Part I (SAD): 5 mg||0||
59651171|NCT04036227|75769465|FG010|COMPLETED|Part I (SAD): 5 mg||0||
59651172|NCT04036227|75769455|FG000|NOT COMPLETED|Part I (SAD): 5 mg||0||
59651173|NCT04036227|75769456|FG001|NOT COMPLETED|Part I (SAD): 5 mg||0||
59651174|NCT04036227|75769457|FG002|NOT COMPLETED|Part I (SAD): 5 mg||0||
59651175|NCT04036227|75769458|FG003|NOT COMPLETED|Part I (SAD): 5 mg||0||
59651176|NCT04036227|75769459|FG004|NOT COMPLETED|Part I (SAD): 5 mg||0||
59651177|NCT04036227|75769460|FG005|NOT COMPLETED|Part I (SAD): 5 mg||0||
59651178|NCT04036227|75769461|FG006|NOT COMPLETED|Part I (SAD): 5 mg||0||
59651179|NCT04036227|75769462|FG007|NOT COMPLETED|Part I (SAD): 5 mg||0||
59651180|NCT04036227|75769463|FG008|NOT COMPLETED|Part I (SAD): 5 mg||0||
59651181|NCT04036227|75769464|FG009|NOT COMPLETED|Part I (SAD): 5 mg||0||
59651182|NCT04036227|75769465|FG010|NOT COMPLETED|Part I (SAD): 5 mg||0||
59651183|NCT04036227|75769455|FG000|STARTED|Part I (SAD): 8 mg||0||
59651184|NCT04036227|75769456|FG001|STARTED|Part I (SAD): 8 mg||0||
59651185|NCT04036227|75769457|FG002|STARTED|Part I (SAD): 8 mg||6||
59651186|NCT04036227|75769458|FG003|STARTED|Part I (SAD): 8 mg||0||
59651187|NCT04036227|75769459|FG004|STARTED|Part I (SAD): 8 mg||0||
59651188|NCT04036227|75769460|FG005|STARTED|Part I (SAD): 8 mg||0||
59651189|NCT04036227|75769461|FG006|STARTED|Part I (SAD): 8 mg||0||
59651190|NCT04036227|75769462|FG007|STARTED|Part I (SAD): 8 mg||0||
59651191|NCT04036227|75769463|FG008|STARTED|Part I (SAD): 8 mg||0||
59651192|NCT04036227|75769464|FG009|STARTED|Part I (SAD): 8 mg||0||
59651193|NCT04036227|75769465|FG010|STARTED|Part I (SAD): 8 mg||0||
59651194|NCT04036227|75769455|FG000|COMPLETED|Part I (SAD): 8 mg||0||
59651195|NCT04036227|75769456|FG001|COMPLETED|Part I (SAD): 8 mg||0||
59651196|NCT04036227|75769457|FG002|COMPLETED|Part I (SAD): 8 mg||6||
59651197|NCT04036227|75769458|FG003|COMPLETED|Part I (SAD): 8 mg||0||
59651198|NCT04036227|75769459|FG004|COMPLETED|Part I (SAD): 8 mg||0||
59651199|NCT04036227|75769460|FG005|COMPLETED|Part I (SAD): 8 mg||0||
59651200|NCT04036227|75769461|FG006|COMPLETED|Part I (SAD): 8 mg||0||
59651201|NCT04036227|75769462|FG007|COMPLETED|Part I (SAD): 8 mg||0||
59651202|NCT04036227|75769463|FG008|COMPLETED|Part I (SAD): 8 mg||0||
59651203|NCT04036227|75769464|FG009|COMPLETED|Part I (SAD): 8 mg||0||
59651204|NCT04036227|75769465|FG010|COMPLETED|Part I (SAD): 8 mg||0||
59651205|NCT04036227|75769455|FG000|NOT COMPLETED|Part I (SAD): 8 mg||0||
59651206|NCT04036227|75769456|FG001|NOT COMPLETED|Part I (SAD): 8 mg||0||
59651207|NCT04036227|75769457|FG002|NOT COMPLETED|Part I (SAD): 8 mg||0||
59651208|NCT04036227|75769458|FG003|NOT COMPLETED|Part I (SAD): 8 mg||0||
59651209|NCT04036227|75769459|FG004|NOT COMPLETED|Part I (SAD): 8 mg||0||
59651210|NCT04036227|75769460|FG005|NOT COMPLETED|Part I (SAD): 8 mg||0||
59651211|NCT04036227|75769461|FG006|NOT COMPLETED|Part I (SAD): 8 mg||0||
59651212|NCT04036227|75769462|FG007|NOT COMPLETED|Part I (SAD): 8 mg||0||
59651213|NCT04036227|75769463|FG008|NOT COMPLETED|Part I (SAD): 8 mg||0||
59651214|NCT04036227|75769464|FG009|NOT COMPLETED|Part I (SAD): 8 mg||0||
59651215|NCT04036227|75769465|FG010|NOT COMPLETED|Part I (SAD): 8 mg||0||
59651216|NCT04036227|75769455|FG000|STARTED|Part I (SAD): 40 mg||0||
59651217|NCT04036227|75769456|FG001|STARTED|Part I (SAD): 40 mg||0||
59651218|NCT04036227|75769457|FG002|STARTED|Part I (SAD): 40 mg||0||
59651219|NCT04036227|75769458|FG003|STARTED|Part I (SAD): 40 mg||6||
59651220|NCT04036227|75769459|FG004|STARTED|Part I (SAD): 40 mg||0||
59651221|NCT04036227|75769460|FG005|STARTED|Part I (SAD): 40 mg||0||
59651222|NCT04036227|75769461|FG006|STARTED|Part I (SAD): 40 mg||0||
59651223|NCT04036227|75769462|FG007|STARTED|Part I (SAD): 40 mg||0||
59651224|NCT04036227|75769463|FG008|STARTED|Part I (SAD): 40 mg||0||
59651225|NCT04036227|75769464|FG009|STARTED|Part I (SAD): 40 mg||0||
59651226|NCT04036227|75769465|FG010|STARTED|Part I (SAD): 40 mg||0||
59651227|NCT04036227|75769455|FG000|COMPLETED|Part I (SAD): 40 mg||0||
59651228|NCT04036227|75769456|FG001|COMPLETED|Part I (SAD): 40 mg||0||
59651229|NCT04036227|75769457|FG002|COMPLETED|Part I (SAD): 40 mg||0||
59651230|NCT04036227|75769458|FG003|COMPLETED|Part I (SAD): 40 mg||6||
59651231|NCT04036227|75769459|FG004|COMPLETED|Part I (SAD): 40 mg||0||
59651232|NCT04036227|75769460|FG005|COMPLETED|Part I (SAD): 40 mg||0||
59651233|NCT04036227|75769461|FG006|COMPLETED|Part I (SAD): 40 mg||0||
59651234|NCT04036227|75769462|FG007|COMPLETED|Part I (SAD): 40 mg||0||
59651235|NCT04036227|75769463|FG008|COMPLETED|Part I (SAD): 40 mg||0||
59651236|NCT04036227|75769464|FG009|COMPLETED|Part I (SAD): 40 mg||0||
59651237|NCT04036227|75769465|FG010|COMPLETED|Part I (SAD): 40 mg||0||
59651238|NCT04036227|75769455|FG000|NOT COMPLETED|Part I (SAD): 40 mg||0||
59651239|NCT04036227|75769456|FG001|NOT COMPLETED|Part I (SAD): 40 mg||0||
59651240|NCT04036227|75769457|FG002|NOT COMPLETED|Part I (SAD): 40 mg||0||
59651241|NCT04036227|75769458|FG003|NOT COMPLETED|Part I (SAD): 40 mg||0||
59651242|NCT04036227|75769459|FG004|NOT COMPLETED|Part I (SAD): 40 mg||0||
59651243|NCT04036227|75769460|FG005|NOT COMPLETED|Part I (SAD): 40 mg||0||
59651244|NCT04036227|75769461|FG006|NOT COMPLETED|Part I (SAD): 40 mg||0||
59651245|NCT04036227|75769462|FG007|NOT COMPLETED|Part I (SAD): 40 mg||0||
59651246|NCT04036227|75769463|FG008|NOT COMPLETED|Part I (SAD): 40 mg||0||
59651247|NCT04036227|75769464|FG009|NOT COMPLETED|Part I (SAD): 40 mg||0||
59651248|NCT04036227|75769465|FG010|NOT COMPLETED|Part I (SAD): 40 mg||0||
59651249|NCT04036227|75769455|FG000|STARTED|Part I (SAD): 100 mg||0||
59651250|NCT04036227|75769456|FG001|STARTED|Part I (SAD): 100 mg||0||
59651251|NCT04036227|75769457|FG002|STARTED|Part I (SAD): 100 mg||0||
59651252|NCT04036227|75769458|FG003|STARTED|Part I (SAD): 100 mg||0||
59651253|NCT04036227|75769459|FG004|STARTED|Part I (SAD): 100 mg||6||
59651254|NCT04036227|75769460|FG005|STARTED|Part I (SAD): 100 mg||0||
59651255|NCT04036227|75769461|FG006|STARTED|Part I (SAD): 100 mg||0||
59651256|NCT04036227|75769462|FG007|STARTED|Part I (SAD): 100 mg||0||
59651257|NCT04036227|75769463|FG008|STARTED|Part I (SAD): 100 mg||0||
59651258|NCT04036227|75769464|FG009|STARTED|Part I (SAD): 100 mg||0||
59651259|NCT04036227|75769465|FG010|STARTED|Part I (SAD): 100 mg||0||
59651260|NCT04036227|75769455|FG000|COMPLETED|Part I (SAD): 100 mg||0||
59651261|NCT04036227|75769456|FG001|COMPLETED|Part I (SAD): 100 mg||0||
59651262|NCT04036227|75769457|FG002|COMPLETED|Part I (SAD): 100 mg||0||
59651263|NCT04036227|75769458|FG003|COMPLETED|Part I (SAD): 100 mg||0||
59651264|NCT04036227|75769459|FG004|COMPLETED|Part I (SAD): 100 mg||6||
59651265|NCT04036227|75769460|FG005|COMPLETED|Part I (SAD): 100 mg||0||
59651266|NCT04036227|75769461|FG006|COMPLETED|Part I (SAD): 100 mg||0||
59651267|NCT04036227|75769462|FG007|COMPLETED|Part I (SAD): 100 mg||0||
59651268|NCT04036227|75769463|FG008|COMPLETED|Part I (SAD): 100 mg||0||
59651269|NCT04036227|75769464|FG009|COMPLETED|Part I (SAD): 100 mg||0||
59651270|NCT04036227|75769465|FG010|COMPLETED|Part I (SAD): 100 mg||0||
59651271|NCT04036227|75769455|FG000|NOT COMPLETED|Part I (SAD): 100 mg||0||
59815785|NCT03026283|75938211|FG000|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0||
60076883|NCT01925989|76191897|FG001|COMPLETED|Period 2||6||
59651272|NCT04036227|75769456|FG001|NOT COMPLETED|Part I (SAD): 100 mg||0||
59651273|NCT04036227|75769457|FG002|NOT COMPLETED|Part I (SAD): 100 mg||0||
59651274|NCT04036227|75769458|FG003|NOT COMPLETED|Part I (SAD): 100 mg||0||
59651275|NCT04036227|75769459|FG004|NOT COMPLETED|Part I (SAD): 100 mg||0||
59651276|NCT04036227|75769460|FG005|NOT COMPLETED|Part I (SAD): 100 mg||0||
59651277|NCT04036227|75769461|FG006|NOT COMPLETED|Part I (SAD): 100 mg||0||
59651278|NCT04036227|75769462|FG007|NOT COMPLETED|Part I (SAD): 100 mg||0||
59651279|NCT04036227|75769463|FG008|NOT COMPLETED|Part I (SAD): 100 mg||0||
59651280|NCT04036227|75769464|FG009|NOT COMPLETED|Part I (SAD): 100 mg||0||
59651281|NCT04036227|75769465|FG010|NOT COMPLETED|Part I (SAD): 100 mg||0||
59651282|NCT04036227|75769455|FG000|STARTED|Part I (SAD): 300 mg||0||
59651283|NCT04036227|75769456|FG001|STARTED|Part I (SAD): 300 mg||0||
59651284|NCT04036227|75769457|FG002|STARTED|Part I (SAD): 300 mg||0||
59651285|NCT04036227|75769458|FG003|STARTED|Part I (SAD): 300 mg||0||
59651286|NCT04036227|75769459|FG004|STARTED|Part I (SAD): 300 mg||0||
59651287|NCT04036227|75769460|FG005|STARTED|Part I (SAD): 300 mg||6||
59651288|NCT04036227|75769461|FG006|STARTED|Part I (SAD): 300 mg||0||
59651289|NCT04036227|75769462|FG007|STARTED|Part I (SAD): 300 mg||0||
59651290|NCT04036227|75769463|FG008|STARTED|Part I (SAD): 300 mg||0||
59651291|NCT04036227|75769464|FG009|STARTED|Part I (SAD): 300 mg||0||
59651292|NCT04036227|75769465|FG010|STARTED|Part I (SAD): 300 mg||0||
59651293|NCT04036227|75769455|FG000|COMPLETED|Part I (SAD): 300 mg||0||
59651294|NCT04036227|75769456|FG001|COMPLETED|Part I (SAD): 300 mg||0||
59651295|NCT04036227|75769457|FG002|COMPLETED|Part I (SAD): 300 mg||0||
59651296|NCT04036227|75769458|FG003|COMPLETED|Part I (SAD): 300 mg||0||
59651297|NCT04036227|75769459|FG004|COMPLETED|Part I (SAD): 300 mg||0||
59651298|NCT04036227|75769460|FG005|COMPLETED|Part I (SAD): 300 mg||6||
59651299|NCT04036227|75769461|FG006|COMPLETED|Part I (SAD): 300 mg||0||
59651300|NCT04036227|75769462|FG007|COMPLETED|Part I (SAD): 300 mg||0||
59651301|NCT04036227|75769463|FG008|COMPLETED|Part I (SAD): 300 mg||0||
59651302|NCT04036227|75769464|FG009|COMPLETED|Part I (SAD): 300 mg||0||
59651303|NCT04036227|75769465|FG010|COMPLETED|Part I (SAD): 300 mg||0||
59651304|NCT04036227|75769455|FG000|NOT COMPLETED|Part I (SAD): 300 mg||0||
59651305|NCT04036227|75769456|FG001|NOT COMPLETED|Part I (SAD): 300 mg||0||
59651306|NCT04036227|75769457|FG002|NOT COMPLETED|Part I (SAD): 300 mg||0||
59651307|NCT04036227|75769458|FG003|NOT COMPLETED|Part I (SAD): 300 mg||0||
59651308|NCT04036227|75769459|FG004|NOT COMPLETED|Part I (SAD): 300 mg||0||
59651309|NCT04036227|75769460|FG005|NOT COMPLETED|Part I (SAD): 300 mg||0||
59651310|NCT04036227|75769461|FG006|NOT COMPLETED|Part I (SAD): 300 mg||0||
59651311|NCT04036227|75769462|FG007|NOT COMPLETED|Part I (SAD): 300 mg||0||
59651312|NCT04036227|75769463|FG008|NOT COMPLETED|Part I (SAD): 300 mg||0||
59651313|NCT04036227|75769464|FG009|NOT COMPLETED|Part I (SAD): 300 mg||0||
59651314|NCT04036227|75769465|FG010|NOT COMPLETED|Part I (SAD): 300 mg||0||
59651315|NCT04036227|75769455|FG000|STARTED|Part I (SAD): Placebo||0||
59651316|NCT04036227|75769456|FG001|STARTED|Part I (SAD): Placebo||0||
59651317|NCT04036227|75769457|FG002|STARTED|Part I (SAD): Placebo||0||
59651318|NCT04036227|75769458|FG003|STARTED|Part I (SAD): Placebo||0||
59651319|NCT04036227|75769459|FG004|STARTED|Part I (SAD): Placebo||0||
59651320|NCT04036227|75769460|FG005|STARTED|Part I (SAD): Placebo||0||
59651321|NCT04036227|75769461|FG006|STARTED|Part I (SAD): Placebo||12||
59651322|NCT04036227|75769462|FG007|STARTED|Part I (SAD): Placebo||0||
59651323|NCT04036227|75769463|FG008|STARTED|Part I (SAD): Placebo||0||
59651324|NCT04036227|75769464|FG009|STARTED|Part I (SAD): Placebo||0||
59651325|NCT04036227|75769465|FG010|STARTED|Part I (SAD): Placebo||0||
59651326|NCT04036227|75769455|FG000|COMPLETED|Part I (SAD): Placebo||0||
59651327|NCT04036227|75769456|FG001|COMPLETED|Part I (SAD): Placebo||0||
59651328|NCT04036227|75769457|FG002|COMPLETED|Part I (SAD): Placebo||0||
59651329|NCT04036227|75769458|FG003|COMPLETED|Part I (SAD): Placebo||0||
59651330|NCT04036227|75769459|FG004|COMPLETED|Part I (SAD): Placebo||0||
59651331|NCT04036227|75769460|FG005|COMPLETED|Part I (SAD): Placebo||0||
59651332|NCT04036227|75769461|FG006|COMPLETED|Part I (SAD): Placebo||12||
59651333|NCT04036227|75769462|FG007|COMPLETED|Part I (SAD): Placebo||0||
59651334|NCT04036227|75769463|FG008|COMPLETED|Part I (SAD): Placebo||0||
59651335|NCT04036227|75769464|FG009|COMPLETED|Part I (SAD): Placebo||0||
59651336|NCT04036227|75769465|FG010|COMPLETED|Part I (SAD): Placebo||0||
59651337|NCT04036227|75769455|FG000|NOT COMPLETED|Part I (SAD): Placebo||0||
59651338|NCT04036227|75769456|FG001|NOT COMPLETED|Part I (SAD): Placebo||0||
59651339|NCT04036227|75769457|FG002|NOT COMPLETED|Part I (SAD): Placebo||0||
59651340|NCT04036227|75769458|FG003|NOT COMPLETED|Part I (SAD): Placebo||0||
59651341|NCT04036227|75769459|FG004|NOT COMPLETED|Part I (SAD): Placebo||0||
59651342|NCT04036227|75769460|FG005|NOT COMPLETED|Part I (SAD): Placebo||0||
59651343|NCT04036227|75769461|FG006|NOT COMPLETED|Part I (SAD): Placebo||0||
59651344|NCT04036227|75769462|FG007|NOT COMPLETED|Part I (SAD): Placebo||0||
59651345|NCT04036227|75769463|FG008|NOT COMPLETED|Part I (SAD): Placebo||0||
59651346|NCT04036227|75769464|FG009|NOT COMPLETED|Part I (SAD): Placebo||0||
59651347|NCT04036227|75769465|FG010|NOT COMPLETED|Part I (SAD): Placebo||0||
59651348|NCT04036227|75769455|FG000|STARTED|Part II (MAD): 20 mg||0||
59651349|NCT04036227|75769456|FG001|STARTED|Part II (MAD): 20 mg||0||
59651350|NCT04036227|75769457|FG002|STARTED|Part II (MAD): 20 mg||0||
59651351|NCT04036227|75769458|FG003|STARTED|Part II (MAD): 20 mg||0||
59651352|NCT04036227|75769459|FG004|STARTED|Part II (MAD): 20 mg||0||
59815786|NCT03026283|75938212|FG001|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||3||
59815787|NCT03026283|75938213|FG002|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||15||
59815788|NCT03026283|75938214|FG003|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0||
59815789|NCT03026283|75938215|FG004|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0||
59543340|NCT02223065|75641573|FG001|NOT COMPLETED|Overall Study||0||
59543341|NCT02223455|75641582|FG000|STARTED|Overall Study|Participant level data not collected.|||19
59543342|NCT02223455|75641583|FG001|STARTED|Overall Study|Participant level data not collected.|||19
59543343|NCT02223455|75641584|FG002|STARTED|Overall Study|Participant level data not collected.|||20
59543344|NCT02223455|75641582|FG000|COMPLETED|Overall Study|Participant level data not collected.|||19
59543345|NCT02223455|75641583|FG001|COMPLETED|Overall Study|Participant level data not collected.|||19
59543346|NCT02223455|75641584|FG002|COMPLETED|Overall Study|Participant level data not collected.|||20
59651353|NCT04036227|75769460|FG005|STARTED|Part II (MAD): 20 mg||0||
59651354|NCT04036227|75769461|FG006|STARTED|Part II (MAD): 20 mg||0||
59995453|NCT02675114|76111277|FG001|As Treated|Overall Study||496||
59543347|NCT02223455|75641582|FG000|NOT COMPLETED|Overall Study||||0
59543348|NCT02223455|75641583|FG001|NOT COMPLETED|Overall Study||||0
59651355|NCT04036227|75769462|FG007|STARTED|Part II (MAD): 20 mg||6||
59651356|NCT04036227|75769463|FG008|STARTED|Part II (MAD): 20 mg||0||
59651357|NCT04036227|75769464|FG009|STARTED|Part II (MAD): 20 mg||0||
59651358|NCT04036227|75769465|FG010|STARTED|Part II (MAD): 20 mg||0||
59651359|NCT04036227|75769455|FG000|COMPLETED|Part II (MAD): 20 mg||0||
59651360|NCT04036227|75769456|FG001|COMPLETED|Part II (MAD): 20 mg||0||
59651361|NCT04036227|75769457|FG002|COMPLETED|Part II (MAD): 20 mg||0||
59651362|NCT04036227|75769458|FG003|COMPLETED|Part II (MAD): 20 mg||0||
59651363|NCT04036227|75769459|FG004|COMPLETED|Part II (MAD): 20 mg||0||
59651364|NCT04036227|75769460|FG005|COMPLETED|Part II (MAD): 20 mg||0||
59651365|NCT04036227|75769461|FG006|COMPLETED|Part II (MAD): 20 mg||0||
59651366|NCT04036227|75769462|FG007|COMPLETED|Part II (MAD): 20 mg||6||
59651367|NCT04036227|75769463|FG008|COMPLETED|Part II (MAD): 20 mg||0||
59651368|NCT04036227|75769464|FG009|COMPLETED|Part II (MAD): 20 mg||0||
59651369|NCT04036227|75769465|FG010|COMPLETED|Part II (MAD): 20 mg||0||
59651370|NCT04036227|75769455|FG000|NOT COMPLETED|Part II (MAD): 20 mg||0||
59651371|NCT04036227|75769456|FG001|NOT COMPLETED|Part II (MAD): 20 mg||0||
59651372|NCT04036227|75769457|FG002|NOT COMPLETED|Part II (MAD): 20 mg||0||
59651373|NCT04036227|75769458|FG003|NOT COMPLETED|Part II (MAD): 20 mg||0||
59651374|NCT04036227|75769459|FG004|NOT COMPLETED|Part II (MAD): 20 mg||0||
59651375|NCT04036227|75769460|FG005|NOT COMPLETED|Part II (MAD): 20 mg||0||
59651376|NCT04036227|75769461|FG006|NOT COMPLETED|Part II (MAD): 20 mg||0||
59651377|NCT04036227|75769462|FG007|NOT COMPLETED|Part II (MAD): 20 mg||0||
59651378|NCT04036227|75769463|FG008|NOT COMPLETED|Part II (MAD): 20 mg||0||
59651379|NCT04036227|75769464|FG009|NOT COMPLETED|Part II (MAD): 20 mg||0||
59651380|NCT04036227|75769465|FG010|NOT COMPLETED|Part II (MAD): 20 mg||0||
59651381|NCT04036227|75769455|FG000|STARTED|Part II (MAD): 60 mg||0||
59651382|NCT04036227|75769456|FG001|STARTED|Part II (MAD): 60 mg||0||
59651383|NCT04036227|75769457|FG002|STARTED|Part II (MAD): 60 mg||0||
59651384|NCT04036227|75769458|FG003|STARTED|Part II (MAD): 60 mg||0||
59651385|NCT04036227|75769459|FG004|STARTED|Part II (MAD): 60 mg||0||
59651386|NCT04036227|75769460|FG005|STARTED|Part II (MAD): 60 mg||0||
59651387|NCT04036227|75769461|FG006|STARTED|Part II (MAD): 60 mg||0||
59651388|NCT04036227|75769462|FG007|STARTED|Part II (MAD): 60 mg||0||
59651389|NCT04036227|75769463|FG008|STARTED|Part II (MAD): 60 mg||6||
59651390|NCT04036227|75769464|FG009|STARTED|Part II (MAD): 60 mg||0||
59651391|NCT04036227|75769465|FG010|STARTED|Part II (MAD): 60 mg||0||
59651392|NCT04036227|75769455|FG000|COMPLETED|Part II (MAD): 60 mg||0||
59651393|NCT04036227|75769456|FG001|COMPLETED|Part II (MAD): 60 mg||0||
59651394|NCT04036227|75769457|FG002|COMPLETED|Part II (MAD): 60 mg||0||
59651395|NCT04036227|75769458|FG003|COMPLETED|Part II (MAD): 60 mg||0||
59651396|NCT04036227|75769459|FG004|COMPLETED|Part II (MAD): 60 mg||0||
59651397|NCT04036227|75769460|FG005|COMPLETED|Part II (MAD): 60 mg||0||
59651398|NCT04036227|75769461|FG006|COMPLETED|Part II (MAD): 60 mg||0||
59651399|NCT04036227|75769462|FG007|COMPLETED|Part II (MAD): 60 mg||0||
59651400|NCT04036227|75769463|FG008|COMPLETED|Part II (MAD): 60 mg||6||
59651401|NCT04036227|75769464|FG009|COMPLETED|Part II (MAD): 60 mg||0||
59651402|NCT04036227|75769465|FG010|COMPLETED|Part II (MAD): 60 mg||0||
59651403|NCT04036227|75769455|FG000|NOT COMPLETED|Part II (MAD): 60 mg||0||
59651404|NCT04036227|75769456|FG001|NOT COMPLETED|Part II (MAD): 60 mg||0||
59651405|NCT04036227|75769457|FG002|NOT COMPLETED|Part II (MAD): 60 mg||0||
59651406|NCT04036227|75769458|FG003|NOT COMPLETED|Part II (MAD): 60 mg||0||
59651407|NCT04036227|75769459|FG004|NOT COMPLETED|Part II (MAD): 60 mg||0||
59651408|NCT04036227|75769460|FG005|NOT COMPLETED|Part II (MAD): 60 mg||0||
59651409|NCT04036227|75769461|FG006|NOT COMPLETED|Part II (MAD): 60 mg||0||
59651410|NCT04036227|75769462|FG007|NOT COMPLETED|Part II (MAD): 60 mg||0||
59651411|NCT04036227|75769463|FG008|NOT COMPLETED|Part II (MAD): 60 mg||0||
59651412|NCT04036227|75769464|FG009|NOT COMPLETED|Part II (MAD): 60 mg||0||
59651413|NCT04036227|75769465|FG010|NOT COMPLETED|Part II (MAD): 60 mg||0||
59651414|NCT04036227|75769455|FG000|STARTED|Part II (MAD): 180 mg||0||
59651415|NCT04036227|75769456|FG001|STARTED|Part II (MAD): 180 mg||0||
59651416|NCT04036227|75769457|FG002|STARTED|Part II (MAD): 180 mg||0||
59651417|NCT04036227|75769458|FG003|STARTED|Part II (MAD): 180 mg||0||
59651418|NCT04036227|75769459|FG004|STARTED|Part II (MAD): 180 mg||0||
59651419|NCT04036227|75769460|FG005|STARTED|Part II (MAD): 180 mg||0||
59651420|NCT04036227|75769461|FG006|STARTED|Part II (MAD): 180 mg||0||
59651421|NCT04036227|75769462|FG007|STARTED|Part II (MAD): 180 mg||0||
59651422|NCT04036227|75769463|FG008|STARTED|Part II (MAD): 180 mg||0||
59651423|NCT04036227|75769464|FG009|STARTED|Part II (MAD): 180 mg||6||
59651424|NCT04036227|75769465|FG010|STARTED|Part II (MAD): 180 mg||0||
59651425|NCT04036227|75769455|FG000|COMPLETED|Part II (MAD): 180 mg||0||
59651426|NCT04036227|75769456|FG001|COMPLETED|Part II (MAD): 180 mg||0||
59651427|NCT04036227|75769457|FG002|COMPLETED|Part II (MAD): 180 mg||0||
59651428|NCT04036227|75769458|FG003|COMPLETED|Part II (MAD): 180 mg||0||
59651429|NCT04036227|75769459|FG004|COMPLETED|Part II (MAD): 180 mg||0||
59651430|NCT04036227|75769460|FG005|COMPLETED|Part II (MAD): 180 mg||0||
59651431|NCT04036227|75769461|FG006|COMPLETED|Part II (MAD): 180 mg||0||
59651432|NCT04036227|75769462|FG007|COMPLETED|Part II (MAD): 180 mg||0||
59651433|NCT04036227|75769463|FG008|COMPLETED|Part II (MAD): 180 mg||0||
59651434|NCT04036227|75769464|FG009|COMPLETED|Part II (MAD): 180 mg||5||
59651435|NCT04036227|75769465|FG010|COMPLETED|Part II (MAD): 180 mg||0||
59651436|NCT04036227|75769455|FG000|NOT COMPLETED|Part II (MAD): 180 mg||0||
59651437|NCT04036227|75769456|FG001|NOT COMPLETED|Part II (MAD): 180 mg||0||
59651438|NCT04036227|75769457|FG002|NOT COMPLETED|Part II (MAD): 180 mg||0||
59651439|NCT04036227|75769458|FG003|NOT COMPLETED|Part II (MAD): 180 mg||0||
59651440|NCT04036227|75769459|FG004|NOT COMPLETED|Part II (MAD): 180 mg||0||
59651441|NCT04036227|75769460|FG005|NOT COMPLETED|Part II (MAD): 180 mg||0||
59651442|NCT04036227|75769461|FG006|NOT COMPLETED|Part II (MAD): 180 mg||0||
59651443|NCT04036227|75769462|FG007|NOT COMPLETED|Part II (MAD): 180 mg||0||
59651444|NCT04036227|75769463|FG008|NOT COMPLETED|Part II (MAD): 180 mg||0||
59651445|NCT04036227|75769464|FG009|NOT COMPLETED|Part II (MAD): 180 mg||1||
59651446|NCT04036227|75769465|FG010|NOT COMPLETED|Part II (MAD): 180 mg||0||
59651447|NCT04036227|75769455|FG000|STARTED|Part II (MAD): Placebo||0||
59651448|NCT04036227|75769456|FG001|STARTED|Part II (MAD): Placebo||0||
59651449|NCT04036227|75769457|FG002|STARTED|Part II (MAD): Placebo||0||
59651450|NCT04036227|75769458|FG003|STARTED|Part II (MAD): Placebo||0||
59651451|NCT04036227|75769459|FG004|STARTED|Part II (MAD): Placebo||0||
59651452|NCT04036227|75769460|FG005|STARTED|Part II (MAD): Placebo||0||
59651453|NCT04036227|75769461|FG006|STARTED|Part II (MAD): Placebo||0||
59651454|NCT04036227|75769462|FG007|STARTED|Part II (MAD): Placebo||0||
59651455|NCT04036227|75769463|FG008|STARTED|Part II (MAD): Placebo||0||
59651456|NCT04036227|75769464|FG009|STARTED|Part II (MAD): Placebo||0||
59651457|NCT04036227|75769465|FG010|STARTED|Part II (MAD): Placebo||6||
59651458|NCT04036227|75769455|FG000|COMPLETED|Part II (MAD): Placebo||0||
59651459|NCT04036227|75769456|FG001|COMPLETED|Part II (MAD): Placebo||0||
59651460|NCT04036227|75769457|FG002|COMPLETED|Part II (MAD): Placebo||0||
59651461|NCT04036227|75769458|FG003|COMPLETED|Part II (MAD): Placebo||0||
59651462|NCT04036227|75769459|FG004|COMPLETED|Part II (MAD): Placebo||0||
59651463|NCT04036227|75769460|FG005|COMPLETED|Part II (MAD): Placebo||0||
59651464|NCT04036227|75769461|FG006|COMPLETED|Part II (MAD): Placebo||0||
59651465|NCT04036227|75769462|FG007|COMPLETED|Part II (MAD): Placebo||0||
59651466|NCT04036227|75769463|FG008|COMPLETED|Part II (MAD): Placebo||0||
59651467|NCT04036227|75769464|FG009|COMPLETED|Part II (MAD): Placebo||0||
59651468|NCT04036227|75769465|FG010|COMPLETED|Part II (MAD): Placebo||6||
59651469|NCT04036227|75769455|FG000|NOT COMPLETED|Part II (MAD): Placebo||0||
59651470|NCT04036227|75769456|FG001|NOT COMPLETED|Part II (MAD): Placebo||0||
59651471|NCT04036227|75769457|FG002|NOT COMPLETED|Part II (MAD): Placebo||0||
59651472|NCT04036227|75769458|FG003|NOT COMPLETED|Part II (MAD): Placebo||0||
59651473|NCT04036227|75769459|FG004|NOT COMPLETED|Part II (MAD): Placebo||0||
59651474|NCT04036227|75769460|FG005|NOT COMPLETED|Part II (MAD): Placebo||0||
59651475|NCT04036227|75769461|FG006|NOT COMPLETED|Part II (MAD): Placebo||0||
59651476|NCT04036227|75769462|FG007|NOT COMPLETED|Part II (MAD): Placebo||0||
59651477|NCT04036227|75769463|FG008|NOT COMPLETED|Part II (MAD): Placebo||0||
59651478|NCT04036227|75769464|FG009|NOT COMPLETED|Part II (MAD): Placebo||0||
59651479|NCT04036227|75769465|FG010|NOT COMPLETED|Part II (MAD): Placebo||0||
59651480|NCT04034004|75769548|FG000|STARTED|Overall Study||18||
59651481|NCT04034004|75769549|FG001|STARTED|Overall Study||18||
59651482|NCT04034004|75769550|FG002|STARTED|Overall Study||17||
59651483|NCT04034004|75769551|FG003|STARTED|Overall Study||18||
59651484|NCT04034004|75769548|FG000|COMPLETED|Overall Study||15||
59651485|NCT04034004|75769549|FG001|COMPLETED|Overall Study||15||
59543349|NCT02223455|75641584|FG002|NOT COMPLETED|Overall Study||||0
59543350|NCT02460978|75641595|FG000|STARTED|Overall Study||271||
59543351|NCT02460978|75641596|FG001|STARTED|Overall Study||270||
59543352|NCT02460978|75641597|FG002|STARTED|Overall Study||272||
59543353|NCT02460978|75641595|FG000|COMPLETED|Overall Study||244||
59543354|NCT02460978|75641596|FG001|COMPLETED|Overall Study||245||
59543355|NCT02460978|75641597|FG002|COMPLETED|Overall Study||239||
59543356|NCT02460978|75641595|FG000|NOT COMPLETED|Overall Study||27||
59543357|NCT02460978|75641596|FG001|NOT COMPLETED|Overall Study||25||
59543358|NCT02460978|75641597|FG002|NOT COMPLETED|Overall Study||33||
59543359|NCT02221739|75641605|FG000|STARTED|Overall Study||39||
59543360|NCT02221739|75641605|FG000|COMPLETED|Overall Study||21||
59543361|NCT02221739|75641605|FG000|NOT COMPLETED|Overall Study||18||
59543362|NCT02489448|75641612|FG000|STARTED|Overall Study||68||
59651486|NCT04034004|75769550|FG002|COMPLETED|Overall Study||15||
59651487|NCT04034004|75769551|FG003|COMPLETED|Overall Study||14||
59651488|NCT04034004|75769548|FG000|NOT COMPLETED|Overall Study||3||
59651489|NCT04034004|75769549|FG001|NOT COMPLETED|Overall Study||3||
59543363|NCT02489448|75641612|FG000|Phase 1 Started|Overall Study||7||
59543364|NCT02489448|75641612|FG000|3 mg Dose|Overall Study||4||
59543365|NCT02489448|75641612|FG000|10 mg Dose|Overall Study||3||
59543366|NCT02489448|75641612|FG000|Phase 1 Completed|Overall Study||7||
59543367|NCT02489448|75641612|FG000|Phase 2 Started|Overall Study||61||
59543368|NCT02489448|75641612|FG000|Phase 2 Completed|Overall Study|56 phase 2 patients had surgery to be assessed for the primary outcome.|56||
59651490|NCT04034004|75769550|FG002|NOT COMPLETED|Overall Study||2||
59651491|NCT04034004|75769551|FG003|NOT COMPLETED|Overall Study||4||
59651492|NCT03957473|75769559|FG000|STARTED|Overall Study||400||
59651493|NCT03957473|75769559|FG000|COMPLETED|Overall Study||370||
59651494|NCT03957473|75769559|FG000|NOT COMPLETED|Overall Study||30||
59651495|NCT03848065|75769566|FG000|STARTED|Overall Study||44||
59651496|NCT03848065|75769567|FG001|STARTED|Overall Study||45||
59651497|NCT03848065|75769568|FG002|STARTED|Overall Study||44||
59651498|NCT03848065|75769566|FG000|Vaccination 1|Overall Study||44||
59651499|NCT03848065|75769567|FG001|Vaccination 1|Overall Study||45||
59651500|NCT03848065|75769568|FG002|Vaccination 1|Overall Study||43||
59651501|NCT03848065|75769566|FG000|Vaccination 2|Overall Study||44||
59651502|NCT03848065|75769567|FG001|Vaccination 2|Overall Study||45||
59651503|NCT03848065|75769568|FG002|Vaccination 2|Overall Study||43||
59651504|NCT03848065|75769566|FG000|Vaccination 3|Overall Study||44||
59651505|NCT03848065|75769567|FG001|Vaccination 3|Overall Study||45||
59651506|NCT03848065|75769568|FG002|Vaccination 3|Overall Study||42||
59651507|NCT03848065|75769566|FG000|Vaccination 4|Overall Study||44||
59651508|NCT03848065|75769567|FG001|Vaccination 4|Overall Study||44||
59651509|NCT03848065|75769568|FG002|Vaccination 4|Overall Study||42||
59651510|NCT03848065|75769566|FG000|COMPLETED|Overall Study||44||
59651511|NCT03848065|75769567|FG001|COMPLETED|Overall Study||44||
59651512|NCT03848065|75769568|FG002|COMPLETED|Overall Study||42||
59651513|NCT03848065|75769566|FG000|NOT COMPLETED|Overall Study||0||
59651514|NCT03848065|75769567|FG001|NOT COMPLETED|Overall Study||1||
59651515|NCT03848065|75769568|FG002|NOT COMPLETED|Overall Study||2||
59651516|NCT03629223|75769579|FG000|STARTED|Treatment Period 1 (21 Days)||20||
59651517|NCT03629223|75769580|FG001|STARTED|Treatment Period 1 (21 Days)||20||
59651518|NCT03629223|75769581|FG002|STARTED|Treatment Period 1 (21 Days)||6||
59651519|NCT03629223|75769582|FG003|STARTED|Treatment Period 1 (21 Days)||8||
59651520|NCT03629223|75769583|FG004|STARTED|Treatment Period 1 (21 Days)||6||
59651521|NCT03629223|75769584|FG005|STARTED|Treatment Period 1 (21 Days)||6||
59651522|NCT03629223|75769579|FG000|COMPLETED|Treatment Period 1 (21 Days)||20||
59651523|NCT03629223|75769580|FG001|COMPLETED|Treatment Period 1 (21 Days)||18||
59651524|NCT03629223|75769581|FG002|COMPLETED|Treatment Period 1 (21 Days)||6||
59651525|NCT03629223|75769582|FG003|COMPLETED|Treatment Period 1 (21 Days)||6||
59651526|NCT03629223|75769583|FG004|COMPLETED|Treatment Period 1 (21 Days)||6||
59651527|NCT03629223|75769584|FG005|COMPLETED|Treatment Period 1 (21 Days)||6||
59651528|NCT03629223|75769579|FG000|NOT COMPLETED|Treatment Period 1 (21 Days)||0||
59651529|NCT03629223|75769580|FG001|NOT COMPLETED|Treatment Period 1 (21 Days)||2||
59651530|NCT03629223|75769581|FG002|NOT COMPLETED|Treatment Period 1 (21 Days)||0||
59651531|NCT03629223|75769582|FG003|NOT COMPLETED|Treatment Period 1 (21 Days)||2||
59651532|NCT03629223|75769583|FG004|NOT COMPLETED|Treatment Period 1 (21 Days)||0||
59651533|NCT03629223|75769584|FG005|NOT COMPLETED|Treatment Period 1 (21 Days)||0||
59651534|NCT03629223|75769579|FG000|STARTED|Treatment Period 2 (21 Days)||20||
59651535|NCT03629223|75769580|FG001|STARTED|Treatment Period 2 (21 Days)||18||
59651536|NCT03629223|75769581|FG002|STARTED|Treatment Period 2 (21 Days)||6||
59651537|NCT03629223|75769582|FG003|STARTED|Treatment Period 2 (21 Days)||6||
59988690|NCT02361346|76103923|FG007|STARTED|Part 1 and 2 ( Up to Day 112)||0||
59651538|NCT03629223|75769583|FG004|STARTED|Treatment Period 2 (21 Days)||6||
59651539|NCT03629223|75769584|FG005|STARTED|Treatment Period 2 (21 Days)||6||
59651540|NCT03629223|75769579|FG000|COMPLETED|Treatment Period 2 (21 Days)||19||
59651541|NCT03629223|75769580|FG001|COMPLETED|Treatment Period 2 (21 Days)||18||
59651542|NCT03629223|75769581|FG002|COMPLETED|Treatment Period 2 (21 Days)||6||
59651543|NCT03629223|75769582|FG003|COMPLETED|Treatment Period 2 (21 Days)||6||
59651544|NCT03629223|75769583|FG004|COMPLETED|Treatment Period 2 (21 Days)||6||
59651545|NCT03629223|75769584|FG005|COMPLETED|Treatment Period 2 (21 Days)||6||
59651546|NCT03629223|75769579|FG000|NOT COMPLETED|Treatment Period 2 (21 Days)||1||
59651547|NCT03629223|75769580|FG001|NOT COMPLETED|Treatment Period 2 (21 Days)||0||
59651548|NCT03629223|75769581|FG002|NOT COMPLETED|Treatment Period 2 (21 Days)||0||
59651549|NCT03629223|75769582|FG003|NOT COMPLETED|Treatment Period 2 (21 Days)||0||
59651550|NCT03629223|75769583|FG004|NOT COMPLETED|Treatment Period 2 (21 Days)||0||
59651551|NCT03629223|75769584|FG005|NOT COMPLETED|Treatment Period 2 (21 Days)||0||
59651552|NCT03547908|75769600|FG000|STARTED|Overall Study||122||
59651553|NCT03547908|75769601|FG001|STARTED|Overall Study||122||
59651554|NCT03547908|75769600|FG000|COMPLETED|Overall Study||0||
59651555|NCT03547908|75769601|FG001|COMPLETED|Overall Study||0||
59651556|NCT03547908|75769600|FG000|NOT COMPLETED|Overall Study||122||
59651557|NCT03547908|75769601|FG001|NOT COMPLETED|Overall Study||122||
59651558|NCT03395405|75769609|FG000|STARTED|Overall Study||16||
59651559|NCT03395405|75769610|FG001|STARTED|Overall Study||15||
59651560|NCT03395405|75769609|FG000|COMPLETED|Overall Study||12||
59651561|NCT03395405|75769610|FG001|COMPLETED|Overall Study||10||
59988691|NCT02361346|76103924|FG008|STARTED|Part 1 and 2 ( Up to Day 112)||0||
59651562|NCT03395405|75769609|FG000|NOT COMPLETED|Overall Study||4||
59651563|NCT03395405|75769610|FG001|NOT COMPLETED|Overall Study||5||
59651564|NCT03381248|75769618|FG000|STARTED|0-6 Months||89||
59651565|NCT03381248|75769619|FG001|STARTED|0-6 Months||88||
59651566|NCT03381248|75769618|FG000|COMPLETED|0-6 Months||76|Completion is with respect to the 6-month primary outcome.|
59651567|NCT03381248|75769619|FG001|COMPLETED|0-6 Months||82|Completion is with respect to the 6-month primary outcome.|
59651568|NCT03381248|75769618|FG000|NOT COMPLETED|0-6 Months||13||
59651569|NCT03381248|75769619|FG001|NOT COMPLETED|0-6 Months||6||
59651570|NCT03381248|75769618|FG000|STARTED|6-12 Months||76||
59651571|NCT03381248|75769619|FG001|STARTED|6-12 Months||82||
59651572|NCT03381248|75769618|FG000|Received Crossover Treatment|6-12 Months||0||
59651573|NCT03381248|75769619|FG001|Received Crossover Treatment|6-12 Months||68||
59651574|NCT03381248|75769618|FG000|COMPLETED|6-12 Months||66||
59651575|NCT03381248|75769619|FG001|COMPLETED|6-12 Months||73||
59651576|NCT03381248|75769618|FG000|NOT COMPLETED|6-12 Months||10||
59651577|NCT03381248|75769619|FG001|NOT COMPLETED|6-12 Months||9||
59651578|NCT03381248|75769618|FG000|STARTED|12 - 24 Months (Extension Study)|9 subjects ineligible as site was not participating in extension phase of study; 21 additional eligible subjects chose not to participate in extension phase of study|36||
59651579|NCT03381248|75769619|FG001|STARTED|12 - 24 Months (Extension Study)||0||
59651580|NCT03381248|75769618|FG000|COMPLETED|12 - 24 Months (Extension Study)||27||
59651581|NCT03381248|75769619|FG001|COMPLETED|12 - 24 Months (Extension Study)||0||
59651582|NCT03381248|75769618|FG000|NOT COMPLETED|12 - 24 Months (Extension Study)||9||
59651583|NCT03381248|75769619|FG001|NOT COMPLETED|12 - 24 Months (Extension Study)||0||
59651584|NCT03354663|75769630|FG000|STARTED|Enrollment to Catheter Insertion||156||
59651585|NCT03354663|75769630|FG000|COMPLETED|Enrollment to Catheter Insertion||151||
59651586|NCT03354663|75769630|FG000|NOT COMPLETED|Enrollment to Catheter Insertion||5||
59651587|NCT03354663|75769630|FG000|STARTED|Completed 30-day Visit||151||
59651588|NCT03354663|75769630|FG000|COMPLETED|Completed 30-day Visit||149||
59651589|NCT03354663|75769630|FG000|NOT COMPLETED|Completed 30-day Visit||2||
59651590|NCT03305419|75769646|FG000|STARTED|Part A Period 1 (1Day) + Washout (7days)||3|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59651591|NCT03305419|75769647|FG001|STARTED|Part A Period 1 (1Day) + Washout (7days)||3|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59651592|NCT03305419|75769648|FG002|STARTED|Part A Period 1 (1Day) + Washout (7days)||3|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59651593|NCT03305419|75769649|FG003|STARTED|Part A Period 1 (1Day) + Washout (7days)||3|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59651594|NCT03305419|75769650|FG004|STARTED|Part A Period 1 (1Day) + Washout (7days)||0|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59651595|NCT03305419|75769651|FG005|STARTED|Part A Period 1 (1Day) + Washout (7days)||0|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59651596|NCT03305419|75769652|FG006|STARTED|Part A Period 1 (1Day) + Washout (7days)||0|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59651597|NCT03305419|75769653|FG007|STARTED|Part A Period 1 (1Day) + Washout (7days)||0|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59651598|NCT03305419|75769646|FG000|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||3|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59651599|NCT03305419|75769647|FG001|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||2|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59651600|NCT03305419|75769648|FG002|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||3|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59651601|NCT03305419|75769649|FG003|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||3|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59651602|NCT03305419|75769650|FG004|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59651603|NCT03305419|75769651|FG005|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59651604|NCT03305419|75769652|FG006|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59651605|NCT03305419|75769653|FG007|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59651606|NCT03305419|75769646|FG000|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0||
59651607|NCT03305419|75769647|FG001|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||1||
59651608|NCT03305419|75769648|FG002|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0||
59651609|NCT03305419|75769649|FG003|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0||
59651610|NCT03305419|75769650|FG004|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0||
59651611|NCT03305419|75769651|FG005|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0||
59651612|NCT03305419|75769652|FG006|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0||
59651613|NCT03305419|75769653|FG007|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0||
59651614|NCT03305419|75769646|FG000|STARTED|Part A Period 2 (1Day) + Washout (7days)||3|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59651615|NCT03305419|75769647|FG001|STARTED|Part A Period 2 (1Day) + Washout (7days)|1 participant was added to GSK2982772 120 mg TID/240 mg TID/Placebo arm|3|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59651616|NCT03305419|75769648|FG002|STARTED|Part A Period 2 (1Day) + Washout (7days)||3|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59651617|NCT03305419|75769649|FG003|STARTED|Part A Period 2 (1Day) + Washout (7days)||3|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59651618|NCT03305419|75769650|FG004|STARTED|Part A Period 2 (1Day) + Washout (7days)||0|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59651619|NCT03305419|75769651|FG005|STARTED|Part A Period 2 (1Day) + Washout (7days)||0|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59709842|NCT01072149|75828536|FG016|STARTED|Treatment Period 2 (28 Days)||3||
59651620|NCT03305419|75769652|FG006|STARTED|Part A Period 2 (1Day) + Washout (7days)||0|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59651621|NCT03305419|75769653|FG007|STARTED|Part A Period 2 (1Day) + Washout (7days)||0|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59651622|NCT03305419|75769646|FG000|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||1|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59651623|NCT03305419|75769647|FG001|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||3|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59651624|NCT03305419|75769648|FG002|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||3|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59651625|NCT03305419|75769649|FG003|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||3|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59651626|NCT03305419|75769650|FG004|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59651627|NCT03305419|75769651|FG005|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59651628|NCT03305419|75769652|FG006|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59651629|NCT03305419|75769653|FG007|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0|Par. discontinuation was only collected at FU visits.Thus, treatment & washout periods are combined|
59651630|NCT03305419|75769646|FG000|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||2||
59651631|NCT03305419|75769647|FG001|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0||
59651632|NCT03305419|75769648|FG002|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0||
59651633|NCT03305419|75769649|FG003|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0||
59651634|NCT03305419|75769650|FG004|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0||
59651635|NCT03305419|75769651|FG005|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0||
59651636|NCT03305419|75769652|FG006|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0||
59651637|NCT03305419|75769653|FG007|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0||
59651638|NCT03305419|75769646|FG000|STARTED|Part A Period 3 (1Day) + Washout (7days)|2 participants were added to GSK2982772 120 mg TID/240 mg TID/360 mg BID arm after Washout Period.|3||
59651639|NCT03305419|75769647|FG001|STARTED|Part A Period 3 (1Day) + Washout (7days)||3||
59651640|NCT03305419|75769648|FG002|STARTED|Part A Period 3 (1Day) + Washout (7days)||3||
59651641|NCT03305419|75769649|FG003|STARTED|Part A Period 3 (1Day) + Washout (7days)||3||
59651642|NCT03305419|75769650|FG004|STARTED|Part A Period 3 (1Day) + Washout (7days)||0||
59651643|NCT03305419|75769651|FG005|STARTED|Part A Period 3 (1Day) + Washout (7days)||0||
59651644|NCT03305419|75769652|FG006|STARTED|Part A Period 3 (1Day) + Washout (7days)||0||
59651645|NCT03305419|75769653|FG007|STARTED|Part A Period 3 (1Day) + Washout (7days)||0||
59651646|NCT03305419|75769646|FG000|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||3||
59651647|NCT03305419|75769647|FG001|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||3||
59651648|NCT03305419|75769648|FG002|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||3||
59651649|NCT03305419|75769649|FG003|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||3||
59651650|NCT03305419|75769650|FG004|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0||
59651651|NCT03305419|75769651|FG005|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0||
59651652|NCT03305419|75769652|FG006|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0||
59651653|NCT03305419|75769653|FG007|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0||
59651654|NCT03305419|75769646|FG000|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0||
59651655|NCT03305419|75769647|FG001|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0||
59651656|NCT03305419|75769648|FG002|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0||
59651657|NCT03305419|75769649|FG003|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0||
59651658|NCT03305419|75769650|FG004|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0||
59651659|NCT03305419|75769651|FG005|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0||
59651660|NCT03305419|75769652|FG006|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0||
59651661|NCT03305419|75769653|FG007|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0||
59651662|NCT03305419|75769646|FG000|STARTED|Part B (14 Days)||0||
59651663|NCT03305419|75769647|FG001|STARTED|Part B (14 Days)||0||
59651664|NCT03305419|75769648|FG002|STARTED|Part B (14 Days)||0||
59651665|NCT03305419|75769649|FG003|STARTED|Part B (14 Days)||0||
59651666|NCT03305419|75769650|FG004|STARTED|Part B (14 Days)||14||
59651667|NCT03305419|75769651|FG005|STARTED|Part B (14 Days)||20||
59651668|NCT03305419|75769652|FG006|STARTED|Part B (14 Days)||13||
59651669|NCT03305419|75769653|FG007|STARTED|Part B (14 Days)||0||
59651670|NCT03305419|75769646|FG000|COMPLETED|Part B (14 Days)||0||
59651671|NCT03305419|75769647|FG001|COMPLETED|Part B (14 Days)||0||
59651672|NCT03305419|75769648|FG002|COMPLETED|Part B (14 Days)||0||
59651673|NCT03305419|75769649|FG003|COMPLETED|Part B (14 Days)||0||
59651674|NCT03305419|75769650|FG004|COMPLETED|Part B (14 Days)||11||
59651675|NCT03305419|75769651|FG005|COMPLETED|Part B (14 Days)||10||
59651676|NCT03305419|75769652|FG006|COMPLETED|Part B (14 Days)||8||
59651677|NCT03305419|75769653|FG007|COMPLETED|Part B (14 Days)||0||
59651678|NCT03305419|75769646|FG000|NOT COMPLETED|Part B (14 Days)||0||
59651679|NCT03305419|75769647|FG001|NOT COMPLETED|Part B (14 Days)||0||
59651680|NCT03305419|75769648|FG002|NOT COMPLETED|Part B (14 Days)||0||
59651681|NCT03305419|75769649|FG003|NOT COMPLETED|Part B (14 Days)||0||
59651682|NCT03305419|75769650|FG004|NOT COMPLETED|Part B (14 Days)||3||
59651683|NCT03305419|75769651|FG005|NOT COMPLETED|Part B (14 Days)||10||
59651684|NCT03305419|75769652|FG006|NOT COMPLETED|Part B (14 Days)||5||
59651685|NCT03305419|75769653|FG007|NOT COMPLETED|Part B (14 Days)||0||
59651686|NCT03190967|75769679|FG000|STARTED|Level 1 Dose Escalation||3||
59651687|NCT03190967|75769680|FG001|STARTED|Level 1 Dose Escalation||0||
59651688|NCT03190967|75769681|FG002|STARTED|Level 1 Dose Escalation||0||
59651689|NCT03190967|75769682|FG003|STARTED|Level 1 Dose Escalation||0||
59651690|NCT03190967|75769683|FG004|STARTED|Level 1 Dose Escalation||0||
59651691|NCT03190967|75769679|FG000|COMPLETED|Level 1 Dose Escalation||3||
59651692|NCT03190967|75769680|FG001|COMPLETED|Level 1 Dose Escalation||0||
59651693|NCT03190967|75769681|FG002|COMPLETED|Level 1 Dose Escalation||0||
59651694|NCT03190967|75769682|FG003|COMPLETED|Level 1 Dose Escalation||0||
59651695|NCT03190967|75769683|FG004|COMPLETED|Level 1 Dose Escalation||0||
59651696|NCT03190967|75769679|FG000|NOT COMPLETED|Level 1 Dose Escalation||0||
59651697|NCT03190967|75769680|FG001|NOT COMPLETED|Level 1 Dose Escalation||0||
59651698|NCT03190967|75769681|FG002|NOT COMPLETED|Level 1 Dose Escalation||0||
59651699|NCT03190967|75769682|FG003|NOT COMPLETED|Level 1 Dose Escalation||0||
59651700|NCT03190967|75769683|FG004|NOT COMPLETED|Level 1 Dose Escalation||0||
59651701|NCT03190967|75769679|FG000|STARTED|Level 2||0||
59651702|NCT03190967|75769680|FG001|STARTED|Level 2||3||
59651703|NCT03190967|75769681|FG002|STARTED|Level 2||0||
59651704|NCT03190967|75769682|FG003|STARTED|Level 2||0||
59651705|NCT03190967|75769683|FG004|STARTED|Level 2||0||
59651706|NCT03190967|75769679|FG000|COMPLETED|Level 2||0||
59651707|NCT03190967|75769680|FG001|COMPLETED|Level 2||3||
59651708|NCT03190967|75769681|FG002|COMPLETED|Level 2||0||
59651709|NCT03190967|75769682|FG003|COMPLETED|Level 2||0||
59651710|NCT03190967|75769683|FG004|COMPLETED|Level 2||0||
59651711|NCT03190967|75769679|FG000|NOT COMPLETED|Level 2||0||
59651712|NCT03190967|75769680|FG001|NOT COMPLETED|Level 2||0||
59651713|NCT03190967|75769681|FG002|NOT COMPLETED|Level 2||0||
59651714|NCT03190967|75769682|FG003|NOT COMPLETED|Level 2||0||
59651715|NCT03190967|75769683|FG004|NOT COMPLETED|Level 2||0||
59651716|NCT03190967|75769679|FG000|STARTED|Level 3||0||
59651717|NCT03190967|75769680|FG001|STARTED|Level 3||0||
59815790|NCT03026283|75938216|FG005|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0||
59995454|NCT02675114|76111276|FG000|Valve Implant|Overall Study||453||
59543369|NCT02489448|75641612|FG000|COMPLETED|Overall Study|The total comes from: 7 Phase 1 patients and 56 Phase 2 patients with surgery to be assessed for the primary outcome. 5 Phase 2 patients did not complete the study.|63||
59543370|NCT02489448|75641612|FG000|NOT COMPLETED|Overall Study||5||
59543371|NCT00926588|75641619|FG000|STARTED|Overall Study||124||
59543372|NCT00926588|75641620|FG001|STARTED|Overall Study||126||
59543373|NCT00926588|75641619|FG000|COMPLETED|Overall Study||116||
59543374|NCT00926588|75641620|FG001|COMPLETED|Overall Study||122||
59543375|NCT00926588|75641619|FG000|NOT COMPLETED|Overall Study||8||
59543376|NCT00926588|75641620|FG001|NOT COMPLETED|Overall Study||4||
59543377|NCT04365452|75641626|FG000|STARTED|Overall Study||20||
59543378|NCT04365452|75641626|FG000|COMPLETED|Overall Study||20||
59543379|NCT04365452|75641626|FG000|NOT COMPLETED|Overall Study||0||
59651718|NCT03190967|75769681|FG002|STARTED|Level 3||6||
59651719|NCT03190967|75769682|FG003|STARTED|Level 3||0||
59651720|NCT03190967|75769683|FG004|STARTED|Level 3||0||
59651721|NCT03190967|75769679|FG000|COMPLETED|Level 3||0||
59651722|NCT03190967|75769680|FG001|COMPLETED|Level 3||0||
59651723|NCT03190967|75769681|FG002|COMPLETED|Level 3||6||
59651724|NCT03190967|75769682|FG003|COMPLETED|Level 3||0||
59651725|NCT03190967|75769683|FG004|COMPLETED|Level 3||0||
59651726|NCT03190967|75769679|FG000|NOT COMPLETED|Level 3||0||
59651727|NCT03190967|75769680|FG001|NOT COMPLETED|Level 3||0||
59651728|NCT03190967|75769681|FG002|NOT COMPLETED|Level 3||0||
59651729|NCT03190967|75769682|FG003|NOT COMPLETED|Level 3||0||
59651730|NCT03190967|75769683|FG004|NOT COMPLETED|Level 3||0||
59651731|NCT03096782|75769696|FG000|STARTED|Overall Study||6||
59651732|NCT03096782|75769696|FG000|COMPLETED|Overall Study||4||
59651733|NCT03096782|75769696|FG000|NOT COMPLETED|Overall Study||2||
59651734|NCT03070236|75769702|FG000|STARTED|Overall Study||912||
59651735|NCT03070236|75769702|FG000|Guideline Concordant Care (GCC) Arm|Overall Study||538||
59651736|NCT03070236|75769702|FG000|Active Surveillance (AS) Arm|Overall Study||374||
59651737|NCT03070236|75769702|FG000|COMPLETED|Overall Study||912||
59651738|NCT03070236|75769702|FG000|NOT COMPLETED|Overall Study||0||
59651739|NCT03052049|75769707|FG000|STARTED|Overall Study|28 subjects were enrolled between October 2017 and January 2020.|28||
59651740|NCT03052049|75769707|FG000|COMPLETED|Overall Study|26 subjects were treated and 2 withdrew before treatment.|26||
59651741|NCT03052049|75769707|FG000|NOT COMPLETED|Overall Study||2||
59651742|NCT03036657|75769714|FG000|STARTED|Overall Study||20||
59651743|NCT03036657|75769715|FG001|STARTED|Overall Study||20||
59651744|NCT03036657|75769716|FG002|STARTED|Overall Study||20||
59651745|NCT03036657|75769714|FG000|COMPLETED|Overall Study||20||
59651746|NCT03036657|75769715|FG001|COMPLETED|Overall Study||20||
59651747|NCT03036657|75769716|FG002|COMPLETED|Overall Study||20||
59651748|NCT03036657|75769714|FG000|NOT COMPLETED|Overall Study||0||
59651749|NCT03036657|75769715|FG001|NOT COMPLETED|Overall Study||0||
59651750|NCT03036657|75769716|FG002|NOT COMPLETED|Overall Study||0||
59651751|NCT03019536|75769727|FG000|STARTED|Overall Study||6||
59651752|NCT03019536|75769728|FG001|STARTED|Overall Study||7||
59651753|NCT03019536|75769729|FG002|STARTED|Overall Study||9||
59651754|NCT03019536|75769727|FG000|Received at Least One Dose of Study Drug|Overall Study||6||
59651755|NCT03019536|75769728|FG001|Received at Least One Dose of Study Drug|Overall Study||7||
59651756|NCT03019536|75769729|FG002|Received at Least One Dose of Study Drug|Overall Study||9||
59651757|NCT03019536|75769727|FG000|COMPLETED|Overall Study||5||
59651758|NCT03019536|75769728|FG001|COMPLETED|Overall Study||6||
59651759|NCT03019536|75769729|FG002|COMPLETED|Overall Study||7||
59651760|NCT03019536|75769727|FG000|NOT COMPLETED|Overall Study||1||
59651761|NCT03019536|75769728|FG001|NOT COMPLETED|Overall Study||1||
59651762|NCT03019536|75769729|FG002|NOT COMPLETED|Overall Study||2||
59651763|NCT02673775|75769739|FG000|STARTED|First Exposure||25||
59651764|NCT02673775|75769740|FG001|STARTED|First Exposure||37||
59651765|NCT02673775|75769739|FG000|COMPLETED|First Exposure||25||
59651766|NCT02673775|75769740|FG001|COMPLETED|First Exposure||37||
59651767|NCT02673775|75769739|FG000|NOT COMPLETED|First Exposure||0||
59651768|NCT02673775|75769740|FG001|NOT COMPLETED|First Exposure||0||
59651769|NCT02673775|75769739|FG000|STARTED|Washout (at Least 2 Weeks)||25||
59651770|NCT02673775|75769740|FG001|STARTED|Washout (at Least 2 Weeks)||37||
59651771|NCT02673775|75769739|FG000|COMPLETED|Washout (at Least 2 Weeks)||21||
59651772|NCT02673775|75769740|FG001|COMPLETED|Washout (at Least 2 Weeks)||33||
59651773|NCT02673775|75769739|FG000|NOT COMPLETED|Washout (at Least 2 Weeks)||4||
59651774|NCT02673775|75769740|FG001|NOT COMPLETED|Washout (at Least 2 Weeks)||4||
59651775|NCT02673775|75769739|FG000|STARTED|Second Exposure||21||
59651776|NCT02673775|75769740|FG001|STARTED|Second Exposure||33||
59651777|NCT02673775|75769739|FG000|COMPLETED|Second Exposure||21||
59651778|NCT02673775|75769740|FG001|COMPLETED|Second Exposure||33||
59651779|NCT02673775|75769739|FG000|NOT COMPLETED|Second Exposure||0||
59651780|NCT02673775|75769740|FG001|NOT COMPLETED|Second Exposure||0||
59651781|NCT02666768|75769746|FG000|STARTED|Overall Study||5||
59651782|NCT02666768|75769746|FG000|COMPLETED|Overall Study||1||
59651783|NCT02666768|75769746|FG000|NOT COMPLETED|Overall Study||4||
59651784|NCT02471144|75769754|FG000|STARTED|Induction Period (Up to Week 12)||40||
59651785|NCT02471144|75769755|FG001|STARTED|Induction Period (Up to Week 12)||40||
59651786|NCT02471144|75769756|FG002|STARTED|Induction Period (Up to Week 12)||41||
59651787|NCT02471144|75769757|FG003|STARTED|Induction Period (Up to Week 12)||41||
59651788|NCT02471144|75769758|FG004|STARTED|Induction Period (Up to Week 12)||0||
59651789|NCT02471144|75769759|FG005|STARTED|Induction Period (Up to Week 12)||0||
59651790|NCT02471144|75769760|FG006|STARTED|Induction Period (Up to Week 12)||0||
59651791|NCT02471144|75769761|FG007|STARTED|Induction Period (Up to Week 12)||0||
59651792|NCT02471144|75769762|FG008|STARTED|Induction Period (Up to Week 12)||0||
59651793|NCT02471144|75769763|FG009|STARTED|Induction Period (Up to Week 12)||0||
59651794|NCT02471144|75769764|FG010|STARTED|Induction Period (Up to Week 12)||0||
59651795|NCT02471144|75769754|FG000|COMPLETED|Induction Period (Up to Week 12)||39||
59651796|NCT02471144|75769755|FG001|COMPLETED|Induction Period (Up to Week 12)||38||
59651797|NCT02471144|75769756|FG002|COMPLETED|Induction Period (Up to Week 12)||39||
59651798|NCT02471144|75769757|FG003|COMPLETED|Induction Period (Up to Week 12)||40||
59651799|NCT02471144|75769758|FG004|COMPLETED|Induction Period (Up to Week 12)||0||
59651800|NCT02471144|75769759|FG005|COMPLETED|Induction Period (Up to Week 12)||0||
59651801|NCT02471144|75769760|FG006|COMPLETED|Induction Period (Up to Week 12)||0||
59651802|NCT02471144|75769761|FG007|COMPLETED|Induction Period (Up to Week 12)||0||
59651803|NCT02471144|75769762|FG008|COMPLETED|Induction Period (Up to Week 12)||0||
59651804|NCT02471144|75769763|FG009|COMPLETED|Induction Period (Up to Week 12)||0||
59651805|NCT02471144|75769764|FG010|COMPLETED|Induction Period (Up to Week 12)||0||
59651806|NCT02471144|75769754|FG000|NOT COMPLETED|Induction Period (Up to Week 12)||1||
59651807|NCT02471144|75769755|FG001|NOT COMPLETED|Induction Period (Up to Week 12)||2||
59651808|NCT02471144|75769756|FG002|NOT COMPLETED|Induction Period (Up to Week 12)||2||
59651809|NCT02471144|75769757|FG003|NOT COMPLETED|Induction Period (Up to Week 12)||1||
59995455|NCT02675114|76111277|FG001|Valve Implant|Overall Study||495||
59995456|NCT02675114|76111276|FG000|COMPLETED|Overall Study||424||
59995457|NCT02675114|76111277|FG001|COMPLETED|Overall Study||490||
59995458|NCT02675114|76111276|FG000|NOT COMPLETED|Overall Study||73||
59995459|NCT02675114|76111277|FG001|NOT COMPLETED|Overall Study||13||
59995460|NCT02155946|76111287|FG000|STARTED|Overall Study||29||
59995461|NCT02155946|76111288|FG001|STARTED|Overall Study||25||
59995462|NCT02155946|76111289|FG002|STARTED|Overall Study||29||
59651810|NCT02471144|75769758|FG004|NOT COMPLETED|Induction Period (Up to Week 12)||0||
59651811|NCT02471144|75769759|FG005|NOT COMPLETED|Induction Period (Up to Week 12)||0||
59651812|NCT02471144|75769760|FG006|NOT COMPLETED|Induction Period (Up to Week 12)||0||
59651813|NCT02471144|75769761|FG007|NOT COMPLETED|Induction Period (Up to Week 12)||0||
59651814|NCT02471144|75769762|FG008|NOT COMPLETED|Induction Period (Up to Week 12)||0||
59651815|NCT02471144|75769763|FG009|NOT COMPLETED|Induction Period (Up to Week 12)||0||
59651816|NCT02471144|75769764|FG010|NOT COMPLETED|Induction Period (Up to Week 12)||0||
59651817|NCT02471144|75769754|FG000|STARTED|Maintenance Period (Week 12 to Week 52)||0||
59651818|NCT02471144|75769755|FG001|STARTED|Maintenance Period (Week 12 to Week 52)||0||
59651819|NCT02471144|75769756|FG002|STARTED|Maintenance Period (Week 12 to Week 52)||0||
59651820|NCT02471144|75769757|FG003|STARTED|Maintenance Period (Week 12 to Week 52)||0||
59651821|NCT02471144|75769758|FG004|STARTED|Maintenance Period (Week 12 to Week 52)||39||
59651822|NCT02471144|75769759|FG005|STARTED|Maintenance Period (Week 12 to Week 52)||38||
59651823|NCT02471144|75769760|FG006|STARTED|Maintenance Period (Week 12 to Week 52)||16||
59651824|NCT02471144|75769761|FG007|STARTED|Maintenance Period (Week 12 to Week 52)||18||
59651825|NCT02471144|75769762|FG008|STARTED|Maintenance Period (Week 12 to Week 52)||40||
59651826|NCT02471144|75769763|FG009|STARTED|Maintenance Period (Week 12 to Week 52)||0||
59651827|NCT02471144|75769764|FG010|STARTED|Maintenance Period (Week 12 to Week 52)||0||
59651828|NCT02471144|75769754|FG000|COMPLETED|Maintenance Period (Week 12 to Week 52)||0||
59651829|NCT02471144|75769755|FG001|COMPLETED|Maintenance Period (Week 12 to Week 52)||0||
59651830|NCT02471144|75769756|FG002|COMPLETED|Maintenance Period (Week 12 to Week 52)||0||
59651831|NCT02471144|75769757|FG003|COMPLETED|Maintenance Period (Week 12 to Week 52)||0||
59651832|NCT02471144|75769758|FG004|COMPLETED|Maintenance Period (Week 12 to Week 52)||38||
59651833|NCT02471144|75769759|FG005|COMPLETED|Maintenance Period (Week 12 to Week 52)||37||
59651834|NCT02471144|75769760|FG006|COMPLETED|Maintenance Period (Week 12 to Week 52)||15||
59651835|NCT02471144|75769761|FG007|COMPLETED|Maintenance Period (Week 12 to Week 52)||16||
59651836|NCT02471144|75769762|FG008|COMPLETED|Maintenance Period (Week 12 to Week 52)||34||
59651837|NCT02471144|75769763|FG009|COMPLETED|Maintenance Period (Week 12 to Week 52)||0||
59651838|NCT02471144|75769764|FG010|COMPLETED|Maintenance Period (Week 12 to Week 52)||0||
59651839|NCT02471144|75769754|FG000|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||0||
59651840|NCT02471144|75769755|FG001|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||0||
59651841|NCT02471144|75769756|FG002|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||0||
59651842|NCT02471144|75769757|FG003|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||0||
59651843|NCT02471144|75769758|FG004|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||1||
59651844|NCT02471144|75769759|FG005|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||1||
59651845|NCT02471144|75769760|FG006|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||1||
59651846|NCT02471144|75769761|FG007|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||2||
59651847|NCT02471144|75769762|FG008|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||6||
59651848|NCT02471144|75769763|FG009|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||0||
59651849|NCT02471144|75769764|FG010|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||0||
59651850|NCT02471144|75769754|FG000|STARTED|Extension Period (Week 52 to Week 236)||0||
59651851|NCT02471144|75769755|FG001|STARTED|Extension Period (Week 52 to Week 236)||0||
59651852|NCT02471144|75769756|FG002|STARTED|Extension Period (Week 52 to Week 236)||0||
59651853|NCT02471144|75769757|FG003|STARTED|Extension Period (Week 52 to Week 236)||0||
59651854|NCT02471144|75769758|FG004|STARTED|Extension Period (Week 52 to Week 236)||0||
59543380|NCT02488980|75641633|FG000|STARTED|Overall Study||104||
59543381|NCT02488980|75641634|FG001|STARTED|Overall Study||101||
59543382|NCT02488980|75641635|FG002|STARTED|Overall Study||101||
59543383|NCT02488980|75641633|FG000|COMPLETED|Overall Study||102||
59543384|NCT02488980|75641634|FG001|COMPLETED|Overall Study||99||
59543385|NCT02488980|75641635|FG002|COMPLETED|Overall Study||99||
59543386|NCT02488980|75641633|FG000|NOT COMPLETED|Overall Study||2||
59543387|NCT02488980|75641634|FG001|NOT COMPLETED|Overall Study||2||
59543388|NCT02488980|75641635|FG002|NOT COMPLETED|Overall Study||2||
59543389|NCT02227667|75641643|FG000|STARTED|Overall Study||16||
59543390|NCT02227667|75641643|FG000|COMPLETED|Overall Study||16||
59543391|NCT02227667|75641643|FG000|NOT COMPLETED|Overall Study||0||
59651855|NCT02471144|75769759|FG005|STARTED|Extension Period (Week 52 to Week 236)||0||
59651856|NCT02471144|75769760|FG006|STARTED|Extension Period (Week 52 to Week 236)||0||
59651857|NCT02471144|75769761|FG007|STARTED|Extension Period (Week 52 to Week 236)||0||
59651858|NCT02471144|75769762|FG008|STARTED|Extension Period (Week 52 to Week 236)||0||
59651859|NCT02471144|75769763|FG009|STARTED|Extension Period (Week 52 to Week 236)||53||
59651860|NCT02471144|75769764|FG010|STARTED|Extension Period (Week 52 to Week 236)||53||
59651861|NCT02471144|75769754|FG000|COMPLETED|Extension Period (Week 52 to Week 236)||0||
59651862|NCT02471144|75769755|FG001|COMPLETED|Extension Period (Week 52 to Week 236)||0||
59651863|NCT02471144|75769756|FG002|COMPLETED|Extension Period (Week 52 to Week 236)||0||
59651864|NCT02471144|75769757|FG003|COMPLETED|Extension Period (Week 52 to Week 236)||0||
59651865|NCT02471144|75769758|FG004|COMPLETED|Extension Period (Week 52 to Week 236)||0||
59651866|NCT02471144|75769759|FG005|COMPLETED|Extension Period (Week 52 to Week 236)||0||
59651867|NCT02471144|75769760|FG006|COMPLETED|Extension Period (Week 52 to Week 236)||0||
59651868|NCT02471144|75769761|FG007|COMPLETED|Extension Period (Week 52 to Week 236)||0||
59651869|NCT02471144|75769762|FG008|COMPLETED|Extension Period (Week 52 to Week 236)||0||
59651870|NCT02471144|75769763|FG009|COMPLETED|Extension Period (Week 52 to Week 236)||39||
59651871|NCT02471144|75769764|FG010|COMPLETED|Extension Period (Week 52 to Week 236)||43||
59651872|NCT02471144|75769754|FG000|NOT COMPLETED|Extension Period (Week 52 to Week 236)||0||
59651873|NCT02471144|75769755|FG001|NOT COMPLETED|Extension Period (Week 52 to Week 236)||0||
59651874|NCT02471144|75769756|FG002|NOT COMPLETED|Extension Period (Week 52 to Week 236)||0||
59651875|NCT02471144|75769757|FG003|NOT COMPLETED|Extension Period (Week 52 to Week 236)||0||
59651876|NCT02471144|75769758|FG004|NOT COMPLETED|Extension Period (Week 52 to Week 236)||0||
59651877|NCT02471144|75769759|FG005|NOT COMPLETED|Extension Period (Week 52 to Week 236)||0||
59651878|NCT02471144|75769760|FG006|NOT COMPLETED|Extension Period (Week 52 to Week 236)||0||
59651879|NCT02471144|75769761|FG007|NOT COMPLETED|Extension Period (Week 52 to Week 236)||0||
59651880|NCT02471144|75769762|FG008|NOT COMPLETED|Extension Period (Week 52 to Week 236)||0||
59651881|NCT02471144|75769763|FG009|NOT COMPLETED|Extension Period (Week 52 to Week 236)||14||
59651882|NCT02471144|75769764|FG010|NOT COMPLETED|Extension Period (Week 52 to Week 236)||10||
59651883|NCT02408471|75769780|FG000|STARTED|Overall Study||97||
59651884|NCT02408471|75769780|FG000|COMPLETED|Overall Study||69||
59651885|NCT02408471|75769780|FG000|NOT COMPLETED|Overall Study||28||
59651886|NCT02403674|75769786|FG000|STARTED|Overall Study||368|Randomized|
59651887|NCT02403674|75769787|FG001|STARTED|Overall Study||366|Randomized|
59651888|NCT02403674|75769786|FG000|Treated|Overall Study||364|Received ≥1 dose of study medication.|
59651889|NCT02403674|75769787|FG001|Treated|Overall Study||364|Received ≥1 dose of study medication.|
59651890|NCT02403674|75769786|FG000|COMPLETED|Overall Study||313|Completed through Week 48 and ongoing in study|
59651891|NCT02403674|75769787|FG001|COMPLETED|Overall Study||303|Completed through Week 48 and ongoing in study|
59651892|NCT02403674|75769786|FG000|NOT COMPLETED|Overall Study||55||
59651893|NCT02403674|75769787|FG001|NOT COMPLETED|Overall Study||63||
59651894|NCT02354781|75769793|FG000|STARTED|Overall Study||3||
59651895|NCT02354781|75769793|FG000|COMPLETED|Overall Study||3||
59651896|NCT02354781|75769793|FG000|NOT COMPLETED|Overall Study||0||
59651897|NCT02352948|75769804|FG000|STARTED|Overall Study||62||
59651898|NCT02352948|75769805|FG001|STARTED|Overall Study||64||
59651899|NCT02352948|75769806|FG002|STARTED|Overall Study||174||
59651900|NCT02352948|75769807|FG003|STARTED|Overall Study||118||
59651901|NCT02352948|75769808|FG004|STARTED|Overall Study||117||
59651902|NCT02352948|75769809|FG005|STARTED|Overall Study||60||
59651903|NCT02352948|75769804|FG000|Received Treatment|Overall Study||62||
59651904|NCT02352948|75769805|FG001|Received Treatment|Overall Study||63||
59651905|NCT02352948|75769806|FG002|Received Treatment|Overall Study||173||
59651906|NCT02352948|75769807|FG003|Received Treatment|Overall Study||110||
59651907|NCT02352948|75769808|FG004|Received Treatment|Overall Study||117||
59651908|NCT02352948|75769809|FG005|Received Treatment|Overall Study||60||
59651909|NCT02352948|75769804|FG000|Completed Study Treatment|Overall Study||15||
59651910|NCT02352948|75769805|FG001|Completed Study Treatment|Overall Study||0||
59651911|NCT02352948|75769806|FG002|Completed Study Treatment|Overall Study||36||
59651912|NCT02352948|75769807|FG003|Completed Study Treatment|Overall Study||0||
59651913|NCT02352948|75769808|FG004|Completed Study Treatment|Overall Study||23||
59651914|NCT02352948|75769809|FG005|Completed Study Treatment|Overall Study||4||
59651915|NCT02352948|75769804|FG000|COMPLETED|Overall Study||13|Completed the Study|
59651916|NCT02352948|75769805|FG001|COMPLETED|Overall Study||5|Completed the Study|
59651917|NCT02352948|75769806|FG002|COMPLETED|Overall Study||45|Completed the Study|
59651918|NCT02352948|75769807|FG003|COMPLETED|Overall Study||19|Completed the Study|
59651919|NCT02352948|75769808|FG004|COMPLETED|Overall Study||29|Completed the Study|
59651920|NCT02352948|75769809|FG005|COMPLETED|Overall Study||11|Completed the Study|
59651921|NCT02352948|75769804|FG000|NOT COMPLETED|Overall Study||49||
59651922|NCT02352948|75769805|FG001|NOT COMPLETED|Overall Study||59||
59651923|NCT02352948|75769806|FG002|NOT COMPLETED|Overall Study||129||
59651924|NCT02352948|75769807|FG003|NOT COMPLETED|Overall Study||99||
59651925|NCT02352948|75769808|FG004|NOT COMPLETED|Overall Study||88||
59651926|NCT02352948|75769809|FG005|NOT COMPLETED|Overall Study||49||
59651927|NCT02303431|75769839|FG000|STARTED|Overall Study||8||
59651928|NCT02303431|75769840|FG001|STARTED|Overall Study||7||
59651929|NCT02303431|75769841|FG002|STARTED|Overall Study||7||
59651930|NCT02303431|75769842|FG003|STARTED|Overall Study||6||
59651931|NCT02303431|75769843|FG004|STARTED|Overall Study||7||
59651932|NCT02303431|75769844|FG005|STARTED|Overall Study||6||
59651933|NCT02303431|75769845|FG006|STARTED|Overall Study||7||
59651934|NCT02303431|75769846|FG007|STARTED|Overall Study||6||
59651935|NCT02303431|75769847|FG008|STARTED|Overall Study||6||
59651936|NCT02303431|75769848|FG009|STARTED|Overall Study||6||
59651937|NCT02303431|75769839|FG000|COMPLETED|Overall Study||8||
59651938|NCT02303431|75769840|FG001|COMPLETED|Overall Study||7||
59651939|NCT02303431|75769841|FG002|COMPLETED|Overall Study||7||
59651940|NCT02303431|75769842|FG003|COMPLETED|Overall Study||6||
59651941|NCT02303431|75769843|FG004|COMPLETED|Overall Study||7||
59651942|NCT02303431|75769844|FG005|COMPLETED|Overall Study||6||
59651943|NCT02303431|75769845|FG006|COMPLETED|Overall Study||7||
59651944|NCT02303431|75769846|FG007|COMPLETED|Overall Study||6||
59651945|NCT02303431|75769847|FG008|COMPLETED|Overall Study||6||
59651946|NCT02303431|75769848|FG009|COMPLETED|Overall Study||6||
59651947|NCT02303431|75769839|FG000|NOT COMPLETED|Overall Study||0||
59651948|NCT02303431|75769840|FG001|NOT COMPLETED|Overall Study||0||
59651949|NCT02303431|75769841|FG002|NOT COMPLETED|Overall Study||0||
59651950|NCT02303431|75769842|FG003|NOT COMPLETED|Overall Study||0||
59651951|NCT02303431|75769843|FG004|NOT COMPLETED|Overall Study||0||
59651952|NCT02303431|75769844|FG005|NOT COMPLETED|Overall Study||0||
59651953|NCT02303431|75769845|FG006|NOT COMPLETED|Overall Study||0||
59651954|NCT02303431|75769846|FG007|NOT COMPLETED|Overall Study||0||
59651955|NCT02303431|75769847|FG008|NOT COMPLETED|Overall Study||0||
59651956|NCT02303431|75769848|FG009|NOT COMPLETED|Overall Study||0||
59651957|NCT02248597|75769879|FG000|STARTED|Overall Study||27||
59651958|NCT02248597|75769879|FG000|COMPLETED|Overall Study||27||
59651959|NCT02248597|75769879|FG000|NOT COMPLETED|Overall Study||0||
59651960|NCT02246621|75769885|FG000|STARTED|Overall Study||328||
59651961|NCT02246621|75769886|FG001|STARTED|Overall Study||165||
59651962|NCT02246621|75769885|FG000|Received At Least One Dose of Study Drug|Overall Study||327||
59651963|NCT02246621|75769886|FG001|Received At Least One Dose of Study Drug|Overall Study||161||
59651964|NCT02246621|75769885|FG000|COMPLETED|Overall Study||63||
59651965|NCT02246621|75769886|FG001|COMPLETED|Overall Study||30||
59651966|NCT02246621|75769885|FG000|NOT COMPLETED|Overall Study||265||
59543392|NCT02460822|75641647|FG000|STARTED|Overall Study||16||
59543393|NCT02460822|75641647|FG000|COMPLETED|Overall Study||15||
59543394|NCT02460822|75641647|FG000|NOT COMPLETED|Overall Study||1||
59543395|NCT02488824|75641653|FG000|STARTED|Overall Study||21||
59543396|NCT02488824|75641654|FG001|STARTED|Overall Study||20||
59543397|NCT02488824|75641653|FG000|COMPLETED|Overall Study||20||
59543398|NCT02488824|75641654|FG001|COMPLETED|Overall Study||19||
59543399|NCT02488824|75641653|FG000|NOT COMPLETED|Overall Study||1||
59543400|NCT02488824|75641654|FG001|NOT COMPLETED|Overall Study||1||
59543401|NCT01623479|75641660|FG000|STARTED|Overall Study||585||
59543402|NCT01623479|75641660|FG000|COMPLETED|Overall Study||585||
59543403|NCT01623479|75641660|FG000|NOT COMPLETED|Overall Study||0||
59651967|NCT02246621|75769886|FG001|NOT COMPLETED|Overall Study||135||
59651968|NCT02197234|75769892|FG000|STARTED|Part A: Day 1-2 (Simvastatin Alone)||52||
59651969|NCT02197234|75769892|FG000|COMPLETED|Part A: Day 1-2 (Simvastatin Alone)||52||
59651970|NCT02197234|75769892|FG000|NOT COMPLETED|Part A: Day 1-2 (Simvastatin Alone)||0||
59651971|NCT02197234|75769892|FG000|STARTED|Part A: Day 3-30 (AZD9291 Alone)||52||
59651972|NCT02197234|75769892|FG000|COMPLETED|Part A: Day 3-30 (AZD9291 Alone)||49||
59651973|NCT02197234|75769892|FG000|NOT COMPLETED|Part A: Day 3-30 (AZD9291 Alone)||3||
59651974|NCT02197234|75769892|FG000|STARTED|Part A: Day 31-32 (Simvastatin+AZD9291)||49||
59651975|NCT02197234|75769892|FG000|COMPLETED|Part A: Day 31-32 (Simvastatin+AZD9291)||49||
59651976|NCT02197234|75769892|FG000|NOT COMPLETED|Part A: Day 31-32 (Simvastatin+AZD9291)||0||
59651977|NCT02197234|75769892|FG000|STARTED|Part B: Day 33 to End Part B (AZD9291)|49 completed Part A + 1 entered Part B without completing Part A (due to AE) = 50 started Part B|50||
59651978|NCT02197234|75769892|FG000|COMPLETED|Part B: Day 33 to End Part B (AZD9291)||20||
59651979|NCT02197234|75769892|FG000|NOT COMPLETED|Part B: Day 33 to End Part B (AZD9291)||30||
59651980|NCT02125461|75769901|FG000|STARTED|Overall Study||476|Randomized|
59651981|NCT02125461|75769902|FG001|STARTED|Overall Study||237|Randomized|
59651982|NCT02125461|75769901|FG000|Full Analysis Set (FAS)|Overall Study||476||
59651983|NCT02125461|75769902|FG001|Full Analysis Set (FAS)|Overall Study||237||
59651984|NCT02125461|75769901|FG000|Received Treatment|Overall Study||473||
59651985|NCT02125461|75769902|FG001|Received Treatment|Overall Study||236||
59651986|NCT02125461|75769901|FG000|Safety Analysis Set|Overall Study||475||
59651987|NCT02125461|75769902|FG001|Safety Analysis Set|Overall Study||234||
59651988|NCT02125461|75769901|FG000|Completed 12 Months of Treatment|Overall Study||232||
59651989|NCT02125461|75769902|FG001|Completed 12 Months of Treatment|Overall Study||82||
59651990|NCT02125461|75769901|FG000|COMPLETED|Overall Study||178|Ongoing study at final DCO (study complete)|
59651991|NCT02125461|75769902|FG001|COMPLETED|Overall Study||68|Ongoing study at final DCO (study complete)|
59651992|NCT02125461|75769901|FG000|NOT COMPLETED|Overall Study||298||
59651993|NCT02125461|75769902|FG001|NOT COMPLETED|Overall Study||169||
59651994|NCT02096042|75769908|FG000|STARTED|Overall Study||1||
59651995|NCT02096042|75769909|FG001|STARTED|Overall Study||0||
59651996|NCT02096042|75769910|FG002|STARTED|Overall Study||0||
59651997|NCT02096042|75769908|FG000|COMPLETED|Overall Study||0||
59651998|NCT02096042|75769909|FG001|COMPLETED|Overall Study||0||
59651999|NCT02096042|75769910|FG002|COMPLETED|Overall Study||0||
59652000|NCT02096042|75769908|FG000|NOT COMPLETED|Overall Study||1||
59652001|NCT02096042|75769909|FG001|NOT COMPLETED|Overall Study||0||
59652002|NCT02096042|75769910|FG002|NOT COMPLETED|Overall Study||0||
59652003|NCT02003924|75769919|FG000|STARTED|Double-blind Phase||933||
59652004|NCT02003924|75769920|FG001|STARTED|Double-blind Phase||468||
59652005|NCT02003924|75769921|FG002|STARTED|Double-blind Phase||0||
59652006|NCT02003924|75769919|FG000|Treated|Double-blind Phase||930||
59652007|NCT02003924|75769920|FG001|Treated|Double-blind Phase||465||
59652008|NCT02003924|75769921|FG002|Treated|Double-blind Phase||0||
59652009|NCT02003924|75769919|FG000|COMPLETED|Double-blind Phase||478||
59652010|NCT02003924|75769920|FG001|COMPLETED|Double-blind Phase||87||
59652011|NCT02003924|75769921|FG002|COMPLETED|Double-blind Phase||0||
59652012|NCT02003924|75769919|FG000|NOT COMPLETED|Double-blind Phase||455||
59652013|NCT02003924|75769920|FG001|NOT COMPLETED|Double-blind Phase||381||
59652014|NCT02003924|75769921|FG002|NOT COMPLETED|Double-blind Phase||0||
59652015|NCT02003924|75769919|FG000|STARTED|Open-label Phase||478||
59652016|NCT02003924|75769920|FG001|STARTED|Open-label Phase|Participants were offered to switch from double blind placebo to open label Enzalutamide.|0||
59652017|NCT02003924|75769921|FG002|STARTED|Open-label Phase|Participants previously treated with placebo, switched to receive open label Enzalutamide.|87||
59652018|NCT02003924|75769919|FG000|Treated|Open-label Phase||478||
59652019|NCT02003924|75769920|FG001|Treated|Open-label Phase||0||
59652020|NCT02003924|75769921|FG002|Treated|Open-label Phase||87||
59652021|NCT02003924|75769919|FG000|COMPLETED|Open-label Phase||378||
59652022|NCT02003924|75769920|FG001|COMPLETED|Open-label Phase||0||
59652023|NCT02003924|75769921|FG002|COMPLETED|Open-label Phase||70||
59652024|NCT02003924|75769919|FG000|NOT COMPLETED|Open-label Phase||100||
59652025|NCT02003924|75769920|FG001|NOT COMPLETED|Open-label Phase||0||
59652026|NCT02003924|75769921|FG002|NOT COMPLETED|Open-label Phase||17||
59652027|NCT02003924|75769919|FG000|STARTED|Long-term Follow-up Phase|Participants followed up after discontinuing study drug in either double blind or open label phase.|933||
59652028|NCT02003924|75769920|FG001|STARTED|Long-term Follow-up Phase|Participants were followed up after study drug discontinuation in double blind phase.|381||
59652029|NCT02003924|75769921|FG002|STARTED|Long-term Follow-up Phase|Participants were followed up after study drug discontinuation in open label phase.|87||
59652030|NCT02003924|75769919|FG000|COMPLETED|Long-term Follow-up Phase||566||
59652031|NCT02003924|75769920|FG001|COMPLETED|Long-term Follow-up Phase||144||
59652032|NCT02003924|75769921|FG002|COMPLETED|Long-term Follow-up Phase||80||
59652033|NCT02003924|75769919|FG000|NOT COMPLETED|Long-term Follow-up Phase||367||
59652034|NCT02003924|75769920|FG001|NOT COMPLETED|Long-term Follow-up Phase||237||
59652035|NCT02003924|75769921|FG002|NOT COMPLETED|Long-term Follow-up Phase||7||
59652036|NCT01940471|75769930|FG000|STARTED|Period 1: Double-blind Phase||582||
59652037|NCT01940471|75769931|FG001|STARTED|Period 1: Double-blind Phase||293||
59652038|NCT01940471|75769932|FG002|STARTED|Period 1: Double-blind Phase||0||
59988692|NCT02361346|76103916|FG000|COMPLETED|Part 1 and 2 ( Up to Day 112)||3||
59988693|NCT02361346|76103917|FG001|COMPLETED|Part 1 and 2 ( Up to Day 112)||3||
59988694|NCT02361346|76103918|FG002|COMPLETED|Part 1 and 2 ( Up to Day 112)||3||
59988695|NCT02361346|76103919|FG003|COMPLETED|Part 1 and 2 ( Up to Day 112)||3||
59652039|NCT01940471|75769933|FG003|STARTED|Period 1: Double-blind Phase||0||
59652040|NCT01940471|75769930|FG000|COMPLETED|Period 1: Double-blind Phase||515||
59988696|NCT02361346|76103920|FG004|COMPLETED|Part 1 and 2 ( Up to Day 112)||0||
59988697|NCT02361346|76103921|FG005|COMPLETED|Part 1 and 2 ( Up to Day 112)||6||
59988698|NCT02361346|76103922|FG006|COMPLETED|Part 1 and 2 ( Up to Day 112)||6||
59652041|NCT01940471|75769931|FG001|COMPLETED|Period 1: Double-blind Phase||253||
59652042|NCT01940471|75769932|FG002|COMPLETED|Period 1: Double-blind Phase||0||
59652043|NCT01940471|75769933|FG003|COMPLETED|Period 1: Double-blind Phase||0||
59652044|NCT01940471|75769930|FG000|NOT COMPLETED|Period 1: Double-blind Phase||67||
59652045|NCT01940471|75769931|FG001|NOT COMPLETED|Period 1: Double-blind Phase||40||
59652046|NCT01940471|75769932|FG002|NOT COMPLETED|Period 1: Double-blind Phase||0||
59652047|NCT01940471|75769933|FG003|NOT COMPLETED|Period 1: Double-blind Phase||0||
59652048|NCT01940471|75769930|FG000|STARTED|Period 2: Open-Label TAF Extension Phase||0|At the end of Double-blind Phase, participants were given the option to receive TAF in an OL TAF Extension Phase for up to 240 or 288 weeks.|
59652049|NCT01940471|75769931|FG001|STARTED|Period 2: Open-Label TAF Extension Phase||0|At the end of Double-blind Phase, participants were given the option to receive TAF in an OL TAF Extension Phase for up to 240 or 288 weeks.|
59652050|NCT01940471|75769932|FG002|STARTED|Period 2: Open-Label TAF Extension Phase|Out of 515 participants who completed the Double-blind Phase in TAF 25 mg arm, 1 participant did not enter the OL TAF Extension Phase.|514|At the end of Double-blind Phase, participants were given the option to receive TAF in an OL TAF Extension Phase for up to 240 or 288 weeks.|
59652051|NCT01940471|75769933|FG003|STARTED|Period 2: Open-Label TAF Extension Phase||253|At the end of Double-blind Phase, participants were given the option to receive TAF in an OL TAF Extension Phase for up to 240 or 288 weeks.|
59652052|NCT01940471|75769930|FG000|COMPLETED|Period 2: Open-Label TAF Extension Phase||0||
59652053|NCT01940471|75769931|FG001|COMPLETED|Period 2: Open-Label TAF Extension Phase||0||
59652054|NCT01940471|75769932|FG002|COMPLETED|Period 2: Open-Label TAF Extension Phase||422||
59652055|NCT01940471|75769933|FG003|COMPLETED|Period 2: Open-Label TAF Extension Phase||213||
59652056|NCT01940471|75769930|FG000|NOT COMPLETED|Period 2: Open-Label TAF Extension Phase||0||
59652057|NCT01940471|75769931|FG001|NOT COMPLETED|Period 2: Open-Label TAF Extension Phase||0||
59652058|NCT01940471|75769932|FG002|NOT COMPLETED|Period 2: Open-Label TAF Extension Phase||92||
59652059|NCT01940471|75769933|FG003|NOT COMPLETED|Period 2: Open-Label TAF Extension Phase||40||
59652060|NCT01765400|75769944|FG000|STARTED|First Intervention (14 Days)||15||
59652061|NCT01765400|75769945|FG001|STARTED|First Intervention (14 Days)||15||
59652062|NCT01765400|75769944|FG000|COMPLETED|First Intervention (14 Days)||15||
59652063|NCT01765400|75769945|FG001|COMPLETED|First Intervention (14 Days)||15||
59652064|NCT01765400|75769944|FG000|NOT COMPLETED|First Intervention (14 Days)||0||
59652065|NCT01765400|75769945|FG001|NOT COMPLETED|First Intervention (14 Days)||0||
59652066|NCT01765400|75769944|FG000|STARTED|Second Intervention (14 Days)||15||
59652067|NCT01765400|75769945|FG001|STARTED|Second Intervention (14 Days)||15||
59652068|NCT01765400|75769944|FG000|COMPLETED|Second Intervention (14 Days)||15||
59652069|NCT01765400|75769945|FG001|COMPLETED|Second Intervention (14 Days)||15||
59652070|NCT01765400|75769944|FG000|NOT COMPLETED|Second Intervention (14 Days)||0||
59652071|NCT01765400|75769945|FG001|NOT COMPLETED|Second Intervention (14 Days)||0||
59652072|NCT01751906|75769953|FG000|STARTED|Overall Study||1322||
59652073|NCT01751906|75769954|FG001|STARTED|Overall Study||686||
59652074|NCT01751906|75769953|FG000|COMPLETED|Overall Study||1059||
59652075|NCT01751906|75769954|FG001|COMPLETED|Overall Study||555||
59652076|NCT01751906|75769953|FG000|NOT COMPLETED|Overall Study||263||
59652077|NCT01751906|75769954|FG001|NOT COMPLETED|Overall Study||131||
59652078|NCT01730937|75769962|FG000|STARTED|Overall Study||97||
59652079|NCT01730937|75769963|FG001|STARTED|Overall Study||96||
59652080|NCT01730937|75769962|FG000|Eligible Population|Overall Study||92||
59652081|NCT01730937|75769963|FG001|Eligible Population|Overall Study||85||
59652082|NCT01730937|75769962|FG000|Adverse Event Population|Overall Study||88|Eligible, started treatment, and were assessed for adverse events.|
59652083|NCT01730937|75769963|FG001|Adverse Event Population|Overall Study||83|Eligible, started treatment, and were assessed for adverse events.|
59652084|NCT01730937|75769962|FG000|Quality of Life Population|Overall Study||46|Eligible with consent for quality of life study component|
59652085|NCT01730937|75769963|FG001|Quality of Life Population|Overall Study||37|Eligible with consent for quality of life study component|
59652086|NCT01730937|75769962|FG000|COMPLETED|Overall Study||92|Participants contributing data to results are considered to have completed the study.|
59652087|NCT01730937|75769963|FG001|COMPLETED|Overall Study||85|Participants contributing data to results are considered to have completed the study.|
59652088|NCT01730937|75769962|FG000|NOT COMPLETED|Overall Study||5||
59652089|NCT01730937|75769963|FG001|NOT COMPLETED|Overall Study||11||
59652090|NCT01560416|75769971|FG000|STARTED|Randomized Phase||15||
59652091|NCT01560416|75769972|FG001|STARTED|Randomized Phase||35||
59652092|NCT01560416|75769971|FG000|COMPLETED|Randomized Phase||8||
59652093|NCT01560416|75769972|FG001|COMPLETED|Randomized Phase||35||
59652094|NCT01560416|75769971|FG000|NOT COMPLETED|Randomized Phase||7||
59652095|NCT01560416|75769972|FG001|NOT COMPLETED|Randomized Phase||0||
59652096|NCT01560416|75769971|FG000|STARTED|Crossover Phase||7|Only participants randomized to Arm A potentially received crossover treatment.|
59652097|NCT01560416|75769972|FG001|STARTED|Crossover Phase||0|Only participants randomized to Arm A potentially received crossover treatment.|
59815791|NCT03026283|75938217|FG006|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0||
59543404|NCT01623869|75641664|FG000|STARTED|Overall Study||16||
59652098|NCT01560416|75769971|FG000|COMPLETED|Crossover Phase||7||
59652099|NCT01560416|75769972|FG001|COMPLETED|Crossover Phase||0||
59652100|NCT01560416|75769971|FG000|NOT COMPLETED|Crossover Phase||0||
59652101|NCT01560416|75769972|FG001|NOT COMPLETED|Crossover Phase||0||
59652102|NCT01345539|75769980|FG000|STARTED|Overall Study||24||
59652103|NCT01345539|75769980|FG000|COMPLETED|Overall Study||24||
59652104|NCT01345539|75769980|FG000|NOT COMPLETED|Overall Study||0||
59652105|NCT01279850|75769984|FG000|STARTED|Overall Study||891||
59652106|NCT01279850|75769984|FG000|COMPLETED|Overall Study|Number of participants whose survey form were collected and included in analyses is shown.|800||
59652107|NCT01279850|75769984|FG000|NOT COMPLETED|Overall Study||91||
59652108|NCT01035463|75769990|FG000|STARTED|Overall Study||6||
59652109|NCT01035463|75769991|FG001|STARTED|Overall Study||3||
59652110|NCT01035463|75769992|FG002|STARTED|Overall Study||6||
59652111|NCT01035463|75769993|FG003|STARTED|Overall Study||4||
59652112|NCT01035463|75769994|FG004|STARTED|Overall Study||7||
59652113|NCT01035463|75769995|FG005|STARTED|Overall Study||33||
59652114|NCT01035463|75769990|FG000|COMPLETED|Overall Study||6||
59652115|NCT01035463|75769991|FG001|COMPLETED|Overall Study||1||
59652116|NCT01035463|75769992|FG002|COMPLETED|Overall Study||1||
59652117|NCT01035463|75769993|FG003|COMPLETED|Overall Study||2||
59652118|NCT01035463|75769994|FG004|COMPLETED|Overall Study||1||
59652119|NCT01035463|75769995|FG005|COMPLETED|Overall Study||15||
59652120|NCT01035463|75769990|FG000|NOT COMPLETED|Overall Study||0||
59652121|NCT01035463|75769991|FG001|NOT COMPLETED|Overall Study||2||
59652122|NCT01035463|75769992|FG002|NOT COMPLETED|Overall Study||5||
59652123|NCT01035463|75769993|FG003|NOT COMPLETED|Overall Study||2||
59652124|NCT01035463|75769994|FG004|NOT COMPLETED|Overall Study||6||
59652125|NCT01035463|75769995|FG005|NOT COMPLETED|Overall Study||18||
59652126|NCT00936390|75770004|FG000|STARTED|Overall Study||771||
59652127|NCT00936390|75770005|FG001|STARTED|Overall Study||767||
59652128|NCT00936390|75770004|FG000|Eligible|Overall Study||750||
59652129|NCT00936390|75770005|FG001|Eligible|Overall Study||742||
59652130|NCT00936390|75770004|FG000|Eligible, Started Protocol Treatment, Has Adverse Event Data|Overall Study||733||
59652131|NCT00936390|75770005|FG001|Eligible, Started Protocol Treatment, Has Adverse Event Data|Overall Study||725||
59652132|NCT00936390|75770004|FG000|Eligible With Radiation Treatment Data|Overall Study||725||
59652133|NCT00936390|75770005|FG001|Eligible With Radiation Treatment Data|Overall Study||707||
59652134|NCT00936390|75770004|FG000|Eligible and Consented to Quality of Life Component|Overall Study||215||
59652135|NCT00936390|75770005|FG001|Eligible and Consented to Quality of Life Component|Overall Study||205||
59988699|NCT02361346|76103923|FG007|COMPLETED|Part 1 and 2 ( Up to Day 112)||0||
59988700|NCT02361346|76103924|FG008|COMPLETED|Part 1 and 2 ( Up to Day 112)||0||
59988701|NCT02361346|76103916|FG000|NOT COMPLETED|Part 1 and 2 ( Up to Day 112)||0||
59988702|NCT02361346|76103917|FG001|NOT COMPLETED|Part 1 and 2 ( Up to Day 112)||0||
59652136|NCT00936390|75770004|FG000|COMPLETED|Overall Study||750||
59652137|NCT00936390|75770005|FG001|COMPLETED|Overall Study||742||
59652138|NCT00936390|75770004|FG000|NOT COMPLETED|Overall Study||21||
59652139|NCT00936390|75770005|FG001|NOT COMPLETED|Overall Study||25||
59652140|NCT00572234|75770015|FG000|STARTED|Overall Study||19||
59652141|NCT00572234|75770016|FG001|STARTED|Overall Study||21||
59652142|NCT00572234|75770015|FG000|COMPLETED|Overall Study||18||
59652143|NCT00572234|75770016|FG001|COMPLETED|Overall Study||16||
59652144|NCT00572234|75770015|FG000|NOT COMPLETED|Overall Study||1||
59652145|NCT00572234|75770016|FG001|NOT COMPLETED|Overall Study||5||
59652146|NCT00534430|75770022|FG000|STARTED|Overall Study||30||
59652147|NCT00534430|75770022|FG000|COMPLETED|Overall Study||30||
59652148|NCT00534430|75770022|FG000|NOT COMPLETED|Overall Study||0||
59652149|NCT00085202|75770032|FG000|STARTED|Overall Study||269||
59988703|NCT02361346|76103918|FG002|NOT COMPLETED|Part 1 and 2 ( Up to Day 112)||0||
59988704|NCT02361346|76103919|FG003|NOT COMPLETED|Part 1 and 2 ( Up to Day 112)||1||
59543405|NCT01623869|75641664|FG000|COMPLETED|Overall Study||16||
59543406|NCT01623869|75641664|FG000|NOT COMPLETED|Overall Study||0||
59543407|NCT01625507|75641668|FG000|STARTED|Overall Study||73||
59543408|NCT01625507|75641668|FG000|COMPLETED|Overall Study||63||
59543409|NCT01625507|75641668|FG000|NOT COMPLETED|Overall Study||10||
59543410|NCT03207347|75641675|FG000|STARTED|Overall Study||23||
59543411|NCT03207347|75641676|FG001|STARTED|Overall Study||14||
59543412|NCT03207347|75641675|FG000|COMPLETED|Overall Study||23||
59543413|NCT03207347|75641676|FG001|COMPLETED|Overall Study||14||
59543414|NCT03207347|75641675|FG000|NOT COMPLETED|Overall Study||0||
59543415|NCT03207347|75641676|FG001|NOT COMPLETED|Overall Study||0||
59543416|NCT01628159|75641682|FG000|STARTED|Overall Study||657||
59543417|NCT01628159|75641682|FG000|COMPLETED|Overall Study||493||
59543418|NCT01628159|75641682|FG000|NOT COMPLETED|Overall Study||164||
59652150|NCT00085202|75770033|FG001|STARTED|Overall Study||144||
59652151|NCT00085202|75770032|FG000|COMPLETED|Overall Study||251||
59652152|NCT00085202|75770033|FG001|COMPLETED|Overall Study||120||
59652153|NCT00085202|75770032|FG000|NOT COMPLETED|Overall Study||18||
59652154|NCT00085202|75770033|FG001|NOT COMPLETED|Overall Study||24||
59652155|NCT01470326|75770057|FG000|STARTED|Overall Study||3187||
59652156|NCT01470326|75770057|FG000|COMPLETED|Overall Study||3034||
59652157|NCT01470326|75770057|FG000|NOT COMPLETED|Overall Study||153||
59652158|NCT01472276|75770063|FG000|STARTED|Overall Study||33|Randomized|
59652159|NCT01472276|75770064|FG001|STARTED|Overall Study||32|Randomized|
59652160|NCT01472276|75770063|FG000|3-month Follow-up|Overall Study||32||
59652161|NCT01472276|75770064|FG001|3-month Follow-up|Overall Study||25||
59652162|NCT01472276|75770063|FG000|6-month Follow-up|Overall Study||31||
59652163|NCT01472276|75770064|FG001|6-month Follow-up|Overall Study||21||
59652164|NCT01472276|75770063|FG000|COMPLETED|Overall Study||29|12-month follow-up|
59652165|NCT01472276|75770064|FG001|COMPLETED|Overall Study||17|12-month follow-up|
59652166|NCT01472276|75770063|FG000|NOT COMPLETED|Overall Study||4||
59652167|NCT01472276|75770064|FG001|NOT COMPLETED|Overall Study||15||
59652168|NCT01480180|75770072|FG000|STARTED|Main Phase||174||
59652169|NCT01480180|75770073|FG001|STARTED|Main Phase||12||
59652170|NCT01480180|75770074|FG002|STARTED|Main Phase|Not applicable for this phase|0||
59652171|NCT01480180|75770075|FG003|STARTED|Main Phase|Not applicable for this phase|0||
59652172|NCT01480180|75770076|FG004|STARTED|Main Phase|Not applicable for this phase|0||
59652173|NCT01480180|75770077|FG005|STARTED|Main Phase|Not applicable for this phase|0||
59652174|NCT01480180|75770072|FG000|Max. Participants After Switching|Main Phase||175||
59652175|NCT01480180|75770073|FG001|Max. Participants After Switching|Main Phase||11||
59652176|NCT01480180|75770074|FG002|Max. Participants After Switching|Main Phase||0||
59652177|NCT01480180|75770075|FG003|Max. Participants After Switching|Main Phase||0||
59652178|NCT01480180|75770076|FG004|Max. Participants After Switching|Main Phase||0||
59652179|NCT01480180|75770077|FG005|Max. Participants After Switching|Main Phase||0||
59652180|NCT01480180|75770072|FG000|COMPLETED|Main Phase||155||
59652181|NCT01480180|75770073|FG001|COMPLETED|Main Phase||11||
59652182|NCT01480180|75770074|FG002|COMPLETED|Main Phase|Not applicable for this phase|0||
59652183|NCT01480180|75770075|FG003|COMPLETED|Main Phase|Not applicable for this phase|0||
59652184|NCT01480180|75770076|FG004|COMPLETED|Main Phase|Not applicable for this phase|0||
59652185|NCT01480180|75770077|FG005|COMPLETED|Main Phase|Not applicable for this phase|0||
59652186|NCT01480180|75770072|FG000|NOT COMPLETED|Main Phase||19||
59652187|NCT01480180|75770073|FG001|NOT COMPLETED|Main Phase||1||
59652188|NCT01480180|75770074|FG002|NOT COMPLETED|Main Phase||0||
59652189|NCT01480180|75770075|FG003|NOT COMPLETED|Main Phase||0||
59652190|NCT01480180|75770076|FG004|NOT COMPLETED|Main Phase||0||
59652191|NCT01480180|75770077|FG005|NOT COMPLETED|Main Phase||0||
59652192|NCT01480180|75770072|FG000|STARTED|Extension Phase, Part 1||0||
59652193|NCT01480180|75770073|FG001|STARTED|Extension Phase, Part 1||0||
59652194|NCT01480180|75770074|FG002|STARTED|Extension Phase, Part 1||105||
59652195|NCT01480180|75770075|FG003|STARTED|Extension Phase, Part 1||38||
59652196|NCT01480180|75770076|FG004|STARTED|Extension Phase, Part 1||7||
59652197|NCT01480180|75770077|FG005|STARTED|Extension Phase, Part 1||0||
59652198|NCT01480180|75770072|FG000|COMPLETED|Extension Phase, Part 1||0||
59652199|NCT01480180|75770073|FG001|COMPLETED|Extension Phase, Part 1||0||
59652200|NCT01480180|75770074|FG002|COMPLETED|Extension Phase, Part 1||95||
59652201|NCT01480180|75770075|FG003|COMPLETED|Extension Phase, Part 1||28||
59652202|NCT01480180|75770076|FG004|COMPLETED|Extension Phase, Part 1||7||
59652203|NCT01480180|75770077|FG005|COMPLETED|Extension Phase, Part 1||0||
59652204|NCT01480180|75770072|FG000|NOT COMPLETED|Extension Phase, Part 1||0||
59652205|NCT01480180|75770073|FG001|NOT COMPLETED|Extension Phase, Part 1||0||
59652206|NCT01480180|75770074|FG002|NOT COMPLETED|Extension Phase, Part 1||10||
59652207|NCT01480180|75770075|FG003|NOT COMPLETED|Extension Phase, Part 1||10||
59652208|NCT01480180|75770076|FG004|NOT COMPLETED|Extension Phase, Part 1||0||
59652209|NCT01480180|75770077|FG005|NOT COMPLETED|Extension Phase, Part 1||0||
59652210|NCT01480180|75770072|FG000|STARTED|Extension Phase, Part 2||0||
59652211|NCT01480180|75770073|FG001|STARTED|Extension Phase, Part 2||0||
59652212|NCT01480180|75770074|FG002|STARTED|Extension Phase, Part 2||94||
59652213|NCT01480180|75770075|FG003|STARTED|Extension Phase, Part 2||40||
59652214|NCT01480180|75770076|FG004|STARTED|Extension Phase, Part 2||5||
59652215|NCT01480180|75770077|FG005|STARTED|Extension Phase, Part 2||0||
59652216|NCT01480180|75770072|FG000|COMPLETED|Extension Phase, Part 2||0||
59652217|NCT01480180|75770073|FG001|COMPLETED|Extension Phase, Part 2||0||
59652218|NCT01480180|75770074|FG002|COMPLETED|Extension Phase, Part 2||77||
59652219|NCT01480180|75770075|FG003|COMPLETED|Extension Phase, Part 2||33||
59652220|NCT01480180|75770076|FG004|COMPLETED|Extension Phase, Part 2||3||
59652221|NCT01480180|75770077|FG005|COMPLETED|Extension Phase, Part 2||0||
59652222|NCT01480180|75770072|FG000|NOT COMPLETED|Extension Phase, Part 2||0||
59652223|NCT01480180|75770073|FG001|NOT COMPLETED|Extension Phase, Part 2||0||
59652224|NCT01480180|75770074|FG002|NOT COMPLETED|Extension Phase, Part 2||17||
59652225|NCT01480180|75770075|FG003|NOT COMPLETED|Extension Phase, Part 2||7||
59652226|NCT01480180|75770076|FG004|NOT COMPLETED|Extension Phase, Part 2||2||
59652227|NCT01480180|75770077|FG005|NOT COMPLETED|Extension Phase, Part 2||0||
59652228|NCT01504438|75770100|FG000|STARTED|Overall Study||48||
59652229|NCT01504438|75770101|FG001|STARTED|Overall Study||50||
59652230|NCT01504438|75770100|FG000|COMPLETED|Overall Study||22||
59652231|NCT01504438|75770101|FG001|COMPLETED|Overall Study||25||
59652232|NCT01504438|75770100|FG000|NOT COMPLETED|Overall Study||26||
59652233|NCT01504438|75770101|FG001|NOT COMPLETED|Overall Study||25||
59652234|NCT05300087|75770108|FG000|STARTED|Overall Study||30||
59652235|NCT05300087|75770109|FG001|STARTED|Overall Study||30||
59652236|NCT05300087|75770108|FG000|COMPLETED|Overall Study||30||
59652237|NCT05300087|75770109|FG001|COMPLETED|Overall Study||29||
59652238|NCT05300087|75770108|FG000|NOT COMPLETED|Overall Study||0||
59652239|NCT05300087|75770109|FG001|NOT COMPLETED|Overall Study||1||
59652240|NCT05274321|75770115|FG000|STARTED|Overall Study||50||50
59652241|NCT05274321|75770116|FG001|STARTED|Overall Study||50||50
59652242|NCT05274321|75770115|FG000|COMPLETED|Overall Study||50||50
59543419|NCT02231177|75641686|FG000|STARTED|Treatment Period 1 (21 Days)||8||
59543420|NCT02231177|75641687|FG001|STARTED|Treatment Period 1 (21 Days)||7||
59543421|NCT02231177|75641688|FG002|STARTED|Treatment Period 1 (21 Days)||8||
59543422|NCT02231177|75641689|FG003|STARTED|Treatment Period 1 (21 Days)||7||
59543423|NCT02231177|75641690|FG004|STARTED|Treatment Period 1 (21 Days)||8||
59543424|NCT02231177|75641691|FG005|STARTED|Treatment Period 1 (21 Days)||9||
59652243|NCT05274321|75770116|FG001|COMPLETED|Overall Study||50||50
59652244|NCT05274321|75770115|FG000|NOT COMPLETED|Overall Study||0||0
59652245|NCT05274321|75770116|FG001|NOT COMPLETED|Overall Study||0||0
59652246|NCT04803734|75770122|FG000|STARTED|Overall Study||30||
59652247|NCT04803734|75770123|FG001|STARTED|Overall Study||30||
59652248|NCT04803734|75770122|FG000|COMPLETED|Overall Study||30||
59652249|NCT04803734|75770123|FG001|COMPLETED|Overall Study||28||
59652250|NCT04803734|75770122|FG000|NOT COMPLETED|Overall Study||0||
59652251|NCT04803734|75770123|FG001|NOT COMPLETED|Overall Study||2||
59652252|NCT04597619|75770131|FG000|STARTED|Overall Study||20||
59652253|NCT04597619|75770132|FG001|STARTED|Overall Study||10||
59652254|NCT04597619|75770131|FG000|COMPLETED|Overall Study||14||
59652255|NCT04597619|75770132|FG001|COMPLETED|Overall Study||6||
59652256|NCT04597619|75770131|FG000|NOT COMPLETED|Overall Study||6||
59652257|NCT04597619|75770132|FG001|NOT COMPLETED|Overall Study||4||
59652258|NCT04593940|75770142|FG000|STARTED|Overall Study||531||
59652259|NCT04593940|75770143|FG001|STARTED|Overall Study||524||
59652260|NCT04593940|75770144|FG002|STARTED|Overall Study||360||
59652261|NCT04593940|75770145|FG003|STARTED|Overall Study||556||
59652262|NCT04593940|75770142|FG000|COMPLETED|Overall Study||425||
59652263|NCT04593940|75770143|FG001|COMPLETED|Overall Study||394||
59652264|NCT04593940|75770144|FG002|COMPLETED|Overall Study||263||
59652265|NCT04593940|75770145|FG003|COMPLETED|Overall Study||419||
59652266|NCT04593940|75770142|FG000|NOT COMPLETED|Overall Study||106||
59652267|NCT04593940|75770143|FG001|NOT COMPLETED|Overall Study||130||
59652268|NCT04593940|75770144|FG002|NOT COMPLETED|Overall Study||97||
59652269|NCT04593940|75770145|FG003|NOT COMPLETED|Overall Study||137||
59652270|NCT04112173|75770159|FG000|STARTED|Overall Study||1||
59652271|NCT04112173|75770159|FG000|COMPLETED|Overall Study|Study halted on 3/13/2020 due to COVID-19 pandemic. Study was terminated without resuming.|0||
59652272|NCT04112173|75770159|FG000|NOT COMPLETED|Overall Study||1||
59652273|NCT03872453|75770167|FG000|STARTED|Overall Study||418|Randomized|
59652274|NCT03872453|75770168|FG001|STARTED|Overall Study||417|Randomized|
59652275|NCT03872453|75770169|FG002|STARTED|Overall Study||418|Randomized|
59652276|NCT03872453|75770170|FG003|STARTED|Overall Study||420|Randomized|
59652277|NCT03872453|75770167|FG000|Treated|Overall Study||388||
59652278|NCT03872453|75770168|FG001|Treated|Overall Study||394||
59652279|NCT03872453|75770169|FG002|Treated|Overall Study||403||
59652280|NCT03872453|75770170|FG003|Treated|Overall Study||403||
59652281|NCT03872453|75770167|FG000|Modified Intent-to-Treat (mITT) Participants|Overall Study||387|Treated participants who were randomized only once, had moderate to severe pain at on-study migraine attack onset, and had non-missing, post-baseline efficacy data.|
59652282|NCT03872453|75770168|FG001|Modified Intent-to-Treat (mITT) Participants|Overall Study||391|Treated participants who were randomized only once, had moderate to severe pain at on-study migraine attack onset, and had non-missing, post-baseline efficacy data.|
59652283|NCT03872453|75770169|FG002|Modified Intent-to-Treat (mITT) Participants|Overall Study||402|Treated participants who were randomized only once, had moderate to severe pain at on-study migraine attack onset, and had non-missing, post-baseline efficacy data.|
59652284|NCT03872453|75770170|FG003|Modified Intent-to-Treat (mITT) Participants|Overall Study||401|Treated participants who were randomized only once, had moderate to severe pain at on-study migraine attack onset, and had non-missing, post-baseline efficacy data.|
59652285|NCT03872453|75770167|FG000|COMPLETED|Overall Study||386||
59652286|NCT03872453|75770168|FG001|COMPLETED|Overall Study||391||
59652287|NCT03872453|75770169|FG002|COMPLETED|Overall Study||399||
59652288|NCT03872453|75770170|FG003|COMPLETED|Overall Study||402||
59652289|NCT03872453|75770167|FG000|NOT COMPLETED|Overall Study||32||
59652290|NCT03872453|75770168|FG001|NOT COMPLETED|Overall Study||26||
59652291|NCT03872453|75770169|FG002|NOT COMPLETED|Overall Study||19||
59543425|NCT02231177|75641686|FG000|COMPLETED|Treatment Period 1 (21 Days)||8||
59543426|NCT02231177|75641687|FG001|COMPLETED|Treatment Period 1 (21 Days)||7||
59543427|NCT02231177|75641688|FG002|COMPLETED|Treatment Period 1 (21 Days)||8||
59543428|NCT02231177|75641689|FG003|COMPLETED|Treatment Period 1 (21 Days)||7||
59652292|NCT03872453|75770170|FG003|NOT COMPLETED|Overall Study||18||
59652293|NCT03726879|75770182|FG000|STARTED|Overall Study||226||
59652294|NCT03726879|75770183|FG001|STARTED|Overall Study||228||
59652295|NCT03726879|75770182|FG000|COMPLETED|Overall Study||0||
59652296|NCT03726879|75770183|FG001|COMPLETED|Overall Study||0||
59652297|NCT03726879|75770182|FG000|NOT COMPLETED|Overall Study||226||
59652298|NCT03726879|75770183|FG001|NOT COMPLETED|Overall Study||228||
59652299|NCT03721835|75770189|FG000|STARTED|Overall Study||15||
59652300|NCT03721835|75770189|FG000|COMPLETED|Overall Study||3||
59652301|NCT03721835|75770189|FG000|NOT COMPLETED|Overall Study||12||
59652302|NCT03565991|75770195|FG000|STARTED|Overall Study||159||
59652303|NCT03565991|75770196|FG001|STARTED|Overall Study||41||
59652304|NCT03565991|75770195|FG000|COMPLETED|Overall Study||1||
59652305|NCT03565991|75770196|FG001|COMPLETED|Overall Study||0||
59652306|NCT03565991|75770195|FG000|NOT COMPLETED|Overall Study||158||
59652307|NCT03565991|75770196|FG001|NOT COMPLETED|Overall Study||41||
59652308|NCT03186638|75770206|FG000|STARTED|Overall Study||45|Randomized|
59652309|NCT03186638|75770207|FG001|STARTED|Overall Study||42|Randomized|
59652310|NCT03186638|75770206|FG000|Received Intervention and Completed Baseline Assessments|Overall Study||44||
59652311|NCT03186638|75770207|FG001|Received Intervention and Completed Baseline Assessments|Overall Study||40||
59652312|NCT03186638|75770206|FG000|COMPLETED|Overall Study||37||
59652313|NCT03186638|75770207|FG001|COMPLETED|Overall Study||36||
59652314|NCT03186638|75770206|FG000|NOT COMPLETED|Overall Study||8||
59652315|NCT03186638|75770207|FG001|NOT COMPLETED|Overall Study||6||
59652316|NCT02958007|75770215|FG000|STARTED|Overall Study||11||
59652317|NCT02958007|75770216|FG001|STARTED|Overall Study||11||
59652318|NCT02958007|75770215|FG000|COMPLETED|Overall Study||10||
59652319|NCT02958007|75770216|FG001|COMPLETED|Overall Study||8||
59652320|NCT02958007|75770215|FG000|NOT COMPLETED|Overall Study||1||
59652321|NCT02958007|75770216|FG001|NOT COMPLETED|Overall Study||3||
59815792|NCT03026283|75938218|FG007|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0||
59817902|NCT04488770|75940328|FG002|NOT COMPLETED|Part 1-Cohort 2: Period 1 (Up to 5 Days)||0||
59652325|NCT02691663|75770228|FG000|STARTED|Overall Study||41||
59652326|NCT02691663|75770229|FG001|STARTED|Overall Study||42||
59652327|NCT02691663|75770228|FG000|COMPLETED|Overall Study||33||
59652328|NCT02691663|75770229|FG001|COMPLETED|Overall Study||35||
59652329|NCT02691663|75770228|FG000|NOT COMPLETED|Overall Study||8||
59652330|NCT02691663|75770229|FG001|NOT COMPLETED|Overall Study||7||
59652331|NCT02639065|75770236|FG000|STARTED|Study Treatment||39||
59652332|NCT02639065|75770236|FG000|COMPLETED|Study Treatment||16||
59652333|NCT02639065|75770236|FG000|NOT COMPLETED|Study Treatment||23||
59652334|NCT02639065|75770236|FG000|STARTED|Follow up||39||
59652335|NCT02639065|75770236|FG000|COMPLETED|Follow up||30||
59652336|NCT02639065|75770236|FG000|NOT COMPLETED|Follow up||9||
59652337|NCT02566785|75770242|FG000|STARTED|Overall Study||15||
59652338|NCT02566785|75770243|FG001|STARTED|Overall Study||18||
59652339|NCT02566785|75770242|FG000|COMPLETED|Overall Study||14||
59652340|NCT02566785|75770243|FG001|COMPLETED|Overall Study||15||
59652341|NCT02566785|75770242|FG000|NOT COMPLETED|Overall Study||1||
59652342|NCT02566785|75770243|FG001|NOT COMPLETED|Overall Study||3||
59652343|NCT02344537|75770251|FG000|STARTED|Overall Study||16||
59652344|NCT02344537|75770252|FG001|STARTED|Overall Study||10||
59652345|NCT02344537|75770251|FG000|COMPLETED|Overall Study||12||
59652346|NCT02344537|75770252|FG001|COMPLETED|Overall Study||8||
59652347|NCT02344537|75770251|FG000|NOT COMPLETED|Overall Study||4||
59652348|NCT02344537|75770252|FG001|NOT COMPLETED|Overall Study||2||
59652349|NCT01254942|75770260|FG000|STARTED|Overall Study||27||
59652350|NCT01254942|75770261|FG001|STARTED|Overall Study||26||
59652351|NCT01254942|75770260|FG000|COMPLETED|Overall Study||25||
59652352|NCT01254942|75770261|FG001|COMPLETED|Overall Study||24||
59652353|NCT01254942|75770260|FG000|NOT COMPLETED|Overall Study||2||
59652354|NCT01254942|75770261|FG001|NOT COMPLETED|Overall Study||2||
59652355|NCT01092702|75770269|FG000|STARTED|Overall Study||32||
59652356|NCT01092702|75770269|FG000|COMPLETED|Overall Study||23||
59652357|NCT01092702|75770269|FG000|NOT COMPLETED|Overall Study||9||
59652358|NCT01057134|75770273|FG000|STARTED|Overall Study||10||
59652359|NCT01057134|75770273|FG000|COMPLETED|Overall Study||9||
59652360|NCT01057134|75770273|FG000|NOT COMPLETED|Overall Study||1||
59652361|NCT00926848|75770281|FG000|STARTED|Overall Study||34||
59652362|NCT00926848|75770282|FG001|STARTED|Overall Study||34||
59652363|NCT00926848|75770281|FG000|COMPLETED|Overall Study||34||
59652364|NCT00926848|75770282|FG001|COMPLETED|Overall Study||34||
59652365|NCT00926848|75770281|FG000|NOT COMPLETED|Overall Study||0||
59652366|NCT00926848|75770282|FG001|NOT COMPLETED|Overall Study||0||
59652367|NCT00658879|75770298|FG000|STARTED|Overall Study||251||
59652368|NCT00658879|75770298|FG000|COMPLETED|Overall Study||250||
59652369|NCT00658879|75770298|FG000|NOT COMPLETED|Overall Study||1||
59652370|NCT00591851|75770302|FG000|STARTED|Overall Study||70||
59652371|NCT00591851|75770302|FG000|COMPLETED|Overall Study||64||
59652372|NCT00591851|75770302|FG000|NOT COMPLETED|Overall Study||6||
59652373|NCT00336024|75770308|FG000|STARTED|Overall Study||46||
59652374|NCT00336024|75770309|FG001|STARTED|Overall Study||45||
59652375|NCT00336024|75770308|FG000|COMPLETED|Overall Study||26||
59652376|NCT00336024|75770309|FG001|COMPLETED|Overall Study||26||
59652377|NCT00336024|75770308|FG000|NOT COMPLETED|Overall Study||20||
59652378|NCT00336024|75770309|FG001|NOT COMPLETED|Overall Study||19||
59652379|NCT00133705|75770317|FG000|STARTED|Overall Study||22||
59652380|NCT00133705|75770318|FG001|STARTED|Overall Study||20||
59652381|NCT00133705|75770317|FG000|COMPLETED|Overall Study||20||
59652382|NCT00133705|75770318|FG001|COMPLETED|Overall Study||17||
59652383|NCT00133705|75770317|FG000|NOT COMPLETED|Overall Study||2||
59652384|NCT00133705|75770318|FG001|NOT COMPLETED|Overall Study||3||
59652385|NCT01545050|75770329|FG000|STARTED|Overall Study||18||
59652386|NCT01545050|75770330|FG001|STARTED|Overall Study||9||
59652387|NCT01545050|75770331|FG002|STARTED|Overall Study||9||
59652388|NCT01545050|75770332|FG003|STARTED|Overall Study||18||
59652389|NCT01545050|75770333|FG004|STARTED|Overall Study||18||
59652390|NCT01545050|75770329|FG000|COMPLETED|Overall Study||11||
59652391|NCT01545050|75770330|FG001|COMPLETED|Overall Study||4||
59652392|NCT01545050|75770331|FG002|COMPLETED|Overall Study||4||
59652393|NCT01545050|75770332|FG003|COMPLETED|Overall Study||6||
59652394|NCT01545050|75770333|FG004|COMPLETED|Overall Study||9||
59652395|NCT01545050|75770329|FG000|NOT COMPLETED|Overall Study||7||
59652396|NCT01545050|75770330|FG001|NOT COMPLETED|Overall Study||5||
59652397|NCT01545050|75770331|FG002|NOT COMPLETED|Overall Study||5||
59652398|NCT01545050|75770332|FG003|NOT COMPLETED|Overall Study||12||
59652399|NCT01545050|75770333|FG004|NOT COMPLETED|Overall Study||9||
59652400|NCT01550302|75770351|FG000|STARTED|Overall Study||5||
59652401|NCT01550302|75770352|FG001|STARTED|Overall Study||5||
59652402|NCT01550302|75770351|FG000|COMPLETED|Overall Study||5||
59652403|NCT01550302|75770352|FG001|COMPLETED|Overall Study||5||
59652404|NCT01550302|75770351|FG000|NOT COMPLETED|Overall Study||0||
59652405|NCT01550302|75770352|FG001|NOT COMPLETED|Overall Study||0||
59652406|NCT01555021|75770360|FG000|STARTED|Overall Study||2||
59652407|NCT01555021|75770361|FG001|STARTED|Overall Study||2||
59652408|NCT01555021|75770360|FG000|COMPLETED|Overall Study|One treatment as usual subject completed 1 month, 3 month, and 6 month follow up visits|1||
59652409|NCT01555021|75770361|FG001|COMPLETED|Overall Study|None of the AGT subjects competed month 1, month 3, or month 6 follow up visits.|0||
59652410|NCT01555021|75770360|FG000|NOT COMPLETED|Overall Study||1||
59652411|NCT01555021|75770361|FG001|NOT COMPLETED|Overall Study||2||
59652412|NCT04721925|75770375|FG000|STARTED|2-Month Assessment||52||
59652413|NCT04721925|75770376|FG001|STARTED|2-Month Assessment||50||
59652414|NCT04721925|75770375|FG000|COMPLETED|2-Month Assessment||47|Completed 2 Month Assessment|
59988705|NCT02361346|76103920|FG004|NOT COMPLETED|Part 1 and 2 ( Up to Day 112)||2||
59988706|NCT02361346|76103921|FG005|NOT COMPLETED|Part 1 and 2 ( Up to Day 112)||0||
59988707|NCT02361346|76103922|FG006|NOT COMPLETED|Part 1 and 2 ( Up to Day 112)||0||
59988708|NCT02361346|76103923|FG007|NOT COMPLETED|Part 1 and 2 ( Up to Day 112)||0||
59988709|NCT02361346|76103924|FG008|NOT COMPLETED|Part 1 and 2 ( Up to Day 112)||0||
59988710|NCT02361346|76103916|FG000|STARTED|Part 3 (Up to Day 112)||0||
59988711|NCT02361346|76103917|FG001|STARTED|Part 3 (Up to Day 112)||0||
59988712|NCT02361346|76103918|FG002|STARTED|Part 3 (Up to Day 112)||0||
59988713|NCT02361346|76103919|FG003|STARTED|Part 3 (Up to Day 112)||0||
59988714|NCT02361346|76103920|FG004|STARTED|Part 3 (Up to Day 112)||0||
59988715|NCT02361346|76103921|FG005|STARTED|Part 3 (Up to Day 112)||0||
59988716|NCT02361346|76103922|FG006|STARTED|Part 3 (Up to Day 112)||0||
59988717|NCT02361346|76103923|FG007|STARTED|Part 3 (Up to Day 112)||11||
59988718|NCT02361346|76103924|FG008|STARTED|Part 3 (Up to Day 112)||0||
59988719|NCT02361346|76103916|FG000|COMPLETED|Part 3 (Up to Day 112)||0||
59988720|NCT02361346|76103917|FG001|COMPLETED|Part 3 (Up to Day 112)||0||
60076884|NCT01925989|76191898|FG002|COMPLETED|Period 2||12||
60076885|NCT01925989|76191896|FG000|NOT COMPLETED|Period 2||0||
60076886|NCT01925989|76191897|FG001|NOT COMPLETED|Period 2||0||
60076887|NCT01925989|76191898|FG002|NOT COMPLETED|Period 2||0||
59543429|NCT02231177|75641690|FG004|COMPLETED|Treatment Period 1 (21 Days)||8||
59543430|NCT02231177|75641691|FG005|COMPLETED|Treatment Period 1 (21 Days)||9||
59543431|NCT02231177|75641686|FG000|NOT COMPLETED|Treatment Period 1 (21 Days)||0||
59543432|NCT02231177|75641687|FG001|NOT COMPLETED|Treatment Period 1 (21 Days)||0||
59543433|NCT02231177|75641688|FG002|NOT COMPLETED|Treatment Period 1 (21 Days)||0||
59543434|NCT02231177|75641689|FG003|NOT COMPLETED|Treatment Period 1 (21 Days)||0||
59543435|NCT02231177|75641690|FG004|NOT COMPLETED|Treatment Period 1 (21 Days)||0||
59543436|NCT02231177|75641691|FG005|NOT COMPLETED|Treatment Period 1 (21 Days)||0||
59652415|NCT04721925|75770376|FG001|COMPLETED|2-Month Assessment||47|Completed 2 Month Assessment|
59652416|NCT04721925|75770375|FG000|NOT COMPLETED|2-Month Assessment||5||
59652417|NCT04721925|75770376|FG001|NOT COMPLETED|2-Month Assessment||3||
59652418|NCT04721925|75770375|FG000|STARTED|4-Month Assessment||52||
59988721|NCT02361346|76103918|FG002|COMPLETED|Part 3 (Up to Day 112)||0||
59652419|NCT04721925|75770376|FG001|STARTED|4-Month Assessment||50||
59988722|NCT02361346|76103919|FG003|COMPLETED|Part 3 (Up to Day 112)||0||
59988723|NCT02361346|76103920|FG004|COMPLETED|Part 3 (Up to Day 112)||0||
60076888|NCT01901419|76191912|FG000|STARTED|Overall Study||40||
59652420|NCT04721925|75770375|FG000|COMPLETED|4-Month Assessment||49|Completed 4-Month Assessment|
59652421|NCT04721925|75770376|FG001|COMPLETED|4-Month Assessment||44|Completed 4-Month Assessment|
59652422|NCT04721925|75770375|FG000|NOT COMPLETED|4-Month Assessment||3||
59652423|NCT04721925|75770376|FG001|NOT COMPLETED|4-Month Assessment||6||
59652424|NCT04677660|75770383|FG000|STARTED|Overall Study||50||
59652425|NCT04677660|75770384|FG001|STARTED|Overall Study||150||
59652426|NCT04677660|75770383|FG000|COMPLETED|Overall Study||7||
59652427|NCT04677660|75770384|FG001|COMPLETED|Overall Study||137||
59652428|NCT04677660|75770383|FG000|NOT COMPLETED|Overall Study||43||
59652429|NCT04677660|75770384|FG001|NOT COMPLETED|Overall Study||13||
59652430|NCT04518995|75770393|FG000|STARTED|Overall Study||140||
59652431|NCT04518995|75770394|FG001|STARTED|Overall Study||351||
59652432|NCT04518995|75770395|FG002|STARTED|Overall Study||215||
59652433|NCT04518995|75770393|FG000|Efficacy Population|Overall Study||140|Efficacy population included all participants who were randomized in the study and dispensed study drug during the treatment period.|
59652434|NCT04518995|75770394|FG001|Efficacy Population|Overall Study||351|Efficacy population included all participants who were randomized in the study and dispensed study drug during the treatment period.|
59652435|NCT04518995|75770395|FG002|Efficacy Population|Overall Study||215|Efficacy population included all participants who were randomized in the study and dispensed study drug during the treatment period.|
59652436|NCT04518995|75770393|FG000|Safety Population|Overall Study||140|Safety population included all participants who received study drug during the treatment period.|
59652437|NCT04518995|75770394|FG001|Safety Population|Overall Study||350|Safety population included all participants who received study drug during the treatment period.|
59652438|NCT04518995|75770395|FG002|Safety Population|Overall Study||215|Safety population included all participants who received study drug during the treatment period.|
59652439|NCT04518995|75770393|FG000|COMPLETED|Overall Study||129||
59652440|NCT04518995|75770394|FG001|COMPLETED|Overall Study||318||
59652441|NCT04518995|75770395|FG002|COMPLETED|Overall Study||199||
59652442|NCT04518995|75770393|FG000|NOT COMPLETED|Overall Study||11||
59652443|NCT04518995|75770394|FG001|NOT COMPLETED|Overall Study||33||
59652444|NCT04518995|75770395|FG002|NOT COMPLETED|Overall Study||16||
59652445|NCT04474691|75770403|FG000|STARTED|Overall Study|The number reported refers to the number of sessions scheduled across all participants.|15||240
59652446|NCT04474691|75770403|FG000|Visual-acoustic Biofeedback|Overall Study|The number reported refers to the number of sessions completed across all participants.|8||56
59652447|NCT04474691|75770403|FG000|Traditional Articulation Treatment|Overall Study|The number reported refers to the number of sessions completed across all participants.|8||53
59652448|NCT04474691|75770403|FG000|COMPLETED|Overall Study|The number reported refers to the number of sessions completed across all participants.|6||96
59652449|NCT04474691|75770403|FG000|NOT COMPLETED|Overall Study||9||144
59652450|NCT04175262|75770409|FG000|STARTED|Overall Study||102||
59652451|NCT04175262|75770409|FG000|COMPLETED|Overall Study||102||
59652452|NCT04175262|75770409|FG000|NOT COMPLETED|Overall Study||0||
59652453|NCT04149899|75770419|FG000|STARTED|Overall Study||6||
59652454|NCT04149899|75770420|FG001|STARTED|Overall Study||6||
59652455|NCT04149899|75770421|FG002|STARTED|Overall Study||6||
59652456|NCT04149899|75770422|FG003|STARTED|Overall Study||23||
59652457|NCT04149899|75770423|FG004|STARTED|Overall Study||24||
59652458|NCT04149899|75770424|FG005|STARTED|Overall Study||12||
59652459|NCT04149899|75770419|FG000|COMPLETED|Overall Study||6||
59652460|NCT04149899|75770420|FG001|COMPLETED|Overall Study||6||
59652461|NCT04149899|75770421|FG002|COMPLETED|Overall Study||6||
59652462|NCT04149899|75770422|FG003|COMPLETED|Overall Study||23||
59652463|NCT04149899|75770423|FG004|COMPLETED|Overall Study||24||
59652464|NCT04149899|75770424|FG005|COMPLETED|Overall Study||12||
59652465|NCT04149899|75770419|FG000|NOT COMPLETED|Overall Study||0||
59652466|NCT04149899|75770420|FG001|NOT COMPLETED|Overall Study||0||
59652467|NCT04149899|75770421|FG002|NOT COMPLETED|Overall Study||0||
59652468|NCT04149899|75770422|FG003|NOT COMPLETED|Overall Study||0||
59652469|NCT04149899|75770423|FG004|NOT COMPLETED|Overall Study||0||
59652470|NCT04149899|75770424|FG005|NOT COMPLETED|Overall Study||0||
59652471|NCT04014075|75770435|FG000|STARTED|Overall Study||79||
59652472|NCT04014075|75770435|FG000|COMPLETED|Overall Study||10|Completed = Participants ongoing treatment as of 08 Nov 2021, Not Completed = Participants who discontinued treatment|
59652473|NCT04014075|75770435|FG000|NOT COMPLETED|Overall Study||69||
59652474|NCT03840174|75770443|FG000|STARTED|Overall Study||6||
59652475|NCT03840174|75770444|FG001|STARTED|Overall Study||6||
59652476|NCT03840174|75770445|FG002|STARTED|Overall Study||3||
59652477|NCT03840174|75770446|FG003|STARTED|Overall Study||3||
59652478|NCT03840174|75770443|FG000|Vaccination 1|Overall Study||6||
59652479|NCT03840174|75770444|FG001|Vaccination 1|Overall Study||6||
59652480|NCT03840174|75770445|FG002|Vaccination 1|Overall Study||3||
59652481|NCT03840174|75770446|FG003|Vaccination 1|Overall Study||3||
59652482|NCT03840174|75770443|FG000|Vaccination 2|Overall Study||5||
59652483|NCT03840174|75770444|FG001|Vaccination 2|Overall Study||6||
59652484|NCT03840174|75770445|FG002|Vaccination 2|Overall Study||3||
59652485|NCT03840174|75770446|FG003|Vaccination 2|Overall Study||3||
59652486|NCT03840174|75770443|FG000|Vaccination 3|Overall Study||5||
59652487|NCT03840174|75770444|FG001|Vaccination 3|Overall Study||6||
59652488|NCT03840174|75770445|FG002|Vaccination 3|Overall Study||3||
59652489|NCT03840174|75770446|FG003|Vaccination 3|Overall Study||3||
59652490|NCT03840174|75770443|FG000|COMPLETED|Overall Study||5||
59652491|NCT03840174|75770444|FG001|COMPLETED|Overall Study||6||
59652492|NCT03840174|75770445|FG002|COMPLETED|Overall Study||3||
59652493|NCT03840174|75770446|FG003|COMPLETED|Overall Study||3||
59652494|NCT03840174|75770443|FG000|NOT COMPLETED|Overall Study||1||
59652495|NCT03840174|75770444|FG001|NOT COMPLETED|Overall Study||0||
59652496|NCT03840174|75770445|FG002|NOT COMPLETED|Overall Study||0||
59652497|NCT03840174|75770446|FG003|NOT COMPLETED|Overall Study||0||
59652498|NCT03786718|75770457|FG000|STARTED|Overall Study||67||
59652499|NCT03786718|75770457|FG000|COMPLETED|Overall Study||60||
59652500|NCT03786718|75770457|FG000|NOT COMPLETED|Overall Study||7||
59652501|NCT03776864|75770462|FG000|STARTED|Overall Study||6||
59652502|NCT03776864|75770462|FG000|COMPLETED|Overall Study||6||
59652503|NCT03776864|75770462|FG000|NOT COMPLETED|Overall Study||0||
59652504|NCT03552575|75770468|FG000|STARTED|Overall Study||47||
59652505|NCT03552575|75770469|FG001|STARTED|Overall Study||46||
59652506|NCT03552575|75770468|FG000|COMPLETED|Overall Study||46||
59652507|NCT03552575|75770469|FG001|COMPLETED|Overall Study||46||
59652508|NCT03552575|75770468|FG000|NOT COMPLETED|Overall Study||1||
59652509|NCT03552575|75770469|FG001|NOT COMPLETED|Overall Study||0||
59652510|NCT03522714|75770479|FG000|STARTED|Overall Study||38||
59652511|NCT03522714|75770480|FG001|STARTED|Overall Study||42||
59652512|NCT03522714|75770479|FG000|COMPLETED|Overall Study||28||
59652513|NCT03522714|75770480|FG001|COMPLETED|Overall Study||40||
59652514|NCT03522714|75770479|FG000|NOT COMPLETED|Overall Study||10||
59652515|NCT03522714|75770480|FG001|NOT COMPLETED|Overall Study||2||
59652516|NCT03400943|75770490|FG000|STARTED|Treatment Period 1||23|Randomized|
59652517|NCT03400943|75770491|FG001|STARTED|Treatment Period 1||23|Randomized|
59652518|NCT03400943|75770492|FG002|STARTED|Treatment Period 1||24|Randomized|
59652519|NCT03400943|75770493|FG003|STARTED|Treatment Period 1||23|Randomized|
59652520|NCT03400943|75770490|FG000|Treated|Treatment Period 1||18||
59652521|NCT03400943|75770491|FG001|Treated|Treatment Period 1||21||
59652522|NCT03400943|75770492|FG002|Treated|Treatment Period 1||20||
59652523|NCT03400943|75770493|FG003|Treated|Treatment Period 1||20||
59652524|NCT03400943|75770490|FG000|COMPLETED|Treatment Period 1||18||
59652525|NCT03400943|75770491|FG001|COMPLETED|Treatment Period 1||21||
59652526|NCT03400943|75770492|FG002|COMPLETED|Treatment Period 1||18||
59652527|NCT03400943|75770493|FG003|COMPLETED|Treatment Period 1||18||
59652528|NCT03400943|75770490|FG000|NOT COMPLETED|Treatment Period 1||5||
59652529|NCT03400943|75770491|FG001|NOT COMPLETED|Treatment Period 1||2||
59652530|NCT03400943|75770492|FG002|NOT COMPLETED|Treatment Period 1||6||
59652531|NCT03400943|75770493|FG003|NOT COMPLETED|Treatment Period 1||5||
59652532|NCT03400943|75770490|FG000|STARTED|Post-treatment Period 1||18||
59652533|NCT03400943|75770491|FG001|STARTED|Post-treatment Period 1||0||
59652534|NCT03400943|75770492|FG002|STARTED|Post-treatment Period 1||18||
59652535|NCT03400943|75770493|FG003|STARTED|Post-treatment Period 1||18||
59652536|NCT03400943|75770490|FG000|COMPLETED|Post-treatment Period 1||7||
59652537|NCT03400943|75770491|FG001|COMPLETED|Post-treatment Period 1||0||
59652538|NCT03400943|75770492|FG002|COMPLETED|Post-treatment Period 1||7||
59652539|NCT03400943|75770493|FG003|COMPLETED|Post-treatment Period 1||5||
59652540|NCT03400943|75770490|FG000|NOT COMPLETED|Post-treatment Period 1||11||
59652541|NCT03400943|75770491|FG001|NOT COMPLETED|Post-treatment Period 1||0||
59652542|NCT03400943|75770492|FG002|NOT COMPLETED|Post-treatment Period 1||11||
59652543|NCT03400943|75770493|FG003|NOT COMPLETED|Post-treatment Period 1||13||
59652544|NCT03400943|75770490|FG000|STARTED|Treatment Period 2||7|Treatment started|
59652545|NCT03400943|75770491|FG001|STARTED|Treatment Period 2||21|Treatment started|
59652546|NCT03400943|75770492|FG002|STARTED|Treatment Period 2||7|Treatment started|
59652547|NCT03400943|75770493|FG003|STARTED|Treatment Period 2||5|Treatment started|
59652548|NCT03400943|75770490|FG000|COMPLETED|Treatment Period 2||6||
59652549|NCT03400943|75770491|FG001|COMPLETED|Treatment Period 2||13||
59652550|NCT03400943|75770492|FG002|COMPLETED|Treatment Period 2||7||
59652551|NCT03400943|75770493|FG003|COMPLETED|Treatment Period 2||5||
59652552|NCT03400943|75770490|FG000|NOT COMPLETED|Treatment Period 2||1||
59652553|NCT03400943|75770491|FG001|NOT COMPLETED|Treatment Period 2||8||
59652554|NCT03400943|75770492|FG002|NOT COMPLETED|Treatment Period 2||0||
59652555|NCT03400943|75770493|FG003|NOT COMPLETED|Treatment Period 2||0||
59652556|NCT03400943|75770490|FG000|STARTED|Follow-up Period||7||
59652557|NCT03400943|75770491|FG001|STARTED|Follow-up Period||15||
59652558|NCT03400943|75770492|FG002|STARTED|Follow-up Period||7||
59652559|NCT03400943|75770493|FG003|STARTED|Follow-up Period||5||
59652560|NCT03400943|75770490|FG000|COMPLETED|Follow-up Period||6||
59652561|NCT03400943|75770491|FG001|COMPLETED|Follow-up Period||15||
59652562|NCT03400943|75770492|FG002|COMPLETED|Follow-up Period||7||
59652563|NCT03400943|75770493|FG003|COMPLETED|Follow-up Period||5||
59652564|NCT03400943|75770490|FG000|NOT COMPLETED|Follow-up Period||1||
59652565|NCT03400943|75770491|FG001|NOT COMPLETED|Follow-up Period||0||
59652566|NCT03400943|75770492|FG002|NOT COMPLETED|Follow-up Period||0||
59652567|NCT03400943|75770493|FG003|NOT COMPLETED|Follow-up Period||0||
59652568|NCT03321526|75770507|FG000|STARTED|Double-blind Treatment Phase (24 Weeks)||54||
59652569|NCT03321526|75770508|FG001|STARTED|Double-blind Treatment Phase (24 Weeks)||53||
59652570|NCT03321526|75770507|FG000|COMPLETED|Double-blind Treatment Phase (24 Weeks)||30||
59652571|NCT03321526|75770508|FG001|COMPLETED|Double-blind Treatment Phase (24 Weeks)||27||
59652572|NCT03321526|75770507|FG000|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||24||
59652573|NCT03321526|75770508|FG001|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||26||
59652574|NCT03321526|75770507|FG000|STARTED|Follow-up Phase (2 Weeks)|All participants that started the double-blind treatment phase were followed-up in follow-up phase.|54||
59652575|NCT03321526|75770508|FG001|STARTED|Follow-up Phase (2 Weeks)|All participants that started the double-blind treatment phase were followed-up in follow-up phase except 1 participant as that participant did not received any treatment.|52||
59652576|NCT03321526|75770507|FG000|COMPLETED|Follow-up Phase (2 Weeks)||30||
59652577|NCT03321526|75770508|FG001|COMPLETED|Follow-up Phase (2 Weeks)||28||
59652578|NCT03321526|75770507|FG000|NOT COMPLETED|Follow-up Phase (2 Weeks)||24||
59652579|NCT03321526|75770508|FG001|NOT COMPLETED|Follow-up Phase (2 Weeks)||24||
59652580|NCT03153111|75770522|FG000|STARTED|Overall Study||71||
59652581|NCT03153111|75770523|FG001|STARTED|Overall Study||71||
59652582|NCT03153111|75770522|FG000|COMPLETED|Overall Study||60||
59652583|NCT03153111|75770523|FG001|COMPLETED|Overall Study||62||
59652584|NCT03153111|75770522|FG000|NOT COMPLETED|Overall Study||11||
59652585|NCT03153111|75770523|FG001|NOT COMPLETED|Overall Study||9||
59652586|NCT03126435|75770531|FG000|STARTED|Overall Study||108||
59652587|NCT03126435|75770532|FG001|STARTED|Overall Study||110||
59652588|NCT03126435|75770531|FG000|COMPLETED|Overall Study||2||
59652589|NCT03126435|75770532|FG001|COMPLETED|Overall Study||6||
59652590|NCT03126435|75770531|FG000|NOT COMPLETED|Overall Study||106||
59652591|NCT03126435|75770532|FG001|NOT COMPLETED|Overall Study||104||
59652592|NCT03047005|75770542|FG000|STARTED|Overall Study||32||
59652593|NCT03047005|75770543|FG001|STARTED|Overall Study||34||
59652594|NCT03047005|75770542|FG000|COMPLETED|Overall Study||29||
59652595|NCT03047005|75770543|FG001|COMPLETED|Overall Study||28||
59652596|NCT03047005|75770542|FG000|NOT COMPLETED|Overall Study||3||
59652597|NCT03047005|75770543|FG001|NOT COMPLETED|Overall Study||6||
59652598|NCT02823574|75770553|FG000|STARTED|Randomization||159||
59652599|NCT02823574|75770554|FG001|STARTED|Randomization||82||
59652600|NCT02823574|75770555|FG002|STARTED|Randomization||123||
59652601|NCT02823574|75770556|FG003|STARTED|Randomization||61||
59652602|NCT02823574|75770553|FG000|COMPLETED|Randomization||158|Continuing to Treatment Period|
59652603|NCT02823574|75770554|FG001|COMPLETED|Randomization||82|Continuing to Treatment Period|
59652604|NCT02823574|75770555|FG002|COMPLETED|Randomization||122|Continuing to Treatment Period|
59652605|NCT02823574|75770556|FG003|COMPLETED|Randomization||61|Continuing to Treatment Period|
59652606|NCT02823574|75770553|FG000|NOT COMPLETED|Randomization||1||
59652607|NCT02823574|75770554|FG001|NOT COMPLETED|Randomization||0||
59652608|NCT02823574|75770555|FG002|NOT COMPLETED|Randomization||1||
59652609|NCT02823574|75770556|FG003|NOT COMPLETED|Randomization||0||
59652610|NCT02823574|75770553|FG000|STARTED|Treatment Period||158||
59652611|NCT02823574|75770554|FG001|STARTED|Treatment Period||82||
59652612|NCT02823574|75770555|FG002|STARTED|Treatment Period||122||
59652613|NCT02823574|75770556|FG003|STARTED|Treatment Period||61||
59652614|NCT02823574|75770553|FG000|COMPLETED|Treatment Period||0|Completed = Continuing in the Treatment Period|
59652615|NCT02823574|75770554|FG001|COMPLETED|Treatment Period||0|Completed = Continuing in the Treatment Period|
59652616|NCT02823574|75770555|FG002|COMPLETED|Treatment Period||0|Completed = Continuing in the Treatment Period|
59652617|NCT02823574|75770556|FG003|COMPLETED|Treatment Period||0|Completed = Continuing in the Treatment Period|
59652618|NCT02823574|75770553|FG000|NOT COMPLETED|Treatment Period||158||
59652619|NCT02823574|75770554|FG001|NOT COMPLETED|Treatment Period||82||
59652620|NCT02823574|75770555|FG002|NOT COMPLETED|Treatment Period||122||
59652621|NCT02823574|75770556|FG003|NOT COMPLETED|Treatment Period||61||
59652622|NCT02746809|75770569|FG000|STARTED|Enrollment||72||
59652623|NCT02746809|75770569|FG000|COMPLETED|Enrollment||60||
59652624|NCT02746809|75770569|FG000|NOT COMPLETED|Enrollment||12||
59652625|NCT02746809|75770569|FG000|STARTED|Procedure||60||
59652626|NCT02746809|75770569|FG000|COMPLETED|Procedure||59||
59652627|NCT02746809|75770569|FG000|NOT COMPLETED|Procedure||1||
59652628|NCT02746809|75770569|FG000|STARTED|1-Month||59||
59652629|NCT02746809|75770569|FG000|COMPLETED|1-Month||54||
59652630|NCT02746809|75770569|FG000|NOT COMPLETED|1-Month||5||
59652631|NCT02746809|75770569|FG000|STARTED|6-Month||54||
59652632|NCT02746809|75770569|FG000|COMPLETED|6-Month||51||
59652633|NCT02746809|75770569|FG000|NOT COMPLETED|6-Month||3||
59652634|NCT02746809|75770569|FG000|STARTED|12-Month||51||
59652635|NCT02746809|75770569|FG000|COMPLETED|12-Month||46||
59652636|NCT02746809|75770569|FG000|NOT COMPLETED|12-Month||5||
59652637|NCT02746809|75770569|FG000|STARTED|24-Month||46||
59652638|NCT02746809|75770569|FG000|COMPLETED|24-Month||44||
59652639|NCT02746809|75770569|FG000|NOT COMPLETED|24-Month||2||
59652640|NCT02746809|75770569|FG000|STARTED|36-Month||44||
59652641|NCT02746809|75770569|FG000|COMPLETED|36-Month||35||
59652642|NCT02746809|75770569|FG000|NOT COMPLETED|36-Month||9||
59652643|NCT02746809|75770569|FG000|STARTED|48-Month||35||
59652644|NCT02746809|75770569|FG000|COMPLETED|48-Month||27||
59652645|NCT02746809|75770569|FG000|NOT COMPLETED|48-Month||8||
59652646|NCT02746809|75770569|FG000|STARTED|60-Month||27||
59652647|NCT02746809|75770569|FG000|COMPLETED|60-Month||24||
59652648|NCT02746809|75770569|FG000|NOT COMPLETED|60-Month||3||
59652649|NCT02525796|75770578|FG000|STARTED|Randomization to Monotherapy for 4 Weeks||14||
59652650|NCT02525796|75770579|FG001|STARTED|Randomization to Monotherapy for 4 Weeks||14||
59652651|NCT02525796|75770580|FG002|STARTED|Randomization to Monotherapy for 4 Weeks||13||
59652652|NCT02525796|75770578|FG000|COMPLETED|Randomization to Monotherapy for 4 Weeks||12||
59652653|NCT02525796|75770579|FG001|COMPLETED|Randomization to Monotherapy for 4 Weeks||12||
59652654|NCT02525796|75770580|FG002|COMPLETED|Randomization to Monotherapy for 4 Weeks||12||
59652655|NCT02525796|75770578|FG000|NOT COMPLETED|Randomization to Monotherapy for 4 Weeks||2||
59652656|NCT02525796|75770579|FG001|NOT COMPLETED|Randomization to Monotherapy for 4 Weeks||2||
59652657|NCT02525796|75770580|FG002|NOT COMPLETED|Randomization to Monotherapy for 4 Weeks||1||
59652658|NCT02525796|75770578|FG000|STARTED|Open-label Addition of Cinacalcet||12||
59652659|NCT02525796|75770579|FG001|STARTED|Open-label Addition of Cinacalcet||12||
59652660|NCT02525796|75770580|FG002|STARTED|Open-label Addition of Cinacalcet||12||
59652661|NCT02525796|75770578|FG000|Open-label Cinacalcet|Open-label Addition of Cinacalcet|Eplerenone+Cinacalcet|12||
59652662|NCT02525796|75770579|FG001|Open-label Cinacalcet|Open-label Addition of Cinacalcet|Amiloride+Cincalcet|12||
59652663|NCT02525796|75770580|FG002|Open-label Cinacalcet|Open-label Addition of Cinacalcet|Placebo+Cinacalcet|12||
59652664|NCT02525796|75770578|FG000|COMPLETED|Open-label Addition of Cinacalcet||8||
59652665|NCT02525796|75770579|FG001|COMPLETED|Open-label Addition of Cinacalcet||10||
59652666|NCT02525796|75770580|FG002|COMPLETED|Open-label Addition of Cinacalcet||9||
59652667|NCT02525796|75770578|FG000|NOT COMPLETED|Open-label Addition of Cinacalcet||4||
59652668|NCT02525796|75770579|FG001|NOT COMPLETED|Open-label Addition of Cinacalcet||2||
59652669|NCT02525796|75770580|FG002|NOT COMPLETED|Open-label Addition of Cinacalcet||3||
59652670|NCT02360280|75770596|FG000|STARTED|Overall Study||28||
59652671|NCT02360280|75770597|FG001|STARTED|Overall Study||30||
59652672|NCT02360280|75770596|FG000|COMPLETED|Overall Study||25||
59652673|NCT02360280|75770597|FG001|COMPLETED|Overall Study||29||
59652674|NCT02360280|75770596|FG000|NOT COMPLETED|Overall Study||3||
59652675|NCT02360280|75770597|FG001|NOT COMPLETED|Overall Study||1||
59652676|NCT02201251|75770605|FG000|STARTED|Overall Study||28||
59652677|NCT02201251|75770606|FG001|STARTED|Overall Study||35||
59652678|NCT02201251|75770605|FG000|COMPLETED|Overall Study||24||
59652679|NCT02201251|75770606|FG001|COMPLETED|Overall Study||32||
59652680|NCT02201251|75770605|FG000|NOT COMPLETED|Overall Study||4||
59652681|NCT02201251|75770606|FG001|NOT COMPLETED|Overall Study||3||
59652682|NCT02027545|75770614|FG000|STARTED|Overall Study||261||
59652683|NCT02027545|75770615|FG001|STARTED|Overall Study||175||
59652684|NCT02027545|75770614|FG000|COMPLETED|Overall Study||258||
59652685|NCT02027545|75770615|FG001|COMPLETED|Overall Study||173||
59652686|NCT02027545|75770614|FG000|NOT COMPLETED|Overall Study||3||
59652687|NCT02027545|75770615|FG001|NOT COMPLETED|Overall Study||2||
59652688|NCT01889810|75770623|FG000|STARTED|Overall Study||35||
59652689|NCT01889810|75770624|FG001|STARTED|Overall Study||31||
59652690|NCT01889810|75770623|FG000|COMPLETED|Overall Study||34||
59652691|NCT01889810|75770624|FG001|COMPLETED|Overall Study||30||
59652692|NCT01889810|75770623|FG000|NOT COMPLETED|Overall Study||1||
59652693|NCT01889810|75770624|FG001|NOT COMPLETED|Overall Study||1||
59652694|NCT01867242|75770633|FG000|STARTED|Overall Study||64||
59652695|NCT01867242|75770634|FG001|STARTED|Overall Study||60||
59652696|NCT01867242|75770635|FG002|STARTED|Overall Study||26||
59652697|NCT01867242|75770633|FG000|COMPLETED|Overall Study||40||
59652698|NCT01867242|75770634|FG001|COMPLETED|Overall Study||44||
59652699|NCT01867242|75770635|FG002|COMPLETED|Overall Study||18||
59652700|NCT01867242|75770633|FG000|NOT COMPLETED|Overall Study||24||
59652701|NCT01867242|75770634|FG001|NOT COMPLETED|Overall Study||16||
59652702|NCT01867242|75770635|FG002|NOT COMPLETED|Overall Study||8||
59652703|NCT01858688|75770643|FG000|STARTED|Overall Study||101||
59652704|NCT01858688|75770643|FG000|Biopsied at Baseline|Overall Study||97||
59652705|NCT01858688|75770643|FG000|MRI Assessed|Overall Study||91||
59652706|NCT01858688|75770643|FG000|COMPLETED|Overall Study||81|Participants with TRUS biopsy at baseline as well as MRI and TRUS Biopsy post-baseline|
59652707|NCT01858688|75770643|FG000|NOT COMPLETED|Overall Study||20||
59652708|NCT01831895|75770647|FG000|STARTED|Overall Study||17||
59652709|NCT01831895|75770647|FG000|COMPLETED|Overall Study||15||
59652710|NCT01831895|75770647|FG000|NOT COMPLETED|Overall Study||2||
59652711|NCT01734694|75770653|FG000|STARTED|Overall Study||51||
59652712|NCT01734694|75770654|FG001|STARTED|Overall Study||49||
59652713|NCT01734694|75770653|FG000|COMPLETED|Overall Study||51||
59652714|NCT01734694|75770654|FG001|COMPLETED|Overall Study||49||
59652715|NCT01734694|75770653|FG000|NOT COMPLETED|Overall Study||0||
59652716|NCT01734694|75770654|FG001|NOT COMPLETED|Overall Study||0||
59652717|NCT01599234|75770662|FG000|STARTED|Overall Study||167||
59652718|NCT01599234|75770663|FG001|STARTED|Overall Study||170||
59652719|NCT01599234|75770662|FG000|COMPLETED|Overall Study||150||
59652720|NCT01599234|75770663|FG001|COMPLETED|Overall Study||155||
59652721|NCT01599234|75770662|FG000|NOT COMPLETED|Overall Study||17||
59652722|NCT01599234|75770663|FG001|NOT COMPLETED|Overall Study||15||
59652723|NCT01393301|75770671|FG000|STARTED|Overall Study||26||
59652724|NCT01393301|75770672|FG001|STARTED|Overall Study||27||
59652725|NCT01393301|75770671|FG000|COMPLETED|Overall Study||17||
59652726|NCT01393301|75770672|FG001|COMPLETED|Overall Study||24||
59652727|NCT01393301|75770671|FG000|NOT COMPLETED|Overall Study||9||
59652728|NCT01393301|75770672|FG001|NOT COMPLETED|Overall Study||3||
59652729|NCT00716625|75770678|FG000|STARTED|Overall Study||1674||
59652730|NCT00716625|75770678|FG000|COMPLETED|Overall Study||1673||
59652731|NCT00716625|75770678|FG000|NOT COMPLETED|Overall Study||1||
59652732|NCT00713817|75770698|FG000|STARTED|Overall Study||10||
59652733|NCT00713817|75770699|FG001|STARTED|Overall Study||9||
59652734|NCT00713817|75770698|FG000|COMPLETED|Overall Study||10||
59652735|NCT00713817|75770699|FG001|COMPLETED|Overall Study||9||
59652736|NCT00713817|75770698|FG000|NOT COMPLETED|Overall Study||0||
59652737|NCT00713817|75770699|FG001|NOT COMPLETED|Overall Study||0||
59652738|NCT00713323|75770705|FG000|STARTED|Overall Study||380||
59652739|NCT00713323|75770705|FG000|COMPLETED|Overall Study||234||
59652740|NCT00713323|75770705|FG000|NOT COMPLETED|Overall Study||146||
59652741|NCT00713193|75770711|FG000|STARTED|Overall Study||12||
59652742|NCT00713193|75770712|FG001|STARTED|Overall Study||14||
59652743|NCT00713193|75770711|FG000|COMPLETED|Overall Study||12||
59652744|NCT00713193|75770712|FG001|COMPLETED|Overall Study||14||
59652745|NCT00713193|75770711|FG000|NOT COMPLETED|Overall Study||0||
59652746|NCT00713193|75770712|FG001|NOT COMPLETED|Overall Study||0||
59652747|NCT00710554|75770722|FG000|STARTED|Overall Study||128||
59652748|NCT00710554|75770723|FG001|STARTED|Overall Study||118||
59652749|NCT00710554|75770722|FG000|COMPLETED|Overall Study||79||
59652750|NCT00710554|75770723|FG001|COMPLETED|Overall Study||94||
59652751|NCT00710554|75770722|FG000|NOT COMPLETED|Overall Study||49||
59652752|NCT00710554|75770723|FG001|NOT COMPLETED|Overall Study||24||
59652753|NCT00710424|75770731|FG000|STARTED|Overall Study||149||
59652754|NCT00710424|75770732|FG001|STARTED|Overall Study||148||
59652755|NCT00710424|75770731|FG000|COMPLETED|Overall Study||105||
59652756|NCT00710424|75770732|FG001|COMPLETED|Overall Study||125||
59652757|NCT00710424|75770731|FG000|NOT COMPLETED|Overall Study||44||
59652758|NCT00710424|75770732|FG001|NOT COMPLETED|Overall Study||23||
59652759|NCT00674609|75770741|FG000|STARTED|Overall Study||60||
59652760|NCT00674609|75770742|FG001|STARTED|Overall Study||58||
59652761|NCT00674609|75770743|FG002|STARTED|Overall Study||59||
59652762|NCT00674609|75770741|FG000|COMPLETED|Overall Study||48||
59652763|NCT00674609|75770742|FG001|COMPLETED|Overall Study||45||
59652764|NCT00674609|75770743|FG002|COMPLETED|Overall Study||51||
59652765|NCT00674609|75770741|FG000|NOT COMPLETED|Overall Study||12||
59652766|NCT00674609|75770742|FG001|NOT COMPLETED|Overall Study||13||
59652767|NCT00674609|75770743|FG002|NOT COMPLETED|Overall Study||8||
59652768|NCT00289107|75770753|FG000|STARTED|Overall Study||77||
59652769|NCT00289107|75770754|FG001|STARTED|Overall Study||72||
59652770|NCT00289107|75770753|FG000|COMPLETED|Overall Study||24||
59652771|NCT00289107|75770754|FG001|COMPLETED|Overall Study||28||
59652772|NCT00289107|75770753|FG000|NOT COMPLETED|Overall Study||53||
59652773|NCT00289107|75770754|FG001|NOT COMPLETED|Overall Study||44||
59709654|NCT01235741|75828431|FG002|COMPLETED|Follow-Up Post Treatment up to Month 6|7 participants did not complete the 6 month follow up period|29||
59709655|NCT01235741|75828429|FG000|NOT COMPLETED|Follow-Up Post Treatment up to Month 6||0||
59709656|NCT01235741|75828430|FG001|NOT COMPLETED|Follow-Up Post Treatment up to Month 6||9||
59709657|NCT01235741|75828431|FG002|NOT COMPLETED|Follow-Up Post Treatment up to Month 6||7||
59709658|NCT01235507|75828443|FG000|STARTED|Overall Study||71||
59709659|NCT01235507|75828443|FG000|COMPLETED|Overall Study||69||
59709660|NCT01235507|75828443|FG000|NOT COMPLETED|Overall Study||2||
59709661|NCT01235351|75828449|FG000|STARTED|Initial Treatment With 75 mg and 150 mg||247||
59709662|NCT01235351|75828450|FG001|STARTED|Initial Treatment With 75 mg and 150 mg||86||
59709663|NCT01235351|75828449|FG000|COMPLETED|Initial Treatment With 75 mg and 150 mg|4 allocated to initial treatment included in primary analysis|237||
59709664|NCT01235351|75828450|FG001|COMPLETED|Initial Treatment With 75 mg and 150 mg||82||
59709665|NCT01235351|75828449|FG000|NOT COMPLETED|Initial Treatment With 75 mg and 150 mg||10||
59709666|NCT01235351|75828450|FG001|NOT COMPLETED|Initial Treatment With 75 mg and 150 mg||4||
59709667|NCT01235351|75828449|FG000|STARTED|Treatment With Different Dose Sequences||233||
59709668|NCT01235351|75828450|FG001|STARTED|Treatment With Different Dose Sequences||82||
59709669|NCT01235351|75828449|FG000|75 mg First and Then 150 mg|Treatment With Different Dose Sequences||116||
59709670|NCT01235351|75828450|FG001|75 mg First and Then 150 mg|Treatment With Different Dose Sequences||0||
59709671|NCT01235351|75828449|FG000|150 mg First Then 75 mg|Treatment With Different Dose Sequences||117||
59709672|NCT01235351|75828450|FG001|150 mg First Then 75 mg|Treatment With Different Dose Sequences||0||
59709673|NCT01235351|75828449|FG000|225 mg First Then 300 mg|Treatment With Different Dose Sequences||0||
59709674|NCT01235351|75828450|FG001|225 mg First Then 300 mg|Treatment With Different Dose Sequences||41||
59709675|NCT01235351|75828449|FG000|300 mg First Then 225 mg|Treatment With Different Dose Sequences||0||
59709676|NCT01235351|75828450|FG001|300 mg First Then 225 mg|Treatment With Different Dose Sequences||41||
59709677|NCT01235351|75828449|FG000|COMPLETED|Treatment With Different Dose Sequences||233||
59709678|NCT01235351|75828450|FG001|COMPLETED|Treatment With Different Dose Sequences||82||
59709679|NCT01235351|75828449|FG000|NOT COMPLETED|Treatment With Different Dose Sequences||0||
59709680|NCT01235351|75828450|FG001|NOT COMPLETED|Treatment With Different Dose Sequences||0||
59709681|NCT01076205|75828460|FG000|STARTED|Overall Study||7229||
59709682|NCT01076205|75828460|FG000|COMPLETED|Overall Study||1210|Participants who were ongoing at the 60 month visit.|
59709683|NCT01076205|75828460|FG000|NOT COMPLETED|Overall Study||6019||
59709684|NCT01234883|75828482|FG000|STARTED|Overall Study||51||
59652774|NCT00118846|75770762|FG000|STARTED|Overall Study||175||
59652775|NCT00118846|75770763|FG001|STARTED|Overall Study||175||
59652776|NCT00118846|75770762|FG000|COMPLETED|Overall Study||162||
59652777|NCT00118846|75770763|FG001|COMPLETED|Overall Study||163||
59652778|NCT00118846|75770762|FG000|NOT COMPLETED|Overall Study||13||
59652779|NCT00118846|75770763|FG001|NOT COMPLETED|Overall Study||12||
59652780|NCT04705051|75770769|FG000|STARTED|Overall Study||24||
59652781|NCT04705051|75770769|FG000|Treated|Overall Study||23||
59652782|NCT04705051|75770769|FG000|COMPLETED|Overall Study||0||
59652783|NCT04705051|75770769|FG000|NOT COMPLETED|Overall Study||24||
59652784|NCT04464421|75770776|FG000|STARTED|Overall Study||24||
59652785|NCT04464421|75770777|FG001|STARTED|Overall Study||24||
59652786|NCT04464421|75770776|FG000|COMPLETED|Overall Study||22||
59652787|NCT04464421|75770777|FG001|COMPLETED|Overall Study||22||
59652788|NCT04464421|75770776|FG000|NOT COMPLETED|Overall Study||2||
59652789|NCT04464421|75770777|FG001|NOT COMPLETED|Overall Study||2||
59652790|NCT04298853|75770785|FG000|STARTED|Overall Study||9||
59652791|NCT04298853|75770786|FG001|STARTED|Overall Study||8||
59652792|NCT04298853|75770785|FG000|COMPLETED|Overall Study||9||
59652793|NCT04298853|75770786|FG001|COMPLETED|Overall Study||8||
59652794|NCT04298853|75770785|FG000|NOT COMPLETED|Overall Study||0||
59652795|NCT04298853|75770786|FG001|NOT COMPLETED|Overall Study||0||
59652796|NCT04112784|75770795|FG000|STARTED|Overall Study||38||
59652797|NCT04112784|75770795|FG000|COMPLETED|Overall Study||25||
59652798|NCT04112784|75770795|FG000|NOT COMPLETED|Overall Study||13||
59652799|NCT04049617|75770805|FG000|STARTED|Overall Study||3||
59652800|NCT04049617|75770806|FG001|STARTED|Overall Study||3||
59652801|NCT04049617|75770807|FG002|STARTED|Overall Study||6||
59652802|NCT04049617|75770808|FG003|STARTED|Overall Study||3||
59652803|NCT04049617|75770809|FG004|STARTED|Overall Study||2||
59652804|NCT04049617|75770810|FG005|STARTED|Overall Study||1||
59652805|NCT04049617|75770805|FG000|COMPLETED|Overall Study||3||
59652806|NCT04049617|75770806|FG001|COMPLETED|Overall Study||3||
59652807|NCT04049617|75770807|FG002|COMPLETED|Overall Study||5||
59652808|NCT04049617|75770808|FG003|COMPLETED|Overall Study||1||
59652809|NCT04049617|75770809|FG004|COMPLETED|Overall Study||2||
59652810|NCT04049617|75770810|FG005|COMPLETED|Overall Study||0||
59652811|NCT04049617|75770805|FG000|NOT COMPLETED|Overall Study||0||
59652812|NCT04049617|75770806|FG001|NOT COMPLETED|Overall Study||0||
59652813|NCT04049617|75770807|FG002|NOT COMPLETED|Overall Study||1||
59652814|NCT04049617|75770808|FG003|NOT COMPLETED|Overall Study||2||
59652815|NCT04049617|75770809|FG004|NOT COMPLETED|Overall Study||0||
59652816|NCT04049617|75770810|FG005|NOT COMPLETED|Overall Study||1||
59652817|NCT03911154|75770826|FG000|STARTED|Overall Study||9||
59652818|NCT03911154|75770826|FG000|Continuous Fixed Interval|Overall Study||9|Each participant will receive the SmartSleep Continuous fixed interval modality during one night of sleep restriction|
59652819|NCT03911154|75770826|FG000|Block|Overall Study||9|Each participant will receive the SmartSleep Block modality during one night of sleep restriction|
59652820|NCT03911154|75770826|FG000|In-Phase Adjustable|Overall Study||9|Each participant will receive the SmartSleep In-Phase Adjustable modality during one night of sleep restriction|
59652821|NCT03911154|75770826|FG000|SHAM|Overall Study||9|Each participant will receive the SmartSleep SHAM modality during one night of sleep restriction|
59652822|NCT03911154|75770826|FG000|COMPLETED|Overall Study||8||
59652823|NCT03911154|75770826|FG000|NOT COMPLETED|Overall Study||1||
59652824|NCT03813121|75770835|FG000|STARTED|Overall Study||4||
59652825|NCT03813121|75770836|FG001|STARTED|Overall Study||6||
59652826|NCT03813121|75770835|FG000|COMPLETED|Overall Study||4||
59652827|NCT03813121|75770836|FG001|COMPLETED|Overall Study||6||
59652828|NCT03813121|75770835|FG000|NOT COMPLETED|Overall Study||0||
59652829|NCT03813121|75770836|FG001|NOT COMPLETED|Overall Study||0||
59652830|NCT03781778|75770844|FG000|STARTED|Overall Study||4||
59652831|NCT03781778|75770845|FG001|STARTED|Overall Study||6||
59988724|NCT02361346|76103921|FG005|COMPLETED|Part 3 (Up to Day 112)||0||
59988725|NCT02361346|76103922|FG006|COMPLETED|Part 3 (Up to Day 112)||0||
59988726|NCT02361346|76103923|FG007|COMPLETED|Part 3 (Up to Day 112)||0||
59988727|NCT02361346|76103924|FG008|COMPLETED|Part 3 (Up to Day 112)||0||
59988728|NCT02361346|76103916|FG000|NOT COMPLETED|Part 3 (Up to Day 112)||0||
59988729|NCT02361346|76103917|FG001|NOT COMPLETED|Part 3 (Up to Day 112)||0||
59988730|NCT02361346|76103918|FG002|NOT COMPLETED|Part 3 (Up to Day 112)||0||
59988731|NCT02361346|76103919|FG003|NOT COMPLETED|Part 3 (Up to Day 112)||0||
59652832|NCT03781778|75770844|FG000|Started Intervention|Overall Study||3||
59652833|NCT03781778|75770845|FG001|Started Intervention|Overall Study||4||
59652834|NCT03781778|75770844|FG000|COMPLETED|Overall Study||2||
59652835|NCT03781778|75770845|FG001|COMPLETED|Overall Study||4||
59652836|NCT03781778|75770844|FG000|NOT COMPLETED|Overall Study||2||
59652837|NCT03781778|75770845|FG001|NOT COMPLETED|Overall Study||2||
59652838|NCT03710590|75770853|FG000|STARTED|Overall Study||22||
59652839|NCT03710590|75770854|FG001|STARTED|Overall Study||23||
59652840|NCT03710590|75770853|FG000|Session 1: ECIG Lab Session 15 Watts, 10 mg Nicotine|Overall Study||12||
59652841|NCT03710590|75770854|FG001|Session 1: ECIG Lab Session 15 Watts, 10 mg Nicotine|Overall Study||15||
59652842|NCT03710590|75770853|FG000|Session 2: ECIG Lab Session 15 Watts, 15 mg Nicotine|Overall Study||12||
59652843|NCT03710590|75770854|FG001|Session 2: ECIG Lab Session 15 Watts, 15 mg Nicotine|Overall Study||15||
59709685|NCT01234883|75828483|FG001|STARTED|Overall Study||49||
59543437|NCT02231177|75641686|FG000|STARTED|Treatment Period 2 (21 Days)||8||
59543438|NCT02231177|75641687|FG001|STARTED|Treatment Period 2 (21 Days)||7||
59543439|NCT02231177|75641688|FG002|STARTED|Treatment Period 2 (21 Days)||8||
59543440|NCT02231177|75641689|FG003|STARTED|Treatment Period 2 (21 Days)||7||
59543441|NCT02231177|75641690|FG004|STARTED|Treatment Period 2 (21 Days)||8||
59543442|NCT02231177|75641691|FG005|STARTED|Treatment Period 2 (21 Days)||9||
59543443|NCT02231177|75641686|FG000|COMPLETED|Treatment Period 2 (21 Days)||8||
59543444|NCT02231177|75641687|FG001|COMPLETED|Treatment Period 2 (21 Days)||7||
59543445|NCT02231177|75641688|FG002|COMPLETED|Treatment Period 2 (21 Days)||8||
59543446|NCT02231177|75641689|FG003|COMPLETED|Treatment Period 2 (21 Days)||7||
59543447|NCT02231177|75641690|FG004|COMPLETED|Treatment Period 2 (21 Days)||8||
59543448|NCT02231177|75641691|FG005|COMPLETED|Treatment Period 2 (21 Days)||9||
59543449|NCT02231177|75641686|FG000|NOT COMPLETED|Treatment Period 2 (21 Days)||0||
59543450|NCT02231177|75641687|FG001|NOT COMPLETED|Treatment Period 2 (21 Days)||0||
59543451|NCT02231177|75641688|FG002|NOT COMPLETED|Treatment Period 2 (21 Days)||0||
59543452|NCT02231177|75641689|FG003|NOT COMPLETED|Treatment Period 2 (21 Days)||0||
59543453|NCT02231177|75641690|FG004|NOT COMPLETED|Treatment Period 2 (21 Days)||0||
59543454|NCT02231177|75641691|FG005|NOT COMPLETED|Treatment Period 2 (21 Days)||0||
59543455|NCT02231177|75641686|FG000|STARTED|Treatment Period 3 (21 Days)||8||
59543456|NCT02231177|75641687|FG001|STARTED|Treatment Period 3 (21 Days)||7||
59543457|NCT02231177|75641688|FG002|STARTED|Treatment Period 3 (21 Days)||8||
59543458|NCT02231177|75641689|FG003|STARTED|Treatment Period 3 (21 Days)||7||
59543459|NCT02231177|75641690|FG004|STARTED|Treatment Period 3 (21 Days)||8||
59543460|NCT02231177|75641691|FG005|STARTED|Treatment Period 3 (21 Days)||9||
59543461|NCT02231177|75641686|FG000|COMPLETED|Treatment Period 3 (21 Days)||8||
59543462|NCT02231177|75641687|FG001|COMPLETED|Treatment Period 3 (21 Days)||7||
59543463|NCT02231177|75641688|FG002|COMPLETED|Treatment Period 3 (21 Days)||8||
59543464|NCT02231177|75641689|FG003|COMPLETED|Treatment Period 3 (21 Days)||7||
59543465|NCT02231177|75641690|FG004|COMPLETED|Treatment Period 3 (21 Days)||8||
59543466|NCT02231177|75641691|FG005|COMPLETED|Treatment Period 3 (21 Days)||9||
59543467|NCT02231177|75641686|FG000|NOT COMPLETED|Treatment Period 3 (21 Days)||0||
59543468|NCT02231177|75641687|FG001|NOT COMPLETED|Treatment Period 3 (21 Days)||0||
59543469|NCT02231177|75641688|FG002|NOT COMPLETED|Treatment Period 3 (21 Days)||0||
59543470|NCT02231177|75641689|FG003|NOT COMPLETED|Treatment Period 3 (21 Days)||0||
59543471|NCT02231177|75641690|FG004|NOT COMPLETED|Treatment Period 3 (21 Days)||0||
59543472|NCT02231177|75641691|FG005|NOT COMPLETED|Treatment Period 3 (21 Days)||0||
59543473|NCT02223689|75641700|FG000|STARTED|Overall Study||35||
59543474|NCT02223689|75641700|FG000|COMPLETED|Overall Study||35||
59543475|NCT02223689|75641700|FG000|NOT COMPLETED|Overall Study||0||
59543476|NCT00927992|75641705|FG000|STARTED|Overall Study||11||
59543477|NCT00927992|75641705|FG000|COMPLETED|Overall Study||11||
59543478|NCT00927992|75641705|FG000|NOT COMPLETED|Overall Study||0||
59543479|NCT01629797|75641709|FG000|STARTED|Overall Study||100||
59543480|NCT01629797|75641709|FG000|COMPLETED|Overall Study||82||
59543481|NCT01629797|75641709|FG000|NOT COMPLETED|Overall Study||18||
59543482|NCT00928304|75641716|FG000|STARTED|Overall Study||39||
59543483|NCT00928304|75641717|FG001|STARTED|Overall Study||70||
59543484|NCT00928304|75641716|FG000|COMPLETED|Overall Study||39||
59543485|NCT00928304|75641717|FG001|COMPLETED|Overall Study||70||
59543486|NCT00928304|75641716|FG000|NOT COMPLETED|Overall Study||0||
59543487|NCT00928304|75641717|FG001|NOT COMPLETED|Overall Study||0||
59543488|NCT01630109|75641732|FG000|STARTED|Overall Study||1||
59543489|NCT01630109|75641733|FG001|STARTED|Overall Study||1||
59543490|NCT01630109|75641734|FG002|STARTED|Overall Study||3||
59543491|NCT01630109|75641732|FG000|COMPLETED|Overall Study||1||
59543492|NCT01630109|75641733|FG001|COMPLETED|Overall Study||1||
59543493|NCT01630109|75641734|FG002|COMPLETED|Overall Study||3||
59543494|NCT01630109|75641732|FG000|NOT COMPLETED|Overall Study||0||
59543495|NCT01630109|75641733|FG001|NOT COMPLETED|Overall Study||0||
59543496|NCT01630109|75641734|FG002|NOT COMPLETED|Overall Study||0||
59543497|NCT01632215|75641750|FG000|STARTED|Overall Study||20||
59543498|NCT01632215|75641751|FG001|STARTED|Overall Study||20||
59543499|NCT01632215|75641750|FG000|COMPLETED|Overall Study||18||
59543500|NCT01632215|75641751|FG001|COMPLETED|Overall Study||19||
59543501|NCT01632215|75641750|FG000|NOT COMPLETED|Overall Study||2||
59543502|NCT01632215|75641751|FG001|NOT COMPLETED|Overall Study||1||
59543503|NCT03060083|75641759|FG000|STARTED|Overall Study||39||
59543504|NCT03060083|75641760|FG001|STARTED|Overall Study||35||
59543505|NCT03060083|75641759|FG000|Attended End of Baseline Study Visit|Overall Study||36||
59543506|NCT03060083|75641760|FG001|Attended End of Baseline Study Visit|Overall Study||32||
59543507|NCT03060083|75641759|FG000|COMPLETED|Overall Study||31|Completion defined as attended the final study visit.|
59543508|NCT03060083|75641760|FG001|COMPLETED|Overall Study||27|Completion defined as attended the final study visit.|
59543509|NCT03060083|75641759|FG000|NOT COMPLETED|Overall Study||8||
59543510|NCT03060083|75641760|FG001|NOT COMPLETED|Overall Study||8||
59543511|NCT02308241|75641766|FG000|STARTED|Overall Study||12||
59543512|NCT02308241|75641766|FG000|COMPLETED|Overall Study||9||
59543513|NCT02308241|75641766|FG000|NOT COMPLETED|Overall Study||3||
59652844|NCT03710590|75770853|FG000|Session 3: ECIG Lab Session 15 Watts, 30 mg Nicotine|Overall Study||12||
59652845|NCT03710590|75770854|FG001|Session 3: ECIG Lab Session 15 Watts, 30 mg Nicotine|Overall Study||15||
59652846|NCT03710590|75770853|FG000|Session 4: ECIG Lab Session 30 Watts, 10 mg Nicotine|Overall Study||12||
59652847|NCT03710590|75770854|FG001|Session 4: ECIG Lab Session 30 Watts, 10 mg Nicotine|Overall Study||15||
59652848|NCT03710590|75770853|FG000|Session 5: ECIG Lab Session 30 Watts, 15 mg Nicotine|Overall Study||12||
59652849|NCT03710590|75770854|FG001|Session 5: ECIG Lab Session 30 Watts, 15 mg Nicotine|Overall Study||15||
59652850|NCT03710590|75770853|FG000|Session 6: ECIG Lab Session 30 Watts, 30 mg Nicotine|Overall Study||12||
59652851|NCT03710590|75770854|FG001|Session 6: ECIG Lab Session 30 Watts, 30 mg Nicotine|Overall Study||15||
59652852|NCT03710590|75770853|FG000|COMPLETED|Overall Study||12||
59652853|NCT03710590|75770854|FG001|COMPLETED|Overall Study||15||
59652854|NCT03710590|75770853|FG000|NOT COMPLETED|Overall Study||10||
59652855|NCT03710590|75770854|FG001|NOT COMPLETED|Overall Study||8||
59652856|NCT03676725|75770866|FG000|STARTED|Overall Study||23||
59652857|NCT03676725|75770867|FG001|STARTED|Overall Study||14||
59652858|NCT03676725|75770868|FG002|STARTED|Overall Study||22||
59652859|NCT03676725|75770869|FG003|STARTED|Overall Study||5||
59652860|NCT03676725|75770870|FG004|STARTED|Overall Study||15||
59652861|NCT03676725|75770871|FG005|STARTED|Overall Study||11||
59652862|NCT03676725|75770866|FG000|COMPLETED|Overall Study||23||
59652863|NCT03676725|75770867|FG001|COMPLETED|Overall Study||14||
59652864|NCT03676725|75770868|FG002|COMPLETED|Overall Study||22||
59652865|NCT03676725|75770869|FG003|COMPLETED|Overall Study||5||
59652866|NCT03676725|75770870|FG004|COMPLETED|Overall Study||15||
59652867|NCT03676725|75770871|FG005|COMPLETED|Overall Study||11||
59652868|NCT03676725|75770866|FG000|NOT COMPLETED|Overall Study||0||
59652869|NCT03676725|75770867|FG001|NOT COMPLETED|Overall Study||0||
59652870|NCT03676725|75770868|FG002|NOT COMPLETED|Overall Study||0||
59652871|NCT03676725|75770869|FG003|NOT COMPLETED|Overall Study||0||
59652872|NCT03676725|75770870|FG004|NOT COMPLETED|Overall Study||0||
59652873|NCT03676725|75770871|FG005|NOT COMPLETED|Overall Study||0||
59652874|NCT03624816|75770882|FG000|STARTED|Overall Study||107||
59652875|NCT03624816|75770883|FG001|STARTED|Overall Study||33||
59652876|NCT03624816|75770882|FG000|COMPLETED|Overall Study||97||
59652877|NCT03624816|75770883|FG001|COMPLETED|Overall Study||26||
59652878|NCT03624816|75770882|FG000|NOT COMPLETED|Overall Study||10||
59652879|NCT03624816|75770883|FG001|NOT COMPLETED|Overall Study||7||
59652880|NCT03607825|75770889|FG000|STARTED|Overall Study||33||
59652881|NCT03607825|75770889|FG000|COMPLETED|Overall Study||33||
59652882|NCT03607825|75770889|FG000|NOT COMPLETED|Overall Study||0||
59652883|NCT03532490|75770895|FG000|STARTED|Overall Study||16||
59652884|NCT03532490|75770896|FG001|STARTED|Overall Study||22||
59652885|NCT03532490|75770895|FG000|COMPLETED|Overall Study||16||
59652886|NCT03532490|75770896|FG001|COMPLETED|Overall Study||22||
59652887|NCT03532490|75770895|FG000|NOT COMPLETED|Overall Study||0||
59652888|NCT03532490|75770896|FG001|NOT COMPLETED|Overall Study||0||
59652889|NCT03465722|75770906|FG000|STARTED|Overall Study||240||
59652890|NCT03465722|75770907|FG001|STARTED|Overall Study||236||
59652891|NCT03465722|75770906|FG000|COMPLETED|Overall Study||0||
59652892|NCT03465722|75770907|FG001|COMPLETED|Overall Study||0||
59652893|NCT03465722|75770906|FG000|NOT COMPLETED|Overall Study||240||
59988732|NCT02361346|76103920|FG004|NOT COMPLETED|Part 3 (Up to Day 112)||0||
59988733|NCT02361346|76103921|FG005|NOT COMPLETED|Part 3 (Up to Day 112)||0||
59988734|NCT02361346|76103922|FG006|NOT COMPLETED|Part 3 (Up to Day 112)||0||
59988735|NCT02361346|76103923|FG007|NOT COMPLETED|Part 3 (Up to Day 112)||11||
59988736|NCT02361346|76103924|FG008|NOT COMPLETED|Part 3 (Up to Day 112)||0||
59988737|NCT02361346|76103916|FG000|STARTED|Part 4 (Up to Day 112)||0||
59988738|NCT02361346|76103917|FG001|STARTED|Part 4 (Up to Day 112)||0||
59988739|NCT02361346|76103918|FG002|STARTED|Part 4 (Up to Day 112)||0||
59988740|NCT02361346|76103919|FG003|STARTED|Part 4 (Up to Day 112)||0||
59988741|NCT02361346|76103920|FG004|STARTED|Part 4 (Up to Day 112)||0||
59988742|NCT02361346|76103921|FG005|STARTED|Part 4 (Up to Day 112)||0||
59988743|NCT02361346|76103922|FG006|STARTED|Part 4 (Up to Day 112)||0||
59988744|NCT02361346|76103923|FG007|STARTED|Part 4 (Up to Day 112)||0||
59988745|NCT02361346|76103924|FG008|STARTED|Part 4 (Up to Day 112)||0||
59988746|NCT02361346|76103916|FG000|COMPLETED|Part 4 (Up to Day 112)||0||
59988747|NCT02361346|76103917|FG001|COMPLETED|Part 4 (Up to Day 112)||0||
59652894|NCT03465722|75770907|FG001|NOT COMPLETED|Overall Study||236||
59988748|NCT02361346|76103918|FG002|COMPLETED|Part 4 (Up to Day 112)||0||
59652895|NCT03205423|75770913|FG000|STARTED|Overall Study||8||
59988749|NCT02361346|76103919|FG003|COMPLETED|Part 4 (Up to Day 112)||0||
60076889|NCT01901419|76191913|FG001|STARTED|Overall Study||40||
59652896|NCT03205423|75770914|FG001|STARTED|Overall Study||9||
59652897|NCT03205423|75770913|FG000|COMPLETED|Overall Study||7||
59652898|NCT03205423|75770914|FG001|COMPLETED|Overall Study||6||
59652899|NCT03205423|75770913|FG000|NOT COMPLETED|Overall Study||1||
59652900|NCT03205423|75770914|FG001|NOT COMPLETED|Overall Study||3||
59652901|NCT03073603|75770923|FG000|STARTED|Overall Study||128||
59652902|NCT03073603|75770924|FG001|STARTED|Overall Study||131||
59652903|NCT03073603|75770923|FG000|COMPLETED|Overall Study||106||
59988750|NCT02361346|76103920|FG004|COMPLETED|Part 4 (Up to Day 112)||0||
60076890|NCT01901419|76191912|FG000|COMPLETED|Overall Study||32||
60076891|NCT01901419|76191913|FG001|COMPLETED|Overall Study||31||
60076892|NCT01901419|76191912|FG000|NOT COMPLETED|Overall Study||8||
60076893|NCT01901419|76191913|FG001|NOT COMPLETED|Overall Study||9||
60076894|NCT02798536|76191922|FG000|STARTED|Overall Study||3||
60076895|NCT02798536|76191923|FG001|STARTED|Overall Study||7||
60076896|NCT02798536|76191924|FG002|STARTED|Overall Study||11||
60076897|NCT02798536|76191922|FG000|COMPLETED|Overall Study||3||
60076898|NCT02798536|76191923|FG001|COMPLETED|Overall Study||7||
60076899|NCT02798536|76191924|FG002|COMPLETED|Overall Study||11||
60076900|NCT02798536|76191922|FG000|NOT COMPLETED|Overall Study||0||
60076901|NCT02798536|76191923|FG001|NOT COMPLETED|Overall Study||0||
60076902|NCT02798536|76191924|FG002|NOT COMPLETED|Overall Study||0||
60076903|NCT01901341|76191940|FG000|STARTED|Overall Study||22||
60076904|NCT01901341|76191941|FG001|STARTED|Overall Study||22||
60076905|NCT01901341|76191940|FG000|Received at Least 1 Dose of Study Drug|Overall Study||22||
60076906|NCT01901341|76191941|FG001|Received at Least 1 Dose of Study Drug|Overall Study||22||
60076907|NCT01901341|76191940|FG000|COMPLETED|Overall Study||2||
60076908|NCT01901341|76191941|FG001|COMPLETED|Overall Study||1||
60076909|NCT01901341|76191940|FG000|NOT COMPLETED|Overall Study||20||
60076910|NCT01901341|76191941|FG001|NOT COMPLETED|Overall Study||21||
60076911|NCT01615939|76191950|FG000|STARTED|Overall Study||13||
60076912|NCT01615939|76191951|FG001|STARTED|Overall Study||4||
60076913|NCT01615939|76191950|FG000|COMPLETED|Overall Study||8||
60076914|NCT01615939|76191951|FG001|COMPLETED|Overall Study||4||
60076915|NCT01615939|76191950|FG000|NOT COMPLETED|Overall Study||5||
60076916|NCT01615939|76191951|FG001|NOT COMPLETED|Overall Study||0||
60076917|NCT01901185|76191957|FG000|STARTED|Overall Study||77||
60076918|NCT01901185|76191957|FG000|Received Etanercept With Autoinjector A|Overall Study||75||
60076919|NCT01901185|76191957|FG000|COMPLETED|Overall Study||75||
60076920|NCT01901185|76191957|FG000|NOT COMPLETED|Overall Study||2||
60076921|NCT01888003|76191964|FG000|STARTED|Overall Study||5||
60076922|NCT01888003|76191965|FG001|STARTED|Overall Study||6||
60076923|NCT01888003|76191966|FG002|STARTED|Overall Study||40||
60076924|NCT01888003|76191964|FG000|COMPLETED|Overall Study||0||
60076925|NCT01888003|76191965|FG001|COMPLETED|Overall Study||0||
60076926|NCT01888003|76191966|FG002|COMPLETED|Overall Study||0||
60076927|NCT01888003|76191964|FG000|NOT COMPLETED|Overall Study||5||
60076928|NCT01888003|76191965|FG001|NOT COMPLETED|Overall Study||6||
60076929|NCT01888003|76191966|FG002|NOT COMPLETED|Overall Study||40||
60076930|NCT02775214|76191976|FG000|STARTED|Overall Study||30||
60076931|NCT02775214|76191977|FG001|STARTED|Overall Study||32||
60076932|NCT02775214|76191976|FG000|COMPLETED|Overall Study||28||
60076933|NCT02775214|76191977|FG001|COMPLETED|Overall Study||32||
60076934|NCT02775214|76191976|FG000|NOT COMPLETED|Overall Study||2||
60076935|NCT02775214|76191977|FG001|NOT COMPLETED|Overall Study||0||
60076936|NCT02773732|76191985|FG000|STARTED|Ciprofloxacin Dose Level 0||3||
60076937|NCT02773732|76191986|FG001|STARTED|Ciprofloxacin Dose Level 0||0||
60076938|NCT02773732|76191985|FG000|COMPLETED|Ciprofloxacin Dose Level 0||3||
60076939|NCT02773732|76191986|FG001|COMPLETED|Ciprofloxacin Dose Level 0||0||
60076940|NCT02773732|76191985|FG000|NOT COMPLETED|Ciprofloxacin Dose Level 0||0||
60076941|NCT02773732|76191986|FG001|NOT COMPLETED|Ciprofloxacin Dose Level 0||0||
60076942|NCT02773732|76191985|FG000|STARTED|Ciprofloxacin Dose Level +1||0||
59543514|NCT01632683|75641772|FG000|STARTED|Overall Study||548||
59543515|NCT01632683|75641773|FG001|STARTED|Overall Study||552||
60076943|NCT02773732|76191986|FG001|STARTED|Ciprofloxacin Dose Level +1||8||
60076944|NCT02773732|76191985|FG000|COMPLETED|Ciprofloxacin Dose Level +1||0||
60076945|NCT02773732|76191986|FG001|COMPLETED|Ciprofloxacin Dose Level +1||8||
60076946|NCT02773732|76191985|FG000|NOT COMPLETED|Ciprofloxacin Dose Level +1||0||
60076947|NCT02773732|76191986|FG001|NOT COMPLETED|Ciprofloxacin Dose Level +1||0||
60076948|NCT02726542|76191999|FG000|STARTED|Overall Study||13||
60076949|NCT02726542|76192000|FG001|STARTED|Overall Study||11||
60076950|NCT02726542|76191999|FG000|COMPLETED|Overall Study||10||
60076951|NCT02726542|76192000|FG001|COMPLETED|Overall Study||10||
60076952|NCT02726542|76191999|FG000|NOT COMPLETED|Overall Study||3||
59543516|NCT01632683|75641772|FG000|COMPLETED|Overall Study||548||
59543517|NCT01632683|75641773|FG001|COMPLETED|Overall Study||552||
59543518|NCT01632683|75641772|FG000|NOT COMPLETED|Overall Study||0||
59543519|NCT01632683|75641773|FG001|NOT COMPLETED|Overall Study||0||
60076953|NCT02726542|76192000|FG001|NOT COMPLETED|Overall Study||1||
60076954|NCT02718118|76192008|FG000|STARTED|Overall Study||30||
60076955|NCT02718118|76192009|FG001|STARTED|Overall Study||30||
60076956|NCT02718118|76192008|FG000|COMPLETED|Overall Study||28||
60076957|NCT02718118|76192009|FG001|COMPLETED|Overall Study||29||
60076958|NCT02718118|76192008|FG000|NOT COMPLETED|Overall Study||2||
60076959|NCT02718118|76192009|FG001|NOT COMPLETED|Overall Study||1||
60076960|NCT02718040|76192015|FG000|STARTED|Overall Study||30||
60076961|NCT02718040|76192015|FG000|COMPLETED|Overall Study||30||
60076962|NCT02718040|76192015|FG000|NOT COMPLETED|Overall Study||0||
60076963|NCT02688556|76192021|FG000|STARTED|Overall Study||372||
59543520|NCT00932282|75641781|FG000|STARTED|Pre-OIT Anti-IgE Therapy Phase||7||
59543521|NCT00932282|75641782|FG001|STARTED|Pre-OIT Anti-IgE Therapy Phase||6||
60076964|NCT02688556|76192022|FG001|STARTED|Overall Study||373||
60076965|NCT02688556|76192021|FG000|COMPLETED|Overall Study||347||
59543522|NCT00932282|75641781|FG000|COMPLETED|Pre-OIT Anti-IgE Therapy Phase||6||
59543523|NCT00932282|75641782|FG001|COMPLETED|Pre-OIT Anti-IgE Therapy Phase||5||
59543524|NCT00932282|75641781|FG000|NOT COMPLETED|Pre-OIT Anti-IgE Therapy Phase||1||
59543525|NCT00932282|75641782|FG001|NOT COMPLETED|Pre-OIT Anti-IgE Therapy Phase||1||
59543526|NCT00932282|75641781|FG000|STARTED|Modified OIT Rush Desensitization Phase||6||
59543527|NCT00932282|75641782|FG001|STARTED|Modified OIT Rush Desensitization Phase||5||
59988751|NCT02361346|76103921|FG005|COMPLETED|Part 4 (Up to Day 112)||0||
59988752|NCT02361346|76103922|FG006|COMPLETED|Part 4 (Up to Day 112)||0||
59988753|NCT02361346|76103923|FG007|COMPLETED|Part 4 (Up to Day 112)||0||
59988754|NCT02361346|76103924|FG008|COMPLETED|Part 4 (Up to Day 112)||0||
59988755|NCT02361346|76103916|FG000|NOT COMPLETED|Part 4 (Up to Day 112)||0||
59543528|NCT00932282|75641781|FG000|COMPLETED|Modified OIT Rush Desensitization Phase||6||
59543529|NCT00932282|75641782|FG001|COMPLETED|Modified OIT Rush Desensitization Phase||5||
59543530|NCT00932282|75641781|FG000|NOT COMPLETED|Modified OIT Rush Desensitization Phase||0||
59543531|NCT00932282|75641782|FG001|NOT COMPLETED|Modified OIT Rush Desensitization Phase||0||
59543532|NCT00932282|75641781|FG000|STARTED|Biweekly OIT Buildup Phase||6||
59543533|NCT00932282|75641782|FG001|STARTED|Biweekly OIT Buildup Phase||5||
59543534|NCT00932282|75641781|FG000|COMPLETED|Biweekly OIT Buildup Phase||5||
59543535|NCT00932282|75641782|FG001|COMPLETED|Biweekly OIT Buildup Phase||4||
59543536|NCT00932282|75641781|FG000|NOT COMPLETED|Biweekly OIT Buildup Phase||1||
59543537|NCT00932282|75641782|FG001|NOT COMPLETED|Biweekly OIT Buildup Phase||1||
59543538|NCT00932282|75641781|FG000|STARTED|OIT Maintenance Phase||5||
60076966|NCT02688556|76192022|FG001|COMPLETED|Overall Study||361||
60076967|NCT02688556|76192021|FG000|NOT COMPLETED|Overall Study||25||
59543539|NCT00932282|75641782|FG001|STARTED|OIT Maintenance Phase||4||
59543540|NCT00932282|75641781|FG000|COMPLETED|OIT Maintenance Phase||4||
59543541|NCT00932282|75641782|FG001|COMPLETED|OIT Maintenance Phase||2||
59543542|NCT00932282|75641781|FG000|NOT COMPLETED|OIT Maintenance Phase||1||
59543543|NCT00932282|75641782|FG001|NOT COMPLETED|OIT Maintenance Phase||2||
59543544|NCT01632995|75641788|FG000|STARTED|Pre-screening to Enrollment Period||1069|All participants who were assessed for study participation|
59543545|NCT01632995|75641788|FG000|COMPLETED|Pre-screening to Enrollment Period||557|All participants who enrolled in study|
59543546|NCT01632995|75641788|FG000|NOT COMPLETED|Pre-screening to Enrollment Period||512||
59543547|NCT01632995|75641788|FG000|STARTED|Main Study Follow-up Period||557|Participants who enrolled and initiated PrEP|
59543548|NCT01632995|75641788|FG000|COMPLETED|Main Study Follow-up Period||437|Participants who completed 48 weeks of follow-up|
59543549|NCT01632995|75641788|FG000|NOT COMPLETED|Main Study Follow-up Period||120||
59543550|NCT02224313|75641796|FG000|STARTED|Overall Study||10||
59543551|NCT02224313|75641797|FG001|STARTED|Overall Study||10||
59543552|NCT02224313|75641796|FG000|COMPLETED|Overall Study||7||
59988756|NCT02361346|76103917|FG001|NOT COMPLETED|Part 4 (Up to Day 112)||0||
59988757|NCT02361346|76103918|FG002|NOT COMPLETED|Part 4 (Up to Day 112)||0||
59988758|NCT02361346|76103919|FG003|NOT COMPLETED|Part 4 (Up to Day 112)||0||
60076968|NCT02688556|76192022|FG001|NOT COMPLETED|Overall Study||12||
60076969|NCT01925209|76192032|FG000|STARTED|Treatment Epoch||63||
60076970|NCT01925209|76192033|FG001|STARTED|Treatment Epoch||63||
60076971|NCT01925209|76192034|FG002|STARTED|Treatment Epoch||63||
60076972|NCT01925209|76192035|FG003|STARTED|Treatment Epoch||62||
60076973|NCT01925209|76192032|FG000|Full Analysis Set|Treatment Epoch||63||
60076974|NCT01925209|76192033|FG001|Full Analysis Set|Treatment Epoch||63||
60076975|NCT01925209|76192034|FG002|Full Analysis Set|Treatment Epoch||63||
60076976|NCT01925209|76192035|FG003|Full Analysis Set|Treatment Epoch||62||
60076977|NCT01925209|76192032|FG000|COMPLETED|Treatment Epoch||54||
60076978|NCT01925209|76192033|FG001|COMPLETED|Treatment Epoch||55||
60076979|NCT01925209|76192034|FG002|COMPLETED|Treatment Epoch||56||
60076980|NCT01925209|76192035|FG003|COMPLETED|Treatment Epoch||57||
60076981|NCT01925209|76192032|FG000|NOT COMPLETED|Treatment Epoch||9||
60076982|NCT01925209|76192033|FG001|NOT COMPLETED|Treatment Epoch||8||
60076983|NCT01925209|76192034|FG002|NOT COMPLETED|Treatment Epoch||7||
60076984|NCT01925209|76192035|FG003|NOT COMPLETED|Treatment Epoch||5||
60076985|NCT01925209|76192032|FG000|STARTED|Maintenance Treatment Epoch||49||
60076986|NCT01925209|76192033|FG001|STARTED|Maintenance Treatment Epoch||46||
60076987|NCT01925209|76192034|FG002|STARTED|Maintenance Treatment Epoch||52||
60076988|NCT01925209|76192035|FG003|STARTED|Maintenance Treatment Epoch||50||
60076989|NCT01925209|76192032|FG000|COMPLETED|Maintenance Treatment Epoch||49||
60076990|NCT01925209|76192033|FG001|COMPLETED|Maintenance Treatment Epoch||45||
60076991|NCT01925209|76192034|FG002|COMPLETED|Maintenance Treatment Epoch||50||
60076992|NCT01925209|76192035|FG003|COMPLETED|Maintenance Treatment Epoch||48||
60076993|NCT01925209|76192032|FG000|NOT COMPLETED|Maintenance Treatment Epoch||0||
60076994|NCT01925209|76192033|FG001|NOT COMPLETED|Maintenance Treatment Epoch||1||
60076995|NCT01925209|76192034|FG002|NOT COMPLETED|Maintenance Treatment Epoch||2||
60076996|NCT01925209|76192035|FG003|NOT COMPLETED|Maintenance Treatment Epoch||2||
60076997|NCT01925209|76192032|FG000|STARTED|Follow-up||57||
60076998|NCT01925209|76192033|FG001|STARTED|Follow-up||61||
59652904|NCT03073603|75770924|FG001|COMPLETED|Overall Study||123||
59652905|NCT03073603|75770923|FG000|NOT COMPLETED|Overall Study||22||
59652906|NCT03073603|75770924|FG001|NOT COMPLETED|Overall Study||8||
59652907|NCT03008369|75770930|FG000|STARTED|Overall Study||3||
59652908|NCT03008369|75770930|FG000|COMPLETED|Overall Study||3||
59652909|NCT03008369|75770930|FG000|NOT COMPLETED|Overall Study||0||
59652910|NCT03002155|75770936|FG000|STARTED|Overall Study||10||
59652911|NCT03002155|75770937|FG001|STARTED|Overall Study||14||
59652912|NCT03002155|75770936|FG000|COMPLETED|Overall Study||7||
59652913|NCT03002155|75770937|FG001|COMPLETED|Overall Study||11||
59652914|NCT03002155|75770936|FG000|NOT COMPLETED|Overall Study||3||
59652915|NCT03002155|75770937|FG001|NOT COMPLETED|Overall Study||3||
59652916|NCT02918006|75770947|FG000|STARTED|Allocation and Follow-Up||71||
59652917|NCT02918006|75770948|FG001|STARTED|Allocation and Follow-Up||72||
59652918|NCT02918006|75770949|FG002|STARTED|Allocation and Follow-Up||36||
59652919|NCT02918006|75770947|FG000|COMPLETED|Allocation and Follow-Up||69||
59652920|NCT02918006|75770948|FG001|COMPLETED|Allocation and Follow-Up||70||
59652921|NCT02918006|75770949|FG002|COMPLETED|Allocation and Follow-Up||35||
59652922|NCT02918006|75770947|FG000|NOT COMPLETED|Allocation and Follow-Up||2||
59652923|NCT02918006|75770948|FG001|NOT COMPLETED|Allocation and Follow-Up||2||
59652924|NCT02918006|75770949|FG002|NOT COMPLETED|Allocation and Follow-Up||1||
59652925|NCT02918006|75770947|FG000|STARTED|Vaccination Phase Analysis||69||
59652926|NCT02918006|75770948|FG001|STARTED|Vaccination Phase Analysis||70||
59652927|NCT02918006|75770949|FG002|STARTED|Vaccination Phase Analysis||35||
59652928|NCT02918006|75770947|FG000|COMPLETED|Vaccination Phase Analysis||58||
59652929|NCT02918006|75770948|FG001|COMPLETED|Vaccination Phase Analysis||54||
59652930|NCT02918006|75770949|FG002|COMPLETED|Vaccination Phase Analysis||31||
59652931|NCT02918006|75770947|FG000|NOT COMPLETED|Vaccination Phase Analysis||11||
59652932|NCT02918006|75770948|FG001|NOT COMPLETED|Vaccination Phase Analysis||16||
59652933|NCT02918006|75770949|FG002|NOT COMPLETED|Vaccination Phase Analysis||4||
59652934|NCT02918006|75770947|FG000|STARTED|Challenge Phase Analysis||58||
59652935|NCT02918006|75770948|FG001|STARTED|Challenge Phase Analysis||54||
59652936|NCT02918006|75770949|FG002|STARTED|Challenge Phase Analysis||31||
59652937|NCT02918006|75770947|FG000|COMPLETED|Challenge Phase Analysis||58||
59652938|NCT02918006|75770948|FG001|COMPLETED|Challenge Phase Analysis||54||
59652939|NCT02918006|75770949|FG002|COMPLETED|Challenge Phase Analysis||29||
59652940|NCT02918006|75770947|FG000|NOT COMPLETED|Challenge Phase Analysis||0||
59652941|NCT02918006|75770948|FG001|NOT COMPLETED|Challenge Phase Analysis||0||
59652942|NCT02918006|75770949|FG002|NOT COMPLETED|Challenge Phase Analysis||2||
59652943|NCT02885324|75770957|FG000|STARTED|Overall Study||4||
59652944|NCT02885324|75770957|FG000|COMPLETED|Overall Study||4||
59652945|NCT02885324|75770957|FG000|NOT COMPLETED|Overall Study||0||
59652946|NCT02879812|75770963|FG000|STARTED|Overall Study||28246||334
59652947|NCT02879812|75770964|FG001|STARTED|Overall Study||28086||321
59652948|NCT02879812|75770963|FG000|COMPLETED|Overall Study||22153||313
59652949|NCT02879812|75770964|FG001|COMPLETED|Overall Study||21029||302
59652950|NCT02879812|75770963|FG000|NOT COMPLETED|Overall Study||6093||21
59652951|NCT02879812|75770964|FG001|NOT COMPLETED|Overall Study||7057||19
59652952|NCT02713373|75770970|FG000|STARTED|Overall Study||44||
59652953|NCT02713373|75770970|FG000|COMPLETED|Overall Study||44||
59652954|NCT02713373|75770970|FG000|NOT COMPLETED|Overall Study||0||
59652955|NCT02546492|75770974|FG000|STARTED|Overall Study||6||
59652956|NCT02546492|75770974|FG000|COMPLETED|Overall Study||1||
59652957|NCT02546492|75770974|FG000|NOT COMPLETED|Overall Study||5||
59652958|NCT02527564|75770981|FG000|STARTED|Double-blind Phase (1 Week)||23||
59652959|NCT02527564|75770982|FG001|STARTED|Double-blind Phase (1 Week)||25||
59652960|NCT02527564|75770983|FG002|STARTED|Double-blind Phase (1 Week)||0||
59652961|NCT02527564|75770981|FG000|Received Allocated Intervention|Double-blind Phase (1 Week)||19||
59652962|NCT02527564|75770982|FG001|Received Allocated Intervention|Double-blind Phase (1 Week)||17||
59652963|NCT02527564|75770983|FG002|Received Allocated Intervention|Double-blind Phase (1 Week)||0||
59652964|NCT02527564|75770981|FG000|COMPLETED|Double-blind Phase (1 Week)||22||
59652965|NCT02527564|75770982|FG001|COMPLETED|Double-blind Phase (1 Week)||24||
59652966|NCT02527564|75770983|FG002|COMPLETED|Double-blind Phase (1 Week)||0||
59652967|NCT02527564|75770981|FG000|NOT COMPLETED|Double-blind Phase (1 Week)||1||
59652968|NCT02527564|75770982|FG001|NOT COMPLETED|Double-blind Phase (1 Week)||1||
59652969|NCT02527564|75770983|FG002|NOT COMPLETED|Double-blind Phase (1 Week)||0||
59652970|NCT02527564|75770981|FG000|STARTED|Open-label Phase (3 Months)||0||
59652971|NCT02527564|75770982|FG001|STARTED|Open-label Phase (3 Months)||0||
59652972|NCT02527564|75770983|FG002|STARTED|Open-label Phase (3 Months)|Participants who continued after the double-blind phase are represented in the Suvorexant (open-label) group.|46||
59652973|NCT02527564|75770981|FG000|COMPLETED|Open-label Phase (3 Months)||0||
59652974|NCT02527564|75770982|FG001|COMPLETED|Open-label Phase (3 Months)||0||
59652975|NCT02527564|75770983|FG002|COMPLETED|Open-label Phase (3 Months)||26||
59652976|NCT02527564|75770981|FG000|NOT COMPLETED|Open-label Phase (3 Months)||0||
59652977|NCT02527564|75770982|FG001|NOT COMPLETED|Open-label Phase (3 Months)||0||
59652978|NCT02527564|75770983|FG002|NOT COMPLETED|Open-label Phase (3 Months)||20||
59652979|NCT02179749|75770994|FG000|STARTED|Overall Study||49||
59652980|NCT02179749|75770995|FG001|STARTED|Overall Study||32||
59652981|NCT02179749|75770996|FG002|STARTED|Overall Study||22||
59543553|NCT02224313|75641797|FG001|COMPLETED|Overall Study||9||
59543554|NCT02224313|75641796|FG000|NOT COMPLETED|Overall Study||3||
59543555|NCT02224313|75641797|FG001|NOT COMPLETED|Overall Study||1||
59543556|NCT02460198|75641805|FG000|STARTED|Overall Study||61||
59543557|NCT02460198|75641806|FG001|STARTED|Overall Study||63||
59543558|NCT02460198|75641805|FG000|COMPLETED|Overall Study||0||
59543559|NCT02460198|75641806|FG001|COMPLETED|Overall Study||0||
59543560|NCT02460198|75641805|FG000|NOT COMPLETED|Overall Study||61||
59543561|NCT02460198|75641806|FG001|NOT COMPLETED|Overall Study||63||
59543562|NCT01633853|75641816|FG000|STARTED|Overall Study||104||
59543563|NCT01633853|75641817|FG001|STARTED|Overall Study||100||
59543564|NCT01633853|75641816|FG000|COMPLETED|Overall Study||104||
59543565|NCT01633853|75641817|FG001|COMPLETED|Overall Study||100||
59543566|NCT01633853|75641816|FG000|NOT COMPLETED|Overall Study||0||
59543567|NCT01633853|75641817|FG001|NOT COMPLETED|Overall Study||0||
59543568|NCT02487810|75641826|FG000|STARTED|Overall Study||98||
59543569|NCT02487810|75641827|FG001|STARTED|Overall Study||102||
59543570|NCT02487810|75641826|FG000|COMPLETED|Overall Study||97||
59543571|NCT02487810|75641827|FG001|COMPLETED|Overall Study||102||
59543572|NCT02487810|75641826|FG000|NOT COMPLETED|Overall Study||1||
59543573|NCT02487810|75641827|FG001|NOT COMPLETED|Overall Study||0||
59543574|NCT02452320|75641835|FG000|STARTED|Overall Study||64||
59543575|NCT02452320|75641836|FG001|STARTED|Overall Study||64||
59543576|NCT02452320|75641835|FG000|COMPLETED|Overall Study||64||
59543577|NCT02452320|75641836|FG001|COMPLETED|Overall Study||63||
59543578|NCT02452320|75641835|FG000|NOT COMPLETED|Overall Study||0||
59543579|NCT02452320|75641836|FG001|NOT COMPLETED|Overall Study||1||
59543580|NCT02459964|75641845|FG000|STARTED|Overall Study||42||
59543581|NCT02459964|75641846|FG001|STARTED|Overall Study||40||
59543582|NCT02459964|75641847|FG002|STARTED|Overall Study||2||
59543583|NCT02459964|75641845|FG000|COMPLETED|Overall Study||42||
59543584|NCT02459964|75641846|FG001|COMPLETED|Overall Study||40||
59543585|NCT02459964|75641847|FG002|COMPLETED|Overall Study||0||
59543586|NCT02459964|75641845|FG000|NOT COMPLETED|Overall Study||0||
59543587|NCT02459964|75641846|FG001|NOT COMPLETED|Overall Study||0||
59543588|NCT02459964|75641847|FG002|NOT COMPLETED|Overall Study||2||
59543589|NCT01635101|75641857|FG000|STARTED|Overall Study||61||
59543590|NCT01635101|75641858|FG001|STARTED|Overall Study||67||
59543591|NCT01635101|75641859|FG002|STARTED|Overall Study||69||
59543592|NCT01635101|75641857|FG000|Safety Population|Overall Study||61||
59543593|NCT01635101|75641858|FG001|Safety Population|Overall Study||67||
59543594|NCT01635101|75641859|FG002|Safety Population|Overall Study||69||
59543595|NCT01635101|75641857|FG000|Modified Intent to Treat (mITT)|Overall Study||61||
59543596|NCT01635101|75641858|FG001|Modified Intent to Treat (mITT)|Overall Study||67||
59543597|NCT01635101|75641859|FG002|Modified Intent to Treat (mITT)|Overall Study||69||
59543598|NCT01635101|75641857|FG000|Pharmacokinetics Evaluable Population|Overall Study||50||
59543599|NCT01635101|75641858|FG001|Pharmacokinetics Evaluable Population|Overall Study||59||
59543600|NCT01635101|75641859|FG002|Pharmacokinetics Evaluable Population|Overall Study||58||
59543601|NCT01635101|75641857|FG000|COMPLETED|Overall Study||52||
59543602|NCT01635101|75641858|FG001|COMPLETED|Overall Study||55||
59543603|NCT01635101|75641859|FG002|COMPLETED|Overall Study||52||
59543604|NCT01635101|75641857|FG000|NOT COMPLETED|Overall Study||9||
59543605|NCT01635101|75641858|FG001|NOT COMPLETED|Overall Study||12||
59543606|NCT01635101|75641859|FG002|NOT COMPLETED|Overall Study||17||
59543607|NCT00932438|75641872|FG000|STARTED|Overall Study||40||
59543608|NCT00932438|75641873|FG001|STARTED|Overall Study||30||
59543609|NCT00932438|75641872|FG000|COMPLETED|Overall Study||39||
59543610|NCT00932438|75641873|FG001|COMPLETED|Overall Study||30||
59543611|NCT00932438|75641872|FG000|NOT COMPLETED|Overall Study||1||
59543612|NCT00932438|75641873|FG001|NOT COMPLETED|Overall Study||0||
59543613|NCT01635881|75641881|FG000|STARTED|Overall Study||60||
59543614|NCT01635881|75641881|FG000|COMPLETED|Overall Study||60||
59543615|NCT01635881|75641881|FG000|NOT COMPLETED|Overall Study||0||
59543616|NCT01636661|75641887|FG000|STARTED|Overall Study||5||
59543617|NCT01636661|75641888|FG001|STARTED|Overall Study||6||
59543618|NCT01636661|75641887|FG000|COMPLETED|Overall Study||5||
59543619|NCT01636661|75641888|FG001|COMPLETED|Overall Study||6||
59543620|NCT01636661|75641887|FG000|NOT COMPLETED|Overall Study||0||
59543621|NCT01636661|75641888|FG001|NOT COMPLETED|Overall Study||0||
59652982|NCT02179749|75770994|FG000|COMPLETED|Overall Study||49||
59652983|NCT02179749|75770995|FG001|COMPLETED|Overall Study||32||
59543622|NCT01555697|75641902|FG000|STARTED|Overall Study||10||
59543623|NCT01555697|75641903|FG001|STARTED|Overall Study||10||
59543624|NCT01555697|75641904|FG002|STARTED|Overall Study||10||
59543625|NCT01555697|75641905|FG003|STARTED|Overall Study||10||
59543626|NCT01555697|75641906|FG004|STARTED|Overall Study||10||
59543627|NCT01555697|75641907|FG005|STARTED|Overall Study||10||
59543628|NCT01555697|75641908|FG006|STARTED|Overall Study||10||
59543629|NCT01555697|75641909|FG007|STARTED|Overall Study||10||
59543630|NCT01555697|75641902|FG000|6 Hours Lab Testing Day 1|Overall Study||10||
59543631|NCT01555697|75641903|FG001|6 Hours Lab Testing Day 1|Overall Study||10||
59543632|NCT01555697|75641904|FG002|6 Hours Lab Testing Day 1|Overall Study||10||
59543633|NCT01555697|75641905|FG003|6 Hours Lab Testing Day 1|Overall Study||10||
59652984|NCT02179749|75770996|FG002|COMPLETED|Overall Study||20||
59652985|NCT02179749|75770994|FG000|NOT COMPLETED|Overall Study||0||
59652986|NCT02179749|75770995|FG001|NOT COMPLETED|Overall Study||0||
59652987|NCT02179749|75770996|FG002|NOT COMPLETED|Overall Study||2||
59652988|NCT02075593|75771007|FG000|STARTED|Overall Study||4||
59652989|NCT02075593|75771007|FG000|Infants Born to Pregnant Women Who Received at Least One Dose of Study Treatment|Overall Study||4||
59652990|NCT02075593|75771007|FG000|COMPLETED|Overall Study||3||
59652991|NCT02075593|75771007|FG000|NOT COMPLETED|Overall Study||1||
59652992|NCT02065609|75771015|FG000|STARTED|Overall Study||12||
59652993|NCT02065609|75771016|FG001|STARTED|Overall Study||40||
59652994|NCT02065609|75771015|FG000|COMPLETED|Overall Study||12||
59652995|NCT02065609|75771016|FG001|COMPLETED|Overall Study||40||
59652996|NCT02065609|75771015|FG000|NOT COMPLETED|Overall Study||0||
59652997|NCT02065609|75771016|FG001|NOT COMPLETED|Overall Study||0||
59652998|NCT01037816|75771024|FG000|STARTED|Overall Study||126||
59652999|NCT01037816|75771025|FG001|STARTED|Overall Study||126||
59653000|NCT01037816|75771024|FG000|COMPLETED|Overall Study||124||
59653001|NCT01037816|75771025|FG001|COMPLETED|Overall Study||126||
59653002|NCT01037816|75771024|FG000|NOT COMPLETED|Overall Study||2||
59653003|NCT01037816|75771025|FG001|NOT COMPLETED|Overall Study||0||
59653004|NCT01009138|75771033|FG000|STARTED|Overall Study||106||
59653005|NCT01009138|75771034|FG001|STARTED|Overall Study||108||
59653006|NCT01009138|75771033|FG000|COMPLETED|Overall Study||93||
59653007|NCT01009138|75771034|FG001|COMPLETED|Overall Study||88||
59653008|NCT01009138|75771033|FG000|NOT COMPLETED|Overall Study||13||
59653009|NCT01009138|75771034|FG001|NOT COMPLETED|Overall Study||20||
59653010|NCT00641186|75771040|FG000|STARTED|Overall Study||30||
59653011|NCT00641186|75771040|FG000|COMPLETED|Overall Study||27||
59653012|NCT00641186|75771040|FG000|NOT COMPLETED|Overall Study||3||
59653013|NCT01595009|75771046|FG000|STARTED|Core||126||
59653014|NCT01595009|75771047|FG001|STARTED|Core||120||
59653015|NCT01595009|75771048|FG002|STARTED|Core||0||
59653016|NCT01595009|75771049|FG003|STARTED|Core||0||
59653017|NCT01595009|75771046|FG000|COMPLETED|Core||0||
59653018|NCT01595009|75771047|FG001|COMPLETED|Core||0||
59653019|NCT01595009|75771048|FG002|COMPLETED|Core||0||
59653020|NCT01595009|75771049|FG003|COMPLETED|Core||0||
59653021|NCT01595009|75771046|FG000|NOT COMPLETED|Core||126||
59653022|NCT01595009|75771047|FG001|NOT COMPLETED|Core||120||
59653023|NCT01595009|75771048|FG002|NOT COMPLETED|Core||0||
59653024|NCT01595009|75771049|FG003|NOT COMPLETED|Core||0||
59653025|NCT01595009|75771046|FG000|STARTED|Extension||0||
59653026|NCT01595009|75771047|FG001|STARTED|Extension||0||
59653027|NCT01595009|75771048|FG002|STARTED|Extension||4||
59653028|NCT01595009|75771049|FG003|STARTED|Extension||11||
59653029|NCT01595009|75771046|FG000|COMPLETED|Extension||0||
59653030|NCT01595009|75771047|FG001|COMPLETED|Extension||0||
59653031|NCT01595009|75771048|FG002|COMPLETED|Extension||0||
59653032|NCT01595009|75771049|FG003|COMPLETED|Extension||0||
59653033|NCT01595009|75771046|FG000|NOT COMPLETED|Extension||0||
59653034|NCT01595009|75771047|FG001|NOT COMPLETED|Extension||0||
59653035|NCT01595009|75771048|FG002|NOT COMPLETED|Extension||4||
59653036|NCT01595009|75771049|FG003|NOT COMPLETED|Extension||11||
59653037|NCT05553808|75771066|FG000|STARTED|Overall Study||35||
59653038|NCT05553808|75771067|FG001|STARTED|Overall Study||70||
59653039|NCT05553808|75771066|FG000|COMPLETED|Overall Study||0||
59653040|NCT05553808|75771067|FG001|COMPLETED|Overall Study||0||
59653041|NCT05553808|75771066|FG000|NOT COMPLETED|Overall Study||35||
59653042|NCT05553808|75771067|FG001|NOT COMPLETED|Overall Study||70||
59653043|NCT04997161|75771083|FG000|STARTED|Overall Study||3||
59653044|NCT04997161|75771083|FG000|Randomized|Overall Study||1|Randomized to receive SZC 5 g once daily orally until the end of Month 2 in addition to enhanced nutritional advice to consume fruit and vegetables.|
59653045|NCT04997161|75771083|FG000|COMPLETED|Overall Study||0||
59653046|NCT04997161|75771083|FG000|NOT COMPLETED|Overall Study||3||
59653047|NCT04753216|75771087|FG000|STARTED|Screening - 1st Response Assessment||3||
59653048|NCT04753216|75771087|FG000|Cycle 1|Screening - 1st Response Assessment||3||
59653049|NCT04753216|75771087|FG000|Cycle 2|Screening - 1st Response Assessment||3||
59653050|NCT04753216|75771087|FG000|1st Response Assessment|Screening - 1st Response Assessment||2||
59653051|NCT04753216|75771087|FG000|COMPLETED|Screening - 1st Response Assessment||2||
59653052|NCT04753216|75771087|FG000|NOT COMPLETED|Screening - 1st Response Assessment||1||
59653053|NCT04753216|75771087|FG000|STARTED|Cycle 3 - 2nd Response Assessment||2||
59653054|NCT04753216|75771087|FG000|Cycle 3|Cycle 3 - 2nd Response Assessment||2||
59653055|NCT04753216|75771087|FG000|Cycle 4|Cycle 3 - 2nd Response Assessment||2||
59653056|NCT04753216|75771087|FG000|2nd Response Assessment|Cycle 3 - 2nd Response Assessment||2||
59653057|NCT04753216|75771087|FG000|COMPLETED|Cycle 3 - 2nd Response Assessment||1||
59653058|NCT04753216|75771087|FG000|NOT COMPLETED|Cycle 3 - 2nd Response Assessment||1||
59653059|NCT04753216|75771087|FG000|STARTED|Cycle 5 - 3rd Response Assessment||1||
59653060|NCT04753216|75771087|FG000|Cycle 5|Cycle 5 - 3rd Response Assessment||1||
59653061|NCT04753216|75771087|FG000|Cycle 6|Cycle 5 - 3rd Response Assessment||1||
59653062|NCT04753216|75771087|FG000|3rd Response Assessment|Cycle 5 - 3rd Response Assessment||0||
59653063|NCT04753216|75771087|FG000|COMPLETED|Cycle 5 - 3rd Response Assessment||0||
59653064|NCT04753216|75771087|FG000|NOT COMPLETED|Cycle 5 - 3rd Response Assessment||1||
59653065|NCT04753216|75771087|FG000|STARTED|Survival Follow-Up||3||
59653066|NCT04753216|75771087|FG000|COMPLETED|Survival Follow-Up||3||
59653067|NCT04753216|75771087|FG000|NOT COMPLETED|Survival Follow-Up||0||
59653068|NCT04582045|75771095|FG000|STARTED|Overall Study||446||
59653069|NCT04582045|75771096|FG001|STARTED|Overall Study||440||
59653070|NCT04582045|75771097|FG002|STARTED|Overall Study||95||
59653071|NCT04582045|75771098|FG003|STARTED|Overall Study||83||
59653072|NCT04582045|75771095|FG000|COMPLETED|Overall Study||446||
59653073|NCT04582045|75771096|FG001|COMPLETED|Overall Study||440||
59653074|NCT04582045|75771097|FG002|COMPLETED|Overall Study||95||
59653075|NCT04582045|75771098|FG003|COMPLETED|Overall Study||83||
59653076|NCT04582045|75771095|FG000|NOT COMPLETED|Overall Study||0||
59653077|NCT04582045|75771096|FG001|NOT COMPLETED|Overall Study||0||
59653078|NCT04582045|75771097|FG002|NOT COMPLETED|Overall Study||0||
59653079|NCT04582045|75771098|FG003|NOT COMPLETED|Overall Study||0||
59653080|NCT04539795|75771110|FG000|STARTED|Overall Study||7||
59653081|NCT04539795|75771111|FG001|STARTED|Overall Study||8||
59653082|NCT04539795|75771110|FG000|COMPLETED|Overall Study||7||
59653083|NCT04539795|75771111|FG001|COMPLETED|Overall Study||8||
59653084|NCT04539795|75771110|FG000|NOT COMPLETED|Overall Study||0||
59653085|NCT04539795|75771111|FG001|NOT COMPLETED|Overall Study||0||
59653086|NCT04530747|75771120|FG000|STARTED|Overall Study||8||
59653087|NCT04530747|75771121|FG001|STARTED|Overall Study||8||
59653088|NCT04530747|75771120|FG000|COMPLETED|Overall Study||7||
59653089|NCT04530747|75771121|FG001|COMPLETED|Overall Study||8||
59653090|NCT04530747|75771120|FG000|NOT COMPLETED|Overall Study||1||
59653091|NCT04530747|75771121|FG001|NOT COMPLETED|Overall Study||0||
59653092|NCT04493242|75771132|FG000|STARTED|Overall Study||34||
59653093|NCT04493242|75771133|FG001|STARTED|Overall Study||34||
59653094|NCT04493242|75771134|FG002|STARTED|Overall Study||34||
59653095|NCT04493242|75771132|FG000|Received 1 Dose Only|Overall Study||7||
59653096|NCT04493242|75771133|FG001|Received 1 Dose Only|Overall Study||5||
59653097|NCT04493242|75771134|FG002|Received 1 Dose Only|Overall Study||7||
59653098|NCT04493242|75771132|FG000|Received 2 Doses|Overall Study||27||
59653099|NCT04493242|75771133|FG001|Received 2 Doses|Overall Study||29||
59653100|NCT04493242|75771134|FG002|Received 2 Doses|Overall Study||27||
59653101|NCT04493242|75771132|FG000|Subjects Who Did Not Receive a Full Dose at Any Dose (Dose 1 or 2)|Overall Study||1||
59653102|NCT04493242|75771133|FG001|Subjects Who Did Not Receive a Full Dose at Any Dose (Dose 1 or 2)|Overall Study||0||
59653103|NCT04493242|75771134|FG002|Subjects Who Did Not Receive a Full Dose at Any Dose (Dose 1 or 2)|Overall Study||0||
59653104|NCT04493242|75771132|FG000|COMPLETED|Overall Study||20||
59653105|NCT04493242|75771133|FG001|COMPLETED|Overall Study||16||
59653106|NCT04493242|75771134|FG002|COMPLETED|Overall Study||17||
59653107|NCT04493242|75771132|FG000|NOT COMPLETED|Overall Study||14||
59653108|NCT04493242|75771133|FG001|NOT COMPLETED|Overall Study||18||
59653109|NCT04493242|75771134|FG002|NOT COMPLETED|Overall Study||17||
59653110|NCT04229771|75771144|FG000|STARTED|Overall Study||2||
59653111|NCT04229771|75771145|FG001|STARTED|Overall Study||0||
59653112|NCT04229771|75771144|FG000|COMPLETED|Overall Study||2||
59653113|NCT04229771|75771145|FG001|COMPLETED|Overall Study||0||
59653114|NCT04229771|75771144|FG000|NOT COMPLETED|Overall Study||0||
59653115|NCT04229771|75771145|FG001|NOT COMPLETED|Overall Study||0||
59653116|NCT04040751|75771155|FG000|STARTED|Overall Study||17||
59653117|NCT04040751|75771156|FG001|STARTED|Overall Study||6||
59653118|NCT04040751|75771157|FG002|STARTED|Overall Study||17||
59653119|NCT04040751|75771158|FG003|STARTED|Overall Study||6||
59653120|NCT04040751|75771155|FG000|COMPLETED|Overall Study||15||
59653121|NCT04040751|75771156|FG001|COMPLETED|Overall Study||6||
59653122|NCT04040751|75771157|FG002|COMPLETED|Overall Study||15||
59653123|NCT04040751|75771158|FG003|COMPLETED|Overall Study||6||
59653124|NCT04040751|75771155|FG000|NOT COMPLETED|Overall Study||2||
59653125|NCT04040751|75771156|FG001|NOT COMPLETED|Overall Study||0||
59653126|NCT04040751|75771157|FG002|NOT COMPLETED|Overall Study||2||
59988759|NCT02361346|76103920|FG004|NOT COMPLETED|Part 4 (Up to Day 112)||0||
59988760|NCT02361346|76103921|FG005|NOT COMPLETED|Part 4 (Up to Day 112)||0||
59653127|NCT04040751|75771158|FG003|NOT COMPLETED|Overall Study||0||
59815793|NCT03026283|75938211|FG000|STARTED|Optimal Care/Stress Test/ICA||0|Participants diagnosed to receive optimal care, or recommended for stress test diagnosis or ICA|
59815794|NCT03026283|75938212|FG001|STARTED|Optimal Care/Stress Test/ICA||0|Participants diagnosed to receive optimal care, or recommended for stress test diagnosis or ICA|
60076999|NCT01925209|76192034|FG002|STARTED|Follow-up||56||
59653128|NCT03997916|75771168|FG000|STARTED|Overall Study||113||
59653129|NCT03997916|75771168|FG000|COMPLETED|Overall Study||78||
60077000|NCT01925209|76192035|FG003|STARTED|Follow-up||58||
59653130|NCT03997916|75771168|FG000|NOT COMPLETED|Overall Study||35||
59653131|NCT03788616|75771174|FG000|STARTED|Overall Study||35||35
59653132|NCT03788616|75771175|FG001|STARTED|Overall Study||35||35
59653133|NCT03788616|75771174|FG000|COMPLETED|Overall Study||30||30
59653134|NCT03788616|75771175|FG001|COMPLETED|Overall Study||32||32
59653135|NCT03788616|75771174|FG000|NOT COMPLETED|Overall Study||5||5
59653136|NCT03788616|75771175|FG001|NOT COMPLETED|Overall Study||3||3
59653137|NCT03769493|75771181|FG000|STARTED|Overall Study||10||
59653138|NCT03769493|75771181|FG000|COMPLETED|Overall Study||7||
59653139|NCT03769493|75771181|FG000|NOT COMPLETED|Overall Study||3||
59653140|NCT03596177|75771187|FG000|STARTED|Single Blind Period||9||
59653141|NCT03596177|75771188|FG001|STARTED|Single Blind Period||19||
59653142|NCT03596177|75771187|FG000|COMPLETED|Single Blind Period||7||
59653143|NCT03596177|75771188|FG001|COMPLETED|Single Blind Period||18||
59653144|NCT03596177|75771187|FG000|NOT COMPLETED|Single Blind Period||2||
59653145|NCT03596177|75771188|FG001|NOT COMPLETED|Single Blind Period||1||
59653146|NCT03596177|75771187|FG000|STARTED|Double Blind Period||7||
59653147|NCT03596177|75771188|FG001|STARTED|Double Blind Period||18||
59653148|NCT03596177|75771187|FG000|COMPLETED|Double Blind Period||7||
59653149|NCT03596177|75771188|FG001|COMPLETED|Double Blind Period||12||
59653150|NCT03596177|75771187|FG000|NOT COMPLETED|Double Blind Period||0||
59653151|NCT03596177|75771188|FG001|NOT COMPLETED|Double Blind Period||6||
59653152|NCT03579459|75771198|FG000|STARTED|Overall Study||330||
59653153|NCT03579459|75771199|FG001|STARTED|Overall Study||327||
59653154|NCT03579459|75771200|FG002|STARTED|Overall Study||328||
59653155|NCT03579459|75771201|FG003|STARTED|Overall Study||332||
59653156|NCT03579459|75771198|FG000|Dose 1|Overall Study||330||
59653157|NCT03579459|75771199|FG001|Dose 1|Overall Study||325||
59653158|NCT03579459|75771200|FG002|Dose 1|Overall Study||328||
59653159|NCT03579459|75771201|FG003|Dose 1|Overall Study||331||
59653160|NCT03579459|75771198|FG000|Dose 2|Overall Study||324||
59653161|NCT03579459|75771199|FG001|Dose 2|Overall Study||318||
59653162|NCT03579459|75771200|FG002|Dose 2|Overall Study||319||
59653163|NCT03579459|75771201|FG003|Dose 2|Overall Study||322||
59653164|NCT03579459|75771198|FG000|Dose 3|Overall Study||305||
59653165|NCT03579459|75771199|FG001|Dose 3|Overall Study||305||
59653166|NCT03579459|75771200|FG002|Dose 3|Overall Study||307||
59653167|NCT03579459|75771201|FG003|Dose 3|Overall Study||309||
59653168|NCT03579459|75771198|FG000|COMPLETED|Overall Study||301||
59653169|NCT03579459|75771199|FG001|COMPLETED|Overall Study||304||
59653170|NCT03579459|75771200|FG002|COMPLETED|Overall Study||305||
59653171|NCT03579459|75771201|FG003|COMPLETED|Overall Study||308||
59653172|NCT03579459|75771198|FG000|NOT COMPLETED|Overall Study||29||
59653173|NCT03579459|75771199|FG001|NOT COMPLETED|Overall Study||23||
59653174|NCT03579459|75771200|FG002|NOT COMPLETED|Overall Study||23||
59653175|NCT03579459|75771201|FG003|NOT COMPLETED|Overall Study||24||
59653176|NCT03258281|75771213|FG000|STARTED|Overall Study||3||
59653177|NCT03258281|75771214|FG001|STARTED|Overall Study||1||
59653178|NCT03258281|75771213|FG000|COMPLETED|Overall Study||3||
59653179|NCT03258281|75771214|FG001|COMPLETED|Overall Study||1||
59653180|NCT03258281|75771213|FG000|NOT COMPLETED|Overall Study||0||
59653181|NCT03258281|75771214|FG001|NOT COMPLETED|Overall Study||0||
59653182|NCT04449276|75771228|FG000|STARTED|Overall Study||47||
59653183|NCT04449276|75771229|FG001|STARTED|Overall Study||48||
59653184|NCT04449276|75771230|FG002|STARTED|Overall Study||48||
59653185|NCT04449276|75771231|FG003|STARTED|Overall Study||49||
59653186|NCT04449276|75771232|FG004|STARTED|Overall Study||28||
59653187|NCT04449276|75771233|FG005|STARTED|Overall Study||16||
59653188|NCT04449276|75771234|FG006|STARTED|Overall Study||12||
59653189|NCT04449276|75771235|FG007|STARTED|Overall Study||32||
59653190|NCT04449276|75771228|FG000|COMPLETED|Overall Study||44||
59653191|NCT04449276|75771229|FG001|COMPLETED|Overall Study||44||
59653192|NCT04449276|75771230|FG002|COMPLETED|Overall Study||45||
59653193|NCT04449276|75771231|FG003|COMPLETED|Overall Study||46||
59653194|NCT04449276|75771232|FG004|COMPLETED|Overall Study||26||
60077001|NCT01925209|76192032|FG000|COMPLETED|Follow-up||56||
60077002|NCT01925209|76192033|FG001|COMPLETED|Follow-up||55||
60077003|NCT01925209|76192034|FG002|COMPLETED|Follow-up||55||
60077004|NCT01925209|76192035|FG003|COMPLETED|Follow-up||54||
60077005|NCT01925209|76192032|FG000|NOT COMPLETED|Follow-up||1||
60077006|NCT01925209|76192033|FG001|NOT COMPLETED|Follow-up||6||
59653195|NCT04449276|75771233|FG005|COMPLETED|Overall Study||16||
59653196|NCT04449276|75771234|FG006|COMPLETED|Overall Study||12||
59653197|NCT04449276|75771235|FG007|COMPLETED|Overall Study||30||
59653198|NCT04449276|75771228|FG000|NOT COMPLETED|Overall Study||3||
59653199|NCT04449276|75771229|FG001|NOT COMPLETED|Overall Study||4||
59653200|NCT04449276|75771230|FG002|NOT COMPLETED|Overall Study||3||
59653201|NCT04449276|75771231|FG003|NOT COMPLETED|Overall Study||3||
59653202|NCT04449276|75771232|FG004|NOT COMPLETED|Overall Study||2||
59653203|NCT04449276|75771233|FG005|NOT COMPLETED|Overall Study||0||
60077007|NCT01925209|76192034|FG002|NOT COMPLETED|Follow-up||1||
59653204|NCT04449276|75771234|FG006|NOT COMPLETED|Overall Study||0||
59653205|NCT04449276|75771235|FG007|NOT COMPLETED|Overall Study||2||
59653206|NCT04391894|75771275|FG000|STARTED|Overall Study||111|All randomized treated subjects were included in Full Analysis Set 1 (FAS1) and Safety Set 1 (SAF1)|
59653207|NCT04391894|75771276|FG001|STARTED|Overall Study||112|All randomized treated subjects were included in Full Analysis Set 1 (FAS1) and Safety Set 1 (SAF1)|
59653208|NCT04391894|75771277|FG002|STARTED|Overall Study||112|All randomized treated subjects were included in Full Analysis Set 1 (FAS1) and Safety Set 1 (SAF1)|
59653209|NCT04391894|75771278|FG003|STARTED|Overall Study||109|All randomized treated subjects were included in Full Analysis Set 1 (FAS1) and Safety Set 1 (SAF1)|
59653210|NCT04391894|75771279|FG004|STARTED|Overall Study||114|All randomized treated subjects were included in Full Analysis Set 1 (FAS1) and Safety Set 1 (SAF1)|
59653211|NCT04391894|75771275|FG000|COMPLETED|Overall Study||107||
59653212|NCT04391894|75771276|FG001|COMPLETED|Overall Study||111||
60077008|NCT01925209|76192035|FG003|NOT COMPLETED|Follow-up||4||
60077009|NCT01614925|76192047|FG000|STARTED|Overall Study||18||
59653213|NCT04391894|75771277|FG002|COMPLETED|Overall Study||108||
59653214|NCT04391894|75771278|FG003|COMPLETED|Overall Study||107||
59653215|NCT04391894|75771279|FG004|COMPLETED|Overall Study||111||
59653216|NCT04391894|75771275|FG000|NOT COMPLETED|Overall Study||4||
59653217|NCT04391894|75771276|FG001|NOT COMPLETED|Overall Study||1||
59653218|NCT04391894|75771277|FG002|NOT COMPLETED|Overall Study||4||
59653219|NCT04391894|75771278|FG003|NOT COMPLETED|Overall Study||2||
59653220|NCT04391894|75771279|FG004|NOT COMPLETED|Overall Study||3||
59653221|NCT04225533|75771291|FG000|STARTED|Overall Study||10||
59653222|NCT04225533|75771291|FG000|COMPLETED|Overall Study||10||
59653223|NCT04225533|75771291|FG000|NOT COMPLETED|Overall Study||0||
59653224|NCT03851705|75771297|FG000|STARTED|Part 1: Double-Blind Period||37||
59653225|NCT03851705|75771298|FG001|STARTED|Part 1: Double-Blind Period||19||
59653226|NCT03851705|75771299|FG002|STARTED|Part 1: Double-Blind Period||0||
59653227|NCT03851705|75771300|FG003|STARTED|Part 1: Double-Blind Period||0||
59653228|NCT03851705|75771297|FG000|COMPLETED|Part 1: Double-Blind Period||34||
59653229|NCT03851705|75771298|FG001|COMPLETED|Part 1: Double-Blind Period||19||
59653230|NCT03851705|75771299|FG002|COMPLETED|Part 1: Double-Blind Period||0||
59653231|NCT03851705|75771300|FG003|COMPLETED|Part 1: Double-Blind Period||0||
59653232|NCT03851705|75771297|FG000|NOT COMPLETED|Part 1: Double-Blind Period||3||
59653233|NCT03851705|75771298|FG001|NOT COMPLETED|Part 1: Double-Blind Period||0||
59653234|NCT03851705|75771299|FG002|NOT COMPLETED|Part 1: Double-Blind Period||0||
59653235|NCT03851705|75771300|FG003|NOT COMPLETED|Part 1: Double-Blind Period||0||
59653236|NCT03851705|75771297|FG000|STARTED|Part 2: Open-Label Period||0||
59653237|NCT03851705|75771298|FG001|STARTED|Part 2: Open-Label Period||0||
59653238|NCT03851705|75771299|FG002|STARTED|Part 2: Open-Label Period||34||
59653239|NCT03851705|75771300|FG003|STARTED|Part 2: Open-Label Period||19||
59653240|NCT03851705|75771297|FG000|COMPLETED|Part 2: Open-Label Period||0||
59653241|NCT03851705|75771298|FG001|COMPLETED|Part 2: Open-Label Period||0||
59653242|NCT03851705|75771299|FG002|COMPLETED|Part 2: Open-Label Period||29||
59653243|NCT03851705|75771300|FG003|COMPLETED|Part 2: Open-Label Period||18||
59653244|NCT03851705|75771297|FG000|NOT COMPLETED|Part 2: Open-Label Period||0||
59653245|NCT03851705|75771298|FG001|NOT COMPLETED|Part 2: Open-Label Period||0||
59653246|NCT03851705|75771299|FG002|NOT COMPLETED|Part 2: Open-Label Period||5||
59653247|NCT03851705|75771300|FG003|NOT COMPLETED|Part 2: Open-Label Period||1||
59653248|NCT03824366|75771313|FG000|STARTED|Overall Study||20||
59653249|NCT03824366|75771313|FG000|COMPLETED|Overall Study||16||
59653250|NCT03824366|75771313|FG000|NOT COMPLETED|Overall Study||4||
59653251|NCT03810313|75771319|FG000|STARTED|Overall Study||247||
59653252|NCT03810313|75771320|FG001|STARTED|Overall Study||246||
59653253|NCT03810313|75771319|FG000|COMPLETED|Overall Study||66||
59653254|NCT03810313|75771320|FG001|COMPLETED|Overall Study||70||
59653255|NCT03810313|75771319|FG000|NOT COMPLETED|Overall Study||181||
59653256|NCT03810313|75771320|FG001|NOT COMPLETED|Overall Study||176||
59653257|NCT03802630|75771329|FG000|STARTED|Overall Study||226||
59653258|NCT03802630|75771330|FG001|STARTED|Overall Study||224||
59653259|NCT03802630|75771329|FG000|COMPLETED|Overall Study||73||
59653260|NCT03802630|75771330|FG001|COMPLETED|Overall Study||76||
59653261|NCT03802630|75771329|FG000|NOT COMPLETED|Overall Study||153||
59653262|NCT03802630|75771330|FG001|NOT COMPLETED|Overall Study||148||
59653263|NCT03775213|75771339|FG000|STARTED|Overall Study||160||
59653264|NCT03775213|75771340|FG001|STARTED|Overall Study||162||
59653265|NCT03775213|75771339|FG000|COMPLETED|Overall Study||102||
59653266|NCT03775213|75771340|FG001|COMPLETED|Overall Study||102||
59653267|NCT03775213|75771339|FG000|NOT COMPLETED|Overall Study||58||
59653268|NCT03775213|75771340|FG001|NOT COMPLETED|Overall Study||60||
59653269|NCT03710564|75771348|FG000|STARTED|Overall Study||356|All randomized Participants|
59653270|NCT03710564|75771349|FG001|STARTED|Overall Study||179|All randomized Participants|
59653271|NCT03710564|75771348|FG000|COMPLETED|Overall Study||172||
59653272|NCT03710564|75771349|FG001|COMPLETED|Overall Study||86||
59653273|NCT03710564|75771348|FG000|NOT COMPLETED|Overall Study||184||
59653274|NCT03710564|75771349|FG001|NOT COMPLETED|Overall Study||93||
59653275|NCT03624127|75771359|FG000|STARTED|Pre-treatment||332|Started = Randomized|
59653276|NCT03624127|75771360|FG001|STARTED|Pre-treatment||166|Started = Randomized|
59653277|NCT03624127|75771361|FG002|STARTED|Pre-treatment||168|Started = Randomized|
59653278|NCT03624127|75771359|FG000|COMPLETED|Pre-treatment||332|Completed = Entered treatment period|
59653279|NCT03624127|75771360|FG001|COMPLETED|Pre-treatment||165|Completed = Entered treatment period|
59653280|NCT03624127|75771361|FG002|COMPLETED|Pre-treatment||168|Completed = Entered treatment period|
59653281|NCT03624127|75771359|FG000|NOT COMPLETED|Pre-treatment||0||
59653282|NCT03624127|75771360|FG001|NOT COMPLETED|Pre-treatment||1||
59653283|NCT03624127|75771361|FG002|NOT COMPLETED|Pre-treatment||0||
59653284|NCT03624127|75771359|FG000|STARTED|Treatment Week 0 - Week 16||332||
59653285|NCT03624127|75771360|FG001|STARTED|Treatment Week 0 - Week 16||165||
59653286|NCT03624127|75771361|FG002|STARTED|Treatment Week 0 - Week 16||168||
59817903|NCT04488770|75940329|FG003|NOT COMPLETED|Part 1-Cohort 2: Period 1 (Up to 5 Days)||0||
59653287|NCT03624127|75771359|FG000|COMPLETED|Treatment Week 0 - Week 16||307||
59653288|NCT03624127|75771360|FG001|COMPLETED|Treatment Week 0 - Week 16||145||
59653289|NCT03624127|75771361|FG002|COMPLETED|Treatment Week 0 - Week 16||145||
59653290|NCT03624127|75771359|FG000|NOT COMPLETED|Treatment Week 0 - Week 16||25||
59653291|NCT03624127|75771360|FG001|NOT COMPLETED|Treatment Week 0 - Week 16||20||
59653292|NCT03624127|75771361|FG002|NOT COMPLETED|Treatment Week 0 - Week 16||23||
59653293|NCT03624127|75771359|FG000|STARTED|Treatment Week 16 - Week 24||452||
59653294|NCT03624127|75771360|FG001|STARTED|Treatment Week 16 - Week 24||0||
59653295|NCT03624127|75771361|FG002|STARTED|Treatment Week 16 - Week 24||145||
59653296|NCT03624127|75771359|FG000|COMPLETED|Treatment Week 16 - Week 24||442||
59653297|NCT03624127|75771360|FG001|COMPLETED|Treatment Week 16 - Week 24||0||
59653298|NCT03624127|75771361|FG002|COMPLETED|Treatment Week 16 - Week 24||141||
59653299|NCT03624127|75771359|FG000|NOT COMPLETED|Treatment Week 16 - Week 24||10||
59653300|NCT03624127|75771360|FG001|NOT COMPLETED|Treatment Week 16 - Week 24||0||
59653301|NCT03624127|75771361|FG002|NOT COMPLETED|Treatment Week 16 - Week 24||4||
59653302|NCT03624127|75771359|FG000|STARTED|Treatment Week 24 - Week 52||496||
59653303|NCT03624127|75771360|FG001|STARTED|Treatment Week 24 - Week 52||0||
59653304|NCT03624127|75771361|FG002|STARTED|Treatment Week 24 - Week 52||87||
59653305|NCT03624127|75771359|FG000|COMPLETED|Treatment Week 24 - Week 52||444||
59653306|NCT03624127|75771360|FG001|COMPLETED|Treatment Week 24 - Week 52||0||
59653307|NCT03624127|75771361|FG002|COMPLETED|Treatment Week 24 - Week 52||83||
59653308|NCT03624127|75771359|FG000|NOT COMPLETED|Treatment Week 24 - Week 52||52||
59653309|NCT03624127|75771360|FG001|NOT COMPLETED|Treatment Week 24 - Week 52||0||
59653310|NCT03624127|75771361|FG002|NOT COMPLETED|Treatment Week 24 - Week 52||4||
59653311|NCT03616912|75771379|FG000|STARTED|Overall Study||257||
59653312|NCT03616912|75771380|FG001|STARTED|Overall Study||258||
59653313|NCT03616912|75771381|FG002|STARTED|Overall Study||254||
59653314|NCT03616912|75771382|FG003|STARTED|Overall Study||21||
59653315|NCT03616912|75771383|FG004|STARTED|Overall Study||20||
59653316|NCT03616912|75771384|FG005|STARTED|Overall Study||20||
59653317|NCT03616912|75771379|FG000|Received at Least One Dose of Study Drug|Overall Study||257||
59653318|NCT03616912|75771380|FG001|Received at Least One Dose of Study Drug|Overall Study||256||
59653319|NCT03616912|75771381|FG002|Received at Least One Dose of Study Drug|Overall Study||254||
59653320|NCT03616912|75771382|FG003|Received at Least One Dose of Study Drug|Overall Study||21||
59653321|NCT03616912|75771383|FG004|Received at Least One Dose of Study Drug|Overall Study||20||
59653322|NCT03616912|75771384|FG005|Received at Least One Dose of Study Drug|Overall Study||20||
59653323|NCT03616912|75771379|FG000|Excluded Due to Site Misconduct|Overall Study||4||
59653324|NCT03616912|75771380|FG001|Excluded Due to Site Misconduct|Overall Study||1||
59653325|NCT03616912|75771381|FG002|Excluded Due to Site Misconduct|Overall Study||2||
59653326|NCT03616912|75771382|FG003|Excluded Due to Site Misconduct|Overall Study||0||
59653327|NCT03616912|75771383|FG004|Excluded Due to Site Misconduct|Overall Study||0||
59653328|NCT03616912|75771384|FG005|Excluded Due to Site Misconduct|Overall Study||0||
59653329|NCT03616912|75771379|FG000|COMPLETED|Overall Study||204||
59653330|NCT03616912|75771380|FG001|COMPLETED|Overall Study||211||
59653331|NCT03616912|75771381|FG002|COMPLETED|Overall Study||208||
59653332|NCT03616912|75771382|FG003|COMPLETED|Overall Study||5||
59653333|NCT03616912|75771383|FG004|COMPLETED|Overall Study||5||
59653334|NCT03616912|75771384|FG005|COMPLETED|Overall Study||6||
59653335|NCT03616912|75771379|FG000|NOT COMPLETED|Overall Study||53||
59653336|NCT03616912|75771380|FG001|NOT COMPLETED|Overall Study||47||
59653337|NCT03616912|75771381|FG002|NOT COMPLETED|Overall Study||46||
59653338|NCT03616912|75771382|FG003|NOT COMPLETED|Overall Study||16||
59653339|NCT03616912|75771383|FG004|NOT COMPLETED|Overall Study||15||
59653340|NCT03616912|75771384|FG005|NOT COMPLETED|Overall Study||14||
59653341|NCT03499899|75771401|FG000|STARTED|Overall Study||20||
59653342|NCT03499899|75771402|FG001|STARTED|Overall Study||34||
59653343|NCT03499899|75771403|FG002|STARTED|Overall Study||34||
59653344|NCT03499899|75771401|FG000|Treated|Overall Study||19||
59653345|NCT03499899|75771402|FG001|Treated|Overall Study||34||
59653346|NCT03499899|75771403|FG002|Treated|Overall Study||34||
59653347|NCT03499899|75771401|FG000|COMPLETED|Overall Study||0||
59653348|NCT03499899|75771402|FG001|COMPLETED|Overall Study||0||
59653349|NCT03499899|75771403|FG002|COMPLETED|Overall Study||0||
59653350|NCT03499899|75771401|FG000|NOT COMPLETED|Overall Study||20||
59653351|NCT03499899|75771402|FG001|NOT COMPLETED|Overall Study||34||
59653352|NCT03499899|75771403|FG002|NOT COMPLETED|Overall Study||34||
59653353|NCT03481634|75771419|FG000|STARTED|Overall Study||190||
59653354|NCT03481634|75771420|FG001|STARTED|Overall Study||189||
59653355|NCT03481634|75771421|FG002|STARTED|Overall Study||187||
59653356|NCT03481634|75771419|FG000|COMPLETED|Overall Study||157||
59653357|NCT03481634|75771420|FG001|COMPLETED|Overall Study||154||
59653358|NCT03481634|75771421|FG002|COMPLETED|Overall Study||153||
59653359|NCT03481634|75771419|FG000|NOT COMPLETED|Overall Study||33||
59653360|NCT03481634|75771420|FG001|NOT COMPLETED|Overall Study||35||
59653361|NCT03481634|75771421|FG002|NOT COMPLETED|Overall Study||34||
59653362|NCT03373461|75771435|FG000|STARTED|Part 1||9||
59653363|NCT03373461|75771436|FG001|STARTED|Part 1||8||
59653364|NCT03373461|75771437|FG002|STARTED|Part 1||0||
59653365|NCT03373461|75771438|FG003|STARTED|Part 1||15||
59653366|NCT03373461|75771439|FG004|STARTED|Part 1||14||
59653367|NCT03373461|75771435|FG000|COMPLETED|Part 1||9||
59653368|NCT03373461|75771436|FG001|COMPLETED|Part 1||8||
59653369|NCT03373461|75771437|FG002|COMPLETED|Part 1||0||
59653370|NCT03373461|75771438|FG003|COMPLETED|Part 1||15||
59653371|NCT03373461|75771439|FG004|COMPLETED|Part 1||14||
59653372|NCT03373461|75771435|FG000|NOT COMPLETED|Part 1||0||
59653373|NCT03373461|75771436|FG001|NOT COMPLETED|Part 1||0||
59653374|NCT03373461|75771437|FG002|NOT COMPLETED|Part 1||0||
59653375|NCT03373461|75771438|FG003|NOT COMPLETED|Part 1||0||
59653376|NCT03373461|75771439|FG004|NOT COMPLETED|Part 1||0||
59653377|NCT03373461|75771435|FG000|STARTED|Part 2||11||
59653378|NCT03373461|75771436|FG001|STARTED|Part 2||11||
59653379|NCT03373461|75771437|FG002|STARTED|Part 2||22||
59653380|NCT03373461|75771438|FG003|STARTED|Part 2||11||
59653381|NCT03373461|75771439|FG004|STARTED|Part 2||11||
59653382|NCT03373461|75771435|FG000|COMPLETED|Part 2||11||
59653383|NCT03373461|75771436|FG001|COMPLETED|Part 2||10||
59653384|NCT03373461|75771437|FG002|COMPLETED|Part 2||22||
59653385|NCT03373461|75771438|FG003|COMPLETED|Part 2||11||
59653386|NCT03373461|75771439|FG004|COMPLETED|Part 2||10||
59653387|NCT03373461|75771435|FG000|NOT COMPLETED|Part 2||0||
59653388|NCT03373461|75771436|FG001|NOT COMPLETED|Part 2||1||
59653389|NCT03373461|75771437|FG002|NOT COMPLETED|Part 2||0||
59653390|NCT03373461|75771438|FG003|NOT COMPLETED|Part 2||0||
59653391|NCT03373461|75771439|FG004|NOT COMPLETED|Part 2||1||
59653392|NCT03364751|75771490|FG000|STARTED|Overall Study||70||
59653393|NCT03364751|75771491|FG001|STARTED|Overall Study||84||
59653394|NCT03364751|75771492|FG002|STARTED|Overall Study||17||
59653395|NCT03364751|75771493|FG003|STARTED|Overall Study||1||
59653396|NCT03364751|75771490|FG000|COMPLETED|Overall Study||69||
59653397|NCT03364751|75771491|FG001|COMPLETED|Overall Study||83||
59653398|NCT03364751|75771492|FG002|COMPLETED|Overall Study||17||
59653399|NCT03364751|75771493|FG003|COMPLETED|Overall Study||1||
59653400|NCT03364751|75771490|FG000|NOT COMPLETED|Overall Study||1||
59653401|NCT03364751|75771491|FG001|NOT COMPLETED|Overall Study||1||
59653402|NCT03364751|75771492|FG002|NOT COMPLETED|Overall Study||0||
59653403|NCT03364751|75771493|FG003|NOT COMPLETED|Overall Study||0||
59653404|NCT03251508|75771507|FG000|STARTED|Peanut Oral Immunotherapy (Months 1-6)||15||
59653405|NCT03251508|75771507|FG000|COMPLETED|Peanut Oral Immunotherapy (Months 1-6)||11||
59653406|NCT03251508|75771507|FG000|NOT COMPLETED|Peanut Oral Immunotherapy (Months 1-6)||4||
59653407|NCT03251508|75771507|FG000|STARTED|Dietary Peanut (Months 7-12)||11||
59653408|NCT03251508|75771507|FG000|COMPLETED|Dietary Peanut (Months 7-12)||10||
59653409|NCT03251508|75771507|FG000|NOT COMPLETED|Dietary Peanut (Months 7-12)||1||
59653410|NCT02990806|75771513|FG000|STARTED|Stage 1 (22 Weeks)||228||
59653411|NCT02990806|75771514|FG001|STARTED|Stage 1 (22 Weeks)|Participants randomized to receive Remicade-US during stage 1.|455||
59653412|NCT02990806|75771515|FG002|STARTED|Stage 1 (22 Weeks)||0||
59653413|NCT02990806|75771516|FG003|STARTED|Stage 1 (22 Weeks)||0||
59653414|NCT02990806|75771513|FG000|Safety Population|Stage 1 (22 Weeks)||227||
59653415|NCT02990806|75771514|FG001|Safety Population|Stage 1 (22 Weeks)||451||
59653416|NCT02990806|75771515|FG002|Safety Population|Stage 1 (22 Weeks)||0||
59653417|NCT02990806|75771516|FG003|Safety Population|Stage 1 (22 Weeks)||0||
59653418|NCT02990806|75771513|FG000|COMPLETED|Stage 1 (22 Weeks)||214||
59653419|NCT02990806|75771514|FG001|COMPLETED|Stage 1 (22 Weeks)||399||
59653420|NCT02990806|75771515|FG002|COMPLETED|Stage 1 (22 Weeks)||0||
59653421|NCT02990806|75771516|FG003|COMPLETED|Stage 1 (22 Weeks)||0||
59653422|NCT02990806|75771513|FG000|NOT COMPLETED|Stage 1 (22 Weeks)||14||
59653423|NCT02990806|75771514|FG001|NOT COMPLETED|Stage 1 (22 Weeks)||56||
59653424|NCT02990806|75771515|FG002|NOT COMPLETED|Stage 1 (22 Weeks)||0||
59653425|NCT02990806|75771516|FG003|NOT COMPLETED|Stage 1 (22 Weeks)||0||
59653426|NCT02990806|75771513|FG000|STARTED|Stage 2 (32 Weeks)||214||
59653427|NCT02990806|75771514|FG001|STARTED|Stage 2 (32 Weeks)||0||
59653428|NCT02990806|75771515|FG002|STARTED|Stage 2 (32 Weeks)|399 participants completed stage 1 of Remicade US group, of which 201 participants were randomized to this arm.|201||
59653429|NCT02990806|75771516|FG003|STARTED|Stage 2 (32 Weeks)|399 participants completed stage 1 of Remicade US group, of which 196 participants were randomized to this arm.|196||
59653430|NCT02990806|75771513|FG000|COMPLETED|Stage 2 (32 Weeks)||172||
59653431|NCT02990806|75771514|FG001|COMPLETED|Stage 2 (32 Weeks)||0||
59653432|NCT02990806|75771515|FG002|COMPLETED|Stage 2 (32 Weeks)||173||
59653433|NCT02990806|75771516|FG003|COMPLETED|Stage 2 (32 Weeks)||162||
59653434|NCT02990806|75771513|FG000|NOT COMPLETED|Stage 2 (32 Weeks)||42||
59653435|NCT02990806|75771514|FG001|NOT COMPLETED|Stage 2 (32 Weeks)||0||
59653436|NCT02990806|75771515|FG002|NOT COMPLETED|Stage 2 (32 Weeks)||28||
59653437|NCT02990806|75771516|FG003|NOT COMPLETED|Stage 2 (32 Weeks)||34||
59653438|NCT02990806|75771513|FG000|STARTED|Stage 3 (Safety Follow-up) (8 Weeks)||172||
59653439|NCT02990806|75771514|FG001|STARTED|Stage 3 (Safety Follow-up) (8 Weeks)||0||
59653440|NCT02990806|75771515|FG002|STARTED|Stage 3 (Safety Follow-up) (8 Weeks)||173||
59653441|NCT02990806|75771516|FG003|STARTED|Stage 3 (Safety Follow-up) (8 Weeks)||162||
59653442|NCT02990806|75771513|FG000|COMPLETED|Stage 3 (Safety Follow-up) (8 Weeks)||163||
59653443|NCT02990806|75771514|FG001|COMPLETED|Stage 3 (Safety Follow-up) (8 Weeks)||0||
59653444|NCT02990806|75771515|FG002|COMPLETED|Stage 3 (Safety Follow-up) (8 Weeks)||162||
59653445|NCT02990806|75771516|FG003|COMPLETED|Stage 3 (Safety Follow-up) (8 Weeks)||152||
59653446|NCT02990806|75771513|FG000|NOT COMPLETED|Stage 3 (Safety Follow-up) (8 Weeks)||9||
59653447|NCT02990806|75771514|FG001|NOT COMPLETED|Stage 3 (Safety Follow-up) (8 Weeks)||0||
59653448|NCT02990806|75771515|FG002|NOT COMPLETED|Stage 3 (Safety Follow-up) (8 Weeks)||11||
59653449|NCT02990806|75771516|FG003|NOT COMPLETED|Stage 3 (Safety Follow-up) (8 Weeks)||10||
59653450|NCT02979587|75771538|FG000|STARTED|Overall Study||50|Number of subject implanted|
59653451|NCT02979587|75771538|FG000|Catheterized|Overall Study||50|Number of subjects catheterized with the intent to implant Harmony TPV|
59653452|NCT02979587|75771538|FG000|Implanted|Overall Study||50|Number of subjects implanted with a Harmony TPV|
59653453|NCT02979587|75771538|FG000|Implanted > 24 Hours|Overall Study||48|Number of subjects implanted successfully for at least 24 hours|
59653454|NCT02979587|75771538|FG000|COMPLETED|Overall Study||48|Subjects with evaluable data at 6 months|
59653455|NCT02979587|75771538|FG000|NOT COMPLETED|Overall Study||2||
59653456|NCT02866721|75771549|FG000|STARTED|Overall Study||3||
59653457|NCT02866721|75771550|FG001|STARTED|Overall Study||3||
59653458|NCT02866721|75771551|FG002|STARTED|Overall Study||8||
59653459|NCT02866721|75771549|FG000|COMPLETED|Overall Study||3||
59653460|NCT02866721|75771550|FG001|COMPLETED|Overall Study||3||
59653461|NCT02866721|75771551|FG002|COMPLETED|Overall Study||8||
59653462|NCT02866721|75771549|FG000|NOT COMPLETED|Overall Study||0||
59653463|NCT02866721|75771550|FG001|NOT COMPLETED|Overall Study||0||
59653464|NCT02866721|75771551|FG002|NOT COMPLETED|Overall Study||0||
59653465|NCT02814227|75771566|FG000|STARTED|Overall Study||52||
59653466|NCT02814227|75771566|FG000|COMPLETED|Overall Study||52||
59653467|NCT02814227|75771566|FG000|NOT COMPLETED|Overall Study||0||
59653468|NCT02503254|75771572|FG000|STARTED|Overall Study||41||
59653469|NCT02503254|75771573|FG001|STARTED|Overall Study||39||
59653470|NCT02503254|75771572|FG000|COMPLETED|Overall Study||41||
59653471|NCT02503254|75771573|FG001|COMPLETED|Overall Study||39||
59653472|NCT02503254|75771572|FG000|NOT COMPLETED|Overall Study||0||
59653473|NCT02503254|75771573|FG001|NOT COMPLETED|Overall Study||0||
59653474|NCT02432729|75771580|FG000|STARTED|Month 3 Visit||720||
59653475|NCT02432729|75771580|FG000|COMPLETED|Month 3 Visit||718||
59653476|NCT02432729|75771580|FG000|NOT COMPLETED|Month 3 Visit||2||
59653477|NCT02432729|75771580|FG000|STARTED|Month 6 Visit||718||
59653478|NCT02432729|75771580|FG000|COMPLETED|Month 6 Visit||632||
59653479|NCT02432729|75771580|FG000|NOT COMPLETED|Month 6 Visit||86||
59653480|NCT02432729|75771580|FG000|STARTED|Month 12 Visit||632||
59653481|NCT02432729|75771580|FG000|COMPLETED|Month 12 Visit||436||
59653482|NCT02432729|75771580|FG000|NOT COMPLETED|Month 12 Visit||196||
59653483|NCT02420821|75771587|FG000|STARTED|Overall Study||461||
59653484|NCT02420821|75771588|FG001|STARTED|Overall Study||454||
59653485|NCT02420821|75771587|FG000|COMPLETED|Overall Study||1||
59653486|NCT02420821|75771588|FG001|COMPLETED|Overall Study||1||
59653487|NCT02420821|75771587|FG000|NOT COMPLETED|Overall Study||460||
59653488|NCT02420821|75771588|FG001|NOT COMPLETED|Overall Study||453||
59653489|NCT02811263|75771597|FG000|STARTED|Overall Study||257||
59653490|NCT02811263|75771598|FG001|STARTED|Overall Study||243||
59653491|NCT02811263|75771597|FG000|COMPLETED|Overall Study||240||
59653492|NCT02811263|75771598|FG001|COMPLETED|Overall Study||222||
59653493|NCT02811263|75771597|FG000|NOT COMPLETED|Overall Study||17||
59653494|NCT02811263|75771598|FG001|NOT COMPLETED|Overall Study||21||
59653495|NCT02188121|75771608|FG000|STARTED|Overall Study||99||
59653496|NCT02188121|75771609|FG001|STARTED|Overall Study||105||
59653497|NCT02188121|75771608|FG000|COMPLETED|Overall Study||79||
59653498|NCT02188121|75771609|FG001|COMPLETED|Overall Study||78||
59653499|NCT02188121|75771608|FG000|NOT COMPLETED|Overall Study||20||
59653500|NCT02188121|75771609|FG001|NOT COMPLETED|Overall Study||27||
59653501|NCT02039063|75771619|FG000|STARTED|Treatment Phase||6||
59653502|NCT02039063|75771620|FG001|STARTED|Treatment Phase||8||
59653503|NCT02039063|75771621|FG002|STARTED|Treatment Phase||7||
59653504|NCT02039063|75771622|FG003|STARTED|Treatment Phase||7||
59653505|NCT02039063|75771619|FG000|COMPLETED|Treatment Phase||3||
59653506|NCT02039063|75771620|FG001|COMPLETED|Treatment Phase||6||
59653507|NCT02039063|75771621|FG002|COMPLETED|Treatment Phase||5||
59653508|NCT02039063|75771622|FG003|COMPLETED|Treatment Phase||5||
59653509|NCT02039063|75771619|FG000|NOT COMPLETED|Treatment Phase||3||
59653510|NCT02039063|75771620|FG001|NOT COMPLETED|Treatment Phase||2||
59653511|NCT02039063|75771621|FG002|NOT COMPLETED|Treatment Phase||2||
59653512|NCT02039063|75771622|FG003|NOT COMPLETED|Treatment Phase||2||
59653513|NCT02039063|75771619|FG000|STARTED|Extension Phase|Only participants who met extension phase criteria started the period.|1||
59653514|NCT02039063|75771620|FG001|STARTED|Extension Phase|Only participants who met extension phase criteria started the period.|3||
59653515|NCT02039063|75771621|FG002|STARTED|Extension Phase|Only participants who met extension phase criteria started the period.|5||
59653516|NCT02039063|75771622|FG003|STARTED|Extension Phase|Only participants who met extension phase criteria started the period.|3||
59653517|NCT02039063|75771619|FG000|COMPLETED|Extension Phase||1||
59653518|NCT02039063|75771620|FG001|COMPLETED|Extension Phase||2||
59653519|NCT02039063|75771621|FG002|COMPLETED|Extension Phase||2||
59653520|NCT02039063|75771622|FG003|COMPLETED|Extension Phase||2||
59653521|NCT02039063|75771619|FG000|NOT COMPLETED|Extension Phase||0||
59653522|NCT02039063|75771620|FG001|NOT COMPLETED|Extension Phase||1||
59653523|NCT02039063|75771621|FG002|NOT COMPLETED|Extension Phase||3||
59653524|NCT02039063|75771622|FG003|NOT COMPLETED|Extension Phase||1||
59653525|NCT01970410|75771632|FG000|STARTED|Main Study||55||
59653526|NCT01970410|75771632|FG000|Baseline Procedures|Main Study||55||
59653527|NCT01970410|75771632|FG000|COMPLETED|Main Study||28||
59653528|NCT01970410|75771632|FG000|NOT COMPLETED|Main Study||27||
59653529|NCT01970410|75771632|FG000|STARTED|Sub-Study||41||
59653530|NCT01970410|75771632|FG000|COMPLETED|Sub-Study||36||
59653531|NCT01970410|75771632|FG000|NOT COMPLETED|Sub-Study||5||
59653532|NCT01746173|75771639|FG000|STARTED|Overall Study||5||
59653533|NCT01746173|75771639|FG000|COMPLETED|Overall Study||3||
59653534|NCT01746173|75771639|FG000|NOT COMPLETED|Overall Study||2||
59653535|NCT01545843|75771646|FG000|STARTED|Overall Study||19||
59653536|NCT01545843|75771647|FG001|STARTED|Overall Study||24||
59653537|NCT01545843|75771648|FG002|STARTED|Overall Study||25||
59653538|NCT01545843|75771646|FG000|COMPLETED|Overall Study||16||
59653539|NCT01545843|75771647|FG001|COMPLETED|Overall Study||17||
59653540|NCT01545843|75771648|FG002|COMPLETED|Overall Study||21||
59653541|NCT01545843|75771646|FG000|NOT COMPLETED|Overall Study||3||
59653542|NCT01545843|75771647|FG001|NOT COMPLETED|Overall Study||7||
59653543|NCT01545843|75771648|FG002|NOT COMPLETED|Overall Study||4||
59653544|NCT00843791|75771661|FG000|STARTED|Overall Study||3||
59653545|NCT00843791|75771662|FG001|STARTED|Overall Study||3||
59653546|NCT00843791|75771661|FG000|COMPLETED|Overall Study||3||
59653547|NCT00843791|75771662|FG001|COMPLETED|Overall Study||3||
59653548|NCT00843791|75771661|FG000|NOT COMPLETED|Overall Study||0||
59653549|NCT00843791|75771662|FG001|NOT COMPLETED|Overall Study||0||
59653550|NCT03187769|75771670|FG000|STARTED|Overall Study||211||
59653551|NCT03187769|75771671|FG001|STARTED|Overall Study||215||
59653552|NCT03187769|75771670|FG000|COMPLETED|Overall Study||165||
59653553|NCT03187769|75771671|FG001|COMPLETED|Overall Study||161||
59653554|NCT03187769|75771670|FG000|NOT COMPLETED|Overall Study||46||
59653555|NCT03187769|75771671|FG001|NOT COMPLETED|Overall Study||54||
59653556|NCT02995733|75771679|FG000|STARTED|Overall Study||609||
59653557|NCT02995733|75771680|FG001|STARTED|Overall Study||611||
59653558|NCT02995733|75771679|FG000|COMPLETED|Overall Study||542||
59653559|NCT02995733|75771680|FG001|COMPLETED|Overall Study||557||
59653560|NCT02995733|75771679|FG000|NOT COMPLETED|Overall Study||67||
59653561|NCT02995733|75771680|FG001|NOT COMPLETED|Overall Study||54||
59653562|NCT02994043|75771688|FG000|STARTED|Overall Study||90||
59653563|NCT02994043|75771689|FG001|STARTED|Overall Study||92||
59653564|NCT02994043|75771688|FG000|COMPLETED|Overall Study||71||
59653565|NCT02994043|75771689|FG001|COMPLETED|Overall Study||75||
59653566|NCT02994043|75771688|FG000|NOT COMPLETED|Overall Study||19||
59653567|NCT02994043|75771689|FG001|NOT COMPLETED|Overall Study||17||
59653568|NCT02815566|75771697|FG000|STARTED|Overall Study||19||
59653569|NCT02815566|75771698|FG001|STARTED|Overall Study||15||
59653570|NCT02815566|75771697|FG000|COMPLETED|Overall Study||17||
59653571|NCT02815566|75771698|FG001|COMPLETED|Overall Study||13||
59653572|NCT02815566|75771697|FG000|NOT COMPLETED|Overall Study||2||
59653573|NCT02815566|75771698|FG001|NOT COMPLETED|Overall Study||2||
59653574|NCT02525783|75771705|FG000|STARTED|Overall Study||157||
59653575|NCT02525783|75771705|FG000|COMPLETED|Overall Study||147||
59653576|NCT02525783|75771705|FG000|NOT COMPLETED|Overall Study||10||
59653577|NCT02467478|75771712|FG000|STARTED|Overall Study||17||
59653578|NCT02467478|75771713|FG001|STARTED|Overall Study||14||
59653579|NCT02467478|75771712|FG000|COMPLETED|Overall Study||17||
59653580|NCT02467478|75771713|FG001|COMPLETED|Overall Study||14||
59653581|NCT02467478|75771712|FG000|NOT COMPLETED|Overall Study||0||
59653582|NCT02467478|75771713|FG001|NOT COMPLETED|Overall Study||0||
59653583|NCT02466243|75771721|FG000|STARTED|Part A Treatment Period (Double Blind)||11||
59653584|NCT02466243|75771722|FG001|STARTED|Part A Treatment Period (Double Blind)||11||
59653585|NCT02466243|75771721|FG000|COMPLETED|Part A Treatment Period (Double Blind)||11||
59653586|NCT02466243|75771722|FG001|COMPLETED|Part A Treatment Period (Double Blind)||11||
59653587|NCT02466243|75771721|FG000|NOT COMPLETED|Part A Treatment Period (Double Blind)||0||
59653588|NCT02466243|75771722|FG001|NOT COMPLETED|Part A Treatment Period (Double Blind)||0||
59653589|NCT02466243|75771721|FG000|STARTED|Part B Open-label Treatment Period||11||
59653590|NCT02466243|75771722|FG001|STARTED|Part B Open-label Treatment Period|Participant decided not to participate in Part B|10||
59653591|NCT02466243|75771721|FG000|COMPLETED|Part B Open-label Treatment Period||0||
59653592|NCT02466243|75771722|FG001|COMPLETED|Part B Open-label Treatment Period||0||
59653593|NCT02466243|75771721|FG000|NOT COMPLETED|Part B Open-label Treatment Period||11||
59653594|NCT02466243|75771722|FG001|NOT COMPLETED|Part B Open-label Treatment Period||10||
59653595|NCT02321098|75771735|FG000|STARTED|12 Weeks Treament||26||
59653596|NCT02321098|75771736|FG001|STARTED|12 Weeks Treament||24||
59653597|NCT02321098|75771737|FG002|STARTED|12 Weeks Treament||0||
59653598|NCT02321098|75771735|FG000|COMPLETED|12 Weeks Treament||25||
59653599|NCT02321098|75771736|FG001|COMPLETED|12 Weeks Treament||23||
59653600|NCT02321098|75771737|FG002|COMPLETED|12 Weeks Treament||0||
59653601|NCT02321098|75771735|FG000|NOT COMPLETED|12 Weeks Treament||1||
59653602|NCT02321098|75771736|FG001|NOT COMPLETED|12 Weeks Treament||1||
59653603|NCT02321098|75771737|FG002|NOT COMPLETED|12 Weeks Treament||0||
59653604|NCT02321098|75771735|FG000|STARTED|Additional 15 Months Treatment||0||
59653605|NCT02321098|75771736|FG001|STARTED|Additional 15 Months Treatment||0||
59653606|NCT02321098|75771737|FG002|STARTED|Additional 15 Months Treatment||29||
59653607|NCT02321098|75771735|FG000|COMPLETED|Additional 15 Months Treatment||0||
59653608|NCT02321098|75771736|FG001|COMPLETED|Additional 15 Months Treatment||0||
59653609|NCT02321098|75771737|FG002|COMPLETED|Additional 15 Months Treatment||21||
59653610|NCT02321098|75771735|FG000|NOT COMPLETED|Additional 15 Months Treatment||0||
59653611|NCT02321098|75771736|FG001|NOT COMPLETED|Additional 15 Months Treatment||0||
59653612|NCT02321098|75771737|FG002|NOT COMPLETED|Additional 15 Months Treatment||8||
59653613|NCT01613807|75771748|FG000|STARTED|Overall Study||20||
59653614|NCT01613807|75771749|FG001|STARTED|Overall Study||20||
59653615|NCT01613807|75771748|FG000|COMPLETED|Overall Study||20||
59653616|NCT01613807|75771749|FG001|COMPLETED|Overall Study||20||
59653617|NCT01613807|75771748|FG000|NOT COMPLETED|Overall Study||0||
59653618|NCT01613807|75771749|FG001|NOT COMPLETED|Overall Study||0||
59653619|NCT01627561|75771759|FG000|STARTED|Overall Study||74||
59653620|NCT01627561|75771760|FG001|STARTED|Overall Study||74||
59653621|NCT01627561|75771759|FG000|COMPLETED|Overall Study||73||
59653622|NCT01627561|75771760|FG001|COMPLETED|Overall Study||71||
59653623|NCT01627561|75771759|FG000|NOT COMPLETED|Overall Study||1||
59653624|NCT01627561|75771760|FG001|NOT COMPLETED|Overall Study||3||
59653625|NCT01629511|75771770|FG000|STARTED|Overall Study||4||
59653626|NCT01629511|75771771|FG001|STARTED|Overall Study||0||
59653627|NCT01629511|75771772|FG002|STARTED|Overall Study||8||
59653628|NCT01629511|75771773|FG003|STARTED|Overall Study||3||
59653629|NCT01629511|75771770|FG000|COMPLETED|Overall Study||4||
59653630|NCT01629511|75771771|FG001|COMPLETED|Overall Study||0||
59653631|NCT01629511|75771772|FG002|COMPLETED|Overall Study||8||
59653632|NCT01629511|75771773|FG003|COMPLETED|Overall Study||3||
59653633|NCT01629511|75771770|FG000|NOT COMPLETED|Overall Study||0||
59653634|NCT01629511|75771771|FG001|NOT COMPLETED|Overall Study||0||
59653635|NCT01629511|75771772|FG002|NOT COMPLETED|Overall Study||0||
59653636|NCT01629511|75771773|FG003|NOT COMPLETED|Overall Study||0||
59653637|NCT01631994|75771785|FG000|STARTED|Overall Study||2||
59653638|NCT01631994|75771786|FG001|STARTED|Overall Study||4||
59653639|NCT01631994|75771785|FG000|COMPLETED|Overall Study||2||
59653640|NCT01631994|75771786|FG001|COMPLETED|Overall Study||4||
59653641|NCT01631994|75771785|FG000|NOT COMPLETED|Overall Study||0||
59653642|NCT01631994|75771786|FG001|NOT COMPLETED|Overall Study||0||
59653643|NCT01652534|75771794|FG000|STARTED|Overall Study||2||
59653644|NCT01652534|75771795|FG001|STARTED|Overall Study||1||
59653645|NCT01652534|75771794|FG000|COMPLETED|Overall Study||1||
59653646|NCT01652534|75771795|FG001|COMPLETED|Overall Study||1||
59653647|NCT01652534|75771794|FG000|NOT COMPLETED|Overall Study||1||
59653648|NCT01652534|75771795|FG001|NOT COMPLETED|Overall Study||0||
59653649|NCT04709575|75771803|FG000|STARTED|Overall Study||176||
59653650|NCT04709575|75771804|FG001|STARTED|Overall Study||177||
59653651|NCT04709575|75771803|FG000|COMPLETED|Overall Study||166||
59653652|NCT04709575|75771804|FG001|COMPLETED|Overall Study||172||
59653653|NCT04709575|75771803|FG000|NOT COMPLETED|Overall Study||10||
59653654|NCT04709575|75771804|FG001|NOT COMPLETED|Overall Study||5||
59653655|NCT04450407|75771813|FG000|STARTED|Overall Study||124||
59653656|NCT04450407|75771814|FG001|STARTED|Overall Study||16||
59653657|NCT04450407|75771815|FG002|STARTED|Overall Study||126||
59653658|NCT04450407|75771813|FG000|Received at Least One Dose of Study Drug|Overall Study||123||
59653659|NCT04450407|75771814|FG001|Received at Least One Dose of Study Drug|Overall Study||16||
59653660|NCT04450407|75771815|FG002|Received at Least One Dose of Study Drug|Overall Study||126||
59653661|NCT04450407|75771813|FG000|COMPLETED|Overall Study||107||
59653662|NCT04450407|75771814|FG001|COMPLETED|Overall Study||15||
59653663|NCT04450407|75771815|FG002|COMPLETED|Overall Study||118||
59653664|NCT04450407|75771813|FG000|NOT COMPLETED|Overall Study||17||
59653665|NCT04450407|75771814|FG001|NOT COMPLETED|Overall Study||1||
59653666|NCT04450407|75771815|FG002|NOT COMPLETED|Overall Study||8||
59653667|NCT04388826|75771824|FG000|STARTED|Overall Study||19||
59653668|NCT04388826|75771825|FG001|STARTED|Overall Study||20||
59653669|NCT04388826|75771824|FG000|COMPLETED|Overall Study||15||
59653670|NCT04388826|75771825|FG001|COMPLETED|Overall Study||18||
59653671|NCT04388826|75771824|FG000|NOT COMPLETED|Overall Study||4||
59653672|NCT04388826|75771825|FG001|NOT COMPLETED|Overall Study||2||
59653673|NCT04334681|75771835|FG000|STARTED|Overall Study||135||
59653674|NCT04334681|75771836|FG001|STARTED|Overall Study||143||
59653675|NCT04334681|75771835|FG000|COMPLETED|Overall Study||135||
59653676|NCT04334681|75771836|FG001|COMPLETED|Overall Study||143||
59653677|NCT04334681|75771835|FG000|NOT COMPLETED|Overall Study||0||
59653678|NCT04334681|75771836|FG001|NOT COMPLETED|Overall Study||0||
59653679|NCT04218266|75771847|FG000|STARTED|Overall Study||251|Randomized|
59653680|NCT04218266|75771848|FG001|STARTED|Overall Study||254|Randomized|
59653681|NCT04218266|75771849|FG002|STARTED|Overall Study||250|Randomized|
59653682|NCT04218266|75771847|FG000|Treated|Overall Study||249||
59653683|NCT04218266|75771848|FG001|Treated|Overall Study||254||
59653684|NCT04218266|75771849|FG002|Treated|Overall Study||250||
59653685|NCT04218266|75771847|FG000|COMPLETED|Overall Study|Treatment completed|226||
59653686|NCT04218266|75771848|FG001|COMPLETED|Overall Study|Treatment completed|227||
59653687|NCT04218266|75771849|FG002|COMPLETED|Overall Study|Treatment completed|218||
59653688|NCT04218266|75771847|FG000|NOT COMPLETED|Overall Study||25||
59653689|NCT04218266|75771848|FG001|NOT COMPLETED|Overall Study||27||
59653690|NCT04218266|75771849|FG002|NOT COMPLETED|Overall Study||32||
59653691|NCT04061915|75771861|FG000|STARTED|Overall Study||161||
59653692|NCT04061915|75771862|FG001|STARTED|Overall Study||161||
59653693|NCT04061915|75771861|FG000|COMPLETED|Overall Study||161||
59653694|NCT04061915|75771862|FG001|COMPLETED|Overall Study||161||
59653695|NCT04061915|75771861|FG000|NOT COMPLETED|Overall Study||0||
59653696|NCT04061915|75771862|FG001|NOT COMPLETED|Overall Study||0||
59653697|NCT03894904|75771871|FG000|STARTED|Randomized Dosing (Doses 1 and 2)||46||
59653698|NCT03894904|75771872|FG001|STARTED|Randomized Dosing (Doses 1 and 2)||50||
59653699|NCT03894904|75771871|FG000|Received Dose 1|Randomized Dosing (Doses 1 and 2)||44||
59653700|NCT03894904|75771872|FG001|Received Dose 1|Randomized Dosing (Doses 1 and 2)||47||
59653701|NCT03894904|75771871|FG000|Received Dose 2|Randomized Dosing (Doses 1 and 2)||42||
59653702|NCT03894904|75771872|FG001|Received Dose 2|Randomized Dosing (Doses 1 and 2)||46||
59653703|NCT03894904|75771871|FG000|COMPLETED|Randomized Dosing (Doses 1 and 2)||42||
59653704|NCT03894904|75771872|FG001|COMPLETED|Randomized Dosing (Doses 1 and 2)||46||
59653705|NCT03894904|75771871|FG000|NOT COMPLETED|Randomized Dosing (Doses 1 and 2)||4||
59653706|NCT03894904|75771872|FG001|NOT COMPLETED|Randomized Dosing (Doses 1 and 2)||4||
59653707|NCT03894904|75771871|FG000|STARTED|Rescue Papaverine (Optional Dose 3)||7|Only participants who had suboptimal waveforms after the first 2 randomized doses in the previous period went on to receive rescue papaverine in this period. 7 in the Papaverine plus Heparin arm received rescue papaverine. 17 in the Heparin arm received rescue papaverine.|
59653708|NCT03894904|75771872|FG001|STARTED|Rescue Papaverine (Optional Dose 3)||17|Only participants who had suboptimal waveforms after the first 2 randomized doses in the previous period went on to receive rescue papaverine in this period. 7 in the Papaverine plus Heparin arm received rescue papaverine. 17 in the Heparin arm received rescue papaverine.|
59653709|NCT03894904|75771871|FG000|Received Rescue Papaverine|Rescue Papaverine (Optional Dose 3)||7||
59653710|NCT03894904|75771872|FG001|Received Rescue Papaverine|Rescue Papaverine (Optional Dose 3)||17||
59653711|NCT03894904|75771871|FG000|COMPLETED|Rescue Papaverine (Optional Dose 3)||7||
59653712|NCT03894904|75771872|FG001|COMPLETED|Rescue Papaverine (Optional Dose 3)||17||
59653713|NCT03894904|75771871|FG000|NOT COMPLETED|Rescue Papaverine (Optional Dose 3)||0||
59653714|NCT03894904|75771872|FG001|NOT COMPLETED|Rescue Papaverine (Optional Dose 3)||0||
59653715|NCT03722927|75771880|FG000|STARTED|Overall Study||1||
59653716|NCT03722927|75771881|FG001|STARTED|Overall Study||2||
59653717|NCT03722927|75771880|FG000|COMPLETED|Overall Study||1||
59653718|NCT03722927|75771881|FG001|COMPLETED|Overall Study||2||
59653719|NCT03722927|75771880|FG000|NOT COMPLETED|Overall Study||0||
59653720|NCT03722927|75771881|FG001|NOT COMPLETED|Overall Study||0||
59653721|NCT03512964|75771887|FG000|STARTED|Overall Study||32||
59653722|NCT03512964|75771887|FG000|COMPLETED|Overall Study||32||
59653723|NCT03512964|75771887|FG000|NOT COMPLETED|Overall Study||0||
59653724|NCT03099265|75771892|FG000|STARTED|Overall Study||9||
59653725|NCT03099265|75771892|FG000|Per Protocol Week 12|Overall Study||8||
59653726|NCT03099265|75771892|FG000|Per Protocol Week 24|Overall Study||4||
59653727|NCT03099265|75771892|FG000|COMPLETED|Overall Study||8||
59653728|NCT03099265|75771892|FG000|NOT COMPLETED|Overall Study||1||
59653729|NCT02734979|75771896|FG000|STARTED|Overall Study||1||
59653730|NCT02734979|75771896|FG000|COMPLETED|Overall Study||1||
59653731|NCT02734979|75771896|FG000|NOT COMPLETED|Overall Study||0||
59653732|NCT02658656|75771910|FG000|STARTED|Screening||78||
59653733|NCT02658656|75771911|FG001|STARTED|Screening||83||
59653734|NCT02658656|75771912|FG002|STARTED|Screening||263||
59653735|NCT02658656|75771910|FG000|COMPLETED|Screening||78||
59653736|NCT02658656|75771911|FG001|COMPLETED|Screening||83||
59653737|NCT02658656|75771912|FG002|COMPLETED|Screening||0||
59653738|NCT02658656|75771910|FG000|NOT COMPLETED|Screening||0||
59653739|NCT02658656|75771911|FG001|NOT COMPLETED|Screening||0||
59653740|NCT02658656|75771912|FG002|NOT COMPLETED|Screening||263||
59653741|NCT02658656|75771910|FG000|STARTED|Randomization||78||
59653742|NCT02658656|75771911|FG001|STARTED|Randomization||83||
59653743|NCT02658656|75771912|FG002|STARTED|Randomization||0||
59653744|NCT02658656|75771910|FG000|COMPLETED|Randomization||45||
59653745|NCT02658656|75771911|FG001|COMPLETED|Randomization||57||
59653746|NCT02658656|75771912|FG002|COMPLETED|Randomization||0||
59653747|NCT02658656|75771910|FG000|NOT COMPLETED|Randomization||33||
59653748|NCT02658656|75771911|FG001|NOT COMPLETED|Randomization||26||
59653749|NCT02658656|75771912|FG002|NOT COMPLETED|Randomization||0||
59653750|NCT02257970|75771925|FG000|STARTED|Part 1||50||
59653751|NCT02257970|75771926|FG001|STARTED|Part 1||0||
59653752|NCT02257970|75771927|FG002|STARTED|Part 1||0||
59653753|NCT02257970|75771928|FG003|STARTED|Part 1||0||
59653754|NCT02257970|75771925|FG000|COMPLETED|Part 1||50||
59653755|NCT02257970|75771926|FG001|COMPLETED|Part 1||0||
59653756|NCT02257970|75771927|FG002|COMPLETED|Part 1||0||
59653757|NCT02257970|75771928|FG003|COMPLETED|Part 1||0||
59653758|NCT02257970|75771925|FG000|NOT COMPLETED|Part 1||0||
59653759|NCT02257970|75771926|FG001|NOT COMPLETED|Part 1||0||
59653760|NCT02257970|75771927|FG002|NOT COMPLETED|Part 1||0||
59653761|NCT02257970|75771928|FG003|NOT COMPLETED|Part 1||0||
59653762|NCT02257970|75771925|FG000|STARTED|Part 2||0||
59653763|NCT02257970|75771926|FG001|STARTED|Part 2||23||
59653764|NCT02257970|75771927|FG002|STARTED|Part 2||0||
59653765|NCT02257970|75771928|FG003|STARTED|Part 2||0||
59653766|NCT02257970|75771925|FG000|COMPLETED|Part 2||0||
59653767|NCT02257970|75771926|FG001|COMPLETED|Part 2||16||
59653768|NCT02257970|75771927|FG002|COMPLETED|Part 2||0||
59653769|NCT02257970|75771928|FG003|COMPLETED|Part 2||0||
59653770|NCT02257970|75771925|FG000|NOT COMPLETED|Part 2||0||
59653771|NCT02257970|75771926|FG001|NOT COMPLETED|Part 2||7||
59653772|NCT02257970|75771927|FG002|NOT COMPLETED|Part 2||0||
59653773|NCT02257970|75771928|FG003|NOT COMPLETED|Part 2||0||
59653774|NCT02257970|75771925|FG000|STARTED|Part 3||0||
59653775|NCT02257970|75771926|FG001|STARTED|Part 3||0||
59543634|NCT01555697|75641906|FG004|6 Hours Lab Testing Day 1|Overall Study||10||
59543635|NCT01555697|75641907|FG005|6 Hours Lab Testing Day 1|Overall Study||10||
59543636|NCT01555697|75641908|FG006|6 Hours Lab Testing Day 1|Overall Study||10||
59543637|NCT01555697|75641909|FG007|6 Hours Lab Testing Day 1|Overall Study||10||
59543638|NCT01555697|75641902|FG000|Approx 7 Day Washout|Overall Study||10||
59543639|NCT01555697|75641903|FG001|Approx 7 Day Washout|Overall Study||10||
59543640|NCT01555697|75641904|FG002|Approx 7 Day Washout|Overall Study||10||
59653776|NCT02257970|75771927|FG002|STARTED|Part 3||23||
59653777|NCT02257970|75771928|FG003|STARTED|Part 3||21||
59653778|NCT02257970|75771925|FG000|COMPLETED|Part 3||0||
59653779|NCT02257970|75771926|FG001|COMPLETED|Part 3||0||
59653780|NCT02257970|75771927|FG002|COMPLETED|Part 3||16||
59653781|NCT02257970|75771928|FG003|COMPLETED|Part 3||14||
59653782|NCT02257970|75771925|FG000|NOT COMPLETED|Part 3||0||
59653783|NCT02257970|75771926|FG001|NOT COMPLETED|Part 3||0||
59988761|NCT02361346|76103922|FG006|NOT COMPLETED|Part 4 (Up to Day 112)||0||
59988762|NCT02361346|76103923|FG007|NOT COMPLETED|Part 4 (Up to Day 112)||0||
59543641|NCT01555697|75641905|FG003|Approx 7 Day Washout|Overall Study||10||
59653784|NCT02257970|75771927|FG002|NOT COMPLETED|Part 3||7||
59653785|NCT02257970|75771928|FG003|NOT COMPLETED|Part 3||7||
59653786|NCT02246413|75771949|FG000|STARTED|12-months (Primary Outcome)||204||
59653787|NCT02246413|75771950|FG001|STARTED|12-months (Primary Outcome)||205||
59653788|NCT02246413|75771949|FG000|COMPLETED|12-months (Primary Outcome)||169||
59653789|NCT02246413|75771950|FG001|COMPLETED|12-months (Primary Outcome)||175||
59653790|NCT02246413|75771949|FG000|NOT COMPLETED|12-months (Primary Outcome)||35||
59653791|NCT02246413|75771950|FG001|NOT COMPLETED|12-months (Primary Outcome)||30||
59653792|NCT02246413|75771949|FG000|STARTED|24-months (Secondary Outcome)||204||
59653793|NCT02246413|75771950|FG001|STARTED|24-months (Secondary Outcome)||205||
59653794|NCT02246413|75771949|FG000|COMPLETED|24-months (Secondary Outcome)||153||
59653795|NCT02246413|75771950|FG001|COMPLETED|24-months (Secondary Outcome)||173||
59653796|NCT02246413|75771949|FG000|NOT COMPLETED|24-months (Secondary Outcome)||51||
59653797|NCT02246413|75771950|FG001|NOT COMPLETED|24-months (Secondary Outcome)||32||
59653798|NCT05288829|75771959|FG000|STARTED|Overall Study||24||
59653799|NCT05288829|75771960|FG001|STARTED|Overall Study||12||
59653800|NCT05288829|75771961|FG002|STARTED|Overall Study||6||
59653801|NCT05288829|75771959|FG000|Received At Least 1 Dose Of Study Drug|Overall Study||24||
59653802|NCT05288829|75771960|FG001|Received At Least 1 Dose Of Study Drug|Overall Study||12||
59653803|NCT05288829|75771961|FG002|Received At Least 1 Dose Of Study Drug|Overall Study||6||
59653804|NCT05288829|75771959|FG000|COMPLETED|Overall Study||24||
59653805|NCT05288829|75771960|FG001|COMPLETED|Overall Study||12||
59653806|NCT05288829|75771961|FG002|COMPLETED|Overall Study||6||
59653807|NCT05288829|75771959|FG000|NOT COMPLETED|Overall Study||0||
59653808|NCT05288829|75771960|FG001|NOT COMPLETED|Overall Study||0||
59653809|NCT05288829|75771961|FG002|NOT COMPLETED|Overall Study||0||
59653810|NCT05141175|75771970|FG000|STARTED|Overall Study||20||
59653811|NCT05141175|75771970|FG000|COMPLETED|Overall Study||19||
59653812|NCT05141175|75771970|FG000|NOT COMPLETED|Overall Study||1||
59653813|NCT04869345|75771976|FG000|STARTED|Overall Study||49||
59653814|NCT04869345|75771977|FG001|STARTED|Overall Study||46||
59653815|NCT04869345|75771976|FG000|Post-Intervention Week 11|Overall Study||43||
59653816|NCT04869345|75771977|FG001|Post-Intervention Week 11|Overall Study||43||
59653817|NCT04869345|75771976|FG000|1 Month Follow-Up Week 16|Overall Study||41||
59653818|NCT04869345|75771977|FG001|1 Month Follow-Up Week 16|Overall Study||43||
59653819|NCT04869345|75771976|FG000|COMPLETED|Overall Study||41||
59653820|NCT04869345|75771977|FG001|COMPLETED|Overall Study||43||
59653821|NCT04869345|75771976|FG000|NOT COMPLETED|Overall Study||8||
59653822|NCT04869345|75771977|FG001|NOT COMPLETED|Overall Study||3||
59653823|NCT03909529|75771984|FG000|STARTED|Open Label, Balanced, Randomized DDI|14 Subjects received this treatment|14||
59653824|NCT03909529|75771985|FG001|STARTED|Open Label, Balanced, Randomized DDI|14 Subjects received this treatment|14||
59653825|NCT03909529|75771984|FG000|COMPLETED|Open Label, Balanced, Randomized DDI|14 subjects completed this treatment|14||
59653826|NCT03909529|75771985|FG001|COMPLETED|Open Label, Balanced, Randomized DDI|14 Subjects completed this treatment|14||
59653827|NCT03909529|75771984|FG000|NOT COMPLETED|Open Label, Balanced, Randomized DDI||0||
59653828|NCT03909529|75771985|FG001|NOT COMPLETED|Open Label, Balanced, Randomized DDI||0||
59653829|NCT03909529|75771984|FG000|STARTED|Open Label, Balanced, Randomized DDI|14 Subjects received this treatment|14||
59653830|NCT03909529|75771985|FG001|STARTED|Open Label, Balanced, Randomized DDI|14 Subjects received this treatment|14||
59653831|NCT03909529|75771984|FG000|COMPLETED|Open Label, Balanced, Randomized DDI|14 subjects completed this treatment|14||
59653832|NCT03909529|75771985|FG001|COMPLETED|Open Label, Balanced, Randomized DDI|14 subjects completed this treatment|14||
59653833|NCT03909529|75771984|FG000|NOT COMPLETED|Open Label, Balanced, Randomized DDI||0||
59653834|NCT03909529|75771985|FG001|NOT COMPLETED|Open Label, Balanced, Randomized DDI||0||
59653835|NCT03794323|75772003|FG000|STARTED|Treatment Period 1 (SRD and FE Parts)||16||
59653836|NCT03794323|75772004|FG001|STARTED|Treatment Period 1 (SRD and FE Parts)||6||
59543642|NCT01555697|75641906|FG004|Approx 7 Day Washout|Overall Study||10||
59653837|NCT03794323|75772005|FG002|STARTED|Treatment Period 1 (SRD and FE Parts)||6||
59653838|NCT03794323|75772006|FG003|STARTED|Treatment Period 1 (SRD and FE Parts)||6||
59653839|NCT03794323|75772007|FG004|STARTED|Treatment Period 1 (SRD and FE Parts)||6||
59653840|NCT03794323|75772008|FG005|STARTED|Treatment Period 1 (SRD and FE Parts)||6||
59653841|NCT03794323|75772009|FG006|STARTED|Treatment Period 1 (SRD and FE Parts)||6||
59653842|NCT03794323|75772010|FG007|STARTED|Treatment Period 1 (SRD and FE Parts)||6||
59653843|NCT03794323|75772011|FG008|STARTED|Treatment Period 1 (SRD and FE Parts)||6||
59653844|NCT03794323|75772012|FG009|STARTED|Treatment Period 1 (SRD and FE Parts)||6||
59653845|NCT03794323|75772013|FG010|STARTED|Treatment Period 1 (SRD and FE Parts)||6||
59653846|NCT03794323|75772003|FG000|COMPLETED|Treatment Period 1 (SRD and FE Parts)||16||
59653847|NCT03794323|75772004|FG001|COMPLETED|Treatment Period 1 (SRD and FE Parts)||6||
59653848|NCT03794323|75772005|FG002|COMPLETED|Treatment Period 1 (SRD and FE Parts)||6||
59653849|NCT03794323|75772006|FG003|COMPLETED|Treatment Period 1 (SRD and FE Parts)||6||
59653850|NCT03794323|75772007|FG004|COMPLETED|Treatment Period 1 (SRD and FE Parts)||6||
59653851|NCT03794323|75772008|FG005|COMPLETED|Treatment Period 1 (SRD and FE Parts)||6||
59653852|NCT03794323|75772009|FG006|COMPLETED|Treatment Period 1 (SRD and FE Parts)||6||
59653853|NCT03794323|75772010|FG007|COMPLETED|Treatment Period 1 (SRD and FE Parts)||6||
59653854|NCT03794323|75772011|FG008|COMPLETED|Treatment Period 1 (SRD and FE Parts)||6||
59653855|NCT03794323|75772012|FG009|COMPLETED|Treatment Period 1 (SRD and FE Parts)||6||
59653856|NCT03794323|75772013|FG010|COMPLETED|Treatment Period 1 (SRD and FE Parts)||6||
59653857|NCT03794323|75772003|FG000|NOT COMPLETED|Treatment Period 1 (SRD and FE Parts)||0||
59653858|NCT03794323|75772004|FG001|NOT COMPLETED|Treatment Period 1 (SRD and FE Parts)||0||
59653859|NCT03794323|75772005|FG002|NOT COMPLETED|Treatment Period 1 (SRD and FE Parts)||0||
59653860|NCT03794323|75772006|FG003|NOT COMPLETED|Treatment Period 1 (SRD and FE Parts)||0||
59653861|NCT03794323|75772007|FG004|NOT COMPLETED|Treatment Period 1 (SRD and FE Parts)||0||
59653862|NCT03794323|75772008|FG005|NOT COMPLETED|Treatment Period 1 (SRD and FE Parts)||0||
59653863|NCT03794323|75772009|FG006|NOT COMPLETED|Treatment Period 1 (SRD and FE Parts)||0||
59653864|NCT03794323|75772010|FG007|NOT COMPLETED|Treatment Period 1 (SRD and FE Parts)||0||
59653865|NCT03794323|75772011|FG008|NOT COMPLETED|Treatment Period 1 (SRD and FE Parts)||0||
59653866|NCT03794323|75772012|FG009|NOT COMPLETED|Treatment Period 1 (SRD and FE Parts)||0||
59653867|NCT03794323|75772013|FG010|NOT COMPLETED|Treatment Period 1 (SRD and FE Parts)||0||
59653868|NCT03794323|75772003|FG000|STARTED|Wash-out Period (FE Part Only)||0||
59653869|NCT03794323|75772004|FG001|STARTED|Wash-out Period (FE Part Only)||0||
59653870|NCT03794323|75772005|FG002|STARTED|Wash-out Period (FE Part Only)||0||
59653871|NCT03794323|75772006|FG003|STARTED|Wash-out Period (FE Part Only)||0||
59653872|NCT03794323|75772007|FG004|STARTED|Wash-out Period (FE Part Only)||0||
59653873|NCT03794323|75772008|FG005|STARTED|Wash-out Period (FE Part Only)||0||
59653874|NCT03794323|75772009|FG006|STARTED|Wash-out Period (FE Part Only)||0||
59653875|NCT03794323|75772010|FG007|STARTED|Wash-out Period (FE Part Only)||0||
59653876|NCT03794323|75772011|FG008|STARTED|Wash-out Period (FE Part Only)||0||
59653877|NCT03794323|75772012|FG009|STARTED|Wash-out Period (FE Part Only)||6||
59653878|NCT03794323|75772013|FG010|STARTED|Wash-out Period (FE Part Only)||6||
59653879|NCT03794323|75772003|FG000|COMPLETED|Wash-out Period (FE Part Only)||0||
59543643|NCT01555697|75641907|FG005|Approx 7 Day Washout|Overall Study||10||
59543644|NCT01555697|75641908|FG006|Approx 7 Day Washout|Overall Study||10||
59543645|NCT01555697|75641909|FG007|Approx 7 Day Washout|Overall Study||10||
59543646|NCT01555697|75641902|FG000|6 Hours Lab Testing Day 2|Overall Study||10||
59543647|NCT01555697|75641903|FG001|6 Hours Lab Testing Day 2|Overall Study||10||
59543648|NCT01555697|75641904|FG002|6 Hours Lab Testing Day 2|Overall Study||10||
59543649|NCT01555697|75641905|FG003|6 Hours Lab Testing Day 2|Overall Study||10||
59543650|NCT01555697|75641906|FG004|6 Hours Lab Testing Day 2|Overall Study||10||
59543651|NCT01555697|75641907|FG005|6 Hours Lab Testing Day 2|Overall Study||10||
59543652|NCT01555697|75641908|FG006|6 Hours Lab Testing Day 2|Overall Study||10||
59543653|NCT01555697|75641909|FG007|6 Hours Lab Testing Day 2|Overall Study||10||
59543654|NCT01555697|75641902|FG000|COMPLETED|Overall Study||10||
59543655|NCT01555697|75641903|FG001|COMPLETED|Overall Study||10||
59543656|NCT01555697|75641904|FG002|COMPLETED|Overall Study||10||
59543657|NCT01555697|75641905|FG003|COMPLETED|Overall Study||10||
59543658|NCT01555697|75641906|FG004|COMPLETED|Overall Study||10||
59543659|NCT01555697|75641907|FG005|COMPLETED|Overall Study||10||
59543660|NCT01555697|75641908|FG006|COMPLETED|Overall Study||10||
59543661|NCT01555697|75641909|FG007|COMPLETED|Overall Study||10||
59543662|NCT01555697|75641902|FG000|NOT COMPLETED|Overall Study||0||
59543663|NCT01555697|75641903|FG001|NOT COMPLETED|Overall Study||0||
59543664|NCT01555697|75641904|FG002|NOT COMPLETED|Overall Study||0||
59653880|NCT03794323|75772004|FG001|COMPLETED|Wash-out Period (FE Part Only)||0||
59653881|NCT03794323|75772005|FG002|COMPLETED|Wash-out Period (FE Part Only)||0||
59653882|NCT03794323|75772006|FG003|COMPLETED|Wash-out Period (FE Part Only)||0||
59653883|NCT03794323|75772007|FG004|COMPLETED|Wash-out Period (FE Part Only)||0||
59653884|NCT03794323|75772008|FG005|COMPLETED|Wash-out Period (FE Part Only)||0||
59653885|NCT03794323|75772009|FG006|COMPLETED|Wash-out Period (FE Part Only)||0||
59653886|NCT03794323|75772010|FG007|COMPLETED|Wash-out Period (FE Part Only)||0||
59653887|NCT03794323|75772011|FG008|COMPLETED|Wash-out Period (FE Part Only)||0||
59653888|NCT03794323|75772012|FG009|COMPLETED|Wash-out Period (FE Part Only)||6||
59653889|NCT03794323|75772013|FG010|COMPLETED|Wash-out Period (FE Part Only)||6||
59653890|NCT03794323|75772003|FG000|NOT COMPLETED|Wash-out Period (FE Part Only)||0||
59653891|NCT03794323|75772004|FG001|NOT COMPLETED|Wash-out Period (FE Part Only)||0||
59653892|NCT03794323|75772005|FG002|NOT COMPLETED|Wash-out Period (FE Part Only)||0||
59653893|NCT03794323|75772006|FG003|NOT COMPLETED|Wash-out Period (FE Part Only)||0||
59653894|NCT03794323|75772007|FG004|NOT COMPLETED|Wash-out Period (FE Part Only)||0||
59653895|NCT03794323|75772008|FG005|NOT COMPLETED|Wash-out Period (FE Part Only)||0||
59653896|NCT03794323|75772009|FG006|NOT COMPLETED|Wash-out Period (FE Part Only)||0||
59653897|NCT03794323|75772010|FG007|NOT COMPLETED|Wash-out Period (FE Part Only)||0||
59653898|NCT03794323|75772011|FG008|NOT COMPLETED|Wash-out Period (FE Part Only)||0||
59653899|NCT03794323|75772012|FG009|NOT COMPLETED|Wash-out Period (FE Part Only)||0||
59653900|NCT03794323|75772013|FG010|NOT COMPLETED|Wash-out Period (FE Part Only)||0||
59653901|NCT03794323|75772003|FG000|STARTED|Treatment Period 2 (FE Part Only)||0||
59653902|NCT03794323|75772004|FG001|STARTED|Treatment Period 2 (FE Part Only)||0||
59653903|NCT03794323|75772005|FG002|STARTED|Treatment Period 2 (FE Part Only)||0||
59653904|NCT03794323|75772006|FG003|STARTED|Treatment Period 2 (FE Part Only)||0||
59653905|NCT03794323|75772007|FG004|STARTED|Treatment Period 2 (FE Part Only)||0||
59653906|NCT03794323|75772008|FG005|STARTED|Treatment Period 2 (FE Part Only)||0||
59653907|NCT03794323|75772009|FG006|STARTED|Treatment Period 2 (FE Part Only)||0||
59653908|NCT03794323|75772010|FG007|STARTED|Treatment Period 2 (FE Part Only)||0||
59653909|NCT03794323|75772011|FG008|STARTED|Treatment Period 2 (FE Part Only)||0||
59653910|NCT03794323|75772012|FG009|STARTED|Treatment Period 2 (FE Part Only)||6||
59653911|NCT03794323|75772013|FG010|STARTED|Treatment Period 2 (FE Part Only)||6||
59653912|NCT03794323|75772003|FG000|COMPLETED|Treatment Period 2 (FE Part Only)||0||
59653913|NCT03794323|75772004|FG001|COMPLETED|Treatment Period 2 (FE Part Only)||0||
59653914|NCT03794323|75772005|FG002|COMPLETED|Treatment Period 2 (FE Part Only)||0||
59653915|NCT03794323|75772006|FG003|COMPLETED|Treatment Period 2 (FE Part Only)||0||
59653916|NCT03794323|75772007|FG004|COMPLETED|Treatment Period 2 (FE Part Only)||0||
59653917|NCT03794323|75772008|FG005|COMPLETED|Treatment Period 2 (FE Part Only)||0||
59653918|NCT03794323|75772009|FG006|COMPLETED|Treatment Period 2 (FE Part Only)||0||
59653919|NCT03794323|75772010|FG007|COMPLETED|Treatment Period 2 (FE Part Only)||0||
59653920|NCT03794323|75772011|FG008|COMPLETED|Treatment Period 2 (FE Part Only)||0||
59653921|NCT03794323|75772012|FG009|COMPLETED|Treatment Period 2 (FE Part Only)||6||
59653922|NCT03794323|75772013|FG010|COMPLETED|Treatment Period 2 (FE Part Only)||6||
59653923|NCT03794323|75772003|FG000|NOT COMPLETED|Treatment Period 2 (FE Part Only)||0||
59653924|NCT03794323|75772004|FG001|NOT COMPLETED|Treatment Period 2 (FE Part Only)||0||
59653925|NCT03794323|75772005|FG002|NOT COMPLETED|Treatment Period 2 (FE Part Only)||0||
59653926|NCT03794323|75772006|FG003|NOT COMPLETED|Treatment Period 2 (FE Part Only)||0||
59653927|NCT03794323|75772007|FG004|NOT COMPLETED|Treatment Period 2 (FE Part Only)||0||
59653928|NCT03794323|75772008|FG005|NOT COMPLETED|Treatment Period 2 (FE Part Only)||0||
59653929|NCT03794323|75772009|FG006|NOT COMPLETED|Treatment Period 2 (FE Part Only)||0||
59653930|NCT03794323|75772010|FG007|NOT COMPLETED|Treatment Period 2 (FE Part Only)||0||
59653931|NCT03794323|75772011|FG008|NOT COMPLETED|Treatment Period 2 (FE Part Only)||0||
59653932|NCT03794323|75772012|FG009|NOT COMPLETED|Treatment Period 2 (FE Part Only)||0||
59988763|NCT02361346|76103924|FG008|NOT COMPLETED|Part 4 (Up to Day 112)||0||
59988764|NCT02267278|76103966|FG000|STARTED|Overall Study||25||
59988765|NCT02267278|76103966|FG000|COMPLETED|Overall Study||20||
59653933|NCT03794323|75772013|FG010|NOT COMPLETED|Treatment Period 2 (FE Part Only)||0||
59653934|NCT03610737|75772049|FG000|STARTED|Overall Study||77||
59653935|NCT03610737|75772050|FG001|STARTED|Overall Study||78||
59653936|NCT03610737|75772049|FG000|COMPLETED|Overall Study||69||
59653937|NCT03610737|75772050|FG001|COMPLETED|Overall Study||69||
59653938|NCT03610737|75772049|FG000|NOT COMPLETED|Overall Study||8||
59653939|NCT03610737|75772050|FG001|NOT COMPLETED|Overall Study||9||
59653940|NCT03321929|75772056|FG000|STARTED|Overall Study||234||
59653941|NCT03321929|75772056|FG000|COMPLETED|Overall Study|Subjects withdrawn prior to LUM Imaging procedure completed were removed from the modified Intent to Treat population (mITT)|230||
59653942|NCT03321929|75772056|FG000|NOT COMPLETED|Overall Study||4||
59653943|NCT03250624|75772063|FG000|STARTED|Overall Study||32||
59653944|NCT03250624|75772064|FG001|STARTED|Overall Study||31||
59653945|NCT03250624|75772063|FG000|COMPLETED|Overall Study||30||
59653946|NCT03250624|75772064|FG001|COMPLETED|Overall Study||24||
59653947|NCT03250624|75772063|FG000|NOT COMPLETED|Overall Study||2||
59653948|NCT03250624|75772064|FG001|NOT COMPLETED|Overall Study||7||
59988766|NCT02267278|76103966|FG000|NOT COMPLETED|Overall Study||5||
59988767|NCT02360098|76103972|FG000|STARTED|Overall Study||36||
59653949|NCT02507297|75772072|FG000|STARTED|Overall Study||16||
59653950|NCT02507297|75772073|FG001|STARTED|Overall Study||13||
59653951|NCT02507297|75772072|FG000|COMPLETED|Overall Study||15||
59653952|NCT02507297|75772073|FG001|COMPLETED|Overall Study||12||
59653953|NCT02507297|75772072|FG000|NOT COMPLETED|Overall Study||1||
59653954|NCT02507297|75772073|FG001|NOT COMPLETED|Overall Study||1||
59653955|NCT01333514|75772081|FG000|STARTED|Overall Study||8||
59653956|NCT01333514|75772082|FG001|STARTED|Overall Study||6||
59653957|NCT01333514|75772081|FG000|COMPLETED|Overall Study||7|One subject refused to participate after enrolling because he was not allowed to snack in between meals.|
59653958|NCT01333514|75772082|FG001|COMPLETED|Overall Study||6|One subject refused to participate after enrolling because he was not allowed to snack in between meals.|
59653959|NCT01333514|75772081|FG000|NOT COMPLETED|Overall Study||1||
59653960|NCT01333514|75772082|FG001|NOT COMPLETED|Overall Study||0||
59653961|NCT02066636|75772091|FG000|STARTED|Overall Study||127||
59653962|NCT02066636|75772092|FG001|STARTED|Overall Study||125||
59653963|NCT02066636|75772093|FG002|STARTED|Overall Study||1176||
59653964|NCT02066636|75772091|FG000|COMPLETED|Overall Study||0||
59653965|NCT02066636|75772092|FG001|COMPLETED|Overall Study||0||
59653966|NCT02066636|75772093|FG002|COMPLETED|Overall Study||0||
59653967|NCT02066636|75772091|FG000|NOT COMPLETED|Overall Study||127||
59653968|NCT02066636|75772092|FG001|NOT COMPLETED|Overall Study||125||
59653969|NCT02066636|75772093|FG002|NOT COMPLETED|Overall Study||1176||
59653970|NCT01486264|75772105|FG000|STARTED|Overall Study||142||
59653971|NCT01486264|75772106|FG001|STARTED|Overall Study||141||
59653972|NCT01486264|75772105|FG000|Treated|Overall Study||142||
59653973|NCT01486264|75772106|FG001|Treated|Overall Study||140||
59653974|NCT01486264|75772105|FG000|COMPLETED|Overall Study||113||
59653975|NCT01486264|75772106|FG001|COMPLETED|Overall Study||94||
59653976|NCT01486264|75772105|FG000|NOT COMPLETED|Overall Study||29||
59653977|NCT01486264|75772106|FG001|NOT COMPLETED|Overall Study||47||
59653978|NCT01323270|75772114|FG000|STARTED|Overall Study||373||
59653979|NCT01323270|75772115|FG001|STARTED|Overall Study||376||
59653980|NCT01323270|75772114|FG000|COMPLETED|Overall Study||330||
59653981|NCT01323270|75772115|FG001|COMPLETED|Overall Study||347||
59653982|NCT01323270|75772114|FG000|NOT COMPLETED|Overall Study||43||
59653983|NCT01323270|75772115|FG001|NOT COMPLETED|Overall Study||29||
59653984|NCT01300728|75772124|FG000|STARTED|Overall Study||26||
59653985|NCT01300728|75772125|FG001|STARTED|Overall Study||26||
59653986|NCT01300728|75772124|FG000|COMPLETED|Overall Study||24||
59653987|NCT01300728|75772125|FG001|COMPLETED|Overall Study||25||
59653988|NCT01300728|75772124|FG000|NOT COMPLETED|Overall Study||2||
59653989|NCT01300728|75772125|FG001|NOT COMPLETED|Overall Study||1||
59653990|NCT01299480|75772136|FG000|STARTED|Overall Study||427||
59988768|NCT02360098|76103972|FG000|COMPLETED|Overall Study||29||
59988769|NCT02360098|76103972|FG000|NOT COMPLETED|Overall Study||7||
59988770|NCT04320407|76103977|FG000|STARTED|Overall Study||20||
59988771|NCT04320407|76103977|FG000|COMPLETED|Overall Study||20||
59988772|NCT04320407|76103977|FG000|NOT COMPLETED|Overall Study||0||
59988773|NCT02266888|76103983|FG000|STARTED|Overall Study||15||
59988774|NCT02266888|76103984|FG001|STARTED|Overall Study||12||
59988775|NCT02266888|76103985|FG002|STARTED|Overall Study||11||
59988776|NCT02266888|76103986|FG003|STARTED|Overall Study||7||
59988777|NCT02266888|76103983|FG000|COMPLETED|Overall Study||8||
59653991|NCT01299480|75772137|FG001|STARTED|Overall Study||430||
59653992|NCT01299480|75772138|FG002|STARTED|Overall Study||427||
59653993|NCT01299480|75772139|FG003|STARTED|Overall Study||286||
59653994|NCT01299480|75772140|FG004|STARTED|Overall Study||143||
59653995|NCT01299480|75772136|FG000|COMPLETED|Overall Study||385||
60077010|NCT01614925|76192048|FG001|STARTED|Overall Study||17||
59653996|NCT01299480|75772137|FG001|COMPLETED|Overall Study||395||
59653997|NCT01299480|75772138|FG002|COMPLETED|Overall Study||386||
59653998|NCT01299480|75772139|FG003|COMPLETED|Overall Study||261||
59653999|NCT01299480|75772140|FG004|COMPLETED|Overall Study||123||
59654000|NCT01299480|75772136|FG000|NOT COMPLETED|Overall Study||42||
59654001|NCT01299480|75772137|FG001|NOT COMPLETED|Overall Study||35||
59654002|NCT01299480|75772138|FG002|NOT COMPLETED|Overall Study||41||
59654003|NCT01299480|75772139|FG003|NOT COMPLETED|Overall Study||25||
59654004|NCT01299480|75772140|FG004|NOT COMPLETED|Overall Study||20||
59654005|NCT05065905|75772156|FG000|STARTED|Overall Study||30||
59654006|NCT05065905|75772157|FG001|STARTED|Overall Study||28||
59654007|NCT05065905|75772158|FG002|STARTED|Overall Study||20||
59654008|NCT05065905|75772156|FG000|COMPLETED|Overall Study||30||
59654009|NCT05065905|75772157|FG001|COMPLETED|Overall Study||28||
59654010|NCT05065905|75772158|FG002|COMPLETED|Overall Study||20||
59654011|NCT05065905|75772156|FG000|NOT COMPLETED|Overall Study||0||
59654012|NCT05065905|75772157|FG001|NOT COMPLETED|Overall Study||0||
59654013|NCT05065905|75772158|FG002|NOT COMPLETED|Overall Study||0||
59654014|NCT04863417|75772170|FG000|STARTED|Overall Study||4||
59654015|NCT04863417|75772171|FG001|STARTED|Overall Study||2||
59654016|NCT04863417|75772172|FG002|STARTED|Overall Study||4||
59654017|NCT04863417|75772173|FG003|STARTED|Overall Study||2||
59654018|NCT04863417|75772170|FG000|COMPLETED|Overall Study||4||
59654019|NCT04863417|75772171|FG001|COMPLETED|Overall Study||2||
59988778|NCT02266888|76103984|FG001|COMPLETED|Overall Study||8||
59988779|NCT02266888|76103985|FG002|COMPLETED|Overall Study||0||
59654020|NCT04863417|75772172|FG002|COMPLETED|Overall Study||4||
59654021|NCT04863417|75772173|FG003|COMPLETED|Overall Study||2||
59654022|NCT04863417|75772170|FG000|NOT COMPLETED|Overall Study||0||
59654023|NCT04863417|75772171|FG001|NOT COMPLETED|Overall Study||0||
59654024|NCT04863417|75772172|FG002|NOT COMPLETED|Overall Study||0||
59654025|NCT04863417|75772173|FG003|NOT COMPLETED|Overall Study||0||
59654026|NCT04848688|75772188|FG000|STARTED|Overall Study||166||
59654027|NCT04848688|75772189|FG001|STARTED|Overall Study||166||
59654028|NCT04848688|75772188|FG000|COMPLETED|Overall Study||154||
59654029|NCT04848688|75772189|FG001|COMPLETED|Overall Study||161||
59654030|NCT04848688|75772188|FG000|NOT COMPLETED|Overall Study||12||
59654031|NCT04848688|75772189|FG001|NOT COMPLETED|Overall Study||5||
59654032|NCT04700137|75772199|FG000|STARTED|Overall Study||166|Randomized and consented.|
59654033|NCT04700137|75772200|FG001|STARTED|Overall Study||165|Randomized and consented.|
59654034|NCT04700137|75772201|FG002|STARTED|Overall Study||168|Randomized and consented.|
59654035|NCT04700137|75772202|FG003|STARTED|Overall Study||167|Randomized and consented.|
59654036|NCT04700137|75772199|FG000|COMPLETED|Overall Study||165|Completed the study, including the entire final outcome survey.|
59654037|NCT04700137|75772200|FG001|COMPLETED|Overall Study||159|Completed the study, including the entire final outcome survey.|
59654038|NCT04700137|75772201|FG002|COMPLETED|Overall Study||165|Completed the study, including the entire final outcome survey.|
59654039|NCT04700137|75772202|FG003|COMPLETED|Overall Study||166|Completed the study, including the entire final outcome survey.|
59654040|NCT04700137|75772199|FG000|NOT COMPLETED|Overall Study||1||
59654041|NCT04700137|75772200|FG001|NOT COMPLETED|Overall Study||6||
59654042|NCT04700137|75772201|FG002|NOT COMPLETED|Overall Study||3||
59654043|NCT04700137|75772202|FG003|NOT COMPLETED|Overall Study||1||
59654044|NCT04548219|75772214|FG000|STARTED|Overall Study||10||
59654045|NCT04548219|75772215|FG001|STARTED|Overall Study||10||
59654046|NCT04548219|75772216|FG002|STARTED|Overall Study||10||
59654047|NCT04548219|75772217|FG003|STARTED|Overall Study||10||
59654048|NCT04548219|75772218|FG004|STARTED|Overall Study||10||
59654049|NCT04548219|75772219|FG005|STARTED|Overall Study||10||
59654050|NCT04548219|75772214|FG000|Received at Least 1 Dose of Study Drug|Overall Study||10||
59654051|NCT04548219|75772215|FG001|Received at Least 1 Dose of Study Drug|Overall Study||10||
59654052|NCT04548219|75772216|FG002|Received at Least 1 Dose of Study Drug|Overall Study||10||
59654053|NCT04548219|75772217|FG003|Received at Least 1 Dose of Study Drug|Overall Study||10||
59654054|NCT04548219|75772218|FG004|Received at Least 1 Dose of Study Drug|Overall Study||10||
59654055|NCT04548219|75772219|FG005|Received at Least 1 Dose of Study Drug|Overall Study||10||
59654056|NCT04548219|75772214|FG000|COMPLETED|Overall Study||10||
59654057|NCT04548219|75772215|FG001|COMPLETED|Overall Study||10||
59654058|NCT04548219|75772216|FG002|COMPLETED|Overall Study||10||
59654059|NCT04548219|75772217|FG003|COMPLETED|Overall Study||10||
59654060|NCT04548219|75772218|FG004|COMPLETED|Overall Study||10||
59654061|NCT04548219|75772219|FG005|COMPLETED|Overall Study||10||
59654062|NCT04548219|75772214|FG000|NOT COMPLETED|Overall Study||0||
59654063|NCT04548219|75772215|FG001|NOT COMPLETED|Overall Study||0||
59654064|NCT04548219|75772216|FG002|NOT COMPLETED|Overall Study||0||
59654065|NCT04548219|75772217|FG003|NOT COMPLETED|Overall Study||0||
59654066|NCT04548219|75772218|FG004|NOT COMPLETED|Overall Study||0||
59654067|NCT04548219|75772219|FG005|NOT COMPLETED|Overall Study||0||
59654068|NCT04260191|75772232|FG000|STARTED|Overall Study||6||
59654069|NCT04260191|75772233|FG001|STARTED|Overall Study||4||
59654070|NCT04260191|75772234|FG002|STARTED|Overall Study||5||
59654071|NCT04260191|75772232|FG000|Received AMG 910|Overall Study||6||
59654072|NCT04260191|75772233|FG001|Received AMG 910|Overall Study||4||
59654073|NCT04260191|75772234|FG002|Received AMG 910|Overall Study||5||
59654074|NCT04260191|75772232|FG000|COMPLETED|Overall Study||1||
59654075|NCT04260191|75772233|FG001|COMPLETED|Overall Study||0||
59654076|NCT04260191|75772234|FG002|COMPLETED|Overall Study||0||
59654077|NCT04260191|75772232|FG000|NOT COMPLETED|Overall Study||5||
59654078|NCT04260191|75772233|FG001|NOT COMPLETED|Overall Study||4||
59654079|NCT04260191|75772234|FG002|NOT COMPLETED|Overall Study||5||
59654080|NCT04140942|75772244|FG000|STARTED|Overall Study||16||
59654081|NCT04140942|75772245|FG001|STARTED|Overall Study||28||
59654082|NCT04140942|75772244|FG000|Completed Post Test Only|Overall Study||11|Reason for incompletion of post test included: COVID-19 shutdown, early release from prison, and drop out.|
59654083|NCT04140942|75772245|FG001|Completed Post Test Only|Overall Study||22|Reason for incompletion of post test included: COVID-19 shutdown, early release from prison, and drop out.|
59654084|NCT04140942|75772244|FG000|COMPLETED|Overall Study||16|Included in employment analysis|
59654085|NCT04140942|75772245|FG001|COMPLETED|Overall Study||28|Included in employment analysis|
59654086|NCT04140942|75772244|FG000|NOT COMPLETED|Overall Study||0||
59654087|NCT04140942|75772245|FG001|NOT COMPLETED|Overall Study||0||
59654088|NCT03957200|75772251|FG000|STARTED|Overall Study||57||
59654089|NCT03957200|75772251|FG000|COMPLETED|Overall Study||57||
59654090|NCT03957200|75772251|FG000|NOT COMPLETED|Overall Study||0||
59654091|NCT03662100|75772261|FG000|STARTED|Overall Study||11||
59654092|NCT03662100|75772262|FG001|STARTED|Overall Study||11||
59988780|NCT02266888|76103986|FG003|COMPLETED|Overall Study||0||
59988781|NCT02266888|76103983|FG000|NOT COMPLETED|Overall Study||7||
59654093|NCT03662100|75772263|FG002|STARTED|Overall Study||11||
59988782|NCT02266888|76103984|FG001|NOT COMPLETED|Overall Study||4||
59654094|NCT03662100|75772264|FG003|STARTED|Overall Study||11||
59654095|NCT03662100|75772265|FG004|STARTED|Overall Study||11||
59654096|NCT03662100|75772266|FG005|STARTED|Overall Study||11||
59654097|NCT03662100|75772261|FG000|Received at Least One Dose of Drug|Overall Study||11||
59654098|NCT03662100|75772262|FG001|Received at Least One Dose of Drug|Overall Study||11||
59654099|NCT03662100|75772263|FG002|Received at Least One Dose of Drug|Overall Study||11||
59654100|NCT03662100|75772264|FG003|Received at Least One Dose of Drug|Overall Study||11||
59654101|NCT03662100|75772265|FG004|Received at Least One Dose of Drug|Overall Study||11||
59654102|NCT03662100|75772266|FG005|Received at Least One Dose of Drug|Overall Study||11||
59654103|NCT03662100|75772261|FG000|COMPLETED|Overall Study||11||
59654104|NCT03662100|75772262|FG001|COMPLETED|Overall Study||11||
59654105|NCT03662100|75772263|FG002|COMPLETED|Overall Study||11||
59654106|NCT03662100|75772264|FG003|COMPLETED|Overall Study||11||
59654107|NCT03662100|75772265|FG004|COMPLETED|Overall Study||11||
59654108|NCT03662100|75772266|FG005|COMPLETED|Overall Study||11||
59654109|NCT03662100|75772261|FG000|NOT COMPLETED|Overall Study||0||
59654110|NCT03662100|75772262|FG001|NOT COMPLETED|Overall Study||0||
59654111|NCT03662100|75772263|FG002|NOT COMPLETED|Overall Study||0||
59654112|NCT03662100|75772264|FG003|NOT COMPLETED|Overall Study||0||
59654113|NCT03662100|75772265|FG004|NOT COMPLETED|Overall Study||0||
59654114|NCT03662100|75772266|FG005|NOT COMPLETED|Overall Study||0||
59654115|NCT03656133|75772279|FG000|STARTED|Overall Study||55||
59654116|NCT03656133|75772279|FG000|COMPLETED|Overall Study||55||
59654117|NCT03656133|75772279|FG000|NOT COMPLETED|Overall Study||0||
59654118|NCT03280225|75772283|FG000|STARTED|Overall Study|Participants are not enrolled in this study. All enrollment and analysis were conducted at the VAMC level.|||28
59654119|NCT03280225|75772283|FG000|COMPLETED|Overall Study|"Five VAMC's began implementation of REACH VET prior to scheduled facilitation due to latency in scheduling and were thus dropped from the study.~Study was conducted at the unit (VAMC) level, not participant level."|||23
59654120|NCT03280225|75772283|FG000|NOT COMPLETED|Overall Study||||5
59654121|NCT03188510|75772295|FG000|STARTED|Overall Study||18||
59654122|NCT03188510|75772296|FG001|STARTED|Overall Study||18||
59654123|NCT03188510|75772297|FG002|STARTED|Overall Study||18||
59654124|NCT03188510|75772295|FG000|Received at Least 1 Dose of Study Drug|Overall Study||18||
59654125|NCT03188510|75772296|FG001|Received at Least 1 Dose of Study Drug|Overall Study||18||
59654126|NCT03188510|75772297|FG002|Received at Least 1 Dose of Study Drug|Overall Study||18||
59654127|NCT03188510|75772295|FG000|COMPLETED|Overall Study||18||
59654128|NCT03188510|75772296|FG001|COMPLETED|Overall Study||17||
59654129|NCT03188510|75772297|FG002|COMPLETED|Overall Study||18||
59654130|NCT03188510|75772295|FG000|NOT COMPLETED|Overall Study||0||
59654131|NCT03188510|75772296|FG001|NOT COMPLETED|Overall Study||1||
59654132|NCT03188510|75772297|FG002|NOT COMPLETED|Overall Study||0||
59654133|NCT03100149|75772308|FG000|STARTED|Overall Study||105||
59654134|NCT03100149|75772309|FG001|STARTED|Overall Study||105||
59654135|NCT03100149|75772310|FG002|STARTED|Overall Study||106||
59654136|NCT03100149|75772308|FG000|COMPLETED|Overall Study||105|Completed Part 1|
59654137|NCT03100149|75772309|FG001|COMPLETED|Overall Study||101|Completed Part 1|
59654138|NCT03100149|75772310|FG002|COMPLETED|Overall Study||104|Completed Part 1|
59654139|NCT03100149|75772308|FG000|NOT COMPLETED|Overall Study||0||
59654140|NCT03100149|75772309|FG001|NOT COMPLETED|Overall Study||4||
59654141|NCT03100149|75772310|FG002|NOT COMPLETED|Overall Study||2||
59654142|NCT03075527|75772318|FG000|STARTED|Overall Study||19||
59654143|NCT03075527|75772318|FG000|COMPLETED|Overall Study||17||
59654144|NCT03075527|75772318|FG000|NOT COMPLETED|Overall Study||2||
59654145|NCT02931253|75772324|FG000|STARTED|Overall Study||2||
59654146|NCT02931253|75772325|FG001|STARTED|Overall Study||4||
59654147|NCT02931253|75772324|FG000|COMPLETED|Overall Study||2||
59654148|NCT02931253|75772325|FG001|COMPLETED|Overall Study||4||
59654149|NCT02931253|75772324|FG000|NOT COMPLETED|Overall Study||0||
59654150|NCT02931253|75772325|FG001|NOT COMPLETED|Overall Study||0||
59654151|NCT02734004|75772338|FG000|STARTED|Overall Study||40||
59654152|NCT02734004|75772339|FG001|STARTED|Overall Study||34||
59654153|NCT02734004|75772340|FG002|STARTED|Overall Study||34||
59654154|NCT02734004|75772341|FG003|STARTED|Overall Study||40||
59654155|NCT02734004|75772342|FG004|STARTED|Overall Study||51||
59654156|NCT02734004|75772343|FG005|STARTED|Overall Study||31||
59654157|NCT02734004|75772344|FG006|STARTED|Overall Study||32||
59654158|NCT02734004|75772338|FG000|COMPLETED|Overall Study||0||
59654159|NCT02734004|75772339|FG001|COMPLETED|Overall Study||0||
59654160|NCT02734004|75772340|FG002|COMPLETED|Overall Study||0||
59654161|NCT02734004|75772341|FG003|COMPLETED|Overall Study||0||
59654162|NCT02734004|75772342|FG004|COMPLETED|Overall Study||0||
59654163|NCT02734004|75772343|FG005|COMPLETED|Overall Study||0||
59654164|NCT02734004|75772344|FG006|COMPLETED|Overall Study||0||
59654165|NCT02734004|75772338|FG000|NOT COMPLETED|Overall Study||40||
59654166|NCT02734004|75772339|FG001|NOT COMPLETED|Overall Study||34||
59654167|NCT02734004|75772340|FG002|NOT COMPLETED|Overall Study||34||
59654168|NCT02734004|75772341|FG003|NOT COMPLETED|Overall Study||40||
59654169|NCT02734004|75772342|FG004|NOT COMPLETED|Overall Study||51||
59654170|NCT02734004|75772343|FG005|NOT COMPLETED|Overall Study||31||
59654171|NCT02734004|75772344|FG006|NOT COMPLETED|Overall Study||32||
59654172|NCT02677922|75772373|FG000|STARTED|Pre-Treatment Period||3||
59654173|NCT02677922|75772374|FG001|STARTED|Pre-Treatment Period||3||
59654174|NCT02677922|75772375|FG002|STARTED|Pre-Treatment Period||7||
59654175|NCT02677922|75772376|FG003|STARTED|Pre-Treatment Period||16||
59654176|NCT02677922|75772377|FG004|STARTED|Pre-Treatment Period||68||
59654177|NCT02677922|75772378|FG005|STARTED|Pre-Treatment Period||33||
59654178|NCT02677922|75772373|FG000|COMPLETED|Pre-Treatment Period||3||
59654179|NCT02677922|75772374|FG001|COMPLETED|Pre-Treatment Period||3||
59654180|NCT02677922|75772375|FG002|COMPLETED|Pre-Treatment Period||7||
59654181|NCT02677922|75772376|FG003|COMPLETED|Pre-Treatment Period||16||
59654182|NCT02677922|75772377|FG004|COMPLETED|Pre-Treatment Period||68||
59654183|NCT02677922|75772378|FG005|COMPLETED|Pre-Treatment Period||32||
59654184|NCT02677922|75772373|FG000|NOT COMPLETED|Pre-Treatment Period||0||
59654185|NCT02677922|75772374|FG001|NOT COMPLETED|Pre-Treatment Period||0||
59654186|NCT02677922|75772375|FG002|NOT COMPLETED|Pre-Treatment Period||0||
59654187|NCT02677922|75772376|FG003|NOT COMPLETED|Pre-Treatment Period||0||
59654188|NCT02677922|75772377|FG004|NOT COMPLETED|Pre-Treatment Period||0||
59654189|NCT02677922|75772378|FG005|NOT COMPLETED|Pre-Treatment Period||1||
59654190|NCT02677922|75772373|FG000|STARTED|Treatment Period||3||
59654191|NCT02677922|75772374|FG001|STARTED|Treatment Period||3||
59654192|NCT02677922|75772375|FG002|STARTED|Treatment Period||7||
59654193|NCT02677922|75772376|FG003|STARTED|Treatment Period||16||
59654194|NCT02677922|75772377|FG004|STARTED|Treatment Period||68||
59654195|NCT02677922|75772378|FG005|STARTED|Treatment Period||32||
59654196|NCT02677922|75772373|FG000|COMPLETED|Treatment Period||1|Ongoing|
59654197|NCT02677922|75772374|FG001|COMPLETED|Treatment Period||1|Ongoing|
59654198|NCT02677922|75772375|FG002|COMPLETED|Treatment Period||4|Ongoing|
59654199|NCT02677922|75772376|FG003|COMPLETED|Treatment Period||3|Ongoing|
59654200|NCT02677922|75772377|FG004|COMPLETED|Treatment Period||21|Ongoing|
59654201|NCT02677922|75772378|FG005|COMPLETED|Treatment Period||1|Ongoing|
59654202|NCT02677922|75772373|FG000|NOT COMPLETED|Treatment Period||2||
59654203|NCT02677922|75772374|FG001|NOT COMPLETED|Treatment Period||2||
59654204|NCT02677922|75772375|FG002|NOT COMPLETED|Treatment Period||3||
59654205|NCT02677922|75772376|FG003|NOT COMPLETED|Treatment Period||13||
59654206|NCT02677922|75772377|FG004|NOT COMPLETED|Treatment Period||47||
59654207|NCT02677922|75772378|FG005|NOT COMPLETED|Treatment Period||31||
59654208|NCT02567799|75772396|FG000|STARTED|Concurrent Chemoradiotherapy||7||
59654209|NCT02567799|75772397|FG001|STARTED|Concurrent Chemoradiotherapy||7||
59654210|NCT02567799|75772398|FG002|STARTED|Concurrent Chemoradiotherapy||7||
59654211|NCT02567799|75772396|FG000|COMPLETED|Concurrent Chemoradiotherapy||6||
59654212|NCT02567799|75772397|FG001|COMPLETED|Concurrent Chemoradiotherapy||4||
59654213|NCT02567799|75772398|FG002|COMPLETED|Concurrent Chemoradiotherapy||6||
59654214|NCT02567799|75772396|FG000|NOT COMPLETED|Concurrent Chemoradiotherapy||1||
59654215|NCT02567799|75772397|FG001|NOT COMPLETED|Concurrent Chemoradiotherapy||3||
59654216|NCT02567799|75772398|FG002|NOT COMPLETED|Concurrent Chemoradiotherapy||1||
59654217|NCT02567799|75772396|FG000|STARTED|Follow-up||6||
59654218|NCT02567799|75772397|FG001|STARTED|Follow-up||4||
59654219|NCT02567799|75772398|FG002|STARTED|Follow-up||6||
59654220|NCT02567799|75772396|FG000|COMPLETED|Follow-up||4||
59654221|NCT02567799|75772397|FG001|COMPLETED|Follow-up||3||
59654222|NCT02567799|75772398|FG002|COMPLETED|Follow-up||2||
59654223|NCT02567799|75772396|FG000|NOT COMPLETED|Follow-up||2||
59654224|NCT02567799|75772397|FG001|NOT COMPLETED|Follow-up||1||
59654225|NCT02567799|75772398|FG002|NOT COMPLETED|Follow-up||4||
59654226|NCT02299141|75772408|FG000|STARTED|Overall Study||20||
59654227|NCT02299141|75772408|FG000|COMPLETED|Overall Study||20||
59654228|NCT02299141|75772408|FG000|NOT COMPLETED|Overall Study||0||
59654229|NCT02073968|75772419|FG000|STARTED|Overall Study||35||
59654230|NCT02073968|75772419|FG000|COMPLETED|Overall Study||35||
59654231|NCT02073968|75772419|FG000|NOT COMPLETED|Overall Study||0||
59654232|NCT01696994|75772427|FG000|STARTED|Overall Study||39111||
59654233|NCT01696994|75772428|FG001|STARTED|Overall Study||39105||
59654234|NCT01696994|75772427|FG000|COMPLETED|Overall Study||33919||
59654235|NCT01696994|75772428|FG001|COMPLETED|Overall Study||30668||
59654236|NCT01696994|75772427|FG000|NOT COMPLETED|Overall Study||5192||
59654237|NCT01696994|75772428|FG001|NOT COMPLETED|Overall Study||8437||
59654238|NCT01696981|75772438|FG000|STARTED|Overall Study||77455||
59654239|NCT01696981|75772439|FG001|STARTED|Overall Study||77445||
59654240|NCT01696981|75772438|FG000|COMPLETED|Overall Study||76254||
59654241|NCT01696981|75772439|FG001|COMPLETED|Overall Study||67071||
59654242|NCT01696981|75772438|FG000|NOT COMPLETED|Overall Study||1201||
59654243|NCT01696981|75772439|FG001|NOT COMPLETED|Overall Study||10374||
59654244|NCT01696968|75772447|FG000|STARTED|Overall Study||77456||
59654245|NCT01696968|75772448|FG001|STARTED|Overall Study||77445||
59654246|NCT01696968|75772447|FG000|COMPLETED|Overall Study||76255||
59654247|NCT01696968|75772448|FG001|COMPLETED|Overall Study||70633||
59654248|NCT01696968|75772447|FG000|NOT COMPLETED|Overall Study||1201||
59654249|NCT01696968|75772448|FG001|NOT COMPLETED|Overall Study||6812||
59654250|NCT01155050|75772459|FG000|STARTED|Overall Study||50||
59654251|NCT01155050|75772460|FG001|STARTED|Overall Study||51||
59654252|NCT01155050|75772461|FG002|STARTED|Overall Study||52||
59654253|NCT01155050|75772462|FG003|STARTED|Overall Study||49||
59654254|NCT01155050|75772459|FG000|COMPLETED|Overall Study||35||
59654255|NCT01155050|75772460|FG001|COMPLETED|Overall Study||31||
59654256|NCT01155050|75772461|FG002|COMPLETED|Overall Study||33||
59654257|NCT01155050|75772462|FG003|COMPLETED|Overall Study||27||
59654258|NCT01155050|75772459|FG000|NOT COMPLETED|Overall Study||15||
59654259|NCT01155050|75772460|FG001|NOT COMPLETED|Overall Study||20||
59654260|NCT01155050|75772461|FG002|NOT COMPLETED|Overall Study||19||
59654261|NCT01155050|75772462|FG003|NOT COMPLETED|Overall Study||22||
59654262|NCT01148563|75772474|FG000|STARTED|Overall Study||69||
59654263|NCT01148563|75772475|FG001|STARTED|Overall Study||67||
59654264|NCT01148563|75772474|FG000|COMPLETED|Overall Study||40||
59654265|NCT01148563|75772475|FG001|COMPLETED|Overall Study||37||
59654266|NCT01148563|75772474|FG000|NOT COMPLETED|Overall Study||29||
59654267|NCT01148563|75772475|FG001|NOT COMPLETED|Overall Study||30||
59654268|NCT00002540|75772484|FG000|STARTED|Overall Study||38345||
59654269|NCT00002540|75772485|FG001|STARTED|Overall Study||38340||
59654270|NCT00002540|75772484|FG000|COMPLETED|Overall Study||37544||
59654271|NCT00002540|75772485|FG001|COMPLETED|Overall Study||35876||
59654272|NCT00002540|75772484|FG000|NOT COMPLETED|Overall Study||801||
59654273|NCT00002540|75772485|FG001|NOT COMPLETED|Overall Study||2464||
59709686|NCT01234883|75828482|FG000|COMPLETED|Overall Study||41||
59709687|NCT01234883|75828483|FG001|COMPLETED|Overall Study||36||
59709688|NCT01234883|75828482|FG000|NOT COMPLETED|Overall Study||10||
59709689|NCT01234883|75828483|FG001|NOT COMPLETED|Overall Study||13||
59709690|NCT01234649|75828491|FG000|STARTED|Overall Study||78||
59709691|NCT01234649|75828492|FG001|STARTED|Overall Study||75||
59709692|NCT01234649|75828491|FG000|COMPLETED|Overall Study||35||
59709693|NCT01234649|75828492|FG001|COMPLETED|Overall Study||37||
59709694|NCT01234649|75828491|FG000|NOT COMPLETED|Overall Study||43||
59709695|NCT01234649|75828492|FG001|NOT COMPLETED|Overall Study||38||
59709696|NCT01075815|75828500|FG000|STARTED|Overall Study|Number of participants treated.|40||
59709697|NCT01075815|75828501|FG001|STARTED|Overall Study|Number of participants treated.|35||
59709698|NCT01075815|75828500|FG000|COMPLETED|Overall Study||30||
59709699|NCT01075815|75828501|FG001|COMPLETED|Overall Study||31||
59709700|NCT01075815|75828500|FG000|NOT COMPLETED|Overall Study||10||
59709701|NCT01075815|75828501|FG001|NOT COMPLETED|Overall Study||4||
59709702|NCT01075191|75828507|FG000|STARTED|Overall Study|65 participants were enrolled; 5 protocol violations were excluded from all analyses except safety.|60||
59709703|NCT01075191|75828507|FG000|Discontinued Year 1|Overall Study||7||
59709704|NCT01075191|75828507|FG000|Discontinued Year 2|Overall Study||6||
59709705|NCT01075191|75828507|FG000|Discontinued Year 3|Overall Study||5||
59709706|NCT01075191|75828507|FG000|COMPLETED|Overall Study||42||
59709707|NCT01075191|75828507|FG000|NOT COMPLETED|Overall Study||18||
59709708|NCT00905359|75828513|FG000|STARTED|Overall Study||82||
59709709|NCT00905359|75828514|FG001|STARTED|Overall Study||81||
59709710|NCT00905359|75828513|FG000|12 Months Follow up|Overall Study||68||
59709711|NCT00905359|75828514|FG001|12 Months Follow up|Overall Study||72||
59709712|NCT00905359|75828513|FG000|24 Months Follow up|Overall Study||58||
59709713|NCT00905359|75828514|FG001|24 Months Follow up|Overall Study||65||
59709714|NCT00905359|75828513|FG000|COMPLETED|Overall Study||58||
59709715|NCT00905359|75828514|FG001|COMPLETED|Overall Study||65||
59709716|NCT00905359|75828513|FG000|NOT COMPLETED|Overall Study||24||
59709717|NCT00905359|75828514|FG001|NOT COMPLETED|Overall Study||16||
59709718|NCT01072149|75828520|FG000|STARTED|Treatment Period 1 (28 Days)||3||
59709719|NCT01072149|75828521|FG001|STARTED|Treatment Period 1 (28 Days)||3||
59709720|NCT01072149|75828522|FG002|STARTED|Treatment Period 1 (28 Days)||3||
59709721|NCT01072149|75828523|FG003|STARTED|Treatment Period 1 (28 Days)||3||
59709722|NCT01072149|75828524|FG004|STARTED|Treatment Period 1 (28 Days)||3||
59709723|NCT01072149|75828525|FG005|STARTED|Treatment Period 1 (28 Days)||3||
59709724|NCT01072149|75828526|FG006|STARTED|Treatment Period 1 (28 Days)||3||
59709725|NCT01072149|75828527|FG007|STARTED|Treatment Period 1 (28 Days)||3||
59709726|NCT01072149|75828528|FG008|STARTED|Treatment Period 1 (28 Days)||3||
59709727|NCT01072149|75828529|FG009|STARTED|Treatment Period 1 (28 Days)||3||
59709728|NCT01072149|75828530|FG010|STARTED|Treatment Period 1 (28 Days)||3||
59709729|NCT01072149|75828531|FG011|STARTED|Treatment Period 1 (28 Days)||3||
59709730|NCT01072149|75828532|FG012|STARTED|Treatment Period 1 (28 Days)||3||
59709731|NCT01072149|75828533|FG013|STARTED|Treatment Period 1 (28 Days)||3||
59709732|NCT01072149|75828534|FG014|STARTED|Treatment Period 1 (28 Days)||3||
59709733|NCT01072149|75828535|FG015|STARTED|Treatment Period 1 (28 Days)||3||
59709734|NCT01072149|75828536|FG016|STARTED|Treatment Period 1 (28 Days)||3||
59709735|NCT01072149|75828537|FG017|STARTED|Treatment Period 1 (28 Days)||3||
59709736|NCT01072149|75828520|FG000|COMPLETED|Treatment Period 1 (28 Days)||3||
59709737|NCT01072149|75828521|FG001|COMPLETED|Treatment Period 1 (28 Days)||3||
59709738|NCT01072149|75828522|FG002|COMPLETED|Treatment Period 1 (28 Days)||2||
59709739|NCT01072149|75828523|FG003|COMPLETED|Treatment Period 1 (28 Days)||3||
59709740|NCT01072149|75828524|FG004|COMPLETED|Treatment Period 1 (28 Days)||3||
59709741|NCT01072149|75828525|FG005|COMPLETED|Treatment Period 1 (28 Days)||3||
59709742|NCT01072149|75828526|FG006|COMPLETED|Treatment Period 1 (28 Days)||3||
59709743|NCT01072149|75828527|FG007|COMPLETED|Treatment Period 1 (28 Days)||3||
59709744|NCT01072149|75828528|FG008|COMPLETED|Treatment Period 1 (28 Days)||3||
59709745|NCT01072149|75828529|FG009|COMPLETED|Treatment Period 1 (28 Days)||3||
59988783|NCT02266888|76103985|FG002|NOT COMPLETED|Overall Study||11||
59654274|NCT04871425|75772493|FG000|STARTED|Overall Study||57||
59654275|NCT04871425|75772494|FG001|STARTED|Overall Study||53||
59654276|NCT04871425|75772493|FG000|COMPLETED|Overall Study||42||
59654277|NCT04871425|75772494|FG001|COMPLETED|Overall Study||45||
59654278|NCT04871425|75772493|FG000|NOT COMPLETED|Overall Study||15||
59654279|NCT04871425|75772494|FG001|NOT COMPLETED|Overall Study||8||
59654280|NCT04799405|75772500|FG000|STARTED|Phase 1 - Acute Stimulation, Daily tDCS||5||
59654281|NCT04799405|75772500|FG000|COMPLETED|Phase 1 - Acute Stimulation, Daily tDCS||3||
59654282|NCT04799405|75772500|FG000|NOT COMPLETED|Phase 1 - Acute Stimulation, Daily tDCS||2||
59654283|NCT04799405|75772500|FG000|STARTED|Phase 2 - Tapered Stimulation Schedule||3||
59654284|NCT04799405|75772500|FG000|COMPLETED|Phase 2 - Tapered Stimulation Schedule||3||
59654285|NCT04799405|75772500|FG000|NOT COMPLETED|Phase 2 - Tapered Stimulation Schedule||0||
59654286|NCT04799405|75772500|FG000|STARTED|Phase 3 - Follow up Phase||3||
59654287|NCT04799405|75772500|FG000|COMPLETED|Phase 3 - Follow up Phase||3||
59654288|NCT04799405|75772500|FG000|NOT COMPLETED|Phase 3 - Follow up Phase||0||
59654289|NCT04748458|75772504|FG000|STARTED|Overall Study||85||100
59654290|NCT04748458|75772504|FG000|COMPLETED|Overall Study||85||100
59654291|NCT04748458|75772504|FG000|NOT COMPLETED|Overall Study||0||0
59654292|NCT04529499|75772510|FG000|STARTED|Overall Study||175||
59654293|NCT04529499|75772511|FG001|STARTED|Overall Study||178||
59654294|NCT04529499|75772510|FG000|Discharged From Hospital Before Day 28|Overall Study||136|Stage I|
59654295|NCT04529499|75772511|FG001|Discharged From Hospital Before Day 28|Overall Study||136|Stage I|
59654296|NCT04529499|75772510|FG000|Completed 10-day Treatment Course of IMP|Overall Study||150|Stage I|
59654297|NCT04529499|75772511|FG001|Completed 10-day Treatment Course of IMP|Overall Study||147|Stage I|
59654298|NCT04529499|75772510|FG000|Completed Day 14 Telephonic Visit|Overall Study||107|Stage I|
59654299|NCT04529499|75772511|FG001|Completed Day 14 Telephonic Visit|Overall Study||102|Stage I|
59654300|NCT04529499|75772510|FG000|Completed Day 21 Telephonic Visit|Overall Study||119|Stage I|
59654301|NCT04529499|75772511|FG001|Completed Day 21 Telephonic Visit|Overall Study||120|Stage I|
59654302|NCT04529499|75772510|FG000|Completed Day 28 Telephonic Visit|Overall Study||134|Stage I|
59654303|NCT04529499|75772511|FG001|Completed Day 28 Telephonic Visit|Overall Study||131|Stage I|
59654304|NCT04529499|75772510|FG000|Completed Days 14, 21 and 28 Telephonic Visits in Stage I|Overall Study||98|Stage I|
59654305|NCT04529499|75772511|FG001|Completed Days 14, 21 and 28 Telephonic Visits in Stage I|Overall Study||94|Stage I|
59654306|NCT04529499|75772510|FG000|Continue to be in Hospital as of Day 28|Overall Study||6||
59654307|NCT04529499|75772511|FG001|Continue to be in Hospital as of Day 28|Overall Study||4||
59654308|NCT04529499|75772510|FG000|Completed Day 42 Telephonic Visit|Overall Study||136|Stage II|
59654309|NCT04529499|75772511|FG001|Completed Day 42 Telephonic Visit|Overall Study||135|Stage II|
59654310|NCT04529499|75772510|FG000|Completed Day 60 Telephonic Visit|Overall Study||129|Stage II|
59654311|NCT04529499|75772511|FG001|Completed Day 60 Telephonic Visit|Overall Study||132|Stage II|
59654312|NCT04529499|75772510|FG000|Completed Days 42 and 60 Telephonic Visits in Stage II|Overall Study||126|Stage II|
59654313|NCT04529499|75772511|FG001|Completed Days 42 and 60 Telephonic Visits in Stage II|Overall Study||130|Stage II|
59654314|NCT04529499|75772510|FG000|Continued to be in Hospital When Study Was Terminated|Overall Study||11||
59654315|NCT04529499|75772511|FG001|Continued to be in Hospital When Study Was Terminated|Overall Study||17||
59654316|NCT04529499|75772510|FG000|COMPLETED|Overall Study||139|Stage I|
59654317|NCT04529499|75772511|FG001|COMPLETED|Overall Study||138|Stage I|
59654318|NCT04529499|75772510|FG000|NOT COMPLETED|Overall Study||36||
59654319|NCT04529499|75772511|FG001|NOT COMPLETED|Overall Study||40||
59654320|NCT04501094|75772519|FG000|STARTED|Overall Study||1||
59654321|NCT04501094|75772520|FG001|STARTED|Overall Study||1||
59654322|NCT04501094|75772519|FG000|COMPLETED|Overall Study||0||
59654323|NCT04501094|75772520|FG001|COMPLETED|Overall Study||1||
59654324|NCT04501094|75772519|FG000|NOT COMPLETED|Overall Study||1||
59654325|NCT04501094|75772520|FG001|NOT COMPLETED|Overall Study||0||
59654326|NCT04414618|75772528|FG000|STARTED|Overall Study||23||
59654327|NCT04414618|75772529|FG001|STARTED|Overall Study||19||
59654328|NCT04414618|75772528|FG000|COMPLETED|Overall Study||15||
59654329|NCT04414618|75772529|FG001|COMPLETED|Overall Study||12||
59654330|NCT04414618|75772528|FG000|NOT COMPLETED|Overall Study||8||
59654331|NCT04414618|75772529|FG001|NOT COMPLETED|Overall Study||7||
59654332|NCT04412057|75772538|FG000|STARTED|Overall Study||41||
59654333|NCT04412057|75772539|FG001|STARTED|Overall Study||42||
59654334|NCT04412057|75772538|FG000|Randomized Analysis Set|Overall Study||41||
59654335|NCT04412057|75772539|FG001|Randomized Analysis Set|Overall Study||42||
59543665|NCT01555697|75641905|FG003|NOT COMPLETED|Overall Study||0||
59543666|NCT01555697|75641906|FG004|NOT COMPLETED|Overall Study||0||
59543667|NCT01555697|75641907|FG005|NOT COMPLETED|Overall Study||0||
59543668|NCT01555697|75641908|FG006|NOT COMPLETED|Overall Study||0||
59543669|NCT01555697|75641909|FG007|NOT COMPLETED|Overall Study||0||
59543670|NCT02451930|75641924|FG000|STARTED|Overall Study||3||
59543671|NCT02451930|75641925|FG001|STARTED|Overall Study||68||
59543672|NCT02451930|75641924|FG000|Received at Least One Dose of Study Drug|Overall Study||3||
59543673|NCT02451930|75641925|FG001|Received at Least One Dose of Study Drug|Overall Study||68||
59543674|NCT02451930|75641924|FG000|Part A Cohort 2 Participants|Overall Study||0||
59654336|NCT04412057|75772538|FG000|Safety Analysis Set|Overall Study||40||
59654337|NCT04412057|75772539|FG001|Safety Analysis Set|Overall Study||42||
59654338|NCT04412057|75772538|FG000|Full Analysis Set|Overall Study||40||
59654339|NCT04412057|75772539|FG001|Full Analysis Set|Overall Study||42||
59654340|NCT04412057|75772538|FG000|Primary Analysis Set|Overall Study||31||
59654341|NCT04412057|75772539|FG001|Primary Analysis Set|Overall Study||31||
59654342|NCT04412057|75772538|FG000|COMPLETED|Overall Study||37||
59654343|NCT04412057|75772539|FG001|COMPLETED|Overall Study||35||
59654344|NCT04412057|75772538|FG000|NOT COMPLETED|Overall Study||4||
59654345|NCT04412057|75772539|FG001|NOT COMPLETED|Overall Study||7||
59654346|NCT04402060|75772548|FG000|STARTED|Overall Study||6||
59654347|NCT04402060|75772549|FG001|STARTED|Overall Study||34||
59654348|NCT04402060|75772550|FG002|STARTED|Overall Study||32||
59654349|NCT04402060|75772548|FG000|Received Treatment|Overall Study||6||
59654350|NCT04402060|75772549|FG001|Received Treatment|Overall Study||33||
59654351|NCT04402060|75772550|FG002|Received Treatment|Overall Study||32||
59654352|NCT04402060|75772548|FG000|COMPLETED|Overall Study||5|Completed the study|
59654353|NCT04402060|75772549|FG001|COMPLETED|Overall Study||18|Completed the study|
59654354|NCT04402060|75772550|FG002|COMPLETED|Overall Study||21|Completed the study|
59654355|NCT04402060|75772548|FG000|NOT COMPLETED|Overall Study||1||
59654356|NCT04402060|75772549|FG001|NOT COMPLETED|Overall Study||16||
59654357|NCT04402060|75772550|FG002|NOT COMPLETED|Overall Study||11||
59654358|NCT04391179|75772565|FG000|STARTED|Overall Study||49||
59654359|NCT04391179|75772566|FG001|STARTED|Overall Study||50||
59654360|NCT04391179|75772565|FG000|COMPLETED|Overall Study||34||
59654361|NCT04391179|75772566|FG001|COMPLETED|Overall Study||34||
59654362|NCT04391179|75772565|FG000|NOT COMPLETED|Overall Study||15||
59654363|NCT04391179|75772566|FG001|NOT COMPLETED|Overall Study||16||
59654364|NCT04386096|75772574|FG000|STARTED|Overall Study||20||
59654365|NCT04386096|75772575|FG001|STARTED|Overall Study||20||
59654366|NCT04386096|75772574|FG000|COMPLETED|Overall Study||20||
59654367|NCT04386096|75772575|FG001|COMPLETED|Overall Study||20||
59654368|NCT04386096|75772574|FG000|NOT COMPLETED|Overall Study||0||
59654369|NCT04386096|75772575|FG001|NOT COMPLETED|Overall Study||0||
59654370|NCT04376684|75772585|FG000|STARTED|Part 1 (Up to Day 60)||403||
59654371|NCT04376684|75772586|FG001|STARTED|Part 1 (Up to Day 60)||403||
59654372|NCT04376684|75772587|FG002|STARTED|Part 1 (Up to Day 60)||0||
59654373|NCT04376684|75772588|FG003|STARTED|Part 1 (Up to Day 60)||0||
59654374|NCT04376684|75772585|FG000|COMPLETED|Part 1 (Up to Day 60)||388||
59654375|NCT04376684|75772586|FG001|COMPLETED|Part 1 (Up to Day 60)||379||
59654376|NCT04376684|75772587|FG002|COMPLETED|Part 1 (Up to Day 60)||0||
59654377|NCT04376684|75772588|FG003|COMPLETED|Part 1 (Up to Day 60)||0||
59654378|NCT04376684|75772585|FG000|NOT COMPLETED|Part 1 (Up to Day 60)||15||
59654379|NCT04376684|75772586|FG001|NOT COMPLETED|Part 1 (Up to Day 60)||24||
59654380|NCT04376684|75772587|FG002|NOT COMPLETED|Part 1 (Up to Day 60)||0||
59654381|NCT04376684|75772588|FG003|NOT COMPLETED|Part 1 (Up to Day 60)||0||
59654382|NCT04376684|75772585|FG000|STARTED|Part 2 (Up to Day 60)||0||
59654383|NCT04376684|75772586|FG001|STARTED|Part 2 (Up to Day 60)||0||
59654384|NCT04376684|75772587|FG002|STARTED|Part 2 (Up to Day 60)||175||
59654385|NCT04376684|75772588|FG003|STARTED|Part 2 (Up to Day 60)||175||
59654386|NCT04376684|75772585|FG000|COMPLETED|Part 2 (Up to Day 60)||0||
59654387|NCT04376684|75772586|FG001|COMPLETED|Part 2 (Up to Day 60)||0||
59654388|NCT04376684|75772587|FG002|COMPLETED|Part 2 (Up to Day 60)||170||
59654389|NCT04376684|75772588|FG003|COMPLETED|Part 2 (Up to Day 60)||171||
59654390|NCT04376684|75772585|FG000|NOT COMPLETED|Part 2 (Up to Day 60)||0||
59654391|NCT04376684|75772586|FG001|NOT COMPLETED|Part 2 (Up to Day 60)||0||
59654392|NCT04376684|75772587|FG002|NOT COMPLETED|Part 2 (Up to Day 60)||5||
59654393|NCT04376684|75772588|FG003|NOT COMPLETED|Part 2 (Up to Day 60)||4||
59654394|NCT04353284|75772600|FG000|STARTED|Overall Study||35||
59654395|NCT04353284|75772601|FG001|STARTED|Overall Study||35||
59654396|NCT04353284|75772600|FG000|COMPLETED|Overall Study||33||
59654397|NCT04353284|75772601|FG001|COMPLETED|Overall Study||34||
59654398|NCT04353284|75772600|FG000|NOT COMPLETED|Overall Study||2||
59654399|NCT04353284|75772601|FG001|NOT COMPLETED|Overall Study||1||
59654400|NCT04294147|75772609|FG000|STARTED|Overall Study||32||
59654401|NCT04294147|75772610|FG001|STARTED|Overall Study||33||
59654402|NCT04294147|75772609|FG000|Received at Least One Dose of Study Drug|Overall Study||32||
59654403|NCT04294147|75772610|FG001|Received at Least One Dose of Study Drug|Overall Study||33||
59654404|NCT04294147|75772609|FG000|COMPLETED|Overall Study||30||
59654405|NCT04294147|75772610|FG001|COMPLETED|Overall Study||33||
59654406|NCT04294147|75772609|FG000|NOT COMPLETED|Overall Study||2||
59654407|NCT04294147|75772610|FG001|NOT COMPLETED|Overall Study||0||
59654408|NCT04269707|75772616|FG000|STARTED|Overall Study||7||
59654409|NCT04269707|75772616|FG000|COMPLETED|Overall Study||7||
59654410|NCT04269707|75772616|FG000|NOT COMPLETED|Overall Study||0||
59654411|NCT04231825|75772622|FG000|STARTED|Overall Study||23||
59654412|NCT04231825|75772623|FG001|STARTED|Overall Study||24||
59654413|NCT04231825|75772622|FG000|COMPLETED|Overall Study||20||
59654414|NCT04231825|75772623|FG001|COMPLETED|Overall Study||20||
59654415|NCT04231825|75772622|FG000|NOT COMPLETED|Overall Study||3||
59654416|NCT04231825|75772623|FG001|NOT COMPLETED|Overall Study||4||
59654417|NCT04178772|75772629|FG000|STARTED|Overall Study||27||
59654418|NCT04178772|75772629|FG000|COMPLETED|Overall Study||19||
59654419|NCT04178772|75772629|FG000|NOT COMPLETED|Overall Study||8||
59654420|NCT04148651|75772633|FG000|STARTED|Overall Study||12||12
59654421|NCT04148651|75772633|FG000|COMPLETED|Overall Study|2 subjects did not complete the final follow-up due to COVID-19 pandemic|10||10
59654422|NCT04148651|75772633|FG000|NOT COMPLETED|Overall Study||2||2
59654423|NCT04113304|75772638|FG000|STARTED|Overall Study||6||
59654424|NCT04113304|75772638|FG000|COMPLETED|Overall Study||6||
59654425|NCT04113304|75772638|FG000|NOT COMPLETED|Overall Study||0||
59654426|NCT03929588|75772642|FG000|STARTED|Overall Study||230||
59654427|NCT03929588|75772642|FG000|COMPLETED|Overall Study||143||
59654428|NCT03929588|75772642|FG000|NOT COMPLETED|Overall Study||87||
59654429|NCT03924427|75772646|FG000|STARTED|Overall Study||74||
59654430|NCT03924427|75772646|FG000|COMPLETED|Overall Study||68||
59654431|NCT03924427|75772646|FG000|NOT COMPLETED|Overall Study||6||
59654432|NCT05503823|75772652|FG000|STARTED|Overall Study||6||
59654433|NCT05503823|75772652|FG000|COMPLETED|Overall Study||6||
59654434|NCT05503823|75772652|FG000|NOT COMPLETED|Overall Study||0||
59654435|NCT05270980|75772662|FG000|STARTED|Overall Study||14||
59654436|NCT05270980|75772663|FG001|STARTED|Overall Study||2||
59654437|NCT05270980|75772664|FG002|STARTED|Overall Study||50||
59654438|NCT05270980|75772665|FG003|STARTED|Overall Study||21||
59654439|NCT05270980|75772662|FG000|COMPLETED|Overall Study||14||
59654440|NCT05270980|75772663|FG001|COMPLETED|Overall Study||2||
59654441|NCT05270980|75772664|FG002|COMPLETED|Overall Study||50||
59654442|NCT05270980|75772665|FG003|COMPLETED|Overall Study||21||
59654443|NCT05270980|75772662|FG000|NOT COMPLETED|Overall Study||0||
59654444|NCT05270980|75772663|FG001|NOT COMPLETED|Overall Study||0||
59654445|NCT05270980|75772664|FG002|NOT COMPLETED|Overall Study||0||
59654446|NCT05270980|75772665|FG003|NOT COMPLETED|Overall Study||0||
59654447|NCT04033991|75772677|FG000|STARTED|Overall Study||684||
59654448|NCT04033991|75772677|FG000|Participants Who Took First-line Sunitinib Therapy|Overall Study||622||
59654449|NCT04033991|75772677|FG000|Participants Who Took Second-line Axitinib Therapy|Overall Study||121||
59654450|NCT04033991|75772677|FG000|Participants Who Took First-line Sunitinib Therapy and Then Second-line Axitinib Therapy|Overall Study||59||
59654451|NCT04033991|75772677|FG000|Participants Who Took Drugs Other Than Sunitinib as First-line and Then Second-line Axitinib Therapy|Overall Study||62||
59654452|NCT04033991|75772677|FG000|COMPLETED|Overall Study||684||
59654453|NCT04033991|75772677|FG000|NOT COMPLETED|Overall Study||0||
59654454|NCT03941769|75772683|FG000|STARTED|Overall Study||1||
59654455|NCT03941769|75772683|FG000|COMPLETED|Overall Study||1||
59654456|NCT03941769|75772683|FG000|NOT COMPLETED|Overall Study||0||
59654457|NCT03642132|75772690|FG000|STARTED|Chemotherapy Period||32||
59654458|NCT03642132|75772691|FG001|STARTED|Chemotherapy Period||13||
59654459|NCT03642132|75772692|FG002|STARTED|Chemotherapy Period||34||
59654460|NCT03642132|75772690|FG000|COMPLETED|Chemotherapy Period||19||
59654461|NCT03642132|75772691|FG001|COMPLETED|Chemotherapy Period||8||
59654462|NCT03642132|75772692|FG002|COMPLETED|Chemotherapy Period||27||
59654463|NCT03642132|75772690|FG000|NOT COMPLETED|Chemotherapy Period||13||
59654464|NCT03642132|75772691|FG001|NOT COMPLETED|Chemotherapy Period||5||
59654465|NCT03642132|75772692|FG002|NOT COMPLETED|Chemotherapy Period||7||
59654466|NCT03642132|75772690|FG000|STARTED|Maintenance Period||18||
59654467|NCT03642132|75772691|FG001|STARTED|Maintenance Period||9||
59654468|NCT03642132|75772692|FG002|STARTED|Maintenance Period||23||
59654469|NCT03642132|75772690|FG000|COMPLETED|Maintenance Period||5||
59654470|NCT03642132|75772691|FG001|COMPLETED|Maintenance Period||1||
59654471|NCT03642132|75772692|FG002|COMPLETED|Maintenance Period||9||
59654472|NCT03642132|75772690|FG000|NOT COMPLETED|Maintenance Period||13||
59654473|NCT03642132|75772691|FG001|NOT COMPLETED|Maintenance Period||8||
59654474|NCT03642132|75772692|FG002|NOT COMPLETED|Maintenance Period||14||
59654475|NCT03642132|75772690|FG000|STARTED|Follow-up Period||19||
59654476|NCT03642132|75772691|FG001|STARTED|Follow-up Period||9||
59543675|NCT02451930|75641925|FG001|Part A Cohort 2 Participants|Overall Study||6||
59543676|NCT02451930|75641924|FG000|Part B Participants|Overall Study||0||
59543677|NCT02451930|75641925|FG001|Part B Participants|Overall Study||55||
59543678|NCT02451930|75641924|FG000|Part C Participants|Overall Study||0||
59543679|NCT02451930|75641925|FG001|Part C Participants|Overall Study||7||
59543680|NCT02451930|75641924|FG000|COMPLETED|Overall Study||1||
59543681|NCT02451930|75641925|FG001|COMPLETED|Overall Study||38||
59543682|NCT02451930|75641924|FG000|NOT COMPLETED|Overall Study||2||
59543683|NCT02451930|75641925|FG001|NOT COMPLETED|Overall Study||30||
59543684|NCT00932828|75641941|FG000|STARTED|Overall Study||37||
59543685|NCT00932828|75641941|FG000|COMPLETED|Overall Study|5 subjects who did not complete the protocol were considered in an ITT analysis.|32||
59654477|NCT03642132|75772692|FG002|STARTED|Follow-up Period||28||
59654478|NCT03642132|75772690|FG000|COMPLETED|Follow-up Period||14||
59654479|NCT03642132|75772691|FG001|COMPLETED|Follow-up Period||7||
59654480|NCT03642132|75772692|FG002|COMPLETED|Follow-up Period||24||
59654481|NCT03642132|75772690|FG000|NOT COMPLETED|Follow-up Period||5||
59543686|NCT00932828|75641941|FG000|NOT COMPLETED|Overall Study||5||
59654482|NCT03642132|75772691|FG001|NOT COMPLETED|Follow-up Period||2||
59654483|NCT03642132|75772692|FG002|NOT COMPLETED|Follow-up Period||4||
59654484|NCT03008122|75772703|FG000|STARTED|Overall Study||36||
59654485|NCT03008122|75772704|FG001|STARTED|Overall Study||45||
59654486|NCT03008122|75772705|FG002|STARTED|Overall Study||10||
59654487|NCT03008122|75772703|FG000|COMPLETED|Overall Study||26||
59654488|NCT03008122|75772704|FG001|COMPLETED|Overall Study||32||
59654489|NCT03008122|75772705|FG002|COMPLETED|Overall Study||6||
59654490|NCT03008122|75772703|FG000|NOT COMPLETED|Overall Study||10||
59654491|NCT03008122|75772704|FG001|NOT COMPLETED|Overall Study||13||
59654492|NCT03008122|75772705|FG002|NOT COMPLETED|Overall Study||4||
59654493|NCT02462187|75772719|FG000|STARTED|Overall Study||13||
59654494|NCT02462187|75772720|FG001|STARTED|Overall Study||24||
59654495|NCT02462187|75772721|FG002|STARTED|Overall Study||14||
59654496|NCT02462187|75772722|FG003|STARTED|Overall Study||30||
59654497|NCT02462187|75772723|FG004|STARTED|Overall Study||23||
59654498|NCT02462187|75772724|FG005|STARTED|Overall Study||4||
59654499|NCT02462187|75772719|FG000|COMPLETED|Overall Study||8||
59654500|NCT02462187|75772720|FG001|COMPLETED|Overall Study||19||
59654501|NCT02462187|75772721|FG002|COMPLETED|Overall Study||9||
59654502|NCT02462187|75772722|FG003|COMPLETED|Overall Study||23||
59654503|NCT02462187|75772723|FG004|COMPLETED|Overall Study||16||
59654504|NCT02462187|75772724|FG005|COMPLETED|Overall Study||4||
59654505|NCT02462187|75772719|FG000|NOT COMPLETED|Overall Study||5||
59654506|NCT02462187|75772720|FG001|NOT COMPLETED|Overall Study||5||
59654507|NCT02462187|75772721|FG002|NOT COMPLETED|Overall Study||5||
59654508|NCT02462187|75772722|FG003|NOT COMPLETED|Overall Study||7||
59654509|NCT02462187|75772723|FG004|NOT COMPLETED|Overall Study||7||
59654510|NCT02462187|75772724|FG005|NOT COMPLETED|Overall Study||0||
59654511|NCT02342535|75772738|FG000|STARTED|Overall Study|30 women who participated in the aerobic exercise class and 38 children.|68||
59654512|NCT02342535|75772738|FG000|COMPLETED|Overall Study|30 women in aerobic class and 38 kids in kids exercise class|68||
59654513|NCT02342535|75772738|FG000|NOT COMPLETED|Overall Study||0||
59654514|NCT01819064|75772742|FG000|STARTED|Overall Study||60||
59654515|NCT01819064|75772742|FG000|COMPLETED|Overall Study||60||
59654516|NCT01819064|75772742|FG000|NOT COMPLETED|Overall Study||0||
59654517|NCT01817751|75772747|FG000|STARTED|Overall Study||47||
59654518|NCT01817751|75772747|FG000|COMPLETED|Overall Study||46||
59654519|NCT01817751|75772747|FG000|NOT COMPLETED|Overall Study||1||
59654520|NCT01604122|75772753|FG000|STARTED|Overall Study||60||
59654521|NCT01604122|75772754|FG001|STARTED|Overall Study||32||
59654522|NCT01604122|75772753|FG000|COMPLETED|Overall Study||60||
59654523|NCT01604122|75772754|FG001|COMPLETED|Overall Study||32||
59654524|NCT01604122|75772753|FG000|NOT COMPLETED|Overall Study||0||
59654525|NCT01604122|75772754|FG001|NOT COMPLETED|Overall Study||0||
59654526|NCT01349322|75772763|FG000|STARTED|Overall Study||1169||
59654527|NCT01349322|75772764|FG001|STARTED|Overall Study||1185||
59654528|NCT01349322|75772763|FG000|Eligible Population|Overall Study||1124||
59654529|NCT01349322|75772764|FG001|Eligible Population|Overall Study||1138||
59654530|NCT01349322|75772763|FG000|Adverse Event Population|Overall Study||1100|Eligible participants who started protocol treatment and had adverse event data|
59654531|NCT01349322|75772764|FG001|Adverse Event Population|Overall Study||1123|Eligible participants who started protocol treatment and had adverse event data|
59654532|NCT01349322|75772763|FG000|Quality of Life Population|Overall Study||429|Eligible, consented, and accrued when QOL substudy was open to enrollment|
59654533|NCT01349322|75772764|FG001|Quality of Life Population|Overall Study||449|Eligible, consented, and accrued when QOL substudy was open to enrollment|
59654534|NCT01349322|75772763|FG000|COMPLETED|Overall Study||1124||
59654535|NCT01349322|75772764|FG001|COMPLETED|Overall Study||1138||
59654536|NCT01349322|75772763|FG000|NOT COMPLETED|Overall Study||45||
59654537|NCT01349322|75772764|FG001|NOT COMPLETED|Overall Study||47||
59654538|NCT01222390|75772772|FG000|STARTED|Overall Study||12||
59654539|NCT01222390|75772772|FG000|COMPLETED|Overall Study||12||
59654540|NCT01222390|75772772|FG000|NOT COMPLETED|Overall Study||0||
59654541|NCT01182415|75772776|FG000|STARTED|Overall Study||30||
59654542|NCT01182415|75772776|FG000|COMPLETED|Overall Study||29||
59654543|NCT01182415|75772776|FG000|NOT COMPLETED|Overall Study||1||
59654544|NCT01030523|75772782|FG000|STARTED|Initial Study (5 Years)||50||67
59654545|NCT01030523|75772783|FG001|STARTED|Initial Study (5 Years)||51||70
59654546|NCT01030523|75772782|FG000|COMPLETED|Initial Study (5 Years)||44||60
59654547|NCT01030523|75772783|FG001|COMPLETED|Initial Study (5 Years)||46||64
59654548|NCT01030523|75772782|FG000|NOT COMPLETED|Initial Study (5 Years)||6||7
59654549|NCT01030523|75772783|FG001|NOT COMPLETED|Initial Study (5 Years)||5||6
59815795|NCT03026283|75938213|FG002|STARTED|Optimal Care/Stress Test/ICA||0|Participants diagnosed to receive optimal care, or recommended for stress test diagnosis or ICA|
59817904|NCT04488770|75940330|FG004|NOT COMPLETED|Part 1-Cohort 2: Period 1 (Up to 5 Days)||0||
59988784|NCT02266888|76103986|FG003|NOT COMPLETED|Overall Study||7||
59988785|NCT01641952|76103994|FG000|STARTED|Overall Study||505||
59654550|NCT01030523|75772782|FG000|STARTED|Follow-up Extension (10 Years)||36||48
59654551|NCT01030523|75772783|FG001|STARTED|Follow-up Extension (10 Years)||41||57
59654552|NCT01030523|75772782|FG000|COMPLETED|Follow-up Extension (10 Years)||29||39
59654553|NCT01030523|75772783|FG001|COMPLETED|Follow-up Extension (10 Years)||32||47
59654554|NCT01030523|75772782|FG000|NOT COMPLETED|Follow-up Extension (10 Years)||7||9
59654555|NCT01030523|75772783|FG001|NOT COMPLETED|Follow-up Extension (10 Years)||9||10
59654556|NCT03870880|75772795|FG000|STARTED|Overall Study||27||
59654557|NCT03870880|75772796|FG001|STARTED|Overall Study||58||
59988786|NCT01641952|76103994|FG000|Treated|Overall Study||504||
59654558|NCT03870880|75772797|FG002|STARTED|Overall Study||31||
59654559|NCT03870880|75772798|FG003|STARTED|Overall Study||28||
59654560|NCT03870880|75772799|FG004|STARTED|Overall Study||61||
59654561|NCT03870880|75772800|FG005|STARTED|Overall Study||10||
59654562|NCT03870880|75772795|FG000|COMPLETED|Overall Study||21||
59654563|NCT03870880|75772796|FG001|COMPLETED|Overall Study||43||
59654564|NCT03870880|75772797|FG002|COMPLETED|Overall Study||26||
59654565|NCT03870880|75772798|FG003|COMPLETED|Overall Study||20||
59654566|NCT03870880|75772799|FG004|COMPLETED|Overall Study||44||
59654567|NCT03870880|75772800|FG005|COMPLETED|Overall Study||7||
59654568|NCT03870880|75772795|FG000|NOT COMPLETED|Overall Study||6||
59654569|NCT03870880|75772796|FG001|NOT COMPLETED|Overall Study||15||
59654570|NCT03870880|75772797|FG002|NOT COMPLETED|Overall Study||5||
59654571|NCT03870880|75772798|FG003|NOT COMPLETED|Overall Study||8||
59654572|NCT03870880|75772799|FG004|NOT COMPLETED|Overall Study||17||
59654573|NCT03870880|75772800|FG005|NOT COMPLETED|Overall Study||3||
59654574|NCT03811574|75772822|FG000|STARTED|Overall Study||101||
59654575|NCT03811574|75772823|FG001|STARTED|Overall Study||199||
59654576|NCT03811574|75772824|FG002|STARTED|Overall Study||101||
59654577|NCT03811574|75772822|FG000|Full Analysis Set (FAS)|Overall Study||101||
59654578|NCT03811574|75772823|FG001|Full Analysis Set (FAS)|Overall Study||199||
59654579|NCT03811574|75772824|FG002|Full Analysis Set (FAS)|Overall Study||101||
59654580|NCT03811574|75772822|FG000|Safety Analysis Set (SAS)|Overall Study||100||
59654581|NCT03811574|75772823|FG001|Safety Analysis Set (SAS)|Overall Study||199||
59654582|NCT03811574|75772824|FG002|Safety Analysis Set (SAS)|Overall Study||101||
59654583|NCT03811574|75772822|FG000|Treated|Overall Study||100||
59654584|NCT03811574|75772823|FG001|Treated|Overall Study||199||
59654585|NCT03811574|75772824|FG002|Treated|Overall Study||101||
59654586|NCT03811574|75772822|FG000|COMPLETED|Overall Study||99||
59654587|NCT03811574|75772823|FG001|COMPLETED|Overall Study||195||
59654588|NCT03811574|75772824|FG002|COMPLETED|Overall Study||101||
59654589|NCT03811574|75772822|FG000|NOT COMPLETED|Overall Study||2||
59654590|NCT03811574|75772823|FG001|NOT COMPLETED|Overall Study||4||
59654591|NCT03811574|75772824|FG002|NOT COMPLETED|Overall Study||0||
59654592|NCT03759184|75772832|FG000|STARTED|Overall Study||1||
59654593|NCT03759184|75772832|FG000|COMPLETED|Overall Study||1||
59654594|NCT03759184|75772832|FG000|NOT COMPLETED|Overall Study||0||
59654595|NCT03747640|75772838|FG000|STARTED|Overall Study||15||
59654596|NCT03747640|75772839|FG001|STARTED|Overall Study||15||
59654597|NCT03747640|75772838|FG000|COMPLETED|Overall Study||15||
59654598|NCT03747640|75772839|FG001|COMPLETED|Overall Study||15||
59654599|NCT03747640|75772838|FG000|NOT COMPLETED|Overall Study||0||
59654600|NCT03747640|75772839|FG001|NOT COMPLETED|Overall Study||0||
59654601|NCT03727750|75772847|FG000|STARTED|Overall Study||51||
59654602|NCT03727750|75772847|FG000|Safety Set|Overall Study||50||
59654603|NCT03727750|75772847|FG000|COMPLETED|Overall Study||2||
59654604|NCT03727750|75772847|FG000|NOT COMPLETED|Overall Study||49||
59654605|NCT03715829|75772857|FG000|STARTED|Dose Ranging Period||65|The first 6 treatment groups entered this Dose Ranging Period.|
59654606|NCT03715829|75772858|FG001|STARTED|Dose Ranging Period||67|The first 6 treatment groups entered this Dose Ranging Period.|
59654607|NCT03715829|75772859|FG002|STARTED|Dose Ranging Period||67|The first 6 treatment groups entered this Dose Ranging Period.|
59654608|NCT03715829|75772860|FG003|STARTED|Dose Ranging Period||50|The first 6 treatment groups entered this Dose Ranging Period.|
59654609|NCT03715829|75772861|FG004|STARTED|Dose Ranging Period||49|The first 6 treatment groups entered this Dose Ranging Period.|
59654610|NCT03715829|75772862|FG005|STARTED|Dose Ranging Period||66|The first 6 treatment groups entered this Dose Ranging Period.|
59654611|NCT03715829|75772863|FG006|STARTED|Dose Ranging Period||0|The first 6 treatment groups entered this Dose Ranging Period.|
59654612|NCT03715829|75772864|FG007|STARTED|Dose Ranging Period||0|The first 6 treatment groups entered this Dose Ranging Period.|
59543687|NCT00928694|75641945|FG000|STARTED|First Intervention||7||
59543688|NCT00928694|75641946|FG001|STARTED|First Intervention||7||
59543689|NCT00928694|75641945|FG000|COMPLETED|First Intervention||7||
59543690|NCT00928694|75641946|FG001|COMPLETED|First Intervention||7||
59543691|NCT00928694|75641945|FG000|NOT COMPLETED|First Intervention||0||
59543692|NCT00928694|75641946|FG001|NOT COMPLETED|First Intervention||0||
59543693|NCT00928694|75641945|FG000|STARTED|Second Intervention||7||
59543694|NCT00928694|75641946|FG001|STARTED|Second Intervention||7||
59543695|NCT00928694|75641945|FG000|COMPLETED|Second Intervention||7||
59543696|NCT00928694|75641946|FG001|COMPLETED|Second Intervention||7||
59543697|NCT00928694|75641945|FG000|NOT COMPLETED|Second Intervention||0||
59543698|NCT00928694|75641946|FG001|NOT COMPLETED|Second Intervention||0||
59543699|NCT01639157|75641952|FG000|STARTED|Overall Study||4||
59543700|NCT01639157|75641953|FG001|STARTED|Overall Study||5||
59543701|NCT01639157|75641952|FG000|COMPLETED|Overall Study||4||
59654613|NCT03715829|75772865|FG008|STARTED|Dose Ranging Period||0|The first 6 treatment groups entered this Dose Ranging Period.|
59654614|NCT03715829|75772866|FG009|STARTED|Dose Ranging Period||0|The first 6 treatment groups entered this Dose Ranging Period.|
59654615|NCT03715829|75772867|FG010|STARTED|Dose Ranging Period||0|The first 6 treatment groups entered this Dose Ranging Period.|
59654616|NCT03715829|75772857|FG000|COMPLETED|Dose Ranging Period||53||
59543702|NCT01639157|75641953|FG001|COMPLETED|Overall Study||5||
59543703|NCT01639157|75641952|FG000|NOT COMPLETED|Overall Study||0||
59654617|NCT03715829|75772858|FG001|COMPLETED|Dose Ranging Period||58||
59654618|NCT03715829|75772859|FG002|COMPLETED|Dose Ranging Period||54||
59654619|NCT03715829|75772860|FG003|COMPLETED|Dose Ranging Period||36||
59654620|NCT03715829|75772861|FG004|COMPLETED|Dose Ranging Period||42||
59654621|NCT03715829|75772862|FG005|COMPLETED|Dose Ranging Period||55||
59654622|NCT03715829|75772863|FG006|COMPLETED|Dose Ranging Period||0||
59654623|NCT03715829|75772864|FG007|COMPLETED|Dose Ranging Period||0||
59654624|NCT03715829|75772865|FG008|COMPLETED|Dose Ranging Period||0||
59654625|NCT03715829|75772866|FG009|COMPLETED|Dose Ranging Period||0||
59654626|NCT03715829|75772867|FG010|COMPLETED|Dose Ranging Period||0||
59654627|NCT03715829|75772857|FG000|NOT COMPLETED|Dose Ranging Period||12||
59654628|NCT03715829|75772858|FG001|NOT COMPLETED|Dose Ranging Period||9||
59654629|NCT03715829|75772859|FG002|NOT COMPLETED|Dose Ranging Period||13||
59654630|NCT03715829|75772860|FG003|NOT COMPLETED|Dose Ranging Period||14||
59654631|NCT03715829|75772861|FG004|NOT COMPLETED|Dose Ranging Period||7||
59654632|NCT03715829|75772862|FG005|NOT COMPLETED|Dose Ranging Period||11||
59654633|NCT03715829|75772863|FG006|NOT COMPLETED|Dose Ranging Period||0||
59654634|NCT03715829|75772864|FG007|NOT COMPLETED|Dose Ranging Period||0||
59654635|NCT03715829|75772865|FG008|NOT COMPLETED|Dose Ranging Period||0||
59654636|NCT03715829|75772866|FG009|NOT COMPLETED|Dose Ranging Period||0||
59654637|NCT03715829|75772867|FG010|NOT COMPLETED|Dose Ranging Period||0||
59654638|NCT03715829|75772857|FG000|STARTED|Extension Period||0|"The last 5 EXT treatment groups entered this Extension Period.~Three participants were lost to follow-up after completing the Dose Ranging Period, and no extension treatment was recorded for these 3 participants. A total of 295 participants were assigned to the Extension Period, among whom 293 received treatment."|
59654639|NCT03715829|75772858|FG001|STARTED|Extension Period||0|"The last 5 EXT treatment groups entered this Extension Period.~Three participants were lost to follow-up after completing the Dose Ranging Period, and no extension treatment was recorded for these 3 participants. A total of 295 participants were assigned to the Extension Period, among whom 293 received treatment."|
59654640|NCT03715829|75772859|FG002|STARTED|Extension Period||0|"The last 5 EXT treatment groups entered this Extension Period.~Three participants were lost to follow-up after completing the Dose Ranging Period, and no extension treatment was recorded for these 3 participants. A total of 295 participants were assigned to the Extension Period, among whom 293 received treatment."|
59654641|NCT03715829|75772860|FG003|STARTED|Extension Period||0|"The last 5 EXT treatment groups entered this Extension Period.~Three participants were lost to follow-up after completing the Dose Ranging Period, and no extension treatment was recorded for these 3 participants. A total of 295 participants were assigned to the Extension Period, among whom 293 received treatment."|
59654642|NCT03715829|75772861|FG004|STARTED|Extension Period||0|"The last 5 EXT treatment groups entered this Extension Period.~Three participants were lost to follow-up after completing the Dose Ranging Period, and no extension treatment was recorded for these 3 participants. A total of 295 participants were assigned to the Extension Period, among whom 293 received treatment."|
59654643|NCT03715829|75772862|FG005|STARTED|Extension Period||0|"The last 5 EXT treatment groups entered this Extension Period.~Three participants were lost to follow-up after completing the Dose Ranging Period, and no extension treatment was recorded for these 3 participants. A total of 295 participants were assigned to the Extension Period, among whom 293 received treatment."|
59654644|NCT03715829|75772863|FG006|STARTED|Extension Period||55|"The last 5 EXT treatment groups entered this Extension Period.~Three participants were lost to follow-up after completing the Dose Ranging Period, and no extension treatment was recorded for these 3 participants. A total of 295 participants were assigned to the Extension Period, among whom 293 received treatment."|
59654645|NCT03715829|75772864|FG007|STARTED|Extension Period||43|"The last 5 EXT treatment groups entered this Extension Period.~Three participants were lost to follow-up after completing the Dose Ranging Period, and no extension treatment was recorded for these 3 participants. A total of 295 participants were assigned to the Extension Period, among whom 293 received treatment."|
59654646|NCT03715829|75772865|FG008|STARTED|Extension Period||187|"The last 5 EXT treatment groups entered this Extension Period.~Three participants were lost to follow-up after completing the Dose Ranging Period, and no extension treatment was recorded for these 3 participants. A total of 295 participants were assigned to the Extension Period, among whom 293 received treatment."|
59654647|NCT03715829|75772866|FG009|STARTED|Extension Period||6|"The last 5 EXT treatment groups entered this Extension Period.~Three participants were lost to follow-up after completing the Dose Ranging Period, and no extension treatment was recorded for these 3 participants. A total of 295 participants were assigned to the Extension Period, among whom 293 received treatment."|
59654648|NCT03715829|75772867|FG010|STARTED|Extension Period||2|"The last 5 EXT treatment groups entered this Extension Period.~Three participants were lost to follow-up after completing the Dose Ranging Period, and no extension treatment was recorded for these 3 participants. A total of 295 participants were assigned to the Extension Period, among whom 293 received treatment."|
59654649|NCT03715829|75772857|FG000|COMPLETED|Extension Period||0||
59654650|NCT03715829|75772858|FG001|COMPLETED|Extension Period||0||
59654651|NCT03715829|75772859|FG002|COMPLETED|Extension Period||0||
59654652|NCT03715829|75772860|FG003|COMPLETED|Extension Period||0||
59654653|NCT03715829|75772861|FG004|COMPLETED|Extension Period||0||
59654654|NCT03715829|75772862|FG005|COMPLETED|Extension Period||0||
59654655|NCT03715829|75772863|FG006|COMPLETED|Extension Period||47||
59654656|NCT03715829|75772864|FG007|COMPLETED|Extension Period||27||
59654657|NCT03715829|75772865|FG008|COMPLETED|Extension Period||158||
59654658|NCT03715829|75772866|FG009|COMPLETED|Extension Period||3||
59654659|NCT03715829|75772867|FG010|COMPLETED|Extension Period||2||
59654660|NCT03715829|75772857|FG000|NOT COMPLETED|Extension Period||0||
59654661|NCT03715829|75772858|FG001|NOT COMPLETED|Extension Period||0||
59654662|NCT03715829|75772859|FG002|NOT COMPLETED|Extension Period||0||
59654663|NCT03715829|75772860|FG003|NOT COMPLETED|Extension Period||0||
59654664|NCT03715829|75772861|FG004|NOT COMPLETED|Extension Period||0||
59654665|NCT03715829|75772862|FG005|NOT COMPLETED|Extension Period||0||
59654666|NCT03715829|75772863|FG006|NOT COMPLETED|Extension Period||8||
59654667|NCT03715829|75772864|FG007|NOT COMPLETED|Extension Period||16||
59654668|NCT03715829|75772865|FG008|NOT COMPLETED|Extension Period||29||
59654669|NCT03715829|75772866|FG009|NOT COMPLETED|Extension Period||3||
59654670|NCT03715829|75772867|FG010|NOT COMPLETED|Extension Period||0||
59654671|NCT03660839|75772897|FG000|STARTED|Overall Study||35||
59654672|NCT03660839|75772898|FG001|STARTED|Overall Study||36||
59654673|NCT03660839|75772899|FG002|STARTED|Overall Study||36||
59654674|NCT03660839|75772900|FG003|STARTED|Overall Study||33||
59654675|NCT03660839|75772897|FG000|COMPLETED|Overall Study||35|Completed study treatment.|
59654676|NCT03660839|75772898|FG001|COMPLETED|Overall Study||36|Completed study treatment.|
59654677|NCT03660839|75772899|FG002|COMPLETED|Overall Study||36|Completed study treatment.|
59654678|NCT03660839|75772900|FG003|COMPLETED|Overall Study||33|Completed study treatment.|
59654679|NCT03660839|75772897|FG000|NOT COMPLETED|Overall Study||0||
59654680|NCT03660839|75772898|FG001|NOT COMPLETED|Overall Study||0||
59654681|NCT03660839|75772899|FG002|NOT COMPLETED|Overall Study||0||
59654682|NCT03660839|75772900|FG003|NOT COMPLETED|Overall Study||0||
59654683|NCT03660241|75772916|FG000|STARTED|Overall Study||8||
59654684|NCT03660241|75772917|FG001|STARTED|Overall Study||7||
59654685|NCT03660241|75772918|FG002|STARTED|Overall Study||8||
59654686|NCT03660241|75772916|FG000|COMPLETED|Overall Study||8||
59654687|NCT03660241|75772917|FG001|COMPLETED|Overall Study||7||
59654688|NCT03660241|75772918|FG002|COMPLETED|Overall Study||8||
59654689|NCT03660241|75772916|FG000|NOT COMPLETED|Overall Study||0||
59654690|NCT03660241|75772917|FG001|NOT COMPLETED|Overall Study||0||
59654691|NCT03660241|75772918|FG002|NOT COMPLETED|Overall Study||0||
59654692|NCT03575104|75772929|FG000|STARTED|Overall Study||307||
59654693|NCT03575104|75772930|FG001|STARTED|Overall Study||309||
59654694|NCT03575104|75772931|FG002|STARTED|Overall Study||308||
59654695|NCT03575104|75772929|FG000|COMPLETED|Overall Study||283||
59654696|NCT03575104|75772930|FG001|COMPLETED|Overall Study||280||
59654697|NCT03575104|75772931|FG002|COMPLETED|Overall Study||286||
59654698|NCT03575104|75772929|FG000|NOT COMPLETED|Overall Study||24||
59654699|NCT03575104|75772930|FG001|NOT COMPLETED|Overall Study||29||
59654700|NCT03575104|75772931|FG002|NOT COMPLETED|Overall Study||22||
59654701|NCT03569475|75772942|FG000|STARTED|Double-blind Treatment Period (8 Weeks)||164||
59654702|NCT03569475|75772943|FG001|STARTED|Double-blind Treatment Period (8 Weeks)||169||
59654703|NCT03569475|75772944|FG002|STARTED|Double-blind Treatment Period (8 Weeks)||168||
59654704|NCT03569475|75772942|FG000|Safety Population|Double-blind Treatment Period (8 Weeks)||160|Safety Population included all participants in the Randomized Population (all participants who underwent a Screening Visit, received a screening number, for whom informed consent was obtained, and who were randomized to a treatment group in the study) who received at least 1 dose of double-blind investigational product.|
59654705|NCT03569475|75772943|FG001|Safety Population|Double-blind Treatment Period (8 Weeks)||166|Safety Population included all participants in the Randomized Population (all participants who underwent a Screening Visit, received a screening number, for whom informed consent was obtained, and who were randomized to a treatment group in the study) who received at least 1 dose of double-blind investigational product.|
59654706|NCT03569475|75772944|FG002|Safety Population|Double-blind Treatment Period (8 Weeks)||166|Safety Population included all participants in the Randomized Population (all participants who underwent a Screening Visit, received a screening number, for whom informed consent was obtained, and who were randomized to a treatment group in the study) who received at least 1 dose of double-blind investigational product.|
59654707|NCT03569475|75772942|FG000|COMPLETED|Double-blind Treatment Period (8 Weeks)||146||
59654708|NCT03569475|75772943|FG001|COMPLETED|Double-blind Treatment Period (8 Weeks)||146||
59654709|NCT03569475|75772944|FG002|COMPLETED|Double-blind Treatment Period (8 Weeks)||144||
59654710|NCT03569475|75772942|FG000|NOT COMPLETED|Double-blind Treatment Period (8 Weeks)||18||
59654711|NCT03569475|75772943|FG001|NOT COMPLETED|Double-blind Treatment Period (8 Weeks)||23||
59654712|NCT03569475|75772944|FG002|NOT COMPLETED|Double-blind Treatment Period (8 Weeks)||24||
59654713|NCT03569475|75772942|FG000|STARTED|Double-blind Down-taper Period (1 Week)||140||
59654714|NCT03569475|75772943|FG001|STARTED|Double-blind Down-taper Period (1 Week)||141||
59654715|NCT03569475|75772944|FG002|STARTED|Double-blind Down-taper Period (1 Week)||140||
59654716|NCT03569475|75772942|FG000|COMPLETED|Double-blind Down-taper Period (1 Week)||140||
59654717|NCT03569475|75772943|FG001|COMPLETED|Double-blind Down-taper Period (1 Week)||139||
59654718|NCT03569475|75772944|FG002|COMPLETED|Double-blind Down-taper Period (1 Week)||138||
59654719|NCT03569475|75772942|FG000|NOT COMPLETED|Double-blind Down-taper Period (1 Week)||0||
59654720|NCT03569475|75772943|FG001|NOT COMPLETED|Double-blind Down-taper Period (1 Week)||2||
59654721|NCT03569475|75772944|FG002|NOT COMPLETED|Double-blind Down-taper Period (1 Week)||2||
59654722|NCT03545191|75772958|FG000|STARTED|Overall Study||310||
59654723|NCT03545191|75772959|FG001|STARTED|Overall Study||310||
59654724|NCT03545191|75772960|FG002|STARTED|Overall Study||310||
59654725|NCT03545191|75772958|FG000|COMPLETED|Overall Study||288||
59654726|NCT03545191|75772959|FG001|COMPLETED|Overall Study||285||
59654727|NCT03545191|75772960|FG002|COMPLETED|Overall Study||280||
59654728|NCT03545191|75772958|FG000|NOT COMPLETED|Overall Study||22||
59654729|NCT03545191|75772959|FG001|NOT COMPLETED|Overall Study||25||
59654730|NCT03545191|75772960|FG002|NOT COMPLETED|Overall Study||30||
59654731|NCT03500549|75772970|FG000|STARTED|Run-in Period (Day -28 to ≤Day 1)||41||
59654732|NCT03500549|75772971|FG001|STARTED|Run-in Period (Day -28 to ≤Day 1)||39||
59654733|NCT03500549|75772970|FG000|COMPLETED|Run-in Period (Day -28 to ≤Day 1)||41||
59654734|NCT03500549|75772971|FG001|COMPLETED|Run-in Period (Day -28 to ≤Day 1)||39||
59654735|NCT03500549|75772970|FG000|NOT COMPLETED|Run-in Period (Day -28 to ≤Day 1)||0||
59654736|NCT03500549|75772971|FG001|NOT COMPLETED|Run-in Period (Day -28 to ≤Day 1)||0||
59654737|NCT03500549|75772970|FG000|STARTED|RCP (Day 1 - Week 16)||41||
59654738|NCT03500549|75772971|FG001|STARTED|RCP (Day 1 - Week 16)||39||
59654739|NCT03500549|75772970|FG000|COMPLETED|RCP (Day 1 - Week 16)||38|Completed treatment at Week 16 analysis.|
59654740|NCT03500549|75772971|FG001|COMPLETED|RCP (Day 1 - Week 16)||39|Completed treatment at Week 16 analysis.|
59654741|NCT03500549|75772970|FG000|NOT COMPLETED|RCP (Day 1 - Week 16)||3||
59654742|NCT03500549|75772971|FG001|NOT COMPLETED|RCP (Day 1 - Week 16)||0||
59654743|NCT03500549|75772970|FG000|STARTED|Open-label Period (Week 17 to Week 48)||38||
59654744|NCT03500549|75772971|FG001|STARTED|Open-label Period (Week 17 to Week 48)||39||
59654745|NCT03500549|75772970|FG000|COMPLETED|Open-label Period (Week 17 to Week 48)||35|Completed treatment at Week 48 analysis.|
59654746|NCT03500549|75772971|FG001|COMPLETED|Open-label Period (Week 17 to Week 48)||32|Completed treatment at Week 48 analysis.|
59654747|NCT03500549|75772970|FG000|NOT COMPLETED|Open-label Period (Week 17 to Week 48)||3||
59654748|NCT03500549|75772971|FG001|NOT COMPLETED|Open-label Period (Week 17 to Week 48)||7||
59654749|NCT03435185|75772984|FG000|STARTED|Overall Study||44||
59654750|NCT03435185|75772985|FG001|STARTED|Overall Study||43||
59654751|NCT03435185|75772984|FG000|COMPLETED|Overall Study||43||
59654752|NCT03435185|75772985|FG001|COMPLETED|Overall Study||28||
59654753|NCT03435185|75772984|FG000|NOT COMPLETED|Overall Study||1||
59654754|NCT03435185|75772985|FG001|NOT COMPLETED|Overall Study||15||
59654755|NCT03366792|75772991|FG000|STARTED|Overall Study||46||
59654756|NCT03366792|75772991|FG000|COMPLETED|Overall Study||31||
59654757|NCT03366792|75772991|FG000|NOT COMPLETED|Overall Study||15||
59654758|NCT03342053|75772997|FG000|STARTED|Overall Study||23||
59654759|NCT03342053|75772998|FG001|STARTED|Overall Study||23||
59654760|NCT03342053|75772997|FG000|COMPLETED|Overall Study||21||
59654761|NCT03342053|75772998|FG001|COMPLETED|Overall Study||22||
59654762|NCT03342053|75772997|FG000|NOT COMPLETED|Overall Study||2||
59654763|NCT03342053|75772998|FG001|NOT COMPLETED|Overall Study||1||
59654764|NCT03325777|75773006|FG000|STARTED|Overall Study||46||
59654765|NCT03325777|75773007|FG001|STARTED|Overall Study||50||
59654766|NCT03325777|75773006|FG000|COMPLETED|Overall Study||37||
59654767|NCT03325777|75773007|FG001|COMPLETED|Overall Study||38||
59654768|NCT03325777|75773006|FG000|NOT COMPLETED|Overall Study||9||
59654769|NCT03325777|75773007|FG001|NOT COMPLETED|Overall Study||12||
59654770|NCT03283241|75773015|FG000|STARTED|Overall Study||32||57
59654771|NCT03283241|75773016|FG001|STARTED|Overall Study||30||49
59654772|NCT03283241|75773015|FG000|Completed 12 Weeks|Overall Study|Completed 12 weeks|29||50
59654773|NCT03283241|75773016|FG001|Completed 12 Weeks|Overall Study|Completed 12 weeks|29||48
59654774|NCT03283241|75773015|FG000|COMPLETED|Overall Study|Completed 24 month|28||44
59654775|NCT03283241|75773016|FG001|COMPLETED|Overall Study|Completed 24 month|27||47
59654776|NCT03283241|75773015|FG000|NOT COMPLETED|Overall Study||4||13
59654777|NCT03283241|75773016|FG001|NOT COMPLETED|Overall Study||3||2
59654778|NCT03242772|75773024|FG000|STARTED|Overall Study||9||
59654779|NCT03242772|75773025|FG001|STARTED|Overall Study||9||
59654780|NCT03242772|75773024|FG000|COMPLETED|Overall Study||6||
59654781|NCT03242772|75773025|FG001|COMPLETED|Overall Study||8||
59654782|NCT03242772|75773024|FG000|NOT COMPLETED|Overall Study||3||
59654783|NCT03242772|75773025|FG001|NOT COMPLETED|Overall Study||1||
59654784|NCT03236311|75773033|FG000|STARTED|Overall Study||5||
59654785|NCT03236311|75773034|FG001|STARTED|Overall Study||5||
59654786|NCT03236311|75773033|FG000|COMPLETED|Overall Study||5||
59654787|NCT03236311|75773034|FG001|COMPLETED|Overall Study||2||
59654788|NCT03236311|75773033|FG000|NOT COMPLETED|Overall Study||0||
59654789|NCT03236311|75773034|FG001|NOT COMPLETED|Overall Study||3||
59654790|NCT03192046|75773042|FG000|STARTED|Overall Study||5||
59654791|NCT03192046|75773043|FG001|STARTED|Overall Study||4||
59654792|NCT03192046|75773042|FG000|COMPLETED|Overall Study||4||
59654793|NCT03192046|75773043|FG001|COMPLETED|Overall Study||3||
59654794|NCT03192046|75773042|FG000|NOT COMPLETED|Overall Study||1||
59654795|NCT03192046|75773043|FG001|NOT COMPLETED|Overall Study||1||
59654796|NCT03190369|75773051|FG000|STARTED|Overall Study||220||
59654797|NCT03190369|75773052|FG001|STARTED|Overall Study||220||
59654798|NCT03190369|75773051|FG000|Treated|Overall Study||220||
59654799|NCT03190369|75773052|FG001|Treated|Overall Study||218||
59654800|NCT03190369|75773051|FG000|COMPLETED|Overall Study||219||
59817905|NCT04488770|75940331|FG005|NOT COMPLETED|Part 1-Cohort 2: Period 1 (Up to 5 Days)||1||
59654801|NCT03190369|75773052|FG001|COMPLETED|Overall Study||212||
59654802|NCT03190369|75773051|FG000|NOT COMPLETED|Overall Study||1||
59654803|NCT03190369|75773052|FG001|NOT COMPLETED|Overall Study||8||
59654804|NCT04657198|75773061|FG000|STARTED|Overall Study||40||
59654805|NCT04657198|75773062|FG001|STARTED|Overall Study||39||
59654806|NCT04657198|75773063|FG002|STARTED|Overall Study||43||
59654807|NCT04657198|75773061|FG000|COMPLETED|Overall Study||39||
59654808|NCT04657198|75773062|FG001|COMPLETED|Overall Study||39||
59654809|NCT04657198|75773063|FG002|COMPLETED|Overall Study||43||
59654810|NCT04657198|75773061|FG000|NOT COMPLETED|Overall Study||1||
59654811|NCT04657198|75773062|FG001|NOT COMPLETED|Overall Study||0||
59654812|NCT04657198|75773063|FG002|NOT COMPLETED|Overall Study||0||
59654813|NCT04590586|75773077|FG000|STARTED|Overall Study||28||
59654814|NCT04590586|75773078|FG001|STARTED|Overall Study||1||
59654815|NCT04590586|75773079|FG002|STARTED|Overall Study||194||
59654816|NCT04590586|75773080|FG003|STARTED|Overall Study||184||
59654817|NCT04590586|75773081|FG004|STARTED|Overall Study||100||
59654818|NCT04590586|75773082|FG005|STARTED|Overall Study||8||
59654819|NCT04590586|75773077|FG000|Received Study Drug|Overall Study||27||
59654820|NCT04590586|75773078|FG001|Received Study Drug|Overall Study||1||
59654821|NCT04590586|75773079|FG002|Received Study Drug|Overall Study||189||
59654822|NCT04590586|75773080|FG003|Received Study Drug|Overall Study||182||
59654823|NCT04590586|75773081|FG004|Received Study Drug|Overall Study||95||
59654824|NCT04590586|75773082|FG005|Received Study Drug|Overall Study||7||
59654825|NCT04590586|75773077|FG000|Full Analysis Set|Overall Study||28|For each sub-protocol the full analysis set includes all participants randomized to the sub-protocol candidate agent as well as all participants who were randomized to any placebo arm included in the control arm of the candidate agent (i.e. shared placebo). The control arm for analysis of a candidate agent includes participants enrolled in any placebo group, regardless of sub-protocol, if certain criteria were met.|
59654826|NCT04590586|75773078|FG001|Full Analysis Set|Overall Study|Includes participants randomized to this arm (1) and 32 participants from Apremilast Placebo + SOC group and 1 participant from Zilucoplan Placebo + SOC group.|34|For each sub-protocol the full analysis set includes all participants randomized to the sub-protocol candidate agent as well as all participants who were randomized to any placebo arm included in the control arm of the candidate agent (i.e. shared placebo). The control arm for analysis of a candidate agent includes participants enrolled in any placebo group, regardless of sub-protocol, if certain criteria were met.|
59654827|NCT04590586|75773079|FG002|Full Analysis Set|Overall Study||194|For each sub-protocol the full analysis set includes all participants randomized to the sub-protocol candidate agent as well as all participants who were randomized to any placebo arm included in the control arm of the candidate agent (i.e. shared placebo). The control arm for analysis of a candidate agent includes participants enrolled in any placebo group, regardless of sub-protocol, if certain criteria were met.|
59654828|NCT04590586|75773080|FG003|Full Analysis Set|Overall Study|Includes participants randomized to this arm (184) and 1 participant from Lanadelumab Placebo + SOC group and 5 participants from Zilucoplan Placebo + SOC group.|190|For each sub-protocol the full analysis set includes all participants randomized to the sub-protocol candidate agent as well as all participants who were randomized to any placebo arm included in the control arm of the candidate agent (i.e. shared placebo). The control arm for analysis of a candidate agent includes participants enrolled in any placebo group, regardless of sub-protocol, if certain criteria were met.|
59654829|NCT04590586|75773081|FG004|Full Analysis Set|Overall Study||100|For each sub-protocol the full analysis set includes all participants randomized to the sub-protocol candidate agent as well as all participants who were randomized to any placebo arm included in the control arm of the candidate agent (i.e. shared placebo). The control arm for analysis of a candidate agent includes participants enrolled in any placebo group, regardless of sub-protocol, if certain criteria were met.|
59654830|NCT04590586|75773082|FG005|Full Analysis Set|Overall Study|Includes participants randomized to this arm (8) and 1 participant from Lanadelumab Placebo + SOC group and 66 participants from the Apremilast Placebo + SOC group.|75|For each sub-protocol the full analysis set includes all participants randomized to the sub-protocol candidate agent as well as all participants who were randomized to any placebo arm included in the control arm of the candidate agent (i.e. shared placebo). The control arm for analysis of a candidate agent includes participants enrolled in any placebo group, regardless of sub-protocol, if certain criteria were met.|
59654831|NCT04590586|75773077|FG000|COMPLETED|Overall Study||15||
59654832|NCT04590586|75773078|FG001|COMPLETED|Overall Study||0||
59654833|NCT04590586|75773079|FG002|COMPLETED|Overall Study||139||
59654834|NCT04590586|75773080|FG003|COMPLETED|Overall Study||138||
59654835|NCT04590586|75773081|FG004|COMPLETED|Overall Study||70||
59654836|NCT04590586|75773082|FG005|COMPLETED|Overall Study||4||
59654837|NCT04590586|75773077|FG000|NOT COMPLETED|Overall Study||13||
59654838|NCT04590586|75773078|FG001|NOT COMPLETED|Overall Study||1||
59654839|NCT04590586|75773079|FG002|NOT COMPLETED|Overall Study||55||
59654840|NCT04590586|75773080|FG003|NOT COMPLETED|Overall Study||46||
59654841|NCT04590586|75773081|FG004|NOT COMPLETED|Overall Study||30||
59654842|NCT04590586|75773082|FG005|NOT COMPLETED|Overall Study||4||
59654843|NCT04312009|75773108|FG000|STARTED|Overall Study||104||
59654844|NCT04312009|75773109|FG001|STARTED|Overall Study||101||
59654845|NCT04312009|75773108|FG000|COMPLETED|Overall Study||102||
59654846|NCT04312009|75773109|FG001|COMPLETED|Overall Study||100||
59654847|NCT04312009|75773108|FG000|NOT COMPLETED|Overall Study||2||
59654848|NCT04312009|75773109|FG001|NOT COMPLETED|Overall Study||1||
59654849|NCT03964337|75773117|FG000|STARTED|Overall Study||3||
59654850|NCT03964337|75773118|FG001|STARTED|Overall Study||0||
59654851|NCT03964337|75773117|FG000|COMPLETED|Overall Study||3||
59654852|NCT03964337|75773118|FG001|COMPLETED|Overall Study||0||
59654853|NCT03964337|75773117|FG000|NOT COMPLETED|Overall Study||0||
59654854|NCT03964337|75773118|FG001|NOT COMPLETED|Overall Study||0||
59654855|NCT03937466|75773124|FG000|STARTED|Overall Study||38||
59654856|NCT03937466|75773124|FG000|COMPLETED|Overall Study||15||
59654857|NCT03937466|75773124|FG000|NOT COMPLETED|Overall Study||23||
59654858|NCT03850483|75773137|FG000|STARTED|Treatment for Stage 1||37||
59654859|NCT03850483|75773138|FG001|STARTED|Treatment for Stage 1||37||
59654860|NCT03850483|75773139|FG002|STARTED|Treatment for Stage 1||37||
59654861|NCT03850483|75773140|FG003|STARTED|Treatment for Stage 1||36||
59654862|NCT03850483|75773141|FG004|STARTED|Treatment for Stage 1||37||
59654863|NCT03850483|75773142|FG005|STARTED|Treatment for Stage 1||38||
59654864|NCT03850483|75773143|FG006|STARTED|Treatment for Stage 1||36||
59654865|NCT03850483|75773144|FG007|STARTED|Treatment for Stage 1||36||
59654866|NCT03850483|75773145|FG008|STARTED|Treatment for Stage 1||0||
59654867|NCT03850483|75773146|FG009|STARTED|Treatment for Stage 1||0||
59654868|NCT03850483|75773137|FG000|Treated|Treatment for Stage 1||37||
59654869|NCT03850483|75773138|FG001|Treated|Treatment for Stage 1||37||
59654870|NCT03850483|75773139|FG002|Treated|Treatment for Stage 1||37||
59654871|NCT03850483|75773140|FG003|Treated|Treatment for Stage 1||36||
59654872|NCT03850483|75773141|FG004|Treated|Treatment for Stage 1||37||
59654873|NCT03850483|75773142|FG005|Treated|Treatment for Stage 1||37||
59654874|NCT03850483|75773143|FG006|Treated|Treatment for Stage 1||36||
59654875|NCT03850483|75773144|FG007|Treated|Treatment for Stage 1||36||
59654876|NCT03850483|75773145|FG008|Treated|Treatment for Stage 1||0||
59654877|NCT03850483|75773146|FG009|Treated|Treatment for Stage 1||0||
59654878|NCT03850483|75773137|FG000|COMPLETED|Treatment for Stage 1||29||
59654879|NCT03850483|75773138|FG001|COMPLETED|Treatment for Stage 1||29||
59654880|NCT03850483|75773139|FG002|COMPLETED|Treatment for Stage 1||26||
59654881|NCT03850483|75773140|FG003|COMPLETED|Treatment for Stage 1||30||
59654882|NCT03850483|75773141|FG004|COMPLETED|Treatment for Stage 1||28||
59654883|NCT03850483|75773142|FG005|COMPLETED|Treatment for Stage 1||27||
59654884|NCT03850483|75773143|FG006|COMPLETED|Treatment for Stage 1||25||
59654885|NCT03850483|75773144|FG007|COMPLETED|Treatment for Stage 1||30||
59654886|NCT03850483|75773145|FG008|COMPLETED|Treatment for Stage 1||0||
59654887|NCT03850483|75773146|FG009|COMPLETED|Treatment for Stage 1||0||
59654888|NCT03850483|75773137|FG000|NOT COMPLETED|Treatment for Stage 1||8||
59654889|NCT03850483|75773138|FG001|NOT COMPLETED|Treatment for Stage 1||8||
59654890|NCT03850483|75773139|FG002|NOT COMPLETED|Treatment for Stage 1||11||
59654891|NCT03850483|75773140|FG003|NOT COMPLETED|Treatment for Stage 1||6||
59654892|NCT03850483|75773141|FG004|NOT COMPLETED|Treatment for Stage 1||9||
59654893|NCT03850483|75773142|FG005|NOT COMPLETED|Treatment for Stage 1||11||
59654894|NCT03850483|75773143|FG006|NOT COMPLETED|Treatment for Stage 1||11||
59654895|NCT03850483|75773144|FG007|NOT COMPLETED|Treatment for Stage 1||6||
59654896|NCT03850483|75773145|FG008|NOT COMPLETED|Treatment for Stage 1||0||
59654897|NCT03850483|75773146|FG009|NOT COMPLETED|Treatment for Stage 1||0||
59654898|NCT03850483|75773137|FG000|STARTED|Follow-up for Stage 1||37||
59654899|NCT03850483|75773138|FG001|STARTED|Follow-up for Stage 1||37||
59654900|NCT03850483|75773139|FG002|STARTED|Follow-up for Stage 1||37||
59654901|NCT03850483|75773140|FG003|STARTED|Follow-up for Stage 1||36||
59654902|NCT03850483|75773141|FG004|STARTED|Follow-up for Stage 1||37||
59654903|NCT03850483|75773142|FG005|STARTED|Follow-up for Stage 1||37||
59654904|NCT03850483|75773143|FG006|STARTED|Follow-up for Stage 1||36||
59654905|NCT03850483|75773144|FG007|STARTED|Follow-up for Stage 1||36||
59654906|NCT03850483|75773145|FG008|STARTED|Follow-up for Stage 1||0||
59654907|NCT03850483|75773146|FG009|STARTED|Follow-up for Stage 1||0||
59654908|NCT03850483|75773137|FG000|COMPLETED|Follow-up for Stage 1||37||
59654909|NCT03850483|75773138|FG001|COMPLETED|Follow-up for Stage 1||34||
59654910|NCT03850483|75773139|FG002|COMPLETED|Follow-up for Stage 1||35||
59654911|NCT03850483|75773140|FG003|COMPLETED|Follow-up for Stage 1||34||
59654912|NCT03850483|75773141|FG004|COMPLETED|Follow-up for Stage 1||34||
59654913|NCT03850483|75773142|FG005|COMPLETED|Follow-up for Stage 1||33||
59654914|NCT03850483|75773143|FG006|COMPLETED|Follow-up for Stage 1||34||
59654915|NCT03850483|75773144|FG007|COMPLETED|Follow-up for Stage 1||33||
59654916|NCT03850483|75773145|FG008|COMPLETED|Follow-up for Stage 1||0||
59654917|NCT03850483|75773146|FG009|COMPLETED|Follow-up for Stage 1||0||
59654918|NCT03850483|75773137|FG000|NOT COMPLETED|Follow-up for Stage 1||0||
59654919|NCT03850483|75773138|FG001|NOT COMPLETED|Follow-up for Stage 1||3||
59654920|NCT03850483|75773139|FG002|NOT COMPLETED|Follow-up for Stage 1||2||
59654921|NCT03850483|75773140|FG003|NOT COMPLETED|Follow-up for Stage 1||2||
59654922|NCT03850483|75773141|FG004|NOT COMPLETED|Follow-up for Stage 1||3||
59654923|NCT03850483|75773142|FG005|NOT COMPLETED|Follow-up for Stage 1||4||
59654924|NCT03850483|75773143|FG006|NOT COMPLETED|Follow-up for Stage 1||2||
59654925|NCT03850483|75773144|FG007|NOT COMPLETED|Follow-up for Stage 1||3||
59654926|NCT03850483|75773145|FG008|NOT COMPLETED|Follow-up for Stage 1||0||
59654927|NCT03850483|75773146|FG009|NOT COMPLETED|Follow-up for Stage 1||0||
59654928|NCT03850483|75773137|FG000|STARTED|Treatment for Stage 2|Stage 1 enrolment was different from Stage 2.|0||
59654929|NCT03850483|75773138|FG001|STARTED|Treatment for Stage 2|Stage 1 enrolment was different from Stage 2.|0||
59654930|NCT03850483|75773139|FG002|STARTED|Treatment for Stage 2|Stage 1 enrolment was different from Stage 2.|0||
59654931|NCT03850483|75773140|FG003|STARTED|Treatment for Stage 2|Stage 1 enrolment was different from Stage 2.|0||
59654932|NCT03850483|75773141|FG004|STARTED|Treatment for Stage 2|Stage 1 enrolment was different from Stage 2.|0||
59654933|NCT03850483|75773142|FG005|STARTED|Treatment for Stage 2|Stage 1 enrolment was different from Stage 2.|0||
59654934|NCT03850483|75773143|FG006|STARTED|Treatment for Stage 2|Stage 1 enrolment was different from Stage 2.|0||
59654935|NCT03850483|75773144|FG007|STARTED|Treatment for Stage 2|Stage 1 enrolment was different from Stage 2.|0||
59654936|NCT03850483|75773145|FG008|STARTED|Treatment for Stage 2|Stage 1 enrolment was different from Stage 2.|12||
59654937|NCT03850483|75773146|FG009|STARTED|Treatment for Stage 2|Stage 1 enrolment was different from Stage 2.|38||
59654938|NCT03850483|75773137|FG000|COMPLETED|Treatment for Stage 2||0||
59654939|NCT03850483|75773138|FG001|COMPLETED|Treatment for Stage 2||0||
59654940|NCT03850483|75773139|FG002|COMPLETED|Treatment for Stage 2||0||
59654941|NCT03850483|75773140|FG003|COMPLETED|Treatment for Stage 2||0||
59654942|NCT03850483|75773141|FG004|COMPLETED|Treatment for Stage 2||0||
59654943|NCT03850483|75773142|FG005|COMPLETED|Treatment for Stage 2||0||
60077011|NCT01614925|76192047|FG000|COMPLETED|Overall Study||14||
60077012|NCT01614925|76192048|FG001|COMPLETED|Overall Study||15||
60077013|NCT01614925|76192047|FG000|NOT COMPLETED|Overall Study||4||
60077014|NCT01614925|76192048|FG001|NOT COMPLETED|Overall Study||2||
60077015|NCT01886833|76192054|FG000|STARTED|Overall Study||420||
60077016|NCT01886833|76192054|FG000|COMPLETED|Overall Study||216||
60077017|NCT01886833|76192054|FG000|NOT COMPLETED|Overall Study||204||
60077018|NCT01898923|76192063|FG000|STARTED|Overall Study||122||
59654944|NCT03850483|75773143|FG006|COMPLETED|Treatment for Stage 2||0||
59654945|NCT03850483|75773144|FG007|COMPLETED|Treatment for Stage 2||0||
59654946|NCT03850483|75773145|FG008|COMPLETED|Treatment for Stage 2||7||
59654947|NCT03850483|75773146|FG009|COMPLETED|Treatment for Stage 2||27||
59654948|NCT03850483|75773137|FG000|NOT COMPLETED|Treatment for Stage 2||0||
59654949|NCT03850483|75773138|FG001|NOT COMPLETED|Treatment for Stage 2||0||
59654950|NCT03850483|75773139|FG002|NOT COMPLETED|Treatment for Stage 2||0||
59654951|NCT03850483|75773140|FG003|NOT COMPLETED|Treatment for Stage 2||0||
59654952|NCT03850483|75773141|FG004|NOT COMPLETED|Treatment for Stage 2||0||
59654953|NCT03850483|75773142|FG005|NOT COMPLETED|Treatment for Stage 2||0||
59654954|NCT03850483|75773143|FG006|NOT COMPLETED|Treatment for Stage 2||0||
59654955|NCT03850483|75773144|FG007|NOT COMPLETED|Treatment for Stage 2||0||
59654956|NCT03850483|75773145|FG008|NOT COMPLETED|Treatment for Stage 2||5||
59654957|NCT03850483|75773146|FG009|NOT COMPLETED|Treatment for Stage 2||11||
59654958|NCT03850483|75773137|FG000|STARTED|Follow-up For Stage 2||0||
59654959|NCT03850483|75773138|FG001|STARTED|Follow-up For Stage 2||0||
59654960|NCT03850483|75773139|FG002|STARTED|Follow-up For Stage 2||0||
59654961|NCT03850483|75773140|FG003|STARTED|Follow-up For Stage 2||0||
59654962|NCT03850483|75773141|FG004|STARTED|Follow-up For Stage 2||0||
59654963|NCT03850483|75773142|FG005|STARTED|Follow-up For Stage 2||0||
59654964|NCT03850483|75773143|FG006|STARTED|Follow-up For Stage 2||0||
59654965|NCT03850483|75773144|FG007|STARTED|Follow-up For Stage 2||0||
59654966|NCT03850483|75773145|FG008|STARTED|Follow-up For Stage 2||12||
59654967|NCT03850483|75773146|FG009|STARTED|Follow-up For Stage 2||38||
59654968|NCT03850483|75773137|FG000|COMPLETED|Follow-up For Stage 2||0||
59654969|NCT03850483|75773138|FG001|COMPLETED|Follow-up For Stage 2||0||
59654970|NCT03850483|75773139|FG002|COMPLETED|Follow-up For Stage 2||0||
59654971|NCT03850483|75773140|FG003|COMPLETED|Follow-up For Stage 2||0||
59654972|NCT03850483|75773141|FG004|COMPLETED|Follow-up For Stage 2||0||
59654973|NCT03850483|75773142|FG005|COMPLETED|Follow-up For Stage 2||0||
59654974|NCT03850483|75773143|FG006|COMPLETED|Follow-up For Stage 2||0||
59654975|NCT03850483|75773144|FG007|COMPLETED|Follow-up For Stage 2||0||
59654976|NCT03850483|75773145|FG008|COMPLETED|Follow-up For Stage 2||12||
59654977|NCT03850483|75773146|FG009|COMPLETED|Follow-up For Stage 2||36||
59654978|NCT03850483|75773137|FG000|NOT COMPLETED|Follow-up For Stage 2||0||
59654979|NCT03850483|75773138|FG001|NOT COMPLETED|Follow-up For Stage 2||0||
59654980|NCT03850483|75773139|FG002|NOT COMPLETED|Follow-up For Stage 2||0||
59654981|NCT03850483|75773140|FG003|NOT COMPLETED|Follow-up For Stage 2||0||
60077019|NCT01898923|76192064|FG001|STARTED|Overall Study||114||
60077020|NCT01898923|76192063|FG000|COMPLETED|Overall Study||106||
60077021|NCT01898923|76192064|FG001|COMPLETED|Overall Study||93||
60077022|NCT01898923|76192063|FG000|NOT COMPLETED|Overall Study||16||
60077023|NCT01898923|76192064|FG001|NOT COMPLETED|Overall Study||21||
60077024|NCT01924429|76192072|FG000|STARTED|Period 1 - First Intervention (4 Weeks)||17||
59654982|NCT03850483|75773141|FG004|NOT COMPLETED|Follow-up For Stage 2||0||
59654983|NCT03850483|75773142|FG005|NOT COMPLETED|Follow-up For Stage 2||0||
59654984|NCT03850483|75773143|FG006|NOT COMPLETED|Follow-up For Stage 2||0||
60077025|NCT01924429|76192073|FG001|STARTED|Period 1 - First Intervention (4 Weeks)||13||
60077026|NCT01924429|76192072|FG000|COMPLETED|Period 1 - First Intervention (4 Weeks)||17||
60077027|NCT01924429|76192073|FG001|COMPLETED|Period 1 - First Intervention (4 Weeks)||13||
60077028|NCT01924429|76192072|FG000|NOT COMPLETED|Period 1 - First Intervention (4 Weeks)||0||
59543704|NCT01639157|75641953|FG001|NOT COMPLETED|Overall Study||0||
59543705|NCT02451696|75641961|FG000|STARTED|Overall Study||5||
59543706|NCT02451696|75641962|FG001|STARTED|Overall Study||10||
59543707|NCT02451696|75641961|FG000|COMPLETED|Overall Study||4||
59543708|NCT02451696|75641962|FG001|COMPLETED|Overall Study||10||
59543709|NCT02451696|75641961|FG000|NOT COMPLETED|Overall Study||1||
59543710|NCT02451696|75641962|FG001|NOT COMPLETED|Overall Study||0||
59543711|NCT00928772|75641973|FG000|STARTED|Overall Study||39||
59543712|NCT00928772|75641974|FG001|STARTED|Overall Study||38||
59543713|NCT00928772|75641975|FG002|STARTED|Overall Study||38||
59543714|NCT00928772|75641973|FG000|COMPLETED|Overall Study||39||
59654985|NCT03850483|75773144|FG007|NOT COMPLETED|Follow-up For Stage 2||0||
59654986|NCT03850483|75773145|FG008|NOT COMPLETED|Follow-up For Stage 2||0||
59654987|NCT03850483|75773146|FG009|NOT COMPLETED|Follow-up For Stage 2||2||
59654988|NCT03529799|75773168|FG000|STARTED|Overall Study||14||
59654989|NCT03529799|75773169|FG001|STARTED|Overall Study||26||
59654990|NCT03529799|75773168|FG000|COMPLETED|Overall Study||14||
59654991|NCT03529799|75773169|FG001|COMPLETED|Overall Study||26||
59654992|NCT03529799|75773168|FG000|NOT COMPLETED|Overall Study||0||
59654993|NCT03529799|75773169|FG001|NOT COMPLETED|Overall Study||0||
59654994|NCT03473925|75773177|FG000|STARTED|Overall Study||52|Randomized|
59654995|NCT03473925|75773178|FG001|STARTED|Overall Study||55|Randomized|
59654996|NCT03473925|75773177|FG000|Treated|Overall Study||51||
59654997|NCT03473925|75773178|FG001|Treated|Overall Study||54||
59654998|NCT03473925|75773177|FG000|COMPLETED|Overall Study||0||
59654999|NCT03473925|75773178|FG001|COMPLETED|Overall Study||0||
59655000|NCT03473925|75773177|FG000|NOT COMPLETED|Overall Study||52||
59655001|NCT03473925|75773178|FG001|NOT COMPLETED|Overall Study||55||
59655002|NCT03230097|75773186|FG000|STARTED|Overall Study||24||
59655003|NCT03230097|75773187|FG001|STARTED|Overall Study||26||
59655004|NCT03230097|75773186|FG000|COMPLETED|Overall Study||9||
59655005|NCT03230097|75773187|FG001|COMPLETED|Overall Study||10||
59655006|NCT03230097|75773186|FG000|NOT COMPLETED|Overall Study||15||
59655007|NCT03230097|75773187|FG001|NOT COMPLETED|Overall Study||16||
59655008|NCT03226067|75773196|FG000|STARTED|Overall Study||36||
59655009|NCT03226067|75773197|FG001|STARTED|Overall Study||38||
59655010|NCT03226067|75773198|FG002|STARTED|Overall Study||37||
59655011|NCT03226067|75773196|FG000|COMPLETED|Overall Study||36||
59655012|NCT03226067|75773197|FG001|COMPLETED|Overall Study||38||
59655013|NCT03226067|75773198|FG002|COMPLETED|Overall Study||37||
59655014|NCT03226067|75773196|FG000|NOT COMPLETED|Overall Study||0||
59655015|NCT03226067|75773197|FG001|NOT COMPLETED|Overall Study||0||
59655016|NCT03226067|75773198|FG002|NOT COMPLETED|Overall Study||0||
59655017|NCT02968940|75773206|FG000|STARTED|Overall Study||6||
59655018|NCT02968940|75773206|FG000|COMPLETED|Overall Study||6||
59655019|NCT02968940|75773206|FG000|NOT COMPLETED|Overall Study||0||
59655020|NCT02803593|75773212|FG000|STARTED|Overall Study||95||
59655021|NCT02803593|75773213|FG001|STARTED|Overall Study||104||
59655022|NCT02803593|75773212|FG000|Completed Month 1 Assessment|Overall Study||83||
59655023|NCT02803593|75773213|FG001|Completed Month 1 Assessment|Overall Study||76||
59655024|NCT02803593|75773212|FG000|COMPLETED|Overall Study||78|Completed the Month 3 assessment|
59655025|NCT02803593|75773213|FG001|COMPLETED|Overall Study||69|Completed the Month 3 assessment|
59655026|NCT02803593|75773212|FG000|NOT COMPLETED|Overall Study||17||
59655027|NCT02803593|75773213|FG001|NOT COMPLETED|Overall Study||35||
59655028|NCT02663908|75773221|FG000|STARTED|Overall Study||276||
59655029|NCT02663908|75773222|FG001|STARTED|Overall Study||269||
59655030|NCT02663908|75773221|FG000|Full Analysis Set (FAS)|Overall Study||275||
59655031|NCT02663908|75773222|FG001|Full Analysis Set (FAS)|Overall Study||269||
59655032|NCT02663908|75773221|FG000|COMPLETED|Overall Study||244||
59655033|NCT02663908|75773222|FG001|COMPLETED|Overall Study||245||
59655034|NCT02663908|75773221|FG000|NOT COMPLETED|Overall Study||32||
59655035|NCT02663908|75773222|FG001|NOT COMPLETED|Overall Study||24||
59655036|NCT02650284|75773230|FG000|STARTED|Overall Study||8||
59655037|NCT02650284|75773231|FG001|STARTED|Overall Study||9||
59655038|NCT02650284|75773230|FG000|COMPLETED|Overall Study||5||
59655039|NCT02650284|75773231|FG001|COMPLETED|Overall Study||5||
59655040|NCT02650284|75773230|FG000|NOT COMPLETED|Overall Study||3||
59655041|NCT02650284|75773231|FG001|NOT COMPLETED|Overall Study||4||
59655042|NCT02175030|75773239|FG000|STARTED|Overall Study||356||
59655043|NCT02175030|75773240|FG001|STARTED|Overall Study||355||
59655044|NCT02175030|75773239|FG000|COMPLETED|Overall Study||321||
59655045|NCT02175030|75773240|FG001|COMPLETED|Overall Study||317||
59655046|NCT02175030|75773239|FG000|NOT COMPLETED|Overall Study||35||
59655047|NCT02175030|75773240|FG001|NOT COMPLETED|Overall Study||38||
59655048|NCT01555541|75773246|FG000|STARTED|Salvage Response Assessment||19||
59655049|NCT01555541|75773246|FG000|COMPLETED|Salvage Response Assessment||19||
59655050|NCT01555541|75773246|FG000|NOT COMPLETED|Salvage Response Assessment||0||
59655051|NCT01555541|75773246|FG000|STARTED|OVA Treatment||19||
59655052|NCT01555541|75773246|FG000|COMPLETED|OVA Treatment||19||
59655053|NCT01555541|75773246|FG000|NOT COMPLETED|OVA Treatment||0||
59655054|NCT01555541|75773246|FG000|STARTED|Autologous Stem Cell Transplantation|7 patients did not move forward due to non-response/progression on last line of therapy prior to Autologous Stem Cell Transplantation (ASCT)|12||
59655055|NCT01555541|75773246|FG000|COMPLETED|Autologous Stem Cell Transplantation||12||
59655056|NCT01555541|75773246|FG000|NOT COMPLETED|Autologous Stem Cell Transplantation||0||
59655057|NCT01398852|75773250|FG000|STARTED|Overall Study|Due to termination of the study the exact number of participants enrolled is unknown at this time.|372||
59655058|NCT01398852|75773250|FG000|COMPLETED|Overall Study||0||
59655059|NCT01398852|75773250|FG000|NOT COMPLETED|Overall Study||372||
59655060|NCT01398839|75773256|FG000|STARTED|Overall Study||35||
59655061|NCT01398839|75773257|FG001|STARTED|Overall Study||37||
59655062|NCT01398839|75773256|FG000|COMPLETED|Overall Study|The study was terminated. The exact number of patients completing all visits is unknown.|35||
59709746|NCT01072149|75828530|FG010|COMPLETED|Treatment Period 1 (28 Days)||2||
59655063|NCT01398839|75773257|FG001|COMPLETED|Overall Study|The study was terminated. The exact number of patients completing all visits is unknown.|37||
59655064|NCT01398839|75773256|FG000|NOT COMPLETED|Overall Study||0||
59655065|NCT01398839|75773257|FG001|NOT COMPLETED|Overall Study||0||
59655066|NCT03096834|75773265|FG000|STARTED|Double-Blind Treatment Epoch||121||
59655067|NCT03096834|75773266|FG001|STARTED|Double-Blind Treatment Epoch||125||
59655068|NCT03096834|75773267|FG002|STARTED|Double-Blind Treatment Epoch||0||
59655069|NCT03096834|75773268|FG003|STARTED|Double-Blind Treatment Epoch||0||
59655070|NCT03096834|75773265|FG000|COMPLETED|Double-Blind Treatment Epoch||118||
59655071|NCT03096834|75773266|FG001|COMPLETED|Double-Blind Treatment Epoch||122||
59655072|NCT03096834|75773267|FG002|COMPLETED|Double-Blind Treatment Epoch||0||
59655073|NCT03096834|75773268|FG003|COMPLETED|Double-Blind Treatment Epoch||0||
59655074|NCT03096834|75773265|FG000|NOT COMPLETED|Double-Blind Treatment Epoch||3||
59655075|NCT03096834|75773266|FG001|NOT COMPLETED|Double-Blind Treatment Epoch||3||
59655076|NCT03096834|75773267|FG002|NOT COMPLETED|Double-Blind Treatment Epoch||0||
59655077|NCT03096834|75773268|FG003|NOT COMPLETED|Double-Blind Treatment Epoch||0||
59655078|NCT03096834|75773265|FG000|STARTED|Open-Label Treatment Epoch||0||
59655079|NCT03096834|75773266|FG001|STARTED|Open-Label Treatment Epoch||0||
59655080|NCT03096834|75773267|FG002|STARTED|Open-Label Treatment Epoch||118||
59655081|NCT03096834|75773268|FG003|STARTED|Open-Label Treatment Epoch||122||
59655082|NCT03096834|75773265|FG000|COMPLETED|Open-Label Treatment Epoch||0||
59655083|NCT03096834|75773266|FG001|COMPLETED|Open-Label Treatment Epoch||0||
59655084|NCT03096834|75773267|FG002|COMPLETED|Open-Label Treatment Epoch||86||
59655085|NCT03096834|75773268|FG003|COMPLETED|Open-Label Treatment Epoch||83||
59655086|NCT03096834|75773265|FG000|NOT COMPLETED|Open-Label Treatment Epoch||0||
59655087|NCT03096834|75773266|FG001|NOT COMPLETED|Open-Label Treatment Epoch||0||
59655088|NCT03096834|75773267|FG002|NOT COMPLETED|Open-Label Treatment Epoch||32||
59655089|NCT03096834|75773268|FG003|NOT COMPLETED|Open-Label Treatment Epoch||39||
59655090|NCT03096834|75773265|FG000|STARTED|Safety Follow-Up Epoch||0|After completing the Double-Blind and/or Open -Label Epoch, a Follow-Up Visit (16 weeks after the last dose of AMG334) was required as part of routine safety monitoring unless participants continued onto commercial AMG334 (contingent upon marketing authorization and commercial availability in the participating country).|
59655091|NCT03096834|75773266|FG001|STARTED|Safety Follow-Up Epoch||0|After completing the Double-Blind and/or Open -Label Epoch, a Follow-Up Visit (16 weeks after the last dose of AMG334) was required as part of routine safety monitoring unless participants continued onto commercial AMG334 (contingent upon marketing authorization and commercial availability in the participating country).|
59655092|NCT03096834|75773267|FG002|STARTED|Safety Follow-Up Epoch||66|After completing the Double-Blind and/or Open -Label Epoch, a Follow-Up Visit (16 weeks after the last dose of AMG334) was required as part of routine safety monitoring unless participants continued onto commercial AMG334 (contingent upon marketing authorization and commercial availability in the participating country).|
59655093|NCT03096834|75773268|FG003|STARTED|Safety Follow-Up Epoch||61|After completing the Double-Blind and/or Open -Label Epoch, a Follow-Up Visit (16 weeks after the last dose of AMG334) was required as part of routine safety monitoring unless participants continued onto commercial AMG334 (contingent upon marketing authorization and commercial availability in the participating country).|
59655094|NCT03096834|75773265|FG000|COMPLETED|Safety Follow-Up Epoch||0||
59655095|NCT03096834|75773266|FG001|COMPLETED|Safety Follow-Up Epoch||0||
59655096|NCT03096834|75773267|FG002|COMPLETED|Safety Follow-Up Epoch||65||
59655097|NCT03096834|75773268|FG003|COMPLETED|Safety Follow-Up Epoch||59||
59655098|NCT03096834|75773265|FG000|NOT COMPLETED|Safety Follow-Up Epoch||0||
59655099|NCT03096834|75773266|FG001|NOT COMPLETED|Safety Follow-Up Epoch||0||
59655100|NCT03096834|75773267|FG002|NOT COMPLETED|Safety Follow-Up Epoch||1||
59988787|NCT01641952|76103994|FG000|COMPLETED|Overall Study||471||
59655101|NCT03096834|75773268|FG003|NOT COMPLETED|Safety Follow-Up Epoch||2||
59655102|NCT03096834|75773265|FG000|STARTED|Post-Trial Access Epoch||0|Only participants who had demonstrated continued clinical benefit and who did not have access to commercially available drug were eligible to enter to Post-Trial Access Epoch.|
59655103|NCT03096834|75773266|FG001|STARTED|Post-Trial Access Epoch||0|Only participants who had demonstrated continued clinical benefit and who did not have access to commercially available drug were eligible to enter to Post-Trial Access Epoch.|
59655104|NCT03096834|75773267|FG002|STARTED|Post-Trial Access Epoch||21|Only participants who had demonstrated continued clinical benefit and who did not have access to commercially available drug were eligible to enter to Post-Trial Access Epoch.|
59655105|NCT03096834|75773268|FG003|STARTED|Post-Trial Access Epoch||15|Only participants who had demonstrated continued clinical benefit and who did not have access to commercially available drug were eligible to enter to Post-Trial Access Epoch.|
59655106|NCT03096834|75773265|FG000|COMPLETED|Post-Trial Access Epoch||0||
59655107|NCT03096834|75773266|FG001|COMPLETED|Post-Trial Access Epoch||0||
59655108|NCT03096834|75773267|FG002|COMPLETED|Post-Trial Access Epoch||21||
59655109|NCT03096834|75773268|FG003|COMPLETED|Post-Trial Access Epoch||15||
59655110|NCT03096834|75773265|FG000|NOT COMPLETED|Post-Trial Access Epoch||0||
59655111|NCT03096834|75773266|FG001|NOT COMPLETED|Post-Trial Access Epoch||0||
59655112|NCT03096834|75773267|FG002|NOT COMPLETED|Post-Trial Access Epoch||0||
59655113|NCT03096834|75773268|FG003|NOT COMPLETED|Post-Trial Access Epoch||0||
59655114|NCT03012815|75773279|FG000|STARTED|Overall Study||46||
59655115|NCT03012815|75773280|FG001|STARTED|Overall Study||42||
59655116|NCT03012815|75773279|FG000|COMPLETED|Overall Study||41||
59655117|NCT03012815|75773280|FG001|COMPLETED|Overall Study||40||
59988788|NCT01641952|76103994|FG000|NOT COMPLETED|Overall Study||34||
59988789|NCT02359552|76104000|FG000|STARTED|Overall Study||25||
59655118|NCT03012815|75773279|FG000|NOT COMPLETED|Overall Study||5||
59655119|NCT03012815|75773280|FG001|NOT COMPLETED|Overall Study||2||
59655120|NCT03001011|75773289|FG000|STARTED|Overall Study||101||
59655121|NCT03001011|75773290|FG001|STARTED|Overall Study||101||
59655122|NCT03001011|75773289|FG000|COMPLETED|Overall Study||74||
59655123|NCT03001011|75773290|FG001|COMPLETED|Overall Study||80||
59655124|NCT03001011|75773289|FG000|NOT COMPLETED|Overall Study||27||
59655125|NCT03001011|75773290|FG001|NOT COMPLETED|Overall Study||21||
59655126|NCT02993757|75773299|FG000|STARTED|Overall Study||266||
59655127|NCT02993757|75773300|FG001|STARTED|Overall Study||262||
59655128|NCT02993757|75773299|FG000|Safety Analysis Set (SafAS)|Overall Study||263|SafAS was defined as participants who had received at least 1 dose of study vaccines.|
59655129|NCT02993757|75773300|FG001|Safety Analysis Set (SafAS)|Overall Study||260|SafAS was defined as participants who had received at least 1 dose of study vaccines.|
59655130|NCT02993757|75773299|FG000|COMPLETED|Overall Study||102||
59655131|NCT02993757|75773300|FG001|COMPLETED|Overall Study||84||
59655132|NCT02993757|75773299|FG000|NOT COMPLETED|Overall Study||164||
59655133|NCT02993757|75773300|FG001|NOT COMPLETED|Overall Study||178||
59655134|NCT02979535|75773308|FG000|STARTED|Overall Study||239||
59655135|NCT02979535|75773309|FG001|STARTED|Overall Study||241||
59655136|NCT02979535|75773308|FG000|Safety Analysis Set|Overall Study||237|Safety analysis set was defined as participants who had received at least 1 dose of study vaccines.|
59655137|NCT02979535|75773309|FG001|Safety Analysis Set|Overall Study||241|Safety analysis set was defined as participants who had received at least 1 dose of study vaccines.|
59655138|NCT02979535|75773308|FG000|COMPLETED|Overall Study||144||
59988790|NCT02359552|76104001|FG001|STARTED|Overall Study||25||
59988791|NCT02359552|76104000|FG000|COMPLETED|Overall Study||22||
59988792|NCT02359552|76104001|FG001|COMPLETED|Overall Study||21||
59988793|NCT02359552|76104000|FG000|NOT COMPLETED|Overall Study||3||
59988794|NCT02359552|76104001|FG001|NOT COMPLETED|Overall Study||4||
59988795|NCT02743793|76104009|FG000|STARTED|Overall Study||5||
59988796|NCT02743793|76104010|FG001|STARTED|Overall Study||36||
60077029|NCT01924429|76192073|FG001|NOT COMPLETED|Period 1 - First Intervention (4 Weeks)||0||
60077030|NCT01924429|76192072|FG000|STARTED|Washout Period (2 Weeks)||17||
60077031|NCT01924429|76192073|FG001|STARTED|Washout Period (2 Weeks)||13||
60077032|NCT01924429|76192072|FG000|COMPLETED|Washout Period (2 Weeks)||14||
60077033|NCT01924429|76192073|FG001|COMPLETED|Washout Period (2 Weeks)||11||
60077034|NCT01924429|76192072|FG000|NOT COMPLETED|Washout Period (2 Weeks)||3||
60077035|NCT01924429|76192073|FG001|NOT COMPLETED|Washout Period (2 Weeks)||2||
60077036|NCT01924429|76192072|FG000|STARTED|Period 2 - Second Intervention (4 Weeks)||14||
59988797|NCT02743793|76104009|FG000|COMPLETED|Overall Study||0||
59988798|NCT02743793|76104010|FG001|COMPLETED|Overall Study||0||
59988799|NCT02743793|76104009|FG000|NOT COMPLETED|Overall Study||5||
59988800|NCT02743793|76104010|FG001|NOT COMPLETED|Overall Study||36||
59988801|NCT00152009|76104019|FG000|STARTED|Overall Study||87||
59988802|NCT00152009|76104020|FG001|STARTED|Overall Study||86||
59988803|NCT00152009|76104021|FG002|STARTED|Overall Study||86||
59988804|NCT00152009|76104022|FG003|STARTED|Overall Study||86||
59988805|NCT00152009|76104019|FG000|COMPLETED|Overall Study||58||
59988806|NCT00152009|76104020|FG001|COMPLETED|Overall Study||55||
59988807|NCT00152009|76104021|FG002|COMPLETED|Overall Study||49||
59988808|NCT00152009|76104022|FG003|COMPLETED|Overall Study||53||
60077037|NCT01924429|76192073|FG001|STARTED|Period 2 - Second Intervention (4 Weeks)||11||
60077038|NCT01924429|76192072|FG000|COMPLETED|Period 2 - Second Intervention (4 Weeks)||14||
60077039|NCT01924429|76192073|FG001|COMPLETED|Period 2 - Second Intervention (4 Weeks)||11||
59543715|NCT00928772|75641974|FG001|COMPLETED|Overall Study||38||
59543716|NCT00928772|75641975|FG002|COMPLETED|Overall Study||38||
59543717|NCT00928772|75641973|FG000|NOT COMPLETED|Overall Study||0||
59543718|NCT00928772|75641974|FG001|NOT COMPLETED|Overall Study||0||
59543719|NCT00928772|75641975|FG002|NOT COMPLETED|Overall Study||0||
59543720|NCT02459418|75641985|FG000|STARTED|Overall Study||21||
59543721|NCT02459418|75641986|FG001|STARTED|Overall Study||21||
59543722|NCT02459418|75641985|FG000|Received First Treatment|Overall Study||21||
59543723|NCT02459418|75641986|FG001|Received First Treatment|Overall Study||21||
59543724|NCT02459418|75641985|FG000|Received Second Treatment|Overall Study||13||
59543725|NCT02459418|75641986|FG001|Received Second Treatment|Overall Study||15||
59543726|NCT02459418|75641985|FG000|COMPLETED|Overall Study||13||
59543727|NCT02459418|75641986|FG001|COMPLETED|Overall Study||15||
59543728|NCT02459418|75641985|FG000|NOT COMPLETED|Overall Study||8||
59655139|NCT02979535|75773309|FG001|COMPLETED|Overall Study||140||
59655140|NCT02979535|75773308|FG000|NOT COMPLETED|Overall Study||95||
59655141|NCT02979535|75773309|FG001|NOT COMPLETED|Overall Study||101||
59988809|NCT00152009|76104019|FG000|NOT COMPLETED|Overall Study||29||
59988810|NCT00152009|76104020|FG001|NOT COMPLETED|Overall Study||31||
59988811|NCT00152009|76104021|FG002|NOT COMPLETED|Overall Study||37||
59988812|NCT00152009|76104022|FG003|NOT COMPLETED|Overall Study||33||
59988813|NCT02265952|76104032|FG000|STARTED|Main Study Period||9||
59988814|NCT02265952|76104033|FG001|STARTED|Main Study Period||0||
59988815|NCT02265952|76104032|FG000|COMPLETED|Main Study Period||9||
59988816|NCT02265952|76104033|FG001|COMPLETED|Main Study Period||0||
60077040|NCT01924429|76192072|FG000|NOT COMPLETED|Period 2 - Second Intervention (4 Weeks)||0||
59543729|NCT02459418|75641986|FG001|NOT COMPLETED|Overall Study||6||
59655142|NCT02978716|75773318|FG000|STARTED|Overall Study||34||
59655143|NCT02978716|75773319|FG001|STARTED|Overall Study||33||
59655144|NCT02978716|75773320|FG002|STARTED|Overall Study||35||
59655145|NCT02978716|75773318|FG000|ITT Population|Overall Study||34|The Intent-to-Treat (ITT) analysis set included all randomized participants.|
59655146|NCT02978716|75773319|FG001|ITT Population|Overall Study||33|The Intent-to-Treat (ITT) analysis set included all randomized participants.|
59655147|NCT02978716|75773320|FG002|ITT Population|Overall Study||35|The Intent-to-Treat (ITT) analysis set included all randomized participants.|
59655148|NCT02978716|75773318|FG000|Safety Analysis Set|Overall Study||30|The safety analysis set included all enrolled participants who received at least 1 dose of study drug.|
59655149|NCT02978716|75773319|FG001|Safety Analysis Set|Overall Study||33|The safety analysis set included all enrolled participants who received at least 1 dose of study drug.|
59655150|NCT02978716|75773320|FG002|Safety Analysis Set|Overall Study||35|The safety analysis set included all enrolled participants who received at least 1 dose of study drug.|
59655151|NCT02978716|75773318|FG000|Treated|Overall Study||30||
59655152|NCT02978716|75773319|FG001|Treated|Overall Study||33||
59655153|NCT02978716|75773320|FG002|Treated|Overall Study||35||
59655154|NCT02978716|75773318|FG000|COMPLETED|Overall Study||0||
59655155|NCT02978716|75773319|FG001|COMPLETED|Overall Study||0||
59655156|NCT02978716|75773320|FG002|COMPLETED|Overall Study||0||
59655157|NCT02978716|75773318|FG000|NOT COMPLETED|Overall Study||34||
59655158|NCT02978716|75773319|FG001|NOT COMPLETED|Overall Study||33||
59655159|NCT02978716|75773320|FG002|NOT COMPLETED|Overall Study||35||
59655160|NCT02973321|75773335|FG000|STARTED|Overall Study||33||
59655161|NCT02973321|75773336|FG001|STARTED|Overall Study||66||
59655162|NCT02973321|75773337|FG002|STARTED|Overall Study||66||
59655163|NCT02973321|75773338|FG003|STARTED|Overall Study||64||
59655164|NCT02973321|75773339|FG004|STARTED|Overall Study||67||
59655165|NCT02973321|75773335|FG000|COMPLETED|Overall Study||32||
59655166|NCT02973321|75773336|FG001|COMPLETED|Overall Study||51||
59655167|NCT02973321|75773337|FG002|COMPLETED|Overall Study||52||
59655168|NCT02973321|75773338|FG003|COMPLETED|Overall Study||48||
59655169|NCT02973321|75773339|FG004|COMPLETED|Overall Study||62||
59655170|NCT02973321|75773335|FG000|NOT COMPLETED|Overall Study||1||
59655171|NCT02973321|75773336|FG001|NOT COMPLETED|Overall Study||15||
59655172|NCT02973321|75773337|FG002|NOT COMPLETED|Overall Study||14||
59655173|NCT02973321|75773338|FG003|NOT COMPLETED|Overall Study||16||
59655174|NCT02973321|75773339|FG004|NOT COMPLETED|Overall Study||5||
59655175|NCT02943785|75773354|FG000|STARTED|Overall Study||713||
59655176|NCT02943785|75773355|FG001|STARTED|Overall Study||713||
59655177|NCT02943785|75773354|FG000|COMPLETED|Overall Study||431||
59655178|NCT02943785|75773355|FG001|COMPLETED|Overall Study||350||
59655179|NCT02943785|75773354|FG000|NOT COMPLETED|Overall Study||282||
59655180|NCT02943785|75773355|FG001|NOT COMPLETED|Overall Study||363||
59655181|NCT02923674|75773364|FG000|STARTED|Overall Study||60||
59655182|NCT02923674|75773365|FG001|STARTED|Overall Study||60||
59655183|NCT02923674|75773366|FG002|STARTED|Overall Study||63||
59655184|NCT02923674|75773364|FG000|COMPLETED|Overall Study||32||
59655185|NCT02923674|75773365|FG001|COMPLETED|Overall Study||32||
59655186|NCT02923674|75773366|FG002|COMPLETED|Overall Study||38||
59655187|NCT02923674|75773364|FG000|NOT COMPLETED|Overall Study||28||
59655188|NCT02923674|75773365|FG001|NOT COMPLETED|Overall Study||28||
59655189|NCT02923674|75773366|FG002|NOT COMPLETED|Overall Study||25||
59655190|NCT02921971|75773376|FG000|STARTED|Overall Study||49||
59655191|NCT02921971|75773377|FG001|STARTED|Overall Study||48||
59655192|NCT02921971|75773376|FG000|COMPLETED|Overall Study||43||
59655193|NCT02921971|75773377|FG001|COMPLETED|Overall Study||44||
59655194|NCT02921971|75773376|FG000|NOT COMPLETED|Overall Study||6||
59655195|NCT02921971|75773377|FG001|NOT COMPLETED|Overall Study||4||
59655196|NCT02886286|75773385|FG000|STARTED|Overall Study||8||
59655197|NCT02886286|75773386|FG001|STARTED|Overall Study||9||
59655198|NCT02886286|75773385|FG000|COMPLETED|Overall Study||8|one patient had an unrelated motor stall of the pump|
59655199|NCT02886286|75773386|FG001|COMPLETED|Overall Study||8|one patient had an unrelated motor stall of the pump|
59655200|NCT02886286|75773385|FG000|NOT COMPLETED|Overall Study||0||
59655201|NCT02886286|75773386|FG001|NOT COMPLETED|Overall Study||1||
59655202|NCT02865187|75773394|FG000|STARTED|Overall Study||33|Visit 1 - Enrollment|
59655203|NCT02865187|75773395|FG001|STARTED|Overall Study||14|Visit 1 - Enrollment|
59655204|NCT02865187|75773394|FG000|Visit 2 - at 3 Months|Overall Study||23||
59655205|NCT02865187|75773395|FG001|Visit 2 - at 3 Months|Overall Study||7||
59655206|NCT02865187|75773394|FG000|COMPLETED|Overall Study||20|Visit 3 - at 6 months|
59655207|NCT02865187|75773395|FG001|COMPLETED|Overall Study||7|Visit 3 - at 6 months|
59655208|NCT02865187|75773394|FG000|NOT COMPLETED|Overall Study||13||
59655209|NCT02865187|75773395|FG001|NOT COMPLETED|Overall Study||7||
59655210|NCT02824198|75773403|FG000|STARTED|Overall Study||89||
59655211|NCT02824198|75773404|FG001|STARTED|Overall Study||29||
59655212|NCT02824198|75773403|FG000|COMPLETED|Overall Study||74||
59655213|NCT02824198|75773404|FG001|COMPLETED|Overall Study||26||
59655214|NCT02824198|75773403|FG000|NOT COMPLETED|Overall Study||15||
59655215|NCT02824198|75773404|FG001|NOT COMPLETED|Overall Study||3||
59655216|NCT02787551|75773414|FG000|STARTED|Core Period: 26 Weeks||257||
59655217|NCT02787551|75773415|FG001|STARTED|Core Period: 26 Weeks||257||
59655218|NCT02787551|75773414|FG000|Treated|Core Period: 26 Weeks||255||
59655219|NCT02787551|75773415|FG001|Treated|Core Period: 26 Weeks||256||
59655220|NCT02787551|75773414|FG000|COMPLETED|Core Period: 26 Weeks|Out of 230 participants, 206 participants entered in single arm extension period.|230||
59655221|NCT02787551|75773415|FG001|COMPLETED|Core Period: 26 Weeks||246||
59655222|NCT02787551|75773414|FG000|NOT COMPLETED|Core Period: 26 Weeks||27||
59655223|NCT02787551|75773415|FG001|NOT COMPLETED|Core Period: 26 Weeks||11||
59655224|NCT02787551|75773414|FG000|STARTED|Extension Period:26 Weeks(Upto 52 Weeks)|Participants who completed core period and met eligibility criteria for extension period.|206||
59655225|NCT02787551|75773415|FG001|STARTED|Extension Period:26 Weeks(Upto 52 Weeks)||0||
59655226|NCT02787551|75773414|FG000|COMPLETED|Extension Period:26 Weeks(Upto 52 Weeks)||197||
59655227|NCT02787551|75773415|FG001|COMPLETED|Extension Period:26 Weeks(Upto 52 Weeks)||0||
59655228|NCT02787551|75773414|FG000|NOT COMPLETED|Extension Period:26 Weeks(Upto 52 Weeks)||9||
59655229|NCT02787551|75773415|FG001|NOT COMPLETED|Extension Period:26 Weeks(Upto 52 Weeks)||0||
59655230|NCT02747121|75773426|FG000|STARTED|Overall Study||3594||
59655231|NCT02747121|75773427|FG001|STARTED|Overall Study||3813||
59655232|NCT02747121|75773426|FG000|COMPLETED|Overall Study||3594||
59655233|NCT02747121|75773427|FG001|COMPLETED|Overall Study||3813||
59655234|NCT02747121|75773426|FG000|NOT COMPLETED|Overall Study||0||
59655235|NCT02747121|75773427|FG001|NOT COMPLETED|Overall Study||0||
59655236|NCT02735044|75773435|FG000|STARTED|Overall Study||233||
59655237|NCT02735044|75773436|FG001|STARTED|Overall Study||230||
59655238|NCT02735044|75773435|FG000|Treated|Overall Study||233||
59655239|NCT02735044|75773436|FG001|Treated|Overall Study||228||
59655240|NCT02735044|75773435|FG000|COMPLETED|Overall Study||217||
59655241|NCT02735044|75773436|FG001|COMPLETED|Overall Study||207||
59655242|NCT02735044|75773435|FG000|NOT COMPLETED|Overall Study||16||
59655243|NCT02735044|75773436|FG001|NOT COMPLETED|Overall Study||23||
59655244|NCT02720744|75773444|FG000|STARTED|Overall Study||107||
59655245|NCT02720744|75773445|FG001|STARTED|Overall Study||105||
59655246|NCT02720744|75773444|FG000|COMPLETED|Overall Study||69||
59655247|NCT02720744|75773445|FG001|COMPLETED|Overall Study||79||
59655248|NCT02720744|75773444|FG000|NOT COMPLETED|Overall Study||38||
59655249|NCT02720744|75773445|FG001|NOT COMPLETED|Overall Study||26||
59655250|NCT02692651|75773453|FG000|STARTED|Study Treatment||70||
59655251|NCT02692651|75773454|FG001|STARTED|Study Treatment||74||
59655252|NCT02692651|75773453|FG000|COMPLETED|Study Treatment||54||
59655253|NCT02692651|75773454|FG001|COMPLETED|Study Treatment||64||
59655254|NCT02692651|75773453|FG000|NOT COMPLETED|Study Treatment||16||
59655255|NCT02692651|75773454|FG001|NOT COMPLETED|Study Treatment||10||
59655256|NCT02692651|75773453|FG000|STARTED|Post Study Treatment Follow-up||54||
59655257|NCT02692651|75773454|FG001|STARTED|Post Study Treatment Follow-up||64||
59655258|NCT02692651|75773453|FG000|COMPLETED|Post Study Treatment Follow-up||50||
59655259|NCT02692651|75773454|FG001|COMPLETED|Post Study Treatment Follow-up||60||
59655260|NCT02692651|75773453|FG000|NOT COMPLETED|Post Study Treatment Follow-up||4||
59655261|NCT02692651|75773454|FG001|NOT COMPLETED|Post Study Treatment Follow-up||4||
59655262|NCT02686658|75773466|FG000|STARTED|Overall Study||26||
59655263|NCT02686658|75773467|FG001|STARTED|Overall Study||25||
59655264|NCT02686658|75773468|FG002|STARTED|Overall Study||26||
59655265|NCT02686658|75773469|FG003|STARTED|Overall Study||42||
59655266|NCT02686658|75773470|FG004|STARTED|Overall Study||83||
59655267|NCT02686658|75773471|FG005|STARTED|Overall Study||84||
59655268|NCT02686658|75773466|FG000|Month 12|Overall Study||23||
59655269|NCT02686658|75773467|FG001|Month 12|Overall Study||19||
59655270|NCT02686658|75773468|FG002|Month 12|Overall Study||19||
59655271|NCT02686658|75773469|FG003|Month 12|Overall Study||34||
59655272|NCT02686658|75773470|FG004|Month 12|Overall Study||56||
59655273|NCT02686658|75773471|FG005|Month 12|Overall Study||72||
59655274|NCT02686658|75773466|FG000|COMPLETED|Overall Study||22||
59655275|NCT02686658|75773467|FG001|COMPLETED|Overall Study||18||
59655276|NCT02686658|75773468|FG002|COMPLETED|Overall Study||17||
59655277|NCT02686658|75773469|FG003|COMPLETED|Overall Study||30||
59655278|NCT02686658|75773470|FG004|COMPLETED|Overall Study||46||
59655279|NCT02686658|75773471|FG005|COMPLETED|Overall Study||68||
59655280|NCT02686658|75773466|FG000|NOT COMPLETED|Overall Study||4||
59655281|NCT02686658|75773467|FG001|NOT COMPLETED|Overall Study||7||
59655282|NCT02686658|75773468|FG002|NOT COMPLETED|Overall Study||9||
59655283|NCT02686658|75773469|FG003|NOT COMPLETED|Overall Study||12||
59655284|NCT02686658|75773470|FG004|NOT COMPLETED|Overall Study||37||
59655285|NCT02686658|75773471|FG005|NOT COMPLETED|Overall Study||16||
59988817|NCT02265952|76104032|FG000|NOT COMPLETED|Main Study Period||0||
59655286|NCT02674061|75773487|FG000|STARTED|Overall Study||285||
59655287|NCT02674061|75773488|FG001|STARTED|Overall Study||91||
59655288|NCT02674061|75773487|FG000|COMPLETED|Overall Study||0||
59655289|NCT02674061|75773488|FG001|COMPLETED|Overall Study||0||
59655290|NCT02674061|75773487|FG000|NOT COMPLETED|Overall Study||285||
59655291|NCT02674061|75773488|FG001|NOT COMPLETED|Overall Study||91||
59655292|NCT02654314|75773498|FG000|STARTED|Overall Study||136||
59655293|NCT02654314|75773499|FG001|STARTED|Overall Study||141||
59988818|NCT02265952|76104033|FG001|NOT COMPLETED|Main Study Period||0||
59655294|NCT02654314|75773498|FG000|COMPLETED|Overall Study||136||
59655295|NCT02654314|75773499|FG001|COMPLETED|Overall Study||141||
59655296|NCT02654314|75773498|FG000|NOT COMPLETED|Overall Study||0||
59655297|NCT02654314|75773499|FG001|NOT COMPLETED|Overall Study||0||
59815796|NCT03026283|75938214|FG003|STARTED|Optimal Care/Stress Test/ICA||128|Participants diagnosed to receive optimal care, or recommended for stress test diagnosis or ICA|
59543730|NCT01598207|75641997|FG000|STARTED|Overall Study||7||
59543731|NCT01598207|75641998|FG001|STARTED|Overall Study||6||
59543732|NCT01598207|75641997|FG000|COMPLETED|Overall Study||6||
59543733|NCT01598207|75641998|FG001|COMPLETED|Overall Study||6||
59543734|NCT01598207|75641997|FG000|NOT COMPLETED|Overall Study||1||
59543735|NCT01598207|75641998|FG001|NOT COMPLETED|Overall Study||0||
59543736|NCT00937118|75642004|FG000|STARTED|Overall Study||41||
59543737|NCT00937118|75642004|FG000|COMPLETED|Overall Study||41||
59543738|NCT00937118|75642004|FG000|NOT COMPLETED|Overall Study||0||
59543739|NCT01640171|75642011|FG000|STARTED|Overall Study||57||
59543740|NCT01640171|75642011|FG000|COMPLETED|Overall Study||57||
59543741|NCT01640171|75642011|FG000|NOT COMPLETED|Overall Study||0||
59543742|NCT02487498|75642016|FG000|STARTED|Period: Period 1||178||
59543743|NCT02487498|75642017|FG001|STARTED|Period: Period 1||177||
59543744|NCT02487498|75642016|FG000|COMPLETED|Period: Period 1||172||
59543745|NCT02487498|75642017|FG001|COMPLETED|Period: Period 1||166||
59543746|NCT02487498|75642016|FG000|NOT COMPLETED|Period: Period 1||6||
59543747|NCT02487498|75642017|FG001|NOT COMPLETED|Period: Period 1||11||
59543748|NCT02487498|75642016|FG000|STARTED|Period: Washout||172||
59543749|NCT02487498|75642017|FG001|STARTED|Period: Washout||166||
59543750|NCT02487498|75642016|FG000|COMPLETED|Period: Washout||170||
59543751|NCT02487498|75642017|FG001|COMPLETED|Period: Washout||159||
59543752|NCT02487498|75642016|FG000|NOT COMPLETED|Period: Washout||2||
59543753|NCT02487498|75642017|FG001|NOT COMPLETED|Period: Washout||7||
59543754|NCT02487498|75642016|FG000|STARTED|Period: Period 2||170||
59543755|NCT02487498|75642017|FG001|STARTED|Period: Period 2||159||
59543756|NCT02487498|75642016|FG000|COMPLETED|Period: Period 2||164||
59543757|NCT02487498|75642017|FG001|COMPLETED|Period: Period 2||154||
59543758|NCT02487498|75642016|FG000|NOT COMPLETED|Period: Period 2||6||
59543759|NCT02487498|75642017|FG001|NOT COMPLETED|Period: Period 2||5||
59543760|NCT02487108|75642028|FG000|STARTED|Overall Study||142||
59543761|NCT02487108|75642029|FG001|STARTED|Overall Study||142||
59543762|NCT02487108|75642030|FG002|STARTED|Overall Study||143||
59543763|NCT02487108|75642031|FG003|STARTED|Overall Study||142||
59543764|NCT02487108|75642028|FG000|Received at Least 1 Dose of Study Drug|Overall Study||142||
59543765|NCT02487108|75642029|FG001|Received at Least 1 Dose of Study Drug|Overall Study||142||
59543766|NCT02487108|75642030|FG002|Received at Least 1 Dose of Study Drug|Overall Study||141||
59543767|NCT02487108|75642031|FG003|Received at Least 1 Dose of Study Drug|Overall Study||142||
59543768|NCT02487108|75642028|FG000|COMPLETED|Overall Study||126||
59543769|NCT02487108|75642029|FG001|COMPLETED|Overall Study||126||
59543770|NCT02487108|75642030|FG002|COMPLETED|Overall Study||117||
59543771|NCT02487108|75642031|FG003|COMPLETED|Overall Study||131||
59543772|NCT02487108|75642028|FG000|NOT COMPLETED|Overall Study||16||
59543773|NCT02487108|75642029|FG001|NOT COMPLETED|Overall Study||16||
59543774|NCT02487108|75642030|FG002|NOT COMPLETED|Overall Study||26||
59543775|NCT02487108|75642031|FG003|NOT COMPLETED|Overall Study||11||
59543776|NCT02487030|75642048|FG000|STARTED|Overall Study||43||
59543777|NCT02487030|75642049|FG001|STARTED|Overall Study||42||
59543778|NCT02487030|75642050|FG002|STARTED|Overall Study||43||
59543779|NCT02487030|75642051|FG003|STARTED|Overall Study||42||
59543780|NCT02487030|75642052|FG004|STARTED|Overall Study||36||
59543781|NCT02487030|75642053|FG005|STARTED|Overall Study||38||
59543782|NCT02487030|75642054|FG006|STARTED|Overall Study||11||
59543783|NCT02487030|75642048|FG000|COMPLETED|Overall Study||41||
59543784|NCT02487030|75642049|FG001|COMPLETED|Overall Study||38||
59543785|NCT02487030|75642050|FG002|COMPLETED|Overall Study||41||
59543786|NCT02487030|75642051|FG003|COMPLETED|Overall Study||40||
59543787|NCT02487030|75642052|FG004|COMPLETED|Overall Study||34||
59543788|NCT02487030|75642053|FG005|COMPLETED|Overall Study||37||
59543789|NCT02487030|75642054|FG006|COMPLETED|Overall Study||11||
59543790|NCT02487030|75642048|FG000|NOT COMPLETED|Overall Study||2||
59543791|NCT02487030|75642049|FG001|NOT COMPLETED|Overall Study||4||
59543792|NCT02487030|75642050|FG002|NOT COMPLETED|Overall Study||2||
59543793|NCT02487030|75642051|FG003|NOT COMPLETED|Overall Study||2||
59543794|NCT02487030|75642052|FG004|NOT COMPLETED|Overall Study||2||
59543795|NCT02487030|75642053|FG005|NOT COMPLETED|Overall Study||1||
59543796|NCT02487030|75642054|FG006|NOT COMPLETED|Overall Study||0||
59543797|NCT02486952|75642071|FG000|STARTED|Overall Study||154||
59543798|NCT02486952|75642071|FG000|Started Induction Therapy|Overall Study||151||
59543799|NCT02486952|75642071|FG000|COMPLETED|Overall Study||104||
59543800|NCT02486952|75642071|FG000|NOT COMPLETED|Overall Study||50||
59543801|NCT02486796|75642077|FG000|STARTED|Overall Study||3||
59543802|NCT02486796|75642078|FG001|STARTED|Overall Study||2||
59543803|NCT02486796|75642077|FG000|COMPLETED|Overall Study||1||
59543804|NCT02486796|75642078|FG001|COMPLETED|Overall Study||1||
59543805|NCT02486796|75642077|FG000|NOT COMPLETED|Overall Study||2||
59543806|NCT02486796|75642078|FG001|NOT COMPLETED|Overall Study||1||
59543807|NCT02459262|75642095|FG000|STARTED|Overall Study||8||
59543808|NCT02459262|75642096|FG001|STARTED|Overall Study||8||
59543809|NCT02459262|75642097|FG002|STARTED|Overall Study||8||
59543810|NCT02459262|75642098|FG003|STARTED|Overall Study||8||
59543811|NCT02459262|75642099|FG004|STARTED|Overall Study||8||
59543812|NCT02459262|75642100|FG005|STARTED|Overall Study||8||
59543813|NCT02459262|75642101|FG006|STARTED|Overall Study||12||
59543814|NCT02459262|75642102|FG007|STARTED|Overall Study||45||
59543815|NCT02459262|75642103|FG008|STARTED|Overall Study||45||
59543816|NCT02459262|75642104|FG009|STARTED|Overall Study||45||
59543817|NCT02459262|75642105|FG010|STARTED|Overall Study||45||
59543818|NCT02459262|75642095|FG000|COMPLETED|Overall Study||8||
59543819|NCT02459262|75642096|FG001|COMPLETED|Overall Study||8||
59543820|NCT02459262|75642097|FG002|COMPLETED|Overall Study||8||
59543821|NCT02459262|75642098|FG003|COMPLETED|Overall Study||8||
59543822|NCT02459262|75642099|FG004|COMPLETED|Overall Study||8||
59543823|NCT02459262|75642100|FG005|COMPLETED|Overall Study||8||
59543824|NCT02459262|75642101|FG006|COMPLETED|Overall Study||12||
59543825|NCT02459262|75642102|FG007|COMPLETED|Overall Study||45||
59543826|NCT02459262|75642103|FG008|COMPLETED|Overall Study||45||
59543827|NCT02459262|75642104|FG009|COMPLETED|Overall Study||44||
59543828|NCT02459262|75642105|FG010|COMPLETED|Overall Study||45||
59543829|NCT02459262|75642095|FG000|NOT COMPLETED|Overall Study||0||
59543830|NCT02459262|75642096|FG001|NOT COMPLETED|Overall Study||0||
59543831|NCT02459262|75642097|FG002|NOT COMPLETED|Overall Study||0||
59543832|NCT02459262|75642098|FG003|NOT COMPLETED|Overall Study||0||
59543833|NCT02459262|75642099|FG004|NOT COMPLETED|Overall Study||0||
59543834|NCT02459262|75642100|FG005|NOT COMPLETED|Overall Study||0||
59543835|NCT02459262|75642101|FG006|NOT COMPLETED|Overall Study||0||
59543836|NCT02459262|75642102|FG007|NOT COMPLETED|Overall Study||0||
59543837|NCT02459262|75642103|FG008|NOT COMPLETED|Overall Study||0||
59543838|NCT02459262|75642104|FG009|NOT COMPLETED|Overall Study||1||
59543839|NCT02459262|75642105|FG010|NOT COMPLETED|Overall Study||0||
59543840|NCT01598831|75642131|FG000|STARTED|Overall Study||402||
59543841|NCT01598831|75642132|FG001|STARTED|Overall Study||414||
59543842|NCT01598831|75642131|FG000|Received at Least 1 Dose Study Treatment|Overall Study||395||
59543843|NCT01598831|75642132|FG001|Received at Least 1 Dose Study Treatment|Overall Study||405||
59543844|NCT01598831|75642131|FG000|COMPLETED|Overall Study||283||
59543845|NCT01598831|75642132|FG001|COMPLETED|Overall Study||278||
59543846|NCT01598831|75642131|FG000|NOT COMPLETED|Overall Study||119||
59543847|NCT01598831|75642132|FG001|NOT COMPLETED|Overall Study||136||
59543848|NCT01640327|75642140|FG000|STARTED|Overall Study||63||
59543849|NCT01640327|75642141|FG001|STARTED|Overall Study||63||
59543850|NCT01640327|75642140|FG000|COMPLETED|Overall Study||63||
59543851|NCT01640327|75642141|FG001|COMPLETED|Overall Study||63||
59543852|NCT01640327|75642140|FG000|NOT COMPLETED|Overall Study||0||
59543853|NCT01640327|75642141|FG001|NOT COMPLETED|Overall Study||0||
59543854|NCT01641653|75642149|FG000|STARTED|Overall Study||30||
59543855|NCT01641653|75642150|FG001|STARTED|Overall Study||30||
59543856|NCT01641653|75642149|FG000|COMPLETED|Overall Study||30||
59543857|NCT01641653|75642150|FG001|COMPLETED|Overall Study||30||
59543858|NCT01641653|75642149|FG000|NOT COMPLETED|Overall Study||0||
59543859|NCT01641653|75642150|FG001|NOT COMPLETED|Overall Study||0||
59543860|NCT01600703|75642159|FG000|STARTED|First Intervention||7||
59543861|NCT01600703|75642160|FG001|STARTED|First Intervention||8||
59543862|NCT01600703|75642159|FG000|COMPLETED|First Intervention||7||
59543863|NCT01600703|75642160|FG001|COMPLETED|First Intervention||8||
59543864|NCT01600703|75642159|FG000|NOT COMPLETED|First Intervention||0||
59543865|NCT01600703|75642160|FG001|NOT COMPLETED|First Intervention||0||
59543866|NCT01600703|75642159|FG000|STARTED|Second Intervention||7||
59543867|NCT01600703|75642160|FG001|STARTED|Second Intervention||8||
59543868|NCT01600703|75642159|FG000|COMPLETED|Second Intervention||7||
59543869|NCT01600703|75642160|FG001|COMPLETED|Second Intervention||8||
59543870|NCT01600703|75642159|FG000|NOT COMPLETED|Second Intervention||0||
59543871|NCT01600703|75642160|FG001|NOT COMPLETED|Second Intervention||0||
59543872|NCT01643213|75642168|FG000|STARTED|Overall Study||13||
59543873|NCT01643213|75642169|FG001|STARTED|Overall Study||14||
59543874|NCT01643213|75642168|FG000|COMPLETED|Overall Study||12||
59543875|NCT01643213|75642169|FG001|COMPLETED|Overall Study||14||
59543876|NCT01643213|75642168|FG000|NOT COMPLETED|Overall Study||1||
59543877|NCT01643213|75642169|FG001|NOT COMPLETED|Overall Study||0||
59543878|NCT01644695|75642175|FG000|STARTED|Overall Study||85||
59543879|NCT01644695|75642175|FG000|COMPLETED|Overall Study||85||
59543880|NCT01644695|75642175|FG000|NOT COMPLETED|Overall Study||0||
59543881|NCT01602731|75642179|FG000|STARTED|Overall Study||45||
59543882|NCT01602731|75642179|FG000|Cognitive Impairment|Overall Study|After repeat cognitive testing, additional 1 patient had no cognitive impairment and did not proceed|44||
59543883|NCT01602731|75642179|FG000|Poor Medication Adherence|Overall Study|24 out of 35 patients who completed 1-month pill counts had medication adherence <88%.|24||
59543884|NCT01602731|75642179|FG000|COMPLETED|Overall Study||15||
59543885|NCT01602731|75642179|FG000|NOT COMPLETED|Overall Study||30||
59543886|NCT02450526|75642189|FG000|STARTED|DB Period (Cycle 1)||325|Subjects randomised to each treatment group.|
59543887|NCT02450526|75642190|FG001|STARTED|DB Period (Cycle 1)||66|Subjects randomised to each treatment group.|
59543888|NCT02450526|75642191|FG002|STARTED|DB Period (Cycle 1)||107|Subjects randomised to each treatment group.|
59543889|NCT02450526|75642192|FG003|STARTED|DB Period (Cycle 1)||22|Subjects randomised to each treatment group.|
59543890|NCT02450526|75642193|FG004|STARTED|DB Period (Cycle 1)|This arm was not included in DB Period (Cycle 1).|0|Subjects randomised to each treatment group.|
59655298|NCT02628444|75773508|FG000|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||350|Randomized|
59655299|NCT02628444|75773509|FG001|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||348|Randomized|
59655300|NCT02628444|75773510|FG002|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||352|Randomized|
59655301|NCT02628444|75773511|FG003|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||0|Randomized|
59655302|NCT02628444|75773512|FG004|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||0|Randomized|
59655303|NCT02628444|75773513|FG005|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||0|Randomized|
59655304|NCT02628444|75773514|FG006|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||0|Randomized|
59655305|NCT02628444|75773515|FG007|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||0|Randomized|
59655306|NCT02628444|75773516|FG008|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||0|Randomized|
59655307|NCT02628444|75773508|FG000|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||348||
59655308|NCT02628444|75773509|FG001|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||348||
59655309|NCT02628444|75773510|FG002|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||352||
59655310|NCT02628444|75773511|FG003|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||0||
59655311|NCT02628444|75773512|FG004|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||0||
59655312|NCT02628444|75773513|FG005|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||0||
59655313|NCT02628444|75773514|FG006|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||0||
59655314|NCT02628444|75773515|FG007|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||0||
59655315|NCT02628444|75773516|FG008|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||0||
60077041|NCT01924429|76192073|FG001|NOT COMPLETED|Period 2 - Second Intervention (4 Weeks)||0||
60077042|NCT01898299|76192083|FG000|STARTED|Post Treatment (One Week)||47||
60077043|NCT01898299|76192084|FG001|STARTED|Post Treatment (One Week)||42||
60077044|NCT01898299|76192083|FG000|COMPLETED|Post Treatment (One Week)||47||
60077045|NCT01898299|76192084|FG001|COMPLETED|Post Treatment (One Week)||42||
60077046|NCT01898299|76192083|FG000|NOT COMPLETED|Post Treatment (One Week)||0||
60077047|NCT01898299|76192084|FG001|NOT COMPLETED|Post Treatment (One Week)||0||
60077048|NCT01898299|76192083|FG000|STARTED|Post Treatment (One Month)||47||
60077049|NCT01898299|76192084|FG001|STARTED|Post Treatment (One Month)||42||
60077050|NCT01898299|76192083|FG000|COMPLETED|Post Treatment (One Month)||44||
59655316|NCT02628444|75773508|FG000|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||333|FAS population included participants who had received either at least 1 injection of CYD dengue vaccine or placebo; and had at least 1 blood sample drawn and valid post-vaccination serology results.|
59655317|NCT02628444|75773509|FG001|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||328|FAS population included participants who had received either at least 1 injection of CYD dengue vaccine or placebo; and had at least 1 blood sample drawn and valid post-vaccination serology results.|
59655318|NCT02628444|75773510|FG002|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||332|FAS population included participants who had received either at least 1 injection of CYD dengue vaccine or placebo; and had at least 1 blood sample drawn and valid post-vaccination serology results.|
59655319|NCT02628444|75773511|FG003|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||0|FAS population included participants who had received either at least 1 injection of CYD dengue vaccine or placebo; and had at least 1 blood sample drawn and valid post-vaccination serology results.|
59655320|NCT02628444|75773512|FG004|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||0|FAS population included participants who had received either at least 1 injection of CYD dengue vaccine or placebo; and had at least 1 blood sample drawn and valid post-vaccination serology results.|
59655321|NCT02628444|75773513|FG005|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||0|FAS population included participants who had received either at least 1 injection of CYD dengue vaccine or placebo; and had at least 1 blood sample drawn and valid post-vaccination serology results.|
59655322|NCT02628444|75773514|FG006|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||0|FAS population included participants who had received either at least 1 injection of CYD dengue vaccine or placebo; and had at least 1 blood sample drawn and valid post-vaccination serology results.|
59655323|NCT02628444|75773515|FG007|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||0|FAS population included participants who had received either at least 1 injection of CYD dengue vaccine or placebo; and had at least 1 blood sample drawn and valid post-vaccination serology results.|
59655324|NCT02628444|75773516|FG008|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||0|FAS population included participants who had received either at least 1 injection of CYD dengue vaccine or placebo; and had at least 1 blood sample drawn and valid post-vaccination serology results.|
59655325|NCT02628444|75773508|FG000|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||314||
59655326|NCT02628444|75773509|FG001|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||309||
59655327|NCT02628444|75773510|FG002|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||310||
59655328|NCT02628444|75773511|FG003|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0||
59655329|NCT02628444|75773512|FG004|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0||
59655330|NCT02628444|75773513|FG005|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0||
59655331|NCT02628444|75773514|FG006|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0||
59655332|NCT02628444|75773515|FG007|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0||
59655333|NCT02628444|75773516|FG008|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0||
59655334|NCT02628444|75773508|FG000|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||36||
59655335|NCT02628444|75773509|FG001|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||39||
60077051|NCT01898299|76192084|FG001|COMPLETED|Post Treatment (One Month)||38||
60077052|NCT01898299|76192083|FG000|NOT COMPLETED|Post Treatment (One Month)||3||
60077053|NCT01898299|76192084|FG001|NOT COMPLETED|Post Treatment (One Month)||4||
59655336|NCT02628444|75773510|FG002|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||42||
59655337|NCT02628444|75773511|FG003|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0||
59655338|NCT02628444|75773512|FG004|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0||
59655339|NCT02628444|75773513|FG005|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0||
59655340|NCT02628444|75773514|FG006|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0||
59655341|NCT02628444|75773515|FG007|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0||
59655342|NCT02628444|75773516|FG008|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0||
59655343|NCT02628444|75773508|FG000|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||0|Started indicates the number of participants who were enrolled and randomized dengue seropositive subjects at baseline.|
59655344|NCT02628444|75773509|FG001|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||0|Started indicates the number of participants who were enrolled and randomized dengue seropositive subjects at baseline.|
59655345|NCT02628444|75773510|FG002|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||0|Started indicates the number of participants who were enrolled and randomized dengue seropositive subjects at baseline.|
59655346|NCT02628444|75773511|FG003|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||145|Started indicates the number of participants who were enrolled and randomized dengue seropositive subjects at baseline.|
59655347|NCT02628444|75773512|FG004|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||152|Started indicates the number of participants who were enrolled and randomized dengue seropositive subjects at baseline.|
59655348|NCT02628444|75773513|FG005|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||157|Started indicates the number of participants who were enrolled and randomized dengue seropositive subjects at baseline.|
59655349|NCT02628444|75773514|FG006|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||149|Started indicates the number of participants who were enrolled and randomized dengue seropositive subjects at baseline.|
59655350|NCT02628444|75773515|FG007|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||152|Started indicates the number of participants who were enrolled and randomized dengue seropositive subjects at baseline.|
59655351|NCT02628444|75773516|FG008|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||151|Started indicates the number of participants who were enrolled and randomized dengue seropositive subjects at baseline.|
59655352|NCT02628444|75773508|FG000|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||0||
59988819|NCT02265952|76104032|FG000|STARTED|Open Label Extension (OLE) Period||0||
59988820|NCT02265952|76104033|FG001|STARTED|Open Label Extension (OLE) Period||8||
59988821|NCT02265952|76104032|FG000|COMPLETED|Open Label Extension (OLE) Period||0||
59988822|NCT02265952|76104033|FG001|COMPLETED|Open Label Extension (OLE) Period||0||
59988823|NCT02265952|76104032|FG000|NOT COMPLETED|Open Label Extension (OLE) Period||0||
59988824|NCT02265952|76104033|FG001|NOT COMPLETED|Open Label Extension (OLE) Period||8||
59988825|NCT02265796|76104041|FG000|STARTED|Overall Study||25||
59988826|NCT02265796|76104042|FG001|STARTED|Overall Study||25||
59988827|NCT02265796|76104041|FG000|COMPLETED|Overall Study||22||
59988828|NCT02265796|76104042|FG001|COMPLETED|Overall Study||24||
59988829|NCT02265796|76104041|FG000|NOT COMPLETED|Overall Study||3||
59543891|NCT02450526|75642189|FG000|Safety Population|DB Period (Cycle 1)||326|1 subject was randomised to Botox placebo group but received treatment of Dysport® 50 U in Cycle 1.|
59543892|NCT02450526|75642190|FG001|Safety Population|DB Period (Cycle 1)||66|1 subject was randomised to Botox placebo group but received treatment of Dysport® 50 U in Cycle 1.|
59543893|NCT02450526|75642191|FG002|Safety Population|DB Period (Cycle 1)||107|1 subject was randomised to Botox placebo group but received treatment of Dysport® 50 U in Cycle 1.|
59655353|NCT02628444|75773509|FG001|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||0||
59655354|NCT02628444|75773510|FG002|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||0||
59655355|NCT02628444|75773511|FG003|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||55||
59655356|NCT02628444|75773512|FG004|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||59||
59655357|NCT02628444|75773513|FG005|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||62||
59655358|NCT02628444|75773514|FG006|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||53||
59655359|NCT02628444|75773515|FG007|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||56||
59655360|NCT02628444|75773516|FG008|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||53||
59655361|NCT02628444|75773508|FG000|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||0||
59655362|NCT02628444|75773509|FG001|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||0||
59655363|NCT02628444|75773510|FG002|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||0||
59655364|NCT02628444|75773511|FG003|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||55||
59988830|NCT02265796|76104042|FG001|NOT COMPLETED|Overall Study||1||
59988831|NCT02357368|76104052|FG000|STARTED|Overall Study||19||
59988832|NCT02357368|76104053|FG001|STARTED|Overall Study||18||
59988833|NCT02357368|76104054|FG002|STARTED|Overall Study||14||
59988834|NCT02357368|76104055|FG003|STARTED|Overall Study||8||
59988835|NCT02357368|76104052|FG000|COMPLETED|Overall Study||13||
59543894|NCT02450526|75642192|FG003|Safety Population|DB Period (Cycle 1)||21|1 subject was randomised to Botox placebo group but received treatment of Dysport® 50 U in Cycle 1.|
59543895|NCT02450526|75642193|FG004|Safety Population|DB Period (Cycle 1)||0|1 subject was randomised to Botox placebo group but received treatment of Dysport® 50 U in Cycle 1.|
59543896|NCT02450526|75642189|FG000|COMPLETED|DB Period (Cycle 1)||294||
59543897|NCT02450526|75642190|FG001|COMPLETED|DB Period (Cycle 1)||63||
59543898|NCT02450526|75642191|FG002|COMPLETED|DB Period (Cycle 1)||97||
59543899|NCT02450526|75642192|FG003|COMPLETED|DB Period (Cycle 1)||20||
59543900|NCT02450526|75642193|FG004|COMPLETED|DB Period (Cycle 1)|This arm was not included in DB Period (Cycle 1).|0||
59543901|NCT02450526|75642189|FG000|NOT COMPLETED|DB Period (Cycle 1)||31||
59543902|NCT02450526|75642190|FG001|NOT COMPLETED|DB Period (Cycle 1)||3||
59655365|NCT02628444|75773512|FG004|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||59||
59655366|NCT02628444|75773513|FG005|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||62||
59655367|NCT02628444|75773514|FG006|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||53||
59655368|NCT02628444|75773515|FG007|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||54||
59655369|NCT02628444|75773516|FG008|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||52||
59655370|NCT02628444|75773508|FG000|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||0||
59655371|NCT02628444|75773509|FG001|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||0||
59655372|NCT02628444|75773510|FG002|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||0||
59655373|NCT02628444|75773511|FG003|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||90||
59655374|NCT02628444|75773512|FG004|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||93||
59655375|NCT02628444|75773513|FG005|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||95||
59655376|NCT02628444|75773514|FG006|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||96||
59655377|NCT02628444|75773515|FG007|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||98||
59655378|NCT02628444|75773516|FG008|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||99||
59655379|NCT02623998|75773543|FG000|STARTED|Overall Study||50||
59655380|NCT02623998|75773544|FG001|STARTED|Overall Study||52||
59655381|NCT02623998|75773543|FG000|COMPLETED|Overall Study||48||
59655382|NCT02623998|75773544|FG001|COMPLETED|Overall Study||51||
59655383|NCT02623998|75773543|FG000|NOT COMPLETED|Overall Study||2||
59655384|NCT02623998|75773544|FG001|NOT COMPLETED|Overall Study||1||
59655385|NCT02623725|75773552|FG000|STARTED|Overall Study||187||
59655386|NCT02623725|75773553|FG001|STARTED|Overall Study||64||
59655387|NCT02623725|75773552|FG000|COMPLETED|Overall Study||171||
59655388|NCT02623725|75773553|FG001|COMPLETED|Overall Study||58||
59655389|NCT02623725|75773552|FG000|NOT COMPLETED|Overall Study||16||
59655390|NCT02623725|75773553|FG001|NOT COMPLETED|Overall Study||6||
59655391|NCT02608684|75773561|FG000|STARTED|Overall Study||21||
59655392|NCT02608684|75773561|FG000|COMPLETED|Overall Study||18||
59655393|NCT02608684|75773561|FG000|NOT COMPLETED|Overall Study||3||
59655394|NCT02587520|75773583|FG000|STARTED|Overall Study||80||
59655395|NCT02587520|75773584|FG001|STARTED|Overall Study||71||
59655396|NCT02587520|75773585|FG002|STARTED|Overall Study||78||
59655397|NCT02587520|75773586|FG003|STARTED|Overall Study||79||
59655398|NCT02587520|75773587|FG004|STARTED|Overall Study||75||
59655399|NCT02587520|75773588|FG005|STARTED|Overall Study||75||
59655400|NCT02587520|75773589|FG006|STARTED|Overall Study||76||
59655401|NCT02587520|75773590|FG007|STARTED|Overall Study||73||
59655402|NCT02587520|75773591|FG008|STARTED|Overall Study||76||
59655403|NCT02587520|75773592|FG009|STARTED|Overall Study||76||
59655404|NCT02587520|75773593|FG010|STARTED|Overall Study||76||
59655405|NCT02587520|75773594|FG011|STARTED|Overall Study||73||
59655406|NCT02587520|75773595|FG012|STARTED|Overall Study||77||
59655407|NCT02587520|75773596|FG013|STARTED|Overall Study||74||
59655408|NCT02587520|75773597|FG014|STARTED|Overall Study||78||
59655409|NCT02587520|75773598|FG015|STARTED|Overall Study||72||
59655410|NCT02587520|75773599|FG016|STARTED|Overall Study||76||
59655411|NCT02587520|75773600|FG017|STARTED|Overall Study||78||
59655412|NCT02587520|75773583|FG000|Safety Analysis Set (SafAS)|Overall Study||79|All participants who received study vaccine, analyzed according to vaccine actually received.|
59655413|NCT02587520|75773584|FG001|Safety Analysis Set (SafAS)|Overall Study||71|All participants who received study vaccine, analyzed according to vaccine actually received.|
59655414|NCT02587520|75773585|FG002|Safety Analysis Set (SafAS)|Overall Study||77|All participants who received study vaccine, analyzed according to vaccine actually received.|
59655415|NCT02587520|75773586|FG003|Safety Analysis Set (SafAS)|Overall Study||77|All participants who received study vaccine, analyzed according to vaccine actually received.|
59655416|NCT02587520|75773587|FG004|Safety Analysis Set (SafAS)|Overall Study||75|All participants who received study vaccine, analyzed according to vaccine actually received.|
59655417|NCT02587520|75773588|FG005|Safety Analysis Set (SafAS)|Overall Study||75|All participants who received study vaccine, analyzed according to vaccine actually received.|
59655418|NCT02587520|75773589|FG006|Safety Analysis Set (SafAS)|Overall Study||76|All participants who received study vaccine, analyzed according to vaccine actually received.|
59655419|NCT02587520|75773590|FG007|Safety Analysis Set (SafAS)|Overall Study||73|All participants who received study vaccine, analyzed according to vaccine actually received.|
59988836|NCT02357368|76104053|FG001|COMPLETED|Overall Study||15||
59655420|NCT02587520|75773591|FG008|Safety Analysis Set (SafAS)|Overall Study||76|All participants who received study vaccine, analyzed according to vaccine actually received.|
59655421|NCT02587520|75773592|FG009|Safety Analysis Set (SafAS)|Overall Study||76|All participants who received study vaccine, analyzed according to vaccine actually received.|
59655422|NCT02587520|75773593|FG010|Safety Analysis Set (SafAS)|Overall Study||76|All participants who received study vaccine, analyzed according to vaccine actually received.|
59655423|NCT02587520|75773594|FG011|Safety Analysis Set (SafAS)|Overall Study||72|All participants who received study vaccine, analyzed according to vaccine actually received.|
59655424|NCT02587520|75773595|FG012|Safety Analysis Set (SafAS)|Overall Study||77|All participants who received study vaccine, analyzed according to vaccine actually received.|
59655425|NCT02587520|75773596|FG013|Safety Analysis Set (SafAS)|Overall Study||73|All participants who received study vaccine, analyzed according to vaccine actually received.|
59655426|NCT02587520|75773597|FG014|Safety Analysis Set (SafAS)|Overall Study||78|All participants who received study vaccine, analyzed according to vaccine actually received.|
59988837|NCT02357368|76104054|FG002|COMPLETED|Overall Study||13||
59988838|NCT02357368|76104055|FG003|COMPLETED|Overall Study||5||
59655427|NCT02587520|75773598|FG015|Safety Analysis Set (SafAS)|Overall Study||72|All participants who received study vaccine, analyzed according to vaccine actually received.|
59655428|NCT02587520|75773599|FG016|Safety Analysis Set (SafAS)|Overall Study||76|All participants who received study vaccine, analyzed according to vaccine actually received.|
59655429|NCT02587520|75773600|FG017|Safety Analysis Set (SafAS)|Overall Study||78|All participants who received study vaccine, analyzed according to vaccine actually received.|
59655430|NCT02587520|75773583|FG000|COMPLETED|Overall Study||78||
59655431|NCT02587520|75773584|FG001|COMPLETED|Overall Study||69||
59655432|NCT02587520|75773585|FG002|COMPLETED|Overall Study||77||
59655433|NCT02587520|75773586|FG003|COMPLETED|Overall Study||74||
59655434|NCT02587520|75773587|FG004|COMPLETED|Overall Study||75||
59655435|NCT02587520|75773588|FG005|COMPLETED|Overall Study||72||
59655436|NCT02587520|75773589|FG006|COMPLETED|Overall Study||73||
59655437|NCT02587520|75773590|FG007|COMPLETED|Overall Study||71||
59655438|NCT02587520|75773591|FG008|COMPLETED|Overall Study||73||
59655439|NCT02587520|75773592|FG009|COMPLETED|Overall Study||71||
59655440|NCT02587520|75773593|FG010|COMPLETED|Overall Study||73||
59655441|NCT02587520|75773594|FG011|COMPLETED|Overall Study||69||
59655442|NCT02587520|75773595|FG012|COMPLETED|Overall Study||77||
59655443|NCT02587520|75773596|FG013|COMPLETED|Overall Study||73||
59655444|NCT02587520|75773597|FG014|COMPLETED|Overall Study||78||
59655445|NCT02587520|75773598|FG015|COMPLETED|Overall Study||72||
59655446|NCT02587520|75773599|FG016|COMPLETED|Overall Study||76||
59655447|NCT02587520|75773600|FG017|COMPLETED|Overall Study||78||
59655448|NCT02587520|75773583|FG000|NOT COMPLETED|Overall Study||2||
59655449|NCT02587520|75773584|FG001|NOT COMPLETED|Overall Study||2||
59655450|NCT02587520|75773585|FG002|NOT COMPLETED|Overall Study||1||
59655451|NCT02587520|75773586|FG003|NOT COMPLETED|Overall Study||5||
59655452|NCT02587520|75773587|FG004|NOT COMPLETED|Overall Study||0||
59655453|NCT02587520|75773588|FG005|NOT COMPLETED|Overall Study||3||
59655454|NCT02587520|75773589|FG006|NOT COMPLETED|Overall Study||3||
59655455|NCT02587520|75773590|FG007|NOT COMPLETED|Overall Study||2||
59655456|NCT02587520|75773591|FG008|NOT COMPLETED|Overall Study||3||
59655457|NCT02587520|75773592|FG009|NOT COMPLETED|Overall Study||5||
59655458|NCT02587520|75773593|FG010|NOT COMPLETED|Overall Study||3||
59655459|NCT02587520|75773594|FG011|NOT COMPLETED|Overall Study||4||
59655460|NCT02587520|75773595|FG012|NOT COMPLETED|Overall Study||0||
59655461|NCT02587520|75773596|FG013|NOT COMPLETED|Overall Study||1||
59655462|NCT02587520|75773597|FG014|NOT COMPLETED|Overall Study||0||
59655463|NCT02587520|75773598|FG015|NOT COMPLETED|Overall Study||0||
59655464|NCT02587520|75773599|FG016|NOT COMPLETED|Overall Study||0||
59655465|NCT02587520|75773600|FG017|NOT COMPLETED|Overall Study||0||
59655466|NCT02584829|75773640|FG000|STARTED|Overall Study||1||
59655467|NCT02584829|75773641|FG001|STARTED|Overall Study||7||
59655468|NCT02584829|75773640|FG000|COMPLETED|Overall Study||0||
59815797|NCT03026283|75938215|FG004|STARTED|Optimal Care/Stress Test/ICA||52|Participants diagnosed to receive optimal care, or recommended for stress test diagnosis or ICA|
59543903|NCT02450526|75642191|FG002|NOT COMPLETED|DB Period (Cycle 1)||10||
59543904|NCT02450526|75642192|FG003|NOT COMPLETED|DB Period (Cycle 1)||2||
59543905|NCT02450526|75642193|FG004|NOT COMPLETED|DB Period (Cycle 1)||0||
59543906|NCT02450526|75642189|FG000|STARTED|OL Period (Cycles 2-5)|This arm was not included in OL Period (Cycles 2-5).|0||
59543907|NCT02450526|75642190|FG001|STARTED|OL Period (Cycles 2-5)|This arm was not included in OL Period (Cycles 2-5).|0||
59543908|NCT02450526|75642191|FG002|STARTED|OL Period (Cycles 2-5)|This arm was not included in OL Period (Cycles 2-5).|0||
59543909|NCT02450526|75642192|FG003|STARTED|OL Period (Cycles 2-5)|This arm was not included in OL Period (Cycles 2-5).|0||
59543910|NCT02450526|75642193|FG004|STARTED|OL Period (Cycles 2-5)|Nine subjects completed the DB Period but were not eligible for retreatment in the OL Period.|465||
59543911|NCT02450526|75642189|FG000|Safety Population|OL Period (Cycles 2-5)||0||
59543912|NCT02450526|75642190|FG001|Safety Population|OL Period (Cycles 2-5)||0||
59543913|NCT02450526|75642191|FG002|Safety Population|OL Period (Cycles 2-5)||0||
59543914|NCT02450526|75642192|FG003|Safety Population|OL Period (Cycles 2-5)||0||
59543915|NCT02450526|75642193|FG004|Safety Population|OL Period (Cycles 2-5)||465||
59543916|NCT02450526|75642189|FG000|Discontinued During Cycle 2|OL Period (Cycles 2-5)||0||
59655469|NCT02584829|75773641|FG001|COMPLETED|Overall Study||3||
59655470|NCT02584829|75773640|FG000|NOT COMPLETED|Overall Study||1||
59655471|NCT02584829|75773641|FG001|NOT COMPLETED|Overall Study||4||
59655472|NCT02570308|75773654|FG000|STARTED|Overall Study||3||
59655473|NCT02570308|75773655|FG001|STARTED|Overall Study||6||
59655474|NCT02570308|75773656|FG002|STARTED|Overall Study||4||
59655475|NCT02570308|75773657|FG003|STARTED|Overall Study||6||
59655476|NCT02570308|75773658|FG004|STARTED|Overall Study||127||
59655477|NCT02570308|75773654|FG000|COMPLETED|Overall Study||2||
59655478|NCT02570308|75773655|FG001|COMPLETED|Overall Study||1||
59655479|NCT02570308|75773656|FG002|COMPLETED|Overall Study||0||
59655480|NCT02570308|75773657|FG003|COMPLETED|Overall Study||2||
59655481|NCT02570308|75773658|FG004|COMPLETED|Overall Study||53||
59655482|NCT02570308|75773654|FG000|NOT COMPLETED|Overall Study||1||
59655483|NCT02570308|75773655|FG001|NOT COMPLETED|Overall Study||5||
59655484|NCT02570308|75773656|FG002|NOT COMPLETED|Overall Study||4||
59655485|NCT02570308|75773657|FG003|NOT COMPLETED|Overall Study||4||
59655486|NCT02570308|75773658|FG004|NOT COMPLETED|Overall Study||74||
59655487|NCT02497612|75773680|FG000|STARTED|Overall Study||93||
59655488|NCT02497612|75773681|FG001|STARTED|Overall Study||94||
59655489|NCT02497612|75773682|FG002|STARTED|Overall Study||97||
59655490|NCT02497612|75773683|FG003|STARTED|Overall Study||93||
59655491|NCT02497612|75773680|FG000|Treated|Overall Study||92||
59655492|NCT02497612|75773681|FG001|Treated|Overall Study||94||
59655493|NCT02497612|75773682|FG002|Treated|Overall Study||96||
59655494|NCT02497612|75773683|FG003|Treated|Overall Study||91||
59655495|NCT02497612|75773680|FG000|Cohort 1: >14 Years to <70 Years|Overall Study||14||
59655496|NCT02497612|75773681|FG001|Cohort 1: >14 Years to <70 Years|Overall Study||15||
59655497|NCT02497612|75773682|FG002|Cohort 1: >14 Years to <70 Years|Overall Study||18||
59655498|NCT02497612|75773683|FG003|Cohort 1: >14 Years to <70 Years|Overall Study||16||
59655499|NCT02497612|75773680|FG000|Cohort 2: >5 Years to <=14 Years|Overall Study||6||
59655500|NCT02497612|75773681|FG001|Cohort 2: >5 Years to <=14 Years|Overall Study||5||
59655501|NCT02497612|75773682|FG002|Cohort 2: >5 Years to <=14 Years|Overall Study||6||
59655502|NCT02497612|75773683|FG003|Cohort 2: >5 Years to <=14 Years|Overall Study||5||
59655503|NCT02497612|75773680|FG000|Cohort 3: >2 Years to <=5 Years|Overall Study||66||
59655504|NCT02497612|75773681|FG001|Cohort 3: >2 Years to <=5 Years|Overall Study||66||
59655505|NCT02497612|75773682|FG002|Cohort 3: >2 Years to <=5 Years|Overall Study||67||
59655506|NCT02497612|75773683|FG003|Cohort 3: >2 Years to <=5 Years|Overall Study||65||
59655507|NCT02497612|75773680|FG000|Cohort 4: >6 Months to <=2 Years|Overall Study||7||
59655508|NCT02497612|75773681|FG001|Cohort 4: >6 Months to <=2 Years|Overall Study||8||
59655509|NCT02497612|75773682|FG002|Cohort 4: >6 Months to <=2 Years|Overall Study||6||
59655510|NCT02497612|75773683|FG003|Cohort 4: >6 Months to <=2 Years|Overall Study||7||
59655511|NCT02497612|75773680|FG000|COMPLETED|Overall Study||27||
59655512|NCT02497612|75773681|FG001|COMPLETED|Overall Study||37||
59655513|NCT02497612|75773682|FG002|COMPLETED|Overall Study||48||
59655514|NCT02497612|75773683|FG003|COMPLETED|Overall Study||46||
59655515|NCT02497612|75773680|FG000|NOT COMPLETED|Overall Study||66||
59655516|NCT02497612|75773681|FG001|NOT COMPLETED|Overall Study||57||
59655517|NCT02497612|75773682|FG002|NOT COMPLETED|Overall Study||49||
59655518|NCT02497612|75773683|FG003|NOT COMPLETED|Overall Study||47||
59655519|NCT02460458|75773693|FG000|STARTED|Retrospective Phase||265||
59655520|NCT02460458|75773693|FG000|COMPLETED|Retrospective Phase||265||
59655521|NCT02460458|75773693|FG000|NOT COMPLETED|Retrospective Phase||0||
59655522|NCT02460458|75773693|FG000|STARTED|Confirmatory Phase||265||
59655523|NCT02460458|75773693|FG000|COMPLETED|Confirmatory Phase||177||
59655524|NCT02460458|75773693|FG000|NOT COMPLETED|Confirmatory Phase||88||
59655525|NCT02460458|75773693|FG000|STARTED|First Prospective Phase||177||
59655526|NCT02460458|75773693|FG000|COMPLETED|First Prospective Phase||161||
59655527|NCT02460458|75773693|FG000|NOT COMPLETED|First Prospective Phase||16||
59655528|NCT02460458|75773693|FG000|STARTED|Confirmation of Clinical Phase Data||161||
59655529|NCT02460458|75773693|FG000|COMPLETED|Confirmation of Clinical Phase Data||152||
59655530|NCT02460458|75773693|FG000|NOT COMPLETED|Confirmation of Clinical Phase Data||9||
59655531|NCT02460458|75773693|FG000|STARTED|Second Prospective Phase||152||
59655532|NCT02460458|75773693|FG000|COMPLETED|Second Prospective Phase|Information not available yet, anticipated date is december 2022|0||
59655533|NCT02460458|75773693|FG000|NOT COMPLETED|Second Prospective Phase||152||
59655534|NCT02457559|75773708|FG000|STARTED|Overall Study||2||
59655535|NCT02457559|75773709|FG001|STARTED|Overall Study||3||
59655536|NCT02457559|75773710|FG002|STARTED|Overall Study||7||
59655537|NCT02457559|75773711|FG003|STARTED|Overall Study||2||
59655538|NCT02457559|75773712|FG004|STARTED|Overall Study||1||
59655539|NCT02457559|75773713|FG005|STARTED|Overall Study||2||
59655540|NCT02457559|75773714|FG006|STARTED|Overall Study||2||
59655541|NCT02457559|75773715|FG007|STARTED|Overall Study||1||
59655542|NCT02457559|75773716|FG008|STARTED|Overall Study||3||
59655543|NCT02457559|75773717|FG009|STARTED|Overall Study||4||
59655544|NCT02457559|75773718|FG010|STARTED|Overall Study||2||
59655545|NCT02457559|75773708|FG000|COMPLETED|Overall Study||0||
59655546|NCT02457559|75773709|FG001|COMPLETED|Overall Study||0||
59655547|NCT02457559|75773710|FG002|COMPLETED|Overall Study||0||
59655548|NCT02457559|75773711|FG003|COMPLETED|Overall Study||2||
59655549|NCT02457559|75773712|FG004|COMPLETED|Overall Study||0||
59655550|NCT02457559|75773713|FG005|COMPLETED|Overall Study||0||
59655551|NCT02457559|75773714|FG006|COMPLETED|Overall Study||0||
59655552|NCT02457559|75773715|FG007|COMPLETED|Overall Study||1||
59655553|NCT02457559|75773716|FG008|COMPLETED|Overall Study||0||
59655554|NCT02457559|75773717|FG009|COMPLETED|Overall Study||0||
59655555|NCT02457559|75773718|FG010|COMPLETED|Overall Study||0||
59655556|NCT02457559|75773708|FG000|NOT COMPLETED|Overall Study||2||
59655557|NCT02457559|75773709|FG001|NOT COMPLETED|Overall Study||3||
59655558|NCT02457559|75773710|FG002|NOT COMPLETED|Overall Study||7||
59655559|NCT02457559|75773711|FG003|NOT COMPLETED|Overall Study||0||
59655560|NCT02457559|75773712|FG004|NOT COMPLETED|Overall Study||1||
59655561|NCT02457559|75773713|FG005|NOT COMPLETED|Overall Study||2||
59655562|NCT02457559|75773714|FG006|NOT COMPLETED|Overall Study||2||
59655563|NCT02457559|75773715|FG007|NOT COMPLETED|Overall Study||0||
59655564|NCT02457559|75773716|FG008|NOT COMPLETED|Overall Study||3||
59655565|NCT02457559|75773717|FG009|NOT COMPLETED|Overall Study||4||
59655566|NCT02457559|75773718|FG010|NOT COMPLETED|Overall Study||2||
59655567|NCT02417974|75773758|FG000|STARTED|Overall Study||15||
59655568|NCT02417974|75773759|FG001|STARTED|Overall Study||9||
59655569|NCT02417974|75773758|FG000|COMPLETED|Overall Study||15||
59655570|NCT02417974|75773759|FG001|COMPLETED|Overall Study||9||
59655571|NCT02417974|75773758|FG000|NOT COMPLETED|Overall Study||0||
59655572|NCT02417974|75773759|FG001|NOT COMPLETED|Overall Study||0||
59655573|NCT02381652|75773768|FG000|STARTED|Overall Study|Cingal injection in 13-01 study; receiving a 2nd Cingal injection in 13-02|94|Safety Population and Intent to Treat Population consisted of all enrolled subjects|
59655574|NCT02381652|75773769|FG001|STARTED|Overall Study|Monovisc injection in 13-01 study; receiving a Cingal injection in 13-02|98|Safety Population and Intent to Treat Population consisted of all enrolled subjects|
59655575|NCT02381652|75773770|FG002|STARTED|Overall Study|Saline injection in 13-01 study; receiving a Cingal injection in 13-02|50|Safety Population and Intent to Treat Population consisted of all enrolled subjects|
59655576|NCT02381652|75773768|FG000|COMPLETED|Overall Study||94||
59655577|NCT02381652|75773769|FG001|COMPLETED|Overall Study||98||
59655578|NCT02381652|75773770|FG002|COMPLETED|Overall Study||49||
59655579|NCT02381652|75773768|FG000|NOT COMPLETED|Overall Study||0||
59655580|NCT02381652|75773769|FG001|NOT COMPLETED|Overall Study||0||
59655581|NCT02381652|75773770|FG002|NOT COMPLETED|Overall Study||1||
59655582|NCT02367794|75773779|FG000|STARTED|Overall Study||340||
59655583|NCT02367794|75773780|FG001|STARTED|Overall Study||343||
59655584|NCT02367794|75773781|FG002|STARTED|Overall Study||338||
59655585|NCT02367794|75773779|FG000|COMPLETED|Overall Study||0||
59655586|NCT02367794|75773780|FG001|COMPLETED|Overall Study||0||
59655587|NCT02367794|75773781|FG002|COMPLETED|Overall Study||0||
59655588|NCT02367794|75773779|FG000|NOT COMPLETED|Overall Study||340||
59655589|NCT02367794|75773780|FG001|NOT COMPLETED|Overall Study||343||
59655590|NCT02367794|75773781|FG002|NOT COMPLETED|Overall Study||338||
59655591|NCT02363998|75773794|FG000|STARTED|Overall Study||286||
59655592|NCT02363998|75773794|FG000|COMPLETED|Overall Study|A subject was defined as completed if at least one dose was taken on Day 7.|168||
59655593|NCT02363998|75773794|FG000|NOT COMPLETED|Overall Study||118||
59655594|NCT02353832|75773814|FG000|STARTED|Overall Study||44||
59655595|NCT02353832|75773814|FG000|COMPLETED|Overall Study||42||
59655596|NCT02353832|75773814|FG000|NOT COMPLETED|Overall Study||2||
59655597|NCT02353728|75773818|FG000|STARTED|Overall Study||16||
59655598|NCT02353728|75773818|FG000|COMPLETED|Overall Study||15||
59655599|NCT02353728|75773818|FG000|NOT COMPLETED|Overall Study||1||
59655600|NCT02345070|75773825|FG000|STARTED|Overall Study||110|Randomized|
59655601|NCT02345070|75773826|FG001|STARTED|Overall Study||109|Randomized|
59655602|NCT02345070|75773827|FG002|STARTED|Overall Study||108|Randomized|
59655603|NCT02345070|75773825|FG000|Treated|Overall Study||109||
59655604|NCT02345070|75773826|FG001|Treated|Overall Study||108||
59655605|NCT02345070|75773827|FG002|Treated|Overall Study||108||
59655606|NCT02345070|75773825|FG000|COMPLETED|Overall Study||90||
59655607|NCT02345070|75773826|FG001|COMPLETED|Overall Study||98||
59655608|NCT02345070|75773827|FG002|COMPLETED|Overall Study||85||
59988839|NCT02357368|76104052|FG000|NOT COMPLETED|Overall Study||6||
59988840|NCT02357368|76104053|FG001|NOT COMPLETED|Overall Study||3||
59655609|NCT02345070|75773825|FG000|NOT COMPLETED|Overall Study||20||
59655610|NCT02345070|75773826|FG001|NOT COMPLETED|Overall Study||11||
59655611|NCT02345070|75773827|FG002|NOT COMPLETED|Overall Study||23||
59655612|NCT02325466|75773835|FG000|STARTED|Period 1 Timeframe - Baseline to Week 4||23||
59655613|NCT02325466|75773836|FG001|STARTED|Period 1 Timeframe - Baseline to Week 4||23||
59655614|NCT02325466|75773837|FG002|STARTED|Period 1 Timeframe - Baseline to Week 4||24||
59655615|NCT02325466|75773835|FG000|COMPLETED|Period 1 Timeframe - Baseline to Week 4||22||
59655616|NCT02325466|75773836|FG001|COMPLETED|Period 1 Timeframe - Baseline to Week 4||21||
59655617|NCT02325466|75773837|FG002|COMPLETED|Period 1 Timeframe - Baseline to Week 4||21||
59655618|NCT02325466|75773835|FG000|NOT COMPLETED|Period 1 Timeframe - Baseline to Week 4||1||
59988841|NCT02357368|76104054|FG002|NOT COMPLETED|Overall Study||1||
59655619|NCT02325466|75773836|FG001|NOT COMPLETED|Period 1 Timeframe - Baseline to Week 4||2||
59655620|NCT02325466|75773837|FG002|NOT COMPLETED|Period 1 Timeframe - Baseline to Week 4||3||
59655621|NCT02325466|75773835|FG000|STARTED|Period 2 - Timeframe Week 4 to Week 10||22||
59655622|NCT02325466|75773836|FG001|STARTED|Period 2 - Timeframe Week 4 to Week 10||21||
59988842|NCT02357368|76104055|FG003|NOT COMPLETED|Overall Study||3||
59988843|NCT03287245|76104069|FG000|STARTED|Overall Study||15||
59988844|NCT03287245|76104070|FG001|STARTED|Overall Study||5||
59655623|NCT02325466|75773837|FG002|STARTED|Period 2 - Timeframe Week 4 to Week 10||21||
59655624|NCT02325466|75773835|FG000|COMPLETED|Period 2 - Timeframe Week 4 to Week 10||19||
59655625|NCT02325466|75773836|FG001|COMPLETED|Period 2 - Timeframe Week 4 to Week 10||20||
59655626|NCT02325466|75773837|FG002|COMPLETED|Period 2 - Timeframe Week 4 to Week 10||21||
59655627|NCT02325466|75773835|FG000|NOT COMPLETED|Period 2 - Timeframe Week 4 to Week 10||3||
59655628|NCT02325466|75773836|FG001|NOT COMPLETED|Period 2 - Timeframe Week 4 to Week 10||1||
59655629|NCT02325466|75773837|FG002|NOT COMPLETED|Period 2 - Timeframe Week 4 to Week 10||0||
59655630|NCT02325466|75773835|FG000|STARTED|3rd Crossover - Week 10 to Week 16||19||
59655631|NCT02325466|75773836|FG001|STARTED|3rd Crossover - Week 10 to Week 16||20||
59655632|NCT02325466|75773837|FG002|STARTED|3rd Crossover - Week 10 to Week 16||21||
59655633|NCT02325466|75773835|FG000|COMPLETED|3rd Crossover - Week 10 to Week 16||18||
59655634|NCT02325466|75773836|FG001|COMPLETED|3rd Crossover - Week 10 to Week 16||18||
59655635|NCT02325466|75773837|FG002|COMPLETED|3rd Crossover - Week 10 to Week 16||21||
59655636|NCT02325466|75773835|FG000|NOT COMPLETED|3rd Crossover - Week 10 to Week 16||1||
59655637|NCT02325466|75773836|FG001|NOT COMPLETED|3rd Crossover - Week 10 to Week 16||2||
59655638|NCT02325466|75773837|FG002|NOT COMPLETED|3rd Crossover - Week 10 to Week 16||0||
59655639|NCT02322710|75773848|FG000|STARTED|Overall Study||105|Patients randomized|
59655640|NCT02322710|75773849|FG001|STARTED|Overall Study||99|Patients randomized|
59655641|NCT02322710|75773848|FG000|Safety Population|Overall Study||105||
59655642|NCT02322710|75773849|FG001|Safety Population|Overall Study||99||
59655643|NCT02322710|75773848|FG000|Full Analysis Population|Overall Study||105|No efficacy assessment post-baseline (N=1)|
59655644|NCT02322710|75773849|FG001|Full Analysis Population|Overall Study||98|No efficacy assessment post-baseline (N=1)|
59655645|NCT02322710|75773848|FG000|COMPLETED|Overall Study||85|Per protocol population|
59655646|NCT02322710|75773849|FG001|COMPLETED|Overall Study||73|Per protocol population|
59655647|NCT02322710|75773848|FG000|NOT COMPLETED|Overall Study||20||
59655648|NCT02322710|75773849|FG001|NOT COMPLETED|Overall Study||26||
59655649|NCT02303548|75773857|FG000|STARTED|Overall Study||25||
59655650|NCT02303548|75773858|FG001|STARTED|Overall Study||25||
59655651|NCT02303548|75773857|FG000|COMPLETED|Overall Study||25||
59655652|NCT02303548|75773858|FG001|COMPLETED|Overall Study||25||
59655653|NCT02303548|75773857|FG000|NOT COMPLETED|Overall Study||0||
59655654|NCT02303548|75773858|FG001|NOT COMPLETED|Overall Study||0||
59655655|NCT02292654|75773867|FG000|STARTED|Overall Study||4||
59655656|NCT02292654|75773868|FG001|STARTED|Overall Study||9||
59655657|NCT02292654|75773869|FG002|STARTED|Overall Study||7||
59655658|NCT02292654|75773867|FG000|COMPLETED|Overall Study||4||
59655659|NCT02292654|75773868|FG001|COMPLETED|Overall Study||9||
59655660|NCT02292654|75773869|FG002|COMPLETED|Overall Study||7||
59655661|NCT02292654|75773867|FG000|NOT COMPLETED|Overall Study||0||
59655662|NCT02292654|75773868|FG001|NOT COMPLETED|Overall Study||0||
59655663|NCT02292654|75773869|FG002|NOT COMPLETED|Overall Study||0||
59655664|NCT02239354|75773885|FG000|STARTED|Overall Study||19||
59655665|NCT02239354|75773886|FG001|STARTED|Overall Study||0||
59655666|NCT02239354|75773885|FG000|COMPLETED|Overall Study||9||
59655667|NCT02239354|75773886|FG001|COMPLETED|Overall Study||0||
59655668|NCT02239354|75773885|FG000|NOT COMPLETED|Overall Study||10||
59655669|NCT02239354|75773886|FG001|NOT COMPLETED|Overall Study||0||
59655670|NCT02234310|75773892|FG000|STARTED|Overall Study||33||
59655671|NCT02234310|75773892|FG000|Episodic Treatment Regimen|Overall Study|Participants were treated in more than one regimen and counted in all categories wherever applicable|22||
59655672|NCT02234310|75773892|FG000|Prophylactic Treatment Regimen|Overall Study|17 participants among the 22 who started in episodic regimen, switched to the prophylactic regimen.|28||
59655673|NCT02234310|75773892|FG000|COMPLETED|Overall Study||27||
59655674|NCT02234310|75773892|FG000|NOT COMPLETED|Overall Study||6||
59655675|NCT02139436|75773899|FG000|STARTED|Overall Study||41||
59655676|NCT02139436|75773900|FG001|STARTED|Overall Study||14||
59655677|NCT02139436|75773901|FG002|STARTED|Overall Study||13||
59655678|NCT02139436|75773899|FG000|COMPLETED|Overall Study||41||
59655679|NCT02139436|75773900|FG001|COMPLETED|Overall Study||14||
59655680|NCT02139436|75773901|FG002|COMPLETED|Overall Study||13||
59655681|NCT02139436|75773899|FG000|NOT COMPLETED|Overall Study||0||
59655682|NCT02139436|75773900|FG001|NOT COMPLETED|Overall Study||0||
59655683|NCT02139436|75773901|FG002|NOT COMPLETED|Overall Study||0||
59988845|NCT03287245|76104071|FG002|STARTED|Overall Study||6||
59988846|NCT03287245|76104072|FG003|STARTED|Overall Study||1||
59988847|NCT03287245|76104069|FG000|COMPLETED|Overall Study||0||
59988848|NCT03287245|76104070|FG001|COMPLETED|Overall Study||0||
59988849|NCT03287245|76104071|FG002|COMPLETED|Overall Study||0||
59988850|NCT03287245|76104072|FG003|COMPLETED|Overall Study||0||
59988851|NCT03287245|76104069|FG000|NOT COMPLETED|Overall Study||15||
59655684|NCT02120079|75773917|FG000|STARTED|Baseline||17||28
59655685|NCT02120079|75773918|FG001|STARTED|Baseline||20||34
59655686|NCT02120079|75773917|FG000|COMPLETED|Baseline||17||28
59988852|NCT03287245|76104070|FG001|NOT COMPLETED|Overall Study||5||
59988853|NCT03287245|76104071|FG002|NOT COMPLETED|Overall Study||6||
59988854|NCT03287245|76104072|FG003|NOT COMPLETED|Overall Study||1||
59655687|NCT02120079|75773918|FG001|COMPLETED|Baseline||20||34
59655688|NCT02120079|75773917|FG000|NOT COMPLETED|Baseline||0||0
59655689|NCT02120079|75773918|FG001|NOT COMPLETED|Baseline||0||0
59655690|NCT02120079|75773917|FG000|STARTED|2 Weeks||17||28
59655691|NCT02120079|75773918|FG001|STARTED|2 Weeks||20||34
59655692|NCT02120079|75773917|FG000|COMPLETED|2 Weeks||17||28
59655693|NCT02120079|75773918|FG001|COMPLETED|2 Weeks||20||34
59655694|NCT02120079|75773917|FG000|NOT COMPLETED|2 Weeks||0||0
59655695|NCT02120079|75773918|FG001|NOT COMPLETED|2 Weeks||0||0
59655696|NCT02120079|75773917|FG000|STARTED|6 Weeks||17||28
59655697|NCT02120079|75773918|FG001|STARTED|6 Weeks||20||34
59655698|NCT02120079|75773917|FG000|COMPLETED|6 Weeks||17||28
59655699|NCT02120079|75773918|FG001|COMPLETED|6 Weeks||20||34
59655700|NCT02120079|75773917|FG000|NOT COMPLETED|6 Weeks||0||0
59655701|NCT02120079|75773918|FG001|NOT COMPLETED|6 Weeks||0||0
59655702|NCT02106195|75773925|FG000|STARTED|Overall Study||8||
59655703|NCT02106195|75773925|FG000|COMPLETED|Overall Study|Includes all 3 periods of study: Screening, Treatment, Post-treatment|5||
59655704|NCT02106195|75773925|FG000|NOT COMPLETED|Overall Study||3||
59655705|NCT02104180|75773937|FG000|STARTED|Overall Study||31||
59655706|NCT02104180|75773938|FG001|STARTED|Overall Study||31||
59655707|NCT02104180|75773937|FG000|COMPLETED|Overall Study||30||
59655708|NCT02104180|75773938|FG001|COMPLETED|Overall Study||31||
59655709|NCT02104180|75773937|FG000|NOT COMPLETED|Overall Study||1||
59655710|NCT02104180|75773938|FG001|NOT COMPLETED|Overall Study||0||
59655711|NCT02050919|75773944|FG000|STARTED|Overall Study||20||
59655712|NCT02050919|75773944|FG000|COMPLETED|Overall Study||20||
59655713|NCT02050919|75773944|FG000|NOT COMPLETED|Overall Study||0||
59655714|NCT01997463|75773950|FG000|STARTED|Overall Study||192||
59655715|NCT01997463|75773951|FG001|STARTED|Overall Study||250||
59655716|NCT01997463|75773950|FG000|COMPLETED|Overall Study||107||
59655717|NCT01997463|75773951|FG001|COMPLETED|Overall Study||147||
59655718|NCT01997463|75773950|FG000|NOT COMPLETED|Overall Study||85||
59655719|NCT01997463|75773951|FG001|NOT COMPLETED|Overall Study||103||
59655720|NCT01943825|75773961|FG000|STARTED|Overall Study||25||
59655721|NCT01943825|75773962|FG001|STARTED|Overall Study||15||
59655722|NCT01943825|75773963|FG002|STARTED|Overall Study||25||
59655723|NCT01943825|75773964|FG003|STARTED|Overall Study||25||
59655724|NCT01943825|75773961|FG000|COMPLETED|Overall Study||15||
59655725|NCT01943825|75773962|FG001|COMPLETED|Overall Study||11||
59655726|NCT01943825|75773963|FG002|COMPLETED|Overall Study||10||
59655727|NCT01943825|75773964|FG003|COMPLETED|Overall Study||14||
59655728|NCT01943825|75773961|FG000|NOT COMPLETED|Overall Study||10||
59655729|NCT01943825|75773962|FG001|NOT COMPLETED|Overall Study||4||
59655730|NCT01943825|75773963|FG002|NOT COMPLETED|Overall Study||15||
59655731|NCT01943825|75773964|FG003|NOT COMPLETED|Overall Study||11||
59655732|NCT01863186|75773981|FG000|STARTED|Double-blind Phase|Original number of 230. One participant was randomly assigned into the study, but not dosed.|229||
59655733|NCT01863186|75773982|FG001|STARTED|Double-blind Phase||222||
59655734|NCT01863186|75773983|FG002|STARTED|Double-blind Phase||151||
59655735|NCT01863186|75773984|FG003|STARTED|Double-blind Phase||0||
59655736|NCT01863186|75773981|FG000|COMPLETED|Double-blind Phase||95||
59655737|NCT01863186|75773982|FG001|COMPLETED|Double-blind Phase||88||
59655738|NCT01863186|75773983|FG002|COMPLETED|Double-blind Phase||42||
59655739|NCT01863186|75773984|FG003|COMPLETED|Double-blind Phase||0||
59655740|NCT01863186|75773981|FG000|NOT COMPLETED|Double-blind Phase||134||
59655741|NCT01863186|75773982|FG001|NOT COMPLETED|Double-blind Phase||134||
60077054|NCT01886287|76192090|FG000|STARTED|Overall Study||2||
60077055|NCT01886287|76192090|FG000|COMPLETED|Overall Study||0||
60077056|NCT01886287|76192090|FG000|NOT COMPLETED|Overall Study||2||
60077057|NCT01885195|76192094|FG000|STARTED|Overall Study||110||
59655742|NCT01863186|75773983|FG002|NOT COMPLETED|Double-blind Phase||109||
59655743|NCT01863186|75773984|FG003|NOT COMPLETED|Double-blind Phase||0||
60077058|NCT01885195|76192094|FG000|COMPLETED|Overall Study||0||
60077059|NCT01885195|76192094|FG000|NOT COMPLETED|Overall Study||110||
59655744|NCT01863186|75773981|FG000|STARTED|Open-label Phase||0||
59655745|NCT01863186|75773982|FG001|STARTED|Open-label Phase||0||
59655746|NCT01863186|75773983|FG002|STARTED|Open-label Phase|No placebo group in the Open-label Phase.|0||
59655747|NCT01863186|75773984|FG003|STARTED|Open-label Phase|36 from 2.4 mg group, 28 from 3.2mg group, and 19 from Placebo continued to the Open-label phase.|83||
59655748|NCT01863186|75773981|FG000|COMPLETED|Open-label Phase||0||
59655749|NCT01863186|75773982|FG001|COMPLETED|Open-label Phase||0||
59655750|NCT01863186|75773983|FG002|COMPLETED|Open-label Phase||0||
59655751|NCT01863186|75773984|FG003|COMPLETED|Open-label Phase||70||
59655752|NCT01863186|75773981|FG000|NOT COMPLETED|Open-label Phase||0||
59655753|NCT01863186|75773982|FG001|NOT COMPLETED|Open-label Phase||0||
59655754|NCT01863186|75773983|FG002|NOT COMPLETED|Open-label Phase||0||
60077060|NCT01896895|76192101|FG000|STARTED|Double-blind MP||20||
60077061|NCT01896895|76192102|FG001|STARTED|Double-blind MP||22||
60077062|NCT01896895|76192103|FG002|STARTED|Double-blind MP||19||
59655755|NCT01863186|75773984|FG003|NOT COMPLETED|Open-label Phase||13||
59655756|NCT01722331|75773996|FG000|STARTED|Part 1||308||
59655757|NCT01722331|75773997|FG001|STARTED|Part 1||249||
59655758|NCT01722331|75773998|FG002|STARTED|Part 1||41||
59655759|NCT01722331|75773999|FG003|STARTED|Part 1||19||
59543917|NCT02450526|75642190|FG001|Discontinued During Cycle 2|OL Period (Cycles 2-5)||0||
59543918|NCT02450526|75642191|FG002|Discontinued During Cycle 2|OL Period (Cycles 2-5)||0||
59543919|NCT02450526|75642192|FG003|Discontinued During Cycle 2|OL Period (Cycles 2-5)||0||
59655760|NCT01722331|75774000|FG004|STARTED|Part 1||9||
59655761|NCT01722331|75774001|FG005|STARTED|Part 1||72||
59655762|NCT01722331|75774002|FG006|STARTED|Part 1||74||
59655763|NCT01722331|75773996|FG000|COMPLETED|Part 1||298||
59655764|NCT01722331|75773997|FG001|COMPLETED|Part 1||249||
59655765|NCT01722331|75773998|FG002|COMPLETED|Part 1||32||
59543920|NCT02450526|75642193|FG004|Discontinued During Cycle 2|OL Period (Cycles 2-5)||28||
59543921|NCT02450526|75642189|FG000|Discontinued During Cycle 3|OL Period (Cycles 2-5)||0||
59543922|NCT02450526|75642190|FG001|Discontinued During Cycle 3|OL Period (Cycles 2-5)||0||
59543923|NCT02450526|75642191|FG002|Discontinued During Cycle 3|OL Period (Cycles 2-5)||0||
59543924|NCT02450526|75642192|FG003|Discontinued During Cycle 3|OL Period (Cycles 2-5)||0||
59543925|NCT02450526|75642193|FG004|Discontinued During Cycle 3|OL Period (Cycles 2-5)||11||
59543926|NCT02450526|75642189|FG000|Discontinued During Cycle 4|OL Period (Cycles 2-5)||0||
59543927|NCT02450526|75642190|FG001|Discontinued During Cycle 4|OL Period (Cycles 2-5)||0||
59543928|NCT02450526|75642191|FG002|Discontinued During Cycle 4|OL Period (Cycles 2-5)||0||
59543929|NCT02450526|75642192|FG003|Discontinued During Cycle 4|OL Period (Cycles 2-5)||0||
59543930|NCT02450526|75642193|FG004|Discontinued During Cycle 4|OL Period (Cycles 2-5)||2||
59543931|NCT02450526|75642189|FG000|Discontinued During Cycle 5|OL Period (Cycles 2-5)||0||
59543932|NCT02450526|75642190|FG001|Discontinued During Cycle 5|OL Period (Cycles 2-5)||0||
59543933|NCT02450526|75642191|FG002|Discontinued During Cycle 5|OL Period (Cycles 2-5)||0||
59543934|NCT02450526|75642192|FG003|Discontinued During Cycle 5|OL Period (Cycles 2-5)||0||
59543935|NCT02450526|75642193|FG004|Discontinued During Cycle 5|OL Period (Cycles 2-5)||0||
59543936|NCT02450526|75642189|FG000|COMPLETED|OL Period (Cycles 2-5)||0||
59543937|NCT02450526|75642190|FG001|COMPLETED|OL Period (Cycles 2-5)||0||
59543938|NCT02450526|75642191|FG002|COMPLETED|OL Period (Cycles 2-5)||0||
59543939|NCT02450526|75642192|FG003|COMPLETED|OL Period (Cycles 2-5)||0||
59543940|NCT02450526|75642193|FG004|COMPLETED|OL Period (Cycles 2-5)||424||
59655766|NCT01722331|75773999|FG003|COMPLETED|Part 1||19||
59655767|NCT01722331|75774000|FG004|COMPLETED|Part 1||0||
59655768|NCT01722331|75774001|FG005|COMPLETED|Part 1||72||
59655769|NCT01722331|75774002|FG006|COMPLETED|Part 1||74||
59655770|NCT01722331|75773996|FG000|NOT COMPLETED|Part 1||10||
59655771|NCT01722331|75773997|FG001|NOT COMPLETED|Part 1||0||
59655772|NCT01722331|75773998|FG002|NOT COMPLETED|Part 1||9||
59655773|NCT01722331|75773999|FG003|NOT COMPLETED|Part 1||0||
59655774|NCT01722331|75774000|FG004|NOT COMPLETED|Part 1||9||
59655775|NCT01722331|75774001|FG005|NOT COMPLETED|Part 1||0||
59655776|NCT01722331|75774002|FG006|NOT COMPLETED|Part 1||0||
59655777|NCT01722331|75773996|FG000|STARTED|Part 2||298||
59655778|NCT01722331|75773997|FG001|STARTED|Part 2||249||
59655779|NCT01722331|75773998|FG002|STARTED|Part 2|1 participant who completed Part 1 did not enter Part 2|31||
59655780|NCT01722331|75773999|FG003|STARTED|Part 2||19||
59655781|NCT01722331|75774000|FG004|STARTED|Part 2||0||
59655782|NCT01722331|75774001|FG005|STARTED|Part 2||72||
59655783|NCT01722331|75774002|FG006|STARTED|Part 2||74||
59655784|NCT01722331|75773996|FG000|COMPLETED|Part 2||279||
59655785|NCT01722331|75773997|FG001|COMPLETED|Part 2||249||
59655786|NCT01722331|75773998|FG002|COMPLETED|Part 2||0||
59655787|NCT01722331|75773999|FG003|COMPLETED|Part 2||19||
59655788|NCT01722331|75774000|FG004|COMPLETED|Part 2||0||
59655789|NCT01722331|75774001|FG005|COMPLETED|Part 2||62||
59655790|NCT01722331|75774002|FG006|COMPLETED|Part 2||67||
59655791|NCT01722331|75773996|FG000|NOT COMPLETED|Part 2||19||
59655792|NCT01722331|75773997|FG001|NOT COMPLETED|Part 2||0||
59655793|NCT01722331|75773998|FG002|NOT COMPLETED|Part 2||31||
59655794|NCT01722331|75773999|FG003|NOT COMPLETED|Part 2||0||
59655795|NCT01722331|75774000|FG004|NOT COMPLETED|Part 2||0||
59655796|NCT01722331|75774001|FG005|NOT COMPLETED|Part 2||10||
59655797|NCT01722331|75774002|FG006|NOT COMPLETED|Part 2||7||
59655798|NCT01722331|75773996|FG000|STARTED|Part 3||279||
59655799|NCT01722331|75773997|FG001|STARTED|Part 3||249||
59655800|NCT01722331|75773998|FG002|STARTED|Part 3||0||
59655801|NCT01722331|75773999|FG003|STARTED|Part 3||19||
59655802|NCT01722331|75774000|FG004|STARTED|Part 3||0||
59655803|NCT01722331|75774001|FG005|STARTED|Part 3||62||
59655804|NCT01722331|75774002|FG006|STARTED|Part 3||67||
59655805|NCT01722331|75773996|FG000|COMPLETED|Part 3||264||
59655806|NCT01722331|75773997|FG001|COMPLETED|Part 3||232||
59655807|NCT01722331|75773998|FG002|COMPLETED|Part 3||0||
59655808|NCT01722331|75773999|FG003|COMPLETED|Part 3||18||
59655809|NCT01722331|75774000|FG004|COMPLETED|Part 3||0||
59655810|NCT01722331|75774001|FG005|COMPLETED|Part 3||59||
59655811|NCT01722331|75774002|FG006|COMPLETED|Part 3||65||
59655812|NCT01722331|75773996|FG000|NOT COMPLETED|Part 3||15||
59655813|NCT01722331|75773997|FG001|NOT COMPLETED|Part 3||17||
59655814|NCT01722331|75773998|FG002|NOT COMPLETED|Part 3||0||
59655815|NCT01722331|75773999|FG003|NOT COMPLETED|Part 3||1||
59655816|NCT01722331|75774000|FG004|NOT COMPLETED|Part 3||0||
59655817|NCT01722331|75774001|FG005|NOT COMPLETED|Part 3||3||
59655818|NCT01722331|75774002|FG006|NOT COMPLETED|Part 3||2||
59655819|NCT01630590|75774014|FG000|STARTED|Overall Study||62||
59655820|NCT01630590|75774014|FG000|COMPLETED|Overall Study||5||
59655821|NCT01630590|75774014|FG000|NOT COMPLETED|Overall Study||57||
59655822|NCT01619085|75774018|FG000|STARTED|Overall Study||752||
59655823|NCT01619085|75774018|FG000|Treated|Overall Study||751||
59655824|NCT01619085|75774018|FG000|COMPLETED|Overall Study||227|'completed' stands for not prematurely discontinued from trial medication|
59655825|NCT01619085|75774018|FG000|NOT COMPLETED|Overall Study||525||
59655826|NCT01499095|75774031|FG000|STARTED|Overall Study||404||
59655827|NCT01499095|75774032|FG001|STARTED|Overall Study||407||
59655828|NCT01499095|75774031|FG000|Treated|Overall Study||403||
59655829|NCT01499095|75774032|FG001|Treated|Overall Study||406||
59655830|NCT01499095|75774031|FG000|Participated in Substudy|Overall Study|45 participants received adaptable dosing regimen and 44 participants received fixed dosing regimen|89||
59655831|NCT01499095|75774032|FG001|Participated in Substudy|Overall Study||0||
59655832|NCT01499095|75774031|FG000|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|403||
59655833|NCT01499095|75774032|FG001|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|405||
59655834|NCT01499095|75774031|FG000|COMPLETED|Overall Study||315||
59655835|NCT01499095|75774032|FG001|COMPLETED|Overall Study||314||
59655836|NCT01499095|75774031|FG000|NOT COMPLETED|Overall Study||89||
59655837|NCT01499095|75774032|FG001|NOT COMPLETED|Overall Study||93||
59655838|NCT01499082|75774043|FG000|STARTED|Overall Study||404||
59655839|NCT01499082|75774044|FG001|STARTED|Overall Study||403||
59655840|NCT01499082|75774043|FG000|Treated|Overall Study||404||
59655841|NCT01499082|75774044|FG001|Treated|Overall Study||402||
59655842|NCT01499082|75774043|FG000|Participated in Substudy|Overall Study|56 participants received adaptable dosing regimen and 53 participants received fixed dosing regimen|109||
59655843|NCT01499082|75774044|FG001|Participated in Substudy|Overall Study||0||
59655844|NCT01499082|75774043|FG000|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|404||
59655845|NCT01499082|75774044|FG001|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|400||
59655846|NCT01499082|75774043|FG000|COMPLETED|Overall Study||359||
59655847|NCT01499082|75774044|FG001|COMPLETED|Overall Study||355||
59655848|NCT01499082|75774043|FG000|NOT COMPLETED|Overall Study||45||
59655849|NCT01499082|75774044|FG001|NOT COMPLETED|Overall Study||48||
59655850|NCT01488890|75774056|FG000|STARTED|Overall Study||120||
59655851|NCT01488890|75774057|FG001|STARTED|Overall Study||120||
59655852|NCT01488890|75774058|FG002|STARTED|Overall Study||120||
59655853|NCT01488890|75774059|FG003|STARTED|Overall Study||30||
59655854|NCT01488890|75774056|FG000|Treated|Overall Study||120||
59655855|NCT01488890|75774057|FG001|Treated|Overall Study||120||
59655856|NCT01488890|75774058|FG002|Treated|Overall Study||119||
59655857|NCT01488890|75774059|FG003|Treated|Overall Study||30||
59655858|NCT01488890|75774056|FG000|COMPLETED|Overall Study||88||
59655859|NCT01488890|75774057|FG001|COMPLETED|Overall Study||100||
59655860|NCT01488890|75774058|FG002|COMPLETED|Overall Study||85||
59655861|NCT01488890|75774059|FG003|COMPLETED|Overall Study||25||
59655862|NCT01488890|75774056|FG000|NOT COMPLETED|Overall Study||32||
59655863|NCT01488890|75774057|FG001|NOT COMPLETED|Overall Study||20||
59655864|NCT01488890|75774058|FG002|NOT COMPLETED|Overall Study||35||
59655865|NCT01488890|75774059|FG003|NOT COMPLETED|Overall Study||5||
59655866|NCT01436396|75774075|FG000|STARTED|Overall Study||396||
59655867|NCT01436396|75774076|FG001|STARTED|Overall Study||396||
59655868|NCT01436396|75774075|FG000|Vaccinated|Overall Study||394||
59655869|NCT01436396|75774076|FG001|Vaccinated|Overall Study||393||
59655870|NCT01436396|75774075|FG000|COMPLETED|Overall Study||364||
59655871|NCT01436396|75774076|FG001|COMPLETED|Overall Study||354||
59655872|NCT01436396|75774075|FG000|NOT COMPLETED|Overall Study||32||
59655873|NCT01436396|75774076|FG001|NOT COMPLETED|Overall Study||42||
59655874|NCT01411241|75774084|FG000|STARTED|Overall Study||309||
59655875|NCT01411241|75774085|FG001|STARTED|Overall Study||315||
59655876|NCT01411241|75774084|FG000|COMPLETED|Overall Study||298||
59655877|NCT01411241|75774085|FG001|COMPLETED|Overall Study||293||
59655878|NCT01411241|75774084|FG000|NOT COMPLETED|Overall Study||11||
59655879|NCT01411241|75774085|FG001|NOT COMPLETED|Overall Study||22||
59655880|NCT01374516|75774093|FG000|STARTED|Vaccination Phase (Up to 25 Months)||13920||
59655881|NCT01374516|75774094|FG001|STARTED|Vaccination Phase (Up to 25 Months)||6949||
59655882|NCT01374516|75774093|FG000|COMPLETED|Vaccination Phase (Up to 25 Months)||13281||
59655883|NCT01374516|75774094|FG001|COMPLETED|Vaccination Phase (Up to 25 Months)||6640||
59655884|NCT01374516|75774093|FG000|NOT COMPLETED|Vaccination Phase (Up to 25 Months)||639||
59655885|NCT01374516|75774094|FG001|NOT COMPLETED|Vaccination Phase (Up to 25 Months)||309||
59655886|NCT01374516|75774093|FG000|STARTED|Surveillance Expansion Period||13281||
59655887|NCT01374516|75774094|FG001|STARTED|Surveillance Expansion Period||6640||
59655888|NCT01374516|75774093|FG000|COMPLETED|Surveillance Expansion Period||10932||
59655889|NCT01374516|75774094|FG001|COMPLETED|Surveillance Expansion Period||5387||
59655890|NCT01374516|75774093|FG000|NOT COMPLETED|Surveillance Expansion Period||2349||
59655891|NCT01374516|75774094|FG001|NOT COMPLETED|Surveillance Expansion Period||1253||
59655892|NCT01373281|75774109|FG000|STARTED|Vaccination Phase (Up to 25 Months)||6851||
59655893|NCT01373281|75774110|FG001|STARTED|Vaccination Phase (Up to 25 Months)||3424||
59655894|NCT01373281|75774109|FG000|COMPLETED|Vaccination Phase (Up to 25 Months)||6797||
59655895|NCT01373281|75774110|FG001|COMPLETED|Vaccination Phase (Up to 25 Months)||3397||
59655896|NCT01373281|75774109|FG000|NOT COMPLETED|Vaccination Phase (Up to 25 Months)||54||
59655897|NCT01373281|75774110|FG001|NOT COMPLETED|Vaccination Phase (Up to 25 Months)||27||
59655898|NCT01373281|75774109|FG000|STARTED|Surveillance Expansion Period||6797||
59655899|NCT01373281|75774110|FG001|STARTED|Surveillance Expansion Period||3397||
59655900|NCT01373281|75774109|FG000|COMPLETED|Surveillance Expansion Period||6595||
59655901|NCT01373281|75774110|FG001|COMPLETED|Surveillance Expansion Period||3279||
59655902|NCT01373281|75774109|FG000|NOT COMPLETED|Surveillance Expansion Period||202||
59655903|NCT01373281|75774110|FG001|NOT COMPLETED|Surveillance Expansion Period||118||
59655904|NCT01254422|75774125|FG000|STARTED|Overall Study||199||
59655905|NCT01254422|75774126|FG001|STARTED|Overall Study||51||
59655906|NCT01254422|75774125|FG000|COMPLETED|Overall Study||196||
59655907|NCT01254422|75774126|FG001|COMPLETED|Overall Study||50||
59655908|NCT01254422|75774125|FG000|NOT COMPLETED|Overall Study||3||
59655909|NCT01254422|75774126|FG001|NOT COMPLETED|Overall Study||1||
59655910|NCT01187433|75774134|FG000|STARTED|Overall Study||100||
59655911|NCT01187433|75774135|FG001|STARTED|Overall Study||50||
59655912|NCT01187433|75774134|FG000|COMPLETED|Overall Study||89||
59655913|NCT01187433|75774135|FG001|COMPLETED|Overall Study||46||
59655914|NCT01187433|75774134|FG000|NOT COMPLETED|Overall Study||11||
59655915|NCT01187433|75774135|FG001|NOT COMPLETED|Overall Study||4||
59655916|NCT01150045|75774145|FG000|STARTED|Overall Study||615||
59655917|NCT01150045|75774146|FG001|STARTED|Overall Study||647||
59655918|NCT01150045|75774147|FG002|STARTED|Overall Study||646||
59655919|NCT01150045|75774148|FG003|STARTED|Overall Study||618||
59655920|NCT01150045|75774145|FG000|COMPLETED|Overall Study||615||
59655921|NCT01150045|75774146|FG001|COMPLETED|Overall Study||646||
59655922|NCT01150045|75774147|FG002|COMPLETED|Overall Study||646||
59655923|NCT01150045|75774148|FG003|COMPLETED|Overall Study||617||
59655924|NCT01150045|75774145|FG000|NOT COMPLETED|Overall Study||0||
59655925|NCT01150045|75774146|FG001|NOT COMPLETED|Overall Study||1||
59655926|NCT01150045|75774147|FG002|NOT COMPLETED|Overall Study||0||
59655927|NCT01150045|75774148|FG003|NOT COMPLETED|Overall Study||1||
59655928|NCT01098032|75774158|FG000|STARTED|Overall Study|1 patient di not receive the treatment. Therefore this patient was excluded from the analysis.|147||
59655929|NCT01098032|75774159|FG001|STARTED|Overall Study|1 patient di not receive the treatment. Therefore this patient was excluded from the analysis.|147||
59655930|NCT01098032|75774158|FG000|COMPLETED|Overall Study||146||
59655931|NCT01098032|75774159|FG001|COMPLETED|Overall Study||146||
59655932|NCT01098032|75774158|FG000|NOT COMPLETED|Overall Study||1||
59655933|NCT01098032|75774159|FG001|NOT COMPLETED|Overall Study||1||
59655934|NCT01034306|75774167|FG000|STARTED|Overall Study||42||
59655935|NCT01034306|75774168|FG001|STARTED|Overall Study||37||
59655936|NCT01034306|75774167|FG000|COMPLETED|Overall Study||37||
59655937|NCT01034306|75774168|FG001|COMPLETED|Overall Study||34||
59655938|NCT01034306|75774167|FG000|NOT COMPLETED|Overall Study||5||
59655939|NCT01034306|75774168|FG001|NOT COMPLETED|Overall Study||3||
59655940|NCT00993447|75774176|FG000|STARTED|Overall Study||401||
59655941|NCT00993447|75774177|FG001|STARTED|Overall Study||199||
59655942|NCT00993447|75774176|FG000|COMPLETED|Overall Study||364||
59655943|NCT00993447|75774177|FG001|COMPLETED|Overall Study||180||
59655944|NCT00993447|75774176|FG000|NOT COMPLETED|Overall Study||37||
59655945|NCT00993447|75774177|FG001|NOT COMPLETED|Overall Study||19||
59655946|NCT00945009|75774186|FG000|STARTED|Overall Study||201||
59655947|NCT00945009|75774187|FG001|STARTED|Overall Study||39||
59655948|NCT00945009|75774188|FG002|STARTED|Overall Study||9||
59655949|NCT00945009|75774186|FG000|COMPLETED|Overall Study||156||
59655950|NCT00945009|75774187|FG001|COMPLETED|Overall Study||32||
59655951|NCT00945009|75774188|FG002|COMPLETED|Overall Study||6||
59655952|NCT00945009|75774186|FG000|NOT COMPLETED|Overall Study||45||
59655953|NCT00945009|75774187|FG001|NOT COMPLETED|Overall Study||7||
59655954|NCT00945009|75774188|FG002|NOT COMPLETED|Overall Study||3||
59655955|NCT00942877|75774198|FG000|STARTED|Overall Study||46||
59655956|NCT00942877|75774199|FG001|STARTED|Overall Study||7||
59655957|NCT00942877|75774198|FG000|COMPLETED|Overall Study||1||
59655958|NCT00942877|75774199|FG001|COMPLETED|Overall Study||3||
59655959|NCT00942877|75774198|FG000|NOT COMPLETED|Overall Study||45||
59655960|NCT00942877|75774199|FG001|NOT COMPLETED|Overall Study||4||
59655961|NCT00896389|75774206|FG000|STARTED|Salt Loading||124||
59655962|NCT00896389|75774206|FG000|COMPLETED|Salt Loading||124||
59655963|NCT00896389|75774206|FG000|NOT COMPLETED|Salt Loading||0||
59655964|NCT00896389|75774206|FG000|STARTED|HCTZ Low Dose|Only subjects with SBP > 120 mmHg and agreeable to the HCTZ protocol continued to the next period.|28||
59655965|NCT00896389|75774206|FG000|COMPLETED|HCTZ Low Dose||28||
59655966|NCT00896389|75774206|FG000|NOT COMPLETED|HCTZ Low Dose||0||
59655967|NCT00896389|75774206|FG000|STARTED|HCTZ High Dose||25|Of the 28 subjects that started HCTZ intervention, 3 terminated the study without completing.|
59655968|NCT00896389|75774206|FG000|COMPLETED|HCTZ High Dose||25||
59655969|NCT00896389|75774206|FG000|NOT COMPLETED|HCTZ High Dose||0||
59655970|NCT00880893|75774214|FG000|STARTED|Overall Study||898||
59655971|NCT00880893|75774215|FG001|STARTED|Overall Study||300||
59655972|NCT00880893|75774214|FG000|COMPLETED|Overall Study||791||
59655973|NCT00880893|75774215|FG001|COMPLETED|Overall Study||255||
59655974|NCT00880893|75774214|FG000|NOT COMPLETED|Overall Study||107||
59655975|NCT00880893|75774215|FG001|NOT COMPLETED|Overall Study||45||
59655976|NCT00587301|75774221|FG000|STARTED|Overall Study||119||
59655977|NCT00587301|75774221|FG000|COMPLETED|Overall Study||74||
59655978|NCT00587301|75774221|FG000|NOT COMPLETED|Overall Study||45||
59655979|NCT00579527|75774225|FG000|STARTED|Overall Study||14||
59655980|NCT00579527|75774225|FG000|COMPLETED|Overall Study||10||
59655981|NCT00579527|75774225|FG000|NOT COMPLETED|Overall Study||4||
59655982|NCT00576836|75774230|FG000|STARTED|Overall Study||0||
59655983|NCT00576836|75774231|FG001|STARTED|Overall Study||7||
59655984|NCT00576836|75774230|FG000|COMPLETED|Overall Study||0||
59655985|NCT00576836|75774231|FG001|COMPLETED|Overall Study||5||
59655986|NCT00576836|75774230|FG000|NOT COMPLETED|Overall Study||0||
59655987|NCT00576836|75774231|FG001|NOT COMPLETED|Overall Study||2||
59655988|NCT00576407|75774235|FG000|STARTED|Overall Study||26||
59655989|NCT00576407|75774235|FG000|COMPLETED|Overall Study||18||
59655990|NCT00576407|75774235|FG000|NOT COMPLETED|Overall Study||8||
59655991|NCT00531232|75774243|FG000|STARTED|Overall Study||4||
59655992|NCT00531232|75774244|FG001|STARTED|Overall Study||9||
59655993|NCT00531232|75774245|FG002|STARTED|Overall Study||25||
59655994|NCT00531232|75774243|FG000|Treated|Overall Study||4||
59655995|NCT00531232|75774244|FG001|Treated|Overall Study||8||
59655996|NCT00531232|75774245|FG002|Treated|Overall Study||24||
59655997|NCT00531232|75774243|FG000|COMPLETED|Overall Study||0||
59655998|NCT00531232|75774244|FG001|COMPLETED|Overall Study||0||
59655999|NCT00531232|75774245|FG002|COMPLETED|Overall Study||0||
59656000|NCT00531232|75774243|FG000|NOT COMPLETED|Overall Study||4||
59656001|NCT00531232|75774244|FG001|NOT COMPLETED|Overall Study||9||
59656002|NCT00531232|75774245|FG002|NOT COMPLETED|Overall Study||25||
59656003|NCT01701583|75774258|FG000|STARTED|Overall Study||7||
59656004|NCT01701583|75774259|FG001|STARTED|Overall Study||3||
59656005|NCT01701583|75774258|FG000|COMPLETED|Overall Study||5||
59656006|NCT01701583|75774259|FG001|COMPLETED|Overall Study||3||
59656007|NCT01701583|75774258|FG000|NOT COMPLETED|Overall Study||2||
59656008|NCT01701583|75774259|FG001|NOT COMPLETED|Overall Study||0||
59656009|NCT01714817|75774268|FG000|STARTED|Year 1 Period||203||
59656010|NCT01714817|75774269|FG001|STARTED|Year 1 Period||203||
59656011|NCT01714817|75774268|FG000|Treated|Year 1 Period||202||
59656012|NCT01714817|75774269|FG001|Treated|Year 1 Period||203||
59656013|NCT01714817|75774268|FG000|COMPLETED|Year 1 Period|Completed = continued study through Year 1|155||
59656014|NCT01714817|75774269|FG001|COMPLETED|Year 1 Period|Completed = continued study through Year 1|161||
59656015|NCT01714817|75774268|FG000|NOT COMPLETED|Year 1 Period||48||
59656016|NCT01714817|75774269|FG001|NOT COMPLETED|Year 1 Period||42||
59656017|NCT01714817|75774268|FG000|STARTED|Year 2 Period|Started = Completed Year 1|155||
59656018|NCT01714817|75774269|FG001|STARTED|Year 2 Period|Started = Completed Year 1|161||
59815798|NCT03026283|75938216|FG005|STARTED|Optimal Care/Stress Test/ICA||101|Participants diagnosed to receive optimal care, or recommended for stress test diagnosis or ICA|
59815799|NCT03026283|75938217|FG006|STARTED|Optimal Care/Stress Test/ICA||0|Participants diagnosed to receive optimal care, or recommended for stress test diagnosis or ICA|
59656019|NCT01714817|75774268|FG000|COMPLETED|Year 2 Period|Completed = Continued study through Year 2|129||
59656020|NCT01714817|75774269|FG001|COMPLETED|Year 2 Period|Completed = Continued study through Year 2|123||
59656021|NCT01714817|75774268|FG000|NOT COMPLETED|Year 2 Period||26||
59656022|NCT01714817|75774269|FG001|NOT COMPLETED|Year 2 Period||38||
59656023|NCT01714817|75774268|FG000|STARTED|Long-Term Extension (LTE) Period|Started = Completed Year 2|129||
59656024|NCT01714817|75774269|FG001|STARTED|Long-Term Extension (LTE) Period|Started = Completed Year 2|123||
59656025|NCT01714817|75774268|FG000|COMPLETED|Long-Term Extension (LTE) Period|Completed = Continued study through LTE|62||
59656026|NCT01714817|75774269|FG001|COMPLETED|Long-Term Extension (LTE) Period|Completed = Continued study through LTE|53||
59656027|NCT01714817|75774268|FG000|NOT COMPLETED|Long-Term Extension (LTE) Period||67||
59656028|NCT01714817|75774269|FG001|NOT COMPLETED|Long-Term Extension (LTE) Period||70||
59656029|NCT01735708|75774279|FG000|STARTED|Overall Study||95||
59656030|NCT01735708|75774280|FG001|STARTED|Overall Study||92||
59656031|NCT01735708|75774279|FG000|Month 3 Assessment|Overall Study||79||
59656032|NCT01735708|75774280|FG001|Month 3 Assessment|Overall Study||79||
59656033|NCT01735708|75774279|FG000|COMPLETED|Overall Study||84||
59656034|NCT01735708|75774280|FG001|COMPLETED|Overall Study||79||
59656035|NCT01735708|75774279|FG000|NOT COMPLETED|Overall Study||11||
59656036|NCT01735708|75774280|FG001|NOT COMPLETED|Overall Study||13||
59656037|NCT05584644|75774290|FG000|STARTED|Overall Study||105||
59656038|NCT05584644|75774291|FG001|STARTED|Overall Study||45||
59656039|NCT05584644|75774290|FG000|COMPLETED|Overall Study||105||
59656040|NCT05584644|75774291|FG001|COMPLETED|Overall Study||45||
59656041|NCT05584644|75774290|FG000|NOT COMPLETED|Overall Study||0||
59656042|NCT05584644|75774291|FG001|NOT COMPLETED|Overall Study||0||
59656043|NCT05466448|75774299|FG000|STARTED|Overall Study||6||
59656044|NCT05466448|75774300|FG001|STARTED|Overall Study||9||
59656045|NCT05466448|75774299|FG000|COMPLETED|Overall Study||5||
59656046|NCT05466448|75774300|FG001|COMPLETED|Overall Study||9||
59656047|NCT05466448|75774299|FG000|NOT COMPLETED|Overall Study||1||
59656048|NCT05466448|75774300|FG001|NOT COMPLETED|Overall Study||0||
59656049|NCT04477187|75774306|FG000|STARTED|Overall Study||15||
59656050|NCT04477187|75774306|FG000|COMPLETED|Overall Study||13||
59656051|NCT04477187|75774306|FG000|NOT COMPLETED|Overall Study||2||
59656052|NCT04142242|75774326|FG000|STARTED|Stage I||139||
59656053|NCT04142242|75774327|FG001|STARTED|Stage I||176||
59656054|NCT04142242|75774328|FG002|STARTED|Stage I||31||
59656055|NCT04142242|75774329|FG003|STARTED|Stage I||39||
59656056|NCT04142242|75774330|FG004|STARTED|Stage I||26||
59656057|NCT04142242|75774331|FG005|STARTED|Stage I||60||
59656058|NCT04142242|75774326|FG000|Vaccinated|Stage I||138||
59656059|NCT04142242|75774327|FG001|Vaccinated|Stage I||175||
59656060|NCT04142242|75774328|FG002|Vaccinated|Stage I||0||
59656061|NCT04142242|75774329|FG003|Vaccinated|Stage I||0||
59656062|NCT04142242|75774330|FG004|Vaccinated|Stage I||0||
59656063|NCT04142242|75774331|FG005|Vaccinated|Stage I||0||
59656064|NCT04142242|75774326|FG000|Stage I Full Analysis Set (FAS)|Stage I||138|Participants who had a valid serology result for at least 1 serogroup from a pre-vaccination blood sample.|
59656065|NCT04142242|75774327|FG001|Stage I Full Analysis Set (FAS)|Stage I||175|Participants who had a valid serology result for at least 1 serogroup from a pre-vaccination blood sample.|
59656066|NCT04142242|75774328|FG002|Stage I Full Analysis Set (FAS)|Stage I||31|Participants who had a valid serology result for at least 1 serogroup from a pre-vaccination blood sample.|
59656067|NCT04142242|75774329|FG003|Stage I Full Analysis Set (FAS)|Stage I||39|Participants who had a valid serology result for at least 1 serogroup from a pre-vaccination blood sample.|
59656068|NCT04142242|75774330|FG004|Stage I Full Analysis Set (FAS)|Stage I||26|Participants who had a valid serology result for at least 1 serogroup from a pre-vaccination blood sample.|
59656069|NCT04142242|75774331|FG005|Stage I Full Analysis Set (FAS)|Stage I||59|Participants who had a valid serology result for at least 1 serogroup from a pre-vaccination blood sample.|
59656070|NCT04142242|75774326|FG000|Safety Analysis Set (SafAS)|Stage I|1 MenACYW Conjugate vaccine-primed participant was erroneously assigned by Investigator to Group 1 but per planned analysis was counted in Group 2 for safety analysis.|151|Participants of Groups 1 and 2 who had received study MEQ00066 vaccine and had available safety data, were analyzed according to the actually received vaccine.|
59656071|NCT04142242|75774327|FG001|Safety Analysis Set (SafAS)|Stage I|14 Menomune-primed participants were erroneously assigned by Investigator to Group 2 but per planned analysis they were counted in Group 1 for safety analysis.|162|Participants of Groups 1 and 2 who had received study MEQ00066 vaccine and had available safety data, were analyzed according to the actually received vaccine.|
59656072|NCT04142242|75774328|FG002|Safety Analysis Set (SafAS)|Stage I||0|Participants of Groups 1 and 2 who had received study MEQ00066 vaccine and had available safety data, were analyzed according to the actually received vaccine.|
59656073|NCT04142242|75774329|FG003|Safety Analysis Set (SafAS)|Stage I||0|Participants of Groups 1 and 2 who had received study MEQ00066 vaccine and had available safety data, were analyzed according to the actually received vaccine.|
59656074|NCT04142242|75774330|FG004|Safety Analysis Set (SafAS)|Stage I||0|Participants of Groups 1 and 2 who had received study MEQ00066 vaccine and had available safety data, were analyzed according to the actually received vaccine.|
59656075|NCT04142242|75774331|FG005|Safety Analysis Set (SafAS)|Stage I||0|Participants of Groups 1 and 2 who had received study MEQ00066 vaccine and had available safety data, were analyzed according to the actually received vaccine.|
59656076|NCT04142242|75774326|FG000|COMPLETED|Stage I||138||
59656077|NCT04142242|75774327|FG001|COMPLETED|Stage I||175||
59656078|NCT04142242|75774328|FG002|COMPLETED|Stage I||31||
59656079|NCT04142242|75774329|FG003|COMPLETED|Stage I||39||
59656080|NCT04142242|75774330|FG004|COMPLETED|Stage I||26||
59656081|NCT04142242|75774331|FG005|COMPLETED|Stage I||59||
59656082|NCT04142242|75774326|FG000|NOT COMPLETED|Stage I||1||
59656083|NCT04142242|75774327|FG001|NOT COMPLETED|Stage I||1||
59656084|NCT04142242|75774328|FG002|NOT COMPLETED|Stage I||0||
59656085|NCT04142242|75774329|FG003|NOT COMPLETED|Stage I||0||
59656086|NCT04142242|75774330|FG004|NOT COMPLETED|Stage I||0||
59656087|NCT04142242|75774331|FG005|NOT COMPLETED|Stage I||1||
59656088|NCT04142242|75774326|FG000|STARTED|Stage II|Only participants from Group 3 and 4 continued and received vaccination in Stage II part of the study.|0||
59656089|NCT04142242|75774327|FG001|STARTED|Stage II|Only participants from Group 3 and 4 continued and received vaccination in Stage II part of the study.|0||
59656090|NCT04142242|75774328|FG002|STARTED|Stage II||31||
59656091|NCT04142242|75774329|FG003|STARTED|Stage II||39||
59656092|NCT04142242|75774330|FG004|STARTED|Stage II|Only participants from Group 3 and 4 continued and received vaccination in Stage II part of the study.|0||
59709747|NCT01072149|75828531|FG011|COMPLETED|Treatment Period 1 (28 Days)||3||
59656093|NCT04142242|75774331|FG005|STARTED|Stage II|Only participants from Group 3 and 4 continued and received vaccination in Stage II part of the study.|0||
59656094|NCT04142242|75774326|FG000|Vaccinated|Stage II||0||
59656095|NCT04142242|75774327|FG001|Vaccinated|Stage II||0||
59656096|NCT04142242|75774328|FG002|Vaccinated|Stage II||25||
59656097|NCT04142242|75774329|FG003|Vaccinated|Stage II||27||
59656098|NCT04142242|75774330|FG004|Vaccinated|Stage II||0||
59656099|NCT04142242|75774331|FG005|Vaccinated|Stage II||0||
59656100|NCT04142242|75774326|FG000|Stage II FAS for Persistence|Stage II||0||
59656101|NCT04142242|75774327|FG001|Stage II FAS for Persistence|Stage II||0||
59656102|NCT04142242|75774328|FG002|Stage II FAS for Persistence|Stage II||24||
59656103|NCT04142242|75774329|FG003|Stage II FAS for Persistence|Stage II||28||
59656104|NCT04142242|75774330|FG004|Stage II FAS for Persistence|Stage II||0||
59656105|NCT04142242|75774331|FG005|Stage II FAS for Persistence|Stage II||0||
59656106|NCT04142242|75774326|FG000|Safety Analysis Set|Stage II||0||
59656107|NCT04142242|75774327|FG001|Safety Analysis Set|Stage II||0||
59656108|NCT04142242|75774328|FG002|Safety Analysis Set|Stage II|Two participants were incorrectly assessed by Investigator as having received MenACYW Conjugate vaccine in study MET49 and underwent randomization to Group 4 instead of Group 3. These participants were included in Group 3 for safety analysis as per actual vaccination received.|27||
59656109|NCT04142242|75774329|FG003|Safety Analysis Set|Stage II||25||
59656110|NCT04142242|75774330|FG004|Safety Analysis Set|Stage II||0||
59656111|NCT04142242|75774331|FG005|Safety Analysis Set|Stage II||0||
59656112|NCT04142242|75774326|FG000|COMPLETED|Stage II||0||
59656113|NCT04142242|75774327|FG001|COMPLETED|Stage II||0||
59656114|NCT04142242|75774328|FG002|COMPLETED|Stage II||25||
59656115|NCT04142242|75774329|FG003|COMPLETED|Stage II||26||
59656116|NCT04142242|75774330|FG004|COMPLETED|Stage II||0||
59656117|NCT04142242|75774331|FG005|COMPLETED|Stage II||0||
59656118|NCT04142242|75774326|FG000|NOT COMPLETED|Stage II||0||
59656119|NCT04142242|75774327|FG001|NOT COMPLETED|Stage II||0||
59656120|NCT04142242|75774328|FG002|NOT COMPLETED|Stage II||6||
59656121|NCT04142242|75774329|FG003|NOT COMPLETED|Stage II||13||
59656122|NCT04142242|75774330|FG004|NOT COMPLETED|Stage II||0||
59656123|NCT04142242|75774331|FG005|NOT COMPLETED|Stage II||0||
59656124|NCT03912259|75774350|FG000|STARTED|Overall Study||83||
59656125|NCT03912259|75774351|FG001|STARTED|Overall Study||82||
59656126|NCT03912259|75774350|FG000|COMPLETED|Overall Study||66||
59656127|NCT03912259|75774351|FG001|COMPLETED|Overall Study||76||
59656128|NCT03912259|75774350|FG000|NOT COMPLETED|Overall Study||17||
59656129|NCT03912259|75774351|FG001|NOT COMPLETED|Overall Study||6||
59656130|NCT03871829|75774360|FG000|STARTED|Overall Study||44||
59656131|NCT03871829|75774361|FG001|STARTED|Overall Study||44||
59656132|NCT03871829|75774360|FG000|Treated (Safety Analysis Set)|Overall Study||43||
59656133|NCT03871829|75774361|FG001|Treated (Safety Analysis Set)|Overall Study||43||
59656134|NCT03871829|75774360|FG000|COMPLETED|Overall Study||0||
59656135|NCT03871829|75774361|FG001|COMPLETED|Overall Study||0||
59656136|NCT03871829|75774360|FG000|NOT COMPLETED|Overall Study||44||
59656137|NCT03871829|75774361|FG001|NOT COMPLETED|Overall Study||44||
59656138|NCT03783936|75774368|FG000|STARTED|Overall Study||18||
59656139|NCT03783936|75774368|FG000|COMPLETED|Overall Study||18||
59656140|NCT03783936|75774368|FG000|NOT COMPLETED|Overall Study||0||
59656141|NCT03742986|75774374|FG000|STARTED|Overall Study||4||
59656142|NCT03742986|75774375|FG001|STARTED|Overall Study||4||
59656143|NCT03742986|75774374|FG000|COMPLETED|Overall Study||4||
59656144|NCT03742986|75774375|FG001|COMPLETED|Overall Study||4||
59656145|NCT03742986|75774374|FG000|NOT COMPLETED|Overall Study||0||
59656146|NCT03742986|75774375|FG001|NOT COMPLETED|Overall Study||0||
59656147|NCT03736720|75774381|FG000|STARTED|Overall Study||11||
59656148|NCT03736720|75774381|FG000|COMPLETED|Overall Study||11||
59656149|NCT03736720|75774381|FG000|NOT COMPLETED|Overall Study||0||
59656150|NCT03676465|75774387|FG000|STARTED|Overall Study||42||21
59656151|NCT03676465|75774388|FG001|STARTED|Overall Study||52||26
59656152|NCT03676465|75774387|FG000|COMPLETED|Overall Study||42||21
59656153|NCT03676465|75774388|FG001|COMPLETED|Overall Study||44||22
59815800|NCT03026283|75938218|FG007|STARTED|Optimal Care/Stress Test/ICA||0|Participants diagnosed to receive optimal care, or recommended for stress test diagnosis or ICA|
59815801|NCT03026283|75938211|FG000|COMPLETED|Optimal Care/Stress Test/ICA||0|Participants who followed recommendation provided after consultation with referring physician.|
59815802|NCT03026283|75938212|FG001|COMPLETED|Optimal Care/Stress Test/ICA||0|Participants who followed recommendation provided after consultation with referring physician.|
59656154|NCT03676465|75774387|FG000|NOT COMPLETED|Overall Study||0||0
59656155|NCT03676465|75774388|FG001|NOT COMPLETED|Overall Study||8||4
59656156|NCT03562793|75774396|FG000|STARTED|Overall Study||124||
59656157|NCT03562793|75774397|FG001|STARTED|Overall Study||126||
59656158|NCT03562793|75774396|FG000|3 Months|Overall Study||103||
59656159|NCT03562793|75774397|FG001|3 Months|Overall Study||120||
59656160|NCT03562793|75774396|FG000|6 Months|Overall Study||100||
59656161|NCT03562793|75774397|FG001|6 Months|Overall Study||113||
59656162|NCT03562793|75774396|FG000|COMPLETED|Overall Study||99||
59656163|NCT03562793|75774397|FG001|COMPLETED|Overall Study||104||
59656164|NCT03562793|75774396|FG000|NOT COMPLETED|Overall Study||25||
59656165|NCT03562793|75774397|FG001|NOT COMPLETED|Overall Study||22||
59656166|NCT03373383|75774408|FG000|STARTED|Treatment Period: Wk0-16||83||
59656167|NCT03373383|75774409|FG001|STARTED|Treatment Period: Wk0-16||81||
59656168|NCT03373383|75774410|FG002|STARTED|Treatment Period: Wk0-16||83||
59656169|NCT03373383|75774411|FG003|STARTED|Treatment Period: Wk0-16||82||
59656170|NCT03373383|75774412|FG004|STARTED|Treatment Period: Wk0-16||82||
59656171|NCT03373383|75774408|FG000|Completed Titration and Stabilization|Treatment Period: Wk0-16||78||
59656172|NCT03373383|75774409|FG001|Completed Titration and Stabilization|Treatment Period: Wk0-16||72||
59656173|NCT03373383|75774410|FG002|Completed Titration and Stabilization|Treatment Period: Wk0-16||71||
59656174|NCT03373383|75774411|FG003|Completed Titration and Stabilization|Treatment Period: Wk0-16||68||
59656175|NCT03373383|75774412|FG004|Completed Titration and Stabilization|Treatment Period: Wk0-16||65||
59656176|NCT03373383|75774408|FG000|Completed Maintenance Period|Treatment Period: Wk0-16||70||
59656177|NCT03373383|75774409|FG001|Completed Maintenance Period|Treatment Period: Wk0-16||66||
59656178|NCT03373383|75774410|FG002|Completed Maintenance Period|Treatment Period: Wk0-16||68||
59656179|NCT03373383|75774411|FG003|Completed Maintenance Period|Treatment Period: Wk0-16||61||
59656180|NCT03373383|75774412|FG004|Completed Maintenance Period|Treatment Period: Wk0-16||58||
59656181|NCT03373383|75774408|FG000|Had Taper and Safety Follow-up|Treatment Period: Wk0-16||6||
59656182|NCT03373383|75774409|FG001|Had Taper and Safety Follow-up|Treatment Period: Wk0-16||11||
59656183|NCT03373383|75774410|FG002|Had Taper and Safety Follow-up|Treatment Period: Wk0-16||8||
59656184|NCT03373383|75774411|FG003|Had Taper and Safety Follow-up|Treatment Period: Wk0-16||18||
59656185|NCT03373383|75774412|FG004|Had Taper and Safety Follow-up|Treatment Period: Wk0-16||21||
59656186|NCT03373383|75774408|FG000|COMPLETED|Treatment Period: Wk0-16||70||
59656187|NCT03373383|75774409|FG001|COMPLETED|Treatment Period: Wk0-16||66||
59656188|NCT03373383|75774410|FG002|COMPLETED|Treatment Period: Wk0-16||68||
59656189|NCT03373383|75774411|FG003|COMPLETED|Treatment Period: Wk0-16||61||
59656190|NCT03373383|75774412|FG004|COMPLETED|Treatment Period: Wk0-16||58||
59656191|NCT03373383|75774408|FG000|NOT COMPLETED|Treatment Period: Wk0-16||13||
59656192|NCT03373383|75774409|FG001|NOT COMPLETED|Treatment Period: Wk0-16||15||
59656193|NCT03373383|75774410|FG002|NOT COMPLETED|Treatment Period: Wk0-16||15||
59656194|NCT03373383|75774411|FG003|NOT COMPLETED|Treatment Period: Wk0-16||21||
59656195|NCT03373383|75774412|FG004|NOT COMPLETED|Treatment Period: Wk0-16||24||
59656196|NCT03373383|75774408|FG000|STARTED|Post-Treatment Period: Wk16-23||70||
59656197|NCT03373383|75774409|FG001|STARTED|Post-Treatment Period: Wk16-23||66||
59656198|NCT03373383|75774410|FG002|STARTED|Post-Treatment Period: Wk16-23||68||
59656199|NCT03373383|75774411|FG003|STARTED|Post-Treatment Period: Wk16-23||61||
59656200|NCT03373383|75774412|FG004|STARTED|Post-Treatment Period: Wk16-23||58||
59656201|NCT03373383|75774408|FG000|Started Conversion Period|Post-Treatment Period: Wk16-23||69||
59656202|NCT03373383|75774409|FG001|Started Conversion Period|Post-Treatment Period: Wk16-23||64||
59656203|NCT03373383|75774410|FG002|Started Conversion Period|Post-Treatment Period: Wk16-23||66||
59656204|NCT03373383|75774411|FG003|Started Conversion Period|Post-Treatment Period: Wk16-23||55||
59656205|NCT03373383|75774412|FG004|Started Conversion Period|Post-Treatment Period: Wk16-23||57||
59656206|NCT03373383|75774408|FG000|Completed Conversion Period|Post-Treatment Period: Wk16-23||68||
59656207|NCT03373383|75774409|FG001|Completed Conversion Period|Post-Treatment Period: Wk16-23||64||
59656208|NCT03373383|75774410|FG002|Completed Conversion Period|Post-Treatment Period: Wk16-23||66||
59656209|NCT03373383|75774411|FG003|Completed Conversion Period|Post-Treatment Period: Wk16-23||55||
59656210|NCT03373383|75774412|FG004|Completed Conversion Period|Post-Treatment Period: Wk16-23||57||
59656211|NCT03373383|75774408|FG000|Had Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||3||
59656212|NCT03373383|75774409|FG001|Had Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||3||
59656213|NCT03373383|75774410|FG002|Had Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||3||
59656214|NCT03373383|75774411|FG003|Had Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||6||
59656215|NCT03373383|75774412|FG004|Had Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||1||
59656216|NCT03373383|75774408|FG000|Enrolled in EP0093|Post-Treatment Period: Wk16-23||67||
59656217|NCT03373383|75774409|FG001|Enrolled in EP0093|Post-Treatment Period: Wk16-23||63||
59656218|NCT03373383|75774410|FG002|Enrolled in EP0093|Post-Treatment Period: Wk16-23||65||
59656219|NCT03373383|75774411|FG003|Enrolled in EP0093|Post-Treatment Period: Wk16-23||55||
59656220|NCT03373383|75774412|FG004|Enrolled in EP0093|Post-Treatment Period: Wk16-23||57||
59656221|NCT03373383|75774408|FG000|COMPLETED|Post-Treatment Period: Wk16-23||69||
59656222|NCT03373383|75774409|FG001|COMPLETED|Post-Treatment Period: Wk16-23||66||
59656223|NCT03373383|75774410|FG002|COMPLETED|Post-Treatment Period: Wk16-23||68||
59656224|NCT03373383|75774411|FG003|COMPLETED|Post-Treatment Period: Wk16-23||61||
59656225|NCT03373383|75774412|FG004|COMPLETED|Post-Treatment Period: Wk16-23||58||
59656226|NCT03373383|75774408|FG000|NOT COMPLETED|Post-Treatment Period: Wk16-23||1||
59656227|NCT03373383|75774409|FG001|NOT COMPLETED|Post-Treatment Period: Wk16-23||0||
59656228|NCT03373383|75774410|FG002|NOT COMPLETED|Post-Treatment Period: Wk16-23||0||
59656229|NCT03373383|75774411|FG003|NOT COMPLETED|Post-Treatment Period: Wk16-23||0||
59656230|NCT03373383|75774412|FG004|NOT COMPLETED|Post-Treatment Period: Wk16-23||0||
59656231|NCT03320018|75774441|FG000|STARTED|Treatment Period||6||
59656232|NCT03320018|75774442|FG001|STARTED|Treatment Period||8||
59656233|NCT03320018|75774441|FG000|COMPLETED|Treatment Period||5||
59656234|NCT03320018|75774442|FG001|COMPLETED|Treatment Period||8||
59656235|NCT03320018|75774441|FG000|NOT COMPLETED|Treatment Period||1||
59656236|NCT03320018|75774442|FG001|NOT COMPLETED|Treatment Period||0||
59656237|NCT03320018|75774441|FG000|STARTED|Day 45 Follow up||5||
59656238|NCT03320018|75774442|FG001|STARTED|Day 45 Follow up||8||
59656239|NCT03320018|75774441|FG000|COMPLETED|Day 45 Follow up||5||
59656240|NCT03320018|75774442|FG001|COMPLETED|Day 45 Follow up||8||
59656241|NCT03320018|75774441|FG000|NOT COMPLETED|Day 45 Follow up||0||
59656242|NCT03320018|75774442|FG001|NOT COMPLETED|Day 45 Follow up||0||
59656243|NCT03320018|75774441|FG000|STARTED|Day 90 Follow up||5||
59656244|NCT03320018|75774442|FG001|STARTED|Day 90 Follow up||8||
59656245|NCT03320018|75774441|FG000|COMPLETED|Day 90 Follow up||5||
59656246|NCT03320018|75774442|FG001|COMPLETED|Day 90 Follow up||7||
59656247|NCT03320018|75774441|FG000|NOT COMPLETED|Day 90 Follow up||0||
59656248|NCT03320018|75774442|FG001|NOT COMPLETED|Day 90 Follow up||1||
59656249|NCT03230318|75774450|FG000|STARTED|Overall Study||104||
59656250|NCT03230318|75774451|FG001|STARTED|Overall Study||44||
59656251|NCT03230318|75774450|FG000|COMPLETED|Overall Study||0||
59656252|NCT03230318|75774451|FG001|COMPLETED|Overall Study||0||
59656253|NCT03230318|75774450|FG000|NOT COMPLETED|Overall Study||104||
59656254|NCT03230318|75774451|FG001|NOT COMPLETED|Overall Study||44||
59656255|NCT03080883|75774462|FG000|STARTED|Overall Study||179||
59656256|NCT03080883|75774463|FG001|STARTED|Overall Study||181||
59656257|NCT03080883|75774462|FG000|COMPLETED|Overall Study||111||
59656258|NCT03080883|75774463|FG001|COMPLETED|Overall Study||109||
59656259|NCT03080883|75774462|FG000|NOT COMPLETED|Overall Study||68||
59656260|NCT03080883|75774463|FG001|NOT COMPLETED|Overall Study||72||
59656261|NCT03060291|75774472|FG000|STARTED|Baseline||109||
59656262|NCT03060291|75774473|FG001|STARTED|Baseline||108||
59656263|NCT03060291|75774474|FG002|STARTED|Baseline||105||
59656264|NCT03060291|75774472|FG000|COMPLETED|Baseline||109||
59656265|NCT03060291|75774473|FG001|COMPLETED|Baseline||108||
59656266|NCT03060291|75774474|FG002|COMPLETED|Baseline||105||
59656267|NCT03060291|75774472|FG000|NOT COMPLETED|Baseline||0||
59656268|NCT03060291|75774473|FG001|NOT COMPLETED|Baseline||0||
59656269|NCT03060291|75774474|FG002|NOT COMPLETED|Baseline||0||
59656270|NCT03060291|75774472|FG000|STARTED|3-month Follow-up||109||
59656271|NCT03060291|75774473|FG001|STARTED|3-month Follow-up||108||
59656272|NCT03060291|75774474|FG002|STARTED|3-month Follow-up||105||
59656273|NCT03060291|75774472|FG000|COMPLETED|3-month Follow-up||101||
59656274|NCT03060291|75774473|FG001|COMPLETED|3-month Follow-up||98||
59656275|NCT03060291|75774474|FG002|COMPLETED|3-month Follow-up||103||
59656276|NCT03060291|75774472|FG000|NOT COMPLETED|3-month Follow-up||8||
59656277|NCT03060291|75774473|FG001|NOT COMPLETED|3-month Follow-up||10||
59656278|NCT03060291|75774474|FG002|NOT COMPLETED|3-month Follow-up||2||
59656279|NCT03060291|75774472|FG000|STARTED|6-month Follow-up||109||
59656280|NCT03060291|75774473|FG001|STARTED|6-month Follow-up||108||
59656281|NCT03060291|75774474|FG002|STARTED|6-month Follow-up||105||
59656282|NCT03060291|75774472|FG000|COMPLETED|6-month Follow-up||102|Because no families were ever lost to follow-up or withdrew from the study, all families who participated at baseline were invited to participate at each follow-up wave. Thus, there are a a few families who participated at 6-month or 12-month follow-up who did not participate at an earlier follow-up wave.|
59656283|NCT03060291|75774473|FG001|COMPLETED|6-month Follow-up||95|Because no families were ever lost to follow-up or withdrew from the study, all families who participated at baseline were invited to participate at each follow-up wave. Thus, there are a a few families who participated at 6-month or 12-month follow-up who did not participate at an earlier follow-up wave.|
59656284|NCT03060291|75774474|FG002|COMPLETED|6-month Follow-up||101|Because no families were ever lost to follow-up or withdrew from the study, all families who participated at baseline were invited to participate at each follow-up wave. Thus, there are a a few families who participated at 6-month or 12-month follow-up who did not participate at an earlier follow-up wave.|
59656285|NCT03060291|75774472|FG000|NOT COMPLETED|6-month Follow-up||7||
59656286|NCT03060291|75774473|FG001|NOT COMPLETED|6-month Follow-up||13||
59656287|NCT03060291|75774474|FG002|NOT COMPLETED|6-month Follow-up||4||
59656288|NCT03060291|75774472|FG000|STARTED|12-month Follow-up||109||
59656289|NCT03060291|75774473|FG001|STARTED|12-month Follow-up||108||
59656290|NCT03060291|75774474|FG002|STARTED|12-month Follow-up||105||
59656291|NCT03060291|75774472|FG000|COMPLETED|12-month Follow-up||102|Because no families were ever lost to follow-up or withdrew from the study, all families who participated at baseline were invited to participate at each follow-up wave. Thus, there are a a few families who participated at 6-month or 12-month follow-up who did not participate at an earlier follow-up wave.|
59656292|NCT03060291|75774473|FG001|COMPLETED|12-month Follow-up||92|Because no families were ever lost to follow-up or withdrew from the study, all families who participated at baseline were invited to participate at each follow-up wave. Thus, there are a a few families who participated at 6-month or 12-month follow-up who did not participate at an earlier follow-up wave.|
59656293|NCT03060291|75774474|FG002|COMPLETED|12-month Follow-up||99|Because no families were ever lost to follow-up or withdrew from the study, all families who participated at baseline were invited to participate at each follow-up wave. Thus, there are a a few families who participated at 6-month or 12-month follow-up who did not participate at an earlier follow-up wave.|
59656294|NCT03060291|75774472|FG000|NOT COMPLETED|12-month Follow-up||7||
59656295|NCT03060291|75774473|FG001|NOT COMPLETED|12-month Follow-up||16||
59656296|NCT03060291|75774474|FG002|NOT COMPLETED|12-month Follow-up||6||
59656297|NCT02887859|75774482|FG000|STARTED|Overall Study||15||
59656298|NCT02887859|75774482|FG000|COMPLETED|Overall Study||0||
59656299|NCT02887859|75774482|FG000|NOT COMPLETED|Overall Study||15||
59656300|NCT02764801|75774486|FG000|STARTED|Overall Study||131||
59656301|NCT02764801|75774486|FG000|COMPLETED|Overall Study||103||
59656302|NCT02764801|75774486|FG000|NOT COMPLETED|Overall Study||28||
59656303|NCT02723929|75774492|FG000|STARTED|Overall Study||30||
59656304|NCT02723929|75774493|FG001|STARTED|Overall Study||34||
59656305|NCT02723929|75774492|FG000|COMPLETED|Overall Study||24||
59656306|NCT02723929|75774493|FG001|COMPLETED|Overall Study||24||
59656307|NCT02723929|75774492|FG000|NOT COMPLETED|Overall Study||6||
59656308|NCT02723929|75774493|FG001|NOT COMPLETED|Overall Study||10||
59656309|NCT02487966|75774505|FG000|STARTED|Overall Study||29||
59656310|NCT02487966|75774506|FG001|STARTED|Overall Study||28||
59656311|NCT02487966|75774507|FG002|STARTED|Overall Study||28||
59656312|NCT02487966|75774508|FG003|STARTED|Overall Study||27||
59656313|NCT02487966|75774505|FG000|COMPLETED|Overall Study||28||
59656314|NCT02487966|75774506|FG001|COMPLETED|Overall Study||24||
59656315|NCT02487966|75774507|FG002|COMPLETED|Overall Study||26||
59656316|NCT02487966|75774508|FG003|COMPLETED|Overall Study||25||
59656317|NCT02487966|75774505|FG000|NOT COMPLETED|Overall Study||1||
59656318|NCT02487966|75774506|FG001|NOT COMPLETED|Overall Study||4||
59656319|NCT02487966|75774507|FG002|NOT COMPLETED|Overall Study||2||
59656320|NCT02487966|75774508|FG003|NOT COMPLETED|Overall Study||2||
59656321|NCT02373189|75774518|FG000|STARTED|Overall Study||37||
59656322|NCT02373189|75774518|FG000|COMPLETED|Overall Study||25||
59656323|NCT02373189|75774518|FG000|NOT COMPLETED|Overall Study||12||
59656324|NCT01514864|75774524|FG000|STARTED|Overall Study||9||
59656325|NCT01514864|75774525|FG001|STARTED|Overall Study||5||
59656326|NCT01514864|75774524|FG000|COMPLETED|Overall Study|Study was terminated; no patients completed study treatment|0||
59656327|NCT01514864|75774525|FG001|COMPLETED|Overall Study||0||
59656328|NCT01514864|75774524|FG000|NOT COMPLETED|Overall Study||9||
59656329|NCT01514864|75774525|FG001|NOT COMPLETED|Overall Study||5||
59656330|NCT01458366|75774537|FG000|STARTED|Period 1: 70mg/m^2||5||
59656331|NCT01458366|75774538|FG001|STARTED|Period 1: 70mg/m^2||0||
59656332|NCT01458366|75774539|FG002|STARTED|Period 1: 70mg/m^2||0||
59656333|NCT01458366|75774540|FG003|STARTED|Period 1: 70mg/m^2||0||
59656334|NCT01458366|75774541|FG004|STARTED|Period 1: 70mg/m^2||0||
59656335|NCT01458366|75774537|FG000|COMPLETED|Period 1: 70mg/m^2||3||
59656336|NCT01458366|75774538|FG001|COMPLETED|Period 1: 70mg/m^2||0||
59656337|NCT01458366|75774539|FG002|COMPLETED|Period 1: 70mg/m^2||0||
59656338|NCT01458366|75774540|FG003|COMPLETED|Period 1: 70mg/m^2||0||
59656339|NCT01458366|75774541|FG004|COMPLETED|Period 1: 70mg/m^2||0||
59656340|NCT01458366|75774537|FG000|NOT COMPLETED|Period 1: 70mg/m^2||2||
59656341|NCT01458366|75774538|FG001|NOT COMPLETED|Period 1: 70mg/m^2||0||
59656342|NCT01458366|75774539|FG002|NOT COMPLETED|Period 1: 70mg/m^2||0||
59656343|NCT01458366|75774540|FG003|NOT COMPLETED|Period 1: 70mg/m^2||0||
59656344|NCT01458366|75774541|FG004|NOT COMPLETED|Period 1: 70mg/m^2||0||
59656345|NCT01458366|75774537|FG000|STARTED|Period 2: 50mg/m^2||0||
59656346|NCT01458366|75774538|FG001|STARTED|Period 2: 50mg/m^2||0||
59656347|NCT01458366|75774539|FG002|STARTED|Period 2: 50mg/m^2||0||
59656348|NCT01458366|75774540|FG003|STARTED|Period 2: 50mg/m^2||0||
59656349|NCT01458366|75774541|FG004|STARTED|Period 2: 50mg/m^2||0||
59656350|NCT01458366|75774537|FG000|COMPLETED|Period 2: 50mg/m^2||0||
59656351|NCT01458366|75774538|FG001|COMPLETED|Period 2: 50mg/m^2||0||
59656352|NCT01458366|75774539|FG002|COMPLETED|Period 2: 50mg/m^2||0||
59656353|NCT01458366|75774540|FG003|COMPLETED|Period 2: 50mg/m^2||0||
59656354|NCT01458366|75774541|FG004|COMPLETED|Period 2: 50mg/m^2||0||
59656355|NCT01458366|75774537|FG000|NOT COMPLETED|Period 2: 50mg/m^2||0||
59988855|NCT04495179|76104104|FG000|STARTED|Overall Study||2||
59656356|NCT01458366|75774538|FG001|NOT COMPLETED|Period 2: 50mg/m^2||0||
59656357|NCT01458366|75774539|FG002|NOT COMPLETED|Period 2: 50mg/m^2||0||
59656358|NCT01458366|75774540|FG003|NOT COMPLETED|Period 2: 50mg/m^2||0||
59656359|NCT01458366|75774541|FG004|NOT COMPLETED|Period 2: 50mg/m^2||0||
59656360|NCT01458366|75774537|FG000|STARTED|Period 3: 90mg/m^2||0||
59656361|NCT01458366|75774538|FG001|STARTED|Period 3: 90mg/m^2||0||
59656362|NCT01458366|75774539|FG002|STARTED|Period 3: 90mg/m^2||3||
59656363|NCT01458366|75774540|FG003|STARTED|Period 3: 90mg/m^2||0||
59656364|NCT01458366|75774541|FG004|STARTED|Period 3: 90mg/m^2||0||
59656365|NCT01458366|75774537|FG000|COMPLETED|Period 3: 90mg/m^2||0||
59656366|NCT01458366|75774538|FG001|COMPLETED|Period 3: 90mg/m^2||0||
59656367|NCT01458366|75774539|FG002|COMPLETED|Period 3: 90mg/m^2||3||
59656368|NCT01458366|75774540|FG003|COMPLETED|Period 3: 90mg/m^2||0||
59656369|NCT01458366|75774541|FG004|COMPLETED|Period 3: 90mg/m^2||0||
59656370|NCT01458366|75774537|FG000|NOT COMPLETED|Period 3: 90mg/m^2||0||
59656371|NCT01458366|75774538|FG001|NOT COMPLETED|Period 3: 90mg/m^2||0||
59656372|NCT01458366|75774539|FG002|NOT COMPLETED|Period 3: 90mg/m^2||0||
59656373|NCT01458366|75774540|FG003|NOT COMPLETED|Period 3: 90mg/m^2||0||
59988856|NCT04495179|76104105|FG001|STARTED|Overall Study||28||
59988857|NCT04495179|76104104|FG000|COMPLETED|Overall Study||0||
59656374|NCT01458366|75774541|FG004|NOT COMPLETED|Period 3: 90mg/m^2||0||
59656375|NCT01458366|75774537|FG000|STARTED|Period 4: 120mg/m^2||0||
59656376|NCT01458366|75774538|FG001|STARTED|Period 4: 120mg/m^2||0||
59656377|NCT01458366|75774539|FG002|STARTED|Period 4: 120mg/m^2||0||
59656378|NCT01458366|75774540|FG003|STARTED|Period 4: 120mg/m^2||3||
59656379|NCT01458366|75774541|FG004|STARTED|Period 4: 120mg/m^2||0||
59656380|NCT01458366|75774537|FG000|COMPLETED|Period 4: 120mg/m^2||0||
60077063|NCT01896895|76192104|FG003|STARTED|Double-blind MP||0||
60077064|NCT01896895|76192101|FG000|COMPLETED|Double-blind MP||19||
60077065|NCT01896895|76192102|FG001|COMPLETED|Double-blind MP||20||
60077066|NCT01896895|76192103|FG002|COMPLETED|Double-blind MP||16||
60077067|NCT01896895|76192104|FG003|COMPLETED|Double-blind MP||0||
60077068|NCT01896895|76192101|FG000|NOT COMPLETED|Double-blind MP||1||
60077069|NCT01896895|76192102|FG001|NOT COMPLETED|Double-blind MP||2||
60077070|NCT01896895|76192103|FG002|NOT COMPLETED|Double-blind MP||3||
60077071|NCT01896895|76192104|FG003|NOT COMPLETED|Double-blind MP||0||
60077072|NCT01896895|76192101|FG000|STARTED|OLEX Period||0||
60077073|NCT01896895|76192102|FG001|STARTED|OLEX Period||0||
59543941|NCT02450526|75642189|FG000|NOT COMPLETED|OL Period (Cycles 2-5)||0||
59543942|NCT02450526|75642190|FG001|NOT COMPLETED|OL Period (Cycles 2-5)||0||
59543943|NCT02450526|75642191|FG002|NOT COMPLETED|OL Period (Cycles 2-5)||0||
59543944|NCT02450526|75642192|FG003|NOT COMPLETED|OL Period (Cycles 2-5)||0||
59543945|NCT02450526|75642193|FG004|NOT COMPLETED|OL Period (Cycles 2-5)||41||
59543946|NCT01604291|75642217|FG000|STARTED|Overall Study||311||
59543947|NCT01604291|75642218|FG001|STARTED|Overall Study||443||
59543948|NCT01604291|75642219|FG002|STARTED|Overall Study||193||
59543949|NCT01604291|75642220|FG003|STARTED|Overall Study||44||
59543950|NCT01604291|75642217|FG000|COMPLETED|Overall Study||311||
59543951|NCT01604291|75642218|FG001|COMPLETED|Overall Study||443||
59543952|NCT01604291|75642219|FG002|COMPLETED|Overall Study||193||
59543953|NCT01604291|75642220|FG003|COMPLETED|Overall Study||44||
59543954|NCT01604291|75642217|FG000|NOT COMPLETED|Overall Study||0||
59543955|NCT01604291|75642218|FG001|NOT COMPLETED|Overall Study||0||
59543956|NCT01604291|75642219|FG002|NOT COMPLETED|Overall Study||0||
59543957|NCT01604291|75642220|FG003|NOT COMPLETED|Overall Study||0||
59543958|NCT02233517|75642240|FG000|STARTED|Overall Study||19||
59543959|NCT02233517|75642241|FG001|STARTED|Overall Study||17||
59543960|NCT02233517|75642240|FG000|COMPLETED|Overall Study||12||
59543961|NCT02233517|75642241|FG001|COMPLETED|Overall Study||13||
59543962|NCT02233517|75642240|FG000|NOT COMPLETED|Overall Study||7||
59543963|NCT02233517|75642241|FG001|NOT COMPLETED|Overall Study||4||
59543964|NCT01605539|75642249|FG000|STARTED|Overall Study||3||
59543965|NCT01605539|75642250|FG001|STARTED|Overall Study||3||
59543966|NCT01605539|75642251|FG002|STARTED|Overall Study||4||
59543967|NCT01605539|75642249|FG000|COMPLETED|Overall Study||3||
59543968|NCT01605539|75642250|FG001|COMPLETED|Overall Study||2||
59543969|NCT01605539|75642251|FG002|COMPLETED|Overall Study||4||
59543970|NCT01605539|75642249|FG000|NOT COMPLETED|Overall Study||0||
59543971|NCT01605539|75642250|FG001|NOT COMPLETED|Overall Study||1||
59543972|NCT01605539|75642251|FG002|NOT COMPLETED|Overall Study||0||
59543973|NCT02458638|75642260|FG000|STARTED|Overall Study||474||
59543974|NCT02458638|75642260|FG000|COMPLETED|Overall Study||15||
59543975|NCT02458638|75642260|FG000|NOT COMPLETED|Overall Study||459||
59543976|NCT01607255|75642267|FG000|STARTED|Overall Study||161||
59543977|NCT01607255|75642268|FG001|STARTED|Overall Study||160||
59543978|NCT01607255|75642269|FG002|STARTED|Overall Study||159||
59543979|NCT01607255|75642267|FG000|COMPLETED|Overall Study||161||
59543980|NCT01607255|75642268|FG001|COMPLETED|Overall Study||160||
59543981|NCT01607255|75642269|FG002|COMPLETED|Overall Study||159||
59543982|NCT01607255|75642267|FG000|NOT COMPLETED|Overall Study||0||
59543983|NCT01607255|75642268|FG001|NOT COMPLETED|Overall Study||0||
59543984|NCT01607255|75642269|FG002|NOT COMPLETED|Overall Study||0||
59543985|NCT01607411|75642277|FG000|STARTED|Period I||14||
59543986|NCT01607411|75642278|FG001|STARTED|Period I||13||
59543987|NCT01607411|75642279|FG002|STARTED|Period I||14||
59543988|NCT01607411|75642280|FG003|STARTED|Period I||14||
60077074|NCT01896895|76192103|FG002|STARTED|OLEX Period||0||
60077075|NCT01896895|76192104|FG003|STARTED|OLEX Period|Not all participants who completed double-blind MP fulfilled the inclusion criteria for OLEX period.|39||
59543989|NCT01607411|75642277|FG000|COMPLETED|Period I||14||
59543990|NCT01607411|75642278|FG001|COMPLETED|Period I||13||
59543991|NCT01607411|75642279|FG002|COMPLETED|Period I||14||
59543992|NCT01607411|75642280|FG003|COMPLETED|Period I||14||
59543993|NCT01607411|75642277|FG000|NOT COMPLETED|Period I||0||
59543994|NCT01607411|75642278|FG001|NOT COMPLETED|Period I||0||
59543995|NCT01607411|75642279|FG002|NOT COMPLETED|Period I||0||
59543996|NCT01607411|75642280|FG003|NOT COMPLETED|Period I||0||
59543997|NCT01607411|75642277|FG000|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|14||
59543998|NCT01607411|75642278|FG001|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|14||
60077076|NCT01896895|76192101|FG000|COMPLETED|OLEX Period||0||
60077077|NCT01896895|76192102|FG001|COMPLETED|OLEX Period||0||
60077078|NCT01896895|76192103|FG002|COMPLETED|OLEX Period||0||
60077079|NCT01896895|76192104|FG003|COMPLETED|OLEX Period||39||
60077080|NCT01896895|76192101|FG000|NOT COMPLETED|OLEX Period||0||
60077081|NCT01896895|76192102|FG001|NOT COMPLETED|OLEX Period||0||
60077082|NCT01896895|76192103|FG002|NOT COMPLETED|OLEX Period||0||
60077083|NCT01896895|76192104|FG003|NOT COMPLETED|OLEX Period||0||
60077084|NCT02315872|76192115|FG000|STARTED|Overall Study||4||
60077085|NCT02315872|76192116|FG001|STARTED|Overall Study||4||
60077086|NCT02315872|76192115|FG000|COMPLETED|Overall Study||1||
60077087|NCT02315872|76192116|FG001|COMPLETED|Overall Study||3||
60077088|NCT02315872|76192115|FG000|NOT COMPLETED|Overall Study||3||
60077089|NCT02315872|76192116|FG001|NOT COMPLETED|Overall Study||1||
60077090|NCT03014362|76192124|FG000|STARTED|Overall Study||59||
60077091|NCT03014362|76192125|FG001|STARTED|Overall Study||61||
60077092|NCT03014362|76192124|FG000|COMPLETED|Overall Study||41|completed|
59656381|NCT01458366|75774538|FG001|COMPLETED|Period 4: 120mg/m^2||0||
59656382|NCT01458366|75774539|FG002|COMPLETED|Period 4: 120mg/m^2||0||
59656383|NCT01458366|75774540|FG003|COMPLETED|Period 4: 120mg/m^2||3||
59656384|NCT01458366|75774541|FG004|COMPLETED|Period 4: 120mg/m^2||0||
59656385|NCT01458366|75774537|FG000|NOT COMPLETED|Period 4: 120mg/m^2||0||
59656386|NCT01458366|75774538|FG001|NOT COMPLETED|Period 4: 120mg/m^2||0||
59656387|NCT01458366|75774539|FG002|NOT COMPLETED|Period 4: 120mg/m^2||0||
59656388|NCT01458366|75774540|FG003|NOT COMPLETED|Period 4: 120mg/m^2||0||
59656389|NCT01458366|75774541|FG004|NOT COMPLETED|Period 4: 120mg/m^2||0||
59656390|NCT01458366|75774537|FG000|STARTED|Period 5: Maximum Tolerated Dose (MTD)||0||
59656391|NCT01458366|75774538|FG001|STARTED|Period 5: Maximum Tolerated Dose (MTD)||0||
59656392|NCT01458366|75774539|FG002|STARTED|Period 5: Maximum Tolerated Dose (MTD)||0||
59656393|NCT01458366|75774540|FG003|STARTED|Period 5: Maximum Tolerated Dose (MTD)||0||
59656394|NCT01458366|75774541|FG004|STARTED|Period 5: Maximum Tolerated Dose (MTD)||27||
59656395|NCT01458366|75774537|FG000|COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0||
59656396|NCT01458366|75774538|FG001|COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0||
59656397|NCT01458366|75774539|FG002|COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0||
59656398|NCT01458366|75774540|FG003|COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0||
59656399|NCT01458366|75774541|FG004|COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||26||
59656400|NCT01458366|75774537|FG000|NOT COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0||
59656401|NCT01458366|75774538|FG001|NOT COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0||
59656402|NCT01458366|75774539|FG002|NOT COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0||
59656403|NCT01458366|75774540|FG003|NOT COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0||
59656404|NCT01458366|75774541|FG004|NOT COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||1||
59656405|NCT01126723|75774551|FG000|STARTED|Overall Study||35||
59656406|NCT01126723|75774552|FG001|STARTED|Overall Study||31||
59656407|NCT01126723|75774551|FG000|COMPLETED|Overall Study||29||
59656408|NCT01126723|75774552|FG001|COMPLETED|Overall Study||28||
59656409|NCT01126723|75774551|FG000|NOT COMPLETED|Overall Study||6||
59656410|NCT01126723|75774552|FG001|NOT COMPLETED|Overall Study||3||
59656411|NCT00364286|75774558|FG000|STARTED|Overall Study||17||
59656412|NCT00364286|75774558|FG000|COMPLETED|Overall Study||14||
59656413|NCT00364286|75774558|FG000|NOT COMPLETED|Overall Study||3||
59656414|NCT00328614|75774568|FG000|STARTED|Overall Study||4||
59656415|NCT00328614|75774569|FG001|STARTED|Overall Study||4||
59656416|NCT00328614|75774570|FG002|STARTED|Overall Study||6||
59656417|NCT00328614|75774571|FG003|STARTED|Overall Study||6||
59656418|NCT00328614|75774572|FG004|STARTED|Overall Study||6||
59656419|NCT00328614|75774573|FG005|STARTED|Overall Study||6||
59656420|NCT00328614|75774568|FG000|COMPLETED|Overall Study||4||
59656421|NCT00328614|75774569|FG001|COMPLETED|Overall Study||4||
59656422|NCT00328614|75774570|FG002|COMPLETED|Overall Study||6||
59656423|NCT00328614|75774571|FG003|COMPLETED|Overall Study||5||
59656424|NCT00328614|75774572|FG004|COMPLETED|Overall Study||5||
59656425|NCT00328614|75774573|FG005|COMPLETED|Overall Study||5||
59656426|NCT00328614|75774568|FG000|NOT COMPLETED|Overall Study||0||
60077093|NCT03014362|76192125|FG001|COMPLETED|Overall Study||51|completed|
60077094|NCT03014362|76192124|FG000|NOT COMPLETED|Overall Study||18||
60077095|NCT03014362|76192125|FG001|NOT COMPLETED|Overall Study||10||
59656427|NCT00328614|75774569|FG001|NOT COMPLETED|Overall Study||0||
59656428|NCT00328614|75774570|FG002|NOT COMPLETED|Overall Study||0||
59656429|NCT00328614|75774571|FG003|NOT COMPLETED|Overall Study||1||
59656430|NCT00328614|75774572|FG004|NOT COMPLETED|Overall Study||1||
59656431|NCT00328614|75774573|FG005|NOT COMPLETED|Overall Study||1||
59656432|NCT01755689|75774587|FG000|STARTED|Overall Study||259||
59656433|NCT01755689|75774588|FG001|STARTED|Overall Study||259||
59656434|NCT01755689|75774589|FG002|STARTED|Overall Study||261||
59656435|NCT01755689|75774590|FG003|STARTED|Overall Study||260||
59656436|NCT01755689|75774591|FG004|STARTED|Overall Study||261||
59656437|NCT01755689|75774587|FG000|COMPLETED|Overall Study||256||
59656438|NCT01755689|75774588|FG001|COMPLETED|Overall Study||254||
60077096|NCT01923181|76192140|FG000|STARTED|Overall Study||70||
60077097|NCT01923181|76192141|FG001|STARTED|Overall Study||70||
60077098|NCT01923181|76192142|FG002|STARTED|Overall Study||69||
60077099|NCT01923181|76192143|FG003|STARTED|Overall Study||70||
59656439|NCT01755689|75774589|FG002|COMPLETED|Overall Study||255||
59656440|NCT01755689|75774590|FG003|COMPLETED|Overall Study||254||
59656441|NCT01755689|75774591|FG004|COMPLETED|Overall Study||255||
59656442|NCT01755689|75774587|FG000|NOT COMPLETED|Overall Study||3||
59656443|NCT01755689|75774588|FG001|NOT COMPLETED|Overall Study||5||
59656444|NCT01755689|75774589|FG002|NOT COMPLETED|Overall Study||6||
59656445|NCT01755689|75774590|FG003|NOT COMPLETED|Overall Study||6||
59656446|NCT01755689|75774591|FG004|NOT COMPLETED|Overall Study||6||
59656447|NCT01762761|75774613|FG000|STARTED|Overall Study||51||
59656448|NCT01762761|75774614|FG001|STARTED|Overall Study||104||
59656449|NCT01762761|75774613|FG000|COMPLETED|Overall Study||12||
59656450|NCT01762761|75774614|FG001|COMPLETED|Overall Study||39||
59656451|NCT01762761|75774613|FG000|NOT COMPLETED|Overall Study||39||
59656452|NCT01762761|75774614|FG001|NOT COMPLETED|Overall Study||65||
59656453|NCT01763788|75774625|FG000|STARTED|Overall Study||3||
59656454|NCT01763788|75774626|FG001|STARTED|Overall Study||6||
59656455|NCT01763788|75774627|FG002|STARTED|Overall Study||91||
59656456|NCT01763788|75774628|FG003|STARTED|Overall Study||92||
59656457|NCT01763788|75774625|FG000|Received at Least 1dose of Study Drug|Overall Study||3||
59656458|NCT01763788|75774626|FG001|Received at Least 1dose of Study Drug|Overall Study||6||
59656459|NCT01763788|75774627|FG002|Received at Least 1dose of Study Drug|Overall Study||90||
59656460|NCT01763788|75774628|FG003|Received at Least 1dose of Study Drug|Overall Study||91||
59656461|NCT01763788|75774625|FG000|COMPLETED|Overall Study||3||
59656462|NCT01763788|75774626|FG001|COMPLETED|Overall Study||6||
59656463|NCT01763788|75774627|FG002|COMPLETED|Overall Study||90||
59656464|NCT01763788|75774628|FG003|COMPLETED|Overall Study||92||
59656465|NCT01763788|75774625|FG000|NOT COMPLETED|Overall Study||0||
59656466|NCT01763788|75774626|FG001|NOT COMPLETED|Overall Study||0||
59656467|NCT01763788|75774627|FG002|NOT COMPLETED|Overall Study||1||
59656468|NCT01763788|75774628|FG003|NOT COMPLETED|Overall Study||0||
59656469|NCT01774370|75774638|FG000|STARTED|Overall Study||3182||
59656470|NCT01774370|75774638|FG000|COMPLETED|Overall Study||3053||
59656471|NCT01774370|75774638|FG000|NOT COMPLETED|Overall Study||129||
59656472|NCT01777295|75774644|FG000|STARTED|Overall Study||40||
59656473|NCT01777295|75774645|FG001|STARTED|Overall Study||41||
59656474|NCT01777295|75774644|FG000|COMPLETED|Overall Study||36||
59656475|NCT01777295|75774645|FG001|COMPLETED|Overall Study||38||
59656476|NCT01777295|75774644|FG000|NOT COMPLETED|Overall Study||4||
59656477|NCT01777295|75774645|FG001|NOT COMPLETED|Overall Study||3||
59656478|NCT01779362|75774665|FG000|STARTED|Overall Study||65||
59656479|NCT01779362|75774666|FG001|STARTED|Overall Study||67||
59656480|NCT01779362|75774667|FG002|STARTED|Overall Study||67||
59656481|NCT01779362|75774668|FG003|STARTED|Overall Study||68||
59656482|NCT01779362|75774665|FG000|COMPLETED|Overall Study||56||
59656483|NCT01779362|75774666|FG001|COMPLETED|Overall Study||65||
59656484|NCT01779362|75774667|FG002|COMPLETED|Overall Study||58||
59656485|NCT01779362|75774668|FG003|COMPLETED|Overall Study||53||
59656486|NCT01779362|75774665|FG000|NOT COMPLETED|Overall Study||9||
59656487|NCT01779362|75774666|FG001|NOT COMPLETED|Overall Study||2||
59656488|NCT01779362|75774667|FG002|NOT COMPLETED|Overall Study||9||
59656489|NCT01779362|75774668|FG003|NOT COMPLETED|Overall Study||15||
59656490|NCT01787552|75774682|FG000|STARTED|Overall Study||8||
59656491|NCT01787552|75774683|FG001|STARTED|Overall Study||10||
59656492|NCT01787552|75774684|FG002|STARTED|Overall Study||5||
59656493|NCT01787552|75774685|FG003|STARTED|Overall Study||27||
59656494|NCT01787552|75774682|FG000|COMPLETED|Overall Study||0||
59656495|NCT01787552|75774683|FG001|COMPLETED|Overall Study||1||
59656496|NCT01787552|75774684|FG002|COMPLETED|Overall Study||0||
59656497|NCT01787552|75774685|FG003|COMPLETED|Overall Study||0||
59656498|NCT01787552|75774682|FG000|NOT COMPLETED|Overall Study||8||
59656499|NCT01787552|75774683|FG001|NOT COMPLETED|Overall Study||9||
59656500|NCT01787552|75774684|FG002|NOT COMPLETED|Overall Study||5||
59656501|NCT01787552|75774685|FG003|NOT COMPLETED|Overall Study||27||
59656502|NCT01808261|75774702|FG000|STARTED|Overall Study||68||
59656503|NCT01808261|75774703|FG001|STARTED|Overall Study||65||
59656504|NCT01808261|75774702|FG000|COMPLETED|Overall Study||32||
59656505|NCT01808261|75774703|FG001|COMPLETED|Overall Study||32||
59656506|NCT01808261|75774702|FG000|NOT COMPLETED|Overall Study||36||
59656507|NCT01808261|75774703|FG001|NOT COMPLETED|Overall Study||33||
59656508|NCT01814826|75774722|FG000|STARTED|Overall Study|6 participants were enrolled into the dose escalation phase and 26 in the MTD expansion phase.|32||
59656509|NCT01814826|75774723|FG001|STARTED|Overall Study|29 participants were enrolled into the MTD expansion phase.|29||
59656510|NCT01814826|75774724|FG002|STARTED|Overall Study|3 participants were enrolled into the dose escalation phase.|3||
59656511|NCT01814826|75774722|FG000|COMPLETED|Overall Study||0||
59656512|NCT01814826|75774723|FG001|COMPLETED|Overall Study||0||
59656513|NCT01814826|75774724|FG002|COMPLETED|Overall Study||0||
59656514|NCT01814826|75774722|FG000|NOT COMPLETED|Overall Study||32||
59656515|NCT01814826|75774723|FG001|NOT COMPLETED|Overall Study||29||
59656516|NCT01814826|75774724|FG002|NOT COMPLETED|Overall Study||3||
59656517|NCT01819467|75774735|FG000|STARTED|Overall Study||20|29|
59656518|NCT01819467|75774736|FG001|STARTED|Overall Study||9|29|
59656519|NCT01819467|75774735|FG000|COMPLETED|Overall Study||0|Study terminated|
59817906|NCT04488770|75940332|FG006|NOT COMPLETED|Part 1-Cohort 2: Period 1 (Up to 5 Days)||1||
59656520|NCT01819467|75774736|FG001|COMPLETED|Overall Study||0|Study terminated|
59656521|NCT01819467|75774735|FG000|NOT COMPLETED|Overall Study||20||
59656522|NCT01819467|75774736|FG001|NOT COMPLETED|Overall Study||9||
59656523|NCT01829711|75774742|FG000|STARTED|Overall Study||80||
59656524|NCT01829711|75774742|FG000|COMPLETED|Overall Study||37||
59656525|NCT01829711|75774742|FG000|NOT COMPLETED|Overall Study||43||
59656526|NCT01846273|75774749|FG000|STARTED|Overall Study||168|Full Analysis Set|
59656527|NCT01846273|75774750|FG001|STARTED|Overall Study||113|Full Analysis Set|
59656528|NCT01846273|75774751|FG002|STARTED|Overall Study||41|Full Analysis Set|
59656529|NCT01846273|75774749|FG000|Safety Analysis Set|Overall Study||172||
59656530|NCT01846273|75774750|FG001|Safety Analysis Set|Overall Study||135||
59656531|NCT01846273|75774751|FG002|Safety Analysis Set|Overall Study||14||
59656532|NCT01846273|75774749|FG000|COMPLETED|Overall Study||146||
59656533|NCT01846273|75774750|FG001|COMPLETED|Overall Study||87||
59656534|NCT01846273|75774751|FG002|COMPLETED|Overall Study||41||
59656535|NCT01846273|75774749|FG000|NOT COMPLETED|Overall Study||22||
59656536|NCT01846273|75774750|FG001|NOT COMPLETED|Overall Study||26||
59656537|NCT01846273|75774751|FG002|NOT COMPLETED|Overall Study||0||
59656538|NCT01871896|75774759|FG000|STARTED|Overall Study||24||
59656539|NCT01871896|75774759|FG000|Underwent Procedure|Overall Study||23||
59656540|NCT01871896|75774759|FG000|COMPLETED|Overall Study||23||
59656541|NCT01871896|75774759|FG000|NOT COMPLETED|Overall Study||1||
59656542|NCT04752475|75774766|FG000|STARTED|Overall Study||41||
59656543|NCT04752475|75774767|FG001|STARTED|Overall Study||41||
59656544|NCT04752475|75774766|FG000|COMPLETED|Overall Study||40||
59656545|NCT04752475|75774767|FG001|COMPLETED|Overall Study||40||
59656546|NCT04752475|75774766|FG000|NOT COMPLETED|Overall Study||1||
59656547|NCT04752475|75774767|FG001|NOT COMPLETED|Overall Study||1||
59656548|NCT04647032|75774775|FG000|STARTED|Overall Study||15||
59656549|NCT04647032|75774776|FG001|STARTED|Overall Study||15||
59656550|NCT04647032|75774775|FG000|COMPLETED|Overall Study||14||
59656551|NCT04647032|75774776|FG001|COMPLETED|Overall Study||13||
59656552|NCT04647032|75774775|FG000|NOT COMPLETED|Overall Study||1||
59656553|NCT04647032|75774776|FG001|NOT COMPLETED|Overall Study||2||
59656554|NCT04243512|75774782|FG000|STARTED|Overall Study||39||
59656555|NCT04243512|75774782|FG000|COMPLETED|Overall Study||36||
59656556|NCT04243512|75774782|FG000|NOT COMPLETED|Overall Study||3||
59656557|NCT04018313|75774791|FG000|STARTED|Overall Study||15||
59656558|NCT04018313|75774792|FG001|STARTED|Overall Study||15||
59656559|NCT04018313|75774793|FG002|STARTED|Overall Study||47||
59656560|NCT04018313|75774794|FG003|STARTED|Overall Study||49||
59656561|NCT04018313|75774795|FG004|STARTED|Overall Study||50||
59656562|NCT04018313|75774791|FG000|COMPLETED|Overall Study||14||
59656563|NCT04018313|75774792|FG001|COMPLETED|Overall Study||14||
59656564|NCT04018313|75774793|FG002|COMPLETED|Overall Study||46||
59656565|NCT04018313|75774794|FG003|COMPLETED|Overall Study||47||
59656566|NCT04018313|75774795|FG004|COMPLETED|Overall Study||49||
59656567|NCT04018313|75774791|FG000|NOT COMPLETED|Overall Study||1||
59656568|NCT04018313|75774792|FG001|NOT COMPLETED|Overall Study||1||
59656569|NCT04018313|75774793|FG002|NOT COMPLETED|Overall Study||1||
59656570|NCT04018313|75774794|FG003|NOT COMPLETED|Overall Study||2||
59656571|NCT04018313|75774795|FG004|NOT COMPLETED|Overall Study||1||
59656572|NCT03846947|75774813|FG000|STARTED|Overall Study||28||
59656573|NCT03846947|75774813|FG000|COMPLETED|Overall Study||26||
59656574|NCT03846947|75774813|FG000|NOT COMPLETED|Overall Study||2||
59656575|NCT03713645|75774817|FG000|STARTED|Overall Study||36||
59656576|NCT03713645|75774817|FG000|COMPLETED|Overall Study||36||
59656577|NCT03713645|75774817|FG000|NOT COMPLETED|Overall Study||0||
59656578|NCT03675308|75774826|FG000|STARTED|Overall Study||481||
59656579|NCT03675308|75774827|FG001|STARTED|Overall Study||483||
59656580|NCT03675308|75774826|FG000|COMPLETED|Overall Study||467|Completed Period 1 study participation|
59815803|NCT03026283|75938213|FG002|COMPLETED|Optimal Care/Stress Test/ICA||0|Participants who followed recommendation provided after consultation with referring physician.|
59988858|NCT04495179|76104105|FG001|COMPLETED|Overall Study||0||
59656581|NCT03675308|75774827|FG001|COMPLETED|Overall Study||473|Completed Period 1 study participation|
59656582|NCT03675308|75774826|FG000|NOT COMPLETED|Overall Study||14||
59656583|NCT03675308|75774827|FG001|NOT COMPLETED|Overall Study||10||
59656584|NCT03131219|75774835|FG000|STARTED|Initial Evaluation Period||21||
59656585|NCT03131219|75774836|FG001|STARTED|Initial Evaluation Period||10||
59656586|NCT03131219|75774835|FG000|Received At Least 1 Dose of Study Drug|Initial Evaluation Period||21||
59656587|NCT03131219|75774836|FG001|Received At Least 1 Dose of Study Drug|Initial Evaluation Period||10||
59656588|NCT03131219|75774835|FG000|COMPLETED|Initial Evaluation Period||17||
59656589|NCT03131219|75774836|FG001|COMPLETED|Initial Evaluation Period||10||
59656590|NCT03131219|75774835|FG000|NOT COMPLETED|Initial Evaluation Period||4||
59656591|NCT03131219|75774836|FG001|NOT COMPLETED|Initial Evaluation Period||0||
59656592|NCT03131219|75774835|FG000|STARTED|Extension Period||17||
59656593|NCT03131219|75774836|FG001|STARTED|Extension Period||10||
59656594|NCT03131219|75774835|FG000|Received At Least 1 Dose of Study Drug|Extension Period||17||
59656595|NCT03131219|75774836|FG001|Received At Least 1 Dose of Study Drug|Extension Period||10||
59656596|NCT03131219|75774835|FG000|Ongoing|Extension Period||16||
59656597|NCT03131219|75774836|FG001|Ongoing|Extension Period||10||
59656598|NCT03131219|75774835|FG000|COMPLETED|Extension Period||0||
59656599|NCT03131219|75774836|FG001|COMPLETED|Extension Period||0||
59656600|NCT03131219|75774835|FG000|NOT COMPLETED|Extension Period||17||
59656601|NCT03131219|75774836|FG001|NOT COMPLETED|Extension Period||10||
59656602|NCT02914613|75774844|FG000|STARTED|Overall Study||22||
59656603|NCT02914613|75774845|FG001|STARTED|Overall Study||22||
59656604|NCT02914613|75774844|FG000|COMPLETED|Overall Study||20||
59656605|NCT02914613|75774845|FG001|COMPLETED|Overall Study||20||
59656606|NCT02914613|75774844|FG000|NOT COMPLETED|Overall Study||2||
59656607|NCT02914613|75774845|FG001|NOT COMPLETED|Overall Study||2||
59656608|NCT02586207|75774855|FG000|STARTED|Overall Study||59||
59656609|NCT02586207|75774855|FG000|COMPLETED|Overall Study||57||
59656610|NCT02586207|75774855|FG000|NOT COMPLETED|Overall Study||2||
59656611|NCT02573324|75774862|FG000|STARTED|Overall Study||341|Randomized|
59656612|NCT02573324|75774863|FG001|STARTED|Overall Study||344|Randomized|
59656613|NCT02573324|75774864|FG002|STARTED|Overall Study||6|Randomized|
59656614|NCT02573324|75774862|FG000|Received Randomized Study Drug|Overall Study||337||
59656615|NCT02573324|75774863|FG001|Received Randomized Study Drug|Overall Study||344||
59656616|NCT02573324|75774864|FG002|Received Randomized Study Drug|Overall Study||6||
59656617|NCT02573324|75774862|FG000|Entered Adjuvant Phase|Overall Study||285||
59656618|NCT02573324|75774863|FG001|Entered Adjuvant Phase|Overall Study||273||
59656619|NCT02573324|75774864|FG002|Entered Adjuvant Phase|Overall Study||6||
59656620|NCT02573324|75774862|FG000|Entered Follow-Up Phase|Overall Study||328||
59656621|NCT02573324|75774863|FG001|Entered Follow-Up Phase|Overall Study||326||
59656622|NCT02573324|75774864|FG002|Entered Follow-Up Phase|Overall Study||5||
59656623|NCT02573324|75774862|FG000|COMPLETED|Overall Study||0||
59656624|NCT02573324|75774863|FG001|COMPLETED|Overall Study||0||
59656625|NCT02573324|75774864|FG002|COMPLETED|Overall Study||0||
59656626|NCT02573324|75774862|FG000|NOT COMPLETED|Overall Study||341||
59656627|NCT02573324|75774863|FG001|NOT COMPLETED|Overall Study||344||
59656628|NCT02573324|75774864|FG002|NOT COMPLETED|Overall Study||6||
59656629|NCT02296684|75774880|FG000|STARTED|Overall Study||36||
59656630|NCT02296684|75774881|FG001|STARTED|Overall Study||30||
59656631|NCT02296684|75774882|FG002|STARTED|Overall Study||1||
59656632|NCT02296684|75774880|FG000|COMPLETED|Overall Study||34||
59656633|NCT02296684|75774881|FG001|COMPLETED|Overall Study||29||
59656634|NCT02296684|75774882|FG002|COMPLETED|Overall Study||0||
59656635|NCT02296684|75774880|FG000|NOT COMPLETED|Overall Study||2||
59656636|NCT02296684|75774881|FG001|NOT COMPLETED|Overall Study||1||
59656637|NCT02296684|75774882|FG002|NOT COMPLETED|Overall Study||1||
59656638|NCT02107261|75774891|FG000|STARTED|Cycle 1: Week 1-4||11||
59656639|NCT02107261|75774892|FG001|STARTED|Cycle 1: Week 1-4||10||
59656640|NCT02107261|75774891|FG000|COMPLETED|Cycle 1: Week 1-4||11||
59656641|NCT02107261|75774892|FG001|COMPLETED|Cycle 1: Week 1-4||10||
59656642|NCT02107261|75774891|FG000|NOT COMPLETED|Cycle 1: Week 1-4||0||
59656643|NCT02107261|75774892|FG001|NOT COMPLETED|Cycle 1: Week 1-4||0||
59656644|NCT02107261|75774891|FG000|STARTED|Washout: Weakness Back to Baseline||11||
59656645|NCT02107261|75774892|FG001|STARTED|Washout: Weakness Back to Baseline||10||
59656646|NCT02107261|75774891|FG000|COMPLETED|Washout: Weakness Back to Baseline||10||
59656647|NCT02107261|75774892|FG001|COMPLETED|Washout: Weakness Back to Baseline||10||
59656648|NCT02107261|75774891|FG000|NOT COMPLETED|Washout: Weakness Back to Baseline||1||
59656649|NCT02107261|75774892|FG001|NOT COMPLETED|Washout: Weakness Back to Baseline||0||
59656650|NCT02107261|75774891|FG000|STARTED|Cycle 2: Week 12-15||10||
59656651|NCT02107261|75774892|FG001|STARTED|Cycle 2: Week 12-15||10||
59656652|NCT02107261|75774891|FG000|COMPLETED|Cycle 2: Week 12-15||10||
59656653|NCT02107261|75774892|FG001|COMPLETED|Cycle 2: Week 12-15||9||
59656654|NCT02107261|75774891|FG000|NOT COMPLETED|Cycle 2: Week 12-15||0||
59656655|NCT02107261|75774892|FG001|NOT COMPLETED|Cycle 2: Week 12-15||1||
59656656|NCT02014597|75774902|FG000|STARTED|Overall Study||12||24
59656657|NCT02014597|75774903|FG001|STARTED|Overall Study||11||22
59656658|NCT02014597|75774902|FG000|COMPLETED|Overall Study||10||20
59656659|NCT02014597|75774903|FG001|COMPLETED|Overall Study||10||20
59656660|NCT02014597|75774902|FG000|NOT COMPLETED|Overall Study||2||4
59656661|NCT02014597|75774903|FG001|NOT COMPLETED|Overall Study||1||2
59656662|NCT01939275|75774909|FG000|STARTED|Overall Study||8||
59656663|NCT01939275|75774909|FG000|COMPLETED|Overall Study||8||
59656664|NCT01939275|75774909|FG000|NOT COMPLETED|Overall Study||0||
59656665|NCT01342367|75774915|FG000|STARTED|Overall Study||32||
59656666|NCT01342367|75774916|FG001|STARTED|Overall Study||42||
59656667|NCT01342367|75774915|FG000|COMPLETED|Overall Study||30||
59656668|NCT01342367|75774916|FG001|COMPLETED|Overall Study||40||
59656669|NCT01342367|75774915|FG000|NOT COMPLETED|Overall Study||2||
59656670|NCT01342367|75774916|FG001|NOT COMPLETED|Overall Study||2||
59656671|NCT01185171|75774922|FG000|STARTED|Induction Chemotherapy||59||
59656672|NCT01185171|75774922|FG000|COMPLETED|Induction Chemotherapy||57||
59656673|NCT01185171|75774922|FG000|NOT COMPLETED|Induction Chemotherapy||2||
59656674|NCT01185171|75774922|FG000|STARTED|Concurrent Chemo and Radiation Treatment||69||
59656675|NCT01185171|75774922|FG000|COMPLETED|Concurrent Chemo and Radiation Treatment||66||
59656676|NCT01185171|75774922|FG000|NOT COMPLETED|Concurrent Chemo and Radiation Treatment||3||
59656677|NCT01185171|75774922|FG000|STARTED|Maintenance||60||
59656678|NCT01185171|75774922|FG000|COMPLETED|Maintenance||48||
59656679|NCT01185171|75774922|FG000|NOT COMPLETED|Maintenance||12||
59656680|NCT00896493|75774926|FG000|STARTED|Overall Study||38||
59656681|NCT00896493|75774926|FG000|Completed Assigned Treatment|Overall Study||35||
59656682|NCT00896493|75774926|FG000|COMPLETED|Overall Study||35||
59656683|NCT00896493|75774926|FG000|NOT COMPLETED|Overall Study||3||
59656684|NCT00003042|75774932|FG000|STARTED|Overall Study||14||
59656685|NCT00003042|75774933|FG001|STARTED|Overall Study||27||
59656686|NCT00003042|75774932|FG000|COMPLETED|Overall Study||14||
59656687|NCT00003042|75774933|FG001|COMPLETED|Overall Study||27||
59656688|NCT00003042|75774932|FG000|NOT COMPLETED|Overall Study||0||
59656689|NCT00003042|75774933|FG001|NOT COMPLETED|Overall Study||0||
59656690|NCT01875185|75774941|FG000|STARTED|Overall Study||52||
59656691|NCT01875185|75774942|FG001|STARTED|Overall Study||48||
59656692|NCT01875185|75774941|FG000|COMPLETED|Overall Study||0||
59656693|NCT01875185|75774942|FG001|COMPLETED|Overall Study||0||
59656694|NCT01875185|75774941|FG000|NOT COMPLETED|Overall Study||52||
59656695|NCT01875185|75774942|FG001|NOT COMPLETED|Overall Study||48||
59656696|NCT01887743|75774955|FG000|STARTED|Overall Study||20||
59656697|NCT01887743|75774956|FG001|STARTED|Overall Study||19||
59656698|NCT01887743|75774957|FG002|STARTED|Overall Study||32||
59656699|NCT01887743|75774955|FG000|COMPLETED|Overall Study||19||
59656700|NCT01887743|75774956|FG001|COMPLETED|Overall Study||17||
59656701|NCT01887743|75774957|FG002|COMPLETED|Overall Study||29||
59656702|NCT01887743|75774955|FG000|NOT COMPLETED|Overall Study||1||
59656703|NCT01887743|75774956|FG001|NOT COMPLETED|Overall Study||2||
59656704|NCT01887743|75774957|FG002|NOT COMPLETED|Overall Study||3||
59656705|NCT01901432|75774971|FG000|STARTED|Overall Study||3||
59656706|NCT01901432|75774972|FG001|STARTED|Overall Study||3||
59656707|NCT01901432|75774973|FG002|STARTED|Overall Study||3||
59656708|NCT01901432|75774974|FG003|STARTED|Overall Study||3||
59656709|NCT01901432|75774975|FG004|STARTED|Overall Study||36||
59656710|NCT01901432|75774971|FG000|Received Study Drug|Overall Study||3||
59656711|NCT01901432|75774972|FG001|Received Study Drug|Overall Study||3||
59656712|NCT01901432|75774973|FG002|Received Study Drug|Overall Study||3||
59656713|NCT01901432|75774974|FG003|Received Study Drug|Overall Study||3||
59656714|NCT01901432|75774975|FG004|Received Study Drug|Overall Study||35||
59656715|NCT01901432|75774971|FG000|COMPLETED|Overall Study||3||
59656716|NCT01901432|75774972|FG001|COMPLETED|Overall Study||2||
59656717|NCT01901432|75774973|FG002|COMPLETED|Overall Study||1||
59656718|NCT01901432|75774974|FG003|COMPLETED|Overall Study||3||
59656719|NCT01901432|75774975|FG004|COMPLETED|Overall Study||27||
59656720|NCT01901432|75774971|FG000|NOT COMPLETED|Overall Study||0||
59656721|NCT01901432|75774972|FG001|NOT COMPLETED|Overall Study||1||
59656722|NCT01901432|75774973|FG002|NOT COMPLETED|Overall Study||2||
59656723|NCT01901432|75774974|FG003|NOT COMPLETED|Overall Study||0||
59656724|NCT01901432|75774975|FG004|NOT COMPLETED|Overall Study||9||
59656725|NCT01904279|75774996|FG000|STARTED|Overall Study||27||
59656726|NCT01904279|75774997|FG001|STARTED|Overall Study||25||
59656727|NCT01904279|75774996|FG000|COMPLETED|Overall Study||24||
59656728|NCT01904279|75774997|FG001|COMPLETED|Overall Study||22||
59656729|NCT01904279|75774996|FG000|NOT COMPLETED|Overall Study||3||
59656730|NCT01904279|75774997|FG001|NOT COMPLETED|Overall Study||3||
59656731|NCT01917318|75775006|FG000|STARTED|First Treatment||0||
59656732|NCT01917318|75775007|FG001|STARTED|First Treatment||1||
59656733|NCT01917318|75775006|FG000|COMPLETED|First Treatment||0||
59656734|NCT01917318|75775007|FG001|COMPLETED|First Treatment||0||
59656735|NCT01917318|75775006|FG000|NOT COMPLETED|First Treatment||0||
59656736|NCT01917318|75775007|FG001|NOT COMPLETED|First Treatment||1||
59656737|NCT01917318|75775006|FG000|STARTED|Second Treatment||0||
59656738|NCT01917318|75775007|FG001|STARTED|Second Treatment||0||
59656739|NCT01917318|75775006|FG000|COMPLETED|Second Treatment||0||
59656740|NCT01917318|75775007|FG001|COMPLETED|Second Treatment||0||
59656741|NCT01917318|75775006|FG000|NOT COMPLETED|Second Treatment||0||
59656742|NCT01917318|75775007|FG001|NOT COMPLETED|Second Treatment||0||
59656743|NCT01923168|75775016|FG000|STARTED|Overall Study||131||
59656744|NCT01923168|75775017|FG001|STARTED|Overall Study||83||
59656745|NCT01923168|75775018|FG002|STARTED|Overall Study||126||
59815804|NCT03026283|75938214|FG003|COMPLETED|Optimal Care/Stress Test/ICA||108|Participants who followed recommendation provided after consultation with referring physician.|
59817907|NCT04488770|75940333|FG007|NOT COMPLETED|Part 1-Cohort 2: Period 1 (Up to 5 Days)||0||
59656746|NCT01923168|75775016|FG000|COMPLETED|Overall Study||94||
59656747|NCT01923168|75775017|FG001|COMPLETED|Overall Study||44||
59656748|NCT01923168|75775018|FG002|COMPLETED|Overall Study||109||
59656749|NCT01923168|75775016|FG000|NOT COMPLETED|Overall Study||37||
59656750|NCT01923168|75775017|FG001|NOT COMPLETED|Overall Study||39||
59656751|NCT01923168|75775018|FG002|NOT COMPLETED|Overall Study||17||
59656752|NCT01931098|75775028|FG000|STARTED|Overall Study||9||
59656753|NCT01931098|75775029|FG001|STARTED|Overall Study||26||
59656754|NCT01931098|75775028|FG000|COMPLETED|Overall Study||9||
59656755|NCT01931098|75775029|FG001|COMPLETED|Overall Study||22||
59656756|NCT01931098|75775028|FG000|NOT COMPLETED|Overall Study||0||
59656757|NCT01931098|75775029|FG001|NOT COMPLETED|Overall Study||4||
59656758|NCT05097716|75775039|FG000|STARTED|Period 1||12||
59656759|NCT05097716|75775039|FG000|COMPLETED|Period 1||10||
59656760|NCT05097716|75775039|FG000|NOT COMPLETED|Period 1||2||
59656761|NCT05097716|75775039|FG000|STARTED|Period 2||10||
59656762|NCT05097716|75775039|FG000|COMPLETED|Period 2||10||
59656763|NCT05097716|75775039|FG000|NOT COMPLETED|Period 2||0||
59656764|NCT04906512|75775050|FG000|STARTED|Overall Study||62||
59656765|NCT04906512|75775051|FG001|STARTED|Overall Study||61||
59656766|NCT04906512|75775050|FG000|COMPLETED|Overall Study||39||
59656767|NCT04906512|75775051|FG001|COMPLETED|Overall Study||42||
59656768|NCT04906512|75775050|FG000|NOT COMPLETED|Overall Study||23||
59656769|NCT04906512|75775051|FG001|NOT COMPLETED|Overall Study||19||
59656770|NCT04781647|75775060|FG000|STARTED|Overall Study||20||
59656771|NCT04781647|75775061|FG001|STARTED|Overall Study||17||
59656772|NCT04781647|75775062|FG002|STARTED|Overall Study||17||
59656773|NCT04781647|75775060|FG000|COMPLETED|Overall Study||6||
59656774|NCT04781647|75775061|FG001|COMPLETED|Overall Study||5||
59656775|NCT04781647|75775062|FG002|COMPLETED|Overall Study||6||
59656776|NCT04781647|75775060|FG000|NOT COMPLETED|Overall Study||14||
59656777|NCT04781647|75775061|FG001|NOT COMPLETED|Overall Study||12||
59656778|NCT04781647|75775062|FG002|NOT COMPLETED|Overall Study||11||
59656779|NCT04727528|75775074|FG000|STARTED|Open-label Period|After screening on Day 1, all participants received open-label SZC for up to 48 hours, and then were randomized to double-blind treatment of SZC or placebo for 4 weeks.|39|Participants entered open-label period and received treatment|
59656780|NCT04727528|75775075|FG001|STARTED|Open-label Period||0|Participants entered open-label period and received treatment|
59656781|NCT04727528|75775074|FG000|COMPLETED|Open-label Period||37||
59656782|NCT04727528|75775075|FG001|COMPLETED|Open-label Period||0||
59656783|NCT04727528|75775074|FG000|NOT COMPLETED|Open-label Period||2||
59656784|NCT04727528|75775075|FG001|NOT COMPLETED|Open-label Period||0||
59656785|NCT04727528|75775074|FG000|STARTED|Double-blind Treatment Phase|After the open-label period, participants were randomized into either the SZC or placebo group.|17||
59656786|NCT04727528|75775075|FG001|STARTED|Double-blind Treatment Phase|After the open-label period, participants were randomized into either the SZC or placebo group.|20||
59656787|NCT04727528|75775074|FG000|COMPLETED|Double-blind Treatment Phase||16||
59656788|NCT04727528|75775075|FG001|COMPLETED|Double-blind Treatment Phase||15||
59656789|NCT04727528|75775074|FG000|NOT COMPLETED|Double-blind Treatment Phase||1||
59656790|NCT04727528|75775075|FG001|NOT COMPLETED|Double-blind Treatment Phase||5||
59656791|NCT04711837|75775084|FG000|STARTED|Overall Study||170||
59656792|NCT04711837|75775085|FG001|STARTED|Overall Study||85||
59656793|NCT04711837|75775084|FG000|COMPLETED|Overall Study||168||
59656794|NCT04711837|75775085|FG001|COMPLETED|Overall Study||83||
59656795|NCT04711837|75775084|FG000|NOT COMPLETED|Overall Study||2||
59656796|NCT04711837|75775085|FG001|NOT COMPLETED|Overall Study||2||
59656797|NCT04676425|75775093|FG000|STARTED|Overall Study||7||
59656798|NCT04676425|75775094|FG001|STARTED|Overall Study||7||
59656799|NCT04676425|75775093|FG000|COMPLETED|Overall Study||7||
59656800|NCT04676425|75775094|FG001|COMPLETED|Overall Study||7||
59656801|NCT04676425|75775093|FG000|NOT COMPLETED|Overall Study||0||
59656802|NCT04676425|75775094|FG001|NOT COMPLETED|Overall Study||0||
59656803|NCT04674189|75775103|FG000|STARTED|Overall Study||786||
59656804|NCT04674189|75775104|FG001|STARTED|Overall Study||786||
59656805|NCT04674189|75775105|FG002|STARTED|Overall Study||785||
59656806|NCT04674189|75775103|FG000|Safety Analysis Set|Overall Study||783||
59656807|NCT04674189|75775104|FG001|Safety Analysis Set|Overall Study||785||
59656808|NCT04674189|75775105|FG002|Safety Analysis Set|Overall Study||783||
59656809|NCT04674189|75775103|FG000|COMPLETED|Overall Study||617||
59656810|NCT04674189|75775104|FG001|COMPLETED|Overall Study||637||
59656811|NCT04674189|75775105|FG002|COMPLETED|Overall Study||372||
59656812|NCT04674189|75775103|FG000|NOT COMPLETED|Overall Study||169||
59656813|NCT04674189|75775104|FG001|NOT COMPLETED|Overall Study||149||
59656814|NCT04674189|75775105|FG002|NOT COMPLETED|Overall Study||413||
59656815|NCT04652765|75775118|FG000|STARTED|Overall Study||1||
59656816|NCT04652765|75775119|FG001|STARTED|Overall Study||2||
59656817|NCT04652765|75775120|FG002|STARTED|Overall Study||3||
59656818|NCT04652765|75775118|FG000|COMPLETED|Overall Study||1||
59656819|NCT04652765|75775119|FG001|COMPLETED|Overall Study||2||
59656820|NCT04652765|75775120|FG002|COMPLETED|Overall Study||2||
59656821|NCT04652765|75775118|FG000|NOT COMPLETED|Overall Study||0||
59656822|NCT04652765|75775119|FG001|NOT COMPLETED|Overall Study||0||
59656823|NCT04652765|75775120|FG002|NOT COMPLETED|Overall Study||1||
59656824|NCT04591977|75775128|FG000|STARTED|Overall Study||46||
59656825|NCT04591977|75775128|FG000|COMPLETED|Overall Study||35||
59656826|NCT04591977|75775128|FG000|NOT COMPLETED|Overall Study||11||
59656827|NCT04517643|75775133|FG000|STARTED|Overall Study||4||
59656828|NCT04517643|75775133|FG000|COMPLETED|Overall Study||4||
59656829|NCT04517643|75775133|FG000|NOT COMPLETED|Overall Study||0||
59656830|NCT04380857|75775137|FG000|STARTED|Overall Study||20||20
59656831|NCT04380857|75775138|FG001|STARTED|Overall Study||20||20
59656832|NCT04380857|75775137|FG000|COMPLETED|Overall Study||17||17
59656833|NCT04380857|75775138|FG001|COMPLETED|Overall Study||17||17
59656834|NCT04380857|75775137|FG000|NOT COMPLETED|Overall Study||3||3
59656835|NCT04380857|75775138|FG001|NOT COMPLETED|Overall Study||3||3
59656836|NCT04189588|75775147|FG000|STARTED|Overall Study||17||
59656837|NCT04189588|75775148|FG001|STARTED|Overall Study||17||
59656838|NCT04189588|75775147|FG000|Completed Treatment|Overall Study||17||
59656839|NCT04189588|75775148|FG001|Completed Treatment|Overall Study||17||
59656840|NCT04189588|75775147|FG000|COMPLETED|Overall Study||17|Completed 28-day Follow-up Period|
59656841|NCT04189588|75775148|FG001|COMPLETED|Overall Study||15|Completed 28-day Follow-up Period|
59656842|NCT04189588|75775147|FG000|NOT COMPLETED|Overall Study||0||
59656843|NCT04189588|75775148|FG001|NOT COMPLETED|Overall Study||2||
59656844|NCT04162210|75775156|FG000|STARTED|Overall Study||218|Intent-to Treat (ITT) population included all randomized participants whether or not randomized treatment was administered.|
59656845|NCT04162210|75775157|FG001|STARTED|Overall Study||107|Intent-to Treat (ITT) population included all randomized participants whether or not randomized treatment was administered.|
59656846|NCT04162210|75775156|FG000|Safety Population|Overall Study||217|All randomized participants who took at least 1 dose of study intervention.|
59656847|NCT04162210|75775157|FG001|Safety Population|Overall Study||102|All randomized participants who took at least 1 dose of study intervention.|
59656848|NCT04162210|75775156|FG000|COMPLETED|Overall Study||84||
59656849|NCT04162210|75775157|FG001|COMPLETED|Overall Study||38||
59656850|NCT04162210|75775156|FG000|NOT COMPLETED|Overall Study||134||
59656851|NCT04162210|75775157|FG001|NOT COMPLETED|Overall Study||69||
59656852|NCT04010461|75775163|FG000|STARTED|Overall Study||53||
59656853|NCT04010461|75775163|FG000|Participants Who Had Baseline Measurements|Overall Study||47||
59656854|NCT04010461|75775163|FG000|TMS to dlPFC, Without a Concurrent Task (Passive)|Overall Study||41||
59656855|NCT04010461|75775163|FG000|TMS to Vertex, Without Concurrent Task (Control)|Overall Study||43||
59656856|NCT04010461|75775163|FG000|TMS to dlPFC, During Task (Active)|Overall Study||40||
59656857|NCT04010461|75775163|FG000|Completed MRI Sessions|Overall Study||40||
59656858|NCT04010461|75775163|FG000|COMPLETED|Overall Study||40||
59656859|NCT04010461|75775163|FG000|NOT COMPLETED|Overall Study||13||
59656860|NCT03985423|75775172|FG000|STARTED|Overall Study||7||
59656861|NCT03985423|75775172|FG000|COMPLETED|Overall Study||0||
59656862|NCT03985423|75775172|FG000|NOT COMPLETED|Overall Study||7||
59656863|NCT03875092|75775178|FG000|STARTED|Overall Study||65||
59656864|NCT03875092|75775179|FG001|STARTED|Overall Study||60||
59656865|NCT03875092|75775178|FG000|Treated|Overall Study||65||
59656866|NCT03875092|75775179|FG001|Treated|Overall Study||60||
59656867|NCT03875092|75775178|FG000|Switched to Pembrolizumab+Chemotherapy|Overall Study||0||
59656868|NCT03875092|75775179|FG001|Switched to Pembrolizumab+Chemotherapy|Overall Study||38||
59656869|NCT03875092|75775178|FG000|COMPLETED|Overall Study||0||
59656870|NCT03875092|75775179|FG001|COMPLETED|Overall Study||0||
59656871|NCT03875092|75775178|FG000|NOT COMPLETED|Overall Study||65||
59656872|NCT03875092|75775179|FG001|NOT COMPLETED|Overall Study||60||
59656873|NCT03634072|75775187|FG000|STARTED|Overall Study||1||
59656874|NCT03634072|75775188|FG001|STARTED|Overall Study||0||
59656875|NCT03634072|75775187|FG000|COMPLETED|Overall Study|Study was terminated before completion|0||
59656876|NCT03634072|75775188|FG001|COMPLETED|Overall Study||0||
59656877|NCT03634072|75775187|FG000|NOT COMPLETED|Overall Study||1||
59656878|NCT03634072|75775188|FG001|NOT COMPLETED|Overall Study||0||
59656879|NCT03471182|75775199|FG000|STARTED|Overall Study||17||
59656880|NCT03471182|75775200|FG001|STARTED|Overall Study||8||
59656881|NCT03471182|75775201|FG002|STARTED|Overall Study||20||
59656882|NCT03471182|75775199|FG000|Completed MRI Procedures|Overall Study||16||
59656883|NCT03471182|75775200|FG001|Completed MRI Procedures|Overall Study||7||
59656884|NCT03471182|75775201|FG002|Completed MRI Procedures|Overall Study||0||
59656885|NCT03471182|75775199|FG000|Completed PET Procedures|Overall Study||15||
59656886|NCT03471182|75775200|FG001|Completed PET Procedures|Overall Study||0||
59656887|NCT03471182|75775201|FG002|Completed PET Procedures|Overall Study||0||
59656888|NCT03471182|75775199|FG000|Completing Both MRI and PET|Overall Study||14||
59656889|NCT03471182|75775200|FG001|Completing Both MRI and PET|Overall Study||0||
59656890|NCT03471182|75775201|FG002|Completing Both MRI and PET|Overall Study||0||
59656891|NCT03471182|75775199|FG000|COMPLETED|Overall Study||14||
59656892|NCT03471182|75775200|FG001|COMPLETED|Overall Study||7||
59656893|NCT03471182|75775201|FG002|COMPLETED|Overall Study||20||
59656894|NCT03471182|75775199|FG000|NOT COMPLETED|Overall Study||3||
59656895|NCT03471182|75775200|FG001|NOT COMPLETED|Overall Study||1||
59656896|NCT03471182|75775201|FG002|NOT COMPLETED|Overall Study||0||
59656897|NCT03336268|75775210|FG000|STARTED|Overall Study||159||
59656898|NCT03336268|75775211|FG001|STARTED|Overall Study||90||
59656899|NCT03336268|75775210|FG000|COMPLETED|Overall Study||159||
59656900|NCT03336268|75775211|FG001|COMPLETED|Overall Study||90||
59656901|NCT03336268|75775210|FG000|NOT COMPLETED|Overall Study||0||
59656902|NCT03336268|75775211|FG001|NOT COMPLETED|Overall Study||0||
59656903|NCT03297645|75775220|FG000|STARTED|Overall Study||118||
59656904|NCT03297645|75775221|FG001|STARTED|Overall Study||69||
59656905|NCT03297645|75775222|FG002|STARTED|Overall Study||63||
59656906|NCT03297645|75775220|FG000|COMPLETED|Overall Study||81||
59656907|NCT03297645|75775221|FG001|COMPLETED|Overall Study||51||
59656908|NCT03297645|75775222|FG002|COMPLETED|Overall Study||54||
59656909|NCT03297645|75775220|FG000|NOT COMPLETED|Overall Study||37||
59656910|NCT03297645|75775221|FG001|NOT COMPLETED|Overall Study||18||
59656911|NCT03297645|75775222|FG002|NOT COMPLETED|Overall Study||9||
59656912|NCT03121352|75775232|FG000|STARTED|Overall Study||30||
59656913|NCT03121352|75775232|FG000|COMPLETED|Overall Study||30||
59656914|NCT03121352|75775232|FG000|NOT COMPLETED|Overall Study||0||
59656915|NCT03051659|75775238|FG000|STARTED|Treatment Period||44||
59656916|NCT03051659|75775239|FG001|STARTED|Treatment Period||46||
59817908|NCT04488770|75940334|FG008|NOT COMPLETED|Part 1-Cohort 2: Period 1 (Up to 5 Days)||0||
59656917|NCT03051659|75775238|FG000|COMPLETED|Treatment Period||44||
59656918|NCT03051659|75775239|FG001|COMPLETED|Treatment Period||44||
59656919|NCT03051659|75775238|FG000|NOT COMPLETED|Treatment Period||0||
59656920|NCT03051659|75775239|FG001|NOT COMPLETED|Treatment Period||2||
59656921|NCT03051659|75775238|FG000|STARTED|Survival Follow-up||44||
59656922|NCT03051659|75775239|FG001|STARTED|Survival Follow-up||44||
59656923|NCT03051659|75775238|FG000|COMPLETED|Survival Follow-up||21||
59656924|NCT03051659|75775239|FG001|COMPLETED|Survival Follow-up||22||
59656925|NCT03051659|75775238|FG000|NOT COMPLETED|Survival Follow-up||23||
59656926|NCT03051659|75775239|FG001|NOT COMPLETED|Survival Follow-up||22||
59656927|NCT02975882|75775249|FG000|STARTED|Overall Study||5||
59656928|NCT02975882|75775250|FG001|STARTED|Overall Study||13||
59656929|NCT02975882|75775251|FG002|STARTED|Overall Study||9||
59656930|NCT02975882|75775252|FG003|STARTED|Overall Study||6||
59656931|NCT02975882|75775249|FG000|COMPLETED|Overall Study||1||
59656932|NCT02975882|75775250|FG001|COMPLETED|Overall Study||0||
59656933|NCT02975882|75775251|FG002|COMPLETED|Overall Study||0||
59656934|NCT02975882|75775252|FG003|COMPLETED|Overall Study||0||
59656935|NCT02975882|75775249|FG000|NOT COMPLETED|Overall Study||4||
59656936|NCT02975882|75775250|FG001|NOT COMPLETED|Overall Study||13||
59656937|NCT02975882|75775251|FG002|NOT COMPLETED|Overall Study||9||
59656938|NCT02975882|75775252|FG003|NOT COMPLETED|Overall Study||6||
59656939|NCT02908672|75775264|FG000|STARTED|Overall Study||258||
59656940|NCT02908672|75775265|FG001|STARTED|Overall Study||256||
59656941|NCT02908672|75775264|FG000|COMPLETED|Overall Study||0||
59656942|NCT02908672|75775265|FG001|COMPLETED|Overall Study||0||
59656943|NCT02908672|75775264|FG000|NOT COMPLETED|Overall Study||258||
59656944|NCT02908672|75775265|FG001|NOT COMPLETED|Overall Study||256||
59656945|NCT02775435|75775273|FG000|STARTED|Overall Study||278||
59656946|NCT02775435|75775274|FG001|STARTED|Overall Study||281||
59656947|NCT02775435|75775273|FG000|Treated|Overall Study||278||
59656948|NCT02775435|75775274|FG001|Treated|Overall Study||280||
59656949|NCT02775435|75775273|FG000|Switched to Pembrolizumab+Chemotherapy|Overall Study||0||
59656950|NCT02775435|75775274|FG001|Switched to Pembrolizumab+Chemotherapy|Overall Study||75||
59656951|NCT02775435|75775273|FG000|COMPLETED|Overall Study||0||
59656952|NCT02775435|75775274|FG001|COMPLETED|Overall Study||0||
59656953|NCT02775435|75775273|FG000|NOT COMPLETED|Overall Study||278||
59656954|NCT02775435|75775274|FG001|NOT COMPLETED|Overall Study||281||
59656955|NCT02685826|75775283|FG000|STARTED|Overall Study||25||
59656956|NCT02685826|75775284|FG001|STARTED|Overall Study||10||
59656957|NCT02685826|75775285|FG002|STARTED|Overall Study||21||
59656958|NCT02685826|75775283|FG000|COMPLETED|Overall Study||0|Completed treatment|
59656959|NCT02685826|75775284|FG001|COMPLETED|Overall Study||0|Completed treatment|
59656960|NCT02685826|75775285|FG002|COMPLETED|Overall Study||0|Completed treatment|
59656961|NCT02685826|75775283|FG000|NOT COMPLETED|Overall Study||25||
59656962|NCT02685826|75775284|FG001|NOT COMPLETED|Overall Study||10||
59656963|NCT02685826|75775285|FG002|NOT COMPLETED|Overall Study||21||
59656964|NCT01177683|75775296|FG000|STARTED|Study Treatment||3||
59656965|NCT01177683|75775297|FG001|STARTED|Study Treatment||3||
59656966|NCT01177683|75775298|FG002|STARTED|Study Treatment||26||
59656967|NCT01177683|75775296|FG000|COMPLETED|Study Treatment||0||
59656968|NCT01177683|75775297|FG001|COMPLETED|Study Treatment||0||
59656969|NCT01177683|75775298|FG002|COMPLETED|Study Treatment||2||
59656970|NCT01177683|75775296|FG000|NOT COMPLETED|Study Treatment||3||
59656971|NCT01177683|75775297|FG001|NOT COMPLETED|Study Treatment||3||
59656972|NCT01177683|75775298|FG002|NOT COMPLETED|Study Treatment||24||
59656973|NCT01177683|75775296|FG000|STARTED|Follow up||3||
59656974|NCT01177683|75775297|FG001|STARTED|Follow up||3||
59656975|NCT01177683|75775298|FG002|STARTED|Follow up||24||
59656976|NCT01177683|75775296|FG000|COMPLETED|Follow up||0||
59656977|NCT01177683|75775297|FG001|COMPLETED|Follow up||0||
59656978|NCT01177683|75775298|FG002|COMPLETED|Follow up||0||
59656979|NCT01177683|75775296|FG000|NOT COMPLETED|Follow up||3||
59656980|NCT01177683|75775297|FG001|NOT COMPLETED|Follow up||3||
59656981|NCT01177683|75775298|FG002|NOT COMPLETED|Follow up||24||
59656982|NCT01084252|75775323|FG000|STARTED|Phase 1 (120 Weeks)||16||
59656983|NCT01084252|75775324|FG001|STARTED|Phase 1 (120 Weeks)||6||
59656984|NCT01084252|75775325|FG002|STARTED|Phase 1 (120 Weeks)||3||
59656985|NCT01084252|75775326|FG003|STARTED|Phase 1 (120 Weeks)||26||
59656986|NCT01084252|75775327|FG004|STARTED|Phase 1 (120 Weeks)||18||
59656987|NCT01084252|75775328|FG005|STARTED|Phase 1 (120 Weeks)||6||
59656988|NCT01084252|75775329|FG006|STARTED|Phase 1 (120 Weeks)||7||
59656989|NCT01084252|75775330|FG007|STARTED|Phase 1 (120 Weeks)||7||
59656990|NCT01084252|75775331|FG008|STARTED|Phase 1 (120 Weeks)||0||
59656991|NCT01084252|75775332|FG009|STARTED|Phase 1 (120 Weeks)||0||
59656992|NCT01084252|75775333|FG010|STARTED|Phase 1 (120 Weeks)||0||
59656993|NCT01084252|75775334|FG011|STARTED|Phase 1 (120 Weeks)||0||
59656994|NCT01084252|75775335|FG012|STARTED|Phase 1 (120 Weeks)||0||
59656995|NCT01084252|75775336|FG013|STARTED|Phase 1 (120 Weeks)||0||
59988859|NCT04495179|76104104|FG000|NOT COMPLETED|Overall Study||2||
59656996|NCT01084252|75775323|FG000|All Treated (AT) Population|Phase 1 (120 Weeks)||16|Participants who signed informed consent & received at least 1 dose/even incomplete of isatuximab.|
59656997|NCT01084252|75775324|FG001|All Treated (AT) Population|Phase 1 (120 Weeks)||6|Participants who signed informed consent & received at least 1 dose/even incomplete of isatuximab.|
59656998|NCT01084252|75775325|FG002|All Treated (AT) Population|Phase 1 (120 Weeks)||3|Participants who signed informed consent & received at least 1 dose/even incomplete of isatuximab.|
59656999|NCT01084252|75775326|FG003|All Treated (AT) Population|Phase 1 (120 Weeks)||26|Participants who signed informed consent & received at least 1 dose/even incomplete of isatuximab.|
59657000|NCT01084252|75775327|FG004|All Treated (AT) Population|Phase 1 (120 Weeks)||18|Participants who signed informed consent & received at least 1 dose/even incomplete of isatuximab.|
59657001|NCT01084252|75775328|FG005|All Treated (AT) Population|Phase 1 (120 Weeks)||6|Participants who signed informed consent & received at least 1 dose/even incomplete of isatuximab.|
59657002|NCT01084252|75775329|FG006|All Treated (AT) Population|Phase 1 (120 Weeks)||7|Participants who signed informed consent & received at least 1 dose/even incomplete of isatuximab.|
59657003|NCT01084252|75775330|FG007|All Treated (AT) Population|Phase 1 (120 Weeks)||7|Participants who signed informed consent & received at least 1 dose/even incomplete of isatuximab.|
59657004|NCT01084252|75775331|FG008|All Treated (AT) Population|Phase 1 (120 Weeks)||0|Participants who signed informed consent & received at least 1 dose/even incomplete of isatuximab.|
59657005|NCT01084252|75775332|FG009|All Treated (AT) Population|Phase 1 (120 Weeks)||0|Participants who signed informed consent & received at least 1 dose/even incomplete of isatuximab.|
59657006|NCT01084252|75775333|FG010|All Treated (AT) Population|Phase 1 (120 Weeks)||0|Participants who signed informed consent & received at least 1 dose/even incomplete of isatuximab.|
59657007|NCT01084252|75775334|FG011|All Treated (AT) Population|Phase 1 (120 Weeks)||0|Participants who signed informed consent & received at least 1 dose/even incomplete of isatuximab.|
59657008|NCT01084252|75775335|FG012|All Treated (AT) Population|Phase 1 (120 Weeks)||0|Participants who signed informed consent & received at least 1 dose/even incomplete of isatuximab.|
59657009|NCT01084252|75775336|FG013|All Treated (AT) Population|Phase 1 (120 Weeks)||0|Participants who signed informed consent & received at least 1 dose/even incomplete of isatuximab.|
59657010|NCT01084252|75775323|FG000|COMPLETED|Phase 1 (120 Weeks)||0||
59657011|NCT01084252|75775324|FG001|COMPLETED|Phase 1 (120 Weeks)||0||
59657012|NCT01084252|75775325|FG002|COMPLETED|Phase 1 (120 Weeks)||0||
59657013|NCT01084252|75775326|FG003|COMPLETED|Phase 1 (120 Weeks)||0||
59657014|NCT01084252|75775327|FG004|COMPLETED|Phase 1 (120 Weeks)||0||
59657015|NCT01084252|75775328|FG005|COMPLETED|Phase 1 (120 Weeks)||0||
59657016|NCT01084252|75775329|FG006|COMPLETED|Phase 1 (120 Weeks)||0||
59657017|NCT01084252|75775330|FG007|COMPLETED|Phase 1 (120 Weeks)||0||
59657018|NCT01084252|75775331|FG008|COMPLETED|Phase 1 (120 Weeks)||0||
59657019|NCT01084252|75775332|FG009|COMPLETED|Phase 1 (120 Weeks)||0||
59657020|NCT01084252|75775333|FG010|COMPLETED|Phase 1 (120 Weeks)||0||
59657021|NCT01084252|75775334|FG011|COMPLETED|Phase 1 (120 Weeks)||0||
59657022|NCT01084252|75775335|FG012|COMPLETED|Phase 1 (120 Weeks)||0||
59657023|NCT01084252|75775336|FG013|COMPLETED|Phase 1 (120 Weeks)||0||
59657024|NCT01084252|75775323|FG000|NOT COMPLETED|Phase 1 (120 Weeks)||16||
59657025|NCT01084252|75775324|FG001|NOT COMPLETED|Phase 1 (120 Weeks)||6||
59657026|NCT01084252|75775325|FG002|NOT COMPLETED|Phase 1 (120 Weeks)||3||
59657027|NCT01084252|75775326|FG003|NOT COMPLETED|Phase 1 (120 Weeks)||26||
59657028|NCT01084252|75775327|FG004|NOT COMPLETED|Phase 1 (120 Weeks)||18||
59657029|NCT01084252|75775328|FG005|NOT COMPLETED|Phase 1 (120 Weeks)||6||
59657030|NCT01084252|75775329|FG006|NOT COMPLETED|Phase 1 (120 Weeks)||7||
59657031|NCT01084252|75775330|FG007|NOT COMPLETED|Phase 1 (120 Weeks)||7||
59657032|NCT01084252|75775331|FG008|NOT COMPLETED|Phase 1 (120 Weeks)||0||
59657033|NCT01084252|75775332|FG009|NOT COMPLETED|Phase 1 (120 Weeks)||0||
59657034|NCT01084252|75775333|FG010|NOT COMPLETED|Phase 1 (120 Weeks)||0||
59657035|NCT01084252|75775334|FG011|NOT COMPLETED|Phase 1 (120 Weeks)||0||
59657036|NCT01084252|75775335|FG012|NOT COMPLETED|Phase 1 (120 Weeks)||0||
59657037|NCT01084252|75775336|FG013|NOT COMPLETED|Phase 1 (120 Weeks)||0||
59657038|NCT01084252|75775323|FG000|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0||
59657039|NCT01084252|75775324|FG001|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0||
59657040|NCT01084252|75775325|FG002|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0||
59657041|NCT01084252|75775326|FG003|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0||
59657042|NCT01084252|75775327|FG004|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0||
59657043|NCT01084252|75775328|FG005|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0||
59657044|NCT01084252|75775329|FG006|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0||
59657045|NCT01084252|75775330|FG007|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0||
59657046|NCT01084252|75775331|FG008|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Phase 1, Phase 2 Stage 1 and Phase 2 Stage 2 were separate populations.|23||
59657047|NCT01084252|75775332|FG009|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Phase 1, Phase 2 Stage 1 and Phase 2 Stage 2 were separate populations.|24||
59657048|NCT01084252|75775333|FG010|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Phase 1, Phase 2 Stage 1 and Phase 2 Stage 2 were separate populations.|25||
59657049|NCT01084252|75775334|FG011|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Phase 1, Phase 2 Stage 1 and Phase 2 Stage 2 were separate populations.|25||
59657050|NCT01084252|75775335|FG012|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0||
59657051|NCT01084252|75775336|FG013|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0||
59657052|NCT01084252|75775323|FG000|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0|Participants who signed informed consent & received at least 1 dose/even incomplete of isatuximab.|
59709748|NCT01072149|75828532|FG012|COMPLETED|Treatment Period 1 (28 Days)||3||
59657053|NCT01084252|75775324|FG001|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0|Participants who signed informed consent & received at least 1 dose/even incomplete of isatuximab.|
59657054|NCT01084252|75775325|FG002|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0|Participants who signed informed consent & received at least 1 dose/even incomplete of isatuximab.|
59657055|NCT01084252|75775326|FG003|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0|Participants who signed informed consent & received at least 1 dose/even incomplete of isatuximab.|
59657056|NCT01084252|75775327|FG004|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0|Participants who signed informed consent & received at least 1 dose/even incomplete of isatuximab.|
59657057|NCT01084252|75775328|FG005|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0|Participants who signed informed consent & received at least 1 dose/even incomplete of isatuximab.|
59657058|NCT01084252|75775329|FG006|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0|Participants who signed informed consent & received at least 1 dose/even incomplete of isatuximab.|
59657059|NCT01084252|75775330|FG007|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0|Participants who signed informed consent & received at least 1 dose/even incomplete of isatuximab.|
59657060|NCT01084252|75775331|FG008|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||23|Participants who signed informed consent & received at least 1 dose/even incomplete of isatuximab.|
59657061|NCT01084252|75775332|FG009|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||24|Participants who signed informed consent & received at least 1 dose/even incomplete of isatuximab.|
59657062|NCT01084252|75775333|FG010|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||25|Participants who signed informed consent & received at least 1 dose/even incomplete of isatuximab.|
59657063|NCT01084252|75775334|FG011|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||25|Participants who signed informed consent & received at least 1 dose/even incomplete of isatuximab.|
59657064|NCT01084252|75775335|FG012|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0|Participants who signed informed consent & received at least 1 dose/even incomplete of isatuximab.|
59657065|NCT01084252|75775336|FG013|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0|Participants who signed informed consent & received at least 1 dose/even incomplete of isatuximab.|
59657066|NCT01084252|75775323|FG000|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0||
59657067|NCT01084252|75775324|FG001|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0||
59657068|NCT01084252|75775325|FG002|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0||
59657069|NCT01084252|75775326|FG003|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0||
59657070|NCT01084252|75775327|FG004|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0||
59657071|NCT01084252|75775328|FG005|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0||
59657072|NCT01084252|75775329|FG006|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0||
59657073|NCT01084252|75775330|FG007|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0||
59657074|NCT01084252|75775331|FG008|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0||
59657075|NCT01084252|75775332|FG009|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0||
59657076|NCT01084252|75775333|FG010|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0||
59657077|NCT01084252|75775334|FG011|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0||
59657078|NCT01084252|75775335|FG012|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0||
59657079|NCT01084252|75775336|FG013|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0||
59657080|NCT01084252|75775323|FG000|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0||
59657081|NCT01084252|75775324|FG001|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0||
59657082|NCT01084252|75775325|FG002|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0||
59657083|NCT01084252|75775326|FG003|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0||
59657084|NCT01084252|75775327|FG004|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0||
59657085|NCT01084252|75775328|FG005|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0||
59657086|NCT01084252|75775329|FG006|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0||
59657087|NCT01084252|75775330|FG007|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0||
59657088|NCT01084252|75775331|FG008|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||23||
59657089|NCT01084252|75775332|FG009|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||24||
59657090|NCT01084252|75775333|FG010|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||25||
59657091|NCT01084252|75775334|FG011|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||25||
59657092|NCT01084252|75775335|FG012|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0||
59657093|NCT01084252|75775336|FG013|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0||
59657094|NCT01084252|75775323|FG000|STARTED|Phase 2 Stage 2 (97 Weeks)||0||
59657095|NCT01084252|75775324|FG001|STARTED|Phase 2 Stage 2 (97 Weeks)||0||
59657096|NCT01084252|75775325|FG002|STARTED|Phase 2 Stage 2 (97 Weeks)||0||
59657097|NCT01084252|75775326|FG003|STARTED|Phase 2 Stage 2 (97 Weeks)||0||
59657098|NCT01084252|75775327|FG004|STARTED|Phase 2 Stage 2 (97 Weeks)||0||
59657099|NCT01084252|75775328|FG005|STARTED|Phase 2 Stage 2 (97 Weeks)||0||
59657100|NCT01084252|75775329|FG006|STARTED|Phase 2 Stage 2 (97 Weeks)||0||
59657101|NCT01084252|75775330|FG007|STARTED|Phase 2 Stage 2 (97 Weeks)||0||
59657102|NCT01084252|75775331|FG008|STARTED|Phase 2 Stage 2 (97 Weeks)||0||
59657103|NCT01084252|75775332|FG009|STARTED|Phase 2 Stage 2 (97 Weeks)||0||
59657104|NCT01084252|75775333|FG010|STARTED|Phase 2 Stage 2 (97 Weeks)||0||
59657105|NCT01084252|75775334|FG011|STARTED|Phase 2 Stage 2 (97 Weeks)||0||
59657106|NCT01084252|75775335|FG012|STARTED|Phase 2 Stage 2 (97 Weeks)|Phase 1, Phase 2 Stage 1 and Phase 2 Stage 2 were separate populations.|110||
59657107|NCT01084252|75775336|FG013|STARTED|Phase 2 Stage 2 (97 Weeks)|Phase 1, Phase 2 Stage 1 and Phase 2 Stage 2 were separate populations.|55||
59657108|NCT01084252|75775323|FG000|AT Population|Phase 2 Stage 2 (97 Weeks)||0|Participants who signed informed consent & received at least 1 dose/even incomplete of isatuximab.|
59657109|NCT01084252|75775324|FG001|AT Population|Phase 2 Stage 2 (97 Weeks)||0|Participants who signed informed consent & received at least 1 dose/even incomplete of isatuximab.|
59657110|NCT01084252|75775325|FG002|AT Population|Phase 2 Stage 2 (97 Weeks)||0|Participants who signed informed consent & received at least 1 dose/even incomplete of isatuximab.|
59657111|NCT01084252|75775326|FG003|AT Population|Phase 2 Stage 2 (97 Weeks)||0|Participants who signed informed consent & received at least 1 dose/even incomplete of isatuximab.|
59657112|NCT01084252|75775327|FG004|AT Population|Phase 2 Stage 2 (97 Weeks)||0|Participants who signed informed consent & received at least 1 dose/even incomplete of isatuximab.|
59657113|NCT01084252|75775328|FG005|AT Population|Phase 2 Stage 2 (97 Weeks)||0|Participants who signed informed consent & received at least 1 dose/even incomplete of isatuximab.|
59657114|NCT01084252|75775329|FG006|AT Population|Phase 2 Stage 2 (97 Weeks)||0|Participants who signed informed consent & received at least 1 dose/even incomplete of isatuximab.|
59657115|NCT01084252|75775330|FG007|AT Population|Phase 2 Stage 2 (97 Weeks)||0|Participants who signed informed consent & received at least 1 dose/even incomplete of isatuximab.|
59657116|NCT01084252|75775331|FG008|AT Population|Phase 2 Stage 2 (97 Weeks)||0|Participants who signed informed consent & received at least 1 dose/even incomplete of isatuximab.|
59657117|NCT01084252|75775332|FG009|AT Population|Phase 2 Stage 2 (97 Weeks)||0|Participants who signed informed consent & received at least 1 dose/even incomplete of isatuximab.|
59657118|NCT01084252|75775333|FG010|AT Population|Phase 2 Stage 2 (97 Weeks)||0|Participants who signed informed consent & received at least 1 dose/even incomplete of isatuximab.|
59657119|NCT01084252|75775334|FG011|AT Population|Phase 2 Stage 2 (97 Weeks)||0|Participants who signed informed consent & received at least 1 dose/even incomplete of isatuximab.|
59657120|NCT01084252|75775335|FG012|AT Population|Phase 2 Stage 2 (97 Weeks)||109|Participants who signed informed consent & received at least 1 dose/even incomplete of isatuximab.|
59657121|NCT01084252|75775336|FG013|AT Population|Phase 2 Stage 2 (97 Weeks)||55|Participants who signed informed consent & received at least 1 dose/even incomplete of isatuximab.|
59657122|NCT01084252|75775323|FG000|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0||
59657123|NCT01084252|75775324|FG001|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0||
59657124|NCT01084252|75775325|FG002|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0||
59657125|NCT01084252|75775326|FG003|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0||
59657126|NCT01084252|75775327|FG004|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0||
59657127|NCT01084252|75775328|FG005|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0||
59657128|NCT01084252|75775329|FG006|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0||
59657129|NCT01084252|75775330|FG007|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0||
59657130|NCT01084252|75775331|FG008|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0||
59657131|NCT01084252|75775332|FG009|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0||
59657132|NCT01084252|75775333|FG010|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0||
59657133|NCT01084252|75775334|FG011|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0||
59657134|NCT01084252|75775335|FG012|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0||
59657135|NCT01084252|75775336|FG013|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0||
59657136|NCT01084252|75775323|FG000|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0||
59657137|NCT01084252|75775324|FG001|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0||
59657138|NCT01084252|75775325|FG002|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0||
59657139|NCT01084252|75775326|FG003|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0||
59657140|NCT01084252|75775327|FG004|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0||
59657141|NCT01084252|75775328|FG005|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0||
59657142|NCT01084252|75775329|FG006|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0||
59657143|NCT01084252|75775330|FG007|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0||
59657144|NCT01084252|75775331|FG008|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0||
59657145|NCT01084252|75775332|FG009|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0||
59657146|NCT01084252|75775333|FG010|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0||
59657147|NCT01084252|75775334|FG011|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0||
59657148|NCT01084252|75775335|FG012|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||110||
59657149|NCT01084252|75775336|FG013|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||55||
59657150|NCT00993044|75775400|FG000|STARTED|Irinotecan 30 mg||6||
59657151|NCT00993044|75775400|FG000|COMPLETED|Irinotecan 30 mg||6||
59657152|NCT00993044|75775400|FG000|NOT COMPLETED|Irinotecan 30 mg||0||
59657153|NCT00993044|75775400|FG000|STARTED|Irinotecan 50 mg||7||
59657154|NCT00993044|75775400|FG000|COMPLETED|Irinotecan 50 mg||6||
59657155|NCT00993044|75775400|FG000|NOT COMPLETED|Irinotecan 50 mg||1||
59657156|NCT00116272|75775407|FG000|STARTED|Overall Study||370||
59657157|NCT00116272|75775408|FG001|STARTED|Overall Study||164||
59657158|NCT00116272|75775407|FG000|COMPLETED|Overall Study|Indicates participants with a known outcome of pregnancy|359||
59657159|NCT00116272|75775408|FG001|COMPLETED|Overall Study|Indicates participants with a known outcome of pregnancy|158||
59657160|NCT00116272|75775407|FG000|NOT COMPLETED|Overall Study||11||
59657161|NCT00116272|75775408|FG001|NOT COMPLETED|Overall Study||6||
59657162|NCT01945021|75775416|FG000|STARTED|Overall Study||127||
59657163|NCT01945021|75775416|FG000|Safety Population|Overall Study|Received at least 1 dose of study medication.|127||
59657164|NCT01945021|75775416|FG000|Response Evaluable Population|Overall Study|Received at least 1 dose of study drug and an adequate baseline tumor assessment.|127||
59657165|NCT01945021|75775416|FG000|Patient Reported Outcome Evaluable|Overall Study|Received at least 1 dose of study drug, completed baseline with at least 1 post-baseline assessment.|123||
59657166|NCT01945021|75775416|FG000|COMPLETED|Overall Study||44||
59657167|NCT01945021|75775416|FG000|NOT COMPLETED|Overall Study||83||
59657168|NCT01945060|75775422|FG000|STARTED|Overall Study||10||
59657169|NCT01945060|75775423|FG001|STARTED|Overall Study||10||
59657170|NCT01945060|75775422|FG000|COMPLETED|Overall Study||9||
59657171|NCT01945060|75775423|FG001|COMPLETED|Overall Study||9||
59657172|NCT01945060|75775422|FG000|NOT COMPLETED|Overall Study||1||
59657173|NCT01945060|75775423|FG001|NOT COMPLETED|Overall Study||1||
59657174|NCT04747808|75775429|FG000|STARTED|Overall Study||5||
59657175|NCT04747808|75775429|FG000|COMPLETED|Overall Study||5||
59657176|NCT04747808|75775429|FG000|NOT COMPLETED|Overall Study||0||
59657177|NCT04411953|75775435|FG000|STARTED|Treatment Period 1 (8 Days)||16||
59657178|NCT04411953|75775436|FG001|STARTED|Treatment Period 1 (8 Days)||16||
59657179|NCT04411953|75775435|FG000|COMPLETED|Treatment Period 1 (8 Days)||16||
59657180|NCT04411953|75775436|FG001|COMPLETED|Treatment Period 1 (8 Days)||16||
59657181|NCT04411953|75775435|FG000|NOT COMPLETED|Treatment Period 1 (8 Days)||0||
59657182|NCT04411953|75775436|FG001|NOT COMPLETED|Treatment Period 1 (8 Days)||0||
59657183|NCT04411953|75775435|FG000|STARTED|Washout Period (14 Days)||16||
59657184|NCT04411953|75775436|FG001|STARTED|Washout Period (14 Days)||16||
59657185|NCT04411953|75775435|FG000|COMPLETED|Washout Period (14 Days)||16||
59657186|NCT04411953|75775436|FG001|COMPLETED|Washout Period (14 Days)||15||
59657187|NCT04411953|75775435|FG000|NOT COMPLETED|Washout Period (14 Days)||0||
59657188|NCT04411953|75775436|FG001|NOT COMPLETED|Washout Period (14 Days)||1||
59657189|NCT04411953|75775435|FG000|STARTED|Treatment Period 2 (8 Days)||16||
59657190|NCT04411953|75775436|FG001|STARTED|Treatment Period 2 (8 Days)||15||
59657191|NCT04411953|75775435|FG000|COMPLETED|Treatment Period 2 (8 Days)||16||
59657192|NCT04411953|75775436|FG001|COMPLETED|Treatment Period 2 (8 Days)||15||
59657193|NCT04411953|75775435|FG000|NOT COMPLETED|Treatment Period 2 (8 Days)||0||
59657194|NCT04411953|75775436|FG001|NOT COMPLETED|Treatment Period 2 (8 Days)||0||
59657195|NCT04411940|75775444|FG000|STARTED|Treatment Period 1 (8 Days)||16||
59657196|NCT04411940|75775445|FG001|STARTED|Treatment Period 1 (8 Days)||16||
59657197|NCT04411940|75775444|FG000|COMPLETED|Treatment Period 1 (8 Days)||16||
59657198|NCT04411940|75775445|FG001|COMPLETED|Treatment Period 1 (8 Days)||16||
59657199|NCT04411940|75775444|FG000|NOT COMPLETED|Treatment Period 1 (8 Days)||0||
59657200|NCT04411940|75775445|FG001|NOT COMPLETED|Treatment Period 1 (8 Days)||0||
59657201|NCT04411940|75775444|FG000|STARTED|Washout Period (14 Days)||16||
59657202|NCT04411940|75775445|FG001|STARTED|Washout Period (14 Days)||16||
59657203|NCT04411940|75775444|FG000|COMPLETED|Washout Period (14 Days)||16||
59657204|NCT04411940|75775445|FG001|COMPLETED|Washout Period (14 Days)||16||
59657205|NCT04411940|75775444|FG000|NOT COMPLETED|Washout Period (14 Days)||0||
59657206|NCT04411940|75775445|FG001|NOT COMPLETED|Washout Period (14 Days)||0||
59657207|NCT04411940|75775444|FG000|STARTED|Treatment Period 2 (8 Days)||16||
59543999|NCT01607411|75642279|FG002|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|13||
59544000|NCT01607411|75642280|FG003|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|14||
59544001|NCT01607411|75642277|FG000|COMPLETED|Period II||14||
59544002|NCT01607411|75642278|FG001|COMPLETED|Period II||14||
59544003|NCT01607411|75642279|FG002|COMPLETED|Period II||13||
59544004|NCT01607411|75642280|FG003|COMPLETED|Period II||14||
59544005|NCT01607411|75642277|FG000|NOT COMPLETED|Period II||0||
59544006|NCT01607411|75642278|FG001|NOT COMPLETED|Period II||0||
59544007|NCT01607411|75642279|FG002|NOT COMPLETED|Period II||0||
59544008|NCT01607411|75642280|FG003|NOT COMPLETED|Period II||0||
59544009|NCT01607411|75642277|FG000|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|14||
59544010|NCT01607411|75642278|FG001|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|14||
59544011|NCT01607411|75642279|FG002|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|14||
59544012|NCT01607411|75642280|FG003|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|13||
59544013|NCT01607411|75642277|FG000|COMPLETED|Period III||14||
59544014|NCT01607411|75642278|FG001|COMPLETED|Period III||14||
59657208|NCT04411940|75775445|FG001|STARTED|Treatment Period 2 (8 Days)||16||
59657209|NCT04411940|75775444|FG000|COMPLETED|Treatment Period 2 (8 Days)||16||
59657210|NCT04411940|75775445|FG001|COMPLETED|Treatment Period 2 (8 Days)||16||
59657211|NCT04411940|75775444|FG000|NOT COMPLETED|Treatment Period 2 (8 Days)||0||
59657212|NCT04411940|75775445|FG001|NOT COMPLETED|Treatment Period 2 (8 Days)||0||
59657213|NCT04068792|75775453|FG000|STARTED|Overall Study||11||
59544015|NCT01607411|75642279|FG002|COMPLETED|Period III||14||
59657214|NCT04068792|75775454|FG001|STARTED|Overall Study||11||
59657215|NCT04068792|75775453|FG000|COMPLETED|Overall Study||11||
59657216|NCT04068792|75775454|FG001|COMPLETED|Overall Study||11||
59657217|NCT04068792|75775453|FG000|NOT COMPLETED|Overall Study||0||
59657218|NCT04068792|75775454|FG001|NOT COMPLETED|Overall Study||0||
59657219|NCT03951077|75775466|FG000|STARTED|Overall Study||27|Randomized|
59657220|NCT03951077|75775467|FG001|STARTED|Overall Study||18|Randomized|
59657221|NCT03951077|75775468|FG002|STARTED|Overall Study||18|Randomized|
59657222|NCT03951077|75775469|FG003|STARTED|Overall Study||18|Randomized|
59657223|NCT03951077|75775470|FG004|STARTED|Overall Study||19|Randomized|
59657224|NCT03951077|75775471|FG005|STARTED|Overall Study||18|Randomized|
59657225|NCT03951077|75775466|FG000|Randomized and Treated|Overall Study||26||
59657226|NCT03951077|75775467|FG001|Randomized and Treated|Overall Study||18||
59657227|NCT03951077|75775468|FG002|Randomized and Treated|Overall Study||17||
59657228|NCT03951077|75775469|FG003|Randomized and Treated|Overall Study||17||
59657229|NCT03951077|75775470|FG004|Randomized and Treated|Overall Study||18||
59657230|NCT03951077|75775471|FG005|Randomized and Treated|Overall Study||18||
59657231|NCT03951077|75775466|FG000|COMPLETED|Overall Study||9||
59657232|NCT03951077|75775467|FG001|COMPLETED|Overall Study||4||
59657233|NCT03951077|75775468|FG002|COMPLETED|Overall Study||5||
59657234|NCT03951077|75775469|FG003|COMPLETED|Overall Study||6||
59657235|NCT03951077|75775470|FG004|COMPLETED|Overall Study||3||
59657236|NCT03951077|75775471|FG005|COMPLETED|Overall Study||7||
59657237|NCT03951077|75775466|FG000|NOT COMPLETED|Overall Study||18||
59657238|NCT03951077|75775467|FG001|NOT COMPLETED|Overall Study||14||
59657239|NCT03951077|75775468|FG002|NOT COMPLETED|Overall Study||13||
59657240|NCT03951077|75775469|FG003|NOT COMPLETED|Overall Study||12||
59657241|NCT03951077|75775470|FG004|NOT COMPLETED|Overall Study||16||
59657242|NCT03951077|75775471|FG005|NOT COMPLETED|Overall Study||11||
59657243|NCT03873246|75775488|FG000|STARTED|Overall Study||41||
59657244|NCT03873246|75775489|FG001|STARTED|Overall Study||41||
59657245|NCT03873246|75775490|FG002|STARTED|Overall Study||41||
59657246|NCT03873246|75775488|FG000|COMPLETED|Overall Study||36||
59657247|NCT03873246|75775489|FG001|COMPLETED|Overall Study||29||
59657248|NCT03873246|75775490|FG002|COMPLETED|Overall Study||32||
59657249|NCT03873246|75775488|FG000|NOT COMPLETED|Overall Study||5||
59657250|NCT03873246|75775489|FG001|NOT COMPLETED|Overall Study||12||
59657251|NCT03873246|75775490|FG002|NOT COMPLETED|Overall Study||9||
59657252|NCT03769649|75775499|FG000|STARTED|Overall Study||15||
59657253|NCT03769649|75775499|FG000|COMPLETED|Overall Study||11||
59657254|NCT03769649|75775499|FG000|NOT COMPLETED|Overall Study||4||
59657255|NCT03714880|75775505|FG000|STARTED|Overall Study||20||
59657256|NCT03714880|75775506|FG001|STARTED|Overall Study||24||
59657257|NCT03714880|75775505|FG000|COMPLETED|Overall Study||19||
59657258|NCT03714880|75775506|FG001|COMPLETED|Overall Study||22||
59657259|NCT03714880|75775505|FG000|NOT COMPLETED|Overall Study||1||
59657260|NCT03714880|75775506|FG001|NOT COMPLETED|Overall Study||2||
59657261|NCT03645941|75775516|FG000|STARTED|Overall Study||30||
59657262|NCT03645941|75775517|FG001|STARTED|Overall Study||31||
59657263|NCT03645941|75775516|FG000|COMPLETED|Overall Study||16||
59657264|NCT03645941|75775517|FG001|COMPLETED|Overall Study||19||
59657265|NCT03645941|75775516|FG000|NOT COMPLETED|Overall Study||14||
59657266|NCT03645941|75775517|FG001|NOT COMPLETED|Overall Study||12||
59657267|NCT02862548|75775525|FG000|STARTED|Randomized Phase (Up to Week 48)||26||
59657268|NCT02862548|75775526|FG001|STARTED|Randomized Phase (Up to Week 48)||25||
59657269|NCT02862548|75775525|FG000|COMPLETED|Randomized Phase (Up to Week 48)||26||
59657270|NCT02862548|75775526|FG001|COMPLETED|Randomized Phase (Up to Week 48)||24||
59657271|NCT02862548|75775525|FG000|NOT COMPLETED|Randomized Phase (Up to Week 48)||0||
59657272|NCT02862548|75775526|FG001|NOT COMPLETED|Randomized Phase (Up to Week 48)||1||
59657273|NCT02862548|75775525|FG000|STARTED|OLE Phase (Week 49 to Week 192)||26||
59657274|NCT02862548|75775526|FG001|STARTED|OLE Phase (Week 49 to Week 192)||24||
59657275|NCT02862548|75775525|FG000|COMPLETED|OLE Phase (Week 49 to Week 192)||23||
59657276|NCT02862548|75775526|FG001|COMPLETED|OLE Phase (Week 49 to Week 192)||23||
59657277|NCT02862548|75775525|FG000|NOT COMPLETED|OLE Phase (Week 49 to Week 192)||3||
59657278|NCT02862548|75775526|FG001|NOT COMPLETED|OLE Phase (Week 49 to Week 192)||1||
59657279|NCT02377089|75775536|FG000|STARTED|Overall Study||31||
59657280|NCT02377089|75775537|FG001|STARTED|Overall Study||29||
59657281|NCT02377089|75775536|FG000|COMPLETED|Overall Study||22||
59657282|NCT02377089|75775537|FG001|COMPLETED|Overall Study||24||
59657283|NCT02377089|75775536|FG000|NOT COMPLETED|Overall Study||9||
59657284|NCT02377089|75775537|FG001|NOT COMPLETED|Overall Study||5||
59657285|NCT02335099|75775545|FG000|STARTED|Treatment||22||
59657286|NCT02335099|75775546|FG001|STARTED|Treatment||22||
59657287|NCT02335099|75775545|FG000|COMPLETED|Treatment||17||
59657288|NCT02335099|75775546|FG001|COMPLETED|Treatment||17||
59657289|NCT02335099|75775545|FG000|NOT COMPLETED|Treatment||5||
59657290|NCT02335099|75775546|FG001|NOT COMPLETED|Treatment||5||
59657291|NCT02335099|75775545|FG000|STARTED|Follow-up||17||
59657292|NCT02335099|75775546|FG001|STARTED|Follow-up||17||
59657293|NCT02335099|75775545|FG000|COMPLETED|Follow-up||17||
59657294|NCT02335099|75775546|FG001|COMPLETED|Follow-up||16||
59657295|NCT02335099|75775545|FG000|NOT COMPLETED|Follow-up||0||
59657296|NCT02335099|75775546|FG001|NOT COMPLETED|Follow-up||1||
59657297|NCT02330562|75775563|FG000|STARTED|Overall Study||6||
59657298|NCT02330562|75775564|FG001|STARTED|Overall Study||3||
59657299|NCT02330562|75775565|FG002|STARTED|Overall Study||27||
59657300|NCT02330562|75775566|FG003|STARTED|Overall Study||30||
59657301|NCT02330562|75775567|FG004|STARTED|Overall Study||31||
59657302|NCT02330562|75775568|FG005|STARTED|Overall Study||10||
59657303|NCT02330562|75775569|FG006|STARTED|Overall Study||1||
59657304|NCT02330562|75775570|FG007|STARTED|Overall Study||1||
59657305|NCT02330562|75775571|FG008|STARTED|Overall Study||1||
59657306|NCT02330562|75775572|FG009|STARTED|Overall Study||5||
59657307|NCT02330562|75775573|FG010|STARTED|Overall Study||6||
59657308|NCT02330562|75775563|FG000|COMPLETED|Overall Study||0||
59657309|NCT02330562|75775564|FG001|COMPLETED|Overall Study||0||
59657310|NCT02330562|75775565|FG002|COMPLETED|Overall Study||0||
59657311|NCT02330562|75775566|FG003|COMPLETED|Overall Study||0||
59657312|NCT02330562|75775567|FG004|COMPLETED|Overall Study||0||
59657313|NCT02330562|75775568|FG005|COMPLETED|Overall Study||0||
59657314|NCT02330562|75775569|FG006|COMPLETED|Overall Study||0||
59657315|NCT02330562|75775570|FG007|COMPLETED|Overall Study||0||
59657316|NCT02330562|75775571|FG008|COMPLETED|Overall Study||0||
59657317|NCT02330562|75775572|FG009|COMPLETED|Overall Study||0||
59657318|NCT02330562|75775573|FG010|COMPLETED|Overall Study||0||
59657319|NCT02330562|75775563|FG000|NOT COMPLETED|Overall Study||6||
59657320|NCT02330562|75775564|FG001|NOT COMPLETED|Overall Study||3||
59657321|NCT02330562|75775565|FG002|NOT COMPLETED|Overall Study||27||
59657322|NCT02330562|75775566|FG003|NOT COMPLETED|Overall Study||30||
59657323|NCT02330562|75775567|FG004|NOT COMPLETED|Overall Study||31||
59657324|NCT02330562|75775568|FG005|NOT COMPLETED|Overall Study||10||
59657325|NCT02330562|75775569|FG006|NOT COMPLETED|Overall Study||1||
59544016|NCT01607411|75642280|FG003|COMPLETED|Period III||13||
59544017|NCT01607411|75642277|FG000|NOT COMPLETED|Period III||0||
59544018|NCT01607411|75642278|FG001|NOT COMPLETED|Period III||0||
59544019|NCT01607411|75642279|FG002|NOT COMPLETED|Period III||0||
59544020|NCT01607411|75642280|FG003|NOT COMPLETED|Period III||0||
59544021|NCT01607411|75642277|FG000|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|13||
59657326|NCT02330562|75775570|FG007|NOT COMPLETED|Overall Study||1||
59657327|NCT02330562|75775571|FG008|NOT COMPLETED|Overall Study||1||
59657328|NCT02330562|75775572|FG009|NOT COMPLETED|Overall Study||5||
59657329|NCT02330562|75775573|FG010|NOT COMPLETED|Overall Study||6||
59657330|NCT02053363|75775620|FG000|STARTED|Overall Study||25||
59657331|NCT02053363|75775621|FG001|STARTED|Overall Study||27||
59657332|NCT02053363|75775620|FG000|COMPLETED|Overall Study||25||
59657333|NCT02053363|75775621|FG001|COMPLETED|Overall Study||27||
59657334|NCT02053363|75775620|FG000|NOT COMPLETED|Overall Study||0||
59657335|NCT02053363|75775621|FG001|NOT COMPLETED|Overall Study||0||
59657336|NCT01975571|75775630|FG000|STARTED|Overall Study||15||
59657337|NCT01975571|75775631|FG001|STARTED|Overall Study||5||
59657338|NCT01975571|75775632|FG002|STARTED|Overall Study||0||
59657339|NCT01975571|75775630|FG000|COMPLETED|Overall Study||14||
59657340|NCT01975571|75775631|FG001|COMPLETED|Overall Study||3||
59657341|NCT01975571|75775632|FG002|COMPLETED|Overall Study||0||
59657342|NCT01975571|75775630|FG000|NOT COMPLETED|Overall Study||1||
59657343|NCT01975571|75775631|FG001|NOT COMPLETED|Overall Study||2||
59657344|NCT01975571|75775632|FG002|NOT COMPLETED|Overall Study||0||
59657345|NCT01157091|75775640|FG000|STARTED|Overall Study||28||
59657346|NCT01157091|75775640|FG000|COMPLETED|Overall Study||28||
59657347|NCT01157091|75775640|FG000|NOT COMPLETED|Overall Study||0||
59657348|NCT01100775|75775644|FG000|STARTED|Overall Study||6||
59657349|NCT01100775|75775645|FG001|STARTED|Overall Study||6||
59657350|NCT01100775|75775644|FG000|COMPLETED|Overall Study||6||
59657351|NCT01100775|75775645|FG001|COMPLETED|Overall Study||6||
59657352|NCT01100775|75775644|FG000|NOT COMPLETED|Overall Study||0||
59544022|NCT01607411|75642278|FG001|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|14||
59565815|NCT02335242|75668229|FG000|STARTED|Follow-up Period (12 Weeks)||6||
59657353|NCT01100775|75775645|FG001|NOT COMPLETED|Overall Study||0||
59657354|NCT00504712|75775653|FG000|STARTED|Overall Study||11||
59657355|NCT00504712|75775654|FG001|STARTED|Overall Study||13||
59657356|NCT00504712|75775653|FG000|COMPLETED|Overall Study||11||
59657357|NCT00504712|75775654|FG001|COMPLETED|Overall Study||13||
59657358|NCT00504712|75775653|FG000|NOT COMPLETED|Overall Study||0||
59657359|NCT00504712|75775654|FG001|NOT COMPLETED|Overall Study||0||
59657360|NCT05097157|75775660|FG000|STARTED|Overall Study||79||
59657361|NCT05097157|75775660|FG000|COMPLETED|Overall Study||56||
59657362|NCT05097157|75775660|FG000|NOT COMPLETED|Overall Study||23||
59657363|NCT04331795|75775666|FG000|STARTED|Overall Study||12||
59657364|NCT04331795|75775667|FG001|STARTED|Overall Study||20||
59657365|NCT04331795|75775666|FG000|COMPLETED|Overall Study||12||
59657366|NCT04331795|75775667|FG001|COMPLETED|Overall Study||20||
59657367|NCT04331795|75775666|FG000|NOT COMPLETED|Overall Study||0||
59657368|NCT04331795|75775667|FG001|NOT COMPLETED|Overall Study||0||
59657369|NCT04175730|75775675|FG000|STARTED|Overall Study||27||
59657370|NCT04175730|75775676|FG001|STARTED|Overall Study||21||
59657371|NCT04175730|75775675|FG000|COMPLETED|Overall Study||27||
59657372|NCT04175730|75775676|FG001|COMPLETED|Overall Study||21||
59657373|NCT04175730|75775675|FG000|NOT COMPLETED|Overall Study||0||
59657374|NCT04175730|75775676|FG001|NOT COMPLETED|Overall Study||0||
59657375|NCT03703102|75775687|FG000|STARTED|Overall Study||54||
59657376|NCT03703102|75775688|FG001|STARTED|Overall Study||53||
59657377|NCT03703102|75775689|FG002|STARTED|Overall Study||55||
59657378|NCT03703102|75775690|FG003|STARTED|Overall Study||54||
59657379|NCT03703102|75775691|FG004|STARTED|Overall Study||57||
59657380|NCT03703102|75775687|FG000|Completed Treatment Period A|Overall Study||42||
59657381|NCT03703102|75775688|FG001|Completed Treatment Period A|Overall Study||41||
59657382|NCT03703102|75775689|FG002|Completed Treatment Period A|Overall Study||42||
59657383|NCT03703102|75775690|FG003|Completed Treatment Period A|Overall Study||46||
59657384|NCT03703102|75775691|FG004|Completed Treatment Period A|Overall Study||34||
59657385|NCT03703102|75775687|FG000|Completed Treatment Period B|Overall Study||33||
59657386|NCT03703102|75775688|FG001|Completed Treatment Period B|Overall Study||39||
59657387|NCT03703102|75775689|FG002|Completed Treatment Period B|Overall Study||37||
59657388|NCT03703102|75775690|FG003|Completed Treatment Period B|Overall Study||38||
59657389|NCT03703102|75775691|FG004|Completed Treatment Period B|Overall Study||26||
59657390|NCT03703102|75775687|FG000|COMPLETED|Overall Study||32||
59657391|NCT03703102|75775688|FG001|COMPLETED|Overall Study||38||
59657392|NCT03703102|75775689|FG002|COMPLETED|Overall Study||33||
59657393|NCT03703102|75775690|FG003|COMPLETED|Overall Study||37||
59657394|NCT03703102|75775691|FG004|COMPLETED|Overall Study||24||
59657395|NCT03703102|75775687|FG000|NOT COMPLETED|Overall Study||22||
59657396|NCT03703102|75775688|FG001|NOT COMPLETED|Overall Study||15||
59657397|NCT03703102|75775689|FG002|NOT COMPLETED|Overall Study||22||
59657398|NCT03703102|75775690|FG003|NOT COMPLETED|Overall Study||17||
59657399|NCT03703102|75775691|FG004|NOT COMPLETED|Overall Study||33||
59657400|NCT03395704|75775710|FG000|STARTED|Overall Study||34||
59657401|NCT03395704|75775711|FG001|STARTED|Overall Study||36||
59657402|NCT03395704|75775710|FG000|Safety Population|Overall Study||34|The Safety Population included all patients who received at least one dose of study drug.|
59657403|NCT03395704|75775711|FG001|Safety Population|Overall Study||35|The Safety Population included all patients who received at least one dose of study drug.|
59657404|NCT03395704|75775710|FG000|Analysis Population|Overall Study||21|The Analysis Population included enrolled patients under global protocol Version 4.0 or later, as randomized, who received study drug, and who completed 4 months (Week 16) on study or who had at least 1 phlebotomy after the SOC therapeutic phlebotomy on Day 1 (predose) and before Week 16.|
59657405|NCT03395704|75775711|FG001|Analysis Population|Overall Study||28|The Analysis Population included enrolled patients under global protocol Version 4.0 or later, as randomized, who received study drug, and who completed 4 months (Week 16) on study or who had at least 1 phlebotomy after the SOC therapeutic phlebotomy on Day 1 (predose) and before Week 16.|
59657406|NCT03395704|75775710|FG000|COMPLETED|Overall Study||30||
59657407|NCT03395704|75775711|FG001|COMPLETED|Overall Study||33||
59657408|NCT03395704|75775710|FG000|NOT COMPLETED|Overall Study||4||
59657409|NCT03395704|75775711|FG001|NOT COMPLETED|Overall Study||3||
59657410|NCT03335813|75775717|FG000|STARTED|Overall Study||7||
59657411|NCT03335813|75775717|FG000|COMPLETED|Overall Study||6||
59657412|NCT03335813|75775717|FG000|NOT COMPLETED|Overall Study||1||
59657413|NCT03246503|75775721|FG000|STARTED|Overall Study||203||
59657414|NCT03246503|75775721|FG000|COMPLETED|Overall Study||150||
59657415|NCT03246503|75775721|FG000|NOT COMPLETED|Overall Study||53||
59657416|NCT03039595|75775725|FG000|STARTED|Overall Study||150||
59657417|NCT03039595|75775725|FG000|COMPLETED|Overall Study||143||
59657418|NCT03039595|75775725|FG000|NOT COMPLETED|Overall Study||7||
59657419|NCT02864368|75775734|FG000|STARTED|Overall Study||4||
59657420|NCT02864368|75775735|FG001|STARTED|Overall Study||1||
59657421|NCT02864368|75775736|FG002|STARTED|Overall Study||6||
59657422|NCT02864368|75775737|FG003|STARTED|Overall Study||8||
59657423|NCT02864368|75775738|FG004|STARTED|Overall Study||8||
59657424|NCT02864368|75775734|FG000|COMPLETED|Overall Study||4||
59657425|NCT02864368|75775735|FG001|COMPLETED|Overall Study||1||
59657426|NCT02864368|75775736|FG002|COMPLETED|Overall Study||6||
59657427|NCT02864368|75775737|FG003|COMPLETED|Overall Study||8||
59657428|NCT02864368|75775738|FG004|COMPLETED|Overall Study||8||
59657429|NCT02864368|75775734|FG000|NOT COMPLETED|Overall Study||0||
59657430|NCT02864368|75775735|FG001|NOT COMPLETED|Overall Study||0||
59544023|NCT01607411|75642279|FG002|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|14||
59544024|NCT01607411|75642280|FG003|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|14||
59544025|NCT01607411|75642277|FG000|COMPLETED|Period IV||13||
59544026|NCT01607411|75642278|FG001|COMPLETED|Period IV||14||
59544027|NCT01607411|75642279|FG002|COMPLETED|Period IV||14||
59544028|NCT01607411|75642280|FG003|COMPLETED|Period IV||14||
59544029|NCT01607411|75642277|FG000|NOT COMPLETED|Period IV||0||
59544030|NCT01607411|75642278|FG001|NOT COMPLETED|Period IV||0||
59544031|NCT01607411|75642279|FG002|NOT COMPLETED|Period IV||0||
59657431|NCT02864368|75775736|FG002|NOT COMPLETED|Overall Study||0||
59657432|NCT02864368|75775737|FG003|NOT COMPLETED|Overall Study||0||
59657433|NCT02864368|75775738|FG004|NOT COMPLETED|Overall Study||0||
59657434|NCT02856698|75775757|FG000|STARTED|Overall Study||55||
59657435|NCT02856698|75775758|FG001|STARTED|Overall Study||56||
59657436|NCT02856698|75775757|FG000|COMPLETED|Overall Study||48||
59657437|NCT02856698|75775758|FG001|COMPLETED|Overall Study||46||
59657438|NCT02856698|75775757|FG000|NOT COMPLETED|Overall Study||7||
59657439|NCT02856698|75775758|FG001|NOT COMPLETED|Overall Study||10||
59657440|NCT02625610|75775766|FG000|STARTED|Overall Study||250||
59657441|NCT02625610|75775767|FG001|STARTED|Overall Study||249||
59657442|NCT02625610|75775766|FG000|Safety-Maintenance Analysis Set|Overall Study||238||
59544032|NCT01607411|75642280|FG003|NOT COMPLETED|Period IV||0||
59544033|NCT01691339|75642294|FG000|STARTED|Overall Study||50||
59544034|NCT01691339|75642295|FG001|STARTED|Overall Study||50||
59544035|NCT01691339|75642296|FG002|STARTED|Overall Study||51||
59544036|NCT01691339|75642297|FG003|STARTED|Overall Study||49||
59544037|NCT01691339|75642294|FG000|COMPLETED|Overall Study||50||
59657443|NCT02625610|75775767|FG001|Safety-Maintenance Analysis Set|Overall Study||243||
59657444|NCT02625610|75775766|FG000|COMPLETED|Overall Study||250||
59657445|NCT02625610|75775767|FG001|COMPLETED|Overall Study||249||
59657446|NCT02625610|75775766|FG000|NOT COMPLETED|Overall Study||0||
59657447|NCT02625610|75775767|FG001|NOT COMPLETED|Overall Study||0||
59657448|NCT02514447|75775782|FG000|STARTED|Overall Study||29||
59657449|NCT02514447|75775783|FG001|STARTED|Overall Study||30||
59657450|NCT02514447|75775784|FG002|STARTED|Overall Study||32||
59657451|NCT02514447|75775785|FG003|STARTED|Overall Study||2||
59657452|NCT02514447|75775786|FG004|STARTED|Overall Study||3||
59657453|NCT02514447|75775787|FG005|STARTED|Overall Study||4||
59657454|NCT02514447|75775788|FG006|STARTED|Overall Study||8||
59657455|NCT02514447|75775789|FG007|STARTED|Overall Study||7||
59657456|NCT02514447|75775790|FG008|STARTED|Overall Study||8||
59657457|NCT02514447|75775782|FG000|COMPLETED|Overall Study||0||
59657458|NCT02514447|75775783|FG001|COMPLETED|Overall Study||0||
59657459|NCT02514447|75775784|FG002|COMPLETED|Overall Study||0||
59657460|NCT02514447|75775785|FG003|COMPLETED|Overall Study||0||
59657461|NCT02514447|75775786|FG004|COMPLETED|Overall Study||0||
59657462|NCT02514447|75775787|FG005|COMPLETED|Overall Study||0||
59657463|NCT02514447|75775788|FG006|COMPLETED|Overall Study||0||
59657464|NCT02514447|75775789|FG007|COMPLETED|Overall Study||0||
59657465|NCT02514447|75775790|FG008|COMPLETED|Overall Study||0||
59657466|NCT02514447|75775782|FG000|NOT COMPLETED|Overall Study||29||
59657467|NCT02514447|75775783|FG001|NOT COMPLETED|Overall Study||30||
59657468|NCT02514447|75775784|FG002|NOT COMPLETED|Overall Study||32||
59657469|NCT02514447|75775785|FG003|NOT COMPLETED|Overall Study||2||
59657470|NCT02514447|75775786|FG004|NOT COMPLETED|Overall Study||3||
59657471|NCT02514447|75775787|FG005|NOT COMPLETED|Overall Study||4||
59657472|NCT02514447|75775788|FG006|NOT COMPLETED|Overall Study||8||
59657473|NCT02514447|75775789|FG007|NOT COMPLETED|Overall Study||7||
59657474|NCT02514447|75775790|FG008|NOT COMPLETED|Overall Study||8||
59657475|NCT02031978|75775830|FG000|STARTED|Overall Study||4367||
59657476|NCT02031978|75775830|FG000|COMPLETED|Overall Study||4367||
59657477|NCT02031978|75775830|FG000|NOT COMPLETED|Overall Study||0||
59657478|NCT01785563|75775834|FG000|STARTED|Overall Study||40||
59657479|NCT01785563|75775834|FG000|COMPLETED|Overall Study||27||
59657480|NCT01785563|75775834|FG000|NOT COMPLETED|Overall Study||13||
59657481|NCT01434290|75775840|FG000|STARTED|Overall Study||127||
59657482|NCT01434290|75775841|FG001|STARTED|Overall Study||128||
59657483|NCT01434290|75775840|FG000|COMPLETED|Overall Study|Eligible subjects included in analysis|119||
59657484|NCT01434290|75775841|FG001|COMPLETED|Overall Study|Eligible subjects included in analysis|121||
59657485|NCT01434290|75775840|FG000|NOT COMPLETED|Overall Study||8||
59657486|NCT01434290|75775841|FG001|NOT COMPLETED|Overall Study||7||
59657487|NCT00750269|75775853|FG000|STARTED|Overall Study||8||
59657488|NCT00750269|75775854|FG001|STARTED|Overall Study||8||
59657489|NCT00750269|75775855|FG002|STARTED|Overall Study||18||
59657490|NCT00750269|75775856|FG003|STARTED|Overall Study||43||
59657491|NCT00750269|75775857|FG004|STARTED|Overall Study||43||
59657492|NCT00750269|75775853|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study|8||
59657493|NCT00750269|75775854|FG001|COMPLETED|Overall Study||7||
59657494|NCT00750269|75775855|FG002|COMPLETED|Overall Study||14||
59657495|NCT00750269|75775856|FG003|COMPLETED|Overall Study||38||
59657496|NCT00750269|75775857|FG004|COMPLETED|Overall Study||33||
59657497|NCT00750269|75775853|FG000|NOT COMPLETED|Overall Study||0||
59657498|NCT00750269|75775854|FG001|NOT COMPLETED|Overall Study||1||
59544038|NCT01691339|75642295|FG001|COMPLETED|Overall Study||50||
59544039|NCT01691339|75642296|FG002|COMPLETED|Overall Study||51||
59544040|NCT01691339|75642297|FG003|COMPLETED|Overall Study||49||
59544041|NCT01691339|75642294|FG000|NOT COMPLETED|Overall Study||0||
59657499|NCT00750269|75775855|FG002|NOT COMPLETED|Overall Study||4||
59657500|NCT00750269|75775856|FG003|NOT COMPLETED|Overall Study||5||
59657501|NCT00750269|75775857|FG004|NOT COMPLETED|Overall Study||10||
59657502|NCT00712322|75775879|FG000|STARTED|Overall Study||12||
59657503|NCT00712322|75775880|FG001|STARTED|Overall Study||14||
59657504|NCT00712322|75775881|FG002|STARTED|Overall Study||9||
59657505|NCT00712322|75775879|FG000|COMPLETED|Overall Study||12||
59657506|NCT00712322|75775880|FG001|COMPLETED|Overall Study||13||
59657507|NCT00712322|75775881|FG002|COMPLETED|Overall Study||9||
59657508|NCT00712322|75775879|FG000|NOT COMPLETED|Overall Study||0||
59657509|NCT00712322|75775880|FG001|NOT COMPLETED|Overall Study||1||
59657510|NCT00712322|75775881|FG002|NOT COMPLETED|Overall Study||0||
59657511|NCT00323856|75775889|FG000|STARTED|Overall Study||50||
59657512|NCT00323856|75775889|FG000|COMPLETED|Overall Study||45||
59657513|NCT00323856|75775889|FG000|NOT COMPLETED|Overall Study||5||
59657514|NCT05086835|75775893|FG000|STARTED|Overall Study||10||
59544042|NCT01691339|75642295|FG001|NOT COMPLETED|Overall Study||0||
59657515|NCT05086835|75775893|FG000|COMPLETED|Overall Study||10||
59657516|NCT05086835|75775893|FG000|NOT COMPLETED|Overall Study||0||
59657517|NCT04594941|75775904|FG000|STARTED|Overall Study||7||
59657518|NCT04594941|75775905|FG001|STARTED|Overall Study||10||
59657519|NCT04594941|75775906|FG002|STARTED|Overall Study||11||
59657520|NCT04594941|75775907|FG003|STARTED|Overall Study||7||
59657521|NCT04594941|75775904|FG000|Modified Intent-to-Treat (mITT) Population|Overall Study||7|mITT population included all participants who were randomized to receive >=1 dose of Flurpiridaz (18F) Injection and who completed the 2 rest Flurpiridaz (18F) Injection PET-MPI procedures.|
59657522|NCT04594941|75775905|FG001|Modified Intent-to-Treat (mITT) Population|Overall Study||7|mITT population included all participants who were randomized to receive >=1 dose of Flurpiridaz (18F) Injection and who completed the 2 rest Flurpiridaz (18F) Injection PET-MPI procedures.|
59657523|NCT04594941|75775906|FG002|Modified Intent-to-Treat (mITT) Population|Overall Study||10|mITT population included all participants who were randomized to receive >=1 dose of Flurpiridaz (18F) Injection and who completed the 2 rest Flurpiridaz (18F) Injection PET-MPI procedures.|
59657524|NCT04594941|75775907|FG003|Modified Intent-to-Treat (mITT) Population|Overall Study||7|mITT population included all participants who were randomized to receive >=1 dose of Flurpiridaz (18F) Injection and who completed the 2 rest Flurpiridaz (18F) Injection PET-MPI procedures.|
59657525|NCT04594941|75775904|FG000|COMPLETED|Overall Study||7||
59657526|NCT04594941|75775905|FG001|COMPLETED|Overall Study||7||
59657527|NCT04594941|75775906|FG002|COMPLETED|Overall Study||10||
59657528|NCT04594941|75775907|FG003|COMPLETED|Overall Study||7||
59657529|NCT04594941|75775904|FG000|NOT COMPLETED|Overall Study||0||
59657530|NCT04594941|75775905|FG001|NOT COMPLETED|Overall Study||3||
59657531|NCT04594941|75775906|FG002|NOT COMPLETED|Overall Study||1||
59657532|NCT04594941|75775907|FG003|NOT COMPLETED|Overall Study||0||
59657533|NCT04524663|75775925|FG000|STARTED|Overall Study||25||
59657534|NCT04524663|75775926|FG001|STARTED|Overall Study||24||
59657535|NCT04524663|75775925|FG000|COMPLETED|Overall Study||25||
59657536|NCT04524663|75775926|FG001|COMPLETED|Overall Study||22||
59657537|NCT04524663|75775925|FG000|NOT COMPLETED|Overall Study||0||
59657538|NCT04524663|75775926|FG001|NOT COMPLETED|Overall Study||2||
59657539|NCT04435795|75775934|FG000|STARTED|Overall Study||108||
59657540|NCT04435795|75775935|FG001|STARTED|Overall Study||107||
59657541|NCT04435795|75775934|FG000|COMPLETED|Overall Study||105||
59657542|NCT04435795|75775935|FG001|COMPLETED|Overall Study||98||
59657543|NCT04435795|75775934|FG000|NOT COMPLETED|Overall Study||3||
59657544|NCT04435795|75775935|FG001|NOT COMPLETED|Overall Study||9||
59657545|NCT04350593|75775943|FG000|STARTED|Overall Study||625||
59657546|NCT04350593|75775944|FG001|STARTED|Overall Study||625||
59657547|NCT04350593|75775943|FG000|COMPLETED|Overall Study||617||
59657548|NCT04350593|75775944|FG001|COMPLETED|Overall Study||620||
59657549|NCT04350593|75775943|FG000|NOT COMPLETED|Overall Study||8||
59657550|NCT04350593|75775944|FG001|NOT COMPLETED|Overall Study||5||
59657551|NCT03738423|75775955|FG000|STARTED|Overall Study||25||
59657552|NCT03738423|75775956|FG001|STARTED|Overall Study||26||
59657553|NCT03738423|75775957|FG002|STARTED|Overall Study||27||
59657554|NCT03738423|75775958|FG003|STARTED|Overall Study||25||
59657555|NCT03738423|75775959|FG004|STARTED|Overall Study||26||
59657556|NCT03738423|75775955|FG000|Treated|Overall Study||25||
59657557|NCT03738423|75775956|FG001|Treated|Overall Study||26||
59657558|NCT03738423|75775957|FG002|Treated|Overall Study||26||
59657559|NCT03738423|75775958|FG003|Treated|Overall Study||24||
59657560|NCT03738423|75775959|FG004|Treated|Overall Study||26||
59657561|NCT03738423|75775955|FG000|COMPLETED|Overall Study||11||
59657562|NCT03738423|75775956|FG001|COMPLETED|Overall Study||13||
59657563|NCT03738423|75775957|FG002|COMPLETED|Overall Study||14||
59657564|NCT03738423|75775958|FG003|COMPLETED|Overall Study||10||
59657565|NCT03738423|75775959|FG004|COMPLETED|Overall Study||11||
59657566|NCT03738423|75775955|FG000|NOT COMPLETED|Overall Study||14||
59657567|NCT03738423|75775956|FG001|NOT COMPLETED|Overall Study||13||
59657568|NCT03738423|75775957|FG002|NOT COMPLETED|Overall Study||13||
59657569|NCT03738423|75775958|FG003|NOT COMPLETED|Overall Study||15||
59657570|NCT03738423|75775959|FG004|NOT COMPLETED|Overall Study||15||
59657571|NCT03712228|75775977|FG000|STARTED|Treatment Period 1||8||
59657572|NCT03712228|75775978|FG001|STARTED|Treatment Period 1||9||
59657573|NCT03712228|75775979|FG002|STARTED|Treatment Period 1||8||
59657574|NCT03712228|75775980|FG003|STARTED|Treatment Period 1||7||
59657575|NCT03712228|75775981|FG004|STARTED|Treatment Period 1||6||
59657576|NCT03712228|75775982|FG005|STARTED|Treatment Period 1||6||
59657577|NCT03712228|75775977|FG000|COMPLETED|Treatment Period 1||8||
59657578|NCT03712228|75775978|FG001|COMPLETED|Treatment Period 1||9||
59657579|NCT03712228|75775979|FG002|COMPLETED|Treatment Period 1||8||
59657580|NCT03712228|75775980|FG003|COMPLETED|Treatment Period 1||7||
59817909|NCT04488770|75940335|FG009|NOT COMPLETED|Part 1-Cohort 2: Period 1 (Up to 5 Days)||0||
59657581|NCT03712228|75775981|FG004|COMPLETED|Treatment Period 1||6||
59657582|NCT03712228|75775982|FG005|COMPLETED|Treatment Period 1||5||
59657583|NCT03712228|75775977|FG000|NOT COMPLETED|Treatment Period 1||0||
59657584|NCT03712228|75775978|FG001|NOT COMPLETED|Treatment Period 1||0||
59657585|NCT03712228|75775979|FG002|NOT COMPLETED|Treatment Period 1||0||
59657586|NCT03712228|75775980|FG003|NOT COMPLETED|Treatment Period 1||0||
59657587|NCT03712228|75775981|FG004|NOT COMPLETED|Treatment Period 1||0||
59657588|NCT03712228|75775982|FG005|NOT COMPLETED|Treatment Period 1||1||
59657589|NCT03712228|75775977|FG000|STARTED|Treatment Period 2||0||
59657590|NCT03712228|75775978|FG001|STARTED|Treatment Period 2||0||
59657591|NCT03712228|75775979|FG002|STARTED|Treatment Period 2||20||
59657592|NCT03712228|75775980|FG003|STARTED|Treatment Period 2||18||
59657593|NCT03712228|75775981|FG004|STARTED|Treatment Period 2||0||
59657594|NCT03712228|75775982|FG005|STARTED|Treatment Period 2||2||
59657595|NCT03712228|75775977|FG000|COMPLETED|Treatment Period 2||0||
59657596|NCT03712228|75775978|FG001|COMPLETED|Treatment Period 2||0||
59657597|NCT03712228|75775979|FG002|COMPLETED|Treatment Period 2||20||
59657598|NCT03712228|75775980|FG003|COMPLETED|Treatment Period 2||16||
59657599|NCT03712228|75775981|FG004|COMPLETED|Treatment Period 2||0||
59657600|NCT03712228|75775982|FG005|COMPLETED|Treatment Period 2||2||
59544043|NCT01691339|75642296|FG002|NOT COMPLETED|Overall Study||0||
59544044|NCT01691339|75642297|FG003|NOT COMPLETED|Overall Study||0||
59544045|NCT01692743|75642310|FG000|STARTED|Overall Study||117||
59544046|NCT01692743|75642311|FG001|STARTED|Overall Study||116||
59544047|NCT01692743|75642312|FG002|STARTED|Overall Study||115||
59544048|NCT01692743|75642310|FG000|COMPLETED|Overall Study||90||
59544049|NCT01692743|75642311|FG001|COMPLETED|Overall Study||81||
59544050|NCT01692743|75642312|FG002|COMPLETED|Overall Study||88||
59544051|NCT01692743|75642310|FG000|NOT COMPLETED|Overall Study||27||
59544052|NCT01692743|75642311|FG001|NOT COMPLETED|Overall Study||35||
59544053|NCT01692743|75642312|FG002|NOT COMPLETED|Overall Study||27||
59544054|NCT02233751|75642322|FG000|STARTED|Overall Study||6||
59544055|NCT02233751|75642323|FG001|STARTED|Overall Study||6||
59544056|NCT02233751|75642322|FG000|COMPLETED|Overall Study||6||
59544057|NCT02233751|75642323|FG001|COMPLETED|Overall Study||6||
59544058|NCT02233751|75642322|FG000|NOT COMPLETED|Overall Study||0||
59544059|NCT02233751|75642323|FG001|NOT COMPLETED|Overall Study||0||
59544060|NCT02233985|75642331|FG000|STARTED|Overall Study||33||
59544061|NCT02233985|75642332|FG001|STARTED|Overall Study||31||
59544062|NCT02233985|75642331|FG000|COMPLETED|Overall Study||33||
59544063|NCT02233985|75642332|FG001|COMPLETED|Overall Study||31||
59544064|NCT02233985|75642331|FG000|NOT COMPLETED|Overall Study||0||
59544065|NCT02233985|75642332|FG001|NOT COMPLETED|Overall Study||0||
59544066|NCT01607645|75642342|FG000|STARTED|Overall Study||4||
59544067|NCT01607645|75642343|FG001|STARTED|Overall Study||3||
59544068|NCT01607645|75642342|FG000|COMPLETED|Overall Study||4||
59544069|NCT01607645|75642343|FG001|COMPLETED|Overall Study||3||
59544070|NCT01607645|75642342|FG000|NOT COMPLETED|Overall Study||0||
59544071|NCT01607645|75642343|FG001|NOT COMPLETED|Overall Study||0||
59544072|NCT01647581|75642351|FG000|STARTED|Overall Study||547||
59544073|NCT01647581|75642352|FG001|STARTED|Overall Study||551||
59544074|NCT01647581|75642351|FG000|COMPLETED|Overall Study||530||
59544075|NCT01647581|75642352|FG001|COMPLETED|Overall Study||520||
59544076|NCT01647581|75642351|FG000|NOT COMPLETED|Overall Study||17||
59544077|NCT01647581|75642352|FG001|NOT COMPLETED|Overall Study||31||
59544078|NCT01608659|75642358|FG000|STARTED|Overall Study||110||
59544079|NCT01608659|75642358|FG000|COMPLETED|Overall Study||94||
59544080|NCT01608659|75642358|FG000|NOT COMPLETED|Overall Study||16||
59657601|NCT03712228|75775977|FG000|NOT COMPLETED|Treatment Period 2||0||
59657602|NCT03712228|75775978|FG001|NOT COMPLETED|Treatment Period 2||0||
59657603|NCT03712228|75775979|FG002|NOT COMPLETED|Treatment Period 2||0||
59657604|NCT03712228|75775980|FG003|NOT COMPLETED|Treatment Period 2||2||
59657605|NCT03712228|75775981|FG004|NOT COMPLETED|Treatment Period 2||0||
59657606|NCT03712228|75775982|FG005|NOT COMPLETED|Treatment Period 2||0||
59657607|NCT03600818|75776001|FG000|STARTED|Overall Study||58||
59657608|NCT03600818|75776002|FG001|STARTED|Overall Study||60||
59657609|NCT03600818|75776001|FG000|Safety Population|Overall Study||58|All randomized participants who received at least one dose or part of a dose of the study medication (IMP) analyzed according to the treatment they actually received.|
59657610|NCT03600818|75776002|FG001|Safety Population|Overall Study||59|All randomized participants who received at least one dose or part of a dose of the study medication (IMP) analyzed according to the treatment they actually received.|
59657611|NCT03600818|75776001|FG000|COMPLETED|Overall Study||36||
59657612|NCT03600818|75776002|FG001|COMPLETED|Overall Study||42||
59657613|NCT03600818|75776001|FG000|NOT COMPLETED|Overall Study||22||
59657614|NCT03600818|75776002|FG001|NOT COMPLETED|Overall Study||18||
59988860|NCT04495179|76104105|FG001|NOT COMPLETED|Overall Study||28||
59544081|NCT01608815|75642365|FG000|STARTED|Overall Study||188||
59544082|NCT01608815|75642366|FG001|STARTED|Overall Study||7||
59544083|NCT01608815|75642367|FG002|STARTED|Overall Study||5||
59544084|NCT01608815|75642365|FG000|COMPLETED|Overall Study||188||
59544085|NCT01608815|75642366|FG001|COMPLETED|Overall Study||7||
59544086|NCT01608815|75642367|FG002|COMPLETED|Overall Study||5||
59544087|NCT01608815|75642365|FG000|NOT COMPLETED|Overall Study||0||
59657615|NCT03578276|75776011|FG000|STARTED|Overall Study||35||35
59657616|NCT03578276|75776012|FG001|STARTED|Overall Study||35||35
59657617|NCT03578276|75776011|FG000|COMPLETED|Overall Study||33||33
59544088|NCT01608815|75642366|FG001|NOT COMPLETED|Overall Study||0||
59544089|NCT01608815|75642367|FG002|NOT COMPLETED|Overall Study||0||
59544090|NCT01608971|75642378|FG000|STARTED|Overall Study||15||
59544091|NCT01608971|75642379|FG001|STARTED|Overall Study||15||
59544092|NCT01608971|75642378|FG000|COMPLETED|Overall Study||15||
59544093|NCT01608971|75642379|FG001|COMPLETED|Overall Study||15||
59544094|NCT01608971|75642378|FG000|NOT COMPLETED|Overall Study||0||
59657618|NCT03578276|75776012|FG001|COMPLETED|Overall Study||33||33
59657619|NCT03578276|75776011|FG000|NOT COMPLETED|Overall Study||2||2
59657620|NCT03578276|75776012|FG001|NOT COMPLETED|Overall Study||2||2
59657621|NCT03257696|75776020|FG000|STARTED|Overall Study||123||
59657622|NCT03257696|75776021|FG001|STARTED|Overall Study||29||
59657623|NCT03257696|75776020|FG000|COMPLETED|Overall Study||123||
59657624|NCT03257696|75776021|FG001|COMPLETED|Overall Study||29||
59657625|NCT03257696|75776020|FG000|NOT COMPLETED|Overall Study||0||
59657626|NCT03257696|75776021|FG001|NOT COMPLETED|Overall Study||0||
59657627|NCT03174184|75776033|FG000|STARTED|Overall Study||32||
59657628|NCT03174184|75776034|FG001|STARTED|Overall Study||20||
59657629|NCT03174184|75776035|FG002|STARTED|Overall Study||17||
59657630|NCT03174184|75776036|FG003|STARTED|Overall Study||15||
59657631|NCT03174184|75776037|FG004|STARTED|Overall Study||14||
59657632|NCT03174184|75776038|FG005|STARTED|Overall Study||14||
59657633|NCT03174184|75776033|FG000|COMPLETED|Overall Study||23||
59657634|NCT03174184|75776034|FG001|COMPLETED|Overall Study||15||
59657635|NCT03174184|75776035|FG002|COMPLETED|Overall Study||12||
59657636|NCT03174184|75776036|FG003|COMPLETED|Overall Study||12||
59657637|NCT03174184|75776037|FG004|COMPLETED|Overall Study||12||
59657638|NCT03174184|75776038|FG005|COMPLETED|Overall Study||12||
59657639|NCT03174184|75776033|FG000|NOT COMPLETED|Overall Study||9||
59657640|NCT03174184|75776034|FG001|NOT COMPLETED|Overall Study||5||
59657641|NCT03174184|75776035|FG002|NOT COMPLETED|Overall Study||5||
59657642|NCT03174184|75776036|FG003|NOT COMPLETED|Overall Study||3||
59657643|NCT03174184|75776037|FG004|NOT COMPLETED|Overall Study||2||
59657644|NCT03174184|75776038|FG005|NOT COMPLETED|Overall Study||2||
59657645|NCT02900560|75776056|FG000|STARTED|Overall Study||9||
59657646|NCT02900560|75776057|FG001|STARTED|Overall Study||10||
59657647|NCT02900560|75776058|FG002|STARTED|Overall Study||7||
59657648|NCT02900560|75776059|FG003|STARTED|Overall Study||8||
59657649|NCT02900560|75776056|FG000|COMPLETED|Overall Study||7||
59657650|NCT02900560|75776057|FG001|COMPLETED|Overall Study||10||
59657651|NCT02900560|75776058|FG002|COMPLETED|Overall Study||7||
59657652|NCT02900560|75776059|FG003|COMPLETED|Overall Study||8||
59657653|NCT02900560|75776056|FG000|NOT COMPLETED|Overall Study||2||
59657654|NCT02900560|75776057|FG001|NOT COMPLETED|Overall Study||0||
59657655|NCT02900560|75776058|FG002|NOT COMPLETED|Overall Study||0||
59657656|NCT02900560|75776059|FG003|NOT COMPLETED|Overall Study||0||
59657657|NCT02034110|75776077|FG000|STARTED|Overall Study||36|All enrolled participants were included in the Intent-to-treat (ITT), All-treated subjects (ATS) and ITT/Evaluable populations|
59657658|NCT02034110|75776078|FG001|STARTED|Overall Study||43|All enrolled participants were included in the Intent-to-treat (ITT), All-treated subjects (ATS) and ITT/Evaluable populations|
59657659|NCT02034110|75776079|FG002|STARTED|Overall Study||1|All enrolled participants were included in the Intent-to-treat (ITT), All-treated subjects (ATS) and ITT/Evaluable populations|
59657660|NCT02034110|75776080|FG003|STARTED|Overall Study||13|All enrolled participants were included in the Intent-to-treat (ITT), All-treated subjects (ATS) and ITT/Evaluable populations|
59657661|NCT02034110|75776081|FG004|STARTED|Overall Study||45|All enrolled participants were included in the Intent-to-treat (ITT), All-treated subjects (ATS) and ITT/Evaluable populations|
59657662|NCT02034110|75776082|FG005|STARTED|Overall Study||3|All enrolled participants were included in the Intent-to-treat (ITT), All-treated subjects (ATS) and ITT/Evaluable populations|
59657663|NCT02034110|75776083|FG006|STARTED|Overall Study||55|All enrolled participants were included in the Intent-to-treat (ITT), All-treated subjects (ATS) and ITT/Evaluable populations|
59657664|NCT02034110|75776084|FG007|STARTED|Overall Study||10|All enrolled participants were included in the Intent-to-treat (ITT), All-treated subjects (ATS) and ITT/Evaluable populations|
59657665|NCT02034110|75776077|FG000|Primary Analysis Cohort|Overall Study||15||
59657666|NCT02034110|75776078|FG001|Primary Analysis Cohort|Overall Study||18||
59657667|NCT02034110|75776079|FG002|Primary Analysis Cohort|Overall Study||1||
59657668|NCT02034110|75776080|FG003|Primary Analysis Cohort|Overall Study||13||
59657669|NCT02034110|75776081|FG004|Primary Analysis Cohort|Overall Study||24||
59657670|NCT02034110|75776082|FG005|Primary Analysis Cohort|Overall Study||3||
59657671|NCT02034110|75776083|FG006|Primary Analysis Cohort|Overall Study||24||
59657672|NCT02034110|75776084|FG007|Primary Analysis Cohort|Overall Study||10||
59657673|NCT02034110|75776077|FG000|Expansion Cohort|Overall Study||21||
59657674|NCT02034110|75776078|FG001|Expansion Cohort|Overall Study||25||
59657675|NCT02034110|75776079|FG002|Expansion Cohort|Overall Study||0||
59657676|NCT02034110|75776080|FG003|Expansion Cohort|Overall Study||0||
59657677|NCT02034110|75776081|FG004|Expansion Cohort|Overall Study||21||
59657678|NCT02034110|75776082|FG005|Expansion Cohort|Overall Study||0||
59657679|NCT02034110|75776083|FG006|Expansion Cohort|Overall Study||31||
59657680|NCT02034110|75776084|FG007|Expansion Cohort|Overall Study||0||
59657681|NCT02034110|75776077|FG000|COMPLETED|Overall Study||24||
59657682|NCT02034110|75776078|FG001|COMPLETED|Overall Study||34||
59657683|NCT02034110|75776079|FG002|COMPLETED|Overall Study||1||
59657684|NCT02034110|75776080|FG003|COMPLETED|Overall Study||4||
59657685|NCT02034110|75776081|FG004|COMPLETED|Overall Study||28||
59657686|NCT02034110|75776082|FG005|COMPLETED|Overall Study||3||
59657687|NCT02034110|75776083|FG006|COMPLETED|Overall Study||8||
59657688|NCT02034110|75776084|FG007|COMPLETED|Overall Study||9||
59657689|NCT02034110|75776077|FG000|NOT COMPLETED|Overall Study||12||
59657690|NCT02034110|75776078|FG001|NOT COMPLETED|Overall Study||9||
59657691|NCT02034110|75776079|FG002|NOT COMPLETED|Overall Study||0||
59657692|NCT02034110|75776080|FG003|NOT COMPLETED|Overall Study||9||
59657693|NCT02034110|75776081|FG004|NOT COMPLETED|Overall Study||17||
59657694|NCT02034110|75776082|FG005|NOT COMPLETED|Overall Study||0||
59657695|NCT02034110|75776083|FG006|NOT COMPLETED|Overall Study||47||
59657696|NCT02034110|75776084|FG007|NOT COMPLETED|Overall Study||1||
59657697|NCT01968213|75776119|FG000|STARTED|Overall Study||375||
59657698|NCT01968213|75776120|FG001|STARTED|Overall Study||189||
59657699|NCT01968213|75776119|FG000|COMPLETED|Overall Study||375||
59657700|NCT01968213|75776120|FG001|COMPLETED|Overall Study||189||
59657701|NCT01968213|75776119|FG000|NOT COMPLETED|Overall Study||0||
59657702|NCT01968213|75776120|FG001|NOT COMPLETED|Overall Study||0||
59657703|NCT01656486|75776126|FG000|STARTED|Overall Study||1||
59657704|NCT01656486|75776126|FG000|COMPLETED|Overall Study||1||
59657705|NCT01656486|75776126|FG000|NOT COMPLETED|Overall Study||0||
59657706|NCT01627574|75776132|FG000|STARTED|Overall Study||142||
59657707|NCT01627574|75776133|FG001|STARTED|Overall Study||130||
59657708|NCT01627574|75776132|FG000|COMPLETED|Overall Study||121||
59657709|NCT01627574|75776133|FG001|COMPLETED|Overall Study||112||
59657710|NCT01627574|75776132|FG000|NOT COMPLETED|Overall Study||21||
59657711|NCT01627574|75776133|FG001|NOT COMPLETED|Overall Study||18||
59657712|NCT01498458|75776139|FG000|STARTED|Overall Study|9 patients took part in the study of which 8 received pazopanib.|8||
59657713|NCT01498458|75776139|FG000|COMPLETED|Overall Study|only 1 patient was in the study at the end. 7 left due to Adverse Events or Investigators Decision.|1||
59657714|NCT01498458|75776139|FG000|NOT COMPLETED|Overall Study||7||
59657715|NCT01427712|75776148|FG000|STARTED|Overall Study||24||
59657716|NCT01427712|75776148|FG000|Collected CRFs|Overall Study||21||
59657717|NCT01427712|75776148|FG000|Safety Analysis Set|Overall Study||21||
59657718|NCT01427712|75776148|FG000|COMPLETED|Overall Study||17||
59657719|NCT01427712|75776148|FG000|NOT COMPLETED|Overall Study||7||
59657720|NCT01369147|75776155|FG000|STARTED|Overall Study||3||
59657721|NCT01369147|75776156|FG001|STARTED|Overall Study||5||
59657722|NCT01369147|75776157|FG002|STARTED|Overall Study||4||
59657723|NCT01369147|75776155|FG000|COMPLETED|Overall Study||3||
59657724|NCT01369147|75776156|FG001|COMPLETED|Overall Study||4||
59657725|NCT01369147|75776157|FG002|COMPLETED|Overall Study||4||
59657726|NCT01369147|75776155|FG000|NOT COMPLETED|Overall Study||0||
59657727|NCT01369147|75776156|FG001|NOT COMPLETED|Overall Study||1||
59657728|NCT01369147|75776157|FG002|NOT COMPLETED|Overall Study||0||
59657729|NCT04846231|75776173|FG000|STARTED|Overall Study||25||
59657730|NCT04846231|75776174|FG001|STARTED|Overall Study||25||
59657731|NCT04846231|75776175|FG002|STARTED|Overall Study||24||
59657732|NCT04846231|75776176|FG003|STARTED|Overall Study||25||
59657733|NCT04846231|75776177|FG004|STARTED|Overall Study||25||
59657734|NCT04846231|75776178|FG005|STARTED|Overall Study||25||
59657735|NCT04846231|75776179|FG006|STARTED|Overall Study||25||
59657736|NCT04846231|75776180|FG007|STARTED|Overall Study||25||
59657737|NCT04846231|75776173|FG000|COMPLETED|Overall Study||24||
59657738|NCT04846231|75776174|FG001|COMPLETED|Overall Study||23||
59657739|NCT04846231|75776175|FG002|COMPLETED|Overall Study||22||
59657740|NCT04846231|75776176|FG003|COMPLETED|Overall Study||24||
59657741|NCT04846231|75776177|FG004|COMPLETED|Overall Study||25||
59657742|NCT04846231|75776178|FG005|COMPLETED|Overall Study||25||
59657743|NCT04846231|75776179|FG006|COMPLETED|Overall Study||24||
59657744|NCT04846231|75776180|FG007|COMPLETED|Overall Study||23||
59657745|NCT04846231|75776173|FG000|NOT COMPLETED|Overall Study||1||
59657746|NCT04846231|75776174|FG001|NOT COMPLETED|Overall Study||2||
59657747|NCT04846231|75776175|FG002|NOT COMPLETED|Overall Study||2||
59657748|NCT04846231|75776176|FG003|NOT COMPLETED|Overall Study||1||
59657749|NCT04846231|75776177|FG004|NOT COMPLETED|Overall Study||0||
59657750|NCT04846231|75776178|FG005|NOT COMPLETED|Overall Study||0||
59657751|NCT04846231|75776179|FG006|NOT COMPLETED|Overall Study||1||
59657752|NCT04846231|75776180|FG007|NOT COMPLETED|Overall Study||2||
59657753|NCT04533594|75776206|FG000|STARTED|Overall Study|Participants who completed baseline survey|59||
59657754|NCT04533594|75776206|FG000|Started Intervention|Overall Study|Participants who started intervention after completion of baseline survey|53|N=6 participants had their loved one died before being able to start intervention|
59657755|NCT04533594|75776206|FG000|Completed Final Survey|Overall Study|Participants who completed second survey up to 8 weeks after baseline.|44||
59657756|NCT04533594|75776206|FG000|COMPLETED|Overall Study|Participants that observed all 4 videos and, therefore, completed intervention|33|N=20 participants had their loved one died before being able to complete the intervention.|
59657757|NCT04533594|75776206|FG000|NOT COMPLETED|Overall Study||26||
59657758|NCT04447846|75776210|FG000|STARTED|Overall Study||10||
59657759|NCT04447846|75776210|FG000|COMPLETED|Overall Study||9||
59657760|NCT04447846|75776210|FG000|NOT COMPLETED|Overall Study||1||
59657761|NCT04405245|75776217|FG000|STARTED|Overall Study||65||
59657762|NCT04405245|75776218|FG001|STARTED|Overall Study||65||
59657763|NCT04405245|75776219|FG002|STARTED|Overall Study||64||
59657764|NCT04405245|75776217|FG000|COMPLETED|Overall Study||65||
59657765|NCT04405245|75776218|FG001|COMPLETED|Overall Study||64||
59657766|NCT04405245|75776219|FG002|COMPLETED|Overall Study||64||
59657767|NCT04405245|75776217|FG000|NOT COMPLETED|Overall Study||0||
59657768|NCT04405245|75776218|FG001|NOT COMPLETED|Overall Study||1||
59657769|NCT04405245|75776219|FG002|NOT COMPLETED|Overall Study||0||
59657770|NCT04277507|75776227|FG000|STARTED|Overall Study||122||
59657771|NCT04277507|75776227|FG000|COMPLETED|Overall Study|A total of 122 patients were treated and 91 reached (24M Visit) 2 years. The study is still in follow-up through 36M (3 years).|91||
59657772|NCT04277507|75776227|FG000|NOT COMPLETED|Overall Study||31||
59657773|NCT04210557|75776237|FG000|STARTED|Overall Study||1||
59657774|NCT04210557|75776238|FG001|STARTED|Overall Study||0||
59657775|NCT04210557|75776237|FG000|COMPLETED|Overall Study||1||
59657776|NCT04210557|75776238|FG001|COMPLETED|Overall Study||0||
59657777|NCT04210557|75776237|FG000|NOT COMPLETED|Overall Study||0||
59657778|NCT04210557|75776238|FG001|NOT COMPLETED|Overall Study||0||
59657779|NCT04198805|75776248|FG000|STARTED|Overall Study||34||
59657780|NCT04198805|75776249|FG001|STARTED|Overall Study||34||
59657781|NCT04198805|75776250|FG002|STARTED|Overall Study||67||
59657782|NCT04198805|75776251|FG003|STARTED|Overall Study||70||
59657783|NCT04198805|75776248|FG000|COMPLETED|Overall Study||26||
59657784|NCT04198805|75776249|FG001|COMPLETED|Overall Study||30||
59657785|NCT04198805|75776250|FG002|COMPLETED|Overall Study||61||
59657786|NCT04198805|75776251|FG003|COMPLETED|Overall Study||60||
59657787|NCT04198805|75776248|FG000|NOT COMPLETED|Overall Study||8||
59657788|NCT04198805|75776249|FG001|NOT COMPLETED|Overall Study||4||
59657789|NCT04198805|75776250|FG002|NOT COMPLETED|Overall Study||6||
59657790|NCT04198805|75776251|FG003|NOT COMPLETED|Overall Study||10||
59657791|NCT04179890|75776267|FG000|STARTED|Overall Study||255|Reporting Enrolled Patients|
59657792|NCT04179890|75776268|FG001|STARTED|Overall Study||207|Reporting Enrolled Patients|
59657793|NCT04179890|75776267|FG000|Eligible Patients|Overall Study||246||
59657794|NCT04179890|75776268|FG001|Eligible Patients|Overall Study||191||
59657795|NCT04179890|75776267|FG000|COMPLETED|Overall Study||246||
59657796|NCT04179890|75776268|FG001|COMPLETED|Overall Study||191||
59657797|NCT04179890|75776267|FG000|NOT COMPLETED|Overall Study||9||
59657798|NCT04179890|75776268|FG001|NOT COMPLETED|Overall Study||16||
59657799|NCT04084210|75776278|FG000|STARTED|Overall Study||34||
59657800|NCT04084210|75776279|FG001|STARTED|Overall Study||32||
59657801|NCT04084210|75776280|FG002|STARTED|Overall Study||37||
59657802|NCT04084210|75776281|FG003|STARTED|Overall Study||36||
59657803|NCT04084210|75776282|FG004|STARTED|Overall Study||34||
59657804|NCT04084210|75776283|FG005|STARTED|Overall Study||36||
59657805|NCT04084210|75776278|FG000|COMPLETED|Overall Study||27||
59657806|NCT04084210|75776279|FG001|COMPLETED|Overall Study||27||
59657807|NCT04084210|75776280|FG002|COMPLETED|Overall Study||29||
59657808|NCT04084210|75776281|FG003|COMPLETED|Overall Study||24||
59657809|NCT04084210|75776282|FG004|COMPLETED|Overall Study||26||
59657810|NCT04084210|75776283|FG005|COMPLETED|Overall Study||27||
59657811|NCT04084210|75776278|FG000|NOT COMPLETED|Overall Study||7||
59657812|NCT04084210|75776279|FG001|NOT COMPLETED|Overall Study||5||
59657813|NCT04084210|75776280|FG002|NOT COMPLETED|Overall Study||8||
59657814|NCT04084210|75776281|FG003|NOT COMPLETED|Overall Study||12||
59657815|NCT04084210|75776282|FG004|NOT COMPLETED|Overall Study||8||
59657816|NCT04084210|75776283|FG005|NOT COMPLETED|Overall Study||9||
59657817|NCT03764618|75776299|FG000|STARTED|Overall Study||45||
59657818|NCT03764618|75776300|FG001|STARTED|Overall Study||45||
59657819|NCT03764618|75776299|FG000|COMPLETED|Overall Study||38||
59657820|NCT03764618|75776300|FG001|COMPLETED|Overall Study||34||
59657821|NCT03764618|75776299|FG000|NOT COMPLETED|Overall Study||7||
59657822|NCT03764618|75776300|FG001|NOT COMPLETED|Overall Study||11||
59657823|NCT03721016|75776309|FG000|STARTED|Overall Study||82||
59657824|NCT03721016|75776310|FG001|STARTED|Overall Study||173||
59657825|NCT03721016|75776311|FG002|STARTED|Overall Study||160||
59657826|NCT03721016|75776309|FG000|COMPLETED|Overall Study||66||
59657827|NCT03721016|75776310|FG001|COMPLETED|Overall Study||141||
59657828|NCT03721016|75776311|FG002|COMPLETED|Overall Study||133||
59657829|NCT03721016|75776309|FG000|NOT COMPLETED|Overall Study||16||
59657830|NCT03721016|75776310|FG001|NOT COMPLETED|Overall Study||32||
59657831|NCT03721016|75776311|FG002|NOT COMPLETED|Overall Study||27||
59657832|NCT03434275|75776321|FG000|STARTED|Overall Study||98||
59657833|NCT03434275|75776322|FG001|STARTED|Overall Study||96||
59657834|NCT03434275|75776321|FG000|Treated|Overall Study||93||
59657835|NCT03434275|75776322|FG001|Treated|Overall Study||88||
59657836|NCT03434275|75776321|FG000|COMPLETED|Overall Study||93||
59657837|NCT03434275|75776322|FG001|COMPLETED|Overall Study||88||
59657838|NCT03434275|75776321|FG000|NOT COMPLETED|Overall Study||5||
59657839|NCT03434275|75776322|FG001|NOT COMPLETED|Overall Study||8||
59657840|NCT03348423|75776331|FG000|STARTED|Overall Study||15||
59657841|NCT03348423|75776332|FG001|STARTED|Overall Study||15||
59657842|NCT03348423|75776333|FG002|STARTED|Overall Study||15||
59657843|NCT03348423|75776331|FG000|COMPLETED|Overall Study||15||
59657844|NCT03348423|75776332|FG001|COMPLETED|Overall Study||15||
59657845|NCT03348423|75776333|FG002|COMPLETED|Overall Study||15||
59657846|NCT03348423|75776331|FG000|NOT COMPLETED|Overall Study||0||
59657847|NCT03348423|75776332|FG001|NOT COMPLETED|Overall Study||0||
59657848|NCT03348423|75776333|FG002|NOT COMPLETED|Overall Study||0||
59657849|NCT03117998|75776347|FG000|STARTED|Overall Study||25||
59657850|NCT03117998|75776348|FG001|STARTED|Overall Study||25||
59657851|NCT03117998|75776349|FG002|STARTED|Overall Study||25||
59657852|NCT03117998|75776350|FG003|STARTED|Overall Study||26||
59657853|NCT03117998|75776351|FG004|STARTED|Overall Study||26||
59657854|NCT03117998|75776352|FG005|STARTED|Overall Study||27||
59657855|NCT03117998|75776347|FG000|COMPLETED|Overall Study||24||
59657856|NCT03117998|75776348|FG001|COMPLETED|Overall Study||24||
59657857|NCT03117998|75776349|FG002|COMPLETED|Overall Study||21||
59657858|NCT03117998|75776350|FG003|COMPLETED|Overall Study||22||
59657859|NCT03117998|75776351|FG004|COMPLETED|Overall Study||19||
59657860|NCT03117998|75776352|FG005|COMPLETED|Overall Study||24||
59657861|NCT03117998|75776347|FG000|NOT COMPLETED|Overall Study||1||
59657862|NCT03117998|75776348|FG001|NOT COMPLETED|Overall Study||1||
59657863|NCT03117998|75776349|FG002|NOT COMPLETED|Overall Study||4||
59657864|NCT03117998|75776350|FG003|NOT COMPLETED|Overall Study||4||
59657865|NCT03117998|75776351|FG004|NOT COMPLETED|Overall Study||7||
59657866|NCT03117998|75776352|FG005|NOT COMPLETED|Overall Study||3||
59657867|NCT03100370|75776377|FG000|STARTED|First Intervention (2 Weeks)||2||
59657868|NCT03100370|75776378|FG001|STARTED|First Intervention (2 Weeks)||1||
59657869|NCT03100370|75776379|FG002|STARTED|First Intervention (2 Weeks)||1||
59657870|NCT03100370|75776380|FG003|STARTED|First Intervention (2 Weeks)||2||
59657871|NCT03100370|75776381|FG004|STARTED|First Intervention (2 Weeks)||2||
59657872|NCT03100370|75776382|FG005|STARTED|First Intervention (2 Weeks)||1||
59657873|NCT03100370|75776377|FG000|COMPLETED|First Intervention (2 Weeks)||2||
59657874|NCT03100370|75776378|FG001|COMPLETED|First Intervention (2 Weeks)||1||
59657875|NCT03100370|75776379|FG002|COMPLETED|First Intervention (2 Weeks)||1||
59657876|NCT03100370|75776380|FG003|COMPLETED|First Intervention (2 Weeks)||1||
59657877|NCT03100370|75776381|FG004|COMPLETED|First Intervention (2 Weeks)||2||
59657878|NCT03100370|75776382|FG005|COMPLETED|First Intervention (2 Weeks)||1||
59657879|NCT03100370|75776377|FG000|NOT COMPLETED|First Intervention (2 Weeks)||0||
59657880|NCT03100370|75776378|FG001|NOT COMPLETED|First Intervention (2 Weeks)||0||
59657881|NCT03100370|75776379|FG002|NOT COMPLETED|First Intervention (2 Weeks)||0||
59657882|NCT03100370|75776380|FG003|NOT COMPLETED|First Intervention (2 Weeks)||1||
59657883|NCT03100370|75776381|FG004|NOT COMPLETED|First Intervention (2 Weeks)||0||
59657884|NCT03100370|75776382|FG005|NOT COMPLETED|First Intervention (2 Weeks)||0||
59657885|NCT03100370|75776377|FG000|STARTED|Washout (30 Days)||2||
59657886|NCT03100370|75776378|FG001|STARTED|Washout (30 Days)||1||
59657887|NCT03100370|75776379|FG002|STARTED|Washout (30 Days)||1||
59657888|NCT03100370|75776380|FG003|STARTED|Washout (30 Days)||1||
59657889|NCT03100370|75776381|FG004|STARTED|Washout (30 Days)||2||
59657890|NCT03100370|75776382|FG005|STARTED|Washout (30 Days)||1||
59657891|NCT03100370|75776377|FG000|COMPLETED|Washout (30 Days)||2||
59657892|NCT03100370|75776378|FG001|COMPLETED|Washout (30 Days)||1||
59657893|NCT03100370|75776379|FG002|COMPLETED|Washout (30 Days)||1||
59657894|NCT03100370|75776380|FG003|COMPLETED|Washout (30 Days)||1||
59657895|NCT03100370|75776381|FG004|COMPLETED|Washout (30 Days)||2||
59657896|NCT03100370|75776382|FG005|COMPLETED|Washout (30 Days)||1||
59657897|NCT03100370|75776377|FG000|NOT COMPLETED|Washout (30 Days)||0||
59657898|NCT03100370|75776378|FG001|NOT COMPLETED|Washout (30 Days)||0||
59657899|NCT03100370|75776379|FG002|NOT COMPLETED|Washout (30 Days)||0||
59657900|NCT03100370|75776380|FG003|NOT COMPLETED|Washout (30 Days)||0||
59657901|NCT03100370|75776381|FG004|NOT COMPLETED|Washout (30 Days)||0||
59657902|NCT03100370|75776382|FG005|NOT COMPLETED|Washout (30 Days)||0||
59657903|NCT03100370|75776377|FG000|STARTED|Second Intervention (2 Weeks)||2||
59657904|NCT03100370|75776378|FG001|STARTED|Second Intervention (2 Weeks)||1||
59657905|NCT03100370|75776379|FG002|STARTED|Second Intervention (2 Weeks)||0||
59657906|NCT03100370|75776380|FG003|STARTED|Second Intervention (2 Weeks)||1||
59657907|NCT03100370|75776381|FG004|STARTED|Second Intervention (2 Weeks)||2||
59657908|NCT03100370|75776382|FG005|STARTED|Second Intervention (2 Weeks)||1||
59657909|NCT03100370|75776377|FG000|COMPLETED|Second Intervention (2 Weeks)||2||
59657910|NCT03100370|75776378|FG001|COMPLETED|Second Intervention (2 Weeks)||1||
59657911|NCT03100370|75776379|FG002|COMPLETED|Second Intervention (2 Weeks)||0||
59657912|NCT03100370|75776380|FG003|COMPLETED|Second Intervention (2 Weeks)||1||
59657913|NCT03100370|75776381|FG004|COMPLETED|Second Intervention (2 Weeks)||2||
59657914|NCT03100370|75776382|FG005|COMPLETED|Second Intervention (2 Weeks)||1||
59657915|NCT03100370|75776377|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||0||
59657916|NCT03100370|75776378|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||0||
59657917|NCT03100370|75776379|FG002|NOT COMPLETED|Second Intervention (2 Weeks)||0||
60077100|NCT01923181|76192144|FG004|STARTED|Overall Study||71||
60077101|NCT01923181|76192145|FG005|STARTED|Overall Study||70||
59657918|NCT03100370|75776380|FG003|NOT COMPLETED|Second Intervention (2 Weeks)||0||
59657919|NCT03100370|75776381|FG004|NOT COMPLETED|Second Intervention (2 Weeks)||0||
59657920|NCT03100370|75776382|FG005|NOT COMPLETED|Second Intervention (2 Weeks)||0||
59657921|NCT03100370|75776377|FG000|STARTED|Washout (30 Days)||2||
59657922|NCT03100370|75776378|FG001|STARTED|Washout (30 Days)||1||
59657923|NCT03100370|75776379|FG002|STARTED|Washout (30 Days)||0||
59657924|NCT03100370|75776380|FG003|STARTED|Washout (30 Days)||1||
59657925|NCT03100370|75776381|FG004|STARTED|Washout (30 Days)||2||
59657926|NCT03100370|75776382|FG005|STARTED|Washout (30 Days)||1||
59657927|NCT03100370|75776377|FG000|COMPLETED|Washout (30 Days)||2||
59657928|NCT03100370|75776378|FG001|COMPLETED|Washout (30 Days)||1||
59657929|NCT03100370|75776379|FG002|COMPLETED|Washout (30 Days)||0||
60077102|NCT01923181|76192146|FG006|STARTED|Overall Study||70||
60077103|NCT01923181|76192147|FG007|STARTED|Overall Study||69||
59657930|NCT03100370|75776380|FG003|COMPLETED|Washout (30 Days)||1||
59657931|NCT03100370|75776381|FG004|COMPLETED|Washout (30 Days)||2||
59657932|NCT03100370|75776382|FG005|COMPLETED|Washout (30 Days)||1||
59657933|NCT03100370|75776377|FG000|NOT COMPLETED|Washout (30 Days)||0||
59657934|NCT03100370|75776378|FG001|NOT COMPLETED|Washout (30 Days)||0||
59657935|NCT03100370|75776379|FG002|NOT COMPLETED|Washout (30 Days)||0||
59657936|NCT03100370|75776380|FG003|NOT COMPLETED|Washout (30 Days)||0||
59657937|NCT03100370|75776381|FG004|NOT COMPLETED|Washout (30 Days)||0||
59657938|NCT03100370|75776382|FG005|NOT COMPLETED|Washout (30 Days)||0||
59657939|NCT03100370|75776377|FG000|STARTED|Third Intervention (2 Weeks)||2||
59657940|NCT03100370|75776378|FG001|STARTED|Third Intervention (2 Weeks)||0||
59657941|NCT03100370|75776379|FG002|STARTED|Third Intervention (2 Weeks)||0||
59657942|NCT03100370|75776380|FG003|STARTED|Third Intervention (2 Weeks)||1||
59657943|NCT03100370|75776381|FG004|STARTED|Third Intervention (2 Weeks)||2||
59657944|NCT03100370|75776382|FG005|STARTED|Third Intervention (2 Weeks)||1||
59657945|NCT03100370|75776377|FG000|COMPLETED|Third Intervention (2 Weeks)||2||
59657946|NCT03100370|75776378|FG001|COMPLETED|Third Intervention (2 Weeks)||0||
59657947|NCT03100370|75776379|FG002|COMPLETED|Third Intervention (2 Weeks)||0||
59657948|NCT03100370|75776380|FG003|COMPLETED|Third Intervention (2 Weeks)||1||
59657949|NCT03100370|75776381|FG004|COMPLETED|Third Intervention (2 Weeks)||2||
59657950|NCT03100370|75776382|FG005|COMPLETED|Third Intervention (2 Weeks)||1||
59657951|NCT03100370|75776377|FG000|NOT COMPLETED|Third Intervention (2 Weeks)||0||
59657952|NCT03100370|75776378|FG001|NOT COMPLETED|Third Intervention (2 Weeks)||0||
59657953|NCT03100370|75776379|FG002|NOT COMPLETED|Third Intervention (2 Weeks)||0||
59657954|NCT03100370|75776380|FG003|NOT COMPLETED|Third Intervention (2 Weeks)||0||
59657955|NCT03100370|75776381|FG004|NOT COMPLETED|Third Intervention (2 Weeks)||0||
59657956|NCT03100370|75776382|FG005|NOT COMPLETED|Third Intervention (2 Weeks)||0||
59657957|NCT03100370|75776377|FG000|STARTED|Washout (30 Days)||2||
59657958|NCT03100370|75776378|FG001|STARTED|Washout (30 Days)||0||
59657959|NCT03100370|75776379|FG002|STARTED|Washout (30 Days)||0||
59657960|NCT03100370|75776380|FG003|STARTED|Washout (30 Days)||1||
59657961|NCT03100370|75776381|FG004|STARTED|Washout (30 Days)||2||
59657962|NCT03100370|75776382|FG005|STARTED|Washout (30 Days)||1||
59657963|NCT03100370|75776377|FG000|COMPLETED|Washout (30 Days)||2||
59657964|NCT03100370|75776378|FG001|COMPLETED|Washout (30 Days)||0||
59657965|NCT03100370|75776379|FG002|COMPLETED|Washout (30 Days)||0||
59657966|NCT03100370|75776380|FG003|COMPLETED|Washout (30 Days)||1||
59657967|NCT03100370|75776381|FG004|COMPLETED|Washout (30 Days)||2||
59657968|NCT03100370|75776382|FG005|COMPLETED|Washout (30 Days)||1||
59657969|NCT03100370|75776377|FG000|NOT COMPLETED|Washout (30 Days)||0||
59657970|NCT03100370|75776378|FG001|NOT COMPLETED|Washout (30 Days)||0||
59657971|NCT03100370|75776379|FG002|NOT COMPLETED|Washout (30 Days)||0||
59657972|NCT03100370|75776380|FG003|NOT COMPLETED|Washout (30 Days)||0||
59657973|NCT03100370|75776381|FG004|NOT COMPLETED|Washout (30 Days)||0||
59657974|NCT03100370|75776382|FG005|NOT COMPLETED|Washout (30 Days)||0||
59657975|NCT02920008|75776392|FG000|STARTED|Overall Study|Started = Participants who were randomized|148||
59657976|NCT02920008|75776393|FG001|STARTED|Overall Study||154||
59657977|NCT02920008|75776392|FG000|Safety Analysis Set|Overall Study||145|Safety analysis set included data from all participants randomly assigned to study treatment who received any amount of study treatment or any component of a multi-dose study treatment regimen.|
59657978|NCT02920008|75776393|FG001|Safety Analysis Set|Overall Study||147|Safety analysis set included data from all participants randomly assigned to study treatment who received any amount of study treatment or any component of a multi-dose study treatment regimen.|
59657979|NCT02920008|75776392|FG000|COMPLETED|Overall Study||28||
59657980|NCT02920008|75776393|FG001|COMPLETED|Overall Study||20||
59657981|NCT02920008|75776392|FG000|NOT COMPLETED|Overall Study||120||
59657982|NCT02920008|75776393|FG001|NOT COMPLETED|Overall Study||134||
59657983|NCT02766335|75776401|FG000|STARTED|Initial Registration||68||
59657984|NCT02766335|75776402|FG001|STARTED|Initial Registration||30||
59657985|NCT02766335|75776403|FG002|STARTED|Initial Registration||0||
59657986|NCT02766335|75776401|FG000|Eligible Participants Enrolled Before Docetaxel Arm Closed|Initial Registration||32||
59815805|NCT03026283|75938215|FG004|COMPLETED|Optimal Care/Stress Test/ICA||14|Participants who followed recommendation provided after consultation with referring physician.|
59657987|NCT02766335|75776402|FG001|Eligible Participants Enrolled Before Docetaxel Arm Closed|Initial Registration||30||
59657988|NCT02766335|75776403|FG002|Eligible Participants Enrolled Before Docetaxel Arm Closed|Initial Registration||0||
59657989|NCT02766335|75776401|FG000|COMPLETED|Initial Registration||10||
59657990|NCT02766335|75776402|FG001|COMPLETED|Initial Registration||0||
59657991|NCT02766335|75776403|FG002|COMPLETED|Initial Registration||0||
59657992|NCT02766335|75776401|FG000|NOT COMPLETED|Initial Registration||58||
59657993|NCT02766335|75776402|FG001|NOT COMPLETED|Initial Registration||30||
59657994|NCT02766335|75776403|FG002|NOT COMPLETED|Initial Registration||0||
59657995|NCT02766335|75776401|FG000|STARTED|Re-registration of Arm I to MEDI4738||0||
59657996|NCT02766335|75776402|FG001|STARTED|Re-registration of Arm I to MEDI4738||0||
59657997|NCT02766335|75776403|FG002|STARTED|Re-registration of Arm I to MEDI4738||4||
59657998|NCT02766335|75776401|FG000|COMPLETED|Re-registration of Arm I to MEDI4738||0||
59657999|NCT02766335|75776402|FG001|COMPLETED|Re-registration of Arm I to MEDI4738||0||
59658000|NCT02766335|75776403|FG002|COMPLETED|Re-registration of Arm I to MEDI4738||2||
59658001|NCT02766335|75776401|FG000|NOT COMPLETED|Re-registration of Arm I to MEDI4738||0||
59658002|NCT02766335|75776402|FG001|NOT COMPLETED|Re-registration of Arm I to MEDI4738||0||
59658003|NCT02766335|75776403|FG002|NOT COMPLETED|Re-registration of Arm I to MEDI4738||2||
59658004|NCT02577523|75776411|FG000|STARTED|Overall Study||19||
59658005|NCT02577523|75776412|FG001|STARTED|Overall Study||19||
59658006|NCT02577523|75776411|FG000|COMPLETED|Overall Study||16||
59658007|NCT02577523|75776412|FG001|COMPLETED|Overall Study||17||
59658008|NCT02577523|75776411|FG000|NOT COMPLETED|Overall Study||3||
59658009|NCT02577523|75776412|FG001|NOT COMPLETED|Overall Study||2||
59658010|NCT02499328|75776437|FG000|STARTED|Overall Study||4||
59658011|NCT02499328|75776438|FG001|STARTED|Overall Study||7||
59658012|NCT02499328|75776439|FG002|STARTED|Overall Study||10||
59658013|NCT02499328|75776440|FG003|STARTED|Overall Study||11||
59658014|NCT02499328|75776441|FG004|STARTED|Overall Study||15||
59658015|NCT02499328|75776442|FG005|STARTED|Overall Study||9||
59658016|NCT02499328|75776443|FG006|STARTED|Overall Study||7||
59658017|NCT02499328|75776444|FG007|STARTED|Overall Study||6||
59658018|NCT02499328|75776445|FG008|STARTED|Overall Study||14||
59658019|NCT02499328|75776446|FG009|STARTED|Overall Study||24||
59658020|NCT02499328|75776447|FG010|STARTED|Overall Study||20||
59658021|NCT02499328|75776448|FG011|STARTED|Overall Study||54||
59658022|NCT02499328|75776449|FG012|STARTED|Overall Study||25||
59658023|NCT02499328|75776450|FG013|STARTED|Overall Study||17||
59658024|NCT02499328|75776451|FG014|STARTED|Overall Study||10||
59658025|NCT02499328|75776452|FG015|STARTED|Overall Study||1||
59658026|NCT02499328|75776453|FG016|STARTED|Overall Study||1||
59658027|NCT02499328|75776454|FG017|STARTED|Overall Study||55||
59658028|NCT02499328|75776455|FG018|STARTED|Overall Study||50||
59658029|NCT02499328|75776437|FG000|COMPLETED|Overall Study||0||
59658030|NCT02499328|75776438|FG001|COMPLETED|Overall Study||0||
59658031|NCT02499328|75776439|FG002|COMPLETED|Overall Study||0||
59658032|NCT02499328|75776440|FG003|COMPLETED|Overall Study||0||
59658033|NCT02499328|75776441|FG004|COMPLETED|Overall Study||0||
59658034|NCT02499328|75776442|FG005|COMPLETED|Overall Study||0||
59658035|NCT02499328|75776443|FG006|COMPLETED|Overall Study||0||
59658036|NCT02499328|75776444|FG007|COMPLETED|Overall Study||0||
59658037|NCT02499328|75776445|FG008|COMPLETED|Overall Study||0||
59658038|NCT02499328|75776446|FG009|COMPLETED|Overall Study||0||
59658039|NCT02499328|75776447|FG010|COMPLETED|Overall Study||0||
59658040|NCT02499328|75776448|FG011|COMPLETED|Overall Study||0||
59658041|NCT02499328|75776449|FG012|COMPLETED|Overall Study||0||
59658042|NCT02499328|75776450|FG013|COMPLETED|Overall Study||0||
59658043|NCT02499328|75776451|FG014|COMPLETED|Overall Study||0||
59658044|NCT02499328|75776452|FG015|COMPLETED|Overall Study||0||
59658045|NCT02499328|75776453|FG016|COMPLETED|Overall Study||0||
59658046|NCT02499328|75776454|FG017|COMPLETED|Overall Study||0||
59658047|NCT02499328|75776455|FG018|COMPLETED|Overall Study||1||
59658048|NCT02499328|75776437|FG000|NOT COMPLETED|Overall Study||4||
59658049|NCT02499328|75776438|FG001|NOT COMPLETED|Overall Study||7||
59658050|NCT02499328|75776439|FG002|NOT COMPLETED|Overall Study||10||
59658051|NCT02499328|75776440|FG003|NOT COMPLETED|Overall Study||11||
60077104|NCT01923181|76192148|FG008|STARTED|Overall Study||71||
60077105|NCT01923181|76192140|FG000|Full Analysis Set (FAS)|Overall Study||70||
60077106|NCT01923181|76192141|FG001|Full Analysis Set (FAS)|Overall Study||70||
60077107|NCT01923181|76192142|FG002|Full Analysis Set (FAS)|Overall Study||69||
60077108|NCT01923181|76192143|FG003|Full Analysis Set (FAS)|Overall Study||70||
60077109|NCT01923181|76192144|FG004|Full Analysis Set (FAS)|Overall Study||71||
60077110|NCT01923181|76192145|FG005|Full Analysis Set (FAS)|Overall Study||70||
59658052|NCT02499328|75776441|FG004|NOT COMPLETED|Overall Study||15||
59658053|NCT02499328|75776442|FG005|NOT COMPLETED|Overall Study||9||
59658054|NCT02499328|75776443|FG006|NOT COMPLETED|Overall Study||7||
59658055|NCT02499328|75776444|FG007|NOT COMPLETED|Overall Study||6||
59658056|NCT02499328|75776445|FG008|NOT COMPLETED|Overall Study||14||
60077111|NCT01923181|76192146|FG006|Full Analysis Set (FAS)|Overall Study||70||
60077112|NCT01923181|76192147|FG007|Full Analysis Set (FAS)|Overall Study||69||
60077113|NCT01923181|76192148|FG008|Full Analysis Set (FAS)|Overall Study||71||
60077114|NCT01923181|76192140|FG000|Safety Analysis Set (SAS)|Overall Study||70||
60077115|NCT01923181|76192141|FG001|Safety Analysis Set (SAS)|Overall Study||70||
59658057|NCT02499328|75776446|FG009|NOT COMPLETED|Overall Study||24||
59658058|NCT02499328|75776447|FG010|NOT COMPLETED|Overall Study||20||
59658059|NCT02499328|75776448|FG011|NOT COMPLETED|Overall Study||54||
59658060|NCT02499328|75776449|FG012|NOT COMPLETED|Overall Study||25||
59658061|NCT02499328|75776450|FG013|NOT COMPLETED|Overall Study||17||
59658062|NCT02499328|75776451|FG014|NOT COMPLETED|Overall Study||10||
59658063|NCT02499328|75776452|FG015|NOT COMPLETED|Overall Study||1||
59658064|NCT02499328|75776453|FG016|NOT COMPLETED|Overall Study||1||
59658065|NCT02499328|75776454|FG017|NOT COMPLETED|Overall Study||55||
59658066|NCT02499328|75776455|FG018|NOT COMPLETED|Overall Study||49||
59658067|NCT02278185|75776540|FG000|STARTED|Overall Study||10||
59658068|NCT02278185|75776541|FG001|STARTED|Overall Study||9||
59658069|NCT02278185|75776540|FG000|COMPLETED|Overall Study||7||
59658070|NCT02278185|75776541|FG001|COMPLETED|Overall Study||7||
59658071|NCT02278185|75776540|FG000|NOT COMPLETED|Overall Study||3||
59658072|NCT02278185|75776541|FG001|NOT COMPLETED|Overall Study||2||
59658073|NCT02177695|75776551|FG000|STARTED|ITT Analysis||120||
59658074|NCT02177695|75776552|FG001|STARTED|ITT Analysis||117||
59658075|NCT02177695|75776551|FG000|COMPLETED|ITT Analysis||115||
59658076|NCT02177695|75776552|FG001|COMPLETED|ITT Analysis||112||
59658077|NCT02177695|75776551|FG000|NOT COMPLETED|ITT Analysis||5||
59658078|NCT02177695|75776552|FG001|NOT COMPLETED|ITT Analysis||5||
59658079|NCT02177695|75776551|FG000|STARTED|Primary COXEN Analysis||115||
59658080|NCT02177695|75776552|FG001|STARTED|Primary COXEN Analysis||112||
59658081|NCT02177695|75776551|FG000|Participants Excluded From Primary COXEN Analysis|Primary COXEN Analysis||33||
59658082|NCT02177695|75776552|FG001|Participants Excluded From Primary COXEN Analysis|Primary COXEN Analysis||27||
59658083|NCT02177695|75776551|FG000|COMPLETED|Primary COXEN Analysis||82||
59658084|NCT02177695|75776552|FG001|COMPLETED|Primary COXEN Analysis||85||
59658085|NCT02177695|75776551|FG000|NOT COMPLETED|Primary COXEN Analysis||33||
59658086|NCT02177695|75776552|FG001|NOT COMPLETED|Primary COXEN Analysis||27||
59658087|NCT02005172|75776560|FG000|STARTED|Overall Study||33||
59658088|NCT02005172|75776560|FG000|ITT|Overall Study||38|This group includes the patients who met the inclusion criteria and were enrolled into the study but did not complete the study|
59658089|NCT02005172|75776560|FG000|COMPLETED|Overall Study||33||
59658090|NCT02005172|75776560|FG000|NOT COMPLETED|Overall Study||0||
59658091|NCT01719237|75776567|FG000|STARTED|Overall Study||30||
59658092|NCT01719237|75776568|FG001|STARTED|Overall Study||30||
59658093|NCT01719237|75776567|FG000|COMPLETED|Overall Study||30||
59658094|NCT01719237|75776568|FG001|COMPLETED|Overall Study||29||
59658095|NCT01719237|75776567|FG000|NOT COMPLETED|Overall Study||0||
59658096|NCT01719237|75776568|FG001|NOT COMPLETED|Overall Study||1||
59658097|NCT00391365|75776576|FG000|STARTED|Overall Study||103||
59658098|NCT00391365|75776577|FG001|STARTED|Overall Study||170||
59658099|NCT00391365|75776576|FG000|COMPLETED|Overall Study||78||
59658100|NCT00391365|75776577|FG001|COMPLETED|Overall Study||151||
59658101|NCT00391365|75776576|FG000|NOT COMPLETED|Overall Study||25||
59658102|NCT00391365|75776577|FG001|NOT COMPLETED|Overall Study||19||
59658103|NCT01956669|75776591|FG000|STARTED|Overall Study||12|All enrolled subjects who took 1 dose of medication included in mITT and Safety Sets|
59658104|NCT01956669|75776592|FG001|STARTED|Overall Study||11|All enrolled subjects who took 1 dose of medication included in mITT and Safety Sets|
59658105|NCT01956669|75776593|FG002|STARTED|Overall Study||10|All enrolled subjects who took 1 dose of medication included in mITT and Safety Sets|
59658106|NCT01956669|75776594|FG003|STARTED|Overall Study||10|All enrolled subjects who took 1 dose of medication included in mITT and Safety Sets|
59658107|NCT01956669|75776595|FG004|STARTED|Overall Study||4|All enrolled subjects who took 1 dose of medication included in mITT and Safety Sets|
59658108|NCT01956669|75776596|FG005|STARTED|Overall Study||4|All enrolled subjects who took 1 dose of medication included in mITT and Safety Sets|
59658109|NCT01956669|75776597|FG006|STARTED|Overall Study||6|All enrolled subjects who took 1 dose of medication included in mITT and Safety Sets|
59658110|NCT01956669|75776591|FG000|PK Set|Overall Study||11|All mITT subjects who had at least 1 PK sample analyzed|
59658111|NCT01956669|75776592|FG001|PK Set|Overall Study||11|All mITT subjects who had at least 1 PK sample analyzed|
59658112|NCT01956669|75776593|FG002|PK Set|Overall Study||10|All mITT subjects who had at least 1 PK sample analyzed|
59658113|NCT01956669|75776594|FG003|PK Set|Overall Study||10|All mITT subjects who had at least 1 PK sample analyzed|
59658114|NCT01956669|75776595|FG004|PK Set|Overall Study||4|All mITT subjects who had at least 1 PK sample analyzed|
59658115|NCT01956669|75776596|FG005|PK Set|Overall Study||4|All mITT subjects who had at least 1 PK sample analyzed|
59658116|NCT01956669|75776597|FG006|PK Set|Overall Study||6|All mITT subjects who had at least 1 PK sample analyzed|
59658117|NCT01956669|75776591|FG000|PKES Set|Overall Study||4|PK subset (received powder suspension and had at least 1 non-predose extended PK sampling)|
59658118|NCT01956669|75776592|FG001|PKES Set|Overall Study||0|PK subset (received powder suspension and had at least 1 non-predose extended PK sampling)|
59658119|NCT01956669|75776593|FG002|PKES Set|Overall Study||3|PK subset (received powder suspension and had at least 1 non-predose extended PK sampling)|
59658120|NCT01956669|75776594|FG003|PKES Set|Overall Study||0|PK subset (received powder suspension and had at least 1 non-predose extended PK sampling)|
59658121|NCT01956669|75776595|FG004|PKES Set|Overall Study||1|PK subset (received powder suspension and had at least 1 non-predose extended PK sampling)|
59815806|NCT03026283|75938216|FG005|COMPLETED|Optimal Care/Stress Test/ICA||73|Participants who followed recommendation provided after consultation with referring physician.|
59988861|NCT04231318|76104114|FG000|STARTED|Overall Study||99||
59658122|NCT01956669|75776596|FG005|PKES Set|Overall Study||1|PK subset (received powder suspension and had at least 1 non-predose extended PK sampling)|
59658123|NCT01956669|75776597|FG006|PKES Set|Overall Study||5|PK subset (received powder suspension and had at least 1 non-predose extended PK sampling)|
59988862|NCT04231318|76104115|FG001|STARTED|Overall Study||99||
59658124|NCT01956669|75776591|FG000|Biomarker Set|Overall Study||12|All mITT subjects who had valid biomarker samples analyzed|
59658125|NCT01956669|75776592|FG001|Biomarker Set|Overall Study||11|All mITT subjects who had valid biomarker samples analyzed|
59658126|NCT01956669|75776593|FG002|Biomarker Set|Overall Study||9|All mITT subjects who had valid biomarker samples analyzed|
59658127|NCT01956669|75776594|FG003|Biomarker Set|Overall Study||9|All mITT subjects who had valid biomarker samples analyzed|
59709749|NCT01072149|75828533|FG013|COMPLETED|Treatment Period 1 (28 Days)||3||
59658128|NCT01956669|75776595|FG004|Biomarker Set|Overall Study||3|All mITT subjects who had valid biomarker samples analyzed|
59658129|NCT01956669|75776596|FG005|Biomarker Set|Overall Study||4|All mITT subjects who had valid biomarker samples analyzed|
59658130|NCT01956669|75776597|FG006|Biomarker Set|Overall Study||3|All mITT subjects who had valid biomarker samples analyzed|
59658131|NCT01956669|75776591|FG000|Per Protocol Set (PP Set)|Overall Study||9||
59658132|NCT01956669|75776592|FG001|Per Protocol Set (PP Set)|Overall Study||10||
59658133|NCT01956669|75776593|FG002|Per Protocol Set (PP Set)|Overall Study||6||
59658134|NCT01956669|75776594|FG003|Per Protocol Set (PP Set)|Overall Study||9||
59658135|NCT01956669|75776595|FG004|Per Protocol Set (PP Set)|Overall Study||4||
59658136|NCT01956669|75776596|FG005|Per Protocol Set (PP Set)|Overall Study||4||
59658137|NCT01956669|75776597|FG006|Per Protocol Set (PP Set)|Overall Study||5||
59658138|NCT01956669|75776591|FG000|COMPLETED|Overall Study||0||
59658139|NCT01956669|75776592|FG001|COMPLETED|Overall Study||0||
59658140|NCT01956669|75776593|FG002|COMPLETED|Overall Study||0||
59658141|NCT01956669|75776594|FG003|COMPLETED|Overall Study||0||
59658142|NCT01956669|75776595|FG004|COMPLETED|Overall Study||0||
59658143|NCT01956669|75776596|FG005|COMPLETED|Overall Study||0||
59658144|NCT01956669|75776597|FG006|COMPLETED|Overall Study||0||
59658145|NCT01956669|75776591|FG000|NOT COMPLETED|Overall Study||12||
59658146|NCT01956669|75776592|FG001|NOT COMPLETED|Overall Study||11||
59658147|NCT01956669|75776593|FG002|NOT COMPLETED|Overall Study||10||
59658148|NCT01956669|75776594|FG003|NOT COMPLETED|Overall Study||10||
59658149|NCT01956669|75776595|FG004|NOT COMPLETED|Overall Study||4||
59658150|NCT01956669|75776596|FG005|NOT COMPLETED|Overall Study||4||
59658151|NCT01956669|75776597|FG006|NOT COMPLETED|Overall Study||6||
59658152|NCT01958580|75776622|FG000|STARTED|Overall Study||3||
59658153|NCT01958580|75776622|FG000|COMPLETED|Overall Study||3||
59658154|NCT01958580|75776622|FG000|NOT COMPLETED|Overall Study||0||
59658155|NCT01967823|75776626|FG000|STARTED|Overall Study||11||
59658156|NCT01967823|75776626|FG000|COMPLETED|Overall Study||10||
59658157|NCT01967823|75776626|FG000|NOT COMPLETED|Overall Study||1||
59658158|NCT01982760|75776636|FG000|STARTED|Overall Study||14||
59658159|NCT01982760|75776637|FG001|STARTED|Overall Study||0||
59658160|NCT01982760|75776636|FG000|COMPLETED|Overall Study||13||
59658161|NCT01982760|75776637|FG001|COMPLETED|Overall Study||0||
59658162|NCT01982760|75776636|FG000|NOT COMPLETED|Overall Study||1||
59658163|NCT01982760|75776637|FG001|NOT COMPLETED|Overall Study||0||
59658164|NCT01985022|75776645|FG000|STARTED|Overall Study||16||
59658165|NCT01985022|75776646|FG001|STARTED|Overall Study||17||
59658166|NCT01985022|75776645|FG000|COMPLETED|Overall Study||12||
59658167|NCT01985022|75776646|FG001|COMPLETED|Overall Study||14||
59658168|NCT01985022|75776645|FG000|NOT COMPLETED|Overall Study||4||
59658169|NCT01985022|75776646|FG001|NOT COMPLETED|Overall Study||3||
59658170|NCT01989676|75776654|FG000|STARTED|Overall Study||352||
59658171|NCT01989676|75776655|FG001|STARTED|Overall Study||355||
59658172|NCT01989676|75776654|FG000|Treated|Overall Study||349||
59658173|NCT01989676|75776655|FG001|Treated|Overall Study||353||
59658174|NCT01989676|75776654|FG000|COMPLETED|Overall Study||234||
59658175|NCT01989676|75776655|FG001|COMPLETED|Overall Study||217||
59658176|NCT01989676|75776654|FG000|NOT COMPLETED|Overall Study||118||
59658177|NCT01989676|75776655|FG001|NOT COMPLETED|Overall Study||138||
59658178|NCT02001974|75776665|FG000|STARTED|Run-in Period||4||
59658179|NCT02001974|75776666|FG001|STARTED|Run-in Period||3||
59658180|NCT02001974|75776667|FG002|STARTED|Run-in Period||26||
59658181|NCT02001974|75776665|FG000|COMPLETED|Run-in Period||4||
59658182|NCT02001974|75776666|FG001|COMPLETED|Run-in Period||3||
59658183|NCT02001974|75776667|FG002|COMPLETED|Run-in Period||26||
59658184|NCT02001974|75776665|FG000|NOT COMPLETED|Run-in Period||0||
59658185|NCT02001974|75776666|FG001|NOT COMPLETED|Run-in Period||0||
59658186|NCT02001974|75776667|FG002|NOT COMPLETED|Run-in Period||0||
59658187|NCT02001974|75776665|FG000|STARTED|Reparixin + Paclitaxel (28-day Cycles)||4||
59658188|NCT02001974|75776666|FG001|STARTED|Reparixin + Paclitaxel (28-day Cycles)||3||
59658189|NCT02001974|75776667|FG002|STARTED|Reparixin + Paclitaxel (28-day Cycles)||26||
59658190|NCT02001974|75776665|FG000|COMPLETED|Reparixin + Paclitaxel (28-day Cycles)||0||
59988863|NCT04231318|76104116|FG002|STARTED|Overall Study||33||
59988864|NCT04231318|76104114|FG000|COMPLETED|Overall Study||99||
59658191|NCT02001974|75776666|FG001|COMPLETED|Reparixin + Paclitaxel (28-day Cycles)||0||
59658192|NCT02001974|75776667|FG002|COMPLETED|Reparixin + Paclitaxel (28-day Cycles)||0||
59658193|NCT02001974|75776665|FG000|NOT COMPLETED|Reparixin + Paclitaxel (28-day Cycles)||4||
59658194|NCT02001974|75776666|FG001|NOT COMPLETED|Reparixin + Paclitaxel (28-day Cycles)||3||
59658195|NCT02001974|75776667|FG002|NOT COMPLETED|Reparixin + Paclitaxel (28-day Cycles)||26||
59658196|NCT05818527|75776677|FG000|STARTED|Overall Study||16||
59658197|NCT05818527|75776678|FG001|STARTED|Overall Study||16||
59658198|NCT05818527|75776677|FG000|COMPLETED|Overall Study||16||
59658199|NCT05818527|75776678|FG001|COMPLETED|Overall Study||16||
59658200|NCT05818527|75776677|FG000|NOT COMPLETED|Overall Study||0||
59658201|NCT05818527|75776678|FG001|NOT COMPLETED|Overall Study||0||
59658202|NCT05319899|75776690|FG000|STARTED|Overall Study||3||
59658203|NCT05319899|75776691|FG001|STARTED|Overall Study||3||
59658204|NCT05319899|75776692|FG002|STARTED|Overall Study||3||
59658205|NCT05319899|75776693|FG003|STARTED|Overall Study||3||
59658206|NCT05319899|75776694|FG004|STARTED|Overall Study||3||
59658207|NCT05319899|75776695|FG005|STARTED|Overall Study||3||
59658208|NCT05319899|75776690|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3||
59658209|NCT05319899|75776691|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3||
59658210|NCT05319899|75776692|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3||
59658211|NCT05319899|75776693|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3||
59658212|NCT05319899|75776694|FG004|Received at Least 1 Dose of Study Drug|Overall Study||3||
59658213|NCT05319899|75776695|FG005|Received at Least 1 Dose of Study Drug|Overall Study||3||
59658214|NCT05319899|75776690|FG000|COMPLETED|Overall Study||3||
59658215|NCT05319899|75776691|FG001|COMPLETED|Overall Study||3||
59658216|NCT05319899|75776692|FG002|COMPLETED|Overall Study||3||
59658217|NCT05319899|75776693|FG003|COMPLETED|Overall Study||3||
59658218|NCT05319899|75776694|FG004|COMPLETED|Overall Study||3||
59658219|NCT05319899|75776695|FG005|COMPLETED|Overall Study||3||
59658220|NCT05319899|75776690|FG000|NOT COMPLETED|Overall Study||0||
59658221|NCT05319899|75776691|FG001|NOT COMPLETED|Overall Study||0||
59658222|NCT05319899|75776692|FG002|NOT COMPLETED|Overall Study||0||
59658223|NCT05319899|75776693|FG003|NOT COMPLETED|Overall Study||0||
59658224|NCT05319899|75776694|FG004|NOT COMPLETED|Overall Study||0||
59658225|NCT05319899|75776695|FG005|NOT COMPLETED|Overall Study||0||
59658226|NCT05229406|75776705|FG000|STARTED|Overall Study||46||
59658227|NCT05229406|75776706|FG001|STARTED|Overall Study||46||
59658228|NCT05229406|75776705|FG000|COMPLETED|Overall Study||45||
59658229|NCT05229406|75776706|FG001|COMPLETED|Overall Study||44||
59658230|NCT05229406|75776705|FG000|NOT COMPLETED|Overall Study||1||
59658231|NCT05229406|75776706|FG001|NOT COMPLETED|Overall Study||2||
59658232|NCT05005351|75776714|FG000|STARTED|Overall Study||39||
59658233|NCT05005351|75776715|FG001|STARTED|Overall Study||28||
59658234|NCT05005351|75776714|FG000|COMPLETED|Overall Study||37||
59658235|NCT05005351|75776715|FG001|COMPLETED|Overall Study||27||
59658236|NCT05005351|75776714|FG000|NOT COMPLETED|Overall Study||2||
59658237|NCT05005351|75776715|FG001|NOT COMPLETED|Overall Study||1||
59658238|NCT04971187|75776721|FG000|STARTED|Overall Study||3||
59658239|NCT04971187|75776721|FG000|COMPLETED|Overall Study||1||
59658240|NCT04971187|75776721|FG000|NOT COMPLETED|Overall Study||2||
59658241|NCT04771611|75776727|FG000|STARTED|Overall Study||29||
59658242|NCT04771611|75776728|FG001|STARTED|Overall Study||26||
59658243|NCT04771611|75776727|FG000|COMPLETED|Overall Study||29||
59658244|NCT04771611|75776728|FG001|COMPLETED|Overall Study||26||
59658245|NCT04771611|75776727|FG000|NOT COMPLETED|Overall Study||0||
59658246|NCT04771611|75776728|FG001|NOT COMPLETED|Overall Study||0||
59658247|NCT04764604|75776736|FG000|STARTED|Overall Study||16||
59658248|NCT04764604|75776737|FG001|STARTED|Overall Study||14||
59658249|NCT04764604|75776736|FG000|Acapella Choice Task|Overall Study||16||
59658250|NCT04764604|75776737|FG001|Acapella Choice Task|Overall Study||14||
59658251|NCT04764604|75776736|FG000|Tube-in-Water Task|Overall Study||16||
59658252|NCT04764604|75776737|FG001|Tube-in-Water Task|Overall Study||14||
59658253|NCT04764604|75776736|FG000|COMPLETED|Overall Study||16||
59658254|NCT04764604|75776737|FG001|COMPLETED|Overall Study||14||
59658255|NCT04764604|75776736|FG000|NOT COMPLETED|Overall Study||0||
59658256|NCT04764604|75776737|FG001|NOT COMPLETED|Overall Study||0||
59658257|NCT04756154|75776746|FG000|STARTED|Overall Study||135||135
59658258|NCT04756154|75776747|FG001|STARTED|Overall Study||135||135
59658259|NCT04756154|75776748|FG002|STARTED|Overall Study||38||38
59658260|NCT04756154|75776746|FG000|COMPLETED|Overall Study||104||104
59658261|NCT04756154|75776747|FG001|COMPLETED|Overall Study||106||106
59658262|NCT04756154|75776748|FG002|COMPLETED|Overall Study||31||31
59658263|NCT04756154|75776746|FG000|NOT COMPLETED|Overall Study||31||31
59658264|NCT04756154|75776747|FG001|NOT COMPLETED|Overall Study||29||29
59658265|NCT04756154|75776748|FG002|NOT COMPLETED|Overall Study||7||7
59658266|NCT04728620|75776757|FG000|STARTED|Overall Study||50||
59658267|NCT04728620|75776757|FG000|COMPLETED|Overall Study||50||
59658268|NCT04728620|75776757|FG000|NOT COMPLETED|Overall Study||0||
59658269|NCT04614246|75776766|FG000|STARTED|Overall Study||44||
59658270|NCT04614246|75776767|FG001|STARTED|Overall Study||44||
59658271|NCT04614246|75776768|FG002|STARTED|Overall Study||43||
59658272|NCT04614246|75776769|FG003|STARTED|Overall Study||43||
59988865|NCT04231318|76104115|FG001|COMPLETED|Overall Study||99||
59658273|NCT04614246|75776770|FG004|STARTED|Overall Study||41||
59658274|NCT04614246|75776766|FG000|Valid for Safety Analysis Set (SAF)|Overall Study||39||
59658275|NCT04614246|75776767|FG001|Valid for Safety Analysis Set (SAF)|Overall Study||38||
59658276|NCT04614246|75776768|FG002|Valid for Safety Analysis Set (SAF)|Overall Study||38||
59658277|NCT04614246|75776769|FG003|Valid for Safety Analysis Set (SAF)|Overall Study||37||
59658278|NCT04614246|75776770|FG004|Valid for Safety Analysis Set (SAF)|Overall Study||38||
59658279|NCT04614246|75776766|FG000|COMPLETED|Overall Study||28||
59658280|NCT04614246|75776767|FG001|COMPLETED|Overall Study||22||
59658281|NCT04614246|75776768|FG002|COMPLETED|Overall Study||22||
59658282|NCT04614246|75776769|FG003|COMPLETED|Overall Study||24||
59658283|NCT04614246|75776770|FG004|COMPLETED|Overall Study||24||
59658284|NCT04614246|75776766|FG000|NOT COMPLETED|Overall Study||16||
59658285|NCT04614246|75776767|FG001|NOT COMPLETED|Overall Study||22||
59658286|NCT04614246|75776768|FG002|NOT COMPLETED|Overall Study||21||
59658287|NCT04614246|75776769|FG003|NOT COMPLETED|Overall Study||19||
60077116|NCT01923181|76192142|FG002|Safety Analysis Set (SAS)|Overall Study||69||
60077117|NCT01923181|76192143|FG003|Safety Analysis Set (SAS)|Overall Study||70||
60077118|NCT01923181|76192144|FG004|Safety Analysis Set (SAS)|Overall Study||71||
60077119|NCT01923181|76192145|FG005|Safety Analysis Set (SAS)|Overall Study||70||
60077120|NCT01923181|76192146|FG006|Safety Analysis Set (SAS)|Overall Study||70||
60077121|NCT01923181|76192147|FG007|Safety Analysis Set (SAS)|Overall Study||69||
60077122|NCT01923181|76192148|FG008|Safety Analysis Set (SAS)|Overall Study||71||
60077123|NCT01923181|76192140|FG000|COMPLETED|Overall Study||67||
60077124|NCT01923181|76192141|FG001|COMPLETED|Overall Study||64||
60077125|NCT01923181|76192142|FG002|COMPLETED|Overall Study||67||
60077126|NCT01923181|76192143|FG003|COMPLETED|Overall Study||65||
60077127|NCT01923181|76192144|FG004|COMPLETED|Overall Study||63||
60077128|NCT01923181|76192145|FG005|COMPLETED|Overall Study||66||
60077129|NCT01923181|76192146|FG006|COMPLETED|Overall Study||62||
60077130|NCT01923181|76192147|FG007|COMPLETED|Overall Study||61||
59544095|NCT01608971|75642379|FG001|NOT COMPLETED|Overall Study||0||
60077131|NCT01923181|76192148|FG008|COMPLETED|Overall Study||68||
60077132|NCT01923181|76192140|FG000|NOT COMPLETED|Overall Study||3||
60077133|NCT01923181|76192141|FG001|NOT COMPLETED|Overall Study||6||
60077134|NCT01923181|76192142|FG002|NOT COMPLETED|Overall Study||2||
60077135|NCT01923181|76192143|FG003|NOT COMPLETED|Overall Study||5||
60077136|NCT01923181|76192144|FG004|NOT COMPLETED|Overall Study||8||
60077137|NCT01923181|76192145|FG005|NOT COMPLETED|Overall Study||4||
60077138|NCT01923181|76192146|FG006|NOT COMPLETED|Overall Study||8||
59544096|NCT01647737|75642389|FG000|STARTED|Overall Study||30||
60077139|NCT01923181|76192147|FG007|NOT COMPLETED|Overall Study||8||
60077140|NCT01923181|76192148|FG008|NOT COMPLETED|Overall Study||3||
60077141|NCT01896271|76192171|FG000|STARTED|Overall Study||30||
60077142|NCT01896271|76192171|FG000|COMPLETED|Overall Study||20||
60077143|NCT01896271|76192171|FG000|NOT COMPLETED|Overall Study||10||
60077144|NCT01884571|76192175|FG000|STARTED|Overall Study||31||
60077145|NCT01884571|76192175|FG000|COMPLETED|Overall Study||23||
60077146|NCT01884571|76192175|FG000|NOT COMPLETED|Overall Study||8||
60077147|NCT01884337|76192181|FG000|STARTED|Treatment||326||
60077148|NCT01884337|76192182|FG001|STARTED|Treatment||172||
60077149|NCT01884337|76192181|FG000|Continuing Into Follow-up Period|Treatment||324||
60077150|NCT01884337|76192182|FG001|Continuing Into Follow-up Period|Treatment||171||
60077151|NCT01884337|76192181|FG000|COMPLETED|Treatment||322||
60077152|NCT01884337|76192182|FG001|COMPLETED|Treatment||170||
60077153|NCT01884337|76192181|FG000|NOT COMPLETED|Treatment||4||
60077154|NCT01884337|76192182|FG001|NOT COMPLETED|Treatment||2||
60077155|NCT01884337|76192181|FG000|STARTED|Follow-up Period||324||
60077156|NCT01884337|76192182|FG001|STARTED|Follow-up Period||171||
60077157|NCT01884337|76192181|FG000|COMPLETED|Follow-up Period||323||
60077158|NCT01884337|76192182|FG001|COMPLETED|Follow-up Period||170||
60077159|NCT01884337|76192181|FG000|NOT COMPLETED|Follow-up Period||1||
60077160|NCT01884337|76192182|FG001|NOT COMPLETED|Follow-up Period||1||
60077161|NCT01922089|76192190|FG000|STARTED|Overall Study||247||
60077162|NCT01922089|76192191|FG001|STARTED|Overall Study||251||
60077163|NCT01922089|76192190|FG000|Safety Set|Overall Study||246||
60077164|NCT01922089|76192191|FG001|Safety Set|Overall Study||251||
60077165|NCT01922089|76192190|FG000|COMPLETED|Overall Study||208||
60077166|NCT01922089|76192191|FG001|COMPLETED|Overall Study||221||
60077167|NCT01922089|76192190|FG000|NOT COMPLETED|Overall Study||39||
60077168|NCT01922089|76192191|FG001|NOT COMPLETED|Overall Study||30||
60077169|NCT01884025|76192199|FG000|STARTED|Overall Study||13||
60077170|NCT01884025|76192200|FG001|STARTED|Overall Study||14||
60077171|NCT01884025|76192199|FG000|COMPLETED|Overall Study||10||
59544097|NCT01647737|75642390|FG001|STARTED|Overall Study||30||
59544098|NCT01647737|75642389|FG000|COMPLETED|Overall Study||26||
59544099|NCT01647737|75642390|FG001|COMPLETED|Overall Study||25||
59544100|NCT01647737|75642389|FG000|NOT COMPLETED|Overall Study||4||
59544101|NCT01647737|75642390|FG001|NOT COMPLETED|Overall Study||5||
59544102|NCT02458092|75642398|FG000|STARTED|Overall Study||20||
59544103|NCT02458092|75642399|FG001|STARTED|Overall Study||10||
59544104|NCT02458092|75642398|FG000|COMPLETED|Overall Study||19||
59544105|NCT02458092|75642399|FG001|COMPLETED|Overall Study||10||
59544106|NCT02458092|75642398|FG000|NOT COMPLETED|Overall Study||1||
59544107|NCT02458092|75642399|FG001|NOT COMPLETED|Overall Study||0||
59544108|NCT01649609|75642408|FG000|STARTED|Overall Study||20||
59544109|NCT01649609|75642409|FG001|STARTED|Overall Study||20||
59544110|NCT01649609|75642408|FG000|COMPLETED|Overall Study||20||
59544111|NCT01649609|75642409|FG001|COMPLETED|Overall Study||20||
59544112|NCT01649609|75642408|FG000|NOT COMPLETED|Overall Study||0||
59544113|NCT01649609|75642409|FG001|NOT COMPLETED|Overall Study||0||
59544114|NCT01610453|75642415|FG000|STARTED|Overall Study||150||
59544115|NCT01610453|75642415|FG000|COMPLETED|Overall Study||150||
59544116|NCT01610453|75642415|FG000|NOT COMPLETED|Overall Study||0||
59544117|NCT02449902|75642422|FG000|STARTED|Overall Study||24||
59544118|NCT02449902|75642423|FG001|STARTED|Overall Study||26||
59544119|NCT02449902|75642422|FG000|COMPLETED|Overall Study||24||
59544120|NCT02449902|75642423|FG001|COMPLETED|Overall Study||24||
59544121|NCT02449902|75642422|FG000|NOT COMPLETED|Overall Study||0||
59544122|NCT02449902|75642423|FG001|NOT COMPLETED|Overall Study||2||
59544123|NCT02449044|75642431|FG000|STARTED|Overall Study||111||
59544124|NCT02449044|75642431|FG000|COMPLETED|Overall Study|Participants who completed Weeks 58, 106 and 216 visit.|47||
59544125|NCT02449044|75642431|FG000|NOT COMPLETED|Overall Study||64||
59544126|NCT00942578|75642438|FG000|STARTED|Dose Escalation Phase||3||
59544127|NCT00942578|75642439|FG001|STARTED|Dose Escalation Phase||3||
59544128|NCT00942578|75642440|FG002|STARTED|Dose Escalation Phase||3||
59544129|NCT00942578|75642438|FG000|COMPLETED|Dose Escalation Phase||3||
59544130|NCT00942578|75642439|FG001|COMPLETED|Dose Escalation Phase||3||
59544131|NCT00942578|75642440|FG002|COMPLETED|Dose Escalation Phase||3||
59544132|NCT00942578|75642438|FG000|NOT COMPLETED|Dose Escalation Phase||0||
59544133|NCT00942578|75642439|FG001|NOT COMPLETED|Dose Escalation Phase||0||
59544134|NCT00942578|75642440|FG002|NOT COMPLETED|Dose Escalation Phase||0||
59544135|NCT00942578|75642438|FG000|STARTED|Expansion Phase||11||
59544136|NCT00942578|75642439|FG001|STARTED|Expansion Phase||0||
59544137|NCT00942578|75642440|FG002|STARTED|Expansion Phase||43||
59544138|NCT00942578|75642438|FG000|COMPLETED|Expansion Phase||11||
59544139|NCT00942578|75642439|FG001|COMPLETED|Expansion Phase||0||
59544140|NCT00942578|75642440|FG002|COMPLETED|Expansion Phase||43||
59544141|NCT00942578|75642438|FG000|NOT COMPLETED|Expansion Phase||0||
59544142|NCT00942578|75642439|FG001|NOT COMPLETED|Expansion Phase||0||
59544143|NCT00942578|75642440|FG002|NOT COMPLETED|Expansion Phase||0||
59544144|NCT02229461|75642460|FG000|STARTED|Overall Study|Randomized and received treatment|17||
59544145|NCT02229461|75642461|FG001|STARTED|Overall Study|Randomized and received treatment|17||
59544146|NCT02229461|75642462|FG002|STARTED|Overall Study|Randomized and received treatment|17||
59544147|NCT02229461|75642463|FG003|STARTED|Overall Study|Randomized and received treatment|17||
59544148|NCT02229461|75642464|FG004|STARTED|Overall Study|Randomized and received treatment|17||
59544149|NCT02229461|75642465|FG005|STARTED|Overall Study|Randomized and received treatment|17||
59544150|NCT02229461|75642460|FG000|COMPLETED|Overall Study||17||
59988866|NCT04231318|76104116|FG002|COMPLETED|Overall Study||33||
59988867|NCT04231318|76104114|FG000|NOT COMPLETED|Overall Study||0||
59544151|NCT02229461|75642461|FG001|COMPLETED|Overall Study||17||
59544152|NCT02229461|75642462|FG002|COMPLETED|Overall Study||17||
59544153|NCT02229461|75642463|FG003|COMPLETED|Overall Study||17||
59544154|NCT02229461|75642464|FG004|COMPLETED|Overall Study||17||
59544155|NCT02229461|75642465|FG005|COMPLETED|Overall Study||17||
59544156|NCT02229461|75642460|FG000|NOT COMPLETED|Overall Study||0||
59544157|NCT02229461|75642461|FG001|NOT COMPLETED|Overall Study||0||
59544158|NCT02229461|75642462|FG002|NOT COMPLETED|Overall Study||0||
59544159|NCT02229461|75642463|FG003|NOT COMPLETED|Overall Study||0||
59544160|NCT02229461|75642464|FG004|NOT COMPLETED|Overall Study||0||
59544161|NCT02229461|75642465|FG005|NOT COMPLETED|Overall Study||0||
59544162|NCT01695473|75642480|FG000|STARTED|Overall Study||11||
59544163|NCT01695473|75642480|FG000|COMPLETED|Overall Study||11||
59544164|NCT01695473|75642480|FG000|NOT COMPLETED|Overall Study||0||
59544165|NCT02237417|75642488|FG000|STARTED|Overall Study||16||
59544166|NCT02237417|75642489|FG001|STARTED|Overall Study||15||
59544167|NCT02237417|75642490|FG002|STARTED|Overall Study||16||
59544168|NCT02237417|75642488|FG000|COMPLETED|Overall Study||16||
59544169|NCT02237417|75642489|FG001|COMPLETED|Overall Study||9||
59544170|NCT02237417|75642490|FG002|COMPLETED|Overall Study||7||
59544171|NCT02237417|75642488|FG000|NOT COMPLETED|Overall Study||0||
59544172|NCT02237417|75642489|FG001|NOT COMPLETED|Overall Study||6||
59544173|NCT02237417|75642490|FG002|NOT COMPLETED|Overall Study||9||
59544174|NCT00942890|75642500|FG000|STARTED|Overall Study||21||
59544175|NCT00942890|75642501|FG001|STARTED|Overall Study||23||
59544176|NCT00942890|75642500|FG000|COMPLETED|Overall Study||21||
59544177|NCT00942890|75642501|FG001|COMPLETED|Overall Study||23||
59544178|NCT00942890|75642500|FG000|NOT COMPLETED|Overall Study||0||
59544179|NCT00942890|75642501|FG001|NOT COMPLETED|Overall Study||0||
59544180|NCT00934934|75642510|FG000|STARTED|Overall Study||30||
59544181|NCT00934934|75642511|FG001|STARTED|Overall Study||31||
59544182|NCT00934934|75642510|FG000|COMPLETED|Overall Study||29||
59544183|NCT00934934|75642511|FG001|COMPLETED|Overall Study||31||
59544184|NCT00934934|75642510|FG000|NOT COMPLETED|Overall Study||1||
59544185|NCT00934934|75642511|FG001|NOT COMPLETED|Overall Study||0||
59544186|NCT01651793|75642520|FG000|STARTED|Overall Study||6||
59544187|NCT01651793|75642521|FG001|STARTED|Overall Study||6||
59544188|NCT01651793|75642522|FG002|STARTED|Overall Study||6||
59544189|NCT01651793|75642523|FG003|STARTED|Overall Study||6||
59544190|NCT01651793|75642520|FG000|COMPLETED|Overall Study||6||
59544191|NCT01651793|75642521|FG001|COMPLETED|Overall Study||6||
59544192|NCT01651793|75642522|FG002|COMPLETED|Overall Study||6||
59544193|NCT01651793|75642523|FG003|COMPLETED|Overall Study||5||
59544194|NCT01651793|75642520|FG000|NOT COMPLETED|Overall Study||0||
59544195|NCT01651793|75642521|FG001|NOT COMPLETED|Overall Study||0||
59544196|NCT01651793|75642522|FG002|NOT COMPLETED|Overall Study||0||
59544197|NCT01651793|75642523|FG003|NOT COMPLETED|Overall Study||1||
59544198|NCT01611779|75642537|FG000|STARTED|Overall Study||5||
59544199|NCT01611779|75642537|FG000|COMPLETED|Overall Study||5||
59544200|NCT01611779|75642537|FG000|NOT COMPLETED|Overall Study||0||
59544201|NCT01699373|75642543|FG000|STARTED|Overall Study||85||
59544202|NCT01699373|75642544|FG001|STARTED|Overall Study||85||
59544203|NCT01699373|75642543|FG000|COMPLETED|Overall Study||85||
59544204|NCT01699373|75642544|FG001|COMPLETED|Overall Study||85||
59544205|NCT01699373|75642543|FG000|NOT COMPLETED|Overall Study||0||
59544206|NCT01699373|75642544|FG001|NOT COMPLETED|Overall Study||0||
59544207|NCT01652495|75642552|FG000|STARTED|Overall Study||22||
59544208|NCT01652495|75642553|FG001|STARTED|Overall Study||22||
59544209|NCT01652495|75642552|FG000|COMPLETED|Overall Study||20||
59544210|NCT01652495|75642553|FG001|COMPLETED|Overall Study||20||
59544211|NCT01652495|75642552|FG000|NOT COMPLETED|Overall Study||2||
59544212|NCT01652495|75642553|FG001|NOT COMPLETED|Overall Study||2||
59544213|NCT00935792|75642564|FG000|STARTED|Overall Study||7||
59544214|NCT00935792|75642565|FG001|STARTED|Overall Study||9||
59544215|NCT00935792|75642566|FG002|STARTED|Overall Study||12||
59544216|NCT00935792|75642564|FG000|COMPLETED|Overall Study||6||
59544217|NCT00935792|75642565|FG001|COMPLETED|Overall Study||6||
59544218|NCT00935792|75642566|FG002|COMPLETED|Overall Study||12||
59544219|NCT00935792|75642564|FG000|NOT COMPLETED|Overall Study||1||
59544220|NCT00935792|75642565|FG001|NOT COMPLETED|Overall Study||3||
59544221|NCT00935792|75642566|FG002|NOT COMPLETED|Overall Study||0||
59544222|NCT01699607|75642578|FG000|STARTED|Overall Study||6||
59544223|NCT01699607|75642579|FG001|STARTED|Overall Study||4||
59544224|NCT01699607|75642578|FG000|COMPLETED|Overall Study||6||
59988868|NCT04231318|76104115|FG001|NOT COMPLETED|Overall Study||0||
59544225|NCT01699607|75642579|FG001|COMPLETED|Overall Study||4||
59544226|NCT01699607|75642578|FG000|NOT COMPLETED|Overall Study||0||
59544227|NCT01699607|75642579|FG001|NOT COMPLETED|Overall Study||0||
59544228|NCT01699763|75642584|FG000|STARTED|Overall Study||112||
59544229|NCT01699763|75642584|FG000|COMPLETED|Overall Study||112||
59544230|NCT01699763|75642584|FG000|NOT COMPLETED|Overall Study||0||
59544231|NCT01612793|75642590|FG000|STARTED|Overall Study||2||
59544232|NCT01612793|75642591|FG001|STARTED|Overall Study||2||
59658288|NCT04614246|75776770|FG004|NOT COMPLETED|Overall Study||17||
59658289|NCT04612868|75776782|FG000|STARTED|Overall Study|screened and enrolled|531||
59544233|NCT01612793|75642590|FG000|COMPLETED|Overall Study||2||
59544234|NCT01612793|75642591|FG001|COMPLETED|Overall Study||2||
59544235|NCT01612793|75642590|FG000|NOT COMPLETED|Overall Study||0||
59544236|NCT01612793|75642591|FG001|NOT COMPLETED|Overall Study||0||
59544237|NCT01613339|75642599|FG000|STARTED|Overall Study||24||
59544238|NCT01613339|75642600|FG001|STARTED|Overall Study||22||
59544239|NCT01613339|75642599|FG000|COMPLETED|Overall Study||21||
59544240|NCT01613339|75642600|FG001|COMPLETED|Overall Study||21||
59544241|NCT01613339|75642599|FG000|NOT COMPLETED|Overall Study||3||
59544242|NCT01613339|75642600|FG001|NOT COMPLETED|Overall Study||1||
59544243|NCT01653509|75642607|FG000|STARTED|Overall Study||12||
59544244|NCT01653509|75642608|FG001|STARTED|Overall Study||13||
59544245|NCT01653509|75642607|FG000|COMPLETED|Overall Study||12||
59544246|NCT01653509|75642608|FG001|COMPLETED|Overall Study||13||
59544247|NCT01653509|75642607|FG000|NOT COMPLETED|Overall Study||0||
59544248|NCT01653509|75642608|FG001|NOT COMPLETED|Overall Study||0||
59544249|NCT01614509|75642618|FG000|STARTED|Overall Study||24||
59544250|NCT01614509|75642619|FG001|STARTED|Overall Study||21||
59544251|NCT01614509|75642618|FG000|COMPLETED|Overall Study||23||
59544252|NCT01614509|75642619|FG001|COMPLETED|Overall Study||18||
59544253|NCT01614509|75642618|FG000|NOT COMPLETED|Overall Study||1||
59544254|NCT01614509|75642619|FG001|NOT COMPLETED|Overall Study||3||
59544255|NCT01614743|75642627|FG000|STARTED|Overall Study||4||
59544256|NCT01614743|75642628|FG001|STARTED|Overall Study||5||
59544257|NCT01614743|75642627|FG000|COMPLETED|Overall Study||3||
59544258|NCT01614743|75642628|FG001|COMPLETED|Overall Study|Subject in the placebo group (5) also received the treatment (IncobotulinumtoxinA) at Visit 5.|5||
59544259|NCT01614743|75642627|FG000|NOT COMPLETED|Overall Study||1||
59544260|NCT01614743|75642628|FG001|NOT COMPLETED|Overall Study||0||
59544261|NCT01701011|75642637|FG000|STARTED|Overall Study||127||
59544262|NCT01701011|75642638|FG001|STARTED|Overall Study||126||
59544263|NCT01701011|75642639|FG002|STARTED|Overall Study||124||
59544264|NCT01701011|75642637|FG000|COMPLETED|Overall Study||92||
59544265|NCT01701011|75642638|FG001|COMPLETED|Overall Study||102||
59544266|NCT01701011|75642639|FG002|COMPLETED|Overall Study||90||
59544267|NCT01701011|75642637|FG000|NOT COMPLETED|Overall Study||35||
59544268|NCT01701011|75642638|FG001|NOT COMPLETED|Overall Study||24||
59658290|NCT04612868|75776782|FG000|Analyzable|Overall Study||468||
59658291|NCT04612868|75776782|FG000|COMPLETED|Overall Study|participants included in statistical analysis with fully analyzable data with valid ground truth (based on worst eye analysis) and AEYE-DS results output per participant.|462||
59658292|NCT04612868|75776782|FG000|NOT COMPLETED|Overall Study||69||
59658293|NCT04593823|75776788|FG000|STARTED|Overall Study||34||
59658294|NCT04593823|75776789|FG001|STARTED|Overall Study||17||
59544269|NCT01701011|75642639|FG002|NOT COMPLETED|Overall Study||34||
59544270|NCT01653587|75642650|FG000|STARTED|Overall Study||120||
59544271|NCT01653587|75642651|FG001|STARTED|Overall Study||120||
59544272|NCT01653587|75642650|FG000|COMPLETED|Overall Study||120||
59544273|NCT01653587|75642651|FG001|COMPLETED|Overall Study||120||
59544274|NCT01653587|75642650|FG000|NOT COMPLETED|Overall Study||0||
59544275|NCT01653587|75642651|FG001|NOT COMPLETED|Overall Study||0||
59544276|NCT00943202|75642661|FG000|STARTED|Overall Study||133||
59544277|NCT00943202|75642662|FG001|STARTED|Overall Study||133||
59544278|NCT00943202|75642663|FG002|STARTED|Overall Study||133||
59544279|NCT00943202|75642664|FG003|STARTED|Overall Study||132||
59544280|NCT00943202|75642661|FG000|COMPLETED|Overall Study||132||
59658295|NCT04593823|75776788|FG000|COMPLETED|Overall Study||33||
59544281|NCT00943202|75642662|FG001|COMPLETED|Overall Study||131||
59544282|NCT00943202|75642663|FG002|COMPLETED|Overall Study||133||
59544283|NCT00943202|75642664|FG003|COMPLETED|Overall Study||131||
59544284|NCT00943202|75642661|FG000|NOT COMPLETED|Overall Study||1||
59544285|NCT00943202|75642662|FG001|NOT COMPLETED|Overall Study||2||
59544286|NCT00943202|75642663|FG002|NOT COMPLETED|Overall Study||0||
59544287|NCT00943202|75642664|FG003|NOT COMPLETED|Overall Study||1||
59544288|NCT00943436|75642677|FG000|STARTED|Exercise Session: 45 Minutes of Activity||10||
59544289|NCT00943436|75642678|FG001|STARTED|Exercise Session: 45 Minutes of Activity||10||
59544290|NCT00943436|75642677|FG000|COMPLETED|Exercise Session: 45 Minutes of Activity||10||
59544291|NCT00943436|75642678|FG001|COMPLETED|Exercise Session: 45 Minutes of Activity||10||
59544292|NCT00943436|75642677|FG000|NOT COMPLETED|Exercise Session: 45 Minutes of Activity||0||
59544293|NCT00943436|75642678|FG001|NOT COMPLETED|Exercise Session: 45 Minutes of Activity||0||
59544294|NCT00943436|75642677|FG000|STARTED|Rest Session: 45 Minutes of Reading||10||
59658296|NCT04593823|75776789|FG001|COMPLETED|Overall Study||15||
59544295|NCT00943436|75642678|FG001|STARTED|Rest Session: 45 Minutes of Reading||10||
59544296|NCT00943436|75642677|FG000|COMPLETED|Rest Session: 45 Minutes of Reading||10||
59544297|NCT00943436|75642678|FG001|COMPLETED|Rest Session: 45 Minutes of Reading||10||
59544298|NCT00943436|75642677|FG000|NOT COMPLETED|Rest Session: 45 Minutes of Reading||0||
59544299|NCT00943436|75642678|FG001|NOT COMPLETED|Rest Session: 45 Minutes of Reading||0||
59544300|NCT01614821|75642684|FG000|STARTED|Overall Study||63||
59544301|NCT01614821|75642684|FG000|COMPLETED|Overall Study||63||
59544302|NCT01614821|75642684|FG000|NOT COMPLETED|Overall Study||0||
59544303|NCT01654445|75642690|FG000|STARTED|Overall Study||25||
59658297|NCT04593823|75776788|FG000|NOT COMPLETED|Overall Study||1||
59658298|NCT04593823|75776789|FG001|NOT COMPLETED|Overall Study||2||
59658299|NCT04585919|75776797|FG000|STARTED|Usual Care||7|Number of community health center staff|1
59658300|NCT04585919|75776798|FG001|STARTED|Usual Care||6|Number of community health center staff|1
59658301|NCT04585919|75776799|FG002|STARTED|Usual Care||9|Number of community health center staff|1
59658302|NCT04585919|75776800|FG003|STARTED|Usual Care||4|Number of community health center staff|1
59658303|NCT04585919|75776797|FG000|Number of Patients|Usual Care||5947|Patients are not enrolled|1
59658304|NCT04585919|75776798|FG001|Number of Patients|Usual Care||7652|Patients are not enrolled|1
59658305|NCT04585919|75776799|FG002|Number of Patients|Usual Care||7311|Patients are not enrolled|1
59658306|NCT04585919|75776800|FG003|Number of Patients|Usual Care||6317|Patients are not enrolled|1
59658307|NCT04585919|75776797|FG000|COMPLETED|Usual Care||7||1
59658308|NCT04585919|75776798|FG001|COMPLETED|Usual Care||6||1
59658309|NCT04585919|75776799|FG002|COMPLETED|Usual Care||9||1
59658310|NCT04585919|75776800|FG003|COMPLETED|Usual Care||4||1
59658311|NCT04585919|75776797|FG000|NOT COMPLETED|Usual Care||0||0
59658312|NCT04585919|75776798|FG001|NOT COMPLETED|Usual Care||0||0
59658313|NCT04585919|75776799|FG002|NOT COMPLETED|Usual Care||0||0
59658314|NCT04585919|75776800|FG003|NOT COMPLETED|Usual Care||0||0
59658315|NCT04585919|75776797|FG000|STARTED|Paired Outreach||7|Number of community health center staff|1
59658316|NCT04585919|75776798|FG001|STARTED|Paired Outreach||6|Number of community health center staff|1
59658317|NCT04585919|75776799|FG002|STARTED|Paired Outreach||9|Number of community health center staff|1
59658318|NCT04585919|75776800|FG003|STARTED|Paired Outreach||4|Number of community health center staff|1
59658319|NCT04585919|75776797|FG000|Number of Patients|Paired Outreach||6453|Patients are not enrolled|1
59658320|NCT04585919|75776798|FG001|Number of Patients|Paired Outreach||13401|Patients are not enrolled|1
59658321|NCT04585919|75776799|FG002|Number of Patients|Paired Outreach||7272|Patients are not enrolled|1
59658322|NCT04585919|75776800|FG003|Number of Patients|Paired Outreach||6254|Patients are not enrolled|1
59658323|NCT04585919|75776797|FG000|COMPLETED|Paired Outreach||7||1
59658324|NCT04585919|75776798|FG001|COMPLETED|Paired Outreach||6||1
59658325|NCT04585919|75776799|FG002|COMPLETED|Paired Outreach||9||1
59658326|NCT04585919|75776800|FG003|COMPLETED|Paired Outreach||4||1
59658327|NCT04585919|75776797|FG000|NOT COMPLETED|Paired Outreach||0||0
59658328|NCT04585919|75776798|FG001|NOT COMPLETED|Paired Outreach||0||0
59658329|NCT04585919|75776799|FG002|NOT COMPLETED|Paired Outreach||0||0
59658330|NCT04585919|75776800|FG003|NOT COMPLETED|Paired Outreach||0||0
59658331|NCT04556383|75776809|FG000|STARTED|PCP||78||
59658332|NCT04556383|75776810|FG001|STARTED|PCP||78||
59658333|NCT04556383|75776811|FG002|STARTED|PCP||80||
59658334|NCT04556383|75776812|FG003|STARTED|PCP||0||
59658335|NCT04556383|75776809|FG000|COMPLETED|PCP||23||
59658336|NCT04556383|75776810|FG001|COMPLETED|PCP||25||
59658337|NCT04556383|75776811|FG002|COMPLETED|PCP||26||
59658338|NCT04556383|75776812|FG003|COMPLETED|PCP||0||
59658339|NCT04556383|75776809|FG000|NOT COMPLETED|PCP||55||
59658340|NCT04556383|75776810|FG001|NOT COMPLETED|PCP||53||
59658341|NCT04556383|75776811|FG002|NOT COMPLETED|PCP||54||
59658342|NCT04556383|75776812|FG003|NOT COMPLETED|PCP||0||
59658343|NCT04556383|75776809|FG000|STARTED|OLE||0||
59658344|NCT04556383|75776810|FG001|STARTED|OLE||0||
59658345|NCT04556383|75776811|FG002|STARTED|OLE||0||
59658346|NCT04556383|75776812|FG003|STARTED|OLE||130||
59658347|NCT04556383|75776809|FG000|COMPLETED|OLE||0||
59658348|NCT04556383|75776810|FG001|COMPLETED|OLE||0||
59658349|NCT04556383|75776811|FG002|COMPLETED|OLE||0||
59658350|NCT04556383|75776812|FG003|COMPLETED|OLE||39||
59658351|NCT04556383|75776809|FG000|NOT COMPLETED|OLE||0||
59658352|NCT04556383|75776810|FG001|NOT COMPLETED|OLE||0||
59658353|NCT04556383|75776811|FG002|NOT COMPLETED|OLE||0||
59658354|NCT04556383|75776812|FG003|NOT COMPLETED|OLE||91||
59658355|NCT04473664|75776825|FG000|STARTED|Overall Study||6||
59658356|NCT04473664|75776826|FG001|STARTED|Overall Study||6||
59658357|NCT04473664|75776825|FG000|COMPLETED|Overall Study||6||
59658358|NCT04473664|75776826|FG001|COMPLETED|Overall Study||6||
59658359|NCT04473664|75776825|FG000|NOT COMPLETED|Overall Study||0||
59658360|NCT04473664|75776826|FG001|NOT COMPLETED|Overall Study||0||
59658361|NCT04460742|75776834|FG000|STARTED|Overall Study||16||
59658362|NCT04460742|75776835|FG001|STARTED|Overall Study||15||
59658363|NCT04460742|75776834|FG000|COMPLETED|Overall Study||14||
59658364|NCT04460742|75776835|FG001|COMPLETED|Overall Study||14||
59658365|NCT04460742|75776834|FG000|NOT COMPLETED|Overall Study||2||
59658366|NCT04460742|75776835|FG001|NOT COMPLETED|Overall Study||1||
59658367|NCT04444752|75776846|FG000|STARTED|Overall Study||57||
59658368|NCT04444752|75776847|FG001|STARTED|Overall Study||57||
59658369|NCT04444752|75776848|FG002|STARTED|Overall Study||56||
59658370|NCT04444752|75776849|FG003|STARTED|Overall Study||56||
59658371|NCT04444752|75776846|FG000|COMPLETED|Overall Study||46||
59658372|NCT04444752|75776847|FG001|COMPLETED|Overall Study||45||
59658373|NCT04444752|75776848|FG002|COMPLETED|Overall Study||50||
59658374|NCT04444752|75776849|FG003|COMPLETED|Overall Study||40||
59658375|NCT04444752|75776846|FG000|NOT COMPLETED|Overall Study||11||
59658376|NCT04444752|75776847|FG001|NOT COMPLETED|Overall Study||12||
59658377|NCT04444752|75776848|FG002|NOT COMPLETED|Overall Study||6||
59658378|NCT04444752|75776849|FG003|NOT COMPLETED|Overall Study||16||
59658379|NCT04429022|75776861|FG000|STARTED|Overall Study||28||
59658380|NCT04429022|75776862|FG001|STARTED|Overall Study||40||
59658381|NCT04429022|75776861|FG000|COMPLETED|Overall Study||10||
59658382|NCT04429022|75776862|FG001|COMPLETED|Overall Study||39||
59658383|NCT04429022|75776861|FG000|NOT COMPLETED|Overall Study||18||
59658384|NCT04429022|75776862|FG001|NOT COMPLETED|Overall Study||1||
59658385|NCT04410367|75776868|FG000|STARTED|Overall Study||23||
59658386|NCT04410367|75776868|FG000|Underwent 18F-fluciclovine PET|Overall Study||23||
59658387|NCT04410367|75776868|FG000|COMPLETED|Overall Study||23||
59658388|NCT04410367|75776868|FG000|NOT COMPLETED|Overall Study||0||
59658389|NCT04396990|75776876|FG000|STARTED|Overall Study||20||20
59658390|NCT04396990|75776877|FG001|STARTED|Overall Study||20||20
59658391|NCT04396990|75776876|FG000|COMPLETED|Overall Study|Contralateral Eye Study. Each subject randomized to dextenza insert in one eye and topical steroid in contralateral eye.|20||20
59658392|NCT04396990|75776877|FG001|COMPLETED|Overall Study||20||20
59658393|NCT04396990|75776876|FG000|NOT COMPLETED|Overall Study||0||0
59658394|NCT04396990|75776877|FG001|NOT COMPLETED|Overall Study||0||0
59658395|NCT04351373|75776892|FG000|STARTED|Overall Study||12||
59658396|NCT04351373|75776892|FG000|COMPLETED|Overall Study||11||
59658397|NCT04351373|75776892|FG000|NOT COMPLETED|Overall Study||1||
59658398|NCT04254081|75776898|FG000|STARTED|Overall Study||28||
59658399|NCT04254081|75776899|FG001|STARTED|Overall Study||29||
59658400|NCT04254081|75776898|FG000|COMPLETED|Overall Study||28||
59658401|NCT04254081|75776899|FG001|COMPLETED|Overall Study||29||
59658402|NCT04254081|75776898|FG000|NOT COMPLETED|Overall Study||0||
59658403|NCT04254081|75776899|FG001|NOT COMPLETED|Overall Study||0||
59658404|NCT04239924|75776905|FG000|STARTED|Overall Study||20||
59658405|NCT04239924|75776905|FG000|Caregivers|Overall Study||10||
59658406|NCT04239924|75776905|FG000|Patient With Dementia|Overall Study||10||
59658407|NCT04239924|75776905|FG000|COMPLETED|Overall Study||18||
59658408|NCT04239924|75776905|FG000|NOT COMPLETED|Overall Study||2||
59658409|NCT04203745|75776910|FG000|STARTED|Overall Study||26||
59658410|NCT04203745|75776910|FG000|COMPLETED|Overall Study||20||
59658411|NCT04203745|75776910|FG000|NOT COMPLETED|Overall Study||6||
59658412|NCT04154904|75776917|FG000|STARTED|Study Start-up Visit||10||
59658413|NCT04154904|75776918|FG001|STARTED|Study Start-up Visit||10||
59658414|NCT04154904|75776919|FG002|STARTED|Study Start-up Visit||10||
59658415|NCT04154904|75776917|FG000|COMPLETED|Study Start-up Visit||10||
59658416|NCT04154904|75776918|FG001|COMPLETED|Study Start-up Visit||10||
59658417|NCT04154904|75776919|FG002|COMPLETED|Study Start-up Visit||10||
59658418|NCT04154904|75776917|FG000|NOT COMPLETED|Study Start-up Visit||0||
59658419|NCT04154904|75776918|FG001|NOT COMPLETED|Study Start-up Visit||0||
59658420|NCT04154904|75776919|FG002|NOT COMPLETED|Study Start-up Visit||0||
59658421|NCT04154904|75776917|FG000|STARTED|At Home Period (28 Days)||10||
59658422|NCT04154904|75776918|FG001|STARTED|At Home Period (28 Days)||10||
59658423|NCT04154904|75776919|FG002|STARTED|At Home Period (28 Days)||10||
59658424|NCT04154904|75776917|FG000|COMPLETED|At Home Period (28 Days)||10||
59658425|NCT04154904|75776918|FG001|COMPLETED|At Home Period (28 Days)||10||
59658426|NCT04154904|75776919|FG002|COMPLETED|At Home Period (28 Days)||9||
59658427|NCT04154904|75776917|FG000|NOT COMPLETED|At Home Period (28 Days)||0||
59658428|NCT04154904|75776918|FG001|NOT COMPLETED|At Home Period (28 Days)||0||
59658429|NCT04154904|75776919|FG002|NOT COMPLETED|At Home Period (28 Days)||1||
59658430|NCT04154904|75776917|FG000|STARTED|Study Close-out Visit||10||
59658431|NCT04154904|75776918|FG001|STARTED|Study Close-out Visit||10||
59658432|NCT04154904|75776919|FG002|STARTED|Study Close-out Visit||9||
59658433|NCT04154904|75776917|FG000|COMPLETED|Study Close-out Visit||10||
59658434|NCT04154904|75776918|FG001|COMPLETED|Study Close-out Visit||10||
59658435|NCT04154904|75776919|FG002|COMPLETED|Study Close-out Visit||9||
59658436|NCT04154904|75776917|FG000|NOT COMPLETED|Study Close-out Visit||0||
59658437|NCT04154904|75776918|FG001|NOT COMPLETED|Study Close-out Visit||0||
59658438|NCT04154904|75776919|FG002|NOT COMPLETED|Study Close-out Visit||0||
59658439|NCT04114656|75776931|FG000|STARTED|Treatment Period1+Washout(Up to 28 Days)||11|Discontinuation data were collected until the end of the washout irrespective of whether each participant was in a particular period or began washout. The electronic case report form (eCRF) was not designed to differentiate data collection between treatment periods and washout periods|
59658440|NCT04114656|75776932|FG001|STARTED|Treatment Period1+Washout(Up to 28 Days)||10|Discontinuation data were collected until the end of the washout irrespective of whether each participant was in a particular period or began washout. The electronic case report form (eCRF) was not designed to differentiate data collection between treatment periods and washout periods|
59658441|NCT04114656|75776931|FG000|COMPLETED|Treatment Period1+Washout(Up to 28 Days)||9||
59658442|NCT04114656|75776932|FG001|COMPLETED|Treatment Period1+Washout(Up to 28 Days)||7||
59658443|NCT04114656|75776931|FG000|NOT COMPLETED|Treatment Period1+Washout(Up to 28 Days)||2||
59658444|NCT04114656|75776932|FG001|NOT COMPLETED|Treatment Period1+Washout(Up to 28 Days)||3||
59658445|NCT04114656|75776931|FG000|STARTED|Treatment Period2+Washout(Up to 28 Days)||9|Discontinuation data were collected until the end of the washout irrespective of whether each participant was in a particular period or began washout. The electronic case report form (eCRF) was not designed to differentiate data collection between treatment periods and washout periods|
59709750|NCT01072149|75828534|FG014|COMPLETED|Treatment Period 1 (28 Days)||3||
59709751|NCT01072149|75828535|FG015|COMPLETED|Treatment Period 1 (28 Days)||3||
59709752|NCT01072149|75828536|FG016|COMPLETED|Treatment Period 1 (28 Days)||3||
59658446|NCT04114656|75776932|FG001|STARTED|Treatment Period2+Washout(Up to 28 Days)||7|Discontinuation data were collected until the end of the washout irrespective of whether each participant was in a particular period or began washout. The electronic case report form (eCRF) was not designed to differentiate data collection between treatment periods and washout periods|
59658447|NCT04114656|75776931|FG000|COMPLETED|Treatment Period2+Washout(Up to 28 Days)||9||
59658448|NCT04114656|75776932|FG001|COMPLETED|Treatment Period2+Washout(Up to 28 Days)||6||
59658449|NCT04114656|75776931|FG000|NOT COMPLETED|Treatment Period2+Washout(Up to 28 Days)||0||
59658450|NCT04114656|75776932|FG001|NOT COMPLETED|Treatment Period2+Washout(Up to 28 Days)||1||
59658451|NCT04114656|75776931|FG000|STARTED|Treatment Period 3 (Up to 28 Days)||9||
59658452|NCT04114656|75776932|FG001|STARTED|Treatment Period 3 (Up to 28 Days)||6||
59658453|NCT04114656|75776931|FG000|COMPLETED|Treatment Period 3 (Up to 28 Days)||9||
59658454|NCT04114656|75776932|FG001|COMPLETED|Treatment Period 3 (Up to 28 Days)||6||
59658455|NCT04114656|75776931|FG000|NOT COMPLETED|Treatment Period 3 (Up to 28 Days)||0||
59658456|NCT04114656|75776932|FG001|NOT COMPLETED|Treatment Period 3 (Up to 28 Days)||0||
59658457|NCT04038099|75776940|FG000|STARTED|Overall Study||30||
59658458|NCT04038099|75776941|FG001|STARTED|Overall Study||33||
59658459|NCT04038099|75776940|FG000|COMPLETED|Overall Study||30||
59658460|NCT04038099|75776941|FG001|COMPLETED|Overall Study||33||
59658461|NCT04038099|75776940|FG000|NOT COMPLETED|Overall Study||0||
59658462|NCT04038099|75776941|FG001|NOT COMPLETED|Overall Study||0||
59658463|NCT04034238|75776950|FG000|STARTED|Dose Escalation Phase||7||
59658464|NCT04034238|75776951|FG001|STARTED|Dose Escalation Phase||3||
59658465|NCT04034238|75776952|FG002|STARTED|Dose Escalation Phase||0||
59658466|NCT04034238|75776953|FG003|STARTED|Dose Escalation Phase||2||
59658467|NCT04034238|75776950|FG000|COMPLETED|Dose Escalation Phase||6||
59658468|NCT04034238|75776951|FG001|COMPLETED|Dose Escalation Phase||3||
59658469|NCT04034238|75776952|FG002|COMPLETED|Dose Escalation Phase||0||
59658470|NCT04034238|75776953|FG003|COMPLETED|Dose Escalation Phase||0||
59658471|NCT04034238|75776950|FG000|NOT COMPLETED|Dose Escalation Phase||1||
59658472|NCT04034238|75776951|FG001|NOT COMPLETED|Dose Escalation Phase||0||
59658473|NCT04034238|75776952|FG002|NOT COMPLETED|Dose Escalation Phase||0||
59658474|NCT04034238|75776953|FG003|NOT COMPLETED|Dose Escalation Phase||2||
59658475|NCT04034238|75776950|FG000|STARTED|Dose Expansion Phase||0||
59658476|NCT04034238|75776951|FG001|STARTED|Dose Expansion Phase||0||
59658477|NCT04034238|75776952|FG002|STARTED|Dose Expansion Phase||6||
59658478|NCT04034238|75776953|FG003|STARTED|Dose Expansion Phase||1||
59658479|NCT04034238|75776950|FG000|COMPLETED|Dose Expansion Phase||0||
59658480|NCT04034238|75776951|FG001|COMPLETED|Dose Expansion Phase||0||
59658481|NCT04034238|75776952|FG002|COMPLETED|Dose Expansion Phase||5||
59658482|NCT04034238|75776953|FG003|COMPLETED|Dose Expansion Phase||0||
59658483|NCT04034238|75776950|FG000|NOT COMPLETED|Dose Expansion Phase||0||
59658484|NCT04034238|75776951|FG001|NOT COMPLETED|Dose Expansion Phase||0||
59658485|NCT04034238|75776952|FG002|NOT COMPLETED|Dose Expansion Phase||1||
59658486|NCT04034238|75776953|FG003|NOT COMPLETED|Dose Expansion Phase||1||
59658487|NCT03956056|75776964|FG000|STARTED|Overall Study||12||
59658488|NCT03956056|75776964|FG000|COMPLETED|Overall Study||9||
59658489|NCT03956056|75776964|FG000|NOT COMPLETED|Overall Study||3||
59658490|NCT03954041|75776971|FG000|STARTED|Overall Study||48||
59658491|NCT03954041|75776972|FG001|STARTED|Overall Study||23||
59658492|NCT03954041|75776973|FG002|STARTED|Overall Study||21||
59658493|NCT03954041|75776971|FG000|COMPLETED|Overall Study||30||
59658494|NCT03954041|75776972|FG001|COMPLETED|Overall Study||14||
59658495|NCT03954041|75776973|FG002|COMPLETED|Overall Study||11||
59658496|NCT03954041|75776971|FG000|NOT COMPLETED|Overall Study||18||
59658497|NCT03954041|75776972|FG001|NOT COMPLETED|Overall Study||9||
59658498|NCT03954041|75776973|FG002|NOT COMPLETED|Overall Study||10||
59658499|NCT03926195|75776983|FG000|STARTED|DB Treatment Phase (Through Week 13)||54||
59658500|NCT03926195|75776984|FG001|STARTED|DB Treatment Phase (Through Week 13)||55||
59658501|NCT03926195|75776983|FG000|COMPLETED|DB Treatment Phase (Through Week 13)||54||
59658502|NCT03926195|75776984|FG001|COMPLETED|DB Treatment Phase (Through Week 13)||53||
59658503|NCT03926195|75776983|FG000|NOT COMPLETED|DB Treatment Phase (Through Week 13)||0||
59658504|NCT03926195|75776984|FG001|NOT COMPLETED|DB Treatment Phase (Through Week 13)||2||
59658505|NCT03926195|75776983|FG000|STARTED|EXT Phase (Through Week 26)|39 arthritis responder participants entered the EXT phase and received OL treatment filgotinib. 7 arthritis nonresponder participants entered the EXT phase and received SOC treatment.|46||
59658506|NCT03926195|75776984|FG001|STARTED|EXT Phase (Through Week 26)|26 arthritis responder participants and 23 arthritis nonresponder participants entered the EXT phase and received SOC treatment.|49||
59658507|NCT03926195|75776983|FG000|COMPLETED|EXT Phase (Through Week 26)||0||
59658508|NCT03926195|75776984|FG001|COMPLETED|EXT Phase (Through Week 26)||0||
59658509|NCT03926195|75776983|FG000|NOT COMPLETED|EXT Phase (Through Week 26)||46||
59658510|NCT03926195|75776984|FG001|NOT COMPLETED|EXT Phase (Through Week 26)||49||
59658511|NCT03908476|75776999|FG000|STARTED|Overall Study||85||
59658512|NCT03908476|75777000|FG001|STARTED|Overall Study||15||
59658513|NCT03908476|75776999|FG000|COMPLETED|Overall Study||64||
59658514|NCT03908476|75777000|FG001|COMPLETED|Overall Study||13||
59988869|NCT04231318|76104116|FG002|NOT COMPLETED|Overall Study||0||
59988870|NCT04201262|76104130|FG000|STARTED|Overall Study||58||
59988871|NCT04201262|76104131|FG001|STARTED|Overall Study||47||
59658515|NCT03908476|75776999|FG000|NOT COMPLETED|Overall Study||21||
59658516|NCT03908476|75777000|FG001|NOT COMPLETED|Overall Study||2||
59658517|NCT03830866|75777008|FG000|STARTED|Overall Study||385||
59658518|NCT03830866|75777009|FG001|STARTED|Overall Study||385||
59658519|NCT03830866|75777008|FG000|COMPLETED|Overall Study||0||
59658520|NCT03830866|75777009|FG001|COMPLETED|Overall Study||0||
59658521|NCT03830866|75777008|FG000|NOT COMPLETED|Overall Study||385||
59658522|NCT03830866|75777009|FG001|NOT COMPLETED|Overall Study||385||
59658523|NCT03745898|75777017|FG000|STARTED|Overall Study||48||
59658524|NCT03745898|75777018|FG001|STARTED|Overall Study||50||
59658525|NCT03745898|75777017|FG000|COMPLETED|Overall Study||48||
59658526|NCT03745898|75777018|FG001|COMPLETED|Overall Study||50||
59658527|NCT03745898|75777017|FG000|NOT COMPLETED|Overall Study||0||
59658528|NCT03745898|75777018|FG001|NOT COMPLETED|Overall Study||0||
59658529|NCT03699007|75777026|FG000|STARTED|Treatment Phase (Baseline to 3-Month FU)||33||
59658530|NCT03699007|75777027|FG001|STARTED|Treatment Phase (Baseline to 3-Month FU)||35||
59658531|NCT03699007|75777026|FG000|COMPLETED|Treatment Phase (Baseline to 3-Month FU)||26||
59658532|NCT03699007|75777027|FG001|COMPLETED|Treatment Phase (Baseline to 3-Month FU)||33||
59658533|NCT03699007|75777026|FG000|NOT COMPLETED|Treatment Phase (Baseline to 3-Month FU)||7||
59658534|NCT03699007|75777027|FG001|NOT COMPLETED|Treatment Phase (Baseline to 3-Month FU)||2||
59658535|NCT03699007|75777026|FG000|STARTED|6-month Follow Up||26||
59658536|NCT03699007|75777027|FG001|STARTED|6-month Follow Up||33||
59658537|NCT03699007|75777026|FG000|COMPLETED|6-month Follow Up||24||
59658538|NCT03699007|75777027|FG001|COMPLETED|6-month Follow Up||30||
59658539|NCT03699007|75777026|FG000|NOT COMPLETED|6-month Follow Up||2||
59658540|NCT03699007|75777027|FG001|NOT COMPLETED|6-month Follow Up||3||
59658541|NCT03581188|75777037|FG000|STARTED|Overall Study||49||
59658542|NCT03581188|75777038|FG001|STARTED|Overall Study||51||
59658543|NCT03581188|75777037|FG000|COMPLETED|Overall Study||30||
59658544|NCT03581188|75777038|FG001|COMPLETED|Overall Study||36||
59658545|NCT03581188|75777037|FG000|NOT COMPLETED|Overall Study||19||
59658546|NCT03581188|75777038|FG001|NOT COMPLETED|Overall Study||15||
59658547|NCT03576131|75777055|FG000|STARTED|Overall Study||10||
59658548|NCT03576131|75777056|FG001|STARTED|Overall Study||7||
59658549|NCT03576131|75777057|FG002|STARTED|Overall Study||4||
59658550|NCT03576131|75777058|FG003|STARTED|Overall Study||11||
59658551|NCT03576131|75777059|FG004|STARTED|Overall Study||7||
59658552|NCT03576131|75777060|FG005|STARTED|Overall Study||7||
59658553|NCT03576131|75777061|FG006|STARTED|Overall Study||1||
59658554|NCT03576131|75777062|FG007|STARTED|Overall Study||1||
59658555|NCT03576131|75777055|FG000|COMPLETED|Overall Study||1||
59658556|NCT03576131|75777056|FG001|COMPLETED|Overall Study||2||
59658557|NCT03576131|75777057|FG002|COMPLETED|Overall Study||0||
59658558|NCT03576131|75777058|FG003|COMPLETED|Overall Study||0||
59658559|NCT03576131|75777059|FG004|COMPLETED|Overall Study||0||
59658560|NCT03576131|75777060|FG005|COMPLETED|Overall Study||0||
59658561|NCT03576131|75777061|FG006|COMPLETED|Overall Study||0||
59658562|NCT03576131|75777062|FG007|COMPLETED|Overall Study||0||
59658563|NCT03576131|75777055|FG000|NOT COMPLETED|Overall Study||9||
59658564|NCT03576131|75777056|FG001|NOT COMPLETED|Overall Study||5||
59658565|NCT03576131|75777057|FG002|NOT COMPLETED|Overall Study||4||
59658566|NCT03576131|75777058|FG003|NOT COMPLETED|Overall Study||11||
59658567|NCT03576131|75777059|FG004|NOT COMPLETED|Overall Study||7||
59658568|NCT03576131|75777060|FG005|NOT COMPLETED|Overall Study||7||
59658569|NCT03576131|75777061|FG006|NOT COMPLETED|Overall Study||1||
59658570|NCT03576131|75777062|FG007|NOT COMPLETED|Overall Study||1||
59658571|NCT03538587|75777086|FG000|STARTED|Overall Study|2 dyads (each dyad = 1 child, 1 parent)|4||
59658572|NCT03538587|75777087|FG001|STARTED|Overall Study|3 dyads (each dyad = 1 child, 1 parent)|6||
59658573|NCT03538587|75777086|FG000|Child Participants|Overall Study||2||
59658574|NCT03538587|75777087|FG001|Child Participants|Overall Study||3||
59658575|NCT03538587|75777086|FG000|Parent Participants|Overall Study||2||
59658576|NCT03538587|75777087|FG001|Parent Participants|Overall Study||3||
59658577|NCT03538587|75777086|FG000|COMPLETED|Overall Study|1 dyad (each dyad = 1 child, 1 parent)|2||
59658578|NCT03538587|75777087|FG001|COMPLETED|Overall Study|1 dyad (each dyad = 1 child, 1 parent)|2||
59658579|NCT03538587|75777086|FG000|NOT COMPLETED|Overall Study||2||
59658580|NCT03538587|75777087|FG001|NOT COMPLETED|Overall Study||4||
59658581|NCT03520842|75777095|FG000|STARTED|Overall Study||18||
59658582|NCT03520842|75777095|FG000|COMPLETED|Overall Study||18||
59658583|NCT03520842|75777095|FG000|NOT COMPLETED|Overall Study||0||
59658584|NCT03454529|75777099|FG000|STARTED|Overall Study||24||
59658585|NCT03454529|75777099|FG000|COMPLETED|Overall Study||17||
59658586|NCT03454529|75777099|FG000|NOT COMPLETED|Overall Study||7||
59658587|NCT03409731|75777103|FG000|STARTED|Overall Study||135||
59658588|NCT03409731|75777103|FG000|COMPLETED|Overall Study||130||
59658589|NCT03409731|75777103|FG000|NOT COMPLETED|Overall Study||5||
59658590|NCT03284333|75777108|FG000|STARTED|Overall Study||43||
59658591|NCT03284333|75777108|FG000|COMPLETED|Overall Study||38||
59658592|NCT03284333|75777108|FG000|NOT COMPLETED|Overall Study||5||
59658593|NCT03267186|75777112|FG000|STARTED|Overall Study||8||
59658594|NCT03267186|75777112|FG000|COMPLETED|Overall Study||8||
59658595|NCT03267186|75777112|FG000|NOT COMPLETED|Overall Study||0||
59658596|NCT03246061|75777118|FG000|STARTED|Overall Study||66||
59658597|NCT03246061|75777119|FG001|STARTED|Overall Study||74||
59658598|NCT03246061|75777118|FG000|Interim Analysis|Overall Study||51||
59658599|NCT03246061|75777119|FG001|Interim Analysis|Overall Study||53||
59658600|NCT03246061|75777118|FG000|COMPLETED|Overall Study||51||
59658601|NCT03246061|75777119|FG001|COMPLETED|Overall Study||53||
59658602|NCT03246061|75777118|FG000|NOT COMPLETED|Overall Study||15||
59658603|NCT03246061|75777119|FG001|NOT COMPLETED|Overall Study||21||
59658604|NCT03111875|75777129|FG000|STARTED|Overall Study||2529||
59658605|NCT03111875|75777130|FG001|STARTED|Overall Study||2527||
59658606|NCT03111875|75777129|FG000|COMPLETED|Overall Study||2506||
59658607|NCT03111875|75777130|FG001|COMPLETED|Overall Study||2507||
59658608|NCT03111875|75777129|FG000|NOT COMPLETED|Overall Study||23||
59658609|NCT03111875|75777130|FG001|NOT COMPLETED|Overall Study||20||
59658610|NCT02988817|75777156|FG000|STARTED|Overall Study||1||
59658611|NCT02988817|75777157|FG001|STARTED|Overall Study||1||
59658612|NCT02988817|75777158|FG002|STARTED|Overall Study||3||
59658613|NCT02988817|75777159|FG003|STARTED|Overall Study||3||
59658614|NCT02988817|75777160|FG004|STARTED|Overall Study||10||
59658615|NCT02988817|75777161|FG005|STARTED|Overall Study||11||
59658616|NCT02988817|75777162|FG006|STARTED|Overall Study||3||
59658617|NCT02988817|75777163|FG007|STARTED|Overall Study||3||
59658618|NCT02988817|75777164|FG008|STARTED|Overall Study||3||
59658619|NCT02988817|75777165|FG009|STARTED|Overall Study||6||
59658620|NCT02988817|75777166|FG010|STARTED|Overall Study||3||
59658621|NCT02988817|75777167|FG011|STARTED|Overall Study||22||
59658622|NCT02988817|75777168|FG012|STARTED|Overall Study||16||
59658623|NCT02988817|75777169|FG013|STARTED|Overall Study||25||
59658624|NCT02988817|75777170|FG014|STARTED|Overall Study||25||
59658625|NCT02988817|75777171|FG015|STARTED|Overall Study||44||
59658626|NCT02988817|75777172|FG016|STARTED|Overall Study||25||
59658627|NCT02988817|75777173|FG017|STARTED|Overall Study||55||
59658628|NCT02988817|75777174|FG018|STARTED|Overall Study||21||
59658629|NCT02988817|75777175|FG019|STARTED|Overall Study||26||
59658630|NCT02988817|75777156|FG000|COMPLETED|Overall Study||0||
59658631|NCT02988817|75777157|FG001|COMPLETED|Overall Study||0||
59658632|NCT02988817|75777158|FG002|COMPLETED|Overall Study||0||
59658633|NCT02988817|75777159|FG003|COMPLETED|Overall Study||0||
59658634|NCT02988817|75777160|FG004|COMPLETED|Overall Study||0||
59658635|NCT02988817|75777161|FG005|COMPLETED|Overall Study||0||
59658636|NCT02988817|75777162|FG006|COMPLETED|Overall Study||0||
59658637|NCT02988817|75777163|FG007|COMPLETED|Overall Study||0||
59658638|NCT02988817|75777164|FG008|COMPLETED|Overall Study||0||
59658639|NCT02988817|75777165|FG009|COMPLETED|Overall Study||0||
59658640|NCT02988817|75777166|FG010|COMPLETED|Overall Study||0||
59658641|NCT02988817|75777167|FG011|COMPLETED|Overall Study||0||
59658642|NCT02988817|75777168|FG012|COMPLETED|Overall Study||0||
59658643|NCT02988817|75777169|FG013|COMPLETED|Overall Study||0||
59658644|NCT02988817|75777170|FG014|COMPLETED|Overall Study||0||
59658645|NCT02988817|75777171|FG015|COMPLETED|Overall Study||0||
59658646|NCT02988817|75777172|FG016|COMPLETED|Overall Study||0||
59658647|NCT02988817|75777173|FG017|COMPLETED|Overall Study||0||
59658648|NCT02988817|75777174|FG018|COMPLETED|Overall Study||0||
59658649|NCT02988817|75777175|FG019|COMPLETED|Overall Study||0||
59658650|NCT02988817|75777156|FG000|NOT COMPLETED|Overall Study||1||
59658651|NCT02988817|75777157|FG001|NOT COMPLETED|Overall Study||1||
59658652|NCT02988817|75777158|FG002|NOT COMPLETED|Overall Study||3||
59658653|NCT02988817|75777159|FG003|NOT COMPLETED|Overall Study||3||
59658654|NCT02988817|75777160|FG004|NOT COMPLETED|Overall Study||10||
59658655|NCT02988817|75777161|FG005|NOT COMPLETED|Overall Study||11||
59658656|NCT02988817|75777162|FG006|NOT COMPLETED|Overall Study||3||
59658657|NCT02988817|75777163|FG007|NOT COMPLETED|Overall Study||3||
59658658|NCT02988817|75777164|FG008|NOT COMPLETED|Overall Study||3||
59658659|NCT02988817|75777165|FG009|NOT COMPLETED|Overall Study||6||
59658660|NCT02988817|75777166|FG010|NOT COMPLETED|Overall Study||3||
59658661|NCT02988817|75777167|FG011|NOT COMPLETED|Overall Study||22||
59658662|NCT02988817|75777168|FG012|NOT COMPLETED|Overall Study||16||
59658663|NCT02988817|75777169|FG013|NOT COMPLETED|Overall Study||25||
59658664|NCT02988817|75777170|FG014|NOT COMPLETED|Overall Study||25||
59658665|NCT02988817|75777171|FG015|NOT COMPLETED|Overall Study||44||
59658666|NCT02988817|75777172|FG016|NOT COMPLETED|Overall Study||25||
59658667|NCT02988817|75777173|FG017|NOT COMPLETED|Overall Study||55||
59658668|NCT02988817|75777174|FG018|NOT COMPLETED|Overall Study||21||
59658669|NCT02988817|75777175|FG019|NOT COMPLETED|Overall Study||26||
59658670|NCT02960659|75777230|FG000|STARTED|Overall Study||13||
59658671|NCT02960659|75777231|FG001|STARTED|Overall Study||11||
59658672|NCT02960659|75777230|FG000|COMPLETED|Overall Study||12||
59658673|NCT02960659|75777231|FG001|COMPLETED|Overall Study||10||
59658674|NCT02960659|75777230|FG000|NOT COMPLETED|Overall Study||1||
59658675|NCT02960659|75777231|FG001|NOT COMPLETED|Overall Study||1||
59658676|NCT02844933|75777239|FG000|STARTED|Overall Study||4||
59658677|NCT02844933|75777240|FG001|STARTED|Overall Study||3||
59658678|NCT02844933|75777239|FG000|Received at Least 1 Dose of Study Drug|Overall Study||4||
59658679|NCT02844933|75777240|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3||
59658680|NCT02844933|75777239|FG000|COMPLETED|Overall Study||1||
59658681|NCT02844933|75777240|FG001|COMPLETED|Overall Study||1||
59658682|NCT02844933|75777239|FG000|NOT COMPLETED|Overall Study||3||
59658683|NCT02844933|75777240|FG001|NOT COMPLETED|Overall Study||2||
59658684|NCT02797470|75777246|FG000|STARTED|Overall Study||5||
59658685|NCT02797470|75777247|FG001|STARTED|Overall Study||4||
59658686|NCT02797470|75777248|FG002|STARTED|Overall Study||2||
59658687|NCT02797470|75777246|FG000|COMPLETED|Overall Study||5||
59658688|NCT02797470|75777247|FG001|COMPLETED|Overall Study||4||
59658689|NCT02797470|75777248|FG002|COMPLETED|Overall Study||2||
59658690|NCT02797470|75777246|FG000|NOT COMPLETED|Overall Study||0||
59658691|NCT02797470|75777247|FG001|NOT COMPLETED|Overall Study||0||
59658692|NCT02797470|75777248|FG002|NOT COMPLETED|Overall Study||0||
59658693|NCT02561221|75777258|FG000|STARTED|Overall Study||452||9
59658694|NCT02561221|75777259|FG001|STARTED|Overall Study||351||9
59658695|NCT02561221|75777258|FG000|Month 6|Overall Study||386||9
59658696|NCT02561221|75777259|FG001|Month 6|Overall Study||340||9
59658697|NCT02561221|75777258|FG000|Month 12|Overall Study||365||9
59658698|NCT02561221|75777259|FG001|Month 12|Overall Study||326||9
59658699|NCT02561221|75777258|FG000|Month 18|Overall Study||357||9
59658700|NCT02561221|75777259|FG001|Month 18|Overall Study||316||9
59658701|NCT02561221|75777258|FG000|COMPLETED|Overall Study||362||9
59658702|NCT02561221|75777259|FG001|COMPLETED|Overall Study||308||9
59658703|NCT02561221|75777258|FG000|NOT COMPLETED|Overall Study||90||0
59658704|NCT02561221|75777259|FG001|NOT COMPLETED|Overall Study||43||0
59658705|NCT02499835|75777269|FG000|STARTED|Overall Study||13||
59658706|NCT02499835|75777270|FG001|STARTED|Overall Study||13||
59658707|NCT02499835|75777271|FG002|STARTED|Overall Study||20||
59658708|NCT02499835|75777272|FG003|STARTED|Overall Study||20||
59658709|NCT02499835|75777269|FG000|COMPLETED|Overall Study||10||
59658710|NCT02499835|75777270|FG001|COMPLETED|Overall Study||9||
59658711|NCT02499835|75777271|FG002|COMPLETED|Overall Study||2||
59658712|NCT02499835|75777272|FG003|COMPLETED|Overall Study||4||
59658713|NCT02499835|75777269|FG000|NOT COMPLETED|Overall Study||3||
59658714|NCT02499835|75777270|FG001|NOT COMPLETED|Overall Study||4||
59658715|NCT02499835|75777271|FG002|NOT COMPLETED|Overall Study||18||
59658716|NCT02499835|75777272|FG003|NOT COMPLETED|Overall Study||16||
59658717|NCT02460497|75777284|FG000|STARTED|Overall Study||61||
59658718|NCT02460497|75777284|FG000|Intent-to-treat (ITT) Population|Overall Study||54||
59658719|NCT02460497|75777284|FG000|Safety Population (SP)|Overall Study||60||
59658720|NCT02460497|75777284|FG000|COMPLETED|Overall Study||52||
59658721|NCT02460497|75777284|FG000|NOT COMPLETED|Overall Study||9||
59658722|NCT02460289|75777288|FG000|STARTED|Overall Study||63||
59658723|NCT02460289|75777288|FG000|Intent to Treat (ITT) Population|Overall Study||56||
59658724|NCT02460289|75777288|FG000|Safety Population (SP)|Overall Study||61||
59658725|NCT02460289|75777288|FG000|COMPLETED|Overall Study||53||
59658726|NCT02460289|75777288|FG000|NOT COMPLETED|Overall Study||10||
59658727|NCT02384317|75777292|FG000|STARTED|Overall Study||7||
59658728|NCT02384317|75777292|FG000|COMPLETED|Overall Study||7||
59658729|NCT02384317|75777292|FG000|NOT COMPLETED|Overall Study||0||
59658730|NCT02354651|75777299|FG000|STARTED|Overall Study||9||
59658731|NCT02354651|75777299|FG000|COMPLETED|Overall Study||6||
59658732|NCT02354651|75777299|FG000|NOT COMPLETED|Overall Study||3||
59658733|NCT02253316|75777306|FG000|STARTED|Consolidation||236||
59658734|NCT02253316|75777307|FG001|STARTED|Consolidation||0||
59658735|NCT02253316|75777308|FG002|STARTED|Consolidation||0||
59658736|NCT02253316|75777306|FG000|COMPLETED|Consolidation||220||
59658737|NCT02253316|75777307|FG001|COMPLETED|Consolidation||0||
59658738|NCT02253316|75777308|FG002|COMPLETED|Consolidation||0||
59658739|NCT02253316|75777306|FG000|NOT COMPLETED|Consolidation||16||
59658740|NCT02253316|75777307|FG001|NOT COMPLETED|Consolidation||0||
59658741|NCT02253316|75777308|FG002|NOT COMPLETED|Consolidation||0||
59658742|NCT02253316|75777306|FG000|STARTED|Maintenance||0||
59658743|NCT02253316|75777307|FG001|STARTED|Maintenance||99||
60077172|NCT01884025|76192200|FG001|COMPLETED|Overall Study||10||
60077173|NCT01884025|76192199|FG000|NOT COMPLETED|Overall Study||3||
60077174|NCT01884025|76192200|FG001|NOT COMPLETED|Overall Study||4||
60077175|NCT01896193|76192210|FG000|STARTED|Overall Study||62||
59658744|NCT02253316|75777308|FG002|STARTED|Maintenance||116||
59658745|NCT02253316|75777306|FG000|COMPLETED|Maintenance||0||
59658746|NCT02253316|75777307|FG001|COMPLETED|Maintenance||68||
59658747|NCT02253316|75777308|FG002|COMPLETED|Maintenance||74||
59658748|NCT02253316|75777306|FG000|NOT COMPLETED|Maintenance||0||
59658749|NCT02253316|75777307|FG001|NOT COMPLETED|Maintenance||31||
59658750|NCT02253316|75777308|FG002|NOT COMPLETED|Maintenance||42||
59658751|NCT02214160|75777319|FG000|STARTED|Overall Study||24||
59658752|NCT02214160|75777320|FG001|STARTED|Overall Study||37||
59658753|NCT02214160|75777321|FG002|STARTED|Overall Study||33||
59658754|NCT02214160|75777319|FG000|COMPLETED|Overall Study||20||
59658755|NCT02214160|75777320|FG001|COMPLETED|Overall Study||29||
59658756|NCT02214160|75777321|FG002|COMPLETED|Overall Study||23||
59658757|NCT02214160|75777319|FG000|NOT COMPLETED|Overall Study||4||
59658758|NCT02214160|75777320|FG001|NOT COMPLETED|Overall Study||8||
60077176|NCT01896193|76192211|FG001|STARTED|Overall Study||65||
59658759|NCT02214160|75777321|FG002|NOT COMPLETED|Overall Study||10||
59658760|NCT02169089|75777335|FG000|STARTED|Overall Study||37||
60077177|NCT01896193|76192210|FG000|COMPLETED|Overall Study||41||
59658761|NCT02169089|75777336|FG001|STARTED|Overall Study||42||
59658762|NCT02169089|75777335|FG000|COMPLETED|Overall Study||26||
59658763|NCT02169089|75777336|FG001|COMPLETED|Overall Study||25||
59658764|NCT02169089|75777335|FG000|NOT COMPLETED|Overall Study||11||
59658765|NCT02169089|75777336|FG001|NOT COMPLETED|Overall Study||17||
59658766|NCT02099864|75777342|FG000|STARTED|Overall Study||36||
59658767|NCT02099864|75777342|FG000|COMPLETED|Overall Study||36||
59658768|NCT02099864|75777342|FG000|NOT COMPLETED|Overall Study||0||
59658769|NCT02059265|75777350|FG000|STARTED|Overall Study||32||
59658770|NCT02059265|75777350|FG000|COMPLETED|Overall Study||28||
59658771|NCT02059265|75777350|FG000|NOT COMPLETED|Overall Study||4||
59658772|NCT01719744|75777354|FG000|STARTED|Overall Study||25||
59658773|NCT01719744|75777354|FG000|COMPLETED|Overall Study||25||
59658774|NCT01719744|75777354|FG000|NOT COMPLETED|Overall Study||0||
59658775|NCT01130519|75777362|FG000|STARTED|Overall Study||20||
59658776|NCT01130519|75777363|FG001|STARTED|Overall Study||21||
59658777|NCT01130519|75777364|FG002|STARTED|Overall Study||23||
59658778|NCT01130519|75777365|FG003|STARTED|Overall Study||19||
59658779|NCT01130519|75777362|FG000|COMPLETED|Overall Study||20||
59658780|NCT01130519|75777363|FG001|COMPLETED|Overall Study||21||
59658781|NCT01130519|75777364|FG002|COMPLETED|Overall Study||23||
59658782|NCT01130519|75777365|FG003|COMPLETED|Overall Study||19||
59658783|NCT01130519|75777362|FG000|NOT COMPLETED|Overall Study||0||
59658784|NCT01130519|75777363|FG001|NOT COMPLETED|Overall Study||0||
59658785|NCT01130519|75777364|FG002|NOT COMPLETED|Overall Study||0||
59658786|NCT01130519|75777365|FG003|NOT COMPLETED|Overall Study||0||
59658787|NCT00601198|75777371|FG000|STARTED|Overall Study||4||
59658788|NCT00601198|75777371|FG000|COMPLETED|Overall Study||4||
59658789|NCT00601198|75777371|FG000|NOT COMPLETED|Overall Study||0||
59658790|NCT04983589|75777377|FG000|STARTED|Overall Study||116||
59658791|NCT04983589|75777378|FG001|STARTED|Overall Study||114||
59658792|NCT04983589|75777377|FG000|COMPLETED|Overall Study||113||
59658793|NCT04983589|75777378|FG001|COMPLETED|Overall Study||111||
59658794|NCT04983589|75777377|FG000|NOT COMPLETED|Overall Study||3||
59658795|NCT04983589|75777378|FG001|NOT COMPLETED|Overall Study||3||
59658796|NCT04850794|75777386|FG000|STARTED|Read 1st Case Study Without Tool||28||
59658797|NCT04850794|75777387|FG001|STARTED|Read 1st Case Study Without Tool||28||
59658798|NCT04850794|75777386|FG000|COMPLETED|Read 1st Case Study Without Tool||28||
59658799|NCT04850794|75777387|FG001|COMPLETED|Read 1st Case Study Without Tool||28||
59658800|NCT04850794|75777386|FG000|NOT COMPLETED|Read 1st Case Study Without Tool||0||
59658801|NCT04850794|75777387|FG001|NOT COMPLETED|Read 1st Case Study Without Tool||0||
59658802|NCT04850794|75777386|FG000|STARTED|Read 2nd Case Study With Tool||28||
59658803|NCT04850794|75777387|FG001|STARTED|Read 2nd Case Study With Tool||28||
59658804|NCT04850794|75777386|FG000|COMPLETED|Read 2nd Case Study With Tool||28||
59658805|NCT04850794|75777387|FG001|COMPLETED|Read 2nd Case Study With Tool||28||
59658806|NCT04850794|75777386|FG000|NOT COMPLETED|Read 2nd Case Study With Tool||0||
59658807|NCT04850794|75777387|FG001|NOT COMPLETED|Read 2nd Case Study With Tool||0||
59658808|NCT04783389|75777399|FG000|STARTED|Overall Study||13||
59658809|NCT04783389|75777400|FG001|STARTED|Overall Study||13||
59658810|NCT04783389|75777401|FG002|STARTED|Overall Study||14||
59658811|NCT04783389|75777399|FG000|COMPLETED|Overall Study||1||
59658812|NCT04783389|75777400|FG001|COMPLETED|Overall Study||1||
59658813|NCT04783389|75777401|FG002|COMPLETED|Overall Study||0||
59658814|NCT04783389|75777399|FG000|NOT COMPLETED|Overall Study||12||
59658815|NCT04783389|75777400|FG001|NOT COMPLETED|Overall Study||12||
59658816|NCT04783389|75777401|FG002|NOT COMPLETED|Overall Study||14||
59658817|NCT04556591|75777422|FG000|STARTED|Overall Study||36||
59658818|NCT04556591|75777423|FG001|STARTED|Overall Study||36||
59658819|NCT04556591|75777422|FG000|COMPLETED|Overall Study||33||
59658820|NCT04556591|75777423|FG001|COMPLETED|Overall Study||36||
59658821|NCT04556591|75777422|FG000|NOT COMPLETED|Overall Study||3||
59658822|NCT04556591|75777423|FG001|NOT COMPLETED|Overall Study||0||
59658823|NCT04428034|75777432|FG000|STARTED|Enrollment to Intervention Completion||41||
59658824|NCT04428034|75777432|FG000|Attended at Least 2 Intervention Sessions in One Cohort|Enrollment to Intervention Completion|Forty-one (41) participants enrolled and completed the baseline survey. Of those who completed the baseline survey, three participants did not attend at least two sessions. Three participants started the intervention in one cohort but completed it in another (off-protocol).|35||
59658825|NCT04428034|75777432|FG000|COMPLETED|Enrollment to Intervention Completion||35||
59988872|NCT04201262|76104130|FG000|Received at Least 1 Dose of Study Drug|Overall Study||58||
59658826|NCT04428034|75777432|FG000|NOT COMPLETED|Enrollment to Intervention Completion||6||
59658827|NCT04428034|75777432|FG000|STARTED|4-Week Follow Up Survey||35||
59658828|NCT04428034|75777432|FG000|COMPLETED|4-Week Follow Up Survey||29||
59658829|NCT04428034|75777432|FG000|NOT COMPLETED|4-Week Follow Up Survey||6||
59658830|NCT04428034|75777432|FG000|STARTED|8-Week Follow Up Survey||29||
59658831|NCT04428034|75777432|FG000|COMPLETED|8-Week Follow Up Survey|Of those 27 who completed the 8-week follow up survey, one participant skipped the 4-week follow up survey but completed the 8-week survey.|27||
59658832|NCT04428034|75777432|FG000|NOT COMPLETED|8-Week Follow Up Survey||2||
59658833|NCT04394247|75777436|FG000|STARTED|Overall Study||242||
59658834|NCT04394247|75777436|FG000|COMPLETED|Overall Study||242||
59658835|NCT04394247|75777436|FG000|NOT COMPLETED|Overall Study||0||
59658836|NCT04364984|75777443|FG000|STARTED|Overall Study||37||
59658837|NCT04364984|75777444|FG001|STARTED|Overall Study||44||
59658838|NCT04364984|75777445|FG002|STARTED|Overall Study||31||
59658839|NCT04364984|75777443|FG000|COMPLETED|Overall Study||35||
59658840|NCT04364984|75777444|FG001|COMPLETED|Overall Study||42||
59658841|NCT04364984|75777445|FG002|COMPLETED|Overall Study||31||
59658842|NCT04364984|75777443|FG000|NOT COMPLETED|Overall Study||2||
59658843|NCT04364984|75777444|FG001|NOT COMPLETED|Overall Study||2||
59658844|NCT04364984|75777445|FG002|NOT COMPLETED|Overall Study||0||
59658845|NCT04294095|75777455|FG000|STARTED|Overall Study||26||
59658846|NCT04294095|75777456|FG001|STARTED|Overall Study||24||
59658847|NCT04294095|75777455|FG000|COMPLETED|Overall Study||25||
59658848|NCT04294095|75777456|FG001|COMPLETED|Overall Study||24||
59658849|NCT04294095|75777455|FG000|NOT COMPLETED|Overall Study||1||
59658850|NCT04294095|75777456|FG001|NOT COMPLETED|Overall Study||0||
59658851|NCT04266028|75777472|FG000|STARTED|Overall Study||4||
59658852|NCT04266028|75777473|FG001|STARTED|Overall Study||2||
59658853|NCT04266028|75777474|FG002|STARTED|Overall Study||6||
59658854|NCT04266028|75777475|FG003|STARTED|Overall Study||2||
59658855|NCT04266028|75777476|FG004|STARTED|Overall Study||6||
59658856|NCT04266028|75777477|FG005|STARTED|Overall Study||2||
59658857|NCT04266028|75777478|FG006|STARTED|Overall Study||4||
59658858|NCT04266028|75777479|FG007|STARTED|Overall Study||1||
59658859|NCT04266028|75777472|FG000|COMPLETED|Overall Study||4||
59658860|NCT04266028|75777473|FG001|COMPLETED|Overall Study||2||
59658861|NCT04266028|75777474|FG002|COMPLETED|Overall Study||5||
59658862|NCT04266028|75777475|FG003|COMPLETED|Overall Study||2||
59658863|NCT04266028|75777476|FG004|COMPLETED|Overall Study||4||
59658864|NCT04266028|75777477|FG005|COMPLETED|Overall Study||2||
59658865|NCT04266028|75777478|FG006|COMPLETED|Overall Study||0||
59658866|NCT04266028|75777479|FG007|COMPLETED|Overall Study||0||
59658867|NCT04266028|75777472|FG000|NOT COMPLETED|Overall Study||0||
59658868|NCT04266028|75777473|FG001|NOT COMPLETED|Overall Study||0||
59658869|NCT04266028|75777474|FG002|NOT COMPLETED|Overall Study||1||
59658870|NCT04266028|75777475|FG003|NOT COMPLETED|Overall Study||0||
59658871|NCT04266028|75777476|FG004|NOT COMPLETED|Overall Study||2||
59658872|NCT04266028|75777477|FG005|NOT COMPLETED|Overall Study||0||
59658873|NCT04266028|75777478|FG006|NOT COMPLETED|Overall Study||4||
59658874|NCT04266028|75777479|FG007|NOT COMPLETED|Overall Study||1||
59658875|NCT04221087|75777503|FG000|STARTED|Overall Study||2||
59658876|NCT04221087|75777504|FG001|STARTED|Overall Study||1||
59658877|NCT04221087|75777503|FG000|COMPLETED|Overall Study||2||
59658878|NCT04221087|75777504|FG001|COMPLETED|Overall Study||0||
59658879|NCT04221087|75777503|FG000|NOT COMPLETED|Overall Study||0||
59658880|NCT04221087|75777504|FG001|NOT COMPLETED|Overall Study||1||
59658881|NCT04026308|75777512|FG000|STARTED|Overall Study||14||
59658882|NCT04026308|75777513|FG001|STARTED|Overall Study||16||
59658883|NCT04026308|75777512|FG000|COMPLETED|Overall Study||14||
59658884|NCT04026308|75777513|FG001|COMPLETED|Overall Study||16||
59658885|NCT04026308|75777512|FG000|NOT COMPLETED|Overall Study||0||
59658886|NCT04026308|75777513|FG001|NOT COMPLETED|Overall Study||0||
59658887|NCT03994731|75777521|FG000|STARTED|Run-in Period (From Week -4 to Day 1)||100|Randomized|
59658888|NCT03994731|75777522|FG001|STARTED|Run-in Period (From Week -4 to Day 1)||52|Randomized|
59658889|NCT03994731|75777521|FG000|Took at Least 1 Dose of MTX or Placebo|Run-in Period (From Week -4 to Day 1)||98||
59658890|NCT03994731|75777522|FG001|Took at Least 1 Dose of MTX or Placebo|Run-in Period (From Week -4 to Day 1)||51||
59658891|NCT03994731|75777521|FG000|COMPLETED|Run-in Period (From Week -4 to Day 1)||96||
59658892|NCT03994731|75777522|FG001|COMPLETED|Run-in Period (From Week -4 to Day 1)||49||
59658893|NCT03994731|75777521|FG000|NOT COMPLETED|Run-in Period (From Week -4 to Day 1)||4||
59658894|NCT03994731|75777522|FG001|NOT COMPLETED|Run-in Period (From Week -4 to Day 1)||3||
59658895|NCT03994731|75777521|FG000|STARTED|Pegloticase + IMM Period||96||
59658896|NCT03994731|75777522|FG001|STARTED|Pegloticase + IMM Period||49||
59658897|NCT03994731|75777521|FG000|COMPLETED|Pegloticase + IMM Period||76||
59658898|NCT03994731|75777522|FG001|COMPLETED|Pegloticase + IMM Period||34||
59658899|NCT03994731|75777521|FG000|NOT COMPLETED|Pegloticase + IMM Period||20||
59658900|NCT03994731|75777522|FG001|NOT COMPLETED|Pegloticase + IMM Period||15||
59658901|NCT03801915|75777534|FG000|STARTED|Overall Study||8||
59658902|NCT03801915|75777535|FG001|STARTED|Overall Study||1||
59658903|NCT03801915|75777536|FG002|STARTED|Overall Study||1||
59658904|NCT03801915|75777534|FG000|COMPLETED|Overall Study||5||
59658905|NCT03801915|75777535|FG001|COMPLETED|Overall Study||0||
59658906|NCT03801915|75777536|FG002|COMPLETED|Overall Study||0||
59658907|NCT03801915|75777534|FG000|NOT COMPLETED|Overall Study||3||
59658908|NCT03801915|75777535|FG001|NOT COMPLETED|Overall Study||1||
59658909|NCT03801915|75777536|FG002|NOT COMPLETED|Overall Study||1||
59658910|NCT03657849|75777542|FG000|STARTED|Overall Study||60||144
59658911|NCT03657849|75777542|FG000|COMPLETED|Overall Study|Although 3 lymph nodes were excluded from analysis, at least 1 lymph node from each participant was included. The 3 excluded lymph nodes were removed due to protocol deviations related to sampling.|60||141
59658912|NCT03657849|75777542|FG000|NOT COMPLETED|Overall Study||0||3
59658913|NCT03581305|75777550|FG000|STARTED|Dopaminergic Study||23||
59658914|NCT03581305|75777551|FG001|STARTED|Dopaminergic Study||23||
59658915|NCT03581305|75777550|FG000|COMPLETED|Dopaminergic Study||20|this includes participants who finished the scan|
59658916|NCT03581305|75777551|FG001|COMPLETED|Dopaminergic Study||22|this includes participants who finished the scan|
59658917|NCT03581305|75777550|FG000|NOT COMPLETED|Dopaminergic Study||3||
59658918|NCT03581305|75777551|FG001|NOT COMPLETED|Dopaminergic Study||1||
59658919|NCT03581305|75777550|FG000|STARTED|Serotonergic Study||23|this includes participants who finished the DASB scan.|
59658920|NCT03581305|75777551|FG001|STARTED|Serotonergic Study||23|this includes participants who finished the DASB scan.|
59658921|NCT03581305|75777550|FG000|COMPLETED|Serotonergic Study||18||
59658922|NCT03581305|75777551|FG001|COMPLETED|Serotonergic Study||22||
59658923|NCT03581305|75777550|FG000|NOT COMPLETED|Serotonergic Study||5||
59658924|NCT03581305|75777551|FG001|NOT COMPLETED|Serotonergic Study||1||
59658925|NCT03556202|75777562|FG000|STARTED|Extension Treatment Period||527||
59658926|NCT03556202|75777563|FG001|STARTED|Extension Treatment Period||1020||
59658927|NCT03556202|75777564|FG002|STARTED|Extension Treatment Period||389||
59658928|NCT03556202|75777562|FG000|Received at Least One Dose of Study Drug|Extension Treatment Period||527||
59658929|NCT03556202|75777563|FG001|Received at Least One Dose of Study Drug|Extension Treatment Period||1020||
59658930|NCT03556202|75777564|FG002|Received at Least One Dose of Study Drug|Extension Treatment Period||389||
59658931|NCT03556202|75777562|FG000|From AMAF|Extension Treatment Period||35||
59658932|NCT03556202|75777563|FG001|From AMAF|Extension Treatment Period||132||
59658933|NCT03556202|75777564|FG002|From AMAF|Extension Treatment Period||0||
59658934|NCT03556202|75777562|FG000|From AMAK|Extension Treatment Period||83||
59658935|NCT03556202|75777563|FG001|From AMAK|Extension Treatment Period||390||
59658936|NCT03556202|75777564|FG002|From AMAK|Extension Treatment Period||0||
59658937|NCT03556202|75777562|FG000|From AMAJ|Extension Treatment Period||409||
59658938|NCT03556202|75777563|FG001|From AMAJ|Extension Treatment Period||498||
59658939|NCT03556202|75777564|FG002|From AMAJ|Extension Treatment Period||389||
59658940|NCT03556202|75777562|FG000|COMPLETED|Extension Treatment Period||0||
59658941|NCT03556202|75777563|FG001|COMPLETED|Extension Treatment Period||0||
59658942|NCT03556202|75777564|FG002|COMPLETED|Extension Treatment Period||0||
59658943|NCT03556202|75777562|FG000|NOT COMPLETED|Extension Treatment Period||527||
59658944|NCT03556202|75777563|FG001|NOT COMPLETED|Extension Treatment Period||1020||
59658945|NCT03556202|75777564|FG002|NOT COMPLETED|Extension Treatment Period||389||
59658946|NCT03556202|75777562|FG000|STARTED|Follow-Up Period (12 Weeks)|Participants were assigned to this arm during follow-up period.|453||
59658947|NCT03556202|75777563|FG001|STARTED|Follow-Up Period (12 Weeks)|Participants were assigned to this arm during follow-up period.|861||
59658948|NCT03556202|75777564|FG002|STARTED|Follow-Up Period (12 Weeks)|Participants were assigned to this arm during follow-up period.|333||
59658949|NCT03556202|75777562|FG000|COMPLETED|Follow-Up Period (12 Weeks)||0||
59658950|NCT03556202|75777563|FG001|COMPLETED|Follow-Up Period (12 Weeks)||0||
59658951|NCT03556202|75777564|FG002|COMPLETED|Follow-Up Period (12 Weeks)||0||
59658952|NCT03556202|75777562|FG000|NOT COMPLETED|Follow-Up Period (12 Weeks)||453||
59658953|NCT03556202|75777563|FG001|NOT COMPLETED|Follow-Up Period (12 Weeks)||861||
59658954|NCT03556202|75777564|FG002|NOT COMPLETED|Follow-Up Period (12 Weeks)||333||
59658955|NCT03541174|75777578|FG000|STARTED|Part 1 Double-Blind||243||
59658956|NCT03541174|75777579|FG001|STARTED|Part 1 Double-Blind||243||
59658957|NCT03541174|75777580|FG002|STARTED|Part 1 Double-Blind||244||
59658958|NCT03541174|75777581|FG003|STARTED|Part 1 Double-Blind||0||
59658959|NCT03541174|75777582|FG004|STARTED|Part 1 Double-Blind||0||
59658960|NCT03541174|75777583|FG005|STARTED|Part 1 Double-Blind||0||
59658961|NCT03541174|75777578|FG000|Safety Set|Part 1 Double-Blind||243|Two participants randomized to placebo received at least one dose of aprocitentan 25 mg during double-blind part 1.|
59658962|NCT03541174|75777579|FG001|Safety Set|Part 1 Double-Blind||245|Two participants randomized to placebo received at least one dose of aprocitentan 25 mg during double-blind part 1.|
59658963|NCT03541174|75777580|FG002|Safety Set|Part 1 Double-Blind||242|Two participants randomized to placebo received at least one dose of aprocitentan 25 mg during double-blind part 1.|
59658964|NCT03541174|75777581|FG003|Safety Set|Part 1 Double-Blind||0|Two participants randomized to placebo received at least one dose of aprocitentan 25 mg during double-blind part 1.|
59658965|NCT03541174|75777582|FG004|Safety Set|Part 1 Double-Blind||0|Two participants randomized to placebo received at least one dose of aprocitentan 25 mg during double-blind part 1.|
59658966|NCT03541174|75777583|FG005|Safety Set|Part 1 Double-Blind||0|Two participants randomized to placebo received at least one dose of aprocitentan 25 mg during double-blind part 1.|
59658967|NCT03541174|75777578|FG000|COMPLETED|Part 1 Double-Blind||232||
59658968|NCT03541174|75777579|FG001|COMPLETED|Part 1 Double-Blind||234||
59658969|NCT03541174|75777580|FG002|COMPLETED|Part 1 Double-Blind||238||
59658970|NCT03541174|75777581|FG003|COMPLETED|Part 1 Double-Blind||0||
59658971|NCT03541174|75777582|FG004|COMPLETED|Part 1 Double-Blind||0||
59658972|NCT03541174|75777583|FG005|COMPLETED|Part 1 Double-Blind||0||
59658973|NCT03541174|75777578|FG000|NOT COMPLETED|Part 1 Double-Blind||11||
59658974|NCT03541174|75777579|FG001|NOT COMPLETED|Part 1 Double-Blind||9||
59658975|NCT03541174|75777580|FG002|NOT COMPLETED|Part 1 Double-Blind||6||
59658976|NCT03541174|75777581|FG003|NOT COMPLETED|Part 1 Double-Blind||0||
59658977|NCT03541174|75777582|FG004|NOT COMPLETED|Part 1 Double-Blind||0||
59658978|NCT03541174|75777583|FG005|NOT COMPLETED|Part 1 Double-Blind||0||
59658979|NCT03541174|75777578|FG000|STARTED|Part 2 Single-Blind|The 232 participants that completed 12.5 mg aprocitentan study treatment in part 1 entered the single-blind 25 mg aprocitentan arm in part 2.|0||
59544304|NCT01654445|75642691|FG001|STARTED|Overall Study||25||
59995463|NCT02155946|76111290|FG003|STARTED|Overall Study||24||
59658980|NCT03541174|75777579|FG001|STARTED|Part 2 Single-Blind|The 236 participants that completed 25 mg aprocitentan study treatment in part 1 entered the single-blind 25 mg aprocitentan arm in part 2.|0||
59658981|NCT03541174|75777580|FG002|STARTED|Part 2 Single-Blind|The 236 participants that completed placebo study treatment in part 1 entered the single-blind 25 mg aprocitentan arm in part 2.|0||
59658982|NCT03541174|75777581|FG003|STARTED|Part 2 Single-Blind|Total number of participants that completed the double-blind part 1 who entered the single-blind, single-arm part 2.|704||
59658983|NCT03541174|75777582|FG004|STARTED|Part 2 Single-Blind||0||
59658984|NCT03541174|75777583|FG005|STARTED|Part 2 Single-Blind||0||
59658985|NCT03541174|75777578|FG000|COMPLETED|Part 2 Single-Blind||0||
59658986|NCT03541174|75777579|FG001|COMPLETED|Part 2 Single-Blind||0||
59658987|NCT03541174|75777580|FG002|COMPLETED|Part 2 Single-Blind||0||
59658988|NCT03541174|75777581|FG003|COMPLETED|Part 2 Single-Blind||613||
59658989|NCT03541174|75777582|FG004|COMPLETED|Part 2 Single-Blind||0||
59658990|NCT03541174|75777583|FG005|COMPLETED|Part 2 Single-Blind||0||
59658991|NCT03541174|75777578|FG000|NOT COMPLETED|Part 2 Single-Blind||0||
59658992|NCT03541174|75777579|FG001|NOT COMPLETED|Part 2 Single-Blind||0||
59658993|NCT03541174|75777580|FG002|NOT COMPLETED|Part 2 Single-Blind||0||
59658994|NCT03541174|75777581|FG003|NOT COMPLETED|Part 2 Single-Blind||91||
59658995|NCT03541174|75777582|FG004|NOT COMPLETED|Part 2 Single-Blind||0||
59658996|NCT03541174|75777583|FG005|NOT COMPLETED|Part 2 Single-Blind||0||
59658997|NCT03541174|75777578|FG000|STARTED|Part 3 Double-Blind Withdrawal||0||
59658998|NCT03541174|75777579|FG001|STARTED|Part 3 Double-Blind Withdrawal||0||
59658999|NCT03541174|75777580|FG002|STARTED|Part 3 Double-Blind Withdrawal||0||
59659000|NCT03541174|75777581|FG003|STARTED|Part 3 Double-Blind Withdrawal||0||
59659001|NCT03541174|75777582|FG004|STARTED|Part 3 Double-Blind Withdrawal||307||
59659002|NCT03541174|75777583|FG005|STARTED|Part 3 Double-Blind Withdrawal||307||
59659003|NCT03541174|75777578|FG000|Safety Set|Part 3 Double-Blind Withdrawal||0|613 participants started study treatment in Part 3. Four participants re-randomised to placebo received at least one dose of aprocitentan 25 mg during part 3.|
59659004|NCT03541174|75777579|FG001|Safety Set|Part 3 Double-Blind Withdrawal||0|613 participants started study treatment in Part 3. Four participants re-randomised to placebo received at least one dose of aprocitentan 25 mg during part 3.|
59659005|NCT03541174|75777580|FG002|Safety Set|Part 3 Double-Blind Withdrawal||0|613 participants started study treatment in Part 3. Four participants re-randomised to placebo received at least one dose of aprocitentan 25 mg during part 3.|
59659006|NCT03541174|75777581|FG003|Safety Set|Part 3 Double-Blind Withdrawal||0|613 participants started study treatment in Part 3. Four participants re-randomised to placebo received at least one dose of aprocitentan 25 mg during part 3.|
59659007|NCT03541174|75777582|FG004|Safety Set|Part 3 Double-Blind Withdrawal||310|613 participants started study treatment in Part 3. Four participants re-randomised to placebo received at least one dose of aprocitentan 25 mg during part 3.|
59659008|NCT03541174|75777583|FG005|Safety Set|Part 3 Double-Blind Withdrawal||303|613 participants started study treatment in Part 3. Four participants re-randomised to placebo received at least one dose of aprocitentan 25 mg during part 3.|
59659009|NCT03541174|75777578|FG000|COMPLETED|Part 3 Double-Blind Withdrawal||0||
59659010|NCT03541174|75777579|FG001|COMPLETED|Part 3 Double-Blind Withdrawal||0||
59659011|NCT03541174|75777580|FG002|COMPLETED|Part 3 Double-Blind Withdrawal||0||
59659012|NCT03541174|75777581|FG003|COMPLETED|Part 3 Double-Blind Withdrawal||0||
59659013|NCT03541174|75777582|FG004|COMPLETED|Part 3 Double-Blind Withdrawal||288||
59659014|NCT03541174|75777583|FG005|COMPLETED|Part 3 Double-Blind Withdrawal||289||
59659015|NCT03541174|75777578|FG000|NOT COMPLETED|Part 3 Double-Blind Withdrawal||0||
59659016|NCT03541174|75777579|FG001|NOT COMPLETED|Part 3 Double-Blind Withdrawal||0||
59659017|NCT03541174|75777580|FG002|NOT COMPLETED|Part 3 Double-Blind Withdrawal||0||
59659018|NCT03541174|75777581|FG003|NOT COMPLETED|Part 3 Double-Blind Withdrawal||0||
59659019|NCT03541174|75777582|FG004|NOT COMPLETED|Part 3 Double-Blind Withdrawal||19||
59659020|NCT03541174|75777583|FG005|NOT COMPLETED|Part 3 Double-Blind Withdrawal||18||
60077178|NCT01896193|76192211|FG001|COMPLETED|Overall Study||53||
59659021|NCT03329508|75777600|FG000|STARTED|Overall Study||157||
59659022|NCT03329508|75777601|FG001|STARTED|Overall Study||154||
59659023|NCT03329508|75777602|FG002|STARTED|Overall Study||156||
59659024|NCT03329508|75777603|FG003|STARTED|Overall Study||77||
59659025|NCT03329508|75777600|FG000|COMPLETED|Overall Study||137||
59659026|NCT03329508|75777601|FG001|COMPLETED|Overall Study||134||
59659027|NCT03329508|75777602|FG002|COMPLETED|Overall Study||137||
59659028|NCT03329508|75777603|FG003|COMPLETED|Overall Study||67||
59659029|NCT03329508|75777600|FG000|NOT COMPLETED|Overall Study||20||
59659030|NCT03329508|75777601|FG001|NOT COMPLETED|Overall Study||20||
59659031|NCT03329508|75777602|FG002|NOT COMPLETED|Overall Study||19||
59659032|NCT03329508|75777603|FG003|NOT COMPLETED|Overall Study||10||
59659033|NCT03289039|75777615|FG000|STARTED|Overall Study||11||
59659034|NCT03289039|75777616|FG001|STARTED|Overall Study||10||
59659035|NCT03289039|75777615|FG000|COMPLETED|Overall Study||10||
59659036|NCT03289039|75777616|FG001|COMPLETED|Overall Study||8||
59659037|NCT03289039|75777615|FG000|NOT COMPLETED|Overall Study||1||
59659038|NCT03289039|75777616|FG001|NOT COMPLETED|Overall Study||2||
59659039|NCT03281304|75777624|FG000|STARTED|Treatment Phase (up to 42 Months)||70||
59659040|NCT03281304|75777625|FG001|STARTED|Treatment Phase (up to 42 Months)||70||
59659041|NCT03281304|75777624|FG000|COMPLETED|Treatment Phase (up to 42 Months)||36||
59659042|NCT03281304|75777625|FG001|COMPLETED|Treatment Phase (up to 42 Months)||27||
59659043|NCT03281304|75777624|FG000|NOT COMPLETED|Treatment Phase (up to 42 Months)||34||
59659044|NCT03281304|75777625|FG001|NOT COMPLETED|Treatment Phase (up to 42 Months)||43||
59659045|NCT03281304|75777624|FG000|STARTED|Follow-up Phase (up to 4 Weeks)|Participants could be followed up even if they did not complete treatment.|63||
59659046|NCT03281304|75777625|FG001|STARTED|Follow-up Phase (up to 4 Weeks)|Participants could be followed up even if they did not complete treatment.|57||
59659047|NCT03281304|75777624|FG000|COMPLETED|Follow-up Phase (up to 4 Weeks)||61||
59659048|NCT03281304|75777625|FG001|COMPLETED|Follow-up Phase (up to 4 Weeks)||56||
59659049|NCT03281304|75777624|FG000|NOT COMPLETED|Follow-up Phase (up to 4 Weeks)||2||
59659050|NCT03281304|75777625|FG001|NOT COMPLETED|Follow-up Phase (up to 4 Weeks)||1||
59659051|NCT03204305|75777634|FG000|STARTED|Overall Study||21||
59659052|NCT03204305|75777635|FG001|STARTED|Overall Study||7||
59659053|NCT03204305|75777636|FG002|STARTED|Overall Study||8||
59659054|NCT03204305|75777637|FG003|STARTED|Overall Study||7||
59659055|NCT03204305|75777634|FG000|COMPLETED|Overall Study||10||
59659056|NCT03204305|75777635|FG001|COMPLETED|Overall Study||2||
59659057|NCT03204305|75777636|FG002|COMPLETED|Overall Study||8||
59659058|NCT03204305|75777637|FG003|COMPLETED|Overall Study||7||
59659059|NCT03204305|75777634|FG000|NOT COMPLETED|Overall Study||11||
59659060|NCT03204305|75777635|FG001|NOT COMPLETED|Overall Study||5||
59659061|NCT03204305|75777636|FG002|NOT COMPLETED|Overall Study||0||
59659062|NCT03204305|75777637|FG003|NOT COMPLETED|Overall Study||0||
59659063|NCT03200717|75777649|FG000|STARTED|Overall Study||47||
59659064|NCT03200717|75777650|FG001|STARTED|Overall Study||15||
59659065|NCT03200717|75777649|FG000|COMPLETED|Overall Study||6||
59659066|NCT03200717|75777650|FG001|COMPLETED|Overall Study||0||
59659067|NCT03200717|75777649|FG000|NOT COMPLETED|Overall Study||41||
59659068|NCT03200717|75777650|FG001|NOT COMPLETED|Overall Study||15||
59659069|NCT03105700|75777659|FG000|STARTED|Overall Study||15||
59659070|NCT03105700|75777659|FG000|COMPLETED|Overall Study||8||
59659071|NCT03105700|75777659|FG000|NOT COMPLETED|Overall Study||7||
59659072|NCT02807506|75777663|FG000|STARTED|Aim 1: Survey||5||
59659073|NCT02807506|75777664|FG001|STARTED|Aim 1: Survey||8||
59659074|NCT02807506|75777665|FG002|STARTED|Aim 1: Survey||6||
59659075|NCT02807506|75777666|FG003|STARTED|Aim 1: Survey||0||
59659076|NCT02807506|75777667|FG004|STARTED|Aim 1: Survey||0||
59659077|NCT02807506|75777663|FG000|COMPLETED|Aim 1: Survey||5||
59659078|NCT02807506|75777664|FG001|COMPLETED|Aim 1: Survey||8||
59659079|NCT02807506|75777665|FG002|COMPLETED|Aim 1: Survey||6||
59659080|NCT02807506|75777666|FG003|COMPLETED|Aim 1: Survey||0||
59659081|NCT02807506|75777667|FG004|COMPLETED|Aim 1: Survey||0||
59659082|NCT02807506|75777663|FG000|NOT COMPLETED|Aim 1: Survey||0||
59659083|NCT02807506|75777664|FG001|NOT COMPLETED|Aim 1: Survey||0||
59659084|NCT02807506|75777665|FG002|NOT COMPLETED|Aim 1: Survey||0||
59659085|NCT02807506|75777666|FG003|NOT COMPLETED|Aim 1: Survey||0||
59659086|NCT02807506|75777667|FG004|NOT COMPLETED|Aim 1: Survey||0||
59659087|NCT02807506|75777663|FG000|STARTED|Aim 2: Deployment 1||0||
59659088|NCT02807506|75777664|FG001|STARTED|Aim 2: Deployment 1||0||
59659089|NCT02807506|75777665|FG002|STARTED|Aim 2: Deployment 1||0||
59659090|NCT02807506|75777666|FG003|STARTED|Aim 2: Deployment 1||16||
59659091|NCT02807506|75777667|FG004|STARTED|Aim 2: Deployment 1||0||
59659092|NCT02807506|75777663|FG000|COMPLETED|Aim 2: Deployment 1||0||
59659093|NCT02807506|75777664|FG001|COMPLETED|Aim 2: Deployment 1||0||
59659094|NCT02807506|75777665|FG002|COMPLETED|Aim 2: Deployment 1||0||
59659095|NCT02807506|75777666|FG003|COMPLETED|Aim 2: Deployment 1||16||
59659096|NCT02807506|75777667|FG004|COMPLETED|Aim 2: Deployment 1||0||
59659097|NCT02807506|75777663|FG000|NOT COMPLETED|Aim 2: Deployment 1||0||
59659098|NCT02807506|75777664|FG001|NOT COMPLETED|Aim 2: Deployment 1||0||
59659099|NCT02807506|75777665|FG002|NOT COMPLETED|Aim 2: Deployment 1||0||
59659100|NCT02807506|75777666|FG003|NOT COMPLETED|Aim 2: Deployment 1||0||
59659101|NCT02807506|75777667|FG004|NOT COMPLETED|Aim 2: Deployment 1||0||
59659102|NCT02807506|75777663|FG000|STARTED|Aim 2: Deployment 2||0||
59659103|NCT02807506|75777664|FG001|STARTED|Aim 2: Deployment 2||0||
59659104|NCT02807506|75777665|FG002|STARTED|Aim 2: Deployment 2||0||
59659105|NCT02807506|75777666|FG003|STARTED|Aim 2: Deployment 2||0||
59659106|NCT02807506|75777667|FG004|STARTED|Aim 2: Deployment 2||18||
59659107|NCT02807506|75777663|FG000|COMPLETED|Aim 2: Deployment 2||0||
59659108|NCT02807506|75777664|FG001|COMPLETED|Aim 2: Deployment 2||0||
59659109|NCT02807506|75777665|FG002|COMPLETED|Aim 2: Deployment 2||0||
59659110|NCT02807506|75777666|FG003|COMPLETED|Aim 2: Deployment 2||0||
59659111|NCT02807506|75777667|FG004|COMPLETED|Aim 2: Deployment 2||18||
59659112|NCT02807506|75777663|FG000|NOT COMPLETED|Aim 2: Deployment 2||0||
59659113|NCT02807506|75777664|FG001|NOT COMPLETED|Aim 2: Deployment 2||0||
59659114|NCT02807506|75777665|FG002|NOT COMPLETED|Aim 2: Deployment 2||0||
59659115|NCT02807506|75777666|FG003|NOT COMPLETED|Aim 2: Deployment 2||0||
59659116|NCT02807506|75777667|FG004|NOT COMPLETED|Aim 2: Deployment 2||0||
59659117|NCT02787499|75777675|FG000|STARTED|Overall Study||423||
59659118|NCT02787499|75777676|FG001|STARTED|Overall Study||417||
59659119|NCT02787499|75777675|FG000|COMPLETED|Overall Study||423||
59659120|NCT02787499|75777676|FG001|COMPLETED|Overall Study||417||
59659121|NCT02787499|75777675|FG000|NOT COMPLETED|Overall Study||0||
59659122|NCT02787499|75777676|FG001|NOT COMPLETED|Overall Study||0||
59659123|NCT02738853|75777682|FG000|STARTED|Enrollment||93||
59659124|NCT02738853|75777682|FG000|COMPLETED|Enrollment||60||
59659125|NCT02738853|75777682|FG000|NOT COMPLETED|Enrollment||33||
59659126|NCT02738853|75777682|FG000|STARTED|Procedure||60||
59659127|NCT02738853|75777682|FG000|COMPLETED|Procedure||59||
59659128|NCT02738853|75777682|FG000|NOT COMPLETED|Procedure||1||
59659129|NCT02738853|75777682|FG000|STARTED|1 Month||59||
59659130|NCT02738853|75777682|FG000|COMPLETED|1 Month||57||
59659131|NCT02738853|75777682|FG000|NOT COMPLETED|1 Month||2||
59659132|NCT02738853|75777682|FG000|STARTED|6 Month||57||
59659133|NCT02738853|75777682|FG000|COMPLETED|6 Month||51||
59659134|NCT02738853|75777682|FG000|NOT COMPLETED|6 Month||6||
59659135|NCT02738853|75777682|FG000|STARTED|1 Year||51||
59659136|NCT02738853|75777682|FG000|COMPLETED|1 Year||44||
59659137|NCT02738853|75777682|FG000|NOT COMPLETED|1 Year||7||
59659138|NCT02738853|75777682|FG000|STARTED|2 Year||44||
59659139|NCT02738853|75777682|FG000|COMPLETED|2 Year||41||
59659140|NCT02738853|75777682|FG000|NOT COMPLETED|2 Year||3||
59659141|NCT02738853|75777682|FG000|STARTED|3 Year||41||
59659142|NCT02738853|75777682|FG000|COMPLETED|3 Year||38||
59659143|NCT02738853|75777682|FG000|NOT COMPLETED|3 Year||3||
59659144|NCT02738853|75777682|FG000|STARTED|4 Year||38||
59659145|NCT02738853|75777682|FG000|COMPLETED|4 Year||29||
59659146|NCT02738853|75777682|FG000|NOT COMPLETED|4 Year||9||
59659147|NCT02738853|75777682|FG000|STARTED|5 Year||29||
59659148|NCT02738853|75777682|FG000|COMPLETED|5 Year||25||
59659149|NCT02738853|75777682|FG000|NOT COMPLETED|5 Year||4||
59659150|NCT02358538|75777690|FG000|STARTED|Through Week 26||7||
59659151|NCT02358538|75777691|FG001|STARTED|Through Week 26||2||
59659152|NCT02358538|75777692|FG002|STARTED|Through Week 26||10||
59659153|NCT02358538|75777693|FG003|STARTED|Through Week 26||11||
59659154|NCT02358538|75777690|FG000|COMPLETED|Through Week 26||4||
59659155|NCT02358538|75777691|FG001|COMPLETED|Through Week 26||0||
59659156|NCT02358538|75777692|FG002|COMPLETED|Through Week 26||5||
59659157|NCT02358538|75777693|FG003|COMPLETED|Through Week 26||6||
59659158|NCT02358538|75777690|FG000|NOT COMPLETED|Through Week 26||3||
59659159|NCT02358538|75777691|FG001|NOT COMPLETED|Through Week 26||2||
59659160|NCT02358538|75777692|FG002|NOT COMPLETED|Through Week 26||5||
59659161|NCT02358538|75777693|FG003|NOT COMPLETED|Through Week 26||5||
59659162|NCT02358538|75777690|FG000|STARTED|52 Week Extension Period||4||
59659163|NCT02358538|75777691|FG001|STARTED|52 Week Extension Period||0||
59659164|NCT02358538|75777692|FG002|STARTED|52 Week Extension Period||4||
59659165|NCT02358538|75777693|FG003|STARTED|52 Week Extension Period||6||
59659166|NCT02358538|75777690|FG000|COMPLETED|52 Week Extension Period||4||
59659167|NCT02358538|75777691|FG001|COMPLETED|52 Week Extension Period||0||
59659168|NCT02358538|75777692|FG002|COMPLETED|52 Week Extension Period||2||
59659169|NCT02358538|75777693|FG003|COMPLETED|52 Week Extension Period||2||
59659170|NCT02358538|75777690|FG000|NOT COMPLETED|52 Week Extension Period||0||
59659171|NCT02358538|75777691|FG001|NOT COMPLETED|52 Week Extension Period||0||
59659172|NCT02358538|75777692|FG002|NOT COMPLETED|52 Week Extension Period||2||
59659173|NCT02358538|75777693|FG003|NOT COMPLETED|52 Week Extension Period||4||
59659174|NCT02332980|75777710|FG000|STARTED|Initial Study Phase||25||
59659175|NCT02332980|75777711|FG001|STARTED|Initial Study Phase||23||
59659176|NCT02332980|75777712|FG002|STARTED|Initial Study Phase||17||
59659177|NCT02332980|75777710|FG000|COMPLETED|Initial Study Phase||25||
59659178|NCT02332980|75777711|FG001|COMPLETED|Initial Study Phase||23||
59659179|NCT02332980|75777712|FG002|COMPLETED|Initial Study Phase||17||
59659180|NCT02332980|75777710|FG000|NOT COMPLETED|Initial Study Phase||0||
59659181|NCT02332980|75777711|FG001|NOT COMPLETED|Initial Study Phase||0||
59659182|NCT02332980|75777712|FG002|NOT COMPLETED|Initial Study Phase||0||
59659183|NCT02332980|75777710|FG000|STARTED|Continuation Phase||5||
59659184|NCT02332980|75777711|FG001|STARTED|Continuation Phase||0||
59659185|NCT02332980|75777712|FG002|STARTED|Continuation Phase||13||
59659186|NCT02332980|75777710|FG000|COMPLETED|Continuation Phase||5||
59659187|NCT02332980|75777711|FG001|COMPLETED|Continuation Phase||0||
59659188|NCT02332980|75777712|FG002|COMPLETED|Continuation Phase||13||
59659189|NCT02332980|75777710|FG000|NOT COMPLETED|Continuation Phase||0||
59659190|NCT02332980|75777711|FG001|NOT COMPLETED|Continuation Phase||0||
59659191|NCT02332980|75777712|FG002|NOT COMPLETED|Continuation Phase||0||
59659192|NCT02056119|75777728|FG000|STARTED|Overall Study||58||
59659193|NCT02056119|75777729|FG001|STARTED|Overall Study||62||
59659194|NCT02056119|75777728|FG000|COMPLETED|Overall Study||48||
59659195|NCT02056119|75777729|FG001|COMPLETED|Overall Study||42||
59659196|NCT02056119|75777728|FG000|NOT COMPLETED|Overall Study||10||
59659197|NCT02056119|75777729|FG001|NOT COMPLETED|Overall Study||20||
59659198|NCT02038452|75777737|FG000|STARTED|Overall Study||116||
59659199|NCT02038452|75777738|FG001|STARTED|Overall Study||118||
59659200|NCT02038452|75777737|FG000|Baseline|Overall Study||113||
59659201|NCT02038452|75777738|FG001|Baseline|Overall Study||117||
59659202|NCT02038452|75777737|FG000|6 Weeks Follow-up|Overall Study||108||
59659203|NCT02038452|75777738|FG001|6 Weeks Follow-up|Overall Study||109||
59659204|NCT02038452|75777737|FG000|6 Months Follow-up|Overall Study||96||
59659205|NCT02038452|75777738|FG001|6 Months Follow-up|Overall Study||97||
59659206|NCT02038452|75777737|FG000|12 Months Follow-up|Overall Study||87||
59659207|NCT02038452|75777738|FG001|12 Months Follow-up|Overall Study||88||
59659208|NCT02038452|75777737|FG000|24 Months Follow-up|Overall Study||78||
59659209|NCT02038452|75777738|FG001|24 Months Follow-up|Overall Study||81||
59659210|NCT02038452|75777737|FG000|COMPLETED|Overall Study||78||
59659211|NCT02038452|75777738|FG001|COMPLETED|Overall Study||81||
59659212|NCT02038452|75777737|FG000|NOT COMPLETED|Overall Study||38||
59659213|NCT02038452|75777738|FG001|NOT COMPLETED|Overall Study||37||
59659214|NCT02019693|75777744|FG000|STARTED|Overall Study||20||
59659215|NCT02019693|75777744|FG000|COMPLETED|Overall Study||20||
59659216|NCT02019693|75777744|FG000|NOT COMPLETED|Overall Study||0||
59659217|NCT01332097|75777754|FG000|STARTED|Overall Study||31||
59659218|NCT01332097|75777755|FG001|STARTED|Overall Study||30||
59659219|NCT01332097|75777756|FG002|STARTED|Overall Study||25||
59659220|NCT01332097|75777757|FG003|STARTED|Overall Study||27||
59659221|NCT01332097|75777758|FG004|STARTED|Overall Study||25||
59659222|NCT01332097|75777759|FG005|STARTED|Overall Study||45||
59659223|NCT01332097|75777754|FG000|COMPLETED|Overall Study||30||
59659224|NCT01332097|75777755|FG001|COMPLETED|Overall Study||26||
59659225|NCT01332097|75777756|FG002|COMPLETED|Overall Study||23||
59659226|NCT01332097|75777757|FG003|COMPLETED|Overall Study||24||
59659227|NCT01332097|75777758|FG004|COMPLETED|Overall Study||22||
59659228|NCT01332097|75777759|FG005|COMPLETED|Overall Study||44||
59659229|NCT01332097|75777754|FG000|NOT COMPLETED|Overall Study||1||
59659230|NCT01332097|75777755|FG001|NOT COMPLETED|Overall Study||4||
59659231|NCT01332097|75777756|FG002|NOT COMPLETED|Overall Study||2||
59659232|NCT01332097|75777757|FG003|NOT COMPLETED|Overall Study||3||
59659233|NCT01332097|75777758|FG004|NOT COMPLETED|Overall Study||3||
59659234|NCT01332097|75777759|FG005|NOT COMPLETED|Overall Study||1||
59659235|NCT01238172|75777777|FG000|STARTED|Overall Study||237|Intention-to-treat (ITT) Cohort|
59659236|NCT01238172|75777778|FG001|STARTED|Overall Study||241|Intention-to-treat (ITT) Cohort|
59659237|NCT01238172|75777777|FG000|COMPLETED|Overall Study||226|modified intention-to-treat (m-ITT) Cohort|
59659238|NCT01238172|75777778|FG001|COMPLETED|Overall Study||217|modified intention-to-treat (m-ITT) Cohort|
59659239|NCT01238172|75777777|FG000|NOT COMPLETED|Overall Study||11||
59659240|NCT01238172|75777778|FG001|NOT COMPLETED|Overall Study||24||
59659241|NCT00967005|75777786|FG000|STARTED|Overall Study||13||
59659242|NCT00967005|75777787|FG001|STARTED|Overall Study||15||
59659243|NCT00967005|75777786|FG000|Treatment Completion|Overall Study||10||
59659244|NCT00967005|75777787|FG001|Treatment Completion|Overall Study||10||
59659245|NCT00967005|75777786|FG000|COMPLETED|Overall Study||6||
59659246|NCT00967005|75777787|FG001|COMPLETED|Overall Study||5||
59659247|NCT00967005|75777786|FG000|NOT COMPLETED|Overall Study||7||
59659248|NCT00967005|75777787|FG001|NOT COMPLETED|Overall Study||10||
59659249|NCT00873288|75777795|FG000|STARTED|Overall Study||127||
59659250|NCT00873288|75777796|FG001|STARTED|Overall Study||127||
59659251|NCT00873288|75777795|FG000|COMPLETED|Overall Study||127||
59659252|NCT00873288|75777796|FG001|COMPLETED|Overall Study||127||
59659253|NCT00873288|75777795|FG000|NOT COMPLETED|Overall Study||0||
59659254|NCT00873288|75777796|FG001|NOT COMPLETED|Overall Study||0||
59659255|NCT00863369|75777810|FG000|STARTED|Overall Study||4||
59659256|NCT00863369|75777811|FG001|STARTED|Overall Study||5||
59659257|NCT00863369|75777812|FG002|STARTED|Overall Study||4||
59659258|NCT00863369|75777813|FG003|STARTED|Overall Study||3||
59659259|NCT00863369|75777814|FG004|STARTED|Overall Study||6||
59659260|NCT00863369|75777815|FG005|STARTED|Overall Study||11||
59659261|NCT00863369|75777810|FG000|COMPLETED|Overall Study||4||
59659262|NCT00863369|75777811|FG001|COMPLETED|Overall Study||5||
59659263|NCT00863369|75777812|FG002|COMPLETED|Overall Study||4||
59659264|NCT00863369|75777813|FG003|COMPLETED|Overall Study||3||
60077179|NCT01896193|76192210|FG000|NOT COMPLETED|Overall Study||21||
60077180|NCT01896193|76192211|FG001|NOT COMPLETED|Overall Study||12||
60077181|NCT01922011|76192221|FG000|STARTED|Overall Study|Randomized participants|75||
60077182|NCT01922011|76192222|FG001|STARTED|Overall Study|Randomized participants|74||
59659265|NCT00863369|75777814|FG004|COMPLETED|Overall Study||6||
59659266|NCT00863369|75777815|FG005|COMPLETED|Overall Study||11||
59659267|NCT00863369|75777810|FG000|NOT COMPLETED|Overall Study||0||
59659268|NCT00863369|75777811|FG001|NOT COMPLETED|Overall Study||0||
59659269|NCT00863369|75777812|FG002|NOT COMPLETED|Overall Study||0||
59659270|NCT00863369|75777813|FG003|NOT COMPLETED|Overall Study||0||
59659271|NCT00863369|75777814|FG004|NOT COMPLETED|Overall Study||0||
59659272|NCT00863369|75777815|FG005|NOT COMPLETED|Overall Study||0||
59659273|NCT00538031|75777832|FG000|STARTED|Overall Study||26||
59659274|NCT00538031|75777833|FG001|STARTED|Overall Study||26||
59659275|NCT00538031|75777832|FG000|COMPLETED|Overall Study||26||
59659276|NCT00538031|75777833|FG001|COMPLETED|Overall Study||26||
59659277|NCT00538031|75777832|FG000|NOT COMPLETED|Overall Study||0||
59659278|NCT00538031|75777833|FG001|NOT COMPLETED|Overall Study||0||
59659279|NCT00203996|75777845|FG000|STARTED|Overall Study||0||
59659280|NCT00203996|75777846|FG001|STARTED|Overall Study||0||
59659281|NCT00203996|75777847|FG002|STARTED|Overall Study||0||
59659282|NCT00203996|75777848|FG003|STARTED|Overall Study||19||
59659283|NCT00203996|75777849|FG004|STARTED|Overall Study||4||
59659284|NCT00203996|75777850|FG005|STARTED|Overall Study||3||
59659285|NCT00203996|75777851|FG006|STARTED|Overall Study||2||
59659286|NCT00203996|75777852|FG007|STARTED|Overall Study||4||
59659287|NCT00203996|75777853|FG008|STARTED|Overall Study||2||
59659288|NCT00203996|75777854|FG009|STARTED|Overall Study||3||
59659289|NCT00203996|75777845|FG000|Aim 3 Only: First Intervention|Overall Study||0||
59659290|NCT00203996|75777846|FG001|Aim 3 Only: First Intervention|Overall Study||0||
59659291|NCT00203996|75777847|FG002|Aim 3 Only: First Intervention|Overall Study||0||
59659292|NCT00203996|75777848|FG003|Aim 3 Only: First Intervention|Overall Study||0||
59659293|NCT00203996|75777849|FG004|Aim 3 Only: First Intervention|Overall Study||0||
59659294|NCT00203996|75777850|FG005|Aim 3 Only: First Intervention|Overall Study||3||
59659295|NCT00203996|75777851|FG006|Aim 3 Only: First Intervention|Overall Study||2||
59659296|NCT00203996|75777852|FG007|Aim 3 Only: First Intervention|Overall Study||4||
59659297|NCT00203996|75777853|FG008|Aim 3 Only: First Intervention|Overall Study||2||
59659298|NCT00203996|75777854|FG009|Aim 3 Only: First Intervention|Overall Study||3||
59659299|NCT00203996|75777845|FG000|Aim 3 Only: Washout|Overall Study||0||
59659300|NCT00203996|75777846|FG001|Aim 3 Only: Washout|Overall Study||0||
59659301|NCT00203996|75777847|FG002|Aim 3 Only: Washout|Overall Study||0||
59659302|NCT00203996|75777848|FG003|Aim 3 Only: Washout|Overall Study||0||
59659303|NCT00203996|75777849|FG004|Aim 3 Only: Washout|Overall Study||0||
59659304|NCT00203996|75777850|FG005|Aim 3 Only: Washout|Overall Study||3||
59659305|NCT00203996|75777851|FG006|Aim 3 Only: Washout|Overall Study||2||
59659306|NCT00203996|75777852|FG007|Aim 3 Only: Washout|Overall Study||2||
59659307|NCT00203996|75777853|FG008|Aim 3 Only: Washout|Overall Study||2||
59659308|NCT00203996|75777854|FG009|Aim 3 Only: Washout|Overall Study||2||
59659309|NCT00203996|75777845|FG000|Aim 3 Only: Second Intervention|Overall Study||0||
59659310|NCT00203996|75777846|FG001|Aim 3 Only: Second Intervention|Overall Study||0||
59659311|NCT00203996|75777847|FG002|Aim 3 Only: Second Intervention|Overall Study||0||
59659312|NCT00203996|75777848|FG003|Aim 3 Only: Second Intervention|Overall Study||0||
59659313|NCT00203996|75777849|FG004|Aim 3 Only: Second Intervention|Overall Study||0||
59659314|NCT00203996|75777850|FG005|Aim 3 Only: Second Intervention|Overall Study||3||
59659315|NCT00203996|75777851|FG006|Aim 3 Only: Second Intervention|Overall Study||2||
59659316|NCT00203996|75777852|FG007|Aim 3 Only: Second Intervention|Overall Study||2||
59659317|NCT00203996|75777853|FG008|Aim 3 Only: Second Intervention|Overall Study||2||
59659318|NCT00203996|75777854|FG009|Aim 3 Only: Second Intervention|Overall Study||2||
59659319|NCT00203996|75777845|FG000|Aim 3 Only: Second Washout|Overall Study||0||
59659320|NCT00203996|75777846|FG001|Aim 3 Only: Second Washout|Overall Study||0||
59659321|NCT00203996|75777847|FG002|Aim 3 Only: Second Washout|Overall Study||0||
59659322|NCT00203996|75777848|FG003|Aim 3 Only: Second Washout|Overall Study||0||
59659323|NCT00203996|75777849|FG004|Aim 3 Only: Second Washout|Overall Study||0||
59659324|NCT00203996|75777850|FG005|Aim 3 Only: Second Washout|Overall Study||3||
59659325|NCT00203996|75777851|FG006|Aim 3 Only: Second Washout|Overall Study||2||
59659326|NCT00203996|75777852|FG007|Aim 3 Only: Second Washout|Overall Study||2||
59659327|NCT00203996|75777853|FG008|Aim 3 Only: Second Washout|Overall Study||2||
59659328|NCT00203996|75777854|FG009|Aim 3 Only: Second Washout|Overall Study||2||
59659329|NCT00203996|75777845|FG000|Aim 3 Only: Third Intervention|Overall Study||0||
59659330|NCT00203996|75777846|FG001|Aim 3 Only: Third Intervention|Overall Study||0||
59659331|NCT00203996|75777847|FG002|Aim 3 Only: Third Intervention|Overall Study||0||
59659332|NCT00203996|75777848|FG003|Aim 3 Only: Third Intervention|Overall Study||0||
59659333|NCT00203996|75777849|FG004|Aim 3 Only: Third Intervention|Overall Study||0||
59659334|NCT00203996|75777850|FG005|Aim 3 Only: Third Intervention|Overall Study||3||
59659335|NCT00203996|75777851|FG006|Aim 3 Only: Third Intervention|Overall Study||2||
59659336|NCT00203996|75777852|FG007|Aim 3 Only: Third Intervention|Overall Study||2||
59659337|NCT00203996|75777853|FG008|Aim 3 Only: Third Intervention|Overall Study||2||
59659338|NCT00203996|75777854|FG009|Aim 3 Only: Third Intervention|Overall Study||2||
59659339|NCT00203996|75777845|FG000|COMPLETED|Overall Study||0||
59659340|NCT00203996|75777846|FG001|COMPLETED|Overall Study||0||
59659341|NCT00203996|75777847|FG002|COMPLETED|Overall Study||0||
59659342|NCT00203996|75777848|FG003|COMPLETED|Overall Study||9||
59659343|NCT00203996|75777849|FG004|COMPLETED|Overall Study||3||
59659344|NCT00203996|75777850|FG005|COMPLETED|Overall Study||3||
59659345|NCT00203996|75777851|FG006|COMPLETED|Overall Study||2||
59659346|NCT00203996|75777852|FG007|COMPLETED|Overall Study||2||
59659347|NCT00203996|75777853|FG008|COMPLETED|Overall Study||2||
59659348|NCT00203996|75777854|FG009|COMPLETED|Overall Study||2||
59659349|NCT00203996|75777845|FG000|NOT COMPLETED|Overall Study||0||
59659350|NCT00203996|75777846|FG001|NOT COMPLETED|Overall Study||0||
59659351|NCT00203996|75777847|FG002|NOT COMPLETED|Overall Study||0||
59659352|NCT00203996|75777848|FG003|NOT COMPLETED|Overall Study||10||
59659353|NCT00203996|75777849|FG004|NOT COMPLETED|Overall Study||1||
59659354|NCT00203996|75777850|FG005|NOT COMPLETED|Overall Study||0||
59659355|NCT00203996|75777851|FG006|NOT COMPLETED|Overall Study||0||
59659356|NCT00203996|75777852|FG007|NOT COMPLETED|Overall Study||2||
59659357|NCT00203996|75777853|FG008|NOT COMPLETED|Overall Study||0||
59659358|NCT00203996|75777854|FG009|NOT COMPLETED|Overall Study||1||
59659359|NCT02014558|75777883|FG000|STARTED|Overall Study||5|Re-enrolled participants (assigned to the 120 mg [1] & 200 mg [4] expansion groups) were excluded.|
59659360|NCT02014558|75777884|FG001|STARTED|Overall Study||3|Re-enrolled participants (assigned to the 120 mg [1] & 200 mg [4] expansion groups) were excluded.|
59659361|NCT02014558|75777885|FG002|STARTED|Overall Study||3|Re-enrolled participants (assigned to the 120 mg [1] & 200 mg [4] expansion groups) were excluded.|
59659362|NCT02014558|75777886|FG003|STARTED|Overall Study||3|Re-enrolled participants (assigned to the 120 mg [1] & 200 mg [4] expansion groups) were excluded.|
59659363|NCT02014558|75777887|FG004|STARTED|Overall Study||4|Re-enrolled participants (assigned to the 120 mg [1] & 200 mg [4] expansion groups) were excluded.|
59659364|NCT02014558|75777888|FG005|STARTED|Overall Study||3|Re-enrolled participants (assigned to the 120 mg [1] & 200 mg [4] expansion groups) were excluded.|
59659365|NCT02014558|75777889|FG006|STARTED|Overall Study||4|Re-enrolled participants (assigned to the 120 mg [1] & 200 mg [4] expansion groups) were excluded.|
59659366|NCT02014558|75777890|FG007|STARTED|Overall Study||11|Re-enrolled participants (assigned to the 120 mg [1] & 200 mg [4] expansion groups) were excluded.|
59659367|NCT02014558|75777891|FG008|STARTED|Overall Study||15|Re-enrolled participants (assigned to the 120 mg [1] & 200 mg [4] expansion groups) were excluded.|
59659368|NCT02014558|75777892|FG009|STARTED|Overall Study||21|Re-enrolled participants (assigned to the 120 mg [1] & 200 mg [4] expansion groups) were excluded.|
59659369|NCT02014558|75777893|FG010|STARTED|Overall Study||69|Re-enrolled participants (assigned to the 120 mg [1] & 200 mg [4] expansion groups) were excluded.|
59659370|NCT02014558|75777894|FG011|STARTED|Overall Study||102|Re-enrolled participants (assigned to the 120 mg [1] & 200 mg [4] expansion groups) were excluded.|
59659371|NCT02014558|75777895|FG012|STARTED|Overall Study||17|Re-enrolled participants (assigned to the 120 mg [1] & 200 mg [4] expansion groups) were excluded.|
59659372|NCT02014558|75777883|FG000|Treated|Overall Study||5||
59659373|NCT02014558|75777884|FG001|Treated|Overall Study||3||
59659374|NCT02014558|75777885|FG002|Treated|Overall Study||3||
59659375|NCT02014558|75777886|FG003|Treated|Overall Study||3||
59659376|NCT02014558|75777887|FG004|Treated|Overall Study||3||
59659377|NCT02014558|75777888|FG005|Treated|Overall Study||3||
59659378|NCT02014558|75777889|FG006|Treated|Overall Study||3||
59659379|NCT02014558|75777890|FG007|Treated|Overall Study|A participant randomized to the 120 mg was treated with an initial dose of 20 mg by mistake.|12||
59659380|NCT02014558|75777891|FG008|Treated|Overall Study||13||
59659381|NCT02014558|75777892|FG009|Treated|Overall Study||21||
59659382|NCT02014558|75777893|FG010|Treated|Overall Study|A participant randomized to the 120 mg was treated with an initial dose of 20 mg by mistake.|66||
59659383|NCT02014558|75777894|FG011|Treated|Overall Study||100||
59659384|NCT02014558|75777895|FG012|Treated|Overall Study||17||
59659385|NCT02014558|75777883|FG000|COMPLETED|Overall Study||0||
59659386|NCT02014558|75777884|FG001|COMPLETED|Overall Study||0||
59659387|NCT02014558|75777885|FG002|COMPLETED|Overall Study||0||
59659388|NCT02014558|75777886|FG003|COMPLETED|Overall Study||0||
59659389|NCT02014558|75777887|FG004|COMPLETED|Overall Study||0||
59659390|NCT02014558|75777888|FG005|COMPLETED|Overall Study||0||
59659391|NCT02014558|75777889|FG006|COMPLETED|Overall Study||0||
59659392|NCT02014558|75777890|FG007|COMPLETED|Overall Study||0||
59659393|NCT02014558|75777891|FG008|COMPLETED|Overall Study||0||
59659394|NCT02014558|75777892|FG009|COMPLETED|Overall Study||0||
59659395|NCT02014558|75777893|FG010|COMPLETED|Overall Study||0||
59659396|NCT02014558|75777894|FG011|COMPLETED|Overall Study||0||
59659397|NCT02014558|75777895|FG012|COMPLETED|Overall Study||0||
59659398|NCT02014558|75777883|FG000|NOT COMPLETED|Overall Study||5||
59659399|NCT02014558|75777884|FG001|NOT COMPLETED|Overall Study||3||
59659400|NCT02014558|75777885|FG002|NOT COMPLETED|Overall Study||3||
59659401|NCT02014558|75777886|FG003|NOT COMPLETED|Overall Study||3||
59659402|NCT02014558|75777887|FG004|NOT COMPLETED|Overall Study||4||
59659403|NCT02014558|75777888|FG005|NOT COMPLETED|Overall Study||3||
59659404|NCT02014558|75777889|FG006|NOT COMPLETED|Overall Study||4||
59659405|NCT02014558|75777890|FG007|NOT COMPLETED|Overall Study||11||
59659406|NCT02014558|75777891|FG008|NOT COMPLETED|Overall Study||15||
59659407|NCT02014558|75777892|FG009|NOT COMPLETED|Overall Study||21||
59659408|NCT02014558|75777893|FG010|NOT COMPLETED|Overall Study||69||
59659409|NCT02014558|75777894|FG011|NOT COMPLETED|Overall Study||102||
59659410|NCT02014558|75777895|FG012|NOT COMPLETED|Overall Study||17||
59659411|NCT02015455|75777939|FG000|STARTED|Step 0 - Oct 2013 to Mar 2014||48233|By pretrial design, for 1 site (21 clinics), step 0 extended through May 2014, and step 1 began June 2014.|98
59659412|NCT02015455|75777940|FG001|STARTED|Step 0 - Oct 2013 to Mar 2014||0|By pretrial design, for 1 site (21 clinics), step 0 extended through May 2014, and step 1 began June 2014.|0
59659413|NCT02015455|75777939|FG000|Did Not Receive Intended Inclusion/Exclusion of Intervention Report Text|Step 0 - Oct 2013 to Mar 2014||135||98
59659414|NCT02015455|75777940|FG001|Did Not Receive Intended Inclusion/Exclusion of Intervention Report Text|Step 0 - Oct 2013 to Mar 2014||0||0
59659415|NCT02015455|75777939|FG000|COMPLETED|Step 0 - Oct 2013 to Mar 2014||48233||98
59659416|NCT02015455|75777940|FG001|COMPLETED|Step 0 - Oct 2013 to Mar 2014||0||0
59659417|NCT02015455|75777939|FG000|NOT COMPLETED|Step 0 - Oct 2013 to Mar 2014||0||0
59659418|NCT02015455|75777940|FG001|NOT COMPLETED|Step 0 - Oct 2013 to Mar 2014||0||0
59659419|NCT02015455|75777939|FG000|STARTED|Step 1 - Apr 2014 to Sep 2014||24074|By pretrial design, for 1 site (21 clinics), step 0 extended through May 2014, and step 1 began June 2014.|79
59659420|NCT02015455|75777940|FG001|STARTED|Step 1 - Apr 2014 to Sep 2014||6455|By pretrial design, for 1 site (21 clinics), step 0 extended through May 2014, and step 1 began June 2014.|19
59659421|NCT02015455|75777939|FG000|Did Not Receive Intended Inclusion/Exclusion of Intervention Report Text|Step 1 - Apr 2014 to Sep 2014||390||79
59659422|NCT02015455|75777940|FG001|Did Not Receive Intended Inclusion/Exclusion of Intervention Report Text|Step 1 - Apr 2014 to Sep 2014||2208||19
59659423|NCT02015455|75777939|FG000|COMPLETED|Step 1 - Apr 2014 to Sep 2014||24074||79
59659424|NCT02015455|75777940|FG001|COMPLETED|Step 1 - Apr 2014 to Sep 2014||6455||19
59659425|NCT02015455|75777939|FG000|NOT COMPLETED|Step 1 - Apr 2014 to Sep 2014||0||0
59659426|NCT02015455|75777940|FG001|NOT COMPLETED|Step 1 - Apr 2014 to Sep 2014||0||0
59659427|NCT02015455|75777939|FG000|STARTED|Step 2 - Oct 2014 to Mar 2015||23139||59
59659428|NCT02015455|75777940|FG001|STARTED|Step 2 - Oct 2014 to Mar 2015||16285||39
59659429|NCT02015455|75777939|FG000|Did Not Receive Intended Inclusion/Exclusion of Intervention Report Text|Step 2 - Oct 2014 to Mar 2015||98||59
59659430|NCT02015455|75777940|FG001|Did Not Receive Intended Inclusion/Exclusion of Intervention Report Text|Step 2 - Oct 2014 to Mar 2015||1511||39
59659431|NCT02015455|75777939|FG000|COMPLETED|Step 2 - Oct 2014 to Mar 2015||23139||59
59659432|NCT02015455|75777940|FG001|COMPLETED|Step 2 - Oct 2014 to Mar 2015||16285||39
59659433|NCT02015455|75777939|FG000|NOT COMPLETED|Step 2 - Oct 2014 to Mar 2015||0||0
59659434|NCT02015455|75777940|FG001|NOT COMPLETED|Step 2 - Oct 2014 to Mar 2015||0||0
59659435|NCT02015455|75777939|FG000|STARTED|Step 3 - Apr 2015 to Sep 2015||14135||39
59659436|NCT02015455|75777940|FG001|STARTED|Step 3 - Apr 2015 to Sep 2015||27661||59
59659437|NCT02015455|75777939|FG000|Did Not Receive Intended Inclusion/Exclusion of Intervention Report Text|Step 3 - Apr 2015 to Sep 2015||72||39
59659438|NCT02015455|75777940|FG001|Did Not Receive Intended Inclusion/Exclusion of Intervention Report Text|Step 3 - Apr 2015 to Sep 2015||4915||59
59659439|NCT02015455|75777939|FG000|COMPLETED|Step 3 - Apr 2015 to Sep 2015||14135||39
59659440|NCT02015455|75777940|FG001|COMPLETED|Step 3 - Apr 2015 to Sep 2015||27661||59
59659441|NCT02015455|75777939|FG000|NOT COMPLETED|Step 3 - Apr 2015 to Sep 2015||0||0
59659442|NCT02015455|75777940|FG001|NOT COMPLETED|Step 3 - Apr 2015 to Sep 2015||0||0
59659443|NCT02015455|75777939|FG000|STARTED|Step 4 - Oct 2015 to Mar 2016||7874||21
59659444|NCT02015455|75777940|FG001|STARTED|Step 4 - Oct 2015 to Mar 2016||31316||77
59659445|NCT02015455|75777939|FG000|Did Not Receive Intended Inclusion/Exclusion of Intervention Report Text|Step 4 - Oct 2015 to Mar 2016||76||21
59659446|NCT02015455|75777940|FG001|Did Not Receive Intended Inclusion/Exclusion of Intervention Report Text|Step 4 - Oct 2015 to Mar 2016||3742||77
59659447|NCT02015455|75777939|FG000|COMPLETED|Step 4 - Oct 2015 to Mar 2016||7874||21
59659448|NCT02015455|75777940|FG001|COMPLETED|Step 4 - Oct 2015 to Mar 2016||31316||77
59659449|NCT02015455|75777939|FG000|NOT COMPLETED|Step 4 - Oct 2015 to Mar 2016||0||0
59659450|NCT02015455|75777940|FG001|NOT COMPLETED|Step 4 - Oct 2015 to Mar 2016||0||0
59659451|NCT02015455|75777939|FG000|STARTED|Step 5 - Apr 2016 to Sep 2016||0||0
59659452|NCT02015455|75777940|FG001|STARTED|Step 5 - Apr 2016 to Sep 2016||39714||98
59659453|NCT02015455|75777939|FG000|Did Not Receive Intended Inclusion/Exclusion of Intervention Report Text|Step 5 - Apr 2016 to Sep 2016||0||0
59659454|NCT02015455|75777940|FG001|Did Not Receive Intended Inclusion/Exclusion of Intervention Report Text|Step 5 - Apr 2016 to Sep 2016||3512||98
59659455|NCT02015455|75777939|FG000|COMPLETED|Step 5 - Apr 2016 to Sep 2016||0||0
59659456|NCT02015455|75777940|FG001|COMPLETED|Step 5 - Apr 2016 to Sep 2016||39714||98
59659457|NCT02015455|75777939|FG000|NOT COMPLETED|Step 5 - Apr 2016 to Sep 2016||0||0
59659458|NCT02015455|75777940|FG001|NOT COMPLETED|Step 5 - Apr 2016 to Sep 2016||0||0
59659459|NCT02024555|75777950|FG000|STARTED|Overall Study||49||
59659460|NCT02024555|75777951|FG001|STARTED|Overall Study||48||
59659461|NCT02024555|75777950|FG000|COMPLETED|Overall Study||43|includes those who did not complete the entire study drug regime but did complete study visits|
59659462|NCT02024555|75777951|FG001|COMPLETED|Overall Study||46|includes those who did not complete the entire study drug regime but did complete study visits|
59659463|NCT02024555|75777950|FG000|NOT COMPLETED|Overall Study||6||
59659464|NCT02024555|75777951|FG001|NOT COMPLETED|Overall Study||2||
59659465|NCT02040584|75777959|FG000|STARTED|Overall Study||105||
59659466|NCT02040584|75777960|FG001|STARTED|Overall Study||106||
59659467|NCT02040584|75777959|FG000|COMPLETED|Overall Study||70||
59659468|NCT02040584|75777960|FG001|COMPLETED|Overall Study||74||
59659469|NCT02040584|75777959|FG000|NOT COMPLETED|Overall Study||35||
59659470|NCT02040584|75777960|FG001|NOT COMPLETED|Overall Study||32||
59659471|NCT02045797|75777979|FG000|STARTED|Overall Study||58||
59659472|NCT02045797|75777980|FG001|STARTED|Overall Study||39||
59659473|NCT02045797|75777981|FG002|STARTED|Overall Study||25||
59659474|NCT02045797|75777979|FG000|COMPLETED|Overall Study||51||
59659475|NCT02045797|75777980|FG001|COMPLETED|Overall Study||32||
59659476|NCT02045797|75777981|FG002|COMPLETED|Overall Study||24||
59659477|NCT02045797|75777979|FG000|NOT COMPLETED|Overall Study||7||
59659478|NCT02045797|75777980|FG001|NOT COMPLETED|Overall Study||7||
59659479|NCT02045797|75777981|FG002|NOT COMPLETED|Overall Study||1||
59659480|NCT04330989|75777993|FG000|STARTED|Overall Study||51||
59659481|NCT04330989|75777994|FG001|STARTED|Overall Study||49||
59659482|NCT04330989|75777995|FG002|STARTED|Overall Study||100||
59659483|NCT04330989|75777996|FG003|STARTED|Overall Study||100||
59659484|NCT04330989|75777993|FG000|Liveborn Infants During Study|Overall Study||43||
59659485|NCT04330989|75777994|FG001|Liveborn Infants During Study|Overall Study||46||
59659486|NCT04330989|75777995|FG002|Liveborn Infants During Study|Overall Study||87||
59659487|NCT04330989|75777996|FG003|Liveborn Infants During Study|Overall Study||90||
59659488|NCT04330989|75777993|FG000|COMPLETED|Overall Study||41||
59659489|NCT04330989|75777994|FG001|COMPLETED|Overall Study||43||
59659490|NCT04330989|75777995|FG002|COMPLETED|Overall Study||88||
59659491|NCT04330989|75777996|FG003|COMPLETED|Overall Study||83||
59659492|NCT04330989|75777993|FG000|NOT COMPLETED|Overall Study||10||
59659493|NCT04330989|75777994|FG001|NOT COMPLETED|Overall Study||6||
59659494|NCT04330989|75777995|FG002|NOT COMPLETED|Overall Study||12||
59659495|NCT04330989|75777996|FG003|NOT COMPLETED|Overall Study||17||
59659496|NCT03385239|75778011|FG000|STARTED|Overall Study||24||
59659497|NCT03385239|75778012|FG001|STARTED|Overall Study||22||
59659498|NCT03385239|75778013|FG002|STARTED|Overall Study||23||
59659499|NCT03385239|75778014|FG003|STARTED|Overall Study||23||
59659500|NCT03385239|75778015|FG004|STARTED|Overall Study||22||
59659501|NCT03385239|75778011|FG000|COMPLETED|Overall Study||22|Completed here refers to participants who completed post-treatment follow-up.|
59659502|NCT03385239|75778012|FG001|COMPLETED|Overall Study||19|Completed here refers to participants who completed post-treatment follow-up.|
59659503|NCT03385239|75778013|FG002|COMPLETED|Overall Study||20|Completed here refers to participants who completed post-treatment follow-up.|
59659504|NCT03385239|75778014|FG003|COMPLETED|Overall Study||19|Completed here refers to participants who completed post-treatment follow-up.|
59659505|NCT03385239|75778015|FG004|COMPLETED|Overall Study||22|Completed here refers to participants who completed post-treatment follow-up.|
59659506|NCT03385239|75778011|FG000|NOT COMPLETED|Overall Study||2||
59659507|NCT03385239|75778012|FG001|NOT COMPLETED|Overall Study||3||
59544305|NCT01654445|75642690|FG000|COMPLETED|Overall Study||25||
59544306|NCT01654445|75642691|FG001|COMPLETED|Overall Study||25||
59659508|NCT03385239|75778013|FG002|NOT COMPLETED|Overall Study||3||
59659509|NCT03385239|75778014|FG003|NOT COMPLETED|Overall Study||4||
59659510|NCT03385239|75778015|FG004|NOT COMPLETED|Overall Study||0||
59659511|NCT03020160|75778033|FG000|STARTED|Overall Study||7||
59659512|NCT03020160|75778034|FG001|STARTED|Overall Study||41||
59659513|NCT03020160|75778033|FG000|Completed 24 Weeks in the Study|Overall Study||7||
59659514|NCT03020160|75778034|FG001|Completed 24 Weeks in the Study|Overall Study||41||
59659515|NCT03020160|75778033|FG000|Emicizumab Dose Was Up-Titrated|Overall Study||0||
59659516|NCT03020160|75778034|FG001|Emicizumab Dose Was Up-Titrated|Overall Study||4||
59659517|NCT03020160|75778033|FG000|Opted for a Change in Emicizumab Dosing Regimen|Overall Study||0|Upon Implementation of Protocol Version 5|
59659518|NCT03020160|75778034|FG001|Opted for a Change in Emicizumab Dosing Regimen|Overall Study||1|Upon Implementation of Protocol Version 5|
59659519|NCT03020160|75778033|FG000|COMPLETED|Overall Study||6||
59659520|NCT03020160|75778034|FG001|COMPLETED|Overall Study||41||
59659521|NCT03020160|75778033|FG000|NOT COMPLETED|Overall Study||1||
59659522|NCT03020160|75778034|FG001|NOT COMPLETED|Overall Study||0||
59659523|NCT02593110|75778045|FG000|STARTED|Overall Study||30||
59659524|NCT02593110|75778046|FG001|STARTED|Overall Study||29||
59659525|NCT02593110|75778047|FG002|STARTED|Overall Study||28||
59659526|NCT02593110|75778048|FG003|STARTED|Overall Study||27||
59659527|NCT02593110|75778045|FG000|COMPLETED|Overall Study||30||
59659528|NCT02593110|75778046|FG001|COMPLETED|Overall Study||26||
59659529|NCT02593110|75778047|FG002|COMPLETED|Overall Study||24||
59659530|NCT02593110|75778048|FG003|COMPLETED|Overall Study||25||
59659531|NCT02593110|75778045|FG000|NOT COMPLETED|Overall Study||0||
59988873|NCT04201262|76104131|FG001|Received at Least 1 Dose of Study Drug|Overall Study||47||
59988874|NCT04201262|76104130|FG000|COMPLETED|Overall Study||0||
59988875|NCT04201262|76104131|FG001|COMPLETED|Overall Study||44||
59988876|NCT04201262|76104130|FG000|NOT COMPLETED|Overall Study||58||
59988877|NCT04201262|76104131|FG001|NOT COMPLETED|Overall Study||3||
59988878|NCT04072445|76104137|FG000|STARTED|Overall Study||28||
59988879|NCT04072445|76104137|FG000|COMPLETED|Overall Study||27||
59988880|NCT04072445|76104137|FG000|NOT COMPLETED|Overall Study||1||
59988881|NCT03831100|76104143|FG000|STARTED|Overall Study||26||
59988882|NCT03831100|76104144|FG001|STARTED|Overall Study||28||
59544307|NCT01654445|75642690|FG000|NOT COMPLETED|Overall Study||0||
59659532|NCT02593110|75778046|FG001|NOT COMPLETED|Overall Study||3||
59659533|NCT02593110|75778047|FG002|NOT COMPLETED|Overall Study||4||
59659534|NCT02593110|75778048|FG003|NOT COMPLETED|Overall Study||2||
59659535|NCT02373813|75778061|FG000|STARTED|Run-In Period||371||
59659536|NCT02373813|75778062|FG001|STARTED|Run-In Period||0||
59659537|NCT02373813|75778063|FG002|STARTED|Run-In Period||0||
59659538|NCT02373813|75778064|FG003|STARTED|Run-In Period||0||
59659539|NCT02373813|75778061|FG000|Treated|Run-In Period||368||
59659540|NCT02373813|75778062|FG001|Treated|Run-In Period||0||
59988883|NCT03831100|76104143|FG000|COMPLETED|Overall Study||20||
59988884|NCT03831100|76104144|FG001|COMPLETED|Overall Study||24||
59988885|NCT03831100|76104143|FG000|NOT COMPLETED|Overall Study||6||
59988886|NCT03831100|76104144|FG001|NOT COMPLETED|Overall Study||4||
59544308|NCT01654445|75642691|FG001|NOT COMPLETED|Overall Study||0||
59544309|NCT01615367|75642699|FG000|STARTED|Overall Study||19||
59544310|NCT01615367|75642700|FG001|STARTED|Overall Study||19||
59544311|NCT01615367|75642699|FG000|COMPLETED|Overall Study||14||
59544312|NCT01615367|75642700|FG001|COMPLETED|Overall Study|11 TAU participants chose to participate in NEW Tx after the completion of the waitlist period.|13||
59544313|NCT01615367|75642699|FG000|NOT COMPLETED|Overall Study||5||
59544314|NCT01615367|75642700|FG001|NOT COMPLETED|Overall Study||6||
59544315|NCT01702259|75642708|FG000|STARTED|Overall Study||34||
59544316|NCT01702259|75642709|FG001|STARTED|Overall Study||34||
59659541|NCT02373813|75778063|FG002|Treated|Run-In Period||0||
59659542|NCT02373813|75778064|FG003|Treated|Run-In Period||0||
59659543|NCT02373813|75778061|FG000|COMPLETED|Run-In Period|1 participant who completed the run-in period had no end of study case report form.|255||
59659544|NCT02373813|75778062|FG001|COMPLETED|Run-In Period||0||
59659545|NCT02373813|75778063|FG002|COMPLETED|Run-In Period||0||
59659546|NCT02373813|75778064|FG003|COMPLETED|Run-In Period||0||
59659547|NCT02373813|75778061|FG000|NOT COMPLETED|Run-In Period||116||
59659548|NCT02373813|75778062|FG001|NOT COMPLETED|Run-In Period||0||
59659549|NCT02373813|75778063|FG002|NOT COMPLETED|Run-In Period||0||
59659550|NCT02373813|75778064|FG003|NOT COMPLETED|Run-In Period||0||
59659551|NCT02373813|75778061|FG000|STARTED|Double-Blind Treatment Period||0|One participant who completed the run-in period was not randomized.|
59659552|NCT02373813|75778062|FG001|STARTED|Double-Blind Treatment Period||101|One participant who completed the run-in period was not randomized.|
59659553|NCT02373813|75778063|FG002|STARTED|Double-Blind Treatment Period||101|One participant who completed the run-in period was not randomized.|
59659554|NCT02373813|75778064|FG003|STARTED|Double-Blind Treatment Period||51|One participant who completed the run-in period was not randomized.|
59659555|NCT02373813|75778061|FG000|Received Investigational Product (IP)|Double-Blind Treatment Period||0||
59659556|NCT02373813|75778062|FG001|Received Investigational Product (IP)|Double-Blind Treatment Period||101||
59659557|NCT02373813|75778063|FG002|Received Investigational Product (IP)|Double-Blind Treatment Period||100||
59659558|NCT02373813|75778064|FG003|Received Investigational Product (IP)|Double-Blind Treatment Period||51||
59659559|NCT02373813|75778061|FG000|Received Rescue Treatment|Double-Blind Treatment Period||0||
59659560|NCT02373813|75778062|FG001|Received Rescue Treatment|Double-Blind Treatment Period||52||
59659561|NCT02373813|75778063|FG002|Received Rescue Treatment|Double-Blind Treatment Period||36||
59659562|NCT02373813|75778064|FG003|Received Rescue Treatment|Double-Blind Treatment Period||15||
59659563|NCT02373813|75778061|FG000|COMPLETED|Double-Blind Treatment Period||0||
59659564|NCT02373813|75778062|FG001|COMPLETED|Double-Blind Treatment Period||88||
59659565|NCT02373813|75778063|FG002|COMPLETED|Double-Blind Treatment Period||92||
59659566|NCT02373813|75778064|FG003|COMPLETED|Double-Blind Treatment Period||47||
59659567|NCT02373813|75778061|FG000|NOT COMPLETED|Double-Blind Treatment Period||0||
59659568|NCT02373813|75778062|FG001|NOT COMPLETED|Double-Blind Treatment Period||13||
59659569|NCT02373813|75778063|FG002|NOT COMPLETED|Double-Blind Treatment Period||9||
59659570|NCT02373813|75778064|FG003|NOT COMPLETED|Double-Blind Treatment Period||4||
59659571|NCT01959204|75778075|FG000|STARTED|Overall Study||97||
59659572|NCT01959204|75778075|FG000|COMPLETED|Overall Study||89||
59659573|NCT01959204|75778075|FG000|NOT COMPLETED|Overall Study||8||
59659574|NCT03996148|75778082|FG000|STARTED|Overall Study||7||
59659575|NCT03996148|75778083|FG001|STARTED|Overall Study||7||
59659576|NCT03996148|75778084|FG002|STARTED|Overall Study||7||
59659577|NCT03996148|75778082|FG000|COMPLETED|Overall Study||7||
59659578|NCT03996148|75778083|FG001|COMPLETED|Overall Study||6||
59659579|NCT03996148|75778084|FG002|COMPLETED|Overall Study||7||
59659580|NCT03996148|75778082|FG000|NOT COMPLETED|Overall Study||0||
59659581|NCT03996148|75778083|FG001|NOT COMPLETED|Overall Study||1||
59659582|NCT03996148|75778084|FG002|NOT COMPLETED|Overall Study||0||
59659583|NCT04918381|75778092|FG000|STARTED|Overall Study||30||37
59659584|NCT04918381|75778092|FG000|COMPLETED|Overall Study||30||37
59659585|NCT04918381|75778092|FG000|NOT COMPLETED|Overall Study||0||0
59659586|NCT03863509|75778099|FG000|STARTED|Overall Study||139||
59659587|NCT03863509|75778100|FG001|STARTED|Overall Study||192||
59659588|NCT03863509|75778101|FG002|STARTED|Overall Study||119||
59659589|NCT03863509|75778099|FG000|COMPLETED|Overall Study||117||
59659590|NCT03863509|75778100|FG001|COMPLETED|Overall Study||164||
59659591|NCT03863509|75778101|FG002|COMPLETED|Overall Study||114||
59659592|NCT03863509|75778099|FG000|NOT COMPLETED|Overall Study||22||
59659593|NCT03863509|75778100|FG001|NOT COMPLETED|Overall Study||28||
59659594|NCT03863509|75778101|FG002|NOT COMPLETED|Overall Study||5||
59659595|NCT03407794|75778118|FG000|STARTED|Overall Study||10||
59659596|NCT03407794|75778119|FG001|STARTED|Overall Study||11||
59659597|NCT03407794|75778120|FG002|STARTED|Overall Study||13||
59659598|NCT03407794|75778118|FG000|COMPLETED|Overall Study||10||
59659599|NCT03407794|75778119|FG001|COMPLETED|Overall Study||10||
59659600|NCT03407794|75778120|FG002|COMPLETED|Overall Study||11||
59659601|NCT03407794|75778118|FG000|NOT COMPLETED|Overall Study||0||
59659602|NCT03407794|75778119|FG001|NOT COMPLETED|Overall Study||1||
59659603|NCT03407794|75778120|FG002|NOT COMPLETED|Overall Study||2||
59659604|NCT03116347|75778130|FG000|STARTED|Overall Study||23||
59659605|NCT03116347|75778131|FG001|STARTED|Overall Study||19||
59659606|NCT03116347|75778130|FG000|Started Epoch 1|Overall Study||23||
59659607|NCT03116347|75778131|FG001|Started Epoch 1|Overall Study||0||
59659608|NCT03116347|75778130|FG000|Completed Epoch 1|Overall Study||22||
59659609|NCT03116347|75778131|FG001|Completed Epoch 1|Overall Study||0||
59659610|NCT03116347|75778130|FG000|Started Epoch 2|Overall Study||22||
59659611|NCT03116347|75778131|FG001|Started Epoch 2|Overall Study||19||
59659612|NCT03116347|75778130|FG000|Completed Epoch 2|Overall Study||22||
59659613|NCT03116347|75778131|FG001|Completed Epoch 2|Overall Study||17||
59659614|NCT03116347|75778130|FG000|Moved From Epoch 2 to Epoch 3|Overall Study||1||
59659615|NCT03116347|75778131|FG001|Moved From Epoch 2 to Epoch 3|Overall Study||0||
59659616|NCT03116347|75778130|FG000|Completed Epoch 3|Overall Study||1||
59659617|NCT03116347|75778131|FG001|Completed Epoch 3|Overall Study||0||
59659618|NCT03116347|75778130|FG000|COMPLETED|Overall Study||22||
59659619|NCT03116347|75778131|FG001|COMPLETED|Overall Study||17||
59659620|NCT03116347|75778130|FG000|NOT COMPLETED|Overall Study||1||
59659621|NCT03116347|75778131|FG001|NOT COMPLETED|Overall Study||2||
59659622|NCT01541839|75778139|FG000|STARTED|Overall Study||8||
59659623|NCT01541839|75778140|FG001|STARTED|Overall Study||8||
59659624|NCT01541839|75778139|FG000|COMPLETED|Overall Study||8||
59659625|NCT01541839|75778140|FG001|COMPLETED|Overall Study||8||
59659626|NCT01541839|75778139|FG000|NOT COMPLETED|Overall Study||0||
59659627|NCT01541839|75778140|FG001|NOT COMPLETED|Overall Study||0||
59659628|NCT00000136|75778148|FG000|STARTED|Overall Study||107||
59659629|NCT00000136|75778149|FG001|STARTED|Overall Study||127||
59659630|NCT00000136|75778148|FG000|COMPLETED|Overall Study||107||
59659631|NCT00000136|75778149|FG001|COMPLETED|Overall Study||127||
59659632|NCT00000136|75778148|FG000|NOT COMPLETED|Overall Study||0||
59659633|NCT00000136|75778149|FG001|NOT COMPLETED|Overall Study||0||
59659634|NCT00000142|75778158|FG000|STARTED|Overall Study||26||
59659635|NCT00000142|75778159|FG001|STARTED|Overall Study||26||
59659636|NCT00000142|75778160|FG002|STARTED|Overall Study||12||
59659637|NCT00000142|75778158|FG000|COMPLETED|Overall Study||26||
59659638|NCT00000142|75778159|FG001|COMPLETED|Overall Study||26||
59659639|NCT00000142|75778160|FG002|COMPLETED|Overall Study||12||
59659640|NCT00000142|75778158|FG000|NOT COMPLETED|Overall Study||0||
59659641|NCT00000142|75778159|FG001|NOT COMPLETED|Overall Study||0||
59659642|NCT00000142|75778160|FG002|NOT COMPLETED|Overall Study||0||
59659643|NCT03562156|75778170|FG000|STARTED|Overall Study||217||
59659644|NCT03562156|75778171|FG001|STARTED|Overall Study||109||
59659645|NCT03562156|75778170|FG000|COMPLETED|Overall Study||182||
59659646|NCT03562156|75778171|FG001|COMPLETED|Overall Study||91||
59659647|NCT03562156|75778170|FG000|NOT COMPLETED|Overall Study||35||
59659648|NCT03562156|75778171|FG001|NOT COMPLETED|Overall Study||18||
59659649|NCT00001213|75778177|FG000|STARTED|Overall Study||328||
59659650|NCT00001213|75778177|FG000|COMPLETED|Overall Study||310||
59659651|NCT00001213|75778177|FG000|NOT COMPLETED|Overall Study||18||
59659652|NCT00000135|75778183|FG000|STARTED|Overall Study||104||
59659653|NCT00000135|75778184|FG001|STARTED|Overall Study||105||
59659654|NCT00000135|75778183|FG000|COMPLETED|Overall Study||77||
59659655|NCT00000135|75778184|FG001|COMPLETED|Overall Study||91||
59659656|NCT00000135|75778183|FG000|NOT COMPLETED|Overall Study||27||
59659657|NCT00000135|75778184|FG001|NOT COMPLETED|Overall Study||14||
59659658|NCT00001723|75778192|FG000|STARTED|Overall Study||100||
59659659|NCT00001723|75778193|FG001|STARTED|Overall Study||100||
59659660|NCT00001723|75778192|FG000|COMPLETED|Overall Study||87||
59659661|NCT00001723|75778193|FG001|COMPLETED|Overall Study||84||
59659662|NCT00001723|75778192|FG000|NOT COMPLETED|Overall Study||13||
59659663|NCT00001723|75778193|FG001|NOT COMPLETED|Overall Study||16||
59659664|NCT00000378|75778205|FG000|STARTED|Overall Study||58||
59659665|NCT00000378|75778206|FG001|STARTED|Overall Study||52||
59659666|NCT00000378|75778205|FG000|COMPLETED|Overall Study||42||
59659667|NCT00000378|75778206|FG001|COMPLETED|Overall Study||38||
59659668|NCT00000378|75778205|FG000|NOT COMPLETED|Overall Study||16||
59659669|NCT00000378|75778206|FG001|NOT COMPLETED|Overall Study||14||
59659670|NCT01350115|75778214|FG000|STARTED|Core Study (All Patients)||8||
59659671|NCT01350115|75778215|FG001|STARTED|Core Study (All Patients)||2||
59659672|NCT01350115|75778214|FG000|Safety Anlysis Set|Core Study (All Patients)||8||
59659673|NCT01350115|75778215|FG001|Safety Anlysis Set|Core Study (All Patients)||2||
59659674|NCT01350115|75778214|FG000|Pharmacodynamic Set|Core Study (All Patients)||7||
59659675|NCT01350115|75778215|FG001|Pharmacodynamic Set|Core Study (All Patients)||2||
59659676|NCT01350115|75778214|FG000|COMPLETED|Core Study (All Patients)||8||
59659677|NCT01350115|75778215|FG001|COMPLETED|Core Study (All Patients)||2||
59659678|NCT01350115|75778214|FG000|NOT COMPLETED|Core Study (All Patients)||0||
59659679|NCT01350115|75778215|FG001|NOT COMPLETED|Core Study (All Patients)||0||
59659680|NCT01350115|75778214|FG000|STARTED|Long Term Follow-Up (All Patients)||8||
59659681|NCT01350115|75778215|FG001|STARTED|Long Term Follow-Up (All Patients)||2||
59659682|NCT01350115|75778214|FG000|COMPLETED|Long Term Follow-Up (All Patients)||7||
59659683|NCT01350115|75778215|FG001|COMPLETED|Long Term Follow-Up (All Patients)||0||
59659684|NCT01350115|75778214|FG000|NOT COMPLETED|Long Term Follow-Up (All Patients)||1||
59659685|NCT01350115|75778215|FG001|NOT COMPLETED|Long Term Follow-Up (All Patients)||2||
59659686|NCT04142983|75778223|FG000|STARTED|Overall Study||110||
59659687|NCT04142983|75778223|FG000|Treatment Population|Overall Study||100||
59659688|NCT04142983|75778223|FG000|COMPLETED|Overall Study||11||
59659689|NCT04142983|75778223|FG000|NOT COMPLETED|Overall Study||99||
59659690|NCT03801031|75778230|FG000|STARTED|Overall Study||3||
59659691|NCT03801031|75778231|FG001|STARTED|Overall Study||1||
59659692|NCT03801031|75778230|FG000|COMPLETED|Overall Study||1||
59659693|NCT03801031|75778231|FG001|COMPLETED|Overall Study||0||
59659694|NCT03801031|75778230|FG000|NOT COMPLETED|Overall Study||2||
59659695|NCT03801031|75778231|FG001|NOT COMPLETED|Overall Study||1||
59659696|NCT03357952|75778239|FG000|STARTED|Overall Study||9||
59659697|NCT03357952|75778240|FG001|STARTED|Overall Study||1||
59659698|NCT03357952|75778239|FG000|COMPLETED|Overall Study||0||
59659699|NCT03357952|75778240|FG001|COMPLETED|Overall Study||0||
59659700|NCT03357952|75778239|FG000|NOT COMPLETED|Overall Study||9||
59659701|NCT03357952|75778240|FG001|NOT COMPLETED|Overall Study||1||
59659702|NCT03055858|75778246|FG000|STARTED|Overall Study||200||
59659703|NCT03055858|75778246|FG000|IDE|Overall Study||136||
59659704|NCT03055858|75778246|FG000|CAP|Overall Study||46||
59659705|NCT03055858|75778246|FG000|COMPLETED|Overall Study||156||
59659706|NCT03055858|75778246|FG000|NOT COMPLETED|Overall Study||44||
59659707|NCT02987335|75778255|FG000|STARTED|Overall Study||20||
59659708|NCT02987335|75778256|FG001|STARTED|Overall Study||13||
59659709|NCT02987335|75778257|FG002|STARTED|Overall Study||15||
59659710|NCT02987335|75778258|FG003|STARTED|Overall Study||16||
59659711|NCT02987335|75778259|FG004|STARTED|Overall Study||9||
59659712|NCT02987335|75778255|FG000|COMPLETED|Overall Study||20||
59659713|NCT02987335|75778256|FG001|COMPLETED|Overall Study||13||
59659714|NCT02987335|75778257|FG002|COMPLETED|Overall Study||15||
59659715|NCT02987335|75778258|FG003|COMPLETED|Overall Study||16||
59659716|NCT02987335|75778259|FG004|COMPLETED|Overall Study||9||
59659717|NCT02987335|75778255|FG000|NOT COMPLETED|Overall Study||0||
59659718|NCT02987335|75778256|FG001|NOT COMPLETED|Overall Study||0||
59659719|NCT02987335|75778257|FG002|NOT COMPLETED|Overall Study||0||
59659720|NCT02987335|75778258|FG003|NOT COMPLETED|Overall Study||0||
59659721|NCT02987335|75778259|FG004|NOT COMPLETED|Overall Study||0||
59659722|NCT02393716|75778271|FG000|STARTED|Overall Study||139||
59659723|NCT02393716|75778271|FG000|COMPLETED|Overall Study||78||
59659724|NCT02393716|75778271|FG000|NOT COMPLETED|Overall Study||61||
59659725|NCT00584233|75778276|FG000|STARTED|Overall Study||75||
59659726|NCT00584233|75778276|FG000|COMPLETED|Overall Study||57||
59659727|NCT00584233|75778276|FG000|NOT COMPLETED|Overall Study||18||
59659728|NCT00556972|75778280|FG000|STARTED|Overall Study||4||
59659729|NCT00556972|75778280|FG000|COMPLETED|Overall Study||4||
59659730|NCT00556972|75778280|FG000|NOT COMPLETED|Overall Study||0||
59659731|NCT00001305|75778284|FG000|STARTED|Overall Study||42||
59659732|NCT00001305|75778284|FG000|COMPLETED|Overall Study||42||
59659733|NCT00001305|75778284|FG000|NOT COMPLETED|Overall Study||0||
59659734|NCT00001566|75778288|FG000|STARTED|Overall Study||42||
59659735|NCT00001566|75778288|FG000|Completed Immunotherapy|Overall Study||23||
59659736|NCT00001566|75778288|FG000|COMPLETED|Overall Study||23||
59659737|NCT00001566|75778288|FG000|NOT COMPLETED|Overall Study||19||
59659738|NCT00001575|75778292|FG000|STARTED|Overall Study||87||
59659739|NCT00001575|75778292|FG000|Treated|Overall Study||65||
59659740|NCT00001575|75778292|FG000|COMPLETED|Overall Study||42||
59659741|NCT00001575|75778292|FG000|NOT COMPLETED|Overall Study||45||
59659742|NCT00001596|75778298|FG000|STARTED|Overall Study||23||
59659743|NCT00001596|75778299|FG001|STARTED|Overall Study||12||
59659744|NCT00001596|75778298|FG000|COMPLETED|Overall Study||6||
59659745|NCT00001596|75778299|FG001|COMPLETED|Overall Study||2||
59659746|NCT00001596|75778298|FG000|NOT COMPLETED|Overall Study||17||
59659747|NCT00001596|75778299|FG001|NOT COMPLETED|Overall Study||10||
59659748|NCT00001656|75778307|FG000|STARTED|Overall Study||13||
59659749|NCT00001656|75778308|FG001|STARTED|Overall Study||12||
59659750|NCT00001656|75778307|FG000|COMPLETED|Overall Study||12||
59659751|NCT00001656|75778308|FG001|COMPLETED|Overall Study||12||
59659752|NCT00001656|75778307|FG000|NOT COMPLETED|Overall Study||1||
59659753|NCT00001656|75778308|FG001|NOT COMPLETED|Overall Study||0||
59659754|NCT04017910|75778314|FG000|STARTED|Overall Study||17||
59659755|NCT04017910|75778314|FG000|COMPLETED|Overall Study||17||
59659756|NCT04017910|75778314|FG000|NOT COMPLETED|Overall Study||0||
59659757|NCT03959332|75778320|FG000|STARTED|Overall Study||16||
59659758|NCT03959332|75778321|FG001|STARTED|Overall Study||16||
59659759|NCT03959332|75778320|FG000|COMPLETED|Overall Study||16||
59659760|NCT03959332|75778321|FG001|COMPLETED|Overall Study||16||
59659761|NCT03959332|75778320|FG000|NOT COMPLETED|Overall Study||0||
59659762|NCT03959332|75778321|FG001|NOT COMPLETED|Overall Study||0||
59659763|NCT04796831|75778327|FG000|STARTED|Overall Study||8||
59659764|NCT04796831|75778327|FG000|COMPLETED|Overall Study||8||
59659765|NCT04796831|75778327|FG000|NOT COMPLETED|Overall Study||0||
59659766|NCT01349803|75778336|FG000|STARTED|Overall Study||60||
59659767|NCT01349803|75778337|FG001|STARTED|Overall Study||58||
59659768|NCT01349803|75778338|FG002|STARTED|Overall Study||60||
59659769|NCT01349803|75778339|FG003|STARTED|Overall Study||59||
59659770|NCT01349803|75778336|FG000|COMPLETED|Overall Study||59||
59659771|NCT01349803|75778337|FG001|COMPLETED|Overall Study||57||
59659772|NCT01349803|75778338|FG002|COMPLETED|Overall Study||57||
59659773|NCT01349803|75778339|FG003|COMPLETED|Overall Study||57||
59659774|NCT01349803|75778336|FG000|NOT COMPLETED|Overall Study||1||
59659775|NCT01349803|75778337|FG001|NOT COMPLETED|Overall Study||1||
59659776|NCT01349803|75778338|FG002|NOT COMPLETED|Overall Study||3||
59659777|NCT01349803|75778339|FG003|NOT COMPLETED|Overall Study||2||
59659778|NCT01807000|75778357|FG000|STARTED|Overall Study||6||
59659779|NCT01807000|75778357|FG000|COMPLETED|Overall Study||6||
59659780|NCT01807000|75778357|FG000|NOT COMPLETED|Overall Study||0||
59659781|NCT01806688|75778363|FG000|STARTED|First Intervention Seed Study|"Participants received one of the following:~experimental snack #1 gluten-free high protein snack a 30 g serving of buckwheat groats~placebo comparator reference product, a gluten-free snack with similar energy density but 1/2 the protein as the experimental snack, a 32g serving of corn nuts~placebo comparator non-caloric control water"|38|Day 1|
59659782|NCT01806688|75778364|FG001|STARTED|First Intervention Seed Study|"Participants received one of the following:~experimental snack #1 gluten-free high protein snack a 30 g serving of buckwheat groats~placebo comparator reference product, a gluten-free snack with similar energy density but 1/2 the protein as the experimental snack, a 32g serving of corn nuts~placebo comparator non-caloric control water"|0|Day 1|
59659783|NCT01806688|75778363|FG000|Experimental Snack #1|First Intervention Seed Study|Received experimental snack #1 at the first visit, a 30g serving of buckwheat groats|13||
59659784|NCT01806688|75778364|FG001|Experimental Snack #1|First Intervention Seed Study|Received experimental snack #1 at the first visit, a 30g serving of buckwheat groats|0||
59659785|NCT01806688|75778363|FG000|Placebo Comparator Reference Product #1|First Intervention Seed Study|Received the placebo comparator reference product #1 at the first visit, a 32g serving of corn nuts|13||
59659786|NCT01806688|75778364|FG001|Placebo Comparator Reference Product #1|First Intervention Seed Study|Received the placebo comparator reference product #1 at the first visit, a 32g serving of corn nuts|0||
59659787|NCT01806688|75778363|FG000|Placebo Comparator Non-caloric Control #1|First Intervention Seed Study|Received water, the placebo comparator non-caloric control #1 at the first visit|12||
59659788|NCT01806688|75778364|FG001|Placebo Comparator Non-caloric Control #1|First Intervention Seed Study|Received water, the placebo comparator non-caloric control #1 at the first visit|0||
59659789|NCT01806688|75778363|FG000|COMPLETED|First Intervention Seed Study||38||
59659790|NCT01806688|75778364|FG001|COMPLETED|First Intervention Seed Study||0||
59659791|NCT01806688|75778363|FG000|NOT COMPLETED|First Intervention Seed Study||0||
59659792|NCT01806688|75778364|FG001|NOT COMPLETED|First Intervention Seed Study||0||
59659793|NCT01806688|75778363|FG000|STARTED|Second Intervention Seed Study|"Participants received one of the following they hadn't previously received at visit 1:~experimental snack #1 gluten-free high protein snack a 30 g serving of buckwheat groats~placebo comparator reference product #1, a gluten-free snack with similar energy density but 1/2 the protein as the experimental snack, a 32g serving of corn nuts~placebo comparator non-caloric control #1, water"|38|Day 8|
59659794|NCT01806688|75778364|FG001|STARTED|Second Intervention Seed Study|"Participants received one of the following they hadn't previously received at visit 1:~experimental snack #1 gluten-free high protein snack a 30 g serving of buckwheat groats~placebo comparator reference product #1, a gluten-free snack with similar energy density but 1/2 the protein as the experimental snack, a 32g serving of corn nuts~placebo comparator non-caloric control #1, water"|0|Day 8|
59659795|NCT01806688|75778363|FG000|Experimental Snack #1|Second Intervention Seed Study|Received the experimental snack #1, a 30g serving of buckwheat groats at visit 2|13||
59659796|NCT01806688|75778364|FG001|Experimental Snack #1|Second Intervention Seed Study|Received the experimental snack #1, a 30g serving of buckwheat groats at visit 2|0||
59659797|NCT01806688|75778363|FG000|Placebo Comparator Reference Product #1|Second Intervention Seed Study|Received the Placebo comparator reference product #1, a 32g serving of corn nuts at visit 2|13||
59659798|NCT01806688|75778364|FG001|Placebo Comparator Reference Product #1|Second Intervention Seed Study|Received the Placebo comparator reference product #1, a 32g serving of corn nuts at visit 2|0||
59659799|NCT01806688|75778363|FG000|Placebo Comparator Non-caloric Control #1|Second Intervention Seed Study|Received water, the placebo comparator non-caloric control #1 at visit 2|12||
59659800|NCT01806688|75778364|FG001|Placebo Comparator Non-caloric Control #1|Second Intervention Seed Study|Received water, the placebo comparator non-caloric control #1 at visit 2|0||
59659801|NCT01806688|75778363|FG000|COMPLETED|Second Intervention Seed Study||38||
59659802|NCT01806688|75778364|FG001|COMPLETED|Second Intervention Seed Study||0||
59659803|NCT01806688|75778363|FG000|NOT COMPLETED|Second Intervention Seed Study||0||
59659804|NCT01806688|75778364|FG001|NOT COMPLETED|Second Intervention Seed Study||0||
59709753|NCT01072149|75828537|FG017|COMPLETED|Treatment Period 1 (28 Days)||2||
59709754|NCT01072149|75828520|FG000|NOT COMPLETED|Treatment Period 1 (28 Days)||0||
59709755|NCT01072149|75828521|FG001|NOT COMPLETED|Treatment Period 1 (28 Days)||0||
59544317|NCT01702259|75642708|FG000|COMPLETED|Overall Study||34||
59544318|NCT01702259|75642709|FG001|COMPLETED|Overall Study||34||
59544319|NCT01702259|75642708|FG000|NOT COMPLETED|Overall Study||0||
59544320|NCT01702259|75642709|FG001|NOT COMPLETED|Overall Study||0||
59544321|NCT01703039|75642717|FG000|STARTED|Overall Study||9||
59544322|NCT01703039|75642718|FG001|STARTED|Overall Study||12||
59544323|NCT01703039|75642717|FG000|COMPLETED|Overall Study||6||
59544324|NCT01703039|75642718|FG001|COMPLETED|Overall Study||7||
59544325|NCT01703039|75642717|FG000|NOT COMPLETED|Overall Study||3||
59544326|NCT01703039|75642718|FG001|NOT COMPLETED|Overall Study||5||
59544327|NCT01656629|75642729|FG000|STARTED|Overall Study||21||
59544328|NCT01656629|75642730|FG001|STARTED|Overall Study||18||
59544329|NCT01656629|75642731|FG002|STARTED|Overall Study||16||
59544330|NCT01656629|75642729|FG000|COMPLETED|Overall Study||16||
59659805|NCT01806688|75778363|FG000|STARTED|Third Intervention Seed Study|"Participants received one of the following they hadn't previously received at visit 1 or visit 2:~experimental snack #1 gluten-free high protein snack a 30 g serving of buckwheat groats~placebo comparator reference product, a gluten-free snack with similar energy density but 1/2 the protein as the experimental snack, a 32g serving of corn nuts~placebo comparator non-caloric control water"|38|Day 15|
59659806|NCT01806688|75778364|FG001|STARTED|Third Intervention Seed Study|"Participants received one of the following they hadn't previously received at visit 1 or visit 2:~experimental snack #1 gluten-free high protein snack a 30 g serving of buckwheat groats~placebo comparator reference product, a gluten-free snack with similar energy density but 1/2 the protein as the experimental snack, a 32g serving of corn nuts~placebo comparator non-caloric control water"|0|Day 15|
59659807|NCT01806688|75778363|FG000|Experimental Snack #1|Third Intervention Seed Study|Received the Experimental snack #1, a 30g serving of buckwheat groats at visit 3|12||
59659808|NCT01806688|75778364|FG001|Experimental Snack #1|Third Intervention Seed Study|Received the Experimental snack #1, a 30g serving of buckwheat groats at visit 3|0||
59659809|NCT01806688|75778363|FG000|Placebo Comparator Reference Product #1|Third Intervention Seed Study|Received the placebo comparator reference product #1, a 32g serving of corn nuts at visit 3|12||
59659810|NCT01806688|75778364|FG001|Placebo Comparator Reference Product #1|Third Intervention Seed Study|Received the placebo comparator reference product #1, a 32g serving of corn nuts at visit 3|0||
59659811|NCT01806688|75778363|FG000|Placebo Comparator Non-caloric Control #1|Third Intervention Seed Study|Received water, the placebo comparator non-caloric control #1 at visit 3|14||
59659812|NCT01806688|75778364|FG001|Placebo Comparator Non-caloric Control #1|Third Intervention Seed Study|Received water, the placebo comparator non-caloric control #1 at visit 3|0||
59659813|NCT01806688|75778363|FG000|COMPLETED|Third Intervention Seed Study||38||
59659814|NCT01806688|75778364|FG001|COMPLETED|Third Intervention Seed Study||0||
59659815|NCT01806688|75778363|FG000|NOT COMPLETED|Third Intervention Seed Study||0||
59659816|NCT01806688|75778364|FG001|NOT COMPLETED|Third Intervention Seed Study||0||
59659817|NCT01806688|75778363|FG000|STARTED|First Intervention Pita Study|"Participants received one of the following:~experimental snack #2 gluten-free high protein and high fibre snack a 50 g serving of buckwheat and pinto bean flour pita bread~placebo comparator reference product, a gluten-free snack with similar energy density but less protein and fibre as the experimental snack, a 50g serving of rice bread~placebo comparator non-caloric control water"|0|Day 1|
59659818|NCT01806688|75778364|FG001|STARTED|First Intervention Pita Study|"Participants received one of the following:~experimental snack #2 gluten-free high protein and high fibre snack a 50 g serving of buckwheat and pinto bean flour pita bread~placebo comparator reference product, a gluten-free snack with similar energy density but less protein and fibre as the experimental snack, a 50g serving of rice bread~placebo comparator non-caloric control water"|38|Day 1|
59659819|NCT01806688|75778363|FG000|Experimental Snack #2|First Intervention Pita Study|Received the Experimental snack #2, a 50 g serving of buckwheat and pinto bean flour pita bread at the first visit|0||
59659820|NCT01806688|75778364|FG001|Experimental Snack #2|First Intervention Pita Study|Received the Experimental snack #2, a 50 g serving of buckwheat and pinto bean flour pita bread at the first visit|14||
59659821|NCT01806688|75778363|FG000|Placebo Comparator Reference Product #2|First Intervention Pita Study|Received the placebo comparator reference product #2 at the first visit, a 50g serving of rice bread|0||
59659822|NCT01806688|75778364|FG001|Placebo Comparator Reference Product #2|First Intervention Pita Study|Received the placebo comparator reference product #2 at the first visit, a 50g serving of rice bread|12||
59659823|NCT01806688|75778363|FG000|Placebo Comparator Non-caloric Control #2|First Intervention Pita Study|Received water, the placebo comparator non-caloric control #2 at the first visit|0||
59659824|NCT01806688|75778364|FG001|Placebo Comparator Non-caloric Control #2|First Intervention Pita Study|Received water, the placebo comparator non-caloric control #2 at the first visit|12||
59659825|NCT01806688|75778363|FG000|COMPLETED|First Intervention Pita Study||0||
59659826|NCT01806688|75778364|FG001|COMPLETED|First Intervention Pita Study||38||
59659827|NCT01806688|75778363|FG000|NOT COMPLETED|First Intervention Pita Study||0||
59659828|NCT01806688|75778364|FG001|NOT COMPLETED|First Intervention Pita Study||0||
59659829|NCT01806688|75778363|FG000|STARTED|Second Intervention Pita Study|"Participants received one of the following:~experimental snack #2 gluten-free high protein and high fibre snack a 50 g serving of buckwheat and pinto bean flour pita bread~placebo comparator reference product, a gluten-free snack with similar energy density but less protein and fibre as the experimental snack, a 50g serving of rice bread~placebo comparator non-caloric control water"|0|Day 8|
59659830|NCT01806688|75778364|FG001|STARTED|Second Intervention Pita Study|"Participants received one of the following:~experimental snack #2 gluten-free high protein and high fibre snack a 50 g serving of buckwheat and pinto bean flour pita bread~placebo comparator reference product, a gluten-free snack with similar energy density but less protein and fibre as the experimental snack, a 50g serving of rice bread~placebo comparator non-caloric control water"|38|Day 8|
59659831|NCT01806688|75778363|FG000|Experimental Snack #2|Second Intervention Pita Study|Received the Experimental snack #2, a 50 g serving of buckwheat and pinto bean flour pita bread at the second visit|0||
59659832|NCT01806688|75778364|FG001|Experimental Snack #2|Second Intervention Pita Study|Received the Experimental snack #2, a 50 g serving of buckwheat and pinto bean flour pita bread at the second visit|12||
59659833|NCT01806688|75778363|FG000|Placebo Comparator Reference Product #2|Second Intervention Pita Study|Received the placebo comparator reference product #2 at the second visit, a 50g serving of rice bread|0||
59659834|NCT01806688|75778364|FG001|Placebo Comparator Reference Product #2|Second Intervention Pita Study|Received the placebo comparator reference product #2 at the second visit, a 50g serving of rice bread|13||
59988887|NCT03691662|76104154|FG000|STARTED|Overall Study||208||
60077183|NCT01922011|76192221|FG000|Treated|Overall Study|Treated Participants|73||
60077184|NCT01922011|76192222|FG001|Treated|Overall Study|Treated Participants|73||
60077185|NCT01922011|76192221|FG000|Treatment Actually Received|Overall Study|One participant intended for treatment with Vancomycin or Nafcillin was treated with Daptomycin|74||
59659835|NCT01806688|75778363|FG000|Placebo Comparator Non-caloric Control #2|Second Intervention Pita Study|Received water, the placebo comparator non-caloric control #2 at the second visit|0||
59659836|NCT01806688|75778364|FG001|Placebo Comparator Non-caloric Control #2|Second Intervention Pita Study|Received water, the placebo comparator non-caloric control #2 at the second visit|13||
59659837|NCT01806688|75778363|FG000|COMPLETED|Second Intervention Pita Study||0||
59659838|NCT01806688|75778364|FG001|COMPLETED|Second Intervention Pita Study||38||
59659839|NCT01806688|75778363|FG000|NOT COMPLETED|Second Intervention Pita Study||0||
59659840|NCT01806688|75778364|FG001|NOT COMPLETED|Second Intervention Pita Study||0||
59659841|NCT01806688|75778363|FG000|STARTED|Third Intervention Pita Study|"Participants received one of the following:~experimental snack #2 gluten-free high protein and high fibre snack a 50 g serving of buckwheat and pinto bean flour pita bread placebo comparator reference product, a gluten-free snack with similar energy density but less protein and fibre as the experimental snack, a 50g serving of rice bread placebo comparator non-caloric control water"|0|Day 15|
59659842|NCT01806688|75778364|FG001|STARTED|Third Intervention Pita Study|"Participants received one of the following:~experimental snack #2 gluten-free high protein and high fibre snack a 50 g serving of buckwheat and pinto bean flour pita bread placebo comparator reference product, a gluten-free snack with similar energy density but less protein and fibre as the experimental snack, a 50g serving of rice bread placebo comparator non-caloric control water"|38|Day 15|
59659843|NCT01806688|75778363|FG000|Experimental Snack #2|Third Intervention Pita Study|Received the Experimental snack #2, a 50 g serving of buckwheat and pinto bean flour pita bread at the third visit|0||
59659844|NCT01806688|75778364|FG001|Experimental Snack #2|Third Intervention Pita Study|Received the Experimental snack #2, a 50 g serving of buckwheat and pinto bean flour pita bread at the third visit|12||
59659845|NCT01806688|75778363|FG000|Placebo Comparator Reference Product #2|Third Intervention Pita Study|Received the placebo comparator reference product #2 at the third visit, a 50g serving of rice bread|0||
59659846|NCT01806688|75778364|FG001|Placebo Comparator Reference Product #2|Third Intervention Pita Study|Received the placebo comparator reference product #2 at the third visit, a 50g serving of rice bread|13||
60077186|NCT01922011|76192222|FG001|Treatment Actually Received|Overall Study|One participant intended for treatment with Vancomycin or Nafcillin was treated with Daptomycin|72||
60077187|NCT01922011|76192221|FG000|COMPLETED|Overall Study||69||
60077188|NCT01922011|76192222|FG001|COMPLETED|Overall Study||69||
60077189|NCT01922011|76192221|FG000|NOT COMPLETED|Overall Study||6||
60077190|NCT01922011|76192222|FG001|NOT COMPLETED|Overall Study||5||
60077191|NCT01883635|76192236|FG000|STARTED|Overall Study||24||
60077192|NCT01883635|76192237|FG001|STARTED|Overall Study||20||
60077193|NCT01883635|76192236|FG000|COMPLETED|Overall Study||20||
59544331|NCT01656629|75642730|FG001|COMPLETED|Overall Study||16||
59544332|NCT01656629|75642731|FG002|COMPLETED|Overall Study||14||
59544333|NCT01656629|75642729|FG000|NOT COMPLETED|Overall Study||5||
59544334|NCT01656629|75642730|FG001|NOT COMPLETED|Overall Study||2||
59544335|NCT01656629|75642731|FG002|NOT COMPLETED|Overall Study||2||
59544336|NCT01703507|75642741|FG000|STARTED|Overall Study||6||
60077194|NCT01883635|76192237|FG001|COMPLETED|Overall Study||20||
60077195|NCT01883635|76192236|FG000|NOT COMPLETED|Overall Study||4||
60077196|NCT01883635|76192237|FG001|NOT COMPLETED|Overall Study||0||
60077197|NCT01921387|76192245|FG000|STARTED|Overall Study||20||
60077198|NCT01921387|76192245|FG000|COMPLETED|Overall Study||19||
60077199|NCT01921387|76192245|FG000|NOT COMPLETED|Overall Study||1||
60077200|NCT01895335|76192249|FG000|STARTED|Overall Study||1001||
60077201|NCT01895335|76192249|FG000|Treated|Overall Study||1000||
60077202|NCT01895335|76192249|FG000|COMPLETED|Overall Study||786||
59544337|NCT01703507|75642742|FG001|STARTED|Overall Study||11||
60077203|NCT01895335|76192249|FG000|NOT COMPLETED|Overall Study||215||
60077204|NCT01617655|76192255|FG000|STARTED|Overall Study|Randomized|35||
60077205|NCT01617655|76192256|FG001|STARTED|Overall Study|Randomized|72||
60077206|NCT01617655|76192255|FG000|Treated|Overall Study||35||
60077207|NCT01617655|76192256|FG001|Treated|Overall Study||72||
60077208|NCT01617655|76192255|FG000|COMPLETED|Overall Study||26||
60077209|NCT01617655|76192256|FG001|COMPLETED|Overall Study||43||
60077210|NCT01617655|76192255|FG000|NOT COMPLETED|Overall Study||9||
60077211|NCT01617655|76192256|FG001|NOT COMPLETED|Overall Study||29||
60077212|NCT01895101|76192267|FG000|STARTED|Overall Study||250||
60077213|NCT01895101|76192268|FG001|STARTED|Overall Study||250||
60077214|NCT01895101|76192269|FG002|STARTED|Overall Study||250||
60077215|NCT01895101|76192267|FG000|COMPLETED|Overall Study||249||
60077216|NCT01895101|76192268|FG001|COMPLETED|Overall Study||245||
60077217|NCT01895101|76192269|FG002|COMPLETED|Overall Study||245||
59544338|NCT01703507|75642741|FG000|COMPLETED|Overall Study||5||
59544339|NCT01703507|75642742|FG001|COMPLETED|Overall Study||11||
59544340|NCT01703507|75642741|FG000|NOT COMPLETED|Overall Study||1||
59544341|NCT01703507|75642742|FG001|NOT COMPLETED|Overall Study||0||
59544342|NCT02158520|75642750|FG000|STARTED|Overall Study||12||
59544343|NCT02158520|75642751|FG001|STARTED|Overall Study||12||
60077218|NCT01895101|76192267|FG000|NOT COMPLETED|Overall Study||1||
60077219|NCT01895101|76192268|FG001|NOT COMPLETED|Overall Study||5||
60077220|NCT01895101|76192269|FG002|NOT COMPLETED|Overall Study||5||
60077221|NCT01894477|76192279|FG000|STARTED|Overall Study||35||
60077222|NCT01894477|76192280|FG001|STARTED|Overall Study||67||
59659847|NCT01806688|75778363|FG000|Placebo Comparator Non-caloric Control #2|Third Intervention Pita Study|Received water, the placebo comparator non-caloric control #2 at the third visit|0||
59659848|NCT01806688|75778364|FG001|Placebo Comparator Non-caloric Control #2|Third Intervention Pita Study|Received water, the placebo comparator non-caloric control #2 at the third visit|13||
59659849|NCT01806688|75778363|FG000|COMPLETED|Third Intervention Pita Study||0||
59659850|NCT01806688|75778364|FG001|COMPLETED|Third Intervention Pita Study||38||
59659851|NCT01806688|75778363|FG000|NOT COMPLETED|Third Intervention Pita Study||0||
59659852|NCT01806688|75778364|FG001|NOT COMPLETED|Third Intervention Pita Study||0||
59659853|NCT01806259|75778375|FG000|STARTED|Overall Study||96||
59659854|NCT01806259|75778376|FG001|STARTED|Overall Study||107||
59659855|NCT01806259|75778375|FG000|COMPLETED|Overall Study||96||
59659856|NCT01806259|75778376|FG001|COMPLETED|Overall Study||107||
59659857|NCT01806259|75778375|FG000|NOT COMPLETED|Overall Study||0||
59659858|NCT01806259|75778376|FG001|NOT COMPLETED|Overall Study||0||
59659859|NCT01805791|75778386|FG000|STARTED|Overall Study||66||
59659860|NCT01805791|75778387|FG001|STARTED|Overall Study||67||
59659861|NCT01805791|75778388|FG002|STARTED|Overall Study||68||
59659862|NCT01805791|75778386|FG000|COMPLETED|Overall Study||44||
60077223|NCT01894477|76192279|FG000|COMPLETED|Overall Study||35||
60077224|NCT01894477|76192280|FG001|COMPLETED|Overall Study||65||
60077225|NCT01894477|76192279|FG000|NOT COMPLETED|Overall Study||0||
60077226|NCT01894477|76192280|FG001|NOT COMPLETED|Overall Study||2||
60077227|NCT01894243|76192289|FG000|STARTED|Overall Study||13|Received treatment in Part A|
59659863|NCT01805791|75778387|FG001|COMPLETED|Overall Study||50||
60077228|NCT01894243|76192290|FG001|STARTED|Overall Study||10|Received treatment in Part A|
60077229|NCT01894243|76192291|FG002|STARTED|Overall Study||8|Received treatment in Part A|
59988888|NCT03691662|76104155|FG001|STARTED|Overall Study||209||
59988889|NCT03691662|76104154|FG000|Safety and Full Analysis Set (FAS) Participants|Overall Study|4 Participants did not receive DE-117 study drug.|204||
59988890|NCT03691662|76104155|FG001|Safety and Full Analysis Set (FAS) Participants|Overall Study|4 Participants did not receive Timolol.|205||
59988891|NCT03691662|76104154|FG000|COMPLETED|Overall Study||187||
59988892|NCT03691662|76104155|FG001|COMPLETED|Overall Study||196||
59988893|NCT03691662|76104154|FG000|NOT COMPLETED|Overall Study||21||
59988894|NCT03691662|76104155|FG001|NOT COMPLETED|Overall Study||13||
59544344|NCT02158520|75642750|FG000|AE Evaluated Prior to Crossover|Overall Study||12||
59544345|NCT02158520|75642751|FG001|AE Evaluated Prior to Crossover|Overall Study||12||
59544346|NCT02158520|75642750|FG000|Eligible for Crossover|Overall Study||8|Discontinued initial treatment due to disease progression|
59544347|NCT02158520|75642751|FG001|Eligible for Crossover|Overall Study||8|Discontinued initial treatment due to disease progression|
59544348|NCT02158520|75642750|FG000|Eligible for Crossover With AE Evaluated|Overall Study||7|Patients eligible for crossover AND evaluated for adverse events|
59544349|NCT02158520|75642751|FG001|Eligible for Crossover With AE Evaluated|Overall Study||7|Patients eligible for crossover AND evaluated for adverse events|
59544350|NCT02158520|75642750|FG000|Crossover Cohort|Overall Study||4|Patients who experienced progressive disease and did crossover|
59544351|NCT02158520|75642751|FG001|Crossover Cohort|Overall Study||6|Patients who experienced progressive disease and did crossover|
59544352|NCT02158520|75642750|FG000|COMPLETED|Overall Study||12|Eligible patients|
59659864|NCT01805791|75778388|FG002|COMPLETED|Overall Study||48||
59544353|NCT02158520|75642751|FG001|COMPLETED|Overall Study||12|Eligible patients|
59659865|NCT01805791|75778386|FG000|NOT COMPLETED|Overall Study||22||
59659866|NCT01805791|75778387|FG001|NOT COMPLETED|Overall Study||17||
59988895|NCT03689244|76104163|FG000|STARTED|Double Blind Period (Up to 27.7 Months)||64||
59988896|NCT03689244|76104164|FG001|STARTED|Double Blind Period (Up to 27.7 Months)||64||
59659867|NCT01805791|75778388|FG002|NOT COMPLETED|Overall Study||20||
59659868|NCT01805440|75778399|FG000|STARTED|Overall Study||19||
59659869|NCT01805440|75778400|FG001|STARTED|Overall Study||17||
59659870|NCT01805440|75778401|FG002|STARTED|Overall Study||26||
59659871|NCT01805440|75778399|FG000|COMPLETED|Overall Study||18||
59659872|NCT01805440|75778400|FG001|COMPLETED|Overall Study||17||
59659873|NCT01805440|75778401|FG002|COMPLETED|Overall Study||26||
59659874|NCT01805440|75778399|FG000|NOT COMPLETED|Overall Study||1||
59659875|NCT01805440|75778400|FG001|NOT COMPLETED|Overall Study||0||
59659876|NCT01805440|75778401|FG002|NOT COMPLETED|Overall Study||0||
59659877|NCT04404257|75778410|FG000|STARTED|Overall Study||85||
59659878|NCT04404257|75778411|FG001|STARTED|Overall Study||85||
59659879|NCT04404257|75778410|FG000|COMPLETED|Overall Study||85||
59659880|NCT04404257|75778411|FG001|COMPLETED|Overall Study||85||
59659881|NCT04404257|75778410|FG000|NOT COMPLETED|Overall Study||0||
59659882|NCT04404257|75778411|FG001|NOT COMPLETED|Overall Study||0||
59659883|NCT01465048|75778420|FG000|STARTED|Overall Study||6||
59659884|NCT01465048|75778421|FG001|STARTED|Overall Study||6||
59659885|NCT01465048|75778422|FG002|STARTED|Overall Study||6||
59659886|NCT01465048|75778420|FG000|COMPLETED|Overall Study||6||
59659887|NCT01465048|75778421|FG001|COMPLETED|Overall Study||6||
59659888|NCT01465048|75778422|FG002|COMPLETED|Overall Study||6||
59659889|NCT01465048|75778420|FG000|NOT COMPLETED|Overall Study||0||
59659890|NCT01465048|75778421|FG001|NOT COMPLETED|Overall Study||0||
59659891|NCT01465048|75778422|FG002|NOT COMPLETED|Overall Study||0||
59659892|NCT01464775|75778432|FG000|STARTED|Overall Study||123||
59659893|NCT01464775|75778433|FG001|STARTED|Overall Study||44||
59659894|NCT01464775|75778432|FG000|COMPLETED|Overall Study||112||
59659895|NCT01464775|75778433|FG001|COMPLETED|Overall Study||38||
59659896|NCT01464775|75778432|FG000|NOT COMPLETED|Overall Study||11||
59659897|NCT01464775|75778433|FG001|NOT COMPLETED|Overall Study||6||
59659898|NCT01464697|75778443|FG000|STARTED|Overall Study||93||
59659899|NCT01464697|75778444|FG001|STARTED|Overall Study||96||
59659900|NCT01464697|75778443|FG000|COMPLETED|Overall Study||90||
59659901|NCT01464697|75778444|FG001|COMPLETED|Overall Study||86||
59659902|NCT01464697|75778443|FG000|NOT COMPLETED|Overall Study||3||
59659903|NCT01464697|75778444|FG001|NOT COMPLETED|Overall Study||10||
59659904|NCT04059146|75778452|FG000|STARTED|Overall Study||33||
59659905|NCT04059146|75778453|FG001|STARTED|Overall Study||33||
59659906|NCT04059146|75778452|FG000|COMPLETED|Overall Study||33||
59659907|NCT04059146|75778453|FG001|COMPLETED|Overall Study||32||
59659908|NCT04059146|75778452|FG000|NOT COMPLETED|Overall Study||0||
59659909|NCT04059146|75778453|FG001|NOT COMPLETED|Overall Study||1||
59659910|NCT00847522|75778459|FG000|STARTED|Overall Study||90||
59659911|NCT00847522|75778459|FG000|Phase I|Overall Study||10||
59659912|NCT00847522|75778459|FG000|Phase II|Overall Study||80||
59659913|NCT00847522|75778459|FG000|COMPLETED|Overall Study||90||
59659914|NCT00847522|75778459|FG000|NOT COMPLETED|Overall Study||0||
59659915|NCT00847288|75778465|FG000|STARTED|Overall Study||841||
59659916|NCT00847288|75778466|FG001|STARTED|Overall Study||827||
59659917|NCT00847288|75778465|FG000|COMPLETED|Overall Study||811||
59659918|NCT00847288|75778466|FG001|COMPLETED|Overall Study||780||
59659919|NCT00847288|75778465|FG000|NOT COMPLETED|Overall Study||30||
59659920|NCT00847288|75778466|FG001|NOT COMPLETED|Overall Study||47||
59659921|NCT03969641|75778474|FG000|STARTED|Overall Study||193||
59659922|NCT03969641|75778475|FG001|STARTED|Overall Study||191||
59659923|NCT03969641|75778474|FG000|COMPLETED|Overall Study||184||
59659924|NCT03969641|75778475|FG001|COMPLETED|Overall Study||181||
59659925|NCT03969641|75778474|FG000|NOT COMPLETED|Overall Study||9||
59659926|NCT03969641|75778475|FG001|NOT COMPLETED|Overall Study||10||
59659927|NCT00847210|75778483|FG000|STARTED|Overall Study||18||
59659928|NCT00847210|75778484|FG001|STARTED|Overall Study||18||
59659929|NCT00847210|75778483|FG000|COMPLETED|Overall Study||18||
59659930|NCT00847210|75778484|FG001|COMPLETED|Overall Study||18||
59659931|NCT00847210|75778483|FG000|NOT COMPLETED|Overall Study||0||
59659932|NCT00847210|75778484|FG001|NOT COMPLETED|Overall Study||0||
59659933|NCT00847171|75778490|FG000|STARTED|Overall Study||20||
59659934|NCT00847171|75778490|FG000|COMPLETED|Overall Study||20||
59659935|NCT00847171|75778490|FG000|NOT COMPLETED|Overall Study||0||
59659936|NCT03772964|75778499|FG000|STARTED|Overall Study||8||
59659937|NCT03772964|75778500|FG001|STARTED|Overall Study||8||
59659938|NCT03772964|75778501|FG002|STARTED|Overall Study||8||
59659939|NCT03772964|75778502|FG003|STARTED|Overall Study||8||
59659940|NCT03772964|75778499|FG000|COMPLETED|Overall Study|Could not attend final in-person evaluation due to COVID-19 shut down limitations|7||
59659941|NCT03772964|75778500|FG001|COMPLETED|Overall Study||8||
59659942|NCT03772964|75778501|FG002|COMPLETED|Overall Study||8||
59659943|NCT03772964|75778502|FG003|COMPLETED|Overall Study||8||
59659944|NCT03772964|75778499|FG000|NOT COMPLETED|Overall Study||1||
59659945|NCT03772964|75778500|FG001|NOT COMPLETED|Overall Study||0||
59659946|NCT03772964|75778501|FG002|NOT COMPLETED|Overall Study||0||
59659947|NCT03772964|75778502|FG003|NOT COMPLETED|Overall Study||0||
59659948|NCT00846547|75778515|FG000|STARTED|Overall Study||32||
59659949|NCT00846547|75778515|FG000|COMPLETED|Overall Study||25||
59659950|NCT00846547|75778515|FG000|NOT COMPLETED|Overall Study||7||
59659951|NCT05291949|75778519|FG000|STARTED|Overall Study||70||
59659952|NCT05291949|75778519|FG000|COMPLETED|Overall Study||66||
59659953|NCT05291949|75778519|FG000|NOT COMPLETED|Overall Study||4||
59659954|NCT03721172|75778525|FG000|STARTED|Placebo-controlled Phase||298||
59659955|NCT03721172|75778526|FG001|STARTED|Placebo-controlled Phase||297||
59659956|NCT03721172|75778527|FG002|STARTED|Placebo-controlled Phase|This arm was not included in the placebo-controlled phase.|0||
59659957|NCT03721172|75778525|FG000|Received at Least 1 Dose of Treatment|Placebo-controlled Phase||297||
59659958|NCT03721172|75778526|FG001|Received at Least 1 Dose of Treatment|Placebo-controlled Phase||297||
59659959|NCT03721172|75778527|FG002|Received at Least 1 Dose of Treatment|Placebo-controlled Phase|This arm was not included in the placebo-controlled phase.|0||
59659960|NCT03721172|75778525|FG000|COMPLETED|Placebo-controlled Phase||246||
59659961|NCT03721172|75778526|FG001|COMPLETED|Placebo-controlled Phase||258||
59659962|NCT03721172|75778527|FG002|COMPLETED|Placebo-controlled Phase|This arm was not included in the placebo-controlled phase.|0||
59659963|NCT03721172|75778525|FG000|NOT COMPLETED|Placebo-controlled Phase||52||
59659964|NCT03721172|75778526|FG001|NOT COMPLETED|Placebo-controlled Phase||39||
59659965|NCT03721172|75778527|FG002|NOT COMPLETED|Placebo-controlled Phase||0||
59659966|NCT03721172|75778525|FG000|STARTED|Apremilast Extension Phase|This arm was not included in the extension phase.|0||
59659967|NCT03721172|75778526|FG001|STARTED|Apremilast Extension Phase|This arm was not included in the extension phase.|0||
59659968|NCT03721172|75778527|FG002|STARTED|Apremilast Extension Phase|1 participant did not enter the extension phase due to physician decision.|503||
59659969|NCT03721172|75778525|FG000|Received at Least 1 Dose|Apremilast Extension Phase|This arm was not included in the extension phase.|0||
59659970|NCT03721172|75778526|FG001|Received at Least 1 Dose|Apremilast Extension Phase|This arm was not included in the extension phase.|0||
59659971|NCT03721172|75778527|FG002|Received at Least 1 Dose|Apremilast Extension Phase||503||
59659972|NCT03721172|75778525|FG000|COMPLETED|Apremilast Extension Phase|This arm was not included in the extension phase.|0||
59659973|NCT03721172|75778526|FG001|COMPLETED|Apremilast Extension Phase|This arm was not included in the extension phase.|0||
59659974|NCT03721172|75778527|FG002|COMPLETED|Apremilast Extension Phase||437||
59659975|NCT03721172|75778525|FG000|NOT COMPLETED|Apremilast Extension Phase||0||
59659976|NCT03721172|75778526|FG001|NOT COMPLETED|Apremilast Extension Phase||0||
59659977|NCT03721172|75778527|FG002|NOT COMPLETED|Apremilast Extension Phase||66||
59659978|NCT00276406|75778537|FG000|STARTED|Overall Study||16||
59659979|NCT00276406|75778538|FG001|STARTED|Overall Study||14||
59659980|NCT00276406|75778537|FG000|COMPLETED|Overall Study|14 of 16 subjects tolerated 360mg daily, while 2 of 16 tolerated 180mg daily.|16||
59659981|NCT00276406|75778538|FG001|COMPLETED|Overall Study||14||
59659982|NCT00276406|75778537|FG000|NOT COMPLETED|Overall Study||0||
59659983|NCT00276406|75778538|FG001|NOT COMPLETED|Overall Study||0||
59659984|NCT00276250|75778547|FG000|STARTED|Overall Study||4||
59659985|NCT00276250|75778548|FG001|STARTED|Overall Study||1||
59659986|NCT00276250|75778549|FG002|STARTED|Overall Study||0||
59659987|NCT00276250|75778547|FG000|COMPLETED|Overall Study||4||
59659988|NCT00276250|75778548|FG001|COMPLETED|Overall Study||1||
59659989|NCT00276250|75778549|FG002|COMPLETED|Overall Study||0||
59659990|NCT00276250|75778547|FG000|NOT COMPLETED|Overall Study||0||
59659991|NCT00276250|75778548|FG001|NOT COMPLETED|Overall Study||0||
59659992|NCT00276250|75778549|FG002|NOT COMPLETED|Overall Study||0||
59659993|NCT02972606|75778557|FG000|STARTED|Overall Study||26||
59659994|NCT02972606|75778557|FG000|COMPLETED|Overall Study||26||
59659995|NCT02972606|75778557|FG000|NOT COMPLETED|Overall Study||0||
59659996|NCT03794908|75778563|FG000|STARTED|Overall Study||29||
59659997|NCT03794908|75778564|FG001|STARTED|Overall Study||28||
59659998|NCT03794908|75778563|FG000|Began Use of Re-Timer|Overall Study||27||
59659999|NCT03794908|75778564|FG001|Began Use of Re-Timer|Overall Study||27||
59660000|NCT03794908|75778563|FG000|COMPLETED|Overall Study||27||
59660001|NCT03794908|75778564|FG001|COMPLETED|Overall Study||27||
59660002|NCT03794908|75778563|FG000|NOT COMPLETED|Overall Study||2||
59660003|NCT03794908|75778564|FG001|NOT COMPLETED|Overall Study||1||
59660004|NCT04784637|75778572|FG000|STARTED|Overall Study||15||
59660005|NCT04784637|75778573|FG001|STARTED|Overall Study||15||
59660006|NCT04784637|75778572|FG000|COMPLETED|Overall Study||15||
59660007|NCT04784637|75778573|FG001|COMPLETED|Overall Study||15||
59660008|NCT04784637|75778572|FG000|NOT COMPLETED|Overall Study||0||
59660009|NCT04784637|75778573|FG001|NOT COMPLETED|Overall Study||0||
59660010|NCT04540887|75778583|FG000|STARTED|Overall Study||10||
59660011|NCT04540887|75778583|FG000|COMPLETED|Overall Study||8||
59660012|NCT04540887|75778583|FG000|NOT COMPLETED|Overall Study||2||
59660013|NCT04538430|75778588|FG000|STARTED|Overall Study||7||
59660014|NCT04538430|75778588|FG000|COMPLETED|Overall Study||7||
59660015|NCT04538430|75778588|FG000|NOT COMPLETED|Overall Study||0||
59660016|NCT04294680|75778594|FG000|STARTED|Overall Study||39||
59660017|NCT04294680|75778595|FG001|STARTED|Overall Study||43||
59660018|NCT04294680|75778594|FG000|Received Allocated Intervention|Overall Study|2 patients withdrew consent prior to surgery|37||
59660019|NCT04294680|75778595|FG001|Received Allocated Intervention|Overall Study|1 patient withdrew consent before surgery|42||
59660020|NCT04294680|75778594|FG000|COMPLETED|Overall Study|1 patient was excluded from analysis due to having follow-up visits completed outside of window|36||
59660021|NCT04294680|75778595|FG001|COMPLETED|Overall Study||42||
59660022|NCT04294680|75778594|FG000|NOT COMPLETED|Overall Study||3||
59660023|NCT04294680|75778595|FG001|NOT COMPLETED|Overall Study||1||
59660024|NCT01350102|75778605|FG000|STARTED|Overall Study||0||
59660025|NCT01350102|75778606|FG001|STARTED|Overall Study||1||
59660026|NCT01350102|75778607|FG002|STARTED|Overall Study||1||
59660027|NCT01350102|75778608|FG003|STARTED|Overall Study||0||
59660028|NCT01350102|75778605|FG000|COMPLETED|Overall Study||0||
59660029|NCT01350102|75778606|FG001|COMPLETED|Overall Study||1||
59660030|NCT01350102|75778607|FG002|COMPLETED|Overall Study||0||
59660031|NCT01350102|75778608|FG003|COMPLETED|Overall Study||0||
59660032|NCT01350102|75778605|FG000|NOT COMPLETED|Overall Study||0||
59660033|NCT01350102|75778606|FG001|NOT COMPLETED|Overall Study||0||
59660034|NCT01350102|75778607|FG002|NOT COMPLETED|Overall Study||1||
59660035|NCT01350102|75778608|FG003|NOT COMPLETED|Overall Study||0||
59660036|NCT04059549|75778622|FG000|STARTED|Overall Study|16 dyads|32||
59660037|NCT04059549|75778623|FG001|STARTED|Overall Study|18 dyads|36||
59660038|NCT04059549|75778622|FG000|COMPLETED|Overall Study|15 dyads|30||
59660039|NCT04059549|75778623|FG001|COMPLETED|Overall Study|18 dyads|36||
59660040|NCT04059549|75778622|FG000|NOT COMPLETED|Overall Study||2||
59660041|NCT04059549|75778623|FG001|NOT COMPLETED|Overall Study||0||
59660042|NCT04041570|75778635|FG000|STARTED|Overall Study||20||
59660043|NCT04041570|75778636|FG001|STARTED|Overall Study||20||
59660044|NCT04041570|75778635|FG000|COMPLETED|Overall Study||20||
59660045|NCT04041570|75778636|FG001|COMPLETED|Overall Study||18||
59660046|NCT04041570|75778635|FG000|NOT COMPLETED|Overall Study||0||
59660047|NCT04041570|75778636|FG001|NOT COMPLETED|Overall Study||2||
59660048|NCT03879408|75778648|FG000|STARTED|Overall Study||35||
59660049|NCT03879408|75778649|FG001|STARTED|Overall Study||69||
59660050|NCT03879408|75778650|FG002|STARTED|Overall Study||61||
59660051|NCT03879408|75778651|FG003|STARTED|Overall Study||63||
59660052|NCT03879408|75778652|FG004|STARTED|Overall Study||62||
59660053|NCT03879408|75778648|FG000|COMPLETED|Overall Study||33||
59660054|NCT03879408|75778649|FG001|COMPLETED|Overall Study||65||
59660055|NCT03879408|75778650|FG002|COMPLETED|Overall Study||58||
59660056|NCT03879408|75778651|FG003|COMPLETED|Overall Study||62||
59660057|NCT03879408|75778652|FG004|COMPLETED|Overall Study||61||
59660058|NCT03879408|75778648|FG000|NOT COMPLETED|Overall Study||2||
59660059|NCT03879408|75778649|FG001|NOT COMPLETED|Overall Study||4||
59660060|NCT03879408|75778650|FG002|NOT COMPLETED|Overall Study||3||
59660061|NCT03879408|75778651|FG003|NOT COMPLETED|Overall Study||1||
59660062|NCT03879408|75778652|FG004|NOT COMPLETED|Overall Study||1||
59660063|NCT03007407|75778664|FG000|STARTED|Overall Study||33||
59660064|NCT03007407|75778664|FG000|COMPLETED|Overall Study||21||
59660065|NCT03007407|75778664|FG000|NOT COMPLETED|Overall Study||12||
59660066|NCT02993406|75778670|FG000|STARTED|Overall Study||6992||
59660067|NCT02993406|75778671|FG001|STARTED|Overall Study||6978||
59660068|NCT02993406|75778670|FG000|COMPLETED|Overall Study||6697||
59660069|NCT02993406|75778671|FG001|COMPLETED|Overall Study||6620||
59660070|NCT02993406|75778670|FG000|NOT COMPLETED|Overall Study||295||
59660071|NCT02993406|75778671|FG001|NOT COMPLETED|Overall Study||358||
59544354|NCT02158520|75642750|FG000|NOT COMPLETED|Overall Study||0||
59544355|NCT02158520|75642751|FG001|NOT COMPLETED|Overall Study||0||
59544356|NCT01703663|75642759|FG000|STARTED|First Treatment Period||20||
59544357|NCT01703663|75642760|FG001|STARTED|First Treatment Period||20||
59544358|NCT01703663|75642759|FG000|COMPLETED|First Treatment Period||20||
59544359|NCT01703663|75642760|FG001|COMPLETED|First Treatment Period||20||
59544360|NCT01703663|75642759|FG000|NOT COMPLETED|First Treatment Period||0||
59544361|NCT01703663|75642760|FG001|NOT COMPLETED|First Treatment Period||0||
59544362|NCT01703663|75642759|FG000|STARTED|Second Treatment Period||11||
59544363|NCT01703663|75642760|FG001|STARTED|Second Treatment Period||8||
59544364|NCT01703663|75642759|FG000|COMPLETED|Second Treatment Period||11||
59544365|NCT01703663|75642760|FG001|COMPLETED|Second Treatment Period||8||
59544366|NCT01703663|75642759|FG000|NOT COMPLETED|Second Treatment Period||0||
59544367|NCT01703663|75642760|FG001|NOT COMPLETED|Second Treatment Period||0||
59544368|NCT01704521|75642768|FG000|STARTED|Overall Study||3||
59544369|NCT01704521|75642769|FG001|STARTED|Overall Study||2||
59544370|NCT01704521|75642768|FG000|COMPLETED|Overall Study||3||
59544371|NCT01704521|75642769|FG001|COMPLETED|Overall Study||2||
59544372|NCT01704521|75642768|FG000|NOT COMPLETED|Overall Study||0||
59544373|NCT01704521|75642769|FG001|NOT COMPLETED|Overall Study||0||
59544374|NCT01617083|75642778|FG000|STARTED|Overall Study||18||
59544375|NCT01617083|75642779|FG001|STARTED|Overall Study||14||
59660072|NCT00819780|75778679|FG000|STARTED|Overall Study||142||
59660073|NCT00819780|75778680|FG001|STARTED|Overall Study||143||
59660074|NCT00819780|75778679|FG000|Received Study Treatment|Overall Study||139||
59660075|NCT00819780|75778680|FG001|Received Study Treatment|Overall Study||139||
59660076|NCT00819780|75778679|FG000|COMPLETED|Overall Study|Indicates participants who ended study treatment|114||
59660077|NCT00819780|75778680|FG001|COMPLETED|Overall Study|Indicates participants who ended study treatment|122||
59660078|NCT00819780|75778679|FG000|NOT COMPLETED|Overall Study||28||
59660079|NCT00819780|75778680|FG001|NOT COMPLETED|Overall Study||21||
59660080|NCT00128713|75778689|FG000|STARTED|Overall Study||453||
59544376|NCT01617083|75642780|FG002|STARTED|Overall Study||15||
59544377|NCT01617083|75642778|FG000|COMPLETED|Overall Study||18||
59544378|NCT01617083|75642779|FG001|COMPLETED|Overall Study||14||
59544379|NCT01617083|75642780|FG002|COMPLETED|Overall Study||15||
59544380|NCT01617083|75642778|FG000|NOT COMPLETED|Overall Study||0||
59544381|NCT01617083|75642779|FG001|NOT COMPLETED|Overall Study||0||
59544382|NCT01617083|75642780|FG002|NOT COMPLETED|Overall Study||0||
59544383|NCT00943904|75642787|FG000|STARTED|Overall Study||31||
59544384|NCT00943904|75642787|FG000|COMPLETED|Overall Study||31||
59544385|NCT00943904|75642787|FG000|NOT COMPLETED|Overall Study||0||
59544386|NCT01658657|75642793|FG000|STARTED|Overall Study||7||
59544387|NCT01658657|75642794|FG001|STARTED|Overall Study||10||
59544388|NCT01658657|75642793|FG000|COMPLETED|Overall Study||4||
59544389|NCT01658657|75642794|FG001|COMPLETED|Overall Study||7||
59544390|NCT01658657|75642793|FG000|NOT COMPLETED|Overall Study||3||
59544391|NCT01658657|75642794|FG001|NOT COMPLETED|Overall Study||3||
59544392|NCT01618955|75642804|FG000|STARTED|Overall Study||20||
59544393|NCT01618955|75642805|FG001|STARTED|Overall Study||30||
59544394|NCT01618955|75642806|FG002|STARTED|Overall Study||31||
59544395|NCT01618955|75642807|FG003|STARTED|Overall Study||20||
59544396|NCT01618955|75642804|FG000|COMPLETED|Overall Study||20||
59544397|NCT01618955|75642805|FG001|COMPLETED|Overall Study||30||
59544398|NCT01618955|75642806|FG002|COMPLETED|Overall Study||31||
59544399|NCT01618955|75642807|FG003|COMPLETED|Overall Study||20||
59544400|NCT01618955|75642804|FG000|NOT COMPLETED|Overall Study||0||
59544401|NCT01618955|75642805|FG001|NOT COMPLETED|Overall Study||0||
59544402|NCT01618955|75642806|FG002|NOT COMPLETED|Overall Study||0||
59544403|NCT01618955|75642807|FG003|NOT COMPLETED|Overall Study||0||
59544404|NCT01620047|75642820|FG000|STARTED|Overall Study||20||
59544405|NCT01620047|75642821|FG001|STARTED|Overall Study||20||
59544406|NCT01620047|75642822|FG002|STARTED|Overall Study||20||
59544407|NCT01620047|75642820|FG000|COMPLETED|Overall Study||20||
59544408|NCT01620047|75642821|FG001|COMPLETED|Overall Study||20||
59544409|NCT01620047|75642822|FG002|COMPLETED|Overall Study||20||
59544410|NCT01620047|75642820|FG000|NOT COMPLETED|Overall Study||0||
59544411|NCT01620047|75642821|FG001|NOT COMPLETED|Overall Study||0||
59544412|NCT01620047|75642822|FG002|NOT COMPLETED|Overall Study||0||
59544413|NCT00944450|75642830|FG000|STARTED|Period 1||6||
59544414|NCT00944450|75642831|FG001|STARTED|Period 1||6||
59544415|NCT00944450|75642830|FG000|COMPLETED|Period 1||6||
59544416|NCT00944450|75642831|FG001|COMPLETED|Period 1||6||
59544417|NCT00944450|75642830|FG000|NOT COMPLETED|Period 1||0||
59544418|NCT00944450|75642831|FG001|NOT COMPLETED|Period 1||0||
59544419|NCT00944450|75642830|FG000|STARTED|Period 2||6||
59544420|NCT00944450|75642831|FG001|STARTED|Period 2||6||
59544421|NCT00944450|75642830|FG000|COMPLETED|Period 2||6||
59544422|NCT00944450|75642831|FG001|COMPLETED|Period 2||6||
59544423|NCT00944450|75642830|FG000|NOT COMPLETED|Period 2||0||
59544424|NCT00944450|75642831|FG001|NOT COMPLETED|Period 2||0||
59544425|NCT01706081|75642839|FG000|STARTED|Overall Study||40||
59544426|NCT01706081|75642840|FG001|STARTED|Overall Study||42||
59544427|NCT01706081|75642839|FG000|COMPLETED|Overall Study||40||
59544428|NCT01706081|75642840|FG001|COMPLETED|Overall Study||42||
59544429|NCT01706081|75642839|FG000|NOT COMPLETED|Overall Study||0||
59544430|NCT01706081|75642840|FG001|NOT COMPLETED|Overall Study||0||
59544431|NCT01706549|75642846|FG000|STARTED|Overall Study||16||
59544432|NCT01706549|75642846|FG000|COMPLETED|Overall Study||16||
59544433|NCT01706549|75642846|FG000|NOT COMPLETED|Overall Study||0||
59544434|NCT01661621|75642852|FG000|STARTED|Overall Study||116||
59544435|NCT01661621|75642853|FG001|STARTED|Overall Study||279||
59544436|NCT01661621|75642852|FG000|COMPLETED|Overall Study||116||
59544437|NCT01661621|75642853|FG001|COMPLETED|Overall Study||279||
59544438|NCT01661621|75642852|FG000|NOT COMPLETED|Overall Study||0||
59544439|NCT01661621|75642853|FG001|NOT COMPLETED|Overall Study||0||
59544440|NCT01707095|75642861|FG000|STARTED|Overall Study||42||
59544441|NCT01707095|75642862|FG001|STARTED|Overall Study||42||
59660081|NCT00128713|75778690|FG001|STARTED|Overall Study||449||
59660082|NCT00128713|75778691|FG002|STARTED|Overall Study||449||
59660083|NCT00128713|75778689|FG000|COMPLETED|Overall Study||453||
59660084|NCT00128713|75778690|FG001|COMPLETED|Overall Study||449||
59660085|NCT00128713|75778691|FG002|COMPLETED|Overall Study||449||
59660086|NCT00128713|75778689|FG000|NOT COMPLETED|Overall Study||0||
59660087|NCT00128713|75778690|FG001|NOT COMPLETED|Overall Study||0||
59660088|NCT00128713|75778691|FG002|NOT COMPLETED|Overall Study||0||
59660089|NCT00128401|75778701|FG000|STARTED|Overall Study||20||
59660090|NCT00128401|75778702|FG001|STARTED|Overall Study||19||
59660091|NCT00128401|75778701|FG000|COMPLETED|Overall Study||14||
59660092|NCT00128401|75778702|FG001|COMPLETED|Overall Study||15||
59660093|NCT00128401|75778701|FG000|NOT COMPLETED|Overall Study||6||
59660094|NCT00128401|75778702|FG001|NOT COMPLETED|Overall Study||4||
59660095|NCT00000134|75778712|FG000|STARTED|Overall Study||89||
59660096|NCT00000134|75778713|FG001|STARTED|Overall Study||94||
59660097|NCT00000134|75778714|FG002|STARTED|Overall Study||96||
59660098|NCT00000134|75778712|FG000|COMPLETED|Overall Study||89||
59660099|NCT00000134|75778713|FG001|COMPLETED|Overall Study||94||
59660100|NCT00000134|75778714|FG002|COMPLETED|Overall Study||96||
59660101|NCT00000134|75778712|FG000|NOT COMPLETED|Overall Study||0||
59660102|NCT00000134|75778713|FG001|NOT COMPLETED|Overall Study||0||
59660103|NCT00000134|75778714|FG002|NOT COMPLETED|Overall Study||0||
59660104|NCT00000143|75778724|FG000|STARTED|Overall Study||31||
59660105|NCT00000143|75778725|FG001|STARTED|Overall Study||30||
59660106|NCT00000143|75778724|FG000|COMPLETED|Overall Study||31||
59660107|NCT00000143|75778725|FG001|COMPLETED|Overall Study||30||
59660108|NCT00000143|75778724|FG000|NOT COMPLETED|Overall Study||0||
59660109|NCT00000143|75778725|FG001|NOT COMPLETED|Overall Study||0||
59660110|NCT00000392|75778733|FG000|STARTED|Overall Study||106||
59660111|NCT00000392|75778734|FG001|STARTED|Overall Study||109||
59660112|NCT00000392|75778733|FG000|COMPLETED|Overall Study|provided complete NP outcome data constituted the sample for the primary efficacy analyses|66||
59660113|NCT00000392|75778734|FG001|COMPLETED|Overall Study|provided complete NP outcome data constituted the sample for the primary efficacy analyses|77||
59660114|NCT00000392|75778733|FG000|NOT COMPLETED|Overall Study||40||
59660115|NCT00000392|75778734|FG001|NOT COMPLETED|Overall Study||32||
59660116|NCT00000479|75778744|FG000|STARTED|Overall Study||9968||
59660117|NCT00000479|75778745|FG001|STARTED|Overall Study||9971||
59660118|NCT00000479|75778746|FG002|STARTED|Overall Study||9966||
59660119|NCT00000479|75778747|FG003|STARTED|Overall Study||9971||
59660120|NCT00000479|75778744|FG000|COMPLETED|Overall Study||9968||
59660121|NCT00000479|75778745|FG001|COMPLETED|Overall Study||9971||
59660122|NCT00000479|75778746|FG002|COMPLETED|Overall Study||9966||
59660123|NCT00000479|75778747|FG003|COMPLETED|Overall Study||9971||
59660124|NCT00000479|75778744|FG000|NOT COMPLETED|Overall Study||0||
59660125|NCT00000479|75778745|FG001|NOT COMPLETED|Overall Study||0||
59660126|NCT00000479|75778746|FG002|NOT COMPLETED|Overall Study||0||
59660127|NCT00000479|75778747|FG003|NOT COMPLETED|Overall Study||0||
59660128|NCT00000575|75778760|FG000|STARTED|Overall Study||311||
59660129|NCT00000575|75778761|FG001|STARTED|Overall Study||312||
59660130|NCT00000575|75778762|FG002|STARTED|Overall Study||418||
59660131|NCT00000575|75778760|FG000|COMPLETED|Overall Study||311||
59660132|NCT00000575|75778761|FG001|COMPLETED|Overall Study||312||
59660133|NCT00000575|75778762|FG002|COMPLETED|Overall Study||418||
59660134|NCT00000575|75778760|FG000|NOT COMPLETED|Overall Study||0||
59660135|NCT00000575|75778761|FG001|NOT COMPLETED|Overall Study||0||
59660136|NCT00000575|75778762|FG002|NOT COMPLETED|Overall Study||0||
59660137|NCT00000620|75778772|FG000|STARTED|Overall Study||1178||
59660138|NCT00000620|75778773|FG001|STARTED|Overall Study||1193||
59660139|NCT00000620|75778774|FG002|STARTED|Overall Study||1374||
59660140|NCT00000620|75778775|FG003|STARTED|Overall Study||1383||
59660141|NCT00000620|75778776|FG004|STARTED|Overall Study||1184||
59660142|NCT00000620|75778777|FG005|STARTED|Overall Study||1178||
59660143|NCT00000620|75778778|FG006|STARTED|Overall Study||1391||
59660144|NCT00000620|75778779|FG007|STARTED|Overall Study||1370||
59660145|NCT00000620|75778772|FG000|COMPLETED|Overall Study||1016||
59660146|NCT00000620|75778773|FG001|COMPLETED|Overall Study||1057||
60077230|NCT01894243|76192289|FG000|Completed Treatment in Part A|Overall Study||13||
59660147|NCT00000620|75778774|FG002|COMPLETED|Overall Study||1204||
59660148|NCT00000620|75778775|FG003|COMPLETED|Overall Study||1205||
59660149|NCT00000620|75778776|FG004|COMPLETED|Overall Study||1049||
59660150|NCT00000620|75778777|FG005|COMPLETED|Overall Study||1026||
59660151|NCT00000620|75778778|FG006|COMPLETED|Overall Study||1242||
59660152|NCT00000620|75778779|FG007|COMPLETED|Overall Study||1224||
59660153|NCT00000620|75778772|FG000|NOT COMPLETED|Overall Study||162||
59660154|NCT00000620|75778773|FG001|NOT COMPLETED|Overall Study||136||
59660155|NCT00000620|75778774|FG002|NOT COMPLETED|Overall Study||170||
59660156|NCT00000620|75778775|FG003|NOT COMPLETED|Overall Study||178||
59660157|NCT00000620|75778776|FG004|NOT COMPLETED|Overall Study||135||
59660158|NCT00000620|75778777|FG005|NOT COMPLETED|Overall Study||152||
59660159|NCT00000620|75778778|FG006|NOT COMPLETED|Overall Study||149||
59660160|NCT00000620|75778779|FG007|NOT COMPLETED|Overall Study||146||
59660161|NCT04732819|75778793|FG000|STARTED|Overall Study||12582||70
59660162|NCT04732819|75778794|FG001|STARTED|Overall Study||11186||63
59660163|NCT04732819|75778793|FG000|COMPLETED|Overall Study||12582||70
59660164|NCT04732819|75778794|FG001|COMPLETED|Overall Study||11186||63
59660165|NCT04732819|75778793|FG000|NOT COMPLETED|Overall Study||0||0
59660166|NCT04732819|75778794|FG001|NOT COMPLETED|Overall Study||0||0
59660167|NCT03476135|75778802|FG000|STARTED|Overall Study||42||
59660168|NCT03476135|75778803|FG001|STARTED|Overall Study||49||
59660169|NCT03476135|75778802|FG000|COMPLETED|Overall Study||42||
59660170|NCT03476135|75778803|FG001|COMPLETED|Overall Study||49||
59660171|NCT03476135|75778802|FG000|NOT COMPLETED|Overall Study||0||
59660172|NCT03476135|75778803|FG001|NOT COMPLETED|Overall Study||0||
59660173|NCT04219618|75778811|FG000|STARTED|Overall Study||1||
59660174|NCT04219618|75778812|FG001|STARTED|Overall Study||1||
59660175|NCT04219618|75778811|FG000|COMPLETED|Overall Study||1||
59660176|NCT04219618|75778812|FG001|COMPLETED|Overall Study||1||
59660177|NCT04219618|75778811|FG000|NOT COMPLETED|Overall Study||0||
59660178|NCT04219618|75778812|FG001|NOT COMPLETED|Overall Study||0||
59660179|NCT03206476|75778820|FG000|STARTED|Overall Study||54||
59660180|NCT03206476|75778821|FG001|STARTED|Overall Study||53||
59660181|NCT03206476|75778820|FG000|Completed Short-term Evaluation (4 Months)|Overall Study||48||
59660182|NCT03206476|75778821|FG001|Completed Short-term Evaluation (4 Months)|Overall Study||40||
59660183|NCT03206476|75778820|FG000|COMPLETED|Overall Study||42|Completed medium-term evaluation (7 months)|
59660184|NCT03206476|75778821|FG001|COMPLETED|Overall Study||37|Completed medium-term evaluation (7 months)|
59660185|NCT03206476|75778820|FG000|NOT COMPLETED|Overall Study||12||
59660186|NCT03206476|75778821|FG001|NOT COMPLETED|Overall Study||16||
59660187|NCT00001151|75778827|FG000|STARTED|Overall Study||6||
59660188|NCT00001151|75778827|FG000|COMPLETED|Overall Study||1||
59660189|NCT00001151|75778827|FG000|NOT COMPLETED|Overall Study||5||
59660190|NCT02892955|75778831|FG000|STARTED|Overall Study||1685||
59660191|NCT02892955|75778831|FG000|COMPLETED|Overall Study||1685||
59660192|NCT02892955|75778831|FG000|NOT COMPLETED|Overall Study||0||
59660193|NCT02307253|75778835|FG000|STARTED|Overall Study||246||
59660194|NCT02307253|75778835|FG000|COMPLETED|Overall Study||246||
59660195|NCT02307253|75778835|FG000|NOT COMPLETED|Overall Study||0||
59660196|NCT00001262|75778842|FG000|STARTED|Overall Study||35||
59660197|NCT00001262|75778843|FG001|STARTED|Overall Study||22||
59660198|NCT00001262|75778844|FG002|STARTED|Overall Study||3||
59660199|NCT00001262|75778842|FG000|COMPLETED|Overall Study||25||
59660200|NCT00001262|75778843|FG001|COMPLETED|Overall Study||8||
59660201|NCT00001262|75778844|FG002|COMPLETED|Overall Study||3||
59660202|NCT00001262|75778842|FG000|NOT COMPLETED|Overall Study||10||
59660203|NCT00001262|75778843|FG001|NOT COMPLETED|Overall Study||14||
59660204|NCT00001262|75778844|FG002|NOT COMPLETED|Overall Study||0||
59660205|NCT02170363|75778852|FG000|STARTED|Overall Study||50||
59660206|NCT02170363|75778852|FG000|COMPLETED|Overall Study|Followed to the 6-Month Primary Endpoint|50||
59660207|NCT02170363|75778852|FG000|NOT COMPLETED|Overall Study||0||
59660208|NCT00001277|75778861|FG000|STARTED|Overall Study||634||
59660209|NCT00001277|75778862|FG001|STARTED|Overall Study||900||
59660210|NCT00001277|75778863|FG002|STARTED|Overall Study||19||
59660211|NCT00001277|75778861|FG000|COMPLETED|Overall Study||634||
59660212|NCT00001277|75778862|FG001|COMPLETED|Overall Study||900||
59660213|NCT00001277|75778863|FG002|COMPLETED|Overall Study||16||
59660214|NCT00001277|75778861|FG000|NOT COMPLETED|Overall Study||0||
59660215|NCT00001277|75778862|FG001|NOT COMPLETED|Overall Study||0||
59660216|NCT00001277|75778863|FG002|NOT COMPLETED|Overall Study||3||
59660217|NCT00819793|75778872|FG000|STARTED|Overall Study||32||
59660218|NCT00819793|75778872|FG000|COMPLETED|Overall Study||32||
59660219|NCT00819793|75778872|FG000|NOT COMPLETED|Overall Study||0||
59660220|NCT00001304|75778879|FG000|STARTED|Overall Study||13||
59660221|NCT00001304|75778880|FG001|STARTED|Overall Study||14||
59660222|NCT00001304|75778879|FG000|COMPLETED|Overall Study||13||
59660223|NCT00001304|75778880|FG001|COMPLETED|Overall Study||14||
59660224|NCT00001304|75778879|FG000|NOT COMPLETED|Overall Study||0||
59660225|NCT00001304|75778880|FG001|NOT COMPLETED|Overall Study||0||
59660226|NCT00001322|75778886|FG000|STARTED|Phase 1 - Lupron Only||92||
59660227|NCT00001322|75778887|FG001|STARTED|Phase 1 - Lupron Only||0||
59660228|NCT00001322|75778888|FG002|STARTED|Phase 1 - Lupron Only||0||
59660229|NCT00001322|75778886|FG000|COMPLETED|Phase 1 - Lupron Only||92||
59660230|NCT00001322|75778887|FG001|COMPLETED|Phase 1 - Lupron Only||0||
59660231|NCT00001322|75778888|FG002|COMPLETED|Phase 1 - Lupron Only||0||
59660232|NCT00001322|75778886|FG000|NOT COMPLETED|Phase 1 - Lupron Only||0||
59660233|NCT00001322|75778887|FG001|NOT COMPLETED|Phase 1 - Lupron Only||0||
59660234|NCT00001322|75778888|FG002|NOT COMPLETED|Phase 1 - Lupron Only||0||
59660235|NCT00001322|75778886|FG000|STARTED|Phase 2, Period 1 - Crossover Phase||0||
59660236|NCT00001322|75778887|FG001|STARTED|Phase 2, Period 1 - Crossover Phase||42||
59660237|NCT00001322|75778888|FG002|STARTED|Phase 2, Period 1 - Crossover Phase||40||
59660238|NCT00001322|75778886|FG000|COMPLETED|Phase 2, Period 1 - Crossover Phase||0||
59660239|NCT00001322|75778887|FG001|COMPLETED|Phase 2, Period 1 - Crossover Phase||42||
59660240|NCT00001322|75778888|FG002|COMPLETED|Phase 2, Period 1 - Crossover Phase||40||
59660241|NCT00001322|75778886|FG000|NOT COMPLETED|Phase 2, Period 1 - Crossover Phase||0||
59660242|NCT00001322|75778887|FG001|NOT COMPLETED|Phase 2, Period 1 - Crossover Phase||0||
59660243|NCT00001322|75778888|FG002|NOT COMPLETED|Phase 2, Period 1 - Crossover Phase||0||
59660244|NCT00001322|75778886|FG000|STARTED|Phase 2, Period 2 - Crossover Phase||0||
59660245|NCT00001322|75778887|FG001|STARTED|Phase 2, Period 2 - Crossover Phase||42||
59660246|NCT00001322|75778888|FG002|STARTED|Phase 2, Period 2 - Crossover Phase||40||
59660247|NCT00001322|75778886|FG000|COMPLETED|Phase 2, Period 2 - Crossover Phase||0||
59660248|NCT00001322|75778887|FG001|COMPLETED|Phase 2, Period 2 - Crossover Phase||42||
59660249|NCT00001322|75778888|FG002|COMPLETED|Phase 2, Period 2 - Crossover Phase||40||
59660250|NCT00001322|75778886|FG000|NOT COMPLETED|Phase 2, Period 2 - Crossover Phase||0||
59660251|NCT00001322|75778887|FG001|NOT COMPLETED|Phase 2, Period 2 - Crossover Phase||0||
59660252|NCT00001322|75778888|FG002|NOT COMPLETED|Phase 2, Period 2 - Crossover Phase||0||
59660253|NCT00001586|75778898|FG000|STARTED|Overall Study||49||
59660254|NCT00001586|75778899|FG001|STARTED|Overall Study||56||
59660255|NCT00001586|75778898|FG000|COMPLETED|Overall Study||49||
59660256|NCT00001586|75778899|FG001|COMPLETED|Overall Study||56||
59660257|NCT00001586|75778898|FG000|NOT COMPLETED|Overall Study||0||
59660258|NCT00001586|75778899|FG001|NOT COMPLETED|Overall Study||0||
59660259|NCT00001703|75778905|FG000|STARTED|Overall Study||6||
59660260|NCT00001703|75778905|FG000|Peptide Stock Completed|Overall Study|off therapy reason for 3 patients|3||
59660261|NCT00001703|75778905|FG000|COMPLETED|Overall Study||1||
59660262|NCT00001703|75778905|FG000|NOT COMPLETED|Overall Study||5||
59660263|NCT00291447|75778913|FG000|STARTED|Overall Study||2||
59660264|NCT00291447|75778914|FG001|STARTED|Overall Study||2||
59660265|NCT00291447|75778915|FG002|STARTED|Overall Study||2||
59660266|NCT00291447|75778916|FG003|STARTED|Overall Study||2||
59660267|NCT00291447|75778913|FG000|COMPLETED|Overall Study||2||
59660268|NCT00291447|75778914|FG001|COMPLETED|Overall Study||2||
59660269|NCT00291447|75778915|FG002|COMPLETED|Overall Study||2||
59660270|NCT00291447|75778916|FG003|COMPLETED|Overall Study||2||
59660271|NCT00291447|75778913|FG000|NOT COMPLETED|Overall Study||0||
59660272|NCT00291447|75778914|FG001|NOT COMPLETED|Overall Study||0||
59660273|NCT00291447|75778915|FG002|NOT COMPLETED|Overall Study||0||
59660274|NCT00291447|75778916|FG003|NOT COMPLETED|Overall Study||0||
59660275|NCT01349907|75778929|FG000|STARTED|Overall Study|Enrolled and Treated|241||
59660276|NCT01349907|75778930|FG001|STARTED|Overall Study|Enrolled and Treated|81||
59660277|NCT01349907|75778929|FG000|COMPLETED|Overall Study||102||
59660278|NCT01349907|75778930|FG001|COMPLETED|Overall Study||38||
59660279|NCT01349907|75778929|FG000|NOT COMPLETED|Overall Study||139||
59660280|NCT01349907|75778930|FG001|NOT COMPLETED|Overall Study||43||
59660281|NCT05512949|75778939|FG000|STARTED|Overall Study||75||
59660282|NCT05512949|75778940|FG001|STARTED|Overall Study||78||
59660283|NCT05512949|75778941|FG002|STARTED|Overall Study||76||
59660284|NCT05512949|75778939|FG000|COMPLETED|Overall Study||69||
59660285|NCT05512949|75778940|FG001|COMPLETED|Overall Study||68||
59660286|NCT05512949|75778941|FG002|COMPLETED|Overall Study||71||
59660287|NCT05512949|75778939|FG000|NOT COMPLETED|Overall Study||6||
59660288|NCT05512949|75778940|FG001|NOT COMPLETED|Overall Study||10||
59660289|NCT05512949|75778941|FG002|NOT COMPLETED|Overall Study||5||
59660290|NCT05372094|75778949|FG000|STARTED|Overall Study||18||
59660291|NCT05372094|75778949|FG000|COMPLETED|Overall Study||18||
59660292|NCT05372094|75778949|FG000|NOT COMPLETED|Overall Study||0||
59660293|NCT05236712|75778955|FG000|STARTED|Overall Study||8||
59660294|NCT05236712|75778956|FG001|STARTED|Overall Study||7||
59660295|NCT05236712|75778955|FG000|COMPLETED|Overall Study||8||
59660296|NCT05236712|75778956|FG001|COMPLETED|Overall Study||7||
59660297|NCT05236712|75778955|FG000|NOT COMPLETED|Overall Study||0||
59660298|NCT05236712|75778956|FG001|NOT COMPLETED|Overall Study||0||
59660299|NCT05058430|75778962|FG000|STARTED|Selection of the SaliPen Device||8||
59660300|NCT05058430|75778963|FG001|STARTED|Selection of the SaliPen Device||8||
59660301|NCT05058430|75778962|FG000|COMPLETED|Selection of the SaliPen Device||8||
59660302|NCT05058430|75778963|FG001|COMPLETED|Selection of the SaliPen Device||8||
59660303|NCT05058430|75778962|FG000|NOT COMPLETED|Selection of the SaliPen Device||0||
59660304|NCT05058430|75778963|FG001|NOT COMPLETED|Selection of the SaliPen Device||0||
59660305|NCT05058430|75778962|FG000|STARTED|Use of the SaliPen Device|Participants were the 8 subjects with xerostomia of Phase 1 and other 8 additional subjects with xerostomia|16|"Participants of Arm I were the 8 subjects with xerostomia of Phase 1 and other 8 additional subjects with xerostomia.~Arm II was not part of Phase II. Thus, none of the subjects without xerostomia of Phase I participated in Phase II"|
59660306|NCT05058430|75778963|FG001|STARTED|Use of the SaliPen Device|None of the subjects without xerostomia of Phase I participated in Phase II|0|"Participants of Arm I were the 8 subjects with xerostomia of Phase 1 and other 8 additional subjects with xerostomia.~Arm II was not part of Phase II. Thus, none of the subjects without xerostomia of Phase I participated in Phase II"|
59660307|NCT05058430|75778962|FG000|COMPLETED|Use of the SaliPen Device||16||
59660308|NCT05058430|75778963|FG001|COMPLETED|Use of the SaliPen Device||0||
59660309|NCT05058430|75778962|FG000|NOT COMPLETED|Use of the SaliPen Device||0||
59660310|NCT05058430|75778963|FG001|NOT COMPLETED|Use of the SaliPen Device||0||
59660311|NCT04794491|75778968|FG000|STARTED|Overall Study||62||
59660312|NCT04794491|75778968|FG000|Baseline Period|Overall Study||62||
59660313|NCT04794491|75778968|FG000|Intervention (XYWAV) Period|Overall Study||60||
59660314|NCT04794491|75778968|FG000|Safety Follow-Up Period|Overall Study||59||
59660315|NCT04794491|75778968|FG000|COMPLETED|Overall Study||54||
59660316|NCT04794491|75778968|FG000|NOT COMPLETED|Overall Study||8||
59660317|NCT04533737|75778974|FG000|STARTED|Overall Study||56||
59660318|NCT04533737|75778975|FG001|STARTED|Overall Study||57||
59660319|NCT04533737|75778974|FG000|COMPLETED|Overall Study||50||
59660320|NCT04533737|75778975|FG001|COMPLETED|Overall Study||50||
59660321|NCT04533737|75778974|FG000|NOT COMPLETED|Overall Study||6||
59660322|NCT04533737|75778975|FG001|NOT COMPLETED|Overall Study||7||
59660323|NCT04458922|75778984|FG000|STARTED|Overall Study||9||
59660324|NCT04458922|75778985|FG001|STARTED|Overall Study||9||
59660325|NCT04458922|75778986|FG002|STARTED|Overall Study||9||
59660326|NCT04458922|75778984|FG000|COMPLETED|Overall Study||0||
59660327|NCT04458922|75778985|FG001|COMPLETED|Overall Study||0||
59660328|NCT04458922|75778986|FG002|COMPLETED|Overall Study||1||
59660329|NCT04458922|75778984|FG000|NOT COMPLETED|Overall Study||9||
59660330|NCT04458922|75778985|FG001|NOT COMPLETED|Overall Study||9||
59660331|NCT04458922|75778986|FG002|NOT COMPLETED|Overall Study||8||
59660332|NCT04453202|75779005|FG000|STARTED|Overall Study||51||
59660333|NCT04453202|75779006|FG001|STARTED|Overall Study||51||
59660334|NCT04453202|75779007|FG002|STARTED|Overall Study||51||
59988897|NCT03689244|76104165|FG002|STARTED|Double Blind Period (Up to 27.7 Months)||0||
59988898|NCT03689244|76104166|FG003|STARTED|Double Blind Period (Up to 27.7 Months)||0||
59988899|NCT03689244|76104163|FG000|COMPLETED|Double Blind Period (Up to 27.7 Months)||9||
59988900|NCT03689244|76104164|FG001|COMPLETED|Double Blind Period (Up to 27.7 Months)||6||
59988901|NCT03689244|76104165|FG002|COMPLETED|Double Blind Period (Up to 27.7 Months)||0||
59988902|NCT03689244|76104166|FG003|COMPLETED|Double Blind Period (Up to 27.7 Months)||0||
59660335|NCT04453202|75779008|FG003|STARTED|Overall Study||48||
59660336|NCT04453202|75779009|FG004|STARTED|Overall Study||25||
59660337|NCT04453202|75779010|FG005|STARTED|Overall Study||49||
59660338|NCT04453202|75779011|FG006|STARTED|Overall Study||49||
59660339|NCT04453202|75779012|FG007|STARTED|Overall Study||26||
59660340|NCT04453202|75779013|FG008|STARTED|Overall Study||27||
59660341|NCT04453202|75779014|FG009|STARTED|Overall Study||51||
59660342|NCT04453202|75779015|FG010|STARTED|Overall Study||26||
59660343|NCT04453202|75779005|FG000|Full Analysis Set (FAS)|Overall Study||51||
59660344|NCT04453202|75779006|FG001|Full Analysis Set (FAS)|Overall Study||51||
59988903|NCT03689244|76104163|FG000|NOT COMPLETED|Double Blind Period (Up to 27.7 Months)||55||
59988904|NCT03689244|76104164|FG001|NOT COMPLETED|Double Blind Period (Up to 27.7 Months)||58||
59988905|NCT03689244|76104165|FG002|NOT COMPLETED|Double Blind Period (Up to 27.7 Months)||0||
59544442|NCT01707095|75642861|FG000|COMPLETED|Overall Study||42||
59544443|NCT01707095|75642862|FG001|COMPLETED|Overall Study||42||
59544444|NCT01707095|75642861|FG000|NOT COMPLETED|Overall Study||0||
59544445|NCT01707095|75642862|FG001|NOT COMPLETED|Overall Study||0||
59544446|NCT01620593|75642870|FG000|STARTED|Overall Study||21||
59544447|NCT01620593|75642871|FG001|STARTED|Overall Study||20||
59544448|NCT01620593|75642870|FG000|COMPLETED|Overall Study||17||
59544449|NCT01620593|75642871|FG001|COMPLETED|Overall Study||19||
59544450|NCT01620593|75642870|FG000|NOT COMPLETED|Overall Study||4||
59544451|NCT01620593|75642871|FG001|NOT COMPLETED|Overall Study||1||
59544452|NCT00939536|75642879|FG000|STARTED|First Intervention||12||
59544453|NCT00939536|75642880|FG001|STARTED|First Intervention||12||
59544454|NCT00939536|75642879|FG000|COMPLETED|First Intervention||12||
59544455|NCT00939536|75642880|FG001|COMPLETED|First Intervention||12||
59660345|NCT04453202|75779007|FG002|Full Analysis Set (FAS)|Overall Study||51||
59660346|NCT04453202|75779008|FG003|Full Analysis Set (FAS)|Overall Study||48||
59660347|NCT04453202|75779009|FG004|Full Analysis Set (FAS)|Overall Study||25||
59660348|NCT04453202|75779010|FG005|Full Analysis Set (FAS)|Overall Study||49||
59660349|NCT04453202|75779011|FG006|Full Analysis Set (FAS)|Overall Study||49||
59660350|NCT04453202|75779012|FG007|Full Analysis Set (FAS)|Overall Study||26||
59660351|NCT04453202|75779013|FG008|Full Analysis Set (FAS)|Overall Study||27||
59660352|NCT04453202|75779014|FG009|Full Analysis Set (FAS)|Overall Study||51||
59660353|NCT04453202|75779015|FG010|Full Analysis Set (FAS)|Overall Study||26||
59660354|NCT04453202|75779005|FG000|Per-protocol Immunogenicity (PPI) Set|Overall Study||51||
59660355|NCT04453202|75779006|FG001|Per-protocol Immunogenicity (PPI) Set|Overall Study||50||
59660356|NCT04453202|75779007|FG002|Per-protocol Immunogenicity (PPI) Set|Overall Study||51||
59660357|NCT04453202|75779008|FG003|Per-protocol Immunogenicity (PPI) Set|Overall Study||48||
59660358|NCT04453202|75779009|FG004|Per-protocol Immunogenicity (PPI) Set|Overall Study||25||
59660359|NCT04453202|75779010|FG005|Per-protocol Immunogenicity (PPI) Set|Overall Study||47||
59660360|NCT04453202|75779011|FG006|Per-protocol Immunogenicity (PPI) Set|Overall Study||49||
59660361|NCT04453202|75779012|FG007|Per-protocol Immunogenicity (PPI) Set|Overall Study||26||
59660362|NCT04453202|75779013|FG008|Per-protocol Immunogenicity (PPI) Set|Overall Study||27||
59660363|NCT04453202|75779014|FG009|Per-protocol Immunogenicity (PPI) Set|Overall Study||50||
59660364|NCT04453202|75779015|FG010|Per-protocol Immunogenicity (PPI) Set|Overall Study||26||
59660365|NCT04453202|75779005|FG000|COMPLETED|Overall Study||50||
59660366|NCT04453202|75779006|FG001|COMPLETED|Overall Study||48||
59660367|NCT04453202|75779007|FG002|COMPLETED|Overall Study||50||
59660368|NCT04453202|75779008|FG003|COMPLETED|Overall Study||45||
59660369|NCT04453202|75779009|FG004|COMPLETED|Overall Study||24||
59660370|NCT04453202|75779010|FG005|COMPLETED|Overall Study||47||
59660371|NCT04453202|75779011|FG006|COMPLETED|Overall Study||48||
59660372|NCT04453202|75779012|FG007|COMPLETED|Overall Study||26||
59660373|NCT04453202|75779013|FG008|COMPLETED|Overall Study||27||
59660374|NCT04453202|75779014|FG009|COMPLETED|Overall Study||48||
59660375|NCT04453202|75779015|FG010|COMPLETED|Overall Study||25||
59660376|NCT04453202|75779005|FG000|NOT COMPLETED|Overall Study||1||
59660377|NCT04453202|75779006|FG001|NOT COMPLETED|Overall Study||3||
59660378|NCT04453202|75779007|FG002|NOT COMPLETED|Overall Study||1||
59660379|NCT04453202|75779008|FG003|NOT COMPLETED|Overall Study||3||
59660380|NCT04453202|75779009|FG004|NOT COMPLETED|Overall Study||1||
59660381|NCT04453202|75779010|FG005|NOT COMPLETED|Overall Study||2||
59660382|NCT04453202|75779011|FG006|NOT COMPLETED|Overall Study||1||
59660383|NCT04453202|75779012|FG007|NOT COMPLETED|Overall Study||0||
59660384|NCT04453202|75779013|FG008|NOT COMPLETED|Overall Study||0||
59660385|NCT04453202|75779014|FG009|NOT COMPLETED|Overall Study||3||
59660386|NCT04453202|75779015|FG010|NOT COMPLETED|Overall Study||1||
59660387|NCT04436289|75779043|FG000|STARTED|Overall Study||63||
59660388|NCT04436289|75779044|FG001|STARTED|Overall Study||62||
59660389|NCT04436289|75779045|FG002|STARTED|Overall Study||35||
59660390|NCT04436289|75779046|FG003|STARTED|Overall Study||35||
59660391|NCT04436289|75779043|FG000|COMPLETED|Overall Study||55||
59660392|NCT04436289|75779044|FG001|COMPLETED|Overall Study||51||
59660393|NCT04436289|75779045|FG002|COMPLETED|Overall Study||30||
59660394|NCT04436289|75779046|FG003|COMPLETED|Overall Study||31||
59660395|NCT04436289|75779043|FG000|NOT COMPLETED|Overall Study||8||
59660396|NCT04436289|75779044|FG001|NOT COMPLETED|Overall Study||11||
59660397|NCT04436289|75779045|FG002|NOT COMPLETED|Overall Study||5||
59660398|NCT04436289|75779046|FG003|NOT COMPLETED|Overall Study||4||
59660399|NCT04396795|75779061|FG000|STARTED|Baseline||28||
59660400|NCT04396795|75779062|FG001|STARTED|Baseline||33||
59660401|NCT04396795|75779061|FG000|COMPLETED|Baseline||28||
59660402|NCT04396795|75779062|FG001|COMPLETED|Baseline||33||
59660403|NCT04396795|75779061|FG000|NOT COMPLETED|Baseline||0||
59660404|NCT04396795|75779062|FG001|NOT COMPLETED|Baseline||0||
59660405|NCT04396795|75779061|FG000|STARTED|Month 1||28||
59660406|NCT04396795|75779062|FG001|STARTED|Month 1||33||
59660407|NCT04396795|75779061|FG000|COMPLETED|Month 1||26||
59988906|NCT03689244|76104166|FG003|NOT COMPLETED|Double Blind Period (Up to 27.7 Months)||0||
59988907|NCT03689244|76104163|FG000|STARTED|Open Label Period (Up to 20.8 Months)||0||
59660408|NCT04396795|75779062|FG001|COMPLETED|Month 1||30||
59660409|NCT04396795|75779061|FG000|NOT COMPLETED|Month 1||2||
59660410|NCT04396795|75779062|FG001|NOT COMPLETED|Month 1||3||
59660411|NCT04396795|75779061|FG000|STARTED|Month 3||26||
59660412|NCT04396795|75779062|FG001|STARTED|Month 3||30||
59660413|NCT04396795|75779061|FG000|COMPLETED|Month 3||25||
59660414|NCT04396795|75779062|FG001|COMPLETED|Month 3||27||
59660415|NCT04396795|75779061|FG000|NOT COMPLETED|Month 3||1||
59660416|NCT04396795|75779062|FG001|NOT COMPLETED|Month 3||3||
59660417|NCT04396795|75779061|FG000|STARTED|Month 6||25||
59660418|NCT04396795|75779062|FG001|STARTED|Month 6||27||
59660419|NCT04396795|75779061|FG000|COMPLETED|Month 6||22||
59660420|NCT04396795|75779062|FG001|COMPLETED|Month 6||24||
59660421|NCT04396795|75779061|FG000|NOT COMPLETED|Month 6||3||
59660422|NCT04396795|75779062|FG001|NOT COMPLETED|Month 6||3||
59660423|NCT04211766|75779070|FG000|STARTED|Overall Study||19||
59660424|NCT04211766|75779071|FG001|STARTED|Overall Study||16||
59660425|NCT04211766|75779070|FG000|Completed Only Period 1|Overall Study||1||
59660426|NCT04211766|75779071|FG001|Completed Only Period 1|Overall Study||1||
59660427|NCT04211766|75779070|FG000|COMPLETED|Overall Study||14|This total does not include the participants that only completed only study Period 1 and dropped out during the washout. The 2 participants who dropped out during the washout have partial measures (blood and stools) that may be included in some of the statistical analysis.|
59660428|NCT04211766|75779071|FG001|COMPLETED|Overall Study||15|This total does not include the participants that only completed only study Period 1 and dropped out during the washout. The 2 participants who dropped out during the washout have partial measures (blood and stools) that may be included in some of the statistical analysis.|
59660429|NCT04211766|75779070|FG000|NOT COMPLETED|Overall Study||5||
59660430|NCT04211766|75779071|FG001|NOT COMPLETED|Overall Study||1||
59660431|NCT04126408|75779079|FG000|STARTED|Overall Study||21||
59660432|NCT04126408|75779080|FG001|STARTED|Overall Study||19||
59660433|NCT04126408|75779079|FG000|COMPLETED|Overall Study||21||
59660434|NCT04126408|75779080|FG001|COMPLETED|Overall Study||19||
59660435|NCT04126408|75779079|FG000|NOT COMPLETED|Overall Study||0||
59660436|NCT04126408|75779080|FG001|NOT COMPLETED|Overall Study||0||
59660437|NCT03870529|75779094|FG000|STARTED|Overall Study||11||
59660438|NCT03870529|75779095|FG001|STARTED|Overall Study||9||
59660439|NCT03870529|75779094|FG000|COMPLETED|Overall Study||11||
59660440|NCT03870529|75779095|FG001|COMPLETED|Overall Study||9||
59660441|NCT03870529|75779094|FG000|NOT COMPLETED|Overall Study||0||
59660442|NCT03870529|75779095|FG001|NOT COMPLETED|Overall Study||0||
59660443|NCT03816644|75779103|FG000|STARTED|Overall Study||599||
59660444|NCT03816644|75779104|FG001|STARTED|Overall Study||602||
59660445|NCT03816644|75779103|FG000|COMPLETED|Overall Study||592||
59660446|NCT03816644|75779104|FG001|COMPLETED|Overall Study||600||
59660447|NCT03816644|75779103|FG000|NOT COMPLETED|Overall Study||7||
59660448|NCT03816644|75779104|FG001|NOT COMPLETED|Overall Study||2||
59660449|NCT03815344|75779112|FG000|STARTED|Overall Study||42||
59660450|NCT03815344|75779113|FG001|STARTED|Overall Study||32||
59660451|NCT03815344|75779112|FG000|COMPLETED|Overall Study||42||
59660452|NCT03815344|75779113|FG001|COMPLETED|Overall Study||32||
59660453|NCT03815344|75779112|FG000|NOT COMPLETED|Overall Study||0||
59660454|NCT03815344|75779113|FG001|NOT COMPLETED|Overall Study||0||
59660455|NCT03773562|75779119|FG000|STARTED|Overall Study||50||
59660456|NCT03773562|75779119|FG000|COMPLETED|Overall Study||29||
59660457|NCT03773562|75779119|FG000|NOT COMPLETED|Overall Study||21||
59660458|NCT03769714|75779125|FG000|STARTED|Overall Study||30||
59660459|NCT03769714|75779126|FG001|STARTED|Overall Study||30||
59660460|NCT03769714|75779125|FG000|COMPLETED|Overall Study||30||
59660461|NCT03769714|75779126|FG001|COMPLETED|Overall Study||30||
59660462|NCT03769714|75779125|FG000|NOT COMPLETED|Overall Study||0||
59660463|NCT03769714|75779126|FG001|NOT COMPLETED|Overall Study||0||
59660464|NCT03706456|75779132|FG000|STARTED|Overall Study||22||
59660465|NCT03706456|75779132|FG000|Started|Overall Study||22||
59660466|NCT03706456|75779132|FG000|Completed|Overall Study||0||
59660467|NCT03706456|75779132|FG000|COMPLETED|Overall Study||0||
59660468|NCT03706456|75779132|FG000|NOT COMPLETED|Overall Study||22||
59660469|NCT03667014|75779136|FG000|STARTED|Overall Study||34||
59988908|NCT03689244|76104164|FG001|STARTED|Open Label Period (Up to 20.8 Months)||0||
59988909|NCT03689244|76104165|FG002|STARTED|Open Label Period (Up to 20.8 Months)||9||
59988910|NCT03689244|76104166|FG003|STARTED|Open Label Period (Up to 20.8 Months)||6||
59544456|NCT00939536|75642879|FG000|NOT COMPLETED|First Intervention||0||
59544457|NCT00939536|75642880|FG001|NOT COMPLETED|First Intervention||0||
59660470|NCT03667014|75779136|FG000|COMPLETED|Overall Study||24||
59660471|NCT03667014|75779136|FG000|NOT COMPLETED|Overall Study||10||
59660472|NCT03618641|75779140|FG000|STARTED|Overall Study||34||
59660473|NCT03618641|75779140|FG000|COMPLETED|Overall Study||34||
59660474|NCT03618641|75779140|FG000|NOT COMPLETED|Overall Study||0||
59660475|NCT03599141|75779146|FG000|STARTED|Overall Study||8||
59660476|NCT03599141|75779147|FG001|STARTED|Overall Study||8||
59988911|NCT03689244|76104163|FG000|COMPLETED|Open Label Period (Up to 20.8 Months)||0||
59988912|NCT03689244|76104164|FG001|COMPLETED|Open Label Period (Up to 20.8 Months)||0||
59988913|NCT03689244|76104165|FG002|COMPLETED|Open Label Period (Up to 20.8 Months)||0||
59544458|NCT00939536|75642879|FG000|STARTED|Second Intervention||12||
59544459|NCT00939536|75642880|FG001|STARTED|Second Intervention||12||
59544460|NCT00939536|75642879|FG000|COMPLETED|Second Intervention||12||
59544461|NCT00939536|75642880|FG001|COMPLETED|Second Intervention||12||
59544462|NCT00939536|75642879|FG000|NOT COMPLETED|Second Intervention||0||
59660477|NCT03599141|75779146|FG000|3 Months Post Baseline|Overall Study||8||
59660478|NCT03599141|75779147|FG001|3 Months Post Baseline|Overall Study||8||
59660479|NCT03599141|75779146|FG000|6 Months Post Baseline|Overall Study||5||
59660480|NCT03599141|75779147|FG001|6 Months Post Baseline|Overall Study||7||
59660481|NCT03599141|75779146|FG000|COMPLETED|Overall Study||5||
59660482|NCT03599141|75779147|FG001|COMPLETED|Overall Study||7||
59544463|NCT00939536|75642880|FG001|NOT COMPLETED|Second Intervention||0||
59660483|NCT03599141|75779146|FG000|NOT COMPLETED|Overall Study||3||
59660484|NCT03599141|75779147|FG001|NOT COMPLETED|Overall Study||1||
59544464|NCT02777372|75642888|FG000|STARTED|Overall Study||43||
59544465|NCT02777372|75642889|FG001|STARTED|Overall Study||41||
59544466|NCT02777372|75642888|FG000|COMPLETED|Overall Study||24||
59660485|NCT03525678|75779156|FG000|STARTED|Overall Study||97||
59660486|NCT03525678|75779157|FG001|STARTED|Overall Study||99||
59660487|NCT03525678|75779158|FG002|STARTED|Overall Study||25||
59660488|NCT03525678|75779156|FG000|Received Study Treatment|Overall Study||95|3 randomized participants never received treatment (2-withdrawal by physician decision and 1-death).|
59660489|NCT03525678|75779157|FG001|Received Study Treatment|Overall Study||99|3 randomized participants never received treatment (2-withdrawal by physician decision and 1-death).|
59660490|NCT03525678|75779158|FG002|Received Study Treatment|Overall Study||24|3 randomized participants never received treatment (2-withdrawal by physician decision and 1-death).|
59660491|NCT03525678|75779156|FG000|COMPLETED|Overall Study||0|Discontinued|
59660492|NCT03525678|75779157|FG001|COMPLETED|Overall Study||0|Discontinued|
59660493|NCT03525678|75779158|FG002|COMPLETED|Overall Study||0|Discontinued|
59660494|NCT03525678|75779156|FG000|NOT COMPLETED|Overall Study||97||
59660495|NCT03525678|75779157|FG001|NOT COMPLETED|Overall Study||99||
59660496|NCT03525678|75779158|FG002|NOT COMPLETED|Overall Study||25||
59660497|NCT03506360|75779166|FG000|STARTED|Overall Study||13||
59660498|NCT03506360|75779166|FG000|COMPLETED|Overall Study||13||
59660499|NCT03506360|75779166|FG000|NOT COMPLETED|Overall Study||0||
59660500|NCT03467698|75779172|FG000|STARTED|Overall Study||15||
59660501|NCT03467698|75779173|FG001|STARTED|Overall Study||15||
59660502|NCT03467698|75779172|FG000|COMPLETED|Overall Study||15||
59660503|NCT03467698|75779173|FG001|COMPLETED|Overall Study||15||
59660504|NCT03467698|75779172|FG000|NOT COMPLETED|Overall Study||0||
59660505|NCT03467698|75779173|FG001|NOT COMPLETED|Overall Study||0||
59660506|NCT03439514|75779181|FG000|STARTED|Double-Blind Treatment Period||40||
59660507|NCT03439514|75779182|FG001|STARTED|Double-Blind Treatment Period||37||
59660508|NCT03439514|75779181|FG000|COMPLETED|Double-Blind Treatment Period||0||
59660509|NCT03439514|75779182|FG001|COMPLETED|Double-Blind Treatment Period||0||
59660510|NCT03439514|75779181|FG000|NOT COMPLETED|Double-Blind Treatment Period||40||
59660511|NCT03439514|75779182|FG001|NOT COMPLETED|Double-Blind Treatment Period||37||
59660512|NCT03439514|75779181|FG000|STARTED|Open-Label Treatment Period||0||
59660513|NCT03439514|75779182|FG001|STARTED|Open-Label Treatment Period||0||
59660514|NCT03439514|75779181|FG000|COMPLETED|Open-Label Treatment Period||0||
59660515|NCT03439514|75779182|FG001|COMPLETED|Open-Label Treatment Period||0||
59660516|NCT03439514|75779181|FG000|NOT COMPLETED|Open-Label Treatment Period||0||
59660517|NCT03439514|75779182|FG001|NOT COMPLETED|Open-Label Treatment Period||0||
59660518|NCT03420521|75779188|FG000|STARTED|Overall Study||9||
59660519|NCT03420521|75779188|FG000|COMPLETED|Overall Study||9||
59660520|NCT03420521|75779188|FG000|NOT COMPLETED|Overall Study||0||
59660521|NCT03272828|75779194|FG000|STARTED|Overall Study||24||
59660522|NCT03272828|75779195|FG001|STARTED|Overall Study||23||
59660523|NCT03272828|75779194|FG000|COMPLETED|Overall Study||13||
59660524|NCT03272828|75779195|FG001|COMPLETED|Overall Study||13||
59660525|NCT03272828|75779194|FG000|NOT COMPLETED|Overall Study||11||
59660526|NCT03272828|75779195|FG001|NOT COMPLETED|Overall Study||10||
59660527|NCT03270241|75779201|FG000|STARTED|Overall Study||10||
59660528|NCT03270241|75779201|FG000|COMPLETED|Overall Study||10||
59660529|NCT03270241|75779201|FG000|NOT COMPLETED|Overall Study||0||
59660530|NCT03250273|75779207|FG000|STARTED|Overall Study||13||
59660531|NCT03250273|75779208|FG001|STARTED|Overall Study||30||
59660532|NCT03250273|75779207|FG000|COMPLETED|Overall Study||11||
59660533|NCT03250273|75779208|FG001|COMPLETED|Overall Study||18||
59660534|NCT03250273|75779207|FG000|NOT COMPLETED|Overall Study||2||
59660535|NCT03250273|75779208|FG001|NOT COMPLETED|Overall Study||12||
59660536|NCT03128359|75779217|FG000|STARTED|Overall Study||19||
59660537|NCT03128359|75779218|FG001|STARTED|Overall Study||0||
59660538|NCT03128359|75779219|FG002|STARTED|Overall Study||19||
59660539|NCT03128359|75779217|FG000|COMPLETED|Overall Study||19||
59660540|NCT03128359|75779218|FG001|COMPLETED|Overall Study||0||
59660541|NCT03128359|75779219|FG002|COMPLETED|Overall Study||19||
59660542|NCT03128359|75779217|FG000|NOT COMPLETED|Overall Study||0||
59660543|NCT03128359|75779218|FG001|NOT COMPLETED|Overall Study||0||
59660544|NCT03128359|75779219|FG002|NOT COMPLETED|Overall Study||0||
59660545|NCT03122886|75779227|FG000|STARTED|Overall Study||10||
59660546|NCT03122886|75779228|FG001|STARTED|Overall Study||9||
59660547|NCT03122886|75779227|FG000|COMPLETED|Overall Study||9||
59660548|NCT03122886|75779228|FG001|COMPLETED|Overall Study||7||
59660549|NCT03122886|75779227|FG000|NOT COMPLETED|Overall Study||1||
59660550|NCT03122886|75779228|FG001|NOT COMPLETED|Overall Study||2||
59660551|NCT03113422|75779234|FG000|STARTED|Overall Study||56||
59660552|NCT03113422|75779234|FG000|COMPLETED|Overall Study||56||
59660553|NCT03113422|75779234|FG000|NOT COMPLETED|Overall Study||0||
59660554|NCT02910401|75779242|FG000|STARTED|Overall Study||6||
59660555|NCT02910401|75779243|FG001|STARTED|Overall Study||17||
59660556|NCT02910401|75779244|FG002|STARTED|Overall Study||15||
59660557|NCT02910401|75779242|FG000|COMPLETED|Overall Study||5||
59660558|NCT02910401|75779243|FG001|COMPLETED|Overall Study||17||
59660559|NCT02910401|75779244|FG002|COMPLETED|Overall Study||13||
59660560|NCT02910401|75779242|FG000|NOT COMPLETED|Overall Study||1||
59660561|NCT02910401|75779243|FG001|NOT COMPLETED|Overall Study||0||
59660562|NCT02910401|75779244|FG002|NOT COMPLETED|Overall Study||2||
59660563|NCT02864953|75779254|FG000|STARTED|Overall Study||268||
59660564|NCT02864953|75779255|FG001|STARTED|Overall Study||267||
59660565|NCT02864953|75779254|FG000|COMPLETED|Overall Study||215||
59660566|NCT02864953|75779255|FG001|COMPLETED|Overall Study||213||
59660567|NCT02864953|75779254|FG000|NOT COMPLETED|Overall Study||53||
59660568|NCT02864953|75779255|FG001|NOT COMPLETED|Overall Study||54||
59660569|NCT02840240|75779263|FG000|STARTED|Overall Study||56||
59660570|NCT02840240|75779264|FG001|STARTED|Overall Study||51||
59660571|NCT02840240|75779263|FG000|COMPLETED|Overall Study||28||
59660572|NCT02840240|75779264|FG001|COMPLETED|Overall Study||32||
59660573|NCT02840240|75779263|FG000|NOT COMPLETED|Overall Study||28||
59660574|NCT02840240|75779264|FG001|NOT COMPLETED|Overall Study||19||
59660575|NCT02718820|75779270|FG000|STARTED|Overall Study||22||
59660576|NCT02718820|75779270|FG000|COMPLETED|Overall Study||22||
59660577|NCT02718820|75779270|FG000|NOT COMPLETED|Overall Study||0||
59660578|NCT02657954|75779276|FG000|STARTED|Overall Study||39||
59660579|NCT02657954|75779277|FG001|STARTED|Overall Study||40||
59660580|NCT02657954|75779276|FG000|Received at Least One Session|Overall Study||34||
59660581|NCT02657954|75779277|FG001|Received at Least One Session|Overall Study||35||
59660582|NCT02657954|75779276|FG000|COMPLETED|Overall Study||20||
59660583|NCT02657954|75779277|FG001|COMPLETED|Overall Study||26||
59660584|NCT02657954|75779276|FG000|NOT COMPLETED|Overall Study||19||
59660585|NCT02657954|75779277|FG001|NOT COMPLETED|Overall Study||14||
59660586|NCT02609503|75779283|FG000|STARTED|Overall Study||29||
59660587|NCT02609503|75779283|FG000|COMPLETED|Overall Study||25||
59660588|NCT02609503|75779283|FG000|NOT COMPLETED|Overall Study||4||
59660589|NCT02479451|75779290|FG000|STARTED|Overall Study||7||
59660590|NCT02479451|75779290|FG000|COMPLETED|Overall Study||7||
59660591|NCT02479451|75779290|FG000|NOT COMPLETED|Overall Study||0||
59660592|NCT02466776|75779296|FG000|STARTED|Overall Study||119||
59660593|NCT02466776|75779297|FG001|STARTED|Overall Study||119||
59660594|NCT02466776|75779296|FG000|COMPLETED|Overall Study||119||
59660595|NCT02466776|75779297|FG001|COMPLETED|Overall Study||119||
59660596|NCT02466776|75779296|FG000|NOT COMPLETED|Overall Study||0||
59660597|NCT02466776|75779297|FG001|NOT COMPLETED|Overall Study||0||
59660598|NCT02437110|75779315|FG000|STARTED|Screening||118||
59660599|NCT02437110|75779315|FG000|COMPLETED|Screening||114||
59660600|NCT02437110|75779315|FG000|NOT COMPLETED|Screening||4||
59660601|NCT02437110|75779315|FG000|STARTED|ART||34||
59660602|NCT02437110|75779315|FG000|COMPLETED|ART||20||
59660603|NCT02437110|75779315|FG000|NOT COMPLETED|ART||14||
59660604|NCT02437110|75779315|FG000|STARTED|Post-ART||19||
59660605|NCT02437110|75779315|FG000|COMPLETED|Post-ART||9||
59660606|NCT02437110|75779315|FG000|NOT COMPLETED|Post-ART||10||
59660607|NCT02268851|75779327|FG000|STARTED|Overall Study||3||
59660608|NCT02268851|75779328|FG001|STARTED|Overall Study||3||
59660609|NCT02268851|75779329|FG002|STARTED|Overall Study||4||
59660610|NCT02268851|75779330|FG003|STARTED|Overall Study||3||
59660611|NCT02268851|75779331|FG004|STARTED|Overall Study||15||
59660612|NCT02268851|75779332|FG005|STARTED|Overall Study||15||
59660613|NCT02268851|75779327|FG000|COMPLETED|Overall Study||2||
59660614|NCT02268851|75779328|FG001|COMPLETED|Overall Study||0||
59660615|NCT02268851|75779329|FG002|COMPLETED|Overall Study||3||
59660616|NCT02268851|75779330|FG003|COMPLETED|Overall Study||0||
59660617|NCT02268851|75779331|FG004|COMPLETED|Overall Study||8||
59660618|NCT02268851|75779332|FG005|COMPLETED|Overall Study||4||
59660619|NCT02268851|75779327|FG000|NOT COMPLETED|Overall Study||1||
59660620|NCT02268851|75779328|FG001|NOT COMPLETED|Overall Study||3||
59660621|NCT02268851|75779329|FG002|NOT COMPLETED|Overall Study||1||
59660622|NCT02268851|75779330|FG003|NOT COMPLETED|Overall Study||3||
59660623|NCT02268851|75779331|FG004|NOT COMPLETED|Overall Study||7||
59660624|NCT02268851|75779332|FG005|NOT COMPLETED|Overall Study||11||
59660625|NCT02136134|75779348|FG000|STARTED|Overall Study||247||
59660626|NCT02136134|75779349|FG001|STARTED|Overall Study||251||
59660627|NCT02136134|75779348|FG000|Daratumumab Monotherapy|Overall Study||87||
59660628|NCT02136134|75779349|FG001|Daratumumab Monotherapy|Overall Study||0||
59660629|NCT02136134|75779348|FG000|COMPLETED|Overall Study||0||
59660630|NCT02136134|75779349|FG001|COMPLETED|Overall Study||0||
59660631|NCT02136134|75779348|FG000|NOT COMPLETED|Overall Study||247||
59660632|NCT02136134|75779349|FG001|NOT COMPLETED|Overall Study||251||
59660633|NCT01846663|75779358|FG000|STARTED|Overall Study||3||
59660634|NCT01846663|75779359|FG001|STARTED|Overall Study||3||
59660635|NCT01846663|75779358|FG000|COMPLETED|Overall Study||0||
59660636|NCT01846663|75779359|FG001|COMPLETED|Overall Study||1||
59660637|NCT01846663|75779358|FG000|NOT COMPLETED|Overall Study||3||
59660638|NCT01846663|75779359|FG001|NOT COMPLETED|Overall Study||2||
59660639|NCT01659151|75779365|FG000|STARTED|Overall Study||17||
59660640|NCT01659151|75779365|FG000|COMPLETED|Overall Study||16||
59660641|NCT01659151|75779365|FG000|NOT COMPLETED|Overall Study||1||
59660642|NCT01597388|75779378|FG000|STARTED|Overall Study||6||
59660643|NCT01597388|75779379|FG001|STARTED|Overall Study||13||
59660644|NCT01597388|75779380|FG002|STARTED|Overall Study||14||
59660645|NCT01597388|75779381|FG003|STARTED|Overall Study||10||
59660646|NCT01597388|75779382|FG004|STARTED|Overall Study||37||
59660647|NCT01597388|75779383|FG005|STARTED|Overall Study||4||
59660648|NCT01597388|75779384|FG006|STARTED|Overall Study||8||
59660649|NCT01597388|75779385|FG007|STARTED|Overall Study||5||
59660650|NCT01597388|75779386|FG008|STARTED|Overall Study||2||
59660651|NCT01597388|75779378|FG000|COMPLETED|Overall Study||6||
59660652|NCT01597388|75779379|FG001|COMPLETED|Overall Study||13||
59660653|NCT01597388|75779380|FG002|COMPLETED|Overall Study||14||
59660654|NCT01597388|75779381|FG003|COMPLETED|Overall Study||10||
59660655|NCT01597388|75779382|FG004|COMPLETED|Overall Study||37||
59660656|NCT01597388|75779383|FG005|COMPLETED|Overall Study||4||
59660657|NCT01597388|75779384|FG006|COMPLETED|Overall Study||8||
59660658|NCT01597388|75779385|FG007|COMPLETED|Overall Study||5||
59660659|NCT01597388|75779386|FG008|COMPLETED|Overall Study||2||
59660660|NCT01597388|75779378|FG000|NOT COMPLETED|Overall Study||0||
59660661|NCT01597388|75779379|FG001|NOT COMPLETED|Overall Study||0||
59660662|NCT01597388|75779380|FG002|NOT COMPLETED|Overall Study||0||
59660663|NCT01597388|75779381|FG003|NOT COMPLETED|Overall Study||0||
59660664|NCT01597388|75779382|FG004|NOT COMPLETED|Overall Study||0||
59660665|NCT01597388|75779383|FG005|NOT COMPLETED|Overall Study||0||
59660666|NCT01597388|75779384|FG006|NOT COMPLETED|Overall Study||0||
59660667|NCT01597388|75779385|FG007|NOT COMPLETED|Overall Study||0||
59660668|NCT01597388|75779386|FG008|NOT COMPLETED|Overall Study||0||
59660669|NCT01491789|75779423|FG000|STARTED|Overall Study||18||
59660670|NCT01491789|75779423|FG000|COMPLETED|Overall Study||14||
59660671|NCT01491789|75779423|FG000|NOT COMPLETED|Overall Study||4||
59660672|NCT01364480|75779427|FG000|STARTED|Overall Study||1||
59660673|NCT01364480|75779427|FG000|COMPLETED|Overall Study||1||
59660674|NCT01364480|75779427|FG000|NOT COMPLETED|Overall Study||0||
59660675|NCT00745030|75779433|FG000|STARTED|Overall Study||1||
59660676|NCT00745030|75779434|FG001|STARTED|Overall Study||2||
59660677|NCT00745030|75779433|FG000|COMPLETED|Overall Study||1||
59660678|NCT00745030|75779434|FG001|COMPLETED|Overall Study||2||
59660679|NCT00745030|75779433|FG000|NOT COMPLETED|Overall Study||0||
59660680|NCT00745030|75779434|FG001|NOT COMPLETED|Overall Study||0||
59660681|NCT00055224|75779445|FG000|STARTED|Overall Study Participants||557||
59660682|NCT00055224|75779446|FG001|STARTED|Overall Study Participants||361||
59660683|NCT00055224|75779445|FG000|COMPLETED|Overall Study Participants||557||
59660684|NCT00055224|75779446|FG001|COMPLETED|Overall Study Participants||361||
59660685|NCT00055224|75779445|FG000|NOT COMPLETED|Overall Study Participants||0||
59660686|NCT00055224|75779446|FG001|NOT COMPLETED|Overall Study Participants||0||
59660687|NCT00055224|75779445|FG000|STARTED|Substudy 1||23||
59660688|NCT00055224|75779446|FG001|STARTED|Substudy 1||78||
59660689|NCT00055224|75779445|FG000|COMPLETED|Substudy 1||23||
59660690|NCT00055224|75779446|FG001|COMPLETED|Substudy 1||78||
59660691|NCT00055224|75779445|FG000|NOT COMPLETED|Substudy 1||0||
59660692|NCT00055224|75779446|FG001|NOT COMPLETED|Substudy 1||0||
59660693|NCT00055224|75779445|FG000|STARTED|Substudy 2||42||
59660694|NCT00055224|75779446|FG001|STARTED|Substudy 2||35||
59660695|NCT00055224|75779445|FG000|COMPLETED|Substudy 2||42||
59660696|NCT00055224|75779446|FG001|COMPLETED|Substudy 2||35||
59660697|NCT00055224|75779445|FG000|NOT COMPLETED|Substudy 2||0||
59660698|NCT00055224|75779446|FG001|NOT COMPLETED|Substudy 2||0||
59660699|NCT00055224|75779445|FG000|STARTED|Substudy 5|Include subjects who previously participated in sub-study 1 (two participants) and sub-study 2 (one participant)|33||
59660700|NCT00055224|75779446|FG001|STARTED|Substudy 5|Include subjects who previously participated in sub-study 1 (two participants) and sub-study 2 (two participants)|36||
59660701|NCT00055224|75779445|FG000|COMPLETED|Substudy 5||33||
59660702|NCT00055224|75779446|FG001|COMPLETED|Substudy 5||36||
59660703|NCT00055224|75779445|FG000|NOT COMPLETED|Substudy 5||0||
59660704|NCT00055224|75779446|FG001|NOT COMPLETED|Substudy 5||0||
59660705|NCT00055224|75779445|FG000|STARTED|Substudy 7|Include subjects who previously participated in sub-study 1 (seven participants), sub-study 2 (1 participant), and sub-study 5 (one participant)|65||
59660706|NCT00055224|75779446|FG001|STARTED|Substudy 7|Include subjects who previously participated in sub-study 1 (36 participants), sub-study 2 (seven participants), and sub-study 5 (11 participants)|91||
59660707|NCT00055224|75779445|FG000|COMPLETED|Substudy 7||65||
59660708|NCT00055224|75779446|FG001|COMPLETED|Substudy 7||91||
59660709|NCT00055224|75779445|FG000|NOT COMPLETED|Substudy 7||0||
59660710|NCT00055224|75779446|FG001|NOT COMPLETED|Substudy 7||0||
59660711|NCT00055224|75779445|FG000|STARTED|Pilot Tasks||406||
59660712|NCT00055224|75779446|FG001|STARTED|Pilot Tasks||183||
59660713|NCT00055224|75779445|FG000|COMPLETED|Pilot Tasks||406||
59660714|NCT00055224|75779446|FG001|COMPLETED|Pilot Tasks||183||
59660715|NCT00055224|75779445|FG000|NOT COMPLETED|Pilot Tasks||0||
59660716|NCT00055224|75779446|FG001|NOT COMPLETED|Pilot Tasks||0||
59660717|NCT00026559|75779468|FG000|STARTED|Healthy Volunteers||1418||
59660718|NCT00026559|75779468|FG000|COMPLETED|Healthy Volunteers||1418||
59660719|NCT00026559|75779468|FG000|NOT COMPLETED|Healthy Volunteers||0||
59660720|NCT00026559|75779468|FG000|STARTED|Working Memory Task||115||
59660721|NCT00026559|75779468|FG000|COMPLETED|Working Memory Task||115||
59660722|NCT00026559|75779468|FG000|NOT COMPLETED|Working Memory Task||0||
59660723|NCT00026559|75779468|FG000|STARTED|Sustained Attention to Response Task|Include seven subjects who also participated in the working memory task sub-study|61||
59660724|NCT00026559|75779468|FG000|COMPLETED|Sustained Attention to Response Task||61||
59660725|NCT00026559|75779468|FG000|NOT COMPLETED|Sustained Attention to Response Task||0||
59660726|NCT00026559|75779468|FG000|STARTED|Stroop Task|Include 28 subjects who also participated in the working memory task and two subjects who participated in the Sustained attention to response task sub-studies|69||
59660727|NCT00026559|75779468|FG000|COMPLETED|Stroop Task||69||
59660728|NCT00026559|75779468|FG000|NOT COMPLETED|Stroop Task||0||
59660729|NCT00026559|75779468|FG000|STARTED|Pilot Studies||1210||
59660730|NCT00026559|75779468|FG000|COMPLETED|Pilot Studies||1210||
59660731|NCT00026559|75779468|FG000|NOT COMPLETED|Pilot Studies||0||
59660732|NCT04648683|75779477|FG000|STARTED|Overall Study||10||
59660733|NCT04648683|75779478|FG001|STARTED|Overall Study||0||
59660734|NCT04648683|75779477|FG000|COMPLETED|Overall Study||3||
59660735|NCT04648683|75779478|FG001|COMPLETED|Overall Study||0||
59660736|NCT04648683|75779477|FG000|NOT COMPLETED|Overall Study||7||
59660737|NCT04648683|75779478|FG001|NOT COMPLETED|Overall Study||0||
59660738|NCT04847141|75779486|FG000|STARTED|Overall Study||152|Started participants were defined as participants who were also dosed.|
59660739|NCT04847141|75779487|FG001|STARTED|Overall Study||153|Started participants were defined as participants who were also dosed.|
59660740|NCT04847141|75779488|FG002|STARTED|Overall Study||156|Started participants were defined as participants who were also dosed.|
59660741|NCT04847141|75779486|FG000|COMPLETED|Overall Study||142||
59660742|NCT04847141|75779487|FG001|COMPLETED|Overall Study||143||
59660743|NCT04847141|75779488|FG002|COMPLETED|Overall Study||145||
59660744|NCT04847141|75779486|FG000|NOT COMPLETED|Overall Study||10||
59660745|NCT04847141|75779487|FG001|NOT COMPLETED|Overall Study||10||
59660746|NCT04847141|75779488|FG002|NOT COMPLETED|Overall Study||11||
59660747|NCT01349829|75779498|FG000|STARTED|Overall Study||126||
59660748|NCT01349829|75779499|FG001|STARTED|Overall Study||125||
59660749|NCT01349829|75779498|FG000|COMPLETED|Overall Study||117||
59660750|NCT01349829|75779499|FG001|COMPLETED|Overall Study||102||
59660751|NCT01349829|75779498|FG000|NOT COMPLETED|Overall Study||9||
59660752|NCT01349829|75779499|FG001|NOT COMPLETED|Overall Study||23||
59660753|NCT01350128|75779507|FG000|STARTED|Overall Study||103||
59660754|NCT01350128|75779507|FG000|GP MDI 36 µg BID|Overall Study|Glycopyrronium Metered Dose Inhaler|49||
59660755|NCT01350128|75779507|FG000|GP MDI 18 µg BID|Overall Study||49||
59660756|NCT01350128|75779507|FG000|GP MDI 9 µg BID|Overall Study||49||
59660757|NCT01350128|75779507|FG000|GP MDI 4.6 µg BID|Overall Study||45||
59660758|NCT01350128|75779507|FG000|Placebo MDI BID|Overall Study||48||
59660759|NCT01350128|75779507|FG000|Atrovent HFA 34 µg BID|Overall Study||48||
59660760|NCT01350128|75779507|FG000|COMPLETED|Overall Study||89||
59660761|NCT01350128|75779507|FG000|NOT COMPLETED|Overall Study||14||
59660762|NCT03152136|75779524|FG000|STARTED|Overall Study||32||
59660763|NCT03152136|75779525|FG001|STARTED|Overall Study||15||
59660764|NCT03152136|75779526|FG002|STARTED|Overall Study||15||
59660765|NCT03152136|75779524|FG000|COMPLETED|Overall Study||29||
59660766|NCT03152136|75779525|FG001|COMPLETED|Overall Study||15||
59660767|NCT03152136|75779526|FG002|COMPLETED|Overall Study||14||
59660768|NCT03152136|75779524|FG000|NOT COMPLETED|Overall Study||3||
59660769|NCT03152136|75779525|FG001|NOT COMPLETED|Overall Study||0||
59660770|NCT03152136|75779526|FG002|NOT COMPLETED|Overall Study||1||
59660771|NCT03151746|75779535|FG000|STARTED|Overall Study||9||
59660772|NCT03151746|75779536|FG001|STARTED|Overall Study||11||
59660773|NCT03151746|75779535|FG000|COMPLETED|Overall Study||9||
59660774|NCT03151746|75779536|FG001|COMPLETED|Overall Study||11||
59660775|NCT03151746|75779535|FG000|NOT COMPLETED|Overall Study||0||
59660776|NCT03151746|75779536|FG001|NOT COMPLETED|Overall Study||0||
59660777|NCT04172714|75779542|FG000|STARTED|Overall Study||30||
59660778|NCT04172714|75779542|FG000|COMPLETED|Overall Study||30||
59660779|NCT04172714|75779542|FG000|NOT COMPLETED|Overall Study||0||
59660780|NCT03151434|75779551|FG000|STARTED|Overall Study||53||
59660781|NCT03151434|75779552|FG001|STARTED|Overall Study||47||
59660782|NCT03151434|75779553|FG002|STARTED|Overall Study||47||
59988914|NCT03689244|76104166|FG003|COMPLETED|Open Label Period (Up to 20.8 Months)||0||
59988915|NCT03689244|76104163|FG000|NOT COMPLETED|Open Label Period (Up to 20.8 Months)||0||
59660783|NCT03151434|75779551|FG000|COMPLETED|Overall Study||40||
59660784|NCT03151434|75779552|FG001|COMPLETED|Overall Study||40||
59660785|NCT03151434|75779553|FG002|COMPLETED|Overall Study||40||
59660786|NCT03151434|75779551|FG000|NOT COMPLETED|Overall Study||13||
59660787|NCT03151434|75779552|FG001|NOT COMPLETED|Overall Study||7||
59660788|NCT03151434|75779553|FG002|NOT COMPLETED|Overall Study||7||
59660789|NCT03893825|75779566|FG000|STARTED|Overall Study||174||
59660790|NCT03893825|75779567|FG001|STARTED|Overall Study||162||
59660791|NCT03893825|75779566|FG000|Received at Least 1 Dose of Study Drug|Overall Study||172||
59660792|NCT03893825|75779567|FG001|Received at Least 1 Dose of Study Drug|Overall Study||162||
59660793|NCT03893825|75779566|FG000|COMPLETED|Overall Study||135||
59660794|NCT03893825|75779567|FG001|COMPLETED|Overall Study||122||
59660795|NCT03893825|75779566|FG000|NOT COMPLETED|Overall Study||39||
59660796|NCT03893825|75779567|FG001|NOT COMPLETED|Overall Study||40||
59660797|NCT03890666|75779575|FG000|STARTED|Overall Study||166|Intent-to-treat (ITT) analysis set: included all randomized participants|
59660798|NCT03890666|75779576|FG001|STARTED|Overall Study||167|Intent-to-treat (ITT) analysis set: included all randomized participants|
59660799|NCT03890666|75779575|FG000|Safety Analysis Set|Overall Study||166|All participants in the DS group who receive at least 1 dose of IMP and all participants in the CC group.|
59660800|NCT03890666|75779576|FG001|Safety Analysis Set|Overall Study||150|All participants in the DS group who receive at least 1 dose of IMP and all participants in the CC group.|
59660801|NCT03890666|75779575|FG000|Modified Intent-to-treat (mITT) Analysis Set|Overall Study||163|Al participants who received at least 1 dose of IMP and at least 1 postbaseline assessment on any of the study endpoints.|
59660802|NCT03890666|75779576|FG001|Modified Intent-to-treat (mITT) Analysis Set|Overall Study||150|Al participants who received at least 1 dose of IMP and at least 1 postbaseline assessment on any of the study endpoints.|
59660803|NCT03890666|75779575|FG000|COMPLETED|Overall Study||162||
59660804|NCT03890666|75779576|FG001|COMPLETED|Overall Study||149||
59660805|NCT03890666|75779575|FG000|NOT COMPLETED|Overall Study||4||
59660806|NCT03890666|75779576|FG001|NOT COMPLETED|Overall Study||18||
59660807|NCT03487913|75779587|FG000|STARTED|Overall Study||9||
59660808|NCT03487913|75779588|FG001|STARTED|Overall Study||7||
59660809|NCT03487913|75779589|FG002|STARTED|Overall Study||8||
59660810|NCT03487913|75779590|FG003|STARTED|Overall Study||7||
59660811|NCT03487913|75779587|FG000|COMPLETED|Overall Study||9||
59660812|NCT03487913|75779588|FG001|COMPLETED|Overall Study||7||
59660813|NCT03487913|75779589|FG002|COMPLETED|Overall Study||8||
59660814|NCT03487913|75779590|FG003|COMPLETED|Overall Study||7||
59660815|NCT03487913|75779587|FG000|NOT COMPLETED|Overall Study||0||
59660816|NCT03487913|75779588|FG001|NOT COMPLETED|Overall Study||0||
59660817|NCT03487913|75779589|FG002|NOT COMPLETED|Overall Study||0||
59660818|NCT03487913|75779590|FG003|NOT COMPLETED|Overall Study||0||
59660819|NCT01891695|75779606|FG000|STARTED|Overall Study||1||
59660820|NCT01891695|75779606|FG000|COMPLETED|Overall Study||1||
59660821|NCT01891695|75779606|FG000|NOT COMPLETED|Overall Study||0||
59660822|NCT01807455|75779610|FG000|STARTED|Overall Study||12||
59660823|NCT01807455|75779610|FG000|COMPLETED|Overall Study||12||
59660824|NCT01807455|75779610|FG000|NOT COMPLETED|Overall Study||0||
59660825|NCT03090737|75779614|FG000|STARTED|Overall Study||129|Started=Treated|
59660826|NCT03090737|75779614|FG000|COMPLETED|Overall Study||0||
59660827|NCT03090737|75779614|FG000|NOT COMPLETED|Overall Study||129||
59660828|NCT01807104|75779620|FG000|STARTED|Overall Study||43||
59660829|NCT01807104|75779621|FG001|STARTED|Overall Study||44||
59660830|NCT01807104|75779620|FG000|COMPLETED|Overall Study||39||
59660831|NCT01807104|75779621|FG001|COMPLETED|Overall Study||40||
59660832|NCT01807104|75779620|FG000|NOT COMPLETED|Overall Study||4||
59660833|NCT01807104|75779621|FG001|NOT COMPLETED|Overall Study||4||
59660834|NCT01807026|75779633|FG000|STARTED|Overall Study||10||
59660835|NCT01807026|75779634|FG001|STARTED|Overall Study||2||
59660836|NCT01807026|75779635|FG002|STARTED|Overall Study||10||
59660837|NCT01807026|75779636|FG003|STARTED|Overall Study||2||
59660838|NCT01807026|75779637|FG004|STARTED|Overall Study||9||
59660839|NCT01807026|75779638|FG005|STARTED|Overall Study||3||
59660840|NCT01807026|75779633|FG000|Received at Least One Dose of Study Drug|Overall Study||10||
59660841|NCT01807026|75779634|FG001|Received at Least One Dose of Study Drug|Overall Study||2||
59660842|NCT01807026|75779635|FG002|Received at Least One Dose of Study Drug|Overall Study||10||
59660843|NCT01807026|75779636|FG003|Received at Least One Dose of Study Drug|Overall Study||2||
59660844|NCT01807026|75779637|FG004|Received at Least One Dose of Study Drug|Overall Study||9||
59660845|NCT01807026|75779638|FG005|Received at Least One Dose of Study Drug|Overall Study||3||
59660846|NCT01807026|75779633|FG000|COMPLETED|Overall Study||10||
59660847|NCT01807026|75779634|FG001|COMPLETED|Overall Study||2||
59660848|NCT01807026|75779635|FG002|COMPLETED|Overall Study||10||
59660849|NCT01807026|75779636|FG003|COMPLETED|Overall Study||2||
59660850|NCT01807026|75779637|FG004|COMPLETED|Overall Study||9||
59660851|NCT01807026|75779638|FG005|COMPLETED|Overall Study||3||
59660852|NCT01807026|75779633|FG000|NOT COMPLETED|Overall Study||0||
59660853|NCT01807026|75779634|FG001|NOT COMPLETED|Overall Study||0||
59660854|NCT01807026|75779635|FG002|NOT COMPLETED|Overall Study||0||
59660855|NCT01807026|75779636|FG003|NOT COMPLETED|Overall Study||0||
59660856|NCT01807026|75779637|FG004|NOT COMPLETED|Overall Study||0||
59660857|NCT01807026|75779638|FG005|NOT COMPLETED|Overall Study||0||
59660858|NCT03004976|75779659|FG000|STARTED|Overall Study||52||
59660859|NCT03004976|75779660|FG001|STARTED|Overall Study||27||
59660860|NCT03004976|75779659|FG000|COMPLETED|Overall Study||39||
59660861|NCT03004976|75779660|FG001|COMPLETED|Overall Study||21||
59660862|NCT03004976|75779659|FG000|NOT COMPLETED|Overall Study||13||
59660863|NCT03004976|75779660|FG001|NOT COMPLETED|Overall Study||6||
59660864|NCT02985866|75779668|FG000|STARTED|Overall Study||65||
59660865|NCT02985866|75779669|FG001|STARTED|Overall Study||62||
59660866|NCT02985866|75779668|FG000|COMPLETED|Overall Study||64||
59660867|NCT02985866|75779669|FG001|COMPLETED|Overall Study||61||
59660868|NCT02985866|75779668|FG000|NOT COMPLETED|Overall Study||1||
59660869|NCT02985866|75779669|FG001|NOT COMPLETED|Overall Study||1||
59660870|NCT01806675|75779679|FG000|STARTED|Overall Study||11||
59660871|NCT01806675|75779680|FG001|STARTED|Overall Study||6||
59660872|NCT01806675|75779681|FG002|STARTED|Overall Study||8||
59660873|NCT01806675|75779679|FG000|COMPLETED|Overall Study||11||
59660874|NCT01806675|75779680|FG001|COMPLETED|Overall Study||6||
59660875|NCT01806675|75779681|FG002|COMPLETED|Overall Study||8||
59660876|NCT01806675|75779679|FG000|NOT COMPLETED|Overall Study||0||
59660877|NCT01806675|75779680|FG001|NOT COMPLETED|Overall Study||0||
59660878|NCT01806675|75779681|FG002|NOT COMPLETED|Overall Study||0||
59660879|NCT02762981|75779694|FG000|STARTED|Overall Study||17||
59660880|NCT02762981|75779695|FG001|STARTED|Overall Study||40||
59660881|NCT02762981|75779696|FG002|STARTED|Overall Study||7||
59660882|NCT02762981|75779697|FG003|STARTED|Overall Study||16||
59660883|NCT02762981|75779698|FG004|STARTED|Overall Study||5||
59660884|NCT02762981|75779694|FG000|COMPLETED|Overall Study||0||
59660885|NCT02762981|75779695|FG001|COMPLETED|Overall Study||0||
59660886|NCT02762981|75779696|FG002|COMPLETED|Overall Study||0||
59660887|NCT02762981|75779697|FG003|COMPLETED|Overall Study||0||
59660888|NCT02762981|75779698|FG004|COMPLETED|Overall Study||0||
59660889|NCT02762981|75779694|FG000|NOT COMPLETED|Overall Study||17||
59660890|NCT02762981|75779695|FG001|NOT COMPLETED|Overall Study||40||
59660891|NCT02762981|75779696|FG002|NOT COMPLETED|Overall Study||7||
59660892|NCT02762981|75779697|FG003|NOT COMPLETED|Overall Study||16||
59660893|NCT02762981|75779698|FG004|NOT COMPLETED|Overall Study||5||
59660894|NCT02423876|75779717|FG000|STARTED|Overall Study||52||
59660895|NCT02423876|75779718|FG001|STARTED|Overall Study||52||
59660896|NCT02423876|75779717|FG000|COMPLETED|Overall Study||52||
59660897|NCT02423876|75779718|FG001|COMPLETED|Overall Study||52||
59660898|NCT02423876|75779717|FG000|NOT COMPLETED|Overall Study||0||
59660899|NCT02423876|75779718|FG001|NOT COMPLETED|Overall Study||0||
59660900|NCT02316002|75779725|FG000|STARTED|Overall Study||51||
59660901|NCT02316002|75779725|FG000|COMPLETED|Overall Study||45||
59660902|NCT02316002|75779725|FG000|NOT COMPLETED|Overall Study||6||
59660903|NCT01805895|75779731|FG000|STARTED|Overall Study||8||
59660904|NCT01805895|75779732|FG001|STARTED|Overall Study||8||
59660905|NCT01805895|75779731|FG000|COMPLETED|Overall Study||8||
59660906|NCT01805895|75779732|FG001|COMPLETED|Overall Study||8||
59660907|NCT01805895|75779731|FG000|NOT COMPLETED|Overall Study||0||
59660908|NCT01805895|75779732|FG001|NOT COMPLETED|Overall Study||0||
59660909|NCT01723839|75779738|FG000|STARTED|Overall Study||21||
59660910|NCT01723839|75779738|FG000|COMPLETED|Overall Study||12||
59660911|NCT01723839|75779738|FG000|NOT COMPLETED|Overall Study||9||
59660912|NCT01466361|75779746|FG000|STARTED|Overall Study||52||
59660913|NCT01466361|75779747|FG001|STARTED|Overall Study||34||
59660914|NCT01466361|75779748|FG002|STARTED|Overall Study||60||
59660915|NCT01466361|75779749|FG003|STARTED|Overall Study||41||
59660916|NCT01466361|75779746|FG000|COMPLETED|Overall Study||52||
59660917|NCT01466361|75779747|FG001|COMPLETED|Overall Study||34||
59660918|NCT01466361|75779748|FG002|COMPLETED|Overall Study||60||
59660919|NCT01466361|75779749|FG003|COMPLETED|Overall Study||41||
59660920|NCT01466361|75779746|FG000|NOT COMPLETED|Overall Study||0||
59660921|NCT01466361|75779747|FG001|NOT COMPLETED|Overall Study||0||
59660922|NCT01466361|75779748|FG002|NOT COMPLETED|Overall Study||0||
59660923|NCT01466361|75779749|FG003|NOT COMPLETED|Overall Study||0||
59660924|NCT00001832|75779778|FG000|STARTED|Apheresis Period||170||
59660925|NCT00001832|75779779|FG001|STARTED|Apheresis Period||0||
59660926|NCT00001832|75779780|FG002|STARTED|Apheresis Period||0||
59660927|NCT00001832|75779781|FG003|STARTED|Apheresis Period||0||
59660928|NCT00001832|75779782|FG004|STARTED|Apheresis Period||0||
59660929|NCT00001832|75779783|FG005|STARTED|Apheresis Period||0||
59660930|NCT00001832|75779784|FG006|STARTED|Apheresis Period||0||
59660931|NCT00001832|75779785|FG007|STARTED|Apheresis Period||0||
59660932|NCT00001832|75779786|FG008|STARTED|Apheresis Period||0||
59660933|NCT00001832|75779787|FG009|STARTED|Apheresis Period||0||
59660934|NCT00001832|75779788|FG010|STARTED|Apheresis Period||0||
59660935|NCT00001832|75779789|FG011|STARTED|Apheresis Period||0||
59660936|NCT00001832|75779790|FG012|STARTED|Apheresis Period||0||
59660937|NCT00001832|75779791|FG013|STARTED|Apheresis Period||0||
59660938|NCT00001832|75779792|FG014|STARTED|Apheresis Period||0||
59660939|NCT00001832|75779778|FG000|COMPLETED|Apheresis Period||110||
59660940|NCT00001832|75779779|FG001|COMPLETED|Apheresis Period||0||
59660941|NCT00001832|75779780|FG002|COMPLETED|Apheresis Period||0||
59660942|NCT00001832|75779781|FG003|COMPLETED|Apheresis Period||0||
59660943|NCT00001832|75779782|FG004|COMPLETED|Apheresis Period||0||
59660944|NCT00001832|75779783|FG005|COMPLETED|Apheresis Period||0||
59660945|NCT00001832|75779784|FG006|COMPLETED|Apheresis Period||0||
59660946|NCT00001832|75779785|FG007|COMPLETED|Apheresis Period||0||
59660947|NCT00001832|75779786|FG008|COMPLETED|Apheresis Period||0||
59660948|NCT00001832|75779787|FG009|COMPLETED|Apheresis Period||0||
59660949|NCT00001832|75779788|FG010|COMPLETED|Apheresis Period||0||
59660950|NCT00001832|75779789|FG011|COMPLETED|Apheresis Period||0||
59660951|NCT00001832|75779790|FG012|COMPLETED|Apheresis Period||0||
59660952|NCT00001832|75779791|FG013|COMPLETED|Apheresis Period||0||
59660953|NCT00001832|75779792|FG014|COMPLETED|Apheresis Period||0||
59660954|NCT00001832|75779778|FG000|NOT COMPLETED|Apheresis Period||60||
59660955|NCT00001832|75779779|FG001|NOT COMPLETED|Apheresis Period||0||
59660956|NCT00001832|75779780|FG002|NOT COMPLETED|Apheresis Period||0||
59660957|NCT00001832|75779781|FG003|NOT COMPLETED|Apheresis Period||0||
59660958|NCT00001832|75779782|FG004|NOT COMPLETED|Apheresis Period||0||
59660959|NCT00001832|75779783|FG005|NOT COMPLETED|Apheresis Period||0||
59660960|NCT00001832|75779784|FG006|NOT COMPLETED|Apheresis Period||0||
59660961|NCT00001832|75779785|FG007|NOT COMPLETED|Apheresis Period||0||
59660962|NCT00001832|75779786|FG008|NOT COMPLETED|Apheresis Period||0||
59660963|NCT00001832|75779787|FG009|NOT COMPLETED|Apheresis Period||0||
59660964|NCT00001832|75779788|FG010|NOT COMPLETED|Apheresis Period||0||
59660965|NCT00001832|75779789|FG011|NOT COMPLETED|Apheresis Period||0||
59660966|NCT00001832|75779790|FG012|NOT COMPLETED|Apheresis Period||0||
59660967|NCT00001832|75779791|FG013|NOT COMPLETED|Apheresis Period||0||
59660968|NCT00001832|75779792|FG014|NOT COMPLETED|Apheresis Period||0||
59660969|NCT00001832|75779778|FG000|STARTED|Treatment Period||0||
59660970|NCT00001832|75779779|FG001|STARTED|Treatment Period||3||
59660971|NCT00001832|75779780|FG002|STARTED|Treatment Period||3||
59660972|NCT00001832|75779781|FG003|STARTED|Treatment Period||3||
59660973|NCT00001832|75779782|FG004|STARTED|Treatment Period||6||
59660974|NCT00001832|75779783|FG005|STARTED|Treatment Period||51||
59660975|NCT00001832|75779784|FG006|STARTED|Treatment Period||4||
59660976|NCT00001832|75779785|FG007|STARTED|Treatment Period||7||
59660977|NCT00001832|75779786|FG008|STARTED|Treatment Period||8||
59660978|NCT00001832|75779787|FG009|STARTED|Treatment Period||6||
59660979|NCT00001832|75779788|FG010|STARTED|Treatment Period||1||
59660980|NCT00001832|75779789|FG011|STARTED|Treatment Period||7||
59660981|NCT00001832|75779790|FG012|STARTED|Treatment Period||6||
59660982|NCT00001832|75779791|FG013|STARTED|Treatment Period||3||
59660983|NCT00001832|75779792|FG014|STARTED|Treatment Period||2||
59660984|NCT00001832|75779778|FG000|COMPLETED|Treatment Period||0||
59660985|NCT00001832|75779779|FG001|COMPLETED|Treatment Period||3||
59660986|NCT00001832|75779780|FG002|COMPLETED|Treatment Period||3||
59660987|NCT00001832|75779781|FG003|COMPLETED|Treatment Period||3||
59660988|NCT00001832|75779782|FG004|COMPLETED|Treatment Period||6||
59660989|NCT00001832|75779783|FG005|COMPLETED|Treatment Period||50||
59660990|NCT00001832|75779784|FG006|COMPLETED|Treatment Period||4||
59660991|NCT00001832|75779785|FG007|COMPLETED|Treatment Period||6||
59660992|NCT00001832|75779786|FG008|COMPLETED|Treatment Period||8||
59660993|NCT00001832|75779787|FG009|COMPLETED|Treatment Period||6||
59660994|NCT00001832|75779788|FG010|COMPLETED|Treatment Period||1||
59660995|NCT00001832|75779789|FG011|COMPLETED|Treatment Period||7||
59660996|NCT00001832|75779790|FG012|COMPLETED|Treatment Period||6||
59660997|NCT00001832|75779791|FG013|COMPLETED|Treatment Period||3||
59660998|NCT00001832|75779792|FG014|COMPLETED|Treatment Period||2||
59660999|NCT00001832|75779778|FG000|NOT COMPLETED|Treatment Period||0||
59661000|NCT00001832|75779779|FG001|NOT COMPLETED|Treatment Period||0||
59661001|NCT00001832|75779780|FG002|NOT COMPLETED|Treatment Period||0||
59661002|NCT00001832|75779781|FG003|NOT COMPLETED|Treatment Period||0||
59661003|NCT00001832|75779782|FG004|NOT COMPLETED|Treatment Period||0||
59661004|NCT00001832|75779783|FG005|NOT COMPLETED|Treatment Period||1||
59661005|NCT00001832|75779784|FG006|NOT COMPLETED|Treatment Period||0||
59661006|NCT00001832|75779785|FG007|NOT COMPLETED|Treatment Period||1||
59661007|NCT00001832|75779786|FG008|NOT COMPLETED|Treatment Period||0||
59661008|NCT00001832|75779787|FG009|NOT COMPLETED|Treatment Period||0||
59661009|NCT00001832|75779788|FG010|NOT COMPLETED|Treatment Period||0||
59661010|NCT00001832|75779789|FG011|NOT COMPLETED|Treatment Period||0||
59661011|NCT00001832|75779790|FG012|NOT COMPLETED|Treatment Period||0||
59661012|NCT00001832|75779791|FG013|NOT COMPLETED|Treatment Period||0||
59661013|NCT00001832|75779792|FG014|NOT COMPLETED|Treatment Period||0||
59661014|NCT01466127|75779824|FG000|STARTED|Overall Study||30||
59661015|NCT01466127|75779825|FG001|STARTED|Overall Study||30||
59661016|NCT01466127|75779824|FG000|COMPLETED|Overall Study||16||
59661017|NCT01466127|75779825|FG001|COMPLETED|Overall Study||14||
59661018|NCT01466127|75779824|FG000|NOT COMPLETED|Overall Study||14||
59661019|NCT01466127|75779825|FG001|NOT COMPLETED|Overall Study||16||
59661020|NCT01464996|75779831|FG000|STARTED|Overall Study||24||
59661021|NCT01464996|75779831|FG000|OptiBond XTR|Overall Study||23||
59661022|NCT01464996|75779831|FG000|OptiBond FL|Overall Study||24||
59815807|NCT03026283|75938217|FG006|COMPLETED|Optimal Care/Stress Test/ICA||0|Participants who followed recommendation provided after consultation with referring physician.|
59661023|NCT01464996|75779831|FG000|COMPLETED|Overall Study||24||
59661024|NCT01464996|75779831|FG000|NOT COMPLETED|Overall Study||0||
59661025|NCT01464840|75779840|FG000|STARTED|Overall Study||10||
59661026|NCT01464840|75779841|FG001|STARTED|Overall Study||10||
59661027|NCT01464840|75779842|FG002|STARTED|Overall Study||10||
59661028|NCT01464840|75779840|FG000|COMPLETED|Overall Study||10||
59661029|NCT01464840|75779841|FG001|COMPLETED|Overall Study||10||
59661030|NCT01464840|75779842|FG002|COMPLETED|Overall Study||10||
59661031|NCT01464840|75779840|FG000|NOT COMPLETED|Overall Study||0||
59661032|NCT01464840|75779841|FG001|NOT COMPLETED|Overall Study||0||
59661033|NCT01464840|75779842|FG002|NOT COMPLETED|Overall Study||0||
59661034|NCT01464723|75779850|FG000|STARTED|Overall Study||0||
59661035|NCT01464723|75779850|FG000|COMPLETED|Overall Study||0||
59661036|NCT01464723|75779850|FG000|NOT COMPLETED|Overall Study||0||
59661037|NCT00847938|75779858|FG000|STARTED|Overall Study||16||
59661038|NCT00847938|75779859|FG001|STARTED|Overall Study||15||
59661039|NCT00847938|75779860|FG002|STARTED|Overall Study||16||
59661040|NCT00847938|75779861|FG003|STARTED|Overall Study||15||
59661041|NCT00847938|75779858|FG000|COMPLETED|Overall Study||16||
59661042|NCT00847938|75779859|FG001|COMPLETED|Overall Study||14||
59661043|NCT00847938|75779860|FG002|COMPLETED|Overall Study||15||
59661044|NCT00847938|75779861|FG003|COMPLETED|Overall Study||15||
59661045|NCT00847938|75779858|FG000|NOT COMPLETED|Overall Study||0||
59661046|NCT00847938|75779859|FG001|NOT COMPLETED|Overall Study||1||
59661047|NCT00847938|75779860|FG002|NOT COMPLETED|Overall Study||1||
59661048|NCT00847938|75779861|FG003|NOT COMPLETED|Overall Study||0||
59661049|NCT00847587|75779873|FG000|STARTED|Overall Study||35||
59661050|NCT00847587|75779874|FG001|STARTED|Overall Study||34||
59661051|NCT00847587|75779873|FG000|COMPLETED|Overall Study|Patient declined study after randomization.|34||
59661052|NCT00847587|75779874|FG001|COMPLETED|Overall Study||34||
59661053|NCT00847587|75779873|FG000|NOT COMPLETED|Overall Study||1||
59661054|NCT00847587|75779874|FG001|NOT COMPLETED|Overall Study||0||
59661055|NCT00847509|75779880|FG000|STARTED|Overall Study||49||
59661056|NCT00847509|75779880|FG000|COMPLETED|Overall Study||38||
59661057|NCT00847509|75779880|FG000|NOT COMPLETED|Overall Study||11||
59661058|NCT00847002|75779886|FG000|STARTED|Overall Study||4||
59661059|NCT00847002|75779887|FG001|STARTED|Overall Study||4||
59661060|NCT00847002|75779886|FG000|COMPLETED|Overall Study||4||
59661061|NCT00847002|75779887|FG001|COMPLETED|Overall Study||4||
59661062|NCT00847002|75779886|FG000|NOT COMPLETED|Overall Study||0||
59661063|NCT00847002|75779887|FG001|NOT COMPLETED|Overall Study||0||
59661064|NCT00846885|75779895|FG000|STARTED|First Intervention||14||
59661065|NCT00846885|75779896|FG001|STARTED|First Intervention||14||
59661066|NCT00846885|75779895|FG000|COMPLETED|First Intervention||14||
59661067|NCT00846885|75779896|FG001|COMPLETED|First Intervention||14||
59661068|NCT00846885|75779895|FG000|NOT COMPLETED|First Intervention||0||
59661069|NCT00846885|75779896|FG001|NOT COMPLETED|First Intervention||0||
59661070|NCT00846885|75779895|FG000|STARTED|Washout of 7 Days||14||
59661071|NCT00846885|75779896|FG001|STARTED|Washout of 7 Days||14||
59661072|NCT00846885|75779895|FG000|COMPLETED|Washout of 7 Days||14||
59661073|NCT00846885|75779896|FG001|COMPLETED|Washout of 7 Days||14||
59661074|NCT00846885|75779895|FG000|NOT COMPLETED|Washout of 7 Days||0||
59661075|NCT00846885|75779896|FG001|NOT COMPLETED|Washout of 7 Days||0||
59661076|NCT00846885|75779895|FG000|STARTED|Second Intervention||14||
59815808|NCT03026283|75938218|FG007|COMPLETED|Optimal Care/Stress Test/ICA||0|Participants who followed recommendation provided after consultation with referring physician.|
59988916|NCT03689244|76104164|FG001|NOT COMPLETED|Open Label Period (Up to 20.8 Months)||0||
59544467|NCT02777372|75642889|FG001|COMPLETED|Overall Study||23||
59544468|NCT02777372|75642888|FG000|NOT COMPLETED|Overall Study||19||
59544469|NCT02777372|75642889|FG001|NOT COMPLETED|Overall Study||18||
59544470|NCT01622699|75642897|FG000|STARTED|Overall Study||213||
59544471|NCT01622699|75642898|FG001|STARTED|Overall Study||217||
59544472|NCT01622699|75642897|FG000|COMPLETED|Overall Study||213||
59544473|NCT01622699|75642898|FG001|COMPLETED|Overall Study||217||
59544474|NCT01622699|75642897|FG000|NOT COMPLETED|Overall Study||0||
59544475|NCT01622699|75642898|FG001|NOT COMPLETED|Overall Study||0||
59988917|NCT03689244|76104165|FG002|NOT COMPLETED|Open Label Period (Up to 20.8 Months)||9||
59544476|NCT01623323|75642904|FG000|STARTED|Overall Study||705||
59544477|NCT01623323|75642904|FG000|COMPLETED|Overall Study||601||
59544478|NCT01623323|75642904|FG000|NOT COMPLETED|Overall Study||104||
59661077|NCT00846885|75779896|FG001|STARTED|Second Intervention||14||
59661078|NCT00846885|75779895|FG000|COMPLETED|Second Intervention||14||
59661079|NCT00846885|75779896|FG001|COMPLETED|Second Intervention||14||
59661080|NCT00846885|75779895|FG000|NOT COMPLETED|Second Intervention||0||
59661081|NCT00846885|75779896|FG001|NOT COMPLETED|Second Intervention||0||
59661082|NCT00846651|75779902|FG000|STARTED|Overall Study||41||
59661083|NCT00846651|75779903|FG001|STARTED|Overall Study||41||
59661084|NCT00846651|75779902|FG000|COMPLETED|Overall Study||37||
59661085|NCT00846651|75779903|FG001|COMPLETED|Overall Study||37||
59661086|NCT00846651|75779902|FG000|NOT COMPLETED|Overall Study||4||
59661087|NCT00846651|75779903|FG001|NOT COMPLETED|Overall Study||4||
59661088|NCT00846573|75779914|FG000|STARTED|Overall Study||5||
59661089|NCT00846573|75779915|FG001|STARTED|Overall Study||2||
59661090|NCT00846573|75779916|FG002|STARTED|Overall Study||7||
59661091|NCT00846573|75779917|FG003|STARTED|Overall Study||0||
59661092|NCT00846573|75779914|FG000|COMPLETED|Overall Study||5||
59661093|NCT00846573|75779915|FG001|COMPLETED|Overall Study||2||
59661094|NCT00846573|75779916|FG002|COMPLETED|Overall Study||7||
59661095|NCT00846573|75779917|FG003|COMPLETED|Overall Study||0||
59661096|NCT00846573|75779914|FG000|NOT COMPLETED|Overall Study||0||
59661097|NCT00846573|75779915|FG001|NOT COMPLETED|Overall Study||0||
59661098|NCT00846573|75779916|FG002|NOT COMPLETED|Overall Study||0||
59661099|NCT00846573|75779917|FG003|NOT COMPLETED|Overall Study||0||
59661100|NCT00846066|75779927|FG000|STARTED|Overall Study||27||
59661101|NCT00846066|75779928|FG001|STARTED|Overall Study||29||
59661102|NCT00846066|75779927|FG000|COMPLETED|Overall Study||27||
59661103|NCT00846066|75779928|FG001|COMPLETED|Overall Study||29||
59661104|NCT00846066|75779927|FG000|NOT COMPLETED|Overall Study||0||
59661105|NCT00846066|75779928|FG001|NOT COMPLETED|Overall Study||0||
59544479|NCT01708967|75642910|FG000|STARTED|Overall Study||50||
59544480|NCT01708967|75642911|FG001|STARTED|Overall Study||50||
59544481|NCT01708967|75642910|FG000|COMPLETED|Overall Study||50||
59544482|NCT01708967|75642911|FG001|COMPLETED|Overall Study||43||
59544483|NCT01708967|75642910|FG000|NOT COMPLETED|Overall Study||0||
59661106|NCT00680628|75779937|FG000|STARTED|Overall Study||43||
59661107|NCT00680628|75779938|FG001|STARTED|Overall Study||40||
59661108|NCT00680628|75779937|FG000|COMPLETED|Overall Study||43||
59661109|NCT00680628|75779938|FG001|COMPLETED|Overall Study||40||
59661110|NCT00680628|75779937|FG000|NOT COMPLETED|Overall Study||0||
59661111|NCT00680628|75779938|FG001|NOT COMPLETED|Overall Study||0||
59661112|NCT00276861|75779944|FG000|STARTED|Overall Study||10||
59661113|NCT00276861|75779944|FG000|COMPLETED|Overall Study||10||
59661114|NCT00276861|75779944|FG000|NOT COMPLETED|Overall Study||0||
59661115|NCT00276549|75779949|FG000|STARTED|Overall Study||35||
59661116|NCT00276549|75779949|FG000|COMPLETED|Overall Study||35||
59661117|NCT00276549|75779949|FG000|NOT COMPLETED|Overall Study||0||
59661118|NCT00129480|75779955|FG000|STARTED|Overall Study||187||
59661119|NCT00129480|75779956|FG001|STARTED|Overall Study||214||
59661120|NCT00129480|75779955|FG000|COMPLETED|Overall Study||187||
59661121|NCT00129480|75779956|FG001|COMPLETED|Overall Study||214||
59661122|NCT00129480|75779955|FG000|NOT COMPLETED|Overall Study||0||
59661123|NCT00129480|75779956|FG001|NOT COMPLETED|Overall Study||0||
59661124|NCT00129441|75779964|FG000|STARTED|Overall Study||9||
59661125|NCT00129441|75779965|FG001|STARTED|Overall Study||6||
59661126|NCT00129441|75779964|FG000|Baseline, Visit 1|Overall Study|Baseline # only includes those who completed 4-week trial (one L-830982 subject did not complete).|9||
59661127|NCT00129441|75779965|FG001|Baseline, Visit 1|Overall Study||6||
59661128|NCT00129441|75779964|FG000|Week 1, Visit 2|Overall Study||9||
59661129|NCT00129441|75779965|FG001|Week 1, Visit 2|Overall Study||6||
59661130|NCT00129441|75779964|FG000|Week 2, Visit 3|Overall Study||9||
59661131|NCT00129441|75779965|FG001|Week 2, Visit 3|Overall Study||6||
59661132|NCT00129441|75779964|FG000|Week 3, Visit 4|Overall Study||9||
59661133|NCT00129441|75779965|FG001|Week 3, Visit 4|Overall Study||6||
59661134|NCT00129441|75779964|FG000|Week 4, Visit 5|Overall Study||9||
59661135|NCT00129441|75779965|FG001|Week 4, Visit 5|Overall Study||6||
59661136|NCT00129441|75779964|FG000|Week 5, Visit 6|Overall Study||9||
59661137|NCT00129441|75779965|FG001|Week 5, Visit 6|Overall Study||6||
59661138|NCT00129441|75779964|FG000|Week 26, Visit 7|Overall Study||9||
59661139|NCT00129441|75779965|FG001|Week 26, Visit 7|Overall Study||6||
59661140|NCT00129441|75779964|FG000|Year 1, Visit 8|Overall Study||9||
59661141|NCT00129441|75779965|FG001|Year 1, Visit 8|Overall Study||6||
59661142|NCT00129441|75779964|FG000|COMPLETED|Overall Study||9||
59661143|NCT00129441|75779965|FG001|COMPLETED|Overall Study||6||
59661144|NCT00129441|75779964|FG000|NOT COMPLETED|Overall Study||0||
59661145|NCT00129441|75779965|FG001|NOT COMPLETED|Overall Study||0||
59661146|NCT00129285|75779974|FG000|STARTED|Overall Study||65||
59661147|NCT00129285|75779975|FG001|STARTED|Overall Study||70||
59661148|NCT00129285|75779976|FG002|STARTED|Overall Study||75||
59661149|NCT00129285|75779974|FG000|COMPLETED|Overall Study||40||
59661150|NCT00129285|75779975|FG001|COMPLETED|Overall Study||43||
59661151|NCT00129285|75779976|FG002|COMPLETED|Overall Study||37||
59661152|NCT00129285|75779974|FG000|NOT COMPLETED|Overall Study||25||
59661153|NCT00129285|75779975|FG001|NOT COMPLETED|Overall Study||27||
59661154|NCT00129285|75779976|FG002|NOT COMPLETED|Overall Study||38||
59661155|NCT00129246|75779990|FG000|STARTED|Overall Study||20||
59661156|NCT00129246|75779991|FG001|STARTED|Overall Study||20||
59661157|NCT00129246|75779990|FG000|COMPLETED|Overall Study||20||
59661158|NCT00129246|75779991|FG001|COMPLETED|Overall Study||20||
59661159|NCT00129246|75779990|FG000|NOT COMPLETED|Overall Study||0||
59661160|NCT00129246|75779991|FG001|NOT COMPLETED|Overall Study||0||
59661161|NCT00142454|75779997|FG000|STARTED|Overall Study||9||
59661162|NCT00142454|75779997|FG000|COMPLETED|Overall Study||9||
59661163|NCT00142454|75779997|FG000|NOT COMPLETED|Overall Study||0||
59661164|NCT03959189|75780003|FG000|STARTED|Overall Study||7||
59661165|NCT03959189|75780004|FG001|STARTED|Overall Study||5||
59661166|NCT03959189|75780003|FG000|COMPLETED|Overall Study||7||
59661167|NCT03959189|75780004|FG001|COMPLETED|Overall Study||5||
59661168|NCT03959189|75780003|FG000|NOT COMPLETED|Overall Study||0||
59661169|NCT03959189|75780004|FG001|NOT COMPLETED|Overall Study||0||
59661170|NCT01349816|75780017|FG000|STARTED|Overall Study||185||
59661171|NCT01349816|75780017|FG000|GP MDI 36 µg|Overall Study||61||
59661172|NCT01349816|75780017|FG000|GFF MDI 36/7.2 µg|Overall Study||58||
59661173|NCT01349816|75780017|FG000|GFF MDI 36/9.6 µg|Overall Study||56||
59661174|NCT01349816|75780017|FG000|GFF MDI 18/9.6 µg|Overall Study||57||
59661175|NCT01349816|75780017|FG000|GFF MDI 9/9.6 µg|Overall Study||57||
59661176|NCT01349816|75780017|FG000|FF MDI 9.6 µg|Overall Study||61||
59661177|NCT01349816|75780017|FG000|COMPLETED|Overall Study||155||
59661178|NCT01349816|75780017|FG000|NOT COMPLETED|Overall Study||30||
59661179|NCT03152084|75780033|FG000|STARTED|Overall Study||17||
59661180|NCT03152084|75780034|FG001|STARTED|Overall Study||7||
59661181|NCT03152084|75780033|FG000|COMPLETED|Overall Study||17||
59661182|NCT03152084|75780034|FG001|COMPLETED|Overall Study||7||
59661183|NCT03152084|75780033|FG000|NOT COMPLETED|Overall Study||0||
59661184|NCT03152084|75780034|FG001|NOT COMPLETED|Overall Study||0||
59661185|NCT03151265|75780042|FG000|STARTED|Overall Study||20||
59661186|NCT03151265|75780043|FG001|STARTED|Overall Study||20||
59661187|NCT03151265|75780042|FG000|COMPLETED|Overall Study||20||
59661188|NCT03151265|75780043|FG001|COMPLETED|Overall Study||20||
59661189|NCT03151265|75780042|FG000|NOT COMPLETED|Overall Study||0||
59661190|NCT03151265|75780043|FG001|NOT COMPLETED|Overall Study||0||
59661191|NCT03150758|75780049|FG000|STARTED|Overall Study||6||
59661192|NCT03150758|75780049|FG000|COMPLETED|Overall Study||6||
59661193|NCT03150758|75780049|FG000|NOT COMPLETED|Overall Study||0||
59661194|NCT01807091|75780053|FG000|STARTED|Overall Study||17||
59661195|NCT01807091|75780053|FG000|COMPLETED|Overall Study||17||
59661196|NCT01807091|75780053|FG000|NOT COMPLETED|Overall Study||0||
59661197|NCT01806857|75780057|FG000|STARTED|Overall Study||31||
59661198|NCT01806857|75780058|FG001|STARTED|Overall Study||29||
59661199|NCT01806857|75780057|FG000|COMPLETED|Overall Study||30||
59661200|NCT01806857|75780058|FG001|COMPLETED|Overall Study||29||
59661201|NCT01806857|75780057|FG000|NOT COMPLETED|Overall Study||1||
59661202|NCT01806857|75780058|FG001|NOT COMPLETED|Overall Study||0||
59661203|NCT01805882|75780074|FG000|STARTED|Overall Study||20||
59661204|NCT01805882|75780075|FG001|STARTED|Overall Study||20||
59661205|NCT01805882|75780076|FG002|STARTED|Overall Study||20||
59661206|NCT01805882|75780077|FG003|STARTED|Overall Study||34||
59661207|NCT01805882|75780078|FG004|STARTED|Overall Study||14||
59661208|NCT01805882|75780079|FG005|STARTED|Overall Study||21||
59661209|NCT01805882|75780080|FG006|STARTED|Overall Study||50||
59661210|NCT01805882|75780081|FG007|STARTED|Overall Study||25||
59661211|NCT01805882|75780082|FG008|STARTED|Overall Study||25||
59661212|NCT01805882|75780074|FG000|COMPLETED|Overall Study||20||
59661213|NCT01805882|75780075|FG001|COMPLETED|Overall Study||20||
59661214|NCT01805882|75780076|FG002|COMPLETED|Overall Study||19||
59661215|NCT01805882|75780077|FG003|COMPLETED|Overall Study||32||
59661216|NCT01805882|75780078|FG004|COMPLETED|Overall Study||14||
59661217|NCT01805882|75780079|FG005|COMPLETED|Overall Study||20||
59661218|NCT01805882|75780080|FG006|COMPLETED|Overall Study||48||
59661219|NCT01805882|75780081|FG007|COMPLETED|Overall Study||25||
59661220|NCT01805882|75780082|FG008|COMPLETED|Overall Study||24||
59661221|NCT01805882|75780074|FG000|NOT COMPLETED|Overall Study||0||
59661222|NCT01805882|75780075|FG001|NOT COMPLETED|Overall Study||0||
59661223|NCT01805882|75780076|FG002|NOT COMPLETED|Overall Study||1||
59661224|NCT01805882|75780077|FG003|NOT COMPLETED|Overall Study||2||
59661225|NCT01805882|75780078|FG004|NOT COMPLETED|Overall Study||0||
59661226|NCT01805882|75780079|FG005|NOT COMPLETED|Overall Study||1||
59661227|NCT01805882|75780080|FG006|NOT COMPLETED|Overall Study||2||
59661228|NCT01805882|75780081|FG007|NOT COMPLETED|Overall Study||0||
59661229|NCT01805882|75780082|FG008|NOT COMPLETED|Overall Study||1||
59661230|NCT01805687|75780102|FG000|STARTED|Overall Study||25||
59661231|NCT01805687|75780102|FG000|COMPLETED|Overall Study||25||
59661232|NCT01805687|75780102|FG000|NOT COMPLETED|Overall Study||0||
59661233|NCT01466075|75780106|FG000|STARTED|Overall Study||207||
59661234|NCT01466075|75780106|FG000|COMPLETED|Overall Study||207||
59661235|NCT01466075|75780106|FG000|NOT COMPLETED|Overall Study||0||
59661236|NCT01465841|75780110|FG000|STARTED|Overall Study||517||
59661237|NCT01465841|75780110|FG000|COMPLETED|Overall Study||449||
59661238|NCT01465841|75780110|FG000|NOT COMPLETED|Overall Study||68||
59661239|NCT01465412|75780118|FG000|STARTED|Overall Study||12||
59661240|NCT01465412|75780119|FG001|STARTED|Overall Study||12||
59661241|NCT01465412|75780120|FG002|STARTED|Overall Study||9||
59661242|NCT01465412|75780121|FG003|STARTED|Overall Study||9||
59661243|NCT01465412|75780118|FG000|COMPLETED|Overall Study||12||
59661244|NCT01465412|75780119|FG001|COMPLETED|Overall Study||12||
59661245|NCT01465412|75780120|FG002|COMPLETED|Overall Study||9||
59661246|NCT01465412|75780121|FG003|COMPLETED|Overall Study||9||
59661247|NCT01465412|75780118|FG000|NOT COMPLETED|Overall Study||0||
59661248|NCT01465412|75780119|FG001|NOT COMPLETED|Overall Study||0||
59661249|NCT01465412|75780120|FG002|NOT COMPLETED|Overall Study||0||
59988918|NCT03689244|76104166|FG003|NOT COMPLETED|Open Label Period (Up to 20.8 Months)||6||
59988919|NCT03649074|76104176|FG000|STARTED|Overall Study||130||
59988920|NCT03649074|76104177|FG001|STARTED|Overall Study||76||
59988921|NCT03649074|76104176|FG000|COMPLETED|Overall Study||124|Completed study through Day 28|
59988922|NCT03649074|76104177|FG001|COMPLETED|Overall Study||71|Completed study through Day 28|
59661250|NCT01465412|75780121|FG003|NOT COMPLETED|Overall Study||0||
59661251|NCT00846482|75780131|FG000|STARTED|Overall Study||64||
59661252|NCT00846482|75780131|FG000|COMPLETED|Overall Study||54||
59661253|NCT00846482|75780131|FG000|NOT COMPLETED|Overall Study||10||
59661254|NCT00846287|75780138|FG000|STARTED|Overall Study||16||
59988923|NCT03649074|76104176|FG000|NOT COMPLETED|Overall Study||6||
59661255|NCT00846287|75780139|FG001|STARTED|Overall Study||15||
59661256|NCT00846287|75780138|FG000|COMPLETED|Overall Study||6||
59661257|NCT00846287|75780139|FG001|COMPLETED|Overall Study||10||
59661258|NCT00846287|75780138|FG000|NOT COMPLETED|Overall Study||10||
59661259|NCT00846287|75780139|FG001|NOT COMPLETED|Overall Study||5||
59988924|NCT03649074|76104177|FG001|NOT COMPLETED|Overall Study||5||
59661260|NCT00845975|75780147|FG000|STARTED|Overall Study||9||
59661261|NCT00845975|75780148|FG001|STARTED|Overall Study||9||
59661262|NCT00845975|75780147|FG000|COMPLETED|Overall Study||9||
59661263|NCT00845975|75780148|FG001|COMPLETED|Overall Study||9||
59661264|NCT00845975|75780147|FG000|NOT COMPLETED|Overall Study||0||
59661265|NCT00845975|75780148|FG001|NOT COMPLETED|Overall Study||0||
59661266|NCT00275834|75780157|FG000|STARTED|Overall Study||74||
59661267|NCT00275834|75780158|FG001|STARTED|Overall Study||76||
59661268|NCT00275834|75780159|FG002|STARTED|Overall Study||75||
59661269|NCT00275834|75780157|FG000|Completed Study While on Study Drug|Overall Study||54||
59661270|NCT00275834|75780158|FG001|Completed Study While on Study Drug|Overall Study||51||
59661271|NCT00275834|75780159|FG002|Completed Study While on Study Drug|Overall Study||62||
59661272|NCT00275834|75780157|FG000|COMPLETED|Overall Study||71||
59661273|NCT00275834|75780158|FG001|COMPLETED|Overall Study||73||
59661274|NCT00275834|75780159|FG002|COMPLETED|Overall Study||74||
59661275|NCT00275834|75780157|FG000|NOT COMPLETED|Overall Study||3||
59661276|NCT00275834|75780158|FG001|NOT COMPLETED|Overall Study||3||
59661277|NCT00275834|75780159|FG002|NOT COMPLETED|Overall Study||1||
59661278|NCT00129740|75780169|FG000|STARTED|Overall Study||148||
59661279|NCT00129740|75780169|FG000|COMPLETED|Overall Study||148||
59661280|NCT00129740|75780169|FG000|NOT COMPLETED|Overall Study||0||
59661281|NCT01568424|75780173|FG000|STARTED|Overall Study||25||
59661282|NCT01568424|75780173|FG000|COMPLETED|Overall Study||25||
59661283|NCT01568424|75780173|FG000|NOT COMPLETED|Overall Study||0||
59661284|NCT00128921|75780180|FG000|STARTED|Overall Study||10||
59661285|NCT00128921|75780181|FG001|STARTED|Overall Study||8||
59661286|NCT00128921|75780182|FG002|STARTED|Overall Study||0||
59661287|NCT00128921|75780180|FG000|Received Bortezomib|Overall Study||10||
59661288|NCT00128921|75780181|FG001|Received Bortezomib|Overall Study||6||
59661289|NCT00128921|75780182|FG002|Received Bortezomib|Overall Study||0||
59661290|NCT00128921|75780180|FG000|COMPLETED|Overall Study||5||
59661291|NCT00128921|75780181|FG001|COMPLETED|Overall Study||3||
59661292|NCT00128921|75780182|FG002|COMPLETED|Overall Study||0||
59661293|NCT00128921|75780180|FG000|NOT COMPLETED|Overall Study||5||
59661294|NCT00128921|75780181|FG001|NOT COMPLETED|Overall Study||5||
59661295|NCT00128921|75780182|FG002|NOT COMPLETED|Overall Study||0||
59661296|NCT05258721|75780192|FG000|STARTED|Overall Study||60||
59661297|NCT05258721|75780192|FG000|COMPLETED|Overall Study||52||
59661298|NCT05258721|75780192|FG000|NOT COMPLETED|Overall Study||8||
59661299|NCT05201807|75780196|FG000|STARTED|Overall Study||80||
59661300|NCT05201807|75780196|FG000|COMPLETED|Overall Study||78||
59661301|NCT05201807|75780196|FG000|NOT COMPLETED|Overall Study||2||
59661302|NCT04978337|75780202|FG000|STARTED|Overall Study||1||
59661303|NCT04978337|75780203|FG001|STARTED|Overall Study||4||
59661304|NCT04978337|75780202|FG000|COMPLETED|Overall Study||1||
59661305|NCT04978337|75780203|FG001|COMPLETED|Overall Study||3||
59661306|NCT04978337|75780202|FG000|NOT COMPLETED|Overall Study||0||
59661307|NCT04978337|75780203|FG001|NOT COMPLETED|Overall Study||1||
59661308|NCT04828707|75780212|FG000|STARTED|Overall Study|248 out of the 335 enrolled participants were eligible for randomization following the baseline phase. out of these 248 participants, 128 were randomized into the Nerivio Active group|128||
59661309|NCT04828707|75780213|FG001|STARTED|Overall Study|248 out of the 335 enrolled participants were eligible for randomization following the baseline phase. out of these 248 participants, 120 were randomized into the Nerivio Sham group|120||
59661310|NCT04828707|75780212|FG000|COMPLETED|Overall Study||123||
59661311|NCT04828707|75780213|FG001|COMPLETED|Overall Study||117||
59661312|NCT04828707|75780212|FG000|NOT COMPLETED|Overall Study||5||
59661313|NCT04828707|75780213|FG001|NOT COMPLETED|Overall Study||3||
59661314|NCT04629534|75780221|FG000|STARTED|Overall Study||4||
59661315|NCT04629534|75780222|FG001|STARTED|Overall Study||4||
59661316|NCT04629534|75780221|FG000|COMPLETED|Overall Study|An infant with withdrawal as they became ineligible due to physician discretion.|3||
59661317|NCT04629534|75780222|FG001|COMPLETED|Overall Study|A mother and infant dyad were removed as she stopped breast feeding and no longer met qualifications for this study|2||
59661318|NCT04629534|75780221|FG000|NOT COMPLETED|Overall Study||1||
59661319|NCT04629534|75780222|FG001|NOT COMPLETED|Overall Study||2||
59661320|NCT04573777|75780228|FG000|STARTED|Overall Study||10||
59988925|NCT03144232|76104185|FG000|STARTED|Overall Study||37||
59988926|NCT03144232|76104186|FG001|STARTED|Overall Study||35||
59988927|NCT03144232|76104185|FG000|COMPLETED|Overall Study||28||
59988928|NCT03144232|76104186|FG001|COMPLETED|Overall Study||23||
59988929|NCT03144232|76104185|FG000|NOT COMPLETED|Overall Study||9||
59988930|NCT03144232|76104186|FG001|NOT COMPLETED|Overall Study||12||
59988931|NCT02133573|76104194|FG000|STARTED|Overall Study||52||
59661321|NCT04573777|75780228|FG000|COMPLETED|Overall Study||0||
59661322|NCT04573777|75780228|FG000|NOT COMPLETED|Overall Study||10||
59661323|NCT04481191|75780234|FG000|STARTED|Overall Study||200||
59661324|NCT04481191|75780235|FG001|STARTED|Overall Study||200||
59661325|NCT04481191|75780234|FG000|≥1 V260 Vaccination|Overall Study||189||
59661326|NCT04481191|75780235|FG001|≥1 V260 Vaccination|Overall Study||200||
59661327|NCT04481191|75780234|FG000|COMPLETED|Overall Study||185||
59661328|NCT04481191|75780235|FG001|COMPLETED|Overall Study||190||
59661329|NCT04481191|75780234|FG000|NOT COMPLETED|Overall Study||15||
59661330|NCT04481191|75780235|FG001|NOT COMPLETED|Overall Study||10||
59661331|NCT04084483|75780245|FG000|STARTED|Overall Study||59||
59661332|NCT04084483|75780246|FG001|STARTED|Overall Study||59||
59661333|NCT04084483|75780247|FG002|STARTED|Overall Study||61||
59661334|NCT04084483|75780248|FG003|STARTED|Overall Study||59||
59988932|NCT02133573|76104195|FG001|STARTED|Overall Study||50||
59988933|NCT02133573|76104194|FG000|Dyads Allocated to Intervention|Overall Study||52||
59661335|NCT04084483|75780245|FG000|COMPLETED|Overall Study||56||
59661336|NCT04084483|75780246|FG001|COMPLETED|Overall Study||57||
59661337|NCT04084483|75780247|FG002|COMPLETED|Overall Study||59||
59661338|NCT04084483|75780248|FG003|COMPLETED|Overall Study||57||
59661339|NCT04084483|75780245|FG000|NOT COMPLETED|Overall Study||3||
59661340|NCT04084483|75780246|FG001|NOT COMPLETED|Overall Study||2||
59661341|NCT04084483|75780247|FG002|NOT COMPLETED|Overall Study||2||
59661342|NCT04084483|75780248|FG003|NOT COMPLETED|Overall Study||2||
59661343|NCT03695185|75780258|FG000|STARTED|Induction Period (Week 0 to Week 12)||42||
59661344|NCT03695185|75780258|FG000|COMPLETED|Induction Period (Week 0 to Week 12)||29||
59661345|NCT03695185|75780258|FG000|NOT COMPLETED|Induction Period (Week 0 to Week 12)||13||
59661346|NCT03695185|75780258|FG000|STARTED|Maintenance Period (Week 12 to Week 102)||29|Participants who completed the Induction Period and had a clinical response at Week 12 entered the Maintenance Period.|
59661347|NCT03695185|75780258|FG000|COMPLETED|Maintenance Period (Week 12 to Week 102)||1||
59661348|NCT03695185|75780258|FG000|NOT COMPLETED|Maintenance Period (Week 12 to Week 102)||28||
59661349|NCT03596164|75780265|FG000|STARTED|Overall Study||4||
59661350|NCT03596164|75780266|FG001|STARTED|Overall Study||7||
59661351|NCT03596164|75780265|FG000|COMPLETED|Overall Study||3||
59661352|NCT03596164|75780266|FG001|COMPLETED|Overall Study||6||
59661353|NCT03596164|75780265|FG000|NOT COMPLETED|Overall Study||1||
59661354|NCT03596164|75780266|FG001|NOT COMPLETED|Overall Study||1||
59661355|NCT02990468|75780277|FG000|STARTED|Phase 1: Dose Escalation||3||
59661356|NCT02990468|75780278|FG001|STARTED|Phase 1: Dose Escalation||3||
59661357|NCT02990468|75780279|FG002|STARTED|Phase 1: Dose Escalation||0||
59661358|NCT02990468|75780277|FG000|COMPLETED|Phase 1: Dose Escalation||3||
59661359|NCT02990468|75780278|FG001|COMPLETED|Phase 1: Dose Escalation||3||
59661360|NCT02990468|75780279|FG002|COMPLETED|Phase 1: Dose Escalation||0||
59661361|NCT02990468|75780277|FG000|NOT COMPLETED|Phase 1: Dose Escalation||0||
59661362|NCT02990468|75780278|FG001|NOT COMPLETED|Phase 1: Dose Escalation||0||
59661363|NCT02990468|75780279|FG002|NOT COMPLETED|Phase 1: Dose Escalation||0||
59661364|NCT02990468|75780277|FG000|STARTED|Phase 2: MTD||0||
59661365|NCT02990468|75780278|FG001|STARTED|Phase 2: MTD||0||
59661366|NCT02990468|75780279|FG002|STARTED|Phase 2: MTD||23||
59661367|NCT02990468|75780277|FG000|COMPLETED|Phase 2: MTD||0||
59661368|NCT02990468|75780278|FG001|COMPLETED|Phase 2: MTD||0||
59661369|NCT02990468|75780279|FG002|COMPLETED|Phase 2: MTD||22||
59661370|NCT02990468|75780277|FG000|NOT COMPLETED|Phase 2: MTD||0||
59661371|NCT02990468|75780278|FG001|NOT COMPLETED|Phase 2: MTD||0||
59661372|NCT02990468|75780279|FG002|NOT COMPLETED|Phase 2: MTD||1||
59661373|NCT02855944|75780289|FG000|STARTED|Period 1: Treatment||233||
59661374|NCT02855944|75780290|FG001|STARTED|Period 1: Treatment||116||
59988934|NCT02133573|76104195|FG001|Dyads Allocated to Intervention|Overall Study|One participant had a maternal adverse event prior to initiating the allocated intervention.|49||
59544484|NCT01708967|75642911|FG001|NOT COMPLETED|Overall Study||7||
59544485|NCT01709747|75642917|FG000|STARTED|Overall Study||364||
59544486|NCT01709747|75642917|FG000|COMPLETED|Overall Study||287||
59544487|NCT01709747|75642917|FG000|NOT COMPLETED|Overall Study||77||
59544488|NCT01662791|75642924|FG000|STARTED|Part 1 - Observational||8||
59544489|NCT01662791|75642925|FG001|STARTED|Part 1 - Observational||41||
59544490|NCT01662791|75642924|FG000|COMPLETED|Part 1 - Observational||8||
59544491|NCT01662791|75642925|FG001|COMPLETED|Part 1 - Observational||41||
59544492|NCT01662791|75642924|FG000|NOT COMPLETED|Part 1 - Observational||0||
59544493|NCT01662791|75642925|FG001|NOT COMPLETED|Part 1 - Observational||0||
59544494|NCT01662791|75642924|FG000|STARTED|Part 2 - Interventional||8||
59544495|NCT01662791|75642925|FG001|STARTED|Part 2 - Interventional|The Control Group did not take part in the second part of the study.|0||
59544496|NCT01662791|75642924|FG000|COMPLETED|Part 2 - Interventional||8||
59661375|NCT02855944|75780289|FG000|COMPLETED|Period 1: Treatment||218||
59661376|NCT02855944|75780290|FG001|COMPLETED|Period 1: Treatment||113||
59661377|NCT02855944|75780289|FG000|NOT COMPLETED|Period 1: Treatment||15||
59661378|NCT02855944|75780290|FG001|NOT COMPLETED|Period 1: Treatment||3||
59661379|NCT02855944|75780289|FG000|STARTED|Period 2: Crossover to Rucaparib||0||
59661380|NCT02855944|75780290|FG001|STARTED|Period 2: Crossover to Rucaparib||80||
59661381|NCT02855944|75780289|FG000|COMPLETED|Period 2: Crossover to Rucaparib||0||
59661382|NCT02855944|75780290|FG001|COMPLETED|Period 2: Crossover to Rucaparib||75||
59661383|NCT02855944|75780289|FG000|NOT COMPLETED|Period 2: Crossover to Rucaparib||0||
59661384|NCT02855944|75780290|FG001|NOT COMPLETED|Period 2: Crossover to Rucaparib||5||
59988935|NCT02133573|76104194|FG000|Number of Toddlers That Returned for 18 Month Follow Up Visit|Overall Study||45||
59988936|NCT02133573|76104195|FG001|Number of Toddlers That Returned for 18 Month Follow Up Visit|Overall Study||43||
59544497|NCT01662791|75642925|FG001|COMPLETED|Part 2 - Interventional||0||
59544498|NCT01662791|75642924|FG000|NOT COMPLETED|Part 2 - Interventional||0||
59544499|NCT01662791|75642925|FG001|NOT COMPLETED|Part 2 - Interventional||0||
59544500|NCT01663259|75642931|FG000|STARTED|Overall Study||42||
59661385|NCT02681055|75780297|FG000|STARTED|Weeks 1-4||19||
59661386|NCT02681055|75780297|FG000|COMPLETED|Weeks 1-4||19||
59661387|NCT02681055|75780297|FG000|NOT COMPLETED|Weeks 1-4||0||
59661388|NCT02681055|75780297|FG000|STARTED|Weeks 5-12||19||
59661389|NCT02681055|75780297|FG000|COMPLETED|Weeks 5-12||18||
59661390|NCT02681055|75780297|FG000|NOT COMPLETED|Weeks 5-12||1||
59661391|NCT02409342|75780304|FG000|STARTED|Overall Study||287||
59661392|NCT02409342|75780305|FG001|STARTED|Overall Study||285||
59661393|NCT02409342|75780304|FG000|COMPLETED|Overall Study||0||
59661394|NCT02409342|75780305|FG001|COMPLETED|Overall Study||0||
59661395|NCT02409342|75780304|FG000|NOT COMPLETED|Overall Study||287||
59661396|NCT02409342|75780305|FG001|NOT COMPLETED|Overall Study||285||
59661397|NCT02336503|75780317|FG000|STARTED|Overall Study||47||
59661398|NCT02336503|75780318|FG001|STARTED|Overall Study||48||
59661399|NCT02336503|75780319|FG002|STARTED|Overall Study||48||
59661400|NCT02336503|75780320|FG003|STARTED|Overall Study||46||
59661401|NCT02336503|75780317|FG000|COMPLETED|Overall Study||45||
59661402|NCT02336503|75780318|FG001|COMPLETED|Overall Study||45||
59661403|NCT02336503|75780319|FG002|COMPLETED|Overall Study||47||
59661404|NCT02336503|75780320|FG003|COMPLETED|Overall Study||40||
59661405|NCT02336503|75780317|FG000|NOT COMPLETED|Overall Study||2||
59661406|NCT02336503|75780318|FG001|NOT COMPLETED|Overall Study||3||
59661407|NCT02336503|75780319|FG002|NOT COMPLETED|Overall Study||1||
59661408|NCT02336503|75780320|FG003|NOT COMPLETED|Overall Study||6||
59661409|NCT02255409|75780336|FG000|STARTED|Overall Study||318||
59661410|NCT02255409|75780337|FG001|STARTED|Overall Study||289||
59661411|NCT02255409|75780336|FG000|COMPLETED|Overall Study||304||
59661412|NCT02255409|75780337|FG001|COMPLETED|Overall Study||258||
59661413|NCT02255409|75780336|FG000|NOT COMPLETED|Overall Study||14||
59661414|NCT02255409|75780337|FG001|NOT COMPLETED|Overall Study||31||
59661415|NCT02213757|75780350|FG000|STARTED|Overall Study||15||
59661416|NCT02213757|75780351|FG001|STARTED|Overall Study||14||
59661417|NCT02213757|75780350|FG000|COMPLETED|Overall Study||10||
59661418|NCT02213757|75780351|FG001|COMPLETED|Overall Study||10||
59661419|NCT02213757|75780350|FG000|NOT COMPLETED|Overall Study||5||
59661420|NCT02213757|75780351|FG001|NOT COMPLETED|Overall Study||4||
59661421|NCT00644189|75780357|FG000|STARTED|Phase I||3||
59661422|NCT00644189|75780358|FG001|STARTED|Phase I||3||
59661423|NCT00644189|75780359|FG002|STARTED|Phase I||6||
59661424|NCT00644189|75780360|FG003|STARTED|Phase I||18||
59661425|NCT00644189|75780357|FG000|COMPLETED|Phase I||3||
59661426|NCT00644189|75780358|FG001|COMPLETED|Phase I||3||
59661427|NCT00644189|75780359|FG002|COMPLETED|Phase I||6||
59661428|NCT00644189|75780360|FG003|COMPLETED|Phase I||18||
59661429|NCT00644189|75780357|FG000|NOT COMPLETED|Phase I||0||
59661430|NCT00644189|75780358|FG001|NOT COMPLETED|Phase I||0||
59661431|NCT00644189|75780359|FG002|NOT COMPLETED|Phase I||0||
59661432|NCT00644189|75780360|FG003|NOT COMPLETED|Phase I||0||
59661433|NCT00644189|75780357|FG000|STARTED|Phase II|All phase I participants were included in the 3mg Phase II dose group|0||
59661434|NCT00644189|75780358|FG001|STARTED|Phase II|All phase I participants were included in the 3mg Phase II dose group|0||
59661435|NCT00644189|75780359|FG002|STARTED|Phase II|All phase I participants were included in the 3mg Phase II dose group|0||
59661436|NCT00644189|75780360|FG003|STARTED|Phase II|Additional participants were added to the phase I sample at the phase II 3mg dose level|50||
59661437|NCT00644189|75780357|FG000|Completed All 6 Cycles of Treatment|Phase II||0||
59661438|NCT00644189|75780358|FG001|Completed All 6 Cycles of Treatment|Phase II||0||
59661439|NCT00644189|75780359|FG002|Completed All 6 Cycles of Treatment|Phase II||0||
59661440|NCT00644189|75780360|FG003|Completed All 6 Cycles of Treatment|Phase II||19||
59661441|NCT00644189|75780357|FG000|COMPLETED|Phase II||0||
59661442|NCT00644189|75780358|FG001|COMPLETED|Phase II||0||
59661443|NCT00644189|75780359|FG002|COMPLETED|Phase II||0||
59661444|NCT00644189|75780360|FG003|COMPLETED|Phase II||50||
59661445|NCT00644189|75780357|FG000|NOT COMPLETED|Phase II||0||
59661446|NCT00644189|75780358|FG001|NOT COMPLETED|Phase II||0||
59661447|NCT00644189|75780359|FG002|NOT COMPLETED|Phase II||0||
59661448|NCT00644189|75780360|FG003|NOT COMPLETED|Phase II||0||
59661449|NCT00630032|75780368|FG000|STARTED|Overall Study||398||
59661450|NCT00630032|75780369|FG001|STARTED|Overall Study||364||
59661451|NCT00630032|75780368|FG000|COMPLETED|Overall Study||308||
59661452|NCT00630032|75780369|FG001|COMPLETED|Overall Study||269||
59661453|NCT00630032|75780368|FG000|NOT COMPLETED|Overall Study||90||
59661454|NCT00630032|75780369|FG001|NOT COMPLETED|Overall Study||95||
59661455|NCT00465517|75780377|FG000|STARTED|Overall Study||98||
59661456|NCT00465517|75780378|FG001|STARTED|Overall Study||49||
59661457|NCT00465517|75780377|FG000|COMPLETED|Overall Study||86||
59661458|NCT00465517|75780378|FG001|COMPLETED|Overall Study||45||
59661459|NCT00465517|75780377|FG000|NOT COMPLETED|Overall Study||12||
59661460|NCT00465517|75780378|FG001|NOT COMPLETED|Overall Study||4||
59661461|NCT05050578|75780386|FG000|STARTED|Period 1, 30 Days||82||164
59661462|NCT05050578|75780387|FG001|STARTED|Period 1, 30 Days||80||160
59661463|NCT05050578|75780386|FG000|COMPLETED|Period 1, 30 Days||80||160
59661464|NCT05050578|75780387|FG001|COMPLETED|Period 1, 30 Days||79||158
59988937|NCT02133573|76104194|FG000|Number of Toddlers With Analyzed Primary Endpoint|Overall Study||43||
59661465|NCT05050578|75780386|FG000|NOT COMPLETED|Period 1, 30 Days||2||4
59661466|NCT05050578|75780387|FG001|NOT COMPLETED|Period 1, 30 Days||1||2
59661467|NCT05050578|75780386|FG000|STARTED|Period 2, 30 Days||80||160
59661468|NCT05050578|75780387|FG001|STARTED|Period 2, 30 Days||79||158
59661469|NCT05050578|75780386|FG000|COMPLETED|Period 2, 30 Days||80||160
59661470|NCT05050578|75780387|FG001|COMPLETED|Period 2, 30 Days||78||156
59661471|NCT05050578|75780386|FG000|NOT COMPLETED|Period 2, 30 Days||0||0
59661472|NCT05050578|75780387|FG001|NOT COMPLETED|Period 2, 30 Days||1||2
59661473|NCT04490278|75780396|FG000|STARTED|Overall Study||20||
59661474|NCT04490278|75780396|FG000|COMPLETED|Overall Study||14||
59661475|NCT04490278|75780396|FG000|NOT COMPLETED|Overall Study||6||
59661476|NCT04004221|75780400|FG000|STARTED|Overall Study||113||
59661477|NCT04004221|75780400|FG000|COMPLETED|Overall Study||0||
59661478|NCT04004221|75780400|FG000|NOT COMPLETED|Overall Study||113||
59661479|NCT03775512|75780406|FG000|STARTED|Overall Study||191||
59661480|NCT03775512|75780407|FG001|STARTED|Overall Study||92||
59661481|NCT03775512|75780406|FG000|Treated|Overall Study||177||
59661482|NCT03775512|75780407|FG001|Treated|Overall Study||87||
59661483|NCT03775512|75780406|FG000|COMPLETED|Overall Study||162||
59661484|NCT03775512|75780407|FG001|COMPLETED|Overall Study||75||
59661485|NCT03775512|75780406|FG000|NOT COMPLETED|Overall Study||29||
59661486|NCT03775512|75780407|FG001|NOT COMPLETED|Overall Study||17||
59661487|NCT03620747|75780413|FG000|STARTED|Overall Study||393||
59661488|NCT03620747|75780413|FG000|COMPLETED|Overall Study||374||
59661489|NCT03620747|75780413|FG000|NOT COMPLETED|Overall Study||19||
59661490|NCT03479307|75780420|FG000|STARTED|Overall Study||91||
59661491|NCT03479307|75780421|FG001|STARTED|Overall Study||90||
59661492|NCT03479307|75780422|FG002|STARTED|Overall Study||47||
59661493|NCT03479307|75780420|FG000|COMPLETED|Overall Study||90||
59661494|NCT03479307|75780421|FG001|COMPLETED|Overall Study||89||
59661495|NCT03479307|75780422|FG002|COMPLETED|Overall Study||47||
59661496|NCT03479307|75780420|FG000|NOT COMPLETED|Overall Study||1||
59661497|NCT03479307|75780421|FG001|NOT COMPLETED|Overall Study||1||
59661498|NCT03479307|75780422|FG002|NOT COMPLETED|Overall Study||0||
59661499|NCT03364036|75780430|FG000|STARTED|Overall Study||270||
59661500|NCT03364036|75780430|FG000|Full Analysis Set (FAS)|Overall Study||270||
59661501|NCT03364036|75780430|FG000|COMPLETED|Overall Study||270||
59661502|NCT03364036|75780430|FG000|NOT COMPLETED|Overall Study||0||
59661503|NCT03338790|75780438|FG000|STARTED|Overall Study||88|Started = Treated|
59661504|NCT03338790|75780439|FG001|STARTED|Overall Study||71|Started = Treated|
59661505|NCT03338790|75780440|FG002|STARTED|Overall Study||84|Started = Treated|
59661506|NCT03338790|75780441|FG003|STARTED|Overall Study||49|Started = Treated|
59661507|NCT03338790|75780438|FG000|COMPLETED|Overall Study||4|Completed = Continuing treatment|
59661508|NCT03338790|75780439|FG001|COMPLETED|Overall Study||4|Completed = Continuing treatment|
59661509|NCT03338790|75780440|FG002|COMPLETED|Overall Study||8|Completed = Continuing treatment|
59661510|NCT03338790|75780441|FG003|COMPLETED|Overall Study||4|Completed = Continuing treatment|
59988938|NCT02133573|76104195|FG001|Number of Toddlers With Analyzed Primary Endpoint|Overall Study||42||
59988939|NCT02133573|76104194|FG000|COMPLETED|Overall Study||43||
59988940|NCT02133573|76104195|FG001|COMPLETED|Overall Study||42||
59988941|NCT02133573|76104194|FG000|NOT COMPLETED|Overall Study||9||
59661511|NCT03338790|75780438|FG000|NOT COMPLETED|Overall Study||84||
59661512|NCT03338790|75780439|FG001|NOT COMPLETED|Overall Study||67||
59661513|NCT03338790|75780440|FG002|NOT COMPLETED|Overall Study||76||
59661514|NCT03338790|75780441|FG003|NOT COMPLETED|Overall Study||45||
59661515|NCT03231969|75780455|FG000|STARTED|Overall Study||30||
59661516|NCT03231969|75780456|FG001|STARTED|Overall Study||30||
59661517|NCT03231969|75780457|FG002|STARTED|Overall Study||31||
59661518|NCT03231969|75780458|FG003|STARTED|Overall Study||30||
59661519|NCT03231969|75780455|FG000|COMPLETED|Overall Study||28||
59661520|NCT03231969|75780456|FG001|COMPLETED|Overall Study||28||
59661521|NCT03231969|75780457|FG002|COMPLETED|Overall Study||30||
59661522|NCT03231969|75780458|FG003|COMPLETED|Overall Study||30||
59661523|NCT03231969|75780455|FG000|NOT COMPLETED|Overall Study||2||
59661524|NCT03231969|75780456|FG001|NOT COMPLETED|Overall Study||2||
59661525|NCT03231969|75780457|FG002|NOT COMPLETED|Overall Study||1||
59661526|NCT03231969|75780458|FG003|NOT COMPLETED|Overall Study||0||
59661527|NCT02954536|75780468|FG000|STARTED|Overall Study||37||
59661528|NCT02954536|75780468|FG000|COMPLETED|Overall Study||23||
59661529|NCT02954536|75780468|FG000|NOT COMPLETED|Overall Study||14||
59661530|NCT02919670|75780474|FG000|STARTED|Overall Study||49||
59661531|NCT02919670|75780475|FG001|STARTED|Overall Study||50||
59661532|NCT02919670|75780474|FG000|COMPLETED|Overall Study||6||
59661533|NCT02919670|75780475|FG001|COMPLETED|Overall Study||11||
59661534|NCT02919670|75780474|FG000|NOT COMPLETED|Overall Study||43||
59988942|NCT02133573|76104195|FG001|NOT COMPLETED|Overall Study||8||
59988943|NCT01917916|76104210|FG000|STARTED|Overall Study||12||
59544501|NCT01663259|75642931|FG000|COMPLETED|Overall Study||42||
59661535|NCT02919670|75780475|FG001|NOT COMPLETED|Overall Study||39||
59661536|NCT02776644|75780488|FG000|STARTED|Overall Study||1223||
59661537|NCT02776644|75780489|FG001|STARTED|Overall Study||126||
59661538|NCT02776644|75780488|FG000|COMPLETED|Overall Study||1223||
59661539|NCT02776644|75780489|FG001|COMPLETED|Overall Study||126||
59544502|NCT01663259|75642931|FG000|NOT COMPLETED|Overall Study||0||
59544503|NCT01664117|75642935|FG000|STARTED|Overall Study||209||
59544504|NCT01664117|75642935|FG000|COMPLETED|Overall Study||209||
59544505|NCT01664117|75642935|FG000|NOT COMPLETED|Overall Study||0||
59544506|NCT02238977|75642944|FG000|STARTED|Overall Study||0||
59544507|NCT02238977|75642945|FG001|STARTED|Overall Study||1||
59544508|NCT02238977|75642944|FG000|COMPLETED|Overall Study||0||
59544509|NCT02238977|75642945|FG001|COMPLETED|Overall Study||1||
59544510|NCT02238977|75642944|FG000|NOT COMPLETED|Overall Study||0||
59544511|NCT02238977|75642945|FG001|NOT COMPLETED|Overall Study||0||
59544512|NCT00945854|75642953|FG000|STARTED|Overall Study||30||
59544513|NCT00945854|75642954|FG001|STARTED|Overall Study||30||
59661540|NCT02776644|75780488|FG000|NOT COMPLETED|Overall Study||0||
59661541|NCT02776644|75780489|FG001|NOT COMPLETED|Overall Study||0||
59661542|NCT02278250|75780513|FG000|STARTED|Overall Study||2||
59661543|NCT02278250|75780514|FG001|STARTED|Overall Study||1||
59661544|NCT02278250|75780515|FG002|STARTED|Overall Study||2||
59661545|NCT02278250|75780516|FG003|STARTED|Overall Study||1||
59661546|NCT02278250|75780517|FG004|STARTED|Overall Study||1||
59661547|NCT02278250|75780518|FG005|STARTED|Overall Study||2||
59661548|NCT02278250|75780519|FG006|STARTED|Overall Study||4||
59661549|NCT02278250|75780520|FG007|STARTED|Overall Study||12||
59661550|NCT02278250|75780521|FG008|STARTED|Overall Study||10||
59661551|NCT02278250|75780522|FG009|STARTED|Overall Study||7||
59661552|NCT02278250|75780523|FG010|STARTED|Overall Study||7||
59661553|NCT02278250|75780524|FG011|STARTED|Overall Study||5||
59661554|NCT02278250|75780525|FG012|STARTED|Overall Study||7||
59661555|NCT02278250|75780526|FG013|STARTED|Overall Study||7||
59661556|NCT02278250|75780527|FG014|STARTED|Overall Study||3||
59661557|NCT02278250|75780528|FG015|STARTED|Overall Study||7||
59661558|NCT02278250|75780529|FG016|STARTED|Overall Study||6||
59661559|NCT02278250|75780530|FG017|STARTED|Overall Study||13||
59661560|NCT02278250|75780513|FG000|COMPLETED|Overall Study||2||
59661561|NCT02278250|75780514|FG001|COMPLETED|Overall Study||1||
59661562|NCT02278250|75780515|FG002|COMPLETED|Overall Study||2||
59661563|NCT02278250|75780516|FG003|COMPLETED|Overall Study||1||
59661564|NCT02278250|75780517|FG004|COMPLETED|Overall Study||1||
59661565|NCT02278250|75780518|FG005|COMPLETED|Overall Study||2||
59661566|NCT02278250|75780519|FG006|COMPLETED|Overall Study||4||
59661567|NCT02278250|75780520|FG007|COMPLETED|Overall Study||12||
59661568|NCT02278250|75780521|FG008|COMPLETED|Overall Study||10||
59661569|NCT02278250|75780522|FG009|COMPLETED|Overall Study||7||
59661570|NCT02278250|75780523|FG010|COMPLETED|Overall Study||7||
59661571|NCT02278250|75780524|FG011|COMPLETED|Overall Study||5||
59661572|NCT02278250|75780525|FG012|COMPLETED|Overall Study||7||
59988944|NCT01917916|76104211|FG001|STARTED|Overall Study||12||
59988945|NCT01917916|76104212|FG002|STARTED|Overall Study||12||
59988946|NCT01917916|76104213|FG003|STARTED|Overall Study||12||
59988947|NCT01917916|76104214|FG004|STARTED|Overall Study||16||
59544514|NCT00945854|75642953|FG000|COMPLETED|Overall Study||28||
59544515|NCT00945854|75642954|FG001|COMPLETED|Overall Study||26||
59544516|NCT00945854|75642953|FG000|NOT COMPLETED|Overall Study||2||
59544517|NCT00945854|75642954|FG001|NOT COMPLETED|Overall Study||4||
59661573|NCT02278250|75780526|FG013|COMPLETED|Overall Study||7||
59661574|NCT02278250|75780527|FG014|COMPLETED|Overall Study||3||
59661575|NCT02278250|75780528|FG015|COMPLETED|Overall Study||7||
59661576|NCT02278250|75780529|FG016|COMPLETED|Overall Study||6||
59544518|NCT02239289|75642960|FG000|STARTED|Overall Study||21||
59544519|NCT02239289|75642960|FG000|COMPLETED|Overall Study||21||
59544520|NCT02239289|75642960|FG000|NOT COMPLETED|Overall Study||0||
59661577|NCT02278250|75780530|FG017|COMPLETED|Overall Study||13||
59661578|NCT02278250|75780513|FG000|NOT COMPLETED|Overall Study||0||
59661579|NCT02278250|75780514|FG001|NOT COMPLETED|Overall Study||0||
59661580|NCT02278250|75780515|FG002|NOT COMPLETED|Overall Study||0||
59661581|NCT02278250|75780516|FG003|NOT COMPLETED|Overall Study||0||
59988948|NCT01917916|76104210|FG000|COMPLETED|Overall Study||12||
59988949|NCT01917916|76104211|FG001|COMPLETED|Overall Study||12||
59988950|NCT01917916|76104212|FG002|COMPLETED|Overall Study||12||
59988951|NCT01917916|76104213|FG003|COMPLETED|Overall Study||12||
59988952|NCT01917916|76104214|FG004|COMPLETED|Overall Study||16||
59988953|NCT01917916|76104210|FG000|NOT COMPLETED|Overall Study||0||
59988954|NCT01917916|76104211|FG001|NOT COMPLETED|Overall Study||0||
59988955|NCT01917916|76104212|FG002|NOT COMPLETED|Overall Study||0||
59988956|NCT01917916|76104213|FG003|NOT COMPLETED|Overall Study||0||
59988957|NCT01917916|76104214|FG004|NOT COMPLETED|Overall Study||0||
59988958|NCT00765765|76104226|FG000|STARTED|Overall Study||6||
59988959|NCT00765765|76104226|FG000|COMPLETED|Overall Study||6||
59544521|NCT01664741|75642967|FG000|STARTED|Overall Study||6||
59661582|NCT02278250|75780517|FG004|NOT COMPLETED|Overall Study||0||
59988960|NCT00765765|76104226|FG000|NOT COMPLETED|Overall Study||0||
59661583|NCT02278250|75780518|FG005|NOT COMPLETED|Overall Study||0||
59661584|NCT02278250|75780519|FG006|NOT COMPLETED|Overall Study||0||
59661585|NCT02278250|75780520|FG007|NOT COMPLETED|Overall Study||0||
59661586|NCT02278250|75780521|FG008|NOT COMPLETED|Overall Study||0||
59544522|NCT01664741|75642968|FG001|STARTED|Overall Study||6||
59544523|NCT01664741|75642969|FG002|STARTED|Overall Study||13||
59544524|NCT01664741|75642967|FG000|COMPLETED|Overall Study||6||
59661587|NCT02278250|75780522|FG009|NOT COMPLETED|Overall Study||0||
59661588|NCT02278250|75780523|FG010|NOT COMPLETED|Overall Study||0||
59661589|NCT02278250|75780524|FG011|NOT COMPLETED|Overall Study||0||
59661590|NCT02278250|75780525|FG012|NOT COMPLETED|Overall Study||0||
59661591|NCT02278250|75780526|FG013|NOT COMPLETED|Overall Study||0||
59661592|NCT02278250|75780527|FG014|NOT COMPLETED|Overall Study||0||
59661593|NCT02278250|75780528|FG015|NOT COMPLETED|Overall Study||0||
59661594|NCT02278250|75780529|FG016|NOT COMPLETED|Overall Study||0||
59661595|NCT02278250|75780530|FG017|NOT COMPLETED|Overall Study||0||
59661596|NCT02250326|75780574|FG000|STARTED|Treatment Period||81||
59988961|NCT00686595|76104230|FG000|STARTED|Overall Study||38||
59661597|NCT02250326|75780575|FG001|STARTED|Treatment Period||79||
59661598|NCT02250326|75780576|FG002|STARTED|Treatment Period||80||
59661599|NCT02250326|75780574|FG000|Treated Population|Treatment Period||79||
59661600|NCT02250326|75780575|FG001|Treated Population|Treatment Period||78||
59661601|NCT02250326|75780576|FG002|Treated Population|Treatment Period||79||
59661602|NCT02250326|75780574|FG000|COMPLETED|Treatment Period|Data Cut-off Date = 30 August 2017|0|Completed = Participants still on treatment at the end of the time of the data cut-off date.|
59661603|NCT02250326|75780575|FG001|COMPLETED|Treatment Period|Data Cut-off Date = 23 December 2017|15|Completed = Participants still on treatment at the end of the time of the data cut-off date.|
59661604|NCT02250326|75780576|FG002|COMPLETED|Treatment Period|Data Cut-off Date = 30 August 2017|3|Completed = Participants still on treatment at the end of the time of the data cut-off date.|
59661605|NCT02250326|75780574|FG000|NOT COMPLETED|Treatment Period||81||
59661606|NCT02250326|75780575|FG001|NOT COMPLETED|Treatment Period||64||
59661607|NCT02250326|75780576|FG002|NOT COMPLETED|Treatment Period||77||
59661608|NCT02250326|75780574|FG000|STARTED|Follow-Up Period||67||
59661609|NCT02250326|75780575|FG001|STARTED|Follow-Up Period||43||
59661610|NCT02250326|75780576|FG002|STARTED|Follow-Up Period||64||
59661611|NCT02250326|75780574|FG000|COMPLETED|Follow-Up Period||18|Completed = Participants in follow-up at the time of data cut-off date|
59661612|NCT02250326|75780575|FG001|COMPLETED|Follow-Up Period||13|Completed = Participants in follow-up at the time of data cut-off date|
59661613|NCT02250326|75780576|FG002|COMPLETED|Follow-Up Period||26|Completed = Participants in follow-up at the time of data cut-off date|
59661614|NCT02250326|75780574|FG000|NOT COMPLETED|Follow-Up Period||49||
59661615|NCT02250326|75780575|FG001|NOT COMPLETED|Follow-Up Period||30||
59661616|NCT02250326|75780576|FG002|NOT COMPLETED|Follow-Up Period||38||
59661617|NCT01567722|75780588|FG000|STARTED|Overall Study||93||
59661618|NCT01567722|75780589|FG001|STARTED|Overall Study||19||
59661619|NCT01567722|75780590|FG002|STARTED|Overall Study||2||
59661620|NCT01567722|75780588|FG000|COMPLETED|Overall Study||87||
59661621|NCT01567722|75780589|FG001|COMPLETED|Overall Study||19||
59661622|NCT01567722|75780590|FG002|COMPLETED|Overall Study||2||
59661623|NCT01567722|75780588|FG000|NOT COMPLETED|Overall Study||6||
59661624|NCT01567722|75780589|FG001|NOT COMPLETED|Overall Study||0||
59661625|NCT01567722|75780590|FG002|NOT COMPLETED|Overall Study||0||
59661626|NCT00070070|75780602|FG000|STARTED|Overall Study||1||
59661627|NCT00070070|75780603|FG001|STARTED|Overall Study||0||
59661628|NCT00070070|75780604|FG002|STARTED|Overall Study||0||
59661629|NCT00070070|75780605|FG003|STARTED|Overall Study||5||
59661630|NCT00070070|75780602|FG000|COMPLETED|Overall Study||1||
59661631|NCT00070070|75780603|FG001|COMPLETED|Overall Study||0||
59661632|NCT00070070|75780604|FG002|COMPLETED|Overall Study||0||
59661633|NCT00070070|75780605|FG003|COMPLETED|Overall Study||5||
59661634|NCT00070070|75780602|FG000|NOT COMPLETED|Overall Study||0||
59661635|NCT00070070|75780603|FG001|NOT COMPLETED|Overall Study||0||
59661636|NCT00070070|75780604|FG002|NOT COMPLETED|Overall Study||0||
59661637|NCT00070070|75780605|FG003|NOT COMPLETED|Overall Study||0||
59661638|NCT01349790|75780615|FG000|STARTED|Overall Study||40||
59661639|NCT01349790|75780615|FG000|COMPLETED|Overall Study||31||
59661640|NCT01349790|75780615|FG000|NOT COMPLETED|Overall Study||9||
59661641|NCT01349595|75780621|FG000|STARTED|Overall Study||2||
59661642|NCT01349595|75780622|FG001|STARTED|Overall Study||2||
59661643|NCT01349595|75780621|FG000|COMPLETED|Overall Study||0||
59661644|NCT01349595|75780622|FG001|COMPLETED|Overall Study||0||
59661645|NCT01349595|75780621|FG000|NOT COMPLETED|Overall Study||2||
59661646|NCT01349595|75780622|FG001|NOT COMPLETED|Overall Study||2||
59661647|NCT04941521|75780628|FG000|STARTED|Overall Study||3||
59661648|NCT04941521|75780628|FG000|COMPLETED|Overall Study||3||
59661649|NCT04941521|75780628|FG000|NOT COMPLETED|Overall Study||0||
59661650|NCT01349673|75780632|FG000|STARTED|Overall Study||114||
59988962|NCT00686595|76104230|FG000|COMPLETED|Overall Study||31||
59988963|NCT00686595|76104230|FG000|NOT COMPLETED|Overall Study||7||
59988964|NCT00640159|76104234|FG000|STARTED|Overall Study||48||
59988965|NCT00640159|76104234|FG000|Patients Who Preferred Zydis Selegiline|Overall Study||25||
59988966|NCT00640159|76104234|FG000|Patients Who Preferred Oral Selegiline|Overall Study||13||
59988967|NCT00640159|76104234|FG000|Patients Who Had no Specific Preferred Medication|Overall Study||10||
59988968|NCT00640159|76104234|FG000|COMPLETED|Overall Study||46||
59988969|NCT00640159|76104234|FG000|NOT COMPLETED|Overall Study||2||
59988970|NCT02262754|76104244|FG000|STARTED|Overall Study||74||
59988971|NCT02262754|76104245|FG001|STARTED|Overall Study||74||
59988972|NCT02262754|76104246|FG002|STARTED|Overall Study||74||
59988973|NCT02262754|76104244|FG000|COMPLETED|Overall Study||58||
59661651|NCT01349673|75780632|FG000|Participants Entered Cycle 1|Overall Study||114||
59661652|NCT01349673|75780632|FG000|Participants Entered Cycle 2|Overall Study||65||
59661653|NCT01349673|75780632|FG000|Participants Entered Cycle 3|Overall Study||41||
59661654|NCT01349673|75780632|FG000|Participants Entered Cycle 4|Overall Study||22||
59661655|NCT01349673|75780632|FG000|Participants Entered Cycle 5|Overall Study||12||
59661656|NCT01349673|75780632|FG000|Participants Entered Cycle 6|Overall Study||5||
59661657|NCT01349673|75780632|FG000|Participants Entered Cycle 7|Overall Study||3||
59661658|NCT01349673|75780632|FG000|Participants Entered Cycle 8|Overall Study||1||
59661659|NCT01349673|75780632|FG000|Received At Least 1 Dose Of Study Drug|Overall Study||114||
59988974|NCT02262754|76104245|FG001|COMPLETED|Overall Study||65||
59661660|NCT01349673|75780632|FG000|COMPLETED|Overall Study||0||
59661661|NCT01349673|75780632|FG000|NOT COMPLETED|Overall Study||114||
59661662|NCT02396342|75780638|FG000|STARTED|Overall Study||5||
59661663|NCT02396342|75780639|FG001|STARTED|Overall Study||5||
59661664|NCT02396342|75780638|FG000|COMPLETED|Overall Study||5||
59661665|NCT02396342|75780639|FG001|COMPLETED|Overall Study||5||
59661666|NCT02396342|75780638|FG000|NOT COMPLETED|Overall Study||0||
59661667|NCT02396342|75780639|FG001|NOT COMPLETED|Overall Study||0||
59661668|NCT00121472|75780645|FG000|STARTED|Overall Study||194||
59661669|NCT00121472|75780645|FG000|COMPLETED|Overall Study|Followed for at least 1 year after implantation of HM II LVAS.|194||
59661670|NCT00121472|75780645|FG000|NOT COMPLETED|Overall Study||0||
59661671|NCT04065451|75780655|FG000|STARTED|Overall Study||10||
59661672|NCT04065451|75780656|FG001|STARTED|Overall Study||10||
59661673|NCT04065451|75780655|FG000|COMPLETED|Overall Study||10||
59661674|NCT04065451|75780656|FG001|COMPLETED|Overall Study||10||
59661675|NCT04065451|75780655|FG000|NOT COMPLETED|Overall Study||0||
59661676|NCT04065451|75780656|FG001|NOT COMPLETED|Overall Study||0||
59661677|NCT04725682|75780662|FG000|STARTED|Overall Study||33||
59661678|NCT04725682|75780663|FG001|STARTED|Overall Study||34||
59661679|NCT04725682|75780662|FG000|COMPLETED|Overall Study||23||
59661680|NCT04725682|75780663|FG001|COMPLETED|Overall Study||26||
59661681|NCT04725682|75780662|FG000|NOT COMPLETED|Overall Study||10||
59661682|NCT04725682|75780663|FG001|NOT COMPLETED|Overall Study||8||
59661683|NCT04063761|75780669|FG000|STARTED|Overall Study||20||
59661684|NCT04063761|75780669|FG000|COMPLETED|Overall Study||20||
59661685|NCT04063761|75780669|FG000|NOT COMPLETED|Overall Study||0||
59661686|NCT02910726|75780673|FG000|STARTED|Overall Study||6||
59661687|NCT02910726|75780673|FG000|COMPLETED|Overall Study||6||
59661688|NCT02910726|75780673|FG000|NOT COMPLETED|Overall Study||0||
59661689|NCT04728594|75780680|FG000|STARTED|Overall Study|The number of participants who were sent a follow up email (delayed, three days after the other two arms) was used to see how many started.|3178|Participants who were sent an email.|
59661690|NCT04728594|75780681|FG001|STARTED|Overall Study||3198|Participants who were sent an email.|
59661691|NCT04728594|75780682|FG002|STARTED|Overall Study||3190|Participants who were sent an email.|
59661692|NCT04728594|75780680|FG000|COMPLETED|Overall Study||3178|Participants who were sent an email were also considered as those who completed the study, as inaction is a possible response to the intervention|
59661693|NCT04728594|75780681|FG001|COMPLETED|Overall Study||3198|Participants who were sent an email were also considered as those who completed the study, as inaction is a possible response to the intervention|
59661694|NCT04728594|75780682|FG002|COMPLETED|Overall Study||3190|Participants who were sent an email were also considered as those who completed the study, as inaction is a possible response to the intervention|
59661695|NCT04728594|75780680|FG000|NOT COMPLETED|Overall Study||0||
59661696|NCT04728594|75780681|FG001|NOT COMPLETED|Overall Study||0||
59661697|NCT04728594|75780682|FG002|NOT COMPLETED|Overall Study||0||
59661698|NCT01349660|75780695|FG000|STARTED|Overall Study||6||
59661699|NCT01349660|75780696|FG001|STARTED|Overall Study||6||
59661700|NCT01349660|75780697|FG002|STARTED|Overall Study||76||
59661701|NCT01349660|75780695|FG000|COMPLETED|Overall Study||0||
59661702|NCT01349660|75780696|FG001|COMPLETED|Overall Study||0||
59661703|NCT01349660|75780697|FG002|COMPLETED|Overall Study||0||
59661704|NCT01349660|75780695|FG000|NOT COMPLETED|Overall Study||6||
59661705|NCT01349660|75780696|FG001|NOT COMPLETED|Overall Study||6||
59661706|NCT01349660|75780697|FG002|NOT COMPLETED|Overall Study||76||
59661707|NCT04709068|75780712|FG000|STARTED|Overall Study||8||
59661708|NCT04709068|75780712|FG000|COMPLETED|Overall Study||8||
59661709|NCT04709068|75780712|FG000|NOT COMPLETED|Overall Study||0||
59661710|NCT01349569|75780716|FG000|STARTED|Overall Study||16||
59661711|NCT01349569|75780716|FG000|COMPLETED|Overall Study||12||
59661712|NCT01349569|75780716|FG000|NOT COMPLETED|Overall Study||4||
59661713|NCT00275392|75780725|FG000|STARTED|Overall Study||20||
59661714|NCT00275392|75780726|FG001|STARTED|Overall Study||19||
59661715|NCT00275392|75780725|FG000|COMPLETED|Overall Study||20||
59661716|NCT00275392|75780726|FG001|COMPLETED|Overall Study||17||
59661717|NCT00275392|75780725|FG000|NOT COMPLETED|Overall Study||0||
59661718|NCT00275392|75780726|FG001|NOT COMPLETED|Overall Study||2||
59661719|NCT00275275|75780735|FG000|STARTED|Overall Study||20||
59661720|NCT00275275|75780736|FG001|STARTED|Overall Study||20||
59661721|NCT00275275|75780737|FG002|STARTED|Overall Study|One participant was removed after enrollment and before any data was collected for him.|21||
59661722|NCT00275275|75780735|FG000|COMPLETED|Overall Study||14||
59661723|NCT00275275|75780736|FG001|COMPLETED|Overall Study||18||
59661724|NCT00275275|75780737|FG002|COMPLETED|Overall Study||15||
59661725|NCT00275275|75780735|FG000|NOT COMPLETED|Overall Study||6||
59661726|NCT00275275|75780736|FG001|NOT COMPLETED|Overall Study||2||
59661727|NCT00275275|75780737|FG002|NOT COMPLETED|Overall Study||6||
59661728|NCT00130117|75780747|FG000|STARTED|Overall Study||11||
59661729|NCT00130117|75780748|FG001|STARTED|Overall Study||9||
59661730|NCT00130117|75780747|FG000|COMPLETED|Overall Study||7||
59661731|NCT00130117|75780748|FG001|COMPLETED|Overall Study||6||
59661732|NCT00130117|75780747|FG000|NOT COMPLETED|Overall Study||4||
59661733|NCT00130117|75780748|FG001|NOT COMPLETED|Overall Study||3||
59661734|NCT00129727|75780755|FG000|STARTED|Overall Study||62||
59661735|NCT00129727|75780755|FG000|COMPLETED|Overall Study||57||
59661736|NCT00129727|75780755|FG000|NOT COMPLETED|Overall Study||5||
59661737|NCT05226104|75780759|FG000|STARTED|Overall Study||27||
59661738|NCT05226104|75780759|FG000|COMPLETED|Overall Study||24||
59661739|NCT05226104|75780759|FG000|NOT COMPLETED|Overall Study||3||
59661740|NCT05221749|75780767|FG000|STARTED|Overall Study||25||
59661741|NCT05221749|75780768|FG001|STARTED|Overall Study||25||
59661742|NCT05221749|75780767|FG000|COMPLETED|Overall Study||23||
59661743|NCT05221749|75780768|FG001|COMPLETED|Overall Study||22||
59661744|NCT05221749|75780767|FG000|NOT COMPLETED|Overall Study||2||
59661745|NCT05221749|75780768|FG001|NOT COMPLETED|Overall Study||3||
59661746|NCT05085613|75780780|FG000|STARTED|Overall Study||27||
59661747|NCT05085613|75780781|FG001|STARTED|Overall Study||27||
59661748|NCT05085613|75780782|FG002|STARTED|Overall Study||24||
59661749|NCT05085613|75780783|FG003|STARTED|Overall Study||22||
59661750|NCT05085613|75780780|FG000|COMPLETED|Overall Study||27||
59661751|NCT05085613|75780781|FG001|COMPLETED|Overall Study||27||
59661752|NCT05085613|75780782|FG002|COMPLETED|Overall Study||24||
59661753|NCT05085613|75780783|FG003|COMPLETED|Overall Study||22||
59661754|NCT05085613|75780780|FG000|NOT COMPLETED|Overall Study||0||
59661755|NCT05085613|75780781|FG001|NOT COMPLETED|Overall Study||0||
59661756|NCT05085613|75780782|FG002|NOT COMPLETED|Overall Study||0||
59661757|NCT05085613|75780783|FG003|NOT COMPLETED|Overall Study||0||
59661758|NCT05074173|75780793|FG000|STARTED|Overall Study||36||
59661759|NCT05074173|75780793|FG000|COMPLETED|Overall Study||36||
59661760|NCT05074173|75780793|FG000|NOT COMPLETED|Overall Study||0||
59661761|NCT05063734|75780799|FG000|STARTED|Overall Study||7||
59661762|NCT05063734|75780800|FG001|STARTED|Overall Study||9||
59661763|NCT05063734|75780799|FG000|COMPLETED|Overall Study||6||
59661764|NCT05063734|75780800|FG001|COMPLETED|Overall Study||9||
59661765|NCT05063734|75780799|FG000|NOT COMPLETED|Overall Study||1||
59661766|NCT05063734|75780800|FG001|NOT COMPLETED|Overall Study||0||
59661767|NCT05040295|75780808|FG000|STARTED|Period 1||6||
59661768|NCT05040295|75780809|FG001|STARTED|Period 1||6||
59661769|NCT05040295|75780808|FG000|COMPLETED|Period 1||6||
59661770|NCT05040295|75780809|FG001|COMPLETED|Period 1||6||
59661771|NCT05040295|75780808|FG000|NOT COMPLETED|Period 1||0||
59544525|NCT01664741|75642968|FG001|COMPLETED|Overall Study||6||
59544526|NCT01664741|75642969|FG002|COMPLETED|Overall Study||13||
59544527|NCT01664741|75642967|FG000|NOT COMPLETED|Overall Study||0||
59544528|NCT01664741|75642968|FG001|NOT COMPLETED|Overall Study||0||
59544529|NCT01664741|75642969|FG002|NOT COMPLETED|Overall Study||0||
59544530|NCT01664897|75642976|FG000|STARTED|Overall Study||29||
59661772|NCT05040295|75780809|FG001|NOT COMPLETED|Period 1||0||
59661773|NCT05040295|75780808|FG000|STARTED|Period 2||6||
59661774|NCT05040295|75780809|FG001|STARTED|Period 2||6||
59661775|NCT05040295|75780808|FG000|COMPLETED|Period 2||6||
59661776|NCT05040295|75780809|FG001|COMPLETED|Period 2||6||
59661777|NCT05040295|75780808|FG000|NOT COMPLETED|Period 2||0||
59661778|NCT05040295|75780809|FG001|NOT COMPLETED|Period 2||0||
59661779|NCT05040295|75780808|FG000|STARTED|Period 3||6||
59661780|NCT05040295|75780809|FG001|STARTED|Period 3||6||
59661781|NCT05040295|75780808|FG000|COMPLETED|Period 3||6||
59661782|NCT05040295|75780809|FG001|COMPLETED|Period 3||6||
59661783|NCT05040295|75780808|FG000|NOT COMPLETED|Period 3||0||
59661784|NCT05040295|75780809|FG001|NOT COMPLETED|Period 3||0||
59661785|NCT04965389|75780822|FG000|STARTED|Overall Study||4|Started = Randomized|
59661786|NCT04965389|75780823|FG001|STARTED|Overall Study||5|Started = Randomized|
59661787|NCT04965389|75780824|FG002|STARTED|Overall Study||4|Started = Randomized|
59661788|NCT04965389|75780825|FG003|STARTED|Overall Study||4|Started = Randomized|
59661789|NCT04965389|75780822|FG000|Participants Completed Treatment Period 1|Overall Study|Treatment A=Oral solution with IV microdose|4||
59661790|NCT04965389|75780823|FG001|Participants Completed Treatment Period 1|Overall Study|Treatment A=Oral solution with IV microdose|5||
59661791|NCT04965389|75780824|FG002|Participants Completed Treatment Period 1|Overall Study|Treatment A=Oral solution with IV microdose|4||
59661792|NCT04965389|75780825|FG003|Participants Completed Treatment Period 1|Overall Study|Treatment A=Oral solution with IV microdose|4||
59661793|NCT04965389|75780822|FG000|Participants Completed Treatment Period 2|Overall Study|Treatment B=high dose milvexian SDD fasted|4||
59661794|NCT04965389|75780823|FG001|Participants Completed Treatment Period 2|Overall Study|Treatment C=low dose milvexian SDD fed|4||
59815809|NCT03026283|75938211|FG000|NOT COMPLETED|Optimal Care/Stress Test/ICA||0||
59544531|NCT01664897|75642976|FG000|COMPLETED|Overall Study||29||
59661795|NCT04965389|75780824|FG002|Participants Completed Treatment Period 2|Overall Study|Treatment D=low dose milvexian SDD fasted|4||
59661796|NCT04965389|75780825|FG003|Participants Completed Treatment Period 2|Overall Study|Treatment E=high dose milvexian SDD fed|4||
59661797|NCT04965389|75780822|FG000|Participants Completed Treatment Period 3|Overall Study|Treatment C=low dose milvexian SDD fed|3||
59661798|NCT04965389|75780823|FG001|Participants Completed Treatment Period 3|Overall Study|Treatment D=low dose milvexian SDD fasted|4||
59661799|NCT04965389|75780824|FG002|Participants Completed Treatment Period 3|Overall Study|Treatment E=high dose milvexian SDD fed|4||
59661800|NCT04965389|75780825|FG003|Participants Completed Treatment Period 3|Overall Study|Treatment B=high dose milvexian SDD fasted|4||
59544532|NCT01664897|75642976|FG000|NOT COMPLETED|Overall Study||0||
59544533|NCT01664975|75642982|FG000|STARTED|Overall Study||57||
59815810|NCT03026283|75938212|FG001|NOT COMPLETED|Optimal Care/Stress Test/ICA||0||
59544534|NCT01664975|75642983|FG001|STARTED|Overall Study||54||
59661801|NCT04965389|75780822|FG000|Participants Completed Treatment Period 4|Overall Study|Treatment E=high dose milvexian SDD fed|3||
59661802|NCT04965389|75780823|FG001|Participants Completed Treatment Period 4|Overall Study|Treatment B=high dose milvexian SDD fasted|3||
59661803|NCT04965389|75780824|FG002|Participants Completed Treatment Period 4|Overall Study|Treatment C=low dose milvexian SDD fed|4||
59661804|NCT04965389|75780825|FG003|Participants Completed Treatment Period 4|Overall Study|Treatment D=low dose milvexian SDD fasted|4||
59661805|NCT04965389|75780822|FG000|Participants Completed Treatment Period 5|Overall Study|Treatment D=low dose milvexian SDD fasted|3||
59661806|NCT04965389|75780823|FG001|Participants Completed Treatment Period 5|Overall Study|Treatment E=high dose milvexian SDD fed|3||
59661807|NCT04965389|75780824|FG002|Participants Completed Treatment Period 5|Overall Study|Treatment B=high dose milvexian SDD fasted|4||
59661808|NCT04965389|75780825|FG003|Participants Completed Treatment Period 5|Overall Study|Treatment C=low dose milvexian SDD fed|4||
59661809|NCT04965389|75780822|FG000|COMPLETED|Overall Study||3|Completed=completed the study|
59661810|NCT04965389|75780823|FG001|COMPLETED|Overall Study||3|Completed=completed the study|
59661811|NCT04965389|75780824|FG002|COMPLETED|Overall Study||4|Completed=completed the study|
59661812|NCT04965389|75780825|FG003|COMPLETED|Overall Study||4|Completed=completed the study|
59661813|NCT04965389|75780822|FG000|NOT COMPLETED|Overall Study||1||
59661814|NCT04965389|75780823|FG001|NOT COMPLETED|Overall Study||2||
59661815|NCT04965389|75780824|FG002|NOT COMPLETED|Overall Study||0||
59661816|NCT04965389|75780825|FG003|NOT COMPLETED|Overall Study||0||
59661817|NCT04935931|75780842|FG000|STARTED|Overall Study||13||
59661818|NCT04935931|75780842|FG000|COMPLETED|Overall Study||12||
59661819|NCT04935931|75780842|FG000|NOT COMPLETED|Overall Study||1||
59661820|NCT04895618|75780847|FG000|STARTED|Overall Study||43||
59661821|NCT04895618|75780847|FG000|COMPLETED|Overall Study||43||
59661822|NCT04895618|75780847|FG000|NOT COMPLETED|Overall Study||0||
59661823|NCT04839393|75780854|FG000|STARTED|Overall Study||4||
59661824|NCT04839393|75780855|FG001|STARTED|Overall Study||4||
59661825|NCT04839393|75780856|FG002|STARTED|Overall Study||19||
59661826|NCT04839393|75780854|FG000|Received Treatment|Overall Study||4||
59661827|NCT04839393|75780855|FG001|Received Treatment|Overall Study||4||
59661828|NCT04839393|75780856|FG002|Received Treatment|Overall Study||19||
59661829|NCT04839393|75780854|FG000|COMPLETED|Overall Study||4||
59661830|NCT04839393|75780855|FG001|COMPLETED|Overall Study||4||
59661831|NCT04839393|75780856|FG002|COMPLETED|Overall Study||16||
59661832|NCT04839393|75780854|FG000|NOT COMPLETED|Overall Study||0||
59661833|NCT04839393|75780855|FG001|NOT COMPLETED|Overall Study||0||
59661834|NCT04839393|75780856|FG002|NOT COMPLETED|Overall Study||3||
59661835|NCT04826965|75780880|FG000|STARTED|Overall Study||3||
59661836|NCT04826965|75780881|FG001|STARTED|Overall Study||2||
59661837|NCT04826965|75780880|FG000|COMPLETED|Overall Study||3||
59661838|NCT04826965|75780881|FG001|COMPLETED|Overall Study||2||
59661839|NCT04826965|75780880|FG000|NOT COMPLETED|Overall Study||0||
59661840|NCT04826965|75780881|FG001|NOT COMPLETED|Overall Study||0||
59661841|NCT04802837|75780889|FG000|STARTED|Overall Study||1||
59661842|NCT04802837|75780890|FG001|STARTED|Overall Study||1||
59661843|NCT04802837|75780889|FG000|COMPLETED|Overall Study||1||
59661844|NCT04802837|75780890|FG001|COMPLETED|Overall Study||1||
59661845|NCT04802837|75780889|FG000|NOT COMPLETED|Overall Study||0||
59661846|NCT04802837|75780890|FG001|NOT COMPLETED|Overall Study||0||
59661847|NCT04716010|75780900|FG000|STARTED|Overall Study||1039||
59661848|NCT04716010|75780901|FG001|STARTED|Overall Study||1040||
59661849|NCT04716010|75780902|FG002|STARTED|Overall Study||1039||
59661850|NCT04716010|75780903|FG003|STARTED|Overall Study||1042||
59661851|NCT04716010|75780900|FG000|COMPLETED|Overall Study||887||
59815811|NCT03026283|75938213|FG002|NOT COMPLETED|Optimal Care/Stress Test/ICA||0||
59544535|NCT01664975|75642982|FG000|COMPLETED|Overall Study||52||
59544536|NCT01664975|75642983|FG001|COMPLETED|Overall Study||51||
59544537|NCT01664975|75642982|FG000|NOT COMPLETED|Overall Study||5||
59544538|NCT01664975|75642983|FG001|NOT COMPLETED|Overall Study||3||
59544539|NCT00950612|75642991|FG000|STARTED|Overall Study||40||
59544540|NCT00950612|75642992|FG001|STARTED|Overall Study||20||
59544541|NCT00950612|75642991|FG000|COMPLETED|Overall Study||40||
59544542|NCT00950612|75642992|FG001|COMPLETED|Overall Study||20||
59544543|NCT00950612|75642991|FG000|NOT COMPLETED|Overall Study||0||
59544544|NCT00950612|75642992|FG001|NOT COMPLETED|Overall Study||0||
59544545|NCT01665053|75643000|FG000|STARTED|Overall Study||838||
59544546|NCT01665053|75643001|FG001|STARTED|Overall Study||846||
59544547|NCT01665053|75643000|FG000|Completed 12-Month Clinical F/U|Overall Study||797||
59544548|NCT01665053|75643001|FG001|Completed 12-Month Clinical F/U|Overall Study||822||
59544549|NCT01665053|75643000|FG000|No 12-Month F/U|Overall Study||32||
59544550|NCT01665053|75643001|FG001|No 12-Month F/U|Overall Study||15||
59544551|NCT01665053|75643000|FG000|Death With No 12-month Clinical FU|Overall Study||9||
59544552|NCT01665053|75643001|FG001|Death With No 12-month Clinical FU|Overall Study||9||
59544553|NCT01665053|75643000|FG000|COMPLETED|Overall Study||806||
59661852|NCT04716010|75780901|FG001|COMPLETED|Overall Study||891||
59661853|NCT04716010|75780902|FG002|COMPLETED|Overall Study||874||
59661854|NCT04716010|75780903|FG003|COMPLETED|Overall Study||866||
59661855|NCT04716010|75780900|FG000|NOT COMPLETED|Overall Study||152||
59815812|NCT03026283|75938214|FG003|NOT COMPLETED|Optimal Care/Stress Test/ICA||20||
59544554|NCT01665053|75643001|FG001|COMPLETED|Overall Study||831||
59661856|NCT04716010|75780901|FG001|NOT COMPLETED|Overall Study||149||
59661857|NCT04716010|75780902|FG002|NOT COMPLETED|Overall Study||165||
59661858|NCT04716010|75780903|FG003|NOT COMPLETED|Overall Study||176||
59661859|NCT04692103|75780913|FG000|STARTED|Overall Study||2||
59661860|NCT04692103|75780913|FG000|COMPLETED|Overall Study||2||
59661861|NCT04692103|75780913|FG000|NOT COMPLETED|Overall Study||0||
59661862|NCT04677712|75780923|FG000|STARTED|Overall Study||7||
59661863|NCT04677712|75780924|FG001|STARTED|Overall Study||8||
59661864|NCT04677712|75780925|FG002|STARTED|Overall Study||9||
59661865|NCT04677712|75780926|FG003|STARTED|Overall Study||9||
59661866|NCT04677712|75780927|FG004|STARTED|Overall Study||8||
59661867|NCT04677712|75780928|FG005|STARTED|Overall Study||7||
59661868|NCT04677712|75780923|FG000|Received at Least 1 Dose of Study Drug|Overall Study||7||
59661869|NCT04677712|75780924|FG001|Received at Least 1 Dose of Study Drug|Overall Study||8||
59661870|NCT04677712|75780925|FG002|Received at Least 1 Dose of Study Drug|Overall Study||9||
59661871|NCT04677712|75780926|FG003|Received at Least 1 Dose of Study Drug|Overall Study||9||
59661872|NCT04677712|75780927|FG004|Received at Least 1 Dose of Study Drug|Overall Study||8||
59661873|NCT04677712|75780928|FG005|Received at Least 1 Dose of Study Drug|Overall Study||7||
59661874|NCT04677712|75780923|FG000|COMPLETED|Overall Study||7||
59661875|NCT04677712|75780924|FG001|COMPLETED|Overall Study||7||
59661876|NCT04677712|75780925|FG002|COMPLETED|Overall Study||9||
59661877|NCT04677712|75780926|FG003|COMPLETED|Overall Study||9||
59661878|NCT04677712|75780927|FG004|COMPLETED|Overall Study||8||
59661879|NCT04677712|75780928|FG005|COMPLETED|Overall Study||7||
59661880|NCT04677712|75780923|FG000|NOT COMPLETED|Overall Study||0||
59661881|NCT04677712|75780924|FG001|NOT COMPLETED|Overall Study||1||
59661882|NCT04677712|75780925|FG002|NOT COMPLETED|Overall Study||0||
59661883|NCT04677712|75780926|FG003|NOT COMPLETED|Overall Study||0||
59661884|NCT04677712|75780927|FG004|NOT COMPLETED|Overall Study||0||
59661885|NCT04677712|75780928|FG005|NOT COMPLETED|Overall Study||0||
59661886|NCT04630002|75780951|FG000|STARTED|Cohort 1:Treatment Period 1(Days 1 to 7)||19||
59661887|NCT04630002|75780952|FG001|STARTED|Cohort 1:Treatment Period 1(Days 1 to 7)||0||
59661888|NCT04630002|75780953|FG002|STARTED|Cohort 1:Treatment Period 1(Days 1 to 7)||0||
59661889|NCT04630002|75780951|FG000|COMPLETED|Cohort 1:Treatment Period 1(Days 1 to 7)||19||
59661890|NCT04630002|75780952|FG001|COMPLETED|Cohort 1:Treatment Period 1(Days 1 to 7)||0||
59661891|NCT04630002|75780953|FG002|COMPLETED|Cohort 1:Treatment Period 1(Days 1 to 7)||0||
59661892|NCT04630002|75780951|FG000|NOT COMPLETED|Cohort 1:Treatment Period 1(Days 1 to 7)||0||
59661893|NCT04630002|75780952|FG001|NOT COMPLETED|Cohort 1:Treatment Period 1(Days 1 to 7)||0||
59661894|NCT04630002|75780953|FG002|NOT COMPLETED|Cohort 1:Treatment Period 1(Days 1 to 7)||0||
59661895|NCT04630002|75780951|FG000|STARTED|Cohort 1:Washout Period (Days 8 to 11)||19||
59661896|NCT04630002|75780952|FG001|STARTED|Cohort 1:Washout Period (Days 8 to 11)||0||
59815813|NCT03026283|75938215|FG004|NOT COMPLETED|Optimal Care/Stress Test/ICA||38||
59544555|NCT01665053|75643000|FG000|NOT COMPLETED|Overall Study||32||
59544556|NCT01665053|75643001|FG001|NOT COMPLETED|Overall Study||15||
59544557|NCT00946478|75643009|FG000|STARTED|Overall Study||20||
59544558|NCT00946478|75643010|FG001|STARTED|Overall Study||20||
59544559|NCT00946478|75643009|FG000|COMPLETED|Overall Study||20||
59544560|NCT00946478|75643010|FG001|COMPLETED|Overall Study||20||
59544561|NCT00946478|75643009|FG000|NOT COMPLETED|Overall Study||0||
59544562|NCT00946478|75643010|FG001|NOT COMPLETED|Overall Study||0||
59544563|NCT01667471|75643016|FG000|STARTED|Overall Study||7||
59544564|NCT01667471|75643016|FG000|COMPLETED|Overall Study||7||
59544565|NCT01667471|75643016|FG000|NOT COMPLETED|Overall Study||0||
59544566|NCT01006538|75643023|FG000|STARTED|Overall Study||244||
59544567|NCT01006538|75643024|FG001|STARTED|Overall Study||119||
59544568|NCT01006538|75643023|FG000|COMPLETED|Overall Study||233||
59544569|NCT01006538|75643024|FG001|COMPLETED|Overall Study||115||
59544570|NCT01006538|75643023|FG000|NOT COMPLETED|Overall Study||11||
59544571|NCT01006538|75643024|FG001|NOT COMPLETED|Overall Study||4||
59544572|NCT01008722|75643032|FG000|STARTED|Overall Study|Based on Power Calculations to see 20% outcome improvement by adding FIRM-guided ablation to PVI|36||
59544573|NCT01008722|75643033|FG001|STARTED|Overall Study|Based on Power Calculations to see 20% outcome improvement by adding FIRM-guided ablation to PVI|71||
59544574|NCT01008722|75643032|FG000|COMPLETED|Overall Study||36||
59544575|NCT01008722|75643033|FG001|COMPLETED|Overall Study||71||
59544576|NCT01008722|75643032|FG000|NOT COMPLETED|Overall Study||0||
59544577|NCT01008722|75643033|FG001|NOT COMPLETED|Overall Study||0||
59544578|NCT00952718|75643041|FG000|STARTED|Overall Study||19||
59544579|NCT00952718|75643042|FG001|STARTED|Overall Study||19||
59544580|NCT00952718|75643041|FG000|COMPLETED|Overall Study||13||
59544581|NCT00952718|75643042|FG001|COMPLETED|Overall Study||13||
59544582|NCT00952718|75643041|FG000|NOT COMPLETED|Overall Study||6||
59544583|NCT00952718|75643042|FG001|NOT COMPLETED|Overall Study||6||
59544584|NCT01010282|75643053|FG000|STARTED|Overall Study||97||
59544585|NCT01010282|75643054|FG001|STARTED|Overall Study||95||
59544586|NCT01010282|75643055|FG002|STARTED|Overall Study||96||
59544587|NCT01010282|75643053|FG000|COMPLETED|Overall Study||91||
59544588|NCT01010282|75643054|FG001|COMPLETED|Overall Study||88||
59544589|NCT01010282|75643055|FG002|COMPLETED|Overall Study||77||
59544590|NCT01010282|75643053|FG000|NOT COMPLETED|Overall Study||6||
59661897|NCT04630002|75780953|FG002|STARTED|Cohort 1:Washout Period (Days 8 to 11)||0||
59661898|NCT04630002|75780951|FG000|COMPLETED|Cohort 1:Washout Period (Days 8 to 11)||19||
59661899|NCT04630002|75780952|FG001|COMPLETED|Cohort 1:Washout Period (Days 8 to 11)||0||
59661900|NCT04630002|75780953|FG002|COMPLETED|Cohort 1:Washout Period (Days 8 to 11)||0||
59661901|NCT04630002|75780951|FG000|NOT COMPLETED|Cohort 1:Washout Period (Days 8 to 11)||0||
59661902|NCT04630002|75780952|FG001|NOT COMPLETED|Cohort 1:Washout Period (Days 8 to 11)||0||
59661903|NCT04630002|75780953|FG002|NOT COMPLETED|Cohort 1:Washout Period (Days 8 to 11)||0||
59661904|NCT04630002|75780951|FG000|STARTED|Cohort1:Treatment Period2(Days 12 to 21)||19||
59661905|NCT04630002|75780952|FG001|STARTED|Cohort1:Treatment Period2(Days 12 to 21)||0||
59661906|NCT04630002|75780953|FG002|STARTED|Cohort1:Treatment Period2(Days 12 to 21)||0||
59661907|NCT04630002|75780951|FG000|COMPLETED|Cohort1:Treatment Period2(Days 12 to 21)||17||
59661908|NCT04630002|75780952|FG001|COMPLETED|Cohort1:Treatment Period2(Days 12 to 21)||0||
59661909|NCT04630002|75780953|FG002|COMPLETED|Cohort1:Treatment Period2(Days 12 to 21)||0||
59661910|NCT04630002|75780951|FG000|NOT COMPLETED|Cohort1:Treatment Period2(Days 12 to 21)||2||
59661911|NCT04630002|75780952|FG001|NOT COMPLETED|Cohort1:Treatment Period2(Days 12 to 21)||0||
59661912|NCT04630002|75780953|FG002|NOT COMPLETED|Cohort1:Treatment Period2(Days 12 to 21)||0||
59661913|NCT04630002|75780951|FG000|STARTED|Cohort1:Treatment Period3(Days 22 to 31)||17||
59661914|NCT04630002|75780952|FG001|STARTED|Cohort1:Treatment Period3(Days 22 to 31)||0||
59661915|NCT04630002|75780953|FG002|STARTED|Cohort1:Treatment Period3(Days 22 to 31)||0||
59661916|NCT04630002|75780951|FG000|COMPLETED|Cohort1:Treatment Period3(Days 22 to 31)||15||
59661917|NCT04630002|75780952|FG001|COMPLETED|Cohort1:Treatment Period3(Days 22 to 31)||0||
59661918|NCT04630002|75780953|FG002|COMPLETED|Cohort1:Treatment Period3(Days 22 to 31)||0||
59661919|NCT04630002|75780951|FG000|NOT COMPLETED|Cohort1:Treatment Period3(Days 22 to 31)||2||
59661920|NCT04630002|75780952|FG001|NOT COMPLETED|Cohort1:Treatment Period3(Days 22 to 31)||0||
59661921|NCT04630002|75780953|FG002|NOT COMPLETED|Cohort1:Treatment Period3(Days 22 to 31)||0||
59661922|NCT04630002|75780951|FG000|STARTED|Cohort 2:Treatment Period 1(Days 1 to 7)||0||
59661923|NCT04630002|75780952|FG001|STARTED|Cohort 2:Treatment Period 1(Days 1 to 7)||19||
59661924|NCT04630002|75780953|FG002|STARTED|Cohort 2:Treatment Period 1(Days 1 to 7)||0||
59661925|NCT04630002|75780951|FG000|COMPLETED|Cohort 2:Treatment Period 1(Days 1 to 7)||0||
59661926|NCT04630002|75780952|FG001|COMPLETED|Cohort 2:Treatment Period 1(Days 1 to 7)||19||
59661927|NCT04630002|75780953|FG002|COMPLETED|Cohort 2:Treatment Period 1(Days 1 to 7)||0||
59661928|NCT04630002|75780951|FG000|NOT COMPLETED|Cohort 2:Treatment Period 1(Days 1 to 7)||0||
59661929|NCT04630002|75780952|FG001|NOT COMPLETED|Cohort 2:Treatment Period 1(Days 1 to 7)||0||
59661930|NCT04630002|75780953|FG002|NOT COMPLETED|Cohort 2:Treatment Period 1(Days 1 to 7)||0||
59661931|NCT04630002|75780951|FG000|STARTED|Cohort 2: Washout Period (Days 8 to 11)||0||
59661932|NCT04630002|75780952|FG001|STARTED|Cohort 2: Washout Period (Days 8 to 11)||19||
59661933|NCT04630002|75780953|FG002|STARTED|Cohort 2: Washout Period (Days 8 to 11)||0||
59661934|NCT04630002|75780951|FG000|COMPLETED|Cohort 2: Washout Period (Days 8 to 11)||0||
59661935|NCT04630002|75780952|FG001|COMPLETED|Cohort 2: Washout Period (Days 8 to 11)||19||
59661936|NCT04630002|75780953|FG002|COMPLETED|Cohort 2: Washout Period (Days 8 to 11)||0||
59661937|NCT04630002|75780951|FG000|NOT COMPLETED|Cohort 2: Washout Period (Days 8 to 11)||0||
59661938|NCT04630002|75780952|FG001|NOT COMPLETED|Cohort 2: Washout Period (Days 8 to 11)||0||
59661939|NCT04630002|75780953|FG002|NOT COMPLETED|Cohort 2: Washout Period (Days 8 to 11)||0||
59661940|NCT04630002|75780951|FG000|STARTED|Cohort2:Treatment Period2(Days 12 to 21)||0||
59661941|NCT04630002|75780952|FG001|STARTED|Cohort2:Treatment Period2(Days 12 to 21)||19||
59661942|NCT04630002|75780953|FG002|STARTED|Cohort2:Treatment Period2(Days 12 to 21)||0||
59661943|NCT04630002|75780951|FG000|COMPLETED|Cohort2:Treatment Period2(Days 12 to 21)||0||
59661944|NCT04630002|75780952|FG001|COMPLETED|Cohort2:Treatment Period2(Days 12 to 21)||17||
59661945|NCT04630002|75780953|FG002|COMPLETED|Cohort2:Treatment Period2(Days 12 to 21)||0||
59661946|NCT04630002|75780951|FG000|NOT COMPLETED|Cohort2:Treatment Period2(Days 12 to 21)||0||
59661947|NCT04630002|75780952|FG001|NOT COMPLETED|Cohort2:Treatment Period2(Days 12 to 21)||2||
59661948|NCT04630002|75780953|FG002|NOT COMPLETED|Cohort2:Treatment Period2(Days 12 to 21)||0||
59661949|NCT04630002|75780951|FG000|STARTED|Cohort2:Treatment Period3(Days 22 to 31)||0||
59661950|NCT04630002|75780952|FG001|STARTED|Cohort2:Treatment Period3(Days 22 to 31)||17||
59661951|NCT04630002|75780953|FG002|STARTED|Cohort2:Treatment Period3(Days 22 to 31)||0||
59661952|NCT04630002|75780951|FG000|COMPLETED|Cohort2:Treatment Period3(Days 22 to 31)||0||
59661953|NCT04630002|75780952|FG001|COMPLETED|Cohort2:Treatment Period3(Days 22 to 31)||14||
59661954|NCT04630002|75780953|FG002|COMPLETED|Cohort2:Treatment Period3(Days 22 to 31)||0||
59661955|NCT04630002|75780951|FG000|NOT COMPLETED|Cohort2:Treatment Period3(Days 22 to 31)||0||
59661956|NCT04630002|75780952|FG001|NOT COMPLETED|Cohort2:Treatment Period3(Days 22 to 31)||3||
59988975|NCT02262754|76104246|FG002|COMPLETED|Overall Study||65||
59661957|NCT04630002|75780953|FG002|NOT COMPLETED|Cohort2:Treatment Period3(Days 22 to 31)||0||
59661958|NCT04630002|75780951|FG000|STARTED|Cohort 3:Treatment Period 1(Days 1 to 7)||0||
59661959|NCT04630002|75780952|FG001|STARTED|Cohort 3:Treatment Period 1(Days 1 to 7)||0||
59661960|NCT04630002|75780953|FG002|STARTED|Cohort 3:Treatment Period 1(Days 1 to 7)||16||
59661961|NCT04630002|75780951|FG000|COMPLETED|Cohort 3:Treatment Period 1(Days 1 to 7)||0||
59661962|NCT04630002|75780952|FG001|COMPLETED|Cohort 3:Treatment Period 1(Days 1 to 7)||0||
59661963|NCT04630002|75780953|FG002|COMPLETED|Cohort 3:Treatment Period 1(Days 1 to 7)||16||
59661964|NCT04630002|75780951|FG000|NOT COMPLETED|Cohort 3:Treatment Period 1(Days 1 to 7)||0||
59661965|NCT04630002|75780952|FG001|NOT COMPLETED|Cohort 3:Treatment Period 1(Days 1 to 7)||0||
59661966|NCT04630002|75780953|FG002|NOT COMPLETED|Cohort 3:Treatment Period 1(Days 1 to 7)||0||
59661967|NCT04630002|75780951|FG000|STARTED|Cohort 3:Treatment Period2(Days 8 to 21)||0||
59661968|NCT04630002|75780952|FG001|STARTED|Cohort 3:Treatment Period2(Days 8 to 21)||0||
59661969|NCT04630002|75780953|FG002|STARTED|Cohort 3:Treatment Period2(Days 8 to 21)||16||
59661970|NCT04630002|75780951|FG000|COMPLETED|Cohort 3:Treatment Period2(Days 8 to 21)||0||
59661971|NCT04630002|75780952|FG001|COMPLETED|Cohort 3:Treatment Period2(Days 8 to 21)||0||
59661972|NCT04630002|75780953|FG002|COMPLETED|Cohort 3:Treatment Period2(Days 8 to 21)||14||
59661973|NCT04630002|75780951|FG000|NOT COMPLETED|Cohort 3:Treatment Period2(Days 8 to 21)||0||
59661974|NCT04630002|75780952|FG001|NOT COMPLETED|Cohort 3:Treatment Period2(Days 8 to 21)||0||
59661975|NCT04630002|75780953|FG002|NOT COMPLETED|Cohort 3:Treatment Period2(Days 8 to 21)||2||
59661976|NCT04591054|75780979|FG000|STARTED|Overall Study||28||
59661977|NCT04591054|75780980|FG001|STARTED|Overall Study||28||
59661978|NCT04591054|75780979|FG000|COMPLETED|Overall Study||24||
59661979|NCT04591054|75780980|FG001|COMPLETED|Overall Study||27||
59661980|NCT04591054|75780979|FG000|NOT COMPLETED|Overall Study||4||
59661981|NCT04591054|75780980|FG001|NOT COMPLETED|Overall Study||1||
59661982|NCT04576923|75780986|FG000|STARTED|Overall Study||36||
59661983|NCT04576923|75780986|FG000|COMPLETED|Overall Study||21||
59661984|NCT04576923|75780986|FG000|NOT COMPLETED|Overall Study||15||
59661985|NCT04566133|75780994|FG000|STARTED|Overall Study||2||
59661986|NCT04566133|75780994|FG000|COMPLETED|Overall Study||2||
59661987|NCT04566133|75780994|FG000|NOT COMPLETED|Overall Study||0||
59661988|NCT04526197|75781000|FG000|STARTED|Period 1||18||
59661989|NCT04526197|75781001|FG001|STARTED|Period 1||18||
59661990|NCT04526197|75781000|FG000|Received at Least 1 Dose of Study Drug|Period 1||18||
59661991|NCT04526197|75781001|FG001|Received at Least 1 Dose of Study Drug|Period 1||18||
59661992|NCT04526197|75781000|FG000|COMPLETED|Period 1||17||
59661993|NCT04526197|75781001|FG001|COMPLETED|Period 1||17||
59661994|NCT04526197|75781000|FG000|NOT COMPLETED|Period 1||1||
59661995|NCT04526197|75781001|FG001|NOT COMPLETED|Period 1||1||
59661996|NCT04526197|75781000|FG000|STARTED|Period 2||17||
59661997|NCT04526197|75781001|FG001|STARTED|Period 2||17||
59661998|NCT04526197|75781000|FG000|Received at Least 1 Dose of Study Drug|Period 2||17||
59661999|NCT04526197|75781001|FG001|Received at Least 1 Dose of Study Drug|Period 2||17||
59662000|NCT04526197|75781000|FG000|COMPLETED|Period 2||17||
59662001|NCT04526197|75781001|FG001|COMPLETED|Period 2||15||
59662002|NCT04526197|75781000|FG000|NOT COMPLETED|Period 2||0||
59662003|NCT04526197|75781001|FG001|NOT COMPLETED|Period 2||2||
59662004|NCT04412668|75781011|FG000|STARTED|Overall Study||14||
59662005|NCT04412668|75781012|FG001|STARTED|Overall Study||12||
59662006|NCT04412668|75781013|FG002|STARTED|Overall Study||10||
59662007|NCT04412668|75781011|FG000|Received at Least 1 Dose of Study Drug|Overall Study||10||
59662008|NCT04412668|75781012|FG001|Received at Least 1 Dose of Study Drug|Overall Study||12||
59662009|NCT04412668|75781013|FG002|Received at Least 1 Dose of Study Drug|Overall Study||10||
59662010|NCT04412668|75781011|FG000|COMPLETED|Overall Study||7||
59662011|NCT04412668|75781012|FG001|COMPLETED|Overall Study||12||
59662012|NCT04412668|75781013|FG002|COMPLETED|Overall Study||10||
59662013|NCT04412668|75781011|FG000|NOT COMPLETED|Overall Study||7||
59662014|NCT04412668|75781012|FG001|NOT COMPLETED|Overall Study||0||
59662015|NCT04412668|75781013|FG002|NOT COMPLETED|Overall Study||0||
59662016|NCT04360551|75781023|FG000|STARTED|Overall Study||12||
59662017|NCT04360551|75781024|FG001|STARTED|Overall Study||12||
59662018|NCT04360551|75781023|FG000|COMPLETED|Overall Study||11||
59662019|NCT04360551|75781024|FG001|COMPLETED|Overall Study||12||
59662020|NCT04360551|75781023|FG000|NOT COMPLETED|Overall Study||1||
59662021|NCT04360551|75781024|FG001|NOT COMPLETED|Overall Study||0||
59662022|NCT04299087|75781032|FG000|STARTED|Overall Study||11||
59662023|NCT04299087|75781033|FG001|STARTED|Overall Study||1||
59662024|NCT04299087|75781032|FG000|COMPLETED|Overall Study||9||
59662025|NCT04299087|75781033|FG001|COMPLETED|Overall Study||0||
59662026|NCT04299087|75781032|FG000|NOT COMPLETED|Overall Study||2||
59662027|NCT04299087|75781033|FG001|NOT COMPLETED|Overall Study||1||
59662028|NCT04288778|75781039|FG000|STARTED|Overall Study||276||
59662029|NCT04288778|75781039|FG000|Treated|Overall Study||274||
59662030|NCT04288778|75781039|FG000|COMPLETED|Overall Study||265||
59662031|NCT04288778|75781039|FG000|NOT COMPLETED|Overall Study||11||
59662032|NCT04270695|75781045|FG000|STARTED|Overall Study||17||
59662033|NCT04270695|75781046|FG001|STARTED|Overall Study||17||
59662034|NCT04270695|75781045|FG000|COMPLETED|Overall Study||17||
59662035|NCT04270695|75781046|FG001|COMPLETED|Overall Study||17||
59662036|NCT04270695|75781045|FG000|NOT COMPLETED|Overall Study||0||
59662037|NCT04270695|75781046|FG001|NOT COMPLETED|Overall Study||0||
59662038|NCT04233164|75781058|FG000|STARTED|Overall Study||20||
59662039|NCT04233164|75781059|FG001|STARTED|Overall Study||21||
59662040|NCT04233164|75781058|FG000|COMPLETED|Overall Study||20||
59662041|NCT04233164|75781059|FG001|COMPLETED|Overall Study||20||
59662042|NCT04233164|75781058|FG000|NOT COMPLETED|Overall Study||0||
59662043|NCT04233164|75781059|FG001|NOT COMPLETED|Overall Study||1||
59662044|NCT04204993|75781065|FG000|STARTED|Overall Study||20||
59662045|NCT04204993|75781065|FG000|Group A|Overall Study||4||
59662046|NCT04204993|75781065|FG000|Group B|Overall Study||6||
59662047|NCT04204993|75781065|FG000|Group C|Overall Study||6||
59662048|NCT04204993|75781065|FG000|Group D|Overall Study||4||
59662049|NCT04204993|75781065|FG000|COMPLETED|Overall Study|Last follow-up visit on Day 180.|20||
59662050|NCT04204993|75781065|FG000|NOT COMPLETED|Overall Study||0||
59662051|NCT04147195|75781075|FG000|STARTED|Overall Study||20||
59662052|NCT04147195|75781076|FG001|STARTED|Overall Study||21||
59662053|NCT04147195|75781075|FG000|PD Analysis Set|Overall Study||20|Participants with available PD data and no major protocol deviations with impact on PD data.|
59662054|NCT04147195|75781076|FG001|PD Analysis Set|Overall Study||17|Participants with available PD data and no major protocol deviations with impact on PD data.|
59662055|NCT04147195|75781075|FG000|COMPLETED|Overall Study||16||
59662056|NCT04147195|75781076|FG001|COMPLETED|Overall Study||15||
59662057|NCT04147195|75781075|FG000|NOT COMPLETED|Overall Study||4||
59662058|NCT04147195|75781076|FG001|NOT COMPLETED|Overall Study||6||
59662059|NCT04119336|75781083|FG000|STARTED|Overall Study||2||
59662060|NCT04119336|75781083|FG000|COMPLETED|Overall Study||2||
59662061|NCT04119336|75781083|FG000|NOT COMPLETED|Overall Study||0||
59662062|NCT04092816|75781089|FG000|STARTED|Overall Study||5||
59662063|NCT04092816|75781090|FG001|STARTED|Overall Study||5||
59662064|NCT04092816|75781089|FG000|COMPLETED|Overall Study||4||
59662065|NCT04092816|75781090|FG001|COMPLETED|Overall Study||3||
59662066|NCT04092816|75781089|FG000|NOT COMPLETED|Overall Study||1||
59662067|NCT04092816|75781090|FG001|NOT COMPLETED|Overall Study||2||
59662068|NCT04089020|75781099|FG000|STARTED|Overall Study|18 youth participants 14 parent participants|32||
59662069|NCT04089020|75781099|FG000|COMPLETED|Overall Study|18 youth participants 13 parent participants|31||
59662070|NCT04089020|75781099|FG000|NOT COMPLETED|Overall Study||1||
59662071|NCT04039867|75781103|FG000|STARTED|Overall Study||17||
59662072|NCT04039867|75781103|FG000|COMPLETED|Overall Study||17||
59662073|NCT04039867|75781103|FG000|NOT COMPLETED|Overall Study||0||
59662074|NCT03985878|75781107|FG000|STARTED|Overall Study||15||
59662075|NCT03985878|75781107|FG000|Received At Least 1 Dose Of Study Drug|Overall Study||15|Safety Set|
59662076|NCT03985878|75781107|FG000|COMPLETED|Overall Study||0||
59662077|NCT03985878|75781107|FG000|NOT COMPLETED|Overall Study||15||
59662078|NCT03971539|75781120|FG000|STARTED|Overall Study||6||
59662079|NCT03971539|75781121|FG001|STARTED|Overall Study||7||
59662080|NCT03971539|75781122|FG002|STARTED|Overall Study||8||
59662081|NCT03971539|75781123|FG003|STARTED|Overall Study||8||
59662082|NCT03971539|75781124|FG004|STARTED|Overall Study||8||
59662083|NCT03971539|75781125|FG005|STARTED|Overall Study||7||
59662084|NCT03971539|75781126|FG006|STARTED|Overall Study||8||
59662085|NCT03971539|75781127|FG007|STARTED|Overall Study||8||
59662086|NCT03971539|75781128|FG008|STARTED|Overall Study||8||
59662087|NCT03971539|75781120|FG000|COMPLETED|Overall Study||6||
59662088|NCT03971539|75781121|FG001|COMPLETED|Overall Study||7||
59662089|NCT03971539|75781122|FG002|COMPLETED|Overall Study||8||
59662090|NCT03971539|75781123|FG003|COMPLETED|Overall Study||8||
59662091|NCT03971539|75781124|FG004|COMPLETED|Overall Study||8||
59662092|NCT03971539|75781125|FG005|COMPLETED|Overall Study||7||
59662093|NCT03971539|75781126|FG006|COMPLETED|Overall Study||8||
59662094|NCT03971539|75781127|FG007|COMPLETED|Overall Study||8||
59662095|NCT03971539|75781128|FG008|COMPLETED|Overall Study||8||
59662096|NCT03971539|75781120|FG000|NOT COMPLETED|Overall Study||0||
59662097|NCT03971539|75781121|FG001|NOT COMPLETED|Overall Study||0||
59662098|NCT03971539|75781122|FG002|NOT COMPLETED|Overall Study||0||
59662099|NCT03971539|75781123|FG003|NOT COMPLETED|Overall Study||0||
59662100|NCT03971539|75781124|FG004|NOT COMPLETED|Overall Study||0||
59662101|NCT03971539|75781125|FG005|NOT COMPLETED|Overall Study||0||
59662102|NCT03971539|75781126|FG006|NOT COMPLETED|Overall Study||0||
59662103|NCT03971539|75781127|FG007|NOT COMPLETED|Overall Study||0||
59662104|NCT03971539|75781128|FG008|NOT COMPLETED|Overall Study||0||
59662105|NCT03840915|75781174|FG000|STARTED|Overall Study||40||
59662106|NCT03840915|75781175|FG001|STARTED|Overall Study||9||
59662107|NCT03840915|75781176|FG002|STARTED|Overall Study||9||
59662108|NCT03840915|75781177|FG003|STARTED|Overall Study||12||
59662109|NCT03840915|75781174|FG000|Safety Analysis Set|Overall Study||40|All participants who were administered any dose of any study intervention (bintrafusp alfa or one of the chemotherapies).|
59662110|NCT03840915|75781175|FG001|Safety Analysis Set|Overall Study||9|All participants who were administered any dose of any study intervention (bintrafusp alfa or one of the chemotherapies).|
59662111|NCT03840915|75781176|FG002|Safety Analysis Set|Overall Study||9|All participants who were administered any dose of any study intervention (bintrafusp alfa or one of the chemotherapies).|
59709756|NCT01072149|75828522|FG002|NOT COMPLETED|Treatment Period 1 (28 Days)||1||
59988976|NCT02262754|76104244|FG000|NOT COMPLETED|Overall Study||16||
59662112|NCT03840915|75781177|FG003|Safety Analysis Set|Overall Study||12|All participants who were administered any dose of any study intervention (bintrafusp alfa or one of the chemotherapies).|
59662113|NCT03840915|75781174|FG000|Full Analysis Set|Overall Study||40|All participants who were administered any dose of any study intervention (bintrafusp alfa or one of the chemotherapies).|
59662114|NCT03840915|75781175|FG001|Full Analysis Set|Overall Study||9|All participants who were administered any dose of any study intervention (bintrafusp alfa or one of the chemotherapies).|
59662115|NCT03840915|75781176|FG002|Full Analysis Set|Overall Study||9|All participants who were administered any dose of any study intervention (bintrafusp alfa or one of the chemotherapies).|
59662116|NCT03840915|75781177|FG003|Full Analysis Set|Overall Study||12|All participants who were administered any dose of any study intervention (bintrafusp alfa or one of the chemotherapies).|
59662117|NCT03840915|75781174|FG000|Dose-Limiting Toxicity Analysis Set|Overall Study||8|All participants who received at least 90% of the bintrafusp alfa infusion and all other planned study administrations during the DLT observation period of 3 weeks and who did not discontinue the study for other reasons than DLT during the first cycle, or who experienced at least one DLT.|
59662118|NCT03840915|75781175|FG001|Dose-Limiting Toxicity Analysis Set|Overall Study||8|All participants who received at least 90% of the bintrafusp alfa infusion and all other planned study administrations during the DLT observation period of 3 weeks and who did not discontinue the study for other reasons than DLT during the first cycle, or who experienced at least one DLT.|
59662119|NCT03840915|75781176|FG002|Dose-Limiting Toxicity Analysis Set|Overall Study||8|All participants who received at least 90% of the bintrafusp alfa infusion and all other planned study administrations during the DLT observation period of 3 weeks and who did not discontinue the study for other reasons than DLT during the first cycle, or who experienced at least one DLT.|
59662120|NCT03840915|75781177|FG003|Dose-Limiting Toxicity Analysis Set|Overall Study||11|All participants who received at least 90% of the bintrafusp alfa infusion and all other planned study administrations during the DLT observation period of 3 weeks and who did not discontinue the study for other reasons than DLT during the first cycle, or who experienced at least one DLT.|
59662121|NCT03840915|75781174|FG000|COMPLETED|Overall Study||40||
59662122|NCT03840915|75781175|FG001|COMPLETED|Overall Study||9||
59662123|NCT03840915|75781176|FG002|COMPLETED|Overall Study||9||
59662124|NCT03840915|75781177|FG003|COMPLETED|Overall Study||12||
59662125|NCT03840915|75781174|FG000|NOT COMPLETED|Overall Study||0||
59662126|NCT03840915|75781175|FG001|NOT COMPLETED|Overall Study||0||
59662127|NCT03840915|75781176|FG002|NOT COMPLETED|Overall Study||0||
59662128|NCT03840915|75781177|FG003|NOT COMPLETED|Overall Study||0||
59662129|NCT03774394|75781189|FG000|STARTED|Overall Study||31||
59662130|NCT03774394|75781190|FG001|STARTED|Overall Study||30||
59662131|NCT03774394|75781189|FG000|COMPLETED|Overall Study||29||
59662132|NCT03774394|75781190|FG001|COMPLETED|Overall Study||30||
59662133|NCT03774394|75781189|FG000|NOT COMPLETED|Overall Study||2||
59662134|NCT03774394|75781190|FG001|NOT COMPLETED|Overall Study||0||
59662135|NCT03765788|75781198|FG000|STARTED|Overall Study||27||
59662136|NCT03765788|75781199|FG001|STARTED|Overall Study||25||
59662137|NCT03765788|75781198|FG000|COMPLETED|Overall Study||22||
59662138|NCT03765788|75781199|FG001|COMPLETED|Overall Study||17||
59662139|NCT03765788|75781198|FG000|NOT COMPLETED|Overall Study||5||
59662140|NCT03765788|75781199|FG001|NOT COMPLETED|Overall Study||8||
59662141|NCT03692403|75781210|FG000|STARTED|Overall Study||6||
59662142|NCT03692403|75781211|FG001|STARTED|Overall Study||5||
59662143|NCT03692403|75781212|FG002|STARTED|Overall Study||8||
59662144|NCT03692403|75781213|FG003|STARTED|Overall Study||3||
59662145|NCT03692403|75781210|FG000|COMPLETED|Overall Study||5||
59662146|NCT03692403|75781211|FG001|COMPLETED|Overall Study||4||
59662147|NCT03692403|75781212|FG002|COMPLETED|Overall Study||6||
59662148|NCT03692403|75781213|FG003|COMPLETED|Overall Study||2||
59662149|NCT03692403|75781210|FG000|NOT COMPLETED|Overall Study||1||
59662150|NCT03692403|75781211|FG001|NOT COMPLETED|Overall Study||1||
59662151|NCT03692403|75781212|FG002|NOT COMPLETED|Overall Study||2||
59662152|NCT03692403|75781213|FG003|NOT COMPLETED|Overall Study||1||
59662153|NCT03654651|75781228|FG000|STARTED|First Intervention (6 Weeks)||26||
59662154|NCT03654651|75781229|FG001|STARTED|First Intervention (6 Weeks)||25||
59662155|NCT03654651|75781228|FG000|COMPLETED|First Intervention (6 Weeks)||25||
59662156|NCT03654651|75781229|FG001|COMPLETED|First Intervention (6 Weeks)||25||
59662157|NCT03654651|75781228|FG000|NOT COMPLETED|First Intervention (6 Weeks)||1||
59662158|NCT03654651|75781229|FG001|NOT COMPLETED|First Intervention (6 Weeks)||0||
59662159|NCT03654651|75781228|FG000|STARTED|Washout Period (2-weeks)||25||
59662160|NCT03654651|75781229|FG001|STARTED|Washout Period (2-weeks)||25||
59662161|NCT03654651|75781228|FG000|COMPLETED|Washout Period (2-weeks)||25||
59662162|NCT03654651|75781229|FG001|COMPLETED|Washout Period (2-weeks)||25||
59662163|NCT03654651|75781228|FG000|NOT COMPLETED|Washout Period (2-weeks)||0||
59662164|NCT03654651|75781229|FG001|NOT COMPLETED|Washout Period (2-weeks)||0||
59662165|NCT03654651|75781228|FG000|STARTED|Second Intervention (6 Weeks)||25||
59662166|NCT03654651|75781229|FG001|STARTED|Second Intervention (6 Weeks)||25||
59662167|NCT03654651|75781228|FG000|COMPLETED|Second Intervention (6 Weeks)||25||
59662168|NCT03654651|75781229|FG001|COMPLETED|Second Intervention (6 Weeks)||25||
59662169|NCT03654651|75781228|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0||
59662170|NCT03654651|75781229|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||0||
59662171|NCT03649230|75781236|FG000|STARTED|Overall Study||207||
59662172|NCT03649230|75781236|FG000|COMPLETED|Overall Study||150||
59662173|NCT03649230|75781236|FG000|NOT COMPLETED|Overall Study||57||
59662174|NCT03626545|75781247|FG000|STARTED|Overall Study||8||
59662175|NCT03626545|75781248|FG001|STARTED|Overall Study||120||
59662176|NCT03626545|75781249|FG002|STARTED|Overall Study||117||
59662177|NCT03626545|75781247|FG000|Treated|Overall Study||8||
59662178|NCT03626545|75781248|FG001|Treated|Overall Study||120||
59662179|NCT03626545|75781249|FG002|Treated|Overall Study||114||
59662180|NCT03626545|75781247|FG000|COMPLETED|Overall Study||0||
59662181|NCT03626545|75781248|FG001|COMPLETED|Overall Study||0||
59662182|NCT03626545|75781249|FG002|COMPLETED|Overall Study||0||
59662183|NCT03626545|75781247|FG000|NOT COMPLETED|Overall Study||8||
59662184|NCT03626545|75781248|FG001|NOT COMPLETED|Overall Study||120||
59662185|NCT03626545|75781249|FG002|NOT COMPLETED|Overall Study||117||
59662186|NCT03575143|75781266|FG000|STARTED|Overall Study||66||
59662187|NCT03575143|75781267|FG001|STARTED|Overall Study||55||
59662188|NCT03575143|75781268|FG002|STARTED|Overall Study||11||
59662189|NCT03575143|75781266|FG000|COMPLETED|Overall Study||66||
59662190|NCT03575143|75781267|FG001|COMPLETED|Overall Study||55||
59662191|NCT03575143|75781268|FG002|COMPLETED|Overall Study||0||
59662192|NCT03575143|75781266|FG000|NOT COMPLETED|Overall Study||0||
59662193|NCT03575143|75781267|FG001|NOT COMPLETED|Overall Study||0||
59662194|NCT03575143|75781268|FG002|NOT COMPLETED|Overall Study||11||
59662195|NCT03548064|75781286|FG000|STARTED|Overall Study||12||
59662196|NCT03548064|75781287|FG001|STARTED|Overall Study||12||
59662197|NCT03548064|75781288|FG002|STARTED|Overall Study||6||
59662198|NCT03548064|75781289|FG003|STARTED|Overall Study||12||
59662199|NCT03548064|75781290|FG004|STARTED|Overall Study||12||
59662200|NCT03548064|75781291|FG005|STARTED|Overall Study||6||
59662201|NCT03548064|75781292|FG006|STARTED|Overall Study||12||
59662202|NCT03548064|75781293|FG007|STARTED|Overall Study||3||
59662203|NCT03548064|75781286|FG000|COMPLETED|Overall Study||12||
59662204|NCT03548064|75781287|FG001|COMPLETED|Overall Study||12||
59662205|NCT03548064|75781288|FG002|COMPLETED|Overall Study||6||
59662206|NCT03548064|75781289|FG003|COMPLETED|Overall Study||11||
59662207|NCT03548064|75781290|FG004|COMPLETED|Overall Study||0||
59662208|NCT03548064|75781291|FG005|COMPLETED|Overall Study||3||
59662209|NCT03548064|75781292|FG006|COMPLETED|Overall Study||12||
59662210|NCT03548064|75781293|FG007|COMPLETED|Overall Study||3||
59662211|NCT03548064|75781286|FG000|NOT COMPLETED|Overall Study||0||
59662212|NCT03548064|75781287|FG001|NOT COMPLETED|Overall Study||0||
59662213|NCT03548064|75781288|FG002|NOT COMPLETED|Overall Study||0||
59662214|NCT03548064|75781289|FG003|NOT COMPLETED|Overall Study||1||
59662215|NCT03548064|75781290|FG004|NOT COMPLETED|Overall Study||12||
59662216|NCT03548064|75781291|FG005|NOT COMPLETED|Overall Study||3||
59662217|NCT03548064|75781292|FG006|NOT COMPLETED|Overall Study||0||
59662218|NCT03548064|75781293|FG007|NOT COMPLETED|Overall Study||0||
59662219|NCT03512197|75781319|FG000|STARTED|Overall Study||250|Randomized|
59662220|NCT03512197|75781320|FG001|STARTED|Overall Study||251|Randomized|
59662221|NCT03512197|75781319|FG000|Treated With Midostaurin/Placebo|Overall Study||245||
59662222|NCT03512197|75781320|FG001|Treated With Midostaurin/Placebo|Overall Study||249||
59662223|NCT03512197|75781319|FG000|Entered Induction Phase|Overall Study||250||
59662224|NCT03512197|75781320|FG001|Entered Induction Phase|Overall Study||251||
59662225|NCT03512197|75781319|FG000|Entered Consolidation Phase|Overall Study||120||
59662226|NCT03512197|75781320|FG001|Entered Consolidation Phase|Overall Study||129||
59662227|NCT03512197|75781319|FG000|Entered Post-Consolidation Phase|Overall Study||45||
59662228|NCT03512197|75781320|FG001|Entered Post-Consolidation Phase|Overall Study||27||
59662229|NCT03512197|75781319|FG000|COMPLETED|Overall Study||2|Completed entire study treatment as per protocol - defined as completion of induction, consolidation and post-consolidation treatment phases|
59662230|NCT03512197|75781320|FG001|COMPLETED|Overall Study||1|Completed entire study treatment as per protocol - defined as completion of induction, consolidation and post-consolidation treatment phases|
59662231|NCT03512197|75781319|FG000|NOT COMPLETED|Overall Study||248||
59662232|NCT03512197|75781320|FG001|NOT COMPLETED|Overall Study||250||
59662233|NCT03502330|75781340|FG000|STARTED|Overall Study||3||
59662234|NCT03502330|75781341|FG001|STARTED|Overall Study||6||
59662235|NCT03502330|75781342|FG002|STARTED|Overall Study||3||
59662236|NCT03502330|75781343|FG003|STARTED|Overall Study||5||
59662237|NCT03502330|75781344|FG004|STARTED|Overall Study||3||
59662238|NCT03502330|75781345|FG005|STARTED|Overall Study||6||
59662239|NCT03502330|75781346|FG006|STARTED|Overall Study||8||
59662240|NCT03502330|75781347|FG007|STARTED|Overall Study||8||
59662241|NCT03502330|75781348|FG008|STARTED|Overall Study||0||
59662242|NCT03502330|75781340|FG000|COMPLETED|Overall Study||0||
59662243|NCT03502330|75781341|FG001|COMPLETED|Overall Study||0||
59662244|NCT03502330|75781342|FG002|COMPLETED|Overall Study||0||
59662245|NCT03502330|75781343|FG003|COMPLETED|Overall Study||0||
59662246|NCT03502330|75781344|FG004|COMPLETED|Overall Study||0||
59662247|NCT03502330|75781345|FG005|COMPLETED|Overall Study||0||
59662248|NCT03502330|75781346|FG006|COMPLETED|Overall Study||0||
59662249|NCT03502330|75781347|FG007|COMPLETED|Overall Study||0||
59662250|NCT03502330|75781348|FG008|COMPLETED|Overall Study||0||
59662251|NCT03502330|75781340|FG000|NOT COMPLETED|Overall Study||3||
59662252|NCT03502330|75781341|FG001|NOT COMPLETED|Overall Study||6||
59662253|NCT03502330|75781342|FG002|NOT COMPLETED|Overall Study||3||
59662254|NCT03502330|75781343|FG003|NOT COMPLETED|Overall Study||5||
59662255|NCT03502330|75781344|FG004|NOT COMPLETED|Overall Study||3||
59662256|NCT03502330|75781345|FG005|NOT COMPLETED|Overall Study||6||
59662257|NCT03502330|75781346|FG006|NOT COMPLETED|Overall Study||8||
59662258|NCT03502330|75781347|FG007|NOT COMPLETED|Overall Study||8||
59662259|NCT03502330|75781348|FG008|NOT COMPLETED|Overall Study||0||
59662260|NCT03460756|75781370|FG000|STARTED|Overall Study||2||
59662261|NCT03460756|75781371|FG001|STARTED|Overall Study||14||
59662262|NCT03460756|75781372|FG002|STARTED|Overall Study||25||
59662263|NCT03460756|75781373|FG003|STARTED|Overall Study||43||
59662264|NCT03460756|75781370|FG000|COMPLETED|Overall Study||2|2-week TID group was discontinued after 2 subjects were enrolled due to daytime TEAE of sedation and dizziness|
59662265|NCT03460756|75781371|FG001|COMPLETED|Overall Study||9|2-week TID group was discontinued after 2 subjects were enrolled due to daytime TEAE of sedation and dizziness|
59662266|NCT03460756|75781372|FG002|COMPLETED|Overall Study||16|2-week TID group was discontinued after 2 subjects were enrolled due to daytime TEAE of sedation and dizziness|
59662267|NCT03460756|75781373|FG003|COMPLETED|Overall Study||34|2-week TID group was discontinued after 2 subjects were enrolled due to daytime TEAE of sedation and dizziness|
59662268|NCT03460756|75781370|FG000|NOT COMPLETED|Overall Study||0||
59662269|NCT03460756|75781371|FG001|NOT COMPLETED|Overall Study||5||
59662270|NCT03460756|75781372|FG002|NOT COMPLETED|Overall Study||9||
59662271|NCT03460756|75781373|FG003|NOT COMPLETED|Overall Study||9||
59662272|NCT03459443|75781385|FG000|STARTED|Overall Study||22||
59662273|NCT03459443|75781385|FG000|Received at Least 1 Dose of Study Drug|Overall Study||22||
59662274|NCT03459443|75781385|FG000|COMPLETED|Overall Study||0||
59662275|NCT03459443|75781385|FG000|NOT COMPLETED|Overall Study||22||
59662276|NCT03339271|75781391|FG000|STARTED|Overall Study||195||
59662277|NCT03339271|75781392|FG001|STARTED|Overall Study||189||
59662278|NCT03339271|75781391|FG000|COMPLETED|Overall Study||195||
59662279|NCT03339271|75781392|FG001|COMPLETED|Overall Study||189||
59662280|NCT03339271|75781391|FG000|NOT COMPLETED|Overall Study||0||
59662281|NCT03339271|75781392|FG001|NOT COMPLETED|Overall Study||0||
59662282|NCT03316885|75781398|FG000|STARTED|Overall Study||215||430
59662283|NCT03316885|75781398|FG000|Implanted in First Eye Only|Overall Study||215||215
59662284|NCT03316885|75781398|FG000|Implanted in Second Eye Only|Overall Study||209||209
59662285|NCT03316885|75781398|FG000|Implanted in 1 Eye Only|Overall Study||6||6
59662286|NCT03316885|75781398|FG000|COMPLETED|Overall Study|One participant was monocular at Year 3.|183||365
59662287|NCT03316885|75781398|FG000|NOT COMPLETED|Overall Study||32||65
59662288|NCT03291847|75781405|FG000|STARTED|Overall Study||42||
59662289|NCT03291847|75781405|FG000|COMPLETED|Overall Study||24|There were 26 fetuses associated with 24 women|
59662290|NCT03291847|75781405|FG000|NOT COMPLETED|Overall Study||18||
59662291|NCT03283072|75781413|FG000|STARTED|Overall Study||7||
59662292|NCT03283072|75781414|FG001|STARTED|Overall Study||5||
59662293|NCT03283072|75781415|FG002|STARTED|Overall Study||5||
59662294|NCT03283072|75781416|FG003|STARTED|Overall Study||5||
59662295|NCT03283072|75781413|FG000|COMPLETED|Overall Study||5||
59662296|NCT03283072|75781414|FG001|COMPLETED|Overall Study||5||
59662297|NCT03283072|75781415|FG002|COMPLETED|Overall Study||5||
59662298|NCT03283072|75781416|FG003|COMPLETED|Overall Study||5||
59662299|NCT03283072|75781413|FG000|NOT COMPLETED|Overall Study||2||
59662300|NCT03283072|75781414|FG001|NOT COMPLETED|Overall Study||0||
59662301|NCT03283072|75781415|FG002|NOT COMPLETED|Overall Study||0||
59662302|NCT03283072|75781416|FG003|NOT COMPLETED|Overall Study||0||
59662303|NCT03259074|75781434|FG000|STARTED|Overall Study||287||
59662304|NCT03259074|75781435|FG001|STARTED|Overall Study||286||
59662305|NCT03259074|75781436|FG002|STARTED|Overall Study||286||
59662306|NCT03259074|75781434|FG000|COMPLETED|Overall Study||254||
59662307|NCT03259074|75781435|FG001|COMPLETED|Overall Study||237||
59662308|NCT03259074|75781436|FG002|COMPLETED|Overall Study||243||
59662309|NCT03259074|75781434|FG000|NOT COMPLETED|Overall Study||33||
59662310|NCT03259074|75781435|FG001|NOT COMPLETED|Overall Study||49||
59662311|NCT03259074|75781436|FG002|NOT COMPLETED|Overall Study||43||
59662312|NCT03159104|75781446|FG000|STARTED|Overall Study||122||
59662313|NCT03159104|75781447|FG001|STARTED|Overall Study||118||
59662314|NCT03159104|75781446|FG000|COMPLETED|Overall Study||121||
59662315|NCT03159104|75781447|FG001|COMPLETED|Overall Study||116||
59662316|NCT03159104|75781446|FG000|NOT COMPLETED|Overall Study||1||
59662317|NCT03159104|75781447|FG001|NOT COMPLETED|Overall Study||2||
59662318|NCT03149237|75781455|FG000|STARTED|Overall Study||1108||12
59662319|NCT03149237|75781456|FG001|STARTED|Overall Study||1052||12
59662320|NCT03149237|75781455|FG000|COMPLETED|Overall Study||1104||12
59662321|NCT03149237|75781456|FG001|COMPLETED|Overall Study||1047||12
59662322|NCT03149237|75781455|FG000|NOT COMPLETED|Overall Study||4||0
59662323|NCT03149237|75781456|FG001|NOT COMPLETED|Overall Study||5||0
59662324|NCT03132467|75781462|FG000|STARTED|Overall Study||8||
59662325|NCT03132467|75781462|FG000|COMPLETED|Overall Study||4||
59662326|NCT03132467|75781462|FG000|NOT COMPLETED|Overall Study||4||
59662327|NCT03127852|75781469|FG000|STARTED|Overall Study||46||
59662328|NCT03127852|75781470|FG001|STARTED|Overall Study||50||
59662329|NCT03127852|75781469|FG000|COMPLETED|Overall Study||41||
59662330|NCT03127852|75781470|FG001|COMPLETED|Overall Study||48||
59662331|NCT03127852|75781469|FG000|NOT COMPLETED|Overall Study||5||
59662332|NCT03127852|75781470|FG001|NOT COMPLETED|Overall Study||2||
59662333|NCT03107793|75781476|FG000|STARTED|Induction Period (16 Weeks)||498||
59662334|NCT03107793|75781477|FG001|STARTED|Induction Period (16 Weeks)||0||
59662335|NCT03107793|75781478|FG002|STARTED|Induction Period (16 Weeks)||0||
59662336|NCT03107793|75781479|FG003|STARTED|Induction Period (16 Weeks)||0||
59662337|NCT03107793|75781480|FG004|STARTED|Induction Period (16 Weeks)||0||
59662338|NCT03107793|75781476|FG000|Participants Who Entered the Maintenance Period|Induction Period (16 Weeks)||0||
59662339|NCT03107793|75781477|FG001|Participants Who Entered the Maintenance Period|Induction Period (16 Weeks)||219||
59662340|NCT03107793|75781478|FG002|Participants Who Entered the Maintenance Period|Induction Period (16 Weeks)||221||
59662341|NCT03107793|75781479|FG003|Participants Who Entered the Maintenance Period|Induction Period (16 Weeks)||0||
59662342|NCT03107793|75781480|FG004|Participants Who Entered the Maintenance Period|Induction Period (16 Weeks)||0||
59662343|NCT03107793|75781476|FG000|Participants Who Entered the Extension Period|Induction Period (16 Weeks)||0||
59662344|NCT03107793|75781477|FG001|Participants Who Entered the Extension Period|Induction Period (16 Weeks)||0||
59662345|NCT03107793|75781478|FG002|Participants Who Entered the Extension Period|Induction Period (16 Weeks)||0||
59662346|NCT03107793|75781479|FG003|Participants Who Entered the Extension Period|Induction Period (16 Weeks)||147||
59662347|NCT03107793|75781480|FG004|Participants Who Entered the Extension Period|Induction Period (16 Weeks)||176||
59662348|NCT03107793|75781476|FG000|COMPLETED|Induction Period (16 Weeks)||488||
59544591|NCT01010282|75643054|FG001|NOT COMPLETED|Overall Study||7||
59544592|NCT01010282|75643055|FG002|NOT COMPLETED|Overall Study||19||
59544593|NCT00953654|75643066|FG000|STARTED|Overall Study||10||
59544594|NCT00953654|75643067|FG001|STARTED|Overall Study||10||
59544595|NCT00953654|75643068|FG002|STARTED|Overall Study||10||
59544596|NCT00953654|75643066|FG000|COMPLETED|Overall Study||10||
59544597|NCT00953654|75643067|FG001|COMPLETED|Overall Study||10||
59544598|NCT00953654|75643068|FG002|COMPLETED|Overall Study||10||
59544599|NCT00953654|75643066|FG000|NOT COMPLETED|Overall Study||0||
59544600|NCT00953654|75643067|FG001|NOT COMPLETED|Overall Study||0||
59544601|NCT00953654|75643068|FG002|NOT COMPLETED|Overall Study||0||
59544602|NCT00955916|75643076|FG000|STARTED|Overall Study||38||
59544603|NCT00955916|75643076|FG000|COMPLETED|Overall Study||38||
59544604|NCT00955916|75643076|FG000|NOT COMPLETED|Overall Study||0||
59544605|NCT01010906|75643086|FG000|STARTED|Overall Study||10||
59544606|NCT01010906|75643087|FG001|STARTED|Overall Study||10||
59544607|NCT01010906|75643088|FG002|STARTED|Overall Study||10||
59544608|NCT01010906|75643089|FG003|STARTED|Overall Study||10||
59544609|NCT01010906|75643090|FG004|STARTED|Overall Study||10||
59544610|NCT01010906|75643091|FG005|STARTED|Overall Study||10||
59544611|NCT01010906|75643086|FG000|COMPLETED|Overall Study||10||
59544612|NCT01010906|75643087|FG001|COMPLETED|Overall Study||10||
59544613|NCT01010906|75643088|FG002|COMPLETED|Overall Study||10||
59544614|NCT01010906|75643089|FG003|COMPLETED|Overall Study||10||
59544615|NCT01010906|75643090|FG004|COMPLETED|Overall Study||10||
59544616|NCT01010906|75643091|FG005|COMPLETED|Overall Study||10||
59544617|NCT01010906|75643086|FG000|NOT COMPLETED|Overall Study||0||
59544618|NCT01010906|75643087|FG001|NOT COMPLETED|Overall Study||0||
59544619|NCT01010906|75643088|FG002|NOT COMPLETED|Overall Study||0||
59544620|NCT01010906|75643089|FG003|NOT COMPLETED|Overall Study||0||
59544621|NCT01010906|75643090|FG004|NOT COMPLETED|Overall Study||0||
59544622|NCT01010906|75643091|FG005|NOT COMPLETED|Overall Study||0||
59544623|NCT01668017|75643110|FG000|STARTED|Overall Study||4||
59544624|NCT01668017|75643111|FG001|STARTED|Overall Study||9||
59544625|NCT01668017|75643112|FG002|STARTED|Overall Study||6||
59544626|NCT01668017|75643113|FG003|STARTED|Overall Study||5||
59544627|NCT01668017|75643114|FG004|STARTED|Overall Study||2||
59544628|NCT01668017|75643110|FG000|COMPLETED|Overall Study||4||
59544629|NCT01668017|75643111|FG001|COMPLETED|Overall Study||9||
59544630|NCT01668017|75643112|FG002|COMPLETED|Overall Study||6||
59544631|NCT01668017|75643113|FG003|COMPLETED|Overall Study||5||
59544632|NCT01668017|75643114|FG004|COMPLETED|Overall Study||2||
59544633|NCT01668017|75643110|FG000|NOT COMPLETED|Overall Study||0||
59544634|NCT01668017|75643111|FG001|NOT COMPLETED|Overall Study||0||
59544635|NCT01668017|75643112|FG002|NOT COMPLETED|Overall Study||0||
59544636|NCT01668017|75643113|FG003|NOT COMPLETED|Overall Study||0||
59544637|NCT01668017|75643114|FG004|NOT COMPLETED|Overall Study||0||
59544638|NCT01010984|75643141|FG000|STARTED|Overall Study||20||
59544639|NCT01010984|75643141|FG000|COMPLETED|Overall Study||20||
59662349|NCT03107793|75781477|FG001|COMPLETED|Induction Period (16 Weeks)||0||
59662350|NCT03107793|75781478|FG002|COMPLETED|Induction Period (16 Weeks)||0||
59544640|NCT01010984|75643141|FG000|NOT COMPLETED|Overall Study||0||
59544641|NCT01011218|75643150|FG000|STARTED|Overall Study||9||
59544642|NCT01011218|75643151|FG001|STARTED|Overall Study||9||
59544643|NCT01011218|75643152|FG002|STARTED|Overall Study||26||
59544644|NCT01011218|75643153|FG003|STARTED|Overall Study||26||
59544645|NCT01011218|75643150|FG000|COMPLETED|Overall Study||9||
59544646|NCT01011218|75643151|FG001|COMPLETED|Overall Study||9||
59544647|NCT01011218|75643152|FG002|COMPLETED|Overall Study||26||
59544648|NCT01011218|75643153|FG003|COMPLETED|Overall Study||26||
59544649|NCT01011218|75643150|FG000|NOT COMPLETED|Overall Study||0||
59544650|NCT01011218|75643151|FG001|NOT COMPLETED|Overall Study||0||
59544651|NCT01011218|75643152|FG002|NOT COMPLETED|Overall Study||0||
59662351|NCT03107793|75781479|FG003|COMPLETED|Induction Period (16 Weeks)||0||
59662352|NCT03107793|75781480|FG004|COMPLETED|Induction Period (16 Weeks)||0||
59662353|NCT03107793|75781476|FG000|NOT COMPLETED|Induction Period (16 Weeks)||10||
59662354|NCT03107793|75781477|FG001|NOT COMPLETED|Induction Period (16 Weeks)||0||
59662355|NCT03107793|75781478|FG002|NOT COMPLETED|Induction Period (16 Weeks)||0||
59662356|NCT03107793|75781479|FG003|NOT COMPLETED|Induction Period (16 Weeks)||0||
59662357|NCT03107793|75781480|FG004|NOT COMPLETED|Induction Period (16 Weeks)||0||
59662358|NCT03107793|75781476|FG000|STARTED|Maintenance Period (Week 16-Week 48)||0||
59662359|NCT03107793|75781477|FG001|STARTED|Maintenance Period (Week 16-Week 48)||219||
59662360|NCT03107793|75781478|FG002|STARTED|Maintenance Period (Week 16-Week 48)||221||
59662361|NCT03107793|75781479|FG003|STARTED|Maintenance Period (Week 16-Week 48)||0||
59662362|NCT03107793|75781480|FG004|STARTED|Maintenance Period (Week 16-Week 48)||0||
59662363|NCT03107793|75781476|FG000|COMPLETED|Maintenance Period (Week 16-Week 48)||0||
59662364|NCT03107793|75781477|FG001|COMPLETED|Maintenance Period (Week 16-Week 48)||173||
59662365|NCT03107793|75781478|FG002|COMPLETED|Maintenance Period (Week 16-Week 48)||193||
59662366|NCT03107793|75781479|FG003|COMPLETED|Maintenance Period (Week 16-Week 48)||0||
59662367|NCT03107793|75781480|FG004|COMPLETED|Maintenance Period (Week 16-Week 48)||0||
59662368|NCT03107793|75781476|FG000|NOT COMPLETED|Maintenance Period (Week 16-Week 48)||0||
59662369|NCT03107793|75781477|FG001|NOT COMPLETED|Maintenance Period (Week 16-Week 48)||46||
59662370|NCT03107793|75781478|FG002|NOT COMPLETED|Maintenance Period (Week 16-Week 48)||28||
59662371|NCT03107793|75781479|FG003|NOT COMPLETED|Maintenance Period (Week 16-Week 48)||0||
59662372|NCT03107793|75781480|FG004|NOT COMPLETED|Maintenance Period (Week 16-Week 48)||0||
59662373|NCT03107793|75781476|FG000|STARTED|Extension Period (Week 48- Week 104)||0||
59662374|NCT03107793|75781477|FG001|STARTED|Extension Period (Week 48- Week 104)||0||
59662375|NCT03107793|75781478|FG002|STARTED|Extension Period (Week 48- Week 104)||0||
59662376|NCT03107793|75781479|FG003|STARTED|Extension Period (Week 48- Week 104)||147||
59662377|NCT03107793|75781480|FG004|STARTED|Extension Period (Week 48- Week 104)||176||
59662378|NCT03107793|75781476|FG000|COMPLETED|Extension Period (Week 48- Week 104)||0||
59662379|NCT03107793|75781477|FG001|COMPLETED|Extension Period (Week 48- Week 104)||0||
59662380|NCT03107793|75781478|FG002|COMPLETED|Extension Period (Week 48- Week 104)||0||
59662381|NCT03107793|75781479|FG003|COMPLETED|Extension Period (Week 48- Week 104)||119||
59662382|NCT03107793|75781480|FG004|COMPLETED|Extension Period (Week 48- Week 104)||139||
59662383|NCT03107793|75781476|FG000|NOT COMPLETED|Extension Period (Week 48- Week 104)||0||
59662384|NCT03107793|75781477|FG001|NOT COMPLETED|Extension Period (Week 48- Week 104)||0||
59662385|NCT03107793|75781478|FG002|NOT COMPLETED|Extension Period (Week 48- Week 104)||0||
59662386|NCT03107793|75781479|FG003|NOT COMPLETED|Extension Period (Week 48- Week 104)||28||
59662387|NCT03107793|75781480|FG004|NOT COMPLETED|Extension Period (Week 48- Week 104)||37||
59662388|NCT03013543|75781499|FG000|STARTED|Overall Study||19||
59662389|NCT03013543|75781500|FG001|STARTED|Overall Study||4||
59662390|NCT03013543|75781501|FG002|STARTED|Overall Study||10||
59662391|NCT03013543|75781502|FG003|STARTED|Overall Study||49||
59662392|NCT03013543|75781503|FG004|STARTED|Overall Study||33||
59662393|NCT03013543|75781504|FG005|STARTED|Overall Study||5||
59662394|NCT03013543|75781505|FG006|STARTED|Overall Study||27||
59662395|NCT03013543|75781506|FG007|STARTED|Overall Study||22||
59662396|NCT03013543|75781507|FG008|STARTED|Overall Study||12||
59662397|NCT03013543|75781508|FG009|STARTED|Overall Study||32||
59662398|NCT03013543|75781499|FG000|COMPLETED|Overall Study||19||
59662399|NCT03013543|75781500|FG001|COMPLETED|Overall Study||2||
59662400|NCT03013543|75781501|FG002|COMPLETED|Overall Study||7||
59662401|NCT03013543|75781502|FG003|COMPLETED|Overall Study||37||
59662402|NCT03013543|75781503|FG004|COMPLETED|Overall Study||22||
59662403|NCT03013543|75781504|FG005|COMPLETED|Overall Study||2||
59662404|NCT03013543|75781505|FG006|COMPLETED|Overall Study||20||
59662405|NCT03013543|75781506|FG007|COMPLETED|Overall Study||13||
59662406|NCT03013543|75781507|FG008|COMPLETED|Overall Study||9||
59662407|NCT03013543|75781508|FG009|COMPLETED|Overall Study||22||
59662408|NCT03013543|75781499|FG000|NOT COMPLETED|Overall Study||0||
59662409|NCT03013543|75781500|FG001|NOT COMPLETED|Overall Study||2||
59662410|NCT03013543|75781501|FG002|NOT COMPLETED|Overall Study||3||
59662411|NCT03013543|75781502|FG003|NOT COMPLETED|Overall Study||12||
59662412|NCT03013543|75781503|FG004|NOT COMPLETED|Overall Study||11||
59662413|NCT03013543|75781504|FG005|NOT COMPLETED|Overall Study||3||
59662414|NCT03013543|75781505|FG006|NOT COMPLETED|Overall Study||7||
59662415|NCT03013543|75781506|FG007|NOT COMPLETED|Overall Study||9||
59662416|NCT03013543|75781507|FG008|NOT COMPLETED|Overall Study||3||
59662417|NCT03013543|75781508|FG009|NOT COMPLETED|Overall Study||10||
59662418|NCT02978690|75781530|FG000|STARTED|Overall Study||7||
59815814|NCT03026283|75938216|FG005|NOT COMPLETED|Optimal Care/Stress Test/ICA||28||
59662419|NCT02978690|75781530|FG000|COMPLETED|Overall Study||7||
59662420|NCT02978690|75781530|FG000|NOT COMPLETED|Overall Study||0||
59662421|NCT02811549|75781534|FG000|STARTED|Overall Study||24||
59662422|NCT02811549|75781534|FG000|COMPLETED|Overall Study||14||
59662423|NCT02811549|75781534|FG000|NOT COMPLETED|Overall Study||10||
59662424|NCT02741323|75781540|FG000|STARTED|Overall Study||49||
59662425|NCT02741323|75781541|FG001|STARTED|Overall Study||48||
59709757|NCT01072149|75828523|FG003|NOT COMPLETED|Treatment Period 1 (28 Days)||0||
59662426|NCT02741323|75781540|FG000|COMPLETED|Overall Study||43|Provided at least 1-year survival data, completing the requirement for at least 1-3 years of follow-up in the study|
59662427|NCT02741323|75781541|FG001|COMPLETED|Overall Study||40|Provided at least 1-year survival data, completing the requirement for at least 1-3 years of follow-up in the study|
59662428|NCT02741323|75781540|FG000|NOT COMPLETED|Overall Study||6||
59662429|NCT02741323|75781541|FG001|NOT COMPLETED|Overall Study||8||
59662430|NCT02531217|75781547|FG000|STARTED|Overall Study||9||
59662431|NCT02531217|75781547|FG000|Received at Least One Dose of Study Drug|Overall Study||9||
59662432|NCT02531217|75781547|FG000|COMPLETED|Overall Study||9||
59662433|NCT02531217|75781547|FG000|NOT COMPLETED|Overall Study||0||
59662434|NCT02473926|75781553|FG000|STARTED|Overall Study||28||
59662435|NCT02473926|75781554|FG001|STARTED|Overall Study||22||
59662436|NCT02473926|75781553|FG000|COMPLETED|Overall Study||25||
59662437|NCT02473926|75781554|FG001|COMPLETED|Overall Study||22||
59662438|NCT02473926|75781553|FG000|NOT COMPLETED|Overall Study||3||
59662439|NCT02473926|75781554|FG001|NOT COMPLETED|Overall Study||0||
59662440|NCT02426125|75781562|FG000|STARTED|Overall Study||263||
59662441|NCT02426125|75781563|FG001|STARTED|Overall Study||267||
59662442|NCT02426125|75781562|FG000|Received at Least One Dose of Study Drug|Overall Study||258||
59662443|NCT02426125|75781563|FG001|Received at Least One Dose of Study Drug|Overall Study||265||
59662444|NCT02426125|75781562|FG000|COMPLETED|Overall Study||46||
59662445|NCT02426125|75781563|FG001|COMPLETED|Overall Study||39||
59662446|NCT02426125|75781562|FG000|NOT COMPLETED|Overall Study||217||
59662447|NCT02426125|75781563|FG001|NOT COMPLETED|Overall Study||228||
59662448|NCT02396134|75781573|FG000|STARTED|Overall Study||32||
59662449|NCT02396134|75781574|FG001|STARTED|Overall Study||29||
59662450|NCT02396134|75781573|FG000|COMPLETED|Overall Study||32||
59662451|NCT02396134|75781574|FG001|COMPLETED|Overall Study||29||
59662452|NCT02396134|75781573|FG000|NOT COMPLETED|Overall Study||0||
59662453|NCT02396134|75781574|FG001|NOT COMPLETED|Overall Study||0||
59662454|NCT02362594|75781582|FG000|STARTED|Overall Study||514||
59662455|NCT02362594|75781583|FG001|STARTED|Overall Study||505||
59662456|NCT02362594|75781582|FG000|Treated|Overall Study||509||
59662457|NCT02362594|75781583|FG001|Treated|Overall Study||502||
59662458|NCT02362594|75781582|FG000|Continuing Part 1 Adjuvant Therapy|Overall Study||41||
59662459|NCT02362594|75781583|FG001|Continuing Part 1 Adjuvant Therapy|Overall Study||21||
59662460|NCT02362594|75781582|FG000|COMPLETED|Overall Study||264|Completed Part 1 Adjuvant Therapy|
59662461|NCT02362594|75781583|FG001|COMPLETED|Overall Study||280|Completed Part 1 Adjuvant Therapy|
59662462|NCT02362594|75781582|FG000|NOT COMPLETED|Overall Study||250||
59662463|NCT02362594|75781583|FG001|NOT COMPLETED|Overall Study||225||
59662464|NCT02331277|75781591|FG000|STARTED|Overall Study||3||
59662465|NCT02331277|75781592|FG001|STARTED|Overall Study||9||
59662466|NCT02331277|75781591|FG000|COMPLETED|Overall Study||2||
59662467|NCT02331277|75781592|FG001|COMPLETED|Overall Study||9||
59662468|NCT02331277|75781591|FG000|NOT COMPLETED|Overall Study||1||
59662469|NCT02331277|75781592|FG001|NOT COMPLETED|Overall Study||0||
59662470|NCT02173509|75781601|FG000|STARTED|Overall Study||1679||
59662471|NCT02173509|75781602|FG001|STARTED|Overall Study||621||
59662472|NCT02173509|75781601|FG000|COMPLETED|Overall Study||1679||
59662473|NCT02173509|75781602|FG001|COMPLETED|Overall Study||621||
59662474|NCT02173509|75781601|FG000|NOT COMPLETED|Overall Study||0||
59662475|NCT02173509|75781602|FG001|NOT COMPLETED|Overall Study||0||
59662476|NCT02120365|75781610|FG000|STARTED|Overall Study||4||
59662477|NCT02120365|75781611|FG001|STARTED|Overall Study||4||
59662478|NCT02120365|75781612|FG002|STARTED|Overall Study||5||
59662479|NCT02120365|75781613|FG003|STARTED|Overall Study||4||
59662480|NCT02120365|75781614|FG004|STARTED|Overall Study||3||
59662481|NCT02120365|75781615|FG005|STARTED|Overall Study||2||
59662482|NCT02120365|75781610|FG000|COMPLETED|Overall Study||4||
59662483|NCT02120365|75781611|FG001|COMPLETED|Overall Study||4||
59662484|NCT02120365|75781612|FG002|COMPLETED|Overall Study||3||
59662485|NCT02120365|75781613|FG003|COMPLETED|Overall Study||0||
59662486|NCT02120365|75781614|FG004|COMPLETED|Overall Study||3||
59662487|NCT02120365|75781615|FG005|COMPLETED|Overall Study||0||
59662488|NCT02120365|75781610|FG000|NOT COMPLETED|Overall Study||0||
59662489|NCT02120365|75781611|FG001|NOT COMPLETED|Overall Study||0||
59662490|NCT02120365|75781612|FG002|NOT COMPLETED|Overall Study||2||
59662491|NCT02120365|75781613|FG003|NOT COMPLETED|Overall Study||4||
59662492|NCT02120365|75781614|FG004|NOT COMPLETED|Overall Study||0||
59662493|NCT02120365|75781615|FG005|NOT COMPLETED|Overall Study||2||
59662494|NCT02046395|75781638|FG000|STARTED|Pre RAS Blockade Washout Period||28||
59662495|NCT02046395|75781638|FG000|COMPLETED|Pre RAS Blockade Washout Period||28||
59662496|NCT02046395|75781638|FG000|NOT COMPLETED|Pre RAS Blockade Washout Period||0||
59662497|NCT02046395|75781638|FG000|STARTED|RAS Blockade Washout Period||28||
59662498|NCT02046395|75781638|FG000|COMPLETED|RAS Blockade Washout Period||28||
59662499|NCT02046395|75781638|FG000|NOT COMPLETED|RAS Blockade Washout Period||0||
59662500|NCT02046395|75781638|FG000|STARTED|Post RAS Blockade Washout Period||28||
59662501|NCT02046395|75781638|FG000|COMPLETED|Post RAS Blockade Washout Period||27||
59662502|NCT02046395|75781638|FG000|NOT COMPLETED|Post RAS Blockade Washout Period||1||
59662503|NCT01982786|75781646|FG000|STARTED|Overall Study||29||
59662504|NCT01982786|75781647|FG001|STARTED|Overall Study||28||
59662505|NCT01982786|75781646|FG000|COMPLETED|Overall Study||29||
59544652|NCT01011218|75643153|FG003|NOT COMPLETED|Overall Study||0||
59544653|NCT01670201|75643163|FG000|STARTED|Overall Study||8||
59544654|NCT01670201|75643163|FG000|COMPLETED|Overall Study||8||
59544655|NCT01670201|75643163|FG000|NOT COMPLETED|Overall Study||0||
59544656|NCT02245217|75643167|FG000|STARTED|Overall Study||9||
59544657|NCT02245217|75643167|FG000|COMPLETED|Overall Study||7||
59544658|NCT02245217|75643167|FG000|NOT COMPLETED|Overall Study||2||
59544659|NCT01012388|75643171|FG000|STARTED|Overall Study||100||
59544660|NCT01012388|75643171|FG000|COMPLETED|Overall Study||100||
59544661|NCT01012388|75643171|FG000|NOT COMPLETED|Overall Study||0||
59544662|NCT01670825|75643177|FG000|STARTED|Overall Study||42||
59544663|NCT01670825|75643178|FG001|STARTED|Overall Study||39||
59544664|NCT01670825|75643177|FG000|COMPLETED|Overall Study||42||
59988977|NCT02262754|76104245|FG001|NOT COMPLETED|Overall Study||9||
59988978|NCT02262754|76104246|FG002|NOT COMPLETED|Overall Study||9||
59988979|NCT02262364|76104256|FG000|STARTED|Study Enrollment||11||
59988980|NCT02262364|76104256|FG000|COMPLETED|Study Enrollment||11||
59544665|NCT01670825|75643178|FG001|COMPLETED|Overall Study||39||
59544666|NCT01670825|75643177|FG000|NOT COMPLETED|Overall Study||0||
59544667|NCT01670825|75643178|FG001|NOT COMPLETED|Overall Study||0||
59544668|NCT00956540|75643190|FG000|STARTED|Overall Study||54||
59988981|NCT02262364|76104256|FG000|NOT COMPLETED|Study Enrollment||0||
59988982|NCT02262364|76104256|FG000|STARTED|Blood Draw for Device Processing||11||
59988983|NCT02262364|76104256|FG000|COMPLETED|Blood Draw for Device Processing||10||
59988984|NCT02262364|76104256|FG000|NOT COMPLETED|Blood Draw for Device Processing||1||
59988985|NCT02262364|76104256|FG000|STARTED|Injection With APS||10||
59988986|NCT02262364|76104256|FG000|COMPLETED|Injection With APS||10||
59988987|NCT02262364|76104256|FG000|NOT COMPLETED|Injection With APS||0||
59988988|NCT02262364|76104256|FG000|STARTED|Follow-Up Through 12 Months||10||
59988989|NCT02262364|76104256|FG000|COMPLETED|Follow-Up Through 12 Months||10||
59988990|NCT02262364|76104256|FG000|NOT COMPLETED|Follow-Up Through 12 Months||0||
59988991|NCT02261974|76104262|FG000|STARTED|Overall Study||123||
60077231|NCT01894243|76192290|FG001|Completed Treatment in Part A|Overall Study||10||
60077232|NCT01894243|76192291|FG002|Completed Treatment in Part A|Overall Study||8||
60077233|NCT01894243|76192289|FG000|Ongoing Into Part B|Overall Study||13||
60077234|NCT01894243|76192290|FG001|Ongoing Into Part B|Overall Study||10||
60077235|NCT01894243|76192291|FG002|Ongoing Into Part B|Overall Study||8||
60077236|NCT01894243|76192289|FG000|COMPLETED|Overall Study||0|Completed treatment in Part B|
60077237|NCT01894243|76192290|FG001|COMPLETED|Overall Study||0|Completed treatment in Part B|
60077238|NCT01894243|76192291|FG002|COMPLETED|Overall Study||0|Completed treatment in Part B|
60077239|NCT01894243|76192289|FG000|NOT COMPLETED|Overall Study||13||
60077240|NCT01894243|76192290|FG001|NOT COMPLETED|Overall Study||10||
60077241|NCT01894243|76192291|FG002|NOT COMPLETED|Overall Study||8||
60077242|NCT03822832|76192308|FG000|STARTED|Period 1 - Double Blind Period||18||
60077243|NCT03822832|76192309|FG001|STARTED|Period 1 - Double Blind Period||33||
60077244|NCT03822832|76192308|FG000|COMPLETED|Period 1 - Double Blind Period||8||
60077245|NCT03822832|76192309|FG001|COMPLETED|Period 1 - Double Blind Period||22||
59544669|NCT00956540|75643191|FG001|STARTED|Overall Study||50||
59544670|NCT00956540|75643192|FG002|STARTED|Overall Study||46||
59544671|NCT00956540|75643193|FG003|STARTED|Overall Study||45||
59544672|NCT00956540|75643190|FG000|COMPLETED|Overall Study||51||
59988992|NCT02261974|76104263|FG001|STARTED|Overall Study||63||
59662506|NCT01982786|75781647|FG001|COMPLETED|Overall Study||28||
59662507|NCT01982786|75781646|FG000|NOT COMPLETED|Overall Study||0||
59662508|NCT01982786|75781647|FG001|NOT COMPLETED|Overall Study||0||
59662509|NCT01854775|75781656|FG000|STARTED|Treatment Phase (48 Weeks)||50||
59662510|NCT01854775|75781657|FG001|STARTED|Treatment Phase (48 Weeks)||52||
59662511|NCT01854775|75781658|FG002|STARTED|Treatment Phase (48 Weeks)||27||
59662512|NCT01854775|75781656|FG000|COMPLETED|Treatment Phase (48 Weeks)||48||
59662513|NCT01854775|75781657|FG001|COMPLETED|Treatment Phase (48 Weeks)||51||
59662514|NCT01854775|75781658|FG002|COMPLETED|Treatment Phase (48 Weeks)||18||
59662515|NCT01854775|75781656|FG000|NOT COMPLETED|Treatment Phase (48 Weeks)||2||
59662516|NCT01854775|75781657|FG001|NOT COMPLETED|Treatment Phase (48 Weeks)||1||
59662517|NCT01854775|75781658|FG002|NOT COMPLETED|Treatment Phase (48 Weeks)||9||
59662518|NCT01854775|75781656|FG000|STARTED|Extension Phase||48||
59662519|NCT01854775|75781657|FG001|STARTED|Extension Phase||50||
59662520|NCT01854775|75781658|FG002|STARTED|Extension Phase||18||
59662521|NCT01854775|75781656|FG000|COMPLETED|Extension Phase||9||
59662522|NCT01854775|75781657|FG001|COMPLETED|Extension Phase||3||
59662523|NCT01854775|75781658|FG002|COMPLETED|Extension Phase||0||
59662524|NCT01854775|75781656|FG000|NOT COMPLETED|Extension Phase||39||
59662525|NCT01854775|75781657|FG001|NOT COMPLETED|Extension Phase||47||
59662526|NCT01854775|75781658|FG002|NOT COMPLETED|Extension Phase||18||
59662527|NCT01367301|75781666|FG000|STARTED|Overall Study||11||
59662528|NCT01367301|75781666|FG000|COMPLETED|Overall Study||11||
59662529|NCT01367301|75781666|FG000|NOT COMPLETED|Overall Study||0||
59662530|NCT01314313|75781672|FG000|STARTED|Overall Study||1011||
59662531|NCT01314313|75781673|FG001|STARTED|Overall Study||1021||
59662532|NCT01314313|75781672|FG000|As Treated|Overall Study||994||
59662533|NCT01314313|75781673|FG001|As Treated|Overall Study||944||
59662534|NCT01314313|75781672|FG000|Valve Implanted|Overall Study||974||
59662535|NCT01314313|75781673|FG001|Valve Implanted|Overall Study||936||
59662536|NCT01314313|75781672|FG000|COMPLETED|Overall Study||784|This is two year follow-up|
59662537|NCT01314313|75781673|FG001|COMPLETED|Overall Study||710|This is two year follow-up|
59662538|NCT01314313|75781672|FG000|NOT COMPLETED|Overall Study||227||
59662539|NCT01314313|75781673|FG001|NOT COMPLETED|Overall Study||311||
59662540|NCT01166594|75781683|FG000|STARTED|Overall Study||30||
59662541|NCT01166594|75781684|FG001|STARTED|Overall Study||29||
59662542|NCT01166594|75781683|FG000|COMPLETED|Overall Study||23||
59662543|NCT01166594|75781684|FG001|COMPLETED|Overall Study||24||
59662544|NCT01166594|75781683|FG000|NOT COMPLETED|Overall Study||7||
59662545|NCT01166594|75781684|FG001|NOT COMPLETED|Overall Study||5||
59662546|NCT01078909|75781695|FG000|STARTED|Overall Study||25||
59662547|NCT01078909|75781696|FG001|STARTED|Overall Study||25||
59662548|NCT01078909|75781697|FG002|STARTED|Overall Study||25||
59662549|NCT01078909|75781698|FG003|STARTED|Overall Study||25||
59662550|NCT01078909|75781699|FG004|STARTED|Overall Study||25||
59662551|NCT01078909|75781695|FG000|COMPLETED|Overall Study||23||
59662552|NCT01078909|75781696|FG001|COMPLETED|Overall Study||21||
59662553|NCT01078909|75781697|FG002|COMPLETED|Overall Study||24||
59662554|NCT01078909|75781698|FG003|COMPLETED|Overall Study||24||
59662555|NCT01078909|75781699|FG004|COMPLETED|Overall Study||23||
59662556|NCT01078909|75781695|FG000|NOT COMPLETED|Overall Study||2||
59662557|NCT01078909|75781696|FG001|NOT COMPLETED|Overall Study||4||
59662558|NCT01078909|75781697|FG002|NOT COMPLETED|Overall Study||1||
59662559|NCT01078909|75781698|FG003|NOT COMPLETED|Overall Study||1||
59662560|NCT01078909|75781699|FG004|NOT COMPLETED|Overall Study||2||
59662561|NCT00938340|75781711|FG000|STARTED|Overall Study||20||
59662562|NCT00938340|75781711|FG000|Received Whole Walnut Intervention|Overall Study||16||
59662563|NCT00938340|75781711|FG000|Received Walnut Nutmeat Intervention|Overall Study||19||
59662564|NCT00938340|75781711|FG000|Received Walnut Skins Intervention|Overall Study||15||
59662565|NCT00938340|75781711|FG000|Received Walnut Oil Intervention|Overall Study||15||
59662566|NCT00938340|75781711|FG000|COMPLETED|Overall Study||15||
59662567|NCT00938340|75781711|FG000|NOT COMPLETED|Overall Study||5||
59662568|NCT00585650|75781759|FG000|STARTED|Overall Study||8||
59662569|NCT00585650|75781760|FG001|STARTED|Overall Study||12||
59662570|NCT00585650|75781759|FG000|COMPLETED|Overall Study||8||
59662571|NCT00585650|75781760|FG001|COMPLETED|Overall Study||12||
59662572|NCT00585650|75781759|FG000|NOT COMPLETED|Overall Study||0||
59662573|NCT00585650|75781760|FG001|NOT COMPLETED|Overall Study||0||
59662574|NCT00539643|75781768|FG000|STARTED|Overall Study||51||
59662575|NCT00539643|75781769|FG001|STARTED|Overall Study||50||
59662576|NCT00539643|75781768|FG000|COMPLETED|Overall Study||45||
59662577|NCT00539643|75781769|FG001|COMPLETED|Overall Study||47||
59662578|NCT00539643|75781768|FG000|NOT COMPLETED|Overall Study||6||
59662579|NCT00539643|75781769|FG001|NOT COMPLETED|Overall Study||3||
59662580|NCT00080912|75781777|FG000|STARTED|Overall Study||425||
59662581|NCT00080912|75781778|FG001|STARTED|Overall Study||425||
59662582|NCT00080912|75781777|FG000|COMPLETED|Overall Study||425||
59662583|NCT00080912|75781778|FG001|COMPLETED|Overall Study||425||
59662584|NCT00080912|75781777|FG000|NOT COMPLETED|Overall Study||0||
59662585|NCT00080912|75781778|FG001|NOT COMPLETED|Overall Study||0||
59662586|NCT00039130|75781784|FG000|STARTED|Overall Study||105||
59662587|NCT00039130|75781784|FG000|COMPLETED|Overall Study||75||
59662588|NCT00039130|75781784|FG000|NOT COMPLETED|Overall Study||30||
59662589|NCT00005957|75781790|FG000|STARTED|Overall Study||916||
59662590|NCT00005957|75781791|FG001|STARTED|Overall Study||916||
59662591|NCT00005957|75781790|FG000|COMPLETED|Overall Study||908||
59662592|NCT00005957|75781791|FG001|COMPLETED|Overall Study||888||
59662593|NCT00005957|75781790|FG000|NOT COMPLETED|Overall Study||8||
59662594|NCT00005957|75781791|FG001|NOT COMPLETED|Overall Study||28||
59662595|NCT03690544|75781797|FG000|STARTED|Overall Study||15||
59662596|NCT03690544|75781797|FG000|COMPLETED|Overall Study||15||
59662597|NCT03690544|75781797|FG000|NOT COMPLETED|Overall Study||0||
59662598|NCT03325426|75781803|FG000|STARTED|Overall Study||21||
59662599|NCT03325426|75781804|FG001|STARTED|Overall Study||42||
59662600|NCT03325426|75781803|FG000|COMPLETED|Overall Study||11||
59662601|NCT03325426|75781804|FG001|COMPLETED|Overall Study||18||
59662602|NCT03325426|75781803|FG000|NOT COMPLETED|Overall Study||10||
59662603|NCT03325426|75781804|FG001|NOT COMPLETED|Overall Study||24||
59662604|NCT03195088|75781816|FG000|STARTED|Overall Study||4|Started are treated|
59662605|NCT03195088|75781817|FG001|STARTED|Overall Study||6|Started are treated|
59662606|NCT03195088|75781818|FG002|STARTED|Overall Study||6|Started are treated|
59662607|NCT03195088|75781816|FG000|COMPLETED|Overall Study||4||
59662608|NCT03195088|75781817|FG001|COMPLETED|Overall Study||6||
59662609|NCT03195088|75781818|FG002|COMPLETED|Overall Study||6||
59662610|NCT03195088|75781816|FG000|NOT COMPLETED|Overall Study||0||
59662611|NCT03195088|75781817|FG001|NOT COMPLETED|Overall Study||0||
59662612|NCT03195088|75781818|FG002|NOT COMPLETED|Overall Study||0||
59662613|NCT02838979|75781830|FG000|STARTED|Overall Study||6||
59662614|NCT02838979|75781831|FG001|STARTED|Overall Study||5||
59662615|NCT02838979|75781830|FG000|COMPLETED|Overall Study||6||
59662616|NCT02838979|75781831|FG001|COMPLETED|Overall Study||5||
59662617|NCT02838979|75781830|FG000|NOT COMPLETED|Overall Study||0||
59662618|NCT02838979|75781831|FG001|NOT COMPLETED|Overall Study||0||
59662619|NCT02728726|75781839|FG000|STARTED|Overall Study||127||
59662620|NCT02728726|75781840|FG001|STARTED|Overall Study||133||
59662621|NCT02728726|75781839|FG000|COMPLETED|Overall Study||127||
59662622|NCT02728726|75781840|FG001|COMPLETED|Overall Study||133||
59662623|NCT02728726|75781839|FG000|NOT COMPLETED|Overall Study||0||
59662624|NCT02728726|75781840|FG001|NOT COMPLETED|Overall Study||0||
59662625|NCT01691833|75781849|FG000|STARTED|Overall Study||50||
59662626|NCT01691833|75781850|FG001|STARTED|Overall Study||50||
59662627|NCT01691833|75781851|FG002|STARTED|Overall Study||13||
59662628|NCT01691833|75781849|FG000|COMPLETED|Overall Study||49||
59662629|NCT01691833|75781850|FG001|COMPLETED|Overall Study||49||
59662630|NCT01691833|75781851|FG002|COMPLETED|Overall Study||13||
59662631|NCT01691833|75781849|FG000|NOT COMPLETED|Overall Study||1||
59662632|NCT01691833|75781850|FG001|NOT COMPLETED|Overall Study||1||
59662633|NCT01691833|75781851|FG002|NOT COMPLETED|Overall Study||0||
59662634|NCT03944486|75781859|FG000|STARTED|Overall Study||24||
59662635|NCT03944486|75781859|FG000|COMPLETED|Overall Study||12||
59662636|NCT03944486|75781859|FG000|NOT COMPLETED|Overall Study||12||
59662637|NCT03352427|75781865|FG000|STARTED|Overall Study||3||
59662638|NCT03352427|75781865|FG000|COMPLETED|Overall Study||3||
59662639|NCT03352427|75781865|FG000|NOT COMPLETED|Overall Study||0||
59662640|NCT05127018|75781869|FG000|STARTED|the Average-dose Period||33|With the average-dose method, the dose was individualized according to the severity of anterior gingival exposure pretreatment.|
59662641|NCT05127018|75781869|FG000|COMPLETED|the Average-dose Period||33||
59662642|NCT05127018|75781869|FG000|NOT COMPLETED|the Average-dose Period||0||
59662643|NCT05127018|75781869|FG000|STARTED|the Higher-dose Method Period||33|With this method, patients were administered botulinum toxin type A after 8 months when the effect of the previous injection had vanished. The injection dose (U) per side was set as the absolute value of the preoperative anterior gingival exposure (mm).|
59662644|NCT05127018|75781869|FG000|COMPLETED|the Higher-dose Method Period||33||
59662645|NCT05127018|75781869|FG000|NOT COMPLETED|the Higher-dose Method Period||0||
59662646|NCT04920916|75781877|FG000|STARTED|Phase IIa 60 Day Study||19||
59662647|NCT04920916|75781878|FG001|STARTED|Phase IIa 60 Day Study||21||
60077246|NCT03822832|76192308|FG000|NOT COMPLETED|Period 1 - Double Blind Period||10||
59662648|NCT04920916|75781877|FG000|COMPLETED|Phase IIa 60 Day Study||17||
59662649|NCT04920916|75781878|FG001|COMPLETED|Phase IIa 60 Day Study||16||
59662650|NCT04920916|75781877|FG000|NOT COMPLETED|Phase IIa 60 Day Study||2||
60077247|NCT03822832|76192309|FG001|NOT COMPLETED|Period 1 - Double Blind Period||11||
59662651|NCT04920916|75781878|FG001|NOT COMPLETED|Phase IIa 60 Day Study||5||
59662652|NCT04920916|75781877|FG000|STARTED|1 Year Follow up (Phone Call)||17||
59662653|NCT04920916|75781878|FG001|STARTED|1 Year Follow up (Phone Call)||16||
59815815|NCT03026283|75938217|FG006|NOT COMPLETED|Optimal Care/Stress Test/ICA||0||
60077248|NCT03822832|76192308|FG000|STARTED|Re-allocation||8||
60077249|NCT03822832|76192309|FG001|STARTED|Re-allocation||22||
60077250|NCT03822832|76192308|FG000|COMPLETED|Re-allocation|Patient re-allocated to open label Spesolimab treatment|6|Patient re-allocated to open label Spesolimab treatment|
60103615|NCT01291108|76221866|FG003|NOT COMPLETED|Month 1 (Monotherapy)||0||
59662654|NCT04920916|75781877|FG000|COMPLETED|1 Year Follow up (Phone Call)||16||
59662655|NCT04920916|75781878|FG001|COMPLETED|1 Year Follow up (Phone Call)||13||
59662656|NCT04920916|75781877|FG000|NOT COMPLETED|1 Year Follow up (Phone Call)||1||
59662657|NCT04920916|75781878|FG001|NOT COMPLETED|1 Year Follow up (Phone Call)||3||
59662658|NCT04920916|75781877|FG000|STARTED|1 Year Follow up Visits||16||
59662659|NCT04920916|75781878|FG001|STARTED|1 Year Follow up Visits||13||
59662660|NCT04920916|75781877|FG000|COMPLETED|1 Year Follow up Visits||10||
59662661|NCT04920916|75781878|FG001|COMPLETED|1 Year Follow up Visits||6||
59662662|NCT04920916|75781877|FG000|NOT COMPLETED|1 Year Follow up Visits||6||
59662663|NCT04920916|75781878|FG001|NOT COMPLETED|1 Year Follow up Visits||7||
59662664|NCT04419493|75781891|FG000|STARTED|Period 1||6||
59662665|NCT04419493|75781892|FG001|STARTED|Period 1||6||
59662666|NCT04419493|75781893|FG002|STARTED|Period 1||9||
59662667|NCT04419493|75781894|FG003|STARTED|Period 1||9||
59662668|NCT04419493|75781891|FG000|COMPLETED|Period 1||6||
59662669|NCT04419493|75781892|FG001|COMPLETED|Period 1||6||
59662670|NCT04419493|75781893|FG002|COMPLETED|Period 1||9||
59662671|NCT04419493|75781894|FG003|COMPLETED|Period 1||9||
59662672|NCT04419493|75781891|FG000|NOT COMPLETED|Period 1||0||
59662673|NCT04419493|75781892|FG001|NOT COMPLETED|Period 1||0||
59662674|NCT04419493|75781893|FG002|NOT COMPLETED|Period 1||0||
59662675|NCT04419493|75781894|FG003|NOT COMPLETED|Period 1||0||
59662676|NCT04419493|75781891|FG000|STARTED|Wash-out After Period 1||6||
59662677|NCT04419493|75781892|FG001|STARTED|Wash-out After Period 1||6||
59662678|NCT04419493|75781893|FG002|STARTED|Wash-out After Period 1||9||
59662679|NCT04419493|75781894|FG003|STARTED|Wash-out After Period 1||9||
59662680|NCT04419493|75781891|FG000|COMPLETED|Wash-out After Period 1||5||
59662681|NCT04419493|75781892|FG001|COMPLETED|Wash-out After Period 1||4||
59662682|NCT04419493|75781893|FG002|COMPLETED|Wash-out After Period 1||8||
59662683|NCT04419493|75781894|FG003|COMPLETED|Wash-out After Period 1||9||
59662684|NCT04419493|75781891|FG000|NOT COMPLETED|Wash-out After Period 1||1||
59662685|NCT04419493|75781892|FG001|NOT COMPLETED|Wash-out After Period 1||2||
59662686|NCT04419493|75781893|FG002|NOT COMPLETED|Wash-out After Period 1||1||
59662687|NCT04419493|75781894|FG003|NOT COMPLETED|Wash-out After Period 1||0||
59662688|NCT04419493|75781891|FG000|STARTED|Period 2||5||
59662689|NCT04419493|75781892|FG001|STARTED|Period 2||4||
59662690|NCT04419493|75781893|FG002|STARTED|Period 2||8||
59662691|NCT04419493|75781894|FG003|STARTED|Period 2||9||
59662692|NCT04419493|75781891|FG000|COMPLETED|Period 2||5||
59662693|NCT04419493|75781892|FG001|COMPLETED|Period 2||4||
59662694|NCT04419493|75781893|FG002|COMPLETED|Period 2||8||
59662695|NCT04419493|75781894|FG003|COMPLETED|Period 2||9||
59662696|NCT04419493|75781891|FG000|NOT COMPLETED|Period 2||0||
59662697|NCT04419493|75781892|FG001|NOT COMPLETED|Period 2||0||
59662698|NCT04419493|75781893|FG002|NOT COMPLETED|Period 2||0||
59662699|NCT04419493|75781894|FG003|NOT COMPLETED|Period 2||0||
59662700|NCT04334876|75781905|FG000|STARTED|Overall Study||571||
59662701|NCT04334876|75781905|FG000|COMPLETED|Overall Study||500||
59662702|NCT04334876|75781905|FG000|NOT COMPLETED|Overall Study||71||
59662703|NCT04229095|75781911|FG000|STARTED|Overall Study||14||
59662704|NCT04229095|75781912|FG001|STARTED|Overall Study||12||
59662705|NCT04229095|75781911|FG000|COMPLETED|Overall Study||14||
59662706|NCT04229095|75781912|FG001|COMPLETED|Overall Study||12||
59662707|NCT04229095|75781911|FG000|NOT COMPLETED|Overall Study||0||
59662708|NCT04229095|75781912|FG001|NOT COMPLETED|Overall Study||0||
59662709|NCT04147611|75781922|FG000|STARTED|Overall Study||9||
59662710|NCT04147611|75781923|FG001|STARTED|Overall Study||13||
59662711|NCT04147611|75781922|FG000|COMPLETED|Overall Study||9||
59662712|NCT04147611|75781923|FG001|COMPLETED|Overall Study||12||
59662713|NCT04147611|75781922|FG000|NOT COMPLETED|Overall Study||0||
59662714|NCT04147611|75781923|FG001|NOT COMPLETED|Overall Study||1||
59662715|NCT04006288|75781935|FG000|STARTED|Overall Study||15||
59662716|NCT04006288|75781936|FG001|STARTED|Overall Study||15||
59662717|NCT04006288|75781937|FG002|STARTED|Overall Study||15||
59662718|NCT04006288|75781938|FG003|STARTED|Overall Study||15||
59662719|NCT04006288|75781939|FG004|STARTED|Overall Study||15||
59662720|NCT04006288|75781940|FG005|STARTED|Overall Study||15||
59662721|NCT04006288|75781935|FG000|COMPLETED|Overall Study||14||
59662722|NCT04006288|75781936|FG001|COMPLETED|Overall Study||14||
59662723|NCT04006288|75781937|FG002|COMPLETED|Overall Study||15||
59815816|NCT03026283|75938218|FG007|NOT COMPLETED|Optimal Care/Stress Test/ICA||0||
59662724|NCT04006288|75781938|FG003|COMPLETED|Overall Study||15||
59662725|NCT04006288|75781939|FG004|COMPLETED|Overall Study||15||
59662726|NCT04006288|75781940|FG005|COMPLETED|Overall Study||15||
59662727|NCT04006288|75781935|FG000|NOT COMPLETED|Overall Study||1||
59662728|NCT04006288|75781936|FG001|NOT COMPLETED|Overall Study||1||
59662729|NCT04006288|75781937|FG002|NOT COMPLETED|Overall Study||0||
59662730|NCT04006288|75781938|FG003|NOT COMPLETED|Overall Study||0||
59662731|NCT04006288|75781939|FG004|NOT COMPLETED|Overall Study||0||
59662732|NCT04006288|75781940|FG005|NOT COMPLETED|Overall Study||0||
59662733|NCT03603964|75781954|FG000|STARTED|Overall Study||35||
59662734|NCT03603964|75781954|FG000|COMPLETED|Overall Study||0||
59662735|NCT03603964|75781954|FG000|NOT COMPLETED|Overall Study||35||
59662736|NCT03495921|75781960|FG000|STARTED|Main Study||3||
59662737|NCT03495921|75781961|FG001|STARTED|Main Study||2||
59662738|NCT03495921|75781960|FG000|COMPLETED|Main Study||3||
59662739|NCT03495921|75781961|FG001|COMPLETED|Main Study||2||
59662740|NCT03495921|75781960|FG000|NOT COMPLETED|Main Study||0||
59662741|NCT03495921|75781961|FG001|NOT COMPLETED|Main Study||0||
59662742|NCT03495921|75781960|FG000|STARTED|Group B Crossover to Vigil Alone|Crossover is not applicable to Group A.|0||
59662743|NCT03495921|75781961|FG001|STARTED|Group B Crossover to Vigil Alone|Only one subject from Group B was eligible to Crossover to receive treatment with Vigil.|1||
59662744|NCT03495921|75781960|FG000|COMPLETED|Group B Crossover to Vigil Alone||0||
59662745|NCT03495921|75781961|FG001|COMPLETED|Group B Crossover to Vigil Alone||1||
59662746|NCT03495921|75781960|FG000|NOT COMPLETED|Group B Crossover to Vigil Alone||0||
59662747|NCT03495921|75781961|FG001|NOT COMPLETED|Group B Crossover to Vigil Alone||0||
59662748|NCT03191864|75781974|FG000|STARTED|Baseline Symptom Assessment||0|Due to the high placebo response rates, the study utilized a 4-week single-blind placebo run-in period to not only establish the baseline symptoms for the study, but also to ensure that all subjects enrolled had sufficient severity of EoE to warrant inclusion in the study.|
59662749|NCT03191864|75781975|FG001|STARTED|Baseline Symptom Assessment||0|Due to the high placebo response rates, the study utilized a 4-week single-blind placebo run-in period to not only establish the baseline symptoms for the study, but also to ensure that all subjects enrolled had sufficient severity of EoE to warrant inclusion in the study.|
59662750|NCT03191864|75781976|FG002|STARTED|Baseline Symptom Assessment||0|Due to the high placebo response rates, the study utilized a 4-week single-blind placebo run-in period to not only establish the baseline symptoms for the study, but also to ensure that all subjects enrolled had sufficient severity of EoE to warrant inclusion in the study.|
59662751|NCT03191864|75781977|FG003|STARTED|Baseline Symptom Assessment||0|Due to the high placebo response rates, the study utilized a 4-week single-blind placebo run-in period to not only establish the baseline symptoms for the study, but also to ensure that all subjects enrolled had sufficient severity of EoE to warrant inclusion in the study.|
59662752|NCT03191864|75781978|FG004|STARTED|Baseline Symptom Assessment||0|Due to the high placebo response rates, the study utilized a 4-week single-blind placebo run-in period to not only establish the baseline symptoms for the study, but also to ensure that all subjects enrolled had sufficient severity of EoE to warrant inclusion in the study.|
59662753|NCT03191864|75781979|FG005|STARTED|Baseline Symptom Assessment||308|Due to the high placebo response rates, the study utilized a 4-week single-blind placebo run-in period to not only establish the baseline symptoms for the study, but also to ensure that all subjects enrolled had sufficient severity of EoE to warrant inclusion in the study.|
59662754|NCT03191864|75781974|FG000|COMPLETED|Baseline Symptom Assessment||0||
59662755|NCT03191864|75781975|FG001|COMPLETED|Baseline Symptom Assessment||0||
59662756|NCT03191864|75781976|FG002|COMPLETED|Baseline Symptom Assessment||0||
59662757|NCT03191864|75781977|FG003|COMPLETED|Baseline Symptom Assessment||0||
59662758|NCT03191864|75781978|FG004|COMPLETED|Baseline Symptom Assessment||0||
59662759|NCT03191864|75781979|FG005|COMPLETED|Baseline Symptom Assessment||106||
59662760|NCT03191864|75781974|FG000|NOT COMPLETED|Baseline Symptom Assessment||0||
59662761|NCT03191864|75781975|FG001|NOT COMPLETED|Baseline Symptom Assessment||0||
59662762|NCT03191864|75781976|FG002|NOT COMPLETED|Baseline Symptom Assessment||0||
59662763|NCT03191864|75781977|FG003|NOT COMPLETED|Baseline Symptom Assessment||0||
59662764|NCT03191864|75781978|FG004|NOT COMPLETED|Baseline Symptom Assessment||0||
59662765|NCT03191864|75781979|FG005|NOT COMPLETED|Baseline Symptom Assessment||202||
59662766|NCT03191864|75781974|FG000|STARTED|Part 1 - Induction||21||
59662767|NCT03191864|75781975|FG001|STARTED|Part 1 - Induction||22||
59662768|NCT03191864|75781976|FG002|STARTED|Part 1 - Induction||22||
59662769|NCT03191864|75781977|FG003|STARTED|Part 1 - Induction||20||
59662770|NCT03191864|75781978|FG004|STARTED|Part 1 - Induction||0||
59662771|NCT03191864|75781979|FG005|STARTED|Part 1 - Induction||21||
59662772|NCT03191864|75781974|FG000|COMPLETED|Part 1 - Induction||18||
59662773|NCT03191864|75781975|FG001|COMPLETED|Part 1 - Induction||19||
59662774|NCT03191864|75781976|FG002|COMPLETED|Part 1 - Induction||20||
59662775|NCT03191864|75781977|FG003|COMPLETED|Part 1 - Induction||19||
59662776|NCT03191864|75781978|FG004|COMPLETED|Part 1 - Induction||0||
59662777|NCT03191864|75781979|FG005|COMPLETED|Part 1 - Induction||16||
59662778|NCT03191864|75781974|FG000|NOT COMPLETED|Part 1 - Induction||3||
59662779|NCT03191864|75781975|FG001|NOT COMPLETED|Part 1 - Induction||3||
60077251|NCT03822832|76192309|FG001|COMPLETED|Re-allocation|Patient re-allocated to open label Spesolimab treatment|16|Patient re-allocated to open label Spesolimab treatment|
60077252|NCT03822832|76192308|FG000|NOT COMPLETED|Re-allocation||2||
60077253|NCT03822832|76192309|FG001|NOT COMPLETED|Re-allocation||6||
60077254|NCT03822832|76192308|FG000|STARTED|Period 2 - Open Label Period|Patient re-allocated to open label Spesolimab treatment|6||
60077255|NCT03822832|76192309|FG001|STARTED|Period 2 - Open Label Period|Patient re-allocated to open label Spesolimab treatment|16||
60077256|NCT03822832|76192308|FG000|COMPLETED|Period 2 - Open Label Period||5||
59544673|NCT00956540|75643191|FG001|COMPLETED|Overall Study||46||
59544674|NCT00956540|75643192|FG002|COMPLETED|Overall Study||43||
59544675|NCT00956540|75643193|FG003|COMPLETED|Overall Study||41||
59544676|NCT00956540|75643190|FG000|NOT COMPLETED|Overall Study||3||
59544677|NCT00956540|75643191|FG001|NOT COMPLETED|Overall Study||4||
59544678|NCT00956540|75643192|FG002|NOT COMPLETED|Overall Study||3||
59544679|NCT00956540|75643193|FG003|NOT COMPLETED|Overall Study||4||
59544680|NCT01671293|75643205|FG000|STARTED|Overall Study||36||
59544681|NCT01671293|75643206|FG001|STARTED|Overall Study||34||
59544682|NCT01671293|75643205|FG000|COMPLETED|Overall Study||33||
59544683|NCT01671293|75643206|FG001|COMPLETED|Overall Study||32||
59544684|NCT01671293|75643205|FG000|NOT COMPLETED|Overall Study||3||
59544685|NCT01671293|75643206|FG001|NOT COMPLETED|Overall Study||2||
59544686|NCT01671605|75643214|FG000|STARTED|Overall Study||72||
59544687|NCT01671605|75643215|FG001|STARTED|Overall Study||31||
59544688|NCT01671605|75643214|FG000|COMPLETED|Overall Study||72||
59662780|NCT03191864|75781976|FG002|NOT COMPLETED|Part 1 - Induction||2||
59662781|NCT03191864|75781977|FG003|NOT COMPLETED|Part 1 - Induction||1||
59662782|NCT03191864|75781978|FG004|NOT COMPLETED|Part 1 - Induction||0||
59662783|NCT03191864|75781979|FG005|NOT COMPLETED|Part 1 - Induction||5||
59662784|NCT03191864|75781974|FG000|STARTED|Part 2 - Maintenance||10|Note that those subjects that were non-responders at Week 12 were switched from another arm to the Single-blind APT-1011 3 mg BID arm. This arm was a single-blinded arm for the subjects only.|
59662785|NCT03191864|75781975|FG001|STARTED|Part 2 - Maintenance||19|Note that those subjects that were non-responders at Week 12 were switched from another arm to the Single-blind APT-1011 3 mg BID arm. This arm was a single-blinded arm for the subjects only.|
59662786|NCT03191864|75781976|FG002|STARTED|Part 2 - Maintenance||14|Note that those subjects that were non-responders at Week 12 were switched from another arm to the Single-blind APT-1011 3 mg BID arm. This arm was a single-blinded arm for the subjects only.|
59662787|NCT03191864|75781977|FG003|STARTED|Part 2 - Maintenance||16|Note that those subjects that were non-responders at Week 12 were switched from another arm to the Single-blind APT-1011 3 mg BID arm. This arm was a single-blinded arm for the subjects only.|
59662788|NCT03191864|75781978|FG004|STARTED|Part 2 - Maintenance||34|Note that those subjects that were non-responders at Week 12 were switched from another arm to the Single-blind APT-1011 3 mg BID arm. This arm was a single-blinded arm for the subjects only.|
59662789|NCT03191864|75781979|FG005|STARTED|Part 2 - Maintenance||0|Note that those subjects that were non-responders at Week 12 were switched from another arm to the Single-blind APT-1011 3 mg BID arm. This arm was a single-blinded arm for the subjects only.|
59662790|NCT03191864|75781974|FG000|COMPLETED|Part 2 - Maintenance||5||
59662791|NCT03191864|75781975|FG001|COMPLETED|Part 2 - Maintenance||17||
59662792|NCT03191864|75781976|FG002|COMPLETED|Part 2 - Maintenance||11||
59662793|NCT03191864|75781977|FG003|COMPLETED|Part 2 - Maintenance||14||
59662794|NCT03191864|75781978|FG004|COMPLETED|Part 2 - Maintenance||19||
59662795|NCT03191864|75781979|FG005|COMPLETED|Part 2 - Maintenance||0||
59662796|NCT03191864|75781974|FG000|NOT COMPLETED|Part 2 - Maintenance||5||
59662797|NCT03191864|75781975|FG001|NOT COMPLETED|Part 2 - Maintenance||2||
59662798|NCT03191864|75781976|FG002|NOT COMPLETED|Part 2 - Maintenance||3||
59662799|NCT03191864|75781977|FG003|NOT COMPLETED|Part 2 - Maintenance||2||
59662800|NCT03191864|75781978|FG004|NOT COMPLETED|Part 2 - Maintenance||15||
59662801|NCT03191864|75781979|FG005|NOT COMPLETED|Part 2 - Maintenance||0||
59662802|NCT02898207|75782013|FG000|STARTED|Dose Level 0||3||
59662803|NCT02898207|75782014|FG001|STARTED|Dose Level 0||0||
59662804|NCT02898207|75782015|FG002|STARTED|Dose Level 0||0||
59662805|NCT02898207|75782016|FG003|STARTED|Dose Level 0||0||
59662806|NCT02898207|75782017|FG004|STARTED|Dose Level 0||0||
59662807|NCT02898207|75782018|FG005|STARTED|Dose Level 0||0||
59662808|NCT02898207|75782013|FG000|COMPLETED|Dose Level 0||3||
59662809|NCT02898207|75782014|FG001|COMPLETED|Dose Level 0||0||
59662810|NCT02898207|75782015|FG002|COMPLETED|Dose Level 0||0||
59662811|NCT02898207|75782016|FG003|COMPLETED|Dose Level 0||0||
59662812|NCT02898207|75782017|FG004|COMPLETED|Dose Level 0||0||
59662813|NCT02898207|75782018|FG005|COMPLETED|Dose Level 0||0||
59662814|NCT02898207|75782013|FG000|NOT COMPLETED|Dose Level 0||0||
59662815|NCT02898207|75782014|FG001|NOT COMPLETED|Dose Level 0||0||
59662816|NCT02898207|75782015|FG002|NOT COMPLETED|Dose Level 0||0||
59662817|NCT02898207|75782016|FG003|NOT COMPLETED|Dose Level 0||0||
59662818|NCT02898207|75782017|FG004|NOT COMPLETED|Dose Level 0||0||
59662819|NCT02898207|75782018|FG005|NOT COMPLETED|Dose Level 0||0||
59662820|NCT02898207|75782013|FG000|STARTED|Dose Level 1||0||
59662821|NCT02898207|75782014|FG001|STARTED|Dose Level 1||4||
59662822|NCT02898207|75782015|FG002|STARTED|Dose Level 1||0||
59662823|NCT02898207|75782016|FG003|STARTED|Dose Level 1||0||
59662824|NCT02898207|75782017|FG004|STARTED|Dose Level 1||0||
59662825|NCT02898207|75782018|FG005|STARTED|Dose Level 1||0||
59662826|NCT02898207|75782013|FG000|COMPLETED|Dose Level 1||0||
59662827|NCT02898207|75782014|FG001|COMPLETED|Dose Level 1||4||
59662828|NCT02898207|75782015|FG002|COMPLETED|Dose Level 1||0||
59662829|NCT02898207|75782016|FG003|COMPLETED|Dose Level 1||0||
59662830|NCT02898207|75782017|FG004|COMPLETED|Dose Level 1||0||
59662831|NCT02898207|75782018|FG005|COMPLETED|Dose Level 1||0||
59662832|NCT02898207|75782013|FG000|NOT COMPLETED|Dose Level 1||0||
59662833|NCT02898207|75782014|FG001|NOT COMPLETED|Dose Level 1||0||
59662834|NCT02898207|75782015|FG002|NOT COMPLETED|Dose Level 1||0||
59662835|NCT02898207|75782016|FG003|NOT COMPLETED|Dose Level 1||0||
59662836|NCT02898207|75782017|FG004|NOT COMPLETED|Dose Level 1||0||
59662837|NCT02898207|75782018|FG005|NOT COMPLETED|Dose Level 1||0||
59662838|NCT02898207|75782013|FG000|STARTED|Dose Level 2||0||
60077257|NCT03822832|76192309|FG001|COMPLETED|Period 2 - Open Label Period||13||
59662839|NCT02898207|75782014|FG001|STARTED|Dose Level 2||0||
59662840|NCT02898207|75782015|FG002|STARTED|Dose Level 2||6||
59662841|NCT02898207|75782016|FG003|STARTED|Dose Level 2||0||
59662842|NCT02898207|75782017|FG004|STARTED|Dose Level 2||0||
59662843|NCT02898207|75782018|FG005|STARTED|Dose Level 2||0||
59662844|NCT02898207|75782013|FG000|COMPLETED|Dose Level 2||0||
59662845|NCT02898207|75782014|FG001|COMPLETED|Dose Level 2||0||
60077258|NCT03822832|76192308|FG000|NOT COMPLETED|Period 2 - Open Label Period||1||
59662846|NCT02898207|75782015|FG002|COMPLETED|Dose Level 2||6||
59662847|NCT02898207|75782016|FG003|COMPLETED|Dose Level 2||0||
59662848|NCT02898207|75782017|FG004|COMPLETED|Dose Level 2||0||
59662849|NCT02898207|75782018|FG005|COMPLETED|Dose Level 2||0||
59662850|NCT02898207|75782013|FG000|NOT COMPLETED|Dose Level 2||0||
59662851|NCT02898207|75782014|FG001|NOT COMPLETED|Dose Level 2||0||
59662852|NCT02898207|75782015|FG002|NOT COMPLETED|Dose Level 2||0||
59662853|NCT02898207|75782016|FG003|NOT COMPLETED|Dose Level 2||0||
59662854|NCT02898207|75782017|FG004|NOT COMPLETED|Dose Level 2||0||
59662855|NCT02898207|75782018|FG005|NOT COMPLETED|Dose Level 2||0||
59662856|NCT02898207|75782013|FG000|STARTED|Dose Level 3||0||
59662857|NCT02898207|75782014|FG001|STARTED|Dose Level 3||0||
59662858|NCT02898207|75782015|FG002|STARTED|Dose Level 3||0||
59662859|NCT02898207|75782016|FG003|STARTED|Dose Level 3||7||
59662860|NCT02898207|75782017|FG004|STARTED|Dose Level 3||0||
59662861|NCT02898207|75782018|FG005|STARTED|Dose Level 3||0||
59662862|NCT02898207|75782013|FG000|COMPLETED|Dose Level 3||0||
59662863|NCT02898207|75782014|FG001|COMPLETED|Dose Level 3||0||
59662864|NCT02898207|75782015|FG002|COMPLETED|Dose Level 3||0||
59662865|NCT02898207|75782016|FG003|COMPLETED|Dose Level 3||7||
59662866|NCT02898207|75782017|FG004|COMPLETED|Dose Level 3||0||
59662867|NCT02898207|75782018|FG005|COMPLETED|Dose Level 3||0||
59662868|NCT02898207|75782013|FG000|NOT COMPLETED|Dose Level 3||0||
59662869|NCT02898207|75782014|FG001|NOT COMPLETED|Dose Level 3||0||
59662870|NCT02898207|75782015|FG002|NOT COMPLETED|Dose Level 3||0||
59662871|NCT02898207|75782016|FG003|NOT COMPLETED|Dose Level 3||0||
59662872|NCT02898207|75782017|FG004|NOT COMPLETED|Dose Level 3||0||
59662873|NCT02898207|75782018|FG005|NOT COMPLETED|Dose Level 3||0||
59662874|NCT02898207|75782013|FG000|STARTED|Dose Level 2a||0||
59662875|NCT02898207|75782014|FG001|STARTED|Dose Level 2a||0||
59662876|NCT02898207|75782015|FG002|STARTED|Dose Level 2a||0||
59662877|NCT02898207|75782016|FG003|STARTED|Dose Level 2a||0||
59662878|NCT02898207|75782017|FG004|STARTED|Dose Level 2a||3||
59662879|NCT02898207|75782018|FG005|STARTED|Dose Level 2a||0||
59662880|NCT02898207|75782013|FG000|COMPLETED|Dose Level 2a||0||
59662881|NCT02898207|75782014|FG001|COMPLETED|Dose Level 2a||0||
59662882|NCT02898207|75782015|FG002|COMPLETED|Dose Level 2a||0||
59662883|NCT02898207|75782016|FG003|COMPLETED|Dose Level 2a||0||
59662884|NCT02898207|75782017|FG004|COMPLETED|Dose Level 2a||3||
59662885|NCT02898207|75782018|FG005|COMPLETED|Dose Level 2a||0||
59662886|NCT02898207|75782013|FG000|NOT COMPLETED|Dose Level 2a||0||
59662887|NCT02898207|75782014|FG001|NOT COMPLETED|Dose Level 2a||0||
59662888|NCT02898207|75782015|FG002|NOT COMPLETED|Dose Level 2a||0||
59662889|NCT02898207|75782016|FG003|NOT COMPLETED|Dose Level 2a||0||
59662890|NCT02898207|75782017|FG004|NOT COMPLETED|Dose Level 2a||0||
59662891|NCT02898207|75782018|FG005|NOT COMPLETED|Dose Level 2a||0||
59662892|NCT02898207|75782013|FG000|STARTED|Dose Level 3a||0||
59662893|NCT02898207|75782014|FG001|STARTED|Dose Level 3a||0||
59662894|NCT02898207|75782015|FG002|STARTED|Dose Level 3a||0||
59662895|NCT02898207|75782016|FG003|STARTED|Dose Level 3a||0||
59662896|NCT02898207|75782017|FG004|STARTED|Dose Level 3a||0||
59662897|NCT02898207|75782018|FG005|STARTED|Dose Level 3a||5||
59662898|NCT02898207|75782013|FG000|COMPLETED|Dose Level 3a||0||
59662899|NCT02898207|75782014|FG001|COMPLETED|Dose Level 3a||0||
59662900|NCT02898207|75782015|FG002|COMPLETED|Dose Level 3a||0||
59662901|NCT02898207|75782016|FG003|COMPLETED|Dose Level 3a||0||
59662902|NCT02898207|75782017|FG004|COMPLETED|Dose Level 3a||0||
59662903|NCT02898207|75782018|FG005|COMPLETED|Dose Level 3a||5||
59662904|NCT02898207|75782013|FG000|NOT COMPLETED|Dose Level 3a||0||
59662905|NCT02898207|75782014|FG001|NOT COMPLETED|Dose Level 3a||0||
59662906|NCT02898207|75782015|FG002|NOT COMPLETED|Dose Level 3a||0||
59662907|NCT02898207|75782016|FG003|NOT COMPLETED|Dose Level 3a||0||
59662908|NCT02898207|75782017|FG004|NOT COMPLETED|Dose Level 3a||0||
59662909|NCT02898207|75782018|FG005|NOT COMPLETED|Dose Level 3a||0||
59662910|NCT02713126|75782036|FG000|STARTED|Overall Study||36||
59662911|NCT02713126|75782037|FG001|STARTED|Overall Study||56||
59662912|NCT02713126|75782036|FG000|COMPLETED|Overall Study||36||
59662913|NCT02713126|75782037|FG001|COMPLETED|Overall Study||37||
59662914|NCT02713126|75782036|FG000|NOT COMPLETED|Overall Study||0||
59662915|NCT02713126|75782037|FG001|NOT COMPLETED|Overall Study||19||
59662916|NCT02636725|75782043|FG000|STARTED|Baseline||33||
59662917|NCT02636725|75782043|FG000|COMPLETED|Baseline||30||
59662918|NCT02636725|75782043|FG000|NOT COMPLETED|Baseline||3||
59662919|NCT02636725|75782043|FG000|STARTED|Post-Baseline Imaging Assessment||30||
59662920|NCT02636725|75782043|FG000|COMPLETED|Post-Baseline Imaging Assessment||30||
59662921|NCT02636725|75782043|FG000|NOT COMPLETED|Post-Baseline Imaging Assessment||0||
59662922|NCT02573493|75782051|FG000|STARTED|Overall Study||40||
59662923|NCT02573493|75782052|FG001|STARTED|Overall Study||40||
59662924|NCT02573493|75782053|FG002|STARTED|Overall Study||15||
59662925|NCT02573493|75782054|FG003|STARTED|Overall Study||1||
59662926|NCT02573493|75782051|FG000|COMPLETED|Overall Study||40||
59662927|NCT02573493|75782052|FG001|COMPLETED|Overall Study||40||
59662928|NCT02573493|75782053|FG002|COMPLETED|Overall Study||15||
59662929|NCT02573493|75782054|FG003|COMPLETED|Overall Study||0||
59662930|NCT02573493|75782051|FG000|NOT COMPLETED|Overall Study||0||
59662931|NCT02573493|75782052|FG001|NOT COMPLETED|Overall Study||0||
59662932|NCT02573493|75782053|FG002|NOT COMPLETED|Overall Study||0||
59662933|NCT02573493|75782054|FG003|NOT COMPLETED|Overall Study||1||
59662934|NCT02327078|75782087|FG000|STARTED|Overall Study||3||
59662935|NCT02327078|75782088|FG001|STARTED|Overall Study||6||
59662936|NCT02327078|75782089|FG002|STARTED|Overall Study||14||
59662937|NCT02327078|75782090|FG003|STARTED|Overall Study||13||
59662938|NCT02327078|75782091|FG004|STARTED|Overall Study||6||
59662939|NCT02327078|75782092|FG005|STARTED|Overall Study||3||
59662940|NCT02327078|75782093|FG006|STARTED|Overall Study||3||
59662941|NCT02327078|75782094|FG007|STARTED|Overall Study||83||
59662942|NCT02327078|75782095|FG008|STARTED|Overall Study||176||
59662943|NCT02327078|75782087|FG000|COMPLETED|Overall Study||0||
59662944|NCT02327078|75782088|FG001|COMPLETED|Overall Study||0||
59662945|NCT02327078|75782089|FG002|COMPLETED|Overall Study||0||
59662946|NCT02327078|75782090|FG003|COMPLETED|Overall Study||0||
59662947|NCT02327078|75782091|FG004|COMPLETED|Overall Study||0||
59662948|NCT02327078|75782092|FG005|COMPLETED|Overall Study||0||
59662949|NCT02327078|75782093|FG006|COMPLETED|Overall Study||0||
59662950|NCT02327078|75782094|FG007|COMPLETED|Overall Study||0||
59662951|NCT02327078|75782095|FG008|COMPLETED|Overall Study||0||
59662952|NCT02327078|75782087|FG000|NOT COMPLETED|Overall Study||3||
59662953|NCT02327078|75782088|FG001|NOT COMPLETED|Overall Study||6||
59662954|NCT02327078|75782089|FG002|NOT COMPLETED|Overall Study||14||
59662955|NCT02327078|75782090|FG003|NOT COMPLETED|Overall Study||13||
59662956|NCT02327078|75782091|FG004|NOT COMPLETED|Overall Study||6||
59662957|NCT02327078|75782092|FG005|NOT COMPLETED|Overall Study||3||
59662958|NCT02327078|75782093|FG006|NOT COMPLETED|Overall Study||3||
59662959|NCT02327078|75782094|FG007|NOT COMPLETED|Overall Study||83||
59662960|NCT02327078|75782095|FG008|NOT COMPLETED|Overall Study||176||
59662961|NCT02304458|75782138|FG000|STARTED|Overall Study||7||
59662962|NCT02304458|75782139|FG001|STARTED|Overall Study||6||
59662963|NCT02304458|75782140|FG002|STARTED|Overall Study||72||
59662964|NCT02304458|75782141|FG003|STARTED|Overall Study||6||
59662965|NCT02304458|75782142|FG004|STARTED|Overall Study||6||
59662966|NCT02304458|75782143|FG005|STARTED|Overall Study||6||
59662967|NCT02304458|75782144|FG006|STARTED|Overall Study||29||
59662968|NCT02304458|75782145|FG007|STARTED|Overall Study||8||
59662969|NCT02304458|75782138|FG000|COMPLETED|Overall Study||0||
59662970|NCT02304458|75782139|FG001|COMPLETED|Overall Study||0||
59662971|NCT02304458|75782140|FG002|COMPLETED|Overall Study||1||
59662972|NCT02304458|75782141|FG003|COMPLETED|Overall Study||0||
59662973|NCT02304458|75782142|FG004|COMPLETED|Overall Study||0||
59662974|NCT02304458|75782143|FG005|COMPLETED|Overall Study||0||
59662975|NCT02304458|75782144|FG006|COMPLETED|Overall Study||0||
59662976|NCT02304458|75782145|FG007|COMPLETED|Overall Study||0||
59662977|NCT02304458|75782138|FG000|NOT COMPLETED|Overall Study||7||
59662978|NCT02304458|75782139|FG001|NOT COMPLETED|Overall Study||6||
59662979|NCT02304458|75782140|FG002|NOT COMPLETED|Overall Study||71||
59662980|NCT02304458|75782141|FG003|NOT COMPLETED|Overall Study||6||
59662981|NCT02304458|75782142|FG004|NOT COMPLETED|Overall Study||6||
59662982|NCT02304458|75782143|FG005|NOT COMPLETED|Overall Study||6||
59662983|NCT02304458|75782144|FG006|NOT COMPLETED|Overall Study||29||
59662984|NCT02304458|75782145|FG007|NOT COMPLETED|Overall Study||8||
59662985|NCT02187224|75782181|FG000|STARTED|Overall Study||8||
59662986|NCT02187224|75782182|FG001|STARTED|Overall Study||5||
59662987|NCT02187224|75782181|FG000|Received Trauma Script First|Overall Study||1||
59662988|NCT02187224|75782182|FG001|Received Trauma Script First|Overall Study||4||
59662989|NCT02187224|75782181|FG000|Received Neutral Script First|Overall Study||7||
59662990|NCT02187224|75782182|FG001|Received Neutral Script First|Overall Study||1||
59662991|NCT02187224|75782181|FG000|COMPLETED|Overall Study||7||
59662992|NCT02187224|75782182|FG001|COMPLETED|Overall Study||5||
59662993|NCT02187224|75782181|FG000|NOT COMPLETED|Overall Study||1||
59662994|NCT02187224|75782182|FG001|NOT COMPLETED|Overall Study||0||
59662995|NCT02176226|75782192|FG000|STARTED|Overall Study||105||
59662996|NCT02176226|75782192|FG000|COMPLETED|Overall Study||96||
59662997|NCT02176226|75782192|FG000|NOT COMPLETED|Overall Study||9||
59662998|NCT01958021|75782198|FG000|STARTED|Overall Study||334||
59662999|NCT01958021|75782199|FG001|STARTED|Overall Study||334||
59663000|NCT01958021|75782198|FG000|Patients Untreated|Overall Study||0||
59663001|NCT01958021|75782199|FG001|Patients Untreated|Overall Study||4||
59663002|NCT01958021|75782198|FG000|Patients Treated|Overall Study||334||
59663003|NCT01958021|75782199|FG001|Patients Treated|Overall Study||330||
59663004|NCT01958021|75782198|FG000|COMPLETED|Overall Study|Completed = Treatment ongoing|195||
59663005|NCT01958021|75782199|FG001|COMPLETED|Overall Study|Completed = Treatment ongoing|154||
59663006|NCT01958021|75782198|FG000|NOT COMPLETED|Overall Study||139||
59663007|NCT01958021|75782199|FG001|NOT COMPLETED|Overall Study||180||
59663008|NCT05059600|75782205|FG000|STARTED|Overall Study||52||
59663009|NCT05059600|75782205|FG000|Treated|Overall Study||42||
59663010|NCT05059600|75782205|FG000|COMPLETED|Overall Study||42||
59663011|NCT05059600|75782205|FG000|NOT COMPLETED|Overall Study||10||
59663012|NCT04716413|75782211|FG000|STARTED|Overall Study||3||
59663013|NCT04716413|75782212|FG001|STARTED|Overall Study||0||
59663014|NCT04716413|75782211|FG000|COMPLETED|Overall Study||3||
59663015|NCT04716413|75782212|FG001|COMPLETED|Overall Study||0||
59663016|NCT04716413|75782211|FG000|NOT COMPLETED|Overall Study||0||
59663017|NCT04716413|75782212|FG001|NOT COMPLETED|Overall Study||0||
59663018|NCT04608448|75782218|FG000|STARTED|Overall Study||22||44
59663019|NCT04608448|75782218|FG000|COMPLETED|Overall Study||20||40
59663020|NCT04608448|75782218|FG000|NOT COMPLETED|Overall Study||2||4
59663021|NCT04530344|75782228|FG000|STARTED|Overall Study||58||
59663022|NCT04530344|75782229|FG001|STARTED|Overall Study||58||
59663023|NCT04530344|75782230|FG002|STARTED|Overall Study||118||
59663024|NCT04530344|75782231|FG003|STARTED|Overall Study||224||
59663025|NCT04530344|75782228|FG000|COMPLETED|Overall Study||41||
59663026|NCT04530344|75782229|FG001|COMPLETED|Overall Study||50||
59663027|NCT04530344|75782230|FG002|COMPLETED|Overall Study||92||
59663028|NCT04530344|75782231|FG003|COMPLETED|Overall Study||173||
59663029|NCT04530344|75782228|FG000|NOT COMPLETED|Overall Study||17||
59663030|NCT04530344|75782229|FG001|NOT COMPLETED|Overall Study||8||
59663031|NCT04530344|75782230|FG002|NOT COMPLETED|Overall Study||26||
59663032|NCT04530344|75782231|FG003|NOT COMPLETED|Overall Study||51||
59663033|NCT04181307|75782249|FG000|STARTED|Overall Study||2986||
59663034|NCT04181307|75782250|FG001|STARTED|Overall Study||4644||
59663035|NCT04181307|75782249|FG000|Assessed at Baseline|Overall Study||1342||
59663036|NCT04181307|75782250|FG001|Assessed at Baseline|Overall Study||2086||
59663037|NCT04181307|75782249|FG000|Assessed at 18 Months|Overall Study||1644||
59663038|NCT04181307|75782250|FG001|Assessed at 18 Months|Overall Study||2558||
59663039|NCT04181307|75782249|FG000|COMPLETED|Overall Study||1342||
59663040|NCT04181307|75782250|FG001|COMPLETED|Overall Study||2086||
59663041|NCT04181307|75782249|FG000|NOT COMPLETED|Overall Study||1644||
59663042|NCT04181307|75782250|FG001|NOT COMPLETED|Overall Study||2558||
59663043|NCT04058886|75782256|FG000|STARTED|Overall Study||57||
59663044|NCT04058886|75782256|FG000|Primary Caregivers Started|Overall Study||29||
59663045|NCT04058886|75782256|FG000|Care Partners Started|Overall Study||28||
59663046|NCT04058886|75782256|FG000|Primary Caregivers Completed|Overall Study||27||
59663047|NCT04058886|75782256|FG000|Care Partners Completed|Overall Study||25||
59663048|NCT04058886|75782256|FG000|COMPLETED|Overall Study||52||
59663049|NCT04058886|75782256|FG000|NOT COMPLETED|Overall Study||5||
59663050|NCT04020887|75782270|FG000|STARTED|Overall Study||304||
59663051|NCT04020887|75782271|FG001|STARTED|Overall Study||256||
59663052|NCT04020887|75782270|FG000|COMPLETED|Overall Study||304||
59663053|NCT04020887|75782271|FG001|COMPLETED|Overall Study||256||
59663054|NCT04020887|75782270|FG000|NOT COMPLETED|Overall Study||0||
59663055|NCT04020887|75782271|FG001|NOT COMPLETED|Overall Study||0||
59663056|NCT03704194|75782279|FG000|STARTED|Overall Study||8||
59663057|NCT03704194|75782280|FG001|STARTED|Overall Study||9||
59663058|NCT03704194|75782279|FG000|COMPLETED|Overall Study||8||
59663059|NCT03704194|75782280|FG001|COMPLETED|Overall Study||8||
59663060|NCT03704194|75782279|FG000|NOT COMPLETED|Overall Study||0||
59663061|NCT03704194|75782280|FG001|NOT COMPLETED|Overall Study||1||
59663062|NCT03451422|75782294|FG000|STARTED|Overall Study||10||
59663063|NCT03451422|75782295|FG001|STARTED|Overall Study||5||
59663064|NCT03451422|75782296|FG002|STARTED|Overall Study||5||
59663065|NCT03451422|75782297|FG003|STARTED|Overall Study||7||
59663066|NCT03451422|75782298|FG004|STARTED|Overall Study||4||
59663067|NCT03451422|75782299|FG005|STARTED|Overall Study||4||
59663068|NCT03451422|75782294|FG000|COMPLETED|Overall Study||9||
59663069|NCT03451422|75782295|FG001|COMPLETED|Overall Study||5||
59663070|NCT03451422|75782296|FG002|COMPLETED|Overall Study||2||
59663071|NCT03451422|75782297|FG003|COMPLETED|Overall Study||4||
59663072|NCT03451422|75782298|FG004|COMPLETED|Overall Study||2||
59663073|NCT03451422|75782299|FG005|COMPLETED|Overall Study||2||
59663074|NCT03451422|75782294|FG000|NOT COMPLETED|Overall Study||1||
59663075|NCT03451422|75782295|FG001|NOT COMPLETED|Overall Study||0||
59663076|NCT03451422|75782296|FG002|NOT COMPLETED|Overall Study||3||
59663077|NCT03451422|75782297|FG003|NOT COMPLETED|Overall Study||3||
59663078|NCT03451422|75782298|FG004|NOT COMPLETED|Overall Study||2||
59663079|NCT03451422|75782299|FG005|NOT COMPLETED|Overall Study||2||
59663080|NCT03446573|75782320|FG000|STARTED|Early Switch Phase (Day 1 to Week 148)||371|Randomised|
59663081|NCT03446573|75782321|FG001|STARTED|Early Switch Phase (Day 1 to Week 148)||372|Randomised|
59663082|NCT03446573|75782320|FG000|ITT-E Population|Early Switch Phase (Day 1 to Week 148)||369||
59663083|NCT03446573|75782321|FG001|ITT-E Population|Early Switch Phase (Day 1 to Week 148)||372||
59663084|NCT03446573|75782320|FG000|COMPLETED|Early Switch Phase (Day 1 to Week 148)||319||
59663085|NCT03446573|75782321|FG001|COMPLETED|Early Switch Phase (Day 1 to Week 148)||299||
59663086|NCT03446573|75782320|FG000|NOT COMPLETED|Early Switch Phase (Day 1 to Week 148)||52||
59663087|NCT03446573|75782321|FG001|NOT COMPLETED|Early Switch Phase (Day 1 to Week 148)||73||
59663088|NCT03446573|75782320|FG000|STARTED|Late Switch Phase (Week 148 to Week 196)||319||
59663089|NCT03446573|75782321|FG001|STARTED|Late Switch Phase (Week 148 to Week 196)|One participant was not switched to DTG+ 3TC FDC due to being lost to follow up post Week 148 visit, hence did not enter in the late switch phase|298||
59663090|NCT03446573|75782320|FG000|COMPLETED|Late Switch Phase (Week 148 to Week 196)||307||
59663091|NCT03446573|75782321|FG001|COMPLETED|Late Switch Phase (Week 148 to Week 196)||274||
59663092|NCT03446573|75782320|FG000|NOT COMPLETED|Late Switch Phase (Week 148 to Week 196)||12||
59663093|NCT03446573|75782321|FG001|NOT COMPLETED|Late Switch Phase (Week 148 to Week 196)||24||
59663094|NCT03422536|75782339|FG000|STARTED|Randomized||27||
59663095|NCT03422536|75782340|FG001|STARTED|Randomized||33||
59663096|NCT03422536|75782339|FG000|COMPLETED|Randomized||26||
59663097|NCT03422536|75782340|FG001|COMPLETED|Randomized||32||
59663098|NCT03422536|75782339|FG000|NOT COMPLETED|Randomized||1||
59663099|NCT03422536|75782340|FG001|NOT COMPLETED|Randomized||1||
59663100|NCT03422536|75782339|FG000|STARTED|Allocation - Received Intervention||26||
59663101|NCT03422536|75782340|FG001|STARTED|Allocation - Received Intervention||32||
59663102|NCT03422536|75782339|FG000|COMPLETED|Allocation - Received Intervention||0||
59663103|NCT03422536|75782340|FG001|COMPLETED|Allocation - Received Intervention||1||
59663104|NCT03422536|75782339|FG000|NOT COMPLETED|Allocation - Received Intervention||26||
59663105|NCT03422536|75782340|FG001|NOT COMPLETED|Allocation - Received Intervention||31||
59663106|NCT03228394|75782354|FG000|STARTED|Overall Study||4||
59663107|NCT03228394|75782355|FG001|STARTED|Overall Study||5||
59663108|NCT03228394|75782356|FG002|STARTED|Overall Study||14||
59663109|NCT03228394|75782357|FG003|STARTED|Overall Study||15||
59663110|NCT03228394|75782358|FG004|STARTED|Overall Study||10||
59663111|NCT03228394|75782359|FG005|STARTED|Overall Study||10||
59663112|NCT03228394|75782360|FG006|STARTED|Overall Study||17||
59663113|NCT03228394|75782361|FG007|STARTED|Overall Study||16||
59663114|NCT03228394|75782354|FG000|COMPLETED|Overall Study||4||
59663115|NCT03228394|75782355|FG001|COMPLETED|Overall Study||5||
59663116|NCT03228394|75782356|FG002|COMPLETED|Overall Study||12||
59663117|NCT03228394|75782357|FG003|COMPLETED|Overall Study||13||
59663118|NCT03228394|75782358|FG004|COMPLETED|Overall Study||10||
59663119|NCT03228394|75782359|FG005|COMPLETED|Overall Study||10||
59663120|NCT03228394|75782360|FG006|COMPLETED|Overall Study||12||
59663121|NCT03228394|75782361|FG007|COMPLETED|Overall Study||13||
59663122|NCT03228394|75782354|FG000|NOT COMPLETED|Overall Study||0||
59663123|NCT03228394|75782355|FG001|NOT COMPLETED|Overall Study||0||
59663124|NCT03228394|75782356|FG002|NOT COMPLETED|Overall Study||2||
59663125|NCT03228394|75782357|FG003|NOT COMPLETED|Overall Study||2||
59663126|NCT03228394|75782358|FG004|NOT COMPLETED|Overall Study||0||
59663127|NCT03228394|75782359|FG005|NOT COMPLETED|Overall Study||0||
59663128|NCT03228394|75782360|FG006|NOT COMPLETED|Overall Study||5||
59663129|NCT03228394|75782361|FG007|NOT COMPLETED|Overall Study||3||
59663130|NCT03008070|75782383|FG000|STARTED|Overall Study||83||
59663131|NCT03008070|75782384|FG001|STARTED|Overall Study||83||
59663132|NCT03008070|75782385|FG002|STARTED|Overall Study||81||
59663133|NCT03008070|75782383|FG000|COMPLETED|Overall Study||77||
59663134|NCT03008070|75782384|FG001|COMPLETED|Overall Study||77||
59663135|NCT03008070|75782385|FG002|COMPLETED|Overall Study||74||
59663136|NCT03008070|75782383|FG000|NOT COMPLETED|Overall Study||6||
59663137|NCT03008070|75782384|FG001|NOT COMPLETED|Overall Study||6||
59663138|NCT03008070|75782385|FG002|NOT COMPLETED|Overall Study||7||
59663139|NCT02979353|75782397|FG000|STARTED|Overall Study||186||
59663140|NCT02979353|75782398|FG001|STARTED|Overall Study||186||
59663141|NCT02979353|75782397|FG000|Hospital Phase|Overall Study||174||
59663142|NCT02979353|75782398|FG001|Hospital Phase|Overall Study||181||
59663143|NCT02979353|75782397|FG000|Post-Acute Care Phase|Overall Study||142||
59663144|NCT02979353|75782398|FG001|Post-Acute Care Phase|Overall Study||142||
59663145|NCT02979353|75782397|FG000|7-Day Follow-Up|Overall Study||137||
59663146|NCT02979353|75782398|FG001|7-Day Follow-Up|Overall Study||133||
59663147|NCT02979353|75782397|FG000|60-Day Follow-Up|Overall Study||128||
59663148|NCT02979353|75782398|FG001|60-Day Follow-Up|Overall Study||125||
59663149|NCT02979353|75782397|FG000|COMPLETED|Overall Study||116||
59663150|NCT02979353|75782398|FG001|COMPLETED|Overall Study||115||
59663151|NCT02979353|75782397|FG000|NOT COMPLETED|Overall Study||70||
59663152|NCT02979353|75782398|FG001|NOT COMPLETED|Overall Study||71||
59663153|NCT02849639|75782406|FG000|STARTED|Overall Study||44||
59663154|NCT02849639|75782407|FG001|STARTED|Overall Study||46||
59663155|NCT02849639|75782406|FG000|COMPLETED|Overall Study||41||
59663156|NCT02849639|75782407|FG001|COMPLETED|Overall Study||44||
59663157|NCT02849639|75782406|FG000|NOT COMPLETED|Overall Study||3||
59663158|NCT02849639|75782407|FG001|NOT COMPLETED|Overall Study||2||
59663159|NCT02633397|75782417|FG000|STARTED|Overall Study||66||
59663160|NCT02633397|75782418|FG001|STARTED|Overall Study||64||
59663161|NCT02633397|75782417|FG000|COMPLETED|Overall Study||50||
59663162|NCT02633397|75782418|FG001|COMPLETED|Overall Study||47||
59663163|NCT02633397|75782417|FG000|NOT COMPLETED|Overall Study||16||
59663164|NCT02633397|75782418|FG001|NOT COMPLETED|Overall Study||17||
59663165|NCT02592707|75782428|FG000|STARTED|Overall Study||15||
59663166|NCT02592707|75782429|FG001|STARTED|Overall Study||6||
59663167|NCT02592707|75782430|FG002|STARTED|Overall Study||9||
59663168|NCT02592707|75782431|FG003|STARTED|Overall Study||10||
59663169|NCT02592707|75782428|FG000|COMPLETED|Overall Study||9|Completed LTFU period|
59663170|NCT02592707|75782429|FG001|COMPLETED|Overall Study||1|Completed LTFU period|
59663171|NCT02592707|75782430|FG002|COMPLETED|Overall Study||3|Completed LTFU period|
59663172|NCT02592707|75782431|FG003|COMPLETED|Overall Study||3|Completed LTFU period|
59663173|NCT02592707|75782428|FG000|NOT COMPLETED|Overall Study||6||
59663174|NCT02592707|75782429|FG001|NOT COMPLETED|Overall Study||5||
59663175|NCT02592707|75782430|FG002|NOT COMPLETED|Overall Study||6||
59663176|NCT02592707|75782431|FG003|NOT COMPLETED|Overall Study||7||
59663177|NCT02326805|75782450|FG000|STARTED|Overall Study||106||
59663178|NCT02326805|75782451|FG001|STARTED|Overall Study||48||
59663179|NCT02326805|75782450|FG000|COMPLETED|Overall Study||103||
59663180|NCT02326805|75782451|FG001|COMPLETED|Overall Study||47||
59663181|NCT02326805|75782450|FG000|NOT COMPLETED|Overall Study||3||
59663182|NCT02326805|75782451|FG001|NOT COMPLETED|Overall Study||1||
59663183|NCT01423812|75782459|FG000|STARTED|Overall Study||30||
59663184|NCT01423812|75782460|FG001|STARTED|Overall Study||30||
59663185|NCT01423812|75782459|FG000|COMPLETED|Overall Study||27||
59663186|NCT01423812|75782460|FG001|COMPLETED|Overall Study||26||
59663187|NCT01423812|75782459|FG000|NOT COMPLETED|Overall Study||3||
59663188|NCT01423812|75782460|FG001|NOT COMPLETED|Overall Study||4||
59663189|NCT00965718|75782468|FG000|STARTED|Overall Study||20||
59663190|NCT00965718|75782468|FG000|COMPLETED|Overall Study||16||
59663191|NCT00965718|75782468|FG000|NOT COMPLETED|Overall Study||4||
59663192|NCT00859781|75782474|FG000|STARTED|Overall Study||38||
59663193|NCT00859781|75782475|FG001|STARTED|Overall Study||17||
59663194|NCT00859781|75782474|FG000|COMPLETED|Overall Study||38||
59663195|NCT00859781|75782475|FG001|COMPLETED|Overall Study||17||
59663196|NCT00859781|75782474|FG000|NOT COMPLETED|Overall Study||0||
59663197|NCT00859781|75782475|FG001|NOT COMPLETED|Overall Study||0||
59663198|NCT00792740|75782483|FG000|STARTED|Overall Study||26||
59663199|NCT00792740|75782484|FG001|STARTED|Overall Study||25||
59663200|NCT00792740|75782483|FG000|COMPLETED|Overall Study||19||
59663201|NCT00792740|75782484|FG001|COMPLETED|Overall Study||18||
59663202|NCT00792740|75782483|FG000|NOT COMPLETED|Overall Study||7||
59663203|NCT00792740|75782484|FG001|NOT COMPLETED|Overall Study||7||
59663204|NCT00729300|75782493|FG000|STARTED|Overall Study||26||
59663205|NCT00729300|75782494|FG001|STARTED|Overall Study||26||
59663206|NCT00729300|75782493|FG000|COMPLETED|Overall Study||17||
59663207|NCT00729300|75782494|FG001|COMPLETED|Overall Study||17||
59663208|NCT00729300|75782493|FG000|NOT COMPLETED|Overall Study||9||
59663209|NCT00729300|75782494|FG001|NOT COMPLETED|Overall Study||9||
59663210|NCT00567580|75782503|FG000|STARTED|Overall Study||592||
59663211|NCT00567580|75782504|FG001|STARTED|Overall Study||602||
59663212|NCT00567580|75782505|FG002|STARTED|Overall Study||598||
59663213|NCT00567580|75782503|FG000|Eligible|Overall Study||564||
59663214|NCT00567580|75782504|FG001|Eligible|Overall Study||578||
59663215|NCT00567580|75782505|FG002|Eligible|Overall Study||574||
59663216|NCT00567580|75782503|FG000|Eligible, Started Study Treatment, and Have Adverse Event Data|Overall Study||547||
59663217|NCT00567580|75782504|FG001|Eligible, Started Study Treatment, and Have Adverse Event Data|Overall Study||563||
59663218|NCT00567580|75782505|FG002|Eligible, Started Study Treatment, and Have Adverse Event Data|Overall Study||563||
59663219|NCT00567580|75782503|FG000|COMPLETED|Overall Study||564|Participants contributing data to analysis are considered to have completed the study.|
59663220|NCT00567580|75782504|FG001|COMPLETED|Overall Study||578|Participants contributing data to analysis are considered to have completed the study.|
59663221|NCT00567580|75782505|FG002|COMPLETED|Overall Study||574|Participants contributing data to analysis are considered to have completed the study.|
59663222|NCT00567580|75782503|FG000|NOT COMPLETED|Overall Study||28||
59663223|NCT00567580|75782504|FG001|NOT COMPLETED|Overall Study||24||
59663224|NCT00567580|75782505|FG002|NOT COMPLETED|Overall Study||24||
59663225|NCT01058863|75782516|FG000|STARTED|Overall Study||72||
59663226|NCT01058863|75782516|FG000|Safety and ITT Populations|Overall Study|One patient was randomized in error and never received the study drug.|71||
59663227|NCT01058863|75782516|FG000|Treated With Albuterol Spiromax® 90 mcg|Overall Study||68||
59663228|NCT01058863|75782516|FG000|Treated With Albuterol Spiromax® 180 mcg|Overall Study||68||
59663229|NCT01058863|75782516|FG000|Treated With ProAir® HFA 90 mcg|Overall Study||70||
59663230|NCT01058863|75782516|FG000|Treated With ProAir® HFA 180 mcg|Overall Study||68||
59663231|NCT01058863|75782516|FG000|Treated With Placebo Inhaler|Overall Study||69||
59663232|NCT01058863|75782516|FG000|COMPLETED|Overall Study||68||
59663233|NCT01058863|75782516|FG000|NOT COMPLETED|Overall Study||4||
59663234|NCT01058395|75782531|FG000|STARTED|Overall Study||7||
59663235|NCT01058395|75782532|FG001|STARTED|Overall Study||8||
59663236|NCT01058395|75782531|FG000|COMPLETED|Overall Study|Two died, and one was lost to followup.|4||
59663237|NCT01058395|75782532|FG001|COMPLETED|Overall Study|One died after enrollment. The patient died in the first 48 hours.|7||
59663238|NCT01058395|75782531|FG000|NOT COMPLETED|Overall Study||3||
59663239|NCT01058395|75782532|FG001|NOT COMPLETED|Overall Study||1||
59663240|NCT01058356|75782538|FG000|STARTED|Overall Study||214||
59663241|NCT01058356|75782538|FG000|COMPLETED|Overall Study||172||
59663242|NCT01058356|75782538|FG000|NOT COMPLETED|Overall Study||42||
59663243|NCT01058005|75782545|FG000|STARTED|Overall Study||38||
59663244|NCT01058005|75782546|FG001|STARTED|Overall Study||25||
59663245|NCT01058005|75782547|FG002|STARTED|Overall Study||21||
59663246|NCT01058005|75782545|FG000|Dosed With Study Treatment|Overall Study||36||
59663247|NCT01058005|75782546|FG001|Dosed With Study Treatment|Overall Study||22||
59663248|NCT01058005|75782547|FG002|Dosed With Study Treatment|Overall Study||17||
59663249|NCT01058005|75782545|FG000|COMPLETED|Overall Study||0||
59663250|NCT01058005|75782546|FG001|COMPLETED|Overall Study||0||
59663251|NCT01058005|75782547|FG002|COMPLETED|Overall Study||1||
59663252|NCT01058005|75782545|FG000|NOT COMPLETED|Overall Study||38||
59663253|NCT01058005|75782546|FG001|NOT COMPLETED|Overall Study||25||
59663254|NCT01058005|75782547|FG002|NOT COMPLETED|Overall Study||20||
59663255|NCT01056640|75782557|FG000|STARTED|Overall Study||102||
59663256|NCT01056640|75782558|FG001|STARTED|Overall Study||103||
59663257|NCT01056640|75782557|FG000|COMPLETED|Overall Study||76||
59663258|NCT01056640|75782558|FG001|COMPLETED|Overall Study||91||
59663259|NCT01056640|75782557|FG000|NOT COMPLETED|Overall Study||26||
59663260|NCT01056640|75782558|FG001|NOT COMPLETED|Overall Study||12||
59663261|NCT01056484|75782566|FG000|STARTED|Randomized Controlled Trial||64||
59663262|NCT01056484|75782567|FG001|STARTED|Randomized Controlled Trial||59||
59663263|NCT01056484|75782566|FG000|COMPLETED|Randomized Controlled Trial||57||
59663264|NCT01056484|75782567|FG001|COMPLETED|Randomized Controlled Trial||58||
59663265|NCT01056484|75782566|FG000|NOT COMPLETED|Randomized Controlled Trial||7||
59663266|NCT01056484|75782567|FG001|NOT COMPLETED|Randomized Controlled Trial||1||
59663267|NCT01056484|75782566|FG000|STARTED|Follow up - Non-randomized|Out of the enrolled experimental subjects (N=64), 57 completed Period 1 and entered into Period 2.|57||
59663268|NCT01056484|75782567|FG001|STARTED|Follow up - Non-randomized|Out of the enrolled control subjects (N=59), 58 completed Period 1 and entered into Period 2.|58||
59663269|NCT01056484|75782566|FG000|COMPLETED|Follow up - Non-randomized||57||
59663270|NCT01056484|75782567|FG001|COMPLETED|Follow up - Non-randomized||56||
59663271|NCT01056484|75782566|FG000|NOT COMPLETED|Follow up - Non-randomized||0||
59663272|NCT01056484|75782567|FG001|NOT COMPLETED|Follow up - Non-randomized||2||
59663273|NCT01055314|75782576|FG000|STARTED|Overall Study||100||
59663274|NCT01055314|75782577|FG001|STARTED|Overall Study||75||
59663275|NCT01055314|75782576|FG000|COMPLETED|Overall Study||55||
59663276|NCT01055314|75782577|FG001|COMPLETED|Overall Study||37||
59663277|NCT01055314|75782576|FG000|NOT COMPLETED|Overall Study||45||
59663278|NCT01055314|75782577|FG001|NOT COMPLETED|Overall Study||38||
59663279|NCT01055197|75782586|FG000|STARTED|Overall Study||51||
59663280|NCT01055197|75782587|FG001|STARTED|Overall Study||46||
59663281|NCT01055197|75782586|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|42||
59663282|NCT01055197|75782587|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|44||
59663283|NCT01055197|75782586|FG000|NOT COMPLETED|Overall Study||9||
59663284|NCT01055197|75782587|FG001|NOT COMPLETED|Overall Study||2||
59663285|NCT01054885|75782599|FG000|STARTED|2-week, Single-blind Run-In Period||1577||
59663286|NCT01054885|75782600|FG001|STARTED|2-week, Single-blind Run-In Period||0||
59663287|NCT01054885|75782601|FG002|STARTED|2-week, Single-blind Run-In Period||0||
59663288|NCT01054885|75782602|FG003|STARTED|2-week, Single-blind Run-In Period||0||
59663289|NCT01054885|75782603|FG004|STARTED|2-week, Single-blind Run-In Period||0||
59663290|NCT01054885|75782604|FG005|STARTED|2-week, Single-blind Run-In Period||0||
59663291|NCT01054885|75782605|FG006|STARTED|2-week, Single-blind Run-In Period||0||
59663292|NCT01054885|75782599|FG000|COMPLETED|2-week, Single-blind Run-In Period||1226||
59663293|NCT01054885|75782600|FG001|COMPLETED|2-week, Single-blind Run-In Period||0||
59663294|NCT01054885|75782601|FG002|COMPLETED|2-week, Single-blind Run-In Period||0||
59663295|NCT01054885|75782602|FG003|COMPLETED|2-week, Single-blind Run-In Period||0||
59663296|NCT01054885|75782603|FG004|COMPLETED|2-week, Single-blind Run-In Period||0||
59663297|NCT01054885|75782604|FG005|COMPLETED|2-week, Single-blind Run-In Period||0||
59663298|NCT01054885|75782605|FG006|COMPLETED|2-week, Single-blind Run-In Period||0||
59663299|NCT01054885|75782599|FG000|NOT COMPLETED|2-week, Single-blind Run-In Period||351||
60077259|NCT03822832|76192309|FG001|NOT COMPLETED|Period 2 - Open Label Period||3||
60077260|NCT01513239|76192319|FG000|STARTED|Period 1: Main Phase|Randomized participants|397||
59663300|NCT01054885|75782600|FG001|NOT COMPLETED|2-week, Single-blind Run-In Period||0||
59663301|NCT01054885|75782601|FG002|NOT COMPLETED|2-week, Single-blind Run-In Period||0||
59663302|NCT01054885|75782602|FG003|NOT COMPLETED|2-week, Single-blind Run-In Period||0||
59663303|NCT01054885|75782603|FG004|NOT COMPLETED|2-week, Single-blind Run-In Period||0||
59663304|NCT01054885|75782604|FG005|NOT COMPLETED|2-week, Single-blind Run-In Period||0||
59663305|NCT01054885|75782605|FG006|NOT COMPLETED|2-week, Single-blind Run-In Period||0||
59663306|NCT01054885|75782599|FG000|STARTED|24-week, Double-blind Treatment Period||0||
59663307|NCT01054885|75782600|FG001|STARTED|24-week, Double-blind Treatment Period||205||
59663308|NCT01054885|75782601|FG002|STARTED|24-week, Double-blind Treatment Period||204||
59663309|NCT01054885|75782602|FG003|STARTED|24-week, Double-blind Treatment Period||203||
59663310|NCT01054885|75782603|FG004|STARTED|24-week, Double-blind Treatment Period||203||
59663311|NCT01054885|75782604|FG005|STARTED|24-week, Double-blind Treatment Period||204||
59663312|NCT01054885|75782605|FG006|STARTED|24-week, Double-blind Treatment Period||205||
59663313|NCT01054885|75782599|FG000|COMPLETED|24-week, Double-blind Treatment Period||0||
59663314|NCT01054885|75782600|FG001|COMPLETED|24-week, Double-blind Treatment Period||146||
59663315|NCT01054885|75782601|FG002|COMPLETED|24-week, Double-blind Treatment Period||155||
59663316|NCT01054885|75782602|FG003|COMPLETED|24-week, Double-blind Treatment Period||160||
59663317|NCT01054885|75782603|FG004|COMPLETED|24-week, Double-blind Treatment Period||161||
59663318|NCT01054885|75782604|FG005|COMPLETED|24-week, Double-blind Treatment Period||144||
59663319|NCT01054885|75782605|FG006|COMPLETED|24-week, Double-blind Treatment Period||158||
59663320|NCT01054885|75782599|FG000|NOT COMPLETED|24-week, Double-blind Treatment Period||0||
59663321|NCT01054885|75782600|FG001|NOT COMPLETED|24-week, Double-blind Treatment Period||59||
59663322|NCT01054885|75782601|FG002|NOT COMPLETED|24-week, Double-blind Treatment Period||49||
59663323|NCT01054885|75782602|FG003|NOT COMPLETED|24-week, Double-blind Treatment Period||43||
59663324|NCT01054885|75782603|FG004|NOT COMPLETED|24-week, Double-blind Treatment Period||42||
59663325|NCT01054885|75782604|FG005|NOT COMPLETED|24-week, Double-blind Treatment Period||60||
59663326|NCT01054885|75782605|FG006|NOT COMPLETED|24-week, Double-blind Treatment Period||47||
59663327|NCT01054846|75782622|FG000|STARTED|Overall Study||322||
59663328|NCT01054846|75782623|FG001|STARTED|Overall Study||68||
59663329|NCT01054846|75782622|FG000|COMPLETED|Overall Study||246||
59663330|NCT01054846|75782623|FG001|COMPLETED|Overall Study||51||
59663331|NCT01054846|75782622|FG000|NOT COMPLETED|Overall Study||76||
59663332|NCT01054846|75782623|FG001|NOT COMPLETED|Overall Study||17||
59663333|NCT01054729|75782632|FG000|STARTED|Overall Study||16||
59663334|NCT01054729|75782633|FG001|STARTED|Overall Study||19||
59663335|NCT01054729|75782634|FG002|STARTED|Overall Study||15||
59663336|NCT01054729|75782635|FG003|STARTED|Overall Study||14||
59663337|NCT01054729|75782632|FG000|Randomized and Treated|Overall Study||16||
59663338|NCT01054729|75782633|FG001|Randomized and Treated|Overall Study||18||
59663339|NCT01054729|75782634|FG002|Randomized and Treated|Overall Study||15||
59663340|NCT01054729|75782635|FG003|Randomized and Treated|Overall Study||14||
59663341|NCT01054729|75782632|FG000|COMPLETED|Overall Study||12||
59663342|NCT01054729|75782633|FG001|COMPLETED|Overall Study||14||
59663343|NCT01054729|75782634|FG002|COMPLETED|Overall Study||9||
59663344|NCT01054729|75782635|FG003|COMPLETED|Overall Study||11||
59663345|NCT01054729|75782632|FG000|NOT COMPLETED|Overall Study||4||
59663346|NCT01054729|75782633|FG001|NOT COMPLETED|Overall Study||5||
59663347|NCT01054729|75782634|FG002|NOT COMPLETED|Overall Study||6||
59663348|NCT01054729|75782635|FG003|NOT COMPLETED|Overall Study||3||
59663349|NCT01054573|75782649|FG000|STARTED|Overall Study||9||
59663350|NCT01054573|75782650|FG001|STARTED|Overall Study||32||
59663351|NCT01054573|75782651|FG002|STARTED|Overall Study||22||
59663352|NCT01054573|75782652|FG003|STARTED|Overall Study||27||
59663353|NCT01054573|75782649|FG000|COMPLETED|Overall Study||8||
59663354|NCT01054573|75782650|FG001|COMPLETED|Overall Study||28||
59663355|NCT01054573|75782651|FG002|COMPLETED|Overall Study||19||
59663356|NCT01054573|75782652|FG003|COMPLETED|Overall Study||25||
59663357|NCT01054573|75782649|FG000|NOT COMPLETED|Overall Study||1||
59663358|NCT01054573|75782650|FG001|NOT COMPLETED|Overall Study||4||
59663359|NCT01054573|75782651|FG002|NOT COMPLETED|Overall Study||3||
59663360|NCT01054573|75782652|FG003|NOT COMPLETED|Overall Study||2||
59663361|NCT01054456|75782671|FG000|STARTED|Overall Study||36||
59663362|NCT01054456|75782671|FG000|COMPLETED|Overall Study||35||
59663363|NCT01054456|75782671|FG000|NOT COMPLETED|Overall Study||1||
59663364|NCT01054300|75782677|FG000|STARTED|Period 1||13||
59663365|NCT01054300|75782678|FG001|STARTED|Period 1||13||
59663366|NCT01054300|75782679|FG002|STARTED|Period 1||13||
59663367|NCT01054300|75782680|FG003|STARTED|Period 1||13||
59663368|NCT01054300|75782677|FG000|COMPLETED|Period 1|Discontinuation occurred prior to Period 2 dose.|12||
59663369|NCT01054300|75782678|FG001|COMPLETED|Period 1||13||
59663370|NCT01054300|75782679|FG002|COMPLETED|Period 1||13||
59663371|NCT01054300|75782680|FG003|COMPLETED|Period 1||13||
59663372|NCT01054300|75782677|FG000|NOT COMPLETED|Period 1||1||
59663373|NCT01054300|75782678|FG001|NOT COMPLETED|Period 1||0||
59663374|NCT01054300|75782679|FG002|NOT COMPLETED|Period 1||0||
59663375|NCT01054300|75782680|FG003|NOT COMPLETED|Period 1||0||
59663376|NCT01054300|75782677|FG000|STARTED|Period 2||12||
59663377|NCT01054300|75782678|FG001|STARTED|Period 2||13||
59663378|NCT01054300|75782679|FG002|STARTED|Period 2||13||
59663379|NCT01054300|75782680|FG003|STARTED|Period 2||13||
59663380|NCT01054300|75782677|FG000|COMPLETED|Period 2||12||
59663381|NCT01054300|75782678|FG001|COMPLETED|Period 2||13||
59663382|NCT01054300|75782679|FG002|COMPLETED|Period 2||12||
59663383|NCT01054300|75782680|FG003|COMPLETED|Period 2||13||
59663384|NCT01054300|75782677|FG000|NOT COMPLETED|Period 2||0||
59663385|NCT01054300|75782678|FG001|NOT COMPLETED|Period 2||0||
59663386|NCT01054300|75782679|FG002|NOT COMPLETED|Period 2||1||
59663387|NCT01054300|75782680|FG003|NOT COMPLETED|Period 2||0||
59663388|NCT01053988|75782695|FG000|STARTED|2-week, Single-blind Run-In Period||1390||
59663389|NCT01053988|75782696|FG001|STARTED|2-week, Single-blind Run-In Period||0||
59663390|NCT01053988|75782697|FG002|STARTED|2-week, Single-blind Run-In Period||0||
59663391|NCT01053988|75782698|FG003|STARTED|2-week, Single-blind Run-In Period||0||
59663392|NCT01053988|75782699|FG004|STARTED|2-week, Single-blind Run-In Period||0||
59663393|NCT01053988|75782700|FG005|STARTED|2-week, Single-blind Run-In Period||0||
59663394|NCT01053988|75782695|FG000|COMPLETED|2-week, Single-blind Run-In Period||1030||
59663395|NCT01053988|75782696|FG001|COMPLETED|2-week, Single-blind Run-In Period||0||
59663396|NCT01053988|75782697|FG002|COMPLETED|2-week, Single-blind Run-In Period||0||
59663397|NCT01053988|75782698|FG003|COMPLETED|2-week, Single-blind Run-In Period||0||
59663398|NCT01053988|75782699|FG004|COMPLETED|2-week, Single-blind Run-In Period||0||
59663399|NCT01053988|75782700|FG005|COMPLETED|2-week, Single-blind Run-In Period||0||
59663400|NCT01053988|75782695|FG000|NOT COMPLETED|2-week, Single-blind Run-In Period||360||
59663401|NCT01053988|75782696|FG001|NOT COMPLETED|2-week, Single-blind Run-In Period||0||
59663402|NCT01053988|75782697|FG002|NOT COMPLETED|2-week, Single-blind Run-In Period||0||
59663403|NCT01053988|75782698|FG003|NOT COMPLETED|2-week, Single-blind Run-In Period||0||
59663404|NCT01053988|75782699|FG004|NOT COMPLETED|2-week, Single-blind Run-In Period||0||
59663405|NCT01053988|75782700|FG005|NOT COMPLETED|2-week, Single-blind Run-In Period||0||
59663406|NCT01053988|75782695|FG000|STARTED|24-week, Double-blind Treatment Period||0||
59663407|NCT01053988|75782696|FG001|STARTED|24-week, Double-blind Treatment Period||207||
59663408|NCT01053988|75782697|FG002|STARTED|24-week, Double-blind Treatment Period||206||
59663409|NCT01053988|75782698|FG003|STARTED|24-week, Double-blind Treatment Period||205||
59663410|NCT01053988|75782699|FG004|STARTED|24-week, Double-blind Treatment Period||206||
59663411|NCT01053988|75782700|FG005|STARTED|24-week, Double-blind Treatment Period||206||
59663412|NCT01053988|75782695|FG000|COMPLETED|24-week, Double-blind Treatment Period||0||
59663413|NCT01053988|75782696|FG001|COMPLETED|24-week, Double-blind Treatment Period||138||
59663414|NCT01053988|75782697|FG002|COMPLETED|24-week, Double-blind Treatment Period||145||
59663415|NCT01053988|75782698|FG003|COMPLETED|24-week, Double-blind Treatment Period||142||
59663416|NCT01053988|75782699|FG004|COMPLETED|24-week, Double-blind Treatment Period||147||
59663417|NCT01053988|75782700|FG005|COMPLETED|24-week, Double-blind Treatment Period||151||
59663418|NCT01053988|75782695|FG000|NOT COMPLETED|24-week, Double-blind Treatment Period||0||
59663419|NCT01053988|75782696|FG001|NOT COMPLETED|24-week, Double-blind Treatment Period||69||
59663420|NCT01053988|75782697|FG002|NOT COMPLETED|24-week, Double-blind Treatment Period||61||
59663421|NCT01053988|75782698|FG003|NOT COMPLETED|24-week, Double-blind Treatment Period||63||
59663422|NCT01053988|75782699|FG004|NOT COMPLETED|24-week, Double-blind Treatment Period||59||
59663423|NCT01053988|75782700|FG005|NOT COMPLETED|24-week, Double-blind Treatment Period||55||
59663424|NCT01053247|75782715|FG000|STARTED|Overall Study||269||
59663425|NCT01053247|75782716|FG001|STARTED|Overall Study||260||
59663426|NCT01053247|75782717|FG002|STARTED|Overall Study||264||
59663427|NCT01053247|75782715|FG000|COMPLETED|Overall Study||249||
59663428|NCT01053247|75782716|FG001|COMPLETED|Overall Study||241||
59663429|NCT01053247|75782717|FG002|COMPLETED|Overall Study||236||
59663430|NCT01053247|75782715|FG000|NOT COMPLETED|Overall Study||20||
59663431|NCT01053247|75782716|FG001|NOT COMPLETED|Overall Study||19||
59663432|NCT01053247|75782717|FG002|NOT COMPLETED|Overall Study||28||
59663433|NCT01052662|75782728|FG000|STARTED|Overall Study|1 subject excluded from Intent-to-treat sample for final analysis due to pharmacy issue.|28||
59663434|NCT01052662|75782729|FG001|STARTED|Overall Study|3 subjects excluded from Intent-to-treat sample for final analysis due to pharmacy issue|27||
59663435|NCT01052662|75782730|FG002|STARTED|Overall Study|3 subjects excluded from Intent-to-treat sample for final analysis due to pharmacy issue|32||
59663436|NCT01052662|75782728|FG000|Stabilization Phase|Overall Study||21||
59663437|NCT01052662|75782729|FG001|Stabilization Phase|Overall Study||21||
59663438|NCT01052662|75782730|FG002|Stabilization Phase|Overall Study||26||
59663439|NCT01052662|75782728|FG000|Discontinuation Phase|Overall Study||6||
59663440|NCT01052662|75782729|FG001|Discontinuation Phase|Overall Study||5||
59663441|NCT01052662|75782730|FG002|Discontinuation Phase|Overall Study||10||
59663442|NCT01052662|75782728|FG000|COMPLETED|Overall Study||6||
59663443|NCT01052662|75782729|FG001|COMPLETED|Overall Study||5||
59663444|NCT01052662|75782730|FG002|COMPLETED|Overall Study||10||
59663445|NCT01052662|75782728|FG000|NOT COMPLETED|Overall Study||22||
59663446|NCT01052662|75782729|FG001|NOT COMPLETED|Overall Study||22||
59663447|NCT01052662|75782730|FG002|NOT COMPLETED|Overall Study||22||
59663448|NCT01052116|75782740|FG000|STARTED|Overall Study||193||
59663449|NCT01052116|75782741|FG001|STARTED|Overall Study||193||
59663450|NCT01052116|75782740|FG000|COMPLETED|Overall Study|Completed: defined as having an FEV1 measurement at 24 weeks|179||
59663451|NCT01052116|75782741|FG001|COMPLETED|Overall Study|Completed: defined as having an FEV1 measurement at 24 weeks|166||
59663452|NCT01052116|75782740|FG000|NOT COMPLETED|Overall Study||14||
59663453|NCT01052116|75782741|FG001|NOT COMPLETED|Overall Study||27||
59663454|NCT01052077|75782749|FG000|STARTED|Phase A||769||
59663455|NCT01052077|75782750|FG001|STARTED|Phase A||0||
59663456|NCT01052077|75782751|FG002|STARTED|Phase A||0||
59663457|NCT01052077|75782752|FG003|STARTED|Phase A||0||
59663458|NCT01052077|75782749|FG000|COMPLETED|Phase A||623||
59663459|NCT01052077|75782750|FG001|COMPLETED|Phase A||0||
59663460|NCT01052077|75782751|FG002|COMPLETED|Phase A||0||
59663461|NCT01052077|75782752|FG003|COMPLETED|Phase A||0||
59663462|NCT01052077|75782749|FG000|NOT COMPLETED|Phase A||146||
59663463|NCT01052077|75782750|FG001|NOT COMPLETED|Phase A||0||
59663464|NCT01052077|75782751|FG002|NOT COMPLETED|Phase A||0||
59663465|NCT01052077|75782752|FG003|NOT COMPLETED|Phase A||0||
59663466|NCT01052077|75782749|FG000|STARTED|Phase B||0||
59663467|NCT01052077|75782750|FG001|STARTED|Phase B||185||
59663468|NCT01052077|75782751|FG002|STARTED|Phase B||187||
59663469|NCT01052077|75782752|FG003|STARTED|Phase B||0||
59663470|NCT01052077|75782749|FG000|COMPLETED|Phase B||0||
59663471|NCT01052077|75782750|FG001|COMPLETED|Phase B||167||
59663472|NCT01052077|75782751|FG002|COMPLETED|Phase B||171||
59663473|NCT01052077|75782752|FG003|COMPLETED|Phase B||0||
59663474|NCT01052077|75782749|FG000|NOT COMPLETED|Phase B||0||
59663475|NCT01052077|75782750|FG001|NOT COMPLETED|Phase B||18||
59663476|NCT01052077|75782751|FG002|NOT COMPLETED|Phase B||16||
59663477|NCT01052077|75782752|FG003|NOT COMPLETED|Phase B||0||
59663478|NCT01052077|75782749|FG000|STARTED|Phase A+||0||
59663479|NCT01052077|75782750|FG001|STARTED|Phase A+||0||
59663480|NCT01052077|75782751|FG002|STARTED|Phase A+||0||
59663481|NCT01052077|75782752|FG003|STARTED|Phase A+||251||
59663482|NCT01052077|75782749|FG000|COMPLETED|Phase A+||0||
59663483|NCT01052077|75782750|FG001|COMPLETED|Phase A+||0||
59663484|NCT01052077|75782751|FG002|COMPLETED|Phase A+||0||
59663485|NCT01052077|75782752|FG003|COMPLETED|Phase A+||230||
59663486|NCT01052077|75782749|FG000|NOT COMPLETED|Phase A+||0||
59663487|NCT01052077|75782750|FG001|NOT COMPLETED|Phase A+||0||
59663488|NCT01052077|75782751|FG002|NOT COMPLETED|Phase A+||0||
59663489|NCT01052077|75782752|FG003|NOT COMPLETED|Phase A+||21||
59663490|NCT01052038|75782761|FG000|STARTED|Overall Study||40||
59663491|NCT01052038|75782762|FG001|STARTED|Overall Study||40||
59663492|NCT01052038|75782763|FG002|STARTED|Overall Study||40||
59663493|NCT01052038|75782761|FG000|COMPLETED|Overall Study||36||
59663494|NCT01052038|75782762|FG001|COMPLETED|Overall Study||34||
59663495|NCT01052038|75782763|FG002|COMPLETED|Overall Study||36||
59663496|NCT01052038|75782761|FG000|NOT COMPLETED|Overall Study||4||
59663497|NCT01052038|75782762|FG001|NOT COMPLETED|Overall Study||6||
59663498|NCT01052038|75782763|FG002|NOT COMPLETED|Overall Study||4||
59663499|NCT01051960|75782771|FG000|STARTED|Overall Study||12||
59663500|NCT01051960|75782771|FG000|COMPLETED|Overall Study||11||
59663501|NCT01051960|75782771|FG000|NOT COMPLETED|Overall Study||1||
59663502|NCT01051921|75782775|FG000|STARTED|Overall Study||67||
59663503|NCT01051921|75782775|FG000|COMPLETED|Overall Study||37||
59663504|NCT01051921|75782775|FG000|NOT COMPLETED|Overall Study||30||
59663505|NCT01051063|75782781|FG000|STARTED|Overall Study||12||
59663506|NCT01051063|75782782|FG001|STARTED|Overall Study||5||
59663507|NCT01051063|75782781|FG000|COMPLETED|Overall Study||2||
59663508|NCT01051063|75782782|FG001|COMPLETED|Overall Study||1||
59663509|NCT01051063|75782781|FG000|NOT COMPLETED|Overall Study||10||
59663510|NCT01051063|75782782|FG001|NOT COMPLETED|Overall Study||4||
59663511|NCT01050790|75782789|FG000|STARTED|Overall Study||17||
59663512|NCT01050790|75782789|FG000|COMPLETED|Overall Study||16||
59663513|NCT01050790|75782789|FG000|NOT COMPLETED|Overall Study||1||
59663514|NCT01050673|75782796|FG000|STARTED|Overall Study||21||
59663515|NCT01050673|75782797|FG001|STARTED|Overall Study||19||
59663516|NCT01050673|75782796|FG000|COMPLETED|Overall Study||17||
59663517|NCT01050673|75782797|FG001|COMPLETED|Overall Study||14||
59663518|NCT01050673|75782796|FG000|NOT COMPLETED|Overall Study||4||
59663519|NCT01050673|75782797|FG001|NOT COMPLETED|Overall Study||5||
59663520|NCT01050205|75782805|FG000|STARTED|Overall Study||148||
59663521|NCT01050205|75782806|FG001|STARTED|Overall Study||75||
59663522|NCT01050205|75782805|FG000|COMPLETED|Overall Study||137||
59663523|NCT01050205|75782806|FG001|COMPLETED|Overall Study||71||
59663524|NCT01050205|75782805|FG000|NOT COMPLETED|Overall Study||11||
59663525|NCT01050205|75782806|FG001|NOT COMPLETED|Overall Study||4||
59663526|NCT01059448|75782816|FG000|STARTED|Overall Study||49||
59663527|NCT01059448|75782817|FG001|STARTED|Overall Study||55||
59663528|NCT01059448|75782818|FG002|STARTED|Overall Study||53||
59663529|NCT01059448|75782819|FG003|STARTED|Overall Study||54||
59663530|NCT01059448|75782816|FG000|COMPLETED|Overall Study||0||
59663531|NCT01059448|75782817|FG001|COMPLETED|Overall Study||0||
59663532|NCT01059448|75782818|FG002|COMPLETED|Overall Study||0||
59663533|NCT01059448|75782819|FG003|COMPLETED|Overall Study||0||
59663534|NCT01059448|75782816|FG000|NOT COMPLETED|Overall Study||49||
59663535|NCT01059448|75782817|FG001|NOT COMPLETED|Overall Study||55||
59663536|NCT01059448|75782818|FG002|NOT COMPLETED|Overall Study||53||
59663537|NCT01059448|75782819|FG003|NOT COMPLETED|Overall Study||54||
59663538|NCT02958293|75782829|FG000|STARTED|Overall Study||19872||
59663539|NCT02958293|75782829|FG000|COMPLETED|Overall Study||19872||
59663540|NCT02958293|75782829|FG000|NOT COMPLETED|Overall Study||0||
59663541|NCT01058707|75782840|FG000|STARTED|Overall Study||31||
59663542|NCT01058707|75782841|FG001|STARTED|Overall Study||30||
59663543|NCT01058707|75782842|FG002|STARTED|Overall Study||33||
59663544|NCT01058707|75782843|FG003|STARTED|Overall Study||22||
59663545|NCT01058707|75782844|FG004|STARTED|Overall Study||39||
59663546|NCT01058707|75782845|FG005|STARTED|Overall Study||17||
59663547|NCT01058707|75782846|FG006|STARTED|Overall Study||26||
59663548|NCT01058707|75782840|FG000|COMPLETED|Overall Study||0||
59663549|NCT01058707|75782841|FG001|COMPLETED|Overall Study||0||
59663550|NCT01058707|75782842|FG002|COMPLETED|Overall Study||0||
59663551|NCT01058707|75782843|FG003|COMPLETED|Overall Study||0||
59663552|NCT01058707|75782844|FG004|COMPLETED|Overall Study||0||
59663553|NCT01058707|75782845|FG005|COMPLETED|Overall Study||0||
59663554|NCT01058707|75782846|FG006|COMPLETED|Overall Study||0||
59663555|NCT01058707|75782840|FG000|NOT COMPLETED|Overall Study||31||
59663556|NCT01058707|75782841|FG001|NOT COMPLETED|Overall Study||30||
59663557|NCT01058707|75782842|FG002|NOT COMPLETED|Overall Study||33||
59663558|NCT01058707|75782843|FG003|NOT COMPLETED|Overall Study||22||
59663559|NCT01058707|75782844|FG004|NOT COMPLETED|Overall Study||39||
59663560|NCT01058707|75782845|FG005|NOT COMPLETED|Overall Study||17||
59663561|NCT01058707|75782846|FG006|NOT COMPLETED|Overall Study||26||
59663562|NCT01054144|75782884|FG000|STARTED|Overall Study||27||
59663563|NCT01054144|75782884|FG000|COMPLETED|Overall Study||25||
59663564|NCT01054144|75782884|FG000|NOT COMPLETED|Overall Study||2||
59663565|NCT03276052|75782891|FG000|STARTED|Overall Study||43||
59663566|NCT03276052|75782891|FG000|COMPLETED|Overall Study||20||
59663567|NCT03276052|75782891|FG000|NOT COMPLETED|Overall Study||23||
59663568|NCT00105586|75782901|FG000|STARTED|Overall Study||92||
59663569|NCT00105586|75782902|FG001|STARTED|Overall Study||85||
59663570|NCT00105586|75782901|FG000|COMPLETED|Overall Study||75||
59663571|NCT00105586|75782902|FG001|COMPLETED|Overall Study||69||
59663572|NCT00105586|75782901|FG000|NOT COMPLETED|Overall Study||17||
59663573|NCT00105586|75782902|FG001|NOT COMPLETED|Overall Study||16||
59663574|NCT01059643|75782910|FG000|STARTED|Overall Study||103||
59663575|NCT01059643|75782910|FG000|Received at Least 1 Dose of Study Drug|Overall Study||103||
59663576|NCT01059643|75782910|FG000|COMPLETED|Overall Study||97||
59663577|NCT01059643|75782910|FG000|NOT COMPLETED|Overall Study||6||
59663578|NCT01059565|75782919|FG000|STARTED|24-Week Randomized Phase||49||
59663579|NCT01059565|75782920|FG001|STARTED|24-Week Randomized Phase||52||
59663580|NCT01059565|75782919|FG000|Randomized and Treated|24-Week Randomized Phase||48||
59663581|NCT01059565|75782920|FG001|Randomized and Treated|24-Week Randomized Phase||52||
59663582|NCT01059565|75782919|FG000|COMPLETED|24-Week Randomized Phase||39||
59663583|NCT01059565|75782920|FG001|COMPLETED|24-Week Randomized Phase||45||
59663584|NCT01059565|75782919|FG000|NOT COMPLETED|24-Week Randomized Phase||10||
59663585|NCT01059565|75782920|FG001|NOT COMPLETED|24-Week Randomized Phase||7||
59663586|NCT01059565|75782919|FG000|STARTED|24-Week Open-Label Phase||39||
59663587|NCT01059565|75782920|FG001|STARTED|24-Week Open-Label Phase||45||
59663588|NCT01059565|75782919|FG000|COMPLETED|24-Week Open-Label Phase||34||
59663589|NCT01059565|75782920|FG001|COMPLETED|24-Week Open-Label Phase||42||
59663590|NCT01059565|75782919|FG000|NOT COMPLETED|24-Week Open-Label Phase||5||
59663591|NCT01059565|75782920|FG001|NOT COMPLETED|24-Week Open-Label Phase||3||
59663592|NCT01059526|75782930|FG000|STARTED|Overall Study|ITT population; defined as signing informed consent and meeting all inclusion/ exclusion criteria|41||
59663593|NCT01059526|75782931|FG001|STARTED|Overall Study|ITT population; defined as signing informed consent and meeting all inclusion/ exclusion criteria|40||
59663594|NCT01059526|75782930|FG000|Treated|Overall Study|Safety population; defined as all patients who received at least 1 treatment dose of KALBITOR|21||
59663595|NCT01059526|75782931|FG001|Treated|Overall Study|Safety population; defined as all patients who received at least 1 treatment dose of KALBITOR|23||
59663596|NCT01059526|75782930|FG000|COMPLETED|Overall Study||11||
59663597|NCT01059526|75782931|FG001|COMPLETED|Overall Study||18||
59663598|NCT01059526|75782930|FG000|NOT COMPLETED|Overall Study||30||
59663599|NCT01059526|75782931|FG001|NOT COMPLETED|Overall Study||22||
59663600|NCT03277261|75782939|FG000|STARTED|Overall Study||274||
59663601|NCT03277261|75782940|FG001|STARTED|Overall Study||275||
59663602|NCT03277261|75782939|FG000|COMPLETED|Overall Study||240|The completed number of participants denote the population who completed the 96 weeks Treatment Period.|
59663603|NCT03277261|75782940|FG001|COMPLETED|Overall Study||252|The completed number of participants denote the population who completed the 96 weeks Treatment Period.|
59663604|NCT03277261|75782939|FG000|NOT COMPLETED|Overall Study||34||
59663605|NCT03277261|75782940|FG001|NOT COMPLETED|Overall Study||23||
59663606|NCT03277066|75782950|FG000|STARTED|Overall Study||71||
59663607|NCT03277066|75782951|FG001|STARTED|Overall Study||72||
59663608|NCT03277066|75782952|FG002|STARTED|Overall Study||146||
59663609|NCT03277066|75782950|FG000|COMPLETED|Overall Study||69|These numbers are the Full Analysis Set population include all randomized subjects who have had at least 1 patch of double-blind study drug applied and who have at least 1 post-baseline assessment of the primary efficacy measure.|
59663610|NCT03277066|75782951|FG001|COMPLETED|Overall Study||71|These numbers are the Full Analysis Set population include all randomized subjects who have had at least 1 patch of double-blind study drug applied and who have at least 1 post-baseline assessment of the primary efficacy measure.|
59663611|NCT03277066|75782952|FG002|COMPLETED|Overall Study||143|These numbers are the Full Analysis Set population include all randomized subjects who have had at least 1 patch of double-blind study drug applied and who have at least 1 post-baseline assessment of the primary efficacy measure.|
59663612|NCT03277066|75782950|FG000|NOT COMPLETED|Overall Study||2||
59663613|NCT03277066|75782951|FG001|NOT COMPLETED|Overall Study||1||
59663614|NCT03277066|75782952|FG002|NOT COMPLETED|Overall Study||3||
59663615|NCT03277690|75782962|FG000|STARTED|Dose Titration and Maintenance||79||
59663616|NCT03277690|75782963|FG001|STARTED|Dose Titration and Maintenance||0||
59663617|NCT03277690|75782962|FG000|COMPLETED|Dose Titration and Maintenance||39||
59663618|NCT03277690|75782963|FG001|COMPLETED|Dose Titration and Maintenance||0||
59663619|NCT03277690|75782962|FG000|NOT COMPLETED|Dose Titration and Maintenance||40||
59663620|NCT03277690|75782963|FG001|NOT COMPLETED|Dose Titration and Maintenance||0||
59663621|NCT03277690|75782962|FG000|STARTED|Randomized Withdrawal||22|The number of participants starting this Period is not equal to the number who completed previous Period as 5 additional participants from the parent (SONICS) study directly entered the randomized withdrawal phase.|
59663622|NCT03277690|75782963|FG001|STARTED|Randomized Withdrawal||22|The number of participants starting this Period is not equal to the number who completed previous Period as 5 additional participants from the parent (SONICS) study directly entered the randomized withdrawal phase.|
59663623|NCT03277690|75782962|FG000|Subjects Which Were Previous Levoketoconazole Study Completers|Randomized Withdrawal||1||
59663624|NCT03277690|75782963|FG001|Subjects Which Were Previous Levoketoconazole Study Completers|Randomized Withdrawal||4||
59663625|NCT03277690|75782962|FG000|Subjects That Are Levoketoconazole Treatment naïve Subjects|Randomized Withdrawal||21||
59663626|NCT03277690|75782963|FG001|Subjects That Are Levoketoconazole Treatment naïve Subjects|Randomized Withdrawal||18||
59663627|NCT03277690|75782962|FG000|COMPLETED|Randomized Withdrawal||21||
59663628|NCT03277690|75782963|FG001|COMPLETED|Randomized Withdrawal||22||
59663629|NCT03277690|75782962|FG000|NOT COMPLETED|Randomized Withdrawal||1||
59663630|NCT03277690|75782963|FG001|NOT COMPLETED|Randomized Withdrawal||0||
59663631|NCT03277690|75782962|FG000|STARTED|Restoration||21||
59663632|NCT03277690|75782963|FG001|STARTED|Restoration||22||
59663633|NCT03277690|75782962|FG000|Subjects Which Were Previous Levoketoconazole Study Completers|Restoration||1||
59663634|NCT03277690|75782963|FG001|Subjects Which Were Previous Levoketoconazole Study Completers|Restoration||4||
59663635|NCT03277690|75782962|FG000|Subjects That Are Levoketoconazole Treatment naïve Subjects|Restoration||20||
59663636|NCT03277690|75782963|FG001|Subjects That Are Levoketoconazole Treatment naïve Subjects|Restoration||18||
59663637|NCT03277690|75782962|FG000|COMPLETED|Restoration||21||
59663638|NCT03277690|75782963|FG001|COMPLETED|Restoration||22||
59663639|NCT03277690|75782962|FG000|NOT COMPLETED|Restoration||0||
59663640|NCT03277690|75782963|FG001|NOT COMPLETED|Restoration||0||
59663641|NCT03271021|75782972|FG000|STARTED|Overall Study||738||
59663642|NCT03271021|75782973|FG001|STARTED|Overall Study||750||
59663643|NCT03271021|75782972|FG000|COMPLETED|Overall Study||649||
59663644|NCT03271021|75782973|FG001|COMPLETED|Overall Study||644||
59663645|NCT03271021|75782972|FG000|NOT COMPLETED|Overall Study||89||
59663646|NCT03271021|75782973|FG001|NOT COMPLETED|Overall Study||106||
59663647|NCT04331730|75782982|FG000|STARTED|Overall Study||36||
59663648|NCT04331730|75782983|FG001|STARTED|Overall Study||35||
59663649|NCT04331730|75782984|FG002|STARTED|Overall Study||36||
59663650|NCT04331730|75782982|FG000|COMPLETED|Overall Study||36||
59663651|NCT04331730|75782983|FG001|COMPLETED|Overall Study||29||
59663652|NCT04331730|75782984|FG002|COMPLETED|Overall Study||34||
59663653|NCT04331730|75782982|FG000|NOT COMPLETED|Overall Study||0||
59663654|NCT04331730|75782983|FG001|NOT COMPLETED|Overall Study||6||
59663655|NCT04331730|75782984|FG002|NOT COMPLETED|Overall Study||2||
59663656|NCT01249651|75782994|FG000|STARTED|Overall Study|Enrolled|101||
59663657|NCT01249651|75782994|FG000|COMPLETED|Overall Study|Completed the 8-week treatment period|94||
59663658|NCT01249651|75782994|FG000|NOT COMPLETED|Overall Study||7||
59663659|NCT01249417|75783001|FG000|STARTED|Randomised Population||80||
59663660|NCT01249417|75783002|FG001|STARTED|Randomised Population||80||
59663661|NCT01249417|75783003|FG002|STARTED|Randomised Population||81||
59663662|NCT01249417|75783001|FG000|Treated|Randomised Population||80|Constitutes the safety population.|
59663663|NCT01249417|75783002|FG001|Treated|Randomised Population||80|Constitutes the safety population.|
59663664|NCT01249417|75783003|FG002|Treated|Randomised Population||79|Constitutes the safety population.|
59663665|NCT01249417|75783001|FG000|COMPLETED|Randomised Population||79||
59663666|NCT01249417|75783002|FG001|COMPLETED|Randomised Population||79||
59663667|NCT01249417|75783003|FG002|COMPLETED|Randomised Population||77||
59663668|NCT01249417|75783001|FG000|NOT COMPLETED|Randomised Population||1||
59663669|NCT01249417|75783002|FG001|NOT COMPLETED|Randomised Population||1||
59663670|NCT01249417|75783003|FG002|NOT COMPLETED|Randomised Population||4||
59663671|NCT01249417|75783001|FG000|STARTED|Treatment Phase - ITT Population||79||
59663672|NCT01249417|75783002|FG001|STARTED|Treatment Phase - ITT Population||79||
59663673|NCT01249417|75783003|FG002|STARTED|Treatment Phase - ITT Population||77||
59663674|NCT01249417|75783001|FG000|COMPLETED|Treatment Phase - ITT Population||78||
59663675|NCT01249417|75783002|FG001|COMPLETED|Treatment Phase - ITT Population||75||
59663676|NCT01249417|75783003|FG002|COMPLETED|Treatment Phase - ITT Population||73||
59663677|NCT01249417|75783001|FG000|NOT COMPLETED|Treatment Phase - ITT Population||1||
59663678|NCT01249417|75783002|FG001|NOT COMPLETED|Treatment Phase - ITT Population||4||
59663679|NCT01249417|75783003|FG002|NOT COMPLETED|Treatment Phase - ITT Population||4||
59663680|NCT01249261|75783013|FG000|STARTED|Overall Study||30||
59663681|NCT01249261|75783014|FG001|STARTED|Overall Study||31||
59663682|NCT01249261|75783013|FG000|COMPLETED|Overall Study||29||
59663683|NCT01249261|75783014|FG001|COMPLETED|Overall Study||31||
59663684|NCT01249261|75783013|FG000|NOT COMPLETED|Overall Study||1||
59663685|NCT01249261|75783014|FG001|NOT COMPLETED|Overall Study||0||
59663686|NCT02065154|75783020|FG000|STARTED|Overall Study||39||
59663687|NCT02065154|75783020|FG000|COMPLETED|Overall Study||39||
59663688|NCT02065154|75783020|FG000|NOT COMPLETED|Overall Study||0||
59663689|NCT01248949|75783030|FG000|STARTED|Overall Study||42||
59663690|NCT01248949|75783031|FG001|STARTED|Overall Study||16||
59663691|NCT01248949|75783032|FG002|STARTED|Overall Study||38||
59663692|NCT01248949|75783033|FG003|STARTED|Overall Study||13||
59663693|NCT01248949|75783034|FG004|STARTED|Overall Study||7||
59663694|NCT01248949|75783030|FG000|COMPLETED|Overall Study||9||
59663695|NCT01248949|75783031|FG001|COMPLETED|Overall Study||3||
59663696|NCT01248949|75783032|FG002|COMPLETED|Overall Study||1||
59663697|NCT01248949|75783033|FG003|COMPLETED|Overall Study||3||
59663698|NCT01248949|75783034|FG004|COMPLETED|Overall Study||3||
59663699|NCT01248949|75783030|FG000|NOT COMPLETED|Overall Study||33||
59663700|NCT01248949|75783031|FG001|NOT COMPLETED|Overall Study||13||
59663701|NCT01248949|75783032|FG002|NOT COMPLETED|Overall Study||37||
59663702|NCT01248949|75783033|FG003|NOT COMPLETED|Overall Study||10||
59663703|NCT01248949|75783034|FG004|NOT COMPLETED|Overall Study||4||
59663704|NCT01248793|75783048|FG000|STARTED|Overall Study||105||
59663705|NCT01248793|75783049|FG001|STARTED|Overall Study||108||
59663706|NCT01248793|75783048|FG000|COMPLETED|Overall Study||101||
59663707|NCT01248793|75783049|FG001|COMPLETED|Overall Study||102||
59663708|NCT01248793|75783048|FG000|NOT COMPLETED|Overall Study||4||
59663709|NCT01248793|75783049|FG001|NOT COMPLETED|Overall Study||6||
59663710|NCT01248364|75783059|FG000|STARTED|Overall Study||32||
59663711|NCT01248364|75783060|FG001|STARTED|Overall Study||34||
59663712|NCT01248364|75783061|FG002|STARTED|Overall Study||13||
59663713|NCT01248364|75783062|FG003|STARTED|Overall Study||12||
59663714|NCT01248364|75783059|FG000|Completed Acute Phase:Single Dose, Day 1|Overall Study||32||
59663715|NCT01248364|75783060|FG001|Completed Acute Phase:Single Dose, Day 1|Overall Study||34||
59663716|NCT01248364|75783061|FG002|Completed Acute Phase:Single Dose, Day 1|Overall Study||13||
59663717|NCT01248364|75783062|FG003|Completed Acute Phase:Single Dose, Day 1|Overall Study||12||
59663718|NCT01248364|75783059|FG000|Completed Chronic Phase:28-day Treatment|Overall Study||32||
59663719|NCT01248364|75783060|FG001|Completed Chronic Phase:28-day Treatment|Overall Study||33||
59663720|NCT01248364|75783061|FG002|Completed Chronic Phase:28-day Treatment|Overall Study||13||
59663721|NCT01248364|75783062|FG003|Completed Chronic Phase:28-day Treatment|Overall Study||0||
59663722|NCT01248364|75783059|FG000|COMPLETED|Overall Study||32||
59663723|NCT01248364|75783060|FG001|COMPLETED|Overall Study||33||
59663724|NCT01248364|75783061|FG002|COMPLETED|Overall Study||13||
59663725|NCT01248364|75783062|FG003|COMPLETED|Overall Study||12||
59663726|NCT01248364|75783059|FG000|NOT COMPLETED|Overall Study||0||
59663727|NCT01248364|75783060|FG001|NOT COMPLETED|Overall Study||1||
59663728|NCT01248364|75783061|FG002|NOT COMPLETED|Overall Study||0||
59663729|NCT01248364|75783062|FG003|NOT COMPLETED|Overall Study||0||
59663730|NCT01248130|75783074|FG000|STARTED|Overall Study||3||
59663731|NCT01248130|75783075|FG001|STARTED|Overall Study||4||
59663732|NCT01248130|75783074|FG000|COMPLETED|Overall Study||1||
59663733|NCT01248130|75783075|FG001|COMPLETED|Overall Study||4||
59663734|NCT01248130|75783074|FG000|NOT COMPLETED|Overall Study||2||
59663735|NCT01248130|75783075|FG001|NOT COMPLETED|Overall Study||0||
59663736|NCT01248013|75783081|FG000|STARTED|Overall Study||89||
59663737|NCT01248013|75783081|FG000|Irritable Bowel Syndrome Hypnotherapy|Overall Study||75||
59663738|NCT01248013|75783081|FG000|COMPLETED|Overall Study||75||
59663739|NCT01248013|75783081|FG000|NOT COMPLETED|Overall Study||14||
59663740|NCT01247350|75783090|FG000|STARTED|Overall Study||6||
59663741|NCT01247350|75783091|FG001|STARTED|Overall Study||6||
59663742|NCT01247350|75783092|FG002|STARTED|Overall Study||6||
59663743|NCT01247350|75783093|FG003|STARTED|Overall Study||7||
59663744|NCT01247350|75783094|FG004|STARTED|Overall Study||9||
59663745|NCT01247350|75783090|FG000|Received Multiple Doses of Study Drug|Overall Study||0||
59663746|NCT01247350|75783091|FG001|Received Multiple Doses of Study Drug|Overall Study||0||
59663747|NCT01247350|75783092|FG002|Received Multiple Doses of Study Drug|Overall Study||6||
59663748|NCT01247350|75783093|FG003|Received Multiple Doses of Study Drug|Overall Study||6||
59663749|NCT01247350|75783094|FG004|Received Multiple Doses of Study Drug|Overall Study||5||
59663750|NCT01247350|75783090|FG000|COMPLETED|Overall Study||6||
59663751|NCT01247350|75783091|FG001|COMPLETED|Overall Study||6||
59663752|NCT01247350|75783092|FG002|COMPLETED|Overall Study||5||
59663753|NCT01247350|75783093|FG003|COMPLETED|Overall Study||6||
59663754|NCT01247350|75783094|FG004|COMPLETED|Overall Study||8||
59663755|NCT01247350|75783090|FG000|NOT COMPLETED|Overall Study||0||
59663756|NCT01247350|75783091|FG001|NOT COMPLETED|Overall Study||0||
59663757|NCT01247350|75783092|FG002|NOT COMPLETED|Overall Study||1||
59663758|NCT01247350|75783093|FG003|NOT COMPLETED|Overall Study||1||
59663759|NCT01247350|75783094|FG004|NOT COMPLETED|Overall Study||1||
59663760|NCT01246999|75783124|FG000|STARTED|Overall Study||11||
59663761|NCT01246999|75783125|FG001|STARTED|Overall Study||4||
59663762|NCT01246999|75783126|FG002|STARTED|Overall Study||2||
59663763|NCT01246999|75783127|FG003|STARTED|Overall Study||17||
59663764|NCT01246999|75783124|FG000|COMPLETED|Overall Study||11||
59663765|NCT01246999|75783125|FG001|COMPLETED|Overall Study||3||
59663766|NCT01246999|75783126|FG002|COMPLETED|Overall Study||2||
59663767|NCT01246999|75783127|FG003|COMPLETED|Overall Study||15||
59663768|NCT01246999|75783124|FG000|NOT COMPLETED|Overall Study||0||
59663769|NCT01246999|75783125|FG001|NOT COMPLETED|Overall Study||1||
59663770|NCT01246999|75783126|FG002|NOT COMPLETED|Overall Study||0||
59663771|NCT01246999|75783127|FG003|NOT COMPLETED|Overall Study||2||
59663772|NCT02443623|75783140|FG000|STARTED|Overall Study||3032||
59663773|NCT02443623|75783140|FG000|COMPLETED|Overall Study||2788||
59663774|NCT02443623|75783140|FG000|NOT COMPLETED|Overall Study||244||
59663775|NCT01245751|75783149|FG000|STARTED|Part 1: Day 1 to Week 52 (1 Year)||201||
59663776|NCT01245751|75783150|FG001|STARTED|Part 1: Day 1 to Week 52 (1 Year)||199||
59663777|NCT01245751|75783151|FG002|STARTED|Part 1: Day 1 to Week 52 (1 Year)||100||
59663778|NCT01245751|75783152|FG003|STARTED|Part 1: Day 1 to Week 52 (1 Year)||100||
59663779|NCT01245751|75783149|FG000|Completed 42-day Postvaccination Period|Part 1: Day 1 to Week 52 (1 Year)||201||
59663780|NCT01245751|75783150|FG001|Completed 42-day Postvaccination Period|Part 1: Day 1 to Week 52 (1 Year)||199||
59663781|NCT01245751|75783151|FG002|Completed 42-day Postvaccination Period|Part 1: Day 1 to Week 52 (1 Year)||100||
59663782|NCT01245751|75783152|FG003|Completed 42-day Postvaccination Period|Part 1: Day 1 to Week 52 (1 Year)||100||
59663783|NCT01245751|75783149|FG000|COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||199||
59663784|NCT01245751|75783150|FG001|COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||194||
59663785|NCT01245751|75783151|FG002|COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||100||
59663786|NCT01245751|75783152|FG003|COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||98||
59663787|NCT01245751|75783149|FG000|NOT COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||2||
59663788|NCT01245751|75783150|FG001|NOT COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||5||
59663789|NCT01245751|75783151|FG002|NOT COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||0||
59663790|NCT01245751|75783152|FG003|NOT COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||2||
59663791|NCT01245751|75783149|FG000|STARTED|Part 2: Week 156 (3 Year) Visit|Enrollment in Part 2 was voluntary|161||
59663792|NCT01245751|75783150|FG001|STARTED|Part 2: Week 156 (3 Year) Visit|Enrollment in Part 2 was voluntary|139||
59663793|NCT01245751|75783151|FG002|STARTED|Part 2: Week 156 (3 Year) Visit|Part 2 was planned for Groups 1 and 2 only|0||
59663794|NCT01245751|75783152|FG003|STARTED|Part 2: Week 156 (3 Year) Visit|Part 2 was planned for Groups 1 and 2 only|0||
59663795|NCT01245751|75783149|FG000|COMPLETED|Part 2: Week 156 (3 Year) Visit||161||
59663796|NCT01245751|75783150|FG001|COMPLETED|Part 2: Week 156 (3 Year) Visit||139||
59663797|NCT01245751|75783151|FG002|COMPLETED|Part 2: Week 156 (3 Year) Visit||0||
59663798|NCT01245751|75783152|FG003|COMPLETED|Part 2: Week 156 (3 Year) Visit||0||
59663799|NCT01245751|75783149|FG000|NOT COMPLETED|Part 2: Week 156 (3 Year) Visit||0||
59663800|NCT01245751|75783150|FG001|NOT COMPLETED|Part 2: Week 156 (3 Year) Visit||0||
59663801|NCT01245751|75783151|FG002|NOT COMPLETED|Part 2: Week 156 (3 Year) Visit||0||
59663802|NCT01245751|75783152|FG003|NOT COMPLETED|Part 2: Week 156 (3 Year) Visit||0||
59663803|NCT01245673|75783163|FG000|STARTED|Enrollment||28||
59663804|NCT01245673|75783163|FG000|COMPLETED|Enrollment|One subject failed to meet screening criteria for the trial.|27||
59663805|NCT01245673|75783163|FG000|NOT COMPLETED|Enrollment||1||
59663806|NCT01245673|75783163|FG000|STARTED|Pre Transplant Vaccinations||27||
59663807|NCT01245673|75783163|FG000|Pre Transplant Vaccinations 1-3|Pre Transplant Vaccinations||27|MAGE-A3, GM-CSF, Hiltonol®, PCV vaccine ~10 days before apheresis.|
59663808|NCT01245673|75783163|FG000|COMPLETED|Pre Transplant Vaccinations||27||
59663809|NCT01245673|75783163|FG000|NOT COMPLETED|Pre Transplant Vaccinations||0||
59663810|NCT01245673|75783163|FG000|STARTED|Activated/Costimulated Autologous T Cell||27||
59663811|NCT01245673|75783163|FG000|COMPLETED|Activated/Costimulated Autologous T Cell||27||
59663812|NCT01245673|75783163|FG000|NOT COMPLETED|Activated/Costimulated Autologous T Cell||0||
59663813|NCT01245673|75783163|FG000|STARTED|MAGE-A3, Hiltonol®, PVC After T Cells||27|On study Days 14, 42 and 90 study participants will receive MAGE-A3, Hiltonol® and PVC vaccine.|
59663814|NCT01245673|75783163|FG000|COMPLETED|MAGE-A3, Hiltonol®, PVC After T Cells||26||
59663815|NCT01245673|75783163|FG000|NOT COMPLETED|MAGE-A3, Hiltonol®, PVC After T Cells||1||
59663816|NCT01245673|75783163|FG000|STARTED|Start Lenalidomide||26||
59663817|NCT01245673|75783163|FG000|COMPLETED|Start Lenalidomide||26||
59663818|NCT01245673|75783163|FG000|NOT COMPLETED|Start Lenalidomide||0||
59663819|NCT01245673|75783163|FG000|STARTED|Maintenance: MAGE-A3, PVC After T Cells||26||
59663820|NCT01245673|75783163|FG000|COMPLETED|Maintenance: MAGE-A3, PVC After T Cells||26||
59663821|NCT01245673|75783163|FG000|NOT COMPLETED|Maintenance: MAGE-A3, PVC After T Cells||0||
59663822|NCT01245283|75783170|FG000|STARTED|Overall Study||32||
59663823|NCT01245283|75783171|FG001|STARTED|Overall Study||28||
59663824|NCT01245283|75783172|FG002|STARTED|Overall Study||30||
59663825|NCT01245283|75783170|FG000|COMPLETED|Overall Study||18||
59663826|NCT01245283|75783171|FG001|COMPLETED|Overall Study||17||
59663827|NCT01245283|75783172|FG002|COMPLETED|Overall Study||19||
59663828|NCT01245283|75783170|FG000|NOT COMPLETED|Overall Study||14||
59663829|NCT01245283|75783171|FG001|NOT COMPLETED|Overall Study||11||
59663830|NCT01245283|75783172|FG002|NOT COMPLETED|Overall Study||11||
59663831|NCT01245049|75783185|FG000|STARTED|Overall Study||255||
59663832|NCT01245049|75783186|FG001|STARTED|Overall Study||130||
59663833|NCT01245049|75783185|FG000|COMPLETED|Overall Study||254||
59663834|NCT01245049|75783186|FG001|COMPLETED|Overall Study||126||
59663835|NCT01245049|75783185|FG000|NOT COMPLETED|Overall Study||1||
59663836|NCT01245049|75783186|FG001|NOT COMPLETED|Overall Study||4||
59663837|NCT01244893|75783192|FG000|STARTED|Baseline||22||
59663838|NCT01244893|75783193|FG001|STARTED|Baseline||22||
59663839|NCT01244893|75783192|FG000|COMPLETED|Baseline||22||
59663840|NCT01244893|75783193|FG001|COMPLETED|Baseline||21||
60077261|NCT01513239|76192320|FG001|STARTED|Period 1: Main Phase|Randomized participants|407||
60077262|NCT01513239|76192321|FG002|STARTED|Period 1: Main Phase|Randomized participants|399||
60077263|NCT01513239|76192322|FG003|STARTED|Period 1: Main Phase||0||
60077264|NCT01513239|76192323|FG004|STARTED|Period 1: Main Phase||0||
59544689|NCT01671605|75643215|FG001|COMPLETED|Overall Study||31||
59544690|NCT01671605|75643214|FG000|NOT COMPLETED|Overall Study||0||
59544691|NCT01671605|75643215|FG001|NOT COMPLETED|Overall Study||0||
59544692|NCT00957242|75643223|FG000|STARTED|Overall Study||73||
59544693|NCT00957242|75643224|FG001|STARTED|Overall Study||72||
59544694|NCT00957242|75643223|FG000|COMPLETED|Overall Study||73||
59544695|NCT00957242|75643224|FG001|COMPLETED|Overall Study||72||
59544696|NCT00957242|75643223|FG000|NOT COMPLETED|Overall Study||0||
59544697|NCT00957242|75643224|FG001|NOT COMPLETED|Overall Study||0||
59663841|NCT01244893|75783192|FG000|NOT COMPLETED|Baseline||0||
59663842|NCT01244893|75783193|FG001|NOT COMPLETED|Baseline||1||
59663843|NCT01244893|75783192|FG000|STARTED|1-Week Follow Up||22||
59663844|NCT01244893|75783193|FG001|STARTED|1-Week Follow Up||21||
59663845|NCT01244893|75783192|FG000|COMPLETED|1-Week Follow Up||21||
59663846|NCT01244893|75783193|FG001|COMPLETED|1-Week Follow Up||21||
59663847|NCT01244893|75783192|FG000|NOT COMPLETED|1-Week Follow Up||1||
60077265|NCT01513239|76192324|FG005|STARTED|Period 1: Main Phase||0||
59544698|NCT01671839|75643232|FG000|STARTED|Overall Study||55||
59544699|NCT01671839|75643232|FG000|3-year Follow-up|Overall Study||45||
59544700|NCT01671839|75643232|FG000|5-year Follow-up|Overall Study||37||
60077266|NCT01513239|76192319|FG000|Treated|Period 1: Main Phase|Treated participants|391||
60077267|NCT01513239|76192320|FG001|Treated|Period 1: Main Phase|Treated participants|396||
59663848|NCT01244893|75783193|FG001|NOT COMPLETED|1-Week Follow Up||0||
59663849|NCT01244893|75783192|FG000|STARTED|Final Visit||21||
59663850|NCT01244893|75783193|FG001|STARTED|Final Visit||21||
59663851|NCT01244893|75783192|FG000|COMPLETED|Final Visit||21||
59663852|NCT01244893|75783193|FG001|COMPLETED|Final Visit||21||
59663853|NCT01244893|75783192|FG000|NOT COMPLETED|Final Visit||0||
59663854|NCT01244893|75783193|FG001|NOT COMPLETED|Final Visit||0||
59663855|NCT01244815|75783208|FG000|STARTED|Overall Study|Randomized|101||
59663856|NCT01244815|75783209|FG001|STARTED|Overall Study|Randomized|105||
59663857|NCT01244815|75783210|FG002|STARTED|Overall Study|Randomized|99||
59663858|NCT01244815|75783211|FG003|STARTED|Overall Study|Randomized|99||
59663859|NCT01244815|75783208|FG000|Treated|Overall Study||101||
59663860|NCT01244815|75783209|FG001|Treated|Overall Study||104||
59663861|NCT01244815|75783210|FG002|Treated|Overall Study||99||
59663862|NCT01244815|75783211|FG003|Treated|Overall Study||99||
59663863|NCT01244815|75783208|FG000|COMPLETED|Overall Study||87||
59663864|NCT01244815|75783209|FG001|COMPLETED|Overall Study||88||
59663865|NCT01244815|75783210|FG002|COMPLETED|Overall Study||88||
59663866|NCT01244815|75783211|FG003|COMPLETED|Overall Study||87||
59663867|NCT01244815|75783208|FG000|NOT COMPLETED|Overall Study||14||
59663868|NCT01244815|75783209|FG001|NOT COMPLETED|Overall Study||17||
59663869|NCT01244815|75783210|FG002|NOT COMPLETED|Overall Study||11||
59663870|NCT01244815|75783211|FG003|NOT COMPLETED|Overall Study||12||
59663871|NCT01244425|75783223|FG000|STARTED|Overall Study||35||
59663872|NCT01244425|75783224|FG001|STARTED|Overall Study||35||
59663873|NCT01244425|75783223|FG000|COMPLETED|Overall Study|Adverse Event: multi-organ failure (death)|32||
59663874|NCT01244425|75783224|FG001|COMPLETED|Overall Study|Adverse Event: septic shock with multi-organ failure due to liver abscess (death)|32||
59663875|NCT01244425|75783223|FG000|NOT COMPLETED|Overall Study||3||
59663876|NCT01244425|75783224|FG001|NOT COMPLETED|Overall Study||3||
59663877|NCT01244191|75783240|FG000|STARTED|Overall Study||526||
59663878|NCT01244191|75783241|FG001|STARTED|Overall Study||522||
59663879|NCT01244191|75783240|FG000|Did Not Receive Treatment|Overall Study||6||
59663880|NCT01244191|75783241|FG001|Did Not Receive Treatment|Overall Study||5||
59663881|NCT01244191|75783240|FG000|COMPLETED|Overall Study||46||
59663882|NCT01244191|75783241|FG001|COMPLETED|Overall Study||24||
59663883|NCT01244191|75783240|FG000|NOT COMPLETED|Overall Study||480||
59663884|NCT01244191|75783241|FG001|NOT COMPLETED|Overall Study||498||
59663885|NCT01244035|75783247|FG000|STARTED|Part 1: Period 1||5|This was a 3-period crossover study with a 4-day washout between treatment periods|
59663886|NCT01244035|75783248|FG001|STARTED|Part 1: Period 1||5|This was a 3-period crossover study with a 4-day washout between treatment periods|
59663887|NCT01244035|75783249|FG002|STARTED|Part 1: Period 1||6|This was a 3-period crossover study with a 4-day washout between treatment periods|
59663888|NCT01244035|75783250|FG003|STARTED|Part 1: Period 1||5|This was a 3-period crossover study with a 4-day washout between treatment periods|
59663889|NCT01244035|75783251|FG004|STARTED|Part 1: Period 1||5|This was a 3-period crossover study with a 4-day washout between treatment periods|
60077268|NCT01513239|76192321|FG002|Treated|Period 1: Main Phase|Treated participants|381||
60077269|NCT01513239|76192322|FG003|Treated|Period 1: Main Phase||0||
60077270|NCT01513239|76192323|FG004|Treated|Period 1: Main Phase||0||
60077271|NCT01513239|76192324|FG005|Treated|Period 1: Main Phase||0||
60077272|NCT01513239|76192319|FG000|All Participants as Treated|Period 1: Main Phase|One participant randomized to receive MK-3415A (MK-3415 plus MK-6072) received only MK-3415|390||
60077273|NCT01513239|76192320|FG001|All Participants as Treated|Period 1: Main Phase|Treatment actually received|396||
59544701|NCT01671839|75643232|FG000|COMPLETED|Overall Study||37||
59544702|NCT01671839|75643232|FG000|NOT COMPLETED|Overall Study||18||
59544703|NCT01014728|75643241|FG000|STARTED|Overall Study||18||
59544704|NCT01014728|75643242|FG001|STARTED|Overall Study||15||
59544705|NCT01014728|75643241|FG000|COMPLETED|Overall Study||18||
59544706|NCT01014728|75643242|FG001|COMPLETED|Overall Study||15||
59544707|NCT01014728|75643241|FG000|NOT COMPLETED|Overall Study||0||
59544708|NCT01014728|75643242|FG001|NOT COMPLETED|Overall Study||0||
59544709|NCT01015586|75643250|FG000|STARTED|Overall Study||21||
59544710|NCT01015586|75643251|FG001|STARTED|Overall Study||22||
59663890|NCT01244035|75783252|FG005|STARTED|Part 1: Period 1||5|This was a 3-period crossover study with a 4-day washout between treatment periods|
59663891|NCT01244035|75783247|FG000|COMPLETED|Part 1: Period 1||4||
59663892|NCT01244035|75783248|FG001|COMPLETED|Part 1: Period 1||3||
59663893|NCT01244035|75783249|FG002|COMPLETED|Part 1: Period 1||4||
59544711|NCT01015586|75643250|FG000|COMPLETED|Overall Study||14||
59544712|NCT01015586|75643251|FG001|COMPLETED|Overall Study||11||
59544713|NCT01015586|75643250|FG000|NOT COMPLETED|Overall Study||7||
59663894|NCT01244035|75783250|FG003|COMPLETED|Part 1: Period 1||5||
59663895|NCT01244035|75783251|FG004|COMPLETED|Part 1: Period 1||4||
59663896|NCT01244035|75783252|FG005|COMPLETED|Part 1: Period 1||3||
59663897|NCT01244035|75783247|FG000|NOT COMPLETED|Part 1: Period 1||1||
59663898|NCT01244035|75783248|FG001|NOT COMPLETED|Part 1: Period 1||2||
59663899|NCT01244035|75783249|FG002|NOT COMPLETED|Part 1: Period 1||2||
59663900|NCT01244035|75783250|FG003|NOT COMPLETED|Part 1: Period 1||0||
59663901|NCT01244035|75783251|FG004|NOT COMPLETED|Part 1: Period 1||1||
59663902|NCT01244035|75783252|FG005|NOT COMPLETED|Part 1: Period 1||2||
59663903|NCT01244035|75783247|FG000|STARTED|Part 1: Period 2||4||
59663904|NCT01244035|75783248|FG001|STARTED|Part 1: Period 2||3||
59663905|NCT01244035|75783249|FG002|STARTED|Part 1: Period 2||4||
59663906|NCT01244035|75783250|FG003|STARTED|Part 1: Period 2||5||
59663907|NCT01244035|75783251|FG004|STARTED|Part 1: Period 2||4||
59663908|NCT01244035|75783252|FG005|STARTED|Part 1: Period 2||3||
59663909|NCT01244035|75783247|FG000|COMPLETED|Part 1: Period 2||4||
59663910|NCT01244035|75783248|FG001|COMPLETED|Part 1: Period 2||3||
59663911|NCT01244035|75783249|FG002|COMPLETED|Part 1: Period 2||3||
59663912|NCT01244035|75783250|FG003|COMPLETED|Part 1: Period 2||5||
59663913|NCT01244035|75783251|FG004|COMPLETED|Part 1: Period 2||4||
59663914|NCT01244035|75783252|FG005|COMPLETED|Part 1: Period 2||3||
59663915|NCT01244035|75783247|FG000|NOT COMPLETED|Part 1: Period 2||0||
59663916|NCT01244035|75783248|FG001|NOT COMPLETED|Part 1: Period 2||0||
59663917|NCT01244035|75783249|FG002|NOT COMPLETED|Part 1: Period 2||1||
59663918|NCT01244035|75783250|FG003|NOT COMPLETED|Part 1: Period 2||0||
59663919|NCT01244035|75783251|FG004|NOT COMPLETED|Part 1: Period 2||0||
59663920|NCT01244035|75783252|FG005|NOT COMPLETED|Part 1: Period 2||0||
59663921|NCT01244035|75783247|FG000|STARTED|Part 1: Period 3||4||
59663922|NCT01244035|75783248|FG001|STARTED|Part 1: Period 3||3||
59663923|NCT01244035|75783249|FG002|STARTED|Part 1: Period 3||3||
59663924|NCT01244035|75783250|FG003|STARTED|Part 1: Period 3||5||
59663925|NCT01244035|75783251|FG004|STARTED|Part 1: Period 3||4||
59663926|NCT01244035|75783252|FG005|STARTED|Part 1: Period 3||3||
59663927|NCT01244035|75783247|FG000|COMPLETED|Part 1: Period 3||4||
59663928|NCT01244035|75783248|FG001|COMPLETED|Part 1: Period 3||2||
59663929|NCT01244035|75783249|FG002|COMPLETED|Part 1: Period 3||3||
59663930|NCT01244035|75783250|FG003|COMPLETED|Part 1: Period 3||5||
59663931|NCT01244035|75783251|FG004|COMPLETED|Part 1: Period 3||3||
59663932|NCT01244035|75783252|FG005|COMPLETED|Part 1: Period 3||2||
59663933|NCT01244035|75783247|FG000|NOT COMPLETED|Part 1: Period 3||0||
59663934|NCT01244035|75783248|FG001|NOT COMPLETED|Part 1: Period 3||1||
59663935|NCT01244035|75783249|FG002|NOT COMPLETED|Part 1: Period 3||0||
59663936|NCT01244035|75783250|FG003|NOT COMPLETED|Part 1: Period 3||0||
59663937|NCT01244035|75783251|FG004|NOT COMPLETED|Part 1: Period 3||1||
59663938|NCT01244035|75783252|FG005|NOT COMPLETED|Part 1: Period 3||1||
59663939|NCT04724538|75783274|FG000|STARTED|Overall Study||11||
59663940|NCT04724538|75783275|FG001|STARTED|Overall Study||14||
59663941|NCT04724538|75783274|FG000|COMPLETED|Overall Study||11||
59663942|NCT04724538|75783275|FG001|COMPLETED|Overall Study||14||
59663943|NCT04724538|75783274|FG000|NOT COMPLETED|Overall Study||0||
59663944|NCT04724538|75783275|FG001|NOT COMPLETED|Overall Study||0||
59663945|NCT01243762|75783288|FG000|STARTED|Part 1 (Dose Escalation/MTD)||4||
59663946|NCT01243762|75783289|FG001|STARTED|Part 1 (Dose Escalation/MTD)||13||
59663947|NCT01243762|75783290|FG002|STARTED|Part 1 (Dose Escalation/MTD)||3||
59663948|NCT01243762|75783291|FG003|STARTED|Part 1 (Dose Escalation/MTD)||8||
59663949|NCT01243762|75783292|FG004|STARTED|Part 1 (Dose Escalation/MTD)||10||
59663950|NCT01243762|75783293|FG005|STARTED|Part 1 (Dose Escalation/MTD)||3||
59663951|NCT01243762|75783294|FG006|STARTED|Part 1 (Dose Escalation/MTD)||0||
59663952|NCT01243762|75783288|FG000|COMPLETED|Part 1 (Dose Escalation/MTD)|Entered Part 2 of Study|1||
59663953|NCT01243762|75783289|FG001|COMPLETED|Part 1 (Dose Escalation/MTD)|Entered Part 2 of Study|5||
59663954|NCT01243762|75783290|FG002|COMPLETED|Part 1 (Dose Escalation/MTD)||0||
59663955|NCT01243762|75783291|FG003|COMPLETED|Part 1 (Dose Escalation/MTD)|Entered Part 2 of Study|2||
59663956|NCT01243762|75783292|FG004|COMPLETED|Part 1 (Dose Escalation/MTD)|Entered Part 2 of Study|4||
59663957|NCT01243762|75783293|FG005|COMPLETED|Part 1 (Dose Escalation/MTD)||0||
59663958|NCT01243762|75783294|FG006|COMPLETED|Part 1 (Dose Escalation/MTD)||0||
59663959|NCT01243762|75783288|FG000|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||3||
59663960|NCT01243762|75783289|FG001|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||8||
59663961|NCT01243762|75783290|FG002|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||3||
59663962|NCT01243762|75783291|FG003|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||6||
59663963|NCT01243762|75783292|FG004|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||6||
59663964|NCT01243762|75783293|FG005|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||3||
59663965|NCT01243762|75783294|FG006|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||0||
59663966|NCT01243762|75783288|FG000|STARTED|Part 2 (Dose Confirmation/Efficacy)||1||
59663967|NCT01243762|75783289|FG001|STARTED|Part 2 (Dose Confirmation/Efficacy)||5||
59663968|NCT01243762|75783290|FG002|STARTED|Part 2 (Dose Confirmation/Efficacy)||0||
59663969|NCT01243762|75783291|FG003|STARTED|Part 2 (Dose Confirmation/Efficacy)||2||
59663970|NCT01243762|75783292|FG004|STARTED|Part 2 (Dose Confirmation/Efficacy)||4||
59663971|NCT01243762|75783293|FG005|STARTED|Part 2 (Dose Confirmation/Efficacy)||0||
59663972|NCT01243762|75783294|FG006|STARTED|Part 2 (Dose Confirmation/Efficacy)|New participants were enrolled in Part 2 of the study that did not participate in Part 1|6||
59663973|NCT01243762|75783288|FG000|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0||
59663974|NCT01243762|75783289|FG001|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0||
59663975|NCT01243762|75783290|FG002|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0||
59663976|NCT01243762|75783291|FG003|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0||
59663977|NCT01243762|75783292|FG004|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0||
59663978|NCT01243762|75783293|FG005|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0||
59663979|NCT01243762|75783294|FG006|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0||
59663980|NCT01243762|75783288|FG000|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||1||
59663981|NCT01243762|75783289|FG001|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||5||
59663982|NCT01243762|75783290|FG002|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0||
59663983|NCT01243762|75783291|FG003|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||2||
59663984|NCT01243762|75783292|FG004|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||4||
59663985|NCT01243762|75783293|FG005|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0||
59663986|NCT01243762|75783294|FG006|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||6||
59663987|NCT01243411|75783313|FG000|STARTED|Overall Study||347||
59663988|NCT01243411|75783313|FG000|COMPLETED|Overall Study||306||
59663989|NCT01243411|75783313|FG000|NOT COMPLETED|Overall Study||41||
59663990|NCT01243177|75783319|FG000|STARTED|Overall Study||444||
59663991|NCT01243177|75783320|FG001|STARTED|Overall Study||442||
59663992|NCT01243177|75783319|FG000|COMPLETED|Overall Study||266||
59663993|NCT01243177|75783320|FG001|COMPLETED|Overall Study||264||
59663994|NCT01243177|75783319|FG000|NOT COMPLETED|Overall Study||178||
59663995|NCT01243177|75783320|FG001|NOT COMPLETED|Overall Study||178||
59663996|NCT01242748|75783328|FG000|STARTED|Overall Study|Enrolled in CS35A, CS35A Full Analysis Set.|194||
59663997|NCT01242748|75783329|FG001|STARTED|Overall Study||94||
59663998|NCT01242748|75783328|FG000|CS35/CS35A Safety Analysis Set|Overall Study|Received at least 1 dose of trial drug during the main CS35 trial.|565||
59663999|NCT01242748|75783329|FG001|CS35/CS35A Safety Analysis Set|Overall Study||283||
59664000|NCT01242748|75783328|FG000|CS35/CS35A Full Analysis Set (FAS)|Overall Study|Received at least 1 dose of trial drug during CS35+had at least 1 efficacy assessment after dosing.|565||
59664001|NCT01242748|75783329|FG001|CS35/CS35A Full Analysis Set (FAS)|Overall Study||282||
59664002|NCT01242748|75783328|FG000|COMPLETED|Overall Study|These participants were ongoing when the trial was closed by the Sponsor.|156||
59664003|NCT01242748|75783329|FG001|COMPLETED|Overall Study||80||
59664004|NCT01242748|75783328|FG000|NOT COMPLETED|Overall Study||38||
59664005|NCT01242748|75783329|FG001|NOT COMPLETED|Overall Study||14||
59664006|NCT01242514|75783338|FG000|STARTED|Overall Study|Patients who received treatment|1343||
59664007|NCT01242514|75783339|FG001|STARTED|Overall Study|Patients who received treatment|357||
59664008|NCT01242514|75783340|FG002|STARTED|Overall Study|Patients who received treatment|212||
59664009|NCT01242514|75783338|FG000|Enrolled But Did Not Receive Treatment|Overall Study|Other|3||
59664010|NCT01242514|75783339|FG001|Enrolled But Did Not Receive Treatment|Overall Study||0||
59664011|NCT01242514|75783340|FG002|Enrolled But Did Not Receive Treatment|Overall Study|Adverse event/other|2||
59664012|NCT01242514|75783338|FG000|COMPLETED|Overall Study|Due to project closure.|0||
59664013|NCT01242514|75783339|FG001|COMPLETED|Overall Study|Due to project closure.|0||
59664014|NCT01242514|75783340|FG002|COMPLETED|Overall Study|Due to project closure.|0||
59664015|NCT01242514|75783338|FG000|NOT COMPLETED|Overall Study||1343||
59664016|NCT01242514|75783339|FG001|NOT COMPLETED|Overall Study||357||
59664017|NCT01242514|75783340|FG002|NOT COMPLETED|Overall Study||212||
59664018|NCT01242085|75783351|FG000|STARTED|Overall Study||30||
59664019|NCT01242085|75783352|FG001|STARTED|Overall Study||33||
59664020|NCT01242085|75783353|FG002|STARTED|Overall Study||1||
59664021|NCT01242085|75783351|FG000|COMPLETED|Overall Study|8 patients did not undergo intervention since 4 had medical problems and 4 withdrew|22||
59664022|NCT01242085|75783352|FG001|COMPLETED|Overall Study|7 patients did not receive allocated intervention since 5 had medical problems and 2 withdrew|26||
59664023|NCT01242085|75783353|FG002|COMPLETED|Overall Study||1||
59664024|NCT01242085|75783351|FG000|NOT COMPLETED|Overall Study||8||
59664025|NCT01242085|75783352|FG001|NOT COMPLETED|Overall Study||7||
59664026|NCT01242085|75783353|FG002|NOT COMPLETED|Overall Study||0||
59664027|NCT01241461|75783361|FG000|STARTED|Overall Study||3||
59664028|NCT01241461|75783362|FG001|STARTED|Overall Study||6||
59664029|NCT01241461|75783361|FG000|COMPLETED|Overall Study||0||
59664030|NCT01241461|75783362|FG001|COMPLETED|Overall Study||0||
59664031|NCT01241461|75783361|FG000|NOT COMPLETED|Overall Study||3||
59664032|NCT01241461|75783362|FG001|NOT COMPLETED|Overall Study||6||
59664033|NCT01240135|75783374|FG000|STARTED|Period One, 14 Days of Wear||44||
59664034|NCT01240135|75783375|FG001|STARTED|Period One, 14 Days of Wear||45||
59664035|NCT01240135|75783374|FG000|COMPLETED|Period One, 14 Days of Wear||44||
59664036|NCT01240135|75783375|FG001|COMPLETED|Period One, 14 Days of Wear||45||
59664037|NCT01240135|75783374|FG000|NOT COMPLETED|Period One, 14 Days of Wear||0||
59664038|NCT01240135|75783375|FG001|NOT COMPLETED|Period One, 14 Days of Wear||0||
59664039|NCT01240135|75783374|FG000|STARTED|Period Two, 14 Days of Wear||44||
59664040|NCT01240135|75783375|FG001|STARTED|Period Two, 14 Days of Wear||45||
59664041|NCT01240135|75783374|FG000|COMPLETED|Period Two, 14 Days of Wear||43||
59664042|NCT01240135|75783375|FG001|COMPLETED|Period Two, 14 Days of Wear||43||
59664043|NCT01240135|75783374|FG000|NOT COMPLETED|Period Two, 14 Days of Wear||1||
59664044|NCT01240135|75783375|FG001|NOT COMPLETED|Period Two, 14 Days of Wear||2||
59664045|NCT01247701|75783381|FG000|STARTED|Overall Study||16||
59664046|NCT01247701|75783381|FG000|COMPLETED|Overall Study||6||
59664047|NCT01247701|75783381|FG000|NOT COMPLETED|Overall Study||10||
59664048|NCT01248247|75783389|FG000|STARTED|Overall Study||22||
59664049|NCT01248247|75783390|FG001|STARTED|Overall Study||42||
59664050|NCT01248247|75783391|FG002|STARTED|Overall Study||75||
59664051|NCT01248247|75783392|FG003|STARTED|Overall Study||61||
59664052|NCT01248247|75783389|FG000|COMPLETED|Overall Study||0||
59664053|NCT01248247|75783390|FG001|COMPLETED|Overall Study||0||
59664054|NCT01248247|75783391|FG002|COMPLETED|Overall Study||0||
59664055|NCT01248247|75783392|FG003|COMPLETED|Overall Study||0||
59664056|NCT01248247|75783389|FG000|NOT COMPLETED|Overall Study||22||
59664057|NCT01248247|75783390|FG001|NOT COMPLETED|Overall Study||42||
59664058|NCT01248247|75783391|FG002|NOT COMPLETED|Overall Study||75||
59664059|NCT01248247|75783392|FG003|NOT COMPLETED|Overall Study||61||
59664060|NCT02598583|75783404|FG000|STARTED|Primary Evaluation Period||6||
59664061|NCT02598583|75783405|FG001|STARTED|Primary Evaluation Period||7||
59664062|NCT02598583|75783404|FG000|COMPLETED|Primary Evaluation Period||6|Completed 169-day Primary Evaluation Period.|
59664063|NCT02598583|75783405|FG001|COMPLETED|Primary Evaluation Period||7|Completed 169-day Primary Evaluation Period.|
59664064|NCT02598583|75783404|FG000|NOT COMPLETED|Primary Evaluation Period||0||
59664065|NCT02598583|75783405|FG001|NOT COMPLETED|Primary Evaluation Period||0||
59664066|NCT02598583|75783404|FG000|STARTED|Extension Period||6||
59664067|NCT02598583|75783405|FG001|STARTED|Extension Period||7||
59664068|NCT02598583|75783404|FG000|COMPLETED|Extension Period||5||
59664069|NCT02598583|75783405|FG001|COMPLETED|Extension Period||7||
59664070|NCT02598583|75783404|FG000|NOT COMPLETED|Extension Period||1||
59664071|NCT02598583|75783405|FG001|NOT COMPLETED|Extension Period||0||
59664072|NCT02598895|75783411|FG000|STARTED|Overall Study||14||
59664073|NCT02598895|75783411|FG000|PSA50|Overall Study||14||
59664074|NCT02598895|75783411|FG000|COMPLETED|Overall Study||14||
59664075|NCT02598895|75783411|FG000|NOT COMPLETED|Overall Study||0||
59664076|NCT05780281|75783417|FG000|STARTED|Overall Study||184||
59664077|NCT05780281|75783418|FG001|STARTED|Overall Study||183||
59664078|NCT05780281|75783417|FG000|COMPLETED|Overall Study||182||
59664079|NCT05780281|75783418|FG001|COMPLETED|Overall Study||178||
59664080|NCT05780281|75783417|FG000|NOT COMPLETED|Overall Study||2||
59664081|NCT05780281|75783418|FG001|NOT COMPLETED|Overall Study||5||
59664082|NCT05780268|75783426|FG000|STARTED|Overall Study||163||
59664083|NCT05780268|75783427|FG001|STARTED|Overall Study||151||
59664084|NCT05780268|75783426|FG000|COMPLETED|Overall Study||163||
59664085|NCT05780268|75783427|FG001|COMPLETED|Overall Study||151||
59664086|NCT05780268|75783426|FG000|NOT COMPLETED|Overall Study||0||
59664087|NCT05780268|75783427|FG001|NOT COMPLETED|Overall Study||0||
59664088|NCT05656885|75783433|FG000|STARTED|Period 1: Lens A, 15 Minutes||40||
59664089|NCT05656885|75783434|FG001|STARTED|Period 1: Lens A, 15 Minutes|All participants wore Lens A in Period 1|0||
59664090|NCT05656885|75783433|FG000|COMPLETED|Period 1: Lens A, 15 Minutes||40||
59664091|NCT05656885|75783434|FG001|COMPLETED|Period 1: Lens A, 15 Minutes||0||
59664092|NCT05656885|75783433|FG000|NOT COMPLETED|Period 1: Lens A, 15 Minutes||0||
59664093|NCT05656885|75783434|FG001|NOT COMPLETED|Period 1: Lens A, 15 Minutes||0||
59664094|NCT05656885|75783433|FG000|STARTED|Period 2: Lens B, 15 Minutes|All participants wore Lens B in Period 2|0||
59664095|NCT05656885|75783434|FG001|STARTED|Period 2: Lens B, 15 Minutes||40||
59664096|NCT05656885|75783433|FG000|COMPLETED|Period 2: Lens B, 15 Minutes||0||
59664097|NCT05656885|75783434|FG001|COMPLETED|Period 2: Lens B, 15 Minutes||40||
59664098|NCT05656885|75783433|FG000|NOT COMPLETED|Period 2: Lens B, 15 Minutes||0||
59664099|NCT05656885|75783434|FG001|NOT COMPLETED|Period 2: Lens B, 15 Minutes||0||
59664100|NCT05393869|75783447|FG000|STARTED|Overall Study||407||
59664101|NCT05393869|75783448|FG001|STARTED|Overall Study||407||
59664102|NCT05393869|75783449|FG002|STARTED|Overall Study||407||
59664103|NCT05393869|75783450|FG003|STARTED|Overall Study||407||
59664104|NCT05393869|75783451|FG004|STARTED|Overall Study||407||
59664105|NCT05393869|75783452|FG005|STARTED|Overall Study||407||
59664106|NCT05393869|75783453|FG006|STARTED|Overall Study||407||
59664107|NCT05393869|75783447|FG000|COMPLETED|Overall Study||400||
59664108|NCT05393869|75783448|FG001|COMPLETED|Overall Study||405||
59664109|NCT05393869|75783449|FG002|COMPLETED|Overall Study||398||
59664110|NCT05393869|75783450|FG003|COMPLETED|Overall Study||404||
59664111|NCT05393869|75783451|FG004|COMPLETED|Overall Study||402||
59664112|NCT05393869|75783452|FG005|COMPLETED|Overall Study||403||
59664113|NCT05393869|75783453|FG006|COMPLETED|Overall Study||404||
59664114|NCT05393869|75783447|FG000|NOT COMPLETED|Overall Study||7||
59664115|NCT05393869|75783448|FG001|NOT COMPLETED|Overall Study||2||
59664116|NCT05393869|75783449|FG002|NOT COMPLETED|Overall Study||9||
59664117|NCT05393869|75783450|FG003|NOT COMPLETED|Overall Study||3||
59664118|NCT05393869|75783451|FG004|NOT COMPLETED|Overall Study||5||
59664119|NCT05393869|75783452|FG005|NOT COMPLETED|Overall Study||4||
59664120|NCT05393869|75783453|FG006|NOT COMPLETED|Overall Study||3||
60077274|NCT01513239|76192321|FG002|All Participants as Treated|Period 1: Main Phase|Treatment actually received|381||
60077275|NCT01513239|76192322|FG003|All Participants as Treated|Period 1: Main Phase||0||
60077276|NCT01513239|76192323|FG004|All Participants as Treated|Period 1: Main Phase||0||
60077277|NCT01513239|76192324|FG005|All Participants as Treated|Period 1: Main Phase||0||
60077278|NCT01513239|76192319|FG000|COMPLETED|Period 1: Main Phase||322||
60077279|NCT01513239|76192320|FG001|COMPLETED|Period 1: Main Phase||337||
60077280|NCT01513239|76192321|FG002|COMPLETED|Period 1: Main Phase||311||
60077281|NCT01513239|76192322|FG003|COMPLETED|Period 1: Main Phase||0||
60077282|NCT01513239|76192323|FG004|COMPLETED|Period 1: Main Phase||0||
60077283|NCT01513239|76192324|FG005|COMPLETED|Period 1: Main Phase||0||
60077284|NCT01513239|76192319|FG000|NOT COMPLETED|Period 1: Main Phase||75||
60077285|NCT01513239|76192320|FG001|NOT COMPLETED|Period 1: Main Phase||70||
60077286|NCT01513239|76192321|FG002|NOT COMPLETED|Period 1: Main Phase||88||
60077287|NCT01513239|76192322|FG003|NOT COMPLETED|Period 1: Main Phase||0||
60077288|NCT01513239|76192323|FG004|NOT COMPLETED|Period 1: Main Phase||0||
60077289|NCT01513239|76192324|FG005|NOT COMPLETED|Period 1: Main Phase||0||
60077290|NCT01513239|76192319|FG000|STARTED|Period 2: 9 Month Extension Phase||0||
60077291|NCT01513239|76192320|FG001|STARTED|Period 2: 9 Month Extension Phase||0||
60077292|NCT01513239|76192321|FG002|STARTED|Period 2: 9 Month Extension Phase||0||
60077293|NCT01513239|76192322|FG003|STARTED|Period 2: 9 Month Extension Phase||112||
60077294|NCT01513239|76192323|FG004|STARTED|Period 2: 9 Month Extension Phase||100||
60077295|NCT01513239|76192324|FG005|STARTED|Period 2: 9 Month Extension Phase||83||
60077296|NCT01513239|76192319|FG000|COMPLETED|Period 2: 9 Month Extension Phase||0||
60077297|NCT01513239|76192320|FG001|COMPLETED|Period 2: 9 Month Extension Phase||0||
60077298|NCT01513239|76192321|FG002|COMPLETED|Period 2: 9 Month Extension Phase||0||
60077299|NCT01513239|76192322|FG003|COMPLETED|Period 2: 9 Month Extension Phase||102||
60077300|NCT01513239|76192323|FG004|COMPLETED|Period 2: 9 Month Extension Phase||90||
60077301|NCT01513239|76192324|FG005|COMPLETED|Period 2: 9 Month Extension Phase||78||
60077302|NCT01513239|76192319|FG000|NOT COMPLETED|Period 2: 9 Month Extension Phase||0||
60077303|NCT01513239|76192320|FG001|NOT COMPLETED|Period 2: 9 Month Extension Phase||0||
59664151|NCT05172050|75783481|FG000|STARTED|Overall Study||22||
59664152|NCT05172050|75783482|FG001|STARTED|Overall Study||20||
59664153|NCT05172050|75783483|FG002|STARTED|Overall Study||19||
59664154|NCT05172050|75783481|FG000|Full Analysis Set Population (FAS)|Overall Study||22||
59664155|NCT05172050|75783482|FG001|Full Analysis Set Population (FAS)|Overall Study||20||
59664156|NCT05172050|75783483|FG002|Full Analysis Set Population (FAS)|Overall Study||19||
59664157|NCT05172050|75783481|FG000|Per-Protocol Population (PP)|Overall Study||18||
59664158|NCT05172050|75783482|FG001|Per-Protocol Population (PP)|Overall Study||17||
59664159|NCT05172050|75783483|FG002|Per-Protocol Population (PP)|Overall Study||17||
59664160|NCT05172050|75783481|FG000|Safety Population (SAF)|Overall Study||22||
59664161|NCT05172050|75783482|FG001|Safety Population (SAF)|Overall Study||20||
59664162|NCT05172050|75783483|FG002|Safety Population (SAF)|Overall Study||19||
59664163|NCT05172050|75783481|FG000|COMPLETED|Overall Study||10|treatment completion|
59664164|NCT05172050|75783482|FG001|COMPLETED|Overall Study||9|treatment completion|
59664165|NCT05172050|75783483|FG002|COMPLETED|Overall Study||8|treatment completion|
59664166|NCT05172050|75783481|FG000|NOT COMPLETED|Overall Study||12||
59664167|NCT05172050|75783482|FG001|NOT COMPLETED|Overall Study||11||
59664168|NCT05172050|75783483|FG002|NOT COMPLETED|Overall Study||11||
59664169|NCT04924062|75783496|FG000|STARTED|Overall Study||75||
59664170|NCT04924062|75783497|FG001|STARTED|Overall Study||83||
59817910|NCT04488770|75940336|FG010|NOT COMPLETED|Part 1-Cohort 2: Period 1 (Up to 5 Days)||0||
59664171|NCT04924062|75783496|FG000|COMPLETED|Overall Study||0||
59664172|NCT04924062|75783497|FG001|COMPLETED|Overall Study||0||
59664173|NCT04924062|75783496|FG000|NOT COMPLETED|Overall Study||75||
59664174|NCT04924062|75783497|FG001|NOT COMPLETED|Overall Study||83||
59664175|NCT04826484|75783505|FG000|STARTED|Overall Study||52||
59664176|NCT04826484|75783506|FG001|STARTED|Overall Study||52||
59664177|NCT04826484|75783505|FG000|COMPLETED|Overall Study||50||
59664178|NCT04826484|75783506|FG001|COMPLETED|Overall Study||52||
59664179|NCT04826484|75783505|FG000|NOT COMPLETED|Overall Study||2||
59664180|NCT04826484|75783506|FG001|NOT COMPLETED|Overall Study||0||
59664181|NCT04820842|75783515|FG000|STARTED|Active Drug Extension Period (8 Weeks)||8||
59664182|NCT04820842|75783516|FG001|STARTED|Active Drug Extension Period (8 Weeks)||9||
59664183|NCT04820842|75783517|FG002|STARTED|Active Drug Extension Period (8 Weeks)||9||
59664184|NCT04820842|75783518|FG003|STARTED|Active Drug Extension Period (8 Weeks)||0||
59664185|NCT04820842|75783519|FG004|STARTED|Active Drug Extension Period (8 Weeks)||0||
59664186|NCT04820842|75783520|FG005|STARTED|Active Drug Extension Period (8 Weeks)||0||
59664187|NCT04820842|75783521|FG006|STARTED|Active Drug Extension Period (8 Weeks)||0||
60077304|NCT01513239|76192321|FG002|NOT COMPLETED|Period 2: 9 Month Extension Phase||0||
59664188|NCT04820842|75783515|FG000|COMPLETED|Active Drug Extension Period (8 Weeks)||5||
59664189|NCT04820842|75783516|FG001|COMPLETED|Active Drug Extension Period (8 Weeks)||1||
59664190|NCT04820842|75783517|FG002|COMPLETED|Active Drug Extension Period (8 Weeks)||2||
59664191|NCT04820842|75783518|FG003|COMPLETED|Active Drug Extension Period (8 Weeks)||0||
59664192|NCT04820842|75783519|FG004|COMPLETED|Active Drug Extension Period (8 Weeks)||0||
59664193|NCT04820842|75783520|FG005|COMPLETED|Active Drug Extension Period (8 Weeks)||0||
59664194|NCT04820842|75783521|FG006|COMPLETED|Active Drug Extension Period (8 Weeks)||0||
59664195|NCT04820842|75783515|FG000|NOT COMPLETED|Active Drug Extension Period (8 Weeks)||3||
59664196|NCT04820842|75783516|FG001|NOT COMPLETED|Active Drug Extension Period (8 Weeks)||8||
59664197|NCT04820842|75783517|FG002|NOT COMPLETED|Active Drug Extension Period (8 Weeks)||7||
59664198|NCT04820842|75783518|FG003|NOT COMPLETED|Active Drug Extension Period (8 Weeks)||0||
59664199|NCT04820842|75783519|FG004|NOT COMPLETED|Active Drug Extension Period (8 Weeks)||0||
59664200|NCT04820842|75783520|FG005|NOT COMPLETED|Active Drug Extension Period (8 Weeks)||0||
59664201|NCT04820842|75783521|FG006|NOT COMPLETED|Active Drug Extension Period (8 Weeks)||0||
59664202|NCT04820842|75783515|FG000|STARTED|Randomized Withdrawal Period (4 Weeks)||0||
59664203|NCT04820842|75783516|FG001|STARTED|Randomized Withdrawal Period (4 Weeks)||0||
59664204|NCT04820842|75783517|FG002|STARTED|Randomized Withdrawal Period (4 Weeks)||0||
59664205|NCT04820842|75783518|FG003|STARTED|Randomized Withdrawal Period (4 Weeks)||3||
59544714|NCT01015586|75643251|FG001|NOT COMPLETED|Overall Study||11||
59544715|NCT01676831|75643259|FG000|STARTED|Overall Study||8||
59544716|NCT01676831|75643260|FG001|STARTED|Overall Study||5||
59544717|NCT01676831|75643259|FG000|COMPLETED|Overall Study||8||
59664206|NCT04820842|75783519|FG004|STARTED|Randomized Withdrawal Period (4 Weeks)||1||
59664207|NCT04820842|75783520|FG005|STARTED|Randomized Withdrawal Period (4 Weeks)||1||
59664208|NCT04820842|75783521|FG006|STARTED|Randomized Withdrawal Period (4 Weeks)||3||
59664209|NCT04820842|75783515|FG000|COMPLETED|Randomized Withdrawal Period (4 Weeks)||0||
59664210|NCT04820842|75783516|FG001|COMPLETED|Randomized Withdrawal Period (4 Weeks)||0||
59664211|NCT04820842|75783517|FG002|COMPLETED|Randomized Withdrawal Period (4 Weeks)||0||
59664212|NCT04820842|75783518|FG003|COMPLETED|Randomized Withdrawal Period (4 Weeks)||1||
59664213|NCT04820842|75783519|FG004|COMPLETED|Randomized Withdrawal Period (4 Weeks)||1||
59664214|NCT04820842|75783520|FG005|COMPLETED|Randomized Withdrawal Period (4 Weeks)||1||
59664215|NCT04820842|75783521|FG006|COMPLETED|Randomized Withdrawal Period (4 Weeks)||2||
59664216|NCT04820842|75783515|FG000|NOT COMPLETED|Randomized Withdrawal Period (4 Weeks)||0||
59664217|NCT04820842|75783516|FG001|NOT COMPLETED|Randomized Withdrawal Period (4 Weeks)||0||
59664218|NCT04820842|75783517|FG002|NOT COMPLETED|Randomized Withdrawal Period (4 Weeks)||0||
59664219|NCT04820842|75783518|FG003|NOT COMPLETED|Randomized Withdrawal Period (4 Weeks)||2||
59664220|NCT04820842|75783519|FG004|NOT COMPLETED|Randomized Withdrawal Period (4 Weeks)||0||
59664221|NCT04820842|75783520|FG005|NOT COMPLETED|Randomized Withdrawal Period (4 Weeks)||0||
59664222|NCT04820842|75783521|FG006|NOT COMPLETED|Randomized Withdrawal Period (4 Weeks)||1||
59664223|NCT04818216|75783540|FG000|STARTED|Overall Study||13||
59664224|NCT04818216|75783541|FG001|STARTED|Overall Study||15||
59664225|NCT04818216|75783540|FG000|COMPLETED|Overall Study||9||
59664226|NCT04818216|75783541|FG001|COMPLETED|Overall Study||13||
59664227|NCT04818216|75783540|FG000|NOT COMPLETED|Overall Study||4||
59664228|NCT04818216|75783541|FG001|NOT COMPLETED|Overall Study||2||
59664229|NCT04744285|75783551|FG000|STARTED|Overall Study||31||
59664230|NCT04744285|75783552|FG001|STARTED|Overall Study||29||
59664231|NCT04744285|75783553|FG002|STARTED|Overall Study||33||
59664232|NCT04744285|75783554|FG003|STARTED|Overall Study||22||
59664233|NCT04744285|75783551|FG000|COMPLETED|Overall Study||30||
59664234|NCT04744285|75783552|FG001|COMPLETED|Overall Study||28||
59664235|NCT04744285|75783553|FG002|COMPLETED|Overall Study||31||
59664236|NCT04744285|75783554|FG003|COMPLETED|Overall Study||21||
59817911|NCT04488770|75940337|FG011|NOT COMPLETED|Part 1-Cohort 2: Period 1 (Up to 5 Days)||0||
59544718|NCT01676831|75643260|FG001|COMPLETED|Overall Study||4||
59544719|NCT01676831|75643259|FG000|NOT COMPLETED|Overall Study||0||
59544720|NCT01676831|75643260|FG001|NOT COMPLETED|Overall Study||1||
59544721|NCT02246309|75643268|FG000|STARTED|Overall Study|16 patients going through Time Lapse System and 15 through Standard Embryo Culture.|16||
59544722|NCT02246309|75643269|FG001|STARTED|Overall Study||15||
59544723|NCT02246309|75643268|FG000|COMPLETED|Overall Study||16||
59664237|NCT04744285|75783551|FG000|NOT COMPLETED|Overall Study||1||
59664238|NCT04744285|75783552|FG001|NOT COMPLETED|Overall Study||1||
59664239|NCT04744285|75783553|FG002|NOT COMPLETED|Overall Study||2||
59664240|NCT04744285|75783554|FG003|NOT COMPLETED|Overall Study||1||
59664241|NCT04737187|75783566|FG000|STARTED|Overall Study||246||
59664242|NCT04737187|75783567|FG001|STARTED|Overall Study||246||
59664243|NCT04737187|75783566|FG000|COMPLETED|Overall Study||0||
59664244|NCT04737187|75783567|FG001|COMPLETED|Overall Study||0||
59664245|NCT04737187|75783566|FG000|NOT COMPLETED|Overall Study||246||
59664246|NCT04737187|75783567|FG001|NOT COMPLETED|Overall Study||246||
59664247|NCT04737031|75783577|FG000|STARTED|Overall Study||490|Engaged patients (Intent-to-treat, ITT)|22
59664248|NCT04737031|75783578|FG001|STARTED|Overall Study||506|Engaged patients (Intent-to-treat, ITT)|24
59664249|NCT04737031|75783579|FG002|STARTED|Overall Study||405|Engaged patients (Intent-to-treat, ITT)|19
59664250|NCT04737031|75783580|FG003|STARTED|Overall Study||745|Engaged patients (Intent-to-treat, ITT)|23
59664251|NCT04737031|75783577|FG000|COMPLETED|Overall Study|"For the Assigned to Usual Care arm, treatment visit=0 due to the nature of the intervention design. There are no nudges to be delivered. In other words, treatment is completed with the engaged visit, and there are no additional treatment visits."|490|This was an ITT analysis. All engaged patients (2,146) were included in the analysis, even if they did not complete treatment.|22
59664252|NCT04737031|75783578|FG001|COMPLETED|Overall Study||475|This was an ITT analysis. All engaged patients (2,146) were included in the analysis, even if they did not complete treatment.|24
59664253|NCT04737031|75783579|FG002|COMPLETED|Overall Study||312|This was an ITT analysis. All engaged patients (2,146) were included in the analysis, even if they did not complete treatment.|19
59664254|NCT04737031|75783580|FG003|COMPLETED|Overall Study||518|This was an ITT analysis. All engaged patients (2,146) were included in the analysis, even if they did not complete treatment.|23
59664255|NCT04737031|75783577|FG000|NOT COMPLETED|Overall Study||0||0
59664256|NCT04737031|75783578|FG001|NOT COMPLETED|Overall Study||31||0
59664257|NCT04737031|75783579|FG002|NOT COMPLETED|Overall Study||93||0
59664258|NCT04737031|75783580|FG003|NOT COMPLETED|Overall Study||227||0
59664259|NCT04555044|75783592|FG000|STARTED|Overall Study||50||
59664260|NCT04555044|75783593|FG001|STARTED|Overall Study||51||
59664261|NCT04555044|75783592|FG000|COMPLETED|Overall Study||50||
59664262|NCT04555044|75783593|FG001|COMPLETED|Overall Study||50||
59664263|NCT04555044|75783592|FG000|NOT COMPLETED|Overall Study||0||
59664264|NCT04555044|75783593|FG001|NOT COMPLETED|Overall Study||1||
59664265|NCT04542278|75783602|FG000|STARTED|Overall Study||14||
59664266|NCT04542278|75783603|FG001|STARTED|Overall Study||16||
59664267|NCT04542278|75783602|FG000|COMPLETED|Overall Study||14||
59664268|NCT04542278|75783603|FG001|COMPLETED|Overall Study||16||
59664269|NCT04542278|75783602|FG000|NOT COMPLETED|Overall Study||0||
59664270|NCT04542278|75783603|FG001|NOT COMPLETED|Overall Study||0||
59664271|NCT04508647|75783611|FG000|STARTED|Cycle 1: Baseline to 8 Weeks||4||
59664272|NCT04508647|75783612|FG001|STARTED|Cycle 1: Baseline to 8 Weeks||0||
59664273|NCT04508647|75783611|FG000|COMPLETED|Cycle 1: Baseline to 8 Weeks||4||
59664274|NCT04508647|75783612|FG001|COMPLETED|Cycle 1: Baseline to 8 Weeks||0||
59664275|NCT04508647|75783611|FG000|NOT COMPLETED|Cycle 1: Baseline to 8 Weeks||0||
59664276|NCT04508647|75783612|FG001|NOT COMPLETED|Cycle 1: Baseline to 8 Weeks||0||
59664277|NCT04508647|75783611|FG000|STARTED|Cycle 2: 8 Weeks to 12 Months||2||
59664278|NCT04508647|75783612|FG001|STARTED|Cycle 2: 8 Weeks to 12 Months||2||
59664279|NCT04508647|75783611|FG000|COMPLETED|Cycle 2: 8 Weeks to 12 Months||2||
59664280|NCT04508647|75783612|FG001|COMPLETED|Cycle 2: 8 Weeks to 12 Months||2||
59664281|NCT04508647|75783611|FG000|NOT COMPLETED|Cycle 2: 8 Weeks to 12 Months||0||
59664282|NCT04508647|75783612|FG001|NOT COMPLETED|Cycle 2: 8 Weeks to 12 Months||0||
59664283|NCT04492722|75783624|FG000|STARTED|Overall Study||154||
59664284|NCT04492722|75783625|FG001|STARTED|Overall Study||153||
59664285|NCT04492722|75783626|FG002|STARTED|Overall Study||153||
59664286|NCT04492722|75783627|FG003|STARTED|Overall Study||153||
59664287|NCT04492722|75783624|FG000|COMPLETED|Overall Study||72||
59664288|NCT04492722|75783625|FG001|COMPLETED|Overall Study||82||
59664289|NCT04492722|75783626|FG002|COMPLETED|Overall Study||82||
59664290|NCT04492722|75783627|FG003|COMPLETED|Overall Study||82||
59664291|NCT04492722|75783624|FG000|NOT COMPLETED|Overall Study||82||
59664292|NCT04492722|75783625|FG001|NOT COMPLETED|Overall Study||71||
59664293|NCT04492722|75783626|FG002|NOT COMPLETED|Overall Study||71||
59664294|NCT04492722|75783627|FG003|NOT COMPLETED|Overall Study||71||
59664295|NCT04466618|75783639|FG000|STARTED|Overall Study||12||
59664296|NCT04466618|75783640|FG001|STARTED|Overall Study||11||
59544724|NCT02246309|75643269|FG001|COMPLETED|Overall Study||15||
59544725|NCT02246309|75643268|FG000|NOT COMPLETED|Overall Study||0||
59544726|NCT02246309|75643269|FG001|NOT COMPLETED|Overall Study||0||
59544727|NCT01680653|75643275|FG000|STARTED|Overall Study||57||
59544728|NCT01680653|75643275|FG000|COMPLETED|Overall Study||57||
59544729|NCT01680653|75643275|FG000|NOT COMPLETED|Overall Study||0||
59544730|NCT02448810|75643293|FG000|STARTED|Overall Study||3||
59544731|NCT02448810|75643294|FG001|STARTED|Overall Study||3||
59544732|NCT02448810|75643295|FG002|STARTED|Overall Study||3||
59544733|NCT02448810|75643296|FG003|STARTED|Overall Study||3||
59544734|NCT02448810|75643297|FG004|STARTED|Overall Study||31||
59544735|NCT02448810|75643298|FG005|STARTED|Overall Study||16||
59544736|NCT02448810|75643299|FG006|STARTED|Overall Study||18||
59544737|NCT02448810|75643300|FG007|STARTED|Overall Study||8||
59544738|NCT02448810|75643293|FG000|Treated|Overall Study||3||
59544739|NCT02448810|75643294|FG001|Treated|Overall Study||3||
59544740|NCT02448810|75643295|FG002|Treated|Overall Study||3||
59544741|NCT02448810|75643296|FG003|Treated|Overall Study||3||
59544742|NCT02448810|75643297|FG004|Treated|Overall Study||29||
59544743|NCT02448810|75643298|FG005|Treated|Overall Study||13||
59544744|NCT02448810|75643299|FG006|Treated|Overall Study||18||
59544745|NCT02448810|75643300|FG007|Treated|Overall Study||7||
59544746|NCT02448810|75643293|FG000|COMPLETED|Overall Study||0||
59544747|NCT02448810|75643294|FG001|COMPLETED|Overall Study||0||
59544748|NCT02448810|75643295|FG002|COMPLETED|Overall Study||0||
59544749|NCT02448810|75643296|FG003|COMPLETED|Overall Study||0||
59544750|NCT02448810|75643297|FG004|COMPLETED|Overall Study||0||
59544751|NCT02448810|75643298|FG005|COMPLETED|Overall Study||0||
59544752|NCT02448810|75643299|FG006|COMPLETED|Overall Study||0||
59544753|NCT02448810|75643300|FG007|COMPLETED|Overall Study||0||
59664297|NCT04466618|75783639|FG000|COMPLETED|Overall Study||12||
59664298|NCT04466618|75783640|FG001|COMPLETED|Overall Study||10||
59664299|NCT04466618|75783639|FG000|NOT COMPLETED|Overall Study||0||
59664300|NCT04466618|75783640|FG001|NOT COMPLETED|Overall Study||1||
59664301|NCT04271735|75783652|FG000|STARTED|Overall Study||17||
59664302|NCT04271735|75783653|FG001|STARTED|Overall Study||12||
59664303|NCT04271735|75783652|FG000|COMPLETED|Overall Study||15||
59664304|NCT04271735|75783653|FG001|COMPLETED|Overall Study||12||
59664305|NCT04271735|75783652|FG000|NOT COMPLETED|Overall Study||2||
59664306|NCT04271735|75783653|FG001|NOT COMPLETED|Overall Study||0||
59664307|NCT04221373|75783661|FG000|STARTED|Overall Study||20||
59664308|NCT04221373|75783662|FG001|STARTED|Overall Study||12||
59664309|NCT04221373|75783661|FG000|COMPLETED|Overall Study||16||
59664310|NCT04221373|75783662|FG001|COMPLETED|Overall Study||12||
59664311|NCT04221373|75783661|FG000|NOT COMPLETED|Overall Study||4||
59664312|NCT04221373|75783662|FG001|NOT COMPLETED|Overall Study||0||
59664313|NCT04206605|75783670|FG000|STARTED|Overall Study||27||
59664314|NCT04206605|75783671|FG001|STARTED|Overall Study||50||
59664315|NCT04206605|75783670|FG000|Steady State Full Analysis Set (SS-FAS)|Overall Study||27|SS-FAS included all randomized participants who received any exposure to the investigational product during the presumed steady state period (Day 70 through Day 182).|
59664316|NCT04206605|75783671|FG001|Steady State Full Analysis Set (SS-FAS)|Overall Study||49|SS-FAS included all randomized participants who received any exposure to the investigational product during the presumed steady state period (Day 70 through Day 182).|
59664317|NCT04206605|75783670|FG000|COMPLETED|Overall Study||26||
59664318|NCT04206605|75783671|FG001|COMPLETED|Overall Study||49||
59664319|NCT04206605|75783670|FG000|NOT COMPLETED|Overall Study||1||
59664320|NCT04206605|75783671|FG001|NOT COMPLETED|Overall Study||1||
59664321|NCT04177212|75783681|FG000|STARTED|Overall Study||55||
59664322|NCT04177212|75783682|FG001|STARTED|Overall Study||62||
59664323|NCT04177212|75783681|FG000|Safety Analysis Set|Overall Study||43|Participants who were randomized to Group A but treated according to the injection scheme of Group B due to coronavirus disease 2019 (COVID-19) pandemic measures were analyzed in Group B. Participants who were treated only once due to any reason were analyzed in Group B.|
59664324|NCT04177212|75783682|FG001|Safety Analysis Set|Overall Study||74|Participants who were randomized to Group A but treated according to the injection scheme of Group B due to coronavirus disease 2019 (COVID-19) pandemic measures were analyzed in Group B. Participants who were treated only once due to any reason were analyzed in Group B.|
59664325|NCT04177212|75783681|FG000|Modified Full Analysis Set|Overall Study||46|Participants randomized to Group A but treated as per Group B injection scheme due to COVID-19 pandemic measures were analyzed in Group B. Participants treated only once with all missing treatments due to reasons not related to pandemic measures such as premature withdrawal/protocol deviations, were analyzed in treatment group they were randomized to and participants treated only once with at least one missing treatment due to reasons related to pandemic measures were analyzed in Group B.|
59664326|NCT04177212|75783682|FG001|Modified Full Analysis Set|Overall Study||71|Participants randomized to Group A but treated as per Group B injection scheme due to COVID-19 pandemic measures were analyzed in Group B. Participants treated only once with all missing treatments due to reasons not related to pandemic measures such as premature withdrawal/protocol deviations, were analyzed in treatment group they were randomized to and participants treated only once with at least one missing treatment due to reasons related to pandemic measures were analyzed in Group B.|
59664327|NCT04177212|75783681|FG000|COMPLETED|Overall Study||43||
59664328|NCT04177212|75783682|FG001|COMPLETED|Overall Study||47||
59664329|NCT04177212|75783681|FG000|NOT COMPLETED|Overall Study||12||
59664330|NCT04177212|75783682|FG001|NOT COMPLETED|Overall Study||15||
59664331|NCT04099836|75783690|FG000|STARTED|Overall Study||7||
59664332|NCT04099836|75783690|FG000|COMPLETED|Overall Study||7||
59664333|NCT04099836|75783690|FG000|NOT COMPLETED|Overall Study||0||
59664334|NCT04065841|75783698|FG000|STARTED|Overall Study||54||
59664335|NCT04065841|75783699|FG001|STARTED|Overall Study||55||
59664336|NCT04065841|75783700|FG002|STARTED|Overall Study||84||
59664337|NCT04065841|75783701|FG003|STARTED|Overall Study||41||
59664338|NCT04065841|75783698|FG000|COMPLETED|Overall Study||25||
59664339|NCT04065841|75783699|FG001|COMPLETED|Overall Study||33||
59664340|NCT04065841|75783700|FG002|COMPLETED|Overall Study||42||
59664341|NCT04065841|75783701|FG003|COMPLETED|Overall Study||21||
59664342|NCT04065841|75783698|FG000|NOT COMPLETED|Overall Study||29||
59664343|NCT04065841|75783699|FG001|NOT COMPLETED|Overall Study||22||
59664344|NCT04065841|75783700|FG002|NOT COMPLETED|Overall Study||42||
59664345|NCT04065841|75783701|FG003|NOT COMPLETED|Overall Study||20||
59664346|NCT04045132|75783714|FG000|STARTED|Overall Study||37|These numbers represent the participants who completed a baseline visit and were randomized.|
59664347|NCT04045132|75783715|FG001|STARTED|Overall Study||38|These numbers represent the participants who completed a baseline visit and were randomized.|
59664348|NCT04045132|75783714|FG000|COMPLETED|Overall Study||34|These numbers represent the participants who at the 3-month follow up completed all secondary measures as well as the Parent Child Early Relational Assessment (PCERA). Those who did not complete the PCERA and/or who did not complete all the follow up measures were not considered to have completed their study participation.|
59664349|NCT04045132|75783715|FG001|COMPLETED|Overall Study||32|These numbers represent the participants who at the 3-month follow up completed all secondary measures as well as the Parent Child Early Relational Assessment (PCERA). Those who did not complete the PCERA and/or who did not complete all the follow up measures were not considered to have completed their study participation.|
59664350|NCT04045132|75783714|FG000|NOT COMPLETED|Overall Study||3||
59664351|NCT04045132|75783715|FG001|NOT COMPLETED|Overall Study||6||
59664352|NCT03939923|75783725|FG000|STARTED|Overall Study||42||
59664353|NCT03939923|75783726|FG001|STARTED|Overall Study||42||
59664354|NCT03939923|75783725|FG000|COMPLETED|Overall Study||36||
59664355|NCT03939923|75783726|FG001|COMPLETED|Overall Study||35||
59664356|NCT03939923|75783725|FG000|NOT COMPLETED|Overall Study||6||
59664357|NCT03939923|75783726|FG001|NOT COMPLETED|Overall Study||7||
59664358|NCT03912831|75783738|FG000|STARTED|Overall Study||1||
59664359|NCT03912831|75783739|FG001|STARTED|Overall Study||1||
59664360|NCT03912831|75783740|FG002|STARTED|Overall Study||1||
59664361|NCT03912831|75783741|FG003|STARTED|Overall Study||1||
59664362|NCT03912831|75783742|FG004|STARTED|Overall Study||3||
59664363|NCT03912831|75783743|FG005|STARTED|Overall Study||1||
59664364|NCT03912831|75783738|FG000|COMPLETED|Overall Study||0||
59664365|NCT03912831|75783739|FG001|COMPLETED|Overall Study||0||
59664366|NCT03912831|75783740|FG002|COMPLETED|Overall Study||0||
59664367|NCT03912831|75783741|FG003|COMPLETED|Overall Study||0||
59664368|NCT03912831|75783742|FG004|COMPLETED|Overall Study||0||
59664369|NCT03912831|75783743|FG005|COMPLETED|Overall Study||0||
59664370|NCT03912831|75783738|FG000|NOT COMPLETED|Overall Study||1||
59664371|NCT03912831|75783739|FG001|NOT COMPLETED|Overall Study||1||
59664372|NCT03912831|75783740|FG002|NOT COMPLETED|Overall Study||1||
59664373|NCT03912831|75783741|FG003|NOT COMPLETED|Overall Study||1||
59664374|NCT03912831|75783742|FG004|NOT COMPLETED|Overall Study||3||
59664375|NCT03912831|75783743|FG005|NOT COMPLETED|Overall Study||1||
59664376|NCT03879655|75783758|FG000|STARTED|Overall Study||2||
59664377|NCT03879655|75783758|FG000|Received at Least 1 Dose of Study Drug|Overall Study||2||
59664378|NCT03879655|75783758|FG000|COMPLETED|Overall Study||2||
59664379|NCT03879655|75783758|FG000|NOT COMPLETED|Overall Study||0||
59664380|NCT03836859|75783764|FG000|STARTED|Overall Study||20||
59664381|NCT03836859|75783765|FG001|STARTED|Overall Study||10||
59664382|NCT03836859|75783764|FG000|COMPLETED|Overall Study||20||
59664383|NCT03836859|75783765|FG001|COMPLETED|Overall Study||10||
59664384|NCT03836859|75783764|FG000|NOT COMPLETED|Overall Study||0||
59664385|NCT03836859|75783765|FG001|NOT COMPLETED|Overall Study||0||
59664392|NCT03655262|75783783|FG000|STARTED|Overall Study||7||
59664393|NCT03655262|75783784|FG001|STARTED|Overall Study||8||
59664394|NCT03655262|75783785|FG002|STARTED|Overall Study||8||
59664395|NCT03655262|75783783|FG000|COMPLETED|Overall Study||7||
59664396|NCT03655262|75783784|FG001|COMPLETED|Overall Study||8||
59664397|NCT03655262|75783785|FG002|COMPLETED|Overall Study||7||
59664398|NCT03655262|75783783|FG000|NOT COMPLETED|Overall Study||0||
59664399|NCT03655262|75783784|FG001|NOT COMPLETED|Overall Study||0||
59664400|NCT03655262|75783785|FG002|NOT COMPLETED|Overall Study||1||
59664401|NCT03637660|75783798|FG000|STARTED|Overall Study||124||
59664402|NCT03637660|75783799|FG001|STARTED|Overall Study||125||
59664403|NCT03637660|75783798|FG000|COMPLETED|Overall Study||82||
59664404|NCT03637660|75783799|FG001|COMPLETED|Overall Study||82||
59664405|NCT03637660|75783798|FG000|NOT COMPLETED|Overall Study||42||
59664406|NCT03637660|75783799|FG001|NOT COMPLETED|Overall Study||43||
59664407|NCT03524612|75783805|FG000|STARTED|Overall Study||105|All patients were included in the Full Analysis Set (FAS) and Safety Set (SAF)|
59664408|NCT03524612|75783805|FG000|COMPLETED|Overall Study||63||
59664409|NCT03524612|75783805|FG000|NOT COMPLETED|Overall Study||42||
59664410|NCT03495453|75783812|FG000|STARTED|Overall Study||30||
59664411|NCT03495453|75783813|FG001|STARTED|Overall Study||30||
59664412|NCT03495453|75783812|FG000|COMPLETED|Overall Study||30||
59664413|NCT03495453|75783813|FG001|COMPLETED|Overall Study||29||
59664414|NCT03495453|75783812|FG000|NOT COMPLETED|Overall Study||0||
59664415|NCT03495453|75783813|FG001|NOT COMPLETED|Overall Study||1||
59664416|NCT03473743|75783827|FG000|STARTED|Overall Study||4||
59664417|NCT03473743|75783828|FG001|STARTED|Overall Study||3||
59664418|NCT03473743|75783829|FG002|STARTED|Overall Study||11||
59664419|NCT03473743|75783830|FG003|STARTED|Overall Study||12||
59664420|NCT03473743|75783831|FG004|STARTED|Overall Study||3||
59664421|NCT03473743|75783832|FG005|STARTED|Overall Study||3||
59664422|NCT03473743|75783833|FG006|STARTED|Overall Study||44||
59664423|NCT03473743|75783834|FG007|STARTED|Overall Study||45||
59664424|NCT03473743|75783827|FG000|Treated (Treated Analysis Set)|Overall Study||4||
59664425|NCT03473743|75783828|FG001|Treated (Treated Analysis Set)|Overall Study||3||
59664426|NCT03473743|75783829|FG002|Treated (Treated Analysis Set)|Overall Study||11||
59664427|NCT03473743|75783830|FG003|Treated (Treated Analysis Set)|Overall Study||12||
59664428|NCT03473743|75783831|FG004|Treated (Treated Analysis Set)|Overall Study||3||
59664429|NCT03473743|75783832|FG005|Treated (Treated Analysis Set)|Overall Study||3||
59664430|NCT03473743|75783833|FG006|Treated (Treated Analysis Set)|Overall Study||43||
59664431|NCT03473743|75783834|FG007|Treated (Treated Analysis Set)|Overall Study||44||
59664432|NCT03473743|75783827|FG000|COMPLETED|Overall Study||4||
59664433|NCT03473743|75783828|FG001|COMPLETED|Overall Study||3||
59664434|NCT03473743|75783829|FG002|COMPLETED|Overall Study||5||
59664435|NCT03473743|75783830|FG003|COMPLETED|Overall Study||3||
59664436|NCT03473743|75783831|FG004|COMPLETED|Overall Study||2||
59664437|NCT03473743|75783832|FG005|COMPLETED|Overall Study||2||
59544754|NCT02448810|75643293|FG000|NOT COMPLETED|Overall Study||3||
59544755|NCT02448810|75643294|FG001|NOT COMPLETED|Overall Study||3||
59544756|NCT02448810|75643295|FG002|NOT COMPLETED|Overall Study||3||
59544757|NCT02448810|75643296|FG003|NOT COMPLETED|Overall Study||3||
59664438|NCT03473743|75783833|FG006|COMPLETED|Overall Study||21||
59664439|NCT03473743|75783834|FG007|COMPLETED|Overall Study||17||
59664440|NCT03473743|75783827|FG000|NOT COMPLETED|Overall Study||0||
59664441|NCT03473743|75783828|FG001|NOT COMPLETED|Overall Study||0||
59664442|NCT03473743|75783829|FG002|NOT COMPLETED|Overall Study||6||
59664443|NCT03473743|75783830|FG003|NOT COMPLETED|Overall Study||9||
59664444|NCT03473743|75783831|FG004|NOT COMPLETED|Overall Study||1||
59664445|NCT03473743|75783832|FG005|NOT COMPLETED|Overall Study||1||
59664446|NCT03473743|75783833|FG006|NOT COMPLETED|Overall Study||23||
59664447|NCT03473743|75783834|FG007|NOT COMPLETED|Overall Study||28||
59664448|NCT03212794|75783854|FG000|STARTED|Overall Study||16||
59664449|NCT03212794|75783855|FG001|STARTED|Overall Study||13||
59664450|NCT03212794|75783854|FG000|COMPLETED|Overall Study||5||
59664451|NCT03212794|75783855|FG001|COMPLETED|Overall Study||5||
59664452|NCT03212794|75783854|FG000|NOT COMPLETED|Overall Study||11||
59664453|NCT03212794|75783855|FG001|NOT COMPLETED|Overall Study||8||
59664454|NCT03200574|75783861|FG000|STARTED|Overall Study|96 patients were consented, 8 not eligible and 88 enrolled|88||
59664455|NCT03200574|75783861|FG000|COMPLETED|Overall Study||71||
59664456|NCT03200574|75783861|FG000|NOT COMPLETED|Overall Study||17||
59664457|NCT03194958|75783878|FG000|STARTED|Overall Study||485||
59664458|NCT03194958|75783879|FG001|STARTED|Overall Study||485||
59664459|NCT03194958|75783880|FG002|STARTED|Overall Study||484||
59664460|NCT03194958|75783881|FG003|STARTED|Overall Study||490||
59664461|NCT03194958|75783878|FG000|COMPLETED|Overall Study||293||
59664462|NCT03194958|75783879|FG001|COMPLETED|Overall Study||261||
59664463|NCT03194958|75783880|FG002|COMPLETED|Overall Study||302||
59664464|NCT03194958|75783881|FG003|COMPLETED|Overall Study||281||
59664465|NCT03194958|75783878|FG000|NOT COMPLETED|Overall Study||192||
59664466|NCT03194958|75783879|FG001|NOT COMPLETED|Overall Study||224||
59664467|NCT03194958|75783880|FG002|NOT COMPLETED|Overall Study||182||
59664468|NCT03194958|75783881|FG003|NOT COMPLETED|Overall Study||209||
59664469|NCT03123783|75783898|FG000|STARTED|Phase 1b||3||
59664470|NCT03123783|75783899|FG001|STARTED|Phase 1b||4||
59664471|NCT03123783|75783900|FG002|STARTED|Phase 1b||3||
59664472|NCT03123783|75783901|FG003|STARTED|Phase 1b||0||
59664473|NCT03123783|75783902|FG004|STARTED|Phase 1b||0||
59664474|NCT03123783|75783903|FG005|STARTED|Phase 1b||0||
59664475|NCT03123783|75783904|FG006|STARTED|Phase 1b||0||
59664476|NCT03123783|75783898|FG000|Participants in the Safety Population|Phase 1b||3||
59664477|NCT03123783|75783899|FG001|Participants in the Safety Population|Phase 1b||3||
59664478|NCT03123783|75783900|FG002|Participants in the Safety Population|Phase 1b||3||
59664479|NCT03123783|75783901|FG003|Participants in the Safety Population|Phase 1b||0||
59664480|NCT03123783|75783902|FG004|Participants in the Safety Population|Phase 1b||0||
59664481|NCT03123783|75783903|FG005|Participants in the Safety Population|Phase 1b||0||
59664482|NCT03123783|75783904|FG006|Participants in the Safety Population|Phase 1b||0||
59664483|NCT03123783|75783898|FG000|Participants in the Efficacy Population|Phase 1b||3||
59664484|NCT03123783|75783899|FG001|Participants in the Efficacy Population|Phase 1b||3||
59664485|NCT03123783|75783900|FG002|Participants in the Efficacy Population|Phase 1b||3||
59664486|NCT03123783|75783901|FG003|Participants in the Efficacy Population|Phase 1b||0||
59544758|NCT02448810|75643297|FG004|NOT COMPLETED|Overall Study||31||
59544759|NCT02448810|75643298|FG005|NOT COMPLETED|Overall Study||16||
59544760|NCT02448810|75643299|FG006|NOT COMPLETED|Overall Study||18||
59544761|NCT02448810|75643300|FG007|NOT COMPLETED|Overall Study||8||
59544762|NCT00958334|75643325|FG000|STARTED|Overall Study||22||
59544763|NCT00958334|75643326|FG001|STARTED|Overall Study||22||
59544764|NCT00958334|75643327|FG002|STARTED|Overall Study||21||
59664487|NCT03123783|75783902|FG004|Participants in the Efficacy Population|Phase 1b||0||
59664488|NCT03123783|75783903|FG005|Participants in the Efficacy Population|Phase 1b||0||
59664489|NCT03123783|75783904|FG006|Participants in the Efficacy Population|Phase 1b||0||
59664490|NCT03123783|75783898|FG000|COMPLETED|Phase 1b||3|Participants completed Ph1b who did not receive RP2D did not roll over to Phase 2|
59664491|NCT03123783|75783899|FG001|COMPLETED|Phase 1b||3|Participants completed Ph1b who did not receive RP2D did not roll over to Phase 2|
59664492|NCT03123783|75783900|FG002|COMPLETED|Phase 1b||0|Participants completed Ph1b who did not receive RP2D did not roll over to Phase 2|
59664493|NCT03123783|75783901|FG003|COMPLETED|Phase 1b||0|Participants completed Ph1b who did not receive RP2D did not roll over to Phase 2|
59664494|NCT03123783|75783902|FG004|COMPLETED|Phase 1b||0|Participants completed Ph1b who did not receive RP2D did not roll over to Phase 2|
59664495|NCT03123783|75783903|FG005|COMPLETED|Phase 1b||0|Participants completed Ph1b who did not receive RP2D did not roll over to Phase 2|
59664496|NCT03123783|75783904|FG006|COMPLETED|Phase 1b||0|Participants completed Ph1b who did not receive RP2D did not roll over to Phase 2|
59664497|NCT03123783|75783898|FG000|NOT COMPLETED|Phase 1b||0||
59544765|NCT00958334|75643325|FG000|COMPLETED|Overall Study||8||
59544766|NCT00958334|75643326|FG001|COMPLETED|Overall Study||5||
59544767|NCT00958334|75643327|FG002|COMPLETED|Overall Study||8||
59664498|NCT03123783|75783899|FG001|NOT COMPLETED|Phase 1b||1||
59664499|NCT03123783|75783900|FG002|NOT COMPLETED|Phase 1b||3||
59664500|NCT03123783|75783901|FG003|NOT COMPLETED|Phase 1b||0||
59664501|NCT03123783|75783902|FG004|NOT COMPLETED|Phase 1b||0||
59664502|NCT03123783|75783903|FG005|NOT COMPLETED|Phase 1b||0||
59664503|NCT03123783|75783904|FG006|NOT COMPLETED|Phase 1b||0||
59664504|NCT03123783|75783898|FG000|STARTED|Phase 2||0|Only 3 participants in Phase 1b rolled over to Phase 2 study|
59664505|NCT03123783|75783899|FG001|STARTED|Phase 2||0|Only 3 participants in Phase 1b rolled over to Phase 2 study|
59664506|NCT03123783|75783900|FG002|STARTED|Phase 2||0|Only 3 participants in Phase 1b rolled over to Phase 2 study|
59664507|NCT03123783|75783901|FG003|STARTED|Phase 2||53|Only 3 participants in Phase 1b rolled over to Phase 2 study|
59664508|NCT03123783|75783902|FG004|STARTED|Phase 2||38|Only 3 participants in Phase 1b rolled over to Phase 2 study|
59664509|NCT03123783|75783903|FG005|STARTED|Phase 2||14|Only 3 participants in Phase 1b rolled over to Phase 2 study|
59664510|NCT03123783|75783904|FG006|STARTED|Phase 2||28|Only 3 participants in Phase 1b rolled over to Phase 2 study|
59664511|NCT03123783|75783898|FG000|Phase 2 Participants in Safety Population|Phase 2||0||
59664512|NCT03123783|75783899|FG001|Phase 2 Participants in Safety Population|Phase 2||0||
59664513|NCT03123783|75783900|FG002|Phase 2 Participants in Safety Population|Phase 2||0||
59664514|NCT03123783|75783901|FG003|Phase 2 Participants in Safety Population|Phase 2||53||
59664515|NCT03123783|75783902|FG004|Phase 2 Participants in Safety Population|Phase 2||38||
59664516|NCT03123783|75783903|FG005|Phase 2 Participants in Safety Population|Phase 2||14||
59664517|NCT03123783|75783904|FG006|Phase 2 Participants in Safety Population|Phase 2||28||
59664518|NCT03123783|75783898|FG000|Phase 2 Participants in the Efficacy (EE) Population|Phase 2||0||
59664519|NCT03123783|75783899|FG001|Phase 2 Participants in the Efficacy (EE) Population|Phase 2||0||
59664520|NCT03123783|75783900|FG002|Phase 2 Participants in the Efficacy (EE) Population|Phase 2||0||
59664521|NCT03123783|75783901|FG003|Phase 2 Participants in the Efficacy (EE) Population|Phase 2||48||
59664522|NCT03123783|75783902|FG004|Phase 2 Participants in the Efficacy (EE) Population|Phase 2||33||
59664523|NCT03123783|75783903|FG005|Phase 2 Participants in the Efficacy (EE) Population|Phase 2||12||
59664524|NCT03123783|75783904|FG006|Phase 2 Participants in the Efficacy (EE) Population|Phase 2||25||
59664525|NCT03123783|75783898|FG000|COMPLETED|Phase 2||0||
59664526|NCT03123783|75783899|FG001|COMPLETED|Phase 2||0||
59664527|NCT03123783|75783900|FG002|COMPLETED|Phase 2||0||
59664528|NCT03123783|75783901|FG003|COMPLETED|Phase 2||48||
59664529|NCT03123783|75783902|FG004|COMPLETED|Phase 2||33||
59664530|NCT03123783|75783903|FG005|COMPLETED|Phase 2||12||
59664531|NCT03123783|75783904|FG006|COMPLETED|Phase 2||25||
59664532|NCT03123783|75783898|FG000|NOT COMPLETED|Phase 2||0||
59664533|NCT03123783|75783899|FG001|NOT COMPLETED|Phase 2||0||
59664534|NCT03123783|75783900|FG002|NOT COMPLETED|Phase 2||0||
59664535|NCT03123783|75783901|FG003|NOT COMPLETED|Phase 2||5||
59664536|NCT03123783|75783902|FG004|NOT COMPLETED|Phase 2||5||
59664537|NCT03123783|75783903|FG005|NOT COMPLETED|Phase 2||2||
59664538|NCT03123783|75783904|FG006|NOT COMPLETED|Phase 2||3||
59664539|NCT03118232|75783921|FG000|STARTED|Overall Study||7388||14
59664540|NCT03118232|75783922|FG001|STARTED|Overall Study||6564||14
59664541|NCT03118232|75783921|FG000|COMPLETED|Overall Study||7388||14
59664542|NCT03118232|75783922|FG001|COMPLETED|Overall Study||6564||14
59664543|NCT03118232|75783921|FG000|NOT COMPLETED|Overall Study||0||0
59664544|NCT03118232|75783922|FG001|NOT COMPLETED|Overall Study||0||0
59664545|NCT03047629|75783931|FG000|STARTED|Overall Study||10||
59664546|NCT03047629|75783932|FG001|STARTED|Overall Study||26||
59664547|NCT03047629|75783933|FG002|STARTED|Overall Study||8||
59664548|NCT03047629|75783931|FG000|COMPLETED|Overall Study||9||
59664549|NCT03047629|75783932|FG001|COMPLETED|Overall Study||20||
59664550|NCT03047629|75783933|FG002|COMPLETED|Overall Study||8||
60077305|NCT01513239|76192322|FG003|NOT COMPLETED|Period 2: 9 Month Extension Phase||10||
59664551|NCT03047629|75783931|FG000|NOT COMPLETED|Overall Study||1||
59664552|NCT03047629|75783932|FG001|NOT COMPLETED|Overall Study||6||
59664553|NCT03047629|75783933|FG002|NOT COMPLETED|Overall Study||0||
59664554|NCT03003962|75783945|FG000|STARTED|Overall Study||335|Randomized|
59664555|NCT03003962|75783946|FG001|STARTED|Overall Study||334|Randomized|
59664556|NCT03003962|75783945|FG000|PD L1 TC ≥ 25% LREM Analysis Set|Overall Study||278||
59664557|NCT03003962|75783946|FG001|PD L1 TC ≥ 25% LREM Analysis Set|Overall Study||271||
59664558|NCT03003962|75783945|FG000|PD L1 TC ≥ 50% Analysis Set|Overall Study||247||
59664559|NCT03003962|75783946|FG001|PD L1 TC ≥ 50% Analysis Set|Overall Study||246||
59664560|NCT03003962|75783945|FG000|PD L1 TC ≥ 50% LREM Analysis Set|Overall Study||207||
59664561|NCT03003962|75783946|FG001|PD L1 TC ≥ 50% LREM Analysis Set|Overall Study||199||
59664562|NCT03003962|75783945|FG000|COMPLETED|Overall Study||1||
59664563|NCT03003962|75783946|FG001|COMPLETED|Overall Study||0||
59664564|NCT03003962|75783945|FG000|NOT COMPLETED|Overall Study||334||
59664565|NCT03003962|75783946|FG001|NOT COMPLETED|Overall Study||334||
59664566|NCT02943408|75783956|FG000|STARTED|Overall Study||24||
59664567|NCT02943408|75783957|FG001|STARTED|Overall Study||24||
59664568|NCT02943408|75783956|FG000|Baseline|Overall Study||24||
59664569|NCT02943408|75783957|FG001|Baseline|Overall Study||23||
59664570|NCT02943408|75783956|FG000|Time Point 2 : 4-7 Weeks Post Baseline|Overall Study||21||
59664571|NCT02943408|75783957|FG001|Time Point 2 : 4-7 Weeks Post Baseline|Overall Study||19||
59988993|NCT02261974|76104262|FG000|Treated|Overall Study||117||
59664572|NCT02943408|75783956|FG000|Time Point 3: 3 Months Post Time Point 2|Overall Study||21||
59664573|NCT02943408|75783957|FG001|Time Point 3: 3 Months Post Time Point 2|Overall Study||22||
59664574|NCT02943408|75783956|FG000|COMPLETED|Overall Study||17||
59664575|NCT02943408|75783957|FG001|COMPLETED|Overall Study||22||
59664576|NCT02943408|75783956|FG000|NOT COMPLETED|Overall Study||7||
59664577|NCT02943408|75783957|FG001|NOT COMPLETED|Overall Study||2||
59664578|NCT02728102|75783966|FG000|STARTED|Overall Study||68||
59664579|NCT02728102|75783967|FG001|STARTED|Overall Study||37||
59664580|NCT02728102|75783968|FG002|STARTED|Overall Study||35||
59664581|NCT02728102|75783966|FG000|COMPLETED|Overall Study||61||
59664582|NCT02728102|75783967|FG001|COMPLETED|Overall Study||33||
59664583|NCT02728102|75783968|FG002|COMPLETED|Overall Study||30||
59664584|NCT02728102|75783966|FG000|NOT COMPLETED|Overall Study||7||
59664585|NCT02728102|75783967|FG001|NOT COMPLETED|Overall Study||4||
59664586|NCT02728102|75783968|FG002|NOT COMPLETED|Overall Study||5||
59664587|NCT02660580|75783979|FG000|STARTED|Core Treatment Period (Week 1 to 16)||222||
59664588|NCT02660580|75783980|FG001|STARTED|Core Treatment Period (Week 1 to 16)||221||
59664589|NCT02660580|75783981|FG002|STARTED|Core Treatment Period (Week 1 to 16)||0||
59664590|NCT02660580|75783982|FG003|STARTED|Core Treatment Period (Week 1 to 16)||0||
59664591|NCT02660580|75783983|FG004|STARTED|Core Treatment Period (Week 1 to 16)||0||
59664592|NCT02660580|75783979|FG000|Treated|Core Treatment Period (Week 1 to 16)||221||
59664593|NCT02660580|75783980|FG001|Treated|Core Treatment Period (Week 1 to 16)||220||
59664594|NCT02660580|75783981|FG002|Treated|Core Treatment Period (Week 1 to 16)||0||
59664595|NCT02660580|75783982|FG003|Treated|Core Treatment Period (Week 1 to 16)||0||
59664596|NCT02660580|75783983|FG004|Treated|Core Treatment Period (Week 1 to 16)||0||
59664597|NCT02660580|75783979|FG000|COMPLETED|Core Treatment Period (Week 1 to 16)||213||
59664598|NCT02660580|75783980|FG001|COMPLETED|Core Treatment Period (Week 1 to 16)||202||
59664599|NCT02660580|75783981|FG002|COMPLETED|Core Treatment Period (Week 1 to 16)||0||
59664600|NCT02660580|75783982|FG003|COMPLETED|Core Treatment Period (Week 1 to 16)||0||
59664601|NCT02660580|75783983|FG004|COMPLETED|Core Treatment Period (Week 1 to 16)||0||
59664602|NCT02660580|75783979|FG000|NOT COMPLETED|Core Treatment Period (Week 1 to 16)||9||
59664603|NCT02660580|75783980|FG001|NOT COMPLETED|Core Treatment Period (Week 1 to 16)||19||
59664604|NCT02660580|75783981|FG002|NOT COMPLETED|Core Treatment Period (Week 1 to 16)||0||
59664605|NCT02660580|75783982|FG003|NOT COMPLETED|Core Treatment Period (Week 1 to 16)||0||
59664606|NCT02660580|75783983|FG004|NOT COMPLETED|Core Treatment Period (Week 1 to 16)||0||
59664607|NCT02660580|75783979|FG000|STARTED|Extended Treatment Period(Week 16 to 52)||0||
59664608|NCT02660580|75783980|FG001|STARTED|Extended Treatment Period(Week 16 to 52)||0||
59664609|NCT02660580|75783981|FG002|STARTED|Extended Treatment Period(Week 16 to 52)||213||
59664610|NCT02660580|75783982|FG003|STARTED|Extended Treatment Period(Week 16 to 52)||101||
59664611|NCT02660580|75783983|FG004|STARTED|Extended Treatment Period(Week 16 to 52)||101||
59664612|NCT02660580|75783979|FG000|COMPLETED|Extended Treatment Period(Week 16 to 52)||0||
59664613|NCT02660580|75783980|FG001|COMPLETED|Extended Treatment Period(Week 16 to 52)||0||
59664614|NCT02660580|75783981|FG002|COMPLETED|Extended Treatment Period(Week 16 to 52)||195||
59664615|NCT02660580|75783982|FG003|COMPLETED|Extended Treatment Period(Week 16 to 52)||90||
59664616|NCT02660580|75783983|FG004|COMPLETED|Extended Treatment Period(Week 16 to 52)||90||
59664617|NCT02660580|75783979|FG000|NOT COMPLETED|Extended Treatment Period(Week 16 to 52)||0||
59664618|NCT02660580|75783980|FG001|NOT COMPLETED|Extended Treatment Period(Week 16 to 52)||0||
59664619|NCT02660580|75783981|FG002|NOT COMPLETED|Extended Treatment Period(Week 16 to 52)||18||
59664620|NCT02660580|75783982|FG003|NOT COMPLETED|Extended Treatment Period(Week 16 to 52)||11||
59664621|NCT02660580|75783983|FG004|NOT COMPLETED|Extended Treatment Period(Week 16 to 52)||11||
59664622|NCT02600897|75784011|FG000|STARTED|Overall Study||3||
59664623|NCT02600897|75784012|FG001|STARTED|Overall Study||4||
59664624|NCT02600897|75784013|FG002|STARTED|Overall Study||3||
59664625|NCT02600897|75784014|FG003|STARTED|Overall Study||6||
59664626|NCT02600897|75784015|FG004|STARTED|Overall Study||3||
59664627|NCT02600897|75784016|FG005|STARTED|Overall Study||5||
59664628|NCT02600897|75784017|FG006|STARTED|Overall Study||10||
59988994|NCT02261974|76104263|FG001|Treated|Overall Study||57||
59664629|NCT02600897|75784018|FG007|STARTED|Overall Study||40||
59664630|NCT02600897|75784019|FG008|STARTED|Overall Study||40||
59664631|NCT02600897|75784011|FG000|Intent-to-Treat Population|Overall Study||3|The intent-to-treat (ITT) population included all participants enrolled in the study.|
59664632|NCT02600897|75784012|FG001|Intent-to-Treat Population|Overall Study||4|The intent-to-treat (ITT) population included all participants enrolled in the study.|
59664633|NCT02600897|75784013|FG002|Intent-to-Treat Population|Overall Study||3|The intent-to-treat (ITT) population included all participants enrolled in the study.|
59664634|NCT02600897|75784014|FG003|Intent-to-Treat Population|Overall Study||6|The intent-to-treat (ITT) population included all participants enrolled in the study.|
59664635|NCT02600897|75784015|FG004|Intent-to-Treat Population|Overall Study||3|The intent-to-treat (ITT) population included all participants enrolled in the study.|
59664636|NCT02600897|75784016|FG005|Intent-to-Treat Population|Overall Study||5|The intent-to-treat (ITT) population included all participants enrolled in the study.|
59664637|NCT02600897|75784017|FG006|Intent-to-Treat Population|Overall Study||10|The intent-to-treat (ITT) population included all participants enrolled in the study.|
59709758|NCT01072149|75828524|FG004|NOT COMPLETED|Treatment Period 1 (28 Days)||0||
59988995|NCT02261974|76104262|FG000|COMPLETED|Overall Study||108||
59664638|NCT02600897|75784018|FG007|Intent-to-Treat Population|Overall Study||40|The intent-to-treat (ITT) population included all participants enrolled in the study.|
59664639|NCT02600897|75784019|FG008|Intent-to-Treat Population|Overall Study||40|The intent-to-treat (ITT) population included all participants enrolled in the study.|
59664640|NCT02600897|75784011|FG000|Safety-evaluable Population|Overall Study||3|The safety-evaluable population included all participants who received at least one dose of any component of the combination.|
59664641|NCT02600897|75784012|FG001|Safety-evaluable Population|Overall Study||4|The safety-evaluable population included all participants who received at least one dose of any component of the combination.|
59664642|NCT02600897|75784013|FG002|Safety-evaluable Population|Overall Study||3|The safety-evaluable population included all participants who received at least one dose of any component of the combination.|
59664643|NCT02600897|75784014|FG003|Safety-evaluable Population|Overall Study||6|The safety-evaluable population included all participants who received at least one dose of any component of the combination.|
59664644|NCT02600897|75784015|FG004|Safety-evaluable Population|Overall Study||3|The safety-evaluable population included all participants who received at least one dose of any component of the combination.|
59664645|NCT02600897|75784016|FG005|Safety-evaluable Population|Overall Study||5|The safety-evaluable population included all participants who received at least one dose of any component of the combination.|
59664646|NCT02600897|75784017|FG006|Safety-evaluable Population|Overall Study||10|The safety-evaluable population included all participants who received at least one dose of any component of the combination.|
59664647|NCT02600897|75784018|FG007|Safety-evaluable Population|Overall Study||40|The safety-evaluable population included all participants who received at least one dose of any component of the combination.|
59664648|NCT02600897|75784019|FG008|Safety-evaluable Population|Overall Study||39|The safety-evaluable population included all participants who received at least one dose of any component of the combination.|
59664649|NCT02600897|75784011|FG000|Immunogenicity-evaluable Population|Overall Study||3|Immunogenicity population included all safety-evaluable participants with at least one ADA sample.|
59664650|NCT02600897|75784012|FG001|Immunogenicity-evaluable Population|Overall Study||4|Immunogenicity population included all safety-evaluable participants with at least one ADA sample.|
59664651|NCT02600897|75784013|FG002|Immunogenicity-evaluable Population|Overall Study||3|Immunogenicity population included all safety-evaluable participants with at least one ADA sample.|
59664652|NCT02600897|75784014|FG003|Immunogenicity-evaluable Population|Overall Study||6|Immunogenicity population included all safety-evaluable participants with at least one ADA sample.|
59664653|NCT02600897|75784015|FG004|Immunogenicity-evaluable Population|Overall Study||3|Immunogenicity population included all safety-evaluable participants with at least one ADA sample.|
59664654|NCT02600897|75784016|FG005|Immunogenicity-evaluable Population|Overall Study||5|Immunogenicity population included all safety-evaluable participants with at least one ADA sample.|
59664655|NCT02600897|75784017|FG006|Immunogenicity-evaluable Population|Overall Study||10|Immunogenicity population included all safety-evaluable participants with at least one ADA sample.|
59664656|NCT02600897|75784018|FG007|Immunogenicity-evaluable Population|Overall Study||39|Immunogenicity population included all safety-evaluable participants with at least one ADA sample.|
59664657|NCT02600897|75784019|FG008|Immunogenicity-evaluable Population|Overall Study||38|Immunogenicity population included all safety-evaluable participants with at least one ADA sample.|
59664658|NCT02600897|75784011|FG000|Pharmacokinetic-evaluable Population|Overall Study||3|The pharmacokinetic-evaluable population included all participants who received at least one dose of any component of the combination and who provided at least one suitable postdose PK sample.|
59664659|NCT02600897|75784012|FG001|Pharmacokinetic-evaluable Population|Overall Study||4|The pharmacokinetic-evaluable population included all participants who received at least one dose of any component of the combination and who provided at least one suitable postdose PK sample.|
59664660|NCT02600897|75784013|FG002|Pharmacokinetic-evaluable Population|Overall Study||3|The pharmacokinetic-evaluable population included all participants who received at least one dose of any component of the combination and who provided at least one suitable postdose PK sample.|
59664661|NCT02600897|75784014|FG003|Pharmacokinetic-evaluable Population|Overall Study||6|The pharmacokinetic-evaluable population included all participants who received at least one dose of any component of the combination and who provided at least one suitable postdose PK sample.|
59664662|NCT02600897|75784015|FG004|Pharmacokinetic-evaluable Population|Overall Study||3|The pharmacokinetic-evaluable population included all participants who received at least one dose of any component of the combination and who provided at least one suitable postdose PK sample.|
59664663|NCT02600897|75784016|FG005|Pharmacokinetic-evaluable Population|Overall Study||5|The pharmacokinetic-evaluable population included all participants who received at least one dose of any component of the combination and who provided at least one suitable postdose PK sample.|
59988996|NCT02261974|76104263|FG001|COMPLETED|Overall Study||56||
59988997|NCT02261974|76104262|FG000|NOT COMPLETED|Overall Study||15||
59988998|NCT02261974|76104263|FG001|NOT COMPLETED|Overall Study||7||
59664664|NCT02600897|75784017|FG006|Pharmacokinetic-evaluable Population|Overall Study||10|The pharmacokinetic-evaluable population included all participants who received at least one dose of any component of the combination and who provided at least one suitable postdose PK sample.|
59664665|NCT02600897|75784018|FG007|Pharmacokinetic-evaluable Population|Overall Study||40|The pharmacokinetic-evaluable population included all participants who received at least one dose of any component of the combination and who provided at least one suitable postdose PK sample.|
59664666|NCT02600897|75784019|FG008|Pharmacokinetic-evaluable Population|Overall Study||39|The pharmacokinetic-evaluable population included all participants who received at least one dose of any component of the combination and who provided at least one suitable postdose PK sample.|
59664667|NCT02600897|75784011|FG000|COMPLETED|Overall Study||1||
59664668|NCT02600897|75784012|FG001|COMPLETED|Overall Study||2||
59664669|NCT02600897|75784013|FG002|COMPLETED|Overall Study||2||
59664670|NCT02600897|75784014|FG003|COMPLETED|Overall Study||4||
59988999|NCT02356588|76104271|FG000|STARTED|Overall Study||107||
59664671|NCT02600897|75784015|FG004|COMPLETED|Overall Study||0||
59664672|NCT02600897|75784016|FG005|COMPLETED|Overall Study||3||
59664673|NCT02600897|75784017|FG006|COMPLETED|Overall Study||0||
59664674|NCT02600897|75784018|FG007|COMPLETED|Overall Study||28||
59664675|NCT02600897|75784019|FG008|COMPLETED|Overall Study||17||
59664676|NCT02600897|75784011|FG000|NOT COMPLETED|Overall Study||2||
59664677|NCT02600897|75784012|FG001|NOT COMPLETED|Overall Study||2||
59664678|NCT02600897|75784013|FG002|NOT COMPLETED|Overall Study||1||
59664679|NCT02600897|75784014|FG003|NOT COMPLETED|Overall Study||2||
59664680|NCT02600897|75784015|FG004|NOT COMPLETED|Overall Study||3||
59664681|NCT02600897|75784016|FG005|NOT COMPLETED|Overall Study||2||
59664682|NCT02600897|75784017|FG006|NOT COMPLETED|Overall Study||10||
59664683|NCT02600897|75784018|FG007|NOT COMPLETED|Overall Study||12||
59664684|NCT02600897|75784019|FG008|NOT COMPLETED|Overall Study||23||
59664685|NCT02399215|75784048|FG000|STARTED|Overall Study||32||
59664686|NCT02399215|75784048|FG000|COMPLETED|Overall Study||30||
59664687|NCT02399215|75784048|FG000|NOT COMPLETED|Overall Study||2||
59664688|NCT02365649|75784058|FG000|STARTED|Double-Blind Induction (Weeks 1-16)||37||
59664689|NCT02365649|75784059|FG001|STARTED|Double-Blind Induction (Weeks 1-16)||39||
59664690|NCT02365649|75784060|FG002|STARTED|Double-Blind Induction (Weeks 1-16)||37||
59664691|NCT02365649|75784061|FG003|STARTED|Double-Blind Induction (Weeks 1-16)||36||
59664692|NCT02365649|75784062|FG004|STARTED|Double-Blind Induction (Weeks 1-16)||36||
59664693|NCT02365649|75784063|FG005|STARTED|Double-Blind Induction (Weeks 1-16)||35||
59664694|NCT02365649|75784064|FG006|STARTED|Double-Blind Induction (Weeks 1-16)||0||
59664695|NCT02365649|75784065|FG007|STARTED|Double-Blind Induction (Weeks 1-16)||0||
59664696|NCT02365649|75784066|FG008|STARTED|Double-Blind Induction (Weeks 1-16)||0||
59664697|NCT02365649|75784067|FG009|STARTED|Double-Blind Induction (Weeks 1-16)||0||
59664698|NCT02365649|75784058|FG000|COMPLETED|Double-Blind Induction (Weeks 1-16)||27||
59664699|NCT02365649|75784059|FG001|COMPLETED|Double-Blind Induction (Weeks 1-16)||34||
59664700|NCT02365649|75784060|FG002|COMPLETED|Double-Blind Induction (Weeks 1-16)||33||
59664701|NCT02365649|75784061|FG003|COMPLETED|Double-Blind Induction (Weeks 1-16)||27||
59664702|NCT02365649|75784062|FG004|COMPLETED|Double-Blind Induction (Weeks 1-16)||29||
59664703|NCT02365649|75784063|FG005|COMPLETED|Double-Blind Induction (Weeks 1-16)||30||
59664704|NCT02365649|75784064|FG006|COMPLETED|Double-Blind Induction (Weeks 1-16)||0||
59664705|NCT02365649|75784065|FG007|COMPLETED|Double-Blind Induction (Weeks 1-16)||0||
59664706|NCT02365649|75784066|FG008|COMPLETED|Double-Blind Induction (Weeks 1-16)||0||
59664707|NCT02365649|75784067|FG009|COMPLETED|Double-Blind Induction (Weeks 1-16)||0||
59664708|NCT02365649|75784058|FG000|NOT COMPLETED|Double-Blind Induction (Weeks 1-16)||10||
59664709|NCT02365649|75784059|FG001|NOT COMPLETED|Double-Blind Induction (Weeks 1-16)||5||
59664710|NCT02365649|75784060|FG002|NOT COMPLETED|Double-Blind Induction (Weeks 1-16)||4||
59664711|NCT02365649|75784061|FG003|NOT COMPLETED|Double-Blind Induction (Weeks 1-16)||9||
59664712|NCT02365649|75784062|FG004|NOT COMPLETED|Double-Blind Induction (Weeks 1-16)||7||
59664713|NCT02365649|75784063|FG005|NOT COMPLETED|Double-Blind Induction (Weeks 1-16)||5||
59664714|NCT02365649|75784064|FG006|NOT COMPLETED|Double-Blind Induction (Weeks 1-16)||0||
59664715|NCT02365649|75784065|FG007|NOT COMPLETED|Double-Blind Induction (Weeks 1-16)||0||
59664716|NCT02365649|75784066|FG008|NOT COMPLETED|Double-Blind Induction (Weeks 1-16)||0||
59664717|NCT02365649|75784067|FG009|NOT COMPLETED|Double-Blind Induction (Weeks 1-16)||0||
59664718|NCT02365649|75784058|FG000|STARTED|Double-Blind Extension (Weeks 16-52)||0||
59664719|NCT02365649|75784059|FG001|STARTED|Double-Blind Extension (Weeks 16-52)||0||
59664720|NCT02365649|75784060|FG002|STARTED|Double-Blind Extension (Weeks 16-52)||0||
59664721|NCT02365649|75784061|FG003|STARTED|Double-Blind Extension (Weeks 16-52)||0||
59664722|NCT02365649|75784062|FG004|STARTED|Double-Blind Extension (Weeks 16-52)||0||
59664723|NCT02365649|75784063|FG005|STARTED|Double-Blind Extension (Weeks 16-52)||0||
59664724|NCT02365649|75784064|FG006|STARTED|Double-Blind Extension (Weeks 16-52)||61||
59664725|NCT02365649|75784065|FG007|STARTED|Double-Blind Extension (Weeks 16-52)||23||
59664726|NCT02365649|75784066|FG008|STARTED|Double-Blind Extension (Weeks 16-52)||59||
59664727|NCT02365649|75784067|FG009|STARTED|Double-Blind Extension (Weeks 16-52)||37||
59664728|NCT02365649|75784058|FG000|Switched to OL 12 mg BID|Double-Blind Extension (Weeks 16-52)||0|Participants who met inadequate response criteria at or after Week 20 and switched to OL 12 mg BID.|
59664729|NCT02365649|75784059|FG001|Switched to OL 12 mg BID|Double-Blind Extension (Weeks 16-52)||0|Participants who met inadequate response criteria at or after Week 20 and switched to OL 12 mg BID.|
59664730|NCT02365649|75784060|FG002|Switched to OL 12 mg BID|Double-Blind Extension (Weeks 16-52)||0|Participants who met inadequate response criteria at or after Week 20 and switched to OL 12 mg BID.|
59664731|NCT02365649|75784061|FG003|Switched to OL 12 mg BID|Double-Blind Extension (Weeks 16-52)||0|Participants who met inadequate response criteria at or after Week 20 and switched to OL 12 mg BID.|
59664732|NCT02365649|75784062|FG004|Switched to OL 12 mg BID|Double-Blind Extension (Weeks 16-52)||0|Participants who met inadequate response criteria at or after Week 20 and switched to OL 12 mg BID.|
59664733|NCT02365649|75784063|FG005|Switched to OL 12 mg BID|Double-Blind Extension (Weeks 16-52)||0|Participants who met inadequate response criteria at or after Week 20 and switched to OL 12 mg BID.|
59664734|NCT02365649|75784064|FG006|Switched to OL 12 mg BID|Double-Blind Extension (Weeks 16-52)||21|Participants who met inadequate response criteria at or after Week 20 and switched to OL 12 mg BID.|
59664735|NCT02365649|75784065|FG007|Switched to OL 12 mg BID|Double-Blind Extension (Weeks 16-52)||5|Participants who met inadequate response criteria at or after Week 20 and switched to OL 12 mg BID.|
59664736|NCT02365649|75784066|FG008|Switched to OL 12 mg BID|Double-Blind Extension (Weeks 16-52)||17|Participants who met inadequate response criteria at or after Week 20 and switched to OL 12 mg BID.|
59664737|NCT02365649|75784067|FG009|Switched to OL 12 mg BID|Double-Blind Extension (Weeks 16-52)||17|Participants who met inadequate response criteria at or after Week 20 and switched to OL 12 mg BID.|
59664738|NCT02365649|75784058|FG000|Further Dose Escalated to OL 24 mg BID|Double-Blind Extension (Weeks 16-52)||0|Participants who were switched to OL 12 mg BID and then further dose escalated to OL 24 mg BID.|
59664739|NCT02365649|75784059|FG001|Further Dose Escalated to OL 24 mg BID|Double-Blind Extension (Weeks 16-52)||0|Participants who were switched to OL 12 mg BID and then further dose escalated to OL 24 mg BID.|
59664740|NCT02365649|75784060|FG002|Further Dose Escalated to OL 24 mg BID|Double-Blind Extension (Weeks 16-52)||0|Participants who were switched to OL 12 mg BID and then further dose escalated to OL 24 mg BID.|
59664741|NCT02365649|75784061|FG003|Further Dose Escalated to OL 24 mg BID|Double-Blind Extension (Weeks 16-52)||0|Participants who were switched to OL 12 mg BID and then further dose escalated to OL 24 mg BID.|
59664742|NCT02365649|75784062|FG004|Further Dose Escalated to OL 24 mg BID|Double-Blind Extension (Weeks 16-52)||0|Participants who were switched to OL 12 mg BID and then further dose escalated to OL 24 mg BID.|
59664743|NCT02365649|75784063|FG005|Further Dose Escalated to OL 24 mg BID|Double-Blind Extension (Weeks 16-52)||0|Participants who were switched to OL 12 mg BID and then further dose escalated to OL 24 mg BID.|
59664744|NCT02365649|75784064|FG006|Further Dose Escalated to OL 24 mg BID|Double-Blind Extension (Weeks 16-52)||5|Participants who were switched to OL 12 mg BID and then further dose escalated to OL 24 mg BID.|
59664745|NCT02365649|75784065|FG007|Further Dose Escalated to OL 24 mg BID|Double-Blind Extension (Weeks 16-52)||2|Participants who were switched to OL 12 mg BID and then further dose escalated to OL 24 mg BID.|
59664746|NCT02365649|75784066|FG008|Further Dose Escalated to OL 24 mg BID|Double-Blind Extension (Weeks 16-52)||10|Participants who were switched to OL 12 mg BID and then further dose escalated to OL 24 mg BID.|
59664747|NCT02365649|75784067|FG009|Further Dose Escalated to OL 24 mg BID|Double-Blind Extension (Weeks 16-52)||10|Participants who were switched to OL 12 mg BID and then further dose escalated to OL 24 mg BID.|
59664748|NCT02365649|75784058|FG000|Dose De-escalated to OL 12 mg BID|Double-Blind Extension (Weeks 16-52)||0|Participants who were dose escalated to OL 24 mg BID and then dose de-escalated to OL 12 mg BID.|
59664749|NCT02365649|75784059|FG001|Dose De-escalated to OL 12 mg BID|Double-Blind Extension (Weeks 16-52)||0|Participants who were dose escalated to OL 24 mg BID and then dose de-escalated to OL 12 mg BID.|
59664750|NCT02365649|75784060|FG002|Dose De-escalated to OL 12 mg BID|Double-Blind Extension (Weeks 16-52)||0|Participants who were dose escalated to OL 24 mg BID and then dose de-escalated to OL 12 mg BID.|
59664751|NCT02365649|75784061|FG003|Dose De-escalated to OL 12 mg BID|Double-Blind Extension (Weeks 16-52)||0|Participants who were dose escalated to OL 24 mg BID and then dose de-escalated to OL 12 mg BID.|
59664752|NCT02365649|75784062|FG004|Dose De-escalated to OL 12 mg BID|Double-Blind Extension (Weeks 16-52)||0|Participants who were dose escalated to OL 24 mg BID and then dose de-escalated to OL 12 mg BID.|
59664753|NCT02365649|75784063|FG005|Dose De-escalated to OL 12 mg BID|Double-Blind Extension (Weeks 16-52)||0|Participants who were dose escalated to OL 24 mg BID and then dose de-escalated to OL 12 mg BID.|
59664754|NCT02365649|75784064|FG006|Dose De-escalated to OL 12 mg BID|Double-Blind Extension (Weeks 16-52)||0|Participants who were dose escalated to OL 24 mg BID and then dose de-escalated to OL 12 mg BID.|
59664755|NCT02365649|75784065|FG007|Dose De-escalated to OL 12 mg BID|Double-Blind Extension (Weeks 16-52)||0|Participants who were dose escalated to OL 24 mg BID and then dose de-escalated to OL 12 mg BID.|
59664756|NCT02365649|75784066|FG008|Dose De-escalated to OL 12 mg BID|Double-Blind Extension (Weeks 16-52)||0|Participants who were dose escalated to OL 24 mg BID and then dose de-escalated to OL 12 mg BID.|
59664757|NCT02365649|75784067|FG009|Dose De-escalated to OL 12 mg BID|Double-Blind Extension (Weeks 16-52)||0|Participants who were dose escalated to OL 24 mg BID and then dose de-escalated to OL 12 mg BID.|
59664758|NCT02365649|75784058|FG000|COMPLETED|Double-Blind Extension (Weeks 16-52)||0||
59664759|NCT02365649|75784059|FG001|COMPLETED|Double-Blind Extension (Weeks 16-52)||0||
59664760|NCT02365649|75784060|FG002|COMPLETED|Double-Blind Extension (Weeks 16-52)||0||
59664761|NCT02365649|75784061|FG003|COMPLETED|Double-Blind Extension (Weeks 16-52)||0||
59664762|NCT02365649|75784062|FG004|COMPLETED|Double-Blind Extension (Weeks 16-52)||0||
59664763|NCT02365649|75784063|FG005|COMPLETED|Double-Blind Extension (Weeks 16-52)||0||
59664764|NCT02365649|75784064|FG006|COMPLETED|Double-Blind Extension (Weeks 16-52)||43||
59664765|NCT02365649|75784065|FG007|COMPLETED|Double-Blind Extension (Weeks 16-52)||21||
59664766|NCT02365649|75784066|FG008|COMPLETED|Double-Blind Extension (Weeks 16-52)||43||
59664767|NCT02365649|75784067|FG009|COMPLETED|Double-Blind Extension (Weeks 16-52)||22||
59664768|NCT02365649|75784058|FG000|NOT COMPLETED|Double-Blind Extension (Weeks 16-52)||0||
59664769|NCT02365649|75784059|FG001|NOT COMPLETED|Double-Blind Extension (Weeks 16-52)||0||
59664770|NCT02365649|75784060|FG002|NOT COMPLETED|Double-Blind Extension (Weeks 16-52)||0||
59664771|NCT02365649|75784061|FG003|NOT COMPLETED|Double-Blind Extension (Weeks 16-52)||0||
59664772|NCT02365649|75784062|FG004|NOT COMPLETED|Double-Blind Extension (Weeks 16-52)||0||
59664773|NCT02365649|75784063|FG005|NOT COMPLETED|Double-Blind Extension (Weeks 16-52)||0||
59664774|NCT02365649|75784064|FG006|NOT COMPLETED|Double-Blind Extension (Weeks 16-52)||18||
59664775|NCT02365649|75784065|FG007|NOT COMPLETED|Double-Blind Extension (Weeks 16-52)||2||
59664776|NCT02365649|75784066|FG008|NOT COMPLETED|Double-Blind Extension (Weeks 16-52)||16||
59664777|NCT02365649|75784067|FG009|NOT COMPLETED|Double-Blind Extension (Weeks 16-52)||15||
59664778|NCT02110225|75784109|FG000|STARTED|Overall Study||20||
59664779|NCT02110225|75784110|FG001|STARTED|Overall Study||20||
59664780|NCT02110225|75784111|FG002|STARTED|Overall Study||10||
59664781|NCT02110225|75784109|FG000|COMPLETED|Overall Study||20||
59664782|NCT02110225|75784110|FG001|COMPLETED|Overall Study||19||
59664783|NCT02110225|75784111|FG002|COMPLETED|Overall Study||10||
59664784|NCT02110225|75784109|FG000|NOT COMPLETED|Overall Study||0||
59664785|NCT02110225|75784110|FG001|NOT COMPLETED|Overall Study||1||
59664786|NCT02110225|75784111|FG002|NOT COMPLETED|Overall Study||0||
59664787|NCT02016820|75784122|FG000|STARTED|Overall Study||3||
59664788|NCT02016820|75784123|FG001|STARTED|Overall Study||4||
59664789|NCT02016820|75784122|FG000|COMPLETED|Overall Study||1||
59664790|NCT02016820|75784123|FG001|COMPLETED|Overall Study||0||
59664791|NCT02016820|75784122|FG000|NOT COMPLETED|Overall Study||2||
59664792|NCT02016820|75784123|FG001|NOT COMPLETED|Overall Study||4||
59664793|NCT01902173|75784135|FG000|STARTED|Phase 1 Doublet Regimen Cohort 1||3||
59664794|NCT01902173|75784136|FG001|STARTED|Phase 1 Doublet Regimen Cohort 1||0||
59664795|NCT01902173|75784137|FG002|STARTED|Phase 1 Doublet Regimen Cohort 1||0||
59664796|NCT01902173|75784138|FG003|STARTED|Phase 1 Doublet Regimen Cohort 1||0||
59664797|NCT01902173|75784139|FG004|STARTED|Phase 1 Doublet Regimen Cohort 1||0||
59664798|NCT01902173|75784140|FG005|STARTED|Phase 1 Doublet Regimen Cohort 1||0||
59664799|NCT01902173|75784135|FG000|COMPLETED|Phase 1 Doublet Regimen Cohort 1||0||
59664800|NCT01902173|75784136|FG001|COMPLETED|Phase 1 Doublet Regimen Cohort 1||0||
59664801|NCT01902173|75784137|FG002|COMPLETED|Phase 1 Doublet Regimen Cohort 1||0||
59664802|NCT01902173|75784138|FG003|COMPLETED|Phase 1 Doublet Regimen Cohort 1||0||
59664803|NCT01902173|75784139|FG004|COMPLETED|Phase 1 Doublet Regimen Cohort 1||0||
59664804|NCT01902173|75784140|FG005|COMPLETED|Phase 1 Doublet Regimen Cohort 1||0||
59664805|NCT01902173|75784135|FG000|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 1||3||
59664806|NCT01902173|75784136|FG001|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 1||0||
59664807|NCT01902173|75784137|FG002|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 1||0||
59664808|NCT01902173|75784138|FG003|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 1||0||
59664809|NCT01902173|75784139|FG004|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 1||0||
59664810|NCT01902173|75784140|FG005|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 1||0||
59664811|NCT01902173|75784135|FG000|STARTED|Phase 1 Doublet Regimen Cohort 2||0||
59664812|NCT01902173|75784136|FG001|STARTED|Phase 1 Doublet Regimen Cohort 2||9||
59664813|NCT01902173|75784137|FG002|STARTED|Phase 1 Doublet Regimen Cohort 2||0||
59664814|NCT01902173|75784138|FG003|STARTED|Phase 1 Doublet Regimen Cohort 2||0||
59664815|NCT01902173|75784139|FG004|STARTED|Phase 1 Doublet Regimen Cohort 2||0||
59664816|NCT01902173|75784140|FG005|STARTED|Phase 1 Doublet Regimen Cohort 2||0||
59664817|NCT01902173|75784135|FG000|COMPLETED|Phase 1 Doublet Regimen Cohort 2||0||
59664818|NCT01902173|75784136|FG001|COMPLETED|Phase 1 Doublet Regimen Cohort 2||0||
59664819|NCT01902173|75784137|FG002|COMPLETED|Phase 1 Doublet Regimen Cohort 2||0||
59664820|NCT01902173|75784138|FG003|COMPLETED|Phase 1 Doublet Regimen Cohort 2||0||
59664821|NCT01902173|75784139|FG004|COMPLETED|Phase 1 Doublet Regimen Cohort 2||0||
59664822|NCT01902173|75784140|FG005|COMPLETED|Phase 1 Doublet Regimen Cohort 2||0||
59664823|NCT01902173|75784135|FG000|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 2||0||
59664824|NCT01902173|75784136|FG001|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 2||9||
59664825|NCT01902173|75784137|FG002|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 2||0||
59664826|NCT01902173|75784138|FG003|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 2||0||
59664827|NCT01902173|75784139|FG004|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 2||0||
59664828|NCT01902173|75784140|FG005|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 2||0||
59664829|NCT01902173|75784135|FG000|STARTED|Phase 1 Triplet Regimen Cohort 1||0||
59664830|NCT01902173|75784136|FG001|STARTED|Phase 1 Triplet Regimen Cohort 1||0||
59664831|NCT01902173|75784137|FG002|STARTED|Phase 1 Triplet Regimen Cohort 1||4||
59664832|NCT01902173|75784138|FG003|STARTED|Phase 1 Triplet Regimen Cohort 1||0||
59664833|NCT01902173|75784139|FG004|STARTED|Phase 1 Triplet Regimen Cohort 1||0||
59664834|NCT01902173|75784140|FG005|STARTED|Phase 1 Triplet Regimen Cohort 1||0||
59664835|NCT01902173|75784135|FG000|COMPLETED|Phase 1 Triplet Regimen Cohort 1||0||
59664836|NCT01902173|75784136|FG001|COMPLETED|Phase 1 Triplet Regimen Cohort 1||0||
59664837|NCT01902173|75784137|FG002|COMPLETED|Phase 1 Triplet Regimen Cohort 1||0||
59664838|NCT01902173|75784138|FG003|COMPLETED|Phase 1 Triplet Regimen Cohort 1||0||
60077306|NCT01513239|76192323|FG004|NOT COMPLETED|Period 2: 9 Month Extension Phase||10||
60077307|NCT01513239|76192324|FG005|NOT COMPLETED|Period 2: 9 Month Extension Phase||5||
60077308|NCT01544127|76192339|FG000|STARTED|Overall Study||33||
59664839|NCT01902173|75784139|FG004|COMPLETED|Phase 1 Triplet Regimen Cohort 1||0||
59664840|NCT01902173|75784140|FG005|COMPLETED|Phase 1 Triplet Regimen Cohort 1||0||
59664841|NCT01902173|75784135|FG000|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 1||0||
59664842|NCT01902173|75784136|FG001|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 1||0||
59664843|NCT01902173|75784137|FG002|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 1||4||
59664844|NCT01902173|75784138|FG003|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 1||0||
59664845|NCT01902173|75784139|FG004|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 1||0||
59664846|NCT01902173|75784140|FG005|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 1||0||
59664847|NCT01902173|75784135|FG000|STARTED|Phase 1 Triplet Regimen Cohort 2||0||
59664848|NCT01902173|75784136|FG001|STARTED|Phase 1 Triplet Regimen Cohort 2||0||
59664849|NCT01902173|75784137|FG002|STARTED|Phase 1 Triplet Regimen Cohort 2||0||
59664850|NCT01902173|75784138|FG003|STARTED|Phase 1 Triplet Regimen Cohort 2||3||
59989000|NCT02356588|76104272|FG001|STARTED|Overall Study||54||
59664851|NCT01902173|75784139|FG004|STARTED|Phase 1 Triplet Regimen Cohort 2||0||
59664852|NCT01902173|75784140|FG005|STARTED|Phase 1 Triplet Regimen Cohort 2||0||
59664853|NCT01902173|75784135|FG000|COMPLETED|Phase 1 Triplet Regimen Cohort 2||0||
59664854|NCT01902173|75784136|FG001|COMPLETED|Phase 1 Triplet Regimen Cohort 2||0||
59664855|NCT01902173|75784137|FG002|COMPLETED|Phase 1 Triplet Regimen Cohort 2||0||
59664856|NCT01902173|75784138|FG003|COMPLETED|Phase 1 Triplet Regimen Cohort 2||0||
59664857|NCT01902173|75784139|FG004|COMPLETED|Phase 1 Triplet Regimen Cohort 2||0||
59664858|NCT01902173|75784140|FG005|COMPLETED|Phase 1 Triplet Regimen Cohort 2||0||
59664859|NCT01902173|75784135|FG000|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 2||0||
59664860|NCT01902173|75784136|FG001|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 2||0||
59664861|NCT01902173|75784137|FG002|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 2||0||
59664862|NCT01902173|75784138|FG003|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 2||3||
59664863|NCT01902173|75784139|FG004|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 2||0||
59664864|NCT01902173|75784140|FG005|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 2||0||
59664865|NCT01902173|75784135|FG000|STARTED|Phase 1 Triplet Regimen Cohort 3||0||
59664866|NCT01902173|75784136|FG001|STARTED|Phase 1 Triplet Regimen Cohort 3||0||
59664867|NCT01902173|75784137|FG002|STARTED|Phase 1 Triplet Regimen Cohort 3||0||
59664868|NCT01902173|75784138|FG003|STARTED|Phase 1 Triplet Regimen Cohort 3||0||
59664869|NCT01902173|75784139|FG004|STARTED|Phase 1 Triplet Regimen Cohort 3||3||
59664870|NCT01902173|75784140|FG005|STARTED|Phase 1 Triplet Regimen Cohort 3||0||
59664871|NCT01902173|75784135|FG000|COMPLETED|Phase 1 Triplet Regimen Cohort 3||0||
59664872|NCT01902173|75784136|FG001|COMPLETED|Phase 1 Triplet Regimen Cohort 3||0||
59664873|NCT01902173|75784137|FG002|COMPLETED|Phase 1 Triplet Regimen Cohort 3||0||
59664874|NCT01902173|75784138|FG003|COMPLETED|Phase 1 Triplet Regimen Cohort 3||0||
59664875|NCT01902173|75784139|FG004|COMPLETED|Phase 1 Triplet Regimen Cohort 3||0||
59664876|NCT01902173|75784140|FG005|COMPLETED|Phase 1 Triplet Regimen Cohort 3||0||
59664877|NCT01902173|75784135|FG000|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 3||0||
59664878|NCT01902173|75784136|FG001|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 3||0||
59664879|NCT01902173|75784137|FG002|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 3||0||
59664880|NCT01902173|75784138|FG003|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 3||0||
59664881|NCT01902173|75784139|FG004|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 3||3||
59664882|NCT01902173|75784140|FG005|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 3||0||
59664883|NCT01902173|75784135|FG000|STARTED|Phase 1 Triplet Regimen Cohort 4||0||
59664884|NCT01902173|75784136|FG001|STARTED|Phase 1 Triplet Regimen Cohort 4||0||
59664885|NCT01902173|75784137|FG002|STARTED|Phase 1 Triplet Regimen Cohort 4||0||
59664886|NCT01902173|75784138|FG003|STARTED|Phase 1 Triplet Regimen Cohort 4||0||
59664887|NCT01902173|75784139|FG004|STARTED|Phase 1 Triplet Regimen Cohort 4||0||
59664888|NCT01902173|75784140|FG005|STARTED|Phase 1 Triplet Regimen Cohort 4||5||
59664889|NCT01902173|75784135|FG000|COMPLETED|Phase 1 Triplet Regimen Cohort 4||0||
59664890|NCT01902173|75784136|FG001|COMPLETED|Phase 1 Triplet Regimen Cohort 4||0||
59664891|NCT01902173|75784137|FG002|COMPLETED|Phase 1 Triplet Regimen Cohort 4||0||
59664892|NCT01902173|75784138|FG003|COMPLETED|Phase 1 Triplet Regimen Cohort 4||0||
59664893|NCT01902173|75784139|FG004|COMPLETED|Phase 1 Triplet Regimen Cohort 4||0||
59664894|NCT01902173|75784140|FG005|COMPLETED|Phase 1 Triplet Regimen Cohort 4||0||
59664895|NCT01902173|75784135|FG000|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 4||0||
59664896|NCT01902173|75784136|FG001|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 4||0||
59664897|NCT01902173|75784137|FG002|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 4||0||
59664898|NCT01902173|75784138|FG003|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 4||0||
59664899|NCT01902173|75784139|FG004|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 4||0||
59664900|NCT01902173|75784140|FG005|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 4||5||
59664901|NCT01902173|75784135|FG000|STARTED|Phase II||0||
59664902|NCT01902173|75784136|FG001|STARTED|Phase II||0||
59664903|NCT01902173|75784137|FG002|STARTED|Phase II||0||
59664904|NCT01902173|75784138|FG003|STARTED|Phase II||0||
59664905|NCT01902173|75784139|FG004|STARTED|Phase II||0||
59664906|NCT01902173|75784140|FG005|STARTED|Phase II||0||
59664907|NCT01902173|75784135|FG000|COMPLETED|Phase II||0||
59664908|NCT01902173|75784136|FG001|COMPLETED|Phase II||0||
59664909|NCT01902173|75784137|FG002|COMPLETED|Phase II||0||
59664910|NCT01902173|75784138|FG003|COMPLETED|Phase II||0||
59664911|NCT01902173|75784139|FG004|COMPLETED|Phase II||0||
59664912|NCT01902173|75784140|FG005|COMPLETED|Phase II||0||
59664913|NCT01902173|75784135|FG000|NOT COMPLETED|Phase II||0||
59664914|NCT01902173|75784136|FG001|NOT COMPLETED|Phase II||0||
59664915|NCT01902173|75784137|FG002|NOT COMPLETED|Phase II||0||
59664916|NCT01902173|75784138|FG003|NOT COMPLETED|Phase II||0||
59664917|NCT01902173|75784139|FG004|NOT COMPLETED|Phase II||0||
59664918|NCT01902173|75784140|FG005|NOT COMPLETED|Phase II||0||
59664927|NCT01815957|75784167|FG000|STARTED|Overall Study||7||
59664928|NCT01815957|75784167|FG000|COMPLETED|Overall Study||0||
59664929|NCT01815957|75784167|FG000|NOT COMPLETED|Overall Study||7||
59664930|NCT01805297|75784174|FG000|STARTED|Overall Study||6||
59664931|NCT01805297|75784175|FG001|STARTED|Overall Study||6||
59664932|NCT01805297|75784174|FG000|COMPLETED|Overall Study||4||
59664933|NCT01805297|75784175|FG001|COMPLETED|Overall Study||3||
59664934|NCT01805297|75784174|FG000|NOT COMPLETED|Overall Study||2||
59664935|NCT01805297|75784175|FG001|NOT COMPLETED|Overall Study||3||
59664936|NCT01756456|75784188|FG000|STARTED|Treatment Period: Phase I/II||7||
59664937|NCT01756456|75784189|FG001|STARTED|Treatment Period: Phase I/II||7||
59664938|NCT01756456|75784190|FG002|STARTED|Treatment Period: Phase I/II||4||
59664939|NCT01756456|75784191|FG003|STARTED|Treatment Period: Phase I/II||52||
59664940|NCT01756456|75784192|FG004|STARTED|Treatment Period: Phase I/II||52||
59664941|NCT01756456|75784193|FG005|STARTED|Treatment Period: Phase I/II||52||
59664942|NCT01756456|75784188|FG000|COMPLETED|Treatment Period: Phase I/II||6||
59664943|NCT01756456|75784189|FG001|COMPLETED|Treatment Period: Phase I/II||6||
59664944|NCT01756456|75784190|FG002|COMPLETED|Treatment Period: Phase I/II||2||
59664945|NCT01756456|75784191|FG003|COMPLETED|Treatment Period: Phase I/II||45||
59664946|NCT01756456|75784192|FG004|COMPLETED|Treatment Period: Phase I/II||39||
59664947|NCT01756456|75784193|FG005|COMPLETED|Treatment Period: Phase I/II||48||
59664948|NCT01756456|75784188|FG000|NOT COMPLETED|Treatment Period: Phase I/II||1||
59664949|NCT01756456|75784189|FG001|NOT COMPLETED|Treatment Period: Phase I/II||1||
59664950|NCT01756456|75784190|FG002|NOT COMPLETED|Treatment Period: Phase I/II||2||
59664951|NCT01756456|75784191|FG003|NOT COMPLETED|Treatment Period: Phase I/II||7||
59664952|NCT01756456|75784192|FG004|NOT COMPLETED|Treatment Period: Phase I/II||13||
59664953|NCT01756456|75784193|FG005|NOT COMPLETED|Treatment Period: Phase I/II||4||
59664954|NCT01756456|75784188|FG000|STARTED|Follow Up Period Phase I/II||6||
59664955|NCT01756456|75784189|FG001|STARTED|Follow Up Period Phase I/II||6||
59664956|NCT01756456|75784190|FG002|STARTED|Follow Up Period Phase I/II||2||
59664957|NCT01756456|75784191|FG003|STARTED|Follow Up Period Phase I/II||45||
59664958|NCT01756456|75784192|FG004|STARTED|Follow Up Period Phase I/II||39||
59664959|NCT01756456|75784193|FG005|STARTED|Follow Up Period Phase I/II||48||
59664960|NCT01756456|75784188|FG000|COMPLETED|Follow Up Period Phase I/II||5||
59664961|NCT01756456|75784189|FG001|COMPLETED|Follow Up Period Phase I/II||5||
59664962|NCT01756456|75784190|FG002|COMPLETED|Follow Up Period Phase I/II||1||
59664963|NCT01756456|75784191|FG003|COMPLETED|Follow Up Period Phase I/II||12||
59664964|NCT01756456|75784192|FG004|COMPLETED|Follow Up Period Phase I/II||13||
59664965|NCT01756456|75784193|FG005|COMPLETED|Follow Up Period Phase I/II||15||
59989001|NCT02356588|76104271|FG000|COMPLETED|Overall Study||102||
59664966|NCT01756456|75784188|FG000|NOT COMPLETED|Follow Up Period Phase I/II||1||
59664967|NCT01756456|75784189|FG001|NOT COMPLETED|Follow Up Period Phase I/II||1||
59664968|NCT01756456|75784190|FG002|NOT COMPLETED|Follow Up Period Phase I/II||1||
59664969|NCT01756456|75784191|FG003|NOT COMPLETED|Follow Up Period Phase I/II||33||
59664970|NCT01756456|75784192|FG004|NOT COMPLETED|Follow Up Period Phase I/II||26||
59664971|NCT01756456|75784193|FG005|NOT COMPLETED|Follow Up Period Phase I/II||33||
59664972|NCT01744704|75784227|FG000|STARTED|Overall Study||3||
59664973|NCT01744704|75784228|FG001|STARTED|Overall Study||3||
59664974|NCT01744704|75784229|FG002|STARTED|Overall Study||3||
59664975|NCT01744704|75784230|FG003|STARTED|Overall Study||6||
59664976|NCT01744704|75784231|FG004|STARTED|Overall Study||6||
59664977|NCT01744704|75784232|FG005|STARTED|Overall Study||7||
59664978|NCT01744704|75784233|FG006|STARTED|Overall Study||6||
59664979|NCT01744704|75784234|FG007|STARTED|Overall Study||9||
59664980|NCT01744704|75784235|FG008|STARTED|Overall Study||3||
59664981|NCT01744704|75784236|FG009|STARTED|Overall Study||9||
59664982|NCT01744704|75784237|FG010|STARTED|Overall Study||9||
59664983|NCT01744704|75784238|FG011|STARTED|Overall Study||10||
59664984|NCT01744704|75784227|FG000|COMPLETED|Overall Study||3||
59664985|NCT01744704|75784228|FG001|COMPLETED|Overall Study||3||
59664986|NCT01744704|75784229|FG002|COMPLETED|Overall Study||3||
59664987|NCT01744704|75784230|FG003|COMPLETED|Overall Study||6||
59664988|NCT01744704|75784231|FG004|COMPLETED|Overall Study||6||
59664989|NCT01744704|75784232|FG005|COMPLETED|Overall Study||7||
59664990|NCT01744704|75784233|FG006|COMPLETED|Overall Study||6||
59664991|NCT01744704|75784234|FG007|COMPLETED|Overall Study||9||
59664992|NCT01744704|75784235|FG008|COMPLETED|Overall Study||3||
59664993|NCT01744704|75784236|FG009|COMPLETED|Overall Study||9||
59664994|NCT01744704|75784237|FG010|COMPLETED|Overall Study||9||
59664995|NCT01744704|75784238|FG011|COMPLETED|Overall Study||10||
59664996|NCT01744704|75784227|FG000|NOT COMPLETED|Overall Study||0||
59664997|NCT01744704|75784228|FG001|NOT COMPLETED|Overall Study||0||
59664998|NCT01744704|75784229|FG002|NOT COMPLETED|Overall Study||0||
59664999|NCT01744704|75784230|FG003|NOT COMPLETED|Overall Study||0||
59665000|NCT01744704|75784231|FG004|NOT COMPLETED|Overall Study||0||
59665001|NCT01744704|75784232|FG005|NOT COMPLETED|Overall Study||0||
59665002|NCT01744704|75784233|FG006|NOT COMPLETED|Overall Study||0||
59665003|NCT01744704|75784234|FG007|NOT COMPLETED|Overall Study||0||
59665004|NCT01744704|75784235|FG008|NOT COMPLETED|Overall Study||0||
59665005|NCT01744704|75784236|FG009|NOT COMPLETED|Overall Study||0||
59665006|NCT01744704|75784237|FG010|NOT COMPLETED|Overall Study||0||
59665007|NCT01744704|75784238|FG011|NOT COMPLETED|Overall Study||0||
59665008|NCT01734512|75784265|FG000|STARTED|Overall Study||65||
59665009|NCT01734512|75784265|FG000|COMPLETED|Overall Study||65||
59665010|NCT01734512|75784265|FG000|NOT COMPLETED|Overall Study||0||
59665011|NCT01477333|75784269|FG000|STARTED|Overall Study||18||
59665012|NCT01477333|75784269|FG000|COMPLETED|Overall Study||15||
59665013|NCT01477333|75784269|FG000|NOT COMPLETED|Overall Study||3||
59665014|NCT01336803|75784277|FG000|STARTED|Overall Study||21||
59665015|NCT01336803|75784277|FG000|Bone Sarcoma|Overall Study||10||
59665016|NCT01336803|75784277|FG000|Osteomyelitis|Overall Study||4||
59665017|NCT01336803|75784277|FG000|Lymphoma|Overall Study||7||
59665018|NCT01336803|75784277|FG000|COMPLETED|Overall Study||21||
59665019|NCT01336803|75784277|FG000|NOT COMPLETED|Overall Study||0||
59665020|NCT01262625|75784291|FG000|STARTED|Overall Study||518||
59665021|NCT01262625|75784292|FG001|STARTED|Overall Study||532||
59665022|NCT01262625|75784291|FG000|Scan Available|Overall Study||475||
59665023|NCT01262625|75784292|FG001|Scan Available|Overall Study||465||
59665024|NCT01262625|75784291|FG000|Uninterpretable Scan|Overall Study||6||
59665025|NCT01262625|75784292|FG001|Uninterpretable Scan|Overall Study||4||
59665026|NCT01262625|75784291|FG000|COMPLETED|Overall Study||516||
59665027|NCT01262625|75784292|FG001|COMPLETED|Overall Study||531||
59665028|NCT01262625|75784291|FG000|NOT COMPLETED|Overall Study||2||
59665029|NCT01262625|75784292|FG001|NOT COMPLETED|Overall Study||1||
59665030|NCT01206465|75784306|FG000|STARTED|Overall Study||3||
59665031|NCT01206465|75784307|FG001|STARTED|Overall Study||6||
59665032|NCT01206465|75784308|FG002|STARTED|Overall Study||6||
59665033|NCT01206465|75784309|FG003|STARTED|Overall Study||6||
59665034|NCT01206465|75784310|FG004|STARTED|Overall Study||6||
59665035|NCT01206465|75784306|FG000|COMPLETED|Overall Study||3||
59665036|NCT01206465|75784307|FG001|COMPLETED|Overall Study||6||
59665037|NCT01206465|75784308|FG002|COMPLETED|Overall Study||6||
59665038|NCT01206465|75784309|FG003|COMPLETED|Overall Study||6||
59665039|NCT01206465|75784310|FG004|COMPLETED|Overall Study||6||
59665040|NCT01206465|75784306|FG000|NOT COMPLETED|Overall Study||0||
59665041|NCT01206465|75784307|FG001|NOT COMPLETED|Overall Study||0||
59665042|NCT01206465|75784308|FG002|NOT COMPLETED|Overall Study||0||
59665043|NCT01206465|75784309|FG003|NOT COMPLETED|Overall Study||0||
59665044|NCT01206465|75784310|FG004|NOT COMPLETED|Overall Study||0||
59665045|NCT01116648|75784341|FG000|STARTED|Phase 1 Dose Level 0||3||
59665046|NCT01116648|75784342|FG001|STARTED|Phase 1 Dose Level 0||0||
59665047|NCT01116648|75784343|FG002|STARTED|Phase 1 Dose Level 0||0||
59665048|NCT01116648|75784344|FG003|STARTED|Phase 1 Dose Level 0||0||
59665049|NCT01116648|75784345|FG004|STARTED|Phase 1 Dose Level 0||0||
59665050|NCT01116648|75784346|FG005|STARTED|Phase 1 Dose Level 0||0||
59665051|NCT01116648|75784347|FG006|STARTED|Phase 1 Dose Level 0||0||
59665052|NCT01116648|75784348|FG007|STARTED|Phase 1 Dose Level 0||0||
59665053|NCT01116648|75784349|FG008|STARTED|Phase 1 Dose Level 0||0||
59665054|NCT01116648|75784350|FG009|STARTED|Phase 1 Dose Level 0||0||
59665055|NCT01116648|75784351|FG010|STARTED|Phase 1 Dose Level 0||0||
59665056|NCT01116648|75784352|FG011|STARTED|Phase 1 Dose Level 0||0||
59665057|NCT01116648|75784353|FG012|STARTED|Phase 1 Dose Level 0||0||
59665058|NCT01116648|75784354|FG013|STARTED|Phase 1 Dose Level 0||0||
59665059|NCT01116648|75784355|FG014|STARTED|Phase 1 Dose Level 0||0||
59665060|NCT01116648|75784341|FG000|COMPLETED|Phase 1 Dose Level 0||3||
59665061|NCT01116648|75784342|FG001|COMPLETED|Phase 1 Dose Level 0||0||
59665062|NCT01116648|75784343|FG002|COMPLETED|Phase 1 Dose Level 0||0||
59665063|NCT01116648|75784344|FG003|COMPLETED|Phase 1 Dose Level 0||0||
59665064|NCT01116648|75784345|FG004|COMPLETED|Phase 1 Dose Level 0||0||
59665065|NCT01116648|75784346|FG005|COMPLETED|Phase 1 Dose Level 0||0||
59665066|NCT01116648|75784347|FG006|COMPLETED|Phase 1 Dose Level 0||0||
59665067|NCT01116648|75784348|FG007|COMPLETED|Phase 1 Dose Level 0||0||
59665068|NCT01116648|75784349|FG008|COMPLETED|Phase 1 Dose Level 0||0||
59665069|NCT01116648|75784350|FG009|COMPLETED|Phase 1 Dose Level 0||0||
59817912|NCT04488770|75940338|FG012|NOT COMPLETED|Part 1-Cohort 2: Period 1 (Up to 5 Days)||0||
59665070|NCT01116648|75784351|FG010|COMPLETED|Phase 1 Dose Level 0||0||
59665071|NCT01116648|75784352|FG011|COMPLETED|Phase 1 Dose Level 0||0||
59665072|NCT01116648|75784353|FG012|COMPLETED|Phase 1 Dose Level 0||0||
59665073|NCT01116648|75784354|FG013|COMPLETED|Phase 1 Dose Level 0||0||
59665074|NCT01116648|75784355|FG014|COMPLETED|Phase 1 Dose Level 0||0||
59665075|NCT01116648|75784341|FG000|NOT COMPLETED|Phase 1 Dose Level 0||0||
59665076|NCT01116648|75784342|FG001|NOT COMPLETED|Phase 1 Dose Level 0||0||
59665077|NCT01116648|75784343|FG002|NOT COMPLETED|Phase 1 Dose Level 0||0||
59665078|NCT01116648|75784344|FG003|NOT COMPLETED|Phase 1 Dose Level 0||0||
59665079|NCT01116648|75784345|FG004|NOT COMPLETED|Phase 1 Dose Level 0||0||
59665080|NCT01116648|75784346|FG005|NOT COMPLETED|Phase 1 Dose Level 0||0||
59665081|NCT01116648|75784347|FG006|NOT COMPLETED|Phase 1 Dose Level 0||0||
59665082|NCT01116648|75784348|FG007|NOT COMPLETED|Phase 1 Dose Level 0||0||
59665083|NCT01116648|75784349|FG008|NOT COMPLETED|Phase 1 Dose Level 0||0||
59665084|NCT01116648|75784350|FG009|NOT COMPLETED|Phase 1 Dose Level 0||0||
59665085|NCT01116648|75784351|FG010|NOT COMPLETED|Phase 1 Dose Level 0||0||
59665086|NCT01116648|75784352|FG011|NOT COMPLETED|Phase 1 Dose Level 0||0||
59665087|NCT01116648|75784353|FG012|NOT COMPLETED|Phase 1 Dose Level 0||0||
59665088|NCT01116648|75784354|FG013|NOT COMPLETED|Phase 1 Dose Level 0||0||
59665089|NCT01116648|75784355|FG014|NOT COMPLETED|Phase 1 Dose Level 0||0||
59665090|NCT01116648|75784341|FG000|STARTED|Phase 1 Dose Level 1||0||
59665091|NCT01116648|75784342|FG001|STARTED|Phase 1 Dose Level 1||3||
59665092|NCT01116648|75784343|FG002|STARTED|Phase 1 Dose Level 1||0||
59665093|NCT01116648|75784344|FG003|STARTED|Phase 1 Dose Level 1||0||
59665094|NCT01116648|75784345|FG004|STARTED|Phase 1 Dose Level 1||0||
59665095|NCT01116648|75784346|FG005|STARTED|Phase 1 Dose Level 1||0||
59665096|NCT01116648|75784347|FG006|STARTED|Phase 1 Dose Level 1||0||
59665097|NCT01116648|75784348|FG007|STARTED|Phase 1 Dose Level 1||0||
59665098|NCT01116648|75784349|FG008|STARTED|Phase 1 Dose Level 1||0||
59665099|NCT01116648|75784350|FG009|STARTED|Phase 1 Dose Level 1||0||
59665100|NCT01116648|75784351|FG010|STARTED|Phase 1 Dose Level 1||0||
59665101|NCT01116648|75784352|FG011|STARTED|Phase 1 Dose Level 1||0||
59665102|NCT01116648|75784353|FG012|STARTED|Phase 1 Dose Level 1||0||
59665103|NCT01116648|75784354|FG013|STARTED|Phase 1 Dose Level 1||0||
59665104|NCT01116648|75784355|FG014|STARTED|Phase 1 Dose Level 1||0||
59665105|NCT01116648|75784341|FG000|COMPLETED|Phase 1 Dose Level 1||0||
59665106|NCT01116648|75784342|FG001|COMPLETED|Phase 1 Dose Level 1||3||
59665107|NCT01116648|75784343|FG002|COMPLETED|Phase 1 Dose Level 1||0||
59665108|NCT01116648|75784344|FG003|COMPLETED|Phase 1 Dose Level 1||0||
59665109|NCT01116648|75784345|FG004|COMPLETED|Phase 1 Dose Level 1||0||
59665110|NCT01116648|75784346|FG005|COMPLETED|Phase 1 Dose Level 1||0||
59665111|NCT01116648|75784347|FG006|COMPLETED|Phase 1 Dose Level 1||0||
59665112|NCT01116648|75784348|FG007|COMPLETED|Phase 1 Dose Level 1||0||
59665113|NCT01116648|75784349|FG008|COMPLETED|Phase 1 Dose Level 1||0||
59665114|NCT01116648|75784350|FG009|COMPLETED|Phase 1 Dose Level 1||0||
59665115|NCT01116648|75784351|FG010|COMPLETED|Phase 1 Dose Level 1||0||
59665116|NCT01116648|75784352|FG011|COMPLETED|Phase 1 Dose Level 1||0||
59665117|NCT01116648|75784353|FG012|COMPLETED|Phase 1 Dose Level 1||0||
59665118|NCT01116648|75784354|FG013|COMPLETED|Phase 1 Dose Level 1||0||
59665119|NCT01116648|75784355|FG014|COMPLETED|Phase 1 Dose Level 1||0||
59665120|NCT01116648|75784341|FG000|NOT COMPLETED|Phase 1 Dose Level 1||0||
59665121|NCT01116648|75784342|FG001|NOT COMPLETED|Phase 1 Dose Level 1||0||
59665122|NCT01116648|75784343|FG002|NOT COMPLETED|Phase 1 Dose Level 1||0||
59665123|NCT01116648|75784344|FG003|NOT COMPLETED|Phase 1 Dose Level 1||0||
59665124|NCT01116648|75784345|FG004|NOT COMPLETED|Phase 1 Dose Level 1||0||
59665125|NCT01116648|75784346|FG005|NOT COMPLETED|Phase 1 Dose Level 1||0||
59665126|NCT01116648|75784347|FG006|NOT COMPLETED|Phase 1 Dose Level 1||0||
59665127|NCT01116648|75784348|FG007|NOT COMPLETED|Phase 1 Dose Level 1||0||
59665128|NCT01116648|75784349|FG008|NOT COMPLETED|Phase 1 Dose Level 1||0||
59665129|NCT01116648|75784350|FG009|NOT COMPLETED|Phase 1 Dose Level 1||0||
59665130|NCT01116648|75784351|FG010|NOT COMPLETED|Phase 1 Dose Level 1||0||
59665131|NCT01116648|75784352|FG011|NOT COMPLETED|Phase 1 Dose Level 1||0||
59665132|NCT01116648|75784353|FG012|NOT COMPLETED|Phase 1 Dose Level 1||0||
59665133|NCT01116648|75784354|FG013|NOT COMPLETED|Phase 1 Dose Level 1||0||
59665134|NCT01116648|75784355|FG014|NOT COMPLETED|Phase 1 Dose Level 1||0||
59665135|NCT01116648|75784341|FG000|STARTED|Phase 1 Dose Level 2||0||
59665136|NCT01116648|75784342|FG001|STARTED|Phase 1 Dose Level 2||0||
59665137|NCT01116648|75784343|FG002|STARTED|Phase 1 Dose Level 2||7||
59665138|NCT01116648|75784344|FG003|STARTED|Phase 1 Dose Level 2||0||
59665139|NCT01116648|75784345|FG004|STARTED|Phase 1 Dose Level 2||0||
59665140|NCT01116648|75784346|FG005|STARTED|Phase 1 Dose Level 2||0||
59665141|NCT01116648|75784347|FG006|STARTED|Phase 1 Dose Level 2||0||
59665142|NCT01116648|75784348|FG007|STARTED|Phase 1 Dose Level 2||0||
59665143|NCT01116648|75784349|FG008|STARTED|Phase 1 Dose Level 2||0||
59665144|NCT01116648|75784350|FG009|STARTED|Phase 1 Dose Level 2||0||
59665145|NCT01116648|75784351|FG010|STARTED|Phase 1 Dose Level 2||0||
59665146|NCT01116648|75784352|FG011|STARTED|Phase 1 Dose Level 2||0||
59665147|NCT01116648|75784353|FG012|STARTED|Phase 1 Dose Level 2||0||
59665148|NCT01116648|75784354|FG013|STARTED|Phase 1 Dose Level 2||0||
59665149|NCT01116648|75784355|FG014|STARTED|Phase 1 Dose Level 2||0||
59665150|NCT01116648|75784341|FG000|COMPLETED|Phase 1 Dose Level 2||0||
59665151|NCT01116648|75784342|FG001|COMPLETED|Phase 1 Dose Level 2||0||
59665152|NCT01116648|75784343|FG002|COMPLETED|Phase 1 Dose Level 2||7||
59665153|NCT01116648|75784344|FG003|COMPLETED|Phase 1 Dose Level 2||0||
59665154|NCT01116648|75784345|FG004|COMPLETED|Phase 1 Dose Level 2||0||
59665155|NCT01116648|75784346|FG005|COMPLETED|Phase 1 Dose Level 2||0||
59665156|NCT01116648|75784347|FG006|COMPLETED|Phase 1 Dose Level 2||0||
59665157|NCT01116648|75784348|FG007|COMPLETED|Phase 1 Dose Level 2||0||
59665158|NCT01116648|75784349|FG008|COMPLETED|Phase 1 Dose Level 2||0||
59665159|NCT01116648|75784350|FG009|COMPLETED|Phase 1 Dose Level 2||0||
59665160|NCT01116648|75784351|FG010|COMPLETED|Phase 1 Dose Level 2||0||
59665161|NCT01116648|75784352|FG011|COMPLETED|Phase 1 Dose Level 2||0||
59665162|NCT01116648|75784353|FG012|COMPLETED|Phase 1 Dose Level 2||0||
59665163|NCT01116648|75784354|FG013|COMPLETED|Phase 1 Dose Level 2||0||
59665164|NCT01116648|75784355|FG014|COMPLETED|Phase 1 Dose Level 2||0||
59665165|NCT01116648|75784341|FG000|NOT COMPLETED|Phase 1 Dose Level 2||0||
59665166|NCT01116648|75784342|FG001|NOT COMPLETED|Phase 1 Dose Level 2||0||
59665167|NCT01116648|75784343|FG002|NOT COMPLETED|Phase 1 Dose Level 2||0||
59665168|NCT01116648|75784344|FG003|NOT COMPLETED|Phase 1 Dose Level 2||0||
59665169|NCT01116648|75784345|FG004|NOT COMPLETED|Phase 1 Dose Level 2||0||
59665170|NCT01116648|75784346|FG005|NOT COMPLETED|Phase 1 Dose Level 2||0||
59665171|NCT01116648|75784347|FG006|NOT COMPLETED|Phase 1 Dose Level 2||0||
59665172|NCT01116648|75784348|FG007|NOT COMPLETED|Phase 1 Dose Level 2||0||
59665173|NCT01116648|75784349|FG008|NOT COMPLETED|Phase 1 Dose Level 2||0||
59665174|NCT01116648|75784350|FG009|NOT COMPLETED|Phase 1 Dose Level 2||0||
59665175|NCT01116648|75784351|FG010|NOT COMPLETED|Phase 1 Dose Level 2||0||
59665176|NCT01116648|75784352|FG011|NOT COMPLETED|Phase 1 Dose Level 2||0||
59665177|NCT01116648|75784353|FG012|NOT COMPLETED|Phase 1 Dose Level 2||0||
59665178|NCT01116648|75784354|FG013|NOT COMPLETED|Phase 1 Dose Level 2||0||
59665179|NCT01116648|75784355|FG014|NOT COMPLETED|Phase 1 Dose Level 2||0||
59665180|NCT01116648|75784341|FG000|STARTED|Phase 1 Dose Level 3||0||
59665181|NCT01116648|75784342|FG001|STARTED|Phase 1 Dose Level 3||0||
59665182|NCT01116648|75784343|FG002|STARTED|Phase 1 Dose Level 3||0||
59665183|NCT01116648|75784344|FG003|STARTED|Phase 1 Dose Level 3||6||
59665184|NCT01116648|75784345|FG004|STARTED|Phase 1 Dose Level 3||0||
59665185|NCT01116648|75784346|FG005|STARTED|Phase 1 Dose Level 3||0||
59665186|NCT01116648|75784347|FG006|STARTED|Phase 1 Dose Level 3||0||
59665187|NCT01116648|75784348|FG007|STARTED|Phase 1 Dose Level 3||0||
59665188|NCT01116648|75784349|FG008|STARTED|Phase 1 Dose Level 3||0||
59665189|NCT01116648|75784350|FG009|STARTED|Phase 1 Dose Level 3||0||
59665190|NCT01116648|75784351|FG010|STARTED|Phase 1 Dose Level 3||0||
59665191|NCT01116648|75784352|FG011|STARTED|Phase 1 Dose Level 3||0||
59665192|NCT01116648|75784353|FG012|STARTED|Phase 1 Dose Level 3||0||
59665193|NCT01116648|75784354|FG013|STARTED|Phase 1 Dose Level 3||0||
59665194|NCT01116648|75784355|FG014|STARTED|Phase 1 Dose Level 3||0||
59665195|NCT01116648|75784341|FG000|COMPLETED|Phase 1 Dose Level 3||0||
59665196|NCT01116648|75784342|FG001|COMPLETED|Phase 1 Dose Level 3||0||
59665197|NCT01116648|75784343|FG002|COMPLETED|Phase 1 Dose Level 3||0||
59665198|NCT01116648|75784344|FG003|COMPLETED|Phase 1 Dose Level 3||4||
59665199|NCT01116648|75784345|FG004|COMPLETED|Phase 1 Dose Level 3||0||
59665200|NCT01116648|75784346|FG005|COMPLETED|Phase 1 Dose Level 3||0||
59665201|NCT01116648|75784347|FG006|COMPLETED|Phase 1 Dose Level 3||0||
59665202|NCT01116648|75784348|FG007|COMPLETED|Phase 1 Dose Level 3||0||
59665203|NCT01116648|75784349|FG008|COMPLETED|Phase 1 Dose Level 3||0||
59665204|NCT01116648|75784350|FG009|COMPLETED|Phase 1 Dose Level 3||0||
59665205|NCT01116648|75784351|FG010|COMPLETED|Phase 1 Dose Level 3||0||
59665206|NCT01116648|75784352|FG011|COMPLETED|Phase 1 Dose Level 3||0||
59665207|NCT01116648|75784353|FG012|COMPLETED|Phase 1 Dose Level 3||0||
59665208|NCT01116648|75784354|FG013|COMPLETED|Phase 1 Dose Level 3||0||
59665209|NCT01116648|75784355|FG014|COMPLETED|Phase 1 Dose Level 3||0||
59665210|NCT01116648|75784341|FG000|NOT COMPLETED|Phase 1 Dose Level 3||0||
59665211|NCT01116648|75784342|FG001|NOT COMPLETED|Phase 1 Dose Level 3||0||
59665212|NCT01116648|75784343|FG002|NOT COMPLETED|Phase 1 Dose Level 3||0||
59665213|NCT01116648|75784344|FG003|NOT COMPLETED|Phase 1 Dose Level 3||2||
59665214|NCT01116648|75784345|FG004|NOT COMPLETED|Phase 1 Dose Level 3||0||
59665215|NCT01116648|75784346|FG005|NOT COMPLETED|Phase 1 Dose Level 3||0||
59665216|NCT01116648|75784347|FG006|NOT COMPLETED|Phase 1 Dose Level 3||0||
59665217|NCT01116648|75784348|FG007|NOT COMPLETED|Phase 1 Dose Level 3||0||
59665218|NCT01116648|75784349|FG008|NOT COMPLETED|Phase 1 Dose Level 3||0||
59665219|NCT01116648|75784350|FG009|NOT COMPLETED|Phase 1 Dose Level 3||0||
59665220|NCT01116648|75784351|FG010|NOT COMPLETED|Phase 1 Dose Level 3||0||
59665221|NCT01116648|75784352|FG011|NOT COMPLETED|Phase 1 Dose Level 3||0||
59665222|NCT01116648|75784353|FG012|NOT COMPLETED|Phase 1 Dose Level 3||0||
59989002|NCT02356588|76104272|FG001|COMPLETED|Overall Study||41||
59665223|NCT01116648|75784354|FG013|NOT COMPLETED|Phase 1 Dose Level 3||0||
59665224|NCT01116648|75784355|FG014|NOT COMPLETED|Phase 1 Dose Level 3||0||
59665225|NCT01116648|75784341|FG000|STARTED|Expansion at Maximum Tolerated Dose||0||
59665226|NCT01116648|75784342|FG001|STARTED|Expansion at Maximum Tolerated Dose||0||
59665227|NCT01116648|75784343|FG002|STARTED|Expansion at Maximum Tolerated Dose||0||
59665228|NCT01116648|75784344|FG003|STARTED|Expansion at Maximum Tolerated Dose||0||
59665229|NCT01116648|75784345|FG004|STARTED|Expansion at Maximum Tolerated Dose||9||
59665230|NCT01116648|75784346|FG005|STARTED|Expansion at Maximum Tolerated Dose||0||
59665231|NCT01116648|75784347|FG006|STARTED|Expansion at Maximum Tolerated Dose||0||
59665232|NCT01116648|75784348|FG007|STARTED|Expansion at Maximum Tolerated Dose||0||
59665233|NCT01116648|75784349|FG008|STARTED|Expansion at Maximum Tolerated Dose||0||
59665234|NCT01116648|75784350|FG009|STARTED|Expansion at Maximum Tolerated Dose||0||
59665235|NCT01116648|75784351|FG010|STARTED|Expansion at Maximum Tolerated Dose||0||
59665236|NCT01116648|75784352|FG011|STARTED|Expansion at Maximum Tolerated Dose||0||
59665237|NCT01116648|75784353|FG012|STARTED|Expansion at Maximum Tolerated Dose||0||
59665238|NCT01116648|75784354|FG013|STARTED|Expansion at Maximum Tolerated Dose||0||
59665239|NCT01116648|75784355|FG014|STARTED|Expansion at Maximum Tolerated Dose||0||
59665240|NCT01116648|75784341|FG000|COMPLETED|Expansion at Maximum Tolerated Dose||0||
59665241|NCT01116648|75784342|FG001|COMPLETED|Expansion at Maximum Tolerated Dose||0||
59665242|NCT01116648|75784343|FG002|COMPLETED|Expansion at Maximum Tolerated Dose||0||
59665243|NCT01116648|75784344|FG003|COMPLETED|Expansion at Maximum Tolerated Dose||0||
59665244|NCT01116648|75784345|FG004|COMPLETED|Expansion at Maximum Tolerated Dose||9||
59665245|NCT01116648|75784346|FG005|COMPLETED|Expansion at Maximum Tolerated Dose||0||
59665246|NCT01116648|75784347|FG006|COMPLETED|Expansion at Maximum Tolerated Dose||0||
59665247|NCT01116648|75784348|FG007|COMPLETED|Expansion at Maximum Tolerated Dose||0||
59665248|NCT01116648|75784349|FG008|COMPLETED|Expansion at Maximum Tolerated Dose||0||
59665249|NCT01116648|75784350|FG009|COMPLETED|Expansion at Maximum Tolerated Dose||0||
59665250|NCT01116648|75784351|FG010|COMPLETED|Expansion at Maximum Tolerated Dose||0||
59665251|NCT01116648|75784352|FG011|COMPLETED|Expansion at Maximum Tolerated Dose||0||
59665252|NCT01116648|75784353|FG012|COMPLETED|Expansion at Maximum Tolerated Dose||0||
59665253|NCT01116648|75784354|FG013|COMPLETED|Expansion at Maximum Tolerated Dose||0||
59665254|NCT01116648|75784355|FG014|COMPLETED|Expansion at Maximum Tolerated Dose||0||
59665255|NCT01116648|75784341|FG000|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0||
59665256|NCT01116648|75784342|FG001|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0||
59665257|NCT01116648|75784343|FG002|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0||
59665258|NCT01116648|75784344|FG003|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0||
59665259|NCT01116648|75784345|FG004|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0||
59665260|NCT01116648|75784346|FG005|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0||
59665261|NCT01116648|75784347|FG006|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0||
59665262|NCT01116648|75784348|FG007|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0||
59665263|NCT01116648|75784349|FG008|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0||
59665264|NCT01116648|75784350|FG009|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0||
59665265|NCT01116648|75784351|FG010|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0||
59665266|NCT01116648|75784352|FG011|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0||
59665267|NCT01116648|75784353|FG012|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0||
59665268|NCT01116648|75784354|FG013|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0||
59665269|NCT01116648|75784355|FG014|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0||
59665270|NCT01116648|75784341|FG000|STARTED|Phase 2||0||
59665271|NCT01116648|75784342|FG001|STARTED|Phase 2||0||
59665272|NCT01116648|75784343|FG002|STARTED|Phase 2||0||
59665273|NCT01116648|75784344|FG003|STARTED|Phase 2||0||
59665274|NCT01116648|75784345|FG004|STARTED|Phase 2||0||
60077309|NCT01544127|76192340|FG001|STARTED|Overall Study||33||
60077310|NCT01544127|76192341|FG002|STARTED|Overall Study||66||
60077311|NCT01544127|76192339|FG000|COMPLETED|Overall Study||22||
59665275|NCT01116648|75784346|FG005|STARTED|Phase 2||46||
59665276|NCT01116648|75784347|FG006|STARTED|Phase 2||44||
59665277|NCT01116648|75784348|FG007|STARTED|Phase 2||0||
59665278|NCT01116648|75784349|FG008|STARTED|Phase 2||0||
59665279|NCT01116648|75784350|FG009|STARTED|Phase 2||0||
59665280|NCT01116648|75784351|FG010|STARTED|Phase 2||0||
59665281|NCT01116648|75784352|FG011|STARTED|Phase 2||0||
59665282|NCT01116648|75784353|FG012|STARTED|Phase 2||0||
59665283|NCT01116648|75784354|FG013|STARTED|Phase 2||0||
59665284|NCT01116648|75784355|FG014|STARTED|Phase 2||0||
59665285|NCT01116648|75784341|FG000|COMPLETED|Phase 2||0||
59665286|NCT01116648|75784342|FG001|COMPLETED|Phase 2||0||
59665287|NCT01116648|75784343|FG002|COMPLETED|Phase 2||0||
60077312|NCT01544127|76192340|FG001|COMPLETED|Overall Study||27||
60077313|NCT01544127|76192341|FG002|COMPLETED|Overall Study||52||
60077314|NCT01544127|76192339|FG000|NOT COMPLETED|Overall Study||11||
60077315|NCT01544127|76192340|FG001|NOT COMPLETED|Overall Study||6||
60077316|NCT01544127|76192341|FG002|NOT COMPLETED|Overall Study||14||
60077317|NCT01512693|76192352|FG000|STARTED|Overall Study||8||
60077318|NCT01512693|76192353|FG001|STARTED|Overall Study||9||
60077319|NCT01512693|76192352|FG000|COMPLETED|Overall Study||8||
60077320|NCT01512693|76192353|FG001|COMPLETED|Overall Study||8||
60077321|NCT01512693|76192352|FG000|NOT COMPLETED|Overall Study||0||
60077322|NCT01512693|76192353|FG001|NOT COMPLETED|Overall Study||1||
59665288|NCT01116648|75784344|FG003|COMPLETED|Phase 2||0||
59665289|NCT01116648|75784345|FG004|COMPLETED|Phase 2||0||
59665290|NCT01116648|75784346|FG005|COMPLETED|Phase 2||46||
59665291|NCT01116648|75784347|FG006|COMPLETED|Phase 2||44||
59665292|NCT01116648|75784348|FG007|COMPLETED|Phase 2||0||
59665293|NCT01116648|75784349|FG008|COMPLETED|Phase 2||0||
59665294|NCT01116648|75784350|FG009|COMPLETED|Phase 2||0||
59665295|NCT01116648|75784351|FG010|COMPLETED|Phase 2||0||
60077323|NCT01458340|76192362|FG000|STARTED|Overall Study||97|Intent-to-treat (ITT) population|
59665296|NCT01116648|75784352|FG011|COMPLETED|Phase 2||0||
59665297|NCT01116648|75784353|FG012|COMPLETED|Phase 2||0||
59665298|NCT01116648|75784354|FG013|COMPLETED|Phase 2||0||
59665299|NCT01116648|75784355|FG014|COMPLETED|Phase 2||0||
59665300|NCT01116648|75784341|FG000|NOT COMPLETED|Phase 2||0||
59665301|NCT01116648|75784342|FG001|NOT COMPLETED|Phase 2||0||
59665302|NCT01116648|75784343|FG002|NOT COMPLETED|Phase 2||0||
59665303|NCT01116648|75784344|FG003|NOT COMPLETED|Phase 2||0||
59665304|NCT01116648|75784345|FG004|NOT COMPLETED|Phase 2||0||
59665305|NCT01116648|75784346|FG005|NOT COMPLETED|Phase 2||0||
59665306|NCT01116648|75784347|FG006|NOT COMPLETED|Phase 2||0||
59665307|NCT01116648|75784348|FG007|NOT COMPLETED|Phase 2||0||
59665308|NCT01116648|75784349|FG008|NOT COMPLETED|Phase 2||0||
59665309|NCT01116648|75784350|FG009|NOT COMPLETED|Phase 2||0||
59665310|NCT01116648|75784351|FG010|NOT COMPLETED|Phase 2||0||
59665311|NCT01116648|75784352|FG011|NOT COMPLETED|Phase 2||0||
59665312|NCT01116648|75784353|FG012|NOT COMPLETED|Phase 2||0||
59665313|NCT01116648|75784354|FG013|NOT COMPLETED|Phase 2||0||
59665314|NCT01116648|75784355|FG014|NOT COMPLETED|Phase 2||0||
59665315|NCT01116648|75784341|FG000|STARTED|Phase 1-T Dose Level 0-TA||0||
59665316|NCT01116648|75784342|FG001|STARTED|Phase 1-T Dose Level 0-TA||0||
59665317|NCT01116648|75784343|FG002|STARTED|Phase 1-T Dose Level 0-TA||0||
59665318|NCT01116648|75784344|FG003|STARTED|Phase 1-T Dose Level 0-TA||0||
59665319|NCT01116648|75784345|FG004|STARTED|Phase 1-T Dose Level 0-TA||0||
59665320|NCT01116648|75784346|FG005|STARTED|Phase 1-T Dose Level 0-TA||0||
59665321|NCT01116648|75784347|FG006|STARTED|Phase 1-T Dose Level 0-TA||0||
59665322|NCT01116648|75784348|FG007|STARTED|Phase 1-T Dose Level 0-TA||3||
59665323|NCT01116648|75784349|FG008|STARTED|Phase 1-T Dose Level 0-TA||0||
59665324|NCT01116648|75784350|FG009|STARTED|Phase 1-T Dose Level 0-TA||0||
59665325|NCT01116648|75784351|FG010|STARTED|Phase 1-T Dose Level 0-TA||0||
59665326|NCT01116648|75784352|FG011|STARTED|Phase 1-T Dose Level 0-TA||0||
59665327|NCT01116648|75784353|FG012|STARTED|Phase 1-T Dose Level 0-TA||0||
59665328|NCT01116648|75784354|FG013|STARTED|Phase 1-T Dose Level 0-TA||0||
59665329|NCT01116648|75784355|FG014|STARTED|Phase 1-T Dose Level 0-TA||0||
59665330|NCT01116648|75784341|FG000|COMPLETED|Phase 1-T Dose Level 0-TA||0||
59665331|NCT01116648|75784342|FG001|COMPLETED|Phase 1-T Dose Level 0-TA||0||
59665332|NCT01116648|75784343|FG002|COMPLETED|Phase 1-T Dose Level 0-TA||0||
59665333|NCT01116648|75784344|FG003|COMPLETED|Phase 1-T Dose Level 0-TA||0||
59665334|NCT01116648|75784345|FG004|COMPLETED|Phase 1-T Dose Level 0-TA||0||
59665335|NCT01116648|75784346|FG005|COMPLETED|Phase 1-T Dose Level 0-TA||0||
59665336|NCT01116648|75784347|FG006|COMPLETED|Phase 1-T Dose Level 0-TA||0||
59665337|NCT01116648|75784348|FG007|COMPLETED|Phase 1-T Dose Level 0-TA||3||
59665338|NCT01116648|75784349|FG008|COMPLETED|Phase 1-T Dose Level 0-TA||0||
59665339|NCT01116648|75784350|FG009|COMPLETED|Phase 1-T Dose Level 0-TA||0||
59665340|NCT01116648|75784351|FG010|COMPLETED|Phase 1-T Dose Level 0-TA||0||
59665341|NCT01116648|75784352|FG011|COMPLETED|Phase 1-T Dose Level 0-TA||0||
59665342|NCT01116648|75784353|FG012|COMPLETED|Phase 1-T Dose Level 0-TA||0||
59665343|NCT01116648|75784354|FG013|COMPLETED|Phase 1-T Dose Level 0-TA||0||
59665344|NCT01116648|75784355|FG014|COMPLETED|Phase 1-T Dose Level 0-TA||0||
59665345|NCT01116648|75784341|FG000|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0||
59665346|NCT01116648|75784342|FG001|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0||
59665347|NCT01116648|75784343|FG002|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0||
59665348|NCT01116648|75784344|FG003|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0||
59665349|NCT01116648|75784345|FG004|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0||
59665350|NCT01116648|75784346|FG005|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0||
59665351|NCT01116648|75784347|FG006|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0||
59665352|NCT01116648|75784348|FG007|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0||
59665353|NCT01116648|75784349|FG008|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0||
59665354|NCT01116648|75784350|FG009|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0||
59665355|NCT01116648|75784351|FG010|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0||
59665356|NCT01116648|75784352|FG011|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0||
59665357|NCT01116648|75784353|FG012|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0||
59665358|NCT01116648|75784354|FG013|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0||
59665359|NCT01116648|75784355|FG014|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0||
59665360|NCT01116648|75784341|FG000|STARTED|Phase 1-T Dose Level 1-TA||0||
59665361|NCT01116648|75784342|FG001|STARTED|Phase 1-T Dose Level 1-TA||0||
59665362|NCT01116648|75784343|FG002|STARTED|Phase 1-T Dose Level 1-TA||0||
59665363|NCT01116648|75784344|FG003|STARTED|Phase 1-T Dose Level 1-TA||0||
59665364|NCT01116648|75784345|FG004|STARTED|Phase 1-T Dose Level 1-TA||0||
59665365|NCT01116648|75784346|FG005|STARTED|Phase 1-T Dose Level 1-TA||0||
59665366|NCT01116648|75784347|FG006|STARTED|Phase 1-T Dose Level 1-TA||0||
59665367|NCT01116648|75784348|FG007|STARTED|Phase 1-T Dose Level 1-TA||0||
59665368|NCT01116648|75784349|FG008|STARTED|Phase 1-T Dose Level 1-TA||6||
59665369|NCT01116648|75784350|FG009|STARTED|Phase 1-T Dose Level 1-TA||0||
59665370|NCT01116648|75784351|FG010|STARTED|Phase 1-T Dose Level 1-TA||0||
59665371|NCT01116648|75784352|FG011|STARTED|Phase 1-T Dose Level 1-TA||0||
59665372|NCT01116648|75784353|FG012|STARTED|Phase 1-T Dose Level 1-TA||0||
59665373|NCT01116648|75784354|FG013|STARTED|Phase 1-T Dose Level 1-TA||0||
59665374|NCT01116648|75784355|FG014|STARTED|Phase 1-T Dose Level 1-TA||0||
59665375|NCT01116648|75784341|FG000|COMPLETED|Phase 1-T Dose Level 1-TA||0||
59989003|NCT02356588|76104271|FG000|NOT COMPLETED|Overall Study||5||
59544768|NCT00958334|75643325|FG000|NOT COMPLETED|Overall Study||14||
59544769|NCT00958334|75643326|FG001|NOT COMPLETED|Overall Study||17||
59544770|NCT00958334|75643327|FG002|NOT COMPLETED|Overall Study||13||
59544771|NCT01015976|75643335|FG000|STARTED|Overall Study||5||
59544772|NCT01015976|75643336|FG001|STARTED|Overall Study||5||
59544773|NCT01015976|75643335|FG000|COMPLETED|Overall Study||5||
59544774|NCT01015976|75643336|FG001|COMPLETED|Overall Study||5||
59544775|NCT01015976|75643335|FG000|NOT COMPLETED|Overall Study||0||
59544776|NCT01015976|75643336|FG001|NOT COMPLETED|Overall Study||0||
59544777|NCT01680887|75643342|FG000|STARTED|Overall Study||80||
59544778|NCT01680887|75643343|FG001|STARTED|Overall Study||76||
59544779|NCT01680887|75643342|FG000|COMPLETED|Overall Study||51||
59544780|NCT01680887|75643343|FG001|COMPLETED|Overall Study||52||
59544781|NCT01680887|75643342|FG000|NOT COMPLETED|Overall Study||29||
59544782|NCT01680887|75643343|FG001|NOT COMPLETED|Overall Study||24||
59544783|NCT01016678|75643349|FG000|STARTED|Overall Study||20||
59544784|NCT01016678|75643350|FG001|STARTED|Overall Study||17||
59544785|NCT01016678|75643351|FG002|STARTED|Overall Study||19||
59544786|NCT01016678|75643352|FG003|STARTED|Overall Study||19||
59544787|NCT01016678|75643353|FG004|STARTED|Overall Study||19||
59544788|NCT01016678|75643349|FG000|COMPLETED|Overall Study||18||
59544789|NCT01016678|75643350|FG001|COMPLETED|Overall Study||14||
59544790|NCT01016678|75643351|FG002|COMPLETED|Overall Study||15||
59544791|NCT01016678|75643352|FG003|COMPLETED|Overall Study||19||
59544792|NCT01016678|75643353|FG004|COMPLETED|Overall Study||13||
59544793|NCT01016678|75643349|FG000|NOT COMPLETED|Overall Study||2||
59544794|NCT01016678|75643350|FG001|NOT COMPLETED|Overall Study||3||
59544795|NCT01016678|75643351|FG002|NOT COMPLETED|Overall Study||4||
59544796|NCT01016678|75643352|FG003|NOT COMPLETED|Overall Study||0||
59544797|NCT01016678|75643353|FG004|NOT COMPLETED|Overall Study||6||
59544798|NCT02457546|75643373|FG000|STARTED|Overall Study||114||
59544799|NCT02457546|75643374|FG001|STARTED|Overall Study||120||
59544800|NCT02457546|75643373|FG000|COMPLETED|Overall Study||105||
59544801|NCT02457546|75643374|FG001|COMPLETED|Overall Study||116||
59544802|NCT02457546|75643373|FG000|NOT COMPLETED|Overall Study||9||
59544803|NCT02457546|75643374|FG001|NOT COMPLETED|Overall Study||4||
59544804|NCT01681121|75643382|FG000|STARTED|Overall Study||44||
59544805|NCT01681121|75643383|FG001|STARTED|Overall Study||49||
59544806|NCT01681121|75643382|FG000|COMPLETED|Overall Study||36||
59544807|NCT01681121|75643383|FG001|COMPLETED|Overall Study||38||
59544808|NCT01681121|75643382|FG000|NOT COMPLETED|Overall Study||8||
59544809|NCT01681121|75643383|FG001|NOT COMPLETED|Overall Study||11||
59544810|NCT01016834|75643391|FG000|STARTED|Overall Study||242||
59544811|NCT01016834|75643391|FG000|COMPLETED|Overall Study||220||
59544812|NCT01016834|75643391|FG000|NOT COMPLETED|Overall Study||22||
59544813|NCT02447952|75643395|FG000|STARTED|Overall Study||25||
59544814|NCT02447952|75643395|FG000|COMPLETED|Overall Study||18||
59544815|NCT02447952|75643395|FG000|NOT COMPLETED|Overall Study||7||
59544816|NCT00959660|75643403|FG000|STARTED|Overall Study||26||
59544817|NCT00959660|75643404|FG001|STARTED|Overall Study||24||
59544818|NCT00959660|75643405|FG002|STARTED|Overall Study||25||
59544819|NCT00959660|75643406|FG003|STARTED|Overall Study||25||
59544820|NCT00959660|75643403|FG000|COMPLETED|Overall Study||24||
59544821|NCT00959660|75643404|FG001|COMPLETED|Overall Study||24||
59544822|NCT00959660|75643405|FG002|COMPLETED|Overall Study||22||
59544823|NCT00959660|75643406|FG003|COMPLETED|Overall Study||22||
59544824|NCT00959660|75643403|FG000|NOT COMPLETED|Overall Study||2||
59544825|NCT00959660|75643404|FG001|NOT COMPLETED|Overall Study||0||
59544826|NCT00959660|75643405|FG002|NOT COMPLETED|Overall Study||3||
59544827|NCT00959660|75643406|FG003|NOT COMPLETED|Overall Study||3||
59544828|NCT00961532|75643416|FG000|STARTED|Overall Study||14||
59544829|NCT00961532|75643416|FG000|COMPLETED|Overall Study||14||
59544830|NCT00961532|75643416|FG000|NOT COMPLETED|Overall Study||0||
59544831|NCT00962000|75643420|FG000|STARTED|Period 1 - 1 Week||21||
59544832|NCT00962000|75643421|FG001|STARTED|Period 1 - 1 Week||21||
59544833|NCT00962000|75643420|FG000|COMPLETED|Period 1 - 1 Week||21||
59544834|NCT00962000|75643421|FG001|COMPLETED|Period 1 - 1 Week||21||
59544835|NCT00962000|75643420|FG000|NOT COMPLETED|Period 1 - 1 Week||0||
59544836|NCT00962000|75643421|FG001|NOT COMPLETED|Period 1 - 1 Week||0||
59544837|NCT00962000|75643420|FG000|STARTED|Period 2 - 1 Week||21||
59544838|NCT00962000|75643421|FG001|STARTED|Period 2 - 1 Week||21||
59544839|NCT00962000|75643420|FG000|COMPLETED|Period 2 - 1 Week||21||
59544840|NCT00962000|75643421|FG001|COMPLETED|Period 2 - 1 Week||21||
59544841|NCT00962000|75643420|FG000|NOT COMPLETED|Period 2 - 1 Week||0||
59544842|NCT00962000|75643421|FG001|NOT COMPLETED|Period 2 - 1 Week||0||
59544843|NCT00962000|75643420|FG000|STARTED|Period 3 - 1 Week||21||
59544844|NCT00962000|75643421|FG001|STARTED|Period 3 - 1 Week||21||
59544845|NCT00962000|75643420|FG000|COMPLETED|Period 3 - 1 Week||21||
59544846|NCT00962000|75643421|FG001|COMPLETED|Period 3 - 1 Week||21||
59544847|NCT00962000|75643420|FG000|NOT COMPLETED|Period 3 - 1 Week||0||
59544848|NCT00962000|75643421|FG001|NOT COMPLETED|Period 3 - 1 Week||0||
59544849|NCT00962000|75643420|FG000|STARTED|Period 4 - 1 Week||21||
59544850|NCT00962000|75643421|FG001|STARTED|Period 4 - 1 Week||21||
59544851|NCT00962000|75643420|FG000|COMPLETED|Period 4 - 1 Week||21||
59544852|NCT00962000|75643421|FG001|COMPLETED|Period 4 - 1 Week||21||
59665376|NCT01116648|75784342|FG001|COMPLETED|Phase 1-T Dose Level 1-TA||0||
59665377|NCT01116648|75784343|FG002|COMPLETED|Phase 1-T Dose Level 1-TA||0||
59665378|NCT01116648|75784344|FG003|COMPLETED|Phase 1-T Dose Level 1-TA||0||
59665379|NCT01116648|75784345|FG004|COMPLETED|Phase 1-T Dose Level 1-TA||0||
59665380|NCT01116648|75784346|FG005|COMPLETED|Phase 1-T Dose Level 1-TA||0||
59665381|NCT01116648|75784347|FG006|COMPLETED|Phase 1-T Dose Level 1-TA||0||
59665382|NCT01116648|75784348|FG007|COMPLETED|Phase 1-T Dose Level 1-TA||0||
59665383|NCT01116648|75784349|FG008|COMPLETED|Phase 1-T Dose Level 1-TA||6||
59665384|NCT01116648|75784350|FG009|COMPLETED|Phase 1-T Dose Level 1-TA||0||
59665385|NCT01116648|75784351|FG010|COMPLETED|Phase 1-T Dose Level 1-TA||0||
59665386|NCT01116648|75784352|FG011|COMPLETED|Phase 1-T Dose Level 1-TA||0||
59665387|NCT01116648|75784353|FG012|COMPLETED|Phase 1-T Dose Level 1-TA||0||
59665388|NCT01116648|75784354|FG013|COMPLETED|Phase 1-T Dose Level 1-TA||0||
59665389|NCT01116648|75784355|FG014|COMPLETED|Phase 1-T Dose Level 1-TA||0||
59665390|NCT01116648|75784341|FG000|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0||
59665391|NCT01116648|75784342|FG001|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0||
59665392|NCT01116648|75784343|FG002|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0||
59665393|NCT01116648|75784344|FG003|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0||
59665394|NCT01116648|75784345|FG004|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0||
59665395|NCT01116648|75784346|FG005|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0||
59665396|NCT01116648|75784347|FG006|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0||
59665397|NCT01116648|75784348|FG007|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0||
59665398|NCT01116648|75784349|FG008|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0||
59665399|NCT01116648|75784350|FG009|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0||
59665400|NCT01116648|75784351|FG010|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0||
59665401|NCT01116648|75784352|FG011|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0||
59665402|NCT01116648|75784353|FG012|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0||
59989004|NCT02356588|76104272|FG001|NOT COMPLETED|Overall Study||13||
59989005|NCT02355028|76104280|FG000|STARTED|Overall Study||47||
59989006|NCT02355028|76104281|FG001|STARTED|Overall Study||46||
59989007|NCT02355028|76104280|FG000|Treated|Overall Study||46||
59989008|NCT02355028|76104281|FG001|Treated|Overall Study||45||
59989009|NCT02355028|76104280|FG000|COMPLETED|Overall Study||36||
59665403|NCT01116648|75784354|FG013|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0||
59665404|NCT01116648|75784355|FG014|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0||
59665405|NCT01116648|75784341|FG000|STARTED|Phase 1-T Dose Level 2-TA||0||
59665406|NCT01116648|75784342|FG001|STARTED|Phase 1-T Dose Level 2-TA||0||
59665407|NCT01116648|75784343|FG002|STARTED|Phase 1-T Dose Level 2-TA||0||
59665408|NCT01116648|75784344|FG003|STARTED|Phase 1-T Dose Level 2-TA||0||
59665409|NCT01116648|75784345|FG004|STARTED|Phase 1-T Dose Level 2-TA||0||
59665410|NCT01116648|75784346|FG005|STARTED|Phase 1-T Dose Level 2-TA||0||
59665411|NCT01116648|75784347|FG006|STARTED|Phase 1-T Dose Level 2-TA||0||
59665412|NCT01116648|75784348|FG007|STARTED|Phase 1-T Dose Level 2-TA||0||
59665413|NCT01116648|75784349|FG008|STARTED|Phase 1-T Dose Level 2-TA||0||
59665414|NCT01116648|75784350|FG009|STARTED|Phase 1-T Dose Level 2-TA||3||
59665415|NCT01116648|75784351|FG010|STARTED|Phase 1-T Dose Level 2-TA||0||
59665416|NCT01116648|75784352|FG011|STARTED|Phase 1-T Dose Level 2-TA||0||
59665417|NCT01116648|75784353|FG012|STARTED|Phase 1-T Dose Level 2-TA||0||
59665418|NCT01116648|75784354|FG013|STARTED|Phase 1-T Dose Level 2-TA||0||
59665419|NCT01116648|75784355|FG014|STARTED|Phase 1-T Dose Level 2-TA||0||
59665420|NCT01116648|75784341|FG000|COMPLETED|Phase 1-T Dose Level 2-TA||0||
59665421|NCT01116648|75784342|FG001|COMPLETED|Phase 1-T Dose Level 2-TA||0||
59989010|NCT02355028|76104281|FG001|COMPLETED|Overall Study||41||
59989011|NCT02355028|76104280|FG000|NOT COMPLETED|Overall Study||11||
59665422|NCT01116648|75784343|FG002|COMPLETED|Phase 1-T Dose Level 2-TA||0||
59665423|NCT01116648|75784344|FG003|COMPLETED|Phase 1-T Dose Level 2-TA||0||
59665424|NCT01116648|75784345|FG004|COMPLETED|Phase 1-T Dose Level 2-TA||0||
59665425|NCT01116648|75784346|FG005|COMPLETED|Phase 1-T Dose Level 2-TA||0||
59665426|NCT01116648|75784347|FG006|COMPLETED|Phase 1-T Dose Level 2-TA||0||
59665427|NCT01116648|75784348|FG007|COMPLETED|Phase 1-T Dose Level 2-TA||0||
59665428|NCT01116648|75784349|FG008|COMPLETED|Phase 1-T Dose Level 2-TA||0||
59815817|NCT03026283|75938211|FG000|STARTED|Optimal Care/ICA Diagnostic Cath||0|Participants recommended for ICA or optimal medical care after stress testing|
59665429|NCT01116648|75784350|FG009|COMPLETED|Phase 1-T Dose Level 2-TA||3||
59665430|NCT01116648|75784351|FG010|COMPLETED|Phase 1-T Dose Level 2-TA||0||
59665431|NCT01116648|75784352|FG011|COMPLETED|Phase 1-T Dose Level 2-TA||0||
59665432|NCT01116648|75784353|FG012|COMPLETED|Phase 1-T Dose Level 2-TA||0||
59815818|NCT03026283|75938212|FG001|STARTED|Optimal Care/ICA Diagnostic Cath||0|Participants recommended for ICA or optimal medical care after stress testing|
59989012|NCT02355028|76104281|FG001|NOT COMPLETED|Overall Study||5||
59989013|NCT01595503|76104292|FG000|STARTED|Overall Study||5||
59989014|NCT01595503|76104292|FG000|COMPLETED|Overall Study||5|Study was discontinued because of poor recruitment and insufficient data for analysis|
59989015|NCT01595503|76104292|FG000|NOT COMPLETED|Overall Study||0||
59989016|NCT01643668|76104296|FG000|STARTED|Overall Study||34||
59989017|NCT01643668|76104296|FG000|COMPLETED|Overall Study||33||
59989018|NCT01643668|76104296|FG000|NOT COMPLETED|Overall Study||1||
59989019|NCT02260882|76104302|FG000|STARTED|Overall Study||161||
59989020|NCT02260882|76104303|FG001|STARTED|Overall Study||82||
59665433|NCT01116648|75784354|FG013|COMPLETED|Phase 1-T Dose Level 2-TA||0||
59665434|NCT01116648|75784355|FG014|COMPLETED|Phase 1-T Dose Level 2-TA||0||
59665435|NCT01116648|75784341|FG000|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0||
59665436|NCT01116648|75784342|FG001|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0||
59665437|NCT01116648|75784343|FG002|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0||
59665438|NCT01116648|75784344|FG003|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0||
59665439|NCT01116648|75784345|FG004|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0||
59665440|NCT01116648|75784346|FG005|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0||
59665441|NCT01116648|75784347|FG006|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0||
59665442|NCT01116648|75784348|FG007|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0||
59665443|NCT01116648|75784349|FG008|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0||
59665444|NCT01116648|75784350|FG009|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0||
59665445|NCT01116648|75784351|FG010|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0||
59665446|NCT01116648|75784352|FG011|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0||
59665447|NCT01116648|75784353|FG012|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0||
59665448|NCT01116648|75784354|FG013|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0||
59665449|NCT01116648|75784355|FG014|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0||
59665450|NCT01116648|75784341|FG000|STARTED|Phase 1-T Dose Level 0-TB||0||
59665451|NCT01116648|75784342|FG001|STARTED|Phase 1-T Dose Level 0-TB||0||
59665452|NCT01116648|75784343|FG002|STARTED|Phase 1-T Dose Level 0-TB||0||
59665453|NCT01116648|75784344|FG003|STARTED|Phase 1-T Dose Level 0-TB||0||
59665454|NCT01116648|75784345|FG004|STARTED|Phase 1-T Dose Level 0-TB||0||
59665455|NCT01116648|75784346|FG005|STARTED|Phase 1-T Dose Level 0-TB||0||
59665456|NCT01116648|75784347|FG006|STARTED|Phase 1-T Dose Level 0-TB||0||
59665457|NCT01116648|75784348|FG007|STARTED|Phase 1-T Dose Level 0-TB||0||
59665458|NCT01116648|75784349|FG008|STARTED|Phase 1-T Dose Level 0-TB||0||
59665459|NCT01116648|75784350|FG009|STARTED|Phase 1-T Dose Level 0-TB||0||
59665460|NCT01116648|75784351|FG010|STARTED|Phase 1-T Dose Level 0-TB||3||
59665461|NCT01116648|75784352|FG011|STARTED|Phase 1-T Dose Level 0-TB||0||
59665462|NCT01116648|75784353|FG012|STARTED|Phase 1-T Dose Level 0-TB||0||
59665463|NCT01116648|75784354|FG013|STARTED|Phase 1-T Dose Level 0-TB||0||
59665464|NCT01116648|75784355|FG014|STARTED|Phase 1-T Dose Level 0-TB||0||
59665465|NCT01116648|75784341|FG000|COMPLETED|Phase 1-T Dose Level 0-TB||0||
59665466|NCT01116648|75784342|FG001|COMPLETED|Phase 1-T Dose Level 0-TB||0||
59665467|NCT01116648|75784343|FG002|COMPLETED|Phase 1-T Dose Level 0-TB||0||
59665468|NCT01116648|75784344|FG003|COMPLETED|Phase 1-T Dose Level 0-TB||0||
59665469|NCT01116648|75784345|FG004|COMPLETED|Phase 1-T Dose Level 0-TB||0||
59665470|NCT01116648|75784346|FG005|COMPLETED|Phase 1-T Dose Level 0-TB||0||
59665471|NCT01116648|75784347|FG006|COMPLETED|Phase 1-T Dose Level 0-TB||0||
59665472|NCT01116648|75784348|FG007|COMPLETED|Phase 1-T Dose Level 0-TB||0||
59665473|NCT01116648|75784349|FG008|COMPLETED|Phase 1-T Dose Level 0-TB||0||
59665474|NCT01116648|75784350|FG009|COMPLETED|Phase 1-T Dose Level 0-TB||0||
59665475|NCT01116648|75784351|FG010|COMPLETED|Phase 1-T Dose Level 0-TB||3||
59665476|NCT01116648|75784352|FG011|COMPLETED|Phase 1-T Dose Level 0-TB||0||
59665477|NCT01116648|75784353|FG012|COMPLETED|Phase 1-T Dose Level 0-TB||0||
59665478|NCT01116648|75784354|FG013|COMPLETED|Phase 1-T Dose Level 0-TB||0||
60077324|NCT01458340|76192363|FG001|STARTED|Overall Study||99|Intent-to-treat (ITT) population|
60077325|NCT01458340|76192364|FG002|STARTED|Overall Study||99|Intent-to-treat (ITT) population|
60077326|NCT01458340|76192362|FG000|Received Study Treatment|Overall Study||97|Safety Analysis Group|
60077327|NCT01458340|76192363|FG001|Received Study Treatment|Overall Study||98|Safety Analysis Group|
59665479|NCT01116648|75784355|FG014|COMPLETED|Phase 1-T Dose Level 0-TB||0||
59665480|NCT01116648|75784341|FG000|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0||
59665481|NCT01116648|75784342|FG001|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0||
59665482|NCT01116648|75784343|FG002|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0||
59665483|NCT01116648|75784344|FG003|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0||
59665484|NCT01116648|75784345|FG004|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0||
59665485|NCT01116648|75784346|FG005|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0||
59665486|NCT01116648|75784347|FG006|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0||
59665487|NCT01116648|75784348|FG007|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0||
59665488|NCT01116648|75784349|FG008|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0||
59665489|NCT01116648|75784350|FG009|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0||
59665490|NCT01116648|75784351|FG010|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0||
59665491|NCT01116648|75784352|FG011|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0||
59665492|NCT01116648|75784353|FG012|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0||
59665493|NCT01116648|75784354|FG013|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0||
59665494|NCT01116648|75784355|FG014|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0||
59665495|NCT01116648|75784341|FG000|STARTED|Phase 1-T Dose Level 1-TB||0||
59665496|NCT01116648|75784342|FG001|STARTED|Phase 1-T Dose Level 1-TB||0||
59665497|NCT01116648|75784343|FG002|STARTED|Phase 1-T Dose Level 1-TB||0||
59665498|NCT01116648|75784344|FG003|STARTED|Phase 1-T Dose Level 1-TB||0||
59665499|NCT01116648|75784345|FG004|STARTED|Phase 1-T Dose Level 1-TB||0||
59665500|NCT01116648|75784346|FG005|STARTED|Phase 1-T Dose Level 1-TB||0||
59665501|NCT01116648|75784347|FG006|STARTED|Phase 1-T Dose Level 1-TB||0||
59665502|NCT01116648|75784348|FG007|STARTED|Phase 1-T Dose Level 1-TB||0||
59665503|NCT01116648|75784349|FG008|STARTED|Phase 1-T Dose Level 1-TB||0||
59665504|NCT01116648|75784350|FG009|STARTED|Phase 1-T Dose Level 1-TB||0||
59665505|NCT01116648|75784351|FG010|STARTED|Phase 1-T Dose Level 1-TB||0||
59665506|NCT01116648|75784352|FG011|STARTED|Phase 1-T Dose Level 1-TB||3||
59665507|NCT01116648|75784353|FG012|STARTED|Phase 1-T Dose Level 1-TB||0||
59665508|NCT01116648|75784354|FG013|STARTED|Phase 1-T Dose Level 1-TB||0||
59665509|NCT01116648|75784355|FG014|STARTED|Phase 1-T Dose Level 1-TB||0||
59665510|NCT01116648|75784341|FG000|COMPLETED|Phase 1-T Dose Level 1-TB||0||
59665511|NCT01116648|75784342|FG001|COMPLETED|Phase 1-T Dose Level 1-TB||0||
59665512|NCT01116648|75784343|FG002|COMPLETED|Phase 1-T Dose Level 1-TB||0||
59665513|NCT01116648|75784344|FG003|COMPLETED|Phase 1-T Dose Level 1-TB||0||
59665514|NCT01116648|75784345|FG004|COMPLETED|Phase 1-T Dose Level 1-TB||0||
59665515|NCT01116648|75784346|FG005|COMPLETED|Phase 1-T Dose Level 1-TB||0||
59665516|NCT01116648|75784347|FG006|COMPLETED|Phase 1-T Dose Level 1-TB||0||
59665517|NCT01116648|75784348|FG007|COMPLETED|Phase 1-T Dose Level 1-TB||0||
59665518|NCT01116648|75784349|FG008|COMPLETED|Phase 1-T Dose Level 1-TB||0||
59665519|NCT01116648|75784350|FG009|COMPLETED|Phase 1-T Dose Level 1-TB||0||
59665520|NCT01116648|75784351|FG010|COMPLETED|Phase 1-T Dose Level 1-TB||0||
59665521|NCT01116648|75784352|FG011|COMPLETED|Phase 1-T Dose Level 1-TB||3||
59665522|NCT01116648|75784353|FG012|COMPLETED|Phase 1-T Dose Level 1-TB||0||
59665523|NCT01116648|75784354|FG013|COMPLETED|Phase 1-T Dose Level 1-TB||0||
59665524|NCT01116648|75784355|FG014|COMPLETED|Phase 1-T Dose Level 1-TB||0||
59665525|NCT01116648|75784341|FG000|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0||
59665526|NCT01116648|75784342|FG001|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0||
59665527|NCT01116648|75784343|FG002|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0||
59665528|NCT01116648|75784344|FG003|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0||
59665529|NCT01116648|75784345|FG004|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0||
59665530|NCT01116648|75784346|FG005|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0||
59665531|NCT01116648|75784347|FG006|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0||
59665532|NCT01116648|75784348|FG007|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0||
59665533|NCT01116648|75784349|FG008|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0||
59665534|NCT01116648|75784350|FG009|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0||
59665535|NCT01116648|75784351|FG010|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0||
59665536|NCT01116648|75784352|FG011|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0||
59665537|NCT01116648|75784353|FG012|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0||
59665538|NCT01116648|75784354|FG013|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0||
59815819|NCT03026283|75938213|FG002|STARTED|Optimal Care/ICA Diagnostic Cath||0|Participants recommended for ICA or optimal medical care after stress testing|
59989021|NCT02260882|76104302|FG000|COMPLETED|Overall Study||161||
59989022|NCT02260882|76104303|FG001|COMPLETED|Overall Study||81||
59665539|NCT01116648|75784355|FG014|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0||
59665540|NCT01116648|75784341|FG000|STARTED|Phase 1-T Dose Level 2-TB||0||
59665541|NCT01116648|75784342|FG001|STARTED|Phase 1-T Dose Level 2-TB||0||
59665542|NCT01116648|75784343|FG002|STARTED|Phase 1-T Dose Level 2-TB||0||
59665543|NCT01116648|75784344|FG003|STARTED|Phase 1-T Dose Level 2-TB||0||
59665544|NCT01116648|75784345|FG004|STARTED|Phase 1-T Dose Level 2-TB||0||
59665545|NCT01116648|75784346|FG005|STARTED|Phase 1-T Dose Level 2-TB||0||
59665546|NCT01116648|75784347|FG006|STARTED|Phase 1-T Dose Level 2-TB||0||
59665547|NCT01116648|75784348|FG007|STARTED|Phase 1-T Dose Level 2-TB||0||
59665548|NCT01116648|75784349|FG008|STARTED|Phase 1-T Dose Level 2-TB||0||
59665549|NCT01116648|75784350|FG009|STARTED|Phase 1-T Dose Level 2-TB||0||
59665550|NCT01116648|75784351|FG010|STARTED|Phase 1-T Dose Level 2-TB||0||
59665551|NCT01116648|75784352|FG011|STARTED|Phase 1-T Dose Level 2-TB||0||
59665552|NCT01116648|75784353|FG012|STARTED|Phase 1-T Dose Level 2-TB||6||
59665553|NCT01116648|75784354|FG013|STARTED|Phase 1-T Dose Level 2-TB||0||
59665554|NCT01116648|75784355|FG014|STARTED|Phase 1-T Dose Level 2-TB||0||
59665555|NCT01116648|75784341|FG000|COMPLETED|Phase 1-T Dose Level 2-TB||0||
59665556|NCT01116648|75784342|FG001|COMPLETED|Phase 1-T Dose Level 2-TB||0||
59665557|NCT01116648|75784343|FG002|COMPLETED|Phase 1-T Dose Level 2-TB||0||
59665558|NCT01116648|75784344|FG003|COMPLETED|Phase 1-T Dose Level 2-TB||0||
59665559|NCT01116648|75784345|FG004|COMPLETED|Phase 1-T Dose Level 2-TB||0||
59665560|NCT01116648|75784346|FG005|COMPLETED|Phase 1-T Dose Level 2-TB||0||
59665561|NCT01116648|75784347|FG006|COMPLETED|Phase 1-T Dose Level 2-TB||0||
59665562|NCT01116648|75784348|FG007|COMPLETED|Phase 1-T Dose Level 2-TB||0||
59665563|NCT01116648|75784349|FG008|COMPLETED|Phase 1-T Dose Level 2-TB||0||
59665564|NCT01116648|75784350|FG009|COMPLETED|Phase 1-T Dose Level 2-TB||0||
59665565|NCT01116648|75784351|FG010|COMPLETED|Phase 1-T Dose Level 2-TB||0||
59665566|NCT01116648|75784352|FG011|COMPLETED|Phase 1-T Dose Level 2-TB||0||
59665567|NCT01116648|75784353|FG012|COMPLETED|Phase 1-T Dose Level 2-TB||6||
59665568|NCT01116648|75784354|FG013|COMPLETED|Phase 1-T Dose Level 2-TB||0||
59665569|NCT01116648|75784355|FG014|COMPLETED|Phase 1-T Dose Level 2-TB||0||
59665570|NCT01116648|75784341|FG000|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0||
59665571|NCT01116648|75784342|FG001|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0||
59665572|NCT01116648|75784343|FG002|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0||
59665573|NCT01116648|75784344|FG003|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0||
59665574|NCT01116648|75784345|FG004|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0||
59665575|NCT01116648|75784346|FG005|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0||
59989023|NCT02260882|76104302|FG000|NOT COMPLETED|Overall Study||0||
59989024|NCT02260882|76104303|FG001|NOT COMPLETED|Overall Study||1||
59665576|NCT01116648|75784347|FG006|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0||
59665577|NCT01116648|75784348|FG007|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0||
59665578|NCT01116648|75784349|FG008|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0||
59665579|NCT01116648|75784350|FG009|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0||
59665580|NCT01116648|75784351|FG010|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0||
59665581|NCT01116648|75784352|FG011|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0||
59665582|NCT01116648|75784353|FG012|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0||
59665583|NCT01116648|75784354|FG013|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0||
59665584|NCT01116648|75784355|FG014|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0||
59665585|NCT01116648|75784341|FG000|STARTED|Phase 1-T PKOlap Expansion||0||
59665586|NCT01116648|75784342|FG001|STARTED|Phase 1-T PKOlap Expansion||0||
59665587|NCT01116648|75784343|FG002|STARTED|Phase 1-T PKOlap Expansion||0||
59665588|NCT01116648|75784344|FG003|STARTED|Phase 1-T PKOlap Expansion||0||
59665589|NCT01116648|75784345|FG004|STARTED|Phase 1-T PKOlap Expansion||0||
59665590|NCT01116648|75784346|FG005|STARTED|Phase 1-T PKOlap Expansion||0||
59665591|NCT01116648|75784347|FG006|STARTED|Phase 1-T PKOlap Expansion||0||
59665592|NCT01116648|75784348|FG007|STARTED|Phase 1-T PKOlap Expansion||0||
59665593|NCT01116648|75784349|FG008|STARTED|Phase 1-T PKOlap Expansion||0||
59665594|NCT01116648|75784350|FG009|STARTED|Phase 1-T PKOlap Expansion||0||
59665595|NCT01116648|75784351|FG010|STARTED|Phase 1-T PKOlap Expansion||0||
59665596|NCT01116648|75784352|FG011|STARTED|Phase 1-T PKOlap Expansion||0||
59665597|NCT01116648|75784353|FG012|STARTED|Phase 1-T PKOlap Expansion||0||
59665598|NCT01116648|75784354|FG013|STARTED|Phase 1-T PKOlap Expansion||6||
59665599|NCT01116648|75784355|FG014|STARTED|Phase 1-T PKOlap Expansion||0||
59665600|NCT01116648|75784341|FG000|COMPLETED|Phase 1-T PKOlap Expansion||0||
59665601|NCT01116648|75784342|FG001|COMPLETED|Phase 1-T PKOlap Expansion||0||
59665602|NCT01116648|75784343|FG002|COMPLETED|Phase 1-T PKOlap Expansion||0||
59665603|NCT01116648|75784344|FG003|COMPLETED|Phase 1-T PKOlap Expansion||0||
59665604|NCT01116648|75784345|FG004|COMPLETED|Phase 1-T PKOlap Expansion||0||
59665605|NCT01116648|75784346|FG005|COMPLETED|Phase 1-T PKOlap Expansion||0||
59665606|NCT01116648|75784347|FG006|COMPLETED|Phase 1-T PKOlap Expansion||0||
59665607|NCT01116648|75784348|FG007|COMPLETED|Phase 1-T PKOlap Expansion||0||
59665608|NCT01116648|75784349|FG008|COMPLETED|Phase 1-T PKOlap Expansion||0||
59665609|NCT01116648|75784350|FG009|COMPLETED|Phase 1-T PKOlap Expansion||0||
59665610|NCT01116648|75784351|FG010|COMPLETED|Phase 1-T PKOlap Expansion||0||
59665611|NCT01116648|75784352|FG011|COMPLETED|Phase 1-T PKOlap Expansion||0||
59665612|NCT01116648|75784353|FG012|COMPLETED|Phase 1-T PKOlap Expansion||0||
59665613|NCT01116648|75784354|FG013|COMPLETED|Phase 1-T PKOlap Expansion||6||
59665614|NCT01116648|75784355|FG014|COMPLETED|Phase 1-T PKOlap Expansion||0||
59665615|NCT01116648|75784341|FG000|NOT COMPLETED|Phase 1-T PKOlap Expansion||0||
59665616|NCT01116648|75784342|FG001|NOT COMPLETED|Phase 1-T PKOlap Expansion||0||
59665617|NCT01116648|75784343|FG002|NOT COMPLETED|Phase 1-T PKOlap Expansion||0||
59665618|NCT01116648|75784344|FG003|NOT COMPLETED|Phase 1-T PKOlap Expansion||0||
59665619|NCT01116648|75784345|FG004|NOT COMPLETED|Phase 1-T PKOlap Expansion||0||
59665620|NCT01116648|75784346|FG005|NOT COMPLETED|Phase 1-T PKOlap Expansion||0||
59665621|NCT01116648|75784347|FG006|NOT COMPLETED|Phase 1-T PKOlap Expansion||0||
59665622|NCT01116648|75784348|FG007|NOT COMPLETED|Phase 1-T PKOlap Expansion||0||
59665623|NCT01116648|75784349|FG008|NOT COMPLETED|Phase 1-T PKOlap Expansion||0||
59665624|NCT01116648|75784350|FG009|NOT COMPLETED|Phase 1-T PKOlap Expansion||0||
59665625|NCT01116648|75784351|FG010|NOT COMPLETED|Phase 1-T PKOlap Expansion||0||
59665626|NCT01116648|75784352|FG011|NOT COMPLETED|Phase 1-T PKOlap Expansion||0||
59665627|NCT01116648|75784353|FG012|NOT COMPLETED|Phase 1-T PKOlap Expansion||0||
59665628|NCT01116648|75784354|FG013|NOT COMPLETED|Phase 1-T PKOlap Expansion||0||
59665629|NCT01116648|75784355|FG014|NOT COMPLETED|Phase 1-T PKOlap Expansion||0||
59665630|NCT01116648|75784341|FG000|STARTED|Phase 1-T PKCed Expansion||0||
59665631|NCT01116648|75784342|FG001|STARTED|Phase 1-T PKCed Expansion||0||
59665632|NCT01116648|75784343|FG002|STARTED|Phase 1-T PKCed Expansion||0||
59665633|NCT01116648|75784344|FG003|STARTED|Phase 1-T PKCed Expansion||0||
59665634|NCT01116648|75784345|FG004|STARTED|Phase 1-T PKCed Expansion||0||
59665635|NCT01116648|75784346|FG005|STARTED|Phase 1-T PKCed Expansion||0||
59665636|NCT01116648|75784347|FG006|STARTED|Phase 1-T PKCed Expansion||0||
59665637|NCT01116648|75784348|FG007|STARTED|Phase 1-T PKCed Expansion||0||
59665638|NCT01116648|75784349|FG008|STARTED|Phase 1-T PKCed Expansion||0||
59665639|NCT01116648|75784350|FG009|STARTED|Phase 1-T PKCed Expansion||0||
59665640|NCT01116648|75784351|FG010|STARTED|Phase 1-T PKCed Expansion||0||
59665641|NCT01116648|75784352|FG011|STARTED|Phase 1-T PKCed Expansion||0||
59665642|NCT01116648|75784353|FG012|STARTED|Phase 1-T PKCed Expansion||0||
59665643|NCT01116648|75784354|FG013|STARTED|Phase 1-T PKCed Expansion||0||
59665644|NCT01116648|75784355|FG014|STARTED|Phase 1-T PKCed Expansion||7||
59665645|NCT01116648|75784341|FG000|COMPLETED|Phase 1-T PKCed Expansion||0||
59665646|NCT01116648|75784342|FG001|COMPLETED|Phase 1-T PKCed Expansion||0||
59665647|NCT01116648|75784343|FG002|COMPLETED|Phase 1-T PKCed Expansion||0||
59665648|NCT01116648|75784344|FG003|COMPLETED|Phase 1-T PKCed Expansion||0||
59665649|NCT01116648|75784345|FG004|COMPLETED|Phase 1-T PKCed Expansion||0||
59665650|NCT01116648|75784346|FG005|COMPLETED|Phase 1-T PKCed Expansion||0||
59665651|NCT01116648|75784347|FG006|COMPLETED|Phase 1-T PKCed Expansion||0||
59665652|NCT01116648|75784348|FG007|COMPLETED|Phase 1-T PKCed Expansion||0||
59665653|NCT01116648|75784349|FG008|COMPLETED|Phase 1-T PKCed Expansion||0||
59665654|NCT01116648|75784350|FG009|COMPLETED|Phase 1-T PKCed Expansion||0||
59665655|NCT01116648|75784351|FG010|COMPLETED|Phase 1-T PKCed Expansion||0||
59665656|NCT01116648|75784352|FG011|COMPLETED|Phase 1-T PKCed Expansion||0||
59665657|NCT01116648|75784353|FG012|COMPLETED|Phase 1-T PKCed Expansion||0||
59665658|NCT01116648|75784354|FG013|COMPLETED|Phase 1-T PKCed Expansion||0||
59665659|NCT01116648|75784355|FG014|COMPLETED|Phase 1-T PKCed Expansion||7||
59665660|NCT01116648|75784341|FG000|NOT COMPLETED|Phase 1-T PKCed Expansion||0||
59665661|NCT01116648|75784342|FG001|NOT COMPLETED|Phase 1-T PKCed Expansion||0||
59665662|NCT01116648|75784343|FG002|NOT COMPLETED|Phase 1-T PKCed Expansion||0||
59665663|NCT01116648|75784344|FG003|NOT COMPLETED|Phase 1-T PKCed Expansion||0||
59665664|NCT01116648|75784345|FG004|NOT COMPLETED|Phase 1-T PKCed Expansion||0||
59665665|NCT01116648|75784346|FG005|NOT COMPLETED|Phase 1-T PKCed Expansion||0||
59665666|NCT01116648|75784347|FG006|NOT COMPLETED|Phase 1-T PKCed Expansion||0||
59665667|NCT01116648|75784348|FG007|NOT COMPLETED|Phase 1-T PKCed Expansion||0||
59665668|NCT01116648|75784349|FG008|NOT COMPLETED|Phase 1-T PKCed Expansion||0||
59665669|NCT01116648|75784350|FG009|NOT COMPLETED|Phase 1-T PKCed Expansion||0||
59665670|NCT01116648|75784351|FG010|NOT COMPLETED|Phase 1-T PKCed Expansion||0||
59665671|NCT01116648|75784352|FG011|NOT COMPLETED|Phase 1-T PKCed Expansion||0||
59665672|NCT01116648|75784353|FG012|NOT COMPLETED|Phase 1-T PKCed Expansion||0||
59665673|NCT01116648|75784354|FG013|NOT COMPLETED|Phase 1-T PKCed Expansion||0||
59665674|NCT01116648|75784355|FG014|NOT COMPLETED|Phase 1-T PKCed Expansion||0||
59665675|NCT00642434|75784382|FG000|STARTED|Overall Study||10||
59665676|NCT00642434|75784383|FG001|STARTED|Overall Study||12||
59665677|NCT00642434|75784382|FG000|Number of Participants Treated|Overall Study||10||
59665678|NCT00642434|75784383|FG001|Number of Participants Treated|Overall Study||12||
59665679|NCT00642434|75784382|FG000|COMPLETED|Overall Study||10||
59665680|NCT00642434|75784383|FG001|COMPLETED|Overall Study||12||
59665681|NCT00642434|75784382|FG000|NOT COMPLETED|Overall Study||0||
59665682|NCT00642434|75784383|FG001|NOT COMPLETED|Overall Study||0||
59665683|NCT05128682|75784389|FG000|STARTED|Overall Study||4||
59665684|NCT05128682|75784389|FG000|COMPLETED|Overall Study||4||
59665685|NCT05128682|75784389|FG000|NOT COMPLETED|Overall Study||0||
59665686|NCT04831736|75784396|FG000|STARTED|Overall Study||15||
59665687|NCT04831736|75784397|FG001|STARTED|Overall Study||16||
59665688|NCT04831736|75784396|FG000|COMPLETED|Overall Study||15||
59665689|NCT04831736|75784397|FG001|COMPLETED|Overall Study||15||
59665690|NCT04831736|75784396|FG000|NOT COMPLETED|Overall Study||0||
59665691|NCT04831736|75784397|FG001|NOT COMPLETED|Overall Study||1||
59665692|NCT04634162|75784403|FG000|STARTED|Phase 1 Pre-cossover||10||
59665693|NCT04634162|75784404|FG001|STARTED|Phase 1 Pre-cossover||10||
59665694|NCT04634162|75784403|FG000|COMPLETED|Phase 1 Pre-cossover||10||
59665695|NCT04634162|75784404|FG001|COMPLETED|Phase 1 Pre-cossover||10||
59665696|NCT04634162|75784403|FG000|NOT COMPLETED|Phase 1 Pre-cossover||0||
59665697|NCT04634162|75784404|FG001|NOT COMPLETED|Phase 1 Pre-cossover||0||
59665698|NCT04634162|75784403|FG000|STARTED|Phase 2 Post-cossover||10||
59665699|NCT04634162|75784404|FG001|STARTED|Phase 2 Post-cossover||10||
59665700|NCT04634162|75784403|FG000|COMPLETED|Phase 2 Post-cossover||10||
59665701|NCT04634162|75784404|FG001|COMPLETED|Phase 2 Post-cossover||10||
59665702|NCT04634162|75784403|FG000|NOT COMPLETED|Phase 2 Post-cossover||0||
59665703|NCT04634162|75784404|FG001|NOT COMPLETED|Phase 2 Post-cossover||0||
59665704|NCT04583956|75784412|FG000|STARTED|Overall Study||104||
59665705|NCT04583956|75784413|FG001|STARTED|Overall Study||110||
59665706|NCT04583956|75784412|FG000|Included in Modified Intention-to-treat (mITT) Population|Overall Study||100||
59665707|NCT04583956|75784413|FG001|Included in Modified Intention-to-treat (mITT) Population|Overall Study||107||
59665708|NCT04583956|75784412|FG000|COMPLETED|Overall Study||83||
59665709|NCT04583956|75784413|FG001|COMPLETED|Overall Study||85||
59665710|NCT04583956|75784412|FG000|NOT COMPLETED|Overall Study||21||
59665711|NCT04583956|75784413|FG001|NOT COMPLETED|Overall Study||25||
59665712|NCT04544358|75784421|FG000|STARTED|Overall Study||12||
59665713|NCT04544358|75784422|FG001|STARTED|Overall Study||10||
59665714|NCT04544358|75784421|FG000|COMPLETED|Overall Study||12||
59665715|NCT04544358|75784422|FG001|COMPLETED|Overall Study||10||
59665716|NCT04544358|75784421|FG000|NOT COMPLETED|Overall Study||0||
59665717|NCT04544358|75784422|FG001|NOT COMPLETED|Overall Study||0||
59665718|NCT04463680|75784429|FG000|STARTED|Overall Study||24||
59665719|NCT04463680|75784429|FG000|COMPLETED|Overall Study||15||
59665720|NCT04463680|75784429|FG000|NOT COMPLETED|Overall Study||9||
59665721|NCT04449029|75784441|FG000|STARTED|Overall Study||68||
59665722|NCT04449029|75784442|FG001|STARTED|Overall Study||68||
59665723|NCT04449029|75784443|FG002|STARTED|Overall Study||68||
59665724|NCT04449029|75784444|FG003|STARTED|Overall Study||23||
59665725|NCT04449029|75784445|FG004|STARTED|Overall Study||70||
59665726|NCT04449029|75784446|FG005|STARTED|Overall Study||68||
59665727|NCT04449029|75784447|FG006|STARTED|Overall Study||68||
59665728|NCT04449029|75784448|FG007|STARTED|Overall Study||24||
59665729|NCT04449029|75784441|FG000|COMPLETED|Overall Study||65||
59665730|NCT04449029|75784442|FG001|COMPLETED|Overall Study||65||
59665731|NCT04449029|75784443|FG002|COMPLETED|Overall Study||66||
59665732|NCT04449029|75784444|FG003|COMPLETED|Overall Study||22||
59665733|NCT04449029|75784445|FG004|COMPLETED|Overall Study||64||
59665734|NCT04449029|75784446|FG005|COMPLETED|Overall Study||66||
59665735|NCT04449029|75784447|FG006|COMPLETED|Overall Study||63||
59665736|NCT04449029|75784448|FG007|COMPLETED|Overall Study||24||
59665737|NCT04449029|75784441|FG000|NOT COMPLETED|Overall Study||3||
59665738|NCT04449029|75784442|FG001|NOT COMPLETED|Overall Study||3||
59665739|NCT04449029|75784443|FG002|NOT COMPLETED|Overall Study||2||
59665740|NCT04449029|75784444|FG003|NOT COMPLETED|Overall Study||1||
59665741|NCT04449029|75784445|FG004|NOT COMPLETED|Overall Study||6||
59665742|NCT04449029|75784446|FG005|NOT COMPLETED|Overall Study||2||
59665743|NCT04449029|75784447|FG006|NOT COMPLETED|Overall Study||5||
59665744|NCT04449029|75784448|FG007|NOT COMPLETED|Overall Study||0||
59665745|NCT04193202|75784478|FG000|STARTED|Overall Study||208||
59665746|NCT04193202|75784479|FG001|STARTED|Overall Study||211||
59665747|NCT04193202|75784478|FG000|Treated|Overall Study||206||
59665748|NCT04193202|75784479|FG001|Treated|Overall Study||209||
59665749|NCT04193202|75784478|FG000|COMPLETED|Overall Study||192||
59665750|NCT04193202|75784479|FG001|COMPLETED|Overall Study||201||
59665751|NCT04193202|75784478|FG000|NOT COMPLETED|Overall Study||16||
59665752|NCT04193202|75784479|FG001|NOT COMPLETED|Overall Study||10||
59665753|NCT04159935|75784487|FG000|STARTED|Overall Study||4||
59665754|NCT04159935|75784488|FG001|STARTED|Overall Study||4||
59665755|NCT04159935|75784487|FG000|Month 1 Post-treatment|Overall Study||3||
59665756|NCT04159935|75784488|FG001|Month 1 Post-treatment|Overall Study||3||
59665757|NCT04159935|75784487|FG000|Month 3 Post-treatment|Overall Study||3||
59665758|NCT04159935|75784488|FG001|Month 3 Post-treatment|Overall Study||1||
59665759|NCT04159935|75784487|FG000|COMPLETED|Overall Study||3||
59665760|NCT04159935|75784488|FG001|COMPLETED|Overall Study||1||
59665761|NCT04159935|75784487|FG000|NOT COMPLETED|Overall Study||1||
59665762|NCT04159935|75784488|FG001|NOT COMPLETED|Overall Study||3||
59665763|NCT04079634|75784496|FG000|STARTED|Overall Study||23||
59665764|NCT04079634|75784497|FG001|STARTED|Overall Study||19||
59665765|NCT04079634|75784496|FG000|COMPLETED|Overall Study||23||
59665766|NCT04079634|75784497|FG001|COMPLETED|Overall Study||19||
59665767|NCT04079634|75784496|FG000|NOT COMPLETED|Overall Study||0||
59665768|NCT04079634|75784497|FG001|NOT COMPLETED|Overall Study||0||
59665769|NCT03944668|75784503|FG000|STARTED|Overall Study|Enrolled in Study|17||
59665770|NCT03944668|75784503|FG000|Able to Use Patient Data|Overall Study|3 Patient's Data Unusable|14||
59665771|NCT03944668|75784503|FG000|Participated in Intervention|Overall Study|Started Cardiac Rehabilitation|10||
59665772|NCT03944668|75784503|FG000|COMPLETED|Overall Study|Completed 75% of Comprehensive Cardiac Rehabilitation Sessions|8||
59665773|NCT03944668|75784503|FG000|NOT COMPLETED|Overall Study||9||
59665774|NCT03871543|75784512|FG000|STARTED|Period 1||184||
59665775|NCT03871543|75784512|FG000|COMPLETED|Period 1||48||
59665776|NCT03871543|75784512|FG000|NOT COMPLETED|Period 1||136||
59665777|NCT03871543|75784512|FG000|STARTED|Period 2||48||
59665778|NCT03871543|75784512|FG000|COMPLETED|Period 2||46||
59665779|NCT03871543|75784512|FG000|NOT COMPLETED|Period 2||2||
59665780|NCT03843125|75784524|FG000|STARTED|Overall Study||388||
59665781|NCT03843125|75784525|FG001|STARTED|Overall Study||379||
59665782|NCT03843125|75784526|FG002|STARTED|Overall Study||189||
59665783|NCT03843125|75784527|FG003|STARTED|Overall Study||191||
59665784|NCT03843125|75784524|FG000|Safety Population|Overall Study||388|All participants who received at least one dose of study drug and who did not discontinue from the study for the reason 'Lost to Follow-up' at the first postbaseline visit.|
59665785|NCT03843125|75784525|FG001|Safety Population|Overall Study||378|All participants who received at least one dose of study drug and who did not discontinue from the study for the reason 'Lost to Follow-up' at the first postbaseline visit.|
59665786|NCT03843125|75784526|FG002|Safety Population|Overall Study||189|All participants who received at least one dose of study drug and who did not discontinue from the study for the reason 'Lost to Follow-up' at the first postbaseline visit.|
59665787|NCT03843125|75784527|FG003|Safety Population|Overall Study||191|All participants who received at least one dose of study drug and who did not discontinue from the study for the reason 'Lost to Follow-up' at the first postbaseline visit.|
59665788|NCT03843125|75784524|FG000|COMPLETED|Overall Study||0||
59665789|NCT03843125|75784525|FG001|COMPLETED|Overall Study||0||
59665790|NCT03843125|75784526|FG002|COMPLETED|Overall Study||0||
59665791|NCT03843125|75784527|FG003|COMPLETED|Overall Study||0||
59665792|NCT03843125|75784524|FG000|NOT COMPLETED|Overall Study||388||
59665793|NCT03843125|75784525|FG001|NOT COMPLETED|Overall Study||379||
59665794|NCT03843125|75784526|FG002|NOT COMPLETED|Overall Study||189||
59665795|NCT03843125|75784527|FG003|NOT COMPLETED|Overall Study||191||
59665796|NCT03603509|75784540|FG000|STARTED|Overall Study||120||
59665797|NCT03603509|75784541|FG001|STARTED|Overall Study||121||
59665798|NCT03603509|75784540|FG000|COMPLETED|Overall Study||117||
59665799|NCT03603509|75784541|FG001|COMPLETED|Overall Study||117||
59665800|NCT03603509|75784540|FG000|NOT COMPLETED|Overall Study||3||
59665801|NCT03603509|75784541|FG001|NOT COMPLETED|Overall Study||4||
59665802|NCT03428932|75784549|FG000|STARTED|Overall Study||21||
59665803|NCT03428932|75784550|FG001|STARTED|Overall Study||21||
59665804|NCT03428932|75784549|FG000|COMPLETED|Overall Study||21||
59665805|NCT03428932|75784550|FG001|COMPLETED|Overall Study||21||
59665806|NCT03428932|75784549|FG000|NOT COMPLETED|Overall Study||0||
59665807|NCT03428932|75784550|FG001|NOT COMPLETED|Overall Study||0||
59665808|NCT03123913|75784556|FG000|STARTED|Overall Study||20||
59665809|NCT03123913|75784556|FG000|COMPLETED|Overall Study||19||
59665810|NCT03123913|75784556|FG000|NOT COMPLETED|Overall Study||1||
59665811|NCT03066258|75784565|FG000|STARTED|Overall Study||6||
59665812|NCT03066258|75784566|FG001|STARTED|Overall Study||6||
59665813|NCT03066258|75784567|FG002|STARTED|Overall Study||6||
59665814|NCT03066258|75784568|FG003|STARTED|Overall Study||12||
59665815|NCT03066258|75784569|FG004|STARTED|Overall Study||12||
59665816|NCT03066258|75784565|FG000|COMPLETED|Overall Study||5||
59665817|NCT03066258|75784566|FG001|COMPLETED|Overall Study||6||
59665818|NCT03066258|75784567|FG002|COMPLETED|Overall Study||6||
59665819|NCT03066258|75784568|FG003|COMPLETED|Overall Study||12||
59665820|NCT03066258|75784569|FG004|COMPLETED|Overall Study||11||
59665821|NCT03066258|75784565|FG000|NOT COMPLETED|Overall Study||1||
59665822|NCT03066258|75784566|FG001|NOT COMPLETED|Overall Study||0||
59665823|NCT03066258|75784567|FG002|NOT COMPLETED|Overall Study||0||
59665824|NCT03066258|75784568|FG003|NOT COMPLETED|Overall Study||0||
59665825|NCT03066258|75784569|FG004|NOT COMPLETED|Overall Study||1||
59665826|NCT03024255|75784585|FG000|STARTED|Overall Study||57||
59665827|NCT03024255|75784586|FG001|STARTED|Overall Study||57||
59665828|NCT03024255|75784587|FG002|STARTED|Overall Study||56||
59665829|NCT03024255|75784588|FG003|STARTED|Overall Study||57||
59665830|NCT03024255|75784585|FG000|COMPLETED|Overall Study||50||
59665831|NCT03024255|75784586|FG001|COMPLETED|Overall Study||49||
59665832|NCT03024255|75784587|FG002|COMPLETED|Overall Study||45||
59665833|NCT03024255|75784588|FG003|COMPLETED|Overall Study||52||
59665834|NCT03024255|75784585|FG000|NOT COMPLETED|Overall Study||7||
59665835|NCT03024255|75784586|FG001|NOT COMPLETED|Overall Study||8||
59665836|NCT03024255|75784587|FG002|NOT COMPLETED|Overall Study||11||
59665837|NCT03024255|75784588|FG003|NOT COMPLETED|Overall Study||5||
59665838|NCT01555905|75784605|FG000|STARTED|Overall Study||17||
59665839|NCT01555905|75784605|FG000|COMPLETED|Overall Study||7||
59665840|NCT01555905|75784605|FG000|NOT COMPLETED|Overall Study||10||
59665841|NCT01252953|75784611|FG000|STARTED|Overall Study||15225||
59665842|NCT01252953|75784612|FG001|STARTED|Overall Study||15224||
59665843|NCT01252953|75784611|FG000|COMPLETED|Overall Study||15187||
59665844|NCT01252953|75784612|FG001|COMPLETED|Overall Study||15186||
59665845|NCT01252953|75784611|FG000|NOT COMPLETED|Overall Study||38||
59665846|NCT01252953|75784612|FG001|NOT COMPLETED|Overall Study||38||
59665847|NCT01234480|75784619|FG000|STARTED|Overall Study||5859||
59665848|NCT01234480|75784619|FG000|COMPLETED|Overall Study||5416||
59665849|NCT01234480|75784619|FG000|NOT COMPLETED|Overall Study||443||
59665850|NCT00877851|75784628|FG000|STARTED|Overall Study||41||
59665851|NCT00877851|75784629|FG001|STARTED|Overall Study||43||
59665852|NCT00877851|75784628|FG000|COMPLETED|Overall Study||32||
59665853|NCT00877851|75784629|FG001|COMPLETED|Overall Study||38||
59665854|NCT00877851|75784628|FG000|NOT COMPLETED|Overall Study||9||
59665855|NCT00877851|75784629|FG001|NOT COMPLETED|Overall Study||5||
59665856|NCT00837616|75784637|FG000|STARTED|Overall Study||20||
59665857|NCT00837616|75784638|FG001|STARTED|Overall Study||21||
59665858|NCT00837616|75784637|FG000|COMPLETED|Overall Study||20||
59665859|NCT00837616|75784638|FG001|COMPLETED|Overall Study||20||
59665860|NCT00837616|75784637|FG000|NOT COMPLETED|Overall Study||0||
59665861|NCT00837616|75784638|FG001|NOT COMPLETED|Overall Study||1||
59665862|NCT00176254|75784644|FG000|STARTED|Overall Study||40||
59665863|NCT00176254|75784644|FG000|COMPLETED|Overall Study|1 patient only received 1 cycle and refused further induction, another progressed in neck nodes|39||
59665864|NCT00176254|75784644|FG000|NOT COMPLETED|Overall Study||1||
59665865|NCT04693078|75784648|FG000|STARTED|Overall Study||100||
59665866|NCT04693078|75784648|FG000|COMPLETED|Overall Study||100||
59665867|NCT04693078|75784648|FG000|NOT COMPLETED|Overall Study||0||
59665868|NCT03083873|75784657|FG000|STARTED|Overall Study||10|Enrolled / Tumor Harvested|
59665869|NCT03083873|75784658|FG001|STARTED|Overall Study||22|Enrolled / Tumor Harvested|
59665870|NCT03083873|75784659|FG002|STARTED|Overall Study||19|Enrolled / Tumor Harvested|
59665871|NCT03083873|75784660|FG003|STARTED|Overall Study||13|Enrolled / Tumor Harvested|
59665872|NCT03083873|75784661|FG004|STARTED|Overall Study||0|Enrolled / Tumor Harvested|
59665873|NCT03083873|75784657|FG000|Infused With TIL|Overall Study||8||
59665874|NCT03083873|75784658|FG001|Infused With TIL|Overall Study||17||
59665875|NCT03083873|75784659|FG002|Infused With TIL|Overall Study||16||
59665876|NCT03083873|75784660|FG003|Infused With TIL|Overall Study||12||
59665877|NCT03083873|75784661|FG004|Infused With TIL|Overall Study||0||
59665878|NCT03083873|75784657|FG000|Completed Assessment Period|Overall Study||8|From TIL infusion on Day 0 and ends upon disease progression, the start of a new anticancer therapy, withdrawal of consent, or after 2 years (Month 24), whichever occurred first.|
59665879|NCT03083873|75784658|FG001|Completed Assessment Period|Overall Study||15|From TIL infusion on Day 0 and ends upon disease progression, the start of a new anticancer therapy, withdrawal of consent, or after 2 years (Month 24), whichever occurred first.|
59665880|NCT03083873|75784659|FG002|Completed Assessment Period|Overall Study||11|From TIL infusion on Day 0 and ends upon disease progression, the start of a new anticancer therapy, withdrawal of consent, or after 2 years (Month 24), whichever occurred first.|
59665881|NCT03083873|75784660|FG003|Completed Assessment Period|Overall Study||9|From TIL infusion on Day 0 and ends upon disease progression, the start of a new anticancer therapy, withdrawal of consent, or after 2 years (Month 24), whichever occurred first.|
59709759|NCT01072149|75828525|FG005|NOT COMPLETED|Treatment Period 1 (28 Days)||0||
59665882|NCT03083873|75784661|FG004|Completed Assessment Period|Overall Study||0|From TIL infusion on Day 0 and ends upon disease progression, the start of a new anticancer therapy, withdrawal of consent, or after 2 years (Month 24), whichever occurred first.|
59665883|NCT03083873|75784657|FG000|COMPLETED|Overall Study||0|Completed 3 years after enrollment.|
59665884|NCT03083873|75784658|FG001|COMPLETED|Overall Study||0|Completed 3 years after enrollment.|
59665885|NCT03083873|75784659|FG002|COMPLETED|Overall Study||0|Completed 3 years after enrollment.|
59665886|NCT03083873|75784660|FG003|COMPLETED|Overall Study||0|Completed 3 years after enrollment.|
59665887|NCT03083873|75784661|FG004|COMPLETED|Overall Study||0|Completed 3 years after enrollment.|
59665888|NCT03083873|75784657|FG000|NOT COMPLETED|Overall Study||10||
59665889|NCT03083873|75784658|FG001|NOT COMPLETED|Overall Study||22||
59665890|NCT03083873|75784659|FG002|NOT COMPLETED|Overall Study||19||
59665891|NCT03083873|75784660|FG003|NOT COMPLETED|Overall Study||13||
59665892|NCT03083873|75784661|FG004|NOT COMPLETED|Overall Study||0||
59665893|NCT02484430|75784672|FG000|STARTED|Overall Study||16||
59665894|NCT02484430|75784672|FG000|COMPLETED|Overall Study||16||
59665895|NCT02484430|75784672|FG000|NOT COMPLETED|Overall Study||0||
59665896|NCT02489422|75784678|FG000|STARTED|Overall Study||23||
59665897|NCT02489422|75784679|FG001|STARTED|Overall Study||21||
59665898|NCT02489422|75784678|FG000|COMPLETED|Overall Study||23||
59665899|NCT02489422|75784679|FG001|COMPLETED|Overall Study||21||
59665900|NCT02489422|75784678|FG000|NOT COMPLETED|Overall Study||0||
59665901|NCT02489422|75784679|FG001|NOT COMPLETED|Overall Study||0||
59665902|NCT04834726|75784695|FG000|STARTED|Overall Study||472||
59665903|NCT04834726|75784696|FG001|STARTED|Overall Study||2393||
59665904|NCT04834726|75784697|FG002|STARTED|Overall Study||2389||
59665905|NCT04834726|75784698|FG003|STARTED|Overall Study||2392||
59665906|NCT04834726|75784699|FG004|STARTED|Overall Study||2385||
59665907|NCT04834726|75784700|FG005|STARTED|Overall Study||2380||
59665908|NCT04834726|75784701|FG006|STARTED|Overall Study||2382||
59665909|NCT04834726|75784702|FG007|STARTED|Overall Study||2383||
59665910|NCT04834726|75784703|FG008|STARTED|Overall Study||2378||
59665911|NCT04834726|75784695|FG000|COMPLETED|Overall Study||390||
59665912|NCT04834726|75784696|FG001|COMPLETED|Overall Study||1971||
59665913|NCT04834726|75784697|FG002|COMPLETED|Overall Study||1985||
59665914|NCT04834726|75784698|FG003|COMPLETED|Overall Study||1977||
59665915|NCT04834726|75784699|FG004|COMPLETED|Overall Study||1957||
59665916|NCT04834726|75784700|FG005|COMPLETED|Overall Study||1918||
59665917|NCT04834726|75784701|FG006|COMPLETED|Overall Study||1935||
59665918|NCT04834726|75784702|FG007|COMPLETED|Overall Study||1934||
59665919|NCT04834726|75784703|FG008|COMPLETED|Overall Study||1978||
59665920|NCT04834726|75784695|FG000|NOT COMPLETED|Overall Study||82||
59665921|NCT04834726|75784696|FG001|NOT COMPLETED|Overall Study||422||
59665922|NCT04834726|75784697|FG002|NOT COMPLETED|Overall Study||404||
59665923|NCT04834726|75784698|FG003|NOT COMPLETED|Overall Study||415||
59665924|NCT04834726|75784699|FG004|NOT COMPLETED|Overall Study||428||
59665925|NCT04834726|75784700|FG005|NOT COMPLETED|Overall Study||462||
59665926|NCT04834726|75784701|FG006|NOT COMPLETED|Overall Study||447||
59665927|NCT04834726|75784702|FG007|NOT COMPLETED|Overall Study||449||
59665928|NCT04834726|75784703|FG008|NOT COMPLETED|Overall Study||400||
59665929|NCT04732949|75784719|FG000|STARTED|Overall Study||309||
59665930|NCT04732949|75784720|FG001|STARTED|Overall Study||314||
59665931|NCT04732949|75784719|FG000|COMPLETED|Overall Study||233||
59665932|NCT04732949|75784720|FG001|COMPLETED|Overall Study||231||
59665933|NCT04732949|75784719|FG000|NOT COMPLETED|Overall Study||76||
59665934|NCT04732949|75784720|FG001|NOT COMPLETED|Overall Study||83||
59665935|NCT04532918|75784726|FG000|STARTED|Overall Study||14||
59665936|NCT04532918|75784726|FG000|COMPLETED|Overall Study||14||
59665937|NCT04532918|75784726|FG000|NOT COMPLETED|Overall Study||0||
59665938|NCT04241120|75784736|FG000|STARTED|Overall Study||10||
59665939|NCT04241120|75784737|FG001|STARTED|Overall Study||5||
59665940|NCT04241120|75784736|FG000|COMPLETED|Overall Study||10||
59665941|NCT04241120|75784737|FG001|COMPLETED|Overall Study||5||
59665942|NCT04241120|75784736|FG000|NOT COMPLETED|Overall Study||0||
59665943|NCT04241120|75784737|FG001|NOT COMPLETED|Overall Study||0||
59665944|NCT04240574|75784743|FG000|STARTED|Overall Study|Due to the pandemic we were only able to recruit 2 participants. Study was terminated early due to the pandemic.|2||
59665945|NCT04240574|75784743|FG000|COMPLETED|Overall Study|Due to the pandemic we were only able to recruit 2 participants. Study was terminated early due to the pandemic.|2||
59665946|NCT04240574|75784743|FG000|NOT COMPLETED|Overall Study||0||
59665947|NCT04238689|75784755|FG000|STARTED|Overall Study||5||
59665948|NCT04238689|75784756|FG001|STARTED|Overall Study||5||
59665949|NCT04238689|75784757|FG002|STARTED|Overall Study||5||
59665950|NCT04238689|75784758|FG003|STARTED|Overall Study||5||
59665951|NCT04238689|75784759|FG004|STARTED|Overall Study||5||
59665952|NCT04238689|75784755|FG000|COMPLETED|Overall Study||5||
59665953|NCT04238689|75784756|FG001|COMPLETED|Overall Study||5||
59665954|NCT04238689|75784757|FG002|COMPLETED|Overall Study||5||
59665955|NCT04238689|75784758|FG003|COMPLETED|Overall Study||5||
59665956|NCT04238689|75784759|FG004|COMPLETED|Overall Study||5||
59665957|NCT04238689|75784755|FG000|NOT COMPLETED|Overall Study||0||
59665958|NCT04238689|75784756|FG001|NOT COMPLETED|Overall Study||0||
59665959|NCT04238689|75784757|FG002|NOT COMPLETED|Overall Study||0||
59665960|NCT04238689|75784758|FG003|NOT COMPLETED|Overall Study||0||
59665961|NCT04238689|75784759|FG004|NOT COMPLETED|Overall Study||0||
59665962|NCT04235504|75784775|FG000|STARTED|Study Phase|Subjects entering the study phase (randomized)|41||
59665963|NCT04235504|75784776|FG001|STARTED|Study Phase|Subjects entering the study phase (randomized)|41||
59665964|NCT04235504|75784777|FG002|STARTED|Study Phase|Subjects entering the study phase (randomized)|8||
59665965|NCT04235504|75784778|FG003|STARTED|Study Phase|Subjects entering the study phase (randomized)|5||
59665966|NCT04235504|75784775|FG000|COMPLETED|Study Phase||36||
59665967|NCT04235504|75784776|FG001|COMPLETED|Study Phase||39||
59665968|NCT04235504|75784777|FG002|COMPLETED|Study Phase||8||
59665969|NCT04235504|75784778|FG003|COMPLETED|Study Phase||5||
59665970|NCT04235504|75784775|FG000|NOT COMPLETED|Study Phase||5||
59665971|NCT04235504|75784776|FG001|NOT COMPLETED|Study Phase||2||
59665972|NCT04235504|75784777|FG002|NOT COMPLETED|Study Phase||0||
59665973|NCT04235504|75784778|FG003|NOT COMPLETED|Study Phase||0||
59665974|NCT04235504|75784775|FG000|STARTED|Continuation Phase||36||
59665975|NCT04235504|75784776|FG001|STARTED|Continuation Phase|One subject in cohort A control arm withdrew at day of completion of study phase|39||
59665976|NCT04235504|75784777|FG002|STARTED|Continuation Phase||8||
59665977|NCT04235504|75784778|FG003|STARTED|Continuation Phase||5||
59665978|NCT04235504|75784775|FG000|COMPLETED|Continuation Phase||35||
59665979|NCT04235504|75784776|FG001|COMPLETED|Continuation Phase||32||
59665980|NCT04235504|75784777|FG002|COMPLETED|Continuation Phase||7||
59665981|NCT04235504|75784778|FG003|COMPLETED|Continuation Phase||5||
59665982|NCT04235504|75784775|FG000|NOT COMPLETED|Continuation Phase||1||
59665983|NCT04235504|75784776|FG001|NOT COMPLETED|Continuation Phase||7||
59665984|NCT04235504|75784777|FG002|NOT COMPLETED|Continuation Phase||1||
59665985|NCT04235504|75784778|FG003|NOT COMPLETED|Continuation Phase||0||
59665986|NCT04172987|75784793|FG000|STARTED|Lead In Period||40||
59665987|NCT04172987|75784793|FG000|Received at Least One Dose of OC|Lead In Period||40||
59665988|NCT04172987|75784793|FG000|COMPLETED|Lead In Period||38||
59665989|NCT04172987|75784793|FG000|NOT COMPLETED|Lead In Period||2||
59665990|NCT04172987|75784793|FG000|STARTED|Period 1||38||
59665991|NCT04172987|75784793|FG000|Received at Least One Dose of OC|Period 1||38||
59665992|NCT04172987|75784793|FG000|COMPLETED|Period 1||37||
59665993|NCT04172987|75784793|FG000|NOT COMPLETED|Period 1||1||
59665994|NCT04172987|75784793|FG000|STARTED|Period 2||37||
59665995|NCT04172987|75784793|FG000|Received at Least One Dose of OC|Period 2||37||
59665996|NCT04172987|75784793|FG000|Received at Least 1 Dose of Tirzepatide|Period 2||28||
59665997|NCT04172987|75784793|FG000|COMPLETED|Period 2||28||
59665998|NCT04172987|75784793|FG000|NOT COMPLETED|Period 2||9||
59665999|NCT03705832|75784802|FG000|STARTED|Overall Study||21||
59666000|NCT03705832|75784803|FG001|STARTED|Overall Study||13||
59666001|NCT03705832|75784802|FG000|COMPLETED|Overall Study||20||
59666002|NCT03705832|75784803|FG001|COMPLETED|Overall Study||12||
59666003|NCT03705832|75784802|FG000|NOT COMPLETED|Overall Study||1||
59666004|NCT03705832|75784803|FG001|NOT COMPLETED|Overall Study||1||
59666005|NCT03447743|75784809|FG000|STARTED|Overall Study||9||
59666006|NCT03447743|75784809|FG000|COMPLETED|Overall Study||2||
59666007|NCT03447743|75784809|FG000|NOT COMPLETED|Overall Study||7||
59666008|NCT03433755|75784817|FG000|STARTED|Overall Study||42||
59666009|NCT03433755|75784818|FG001|STARTED|Overall Study||41||
59666010|NCT03433755|75784819|FG002|STARTED|Overall Study||79||
59666011|NCT03433755|75784820|FG003|STARTED|Overall Study||80||
59666012|NCT03433755|75784817|FG000|Randomized and Treated|Overall Study||41||
59666013|NCT03433755|75784818|FG001|Randomized and Treated|Overall Study||41||
59666014|NCT03433755|75784819|FG002|Randomized and Treated|Overall Study||79||
59666015|NCT03433755|75784820|FG003|Randomized and Treated|Overall Study||80||
59666016|NCT03433755|75784817|FG000|COMPLETED|Overall Study||40||
59666017|NCT03433755|75784818|FG001|COMPLETED|Overall Study||41||
59666018|NCT03433755|75784819|FG002|COMPLETED|Overall Study||79||
59666019|NCT03433755|75784820|FG003|COMPLETED|Overall Study||80||
59666020|NCT03433755|75784817|FG000|NOT COMPLETED|Overall Study||2||
59666021|NCT03433755|75784818|FG001|NOT COMPLETED|Overall Study||0||
59666022|NCT03433755|75784819|FG002|NOT COMPLETED|Overall Study||0||
59666023|NCT03433755|75784820|FG003|NOT COMPLETED|Overall Study||0||
59666024|NCT03430674|75784832|FG000|STARTED|Overall Study||10||
59666025|NCT03430674|75784832|FG000|COMPLETED|Overall Study||10||
59666026|NCT03430674|75784832|FG000|NOT COMPLETED|Overall Study||0||
59666027|NCT03406507|75784843|FG000|STARTED|Primary Evaluation Period||5||
59666028|NCT03406507|75784844|FG001|STARTED|Primary Evaluation Period||8||
59666029|NCT03406507|75784843|FG000|Received at Least 1 Dose of Study Drug|Primary Evaluation Period||5||
59666030|NCT03406507|75784844|FG001|Received at Least 1 Dose of Study Drug|Primary Evaluation Period||8||
59666031|NCT03406507|75784843|FG000|COMPLETED|Primary Evaluation Period||5||
59666032|NCT03406507|75784844|FG001|COMPLETED|Primary Evaluation Period||8||
59666033|NCT03406507|75784843|FG000|NOT COMPLETED|Primary Evaluation Period||0||
59666034|NCT03406507|75784844|FG001|NOT COMPLETED|Primary Evaluation Period||0||
59666035|NCT03406507|75784843|FG000|STARTED|Extension Period||5||
59666036|NCT03406507|75784844|FG001|STARTED|Extension Period||8||
59666037|NCT03406507|75784843|FG000|Received at Least 1 Dose of Study Drug|Extension Period||5||
59666038|NCT03406507|75784844|FG001|Received at Least 1 Dose of Study Drug|Extension Period||8||
59666039|NCT03406507|75784843|FG000|COMPLETED|Extension Period||5||
59666040|NCT03406507|75784844|FG001|COMPLETED|Extension Period||7||
59666041|NCT03406507|75784843|FG000|NOT COMPLETED|Extension Period||0||
59666042|NCT03406507|75784844|FG001|NOT COMPLETED|Extension Period||1||
59666043|NCT03283150|75784853|FG000|STARTED|Overall Study||20||
59666044|NCT03283150|75784854|FG001|STARTED|Overall Study||0||
59666045|NCT03283150|75784855|FG002|STARTED|Overall Study||0||
59666046|NCT03283150|75784853|FG000|COMPLETED|Overall Study||14||
59666047|NCT03283150|75784854|FG001|COMPLETED|Overall Study||0||
59666048|NCT03283150|75784855|FG002|COMPLETED|Overall Study||0||
59666049|NCT03283150|75784853|FG000|NOT COMPLETED|Overall Study||6||
59666050|NCT03283150|75784854|FG001|NOT COMPLETED|Overall Study||0||
59666051|NCT03283150|75784855|FG002|NOT COMPLETED|Overall Study||0||
59666052|NCT03218917|75784866|FG000|STARTED|Overall Study||82|Intent-to-treat (ITT) population included all the participants who were randomized.|
59666053|NCT03218917|75784867|FG001|STARTED|Overall Study||87|Intent-to-treat (ITT) population included all the participants who were randomized.|
59666054|NCT03218917|75784868|FG002|STARTED|Overall Study||87|Intent-to-treat (ITT) population included all the participants who were randomized.|
59666055|NCT03218917|75784866|FG000|Received Study Treatment (Safety Population)|Overall Study||81|Safety population included all participants who received at least 1 dose of the study drug.|
59666056|NCT03218917|75784867|FG001|Received Study Treatment (Safety Population)|Overall Study|2 participants, each randomized to placebo and Brensocatib 10 mg, received Brensocatib 25 mg. Both participants were included as randomized in the ITT population and in the INS1007 25 mg group in the Safety population.|89|Safety population included all participants who received at least 1 dose of the study drug.|
59666057|NCT03218917|75784868|FG002|Received Study Treatment (Safety Population)|Overall Study||85|Safety population included all participants who received at least 1 dose of the study drug.|
59666058|NCT03218917|75784866|FG000|Participants Did Not Receive Drug|Overall Study||0||
59666059|NCT03218917|75784867|FG001|Participants Did Not Receive Drug|Overall Study||0||
59666060|NCT03218917|75784868|FG002|Participants Did Not Receive Drug|Overall Study||1||
59666061|NCT03218917|75784866|FG000|Pharmacodynamic (PD) Population|Overall Study||80|PD population included participants who received at least 1 dose of the study drugs, have at least 1 pre-dose and 1 post-dose measurement for neutrophil elastase (NE), or proteinase 3, or cathepsin G, or other biomarkers, and have no major protocol deviations that considered to impact on the analysis of the PD data.|
59666062|NCT03218917|75784867|FG001|Pharmacodynamic (PD) Population|Overall Study||89|PD population included participants who received at least 1 dose of the study drugs, have at least 1 pre-dose and 1 post-dose measurement for neutrophil elastase (NE), or proteinase 3, or cathepsin G, or other biomarkers, and have no major protocol deviations that considered to impact on the analysis of the PD data.|
59666063|NCT03218917|75784868|FG002|Pharmacodynamic (PD) Population|Overall Study||84|PD population included participants who received at least 1 dose of the study drugs, have at least 1 pre-dose and 1 post-dose measurement for neutrophil elastase (NE), or proteinase 3, or cathepsin G, or other biomarkers, and have no major protocol deviations that considered to impact on the analysis of the PD data.|
59666064|NCT03218917|75784866|FG000|COMPLETED|Overall Study||76||
59666065|NCT03218917|75784867|FG001|COMPLETED|Overall Study||75||
59666066|NCT03218917|75784868|FG002|COMPLETED|Overall Study||74||
59666067|NCT03218917|75784866|FG000|NOT COMPLETED|Overall Study||6||
59666068|NCT03218917|75784867|FG001|NOT COMPLETED|Overall Study||12||
59666069|NCT03218917|75784868|FG002|NOT COMPLETED|Overall Study||13||
59666070|NCT03056040|75784879|FG000|STARTED|Primary Evaluation Period||97||
59666071|NCT03056040|75784880|FG001|STARTED|Primary Evaluation Period||98||
59666072|NCT03056040|75784879|FG000|Received at Least 1 Dose of Study Drug|Primary Evaluation Period||97|Participants included in the Safety Set|
59666073|NCT03056040|75784880|FG001|Received at Least 1 Dose of Study Drug|Primary Evaluation Period||98|Participants included in the Safety Set|
59666074|NCT03056040|75784879|FG000|Participants in the Full Analysis Set (FAS)|Primary Evaluation Period||97||
59666075|NCT03056040|75784880|FG001|Participants in the Full Analysis Set (FAS)|Primary Evaluation Period||98||
59666076|NCT03056040|75784879|FG000|COMPLETED|Primary Evaluation Period||96||
59666077|NCT03056040|75784880|FG001|COMPLETED|Primary Evaluation Period||95||
59666078|NCT03056040|75784879|FG000|NOT COMPLETED|Primary Evaluation Period||1||
59666079|NCT03056040|75784880|FG001|NOT COMPLETED|Primary Evaluation Period||3||
59666080|NCT03056040|75784879|FG000|STARTED|Extension Period||96||
59666081|NCT03056040|75784880|FG001|STARTED|Extension Period||95||
59666082|NCT03056040|75784879|FG000|COMPLETED|Extension Period||92||
59666083|NCT03056040|75784880|FG001|COMPLETED|Extension Period||88||
59666084|NCT03056040|75784879|FG000|NOT COMPLETED|Extension Period||4||
59666085|NCT03056040|75784880|FG001|NOT COMPLETED|Extension Period||7||
59666086|NCT03021499|75784891|FG000|STARTED|Overall Study||179||
59666087|NCT03021499|75784892|FG001|STARTED|Overall Study||178||
59666088|NCT03021499|75784891|FG000|Week 24|Overall Study||167||
59666089|NCT03021499|75784892|FG001|Week 24|Overall Study||162||
59666090|NCT03021499|75784891|FG000|Week 52|Overall Study||162||
59666091|NCT03021499|75784892|FG001|Week 52|Overall Study||147||
59666092|NCT03021499|75784891|FG000|COMPLETED|Overall Study||163||
59666093|NCT03021499|75784892|FG001|COMPLETED|Overall Study||147||
59666094|NCT03021499|75784891|FG000|NOT COMPLETED|Overall Study||16||
59666095|NCT03021499|75784892|FG001|NOT COMPLETED|Overall Study||31||
59666096|NCT02913222|75784902|FG000|STARTED|Overall Study||23||
59666097|NCT02913222|75784903|FG001|STARTED|Overall Study||23||
59666098|NCT02913222|75784902|FG000|COMPLETED|Overall Study||22||
59666099|NCT02913222|75784903|FG001|COMPLETED|Overall Study||21||
59666100|NCT02913222|75784902|FG000|NOT COMPLETED|Overall Study||1||
59666101|NCT02913222|75784903|FG001|NOT COMPLETED|Overall Study||2||
59666102|NCT02798458|75784911|FG000|STARTED|Smart Pill Test (1 Day)||35|48 patients total enrolled, 35 started and completed the SmartPill only and 13 started and completed the EMR and SmartPill.|
59666103|NCT02798458|75784912|FG001|STARTED|Smart Pill Test (1 Day)|48 patients total enrolled, 35 started and completed the SmartPill only and 13 started and completed the EMR and SmartPill.|13|48 patients total enrolled, 35 started and completed the SmartPill only and 13 started and completed the EMR and SmartPill.|
59666104|NCT02798458|75784911|FG000|COMPLETED|Smart Pill Test (1 Day)||35|48 patients total enrolled, 35 started and completed the SmartPill only and 13 started and completed the EMR and SmartPill.|
59666105|NCT02798458|75784912|FG001|COMPLETED|Smart Pill Test (1 Day)|48 patients total enrolled, 35 started and completed the SmartPill only and 13 started and completed the EMR and SmartPill.|13|48 patients total enrolled, 35 started and completed the SmartPill only and 13 started and completed the EMR and SmartPill.|
59666106|NCT02798458|75784911|FG000|NOT COMPLETED|Smart Pill Test (1 Day)||0||
59666107|NCT02798458|75784912|FG001|NOT COMPLETED|Smart Pill Test (1 Day)||0||
59666108|NCT02798458|75784911|FG000|STARTED|Endoscopic Mucosal Resection (1 Day)||0||
59666109|NCT02798458|75784912|FG001|STARTED|Endoscopic Mucosal Resection (1 Day)||13||
59666110|NCT02798458|75784911|FG000|COMPLETED|Endoscopic Mucosal Resection (1 Day)||0||
59666111|NCT02798458|75784912|FG001|COMPLETED|Endoscopic Mucosal Resection (1 Day)||13||
59666112|NCT02798458|75784911|FG000|NOT COMPLETED|Endoscopic Mucosal Resection (1 Day)||0||
59666113|NCT02798458|75784912|FG001|NOT COMPLETED|Endoscopic Mucosal Resection (1 Day)||0||
59666114|NCT02726581|75784921|FG000|STARTED|Pre-Treatment Period||75||
59666115|NCT02726581|75784922|FG001|STARTED|Pre-Treatment Period||71||
59666116|NCT02726581|75784923|FG002|STARTED|Pre-Treatment Period||24||
59666117|NCT02726581|75784921|FG000|COMPLETED|Pre-Treatment Period||72||
59666118|NCT02726581|75784922|FG001|COMPLETED|Pre-Treatment Period||70||
59666119|NCT02726581|75784923|FG002|COMPLETED|Pre-Treatment Period||24||
59666120|NCT02726581|75784921|FG000|NOT COMPLETED|Pre-Treatment Period||3||
59666121|NCT02726581|75784922|FG001|NOT COMPLETED|Pre-Treatment Period||1||
59666122|NCT02726581|75784923|FG002|NOT COMPLETED|Pre-Treatment Period||0||
59666123|NCT02726581|75784921|FG000|STARTED|Treatment Period||72||
59666124|NCT02726581|75784922|FG001|STARTED|Treatment Period||70||
59666125|NCT02726581|75784923|FG002|STARTED|Treatment Period||24||
59666126|NCT02726581|75784921|FG000|NE-Pd Crossover|Treatment Period||0||
59666127|NCT02726581|75784922|FG001|NE-Pd Crossover|Treatment Period||8||
59666128|NCT02726581|75784923|FG002|NE-Pd Crossover|Treatment Period||0||
59666129|NCT02726581|75784921|FG000|COMPLETED|Treatment Period||0|Completed treatment|
59666130|NCT02726581|75784922|FG001|COMPLETED|Treatment Period||0|Completed treatment|
59666131|NCT02726581|75784923|FG002|COMPLETED|Treatment Period||0|Completed treatment|
59666132|NCT02726581|75784921|FG000|NOT COMPLETED|Treatment Period||72||
59666133|NCT02726581|75784922|FG001|NOT COMPLETED|Treatment Period||70||
59666134|NCT02726581|75784923|FG002|NOT COMPLETED|Treatment Period||24||
59666135|NCT02700048|75784933|FG000|STARTED|Overall Study||0||
59666136|NCT02700048|75784934|FG001|STARTED|Overall Study||3||
59666137|NCT02700048|75784933|FG000|COMPLETED|Overall Study||0||
59666138|NCT02700048|75784934|FG001|COMPLETED|Overall Study||0||
59666139|NCT02700048|75784933|FG000|NOT COMPLETED|Overall Study||0||
59666140|NCT02700048|75784934|FG001|NOT COMPLETED|Overall Study||3||
59666141|NCT02678429|75784942|FG000|STARTED|Overall Study||3||
59666142|NCT02678429|75784943|FG001|STARTED|Overall Study||1||
59666143|NCT02678429|75784942|FG000|COMPLETED|Overall Study||0||
59666144|NCT02678429|75784943|FG001|COMPLETED|Overall Study||0||
59666145|NCT02678429|75784942|FG000|NOT COMPLETED|Overall Study||3||
59666146|NCT02678429|75784943|FG001|NOT COMPLETED|Overall Study||1||
59666147|NCT02425904|75784951|FG000|STARTED|Overall Study||20||
59666148|NCT02425904|75784952|FG001|STARTED|Overall Study||5||
59666149|NCT02425904|75784951|FG000|Efficacy Analysis|Overall Study||20||
59666150|NCT02425904|75784952|FG001|Efficacy Analysis|Overall Study|1 patient was incorrectly assigned to LCH-related disorders cohort but it is actually LCH patients, so excluded from efficacy analysis.|4||
59666151|NCT02425904|75784951|FG000|COMPLETED|Overall Study||17||
59666152|NCT02425904|75784952|FG001|COMPLETED|Overall Study||2||
59666153|NCT02425904|75784951|FG000|NOT COMPLETED|Overall Study||3||
59666154|NCT02425904|75784952|FG001|NOT COMPLETED|Overall Study||3||
59666155|NCT02406209|75784962|FG000|STARTED|Overall Study||15||
59666156|NCT02406209|75784963|FG001|STARTED|Overall Study||16||
59666157|NCT02406209|75784964|FG002|STARTED|Overall Study||14||
59666158|NCT02406209|75784962|FG000|COMPLETED|Overall Study||7||
59666159|NCT02406209|75784963|FG001|COMPLETED|Overall Study||7||
59666160|NCT02406209|75784964|FG002|COMPLETED|Overall Study||6||
59666161|NCT02406209|75784962|FG000|NOT COMPLETED|Overall Study||8||
59666162|NCT02406209|75784963|FG001|NOT COMPLETED|Overall Study||9||
59666163|NCT02406209|75784964|FG002|NOT COMPLETED|Overall Study||8||
59666164|NCT01964989|75784974|FG000|STARTED|Overall Study||5352||
59666165|NCT01964989|75784975|FG001|STARTED|Overall Study||5292||
59666166|NCT01964989|75784974|FG000|COMPLETED|Overall Study||4568||
59666167|NCT01964989|75784975|FG001|COMPLETED|Overall Study||4545||
59666168|NCT01964989|75784974|FG000|NOT COMPLETED|Overall Study||784||
59666169|NCT01964989|75784975|FG001|NOT COMPLETED|Overall Study||747||
59666170|NCT01575860|75785003|FG000|STARTED|Overall Study||8||
59666171|NCT01575860|75785003|FG000|COMPLETED|Overall Study||6||
59666172|NCT01575860|75785003|FG000|NOT COMPLETED|Overall Study||2||
59666173|NCT01416831|75785010|FG000|STARTED|Cycles 1 & 2 (Weeks 1-14)||20||
59666174|NCT01416831|75785011|FG001|STARTED|Cycles 1 & 2 (Weeks 1-14)||24||
59666175|NCT01416831|75785010|FG000|COMPLETED|Cycles 1 & 2 (Weeks 1-14)||19||
59666176|NCT01416831|75785011|FG001|COMPLETED|Cycles 1 & 2 (Weeks 1-14)||22||
59666177|NCT01416831|75785010|FG000|NOT COMPLETED|Cycles 1 & 2 (Weeks 1-14)||1||
59666178|NCT01416831|75785011|FG001|NOT COMPLETED|Cycles 1 & 2 (Weeks 1-14)||2||
59666179|NCT01416831|75785010|FG000|STARTED|SBRT Crossover Period||7|Of the 8 patients enrolled into Arm A whose melanoma progressed after the first imaging, 7 agreed to participate in the crossover portion of the study after completion of Cycle 2.|
59666180|NCT01416831|75785011|FG001|STARTED|SBRT Crossover Period||0|Of the 8 patients enrolled into Arm A whose melanoma progressed after the first imaging, 7 agreed to participate in the crossover portion of the study after completion of Cycle 2.|
59666181|NCT01416831|75785010|FG000|COMPLETED|SBRT Crossover Period||7||
59666182|NCT01416831|75785011|FG001|COMPLETED|SBRT Crossover Period||0||
59666183|NCT01416831|75785010|FG000|NOT COMPLETED|SBRT Crossover Period||0||
59666184|NCT01416831|75785011|FG001|NOT COMPLETED|SBRT Crossover Period||0||
59666185|NCT00635700|75785019|FG000|STARTED|Overall Study||24||
59666186|NCT00635700|75785020|FG001|STARTED|Overall Study||27||
59666187|NCT00635700|75785019|FG000|COMPLETED|Overall Study||9||
59666188|NCT00635700|75785020|FG001|COMPLETED|Overall Study||13||
59666189|NCT00635700|75785019|FG000|NOT COMPLETED|Overall Study||15||
59666190|NCT00635700|75785020|FG001|NOT COMPLETED|Overall Study||14||
59666191|NCT00582075|75785026|FG000|STARTED|Overall Study||25||
59666192|NCT00582075|75785026|FG000|COMPLETED|Overall Study||25||
59666193|NCT00582075|75785026|FG000|NOT COMPLETED|Overall Study||0||
59666194|NCT00382070|75785032|FG000|STARTED|Overall Study||1983||
59666195|NCT00382070|75785033|FG001|STARTED|Overall Study||1983||
59666196|NCT00382070|75785032|FG000|COMPLETED|Overall Study||1950||
59666197|NCT00382070|75785033|FG001|COMPLETED|Overall Study||1953||
59666198|NCT00382070|75785032|FG000|NOT COMPLETED|Overall Study||33||
59666199|NCT00382070|75785033|FG001|NOT COMPLETED|Overall Study||30||
59666200|NCT00244842|75785043|FG000|STARTED|Overall Study||115||
59666201|NCT00244842|75785044|FG001|STARTED|Overall Study||107||
59666202|NCT00244842|75785045|FG002|STARTED|Overall Study||113||
59666203|NCT00244842|75785046|FG003|STARTED|Overall Study||116||
59666204|NCT00244842|75785043|FG000|COMPLETED|Overall Study||92||
59666205|NCT00244842|75785044|FG001|COMPLETED|Overall Study||76||
59666206|NCT00244842|75785045|FG002|COMPLETED|Overall Study||91||
59666207|NCT00244842|75785046|FG003|COMPLETED|Overall Study||83||
59666208|NCT00244842|75785043|FG000|NOT COMPLETED|Overall Study||23||
59666209|NCT00244842|75785044|FG001|NOT COMPLETED|Overall Study||31||
59666210|NCT00244842|75785045|FG002|NOT COMPLETED|Overall Study||22||
59666211|NCT00244842|75785046|FG003|NOT COMPLETED|Overall Study||33||
59666212|NCT02910505|75785056|FG000|STARTED|Overall Study||8||
59666213|NCT02910505|75785056|FG000|COMPLETED|Overall Study||1||
59666214|NCT02910505|75785056|FG000|NOT COMPLETED|Overall Study||7||
59666215|NCT02935660|75785060|FG000|STARTED|Overall Study||27||
59666216|NCT02935660|75785060|FG000|COMPLETED|Overall Study||25||
59666217|NCT02935660|75785060|FG000|NOT COMPLETED|Overall Study||2||
59666218|NCT02921269|75785064|FG000|STARTED|Overall Study||11||
59666219|NCT02921269|75785064|FG000|COMPLETED|Overall Study||10||
59666220|NCT02921269|75785064|FG000|NOT COMPLETED|Overall Study||1||
59666221|NCT03139318|75785068|FG000|STARTED|Overall Study||1||
59666222|NCT03139318|75785068|FG000|COMPLETED|Overall Study||1||
59666223|NCT03139318|75785068|FG000|NOT COMPLETED|Overall Study||0||
59666224|NCT04355143|75785074|FG000|STARTED|Overall Study||48||
59666225|NCT04355143|75785075|FG001|STARTED|Overall Study||45||
59666226|NCT04355143|75785074|FG000|COMPLETED|Overall Study||48||
59666227|NCT04355143|75785075|FG001|COMPLETED|Overall Study||45||
59666228|NCT04355143|75785074|FG000|NOT COMPLETED|Overall Study||0||
59666229|NCT04355143|75785075|FG001|NOT COMPLETED|Overall Study||0||
59666230|NCT03970330|75785083|FG000|STARTED|Overall Study||5||
59666231|NCT03970330|75785084|FG001|STARTED|Overall Study||4||
59666232|NCT03970330|75785083|FG000|COMPLETED|Overall Study||5||
59666233|NCT03970330|75785084|FG001|COMPLETED|Overall Study||4||
59666234|NCT03970330|75785083|FG000|NOT COMPLETED|Overall Study||0||
59666235|NCT03970330|75785084|FG001|NOT COMPLETED|Overall Study||0||
59666236|NCT02556931|75785092|FG000|STARTED|Overall Study||57||
59666237|NCT02556931|75785093|FG001|STARTED|Overall Study||60||
59666238|NCT02556931|75785092|FG000|COMPLETED|Overall Study||57||
59666239|NCT02556931|75785093|FG001|COMPLETED|Overall Study||60||
59666240|NCT02556931|75785092|FG000|NOT COMPLETED|Overall Study||0||
59666241|NCT02556931|75785093|FG001|NOT COMPLETED|Overall Study||0||
59666242|NCT04962503|75785099|FG000|STARTED|Overall Study||6||
59666243|NCT04962503|75785099|FG000|COMPLETED|Overall Study||5||
59666244|NCT04962503|75785099|FG000|NOT COMPLETED|Overall Study||1||
59666245|NCT04303559|75785103|FG000|STARTED|Overall Study||1||
59666246|NCT04303559|75785103|FG000|COMPLETED|Overall Study||0||
59666247|NCT04303559|75785103|FG000|NOT COMPLETED|Overall Study||1||
59666248|NCT03784820|75785109|FG000|STARTED|Overall Study||11||
59666249|NCT03784820|75785110|FG001|STARTED|Overall Study||11||
59666250|NCT03784820|75785111|FG002|STARTED|Overall Study||11||
59666251|NCT03784820|75785112|FG003|STARTED|Overall Study||11||
59666252|NCT03784820|75785109|FG000|Pre (T0) Intent-to-Treat (ITT)|Overall Study||11||
59666253|NCT03784820|75785110|FG001|Pre (T0) Intent-to-Treat (ITT)|Overall Study||11||
59666254|NCT03784820|75785111|FG002|Pre (T0) Intent-to-Treat (ITT)|Overall Study||11||
59666255|NCT03784820|75785112|FG003|Pre (T0) Intent-to-Treat (ITT)|Overall Study||11||
59666256|NCT03784820|75785109|FG000|Mid-Treatment (T1) Intent-to-Treat (ITT)|Overall Study||10||
59666257|NCT03784820|75785110|FG001|Mid-Treatment (T1) Intent-to-Treat (ITT)|Overall Study||7||
59666258|NCT03784820|75785111|FG002|Mid-Treatment (T1) Intent-to-Treat (ITT)|Overall Study||9||
59989025|NCT02260804|76104312|FG000|STARTED|Induction Study Period||130||
59989026|NCT02260804|76104313|FG001|STARTED|Induction Study Period||128||
59666259|NCT03784820|75785112|FG003|Mid-Treatment (T1) Intent-to-Treat (ITT)|Overall Study||9||
59666260|NCT03784820|75785109|FG000|Post (T2) Intent-to-Treat (ITT)|Overall Study||7||
59666261|NCT03784820|75785110|FG001|Post (T2) Intent-to-Treat (ITT)|Overall Study||6||
59666262|NCT03784820|75785111|FG002|Post (T2) Intent-to-Treat (ITT)|Overall Study||9||
59666263|NCT03784820|75785112|FG003|Post (T2) Intent-to-Treat (ITT)|Overall Study||9||
59666264|NCT03784820|75785109|FG000|3 Month Fup (T3) Intent-to-Treat (ITT)|Overall Study||6||
59666265|NCT03784820|75785110|FG001|3 Month Fup (T3) Intent-to-Treat (ITT)|Overall Study||6||
59666266|NCT03784820|75785111|FG002|3 Month Fup (T3) Intent-to-Treat (ITT)|Overall Study||9||
59666267|NCT03784820|75785112|FG003|3 Month Fup (T3) Intent-to-Treat (ITT)|Overall Study||9||
59666268|NCT03784820|75785109|FG000|6 Month Fup (T4) Intent-to-Treat (ITT)|Overall Study||6||
59666269|NCT03784820|75785110|FG001|6 Month Fup (T4) Intent-to-Treat (ITT)|Overall Study||6||
59666270|NCT03784820|75785111|FG002|6 Month Fup (T4) Intent-to-Treat (ITT)|Overall Study||8||
59666271|NCT03784820|75785112|FG003|6 Month Fup (T4) Intent-to-Treat (ITT)|Overall Study||8||
59666272|NCT03784820|75785109|FG000|Pre (T0) Modified Intent-to-Treat (mITT)|Overall Study||11||
59666273|NCT03784820|75785110|FG001|Pre (T0) Modified Intent-to-Treat (mITT)|Overall Study||11||
59666274|NCT03784820|75785111|FG002|Pre (T0) Modified Intent-to-Treat (mITT)|Overall Study||10||
59666275|NCT03784820|75785112|FG003|Pre (T0) Modified Intent-to-Treat (mITT)|Overall Study||10||
59666276|NCT03784820|75785109|FG000|Mid-Treatment (T1) Modified Intent-to-Treat (mITT)|Overall Study||10||
59666277|NCT03784820|75785110|FG001|Mid-Treatment (T1) Modified Intent-to-Treat (mITT)|Overall Study||7||
59666278|NCT03784820|75785111|FG002|Mid-Treatment (T1) Modified Intent-to-Treat (mITT)|Overall Study||8||
59666279|NCT03784820|75785112|FG003|Mid-Treatment (T1) Modified Intent-to-Treat (mITT)|Overall Study||8||
59666280|NCT03784820|75785109|FG000|Post (T2) Modified Intent-to-Treat (mITT)|Overall Study||7||
59666281|NCT03784820|75785110|FG001|Post (T2) Modified Intent-to-Treat (mITT)|Overall Study||6||
59666282|NCT03784820|75785111|FG002|Post (T2) Modified Intent-to-Treat (mITT)|Overall Study||8||
59666283|NCT03784820|75785112|FG003|Post (T2) Modified Intent-to-Treat (mITT)|Overall Study||8||
59666284|NCT03784820|75785109|FG000|3 Month Fup (T3) Modified Intent-to-Treat (mITT)|Overall Study||6||
59666285|NCT03784820|75785110|FG001|3 Month Fup (T3) Modified Intent-to-Treat (mITT)|Overall Study||6||
59666286|NCT03784820|75785111|FG002|3 Month Fup (T3) Modified Intent-to-Treat (mITT)|Overall Study||8||
59666287|NCT03784820|75785112|FG003|3 Month Fup (T3) Modified Intent-to-Treat (mITT)|Overall Study||8||
59666288|NCT03784820|75785109|FG000|6 Month Fup (T4) Modified Intent-to-Treat (mITT)|Overall Study||6||
59666289|NCT03784820|75785110|FG001|6 Month Fup (T4) Modified Intent-to-Treat (mITT)|Overall Study||6||
59666290|NCT03784820|75785111|FG002|6 Month Fup (T4) Modified Intent-to-Treat (mITT)|Overall Study||7||
59666291|NCT03784820|75785112|FG003|6 Month Fup (T4) Modified Intent-to-Treat (mITT)|Overall Study||7||
59666292|NCT03784820|75785109|FG000|COMPLETED|Overall Study||6||
59666293|NCT03784820|75785110|FG001|COMPLETED|Overall Study||6||
59666294|NCT03784820|75785111|FG002|COMPLETED|Overall Study||8||
59666295|NCT03784820|75785112|FG003|COMPLETED|Overall Study||8||
59666296|NCT03784820|75785109|FG000|NOT COMPLETED|Overall Study||5||
59666297|NCT03784820|75785110|FG001|NOT COMPLETED|Overall Study||5||
59666298|NCT03784820|75785111|FG002|NOT COMPLETED|Overall Study||3||
59666299|NCT03784820|75785112|FG003|NOT COMPLETED|Overall Study||3||
59666300|NCT03769675|75785120|FG000|STARTED|Overall Study||10||
59666301|NCT03769675|75785120|FG000|COMPLETED|Overall Study||9||
59666302|NCT03769675|75785120|FG000|NOT COMPLETED|Overall Study||1||
59666303|NCT03729245|75785126|FG000|STARTED|Overall Study||311||
59666304|NCT03729245|75785127|FG001|STARTED|Overall Study||312||
59666305|NCT03729245|75785126|FG000|COMPLETED|Overall Study||289||
59666306|NCT03729245|75785127|FG001|COMPLETED|Overall Study||287||
59666307|NCT03729245|75785126|FG000|NOT COMPLETED|Overall Study||22||
59666308|NCT03729245|75785127|FG001|NOT COMPLETED|Overall Study||25||
59666309|NCT03451786|75785133|FG000|STARTED|Overall Study||369||
59666310|NCT03451786|75785133|FG000|COMPLETED|Overall Study||310||
59666311|NCT03451786|75785133|FG000|NOT COMPLETED|Overall Study||59||
59666312|NCT03311711|75785147|FG000|STARTED|Overall Study||15||
59666313|NCT03311711|75785148|FG001|STARTED|Overall Study||15||
59666314|NCT03311711|75785149|FG002|STARTED|Overall Study||12||
59666315|NCT03311711|75785150|FG003|STARTED|Overall Study||12||
59666316|NCT03311711|75785151|FG004|STARTED|Overall Study||15||
59666317|NCT03311711|75785152|FG005|STARTED|Overall Study||15||
59666318|NCT03311711|75785153|FG006|STARTED|Overall Study||40||
59666319|NCT03311711|75785154|FG007|STARTED|Overall Study||40||
59666320|NCT03311711|75785155|FG008|STARTED|Overall Study||39||
59666321|NCT03311711|75785156|FG009|STARTED|Overall Study||39||
59666322|NCT03311711|75785147|FG000|COMPLETED|Overall Study||11||
59989027|NCT02260804|76104312|FG000|COMPLETED|Induction Study Period||128||
59989028|NCT02260804|76104313|FG001|COMPLETED|Induction Study Period||128||
59989029|NCT02260804|76104312|FG000|NOT COMPLETED|Induction Study Period||2||
59989030|NCT02260804|76104313|FG001|NOT COMPLETED|Induction Study Period||0||
59989031|NCT02260804|76104312|FG000|STARTED|1st Year of the Maintenance Period (MP1)|Five subjects completed the induction period but did not initiate this period in the CT-P10 group.|123||
59989032|NCT02260804|76104313|FG001|STARTED|1st Year of the Maintenance Period (MP1)|Eight subjects completed the induction period but did not initiate this period in the Rituxan group.|120||
59989033|NCT02260804|76104312|FG000|COMPLETED|1st Year of the Maintenance Period (MP1)||111||
59989034|NCT02260804|76104313|FG001|COMPLETED|1st Year of the Maintenance Period (MP1)||105||
59989035|NCT02260804|76104312|FG000|NOT COMPLETED|1st Year of the Maintenance Period (MP1)||12||
59989036|NCT02260804|76104313|FG001|NOT COMPLETED|1st Year of the Maintenance Period (MP1)||15||
59989037|NCT02260804|76104312|FG000|STARTED|2nd Year of the Maintenance Period (MP2)|One subject completed the MP1 but did not initiate this period in the CT-P10 group.|110||
59989038|NCT02260804|76104313|FG001|STARTED|2nd Year of the Maintenance Period (MP2)|Two subjects completed the MP1 but did not initiate this period in the Rituxan group.|103||
59989039|NCT02260804|76104312|FG000|COMPLETED|2nd Year of the Maintenance Period (MP2)||101||
59989040|NCT02260804|76104313|FG001|COMPLETED|2nd Year of the Maintenance Period (MP2)||97||
59989041|NCT02260804|76104312|FG000|NOT COMPLETED|2nd Year of the Maintenance Period (MP2)||9||
59989042|NCT02260804|76104313|FG001|NOT COMPLETED|2nd Year of the Maintenance Period (MP2)||6||
59989043|NCT02260648|76104322|FG000|STARTED|Overall Study||53||
59989044|NCT02260648|76104323|FG001|STARTED|Overall Study||46||
59989045|NCT02260648|76104324|FG002|STARTED|Overall Study||50||
60077328|NCT01458340|76192364|FG002|Received Study Treatment|Overall Study||98|Safety Analysis Group|
60077329|NCT01458340|76192362|FG000|COMPLETED|Overall Study||70||
60077330|NCT01458340|76192363|FG001|COMPLETED|Overall Study||78||
60077331|NCT01458340|76192364|FG002|COMPLETED|Overall Study||76||
60077332|NCT01458340|76192362|FG000|NOT COMPLETED|Overall Study||27||
60077333|NCT01458340|76192363|FG001|NOT COMPLETED|Overall Study||21||
60077334|NCT01458340|76192364|FG002|NOT COMPLETED|Overall Study||23||
60077335|NCT02818894|76192378|FG000|STARTED|Overall Study||67||
60077336|NCT02818894|76192379|FG001|STARTED|Overall Study||68||
60077337|NCT02818894|76192378|FG000|COMPLETED|Overall Study||11||
60077338|NCT02818894|76192379|FG001|COMPLETED|Overall Study||12||
60077339|NCT02818894|76192378|FG000|NOT COMPLETED|Overall Study||56||
60077340|NCT02818894|76192379|FG001|NOT COMPLETED|Overall Study||56||
60077341|NCT02543944|76192387|FG000|STARTED|Phase 1: GBN/BUP Induction and BUP Detox||60||
60077342|NCT02543944|76192388|FG001|STARTED|Phase 1: GBN/BUP Induction and BUP Detox||57||
60077343|NCT02543944|76192387|FG000|COMPLETED|Phase 1: GBN/BUP Induction and BUP Detox||41||
60077344|NCT02543944|76192388|FG001|COMPLETED|Phase 1: GBN/BUP Induction and BUP Detox||34||
60077345|NCT02543944|76192387|FG000|NOT COMPLETED|Phase 1: GBN/BUP Induction and BUP Detox||19||
60077346|NCT02543944|76192388|FG001|NOT COMPLETED|Phase 1: GBN/BUP Induction and BUP Detox||23||
60077347|NCT02543944|76192387|FG000|STARTED|Phase 2: Transition From BUP to XR-NTX||33||
60077348|NCT02543944|76192388|FG001|STARTED|Phase 2: Transition From BUP to XR-NTX||29||
60077349|NCT02543944|76192387|FG000|COMPLETED|Phase 2: Transition From BUP to XR-NTX||12||
60077350|NCT02543944|76192388|FG001|COMPLETED|Phase 2: Transition From BUP to XR-NTX||12||
59544853|NCT00962000|75643420|FG000|NOT COMPLETED|Period 4 - 1 Week||0||
59544854|NCT00962000|75643421|FG001|NOT COMPLETED|Period 4 - 1 Week||0||
59544855|NCT02447718|75643429|FG000|STARTED|Overall Study||78||
59544856|NCT02447718|75643430|FG001|STARTED|Overall Study||78||
59544857|NCT02447718|75643429|FG000|Received Prevnar®13|Overall Study||74||
59989046|NCT02260648|76104322|FG000|Received at Least One Dose of Study Drug|Overall Study||53||
59989047|NCT02260648|76104323|FG001|Received at Least One Dose of Study Drug|Overall Study||46||
59989048|NCT02260648|76104324|FG002|Received at Least One Dose of Study Drug|Overall Study||50||
59989049|NCT02260648|76104322|FG000|COMPLETED|Overall Study||35||
59989050|NCT02260648|76104323|FG001|COMPLETED|Overall Study||33||
59989051|NCT02260648|76104324|FG002|COMPLETED|Overall Study||42||
59989052|NCT02260648|76104322|FG000|NOT COMPLETED|Overall Study||18||
60077351|NCT02543944|76192387|FG000|NOT COMPLETED|Phase 2: Transition From BUP to XR-NTX||21||
60077352|NCT02543944|76192388|FG001|NOT COMPLETED|Phase 2: Transition From BUP to XR-NTX||17||
60077353|NCT02543944|76192387|FG000|STARTED|Phase 3: XR-NTX Maintenance||12||
60077354|NCT02543944|76192388|FG001|STARTED|Phase 3: XR-NTX Maintenance||12||
59544858|NCT02447718|75643430|FG001|Received Prevnar®13|Overall Study|Do not receive vaccination|0||
59544859|NCT02447718|75643429|FG000|Received Pediacel®|Overall Study||73||
59544860|NCT02447718|75643430|FG001|Received Pediacel®|Overall Study|Do not receive vaccination|0||
59544861|NCT02447718|75643429|FG000|Received Pneumovax® 23|Overall Study||73||
59544862|NCT02447718|75643430|FG001|Received Pneumovax® 23|Overall Study|Do not receive vaccination|0||
59544863|NCT02447718|75643429|FG000|COMPLETED|Overall Study||66||
59544864|NCT02447718|75643430|FG001|COMPLETED|Overall Study||78||
59544865|NCT02447718|75643429|FG000|NOT COMPLETED|Overall Study||12||
59544866|NCT02447718|75643430|FG001|NOT COMPLETED|Overall Study||0||
59544867|NCT01017536|75643439|FG000|STARTED|Overall Study||13||
59544868|NCT01017536|75643440|FG001|STARTED|Overall Study||13||
59544869|NCT01017536|75643439|FG000|COMPLETED|Overall Study||13||
59544870|NCT01017536|75643440|FG001|COMPLETED|Overall Study||13||
59544871|NCT01017536|75643439|FG000|NOT COMPLETED|Overall Study||0||
59544872|NCT01017536|75643440|FG001|NOT COMPLETED|Overall Study||0||
59666323|NCT03311711|75785148|FG001|COMPLETED|Overall Study||11||
59666324|NCT03311711|75785149|FG002|COMPLETED|Overall Study||12||
59666325|NCT03311711|75785150|FG003|COMPLETED|Overall Study||12||
59666326|NCT03311711|75785151|FG004|COMPLETED|Overall Study||15||
59666327|NCT03311711|75785152|FG005|COMPLETED|Overall Study||15||
59666328|NCT03311711|75785153|FG006|COMPLETED|Overall Study||35||
59666329|NCT03311711|75785154|FG007|COMPLETED|Overall Study||35||
59666330|NCT03311711|75785155|FG008|COMPLETED|Overall Study||38||
59666331|NCT03311711|75785156|FG009|COMPLETED|Overall Study||38||
59666332|NCT03311711|75785147|FG000|NOT COMPLETED|Overall Study||4||
59666333|NCT03311711|75785148|FG001|NOT COMPLETED|Overall Study||4||
59666334|NCT03311711|75785149|FG002|NOT COMPLETED|Overall Study||0||
59666335|NCT03311711|75785150|FG003|NOT COMPLETED|Overall Study||0||
59666336|NCT03311711|75785151|FG004|NOT COMPLETED|Overall Study||0||
59666337|NCT03311711|75785152|FG005|NOT COMPLETED|Overall Study||0||
59666338|NCT03311711|75785153|FG006|NOT COMPLETED|Overall Study||5||
59666339|NCT03311711|75785154|FG007|NOT COMPLETED|Overall Study||5||
59666340|NCT03311711|75785155|FG008|NOT COMPLETED|Overall Study||1||
59666341|NCT03311711|75785156|FG009|NOT COMPLETED|Overall Study||1||
59666342|NCT03270891|75785186|FG000|STARTED|Overall Study||26||
59666343|NCT03270891|75785187|FG001|STARTED|Overall Study||25||
59666344|NCT03270891|75785188|FG002|STARTED|Overall Study||24||
59666345|NCT03270891|75785186|FG000|Received Intervention|Overall Study||25||
59666346|NCT03270891|75785187|FG001|Received Intervention|Overall Study||25||
59666347|NCT03270891|75785188|FG002|Received Intervention|Overall Study||0||
59666348|NCT03270891|75785186|FG000|For Physician Arm Only; Those Physicians Who Had Patients Who Participated|Overall Study||0||
59666349|NCT03270891|75785187|FG001|For Physician Arm Only; Those Physicians Who Had Patients Who Participated|Overall Study||0||
59666350|NCT03270891|75785188|FG002|For Physician Arm Only; Those Physicians Who Had Patients Who Participated|Overall Study||17||
59666351|NCT03270891|75785186|FG000|COMPLETED|Overall Study||22||
59666352|NCT03270891|75785187|FG001|COMPLETED|Overall Study||19||
59666353|NCT03270891|75785188|FG002|COMPLETED|Overall Study||17||
59666354|NCT03270891|75785186|FG000|NOT COMPLETED|Overall Study||4||
59666355|NCT03270891|75785187|FG001|NOT COMPLETED|Overall Study||6||
59666356|NCT03270891|75785188|FG002|NOT COMPLETED|Overall Study||7||
59666357|NCT02992743|75785196|FG000|STARTED|Overall Study||13||
59666358|NCT02992743|75785197|FG001|STARTED|Overall Study||10||
59666359|NCT02992743|75785196|FG000|Received T-cell Infusion|Overall Study||10||
59666360|NCT02992743|75785197|FG001|Received T-cell Infusion|Overall Study||10||
59666361|NCT02992743|75785196|FG000|COMPLETED|Overall Study|5 participants were transferred to separate long term follow-up study 208750 (NCT03391778) and 4 participants died.|9|Participants who received T-cell infusion and were followed up in this study until death, 15 years post infusion or until transfer to the separate long term follow-up study are considered to have completed.|
59666362|NCT02992743|75785197|FG001|COMPLETED|Overall Study|8 participants were transferred to separate long term follow-up study 208750 (NCT03391778).|8|Participants who received T-cell infusion and were followed up in this study until death, 15 years post infusion or until transfer to the separate long term follow-up study are considered to have completed.|
59666363|NCT02992743|75785196|FG000|NOT COMPLETED|Overall Study||4||
59666364|NCT02992743|75785197|FG001|NOT COMPLETED|Overall Study||2||
59815820|NCT03026283|75938214|FG003|STARTED|Optimal Care/ICA Diagnostic Cath||0|Participants recommended for ICA or optimal medical care after stress testing|
59815821|NCT03026283|75938215|FG004|STARTED|Optimal Care/ICA Diagnostic Cath||0|Participants recommended for ICA or optimal medical care after stress testing|
59815822|NCT03026283|75938216|FG005|STARTED|Optimal Care/ICA Diagnostic Cath||0|Participants recommended for ICA or optimal medical care after stress testing|
59815823|NCT03026283|75938217|FG006|STARTED|Optimal Care/ICA Diagnostic Cath||21|Participants recommended for ICA or optimal medical care after stress testing|
59815824|NCT03026283|75938218|FG007|STARTED|Optimal Care/ICA Diagnostic Cath||0|Participants recommended for ICA or optimal medical care after stress testing|
59815825|NCT03026283|75938211|FG000|COMPLETED|Optimal Care/ICA Diagnostic Cath||0||
59815826|NCT03026283|75938212|FG001|COMPLETED|Optimal Care/ICA Diagnostic Cath||0||
59815827|NCT03026283|75938213|FG002|COMPLETED|Optimal Care/ICA Diagnostic Cath||0||
59815828|NCT03026283|75938214|FG003|COMPLETED|Optimal Care/ICA Diagnostic Cath||0||
59815829|NCT03026283|75938215|FG004|COMPLETED|Optimal Care/ICA Diagnostic Cath||0||
59815830|NCT03026283|75938216|FG005|COMPLETED|Optimal Care/ICA Diagnostic Cath||0||
59815831|NCT03026283|75938217|FG006|COMPLETED|Optimal Care/ICA Diagnostic Cath||21||
59815832|NCT03026283|75938218|FG007|COMPLETED|Optimal Care/ICA Diagnostic Cath||0||
59815833|NCT03026283|75938211|FG000|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0||
59815834|NCT03026283|75938212|FG001|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0||
59815835|NCT03026283|75938213|FG002|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0||
59815836|NCT03026283|75938214|FG003|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0||
59815837|NCT03026283|75938215|FG004|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0||
59815838|NCT03026283|75938216|FG005|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0||
59815839|NCT03026283|75938217|FG006|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0||
59815840|NCT03026283|75938218|FG007|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0||
59815841|NCT02915367|75938233|FG000|STARTED|Overall Study||173||
59989053|NCT02260648|76104323|FG001|NOT COMPLETED|Overall Study||13||
59989054|NCT02260648|76104324|FG002|NOT COMPLETED|Overall Study||8||
59666365|NCT02853344|75785205|FG000|STARTED|Overall Study||110||
59989055|NCT02260492|76104335|FG000|STARTED|Overall Study||418||
59989056|NCT02260492|76104336|FG001|STARTED|Overall Study||419||
59989057|NCT02260492|76104337|FG002|STARTED|Overall Study||42||
60077355|NCT02543944|76192387|FG000|COMPLETED|Phase 3: XR-NTX Maintenance||7||
60077356|NCT02543944|76192388|FG001|COMPLETED|Phase 3: XR-NTX Maintenance||3||
59544873|NCT00962078|75643448|FG000|STARTED|Overall Study||35||
59544874|NCT00962078|75643449|FG001|STARTED|Overall Study||36||
59544875|NCT00962078|75643448|FG000|COMPLETED|Overall Study||30||
59544876|NCT00962078|75643449|FG001|COMPLETED|Overall Study||30||
59544877|NCT00962078|75643448|FG000|NOT COMPLETED|Overall Study||5||
59544878|NCT00962078|75643449|FG001|NOT COMPLETED|Overall Study||6||
59544879|NCT00963482|75643457|FG000|STARTED|Overall Study||53||
59544880|NCT00963482|75643458|FG001|STARTED|Overall Study||50||
59666366|NCT02853344|75785206|FG001|STARTED|Overall Study||165||
59666367|NCT02853344|75785205|FG000|Received Second Course of Pembrolizumab|Overall Study||3||
59666368|NCT02853344|75785206|FG001|Received Second Course of Pembrolizumab|Overall Study||5||
59666369|NCT02853344|75785205|FG000|COMPLETED|Overall Study||0||
59666370|NCT02853344|75785206|FG001|COMPLETED|Overall Study||0||
59666371|NCT02853344|75785205|FG000|NOT COMPLETED|Overall Study||110||
59666372|NCT02853344|75785206|FG001|NOT COMPLETED|Overall Study||165||
59666373|NCT02739620|75785217|FG000|STARTED|Overall Study||12||
59666374|NCT02739620|75785218|FG001|STARTED|Overall Study||10||
59666375|NCT02739620|75785217|FG000|Baseline Testing|Overall Study||12||
59666376|NCT02739620|75785218|FG001|Baseline Testing|Overall Study||10||
59666377|NCT02739620|75785217|FG000|Intervention Phase|Overall Study||10||
59666378|NCT02739620|75785218|FG001|Intervention Phase|Overall Study||10||
59666379|NCT02739620|75785217|FG000|Post-intervention Testing|Overall Study||9||
59666380|NCT02739620|75785218|FG001|Post-intervention Testing|Overall Study||8||
59666381|NCT02739620|75785217|FG000|COMPLETED|Overall Study||9||
59666382|NCT02739620|75785218|FG001|COMPLETED|Overall Study||8||
59989058|NCT02260492|76104335|FG000|Completed Day 1|Overall Study||418||
59989059|NCT02260492|76104336|FG001|Completed Day 1|Overall Study||419||
59989060|NCT02260492|76104337|FG002|Completed Day 1|Overall Study||42||
59989061|NCT02260492|76104335|FG000|COMPLETED|Overall Study||395||
59989062|NCT02260492|76104336|FG001|COMPLETED|Overall Study||406||
59989063|NCT02260492|76104337|FG002|COMPLETED|Overall Study||37||
59989064|NCT02260492|76104335|FG000|NOT COMPLETED|Overall Study||23||
59989065|NCT02260492|76104336|FG001|NOT COMPLETED|Overall Study||13||
59989066|NCT02260492|76104337|FG002|NOT COMPLETED|Overall Study||5||
59989067|NCT02260258|76104347|FG000|STARTED|Overall Study||39||
59989068|NCT02260258|76104348|FG001|STARTED|Overall Study||44||
59989069|NCT02260258|76104347|FG000|COMPLETED|Overall Study||37||
59989070|NCT02260258|76104348|FG001|COMPLETED|Overall Study||43||
59989071|NCT02260258|76104347|FG000|NOT COMPLETED|Overall Study||2||
59989072|NCT02260258|76104348|FG001|NOT COMPLETED|Overall Study||1||
59989073|NCT02260180|76104358|FG000|STARTED|Overall Study||39||
59989074|NCT02260180|76104359|FG001|STARTED|Overall Study||39||
59989075|NCT02260180|76104360|FG002|STARTED|Overall Study||41||
59989076|NCT02260180|76104358|FG000|COMPLETED|Overall Study||37||
59989077|NCT02260180|76104359|FG001|COMPLETED|Overall Study||39||
59989078|NCT02260180|76104360|FG002|COMPLETED|Overall Study||40||
59989079|NCT02260180|76104358|FG000|NOT COMPLETED|Overall Study||2||
59989080|NCT02260180|76104359|FG001|NOT COMPLETED|Overall Study||0||
59989081|NCT02260180|76104360|FG002|NOT COMPLETED|Overall Study||1||
59989082|NCT02353468|76104368|FG000|STARTED|Overall Study||3||
59989083|NCT02353468|76104368|FG000|COMPLETED|Overall Study||0||
59989084|NCT02353468|76104368|FG000|NOT COMPLETED|Overall Study||3||
59989085|NCT02349412|76104374|FG000|STARTED|Overall Study||202||
59989086|NCT02349412|76104375|FG001|STARTED|Overall Study||203||
59989087|NCT02349412|76104374|FG000|Completed Week-12 QOL Assessment Measure|Overall Study||92||
59989088|NCT02349412|76104375|FG001|Completed Week-12 QOL Assessment Measure|Overall Study||101||
59989089|NCT02349412|76104374|FG000|Completed Week-24 QOL Assessment Measure|Overall Study||68||
59989090|NCT02349412|76104375|FG001|Completed Week-24 QOL Assessment Measure|Overall Study||80||
59989091|NCT02349412|76104374|FG000|COMPLETED|Overall Study||195||
60077357|NCT02543944|76192387|FG000|NOT COMPLETED|Phase 3: XR-NTX Maintenance||5||
59544881|NCT00963482|75643457|FG000|COMPLETED|Overall Study||25||
59666383|NCT02739620|75785217|FG000|NOT COMPLETED|Overall Study||3||
59989092|NCT02349412|76104375|FG001|COMPLETED|Overall Study||196||
59666384|NCT02739620|75785218|FG001|NOT COMPLETED|Overall Study||2||
59815842|NCT02915367|75938234|FG001|STARTED|Overall Study||175||
59989093|NCT02349412|76104374|FG000|NOT COMPLETED|Overall Study||7||
59989094|NCT02349412|76104375|FG001|NOT COMPLETED|Overall Study||7||
59989095|NCT02259400|76104383|FG000|STARTED|Overall Study||62||
59989096|NCT02259400|76104384|FG001|STARTED|Overall Study||62||
60077358|NCT02543944|76192388|FG001|NOT COMPLETED|Phase 3: XR-NTX Maintenance||9||
59544882|NCT00963482|75643458|FG001|COMPLETED|Overall Study||33||
59666385|NCT02675426|75785227|FG000|STARTED|Period 1: Week 1 to Week 12||110||
59666386|NCT02675426|75785228|FG001|STARTED|Period 1: Week 1 to Week 12||111||
59666387|NCT02675426|75785229|FG002|STARTED|Period 1: Week 1 to Week 12||221||
59989097|NCT02259400|76104383|FG000|COMPLETED|Overall Study||62||
59544883|NCT00963482|75643457|FG000|NOT COMPLETED|Overall Study||28||
59544884|NCT00963482|75643458|FG001|NOT COMPLETED|Overall Study||17||
59989098|NCT02259400|76104384|FG001|COMPLETED|Overall Study||60||
59989099|NCT02259400|76104383|FG000|NOT COMPLETED|Overall Study||0||
59666388|NCT02675426|75785230|FG003|STARTED|Period 1: Week 1 to Week 12||219||
59666389|NCT02675426|75785227|FG000|Received Study Drug|Period 1: Week 1 to Week 12||110||
59666390|NCT02675426|75785228|FG001|Received Study Drug|Period 1: Week 1 to Week 12||111||
59666391|NCT02675426|75785229|FG002|Received Study Drug|Period 1: Week 1 to Week 12||221||
59666392|NCT02675426|75785230|FG003|Received Study Drug|Period 1: Week 1 to Week 12||219||
59666393|NCT02675426|75785227|FG000|COMPLETED|Period 1: Week 1 to Week 12||104||
59666394|NCT02675426|75785228|FG001|COMPLETED|Period 1: Week 1 to Week 12||104||
59666395|NCT02675426|75785229|FG002|COMPLETED|Period 1: Week 1 to Week 12||213||
59666396|NCT02675426|75785230|FG003|COMPLETED|Period 1: Week 1 to Week 12||201||
59666397|NCT02675426|75785227|FG000|NOT COMPLETED|Period 1: Week 1 to Week 12||6||
59666398|NCT02675426|75785228|FG001|NOT COMPLETED|Period 1: Week 1 to Week 12||7||
59666399|NCT02675426|75785229|FG002|NOT COMPLETED|Period 1: Week 1 to Week 12||8||
59666400|NCT02675426|75785230|FG003|NOT COMPLETED|Period 1: Week 1 to Week 12||18||
59666401|NCT02675426|75785227|FG000|STARTED|Period 2: Week 12 to Week 260||103|Four participants completed the Week 12 visit but did not continue into Period 2.|
59666402|NCT02675426|75785228|FG001|STARTED|Period 2: Week 12 to Week 260||103|Four participants completed the Week 12 visit but did not continue into Period 2.|
59666403|NCT02675426|75785229|FG002|STARTED|Period 2: Week 12 to Week 260||212|Four participants completed the Week 12 visit but did not continue into Period 2.|
59666404|NCT02675426|75785230|FG003|STARTED|Period 2: Week 12 to Week 260||200|Four participants completed the Week 12 visit but did not continue into Period 2.|
59666405|NCT02675426|75785227|FG000|Received Study Drug|Period 2: Week 12 to Week 260||103||
59666406|NCT02675426|75785228|FG001|Received Study Drug|Period 2: Week 12 to Week 260||102||
59666407|NCT02675426|75785229|FG002|Received Study Drug|Period 2: Week 12 to Week 260||207||
59666408|NCT02675426|75785230|FG003|Received Study Drug|Period 2: Week 12 to Week 260||199||
59666409|NCT02675426|75785227|FG000|Switched to Upadacitinib 15 mg After Protocol Amendment 6|Period 2: Week 12 to Week 260||0||
59666410|NCT02675426|75785228|FG001|Switched to Upadacitinib 15 mg After Protocol Amendment 6|Period 2: Week 12 to Week 260||53||
59666411|NCT02675426|75785229|FG002|Switched to Upadacitinib 15 mg After Protocol Amendment 6|Period 2: Week 12 to Week 260||0||
59666412|NCT02675426|75785230|FG003|Switched to Upadacitinib 15 mg After Protocol Amendment 6|Period 2: Week 12 to Week 260||126||
59666413|NCT02675426|75785227|FG000|COMPLETED|Period 2: Week 12 to Week 260||61||
59666414|NCT02675426|75785228|FG001|COMPLETED|Period 2: Week 12 to Week 260||49||
59666415|NCT02675426|75785229|FG002|COMPLETED|Period 2: Week 12 to Week 260||130||
59666416|NCT02675426|75785230|FG003|COMPLETED|Period 2: Week 12 to Week 260||120||
59666417|NCT02675426|75785227|FG000|NOT COMPLETED|Period 2: Week 12 to Week 260||42||
59666418|NCT02675426|75785228|FG001|NOT COMPLETED|Period 2: Week 12 to Week 260||54||
59666419|NCT02675426|75785229|FG002|NOT COMPLETED|Period 2: Week 12 to Week 260||82||
59666420|NCT02675426|75785230|FG003|NOT COMPLETED|Period 2: Week 12 to Week 260||80||
59989100|NCT02259400|76104384|FG001|NOT COMPLETED|Overall Study||2||
59989101|NCT01530997|76104390|FG000|STARTED|Overall Study||45||
59989102|NCT01530997|76104390|FG000|COMPLETED|Overall Study||43||
59989103|NCT01530997|76104390|FG000|NOT COMPLETED|Overall Study||2||
59989104|NCT02259088|76104403|FG000|STARTED|Overall Study||307|All randomized participants|
59989105|NCT02259088|76104404|FG001|STARTED|Overall Study||77|All randomized participants|
59989106|NCT02259088|76104403|FG000|Full Analysis Set|Overall Study||307||
59989107|NCT02259088|76104404|FG001|Full Analysis Set|Overall Study||77||
59989108|NCT02259088|76104403|FG000|Treated (Safety Analysis Set)|Overall Study||307||
59989109|NCT02259088|76104404|FG001|Treated (Safety Analysis Set)|Overall Study||75||
59989110|NCT02259088|76104403|FG000|COMPLETED|Overall Study||279||
59989111|NCT02259088|76104404|FG001|COMPLETED|Overall Study||63||
59989112|NCT02259088|76104403|FG000|NOT COMPLETED|Overall Study||28||
59544885|NCT00963560|75643467|FG000|STARTED|Overall Study||47||
59544886|NCT00963560|75643468|FG001|STARTED|Overall Study||44||
59544887|NCT00963560|75643469|FG002|STARTED|Overall Study||41||
59544888|NCT00963560|75643467|FG000|COMPLETED|Overall Study||44||
59544889|NCT00963560|75643468|FG001|COMPLETED|Overall Study||41||
59544890|NCT00963560|75643469|FG002|COMPLETED|Overall Study||41||
59544891|NCT00963560|75643467|FG000|NOT COMPLETED|Overall Study||3||
59544892|NCT00963560|75643468|FG001|NOT COMPLETED|Overall Study||3||
59544893|NCT00963560|75643469|FG002|NOT COMPLETED|Overall Study||0||
59544894|NCT00963638|75643479|FG000|STARTED|Overall Study||20||
59544895|NCT00963638|75643480|FG001|STARTED|Overall Study||20||
59544896|NCT00963638|75643479|FG000|COMPLETED|Overall Study||20||
59544897|NCT00963638|75643480|FG001|COMPLETED|Overall Study||20||
59544898|NCT00963638|75643479|FG000|NOT COMPLETED|Overall Study||0||
59544899|NCT00963638|75643480|FG001|NOT COMPLETED|Overall Study||0||
59544900|NCT01682135|75643489|FG000|STARTED|Overall Study||6||
59544901|NCT01682135|75643490|FG001|STARTED|Overall Study||10||
59544902|NCT01682135|75643491|FG002|STARTED|Overall Study||12||
59989113|NCT02259088|76104404|FG001|NOT COMPLETED|Overall Study||14||
59544903|NCT01682135|75643489|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6||
59544904|NCT01682135|75643490|FG001|Received at Least 1 Dose of Study Drug|Overall Study||10||
59544905|NCT01682135|75643491|FG002|Received at Least 1 Dose of Study Drug|Overall Study||12||
59544906|NCT01682135|75643489|FG000|COMPLETED|Overall Study||6||
59544907|NCT01682135|75643490|FG001|COMPLETED|Overall Study||10||
59666421|NCT02631837|75785243|FG000|STARTED|Overall Study||35||
59666422|NCT02631837|75785244|FG001|STARTED|Overall Study||35||
59666423|NCT02631837|75785243|FG000|COMPLETED|Overall Study||35||
59666424|NCT02631837|75785244|FG001|COMPLETED|Overall Study||35||
59666425|NCT02631837|75785243|FG000|NOT COMPLETED|Overall Study||0||
59666426|NCT02631837|75785244|FG001|NOT COMPLETED|Overall Study||0||
59666427|NCT02153944|75785255|FG000|STARTED|Behavioral Sub-study||20||
59666428|NCT02153944|75785256|FG001|STARTED|Behavioral Sub-study||20||
59666429|NCT02153944|75785257|FG002|STARTED|Behavioral Sub-study||20||
59666430|NCT02153944|75785258|FG003|STARTED|Behavioral Sub-study||0||
59666431|NCT02153944|75785259|FG004|STARTED|Behavioral Sub-study||0||
59666432|NCT02153944|75785255|FG000|COMPLETED|Behavioral Sub-study||20||
59666433|NCT02153944|75785256|FG001|COMPLETED|Behavioral Sub-study||20||
59666434|NCT02153944|75785257|FG002|COMPLETED|Behavioral Sub-study||20||
59666435|NCT02153944|75785258|FG003|COMPLETED|Behavioral Sub-study||0||
59666436|NCT02153944|75785259|FG004|COMPLETED|Behavioral Sub-study||0||
59666437|NCT02153944|75785255|FG000|NOT COMPLETED|Behavioral Sub-study||0||
59666438|NCT02153944|75785256|FG001|NOT COMPLETED|Behavioral Sub-study||0||
59666439|NCT02153944|75785257|FG002|NOT COMPLETED|Behavioral Sub-study||0||
59666440|NCT02153944|75785258|FG003|NOT COMPLETED|Behavioral Sub-study||0||
59666441|NCT02153944|75785259|FG004|NOT COMPLETED|Behavioral Sub-study||0||
59666442|NCT02153944|75785255|FG000|STARTED|fMRI Sub-study||0||
59666443|NCT02153944|75785256|FG001|STARTED|fMRI Sub-study||0||
59666444|NCT02153944|75785257|FG002|STARTED|fMRI Sub-study||0||
59666445|NCT02153944|75785258|FG003|STARTED|fMRI Sub-study||34||
59666446|NCT02153944|75785259|FG004|STARTED|fMRI Sub-study|Include one subject from Behavioral: Drug challenge with propranolol|35||
59666447|NCT02153944|75785255|FG000|COMPLETED|fMRI Sub-study||0||
59666448|NCT02153944|75785256|FG001|COMPLETED|fMRI Sub-study||0||
59666449|NCT02153944|75785257|FG002|COMPLETED|fMRI Sub-study||0||
59666450|NCT02153944|75785258|FG003|COMPLETED|fMRI Sub-study||34||
59666451|NCT02153944|75785259|FG004|COMPLETED|fMRI Sub-study||35||
59666452|NCT02153944|75785255|FG000|NOT COMPLETED|fMRI Sub-study||0||
59666453|NCT02153944|75785256|FG001|NOT COMPLETED|fMRI Sub-study||0||
59666454|NCT02153944|75785257|FG002|NOT COMPLETED|fMRI Sub-study||0||
59666455|NCT02153944|75785258|FG003|NOT COMPLETED|fMRI Sub-study||0||
59666456|NCT02153944|75785259|FG004|NOT COMPLETED|fMRI Sub-study||0||
59666457|NCT02060721|75785271|FG000|STARTED|Overall Study||76||
59666458|NCT02060721|75785271|FG000|COMPLETED|Overall Study||38||
59666459|NCT02060721|75785271|FG000|NOT COMPLETED|Overall Study||38||
59666460|NCT01527149|75785275|FG000|STARTED|Overall Study||37||
59666461|NCT01527149|75785275|FG000|COMPLETED|Overall Study||35||
59666462|NCT01527149|75785275|FG000|NOT COMPLETED|Overall Study||2||
59666463|NCT01359956|75785283|FG000|STARTED|Overall Study||67||
59666464|NCT01359956|75785284|FG001|STARTED|Overall Study||69||
59666465|NCT01359956|75785285|FG002|STARTED|Overall Study||71||
59666466|NCT01359956|75785286|FG003|STARTED|Overall Study||62||
59666467|NCT01359956|75785283|FG000|COMPLETED|Overall Study||6||
59666468|NCT01359956|75785284|FG001|COMPLETED|Overall Study||5||
59666469|NCT01359956|75785285|FG002|COMPLETED|Overall Study||4||
59666470|NCT01359956|75785286|FG003|COMPLETED|Overall Study||4||
59666471|NCT01359956|75785283|FG000|NOT COMPLETED|Overall Study||61||
59666472|NCT01359956|75785284|FG001|NOT COMPLETED|Overall Study||64||
59666473|NCT01359956|75785285|FG002|NOT COMPLETED|Overall Study||67||
59666474|NCT01359956|75785286|FG003|NOT COMPLETED|Overall Study||58||
59666475|NCT01306045|75785299|FG000|STARTED|Met General Eligibility Criteria||481|647met eligibility criteria/underwent molecular profiling, 257 had 1 of the core mutations&45 enrolled in 1 of the treatment arms. 602 enrolled in Not Otherwise Specified Arm&received standard of care treatment or enrolled in other clinical trials&followed prospectively until death(312 with tumors-wild type or unknown for the mutation of interest, 212positive for 1 of the core mutations of interest but failed to enroll in treatment arms (screen failures)&78 with unsuccessful molecular profiling.|
59666476|NCT01306045|75785300|FG001|STARTED|Met General Eligibility Criteria||68|647met eligibility criteria/underwent molecular profiling, 257 had 1 of the core mutations&45 enrolled in 1 of the treatment arms. 602 enrolled in Not Otherwise Specified Arm&received standard of care treatment or enrolled in other clinical trials&followed prospectively until death(312 with tumors-wild type or unknown for the mutation of interest, 212positive for 1 of the core mutations of interest but failed to enroll in treatment arms (screen failures)&78 with unsuccessful molecular profiling.|
59666477|NCT01306045|75785301|FG002|STARTED|Met General Eligibility Criteria||98|647met eligibility criteria/underwent molecular profiling, 257 had 1 of the core mutations&45 enrolled in 1 of the treatment arms. 602 enrolled in Not Otherwise Specified Arm&received standard of care treatment or enrolled in other clinical trials&followed prospectively until death(312 with tumors-wild type or unknown for the mutation of interest, 212positive for 1 of the core mutations of interest but failed to enroll in treatment arms (screen failures)&78 with unsuccessful molecular profiling.|
59666478|NCT01306045|75785299|FG000|Had EGFR Mutations|Met General Eligibility Criteria||88||
59666479|NCT01306045|75785300|FG001|Had EGFR Mutations|Met General Eligibility Criteria||1||
59666480|NCT01306045|75785301|FG002|Had EGFR Mutations|Met General Eligibility Criteria||1||
59666481|NCT01306045|75785299|FG000|Had KRAS, HRAS, NRAS, or BRAF Mutations|Met General Eligibility Criteria||103||
59666482|NCT01306045|75785300|FG001|Had KRAS, HRAS, NRAS, or BRAF Mutations|Met General Eligibility Criteria||5||
59666483|NCT01306045|75785301|FG002|Had KRAS, HRAS, NRAS, or BRAF Mutations|Met General Eligibility Criteria||2||
59666484|NCT01306045|75785299|FG000|Had PTEN, Akt1, or PIK3CA Abnormalities|Met General Eligibility Criteria||22||
59666485|NCT01306045|75785300|FG001|Had PTEN, Akt1, or PIK3CA Abnormalities|Met General Eligibility Criteria||7||
59666486|NCT01306045|75785301|FG002|Had PTEN, Akt1, or PIK3CA Abnormalities|Met General Eligibility Criteria||2||
59666487|NCT01306045|75785299|FG000|Had ERBB2 Mutations or Amplifications|Met General Eligibility Criteria||13||
59666488|NCT01306045|75785300|FG001|Had ERBB2 Mutations or Amplifications|Met General Eligibility Criteria||1||
59666489|NCT01306045|75785301|FG002|Had ERBB2 Mutations or Amplifications|Met General Eligibility Criteria||1||
59666490|NCT01306045|75785299|FG000|Had KIT or PDGFRA Mutations or Amplifications|Met General Eligibility Criteria||5||
59666491|NCT01306045|75785300|FG001|Had KIT or PDGFRA Mutations or Amplifications|Met General Eligibility Criteria||1||
59666492|NCT01306045|75785301|FG002|Had KIT or PDGFRA Mutations or Amplifications|Met General Eligibility Criteria||5||
59666493|NCT01306045|75785299|FG000|Enrolled Onto Treatment Arm|Met General Eligibility Criteria||38||
59666494|NCT01306045|75785300|FG001|Enrolled Onto Treatment Arm|Met General Eligibility Criteria||4||
59666495|NCT01306045|75785301|FG002|Enrolled Onto Treatment Arm|Met General Eligibility Criteria||3||
59666496|NCT01306045|75785299|FG000|COMPLETED|Met General Eligibility Criteria||288||
59666497|NCT01306045|75785300|FG001|COMPLETED|Met General Eligibility Criteria||57||
59666498|NCT01306045|75785301|FG002|COMPLETED|Met General Eligibility Criteria||90||
59666499|NCT01306045|75785299|FG000|NOT COMPLETED|Met General Eligibility Criteria||193||
59666500|NCT01306045|75785300|FG001|NOT COMPLETED|Met General Eligibility Criteria||11||
59666501|NCT01306045|75785301|FG002|NOT COMPLETED|Met General Eligibility Criteria||8||
59666502|NCT01306045|75785299|FG000|STARTED|Treatments Received|Group could be evaluated for response and survival.|38||
59666503|NCT01306045|75785300|FG001|STARTED|Treatments Received|Group could be evaluated for response and survival.|4||
59666504|NCT01306045|75785301|FG002|STARTED|Treatments Received|Group could be evaluated for response and survival.|3||
59666505|NCT01306045|75785299|FG000|Received Erlotinib: Arm 1, Arm 2, and Arm 3 Respectively.|Treatments Received||15||
59666506|NCT01306045|75785300|FG001|Received Erlotinib: Arm 1, Arm 2, and Arm 3 Respectively.|Treatments Received||0||
59666507|NCT01306045|75785301|FG002|Received Erlotinib: Arm 1, Arm 2, and Arm 3 Respectively.|Treatments Received||1||
59666508|NCT01306045|75785299|FG000|Received Selumetinib: Arm 4, Arm 5, and Arm 6 Respectively.|Treatments Received||9||
59666509|NCT01306045|75785300|FG001|Received Selumetinib: Arm 4, Arm 5, and Arm 6 Respectively.|Treatments Received||1||
59666510|NCT01306045|75785301|FG002|Received Selumetinib: Arm 4, Arm 5, and Arm 6 Respectively.|Treatments Received||0||
59666511|NCT01306045|75785299|FG000|Received MK2206: Arm 7, Arm 8, and Arm 9 Respectively.|Treatments Received||4||
59666512|NCT01306045|75785300|FG001|Received MK2206: Arm 7, Arm 8, and Arm 9 Respectively.|Treatments Received||2||
59666513|NCT01306045|75785301|FG002|Received MK2206: Arm 7, Arm 8, and Arm 9 Respectively.|Treatments Received||1||
59666514|NCT01306045|75785299|FG000|Received Lapatinib: Arm 10, Arm 11, and Arm 12 Respectively.|Treatments Received||6||
59666515|NCT01306045|75785300|FG001|Received Lapatinib: Arm 10, Arm 11, and Arm 12 Respectively.|Treatments Received||1||
59666516|NCT01306045|75785301|FG002|Received Lapatinib: Arm 10, Arm 11, and Arm 12 Respectively.|Treatments Received||0||
59666517|NCT01306045|75785299|FG000|Received Sunitinib: Arm 13, Arm 14, and Arm 15 Respectively.|Treatments Received||2||
59666518|NCT01306045|75785300|FG001|Received Sunitinib: Arm 13, Arm 14, and Arm 15 Respectively.|Treatments Received||0||
59666519|NCT01306045|75785301|FG002|Received Sunitinib: Arm 13, Arm 14, and Arm 15 Respectively.|Treatments Received||1||
59666520|NCT01306045|75785299|FG000|COMPLETED|Treatments Received||36||
59666521|NCT01306045|75785300|FG001|COMPLETED|Treatments Received||4||
59666522|NCT01306045|75785301|FG002|COMPLETED|Treatments Received||3||
59666523|NCT01306045|75785299|FG000|NOT COMPLETED|Treatments Received||2||
59666524|NCT01306045|75785300|FG001|NOT COMPLETED|Treatments Received||0||
59666525|NCT01306045|75785301|FG002|NOT COMPLETED|Treatments Received||0||
59666526|NCT01278303|75785309|FG000|STARTED|Overall Study||82||
59666527|NCT01278303|75785309|FG000|COMPLETED|Overall Study||82||
59666528|NCT01278303|75785309|FG000|NOT COMPLETED|Overall Study||0||
59666529|NCT01196936|75785315|FG000|STARTED|Overall Study||34||
59666530|NCT01196936|75785316|FG001|STARTED|Overall Study||38||
59666531|NCT01196936|75785315|FG000|Year One Post Treatment|Overall Study||27||
59666532|NCT01196936|75785316|FG001|Year One Post Treatment|Overall Study||28||
59666533|NCT01196936|75785315|FG000|COMPLETED|Overall Study||23||
59666534|NCT01196936|75785316|FG001|COMPLETED|Overall Study||21||
59666535|NCT01196936|75785315|FG000|NOT COMPLETED|Overall Study||11||
59666536|NCT01196936|75785316|FG001|NOT COMPLETED|Overall Study||17||
59666537|NCT01075971|75785322|FG000|STARTED|Overall Study||52||
59666538|NCT01075971|75785322|FG000|COMPLETED|Overall Study||52||
59666539|NCT01075971|75785322|FG000|NOT COMPLETED|Overall Study||0||
59666540|NCT04427917|75785328|FG000|STARTED|Overall Study||2||
59666541|NCT04427917|75785329|FG001|STARTED|Overall Study||6||
59666542|NCT04427917|75785328|FG000|COMPLETED|Overall Study||2||
59666543|NCT04427917|75785329|FG001|COMPLETED|Overall Study||6||
59666544|NCT04427917|75785328|FG000|NOT COMPLETED|Overall Study||0||
59666545|NCT04427917|75785329|FG001|NOT COMPLETED|Overall Study||0||
59666546|NCT00583804|75785336|FG000|STARTED|Overall Study||10||
59666547|NCT00583804|75785336|FG000|COMPLETED|Overall Study|Subjects were considered enrolled when they underwent implantation of the device. All completed.|10||
59666548|NCT00583804|75785336|FG000|NOT COMPLETED|Overall Study||0||
59666549|NCT05121480|75785350|FG000|STARTED|Overall Study||25||
59666550|NCT05121480|75785351|FG001|STARTED|Overall Study||74||
59666551|NCT05121480|75785352|FG002|STARTED|Overall Study||25||
59666552|NCT05121480|75785353|FG003|STARTED|Overall Study||74||
59666553|NCT05121480|75785354|FG004|STARTED|Overall Study||25||
59666554|NCT05121480|75785355|FG005|STARTED|Overall Study||86||
59666555|NCT05121480|75785356|FG006|STARTED|Overall Study||38||
59666556|NCT05121480|75785357|FG007|STARTED|Overall Study||74||
59666557|NCT05121480|75785350|FG000|COMPLETED|Overall Study||19||
59666558|NCT05121480|75785351|FG001|COMPLETED|Overall Study||56||
59666559|NCT05121480|75785352|FG002|COMPLETED|Overall Study||22||
59666560|NCT05121480|75785353|FG003|COMPLETED|Overall Study||53||
59666561|NCT05121480|75785354|FG004|COMPLETED|Overall Study||20||
59666562|NCT05121480|75785355|FG005|COMPLETED|Overall Study||65||
59666563|NCT05121480|75785356|FG006|COMPLETED|Overall Study||36||
59666564|NCT05121480|75785357|FG007|COMPLETED|Overall Study||57||
59666565|NCT05121480|75785350|FG000|NOT COMPLETED|Overall Study||6||
59666566|NCT05121480|75785351|FG001|NOT COMPLETED|Overall Study||18||
59666567|NCT05121480|75785352|FG002|NOT COMPLETED|Overall Study||3||
59666568|NCT05121480|75785353|FG003|NOT COMPLETED|Overall Study||21||
59666569|NCT05121480|75785354|FG004|NOT COMPLETED|Overall Study||5||
59666570|NCT05121480|75785355|FG005|NOT COMPLETED|Overall Study||21||
59666571|NCT05121480|75785356|FG006|NOT COMPLETED|Overall Study||2||
59666572|NCT05121480|75785357|FG007|NOT COMPLETED|Overall Study||17||
59666573|NCT04772755|75785383|FG000|STARTED|Overall Study||170||
59666574|NCT04772755|75785384|FG001|STARTED|Overall Study||168||
59666575|NCT04772755|75785383|FG000|COMPLETED|Overall Study||167||
59666576|NCT04772755|75785384|FG001|COMPLETED|Overall Study||165||
59666577|NCT04772755|75785383|FG000|NOT COMPLETED|Overall Study||3||
59666578|NCT04772755|75785384|FG001|NOT COMPLETED|Overall Study||3||
59666579|NCT04590040|75785394|FG000|STARTED|Washout Period||64||
59666580|NCT04590040|75785395|FG001|STARTED|Washout Period||64||
59666581|NCT04590040|75785396|FG002|STARTED|Washout Period||64||
59666582|NCT04590040|75785394|FG000|COMPLETED|Washout Period||64||
59666583|NCT04590040|75785395|FG001|COMPLETED|Washout Period||64||
59666584|NCT04590040|75785396|FG002|COMPLETED|Washout Period||64||
59666585|NCT04590040|75785394|FG000|NOT COMPLETED|Washout Period||0||
59666586|NCT04590040|75785395|FG001|NOT COMPLETED|Washout Period||0||
59666587|NCT04590040|75785396|FG002|NOT COMPLETED|Washout Period||0||
59666588|NCT04590040|75785394|FG000|STARTED|Treatment Period||64||
59666589|NCT04590040|75785395|FG001|STARTED|Treatment Period||64||
59666590|NCT04590040|75785396|FG002|STARTED|Treatment Period||64||
59666591|NCT04590040|75785394|FG000|COMPLETED|Treatment Period||62||
59666592|NCT04590040|75785395|FG001|COMPLETED|Treatment Period||59||
59666593|NCT04590040|75785396|FG002|COMPLETED|Treatment Period||62||
59666594|NCT04590040|75785394|FG000|NOT COMPLETED|Treatment Period||2||
59666595|NCT04590040|75785395|FG001|NOT COMPLETED|Treatment Period||5||
59666596|NCT04590040|75785396|FG002|NOT COMPLETED|Treatment Period||2||
59666597|NCT04540874|75785406|FG000|STARTED|Overall Study||6||
59666598|NCT04540874|75785407|FG001|STARTED|Overall Study||2||
59666599|NCT04540874|75785406|FG000|COMPLETED|Overall Study||6||
59666600|NCT04540874|75785407|FG001|COMPLETED|Overall Study||2||
59666601|NCT04540874|75785406|FG000|NOT COMPLETED|Overall Study||0||
59666602|NCT04540874|75785407|FG001|NOT COMPLETED|Overall Study||0||
59666603|NCT04430335|75785414|FG000|STARTED|Overall Study||8||
59666604|NCT04430335|75785414|FG000|COMPLETED|Overall Study||7||
59666605|NCT04430335|75785414|FG000|NOT COMPLETED|Overall Study||1||
59666606|NCT04289753|75785420|FG000|STARTED|Overall Study||18709||30
59666607|NCT04289753|75785421|FG001|STARTED|Overall Study||18425||30
59666608|NCT04289753|75785420|FG000|COMPLETED|Overall Study||18709||30
59666609|NCT04289753|75785421|FG001|COMPLETED|Overall Study||18425||30
59666610|NCT04289753|75785420|FG000|NOT COMPLETED|Overall Study||0||0
59666611|NCT04289753|75785421|FG001|NOT COMPLETED|Overall Study||0||0
59666612|NCT03690427|75785427|FG000|STARTED|Overall Study||9||
59666613|NCT03690427|75785428|FG001|STARTED|Overall Study||10||
59666614|NCT03690427|75785427|FG000|COMPLETED|Overall Study||9||
59666615|NCT03690427|75785428|FG001|COMPLETED|Overall Study||8||
59666616|NCT03690427|75785427|FG000|NOT COMPLETED|Overall Study||0||
59666617|NCT03690427|75785428|FG001|NOT COMPLETED|Overall Study||2||
59666618|NCT03658668|75785437|FG000|STARTED|Overall Study||13||
59666619|NCT03658668|75785438|FG001|STARTED|Overall Study||9||
59666620|NCT03658668|75785437|FG000|COMPLETED|Overall Study||12||
59666621|NCT03658668|75785438|FG001|COMPLETED|Overall Study||8||
59666622|NCT03658668|75785437|FG000|NOT COMPLETED|Overall Study||1||
59666623|NCT03658668|75785438|FG001|NOT COMPLETED|Overall Study||1||
59666624|NCT03469934|75785446|FG000|STARTED|Overall Study||12||
59666625|NCT03469934|75785447|FG001|STARTED|Overall Study||13||
59666626|NCT03469934|75785446|FG000|Pharmacodynamic (PD) Analysis Set|Overall Study||12|All participants who received etokimab or placebo and provided at least one evaluable post-dose PD measurement without any events or protocol deviation deemed to affect PD assessment.|
59666627|NCT03469934|75785447|FG001|Pharmacodynamic (PD) Analysis Set|Overall Study||13|All participants who received etokimab or placebo and provided at least one evaluable post-dose PD measurement without any events or protocol deviation deemed to affect PD assessment.|
59666628|NCT03469934|75785446|FG000|COMPLETED|Overall Study||12||
59666629|NCT03469934|75785447|FG001|COMPLETED|Overall Study||12||
59666630|NCT03469934|75785446|FG000|NOT COMPLETED|Overall Study||0||
59666631|NCT03469934|75785447|FG001|NOT COMPLETED|Overall Study||1||
59666632|NCT03004404|75785464|FG000|STARTED|Period 1||18||
59666633|NCT03004404|75785465|FG001|STARTED|Period 1||6||
59666634|NCT03004404|75785466|FG002|STARTED|Period 1||6||
59544908|NCT01682135|75643491|FG002|COMPLETED|Overall Study||12||
59544909|NCT01682135|75643489|FG000|NOT COMPLETED|Overall Study||0||
59544910|NCT01682135|75643490|FG001|NOT COMPLETED|Overall Study||0||
59544911|NCT01682135|75643491|FG002|NOT COMPLETED|Overall Study||0||
59544912|NCT01684007|75643503|FG000|STARTED|Overall Study||53||
59544913|NCT01684007|75643504|FG001|STARTED|Overall Study||50||
59544914|NCT01684007|75643503|FG000|COMPLETED|Overall Study||53||
59544915|NCT01684007|75643504|FG001|COMPLETED|Overall Study||50||
59544916|NCT01684007|75643503|FG000|NOT COMPLETED|Overall Study||0||
59544917|NCT01684007|75643504|FG001|NOT COMPLETED|Overall Study||0||
59544918|NCT00963872|75643512|FG000|STARTED|Overall Study||25||
59544919|NCT00963872|75643513|FG001|STARTED|Overall Study||6||
59544920|NCT00963872|75643512|FG000|COMPLETED|Overall Study||24||
59544921|NCT00963872|75643513|FG001|COMPLETED|Overall Study||5||
59544922|NCT00963872|75643512|FG000|NOT COMPLETED|Overall Study||1||
59544923|NCT00963872|75643513|FG001|NOT COMPLETED|Overall Study||1||
59544924|NCT00964496|75643521|FG000|STARTED|Overall Study||28||
59544925|NCT00964496|75643522|FG001|STARTED|Overall Study||27||
59544926|NCT00964496|75643521|FG000|COMPLETED|Overall Study||26||
59544927|NCT00964496|75643522|FG001|COMPLETED|Overall Study||26||
59544928|NCT00964496|75643521|FG000|NOT COMPLETED|Overall Study||2||
59544929|NCT00964496|75643522|FG001|NOT COMPLETED|Overall Study||1||
59544930|NCT01685021|75643528|FG000|STARTED|Overall Study||22||
59544931|NCT01685021|75643528|FG000|COMPLETED|Overall Study|Last patient last visit date. Study was Terminated prematurely.|6||
59544932|NCT01685021|75643528|FG000|NOT COMPLETED|Overall Study||16||
59544933|NCT00966446|75643535|FG000|STARTED|Overall Study||76||
59544934|NCT00966446|75643536|FG001|STARTED|Overall Study||74||
59544935|NCT00966446|75643537|FG002|STARTED|Overall Study||73||
59544936|NCT00966446|75643535|FG000|COMPLETED|Overall Study||48||
59544937|NCT00966446|75643536|FG001|COMPLETED|Overall Study||49||
59544938|NCT00966446|75643537|FG002|COMPLETED|Overall Study||52||
59544939|NCT00966446|75643535|FG000|NOT COMPLETED|Overall Study||28||
59666635|NCT03004404|75785467|FG003|STARTED|Period 1||6||
59666636|NCT03004404|75785468|FG004|STARTED|Period 1||6||
59544940|NCT00966446|75643536|FG001|NOT COMPLETED|Overall Study||25||
59544941|NCT00966446|75643537|FG002|NOT COMPLETED|Overall Study||21||
59544942|NCT01685411|75643545|FG000|STARTED|Overall Study||5||
59544943|NCT01685411|75643545|FG000|COMPLETED|Overall Study||5||
59544944|NCT01685411|75643545|FG000|NOT COMPLETED|Overall Study||0||
59544945|NCT00954356|75643551|FG000|STARTED|Overall Study||41||
59544946|NCT00954356|75643552|FG001|STARTED|Overall Study||20||
59544947|NCT00954356|75643551|FG000|COMPLETED|Overall Study||41||
59544948|NCT00954356|75643552|FG001|COMPLETED|Overall Study||20||
59544949|NCT00954356|75643551|FG000|NOT COMPLETED|Overall Study||0||
59544950|NCT00954356|75643552|FG001|NOT COMPLETED|Overall Study||0||
59544951|NCT00954824|75643558|FG000|STARTED|Overall Study||100||
59544952|NCT00954824|75643558|FG000|COMPLETED|Overall Study||50||
59544953|NCT00954824|75643558|FG000|NOT COMPLETED|Overall Study||50||
59544954|NCT01685567|75643562|FG000|STARTED|Overall Study||219||
59544955|NCT01685567|75643562|FG000|COMPLETED|Overall Study||219||
59544956|NCT01685567|75643562|FG000|NOT COMPLETED|Overall Study||0||
59544957|NCT01686503|75643570|FG000|STARTED|Overall Study||66||
59666637|NCT03004404|75785469|FG005|STARTED|Period 1||6||
59544958|NCT01686503|75643571|FG001|STARTED|Overall Study||66||
59544959|NCT01686503|75643572|FG002|STARTED|Overall Study||66||
59544960|NCT01686503|75643573|FG003|STARTED|Overall Study||33||
59544961|NCT01686503|75643570|FG000|COMPLETED|Overall Study||65||
59544962|NCT01686503|75643571|FG001|COMPLETED|Overall Study||63||
59544963|NCT01686503|75643572|FG002|COMPLETED|Overall Study||64||
59544964|NCT01686503|75643573|FG003|COMPLETED|Overall Study||32||
59544965|NCT01686503|75643570|FG000|NOT COMPLETED|Overall Study||1||
59544966|NCT01686503|75643571|FG001|NOT COMPLETED|Overall Study||3||
59666638|NCT03004404|75785470|FG006|STARTED|Period 1||6||
59666639|NCT03004404|75785471|FG007|STARTED|Period 1||6||
59666640|NCT03004404|75785472|FG008|STARTED|Period 1||6||
59666641|NCT03004404|75785473|FG009|STARTED|Period 1||6||
59666642|NCT03004404|75785474|FG010|STARTED|Period 1||2||
59666643|NCT03004404|75785475|FG011|STARTED|Period 1||2||
59666644|NCT03004404|75785476|FG012|STARTED|Period 1||2||
59666645|NCT03004404|75785477|FG013|STARTED|Period 1||2||
59666646|NCT03004404|75785478|FG014|STARTED|Period 1||2||
59666647|NCT03004404|75785479|FG015|STARTED|Period 1||2||
59666648|NCT03004404|75785464|FG000|COMPLETED|Period 1||18||
59666649|NCT03004404|75785465|FG001|COMPLETED|Period 1||6||
59666650|NCT03004404|75785466|FG002|COMPLETED|Period 1||6||
59666651|NCT03004404|75785467|FG003|COMPLETED|Period 1||6||
59666652|NCT03004404|75785468|FG004|COMPLETED|Period 1||6||
59666653|NCT03004404|75785469|FG005|COMPLETED|Period 1||6||
59666654|NCT03004404|75785470|FG006|COMPLETED|Period 1||6||
59666655|NCT03004404|75785471|FG007|COMPLETED|Period 1||6||
59666656|NCT03004404|75785472|FG008|COMPLETED|Period 1||6||
59666657|NCT03004404|75785473|FG009|COMPLETED|Period 1||6||
59666658|NCT03004404|75785474|FG010|COMPLETED|Period 1||2||
59666659|NCT03004404|75785475|FG011|COMPLETED|Period 1||2||
59666660|NCT03004404|75785476|FG012|COMPLETED|Period 1||2||
59666661|NCT03004404|75785477|FG013|COMPLETED|Period 1||2||
59666662|NCT03004404|75785478|FG014|COMPLETED|Period 1||2||
59666663|NCT03004404|75785479|FG015|COMPLETED|Period 1||2||
59666664|NCT03004404|75785464|FG000|NOT COMPLETED|Period 1||0||
59666665|NCT03004404|75785465|FG001|NOT COMPLETED|Period 1||0||
59666666|NCT03004404|75785466|FG002|NOT COMPLETED|Period 1||0||
59666667|NCT03004404|75785467|FG003|NOT COMPLETED|Period 1||0||
59666668|NCT03004404|75785468|FG004|NOT COMPLETED|Period 1||0||
59666669|NCT03004404|75785469|FG005|NOT COMPLETED|Period 1||0||
59666670|NCT03004404|75785470|FG006|NOT COMPLETED|Period 1||0||
59666671|NCT03004404|75785471|FG007|NOT COMPLETED|Period 1||0||
59666672|NCT03004404|75785472|FG008|NOT COMPLETED|Period 1||0||
59666673|NCT03004404|75785473|FG009|NOT COMPLETED|Period 1||0||
59666674|NCT03004404|75785474|FG010|NOT COMPLETED|Period 1||0||
59666675|NCT03004404|75785475|FG011|NOT COMPLETED|Period 1||0||
59666676|NCT03004404|75785476|FG012|NOT COMPLETED|Period 1||0||
59666677|NCT03004404|75785477|FG013|NOT COMPLETED|Period 1||0||
59666678|NCT03004404|75785478|FG014|NOT COMPLETED|Period 1||0||
59666679|NCT03004404|75785479|FG015|NOT COMPLETED|Period 1||0||
59666680|NCT03004404|75785464|FG000|STARTED|Period 2||0||
59666681|NCT03004404|75785465|FG001|STARTED|Period 2||0||
59666682|NCT03004404|75785466|FG002|STARTED|Period 2||0||
59666683|NCT03004404|75785467|FG003|STARTED|Period 2||0||
59666684|NCT03004404|75785468|FG004|STARTED|Period 2||0||
59666685|NCT03004404|75785469|FG005|STARTED|Period 2||0||
59666686|NCT03004404|75785470|FG006|STARTED|Period 2||0||
59666687|NCT03004404|75785471|FG007|STARTED|Period 2||0||
59666688|NCT03004404|75785472|FG008|STARTED|Period 2||6||
59666689|NCT03004404|75785473|FG009|STARTED|Period 2||0||
59666690|NCT03004404|75785474|FG010|STARTED|Period 2||2||
59666691|NCT03004404|75785475|FG011|STARTED|Period 2||2||
59666692|NCT03004404|75785476|FG012|STARTED|Period 2||2||
59666693|NCT03004404|75785477|FG013|STARTED|Period 2||2||
59666694|NCT03004404|75785478|FG014|STARTED|Period 2||2||
59666695|NCT03004404|75785479|FG015|STARTED|Period 2||2||
59666696|NCT03004404|75785464|FG000|COMPLETED|Period 2||0||
59666697|NCT03004404|75785465|FG001|COMPLETED|Period 2||0||
59666698|NCT03004404|75785466|FG002|COMPLETED|Period 2||0||
59666699|NCT03004404|75785467|FG003|COMPLETED|Period 2||0||
59666700|NCT03004404|75785468|FG004|COMPLETED|Period 2||0||
59666701|NCT03004404|75785469|FG005|COMPLETED|Period 2||0||
59666702|NCT03004404|75785470|FG006|COMPLETED|Period 2||0||
59666703|NCT03004404|75785471|FG007|COMPLETED|Period 2||0||
59666704|NCT03004404|75785472|FG008|COMPLETED|Period 2||5||
59666705|NCT03004404|75785473|FG009|COMPLETED|Period 2||0||
59666706|NCT03004404|75785474|FG010|COMPLETED|Period 2||2||
59666707|NCT03004404|75785475|FG011|COMPLETED|Period 2||2||
59666708|NCT03004404|75785476|FG012|COMPLETED|Period 2||2||
59666709|NCT03004404|75785477|FG013|COMPLETED|Period 2||2||
59666710|NCT03004404|75785478|FG014|COMPLETED|Period 2||2||
59666711|NCT03004404|75785479|FG015|COMPLETED|Period 2||1||
59666712|NCT03004404|75785464|FG000|NOT COMPLETED|Period 2||0||
59666713|NCT03004404|75785465|FG001|NOT COMPLETED|Period 2||0||
59666714|NCT03004404|75785466|FG002|NOT COMPLETED|Period 2||0||
59666715|NCT03004404|75785467|FG003|NOT COMPLETED|Period 2||0||
59666716|NCT03004404|75785468|FG004|NOT COMPLETED|Period 2||0||
59666717|NCT03004404|75785469|FG005|NOT COMPLETED|Period 2||0||
59666718|NCT03004404|75785470|FG006|NOT COMPLETED|Period 2||0||
59666719|NCT03004404|75785471|FG007|NOT COMPLETED|Period 2||0||
59666720|NCT03004404|75785472|FG008|NOT COMPLETED|Period 2||1||
59666721|NCT03004404|75785473|FG009|NOT COMPLETED|Period 2||0||
59666722|NCT03004404|75785474|FG010|NOT COMPLETED|Period 2||0||
59666723|NCT03004404|75785475|FG011|NOT COMPLETED|Period 2||0||
59666724|NCT03004404|75785476|FG012|NOT COMPLETED|Period 2||0||
59666725|NCT03004404|75785477|FG013|NOT COMPLETED|Period 2||0||
59666726|NCT03004404|75785478|FG014|NOT COMPLETED|Period 2||0||
59666727|NCT03004404|75785479|FG015|NOT COMPLETED|Period 2||1||
59666728|NCT03004404|75785464|FG000|STARTED|Period 3||0||
59666729|NCT03004404|75785465|FG001|STARTED|Period 3||0||
59666730|NCT03004404|75785466|FG002|STARTED|Period 3||0||
59666731|NCT03004404|75785467|FG003|STARTED|Period 3||0||
59666732|NCT03004404|75785468|FG004|STARTED|Period 3||0||
59666733|NCT03004404|75785469|FG005|STARTED|Period 3||0||
59666734|NCT03004404|75785470|FG006|STARTED|Period 3||0||
59666735|NCT03004404|75785471|FG007|STARTED|Period 3||0||
59666736|NCT03004404|75785472|FG008|STARTED|Period 3||0||
59666737|NCT03004404|75785473|FG009|STARTED|Period 3||0||
59666738|NCT03004404|75785474|FG010|STARTED|Period 3||2||
59666739|NCT03004404|75785475|FG011|STARTED|Period 3||2||
59666740|NCT03004404|75785476|FG012|STARTED|Period 3||2||
59666741|NCT03004404|75785477|FG013|STARTED|Period 3||2||
59666742|NCT03004404|75785478|FG014|STARTED|Period 3||2||
59666743|NCT03004404|75785479|FG015|STARTED|Period 3||1||
59666744|NCT03004404|75785464|FG000|COMPLETED|Period 3||0||
59666745|NCT03004404|75785465|FG001|COMPLETED|Period 3||0||
59666746|NCT03004404|75785466|FG002|COMPLETED|Period 3||0||
59666747|NCT03004404|75785467|FG003|COMPLETED|Period 3||0||
59666748|NCT03004404|75785468|FG004|COMPLETED|Period 3||0||
59666749|NCT03004404|75785469|FG005|COMPLETED|Period 3||0||
59666750|NCT03004404|75785470|FG006|COMPLETED|Period 3||0||
59666751|NCT03004404|75785471|FG007|COMPLETED|Period 3||0||
59666752|NCT03004404|75785472|FG008|COMPLETED|Period 3||0||
59666753|NCT03004404|75785473|FG009|COMPLETED|Period 3||0||
59666754|NCT03004404|75785474|FG010|COMPLETED|Period 3||2||
59666755|NCT03004404|75785475|FG011|COMPLETED|Period 3||2||
59666756|NCT03004404|75785476|FG012|COMPLETED|Period 3||2||
59666757|NCT03004404|75785477|FG013|COMPLETED|Period 3||2||
59666758|NCT03004404|75785478|FG014|COMPLETED|Period 3||2||
59666759|NCT03004404|75785479|FG015|COMPLETED|Period 3||1||
59666760|NCT03004404|75785464|FG000|NOT COMPLETED|Period 3||0||
59666761|NCT03004404|75785465|FG001|NOT COMPLETED|Period 3||0||
59666762|NCT03004404|75785466|FG002|NOT COMPLETED|Period 3||0||
59666763|NCT03004404|75785467|FG003|NOT COMPLETED|Period 3||0||
59666764|NCT03004404|75785468|FG004|NOT COMPLETED|Period 3||0||
59666765|NCT03004404|75785469|FG005|NOT COMPLETED|Period 3||0||
59666766|NCT03004404|75785470|FG006|NOT COMPLETED|Period 3||0||
59666767|NCT03004404|75785471|FG007|NOT COMPLETED|Period 3||0||
59666768|NCT03004404|75785472|FG008|NOT COMPLETED|Period 3||0||
59666769|NCT03004404|75785473|FG009|NOT COMPLETED|Period 3||0||
59666770|NCT03004404|75785474|FG010|NOT COMPLETED|Period 3||0||
59666771|NCT03004404|75785475|FG011|NOT COMPLETED|Period 3||0||
59666772|NCT03004404|75785476|FG012|NOT COMPLETED|Period 3||0||
59666773|NCT03004404|75785477|FG013|NOT COMPLETED|Period 3||0||
59666774|NCT03004404|75785478|FG014|NOT COMPLETED|Period 3||0||
59666775|NCT03004404|75785479|FG015|NOT COMPLETED|Period 3||0||
59666776|NCT03002597|75785522|FG000|STARTED|Overall Study||9||
59666777|NCT03002597|75785522|FG000|COMPLETED|Overall Study||9||
59666778|NCT03002597|75785522|FG000|NOT COMPLETED|Overall Study||0||
59666779|NCT02985749|75785528|FG000|STARTED|Overall Study||2||
59666780|NCT02985749|75785529|FG001|STARTED|Overall Study||5||
59666781|NCT02985749|75785528|FG000|COMPLETED|Overall Study||2||
59666782|NCT02985749|75785529|FG001|COMPLETED|Overall Study||3||
59666783|NCT02985749|75785528|FG000|NOT COMPLETED|Overall Study||0||
59666784|NCT02985749|75785529|FG001|NOT COMPLETED|Overall Study||2||
59666785|NCT02589600|75785537|FG000|STARTED|Overall Study||154||
59666786|NCT02589600|75785538|FG001|STARTED|Overall Study||156||
59666787|NCT02589600|75785537|FG000|COMPLETED|Overall Study||101||
59666788|NCT02589600|75785538|FG001|COMPLETED|Overall Study||102||
59666789|NCT02589600|75785537|FG000|NOT COMPLETED|Overall Study||53||
59666790|NCT02589600|75785538|FG001|NOT COMPLETED|Overall Study||54||
59666791|NCT02512965|75785546|FG000|STARTED|Overall Study||115||
59666792|NCT02512965|75785547|FG001|STARTED|Overall Study||114||
59666793|NCT02512965|75785546|FG000|COMPLETED|Overall Study||115||
59666794|NCT02512965|75785547|FG001|COMPLETED|Overall Study|4 patients did not receive any dose of the assigned treatment.|110||
59666795|NCT02512965|75785546|FG000|NOT COMPLETED|Overall Study||0||
59666796|NCT02512965|75785547|FG001|NOT COMPLETED|Overall Study||4||
59666797|NCT02335268|75785555|FG000|STARTED|Overall Study||51||
59666798|NCT02335268|75785556|FG001|STARTED|Overall Study||26||
59666799|NCT02335268|75785555|FG000|COMPLETED|Overall Study||34||
59666800|NCT02335268|75785556|FG001|COMPLETED|Overall Study||20||
59666801|NCT02335268|75785555|FG000|NOT COMPLETED|Overall Study||17||
59666802|NCT02335268|75785556|FG001|NOT COMPLETED|Overall Study||6||
59666803|NCT02222155|75785566|FG000|STARTED|Overall Study||13||
59666804|NCT02222155|75785567|FG001|STARTED|Overall Study||13||
59666805|NCT02222155|75785568|FG002|STARTED|Overall Study||16||
59666806|NCT02222155|75785566|FG000|COMPLETED|Overall Study||13||
59666807|NCT02222155|75785567|FG001|COMPLETED|Overall Study||12||
59666808|NCT02222155|75785568|FG002|COMPLETED|Overall Study||15||
59666809|NCT02222155|75785566|FG000|NOT COMPLETED|Overall Study||0||
59666810|NCT02222155|75785567|FG001|NOT COMPLETED|Overall Study||1||
59666811|NCT02222155|75785568|FG002|NOT COMPLETED|Overall Study||1||
59666812|NCT01029002|75785578|FG000|STARTED|Overall Study||36||
59666813|NCT01029002|75785579|FG001|STARTED|Overall Study||38||
59666814|NCT01029002|75785578|FG000|COMPLETED|Overall Study||34||
59666815|NCT01029002|75785579|FG001|COMPLETED|Overall Study||34||
59666816|NCT01029002|75785578|FG000|NOT COMPLETED|Overall Study||2||
59666817|NCT01029002|75785579|FG001|NOT COMPLETED|Overall Study||4||
59666818|NCT01011478|75785587|FG000|STARTED|Overall Study||204||
59666819|NCT01011478|75785588|FG001|STARTED|Overall Study||202||
59666820|NCT01011478|75785587|FG000|COMPLETED|Overall Study||192||
59666821|NCT01011478|75785588|FG001|COMPLETED|Overall Study||195||
59666822|NCT01011478|75785587|FG000|NOT COMPLETED|Overall Study||12||
59666823|NCT01011478|75785588|FG001|NOT COMPLETED|Overall Study||7||
59666824|NCT00546260|75785596|FG000|STARTED|Overall Study||36||
59666825|NCT00546260|75785597|FG001|STARTED|Overall Study||34||
59666826|NCT00546260|75785596|FG000|COMPLETED|Overall Study||28||
59666827|NCT00546260|75785597|FG001|COMPLETED|Overall Study||32||
59666828|NCT00546260|75785596|FG000|NOT COMPLETED|Overall Study||8||
59666829|NCT00546260|75785597|FG001|NOT COMPLETED|Overall Study||2||
59666830|NCT00178620|75785607|FG000|STARTED|Overall Study||37||
59666831|NCT00178620|75785608|FG001|STARTED|Overall Study||253||
59666832|NCT00178620|75785609|FG002|STARTED|Overall Study||37||
59666833|NCT00178620|75785610|FG003|STARTED|Overall Study||63||
59666834|NCT00178620|75785607|FG000|COMPLETED|Overall Study||37||
59666835|NCT00178620|75785608|FG001|COMPLETED|Overall Study||253||
59666836|NCT00178620|75785609|FG002|COMPLETED|Overall Study||37||
59666837|NCT00178620|75785610|FG003|COMPLETED|Overall Study||63||
59666838|NCT00178620|75785607|FG000|NOT COMPLETED|Overall Study||0||
59666839|NCT00178620|75785608|FG001|NOT COMPLETED|Overall Study||0||
59666840|NCT00178620|75785609|FG002|NOT COMPLETED|Overall Study||0||
59666841|NCT00178620|75785610|FG003|NOT COMPLETED|Overall Study||0||
59666842|NCT02896192|75785620|FG000|STARTED|Titration Period (2 to 12 Weeks)||15||
59666843|NCT02896192|75785620|FG000|Treated|Titration Period (2 to 12 Weeks)||15||
59666844|NCT02896192|75785620|FG000|COMPLETED|Titration Period (2 to 12 Weeks)||15||
59666845|NCT02896192|75785620|FG000|NOT COMPLETED|Titration Period (2 to 12 Weeks)||0||
59666846|NCT02896192|75785620|FG000|STARTED|Open-Label Period (10 Weeks)||15||
59666847|NCT02896192|75785620|FG000|COMPLETED|Open-Label Period (10 Weeks)||13||
59666848|NCT02896192|75785620|FG000|NOT COMPLETED|Open-Label Period (10 Weeks)||2||
59666849|NCT02896192|75785620|FG000|STARTED|Double-Blind Withdrawal Period (8 Weeks)||13||
59666850|NCT02896192|75785620|FG000|COMPLETED|Double-Blind Withdrawal Period (8 Weeks)||13||
59666851|NCT02896192|75785620|FG000|NOT COMPLETED|Double-Blind Withdrawal Period (8 Weeks)||0||
59666852|NCT02896192|75785620|FG000|STARTED|Open-Label Period (32 Weeks)||13||
59666853|NCT02896192|75785620|FG000|COMPLETED|Open-Label Period (32 Weeks)||12||
59666854|NCT02896192|75785620|FG000|NOT COMPLETED|Open-Label Period (32 Weeks)||1||
59666855|NCT03014635|75785627|FG000|STARTED|Overall Study||204||
59666856|NCT03014635|75785628|FG001|STARTED|Overall Study||102||
59666857|NCT03014635|75785627|FG000|COMPLETED|Overall Study||191||
59666858|NCT03014635|75785628|FG001|COMPLETED|Overall Study||93||
59666859|NCT03014635|75785627|FG000|NOT COMPLETED|Overall Study||13||
59666860|NCT03014635|75785628|FG001|NOT COMPLETED|Overall Study||9||
59666861|NCT01356940|75785636|FG000|STARTED|First Intervention (28 Days)||22||
59666862|NCT01356940|75785637|FG001|STARTED|First Intervention (28 Days)||21||
59666863|NCT01356940|75785636|FG000|COMPLETED|First Intervention (28 Days)||21||
59666864|NCT01356940|75785637|FG001|COMPLETED|First Intervention (28 Days)||21||
59666865|NCT01356940|75785636|FG000|NOT COMPLETED|First Intervention (28 Days)||1||
59666866|NCT01356940|75785637|FG001|NOT COMPLETED|First Intervention (28 Days)||0||
59666867|NCT01356940|75785636|FG000|STARTED|Washout (14 Days)||21||
59666868|NCT01356940|75785637|FG001|STARTED|Washout (14 Days)||21||
59666869|NCT01356940|75785636|FG000|COMPLETED|Washout (14 Days)||21||
59666870|NCT01356940|75785637|FG001|COMPLETED|Washout (14 Days)||21||
59666871|NCT01356940|75785636|FG000|NOT COMPLETED|Washout (14 Days)||0||
59666872|NCT01356940|75785637|FG001|NOT COMPLETED|Washout (14 Days)||0||
59666873|NCT01356940|75785636|FG000|STARTED|Second Intervention (28 Days)||21||
59666874|NCT01356940|75785637|FG001|STARTED|Second Intervention (28 Days)||21||
59666875|NCT01356940|75785636|FG000|COMPLETED|Second Intervention (28 Days)||20||
59666876|NCT01356940|75785637|FG001|COMPLETED|Second Intervention (28 Days)||21||
59666877|NCT01356940|75785636|FG000|NOT COMPLETED|Second Intervention (28 Days)||1||
59666878|NCT01356940|75785637|FG001|NOT COMPLETED|Second Intervention (28 Days)||0||
59666879|NCT01539811|75785647|FG000|STARTED|Overall Study|Antibiotics never given. Study closed prior to initiating treatment.|0||
59666880|NCT01539811|75785648|FG001|STARTED|Overall Study|Antibiotics never given. Study closed prior to initiating treatment.|0||
59666881|NCT01539811|75785647|FG000|COMPLETED|Overall Study|Antibiotics never given. Study closed prior to initiating treatment.|0||
59666882|NCT01539811|75785648|FG001|COMPLETED|Overall Study|Antibiotics never given. Study closed prior to initiating treatment.|0||
59666883|NCT01539811|75785647|FG000|NOT COMPLETED|Overall Study||0||
59666884|NCT01539811|75785648|FG001|NOT COMPLETED|Overall Study||0||
59666885|NCT01330030|75785656|FG000|STARTED|Overall Study||121||
59666886|NCT01330030|75785657|FG001|STARTED|Overall Study||122||
59666887|NCT01330030|75785656|FG000|COMPLETED|Overall Study|number assessed at week 52 follow-up|105||
59666888|NCT01330030|75785657|FG001|COMPLETED|Overall Study|number assessed at week 52 follow-up|105||
59666889|NCT01330030|75785656|FG000|NOT COMPLETED|Overall Study||16||
59666890|NCT01330030|75785657|FG001|NOT COMPLETED|Overall Study||17||
59666891|NCT02417701|75785663|FG000|STARTED|Overall Study||34||
59666892|NCT02417701|75785663|FG000|COMPLETED|Overall Study||34||
59666893|NCT02417701|75785663|FG000|NOT COMPLETED|Overall Study||0||
59666894|NCT02158585|75785672|FG000|STARTED|Overall Study||8||
59544967|NCT01686503|75643572|FG002|NOT COMPLETED|Overall Study||2||
59544968|NCT01686503|75643573|FG003|NOT COMPLETED|Overall Study||1||
59544969|NCT00969878|75643585|FG000|STARTED|Overall Study||148||
59544970|NCT00969878|75643586|FG001|STARTED|Overall Study||152||
59544971|NCT00969878|75643585|FG000|COMPLETED|Overall Study||118||
59544972|NCT00969878|75643586|FG001|COMPLETED|Overall Study||126||
59544973|NCT00969878|75643585|FG000|NOT COMPLETED|Overall Study||30||
59544974|NCT00969878|75643586|FG001|NOT COMPLETED|Overall Study||26||
59544975|NCT00970814|75643596|FG000|STARTED|Overall Study||66||
59544976|NCT00970814|75643597|FG001|STARTED|Overall Study||64||
59544977|NCT00970814|75643596|FG000|COMPLETED|Overall Study||58||
59544978|NCT00970814|75643597|FG001|COMPLETED|Overall Study||50||
59544979|NCT00970814|75643596|FG000|NOT COMPLETED|Overall Study||8||
59544980|NCT00970814|75643597|FG001|NOT COMPLETED|Overall Study||14||
59544981|NCT02486406|75643607|FG000|STARTED|Overall Study||12||
59544982|NCT02486406|75643608|FG001|STARTED|Overall Study||26||
59544983|NCT02486406|75643609|FG002|STARTED|Overall Study||12||
59544984|NCT02486406|75643610|FG003|STARTED|Overall Study||14||
59544985|NCT02486406|75643607|FG000|COMPLETED|Overall Study||10||
59544986|NCT02486406|75643608|FG001|COMPLETED|Overall Study||23||
59544987|NCT02486406|75643609|FG002|COMPLETED|Overall Study||10||
59544988|NCT02486406|75643610|FG003|COMPLETED|Overall Study||10||
59544989|NCT02486406|75643607|FG000|NOT COMPLETED|Overall Study||2||
59544990|NCT02486406|75643608|FG001|NOT COMPLETED|Overall Study||3||
59544991|NCT02486406|75643609|FG002|NOT COMPLETED|Overall Study||2||
59544992|NCT02486406|75643610|FG003|NOT COMPLETED|Overall Study||4||
59544993|NCT00971282|75643642|FG000|STARTED|Overall Study||30||
59544994|NCT00971282|75643642|FG000|COMPLETED|Overall Study||30||
59544995|NCT00971282|75643642|FG000|NOT COMPLETED|Overall Study||0||
59544996|NCT01688141|75643650|FG000|STARTED|Overall Study||11706||
59544997|NCT01688141|75643651|FG001|STARTED|Overall Study||11651||
59544998|NCT01688141|75643650|FG000|COMPLETED|Overall Study||11706||
59544999|NCT01688141|75643651|FG001|COMPLETED|Overall Study||11651||
59545000|NCT01688141|75643650|FG000|NOT COMPLETED|Overall Study||0||
59545001|NCT01688141|75643651|FG001|NOT COMPLETED|Overall Study||0||
59545002|NCT02247245|75643661|FG000|STARTED|Overall Study||13||
59545003|NCT02247245|75643662|FG001|STARTED|Overall Study||13||
59545004|NCT02247245|75643663|FG002|STARTED|Overall Study||7||
59545005|NCT02247245|75643664|FG003|STARTED|Overall Study||7||
59545006|NCT02247245|75643661|FG000|COMPLETED|Overall Study||13||
59545007|NCT02247245|75643662|FG001|COMPLETED|Overall Study||13||
59545008|NCT02247245|75643663|FG002|COMPLETED|Overall Study||7||
59545009|NCT02247245|75643664|FG003|COMPLETED|Overall Study||7||
59545010|NCT02247245|75643661|FG000|NOT COMPLETED|Overall Study||0||
59545011|NCT02247245|75643662|FG001|NOT COMPLETED|Overall Study||0||
59545012|NCT02247245|75643663|FG002|NOT COMPLETED|Overall Study||0||
59545013|NCT02247245|75643664|FG003|NOT COMPLETED|Overall Study||0||
59545014|NCT00971750|75643674|FG000|STARTED|Overall Study||253||
59545015|NCT00971750|75643674|FG000|COMPLETED|Overall Study||253||
59545016|NCT00971750|75643674|FG000|NOT COMPLETED|Overall Study||0||
59545017|NCT02485704|75643682|FG000|STARTED|Overall Study||154||
59545018|NCT02485704|75643683|FG001|STARTED|Overall Study||126||
59545019|NCT02485704|75643682|FG000|COMPLETED|Overall Study||149||
59545020|NCT02485704|75643683|FG001|COMPLETED|Overall Study||118||
59545021|NCT02485704|75643682|FG000|NOT COMPLETED|Overall Study||5||
59545022|NCT02485704|75643683|FG001|NOT COMPLETED|Overall Study||8||
59545023|NCT01688609|75643689|FG000|STARTED|Overall Study||18||
59545024|NCT01688609|75643689|FG000|COMPLETED|Overall Study||18||
59545025|NCT01688609|75643689|FG000|NOT COMPLETED|Overall Study||0||
59545026|NCT02485158|75643693|FG000|STARTED|Overall Study||28||
59545027|NCT02485158|75643693|FG000|COMPLETED|Overall Study||24||
59545028|NCT02485158|75643693|FG000|NOT COMPLETED|Overall Study||4||
59545029|NCT01688843|75643702|FG000|STARTED|Overall Study||1060||1599
59545030|NCT01688843|75643702|FG000|COMPLETED|Overall Study||1060||1599
59545031|NCT01688843|75643702|FG000|NOT COMPLETED|Overall Study||0||0
59545032|NCT02455518|75643712|FG000|STARTED|Overall Study||104||
59545033|NCT02455518|75643713|FG001|STARTED|Overall Study||104||
59545034|NCT02455518|75643714|FG002|STARTED|Overall Study||104||
59545035|NCT02455518|75643715|FG003|STARTED|Overall Study||104||
59545036|NCT02455518|75643712|FG000|COMPLETED|Overall Study||104||
59545037|NCT02455518|75643713|FG001|COMPLETED|Overall Study||103||
59545038|NCT02455518|75643714|FG002|COMPLETED|Overall Study||103||
59545039|NCT02455518|75643715|FG003|COMPLETED|Overall Study||101||
59545040|NCT02455518|75643712|FG000|NOT COMPLETED|Overall Study||0||
59545041|NCT02455518|75643713|FG001|NOT COMPLETED|Overall Study||1||
59545042|NCT02455518|75643714|FG002|NOT COMPLETED|Overall Study||1||
59545043|NCT02455518|75643715|FG003|NOT COMPLETED|Overall Study||3||
59545044|NCT00972374|75643728|FG000|STARTED|Overall Study||15||
59545045|NCT00972374|75643729|FG001|STARTED|Overall Study||15||
59545046|NCT00972374|75643730|FG002|STARTED|Overall Study||14||
59545047|NCT00972374|75643728|FG000|COMPLETED|Overall Study||13||
59545048|NCT00972374|75643729|FG001|COMPLETED|Overall Study||15||
59545049|NCT00972374|75643730|FG002|COMPLETED|Overall Study||13||
59545050|NCT00972374|75643728|FG000|NOT COMPLETED|Overall Study||2||
59545051|NCT00972374|75643729|FG001|NOT COMPLETED|Overall Study||0||
59545052|NCT00972374|75643730|FG002|NOT COMPLETED|Overall Study||1||
59666895|NCT02158585|75785673|FG001|STARTED|Overall Study||7||
59666896|NCT02158585|75785672|FG000|COMPLETED|Overall Study||7||
59666897|NCT02158585|75785673|FG001|COMPLETED|Overall Study||6||
59666898|NCT02158585|75785672|FG000|NOT COMPLETED|Overall Study||1||
59666899|NCT02158585|75785673|FG001|NOT COMPLETED|Overall Study||1||
59666900|NCT01235923|75785682|FG000|STARTED|Overall Study||10||
59666901|NCT01235923|75785683|FG001|STARTED|Overall Study||10||
59666902|NCT01235923|75785682|FG000|COMPLETED|Overall Study||10||
59666903|NCT01235923|75785683|FG001|COMPLETED|Overall Study||10||
59666904|NCT01235923|75785682|FG000|NOT COMPLETED|Overall Study||0||
59666905|NCT01235923|75785683|FG001|NOT COMPLETED|Overall Study||0||
59666906|NCT01080196|75785691|FG000|STARTED|Overall Study||68||
59666907|NCT01080196|75785692|FG001|STARTED|Overall Study||66||
59666908|NCT01080196|75785691|FG000|COMPLETED|Overall Study||68||
59666909|NCT01080196|75785692|FG001|COMPLETED|Overall Study||66||
59666910|NCT01080196|75785691|FG000|NOT COMPLETED|Overall Study||0||
59666911|NCT01080196|75785692|FG001|NOT COMPLETED|Overall Study||0||
59666912|NCT00712582|75785703|FG000|STARTED|Overall Study||60||
59666913|NCT00712582|75785704|FG001|STARTED|Overall Study||32||
59666914|NCT00712582|75785705|FG002|STARTED|Overall Study||4||
59666915|NCT00712582|75785703|FG000|COMPLETED|Overall Study||60||
59666916|NCT00712582|75785704|FG001|COMPLETED|Overall Study||32||
59666917|NCT00712582|75785705|FG002|COMPLETED|Overall Study||4||
59666918|NCT00712582|75785703|FG000|NOT COMPLETED|Overall Study||0||
59666919|NCT00712582|75785704|FG001|NOT COMPLETED|Overall Study||0||
59666920|NCT00712582|75785705|FG002|NOT COMPLETED|Overall Study||0||
59666921|NCT03986671|75785716|FG000|STARTED|Overall Study||36||
59666922|NCT03986671|75785717|FG001|STARTED|Overall Study||9||
59666923|NCT03986671|75785718|FG002|STARTED|Overall Study||5||
59666924|NCT03986671|75785716|FG000|Passed a Screening Visit With ENT|Overall Study||6||
59666925|NCT03986671|75785717|FG001|Passed a Screening Visit With ENT|Overall Study||5||
59666926|NCT03986671|75785718|FG002|Passed a Screening Visit With ENT|Overall Study||5||
59666927|NCT03986671|75785716|FG000|COMPLETED|Overall Study||6||
59666928|NCT03986671|75785717|FG001|COMPLETED|Overall Study||5||
59666929|NCT03986671|75785718|FG002|COMPLETED|Overall Study||5||
59666930|NCT03986671|75785716|FG000|NOT COMPLETED|Overall Study||30||
59666931|NCT03986671|75785717|FG001|NOT COMPLETED|Overall Study||4||
59666932|NCT03986671|75785718|FG002|NOT COMPLETED|Overall Study||0||
59666933|NCT03726346|75785726|FG000|STARTED|Overall Study||39||
59666934|NCT03726346|75785726|FG000|COMPLETED|Overall Study||39||
59666935|NCT03726346|75785726|FG000|NOT COMPLETED|Overall Study||0||
59666936|NCT03635515|75785732|FG000|STARTED|Overall Study||44||
59666937|NCT03635515|75785733|FG001|STARTED|Overall Study||43||
59666938|NCT03635515|75785732|FG000|COMPLETED|Overall Study||38||
59666939|NCT03635515|75785733|FG001|COMPLETED|Overall Study||38||
59666940|NCT03635515|75785732|FG000|NOT COMPLETED|Overall Study||6||
59666941|NCT03635515|75785733|FG001|NOT COMPLETED|Overall Study||5||
59666942|NCT03523117|75785741|FG000|STARTED|Overall Study||40||
59666943|NCT03523117|75785742|FG001|STARTED|Overall Study||39||
59666944|NCT03523117|75785741|FG000|COMPLETED|Overall Study||39||
59666945|NCT03523117|75785742|FG001|COMPLETED|Overall Study||37||
59666946|NCT03523117|75785741|FG000|NOT COMPLETED|Overall Study||1||
59666947|NCT03523117|75785742|FG001|NOT COMPLETED|Overall Study||2||
59666948|NCT02968381|75785750|FG000|STARTED|Overall Study||61||
59666949|NCT02968381|75785751|FG001|STARTED|Overall Study||60||
59666950|NCT02968381|75785750|FG000|COMPLETED|Overall Study||56||
59666951|NCT02968381|75785751|FG001|COMPLETED|Overall Study||50||
59666952|NCT02968381|75785750|FG000|NOT COMPLETED|Overall Study||5||
59666953|NCT02968381|75785751|FG001|NOT COMPLETED|Overall Study||10||
59666954|NCT04633174|75785757|FG000|STARTED|Overall Study||1||2
59666955|NCT04633174|75785757|FG000|COMPLETED|Overall Study||1||2
59666956|NCT04633174|75785757|FG000|NOT COMPLETED|Overall Study||0||0
59666957|NCT00577798|75785762|FG000|STARTED|Overall Study||10||
59666958|NCT00577798|75785762|FG000|COMPLETED|Overall Study||10||
59666959|NCT00577798|75785762|FG000|NOT COMPLETED|Overall Study||0||
59666960|NCT04578496|75785766|FG000|STARTED|Overall Study||16||
59666961|NCT04578496|75785766|FG000|COMPLETED|Overall Study||12||
59666962|NCT04578496|75785766|FG000|NOT COMPLETED|Overall Study||4||
59666963|NCT00477295|75785772|FG000|STARTED|Overall Study||282||
59666964|NCT00477295|75785773|FG001|STARTED|Overall Study||301||
59666965|NCT00477295|75785772|FG000|COMPLETED|Overall Study||161||
59666966|NCT00477295|75785773|FG001|COMPLETED|Overall Study||192||
59666967|NCT00477295|75785772|FG000|NOT COMPLETED|Overall Study||121||
59666968|NCT00477295|75785773|FG001|NOT COMPLETED|Overall Study||109||
59666969|NCT00476593|75785785|FG000|STARTED|Overall Study||32||
59666970|NCT00476593|75785786|FG001|STARTED|Overall Study||19||
59666971|NCT00476593|75785787|FG002|STARTED|Overall Study||38||
59666972|NCT00476593|75785788|FG003|STARTED|Overall Study||129||
59666973|NCT00476593|75785785|FG000|COMPLETED|Overall Study|all subjects completed treatment in one eye. However, bilateral OCT scans included only in 22 cases|22||
59666974|NCT00476593|75785786|FG001|COMPLETED|Overall Study|all subjects completed treatment in one eye. However, bilateral OCT scans included only in 17 cases|17||
59666975|NCT00476593|75785787|FG002|COMPLETED|Overall Study||30||
59666976|NCT00476593|75785788|FG003|COMPLETED|Overall Study||107||
59666977|NCT00476593|75785785|FG000|NOT COMPLETED|Overall Study||10||
59666978|NCT00476593|75785786|FG001|NOT COMPLETED|Overall Study||2||
59666979|NCT00476593|75785787|FG002|NOT COMPLETED|Overall Study||8||
59666980|NCT00476593|75785788|FG003|NOT COMPLETED|Overall Study||22||
59666981|NCT00476476|75785800|FG000|STARTED|Overall Study||17||
59666982|NCT00476476|75785801|FG001|STARTED|Overall Study||24||
59666983|NCT00476476|75785800|FG000|Response Evaluable|Overall Study||17||
59666984|NCT00476476|75785801|FG001|Response Evaluable|Overall Study|One woman was unevaluable due to an allergic reaction that developed after the 2nd dose.|23||
59666985|NCT00476476|75785800|FG000|COMPLETED|Overall Study||15||
59666986|NCT00476476|75785801|FG001|COMPLETED|Overall Study|Treatment was not of fixed duration and thus pts are not considered to have 'Completed' treatment.|0||
59666987|NCT00476476|75785800|FG000|NOT COMPLETED|Overall Study||2||
59666988|NCT00476476|75785801|FG001|NOT COMPLETED|Overall Study||24||
59666989|NCT00476086|75785806|FG000|STARTED|Overall Study||20||
59666990|NCT00476086|75785806|FG000|Received Chemotherapy|Overall Study||19||
59666991|NCT00476086|75785806|FG000|Received Radiation|Overall Study||15||
59666992|NCT00476086|75785806|FG000|COMPLETED|Overall Study||15||
59666993|NCT00476086|75785806|FG000|NOT COMPLETED|Overall Study||5||
59666994|NCT00476047|75785812|FG000|STARTED|Overall Study||16||
59666995|NCT00476047|75785812|FG000|Completed Treatment|Overall Study||16||
59666996|NCT00476047|75785812|FG000|COMPLETED|Overall Study||15||
59666997|NCT00476047|75785812|FG000|NOT COMPLETED|Overall Study||1||
59666998|NCT00476008|75785820|FG000|STARTED|Overall Study||22||
59666999|NCT00476008|75785821|FG001|STARTED|Overall Study||21||
59667000|NCT00476008|75785820|FG000|6 Month Testing|Overall Study||15||
59667001|NCT00476008|75785821|FG001|6 Month Testing|Overall Study||14||
59667002|NCT00476008|75785820|FG000|COMPLETED|Overall Study||13||
59667003|NCT00476008|75785821|FG001|COMPLETED|Overall Study||13||
59667004|NCT00476008|75785820|FG000|NOT COMPLETED|Overall Study||9||
59667005|NCT00476008|75785821|FG001|NOT COMPLETED|Overall Study||8||
59667006|NCT00475735|75785837|FG000|STARTED|Treatment Period 1||14||
59667007|NCT00475735|75785838|FG001|STARTED|Treatment Period 1||13||
59667008|NCT00475735|75785839|FG002|STARTED|Treatment Period 1||7||
59667009|NCT00475735|75785840|FG003|STARTED|Treatment Period 1||7||
59667010|NCT00475735|75785841|FG004|STARTED|Treatment Period 1||16||
59667011|NCT00475735|75785842|FG005|STARTED|Treatment Period 1||15||
59667012|NCT00475735|75785837|FG000|COMPLETED|Treatment Period 1||10||
59667013|NCT00475735|75785838|FG001|COMPLETED|Treatment Period 1||11||
59667014|NCT00475735|75785839|FG002|COMPLETED|Treatment Period 1||7||
59667015|NCT00475735|75785840|FG003|COMPLETED|Treatment Period 1||5||
59667016|NCT00475735|75785841|FG004|COMPLETED|Treatment Period 1||14||
59667017|NCT00475735|75785842|FG005|COMPLETED|Treatment Period 1||12||
59667018|NCT00475735|75785837|FG000|NOT COMPLETED|Treatment Period 1||4||
59667019|NCT00475735|75785838|FG001|NOT COMPLETED|Treatment Period 1||2||
59667020|NCT00475735|75785839|FG002|NOT COMPLETED|Treatment Period 1||0||
59667021|NCT00475735|75785840|FG003|NOT COMPLETED|Treatment Period 1||2||
59667022|NCT00475735|75785841|FG004|NOT COMPLETED|Treatment Period 1||2||
59667023|NCT00475735|75785842|FG005|NOT COMPLETED|Treatment Period 1||3||
59667024|NCT00475735|75785837|FG000|STARTED|Treatment Washout||10||
59667025|NCT00475735|75785838|FG001|STARTED|Treatment Washout|Includes 1 patient that discontinued Treatment Period 1 but continued the Study.|12||
59667026|NCT00475735|75785839|FG002|STARTED|Treatment Washout||7||
59667027|NCT00475735|75785840|FG003|STARTED|Treatment Washout|Includes 1 patient that discontinued Treatment Period 1 but continued the Study.|6||
59667028|NCT00475735|75785841|FG004|STARTED|Treatment Washout|Includes 2 patients that discontinued Treatment Period 1 but continued the Study.|16||
59667029|NCT00475735|75785842|FG005|STARTED|Treatment Washout|Includes 2 patients that discontinued Treatment Period 1 but continued the Study.|14||
59667030|NCT00475735|75785837|FG000|COMPLETED|Treatment Washout||10||
59667031|NCT00475735|75785838|FG001|COMPLETED|Treatment Washout||10||
59667032|NCT00475735|75785839|FG002|COMPLETED|Treatment Washout||7||
59667033|NCT00475735|75785840|FG003|COMPLETED|Treatment Washout||6||
59667034|NCT00475735|75785841|FG004|COMPLETED|Treatment Washout||16||
59667035|NCT00475735|75785842|FG005|COMPLETED|Treatment Washout||14||
59667036|NCT00475735|75785837|FG000|NOT COMPLETED|Treatment Washout||0||
59667037|NCT00475735|75785838|FG001|NOT COMPLETED|Treatment Washout||2||
59667038|NCT00475735|75785839|FG002|NOT COMPLETED|Treatment Washout||0||
59667039|NCT00475735|75785840|FG003|NOT COMPLETED|Treatment Washout||0||
59667040|NCT00475735|75785841|FG004|NOT COMPLETED|Treatment Washout||0||
59667041|NCT00475735|75785842|FG005|NOT COMPLETED|Treatment Washout||0||
59667042|NCT00475735|75785837|FG000|STARTED|Treatment Period 2||10||
59667043|NCT00475735|75785838|FG001|STARTED|Treatment Period 2||10||
59667044|NCT00475735|75785839|FG002|STARTED|Treatment Period 2||7||
59667045|NCT00475735|75785840|FG003|STARTED|Treatment Period 2||6||
59667046|NCT00475735|75785841|FG004|STARTED|Treatment Period 2||16||
59667047|NCT00475735|75785842|FG005|STARTED|Treatment Period 2||14||
59667048|NCT00475735|75785837|FG000|COMPLETED|Treatment Period 2||10||
59667049|NCT00475735|75785838|FG001|COMPLETED|Treatment Period 2||9||
59667050|NCT00475735|75785839|FG002|COMPLETED|Treatment Period 2||7||
59667051|NCT00475735|75785840|FG003|COMPLETED|Treatment Period 2||4||
59667052|NCT00475735|75785841|FG004|COMPLETED|Treatment Period 2||15||
59667053|NCT00475735|75785842|FG005|COMPLETED|Treatment Period 2||13||
59667054|NCT00475735|75785837|FG000|NOT COMPLETED|Treatment Period 2||0||
59667055|NCT00475735|75785838|FG001|NOT COMPLETED|Treatment Period 2||1||
59667056|NCT00475735|75785839|FG002|NOT COMPLETED|Treatment Period 2||0||
59667057|NCT00475735|75785840|FG003|NOT COMPLETED|Treatment Period 2||2||
59667058|NCT00475735|75785841|FG004|NOT COMPLETED|Treatment Period 2||1||
59667059|NCT00475735|75785842|FG005|NOT COMPLETED|Treatment Period 2||1||
59667060|NCT00475657|75785850|FG000|STARTED|Overall Study||5||
59667061|NCT00475657|75785850|FG000|COMPLETED|Overall Study||1||
59667062|NCT00475657|75785850|FG000|NOT COMPLETED|Overall Study||4||
59667063|NCT00475423|75785854|FG000|STARTED|Overall Study||122||
59667064|NCT00475423|75785854|FG000|COMPLETED|Overall Study||90||
59667065|NCT00475423|75785854|FG000|NOT COMPLETED|Overall Study||32||
59667066|NCT00475306|75785862|FG000|STARTED|Overall Study||73||
59667067|NCT00475306|75785863|FG001|STARTED|Overall Study||72||
59667068|NCT00475306|75785864|FG002|STARTED|Overall Study||72||
59667069|NCT00475306|75785865|FG003|STARTED|Overall Study||72||
59667070|NCT00475306|75785862|FG000|COMPLETED|Overall Study|1 patient had resolution of nausea prior and did not receive the investigational medication|72||
59667071|NCT00475306|75785863|FG001|COMPLETED|Overall Study|For 1 patient, data collection was incomplete and results could not be analyzed|71||
59667072|NCT00475306|75785864|FG002|COMPLETED|Overall Study||72||
59667073|NCT00475306|75785865|FG003|COMPLETED|Overall Study|1 patient's intravenous line infiltrated.|71||
59667074|NCT00475306|75785862|FG000|NOT COMPLETED|Overall Study||1||
59667075|NCT00475306|75785863|FG001|NOT COMPLETED|Overall Study||1||
59667076|NCT00475306|75785864|FG002|NOT COMPLETED|Overall Study||0||
59667077|NCT00475306|75785865|FG003|NOT COMPLETED|Overall Study||1||
59667078|NCT00475228|75785877|FG000|STARTED|Overall Study||44||
59667079|NCT00475228|75785878|FG001|STARTED|Overall Study||44||
59667080|NCT00475228|75785877|FG000|COMPLETED|Overall Study||27||
59667081|NCT00475228|75785878|FG001|COMPLETED|Overall Study||27||
59667082|NCT00475228|75785877|FG000|NOT COMPLETED|Overall Study||17||
59667083|NCT00475228|75785878|FG001|NOT COMPLETED|Overall Study||17||
59667084|NCT05894538|75785890|FG000|STARTED|Overall Study||718||
59667085|NCT05894538|75785891|FG001|STARTED|Overall Study||741||
59667086|NCT05894538|75785890|FG000|COMPLETED|Overall Study||708||
59667087|NCT05894538|75785891|FG001|COMPLETED|Overall Study||724||
59667088|NCT05894538|75785890|FG000|NOT COMPLETED|Overall Study||10||
59667089|NCT05894538|75785891|FG001|NOT COMPLETED|Overall Study||17||
59667090|NCT05244525|75785899|FG000|STARTED|Overall Study||30||
59667091|NCT05244525|75785900|FG001|STARTED|Overall Study||30||
59667092|NCT05244525|75785899|FG000|COMPLETED|Overall Study||30||
59667093|NCT05244525|75785900|FG001|COMPLETED|Overall Study||30||
59667094|NCT05244525|75785899|FG000|NOT COMPLETED|Overall Study||0||
59667095|NCT05244525|75785900|FG001|NOT COMPLETED|Overall Study||0||
59667096|NCT05186311|75785906|FG000|STARTED|Part A: Serum||136||
59667097|NCT05186311|75785906|FG000|COMPLETED|Part A: Serum||135||
59667098|NCT05186311|75785906|FG000|NOT COMPLETED|Part A: Serum||1||
59667099|NCT05186311|75785906|FG000|STARTED|Part B: EDTA||126||
59667100|NCT05186311|75785906|FG000|COMPLETED|Part B: EDTA||125||
59667101|NCT05186311|75785906|FG000|NOT COMPLETED|Part B: EDTA||1||
59667102|NCT04854434|75785914|FG000|STARTED|Overall Study||4||
59667103|NCT04854434|75785915|FG001|STARTED|Overall Study||5||
59667104|NCT04854434|75785916|FG002|STARTED|Overall Study||4||
59667105|NCT04854434|75785914|FG000|COMPLETED|Overall Study||0||
59667106|NCT04854434|75785915|FG001|COMPLETED|Overall Study||1||
59667107|NCT04854434|75785916|FG002|COMPLETED|Overall Study||0||
59667108|NCT04854434|75785914|FG000|NOT COMPLETED|Overall Study||4||
59667109|NCT04854434|75785915|FG001|NOT COMPLETED|Overall Study||4||
59667110|NCT04854434|75785916|FG002|NOT COMPLETED|Overall Study||4||
59667111|NCT04056468|75785929|FG000|STARTED|Overall Study||8||
59667112|NCT04056468|75785930|FG001|STARTED|Overall Study||8||
59667113|NCT04056468|75785931|FG002|STARTED|Overall Study||8||
59667114|NCT04056468|75785929|FG000|COMPLETED|Overall Study||8||
59667115|NCT04056468|75785930|FG001|COMPLETED|Overall Study||8||
59667116|NCT04056468|75785931|FG002|COMPLETED|Overall Study||8||
59667117|NCT04056468|75785929|FG000|NOT COMPLETED|Overall Study||0||
59667118|NCT04056468|75785930|FG001|NOT COMPLETED|Overall Study||0||
59667119|NCT04056468|75785931|FG002|NOT COMPLETED|Overall Study||0||
59667120|NCT03975400|75785941|FG000|STARTED|Baseline: Pre-Campaign Activation|Campaign activation period across NY state|65|6-month baseline period where all regions were in the control condition (no campaign).|2
59667121|NCT03975400|75785942|FG001|STARTED|Baseline: Pre-Campaign Activation||84|6-month baseline period where all regions were in the control condition (no campaign).|2
59667122|NCT03975400|75785943|FG002|STARTED|Baseline: Pre-Campaign Activation||42|6-month baseline period where all regions were in the control condition (no campaign).|2
59667123|NCT03975400|75785941|FG000|COMPLETED|Baseline: Pre-Campaign Activation||65||2
59667124|NCT03975400|75785942|FG001|COMPLETED|Baseline: Pre-Campaign Activation||84||2
59667125|NCT03975400|75785943|FG002|COMPLETED|Baseline: Pre-Campaign Activation||42||2
59667126|NCT03975400|75785941|FG000|NOT COMPLETED|Baseline: Pre-Campaign Activation||0||0
59667127|NCT03975400|75785942|FG001|NOT COMPLETED|Baseline: Pre-Campaign Activation||0||0
59667128|NCT03975400|75785943|FG002|NOT COMPLETED|Baseline: Pre-Campaign Activation||0||0
59667129|NCT03975400|75785941|FG000|STARTED|Phase 1 (Active in 2 Regions)||62|Campaign activated in Manhattan and Queens|2
59667130|NCT03975400|75785942|FG001|STARTED|Phase 1 (Active in 2 Regions)||79|Campaign activated in Manhattan and Queens|2
59667131|NCT03975400|75785943|FG002|STARTED|Phase 1 (Active in 2 Regions)||42|Campaign activated in Manhattan and Queens|2
59667132|NCT03975400|75785941|FG000|COMPLETED|Phase 1 (Active in 2 Regions)||62||2
59667133|NCT03975400|75785942|FG001|COMPLETED|Phase 1 (Active in 2 Regions)||79||2
59667134|NCT03975400|75785943|FG002|COMPLETED|Phase 1 (Active in 2 Regions)||42||2
59667135|NCT03975400|75785941|FG000|NOT COMPLETED|Phase 1 (Active in 2 Regions)||0||0
59667136|NCT03975400|75785942|FG001|NOT COMPLETED|Phase 1 (Active in 2 Regions)||0||0
59667137|NCT03975400|75785943|FG002|NOT COMPLETED|Phase 1 (Active in 2 Regions)||0||0
59667138|NCT03975400|75785941|FG000|STARTED|Phase 2 (Active in 4 Regions)||54|Campaign expanded to Brooklyn and Hudson Valley/Central NY/Westchester/Middleton|2
59667139|NCT03975400|75785942|FG001|STARTED|Phase 2 (Active in 4 Regions)||78|Campaign expanded to Brooklyn and Hudson Valley/Central NY/Westchester/Middleton|2
59667140|NCT03975400|75785943|FG002|STARTED|Phase 2 (Active in 4 Regions)||44|Campaign expanded to Brooklyn and Hudson Valley/Central NY/Westchester/Middleton|2
59667141|NCT03975400|75785941|FG000|COMPLETED|Phase 2 (Active in 4 Regions)||54||2
59667142|NCT03975400|75785942|FG001|COMPLETED|Phase 2 (Active in 4 Regions)||78||2
59667143|NCT03975400|75785943|FG002|COMPLETED|Phase 2 (Active in 4 Regions)||44||2
59667144|NCT03975400|75785941|FG000|NOT COMPLETED|Phase 2 (Active in 4 Regions)||0||0
59667145|NCT03975400|75785942|FG001|NOT COMPLETED|Phase 2 (Active in 4 Regions)||0||0
59667146|NCT03975400|75785943|FG002|NOT COMPLETED|Phase 2 (Active in 4 Regions)||0||0
59667147|NCT03975400|75785941|FG000|STARTED|Phase 3 (Active in All 6 Regions)||55|Campaign expanded to Bronx and Staten Island/Long Island/Western NY|2
59667148|NCT03975400|75785942|FG001|STARTED|Phase 3 (Active in All 6 Regions)||52|Campaign expanded to Bronx and Staten Island/Long Island/Western NY|2
59667149|NCT03975400|75785943|FG002|STARTED|Phase 3 (Active in All 6 Regions)||41|Campaign expanded to Bronx and Staten Island/Long Island/Western NY|2
59667150|NCT03975400|75785941|FG000|COMPLETED|Phase 3 (Active in All 6 Regions)||55||2
59667151|NCT03975400|75785942|FG001|COMPLETED|Phase 3 (Active in All 6 Regions)||52||2
59667152|NCT03975400|75785943|FG002|COMPLETED|Phase 3 (Active in All 6 Regions)||41||2
59667153|NCT03975400|75785941|FG000|NOT COMPLETED|Phase 3 (Active in All 6 Regions)||0||0
59667154|NCT03975400|75785942|FG001|NOT COMPLETED|Phase 3 (Active in All 6 Regions)||0||0
59667155|NCT03975400|75785943|FG002|NOT COMPLETED|Phase 3 (Active in All 6 Regions)||0||0
59667156|NCT03797014|75785951|FG000|STARTED|Overall Study||28||
59667157|NCT03797014|75785951|FG000|COMPLETED|Overall Study||25||
59667158|NCT03797014|75785951|FG000|NOT COMPLETED|Overall Study||3||
59667159|NCT03596450|75785957|FG000|STARTED|Overall Study||644||
59667160|NCT03596450|75785958|FG001|STARTED|Overall Study||634||
59667161|NCT03596450|75785957|FG000|COMPLETED|Overall Study||522|Includes participants that completed year 1 study visit|
59667162|NCT03596450|75785958|FG001|COMPLETED|Overall Study||525|Includes participants that completed year 1 study visit|
59667163|NCT03596450|75785957|FG000|NOT COMPLETED|Overall Study||122||
59667164|NCT03596450|75785958|FG001|NOT COMPLETED|Overall Study||109||
59667165|NCT03396874|75785966|FG000|STARTED|Overall Study||1181||
59667166|NCT03396874|75785967|FG001|STARTED|Overall Study||254||
59667167|NCT03396874|75785966|FG000|68Ga-PSMA Scan|Overall Study|received 68Ga-PSMA scan|1181||
59667168|NCT03396874|75785967|FG001|68Ga-PSMA Scan|Overall Study|did not receive scans|0||
59667169|NCT03396874|75785966|FG000|COMPLETED|Overall Study||1181||
59667170|NCT03396874|75785967|FG001|COMPLETED|Overall Study||254||
59667171|NCT03396874|75785966|FG000|NOT COMPLETED|Overall Study||0||
59667172|NCT03396874|75785967|FG001|NOT COMPLETED|Overall Study||0||
59667173|NCT03300817|75785973|FG000|STARTED|Overall Study||49||
59667174|NCT03300817|75785973|FG000|COMPLETED|Overall Study||45||
59667175|NCT03300817|75785973|FG000|NOT COMPLETED|Overall Study||4||
59667176|NCT03097783|75785983|FG000|STARTED|Overall Study||132||
59667177|NCT03097783|75785984|FG001|STARTED|Overall Study||37||
59667178|NCT03097783|75785983|FG000|COMPLETED|Overall Study||123||
59667179|NCT03097783|75785984|FG001|COMPLETED|Overall Study||31||
59667180|NCT03097783|75785983|FG000|NOT COMPLETED|Overall Study||9||
59667181|NCT03097783|75785984|FG001|NOT COMPLETED|Overall Study||6||
59667182|NCT03003130|75785992|FG000|STARTED|Overall Study||88||
59667183|NCT03003130|75785993|FG001|STARTED|Overall Study||87||
59667184|NCT03003130|75785992|FG000|COMPLETED|Overall Study||80||
59667185|NCT03003130|75785993|FG001|COMPLETED|Overall Study||80||
59667186|NCT03003130|75785992|FG000|NOT COMPLETED|Overall Study||8||
59667187|NCT03003130|75785993|FG001|NOT COMPLETED|Overall Study||7||
59667188|NCT02989844|75785999|FG000|STARTED|Overall Study||20||
59667189|NCT02989844|75785999|FG000|COMPLETED|Overall Study||20||
59667190|NCT02989844|75785999|FG000|NOT COMPLETED|Overall Study||0||
59667191|NCT02948842|75786003|FG000|STARTED|Overall Study||5||
59667192|NCT02948842|75786003|FG000|COMPLETED|Overall Study||1||
59667193|NCT02948842|75786003|FG000|NOT COMPLETED|Overall Study||4||
59667194|NCT02782468|75786011|FG000|STARTED|Overall Study||3||
59667195|NCT02782468|75786012|FG001|STARTED|Overall Study||7||
59667196|NCT02782468|75786013|FG002|STARTED|Overall Study||3||
59667197|NCT02782468|75786014|FG003|STARTED|Overall Study||10||
59667198|NCT02782468|75786011|FG000|COMPLETED|Overall Study||0||
59667199|NCT02782468|75786012|FG001|COMPLETED|Overall Study||0||
59667200|NCT02782468|75786013|FG002|COMPLETED|Overall Study||0||
59667201|NCT02782468|75786014|FG003|COMPLETED|Overall Study||0||
59667202|NCT02782468|75786011|FG000|NOT COMPLETED|Overall Study||3||
59667203|NCT02782468|75786012|FG001|NOT COMPLETED|Overall Study||7||
59667204|NCT02782468|75786013|FG002|NOT COMPLETED|Overall Study||3||
59667205|NCT02782468|75786014|FG003|NOT COMPLETED|Overall Study||10||
59667206|NCT02664181|75786026|FG000|STARTED|Overall Study||8||
59667207|NCT02664181|75786027|FG001|STARTED|Overall Study||5||
59667208|NCT02664181|75786026|FG000|COMPLETED|Overall Study||8||
59667209|NCT02664181|75786027|FG001|COMPLETED|Overall Study||5||
59667210|NCT02664181|75786026|FG000|NOT COMPLETED|Overall Study||0||
59667211|NCT02664181|75786027|FG001|NOT COMPLETED|Overall Study||0||
59667212|NCT02563769|75786036|FG000|STARTED|IV Cocaine Only (Day 1)||3||
59667213|NCT02563769|75786037|FG001|STARTED|IV Cocaine Only (Day 1)||3||
59667214|NCT02563769|75786038|FG002|STARTED|IV Cocaine Only (Day 1)||4||
59667215|NCT02563769|75786036|FG000|COMPLETED|IV Cocaine Only (Day 1)||3||
59667216|NCT02563769|75786037|FG001|COMPLETED|IV Cocaine Only (Day 1)||3||
59667217|NCT02563769|75786038|FG002|COMPLETED|IV Cocaine Only (Day 1)||4||
59667218|NCT02563769|75786036|FG000|NOT COMPLETED|IV Cocaine Only (Day 1)||0||
59667219|NCT02563769|75786037|FG001|NOT COMPLETED|IV Cocaine Only (Day 1)||0||
59667220|NCT02563769|75786038|FG002|NOT COMPLETED|IV Cocaine Only (Day 1)||0||
59667221|NCT02563769|75786036|FG000|STARTED|FIrst Treatment (Day 2)||3||
59667222|NCT02563769|75786037|FG001|STARTED|FIrst Treatment (Day 2)||3||
59667223|NCT02563769|75786038|FG002|STARTED|FIrst Treatment (Day 2)||4||
59667224|NCT02563769|75786036|FG000|COMPLETED|FIrst Treatment (Day 2)||3||
59667225|NCT02563769|75786037|FG001|COMPLETED|FIrst Treatment (Day 2)||3||
59667226|NCT02563769|75786038|FG002|COMPLETED|FIrst Treatment (Day 2)||4||
59667227|NCT02563769|75786036|FG000|NOT COMPLETED|FIrst Treatment (Day 2)||0||
59667228|NCT02563769|75786037|FG001|NOT COMPLETED|FIrst Treatment (Day 2)||0||
59667229|NCT02563769|75786038|FG002|NOT COMPLETED|FIrst Treatment (Day 2)||0||
59667230|NCT02563769|75786036|FG000|STARTED|Second Treatment (Day 3)||3||
59667231|NCT02563769|75786037|FG001|STARTED|Second Treatment (Day 3)||3||
59667232|NCT02563769|75786038|FG002|STARTED|Second Treatment (Day 3)||4||
59667233|NCT02563769|75786036|FG000|COMPLETED|Second Treatment (Day 3)||3||
59667234|NCT02563769|75786037|FG001|COMPLETED|Second Treatment (Day 3)||3||
59667235|NCT02563769|75786038|FG002|COMPLETED|Second Treatment (Day 3)||4||
59667236|NCT02563769|75786036|FG000|NOT COMPLETED|Second Treatment (Day 3)||0||
59667237|NCT02563769|75786037|FG001|NOT COMPLETED|Second Treatment (Day 3)||0||
59667238|NCT02563769|75786038|FG002|NOT COMPLETED|Second Treatment (Day 3)||0||
59667239|NCT02563769|75786036|FG000|STARTED|Third Treatment (Day 4)||3||
59667240|NCT02563769|75786037|FG001|STARTED|Third Treatment (Day 4)||3||
59667241|NCT02563769|75786038|FG002|STARTED|Third Treatment (Day 4)||4||
59667242|NCT02563769|75786036|FG000|COMPLETED|Third Treatment (Day 4)||3||
59667243|NCT02563769|75786037|FG001|COMPLETED|Third Treatment (Day 4)||3||
59667244|NCT02563769|75786038|FG002|COMPLETED|Third Treatment (Day 4)||4||
59667245|NCT02563769|75786036|FG000|NOT COMPLETED|Third Treatment (Day 4)||0||
59667246|NCT02563769|75786037|FG001|NOT COMPLETED|Third Treatment (Day 4)||0||
59667247|NCT02563769|75786038|FG002|NOT COMPLETED|Third Treatment (Day 4)||0||
59667248|NCT02563769|75786036|FG000|STARTED|Added 750mg Dose of CLAV (Day 5)|Version 2 of Protocol which added a single blind dose of CLAV 750mg (Period 5) was started after 1 participant had already completed the 4 periods (under Protocol 1) and was discharged. One subject who was enrolled on Protocol version 2 was discontinued before the 750mg dose of CLAV due to an adverse event at a lower dose and never started period 5. Thus, only 1 of the 3 in this arm started period 5.|1||
59667249|NCT02563769|75786037|FG001|STARTED|Added 750mg Dose of CLAV (Day 5)|Version 2 of Protocol which added a single blind dose of CLAV 750mg (Period 5) was started after 2 of the subjects in this arm had already completed the 4 periods (under Protocol version 1) and had been discharged. Thus, only 1 subject started Period 5 in this arm.|1||
59667250|NCT02563769|75786038|FG002|STARTED|Added 750mg Dose of CLAV (Day 5)|Version 2 of Protocol which added a single blind dose of CLAV 750mg (Period 5) was started after 1 of the participants in this arm had already completed the 4 periods (in protocol 1) and was discharged. Thus, only 3 subjects started Period 5 in this arm.|3||
59667251|NCT02563769|75786036|FG000|COMPLETED|Added 750mg Dose of CLAV (Day 5)||1||
59667252|NCT02563769|75786037|FG001|COMPLETED|Added 750mg Dose of CLAV (Day 5)||1||
59667253|NCT02563769|75786038|FG002|COMPLETED|Added 750mg Dose of CLAV (Day 5)|Two of three subjects completed this period. One subject had technical difficulty with IV cocaine infusion resulting in not completed status (Physician decision)|2||
59667254|NCT02563769|75786036|FG000|NOT COMPLETED|Added 750mg Dose of CLAV (Day 5)||0||
59667255|NCT02563769|75786037|FG001|NOT COMPLETED|Added 750mg Dose of CLAV (Day 5)||0||
59667256|NCT02563769|75786038|FG002|NOT COMPLETED|Added 750mg Dose of CLAV (Day 5)||1||
59667257|NCT02420717|75786074|FG000|STARTED|Overall Study||5||
59667258|NCT02420717|75786075|FG001|STARTED|Overall Study||3||
59667259|NCT02420717|75786076|FG002|STARTED|Overall Study||3||
59667260|NCT02420717|75786074|FG000|COMPLETED|Overall Study||3||
59667261|NCT02420717|75786075|FG001|COMPLETED|Overall Study||3||
59667262|NCT02420717|75786076|FG002|COMPLETED|Overall Study||3||
59667263|NCT02420717|75786074|FG000|NOT COMPLETED|Overall Study||2||
59667264|NCT02420717|75786075|FG001|NOT COMPLETED|Overall Study||0||
59545053|NCT01689155|75643738|FG000|STARTED|Overall Study||116||
59545054|NCT01689155|75643738|FG000|COMPLETED|Overall Study||116||
59545055|NCT01689155|75643738|FG000|NOT COMPLETED|Overall Study||0||
59545056|NCT00972530|75643745|FG000|STARTED|Overall Study||44||
59545057|NCT00972530|75643746|FG001|STARTED|Overall Study||46||
59545058|NCT00972530|75643745|FG000|COMPLETED|Overall Study||44||
59545059|NCT00972530|75643746|FG001|COMPLETED|Overall Study||46||
59545060|NCT00972530|75643745|FG000|NOT COMPLETED|Overall Study||0||
59545061|NCT00972530|75643746|FG001|NOT COMPLETED|Overall Study||0||
59545062|NCT01689701|75643754|FG000|STARTED|Overall Study||27||
59545063|NCT01689701|75643755|FG001|STARTED|Overall Study||27||
59545064|NCT01689701|75643754|FG000|COMPLETED|Overall Study||22||
59545065|NCT01689701|75643755|FG001|COMPLETED|Overall Study||21||
59545066|NCT01689701|75643754|FG000|NOT COMPLETED|Overall Study||5||
59545067|NCT01689701|75643755|FG001|NOT COMPLETED|Overall Study||6||
59545068|NCT01689779|75643763|FG000|STARTED|Overall Study||28||
59545069|NCT01689779|75643764|FG001|STARTED|Overall Study||32||
59545070|NCT01689779|75643763|FG000|COMPLETED|Overall Study||28||
59545071|NCT01689779|75643764|FG001|COMPLETED|Overall Study||32||
59545072|NCT01689779|75643763|FG000|NOT COMPLETED|Overall Study||0||
59545073|NCT01689779|75643764|FG001|NOT COMPLETED|Overall Study||0||
59545074|NCT01691027|75643770|FG000|STARTED|Scotoma Awareness|Four subjects started scotoma awareness training module|4||
59545075|NCT01691027|75643770|FG000|COMPLETED|Scotoma Awareness|Four subjects were able to complete scotoma awareness training module|4||
59545076|NCT01691027|75643770|FG000|NOT COMPLETED|Scotoma Awareness||0||
59545077|NCT01691027|75643770|FG000|STARTED|Line and Circle Tracing Training|Four subjects started line and circle tracing training module|4||
59545078|NCT01691027|75643770|FG000|COMPLETED|Line and Circle Tracing Training|Four subjects were able to complete line and circle tracing training module.|4||
59545079|NCT01691027|75643770|FG000|NOT COMPLETED|Line and Circle Tracing Training||0||
59545080|NCT01691027|75643770|FG000|STARTED|Video Games Training|Four subjects started video game training module|4||
59545081|NCT01691027|75643770|FG000|COMPLETED|Video Games Training|Four subjects were able to complete video games training module|4||
59545082|NCT01691027|75643770|FG000|NOT COMPLETED|Video Games Training||0||
59545083|NCT02159768|75643775|FG000|STARTED|Overall Study|Started 16 July 2014|30||
59545084|NCT02159768|75643775|FG000|COMPLETED|Overall Study|Completed 27 July 2015|30||
59545085|NCT02159768|75643775|FG000|NOT COMPLETED|Overall Study||0||
59545086|NCT00974246|75643779|FG000|STARTED|Overall Study||27||
59545087|NCT00974246|75643779|FG000|COMPLETED|Overall Study||27||
59545088|NCT00974246|75643779|FG000|NOT COMPLETED|Overall Study||0||
59545089|NCT00974480|75643787|FG000|STARTED|Overall Study||40||
59545090|NCT00974480|75643788|FG001|STARTED|Overall Study||40||
59545091|NCT00974480|75643789|FG002|STARTED|Overall Study||40||
59545092|NCT00974480|75643787|FG000|COMPLETED|Overall Study||29||
59545093|NCT00974480|75643788|FG001|COMPLETED|Overall Study||33||
59545094|NCT00974480|75643789|FG002|COMPLETED|Overall Study||30||
59545095|NCT00974480|75643787|FG000|NOT COMPLETED|Overall Study||11||
59545096|NCT00974480|75643788|FG001|NOT COMPLETED|Overall Study||7||
59545097|NCT00974480|75643789|FG002|NOT COMPLETED|Overall Study||10||
59545098|NCT00975650|75643803|FG000|STARTED|Period 1||13||
59545099|NCT00975650|75643804|FG001|STARTED|Period 1||16||
59545100|NCT00975650|75643805|FG002|STARTED|Period 1||14||
59545101|NCT00975650|75643806|FG003|STARTED|Period 1||14||
59545102|NCT00975650|75643803|FG000|COMPLETED|Period 1||13||
59545103|NCT00975650|75643804|FG001|COMPLETED|Period 1||16||
59545104|NCT00975650|75643805|FG002|COMPLETED|Period 1||14||
59545105|NCT00975650|75643806|FG003|COMPLETED|Period 1||14||
59545106|NCT00975650|75643803|FG000|NOT COMPLETED|Period 1||0||
59545107|NCT00975650|75643804|FG001|NOT COMPLETED|Period 1||0||
59545108|NCT00975650|75643805|FG002|NOT COMPLETED|Period 1||0||
59545109|NCT00975650|75643806|FG003|NOT COMPLETED|Period 1||0||
59545110|NCT00975650|75643803|FG000|STARTED|Period 2||13||
59545111|NCT00975650|75643804|FG001|STARTED|Period 2||16||
59545112|NCT00975650|75643805|FG002|STARTED|Period 2||14||
59545113|NCT00975650|75643806|FG003|STARTED|Period 2||14||
59545114|NCT00975650|75643803|FG000|COMPLETED|Period 2||12||
59545115|NCT00975650|75643804|FG001|COMPLETED|Period 2||14||
59545116|NCT00975650|75643805|FG002|COMPLETED|Period 2||14||
59545117|NCT00975650|75643806|FG003|COMPLETED|Period 2||14||
59545118|NCT00975650|75643803|FG000|NOT COMPLETED|Period 2||1||
59545119|NCT00975650|75643804|FG001|NOT COMPLETED|Period 2||2||
59545120|NCT00975650|75643805|FG002|NOT COMPLETED|Period 2||0||
59545121|NCT00975650|75643806|FG003|NOT COMPLETED|Period 2||0||
59545122|NCT00975650|75643803|FG000|STARTED|Period 3||12||
59545123|NCT00975650|75643804|FG001|STARTED|Period 3||14||
59545124|NCT00975650|75643805|FG002|STARTED|Period 3||14||
59667265|NCT02420717|75786076|FG002|NOT COMPLETED|Overall Study||0||
59545125|NCT00975650|75643806|FG003|STARTED|Period 3||14||
59545126|NCT00975650|75643803|FG000|COMPLETED|Period 3||12||
59545127|NCT00975650|75643804|FG001|COMPLETED|Period 3||14||
59545128|NCT00975650|75643805|FG002|COMPLETED|Period 3||14||
59545129|NCT00975650|75643806|FG003|COMPLETED|Period 3||14||
59545130|NCT00975650|75643803|FG000|NOT COMPLETED|Period 3||0||
59545131|NCT00975650|75643804|FG001|NOT COMPLETED|Period 3||0||
59545132|NCT00975650|75643805|FG002|NOT COMPLETED|Period 3||0||
59667266|NCT02257138|75786089|FG000|STARTED|Overall Study||5||
59667267|NCT02257138|75786090|FG001|STARTED|Overall Study||3||
59667268|NCT02257138|75786091|FG002|STARTED|Overall Study||3||
59667269|NCT02257138|75786092|FG003|STARTED|Overall Study||3||
59667270|NCT02257138|75786093|FG004|STARTED|Overall Study||16||
59667271|NCT02257138|75786089|FG000|COMPLETED|Overall Study||5||
59667272|NCT02257138|75786090|FG001|COMPLETED|Overall Study||3||
59667273|NCT02257138|75786091|FG002|COMPLETED|Overall Study||3||
59667274|NCT02257138|75786092|FG003|COMPLETED|Overall Study||3||
59667275|NCT02257138|75786093|FG004|COMPLETED|Overall Study||16||
59667276|NCT02257138|75786089|FG000|NOT COMPLETED|Overall Study||0||
59667277|NCT02257138|75786090|FG001|NOT COMPLETED|Overall Study||0||
59667278|NCT02257138|75786091|FG002|NOT COMPLETED|Overall Study||0||
59667279|NCT02257138|75786092|FG003|NOT COMPLETED|Overall Study||0||
59989114|NCT02880241|76104416|FG000|STARTED|Overall Study|Study terminated|8||
59989115|NCT02880241|76104417|FG001|STARTED|Overall Study|Study terminated|0||
59989116|NCT02880241|76104418|FG002|STARTED|Overall Study|Study terminated|0||
59989117|NCT02880241|76104419|FG003|STARTED|Overall Study|Study terminated|0||
59989118|NCT02880241|76104420|FG004|STARTED|Overall Study|Study terminated|0||
59989119|NCT02880241|76104421|FG005|STARTED|Overall Study|Study terminated|0||
59989120|NCT02880241|76104416|FG000|COMPLETED|Overall Study|Study terminated|7||
59989121|NCT02880241|76104417|FG001|COMPLETED|Overall Study|Study terminated|0||
59545133|NCT00975650|75643806|FG003|NOT COMPLETED|Period 3||0||
59545134|NCT00975650|75643803|FG000|STARTED|Period 4||12||
59545135|NCT00975650|75643804|FG001|STARTED|Period 4||14||
59545136|NCT00975650|75643805|FG002|STARTED|Period 4||14||
59545137|NCT00975650|75643806|FG003|STARTED|Period 4||14||
59545138|NCT00975650|75643803|FG000|COMPLETED|Period 4||12||
59545139|NCT00975650|75643804|FG001|COMPLETED|Period 4||14||
59545140|NCT00975650|75643805|FG002|COMPLETED|Period 4||14||
59545141|NCT00975650|75643806|FG003|COMPLETED|Period 4||14||
59545142|NCT00975650|75643803|FG000|NOT COMPLETED|Period 4||0||
59545143|NCT00975650|75643804|FG001|NOT COMPLETED|Period 4||0||
59667280|NCT02257138|75786093|FG004|NOT COMPLETED|Overall Study||0||
59667281|NCT02126579|75786109|FG000|STARTED|Overall Study||5||
59667282|NCT02126579|75786110|FG001|STARTED|Overall Study||7||
59667283|NCT02126579|75786111|FG002|STARTED|Overall Study||4||
59667284|NCT02126579|75786112|FG003|STARTED|Overall Study||6||
59667285|NCT02126579|75786113|FG004|STARTED|Overall Study||16||
59667286|NCT02126579|75786114|FG005|STARTED|Overall Study||6||
59667287|NCT02126579|75786115|FG006|STARTED|Overall Study||6||
59989122|NCT02880241|76104418|FG002|COMPLETED|Overall Study|Study terminated|0||
59989123|NCT02880241|76104419|FG003|COMPLETED|Overall Study|Study terminated|0||
59545144|NCT00975650|75643805|FG002|NOT COMPLETED|Period 4||0||
59545145|NCT00975650|75643806|FG003|NOT COMPLETED|Period 4||0||
59545146|NCT00976352|75643818|FG000|STARTED|Overall Study||3||
59667288|NCT02126579|75786109|FG000|Received at Least 3 Vaccines|Overall Study||5||
59667289|NCT02126579|75786110|FG001|Received at Least 3 Vaccines|Overall Study||7||
59667290|NCT02126579|75786111|FG002|Received at Least 3 Vaccines|Overall Study||4||
59667291|NCT02126579|75786112|FG003|Received at Least 3 Vaccines|Overall Study||6||
59667292|NCT02126579|75786113|FG004|Received at Least 3 Vaccines|Overall Study||16||
59667293|NCT02126579|75786114|FG005|Received at Least 3 Vaccines|Overall Study||6||
59667294|NCT02126579|75786115|FG006|Received at Least 3 Vaccines|Overall Study||6||
59667295|NCT02126579|75786109|FG000|COMPLETED|Overall Study||5|Completed all 6 vaccines|
59667296|NCT02126579|75786110|FG001|COMPLETED|Overall Study||7|Completed all 6 vaccines|
59667297|NCT02126579|75786111|FG002|COMPLETED|Overall Study||4|Completed all 6 vaccines|
59667298|NCT02126579|75786112|FG003|COMPLETED|Overall Study||5|Completed all 6 vaccines|
59667299|NCT02126579|75786113|FG004|COMPLETED|Overall Study||16|Completed all 6 vaccines|
59667300|NCT02126579|75786114|FG005|COMPLETED|Overall Study||6|Completed all 6 vaccines|
59667301|NCT02126579|75786115|FG006|COMPLETED|Overall Study||5|Completed all 6 vaccines|
59667302|NCT02126579|75786109|FG000|NOT COMPLETED|Overall Study||0||
59545147|NCT00976352|75643819|FG001|STARTED|Overall Study||10||
59545148|NCT00976352|75643818|FG000|COMPLETED|Overall Study||3||
59545149|NCT00976352|75643819|FG001|COMPLETED|Overall Study|Last evaluation of last subject in cohort.|6||
59667303|NCT02126579|75786110|FG001|NOT COMPLETED|Overall Study||0||
59667304|NCT02126579|75786111|FG002|NOT COMPLETED|Overall Study||0||
59667305|NCT02126579|75786112|FG003|NOT COMPLETED|Overall Study||1||
59667306|NCT02126579|75786113|FG004|NOT COMPLETED|Overall Study||0||
59667307|NCT02126579|75786114|FG005|NOT COMPLETED|Overall Study||0||
59667308|NCT02126579|75786115|FG006|NOT COMPLETED|Overall Study||1||
59667309|NCT01970306|75786133|FG000|STARTED|Overall Study||78||
59667310|NCT01970306|75786133|FG000|COMPLETED|Overall Study||66||
59667311|NCT01970306|75786133|FG000|NOT COMPLETED|Overall Study||12||
59667312|NCT01574274|75786139|FG000|STARTED|Overall Study||119|Randomized|
59667313|NCT01574274|75786140|FG001|STARTED|Overall Study||121|Randomized|
59545150|NCT00976352|75643818|FG000|NOT COMPLETED|Overall Study||0||
59545151|NCT00976352|75643819|FG001|NOT COMPLETED|Overall Study||4||
59667314|NCT01574274|75786139|FG000|Evaluable for Induction Events|Overall Study||115||
59545152|NCT00976664|75643831|FG000|STARTED|Overall Study||25||
59545153|NCT00976664|75643832|FG001|STARTED|Overall Study||25||
59667315|NCT01574274|75786140|FG001|Evaluable for Induction Events|Overall Study||115||
59667316|NCT01574274|75786139|FG000|Achieved Complete Remission|Overall Study||109||
59667317|NCT01574274|75786140|FG001|Achieved Complete Remission|Overall Study||114||
59667318|NCT01574274|75786139|FG000|Received Post-induction Asparaginase|Overall Study||109||
59667319|NCT01574274|75786140|FG001|Received Post-induction Asparaginase|Overall Study||114||
59667320|NCT01574274|75786139|FG000|Eligible|Overall Study||119||
59667321|NCT01574274|75786140|FG001|Eligible|Overall Study||120||
59667322|NCT01574274|75786139|FG000|COMPLETED|Overall Study||87||
59667323|NCT01574274|75786140|FG001|COMPLETED|Overall Study||99||
59667324|NCT01574274|75786139|FG000|NOT COMPLETED|Overall Study||32||
59667325|NCT01574274|75786140|FG001|NOT COMPLETED|Overall Study||22||
59667326|NCT01375140|75786146|FG000|STARTED|Overall Study||31||
59667327|NCT01375140|75786146|FG000|COMPLETED|Overall Study||31||
59667328|NCT01375140|75786146|FG000|NOT COMPLETED|Overall Study||0||
59667329|NCT01268514|75786150|FG000|STARTED|Overall Study||115||
59667330|NCT01268514|75786150|FG000|Participants Who Received the Device|Overall Study||114||
59667331|NCT01268514|75786150|FG000|COMPLETED|Overall Study||74||
59667332|NCT01268514|75786150|FG000|NOT COMPLETED|Overall Study||41||
59667333|NCT00625586|75786156|FG000|STARTED|Overall Study||2||
59667334|NCT00625586|75786156|FG000|COMPLETED|Overall Study||0||
59667335|NCT00625586|75786156|FG000|NOT COMPLETED|Overall Study||2||
59667336|NCT00400946|75786165|FG000|STARTED|Overall Study||231||
59667337|NCT00400946|75786166|FG001|STARTED|Overall Study||232||
59667338|NCT00400946|75786167|FG002|STARTED|Overall Study||42||
59667339|NCT00400946|75786168|FG003|STARTED|Overall Study||51||
59667340|NCT00400946|75786169|FG004|STARTED|Overall Study||244||
59667341|NCT00400946|75786165|FG000|Evaluable for CNS Directed-Treatment|Overall Study||231|Patients who achieved an induction complete remission with an evaluable sample at diagnosis.|
59667342|NCT00400946|75786166|FG001|Evaluable for CNS Directed-Treatment|Overall Study||232|Patients who achieved an induction complete remission with an evaluable sample at diagnosis.|
59667343|NCT00400946|75786167|FG002|Evaluable for CNS Directed-Treatment|Overall Study||42|Patients who achieved an induction complete remission with an evaluable sample at diagnosis.|
59667344|NCT00400946|75786168|FG003|Evaluable for CNS Directed-Treatment|Overall Study||21|Patients who achieved an induction complete remission with an evaluable sample at diagnosis.|
59667345|NCT00400946|75786169|FG004|Evaluable for CNS Directed-Treatment|Overall Study||227|Patients who achieved an induction complete remission with an evaluable sample at diagnosis.|
59815843|NCT02915367|75938233|FG000|COMPLETED|Overall Study||136||
59815844|NCT02915367|75938234|FG001|COMPLETED|Overall Study||144||
59815845|NCT02915367|75938233|FG000|NOT COMPLETED|Overall Study||37||
59815846|NCT02915367|75938234|FG001|NOT COMPLETED|Overall Study||31||
59815847|NCT02871882|75938242|FG000|STARTED|Overall Study||11||
59667346|NCT00400946|75786165|FG000|Evaluable for Day 18 Marrow Morphology|Overall Study||158|Patients who achieved an induction complete remission with an optional evaluable sample at day 18.|
59667347|NCT00400946|75786166|FG001|Evaluable for Day 18 Marrow Morphology|Overall Study||161|Patients who achieved an induction complete remission with an optional evaluable sample at day 18.|
59667348|NCT00400946|75786167|FG002|Evaluable for Day 18 Marrow Morphology|Overall Study||19|Patients who achieved an induction complete remission with an optional evaluable sample at day 18.|
59667349|NCT00400946|75786168|FG003|Evaluable for Day 18 Marrow Morphology|Overall Study||13|Patients who achieved an induction complete remission with an optional evaluable sample at day 18.|
59667350|NCT00400946|75786169|FG004|Evaluable for Day 18 Marrow Morphology|Overall Study||152|Patients who achieved an induction complete remission with an optional evaluable sample at day 18.|
59667351|NCT00400946|75786165|FG000|Evaluable for Day 32 MRD|Overall Study||166|B cell patients who achieved an induction complete remission with an evaluable sample at day 32.|
59667352|NCT00400946|75786166|FG001|Evaluable for Day 32 MRD|Overall Study||167|B cell patients who achieved an induction complete remission with an evaluable sample at day 32.|
59667353|NCT00400946|75786167|FG002|Evaluable for Day 32 MRD|Overall Study||33|B cell patients who achieved an induction complete remission with an evaluable sample at day 32.|
59667354|NCT00400946|75786168|FG003|Evaluable for Day 32 MRD|Overall Study||12|B cell patients who achieved an induction complete remission with an evaluable sample at day 32.|
59667355|NCT00400946|75786169|FG004|Evaluable for Day 32 MRD|Overall Study||168|B cell patients who achieved an induction complete remission with an evaluable sample at day 32.|
59667356|NCT00400946|75786165|FG000|Eligible and Treated|Overall Study||231|Ineligible: Burkitt's leuk diag (n=2), pr therapy (n=1), hyperbilirubinemia (n=1), w/d consent (n=2)|
59667357|NCT00400946|75786166|FG001|Eligible and Treated|Overall Study||232|Ineligible: Burkitt's leuk diag (n=2), pr therapy (n=1), hyperbilirubinemia (n=1), w/d consent (n=2)|
59667358|NCT00400946|75786167|FG002|Eligible and Treated|Overall Study||42|Ineligible: Burkitt's leuk diag (n=2), pr therapy (n=1), hyperbilirubinemia (n=1), w/d consent (n=2)|
59667359|NCT00400946|75786168|FG003|Eligible and Treated|Overall Study||46|Ineligible: Burkitt's leuk diag (n=2), pr therapy (n=1), hyperbilirubinemia (n=1), w/d consent (n=2)|
59667360|NCT00400946|75786169|FG004|Eligible and Treated|Overall Study||243|Ineligible: Burkitt's leuk diag (n=2), pr therapy (n=1), hyperbilirubinemia (n=1), w/d consent (n=2)|
59667361|NCT00400946|75786165|FG000|COMPLETED|Overall Study||217||
59667362|NCT00400946|75786166|FG001|COMPLETED|Overall Study||221||
59667363|NCT00400946|75786167|FG002|COMPLETED|Overall Study||40||
59667364|NCT00400946|75786168|FG003|COMPLETED|Overall Study||4||
59667365|NCT00400946|75786169|FG004|COMPLETED|Overall Study||206||
59815848|NCT02871882|75938243|FG001|STARTED|Overall Study||12||
59815849|NCT02871882|75938242|FG000|COMPLETED|Overall Study||11||
59815850|NCT02871882|75938243|FG001|COMPLETED|Overall Study||12||
59667366|NCT00400946|75786165|FG000|NOT COMPLETED|Overall Study||14||
59667367|NCT00400946|75786166|FG001|NOT COMPLETED|Overall Study||11||
59667368|NCT00400946|75786167|FG002|NOT COMPLETED|Overall Study||2||
59667369|NCT00400946|75786168|FG003|NOT COMPLETED|Overall Study||47||
59667370|NCT00400946|75786169|FG004|NOT COMPLETED|Overall Study||38||
59667371|NCT00475033|75786189|FG000|STARTED|Infant Series||300||
59667372|NCT00475033|75786190|FG001|STARTED|Infant Series||303||
59667373|NCT00475033|75786189|FG000|Vaccinated Dose 1|Infant Series||300||
59667374|NCT00475033|75786190|FG001|Vaccinated Dose 1|Infant Series||303||
59667375|NCT00475033|75786189|FG000|Vaccinated Dose 2|Infant Series||297||
59667376|NCT00475033|75786190|FG001|Vaccinated Dose 2|Infant Series||296||
59667377|NCT00475033|75786189|FG000|Vaccinated Dose 3|Infant Series||293||
59667378|NCT00475033|75786190|FG001|Vaccinated Dose 3|Infant Series||294||
59667379|NCT00475033|75786189|FG000|COMPLETED|Infant Series||293||
59667380|NCT00475033|75786190|FG001|COMPLETED|Infant Series||290||
59667381|NCT00475033|75786189|FG000|NOT COMPLETED|Infant Series||7||
59667382|NCT00475033|75786190|FG001|NOT COMPLETED|Infant Series||13||
59667383|NCT00475033|75786189|FG000|STARTED|After the Infant Series||293||
59667384|NCT00475033|75786190|FG001|STARTED|After the Infant Series||290||
59667385|NCT00475033|75786189|FG000|Withdrawn After Infant Series|After the Infant Series||6||
59667386|NCT00475033|75786190|FG001|Withdrawn After Infant Series|After the Infant Series||8||
59667387|NCT00475033|75786189|FG000|COMPLETED|After the Infant Series||287||
59667388|NCT00475033|75786190|FG001|COMPLETED|After the Infant Series||282||
59667389|NCT00475033|75786189|FG000|NOT COMPLETED|After the Infant Series||6||
59667390|NCT00475033|75786190|FG001|NOT COMPLETED|After the Infant Series||8||
59667391|NCT00475033|75786189|FG000|STARTED|Toddler Dose|Vaccinated Toddler Dose|287||
59667392|NCT00475033|75786190|FG001|STARTED|Toddler Dose|Vaccinated Toddler Dose|282||
59667393|NCT00475033|75786189|FG000|COMPLETED|Toddler Dose||283||
59667394|NCT00475033|75786190|FG001|COMPLETED|Toddler Dose||282||
59667395|NCT00475033|75786189|FG000|NOT COMPLETED|Toddler Dose||4||
59667396|NCT00475033|75786190|FG001|NOT COMPLETED|Toddler Dose||0||
59667397|NCT00474994|75786203|FG000|STARTED|Overall Study||53||
59545154|NCT00976664|75643831|FG000|COMPLETED|Overall Study||22||
59545155|NCT00976664|75643832|FG001|COMPLETED|Overall Study||24||
59545156|NCT00976664|75643831|FG000|NOT COMPLETED|Overall Study||3||
59545157|NCT00976664|75643832|FG001|NOT COMPLETED|Overall Study||1||
59545158|NCT00979940|75643840|FG000|STARTED|Overall Study||32||
59545159|NCT00979940|75643841|FG001|STARTED|Overall Study||28||
59545160|NCT00979940|75643840|FG000|COMPLETED|Overall Study||32||
59545161|NCT00979940|75643841|FG001|COMPLETED|Overall Study||28||
59545162|NCT00979940|75643840|FG000|NOT COMPLETED|Overall Study||0||
59545163|NCT00979940|75643841|FG001|NOT COMPLETED|Overall Study||0||
59545164|NCT00980642|75643849|FG000|STARTED|Overall Study||36||
59545165|NCT00980642|75643850|FG001|STARTED|Overall Study||20||
59545166|NCT00980642|75643849|FG000|COMPLETED|Overall Study||36||
59545167|NCT00980642|75643850|FG001|COMPLETED|Overall Study||20||
59545168|NCT00980642|75643849|FG000|NOT COMPLETED|Overall Study||0||
59545169|NCT00980642|75643850|FG001|NOT COMPLETED|Overall Study||0||
59545170|NCT00981812|75643857|FG000|STARTED|Overall Study||20||
59545171|NCT00981812|75643857|FG000|COMPLETED|Overall Study||20||
59545172|NCT00981812|75643857|FG000|NOT COMPLETED|Overall Study||0||
59545173|NCT02248103|75643863|FG000|STARTED|Overall Study||10||
59545174|NCT02248103|75643864|FG001|STARTED|Overall Study||10||
59545175|NCT02248103|75643863|FG000|COMPLETED|Overall Study||10||
59545176|NCT02248103|75643864|FG001|COMPLETED|Overall Study||10||
59545177|NCT02248103|75643863|FG000|NOT COMPLETED|Overall Study||0||
59545178|NCT02248103|75643864|FG001|NOT COMPLETED|Overall Study||0||
59545179|NCT02242019|75643870|FG000|STARTED|Overall Study||109||
59545180|NCT02242019|75643870|FG000|COMPLETED|Overall Study||109||
59545181|NCT02242019|75643870|FG000|NOT COMPLETED|Overall Study||0||
59545182|NCT00982592|75643876|FG000|STARTED|Overall Study||64||
59545183|NCT00982592|75643877|FG001|STARTED|Overall Study||60||
59667398|NCT00474994|75786203|FG000|COMPLETED|Overall Study||48||
59667399|NCT00474994|75786203|FG000|NOT COMPLETED|Overall Study||5||
59667400|NCT00474955|75786207|FG000|STARTED|Overall Study||27||
59667401|NCT00474955|75786207|FG000|COMPLETED|Overall Study||19||
59667402|NCT00474955|75786207|FG000|NOT COMPLETED|Overall Study||8||
59667403|NCT00474487|75786215|FG000|STARTED|Overall Study||1606||
59667404|NCT00474487|75786216|FG001|STARTED|Overall Study||217||
59667405|NCT00474487|75786217|FG002|STARTED|Overall Study||899||
59667406|NCT00474487|75786218|FG003|STARTED|Overall Study||109||
59667407|NCT00474487|75786215|FG000|COMPLETED|Overall Study||1576||
59667408|NCT00474487|75786216|FG001|COMPLETED|Overall Study||215||
59667409|NCT00474487|75786217|FG002|COMPLETED|Overall Study||885||
59667410|NCT00474487|75786218|FG003|COMPLETED|Overall Study||109||
59667411|NCT00474487|75786215|FG000|NOT COMPLETED|Overall Study||30||
59667412|NCT00474487|75786216|FG001|NOT COMPLETED|Overall Study||2||
60077359|NCT02531308|76192394|FG000|STARTED|Overall Study||5||
60077360|NCT02531308|76192394|FG000|COMPLETED|Overall Study||2||
60077361|NCT02531308|76192394|FG000|NOT COMPLETED|Overall Study||3||
60077362|NCT02460874|76192400|FG000|STARTED|Overall Study||1||
59667413|NCT00474487|75786217|FG002|NOT COMPLETED|Overall Study||14||
59667414|NCT00474487|75786218|FG003|NOT COMPLETED|Overall Study||0||
59667415|NCT00474253|75786230|FG000|STARTED|Overall Study|Includes 2 participants randomized to succinylcholine group who received rocuronium + sugammadex.|58||
59667416|NCT00474253|75786231|FG001|STARTED|Overall Study|Includes 1 participant randomized to rocuronium + sugammadex group who received succinylcholine.|57||
59667417|NCT00474253|75786230|FG000|Treated|Overall Study|Based on actual treatment received.|56||
59667418|NCT00474253|75786231|FG001|Treated|Overall Study|Based on actual treatment received.|54||
59667419|NCT00474253|75786230|FG000|COMPLETED|Overall Study|Based on actual treatment received.|55||
59667420|NCT00474253|75786231|FG001|COMPLETED|Overall Study|Based on actual treatment received.|53||
59667421|NCT00474253|75786230|FG000|NOT COMPLETED|Overall Study||3||
59667422|NCT00474253|75786231|FG001|NOT COMPLETED|Overall Study||4||
59667423|NCT00474058|75786239|FG000|STARTED|Overall Study||190||
59667424|NCT00474058|75786240|FG001|STARTED|Overall Study||97||
59667425|NCT00474058|75786239|FG000|COMPLETED|Overall Study||166||
59667426|NCT00474058|75786240|FG001|COMPLETED|Overall Study||80||
59667427|NCT00474058|75786239|FG000|NOT COMPLETED|Overall Study||24||
59667428|NCT00474058|75786240|FG001|NOT COMPLETED|Overall Study||17||
59667429|NCT00473824|75786248|FG000|STARTED|Overall Study||5||
59667430|NCT00473824|75786249|FG001|STARTED|Overall Study||2||
59667431|NCT00473824|75786248|FG000|COMPLETED|Overall Study|Study Completion/Early Termination Date|0||
59667432|NCT00473824|75786249|FG001|COMPLETED|Overall Study|Study Completion/Early Termination Date|2||
59667433|NCT00473824|75786248|FG000|NOT COMPLETED|Overall Study||5||
59667434|NCT00473824|75786249|FG001|NOT COMPLETED|Overall Study||0||
59667435|NCT00473746|75786260|FG000|STARTED|Period 1 (Phase 1)||6||
59667436|NCT00473746|75786261|FG001|STARTED|Period 1 (Phase 1)||9||
59667437|NCT00473746|75786262|FG002|STARTED|Period 1 (Phase 1)||6||
59667438|NCT00473746|75786263|FG003|STARTED|Period 1 (Phase 1)||12||
60077363|NCT02460874|76192401|FG001|STARTED|Overall Study||0||
60077364|NCT02460874|76192400|FG000|COMPLETED|Overall Study||1||
60077365|NCT02460874|76192401|FG001|COMPLETED|Overall Study||0||
59667439|NCT00473746|75786264|FG004|STARTED|Period 1 (Phase 1)||0||
59667440|NCT00473746|75786260|FG000|COMPLETED|Period 1 (Phase 1)||0||
59667441|NCT00473746|75786261|FG001|COMPLETED|Period 1 (Phase 1)||0||
59667442|NCT00473746|75786262|FG002|COMPLETED|Period 1 (Phase 1)||0||
59667443|NCT00473746|75786263|FG003|COMPLETED|Period 1 (Phase 1)|Treatment ongoing|2||
59667444|NCT00473746|75786264|FG004|COMPLETED|Period 1 (Phase 1)||0||
59667445|NCT00473746|75786260|FG000|NOT COMPLETED|Period 1 (Phase 1)||6||
59667446|NCT00473746|75786261|FG001|NOT COMPLETED|Period 1 (Phase 1)||9||
59667447|NCT00473746|75786262|FG002|NOT COMPLETED|Period 1 (Phase 1)||6||
59667448|NCT00473746|75786263|FG003|NOT COMPLETED|Period 1 (Phase 1)||10||
59667449|NCT00473746|75786264|FG004|NOT COMPLETED|Period 1 (Phase 1)||0||
59667450|NCT00473746|75786260|FG000|STARTED|Period 2 (Phase 2)||0||
59667451|NCT00473746|75786261|FG001|STARTED|Period 2 (Phase 2)||0||
59667452|NCT00473746|75786262|FG002|STARTED|Period 2 (Phase 2)||0||
60077366|NCT02460874|76192400|FG000|NOT COMPLETED|Overall Study||0||
59667453|NCT00473746|75786263|FG003|STARTED|Period 2 (Phase 2)||0||
59667454|NCT00473746|75786264|FG004|STARTED|Period 2 (Phase 2)||33||
59667455|NCT00473746|75786260|FG000|COMPLETED|Period 2 (Phase 2)||0||
59667456|NCT00473746|75786261|FG001|COMPLETED|Period 2 (Phase 2)||0||
59667457|NCT00473746|75786262|FG002|COMPLETED|Period 2 (Phase 2)||0||
59667458|NCT00473746|75786263|FG003|COMPLETED|Period 2 (Phase 2)||0||
59667459|NCT00473746|75786264|FG004|COMPLETED|Period 2 (Phase 2)||6||
59667460|NCT00473746|75786260|FG000|NOT COMPLETED|Period 2 (Phase 2)||0||
59667461|NCT00473746|75786261|FG001|NOT COMPLETED|Period 2 (Phase 2)||0||
59667462|NCT00473746|75786262|FG002|NOT COMPLETED|Period 2 (Phase 2)||0||
59667463|NCT00473746|75786263|FG003|NOT COMPLETED|Period 2 (Phase 2)||0||
60077367|NCT02460874|76192401|FG001|NOT COMPLETED|Overall Study||0||
60077368|NCT01539291|76192410|FG000|STARTED|Study GS-US-312-0116|Started = Randomized in Study GS-US-312-0116.|106||
59667464|NCT00473746|75786264|FG004|NOT COMPLETED|Period 2 (Phase 2)||27||
59667465|NCT00473668|75786281|FG000|STARTED|Overall Study||100||
59667466|NCT00473668|75786282|FG001|STARTED|Overall Study||100||
59667467|NCT00473668|75786283|FG002|STARTED|Overall Study||99||
59667468|NCT00473668|75786281|FG000|COMPLETED|Overall Study||95||
59667469|NCT00473668|75786282|FG001|COMPLETED|Overall Study||89||
59667470|NCT00473668|75786283|FG002|COMPLETED|Overall Study||89||
59667471|NCT00473668|75786281|FG000|NOT COMPLETED|Overall Study||5||
59667472|NCT00473668|75786282|FG001|NOT COMPLETED|Overall Study||11||
59667473|NCT00473668|75786283|FG002|NOT COMPLETED|Overall Study||10||
59667474|NCT00473590|75786293|FG000|STARTED|Overall Study||53||
59667475|NCT00473590|75786294|FG001|STARTED|Overall Study||49||
59667476|NCT00473590|75786293|FG000|Treated|Overall Study||52||
59667477|NCT00473590|75786294|FG001|Treated|Overall Study||48||
59667478|NCT00473590|75786293|FG000|Safety Population|Overall Study|2 patients received at least 1 bevacizumab dose & were analyzed as bevacizumab-treated patients|50||
59667479|NCT00473590|75786294|FG001|Safety Population|Overall Study||50||
59667480|NCT00473590|75786293|FG000|COMPLETED|Overall Study|Continuing on study as of the data cutoff date of 9 November 2009.|8||
59667481|NCT00473590|75786294|FG001|COMPLETED|Overall Study|Continuing on study as of the data cutoff date of 9 November 2009.|11||
59667482|NCT00473590|75786293|FG000|NOT COMPLETED|Overall Study||45||
59667483|NCT00473590|75786294|FG001|NOT COMPLETED|Overall Study||38||
59667484|NCT00473512|75786305|FG000|STARTED|Period 1 (Phase 1)||3||
59667485|NCT00473512|75786306|FG001|STARTED|Period 1 (Phase 1)||3||
59667486|NCT00473512|75786307|FG002|STARTED|Period 1 (Phase 1)||3||
59667487|NCT00473512|75786308|FG003|STARTED|Period 1 (Phase 1)||42||
59667488|NCT00473512|75786309|FG004|STARTED|Period 1 (Phase 1)||3||
59667489|NCT00473512|75786305|FG000|COMPLETED|Period 1 (Phase 1)||2||
59667490|NCT00473512|75786306|FG001|COMPLETED|Period 1 (Phase 1)||2||
59667491|NCT00473512|75786307|FG002|COMPLETED|Period 1 (Phase 1)||3||
59667492|NCT00473512|75786308|FG003|COMPLETED|Period 1 (Phase 1)||25||
59667493|NCT00473512|75786309|FG004|COMPLETED|Period 1 (Phase 1)||2||
59667494|NCT00473512|75786305|FG000|NOT COMPLETED|Period 1 (Phase 1)||1||
59667495|NCT00473512|75786306|FG001|NOT COMPLETED|Period 1 (Phase 1)||1||
59667496|NCT00473512|75786307|FG002|NOT COMPLETED|Period 1 (Phase 1)||0||
59667497|NCT00473512|75786308|FG003|NOT COMPLETED|Period 1 (Phase 1)||17||
59667498|NCT00473512|75786309|FG004|NOT COMPLETED|Period 1 (Phase 1)||1||
59667499|NCT00473512|75786305|FG000|STARTED|Period 2 (Phase 2)|1 participant did not continue to Phase 2 of the study.|1||
59667500|NCT00473512|75786306|FG001|STARTED|Period 2 (Phase 2)||2||
59667501|NCT00473512|75786307|FG002|STARTED|Period 2 (Phase 2)|1 participant did not continue to Phase 2 of the study.|2||
59667502|NCT00473512|75786308|FG003|STARTED|Period 2 (Phase 2)|2 participants did not continue to Phase 2 of the study.|23||
59667503|NCT00473512|75786309|FG004|STARTED|Period 2 (Phase 2)||2||
59667504|NCT00473512|75786305|FG000|COMPLETED|Period 2 (Phase 2)||0||
59667505|NCT00473512|75786306|FG001|COMPLETED|Period 2 (Phase 2)||0||
59667506|NCT00473512|75786307|FG002|COMPLETED|Period 2 (Phase 2)||0||
59667507|NCT00473512|75786308|FG003|COMPLETED|Period 2 (Phase 2)||0||
59667508|NCT00473512|75786309|FG004|COMPLETED|Period 2 (Phase 2)||0||
59667509|NCT00473512|75786305|FG000|NOT COMPLETED|Period 2 (Phase 2)||1||
59667510|NCT00473512|75786306|FG001|NOT COMPLETED|Period 2 (Phase 2)||2||
59667511|NCT00473512|75786307|FG002|NOT COMPLETED|Period 2 (Phase 2)||2||
59667512|NCT00473512|75786308|FG003|NOT COMPLETED|Period 2 (Phase 2)||23||
59667513|NCT00473512|75786309|FG004|NOT COMPLETED|Period 2 (Phase 2)||2||
59667514|NCT00473434|75786329|FG000|STARTED|Overall Study||64||
59667515|NCT00473434|75786329|FG000|COMPLETED|Overall Study||32||
59667516|NCT00473434|75786329|FG000|NOT COMPLETED|Overall Study||32||
59667517|NCT00473083|75786349|FG000|STARTED|Overall Study||50||
59667518|NCT00473083|75786350|FG001|STARTED|Overall Study||50||
59667519|NCT00473083|75786351|FG002|STARTED|Overall Study||50||
59667520|NCT00473083|75786349|FG000|COMPLETED|Overall Study|One patient (2%) from treatment arm 1 discontinued the study drug as a result of a TEAE (dizziness)|49||
59667521|NCT00473083|75786350|FG001|COMPLETED|Overall Study||50||
59667522|NCT00473083|75786351|FG002|COMPLETED|Overall Study||50||
59667523|NCT00473083|75786349|FG000|NOT COMPLETED|Overall Study||1||
59667524|NCT00473083|75786350|FG001|NOT COMPLETED|Overall Study||0||
59667525|NCT00473083|75786351|FG002|NOT COMPLETED|Overall Study||0||
59667526|NCT00472420|75786362|FG000|STARTED|Induction Treatment Period||48||
59667527|NCT00472420|75786362|FG000|COMPLETED|Induction Treatment Period||32||
59667528|NCT00472420|75786362|FG000|NOT COMPLETED|Induction Treatment Period||16||
59667529|NCT00472420|75786362|FG000|STARTED|Follow-up Period||32||
59667530|NCT00472420|75786362|FG000|COMPLETED|Follow-up Period||15||
59667531|NCT00472420|75786362|FG000|NOT COMPLETED|Follow-up Period||17||
59667532|NCT00472303|75786368|FG000|STARTED|Titration Phase||338||
59667533|NCT00472303|75786369|FG001|STARTED|Titration Phase||158||
59667534|NCT00472303|75786370|FG002|STARTED|Titration Phase|All participants in the titration phase were in the tapentadol arm during the titration phase.|0||
59667535|NCT00472303|75786368|FG000|COMPLETED|Titration Phase||279||
59667536|NCT00472303|75786369|FG001|COMPLETED|Titration Phase||129||
59667537|NCT00472303|75786370|FG002|COMPLETED|Titration Phase||0||
59667538|NCT00472303|75786368|FG000|NOT COMPLETED|Titration Phase||59||
59667539|NCT00472303|75786369|FG001|NOT COMPLETED|Titration Phase||29||
59667540|NCT00472303|75786370|FG002|NOT COMPLETED|Titration Phase||0||
59667541|NCT00472303|75786368|FG000|STARTED|Discontinuations After Titration Phase||279||
59667542|NCT00472303|75786369|FG001|STARTED|Discontinuations After Titration Phase||129||
59815851|NCT02871882|75938242|FG000|NOT COMPLETED|Overall Study||0||
59667543|NCT00472303|75786370|FG002|STARTED|Discontinuations After Titration Phase||0||
59667544|NCT00472303|75786368|FG000|COMPLETED|Discontinuations After Titration Phase|Participants meeting stabilization criteria on days 13-15 in the titration phase were re-randomized.|218||
59667545|NCT00472303|75786369|FG001|COMPLETED|Discontinuations After Titration Phase|Participants meeting stabilization criteria on days 13-15 in the titration phase were re-randomized.|109||
59667546|NCT00472303|75786370|FG002|COMPLETED|Discontinuations After Titration Phase||0||
59667547|NCT00472303|75786368|FG000|NOT COMPLETED|Discontinuations After Titration Phase||61||
59667548|NCT00472303|75786369|FG001|NOT COMPLETED|Discontinuations After Titration Phase||20||
59667549|NCT00472303|75786370|FG002|NOT COMPLETED|Discontinuations After Titration Phase||0||
59667550|NCT00472303|75786368|FG000|STARTED|Maintenance Phase|106 of 218 participants in the tapentadol titration arm were re-randomized and treated.|106||
59667551|NCT00472303|75786369|FG001|STARTED|Maintenance Phase||109||
59667552|NCT00472303|75786370|FG002|STARTED|Maintenance Phase|112 of 218 participants in the tapentadol titration arm were re-randomized and treated.|112||
59667553|NCT00472303|75786368|FG000|COMPLETED|Maintenance Phase||89||
59667554|NCT00472303|75786369|FG001|COMPLETED|Maintenance Phase||93||
59667555|NCT00472303|75786370|FG002|COMPLETED|Maintenance Phase||95||
59667556|NCT00472303|75786368|FG000|NOT COMPLETED|Maintenance Phase||17||
59667557|NCT00472303|75786369|FG001|NOT COMPLETED|Maintenance Phase||16||
59667558|NCT00472303|75786370|FG002|NOT COMPLETED|Maintenance Phase||17||
59667559|NCT00471718|75786398|FG000|STARTED|Overall Study||27||
59667560|NCT00471718|75786398|FG000|COMPLETED|Overall Study||0||
59667561|NCT00471718|75786398|FG000|NOT COMPLETED|Overall Study||27||
59667562|NCT00471445|75786408|FG000|STARTED|Overall Study||229||
59667563|NCT00471445|75786409|FG001|STARTED|Overall Study||233||
59667564|NCT00471445|75786408|FG000|COMPLETED|Overall Study||227||
59667565|NCT00471445|75786409|FG001|COMPLETED|Overall Study||231||
59667566|NCT00471445|75786408|FG000|NOT COMPLETED|Overall Study||2||
59667567|NCT00471445|75786409|FG001|NOT COMPLETED|Overall Study||2||
59667568|NCT00471328|75786417|FG000|STARTED|Core Phase||165||
59667569|NCT00471328|75786418|FG001|STARTED|Core Phase||83||
59667570|NCT00471328|75786417|FG000|Crossover to Nilotinib:Started Extension|Core Phase||0||
59667571|NCT00471328|75786418|FG001|Crossover to Nilotinib:Started Extension|Core Phase||53||
59667572|NCT00471328|75786417|FG000|COMPLETED|Core Phase|Ongoing on treatment during completion of core.|58||
59667573|NCT00471328|75786418|FG001|COMPLETED|Core Phase|Ongoing on treatment during completion of core|16||
59667574|NCT00471328|75786417|FG000|NOT COMPLETED|Core Phase||107||
59667575|NCT00471328|75786418|FG001|NOT COMPLETED|Core Phase||67||
59667576|NCT00471328|75786417|FG000|STARTED|Extension Phase|Out of 58 ongoing patients, 17 patients had progression or died before they could enter extension|41||
59667577|NCT00471328|75786418|FG001|STARTED|Extension Phase||67||
59667578|NCT00471328|75786417|FG000|Started:CrossOver Before PrimaryAnalysis|Extension Phase||0||
59667579|NCT00471328|75786418|FG001|Started:CrossOver Before PrimaryAnalysis|Extension Phase||53||
59667580|NCT00471328|75786417|FG000|Started:CrossOver After PrimaryAnalysis|Extension Phase||0||
59667581|NCT00471328|75786418|FG001|Started:CrossOver After PrimaryAnalysis|Extension Phase||4||
59667582|NCT00471328|75786417|FG000|Started:CrossOver During Extension|Extension Phase||0||
59667583|NCT00471328|75786418|FG001|Started:CrossOver During Extension|Extension Phase||10||
59667584|NCT00471328|75786417|FG000|COMPLETED|Extension Phase||0||
59667585|NCT00471328|75786418|FG001|COMPLETED|Extension Phase||0||
59667586|NCT00471328|75786417|FG000|NOT COMPLETED|Extension Phase||41||
59667587|NCT00471328|75786418|FG001|NOT COMPLETED|Extension Phase||67||
59667588|NCT00470470|75786426|FG000|STARTED|Overall Study||30||
59667589|NCT00470470|75786426|FG000|COMPLETED|Overall Study||25||
59667590|NCT00470470|75786426|FG000|NOT COMPLETED|Overall Study||5||
59667591|NCT00470275|75786430|FG000|STARTED|Overall Study||10||
59667592|NCT00470275|75786430|FG000|COMPLETED|Overall Study||0||
59667593|NCT00470275|75786430|FG000|NOT COMPLETED|Overall Study||10||
59667594|NCT00470158|75786439|FG000|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|201||
59667595|NCT00470158|75786440|FG001|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|199||
59667596|NCT00470158|75786441|FG002|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|201||
59667597|NCT00470158|75786442|FG003|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|198||
59667598|NCT00470158|75786443|FG004|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|201||
59667599|NCT00470158|75786439|FG000|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|193||
59667600|NCT00470158|75786440|FG001|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|191||
59667601|NCT00470158|75786441|FG002|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|193||
59667602|NCT00470158|75786442|FG003|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|193||
59667603|NCT00470158|75786443|FG004|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|195||
59667604|NCT00470158|75786439|FG000|NOT COMPLETED|Overall Study||8||
59667605|NCT00470158|75786440|FG001|NOT COMPLETED|Overall Study||8||
59667606|NCT00470158|75786441|FG002|NOT COMPLETED|Overall Study||8||
59667607|NCT00470158|75786442|FG003|NOT COMPLETED|Overall Study||5||
59667608|NCT00470158|75786443|FG004|NOT COMPLETED|Overall Study||6||
59667609|NCT00475540|75786457|FG000|STARTED|3 Months||32||
59815852|NCT02871882|75938243|FG001|NOT COMPLETED|Overall Study||0||
59667610|NCT00475540|75786458|FG001|STARTED|3 Months|One originally randomized to the vaginal mesh arm but did not receive mesh due to inadequate vaginal caliber|33||
59667611|NCT00475540|75786457|FG000|COMPLETED|3 Months||32||
59667612|NCT00475540|75786458|FG001|COMPLETED|3 Months||33||
59667613|NCT00475540|75786457|FG000|NOT COMPLETED|3 Months||0||
59667614|NCT00475540|75786458|FG001|NOT COMPLETED|3 Months||0||
59667615|NCT00475540|75786457|FG000|STARTED|12 Months||32||
59667616|NCT00475540|75786458|FG001|STARTED|12 Months||33||
59667617|NCT00475540|75786457|FG000|COMPLETED|12 Months||32||
59667618|NCT00475540|75786458|FG001|COMPLETED|12 Months||33||
59667619|NCT00475540|75786457|FG000|NOT COMPLETED|12 Months||0||
59667620|NCT00475540|75786458|FG001|NOT COMPLETED|12 Months||0||
59667621|NCT00475540|75786457|FG000|STARTED|36 Months|One of these was in the vaginal mesh arm but did not receive mesh due to inadequate vaginal caliber. For the 3 year outcomes, she was placed in the intent to treat but this was managed differently in the primary manuscript at 3 months and 1 year.|33||
59667622|NCT00475540|75786458|FG001|STARTED|36 Months||32||
59667623|NCT00475540|75786457|FG000|COMPLETED|36 Months||25||
59667624|NCT00475540|75786458|FG001|COMPLETED|36 Months||26||
59667625|NCT00475540|75786457|FG000|NOT COMPLETED|36 Months||8||
59667626|NCT00475540|75786458|FG001|NOT COMPLETED|36 Months||6||
59667627|NCT00472186|75786466|FG000|STARTED|Overall Study||2||
59667628|NCT00472186|75786467|FG001|STARTED|Overall Study||0||
59667629|NCT00472186|75786466|FG000|COMPLETED|Overall Study||1||
59667630|NCT00472186|75786467|FG001|COMPLETED|Overall Study||0||
59667631|NCT00472186|75786466|FG000|NOT COMPLETED|Overall Study||1||
59667632|NCT00472186|75786467|FG001|NOT COMPLETED|Overall Study||0||
59667633|NCT00479713|75786477|FG000|STARTED|Overall Study||314||
59667634|NCT00479713|75786478|FG001|STARTED|Overall Study||304||
59667635|NCT00479713|75786477|FG000|COMPLETED|Overall Study||301||
59667636|NCT00479713|75786478|FG001|COMPLETED|Overall Study||295||
59667637|NCT00479713|75786477|FG000|NOT COMPLETED|Overall Study||13||
59667638|NCT00479713|75786478|FG001|NOT COMPLETED|Overall Study||9||
59667639|NCT00204737|75786486|FG000|STARTED|Overall Study||6||
59667640|NCT00204737|75786487|FG001|STARTED|Overall Study||6||
59667641|NCT00204737|75786486|FG000|COMPLETED|Overall Study||6||
59667642|NCT00204737|75786487|FG001|COMPLETED|Overall Study||6||
59667643|NCT00204737|75786486|FG000|NOT COMPLETED|Overall Study||0||
59667644|NCT00204737|75786487|FG001|NOT COMPLETED|Overall Study||0||
59667645|NCT00474526|75786510|FG000|STARTED|Overall Study||154||
59667646|NCT00474526|75786511|FG001|STARTED|Overall Study||166||
59667647|NCT00474526|75786512|FG002|STARTED|Overall Study||159||
59667648|NCT00474526|75786513|FG003|STARTED|Overall Study||680||
59667649|NCT00474526|75786514|FG004|STARTED|Overall Study||76||
59667650|NCT00474526|75786515|FG005|STARTED|Overall Study||70||
59667651|NCT00474526|75786516|FG006|STARTED|Overall Study||203||
59667652|NCT00474526|75786517|FG007|STARTED|Overall Study||151||
59667653|NCT00474526|75786518|FG008|STARTED|Overall Study||150||
59667654|NCT00474526|75786519|FG009|STARTED|Overall Study||148||
59667655|NCT00474526|75786520|FG010|STARTED|Overall Study||151||
59667656|NCT00474526|75786521|FG011|STARTED|Overall Study||150||
59667657|NCT00474526|75786522|FG012|STARTED|Overall Study||150||
59989124|NCT02880241|76104420|FG004|COMPLETED|Overall Study|Study terminated|0||
59989125|NCT02880241|76104421|FG005|COMPLETED|Overall Study|Study terminated|0||
59667658|NCT00474526|75786523|FG013|STARTED|Overall Study||1426||
59667659|NCT00474526|75786524|FG014|STARTED|Overall Study||358||
59667660|NCT00474526|75786525|FG015|STARTED|Overall Study||170||
59667661|NCT00474526|75786526|FG016|STARTED|Overall Study||183||
59667662|NCT00474526|75786510|FG000|COMPLETED|Overall Study||121||
59667663|NCT00474526|75786511|FG001|COMPLETED|Overall Study||120||
59667664|NCT00474526|75786512|FG002|COMPLETED|Overall Study||110||
59667665|NCT00474526|75786513|FG003|COMPLETED|Overall Study||561||
59667666|NCT00474526|75786514|FG004|COMPLETED|Overall Study||8||
59667667|NCT00474526|75786515|FG005|COMPLETED|Overall Study||54||
59667668|NCT00474526|75786516|FG006|COMPLETED|Overall Study||178||
59667669|NCT00474526|75786517|FG007|COMPLETED|Overall Study||145||
59667670|NCT00474526|75786518|FG008|COMPLETED|Overall Study||144||
59815853|NCT02478710|75938251|FG000|STARTED|Overall Study||10||
59815854|NCT02478710|75938252|FG001|STARTED|Overall Study||6||
59815855|NCT02478710|75938251|FG000|COMPLETED|Overall Study||10||
59667671|NCT00474526|75786519|FG009|COMPLETED|Overall Study||121||
59667672|NCT00474526|75786520|FG010|COMPLETED|Overall Study||141||
59667673|NCT00474526|75786521|FG011|COMPLETED|Overall Study||139||
59667674|NCT00474526|75786522|FG012|COMPLETED|Overall Study||135||
59667675|NCT00474526|75786523|FG013|COMPLETED|Overall Study||1270||
59815856|NCT02478710|75938252|FG001|COMPLETED|Overall Study||6||
59667676|NCT00474526|75786524|FG014|COMPLETED|Overall Study||281||
59667677|NCT00474526|75786525|FG015|COMPLETED|Overall Study||152||
59667678|NCT00474526|75786526|FG016|COMPLETED|Overall Study||174||
59667679|NCT00474526|75786510|FG000|NOT COMPLETED|Overall Study||33||
59667680|NCT00474526|75786511|FG001|NOT COMPLETED|Overall Study||46||
59667681|NCT00474526|75786512|FG002|NOT COMPLETED|Overall Study||49||
59667682|NCT00474526|75786513|FG003|NOT COMPLETED|Overall Study||119||
59667683|NCT00474526|75786514|FG004|NOT COMPLETED|Overall Study||68||
59667684|NCT00474526|75786515|FG005|NOT COMPLETED|Overall Study||16||
59667685|NCT00474526|75786516|FG006|NOT COMPLETED|Overall Study||25||
59667686|NCT00474526|75786517|FG007|NOT COMPLETED|Overall Study||6||
59667687|NCT00474526|75786518|FG008|NOT COMPLETED|Overall Study||6||
59667688|NCT00474526|75786519|FG009|NOT COMPLETED|Overall Study||27||
59667689|NCT00474526|75786520|FG010|NOT COMPLETED|Overall Study||10||
59667690|NCT00474526|75786521|FG011|NOT COMPLETED|Overall Study||11||
59667691|NCT00474526|75786522|FG012|NOT COMPLETED|Overall Study||15||
59667692|NCT00474526|75786523|FG013|NOT COMPLETED|Overall Study||156||
59667693|NCT00474526|75786524|FG014|NOT COMPLETED|Overall Study||77||
59667694|NCT00474526|75786525|FG015|NOT COMPLETED|Overall Study||18||
59667695|NCT00474526|75786526|FG016|NOT COMPLETED|Overall Study||9||
59667696|NCT00478426|75786612|FG000|STARTED|Overall Study||34||
59667697|NCT00478426|75786612|FG000|COMPLETED|Overall Study||33||
59667698|NCT00478426|75786612|FG000|NOT COMPLETED|Overall Study||1||
59667699|NCT00477412|75786620|FG000|STARTED|Overall Study||4||
59667700|NCT00477412|75786621|FG001|STARTED|Overall Study||3||
59667701|NCT00477412|75786622|FG002|STARTED|Overall Study||5||
59667702|NCT00477412|75786623|FG003|STARTED|Overall Study||95||
59667703|NCT00477412|75786620|FG000|COMPLETED|Overall Study||3||
59667704|NCT00477412|75786621|FG001|COMPLETED|Overall Study||3||
59667705|NCT00477412|75786622|FG002|COMPLETED|Overall Study||4||
59667706|NCT00477412|75786623|FG003|COMPLETED|Overall Study||87||
59667707|NCT00477412|75786620|FG000|NOT COMPLETED|Overall Study||1||
59667708|NCT00477412|75786621|FG001|NOT COMPLETED|Overall Study||0||
59667709|NCT00477412|75786622|FG002|NOT COMPLETED|Overall Study||1||
59667710|NCT00477412|75786623|FG003|NOT COMPLETED|Overall Study||8||
59667711|NCT01089556|75786633|FG000|STARTED|Study Period II (Weeks 1-8)||404||
59667712|NCT01089556|75786634|FG001|STARTED|Study Period II (Weeks 1-8)||407||
59667713|NCT01089556|75786635|FG002|STARTED|Study Period II (Weeks 1-8)||0||
59667714|NCT01089556|75786636|FG003|STARTED|Study Period II (Weeks 1-8)||0||
59667715|NCT01089556|75786637|FG004|STARTED|Study Period II (Weeks 1-8)||0||
59667716|NCT01089556|75786638|FG005|STARTED|Study Period II (Weeks 1-8)||0||
59667717|NCT01089556|75786633|FG000|Safety Population|Study Period II (Weeks 1-8)|Received at least 1 dose of study drug.|401||
59667718|NCT01089556|75786634|FG001|Safety Population|Study Period II (Weeks 1-8)|Received at least 1 dose of study drug.|403||
59667719|NCT01089556|75786635|FG002|Safety Population|Study Period II (Weeks 1-8)||0||
59667720|NCT01089556|75786636|FG003|Safety Population|Study Period II (Weeks 1-8)||0||
59667721|NCT01089556|75786637|FG004|Safety Population|Study Period II (Weeks 1-8)||0||
59667722|NCT01089556|75786638|FG005|Safety Population|Study Period II (Weeks 1-8)||0||
59667723|NCT01089556|75786633|FG000|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||158||
59667724|NCT01089556|75786634|FG001|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||205||
59667725|NCT01089556|75786635|FG002|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||0||
59667726|NCT01089556|75786636|FG003|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||0||
59667727|NCT01089556|75786637|FG004|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||0||
59667728|NCT01089556|75786638|FG005|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||0||
59667729|NCT01089556|75786633|FG000|COMPLETED|Study Period II (Weeks 1-8)||333||
59667730|NCT01089556|75786634|FG001|COMPLETED|Study Period II (Weeks 1-8)||333||
59667731|NCT01089556|75786635|FG002|COMPLETED|Study Period II (Weeks 1-8)||0||
59667732|NCT01089556|75786636|FG003|COMPLETED|Study Period II (Weeks 1-8)||0||
59667733|NCT01089556|75786637|FG004|COMPLETED|Study Period II (Weeks 1-8)||0||
59667734|NCT01089556|75786638|FG005|COMPLETED|Study Period II (Weeks 1-8)||0||
59667735|NCT01089556|75786633|FG000|NOT COMPLETED|Study Period II (Weeks 1-8)||71||
59667736|NCT01089556|75786634|FG001|NOT COMPLETED|Study Period II (Weeks 1-8)||74||
59667737|NCT01089556|75786635|FG002|NOT COMPLETED|Study Period II (Weeks 1-8)||0||
59667738|NCT01089556|75786636|FG003|NOT COMPLETED|Study Period II (Weeks 1-8)||0||
59667739|NCT01089556|75786637|FG004|NOT COMPLETED|Study Period II (Weeks 1-8)||0||
59667740|NCT01089556|75786638|FG005|NOT COMPLETED|Study Period II (Weeks 1-8)||0||
59667741|NCT01089556|75786633|FG000|STARTED|Study Period III (Weeks 9-16)||0||
59667742|NCT01089556|75786634|FG001|STARTED|Study Period III (Weeks 9-16)||0||
59667743|NCT01089556|75786635|FG002|STARTED|Study Period III (Weeks 9-16)|Of those who completed SPII, 10 non-responders did not enter SPIII, while 4 responders entered SPIII|74||
59667744|NCT01089556|75786636|FG003|STARTED|Study Period III (Weeks 9-16)|Of those who completed SPII, 6 non-responders did not enter SPIII, while 3 responders entered SPIII|75||
59667745|NCT01089556|75786637|FG004|STARTED|Study Period III (Weeks 9-16)|Of those who completed SPII, 10 non-responders did not enter SPIII, while 4 responders entered SPIII|95||
59667746|NCT01089556|75786638|FG005|STARTED|Study Period III (Weeks 9-16)|Of those who completed SPII, 6 non-responders did not enter SPIII, while 1 responders entered SPIII|99||
59815857|NCT02478710|75938251|FG000|NOT COMPLETED|Overall Study||0||
59815858|NCT02478710|75938252|FG001|NOT COMPLETED|Overall Study||0||
59815859|NCT02242760|75938263|FG000|STARTED|Overall Study||27||
59815860|NCT02242760|75938264|FG001|STARTED|Overall Study||29||
59815861|NCT02242760|75938265|FG002|STARTED|Overall Study||53||
59815862|NCT02242760|75938266|FG003|STARTED|Overall Study||52||
59667747|NCT01089556|75786633|FG000|Efficacy and Safety Population|Study Period III (Weeks 9-16)||0||
59667748|NCT01089556|75786634|FG001|Efficacy and Safety Population|Study Period III (Weeks 9-16)||0||
59667749|NCT01089556|75786635|FG002|Efficacy and Safety Population|Study Period III (Weeks 9-16)|Received ≥1 dose study drug, had Week 8 and at least 1 assessment during Weeks 9-16 (SPIII)|73||
59709760|NCT01072149|75828526|FG006|NOT COMPLETED|Treatment Period 1 (28 Days)||0||
59815863|NCT02242760|75938267|FG004|STARTED|Overall Study||52||
59667750|NCT01089556|75786636|FG003|Efficacy and Safety Population|Study Period III (Weeks 9-16)|Received ≥1 dose study drug, had Week 8 and at least 1 assessment during Weeks 9-16 (SPIII)|75||
59667751|NCT01089556|75786637|FG004|Efficacy and Safety Population|Study Period III (Weeks 9-16)|Received ≥1 dose study drug, had Week 8 and at least 1 assessment during Weeks 9-16 (SPIII)|94||
59667752|NCT01089556|75786638|FG005|Efficacy and Safety Population|Study Period III (Weeks 9-16)|Received ≥1 dose study drug, had Week 8 and at least 1 assessment during Weeks 9-16 (SPIII)|97||
59667753|NCT01089556|75786633|FG000|COMPLETED|Study Period III (Weeks 9-16)||0||
59667754|NCT01089556|75786634|FG001|COMPLETED|Study Period III (Weeks 9-16)||0||
59667755|NCT01089556|75786635|FG002|COMPLETED|Study Period III (Weeks 9-16)||60||
59667756|NCT01089556|75786636|FG003|COMPLETED|Study Period III (Weeks 9-16)||66||
59667757|NCT01089556|75786637|FG004|COMPLETED|Study Period III (Weeks 9-16)||83||
59667758|NCT01089556|75786638|FG005|COMPLETED|Study Period III (Weeks 9-16)||92||
59667759|NCT01089556|75786633|FG000|NOT COMPLETED|Study Period III (Weeks 9-16)||0||
59667760|NCT01089556|75786634|FG001|NOT COMPLETED|Study Period III (Weeks 9-16)||0||
59667761|NCT01089556|75786635|FG002|NOT COMPLETED|Study Period III (Weeks 9-16)||14||
59667762|NCT01089556|75786636|FG003|NOT COMPLETED|Study Period III (Weeks 9-16)||9||
59667763|NCT01089556|75786637|FG004|NOT COMPLETED|Study Period III (Weeks 9-16)||12||
59667764|NCT01089556|75786638|FG005|NOT COMPLETED|Study Period III (Weeks 9-16)||7||
59667765|NCT01089127|75786656|FG000|STARTED|Overall Study||92||
59667766|NCT01089127|75786657|FG001|STARTED|Overall Study||91||
59667767|NCT01089127|75786658|FG002|STARTED|Overall Study||94||
59667768|NCT01089127|75786659|FG003|STARTED|Overall Study||92||
59667769|NCT01089127|75786660|FG004|STARTED|Overall Study||92||
59667770|NCT01089127|75786661|FG005|STARTED|Overall Study||91||
59667771|NCT01089127|75786656|FG000|Exposed to Study Drug|Overall Study|3 randomized patients in this group were not exposed to study treatment.|89||
59667772|NCT01089127|75786657|FG001|Exposed to Study Drug|Overall Study|1 randomized patient in this group was not exposed to study treatment.|90||
59667773|NCT01089127|75786658|FG002|Exposed to Study Drug|Overall Study||94||
59667774|NCT01089127|75786659|FG003|Exposed to Study Drug|Overall Study||92||
59667775|NCT01089127|75786660|FG004|Exposed to Study Drug|Overall Study|1 randomized patient in this group was not exposed to study treatment.|91||
59667776|NCT01089127|75786661|FG005|Exposed to Study Drug|Overall Study||91||
59667777|NCT01089127|75786656|FG000|COMPLETED|Overall Study||84||
59667778|NCT01089127|75786657|FG001|COMPLETED|Overall Study||86||
59667779|NCT01089127|75786658|FG002|COMPLETED|Overall Study||92||
59667780|NCT01089127|75786659|FG003|COMPLETED|Overall Study||91||
59667781|NCT01089127|75786660|FG004|COMPLETED|Overall Study||90||
59667782|NCT01089127|75786661|FG005|COMPLETED|Overall Study||88||
59667783|NCT01089127|75786656|FG000|NOT COMPLETED|Overall Study||8||
59667784|NCT01089127|75786657|FG001|NOT COMPLETED|Overall Study||5||
59667785|NCT01089127|75786658|FG002|NOT COMPLETED|Overall Study||2||
59667786|NCT01089127|75786659|FG003|NOT COMPLETED|Overall Study||1||
59667787|NCT01089127|75786660|FG004|NOT COMPLETED|Overall Study||2||
59667788|NCT01089127|75786661|FG005|NOT COMPLETED|Overall Study||3||
59667789|NCT01087957|75786677|FG000|STARTED|Overall Study||253||
59667790|NCT01087957|75786678|FG001|STARTED|Overall Study||242||
59667791|NCT01087957|75786677|FG000|COMPLETED|Overall Study||212||
59667792|NCT01087957|75786678|FG001|COMPLETED|Overall Study||187||
59667793|NCT01087957|75786677|FG000|NOT COMPLETED|Overall Study||41||
59667794|NCT01087957|75786678|FG001|NOT COMPLETED|Overall Study||55||
59667795|NCT01087723|75786686|FG000|STARTED|Overall Study|Randomized participants who signed an informed consent form (ICF); Intent-to-treat (ITT) population|1089||
59667796|NCT01087723|75786687|FG001|STARTED|Overall Study|Randomized participants who signed an informed consent form (ICF); Intent-to-treat (ITT) population|1109||
59667797|NCT01087723|75786686|FG000|Received at Least 1 Dose of Study Drug|Overall Study|Participants who were randomized with signed ICF by treatment actually received; Safety population|1099||
59667798|NCT01087723|75786687|FG001|Received at Least 1 Dose of Study Drug|Overall Study|Participants who were randomized with signed ICF by treatment actually received; Safety population|1094||
59667799|NCT01087723|75786686|FG000|COMPLETED|Overall Study|Completed 1-year follow-up in the study|1075||
59667800|NCT01087723|75786687|FG001|COMPLETED|Overall Study|Completed 1-year follow-up in the study|1089||
59667801|NCT01087723|75786686|FG000|NOT COMPLETED|Overall Study||14||
59667802|NCT01087723|75786687|FG001|NOT COMPLETED|Overall Study||20||
59667803|NCT01087528|75786693|FG000|STARTED|Overall Study||51||
59989126|NCT02880241|76104416|FG000|NOT COMPLETED|Overall Study||1||
59989127|NCT02880241|76104417|FG001|NOT COMPLETED|Overall Study||0||
59989128|NCT02880241|76104418|FG002|NOT COMPLETED|Overall Study||0||
59989129|NCT02880241|76104419|FG003|NOT COMPLETED|Overall Study||0||
59989130|NCT02880241|76104420|FG004|NOT COMPLETED|Overall Study||0||
59989131|NCT02880241|76104421|FG005|NOT COMPLETED|Overall Study||0||
59989132|NCT02259010|76104437|FG000|STARTED|Overall Study||24||
59989133|NCT02259010|76104437|FG000|COMPLETED|Overall Study|Completed=Completed protocol-specified dosing and PK assessment.|19||
59667804|NCT01087528|75786693|FG000|COMPLETED|Overall Study|withdrawn from the study prior to any procedure|44||
59667805|NCT01087528|75786693|FG000|NOT COMPLETED|Overall Study||7||
59667806|NCT01085812|75786699|FG000|STARTED|Open-Label Period||0||
59667807|NCT01085812|75786700|FG001|STARTED|Open-Label Period||734||
59989134|NCT02259010|76104437|FG000|NOT COMPLETED|Overall Study||5||
59989135|NCT02021773|76104446|FG000|STARTED|Overall Study||89|All randomized participants|
59989136|NCT02021773|76104447|FG001|STARTED|Overall Study||88|All randomized participants|
59667808|NCT01085812|75786699|FG000|COMPLETED|Open-Label Period||0||
59667809|NCT01085812|75786700|FG001|COMPLETED|Open-Label Period||494||
59667810|NCT01085812|75786699|FG000|NOT COMPLETED|Open-Label Period||0||
59667811|NCT01085812|75786700|FG001|NOT COMPLETED|Open-Label Period||240||
59667812|NCT01085812|75786699|FG000|STARTED|Double-Blind Period||113||
59667813|NCT01085812|75786700|FG001|STARTED|Double-Blind Period||235||
59667814|NCT01085812|75786699|FG000|COMPLETED|Double-Blind Period||92||
59667815|NCT01085812|75786700|FG001|COMPLETED|Double-Blind Period||177||
59667816|NCT01085812|75786699|FG000|NOT COMPLETED|Double-Blind Period||21||
59667817|NCT01085812|75786700|FG001|NOT COMPLETED|Double-Blind Period||58||
59667818|NCT01085812|75786699|FG000|STARTED|Double-blind Intent-to-treat Population||112||
59667819|NCT01085812|75786700|FG001|STARTED|Double-blind Intent-to-treat Population||230||
59667820|NCT01085812|75786699|FG000|COMPLETED|Double-blind Intent-to-treat Population||92||
59667821|NCT01085812|75786700|FG001|COMPLETED|Double-blind Intent-to-treat Population||174||
59667822|NCT01085812|75786699|FG000|NOT COMPLETED|Double-blind Intent-to-treat Population||20||
59667823|NCT01085812|75786700|FG001|NOT COMPLETED|Double-blind Intent-to-treat Population||56||
59667824|NCT01085734|75786709|FG000|STARTED|Overall Study||15||
59667825|NCT01085734|75786710|FG001|STARTED|Overall Study||15||
59667826|NCT01085734|75786709|FG000|COMPLETED|Overall Study||14||
59667827|NCT01085734|75786710|FG001|COMPLETED|Overall Study||11||
59667828|NCT01085734|75786709|FG000|NOT COMPLETED|Overall Study||1||
59667829|NCT01085734|75786710|FG001|NOT COMPLETED|Overall Study||4||
59667830|NCT01084603|75786717|FG000|STARTED|Baseline||45||
59667831|NCT01084603|75786717|FG000|COMPLETED|Baseline||43||
59667832|NCT01084603|75786717|FG000|NOT COMPLETED|Baseline||2||
59667833|NCT01084603|75786717|FG000|STARTED|NiQuitinTM Lozenge||43||
59667834|NCT01084603|75786717|FG000|COMPLETED|NiQuitinTM Lozenge||42||
59667835|NCT01084603|75786717|FG000|NOT COMPLETED|NiQuitinTM Lozenge||1||
59667836|NCT01084603|75786717|FG000|STARTED|Washout Period 1||42||
59667837|NCT01084603|75786717|FG000|COMPLETED|Washout Period 1||42||
59667838|NCT01084603|75786717|FG000|NOT COMPLETED|Washout Period 1||0||
59667839|NCT01084603|75786717|FG000|STARTED|Nicorette® Gum||42||
59667840|NCT01084603|75786717|FG000|COMPLETED|Nicorette® Gum||41||
59667841|NCT01084603|75786717|FG000|NOT COMPLETED|Nicorette® Gum||1||
59667842|NCT01084603|75786717|FG000|STARTED|Washout Period 2||41||
59667843|NCT01084603|75786717|FG000|COMPLETED|Washout Period 2||41||
59667844|NCT01084603|75786717|FG000|NOT COMPLETED|Washout Period 2||0||
59667845|NCT01084603|75786717|FG000|STARTED|Oral Nicotine 1||41||
59667846|NCT01084603|75786717|FG000|COMPLETED|Oral Nicotine 1||40||
59667847|NCT01084603|75786717|FG000|NOT COMPLETED|Oral Nicotine 1||1||
59667848|NCT01084603|75786717|FG000|STARTED|Washout Period 3||40||
59667849|NCT01084603|75786717|FG000|COMPLETED|Washout Period 3||40||
59667850|NCT01084603|75786717|FG000|NOT COMPLETED|Washout Period 3||0||
59667851|NCT01084603|75786717|FG000|STARTED|Oral Nicotine 2||40||
59667852|NCT01084603|75786717|FG000|COMPLETED|Oral Nicotine 2||40||
59667853|NCT01084603|75786717|FG000|NOT COMPLETED|Oral Nicotine 2||0||
59667854|NCT01084603|75786717|FG000|STARTED|Washout Period 4||40||
59667855|NCT01084603|75786717|FG000|COMPLETED|Washout Period 4||39||
59667856|NCT01084603|75786717|FG000|NOT COMPLETED|Washout Period 4||1||
59667857|NCT01084603|75786717|FG000|STARTED|Oral Nicotine 4||39||
59667858|NCT01084603|75786717|FG000|COMPLETED|Oral Nicotine 4||39||
59667859|NCT01084603|75786717|FG000|NOT COMPLETED|Oral Nicotine 4||0||
59667860|NCT01084174|75786732|FG000|STARTED|Overall Study||10||
59667861|NCT01084174|75786733|FG001|STARTED|Overall Study||11||
59667862|NCT01084174|75786732|FG000|COMPLETED|Overall Study||9||
59667863|NCT01084174|75786733|FG001|COMPLETED|Overall Study||7||
59667864|NCT01084174|75786732|FG000|NOT COMPLETED|Overall Study||1||
59667865|NCT01084174|75786733|FG001|NOT COMPLETED|Overall Study||4||
59667866|NCT01084135|75786743|FG000|STARTED|12 Week||4||
59667867|NCT01084135|75786744|FG001|STARTED|12 Week||4||
59667868|NCT01084135|75786743|FG000|COMPLETED|12 Week||4||
59667869|NCT01084135|75786744|FG001|COMPLETED|12 Week||4||
59667870|NCT01084135|75786743|FG000|NOT COMPLETED|12 Week||0||
59667871|NCT01084135|75786744|FG001|NOT COMPLETED|12 Week||0||
59667872|NCT01084135|75786743|FG000|STARTED|20 Week||12||
59667873|NCT01084135|75786744|FG001|STARTED|20 Week||11||
59667874|NCT01084135|75786743|FG000|COMPLETED|20 Week||12||
59667875|NCT01084135|75786744|FG001|COMPLETED|20 Week||10||
59667876|NCT01084135|75786743|FG000|NOT COMPLETED|20 Week||0||
59667877|NCT01084135|75786744|FG001|NOT COMPLETED|20 Week||1||
59667878|NCT01083316|75786752|FG000|STARTED|Overall Study||35||
59667879|NCT01083316|75786752|FG000|COMPLETED|Overall Study||32||
59667880|NCT01083316|75786752|FG000|NOT COMPLETED|Overall Study||3||
59667881|NCT01083160|75786757|FG000|STARTED|Overall Study||82||
59667882|NCT01083160|75786757|FG000|Evaluable Population|Overall Study||71||
59667883|NCT01083160|75786757|FG000|COMPLETED|Overall Study||81||
59667884|NCT01083160|75786757|FG000|NOT COMPLETED|Overall Study||1||
59667885|NCT01083121|75786761|FG000|STARTED|Overall Study|Participants who were enrolled in the study|1779||
59667886|NCT01083121|75786761|FG000|COMPLETED|Overall Study|Participants included in the analysis|1698||
59667887|NCT01083121|75786761|FG000|NOT COMPLETED|Overall Study||81||
59667888|NCT01082614|75786771|FG000|STARTED|Overall Study||23||
59667889|NCT01082614|75786772|FG001|STARTED|Overall Study||23||
59667890|NCT01082614|75786771|FG000|COMPLETED|Overall Study||20||
59667891|NCT01082614|75786772|FG001|COMPLETED|Overall Study||18||
59667892|NCT01082614|75786771|FG000|NOT COMPLETED|Overall Study||3||
59667893|NCT01082614|75786772|FG001|NOT COMPLETED|Overall Study||5||
59667894|NCT01081873|75786778|FG000|STARTED|Overall Study|3 patients were excluded from this and all analyses due to no available data from Baseline.|2714||
59667895|NCT01081873|75786778|FG000|COMPLETED|Overall Study||2416||
59667896|NCT01081873|75786778|FG000|NOT COMPLETED|Overall Study||298||
59667897|NCT01081795|75786810|FG000|STARTED|Overall Study||130||
59667898|NCT01081795|75786811|FG001|STARTED|Overall Study||130||
59667899|NCT01081795|75786812|FG002|STARTED|Overall Study||127||
59667900|NCT01081795|75786810|FG000|COMPLETED|Overall Study||97||
59667901|NCT01081795|75786811|FG001|COMPLETED|Overall Study||95||
59667902|NCT01081795|75786812|FG002|COMPLETED|Overall Study||97||
59667903|NCT01081795|75786810|FG000|NOT COMPLETED|Overall Study||33||
59667904|NCT01081795|75786811|FG001|NOT COMPLETED|Overall Study||35||
59667905|NCT01081795|75786812|FG002|NOT COMPLETED|Overall Study||30||
59667906|NCT01081678|75786824|FG000|STARTED|Overall Study||89||
59667907|NCT01081678|75786825|FG001|STARTED|Overall Study||60||
59667908|NCT01081678|75786826|FG002|STARTED|Overall Study||93||
59667909|NCT01081678|75786827|FG003|STARTED|Overall Study||90||
59667910|NCT01081678|75786824|FG000|Received Study Drug|Overall Study||87||
59667911|NCT01081678|75786825|FG001|Received Study Drug|Overall Study||60||
59667912|NCT01081678|75786826|FG002|Received Study Drug|Overall Study||89||
59667913|NCT01081678|75786827|FG003|Received Study Drug|Overall Study||89||
59667914|NCT01081678|75786824|FG000|Completed 24 Weeks of Study|Overall Study||73||
59667915|NCT01081678|75786825|FG001|Completed 24 Weeks of Study|Overall Study||50||
59667916|NCT01081678|75786826|FG002|Completed 24 Weeks of Study|Overall Study||72||
59667917|NCT01081678|75786827|FG003|Completed 24 Weeks of Study|Overall Study||68||
59667918|NCT01081678|75786824|FG000|COMPLETED|Overall Study||62||
59667919|NCT01081678|75786825|FG001|COMPLETED|Overall Study||44||
59667920|NCT01081678|75786826|FG002|COMPLETED|Overall Study||62||
59667921|NCT01081678|75786827|FG003|COMPLETED|Overall Study||61||
59667922|NCT01081678|75786824|FG000|NOT COMPLETED|Overall Study||27||
59667923|NCT01081678|75786825|FG001|NOT COMPLETED|Overall Study||16||
59667924|NCT01081678|75786826|FG002|NOT COMPLETED|Overall Study||31||
59667925|NCT01081678|75786827|FG003|NOT COMPLETED|Overall Study||29||
59667926|NCT01081249|75786837|FG000|STARTED|Overall Study||11||
59667927|NCT01081249|75786838|FG001|STARTED|Overall Study||7||
59667928|NCT01081249|75786837|FG000|First Psychotherapy Appointment (1 Day)|Overall Study||11||
59667929|NCT01081249|75786838|FG001|First Psychotherapy Appointment (1 Day)|Overall Study||6||
59667930|NCT01081249|75786837|FG000|Washout (5-10 Days)|Overall Study||11||
59667931|NCT01081249|75786838|FG001|Washout (5-10 Days)|Overall Study||6||
59667932|NCT01081249|75786837|FG000|Second Psychotherapy Appointment (1 Day)|Overall Study||11||
59667933|NCT01081249|75786838|FG001|Second Psychotherapy Appointment (1 Day)|Overall Study||6||
59667934|NCT01081249|75786837|FG000|COMPLETED|Overall Study||11||
59667935|NCT01081249|75786838|FG001|COMPLETED|Overall Study||6||
59667936|NCT01081249|75786837|FG000|NOT COMPLETED|Overall Study||0||
59667937|NCT01081249|75786838|FG001|NOT COMPLETED|Overall Study||1||
59667938|NCT01081132|75786846|FG000|STARTED|Overall Study||157||
59667939|NCT01081132|75786847|FG001|STARTED|Overall Study||157||
59667940|NCT01081132|75786846|FG000|COMPLETED|Overall Study||102||
59667941|NCT01081132|75786847|FG001|COMPLETED|Overall Study||105||
59667942|NCT01081132|75786846|FG000|NOT COMPLETED|Overall Study||55||
59667943|NCT01081132|75786847|FG001|NOT COMPLETED|Overall Study||52||
59667944|NCT01080625|75786856|FG000|STARTED|Overall Study||31||
59667945|NCT01080625|75786857|FG001|STARTED|Overall Study||33||
59667946|NCT01080625|75786858|FG002|STARTED|Overall Study||32||
59667947|NCT01080625|75786856|FG000|COMPLETED|Overall Study||31||
59667948|NCT01080625|75786857|FG001|COMPLETED|Overall Study||31||
59667949|NCT01080625|75786858|FG002|COMPLETED|Overall Study||31||
59667950|NCT01080625|75786856|FG000|NOT COMPLETED|Overall Study||0||
59667951|NCT01080625|75786857|FG001|NOT COMPLETED|Overall Study||2||
59667952|NCT01080625|75786858|FG002|NOT COMPLETED|Overall Study||1||
59667953|NCT01059903|75786868|FG000|STARTED|Period 1: First Intervention- 24 Hours||25||
59667954|NCT01059903|75786869|FG001|STARTED|Period 1: First Intervention- 24 Hours||25||
59667955|NCT01059903|75786868|FG000|COMPLETED|Period 1: First Intervention- 24 Hours||24||
59667956|NCT01059903|75786869|FG001|COMPLETED|Period 1: First Intervention- 24 Hours||24||
59667957|NCT01059903|75786868|FG000|NOT COMPLETED|Period 1: First Intervention- 24 Hours||1||
59667958|NCT01059903|75786869|FG001|NOT COMPLETED|Period 1: First Intervention- 24 Hours||1||
59667959|NCT01059903|75786868|FG000|STARTED|Period 2: Washout Period (>= 5 Days)||24||
59667960|NCT01059903|75786869|FG001|STARTED|Period 2: Washout Period (>= 5 Days)||24||
59667961|NCT01059903|75786868|FG000|COMPLETED|Period 2: Washout Period (>= 5 Days)||24||
59667962|NCT01059903|75786869|FG001|COMPLETED|Period 2: Washout Period (>= 5 Days)||24||
59667963|NCT01059903|75786868|FG000|NOT COMPLETED|Period 2: Washout Period (>= 5 Days)||0||
59667964|NCT01059903|75786869|FG001|NOT COMPLETED|Period 2: Washout Period (>= 5 Days)||0||
59667965|NCT01059903|75786868|FG000|STARTED|Period 3: Second Intervention- 24 Hours||24||
59667966|NCT01059903|75786869|FG001|STARTED|Period 3: Second Intervention- 24 Hours||24||
59667967|NCT01059903|75786868|FG000|Pharmacokinetic Set (PKS)|Period 3: Second Intervention- 24 Hours|Six subjects who fullfilled predefined criteria for patch adhesiveness were excluded from the PKS|18||
59817913|NCT04488770|75940326|FG000|STARTED|Part 1-Cohort 2: Period 2 (Up to 5 Days)||0||
59667968|NCT01059903|75786869|FG001|Pharmacokinetic Set (PKS)|Period 3: Second Intervention- 24 Hours|Two subjects who fullfilled predefined criteria for patch adhesiveness were excluded from the PKS|22||
59667969|NCT01059903|75786868|FG000|COMPLETED|Period 3: Second Intervention- 24 Hours||24||
59667970|NCT01059903|75786869|FG001|COMPLETED|Period 3: Second Intervention- 24 Hours||24||
59667971|NCT01059903|75786868|FG000|NOT COMPLETED|Period 3: Second Intervention- 24 Hours||0||
59667972|NCT01059903|75786869|FG001|NOT COMPLETED|Period 3: Second Intervention- 24 Hours||0||
59667973|NCT04668352|75786877|FG000|STARTED|Overall Study||511||
59667974|NCT04668352|75786878|FG001|STARTED|Overall Study||513||
59667975|NCT04668352|75786877|FG000|COMPLETED|Overall Study||510||
59667976|NCT04668352|75786878|FG001|COMPLETED|Overall Study||511||
59667977|NCT04668352|75786877|FG000|NOT COMPLETED|Overall Study||1||
59667978|NCT04668352|75786878|FG001|NOT COMPLETED|Overall Study||2||
59667979|NCT04644484|75786886|FG000|STARTED|Overall Study||750||
59667980|NCT04644484|75786887|FG001|STARTED|Overall Study||250||
59667981|NCT04644484|75786886|FG000|COMPLETED|Overall Study||750||
59667982|NCT04644484|75786887|FG001|COMPLETED|Overall Study||250||
59667983|NCT04644484|75786886|FG000|NOT COMPLETED|Overall Study||0||
59667984|NCT04644484|75786887|FG001|NOT COMPLETED|Overall Study||0||
59667985|NCT04628221|75786893|FG000|STARTED|Overall Study||40||
59667986|NCT04628221|75786893|FG000|COMPLETED|Overall Study||40||
59667987|NCT04628221|75786893|FG000|NOT COMPLETED|Overall Study||0||
59667988|NCT05688657|75786897|FG000|STARTED|Period 1: Lens A (15 Minutes)||42||
59667989|NCT05688657|75786898|FG001|STARTED|Period 1: Lens A (15 Minutes)|All participants received Lens A in Period 1.|0||
59667990|NCT05688657|75786897|FG000|COMPLETED|Period 1: Lens A (15 Minutes)||42||
59667991|NCT05688657|75786898|FG001|COMPLETED|Period 1: Lens A (15 Minutes)||0||
59667992|NCT05688657|75786897|FG000|NOT COMPLETED|Period 1: Lens A (15 Minutes)||0||
59667993|NCT05688657|75786898|FG001|NOT COMPLETED|Period 1: Lens A (15 Minutes)||0||
59667994|NCT05688657|75786897|FG000|STARTED|Period 2: Lens B (15 Minutes)|All participants received Lens B in Period 2.|0||
59667995|NCT05688657|75786898|FG001|STARTED|Period 2: Lens B (15 Minutes)||42||
59667996|NCT05688657|75786897|FG000|COMPLETED|Period 2: Lens B (15 Minutes)||0||
59667997|NCT05688657|75786898|FG001|COMPLETED|Period 2: Lens B (15 Minutes)||42||
59667998|NCT05688657|75786897|FG000|NOT COMPLETED|Period 2: Lens B (15 Minutes)||0||
59667999|NCT05688657|75786898|FG001|NOT COMPLETED|Period 2: Lens B (15 Minutes)||0||
59668000|NCT05562011|75786904|FG000|STARTED|Overall Study||61||
59668001|NCT05562011|75786904|FG000|COMPLETED|Overall Study||39||
59668002|NCT05562011|75786904|FG000|NOT COMPLETED|Overall Study||22||
59668003|NCT05554640|75786909|FG000|STARTED|Period 1||7||
59668004|NCT05554640|75786910|FG001|STARTED|Period 1||7||
59668005|NCT05554640|75786909|FG000|COMPLETED|Period 1||7||
59668006|NCT05554640|75786910|FG001|COMPLETED|Period 1||7||
59668007|NCT05554640|75786909|FG000|NOT COMPLETED|Period 1||0||
59668008|NCT05554640|75786910|FG001|NOT COMPLETED|Period 1||0||
59668009|NCT05554640|75786909|FG000|STARTED|Period 2||7||
59668010|NCT05554640|75786910|FG001|STARTED|Period 2||7||
59668011|NCT05554640|75786909|FG000|COMPLETED|Period 2||7||
59668012|NCT05554640|75786910|FG001|COMPLETED|Period 2||7||
59668013|NCT05554640|75786909|FG000|NOT COMPLETED|Period 2||0||
59668014|NCT05554640|75786910|FG001|NOT COMPLETED|Period 2||0||
59668015|NCT05457608|75786916|FG000|STARTED|Period 1: Lens A (15 Minutes)||42||
59668016|NCT05457608|75786917|FG001|STARTED|Period 1: Lens A (15 Minutes)|All participants received Lens A in Period 1.|0||
59668017|NCT05457608|75786916|FG000|COMPLETED|Period 1: Lens A (15 Minutes)||42||
59668018|NCT05457608|75786917|FG001|COMPLETED|Period 1: Lens A (15 Minutes)||0||
59668019|NCT05457608|75786916|FG000|NOT COMPLETED|Period 1: Lens A (15 Minutes)||0||
59668020|NCT05457608|75786917|FG001|NOT COMPLETED|Period 1: Lens A (15 Minutes)||0||
59668021|NCT05457608|75786916|FG000|STARTED|Period 2: Lens B (15 Minutes)|All participants received Lens B in Period 2.|0||
59668022|NCT05457608|75786917|FG001|STARTED|Period 2: Lens B (15 Minutes)||42||
59668023|NCT05457608|75786916|FG000|COMPLETED|Period 2: Lens B (15 Minutes)||0||
59668024|NCT05457608|75786917|FG001|COMPLETED|Period 2: Lens B (15 Minutes)||42||
59815864|NCT02242760|75938263|FG000|Number of Subjects Excluded From ITT Population|Overall Study||0|One subject in the SB204 4% BID group was not dispensed study medication after randomization.|
59817914|NCT04488770|75940327|FG001|STARTED|Part 1-Cohort 2: Period 2 (Up to 5 Days)||0||
59668025|NCT05457608|75786916|FG000|NOT COMPLETED|Period 2: Lens B (15 Minutes)||0||
59668026|NCT05457608|75786917|FG001|NOT COMPLETED|Period 2: Lens B (15 Minutes)||0||
59668027|NCT05432271|75786928|FG000|STARTED|Overall Study||1627||
59668028|NCT05432271|75786929|FG001|STARTED|Overall Study||1639||
59668029|NCT05432271|75786930|FG002|STARTED|Overall Study||1623||
59668030|NCT05432271|75786931|FG003|STARTED|Overall Study||1633||
59668031|NCT05432271|75786932|FG004|STARTED|Overall Study||1623||
59668032|NCT05432271|75786928|FG000|COMPLETED|Overall Study||1627||
59668033|NCT05432271|75786929|FG001|COMPLETED|Overall Study||1639||
59668034|NCT05432271|75786930|FG002|COMPLETED|Overall Study||1623||
59668035|NCT05432271|75786931|FG003|COMPLETED|Overall Study||1633||
59668036|NCT05432271|75786932|FG004|COMPLETED|Overall Study||1623||
59668037|NCT05432271|75786928|FG000|NOT COMPLETED|Overall Study||0||
59668038|NCT05432271|75786929|FG001|NOT COMPLETED|Overall Study||0||
59668039|NCT05432271|75786930|FG002|NOT COMPLETED|Overall Study||0||
59668040|NCT05432271|75786931|FG003|NOT COMPLETED|Overall Study||0||
59668041|NCT05432271|75786932|FG004|NOT COMPLETED|Overall Study||0||
59989137|NCT02021773|76104448|FG002|STARTED|Overall Study||87|All randomized participants|
59989138|NCT02021773|76104446|FG000|Safety Analysis Set|Overall Study||89|Safety set: all participants who received at least one dose of study drug|
59989139|NCT02021773|76104447|FG001|Safety Analysis Set|Overall Study||88|Safety set: all participants who received at least one dose of study drug|
59989140|NCT02021773|76104448|FG002|Safety Analysis Set|Overall Study||86|Safety set: all participants who received at least one dose of study drug|
59989141|NCT02021773|76104446|FG000|Intent-to-treat (ITT)|Overall Study||89|All participants evaluable for efficacy|
59989142|NCT02021773|76104447|FG001|Intent-to-treat (ITT)|Overall Study||87|All participants evaluable for efficacy|
59989143|NCT02021773|76104448|FG002|Intent-to-treat (ITT)|Overall Study||85|All participants evaluable for efficacy|
59989144|NCT02021773|76104446|FG000|COMPLETED|Overall Study||77||
59989145|NCT02021773|76104447|FG001|COMPLETED|Overall Study||72||
59989146|NCT02021773|76104448|FG002|COMPLETED|Overall Study||76||
59989147|NCT02021773|76104446|FG000|NOT COMPLETED|Overall Study||12||
59989148|NCT02021773|76104447|FG001|NOT COMPLETED|Overall Study||16||
59989149|NCT02021773|76104448|FG002|NOT COMPLETED|Overall Study||11||
59989150|NCT00151775|76104461|FG000|STARTED|Period 2 - Double-Blind Dose Response||95||
59989151|NCT00151775|76104462|FG001|STARTED|Period 2 - Double-Blind Dose Response||95||
59989152|NCT00151775|76104463|FG002|STARTED|Period 2 - Double-Blind Dose Response||0||
59989153|NCT00151775|76104464|FG003|STARTED|Period 2 - Double-Blind Dose Response||0||
59989154|NCT00151775|76104465|FG004|STARTED|Period 2 - Double-Blind Dose Response||0||
59989155|NCT00151775|76104466|FG005|STARTED|Period 2 - Double-Blind Dose Response||56||
59989156|NCT00151775|76104467|FG006|STARTED|Period 2 - Double-Blind Dose Response||56||
59989157|NCT00151775|76104468|FG007|STARTED|Period 2 - Double-Blind Dose Response||0||
59989158|NCT00151775|76104469|FG008|STARTED|Period 2 - Double-Blind Dose Response||0||
59989159|NCT00151775|76104470|FG009|STARTED|Period 2 - Double-Blind Dose Response||0||
59989160|NCT00151775|76104471|FG010|STARTED|Period 2 - Double-Blind Dose Response||60||
59545184|NCT00982592|75643876|FG000|Treatment Received|Overall Study||63||
59545185|NCT00982592|75643877|FG001|Treatment Received|Overall Study||52||
59545186|NCT00982592|75643876|FG000|COMPLETED|Overall Study|patients who were off treatment due to disease progression|33||
59545187|NCT00982592|75643877|FG001|COMPLETED|Overall Study|patients who were off treatment due to disease progression|27||
59545188|NCT00982592|75643876|FG000|NOT COMPLETED|Overall Study||31||
59545189|NCT00982592|75643877|FG001|NOT COMPLETED|Overall Study||33||
59545190|NCT00983216|75643883|FG000|STARTED|Colchicine Alone||24||
59545191|NCT00983216|75643883|FG000|COMPLETED|Colchicine Alone||24||
59545192|NCT00983216|75643883|FG000|NOT COMPLETED|Colchicine Alone||0||
59545193|NCT00983216|75643883|FG000|STARTED|14 Day Washout Period||24||
59545194|NCT00983216|75643883|FG000|COMPLETED|14 Day Washout Period||24||
59545195|NCT00983216|75643883|FG000|NOT COMPLETED|14 Day Washout Period||0||
59545196|NCT00983216|75643883|FG000|STARTED|Ketoconazole Alone||24||
59545197|NCT00983216|75643883|FG000|COMPLETED|Ketoconazole Alone||24||
59545198|NCT00983216|75643883|FG000|NOT COMPLETED|Ketoconazole Alone||0||
59545199|NCT00983216|75643883|FG000|STARTED|Colchicine With Ketoconazole||24||
59545200|NCT00983216|75643883|FG000|COMPLETED|Colchicine With Ketoconazole||24||
59545201|NCT00983216|75643883|FG000|NOT COMPLETED|Colchicine With Ketoconazole||0||
59545202|NCT00984308|75643892|FG000|STARTED|Overall Study||110||
59545203|NCT00984308|75643893|FG001|STARTED|Overall Study||115||
59545204|NCT00984308|75643892|FG000|COMPLETED|Overall Study||92||
59545205|NCT00984308|75643893|FG001|COMPLETED|Overall Study||109||
59545206|NCT00984308|75643892|FG000|NOT COMPLETED|Overall Study||18||
59545207|NCT00984308|75643893|FG001|NOT COMPLETED|Overall Study||6||
59545208|NCT02249585|75643902|FG000|STARTED|Overall Study||43||
59545209|NCT02249585|75643903|FG001|STARTED|Overall Study||44||
59545210|NCT02249585|75643904|FG002|STARTED|Overall Study||44||
59545211|NCT02249585|75643902|FG000|COMPLETED|Overall Study||43||
59545212|NCT02249585|75643903|FG001|COMPLETED|Overall Study||44||
59545213|NCT02249585|75643904|FG002|COMPLETED|Overall Study||44||
59545214|NCT02249585|75643902|FG000|NOT COMPLETED|Overall Study||0||
59545215|NCT02249585|75643903|FG001|NOT COMPLETED|Overall Study||0||
59545216|NCT02249585|75643904|FG002|NOT COMPLETED|Overall Study||0||
59545217|NCT00984698|75643914|FG000|STARTED|Overall Study||21||
59545218|NCT00984698|75643915|FG001|STARTED|Overall Study||22||
59545219|NCT00984698|75643914|FG000|COMPLETED|Overall Study||18||
59545220|NCT00984698|75643915|FG001|COMPLETED|Overall Study||14||
59545221|NCT00984698|75643914|FG000|NOT COMPLETED|Overall Study||3||
59545222|NCT00984698|75643915|FG001|NOT COMPLETED|Overall Study||8||
59545223|NCT00985010|75643923|FG000|STARTED|Overall Study||4||
59668042|NCT05263037|75786948|FG000|STARTED|Overall Study||275||
59668043|NCT05263037|75786949|FG001|STARTED|Overall Study||272||
59668044|NCT05263037|75786950|FG002|STARTED|Overall Study||273||
59668045|NCT05263037|75786951|FG003|STARTED|Overall Study||273||
59668046|NCT05263037|75786948|FG000|COMPLETED|Overall Study||269||
59668047|NCT05263037|75786949|FG001|COMPLETED|Overall Study||267||
59668048|NCT05263037|75786950|FG002|COMPLETED|Overall Study||266||
59668049|NCT05263037|75786951|FG003|COMPLETED|Overall Study||265||
59668050|NCT05263037|75786948|FG000|NOT COMPLETED|Overall Study||6||
59668051|NCT05263037|75786949|FG001|NOT COMPLETED|Overall Study||5||
59668052|NCT05263037|75786950|FG002|NOT COMPLETED|Overall Study||7||
59668053|NCT05263037|75786951|FG003|NOT COMPLETED|Overall Study||8||
59668054|NCT05089708|75786963|FG000|STARTED|Overall Study||60||
59668055|NCT05089708|75786964|FG001|STARTED|Overall Study||63||
59668056|NCT05089708|75786963|FG000|COMPLETED|Overall Study||45||
59668057|NCT05089708|75786964|FG001|COMPLETED|Overall Study||53||
59668058|NCT05089708|75786963|FG000|NOT COMPLETED|Overall Study||15||
59668059|NCT05089708|75786964|FG001|NOT COMPLETED|Overall Study||10||
59668060|NCT05028374|75786975|FG000|STARTED|Overall Study||52||
59668061|NCT05028374|75786976|FG001|STARTED|Overall Study||51||
59668062|NCT05028374|75786977|FG002|STARTED|Overall Study||16||
59668063|NCT05028374|75786975|FG000|COMPLETED|Overall Study||52||
59668064|NCT05028374|75786976|FG001|COMPLETED|Overall Study||50||
59668065|NCT05028374|75786977|FG002|COMPLETED|Overall Study||16||
59668066|NCT05028374|75786975|FG000|NOT COMPLETED|Overall Study||0||
59668067|NCT05028374|75786976|FG001|NOT COMPLETED|Overall Study||1||
59668068|NCT05028374|75786977|FG002|NOT COMPLETED|Overall Study||0||
59668069|NCT05020990|75786985|FG000|STARTED|Period 1 (One Week)||28||
59668070|NCT05020990|75786986|FG001|STARTED|Period 1 (One Week)||26||
59668071|NCT05020990|75786985|FG000|COMPLETED|Period 1 (One Week)||28||
59668072|NCT05020990|75786986|FG001|COMPLETED|Period 1 (One Week)||26||
59668073|NCT05020990|75786985|FG000|NOT COMPLETED|Period 1 (One Week)||0||
59668074|NCT05020990|75786986|FG001|NOT COMPLETED|Period 1 (One Week)||0||
59668075|NCT05020990|75786985|FG000|STARTED|Period 2 (One Week)||28||
59668076|NCT05020990|75786986|FG001|STARTED|Period 2 (One Week)||26||
59668077|NCT05020990|75786985|FG000|COMPLETED|Period 2 (One Week)||28||
59668078|NCT05020990|75786986|FG001|COMPLETED|Period 2 (One Week)||26||
59668079|NCT05020990|75786985|FG000|NOT COMPLETED|Period 2 (One Week)||0||
59668080|NCT05020990|75786986|FG001|NOT COMPLETED|Period 2 (One Week)||0||
59668081|NCT04926779|75786992|FG000|STARTED|Overall Study||185||
59668082|NCT04926779|75786992|FG000|COMPLETED|Overall Study||185||
59668083|NCT04926779|75786992|FG000|NOT COMPLETED|Overall Study||0||
59668084|NCT04647890|75787000|FG000|STARTED|Overall Study||10||
59668085|NCT04647890|75787001|FG001|STARTED|Overall Study||10||
59668086|NCT04647890|75787002|FG002|STARTED|Overall Study||10||
59668087|NCT04647890|75787000|FG000|COMPLETED|Overall Study||9||
59668088|NCT04647890|75787001|FG001|COMPLETED|Overall Study||9||
59668089|NCT04647890|75787002|FG002|COMPLETED|Overall Study||10||
59668090|NCT04647890|75787000|FG000|NOT COMPLETED|Overall Study||1||
59668091|NCT04647890|75787001|FG001|NOT COMPLETED|Overall Study||1||
59668092|NCT04647890|75787002|FG002|NOT COMPLETED|Overall Study||0||
59668093|NCT04642638|75787016|FG000|STARTED|Overall Study||151||
59668094|NCT04642638|75787017|FG001|STARTED|Overall Study||149||
59668095|NCT04642638|75787018|FG002|STARTED|Overall Study||50||
59668096|NCT04642638|75787019|FG003|STARTED|Overall Study||51||
59668097|NCT04642638|75787020|FG004|STARTED|Overall Study||603||
59668098|NCT04642638|75787021|FG005|STARTED|Overall Study||303||
59668099|NCT04642638|75787016|FG000|Intention-to-treat (ITT) Population|Overall Study||151|ITT population included all participants who were randomized.|
59668100|NCT04642638|75787017|FG001|Intention-to-treat (ITT) Population|Overall Study||149|ITT population included all participants who were randomized.|
59668101|NCT04642638|75787018|FG002|Intention-to-treat (ITT) Population|Overall Study||50|ITT population included all participants who were randomized.|
59668102|NCT04642638|75787019|FG003|Intention-to-treat (ITT) Population|Overall Study||51|ITT population included all participants who were randomized.|
59668103|NCT04642638|75787020|FG004|Intention-to-treat (ITT) Population|Overall Study||603|ITT population included all participants who were randomized.|
59668104|NCT04642638|75787021|FG005|Intention-to-treat (ITT) Population|Overall Study||303|ITT population included all participants who were randomized.|
59668105|NCT04642638|75787016|FG000|Per Protocol (PP) Population|Overall Study||141|PP population included all participants who received all doses of the trial intervention and had no key protocol violations.|
59668106|NCT04642638|75787017|FG001|Per Protocol (PP) Population|Overall Study||130|PP population included all participants who received all doses of the trial intervention and had no key protocol violations.|
59668107|NCT04642638|75787018|FG002|Per Protocol (PP) Population|Overall Study||47|PP population included all participants who received all doses of the trial intervention and had no key protocol violations.|
59989161|NCT00151775|76104472|FG011|STARTED|Period 2 - Double-Blind Dose Response||0||
59989162|NCT00151775|76104461|FG000|COMPLETED|Period 2 - Double-Blind Dose Response||93||
59989163|NCT00151775|76104462|FG001|COMPLETED|Period 2 - Double-Blind Dose Response||89||
59668108|NCT04642638|75787019|FG003|Per Protocol (PP) Population|Overall Study||48|PP population included all participants who received all doses of the trial intervention and had no key protocol violations.|
59709761|NCT01072149|75828527|FG007|NOT COMPLETED|Treatment Period 1 (28 Days)||0||
59989164|NCT00151775|76104463|FG002|COMPLETED|Period 2 - Double-Blind Dose Response||0||
59989165|NCT00151775|76104464|FG003|COMPLETED|Period 2 - Double-Blind Dose Response||0||
59989166|NCT00151775|76104465|FG004|COMPLETED|Period 2 - Double-Blind Dose Response||0||
59989167|NCT00151775|76104466|FG005|COMPLETED|Period 2 - Double-Blind Dose Response||54||
59668109|NCT04642638|75787020|FG004|Per Protocol (PP) Population|Overall Study||507|PP population included all participants who received all doses of the trial intervention and had no key protocol violations.|
59668110|NCT04642638|75787021|FG005|Per Protocol (PP) Population|Overall Study||261|PP population included all participants who received all doses of the trial intervention and had no key protocol violations.|
59668111|NCT04642638|75787016|FG000|Safety Population|Overall Study||151|Safety population included all participants who received at least 1 dose of the trial intervention.|
59668112|NCT04642638|75787017|FG001|Safety Population|Overall Study||147|Safety population included all participants who received at least 1 dose of the trial intervention.|
59668113|NCT04642638|75787018|FG002|Safety Population|Overall Study||50|Safety population included all participants who received at least 1 dose of the trial intervention.|
59668114|NCT04642638|75787019|FG003|Safety Population|Overall Study||51|Safety population included all participants who received at least 1 dose of the trial intervention.|
59668115|NCT04642638|75787020|FG004|Safety Population|Overall Study||601|Safety population included all participants who received at least 1 dose of the trial intervention.|
59668116|NCT04642638|75787021|FG005|Safety Population|Overall Study||302|Safety population included all participants who received at least 1 dose of the trial intervention.|
59668117|NCT04642638|75787016|FG000|COMPLETED|Overall Study||110||
59668118|NCT04642638|75787017|FG001|COMPLETED|Overall Study||98||
59668119|NCT04642638|75787018|FG002|COMPLETED|Overall Study||35||
59668120|NCT04642638|75787019|FG003|COMPLETED|Overall Study||39||
59668121|NCT04642638|75787020|FG004|COMPLETED|Overall Study||0||
59668122|NCT04642638|75787021|FG005|COMPLETED|Overall Study||0||
59668123|NCT04642638|75787016|FG000|NOT COMPLETED|Overall Study||41||
59668124|NCT04642638|75787017|FG001|NOT COMPLETED|Overall Study||51||
59668125|NCT04642638|75787018|FG002|NOT COMPLETED|Overall Study||15||
59668126|NCT04642638|75787019|FG003|NOT COMPLETED|Overall Study||12||
59989168|NCT00151775|76104467|FG006|COMPLETED|Period 2 - Double-Blind Dose Response||53||
59989169|NCT00151775|76104468|FG007|COMPLETED|Period 2 - Double-Blind Dose Response||0||
59989170|NCT00151775|76104469|FG008|COMPLETED|Period 2 - Double-Blind Dose Response||0||
59989171|NCT00151775|76104470|FG009|COMPLETED|Period 2 - Double-Blind Dose Response||0||
59989172|NCT00151775|76104471|FG010|COMPLETED|Period 2 - Double-Blind Dose Response||59||
59989173|NCT00151775|76104472|FG011|COMPLETED|Period 2 - Double-Blind Dose Response||0||
59989174|NCT00151775|76104461|FG000|NOT COMPLETED|Period 2 - Double-Blind Dose Response||2||
59989175|NCT00151775|76104462|FG001|NOT COMPLETED|Period 2 - Double-Blind Dose Response||6||
59989176|NCT00151775|76104463|FG002|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0||
59989177|NCT00151775|76104464|FG003|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0||
59989178|NCT00151775|76104465|FG004|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0||
59989179|NCT00151775|76104466|FG005|NOT COMPLETED|Period 2 - Double-Blind Dose Response||2||
59989180|NCT00151775|76104467|FG006|NOT COMPLETED|Period 2 - Double-Blind Dose Response||3||
59989181|NCT00151775|76104468|FG007|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0||
59545224|NCT00985010|75643924|FG001|STARTED|Overall Study||5||
59545225|NCT00985010|75643923|FG000|COMPLETED|Overall Study||4||
59545226|NCT00985010|75643924|FG001|COMPLETED|Overall Study||5||
59545227|NCT00985010|75643923|FG000|NOT COMPLETED|Overall Study||0||
59545228|NCT00985010|75643924|FG001|NOT COMPLETED|Overall Study||0||
59545229|NCT02240069|75643933|FG000|STARTED|Overall Study||49||47
59545230|NCT02240069|75643934|FG001|STARTED|Overall Study||47||46
59545231|NCT02240069|75643935|FG002|STARTED|Overall Study||47||45
59545232|NCT02240069|75643933|FG000|COMPLETED|Overall Study||44||43
59545233|NCT02240069|75643934|FG001|COMPLETED|Overall Study||42||41
59545234|NCT02240069|75643935|FG002|COMPLETED|Overall Study||45||43
59668127|NCT04642638|75787020|FG004|NOT COMPLETED|Overall Study||603||
59989182|NCT00151775|76104469|FG008|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0||
59989183|NCT00151775|76104470|FG009|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0||
59545235|NCT02240069|75643933|FG000|NOT COMPLETED|Overall Study||5||4
59545236|NCT02240069|75643934|FG001|NOT COMPLETED|Overall Study||5||5
59545237|NCT02240069|75643935|FG002|NOT COMPLETED|Overall Study||2||2
59545238|NCT01023074|75643946|FG000|STARTED|Overall Study||26||
59545239|NCT01023074|75643947|FG001|STARTED|Overall Study||13||
59545240|NCT01023074|75643948|FG002|STARTED|Overall Study||13||
59545241|NCT01023074|75643946|FG000|COMPLETED|Overall Study||26||
60077369|NCT01539291|76192411|FG001|STARTED|Study GS-US-312-0116|Started = Randomized in Study GS-US-312-0116.|4||
60077370|NCT01539291|76192412|FG002|STARTED|Study GS-US-312-0116|Started = Randomized in Study GS-US-312-0116.|42||
59989184|NCT00151775|76104471|FG010|NOT COMPLETED|Period 2 - Double-Blind Dose Response||1||
59989185|NCT00151775|76104472|FG011|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0||
59989186|NCT00151775|76104461|FG000|STARTED|Period 3: Double-blind, Withdrawal||48||
59545242|NCT01023074|75643947|FG001|COMPLETED|Overall Study||13||
59545243|NCT01023074|75643948|FG002|COMPLETED|Overall Study||13||
59545244|NCT01023074|75643946|FG000|NOT COMPLETED|Overall Study||0||
59545245|NCT01023074|75643947|FG001|NOT COMPLETED|Overall Study||0||
59545246|NCT01023074|75643948|FG002|NOT COMPLETED|Overall Study||0||
59545247|NCT02161484|75643962|FG000|STARTED|Overall Study||5||
59989187|NCT00151775|76104462|FG001|STARTED|Period 3: Double-blind, Withdrawal||45||
59989188|NCT00151775|76104463|FG002|STARTED|Period 3: Double-blind, Withdrawal||45||
59989189|NCT00151775|76104464|FG003|STARTED|Period 3: Double-blind, Withdrawal||44||
60077371|NCT01539291|76192413|FG003|STARTED|Study GS-US-312-0116|Started = Randomized in Study GS-US-312-0116.|44||
60077372|NCT01539291|76192410|FG000|COMPLETED|Study GS-US-312-0116|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|81||
59989190|NCT00151775|76104465|FG004|STARTED|Period 3: Double-blind, Withdrawal||0||
60077373|NCT01539291|76192411|FG001|COMPLETED|Study GS-US-312-0116|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|4||
60077374|NCT01539291|76192412|FG002|COMPLETED|Study GS-US-312-0116|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|42||
60077375|NCT01539291|76192413|FG003|COMPLETED|Study GS-US-312-0116|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|44||
60077376|NCT01539291|76192410|FG000|NOT COMPLETED|Study GS-US-312-0116||25||
60077377|NCT01539291|76192411|FG001|NOT COMPLETED|Study GS-US-312-0116||0||
60077378|NCT01539291|76192412|FG002|NOT COMPLETED|Study GS-US-312-0116||0||
59545248|NCT02161484|75643963|FG001|STARTED|Overall Study||5||
59545249|NCT02161484|75643962|FG000|COMPLETED|Overall Study||1||
59545250|NCT02161484|75643963|FG001|COMPLETED|Overall Study||2||
59545251|NCT02161484|75643962|FG000|NOT COMPLETED|Overall Study||4||
59545252|NCT02161484|75643963|FG001|NOT COMPLETED|Overall Study||3||
59545253|NCT00988832|75643969|FG000|STARTED|Overall Study||380||
59545254|NCT00988832|75643969|FG000|COMPLETED|Overall Study||380||
59545255|NCT00988832|75643969|FG000|NOT COMPLETED|Overall Study||0||
59545256|NCT01023776|75643976|FG000|STARTED|Overall Study|Subjects received 2 dose of vaccine 0.1 ml in each nostril intra nasally 28 days apart|20||
59545257|NCT01023776|75643976|FG000|COMPLETED|Overall Study||20||
59545258|NCT01023776|75643976|FG000|NOT COMPLETED|Overall Study||0||
59545259|NCT00989612|75643980|FG000|STARTED|Overall Study||100||
59545260|NCT00989612|75643980|FG000|COMPLETED|Overall Study||100||
59545261|NCT00989612|75643980|FG000|NOT COMPLETED|Overall Study||0||
59545262|NCT00989768|75643986|FG000|STARTED|Overall Study|All patients received both treatments. They are their own controls|29||
59545263|NCT00989768|75643986|FG000|COMPLETED|Overall Study||28||
59545264|NCT00989768|75643986|FG000|NOT COMPLETED|Overall Study||1||
59545265|NCT00990236|75643996|FG000|STARTED|Overall Study||89||
59545266|NCT00990236|75643997|FG001|STARTED|Overall Study||96||
59545267|NCT00990236|75643996|FG000|COMPLETED|Overall Study||89||
59545268|NCT00990236|75643997|FG001|COMPLETED|Overall Study||96||
59545269|NCT00990236|75643996|FG000|NOT COMPLETED|Overall Study||0||
59545270|NCT00990236|75643997|FG001|NOT COMPLETED|Overall Study||0||
59545271|NCT01024010|75644005|FG000|STARTED|Overall Study||48||
59545272|NCT01024010|75644006|FG001|STARTED|Overall Study||34||
59545273|NCT01024010|75644005|FG000|COMPLETED|Overall Study||48||
59545274|NCT01024010|75644006|FG001|COMPLETED|Overall Study||34||
59545275|NCT01024010|75644005|FG000|NOT COMPLETED|Overall Study||0||
59545276|NCT01024010|75644006|FG001|NOT COMPLETED|Overall Study||0||
59545277|NCT00990782|75644012|FG000|STARTED|Overall Study||93||
59545278|NCT00990782|75644012|FG000|COMPLETED|Overall Study||88||
59545279|NCT00990782|75644012|FG000|NOT COMPLETED|Overall Study||5||
59545280|NCT02484690|75644021|FG000|STARTED|Overall Study||68||
59545281|NCT02484690|75644022|FG001|STARTED|Overall Study||46||
59545282|NCT02484690|75644023|FG002|STARTED|Overall Study||39||
59545283|NCT02484690|75644024|FG003|STARTED|Overall Study||46||
59545284|NCT02484690|75644025|FG004|STARTED|Overall Study||64||
59545285|NCT02484690|75644021|FG000|Received at Least One Dose of Study Drug|Overall Study||67|Safety Population|
59545286|NCT02484690|75644022|FG001|Received at Least One Dose of Study Drug|Overall Study||46|Safety Population|
59545287|NCT02484690|75644023|FG002|Received at Least One Dose of Study Drug|Overall Study||39|Safety Population|
59545288|NCT02484690|75644024|FG003|Received at Least One Dose of Study Drug|Overall Study||46|Safety Population|
59545289|NCT02484690|75644025|FG004|Received at Least One Dose of Study Drug|Overall Study||64|Safety Population|
59545290|NCT02484690|75644021|FG000|COMPLETED|Overall Study||64||
59545291|NCT02484690|75644022|FG001|COMPLETED|Overall Study||40||
59545292|NCT02484690|75644023|FG002|COMPLETED|Overall Study||36||
59545293|NCT02484690|75644024|FG003|COMPLETED|Overall Study||44||
59545294|NCT02484690|75644025|FG004|COMPLETED|Overall Study||58||
59545295|NCT02484690|75644021|FG000|NOT COMPLETED|Overall Study||4||
59545296|NCT02484690|75644022|FG001|NOT COMPLETED|Overall Study||6||
59545297|NCT02484690|75644023|FG002|NOT COMPLETED|Overall Study||3||
60077379|NCT01539291|76192413|FG003|NOT COMPLETED|Study GS-US-312-0116||0||
60077380|NCT01539291|76192410|FG000|STARTED|Study GS-US-312-0117|Started = Completed GS-US-312-0116 and Enrolled in GS-US-312-0117.|71||
60077381|NCT01539291|76192411|FG001|STARTED|Study GS-US-312-0117|Started = Completed GS-US-312-0116 and Enrolled in GS-US-312-0117.|4||
60077382|NCT01539291|76192412|FG002|STARTED|Study GS-US-312-0117|Started = Completed GS-US-312-0116 and Enrolled in GS-US-312-0117.|42||
60077383|NCT01539291|76192413|FG003|STARTED|Study GS-US-312-0117|Started = Completed GS-US-312-0116 and Enrolled in GS-US-312-0117.|44||
60077384|NCT01539291|76192410|FG000|COMPLETED|Study GS-US-312-0117|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|30||
60077385|NCT01539291|76192411|FG001|COMPLETED|Study GS-US-312-0117|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|2||
59545298|NCT02484690|75644024|FG003|NOT COMPLETED|Overall Study||2||
59545299|NCT02484690|75644025|FG004|NOT COMPLETED|Overall Study||6||
59545300|NCT01027598|75644040|FG000|STARTED|Overall Study|One patient was enrolled but not treated|134||
59545301|NCT01027598|75644041|FG001|STARTED|Overall Study||67||
59545302|NCT01027598|75644040|FG000|COMPLETED|Overall Study|Patients remained on treatment until coming off for progression, toxicity or any other reason|0||
59545303|NCT01027598|75644041|FG001|COMPLETED|Overall Study|Patients remained on treatment until coming off for progression, toxicity or any other reason|0||
59545304|NCT01027598|75644040|FG000|NOT COMPLETED|Overall Study||134||
59545305|NCT01027598|75644041|FG001|NOT COMPLETED|Overall Study||67||
59545306|NCT01654224|75644049|FG000|STARTED|Overall Study||95||
59545307|NCT01654224|75644050|FG001|STARTED|Overall Study||110||
59545308|NCT01654224|75644049|FG000|COMPLETED|Overall Study||89||
59545309|NCT01654224|75644050|FG001|COMPLETED|Overall Study||98||
59545310|NCT01654224|75644049|FG000|NOT COMPLETED|Overall Study||6||
59545311|NCT01654224|75644050|FG001|NOT COMPLETED|Overall Study||12||
59545312|NCT02447328|75644056|FG000|STARTED|Overall Study|Enrolment 85 Screening Failure 2 starting study drug 83|83||
59545313|NCT02447328|75644056|FG000|COMPLETED|Overall Study||82||
59545314|NCT02447328|75644056|FG000|NOT COMPLETED|Overall Study||1||
59545315|NCT02447250|75644060|FG000|STARTED|First Dose (180 mcg Albuterol)||14||
59545316|NCT02447250|75644060|FG000|COMPLETED|First Dose (180 mcg Albuterol)||14||
59545317|NCT02447250|75644060|FG000|NOT COMPLETED|First Dose (180 mcg Albuterol)||0||
59545318|NCT02447250|75644060|FG000|STARTED|Second Dose (270 mcg Albuterol)||14||
59545319|NCT02447250|75644060|FG000|COMPLETED|Second Dose (270 mcg Albuterol)||13||
59545320|NCT02447250|75644060|FG000|NOT COMPLETED|Second Dose (270 mcg Albuterol)||1||
59545321|NCT02447250|75644060|FG000|STARTED|Third Dose (360 mcg Albuterol)||13||
59545322|NCT02447250|75644060|FG000|COMPLETED|Third Dose (360 mcg Albuterol)||8||
59545323|NCT02447250|75644060|FG000|NOT COMPLETED|Third Dose (360 mcg Albuterol)||5||
59545324|NCT00990938|75644071|FG000|STARTED|Overall Study||3||
59545325|NCT00990938|75644072|FG001|STARTED|Overall Study||12||
59545326|NCT00990938|75644073|FG002|STARTED|Overall Study||12||
59545327|NCT00990938|75644074|FG003|STARTED|Overall Study||12||
59545328|NCT00990938|75644075|FG004|STARTED|Overall Study||12||
59545329|NCT00990938|75644076|FG005|STARTED|Overall Study||12||
59545330|NCT00990938|75644071|FG000|COMPLETED|Overall Study||3||
59545331|NCT00990938|75644072|FG001|COMPLETED|Overall Study||12||
59545332|NCT00990938|75644073|FG002|COMPLETED|Overall Study||12||
59545333|NCT00990938|75644074|FG003|COMPLETED|Overall Study||12||
59545334|NCT00990938|75644075|FG004|COMPLETED|Overall Study||12||
59545335|NCT00990938|75644076|FG005|COMPLETED|Overall Study||12||
59545336|NCT00990938|75644071|FG000|NOT COMPLETED|Overall Study||0||
59545337|NCT00990938|75644072|FG001|NOT COMPLETED|Overall Study||0||
59545338|NCT00990938|75644073|FG002|NOT COMPLETED|Overall Study||0||
59545339|NCT00990938|75644074|FG003|NOT COMPLETED|Overall Study||0||
59668128|NCT04642638|75787021|FG005|NOT COMPLETED|Overall Study||303||
60077386|NCT01539291|76192412|FG002|COMPLETED|Study GS-US-312-0117|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|20||
60077387|NCT01539291|76192413|FG003|COMPLETED|Study GS-US-312-0117|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|18||
60077388|NCT01539291|76192410|FG000|NOT COMPLETED|Study GS-US-312-0117||41||
60077389|NCT01539291|76192411|FG001|NOT COMPLETED|Study GS-US-312-0117||2||
60077390|NCT01539291|76192412|FG002|NOT COMPLETED|Study GS-US-312-0117||22||
60077391|NCT01539291|76192413|FG003|NOT COMPLETED|Study GS-US-312-0117||26||
60077392|NCT01538199|76192436|FG000|STARTED|Overall Study||10||
60077393|NCT01538199|76192437|FG001|STARTED|Overall Study||11||
60077394|NCT01538199|76192438|FG002|STARTED|Overall Study||4||
60077395|NCT01538199|76192439|FG003|STARTED|Overall Study||3||
59545340|NCT00990938|75644075|FG004|NOT COMPLETED|Overall Study||0||
59545341|NCT00990938|75644076|FG005|NOT COMPLETED|Overall Study||0||
59545342|NCT00992264|75644106|FG000|STARTED|Overall Study||116||
59545343|NCT00992264|75644107|FG001|STARTED|Overall Study||116||
59545344|NCT00992264|75644108|FG002|STARTED|Overall Study||117||
59545345|NCT00992264|75644109|FG003|STARTED|Overall Study||117||
59545346|NCT00992264|75644110|FG004|STARTED|Overall Study||117||
59545347|NCT00992264|75644111|FG005|STARTED|Overall Study||117||
59545348|NCT00992264|75644112|FG006|STARTED|Overall Study||116||
59545349|NCT00992264|75644113|FG007|STARTED|Overall Study||117||
59545350|NCT00992264|75644114|FG008|STARTED|Overall Study||116||
59545351|NCT00992264|75644115|FG009|STARTED|Overall Study||116||
59545352|NCT00992264|75644116|FG010|STARTED|Overall Study||117||
59545353|NCT00992264|75644117|FG011|STARTED|Overall Study||117||
59545354|NCT00992264|75644118|FG012|STARTED|Overall Study||116||
59545355|NCT00992264|75644119|FG013|STARTED|Overall Study||117||
59545356|NCT00992264|75644120|FG014|STARTED|Overall Study||117||
60077396|NCT01538199|76192436|FG000|COMPLETED|Overall Study|"1 completed study but was excluded as a completer from analyses because started a new treatment"|8|"1 active participant excluded as completer in analyses because last visit was out of window."|
60077397|NCT01538199|76192437|FG001|COMPLETED|Overall Study|"1 completed study but was excluded as a completer from analyses because started a new treatment"|8|"1 active participant excluded as completer in analyses because last visit was out of window."|
60077398|NCT01538199|76192438|FG002|COMPLETED|Overall Study|1 non-completer included in analyses because only missed follow up, completed all treatment visits.|3|"1 active participant excluded as completer in analyses because last visit was out of window."|
60077399|NCT01538199|76192439|FG003|COMPLETED|Overall Study|Completer excluded from analyses because determined to be not eligible at end of study.|1|"1 active participant excluded as completer in analyses because last visit was out of window."|
60077400|NCT01538199|76192436|FG000|NOT COMPLETED|Overall Study||2||
60077401|NCT01538199|76192437|FG001|NOT COMPLETED|Overall Study||3||
60077402|NCT01538199|76192438|FG002|NOT COMPLETED|Overall Study||1||
60077403|NCT01538199|76192439|FG003|NOT COMPLETED|Overall Study||2||
59545357|NCT00992264|75644121|FG015|STARTED|Overall Study||116||
59545358|NCT00992264|75644106|FG000|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116||
59545359|NCT00992264|75644107|FG001|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116||
59545360|NCT00992264|75644108|FG002|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117||
59545361|NCT00992264|75644109|FG003|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117||
59545362|NCT00992264|75644110|FG004|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117||
59545363|NCT00992264|75644111|FG005|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117||
59545364|NCT00992264|75644112|FG006|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116||
59545365|NCT00992264|75644113|FG007|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117||
59545366|NCT00992264|75644114|FG008|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116||
59545367|NCT00992264|75644115|FG009|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116||
59545368|NCT00992264|75644116|FG010|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117||
59545369|NCT00992264|75644117|FG011|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117||
59545370|NCT00992264|75644118|FG012|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116||
59545371|NCT00992264|75644119|FG013|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117||
59545372|NCT00992264|75644120|FG014|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117||
59545373|NCT00992264|75644121|FG015|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116||
59545374|NCT00992264|75644106|FG000|NOT COMPLETED|Overall Study||0||
59545375|NCT00992264|75644107|FG001|NOT COMPLETED|Overall Study||0||
59545376|NCT00992264|75644108|FG002|NOT COMPLETED|Overall Study||0||
59545377|NCT00992264|75644109|FG003|NOT COMPLETED|Overall Study||0||
59545378|NCT00992264|75644110|FG004|NOT COMPLETED|Overall Study||0||
59545379|NCT00992264|75644111|FG005|NOT COMPLETED|Overall Study||0||
59545380|NCT00992264|75644112|FG006|NOT COMPLETED|Overall Study||0||
59545381|NCT00992264|75644113|FG007|NOT COMPLETED|Overall Study||0||
59668129|NCT04634825|75787039|FG000|STARTED|Overall Study||48||
59668130|NCT04634825|75787040|FG001|STARTED|Overall Study||14||
59668131|NCT04634825|75787039|FG000|COMPLETED|Overall Study||0||
60077404|NCT01511445|76192458|FG000|STARTED|Overall Study|Patient enrollment started in December, 2011.|53|Enrollment|
59668132|NCT04634825|75787040|FG001|COMPLETED|Overall Study||0||
59668133|NCT04634825|75787039|FG000|NOT COMPLETED|Overall Study||48||
59668134|NCT04634825|75787040|FG001|NOT COMPLETED|Overall Study||14||
59668135|NCT04398537|75787054|FG000|STARTED|Overall Study||112||
59668136|NCT04398537|75787055|FG001|STARTED|Overall Study||133||
59668137|NCT04398537|75787054|FG000|COMPLETED|Overall Study||102||
59668138|NCT04398537|75787055|FG001|COMPLETED|Overall Study||118||
59668139|NCT04398537|75787054|FG000|NOT COMPLETED|Overall Study||10||
59668140|NCT04398537|75787055|FG001|NOT COMPLETED|Overall Study||15||
59668141|NCT04392011|75787064|FG000|STARTED|Kratom Only||8||
59668142|NCT04392011|75787065|FG001|STARTED|Kratom Only||0||
59668143|NCT04392011|75787064|FG000|COMPLETED|Kratom Only||6||
59668144|NCT04392011|75787065|FG001|COMPLETED|Kratom Only||0||
59668145|NCT04392011|75787064|FG000|NOT COMPLETED|Kratom Only||2||
59668146|NCT04392011|75787065|FG001|NOT COMPLETED|Kratom Only||0||
59668147|NCT04392011|75787064|FG000|STARTED|Washout||6||
59668148|NCT04392011|75787065|FG001|STARTED|Washout||0||
59668149|NCT04392011|75787064|FG000|COMPLETED|Washout||6||
59668150|NCT04392011|75787065|FG001|COMPLETED|Washout||0||
59668151|NCT04392011|75787064|FG000|NOT COMPLETED|Washout||0||
59668152|NCT04392011|75787065|FG001|NOT COMPLETED|Washout||0||
59668153|NCT04392011|75787064|FG000|STARTED|Drug Cocktail Only||6||
59668154|NCT04392011|75787065|FG001|STARTED|Drug Cocktail Only||7||
59668155|NCT04392011|75787064|FG000|COMPLETED|Drug Cocktail Only||6||
59668156|NCT04392011|75787065|FG001|COMPLETED|Drug Cocktail Only||7||
59668157|NCT04392011|75787064|FG000|NOT COMPLETED|Drug Cocktail Only||0||
59668158|NCT04392011|75787065|FG001|NOT COMPLETED|Drug Cocktail Only||0||
59668159|NCT04392011|75787064|FG000|STARTED|Washout||6||
59668160|NCT04392011|75787065|FG001|STARTED|Washout||7||
59668161|NCT04392011|75787064|FG000|COMPLETED|Washout||6||
59668162|NCT04392011|75787065|FG001|COMPLETED|Washout||6||
59668163|NCT04392011|75787064|FG000|NOT COMPLETED|Washout||0||
59668164|NCT04392011|75787065|FG001|NOT COMPLETED|Washout||1||
59668165|NCT04392011|75787064|FG000|STARTED|Kratom + Drug Cocktail||6||
59668166|NCT04392011|75787065|FG001|STARTED|Kratom + Drug Cocktail||6||
59668167|NCT04392011|75787064|FG000|COMPLETED|Kratom + Drug Cocktail||6||
59668168|NCT04392011|75787065|FG001|COMPLETED|Kratom + Drug Cocktail||6||
59668169|NCT04392011|75787064|FG000|NOT COMPLETED|Kratom + Drug Cocktail||0||
59668170|NCT04392011|75787065|FG001|NOT COMPLETED|Kratom + Drug Cocktail||0||
59668171|NCT04176939|75787075|FG000|STARTED|Overall Study||68|Started = number of participants enrolled in the study (Enrolled Set)|
59668172|NCT04176939|75787075|FG000|Vaccinated|Overall Study||47|Vaccinated = number of participants included in the Exposed Set for revaccination phase|
59668173|NCT04176939|75787075|FG000|COMPLETED|Overall Study||0||
59668174|NCT04176939|75787075|FG000|NOT COMPLETED|Overall Study||68||
59668175|NCT04146909|75787081|FG000|STARTED|Overall Study||7||
59668176|NCT04146909|75787081|FG000|Screened, Consented and Qualified|Overall Study||6||
59668177|NCT04146909|75787081|FG000|Received Intervention|Overall Study||3||
59668178|NCT04146909|75787081|FG000|COMPLETED|Overall Study||3||
59668179|NCT04146909|75787081|FG000|NOT COMPLETED|Overall Study||4||
59668180|NCT03951649|75787089|FG000|STARTED|Overall Study||31||
59668181|NCT03951649|75787090|FG001|STARTED|Overall Study||31||
59668182|NCT03951649|75787089|FG000|COMPLETED|Overall Study||31||
59668183|NCT03951649|75787090|FG001|COMPLETED|Overall Study||31||
59989191|NCT00151775|76104466|FG005|STARTED|Period 3: Double-blind, Withdrawal||26||
59989192|NCT00151775|76104467|FG006|STARTED|Period 3: Double-blind, Withdrawal||27||
59989193|NCT00151775|76104468|FG007|STARTED|Period 3: Double-blind, Withdrawal||28||
59989194|NCT00151775|76104469|FG008|STARTED|Period 3: Double-blind, Withdrawal||26||
59989195|NCT00151775|76104470|FG009|STARTED|Period 3: Double-blind, Withdrawal||0||
59989196|NCT00151775|76104471|FG010|STARTED|Period 3: Double-blind, Withdrawal||29||
59668184|NCT03951649|75787089|FG000|NOT COMPLETED|Overall Study||0||
59989197|NCT00151775|76104472|FG011|STARTED|Period 3: Double-blind, Withdrawal||29||
59989198|NCT00151775|76104461|FG000|COMPLETED|Period 3: Double-blind, Withdrawal||48||
59989199|NCT00151775|76104462|FG001|COMPLETED|Period 3: Double-blind, Withdrawal||45||
60077405|NCT01511445|76192459|FG001|STARTED|Overall Study|Patient enrollment started in December, 2011.|51|Enrollment|
59668185|NCT03951649|75787090|FG001|NOT COMPLETED|Overall Study||0||
60077406|NCT01511445|76192458|FG000|Surgeries Completed|Overall Study|All surgeries were completed by October, 2013.|53||
59668186|NCT03913455|75787096|FG000|STARTED|Overall Study||24||
59668187|NCT03913455|75787096|FG000|COMPLETED|Overall Study||24||
60077407|NCT01511445|76192459|FG001|Surgeries Completed|Overall Study|All surgeries were completed by October, 2013.|51||
60077408|NCT01511445|76192458|FG000|Primary Completion October, 2014|Overall Study|1 was excluded Bechterew's disease. 1 protocol violation. 3 were lost to follow-up.|48||
59668188|NCT03913455|75787096|FG000|NOT COMPLETED|Overall Study||0||
59668189|NCT03894891|75787103|FG000|STARTED|Overall Study||6||
59668190|NCT03894891|75787103|FG000|COMPLETED|Overall Study||0||
59668191|NCT03894891|75787103|FG000|NOT COMPLETED|Overall Study||6||
59668192|NCT03863080|75787110|FG000|STARTED|Double-Blind Treatment Period (6 Weeks)||6||
59668193|NCT03863080|75787111|FG001|STARTED|Double-Blind Treatment Period (6 Weeks)||5||
59668194|NCT03863080|75787112|FG002|STARTED|Double-Blind Treatment Period (6 Weeks)||6||
59668195|NCT03863080|75787113|FG003|STARTED|Double-Blind Treatment Period (6 Weeks)||0||
59668196|NCT03863080|75787110|FG000|COMPLETED|Double-Blind Treatment Period (6 Weeks)||6||
59668197|NCT03863080|75787111|FG001|COMPLETED|Double-Blind Treatment Period (6 Weeks)||5||
59668198|NCT03863080|75787112|FG002|COMPLETED|Double-Blind Treatment Period (6 Weeks)||5||
59668199|NCT03863080|75787113|FG003|COMPLETED|Double-Blind Treatment Period (6 Weeks)||0||
59668200|NCT03863080|75787110|FG000|NOT COMPLETED|Double-Blind Treatment Period (6 Weeks)||0||
59668201|NCT03863080|75787111|FG001|NOT COMPLETED|Double-Blind Treatment Period (6 Weeks)||0||
59668202|NCT03863080|75787112|FG002|NOT COMPLETED|Double-Blind Treatment Period (6 Weeks)||1||
59668203|NCT03863080|75787113|FG003|NOT COMPLETED|Double-Blind Treatment Period (6 Weeks)||0||
59668204|NCT03863080|75787110|FG000|STARTED|Open Label Extension Period (12 Weeks)||0||
59668205|NCT03863080|75787111|FG001|STARTED|Open Label Extension Period (12 Weeks)||0||
59668206|NCT03863080|75787112|FG002|STARTED|Open Label Extension Period (12 Weeks)||0||
59668207|NCT03863080|75787113|FG003|STARTED|Open Label Extension Period (12 Weeks)||15||
59668208|NCT03863080|75787110|FG000|COMPLETED|Open Label Extension Period (12 Weeks)||0||
59668209|NCT03863080|75787111|FG001|COMPLETED|Open Label Extension Period (12 Weeks)||0||
59668210|NCT03863080|75787112|FG002|COMPLETED|Open Label Extension Period (12 Weeks)||0||
59668211|NCT03863080|75787113|FG003|COMPLETED|Open Label Extension Period (12 Weeks)||9||
60077409|NCT01511445|76192459|FG001|Primary Completion October, 2014|Overall Study|3 protocol violations. 1 lost to follow-up.|47||
60077410|NCT01511445|76192458|FG000|Follow-up Completion|Overall Study|Two year follow-up was completed in November, 2015|48||
59545382|NCT00992264|75644114|FG008|NOT COMPLETED|Overall Study||0||
59545383|NCT00992264|75644115|FG009|NOT COMPLETED|Overall Study||0||
59545384|NCT00992264|75644116|FG010|NOT COMPLETED|Overall Study||0||
59545385|NCT00992264|75644117|FG011|NOT COMPLETED|Overall Study||0||
59545386|NCT00992264|75644118|FG012|NOT COMPLETED|Overall Study||0||
59545387|NCT00992264|75644119|FG013|NOT COMPLETED|Overall Study||0||
59545388|NCT00992264|75644120|FG014|NOT COMPLETED|Overall Study||0||
59545389|NCT00992264|75644121|FG015|NOT COMPLETED|Overall Study||0||
59545390|NCT00993200|75644134|FG000|STARTED|Overall Study||13||
59668212|NCT03863080|75787110|FG000|NOT COMPLETED|Open Label Extension Period (12 Weeks)||0||
59668213|NCT03863080|75787111|FG001|NOT COMPLETED|Open Label Extension Period (12 Weeks)||0||
59668214|NCT03863080|75787112|FG002|NOT COMPLETED|Open Label Extension Period (12 Weeks)||0||
59668215|NCT03863080|75787113|FG003|NOT COMPLETED|Open Label Extension Period (12 Weeks)||6||
59668216|NCT03834493|75787128|FG000|STARTED|Overall Study||621||
59668217|NCT03834493|75787129|FG001|STARTED|Overall Study||623||
59668218|NCT03834493|75787128|FG000|Treated|Overall Study||615||
59668219|NCT03834493|75787129|FG001|Treated|Overall Study||620||
59668220|NCT03834493|75787128|FG000|COMPLETED|Overall Study||0||
59668221|NCT03834493|75787129|FG001|COMPLETED|Overall Study||0||
59668222|NCT03834493|75787128|FG000|NOT COMPLETED|Overall Study||621||
59668223|NCT03834493|75787129|FG001|NOT COMPLETED|Overall Study||623||
59668224|NCT03569891|75787136|FG000|STARTED|Lead-in||67||
59668225|NCT03569891|75787136|FG000|COMPLETED|Lead-in||54||
59668226|NCT03569891|75787136|FG000|NOT COMPLETED|Lead-in||13||
59668227|NCT03569891|75787136|FG000|STARTED|AMT-061||54||
59668228|NCT03569891|75787136|FG000|COMPLETED|AMT-061||53||
59668229|NCT03569891|75787136|FG000|NOT COMPLETED|AMT-061||1||
59668230|NCT03483103|75787145|FG000|STARTED|Pre-Treatment Phase||74|Participants who underwent leukapheresis|
60077411|NCT01511445|76192459|FG001|Follow-up Completion|Overall Study|Two year follow-up was completed in November, 2015|47||
60077412|NCT01511445|76192458|FG000|COMPLETED|Overall Study|Data analysis was completed in February, 2016|48||
60077413|NCT01511445|76192459|FG001|COMPLETED|Overall Study|Data analysis was completed in February, 2016|47||
60077414|NCT01511445|76192458|FG000|NOT COMPLETED|Overall Study||5||
60077415|NCT01511445|76192459|FG001|NOT COMPLETED|Overall Study||4||
59545391|NCT00993200|75644135|FG001|STARTED|Overall Study||13||
59545392|NCT00993200|75644134|FG000|COMPLETED|Overall Study||13||
59545393|NCT00993200|75644135|FG001|COMPLETED|Overall Study||13||
59545394|NCT00993200|75644134|FG000|NOT COMPLETED|Overall Study||0||
59545395|NCT00993200|75644135|FG001|NOT COMPLETED|Overall Study||0||
59545396|NCT00993824|75644145|FG000|STARTED|Overall Study||11||
59545397|NCT00993824|75644146|FG001|STARTED|Overall Study||10||
59545398|NCT00993824|75644145|FG000|COMPLETED|Overall Study||11||
59545399|NCT00993824|75644146|FG001|COMPLETED|Overall Study||10||
59545400|NCT00993824|75644145|FG000|NOT COMPLETED|Overall Study||0||
59668231|NCT03483103|75787145|FG000|COMPLETED|Pre-Treatment Phase||63|Participants who completed leukapheresis and continued to lymphodepleting chemotherapy (LDC) treatment period|
59668232|NCT03483103|75787145|FG000|NOT COMPLETED|Pre-Treatment Phase||11||
59668233|NCT03483103|75787145|FG000|STARTED|Treatment Phase||63|Participants who underwent lymphodepleting chemotherapy (LDC) treatment|
59668234|NCT03483103|75787145|FG000|Received JCAR017|Treatment Phase||61||
59668235|NCT03483103|75787145|FG000|Received Nonconforming Product|Treatment Phase||1||
60077416|NCT01543503|76192467|FG000|STARTED|Overall Study||426||
60077417|NCT01543503|76192468|FG001|STARTED|Overall Study||798||
59545401|NCT00993824|75644146|FG001|NOT COMPLETED|Overall Study||0||
59668236|NCT03483103|75787145|FG000|Did Not Receive Either JAR017 or Nonconforming Product|Treatment Phase||1||
59668237|NCT03483103|75787145|FG000|COMPLETED|Treatment Phase||30|Completed study|
59668238|NCT03483103|75787145|FG000|NOT COMPLETED|Treatment Phase||33||
59545402|NCT00994604|75644154|FG000|STARTED|Overall Study||51||
59545403|NCT00994604|75644154|FG000|COMPLETED|Overall Study||45||
59545404|NCT00994604|75644154|FG000|NOT COMPLETED|Overall Study||6||
59545405|NCT02447172|75644164|FG000|STARTED|Overall Study||262||
59668239|NCT03415685|75787151|FG000|STARTED|Overall Study||11||
59668240|NCT03415685|75787152|FG001|STARTED|Overall Study||28||
59668241|NCT03415685|75787151|FG000|COMPLETED|Overall Study||11||
59545406|NCT02447172|75644165|FG001|STARTED|Overall Study||130||
59668242|NCT03415685|75787152|FG001|COMPLETED|Overall Study||9||
59668243|NCT03415685|75787151|FG000|NOT COMPLETED|Overall Study||0||
59668244|NCT03415685|75787152|FG001|NOT COMPLETED|Overall Study||19||
59668245|NCT03412747|75787161|FG000|STARTED|Initial Treatment Period: Wk0-Wk16||161||
59668246|NCT03412747|75787162|FG001|STARTED|Initial Treatment Period: Wk0-Wk16||158||
59668247|NCT03412747|75787163|FG002|STARTED|Initial Treatment Period: Wk0-Wk16||159||
59668248|NCT03412747|75787161|FG000|COMPLETED|Initial Treatment Period: Wk0-Wk16||154||
59668249|NCT03412747|75787162|FG001|COMPLETED|Initial Treatment Period: Wk0-Wk16||153||
59545407|NCT02447172|75644166|FG002|STARTED|Overall Study||132||
59545408|NCT02447172|75644164|FG000|COMPLETED|Overall Study||231||
59545409|NCT02447172|75644165|FG001|COMPLETED|Overall Study||115||
59668250|NCT03412747|75787163|FG002|COMPLETED|Initial Treatment Period: Wk0-Wk16||150||
59668251|NCT03412747|75787161|FG000|NOT COMPLETED|Initial Treatment Period: Wk0-Wk16||7||
59668252|NCT03412747|75787162|FG001|NOT COMPLETED|Initial Treatment Period: Wk0-Wk16||5||
59668253|NCT03412747|75787163|FG002|NOT COMPLETED|Initial Treatment Period: Wk0-Wk16||9||
59668254|NCT03412747|75787161|FG000|STARTED|Maintenance Treatment Period: Wk16-Wk24||154||
59668255|NCT03412747|75787162|FG001|STARTED|Maintenance Treatment Period: Wk16-Wk24||153||
59668256|NCT03412747|75787163|FG002|STARTED|Maintenance Treatment Period: Wk16-Wk24||150||
59668257|NCT03412747|75787161|FG000|COMPLETED|Maintenance Treatment Period: Wk16-Wk24||149||
59668258|NCT03412747|75787162|FG001|COMPLETED|Maintenance Treatment Period: Wk16-Wk24||152||
59668259|NCT03412747|75787163|FG002|COMPLETED|Maintenance Treatment Period: Wk16-Wk24||149||
59668260|NCT03412747|75787161|FG000|NOT COMPLETED|Maintenance Treatment Period: Wk16-Wk24||5||
59668261|NCT03412747|75787162|FG001|NOT COMPLETED|Maintenance Treatment Period: Wk16-Wk24||1||
59668262|NCT03412747|75787163|FG002|NOT COMPLETED|Maintenance Treatment Period: Wk16-Wk24||1||
59668263|NCT03412747|75787161|FG000|STARTED|Maintenance Treatment Period: Wk24-Wk56||149||
59668264|NCT03412747|75787162|FG001|STARTED|Maintenance Treatment Period: Wk24-Wk56||152||
59668265|NCT03412747|75787163|FG002|STARTED|Maintenance Treatment Period: Wk24-Wk56||149||
59668266|NCT03412747|75787161|FG000|COMPLETED|Maintenance Treatment Period: Wk24-Wk56||143||
59668267|NCT03412747|75787162|FG001|COMPLETED|Maintenance Treatment Period: Wk24-Wk56||143||
59668268|NCT03412747|75787163|FG002|COMPLETED|Maintenance Treatment Period: Wk24-Wk56||133||
59668269|NCT03412747|75787161|FG000|NOT COMPLETED|Maintenance Treatment Period: Wk24-Wk56||6||
59668270|NCT03412747|75787162|FG001|NOT COMPLETED|Maintenance Treatment Period: Wk24-Wk56||9||
59668271|NCT03412747|75787163|FG002|NOT COMPLETED|Maintenance Treatment Period: Wk24-Wk56||16||
59668272|NCT03410992|75787183|FG000|STARTED|Initial Treatment Period: up to Wk16||86||
59668273|NCT03410992|75787184|FG001|STARTED|Initial Treatment Period: up to Wk16||349||
59668274|NCT03410992|75787185|FG002|STARTED|Initial Treatment Period: up to Wk16||0||
59668275|NCT03410992|75787186|FG003|STARTED|Initial Treatment Period: up to Wk16||0||
59545410|NCT02447172|75644166|FG002|COMPLETED|Overall Study||114||
59545411|NCT02447172|75644164|FG000|NOT COMPLETED|Overall Study||31||
59545412|NCT02447172|75644165|FG001|NOT COMPLETED|Overall Study||15||
59545413|NCT02447172|75644166|FG002|NOT COMPLETED|Overall Study||18||
59668276|NCT03410992|75787187|FG004|STARTED|Initial Treatment Period: up to Wk16||0||
59668277|NCT03410992|75787188|FG005|STARTED|Initial Treatment Period: up to Wk16||0||
59668278|NCT03410992|75787189|FG006|STARTED|Initial Treatment Period: up to Wk16||0||
59545414|NCT02163824|75644177|FG000|STARTED|Overall Study||129||
59545415|NCT02163824|75644178|FG001|STARTED|Overall Study||125||
59545416|NCT02163824|75644179|FG002|STARTED|Overall Study||126||
59545417|NCT02163824|75644177|FG000|COMPLETED|Overall Study||127||
59668279|NCT03410992|75787190|FG007|STARTED|Initial Treatment Period: up to Wk16||0||
59668280|NCT03410992|75787191|FG008|STARTED|Initial Treatment Period: up to Wk16||0||
59668281|NCT03410992|75787192|FG009|STARTED|Initial Treatment Period: up to Wk16||0||
59668282|NCT03410992|75787193|FG010|STARTED|Initial Treatment Period: up to Wk16||0||
59668283|NCT03410992|75787183|FG000|COMPLETED|Initial Treatment Period: up to Wk16||82||
59668284|NCT03410992|75787184|FG001|COMPLETED|Initial Treatment Period: up to Wk16||340||
59668285|NCT03410992|75787185|FG002|COMPLETED|Initial Treatment Period: up to Wk16||0||
59668286|NCT03410992|75787186|FG003|COMPLETED|Initial Treatment Period: up to Wk16||0||
59668287|NCT03410992|75787187|FG004|COMPLETED|Initial Treatment Period: up to Wk16||0||
59668288|NCT03410992|75787188|FG005|COMPLETED|Initial Treatment Period: up to Wk16||0||
59668289|NCT03410992|75787189|FG006|COMPLETED|Initial Treatment Period: up to Wk16||0||
59668290|NCT03410992|75787190|FG007|COMPLETED|Initial Treatment Period: up to Wk16||0||
59668291|NCT03410992|75787191|FG008|COMPLETED|Initial Treatment Period: up to Wk16||0||
59668292|NCT03410992|75787192|FG009|COMPLETED|Initial Treatment Period: up to Wk16||0||
59668293|NCT03410992|75787193|FG010|COMPLETED|Initial Treatment Period: up to Wk16||0||
59668294|NCT03410992|75787183|FG000|NOT COMPLETED|Initial Treatment Period: up to Wk16||4||
59668295|NCT03410992|75787184|FG001|NOT COMPLETED|Initial Treatment Period: up to Wk16||9||
59668296|NCT03410992|75787185|FG002|NOT COMPLETED|Initial Treatment Period: up to Wk16||0||
59668297|NCT03410992|75787186|FG003|NOT COMPLETED|Initial Treatment Period: up to Wk16||0||
59668298|NCT03410992|75787187|FG004|NOT COMPLETED|Initial Treatment Period: up to Wk16||0||
59668299|NCT03410992|75787188|FG005|NOT COMPLETED|Initial Treatment Period: up to Wk16||0||
59668300|NCT03410992|75787189|FG006|NOT COMPLETED|Initial Treatment Period: up to Wk16||0||
59668301|NCT03410992|75787190|FG007|NOT COMPLETED|Initial Treatment Period: up to Wk16||0||
59668302|NCT03410992|75787191|FG008|NOT COMPLETED|Initial Treatment Period: up to Wk16||0||
59668303|NCT03410992|75787192|FG009|NOT COMPLETED|Initial Treatment Period: up to Wk16||0||
59668304|NCT03410992|75787193|FG010|NOT COMPLETED|Initial Treatment Period: up to Wk16||0||
59668305|NCT03410992|75787183|FG000|STARTED|Week 16 Assessment||82||
59668306|NCT03410992|75787184|FG001|STARTED|Week 16 Assessment||340||
59668307|NCT03410992|75787185|FG002|STARTED|Week 16 Assessment||0||
59668308|NCT03410992|75787186|FG003|STARTED|Week 16 Assessment||0||
59668309|NCT03410992|75787187|FG004|STARTED|Week 16 Assessment||0||
59668310|NCT03410992|75787188|FG005|STARTED|Week 16 Assessment||0||
59668311|NCT03410992|75787189|FG006|STARTED|Week 16 Assessment||0||
59668312|NCT03410992|75787190|FG007|STARTED|Week 16 Assessment||0||
59668313|NCT03410992|75787191|FG008|STARTED|Week 16 Assessment||0||
59668314|NCT03410992|75787192|FG009|STARTED|Week 16 Assessment||0||
59668315|NCT03410992|75787193|FG010|STARTED|Week 16 Assessment||0||
59668316|NCT03410992|75787183|FG000|Received Escape Treatment|Week 16 Assessment||81||
59668317|NCT03410992|75787184|FG001|Received Escape Treatment|Week 16 Assessment||23||
59668318|NCT03410992|75787185|FG002|Received Escape Treatment|Week 16 Assessment||0||
59668319|NCT03410992|75787186|FG003|Received Escape Treatment|Week 16 Assessment||0||
59668320|NCT03410992|75787187|FG004|Received Escape Treatment|Week 16 Assessment||0||
59668321|NCT03410992|75787188|FG005|Received Escape Treatment|Week 16 Assessment||0||
59668322|NCT03410992|75787189|FG006|Received Escape Treatment|Week 16 Assessment||0||
59668323|NCT03410992|75787190|FG007|Received Escape Treatment|Week 16 Assessment||0||
59668324|NCT03410992|75787191|FG008|Received Escape Treatment|Week 16 Assessment||0||
59668325|NCT03410992|75787192|FG009|Received Escape Treatment|Week 16 Assessment||0||
59668326|NCT03410992|75787193|FG010|Received Escape Treatment|Week 16 Assessment||0||
59668327|NCT03410992|75787183|FG000|COMPLETED|Week 16 Assessment||1||
59668328|NCT03410992|75787184|FG001|COMPLETED|Week 16 Assessment||311||
59668329|NCT03410992|75787185|FG002|COMPLETED|Week 16 Assessment||0||
59668330|NCT03410992|75787186|FG003|COMPLETED|Week 16 Assessment||0||
59668331|NCT03410992|75787187|FG004|COMPLETED|Week 16 Assessment||0||
59668332|NCT03410992|75787188|FG005|COMPLETED|Week 16 Assessment||0||
59668333|NCT03410992|75787189|FG006|COMPLETED|Week 16 Assessment||0||
59668334|NCT03410992|75787190|FG007|COMPLETED|Week 16 Assessment||0||
59668335|NCT03410992|75787191|FG008|COMPLETED|Week 16 Assessment||0||
59668336|NCT03410992|75787192|FG009|COMPLETED|Week 16 Assessment||0||
59668337|NCT03410992|75787193|FG010|COMPLETED|Week 16 Assessment||0||
59668338|NCT03410992|75787183|FG000|NOT COMPLETED|Week 16 Assessment||81||
59668339|NCT03410992|75787184|FG001|NOT COMPLETED|Week 16 Assessment||29||
59668340|NCT03410992|75787185|FG002|NOT COMPLETED|Week 16 Assessment||0||
59668341|NCT03410992|75787186|FG003|NOT COMPLETED|Week 16 Assessment||0||
59668342|NCT03410992|75787187|FG004|NOT COMPLETED|Week 16 Assessment||0||
59668343|NCT03410992|75787188|FG005|NOT COMPLETED|Week 16 Assessment||0||
59668344|NCT03410992|75787189|FG006|NOT COMPLETED|Week 16 Assessment||0||
59668345|NCT03410992|75787190|FG007|NOT COMPLETED|Week 16 Assessment||0||
59668346|NCT03410992|75787191|FG008|NOT COMPLETED|Week 16 Assessment||0||
59668347|NCT03410992|75787192|FG009|NOT COMPLETED|Week 16 Assessment||0||
59668348|NCT03410992|75787193|FG010|NOT COMPLETED|Week 16 Assessment||0||
59668349|NCT03410992|75787183|FG000|STARTED|Randomized-Withdrawal Period: up to Wk56||0||
59668350|NCT03410992|75787184|FG001|STARTED|Randomized-Withdrawal Period: up to Wk56||0||
59668351|NCT03410992|75787185|FG002|STARTED|Randomized-Withdrawal Period: up to Wk56||1||
59668352|NCT03410992|75787186|FG003|STARTED|Randomized-Withdrawal Period: up to Wk56||105||
59668353|NCT03410992|75787187|FG004|STARTED|Randomized-Withdrawal Period: up to Wk56||100||
59668354|NCT03410992|75787188|FG005|STARTED|Randomized-Withdrawal Period: up to Wk56||106||
59668355|NCT03410992|75787189|FG006|STARTED|Randomized-Withdrawal Period: up to Wk56||0||
59668356|NCT03410992|75787190|FG007|STARTED|Randomized-Withdrawal Period: up to Wk56||0||
59668357|NCT03410992|75787191|FG008|STARTED|Randomized-Withdrawal Period: up to Wk56||0||
59668358|NCT03410992|75787192|FG009|STARTED|Randomized-Withdrawal Period: up to Wk56||0||
59668359|NCT03410992|75787193|FG010|STARTED|Randomized-Withdrawal Period: up to Wk56||0||
59668360|NCT03410992|75787183|FG000|Received Escape Treatment|Randomized-Withdrawal Period: up to Wk56||0||
59668361|NCT03410992|75787184|FG001|Received Escape Treatment|Randomized-Withdrawal Period: up to Wk56||0||
59668362|NCT03410992|75787185|FG002|Received Escape Treatment|Randomized-Withdrawal Period: up to Wk56||0||
59668363|NCT03410992|75787186|FG003|Received Escape Treatment|Randomized-Withdrawal Period: up to Wk56||67||
59668364|NCT03410992|75787187|FG004|Received Escape Treatment|Randomized-Withdrawal Period: up to Wk56||4||
59668365|NCT03410992|75787188|FG005|Received Escape Treatment|Randomized-Withdrawal Period: up to Wk56||7||
59668366|NCT03410992|75787189|FG006|Received Escape Treatment|Randomized-Withdrawal Period: up to Wk56||0||
59668367|NCT03410992|75787190|FG007|Received Escape Treatment|Randomized-Withdrawal Period: up to Wk56||0||
59668368|NCT03410992|75787191|FG008|Received Escape Treatment|Randomized-Withdrawal Period: up to Wk56||0||
59668369|NCT03410992|75787192|FG009|Received Escape Treatment|Randomized-Withdrawal Period: up to Wk56||0||
59668370|NCT03410992|75787193|FG010|Received Escape Treatment|Randomized-Withdrawal Period: up to Wk56||0||
59668371|NCT03410992|75787183|FG000|COMPLETED|Randomized-Withdrawal Period: up to Wk56||0||
59668372|NCT03410992|75787184|FG001|COMPLETED|Randomized-Withdrawal Period: up to Wk56||0||
59668373|NCT03410992|75787185|FG002|COMPLETED|Randomized-Withdrawal Period: up to Wk56||1||
59668374|NCT03410992|75787186|FG003|COMPLETED|Randomized-Withdrawal Period: up to Wk56||33||
59668375|NCT03410992|75787187|FG004|COMPLETED|Randomized-Withdrawal Period: up to Wk56||93||
59668376|NCT03410992|75787188|FG005|COMPLETED|Randomized-Withdrawal Period: up to Wk56||94||
59668377|NCT03410992|75787189|FG006|COMPLETED|Randomized-Withdrawal Period: up to Wk56||0||
59668378|NCT03410992|75787190|FG007|COMPLETED|Randomized-Withdrawal Period: up to Wk56||0||
59668379|NCT03410992|75787191|FG008|COMPLETED|Randomized-Withdrawal Period: up to Wk56||0||
59668380|NCT03410992|75787192|FG009|COMPLETED|Randomized-Withdrawal Period: up to Wk56||0||
59668381|NCT03410992|75787193|FG010|COMPLETED|Randomized-Withdrawal Period: up to Wk56||0||
59545418|NCT02163824|75644178|FG001|COMPLETED|Overall Study||124||
59545419|NCT02163824|75644179|FG002|COMPLETED|Overall Study||124||
59545420|NCT02163824|75644177|FG000|NOT COMPLETED|Overall Study||2||
59545421|NCT02163824|75644178|FG001|NOT COMPLETED|Overall Study||1||
59545422|NCT02163824|75644179|FG002|NOT COMPLETED|Overall Study||2||
59545423|NCT02165072|75644187|FG000|STARTED|Overall Study||30||
59545424|NCT02165072|75644187|FG000|COMPLETED|Overall Study||30||
59545425|NCT02165072|75644187|FG000|NOT COMPLETED|Overall Study||0||
59545426|NCT02165384|75644191|FG000|STARTED|Overall Study||199||
59545427|NCT02165384|75644191|FG000|COMPLETED|Overall Study||199||
59545428|NCT02165384|75644191|FG000|NOT COMPLETED|Overall Study||0||
59545429|NCT02455050|75644199|FG000|STARTED|Treatment Period 1||20||
59545430|NCT02455050|75644200|FG001|STARTED|Treatment Period 1||19||
59545431|NCT02455050|75644201|FG002|STARTED|Treatment Period 1||20||
59545432|NCT02455050|75644202|FG003|STARTED|Treatment Period 1||20||
59545433|NCT02455050|75644199|FG000|COMPLETED|Treatment Period 1||19||
59545434|NCT02455050|75644200|FG001|COMPLETED|Treatment Period 1||18||
59545435|NCT02455050|75644201|FG002|COMPLETED|Treatment Period 1||19||
59545436|NCT02455050|75644202|FG003|COMPLETED|Treatment Period 1||18||
59545437|NCT02455050|75644199|FG000|NOT COMPLETED|Treatment Period 1||1||
59545438|NCT02455050|75644200|FG001|NOT COMPLETED|Treatment Period 1||1||
59545439|NCT02455050|75644201|FG002|NOT COMPLETED|Treatment Period 1||1||
59545440|NCT02455050|75644202|FG003|NOT COMPLETED|Treatment Period 1||2||
59545441|NCT02455050|75644199|FG000|STARTED|Treatment Period 2||19||
59668382|NCT03410992|75787183|FG000|NOT COMPLETED|Randomized-Withdrawal Period: up to Wk56||0||
60077418|NCT01543503|76192467|FG000|COMPLETED|Overall Study||350||
59545442|NCT02455050|75644200|FG001|STARTED|Treatment Period 2||18||
59545443|NCT02455050|75644201|FG002|STARTED|Treatment Period 2||19||
59668383|NCT03410992|75787184|FG001|NOT COMPLETED|Randomized-Withdrawal Period: up to Wk56||0||
59668384|NCT03410992|75787185|FG002|NOT COMPLETED|Randomized-Withdrawal Period: up to Wk56||0||
59668385|NCT03410992|75787186|FG003|NOT COMPLETED|Randomized-Withdrawal Period: up to Wk56||72||
59668386|NCT03410992|75787187|FG004|NOT COMPLETED|Randomized-Withdrawal Period: up to Wk56||7||
59668387|NCT03410992|75787188|FG005|NOT COMPLETED|Randomized-Withdrawal Period: up to Wk56||12||
59668388|NCT03410992|75787189|FG006|NOT COMPLETED|Randomized-Withdrawal Period: up to Wk56||0||
59668389|NCT03410992|75787190|FG007|NOT COMPLETED|Randomized-Withdrawal Period: up to Wk56||0||
59668390|NCT03410992|75787191|FG008|NOT COMPLETED|Randomized-Withdrawal Period: up to Wk56||0||
59668391|NCT03410992|75787192|FG009|NOT COMPLETED|Randomized-Withdrawal Period: up to Wk56||0||
59668392|NCT03410992|75787193|FG010|NOT COMPLETED|Randomized-Withdrawal Period: up to Wk56||0||
59668393|NCT03410992|75787183|FG000|STARTED|Escape Treatment: 12 Weeks||0||
59668394|NCT03410992|75787184|FG001|STARTED|Escape Treatment: 12 Weeks||0||
59668395|NCT03410992|75787185|FG002|STARTED|Escape Treatment: 12 Weeks||0||
59668396|NCT03410992|75787186|FG003|STARTED|Escape Treatment: 12 Weeks||0||
59668397|NCT03410992|75787187|FG004|STARTED|Escape Treatment: 12 Weeks||0||
59668398|NCT03410992|75787188|FG005|STARTED|Escape Treatment: 12 Weeks||0||
59668399|NCT03410992|75787189|FG006|STARTED|Escape Treatment: 12 Weeks||81||
59668400|NCT03410992|75787190|FG007|STARTED|Escape Treatment: 12 Weeks||23||
59668401|NCT03410992|75787191|FG008|STARTED|Escape Treatment: 12 Weeks||67||
59668402|NCT03410992|75787192|FG009|STARTED|Escape Treatment: 12 Weeks||4||
59668403|NCT03410992|75787193|FG010|STARTED|Escape Treatment: 12 Weeks||7||
59668404|NCT03410992|75787183|FG000|COMPLETED|Escape Treatment: 12 Weeks||0||
59668405|NCT03410992|75787184|FG001|COMPLETED|Escape Treatment: 12 Weeks||0||
59668406|NCT03410992|75787185|FG002|COMPLETED|Escape Treatment: 12 Weeks||0||
59668407|NCT03410992|75787186|FG003|COMPLETED|Escape Treatment: 12 Weeks||0||
59668408|NCT03410992|75787187|FG004|COMPLETED|Escape Treatment: 12 Weeks||0||
59668409|NCT03410992|75787188|FG005|COMPLETED|Escape Treatment: 12 Weeks||0||
59668410|NCT03410992|75787189|FG006|COMPLETED|Escape Treatment: 12 Weeks||81||
59668411|NCT03410992|75787190|FG007|COMPLETED|Escape Treatment: 12 Weeks||22||
59668412|NCT03410992|75787191|FG008|COMPLETED|Escape Treatment: 12 Weeks||66||
60077419|NCT01543503|76192468|FG001|COMPLETED|Overall Study||711||
60077420|NCT01543503|76192467|FG000|NOT COMPLETED|Overall Study||76||
60077421|NCT01543503|76192468|FG001|NOT COMPLETED|Overall Study||87||
60077422|NCT01511055|76192474|FG000|STARTED|Overall Study||27||
59668413|NCT03410992|75787192|FG009|COMPLETED|Escape Treatment: 12 Weeks||4||
59668414|NCT03410992|75787193|FG010|COMPLETED|Escape Treatment: 12 Weeks||7||
59668415|NCT03410992|75787183|FG000|NOT COMPLETED|Escape Treatment: 12 Weeks||0||
60077423|NCT01511055|76192474|FG000|COMPLETED|Overall Study||21||
60077424|NCT01511055|76192474|FG000|NOT COMPLETED|Overall Study||6||
60077425|NCT01537887|76192478|FG000|STARTED|Period 1||12||
59668416|NCT03410992|75787184|FG001|NOT COMPLETED|Escape Treatment: 12 Weeks||0||
60077426|NCT01537887|76192479|FG001|STARTED|Period 1||12||
60077427|NCT01537887|76192480|FG002|STARTED|Period 1||12||
60077428|NCT01537887|76192481|FG003|STARTED|Period 1||12||
59668417|NCT03410992|75787185|FG002|NOT COMPLETED|Escape Treatment: 12 Weeks||0||
59668418|NCT03410992|75787186|FG003|NOT COMPLETED|Escape Treatment: 12 Weeks||0||
59668419|NCT03410992|75787187|FG004|NOT COMPLETED|Escape Treatment: 12 Weeks||0||
59668420|NCT03410992|75787188|FG005|NOT COMPLETED|Escape Treatment: 12 Weeks||0||
60077429|NCT01537887|76192482|FG004|STARTED|Period 1||12||
60077430|NCT01537887|76192483|FG005|STARTED|Period 1||12||
60077431|NCT01537887|76192478|FG000|Received at Least 1 Dose of Study Drug|Period 1||12||
59668421|NCT03410992|75787189|FG006|NOT COMPLETED|Escape Treatment: 12 Weeks||0||
59668422|NCT03410992|75787190|FG007|NOT COMPLETED|Escape Treatment: 12 Weeks||1||
59668423|NCT03410992|75787191|FG008|NOT COMPLETED|Escape Treatment: 12 Weeks||1||
59668424|NCT03410992|75787192|FG009|NOT COMPLETED|Escape Treatment: 12 Weeks||0||
60077432|NCT01537887|76192479|FG001|Received at Least 1 Dose of Study Drug|Period 1||12||
60077433|NCT01537887|76192480|FG002|Received at Least 1 Dose of Study Drug|Period 1||11||
59668425|NCT03410992|75787193|FG010|NOT COMPLETED|Escape Treatment: 12 Weeks||0||
59668426|NCT03370913|75787223|FG000|STARTED|Overall Study||134||
59668427|NCT03370913|75787223|FG000|COMPLETED|Overall Study||132|Participants completed Week 104 Visit|
59668428|NCT03370913|75787223|FG000|NOT COMPLETED|Overall Study||2||
59668429|NCT03342404|75787229|FG000|STARTED|Blinded Treatment Phase||96||
59668430|NCT03342404|75787230|FG001|STARTED|Blinded Treatment Phase||49||
59668431|NCT03342404|75787229|FG000|COMPLETED|Blinded Treatment Phase||68||
59668432|NCT03342404|75787230|FG001|COMPLETED|Blinded Treatment Phase||18||
59668433|NCT03342404|75787229|FG000|NOT COMPLETED|Blinded Treatment Phase||28||
59668434|NCT03342404|75787230|FG001|NOT COMPLETED|Blinded Treatment Phase||31||
59668435|NCT03342404|75787229|FG000|STARTED|Open-Label Phase||0||
59668436|NCT03342404|75787230|FG001|STARTED|Open-Label Phase||38||
59668437|NCT03342404|75787229|FG000|COMPLETED|Open-Label Phase||0||
59668438|NCT03342404|75787230|FG001|COMPLETED|Open-Label Phase||27||
59668439|NCT03342404|75787229|FG000|NOT COMPLETED|Open-Label Phase||0||
59668440|NCT03342404|75787230|FG001|NOT COMPLETED|Open-Label Phase||11||
59668441|NCT03329599|75787239|FG000|STARTED|Overall Study||74||
59668442|NCT03329599|75787240|FG001|STARTED|Overall Study||74||
59668443|NCT03329599|75787239|FG000|COMPLETED|Overall Study||59||
59668444|NCT03329599|75787240|FG001|COMPLETED|Overall Study||64||
59668445|NCT03329599|75787239|FG000|NOT COMPLETED|Overall Study||15||
59668446|NCT03329599|75787240|FG001|NOT COMPLETED|Overall Study||10||
59668447|NCT03213457|75787249|FG000|STARTED|Overall Study||194|Randomized|
59668448|NCT03213457|75787250|FG001|STARTED|Overall Study||98|Randomized|
59668449|NCT03213457|75787251|FG002|STARTED|Overall Study||389|Randomized|
59668450|NCT03213457|75787249|FG000|Randomized and Treated|Overall Study||193||
59668451|NCT03213457|75787250|FG001|Randomized and Treated|Overall Study||97||
59668452|NCT03213457|75787251|FG002|Randomized and Treated|Overall Study||389||
59668453|NCT03213457|75787249|FG000|COMPLETED|Overall Study||106|Completed the placebo-controlled Treatment Period|
59668454|NCT03213457|75787250|FG001|COMPLETED|Overall Study||59|Completed the placebo-controlled Treatment Period|
59668455|NCT03213457|75787251|FG002|COMPLETED|Overall Study||215|Completed the placebo-controlled Treatment Period|
59668456|NCT03213457|75787249|FG000|NOT COMPLETED|Overall Study||88||
59668457|NCT03213457|75787250|FG001|NOT COMPLETED|Overall Study||39||
59668458|NCT03213457|75787251|FG002|NOT COMPLETED|Overall Study||174||
59668459|NCT03198078|75787262|FG000|STARTED|Overall Study||110||
59668460|NCT03198078|75787263|FG001|STARTED|Overall Study||102||
59668461|NCT03198078|75787264|FG002|STARTED|Overall Study||104||
59668462|NCT03198078|75787262|FG000|Safety Sample|Overall Study||110|Safety sample included all randomized participants who received at least 1 dose of investigational medicinal product (IMP).|
59668463|NCT03198078|75787263|FG001|Safety Sample|Overall Study||102|Safety sample included all randomized participants who received at least 1 dose of investigational medicinal product (IMP).|
59668464|NCT03198078|75787264|FG002|Safety Sample|Overall Study||104|Safety sample included all randomized participants who received at least 1 dose of investigational medicinal product (IMP).|
59817915|NCT04488770|75940328|FG002|STARTED|Part 1-Cohort 2: Period 2 (Up to 5 Days)||0||
59989200|NCT00151775|76104463|FG002|COMPLETED|Period 3: Double-blind, Withdrawal||42||
59989201|NCT00151775|76104464|FG003|COMPLETED|Period 3: Double-blind, Withdrawal||44||
59989202|NCT00151775|76104465|FG004|COMPLETED|Period 3: Double-blind, Withdrawal||0||
59989203|NCT00151775|76104466|FG005|COMPLETED|Period 3: Double-blind, Withdrawal||25||
60077434|NCT01537887|76192481|FG003|Received at Least 1 Dose of Study Drug|Period 1||12||
60077435|NCT01537887|76192482|FG004|Received at Least 1 Dose of Study Drug|Period 1||12||
59545444|NCT02455050|75644202|FG003|STARTED|Treatment Period 2||18||
59545445|NCT02455050|75644199|FG000|COMPLETED|Treatment Period 2||18||
59545446|NCT02455050|75644200|FG001|COMPLETED|Treatment Period 2||18||
59545447|NCT02455050|75644201|FG002|COMPLETED|Treatment Period 2||17||
59545448|NCT02455050|75644202|FG003|COMPLETED|Treatment Period 2||17||
59545449|NCT02455050|75644199|FG000|NOT COMPLETED|Treatment Period 2||1||
59545450|NCT02455050|75644200|FG001|NOT COMPLETED|Treatment Period 2||0||
59545451|NCT02455050|75644201|FG002|NOT COMPLETED|Treatment Period 2||2||
59545452|NCT02455050|75644202|FG003|NOT COMPLETED|Treatment Period 2||1||
59545453|NCT00994760|75644222|FG000|STARTED|Overall Study||131||
59545454|NCT00994760|75644222|FG000|COMPLETED|Overall Study||107||
59545455|NCT00994760|75644222|FG000|NOT COMPLETED|Overall Study||24||
59545456|NCT02418468|75644242|FG000|STARTED|Overall Study||13||
59989204|NCT00151775|76104467|FG006|COMPLETED|Period 3: Double-blind, Withdrawal||26||
59989205|NCT00151775|76104468|FG007|COMPLETED|Period 3: Double-blind, Withdrawal||27||
59989206|NCT00151775|76104469|FG008|COMPLETED|Period 3: Double-blind, Withdrawal||26||
60077436|NCT01537887|76192483|FG005|Received at Least 1 Dose of Study Drug|Period 1||12||
60077437|NCT01537887|76192478|FG000|COMPLETED|Period 1||12||
60077438|NCT01537887|76192479|FG001|COMPLETED|Period 1||12||
59545457|NCT02418468|75644243|FG001|STARTED|Overall Study||11||
59545458|NCT02418468|75644242|FG000|COMPLETED|Overall Study||11||
59545459|NCT02418468|75644243|FG001|COMPLETED|Overall Study||10||
59545460|NCT02418468|75644242|FG000|NOT COMPLETED|Overall Study||2||
60077439|NCT01537887|76192480|FG002|COMPLETED|Period 1||11||
60077440|NCT01537887|76192481|FG003|COMPLETED|Period 1||12||
60077441|NCT01537887|76192482|FG004|COMPLETED|Period 1||11||
60077442|NCT01537887|76192483|FG005|COMPLETED|Period 1||11||
60077443|NCT01537887|76192478|FG000|NOT COMPLETED|Period 1||0||
60077444|NCT01537887|76192479|FG001|NOT COMPLETED|Period 1||0||
60077445|NCT01537887|76192480|FG002|NOT COMPLETED|Period 1||1||
60077446|NCT01537887|76192481|FG003|NOT COMPLETED|Period 1||0||
60077447|NCT01537887|76192482|FG004|NOT COMPLETED|Period 1||1||
59545461|NCT02418468|75644243|FG001|NOT COMPLETED|Overall Study||1||
60077448|NCT01537887|76192483|FG005|NOT COMPLETED|Period 1||1||
60077449|NCT01537887|76192478|FG000|STARTED|Period 2||12||
60077450|NCT01537887|76192479|FG001|STARTED|Period 2||12||
60077451|NCT01537887|76192480|FG002|STARTED|Period 2||11||
60077452|NCT01537887|76192481|FG003|STARTED|Period 2||12||
60077453|NCT01537887|76192482|FG004|STARTED|Period 2||11||
60077454|NCT01537887|76192483|FG005|STARTED|Period 2||11||
60077455|NCT01537887|76192478|FG000|COMPLETED|Period 2||12||
60077456|NCT01537887|76192479|FG001|COMPLETED|Period 2||11||
60077457|NCT01537887|76192480|FG002|COMPLETED|Period 2||11||
60077458|NCT01537887|76192481|FG003|COMPLETED|Period 2||12||
60077459|NCT01537887|76192482|FG004|COMPLETED|Period 2||11||
60077460|NCT01537887|76192483|FG005|COMPLETED|Period 2||11||
60077461|NCT01537887|76192478|FG000|NOT COMPLETED|Period 2||0||
60077462|NCT01537887|76192479|FG001|NOT COMPLETED|Period 2||1||
60077463|NCT01537887|76192480|FG002|NOT COMPLETED|Period 2||0||
60077464|NCT01537887|76192481|FG003|NOT COMPLETED|Period 2||0||
60077465|NCT01537887|76192482|FG004|NOT COMPLETED|Period 2||0||
60077466|NCT01537887|76192483|FG005|NOT COMPLETED|Period 2||0||
60077467|NCT01537887|76192478|FG000|STARTED|Period 3||12||
60077468|NCT01537887|76192479|FG001|STARTED|Period 3||11||
60077469|NCT01537887|76192480|FG002|STARTED|Period 3||11||
59545462|NCT00995072|75644251|FG000|STARTED|Overall Study||10||
60077470|NCT01537887|76192481|FG003|STARTED|Period 3||12||
60077471|NCT01537887|76192482|FG004|STARTED|Period 3||11||
60077472|NCT01537887|76192483|FG005|STARTED|Period 3||11||
60077473|NCT01537887|76192478|FG000|COMPLETED|Period 3||12||
60077474|NCT01537887|76192479|FG001|COMPLETED|Period 3||10||
60077475|NCT01537887|76192480|FG002|COMPLETED|Period 3||10||
60077476|NCT01537887|76192481|FG003|COMPLETED|Period 3||12||
60077477|NCT01537887|76192482|FG004|COMPLETED|Period 3||11||
60077478|NCT01537887|76192483|FG005|COMPLETED|Period 3||11||
60077479|NCT01537887|76192478|FG000|NOT COMPLETED|Period 3||0||
60077480|NCT01537887|76192479|FG001|NOT COMPLETED|Period 3||1||
60077481|NCT01537887|76192480|FG002|NOT COMPLETED|Period 3||1||
60077482|NCT01537887|76192481|FG003|NOT COMPLETED|Period 3||0||
60077483|NCT01537887|76192482|FG004|NOT COMPLETED|Period 3||0||
60077484|NCT01537887|76192483|FG005|NOT COMPLETED|Period 3||0||
60077485|NCT01489527|76192493|FG000|STARTED|Overall Study||205||
60077486|NCT01489527|76192494|FG001|STARTED|Overall Study||201||
60077487|NCT01489527|76192493|FG000|COMPLETED|Overall Study||183||
60077488|NCT01489527|76192494|FG001|COMPLETED|Overall Study||175||
60077489|NCT01489527|76192493|FG000|NOT COMPLETED|Overall Study||22||
60077490|NCT01489527|76192494|FG001|NOT COMPLETED|Overall Study||26||
60077491|NCT02315170|76192500|FG000|STARTED|Overall Study||50|Each participant will have one eye randomly selected to receive Intraocular Injection Guide and the other eye will receive Standard Speculum.|50
60077492|NCT02315170|76192501|FG001|STARTED|Overall Study||50|Each participant will have one eye randomly selected to receive Intraocular Injection Guide and the other eye will receive Standard Speculum.|50
60077493|NCT02315170|76192500|FG000|COMPLETED|Overall Study||50||50
60077494|NCT02315170|76192501|FG001|COMPLETED|Overall Study||50||50
60077495|NCT02315170|76192500|FG000|NOT COMPLETED|Overall Study||0||0
60077496|NCT02315170|76192501|FG001|NOT COMPLETED|Overall Study||0||0
60077497|NCT01487577|76192507|FG000|STARTED|Overall Study||19||
60077498|NCT01487577|76192507|FG000|COMPLETED|Overall Study|One participant became ineligible after signing consent, but before receiving protocol therapy.|18||
60077499|NCT01487577|76192507|FG000|NOT COMPLETED|Overall Study||1||
59545463|NCT00995072|75644252|FG001|STARTED|Overall Study||15||
59545464|NCT00995072|75644251|FG000|COMPLETED|Overall Study||9||
59545465|NCT00995072|75644252|FG001|COMPLETED|Overall Study||12||
60077500|NCT01536951|76192513|FG000|STARTED|First Intervention and Washout Period 1||3||
60077501|NCT01536951|76192514|FG001|STARTED|First Intervention and Washout Period 1||3||
60077502|NCT01536951|76192515|FG002|STARTED|First Intervention and Washout Period 1||3||
60077503|NCT01536951|76192516|FG003|STARTED|First Intervention and Washout Period 1||8||
60077504|NCT01536951|76192517|FG004|STARTED|First Intervention and Washout Period 1||9||
60077505|NCT01536951|76192518|FG005|STARTED|First Intervention and Washout Period 1||9||
60077506|NCT01536951|76192519|FG006|STARTED|First Intervention and Washout Period 1||9||
60077507|NCT01536951|76192520|FG007|STARTED|First Intervention and Washout Period 1||9||
60077508|NCT01536951|76192521|FG008|STARTED|First Intervention and Washout Period 1||9||
60077509|NCT01536951|76192513|FG000|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1|Across all reporting groups, study drug is LY3009104, moxifloxacin, or placebo.|3||
60077510|NCT01536951|76192514|FG001|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||3||
60077511|NCT01536951|76192515|FG002|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||3||
60077512|NCT01536951|76192516|FG003|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||8||
60077513|NCT01536951|76192517|FG004|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9||
60077514|NCT01536951|76192518|FG005|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9||
59545466|NCT00995072|75644251|FG000|NOT COMPLETED|Overall Study||1||
59545467|NCT00995072|75644252|FG001|NOT COMPLETED|Overall Study||3||
60077515|NCT01536951|76192519|FG006|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9||
59545468|NCT01027910|75644260|FG000|STARTED|Overall Study||6||
59545469|NCT01027910|75644261|FG001|STARTED|Overall Study||14||
59545470|NCT01027910|75644260|FG000|COMPLETED|Overall Study||6||
60077516|NCT01536951|76192520|FG007|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9||
59989207|NCT00151775|76104470|FG009|COMPLETED|Period 3: Double-blind, Withdrawal||0||
59989208|NCT00151775|76104471|FG010|COMPLETED|Period 3: Double-blind, Withdrawal||29||
59989209|NCT00151775|76104472|FG011|COMPLETED|Period 3: Double-blind, Withdrawal||28||
60077517|NCT01536951|76192521|FG008|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9||
60077518|NCT01536951|76192513|FG000|COMPLETED|First Intervention and Washout Period 1||3||
60077519|NCT01536951|76192514|FG001|COMPLETED|First Intervention and Washout Period 1||3||
60077520|NCT01536951|76192515|FG002|COMPLETED|First Intervention and Washout Period 1||2||
60077521|NCT01536951|76192516|FG003|COMPLETED|First Intervention and Washout Period 1||8||
60077522|NCT01536951|76192517|FG004|COMPLETED|First Intervention and Washout Period 1||9||
60077523|NCT01536951|76192518|FG005|COMPLETED|First Intervention and Washout Period 1||9||
60077524|NCT01536951|76192519|FG006|COMPLETED|First Intervention and Washout Period 1||9||
60077525|NCT01536951|76192520|FG007|COMPLETED|First Intervention and Washout Period 1||9||
60077526|NCT01536951|76192521|FG008|COMPLETED|First Intervention and Washout Period 1||9||
60077527|NCT01536951|76192513|FG000|NOT COMPLETED|First Intervention and Washout Period 1||0||
59989210|NCT00151775|76104461|FG000|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0||
59989211|NCT00151775|76104462|FG001|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0||
59989212|NCT00151775|76104463|FG002|NOT COMPLETED|Period 3: Double-blind, Withdrawal||3||
59989213|NCT00151775|76104464|FG003|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0||
59989214|NCT00151775|76104465|FG004|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0||
59989215|NCT00151775|76104466|FG005|NOT COMPLETED|Period 3: Double-blind, Withdrawal||1||
59989216|NCT00151775|76104467|FG006|NOT COMPLETED|Period 3: Double-blind, Withdrawal||1||
59989217|NCT00151775|76104468|FG007|NOT COMPLETED|Period 3: Double-blind, Withdrawal||1||
60077528|NCT01536951|76192514|FG001|NOT COMPLETED|First Intervention and Washout Period 1||0||
60077529|NCT01536951|76192515|FG002|NOT COMPLETED|First Intervention and Washout Period 1||1||
60077530|NCT01536951|76192516|FG003|NOT COMPLETED|First Intervention and Washout Period 1||0||
60077531|NCT01536951|76192517|FG004|NOT COMPLETED|First Intervention and Washout Period 1||0||
60077532|NCT01536951|76192518|FG005|NOT COMPLETED|First Intervention and Washout Period 1||0||
60077533|NCT01536951|76192519|FG006|NOT COMPLETED|First Intervention and Washout Period 1||0||
60077534|NCT01536951|76192520|FG007|NOT COMPLETED|First Intervention and Washout Period 1||0||
60077535|NCT01536951|76192521|FG008|NOT COMPLETED|First Intervention and Washout Period 1||0||
60077536|NCT01536951|76192513|FG000|STARTED|Second Intervention and Washout Period 2||3||
60077537|NCT01536951|76192514|FG001|STARTED|Second Intervention and Washout Period 2||3||
60077538|NCT01536951|76192515|FG002|STARTED|Second Intervention and Washout Period 2||2||
60077539|NCT01536951|76192516|FG003|STARTED|Second Intervention and Washout Period 2||8||
60077540|NCT01536951|76192517|FG004|STARTED|Second Intervention and Washout Period 2||9||
60077541|NCT01536951|76192518|FG005|STARTED|Second Intervention and Washout Period 2||9||
60077542|NCT01536951|76192519|FG006|STARTED|Second Intervention and Washout Period 2||9||
60077543|NCT01536951|76192520|FG007|STARTED|Second Intervention and Washout Period 2||9||
60077544|NCT01536951|76192521|FG008|STARTED|Second Intervention and Washout Period 2||9||
60077545|NCT01536951|76192513|FG000|COMPLETED|Second Intervention and Washout Period 2||3||
60077546|NCT01536951|76192514|FG001|COMPLETED|Second Intervention and Washout Period 2||3||
60077547|NCT01536951|76192515|FG002|COMPLETED|Second Intervention and Washout Period 2||2||
60077548|NCT01536951|76192516|FG003|COMPLETED|Second Intervention and Washout Period 2||8||
60077549|NCT01536951|76192517|FG004|COMPLETED|Second Intervention and Washout Period 2||9||
60077550|NCT01536951|76192518|FG005|COMPLETED|Second Intervention and Washout Period 2||9||
60077551|NCT01536951|76192519|FG006|COMPLETED|Second Intervention and Washout Period 2||9||
60077552|NCT01536951|76192520|FG007|COMPLETED|Second Intervention and Washout Period 2||8||
60077553|NCT01536951|76192521|FG008|COMPLETED|Second Intervention and Washout Period 2||9||
60077554|NCT01536951|76192513|FG000|NOT COMPLETED|Second Intervention and Washout Period 2||0||
60077555|NCT01536951|76192514|FG001|NOT COMPLETED|Second Intervention and Washout Period 2||0||
60077556|NCT01536951|76192515|FG002|NOT COMPLETED|Second Intervention and Washout Period 2||0||
60077557|NCT01536951|76192516|FG003|NOT COMPLETED|Second Intervention and Washout Period 2||0||
60077558|NCT01536951|76192517|FG004|NOT COMPLETED|Second Intervention and Washout Period 2||0||
60077559|NCT01536951|76192518|FG005|NOT COMPLETED|Second Intervention and Washout Period 2||0||
60077560|NCT01536951|76192519|FG006|NOT COMPLETED|Second Intervention and Washout Period 2||0||
60077561|NCT01536951|76192520|FG007|NOT COMPLETED|Second Intervention and Washout Period 2||1||
60077562|NCT01536951|76192521|FG008|NOT COMPLETED|Second Intervention and Washout Period 2||0||
60077563|NCT01536951|76192513|FG000|STARTED|Third Intervention||3||
60077564|NCT01536951|76192514|FG001|STARTED|Third Intervention||3||
60077565|NCT01536951|76192515|FG002|STARTED|Third Intervention||2||
60077566|NCT01536951|76192516|FG003|STARTED|Third Intervention||8||
60077567|NCT01536951|76192517|FG004|STARTED|Third Intervention||9||
60077568|NCT01536951|76192518|FG005|STARTED|Third Intervention||9||
60077569|NCT01536951|76192519|FG006|STARTED|Third Intervention||9||
60077570|NCT01536951|76192520|FG007|STARTED|Third Intervention||8||
60077571|NCT01536951|76192521|FG008|STARTED|Third Intervention||9||
60077572|NCT01536951|76192513|FG000|COMPLETED|Third Intervention||3||
60077573|NCT01536951|76192514|FG001|COMPLETED|Third Intervention||3||
60077574|NCT01536951|76192515|FG002|COMPLETED|Third Intervention||2||
60077575|NCT01536951|76192516|FG003|COMPLETED|Third Intervention||8||
60077576|NCT01536951|76192517|FG004|COMPLETED|Third Intervention||9||
60077577|NCT01536951|76192518|FG005|COMPLETED|Third Intervention||9||
60077578|NCT01536951|76192519|FG006|COMPLETED|Third Intervention||9||
60077579|NCT01536951|76192520|FG007|COMPLETED|Third Intervention||8||
60077580|NCT01536951|76192521|FG008|COMPLETED|Third Intervention||9||
60077581|NCT01536951|76192513|FG000|NOT COMPLETED|Third Intervention||0||
60077582|NCT01536951|76192514|FG001|NOT COMPLETED|Third Intervention||0||
60077583|NCT01536951|76192515|FG002|NOT COMPLETED|Third Intervention||0||
60077584|NCT01536951|76192516|FG003|NOT COMPLETED|Third Intervention||0||
60077585|NCT01536951|76192517|FG004|NOT COMPLETED|Third Intervention||0||
60077586|NCT01536951|76192518|FG005|NOT COMPLETED|Third Intervention||0||
60077587|NCT01536951|76192519|FG006|NOT COMPLETED|Third Intervention||0||
60077588|NCT01536951|76192520|FG007|NOT COMPLETED|Third Intervention||0||
60077589|NCT01536951|76192521|FG008|NOT COMPLETED|Third Intervention||0||
60077590|NCT01536795|76192546|FG000|STARTED|Overall Study||24||
60077591|NCT01536795|76192547|FG001|STARTED|Overall Study||24||
60077592|NCT01536795|76192546|FG000|COMPLETED|Overall Study||23||
60077593|NCT01536795|76192547|FG001|COMPLETED|Overall Study||22||
60077594|NCT01536795|76192546|FG000|NOT COMPLETED|Overall Study||1||
60077595|NCT01536795|76192547|FG001|NOT COMPLETED|Overall Study||2||
60077596|NCT02249104|76192553|FG000|STARTED|Overall Study||28||
60077597|NCT02249104|76192553|FG000|COMPLETED|Overall Study||25||
60077598|NCT02249104|76192553|FG000|NOT COMPLETED|Overall Study||3||
60077599|NCT01536561|76192557|FG000|STARTED|Dosimetric and Therapeutic Treatment||59||
60077600|NCT01536561|76192557|FG000|COMPLETED|Dosimetric and Therapeutic Treatment||0||
60077601|NCT01536561|76192557|FG000|NOT COMPLETED|Dosimetric and Therapeutic Treatment||59||
60077602|NCT01536561|76192557|FG000|STARTED|Long-Term Follow-Up||13||
60077603|NCT01536561|76192557|FG000|COMPLETED|Long-Term Follow-Up||13||
60077604|NCT01536561|76192557|FG000|NOT COMPLETED|Long-Term Follow-Up||0||
60077605|NCT02243020|76192566|FG000|STARTED|Overall Study||8||
60077606|NCT02243020|76192567|FG001|STARTED|Overall Study||9||
60077607|NCT02243020|76192566|FG000|COMPLETED|Overall Study||8||
60077608|NCT02243020|76192567|FG001|COMPLETED|Overall Study||9||
60077609|NCT02243020|76192566|FG000|NOT COMPLETED|Overall Study||0||
60077610|NCT02243020|76192567|FG001|NOT COMPLETED|Overall Study||0||
60077611|NCT01536405|76192575|FG000|STARTED|Randomization to Visit 1 (Vaccination 1)||706||
60077612|NCT01536405|76192576|FG001|STARTED|Randomization to Visit 1 (Vaccination 1)||706||
60077613|NCT01536405|76192575|FG000|COMPLETED|Randomization to Visit 1 (Vaccination 1)||698||
60077614|NCT01536405|76192576|FG001|COMPLETED|Randomization to Visit 1 (Vaccination 1)||702||
60077615|NCT01536405|76192575|FG000|NOT COMPLETED|Randomization to Visit 1 (Vaccination 1)||8||
60077616|NCT01536405|76192576|FG001|NOT COMPLETED|Randomization to Visit 1 (Vaccination 1)||4||
60077617|NCT01536405|76192575|FG000|STARTED|Visit 1 (Vaccination 1) to Visit 2||698||
60077618|NCT01536405|76192576|FG001|STARTED|Visit 1 (Vaccination 1) to Visit 2||702||
60077619|NCT01536405|76192575|FG000|Received Vaccination 1|Visit 1 (Vaccination 1) to Visit 2||698||
60077620|NCT01536405|76192576|FG001|Received Vaccination 1|Visit 1 (Vaccination 1) to Visit 2||702||
60077621|NCT01536405|76192575|FG000|COMPLETED|Visit 1 (Vaccination 1) to Visit 2||666||
60077622|NCT01536405|76192576|FG001|COMPLETED|Visit 1 (Vaccination 1) to Visit 2||662||
60077623|NCT01536405|76192575|FG000|NOT COMPLETED|Visit 1 (Vaccination 1) to Visit 2||32||
60077624|NCT01536405|76192576|FG001|NOT COMPLETED|Visit 1 (Vaccination 1) to Visit 2||40||
60077625|NCT01536405|76192575|FG000|STARTED|Visit 2 to Visit 3 (Vaccination 2)||666||
60077626|NCT01536405|76192576|FG001|STARTED|Visit 2 to Visit 3 (Vaccination 2)||662||
60077627|NCT01536405|76192575|FG000|COMPLETED|Visit 2 to Visit 3 (Vaccination 2)||635||
60077628|NCT01536405|76192576|FG001|COMPLETED|Visit 2 to Visit 3 (Vaccination 2)||634||
60077629|NCT01536405|76192575|FG000|NOT COMPLETED|Visit 2 to Visit 3 (Vaccination 2)||31||
60077630|NCT01536405|76192576|FG001|NOT COMPLETED|Visit 2 to Visit 3 (Vaccination 2)||28||
60077631|NCT01536405|76192575|FG000|STARTED|Visit 3 (Vaccination 2) to Visit 4||635||
60077632|NCT01536405|76192576|FG001|STARTED|Visit 3 (Vaccination 2) to Visit 4||634||
60077633|NCT01536405|76192575|FG000|Received Vaccination 2|Visit 3 (Vaccination 2) to Visit 4||634||
60077634|NCT01536405|76192576|FG001|Received Vaccination 2|Visit 3 (Vaccination 2) to Visit 4||632||
60077635|NCT01536405|76192575|FG000|COMPLETED|Visit 3 (Vaccination 2) to Visit 4||615||
60077636|NCT01536405|76192576|FG001|COMPLETED|Visit 3 (Vaccination 2) to Visit 4||618||
60077637|NCT01536405|76192575|FG000|NOT COMPLETED|Visit 3 (Vaccination 2) to Visit 4||20||
60077638|NCT01536405|76192576|FG001|NOT COMPLETED|Visit 3 (Vaccination 2) to Visit 4||16||
60077639|NCT01536405|76192575|FG000|STARTED|Visit 4 to Extended Study Follow-up||615||
60077640|NCT01536405|76192576|FG001|STARTED|Visit 4 to Extended Study Follow-up||618||
60077641|NCT01536405|76192575|FG000|COMPLETED|Visit 4 to Extended Study Follow-up||595||
60077642|NCT01536405|76192576|FG001|COMPLETED|Visit 4 to Extended Study Follow-up||595||
60077643|NCT01536405|76192575|FG000|NOT COMPLETED|Visit 4 to Extended Study Follow-up||20||
60077644|NCT01536405|76192576|FG001|NOT COMPLETED|Visit 4 to Extended Study Follow-up||23||
60077645|NCT01487265|76192582|FG000|STARTED|Overall Study||37||
60077646|NCT01487265|76192582|FG000|COMPLETED|Overall Study||0||
60077647|NCT01487265|76192582|FG000|NOT COMPLETED|Overall Study||37||
60077648|NCT01485627|76192588|FG000|STARTED|Overall Study|139 patients and 105 caregivers|244||19
59545471|NCT01027910|75644261|FG001|COMPLETED|Overall Study||14||
60077649|NCT01485627|76192589|FG001|STARTED|Overall Study|142 patients and 99 caregivers|241||19
60077650|NCT01485627|76192588|FG000|Allocated Caregivers: Total|Overall Study||105||19
60077651|NCT01485627|76192589|FG001|Allocated Caregivers: Total|Overall Study||99||19
60077652|NCT01485627|76192588|FG000|Bereaved Caregivers: Total|Overall Study||63||19
60077653|NCT01485627|76192589|FG001|Bereaved Caregivers: Total|Overall Study||64||19
60077654|NCT01485627|76192588|FG000|Bereaved Caregivers: 1 Month|Overall Study||51||19
60077655|NCT01485627|76192589|FG001|Bereaved Caregivers: 1 Month|Overall Study||51||19
60077656|NCT01485627|76192588|FG000|Bereaved Caregivers: 2 Month Completed|Overall Study||49||19
60077657|NCT01485627|76192589|FG001|Bereaved Caregivers: 2 Month Completed|Overall Study||52||19
60077658|NCT01485627|76192588|FG000|Bereaved Caregivers: 7 Month Completed|Overall Study||48||19
60077659|NCT01485627|76192589|FG001|Bereaved Caregivers: 7 Month Completed|Overall Study||49||19
60077660|NCT01485627|76192588|FG000|COMPLETED|Overall Study|130 patients and 48 caregivers|178||19
60077661|NCT01485627|76192589|FG001|COMPLETED|Overall Study|135 patients and 49 caregivers|184||19
60077662|NCT01485627|76192588|FG000|NOT COMPLETED|Overall Study||66||0
60077663|NCT01485627|76192589|FG001|NOT COMPLETED|Overall Study||57||0
60077664|NCT02209636|76192601|FG000|STARTED|Main/Parent Study||32||
60077665|NCT02209636|76192602|FG001|STARTED|Main/Parent Study||29||
60077666|NCT02209636|76192601|FG000|COMPLETED|Main/Parent Study||27||
60077667|NCT02209636|76192602|FG001|COMPLETED|Main/Parent Study||27||
60077668|NCT02209636|76192601|FG000|NOT COMPLETED|Main/Parent Study||5||
60077669|NCT02209636|76192602|FG001|NOT COMPLETED|Main/Parent Study||2||
60077670|NCT02209636|76192601|FG000|STARTED|Balance Sub-study||7||
60077671|NCT02209636|76192602|FG001|STARTED|Balance Sub-study||8||
60077672|NCT02209636|76192601|FG000|COMPLETED|Balance Sub-study||6||
60077673|NCT02209636|76192602|FG001|COMPLETED|Balance Sub-study||8||
60077674|NCT02209636|76192601|FG000|NOT COMPLETED|Balance Sub-study||1||
60077675|NCT02209636|76192602|FG001|NOT COMPLETED|Balance Sub-study||0||
60077676|NCT01508325|76192612|FG000|STARTED|Overall Study||93||
60077677|NCT01508325|76192613|FG001|STARTED|Overall Study||93||
60077678|NCT01508325|76192612|FG000|COMPLETED|Overall Study||75||
60077679|NCT01508325|76192613|FG001|COMPLETED|Overall Study||72||
60077680|NCT01508325|76192612|FG000|NOT COMPLETED|Overall Study||18||
60077681|NCT01508325|76192613|FG001|NOT COMPLETED|Overall Study||21||
60077682|NCT01508169|76192621|FG000|STARTED|Overall Study||47||
60077683|NCT01508169|76192622|FG001|STARTED|Overall Study||47||
60077684|NCT01508169|76192621|FG000|COMPLETED|Overall Study||44||
60077685|NCT01508169|76192622|FG001|COMPLETED|Overall Study||45||
60077686|NCT01508169|76192621|FG000|NOT COMPLETED|Overall Study||3||
60077687|NCT01508169|76192622|FG001|NOT COMPLETED|Overall Study||2||
60077688|NCT01536171|76192634|FG000|STARTED|Overall Study||22||
60077689|NCT01536171|76192634|FG000|COMPLETED|Overall Study||21||
60077690|NCT01536171|76192634|FG000|NOT COMPLETED|Overall Study||1||
60077691|NCT01536093|76192641|FG000|STARTED|Overall Study||24||
60077692|NCT01536093|76192642|FG001|STARTED|Overall Study||24||
60077693|NCT01536093|76192641|FG000|COMPLETED|Overall Study||21||
60077694|NCT01536093|76192642|FG001|COMPLETED|Overall Study||21||
60077695|NCT01536093|76192641|FG000|NOT COMPLETED|Overall Study||3||
60077696|NCT01536093|76192642|FG001|NOT COMPLETED|Overall Study||3||
60077697|NCT01536015|76192650|FG000|STARTED|Overall Study||12||
60077698|NCT01536015|76192651|FG001|STARTED|Overall Study||13||
60077699|NCT01536015|76192650|FG000|COMPLETED|Overall Study||4||
60077700|NCT01536015|76192651|FG001|COMPLETED|Overall Study||3||
60077701|NCT01536015|76192650|FG000|NOT COMPLETED|Overall Study||8||
60077702|NCT01536015|76192651|FG001|NOT COMPLETED|Overall Study||10||
60077703|NCT01484691|76192660|FG000|STARTED|Overall Study||21||
60077704|NCT01484691|76192661|FG001|STARTED|Overall Study||22||
60077705|NCT01484691|76192662|FG002|STARTED|Overall Study||12||
60077706|NCT01484691|76192660|FG000|COMPLETED|Overall Study||20||
60077707|NCT01484691|76192661|FG001|COMPLETED|Overall Study||19||
60077708|NCT01484691|76192662|FG002|COMPLETED|Overall Study||10||
60077709|NCT01484691|76192660|FG000|NOT COMPLETED|Overall Study||1||
60077710|NCT01484691|76192661|FG001|NOT COMPLETED|Overall Study||3||
60077711|NCT01484691|76192662|FG002|NOT COMPLETED|Overall Study||2||
60077712|NCT01535235|76192673|FG000|STARTED|Overall Study||16||
59545472|NCT01027910|75644260|FG000|NOT COMPLETED|Overall Study||0||
59545473|NCT01027910|75644261|FG001|NOT COMPLETED|Overall Study||0||
60077713|NCT01535235|76192674|FG001|STARTED|Overall Study||15||
60077714|NCT01535235|76192673|FG000|COMPLETED|Overall Study||15||
60077715|NCT01535235|76192674|FG001|COMPLETED|Overall Study||15||
60077716|NCT01535235|76192673|FG000|NOT COMPLETED|Overall Study||1||
59545474|NCT01030406|75644274|FG000|STARTED|Overall Study||10||
59545475|NCT01030406|75644275|FG001|STARTED|Overall Study||10||
59545476|NCT01030406|75644276|FG002|STARTED|Overall Study||10||
60077717|NCT01535235|76192674|FG001|NOT COMPLETED|Overall Study||0||
60077718|NCT02168686|76192683|FG000|STARTED|Overall Study||2||
60077719|NCT02168686|76192684|FG001|STARTED|Overall Study||2||
60077720|NCT02168686|76192685|FG002|STARTED|Overall Study||2||
60077721|NCT02168686|76192683|FG000|COMPLETED|Overall Study||2||
60077722|NCT02168686|76192684|FG001|COMPLETED|Overall Study||2||
59545477|NCT01030406|75644277|FG003|STARTED|Overall Study||10||
59545478|NCT01030406|75644278|FG004|STARTED|Overall Study||9||
60077723|NCT02168686|76192685|FG002|COMPLETED|Overall Study||2||
60077724|NCT02168686|76192683|FG000|NOT COMPLETED|Overall Study||0||
60077725|NCT02168686|76192684|FG001|NOT COMPLETED|Overall Study||0||
60077726|NCT02168686|76192685|FG002|NOT COMPLETED|Overall Study||0||
60077727|NCT02317744|76192704|FG000|STARTED|Overall Study||12||
60077728|NCT02317744|76192705|FG001|STARTED|Overall Study||10||
60077729|NCT02317744|76192704|FG000|Completed Treatment|Overall Study||10||
60077730|NCT02317744|76192705|FG001|Completed Treatment|Overall Study||7||
60077731|NCT02317744|76192704|FG000|COMPLETED|Overall Study|One NB participant stopped the treatment but completed assessments.|11||
60077732|NCT02317744|76192705|FG001|COMPLETED|Overall Study|One Placebo participant stopped the treatment but completed assessments.|8||
60077733|NCT02317744|76192704|FG000|NOT COMPLETED|Overall Study||1||
60077734|NCT02317744|76192705|FG001|NOT COMPLETED|Overall Study||2||
60077735|NCT01483599|76192718|FG000|STARTED|Controlled Period (CP) (up to Week 16)||42||
60077736|NCT01483599|76192719|FG001|STARTED|Controlled Period (CP) (up to Week 16)||41||
60077737|NCT01483599|76192720|FG002|STARTED|Controlled Period (CP) (up to Week 16)||41||
59545479|NCT01030406|75644274|FG000|COMPLETED|Overall Study||10||
59545480|NCT01030406|75644275|FG001|COMPLETED|Overall Study||10||
59545481|NCT01030406|75644276|FG002|COMPLETED|Overall Study||9||
59545482|NCT01030406|75644277|FG003|COMPLETED|Overall Study||9||
59545483|NCT01030406|75644278|FG004|COMPLETED|Overall Study||9||
59545484|NCT01030406|75644274|FG000|NOT COMPLETED|Overall Study||0||
59545485|NCT01030406|75644275|FG001|NOT COMPLETED|Overall Study||0||
59545486|NCT01030406|75644276|FG002|NOT COMPLETED|Overall Study||1||
59545487|NCT01030406|75644277|FG003|NOT COMPLETED|Overall Study||1||
59545488|NCT01030406|75644278|FG004|NOT COMPLETED|Overall Study||0||
59545489|NCT00996164|75644292|FG000|STARTED|Overall Study||543||
59545490|NCT00996164|75644293|FG001|STARTED|Overall Study||547||
59545491|NCT00996164|75644292|FG000|COMPLETED|Overall Study||408||
59545492|NCT00996164|75644293|FG001|COMPLETED|Overall Study||446||
59545493|NCT00996164|75644292|FG000|NOT COMPLETED|Overall Study||135||
59545494|NCT00996164|75644293|FG001|NOT COMPLETED|Overall Study||101||
59545495|NCT01031420|75644299|FG000|STARTED|Overall Study||54||
59545496|NCT01031420|75644299|FG000|COMPLETED|Overall Study||44||
59545497|NCT01031420|75644299|FG000|NOT COMPLETED|Overall Study||10||
59545498|NCT01031498|75644306|FG000|STARTED|Overall Study|2 patients were not evaluable in arm 1.|49||
59545499|NCT01031498|75644307|FG001|STARTED|Overall Study|3 patients were not evaluable in arm 2|51||
59545500|NCT01031498|75644308|FG002|STARTED|Overall Study|2 patients were not evaluable in arm 3.|50||
59545501|NCT01031498|75644306|FG000|COMPLETED|Overall Study||47||
59545502|NCT01031498|75644307|FG001|COMPLETED|Overall Study||48||
59545503|NCT01031498|75644308|FG002|COMPLETED|Overall Study||48||
59545504|NCT01031498|75644306|FG000|NOT COMPLETED|Overall Study||2||
59545505|NCT01031498|75644307|FG001|NOT COMPLETED|Overall Study||3||
59545506|NCT01031498|75644308|FG002|NOT COMPLETED|Overall Study||2||
59545507|NCT01031810|75644316|FG000|STARTED|Overall Study||13||
59545508|NCT01031810|75644316|FG000|COMPLETED|Overall Study||9||
60077738|NCT01483599|76192721|FG003|STARTED|Controlled Period (CP) (up to Week 16)||42||
60077739|NCT01483599|76192722|FG004|STARTED|Controlled Period (CP) (up to Week 16)||42||
60077740|NCT01483599|76192723|FG005|STARTED|Controlled Period (CP) (up to Week 16)||42||
60077741|NCT01483599|76192724|FG006|STARTED|Controlled Period (CP) (up to Week 16)||43||
60077742|NCT01483599|76192725|FG007|STARTED|Controlled Period (CP) (up to Week 16)||0||
60077743|NCT01483599|76192726|FG008|STARTED|Controlled Period (CP) (up to Week 16)||0||
60077744|NCT01483599|76192727|FG009|STARTED|Controlled Period (CP) (up to Week 16)||0||
60077745|NCT01483599|76192728|FG010|STARTED|Controlled Period (CP) (up to Week 16)||0||
60077746|NCT01483599|76192729|FG011|STARTED|Controlled Period (CP) (up to Week 16)||0||
60077747|NCT01483599|76192730|FG012|STARTED|Controlled Period (CP) (up to Week 16)||0||
60077748|NCT01483599|76192731|FG013|STARTED|Controlled Period (CP) (up to Week 16)||0||
60077749|NCT01483599|76192718|FG000|Treated|Controlled Period (CP) (up to Week 16)||42||
60077750|NCT01483599|76192719|FG001|Treated|Controlled Period (CP) (up to Week 16)||41||
60077751|NCT01483599|76192720|FG002|Treated|Controlled Period (CP) (up to Week 16)||41||
59545509|NCT01031810|75644316|FG000|NOT COMPLETED|Overall Study||4||
59545510|NCT03426566|75644322|FG000|STARTED|Overall Study||974||1948
59545511|NCT03426566|75644322|FG000|COMPLETED|Overall Study||974||1948
59545512|NCT03426566|75644322|FG000|NOT COMPLETED|Overall Study||0||0
59545513|NCT00998426|75644328|FG000|STARTED|Overall Study||5||
59545514|NCT00998426|75644328|FG000|Blood Glucose Monitoring|Overall Study||5||
59545515|NCT00998426|75644328|FG000|COMPLETED|Overall Study||5||
59545516|NCT00998426|75644328|FG000|NOT COMPLETED|Overall Study||0||
59545517|NCT00998582|75644335|FG000|STARTED|Overall Study||13||
59545518|NCT00998582|75644336|FG001|STARTED|Overall Study||14||
59545519|NCT00998582|75644335|FG000|COMPLETED|Overall Study||13||
59545520|NCT00998582|75644336|FG001|COMPLETED|Overall Study||14||
59545521|NCT00998582|75644335|FG000|NOT COMPLETED|Overall Study||0||
59545522|NCT00998582|75644336|FG001|NOT COMPLETED|Overall Study||0||
59545523|NCT00998660|75644345|FG000|STARTED|Overall Study||100||
59545524|NCT00998660|75644345|FG000|Implanted|Overall Study||93||
59545525|NCT00998660|75644345|FG000|Month 3 Visit|Overall Study||87||
60077752|NCT01483599|76192721|FG003|Treated|Controlled Period (CP) (up to Week 16)||42||
60077753|NCT01483599|76192722|FG004|Treated|Controlled Period (CP) (up to Week 16)||42||
59815865|NCT02242760|75938264|FG001|Number of Subjects Excluded From ITT Population|Overall Study||0|One subject in the SB204 4% BID group was not dispensed study medication after randomization.|
59815866|NCT02242760|75938265|FG002|Number of Subjects Excluded From ITT Population|Overall Study||0|One subject in the SB204 4% BID group was not dispensed study medication after randomization.|
59545526|NCT00998660|75644345|FG000|COMPLETED|Overall Study|87 subjects reached the final study visit at Month 6.|87||
59545527|NCT00998660|75644345|FG000|NOT COMPLETED|Overall Study||13||
59545528|NCT00999830|75644351|FG000|STARTED|Overall Study||14||
59545529|NCT00999830|75644352|FG001|STARTED|Overall Study||13||
59545530|NCT00999830|75644351|FG000|COMPLETED|Overall Study||14||
59545531|NCT00999830|75644352|FG001|COMPLETED|Overall Study||13||
59545532|NCT00999830|75644351|FG000|NOT COMPLETED|Overall Study||0||
59545533|NCT00999830|75644352|FG001|NOT COMPLETED|Overall Study||0||
59545534|NCT01001078|75644360|FG000|STARTED|Overall Study||50||
59545535|NCT01001078|75644361|FG001|STARTED|Overall Study||50||
59545536|NCT01001078|75644360|FG000|Received Allocated Intervention|Overall Study||46||
59545537|NCT01001078|75644361|FG001|Received Allocated Intervention|Overall Study||46||
59545538|NCT01001078|75644360|FG000|Received Crossover|Overall Study||2||
59545539|NCT01001078|75644361|FG001|Received Crossover|Overall Study||3||
59545540|NCT01001078|75644360|FG000|Intubated|Overall Study||2||
59545541|NCT01001078|75644361|FG001|Intubated|Overall Study||1||
59545542|NCT01001078|75644360|FG000|Lost to Followup Interview|Overall Study|Could not be interviewed.|5||
59545543|NCT01001078|75644361|FG001|Lost to Followup Interview|Overall Study|Could not be interviewed.|2||
59545544|NCT01001078|75644360|FG000|COMPLETED|Overall Study|Analyzed: 46, excluded from interview analysis: 5|50||
59545545|NCT01001078|75644361|FG001|COMPLETED|Overall Study|Analyzed: 46, excluded from interview analysis: 2|50||
59545546|NCT01001078|75644360|FG000|NOT COMPLETED|Overall Study||0||
59545547|NCT01001078|75644361|FG001|NOT COMPLETED|Overall Study||0||
59545548|NCT02418000|75644374|FG000|STARTED|Cohort 1: E6201 240 mg/m^2 Weekly||7||
59545549|NCT02418000|75644375|FG001|STARTED|Cohort 1: E6201 240 mg/m^2 Weekly||0||
59545550|NCT02418000|75644376|FG002|STARTED|Cohort 1: E6201 240 mg/m^2 Weekly||0||
59545551|NCT02418000|75644377|FG003|STARTED|Cohort 1: E6201 240 mg/m^2 Weekly||0||
59545552|NCT02418000|75644378|FG004|STARTED|Cohort 1: E6201 240 mg/m^2 Weekly||0||
59545553|NCT02418000|75644374|FG000|COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0||
59545554|NCT02418000|75644375|FG001|COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0||
59545555|NCT02418000|75644376|FG002|COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0||
59545556|NCT02418000|75644377|FG003|COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0||
59545557|NCT02418000|75644378|FG004|COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0||
59545558|NCT02418000|75644374|FG000|NOT COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||7||
59545559|NCT02418000|75644375|FG001|NOT COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0||
59545560|NCT02418000|75644376|FG002|NOT COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0||
59545561|NCT02418000|75644377|FG003|NOT COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0||
59545562|NCT02418000|75644378|FG004|NOT COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0||
59545563|NCT02418000|75644374|FG000|STARTED|Cohort 2: E6201 320 mg/m^2 Weekly||0||
59545564|NCT02418000|75644375|FG001|STARTED|Cohort 2: E6201 320 mg/m^2 Weekly||10||
59545565|NCT02418000|75644376|FG002|STARTED|Cohort 2: E6201 320 mg/m^2 Weekly||0||
59545566|NCT02418000|75644377|FG003|STARTED|Cohort 2: E6201 320 mg/m^2 Weekly||0||
59545567|NCT02418000|75644378|FG004|STARTED|Cohort 2: E6201 320 mg/m^2 Weekly||0||
59545568|NCT02418000|75644374|FG000|COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0||
59545569|NCT02418000|75644375|FG001|COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0||
59545570|NCT02418000|75644376|FG002|COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0||
59545571|NCT02418000|75644377|FG003|COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0||
59545572|NCT02418000|75644378|FG004|COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0||
59545573|NCT02418000|75644374|FG000|NOT COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0||
59545574|NCT02418000|75644375|FG001|NOT COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||10||
59545575|NCT02418000|75644376|FG002|NOT COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0||
59545576|NCT02418000|75644377|FG003|NOT COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0||
59545577|NCT02418000|75644378|FG004|NOT COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0||
59545578|NCT02418000|75644374|FG000|STARTED|Cohort 3: 160 mg/m^2 Twice Weekly||0||
59545579|NCT02418000|75644375|FG001|STARTED|Cohort 3: 160 mg/m^2 Twice Weekly||0||
59545580|NCT02418000|75644376|FG002|STARTED|Cohort 3: 160 mg/m^2 Twice Weekly||3||
59545581|NCT02418000|75644377|FG003|STARTED|Cohort 3: 160 mg/m^2 Twice Weekly||0||
59545582|NCT02418000|75644378|FG004|STARTED|Cohort 3: 160 mg/m^2 Twice Weekly||0||
59545583|NCT02418000|75644374|FG000|COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0||
59545584|NCT02418000|75644375|FG001|COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0||
59545585|NCT02418000|75644376|FG002|COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0||
59545586|NCT02418000|75644377|FG003|COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0||
59545587|NCT02418000|75644378|FG004|COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0||
59545588|NCT02418000|75644374|FG000|NOT COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0||
59545589|NCT02418000|75644375|FG001|NOT COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0||
59545590|NCT02418000|75644376|FG002|NOT COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||3||
59545591|NCT02418000|75644377|FG003|NOT COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0||
59545592|NCT02418000|75644378|FG004|NOT COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0||
59545593|NCT02418000|75644374|FG000|STARTED|Cohort 4: 240 mg/m^2 Twice Weekly||0||
59668465|NCT03198078|75787262|FG000|Efficacy Sample|Overall Study||110|Efficacy sample included all randomized participants who received at least 1 dose of IMP, had a baseline assessment, and at least one post-baseline assessment of the Positive and Negative Syndrome Scale (PANSS) Total Score.|
59668466|NCT03198078|75787263|FG001|Efficacy Sample|Overall Study||101|Efficacy sample included all randomized participants who received at least 1 dose of IMP, had a baseline assessment, and at least one post-baseline assessment of the Positive and Negative Syndrome Scale (PANSS) Total Score.|
59668467|NCT03198078|75787264|FG002|Efficacy Sample|Overall Study||103|Efficacy sample included all randomized participants who received at least 1 dose of IMP, had a baseline assessment, and at least one post-baseline assessment of the Positive and Negative Syndrome Scale (PANSS) Total Score.|
59668468|NCT03198078|75787262|FG000|COMPLETED|Overall Study||107||
59668469|NCT03198078|75787263|FG001|COMPLETED|Overall Study||97||
59668470|NCT03198078|75787264|FG002|COMPLETED|Overall Study||92||
59668471|NCT03198078|75787262|FG000|NOT COMPLETED|Overall Study||3||
59668472|NCT03198078|75787263|FG001|NOT COMPLETED|Overall Study||5||
59668473|NCT03198078|75787264|FG002|NOT COMPLETED|Overall Study||12||
59668474|NCT02923193|75787276|FG000|STARTED|Overall Study||153||
59668475|NCT02923193|75787277|FG001|STARTED|Overall Study||153||
59668476|NCT02923193|75787276|FG000|COMPLETED|Overall Study||121||
59668477|NCT02923193|75787277|FG001|COMPLETED|Overall Study||121||
59668478|NCT02923193|75787276|FG000|NOT COMPLETED|Overall Study||32||
59668479|NCT02923193|75787277|FG001|NOT COMPLETED|Overall Study||32||
59668480|NCT02808650|75787288|FG000|STARTED|Overall Study||6||
59668481|NCT02808650|75787289|FG001|STARTED|Overall Study||6||
59668482|NCT02808650|75787290|FG002|STARTED|Overall Study||6||
59668483|NCT02808650|75787291|FG003|STARTED|Overall Study||6||
59668484|NCT02808650|75787292|FG004|STARTED|Overall Study||6||
59668485|NCT02808650|75787288|FG000|COMPLETED|Overall Study||0||
59668486|NCT02808650|75787289|FG001|COMPLETED|Overall Study||0||
59668487|NCT02808650|75787290|FG002|COMPLETED|Overall Study||0||
59668488|NCT02808650|75787291|FG003|COMPLETED|Overall Study||0||
59668489|NCT02808650|75787292|FG004|COMPLETED|Overall Study||0||
59668490|NCT02808650|75787288|FG000|NOT COMPLETED|Overall Study||6||
59668491|NCT02808650|75787289|FG001|NOT COMPLETED|Overall Study||6||
59668492|NCT02808650|75787290|FG002|NOT COMPLETED|Overall Study||6||
59668493|NCT02808650|75787291|FG003|NOT COMPLETED|Overall Study||6||
59668494|NCT02808650|75787292|FG004|NOT COMPLETED|Overall Study||6||
59668495|NCT02677896|75787307|FG000|STARTED|Double Blind Period (up to 35 Months)||574||
59668496|NCT02677896|75787308|FG001|STARTED|Double Blind Period (up to 35 Months)||576||
59668497|NCT02677896|75787307|FG000|Treated|Double Blind Period (up to 35 Months)||572||
59668498|NCT02677896|75787308|FG001|Treated|Double Blind Period (up to 35 Months)||574||
59668499|NCT02677896|75787307|FG000|COMPLETED|Double Blind Period (up to 35 Months)||0||
59668500|NCT02677896|75787308|FG001|COMPLETED|Double Blind Period (up to 35 Months)||0||
59668501|NCT02677896|75787307|FG000|NOT COMPLETED|Double Blind Period (up to 35 Months)||574||
59668502|NCT02677896|75787308|FG001|NOT COMPLETED|Double Blind Period (up to 35 Months)||576||
59668503|NCT02677896|75787307|FG000|STARTED|Open-Label Extension (up to 25 Months)|Eligible participants who provided consent took part in open-label period|365||
59668504|NCT02677896|75787308|FG001|STARTED|Open-Label Extension (up to 25 Months)|Eligible participants who provided consent took part in open-label period|180||
59668505|NCT02677896|75787307|FG000|COMPLETED|Open-Label Extension (up to 25 Months)||0||
59668506|NCT02677896|75787308|FG001|COMPLETED|Open-Label Extension (up to 25 Months)||0||
59668507|NCT02677896|75787307|FG000|NOT COMPLETED|Open-Label Extension (up to 25 Months)||365||
59668508|NCT02677896|75787308|FG001|NOT COMPLETED|Open-Label Extension (up to 25 Months)||180||
59668509|NCT02630693|75787317|FG000|STARTED|Overall Study||90||
59668510|NCT02630693|75787318|FG001|STARTED|Overall Study||90||
59668511|NCT02630693|75787317|FG000|COMPLETED|Overall Study||90||
59668512|NCT02630693|75787318|FG001|COMPLETED|Overall Study||89||
59668513|NCT02630693|75787317|FG000|NOT COMPLETED|Overall Study||0||
59668514|NCT02630693|75787318|FG001|NOT COMPLETED|Overall Study||1||
59668515|NCT02626338|75787327|FG000|STARTED|Overall Study||9||
59668516|NCT02626338|75787328|FG001|STARTED|Overall Study||6||
59668517|NCT02626338|75787329|FG002|STARTED|Overall Study||1||
59668518|NCT02626338|75787327|FG000|COMPLETED|Overall Study||6||
59668519|NCT02626338|75787328|FG001|COMPLETED|Overall Study||4||
59668520|NCT02626338|75787329|FG002|COMPLETED|Overall Study||1||
59668521|NCT02626338|75787327|FG000|NOT COMPLETED|Overall Study||3||
59668522|NCT02626338|75787328|FG001|NOT COMPLETED|Overall Study||2||
59668523|NCT02626338|75787329|FG002|NOT COMPLETED|Overall Study||0||
59668524|NCT02603146|75787341|FG000|STARTED|Overall Study||71||
59668525|NCT02603146|75787342|FG001|STARTED|Overall Study||73||
59668526|NCT02603146|75787341|FG000|COMPLETED|Overall Study||40||
59668527|NCT02603146|75787342|FG001|COMPLETED|Overall Study||39||
59668528|NCT02603146|75787341|FG000|NOT COMPLETED|Overall Study||31||
59668529|NCT02603146|75787342|FG001|NOT COMPLETED|Overall Study||34||
59668530|NCT02484859|75787350|FG000|STARTED|Overall Study||44||
59668531|NCT02484859|75787351|FG001|STARTED|Overall Study||44||
59668532|NCT02484859|75787350|FG000|COMPLETED|Overall Study||44||
59668533|NCT02484859|75787351|FG001|COMPLETED|Overall Study||44||
59668534|NCT02484859|75787350|FG000|NOT COMPLETED|Overall Study||0||
59668535|NCT02484859|75787351|FG001|NOT COMPLETED|Overall Study||0||
59668536|NCT02482870|75787359|FG000|STARTED|Overall Study||186|Period 1 started with the patient enrollment on 01.01.2014.|
59668537|NCT02482870|75787360|FG001|STARTED|Overall Study||202|Period 1 started with the patient enrollment on 01.01.2014.|
59668538|NCT02482870|75787359|FG000|COMPLETED|Overall Study||186|Period 1 ended on 21.01.2014.|
59668539|NCT02482870|75787360|FG001|COMPLETED|Overall Study||202|Period 1 ended on 21.01.2014.|
59668540|NCT02482870|75787359|FG000|NOT COMPLETED|Overall Study||0||
59668541|NCT02482870|75787360|FG001|NOT COMPLETED|Overall Study||0||
59668542|NCT02452918|75787376|FG000|STARTED|Overall Study||15||
59668543|NCT02452918|75787377|FG001|STARTED|Overall Study||2||
59668544|NCT02452918|75787376|FG000|Received at Least 1 Dose of Study Drug|Overall Study||15||
59668545|NCT02452918|75787377|FG001|Received at Least 1 Dose of Study Drug|Overall Study||2||
59668546|NCT02452918|75787376|FG000|COMPLETED|Overall Study||15||
59668547|NCT02452918|75787377|FG001|COMPLETED|Overall Study||2||
59668548|NCT02452918|75787376|FG000|NOT COMPLETED|Overall Study||0||
59668549|NCT02452918|75787377|FG001|NOT COMPLETED|Overall Study||0||
59668550|NCT02342691|75787386|FG000|STARTED|Overall Study||50||
59668551|NCT02342691|75787387|FG001|STARTED|Overall Study||50||
59668552|NCT02342691|75787388|FG002|STARTED|Overall Study|Per protocol, individuals who dropped out before Day 14 were replaced. 2 subjects were replaced.|27||
59668553|NCT02342691|75787386|FG000|COMPLETED|Overall Study||47||
59668554|NCT02342691|75787387|FG001|COMPLETED|Overall Study||49||
59668555|NCT02342691|75787388|FG002|COMPLETED|Overall Study||27||
59668556|NCT02342691|75787386|FG000|NOT COMPLETED|Overall Study||3||
59668557|NCT02342691|75787387|FG001|NOT COMPLETED|Overall Study||1||
59668558|NCT02342691|75787388|FG002|NOT COMPLETED|Overall Study||0||
59668559|NCT02332902|75787396|FG000|STARTED|Overall Study||24||
59668560|NCT02332902|75787396|FG000|Received Study Drug|Overall Study||22||
59668561|NCT02332902|75787396|FG000|COMPLETED|Overall Study||17||
59668562|NCT02332902|75787396|FG000|NOT COMPLETED|Overall Study||7||
59668563|NCT02324608|75787400|FG000|STARTED|Overall Study||15||
59668564|NCT02324608|75787400|FG000|COMPLETED|Overall Study||15||
59668565|NCT02324608|75787400|FG000|NOT COMPLETED|Overall Study||0||
59668566|NCT01750073|75787404|FG000|STARTED|Overall Study||92||
59668567|NCT01750073|75787404|FG000|HER2-positive|Overall Study||19||
59668568|NCT01750073|75787404|FG000|HER2-negative|Overall Study||73||
59668569|NCT01750073|75787404|FG000|COMPLETED|Overall Study||87||
59668570|NCT01750073|75787404|FG000|NOT COMPLETED|Overall Study||5||
59668571|NCT01723774|75787412|FG000|STARTED|Neoadjuvant||34||
59668572|NCT01723774|75787413|FG001|STARTED|Neoadjuvant||16||
59668573|NCT01723774|75787414|FG002|STARTED|Neoadjuvant||34||
59668574|NCT01723774|75787415|FG003|STARTED|Neoadjuvant||0||
59668575|NCT01723774|75787412|FG000|COMPLETED|Neoadjuvant||27||
59668576|NCT01723774|75787413|FG001|COMPLETED|Neoadjuvant||12||
59668577|NCT01723774|75787414|FG002|COMPLETED|Neoadjuvant||21||
59668578|NCT01723774|75787415|FG003|COMPLETED|Neoadjuvant||0||
59668579|NCT01723774|75787412|FG000|NOT COMPLETED|Neoadjuvant||7||
59668580|NCT01723774|75787413|FG001|NOT COMPLETED|Neoadjuvant||4||
59668581|NCT01723774|75787414|FG002|NOT COMPLETED|Neoadjuvant||13||
60077754|NCT01483599|76192723|FG005|Treated|Controlled Period (CP) (up to Week 16)||41||
60077755|NCT01483599|76192724|FG006|Treated|Controlled Period (CP) (up to Week 16)||43||
60077756|NCT01483599|76192725|FG007|Treated|Controlled Period (CP) (up to Week 16)||0||
60077757|NCT01483599|76192726|FG008|Treated|Controlled Period (CP) (up to Week 16)||0||
60077758|NCT01483599|76192727|FG009|Treated|Controlled Period (CP) (up to Week 16)||0||
60077759|NCT01483599|76192728|FG010|Treated|Controlled Period (CP) (up to Week 16)||0||
60077760|NCT01483599|76192729|FG011|Treated|Controlled Period (CP) (up to Week 16)||0||
60077761|NCT01483599|76192730|FG012|Treated|Controlled Period (CP) (up to Week 16)||0||
60077762|NCT01483599|76192731|FG013|Treated|Controlled Period (CP) (up to Week 16)||0||
59668582|NCT01723774|75787415|FG003|NOT COMPLETED|Neoadjuvant||0||
59668583|NCT01723774|75787412|FG000|STARTED|Adjuvant||0||
59668584|NCT01723774|75787413|FG001|STARTED|Adjuvant||0||
59668585|NCT01723774|75787414|FG002|STARTED|Adjuvant||0||
59668586|NCT01723774|75787415|FG003|STARTED|Adjuvant||7||
59668587|NCT01723774|75787412|FG000|COMPLETED|Adjuvant||0||
59668588|NCT01723774|75787413|FG001|COMPLETED|Adjuvant||0||
59668589|NCT01723774|75787414|FG002|COMPLETED|Adjuvant||0||
59668590|NCT01723774|75787415|FG003|COMPLETED|Adjuvant||7||
59668591|NCT01723774|75787412|FG000|NOT COMPLETED|Adjuvant||0||
59668592|NCT01723774|75787413|FG001|NOT COMPLETED|Adjuvant||0||
59668593|NCT01723774|75787414|FG002|NOT COMPLETED|Adjuvant||0||
59668594|NCT01723774|75787415|FG003|NOT COMPLETED|Adjuvant||0||
59668595|NCT01674140|75787427|FG000|STARTED|Overall Study||968||
59668596|NCT01674140|75787428|FG001|STARTED|Overall Study||971||
59668597|NCT01674140|75787427|FG000|COMPLETED|Overall Study||896||
59668598|NCT01674140|75787428|FG001|COMPLETED|Overall Study||896||
59668599|NCT01674140|75787427|FG000|NOT COMPLETED|Overall Study||72||
59668600|NCT01674140|75787428|FG001|NOT COMPLETED|Overall Study||75||
59668601|NCT01356628|75787434|FG000|STARTED|Overall Study||23||
59668602|NCT01356628|75787434|FG000|COMPLETED|Overall Study||23||
59668603|NCT01356628|75787434|FG000|NOT COMPLETED|Overall Study||0||
59668604|NCT01012817|75787452|FG000|STARTED|Overall Study||3||
59668605|NCT01012817|75787453|FG001|STARTED|Overall Study||3||
59668606|NCT01012817|75787454|FG002|STARTED|Overall Study||3||
59668607|NCT01012817|75787455|FG003|STARTED|Overall Study||4||
60077763|NCT01483599|76192718|FG000|COMPLETED|Controlled Period (CP) (up to Week 16)||39||
59668608|NCT01012817|75787456|FG004|STARTED|Overall Study||6||
59668609|NCT01012817|75787457|FG005|STARTED|Overall Study||7||
59668610|NCT01012817|75787458|FG006|STARTED|Overall Study||3||
59668611|NCT01012817|75787459|FG007|STARTED|Overall Study||4||
59668612|NCT01012817|75787460|FG008|STARTED|Overall Study||3||
59668613|NCT01012817|75787461|FG009|STARTED|Overall Study||6||
59668614|NCT01012817|75787462|FG010|STARTED|Overall Study||5||
59668615|NCT01012817|75787463|FG011|STARTED|Overall Study||7||
59668616|NCT01012817|75787464|FG012|STARTED|Overall Study||3||
59668617|NCT01012817|75787465|FG013|STARTED|Overall Study||31||
59668618|NCT01012817|75787452|FG000|COMPLETED|Overall Study||3||
59668619|NCT01012817|75787453|FG001|COMPLETED|Overall Study||3||
59668620|NCT01012817|75787454|FG002|COMPLETED|Overall Study||3||
59668621|NCT01012817|75787455|FG003|COMPLETED|Overall Study||3||
59668622|NCT01012817|75787456|FG004|COMPLETED|Overall Study||6||
59668623|NCT01012817|75787457|FG005|COMPLETED|Overall Study||6||
59668624|NCT01012817|75787458|FG006|COMPLETED|Overall Study||3||
59668625|NCT01012817|75787459|FG007|COMPLETED|Overall Study||3||
59668626|NCT01012817|75787460|FG008|COMPLETED|Overall Study||3||
59668627|NCT01012817|75787461|FG009|COMPLETED|Overall Study||6||
59668628|NCT01012817|75787462|FG010|COMPLETED|Overall Study||3||
59668629|NCT01012817|75787463|FG011|COMPLETED|Overall Study||6||
59668630|NCT01012817|75787464|FG012|COMPLETED|Overall Study||3||
59668631|NCT01012817|75787465|FG013|COMPLETED|Overall Study||29||
59668632|NCT01012817|75787452|FG000|NOT COMPLETED|Overall Study||0||
59668633|NCT01012817|75787453|FG001|NOT COMPLETED|Overall Study||0||
59668634|NCT01012817|75787454|FG002|NOT COMPLETED|Overall Study||0||
59668635|NCT01012817|75787455|FG003|NOT COMPLETED|Overall Study||1||
59668636|NCT01012817|75787456|FG004|NOT COMPLETED|Overall Study||0||
59668637|NCT01012817|75787457|FG005|NOT COMPLETED|Overall Study||1||
59668638|NCT01012817|75787458|FG006|NOT COMPLETED|Overall Study||0||
59668639|NCT01012817|75787459|FG007|NOT COMPLETED|Overall Study||1||
59668640|NCT01012817|75787460|FG008|NOT COMPLETED|Overall Study||0||
59668641|NCT01012817|75787461|FG009|NOT COMPLETED|Overall Study||0||
59668642|NCT01012817|75787462|FG010|NOT COMPLETED|Overall Study||2||
59668643|NCT01012817|75787463|FG011|NOT COMPLETED|Overall Study||1||
59668644|NCT01012817|75787464|FG012|NOT COMPLETED|Overall Study||0||
59668645|NCT01012817|75787465|FG013|NOT COMPLETED|Overall Study||2||
59668646|NCT00920582|75787499|FG000|STARTED|Overall Study||63||
59668647|NCT00920582|75787500|FG001|STARTED|Overall Study||66||
59668648|NCT00920582|75787501|FG002|STARTED|Overall Study||63||
59668649|NCT00920582|75787502|FG003|STARTED|Overall Study||62||
59668650|NCT00920582|75787499|FG000|COMPLETED|Overall Study||50||
59668651|NCT00920582|75787500|FG001|COMPLETED|Overall Study||60||
59668652|NCT00920582|75787501|FG002|COMPLETED|Overall Study||52||
59668653|NCT00920582|75787502|FG003|COMPLETED|Overall Study||57||
59668654|NCT00920582|75787499|FG000|NOT COMPLETED|Overall Study||13||
59668655|NCT00920582|75787500|FG001|NOT COMPLETED|Overall Study||6||
59668656|NCT00920582|75787501|FG002|NOT COMPLETED|Overall Study||11||
59668657|NCT00920582|75787502|FG003|NOT COMPLETED|Overall Study||5||
59668658|NCT00867048|75787514|FG000|STARTED|Overall Study||2326||
59668659|NCT00867048|75787515|FG001|STARTED|Overall Study||2362||
59668660|NCT00867048|75787514|FG000|COMPLETED|Overall Study||2325||
59668661|NCT00867048|75787515|FG001|COMPLETED|Overall Study||2359||
59668662|NCT00867048|75787514|FG000|NOT COMPLETED|Overall Study||1||
59668663|NCT00867048|75787515|FG001|NOT COMPLETED|Overall Study||3||
59668664|NCT04596085|75787525|FG000|STARTED|Overall Study||59||
59668665|NCT04596085|75787526|FG001|STARTED|Overall Study||59||
59668666|NCT04596085|75787525|FG000|COMPLETED|Overall Study||59||
59668667|NCT04596085|75787526|FG001|COMPLETED|Overall Study||59||
59668668|NCT04596085|75787525|FG000|NOT COMPLETED|Overall Study||0||
59668669|NCT04596085|75787526|FG001|NOT COMPLETED|Overall Study||0||
59668670|NCT04180163|75787534|FG000|STARTED|Run-in Period (4 or up to 8 Weeks)||12||
59668671|NCT04180163|75787534|FG000|COMPLETED|Run-in Period (4 or up to 8 Weeks)||12||
59668672|NCT04180163|75787534|FG000|NOT COMPLETED|Run-in Period (4 or up to 8 Weeks)||0||
59668673|NCT04180163|75787534|FG000|STARTED|Treatment Period A (Weeks 1 to 26)||12||
59817916|NCT04488770|75940329|FG003|STARTED|Part 1-Cohort 2: Period 2 (Up to 5 Days)||0||
59668674|NCT04180163|75787534|FG000|COMPLETED|Treatment Period A (Weeks 1 to 26)||12|Completion of Treatment Period A was defined as completion of any of the Day 182 visit assessments.|
59668675|NCT04180163|75787534|FG000|NOT COMPLETED|Treatment Period A (Weeks 1 to 26)||0||
59668676|NCT04180163|75787534|FG000|STARTED|Treatment Period B (Weeks 27 to 52)||12||
59668677|NCT04180163|75787534|FG000|COMPLETED|Treatment Period B (Weeks 27 to 52)||12|Completion of Treatment Period B was defined as completion of any of the Day 364 visit assessments.|
59668678|NCT04180163|75787534|FG000|NOT COMPLETED|Treatment Period B (Weeks 27 to 52)||0||
59668679|NCT04180163|75787534|FG000|STARTED|Safety Follow-up Period (Weeks 53 to 56)||12|Participants who rolled over to TAK-743-5007 (NCT04687137) had a 2-week follow-up while others had 4 weeks of follow-up.|
59668680|NCT04180163|75787534|FG000|COMPLETED|Safety Follow-up Period (Weeks 53 to 56)||12||
59668681|NCT04180163|75787534|FG000|NOT COMPLETED|Safety Follow-up Period (Weeks 53 to 56)||0||
59668682|NCT00199888|75787551|FG000|STARTED|Overall Study||26||
59668683|NCT00199888|75787551|FG000|COMPLETED|Overall Study||25||
59668684|NCT00199888|75787551|FG000|NOT COMPLETED|Overall Study||1||
59668685|NCT00199849|75787558|FG000|STARTED|Overall Study||3||
59668686|NCT00199849|75787559|FG001|STARTED|Overall Study||7||
59668687|NCT00199849|75787560|FG002|STARTED|Overall Study||8||
59668688|NCT00199849|75787558|FG000|COMPLETED|Overall Study||3||
59668689|NCT00199849|75787559|FG001|COMPLETED|Overall Study||6||
59668690|NCT00199849|75787560|FG002|COMPLETED|Overall Study||6||
59668691|NCT00199849|75787558|FG000|NOT COMPLETED|Overall Study||0||
59668692|NCT00199849|75787559|FG001|NOT COMPLETED|Overall Study||1||
59668693|NCT00199849|75787560|FG002|NOT COMPLETED|Overall Study||2||
59668694|NCT00199381|75787568|FG000|STARTED|Overall Study||504||
59668695|NCT00199381|75787568|FG000|COMPLETED|Overall Study|Premature study termination by the Sponsor.|0||
59668696|NCT00199381|75787568|FG000|NOT COMPLETED|Overall Study||504||
59668697|NCT00198133|75787574|FG000|STARTED|Overall Study||16||
59668698|NCT00198133|75787575|FG001|STARTED|Overall Study||11||
59668699|NCT00198133|75787574|FG000|COMPLETED|Overall Study||11||
59668700|NCT00198133|75787575|FG001|COMPLETED|Overall Study||3||
59668701|NCT00198133|75787574|FG000|NOT COMPLETED|Overall Study||5||
59668702|NCT00198133|75787575|FG001|NOT COMPLETED|Overall Study||8||
59668703|NCT00197236|75787584|FG000|STARTED|Overall Study||135||
59668704|NCT00197236|75787585|FG001|STARTED|Overall Study||127||
59668705|NCT00197236|75787586|FG002|STARTED|Overall Study||132||
59668706|NCT00197236|75787584|FG000|COMPLETED|Overall Study||121||
59668707|NCT00197236|75787585|FG001|COMPLETED|Overall Study||110||
59668708|NCT00197236|75787586|FG002|COMPLETED|Overall Study||109||
59668709|NCT00197236|75787584|FG000|NOT COMPLETED|Overall Study||14||
59668710|NCT00197236|75787585|FG001|NOT COMPLETED|Overall Study||17||
59668711|NCT00197236|75787586|FG002|NOT COMPLETED|Overall Study||23||
59668712|NCT00197002|75787600|FG000|STARTED|Overall Study||147||
59668713|NCT00197002|75787601|FG001|STARTED|Overall Study||137||
59668714|NCT00197002|75787602|FG002|STARTED|Overall Study||149||
59668715|NCT00197002|75787600|FG000|COMPLETED|Overall Study||125||
59668716|NCT00197002|75787601|FG001|COMPLETED|Overall Study||119||
59668717|NCT00197002|75787602|FG002|COMPLETED|Overall Study||132||
59668718|NCT00197002|75787600|FG000|NOT COMPLETED|Overall Study||22||
59668719|NCT00197002|75787601|FG001|NOT COMPLETED|Overall Study||18||
59668720|NCT00197002|75787602|FG002|NOT COMPLETED|Overall Study||17||
59668721|NCT00196105|75787616|FG000|STARTED|Overall Study||64||
59668722|NCT00196105|75787617|FG001|STARTED|Overall Study||88||
59668723|NCT00196105|75787618|FG002|STARTED|Overall Study||89||
59668724|NCT00196105|75787616|FG000|COMPLETED|Overall Study||60||
59668725|NCT00196105|75787617|FG001|COMPLETED|Overall Study||83||
59668726|NCT00196105|75787618|FG002|COMPLETED|Overall Study||82||
59668727|NCT00196105|75787616|FG000|NOT COMPLETED|Overall Study||4||
59668728|NCT00196105|75787617|FG001|NOT COMPLETED|Overall Study||5||
59668729|NCT00196105|75787618|FG002|NOT COMPLETED|Overall Study||7||
59668730|NCT00195715|75787626|FG000|STARTED|Overall Study||777||
59668731|NCT00195715|75787626|FG000|COMPLETED|Overall Study||400||
59668732|NCT00195715|75787626|FG000|NOT COMPLETED|Overall Study||377||
59668733|NCT00195676|75787630|FG000|STARTED|Period O - Open-label Treatment|Number receiving adalimumab in Period O (1 additional participant enrolled but did not receive drug)|1468||
59668734|NCT00195676|75787630|FG000|COMPLETED|Period O - Open-label Treatment|254 Period O completers did not consent or were not eligible to continue into Period W and Period R.|862||
59668735|NCT00195676|75787630|FG000|NOT COMPLETED|Period O - Open-label Treatment||606||
59668736|NCT00195676|75787630|FG000|STARTED|Period W (Withdrawal) - No Treatment|Period O completers with a Physician's Global Assessment =<2 who continued into Periods W and R.|608||
59668737|NCT00195676|75787630|FG000|COMPLETED|Period W (Withdrawal) - No Treatment|Non-completers may have entered Period R, whether or not they relapsed (PGA >= 3).|0||
60077764|NCT01483599|76192719|FG001|COMPLETED|Controlled Period (CP) (up to Week 16)||38||
60077765|NCT01483599|76192720|FG002|COMPLETED|Controlled Period (CP) (up to Week 16)||41||
60077766|NCT01483599|76192721|FG003|COMPLETED|Controlled Period (CP) (up to Week 16)||39||
60077767|NCT01483599|76192722|FG004|COMPLETED|Controlled Period (CP) (up to Week 16)||40||
60077768|NCT01483599|76192723|FG005|COMPLETED|Controlled Period (CP) (up to Week 16)||38||
60077769|NCT01483599|76192724|FG006|COMPLETED|Controlled Period (CP) (up to Week 16)||39||
60077770|NCT01483599|76192725|FG007|COMPLETED|Controlled Period (CP) (up to Week 16)||0||
59668738|NCT00195676|75787630|FG000|NOT COMPLETED|Period W (Withdrawal) - No Treatment||608||
59668739|NCT00195676|75787630|FG000|STARTED|Period R - Retreatment 16 Weeks|Number who entered from Period W, including those who did and did not relapse in that period.|525||
59668740|NCT00195676|75787630|FG000|COMPLETED|Period R - Retreatment 16 Weeks||490||
59668741|NCT00195676|75787630|FG000|NOT COMPLETED|Period R - Retreatment 16 Weeks||35||
59668742|NCT00194077|75787640|FG000|STARTED|Overall Study||30||
59668743|NCT00194077|75787641|FG001|STARTED|Overall Study||30||
59668744|NCT00194077|75787640|FG000|COMPLETED|Overall Study|"Lack of efficacy:~Hypomania n=12 Cycling n=5 Mixed state=4 Mania n=1"|6||
59668745|NCT00194077|75787641|FG001|COMPLETED|Overall Study|"Lack of efficacy:~hypomania n=17 Cycling n=6 Mania n=5 Mixed state n=1 Concern regarding tx n=1"|0||
59668746|NCT00194077|75787640|FG000|NOT COMPLETED|Overall Study||24||
59668747|NCT00194077|75787641|FG001|NOT COMPLETED|Overall Study||30||
59668748|NCT00193609|75787647|FG000|STARTED|Overall Study||48||
59668749|NCT00193609|75787647|FG000|COMPLETED|Overall Study||44||
59668750|NCT00193609|75787647|FG000|NOT COMPLETED|Overall Study||4||
59668751|NCT00193180|75787651|FG000|STARTED|Overall Study||37||
60077771|NCT01483599|76192726|FG008|COMPLETED|Controlled Period (CP) (up to Week 16)||0||
60077772|NCT01483599|76192727|FG009|COMPLETED|Controlled Period (CP) (up to Week 16)||0||
59668752|NCT00193180|75787651|FG000|COMPLETED|Overall Study||27||
59668753|NCT00193180|75787651|FG000|NOT COMPLETED|Overall Study||10||
59668754|NCT00193063|75787656|FG000|STARTED|Overall Study||41||
59668755|NCT00193063|75787656|FG000|COMPLETED|Overall Study||37||
59668756|NCT00193063|75787656|FG000|NOT COMPLETED|Overall Study||4||
59668757|NCT00191854|75787663|FG000|STARTED|Overall Study||49||
59668758|NCT00191854|75787664|FG001|STARTED|Overall Study||47||
59668759|NCT00191854|75787665|FG002|STARTED|Overall Study||51||
59668760|NCT00191854|75787663|FG000|Received at Least One Dose of Study Drug|Overall Study||49||
59668761|NCT00191854|75787664|FG001|Received at Least One Dose of Study Drug|Overall Study||47||
59668762|NCT00191854|75787665|FG002|Received at Least One Dose of Study Drug|Overall Study|Screen failure: discontinued prior to receiving study drug.|50||
59668763|NCT00191854|75787663|FG000|COMPLETED|Overall Study||12||
59668764|NCT00191854|75787664|FG001|COMPLETED|Overall Study||17||
59668765|NCT00191854|75787665|FG002|COMPLETED|Overall Study||12||
59668766|NCT00191854|75787663|FG000|NOT COMPLETED|Overall Study||37||
59668767|NCT00191854|75787664|FG001|NOT COMPLETED|Overall Study||30||
59668768|NCT00191854|75787665|FG002|NOT COMPLETED|Overall Study||39||
59668769|NCT00191815|75787673|FG000|STARTED|Overall Study||70||
59668770|NCT00191815|75787673|FG000|Treated|Overall Study||67||
59668771|NCT00191815|75787673|FG000|COMPLETED|Overall Study||30||
59668772|NCT00191815|75787673|FG000|NOT COMPLETED|Overall Study||40||
59668773|NCT00191386|75787677|FG000|STARTED|Overall Study||228||
59668774|NCT00191386|75787677|FG000|6 Months|Overall Study||183||
59668775|NCT00191386|75787677|FG000|12 Months|Overall Study||149||
59668776|NCT00191386|75787677|FG000|2 Years|Overall Study||105||
59668777|NCT00191386|75787677|FG000|3 Years|Overall Study||65||
59668778|NCT00191386|75787677|FG000|COMPLETED|Overall Study||68||
59668779|NCT00191386|75787677|FG000|NOT COMPLETED|Overall Study||160||
59668780|NCT00191308|75787681|FG000|STARTED|Overall Study||30||
59668781|NCT00191308|75787681|FG000|COMPLETED|Overall Study||29||
59668782|NCT00191308|75787681|FG000|NOT COMPLETED|Overall Study||1||
59668783|NCT00191269|75787687|FG000|STARTED|Overall Study||6||
59668784|NCT00191269|75787688|FG001|STARTED|Overall Study||62||
59668785|NCT00191269|75787687|FG000|COMPLETED|Overall Study||0||
59668786|NCT00191269|75787688|FG001|COMPLETED|Overall Study||4||
59668787|NCT00191269|75787687|FG000|NOT COMPLETED|Overall Study||6||
59668788|NCT00191269|75787688|FG001|NOT COMPLETED|Overall Study||58||
59545594|NCT02418000|75644375|FG001|STARTED|Cohort 4: 240 mg/m^2 Twice Weekly||0||
59668789|NCT00191191|75787697|FG000|STARTED|Overall Study||114||
59668790|NCT00191191|75787698|FG001|STARTED|Overall Study||112||
59668791|NCT00191191|75787697|FG000|Safety Analysis Population|Overall Study||114||
59668792|NCT00191191|75787698|FG001|Safety Analysis Population|Overall Study||111||
59668793|NCT00191191|75787697|FG000|Full Analysis Set Population|Overall Study||108||
59668794|NCT00191191|75787698|FG001|Full Analysis Set Population|Overall Study||108||
59817917|NCT04488770|75940330|FG004|STARTED|Part 1-Cohort 2: Period 2 (Up to 5 Days)||2||
59545595|NCT02418000|75644376|FG002|STARTED|Cohort 4: 240 mg/m^2 Twice Weekly||0||
59545596|NCT02418000|75644377|FG003|STARTED|Cohort 4: 240 mg/m^2 Twice Weekly||3||
59545597|NCT02418000|75644378|FG004|STARTED|Cohort 4: 240 mg/m^2 Twice Weekly||0||
59545598|NCT02418000|75644374|FG000|COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0||
59545599|NCT02418000|75644375|FG001|COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0||
59545600|NCT02418000|75644376|FG002|COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0||
59545601|NCT02418000|75644377|FG003|COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0||
59545602|NCT02418000|75644378|FG004|COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0||
59545603|NCT02418000|75644374|FG000|NOT COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0||
59545604|NCT02418000|75644375|FG001|NOT COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0||
59545605|NCT02418000|75644376|FG002|NOT COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0||
59545606|NCT02418000|75644377|FG003|NOT COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||3||
59545607|NCT02418000|75644378|FG004|NOT COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0||
59545608|NCT02418000|75644374|FG000|STARTED|Cohort 5: 320 mg/m^2 Twice Weekly||0||
59545609|NCT02418000|75644375|FG001|STARTED|Cohort 5: 320 mg/m^2 Twice Weekly||0||
59545610|NCT02418000|75644376|FG002|STARTED|Cohort 5: 320 mg/m^2 Twice Weekly||0||
59545611|NCT02418000|75644377|FG003|STARTED|Cohort 5: 320 mg/m^2 Twice Weekly||0||
59668795|NCT00191191|75787697|FG000|COMPLETED|Overall Study||0||
59668796|NCT00191191|75787698|FG001|COMPLETED|Overall Study||0||
59668797|NCT00191191|75787697|FG000|NOT COMPLETED|Overall Study||114||
59668798|NCT00191191|75787698|FG001|NOT COMPLETED|Overall Study||112||
59668799|NCT00191152|75787706|FG000|STARTED|Initial Treatment||239||
59668800|NCT00191152|75787707|FG001|STARTED|Initial Treatment||236||
59668801|NCT00191152|75787706|FG000|Received Initial Treatment|Initial Treatment||236||
59668802|NCT00191152|75787707|FG001|Received Initial Treatment|Initial Treatment||227||
59668803|NCT00191152|75787706|FG000|COMPLETED|Initial Treatment||98||
59668804|NCT00191152|75787707|FG001|COMPLETED|Initial Treatment||83||
59668805|NCT00191152|75787706|FG000|NOT COMPLETED|Initial Treatment||141||
59668806|NCT00191152|75787707|FG001|NOT COMPLETED|Initial Treatment||153||
59668807|NCT00191152|75787706|FG000|STARTED|Crossover Treatment||77||
59668808|NCT00191152|75787707|FG001|STARTED|Crossover Treatment||81||
59668809|NCT00191152|75787706|FG000|Received Treatment|Crossover Treatment||76||
59668810|NCT00191152|75787707|FG001|Received Treatment|Crossover Treatment||80||
59668811|NCT00191152|75787706|FG000|COMPLETED|Crossover Treatment||50||
59668812|NCT00191152|75787707|FG001|COMPLETED|Crossover Treatment||53||
59668813|NCT00191152|75787706|FG000|NOT COMPLETED|Crossover Treatment||27||
59668814|NCT00191152|75787707|FG001|NOT COMPLETED|Crossover Treatment||28||
59668815|NCT00190684|75787725|FG000|STARTED|Overall Study||1553||
59668816|NCT00190684|75787725|FG000|Received at Least 1 Dose of Study Drug|Overall Study|1553 patients entered the study; 1551 were enrolled and received study drug.|1551||
59668817|NCT00190684|75787725|FG000|COMPLETED|Overall Study|Number of patients that completed overall study (through Period VI)|64||
59668818|NCT00190684|75787725|FG000|NOT COMPLETED|Overall Study||1489||
59668819|NCT00193219|75787729|FG000|STARTED|Overall Study||36||
59668820|NCT00193219|75787729|FG000|COMPLETED|Overall Study||6||
59668821|NCT00193219|75787729|FG000|NOT COMPLETED|Overall Study||30||
59668822|NCT00179959|75787736|FG000|STARTED|Overall Study||15||
59668823|NCT00179959|75787737|FG001|STARTED|Overall Study||16||
59668824|NCT00179959|75787736|FG000|COMPLETED|Overall Study||9||
59668825|NCT00179959|75787737|FG001|COMPLETED|Overall Study||13||
59668826|NCT00179959|75787736|FG000|NOT COMPLETED|Overall Study||6||
59668827|NCT00179959|75787737|FG001|NOT COMPLETED|Overall Study||3||
59668828|NCT00179647|75787743|FG000|STARTED|Overall Study||1913||
59668829|NCT00179647|75787743|FG000|COMPLETED|Overall Study|Subjects participated in study until they presented with reason for discontinuation.|0||
59668830|NCT00179647|75787743|FG000|NOT COMPLETED|Overall Study||1913||
59668831|NCT00179413|75787749|FG000|STARTED|Overall Study||282||
59668832|NCT00179413|75787750|FG001|STARTED|Overall Study||267||
59668833|NCT00179413|75787749|FG000|COMPLETED|Overall Study||157||
59668834|NCT00179413|75787750|FG001|COMPLETED|Overall Study||152||
59668835|NCT00179413|75787749|FG000|NOT COMPLETED|Overall Study||125||
59668836|NCT00179413|75787750|FG001|NOT COMPLETED|Overall Study||115||
59668837|NCT00178633|75787756|FG000|STARTED|Overall Study||43||
59668838|NCT00178633|75787756|FG000|COMPLETED|Overall Study||37||
59668839|NCT00178633|75787756|FG000|NOT COMPLETED|Overall Study||6||
59668840|NCT00178399|75787761|FG000|STARTED|Overall Study||128||
59668841|NCT00178399|75787761|FG000|COMPLETED|Overall Study||115||
59668842|NCT00178399|75787761|FG000|NOT COMPLETED|Overall Study||13||
59668843|NCT00178126|75787768|FG000|STARTED|Overall Study||119||
59668844|NCT00178126|75787769|FG001|STARTED|Overall Study||113||
59668845|NCT00178126|75787768|FG000|COMPLETED|Overall Study||94||
59668846|NCT00178126|75787769|FG001|COMPLETED|Overall Study||86||
59668847|NCT00178126|75787768|FG000|NOT COMPLETED|Overall Study||25||
59668848|NCT00178126|75787769|FG001|NOT COMPLETED|Overall Study||27||
59668849|NCT00177307|75787775|FG000|STARTED|Overall Study||40||
59668850|NCT00177307|75787775|FG000|COMPLETED|Overall Study||39||
59668851|NCT00177307|75787775|FG000|NOT COMPLETED|Overall Study||1||
59668852|NCT02484664|75787779|FG000|STARTED|Overall Study||12||
59668853|NCT02484664|75787779|FG000|COMPLETED|Overall Study||9||
59668854|NCT02484664|75787779|FG000|NOT COMPLETED|Overall Study||3||
59668855|NCT00176605|75787783|FG000|STARTED|Overall Study||15||
59668856|NCT00176605|75787783|FG000|COMPLETED|Overall Study||13||
59668857|NCT00176605|75787783|FG000|NOT COMPLETED|Overall Study||2||
59668858|NCT00176488|75787787|FG000|STARTED|Overall Study||31||
59668859|NCT00176488|75787787|FG000|COMPLETED|Overall Study||30||
59668860|NCT00176488|75787787|FG000|NOT COMPLETED|Overall Study||1||
59668861|NCT00175825|75787795|FG000|STARTED|Overall Study||54||
59668862|NCT00175825|75787796|FG001|STARTED|Overall Study||50||
59668863|NCT00175825|75787797|FG002|STARTED|Overall Study||52||
59668864|NCT00175825|75787798|FG003|STARTED|Overall Study||52||
59668865|NCT00175825|75787795|FG000|COMPLETED|Overall Study||49||
59668866|NCT00175825|75787796|FG001|COMPLETED|Overall Study||46||
59668867|NCT00175825|75787797|FG002|COMPLETED|Overall Study||51||
59668868|NCT00175825|75787798|FG003|COMPLETED|Overall Study||51||
59668869|NCT00175825|75787795|FG000|NOT COMPLETED|Overall Study||5||
59668870|NCT00175825|75787796|FG001|NOT COMPLETED|Overall Study||4||
59668871|NCT00175825|75787797|FG002|NOT COMPLETED|Overall Study||1||
59668872|NCT00175825|75787798|FG003|NOT COMPLETED|Overall Study||1||
59668873|NCT00174967|75787812|FG000|STARTED|Overall Study||37||
59668874|NCT00174967|75787813|FG001|STARTED|Overall Study||40||
59668875|NCT00174967|75787814|FG002|STARTED|Overall Study||38||
59668876|NCT00174967|75787815|FG003|STARTED|Overall Study||38||
59668877|NCT00174967|75787812|FG000|COMPLETED|Overall Study||36||
59668878|NCT00174967|75787813|FG001|COMPLETED|Overall Study||37||
59668879|NCT00174967|75787814|FG002|COMPLETED|Overall Study||36||
59668880|NCT00174967|75787815|FG003|COMPLETED|Overall Study||36||
59668881|NCT00174967|75787812|FG000|NOT COMPLETED|Overall Study||1||
59668882|NCT00174967|75787813|FG001|NOT COMPLETED|Overall Study||3||
59668883|NCT00174967|75787814|FG002|NOT COMPLETED|Overall Study||2||
59668884|NCT00174967|75787815|FG003|NOT COMPLETED|Overall Study||2||
59668885|NCT00174265|75787827|FG000|STARTED|Overall Study|85 participants received randomized treatment assignment and at least one dose of study medication.|86||
59668886|NCT00174265|75787828|FG001|STARTED|Overall Study||110||
59668887|NCT00174265|75787827|FG000|COMPLETED|Overall Study||57||
59668888|NCT00174265|75787828|FG001|COMPLETED|Overall Study||89||
59668889|NCT00174265|75787827|FG000|NOT COMPLETED|Overall Study||29||
59668890|NCT00174265|75787828|FG001|NOT COMPLETED|Overall Study||21||
59668891|NCT00172042|75787836|FG000|STARTED|Overall Study||226||
59668892|NCT00172042|75787837|FG001|STARTED|Overall Study||211||
59668893|NCT00172042|75787836|FG000|COMPLETED|Overall Study||68||
59668894|NCT00172042|75787837|FG001|COMPLETED|Overall Study||86||
59668895|NCT00172042|75787836|FG000|NOT COMPLETED|Overall Study||158||
59668896|NCT00172042|75787837|FG001|NOT COMPLETED|Overall Study||125||
59668897|NCT00171925|75787845|FG000|STARTED|Overall Study||72||
59668898|NCT00171925|75787846|FG001|STARTED|Overall Study||71||
59668899|NCT00171925|75787845|FG000|COMPLETED|Overall Study||42||
59668900|NCT00171925|75787846|FG001|COMPLETED|Overall Study||40||
59668901|NCT00171925|75787845|FG000|NOT COMPLETED|Overall Study||30||
59668902|NCT00171925|75787846|FG001|NOT COMPLETED|Overall Study||31||
59668903|NCT00171340|75787854|FG000|STARTED|Overall Study||532||
59668904|NCT00171340|75787855|FG001|STARTED|Overall Study||533||
59668905|NCT00171340|75787854|FG000|COMPLETED|Overall Study||408||
59668906|NCT00171340|75787855|FG001|COMPLETED|Overall Study||398||
59668907|NCT00171340|75787854|FG000|NOT COMPLETED|Overall Study||124||
59668908|NCT00171340|75787855|FG001|NOT COMPLETED|Overall Study||135||
59668909|NCT00171301|75787865|FG000|STARTED|Overall Study||162||
59668910|NCT00171301|75787866|FG001|STARTED|Overall Study|2 participants in this group never received deferasirox.|71||
59668911|NCT00171301|75787865|FG000|Received Deferasirox|Overall Study||162||
59668912|NCT00171301|75787866|FG001|Received Deferasirox|Overall Study||69||
59668913|NCT00171301|75787865|FG000|COMPLETED|Overall Study||154||
59668914|NCT00171301|75787866|FG001|COMPLETED|Overall Study||62||
59668915|NCT00171301|75787865|FG000|NOT COMPLETED|Overall Study||8||
59668916|NCT00171301|75787866|FG001|NOT COMPLETED|Overall Study||9||
59668917|NCT00171223|75787876|FG000|STARTED|Overall Study||152||
59668918|NCT00171223|75787877|FG001|STARTED|Overall Study||188||
59668919|NCT00171223|75787878|FG002|STARTED|Overall Study||192||
59668920|NCT00171223|75787876|FG000|COMPLETED|Overall Study||12|Disposition data is reported till end of study.|
59668921|NCT00171223|75787877|FG001|COMPLETED|Overall Study||47|Disposition data is reported till end of study.|
59668922|NCT00171223|75787878|FG002|COMPLETED|Overall Study||22|Disposition data is reported till end of study.|
59668923|NCT00171223|75787876|FG000|NOT COMPLETED|Overall Study||140||
59668924|NCT00171223|75787877|FG001|NOT COMPLETED|Overall Study||141||
59668925|NCT00171223|75787878|FG002|NOT COMPLETED|Overall Study||170||
59668926|NCT00479674|75787884|FG000|STARTED|Overall Study||41||
59668927|NCT00479674|75787884|FG000|COMPLETED|Overall Study||0||
59668928|NCT00479674|75787884|FG000|NOT COMPLETED|Overall Study||41||
59668929|NCT00479401|75787891|FG000|STARTED|Overall Study||223||
59668930|NCT00479401|75787892|FG001|STARTED|Overall Study||213||
59668931|NCT00479401|75787893|FG002|STARTED|Overall Study||103||
59668932|NCT00479401|75787891|FG000|COMPLETED|Overall Study||174||
59668933|NCT00479401|75787892|FG001|COMPLETED|Overall Study||176||
59668934|NCT00479401|75787893|FG002|COMPLETED|Overall Study||91||
59668935|NCT00479401|75787891|FG000|NOT COMPLETED|Overall Study||49||
59668936|NCT00479401|75787892|FG001|NOT COMPLETED|Overall Study||37||
59668937|NCT00479401|75787893|FG002|NOT COMPLETED|Overall Study||12||
59668938|NCT00478777|75787901|FG000|STARTED|Overall Study||150||
59668939|NCT00478777|75787901|FG000|Safety and Full Analysis Set (FAS)|Overall Study|6 enrolled participants did not receive lenalidomide.|144||
59668940|NCT00478777|75787901|FG000|COMPLETED|Overall Study|10 participants had >= 6 months and 63 participants < 6 months treatment prior to study termination.|73||
59668941|NCT00478777|75787901|FG000|NOT COMPLETED|Overall Study||77||
59668942|NCT00477607|75787907|FG000|STARTED|Overall Study||19||
59668943|NCT00477607|75787908|FG001|STARTED|Overall Study||20||
59668944|NCT00477607|75787907|FG000|COMPLETED|Overall Study||12||
59668945|NCT00477607|75787908|FG001|COMPLETED|Overall Study||13||
59668946|NCT00477607|75787907|FG000|NOT COMPLETED|Overall Study||7||
59668947|NCT00477607|75787908|FG001|NOT COMPLETED|Overall Study||7||
59668948|NCT00477490|75787919|FG000|STARTED|Part I: 4 Week Efficacy||160||
59668949|NCT00477490|75787920|FG001|STARTED|Part I: 4 Week Efficacy||163||
59668950|NCT00477490|75787921|FG002|STARTED|Part I: 4 Week Efficacy||158||
59668951|NCT00477490|75787922|FG003|STARTED|Part I: 4 Week Efficacy||158||
59668952|NCT00477490|75787923|FG004|STARTED|Part I: 4 Week Efficacy||160||
59668953|NCT00477490|75787924|FG005|STARTED|Part I: 4 Week Efficacy||0||
59668954|NCT00477490|75787925|FG006|STARTED|Part I: 4 Week Efficacy||0||
59668955|NCT00477490|75787926|FG007|STARTED|Part I: 4 Week Efficacy||0||
59668956|NCT00477490|75787927|FG008|STARTED|Part I: 4 Week Efficacy||0||
59668957|NCT00477490|75787919|FG000|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|156||
59668958|NCT00477490|75787920|FG001|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|155||
59668959|NCT00477490|75787921|FG002|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|152||
60077773|NCT01483599|76192728|FG010|COMPLETED|Controlled Period (CP) (up to Week 16)||0||
60077774|NCT01483599|76192729|FG011|COMPLETED|Controlled Period (CP) (up to Week 16)||0||
60077775|NCT01483599|76192730|FG012|COMPLETED|Controlled Period (CP) (up to Week 16)||0||
60077776|NCT01483599|76192731|FG013|COMPLETED|Controlled Period (CP) (up to Week 16)||0||
60077777|NCT01483599|76192718|FG000|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||3||
60077778|NCT01483599|76192719|FG001|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||3||
60077779|NCT01483599|76192720|FG002|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0||
60077780|NCT01483599|76192721|FG003|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||3||
60077781|NCT01483599|76192722|FG004|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||2||
59668960|NCT00477490|75787922|FG003|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|148||
59668961|NCT00477490|75787923|FG004|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|146||
59668962|NCT00477490|75787924|FG005|ITT Population|Part I: 4 Week Efficacy||0||
59668963|NCT00477490|75787925|FG006|ITT Population|Part I: 4 Week Efficacy||0||
59668964|NCT00477490|75787926|FG007|ITT Population|Part I: 4 Week Efficacy||0||
59668965|NCT00477490|75787927|FG008|ITT Population|Part I: 4 Week Efficacy||0||
59668966|NCT00477490|75787919|FG000|COMPLETED|Part I: 4 Week Efficacy||145||
59668967|NCT00477490|75787920|FG001|COMPLETED|Part I: 4 Week Efficacy||144||
59668968|NCT00477490|75787921|FG002|COMPLETED|Part I: 4 Week Efficacy||148||
59668969|NCT00477490|75787922|FG003|COMPLETED|Part I: 4 Week Efficacy||138||
59668970|NCT00477490|75787923|FG004|COMPLETED|Part I: 4 Week Efficacy||135||
59668971|NCT00477490|75787924|FG005|COMPLETED|Part I: 4 Week Efficacy||0||
59668972|NCT00477490|75787925|FG006|COMPLETED|Part I: 4 Week Efficacy||0||
59668973|NCT00477490|75787926|FG007|COMPLETED|Part I: 4 Week Efficacy||0||
59668974|NCT00477490|75787927|FG008|COMPLETED|Part I: 4 Week Efficacy||0||
59668975|NCT00477490|75787919|FG000|NOT COMPLETED|Part I: 4 Week Efficacy||15||
59668976|NCT00477490|75787920|FG001|NOT COMPLETED|Part I: 4 Week Efficacy||19||
59668977|NCT00477490|75787921|FG002|NOT COMPLETED|Part I: 4 Week Efficacy||10||
59668978|NCT00477490|75787922|FG003|NOT COMPLETED|Part I: 4 Week Efficacy||20||
59668979|NCT00477490|75787923|FG004|NOT COMPLETED|Part I: 4 Week Efficacy||25||
59668980|NCT00477490|75787924|FG005|NOT COMPLETED|Part I: 4 Week Efficacy||0||
59668981|NCT00477490|75787925|FG006|NOT COMPLETED|Part I: 4 Week Efficacy||0||
59668982|NCT00477490|75787926|FG007|NOT COMPLETED|Part I: 4 Week Efficacy||0||
59668983|NCT00477490|75787927|FG008|NOT COMPLETED|Part I: 4 Week Efficacy||0||
59668984|NCT00477490|75787919|FG000|STARTED|Part II: Extension Week 5 up to Day 169||0||
59668985|NCT00477490|75787920|FG001|STARTED|Part II: Extension Week 5 up to Day 169||135||
59668986|NCT00477490|75787921|FG002|STARTED|Part II: Extension Week 5 up to Day 169||135||
59668987|NCT00477490|75787922|FG003|STARTED|Part II: Extension Week 5 up to Day 169||132||
59668988|NCT00477490|75787923|FG004|STARTED|Part II: Extension Week 5 up to Day 169||127||
59668989|NCT00477490|75787924|FG005|STARTED|Part II: Extension Week 5 up to Day 169||31||
59668990|NCT00477490|75787925|FG006|STARTED|Part II: Extension Week 5 up to Day 169||37||
59668991|NCT00477490|75787926|FG007|STARTED|Part II: Extension Week 5 up to Day 169||34||
59668992|NCT00477490|75787927|FG008|STARTED|Part II: Extension Week 5 up to Day 169||34||
59668993|NCT00477490|75787919|FG000|COMPLETED|Part II: Extension Week 5 up to Day 169||0||
59668994|NCT00477490|75787920|FG001|COMPLETED|Part II: Extension Week 5 up to Day 169||107||
59668995|NCT00477490|75787921|FG002|COMPLETED|Part II: Extension Week 5 up to Day 169||120||
59668996|NCT00477490|75787922|FG003|COMPLETED|Part II: Extension Week 5 up to Day 169||120||
59668997|NCT00477490|75787923|FG004|COMPLETED|Part II: Extension Week 5 up to Day 169||107||
59668998|NCT00477490|75787924|FG005|COMPLETED|Part II: Extension Week 5 up to Day 169||25||
59668999|NCT00477490|75787925|FG006|COMPLETED|Part II: Extension Week 5 up to Day 169||32||
59669000|NCT00477490|75787926|FG007|COMPLETED|Part II: Extension Week 5 up to Day 169||29||
59669001|NCT00477490|75787927|FG008|COMPLETED|Part II: Extension Week 5 up to Day 169||26||
60077782|NCT01483599|76192723|FG005|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||4||
60077783|NCT01483599|76192724|FG006|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||4||
60077784|NCT01483599|76192725|FG007|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0||
60077785|NCT01483599|76192726|FG008|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0||
60077786|NCT01483599|76192727|FG009|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0||
59545612|NCT02418000|75644378|FG004|STARTED|Cohort 5: 320 mg/m^2 Twice Weekly||4||
59545613|NCT02418000|75644374|FG000|COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0||
59545614|NCT02418000|75644375|FG001|COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0||
59545615|NCT02418000|75644376|FG002|COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0||
59545616|NCT02418000|75644377|FG003|COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0||
59545617|NCT02418000|75644378|FG004|COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0||
59545618|NCT02418000|75644374|FG000|NOT COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0||
59545619|NCT02418000|75644375|FG001|NOT COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0||
59545620|NCT02418000|75644376|FG002|NOT COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0||
59545621|NCT02418000|75644377|FG003|NOT COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0||
59669002|NCT00477490|75787919|FG000|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||0||
59669003|NCT00477490|75787920|FG001|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||28||
59669004|NCT00477490|75787921|FG002|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||15||
59669005|NCT00477490|75787922|FG003|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||12||
59669006|NCT00477490|75787923|FG004|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||20||
59669007|NCT00477490|75787924|FG005|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||6||
59669008|NCT00477490|75787925|FG006|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||5||
59669009|NCT00477490|75787926|FG007|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||5||
59669010|NCT00477490|75787927|FG008|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||8||
59669011|NCT00477334|75787957|FG000|STARTED|Overall Study||312||
59669012|NCT00477334|75787958|FG001|STARTED|Overall Study||151||
59669013|NCT00477334|75787957|FG000|Randomized and Took Study Drug|Overall Study||206||
59669014|NCT00477334|75787958|FG001|Randomized and Took Study Drug|Overall Study||98||
59669015|NCT00477334|75787957|FG000|Intent to Treat Population|Overall Study||201||
59669016|NCT00477334|75787958|FG001|Intent to Treat Population|Overall Study||98||
59669017|NCT00477334|75787957|FG000|Participants Completing First Recurrence|Overall Study||187||
59669018|NCT00477334|75787958|FG001|Participants Completing First Recurrence|Overall Study||92||
59669019|NCT00477334|75787957|FG000|Modified Intent to Treat Population|Overall Study||152||
59669020|NCT00477334|75787958|FG001|Modified Intent to Treat Population|Overall Study||78||
59669021|NCT00477334|75787957|FG000|COMPLETED|Overall Study|Participants completing the first recurrence and follow-up.|142||
59669022|NCT00477334|75787958|FG001|COMPLETED|Overall Study|Participants completing the first recurrence and follow-up.|75||
59669023|NCT00477334|75787957|FG000|NOT COMPLETED|Overall Study||170||
59669024|NCT00477334|75787958|FG001|NOT COMPLETED|Overall Study||76||
59669025|NCT04548622|75787968|FG000|STARTED|Overall Study||15||
59669026|NCT04548622|75787968|FG000|COMPLETED|Overall Study||15||
59669027|NCT04548622|75787968|FG000|NOT COMPLETED|Overall Study||0||
59669028|NCT04555525|75787974|FG000|STARTED|Overall Study||75||
59669029|NCT04555525|75787975|FG001|STARTED|Overall Study||25||
59669030|NCT04555525|75787974|FG000|COMPLETED|Overall Study||72||
59669031|NCT04555525|75787975|FG001|COMPLETED|Overall Study||25||
59669032|NCT04555525|75787974|FG000|NOT COMPLETED|Overall Study||3||
60077787|NCT01483599|76192728|FG010|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0||
60077788|NCT01483599|76192729|FG011|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0||
60077789|NCT01483599|76192730|FG012|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0||
59669033|NCT04555525|75787975|FG001|NOT COMPLETED|Overall Study||0||
59669034|NCT04540627|75787984|FG000|STARTED|Open-label Treatment: PK Sentinel|Participants were not enrolled in this arm in the double-blind period.|6||
59669035|NCT04540627|75787985|FG001|STARTED|Open-label Treatment: PK Sentinel|Participants were not enrolled in this arm in the open-label period.|0||
59669036|NCT04540627|75787986|FG002|STARTED|Open-label Treatment: PK Sentinel|Participants were not enrolled in this arm in the open-label period.|0||
59545622|NCT02418000|75644378|FG004|NOT COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||4||
59545623|NCT01001546|75644404|FG000|STARTED|Overall Study||206||
59545624|NCT01001546|75644405|FG001|STARTED|Overall Study||207||
59545625|NCT01001546|75644404|FG000|COMPLETED|Overall Study||206||
59545626|NCT01001546|75644405|FG001|COMPLETED|Overall Study||207||
59545627|NCT01001546|75644404|FG000|NOT COMPLETED|Overall Study||0||
59545628|NCT01001546|75644405|FG001|NOT COMPLETED|Overall Study||0||
59545629|NCT02168660|75644414|FG000|STARTED|Overall Study||38||
59545630|NCT02168660|75644415|FG001|STARTED|Overall Study||35||
59545631|NCT02168660|75644416|FG002|STARTED|Overall Study||36||
59545632|NCT02168660|75644414|FG000|COMPLETED|Overall Study||22||
59545633|NCT02168660|75644415|FG001|COMPLETED|Overall Study||18||
59669037|NCT04540627|75787984|FG000|COMPLETED|Open-label Treatment: PK Sentinel||6||
59669038|NCT04540627|75787985|FG001|COMPLETED|Open-label Treatment: PK Sentinel||0||
59669039|NCT04540627|75787986|FG002|COMPLETED|Open-label Treatment: PK Sentinel||0||
59669040|NCT04540627|75787984|FG000|NOT COMPLETED|Open-label Treatment: PK Sentinel||0||
59669041|NCT04540627|75787985|FG001|NOT COMPLETED|Open-label Treatment: PK Sentinel||0||
59669042|NCT04540627|75787986|FG002|NOT COMPLETED|Open-label Treatment: PK Sentinel||0||
59669043|NCT04540627|75787984|FG000|STARTED|Double-blind Treatment: Viral Challenge|Participants were not enrolled in this arm in the double-blind period.|0||
59669044|NCT04540627|75787985|FG001|STARTED|Double-blind Treatment: Viral Challenge|Participants were not enrolled in this arm in the open-label period.|25||
59669045|NCT04540627|75787986|FG002|STARTED|Double-blind Treatment: Viral Challenge|Participants were not enrolled in this arm in the open-label period.|25||
59669046|NCT04540627|75787984|FG000|COMPLETED|Double-blind Treatment: Viral Challenge||0||
59669047|NCT04540627|75787985|FG001|COMPLETED|Double-blind Treatment: Viral Challenge||25||
59669048|NCT04540627|75787986|FG002|COMPLETED|Double-blind Treatment: Viral Challenge||25||
59669049|NCT04540627|75787984|FG000|NOT COMPLETED|Double-blind Treatment: Viral Challenge||0||
59669050|NCT04540627|75787985|FG001|NOT COMPLETED|Double-blind Treatment: Viral Challenge||0||
59669051|NCT04540627|75787986|FG002|NOT COMPLETED|Double-blind Treatment: Viral Challenge||0||
59815867|NCT02242760|75938266|FG003|Number of Subjects Excluded From ITT Population|Overall Study||0|One subject in the SB204 4% BID group was not dispensed study medication after randomization.|
59545634|NCT02168660|75644416|FG002|COMPLETED|Overall Study||21||
59545635|NCT02168660|75644414|FG000|NOT COMPLETED|Overall Study||16||
59669052|NCT04544566|75788003|FG000|STARTED|Overall Study||2||
59669053|NCT04544566|75788004|FG001|STARTED|Overall Study||2||
59669054|NCT04544566|75788005|FG002|STARTED|Overall Study||2||
59669055|NCT04544566|75788006|FG003|STARTED|Overall Study||2||
59669056|NCT04544566|75788007|FG004|STARTED|Overall Study||2||
59669057|NCT04544566|75788008|FG005|STARTED|Overall Study||2||
59669058|NCT04544566|75788003|FG000|COMPLETED|Overall Study||2||
59669059|NCT04544566|75788004|FG001|COMPLETED|Overall Study||2||
59669060|NCT04544566|75788005|FG002|COMPLETED|Overall Study||2||
59669061|NCT04544566|75788006|FG003|COMPLETED|Overall Study||2||
59545636|NCT02168660|75644415|FG001|NOT COMPLETED|Overall Study||17||
59545637|NCT02168660|75644416|FG002|NOT COMPLETED|Overall Study||15||
59545638|NCT01003106|75644431|FG000|STARTED|Baseline to Month 6||22||
59545639|NCT01003106|75644432|FG001|STARTED|Baseline to Month 6||20||
59545640|NCT01003106|75644433|FG002|STARTED|Baseline to Month 6||0||
59545641|NCT01003106|75644434|FG003|STARTED|Baseline to Month 6||0||
59669062|NCT04544566|75788007|FG004|COMPLETED|Overall Study||2||
59669063|NCT04544566|75788008|FG005|COMPLETED|Overall Study||2||
59669064|NCT04544566|75788003|FG000|NOT COMPLETED|Overall Study||0||
59669065|NCT04544566|75788004|FG001|NOT COMPLETED|Overall Study||0||
59669066|NCT04544566|75788005|FG002|NOT COMPLETED|Overall Study||0||
59669067|NCT04544566|75788006|FG003|NOT COMPLETED|Overall Study||0||
59669068|NCT04544566|75788007|FG004|NOT COMPLETED|Overall Study||0||
59669069|NCT04544566|75788008|FG005|NOT COMPLETED|Overall Study||0||
59669070|NCT04540510|75788024|FG000|STARTED|Overall Study||5||
59669071|NCT04540510|75788025|FG001|STARTED|Overall Study||6||
59669072|NCT04540510|75788024|FG000|COMPLETED|Overall Study||5||
59669073|NCT04540510|75788025|FG001|COMPLETED|Overall Study||6||
59669074|NCT04540510|75788024|FG000|NOT COMPLETED|Overall Study||0||
59669075|NCT04540510|75788025|FG001|NOT COMPLETED|Overall Study||0||
59669076|NCT04542226|75788031|FG000|STARTED|Overall Study||81||
59669077|NCT04542226|75788031|FG000|COMPLETED|Overall Study||81||
59669078|NCT04542226|75788031|FG000|NOT COMPLETED|Overall Study||0||
59669079|NCT04536727|75788037|FG000|STARTED|Overall Study||13||
59669080|NCT04536727|75788038|FG001|STARTED|Overall Study||15||
59669081|NCT04536727|75788037|FG000|COMPLETED|Overall Study||12||
59669082|NCT04536727|75788038|FG001|COMPLETED|Overall Study||13||
59669083|NCT04536727|75788037|FG000|NOT COMPLETED|Overall Study||1||
59669084|NCT04536727|75788038|FG001|NOT COMPLETED|Overall Study||2||
59669085|NCT04534465|75788044|FG000|STARTED|Overall Study||10||
59669086|NCT04534465|75788045|FG001|STARTED|Overall Study||10||
59669087|NCT04534465|75788046|FG002|STARTED|Overall Study||10||
59669088|NCT04534465|75788047|FG003|STARTED|Overall Study||10||
59669089|NCT04534465|75788048|FG004|STARTED|Overall Study||10||
59669090|NCT04534465|75788044|FG000|COMPLETED|Overall Study||10||
59669091|NCT04534465|75788045|FG001|COMPLETED|Overall Study||10||
59669092|NCT04534465|75788046|FG002|COMPLETED|Overall Study||10||
59669093|NCT04534465|75788047|FG003|COMPLETED|Overall Study||10||
59669094|NCT04534465|75788048|FG004|COMPLETED|Overall Study||10||
59669095|NCT04534465|75788044|FG000|NOT COMPLETED|Overall Study||0||
59669096|NCT04534465|75788045|FG001|NOT COMPLETED|Overall Study||0||
59669097|NCT04534465|75788046|FG002|NOT COMPLETED|Overall Study||0||
59669098|NCT04534465|75788047|FG003|NOT COMPLETED|Overall Study||0||
59669099|NCT04534465|75788048|FG004|NOT COMPLETED|Overall Study||0||
59669100|NCT04533685|75788069|FG000|STARTED|Overall Study||17848||
59669101|NCT04533685|75788070|FG001|STARTED|Overall Study||17842||
59669102|NCT04533685|75788071|FG002|STARTED|Overall Study||17832||
59669103|NCT04533685|75788072|FG003|STARTED|Overall Study||17827||
59669104|NCT04533685|75788073|FG004|STARTED|Overall Study||17821||
59817934|NCT04488770|75940334|FG008|COMPLETED|Part 1-Cohort 2: Period 2 (Up to 5 Days)||0||
59989218|NCT00151775|76104469|FG008|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0||
59989219|NCT00151775|76104470|FG009|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0||
59989220|NCT00151775|76104471|FG010|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0||
59989221|NCT00151775|76104472|FG011|NOT COMPLETED|Period 3: Double-blind, Withdrawal||1||
59545642|NCT01003106|75644435|FG004|STARTED|Baseline to Month 6||19||
59545643|NCT01003106|75644436|FG005|STARTED|Baseline to Month 6||20||
59545644|NCT01003106|75644437|FG006|STARTED|Baseline to Month 6||0||
59669105|NCT04533685|75788074|FG005|STARTED|Overall Study||17819||
59669106|NCT04533685|75788075|FG006|STARTED|Overall Study||17812||
59669107|NCT04533685|75788076|FG007|STARTED|Overall Study||17805||
59989222|NCT00151775|76104461|FG000|STARTED|Period 4: Open Label||0||
59545645|NCT01003106|75644438|FG007|STARTED|Baseline to Month 6||0||
59545646|NCT01003106|75644431|FG000|COMPLETED|Baseline to Month 6||22||
59545647|NCT01003106|75644432|FG001|COMPLETED|Baseline to Month 6||20||
59545648|NCT01003106|75644433|FG002|COMPLETED|Baseline to Month 6||0||
59545649|NCT01003106|75644434|FG003|COMPLETED|Baseline to Month 6||0||
59669108|NCT04533685|75788077|FG008|STARTED|Overall Study||71167||
59669109|NCT04533685|75788069|FG000|COMPLETED|Overall Study||17848||
59669110|NCT04533685|75788070|FG001|COMPLETED|Overall Study||17842||
59669111|NCT04533685|75788071|FG002|COMPLETED|Overall Study||17832||
59669112|NCT04533685|75788072|FG003|COMPLETED|Overall Study||17827||
59669113|NCT04533685|75788073|FG004|COMPLETED|Overall Study||17821||
59669114|NCT04533685|75788074|FG005|COMPLETED|Overall Study||17819||
59669115|NCT04533685|75788075|FG006|COMPLETED|Overall Study||17812||
59669116|NCT04533685|75788076|FG007|COMPLETED|Overall Study||17805||
59669117|NCT04533685|75788077|FG008|COMPLETED|Overall Study||71167||
59669118|NCT04533685|75788069|FG000|NOT COMPLETED|Overall Study||0||
59669119|NCT04533685|75788070|FG001|NOT COMPLETED|Overall Study||0||
59669120|NCT04533685|75788071|FG002|NOT COMPLETED|Overall Study||0||
59669121|NCT04533685|75788072|FG003|NOT COMPLETED|Overall Study||0||
59669122|NCT04533685|75788073|FG004|NOT COMPLETED|Overall Study||0||
59669123|NCT04533685|75788074|FG005|NOT COMPLETED|Overall Study||0||
59669124|NCT04533685|75788075|FG006|NOT COMPLETED|Overall Study||0||
59669125|NCT04533685|75788076|FG007|NOT COMPLETED|Overall Study||0||
59669126|NCT04533685|75788077|FG008|NOT COMPLETED|Overall Study||0||
59669127|NCT04971967|75788099|FG000|STARTED|Overall Study||81||
59669128|NCT04971967|75788100|FG001|STARTED|Overall Study||40||
59669129|NCT04971967|75788099|FG000|COMPLETED|Overall Study||75||
59669130|NCT04971967|75788100|FG001|COMPLETED|Overall Study||33||
59669131|NCT04971967|75788099|FG000|NOT COMPLETED|Overall Study||6||
59669132|NCT04971967|75788100|FG001|NOT COMPLETED|Overall Study||7||
59669133|NCT04902144|75788107|FG000|STARTED|Overall Study||6||
59669134|NCT04902144|75788107|FG000|COMPLETED|Overall Study||6||
59669135|NCT04902144|75788107|FG000|NOT COMPLETED|Overall Study||0||
59669136|NCT04716881|75788114|FG000|STARTED|Overall Study||9||
59669137|NCT04716881|75788114|FG000|COMPLETED|Overall Study||7||
59669138|NCT04716881|75788114|FG000|NOT COMPLETED|Overall Study||2||
59669139|NCT04652479|75788120|FG000|STARTED|Run-in Period (14 Days)||25||
59669140|NCT04652479|75788121|FG001|STARTED|Run-in Period (14 Days)||0||
59669141|NCT04652479|75788122|FG002|STARTED|Run-in Period (14 Days)||0||
59669142|NCT04652479|75788120|FG000|COMPLETED|Run-in Period (14 Days)||25||
59669143|NCT04652479|75788121|FG001|COMPLETED|Run-in Period (14 Days)||0||
59669144|NCT04652479|75788122|FG002|COMPLETED|Run-in Period (14 Days)||0||
59669145|NCT04652479|75788120|FG000|NOT COMPLETED|Run-in Period (14 Days)||0||
59669146|NCT04652479|75788121|FG001|NOT COMPLETED|Run-in Period (14 Days)||0||
59669147|NCT04652479|75788122|FG002|NOT COMPLETED|Run-in Period (14 Days)||0||
59669148|NCT04652479|75788120|FG000|STARTED|Treatment Period 1 (14 Days)||0||
59669149|NCT04652479|75788121|FG001|STARTED|Treatment Period 1 (14 Days)||8||
59669150|NCT04652479|75788122|FG002|STARTED|Treatment Period 1 (14 Days)||9||
59669151|NCT04652479|75788120|FG000|COMPLETED|Treatment Period 1 (14 Days)||0||
60077790|NCT01483599|76192731|FG013|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0||
60077791|NCT01483599|76192718|FG000|STARTED|After Controlled Period(Week 16-Week 40)||0||
60077792|NCT01483599|76192719|FG001|STARTED|After Controlled Period(Week 16-Week 40)||0||
60077793|NCT01483599|76192720|FG002|STARTED|After Controlled Period(Week 16-Week 40)||0||
59669152|NCT04652479|75788121|FG001|COMPLETED|Treatment Period 1 (14 Days)||8||
59669153|NCT04652479|75788122|FG002|COMPLETED|Treatment Period 1 (14 Days)||9||
59669154|NCT04652479|75788120|FG000|NOT COMPLETED|Treatment Period 1 (14 Days)||0||
59669155|NCT04652479|75788121|FG001|NOT COMPLETED|Treatment Period 1 (14 Days)||0||
59669156|NCT04652479|75788122|FG002|NOT COMPLETED|Treatment Period 1 (14 Days)||0||
59669157|NCT04652479|75788120|FG000|STARTED|Washout Period (2 Days)||0||
59669158|NCT04652479|75788121|FG001|STARTED|Washout Period (2 Days)||8||
59669159|NCT04652479|75788122|FG002|STARTED|Washout Period (2 Days)||9||
59669160|NCT04652479|75788120|FG000|COMPLETED|Washout Period (2 Days)||0||
59669161|NCT04652479|75788121|FG001|COMPLETED|Washout Period (2 Days)||8||
59669162|NCT04652479|75788122|FG002|COMPLETED|Washout Period (2 Days)||9||
59669163|NCT04652479|75788120|FG000|NOT COMPLETED|Washout Period (2 Days)||0||
59669164|NCT04652479|75788121|FG001|NOT COMPLETED|Washout Period (2 Days)||0||
59669165|NCT04652479|75788122|FG002|NOT COMPLETED|Washout Period (2 Days)||0||
59669166|NCT04652479|75788120|FG000|STARTED|Treatment Period 2 (14 Days||0||
59669167|NCT04652479|75788121|FG001|STARTED|Treatment Period 2 (14 Days||8||
60077794|NCT01483599|76192721|FG003|STARTED|After Controlled Period(Week 16-Week 40)||0||
60077795|NCT01483599|76192722|FG004|STARTED|After Controlled Period(Week 16-Week 40)||0||
59669168|NCT04652479|75788122|FG002|STARTED|Treatment Period 2 (14 Days||9||
59669169|NCT04652479|75788120|FG000|Completed Both Interventions With no Major Protocol Deviations|Treatment Period 2 (14 Days||0||
59669170|NCT04652479|75788121|FG001|Completed Both Interventions With no Major Protocol Deviations|Treatment Period 2 (14 Days||8||
59669171|NCT04652479|75788122|FG002|Completed Both Interventions With no Major Protocol Deviations|Treatment Period 2 (14 Days||8||
59669172|NCT04652479|75788120|FG000|COMPLETED|Treatment Period 2 (14 Days||0||
59669173|NCT04652479|75788121|FG001|COMPLETED|Treatment Period 2 (14 Days||8||
59669174|NCT04652479|75788122|FG002|COMPLETED|Treatment Period 2 (14 Days||9||
59669175|NCT04652479|75788120|FG000|NOT COMPLETED|Treatment Period 2 (14 Days||0||
59669176|NCT04652479|75788121|FG001|NOT COMPLETED|Treatment Period 2 (14 Days||0||
59669177|NCT04652479|75788122|FG002|NOT COMPLETED|Treatment Period 2 (14 Days||0||
59669178|NCT04582266|75788131|FG000|STARTED|Overall Study||26||
59669179|NCT04582266|75788132|FG001|STARTED|Overall Study||28||
59669180|NCT04582266|75788131|FG000|Received RDV|Overall Study||25||
59669181|NCT04582266|75788132|FG001|Received RDV|Overall Study||28||
59669182|NCT04582266|75788131|FG000|COMPLETED|Overall Study||17||
59669183|NCT04582266|75788132|FG001|COMPLETED|Overall Study||23||
59669184|NCT04582266|75788131|FG000|NOT COMPLETED|Overall Study||9||
59669185|NCT04582266|75788132|FG001|NOT COMPLETED|Overall Study||5||
59669186|NCT04521920|75788138|FG000|STARTED|Overall Study||17||
59669187|NCT04521920|75788138|FG000|Month 3|Overall Study||13||
59669188|NCT04521920|75788138|FG000|COMPLETED|Overall Study||12||
59669189|NCT04521920|75788138|FG000|NOT COMPLETED|Overall Study||5||
59669190|NCT04459338|75788142|FG000|STARTED|Overall Study||5||
59669191|NCT04459338|75788143|FG001|STARTED|Overall Study||6||
59669192|NCT04459338|75788142|FG000|COMPLETED|Overall Study||4||
59669193|NCT04459338|75788143|FG001|COMPLETED|Overall Study||6||
59669194|NCT04459338|75788142|FG000|NOT COMPLETED|Overall Study||1||
59669195|NCT04459338|75788143|FG001|NOT COMPLETED|Overall Study||0||
59669196|NCT04047121|75788155|FG000|STARTED|Overall Study||310||
59669197|NCT04047121|75788156|FG001|STARTED|Overall Study||299||
59669198|NCT04047121|75788157|FG002|STARTED|Overall Study||79||
59669199|NCT04047121|75788158|FG003|STARTED|Overall Study||287||
59669200|NCT04047121|75788159|FG004|STARTED|Overall Study||112||
59669201|NCT04047121|75788160|FG005|STARTED|Overall Study||262||
59669202|NCT04047121|75788155|FG000|COMPLETED|Overall Study||310||
59669203|NCT04047121|75788156|FG001|COMPLETED|Overall Study||299||
59669204|NCT04047121|75788157|FG002|COMPLETED|Overall Study||79||
59669205|NCT04047121|75788158|FG003|COMPLETED|Overall Study||287||
59669206|NCT04047121|75788159|FG004|COMPLETED|Overall Study||112||
59669207|NCT04047121|75788160|FG005|COMPLETED|Overall Study||262||
59669208|NCT04047121|75788155|FG000|NOT COMPLETED|Overall Study||0||
59669209|NCT04047121|75788156|FG001|NOT COMPLETED|Overall Study||0||
59669210|NCT04047121|75788157|FG002|NOT COMPLETED|Overall Study||0||
59669211|NCT04047121|75788158|FG003|NOT COMPLETED|Overall Study||0||
59669212|NCT04047121|75788159|FG004|NOT COMPLETED|Overall Study||0||
59669213|NCT04047121|75788160|FG005|NOT COMPLETED|Overall Study||0||
59669214|NCT03975790|75788177|FG000|STARTED|Overall Study||337||
59669215|NCT03975790|75788178|FG001|STARTED|Overall Study||94||
59669216|NCT03975790|75788179|FG002|STARTED|Overall Study||48||
59669217|NCT03975790|75788177|FG000|COMPLETED|Overall Study||337||
59669218|NCT03975790|75788178|FG001|COMPLETED|Overall Study||94||
59669219|NCT03975790|75788179|FG002|COMPLETED|Overall Study||48||
59669220|NCT03975790|75788177|FG000|NOT COMPLETED|Overall Study||0||
59669221|NCT03975790|75788178|FG001|NOT COMPLETED|Overall Study||0||
59669222|NCT03975790|75788179|FG002|NOT COMPLETED|Overall Study||0||
59669223|NCT03740048|75788189|FG000|STARTED|Overall Study||23||
59669224|NCT03740048|75788190|FG001|STARTED|Overall Study||25||
59669225|NCT03740048|75788189|FG000|COMPLETED|Overall Study||17||
59669226|NCT03740048|75788190|FG001|COMPLETED|Overall Study||16||
59669227|NCT03740048|75788189|FG000|NOT COMPLETED|Overall Study||6||
59545650|NCT01003106|75644435|FG004|COMPLETED|Baseline to Month 6||19||
59545651|NCT01003106|75644436|FG005|COMPLETED|Baseline to Month 6||20||
59545652|NCT01003106|75644437|FG006|COMPLETED|Baseline to Month 6||0||
59545653|NCT01003106|75644438|FG007|COMPLETED|Baseline to Month 6||0||
59545654|NCT01003106|75644431|FG000|NOT COMPLETED|Baseline to Month 6||0||
59545655|NCT01003106|75644432|FG001|NOT COMPLETED|Baseline to Month 6||0||
59545656|NCT01003106|75644433|FG002|NOT COMPLETED|Baseline to Month 6||0||
59545657|NCT01003106|75644434|FG003|NOT COMPLETED|Baseline to Month 6||0||
59545658|NCT01003106|75644435|FG004|NOT COMPLETED|Baseline to Month 6||0||
59545659|NCT01003106|75644436|FG005|NOT COMPLETED|Baseline to Month 6||0||
59545660|NCT01003106|75644437|FG006|NOT COMPLETED|Baseline to Month 6||0||
59545661|NCT01003106|75644438|FG007|NOT COMPLETED|Baseline to Month 6||0||
59545662|NCT01003106|75644431|FG000|STARTED|Month 6-Month 36||0||
59545663|NCT01003106|75644432|FG001|STARTED|Month 6-Month 36||0||
59545664|NCT01003106|75644433|FG002|STARTED|Month 6-Month 36||19||
59545665|NCT01003106|75644434|FG003|STARTED|Month 6-Month 36||20||
59545666|NCT01003106|75644435|FG004|STARTED|Month 6-Month 36||0||
59545667|NCT01003106|75644436|FG005|STARTED|Month 6-Month 36||0||
59545668|NCT01003106|75644437|FG006|STARTED|Month 6-Month 36||20||
59669228|NCT03740048|75788190|FG001|NOT COMPLETED|Overall Study||9||
59669229|NCT03612596|75788198|FG000|STARTED|0 - 12 Weeks||20||
59669230|NCT03612596|75788199|FG001|STARTED|0 - 12 Weeks||20||
59669231|NCT03612596|75788198|FG000|COMPLETED|0 - 12 Weeks||18||
59669232|NCT03612596|75788199|FG001|COMPLETED|0 - 12 Weeks||19||
59669233|NCT03612596|75788198|FG000|NOT COMPLETED|0 - 12 Weeks||2||
59669234|NCT03612596|75788199|FG001|NOT COMPLETED|0 - 12 Weeks||1||
59669235|NCT03612596|75788198|FG000|STARTED|12 - 24 Weeks||18||
59669236|NCT03612596|75788199|FG001|STARTED|12 - 24 Weeks||19||
59669237|NCT03612596|75788198|FG000|COMPLETED|12 - 24 Weeks||18||
59669238|NCT03612596|75788199|FG001|COMPLETED|12 - 24 Weeks||19||
59669239|NCT03612596|75788198|FG000|NOT COMPLETED|12 - 24 Weeks||0||
59669240|NCT03612596|75788199|FG001|NOT COMPLETED|12 - 24 Weeks||0||
59669241|NCT03441633|75788215|FG000|STARTED|Overall Study||4712||
59669242|NCT03441633|75788216|FG001|STARTED|Overall Study||1423||
59669243|NCT03441633|75788217|FG002|STARTED|Overall Study||32212||
59669244|NCT03441633|75788218|FG003|STARTED|Overall Study||192||
59669245|NCT03441633|75788219|FG004|STARTED|Overall Study||2286||
59669246|NCT03441633|75788220|FG005|STARTED|Overall Study||363||
59669247|NCT03441633|75788221|FG006|STARTED|Overall Study||2855||
59669248|NCT03441633|75788222|FG007|STARTED|Overall Study||953||
59669249|NCT03441633|75788223|FG008|STARTED|Overall Study||5132||
59669250|NCT03441633|75788224|FG009|STARTED|Overall Study||1562||
59669251|NCT03441633|75788215|FG000|COMPLETED|Overall Study||4712||
59669252|NCT03441633|75788216|FG001|COMPLETED|Overall Study||1423||
59669253|NCT03441633|75788217|FG002|COMPLETED|Overall Study||32212||
59669254|NCT03441633|75788218|FG003|COMPLETED|Overall Study||192||
59669255|NCT03441633|75788219|FG004|COMPLETED|Overall Study||2286||
59669256|NCT03441633|75788220|FG005|COMPLETED|Overall Study||363||
59669257|NCT03441633|75788221|FG006|COMPLETED|Overall Study||2855||
59669258|NCT03441633|75788222|FG007|COMPLETED|Overall Study||953||
59669259|NCT03441633|75788223|FG008|COMPLETED|Overall Study||5132||
59669260|NCT03441633|75788224|FG009|COMPLETED|Overall Study||1562||
59669261|NCT03441633|75788215|FG000|NOT COMPLETED|Overall Study||0||
59669262|NCT03441633|75788216|FG001|NOT COMPLETED|Overall Study||0||
59669263|NCT03441633|75788217|FG002|NOT COMPLETED|Overall Study||0||
59669264|NCT03441633|75788218|FG003|NOT COMPLETED|Overall Study||0||
59669265|NCT03441633|75788219|FG004|NOT COMPLETED|Overall Study||0||
59669266|NCT03441633|75788220|FG005|NOT COMPLETED|Overall Study||0||
59669267|NCT03441633|75788221|FG006|NOT COMPLETED|Overall Study||0||
59669268|NCT03441633|75788222|FG007|NOT COMPLETED|Overall Study||0||
59669269|NCT03441633|75788223|FG008|NOT COMPLETED|Overall Study||0||
59669270|NCT03441633|75788224|FG009|NOT COMPLETED|Overall Study||0||
59669271|NCT03397394|75788253|FG000|STARTED|Overall Study||47||
59669272|NCT03397394|75788254|FG001|STARTED|Overall Study||30||
59669273|NCT03397394|75788255|FG002|STARTED|Overall Study||20||
59669274|NCT03397394|75788253|FG000|COMPLETED|Overall Study||47||
59669275|NCT03397394|75788254|FG001|COMPLETED|Overall Study||30||
59669276|NCT03397394|75788255|FG002|COMPLETED|Overall Study||20||
59669277|NCT03397394|75788253|FG000|NOT COMPLETED|Overall Study||0||
59669278|NCT03397394|75788254|FG001|NOT COMPLETED|Overall Study||0||
59669279|NCT03397394|75788255|FG002|NOT COMPLETED|Overall Study||0||
59669280|NCT03373760|75788267|FG000|STARTED|Overall Study||58||
59669281|NCT03373760|75788267|FG000|COMPLETED|Overall Study||0||
59669282|NCT03373760|75788267|FG000|NOT COMPLETED|Overall Study||58||
59669283|NCT03324880|75788276|FG000|STARTED|Overall Study||48||
59669284|NCT03324880|75788277|FG001|STARTED|Overall Study||45||
59669285|NCT03324880|75788276|FG000|COMPLETED|Overall Study||46||
59669286|NCT03324880|75788277|FG001|COMPLETED|Overall Study||39||
59669287|NCT03324880|75788276|FG000|NOT COMPLETED|Overall Study||2||
59669288|NCT03324880|75788277|FG001|NOT COMPLETED|Overall Study||6||
59669289|NCT03053440|75788287|FG000|STARTED|Overall Study||99||
59669290|NCT03053440|75788288|FG001|STARTED|Overall Study||102||
59669291|NCT03053440|75788287|FG000|COMPLETED|Overall Study||0||
59669292|NCT03053440|75788288|FG001|COMPLETED|Overall Study||0||
59669293|NCT03053440|75788287|FG000|NOT COMPLETED|Overall Study||99||
59669294|NCT03053440|75788288|FG001|NOT COMPLETED|Overall Study||102||
59669295|NCT02985684|75788295|FG000|STARTED|6-Month Clinical Success Evaluation||125||
59669296|NCT02985684|75788295|FG000|COMPLETED|6-Month Clinical Success Evaluation||120||
59669297|NCT02985684|75788295|FG000|NOT COMPLETED|6-Month Clinical Success Evaluation||5||
59669298|NCT02985684|75788295|FG000|STARTED|6-Month Closure Success Evaluation||120||
59669299|NCT02985684|75788295|FG000|COMPLETED|6-Month Closure Success Evaluation||112||
59669300|NCT02985684|75788295|FG000|NOT COMPLETED|6-Month Closure Success Evaluation||8||
59669301|NCT02959450|75788301|FG000|STARTED|Overall Study||64||
59669302|NCT02959450|75788302|FG001|STARTED|Overall Study||63||
59669303|NCT02959450|75788301|FG000|COMPLETED|Overall Study||54||
59669304|NCT02959450|75788302|FG001|COMPLETED|Overall Study||51||
59669305|NCT02959450|75788301|FG000|NOT COMPLETED|Overall Study||10||
59669306|NCT02959450|75788302|FG001|NOT COMPLETED|Overall Study||12||
59669307|NCT02952534|75788313|FG000|STARTED|Overall Study||172||
59669308|NCT02952534|75788314|FG001|STARTED|Overall Study||59||
59669309|NCT02952534|75788315|FG002|STARTED|Overall Study||14||
59669310|NCT02952534|75788316|FG003|STARTED|Overall Study||7||
59669311|NCT02952534|75788317|FG004|STARTED|Overall Study||25||
59669312|NCT02952534|75788313|FG000|COMPLETED|Overall Study||172||
59669313|NCT02952534|75788314|FG001|COMPLETED|Overall Study||59||
59669314|NCT02952534|75788315|FG002|COMPLETED|Overall Study||14||
59989223|NCT00151775|76104462|FG001|STARTED|Period 4: Open Label||0||
59989224|NCT00151775|76104463|FG002|STARTED|Period 4: Open Label||0||
60077796|NCT01483599|76192723|FG005|STARTED|After Controlled Period(Week 16-Week 40)||0||
59669315|NCT02952534|75788316|FG003|COMPLETED|Overall Study||7||
59669316|NCT02952534|75788317|FG004|COMPLETED|Overall Study||25||
59669317|NCT02952534|75788313|FG000|NOT COMPLETED|Overall Study||0||
59669318|NCT02952534|75788314|FG001|NOT COMPLETED|Overall Study||0||
59669319|NCT02952534|75788315|FG002|NOT COMPLETED|Overall Study||0||
59669320|NCT02952534|75788316|FG003|NOT COMPLETED|Overall Study||0||
59817935|NCT04488770|75940335|FG009|COMPLETED|Part 1-Cohort 2: Period 2 (Up to 5 Days)||0||
59669321|NCT02952534|75788317|FG004|NOT COMPLETED|Overall Study||0||
59669322|NCT02949934|75788334|FG000|STARTED|Natural Drinking Period||16||
59669323|NCT02949934|75788335|FG001|STARTED|Natural Drinking Period||12||
59669324|NCT02949934|75788336|FG002|STARTED|Natural Drinking Period||17||
59669325|NCT02949934|75788337|FG003|STARTED|Natural Drinking Period||16||
59669326|NCT02949934|75788338|FG004|STARTED|Natural Drinking Period||15||
59669327|NCT02949934|75788339|FG005|STARTED|Natural Drinking Period||14||
59669328|NCT02949934|75788334|FG000|COMPLETED|Natural Drinking Period||15||
59669329|NCT02949934|75788335|FG001|COMPLETED|Natural Drinking Period||12||
59669330|NCT02949934|75788336|FG002|COMPLETED|Natural Drinking Period||17||
59669331|NCT02949934|75788337|FG003|COMPLETED|Natural Drinking Period||15||
59669332|NCT02949934|75788338|FG004|COMPLETED|Natural Drinking Period||14||
59669333|NCT02949934|75788339|FG005|COMPLETED|Natural Drinking Period||14||
59669334|NCT02949934|75788334|FG000|NOT COMPLETED|Natural Drinking Period||1||
59669335|NCT02949934|75788335|FG001|NOT COMPLETED|Natural Drinking Period||0||
59669336|NCT02949934|75788336|FG002|NOT COMPLETED|Natural Drinking Period||0||
59669337|NCT02949934|75788337|FG003|NOT COMPLETED|Natural Drinking Period||1||
59669338|NCT02949934|75788338|FG004|NOT COMPLETED|Natural Drinking Period||1||
59669339|NCT02949934|75788339|FG005|NOT COMPLETED|Natural Drinking Period||0||
59669340|NCT02949934|75788334|FG000|STARTED|Neuroimaging||15||
59669341|NCT02949934|75788335|FG001|STARTED|Neuroimaging||12||
59669342|NCT02949934|75788336|FG002|STARTED|Neuroimaging||17||
59669343|NCT02949934|75788337|FG003|STARTED|Neuroimaging||15||
59669344|NCT02949934|75788338|FG004|STARTED|Neuroimaging||14||
59669345|NCT02949934|75788339|FG005|STARTED|Neuroimaging||14||
59669346|NCT02949934|75788334|FG000|COMPLETED|Neuroimaging||12||
59669347|NCT02949934|75788335|FG001|COMPLETED|Neuroimaging||12||
59669348|NCT02949934|75788336|FG002|COMPLETED|Neuroimaging||15||
59669349|NCT02949934|75788337|FG003|COMPLETED|Neuroimaging||15||
59669350|NCT02949934|75788338|FG004|COMPLETED|Neuroimaging||12||
59669351|NCT02949934|75788339|FG005|COMPLETED|Neuroimaging||12||
59669352|NCT02949934|75788334|FG000|NOT COMPLETED|Neuroimaging||3||
59669353|NCT02949934|75788335|FG001|NOT COMPLETED|Neuroimaging||0||
59669354|NCT02949934|75788336|FG002|NOT COMPLETED|Neuroimaging||2||
59669355|NCT02949934|75788337|FG003|NOT COMPLETED|Neuroimaging||0||
59669356|NCT02949934|75788338|FG004|NOT COMPLETED|Neuroimaging||2||
59669357|NCT02949934|75788339|FG005|NOT COMPLETED|Neuroimaging||2||
59669358|NCT02949934|75788334|FG000|STARTED|Bar Laboratory||13|The number of participants who started the bar laboratory on Day 8 is in some cases greater than the number who completed neuroimaging on Day 7. Some participants were not scanned on Day 7 and some had unusable neuroimaging data due to motion, but still started the bar laboratory.|
59669359|NCT02949934|75788335|FG001|STARTED|Bar Laboratory||12|The number of participants who started the bar laboratory on Day 8 is in some cases greater than the number who completed neuroimaging on Day 7. Some participants were not scanned on Day 7 and some had unusable neuroimaging data due to motion, but still started the bar laboratory.|
59669360|NCT02949934|75788336|FG002|STARTED|Bar Laboratory||17|The number of participants who started the bar laboratory on Day 8 is in some cases greater than the number who completed neuroimaging on Day 7. Some participants were not scanned on Day 7 and some had unusable neuroimaging data due to motion, but still started the bar laboratory.|
59669361|NCT02949934|75788337|FG003|STARTED|Bar Laboratory||15|The number of participants who started the bar laboratory on Day 8 is in some cases greater than the number who completed neuroimaging on Day 7. Some participants were not scanned on Day 7 and some had unusable neuroimaging data due to motion, but still started the bar laboratory.|
59669362|NCT02949934|75788338|FG004|STARTED|Bar Laboratory||13|The number of participants who started the bar laboratory on Day 8 is in some cases greater than the number who completed neuroimaging on Day 7. Some participants were not scanned on Day 7 and some had unusable neuroimaging data due to motion, but still started the bar laboratory.|
59669363|NCT02949934|75788339|FG005|STARTED|Bar Laboratory||14|The number of participants who started the bar laboratory on Day 8 is in some cases greater than the number who completed neuroimaging on Day 7. Some participants were not scanned on Day 7 and some had unusable neuroimaging data due to motion, but still started the bar laboratory.|
59669364|NCT02949934|75788334|FG000|COMPLETED|Bar Laboratory||12||
59669365|NCT02949934|75788335|FG001|COMPLETED|Bar Laboratory||7||
59669366|NCT02949934|75788336|FG002|COMPLETED|Bar Laboratory||10||
59669367|NCT02949934|75788337|FG003|COMPLETED|Bar Laboratory||11||
59669368|NCT02949934|75788338|FG004|COMPLETED|Bar Laboratory||7||
59669369|NCT02949934|75788339|FG005|COMPLETED|Bar Laboratory||13||
59669370|NCT02949934|75788334|FG000|NOT COMPLETED|Bar Laboratory||1||
59669371|NCT02949934|75788335|FG001|NOT COMPLETED|Bar Laboratory||5||
59669372|NCT02949934|75788336|FG002|NOT COMPLETED|Bar Laboratory||7||
59669373|NCT02949934|75788337|FG003|NOT COMPLETED|Bar Laboratory||4||
59669374|NCT02949934|75788338|FG004|NOT COMPLETED|Bar Laboratory||6||
59669375|NCT02949934|75788339|FG005|NOT COMPLETED|Bar Laboratory||1||
59669376|NCT02935634|75788371|FG000|STARTED|Randomization||42||
59669377|NCT02935634|75788372|FG001|STARTED|Randomization||54||
59669378|NCT02935634|75788373|FG002|STARTED|Randomization||62||
59669379|NCT02935634|75788374|FG003|STARTED|Randomization||12||
59669380|NCT02935634|75788375|FG004|STARTED|Randomization||10||
59669381|NCT02935634|75788376|FG005|STARTED|Randomization||10||
59669382|NCT02935634|75788371|FG000|Randomized to Track 1|Randomization||23||
59669383|NCT02935634|75788372|FG001|Randomized to Track 1|Randomization||22||
59669384|NCT02935634|75788373|FG002|Randomized to Track 1|Randomization||38||
59669385|NCT02935634|75788374|FG003|Randomized to Track 1|Randomization||7||
59669386|NCT02935634|75788375|FG004|Randomized to Track 1|Randomization||8||
59669387|NCT02935634|75788376|FG005|Randomized to Track 1|Randomization||6||
59669388|NCT02935634|75788371|FG000|Randomized to Track 2|Randomization||19||
59669389|NCT02935634|75788372|FG001|Randomized to Track 2|Randomization||32||
59669390|NCT02935634|75788373|FG002|Randomized to Track 2|Randomization||24||
59669391|NCT02935634|75788374|FG003|Randomized to Track 2|Randomization||5||
59669392|NCT02935634|75788375|FG004|Randomized to Track 2|Randomization||2||
59669393|NCT02935634|75788376|FG005|Randomized to Track 2|Randomization||4||
59669394|NCT02935634|75788371|FG000|COMPLETED|Randomization||40||
59669395|NCT02935634|75788372|FG001|COMPLETED|Randomization||50||
59669396|NCT02935634|75788373|FG002|COMPLETED|Randomization||59||
59669397|NCT02935634|75788374|FG003|COMPLETED|Randomization||12||
59669398|NCT02935634|75788375|FG004|COMPLETED|Randomization||10||
59669399|NCT02935634|75788376|FG005|COMPLETED|Randomization||10||
59669400|NCT02935634|75788371|FG000|NOT COMPLETED|Randomization||2||
59669401|NCT02935634|75788372|FG001|NOT COMPLETED|Randomization||4||
59669402|NCT02935634|75788373|FG002|NOT COMPLETED|Randomization||3||
59669403|NCT02935634|75788374|FG003|NOT COMPLETED|Randomization||0||
59669404|NCT02935634|75788375|FG004|NOT COMPLETED|Randomization||0||
59669405|NCT02935634|75788376|FG005|NOT COMPLETED|Randomization||0||
59669406|NCT02935634|75788371|FG000|STARTED|Treatment: Track 1||23|Treatment naive participants|
59669407|NCT02935634|75788372|FG001|STARTED|Treatment: Track 1||20|Treatment naive participants|
59669408|NCT02935634|75788373|FG002|STARTED|Treatment: Track 1||38|Treatment naive participants|
59669409|NCT02935634|75788374|FG003|STARTED|Treatment: Track 1||7|Treatment naive participants|
59669410|NCT02935634|75788375|FG004|STARTED|Treatment: Track 1||8|Treatment naive participants|
59669411|NCT02935634|75788376|FG005|STARTED|Treatment: Track 1||6|Treatment naive participants|
59669412|NCT02935634|75788371|FG000|Re-Randomized to Track 2|Treatment: Track 1||2||
59669413|NCT02935634|75788372|FG001|Re-Randomized to Track 2|Treatment: Track 1||3||
59669414|NCT02935634|75788373|FG002|Re-Randomized to Track 2|Treatment: Track 1||3||
59669415|NCT02935634|75788374|FG003|Re-Randomized to Track 2|Treatment: Track 1||0||
59669416|NCT02935634|75788375|FG004|Re-Randomized to Track 2|Treatment: Track 1||0||
59669417|NCT02935634|75788376|FG005|Re-Randomized to Track 2|Treatment: Track 1||0||
59669418|NCT02935634|75788371|FG000|COMPLETED|Treatment: Track 1||1||
59669419|NCT02935634|75788372|FG001|COMPLETED|Treatment: Track 1||1||
59669420|NCT02935634|75788373|FG002|COMPLETED|Treatment: Track 1||1||
59669421|NCT02935634|75788374|FG003|COMPLETED|Treatment: Track 1||0||
59669422|NCT02935634|75788375|FG004|COMPLETED|Treatment: Track 1||0||
59669423|NCT02935634|75788376|FG005|COMPLETED|Treatment: Track 1||0||
59669424|NCT02935634|75788371|FG000|NOT COMPLETED|Treatment: Track 1||22||
59669425|NCT02935634|75788372|FG001|NOT COMPLETED|Treatment: Track 1||19||
59669426|NCT02935634|75788373|FG002|NOT COMPLETED|Treatment: Track 1||37||
59669427|NCT02935634|75788374|FG003|NOT COMPLETED|Treatment: Track 1||7||
59669428|NCT02935634|75788375|FG004|NOT COMPLETED|Treatment: Track 1||8||
59669429|NCT02935634|75788376|FG005|NOT COMPLETED|Treatment: Track 1||6||
59669430|NCT02935634|75788371|FG000|STARTED|Treatment: Track 2||23|Treatment experienced participants|
59669431|NCT02935634|75788372|FG001|STARTED|Treatment: Track 2||36|Treatment experienced participants|
59669432|NCT02935634|75788373|FG002|STARTED|Treatment: Track 2||22|Treatment experienced participants|
59669433|NCT02935634|75788374|FG003|STARTED|Treatment: Track 2||6|Treatment experienced participants|
59669434|NCT02935634|75788375|FG004|STARTED|Treatment: Track 2||2|Treatment experienced participants|
59669435|NCT02935634|75788376|FG005|STARTED|Treatment: Track 2||4|Treatment experienced participants|
59669436|NCT02935634|75788371|FG000|No Pre-Randomization|Treatment: Track 2||17||
59669437|NCT02935634|75788372|FG001|No Pre-Randomization|Treatment: Track 2||30||
59669438|NCT02935634|75788373|FG002|No Pre-Randomization|Treatment: Track 2||21||
59669439|NCT02935634|75788374|FG003|No Pre-Randomization|Treatment: Track 2||5||
59669440|NCT02935634|75788375|FG004|No Pre-Randomization|Treatment: Track 2||2||
59669441|NCT02935634|75788376|FG005|No Pre-Randomization|Treatment: Track 2||4||
59669442|NCT02935634|75788371|FG000|Re-Randomized From Track 1 Nivolumab + Relatlimab|Treatment: Track 2||1||
59669443|NCT02935634|75788372|FG001|Re-Randomized From Track 1 Nivolumab + Relatlimab|Treatment: Track 2||0||
59669444|NCT02935634|75788373|FG002|Re-Randomized From Track 1 Nivolumab + Relatlimab|Treatment: Track 2||1||
59669445|NCT02935634|75788374|FG003|Re-Randomized From Track 1 Nivolumab + Relatlimab|Treatment: Track 2||1||
59669446|NCT02935634|75788375|FG004|Re-Randomized From Track 1 Nivolumab + Relatlimab|Treatment: Track 2||0||
59669447|NCT02935634|75788376|FG005|Re-Randomized From Track 1 Nivolumab + Relatlimab|Treatment: Track 2||0||
59669448|NCT02935634|75788371|FG000|Re-Randomized From Track 1 Nivolumab + Ipilimumab|Treatment: Track 2||2||
59669449|NCT02935634|75788372|FG001|Re-Randomized From Track 1 Nivolumab + Ipilimumab|Treatment: Track 2||1||
59669450|NCT02935634|75788373|FG002|Re-Randomized From Track 1 Nivolumab + Ipilimumab|Treatment: Track 2||0||
59815868|NCT02242760|75938267|FG004|Number of Subjects Excluded From ITT Population|Overall Study||1|One subject in the SB204 4% BID group was not dispensed study medication after randomization.|
59669451|NCT02935634|75788374|FG003|Re-Randomized From Track 1 Nivolumab + Ipilimumab|Treatment: Track 2||0||
59669452|NCT02935634|75788375|FG004|Re-Randomized From Track 1 Nivolumab + Ipilimumab|Treatment: Track 2||0||
59669453|NCT02935634|75788376|FG005|Re-Randomized From Track 1 Nivolumab + Ipilimumab|Treatment: Track 2||0||
59669454|NCT02935634|75788371|FG000|Re-Randomized From Track 2 Nivolumab + Relatlimab|Treatment: Track 2||0||
59669455|NCT02935634|75788372|FG001|Re-Randomized From Track 2 Nivolumab + Relatlimab|Treatment: Track 2||2||
59669456|NCT02935634|75788373|FG002|Re-Randomized From Track 2 Nivolumab + Relatlimab|Treatment: Track 2||0||
59669457|NCT02935634|75788374|FG003|Re-Randomized From Track 2 Nivolumab + Relatlimab|Treatment: Track 2||0||
59669458|NCT02935634|75788375|FG004|Re-Randomized From Track 2 Nivolumab + Relatlimab|Treatment: Track 2||0||
59815869|NCT02242760|75938263|FG000|COMPLETED|Overall Study||24||
59815870|NCT02242760|75938264|FG001|COMPLETED|Overall Study||20||
59669459|NCT02935634|75788376|FG005|Re-Randomized From Track 2 Nivolumab + Relatlimab|Treatment: Track 2||0||
59669460|NCT02935634|75788371|FG000|Re-Randomized From Track 2 Nivolumab + BMS986205|Treatment: Track 2||3||
59669461|NCT02935634|75788372|FG001|Re-Randomized From Track 2 Nivolumab + BMS986205|Treatment: Track 2||0||
59669462|NCT02935634|75788373|FG002|Re-Randomized From Track 2 Nivolumab + BMS986205|Treatment: Track 2||0||
59669463|NCT02935634|75788374|FG003|Re-Randomized From Track 2 Nivolumab + BMS986205|Treatment: Track 2||0||
59669464|NCT02935634|75788375|FG004|Re-Randomized From Track 2 Nivolumab + BMS986205|Treatment: Track 2||0||
59669465|NCT02935634|75788376|FG005|Re-Randomized From Track 2 Nivolumab + BMS986205|Treatment: Track 2||0||
59669466|NCT02935634|75788371|FG000|Previously Un-Treated But Re-Randomized|Treatment: Track 2||0||
59669467|NCT02935634|75788372|FG001|Previously Un-Treated But Re-Randomized|Treatment: Track 2||1||
59669468|NCT02935634|75788373|FG002|Previously Un-Treated But Re-Randomized|Treatment: Track 2||0||
59669469|NCT02935634|75788374|FG003|Previously Un-Treated But Re-Randomized|Treatment: Track 2||0||
59669470|NCT02935634|75788375|FG004|Previously Un-Treated But Re-Randomized|Treatment: Track 2||0||
59669471|NCT02935634|75788376|FG005|Previously Un-Treated But Re-Randomized|Treatment: Track 2||0||
59669472|NCT02935634|75788371|FG000|Re-Randomized From Track 2 Nivolumab + Ipilimumab|Treatment: Track 2||0||
59669473|NCT02935634|75788372|FG001|Re-Randomized From Track 2 Nivolumab + Ipilimumab|Treatment: Track 2||2||
59669474|NCT02935634|75788373|FG002|Re-Randomized From Track 2 Nivolumab + Ipilimumab|Treatment: Track 2||0||
59669475|NCT02935634|75788374|FG003|Re-Randomized From Track 2 Nivolumab + Ipilimumab|Treatment: Track 2||0||
59669476|NCT02935634|75788375|FG004|Re-Randomized From Track 2 Nivolumab + Ipilimumab|Treatment: Track 2||0||
59669477|NCT02935634|75788376|FG005|Re-Randomized From Track 2 Nivolumab + Ipilimumab|Treatment: Track 2||0||
59669478|NCT02935634|75788371|FG000|COMPLETED|Treatment: Track 2||1||
59669479|NCT02935634|75788372|FG001|COMPLETED|Treatment: Track 2||2||
59669480|NCT02935634|75788373|FG002|COMPLETED|Treatment: Track 2||0||
59669481|NCT02935634|75788374|FG003|COMPLETED|Treatment: Track 2||1||
59669482|NCT02935634|75788375|FG004|COMPLETED|Treatment: Track 2||0||
59669483|NCT02935634|75788376|FG005|COMPLETED|Treatment: Track 2||0||
59669484|NCT02935634|75788371|FG000|NOT COMPLETED|Treatment: Track 2||22||
59669485|NCT02935634|75788372|FG001|NOT COMPLETED|Treatment: Track 2||34||
59669486|NCT02935634|75788373|FG002|NOT COMPLETED|Treatment: Track 2||22||
59669487|NCT02935634|75788374|FG003|NOT COMPLETED|Treatment: Track 2||5||
59669488|NCT02935634|75788375|FG004|NOT COMPLETED|Treatment: Track 2||2||
59669489|NCT02935634|75788376|FG005|NOT COMPLETED|Treatment: Track 2||4||
59669490|NCT02864992|75788405|FG000|STARTED|Overall Study||152||
59669491|NCT02864992|75788406|FG001|STARTED|Overall Study||24||
59669492|NCT02864992|75788407|FG002|STARTED|Overall Study||161||
59669493|NCT02864992|75788405|FG000|COMPLETED|Overall Study||137||
59669494|NCT02864992|75788406|FG001|COMPLETED|Overall Study||23||
59669495|NCT02864992|75788407|FG002|COMPLETED|Overall Study||128||
59669496|NCT02864992|75788405|FG000|NOT COMPLETED|Overall Study||15||
59669497|NCT02864992|75788406|FG001|NOT COMPLETED|Overall Study||1||
59669498|NCT02864992|75788407|FG002|NOT COMPLETED|Overall Study||33||
59669499|NCT02684578|75788415|FG000|STARTED|Overall Study||32||53
59669500|NCT02684578|75788416|FG001|STARTED|Overall Study||34||57
59669501|NCT02684578|75788415|FG000|COMPLETED|Overall Study||21||34
59669502|NCT02684578|75788416|FG001|COMPLETED|Overall Study||23||37
59669503|NCT02684578|75788415|FG000|NOT COMPLETED|Overall Study||11||19
59669504|NCT02684578|75788416|FG001|NOT COMPLETED|Overall Study||11||20
59669505|NCT02612129|75788424|FG000|STARTED|Single Dose Treatment Period||28||
59669506|NCT02612129|75788425|FG001|STARTED|Single Dose Treatment Period||0||
59669507|NCT02612129|75788426|FG002|STARTED|Single Dose Treatment Period||0||
59669508|NCT02612129|75788424|FG000|COMPLETED|Single Dose Treatment Period||27|One participant who was a screening failure received single-dose arimoclomol for PK evaluation.|
59669509|NCT02612129|75788425|FG001|COMPLETED|Single Dose Treatment Period||0|One participant who was a screening failure received single-dose arimoclomol for PK evaluation.|
59669510|NCT02612129|75788426|FG002|COMPLETED|Single Dose Treatment Period||0|One participant who was a screening failure received single-dose arimoclomol for PK evaluation.|
59669511|NCT02612129|75788424|FG000|NOT COMPLETED|Single Dose Treatment Period||1||
59669512|NCT02612129|75788425|FG001|NOT COMPLETED|Single Dose Treatment Period||0||
59669513|NCT02612129|75788426|FG002|NOT COMPLETED|Single Dose Treatment Period||0||
59669514|NCT02612129|75788424|FG000|STARTED|Continuous Treatment Period||0||
59669515|NCT02612129|75788425|FG001|STARTED|Continuous Treatment Period||34||
59669516|NCT02612129|75788426|FG002|STARTED|Continuous Treatment Period||16||
59669517|NCT02612129|75788424|FG000|COMPLETED|Continuous Treatment Period||0||
59669518|NCT02612129|75788425|FG001|COMPLETED|Continuous Treatment Period||27||
59669519|NCT02612129|75788426|FG002|COMPLETED|Continuous Treatment Period||15||
59669520|NCT02612129|75788424|FG000|NOT COMPLETED|Continuous Treatment Period||0||
59669521|NCT02612129|75788425|FG001|NOT COMPLETED|Continuous Treatment Period||7||
59669522|NCT02612129|75788426|FG002|NOT COMPLETED|Continuous Treatment Period||1||
59669523|NCT02580305|75788436|FG000|STARTED|Overall Study||190||
59669524|NCT02580305|75788437|FG001|STARTED|Overall Study||185||
59669525|NCT02580305|75788438|FG002|STARTED|Overall Study||189||
59669526|NCT02580305|75788436|FG000|Safety Population|Overall Study||187||
59669527|NCT02580305|75788437|FG001|Safety Population|Overall Study||181||
59669528|NCT02580305|75788438|FG002|Safety Population|Overall Study||188||
59669529|NCT02580305|75788436|FG000|Modified Intent-to-treat (mITT) Population|Overall Study||184||
59669530|NCT02580305|75788437|FG001|Modified Intent-to-treat (mITT) Population|Overall Study||176||
59669531|NCT02580305|75788438|FG002|Modified Intent-to-treat (mITT) Population|Overall Study||183||
59815871|NCT02242760|75938265|FG002|COMPLETED|Overall Study||51||
59669532|NCT02580305|75788436|FG000|COMPLETED|Overall Study||147||
59669533|NCT02580305|75788437|FG001|COMPLETED|Overall Study||136||
59669534|NCT02580305|75788438|FG002|COMPLETED|Overall Study||157||
59669535|NCT02580305|75788436|FG000|NOT COMPLETED|Overall Study||43||
59669536|NCT02580305|75788437|FG001|NOT COMPLETED|Overall Study||49||
59669537|NCT02580305|75788438|FG002|NOT COMPLETED|Overall Study||32||
59669538|NCT02279394|75788448|FG000|STARTED|Overall Study||40||
59669539|NCT02279394|75788449|FG001|STARTED|Overall Study||11||
59669540|NCT02279394|75788448|FG000|COMPLETED|Overall Study||40||
59669541|NCT02279394|75788449|FG001|COMPLETED|Overall Study||11||
59669542|NCT02279394|75788448|FG000|NOT COMPLETED|Overall Study||0||
59669543|NCT02279394|75788449|FG001|NOT COMPLETED|Overall Study||0||
59669544|NCT02054741|75788457|FG000|STARTED|Overall Study||362||16
59669545|NCT02054741|75788458|FG001|STARTED|Overall Study||371||24
59669546|NCT02054741|75788457|FG000|COMPLETED|Overall Study||210||16
59669547|NCT02054741|75788458|FG001|COMPLETED|Overall Study||242||24
59669548|NCT02054741|75788457|FG000|NOT COMPLETED|Overall Study||152||0
59669549|NCT02054741|75788458|FG001|NOT COMPLETED|Overall Study||129||0
59669550|NCT01555463|75788466|FG000|STARTED|Treatment||483||
59669551|NCT01555463|75788467|FG001|STARTED|Treatment||478||
59669552|NCT01555463|75788466|FG000|COMPLETED|Treatment||419||
59669553|NCT01555463|75788467|FG001|COMPLETED|Treatment||399||
59669554|NCT01555463|75788466|FG000|NOT COMPLETED|Treatment||64||
59669555|NCT01555463|75788467|FG001|NOT COMPLETED|Treatment||79||
59669556|NCT01555463|75788466|FG000|STARTED|Follow up|Treatment completers and non-completers were asked to participate in the follow-up phase.|447||
59669557|NCT01555463|75788467|FG001|STARTED|Follow up|Treatment completers and non-completers were asked to participate in the follow-up phase.|439||
59669558|NCT01555463|75788466|FG000|COMPLETED|Follow up||409||
59669559|NCT01555463|75788467|FG001|COMPLETED|Follow up||394||
59669560|NCT01555463|75788466|FG000|NOT COMPLETED|Follow up||38||
60077797|NCT01483599|76192724|FG006|STARTED|After Controlled Period(Week 16-Week 40)||0||
60077798|NCT01483599|76192725|FG007|STARTED|After Controlled Period(Week 16-Week 40)||39||
60077799|NCT01483599|76192726|FG008|STARTED|After Controlled Period(Week 16-Week 40)||38||
59669561|NCT01555463|75788467|FG001|NOT COMPLETED|Follow up||45||
59669562|NCT01482715|75788486|FG000|STARTED|Overall Study||6||
59669563|NCT01482715|75788487|FG001|STARTED|Overall Study||3||
59669564|NCT01482715|75788488|FG002|STARTED|Overall Study||4||
59669565|NCT01482715|75788489|FG003|STARTED|Overall Study||9||
59669566|NCT01482715|75788490|FG004|STARTED|Overall Study||4||
59669567|NCT01482715|75788491|FG005|STARTED|Overall Study||3||
59669568|NCT01482715|75788492|FG006|STARTED|Overall Study||8||
59669569|NCT01482715|75788493|FG007|STARTED|Overall Study||9||
59669570|NCT01482715|75788494|FG008|STARTED|Overall Study||7||
59669571|NCT01482715|75788495|FG009|STARTED|Overall Study||3||
59669572|NCT01482715|75788496|FG010|STARTED|Overall Study||42||
59669573|NCT01482715|75788497|FG011|STARTED|Overall Study||12||
59669574|NCT01482715|75788498|FG012|STARTED|Overall Study||26||
59669575|NCT01482715|75788486|FG000|COMPLETED|Overall Study||6||
59669576|NCT01482715|75788487|FG001|COMPLETED|Overall Study||3||
59669577|NCT01482715|75788488|FG002|COMPLETED|Overall Study||4||
59669578|NCT01482715|75788489|FG003|COMPLETED|Overall Study||9||
59669579|NCT01482715|75788490|FG004|COMPLETED|Overall Study||4||
59669580|NCT01482715|75788491|FG005|COMPLETED|Overall Study||3||
59669581|NCT01482715|75788492|FG006|COMPLETED|Overall Study||8||
59989225|NCT00151775|76104464|FG003|STARTED|Period 4: Open Label||0||
59989226|NCT00151775|76104465|FG004|STARTED|Period 4: Open Label||179||
59989227|NCT00151775|76104466|FG005|STARTED|Period 4: Open Label||0||
59989228|NCT00151775|76104467|FG006|STARTED|Period 4: Open Label||0||
59989229|NCT00151775|76104468|FG007|STARTED|Period 4: Open Label||0||
59989230|NCT00151775|76104469|FG008|STARTED|Period 4: Open Label||0||
59989231|NCT00151775|76104470|FG009|STARTED|Period 4: Open Label||104||
59989232|NCT00151775|76104471|FG010|STARTED|Period 4: Open Label||57||
59989233|NCT00151775|76104472|FG011|STARTED|Period 4: Open Label||0||
59989234|NCT00151775|76104461|FG000|COMPLETED|Period 4: Open Label||0||
59989235|NCT00151775|76104462|FG001|COMPLETED|Period 4: Open Label||0||
60077800|NCT01483599|76192727|FG009|STARTED|After Controlled Period(Week 16-Week 40)||41||
59989236|NCT00151775|76104463|FG002|COMPLETED|Period 4: Open Label||0||
60077801|NCT01483599|76192728|FG010|STARTED|After Controlled Period(Week 16-Week 40)||39||
60077802|NCT01483599|76192729|FG011|STARTED|After Controlled Period(Week 16-Week 40)||40||
59669582|NCT01482715|75788493|FG007|COMPLETED|Overall Study||9||
59669583|NCT01482715|75788494|FG008|COMPLETED|Overall Study||7||
59669584|NCT01482715|75788495|FG009|COMPLETED|Overall Study||3||
59669585|NCT01482715|75788496|FG010|COMPLETED|Overall Study||42||
59669586|NCT01482715|75788497|FG011|COMPLETED|Overall Study||12||
59669587|NCT01482715|75788498|FG012|COMPLETED|Overall Study||26||
59669588|NCT01482715|75788486|FG000|NOT COMPLETED|Overall Study||0||
59669589|NCT01482715|75788487|FG001|NOT COMPLETED|Overall Study||0||
59669590|NCT01482715|75788488|FG002|NOT COMPLETED|Overall Study||0||
59669591|NCT01482715|75788489|FG003|NOT COMPLETED|Overall Study||0||
59989237|NCT00151775|76104464|FG003|COMPLETED|Period 4: Open Label||0||
59989238|NCT00151775|76104465|FG004|COMPLETED|Period 4: Open Label||149||
59669592|NCT01482715|75788490|FG004|NOT COMPLETED|Overall Study||0||
59669593|NCT01482715|75788491|FG005|NOT COMPLETED|Overall Study||0||
59669594|NCT01482715|75788492|FG006|NOT COMPLETED|Overall Study||0||
59669595|NCT01482715|75788493|FG007|NOT COMPLETED|Overall Study||0||
59669596|NCT01482715|75788494|FG008|NOT COMPLETED|Overall Study||0||
59669597|NCT01482715|75788495|FG009|NOT COMPLETED|Overall Study||0||
59669598|NCT01482715|75788496|FG010|NOT COMPLETED|Overall Study||0||
59669599|NCT01482715|75788497|FG011|NOT COMPLETED|Overall Study||0||
59669600|NCT01482715|75788498|FG012|NOT COMPLETED|Overall Study||0||
59669601|NCT01378871|75788539|FG000|STARTED|Overall Study||1||
59669602|NCT01378871|75788539|FG000|COMPLETED|Overall Study||1||
59669603|NCT01378871|75788539|FG000|NOT COMPLETED|Overall Study||0||
59669604|NCT02277106|75788543|FG000|STARTED|Stage 1: Treatment Period 1||13||
59669605|NCT02277106|75788544|FG001|STARTED|Stage 1: Treatment Period 1||12||
59989239|NCT00151775|76104466|FG005|COMPLETED|Period 4: Open Label||0||
59989240|NCT00151775|76104467|FG006|COMPLETED|Period 4: Open Label||0||
59989241|NCT00151775|76104468|FG007|COMPLETED|Period 4: Open Label||0||
59989242|NCT00151775|76104469|FG008|COMPLETED|Period 4: Open Label||0||
59989243|NCT00151775|76104470|FG009|COMPLETED|Period 4: Open Label||83||
60077803|NCT01483599|76192730|FG012|STARTED|After Controlled Period(Week 16-Week 40)||38||
59669606|NCT02277106|75788545|FG002|STARTED|Stage 1: Treatment Period 1||0||
59669607|NCT02277106|75788543|FG000|COMPLETED|Stage 1: Treatment Period 1||13||
59669608|NCT02277106|75788544|FG001|COMPLETED|Stage 1: Treatment Period 1||12||
59669609|NCT02277106|75788545|FG002|COMPLETED|Stage 1: Treatment Period 1||0||
59669610|NCT02277106|75788543|FG000|NOT COMPLETED|Stage 1: Treatment Period 1||0||
59669611|NCT02277106|75788544|FG001|NOT COMPLETED|Stage 1: Treatment Period 1||0||
59669612|NCT02277106|75788545|FG002|NOT COMPLETED|Stage 1: Treatment Period 1||0||
59669613|NCT02277106|75788543|FG000|STARTED|Washout||13||
59669614|NCT02277106|75788544|FG001|STARTED|Washout||12||
59669615|NCT02277106|75788545|FG002|STARTED|Washout||0||
59669616|NCT02277106|75788543|FG000|COMPLETED|Washout||13||
59669617|NCT02277106|75788544|FG001|COMPLETED|Washout||12||
60077804|NCT01483599|76192731|FG013|STARTED|After Controlled Period(Week 16-Week 40)||39||
60077805|NCT01483599|76192718|FG000|COMPLETED|After Controlled Period(Week 16-Week 40)||0||
60077806|NCT01483599|76192719|FG001|COMPLETED|After Controlled Period(Week 16-Week 40)||0||
60077807|NCT01483599|76192720|FG002|COMPLETED|After Controlled Period(Week 16-Week 40)||0||
60077808|NCT01483599|76192721|FG003|COMPLETED|After Controlled Period(Week 16-Week 40)||0||
59989244|NCT00151775|76104471|FG010|COMPLETED|Period 4: Open Label||57||
59989245|NCT00151775|76104472|FG011|COMPLETED|Period 4: Open Label||0||
59989246|NCT00151775|76104461|FG000|NOT COMPLETED|Period 4: Open Label||0||
59989247|NCT00151775|76104462|FG001|NOT COMPLETED|Period 4: Open Label||0||
59989248|NCT00151775|76104463|FG002|NOT COMPLETED|Period 4: Open Label||0||
60077809|NCT01483599|76192722|FG004|COMPLETED|After Controlled Period(Week 16-Week 40)||0||
59545669|NCT01003106|75644438|FG007|STARTED|Month 6-Month 36||18||
59545670|NCT01003106|75644431|FG000|COMPLETED|Month 6-Month 36||0||
59545671|NCT01003106|75644432|FG001|COMPLETED|Month 6-Month 36||0||
59545672|NCT01003106|75644433|FG002|COMPLETED|Month 6-Month 36||18||
59545673|NCT01003106|75644434|FG003|COMPLETED|Month 6-Month 36||20||
59545674|NCT01003106|75644435|FG004|COMPLETED|Month 6-Month 36||0||
59545675|NCT01003106|75644436|FG005|COMPLETED|Month 6-Month 36||0||
59545676|NCT01003106|75644437|FG006|COMPLETED|Month 6-Month 36||19||
59545677|NCT01003106|75644438|FG007|COMPLETED|Month 6-Month 36||18||
59669618|NCT02277106|75788545|FG002|COMPLETED|Washout||0||
59669619|NCT02277106|75788543|FG000|NOT COMPLETED|Washout||0||
59669620|NCT02277106|75788544|FG001|NOT COMPLETED|Washout||0||
59669621|NCT02277106|75788545|FG002|NOT COMPLETED|Washout||0||
59669622|NCT02277106|75788543|FG000|STARTED|Stage 1: Treatment Period 2||13||
59669623|NCT02277106|75788544|FG001|STARTED|Stage 1: Treatment Period 2||12||
59669624|NCT02277106|75788545|FG002|STARTED|Stage 1: Treatment Period 2||0||
59669625|NCT02277106|75788543|FG000|COMPLETED|Stage 1: Treatment Period 2||13||
59669626|NCT02277106|75788544|FG001|COMPLETED|Stage 1: Treatment Period 2||12||
59669627|NCT02277106|75788545|FG002|COMPLETED|Stage 1: Treatment Period 2||0||
59669628|NCT02277106|75788543|FG000|NOT COMPLETED|Stage 1: Treatment Period 2||0||
59669629|NCT02277106|75788544|FG001|NOT COMPLETED|Stage 1: Treatment Period 2||0||
59669630|NCT02277106|75788545|FG002|NOT COMPLETED|Stage 1: Treatment Period 2||0||
59989249|NCT00151775|76104464|FG003|NOT COMPLETED|Period 4: Open Label||0||
59545678|NCT01003106|75644431|FG000|NOT COMPLETED|Month 6-Month 36||0||
59669631|NCT02277106|75788543|FG000|STARTED|Stage 2||0||
59669632|NCT02277106|75788544|FG001|STARTED|Stage 2||0||
59669633|NCT02277106|75788545|FG002|STARTED|Stage 2|Out of 25, 17 participants entered Stage 2 after Screening at Stage 2.|17||
59669634|NCT02277106|75788543|FG000|COMPLETED|Stage 2||0||
59669635|NCT02277106|75788544|FG001|COMPLETED|Stage 2||0||
59669636|NCT02277106|75788545|FG002|COMPLETED|Stage 2||16||
59669637|NCT02277106|75788543|FG000|NOT COMPLETED|Stage 2||0||
59669638|NCT02277106|75788544|FG001|NOT COMPLETED|Stage 2||0||
59669639|NCT02277106|75788545|FG002|NOT COMPLETED|Stage 2||1||
59669640|NCT02212015|75788556|FG000|STARTED|Overall Study||26||
59669641|NCT02212015|75788556|FG000|COMPLETED|Overall Study||25||
59669642|NCT02212015|75788556|FG000|NOT COMPLETED|Overall Study||1||
59669643|NCT00278343|75788563|FG000|STARTED|Overall Study||74||
59669644|NCT00278343|75788563|FG000|COMPLETED|Overall Study||74||
59669645|NCT00278343|75788563|FG000|NOT COMPLETED|Overall Study||0||
59669646|NCT02215096|75788568|FG000|STARTED|Run-In Period (Up to Week 2)||37||
59669647|NCT02215096|75788569|FG001|STARTED|Run-In Period (Up to Week 2)||0||
59669648|NCT02215096|75788570|FG002|STARTED|Run-In Period (Up to Week 2)||0||
59669649|NCT02215096|75788571|FG003|STARTED|Run-In Period (Up to Week 2)||0||
59669650|NCT02215096|75788572|FG004|STARTED|Run-In Period (Up to Week 2)||0||
59669651|NCT02215096|75788568|FG000|COMPLETED|Run-In Period (Up to Week 2)||36||
59669652|NCT02215096|75788569|FG001|COMPLETED|Run-In Period (Up to Week 2)||0||
59669653|NCT02215096|75788570|FG002|COMPLETED|Run-In Period (Up to Week 2)||0||
59669654|NCT02215096|75788571|FG003|COMPLETED|Run-In Period (Up to Week 2)||0||
59669655|NCT02215096|75788572|FG004|COMPLETED|Run-In Period (Up to Week 2)||0||
59669656|NCT02215096|75788568|FG000|NOT COMPLETED|Run-In Period (Up to Week 2)||1||
59669657|NCT02215096|75788569|FG001|NOT COMPLETED|Run-In Period (Up to Week 2)||0||
59669658|NCT02215096|75788570|FG002|NOT COMPLETED|Run-In Period (Up to Week 2)||0||
59669659|NCT02215096|75788571|FG003|NOT COMPLETED|Run-In Period (Up to Week 2)||0||
59669660|NCT02215096|75788572|FG004|NOT COMPLETED|Run-In Period (Up to Week 2)||0||
59669661|NCT02215096|75788568|FG000|STARTED|Combination TP (Up to Maximum 654 Days)||0||
59669662|NCT02215096|75788569|FG001|STARTED|Combination TP (Up to Maximum 654 Days)||11||
59669663|NCT02215096|75788570|FG002|STARTED|Combination TP (Up to Maximum 654 Days)||11||
59669664|NCT02215096|75788571|FG003|STARTED|Combination TP (Up to Maximum 654 Days)||12||
59669665|NCT02215096|75788572|FG004|STARTED|Combination TP (Up to Maximum 654 Days)||2||
59669666|NCT02215096|75788568|FG000|COMPLETED|Combination TP (Up to Maximum 654 Days)||0||
59669667|NCT02215096|75788569|FG001|COMPLETED|Combination TP (Up to Maximum 654 Days)||9||
59669668|NCT02215096|75788570|FG002|COMPLETED|Combination TP (Up to Maximum 654 Days)||10||
59669669|NCT02215096|75788571|FG003|COMPLETED|Combination TP (Up to Maximum 654 Days)||10||
59669670|NCT02215096|75788572|FG004|COMPLETED|Combination TP (Up to Maximum 654 Days)||1||
59669671|NCT02215096|75788568|FG000|NOT COMPLETED|Combination TP (Up to Maximum 654 Days)||0||
59669672|NCT02215096|75788569|FG001|NOT COMPLETED|Combination TP (Up to Maximum 654 Days)||2||
59669673|NCT02215096|75788570|FG002|NOT COMPLETED|Combination TP (Up to Maximum 654 Days)||1||
59669674|NCT02215096|75788571|FG003|NOT COMPLETED|Combination TP (Up to Maximum 654 Days)||2||
59669675|NCT02215096|75788572|FG004|NOT COMPLETED|Combination TP (Up to Maximum 654 Days)||1||
59669676|NCT01681147|75788591|FG000|STARTED|Overall Study||10||
59669677|NCT01681147|75788592|FG001|STARTED|Overall Study||8||
59669678|NCT01681147|75788593|FG002|STARTED|Overall Study||12||
59669679|NCT01681147|75788591|FG000|Baseline|Overall Study||9||
59669680|NCT01681147|75788592|FG001|Baseline|Overall Study||7||
59669681|NCT01681147|75788593|FG002|Baseline|Overall Study||10||
59669682|NCT01681147|75788591|FG000|3 Months|Overall Study||8||
59669683|NCT01681147|75788592|FG001|3 Months|Overall Study||5||
59669684|NCT01681147|75788593|FG002|3 Months|Overall Study||8||
59669685|NCT01681147|75788591|FG000|6 Months|Overall Study||7||
59669686|NCT01681147|75788592|FG001|6 Months|Overall Study||6||
59669687|NCT01681147|75788593|FG002|6 Months|Overall Study||7||
59669688|NCT01681147|75788591|FG000|9 Months|Overall Study||7||
59669689|NCT01681147|75788592|FG001|9 Months|Overall Study||5||
59669690|NCT01681147|75788593|FG002|9 Months|Overall Study||6||
59669691|NCT01681147|75788591|FG000|12 Months|Overall Study||5||
59669692|NCT01681147|75788592|FG001|12 Months|Overall Study||4||
59669693|NCT01681147|75788593|FG002|12 Months|Overall Study||5||
59669694|NCT01681147|75788591|FG000|COMPLETED|Overall Study||0||
59669695|NCT01681147|75788592|FG001|COMPLETED|Overall Study||0||
59669696|NCT01681147|75788593|FG002|COMPLETED|Overall Study||1||
59669697|NCT01681147|75788591|FG000|NOT COMPLETED|Overall Study||10||
59669698|NCT01681147|75788592|FG001|NOT COMPLETED|Overall Study||8||
59669699|NCT01681147|75788593|FG002|NOT COMPLETED|Overall Study||11||
59669700|NCT04011826|75788601|FG000|STARTED|Overall Study||45||
59669701|NCT04011826|75788601|FG000|COMPLETED|Overall Study||45||
59669702|NCT04011826|75788601|FG000|NOT COMPLETED|Overall Study||0||
59669703|NCT03189862|75788607|FG000|STARTED|Overall Study||153||
59669704|NCT03189862|75788608|FG001|STARTED|Overall Study||146||
59815872|NCT02242760|75938266|FG003|COMPLETED|Overall Study||48||
59669705|NCT03189862|75788607|FG000|COMPLETED|Overall Study||98||
59669706|NCT03189862|75788608|FG001|COMPLETED|Overall Study||84||
59669707|NCT03189862|75788607|FG000|NOT COMPLETED|Overall Study||55||
59669708|NCT03189862|75788608|FG001|NOT COMPLETED|Overall Study||62||
59669709|NCT04823221|75788614|FG000|STARTED|Overall Study||22||
59669710|NCT04823221|75788614|FG000|COMPLETED|Overall Study||22||
59669711|NCT04823221|75788614|FG000|NOT COMPLETED|Overall Study||0||
59669712|NCT02699086|75788618|FG000|STARTED|Overall Study||0||
59669713|NCT02699086|75788619|FG001|STARTED|Overall Study||6||
59669714|NCT02699086|75788618|FG000|COMPLETED|Overall Study||0||
59669715|NCT02699086|75788619|FG001|COMPLETED|Overall Study||6||
59669716|NCT02699086|75788618|FG000|NOT COMPLETED|Overall Study||0||
59669717|NCT02699086|75788619|FG001|NOT COMPLETED|Overall Study||0||
59669718|NCT01134601|75788627|FG000|STARTED|Overall Study||1||
59669719|NCT01134601|75788627|FG000|COMPLETED|Overall Study||1||
59669720|NCT01134601|75788627|FG000|NOT COMPLETED|Overall Study||0||
59669721|NCT01118026|75788631|FG000|STARTED|Overall Study||101||
59669722|NCT01118026|75788631|FG000|COMPLETED|Overall Study||101||
59669723|NCT01118026|75788631|FG000|NOT COMPLETED|Overall Study||0||
59669724|NCT00107614|75788636|FG000|STARTED|Overall Study||12||
59669725|NCT00107614|75788636|FG000|COMPLETED|Overall Study||0||
59669726|NCT00107614|75788636|FG000|NOT COMPLETED|Overall Study||12||
59669727|NCT00107380|75788640|FG000|STARTED|Overall Study||86||
59669728|NCT00107380|75788640|FG000|Eligible|Overall Study||84||
59669729|NCT00107380|75788640|FG000|COMPLETED|Overall Study||56||
59669730|NCT00107380|75788640|FG000|NOT COMPLETED|Overall Study||30||
59669731|NCT01340014|75788647|FG000|STARTED|Period 1, First 7 Days||55||
59669732|NCT01340014|75788648|FG001|STARTED|Period 1, First 7 Days||57||
59669733|NCT01340014|75788647|FG000|COMPLETED|Period 1, First 7 Days||53||
59815873|NCT02242760|75938267|FG004|COMPLETED|Overall Study||48||
59989250|NCT00151775|76104465|FG004|NOT COMPLETED|Period 4: Open Label||30||
59989251|NCT00151775|76104466|FG005|NOT COMPLETED|Period 4: Open Label||0||
59989252|NCT00151775|76104467|FG006|NOT COMPLETED|Period 4: Open Label||0||
59545679|NCT01003106|75644432|FG001|NOT COMPLETED|Month 6-Month 36||0||
59545680|NCT01003106|75644433|FG002|NOT COMPLETED|Month 6-Month 36||1||
59545681|NCT01003106|75644434|FG003|NOT COMPLETED|Month 6-Month 36||0||
59545682|NCT01003106|75644435|FG004|NOT COMPLETED|Month 6-Month 36||0||
59545683|NCT01003106|75644436|FG005|NOT COMPLETED|Month 6-Month 36||0||
59545684|NCT01003106|75644437|FG006|NOT COMPLETED|Month 6-Month 36||1||
59545685|NCT01003106|75644438|FG007|NOT COMPLETED|Month 6-Month 36||0||
59545686|NCT01003418|75644454|FG000|STARTED|Overall Study||5||
59545687|NCT01003418|75644455|FG001|STARTED|Overall Study||3||
59545688|NCT01003418|75644454|FG000|COMPLETED|Overall Study||5||
59545689|NCT01003418|75644455|FG001|COMPLETED|Overall Study||3||
59545690|NCT01003418|75644454|FG000|NOT COMPLETED|Overall Study||0||
59545691|NCT01003418|75644455|FG001|NOT COMPLETED|Overall Study||0||
59545692|NCT02162576|75644461|FG000|STARTED|Overall Study||95||
59545693|NCT02162576|75644461|FG000|COMPLETED|Overall Study||95||
59545694|NCT02162576|75644461|FG000|NOT COMPLETED|Overall Study||0||
59545695|NCT01004042|75644468|FG000|STARTED|Overall Study||25||
59545696|NCT01004042|75644469|FG001|STARTED|Overall Study||25||
59545697|NCT01004042|75644468|FG000|COMPLETED|Overall Study||21||
59545698|NCT01004042|75644469|FG001|COMPLETED|Overall Study||25||
59545699|NCT01004042|75644468|FG000|NOT COMPLETED|Overall Study||4||
59545700|NCT01004042|75644469|FG001|NOT COMPLETED|Overall Study||0||
59545701|NCT01004354|75644475|FG000|STARTED|Overall Study||12||
59545702|NCT01004354|75644475|FG000|COMPLETED|Overall Study||12||
59545703|NCT01004354|75644475|FG000|NOT COMPLETED|Overall Study||0||
59545704|NCT02417064|75644482|FG000|STARTED|Double-blind Induction Phase (4 Weeks)||117||
59669734|NCT01340014|75788648|FG001|COMPLETED|Period 1, First 7 Days||57||
59669735|NCT01340014|75788647|FG000|NOT COMPLETED|Period 1, First 7 Days||2||
59669736|NCT01340014|75788648|FG001|NOT COMPLETED|Period 1, First 7 Days||0||
59669737|NCT01340014|75788647|FG000|STARTED|Period 2, Second 7 Days||53||
59669738|NCT01340014|75788648|FG001|STARTED|Period 2, Second 7 Days||57||
59669739|NCT01340014|75788647|FG000|COMPLETED|Period 2, Second 7 Days||53||
59669740|NCT01340014|75788648|FG001|COMPLETED|Period 2, Second 7 Days||56||
59669741|NCT01340014|75788647|FG000|NOT COMPLETED|Period 2, Second 7 Days||0||
59669742|NCT01340014|75788648|FG001|NOT COMPLETED|Period 2, Second 7 Days||1||
59669743|NCT01339897|75788658|FG000|STARTED|Overall Study||7||
59669744|NCT01339897|75788659|FG001|STARTED|Overall Study||6||
59815874|NCT02242760|75938263|FG000|NOT COMPLETED|Overall Study||3||
59815875|NCT02242760|75938264|FG001|NOT COMPLETED|Overall Study||9||
59989253|NCT00151775|76104468|FG007|NOT COMPLETED|Period 4: Open Label||0||
59989254|NCT00151775|76104469|FG008|NOT COMPLETED|Period 4: Open Label||0||
59989255|NCT00151775|76104470|FG009|NOT COMPLETED|Period 4: Open Label||21||
59545705|NCT02417064|75644483|FG001|STARTED|Double-blind Induction Phase (4 Weeks)||116||
59545706|NCT02417064|75644484|FG002|STARTED|Double-blind Induction Phase (4 Weeks)||113||
59545707|NCT02417064|75644482|FG000|Full Analysis Set (FAS)|Double-blind Induction Phase (4 Weeks)||115||
59545708|NCT02417064|75644483|FG001|Full Analysis Set (FAS)|Double-blind Induction Phase (4 Weeks)||114||
59669745|NCT01339897|75788660|FG002|STARTED|Overall Study||6||
59669746|NCT01339897|75788661|FG003|STARTED|Overall Study||6||
59669747|NCT01339897|75788658|FG000|COMPLETED|Overall Study||6||
59545709|NCT02417064|75644484|FG002|Full Analysis Set (FAS)|Double-blind Induction Phase (4 Weeks)||113||
59545710|NCT02417064|75644482|FG000|Safety Analysis Set|Double-blind Induction Phase (4 Weeks)||115||
59545711|NCT02417064|75644483|FG001|Safety Analysis Set|Double-blind Induction Phase (4 Weeks)||116||
59669748|NCT01339897|75788659|FG001|COMPLETED|Overall Study||6||
59669749|NCT01339897|75788660|FG002|COMPLETED|Overall Study||6||
59669750|NCT01339897|75788661|FG003|COMPLETED|Overall Study||5||
59669751|NCT01339897|75788658|FG000|NOT COMPLETED|Overall Study||1||
59669752|NCT01339897|75788659|FG001|NOT COMPLETED|Overall Study||0||
59669753|NCT01339897|75788660|FG002|NOT COMPLETED|Overall Study||0||
59669754|NCT01339897|75788661|FG003|NOT COMPLETED|Overall Study||1||
59669755|NCT01339429|75788673|FG000|STARTED|Overall Study||41||
59669756|NCT01339429|75788673|FG000|COMPLETED|Overall Study||37||
59669757|NCT01339429|75788673|FG000|NOT COMPLETED|Overall Study||4||
59669758|NCT01339390|75788679|FG000|STARTED|Overall Study||1571||
59669759|NCT01339390|75788680|FG001|STARTED|Overall Study||1598||
59669760|NCT01339390|75788679|FG000|COMPLETED|Overall Study||1414||
59669761|NCT01339390|75788680|FG001|COMPLETED|Overall Study||1442||
59669762|NCT01339390|75788679|FG000|NOT COMPLETED|Overall Study||157||
59669763|NCT01339390|75788680|FG001|NOT COMPLETED|Overall Study||156||
59669764|NCT01339273|75788688|FG000|STARTED|Overall Study||36||
59669765|NCT01339273|75788689|FG001|STARTED|Overall Study||36||
59669766|NCT01339273|75788688|FG000|COMPLETED|Overall Study||28||
59669767|NCT01339273|75788689|FG001|COMPLETED|Overall Study||28||
59669768|NCT01339273|75788688|FG000|NOT COMPLETED|Overall Study||8||
59669769|NCT01339273|75788689|FG001|NOT COMPLETED|Overall Study||8||
59669770|NCT01334866|75788695|FG000|STARTED|Overall Study|91 subjects were enrolled in the study; with 89 subjects receiving the study treatment.|91||
59669771|NCT01334866|75788695|FG000|COMPLETED|Overall Study||72||
59669772|NCT01334866|75788695|FG000|NOT COMPLETED|Overall Study||19||
59669773|NCT01334710|75788701|FG000|STARTED|Overall Study||3||
59669774|NCT01334710|75788701|FG000|COMPLETED|Overall Study|Due to safety signals in a parallel trial ON OSI906 in hepatocellular cancer the trial was stopped.|0||
59669775|NCT01334710|75788701|FG000|NOT COMPLETED|Overall Study||3||
59669776|NCT01334554|75788708|FG000|STARTED|Overall Study||23||
59669777|NCT01334554|75788709|FG001|STARTED|Overall Study||23||
59669778|NCT01334554|75788708|FG000|COMPLETED|Overall Study||19||
59669779|NCT01334554|75788709|FG001|COMPLETED|Overall Study||21||
59669780|NCT01334554|75788708|FG000|NOT COMPLETED|Overall Study||4||
59669781|NCT01334554|75788709|FG001|NOT COMPLETED|Overall Study||2||
59669782|NCT01332799|75788719|FG000|STARTED|Overall Study||10||
59669783|NCT01332799|75788720|FG001|STARTED|Overall Study||10||
59669784|NCT01332799|75788719|FG000|COMPLETED|Overall Study||0||
59669785|NCT01332799|75788720|FG001|COMPLETED|Overall Study||0||
59669786|NCT01332799|75788719|FG000|NOT COMPLETED|Overall Study||10||
59669787|NCT01332799|75788720|FG001|NOT COMPLETED|Overall Study||10||
59669788|NCT01332331|75788728|FG000|STARTED|Overall Study||21||
59669789|NCT01332331|75788729|FG001|STARTED|Overall Study||20||
59669790|NCT01332331|75788728|FG000|COMPLETED|Overall Study||19||
59669791|NCT01332331|75788729|FG001|COMPLETED|Overall Study||18||
59669792|NCT01332331|75788728|FG000|NOT COMPLETED|Overall Study||2||
59669793|NCT01332331|75788729|FG001|NOT COMPLETED|Overall Study||2||
59669794|NCT01332292|75788736|FG000|STARTED|Treatment Period 1 (14 Days)||14||
59669795|NCT01332292|75788737|FG001|STARTED|Treatment Period 1 (14 Days)||13||
59669796|NCT01332292|75788736|FG000|COMPLETED|Treatment Period 1 (14 Days)||12||
59669797|NCT01332292|75788737|FG001|COMPLETED|Treatment Period 1 (14 Days)||12||
59669798|NCT01332292|75788736|FG000|NOT COMPLETED|Treatment Period 1 (14 Days)||2||
59669799|NCT01332292|75788737|FG001|NOT COMPLETED|Treatment Period 1 (14 Days)||1||
59669800|NCT01332292|75788736|FG000|STARTED|Washout Period (>=7 Days)||12||
59669801|NCT01332292|75788737|FG001|STARTED|Washout Period (>=7 Days)||12||
59669802|NCT01332292|75788736|FG000|COMPLETED|Washout Period (>=7 Days)||12||
59669803|NCT01332292|75788737|FG001|COMPLETED|Washout Period (>=7 Days)||12||
59669804|NCT01332292|75788736|FG000|NOT COMPLETED|Washout Period (>=7 Days)||0||
59669805|NCT01332292|75788737|FG001|NOT COMPLETED|Washout Period (>=7 Days)||0||
59669806|NCT01332292|75788736|FG000|STARTED|Treatment Period 2 (14 Days)||12||
59669807|NCT01332292|75788737|FG001|STARTED|Treatment Period 2 (14 Days)||12||
59669808|NCT01332292|75788736|FG000|COMPLETED|Treatment Period 2 (14 Days)||11||
59669809|NCT01332292|75788737|FG001|COMPLETED|Treatment Period 2 (14 Days)||11||
59669810|NCT01332292|75788736|FG000|NOT COMPLETED|Treatment Period 2 (14 Days)||1||
59669811|NCT01332292|75788737|FG001|NOT COMPLETED|Treatment Period 2 (14 Days)||1||
59669812|NCT01332019|75788747|FG000|STARTED|Overall Study||530||
59669813|NCT01332019|75788748|FG001|STARTED|Overall Study||547||
59669814|NCT01332019|75788747|FG000|COMPLETED|Overall Study||417||
59669815|NCT01332019|75788748|FG001|COMPLETED|Overall Study||425||
59669816|NCT01332019|75788747|FG000|NOT COMPLETED|Overall Study||113||
59669817|NCT01332019|75788748|FG001|NOT COMPLETED|Overall Study||122||
59669818|NCT01331239|75788756|FG000|STARTED|Part I: Core Study||12||
59669819|NCT01331239|75788757|FG001|STARTED|Part I: Core Study||0||
59669820|NCT01331239|75788758|FG002|STARTED|Part I: Core Study||0||
59669821|NCT01331239|75788756|FG000|COMPLETED|Part I: Core Study||12||
59669822|NCT01331239|75788757|FG001|COMPLETED|Part I: Core Study||0||
59669823|NCT01331239|75788758|FG002|COMPLETED|Part I: Core Study||0||
59669824|NCT01331239|75788756|FG000|NOT COMPLETED|Part I: Core Study||0||
59669825|NCT01331239|75788757|FG001|NOT COMPLETED|Part I: Core Study||0||
59669826|NCT01331239|75788758|FG002|NOT COMPLETED|Part I: Core Study||0||
59669827|NCT01331239|75788756|FG000|STARTED|Part II: Core Study||0||
59669828|NCT01331239|75788757|FG001|STARTED|Part II: Core Study||15||
59669829|NCT01331239|75788758|FG002|STARTED|Part II: Core Study||4||
59669830|NCT01331239|75788756|FG000|COMPLETED|Part II: Core Study||0||
59669831|NCT01331239|75788757|FG001|COMPLETED|Part II: Core Study||7||
59669832|NCT01331239|75788758|FG002|COMPLETED|Part II: Core Study||3||
59669833|NCT01331239|75788756|FG000|NOT COMPLETED|Part II: Core Study||0||
59669834|NCT01331239|75788757|FG001|NOT COMPLETED|Part II: Core Study||8||
59669835|NCT01331239|75788758|FG002|NOT COMPLETED|Part II: Core Study||1||
59669836|NCT01331161|75788776|FG000|STARTED|Overall Study||44||
59669837|NCT01331161|75788777|FG001|STARTED|Overall Study||33||
59669838|NCT01331161|75788776|FG000|COMPLETED|Overall Study||43||
59669839|NCT01331161|75788777|FG001|COMPLETED|Overall Study||31||
59669840|NCT01331161|75788776|FG000|NOT COMPLETED|Overall Study||1||
59669841|NCT01331161|75788777|FG001|NOT COMPLETED|Overall Study||2||
59669842|NCT01331005|75788787|FG000|STARTED|Overall Study||64||
59669843|NCT01331005|75788788|FG001|STARTED|Overall Study||61||
59669844|NCT01331005|75788787|FG000|COMPLETED|Overall Study||60||
59669845|NCT01331005|75788788|FG001|COMPLETED|Overall Study||57||
59669846|NCT01331005|75788787|FG000|NOT COMPLETED|Overall Study||4||
59669847|NCT01331005|75788788|FG001|NOT COMPLETED|Overall Study||4||
59669848|NCT01330459|75788796|FG000|STARTED|Overall Study||61||
59669849|NCT01330459|75788797|FG001|STARTED|Overall Study||60||
59669850|NCT01330459|75788796|FG000|COMPLETED|Overall Study||61||
59669851|NCT01330459|75788797|FG001|COMPLETED|Overall Study||58||
59669852|NCT01330459|75788796|FG000|NOT COMPLETED|Overall Study||0||
59669853|NCT01330459|75788797|FG001|NOT COMPLETED|Overall Study||2||
59669854|NCT01330381|75788807|FG000|STARTED|Double-blind Treatment Period (8 Weeks)||107||
59669855|NCT01330381|75788808|FG001|STARTED|Double-blind Treatment Period (8 Weeks)||108||
59669856|NCT01330381|75788809|FG002|STARTED|Double-blind Treatment Period (8 Weeks)||0||
59669857|NCT01330381|75788807|FG000|Received Treatment|Double-blind Treatment Period (8 Weeks)||106||
59669858|NCT01330381|75788808|FG001|Received Treatment|Double-blind Treatment Period (8 Weeks)||107||
59669859|NCT01330381|75788809|FG002|Received Treatment|Double-blind Treatment Period (8 Weeks)||0||
59669860|NCT01330381|75788807|FG000|COMPLETED|Double-blind Treatment Period (8 Weeks)||96||
59669861|NCT01330381|75788808|FG001|COMPLETED|Double-blind Treatment Period (8 Weeks)||101||
59669862|NCT01330381|75788809|FG002|COMPLETED|Double-blind Treatment Period (8 Weeks)||0||
59989256|NCT00151775|76104471|FG010|NOT COMPLETED|Period 4: Open Label||0||
59989257|NCT00151775|76104472|FG011|NOT COMPLETED|Period 4: Open Label||0||
59989258|NCT02258464|76104515|FG000|STARTED|Overall Study||49|Participants randomized in the study|
59989259|NCT02258464|76104516|FG001|STARTED|Overall Study||50|Participants randomized in the study|
59989260|NCT02258464|76104515|FG000|COMPLETED|Overall Study||32|Participants completed treatment of Radium 223/Placebo|
59989261|NCT02258464|76104516|FG001|COMPLETED|Overall Study||25|Participants completed treatment of Radium 223/Placebo|
59989262|NCT02258464|76104515|FG000|NOT COMPLETED|Overall Study||17||
59989263|NCT02258464|76104516|FG001|NOT COMPLETED|Overall Study||25||
59989264|NCT02682901|76104524|FG000|STARTED|Overall Study||43||
59989265|NCT02682901|76104525|FG001|STARTED|Overall Study||41||
59989266|NCT02682901|76104524|FG000|Completed 4 Weeks|Overall Study||38||
59989267|NCT02682901|76104525|FG001|Completed 4 Weeks|Overall Study||39||
59989268|NCT02682901|76104524|FG000|Completed 12 Weeks|Overall Study||36||
59989269|NCT02682901|76104525|FG001|Completed 12 Weeks|Overall Study||37||
59989270|NCT02682901|76104524|FG000|COMPLETED|Overall Study||33||
59989271|NCT02682901|76104525|FG001|COMPLETED|Overall Study||37||
59669863|NCT01330381|75788807|FG000|NOT COMPLETED|Double-blind Treatment Period (8 Weeks)||11||
59669864|NCT01330381|75788808|FG001|NOT COMPLETED|Double-blind Treatment Period (8 Weeks)||7||
59669865|NCT01330381|75788809|FG002|NOT COMPLETED|Double-blind Treatment Period (8 Weeks)||0||
59669866|NCT01330381|75788807|FG000|STARTED|Open-label Treatment Period (16 Weeks)||98||
59669867|NCT01330381|75788808|FG001|STARTED|Open-label Treatment Period (16 Weeks)||0||
59669868|NCT01330381|75788809|FG002|STARTED|Open-label Treatment Period (16 Weeks)||99||
59669869|NCT01330381|75788807|FG000|COMPLETED|Open-label Treatment Period (16 Weeks)||88||
59669870|NCT01330381|75788808|FG001|COMPLETED|Open-label Treatment Period (16 Weeks)||0||
59669871|NCT01330381|75788809|FG002|COMPLETED|Open-label Treatment Period (16 Weeks)||81||
59669872|NCT01330381|75788807|FG000|NOT COMPLETED|Open-label Treatment Period (16 Weeks)||10||
59669873|NCT01330381|75788808|FG001|NOT COMPLETED|Open-label Treatment Period (16 Weeks)||0||
59669874|NCT01330381|75788809|FG002|NOT COMPLETED|Open-label Treatment Period (16 Weeks)||18||
59989272|NCT02682901|76104524|FG000|NOT COMPLETED|Overall Study||10||
59989273|NCT02682901|76104525|FG001|NOT COMPLETED|Overall Study||4||
59989274|NCT02258074|76104535|FG000|STARTED|Overall Study||53||
59989275|NCT02258074|76104536|FG001|STARTED|Overall Study||50||
59989276|NCT02258074|76104537|FG002|STARTED|Overall Study||51||
59989277|NCT02258074|76104538|FG003|STARTED|Overall Study||51||
59989278|NCT02258074|76104535|FG000|COMPLETED|Overall Study||52|Completed with data available for the primary serum phosphorus analysis.|
59989279|NCT02258074|76104536|FG001|COMPLETED|Overall Study||50|Completed with data available for the primary serum phosphorus analysis.|
59989280|NCT02258074|76104537|FG002|COMPLETED|Overall Study||51|Completed with data available for the primary serum phosphorus analysis.|
59989281|NCT02258074|76104538|FG003|COMPLETED|Overall Study||51|Completed with data available for the primary serum phosphorus analysis.|
59669875|NCT01330303|75788818|FG000|STARTED|Period 1||20||
59669876|NCT01330303|75788819|FG001|STARTED|Period 1||20||
59669877|NCT01330303|75788818|FG000|COMPLETED|Period 1||19||
59669878|NCT01330303|75788819|FG001|COMPLETED|Period 1||18||
59669879|NCT01330303|75788818|FG000|NOT COMPLETED|Period 1||1||
59669880|NCT01330303|75788819|FG001|NOT COMPLETED|Period 1||2||
59669881|NCT01330303|75788818|FG000|STARTED|7-Day Washout Period||19||
59669882|NCT01330303|75788819|FG001|STARTED|7-Day Washout Period||18||
59669883|NCT01330303|75788818|FG000|COMPLETED|7-Day Washout Period||19||
59669884|NCT01330303|75788819|FG001|COMPLETED|7-Day Washout Period||18||
59669885|NCT01330303|75788818|FG000|NOT COMPLETED|7-Day Washout Period||0||
59669886|NCT01330303|75788819|FG001|NOT COMPLETED|7-Day Washout Period||0||
59669887|NCT01330303|75788818|FG000|STARTED|Period 2||19||
59669888|NCT01330303|75788819|FG001|STARTED|Period 2||18||
59669889|NCT01330303|75788818|FG000|COMPLETED|Period 2||19||
59669890|NCT01330303|75788819|FG001|COMPLETED|Period 2||18||
59669891|NCT01330303|75788818|FG000|NOT COMPLETED|Period 2||0||
59669892|NCT01330303|75788819|FG001|NOT COMPLETED|Period 2||0||
59669893|NCT01330108|75788826|FG000|STARTED|Overall Study||32||
59669894|NCT01330108|75788826|FG000|COMPLETED|Overall Study||28||
59669895|NCT01330108|75788826|FG000|NOT COMPLETED|Overall Study||4||
59669896|NCT05117229|75788830|FG000|STARTED|Overall Study||40||
59669897|NCT05117229|75788830|FG000|COMPLETED|Overall Study||40||
59669898|NCT05117229|75788830|FG000|NOT COMPLETED|Overall Study||0||
59669899|NCT04671901|75788834|FG000|STARTED|Overall Study||2||
59669900|NCT04671901|75788834|FG000|COMPLETED|Overall Study||2||
59669901|NCT04671901|75788834|FG000|NOT COMPLETED|Overall Study||0||
59669902|NCT04543409|75788840|FG000|STARTED|Double-Blind Treatment Period||103||
59669903|NCT04543409|75788841|FG001|STARTED|Double-Blind Treatment Period||107||
59669904|NCT04543409|75788840|FG000|COMPLETED|Double-Blind Treatment Period||101||
59669905|NCT04543409|75788841|FG001|COMPLETED|Double-Blind Treatment Period||106||
59669906|NCT04543409|75788840|FG000|NOT COMPLETED|Double-Blind Treatment Period||2||
59669907|NCT04543409|75788841|FG001|NOT COMPLETED|Double-Blind Treatment Period||1||
59669908|NCT04543409|75788840|FG000|STARTED|Open-Label Treatment Period|One participant enrolled in OL treatment period off study drug (not included in this count).|100||
59669909|NCT04543409|75788841|FG001|STARTED|Open-Label Treatment Period|One participant chose not to enroll in the OL treatment period.|105||
59669910|NCT04543409|75788840|FG000|COMPLETED|Open-Label Treatment Period||79||
59669911|NCT04543409|75788841|FG001|COMPLETED|Open-Label Treatment Period||82||
59669912|NCT04543409|75788840|FG000|NOT COMPLETED|Open-Label Treatment Period||21||
59669913|NCT04543409|75788841|FG001|NOT COMPLETED|Open-Label Treatment Period||23||
59669914|NCT04543409|75788840|FG000|STARTED|Open-Label Extension Treatment Period|34 participants from previous period chose not to enroll in optional OLE period.|45||
59669915|NCT04543409|75788841|FG001|STARTED|Open-Label Extension Treatment Period|34 participants from previous period chose not to enroll in optional OLE period.|48||
59669916|NCT04543409|75788840|FG000|COMPLETED|Open-Label Extension Treatment Period||0||
59669917|NCT04543409|75788841|FG001|COMPLETED|Open-Label Extension Treatment Period||0||
59669918|NCT04543409|75788840|FG000|NOT COMPLETED|Open-Label Extension Treatment Period||45||
59669919|NCT04543409|75788841|FG001|NOT COMPLETED|Open-Label Extension Treatment Period||48||
59669920|NCT04434937|75788848|FG000|STARTED|Overall Study||42||
59669921|NCT04434937|75788848|FG000|COMPLETED|Overall Study||0||
59669922|NCT04434937|75788848|FG000|NOT COMPLETED|Overall Study||42||
59669923|NCT04268771|75788855|FG000|STARTED|Overall Study||70||
59669924|NCT04268771|75788856|FG001|STARTED|Overall Study||70||
59669925|NCT04268771|75788855|FG000|COMPLETED|Overall Study||66||
59669926|NCT04268771|75788856|FG001|COMPLETED|Overall Study||68||
59669927|NCT04268771|75788855|FG000|NOT COMPLETED|Overall Study||4||
59669928|NCT04268771|75788856|FG001|NOT COMPLETED|Overall Study||2||
59669929|NCT04086823|75788866|FG000|STARTED|Overall Study||8||
59669930|NCT04086823|75788867|FG001|STARTED|Overall Study||4||
59669931|NCT04086823|75788868|FG002|STARTED|Overall Study||10||
59669932|NCT04086823|75788869|FG003|STARTED|Overall Study||6||
59669933|NCT04086823|75788866|FG000|COMPLETED|Overall Study||8||
59669934|NCT04086823|75788867|FG001|COMPLETED|Overall Study||4||
59669935|NCT04086823|75788868|FG002|COMPLETED|Overall Study||10||
59669936|NCT04086823|75788869|FG003|COMPLETED|Overall Study||6||
59669937|NCT04086823|75788866|FG000|NOT COMPLETED|Overall Study||0||
59669938|NCT04086823|75788867|FG001|NOT COMPLETED|Overall Study||0||
59669939|NCT04086823|75788868|FG002|NOT COMPLETED|Overall Study||0||
59669940|NCT04086823|75788869|FG003|NOT COMPLETED|Overall Study||0||
59669941|NCT04030143|75788884|FG000|STARTED|Overall Study||132||
59669942|NCT04030143|75788885|FG001|STARTED|Overall Study||134||
59669943|NCT04030143|75788884|FG000|Safety Sample|Overall Study||132|Safety sample included all randomized participants who received at least 1 dose of aripiprazole injection, regardless of any protocol violation.|
59669944|NCT04030143|75788885|FG001|Safety Sample|Overall Study||134|Safety sample included all randomized participants who received at least 1 dose of aripiprazole injection, regardless of any protocol violation.|
59669945|NCT04030143|75788884|FG000|Efficacy Sample|Overall Study||132|Efficacy sample included all randomized participants who received at least 1 dose of aripiprazole injection and had at least 1 efficacy assessment.|
59669946|NCT04030143|75788885|FG001|Efficacy Sample|Overall Study||134|Efficacy sample included all randomized participants who received at least 1 dose of aripiprazole injection and had at least 1 efficacy assessment.|
59669947|NCT04030143|75788884|FG000|COMPLETED|Overall Study||102||
59669948|NCT04030143|75788885|FG001|COMPLETED|Overall Study||92||
59669949|NCT04030143|75788884|FG000|NOT COMPLETED|Overall Study||30||
59669950|NCT04030143|75788885|FG001|NOT COMPLETED|Overall Study||42||
59669951|NCT03934931|75788900|FG000|STARTED|Overall Study||552||
59669952|NCT03934931|75788901|FG001|STARTED|Overall Study||552||
59669953|NCT03934931|75788902|FG002|STARTED|Overall Study|Participant Choice between Facilitated DOT and Facilitated SAT was not split up to separately describe the number of participants who received each treatment regiment because the Participant Choice arm was analyzed as a single arm in the primary analysis.|552||
59669954|NCT03934931|75788900|FG000|COMPLETED|Overall Study||551||
59669955|NCT03934931|75788901|FG001|COMPLETED|Overall Study||552||
59669956|NCT03934931|75788902|FG002|COMPLETED|Overall Study||552||
59669957|NCT03934931|75788900|FG000|NOT COMPLETED|Overall Study||1||
59669958|NCT03934931|75788901|FG001|NOT COMPLETED|Overall Study||0||
59669959|NCT03934931|75788902|FG002|NOT COMPLETED|Overall Study||0||
59669960|NCT03927144|75788912|FG000|STARTED|Core Phase||413||
59669961|NCT03927144|75788913|FG001|STARTED|Core Phase||208||
59669962|NCT03927144|75788912|FG000|COMPLETED|Core Phase||377|Completed 52 week core phase|
59669963|NCT03927144|75788913|FG001|COMPLETED|Core Phase||146|Completed 52 week core phase|
59669964|NCT03927144|75788912|FG000|NOT COMPLETED|Core Phase||36||
59669965|NCT03927144|75788913|FG001|NOT COMPLETED|Core Phase||62||
59669966|NCT03927144|75788912|FG000|STARTED|Extension Phase|Eligible core phase completers (completed Week 52 and were benefitting from AMG334 treatment) entered the extension phase|343||
59669967|NCT03927144|75788913|FG001|STARTED|Extension Phase|Eligible core phase completers (completed Week 52 and were in need of a treatment switch) entered the extension phase|118||
59669968|NCT03927144|75788912|FG000|COMPLETED|Extension Phase||328||
59669969|NCT03927144|75788913|FG001|COMPLETED|Extension Phase||108||
59669970|NCT03927144|75788912|FG000|NOT COMPLETED|Extension Phase||15||
59669971|NCT03927144|75788913|FG001|NOT COMPLETED|Extension Phase||10||
59669972|NCT03859973|75788923|FG000|STARTED|Overall Study||99||
59669973|NCT03859973|75788924|FG001|STARTED|Overall Study||101||
59669974|NCT03859973|75788923|FG000|COMPLETED|Overall Study||79|Completed trial medication|
59669975|NCT03859973|75788924|FG001|COMPLETED|Overall Study||75|Completed trial medication|
59669976|NCT03859973|75788923|FG000|NOT COMPLETED|Overall Study||20||
59669977|NCT03859973|75788924|FG001|NOT COMPLETED|Overall Study||26||
59669978|NCT03761394|75788934|FG000|STARTED|14-day Intervention & Control Period||90||
59669979|NCT03761394|75788935|FG001|STARTED|14-day Intervention & Control Period||30||
59669980|NCT03761394|75788936|FG002|STARTED|14-day Intervention & Control Period||0||
59669981|NCT03761394|75788937|FG003|STARTED|14-day Intervention & Control Period||0||
59669982|NCT03761394|75788934|FG000|COMPLETED|14-day Intervention & Control Period||87||
59669983|NCT03761394|75788935|FG001|COMPLETED|14-day Intervention & Control Period||28||
59669984|NCT03761394|75788936|FG002|COMPLETED|14-day Intervention & Control Period||0||
59669985|NCT03761394|75788937|FG003|COMPLETED|14-day Intervention & Control Period||0||
59669986|NCT03761394|75788934|FG000|NOT COMPLETED|14-day Intervention & Control Period||3||
59669987|NCT03761394|75788935|FG001|NOT COMPLETED|14-day Intervention & Control Period||2||
59669988|NCT03761394|75788936|FG002|NOT COMPLETED|14-day Intervention & Control Period||0||
59669989|NCT03761394|75788937|FG003|NOT COMPLETED|14-day Intervention & Control Period||0||
59669990|NCT03761394|75788934|FG000|STARTED|30-day Period (Extension 44 Days)||0||
59669991|NCT03761394|75788935|FG001|STARTED|30-day Period (Extension 44 Days)||0||
59669992|NCT03761394|75788936|FG002|STARTED|30-day Period (Extension 44 Days)||57||
59669993|NCT03761394|75788937|FG003|STARTED|30-day Period (Extension 44 Days)||58||
59669994|NCT03761394|75788934|FG000|COMPLETED|30-day Period (Extension 44 Days)||0||
59669995|NCT03761394|75788935|FG001|COMPLETED|30-day Period (Extension 44 Days)||0||
59669996|NCT03761394|75788936|FG002|COMPLETED|30-day Period (Extension 44 Days)||55||
59669997|NCT03761394|75788937|FG003|COMPLETED|30-day Period (Extension 44 Days)||55||
59669998|NCT03761394|75788934|FG000|NOT COMPLETED|30-day Period (Extension 44 Days)||0||
59669999|NCT03761394|75788935|FG001|NOT COMPLETED|30-day Period (Extension 44 Days)||0||
59670000|NCT03761394|75788936|FG002|NOT COMPLETED|30-day Period (Extension 44 Days)||2||
59670001|NCT03761394|75788937|FG003|NOT COMPLETED|30-day Period (Extension 44 Days)||3||
59670002|NCT03699020|75788949|FG000|STARTED|Overall Study||7||
59670003|NCT03699020|75788950|FG001|STARTED|Overall Study||5||
59670004|NCT03699020|75788949|FG000|Intervention Attendance Completion|Overall Study||4||
59670005|NCT03699020|75788950|FG001|Intervention Attendance Completion|Overall Study||3||
59670006|NCT03699020|75788949|FG000|COMPLETED|Overall Study||4||
59670007|NCT03699020|75788950|FG001|COMPLETED|Overall Study||3||
59670008|NCT03699020|75788949|FG000|NOT COMPLETED|Overall Study||3||
59670009|NCT03699020|75788950|FG001|NOT COMPLETED|Overall Study||2||
59670010|NCT03684811|75788962|FG000|STARTED|Overall Study||26||
59670011|NCT03684811|75788963|FG001|STARTED|Overall Study||6||
59670012|NCT03684811|75788964|FG002|STARTED|Overall Study||8||
59670013|NCT03684811|75788965|FG003|STARTED|Overall Study||0||
59670014|NCT03684811|75788966|FG004|STARTED|Overall Study||23||
59670015|NCT03684811|75788967|FG005|STARTED|Overall Study||0||
59670016|NCT03684811|75788968|FG006|STARTED|Overall Study||24||
59670017|NCT03684811|75788969|FG007|STARTED|Overall Study||0||
59670018|NCT03684811|75788970|FG008|STARTED|Overall Study||6||
59670019|NCT03684811|75788962|FG000|COMPLETED|Overall Study||0||
59670020|NCT03684811|75788963|FG001|COMPLETED|Overall Study||0||
59670021|NCT03684811|75788964|FG002|COMPLETED|Overall Study||0||
59670022|NCT03684811|75788965|FG003|COMPLETED|Overall Study||0||
59670023|NCT03684811|75788966|FG004|COMPLETED|Overall Study||0||
59670024|NCT03684811|75788967|FG005|COMPLETED|Overall Study||0||
59670025|NCT03684811|75788968|FG006|COMPLETED|Overall Study||0||
59670026|NCT03684811|75788969|FG007|COMPLETED|Overall Study||0||
59670027|NCT03684811|75788970|FG008|COMPLETED|Overall Study||0||
59670028|NCT03684811|75788962|FG000|NOT COMPLETED|Overall Study||26||
59670029|NCT03684811|75788963|FG001|NOT COMPLETED|Overall Study||6||
59670030|NCT03684811|75788964|FG002|NOT COMPLETED|Overall Study||8||
59670031|NCT03684811|75788965|FG003|NOT COMPLETED|Overall Study||0||
59670032|NCT03684811|75788966|FG004|NOT COMPLETED|Overall Study||23||
59670033|NCT03684811|75788967|FG005|NOT COMPLETED|Overall Study||0||
59670034|NCT03684811|75788968|FG006|NOT COMPLETED|Overall Study||24||
59670035|NCT03684811|75788969|FG007|NOT COMPLETED|Overall Study||0||
59670036|NCT03684811|75788970|FG008|NOT COMPLETED|Overall Study||6||
59670037|NCT03661723|75788988|FG000|STARTED|Overall Study||6||
59670038|NCT03661723|75788989|FG001|STARTED|Overall Study||24||
59670039|NCT03661723|75788990|FG002|STARTED|Overall Study||6||
59670040|NCT03661723|75788991|FG003|STARTED|Overall Study||24||
59670041|NCT03661723|75788988|FG000|COMPLETED|Overall Study||0||
59670042|NCT03661723|75788989|FG001|COMPLETED|Overall Study||0||
59670043|NCT03661723|75788990|FG002|COMPLETED|Overall Study||0||
59670044|NCT03661723|75788991|FG003|COMPLETED|Overall Study||0||
59670045|NCT03661723|75788988|FG000|NOT COMPLETED|Overall Study||6||
59670046|NCT03661723|75788989|FG001|NOT COMPLETED|Overall Study||24||
59670047|NCT03661723|75788990|FG002|NOT COMPLETED|Overall Study||6||
59670048|NCT03661723|75788991|FG003|NOT COMPLETED|Overall Study||24||
59670049|NCT03502018|75788999|FG000|STARTED|Overall Study||25||
59670050|NCT03502018|75789000|FG001|STARTED|Overall Study||25||
59670051|NCT03502018|75788999|FG000|COMPLETED|Overall Study||24||
59670052|NCT03502018|75789000|FG001|COMPLETED|Overall Study||25||
59670053|NCT03502018|75788999|FG000|NOT COMPLETED|Overall Study||1||
59670054|NCT03502018|75789000|FG001|NOT COMPLETED|Overall Study||0||
59670055|NCT03471624|75789006|FG000|STARTED|Overall Study||270||
59670056|NCT03471624|75789006|FG000|COMPLETED|Overall Study||258||
59670057|NCT03471624|75789006|FG000|NOT COMPLETED|Overall Study||12||
59670058|NCT03414983|75789012|FG000|STARTED|Pre-Treatment||127|Started=Randomized|
59670059|NCT03414983|75789013|FG001|STARTED|Pre-Treatment||68|Started=Randomized|
59670060|NCT03414983|75789012|FG000|COMPLETED|Pre-Treatment||123|Completed=Treated|
59670061|NCT03414983|75789013|FG001|COMPLETED|Pre-Treatment||62|Completed=Treated|
59670062|NCT03414983|75789012|FG000|NOT COMPLETED|Pre-Treatment||4||
59670063|NCT03414983|75789013|FG001|NOT COMPLETED|Pre-Treatment||6||
59670064|NCT03414983|75789012|FG000|STARTED|Treatment||123|Started=Treated|
59670065|NCT03414983|75789013|FG001|STARTED|Treatment||62|Started=Treated|
59670066|NCT03414983|75789012|FG000|COMPLETED|Treatment||9||
59670067|NCT03414983|75789013|FG001|COMPLETED|Treatment||0||
59670068|NCT03414983|75789012|FG000|NOT COMPLETED|Treatment||114||
59670069|NCT03414983|75789013|FG001|NOT COMPLETED|Treatment||62||
59670070|NCT03229356|75789023|FG000|STARTED|Phase 1 (Months 1-6)|Number of participants is not available for this study, only practice-level data collected.|||4
59670071|NCT03229356|75789024|FG001|STARTED|Phase 1 (Months 1-6)|Number of participants is not available for this study, only practice-level data collected.|||4
59670072|NCT03229356|75789025|FG002|STARTED|Phase 1 (Months 1-6)|Number of participants is not available for this study, only practice-level data collected.|||7
59670073|NCT03229356|75789026|FG003|STARTED|Phase 1 (Months 1-6)|Number of participants is not available for this study, only practice-level data collected.|||7
59670074|NCT03229356|75789023|FG000|COMPLETED|Phase 1 (Months 1-6)|Number of participants is not available for this study, only practice-level data collected.|||4
59670075|NCT03229356|75789024|FG001|COMPLETED|Phase 1 (Months 1-6)|Number of participants is not available for this study, only practice-level data collected.|||4
59670076|NCT03229356|75789025|FG002|COMPLETED|Phase 1 (Months 1-6)|Number of participants is not available for this study, only practice-level data collected.|||7
59670077|NCT03229356|75789026|FG003|COMPLETED|Phase 1 (Months 1-6)|Number of participants is not available for this study, only practice-level data collected.|||7
59670078|NCT03229356|75789023|FG000|NOT COMPLETED|Phase 1 (Months 1-6)||||0
59670079|NCT03229356|75789024|FG001|NOT COMPLETED|Phase 1 (Months 1-6)||||0
59815876|NCT02242760|75938265|FG002|NOT COMPLETED|Overall Study||2||
59815877|NCT02242760|75938266|FG003|NOT COMPLETED|Overall Study||4||
59670080|NCT03229356|75789025|FG002|NOT COMPLETED|Phase 1 (Months 1-6)||||0
59670081|NCT03229356|75789026|FG003|NOT COMPLETED|Phase 1 (Months 1-6)||||0
59670082|NCT03229356|75789023|FG000|STARTED|Phase 2 (Months 7-12)|Number of participants is not available for this study, only practice-level data collected.|||4
59670083|NCT03229356|75789024|FG001|STARTED|Phase 2 (Months 7-12)|Number of participants is not available for this study, only practice-level data collected.|||4
59670084|NCT03229356|75789025|FG002|STARTED|Phase 2 (Months 7-12)|Number of participants is not available for this study, only practice-level data collected.|||7
59670085|NCT03229356|75789026|FG003|STARTED|Phase 2 (Months 7-12)|Number of participants is not available for this study, only practice-level data collected.|||7
59670086|NCT03229356|75789023|FG000|COMPLETED|Phase 2 (Months 7-12)|Number of participants is not available for this study, only practice-level data collected.|||4
59670087|NCT03229356|75789024|FG001|COMPLETED|Phase 2 (Months 7-12)|Number of participants is not available for this study, only practice-level data collected.|||4
59670088|NCT03229356|75789025|FG002|COMPLETED|Phase 2 (Months 7-12)|Number of participants is not available for this study, only practice-level data collected.|||7
59670089|NCT03229356|75789026|FG003|COMPLETED|Phase 2 (Months 7-12)|Number of participants is not available for this study, only practice-level data collected.|||7
59670090|NCT03229356|75789023|FG000|NOT COMPLETED|Phase 2 (Months 7-12)||||0
59815878|NCT02242760|75938267|FG004|NOT COMPLETED|Overall Study||4||
59815879|NCT01994954|75938285|FG000|STARTED|Overall Study||99||
59670091|NCT03229356|75789024|FG001|NOT COMPLETED|Phase 2 (Months 7-12)||||0
59670092|NCT03229356|75789025|FG002|NOT COMPLETED|Phase 2 (Months 7-12)||||0
59670093|NCT03229356|75789026|FG003|NOT COMPLETED|Phase 2 (Months 7-12)||||0
59670094|NCT03176953|75789038|FG000|STARTED|Overall Study||50||
59670095|NCT03176953|75789039|FG001|STARTED|Overall Study||50||
59670096|NCT03176953|75789038|FG000|COMPLETED|Overall Study||41||
59670097|NCT03176953|75789039|FG001|COMPLETED|Overall Study||40||
59670098|NCT03176953|75789038|FG000|NOT COMPLETED|Overall Study||9||
59670099|NCT03176953|75789039|FG001|NOT COMPLETED|Overall Study||10||
59670100|NCT02986659|75789047|FG000|STARTED|First Intervention Period||15||
59670101|NCT02986659|75789048|FG001|STARTED|First Intervention Period||15||
59670102|NCT02986659|75789047|FG000|COMPLETED|First Intervention Period||11||
59670103|NCT02986659|75789048|FG001|COMPLETED|First Intervention Period||13||
59670104|NCT02986659|75789047|FG000|NOT COMPLETED|First Intervention Period||4||
59670105|NCT02986659|75789048|FG001|NOT COMPLETED|First Intervention Period||2||
59670106|NCT02986659|75789047|FG000|STARTED|Second Intervention Period||11||
59670107|NCT02986659|75789048|FG001|STARTED|Second Intervention Period||13||
59670108|NCT02986659|75789047|FG000|COMPLETED|Second Intervention Period||11||
59670109|NCT02986659|75789048|FG001|COMPLETED|Second Intervention Period||7||
59670110|NCT02986659|75789047|FG000|NOT COMPLETED|Second Intervention Period||0||
59670111|NCT02986659|75789048|FG001|NOT COMPLETED|Second Intervention Period||6||
59670112|NCT02933489|75789056|FG000|STARTED|Overall Study||757||
59670113|NCT02933489|75789057|FG001|STARTED|Overall Study||759||
59670114|NCT02933489|75789056|FG000|DBTperformed|Overall Study||726||
59670115|NCT02933489|75789057|FG001|DBTperformed|Overall Study||737||
59670116|NCT02933489|75789056|FG000|AB MR Performed|Overall Study||713||
59670117|NCT02933489|75789057|FG001|AB MR Performed|Overall Study||733||
59670118|NCT02933489|75789056|FG000|COMPLETED|Overall Study||713||
59670119|NCT02933489|75789057|FG001|COMPLETED|Overall Study||731||
59670120|NCT02933489|75789056|FG000|NOT COMPLETED|Overall Study||44||
59670121|NCT02933489|75789057|FG001|NOT COMPLETED|Overall Study||28||
59670122|NCT02743806|75789075|FG000|STARTED|Overall Study||331||
59670123|NCT02743806|75789075|FG000|COMPLETED|Overall Study||150||
59670124|NCT02743806|75789075|FG000|NOT COMPLETED|Overall Study||181||
59670125|NCT02668653|75789081|FG000|STARTED|Overall Study||268||
59670126|NCT02668653|75789082|FG001|STARTED|Overall Study||271||
59670127|NCT02668653|75789081|FG000|Safety Analysis Set|Overall Study||265||
59670128|NCT02668653|75789082|FG001|Safety Analysis Set|Overall Study||268||
59670129|NCT02668653|75789081|FG000|COMPLETED|Overall Study||56||
59670130|NCT02668653|75789082|FG001|COMPLETED|Overall Study||52||
59670131|NCT02668653|75789081|FG000|NOT COMPLETED|Overall Study||212||
59670132|NCT02668653|75789082|FG001|NOT COMPLETED|Overall Study||219||
59670133|NCT02649972|75789088|FG000|STARTED|Overall Study||35||
59670134|NCT02649972|75789088|FG000|COMPLETED|Overall Study||34||
59670135|NCT02649972|75789088|FG000|NOT COMPLETED|Overall Study||1||
59670136|NCT02558010|75789094|FG000|STARTED|Overall Study||30||
59670137|NCT02558010|75789095|FG001|STARTED|Overall Study||28||
59670138|NCT02558010|75789094|FG000|COMPLETED|Overall Study||25||
59670139|NCT02558010|75789095|FG001|COMPLETED|Overall Study||22||
59670140|NCT02558010|75789094|FG000|NOT COMPLETED|Overall Study||5||
59670141|NCT02558010|75789095|FG001|NOT COMPLETED|Overall Study||6||
59670142|NCT02437318|75789103|FG000|STARTED|Overall Study||284||
59670143|NCT02437318|75789104|FG001|STARTED|Overall Study||288||
59670144|NCT02437318|75789103|FG000|End of Treatment (Didn't Complete)|Overall Study||229||
59670145|NCT02437318|75789104|FG001|End of Treatment (Didn't Complete)|Overall Study||241||
59670146|NCT02437318|75789103|FG000|Untreated (Protocol Deviation)|Overall Study||0||
59670147|NCT02437318|75789104|FG001|Untreated (Protocol Deviation)|Overall Study||1||
59670148|NCT02437318|75789103|FG000|COMPLETED|Overall Study||55|Completed = Subjects ongoing at the time of data cut-off: 12-Jun-2018|
59670149|NCT02437318|75789104|FG001|COMPLETED|Overall Study||46|Completed = Subjects ongoing at the time of data cut-off: 12-Jun-2018|
59670150|NCT02437318|75789103|FG000|NOT COMPLETED|Overall Study||229||
59989282|NCT02258074|76104535|FG000|NOT COMPLETED|Overall Study||1||
59989283|NCT02258074|76104536|FG001|NOT COMPLETED|Overall Study||0||
59989284|NCT02258074|76104537|FG002|NOT COMPLETED|Overall Study||0||
60077810|NCT01483599|76192723|FG005|COMPLETED|After Controlled Period(Week 16-Week 40)||0||
59545712|NCT02417064|75644484|FG002|Safety Analysis Set|Double-blind Induction Phase (4 Weeks)||113||
59545713|NCT02417064|75644482|FG000|COMPLETED|Double-blind Induction Phase (4 Weeks)||111||
59545714|NCT02417064|75644483|FG001|COMPLETED|Double-blind Induction Phase (4 Weeks)||97||
59545715|NCT02417064|75644484|FG002|COMPLETED|Double-blind Induction Phase (4 Weeks)||107||
59545716|NCT02417064|75644482|FG000|NOT COMPLETED|Double-blind Induction Phase (4 Weeks)||6||
59545717|NCT02417064|75644483|FG001|NOT COMPLETED|Double-blind Induction Phase (4 Weeks)||19||
59545718|NCT02417064|75644484|FG002|NOT COMPLETED|Double-blind Induction Phase (4 Weeks)||6||
59545719|NCT02417064|75644482|FG000|STARTED|Follow-up Phase (24 Weeks)||47||
59670151|NCT02437318|75789104|FG001|NOT COMPLETED|Overall Study||242||
59670152|NCT02305238|75789113|FG000|STARTED|Overall Study||124||
59670153|NCT02305238|75789114|FG001|STARTED|Overall Study||123||
59670154|NCT02305238|75789115|FG002|STARTED|Overall Study||8||
59670155|NCT02305238|75789113|FG000|Treated|Overall Study||124||
59670156|NCT02305238|75789114|FG001|Treated|Overall Study||123||
59670157|NCT02305238|75789115|FG002|Treated|Overall Study||7||
59670158|NCT02305238|75789113|FG000|Randomized|Overall Study||124||
59670159|NCT02305238|75789114|FG001|Randomized|Overall Study||123||
59670160|NCT02305238|75789115|FG002|Randomized|Overall Study||0||
59670161|NCT02305238|75789113|FG000|BCVA Post-randomization Assessment|Overall Study||123||
59670162|NCT02305238|75789114|FG001|BCVA Post-randomization Assessment|Overall Study||123||
59670163|NCT02305238|75789115|FG002|BCVA Post-randomization Assessment|Overall Study||0||
59670164|NCT02305238|75789113|FG000|COMPLETED|Overall Study||108|Completed Treatment (Week 96)|
59670165|NCT02305238|75789114|FG001|COMPLETED|Overall Study||104|Completed Treatment (Week 96)|
59670166|NCT02305238|75789115|FG002|COMPLETED|Overall Study||0|Completed Treatment (Week 96)|
59670167|NCT02305238|75789113|FG000|NOT COMPLETED|Overall Study||16||
59670168|NCT02305238|75789114|FG001|NOT COMPLETED|Overall Study||19||
59670169|NCT02305238|75789115|FG002|NOT COMPLETED|Overall Study||8||
59670170|NCT02175004|75789124|FG000|STARTED|Overall Study||50||
59670171|NCT02175004|75789125|FG001|STARTED|Overall Study||85||
59670172|NCT02175004|75789124|FG000|COMPLETED|Overall Study||9||
59670173|NCT02175004|75789125|FG001|COMPLETED|Overall Study||9||
59670174|NCT02175004|75789124|FG000|NOT COMPLETED|Overall Study||41||
59670175|NCT02175004|75789125|FG001|NOT COMPLETED|Overall Study||76||
59670176|NCT02075840|75789133|FG000|STARTED|Overall Study||152||
59670177|NCT02075840|75789134|FG001|STARTED|Overall Study||151||
59670178|NCT02075840|75789133|FG000|COMPLETED|Overall Study||0||
59670179|NCT02075840|75789134|FG001|COMPLETED|Overall Study||0||
59670180|NCT02075840|75789133|FG000|NOT COMPLETED|Overall Study||152||
59670181|NCT02075840|75789134|FG001|NOT COMPLETED|Overall Study||151||
59670182|NCT01059825|75789146|FG000|STARTED|Enrolled, Run-in Period||0||
59670183|NCT01059825|75789147|FG001|STARTED|Enrolled, Run-in Period||0||
59670184|NCT01059825|75789148|FG002|STARTED|Enrolled, Run-in Period||0||
59670185|NCT01059825|75789149|FG003|STARTED|Enrolled, Run-in Period||0||
59670186|NCT01059825|75789150|FG004|STARTED|Enrolled, Run-in Period||0||
59670187|NCT01059825|75789151|FG005|STARTED|Enrolled, Run-in Period||0||
59670188|NCT01059825|75789152|FG006|STARTED|Enrolled, Run-in Period||375||
59670189|NCT01059825|75789146|FG000|COMPLETED|Enrolled, Run-in Period||0||
59670190|NCT01059825|75789147|FG001|COMPLETED|Enrolled, Run-in Period||0||
59670191|NCT01059825|75789148|FG002|COMPLETED|Enrolled, Run-in Period||0||
59670192|NCT01059825|75789149|FG003|COMPLETED|Enrolled, Run-in Period||0||
59670193|NCT01059825|75789150|FG004|COMPLETED|Enrolled, Run-in Period||0||
59670194|NCT01059825|75789151|FG005|COMPLETED|Enrolled, Run-in Period||0||
59670195|NCT01059825|75789152|FG006|COMPLETED|Enrolled, Run-in Period||328||
59670196|NCT01059825|75789146|FG000|NOT COMPLETED|Enrolled, Run-in Period||0||
59670197|NCT01059825|75789147|FG001|NOT COMPLETED|Enrolled, Run-in Period||0||
59670198|NCT01059825|75789148|FG002|NOT COMPLETED|Enrolled, Run-in Period||0||
59670199|NCT01059825|75789149|FG003|NOT COMPLETED|Enrolled, Run-in Period||0||
59545720|NCT02417064|75644483|FG001|STARTED|Follow-up Phase (24 Weeks)||52||
59545721|NCT02417064|75644484|FG002|STARTED|Follow-up Phase (24 Weeks)||69||
59670200|NCT01059825|75789150|FG004|NOT COMPLETED|Enrolled, Run-in Period||0||
59670201|NCT01059825|75789151|FG005|NOT COMPLETED|Enrolled, Run-in Period||0||
59670202|NCT01059825|75789152|FG006|NOT COMPLETED|Enrolled, Run-in Period||47||
59670203|NCT01059825|75789146|FG000|STARTED|Treatment Period|54 participants who completed the run-in period were randomized to this treatment group.|54||
59670204|NCT01059825|75789147|FG001|STARTED|Treatment Period|54 participants who completed the run-in period were randomized to this treatment group.|54||
59670205|NCT01059825|75789148|FG002|STARTED|Treatment Period|55 participants who completed the run-in period were randomized to this treatment group.|55||
59670206|NCT01059825|75789149|FG003|STARTED|Treatment Period|55 participants who completed the run-in period were randomized to this treatment group.|55||
59545722|NCT02417064|75644482|FG000|COMPLETED|Follow-up Phase (24 Weeks)||8||
59545723|NCT02417064|75644483|FG001|COMPLETED|Follow-up Phase (24 Weeks)||10||
59545724|NCT02417064|75644484|FG002|COMPLETED|Follow-up Phase (24 Weeks)||18||
59545725|NCT02417064|75644482|FG000|NOT COMPLETED|Follow-up Phase (24 Weeks)||39||
59545726|NCT02417064|75644483|FG001|NOT COMPLETED|Follow-up Phase (24 Weeks)||42||
59545727|NCT02417064|75644484|FG002|NOT COMPLETED|Follow-up Phase (24 Weeks)||51||
59545728|NCT02165462|75644495|FG000|STARTED|Overall Study||17||
59545729|NCT02165462|75644495|FG000|COMPLETED|Overall Study||17||
59545730|NCT02165462|75644495|FG000|NOT COMPLETED|Overall Study||0||
59545731|NCT01653132|75644499|FG000|STARTED|First Intervention||5||
59545732|NCT01653132|75644500|FG001|STARTED|First Intervention||5||
59545733|NCT01653132|75644499|FG000|COMPLETED|First Intervention|one dropped out: wanted to start anticholinergic drug for tremor that could affect saliva volume|4||
59545734|NCT01653132|75644500|FG001|COMPLETED|First Intervention||5||
59545735|NCT01653132|75644499|FG000|NOT COMPLETED|First Intervention||1||
59545736|NCT01653132|75644500|FG001|NOT COMPLETED|First Intervention||0||
59545737|NCT01653132|75644499|FG000|STARTED|Washout 1-2 Months||4||
59545738|NCT01653132|75644500|FG001|STARTED|Washout 1-2 Months||5||
59545739|NCT01653132|75644499|FG000|COMPLETED|Washout 1-2 Months||4||
59545740|NCT01653132|75644500|FG001|COMPLETED|Washout 1-2 Months||5||
59545741|NCT01653132|75644499|FG000|NOT COMPLETED|Washout 1-2 Months||0||
59545742|NCT01653132|75644500|FG001|NOT COMPLETED|Washout 1-2 Months||0||
59545743|NCT01653132|75644499|FG000|STARTED|Second Intervention||4||
59545744|NCT01653132|75644500|FG001|STARTED|Second Intervention||5||
59545745|NCT01653132|75644499|FG000|COMPLETED|Second Intervention||4||
59545746|NCT01653132|75644500|FG001|COMPLETED|Second Intervention||5||
59545747|NCT01653132|75644499|FG000|NOT COMPLETED|Second Intervention||0||
59545748|NCT01653132|75644500|FG001|NOT COMPLETED|Second Intervention||0||
59545749|NCT01004744|75644510|FG000|STARTED|Overall Study||10||
59545750|NCT01004744|75644510|FG000|COMPLETED|Overall Study||10||
59545751|NCT01004744|75644510|FG000|NOT COMPLETED|Overall Study||0||
59545752|NCT01005290|75644514|FG000|STARTED|Run-In||52||
59545753|NCT01005290|75644515|FG001|STARTED|Run-In||0||
59545754|NCT01005290|75644516|FG002|STARTED|Run-In||0||
59545755|NCT01005290|75644514|FG000|COMPLETED|Run-In||38||
59545756|NCT01005290|75644515|FG001|COMPLETED|Run-In||0||
59545757|NCT01005290|75644516|FG002|COMPLETED|Run-In||0||
59545758|NCT01005290|75644514|FG000|NOT COMPLETED|Run-In||14||
59545759|NCT01005290|75644515|FG001|NOT COMPLETED|Run-In||0||
59545760|NCT01005290|75644516|FG002|NOT COMPLETED|Run-In||0||
59545761|NCT01005290|75644514|FG000|STARTED|Period 1 (5 Weeks)||0||
59545762|NCT01005290|75644515|FG001|STARTED|Period 1 (5 Weeks)||20||
59545763|NCT01005290|75644516|FG002|STARTED|Period 1 (5 Weeks)||18||
59545764|NCT01005290|75644514|FG000|COMPLETED|Period 1 (5 Weeks)||0||
59545765|NCT01005290|75644515|FG001|COMPLETED|Period 1 (5 Weeks)||13||
59545766|NCT01005290|75644516|FG002|COMPLETED|Period 1 (5 Weeks)||9||
59545767|NCT01005290|75644514|FG000|NOT COMPLETED|Period 1 (5 Weeks)||0||
59545768|NCT01005290|75644515|FG001|NOT COMPLETED|Period 1 (5 Weeks)||7||
59545769|NCT01005290|75644516|FG002|NOT COMPLETED|Period 1 (5 Weeks)||9||
59545770|NCT01005290|75644514|FG000|STARTED|Washout Period (2 Weeks)||0||
59545771|NCT01005290|75644515|FG001|STARTED|Washout Period (2 Weeks)||13||
59545772|NCT01005290|75644516|FG002|STARTED|Washout Period (2 Weeks)||9||
59545773|NCT01005290|75644514|FG000|COMPLETED|Washout Period (2 Weeks)||0||
59545774|NCT01005290|75644515|FG001|COMPLETED|Washout Period (2 Weeks)||13||
59545775|NCT01005290|75644516|FG002|COMPLETED|Washout Period (2 Weeks)||9||
59545776|NCT01005290|75644514|FG000|NOT COMPLETED|Washout Period (2 Weeks)||0||
59545777|NCT01005290|75644515|FG001|NOT COMPLETED|Washout Period (2 Weeks)||0||
59545778|NCT01005290|75644516|FG002|NOT COMPLETED|Washout Period (2 Weeks)||0||
59545779|NCT01005290|75644514|FG000|STARTED|Period 2 (5 Weeks)||0||
59545780|NCT01005290|75644515|FG001|STARTED|Period 2 (5 Weeks)||13||
59545781|NCT01005290|75644516|FG002|STARTED|Period 2 (5 Weeks)||9||
59545782|NCT01005290|75644514|FG000|COMPLETED|Period 2 (5 Weeks)||0||
59545783|NCT01005290|75644515|FG001|COMPLETED|Period 2 (5 Weeks)||13||
59545784|NCT01005290|75644516|FG002|COMPLETED|Period 2 (5 Weeks)||7||
59545785|NCT01005290|75644514|FG000|NOT COMPLETED|Period 2 (5 Weeks)||0||
59545786|NCT01005290|75644515|FG001|NOT COMPLETED|Period 2 (5 Weeks)||0||
59545787|NCT01005290|75644516|FG002|NOT COMPLETED|Period 2 (5 Weeks)||2||
59545788|NCT02453334|75644525|FG000|STARTED|Overall Study||122||
59545789|NCT02453334|75644526|FG001|STARTED|Overall Study||122||
59545790|NCT02453334|75644525|FG000|COMPLETED|Overall Study||81||
59545791|NCT02453334|75644526|FG001|COMPLETED|Overall Study||82||
59545792|NCT02453334|75644525|FG000|NOT COMPLETED|Overall Study||41||
59545793|NCT02453334|75644526|FG001|NOT COMPLETED|Overall Study||40||
59545794|NCT01051310|75644532|FG000|STARTED|Overall Study||18||
59545795|NCT01051310|75644532|FG000|COMPLETED|Overall Study||13||
59545796|NCT01051310|75644532|FG000|NOT COMPLETED|Overall Study||5||
59545797|NCT01051778|75644538|FG000|STARTED|Overall Study|June 2006|30||
59545798|NCT01051778|75644539|FG001|STARTED|Overall Study|June 2006|30||
59545799|NCT01051778|75644538|FG000|COMPLETED|Overall Study|November 2009|30||
59545800|NCT01051778|75644539|FG001|COMPLETED|Overall Study|November 2009|30||
59545801|NCT01051778|75644538|FG000|NOT COMPLETED|Overall Study||0||
59545802|NCT01051778|75644539|FG001|NOT COMPLETED|Overall Study||0||
59545803|NCT01052948|75644549|FG000|STARTED|Overall Study||27812||
59545804|NCT01052948|75644550|FG001|STARTED|Overall Study||14669||
59545805|NCT01052948|75644551|FG002|STARTED|Overall Study||15147||
59545806|NCT01052948|75644552|FG003|STARTED|Overall Study||29311||
59545807|NCT01052948|75644549|FG000|COMPLETED|Overall Study||27812||
59545808|NCT01052948|75644550|FG001|COMPLETED|Overall Study||14669||
59545809|NCT01052948|75644551|FG002|COMPLETED|Overall Study||15147||
59545810|NCT01052948|75644552|FG003|COMPLETED|Overall Study||29311||
59545811|NCT01052948|75644549|FG000|NOT COMPLETED|Overall Study||0||
59545812|NCT01052948|75644550|FG001|NOT COMPLETED|Overall Study||0||
59545813|NCT01052948|75644551|FG002|NOT COMPLETED|Overall Study||0||
59670207|NCT01059825|75789150|FG004|STARTED|Treatment Period|55 participants who completed the run-in period were randomized to this treatment group.|55||
59670208|NCT01059825|75789151|FG005|STARTED|Treatment Period|55 participants who completed the run-in period were randomized to this treatment group.|55||
59670209|NCT01059825|75789152|FG006|STARTED|Treatment Period|Participants who completed run-in were randomized to 1 of 6 treatment groups.|0||
59670210|NCT01059825|75789146|FG000|COMPLETED|Treatment Period||44||
59670211|NCT01059825|75789147|FG001|COMPLETED|Treatment Period||50||
59670212|NCT01059825|75789148|FG002|COMPLETED|Treatment Period||49||
59670213|NCT01059825|75789149|FG003|COMPLETED|Treatment Period||44||
59670214|NCT01059825|75789150|FG004|COMPLETED|Treatment Period||47||
59670215|NCT01059825|75789151|FG005|COMPLETED|Treatment Period||52||
59670216|NCT01059825|75789152|FG006|COMPLETED|Treatment Period||0||
59670217|NCT01059825|75789146|FG000|NOT COMPLETED|Treatment Period||10||
59670218|NCT01059825|75789147|FG001|NOT COMPLETED|Treatment Period||4||
59670219|NCT01059825|75789148|FG002|NOT COMPLETED|Treatment Period||6||
59670220|NCT01059825|75789149|FG003|NOT COMPLETED|Treatment Period||11||
59670221|NCT01059825|75789150|FG004|NOT COMPLETED|Treatment Period||8||
59670222|NCT01059825|75789151|FG005|NOT COMPLETED|Treatment Period||3||
59670223|NCT01059825|75789152|FG006|NOT COMPLETED|Treatment Period||0||
59670224|NCT04344600|75789170|FG000|STARTED|Overall Study||2||
59670225|NCT04344600|75789171|FG001|STARTED|Overall Study||4||
59670226|NCT04344600|75789170|FG000|COMPLETED|Overall Study||2||
60077811|NCT01483599|76192724|FG006|COMPLETED|After Controlled Period(Week 16-Week 40)||0||
60077812|NCT01483599|76192725|FG007|COMPLETED|After Controlled Period(Week 16-Week 40)||37||
60077813|NCT01483599|76192726|FG008|COMPLETED|After Controlled Period(Week 16-Week 40)||29||
60077814|NCT01483599|76192727|FG009|COMPLETED|After Controlled Period(Week 16-Week 40)||37||
59670227|NCT04344600|75789171|FG001|COMPLETED|Overall Study||4||
59670228|NCT04344600|75789170|FG000|NOT COMPLETED|Overall Study||0||
59670229|NCT04344600|75789171|FG001|NOT COMPLETED|Overall Study||0||
59670230|NCT03439839|75789179|FG000|STARTED|Overall Study||10||
59670231|NCT03439839|75789180|FG001|STARTED|Overall Study||6||
59670232|NCT03439839|75789179|FG000|COMPLETED|Overall Study||7||
59670233|NCT03439839|75789180|FG001|COMPLETED|Overall Study||6||
59670234|NCT03439839|75789179|FG000|NOT COMPLETED|Overall Study||3||
59670235|NCT03439839|75789180|FG001|NOT COMPLETED|Overall Study||0||
59670236|NCT02808585|75789197|FG000|STARTED|Overall Study||3||
59670237|NCT02808585|75789198|FG001|STARTED|Overall Study||6||
59670238|NCT02808585|75789199|FG002|STARTED|Overall Study||7||
59670239|NCT02808585|75789200|FG003|STARTED|Overall Study||6||
59670240|NCT02808585|75789201|FG004|STARTED|Overall Study||7||
59670241|NCT02808585|75789197|FG000|COMPLETED|Overall Study||3||
59670242|NCT02808585|75789198|FG001|COMPLETED|Overall Study||6||
59670243|NCT02808585|75789199|FG002|COMPLETED|Overall Study||6||
59670244|NCT02808585|75789200|FG003|COMPLETED|Overall Study||4||
59670245|NCT02808585|75789201|FG004|COMPLETED|Overall Study||7||
59670246|NCT02808585|75789197|FG000|NOT COMPLETED|Overall Study||0||
59670247|NCT02808585|75789198|FG001|NOT COMPLETED|Overall Study||0||
59670248|NCT02808585|75789199|FG002|NOT COMPLETED|Overall Study||1||
59670249|NCT02808585|75789200|FG003|NOT COMPLETED|Overall Study||2||
59670250|NCT02808585|75789201|FG004|NOT COMPLETED|Overall Study||0||
59670251|NCT01785459|75789217|FG000|STARTED|Overall Study||11||
59670252|NCT01785459|75789218|FG001|STARTED|Overall Study||12||
59670253|NCT01785459|75789217|FG000|COMPLETED|Overall Study||11||
60077815|NCT01483599|76192728|FG010|COMPLETED|After Controlled Period(Week 16-Week 40)||37||
60077816|NCT01483599|76192729|FG011|COMPLETED|After Controlled Period(Week 16-Week 40)||39||
60077817|NCT01483599|76192730|FG012|COMPLETED|After Controlled Period(Week 16-Week 40)||35||
59670254|NCT01785459|75789218|FG001|COMPLETED|Overall Study||12||
59670255|NCT01785459|75789217|FG000|NOT COMPLETED|Overall Study||0||
59670256|NCT01785459|75789218|FG001|NOT COMPLETED|Overall Study||0||
59670257|NCT05413668|75789229|FG000|STARTED|Overall Study||6||
59670258|NCT05413668|75789230|FG001|STARTED|Overall Study||6||
59670259|NCT05413668|75789231|FG002|STARTED|Overall Study||6||
59670260|NCT05413668|75789232|FG003|STARTED|Overall Study||6||
59670261|NCT05413668|75789233|FG004|STARTED|Overall Study||8||
59670262|NCT05413668|75789229|FG000|Dosed|Overall Study||6||
59670263|NCT05413668|75789230|FG001|Dosed|Overall Study||6||
59670264|NCT05413668|75789231|FG002|Dosed|Overall Study||6||
59670265|NCT05413668|75789232|FG003|Dosed|Overall Study||6||
59670266|NCT05413668|75789233|FG004|Dosed|Overall Study||8||
60077818|NCT01483599|76192731|FG013|COMPLETED|After Controlled Period(Week 16-Week 40)||32||
59670267|NCT05413668|75789229|FG000|COMPLETED|Overall Study||6||
59670268|NCT05413668|75789230|FG001|COMPLETED|Overall Study||6||
59670269|NCT05413668|75789231|FG002|COMPLETED|Overall Study||6||
59670270|NCT05413668|75789232|FG003|COMPLETED|Overall Study||6||
59670271|NCT05413668|75789233|FG004|COMPLETED|Overall Study||8||
59670272|NCT05413668|75789229|FG000|NOT COMPLETED|Overall Study||0||
59670273|NCT05413668|75789230|FG001|NOT COMPLETED|Overall Study||0||
59670274|NCT05413668|75789231|FG002|NOT COMPLETED|Overall Study||0||
59670275|NCT05413668|75789232|FG003|NOT COMPLETED|Overall Study||0||
59670276|NCT05413668|75789233|FG004|NOT COMPLETED|Overall Study||0||
59670277|NCT04618770|75789244|FG000|STARTED|Overall Study||37||
59670278|NCT04618770|75789244|FG000|COMPLETED|Overall Study||0||
59670279|NCT04618770|75789244|FG000|NOT COMPLETED|Overall Study||37||
59670280|NCT04568603|75789248|FG000|STARTED|Overall Study||14||
59670281|NCT04568603|75789248|FG000|Received ISL on Day 2|Overall Study||13||
59670282|NCT04568603|75789248|FG000|COMPLETED|Overall Study||13||
59670283|NCT04568603|75789248|FG000|NOT COMPLETED|Overall Study||1||
59670284|NCT04544709|75789253|FG000|STARTED|Overall Study||3||
59670285|NCT04544709|75789253|FG000|COMPLETED|Overall Study||0||
59670286|NCT04544709|75789253|FG000|NOT COMPLETED|Overall Study||3||
59670287|NCT04528732|75789262|FG000|STARTED|Overall Study||29|child-caregiver dyads|
59670288|NCT04528732|75789263|FG001|STARTED|Overall Study||26|child-caregiver dyads|
59670289|NCT04528732|75789264|FG002|STARTED|Overall Study||34|child-caregiver dyads|
59670290|NCT04528732|75789262|FG000|COMPLETED|Overall Study||28|child-caregiver dyads|
59670291|NCT04528732|75789263|FG001|COMPLETED|Overall Study||25|child-caregiver dyads|
59670292|NCT04528732|75789264|FG002|COMPLETED|Overall Study||31|child-caregiver dyads|
59670293|NCT04528732|75789262|FG000|NOT COMPLETED|Overall Study||1||
59670294|NCT04528732|75789263|FG001|NOT COMPLETED|Overall Study||1||
59670295|NCT04528732|75789264|FG002|NOT COMPLETED|Overall Study||3||
59670296|NCT04505540|75789277|FG000|STARTED|Baseline||104||
59670297|NCT04505540|75789277|FG000|COMPLETED|Baseline||94||
59670298|NCT04505540|75789277|FG000|NOT COMPLETED|Baseline||10||
59670299|NCT04505540|75789277|FG000|STARTED|1 Week Eligible to Self-report||94||
59670300|NCT04505540|75789277|FG000|COMPLETED|1 Week Eligible to Self-report||93||
59670301|NCT04505540|75789277|FG000|NOT COMPLETED|1 Week Eligible to Self-report||1||
59670302|NCT04505540|75789277|FG000|STARTED|1 Week Contacted for Self-report||93||
59670303|NCT04505540|75789277|FG000|COMPLETED|1 Week Contacted for Self-report||66||
59670304|NCT04505540|75789277|FG000|NOT COMPLETED|1 Week Contacted for Self-report||27||
59670305|NCT04505540|75789277|FG000|STARTED|1 Week Eligible for Urinanalysis|Self-reports on treatment retention and urine sampling were conducted separately.|94||
59670306|NCT04505540|75789277|FG000|COMPLETED|1 Week Eligible for Urinanalysis||41||
59670307|NCT04505540|75789277|FG000|NOT COMPLETED|1 Week Eligible for Urinanalysis||53||
59670308|NCT04505540|75789277|FG000|STARTED|1 Week Urine Sample Provided||41||
59670309|NCT04505540|75789277|FG000|COMPLETED|1 Week Urine Sample Provided||28||
59670310|NCT04505540|75789277|FG000|NOT COMPLETED|1 Week Urine Sample Provided||13||
59670311|NCT04505540|75789277|FG000|STARTED|3 Months Eligible to Self-report|Note the protocol followed an intent-to-treat protocol. Participants who were eligible but did not complete a questionnaire or urinalysis were counted as negative for enrollment in treatment and positive for illicit drug use. Participants were not withdrawn if they did not complete 1 week or 3 months testing and were considered eligible again for contact at the next stage.|94||
59670312|NCT04505540|75789277|FG000|COMPLETED|3 Months Eligible to Self-report||87||
59670313|NCT04505540|75789277|FG000|NOT COMPLETED|3 Months Eligible to Self-report||7||
59670314|NCT04505540|75789277|FG000|STARTED|3 Months Contacted for Self-report||87||
59670315|NCT04505540|75789277|FG000|COMPLETED|3 Months Contacted for Self-report||65||
59670316|NCT04505540|75789277|FG000|NOT COMPLETED|3 Months Contacted for Self-report||22||
59670317|NCT04505540|75789277|FG000|STARTED|3 Months Eligible for Urinanalysis|Note the protocol followed an intent-to-treat protocol. Participants who were eligible but did not complete a questionnaire or urinalysis were counted as negative for enrollment in treatment and positive for illicit drug use. Participants were not withdrawn if they did not complete 1 week or 3 months testing and were considered eligible again for contact at the next stage.|94||
59670318|NCT04505540|75789277|FG000|COMPLETED|3 Months Eligible for Urinanalysis||24||
59670319|NCT04505540|75789277|FG000|NOT COMPLETED|3 Months Eligible for Urinanalysis||70||
59670320|NCT04505540|75789277|FG000|STARTED|3 Months Urine Sample Provided||24||
59670321|NCT04505540|75789277|FG000|COMPLETED|3 Months Urine Sample Provided||11||
59670322|NCT04505540|75789277|FG000|NOT COMPLETED|3 Months Urine Sample Provided||13||
59670323|NCT04505540|75789277|FG000|STARTED|6 Months Eligible to Self-report|Note the protocol followed an intent-to-treat protocol. Participants who were eligible but did not complete a questionnaire or urinalysis were counted as negative for enrollment in treatment and positive for illicit drug use. Participants were not withdrawn if they did not complete 1 week or 3 months testing and were considered eligible again for contact at the next stage.|94||
59670324|NCT04505540|75789277|FG000|COMPLETED|6 Months Eligible to Self-report||85||
59670325|NCT04505540|75789277|FG000|NOT COMPLETED|6 Months Eligible to Self-report||9||
60077819|NCT01483599|76192718|FG000|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0||
60077820|NCT01483599|76192719|FG001|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0||
60077821|NCT01483599|76192720|FG002|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0||
60077822|NCT01483599|76192721|FG003|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0||
60077823|NCT01483599|76192722|FG004|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0||
60077824|NCT01483599|76192723|FG005|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0||
59545814|NCT01052948|75644552|FG003|NOT COMPLETED|Overall Study||0||
59545815|NCT02169440|75644564|FG000|STARTED|Overall Study||10||
59545816|NCT02169440|75644565|FG001|STARTED|Overall Study||10||
59545817|NCT02169440|75644564|FG000|COMPLETED|Overall Study||10||
59545818|NCT02169440|75644565|FG001|COMPLETED|Overall Study||10||
59545819|NCT02169440|75644564|FG000|NOT COMPLETED|Overall Study||0||
59545820|NCT02169440|75644565|FG001|NOT COMPLETED|Overall Study||0||
59545821|NCT01054586|75644576|FG000|STARTED|Overall Study||43||
59545822|NCT01054586|75644577|FG001|STARTED|Overall Study||15||
59545823|NCT01054586|75644578|FG002|STARTED|Overall Study||8||
59545824|NCT01054586|75644579|FG003|STARTED|Overall Study||101||
59670326|NCT04505540|75789277|FG000|STARTED|6 Months Contacted for Self-report||85||
59670327|NCT04505540|75789277|FG000|COMPLETED|6 Months Contacted for Self-report||68||
59670328|NCT04505540|75789277|FG000|NOT COMPLETED|6 Months Contacted for Self-report||17||
59670329|NCT04505540|75789277|FG000|STARTED|6 Months Eligible for Urinanalysis|Note the protocol followed an intent-to-treat protocol. Participants who were eligible but did not complete a questionnaire or urinalysis were counted as negative for enrollment in treatment and positive for illicit drug use. Participants were not withdrawn if they did not complete 1 week or 3 months testing and were considered eligible again for contact at the next stage.|94||
59670330|NCT04505540|75789277|FG000|COMPLETED|6 Months Eligible for Urinanalysis||3||
59670331|NCT04505540|75789277|FG000|NOT COMPLETED|6 Months Eligible for Urinanalysis||91||
59670332|NCT04505540|75789277|FG000|STARTED|6 Months Urine Sample Provided||3||
59670333|NCT04505540|75789277|FG000|COMPLETED|6 Months Urine Sample Provided||3||
59670334|NCT04505540|75789277|FG000|NOT COMPLETED|6 Months Urine Sample Provided||0||
59670335|NCT04455815|75789283|FG000|STARTED|Randomisation Phase||16||
59670336|NCT04455815|75789284|FG001|STARTED|Randomisation Phase||18||
59670337|NCT04455815|75789283|FG000|COMPLETED|Randomisation Phase||15||
59670338|NCT04455815|75789284|FG001|COMPLETED|Randomisation Phase||18||
59670339|NCT04455815|75789283|FG000|NOT COMPLETED|Randomisation Phase||1||
59670340|NCT04455815|75789284|FG001|NOT COMPLETED|Randomisation Phase||0||
59670341|NCT04455815|75789283|FG000|STARTED|Treatment Phase||15||
59670342|NCT04455815|75789284|FG001|STARTED|Treatment Phase||18||
59670343|NCT04455815|75789283|FG000|COMPLETED|Treatment Phase||13||
59670344|NCT04455815|75789284|FG001|COMPLETED|Treatment Phase||16||
59670345|NCT04455815|75789283|FG000|NOT COMPLETED|Treatment Phase||2||
59670346|NCT04455815|75789284|FG001|NOT COMPLETED|Treatment Phase||2||
59670347|NCT04220411|75789294|FG000|STARTED|Overall Study||6||
59670348|NCT04220411|75789295|FG001|STARTED|Overall Study||3||
59670349|NCT04220411|75789296|FG002|STARTED|Overall Study||6||
59670350|NCT04220411|75789297|FG003|STARTED|Overall Study||2||
59670351|NCT04220411|75789294|FG000|COMPLETED|Overall Study||6||
59670352|NCT04220411|75789295|FG001|COMPLETED|Overall Study||3||
59670353|NCT04220411|75789296|FG002|COMPLETED|Overall Study||6||
59670354|NCT04220411|75789297|FG003|COMPLETED|Overall Study||1||
59670355|NCT04220411|75789294|FG000|NOT COMPLETED|Overall Study||0||
59670356|NCT04220411|75789295|FG001|NOT COMPLETED|Overall Study||0||
59670357|NCT04220411|75789296|FG002|NOT COMPLETED|Overall Study||0||
59670358|NCT04220411|75789297|FG003|NOT COMPLETED|Overall Study||1||
59670359|NCT04194489|75789309|FG000|STARTED|Overall Study||105||
59670360|NCT04194489|75789309|FG000|Completed Some or All Baseline Surveys|Overall Study||85||
59670361|NCT04194489|75789309|FG000|Installed FMF Connect App|Overall Study||67||
59670362|NCT04194489|75789309|FG000|Completed Some or All Follow-up Surveys|Overall Study||52||
59670363|NCT04194489|75789309|FG000|COMPLETED|Overall Study||52||
59670364|NCT04194489|75789309|FG000|NOT COMPLETED|Overall Study||53||
59670365|NCT04194450|75789313|FG000|STARTED|Overall Study||9||
59670366|NCT04194450|75789314|FG001|STARTED|Overall Study||10||
59670367|NCT04194450|75789313|FG000|COMPLETED|Overall Study||8||
59670368|NCT04194450|75789314|FG001|COMPLETED|Overall Study||10||
59670369|NCT04194450|75789313|FG000|NOT COMPLETED|Overall Study||1||
59670370|NCT04194450|75789314|FG001|NOT COMPLETED|Overall Study||0||
59670371|NCT04158739|75789321|FG000|STARTED|Overall Study||7||
59670372|NCT04158739|75789322|FG001|STARTED|Overall Study||9||
59670373|NCT04158739|75789321|FG000|COMPLETED|Overall Study||0||
59670374|NCT04158739|75789322|FG001|COMPLETED|Overall Study||0||
59670375|NCT04158739|75789321|FG000|NOT COMPLETED|Overall Study||7||
59670376|NCT04158739|75789322|FG001|NOT COMPLETED|Overall Study||9||
59670377|NCT04123093|75789332|FG000|STARTED|Phase 1||11||
59670378|NCT04123093|75789333|FG001|STARTED|Phase 1||0||
59670379|NCT04123093|75789332|FG000|Baseline Visit|Phase 1||10||
59670380|NCT04123093|75789333|FG001|Baseline Visit|Phase 1||0||
59670381|NCT04123093|75789332|FG000|COMPLETED|Phase 1||10||
59670382|NCT04123093|75789333|FG001|COMPLETED|Phase 1||0||
59670383|NCT04123093|75789332|FG000|NOT COMPLETED|Phase 1||1||
59670384|NCT04123093|75789333|FG001|NOT COMPLETED|Phase 1||0||
59670385|NCT04123093|75789332|FG000|STARTED|Phase 2||0||
59670386|NCT04123093|75789333|FG001|STARTED|Phase 2||2||
59670387|NCT04123093|75789332|FG000|Baseline Visit|Phase 2||0||
59670388|NCT04123093|75789333|FG001|Baseline Visit|Phase 2||2||
59670389|NCT04123093|75789332|FG000|COMPLETED|Phase 2||0||
59670390|NCT04123093|75789333|FG001|COMPLETED|Phase 2||0||
59670391|NCT04123093|75789332|FG000|NOT COMPLETED|Phase 2||0||
59670392|NCT04123093|75789333|FG001|NOT COMPLETED|Phase 2||2||
59670393|NCT03905330|75789341|FG000|STARTED|Overall Study||47||
59670394|NCT03905330|75789342|FG001|STARTED|Overall Study||46||
59670395|NCT03905330|75789341|FG000|Dosed 150 ug/kg BID|Overall Study||47|150 ug/kg BID planned for 1 week|
59670396|NCT03905330|75789342|FG001|Dosed 150 ug/kg BID|Overall Study||0|150 ug/kg BID planned for 1 week|
59670397|NCT03905330|75789341|FG000|Dosed 300 ug/kg BID|Overall Study||46|300 ug/kg BID planned for 1 week|
59670398|NCT03905330|75789342|FG001|Dosed 300 ug/kg BID|Overall Study||0|300 ug/kg BID planned for 1 week|
59670399|NCT03905330|75789341|FG000|Dosed 450 ug/kg BID|Overall Study||45|450 ug/kg BID planned for 1 week|
59670400|NCT03905330|75789342|FG001|Dosed 450 ug/kg BID|Overall Study||0|450 ug/kg BID planned for 1 week|
59670401|NCT03905330|75789341|FG000|Dosed 600 ug/kg BID|Overall Study||45|600 ug/kg BID planned for 23 weeks|
59815880|NCT01994954|75938286|FG001|STARTED|Overall Study||97||
59670402|NCT03905330|75789342|FG001|Dosed 600 ug/kg BID|Overall Study||0|600 ug/kg BID planned for 23 weeks|
59670403|NCT03905330|75789341|FG000|COMPLETED|Overall Study||44||
59670404|NCT03905330|75789342|FG001|COMPLETED|Overall Study||42||
59670405|NCT03905330|75789341|FG000|NOT COMPLETED|Overall Study||3||
59670406|NCT03905330|75789342|FG001|NOT COMPLETED|Overall Study||4||
59670407|NCT03824769|75789353|FG000|STARTED|Phase I (Weight Loss): 16 Weeks||24||
59670408|NCT03824769|75789354|FG001|STARTED|Phase I (Weight Loss): 16 Weeks||28||
59670409|NCT03824769|75789355|FG002|STARTED|Phase I (Weight Loss): 16 Weeks||108||
59670410|NCT03824769|75789353|FG000|COMPLETED|Phase I (Weight Loss): 16 Weeks|For this Phase, completion would include 1) participation in the entire 16-week program 2) completion of the post-Phase I assessment and 3) confirmed eligible for Phase II. All participants in this arm were eligible and randomized into the Phase II Weight Maintenance RCT.|24||
59670411|NCT03824769|75789354|FG001|COMPLETED|Phase I (Weight Loss): 16 Weeks|For this Phase, completion would include 1) participation in the entire 16-week program 2) completion of the post-Phase I assessment and 3) confirmed eligible for Phase II. All participants in this arm were eligible and randomized into the Phase II Weight Maintenance RCT.|28||
59670412|NCT03824769|75789355|FG002|COMPLETED|Phase I (Weight Loss): 16 Weeks|For this Phase, completion would include 1) participation in the entire 16-week program 2) completion of the post-Phase I assessment and 3) confirmed eligible for Phase II. Because participants in this group did not meet all 3 of these requirements and were not randomized, all are considered incomplete.|0||
59670413|NCT03824769|75789353|FG000|NOT COMPLETED|Phase I (Weight Loss): 16 Weeks||0||
59670414|NCT03824769|75789354|FG001|NOT COMPLETED|Phase I (Weight Loss): 16 Weeks||0||
59670415|NCT03824769|75789355|FG002|NOT COMPLETED|Phase I (Weight Loss): 16 Weeks||108||
59670416|NCT03824769|75789353|FG000|STARTED|Phase II (Weight Maintenance): 4 Months||24||
59670417|NCT03824769|75789354|FG001|STARTED|Phase II (Weight Maintenance): 4 Months||28||
59670418|NCT03824769|75789355|FG002|STARTED|Phase II (Weight Maintenance): 4 Months|Participants in this group were not eligible for Phase II; therefore, these milestones are not applicable.|0||
59670419|NCT03824769|75789353|FG000|1 Month Assessment|Phase II (Weight Maintenance): 4 Months||22||
59670420|NCT03824769|75789354|FG001|1 Month Assessment|Phase II (Weight Maintenance): 4 Months||27||
59670421|NCT03824769|75789355|FG002|1 Month Assessment|Phase II (Weight Maintenance): 4 Months|Participants in this group were not eligible for Phase II; therefore, these milestones are not applicable.|0||
59670422|NCT03824769|75789353|FG000|2 Month Assessment|Phase II (Weight Maintenance): 4 Months||21||
59670423|NCT03824769|75789354|FG001|2 Month Assessment|Phase II (Weight Maintenance): 4 Months||26||
59670424|NCT03824769|75789355|FG002|2 Month Assessment|Phase II (Weight Maintenance): 4 Months|Participants in this group were not eligible for Phase II; therefore, these milestones are not applicable.|0||
59670425|NCT03824769|75789353|FG000|COMPLETED|Phase II (Weight Maintenance): 4 Months||22||
59670426|NCT03824769|75789354|FG001|COMPLETED|Phase II (Weight Maintenance): 4 Months||28||
59670427|NCT03824769|75789355|FG002|COMPLETED|Phase II (Weight Maintenance): 4 Months|Participants in this group were not eligible for Phase II; therefore, these milestones are not applicable.|0||
59670428|NCT03824769|75789353|FG000|NOT COMPLETED|Phase II (Weight Maintenance): 4 Months||2||
59670429|NCT03824769|75789354|FG001|NOT COMPLETED|Phase II (Weight Maintenance): 4 Months||0||
59670430|NCT03824769|75789355|FG002|NOT COMPLETED|Phase II (Weight Maintenance): 4 Months||0||
59670431|NCT03736213|75789362|FG000|STARTED|Overall Study||7||10
59670432|NCT03736213|75789363|FG001|STARTED|Overall Study||7||10
59670433|NCT03736213|75789362|FG000|COMPLETED|Overall Study||7||10
59670434|NCT03736213|75789363|FG001|COMPLETED|Overall Study||7||10
59670435|NCT03736213|75789362|FG000|NOT COMPLETED|Overall Study||0||0
59670436|NCT03736213|75789363|FG001|NOT COMPLETED|Overall Study||0||0
59670437|NCT03609853|75789369|FG000|STARTED|Overall Study||35||
59670438|NCT03609853|75789369|FG000|Placebo|Overall Study||28||
59670439|NCT03609853|75789369|FG000|Vaporized Low Delta-9-tetrahydrocannabinol (THC)|Overall Study||25||
59670440|NCT03609853|75789369|FG000|Vaporized High THC|Overall Study||27||
59670441|NCT03609853|75789369|FG000|Vaporized Low D-limonene|Overall Study||30||
59815881|NCT01994954|75938285|FG000|COMPLETED|Overall Study||74||
59815882|NCT01994954|75938286|FG001|COMPLETED|Overall Study||67||
59545825|NCT01054586|75644576|FG000|COMPLETED|Overall Study||43||
59545826|NCT01054586|75644577|FG001|COMPLETED|Overall Study||15||
59545827|NCT01054586|75644578|FG002|COMPLETED|Overall Study||8||
59545828|NCT01054586|75644579|FG003|COMPLETED|Overall Study||101||
59545829|NCT01054586|75644576|FG000|NOT COMPLETED|Overall Study||0||
59545830|NCT01054586|75644577|FG001|NOT COMPLETED|Overall Study||0||
59545831|NCT01054586|75644578|FG002|NOT COMPLETED|Overall Study||0||
59545832|NCT01054586|75644579|FG003|NOT COMPLETED|Overall Study||0||
59545833|NCT01054742|75644599|FG000|STARTED|Overall Study||2||
59545834|NCT01054742|75644599|FG000|COMPLETED|Overall Study||2||
59545835|NCT01054742|75644599|FG000|NOT COMPLETED|Overall Study||0||
59545836|NCT01056302|75644603|FG000|STARTED|Overall Study||3||
59670442|NCT03609853|75789369|FG000|Vaporized High D-limonene|Overall Study||27||
59670443|NCT03609853|75789369|FG000|Low THC and Low D-limonene|Overall Study||27||
59670444|NCT03609853|75789369|FG000|High THC and Low D-limonene|Overall Study||31||
59670445|NCT03609853|75789369|FG000|Low THC and High D-limonene|Overall Study||25||
59670446|NCT03609853|75789369|FG000|High THC and High D-limonene|Overall Study||26||
59670447|NCT03609853|75789369|FG000|High THC and 15mg Limonene|Overall Study||12||
59670448|NCT03609853|75789369|FG000|COMPLETED|Overall Study||20||
59670449|NCT03609853|75789369|FG000|NOT COMPLETED|Overall Study||15||
59670450|NCT03538301|75789395|FG000|STARTED|Overall Study||42||
59670451|NCT03538301|75789396|FG001|STARTED|Overall Study||41||
59670452|NCT03538301|75789397|FG002|STARTED|Overall Study||40||
59670453|NCT03538301|75789395|FG000|COMPLETED|Overall Study||31||
59670454|NCT03538301|75789396|FG001|COMPLETED|Overall Study||29||
59670455|NCT03538301|75789397|FG002|COMPLETED|Overall Study||28||
59670456|NCT03538301|75789395|FG000|NOT COMPLETED|Overall Study||11||
59670457|NCT03538301|75789396|FG001|NOT COMPLETED|Overall Study||12||
59670458|NCT03538301|75789397|FG002|NOT COMPLETED|Overall Study||12||
59670459|NCT03485157|75789407|FG000|STARTED|Double Blind Phase||223||
59670460|NCT03485157|75789408|FG001|STARTED|Double Blind Phase||224||
59670461|NCT03485157|75789407|FG000|COMPLETED|Double Blind Phase||208||
59670462|NCT03485157|75789408|FG001|COMPLETED|Double Blind Phase||203||
59670463|NCT03485157|75789407|FG000|NOT COMPLETED|Double Blind Phase||15||
59670464|NCT03485157|75789408|FG001|NOT COMPLETED|Double Blind Phase||21||
59670465|NCT03485157|75789407|FG000|STARTED|Open Label Phase||108||
59670466|NCT03485157|75789408|FG001|STARTED|Open Label Phase||109||
59670467|NCT03485157|75789407|FG000|COMPLETED|Open Label Phase||104||
59670468|NCT03485157|75789408|FG001|COMPLETED|Open Label Phase||104||
59670469|NCT03485157|75789407|FG000|NOT COMPLETED|Open Label Phase||4||
59670470|NCT03485157|75789408|FG001|NOT COMPLETED|Open Label Phase||5||
59670471|NCT03383692|75789417|FG000|STARTED|Overall Study||17||
59670472|NCT03383692|75789418|FG001|STARTED|Overall Study||23||
59670473|NCT03383692|75789417|FG000|COMPLETED|Overall Study||11|Ongoing on study drug as of 26 Sep 2018|
59670474|NCT03383692|75789418|FG001|COMPLETED|Overall Study||19|Ongoing on study drug as of 26 Sep 2018|
59670475|NCT03383692|75789417|FG000|NOT COMPLETED|Overall Study||6||
59670476|NCT03383692|75789418|FG001|NOT COMPLETED|Overall Study||4||
59670477|NCT03309007|75789428|FG000|STARTED|Overall Study||13||
59670478|NCT03309007|75789429|FG001|STARTED|Overall Study||12||
59670479|NCT03309007|75789428|FG000|COMPLETED|Overall Study||13||
59670480|NCT03309007|75789429|FG001|COMPLETED|Overall Study||12||
59670481|NCT03309007|75789428|FG000|NOT COMPLETED|Overall Study||0||
59670482|NCT03309007|75789429|FG001|NOT COMPLETED|Overall Study||0||
59670483|NCT03048019|75789437|FG000|STARTED|Overall Study||5||
59670484|NCT03048019|75789438|FG001|STARTED|Overall Study||5||
59670485|NCT03048019|75789437|FG000|COMPLETED|Overall Study||4||
59670486|NCT03048019|75789438|FG001|COMPLETED|Overall Study||5||
59670487|NCT03048019|75789437|FG000|NOT COMPLETED|Overall Study||1||
59670488|NCT03048019|75789438|FG001|NOT COMPLETED|Overall Study||0||
59670489|NCT02998645|75789444|FG000|STARTED|Treatment Period 1||54||
59670490|NCT02998645|75789444|FG000|East/Southeast Asian Ethnicity|Treatment Period 1||18||
59670491|NCT02998645|75789444|FG000|Non-East/Southeast Asian Ethnicity|Treatment Period 1||36||
59670492|NCT02998645|75789444|FG000|COMPLETED|Treatment Period 1||35||
59670493|NCT02998645|75789444|FG000|NOT COMPLETED|Treatment Period 1||19||
59670494|NCT02998645|75789444|FG000|STARTED|Treatment Period 2||21|Participants who were responders at Month 6|
59989285|NCT02258074|76104538|FG003|NOT COMPLETED|Overall Study||0||
59989286|NCT01643044|76104550|FG000|STARTED|Overall Study||24||
59989287|NCT01643044|76104551|FG001|STARTED|Overall Study||24||
59989288|NCT01643044|76104550|FG000|COMPLETED|Overall Study||20||
59989289|NCT01643044|76104551|FG001|COMPLETED|Overall Study||19||
59989290|NCT01643044|76104550|FG000|NOT COMPLETED|Overall Study||4||
59989291|NCT01643044|76104551|FG001|NOT COMPLETED|Overall Study||5||
59989292|NCT01642732|76104557|FG000|STARTED|Overall Study||1||
59989293|NCT01642732|76104557|FG000|COMPLETED|Overall Study||0||
59989294|NCT01642732|76104557|FG000|NOT COMPLETED|Overall Study||1||
59989295|NCT02257684|76104561|FG000|STARTED|Overall Study||4||
59989296|NCT02257684|76104561|FG000|COMPLETED|Overall Study||0||
59989297|NCT02257684|76104561|FG000|NOT COMPLETED|Overall Study||4||
59670495|NCT02998645|75789444|FG000|COMPLETED|Treatment Period 2||11||
59670496|NCT02998645|75789444|FG000|NOT COMPLETED|Treatment Period 2||10||
59670497|NCT02223377|75789450|FG000|STARTED|Overall Study||199||
59670498|NCT02223377|75789451|FG001|STARTED|Overall Study||203||
59670499|NCT02223377|75789450|FG000|COMPLETED|Overall Study||199||
59670500|NCT02223377|75789451|FG001|COMPLETED|Overall Study||203||
59670501|NCT02223377|75789450|FG000|NOT COMPLETED|Overall Study||0||
59670502|NCT02223377|75789451|FG001|NOT COMPLETED|Overall Study||0||
59670503|NCT02094261|75789457|FG000|STARTED|Overall Study||210||
59670504|NCT02094261|75789457|FG000|COMPLETED|Overall Study||0||
59670505|NCT02094261|75789457|FG000|NOT COMPLETED|Overall Study||210||
59670506|NCT02077192|75789461|FG000|STARTED|Overall Study||123||
59670507|NCT02077192|75789461|FG000|COMPLETED|Overall Study||29||
59670508|NCT02077192|75789461|FG000|NOT COMPLETED|Overall Study||94||
59670509|NCT02074553|75789468|FG000|STARTED|Intervention Period 1||12||
59670510|NCT02074553|75789469|FG001|STARTED|Intervention Period 1||12||
59670511|NCT02074553|75789470|FG002|STARTED|Intervention Period 1||12||
59670512|NCT02074553|75789471|FG003|STARTED|Intervention Period 1||13||
59670513|NCT02074553|75789472|FG004|STARTED|Intervention Period 1||12||
59670514|NCT02074553|75789473|FG005|STARTED|Intervention Period 1||12||
59670515|NCT02074553|75789474|FG006|STARTED|Intervention Period 1||12||
59670516|NCT02074553|75789475|FG007|STARTED|Intervention Period 1||12||
59670517|NCT02074553|75789468|FG000|COMPLETED|Intervention Period 1||12||
59670518|NCT02074553|75789469|FG001|COMPLETED|Intervention Period 1||12||
59670519|NCT02074553|75789470|FG002|COMPLETED|Intervention Period 1||12||
59670520|NCT02074553|75789471|FG003|COMPLETED|Intervention Period 1||12||
59670521|NCT02074553|75789472|FG004|COMPLETED|Intervention Period 1||12||
59670522|NCT02074553|75789473|FG005|COMPLETED|Intervention Period 1||12||
59670523|NCT02074553|75789474|FG006|COMPLETED|Intervention Period 1||12||
59670524|NCT02074553|75789475|FG007|COMPLETED|Intervention Period 1||12||
59670525|NCT02074553|75789468|FG000|NOT COMPLETED|Intervention Period 1||0||
59670526|NCT02074553|75789469|FG001|NOT COMPLETED|Intervention Period 1||0||
59670527|NCT02074553|75789470|FG002|NOT COMPLETED|Intervention Period 1||0||
59670528|NCT02074553|75789471|FG003|NOT COMPLETED|Intervention Period 1||1||
59670529|NCT02074553|75789472|FG004|NOT COMPLETED|Intervention Period 1||0||
59670530|NCT02074553|75789473|FG005|NOT COMPLETED|Intervention Period 1||0||
59670531|NCT02074553|75789474|FG006|NOT COMPLETED|Intervention Period 1||0||
59670532|NCT02074553|75789475|FG007|NOT COMPLETED|Intervention Period 1||0||
59670533|NCT02074553|75789468|FG000|STARTED|Washout Period 1||12||
59670534|NCT02074553|75789469|FG001|STARTED|Washout Period 1||12||
59670535|NCT02074553|75789470|FG002|STARTED|Washout Period 1||12||
59670536|NCT02074553|75789471|FG003|STARTED|Washout Period 1||12||
59670537|NCT02074553|75789472|FG004|STARTED|Washout Period 1||12||
59670538|NCT02074553|75789473|FG005|STARTED|Washout Period 1||12||
59670539|NCT02074553|75789474|FG006|STARTED|Washout Period 1||12||
59670540|NCT02074553|75789475|FG007|STARTED|Washout Period 1||12||
59670541|NCT02074553|75789468|FG000|COMPLETED|Washout Period 1||11||
59670542|NCT02074553|75789469|FG001|COMPLETED|Washout Period 1||12||
59670543|NCT02074553|75789470|FG002|COMPLETED|Washout Period 1||12||
59670544|NCT02074553|75789471|FG003|COMPLETED|Washout Period 1||11||
59670545|NCT02074553|75789472|FG004|COMPLETED|Washout Period 1||12||
59670546|NCT02074553|75789473|FG005|COMPLETED|Washout Period 1||11||
59670547|NCT02074553|75789474|FG006|COMPLETED|Washout Period 1||12||
59670548|NCT02074553|75789475|FG007|COMPLETED|Washout Period 1||12||
59989298|NCT02190721|76104568|FG000|STARTED|Overall Study||2||
59989299|NCT02190721|76104569|FG001|STARTED|Overall Study||30||
59989300|NCT02190721|76104570|FG002|STARTED|Overall Study||18||
59989301|NCT02190721|76104568|FG000|Completed Treatment|Overall Study||2||
59670549|NCT02074553|75789468|FG000|NOT COMPLETED|Washout Period 1||1||
59670550|NCT02074553|75789469|FG001|NOT COMPLETED|Washout Period 1||0||
59670551|NCT02074553|75789470|FG002|NOT COMPLETED|Washout Period 1||0||
59989302|NCT02190721|76104569|FG001|Completed Treatment|Overall Study||30||
59989303|NCT02190721|76104570|FG002|Completed Treatment|Overall Study||18||
59670552|NCT02074553|75789471|FG003|NOT COMPLETED|Washout Period 1||1||
59989304|NCT02190721|76104568|FG000|Completed 30 Day Follow-up|Overall Study||2||
59989305|NCT02190721|76104569|FG001|Completed 30 Day Follow-up|Overall Study||29||
59670553|NCT02074553|75789472|FG004|NOT COMPLETED|Washout Period 1||0||
59670554|NCT02074553|75789473|FG005|NOT COMPLETED|Washout Period 1||1||
59670555|NCT02074553|75789474|FG006|NOT COMPLETED|Washout Period 1||0||
59670556|NCT02074553|75789475|FG007|NOT COMPLETED|Washout Period 1||0||
59670557|NCT02074553|75789468|FG000|STARTED|Intervention Period 2||11||
59670558|NCT02074553|75789469|FG001|STARTED|Intervention Period 2||12||
59670559|NCT02074553|75789470|FG002|STARTED|Intervention Period 2||12||
59670560|NCT02074553|75789471|FG003|STARTED|Intervention Period 2||11||
59670561|NCT02074553|75789472|FG004|STARTED|Intervention Period 2||12||
59670562|NCT02074553|75789473|FG005|STARTED|Intervention Period 2||11||
59670563|NCT02074553|75789474|FG006|STARTED|Intervention Period 2||12||
59670564|NCT02074553|75789475|FG007|STARTED|Intervention Period 2||12||
59670565|NCT02074553|75789468|FG000|COMPLETED|Intervention Period 2||11||
59670566|NCT02074553|75789469|FG001|COMPLETED|Intervention Period 2||12||
59670567|NCT02074553|75789470|FG002|COMPLETED|Intervention Period 2||12||
59670568|NCT02074553|75789471|FG003|COMPLETED|Intervention Period 2||11||
59670569|NCT02074553|75789472|FG004|COMPLETED|Intervention Period 2||12||
59670570|NCT02074553|75789473|FG005|COMPLETED|Intervention Period 2||11||
59670571|NCT02074553|75789474|FG006|COMPLETED|Intervention Period 2||12||
59670572|NCT02074553|75789475|FG007|COMPLETED|Intervention Period 2||12||
59670573|NCT02074553|75789468|FG000|NOT COMPLETED|Intervention Period 2||0||
59670574|NCT02074553|75789469|FG001|NOT COMPLETED|Intervention Period 2||0||
59670575|NCT02074553|75789470|FG002|NOT COMPLETED|Intervention Period 2||0||
59670576|NCT02074553|75789471|FG003|NOT COMPLETED|Intervention Period 2||0||
59670577|NCT02074553|75789472|FG004|NOT COMPLETED|Intervention Period 2||0||
59670578|NCT02074553|75789473|FG005|NOT COMPLETED|Intervention Period 2||0||
59670579|NCT02074553|75789474|FG006|NOT COMPLETED|Intervention Period 2||0||
59670580|NCT02074553|75789475|FG007|NOT COMPLETED|Intervention Period 2||0||
59670581|NCT02074553|75789468|FG000|STARTED|Washout Period 2||11||
59670582|NCT02074553|75789469|FG001|STARTED|Washout Period 2||12||
59670583|NCT02074553|75789470|FG002|STARTED|Washout Period 2||12||
59670584|NCT02074553|75789471|FG003|STARTED|Washout Period 2||11||
59670585|NCT02074553|75789472|FG004|STARTED|Washout Period 2||12||
59670586|NCT02074553|75789473|FG005|STARTED|Washout Period 2||11||
59670587|NCT02074553|75789474|FG006|STARTED|Washout Period 2||12||
59670588|NCT02074553|75789475|FG007|STARTED|Washout Period 2||12||
59670589|NCT02074553|75789468|FG000|COMPLETED|Washout Period 2||11||
59670590|NCT02074553|75789469|FG001|COMPLETED|Washout Period 2||12||
59670591|NCT02074553|75789470|FG002|COMPLETED|Washout Period 2||11||
59670592|NCT02074553|75789471|FG003|COMPLETED|Washout Period 2||11||
59670593|NCT02074553|75789472|FG004|COMPLETED|Washout Period 2||12||
59670594|NCT02074553|75789473|FG005|COMPLETED|Washout Period 2||10||
59670595|NCT02074553|75789474|FG006|COMPLETED|Washout Period 2||11||
59670596|NCT02074553|75789475|FG007|COMPLETED|Washout Period 2||12||
59670597|NCT02074553|75789468|FG000|NOT COMPLETED|Washout Period 2||0||
59670598|NCT02074553|75789469|FG001|NOT COMPLETED|Washout Period 2||0||
59670599|NCT02074553|75789470|FG002|NOT COMPLETED|Washout Period 2||1||
59670600|NCT02074553|75789471|FG003|NOT COMPLETED|Washout Period 2||0||
59670601|NCT02074553|75789472|FG004|NOT COMPLETED|Washout Period 2||0||
59670602|NCT02074553|75789473|FG005|NOT COMPLETED|Washout Period 2||1||
59670603|NCT02074553|75789474|FG006|NOT COMPLETED|Washout Period 2||1||
59670604|NCT02074553|75789475|FG007|NOT COMPLETED|Washout Period 2||0||
59670605|NCT02074553|75789468|FG000|STARTED|Intervention Period 3||11||
59670606|NCT02074553|75789469|FG001|STARTED|Intervention Period 3||12||
59670607|NCT02074553|75789470|FG002|STARTED|Intervention Period 3||11||
59670608|NCT02074553|75789471|FG003|STARTED|Intervention Period 3||11||
59670609|NCT02074553|75789472|FG004|STARTED|Intervention Period 3||12||
59670610|NCT02074553|75789473|FG005|STARTED|Intervention Period 3||10||
59670611|NCT02074553|75789474|FG006|STARTED|Intervention Period 3||11||
59670612|NCT02074553|75789475|FG007|STARTED|Intervention Period 3||12||
59670613|NCT02074553|75789468|FG000|COMPLETED|Intervention Period 3||11||
59670614|NCT02074553|75789469|FG001|COMPLETED|Intervention Period 3||12||
59670615|NCT02074553|75789470|FG002|COMPLETED|Intervention Period 3||11||
59670616|NCT02074553|75789471|FG003|COMPLETED|Intervention Period 3||11||
59670617|NCT02074553|75789472|FG004|COMPLETED|Intervention Period 3||12||
59670618|NCT02074553|75789473|FG005|COMPLETED|Intervention Period 3||10||
59670619|NCT02074553|75789474|FG006|COMPLETED|Intervention Period 3||11||
59670620|NCT02074553|75789475|FG007|COMPLETED|Intervention Period 3||12||
59670621|NCT02074553|75789468|FG000|NOT COMPLETED|Intervention Period 3||0||
59670622|NCT02074553|75789469|FG001|NOT COMPLETED|Intervention Period 3||0||
59670623|NCT02074553|75789470|FG002|NOT COMPLETED|Intervention Period 3||0||
59670624|NCT02074553|75789471|FG003|NOT COMPLETED|Intervention Period 3||0||
59670625|NCT02074553|75789472|FG004|NOT COMPLETED|Intervention Period 3||0||
59670626|NCT02074553|75789473|FG005|NOT COMPLETED|Intervention Period 3||0||
59670627|NCT02074553|75789474|FG006|NOT COMPLETED|Intervention Period 3||0||
59670628|NCT02074553|75789475|FG007|NOT COMPLETED|Intervention Period 3||0||
59670629|NCT02074553|75789468|FG000|STARTED|Washout Period 3||11||
59670630|NCT02074553|75789469|FG001|STARTED|Washout Period 3||12||
59670631|NCT02074553|75789470|FG002|STARTED|Washout Period 3||11||
59670632|NCT02074553|75789471|FG003|STARTED|Washout Period 3||11||
59670633|NCT02074553|75789472|FG004|STARTED|Washout Period 3||12||
59670634|NCT02074553|75789473|FG005|STARTED|Washout Period 3||10||
59670635|NCT02074553|75789474|FG006|STARTED|Washout Period 3||11||
59670636|NCT02074553|75789475|FG007|STARTED|Washout Period 3||12||
59670637|NCT02074553|75789468|FG000|COMPLETED|Washout Period 3||11||
59670638|NCT02074553|75789469|FG001|COMPLETED|Washout Period 3||12||
59670639|NCT02074553|75789470|FG002|COMPLETED|Washout Period 3||11||
59670640|NCT02074553|75789471|FG003|COMPLETED|Washout Period 3||11||
59670641|NCT02074553|75789472|FG004|COMPLETED|Washout Period 3||12||
59670642|NCT02074553|75789473|FG005|COMPLETED|Washout Period 3||10||
59670643|NCT02074553|75789474|FG006|COMPLETED|Washout Period 3||11||
59670644|NCT02074553|75789475|FG007|COMPLETED|Washout Period 3||11||
59670645|NCT02074553|75789468|FG000|NOT COMPLETED|Washout Period 3||0||
59670646|NCT02074553|75789469|FG001|NOT COMPLETED|Washout Period 3||0||
59670647|NCT02074553|75789470|FG002|NOT COMPLETED|Washout Period 3||0||
59670648|NCT02074553|75789471|FG003|NOT COMPLETED|Washout Period 3||0||
59670649|NCT02074553|75789472|FG004|NOT COMPLETED|Washout Period 3||0||
59670650|NCT02074553|75789473|FG005|NOT COMPLETED|Washout Period 3||0||
59670651|NCT02074553|75789474|FG006|NOT COMPLETED|Washout Period 3||0||
59670652|NCT02074553|75789475|FG007|NOT COMPLETED|Washout Period 3||1||
59670653|NCT02074553|75789468|FG000|STARTED|Intervention Period 4||11||
59670654|NCT02074553|75789469|FG001|STARTED|Intervention Period 4||12||
59670655|NCT02074553|75789470|FG002|STARTED|Intervention Period 4||11||
59670656|NCT02074553|75789471|FG003|STARTED|Intervention Period 4||11||
59670657|NCT02074553|75789472|FG004|STARTED|Intervention Period 4||12||
59670658|NCT02074553|75789473|FG005|STARTED|Intervention Period 4||10||
59670659|NCT02074553|75789474|FG006|STARTED|Intervention Period 4||11||
59670660|NCT02074553|75789475|FG007|STARTED|Intervention Period 4||11||
59670661|NCT02074553|75789468|FG000|COMPLETED|Intervention Period 4||11||
59670662|NCT02074553|75789469|FG001|COMPLETED|Intervention Period 4||12||
59670663|NCT02074553|75789470|FG002|COMPLETED|Intervention Period 4||11||
59670664|NCT02074553|75789471|FG003|COMPLETED|Intervention Period 4||11||
59670665|NCT02074553|75789472|FG004|COMPLETED|Intervention Period 4||12||
59670666|NCT02074553|75789473|FG005|COMPLETED|Intervention Period 4||10||
59670667|NCT02074553|75789474|FG006|COMPLETED|Intervention Period 4||11||
59670668|NCT02074553|75789475|FG007|COMPLETED|Intervention Period 4||11||
59670669|NCT02074553|75789468|FG000|NOT COMPLETED|Intervention Period 4||0||
59670670|NCT02074553|75789469|FG001|NOT COMPLETED|Intervention Period 4||0||
59670671|NCT02074553|75789470|FG002|NOT COMPLETED|Intervention Period 4||0||
59670672|NCT02074553|75789471|FG003|NOT COMPLETED|Intervention Period 4||0||
59670673|NCT02074553|75789472|FG004|NOT COMPLETED|Intervention Period 4||0||
59670674|NCT02074553|75789473|FG005|NOT COMPLETED|Intervention Period 4||0||
59670675|NCT02074553|75789474|FG006|NOT COMPLETED|Intervention Period 4||0||
59670676|NCT02074553|75789475|FG007|NOT COMPLETED|Intervention Period 4||0||
59670677|NCT01664598|75789493|FG000|STARTED|Overall Study||49||
59670678|NCT01664598|75789493|FG000|COMPLETED|Overall Study||43||
59670679|NCT01664598|75789493|FG000|NOT COMPLETED|Overall Study||6||
59670680|NCT01387295|75789497|FG000|STARTED|Overall Study||38||
59670681|NCT01387295|75789497|FG000|COMPLETED|Overall Study||38||
59670682|NCT01387295|75789497|FG000|NOT COMPLETED|Overall Study||0||
59670683|NCT01280682|75789503|FG000|STARTED|Overall Study||30||
59670684|NCT01280682|75789504|FG001|STARTED|Overall Study||90||
59670685|NCT01280682|75789503|FG000|COMPLETED|Overall Study||30||
59670686|NCT01280682|75789504|FG001|COMPLETED|Overall Study||77||
59670687|NCT01280682|75789503|FG000|NOT COMPLETED|Overall Study||0||
59670688|NCT01280682|75789504|FG001|NOT COMPLETED|Overall Study||13||
59670689|NCT01209936|75789513|FG000|STARTED|Overall Study||245||
59670690|NCT01209936|75789514|FG001|STARTED|Overall Study||115||
59670691|NCT01209936|75789513|FG000|COMPLETED|Overall Study||245||
59670692|NCT01209936|75789514|FG001|COMPLETED|Overall Study||115||
59670693|NCT01209936|75789513|FG000|NOT COMPLETED|Overall Study||0||
59670694|NCT01209936|75789514|FG001|NOT COMPLETED|Overall Study||0||
59670695|NCT01050218|75789521|FG000|STARTED|Overall Study||237||
59670696|NCT01050218|75789521|FG000|COMPLETED|Overall Study||142||
59670697|NCT01050218|75789521|FG000|NOT COMPLETED|Overall Study||95||
59670698|NCT00679029|75789525|FG000|STARTED|Overall Study||15||
59670699|NCT00679029|75789525|FG000|COMPLETED|Overall Study||10||
59670700|NCT00679029|75789525|FG000|NOT COMPLETED|Overall Study||5||
59670701|NCT00195429|75789531|FG000|STARTED|Overall Study||24||
59670702|NCT00195429|75789532|FG001|STARTED|Overall Study||23||
59670703|NCT00195429|75789531|FG000|COMPLETED|Overall Study||19||
59670704|NCT00195429|75789532|FG001|COMPLETED|Overall Study||18||
59670705|NCT00195429|75789531|FG000|NOT COMPLETED|Overall Study||5||
59815883|NCT01994954|75938285|FG000|NOT COMPLETED|Overall Study||25||
59670706|NCT00195429|75789532|FG001|NOT COMPLETED|Overall Study||5||
59670707|NCT01059773|75789540|FG000|STARTED|Overall Study||244||
59670708|NCT01059773|75789541|FG001|STARTED|Overall Study||245||
59670709|NCT01059773|75789540|FG000|COMPLETED|Overall Study|Completed is refering to no Discontinuation of Study Agent Through Week 52|224||
59670710|NCT01059773|75789541|FG001|COMPLETED|Overall Study|Completed is refering to no Discontinuation of Study Agent Through Week 52|221||
59670711|NCT01059773|75789540|FG000|NOT COMPLETED|Overall Study||20||
59670712|NCT01059773|75789541|FG001|NOT COMPLETED|Overall Study||24||
59815884|NCT01994954|75938286|FG001|NOT COMPLETED|Overall Study||30||
59670713|NCT01059318|75789552|FG000|STARTED|Core Study (26 Week)|This is safety set and Pharmacodynamic set|24||
59670714|NCT01059318|75789552|FG000|Everolimus 2.5 mg for 4 Weeks|Core Study (26 Week)||24||
59670715|NCT01059318|75789552|FG000|Everolimus 5 mg for 4 Weeks|Core Study (26 Week)||24||
59670716|NCT01059318|75789552|FG000|Everolimus 10 mg for 18 Weeks|Core Study (26 Week)||24||
59670717|NCT01059318|75789552|FG000|Pharmacokinetics (PK) Analysis Set|Core Study (26 Week)|For 8 patients plasma rather than whole blood sample was collected, hence excluded from PK set.|16||
59670718|NCT01059318|75789552|FG000|COMPLETED|Core Study (26 Week)||20||
59670719|NCT01059318|75789552|FG000|NOT COMPLETED|Core Study (26 Week)||4||
59670720|NCT01059318|75789552|FG000|STARTED|Extension (36 Week)||20||
59670721|NCT01059318|75789552|FG000|COMPLETED|Extension (36 Week)||17||
59670722|NCT01059318|75789552|FG000|NOT COMPLETED|Extension (36 Week)||3||
59670723|NCT01058655|75789563|FG000|STARTED|Overall Study||3||
59670724|NCT01058655|75789564|FG001|STARTED|Overall Study||3||
59670725|NCT01058655|75789565|FG002|STARTED|Overall Study||8||
59670726|NCT01058655|75789566|FG003|STARTED|Overall Study||42||
59670727|NCT01058655|75789563|FG000|Evaluable|Overall Study||3||
59670728|NCT01058655|75789564|FG001|Evaluable|Overall Study||3||
59670729|NCT01058655|75789565|FG002|Evaluable|Overall Study||6||
59670730|NCT01058655|75789566|FG003|Evaluable|Overall Study||40||
59670731|NCT01058655|75789563|FG000|COMPLETED|Overall Study||0|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|
59670732|NCT01058655|75789564|FG001|COMPLETED|Overall Study||0|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|
59670733|NCT01058655|75789565|FG002|COMPLETED|Overall Study||0|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|
59670734|NCT01058655|75789566|FG003|COMPLETED|Overall Study||0|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|
59670735|NCT01058655|75789563|FG000|NOT COMPLETED|Overall Study||3||
59670736|NCT01058655|75789564|FG001|NOT COMPLETED|Overall Study||3||
59670737|NCT01058655|75789565|FG002|NOT COMPLETED|Overall Study||8||
59670738|NCT01058655|75789566|FG003|NOT COMPLETED|Overall Study||42||
59670739|NCT01058421|75789579|FG000|STARTED|1 Month Outcomes||59||
59670740|NCT01058421|75789580|FG001|STARTED|1 Month Outcomes||61||
59670741|NCT01058421|75789579|FG000|COMPLETED|1 Month Outcomes||20||
59670742|NCT01058421|75789580|FG001|COMPLETED|1 Month Outcomes||19||
59670743|NCT01058421|75789579|FG000|NOT COMPLETED|1 Month Outcomes||39||
59670744|NCT01058421|75789580|FG001|NOT COMPLETED|1 Month Outcomes||42||
59670745|NCT01058421|75789579|FG000|STARTED|3 Month Outcomes|59 (Subjects started Period 1) minus 10 (deceased subjects during Period 1) = 49 started Period 2.|49|Deceased subjects were not included in subsequent Period beginning subject started totals.|
59670746|NCT01058421|75789580|FG001|STARTED|3 Month Outcomes|61 (Subjects started Period 1) minus 6 (deceased subjects during Period 1) = 55 started Period 2.|55|Deceased subjects were not included in subsequent Period beginning subject started totals.|
59670747|NCT01058421|75789579|FG000|COMPLETED|3 Month Outcomes||29||
59670748|NCT01058421|75789580|FG001|COMPLETED|3 Month Outcomes||29||
59670749|NCT01058421|75789579|FG000|NOT COMPLETED|3 Month Outcomes||20||
59670750|NCT01058421|75789580|FG001|NOT COMPLETED|3 Month Outcomes||26||
59670751|NCT01058421|75789579|FG000|STARTED|6 Month Outcomes|55 (subjects started Period 1) minus 13 (deceased subjects in Periods 1 & 2) = 46 started Period 3.|46|Deceased subjects were not included in subsequent Period beginning subject started totals.|
59670752|NCT01058421|75789580|FG001|STARTED|6 Month Outcomes|61 (subjects started Period 1) minus 11 (deceased subjects in Periods 1 & 2) = 50 started Period 3.|50|Deceased subjects were not included in subsequent Period beginning subject started totals.|
59670753|NCT01058421|75789579|FG000|COMPLETED|6 Month Outcomes||27||
59670754|NCT01058421|75789580|FG001|COMPLETED|6 Month Outcomes||24||
59670755|NCT01058421|75789579|FG000|NOT COMPLETED|6 Month Outcomes||19||
59670756|NCT01058421|75789580|FG001|NOT COMPLETED|6 Month Outcomes||26||
59670757|NCT01058304|75789588|FG000|STARTED|Overall Study||159||
59670758|NCT01058304|75789589|FG001|STARTED|Overall Study||161||
59670759|NCT01058304|75789588|FG000|COMPLETED|Overall Study||132||
59670760|NCT01058304|75789589|FG001|COMPLETED|Overall Study||128||
59670761|NCT01058304|75789588|FG000|NOT COMPLETED|Overall Study||27||
59670762|NCT01058304|75789589|FG001|NOT COMPLETED|Overall Study||33||
59670763|NCT01058265|75789597|FG000|STARTED|Overall Study||22||
59670764|NCT01058265|75789598|FG001|STARTED|Overall Study||25||
59670765|NCT01058265|75789597|FG000|COMPLETED|Overall Study||11||
59670766|NCT01058265|75789598|FG001|COMPLETED|Overall Study||13||
59670767|NCT01058265|75789597|FG000|NOT COMPLETED|Overall Study||11||
59670768|NCT01058265|75789598|FG001|NOT COMPLETED|Overall Study||12||
59670769|NCT01057251|75789606|FG000|STARTED|Overall Study||290||
59670770|NCT01057251|75789607|FG001|STARTED|Overall Study|The safety population is 142, as one patient was randomized, but never received study drug.|143||
59670771|NCT01057251|75789606|FG000|COMPLETED|Overall Study||262||
59670772|NCT01057251|75789607|FG001|COMPLETED|Overall Study||114||
59670773|NCT01057251|75789606|FG000|NOT COMPLETED|Overall Study||28||
59670774|NCT01057251|75789607|FG001|NOT COMPLETED|Overall Study||29||
59670775|NCT01056822|75789615|FG000|STARTED|Overall Study||47||
59670776|NCT01056822|75789616|FG001|STARTED|Overall Study||42||
59670777|NCT01056822|75789615|FG000|Intention-to-treat (ITT) Population: YES|Overall Study||43||
59670778|NCT01056822|75789616|FG001|Intention-to-treat (ITT) Population: YES|Overall Study||38||
59670779|NCT01056822|75789615|FG000|Intention-to-treat (ITT) Population: NO|Overall Study||4||
59670780|NCT01056822|75789616|FG001|Intention-to-treat (ITT) Population: NO|Overall Study||4||
59670781|NCT01056822|75789615|FG000|Per-protocol (PP) Population: YES|Overall Study||29||
59670782|NCT01056822|75789616|FG001|Per-protocol (PP) Population: YES|Overall Study||25||
59670783|NCT01056822|75789615|FG000|Per-protocol (PP) Population: NO|Overall Study||18||
59670784|NCT01056822|75789616|FG001|Per-protocol (PP) Population: NO|Overall Study||17||
59670785|NCT01056822|75789615|FG000|Safety (SAF) Population: YES|Overall Study||46||
59670786|NCT01056822|75789616|FG001|Safety (SAF) Population: YES|Overall Study||40||
59670787|NCT01056822|75789615|FG000|Safety (SAF) Population: NO|Overall Study||1||
59670788|NCT01056822|75789616|FG001|Safety (SAF) Population: NO|Overall Study||2||
59670789|NCT01056822|75789615|FG000|COMPLETED|Overall Study||39||
59670790|NCT01056822|75789616|FG001|COMPLETED|Overall Study||35||
59670791|NCT01056822|75789615|FG000|NOT COMPLETED|Overall Study||8||
59670792|NCT01056822|75789616|FG001|NOT COMPLETED|Overall Study||7||
59670793|NCT01051791|75789623|FG000|STARTED|Overall Study||13||
59670794|NCT01051791|75789623|FG000|COMPLETED|Overall Study||9||
59670795|NCT01051791|75789623|FG000|NOT COMPLETED|Overall Study||4||
59670796|NCT04346537|75789628|FG000|STARTED|Overall Study|8 subjects did not undergo the implant procedure and did not have the INGEVITY+ lead implanted or attempted.|109||201
59670797|NCT04346537|75789628|FG000|Implanted/Attempted With INGEVITY+ Lead|Overall Study||101||201
59670798|NCT04346537|75789628|FG000|COMPLETED|Overall Study||99||198
59670799|NCT04346537|75789628|FG000|NOT COMPLETED|Overall Study||10||3
59670800|NCT01056510|75789635|FG000|STARTED|Overall Study||178||
59670801|NCT01056510|75789636|FG001|STARTED|Overall Study||179||
59670802|NCT01056510|75789635|FG000|COMPLETED|Overall Study||124||
59670803|NCT01056510|75789636|FG001|COMPLETED|Overall Study||115||
59670804|NCT01056510|75789635|FG000|NOT COMPLETED|Overall Study||54||
59670805|NCT01056510|75789636|FG001|NOT COMPLETED|Overall Study||64||
59670806|NCT01051323|75789644|FG000|STARTED|Overall Study||1580||
59670807|NCT01051323|75789644|FG000|Received at Least One Dose|Overall Study||1547||
59670808|NCT01051323|75789644|FG000|COMPLETED|Overall Study||1041||
59670809|NCT01051323|75789644|FG000|NOT COMPLETED|Overall Study||539||
59670810|NCT01056276|75789654|FG000|STARTED|Treatment Period-Cycles 1-8||18||
59670811|NCT01056276|75789655|FG001|STARTED|Treatment Period-Cycles 1-8||41||
59670812|NCT01056276|75789654|FG000|COMPLETED|Treatment Period-Cycles 1-8||5||
59670813|NCT01056276|75789655|FG001|COMPLETED|Treatment Period-Cycles 1-8||33||
59670814|NCT01056276|75789654|FG000|NOT COMPLETED|Treatment Period-Cycles 1-8||13||
59670815|NCT01056276|75789655|FG001|NOT COMPLETED|Treatment Period-Cycles 1-8||8||
59670816|NCT01056276|75789654|FG000|STARTED|Maintenance Therapy|Original regimen did not include maintenance therapy.|0||
59670817|NCT01056276|75789655|FG001|STARTED|Maintenance Therapy|5 patients completed 8 cycles but did not have maintenance therapy.|28||
59670818|NCT01056276|75789654|FG000|COMPLETED|Maintenance Therapy||0||
59670819|NCT01056276|75789655|FG001|COMPLETED|Maintenance Therapy|14 patients are continuing maintenance therapy.|0||
59670820|NCT01056276|75789654|FG000|NOT COMPLETED|Maintenance Therapy||0||
59670821|NCT01056276|75789655|FG001|NOT COMPLETED|Maintenance Therapy||28||
59670822|NCT01055886|75789668|FG000|STARTED|Overall Study||33||
59670823|NCT01055886|75789669|FG001|STARTED|Overall Study||32||
59670824|NCT01055886|75789668|FG000|Reached Pre-quit Period|Overall Study|2 withdrawals, 1 lost to contact|30||
59670825|NCT01055886|75789669|FG001|Reached Pre-quit Period|Overall Study|1 lost to contact|31||
59670826|NCT01055886|75789668|FG000|COMPLETED|Overall Study|This includes those who completed all sessions and those with w/d post quit (missing = smoking).|28||
59670827|NCT01055886|75789669|FG001|COMPLETED|Overall Study|This includes those who completed all sessions and those with w/d post quit (missing = smoking).|21||
59670828|NCT01055886|75789668|FG000|NOT COMPLETED|Overall Study||5||
59670829|NCT01055886|75789669|FG001|NOT COMPLETED|Overall Study||11||
59670830|NCT01055613|75789677|FG000|STARTED|Overall Study||200||
59670831|NCT01055613|75789678|FG001|STARTED|Overall Study||100||
59670832|NCT01055613|75789677|FG000|COMPLETED|Overall Study||191||
59670833|NCT01055613|75789678|FG001|COMPLETED|Overall Study||96||
59670834|NCT01055613|75789677|FG000|NOT COMPLETED|Overall Study||9||
59670835|NCT01055613|75789678|FG001|NOT COMPLETED|Overall Study||4||
59670836|NCT01055457|75789694|FG000|STARTED|Overall Study||40||
59670837|NCT01055457|75789695|FG001|STARTED|Overall Study||40||
59670838|NCT01055457|75789696|FG002|STARTED|Overall Study||38||
59670839|NCT01055457|75789697|FG003|STARTED|Overall Study||40||
59670840|NCT01055457|75789698|FG004|STARTED|Overall Study||41||
59670841|NCT01055457|75789699|FG005|STARTED|Overall Study||18||
59670842|NCT01055457|75789700|FG006|STARTED|Overall Study||19||
59815885|NCT01892709|75938298|FG000|STARTED|Overall Study||215||
59815886|NCT01892709|75938298|FG000|COMPLETED|Overall Study||215||
59670843|NCT01055457|75789701|FG007|STARTED|Overall Study||19||
59670844|NCT01055457|75789702|FG008|STARTED|Overall Study||20||
59670845|NCT01055457|75789703|FG009|STARTED|Overall Study||20||
59670846|NCT01055457|75789694|FG000|COMPLETED|Overall Study||39||
59670847|NCT01055457|75789695|FG001|COMPLETED|Overall Study||39||
59670848|NCT01055457|75789696|FG002|COMPLETED|Overall Study||36||
59670849|NCT01055457|75789697|FG003|COMPLETED|Overall Study||37||
59670850|NCT01055457|75789698|FG004|COMPLETED|Overall Study||38||
59670851|NCT01055457|75789699|FG005|COMPLETED|Overall Study||15||
59670852|NCT01055457|75789700|FG006|COMPLETED|Overall Study||18||
59670853|NCT01055457|75789701|FG007|COMPLETED|Overall Study||18||
59670854|NCT01055457|75789702|FG008|COMPLETED|Overall Study||20||
59670855|NCT01055457|75789703|FG009|COMPLETED|Overall Study||19||
59670856|NCT01055457|75789694|FG000|NOT COMPLETED|Overall Study||1||
59670857|NCT01055457|75789695|FG001|NOT COMPLETED|Overall Study||1||
59670858|NCT01055457|75789696|FG002|NOT COMPLETED|Overall Study||2||
59670859|NCT01055457|75789697|FG003|NOT COMPLETED|Overall Study||3||
59670860|NCT01055457|75789698|FG004|NOT COMPLETED|Overall Study||3||
59670861|NCT01055457|75789699|FG005|NOT COMPLETED|Overall Study||3||
59670862|NCT01055457|75789700|FG006|NOT COMPLETED|Overall Study||1||
59670863|NCT01055457|75789701|FG007|NOT COMPLETED|Overall Study||1||
59670864|NCT01055457|75789702|FG008|NOT COMPLETED|Overall Study||0||
59670865|NCT01055457|75789703|FG009|NOT COMPLETED|Overall Study||1||
59670866|NCT01055028|75789727|FG000|STARTED|Screening||9||
59670867|NCT01055028|75789728|FG001|STARTED|Screening||9||
59670868|NCT01055028|75789727|FG000|COMPLETED|Screening||8||
59670869|NCT01055028|75789728|FG001|COMPLETED|Screening||8||
59670870|NCT01055028|75789727|FG000|NOT COMPLETED|Screening||1||
59670871|NCT01055028|75789728|FG001|NOT COMPLETED|Screening||1||
59670872|NCT01055028|75789727|FG000|STARTED|Treatment Cycles 1 to 3||8||
59670873|NCT01055028|75789728|FG001|STARTED|Treatment Cycles 1 to 3||8||
59670874|NCT01055028|75789727|FG000|COMPLETED|Treatment Cycles 1 to 3||6||
59670875|NCT01055028|75789728|FG001|COMPLETED|Treatment Cycles 1 to 3||5||
59670876|NCT01055028|75789727|FG000|NOT COMPLETED|Treatment Cycles 1 to 3||2||
59670877|NCT01055028|75789728|FG001|NOT COMPLETED|Treatment Cycles 1 to 3||3||
59670878|NCT01055028|75789727|FG000|STARTED|Inter-treatment Period||6||
59670879|NCT01055028|75789728|FG001|STARTED|Inter-treatment Period||5||
59670880|NCT01055028|75789727|FG000|COMPLETED|Inter-treatment Period||6||
59670881|NCT01055028|75789728|FG001|COMPLETED|Inter-treatment Period||2||
59670882|NCT01055028|75789727|FG000|NOT COMPLETED|Inter-treatment Period||0||
59670883|NCT01055028|75789728|FG001|NOT COMPLETED|Inter-treatment Period||3||
59670884|NCT01055028|75789727|FG000|STARTED|Treatment Cycles 4 to 6||6||
59670885|NCT01055028|75789728|FG001|STARTED|Treatment Cycles 4 to 6||2||
59670886|NCT01055028|75789727|FG000|COMPLETED|Treatment Cycles 4 to 6||6||
59670887|NCT01055028|75789728|FG001|COMPLETED|Treatment Cycles 4 to 6||2||
59670888|NCT01055028|75789727|FG000|NOT COMPLETED|Treatment Cycles 4 to 6||0||
59670889|NCT01055028|75789728|FG001|NOT COMPLETED|Treatment Cycles 4 to 6||0||
59670890|NCT03114059|75789738|FG000|STARTED|Overall Study||230||
59670891|NCT03114059|75789738|FG000|COMPLETED|Overall Study||230||
59670892|NCT03114059|75789738|FG000|NOT COMPLETED|Overall Study||0||
59670893|NCT03082391|75789744|FG000|STARTED|Overall Study||173||
59670894|NCT03082391|75789745|FG001|STARTED|Overall Study||177||
59670895|NCT03082391|75789744|FG000|COMPLETED|Overall Study||173||
59670896|NCT03082391|75789745|FG001|COMPLETED|Overall Study||177||
59670897|NCT03082391|75789744|FG000|NOT COMPLETED|Overall Study||0||
59670898|NCT03082391|75789745|FG001|NOT COMPLETED|Overall Study||0||
59670899|NCT02841644|75789753|FG000|STARTED|Overall Study||60||
59670900|NCT02841644|75789754|FG001|STARTED|Overall Study||120||
59670901|NCT02841644|75789753|FG000|COMPLETED|Overall Study||60||
59670902|NCT02841644|75789754|FG001|COMPLETED|Overall Study||120||
59670903|NCT02841644|75789753|FG000|NOT COMPLETED|Overall Study||0||
59670904|NCT02841644|75789754|FG001|NOT COMPLETED|Overall Study||0||
59670905|NCT01050816|75789760|FG000|STARTED|Overall Study||30||
59670906|NCT01050816|75789760|FG000|COMPLETED|Overall Study||26||
59670907|NCT01050816|75789760|FG000|NOT COMPLETED|Overall Study||4||
59670908|NCT01054560|75789766|FG000|STARTED|Overall Study||58||
59670909|NCT01054560|75789767|FG001|STARTED|Overall Study||55||
59670910|NCT01054560|75789766|FG000|COMPLETED|Overall Study||45||
59670911|NCT01054560|75789767|FG001|COMPLETED|Overall Study||27||
59670912|NCT01054560|75789766|FG000|NOT COMPLETED|Overall Study||13||
59670913|NCT01054560|75789767|FG001|NOT COMPLETED|Overall Study||28||
59670914|NCT01054443|75789779|FG000|STARTED|Overall Study||5||
59670915|NCT01054443|75789780|FG001|STARTED|Overall Study||5||
59989306|NCT02190721|76104570|FG002|Completed 30 Day Follow-up|Overall Study||18||
59670916|NCT01054443|75789781|FG002|STARTED|Overall Study||5||
59670917|NCT01054443|75789782|FG003|STARTED|Overall Study||5||
59670918|NCT01054443|75789779|FG000|COMPLETED|Overall Study||5||
59670919|NCT01054443|75789780|FG001|COMPLETED|Overall Study||5||
59670920|NCT01054443|75789781|FG002|COMPLETED|Overall Study||5||
59670921|NCT01054443|75789782|FG003|COMPLETED|Overall Study||4||
59670922|NCT01054443|75789779|FG000|NOT COMPLETED|Overall Study||0||
59670923|NCT01054443|75789780|FG001|NOT COMPLETED|Overall Study||0||
59670924|NCT01054443|75789781|FG002|NOT COMPLETED|Overall Study||0||
59670925|NCT01054443|75789782|FG003|NOT COMPLETED|Overall Study||1||
59670926|NCT01050543|75789797|FG000|STARTED|Overall Study|Includes 4 participants who were randomized but discontinued before Treatment Phase.|64||
59670927|NCT01050543|75789798|FG001|STARTED|Overall Study|Includes 4 participants who were randomized but discontinued before Treatment Phase.|64||
59670928|NCT01050543|75789797|FG000|COMPLETED|Overall Study|Includes 1 participant who started & completed the study but was excluded from Full Analysis Set.|60||
59670929|NCT01050543|75789798|FG001|COMPLETED|Overall Study|Includes 1 participant who started & completed the study but was excluded from Full Analysis Set.|60||
59670930|NCT01050543|75789797|FG000|NOT COMPLETED|Overall Study||4||
59670931|NCT01050543|75789798|FG001|NOT COMPLETED|Overall Study||4||
59670932|NCT01051557|75789811|FG000|STARTED|Overall Study||4||
59670933|NCT01051557|75789812|FG001|STARTED|Overall Study||3||
59670934|NCT01051557|75789813|FG002|STARTED|Overall Study||6||
59670935|NCT01051557|75789814|FG003|STARTED|Overall Study||3||
59670936|NCT01051557|75789815|FG004|STARTED|Overall Study||8||
59670937|NCT01051557|75789816|FG005|STARTED|Overall Study||6||
59670938|NCT01051557|75789817|FG006|STARTED|Overall Study||6||
59670939|NCT01051557|75789811|FG000|COMPLETED|Overall Study||0||
59670940|NCT01051557|75789812|FG001|COMPLETED|Overall Study||0||
59670941|NCT01051557|75789813|FG002|COMPLETED|Overall Study||0||
59670942|NCT01051557|75789814|FG003|COMPLETED|Overall Study||0||
59670943|NCT01051557|75789815|FG004|COMPLETED|Overall Study||1||
59670944|NCT01051557|75789816|FG005|COMPLETED|Overall Study||0||
59670945|NCT01051557|75789817|FG006|COMPLETED|Overall Study||0||
59670946|NCT01051557|75789811|FG000|NOT COMPLETED|Overall Study||4||
59670947|NCT01051557|75789812|FG001|NOT COMPLETED|Overall Study||3||
59670948|NCT01051557|75789813|FG002|NOT COMPLETED|Overall Study||6||
59670949|NCT01051557|75789814|FG003|NOT COMPLETED|Overall Study||3||
59670950|NCT01051557|75789815|FG004|NOT COMPLETED|Overall Study||7||
59670951|NCT01051557|75789816|FG005|NOT COMPLETED|Overall Study||6||
59670952|NCT01051557|75789817|FG006|NOT COMPLETED|Overall Study||6||
59670953|NCT01054170|75789836|FG000|STARTED|Overall Study||25||
59670954|NCT01054170|75789837|FG001|STARTED|Overall Study||27||
59670955|NCT01054170|75789836|FG000|COMPLETED|Overall Study||21||
59670956|NCT01054170|75789837|FG001|COMPLETED|Overall Study||21||
59670957|NCT01054170|75789836|FG000|NOT COMPLETED|Overall Study||4||
59670958|NCT01054170|75789837|FG001|NOT COMPLETED|Overall Study||6||
59670959|NCT01053741|75789845|FG000|STARTED|1st Intervention||5||
59670960|NCT01053741|75789846|FG001|STARTED|1st Intervention||6||
59670961|NCT01053741|75789845|FG000|COMPLETED|1st Intervention||5||
59670962|NCT01053741|75789846|FG001|COMPLETED|1st Intervention||6||
59670963|NCT01053741|75789845|FG000|NOT COMPLETED|1st Intervention||0||
59670964|NCT01053741|75789846|FG001|NOT COMPLETED|1st Intervention||0||
59670965|NCT01053741|75789845|FG000|STARTED|14 Day Washout||5||
59670966|NCT01053741|75789846|FG001|STARTED|14 Day Washout||6||
59670967|NCT01053741|75789845|FG000|COMPLETED|14 Day Washout||5||
59670968|NCT01053741|75789846|FG001|COMPLETED|14 Day Washout||6||
59670969|NCT01053741|75789845|FG000|NOT COMPLETED|14 Day Washout||0||
59670970|NCT01053741|75789846|FG001|NOT COMPLETED|14 Day Washout||0||
59670971|NCT01053741|75789845|FG000|STARTED|2nd Study Intervention||5||
59670972|NCT01053741|75789846|FG001|STARTED|2nd Study Intervention||6||
59670973|NCT01053741|75789845|FG000|COMPLETED|2nd Study Intervention||5||
59670974|NCT01053741|75789846|FG001|COMPLETED|2nd Study Intervention||5||
59670975|NCT01053741|75789845|FG000|NOT COMPLETED|2nd Study Intervention||0||
59670976|NCT01053741|75789846|FG001|NOT COMPLETED|2nd Study Intervention||1||
59670977|NCT01052493|75789852|FG000|STARTED|Intervention 1 (Up to 10 Days)||4||
59670978|NCT01052493|75789853|FG001|STARTED|Intervention 1 (Up to 10 Days)||4||
59670979|NCT01052493|75789854|FG002|STARTED|Intervention 1 (Up to 10 Days)||4||
59670980|NCT01052493|75789852|FG000|COMPLETED|Intervention 1 (Up to 10 Days)||3||
59670981|NCT01052493|75789853|FG001|COMPLETED|Intervention 1 (Up to 10 Days)||4||
59670982|NCT01052493|75789854|FG002|COMPLETED|Intervention 1 (Up to 10 Days)||4||
59670983|NCT01052493|75789852|FG000|NOT COMPLETED|Intervention 1 (Up to 10 Days)||1||
59670984|NCT01052493|75789853|FG001|NOT COMPLETED|Intervention 1 (Up to 10 Days)||0||
59670985|NCT01052493|75789854|FG002|NOT COMPLETED|Intervention 1 (Up to 10 Days)||0||
59670986|NCT01052493|75789852|FG000|STARTED|Washout Period 1 (up to 5 Days)||3||
59670987|NCT01052493|75789853|FG001|STARTED|Washout Period 1 (up to 5 Days)||4||
59670988|NCT01052493|75789854|FG002|STARTED|Washout Period 1 (up to 5 Days)||4||
59670989|NCT01052493|75789852|FG000|COMPLETED|Washout Period 1 (up to 5 Days)||3||
59670990|NCT01052493|75789853|FG001|COMPLETED|Washout Period 1 (up to 5 Days)||4||
59670991|NCT01052493|75789854|FG002|COMPLETED|Washout Period 1 (up to 5 Days)||4||
59670992|NCT01052493|75789852|FG000|NOT COMPLETED|Washout Period 1 (up to 5 Days)||0||
59670993|NCT01052493|75789853|FG001|NOT COMPLETED|Washout Period 1 (up to 5 Days)||0||
59670994|NCT01052493|75789854|FG002|NOT COMPLETED|Washout Period 1 (up to 5 Days)||0||
59989307|NCT02190721|76104568|FG000|Completed 90 Day Follow-up|Overall Study||2||
59670995|NCT01052493|75789852|FG000|STARTED|Intervention 2 (up to 10 Days)|Replacement subject recruited|4||
59670996|NCT01052493|75789853|FG001|STARTED|Intervention 2 (up to 10 Days)||4||
59670997|NCT01052493|75789854|FG002|STARTED|Intervention 2 (up to 10 Days)||4||
59670998|NCT01052493|75789852|FG000|COMPLETED|Intervention 2 (up to 10 Days)||4||
59670999|NCT01052493|75789853|FG001|COMPLETED|Intervention 2 (up to 10 Days)||4||
59671000|NCT01052493|75789854|FG002|COMPLETED|Intervention 2 (up to 10 Days)||4||
59989308|NCT02190721|76104569|FG001|Completed 90 Day Follow-up|Overall Study||29||
59671001|NCT01052493|75789852|FG000|NOT COMPLETED|Intervention 2 (up to 10 Days)||0||
59671002|NCT01052493|75789853|FG001|NOT COMPLETED|Intervention 2 (up to 10 Days)||0||
59671003|NCT01052493|75789854|FG002|NOT COMPLETED|Intervention 2 (up to 10 Days)||0||
59671004|NCT01052493|75789852|FG000|STARTED|Washout Period 2 (up to 5 Days)||4||
59671005|NCT01052493|75789853|FG001|STARTED|Washout Period 2 (up to 5 Days)||4||
59671006|NCT01052493|75789854|FG002|STARTED|Washout Period 2 (up to 5 Days)||4||
59989309|NCT02190721|76104570|FG002|Completed 90 Day Follow-up|Overall Study||18||
59671007|NCT01052493|75789852|FG000|COMPLETED|Washout Period 2 (up to 5 Days)||4||
59989310|NCT02190721|76104568|FG000|COMPLETED|Overall Study||2||
59671008|NCT01052493|75789853|FG001|COMPLETED|Washout Period 2 (up to 5 Days)||4||
59671009|NCT01052493|75789854|FG002|COMPLETED|Washout Period 2 (up to 5 Days)||4||
59671010|NCT01052493|75789852|FG000|NOT COMPLETED|Washout Period 2 (up to 5 Days)||0||
59671011|NCT01052493|75789853|FG001|NOT COMPLETED|Washout Period 2 (up to 5 Days)||0||
59671012|NCT01052493|75789854|FG002|NOT COMPLETED|Washout Period 2 (up to 5 Days)||0||
59671013|NCT01052493|75789852|FG000|STARTED|Intervention 3 (up to 10 Days)||4||
59671014|NCT01052493|75789853|FG001|STARTED|Intervention 3 (up to 10 Days)||4||
59671015|NCT01052493|75789854|FG002|STARTED|Intervention 3 (up to 10 Days)||4||
59671016|NCT01052493|75789852|FG000|COMPLETED|Intervention 3 (up to 10 Days)||4||
59671017|NCT01052493|75789853|FG001|COMPLETED|Intervention 3 (up to 10 Days)||4||
59671018|NCT01052493|75789854|FG002|COMPLETED|Intervention 3 (up to 10 Days)||4||
59671019|NCT01052493|75789852|FG000|NOT COMPLETED|Intervention 3 (up to 10 Days)||0||
59671020|NCT01052493|75789853|FG001|NOT COMPLETED|Intervention 3 (up to 10 Days)||0||
59671021|NCT01052493|75789854|FG002|NOT COMPLETED|Intervention 3 (up to 10 Days)||0||
59671022|NCT01052103|75789869|FG000|STARTED|Overall Study||84||
59671023|NCT01052103|75789870|FG001|STARTED|Overall Study||83||
59671024|NCT01052103|75789869|FG000|Received at Least 1 Dose of Study Drug|Overall Study||82||
59671025|NCT01052103|75789870|FG001|Received at Least 1 Dose of Study Drug|Overall Study||82||
59671026|NCT01052103|75789869|FG000|COMPLETED|Overall Study||50||
59671027|NCT01052103|75789870|FG001|COMPLETED|Overall Study||60||
59671028|NCT01052103|75789869|FG000|NOT COMPLETED|Overall Study||34||
59671029|NCT01052103|75789870|FG001|NOT COMPLETED|Overall Study||23||
59671030|NCT01051986|75789879|FG000|STARTED|Overall Study||112||
59671031|NCT01051986|75789880|FG001|STARTED|Overall Study||112||
59671032|NCT01051986|75789879|FG000|COMPLETED|Overall Study||107||
59671033|NCT01051986|75789880|FG001|COMPLETED|Overall Study||108||
59671034|NCT01051986|75789879|FG000|NOT COMPLETED|Overall Study||5||
59671035|NCT01051986|75789880|FG001|NOT COMPLETED|Overall Study||4||
59671036|NCT03279978|75789896|FG000|STARTED|Overall Study||11||
59671037|NCT03279978|75789897|FG001|STARTED|Overall Study||9||
59671038|NCT03279978|75789898|FG002|STARTED|Overall Study||9||
59671039|NCT03279978|75789899|FG003|STARTED|Overall Study||9||
59671040|NCT03279978|75789900|FG004|STARTED|Overall Study||1||
59671041|NCT03279978|75789901|FG005|STARTED|Overall Study||8||
59671042|NCT03279978|75789902|FG006|STARTED|Overall Study||9||
59671043|NCT03279978|75789903|FG007|STARTED|Overall Study||9||
59671044|NCT03279978|75789904|FG008|STARTED|Overall Study||9||
59671045|NCT03279978|75789905|FG009|STARTED|Overall Study||9||
59671046|NCT03279978|75789896|FG000|COMPLETED|Overall Study||10||
59671047|NCT03279978|75789897|FG001|COMPLETED|Overall Study||8||
59671048|NCT03279978|75789898|FG002|COMPLETED|Overall Study||8||
59671049|NCT03279978|75789899|FG003|COMPLETED|Overall Study||9||
59671050|NCT03279978|75789900|FG004|COMPLETED|Overall Study||1||
59671051|NCT03279978|75789901|FG005|COMPLETED|Overall Study||8||
59671052|NCT03279978|75789902|FG006|COMPLETED|Overall Study||8||
59671053|NCT03279978|75789903|FG007|COMPLETED|Overall Study||9||
59671054|NCT03279978|75789904|FG008|COMPLETED|Overall Study||9||
59671055|NCT03279978|75789905|FG009|COMPLETED|Overall Study||8||
59671056|NCT03279978|75789896|FG000|NOT COMPLETED|Overall Study||1||
59671057|NCT03279978|75789897|FG001|NOT COMPLETED|Overall Study||1||
59671058|NCT03279978|75789898|FG002|NOT COMPLETED|Overall Study||1||
59671059|NCT03279978|75789899|FG003|NOT COMPLETED|Overall Study||0||
59671060|NCT03279978|75789900|FG004|NOT COMPLETED|Overall Study||0||
59671061|NCT03279978|75789901|FG005|NOT COMPLETED|Overall Study||0||
59671062|NCT03279978|75789902|FG006|NOT COMPLETED|Overall Study||1||
59671063|NCT03279978|75789903|FG007|NOT COMPLETED|Overall Study||0||
59671064|NCT03279978|75789904|FG008|NOT COMPLETED|Overall Study||0||
59671065|NCT03279978|75789905|FG009|NOT COMPLETED|Overall Study||1||
59671066|NCT00345800|75789932|FG000|STARTED|Overall Study||25||
59671067|NCT00345800|75789932|FG000|COMPLETED|Overall Study||25||
59671068|NCT00345800|75789932|FG000|NOT COMPLETED|Overall Study||0||
59671069|NCT00105534|75789938|FG000|STARTED|Overall Study||335||
59671070|NCT00105534|75789939|FG001|STARTED|Overall Study||350||
59671071|NCT00105534|75789938|FG000|COMPLETED|Overall Study||313||
59671072|NCT00105534|75789939|FG001|COMPLETED|Overall Study||317||
59671073|NCT00105534|75789938|FG000|NOT COMPLETED|Overall Study||22||
59671074|NCT00105534|75789939|FG001|NOT COMPLETED|Overall Study||33||
59671075|NCT00105183|75789948|FG000|STARTED|Overall Study|Randomized|82||
59671076|NCT00105183|75789949|FG001|STARTED|Overall Study|Randomized|79||
59671077|NCT00105183|75789950|FG002|STARTED|Overall Study|Randomized|62||
59671078|NCT00105183|75789948|FG000|COMPLETED|Overall Study|Completed at least 12 months follow up|60||
59671079|NCT00105183|75789949|FG001|COMPLETED|Overall Study|Completed at least 12 months follow up|60||
59671080|NCT00105183|75789950|FG002|COMPLETED|Overall Study|Completed at least 12 months follow up|39||
59671081|NCT00105183|75789948|FG000|NOT COMPLETED|Overall Study||22||
59671082|NCT00105183|75789949|FG001|NOT COMPLETED|Overall Study||19||
59671083|NCT00105183|75789950|FG002|NOT COMPLETED|Overall Study||23||
59671084|NCT01059617|75789962|FG000|STARTED|Overall Study||33||
59671085|NCT01059617|75789963|FG001|STARTED|Overall Study||34||
59671086|NCT01059617|75789964|FG002|STARTED|Overall Study||33||
59671087|NCT01059617|75789965|FG003|STARTED|Overall Study||33||
59671088|NCT01059617|75789962|FG000|COMPLETED|Overall Study||26||
59671089|NCT01059617|75789963|FG001|COMPLETED|Overall Study||33||
59671090|NCT01059617|75789964|FG002|COMPLETED|Overall Study||25||
59671091|NCT01059617|75789965|FG003|COMPLETED|Overall Study||27||
59671092|NCT01059617|75789962|FG000|NOT COMPLETED|Overall Study||7||
59671093|NCT01059617|75789963|FG001|NOT COMPLETED|Overall Study||1||
59671094|NCT01059617|75789964|FG002|NOT COMPLETED|Overall Study||8||
59671095|NCT01059617|75789965|FG003|NOT COMPLETED|Overall Study||6||
59671096|NCT01059344|75789985|FG000|STARTED|Overall Study||140||
59671097|NCT01059344|75789986|FG001|STARTED|Overall Study||141||
59671098|NCT01059344|75789985|FG000|COMPLETED|Overall Study||118||
59671099|NCT01059344|75789986|FG001|COMPLETED|Overall Study||95||
59671100|NCT01059344|75789985|FG000|NOT COMPLETED|Overall Study||22||
59671101|NCT01059344|75789986|FG001|NOT COMPLETED|Overall Study||46||
59671102|NCT01058369|75789994|FG000|STARTED|Overall Study||2||
59671103|NCT01058369|75789994|FG000|COMPLETED|Overall Study||0||
59671104|NCT01058369|75789994|FG000|NOT COMPLETED|Overall Study||2||
59671105|NCT01057433|75789998|FG000|STARTED|Overall Study||24||
59671106|NCT01057433|75789998|FG000|COMPLETED|Overall Study||23||
59671107|NCT01057433|75789998|FG000|NOT COMPLETED|Overall Study||1||
59671108|NCT01057394|75790002|FG000|STARTED|Overall Study||0||
59671109|NCT01057394|75790003|FG001|STARTED|Overall Study|21 enrolled participants|21||
59671110|NCT01057394|75790002|FG000|COMPLETED|Overall Study||0||
59671111|NCT01057394|75790003|FG001|COMPLETED|Overall Study|19 treated participants|19||
59671112|NCT01057394|75790002|FG000|NOT COMPLETED|Overall Study||0||
59671113|NCT01057394|75790003|FG001|NOT COMPLETED|Overall Study||2||
59671114|NCT01058642|75790011|FG000|STARTED|Treatment Period 1||9||
59671115|NCT01058642|75790012|FG001|STARTED|Treatment Period 1||12||
59671116|NCT01058642|75790013|FG002|STARTED|Treatment Period 1||11||
59671117|NCT01058642|75790014|FG003|STARTED|Treatment Period 1||9||
59671118|NCT01058642|75790011|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 1||9||
59671119|NCT01058642|75790012|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 1||12||
59671120|NCT01058642|75790013|FG002|Received at Least 1 Dose of Study Drug|Treatment Period 1||11||
59671121|NCT01058642|75790014|FG003|Received at Least 1 Dose of Study Drug|Treatment Period 1||9||
59671122|NCT01058642|75790011|FG000|COMPLETED|Treatment Period 1||7||
59671123|NCT01058642|75790012|FG001|COMPLETED|Treatment Period 1||11||
59671124|NCT01058642|75790013|FG002|COMPLETED|Treatment Period 1||9||
59671125|NCT01058642|75790014|FG003|COMPLETED|Treatment Period 1||7||
59671126|NCT01058642|75790011|FG000|NOT COMPLETED|Treatment Period 1||2||
59671127|NCT01058642|75790012|FG001|NOT COMPLETED|Treatment Period 1||1||
59671128|NCT01058642|75790013|FG002|NOT COMPLETED|Treatment Period 1||2||
59671129|NCT01058642|75790014|FG003|NOT COMPLETED|Treatment Period 1||2||
59671130|NCT01058642|75790011|FG000|STARTED|Washout Period||7||
59671131|NCT01058642|75790012|FG001|STARTED|Washout Period||11||
59671132|NCT01058642|75790013|FG002|STARTED|Washout Period||9||
59671133|NCT01058642|75790014|FG003|STARTED|Washout Period||7||
59671134|NCT01058642|75790011|FG000|COMPLETED|Washout Period||7||
59671135|NCT01058642|75790012|FG001|COMPLETED|Washout Period||11||
59671136|NCT01058642|75790013|FG002|COMPLETED|Washout Period||9||
59671137|NCT01058642|75790014|FG003|COMPLETED|Washout Period||7||
59671138|NCT01058642|75790011|FG000|NOT COMPLETED|Washout Period||0||
59989311|NCT02190721|76104569|FG001|COMPLETED|Overall Study||29||
59671139|NCT01058642|75790012|FG001|NOT COMPLETED|Washout Period||0||
59671140|NCT01058642|75790013|FG002|NOT COMPLETED|Washout Period||0||
59671141|NCT01058642|75790014|FG003|NOT COMPLETED|Washout Period||0||
59671142|NCT01058642|75790011|FG000|STARTED|Treatment Period 2||7||
59671143|NCT01058642|75790012|FG001|STARTED|Treatment Period 2||11||
59671144|NCT01058642|75790013|FG002|STARTED|Treatment Period 2||9||
59671145|NCT01058642|75790014|FG003|STARTED|Treatment Period 2||7||
59671146|NCT01058642|75790011|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 2||7||
59671147|NCT01058642|75790012|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 2||11||
59671148|NCT01058642|75790013|FG002|Received at Least 1 Dose of Study Drug|Treatment Period 2||9||
59671149|NCT01058642|75790014|FG003|Received at Least 1 Dose of Study Drug|Treatment Period 2||7||
59989312|NCT02190721|76104570|FG002|COMPLETED|Overall Study||18||
59989313|NCT02190721|76104568|FG000|NOT COMPLETED|Overall Study||0||
59671150|NCT01058642|75790011|FG000|COMPLETED|Treatment Period 2||7||
59671151|NCT01058642|75790012|FG001|COMPLETED|Treatment Period 2||11||
59671152|NCT01058642|75790013|FG002|COMPLETED|Treatment Period 2||9||
59671153|NCT01058642|75790014|FG003|COMPLETED|Treatment Period 2||7||
59671154|NCT01058642|75790011|FG000|NOT COMPLETED|Treatment Period 2||0||
59671155|NCT01058642|75790012|FG001|NOT COMPLETED|Treatment Period 2||0||
59671156|NCT01058642|75790013|FG002|NOT COMPLETED|Treatment Period 2||0||
59671157|NCT01058642|75790014|FG003|NOT COMPLETED|Treatment Period 2||0||
59671158|NCT01056653|75790025|FG000|STARTED|Overall Study||46||
59671159|NCT01056653|75790026|FG001|STARTED|Overall Study||23||
59671160|NCT01056653|75790027|FG002|STARTED|Overall Study||44||
59671161|NCT01056653|75790025|FG000|COMPLETED|Overall Study||46||
59671162|NCT01056653|75790026|FG001|COMPLETED|Overall Study||23||
59671163|NCT01056653|75790027|FG002|COMPLETED|Overall Study|2 were lost to follow-up because one mother left the country and one father was too busy.|42||
59671164|NCT01056653|75790025|FG000|NOT COMPLETED|Overall Study||0||
59671165|NCT01056653|75790026|FG001|NOT COMPLETED|Overall Study||0||
59671166|NCT01056653|75790027|FG002|NOT COMPLETED|Overall Study||2||
59989314|NCT02190721|76104569|FG001|NOT COMPLETED|Overall Study||1||
59989315|NCT02190721|76104570|FG002|NOT COMPLETED|Overall Study||0||
59671167|NCT01056536|75790039|FG000|STARTED|Overall Study||596||
59671168|NCT01056536|75790040|FG001|STARTED|Overall Study||356||
59671169|NCT01056536|75790041|FG002|STARTED|Overall Study||729||
59671170|NCT01056536|75790039|FG000|COMPLETED|Overall Study||394||
59671171|NCT01056536|75790040|FG001|COMPLETED|Overall Study||240||
59671172|NCT01056536|75790041|FG002|COMPLETED|Overall Study||481||
59671173|NCT01056536|75790039|FG000|NOT COMPLETED|Overall Study||202||
59671174|NCT01056536|75790040|FG001|NOT COMPLETED|Overall Study||116||
59671175|NCT01056536|75790041|FG002|NOT COMPLETED|Overall Study||248||
59671176|NCT01056380|75790051|FG000|STARTED|Overall Study||37||
59671177|NCT01056380|75790052|FG001|STARTED|Overall Study||42||
59671178|NCT01056380|75790051|FG000|COMPLETED|Overall Study||35||
59671179|NCT01056380|75790052|FG001|COMPLETED|Overall Study||39||
59671180|NCT01056380|75790051|FG000|NOT COMPLETED|Overall Study||2||
59671181|NCT01056380|75790052|FG001|NOT COMPLETED|Overall Study||3||
59671182|NCT01055834|75790062|FG000|STARTED|Treatment Period I||21||
59671183|NCT01055834|75790063|FG001|STARTED|Treatment Period I||21||
59671184|NCT01055834|75790062|FG000|COMPLETED|Treatment Period I||20||
59671185|NCT01055834|75790063|FG001|COMPLETED|Treatment Period I||21||
59671186|NCT01055834|75790062|FG000|NOT COMPLETED|Treatment Period I||1||
59671187|NCT01055834|75790063|FG001|NOT COMPLETED|Treatment Period I||0||
59671188|NCT01055834|75790062|FG000|STARTED|Treatment Period II||20||
59671189|NCT01055834|75790063|FG001|STARTED|Treatment Period II||21||
59671190|NCT01055834|75790062|FG000|COMPLETED|Treatment Period II||20||
59671191|NCT01055834|75790063|FG001|COMPLETED|Treatment Period II||21||
59671192|NCT01055834|75790062|FG000|NOT COMPLETED|Treatment Period II||0||
59671193|NCT01055834|75790063|FG001|NOT COMPLETED|Treatment Period II||0||
59671194|NCT01055834|75790062|FG000|STARTED|Treatment Period III|Participants from Group A did not continue into Period III.|0||
59671195|NCT01055834|75790063|FG001|STARTED|Treatment Period III|14 of 21 participants in Group B who were treated in Period II participated in Period III.|14||
59671196|NCT01055834|75790062|FG000|COMPLETED|Treatment Period III||0||
59671197|NCT01055834|75790063|FG001|COMPLETED|Treatment Period III||14||
59671198|NCT01055834|75790062|FG000|NOT COMPLETED|Treatment Period III||0||
59671199|NCT01055834|75790063|FG001|NOT COMPLETED|Treatment Period III||0||
59671200|NCT01055639|75790074|FG000|STARTED|Overall Study||66||
59671201|NCT01055639|75790075|FG001|STARTED|Overall Study||60||
59671202|NCT01055639|75790074|FG000|COMPLETED|Overall Study||45||
59671203|NCT01055639|75790075|FG001|COMPLETED|Overall Study||31||
59671204|NCT01055639|75790074|FG000|NOT COMPLETED|Overall Study||21||
59671205|NCT01055639|75790075|FG001|NOT COMPLETED|Overall Study||29||
59671206|NCT04704713|75790083|FG000|STARTED|Overall Study||15||
59671207|NCT04704713|75790084|FG001|STARTED|Overall Study||16||
59671208|NCT04704713|75790083|FG000|COMPLETED|Overall Study||11||
59671209|NCT04704713|75790084|FG001|COMPLETED|Overall Study||12||
59671210|NCT04704713|75790083|FG000|NOT COMPLETED|Overall Study||4||
59671211|NCT04704713|75790084|FG001|NOT COMPLETED|Overall Study||4||
59671212|NCT01055132|75790090|FG000|STARTED|Period 1 (5-9 Days)||36||
59671213|NCT01055132|75790091|FG001|STARTED|Period 1 (5-9 Days)||33||
59671214|NCT01055132|75790090|FG000|COMPLETED|Period 1 (5-9 Days)||35||
59671215|NCT01055132|75790091|FG001|COMPLETED|Period 1 (5-9 Days)||33||
59671216|NCT01055132|75790090|FG000|NOT COMPLETED|Period 1 (5-9 Days)||1||
59671217|NCT01055132|75790091|FG001|NOT COMPLETED|Period 1 (5-9 Days)||0||
59671218|NCT01055132|75790090|FG000|STARTED|Period 2 (5-9 Days)||35||
59671219|NCT01055132|75790091|FG001|STARTED|Period 2 (5-9 Days)||33||
59671220|NCT01055132|75790090|FG000|COMPLETED|Period 2 (5-9 Days)||35||
59671221|NCT01055132|75790091|FG001|COMPLETED|Period 2 (5-9 Days)||32||
59671222|NCT01055132|75790090|FG000|NOT COMPLETED|Period 2 (5-9 Days)||0||
59671223|NCT01055132|75790091|FG001|NOT COMPLETED|Period 2 (5-9 Days)||1||
59671224|NCT01054976|75790101|FG000|STARTED|Overall Study||92||
59671225|NCT01054976|75790101|FG000|COMPLETED|Overall Study||57||
59671226|NCT01054976|75790101|FG000|NOT COMPLETED|Overall Study||35||
59671227|NCT06097676|75790105|FG000|STARTED|Overall Study||6||
59671228|NCT06097676|75790106|FG001|STARTED|Overall Study||5||
59671229|NCT06097676|75790107|FG002|STARTED|Overall Study||5||
59671230|NCT06097676|75790108|FG003|STARTED|Overall Study||5||
59671231|NCT06097676|75790109|FG004|STARTED|Overall Study||5||
59671232|NCT06097676|75790110|FG005|STARTED|Overall Study||5||
59671233|NCT06097676|75790111|FG006|STARTED|Overall Study||5||
59671234|NCT06097676|75790112|FG007|STARTED|Overall Study||5||
60077825|NCT01483599|76192724|FG006|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0||
60077826|NCT01483599|76192725|FG007|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||2||
60077827|NCT01483599|76192726|FG008|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||9||
60077828|NCT01483599|76192727|FG009|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||4||
59671235|NCT06097676|75790113|FG008|STARTED|Overall Study||5||
59671236|NCT06097676|75790114|FG009|STARTED|Overall Study||5||
59671237|NCT06097676|75790105|FG000|COMPLETED|Overall Study||6||
59671238|NCT06097676|75790106|FG001|COMPLETED|Overall Study||5||
59671239|NCT06097676|75790107|FG002|COMPLETED|Overall Study||5||
59671240|NCT06097676|75790108|FG003|COMPLETED|Overall Study||5||
59671241|NCT06097676|75790109|FG004|COMPLETED|Overall Study||5||
59671242|NCT06097676|75790110|FG005|COMPLETED|Overall Study||4||
59671243|NCT06097676|75790111|FG006|COMPLETED|Overall Study||5||
59671244|NCT06097676|75790112|FG007|COMPLETED|Overall Study||4||
59671245|NCT06097676|75790113|FG008|COMPLETED|Overall Study||4||
59671246|NCT06097676|75790114|FG009|COMPLETED|Overall Study||5||
59671247|NCT06097676|75790105|FG000|NOT COMPLETED|Overall Study||0||
59671248|NCT06097676|75790106|FG001|NOT COMPLETED|Overall Study||0||
59671249|NCT06097676|75790107|FG002|NOT COMPLETED|Overall Study||0||
59671250|NCT06097676|75790108|FG003|NOT COMPLETED|Overall Study||0||
59671251|NCT06097676|75790109|FG004|NOT COMPLETED|Overall Study||0||
59671252|NCT06097676|75790110|FG005|NOT COMPLETED|Overall Study||1||
59671253|NCT06097676|75790111|FG006|NOT COMPLETED|Overall Study||0||
59671254|NCT06097676|75790112|FG007|NOT COMPLETED|Overall Study||1||
59671255|NCT06097676|75790113|FG008|NOT COMPLETED|Overall Study||1||
59671256|NCT06097676|75790114|FG009|NOT COMPLETED|Overall Study||0||
59671257|NCT05719285|75790128|FG000|STARTED|Overall Study||50||
59671258|NCT05719285|75790129|FG001|STARTED|Overall Study||50||
59671259|NCT05719285|75790128|FG000|COMPLETED|Overall Study||50||
59671260|NCT05719285|75790129|FG001|COMPLETED|Overall Study||50||
59671261|NCT05719285|75790128|FG000|NOT COMPLETED|Overall Study||0||
59671262|NCT05719285|75790129|FG001|NOT COMPLETED|Overall Study||0||
59671263|NCT05490771|75790135|FG000|STARTED|Overall Study||35||
59671264|NCT05490771|75790135|FG000|Eligible|Overall Study||31||
59671265|NCT05490771|75790135|FG000|Started Protocol Therapy|Overall Study||30||
59671266|NCT05490771|75790135|FG000|Eligible and Treated|Overall Study||28||
59671267|NCT05490771|75790135|FG000|Mutation Status Confirmed|Overall Study||30||
59671268|NCT05490771|75790135|FG000|Eligible, Treated and Mutation Status Confirmed|Overall Study||25||
59671269|NCT05490771|75790135|FG000|COMPLETED|Overall Study||0||
59671270|NCT05490771|75790135|FG000|NOT COMPLETED|Overall Study||35||
59671271|NCT05480514|75790139|FG000|STARTED|Period 1||38||
59671272|NCT05480514|75790140|FG001|STARTED|Period 1||39||
59671273|NCT05480514|75790139|FG000|COMPLETED|Period 1||32||
59671274|NCT05480514|75790140|FG001|COMPLETED|Period 1||30||
59671275|NCT05480514|75790139|FG000|NOT COMPLETED|Period 1||6||
59671276|NCT05480514|75790140|FG001|NOT COMPLETED|Period 1||9||
59671277|NCT05480514|75790139|FG000|STARTED|Period 2||32||
59671278|NCT05480514|75790140|FG001|STARTED|Period 2||30||
59671279|NCT05480514|75790139|FG000|COMPLETED|Period 2||28||
59671280|NCT05480514|75790140|FG001|COMPLETED|Period 2||26||
59671281|NCT05480514|75790139|FG000|NOT COMPLETED|Period 2||4||
59671282|NCT05480514|75790140|FG001|NOT COMPLETED|Period 2||4||
59671283|NCT05379920|75790150|FG000|STARTED|Overall Study||17||
59671284|NCT05379920|75790151|FG001|STARTED|Overall Study||15||
59671285|NCT05379920|75790152|FG002|STARTED|Overall Study||15||
59671286|NCT05379920|75790153|FG003|STARTED|Overall Study||13||
59671287|NCT05379920|75790150|FG000|COMPLETED|Overall Study||17||
59671288|NCT05379920|75790151|FG001|COMPLETED|Overall Study||10||
59671289|NCT05379920|75790152|FG002|COMPLETED|Overall Study||15||
59671290|NCT05379920|75790153|FG003|COMPLETED|Overall Study||13||
59671291|NCT05379920|75790150|FG000|NOT COMPLETED|Overall Study||0||
59671292|NCT05379920|75790151|FG001|NOT COMPLETED|Overall Study||5||
59671293|NCT05379920|75790152|FG002|NOT COMPLETED|Overall Study||0||
59815887|NCT01892709|75938298|FG000|NOT COMPLETED|Overall Study||0||
59671294|NCT05379920|75790153|FG003|NOT COMPLETED|Overall Study||0||
59671295|NCT05327816|75790172|FG000|STARTED|Overall Study||12||
59545837|NCT01056302|75644603|FG000|COMPLETED|Overall Study|The study was completed with 3 datasets from patients who had maxillofacial trauma and were treated|3||
59545838|NCT01056302|75644603|FG000|NOT COMPLETED|Overall Study||0||
59545839|NCT02443740|75644612|FG000|STARTED|Intervention Period 1 (3 Days)||2||
59545840|NCT02443740|75644613|FG001|STARTED|Intervention Period 1 (3 Days)||2||
59545841|NCT02443740|75644614|FG002|STARTED|Intervention Period 1 (3 Days)||2||
59545842|NCT02443740|75644615|FG003|STARTED|Intervention Period 1 (3 Days)||3||
59545843|NCT02443740|75644616|FG004|STARTED|Intervention Period 1 (3 Days)||2||
59545844|NCT02443740|75644617|FG005|STARTED|Intervention Period 1 (3 Days)||4||
59671296|NCT05327816|75790173|FG001|STARTED|Overall Study||12||
59671297|NCT05327816|75790174|FG002|STARTED|Overall Study||12||
59671298|NCT05327816|75790175|FG003|STARTED|Overall Study||12||
59671299|NCT05327816|75790176|FG004|STARTED|Overall Study||12||
59671300|NCT05327816|75790177|FG005|STARTED|Overall Study||12||
59671301|NCT05327816|75790178|FG006|STARTED|Overall Study||12||
59671302|NCT05327816|75790179|FG007|STARTED|Overall Study||12||
59671303|NCT05327816|75790180|FG008|STARTED|Overall Study||12||
59671304|NCT05327816|75790181|FG009|STARTED|Overall Study||12||
59671305|NCT05327816|75790182|FG010|STARTED|Overall Study||12||
59671306|NCT05327816|75790172|FG000|Treated (Full Analysis Set)|Overall Study||12||
59545845|NCT02443740|75644618|FG006|STARTED|Intervention Period 1 (3 Days)||3||
59545846|NCT02443740|75644619|FG007|STARTED|Intervention Period 1 (3 Days)||2||
59671307|NCT05327816|75790173|FG001|Treated (Full Analysis Set)|Overall Study||12||
59671308|NCT05327816|75790174|FG002|Treated (Full Analysis Set)|Overall Study||12||
59671309|NCT05327816|75790175|FG003|Treated (Full Analysis Set)|Overall Study||12||
59671310|NCT05327816|75790176|FG004|Treated (Full Analysis Set)|Overall Study||12||
59671311|NCT05327816|75790177|FG005|Treated (Full Analysis Set)|Overall Study||12||
59671312|NCT05327816|75790178|FG006|Treated (Full Analysis Set)|Overall Study||11||
59671313|NCT05327816|75790179|FG007|Treated (Full Analysis Set)|Overall Study||11||
59671314|NCT05327816|75790180|FG008|Treated (Full Analysis Set)|Overall Study||11||
59671315|NCT05327816|75790181|FG009|Treated (Full Analysis Set)|Overall Study||12||
59671316|NCT05327816|75790182|FG010|Treated (Full Analysis Set)|Overall Study||12||
59671317|NCT05327816|75790172|FG000|COMPLETED|Overall Study||0||
59671318|NCT05327816|75790173|FG001|COMPLETED|Overall Study||0||
59671319|NCT05327816|75790174|FG002|COMPLETED|Overall Study||0||
59671320|NCT05327816|75790175|FG003|COMPLETED|Overall Study||0||
59671321|NCT05327816|75790176|FG004|COMPLETED|Overall Study||0||
59671322|NCT05327816|75790177|FG005|COMPLETED|Overall Study||0||
59671323|NCT05327816|75790178|FG006|COMPLETED|Overall Study||0||
59671324|NCT05327816|75790179|FG007|COMPLETED|Overall Study||0||
59671325|NCT05327816|75790180|FG008|COMPLETED|Overall Study||0||
59671326|NCT05327816|75790181|FG009|COMPLETED|Overall Study||0||
59671327|NCT05327816|75790182|FG010|COMPLETED|Overall Study||0||
59671328|NCT05327816|75790172|FG000|NOT COMPLETED|Overall Study||12||
59671329|NCT05327816|75790173|FG001|NOT COMPLETED|Overall Study||12||
59671330|NCT05327816|75790174|FG002|NOT COMPLETED|Overall Study||12||
59671331|NCT05327816|75790175|FG003|NOT COMPLETED|Overall Study||12||
59671332|NCT05327816|75790176|FG004|NOT COMPLETED|Overall Study||12||
59671333|NCT05327816|75790177|FG005|NOT COMPLETED|Overall Study||12||
59671334|NCT05327816|75790178|FG006|NOT COMPLETED|Overall Study||12||
59671335|NCT05327816|75790179|FG007|NOT COMPLETED|Overall Study||12||
59671336|NCT05327816|75790180|FG008|NOT COMPLETED|Overall Study||12||
59671337|NCT05327816|75790181|FG009|NOT COMPLETED|Overall Study||12||
59671338|NCT05327816|75790182|FG010|NOT COMPLETED|Overall Study||12||
59671339|NCT05227027|75790208|FG000|STARTED|Overall Study||251||
59671340|NCT05227027|75790209|FG001|STARTED|Overall Study||249||
59671341|NCT05227027|75790208|FG000|COMPLETED|Overall Study||241||
59671342|NCT05227027|75790209|FG001|COMPLETED|Overall Study||238||
59671343|NCT05227027|75790208|FG000|NOT COMPLETED|Overall Study||10||
59671344|NCT05227027|75790209|FG001|NOT COMPLETED|Overall Study||11||
59671345|NCT05175131|75790218|FG000|STARTED|Overall Study||155||
59671346|NCT05175131|75790219|FG001|STARTED|Overall Study||155||
59671347|NCT05175131|75790220|FG002|STARTED|Overall Study||155||
59671348|NCT05175131|75790218|FG000|COMPLETED|Overall Study||153||
59671349|NCT05175131|75790219|FG001|COMPLETED|Overall Study||154||
59671350|NCT05175131|75790220|FG002|COMPLETED|Overall Study||152||
59671351|NCT05175131|75790218|FG000|NOT COMPLETED|Overall Study||2||
59671352|NCT05175131|75790219|FG001|NOT COMPLETED|Overall Study||1||
59671353|NCT05175131|75790220|FG002|NOT COMPLETED|Overall Study||3||
59671354|NCT05124210|75790230|FG000|STARTED|Overall Study||3||
59671355|NCT05124210|75790231|FG001|STARTED|Overall Study||5||
59671356|NCT05124210|75790230|FG000|COMPLETED|Overall Study||1||
59671357|NCT05124210|75790231|FG001|COMPLETED|Overall Study||5||
59671358|NCT05124210|75790230|FG000|NOT COMPLETED|Overall Study||2||
59671359|NCT05124210|75790231|FG001|NOT COMPLETED|Overall Study||0||
59671360|NCT05081011|75790239|FG000|STARTED|Overall Study||18||
59671361|NCT05081011|75790240|FG001|STARTED|Overall Study||21||
59671362|NCT05081011|75790239|FG000|Received Intervention as Randomized|Overall Study||16||
59671363|NCT05081011|75790240|FG001|Received Intervention as Randomized|Overall Study||16||
59671364|NCT05081011|75790239|FG000|COMPLETED|Overall Study||16||
59671365|NCT05081011|75790240|FG001|COMPLETED|Overall Study||16||
59671366|NCT05081011|75790239|FG000|NOT COMPLETED|Overall Study||2||
59671367|NCT05081011|75790240|FG001|NOT COMPLETED|Overall Study||5||
59671368|NCT05041062|75790246|FG000|STARTED|Overall Study||2||
59671369|NCT05041062|75790246|FG000|COMPLETED|Overall Study||0||
59671370|NCT05041062|75790246|FG000|NOT COMPLETED|Overall Study||2||
59671371|NCT05036343|75790252|FG000|STARTED|First Intervention (90 Days)||5||
59671372|NCT05036343|75790253|FG001|STARTED|First Intervention (90 Days)||8||
59671373|NCT05036343|75790252|FG000|COMPLETED|First Intervention (90 Days)||5||
60077829|NCT01483599|76192728|FG010|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||2||
60077830|NCT01483599|76192729|FG011|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||1||
59671374|NCT05036343|75790253|FG001|COMPLETED|First Intervention (90 Days)||8||
59671375|NCT05036343|75790252|FG000|NOT COMPLETED|First Intervention (90 Days)||0||
59671376|NCT05036343|75790253|FG001|NOT COMPLETED|First Intervention (90 Days)||0||
59671377|NCT05036343|75790252|FG000|STARTED|Second Intervention (90 Days)||5||
60077831|NCT01483599|76192730|FG012|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||3||
59671378|NCT05036343|75790253|FG001|STARTED|Second Intervention (90 Days)||8||
59671379|NCT05036343|75790252|FG000|COMPLETED|Second Intervention (90 Days)||5||
59671380|NCT05036343|75790253|FG001|COMPLETED|Second Intervention (90 Days)||8||
59671381|NCT05036343|75790252|FG000|NOT COMPLETED|Second Intervention (90 Days)||0||
59671382|NCT05036343|75790253|FG001|NOT COMPLETED|Second Intervention (90 Days)||0||
59671383|NCT04899362|75790259|FG000|STARTED|Overall Study||36||
59671384|NCT04899362|75790259|FG000|COMPLETED|Overall Study||22||
59671385|NCT04899362|75790259|FG000|NOT COMPLETED|Overall Study||14||
59671386|NCT04870606|75790265|FG000|STARTED|Overall Study||366||
59671387|NCT04870606|75790266|FG001|STARTED|Overall Study||367||
59671388|NCT04870606|75790265|FG000|Received at Least One Dose of Treatment After Randomised|Overall Study||365||
59671389|NCT04870606|75790266|FG001|Received at Least One Dose of Treatment After Randomised|Overall Study||365||
60077832|NCT01483599|76192731|FG013|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||7||
60077833|NCT01393522|76192762|FG000|STARTED|Overall Study||19||
60077834|NCT01393522|76192763|FG001|STARTED|Overall Study||18||
60077835|NCT01393522|76192762|FG000|COMPLETED|Overall Study||12||
60077836|NCT01393522|76192763|FG001|COMPLETED|Overall Study||14||
60077837|NCT01393522|76192762|FG000|NOT COMPLETED|Overall Study||7||
60077838|NCT01393522|76192763|FG001|NOT COMPLETED|Overall Study||4||
60077839|NCT02086786|76192771|FG000|STARTED|Overall Study||35||
59545847|NCT02443740|75644620|FG008|STARTED|Intervention Period 1 (3 Days)||6||
59545848|NCT02443740|75644621|FG009|STARTED|Intervention Period 1 (3 Days)||3||
59545849|NCT02443740|75644622|FG010|STARTED|Intervention Period 1 (3 Days)||3||
59545850|NCT02443740|75644612|FG000|COMPLETED|Intervention Period 1 (3 Days)||1||
59545851|NCT02443740|75644613|FG001|COMPLETED|Intervention Period 1 (3 Days)||2||
59545852|NCT02443740|75644614|FG002|COMPLETED|Intervention Period 1 (3 Days)||2||
59545853|NCT02443740|75644615|FG003|COMPLETED|Intervention Period 1 (3 Days)||3||
59545854|NCT02443740|75644616|FG004|COMPLETED|Intervention Period 1 (3 Days)||2||
59545855|NCT02443740|75644617|FG005|COMPLETED|Intervention Period 1 (3 Days)||2||
59545856|NCT02443740|75644618|FG006|COMPLETED|Intervention Period 1 (3 Days)||2||
59545857|NCT02443740|75644619|FG007|COMPLETED|Intervention Period 1 (3 Days)||2||
59545858|NCT02443740|75644620|FG008|COMPLETED|Intervention Period 1 (3 Days)||6||
59545859|NCT02443740|75644621|FG009|COMPLETED|Intervention Period 1 (3 Days)||3||
59545860|NCT02443740|75644622|FG010|COMPLETED|Intervention Period 1 (3 Days)||3||
59545861|NCT02443740|75644612|FG000|NOT COMPLETED|Intervention Period 1 (3 Days)||1||
59545862|NCT02443740|75644613|FG001|NOT COMPLETED|Intervention Period 1 (3 Days)||0||
59545863|NCT02443740|75644614|FG002|NOT COMPLETED|Intervention Period 1 (3 Days)||0||
59545864|NCT02443740|75644615|FG003|NOT COMPLETED|Intervention Period 1 (3 Days)||0||
59545865|NCT02443740|75644616|FG004|NOT COMPLETED|Intervention Period 1 (3 Days)||0||
59545866|NCT02443740|75644617|FG005|NOT COMPLETED|Intervention Period 1 (3 Days)||2||
59545867|NCT02443740|75644618|FG006|NOT COMPLETED|Intervention Period 1 (3 Days)||1||
59545868|NCT02443740|75644619|FG007|NOT COMPLETED|Intervention Period 1 (3 Days)||0||
59545869|NCT02443740|75644620|FG008|NOT COMPLETED|Intervention Period 1 (3 Days)||0||
59545870|NCT02443740|75644621|FG009|NOT COMPLETED|Intervention Period 1 (3 Days)||0||
59545871|NCT02443740|75644622|FG010|NOT COMPLETED|Intervention Period 1 (3 Days)||0||
59545872|NCT02443740|75644612|FG000|STARTED|Washout Period 1 (7 Days)||1||
59545873|NCT02443740|75644613|FG001|STARTED|Washout Period 1 (7 Days)||2||
59545874|NCT02443740|75644614|FG002|STARTED|Washout Period 1 (7 Days)||2||
59545875|NCT02443740|75644615|FG003|STARTED|Washout Period 1 (7 Days)||3||
59545876|NCT02443740|75644616|FG004|STARTED|Washout Period 1 (7 Days)||2||
59545877|NCT02443740|75644617|FG005|STARTED|Washout Period 1 (7 Days)||2||
59545878|NCT02443740|75644618|FG006|STARTED|Washout Period 1 (7 Days)||2||
59545879|NCT02443740|75644619|FG007|STARTED|Washout Period 1 (7 Days)||2||
59545880|NCT02443740|75644620|FG008|STARTED|Washout Period 1 (7 Days)||0||
59545881|NCT02443740|75644621|FG009|STARTED|Washout Period 1 (7 Days)||3||
59545882|NCT02443740|75644622|FG010|STARTED|Washout Period 1 (7 Days)||3||
59545883|NCT02443740|75644612|FG000|COMPLETED|Washout Period 1 (7 Days)||1||
59545884|NCT02443740|75644613|FG001|COMPLETED|Washout Period 1 (7 Days)||2||
59545885|NCT02443740|75644614|FG002|COMPLETED|Washout Period 1 (7 Days)||2||
59545886|NCT02443740|75644615|FG003|COMPLETED|Washout Period 1 (7 Days)||3||
59545887|NCT02443740|75644616|FG004|COMPLETED|Washout Period 1 (7 Days)||2||
59545888|NCT02443740|75644617|FG005|COMPLETED|Washout Period 1 (7 Days)||2||
59545889|NCT02443740|75644618|FG006|COMPLETED|Washout Period 1 (7 Days)||2||
59545890|NCT02443740|75644619|FG007|COMPLETED|Washout Period 1 (7 Days)||2||
59545891|NCT02443740|75644620|FG008|COMPLETED|Washout Period 1 (7 Days)||0||
59545892|NCT02443740|75644621|FG009|COMPLETED|Washout Period 1 (7 Days)||3||
59545893|NCT02443740|75644622|FG010|COMPLETED|Washout Period 1 (7 Days)||3||
59545894|NCT02443740|75644612|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0||
59545895|NCT02443740|75644613|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0||
59545896|NCT02443740|75644614|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0||
59545897|NCT02443740|75644615|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0||
59545898|NCT02443740|75644616|FG004|NOT COMPLETED|Washout Period 1 (7 Days)||0||
59545899|NCT02443740|75644617|FG005|NOT COMPLETED|Washout Period 1 (7 Days)||0||
59545900|NCT02443740|75644618|FG006|NOT COMPLETED|Washout Period 1 (7 Days)||0||
59545901|NCT02443740|75644619|FG007|NOT COMPLETED|Washout Period 1 (7 Days)||0||
59545902|NCT02443740|75644620|FG008|NOT COMPLETED|Washout Period 1 (7 Days)||0||
59545903|NCT02443740|75644621|FG009|NOT COMPLETED|Washout Period 1 (7 Days)||0||
59545904|NCT02443740|75644622|FG010|NOT COMPLETED|Washout Period 1 (7 Days)||0||
59545905|NCT02443740|75644612|FG000|STARTED|Intervention Period 2 (3 Days)||1||
59545906|NCT02443740|75644613|FG001|STARTED|Intervention Period 2 (3 Days)||2||
59545907|NCT02443740|75644614|FG002|STARTED|Intervention Period 2 (3 Days)||2||
59545908|NCT02443740|75644615|FG003|STARTED|Intervention Period 2 (3 Days)||3||
59545909|NCT02443740|75644616|FG004|STARTED|Intervention Period 2 (3 Days)||2||
59545910|NCT02443740|75644617|FG005|STARTED|Intervention Period 2 (3 Days)||2||
59545911|NCT02443740|75644618|FG006|STARTED|Intervention Period 2 (3 Days)||2||
59545912|NCT02443740|75644619|FG007|STARTED|Intervention Period 2 (3 Days)||2||
59545913|NCT02443740|75644620|FG008|STARTED|Intervention Period 2 (3 Days)||0||
60077840|NCT02086786|76192772|FG001|STARTED|Overall Study||35||
59545914|NCT02443740|75644621|FG009|STARTED|Intervention Period 2 (3 Days)||3||
59545915|NCT02443740|75644622|FG010|STARTED|Intervention Period 2 (3 Days)||3||
59545916|NCT02443740|75644612|FG000|COMPLETED|Intervention Period 2 (3 Days)||1||
59545917|NCT02443740|75644613|FG001|COMPLETED|Intervention Period 2 (3 Days)||2||
59545918|NCT02443740|75644614|FG002|COMPLETED|Intervention Period 2 (3 Days)||2||
59545919|NCT02443740|75644615|FG003|COMPLETED|Intervention Period 2 (3 Days)||3||
59545920|NCT02443740|75644616|FG004|COMPLETED|Intervention Period 2 (3 Days)||2||
59815888|NCT01858597|75938308|FG000|STARTED|Overall Study||30||
59989316|NCT00581477|76104578|FG000|STARTED|Overall Study|8 patients were enrolled|8|Enrolled|
59989317|NCT00581477|76104578|FG000|Dose Selection Trial With Droxidopa|Overall Study|2 patients had been treated with droxidopa prior to enrollment and their data is not included. Since droxidopa restores the norepinephrine that is absent in untreated patients with DBH deficiency, we present only the results for naive patients.|6||
59989318|NCT00581477|76104578|FG000|Droxidopa 25 mg|Overall Study|Because dosing was individualized for the participants, only 5 of the 6 patients were administered 25 mg of Droxidopa.|6||
59989319|NCT00581477|76104578|FG000|Droxidopa 50 mg|Overall Study|Because dosing was individualized for the participants, only 5 of the 6 patients were administered 50 mg of Droxidopa.|6||
59545921|NCT02443740|75644617|FG005|COMPLETED|Intervention Period 2 (3 Days)||2||
59545922|NCT02443740|75644618|FG006|COMPLETED|Intervention Period 2 (3 Days)||2||
59545923|NCT02443740|75644619|FG007|COMPLETED|Intervention Period 2 (3 Days)||2||
59545924|NCT02443740|75644620|FG008|COMPLETED|Intervention Period 2 (3 Days)||0||
59545925|NCT02443740|75644621|FG009|COMPLETED|Intervention Period 2 (3 Days)||3||
59545926|NCT02443740|75644622|FG010|COMPLETED|Intervention Period 2 (3 Days)||3||
59545927|NCT02443740|75644612|FG000|NOT COMPLETED|Intervention Period 2 (3 Days)||0||
59545928|NCT02443740|75644613|FG001|NOT COMPLETED|Intervention Period 2 (3 Days)||0||
59545929|NCT02443740|75644614|FG002|NOT COMPLETED|Intervention Period 2 (3 Days)||0||
59545930|NCT02443740|75644615|FG003|NOT COMPLETED|Intervention Period 2 (3 Days)||0||
59545931|NCT02443740|75644616|FG004|NOT COMPLETED|Intervention Period 2 (3 Days)||0||
59545932|NCT02443740|75644617|FG005|NOT COMPLETED|Intervention Period 2 (3 Days)||0||
59545933|NCT02443740|75644618|FG006|NOT COMPLETED|Intervention Period 2 (3 Days)||0||
59545934|NCT02443740|75644619|FG007|NOT COMPLETED|Intervention Period 2 (3 Days)||0||
59545935|NCT02443740|75644620|FG008|NOT COMPLETED|Intervention Period 2 (3 Days)||0||
59545936|NCT02443740|75644621|FG009|NOT COMPLETED|Intervention Period 2 (3 Days)||0||
59545937|NCT02443740|75644622|FG010|NOT COMPLETED|Intervention Period 2 (3 Days)||0||
59545938|NCT02443740|75644612|FG000|STARTED|Washout Period 2 (7 Days)||1||
59545939|NCT02443740|75644613|FG001|STARTED|Washout Period 2 (7 Days)||2||
59545940|NCT02443740|75644614|FG002|STARTED|Washout Period 2 (7 Days)||2||
59545941|NCT02443740|75644615|FG003|STARTED|Washout Period 2 (7 Days)||3||
59545942|NCT02443740|75644616|FG004|STARTED|Washout Period 2 (7 Days)||2||
59545943|NCT02443740|75644617|FG005|STARTED|Washout Period 2 (7 Days)||2||
59545944|NCT02443740|75644618|FG006|STARTED|Washout Period 2 (7 Days)||2||
59545945|NCT02443740|75644619|FG007|STARTED|Washout Period 2 (7 Days)||2||
59545946|NCT02443740|75644620|FG008|STARTED|Washout Period 2 (7 Days)||0||
59545947|NCT02443740|75644621|FG009|STARTED|Washout Period 2 (7 Days)||0||
59545948|NCT02443740|75644622|FG010|STARTED|Washout Period 2 (7 Days)||0||
59545949|NCT02443740|75644612|FG000|COMPLETED|Washout Period 2 (7 Days)||1||
59545950|NCT02443740|75644613|FG001|COMPLETED|Washout Period 2 (7 Days)||2||
59545951|NCT02443740|75644614|FG002|COMPLETED|Washout Period 2 (7 Days)||2||
59545952|NCT02443740|75644615|FG003|COMPLETED|Washout Period 2 (7 Days)||3||
59545953|NCT02443740|75644616|FG004|COMPLETED|Washout Period 2 (7 Days)||2||
59545954|NCT02443740|75644617|FG005|COMPLETED|Washout Period 2 (7 Days)||2||
59545955|NCT02443740|75644618|FG006|COMPLETED|Washout Period 2 (7 Days)||2||
59545956|NCT02443740|75644619|FG007|COMPLETED|Washout Period 2 (7 Days)||2||
59545957|NCT02443740|75644620|FG008|COMPLETED|Washout Period 2 (7 Days)||0||
59545958|NCT02443740|75644621|FG009|COMPLETED|Washout Period 2 (7 Days)||0||
59545959|NCT02443740|75644622|FG010|COMPLETED|Washout Period 2 (7 Days)||0||
59545960|NCT02443740|75644612|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0||
59545961|NCT02443740|75644613|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0||
59545962|NCT02443740|75644614|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0||
59545963|NCT02443740|75644615|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0||
59545964|NCT02443740|75644616|FG004|NOT COMPLETED|Washout Period 2 (7 Days)||0||
59545965|NCT02443740|75644617|FG005|NOT COMPLETED|Washout Period 2 (7 Days)||0||
59545966|NCT02443740|75644618|FG006|NOT COMPLETED|Washout Period 2 (7 Days)||0||
59545967|NCT02443740|75644619|FG007|NOT COMPLETED|Washout Period 2 (7 Days)||0||
59545968|NCT02443740|75644620|FG008|NOT COMPLETED|Washout Period 2 (7 Days)||0||
59545969|NCT02443740|75644621|FG009|NOT COMPLETED|Washout Period 2 (7 Days)||0||
59545970|NCT02443740|75644622|FG010|NOT COMPLETED|Washout Period 2 (7 Days)||0||
59545971|NCT02443740|75644612|FG000|STARTED|Intervention Period 3 (3 Days)||1||
59545972|NCT02443740|75644613|FG001|STARTED|Intervention Period 3 (3 Days)||2||
59545973|NCT02443740|75644614|FG002|STARTED|Intervention Period 3 (3 Days)||2||
59545974|NCT02443740|75644615|FG003|STARTED|Intervention Period 3 (3 Days)||3||
59545975|NCT02443740|75644616|FG004|STARTED|Intervention Period 3 (3 Days)||2||
59545976|NCT02443740|75644617|FG005|STARTED|Intervention Period 3 (3 Days)||2||
59545977|NCT02443740|75644618|FG006|STARTED|Intervention Period 3 (3 Days)||2||
59545978|NCT02443740|75644619|FG007|STARTED|Intervention Period 3 (3 Days)||2||
59545979|NCT02443740|75644620|FG008|STARTED|Intervention Period 3 (3 Days)||0||
59671390|NCT04870606|75790265|FG000|COMPLETED|Overall Study||354||
59671391|NCT04870606|75790266|FG001|COMPLETED|Overall Study||359||
59671392|NCT04870606|75790265|FG000|NOT COMPLETED|Overall Study||12||
59671393|NCT04870606|75790266|FG001|NOT COMPLETED|Overall Study||8||
59671394|NCT04856891|75790274|FG000|STARTED|Overall Study||46||
59671395|NCT04856891|75790275|FG001|STARTED|Overall Study||47||
59671396|NCT04856891|75790274|FG000|COMPLETED|Overall Study||38||
59671397|NCT04856891|75790275|FG001|COMPLETED|Overall Study||44||
59671398|NCT04856891|75790274|FG000|NOT COMPLETED|Overall Study||8||
59671399|NCT04856891|75790275|FG001|NOT COMPLETED|Overall Study||3||
59671400|NCT04850781|75790283|FG000|STARTED|Overall Study||128||
59671401|NCT04850781|75790284|FG001|STARTED|Overall Study||115||
59671402|NCT04850781|75790283|FG000|COMPLETED|Overall Study||128||
59671403|NCT04850781|75790284|FG001|COMPLETED|Overall Study||115||
59671404|NCT04850781|75790283|FG000|NOT COMPLETED|Overall Study||0||
59671405|NCT04850781|75790284|FG001|NOT COMPLETED|Overall Study||0||
59671406|NCT04800315|75790294|FG000|STARTED|Randomization||55||
59671407|NCT04800315|75790295|FG001|STARTED|Randomization||55||
59671408|NCT04800315|75790296|FG002|STARTED|Randomization||55||
59671409|NCT04800315|75790297|FG003|STARTED|Randomization||56||
59671410|NCT04800315|75790294|FG000|COMPLETED|Randomization||54|Completed = All randomized participants who recieved at least one dose of study treatment.|
59671411|NCT04800315|75790295|FG001|COMPLETED|Randomization||55|Completed = All randomized participants who recieved at least one dose of study treatment.|
59671412|NCT04800315|75790296|FG002|COMPLETED|Randomization||55|Completed = All randomized participants who recieved at least one dose of study treatment.|
59671413|NCT04800315|75790297|FG003|COMPLETED|Randomization||56|Completed = All randomized participants who recieved at least one dose of study treatment.|
59671414|NCT04800315|75790294|FG000|NOT COMPLETED|Randomization||1||
59671415|NCT04800315|75790295|FG001|NOT COMPLETED|Randomization||0||
59671416|NCT04800315|75790296|FG002|NOT COMPLETED|Randomization||0||
59671417|NCT04800315|75790297|FG003|NOT COMPLETED|Randomization||0||
59671418|NCT04800315|75790294|FG000|STARTED|Treatment Period||54||
59671419|NCT04800315|75790295|FG001|STARTED|Treatment Period||55||
59671420|NCT04800315|75790296|FG002|STARTED|Treatment Period||55||
59671421|NCT04800315|75790297|FG003|STARTED|Treatment Period||56||
59671422|NCT04800315|75790294|FG000|COMPLETED|Treatment Period||49||
59671423|NCT04800315|75790295|FG001|COMPLETED|Treatment Period||50||
59671424|NCT04800315|75790296|FG002|COMPLETED|Treatment Period||52||
59671425|NCT04800315|75790297|FG003|COMPLETED|Treatment Period||44||
59671426|NCT04800315|75790294|FG000|NOT COMPLETED|Treatment Period||5||
59671427|NCT04800315|75790295|FG001|NOT COMPLETED|Treatment Period||5||
59671428|NCT04800315|75790296|FG002|NOT COMPLETED|Treatment Period||3||
59671429|NCT04800315|75790297|FG003|NOT COMPLETED|Treatment Period||12||
59671430|NCT04768114|75790309|FG000|STARTED|Overall Study||74||
59671431|NCT04768114|75790310|FG001|STARTED|Overall Study||74||
59671432|NCT04768114|75790309|FG000|COMPLETED|Overall Study||69||
59671433|NCT04768114|75790310|FG001|COMPLETED|Overall Study||63||
59671434|NCT04768114|75790309|FG000|NOT COMPLETED|Overall Study||5||
59671435|NCT04768114|75790310|FG001|NOT COMPLETED|Overall Study||11||
59671436|NCT04622527|75790320|FG000|STARTED|Overall Study||6||
59671437|NCT04622527|75790321|FG001|STARTED|Overall Study||6||
59671438|NCT04622527|75790322|FG002|STARTED|Overall Study||6||
59671439|NCT04622527|75790323|FG003|STARTED|Overall Study||6||
59671440|NCT04622527|75790320|FG000|COMPLETED|Overall Study||6||
59671441|NCT04622527|75790321|FG001|COMPLETED|Overall Study||6||
59671442|NCT04622527|75790322|FG002|COMPLETED|Overall Study||6||
59671443|NCT04622527|75790323|FG003|COMPLETED|Overall Study||6||
59671444|NCT04622527|75790320|FG000|NOT COMPLETED|Overall Study||0||
59671445|NCT04622527|75790321|FG001|NOT COMPLETED|Overall Study||0||
59671446|NCT04622527|75790322|FG002|NOT COMPLETED|Overall Study||0||
59671447|NCT04622527|75790323|FG003|NOT COMPLETED|Overall Study||0||
59989320|NCT00581477|76104578|FG000|Droxidopa 100 mg|Overall Study|Because dosing was individualized for the participants, only 4 of the 6 patients were administered 100 mg of Droxidopa.|6||
59989321|NCT00581477|76104578|FG000|Droxidopa 200 mg|Overall Study|Because dosing was individualized for the participants, only 5 of the 6 patients were administered 200 mg of Droxidopa.|6||
59989322|NCT00581477|76104578|FG000|Droxidopa 250 mg|Overall Study|Because dosing was individualized for the participants, only 2 of the 6 patients were administered 250 mg of Droxidopa.|6||
59989323|NCT00581477|76104578|FG000|Droxidopa 300 mg|Overall Study|Because dosing was individualized for the participants, only 1 of the 6 patients was administered 300 mg of Droxidopa.|6||
59989324|NCT00581477|76104578|FG000|COMPLETED|Overall Study||6||
59989325|NCT00581477|76104578|FG000|NOT COMPLETED|Overall Study||2||
59671448|NCT04585763|75790337|FG000|STARTED|Overall Study||37||51
59671449|NCT04585763|75790337|FG000|COMPLETED|Overall Study||35||48
59671450|NCT04585763|75790337|FG000|NOT COMPLETED|Overall Study||2||3
59671451|NCT04547192|75790343|FG000|STARTED|Period 1: 0-14 Weeks||377||2
59671452|NCT04547192|75790344|FG001|STARTED|Period 1: 0-14 Weeks||270||2
59671453|NCT04547192|75790345|FG002|STARTED|Period 1: 0-14 Weeks||235||2
59671454|NCT04547192|75790346|FG003|STARTED|Period 1: 0-14 Weeks||107||2
59671455|NCT04547192|75790343|FG000|COMPLETED|Period 1: 0-14 Weeks||370||2
59671456|NCT04547192|75790344|FG001|COMPLETED|Period 1: 0-14 Weeks||268||2
59671457|NCT04547192|75790345|FG002|COMPLETED|Period 1: 0-14 Weeks||230||2
59671458|NCT04547192|75790346|FG003|COMPLETED|Period 1: 0-14 Weeks||106||2
59671459|NCT04547192|75790343|FG000|NOT COMPLETED|Period 1: 0-14 Weeks||7||0
59671460|NCT04547192|75790344|FG001|NOT COMPLETED|Period 1: 0-14 Weeks||2||0
59671461|NCT04547192|75790345|FG002|NOT COMPLETED|Period 1: 0-14 Weeks||5||0
59671462|NCT04547192|75790346|FG003|NOT COMPLETED|Period 1: 0-14 Weeks||1||0
59671463|NCT04547192|75790343|FG000|STARTED|Period 2: 14-28 Weeks||186||2
59671464|NCT04547192|75790344|FG001|STARTED|Period 2: 14-28 Weeks||279||2
59671465|NCT04547192|75790345|FG002|STARTED|Period 2: 14-28 Weeks||265||2
59671466|NCT04547192|75790346|FG003|STARTED|Period 2: 14-28 Weeks||79||2
59671467|NCT04547192|75790343|FG000|COMPLETED|Period 2: 14-28 Weeks||186||2
59671468|NCT04547192|75790344|FG001|COMPLETED|Period 2: 14-28 Weeks||278||2
59671469|NCT04547192|75790345|FG002|COMPLETED|Period 2: 14-28 Weeks||264||2
59671470|NCT04547192|75790346|FG003|COMPLETED|Period 2: 14-28 Weeks||79||2
59671471|NCT04547192|75790343|FG000|NOT COMPLETED|Period 2: 14-28 Weeks||0||0
59671472|NCT04547192|75790344|FG001|NOT COMPLETED|Period 2: 14-28 Weeks||1||0
59671473|NCT04547192|75790345|FG002|NOT COMPLETED|Period 2: 14-28 Weeks||1||0
59671474|NCT04547192|75790346|FG003|NOT COMPLETED|Period 2: 14-28 Weeks||0||0
59671475|NCT04547192|75790343|FG000|STARTED|Period 3: 28-42 Weeks||261||2
59671476|NCT04547192|75790344|FG001|STARTED|Period 3: 28-42 Weeks||274||2
59671477|NCT04547192|75790345|FG002|STARTED|Period 3: 28-42 Weeks||287||2
59671478|NCT04547192|75790346|FG003|STARTED|Period 3: 28-42 Weeks||104||2
59671479|NCT04547192|75790343|FG000|COMPLETED|Period 3: 28-42 Weeks||259||2
59671480|NCT04547192|75790344|FG001|COMPLETED|Period 3: 28-42 Weeks||274||2
59671481|NCT04547192|75790345|FG002|COMPLETED|Period 3: 28-42 Weeks||281||2
59671482|NCT04547192|75790346|FG003|COMPLETED|Period 3: 28-42 Weeks||104||2
59671483|NCT04547192|75790343|FG000|NOT COMPLETED|Period 3: 28-42 Weeks||2||0
59671484|NCT04547192|75790344|FG001|NOT COMPLETED|Period 3: 28-42 Weeks||0||0
59671485|NCT04547192|75790345|FG002|NOT COMPLETED|Period 3: 28-42 Weeks||6||0
59671486|NCT04547192|75790346|FG003|NOT COMPLETED|Period 3: 28-42 Weeks||0||0
59671487|NCT04547192|75790343|FG000|STARTED|Period 4: 42-56 Weeks||250||2
59671488|NCT04547192|75790344|FG001|STARTED|Period 4: 42-56 Weeks||186||2
59671489|NCT04547192|75790345|FG002|STARTED|Period 4: 42-56 Weeks||169||2
59671490|NCT04547192|75790346|FG003|STARTED|Period 4: 42-56 Weeks||87||2
59671491|NCT04547192|75790343|FG000|COMPLETED|Period 4: 42-56 Weeks||248||2
59671492|NCT04547192|75790344|FG001|COMPLETED|Period 4: 42-56 Weeks||186||2
59671493|NCT04547192|75790345|FG002|COMPLETED|Period 4: 42-56 Weeks||169||2
59671494|NCT04547192|75790346|FG003|COMPLETED|Period 4: 42-56 Weeks||87||2
59671495|NCT04547192|75790343|FG000|NOT COMPLETED|Period 4: 42-56 Weeks||2||0
59671496|NCT04547192|75790344|FG001|NOT COMPLETED|Period 4: 42-56 Weeks||0||0
59671497|NCT04547192|75790345|FG002|NOT COMPLETED|Period 4: 42-56 Weeks||0||0
59671498|NCT04547192|75790346|FG003|NOT COMPLETED|Period 4: 42-56 Weeks||0||0
59671499|NCT04547192|75790343|FG000|STARTED|Period 5: 56-70 Weeks||227||2
59671500|NCT04547192|75790344|FG001|STARTED|Period 5: 56-70 Weeks||182||2
59671501|NCT04547192|75790345|FG002|STARTED|Period 5: 56-70 Weeks||226||2
59671502|NCT04547192|75790346|FG003|STARTED|Period 5: 56-70 Weeks||54||2
59671503|NCT04547192|75790343|FG000|COMPLETED|Period 5: 56-70 Weeks||227||2
59671504|NCT04547192|75790344|FG001|COMPLETED|Period 5: 56-70 Weeks||182||2
59671505|NCT04547192|75790345|FG002|COMPLETED|Period 5: 56-70 Weeks||225||2
59671506|NCT04547192|75790346|FG003|COMPLETED|Period 5: 56-70 Weeks||54||2
59671507|NCT04547192|75790343|FG000|NOT COMPLETED|Period 5: 56-70 Weeks||0||0
59671508|NCT04547192|75790344|FG001|NOT COMPLETED|Period 5: 56-70 Weeks||0||0
59671509|NCT04547192|75790345|FG002|NOT COMPLETED|Period 5: 56-70 Weeks||1||0
59671510|NCT04547192|75790346|FG003|NOT COMPLETED|Period 5: 56-70 Weeks||0||0
59671511|NCT04514510|75790356|FG000|STARTED|Overall Study||23||
59671512|NCT04514510|75790357|FG001|STARTED|Overall Study||23||
59671513|NCT04514510|75790356|FG000|COMPLETED|Overall Study||22||
59671514|NCT04514510|75790357|FG001|COMPLETED|Overall Study||22||
59671515|NCT04514510|75790356|FG000|NOT COMPLETED|Overall Study||1||
59671516|NCT04514510|75790357|FG001|NOT COMPLETED|Overall Study||1||
59671517|NCT04496219|75790365|FG000|STARTED|Overall Study||28||
59671518|NCT04496219|75790366|FG001|STARTED|Overall Study||17||
59671519|NCT04496219|75790365|FG000|COMPLETED|Overall Study||25||
59671520|NCT04496219|75790366|FG001|COMPLETED|Overall Study||14||
59671521|NCT04496219|75790365|FG000|NOT COMPLETED|Overall Study||3||
59671522|NCT04496219|75790366|FG001|NOT COMPLETED|Overall Study||3||
59671523|NCT04439123|75790373|FG000|STARTED|Overall Study|All 35 patients enrolled were eligible and treated in the arm|35||
59671524|NCT04439123|75790373|FG000|COMPLETED|Overall Study||0||
59671525|NCT04439123|75790373|FG000|NOT COMPLETED|Overall Study||35||
59671526|NCT04389294|75790377|FG000|STARTED|Overall Study||143||
59671527|NCT04389294|75790377|FG000|COMPLETED|Overall Study||143||
59671528|NCT04389294|75790377|FG000|NOT COMPLETED|Overall Study||0||
59671529|NCT04325828|75790381|FG000|STARTED|Overall Study||31||
59671530|NCT04325828|75790381|FG000|COMPLETED|Overall Study||5||
59671531|NCT04325828|75790381|FG000|NOT COMPLETED|Overall Study||26||
59671532|NCT04322708|75790388|FG000|STARTED|Overall Study||92||
59671533|NCT04322708|75790389|FG001|STARTED|Overall Study||93||
59671534|NCT04322708|75790390|FG002|STARTED|Overall Study||91||
59671535|NCT04322708|75790388|FG000|COMPLETED|Overall Study||89||
59671536|NCT04322708|75790389|FG001|COMPLETED|Overall Study||89||
59671537|NCT04322708|75790390|FG002|COMPLETED|Overall Study||85||
59671538|NCT04322708|75790388|FG000|NOT COMPLETED|Overall Study||3||
59671539|NCT04322708|75790389|FG001|NOT COMPLETED|Overall Study||4||
59671540|NCT04322708|75790390|FG002|NOT COMPLETED|Overall Study||6||
59671541|NCT04322604|75790400|FG000|STARTED|Overall Study||91||
59671542|NCT04322604|75790401|FG001|STARTED|Overall Study||90||
59671543|NCT04322604|75790400|FG000|COMPLETED|Overall Study||85||
59671544|NCT04322604|75790401|FG001|COMPLETED|Overall Study||83||
59671545|NCT04322604|75790400|FG000|NOT COMPLETED|Overall Study||6||
59671546|NCT04322604|75790401|FG001|NOT COMPLETED|Overall Study||7||
59671547|NCT04283461|75790417|FG000|STARTED|Overall Study||0||
59671548|NCT04283461|75790418|FG001|STARTED|Overall Study||15||
59671549|NCT04283461|75790419|FG002|STARTED|Overall Study||15||
59671550|NCT04283461|75790420|FG003|STARTED|Overall Study||15||
59671551|NCT04283461|75790421|FG004|STARTED|Overall Study||15||
59671552|NCT04283461|75790422|FG005|STARTED|Overall Study||10||
59671553|NCT04283461|75790423|FG006|STARTED|Overall Study||10||
59671554|NCT04283461|75790424|FG007|STARTED|Overall Study||10||
59671555|NCT04283461|75790425|FG008|STARTED|Overall Study||0||
59671556|NCT04283461|75790426|FG009|STARTED|Overall Study||10||
59671557|NCT04283461|75790427|FG010|STARTED|Overall Study||10||
59671558|NCT04283461|75790428|FG011|STARTED|Overall Study||10||
59671559|NCT04283461|75790429|FG012|STARTED|Overall Study||0||
59671560|NCT04283461|75790417|FG000|COMPLETED|Overall Study||0||
59671561|NCT04283461|75790418|FG001|COMPLETED|Overall Study||15||
59671562|NCT04283461|75790419|FG002|COMPLETED|Overall Study||7||
59671563|NCT04283461|75790420|FG003|COMPLETED|Overall Study||2||
59671564|NCT04283461|75790421|FG004|COMPLETED|Overall Study||3||
59671565|NCT04283461|75790422|FG005|COMPLETED|Overall Study||10||
59671566|NCT04283461|75790423|FG006|COMPLETED|Overall Study||10||
59671567|NCT04283461|75790424|FG007|COMPLETED|Overall Study||2||
59671568|NCT04283461|75790425|FG008|COMPLETED|Overall Study||0||
59671569|NCT04283461|75790426|FG009|COMPLETED|Overall Study||10||
59671570|NCT04283461|75790427|FG010|COMPLETED|Overall Study||10||
59671571|NCT04283461|75790428|FG011|COMPLETED|Overall Study||3||
59671572|NCT04283461|75790429|FG012|COMPLETED|Overall Study||0||
59671573|NCT04283461|75790417|FG000|NOT COMPLETED|Overall Study||0||
59671574|NCT04283461|75790418|FG001|NOT COMPLETED|Overall Study||0||
59671575|NCT04283461|75790419|FG002|NOT COMPLETED|Overall Study||8||
59671576|NCT04283461|75790420|FG003|NOT COMPLETED|Overall Study||13||
59671577|NCT04283461|75790421|FG004|NOT COMPLETED|Overall Study||12||
59671578|NCT04283461|75790422|FG005|NOT COMPLETED|Overall Study||0||
59671579|NCT04283461|75790423|FG006|NOT COMPLETED|Overall Study||0||
59671580|NCT04283461|75790424|FG007|NOT COMPLETED|Overall Study||8||
59671581|NCT04283461|75790425|FG008|NOT COMPLETED|Overall Study||0||
59671582|NCT04283461|75790426|FG009|NOT COMPLETED|Overall Study||0||
59671583|NCT04283461|75790427|FG010|NOT COMPLETED|Overall Study||0||
59671584|NCT04283461|75790428|FG011|NOT COMPLETED|Overall Study||7||
59671585|NCT04283461|75790429|FG012|NOT COMPLETED|Overall Study||0||
59671586|NCT04278560|75790453|FG000|STARTED|Overall Study||16||
59671587|NCT04278560|75790454|FG001|STARTED|Overall Study||16||
59671588|NCT04278560|75790453|FG000|COMPLETED|Overall Study||13||
59671589|NCT04278560|75790454|FG001|COMPLETED|Overall Study||15||
59671590|NCT04278560|75790453|FG000|NOT COMPLETED|Overall Study||3||
59671591|NCT04278560|75790454|FG001|NOT COMPLETED|Overall Study||1||
59671592|NCT04213079|75790462|FG000|STARTED|Overall Study||24||
59671593|NCT04213079|75790463|FG001|STARTED|Overall Study||23||
59671594|NCT04213079|75790462|FG000|COMPLETED|Overall Study||24||
59671595|NCT04213079|75790463|FG001|COMPLETED|Overall Study||21||
59671596|NCT04213079|75790462|FG000|NOT COMPLETED|Overall Study||0||
59671597|NCT04213079|75790463|FG001|NOT COMPLETED|Overall Study||2||
59671598|NCT04209595|75790471|FG000|STARTED|Phase I - Maximum Tolerated Dose||0||
59671599|NCT04209595|75790472|FG001|STARTED|Phase I - Maximum Tolerated Dose||8||
59671600|NCT04209595|75790473|FG002|STARTED|Phase I - Maximum Tolerated Dose||2||
59671601|NCT04209595|75790474|FG003|STARTED|Phase I - Maximum Tolerated Dose||0||
59671602|NCT04209595|75790475|FG004|STARTED|Phase I - Maximum Tolerated Dose||0||
59671603|NCT04209595|75790471|FG000|COMPLETED|Phase I - Maximum Tolerated Dose||0||
59671604|NCT04209595|75790472|FG001|COMPLETED|Phase I - Maximum Tolerated Dose||8||
59671605|NCT04209595|75790473|FG002|COMPLETED|Phase I - Maximum Tolerated Dose||2||
59671606|NCT04209595|75790474|FG003|COMPLETED|Phase I - Maximum Tolerated Dose||0||
59671607|NCT04209595|75790475|FG004|COMPLETED|Phase I - Maximum Tolerated Dose||0||
59671608|NCT04209595|75790471|FG000|NOT COMPLETED|Phase I - Maximum Tolerated Dose||0||
59671609|NCT04209595|75790472|FG001|NOT COMPLETED|Phase I - Maximum Tolerated Dose||0||
59671610|NCT04209595|75790473|FG002|NOT COMPLETED|Phase I - Maximum Tolerated Dose||0||
59671611|NCT04209595|75790474|FG003|NOT COMPLETED|Phase I - Maximum Tolerated Dose||0||
59671612|NCT04209595|75790475|FG004|NOT COMPLETED|Phase I - Maximum Tolerated Dose||0||
59671613|NCT04209595|75790471|FG000|STARTED|Phase IIA - Assess Efficacy||0||
59671614|NCT04209595|75790472|FG001|STARTED|Phase IIA - Assess Efficacy||0||
59671615|NCT04209595|75790473|FG002|STARTED|Phase IIA - Assess Efficacy||0||
59671616|NCT04209595|75790474|FG003|STARTED|Phase IIA - Assess Efficacy||0||
59671617|NCT04209595|75790475|FG004|STARTED|Phase IIA - Assess Efficacy||0||
59671618|NCT04209595|75790471|FG000|COMPLETED|Phase IIA - Assess Efficacy||0||
59671619|NCT04209595|75790472|FG001|COMPLETED|Phase IIA - Assess Efficacy||0||
59671620|NCT04209595|75790473|FG002|COMPLETED|Phase IIA - Assess Efficacy||0||
59671621|NCT04209595|75790474|FG003|COMPLETED|Phase IIA - Assess Efficacy||0||
59671622|NCT04209595|75790475|FG004|COMPLETED|Phase IIA - Assess Efficacy||0||
59671623|NCT04209595|75790471|FG000|NOT COMPLETED|Phase IIA - Assess Efficacy||0||
59671624|NCT04209595|75790472|FG001|NOT COMPLETED|Phase IIA - Assess Efficacy||0||
59671625|NCT04209595|75790473|FG002|NOT COMPLETED|Phase IIA - Assess Efficacy||0||
60077841|NCT02086786|76192771|FG000|COMPLETED|Overall Study||17||
60077842|NCT02086786|76192772|FG001|COMPLETED|Overall Study||19||
60077843|NCT02086786|76192771|FG000|NOT COMPLETED|Overall Study||18||
60077844|NCT02086786|76192772|FG001|NOT COMPLETED|Overall Study||16||
60077845|NCT02318992|76192783|FG000|STARTED|Overall Study||27||
59671626|NCT04209595|75790474|FG003|NOT COMPLETED|Phase IIA - Assess Efficacy||0||
59671627|NCT04209595|75790475|FG004|NOT COMPLETED|Phase IIA - Assess Efficacy||0||
59671628|NCT04209595|75790471|FG000|STARTED|Phase IIB - Assess Efficacy||0||
59671629|NCT04209595|75790472|FG001|STARTED|Phase IIB - Assess Efficacy||0||
59671630|NCT04209595|75790473|FG002|STARTED|Phase IIB - Assess Efficacy||0||
59671631|NCT04209595|75790474|FG003|STARTED|Phase IIB - Assess Efficacy||0||
59671632|NCT04209595|75790475|FG004|STARTED|Phase IIB - Assess Efficacy||0||
59671633|NCT04209595|75790471|FG000|COMPLETED|Phase IIB - Assess Efficacy||0||
59671634|NCT04209595|75790472|FG001|COMPLETED|Phase IIB - Assess Efficacy||0||
59671635|NCT04209595|75790473|FG002|COMPLETED|Phase IIB - Assess Efficacy||0||
59671636|NCT04209595|75790474|FG003|COMPLETED|Phase IIB - Assess Efficacy||0||
59671637|NCT04209595|75790475|FG004|COMPLETED|Phase IIB - Assess Efficacy||0||
59671638|NCT04209595|75790471|FG000|NOT COMPLETED|Phase IIB - Assess Efficacy||0||
59671639|NCT04209595|75790472|FG001|NOT COMPLETED|Phase IIB - Assess Efficacy||0||
59671640|NCT04209595|75790473|FG002|NOT COMPLETED|Phase IIB - Assess Efficacy||0||
59671641|NCT04209595|75790474|FG003|NOT COMPLETED|Phase IIB - Assess Efficacy||0||
59671642|NCT04209595|75790475|FG004|NOT COMPLETED|Phase IIB - Assess Efficacy||0||
59671643|NCT04182672|75790487|FG000|STARTED|Overall Study||22||24
59671644|NCT04182672|75790487|FG000|COMPLETED|Overall Study||22||24
59671645|NCT04182672|75790487|FG000|NOT COMPLETED|Overall Study||0||0
59671646|NCT04102189|75790493|FG000|STARTED|Overall Study||134||
59671647|NCT04102189|75790494|FG001|STARTED|Overall Study||67||
59671648|NCT04102189|75790493|FG000|Treated|Overall Study||133||
59671649|NCT04102189|75790494|FG001|Treated|Overall Study||67||
59671650|NCT04102189|75790493|FG000|Full Analysis Set (FAS)|Overall Study||134||
59671651|NCT04102189|75790494|FG001|Full Analysis Set (FAS)|Overall Study||67||
59671652|NCT04102189|75790493|FG000|Safety Analysis Set|Overall Study||133||
59671653|NCT04102189|75790494|FG001|Safety Analysis Set|Overall Study||67||
59671654|NCT04102189|75790493|FG000|COMPLETED|Overall Study||132||
59671655|NCT04102189|75790494|FG001|COMPLETED|Overall Study||64||
59671656|NCT04102189|75790493|FG000|NOT COMPLETED|Overall Study||2||
59671657|NCT04102189|75790494|FG001|NOT COMPLETED|Overall Study||3||
59671658|NCT04034927|75790502|FG000|STARTED|Overall Study||30||
59671659|NCT04034927|75790503|FG001|STARTED|Overall Study||31||
59671660|NCT04034927|75790502|FG000|COMPLETED|Overall Study||23||
59671661|NCT04034927|75790503|FG001|COMPLETED|Overall Study||16||
59671662|NCT04034927|75790502|FG000|NOT COMPLETED|Overall Study||7||
59671663|NCT04034927|75790503|FG001|NOT COMPLETED|Overall Study||15||
59671664|NCT04033926|75790511|FG000|STARTED|Treatment Period 1||13||
59671665|NCT04033926|75790512|FG001|STARTED|Treatment Period 1||12||
59671666|NCT04033926|75790511|FG000|COMPLETED|Treatment Period 1||10||
59671667|NCT04033926|75790512|FG001|COMPLETED|Treatment Period 1||12||
59671668|NCT04033926|75790511|FG000|NOT COMPLETED|Treatment Period 1||3||
59671669|NCT04033926|75790512|FG001|NOT COMPLETED|Treatment Period 1||0||
60077846|NCT02318992|76192784|FG001|STARTED|Overall Study||27||
60077847|NCT02318992|76192785|FG002|STARTED|Overall Study||24||
60077848|NCT02318992|76192783|FG000|COMPLETED|Overall Study||25||
60077849|NCT02318992|76192784|FG001|COMPLETED|Overall Study||25||
60077850|NCT02318992|76192785|FG002|COMPLETED|Overall Study||20||
59671670|NCT04033926|75790511|FG000|STARTED|Treatment Period 2||10||
60077851|NCT02318992|76192783|FG000|NOT COMPLETED|Overall Study||2||
60077852|NCT02318992|76192784|FG001|NOT COMPLETED|Overall Study||2||
60077853|NCT02318992|76192785|FG002|NOT COMPLETED|Overall Study||4||
60077854|NCT02086708|76192793|FG000|STARTED|Overall Study||24||
59671671|NCT04033926|75790512|FG001|STARTED|Treatment Period 2||12||
59671672|NCT04033926|75790511|FG000|COMPLETED|Treatment Period 2||8||
59671673|NCT04033926|75790512|FG001|COMPLETED|Treatment Period 2||12||
59671674|NCT04033926|75790511|FG000|NOT COMPLETED|Treatment Period 2||2||
59671675|NCT04033926|75790512|FG001|NOT COMPLETED|Treatment Period 2||0||
59671676|NCT04025580|75790525|FG000|STARTED|Overall Study||24||
59671677|NCT04025580|75790526|FG001|STARTED|Overall Study||34||
59671678|NCT04025580|75790527|FG002|STARTED|Overall Study||40||
59671679|NCT04025580|75790525|FG000|COMPLETED|Overall Study||13||
59671680|NCT04025580|75790526|FG001|COMPLETED|Overall Study||34||
59671681|NCT04025580|75790527|FG002|COMPLETED|Overall Study||40||
59671682|NCT04025580|75790525|FG000|NOT COMPLETED|Overall Study||11||
59671683|NCT04025580|75790526|FG001|NOT COMPLETED|Overall Study||0||
59671684|NCT04025580|75790527|FG002|NOT COMPLETED|Overall Study||0||
59671685|NCT03982368|75790537|FG000|STARTED|Overall Study||87||
60077855|NCT02086708|76192793|FG000|COMPLETED|Overall Study||24||
59671686|NCT03982368|75790538|FG001|STARTED|Overall Study||86||
59671687|NCT03982368|75790539|FG002|STARTED|Overall Study||88||
59671688|NCT03982368|75790537|FG000|FAS Popuation|Overall Study||81|The FAS consisted of all patients randomized who took at least 1 dose of IMP and who had at least 1 postbaseline efficacy measurement for the primary endpoint. This analysis set was used for the primary efficacy analysis. Patients were analyzed according to the randomized treatment.|
59671689|NCT03982368|75790538|FG001|FAS Popuation|Overall Study||82|The FAS consisted of all patients randomized who took at least 1 dose of IMP and who had at least 1 postbaseline efficacy measurement for the primary endpoint. This analysis set was used for the primary efficacy analysis. Patients were analyzed according to the randomized treatment.|
59671690|NCT03982368|75790539|FG002|FAS Popuation|Overall Study||84|The FAS consisted of all patients randomized who took at least 1 dose of IMP and who had at least 1 postbaseline efficacy measurement for the primary endpoint. This analysis set was used for the primary efficacy analysis. Patients were analyzed according to the randomized treatment.|
59671691|NCT03982368|75790537|FG000|PP Population|Overall Study||72|The PP set consisted of all patients in the FAS who fulfilled the study protocol requirements in terms of IMP intake and collection of primary efficacy data and had no major deviations that may have affected study results. This analysis set was used for supportive efficacy analysis.|
59671692|NCT03982368|75790538|FG001|PP Population|Overall Study||71|The PP set consisted of all patients in the FAS who fulfilled the study protocol requirements in terms of IMP intake and collection of primary efficacy data and had no major deviations that may have affected study results. This analysis set was used for supportive efficacy analysis.|
59671693|NCT03982368|75790539|FG002|PP Population|Overall Study||80|The PP set consisted of all patients in the FAS who fulfilled the study protocol requirements in terms of IMP intake and collection of primary efficacy data and had no major deviations that may have affected study results. This analysis set was used for supportive efficacy analysis.|
59671694|NCT03982368|75790537|FG000|COMPLETED|Overall Study||74||
59671695|NCT03982368|75790538|FG001|COMPLETED|Overall Study||79||
59671696|NCT03982368|75790539|FG002|COMPLETED|Overall Study||83||
59671697|NCT03982368|75790537|FG000|NOT COMPLETED|Overall Study||13||
59671698|NCT03982368|75790538|FG001|NOT COMPLETED|Overall Study||7||
59671699|NCT03982368|75790539|FG002|NOT COMPLETED|Overall Study||5||
59671700|NCT03934684|75790552|FG000|STARTED|Overall Study||49||
59671701|NCT03934684|75790553|FG001|STARTED|Overall Study||52||
59671702|NCT03934684|75790552|FG000|COMPLETED|Overall Study||7||
59671703|NCT03934684|75790553|FG001|COMPLETED|Overall Study||3||
59671704|NCT03934684|75790552|FG000|NOT COMPLETED|Overall Study||42||
59671705|NCT03934684|75790553|FG001|NOT COMPLETED|Overall Study||49||
59671706|NCT03899467|75790561|FG000|STARTED|Overall Study||31||
59671707|NCT03899467|75790562|FG001|STARTED|Overall Study||30||
59671708|NCT03899467|75790561|FG000|COMPLETED|Overall Study||19||
59671709|NCT03899467|75790562|FG001|COMPLETED|Overall Study||22||
59671710|NCT03899467|75790561|FG000|NOT COMPLETED|Overall Study||12||
59671711|NCT03899467|75790562|FG001|NOT COMPLETED|Overall Study||8||
59671712|NCT03880019|75790570|FG000|STARTED|Overall Study||23||
59671713|NCT03880019|75790570|FG000|COMPLETED|Overall Study||22||
59671714|NCT03880019|75790570|FG000|NOT COMPLETED|Overall Study||1||
59671715|NCT03818035|75790574|FG000|STARTED|Part 1 (Up to 28 Weeks)||880||
59671716|NCT03818035|75790575|FG001|STARTED|Part 1 (Up to 28 Weeks)||0||
59671717|NCT03818035|75790576|FG002|STARTED|Part 1 (Up to 28 Weeks)||0||
59671718|NCT03818035|75790577|FG003|STARTED|Part 1 (Up to 28 Weeks)||0||
59671719|NCT03818035|75790574|FG000|COMPLETED|Part 1 (Up to 28 Weeks)||823||
59671720|NCT03818035|75790575|FG001|COMPLETED|Part 1 (Up to 28 Weeks)||0||
59671721|NCT03818035|75790576|FG002|COMPLETED|Part 1 (Up to 28 Weeks)||0||
59671722|NCT03818035|75790577|FG003|COMPLETED|Part 1 (Up to 28 Weeks)||0||
59671723|NCT03818035|75790574|FG000|NOT COMPLETED|Part 1 (Up to 28 Weeks)||57||
59671724|NCT03818035|75790575|FG001|NOT COMPLETED|Part 1 (Up to 28 Weeks)||0||
59671725|NCT03818035|75790576|FG002|NOT COMPLETED|Part 1 (Up to 28 Weeks)||0||
59671726|NCT03818035|75790577|FG003|NOT COMPLETED|Part 1 (Up to 28 Weeks)||0||
59671727|NCT03818035|75790574|FG000|STARTED|Part 2 (Week 28 to Week 68)||0||
59671728|NCT03818035|75790575|FG001|STARTED|Part 2 (Week 28 to Week 68)|Only eligible participants from Part 1, were randomized into Part 2.|148||
59671729|NCT03818035|75790576|FG002|STARTED|Part 2 (Week 28 to Week 68)|Only eligible participants from Part 1, were randomized into Part 2.|150||
59671730|NCT03818035|75790577|FG003|STARTED|Part 2 (Week 28 to Week 68)|Only eligible participants from Part 1, entered into Part 2.|525||
59671731|NCT03818035|75790574|FG000|Treated|Part 2 (Week 28 to Week 68)||0||
59671732|NCT03818035|75790575|FG001|Treated|Part 2 (Week 28 to Week 68)||148||
59671733|NCT03818035|75790576|FG002|Treated|Part 2 (Week 28 to Week 68)||149||
59671734|NCT03818035|75790577|FG003|Treated|Part 2 (Week 28 to Week 68)||525||
59671735|NCT03818035|75790574|FG000|COMPLETED|Part 2 (Week 28 to Week 68)||0||
59671736|NCT03818035|75790575|FG001|COMPLETED|Part 2 (Week 28 to Week 68)||137||
59671737|NCT03818035|75790576|FG002|COMPLETED|Part 2 (Week 28 to Week 68)||142||
59671738|NCT03818035|75790577|FG003|COMPLETED|Part 2 (Week 28 to Week 68)||496||
59671739|NCT03818035|75790574|FG000|NOT COMPLETED|Part 2 (Week 28 to Week 68)||0||
59671740|NCT03818035|75790575|FG001|NOT COMPLETED|Part 2 (Week 28 to Week 68)||11||
59671741|NCT03818035|75790576|FG002|NOT COMPLETED|Part 2 (Week 28 to Week 68)||8||
59671742|NCT03818035|75790577|FG003|NOT COMPLETED|Part 2 (Week 28 to Week 68)||29||
59671743|NCT03748641|75790591|FG000|STARTED|Overall Study||212||
59671744|NCT03748641|75790592|FG001|STARTED|Overall Study||211||
59671745|NCT03748641|75790593|FG002|STARTED|Overall Study||123||
59671746|NCT03748641|75790594|FG003|STARTED|Overall Study||124||
59671747|NCT03748641|75790595|FG004|STARTED|Overall Study||95||
59671748|NCT03748641|75790591|FG000|COMPLETED|Overall Study||0||
59671749|NCT03748641|75790592|FG001|COMPLETED|Overall Study||0||
59671750|NCT03748641|75790593|FG002|COMPLETED|Overall Study||0||
59671751|NCT03748641|75790594|FG003|COMPLETED|Overall Study||0||
59671752|NCT03748641|75790595|FG004|COMPLETED|Overall Study||0||
59671753|NCT03748641|75790591|FG000|NOT COMPLETED|Overall Study||212||
59671754|NCT03748641|75790592|FG001|NOT COMPLETED|Overall Study||211||
59671755|NCT03748641|75790593|FG002|NOT COMPLETED|Overall Study||123||
59671756|NCT03748641|75790594|FG003|NOT COMPLETED|Overall Study||124||
59671757|NCT03748641|75790595|FG004|NOT COMPLETED|Overall Study||95||
59671758|NCT03737994|75790609|FG000|STARTED|Overall Study||3||
59671759|NCT03737994|75790610|FG001|STARTED|Overall Study||1||
59671760|NCT03737994|75790611|FG002|STARTED|Overall Study||0||
59671761|NCT03737994|75790612|FG003|STARTED|Overall Study||2||
59671762|NCT03737994|75790613|FG004|STARTED|Overall Study||3||
59671763|NCT03737994|75790614|FG005|STARTED|Overall Study||0||
59671764|NCT03737994|75790615|FG006|STARTED|Overall Study||1||
59671765|NCT03737994|75790609|FG000|Disease Assessment Population|Overall Study||3|Eligible participants who started protocol treatment and had post-baseline disease assessment.|
59671766|NCT03737994|75790610|FG001|Disease Assessment Population|Overall Study||1|Eligible participants who started protocol treatment and had post-baseline disease assessment.|
59671767|NCT03737994|75790611|FG002|Disease Assessment Population|Overall Study||0|Eligible participants who started protocol treatment and had post-baseline disease assessment.|
59671768|NCT03737994|75790612|FG003|Disease Assessment Population|Overall Study||2|Eligible participants who started protocol treatment and had post-baseline disease assessment.|
59671769|NCT03737994|75790613|FG004|Disease Assessment Population|Overall Study||2|Eligible participants who started protocol treatment and had post-baseline disease assessment.|
59671770|NCT03737994|75790614|FG005|Disease Assessment Population|Overall Study||0|Eligible participants who started protocol treatment and had post-baseline disease assessment.|
59671771|NCT03737994|75790615|FG006|Disease Assessment Population|Overall Study||0|Eligible participants who started protocol treatment and had post-baseline disease assessment.|
59671772|NCT03737994|75790609|FG000|Survival Population|Overall Study||3|Eligible participants who started protocol treatment and have post-baseline survival status.|
59671773|NCT03737994|75790610|FG001|Survival Population|Overall Study||1|Eligible participants who started protocol treatment and have post-baseline survival status.|
59671774|NCT03737994|75790611|FG002|Survival Population|Overall Study||0|Eligible participants who started protocol treatment and have post-baseline survival status.|
59671775|NCT03737994|75790612|FG003|Survival Population|Overall Study||2|Eligible participants who started protocol treatment and have post-baseline survival status.|
59671776|NCT03737994|75790613|FG004|Survival Population|Overall Study||3|Eligible participants who started protocol treatment and have post-baseline survival status.|
59671777|NCT03737994|75790614|FG005|Survival Population|Overall Study||0|Eligible participants who started protocol treatment and have post-baseline survival status.|
59671778|NCT03737994|75790615|FG006|Survival Population|Overall Study||0|Eligible participants who started protocol treatment and have post-baseline survival status.|
59671779|NCT03737994|75790609|FG000|Adverse Event Population|Overall Study||3|Eligible participants who started protocol treatment and have adverse event data.|
59671780|NCT03737994|75790610|FG001|Adverse Event Population|Overall Study||1|Eligible participants who started protocol treatment and have adverse event data.|
59671781|NCT03737994|75790611|FG002|Adverse Event Population|Overall Study||0|Eligible participants who started protocol treatment and have adverse event data.|
59671782|NCT03737994|75790612|FG003|Adverse Event Population|Overall Study||2|Eligible participants who started protocol treatment and have adverse event data.|
59671783|NCT03737994|75790613|FG004|Adverse Event Population|Overall Study||3|Eligible participants who started protocol treatment and have adverse event data.|
59671784|NCT03737994|75790614|FG005|Adverse Event Population|Overall Study||0|Eligible participants who started protocol treatment and have adverse event data.|
59671785|NCT03737994|75790615|FG006|Adverse Event Population|Overall Study||0|Eligible participants who started protocol treatment and have adverse event data.|
59671786|NCT03737994|75790609|FG000|COMPLETED|Overall Study||3|Participants contributing data to any results are considered to have completed the study.|
59671787|NCT03737994|75790610|FG001|COMPLETED|Overall Study||1|Participants contributing data to any results are considered to have completed the study.|
59671788|NCT03737994|75790611|FG002|COMPLETED|Overall Study||0|Participants contributing data to any results are considered to have completed the study.|
59671789|NCT03737994|75790612|FG003|COMPLETED|Overall Study||2|Participants contributing data to any results are considered to have completed the study.|
59709762|NCT01072149|75828528|FG008|NOT COMPLETED|Treatment Period 1 (28 Days)||0||
59545980|NCT02443740|75644621|FG009|STARTED|Intervention Period 3 (3 Days)||0||
59545981|NCT02443740|75644622|FG010|STARTED|Intervention Period 3 (3 Days)||0||
59545982|NCT02443740|75644612|FG000|COMPLETED|Intervention Period 3 (3 Days)||1||
59545983|NCT02443740|75644613|FG001|COMPLETED|Intervention Period 3 (3 Days)||2||
59545984|NCT02443740|75644614|FG002|COMPLETED|Intervention Period 3 (3 Days)||2||
59545985|NCT02443740|75644615|FG003|COMPLETED|Intervention Period 3 (3 Days)||3||
59545986|NCT02443740|75644616|FG004|COMPLETED|Intervention Period 3 (3 Days)||2||
59545987|NCT02443740|75644617|FG005|COMPLETED|Intervention Period 3 (3 Days)||2||
59545988|NCT02443740|75644618|FG006|COMPLETED|Intervention Period 3 (3 Days)||2||
59545989|NCT02443740|75644619|FG007|COMPLETED|Intervention Period 3 (3 Days)||2||
59545990|NCT02443740|75644620|FG008|COMPLETED|Intervention Period 3 (3 Days)||0||
59545991|NCT02443740|75644621|FG009|COMPLETED|Intervention Period 3 (3 Days)||0||
59671790|NCT03737994|75790613|FG004|COMPLETED|Overall Study||3|Participants contributing data to any results are considered to have completed the study.|
59671791|NCT03737994|75790614|FG005|COMPLETED|Overall Study||0|Participants contributing data to any results are considered to have completed the study.|
59671792|NCT03737994|75790615|FG006|COMPLETED|Overall Study||0|Participants contributing data to any results are considered to have completed the study.|
59671793|NCT03737994|75790609|FG000|NOT COMPLETED|Overall Study||0||
59671794|NCT03737994|75790610|FG001|NOT COMPLETED|Overall Study||0||
59671795|NCT03737994|75790611|FG002|NOT COMPLETED|Overall Study||0||
59671796|NCT03737994|75790612|FG003|NOT COMPLETED|Overall Study||0||
59671797|NCT03737994|75790613|FG004|NOT COMPLETED|Overall Study||0||
59671798|NCT03737994|75790614|FG005|NOT COMPLETED|Overall Study||0||
59671799|NCT03737994|75790615|FG006|NOT COMPLETED|Overall Study||1||
59671800|NCT03698019|75790637|FG000|STARTED|Step 1: Registration||159||
59671801|NCT03698019|75790638|FG001|STARTED|Step 1: Registration||154||
59671802|NCT03698019|75790637|FG000|COMPLETED|Step 1: Registration||151||
59671803|NCT03698019|75790638|FG001|COMPLETED|Step 1: Registration||127||
59671804|NCT03698019|75790637|FG000|NOT COMPLETED|Step 1: Registration||8||
59671805|NCT03698019|75790638|FG001|NOT COMPLETED|Step 1: Registration||27||
59671806|NCT03698019|75790637|FG000|STARTED|Step 2: Surgery||151||
59671807|NCT03698019|75790638|FG001|STARTED|Step 2: Surgery||127||
59671808|NCT03698019|75790637|FG000|COMPLETED|Step 2: Surgery||130||
59671809|NCT03698019|75790638|FG001|COMPLETED|Step 2: Surgery||109||
59671810|NCT03698019|75790637|FG000|NOT COMPLETED|Step 2: Surgery||21||
59671811|NCT03698019|75790638|FG001|NOT COMPLETED|Step 2: Surgery||18||
59671812|NCT03698019|75790637|FG000|STARTED|Step 3: Adjuvant Pembrolizumab||130||
59671813|NCT03698019|75790638|FG001|STARTED|Step 3: Adjuvant Pembrolizumab||109||
59671814|NCT03698019|75790637|FG000|COMPLETED|Step 3: Adjuvant Pembrolizumab||38||
59671815|NCT03698019|75790638|FG001|COMPLETED|Step 3: Adjuvant Pembrolizumab||50||
59671816|NCT03698019|75790637|FG000|NOT COMPLETED|Step 3: Adjuvant Pembrolizumab||92||
59671817|NCT03698019|75790638|FG001|NOT COMPLETED|Step 3: Adjuvant Pembrolizumab||59||
59671818|NCT03674112|75790648|FG000|STARTED|Treatment Cross-Over (Cycles 1 to 6)||80||
59671819|NCT03674112|75790649|FG001|STARTED|Treatment Cross-Over (Cycles 1 to 6)||80||
59671820|NCT03674112|75790648|FG000|Completed Cross-Over Treatment|Treatment Cross-Over (Cycles 1 to 6)||80|Received all 6 cycles of cross-over treatment|
59671821|NCT03674112|75790649|FG001|Completed Cross-Over Treatment|Treatment Cross-Over (Cycles 1 to 6)||80|Received all 6 cycles of cross-over treatment|
59671822|NCT03674112|75790648|FG000|COMPLETED|Treatment Cross-Over (Cycles 1 to 6)|One participant discontinued the cross-over period after completing cross-over treatment (after receiving Cycle 6) and did not start treatment continuation. They entered directly into the follow-up period.|79|Completed the Treatment Cross-Over Period|
59671823|NCT03674112|75790649|FG001|COMPLETED|Treatment Cross-Over (Cycles 1 to 6)||80|Completed the Treatment Cross-Over Period|
59671824|NCT03674112|75790648|FG000|NOT COMPLETED|Treatment Cross-Over (Cycles 1 to 6)||1||
59671825|NCT03674112|75790649|FG001|NOT COMPLETED|Treatment Cross-Over (Cycles 1 to 6)||0||
59671826|NCT03674112|75790648|FG000|STARTED|Treatment Continuation (Cycles 7 to ≤18)||79||
59671827|NCT03674112|75790649|FG001|STARTED|Treatment Continuation (Cycles 7 to ≤18)||80||
59671828|NCT03674112|75790648|FG000|Received PH FDC SC for Treatment Continuation|Treatment Continuation (Cycles 7 to ≤18)||70||
59671829|NCT03674112|75790649|FG001|Received PH FDC SC for Treatment Continuation|Treatment Continuation (Cycles 7 to ≤18)||68||
59671830|NCT03674112|75790648|FG000|Received P+H IV for Treatment Continuation|Treatment Continuation (Cycles 7 to ≤18)||9||
59671831|NCT03674112|75790649|FG001|Received P+H IV for Treatment Continuation|Treatment Continuation (Cycles 7 to ≤18)||12||
59671832|NCT03674112|75790648|FG000|Completed Continuation Treatment|Treatment Continuation (Cycles 7 to ≤18)||78|Received all cycles of continuation treatment (from Cycle 7 up to 18 total cycles of neo/adjuvant treatment)|
59671833|NCT03674112|75790649|FG001|Completed Continuation Treatment|Treatment Continuation (Cycles 7 to ≤18)|One participant withdrew from the study during the continuation period (withdrawal by subject) and did not enter follow-up.|77|Received all cycles of continuation treatment (from Cycle 7 up to 18 total cycles of neo/adjuvant treatment)|
59671834|NCT03674112|75790648|FG000|COMPLETED|Treatment Continuation (Cycles 7 to ≤18)||78|Completed the Treatment Continuation Period|
59671835|NCT03674112|75790649|FG001|COMPLETED|Treatment Continuation (Cycles 7 to ≤18)||77|Completed the Treatment Continuation Period|
59671836|NCT03674112|75790648|FG000|NOT COMPLETED|Treatment Continuation (Cycles 7 to ≤18)||1||
59671837|NCT03674112|75790649|FG001|NOT COMPLETED|Treatment Continuation (Cycles 7 to ≤18)||3||
59671838|NCT03674112|75790648|FG000|STARTED|Follow-Up Period (≥3 Years)||80|Participants who discontinued previous treatment periods but remained in the study continued into the follow-up period.|
59671839|NCT03674112|75790649|FG001|STARTED|Follow-Up Period (≥3 Years)||79|Participants who discontinued previous treatment periods but remained in the study continued into the follow-up period.|
59671840|NCT03674112|75790648|FG000|COMPLETED|Follow-Up Period (≥3 Years)||73||
59671841|NCT03674112|75790649|FG001|COMPLETED|Follow-Up Period (≥3 Years)||75||
59671842|NCT03674112|75790648|FG000|NOT COMPLETED|Follow-Up Period (≥3 Years)||7||
59671843|NCT03674112|75790649|FG001|NOT COMPLETED|Follow-Up Period (≥3 Years)||4||
59671844|NCT03673501|75790681|FG000|STARTED|Overall Study||226||
59671845|NCT03673501|75790682|FG001|STARTED|Overall Study||227||
59671846|NCT03673501|75790681|FG000|COMPLETED|Overall Study||190|Completed patients are defined as patients that are followed until death or until the sponsor terminates the study.|
59671847|NCT03673501|75790682|FG001|COMPLETED|Overall Study||203|Completed patients are defined as patients that are followed until death or until the sponsor terminates the study.|
59671848|NCT03673501|75790681|FG000|NOT COMPLETED|Overall Study||36||
59671849|NCT03673501|75790682|FG001|NOT COMPLETED|Overall Study||24||
59671850|NCT03661840|75790690|FG000|STARTED|Overall Study||28||
59671851|NCT03661840|75790691|FG001|STARTED|Overall Study||22||
59671852|NCT03661840|75790690|FG000|COMPLETED|Overall Study||28||
59671853|NCT03661840|75790691|FG001|COMPLETED|Overall Study||22||
59671854|NCT03661840|75790690|FG000|NOT COMPLETED|Overall Study||0||
59671855|NCT03661840|75790691|FG001|NOT COMPLETED|Overall Study||0||
59671856|NCT03517722|75790699|FG000|STARTED|Double Blind Period: Week 0-52||208||
59671857|NCT03517722|75790700|FG001|STARTED|Double Blind Period: Week 0-52||308||
59671858|NCT03517722|75790699|FG000|Treated|Double Blind Period: Week 0-52||208||
59671859|NCT03517722|75790700|FG001|Treated|Double Blind Period: Week 0-52||307||
59671860|NCT03517722|75790699|FG000|COMPLETED|Double Blind Period: Week 0-52||105||
59671861|NCT03517722|75790700|FG001|COMPLETED|Double Blind Period: Week 0-52||153||
59671862|NCT03517722|75790699|FG000|NOT COMPLETED|Double Blind Period: Week 0-52||103||
59671863|NCT03517722|75790700|FG001|NOT COMPLETED|Double Blind Period: Week 0-52||155||
59671864|NCT03517722|75790699|FG000|STARTED|Open-label Extension Period: Week 52-113||88||
59671865|NCT03517722|75790700|FG001|STARTED|Open-label Extension Period: Week 52-113||137||
59671866|NCT03517722|75790699|FG000|COMPLETED|Open-label Extension Period: Week 52-113||0||
59671867|NCT03517722|75790700|FG001|COMPLETED|Open-label Extension Period: Week 52-113||0||
59671868|NCT03517722|75790699|FG000|NOT COMPLETED|Open-label Extension Period: Week 52-113||88||
59671869|NCT03517722|75790700|FG001|NOT COMPLETED|Open-label Extension Period: Week 52-113||137||
59671870|NCT03439462|75790710|FG000|STARTED|Overall Study||6||
59671871|NCT03439462|75790711|FG001|STARTED|Overall Study||10||
59671872|NCT03439462|75790712|FG002|STARTED|Overall Study||44||
59671873|NCT03439462|75790710|FG000|COMPLETED|Overall Study||6||
59671874|NCT03439462|75790711|FG001|COMPLETED|Overall Study||10||
59671875|NCT03439462|75790712|FG002|COMPLETED|Overall Study||44||
59671876|NCT03439462|75790710|FG000|NOT COMPLETED|Overall Study||0||
59671877|NCT03439462|75790711|FG001|NOT COMPLETED|Overall Study||0||
59671878|NCT03439462|75790712|FG002|NOT COMPLETED|Overall Study||0||
59671879|NCT03374982|75790730|FG000|STARTED|Overall Study||12||
59671880|NCT03374982|75790731|FG001|STARTED|Overall Study||11||
59671881|NCT03374982|75790730|FG000|COMPLETED|Overall Study||12||
59671882|NCT03374982|75790731|FG001|COMPLETED|Overall Study||11||
59671883|NCT03374982|75790730|FG000|NOT COMPLETED|Overall Study||0||
59671884|NCT03374982|75790731|FG001|NOT COMPLETED|Overall Study||0||
59671885|NCT03258593|75790739|FG000|STARTED|Run-In Induction Phase||12||
59671886|NCT03258593|75790740|FG001|STARTED|Run-In Induction Phase||0||
59671887|NCT03258593|75790741|FG002|STARTED|Run-In Induction Phase||0||
59671888|NCT03258593|75790742|FG003|STARTED|Run-In Induction Phase||0||
59671889|NCT03258593|75790739|FG000|COMPLETED|Run-In Induction Phase||12||
59671890|NCT03258593|75790740|FG001|COMPLETED|Run-In Induction Phase||0||
59671891|NCT03258593|75790741|FG002|COMPLETED|Run-In Induction Phase||0||
59671892|NCT03258593|75790742|FG003|COMPLETED|Run-In Induction Phase||0||
59671893|NCT03258593|75790739|FG000|NOT COMPLETED|Run-In Induction Phase||0||
59671894|NCT03258593|75790740|FG001|NOT COMPLETED|Run-In Induction Phase||0||
59671895|NCT03258593|75790741|FG002|NOT COMPLETED|Run-In Induction Phase||0||
59671896|NCT03258593|75790742|FG003|NOT COMPLETED|Run-In Induction Phase||0||
59671897|NCT03258593|75790739|FG000|STARTED|Run-In Maintenance Phase||12||
59671898|NCT03258593|75790740|FG001|STARTED|Run-In Maintenance Phase||0||
59671899|NCT03258593|75790741|FG002|STARTED|Run-In Maintenance Phase||0||
59671900|NCT03258593|75790742|FG003|STARTED|Run-In Maintenance Phase||0||
59671901|NCT03258593|75790739|FG000|COMPLETED|Run-In Maintenance Phase||5||
59671902|NCT03258593|75790740|FG001|COMPLETED|Run-In Maintenance Phase||0||
59671903|NCT03258593|75790741|FG002|COMPLETED|Run-In Maintenance Phase||0||
59671904|NCT03258593|75790742|FG003|COMPLETED|Run-In Maintenance Phase||0||
59671905|NCT03258593|75790739|FG000|NOT COMPLETED|Run-In Maintenance Phase||7||
59671906|NCT03258593|75790740|FG001|NOT COMPLETED|Run-In Maintenance Phase||0||
59671907|NCT03258593|75790741|FG002|NOT COMPLETED|Run-In Maintenance Phase||0||
59671908|NCT03258593|75790742|FG003|NOT COMPLETED|Run-In Maintenance Phase||0||
59671909|NCT03258593|75790739|FG000|STARTED|Expansion Induction Phase||0||
59671910|NCT03258593|75790740|FG001|STARTED|Expansion Induction Phase||3||
59671911|NCT03258593|75790741|FG002|STARTED|Expansion Induction Phase||0||
59671912|NCT03258593|75790742|FG003|STARTED|Expansion Induction Phase||0||
59671913|NCT03258593|75790739|FG000|COMPLETED|Expansion Induction Phase||0||
59671914|NCT03258593|75790740|FG001|COMPLETED|Expansion Induction Phase||3||
59671915|NCT03258593|75790741|FG002|COMPLETED|Expansion Induction Phase||0||
59671916|NCT03258593|75790742|FG003|COMPLETED|Expansion Induction Phase||0||
59671917|NCT03258593|75790739|FG000|NOT COMPLETED|Expansion Induction Phase||0||
59671918|NCT03258593|75790740|FG001|NOT COMPLETED|Expansion Induction Phase||0||
59671919|NCT03258593|75790741|FG002|NOT COMPLETED|Expansion Induction Phase||0||
59671920|NCT03258593|75790742|FG003|NOT COMPLETED|Expansion Induction Phase||0||
59671921|NCT03258593|75790739|FG000|STARTED|Expansion Maintenance Phase||0||
59671922|NCT03258593|75790740|FG001|STARTED|Expansion Maintenance Phase||3||
59671923|NCT03258593|75790741|FG002|STARTED|Expansion Maintenance Phase||0||
59671924|NCT03258593|75790742|FG003|STARTED|Expansion Maintenance Phase||0||
59671925|NCT03258593|75790739|FG000|COMPLETED|Expansion Maintenance Phase||0||
59671926|NCT03258593|75790740|FG001|COMPLETED|Expansion Maintenance Phase||1||
59545992|NCT02443740|75644622|FG010|COMPLETED|Intervention Period 3 (3 Days)||0||
59545993|NCT02443740|75644612|FG000|NOT COMPLETED|Intervention Period 3 (3 Days)||0||
59545994|NCT02443740|75644613|FG001|NOT COMPLETED|Intervention Period 3 (3 Days)||0||
59671927|NCT03258593|75790741|FG002|COMPLETED|Expansion Maintenance Phase||0||
59671928|NCT03258593|75790742|FG003|COMPLETED|Expansion Maintenance Phase||0||
59671929|NCT03258593|75790739|FG000|NOT COMPLETED|Expansion Maintenance Phase||0||
59671930|NCT03258593|75790740|FG001|NOT COMPLETED|Expansion Maintenance Phase||2||
59671931|NCT03258593|75790741|FG002|NOT COMPLETED|Expansion Maintenance Phase||0||
59671932|NCT03258593|75790742|FG003|NOT COMPLETED|Expansion Maintenance Phase||0||
59671933|NCT03201458|75790755|FG000|STARTED|Overall Study||43||
59671934|NCT03201458|75790756|FG001|STARTED|Overall Study||43||
59671935|NCT03201458|75790755|FG000|COMPLETED|Overall Study||39||
59671936|NCT03201458|75790756|FG001|COMPLETED|Overall Study||38||
59671937|NCT03201458|75790755|FG000|NOT COMPLETED|Overall Study||4||
59671938|NCT03201458|75790756|FG001|NOT COMPLETED|Overall Study||5||
59671939|NCT03011567|75790766|FG000|STARTED|Overall Study||70||
59671940|NCT03011567|75790767|FG001|STARTED|Overall Study||31||
59671941|NCT03011567|75790768|FG002|STARTED|Overall Study||70||
59671942|NCT03011567|75790769|FG003|STARTED|Overall Study||31||
59671943|NCT03011567|75790766|FG000|Randomized|Overall Study||70||
59671944|NCT03011567|75790767|FG001|Randomized|Overall Study||31||
59671945|NCT03011567|75790768|FG002|Randomized|Overall Study||70||
59671946|NCT03011567|75790769|FG003|Randomized|Overall Study||31||
59671947|NCT03011567|75790766|FG000|COMPLETED|Overall Study||70||
59671948|NCT03011567|75790767|FG001|COMPLETED|Overall Study||31||
59671949|NCT03011567|75790768|FG002|COMPLETED|Overall Study||70||
59671950|NCT03011567|75790769|FG003|COMPLETED|Overall Study||30||
59671951|NCT03011567|75790766|FG000|NOT COMPLETED|Overall Study||0||
59671952|NCT03011567|75790767|FG001|NOT COMPLETED|Overall Study||0||
59671953|NCT03011567|75790768|FG002|NOT COMPLETED|Overall Study||0||
59671954|NCT03011567|75790769|FG003|NOT COMPLETED|Overall Study||1||
59671955|NCT02924129|75790789|FG000|STARTED|Overall Study||67||
59671956|NCT02924129|75790790|FG001|STARTED|Overall Study||67||
59671957|NCT02924129|75790789|FG000|COMPLETED|Overall Study||62||
59671958|NCT02924129|75790790|FG001|COMPLETED|Overall Study||63||
59671959|NCT02924129|75790789|FG000|NOT COMPLETED|Overall Study||5||
59671960|NCT02924129|75790790|FG001|NOT COMPLETED|Overall Study||4||
59671961|NCT02824263|75790798|FG000|STARTED|First Intervention (1 Night)||61||
59671962|NCT02824263|75790799|FG001|STARTED|First Intervention (1 Night)||68||
59671963|NCT02824263|75790798|FG000|COMPLETED|First Intervention (1 Night)||61||
59671964|NCT02824263|75790799|FG001|COMPLETED|First Intervention (1 Night)||68||
59671965|NCT02824263|75790798|FG000|NOT COMPLETED|First Intervention (1 Night)||0||
59671966|NCT02824263|75790799|FG001|NOT COMPLETED|First Intervention (1 Night)||0||
59671967|NCT02824263|75790798|FG000|STARTED|Washout (1 to 4 Weeks)||61||
59671968|NCT02824263|75790799|FG001|STARTED|Washout (1 to 4 Weeks)||68||
59671969|NCT02824263|75790798|FG000|COMPLETED|Washout (1 to 4 Weeks)||59||
59671970|NCT02824263|75790799|FG001|COMPLETED|Washout (1 to 4 Weeks)||62||
59671971|NCT02824263|75790798|FG000|NOT COMPLETED|Washout (1 to 4 Weeks)||2||
59671972|NCT02824263|75790799|FG001|NOT COMPLETED|Washout (1 to 4 Weeks)||6||
59545995|NCT02443740|75644614|FG002|NOT COMPLETED|Intervention Period 3 (3 Days)||0||
59545996|NCT02443740|75644615|FG003|NOT COMPLETED|Intervention Period 3 (3 Days)||0||
59545997|NCT02443740|75644616|FG004|NOT COMPLETED|Intervention Period 3 (3 Days)||0||
59545998|NCT02443740|75644617|FG005|NOT COMPLETED|Intervention Period 3 (3 Days)||0||
59545999|NCT02443740|75644618|FG006|NOT COMPLETED|Intervention Period 3 (3 Days)||0||
59546000|NCT02443740|75644619|FG007|NOT COMPLETED|Intervention Period 3 (3 Days)||0||
59671973|NCT02824263|75790798|FG000|STARTED|Second Intervention (1 Night)||59||
59671974|NCT02824263|75790799|FG001|STARTED|Second Intervention (1 Night)||62||
59671975|NCT02824263|75790798|FG000|COMPLETED|Second Intervention (1 Night)||55||
59671976|NCT02824263|75790799|FG001|COMPLETED|Second Intervention (1 Night)||59||
59671977|NCT02824263|75790798|FG000|NOT COMPLETED|Second Intervention (1 Night)||4||
59671978|NCT02824263|75790799|FG001|NOT COMPLETED|Second Intervention (1 Night)||3||
59671979|NCT02814838|75790807|FG000|STARTED|Overall Study||50||
59671980|NCT02814838|75790808|FG001|STARTED|Overall Study||26||
59671981|NCT02814838|75790807|FG000|COMPLETED|Overall Study||48||
59671982|NCT02814838|75790808|FG001|COMPLETED|Overall Study||25||
59546001|NCT02443740|75644620|FG008|NOT COMPLETED|Intervention Period 3 (3 Days)||0||
59546002|NCT02443740|75644621|FG009|NOT COMPLETED|Intervention Period 3 (3 Days)||0||
59546003|NCT02443740|75644622|FG010|NOT COMPLETED|Intervention Period 3 (3 Days)||0||
59546004|NCT02443740|75644612|FG000|STARTED|Washout Period 3 (7 Days)||1||
59546005|NCT02443740|75644613|FG001|STARTED|Washout Period 3 (7 Days)||2||
59546006|NCT02443740|75644614|FG002|STARTED|Washout Period 3 (7 Days)||2||
59546007|NCT02443740|75644615|FG003|STARTED|Washout Period 3 (7 Days)||3||
59671983|NCT02814838|75790807|FG000|NOT COMPLETED|Overall Study||2||
59671984|NCT02814838|75790808|FG001|NOT COMPLETED|Overall Study||1||
59671985|NCT02724878|75790814|FG000|STARTED|Overall Study||65||
59671986|NCT02724878|75790814|FG000|Treated|Overall Study||60||
59671987|NCT02724878|75790814|FG000|Responders|Overall Study||20||
59671988|NCT02724878|75790814|FG000|COMPLETED|Overall Study||0||
59671989|NCT02724878|75790814|FG000|NOT COMPLETED|Overall Study||65||
59989326|NCT02348008|76104594|FG000|STARTED|Overall Study||3||
59989327|NCT02348008|76104595|FG001|STARTED|Overall Study||10||
59989328|NCT02348008|76104596|FG002|STARTED|Overall Study||48||
59989329|NCT02348008|76104594|FG000|COMPLETED|Overall Study||0||
59989330|NCT02348008|76104595|FG001|COMPLETED|Overall Study||0||
59989331|NCT02348008|76104596|FG002|COMPLETED|Overall Study||29||
60077856|NCT02086708|76192793|FG000|NOT COMPLETED|Overall Study||0||
60077857|NCT01507545|76192807|FG000|STARTED|Overall Study||84||
60077858|NCT01507545|76192808|FG001|STARTED|Overall Study||42||
60077859|NCT01507545|76192807|FG000|Treated/Safety Set|Overall Study||82||
60077860|NCT01507545|76192808|FG001|Treated/Safety Set|Overall Study||40||
60077861|NCT01507545|76192807|FG000|COMPLETED|Overall Study||0||
60077862|NCT01507545|76192808|FG001|COMPLETED|Overall Study||0||
60077863|NCT01507545|76192807|FG000|NOT COMPLETED|Overall Study||84||
60077864|NCT01507545|76192808|FG001|NOT COMPLETED|Overall Study||42||
60077865|NCT01482819|76192814|FG000|STARTED|Overall Study||21||
60077866|NCT01482819|76192814|FG000|COMPLETED|Overall Study||19||
60077867|NCT01482819|76192814|FG000|NOT COMPLETED|Overall Study||2||
60077868|NCT01534533|76192826|FG000|STARTED|Overall Study||48||
60077869|NCT01534533|76192827|FG001|STARTED|Overall Study||48||
60077870|NCT01534533|76192828|FG002|STARTED|Overall Study||48||
60077871|NCT01534533|76192829|FG003|STARTED|Overall Study||48||
59989332|NCT02348008|76104594|FG000|NOT COMPLETED|Overall Study||3||
59989333|NCT02348008|76104595|FG001|NOT COMPLETED|Overall Study||10||
59989334|NCT02348008|76104596|FG002|NOT COMPLETED|Overall Study||19||
59989335|NCT04962022|76104602|FG000|STARTED|Period 1||12||
59989336|NCT04962022|76104603|FG001|STARTED|Period 1||0||
59989337|NCT04962022|76104602|FG000|COMPLETED|Period 1||11||
59989338|NCT04962022|76104603|FG001|COMPLETED|Period 1||0||
59989339|NCT04962022|76104602|FG000|NOT COMPLETED|Period 1||1||
59989340|NCT04962022|76104603|FG001|NOT COMPLETED|Period 1||0||
59989341|NCT04962022|76104602|FG000|STARTED|Period 2||0||
59989342|NCT04962022|76104603|FG001|STARTED|Period 2||11||
59989343|NCT04962022|76104602|FG000|COMPLETED|Period 2||0||
59989344|NCT04962022|76104603|FG001|COMPLETED|Period 2||11||
59989345|NCT04962022|76104602|FG000|NOT COMPLETED|Period 2||0||
59989346|NCT04962022|76104603|FG001|NOT COMPLETED|Period 2||0||
59989347|NCT04936594|76104612|FG000|STARTED|Overall Study||8||
60077872|NCT01534533|76192826|FG000|COMPLETED|Overall Study||40||
60077873|NCT01534533|76192827|FG001|COMPLETED|Overall Study||45||
60077874|NCT01534533|76192828|FG002|COMPLETED|Overall Study||40||
60077875|NCT01534533|76192829|FG003|COMPLETED|Overall Study||44||
60077876|NCT01534533|76192826|FG000|NOT COMPLETED|Overall Study||8||
60077877|NCT01534533|76192827|FG001|NOT COMPLETED|Overall Study||3||
60077878|NCT01534533|76192828|FG002|NOT COMPLETED|Overall Study||8||
60077879|NCT01534533|76192829|FG003|NOT COMPLETED|Overall Study||4||
60077880|NCT02061358|76192850|FG000|STARTED|Overall Study||6||
60077881|NCT02061358|76192851|FG001|STARTED|Overall Study||6||
60077882|NCT02061358|76192852|FG002|STARTED|Overall Study||6||
60077883|NCT02061358|76192853|FG003|STARTED|Overall Study||6||
60077884|NCT02061358|76192854|FG004|STARTED|Overall Study||6||
60077885|NCT02061358|76192855|FG005|STARTED|Overall Study||6||
60077886|NCT02061358|76192856|FG006|STARTED|Overall Study||6||
60077887|NCT02061358|76192857|FG007|STARTED|Overall Study||6||
60077888|NCT02061358|76192858|FG008|STARTED|Overall Study||16||
60077889|NCT02061358|76192850|FG000|COMPLETED|Overall Study||6||
60077890|NCT02061358|76192851|FG001|COMPLETED|Overall Study||6||
60077891|NCT02061358|76192852|FG002|COMPLETED|Overall Study||6||
60077892|NCT02061358|76192853|FG003|COMPLETED|Overall Study||6||
59546008|NCT02443740|75644616|FG004|STARTED|Washout Period 3 (7 Days)||2||
59546009|NCT02443740|75644617|FG005|STARTED|Washout Period 3 (7 Days)||2||
60077893|NCT02061358|76192854|FG004|COMPLETED|Overall Study||6||
59989348|NCT04936594|76104612|FG000|COMPLETED|Overall Study||8||
60077894|NCT02061358|76192855|FG005|COMPLETED|Overall Study||6||
60077895|NCT02061358|76192856|FG006|COMPLETED|Overall Study||6||
59546010|NCT02443740|75644618|FG006|STARTED|Washout Period 3 (7 Days)||2||
59989349|NCT04936594|76104612|FG000|NOT COMPLETED|Overall Study||0||
59989350|NCT04740905|76104620|FG000|STARTED|Overall Study|All randomized participants|276|Intent-to-Treat (ITT) Population|
59989351|NCT04740905|76104621|FG001|STARTED|Overall Study|All randomized participants|277|Intent-to-Treat (ITT) Population|
60077896|NCT02061358|76192857|FG007|COMPLETED|Overall Study||6||
60077897|NCT02061358|76192858|FG008|COMPLETED|Overall Study||16||
60077898|NCT02061358|76192850|FG000|NOT COMPLETED|Overall Study||0||
60077899|NCT02061358|76192851|FG001|NOT COMPLETED|Overall Study||0||
60077900|NCT02061358|76192852|FG002|NOT COMPLETED|Overall Study||0||
60077901|NCT02061358|76192853|FG003|NOT COMPLETED|Overall Study||0||
60077902|NCT02061358|76192854|FG004|NOT COMPLETED|Overall Study||0||
60077903|NCT02061358|76192855|FG005|NOT COMPLETED|Overall Study||0||
60077904|NCT02061358|76192856|FG006|NOT COMPLETED|Overall Study||0||
60077905|NCT02061358|76192857|FG007|NOT COMPLETED|Overall Study||0||
60077906|NCT02061358|76192858|FG008|NOT COMPLETED|Overall Study||0||
59989352|NCT04740905|76104620|FG000|Received at Least One Dose of Study Drug|Overall Study||276|Safety-Evaluable Population|
59989353|NCT04740905|76104621|FG001|Received at Least One Dose of Study Drug|Overall Study||274|Safety-Evaluable Population|
60077907|NCT01621906|76192880|FG000|STARTED|Overall Study||12||
60077908|NCT01621906|76192881|FG001|STARTED|Overall Study||5||
59671990|NCT02661464|75790822|FG000|STARTED|Overall Study||617||
59671991|NCT02661464|75790823|FG001|STARTED|Overall Study||57||
59671992|NCT02661464|75790824|FG002|STARTED|Overall Study||2||
59671993|NCT02661464|75790825|FG003|STARTED|Overall Study||1||
59671994|NCT02661464|75790822|FG000|Full Analysis Set|Overall Study||614||
59671995|NCT02661464|75790823|FG001|Full Analysis Set|Overall Study||53||
59671996|NCT02661464|75790824|FG002|Full Analysis Set|Overall Study||2||
59671997|NCT02661464|75790825|FG003|Full Analysis Set|Overall Study||1||
59671998|NCT02661464|75790822|FG000|COMPLETED|Overall Study||295||
59671999|NCT02661464|75790823|FG001|COMPLETED|Overall Study||0||
59672000|NCT02661464|75790824|FG002|COMPLETED|Overall Study||1||
59672001|NCT02661464|75790825|FG003|COMPLETED|Overall Study||0||
59672002|NCT02661464|75790822|FG000|NOT COMPLETED|Overall Study||322||
59672003|NCT02661464|75790823|FG001|NOT COMPLETED|Overall Study||57||
59672004|NCT02661464|75790824|FG002|NOT COMPLETED|Overall Study||1||
59672005|NCT02661464|75790825|FG003|NOT COMPLETED|Overall Study||1||
59672006|NCT02647203|75790837|FG000|STARTED|12 Month Follow-up||173||
59672007|NCT02647203|75790838|FG001|STARTED|12 Month Follow-up||172||
59672008|NCT02647203|75790837|FG000|COMPLETED|12 Month Follow-up||148||
59672009|NCT02647203|75790838|FG001|COMPLETED|12 Month Follow-up||149||
59672010|NCT02647203|75790837|FG000|NOT COMPLETED|12 Month Follow-up||25||
59672011|NCT02647203|75790838|FG001|NOT COMPLETED|12 Month Follow-up||23||
59672012|NCT02647203|75790837|FG000|STARTED|24 Month Follow-up||148||
59672013|NCT02647203|75790838|FG001|STARTED|24 Month Follow-up||149||
59672014|NCT02647203|75790837|FG000|COMPLETED|24 Month Follow-up||142||
59672015|NCT02647203|75790838|FG001|COMPLETED|24 Month Follow-up||138||
59672016|NCT02647203|75790837|FG000|NOT COMPLETED|24 Month Follow-up||6||
59672017|NCT02647203|75790838|FG001|NOT COMPLETED|24 Month Follow-up||11||
59672018|NCT02618408|75790847|FG000|STARTED|Overall Study||130|The number of subjects is based on the randomized population that included all those enrolled subjects who complete the Baseline Period, meet the inclusion/exclusion criteria and are randomized.|
59672019|NCT02618408|75790848|FG001|STARTED|Overall Study||65|The number of subjects is based on the randomized population that included all those enrolled subjects who complete the Baseline Period, meet the inclusion/exclusion criteria and are randomized.|
59672020|NCT02618408|75790849|FG002|STARTED|Overall Study||138|The number of subjects is based on the randomized population that included all those enrolled subjects who complete the Baseline Period, meet the inclusion/exclusion criteria and are randomized.|
59672021|NCT02618408|75790847|FG000|Intent-to-Treat|Overall Study||125|The number of subjects is based on the intent-to-treat population (ITT) which include all subjects who received at least 1 dose of study drug and have a baseline and at least 1 valid post-randomization assessment of frequency of IA behaviors based on IA diary entry.|
59672022|NCT02618408|75790848|FG001|Intent-to-Treat|Overall Study||65|The number of subjects is based on the intent-to-treat population (ITT) which include all subjects who received at least 1 dose of study drug and have a baseline and at least 1 valid post-randomization assessment of frequency of IA behaviors based on IA diary entry.|
59672023|NCT02618408|75790849|FG002|Intent-to-Treat|Overall Study||135|The number of subjects is based on the intent-to-treat population (ITT) which include all subjects who received at least 1 dose of study drug and have a baseline and at least 1 valid post-randomization assessment of frequency of IA behaviors based on IA diary entry.|
59672024|NCT02618408|75790847|FG000|Safety|Overall Study||126|The number of subjects is based on the Safety Population which includes all randomized subjects who received at least 1 dose of study drug and have at least one post-randomization safety measurements.|
59672025|NCT02618408|75790848|FG001|Safety|Overall Study||65|The number of subjects is based on the Safety Population which includes all randomized subjects who received at least 1 dose of study drug and have at least one post-randomization safety measurements.|
59672026|NCT02618408|75790849|FG002|Safety|Overall Study||137|The number of subjects is based on the Safety Population which includes all randomized subjects who received at least 1 dose of study drug and have at least one post-randomization safety measurements.|
59672027|NCT02618408|75790847|FG000|COMPLETED|Overall Study||114|Randomized Population only|
59672028|NCT02618408|75790848|FG001|COMPLETED|Overall Study||58|Randomized Population only|
59672029|NCT02618408|75790849|FG002|COMPLETED|Overall Study||101|Randomized Population only|
59672030|NCT02618408|75790847|FG000|NOT COMPLETED|Overall Study||16||
59672031|NCT02618408|75790848|FG001|NOT COMPLETED|Overall Study||7||
59989354|NCT04740905|76104620|FG000|Completed up to Week 24 (Part 1)|Overall Study||272|Clinical Cutoff for Primary Completion Date|
59989355|NCT04740905|76104621|FG001|Completed up to Week 24 (Part 1)|Overall Study||274|Clinical Cutoff for Primary Completion Date|
59989356|NCT04740905|76104620|FG000|COMPLETED|Overall Study||0||
59989357|NCT04740905|76104621|FG001|COMPLETED|Overall Study||0||
59989358|NCT04740905|76104620|FG000|NOT COMPLETED|Overall Study||276||
59989359|NCT04740905|76104621|FG001|NOT COMPLETED|Overall Study||277||
59989360|NCT04639973|76104629|FG000|STARTED|Overall Study||65||
59989361|NCT04639973|76104630|FG001|STARTED|Overall Study||63||
59989362|NCT04639973|76104629|FG000|COMPLETED|Overall Study||62||
59989363|NCT04639973|76104630|FG001|COMPLETED|Overall Study||62||
59989364|NCT04639973|76104629|FG000|NOT COMPLETED|Overall Study||3||
59989365|NCT04639973|76104630|FG001|NOT COMPLETED|Overall Study||1||
59672032|NCT02618408|75790849|FG002|NOT COMPLETED|Overall Study||37||
59672033|NCT02499172|75790864|FG000|STARTED|Overall Study||900||
59672034|NCT02499172|75790865|FG001|STARTED|Overall Study||899||
59672035|NCT02499172|75790866|FG002|STARTED|Overall Study||523||
59672036|NCT02499172|75790867|FG003|STARTED|Overall Study||436||
59672037|NCT02499172|75790864|FG000|COMPLETED|Overall Study||835||
59672038|NCT02499172|75790865|FG001|COMPLETED|Overall Study||835||
59672039|NCT02499172|75790866|FG002|COMPLETED|Overall Study||0||
59672040|NCT02499172|75790867|FG003|COMPLETED|Overall Study||0||
59672041|NCT02499172|75790864|FG000|NOT COMPLETED|Overall Study||65||
59672042|NCT02499172|75790865|FG001|NOT COMPLETED|Overall Study||64||
59672043|NCT02499172|75790866|FG002|NOT COMPLETED|Overall Study||523||
59672044|NCT02499172|75790867|FG003|NOT COMPLETED|Overall Study||436||
59672045|NCT02446600|75790881|FG000|STARTED|Overall Study||187||
59672046|NCT02446600|75790882|FG001|STARTED|Overall Study|Duplicate enrollment patient has been excluded from all analyses.|190||
59672047|NCT02446600|75790883|FG002|STARTED|Overall Study||189||
59672048|NCT02446600|75790884|FG003|STARTED|Overall Study||13||
59672049|NCT02446600|75790881|FG000|COMPLETED|Overall Study|Completed status includes all clinical reasons for suspending treatment, including disease progression, death and adverse events.|147||
59672050|NCT02446600|75790882|FG001|COMPLETED|Overall Study|Completed status includes all clinical reasons for suspending treatment, including disease progression, death and adverse events.|178||
59672051|NCT02446600|75790883|FG002|COMPLETED|Overall Study|Completed status includes all clinical reasons for suspending treatment, including disease progression, death and adverse events.|162||
59672052|NCT02446600|75790884|FG003|COMPLETED|Overall Study|Completed status includes all clinical reasons for suspending treatment, including disease progression, death and adverse events.|12||
59672053|NCT02446600|75790881|FG000|NOT COMPLETED|Overall Study||40||
59672054|NCT02446600|75790882|FG001|NOT COMPLETED|Overall Study||12||
59672055|NCT02446600|75790883|FG002|NOT COMPLETED|Overall Study||27||
59672056|NCT02446600|75790884|FG003|NOT COMPLETED|Overall Study||1||
59672057|NCT02351063|75790894|FG000|STARTED|Overall Study||1||
59672058|NCT02351063|75790894|FG000|COMPLETED|Overall Study|Study terminated. No study data collected.|1||
59672059|NCT02351063|75790894|FG000|NOT COMPLETED|Overall Study||0||
59672060|NCT02323880|75790906|FG000|STARTED|Overall Study||6||
59672061|NCT02323880|75790907|FG001|STARTED|Overall Study||13||
59672062|NCT02323880|75790908|FG002|STARTED|Overall Study||6||
59672063|NCT02323880|75790909|FG003|STARTED|Overall Study||6||
59672064|NCT02323880|75790910|FG004|STARTED|Overall Study||6||
59672065|NCT02323880|75790911|FG005|STARTED|Overall Study||10||
59672066|NCT02323880|75790912|FG006|STARTED|Overall Study||6||
59672067|NCT02323880|75790913|FG007|STARTED|Overall Study||6||
59672068|NCT02323880|75790906|FG000|COMPLETED|Overall Study||0||
59672069|NCT02323880|75790907|FG001|COMPLETED|Overall Study||0||
59672070|NCT02323880|75790908|FG002|COMPLETED|Overall Study||0||
59672071|NCT02323880|75790909|FG003|COMPLETED|Overall Study||0||
59672072|NCT02323880|75790910|FG004|COMPLETED|Overall Study||0||
59672073|NCT02323880|75790911|FG005|COMPLETED|Overall Study||0||
59672074|NCT02323880|75790912|FG006|COMPLETED|Overall Study||0||
59672075|NCT02323880|75790913|FG007|COMPLETED|Overall Study||0||
59672076|NCT02323880|75790906|FG000|NOT COMPLETED|Overall Study||6||
59672077|NCT02323880|75790907|FG001|NOT COMPLETED|Overall Study||13||
59672078|NCT02323880|75790908|FG002|NOT COMPLETED|Overall Study||6||
59672079|NCT02323880|75790909|FG003|NOT COMPLETED|Overall Study||6||
59672080|NCT02323880|75790910|FG004|NOT COMPLETED|Overall Study||6||
59672081|NCT02323880|75790911|FG005|NOT COMPLETED|Overall Study||10||
59672082|NCT02323880|75790912|FG006|NOT COMPLETED|Overall Study||6||
59672083|NCT02323880|75790913|FG007|NOT COMPLETED|Overall Study||6||
59672084|NCT02228681|75790944|FG000|STARTED|Overall Study||37||
59672085|NCT02228681|75790945|FG001|STARTED|Overall Study||37||
59672086|NCT02228681|75790944|FG000|COMPLETED|Overall Study||37||
59672087|NCT02228681|75790945|FG001|COMPLETED|Overall Study||37||
59546011|NCT02443740|75644619|FG007|STARTED|Washout Period 3 (7 Days)||2||
59546012|NCT02443740|75644620|FG008|STARTED|Washout Period 3 (7 Days)||0||
59546013|NCT02443740|75644621|FG009|STARTED|Washout Period 3 (7 Days)||0||
59546014|NCT02443740|75644622|FG010|STARTED|Washout Period 3 (7 Days)||0||
59546015|NCT02443740|75644612|FG000|COMPLETED|Washout Period 3 (7 Days)||1||
59546016|NCT02443740|75644613|FG001|COMPLETED|Washout Period 3 (7 Days)||2||
59546017|NCT02443740|75644614|FG002|COMPLETED|Washout Period 3 (7 Days)||2||
59546018|NCT02443740|75644615|FG003|COMPLETED|Washout Period 3 (7 Days)||3||
59546019|NCT02443740|75644616|FG004|COMPLETED|Washout Period 3 (7 Days)||2||
59546020|NCT02443740|75644617|FG005|COMPLETED|Washout Period 3 (7 Days)||2||
59546021|NCT02443740|75644618|FG006|COMPLETED|Washout Period 3 (7 Days)||2||
59546022|NCT02443740|75644619|FG007|COMPLETED|Washout Period 3 (7 Days)||2||
59546023|NCT02443740|75644620|FG008|COMPLETED|Washout Period 3 (7 Days)||0||
59546024|NCT02443740|75644621|FG009|COMPLETED|Washout Period 3 (7 Days)||0||
59546025|NCT02443740|75644622|FG010|COMPLETED|Washout Period 3 (7 Days)||0||
59546026|NCT02443740|75644612|FG000|NOT COMPLETED|Washout Period 3 (7 Days)||0||
59546027|NCT02443740|75644613|FG001|NOT COMPLETED|Washout Period 3 (7 Days)||0||
59672088|NCT02228681|75790944|FG000|NOT COMPLETED|Overall Study||0||
59672089|NCT02228681|75790945|FG001|NOT COMPLETED|Overall Study||0||
59672090|NCT02143414|75790953|FG000|STARTED|Induction||29||
59672091|NCT02143414|75790954|FG001|STARTED|Induction||24||
60077909|NCT01621906|76192880|FG000|COMPLETED|Overall Study||12||
60077910|NCT01621906|76192881|FG001|COMPLETED|Overall Study||5||
59546028|NCT02443740|75644614|FG002|NOT COMPLETED|Washout Period 3 (7 Days)||0||
59546029|NCT02443740|75644615|FG003|NOT COMPLETED|Washout Period 3 (7 Days)||0||
59546030|NCT02443740|75644616|FG004|NOT COMPLETED|Washout Period 3 (7 Days)||0||
59546031|NCT02443740|75644617|FG005|NOT COMPLETED|Washout Period 3 (7 Days)||0||
59546032|NCT02443740|75644618|FG006|NOT COMPLETED|Washout Period 3 (7 Days)||0||
59546033|NCT02443740|75644619|FG007|NOT COMPLETED|Washout Period 3 (7 Days)||0||
59546034|NCT02443740|75644620|FG008|NOT COMPLETED|Washout Period 3 (7 Days)||0||
59546035|NCT02443740|75644621|FG009|NOT COMPLETED|Washout Period 3 (7 Days)||0||
59546036|NCT02443740|75644622|FG010|NOT COMPLETED|Washout Period 3 (7 Days)||0||
59546037|NCT02443740|75644612|FG000|STARTED|Intervention Period 4 (3 Days)||1||
59546038|NCT02443740|75644613|FG001|STARTED|Intervention Period 4 (3 Days)||2||
59546039|NCT02443740|75644614|FG002|STARTED|Intervention Period 4 (3 Days)||2||
59546040|NCT02443740|75644615|FG003|STARTED|Intervention Period 4 (3 Days)||3||
59546041|NCT02443740|75644616|FG004|STARTED|Intervention Period 4 (3 Days)||2||
59546042|NCT02443740|75644617|FG005|STARTED|Intervention Period 4 (3 Days)||2||
59546043|NCT02443740|75644618|FG006|STARTED|Intervention Period 4 (3 Days)||2||
59546044|NCT02443740|75644619|FG007|STARTED|Intervention Period 4 (3 Days)||2||
59546045|NCT02443740|75644620|FG008|STARTED|Intervention Period 4 (3 Days)||0||
59546046|NCT02443740|75644621|FG009|STARTED|Intervention Period 4 (3 Days)||0||
59546047|NCT02443740|75644622|FG010|STARTED|Intervention Period 4 (3 Days)||0||
59546048|NCT02443740|75644612|FG000|COMPLETED|Intervention Period 4 (3 Days)||1||
59546049|NCT02443740|75644613|FG001|COMPLETED|Intervention Period 4 (3 Days)||2||
59546050|NCT02443740|75644614|FG002|COMPLETED|Intervention Period 4 (3 Days)||2||
59546051|NCT02443740|75644615|FG003|COMPLETED|Intervention Period 4 (3 Days)||3||
59546052|NCT02443740|75644616|FG004|COMPLETED|Intervention Period 4 (3 Days)||2||
59546053|NCT02443740|75644617|FG005|COMPLETED|Intervention Period 4 (3 Days)||2||
59546054|NCT02443740|75644618|FG006|COMPLETED|Intervention Period 4 (3 Days)||2||
59546055|NCT02443740|75644619|FG007|COMPLETED|Intervention Period 4 (3 Days)||2||
59546056|NCT02443740|75644620|FG008|COMPLETED|Intervention Period 4 (3 Days)||0||
59546057|NCT02443740|75644621|FG009|COMPLETED|Intervention Period 4 (3 Days)||0||
59546058|NCT02443740|75644622|FG010|COMPLETED|Intervention Period 4 (3 Days)||0||
59546059|NCT02443740|75644612|FG000|NOT COMPLETED|Intervention Period 4 (3 Days)||0||
59546060|NCT02443740|75644613|FG001|NOT COMPLETED|Intervention Period 4 (3 Days)||0||
59546061|NCT02443740|75644614|FG002|NOT COMPLETED|Intervention Period 4 (3 Days)||0||
59546062|NCT02443740|75644615|FG003|NOT COMPLETED|Intervention Period 4 (3 Days)||0||
59546063|NCT02443740|75644616|FG004|NOT COMPLETED|Intervention Period 4 (3 Days)||0||
59546064|NCT02443740|75644617|FG005|NOT COMPLETED|Intervention Period 4 (3 Days)||0||
59546065|NCT02443740|75644618|FG006|NOT COMPLETED|Intervention Period 4 (3 Days)||0||
59546066|NCT02443740|75644619|FG007|NOT COMPLETED|Intervention Period 4 (3 Days)||0||
59546067|NCT02443740|75644620|FG008|NOT COMPLETED|Intervention Period 4 (3 Days)||0||
59546068|NCT02443740|75644621|FG009|NOT COMPLETED|Intervention Period 4 (3 Days)||0||
59546069|NCT02443740|75644622|FG010|NOT COMPLETED|Intervention Period 4 (3 Days)||0||
59546070|NCT02170376|75644657|FG000|STARTED|Overall Study||16||
59546071|NCT02170376|75644658|FG001|STARTED|Overall Study||16||
59546072|NCT02170376|75644659|FG002|STARTED|Overall Study||16||
59546073|NCT02170376|75644660|FG003|STARTED|Overall Study||16||
59546074|NCT02170376|75644661|FG004|STARTED|Overall Study||16||
59546075|NCT02170376|75644657|FG000|Pharmacokinetic Population|Overall Study||16||
59546076|NCT02170376|75644658|FG001|Pharmacokinetic Population|Overall Study||15||
59546077|NCT02170376|75644659|FG002|Pharmacokinetic Population|Overall Study||16||
59546078|NCT02170376|75644660|FG003|Pharmacokinetic Population|Overall Study||16||
59546079|NCT02170376|75644661|FG004|Pharmacokinetic Population|Overall Study||16||
59546080|NCT02170376|75644657|FG000|COMPLETED|Overall Study||16||
59546081|NCT02170376|75644658|FG001|COMPLETED|Overall Study||15||
59546082|NCT02170376|75644659|FG002|COMPLETED|Overall Study||16||
59546083|NCT02170376|75644660|FG003|COMPLETED|Overall Study||16||
59546084|NCT02170376|75644661|FG004|COMPLETED|Overall Study||16||
59546085|NCT02170376|75644657|FG000|NOT COMPLETED|Overall Study||0||
59546086|NCT02170376|75644658|FG001|NOT COMPLETED|Overall Study||1||
59546087|NCT02170376|75644659|FG002|NOT COMPLETED|Overall Study||0||
59546088|NCT02170376|75644660|FG003|NOT COMPLETED|Overall Study||0||
59546089|NCT02170376|75644661|FG004|NOT COMPLETED|Overall Study||0||
59546090|NCT02170532|75644673|FG000|STARTED|Overall Study||10||
59546091|NCT02170532|75644673|FG000|COMPLETED|Overall Study||10||
59546092|NCT02170532|75644673|FG000|NOT COMPLETED|Overall Study||0||
59546093|NCT03987854|75644684|FG000|STARTED|Overall Study||29||
59546094|NCT03987854|75644684|FG000|COMPLETED|Overall Study||21||
60077911|NCT01621906|76192880|FG000|NOT COMPLETED|Overall Study||0||
60077912|NCT01621906|76192881|FG001|NOT COMPLETED|Overall Study||0||
59546095|NCT03987854|75644684|FG000|NOT COMPLETED|Overall Study||8||
59546096|NCT02175212|75644690|FG000|STARTED|Overall Study||177||
59546097|NCT02175212|75644691|FG001|STARTED|Overall Study||178||
59546098|NCT02175212|75644690|FG000|COMPLETED|Overall Study||14||
59546099|NCT02175212|75644691|FG001|COMPLETED|Overall Study||31||
59546100|NCT02175212|75644690|FG000|NOT COMPLETED|Overall Study||163||
59546101|NCT02175212|75644691|FG001|NOT COMPLETED|Overall Study||147||
59672092|NCT02143414|75790953|FG000|Completed Induction|Induction||24||
59672093|NCT02143414|75790954|FG001|Completed Induction|Induction||19||
59672094|NCT02143414|75790953|FG000|COMPLETED|Induction||19||
59672095|NCT02143414|75790954|FG001|COMPLETED|Induction||18||
59672096|NCT02143414|75790953|FG000|NOT COMPLETED|Induction||10||
59672097|NCT02143414|75790954|FG001|NOT COMPLETED|Induction||6||
59672098|NCT02143414|75790953|FG000|STARTED|Post-remission||19||
59672099|NCT02143414|75790954|FG001|STARTED|Post-remission||18||
59672100|NCT02143414|75790953|FG000|COMPLETED|Post-remission||14||
59672101|NCT02143414|75790954|FG001|COMPLETED|Post-remission||16||
59672102|NCT02143414|75790953|FG000|NOT COMPLETED|Post-remission||5||
59672103|NCT02143414|75790954|FG001|NOT COMPLETED|Post-remission||2||
59672104|NCT02143414|75790953|FG000|STARTED|Maintenance||14||
59672105|NCT02143414|75790954|FG001|STARTED|Maintenance||16||
59672106|NCT02143414|75790953|FG000|COMPLETED|Maintenance||4||
59672107|NCT02143414|75790954|FG001|COMPLETED|Maintenance||0||
59672108|NCT02143414|75790953|FG000|NOT COMPLETED|Maintenance||10||
59672109|NCT02143414|75790954|FG001|NOT COMPLETED|Maintenance||16||
59672110|NCT02115282|75790973|FG000|STARTED|Overall Study||305||
59672111|NCT02115282|75790974|FG001|STARTED|Overall Study||303||
59672112|NCT02115282|75790973|FG000|Eligible|Overall Study||265||
59672113|NCT02115282|75790974|FG001|Eligible|Overall Study||257||
59672114|NCT02115282|75790973|FG000|Treated|Overall Study||296||
59672115|NCT02115282|75790974|FG001|Treated|Overall Study||293||
59672116|NCT02115282|75790973|FG000|COMPLETED|Overall Study||0|"There was no prespecified maximum cycles in the study. Patients were treated until disease progression or intolerability.~At the time the primary results were reported, 6 patients were still receiving treatment and they stopped treatment afterwards."|
59672117|NCT02115282|75790974|FG001|COMPLETED|Overall Study||0|"There was no prespecified maximum cycles in the study. Patients were treated until disease progression or intolerability.~At the time the primary results were reported, 6 patients were still receiving treatment and they stopped treatment afterwards."|
59672118|NCT02115282|75790973|FG000|NOT COMPLETED|Overall Study||305||
59672119|NCT02115282|75790974|FG001|NOT COMPLETED|Overall Study||303||
59672120|NCT01991977|75790982|FG000|STARTED|Overall Study||91|Enrolled|
59672121|NCT01991977|75790982|FG000|Received PET Tracer|Overall Study||84|Received the experimental FDOPA PET tracer; evaluable for AEs|
59672122|NCT01991977|75790982|FG000|Received IMRT Treatment|Overall Study||79|Received IMRT treatment based on the FDOPA imaging results|
59672123|NCT01991977|75790982|FG000|Evaluable for the Primary Outcome|Overall Study||39|Grade IV MGMT un-methylated glioma patients after radiation therapy|
59672124|NCT01991977|75790982|FG000|COMPLETED|Overall Study||79|Received standard of care CT simulation and received treatment|
59672125|NCT01991977|75790982|FG000|NOT COMPLETED|Overall Study||12||
59672126|NCT01934582|75790986|FG000|STARTED|Overall Study||13||
59672127|NCT01934582|75790986|FG000|COMPLETED|Overall Study||13||
59672128|NCT01934582|75790986|FG000|NOT COMPLETED|Overall Study||0||
59672129|NCT01922076|75790999|FG000|STARTED|Overall Study||6||
59672130|NCT01922076|75791000|FG001|STARTED|Overall Study||6||
59672131|NCT01922076|75791001|FG002|STARTED|Overall Study||7||
59672132|NCT01922076|75791002|FG003|STARTED|Overall Study||7||
59672133|NCT01922076|75791003|FG004|STARTED|Overall Study||7||
59672134|NCT01922076|75791004|FG005|STARTED|Overall Study||6||
59672135|NCT01922076|75791005|FG006|STARTED|Overall Study||7||
59672136|NCT01922076|75790999|FG000|COMPLETED|Overall Study||6||
59672137|NCT01922076|75791000|FG001|COMPLETED|Overall Study||6||
59672138|NCT01922076|75791001|FG002|COMPLETED|Overall Study||6||
59672139|NCT01922076|75791002|FG003|COMPLETED|Overall Study||6||
59672140|NCT01922076|75791003|FG004|COMPLETED|Overall Study||6||
59672141|NCT01922076|75791004|FG005|COMPLETED|Overall Study||5||
59672142|NCT01922076|75791005|FG006|COMPLETED|Overall Study||6||
59672143|NCT01922076|75790999|FG000|NOT COMPLETED|Overall Study||0||
59672144|NCT01922076|75791000|FG001|NOT COMPLETED|Overall Study||0||
59672145|NCT01922076|75791001|FG002|NOT COMPLETED|Overall Study||1||
59672146|NCT01922076|75791002|FG003|NOT COMPLETED|Overall Study||1||
59672147|NCT01922076|75791003|FG004|NOT COMPLETED|Overall Study||1||
59672148|NCT01922076|75791004|FG005|NOT COMPLETED|Overall Study||1||
59672149|NCT01922076|75791005|FG006|NOT COMPLETED|Overall Study||1||
59672150|NCT01854554|75791024|FG000|STARTED|Overall Study||42||
59672151|NCT01854554|75791025|FG001|STARTED|Overall Study||48||
59672152|NCT01854554|75791024|FG000|COMPLETED|Overall Study||28||
59672153|NCT01854554|75791025|FG001|COMPLETED|Overall Study||39||
59672154|NCT01854554|75791024|FG000|NOT COMPLETED|Overall Study||14||
59672155|NCT01854554|75791025|FG001|NOT COMPLETED|Overall Study||9||
59672156|NCT01817959|75791033|FG000|STARTED|Overall Study||29||
59672157|NCT01817959|75791034|FG001|STARTED|Overall Study||19||
59672158|NCT01817959|75791033|FG000|COMPLETED|Overall Study||25||
59672159|NCT01817959|75791034|FG001|COMPLETED|Overall Study||16||
59672160|NCT01817959|75791033|FG000|NOT COMPLETED|Overall Study||4||
59672161|NCT01817959|75791034|FG001|NOT COMPLETED|Overall Study||3||
59672162|NCT01755195|75791040|FG000|STARTED|Overall Study||55||
59672163|NCT01755195|75791040|FG000|COMPLETED|Overall Study||42||
59672164|NCT01755195|75791040|FG000|NOT COMPLETED|Overall Study||13||
59672165|NCT01291836|75791044|FG000|STARTED|Overall Study||930||
59672166|NCT01291836|75791045|FG001|STARTED|Overall Study||71||
59672167|NCT01291836|75791044|FG000|COMPLETED|Overall Study||930||
59672168|NCT01291836|75791045|FG001|COMPLETED|Overall Study||71||
59672169|NCT01291836|75791044|FG000|NOT COMPLETED|Overall Study||0||
59672170|NCT01291836|75791045|FG001|NOT COMPLETED|Overall Study||0||
59672171|NCT01263769|75791051|FG000|STARTED|Overall Study||25||
59672172|NCT01263769|75791051|FG000|COMPLETED|Overall Study||24||
59672173|NCT01263769|75791051|FG000|NOT COMPLETED|Overall Study||1||
59672174|NCT01154764|75791055|FG000|STARTED|Intervention 1 (5days)||14||
59672175|NCT01154764|75791056|FG001|STARTED|Intervention 1 (5days)||14||
59672176|NCT01154764|75791055|FG000|COMPLETED|Intervention 1 (5days)||14||
59672177|NCT01154764|75791056|FG001|COMPLETED|Intervention 1 (5days)||14||
59672178|NCT01154764|75791055|FG000|NOT COMPLETED|Intervention 1 (5days)||0||
59672179|NCT01154764|75791056|FG001|NOT COMPLETED|Intervention 1 (5days)||0||
59672180|NCT01154764|75791055|FG000|STARTED|Intervention 2 (5days)||14||
59672181|NCT01154764|75791056|FG001|STARTED|Intervention 2 (5days)||14||
59672182|NCT01154764|75791055|FG000|COMPLETED|Intervention 2 (5days)||13||
59672183|NCT01154764|75791056|FG001|COMPLETED|Intervention 2 (5days)||13||
59672184|NCT01154764|75791055|FG000|NOT COMPLETED|Intervention 2 (5days)||1||
59672185|NCT01154764|75791056|FG001|NOT COMPLETED|Intervention 2 (5days)||1||
59672186|NCT01004978|75791064|FG000|STARTED|Overall Study||118||
59672187|NCT01004978|75791065|FG001|STARTED|Overall Study||117||
59672188|NCT01004978|75791064|FG000|COMPLETED|Overall Study|Treatment was given until disease progression.|0||
59672189|NCT01004978|75791065|FG001|COMPLETED|Overall Study|Treatment was given until disease progression.|0||
59672190|NCT01004978|75791064|FG000|NOT COMPLETED|Overall Study||118||
59672191|NCT01004978|75791065|FG001|NOT COMPLETED|Overall Study||117||
59672192|NCT00947531|75791073|FG000|STARTED|Overall Study||121||
59672193|NCT00947531|75791074|FG001|STARTED|Overall Study||121||
59672194|NCT00947531|75791073|FG000|COMPLETED|Overall Study||107||
59672195|NCT00947531|75791074|FG001|COMPLETED|Overall Study||110||
59672196|NCT00947531|75791073|FG000|NOT COMPLETED|Overall Study||14||
59672197|NCT00947531|75791074|FG001|NOT COMPLETED|Overall Study||11||
59672198|NCT00643604|75791080|FG000|STARTED|Overall Study||7||
59672199|NCT00643604|75791080|FG000|COMPLETED|Overall Study||6||
59672200|NCT00643604|75791080|FG000|NOT COMPLETED|Overall Study||1||
59672201|NCT00447382|75791086|FG000|STARTED|Overall Study||164||
59672202|NCT00447382|75791087|FG001|STARTED|Overall Study||166||
59672203|NCT00447382|75791086|FG000|COMPLETED|Overall Study||158||
59672204|NCT00447382|75791087|FG001|COMPLETED|Overall Study||160||
59672205|NCT00447382|75791086|FG000|NOT COMPLETED|Overall Study||6||
59672206|NCT00447382|75791087|FG001|NOT COMPLETED|Overall Study||6||
59672207|NCT00439946|75791093|FG000|STARTED|Overall Study||8||
59672208|NCT00439946|75791093|FG000|COMPLETED|Overall Study||8||
59672209|NCT00439946|75791093|FG000|NOT COMPLETED|Overall Study||0||
59672210|NCT00325403|75791099|FG000|STARTED|Overall Study||116||
59672211|NCT00325403|75791100|FG001|STARTED|Overall Study||233||
59672212|NCT00325403|75791099|FG000|COMPLETED|Overall Study|98 subjects receiving placebo completed the study on study drug|98||
59672213|NCT00325403|75791100|FG001|COMPLETED|Overall Study|182 subjects receiving oral treprostinil completed the study on study drug|182||
59672214|NCT00325403|75791099|FG000|NOT COMPLETED|Overall Study||18||
59672215|NCT00325403|75791100|FG001|NOT COMPLETED|Overall Study||51||
59672216|NCT00147199|75791110|FG000|STARTED|Overall Study||115||
59672217|NCT00147199|75791111|FG001|STARTED|Overall Study||120||
59672218|NCT00147199|75791110|FG000|COMPLETED|Overall Study||102||
59672219|NCT00147199|75791111|FG001|COMPLETED|Overall Study||110||
59672220|NCT00147199|75791110|FG000|NOT COMPLETED|Overall Study||13||
59672221|NCT00147199|75791111|FG001|NOT COMPLETED|Overall Study||10||
59672222|NCT00135668|75791121|FG000|STARTED|Overall Study - Randomized to be Dosed||51||
59672223|NCT00135668|75791122|FG001|STARTED|Overall Study - Randomized to be Dosed||49||
59672224|NCT00135668|75791123|FG002|STARTED|Overall Study - Randomized to be Dosed||55||
59672225|NCT00135668|75791124|FG003|STARTED|Overall Study - Randomized to be Dosed||51||
59672226|NCT00135668|75791121|FG000|COMPLETED|Overall Study - Randomized to be Dosed||50||
59672227|NCT00135668|75791122|FG001|COMPLETED|Overall Study - Randomized to be Dosed||49||
59672228|NCT00135668|75791123|FG002|COMPLETED|Overall Study - Randomized to be Dosed||53||
59672229|NCT00135668|75791124|FG003|COMPLETED|Overall Study - Randomized to be Dosed||51||
59672230|NCT00135668|75791121|FG000|NOT COMPLETED|Overall Study - Randomized to be Dosed||1||
59672231|NCT00135668|75791122|FG001|NOT COMPLETED|Overall Study - Randomized to be Dosed||0||
59672232|NCT00135668|75791123|FG002|NOT COMPLETED|Overall Study - Randomized to be Dosed||2||
59672233|NCT00135668|75791124|FG003|NOT COMPLETED|Overall Study - Randomized to be Dosed||0||
59672234|NCT00135668|75791121|FG000|STARTED|Blinded Treatment Phase-Randomized/Dosed||50||
59672235|NCT00135668|75791122|FG001|STARTED|Blinded Treatment Phase-Randomized/Dosed||49||
59672236|NCT00135668|75791123|FG002|STARTED|Blinded Treatment Phase-Randomized/Dosed||53||
59672237|NCT00135668|75791124|FG003|STARTED|Blinded Treatment Phase-Randomized/Dosed||51||
59672238|NCT00135668|75791121|FG000|COMPLETED|Blinded Treatment Phase-Randomized/Dosed||38||
59672239|NCT00135668|75791122|FG001|COMPLETED|Blinded Treatment Phase-Randomized/Dosed||23||
59672240|NCT00135668|75791123|FG002|COMPLETED|Blinded Treatment Phase-Randomized/Dosed||13||
59672241|NCT00135668|75791124|FG003|COMPLETED|Blinded Treatment Phase-Randomized/Dosed||18||
59672242|NCT00135668|75791121|FG000|NOT COMPLETED|Blinded Treatment Phase-Randomized/Dosed||12||
59672243|NCT00135668|75791122|FG001|NOT COMPLETED|Blinded Treatment Phase-Randomized/Dosed||26||
59672244|NCT00135668|75791123|FG002|NOT COMPLETED|Blinded Treatment Phase-Randomized/Dosed||40||
59672245|NCT00135668|75791124|FG003|NOT COMPLETED|Blinded Treatment Phase-Randomized/Dosed||33||
59672246|NCT00066703|75791155|FG000|STARTED|Overall Study||1334||
59672247|NCT00066703|75791156|FG001|STARTED|Overall Study||1338||
59672248|NCT00066703|75791155|FG000|COMPLETED|Overall Study||722||
59672249|NCT00066703|75791156|FG001|COMPLETED|Overall Study||756||
59672250|NCT00066703|75791155|FG000|NOT COMPLETED|Overall Study||612||
59672251|NCT00066703|75791156|FG001|NOT COMPLETED|Overall Study||582||
59672252|NCT00066690|75791165|FG000|STARTED|Overall Study||1021||
59672253|NCT00066690|75791166|FG001|STARTED|Overall Study||1024||
59672254|NCT00066690|75791167|FG002|STARTED|Overall Study||1021||
59672255|NCT00066690|75791165|FG000|COMPLETED|Overall Study||423||
59672256|NCT00066690|75791166|FG001|COMPLETED|Overall Study||502||
59672257|NCT00066690|75791167|FG002|COMPLETED|Overall Study||457||
59672258|NCT00066690|75791165|FG000|NOT COMPLETED|Overall Study||598||
59672259|NCT00066690|75791166|FG001|NOT COMPLETED|Overall Study||522||
59672260|NCT00066690|75791167|FG002|NOT COMPLETED|Overall Study||564||
59672261|NCT01053962|75791183|FG000|STARTED|Pretreatment Period||14||
59672262|NCT01053962|75791184|FG001|STARTED|Pretreatment Period||15||
59672263|NCT01053962|75791185|FG002|STARTED|Pretreatment Period||16||
59672264|NCT01053962|75791186|FG003|STARTED|Pretreatment Period||17||
59672265|NCT01053962|75791187|FG004|STARTED|Pretreatment Period||22||
59672266|NCT01053962|75791183|FG000|COMPLETED|Pretreatment Period||14||
59672267|NCT01053962|75791184|FG001|COMPLETED|Pretreatment Period||14||
59672268|NCT01053962|75791185|FG002|COMPLETED|Pretreatment Period||15||
59672269|NCT01053962|75791186|FG003|COMPLETED|Pretreatment Period||15||
59672270|NCT01053962|75791187|FG004|COMPLETED|Pretreatment Period||20||
59672271|NCT01053962|75791183|FG000|NOT COMPLETED|Pretreatment Period||0||
59672272|NCT01053962|75791184|FG001|NOT COMPLETED|Pretreatment Period||1||
59672273|NCT01053962|75791185|FG002|NOT COMPLETED|Pretreatment Period||1||
59672274|NCT01053962|75791186|FG003|NOT COMPLETED|Pretreatment Period||2||
59672275|NCT01053962|75791187|FG004|NOT COMPLETED|Pretreatment Period||2||
59672276|NCT01053962|75791183|FG000|STARTED|Treatment Period||14||
59672277|NCT01053962|75791184|FG001|STARTED|Treatment Period||14||
59672278|NCT01053962|75791185|FG002|STARTED|Treatment Period||15||
59672279|NCT01053962|75791186|FG003|STARTED|Treatment Period||15||
59672280|NCT01053962|75791187|FG004|STARTED|Treatment Period||20||
59672281|NCT01053962|75791183|FG000|COMPLETED|Treatment Period||13||
59672282|NCT01053962|75791184|FG001|COMPLETED|Treatment Period||14||
59672283|NCT01053962|75791185|FG002|COMPLETED|Treatment Period||15||
59672284|NCT01053962|75791186|FG003|COMPLETED|Treatment Period||15||
59672285|NCT01053962|75791187|FG004|COMPLETED|Treatment Period||17||
59672286|NCT01053962|75791183|FG000|NOT COMPLETED|Treatment Period||1||
59672287|NCT01053962|75791184|FG001|NOT COMPLETED|Treatment Period||0||
59672288|NCT01053962|75791185|FG002|NOT COMPLETED|Treatment Period||0||
59672289|NCT01053962|75791186|FG003|NOT COMPLETED|Treatment Period||0||
59672290|NCT01053962|75791187|FG004|NOT COMPLETED|Treatment Period||3||
59672291|NCT01053962|75791183|FG000|STARTED|Follow-up Period||13||
59672292|NCT01053962|75791184|FG001|STARTED|Follow-up Period||14||
59672293|NCT01053962|75791185|FG002|STARTED|Follow-up Period||15||
59672294|NCT01053962|75791186|FG003|STARTED|Follow-up Period||15||
59672295|NCT01053962|75791187|FG004|STARTED|Follow-up Period||17||
59672296|NCT01053962|75791183|FG000|COMPLETED|Follow-up Period||13||
59672297|NCT01053962|75791184|FG001|COMPLETED|Follow-up Period||14||
59672298|NCT01053962|75791185|FG002|COMPLETED|Follow-up Period||15||
59672299|NCT01053962|75791186|FG003|COMPLETED|Follow-up Period||15||
59672300|NCT01053962|75791187|FG004|COMPLETED|Follow-up Period||17||
59672301|NCT01053962|75791183|FG000|NOT COMPLETED|Follow-up Period||0||
59672302|NCT01053962|75791184|FG001|NOT COMPLETED|Follow-up Period||0||
59672303|NCT01053962|75791185|FG002|NOT COMPLETED|Follow-up Period||0||
59672304|NCT01053962|75791186|FG003|NOT COMPLETED|Follow-up Period||0||
59672305|NCT01053962|75791187|FG004|NOT COMPLETED|Follow-up Period||0||
59672306|NCT01053221|75791206|FG000|STARTED|Overall Study||5||
59672307|NCT01053221|75791207|FG001|STARTED|Overall Study||9||
59672308|NCT01053221|75791206|FG000|COMPLETED|Overall Study||0||
59989366|NCT04510194|76104643|FG000|STARTED|Overall Study||284||
59989367|NCT04510194|76104644|FG001|STARTED|Overall Study||295||
59672309|NCT01053221|75791207|FG001|COMPLETED|Overall Study||0||
59672310|NCT01053221|75791206|FG000|NOT COMPLETED|Overall Study||5||
59672311|NCT01053221|75791207|FG001|NOT COMPLETED|Overall Study||9||
59672312|NCT01052012|75791219|FG000|STARTED|Overall Study||32||
59672313|NCT01052012|75791220|FG001|STARTED|Overall Study||23||
59672314|NCT01052012|75791221|FG002|STARTED|Overall Study||30||
59672315|NCT01052012|75791222|FG003|STARTED|Overall Study||20||
59672316|NCT01052012|75791223|FG004|STARTED|Overall Study||140||
59672317|NCT01052012|75791224|FG005|STARTED|Overall Study||86||
59672318|NCT01052012|75791219|FG000|COMPLETED|Overall Study||28||
59672319|NCT01052012|75791220|FG001|COMPLETED|Overall Study||17||
59672320|NCT01052012|75791221|FG002|COMPLETED|Overall Study||30||
59672321|NCT01052012|75791222|FG003|COMPLETED|Overall Study||19||
59672322|NCT01052012|75791223|FG004|COMPLETED|Overall Study||124||
59672323|NCT01052012|75791224|FG005|COMPLETED|Overall Study||76||
59672324|NCT01052012|75791219|FG000|NOT COMPLETED|Overall Study||4||
59672325|NCT01052012|75791220|FG001|NOT COMPLETED|Overall Study||6||
59672326|NCT01052012|75791221|FG002|NOT COMPLETED|Overall Study||0||
59989368|NCT04510194|76104645|FG002|STARTED|Overall Study||206||
59672327|NCT01052012|75791222|FG003|NOT COMPLETED|Overall Study||1||
59672328|NCT01052012|75791223|FG004|NOT COMPLETED|Overall Study||16||
59672329|NCT01052012|75791224|FG005|NOT COMPLETED|Overall Study||10||
59672330|NCT01051817|75791240|FG000|STARTED|Overall Study||38||
59672331|NCT01051817|75791241|FG001|STARTED|Overall Study||35||
59672332|NCT01051817|75791240|FG000|COMPLETED|Overall Study||35||
59672333|NCT01051817|75791241|FG001|COMPLETED|Overall Study||26||
59672334|NCT01051817|75791240|FG000|NOT COMPLETED|Overall Study||3||
59672335|NCT01051817|75791241|FG001|NOT COMPLETED|Overall Study||9||
59672336|NCT01327846|75791251|FG000|STARTED|Core Phase||2263||
59672337|NCT01327846|75791252|FG001|STARTED|Core Phase||2284||
59672338|NCT01327846|75791253|FG002|STARTED|Core Phase||2170||
59672339|NCT01327846|75791254|FG003|STARTED|Core Phase||3344||
59672340|NCT01327846|75791251|FG000|COMPLETED|Core Phase||2235||
59672341|NCT01327846|75791252|FG001|COMPLETED|Core Phase||2252||
59672342|NCT01327846|75791253|FG002|COMPLETED|Core Phase||2144||
59672343|NCT01327846|75791254|FG003|COMPLETED|Core Phase||3311||
59672344|NCT01327846|75791251|FG000|NOT COMPLETED|Core Phase||28||
59672345|NCT01327846|75791252|FG001|NOT COMPLETED|Core Phase||32||
59672346|NCT01327846|75791253|FG002|NOT COMPLETED|Core Phase||26||
59672347|NCT01327846|75791254|FG003|NOT COMPLETED|Core Phase||33||
59672348|NCT01327846|75791251|FG000|STARTED|Extension Phase||1267||
59672349|NCT01327846|75791252|FG001|STARTED|Extension Phase||1287||
59672350|NCT01327846|75791253|FG002|STARTED|Extension Phase||1279||
59672351|NCT01327846|75791254|FG003|STARTED|Extension Phase||1944||
59672352|NCT01327846|75791251|FG000|Stopped/Discontinued Study at Washout|Extension Phase||127||
59672353|NCT01327846|75791252|FG001|Stopped/Discontinued Study at Washout|Extension Phase||97||
59672354|NCT01327846|75791253|FG002|Stopped/Discontinued Study at Washout|Extension Phase||137||
59672355|NCT01327846|75791254|FG003|Stopped/Discontinued Study at Washout|Extension Phase||178||
59672356|NCT01327846|75791251|FG000|Completed Treatment Period|Extension Phase||41||
59672357|NCT01327846|75791252|FG001|Completed Treatment Period|Extension Phase||45||
59672358|NCT01327846|75791253|FG002|Completed Treatment Period|Extension Phase||49||
59672359|NCT01327846|75791254|FG003|Completed Treatment Period|Extension Phase||60||
59672360|NCT01327846|75791251|FG000|Details Missing|Extension Phase||0||
59672361|NCT01327846|75791252|FG001|Details Missing|Extension Phase||1||
59672362|NCT01327846|75791253|FG002|Details Missing|Extension Phase||1||
59672363|NCT01327846|75791254|FG003|Details Missing|Extension Phase||0||
59672364|NCT01327846|75791251|FG000|COMPLETED|Extension Phase||168||
59672365|NCT01327846|75791252|FG001|COMPLETED|Extension Phase||143||
59989369|NCT04510194|76104646|FG003|STARTED|Overall Study||159||
59672366|NCT01327846|75791253|FG002|COMPLETED|Extension Phase||187||
59672367|NCT01327846|75791254|FG003|COMPLETED|Extension Phase||238||
59672368|NCT01327846|75791251|FG000|NOT COMPLETED|Extension Phase||1099||
59989370|NCT04510194|76104647|FG004|STARTED|Overall Study||175||
59989371|NCT04510194|76104648|FG005|STARTED|Overall Study||204||
59989372|NCT04510194|76104643|FG000|COMPLETED|Overall Study||278||
59989373|NCT04510194|76104644|FG001|COMPLETED|Overall Study||291||
59989374|NCT04510194|76104645|FG002|COMPLETED|Overall Study||206||
59989375|NCT04510194|76104646|FG003|COMPLETED|Overall Study||156||
60077913|NCT00530062|76192888|FG000|STARTED|Overall Study||49||
59672369|NCT01327846|75791252|FG001|NOT COMPLETED|Extension Phase||1144||
59672370|NCT01327846|75791253|FG002|NOT COMPLETED|Extension Phase||1092||
59672371|NCT01327846|75791254|FG003|NOT COMPLETED|Extension Phase||1706||
59672372|NCT01051739|75791267|FG000|STARTED|Overall Study||120||
59989376|NCT04510194|76104647|FG004|COMPLETED|Overall Study||173||
59989377|NCT04510194|76104648|FG005|COMPLETED|Overall Study||201||
59672373|NCT01051739|75791268|FG001|STARTED|Overall Study||60||
59672374|NCT01051739|75791267|FG000|COMPLETED|Overall Study||92||
59672375|NCT01051739|75791268|FG001|COMPLETED|Overall Study||47||
59672376|NCT01051739|75791267|FG000|NOT COMPLETED|Overall Study||28||
59672377|NCT01051739|75791268|FG001|NOT COMPLETED|Overall Study||13||
59672378|NCT01051661|75791280|FG000|STARTED|Overall Study||610||
59672379|NCT01051661|75791281|FG001|STARTED|Overall Study||1438||
59672380|NCT01051661|75791282|FG002|STARTED|Overall Study||612||
59672381|NCT01051661|75791283|FG003|STARTED|Overall Study||1436||
59672382|NCT01051661|75791284|FG004|STARTED|Overall Study||613||
59672383|NCT01051661|75791285|FG005|STARTED|Overall Study||1436||
59672384|NCT01051661|75791280|FG000|COMPLETED|Overall Study||576||
59672385|NCT01051661|75791281|FG001|COMPLETED|Overall Study||1375||
59672386|NCT01051661|75791282|FG002|COMPLETED|Overall Study||573||
59672387|NCT01051661|75791283|FG003|COMPLETED|Overall Study||1380||
59672388|NCT01051661|75791284|FG004|COMPLETED|Overall Study||578||
59672389|NCT01051661|75791285|FG005|COMPLETED|Overall Study||1369||
59672390|NCT01051661|75791280|FG000|NOT COMPLETED|Overall Study||34||
59672391|NCT01051661|75791281|FG001|NOT COMPLETED|Overall Study||63||
59672392|NCT01051661|75791282|FG002|NOT COMPLETED|Overall Study||39||
59672393|NCT01051661|75791283|FG003|NOT COMPLETED|Overall Study||56||
59672394|NCT01051661|75791284|FG004|NOT COMPLETED|Overall Study||35||
59672395|NCT01051661|75791285|FG005|NOT COMPLETED|Overall Study||67||
59672396|NCT01051466|75791322|FG000|STARTED|Overall Study||32||
59672397|NCT01051466|75791323|FG001|STARTED|Overall Study||28||
59672398|NCT01051466|75791322|FG000|COMPLETED|Overall Study||24||
59672399|NCT01051466|75791323|FG001|COMPLETED|Overall Study||23||
59672400|NCT01051466|75791322|FG000|NOT COMPLETED|Overall Study||8||
59672401|NCT01051466|75791323|FG001|NOT COMPLETED|Overall Study||5||
59672402|NCT04446247|75791331|FG000|STARTED|Overall Study||14||
59672403|NCT04446247|75791331|FG000|COMPLETED|Overall Study||14||
59672404|NCT04446247|75791331|FG000|NOT COMPLETED|Overall Study||0||
59672405|NCT01051349|75791337|FG000|STARTED|Overall Study||410||
59672406|NCT01051349|75791337|FG000|COMPLETED|Overall Study||237||
59672407|NCT01051349|75791337|FG000|NOT COMPLETED|Overall Study||173||
59672408|NCT01050998|75791349|FG000|STARTED|Overall Study||48||
59672409|NCT01050998|75791350|FG001|STARTED|Overall Study||49||
59672410|NCT01050998|75791351|FG002|STARTED|Overall Study||49||
59672411|NCT01050998|75791352|FG003|STARTED|Overall Study||48||
59672412|NCT01050998|75791353|FG004|STARTED|Overall Study||96||
59672413|NCT01050998|75791349|FG000|COMPLETED|Overall Study||44||
59989378|NCT04510194|76104643|FG000|NOT COMPLETED|Overall Study||6||
59989379|NCT04510194|76104644|FG001|NOT COMPLETED|Overall Study||4||
59989380|NCT04510194|76104645|FG002|NOT COMPLETED|Overall Study||0||
59989381|NCT04510194|76104646|FG003|NOT COMPLETED|Overall Study||3||
59989382|NCT04510194|76104647|FG004|NOT COMPLETED|Overall Study||2||
60077914|NCT00530062|76192888|FG000|Received at Least 1 Dose of Study Drug|Overall Study||49||
60077915|NCT00530062|76192888|FG000|COMPLETED|Overall Study||49||
60077916|NCT00530062|76192888|FG000|NOT COMPLETED|Overall Study||0||
60077917|NCT02317042|76192894|FG000|STARTED|Overall Study||11|Cross over design. 11/25 started with AutoEPAP and 14/25 started with FixedEPAP|
60077918|NCT02317042|76192895|FG001|STARTED|Overall Study||14|Cross over design. 11/25 started with AutoEPAP and 14/25 started with FixedEPAP|
60077919|NCT02317042|76192894|FG000|COMPLETED|Overall Study||11||
60077920|NCT02317042|76192895|FG001|COMPLETED|Overall Study||14||
60077921|NCT02317042|76192894|FG000|NOT COMPLETED|Overall Study||0||
60077922|NCT02317042|76192895|FG001|NOT COMPLETED|Overall Study||0||
59989383|NCT04510194|76104648|FG005|NOT COMPLETED|Overall Study||3||
59989384|NCT04503174|76104662|FG000|STARTED|Overall Study||3061||
59989385|NCT04503174|76104662|FG000|COMPLETED|Overall Study||2998||
59989386|NCT04503174|76104662|FG000|NOT COMPLETED|Overall Study||63||
59989387|NCT04210843|76104680|FG000|STARTED|First Half Treatment Period (52 Weeks)||290||
59989388|NCT04210843|76104681|FG001|STARTED|First Half Treatment Period (52 Weeks)||743||
59989389|NCT04210843|76104680|FG000|COMPLETED|First Half Treatment Period (52 Weeks)||140||
59989390|NCT04210843|76104681|FG001|COMPLETED|First Half Treatment Period (52 Weeks)||369||
59989391|NCT04210843|76104680|FG000|NOT COMPLETED|First Half Treatment Period (52 Weeks)||150||
59989392|NCT04210843|76104681|FG001|NOT COMPLETED|First Half Treatment Period (52 Weeks)||374||
59989393|NCT04210843|76104680|FG000|STARTED|Second Half Treatment Period (52 Weeks)||77|Participants with Urticaria Activity Score (UAS7)>6 at Week 52 or who relapsed (UAS7 ≥ 16) during the observation period|
59989394|NCT04210843|76104681|FG001|STARTED|Second Half Treatment Period (52 Weeks)||206|Participants with Urticaria Activity Score (UAS7)>6 at Week 52 or who relapsed (UAS7 ≥ 16) during the observation period|
59989395|NCT04210843|76104680|FG000|COMPLETED|Second Half Treatment Period (52 Weeks)||1||
60077923|NCT01125436|76192905|FG000|STARTED|Overall Study||31||
60077924|NCT01125436|76192906|FG001|STARTED|Overall Study||33||
60077925|NCT01125436|76192905|FG000|COMPLETED|Overall Study||19||
60077926|NCT01125436|76192906|FG001|COMPLETED|Overall Study||21||
59672414|NCT01050998|75791350|FG001|COMPLETED|Overall Study||47||
59672415|NCT01050998|75791351|FG002|COMPLETED|Overall Study||46||
59672416|NCT01050998|75791352|FG003|COMPLETED|Overall Study||45||
60077927|NCT01125436|76192905|FG000|NOT COMPLETED|Overall Study||12||
60077928|NCT01125436|76192906|FG001|NOT COMPLETED|Overall Study||12||
59672417|NCT01050998|75791353|FG004|COMPLETED|Overall Study||82||
60077929|NCT01077856|76192915|FG000|STARTED|Overall Study||22199||
59672418|NCT01050998|75791349|FG000|NOT COMPLETED|Overall Study||4||
59672419|NCT01050998|75791350|FG001|NOT COMPLETED|Overall Study||2||
59672420|NCT01050998|75791351|FG002|NOT COMPLETED|Overall Study||3||
59672421|NCT01050998|75791352|FG003|NOT COMPLETED|Overall Study||3||
59672422|NCT01050998|75791353|FG004|NOT COMPLETED|Overall Study||14||
59672423|NCT00106028|75791371|FG000|STARTED|Overall Study|ITT Population: Patients Randomized and Received at least 1 Dose of Study Drug|49||
59672424|NCT00106028|75791372|FG001|STARTED|Overall Study|ITT Population: Patients Randomized and Received at least 1 Dose of Study Drug|94||
59672425|NCT00106028|75791371|FG000|Month 12 Completed/Started Open Label|Overall Study||49||
59672426|NCT00106028|75791372|FG001|Month 12 Completed/Started Open Label|Overall Study||87||
59672427|NCT00106028|75791371|FG000|COMPLETED|Overall Study|Completed Month 36|43||
59672428|NCT00106028|75791372|FG001|COMPLETED|Overall Study|Completed Month 36|82||
59672429|NCT00106028|75791371|FG000|NOT COMPLETED|Overall Study||6||
59672430|NCT00106028|75791372|FG001|NOT COMPLETED|Overall Study||12||
59672431|NCT01050764|75791380|FG000|STARTED|Overall Study||10||
59672432|NCT01050764|75791380|FG000|Received HSCT Graft|Overall Study||8||
59672433|NCT01050764|75791380|FG000|Received Infusion of T-reg Cells|Overall Study||7||
59672434|NCT01050764|75791380|FG000|Received Infusion of T-con Cells|Overall Study||7||
59672435|NCT01050764|75791380|FG000|COMPLETED|Overall Study||7||
59672436|NCT01050764|75791380|FG000|NOT COMPLETED|Overall Study||3||
59672437|NCT01050569|75791387|FG000|STARTED|Overall Study||79||
59672438|NCT01050569|75791388|FG001|STARTED|Overall Study||76||
59672439|NCT01050569|75791389|FG002|STARTED|Overall Study||80||
59672440|NCT01050569|75791387|FG000|COMPLETED|Overall Study||41||
59672441|NCT01050569|75791388|FG001|COMPLETED|Overall Study||52||
59672442|NCT01050569|75791389|FG002|COMPLETED|Overall Study||47||
59672443|NCT01050569|75791387|FG000|NOT COMPLETED|Overall Study||38||
59672444|NCT01050569|75791388|FG001|NOT COMPLETED|Overall Study||24||
59672445|NCT01050569|75791389|FG002|NOT COMPLETED|Overall Study||33||
59672446|NCT01050530|75791403|FG000|STARTED|Overall Study||82||
59672447|NCT01050530|75791404|FG001|STARTED|Overall Study||80||
59672448|NCT01050530|75791403|FG000|COMPLETED|Overall Study||74||
59672449|NCT01050530|75791404|FG001|COMPLETED|Overall Study||70||
59672450|NCT01050530|75791403|FG000|NOT COMPLETED|Overall Study||8||
59672451|NCT01050530|75791404|FG001|NOT COMPLETED|Overall Study||10||
59672452|NCT01050257|75791413|FG000|STARTED|Overall Study||50||
59672453|NCT01050257|75791414|FG001|STARTED|Overall Study||53||
59672454|NCT01050257|75791415|FG002|STARTED|Overall Study||15||
59672455|NCT01050257|75791413|FG000|Received Treatment|Overall Study||49||
59672456|NCT01050257|75791414|FG001|Received Treatment|Overall Study||50||
59672457|NCT01050257|75791415|FG002|Received Treatment|Overall Study||14||
59672458|NCT01050257|75791413|FG000|Safety Population: Actual Dose Received|Overall Study||48||
59672459|NCT01050257|75791414|FG001|Safety Population: Actual Dose Received|Overall Study|One participant randomized to 100 mg actually received the 200 mg doses.|51||
59672460|NCT01050257|75791415|FG002|Safety Population: Actual Dose Received|Overall Study||14||
59672461|NCT01050257|75791413|FG000|Intent-to-treat Infected Confirmed|Overall Study||30||
59672462|NCT01050257|75791414|FG001|Intent-to-treat Infected Confirmed|Overall Study||32||
59672463|NCT01050257|75791415|FG002|Intent-to-treat Infected Confirmed|Overall Study||10||
59672464|NCT01050257|75791413|FG000|Switched to Oral Treatment|Overall Study||28||
59672465|NCT01050257|75791414|FG001|Switched to Oral Treatment|Overall Study||31||
59672466|NCT01050257|75791415|FG002|Switched to Oral Treatment|Overall Study||3||
59672467|NCT01050257|75791413|FG000|COMPLETED|Overall Study|Completed 5 days of treatment either IV or Oral|39||
59672468|NCT01050257|75791414|FG001|COMPLETED|Overall Study||40||
59672469|NCT01050257|75791415|FG002|COMPLETED|Overall Study||8||
59672470|NCT01050257|75791413|FG000|NOT COMPLETED|Overall Study||11||
59672471|NCT01050257|75791414|FG001|NOT COMPLETED|Overall Study||13||
59672472|NCT01050257|75791415|FG002|NOT COMPLETED|Overall Study||7||
59672473|NCT01050062|75791425|FG000|STARTED|Overall Study||1070||
59672474|NCT01050062|75791426|FG001|STARTED|Overall Study||355||
59672475|NCT01050062|75791425|FG000|COMPLETED|Overall Study||799||
59672476|NCT01050062|75791426|FG001|COMPLETED|Overall Study||243||
59672477|NCT01050062|75791425|FG000|NOT COMPLETED|Overall Study||271||
59672478|NCT01050062|75791426|FG001|NOT COMPLETED|Overall Study||112||
59672479|NCT00435227|75791436|FG000|STARTED|Overall Study||5||
59672480|NCT00435227|75791437|FG001|STARTED|Overall Study||7||
59672481|NCT00435227|75791436|FG000|COMPLETED|Overall Study||5||
59672482|NCT00435227|75791437|FG001|COMPLETED|Overall Study||7||
59672483|NCT00435227|75791436|FG000|NOT COMPLETED|Overall Study||0||
59672484|NCT00435227|75791437|FG001|NOT COMPLETED|Overall Study||0||
59672485|NCT00105989|75791444|FG000|STARTED|Acute - Open Label: Week 0-10||514||
59672486|NCT00105989|75791445|FG001|STARTED|Acute - Open Label: Week 0-10||0||
59672487|NCT00105989|75791444|FG000|COMPLETED|Acute - Open Label: Week 0-10||413||
59672488|NCT00105989|75791445|FG001|COMPLETED|Acute - Open Label: Week 0-10||0||
59672489|NCT00105989|75791444|FG000|NOT COMPLETED|Acute - Open Label: Week 0-10||101||
59815889|NCT01858597|75938309|FG001|STARTED|Overall Study||60||
59672490|NCT00105989|75791445|FG001|NOT COMPLETED|Acute - Open Label: Week 0-10||0||
59672491|NCT00105989|75791444|FG000|STARTED|Continuation - Open Label:Week 10-34||413||
59672492|NCT00105989|75791445|FG001|STARTED|Continuation - Open Label:Week 10-34||0||
59672493|NCT00105989|75791444|FG000|COMPLETED|Continuation - Open Label:Week 10-34||288||
59672494|NCT00105989|75791445|FG001|COMPLETED|Continuation - Open Label:Week 10-34||0||
59672495|NCT00105989|75791444|FG000|NOT COMPLETED|Continuation - Open Label:Week 10-34||125||
59672496|NCT00105989|75791445|FG001|NOT COMPLETED|Continuation - Open Label:Week 10-34||0||
59672497|NCT00105989|75791444|FG000|STARTED|Maintenance - Double-Blind:Week 34-86||146||
59672498|NCT00105989|75791445|FG001|STARTED|Maintenance - Double-Blind:Week 34-86||142||
59672499|NCT00105989|75791444|FG000|COMPLETED|Maintenance - Double-Blind:Week 34-86||96||
59672500|NCT00105989|75791445|FG001|COMPLETED|Maintenance - Double-Blind:Week 34-86||73||
59672501|NCT00105989|75791444|FG000|NOT COMPLETED|Maintenance - Double-Blind:Week 34-86||50||
59672502|NCT00105989|75791445|FG001|NOT COMPLETED|Maintenance - Double-Blind:Week 34-86||69||
59672503|NCT03277248|75791463|FG000|STARTED|Overall Study||272||
59672504|NCT03277248|75791464|FG001|STARTED|Overall Study||273||
59672505|NCT03277248|75791463|FG000|COMPLETED|Overall Study||254|Completed = Number of participants who completed the 96 weeks Treatment Period|
59672506|NCT03277248|75791464|FG001|COMPLETED|Overall Study||239|Completed = Number of participants who completed the 96 weeks Treatment Period|
59672507|NCT03277248|75791463|FG000|NOT COMPLETED|Overall Study||18||
59672508|NCT03277248|75791464|FG001|NOT COMPLETED|Overall Study||34||
59672509|NCT03276780|75791472|FG000|STARTED|Overall Study||41||
59672510|NCT03276780|75791473|FG001|STARTED|Overall Study||39||
59672511|NCT03276780|75791472|FG000|COMPLETED|Overall Study||23||
59672512|NCT03276780|75791473|FG001|COMPLETED|Overall Study||29||
59672513|NCT03276780|75791472|FG000|NOT COMPLETED|Overall Study||18||
59672514|NCT03276780|75791473|FG001|NOT COMPLETED|Overall Study||10||
59672515|NCT03270462|75791481|FG000|STARTED|Overall Study||20||
59672516|NCT03270462|75791481|FG000|COMPLETED|Overall Study||20||
59672517|NCT03270462|75791481|FG000|NOT COMPLETED|Overall Study||0||
59672518|NCT03271047|75791489|FG000|STARTED|Phase 1b: Dose Finding Period||10||
59672519|NCT03271047|75791490|FG001|STARTED|Phase 1b: Dose Finding Period||11||
59672520|NCT03271047|75791491|FG002|STARTED|Phase 1b: Dose Finding Period||0||
59672521|NCT03271047|75791492|FG003|STARTED|Phase 1b: Dose Finding Period||0||
59672522|NCT03271047|75791489|FG000|COMPLETED|Phase 1b: Dose Finding Period||0||
59672523|NCT03271047|75791490|FG001|COMPLETED|Phase 1b: Dose Finding Period||0||
59672524|NCT03271047|75791491|FG002|COMPLETED|Phase 1b: Dose Finding Period||0||
59672525|NCT03271047|75791492|FG003|COMPLETED|Phase 1b: Dose Finding Period||0||
59672526|NCT03271047|75791489|FG000|NOT COMPLETED|Phase 1b: Dose Finding Period||10||
59672527|NCT03271047|75791490|FG001|NOT COMPLETED|Phase 1b: Dose Finding Period||11||
59672528|NCT03271047|75791491|FG002|NOT COMPLETED|Phase 1b: Dose Finding Period||0||
59672529|NCT03271047|75791492|FG003|NOT COMPLETED|Phase 1b: Dose Finding Period||0||
59672530|NCT03271047|75791489|FG000|STARTED|Randomized Phase 2 Period||0||
59672531|NCT03271047|75791490|FG001|STARTED|Randomized Phase 2 Period||0||
59672532|NCT03271047|75791491|FG002|STARTED|Randomized Phase 2 Period|Participants randomized to Phase 2 of the study.|27||
59672533|NCT03271047|75791492|FG003|STARTED|Randomized Phase 2 Period|Participants randomized to Phase 2 of the study.|27||
59672534|NCT03271047|75791489|FG000|COMPLETED|Randomized Phase 2 Period||0||
59672535|NCT03271047|75791490|FG001|COMPLETED|Randomized Phase 2 Period||0||
59672536|NCT03271047|75791491|FG002|COMPLETED|Randomized Phase 2 Period||0||
59672537|NCT03271047|75791492|FG003|COMPLETED|Randomized Phase 2 Period||0||
59672538|NCT03271047|75791489|FG000|NOT COMPLETED|Randomized Phase 2 Period||0||
59672539|NCT03271047|75791490|FG001|NOT COMPLETED|Randomized Phase 2 Period||0||
59672540|NCT03271047|75791491|FG002|NOT COMPLETED|Randomized Phase 2 Period||27||
59672541|NCT03271047|75791492|FG003|NOT COMPLETED|Randomized Phase 2 Period||27||
59672542|NCT03276936|75791506|FG000|STARTED|Overall Study||332||
59672543|NCT03276936|75791507|FG001|STARTED|Overall Study||172||
59672544|NCT03276936|75791506|FG000|COMPLETED|Overall Study||276||
59672545|NCT03276936|75791507|FG001|COMPLETED|Overall Study||134||
59672546|NCT03276936|75791506|FG000|NOT COMPLETED|Overall Study||56||
59672547|NCT03276936|75791507|FG001|NOT COMPLETED|Overall Study||38||
59672548|NCT00106002|75791513|FG000|STARTED|Overall Study||37||
59672549|NCT00106002|75791513|FG000|COMPLETED|Overall Study|Completed means that the patient was evaluable for response.|35||
59672550|NCT00106002|75791513|FG000|NOT COMPLETED|Overall Study||2||
59672551|NCT03271983|75791517|FG000|STARTED|Overall Study|The plan was to do n=12 volunteers; however, funding was terminated due to pandemic so only 7 volunteers were completed.|7||
59672552|NCT03271983|75791517|FG000|COMPLETED|Overall Study||7||
59672553|NCT03271983|75791517|FG000|NOT COMPLETED|Overall Study||0||
59672554|NCT03272763|75791525|FG000|STARTED|Overall Study||38||
59672555|NCT03272763|75791525|FG000|COMPLETED|Overall Study||38||
59672556|NCT03272763|75791525|FG000|NOT COMPLETED|Overall Study||0||
59672557|NCT00105482|75791531|FG000|STARTED|Overall Study||87||
59672558|NCT00105482|75791532|FG001|STARTED|Overall Study||85||
59672559|NCT00105482|75791531|FG000|COMPLETED|Overall Study||28||
59672560|NCT00105482|75791532|FG001|COMPLETED|Overall Study||30||
59672561|NCT00105482|75791531|FG000|NOT COMPLETED|Overall Study||59||
59672562|NCT00105482|75791532|FG001|NOT COMPLETED|Overall Study||55||
59672563|NCT01327651|75791547|FG000|STARTED|Self-administered Dosing Period||60|Week 6 (Randomization visit)|
59672564|NCT01327651|75791548|FG001|STARTED|Self-administered Dosing Period||59|Week 6 (Randomization visit)|
59672565|NCT01327651|75791549|FG002|STARTED|Self-administered Dosing Period||60|Week 6 (Randomization visit)|
59672566|NCT01327651|75791550|FG003|STARTED|Self-administered Dosing Period||60|Week 6 (Randomization visit)|
59672567|NCT01327651|75791551|FG004|STARTED|Self-administered Dosing Period||59|Week 6 (Randomization visit)|
59672568|NCT01327651|75791552|FG005|STARTED|Self-administered Dosing Period||59|Week 6 (Randomization visit)|
59672569|NCT01327651|75791553|FG006|STARTED|Self-administered Dosing Period||59|Week 6 (Randomization visit)|
59672570|NCT01327651|75791554|FG007|STARTED|Self-administered Dosing Period||60|Week 6 (Randomization visit)|
59672571|NCT01327651|75791555|FG008|STARTED|Self-administered Dosing Period||60|Week 6 (Randomization visit)|
59672572|NCT01327651|75791547|FG000|Week 10|Self-administered Dosing Period||59||
59672573|NCT01327651|75791548|FG001|Week 10|Self-administered Dosing Period||58||
59672574|NCT01327651|75791549|FG002|Week 10|Self-administered Dosing Period||60||
59672575|NCT01327651|75791550|FG003|Week 10|Self-administered Dosing Period||60||
59672576|NCT01327651|75791551|FG004|Week 10|Self-administered Dosing Period||59||
59672577|NCT01327651|75791552|FG005|Week 10|Self-administered Dosing Period||59||
59672578|NCT01327651|75791553|FG006|Week 10|Self-administered Dosing Period||57||
59672579|NCT01327651|75791554|FG007|Week 10|Self-administered Dosing Period||57||
59672580|NCT01327651|75791555|FG008|Week 10|Self-administered Dosing Period||56||
59672581|NCT01327651|75791547|FG000|Week 14|Self-administered Dosing Period||59||
59672582|NCT01327651|75791548|FG001|Week 14|Self-administered Dosing Period||55||
59672583|NCT01327651|75791549|FG002|Week 14|Self-administered Dosing Period||57||
59672584|NCT01327651|75791550|FG003|Week 14|Self-administered Dosing Period||60||
59672585|NCT01327651|75791551|FG004|Week 14|Self-administered Dosing Period||58||
59672586|NCT01327651|75791552|FG005|Week 14|Self-administered Dosing Period||59||
59672587|NCT01327651|75791553|FG006|Week 14|Self-administered Dosing Period||54||
59672588|NCT01327651|75791554|FG007|Week 14|Self-administered Dosing Period||51||
59672589|NCT01327651|75791555|FG008|Week 14|Self-administered Dosing Period||54||
59672590|NCT01327651|75791547|FG000|Week 18|Self-administered Dosing Period||57||
59672591|NCT01327651|75791548|FG001|Week 18|Self-administered Dosing Period||56||
59672592|NCT01327651|75791549|FG002|Week 18|Self-administered Dosing Period||56||
59672593|NCT01327651|75791550|FG003|Week 18|Self-administered Dosing Period||60||
59672594|NCT01327651|75791551|FG004|Week 18|Self-administered Dosing Period||57||
59672595|NCT01327651|75791552|FG005|Week 18|Self-administered Dosing Period||59||
59672596|NCT01327651|75791553|FG006|Week 18|Self-administered Dosing Period||53||
59672597|NCT01327651|75791554|FG007|Week 18|Self-administered Dosing Period||49||
59672598|NCT01327651|75791555|FG008|Week 18|Self-administered Dosing Period||53||
59672599|NCT01327651|75791547|FG000|Week 22|Self-administered Dosing Period||59||
59672600|NCT01327651|75791548|FG001|Week 22|Self-administered Dosing Period||56||
59672601|NCT01327651|75791549|FG002|Week 22|Self-administered Dosing Period||55||
59672602|NCT01327651|75791550|FG003|Week 22|Self-administered Dosing Period||58||
59672603|NCT01327651|75791551|FG004|Week 22|Self-administered Dosing Period||56||
59672604|NCT01327651|75791552|FG005|Week 22|Self-administered Dosing Period||59||
59672605|NCT01327651|75791553|FG006|Week 22|Self-administered Dosing Period||50||
59672606|NCT01327651|75791554|FG007|Week 22|Self-administered Dosing Period||50||
59672607|NCT01327651|75791555|FG008|Week 22|Self-administered Dosing Period||51||
59672608|NCT01327651|75791547|FG000|Week 26|Self-administered Dosing Period||58||
59672609|NCT01327651|75791548|FG001|Week 26|Self-administered Dosing Period||56||
59672610|NCT01327651|75791549|FG002|Week 26|Self-administered Dosing Period||53||
59672611|NCT01327651|75791550|FG003|Week 26|Self-administered Dosing Period||57||
59672612|NCT01327651|75791551|FG004|Week 26|Self-administered Dosing Period||56||
59989396|NCT04210843|76104681|FG001|COMPLETED|Second Half Treatment Period (52 Weeks)||2||
59989397|NCT04210843|76104680|FG000|NOT COMPLETED|Second Half Treatment Period (52 Weeks)||76||
59989398|NCT04210843|76104681|FG001|NOT COMPLETED|Second Half Treatment Period (52 Weeks)||204||
59989399|NCT04210843|76104680|FG000|STARTED|Observation Period 2 (up to 52 Weeks)||69|Participants with UAS7 ≤ 6 at Week 52|
59989400|NCT04210843|76104681|FG001|STARTED|Observation Period 2 (up to 52 Weeks)||201|Participants with UAS7 ≤ 6 at Week 52|
59672613|NCT01327651|75791552|FG005|Week 26|Self-administered Dosing Period||58||
59989401|NCT04210843|76104680|FG000|COMPLETED|Observation Period 2 (up to 52 Weeks)||24||
59989402|NCT04210843|76104681|FG001|COMPLETED|Observation Period 2 (up to 52 Weeks)||91||
59989403|NCT04210843|76104680|FG000|NOT COMPLETED|Observation Period 2 (up to 52 Weeks)||45||
59989404|NCT04210843|76104681|FG001|NOT COMPLETED|Observation Period 2 (up to 52 Weeks)||110||
60077930|NCT01077856|76192916|FG001|STARTED|Overall Study||16604||
60077931|NCT01077856|76192917|FG002|STARTED|Overall Study||15713||
60077932|NCT01077856|76192915|FG000|COMPLETED|Overall Study||22199||
59672614|NCT01327651|75791553|FG006|Week 26|Self-administered Dosing Period||50||
59672615|NCT01327651|75791554|FG007|Week 26|Self-administered Dosing Period||51||
59672616|NCT01327651|75791555|FG008|Week 26|Self-administered Dosing Period||49||
59672617|NCT01327651|75791547|FG000|COMPLETED|Self-administered Dosing Period||56|Week 30|
59672618|NCT01327651|75791548|FG001|COMPLETED|Self-administered Dosing Period||56|Week 30|
59672619|NCT01327651|75791549|FG002|COMPLETED|Self-administered Dosing Period||56|Week 30|
59672620|NCT01327651|75791550|FG003|COMPLETED|Self-administered Dosing Period||57|Week 30|
59672621|NCT01327651|75791551|FG004|COMPLETED|Self-administered Dosing Period||56|Week 30|
59672622|NCT01327651|75791552|FG005|COMPLETED|Self-administered Dosing Period||59|Week 30|
59672623|NCT01327651|75791553|FG006|COMPLETED|Self-administered Dosing Period||49|Week 30|
59672624|NCT01327651|75791554|FG007|COMPLETED|Self-administered Dosing Period||50|Week 30|
59672625|NCT01327651|75791555|FG008|COMPLETED|Self-administered Dosing Period||49|Week 30|
59672626|NCT01327651|75791547|FG000|NOT COMPLETED|Self-administered Dosing Period||4||
59672627|NCT01327651|75791548|FG001|NOT COMPLETED|Self-administered Dosing Period||3||
59672628|NCT01327651|75791549|FG002|NOT COMPLETED|Self-administered Dosing Period||4||
59672629|NCT01327651|75791550|FG003|NOT COMPLETED|Self-administered Dosing Period||3||
59672630|NCT01327651|75791551|FG004|NOT COMPLETED|Self-administered Dosing Period||3||
59672631|NCT01327651|75791552|FG005|NOT COMPLETED|Self-administered Dosing Period||0||
59672632|NCT01327651|75791553|FG006|NOT COMPLETED|Self-administered Dosing Period||10||
59672633|NCT01327651|75791554|FG007|NOT COMPLETED|Self-administered Dosing Period||10||
59672634|NCT01327651|75791555|FG008|NOT COMPLETED|Self-administered Dosing Period||11||
59672635|NCT01327651|75791547|FG000|STARTED|Post Study Follow-up||56|Week 30|
59672636|NCT01327651|75791548|FG001|STARTED|Post Study Follow-up||56|Week 30|
59672637|NCT01327651|75791549|FG002|STARTED|Post Study Follow-up||56|Week 30|
59672638|NCT01327651|75791550|FG003|STARTED|Post Study Follow-up||57|Week 30|
59672639|NCT01327651|75791551|FG004|STARTED|Post Study Follow-up||56|Week 30|
59672640|NCT01327651|75791552|FG005|STARTED|Post Study Follow-up||59|Week 30|
59672641|NCT01327651|75791553|FG006|STARTED|Post Study Follow-up||49|Week 30|
59672642|NCT01327651|75791554|FG007|STARTED|Post Study Follow-up||50|Week 30|
59672643|NCT01327651|75791555|FG008|STARTED|Post Study Follow-up||49|Week 30|
59672644|NCT01327651|75791547|FG000|COMPLETED|Post Study Follow-up||56|Week 34|
59672645|NCT01327651|75791548|FG001|COMPLETED|Post Study Follow-up||55|Week 34|
59672646|NCT01327651|75791549|FG002|COMPLETED|Post Study Follow-up||55|Week 34|
59672647|NCT01327651|75791550|FG003|COMPLETED|Post Study Follow-up||57|Week 34|
59672648|NCT01327651|75791551|FG004|COMPLETED|Post Study Follow-up||56|Week 34|
59672649|NCT01327651|75791552|FG005|COMPLETED|Post Study Follow-up||59|Week 34|
59672650|NCT01327651|75791553|FG006|COMPLETED|Post Study Follow-up||45|Week 34|
59672651|NCT01327651|75791554|FG007|COMPLETED|Post Study Follow-up||49|Week 34|
59672652|NCT01327651|75791555|FG008|COMPLETED|Post Study Follow-up||47|Week 34|
59672653|NCT01327651|75791547|FG000|NOT COMPLETED|Post Study Follow-up||0||
59672654|NCT01327651|75791548|FG001|NOT COMPLETED|Post Study Follow-up||1||
59672655|NCT01327651|75791549|FG002|NOT COMPLETED|Post Study Follow-up||1||
59672656|NCT01327651|75791550|FG003|NOT COMPLETED|Post Study Follow-up||0||
59672657|NCT01327651|75791551|FG004|NOT COMPLETED|Post Study Follow-up||0||
59672658|NCT01327651|75791552|FG005|NOT COMPLETED|Post Study Follow-up||0||
59672659|NCT01327651|75791553|FG006|NOT COMPLETED|Post Study Follow-up||4||
59672660|NCT01327651|75791554|FG007|NOT COMPLETED|Post Study Follow-up||1||
59672661|NCT01327651|75791555|FG008|NOT COMPLETED|Post Study Follow-up||2||
59672662|NCT00105443|75791596|FG000|STARTED|Double-Blind Treatment||242||
59672663|NCT00105443|75791597|FG001|STARTED|Double-Blind Treatment||57||
59672664|NCT00105443|75791598|FG002|STARTED|Double-Blind Treatment||256||
59672665|NCT00105443|75791599|FG003|STARTED|Double-Blind Treatment||47||
59672666|NCT00105443|75791596|FG000|Received Treatment|Double-Blind Treatment|Subjects at Risk/Safety Population - partly in RG1 and RG3 (RG = Reporting Group for Safety Data)|240||
59672667|NCT00105443|75791597|FG001|Received Treatment|Double-Blind Treatment|Subjects at Risk/Safety Population - partly in RG1 and RG3|57||
59672668|NCT00105443|75791598|FG002|Received Treatment|Double-Blind Treatment|Subjects at Risk/Safety Population - partly in RG2 and RG4|255||
59672669|NCT00105443|75791599|FG003|Received Treatment|Double-Blind Treatment|Subjects at Risk/Safety Population - partly in RG2 and RG4 as well as RG5|47||
59672670|NCT00105443|75791596|FG000|COMPLETED|Double-Blind Treatment|228 participants directly switched to the Follow-up (FU) phase only|228||
59672671|NCT00105443|75791597|FG001|COMPLETED|Double-Blind Treatment|47 participants continued with Sorafenib Open Label (OL); 10 first to FU prior to also switch to OL|57||
59672672|NCT00105443|75791598|FG002|COMPLETED|Double-Blind Treatment|245 participants directly switched to the Follow-up (FU) phase|245||
59672673|NCT00105443|75791599|FG003|COMPLETED|Double-Blind Treatment|36 participants switched to Sorafenib Open Label (OL); 11 first to FU prior to also switch to OL|47||
59672674|NCT00105443|75791596|FG000|NOT COMPLETED|Double-Blind Treatment||14||
59672675|NCT00105443|75791597|FG001|NOT COMPLETED|Double-Blind Treatment||0||
59672676|NCT00105443|75791598|FG002|NOT COMPLETED|Double-Blind Treatment||11||
59672677|NCT00105443|75791599|FG003|NOT COMPLETED|Double-Blind Treatment||0||
59672678|NCT00105443|75791596|FG000|STARTED|Follow-up and/or Open Label Nexavar|At start of period, 228 participants directly switched to Follow-up (FU)|228||
59672679|NCT00105443|75791597|FG001|STARTED|Follow-up and/or Open Label Nexavar|At start of period, 47 participants directly switched to Open Label (OL) Sorafenib treatment|57||
59672680|NCT00105443|75791598|FG002|STARTED|Follow-up and/or Open Label Nexavar|At start of period, 245 participants directly switched to Follow-up (FU)|245||
59672681|NCT00105443|75791599|FG003|STARTED|Follow-up and/or Open Label Nexavar|At start of period, 36 participants directly switched to Open Label (OL) Sorafenib treatment|47||
59672682|NCT00105443|75791596|FG000|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Nexavar|"In parallel to Open Label treatment only phase"|228||
59672683|NCT00105443|75791597|FG001|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Nexavar||0||
59672684|NCT00105443|75791598|FG002|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Nexavar|"In parallel to Open Label treatment only phase"|245||
59672685|NCT00105443|75791599|FG003|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Nexavar||0||
59672686|NCT00105443|75791596|FG000|Open Label Treatment Only (no Follow-up)|Follow-up and/or Open Label Nexavar||0||
59672687|NCT00105443|75791597|FG001|Open Label Treatment Only (no Follow-up)|Follow-up and/or Open Label Nexavar|"In parallel to Follow-up only phase; participants received Sorafenib 400 mg bid"|47||
59672688|NCT00105443|75791598|FG002|Open Label Treatment Only (no Follow-up)|Follow-up and/or Open Label Nexavar||0||
59672689|NCT00105443|75791599|FG003|Open Label Treatment Only (no Follow-up)|Follow-up and/or Open Label Nexavar|"In parallel to Follow-up only phase; participants received Sorafenib 400 mg bid"|36||
59672690|NCT00105443|75791596|FG000|Follow-up First, Then Open Label|Follow-up and/or Open Label Nexavar||0||
59672691|NCT00105443|75791597|FG001|Follow-up First, Then Open Label|Follow-up and/or Open Label Nexavar||10||
59672692|NCT00105443|75791598|FG002|Follow-up First, Then Open Label|Follow-up and/or Open Label Nexavar||0||
59672693|NCT00105443|75791599|FG003|Follow-up First, Then Open Label|Follow-up and/or Open Label Nexavar||11||
59672694|NCT00105443|75791596|FG000|COMPLETED|Follow-up and/or Open Label Nexavar||0||
59672695|NCT00105443|75791597|FG001|COMPLETED|Follow-up and/or Open Label Nexavar|57 participants in total (47 + 10) received Open Label Sorafenib treatment (Subjects at Risk)|0||
59672696|NCT00105443|75791598|FG002|COMPLETED|Follow-up and/or Open Label Nexavar||0||
59672697|NCT00105443|75791599|FG003|COMPLETED|Follow-up and/or Open Label Nexavar|47 participants in total (36 + 11) received Open Label Sorafenib treatment (Subjects at Risk)|0||
59672698|NCT00105443|75791596|FG000|NOT COMPLETED|Follow-up and/or Open Label Nexavar||228||
59672699|NCT00105443|75791597|FG001|NOT COMPLETED|Follow-up and/or Open Label Nexavar||57||
59672700|NCT00105443|75791598|FG002|NOT COMPLETED|Follow-up and/or Open Label Nexavar||245||
59672701|NCT00105443|75791599|FG003|NOT COMPLETED|Follow-up and/or Open Label Nexavar||47||
59672702|NCT01327612|75791615|FG000|STARTED|Overall Study||2||
59672703|NCT01327612|75791616|FG001|STARTED|Overall Study||1||
59672704|NCT01327612|75791617|FG002|STARTED|Overall Study||1||
59672705|NCT01327612|75791618|FG003|STARTED|Overall Study||1||
59672706|NCT01327612|75791619|FG004|STARTED|Overall Study||2||
59672707|NCT01327612|75791620|FG005|STARTED|Overall Study||3||
59672708|NCT01327612|75791621|FG006|STARTED|Overall Study||2||
59672709|NCT01327612|75791615|FG000|COMPLETED|Overall Study||1||
59672710|NCT01327612|75791616|FG001|COMPLETED|Overall Study||0||
59672711|NCT01327612|75791617|FG002|COMPLETED|Overall Study||0||
59672712|NCT01327612|75791618|FG003|COMPLETED|Overall Study||0||
59672713|NCT01327612|75791619|FG004|COMPLETED|Overall Study||0||
59672714|NCT01327612|75791620|FG005|COMPLETED|Overall Study||0||
59672715|NCT01327612|75791621|FG006|COMPLETED|Overall Study||0||
59672716|NCT01327612|75791615|FG000|NOT COMPLETED|Overall Study||1||
59672717|NCT01327612|75791616|FG001|NOT COMPLETED|Overall Study||1||
59672718|NCT01327612|75791617|FG002|NOT COMPLETED|Overall Study||1||
59672719|NCT01327612|75791618|FG003|NOT COMPLETED|Overall Study||1||
59672720|NCT01327612|75791619|FG004|NOT COMPLETED|Overall Study||2||
59672721|NCT01327612|75791620|FG005|NOT COMPLETED|Overall Study||3||
59672722|NCT01327612|75791621|FG006|NOT COMPLETED|Overall Study||2||
59672723|NCT01327573|75791640|FG000|STARTED|Overall Study||11||
59672724|NCT01327573|75791641|FG001|STARTED|Overall Study||5||
59672725|NCT01327573|75791640|FG000|Received Treatment/Control as Allocated|Overall Study||10||
59672726|NCT01327573|75791641|FG001|Received Treatment/Control as Allocated|Overall Study||5||
59672727|NCT01327573|75791640|FG000|COMPLETED|Overall Study||8||
59672728|NCT01327573|75791641|FG001|COMPLETED|Overall Study||4||
59672729|NCT01327573|75791640|FG000|NOT COMPLETED|Overall Study||3||
59672730|NCT01327573|75791641|FG001|NOT COMPLETED|Overall Study||1||
59672731|NCT01327495|75791654|FG000|STARTED|Overall Study||10||
59672732|NCT01327495|75791655|FG001|STARTED|Overall Study||11||
59672733|NCT01327495|75791656|FG002|STARTED|Overall Study||10||
59672734|NCT01327495|75791657|FG003|STARTED|Overall Study||9||
59672735|NCT01327495|75791658|FG004|STARTED|Overall Study||11||
59672736|NCT01327495|75791659|FG005|STARTED|Overall Study||11||
59672737|NCT01327495|75791654|FG000|COMPLETED|Overall Study|1 dropped due to decreased libido & energy, 1 dropped due to too much pain with acyline injections|8||
59672738|NCT01327495|75791655|FG001|COMPLETED|Overall Study|1 subject declined prostate biopsy & no-showed to final visit, 1 subject dropped d/t elevated LFTs.|9||
59672739|NCT01327495|75791656|FG002|COMPLETED|Overall Study|1 withdrawn due to injection AE. 1 drop-out (declined prostate biopsy and final visit).|8||
59672740|NCT01327495|75791657|FG003|COMPLETED|Overall Study||9||
59672741|NCT01327495|75791658|FG004|COMPLETED|Overall Study|1 dropped out pre drug finish, 2 non-compliant subjects dropped|8||
59672742|NCT01327495|75791659|FG005|COMPLETED|Overall Study|1 subject withdrawn d/t elevated LFTs, 1 dropped out d/t ski accident|9||
59672743|NCT01327495|75791654|FG000|NOT COMPLETED|Overall Study||2||
59672744|NCT01327495|75791655|FG001|NOT COMPLETED|Overall Study||2||
59672745|NCT01327495|75791656|FG002|NOT COMPLETED|Overall Study||2||
59672746|NCT01327495|75791657|FG003|NOT COMPLETED|Overall Study||0||
59672747|NCT01327495|75791658|FG004|NOT COMPLETED|Overall Study||3||
59672748|NCT01327495|75791659|FG005|NOT COMPLETED|Overall Study||2||
59672749|NCT01327339|75791679|FG000|STARTED|Overall Study||755||
59672750|NCT01327339|75791679|FG000|COMPLETED|Overall Study||747||
59672751|NCT01327339|75791679|FG000|NOT COMPLETED|Overall Study||8||
59672752|NCT01327300|75791683|FG000|STARTED|First Intervention (12 Weeks)||5||
59672753|NCT01327300|75791684|FG001|STARTED|First Intervention (12 Weeks)||2||
59672754|NCT01327300|75791683|FG000|COMPLETED|First Intervention (12 Weeks)||5||
59672755|NCT01327300|75791684|FG001|COMPLETED|First Intervention (12 Weeks)||2||
59672756|NCT01327300|75791683|FG000|NOT COMPLETED|First Intervention (12 Weeks)||0||
59672757|NCT01327300|75791684|FG001|NOT COMPLETED|First Intervention (12 Weeks)||0||
59672758|NCT01327300|75791683|FG000|STARTED|Washout (3 Weeks)||5||
59672759|NCT01327300|75791684|FG001|STARTED|Washout (3 Weeks)||2||
59672760|NCT01327300|75791683|FG000|COMPLETED|Washout (3 Weeks)||4||
59672761|NCT01327300|75791684|FG001|COMPLETED|Washout (3 Weeks)||2||
59672762|NCT01327300|75791683|FG000|NOT COMPLETED|Washout (3 Weeks)||1||
59672763|NCT01327300|75791684|FG001|NOT COMPLETED|Washout (3 Weeks)||0||
59672764|NCT01327300|75791683|FG000|STARTED|Second Intervention (12 Weeks)||4||
59672765|NCT01327300|75791684|FG001|STARTED|Second Intervention (12 Weeks)||2||
59672766|NCT01327300|75791683|FG000|COMPLETED|Second Intervention (12 Weeks)||4||
59672767|NCT01327300|75791684|FG001|COMPLETED|Second Intervention (12 Weeks)||2||
59672768|NCT01327300|75791683|FG000|NOT COMPLETED|Second Intervention (12 Weeks)||0||
59672769|NCT01327300|75791684|FG001|NOT COMPLETED|Second Intervention (12 Weeks)||0||
59672770|NCT01379521|75791702|FG000|STARTED|Overall Study -Treatment Period||33||
59672771|NCT01379521|75791703|FG001|STARTED|Overall Study -Treatment Period||26||
59672772|NCT01379521|75791702|FG000|COMPLETED|Overall Study -Treatment Period||0||
59672773|NCT01379521|75791703|FG001|COMPLETED|Overall Study -Treatment Period||0||
59672774|NCT01379521|75791702|FG000|NOT COMPLETED|Overall Study -Treatment Period||33||
59672775|NCT01379521|75791703|FG001|NOT COMPLETED|Overall Study -Treatment Period||26||
59672776|NCT01379521|75791702|FG000|STARTED|Post-Treatment Evaluations||25||
59672777|NCT01379521|75791703|FG001|STARTED|Post-Treatment Evaluations||21||
59672778|NCT01379521|75791702|FG000|COMPLETED|Post-Treatment Evaluations||0||
59672779|NCT01379521|75791703|FG001|COMPLETED|Post-Treatment Evaluations||0||
59672780|NCT01379521|75791702|FG000|NOT COMPLETED|Post-Treatment Evaluations||25||
59672781|NCT01379521|75791703|FG001|NOT COMPLETED|Post-Treatment Evaluations||21||
59672782|NCT01371994|75791711|FG000|STARTED|Overall Study||320||
59672783|NCT01371994|75791712|FG001|STARTED|Overall Study||320||
59672784|NCT01371994|75791711|FG000|Received Treatment|Overall Study||310||
59672785|NCT01371994|75791712|FG001|Received Treatment|Overall Study||313||
59672786|NCT01371994|75791711|FG000|COMPLETED|Overall Study||263||
59672787|NCT01371994|75791712|FG001|COMPLETED|Overall Study||278||
59672788|NCT01371994|75791711|FG000|NOT COMPLETED|Overall Study||57||
59672789|NCT01371994|75791712|FG001|NOT COMPLETED|Overall Study||42||
59672790|NCT01371877|75791720|FG000|STARTED|Overall Study||21||
59672791|NCT01371877|75791721|FG001|STARTED|Overall Study||21||
59672792|NCT01371877|75791720|FG000|COMPLETED|Overall Study||21||
59672793|NCT01371877|75791721|FG001|COMPLETED|Overall Study||17||
59672794|NCT01371877|75791720|FG000|NOT COMPLETED|Overall Study||0||
59672795|NCT01371877|75791721|FG001|NOT COMPLETED|Overall Study||4||
59672796|NCT01371838|75791729|FG000|STARTED|Overall Study||381||
59672797|NCT01371838|75791730|FG001|STARTED|Overall Study||383||
59672798|NCT01371838|75791729|FG000|COMPLETED|Overall Study||332||
59672799|NCT01371838|75791730|FG001|COMPLETED|Overall Study||317||
59672800|NCT01371838|75791729|FG000|NOT COMPLETED|Overall Study||49||
59672801|NCT01371838|75791730|FG001|NOT COMPLETED|Overall Study||66||
59672802|NCT01371721|75791739|FG000|STARTED|Overall Study||88||
59672803|NCT01371721|75791740|FG001|STARTED|Overall Study||89||
59672804|NCT01371721|75791741|FG002|STARTED|Overall Study||92||
59672805|NCT01371721|75791739|FG000|Treated|Overall Study||87||
59672806|NCT01371721|75791740|FG001|Treated|Overall Study||89||
59672807|NCT01371721|75791741|FG002|Treated|Overall Study||92||
59672808|NCT01371721|75791739|FG000|COMPLETED|Overall Study||59||
59672809|NCT01371721|75791740|FG001|COMPLETED|Overall Study||65||
59672810|NCT01371721|75791741|FG002|COMPLETED|Overall Study||62||
59672811|NCT01371721|75791739|FG000|NOT COMPLETED|Overall Study||29||
59672812|NCT01371721|75791740|FG001|NOT COMPLETED|Overall Study||24||
59672813|NCT01371721|75791741|FG002|NOT COMPLETED|Overall Study||30||
59672814|NCT01366534|75791754|FG000|STARTED|Overall Study||28||
59672815|NCT01366534|75791755|FG001|STARTED|Overall Study||27||
59672816|NCT01366534|75791756|FG002|STARTED|Overall Study||12||
59672817|NCT01366534|75791754|FG000|COMPLETED|Overall Study||26||
59672818|NCT01366534|75791755|FG001|COMPLETED|Overall Study||25||
59672819|NCT01366534|75791756|FG002|COMPLETED|Overall Study||12||
59672820|NCT01366534|75791754|FG000|NOT COMPLETED|Overall Study||2||
59672821|NCT01366534|75791755|FG001|NOT COMPLETED|Overall Study||2||
59672822|NCT01366534|75791756|FG002|NOT COMPLETED|Overall Study||0||
59672823|NCT01365910|75791764|FG000|STARTED|Overall Study||30||
59672824|NCT01365910|75791764|FG000|COMPLETED|Overall Study||0||
59672825|NCT01365910|75791764|FG000|NOT COMPLETED|Overall Study||30||
59672826|NCT01365481|75791772|FG000|STARTED|Overall Study||23||
59672827|NCT01365481|75791773|FG001|STARTED|Overall Study||52||
59672828|NCT01365481|75791774|FG002|STARTED|Overall Study||18||
59672829|NCT01365481|75791775|FG003|STARTED|Overall Study||57||
59672830|NCT01365481|75791772|FG000|COMPLETED|Overall Study||16||
59672831|NCT01365481|75791773|FG001|COMPLETED|Overall Study||37||
59672832|NCT01365481|75791774|FG002|COMPLETED|Overall Study||14||
59672833|NCT01365481|75791775|FG003|COMPLETED|Overall Study||50||
59672834|NCT01365481|75791772|FG000|NOT COMPLETED|Overall Study||7||
59672835|NCT01365481|75791773|FG001|NOT COMPLETED|Overall Study||15||
59672836|NCT01365481|75791774|FG002|NOT COMPLETED|Overall Study||4||
59672837|NCT01365481|75791775|FG003|NOT COMPLETED|Overall Study||7||
59672838|NCT01357915|75791787|FG000|STARTED|Overall Study||30||
59672839|NCT01357915|75791788|FG001|STARTED|Overall Study||17||
59672840|NCT01357915|75791787|FG000|COMPLETED|Overall Study||27||
59672841|NCT01357915|75791788|FG001|COMPLETED|Overall Study||17||
59672842|NCT01357915|75791787|FG000|NOT COMPLETED|Overall Study||3||
59672843|NCT01357915|75791788|FG001|NOT COMPLETED|Overall Study||0||
59672844|NCT01350973|75791797|FG000|STARTED|Overall Study||206||
59672845|NCT01350973|75791798|FG001|STARTED|Overall Study||210||
59672846|NCT01350973|75791799|FG002|STARTED|Overall Study||195||
59672847|NCT01350973|75791797|FG000|Received Treatment|Overall Study||205||
59672848|NCT01350973|75791798|FG001|Received Treatment|Overall Study||210||
59672849|NCT01350973|75791799|FG002|Received Treatment|Overall Study||195||
59672850|NCT01350973|75791797|FG000|COMPLETED|Overall Study||200||
59672851|NCT01350973|75791798|FG001|COMPLETED|Overall Study||202||
59672852|NCT01350973|75791799|FG002|COMPLETED|Overall Study||187||
59672853|NCT01350973|75791797|FG000|NOT COMPLETED|Overall Study||6||
59672854|NCT01350973|75791798|FG001|NOT COMPLETED|Overall Study||8||
59672855|NCT01350973|75791799|FG002|NOT COMPLETED|Overall Study||8||
59672856|NCT01350544|75791809|FG000|STARTED|Overall Study||108||
59672857|NCT01350544|75791810|FG001|STARTED|Overall Study||108||
59672858|NCT01350544|75791809|FG000|COMPLETED|Overall Study||85||
59672859|NCT01350544|75791810|FG001|COMPLETED|Overall Study||86||
59672860|NCT01350544|75791809|FG000|NOT COMPLETED|Overall Study||23||
59672861|NCT01350544|75791810|FG001|NOT COMPLETED|Overall Study||22||
59672862|NCT01350505|75791816|FG000|STARTED|Overall Study||21||
59672863|NCT01350505|75791816|FG000|COMPLETED|Overall Study||17||
59672864|NCT01350505|75791816|FG000|NOT COMPLETED|Overall Study||4||
59672865|NCT01350271|75791823|FG000|STARTED|Overall Study||70||
59672866|NCT01350271|75791824|FG001|STARTED|Overall Study||70||
59672867|NCT01350271|75791825|FG002|STARTED|Overall Study||74||
59672868|NCT01350271|75791823|FG000|COMPLETED|Overall Study||49||
59672869|NCT01350271|75791824|FG001|COMPLETED|Overall Study||53||
59672870|NCT01350271|75791825|FG002|COMPLETED|Overall Study||48||
59672871|NCT01350271|75791823|FG000|NOT COMPLETED|Overall Study||21||
59672872|NCT01350271|75791824|FG001|NOT COMPLETED|Overall Study||17||
59672873|NCT01350271|75791825|FG002|NOT COMPLETED|Overall Study||26||
59672874|NCT01348828|75791836|FG000|STARTED|Overall Study||49||
59672875|NCT01348828|75791836|FG000|COMPLETED|Overall Study||16||
59672876|NCT01348828|75791836|FG000|NOT COMPLETED|Overall Study||33||
59672877|NCT01348789|75791840|FG000|STARTED|Overall Study||37||
59672878|NCT01348789|75791840|FG000|COMPLETED|Overall Study|4 subjects did not complete all 3 treatments but were evaluated for primary and secondary endpoints.|33||
59672879|NCT01348789|75791840|FG000|NOT COMPLETED|Overall Study||4||
59672880|NCT01342510|75791855|FG000|STARTED|Overall Study||50||
59672881|NCT01342510|75791856|FG001|STARTED|Overall Study||50||
59672882|NCT01342510|75791857|FG002|STARTED|Overall Study||50||
59672883|NCT01342510|75791858|FG003|STARTED|Overall Study||50||
59672884|NCT01342510|75791855|FG000|COMPLETED|Overall Study||38||
59672885|NCT01342510|75791856|FG001|COMPLETED|Overall Study||44||
59672886|NCT01342510|75791857|FG002|COMPLETED|Overall Study||37||
59672887|NCT01342510|75791858|FG003|COMPLETED|Overall Study||39||
59672888|NCT01342510|75791855|FG000|NOT COMPLETED|Overall Study||12||
59672889|NCT01342510|75791856|FG001|NOT COMPLETED|Overall Study||6||
59672890|NCT01342510|75791857|FG002|NOT COMPLETED|Overall Study||13||
59672891|NCT01342510|75791858|FG003|NOT COMPLETED|Overall Study||11||
59672892|NCT04697888|75791872|FG000|STARTED|Overall Study||2||
59672893|NCT04697888|75791872|FG000|COMPLETED|Overall Study||2||
59672894|NCT04697888|75791872|FG000|NOT COMPLETED|Overall Study||0||
59672895|NCT01340872|75791878|FG000|STARTED|Double-blind Phase||64||
59672896|NCT01340872|75791879|FG001|STARTED|Double-blind Phase||64||
59672897|NCT01340872|75791880|FG002|STARTED|Double-blind Phase|Not Applicable to double-blind phase|0||
59672898|NCT01340872|75791881|FG003|STARTED|Double-blind Phase|Not Applicable to double-blind phase|0||
59672899|NCT01340872|75791878|FG000|COMPLETED|Double-blind Phase||55||
59672900|NCT01340872|75791879|FG001|COMPLETED|Double-blind Phase||53||
59672901|NCT01340872|75791880|FG002|COMPLETED|Double-blind Phase|Not Applicable to double-blind phase|0||
59672902|NCT01340872|75791881|FG003|COMPLETED|Double-blind Phase|Not Applicable to double-blind phase|0||
59672903|NCT01340872|75791878|FG000|NOT COMPLETED|Double-blind Phase||9||
59672904|NCT01340872|75791879|FG001|NOT COMPLETED|Double-blind Phase||11||
59672905|NCT01340872|75791880|FG002|NOT COMPLETED|Double-blind Phase||0||
59672906|NCT01340872|75791881|FG003|NOT COMPLETED|Double-blind Phase||0||
59672907|NCT01340872|75791878|FG000|STARTED|Open-label Phase|Not Applicable to open-label phase|0||
59672908|NCT01340872|75791879|FG001|STARTED|Open-label Phase|Not Applicable to open-label phase|0||
59672909|NCT01340872|75791880|FG002|STARTED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|50||
59672910|NCT01340872|75791881|FG003|STARTED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|47||
59672911|NCT01340872|75791878|FG000|COMPLETED|Open-label Phase|Not Applicable to open-label phase|0||
59672912|NCT01340872|75791879|FG001|COMPLETED|Open-label Phase|Not Applicable to open-label phase|0||
59672913|NCT01340872|75791880|FG002|COMPLETED|Open-label Phase||37||
59672914|NCT01340872|75791881|FG003|COMPLETED|Open-label Phase||36||
59672915|NCT01340872|75791878|FG000|NOT COMPLETED|Open-label Phase||0||
59672916|NCT01340872|75791879|FG001|NOT COMPLETED|Open-label Phase||0||
59672917|NCT01340872|75791880|FG002|NOT COMPLETED|Open-label Phase||13||
59672918|NCT01340872|75791881|FG003|NOT COMPLETED|Open-label Phase||11||
59672919|NCT01340794|75791895|FG000|STARTED|Overall Study||2||
59672920|NCT01340794|75791896|FG001|STARTED|Overall Study||5||
59672921|NCT01340794|75791895|FG000|COMPLETED|Overall Study||2||
59672922|NCT01340794|75791896|FG001|COMPLETED|Overall Study||4||
59672923|NCT01340794|75791895|FG000|NOT COMPLETED|Overall Study||0||
59672924|NCT01340794|75791896|FG001|NOT COMPLETED|Overall Study||1||
59672925|NCT01340482|75791907|FG000|STARTED|Overall Study||27||
59672926|NCT01340482|75791908|FG001|STARTED|Overall Study||1||
59672927|NCT01340482|75791909|FG002|STARTED|Overall Study||1||
59672928|NCT01340482|75791907|FG000|COMPLETED|Overall Study||25||
59672929|NCT01340482|75791908|FG001|COMPLETED|Overall Study||1||
59672930|NCT01340482|75791909|FG002|COMPLETED|Overall Study||1||
59672931|NCT01340482|75791907|FG000|NOT COMPLETED|Overall Study||2||
59672932|NCT01340482|75791908|FG001|NOT COMPLETED|Overall Study||0||
59672933|NCT01340482|75791909|FG002|NOT COMPLETED|Overall Study||0||
59672934|NCT01340209|75791922|FG000|STARTED|Overall Study||57||
59672935|NCT01340209|75791923|FG001|STARTED|Overall Study||114||
59672936|NCT01340209|75791924|FG002|STARTED|Overall Study||114||
59672937|NCT01340209|75791922|FG000|COMPLETED|Overall Study||52||
59672938|NCT01340209|75791923|FG001|COMPLETED|Overall Study||106||
59672939|NCT01340209|75791924|FG002|COMPLETED|Overall Study||106||
59672940|NCT01340209|75791922|FG000|NOT COMPLETED|Overall Study||5||
59672941|NCT01340209|75791923|FG001|NOT COMPLETED|Overall Study||8||
59672942|NCT01340209|75791924|FG002|NOT COMPLETED|Overall Study||8||
59672943|NCT01326910|75791934|FG000|STARTED|Overall Study||45||
59672944|NCT01326910|75791935|FG001|STARTED|Overall Study||45||
59672945|NCT01326910|75791934|FG000|COMPLETED|Overall Study||41||
59672946|NCT01326910|75791935|FG001|COMPLETED|Overall Study||42||
59672947|NCT01326910|75791934|FG000|NOT COMPLETED|Overall Study||4||
59672948|NCT01326910|75791935|FG001|NOT COMPLETED|Overall Study||3||
59672949|NCT01326481|75791941|FG000|STARTED|7.5 mg/kg TRC105, 1000 mg/m2 Cape||4||
59672950|NCT01326481|75791941|FG000|COMPLETED|7.5 mg/kg TRC105, 1000 mg/m2 Cape||3||
59672951|NCT01326481|75791941|FG000|NOT COMPLETED|7.5 mg/kg TRC105, 1000 mg/m2 Cape||1||
59672952|NCT01326481|75791941|FG000|STARTED|10 mg/kg TRC105, 1000 mg/m2 Cape||15||
59672953|NCT01326481|75791941|FG000|COMPLETED|10 mg/kg TRC105, 1000 mg/m2 Cape||15||
59672954|NCT01326481|75791941|FG000|NOT COMPLETED|10 mg/kg TRC105, 1000 mg/m2 Cape||0||
59672955|NCT01325701|75791949|FG000|STARTED|Overall Study||70||
59672956|NCT01325701|75791950|FG001|STARTED|Overall Study||8||
59672957|NCT01325701|75791949|FG000|COMPLETED|Overall Study||49||
59672958|NCT01325701|75791950|FG001|COMPLETED|Overall Study||5||
59672959|NCT01325701|75791949|FG000|NOT COMPLETED|Overall Study||21||
59672960|NCT01325701|75791950|FG001|NOT COMPLETED|Overall Study||3||
59672961|NCT01325623|75791957|FG000|STARTED|Overall Study||31||
59672962|NCT01325623|75791957|FG000|COMPLETED|Overall Study||28||
59672963|NCT01325623|75791957|FG000|NOT COMPLETED|Overall Study||3||
59672964|NCT01325584|75791994|FG000|STARTED|Overall Study||12||
59672965|NCT01325584|75791994|FG000|COMPLETED|Overall Study||11||
59672966|NCT01325584|75791994|FG000|NOT COMPLETED|Overall Study||1||
59672967|NCT01325428|75791998|FG000|STARTED|Part A||26||
59672968|NCT01325428|75791998|FG000|COMPLETED|Part A||10||
59672969|NCT01325428|75791998|FG000|NOT COMPLETED|Part A||16||
59672970|NCT01325428|75791998|FG000|STARTED|Part B||10||
59672971|NCT01325428|75791998|FG000|COMPLETED|Part B||7||
59672972|NCT01325428|75791998|FG000|NOT COMPLETED|Part B||3||
59672973|NCT01325350|75792012|FG000|STARTED|Overall Study||61||
59672974|NCT01325350|75792013|FG001|STARTED|Overall Study||61||
59672975|NCT01325350|75792014|FG002|STARTED|Overall Study||61||
59989405|NCT04210843|76104680|FG000|STARTED|Follow-up Period (up to 12 or 52 Weeks)||180||
59672976|NCT01325350|75792015|FG003|STARTED|Overall Study||61||
59672977|NCT01325350|75792016|FG004|STARTED|Overall Study||62||
59672978|NCT01325350|75792012|FG000|COMPLETED|Overall Study||55||
59672979|NCT01325350|75792013|FG001|COMPLETED|Overall Study||56||
59672980|NCT01325350|75792014|FG002|COMPLETED|Overall Study||44||
59672981|NCT01325350|75792015|FG003|COMPLETED|Overall Study||52||
59672982|NCT01325350|75792016|FG004|COMPLETED|Overall Study||50||
59672983|NCT01325350|75792012|FG000|NOT COMPLETED|Overall Study||6||
59672984|NCT01325350|75792013|FG001|NOT COMPLETED|Overall Study||5||
59672985|NCT01325350|75792014|FG002|NOT COMPLETED|Overall Study||17||
59672986|NCT01325350|75792015|FG003|NOT COMPLETED|Overall Study||9||
59672987|NCT01325350|75792016|FG004|NOT COMPLETED|Overall Study||12||
59672988|NCT01324999|75792028|FG000|STARTED|Overall Study||12||
59672989|NCT01324999|75792028|FG000|COMPLETED|Overall Study||7||
59672990|NCT01324999|75792028|FG000|NOT COMPLETED|Overall Study||5||
59672991|NCT01324570|75792034|FG000|STARTED|Overall Study||6||
59672992|NCT01324570|75792035|FG001|STARTED|Overall Study||35||
59672993|NCT01324570|75792034|FG000|COMPLETED|Overall Study||2||
59672994|NCT01324570|75792035|FG001|COMPLETED|Overall Study||21||
59672995|NCT01324570|75792034|FG000|NOT COMPLETED|Overall Study||4||
60077933|NCT01077856|76192916|FG001|COMPLETED|Overall Study||16604||
59672996|NCT01324570|75792035|FG001|NOT COMPLETED|Overall Study||14||
59672997|NCT01324141|75792043|FG000|STARTED|Overall Study||6||
59672998|NCT01324141|75792043|FG000|COMPLETED|Overall Study||4||
59672999|NCT01324141|75792043|FG000|NOT COMPLETED|Overall Study||2||
59673000|NCT01324102|75792059|FG000|STARTED|Overall Study|Yoga groups 3 and 5 (not including pre-randomization group)|11||
59673001|NCT01324102|75792060|FG001|STARTED|Overall Study|Yoga group 4 and 6|12||
59673002|NCT01324102|75792059|FG000|COMPLETED|Overall Study||10||
59673003|NCT01324102|75792060|FG001|COMPLETED|Overall Study||6||
59673004|NCT01324102|75792059|FG000|NOT COMPLETED|Overall Study||1||
59673005|NCT01324102|75792060|FG001|NOT COMPLETED|Overall Study||6||
59673006|NCT01324024|75792067|FG000|STARTED|First Intervention (4 Weeks)||18||
59673007|NCT01324024|75792068|FG001|STARTED|First Intervention (4 Weeks)||17||
59673008|NCT01324024|75792067|FG000|COMPLETED|First Intervention (4 Weeks)||18||
59673009|NCT01324024|75792068|FG001|COMPLETED|First Intervention (4 Weeks)||17||
59673010|NCT01324024|75792067|FG000|NOT COMPLETED|First Intervention (4 Weeks)||0||
59673011|NCT01324024|75792068|FG001|NOT COMPLETED|First Intervention (4 Weeks)||0||
59673012|NCT01324024|75792067|FG000|STARTED|Washout (2 Weeks)||18||
59673013|NCT01324024|75792068|FG001|STARTED|Washout (2 Weeks)||17||
59673014|NCT01324024|75792067|FG000|COMPLETED|Washout (2 Weeks)||18||
59673015|NCT01324024|75792068|FG001|COMPLETED|Washout (2 Weeks)||17||
59673016|NCT01324024|75792067|FG000|NOT COMPLETED|Washout (2 Weeks)||0||
59673017|NCT01324024|75792068|FG001|NOT COMPLETED|Washout (2 Weeks)||0||
59673018|NCT01324024|75792067|FG000|STARTED|Second Intervention (4 Weeks)||18||
59673019|NCT01324024|75792068|FG001|STARTED|Second Intervention (4 Weeks)||17||
59673020|NCT01324024|75792067|FG000|COMPLETED|Second Intervention (4 Weeks)||16||
59673021|NCT01324024|75792068|FG001|COMPLETED|Second Intervention (4 Weeks)||16||
59673022|NCT01324024|75792067|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||2||
59673023|NCT01324024|75792068|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||1||
59673024|NCT01323946|75792081|FG000|STARTED|Overall Study||46||
59673025|NCT01323946|75792082|FG001|STARTED|Overall Study||34||
59673026|NCT01323946|75792083|FG002|STARTED|Overall Study||33||
59673027|NCT01323946|75792081|FG000|COMPLETED|Overall Study||43||
59673028|NCT01323946|75792082|FG001|COMPLETED|Overall Study||31||
59673029|NCT01323946|75792083|FG002|COMPLETED|Overall Study||33||
59673030|NCT01323946|75792081|FG000|NOT COMPLETED|Overall Study||3||
59673031|NCT01323946|75792082|FG001|NOT COMPLETED|Overall Study||3||
59673032|NCT01323946|75792083|FG002|NOT COMPLETED|Overall Study||0||
59673033|NCT01323790|75792096|FG000|STARTED|Overall Study||233||
59673034|NCT01323790|75792097|FG001|STARTED|Overall Study||234||
59673035|NCT01323790|75792098|FG002|STARTED|Overall Study||233||
59673036|NCT01323790|75792096|FG000|COMPLETED|Overall Study||178||
59673037|NCT01323790|75792097|FG001|COMPLETED|Overall Study||174||
59673038|NCT01323790|75792098|FG002|COMPLETED|Overall Study||188||
59673039|NCT01323790|75792096|FG000|NOT COMPLETED|Overall Study||55||
59673040|NCT01323790|75792097|FG001|NOT COMPLETED|Overall Study||60||
59673041|NCT01323790|75792098|FG002|NOT COMPLETED|Overall Study||45||
59673042|NCT01323673|75792108|FG000|STARTED|Overall Study||62||
59673043|NCT01323673|75792109|FG001|STARTED|Overall Study||63||
59673044|NCT01323673|75792108|FG000|COMPLETED|Overall Study||59||
59673045|NCT01323673|75792109|FG001|COMPLETED|Overall Study||58||
59673046|NCT01323673|75792108|FG000|NOT COMPLETED|Overall Study||3||
59673047|NCT01323673|75792109|FG001|NOT COMPLETED|Overall Study||5||
59673048|NCT01323634|75792117|FG000|STARTED|2-week Run-in Period||733||
59673049|NCT01323634|75792118|FG001|STARTED|2-week Run-in Period||0||
59673050|NCT01323634|75792119|FG002|STARTED|2-week Run-in Period||0||
59673051|NCT01323634|75792117|FG000|COMPLETED|2-week Run-in Period||521||
59673052|NCT01323634|75792118|FG001|COMPLETED|2-week Run-in Period||0||
59673053|NCT01323634|75792119|FG002|COMPLETED|2-week Run-in Period||0||
59673054|NCT01323634|75792117|FG000|NOT COMPLETED|2-week Run-in Period||212||
59673055|NCT01323634|75792118|FG001|NOT COMPLETED|2-week Run-in Period||0||
59673056|NCT01323634|75792119|FG002|NOT COMPLETED|2-week Run-in Period||0||
59673057|NCT01323634|75792117|FG000|STARTED|Double-Blind (DB) Treatment Period||0||
59673058|NCT01323634|75792118|FG001|STARTED|Double-Blind (DB) Treatment Period||260||
59673059|NCT01323634|75792119|FG002|STARTED|Double-Blind (DB) Treatment Period||261||
59989406|NCT04210843|76104681|FG001|STARTED|Follow-up Period (up to 12 or 52 Weeks)||471||
59673060|NCT01323634|75792117|FG000|COMPLETED|Double-Blind (DB) Treatment Period||0||
59673061|NCT01323634|75792118|FG001|COMPLETED|Double-Blind (DB) Treatment Period||235||
59673062|NCT01323634|75792119|FG002|COMPLETED|Double-Blind (DB) Treatment Period||239||
59673063|NCT01323634|75792117|FG000|NOT COMPLETED|Double-Blind (DB) Treatment Period||0||
59673064|NCT01323634|75792118|FG001|NOT COMPLETED|Double-Blind (DB) Treatment Period||25||
59673065|NCT01323634|75792119|FG002|NOT COMPLETED|Double-Blind (DB) Treatment Period||22||
59673066|NCT01323478|75792125|FG000|STARTED|Overall Study||71||
59673067|NCT01323478|75792125|FG000|COMPLETED|Overall Study||47||
59673068|NCT01323478|75792125|FG000|NOT COMPLETED|Overall Study||24||
59673069|NCT01322386|75792131|FG000|STARTED|Overall Study||10||
59673070|NCT01322386|75792132|FG001|STARTED|Overall Study||11||
59673071|NCT01322386|75792131|FG000|COMPLETED|Overall Study||10||
59673072|NCT01322386|75792132|FG001|COMPLETED|Overall Study||9||
59673073|NCT01322386|75792131|FG000|NOT COMPLETED|Overall Study||0||
59673074|NCT01322386|75792132|FG001|NOT COMPLETED|Overall Study||2||
59673075|NCT01322347|75792142|FG000|STARTED|Overall Study||147||
59673076|NCT01322347|75792143|FG001|STARTED|Overall Study||147||
59673077|NCT01322347|75792142|FG000|Completed 48 Wks in St 2|Overall Study||28||
59673078|NCT01322347|75792143|FG001|Completed 48 Wks in St 2|Overall Study||22||
59673079|NCT01322347|75792142|FG000|Comp St 2 Due to ESA/IV Iron Needs|Overall Study||68||
59673080|NCT01322347|75792143|FG001|Comp St 2 Due to ESA/IV Iron Needs|Overall Study||90||
59673081|NCT01322347|75792142|FG000|Enrolled in St 3|Overall Study||101||
59673082|NCT01322347|75792143|FG001|Enrolled in St 3|Overall Study||113||
59673083|NCT01322347|75792142|FG000|Completed St 3|Overall Study||82||
59673084|NCT01322347|75792143|FG001|Completed St 3|Overall Study||86||
59673085|NCT01322347|75792142|FG000|COMPLETED|Overall Study||96||
59673086|NCT01322347|75792143|FG001|COMPLETED|Overall Study||112||
59673087|NCT01322347|75792142|FG000|NOT COMPLETED|Overall Study||51||
59673088|NCT01322347|75792143|FG001|NOT COMPLETED|Overall Study||35||
59673089|NCT01321879|75792150|FG000|STARTED|Overall Study||39||
59673090|NCT01321879|75792150|FG000|COMPLETED|Overall Study||25||
59673091|NCT01321879|75792150|FG000|NOT COMPLETED|Overall Study||14||
59673092|NCT01321723|75792157|FG000|STARTED|Overall Study||32||
59673093|NCT01321723|75792158|FG001|STARTED|Overall Study||33||
59673094|NCT01321723|75792159|FG002|STARTED|Overall Study||32||
59673095|NCT01321723|75792157|FG000|COMPLETED|Overall Study||27||
59673096|NCT01321723|75792158|FG001|COMPLETED|Overall Study||28||
59673097|NCT01321723|75792159|FG002|COMPLETED|Overall Study||28||
59673098|NCT01321723|75792157|FG000|NOT COMPLETED|Overall Study||5||
59673099|NCT01321723|75792158|FG001|NOT COMPLETED|Overall Study||5||
59673100|NCT01321723|75792159|FG002|NOT COMPLETED|Overall Study||4||
59673101|NCT01321606|75792169|FG000|STARTED|Overall Study||18||
59673102|NCT01321606|75792170|FG001|STARTED|Overall Study||32||
59673103|NCT01321606|75792171|FG002|STARTED|Overall Study||34||
59673104|NCT01321606|75792172|FG003|STARTED|Overall Study||29||
59673105|NCT01321606|75792169|FG000|COMPLETED|Overall Study||18||
59673106|NCT01321606|75792170|FG001|COMPLETED|Overall Study||32||
59673107|NCT01321606|75792171|FG002|COMPLETED|Overall Study||34||
59673108|NCT01321606|75792172|FG003|COMPLETED|Overall Study||28||
59673109|NCT01321606|75792169|FG000|NOT COMPLETED|Overall Study||0||
59673110|NCT01321606|75792170|FG001|NOT COMPLETED|Overall Study||0||
59673111|NCT01321606|75792171|FG002|NOT COMPLETED|Overall Study||0||
59673112|NCT01321606|75792172|FG003|NOT COMPLETED|Overall Study||1||
59673113|NCT01320943|75792184|FG000|STARTED|Overall Study|13 participants did not restart TDF; 8 participants restarted TDF during the study.|21||
59673114|NCT01320943|75792185|FG001|STARTED|Overall Study||22||
59673115|NCT01320943|75792184|FG000|COMPLETED|Overall Study||20||
59673116|NCT01320943|75792185|FG001|COMPLETED|Overall Study||20||
59673117|NCT01320943|75792184|FG000|NOT COMPLETED|Overall Study||1||
59673118|NCT01320943|75792185|FG001|NOT COMPLETED|Overall Study||2||
59673119|NCT02482233|75792200|FG000|STARTED|Overall Study||10||
59673120|NCT02482233|75792201|FG001|STARTED|Overall Study||20||
59673121|NCT02482233|75792200|FG000|COMPLETED|Overall Study||9||
59673122|NCT02482233|75792201|FG001|COMPLETED|Overall Study||19||
59673123|NCT02482233|75792200|FG000|NOT COMPLETED|Overall Study||1||
59673124|NCT02482233|75792201|FG001|NOT COMPLETED|Overall Study||1||
59673125|NCT01320202|75792211|FG000|STARTED|Overall Study||152||
59673126|NCT01320202|75792212|FG001|STARTED|Overall Study||153||
59673127|NCT01320202|75792211|FG000|Comp 48 Wks in St 2|Overall Study||27||
59673128|NCT01320202|75792212|FG001|Comp 48 Wks in St 2|Overall Study||27||
59673129|NCT01320202|75792211|FG000|Comp St 2 Due to ESA/IV Iron Needs|Overall Study||69||
59673130|NCT01320202|75792212|FG001|Comp St 2 Due to ESA/IV Iron Needs|Overall Study||82||
59673131|NCT01320202|75792211|FG000|Enrolled in St 3|Overall Study||98||
59673132|NCT01320202|75792212|FG001|Enrolled in St 3|Overall Study||109||
59673133|NCT01320202|75792211|FG000|Completed St 3|Overall Study||79||
59673134|NCT01320202|75792212|FG001|Completed St 3|Overall Study||82||
59673135|NCT01320202|75792211|FG000|COMPLETED|Overall Study||96||
59673136|NCT01320202|75792212|FG001|COMPLETED|Overall Study||109||
59673137|NCT01320202|75792211|FG000|NOT COMPLETED|Overall Study||56||
59673138|NCT01320202|75792212|FG001|NOT COMPLETED|Overall Study||44||
59673139|NCT01319383|75792221|FG000|STARTED|Overall Study||12||
59673140|NCT01319383|75792222|FG001|STARTED|Overall Study||13||
59673141|NCT01319383|75792221|FG000|Step 1|Overall Study||8|Demonstrating an ex vivo response to VOR, measured in research lab, permitted study advancement|
59673142|NCT01319383|75792222|FG001|Step 1|Overall Study|The 2 participants without an ex vivo response were terminated from the study.|11|Demonstrating an ex vivo response to VOR, measured in research lab, permitted study advancement|
59673143|NCT01319383|75792221|FG000|Step 2|Overall Study|These participants demonstrated an ex vivo response in Step 1|8|Demonstrated an in vivo response to a single VOR 400 mg PO in Step 2|
59673144|NCT01319383|75792222|FG001|Step 2|Overall Study|The 7 participants without an in vivo response to single dose of VOR 400 mg PO were terminated.|4|Demonstrated an in vivo response to a single VOR 400 mg PO in Step 2|
59673145|NCT01319383|75792221|FG000|Step 2|Overall Study|The 4 without ex vivo response (Step 1) took a single dose to see if in vivo response would occur|4|Did not demonstrate an in vivo response to VOR 400 mg PO|
59673146|NCT01319383|75792222|FG001|Step 2|Overall Study||0|Did not demonstrate an in vivo response to VOR 400 mg PO|
59673147|NCT01319383|75792221|FG000|Step 3|Overall Study|None who qualified for the 2 series of 11 doses of VOR (taken M-T-W & off for 4 days for 4 wks).|0|Demonstrated an in vivo response to multiple doses of VOR 400 mg PO|
59673148|NCT01319383|75792222|FG001|Step 3|Overall Study|3 Arm 1 participants enrolled here; 6/7 had in vivo response to 2 VOR doses given 72 hours apart.|6|Demonstrated an in vivo response to multiple doses of VOR 400 mg PO|
59673149|NCT01319383|75792221|FG000|Step 4|Overall Study|Arm 1 did not have a Step 4|0|Demonstrated an in vivo response to 10 doses taken a designated intervals|
59673150|NCT01319383|75792222|FG001|Step 4|Overall Study|Only 3/6 completed the study.|3|Demonstrated an in vivo response to 10 doses taken a designated intervals|
59673151|NCT01319383|75792221|FG000|COMPLETED|Overall Study||0||
59673152|NCT01319383|75792222|FG001|COMPLETED|Overall Study||3||
59673153|NCT01319383|75792221|FG000|NOT COMPLETED|Overall Study||12||
59673154|NCT01319383|75792222|FG001|NOT COMPLETED|Overall Study||10||
59673155|NCT01316614|75792239|FG000|STARTED|Overall Study||137||
59673156|NCT01316614|75792239|FG000|COMPLETED|Overall Study||100||
59673157|NCT01316614|75792239|FG000|NOT COMPLETED|Overall Study||37||
59673158|NCT01316575|75792246|FG000|STARTED|Overall Study||20||
59673159|NCT01316575|75792247|FG001|STARTED|Overall Study||20||
59673160|NCT01316575|75792246|FG000|COMPLETED|Overall Study||18||
59673161|NCT01316575|75792247|FG001|COMPLETED|Overall Study||19||
59673162|NCT01316575|75792246|FG000|NOT COMPLETED|Overall Study||2||
59673163|NCT01316575|75792247|FG001|NOT COMPLETED|Overall Study||1||
59673164|NCT01315678|75792255|FG000|STARTED|Overall Study||148|Number of participants treated|
59673165|NCT01315678|75792256|FG001|STARTED|Overall Study||146|Number of participants treated|
59673166|NCT01315678|75792255|FG000|COMPLETED|Overall Study||134||
59673167|NCT01315678|75792256|FG001|COMPLETED|Overall Study||140||
59673168|NCT01315678|75792255|FG000|NOT COMPLETED|Overall Study||14||
59673169|NCT01315678|75792256|FG001|NOT COMPLETED|Overall Study||6||
59673170|NCT01315249|75792266|FG000|STARTED|Overall Study||259||
59673171|NCT01315249|75792267|FG001|STARTED|Overall Study||264||
59673172|NCT01315249|75792266|FG000|COMPLETED|Overall Study||215||
59673173|NCT01315249|75792267|FG001|COMPLETED|Overall Study||217||
59673174|NCT01315249|75792266|FG000|NOT COMPLETED|Overall Study||44||
59673175|NCT01315249|75792267|FG001|NOT COMPLETED|Overall Study||47||
59673176|NCT01315132|75792273|FG000|STARTED|Overall Study||47||
59673177|NCT01315132|75792273|FG000|COMPLETED|Overall Study||46||
59673178|NCT01315132|75792273|FG000|NOT COMPLETED|Overall Study||1||
59673179|NCT01313767|75792279|FG000|STARTED|Overall Study||98||
59673180|NCT01313767|75792280|FG001|STARTED|Overall Study||98||
59673181|NCT01313767|75792279|FG000|COMPLETED|Overall Study||91||
59673182|NCT01313767|75792280|FG001|COMPLETED|Overall Study||96||
59673183|NCT01313767|75792279|FG000|NOT COMPLETED|Overall Study||7||
59673184|NCT01313767|75792280|FG001|NOT COMPLETED|Overall Study||2||
59673185|NCT01313728|75792286|FG000|STARTED|Informed Consent to Baseline||26||
59673186|NCT01313728|75792286|FG000|COMPLETED|Informed Consent to Baseline|One subject withdrew after signing informed consent, but prior to Baseline measurements being taken.|25||
59673187|NCT01313728|75792286|FG000|NOT COMPLETED|Informed Consent to Baseline||1||
59673188|NCT01313728|75792286|FG000|STARTED|Baseline to Completion||25||
59673189|NCT01313728|75792286|FG000|COMPLETED|Baseline to Completion||25||
59673190|NCT01313728|75792286|FG000|NOT COMPLETED|Baseline to Completion||0||
59673191|NCT01313650|75792295|FG000|STARTED|Overall Study||280||
59673192|NCT01313650|75792296|FG001|STARTED|Overall Study||418||
59673193|NCT01313650|75792297|FG002|STARTED|Overall Study||421||
59673194|NCT01313650|75792298|FG003|STARTED|Overall Study||413||
59673195|NCT01313650|75792295|FG000|COMPLETED|Overall Study||204||
59673196|NCT01313650|75792296|FG001|COMPLETED|Overall Study||324||
59673197|NCT01313650|75792297|FG002|COMPLETED|Overall Study||318||
59673198|NCT01313650|75792298|FG003|COMPLETED|Overall Study||332||
59673199|NCT01313650|75792295|FG000|NOT COMPLETED|Overall Study||76||
59673200|NCT01313650|75792296|FG001|NOT COMPLETED|Overall Study||94||
59673201|NCT01313650|75792297|FG002|NOT COMPLETED|Overall Study||103||
59673202|NCT01313650|75792298|FG003|NOT COMPLETED|Overall Study||81||
59673203|NCT01313299|75792311|FG000|STARTED|Overall Study||81||
59673204|NCT01313299|75792312|FG001|STARTED|Overall Study||81||
59673205|NCT01313299|75792313|FG002|STARTED|Overall Study||81||
59673206|NCT01313299|75792311|FG000|COMPLETED|Overall Study||74||
59673207|NCT01313299|75792312|FG001|COMPLETED|Overall Study||78||
59673208|NCT01313299|75792313|FG002|COMPLETED|Overall Study||77||
59673209|NCT01313299|75792311|FG000|NOT COMPLETED|Overall Study||7||
59673210|NCT01313299|75792312|FG001|NOT COMPLETED|Overall Study||3||
59673211|NCT01313299|75792313|FG002|NOT COMPLETED|Overall Study||4||
59673212|NCT01313221|75792324|FG000|STARTED|Overall Study||144||
59673213|NCT01313221|75792325|FG001|STARTED|Overall Study||143||
59673214|NCT01313221|75792326|FG002|STARTED|Overall Study||23||
59673215|NCT01313221|75792324|FG000|Randomized|Overall Study||144||
59673216|NCT01313221|75792325|FG001|Randomized|Overall Study||143||
59673217|NCT01313221|75792326|FG002|Randomized|Overall Study||0||
59673218|NCT01313221|75792324|FG000|COMPLETED|Overall Study||132||
59673219|NCT01313221|75792325|FG001|COMPLETED|Overall Study||135||
59673220|NCT01313221|75792326|FG002|COMPLETED|Overall Study||0||
59673221|NCT01313221|75792324|FG000|NOT COMPLETED|Overall Study||12||
59673222|NCT01313221|75792325|FG001|NOT COMPLETED|Overall Study||8||
59673223|NCT01313221|75792326|FG002|NOT COMPLETED|Overall Study||23||
59673224|NCT01313182|75792336|FG000|STARTED|Overall Study||842||
59673225|NCT01313182|75792337|FG001|STARTED|Overall Study||855||
59673226|NCT01313182|75792336|FG000|COMPLETED|Overall Study||776||
59673227|NCT01313182|75792337|FG001|COMPLETED|Overall Study||763||
59673228|NCT01313182|75792336|FG000|NOT COMPLETED|Overall Study||66||
59673229|NCT01313182|75792337|FG001|NOT COMPLETED|Overall Study||92||
59673230|NCT01312909|75792346|FG000|STARTED|Overall Study||109||
59673231|NCT01312909|75792347|FG001|STARTED|Overall Study||103||
59673232|NCT01312909|75792348|FG002|STARTED|Overall Study||100||
59673233|NCT01312909|75792346|FG000|Treated|Overall Study||108||
59673234|NCT01312909|75792347|FG001|Treated|Overall Study||100||
59673235|NCT01312909|75792348|FG002|Treated|Overall Study||99||
59673236|NCT01312909|75792346|FG000|COMPLETED|Overall Study||67||
59673237|NCT01312909|75792347|FG001|COMPLETED|Overall Study||67||
59673238|NCT01312909|75792348|FG002|COMPLETED|Overall Study||53||
59673239|NCT01312909|75792346|FG000|NOT COMPLETED|Overall Study||42||
59673240|NCT01312909|75792347|FG001|NOT COMPLETED|Overall Study||36||
59673241|NCT01312909|75792348|FG002|NOT COMPLETED|Overall Study||47||
59673242|NCT01312129|75792358|FG000|STARTED|First Intervention (24 Hours)||6||
59673243|NCT01312129|75792359|FG001|STARTED|First Intervention (24 Hours)||7||
59673244|NCT01312129|75792358|FG000|Control Cue|First Intervention (24 Hours)||6||
59673245|NCT01312129|75792359|FG001|Control Cue|First Intervention (24 Hours)||7||
59673246|NCT01312129|75792358|FG000|Alcohol Cue|First Intervention (24 Hours)||6||
59673247|NCT01312129|75792359|FG001|Alcohol Cue|First Intervention (24 Hours)||7||
59673248|NCT01312129|75792358|FG000|COMPLETED|First Intervention (24 Hours)||6||
59673249|NCT01312129|75792359|FG001|COMPLETED|First Intervention (24 Hours)||7||
59673250|NCT01312129|75792358|FG000|NOT COMPLETED|First Intervention (24 Hours)||0||
59673251|NCT01312129|75792359|FG001|NOT COMPLETED|First Intervention (24 Hours)||0||
59673252|NCT01312129|75792358|FG000|STARTED|Washout (1 Week)||6||
59673253|NCT01312129|75792359|FG001|STARTED|Washout (1 Week)||7||
59673254|NCT01312129|75792358|FG000|COMPLETED|Washout (1 Week)||6||
59673255|NCT01312129|75792359|FG001|COMPLETED|Washout (1 Week)||7||
59673256|NCT01312129|75792358|FG000|NOT COMPLETED|Washout (1 Week)||0||
59673257|NCT01312129|75792359|FG001|NOT COMPLETED|Washout (1 Week)||0||
59673258|NCT01312129|75792358|FG000|STARTED|Second Intervention (24 Hours)||6||
59673259|NCT01312129|75792359|FG001|STARTED|Second Intervention (24 Hours)||7||
59673260|NCT01312129|75792358|FG000|Control Cue|Second Intervention (24 Hours)||6||
59673261|NCT01312129|75792359|FG001|Control Cue|Second Intervention (24 Hours)||6||
59673262|NCT01312129|75792358|FG000|Alcohol Cue|Second Intervention (24 Hours)||6||
59673263|NCT01312129|75792359|FG001|Alcohol Cue|Second Intervention (24 Hours)||6||
59673264|NCT01312129|75792358|FG000|COMPLETED|Second Intervention (24 Hours)||6||
59673265|NCT01312129|75792359|FG001|COMPLETED|Second Intervention (24 Hours)||6||
59673266|NCT01312129|75792358|FG000|NOT COMPLETED|Second Intervention (24 Hours)||0||
59673267|NCT01312129|75792359|FG001|NOT COMPLETED|Second Intervention (24 Hours)||1||
59673268|NCT01311661|75792365|FG000|STARTED|Overall Study|Entered and treated|206||
59673269|NCT01311661|75792365|FG000|Received Placebo|Overall Study||201||
59673270|NCT01311661|75792365|FG000|Received Olo 2.5 mcg Bid|Overall Study||101||
59673271|NCT01311661|75792365|FG000|Received Olo 5 mcg qd|Overall Study||101||
59673272|NCT01311661|75792365|FG000|Received Olo 5 mcg Bid|Overall Study||101||
59673273|NCT01311661|75792365|FG000|Received Olo 10 mcg qd|Overall Study||102||
59673274|NCT01311661|75792365|FG000|COMPLETED|Overall Study||199||
59673275|NCT01311661|75792365|FG000|NOT COMPLETED|Overall Study||7||
59673276|NCT01311505|75792377|FG000|STARTED|First Intervention Period||10||
59673277|NCT01311505|75792378|FG001|STARTED|First Intervention Period||11||
59673278|NCT01311505|75792377|FG000|COMPLETED|First Intervention Period||10||
59673279|NCT01311505|75792378|FG001|COMPLETED|First Intervention Period||10||
59673280|NCT01311505|75792377|FG000|NOT COMPLETED|First Intervention Period||0||
59673281|NCT01311505|75792378|FG001|NOT COMPLETED|First Intervention Period||1||
59673282|NCT01311505|75792377|FG000|STARTED|Washout Period (at Least 7 Days)||10||
59673283|NCT01311505|75792378|FG001|STARTED|Washout Period (at Least 7 Days)||10||
59673284|NCT01311505|75792377|FG000|COMPLETED|Washout Period (at Least 7 Days)||10||
59673285|NCT01311505|75792378|FG001|COMPLETED|Washout Period (at Least 7 Days)||10||
59673286|NCT01311505|75792377|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||0||
59673287|NCT01311505|75792378|FG001|NOT COMPLETED|Washout Period (at Least 7 Days)||0||
59673288|NCT01311505|75792377|FG000|STARTED|Second Intervention Period||10||
59673289|NCT01311505|75792378|FG001|STARTED|Second Intervention Period||10||
59673290|NCT01311505|75792377|FG000|COMPLETED|Second Intervention Period||10||
59673291|NCT01311505|75792378|FG001|COMPLETED|Second Intervention Period||10||
59673292|NCT01311505|75792377|FG000|NOT COMPLETED|Second Intervention Period||0||
59673293|NCT01311505|75792378|FG001|NOT COMPLETED|Second Intervention Period||0||
59673294|NCT01310803|75792389|FG000|STARTED|Overall Study||1||
59673295|NCT01310803|75792390|FG001|STARTED|Overall Study||0||
59673296|NCT01310803|75792389|FG000|COMPLETED|Overall Study||0||
59673297|NCT01310803|75792390|FG001|COMPLETED|Overall Study||0||
59673298|NCT01310803|75792389|FG000|NOT COMPLETED|Overall Study||1||
59673299|NCT01310803|75792390|FG001|NOT COMPLETED|Overall Study||0||
59673300|NCT01310413|75792402|FG000|STARTED|Day 0 to Day 385||199||
59673301|NCT01310413|75792403|FG001|STARTED|Day 0 to Day 385||198||
59673302|NCT01310413|75792404|FG002|STARTED|Day 0 to Day 385||210||
59673303|NCT01310413|75792405|FG003|STARTED|Day 0 to Day 385||75||
59673304|NCT01310413|75792406|FG004|STARTED|Day 0 to Day 385||76||
59673305|NCT01310413|75792407|FG005|STARTED|Day 0 to Day 385||80||
59815890|NCT01858597|75938308|FG000|COMPLETED|Overall Study||30||
59673306|NCT01310413|75792408|FG006|STARTED|Day 0 to Day 385|This group is only followed during the Unblinded Phase of the study, from Days U0 to U385.|0||
59673307|NCT01310413|75792402|FG000|COMPLETED|Day 0 to Day 385||172||
59673308|NCT01310413|75792403|FG001|COMPLETED|Day 0 to Day 385||190||
59673309|NCT01310413|75792404|FG002|COMPLETED|Day 0 to Day 385||203||
59673310|NCT01310413|75792405|FG003|COMPLETED|Day 0 to Day 385||67||
59673311|NCT01310413|75792406|FG004|COMPLETED|Day 0 to Day 385||73||
59673312|NCT01310413|75792407|FG005|COMPLETED|Day 0 to Day 385||77||
59673313|NCT01310413|75792408|FG006|COMPLETED|Day 0 to Day 385|This group is only followed during the Unblinded Phase of the study, from Days U0 to U385.|0||
59673314|NCT01310413|75792402|FG000|NOT COMPLETED|Day 0 to Day 385||27||
59673315|NCT01310413|75792403|FG001|NOT COMPLETED|Day 0 to Day 385||8||
59673316|NCT01310413|75792404|FG002|NOT COMPLETED|Day 0 to Day 385||7||
59673317|NCT01310413|75792405|FG003|NOT COMPLETED|Day 0 to Day 385||8||
59673318|NCT01310413|75792406|FG004|NOT COMPLETED|Day 0 to Day 385||3||
59673319|NCT01310413|75792407|FG005|NOT COMPLETED|Day 0 to Day 385||3||
59673320|NCT01310413|75792408|FG006|NOT COMPLETED|Day 0 to Day 385||0||
59673321|NCT01310413|75792402|FG000|STARTED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0||
59673322|NCT01310413|75792403|FG001|STARTED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0||
59673323|NCT01310413|75792404|FG002|STARTED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0||
59673324|NCT01310413|75792405|FG003|STARTED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0||
59673325|NCT01310413|75792406|FG004|STARTED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0||
59673326|NCT01310413|75792407|FG005|STARTED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0||
59673327|NCT01310413|75792408|FG006|STARTED|From Day U0 to Day U385|Upto Day U42|155||
59673328|NCT01310413|75792402|FG000|COMPLETED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0||
59673329|NCT01310413|75792403|FG001|COMPLETED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0||
59673330|NCT01310413|75792404|FG002|COMPLETED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0||
59673331|NCT01310413|75792405|FG003|COMPLETED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0||
59673332|NCT01310413|75792406|FG004|COMPLETED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0||
59673333|NCT01310413|75792407|FG005|COMPLETED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0||
59673334|NCT01310413|75792408|FG006|COMPLETED|From Day U0 to Day U385|Upto Day U42|152||
59673335|NCT01310413|75792402|FG000|NOT COMPLETED|From Day U0 to Day U385||0||
59673336|NCT01310413|75792403|FG001|NOT COMPLETED|From Day U0 to Day U385||0||
59673337|NCT01310413|75792404|FG002|NOT COMPLETED|From Day U0 to Day U385||0||
59673338|NCT01310413|75792405|FG003|NOT COMPLETED|From Day U0 to Day U385||0||
59673339|NCT01310413|75792406|FG004|NOT COMPLETED|From Day U0 to Day U385||0||
59673340|NCT01310413|75792407|FG005|NOT COMPLETED|From Day U0 to Day U385||0||
59673341|NCT01310413|75792408|FG006|NOT COMPLETED|From Day U0 to Day U385||3||
59673342|NCT01309828|75792439|FG000|STARTED|Overall Study||77||
59673343|NCT01309828|75792440|FG001|STARTED|Overall Study||76||
59673344|NCT01309828|75792439|FG000|COMPLETED|Overall Study||61||
59673345|NCT01309828|75792440|FG001|COMPLETED|Overall Study||60||
59673346|NCT01309828|75792439|FG000|NOT COMPLETED|Overall Study||16||
59673347|NCT01309828|75792440|FG001|NOT COMPLETED|Overall Study||16||
59673348|NCT01309282|75792446|FG000|STARTED|Overall Study||9||
59673349|NCT01309282|75792446|FG000|COMPLETED|Overall Study||8||
59673350|NCT01309282|75792446|FG000|NOT COMPLETED|Overall Study||1||
59673351|NCT01309243|75792452|FG000|STARTED|Randomized Phase Through Week 96||400||
59673352|NCT01309243|75792453|FG001|STARTED|Randomized Phase Through Week 96||399||
59673353|NCT01309243|75792452|FG000|Randomized and Treated|Randomized Phase Through Week 96||394||
59815891|NCT01858597|75938309|FG001|COMPLETED|Overall Study||60||
59815892|NCT01858597|75938308|FG000|NOT COMPLETED|Overall Study||0||
59815893|NCT01858597|75938309|FG001|NOT COMPLETED|Overall Study||0||
59815894|NCT01806571|75938315|FG000|STARTED|Overall Study||34||
59815895|NCT01806571|75938315|FG000|COMPLETED|Overall Study||34||
59815896|NCT01806571|75938315|FG000|NOT COMPLETED|Overall Study||0||
59815897|NCT01204216|75938321|FG000|STARTED|Overall Study||3||
59815898|NCT01204216|75938322|FG001|STARTED|Overall Study||0||
59815899|NCT01204216|75938321|FG000|COMPLETED|Overall Study||0||
59815900|NCT01204216|75938322|FG001|COMPLETED|Overall Study||0||
59989407|NCT04210843|76104680|FG000|COMPLETED|Follow-up Period (up to 12 or 52 Weeks)||157||
59989408|NCT04210843|76104681|FG001|COMPLETED|Follow-up Period (up to 12 or 52 Weeks)||407||
59989409|NCT04210843|76104680|FG000|NOT COMPLETED|Follow-up Period (up to 12 or 52 Weeks)||23||
59989410|NCT04210843|76104681|FG001|NOT COMPLETED|Follow-up Period (up to 12 or 52 Weeks)||64||
59989411|NCT03221660|76104697|FG000|STARTED|Overall Study||50||75
59989412|NCT03221660|76104697|FG000|COMPLETED|Overall Study||50||75
59989413|NCT03221660|76104697|FG000|NOT COMPLETED|Overall Study||0||0
60077934|NCT01077856|76192917|FG002|COMPLETED|Overall Study||15713||
60077935|NCT01077856|76192915|FG000|NOT COMPLETED|Overall Study||0||
59673354|NCT01309243|75792453|FG001|Randomized and Treated|Randomized Phase Through Week 96||392||
59673355|NCT01309243|75792452|FG000|COMPLETED|Randomized Phase Through Week 96||316||
59673356|NCT01309243|75792453|FG001|COMPLETED|Randomized Phase Through Week 96||290||
59673357|NCT01309243|75792452|FG000|NOT COMPLETED|Randomized Phase Through Week 96||84||
59673358|NCT01309243|75792453|FG001|NOT COMPLETED|Randomized Phase Through Week 96||109||
59673359|NCT01309243|75792452|FG000|STARTED|Extension Phase|40 participants from the Randomized Phase continued the study in the Extension Phase.|40||
59673360|NCT01309243|75792453|FG001|STARTED|Extension Phase|117 participants from the Randomized Phase continued the study in the Extension Phase.|117||
59673361|NCT01309243|75792452|FG000|COMPLETED|Extension Phase||34||
59673362|NCT01309243|75792453|FG001|COMPLETED|Extension Phase||117||
59673363|NCT01309243|75792452|FG000|NOT COMPLETED|Extension Phase||6||
59673364|NCT01309243|75792453|FG001|NOT COMPLETED|Extension Phase||0||
59673365|NCT01309204|75792461|FG000|STARTED|Overall Study||452||
59673366|NCT01309204|75792462|FG001|STARTED|Overall Study||436||
59673367|NCT01309204|75792461|FG000|COMPLETED|Overall Study||385||
59673368|NCT01309204|75792462|FG001|COMPLETED|Overall Study||361||
59673369|NCT01309204|75792461|FG000|NOT COMPLETED|Overall Study||67||
59673370|NCT01309204|75792462|FG001|NOT COMPLETED|Overall Study||75||
59673371|NCT01309165|75792470|FG000|STARTED|Overall Study||19||
59673372|NCT01309165|75792471|FG001|STARTED|Overall Study||16||
59673373|NCT01309165|75792470|FG000|Received Allocated Intervention|Overall Study||16||
59673374|NCT01309165|75792471|FG001|Received Allocated Intervention|Overall Study||14||
59673375|NCT01309165|75792470|FG000|Included in Primary Analysis|Overall Study||14||
59673376|NCT01309165|75792471|FG001|Included in Primary Analysis|Overall Study||12||
59673377|NCT01309165|75792470|FG000|COMPLETED|Overall Study||13||
59673378|NCT01309165|75792471|FG001|COMPLETED|Overall Study||9||
59673379|NCT01309165|75792470|FG000|NOT COMPLETED|Overall Study||6||
59673380|NCT01309165|75792471|FG001|NOT COMPLETED|Overall Study||7||
59673381|NCT01308853|75792478|FG000|STARTED|Overall Study||24||
59673382|NCT01308853|75792478|FG000|COMPLETED|Overall Study||20||
59673383|NCT01308853|75792478|FG000|NOT COMPLETED|Overall Study||4||
59673384|NCT01308736|75792484|FG000|STARTED|Overall Study||31||
59673385|NCT01308736|75792485|FG001|STARTED|Overall Study||32||
59673386|NCT01308736|75792484|FG000|COMPLETED|Overall Study||25||
59673387|NCT01308736|75792485|FG001|COMPLETED|Overall Study||27||
60077936|NCT01077856|76192916|FG001|NOT COMPLETED|Overall Study||0||
60077937|NCT01077856|76192917|FG002|NOT COMPLETED|Overall Study||0||
60077938|NCT01506609|76192963|FG000|STARTED|Overall Study||2||
60077939|NCT01506609|76192964|FG001|STARTED|Overall Study||1||
60077940|NCT01506609|76192965|FG002|STARTED|Overall Study||1||
60077941|NCT01506609|76192966|FG003|STARTED|Overall Study||99||
60077942|NCT01506609|76192967|FG004|STARTED|Overall Study||97||
60077943|NCT01506609|76192968|FG005|STARTED|Overall Study||94||
60077944|NCT01506609|76192963|FG000|COMPLETED|Overall Study||0||
60077945|NCT01506609|76192964|FG001|COMPLETED|Overall Study||0||
59546102|NCT01060592|75644699|FG000|STARTED|4-6w||35||
59546103|NCT01060592|75644700|FG001|STARTED|4-6w||49||
59546104|NCT01060592|75644699|FG000|COMPLETED|4-6w||23||
59546105|NCT01060592|75644700|FG001|COMPLETED|4-6w||39||
59546106|NCT01060592|75644699|FG000|NOT COMPLETED|4-6w||12||
59546107|NCT01060592|75644700|FG001|NOT COMPLETED|4-6w||10||
59546108|NCT01060592|75644699|FG000|STARTED|12m|For some pts, %EWL were not taken/available in the 4-6w period but were available for the 12m period|35||
60077946|NCT01506609|76192965|FG002|COMPLETED|Overall Study||0||
60077947|NCT01506609|76192966|FG003|COMPLETED|Overall Study||0||
60077948|NCT01506609|76192967|FG004|COMPLETED|Overall Study||1||
60077949|NCT01506609|76192968|FG005|COMPLETED|Overall Study||0||
60077950|NCT01506609|76192963|FG000|NOT COMPLETED|Overall Study||2||
59546109|NCT01060592|75644700|FG001|STARTED|12m|For some pts, %EWL were not taken/available in the 4-6w period but were available for the 12m period|49||
59546110|NCT01060592|75644699|FG000|COMPLETED|12m||35||
59546111|NCT01060592|75644700|FG001|COMPLETED|12m|Historic data was not available at 12m for 18 of the historic controls|31||
59673388|NCT01308736|75792484|FG000|NOT COMPLETED|Overall Study||6||
59673389|NCT01308736|75792485|FG001|NOT COMPLETED|Overall Study||5||
59673390|NCT01308580|75792493|FG000|STARTED|Overall Study||598||
59673391|NCT01308580|75792494|FG001|STARTED|Overall Study||602||
59673392|NCT01308580|75792493|FG000|Treated|Overall Study|Random assignment, was not actual treatment in some cases|587||
59709763|NCT01072149|75828529|FG009|NOT COMPLETED|Treatment Period 1 (28 Days)||0||
60077951|NCT01506609|76192964|FG001|NOT COMPLETED|Overall Study||1||
60077952|NCT01506609|76192965|FG002|NOT COMPLETED|Overall Study||1||
59673393|NCT01308580|75792494|FG001|Treated|Overall Study|Random assignment, was not actual treatment in some cases|588||
59673394|NCT01308580|75792493|FG000|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival|586||
59673395|NCT01308580|75792494|FG001|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival|595||
59673396|NCT01308580|75792493|FG000|NOT COMPLETED|Overall Study||12||
59673397|NCT01308580|75792494|FG001|NOT COMPLETED|Overall Study||7||
59673398|NCT01308463|75792501|FG000|STARTED|Overall Study||29||
59673399|NCT01308463|75792501|FG000|6 Months|Overall Study||23||
59673400|NCT01308463|75792501|FG000|1 Year|Overall Study||21||
59673401|NCT01308463|75792501|FG000|2 Years|Overall Study||18||
59673402|NCT01308463|75792501|FG000|3 Years|Overall Study||17||
59673403|NCT01308463|75792501|FG000|4 Years|Overall Study||20||
59673404|NCT01308463|75792501|FG000|5 Years|Overall Study||20||
59673405|NCT01308463|75792501|FG000|6 Years|Overall Study||11||
59673406|NCT01308463|75792501|FG000|7 Years|Overall Study||12||
59673407|NCT01308463|75792501|FG000|8 Years|Overall Study||14||
59673408|NCT01308463|75792501|FG000|9 Years|Overall Study||11||
59673409|NCT01308463|75792501|FG000|10 Years|Overall Study||8||
59673410|NCT01308463|75792501|FG000|11 Years|Overall Study||8||
59673411|NCT01308463|75792501|FG000|12 Years|Overall Study||2||
59673412|NCT01308463|75792501|FG000|COMPLETED|Overall Study||0||
59673413|NCT01308463|75792501|FG000|NOT COMPLETED|Overall Study||29||
59673414|NCT01308424|75792507|FG000|STARTED|Baseline Eligibility||242||
59673415|NCT01308424|75792508|FG001|STARTED|Baseline Eligibility||0||
59673416|NCT01308424|75792509|FG002|STARTED|Baseline Eligibility||0||
59673417|NCT01308424|75792507|FG000|COMPLETED|Baseline Eligibility|Completed baseline run in and were eligible for randomization|171||
59673418|NCT01308424|75792508|FG001|COMPLETED|Baseline Eligibility||0||
59673419|NCT01308424|75792509|FG002|COMPLETED|Baseline Eligibility||0||
59673420|NCT01308424|75792507|FG000|NOT COMPLETED|Baseline Eligibility||71||
59673421|NCT01308424|75792508|FG001|NOT COMPLETED|Baseline Eligibility||0||
59673422|NCT01308424|75792509|FG002|NOT COMPLETED|Baseline Eligibility||0||
59673423|NCT01308424|75792507|FG000|STARTED|Randomization||0||
59673424|NCT01308424|75792508|FG001|STARTED|Randomization||87||
59673425|NCT01308424|75792509|FG002|STARTED|Randomization||84||
59673426|NCT01308424|75792507|FG000|COMPLETED|Randomization||0||
59673427|NCT01308424|75792508|FG001|COMPLETED|Randomization||84||
59673428|NCT01308424|75792509|FG002|COMPLETED|Randomization||82||
59673429|NCT01308424|75792507|FG000|NOT COMPLETED|Randomization||0||
59673430|NCT01308424|75792508|FG001|NOT COMPLETED|Randomization||3||
59673431|NCT01308424|75792509|FG002|NOT COMPLETED|Randomization||2||
59673432|NCT01307800|75792520|FG000|STARTED|Overall Study||111||
59673433|NCT01307800|75792521|FG001|STARTED|Overall Study||110||
59673434|NCT01307800|75792522|FG002|STARTED|Overall Study||118||
59673435|NCT01307800|75792523|FG003|STARTED|Overall Study||228||
59673436|NCT01307800|75792520|FG000|Received Treatment (Rec'd Tx)|Overall Study||111||
59673437|NCT01307800|75792521|FG001|Received Treatment (Rec'd Tx)|Overall Study||110||
59673438|NCT01307800|75792522|FG002|Received Treatment (Rec'd Tx)|Overall Study||118||
59673439|NCT01307800|75792523|FG003|Received Treatment (Rec'd Tx)|Overall Study||228||
59673440|NCT01307800|75792520|FG000|Rec'd Tx, Not a Placebo (PL) Responder|Overall Study|PL responders had ≥25% improvement in PANSS total score (defined in measure 1) in lead-in period.|102||
59673441|NCT01307800|75792521|FG001|Rec'd Tx, Not a Placebo (PL) Responder|Overall Study||103||
59673442|NCT01307800|75792522|FG002|Rec'd Tx, Not a Placebo (PL) Responder|Overall Study||112||
59673443|NCT01307800|75792523|FG003|Rec'd Tx, Not a Placebo (PL) Responder|Overall Study||217||
59673444|NCT01307800|75792520|FG000|COMPLETED|Overall Study||57||
59673445|NCT01307800|75792521|FG001|COMPLETED|Overall Study||45||
59673446|NCT01307800|75792522|FG002|COMPLETED|Overall Study||60||
59673447|NCT01307800|75792523|FG003|COMPLETED|Overall Study||118||
59673448|NCT01307800|75792520|FG000|NOT COMPLETED|Overall Study||54||
59673449|NCT01307800|75792521|FG001|NOT COMPLETED|Overall Study||65||
59673450|NCT01307800|75792522|FG002|NOT COMPLETED|Overall Study||58||
59673451|NCT01307800|75792523|FG003|NOT COMPLETED|Overall Study||110||
59673452|NCT01307449|75792537|FG000|STARTED|Overall Study||33||
59673453|NCT01307449|75792538|FG001|STARTED|Overall Study||33||
59673454|NCT01307449|75792539|FG002|STARTED|Overall Study||11||
59673455|NCT01307449|75792540|FG003|STARTED|Overall Study||11||
59673456|NCT01307449|75792537|FG000|COMPLETED|Overall Study||32||
59673457|NCT01307449|75792538|FG001|COMPLETED|Overall Study||33||
59673458|NCT01307449|75792539|FG002|COMPLETED|Overall Study||11||
59673459|NCT01307449|75792540|FG003|COMPLETED|Overall Study||11||
59673460|NCT01307449|75792537|FG000|NOT COMPLETED|Overall Study||1||
59673461|NCT01307449|75792538|FG001|NOT COMPLETED|Overall Study||0||
59673462|NCT01307449|75792539|FG002|NOT COMPLETED|Overall Study||0||
59673463|NCT01307449|75792540|FG003|NOT COMPLETED|Overall Study||0||
59673464|NCT01307020|75792560|FG000|STARTED|Overall Study||61||
59673465|NCT01307020|75792561|FG001|STARTED|Overall Study||63||
59673466|NCT01307020|75792562|FG002|STARTED|Overall Study||63||
59673467|NCT01307020|75792563|FG003|STARTED|Overall Study||61||
59673468|NCT01307020|75792564|FG004|STARTED|Overall Study||60||
59673469|NCT01307020|75792565|FG005|STARTED|Overall Study||61||
59673470|NCT01307020|75792566|FG006|STARTED|Overall Study||59||
59673471|NCT01307020|75792567|FG007|STARTED|Overall Study||60||
59673472|NCT01307020|75792568|FG008|STARTED|Overall Study||61||
59673473|NCT01307020|75792569|FG009|STARTED|Overall Study||62||
59673474|NCT01307020|75792560|FG000|Safety Population|Overall Study||61||
59673475|NCT01307020|75792561|FG001|Safety Population|Overall Study||63||
59673476|NCT01307020|75792562|FG002|Safety Population|Overall Study||63||
59673477|NCT01307020|75792563|FG003|Safety Population|Overall Study||61||
59673478|NCT01307020|75792564|FG004|Safety Population|Overall Study||60||
59673479|NCT01307020|75792565|FG005|Safety Population|Overall Study||61||
59673480|NCT01307020|75792566|FG006|Safety Population|Overall Study||59||
59673481|NCT01307020|75792567|FG007|Safety Population|Overall Study||60||
59673482|NCT01307020|75792568|FG008|Safety Population|Overall Study||61||
59673483|NCT01307020|75792569|FG009|Safety Population|Overall Study||62||
59673484|NCT01307020|75792560|FG000|ITT (>= 1 Assessment Post Randomization)|Overall Study||60||
59673485|NCT01307020|75792561|FG001|ITT (>= 1 Assessment Post Randomization)|Overall Study||62||
59673486|NCT01307020|75792562|FG002|ITT (>= 1 Assessment Post Randomization)|Overall Study||63||
59673487|NCT01307020|75792563|FG003|ITT (>= 1 Assessment Post Randomization)|Overall Study||61||
59673488|NCT01307020|75792564|FG004|ITT (>= 1 Assessment Post Randomization)|Overall Study||60||
59673489|NCT01307020|75792565|FG005|ITT (>= 1 Assessment Post Randomization)|Overall Study||60||
59673490|NCT01307020|75792566|FG006|ITT (>= 1 Assessment Post Randomization)|Overall Study||59||
59673491|NCT01307020|75792567|FG007|ITT (>= 1 Assessment Post Randomization)|Overall Study||59||
59673492|NCT01307020|75792568|FG008|ITT (>= 1 Assessment Post Randomization)|Overall Study||60||
59673493|NCT01307020|75792569|FG009|ITT (>= 1 Assessment Post Randomization)|Overall Study||62||
59673494|NCT01307020|75792560|FG000|COMPLETED|Overall Study||61||
59673495|NCT01307020|75792561|FG001|COMPLETED|Overall Study||62||
59673496|NCT01307020|75792562|FG002|COMPLETED|Overall Study||62||
59673497|NCT01307020|75792563|FG003|COMPLETED|Overall Study||60||
59673498|NCT01307020|75792564|FG004|COMPLETED|Overall Study||60||
59673499|NCT01307020|75792565|FG005|COMPLETED|Overall Study||61||
59673500|NCT01307020|75792566|FG006|COMPLETED|Overall Study||58||
59673501|NCT01307020|75792567|FG007|COMPLETED|Overall Study||60||
59673502|NCT01307020|75792568|FG008|COMPLETED|Overall Study||61||
59673503|NCT01307020|75792569|FG009|COMPLETED|Overall Study||62||
59673504|NCT01307020|75792560|FG000|NOT COMPLETED|Overall Study||0||
59673505|NCT01307020|75792561|FG001|NOT COMPLETED|Overall Study||1||
59673506|NCT01307020|75792562|FG002|NOT COMPLETED|Overall Study||1||
59673507|NCT01307020|75792563|FG003|NOT COMPLETED|Overall Study||1||
59673508|NCT01307020|75792564|FG004|NOT COMPLETED|Overall Study||0||
59989414|NCT02651675|76104704|FG000|STARTED|Overall Study||3||
59989415|NCT02651675|76104705|FG001|STARTED|Overall Study||3||
59989416|NCT02651675|76104706|FG002|STARTED|Overall Study||3||
59989417|NCT02651675|76104704|FG000|COMPLETED|Overall Study||3||
59989418|NCT02651675|76104705|FG001|COMPLETED|Overall Study||3||
59989419|NCT02651675|76104706|FG002|COMPLETED|Overall Study||2||
59989420|NCT02651675|76104704|FG000|NOT COMPLETED|Overall Study||0||
59989421|NCT02651675|76104705|FG001|NOT COMPLETED|Overall Study||0||
59989422|NCT02651675|76104706|FG002|NOT COMPLETED|Overall Study||1||
59989423|NCT02611960|76104716|FG000|STARTED|Overall Study||117||
59989424|NCT02611960|76104717|FG001|STARTED|Overall Study||116||
59989425|NCT02611960|76104716|FG000|Discontinued|Overall Study||117||
59989426|NCT02611960|76104717|FG001|Discontinued|Overall Study||116||
59989427|NCT02611960|76104716|FG000|COMPLETED|Overall Study||0||
59989428|NCT02611960|76104717|FG001|COMPLETED|Overall Study||0||
59989429|NCT02611960|76104716|FG000|NOT COMPLETED|Overall Study||117||
59989430|NCT02611960|76104717|FG001|NOT COMPLETED|Overall Study||116||
59989431|NCT01845597|76104724|FG000|STARTED|Overall Study||145||
59989432|NCT01845597|76104724|FG000|5 Year Survivorship|Overall Study||134||
59989433|NCT01845597|76104724|FG000|COMPLETED|Overall Study||115||
59989434|NCT01845597|76104724|FG000|NOT COMPLETED|Overall Study||30||
59989435|NCT01839396|76104730|FG000|STARTED|Overall Study||121||
59989436|NCT01839396|76104731|FG001|STARTED|Overall Study||39||
59989437|NCT01839396|76104730|FG000|COMPLETED|Overall Study||121||
59989438|NCT01839396|76104731|FG001|COMPLETED|Overall Study||39||
59673509|NCT01307020|75792565|FG005|NOT COMPLETED|Overall Study||0||
59673510|NCT01307020|75792566|FG006|NOT COMPLETED|Overall Study||1||
59673511|NCT01307020|75792567|FG007|NOT COMPLETED|Overall Study||0||
59673512|NCT01307020|75792568|FG008|NOT COMPLETED|Overall Study||0||
59673513|NCT01307020|75792569|FG009|NOT COMPLETED|Overall Study||0||
59673514|NCT01306201|75792591|FG000|STARTED|Overall Study||63||
59673515|NCT01306201|75792591|FG000|COMPLETED|Overall Study|Total of 10 subjects were excluded from analysis|53||
59673516|NCT01306201|75792591|FG000|NOT COMPLETED|Overall Study||10||
59673517|NCT01306162|75792603|FG000|STARTED|Period 1||9||
59673518|NCT01306162|75792604|FG001|STARTED|Period 1||9||
59673519|NCT01306162|75792605|FG002|STARTED|Period 1||9||
59673520|NCT01306162|75792606|FG003|STARTED|Period 1||9||
59673521|NCT01306162|75792603|FG000|COMPLETED|Period 1||9||
59989439|NCT01839396|76104730|FG000|NOT COMPLETED|Overall Study||0||
59989440|NCT01839396|76104731|FG001|NOT COMPLETED|Overall Study||0||
59989441|NCT01203020|76104737|FG000|STARTED|Overall Study||22||
59989442|NCT01203020|76104737|FG000|COMPLETED|Overall Study||22||
59989443|NCT01203020|76104737|FG000|NOT COMPLETED|Overall Study||0||
59989444|NCT00713206|76104743|FG000|STARTED|Overall Study||65||158
59673522|NCT01306162|75792604|FG001|COMPLETED|Period 1||9||
59673523|NCT01306162|75792605|FG002|COMPLETED|Period 1||9||
59673524|NCT01306162|75792606|FG003|COMPLETED|Period 1||8||
59673525|NCT01306162|75792603|FG000|NOT COMPLETED|Period 1||0||
59673526|NCT01306162|75792604|FG001|NOT COMPLETED|Period 1||0||
59673527|NCT01306162|75792605|FG002|NOT COMPLETED|Period 1||0||
59673528|NCT01306162|75792606|FG003|NOT COMPLETED|Period 1||1||
59673529|NCT01306162|75792603|FG000|STARTED|Washout 1|Treatment A was followed by a washout period of at least 96 hours.|9||
59673530|NCT01306162|75792604|FG001|STARTED|Washout 1|Treatment A was followed by a washout period of at least 96 hours.|9||
59673531|NCT01306162|75792605|FG002|STARTED|Washout 1|No washout period. Treatment D followed directly after treatment B.|9||
59673532|NCT01306162|75792606|FG003|STARTED|Washout 1|No washout period.Treatment E followed directly after treatment C.|8||
59673533|NCT01306162|75792603|FG000|COMPLETED|Washout 1||9||
59673534|NCT01306162|75792604|FG001|COMPLETED|Washout 1||8||
59673535|NCT01306162|75792605|FG002|COMPLETED|Washout 1||9||
59673536|NCT01306162|75792606|FG003|COMPLETED|Washout 1||8||
59673537|NCT01306162|75792603|FG000|NOT COMPLETED|Washout 1||0||
59673538|NCT01306162|75792604|FG001|NOT COMPLETED|Washout 1||1||
59673539|NCT01306162|75792605|FG002|NOT COMPLETED|Washout 1||0||
59673540|NCT01306162|75792606|FG003|NOT COMPLETED|Washout 1||0||
59673541|NCT01306162|75792603|FG000|STARTED|Period 2|No washout phase after Period 2.|9||
59673542|NCT01306162|75792604|FG001|STARTED|Period 2|No washout phase after Period 2.|8||
59673543|NCT01306162|75792605|FG002|STARTED|Period 2|No washout phase after Period 2.|9||
59673544|NCT01306162|75792606|FG003|STARTED|Period 2|No washout phase after Period 2.|8||
59673545|NCT01306162|75792603|FG000|COMPLETED|Period 2||9||
59673546|NCT01306162|75792604|FG001|COMPLETED|Period 2||8||
59673547|NCT01306162|75792605|FG002|COMPLETED|Period 2||9||
59673548|NCT01306162|75792606|FG003|COMPLETED|Period 2||8||
59673549|NCT01306162|75792603|FG000|NOT COMPLETED|Period 2||0||
59673550|NCT01306162|75792604|FG001|NOT COMPLETED|Period 2||0||
59673551|NCT01306162|75792605|FG002|NOT COMPLETED|Period 2||0||
59673552|NCT01306162|75792606|FG003|NOT COMPLETED|Period 2||0||
59673553|NCT01306162|75792603|FG000|STARTED|Period 3||9||
59673554|NCT01306162|75792604|FG001|STARTED|Period 3||8||
59673555|NCT01306162|75792605|FG002|STARTED|Period 3||9||
59673556|NCT01306162|75792606|FG003|STARTED|Period 3||8||
59673557|NCT01306162|75792603|FG000|COMPLETED|Period 3||9||
59673558|NCT01306162|75792604|FG001|COMPLETED|Period 3||8||
59673559|NCT01306162|75792605|FG002|COMPLETED|Period 3||9||
59673560|NCT01306162|75792606|FG003|COMPLETED|Period 3||8||
59673561|NCT01306162|75792603|FG000|NOT COMPLETED|Period 3||0||
59673562|NCT01306162|75792604|FG001|NOT COMPLETED|Period 3||0||
59673563|NCT01306162|75792605|FG002|NOT COMPLETED|Period 3||0||
59673564|NCT01306162|75792606|FG003|NOT COMPLETED|Period 3||0||
59673565|NCT01306162|75792603|FG000|STARTED|Washout 2|No washout period. Treatment E followed directly after treatment D.|9||
59989445|NCT00713206|76104744|FG001|STARTED|Overall Study||57||140
59989446|NCT00713206|76104743|FG000|COMPLETED|Overall Study||60||152
59989447|NCT00713206|76104744|FG001|COMPLETED|Overall Study||53||131
59989448|NCT00713206|76104743|FG000|NOT COMPLETED|Overall Study||5||6
59546112|NCT01060592|75644699|FG000|NOT COMPLETED|12m||0||
59546113|NCT01060592|75644700|FG001|NOT COMPLETED|12m||18||
59546114|NCT02171234|75644711|FG000|STARTED|Overall Study||8||
59546115|NCT02171234|75644712|FG001|STARTED|Overall Study||6||
59546116|NCT02171234|75644713|FG002|STARTED|Overall Study||6||
59546117|NCT02171234|75644714|FG003|STARTED|Overall Study||6||
59546118|NCT02171234|75644715|FG004|STARTED|Overall Study||6||
59546119|NCT02171234|75644711|FG000|COMPLETED|Overall Study||8||
59546120|NCT02171234|75644712|FG001|COMPLETED|Overall Study||6||
59546121|NCT02171234|75644713|FG002|COMPLETED|Overall Study||6||
59546122|NCT02171234|75644714|FG003|COMPLETED|Overall Study||6||
59546123|NCT02171234|75644715|FG004|COMPLETED|Overall Study||6||
59673566|NCT01306162|75792604|FG001|STARTED|Washout 2|No washout period. Treatment D followed directly after treatment E.|8||
59673567|NCT01306162|75792605|FG002|STARTED|Washout 2|The last dose of Dronedarone was followed by a washout period of at least 10 days.|9||
59673568|NCT01306162|75792606|FG003|STARTED|Washout 2|The last dose of Dronedarone was followed by a washout period of at least 10 days.|8||
59673569|NCT01306162|75792603|FG000|COMPLETED|Washout 2||9||
59673570|NCT01306162|75792604|FG001|COMPLETED|Washout 2||8||
59673571|NCT01306162|75792605|FG002|COMPLETED|Washout 2||9||
59673572|NCT01306162|75792606|FG003|COMPLETED|Washout 2||8||
59673573|NCT01306162|75792603|FG000|NOT COMPLETED|Washout 2||0||
59673574|NCT01306162|75792604|FG001|NOT COMPLETED|Washout 2||0||
59673575|NCT01306162|75792605|FG002|NOT COMPLETED|Washout 2||0||
59673576|NCT01306162|75792606|FG003|NOT COMPLETED|Washout 2||0||
59673577|NCT01306162|75792603|FG000|STARTED|Period 4||9||
59673578|NCT01306162|75792604|FG001|STARTED|Period 4||8||
59673579|NCT01306162|75792605|FG002|STARTED|Period 4||9||
59673580|NCT01306162|75792606|FG003|STARTED|Period 4||8||
59673581|NCT01306162|75792603|FG000|COMPLETED|Period 4||9||
59673582|NCT01306162|75792604|FG001|COMPLETED|Period 4||8||
59673583|NCT01306162|75792605|FG002|COMPLETED|Period 4||9||
59673584|NCT01306162|75792606|FG003|COMPLETED|Period 4||8||
59546124|NCT02171234|75644711|FG000|NOT COMPLETED|Overall Study||0||
59546125|NCT02171234|75644712|FG001|NOT COMPLETED|Overall Study||0||
59989449|NCT00713206|76104744|FG001|NOT COMPLETED|Overall Study||4||9
59546126|NCT02171234|75644713|FG002|NOT COMPLETED|Overall Study||0||
59546127|NCT02171234|75644714|FG003|NOT COMPLETED|Overall Study||0||
59546128|NCT02171234|75644715|FG004|NOT COMPLETED|Overall Study||0||
59546129|NCT01061528|75644729|FG000|STARTED|Overall Study||62||
59546130|NCT01061528|75644730|FG001|STARTED|Overall Study||54||
59673585|NCT01306162|75792603|FG000|NOT COMPLETED|Period 4||0||
59673586|NCT01306162|75792604|FG001|NOT COMPLETED|Period 4||0||
59673587|NCT01306162|75792605|FG002|NOT COMPLETED|Period 4||0||
59673588|NCT01306162|75792606|FG003|NOT COMPLETED|Period 4||0||
59673589|NCT01305577|75792622|FG000|STARTED|Overall Study||120||
59673590|NCT01305577|75792623|FG001|STARTED|Overall Study||121||
59673591|NCT01305577|75792624|FG002|STARTED|Overall Study||122||
59673592|NCT01305577|75792622|FG000|Received Treatment|Overall Study||119||
59673593|NCT01305577|75792623|FG001|Received Treatment|Overall Study||121||
59673594|NCT01305577|75792624|FG002|Received Treatment|Overall Study||122||
59673595|NCT01305577|75792622|FG000|COMPLETED|Overall Study||107||
59673596|NCT01305577|75792623|FG001|COMPLETED|Overall Study||110||
59673597|NCT01305577|75792624|FG002|COMPLETED|Overall Study||112||
59673598|NCT01305577|75792622|FG000|NOT COMPLETED|Overall Study||13||
59673599|NCT01305577|75792623|FG001|NOT COMPLETED|Overall Study||11||
59673600|NCT01305577|75792624|FG002|NOT COMPLETED|Overall Study||10||
59673601|NCT01304329|75792632|FG000|STARTED|First Intervention (3 Days)||3||
59673602|NCT01304329|75792633|FG001|STARTED|First Intervention (3 Days)||3||
59673603|NCT01304329|75792634|FG002|STARTED|First Intervention (3 Days)||3||
59673604|NCT01304329|75792635|FG003|STARTED|First Intervention (3 Days)||3||
59673605|NCT01304329|75792636|FG004|STARTED|First Intervention (3 Days)||3||
59673606|NCT01304329|75792637|FG005|STARTED|First Intervention (3 Days)||3||
59673607|NCT01304329|75792632|FG000|COMPLETED|First Intervention (3 Days)||3||
59673608|NCT01304329|75792633|FG001|COMPLETED|First Intervention (3 Days)||3||
59673609|NCT01304329|75792634|FG002|COMPLETED|First Intervention (3 Days)||3||
59673610|NCT01304329|75792635|FG003|COMPLETED|First Intervention (3 Days)||3||
59673611|NCT01304329|75792636|FG004|COMPLETED|First Intervention (3 Days)||3||
59673612|NCT01304329|75792637|FG005|COMPLETED|First Intervention (3 Days)||3||
59673613|NCT01304329|75792632|FG000|NOT COMPLETED|First Intervention (3 Days)||0||
59673614|NCT01304329|75792633|FG001|NOT COMPLETED|First Intervention (3 Days)||0||
59673615|NCT01304329|75792634|FG002|NOT COMPLETED|First Intervention (3 Days)||0||
59673616|NCT01304329|75792635|FG003|NOT COMPLETED|First Intervention (3 Days)||0||
59673617|NCT01304329|75792636|FG004|NOT COMPLETED|First Intervention (3 Days)||0||
59673618|NCT01304329|75792637|FG005|NOT COMPLETED|First Intervention (3 Days)||0||
59673619|NCT01304329|75792632|FG000|STARTED|Second Intervention (3 Days)||3||
59815901|NCT01204216|75938321|FG000|NOT COMPLETED|Overall Study||3||
59546131|NCT01061528|75644729|FG000|COMPLETED|Overall Study||59||
59546132|NCT01061528|75644730|FG001|COMPLETED|Overall Study||52||
59546133|NCT01061528|75644729|FG000|NOT COMPLETED|Overall Study||3||
59546134|NCT01061528|75644730|FG001|NOT COMPLETED|Overall Study||2||
59546135|NCT01062074|75644736|FG000|STARTED|Overall Study||3605||
59546136|NCT01062074|75644736|FG000|COMPLETED|Overall Study||3605||
59546137|NCT01062074|75644736|FG000|NOT COMPLETED|Overall Study||0||
59546138|NCT01062230|75644740|FG000|STARTED|Overall Study||6||
59546139|NCT01062230|75644740|FG000|COMPLETED|Overall Study||6||
59546140|NCT01062230|75644740|FG000|NOT COMPLETED|Overall Study||0||
59546141|NCT01062308|75644746|FG000|STARTED|Overall Study||80||
59546142|NCT01062308|75644747|FG001|STARTED|Overall Study||82||
59546143|NCT01062308|75644746|FG000|COMPLETED|Overall Study||64||
59546144|NCT01062308|75644747|FG001|COMPLETED|Overall Study||72||
59546145|NCT01062308|75644746|FG000|NOT COMPLETED|Overall Study||16||
59546146|NCT01062308|75644747|FG001|NOT COMPLETED|Overall Study||10||
59546147|NCT01063712|75644753|FG000|STARTED|Overall Study||29||
59546148|NCT01063712|75644753|FG000|COMPLETED|Overall Study||29||
59546149|NCT01063712|75644753|FG000|NOT COMPLETED|Overall Study||0||
59546150|NCT01064882|75644761|FG000|STARTED|Overall Study||36||
59546151|NCT01064882|75644762|FG001|STARTED|Overall Study||34||
59546152|NCT01064882|75644763|FG002|STARTED|Overall Study||34||
59546153|NCT01064882|75644761|FG000|COMPLETED|Overall Study||34||
59673620|NCT01304329|75792633|FG001|STARTED|Second Intervention (3 Days)||3||
59673621|NCT01304329|75792634|FG002|STARTED|Second Intervention (3 Days)||3||
59546154|NCT01064882|75644762|FG001|COMPLETED|Overall Study||32||
59673622|NCT01304329|75792635|FG003|STARTED|Second Intervention (3 Days)||3||
59673623|NCT01304329|75792636|FG004|STARTED|Second Intervention (3 Days)||3||
59673624|NCT01304329|75792637|FG005|STARTED|Second Intervention (3 Days)||3||
59673625|NCT01304329|75792632|FG000|COMPLETED|Second Intervention (3 Days)||3||
59673626|NCT01304329|75792633|FG001|COMPLETED|Second Intervention (3 Days)||3||
59673627|NCT01304329|75792634|FG002|COMPLETED|Second Intervention (3 Days)||3||
59673628|NCT01304329|75792635|FG003|COMPLETED|Second Intervention (3 Days)||3||
59673629|NCT01304329|75792636|FG004|COMPLETED|Second Intervention (3 Days)||3||
59673630|NCT01304329|75792637|FG005|COMPLETED|Second Intervention (3 Days)||3||
59546155|NCT01064882|75644763|FG002|COMPLETED|Overall Study||32||
59673631|NCT01304329|75792632|FG000|NOT COMPLETED|Second Intervention (3 Days)||0||
59673632|NCT01304329|75792633|FG001|NOT COMPLETED|Second Intervention (3 Days)||0||
59673633|NCT01304329|75792634|FG002|NOT COMPLETED|Second Intervention (3 Days)||0||
59815902|NCT01204216|75938322|FG001|NOT COMPLETED|Overall Study||0||
59673634|NCT01304329|75792635|FG003|NOT COMPLETED|Second Intervention (3 Days)||0||
59673635|NCT01304329|75792636|FG004|NOT COMPLETED|Second Intervention (3 Days)||0||
59673636|NCT01304329|75792637|FG005|NOT COMPLETED|Second Intervention (3 Days)||0||
59673637|NCT01304329|75792632|FG000|STARTED|Third Intervention (3 Days)||3||
59673638|NCT01304329|75792633|FG001|STARTED|Third Intervention (3 Days)||3||
59673639|NCT01304329|75792634|FG002|STARTED|Third Intervention (3 Days)||3||
59673640|NCT01304329|75792635|FG003|STARTED|Third Intervention (3 Days)||3||
59673641|NCT01304329|75792636|FG004|STARTED|Third Intervention (3 Days)||3||
59673642|NCT01304329|75792637|FG005|STARTED|Third Intervention (3 Days)||3||
59673643|NCT01304329|75792632|FG000|COMPLETED|Third Intervention (3 Days)||3||
59673644|NCT01304329|75792633|FG001|COMPLETED|Third Intervention (3 Days)||2||
59673645|NCT01304329|75792634|FG002|COMPLETED|Third Intervention (3 Days)||3||
59673646|NCT01304329|75792635|FG003|COMPLETED|Third Intervention (3 Days)||3||
59673647|NCT01304329|75792636|FG004|COMPLETED|Third Intervention (3 Days)||3||
59673648|NCT01304329|75792637|FG005|COMPLETED|Third Intervention (3 Days)||3||
59673649|NCT01304329|75792632|FG000|NOT COMPLETED|Third Intervention (3 Days)||0||
59673650|NCT01304329|75792633|FG001|NOT COMPLETED|Third Intervention (3 Days)||1||
59673651|NCT01304329|75792634|FG002|NOT COMPLETED|Third Intervention (3 Days)||0||
59673652|NCT01304329|75792635|FG003|NOT COMPLETED|Third Intervention (3 Days)||0||
59673653|NCT01304329|75792636|FG004|NOT COMPLETED|Third Intervention (3 Days)||0||
59673654|NCT01304329|75792637|FG005|NOT COMPLETED|Third Intervention (3 Days)||0||
59673655|NCT01303861|75792650|FG000|STARTED|Overall Study||109||
59673656|NCT01303861|75792651|FG001|STARTED|Overall Study||50||
59673657|NCT01303861|75792652|FG002|STARTED|Overall Study||55||
59673658|NCT01303861|75792653|FG003|STARTED|Overall Study||113||
59673659|NCT01303861|75792650|FG000|Finished Treatment Phase|Overall Study||71||
59673660|NCT01303861|75792651|FG001|Finished Treatment Phase|Overall Study||34||
59673661|NCT01303861|75792652|FG002|Finished Treatment Phase|Overall Study||39||
59673662|NCT01303861|75792653|FG003|Finished Treatment Phase|Overall Study||72||
59673663|NCT01303861|75792650|FG000|COMPLETED|Overall Study||51||
59673664|NCT01303861|75792651|FG001|COMPLETED|Overall Study||25||
59673665|NCT01303861|75792652|FG002|COMPLETED|Overall Study||19||
59673666|NCT01303861|75792653|FG003|COMPLETED|Overall Study||54||
59673667|NCT01303861|75792650|FG000|NOT COMPLETED|Overall Study||58||
59673668|NCT01303861|75792651|FG001|NOT COMPLETED|Overall Study||25||
59673669|NCT01303861|75792652|FG002|NOT COMPLETED|Overall Study||36||
59673670|NCT01303861|75792653|FG003|NOT COMPLETED|Overall Study||59||
59673671|NCT01303627|75792666|FG000|STARTED|Overall Study||21||
59673672|NCT01303627|75792667|FG001|STARTED|Overall Study||21||
59673673|NCT01303627|75792666|FG000|COMPLETED|Overall Study||21||
59673674|NCT01303627|75792667|FG001|COMPLETED|Overall Study|One patient excluded from the study because of the failure while performing uretero-renoscopy|20||
59673675|NCT01303627|75792666|FG000|NOT COMPLETED|Overall Study||0||
59673676|NCT01303627|75792667|FG001|NOT COMPLETED|Overall Study||1||
59673677|NCT01303510|75792675|FG000|STARTED|Overall Study||55||
59673678|NCT01303510|75792676|FG001|STARTED|Overall Study||56||
59673679|NCT01303510|75792675|FG000|COMPLETED|Overall Study||54||
59673680|NCT01303510|75792676|FG001|COMPLETED|Overall Study||56||
59673681|NCT01303510|75792675|FG000|NOT COMPLETED|Overall Study||1||
59673682|NCT01303510|75792676|FG001|NOT COMPLETED|Overall Study||0||
59673683|NCT01303159|75792682|FG000|STARTED|Overall Study||29||
59673684|NCT01303159|75792682|FG000|COMPLETED|Overall Study||6||
59673685|NCT01303159|75792682|FG000|NOT COMPLETED|Overall Study||23||
59673686|NCT01302964|75792688|FG000|STARTED|Overall Study||20||
59546156|NCT01064882|75644761|FG000|NOT COMPLETED|Overall Study||2||
59546157|NCT01064882|75644762|FG001|NOT COMPLETED|Overall Study||2||
59546158|NCT01064882|75644763|FG002|NOT COMPLETED|Overall Study||2||
59546159|NCT01065428|75644773|FG000|STARTED|Overall Study||17||
59546160|NCT01065428|75644774|FG001|STARTED|Overall Study||35||
59546161|NCT01065428|75644773|FG000|COMPLETED|Overall Study||17||
59546162|NCT01065428|75644774|FG001|COMPLETED|Overall Study||35||
59546163|NCT01065428|75644773|FG000|NOT COMPLETED|Overall Study||0||
59546164|NCT01065428|75644774|FG001|NOT COMPLETED|Overall Study||0||
59546165|NCT01065506|75644782|FG000|STARTED|Overall Study||64||
59546166|NCT01065506|75644783|FG001|STARTED|Overall Study||72||
59546167|NCT01065506|75644782|FG000|End of Treatment|Overall Study||44||
59546168|NCT01065506|75644783|FG001|End of Treatment|Overall Study||37||
59546169|NCT01065506|75644782|FG000|4-Month Follow-Up|Overall Study||35||
59673687|NCT01302964|75792689|FG001|STARTED|Overall Study||10||
59673688|NCT01302964|75792688|FG000|COMPLETED|Overall Study||19||
59673689|NCT01302964|75792689|FG001|COMPLETED|Overall Study||10||
59673690|NCT01302964|75792688|FG000|NOT COMPLETED|Overall Study||1||
59546170|NCT01065506|75644783|FG001|4-Month Follow-Up|Overall Study||34||
59546171|NCT01065506|75644782|FG000|COMPLETED|Overall Study||32||
59673691|NCT01302964|75792689|FG001|NOT COMPLETED|Overall Study||0||
59673692|NCT01302691|75792697|FG000|STARTED|Overall Study||164||
59673693|NCT01302691|75792698|FG001|STARTED|Overall Study||163||
59673694|NCT01302691|75792697|FG000|COMPLETED|Overall Study||154||
59673695|NCT01302691|75792698|FG001|COMPLETED|Overall Study||157||
59673696|NCT01302691|75792697|FG000|NOT COMPLETED|Overall Study||10||
59673697|NCT01302691|75792698|FG001|NOT COMPLETED|Overall Study||6||
59673698|NCT01302418|75792704|FG000|STARTED|Overall Study||272||
59673699|NCT01302418|75792704|FG000|COMPLETED|Overall Study||254||
59673700|NCT01302418|75792704|FG000|NOT COMPLETED|Overall Study||18||
59673701|NCT01302067|75792711|FG000|STARTED|Overall Study||790||
59673702|NCT01302067|75792712|FG001|STARTED|Overall Study||386||
59673703|NCT01302067|75792713|FG002|STARTED|Overall Study||779||
59673704|NCT01302067|75792711|FG000|COMPLETED|Overall Study||712||
59673705|NCT01302067|75792712|FG001|COMPLETED|Overall Study||352||
59673706|NCT01302067|75792713|FG002|COMPLETED|Overall Study||681||
59673707|NCT01302067|75792711|FG000|NOT COMPLETED|Overall Study||78||
59673708|NCT01302067|75792712|FG001|NOT COMPLETED|Overall Study||34||
59673709|NCT01302067|75792713|FG002|NOT COMPLETED|Overall Study||98||
59673710|NCT01301950|75792723|FG000|STARTED|Overall Study||15||
59673711|NCT01301950|75792724|FG001|STARTED|Overall Study||15||
59673712|NCT01301950|75792723|FG000|COMPLETED|Overall Study||15||
59673713|NCT01301950|75792724|FG001|COMPLETED|Overall Study||14||
59673714|NCT01301950|75792723|FG000|NOT COMPLETED|Overall Study||0||
59673715|NCT01301950|75792724|FG001|NOT COMPLETED|Overall Study||1||
59673716|NCT01301833|75792734|FG000|STARTED|Overall Study||212||
59673717|NCT01301833|75792735|FG001|STARTED|Overall Study||80||
59673718|NCT01301833|75792736|FG002|STARTED|Overall Study||95||
59673719|NCT01301833|75792737|FG003|STARTED|Overall Study||75||
59673720|NCT01301833|75792734|FG000|COMPLETED|Overall Study||197||
59673721|NCT01301833|75792735|FG001|COMPLETED|Overall Study||72||
59673722|NCT01301833|75792736|FG002|COMPLETED|Overall Study||88||
59673723|NCT01301833|75792737|FG003|COMPLETED|Overall Study||68||
59673724|NCT01301833|75792734|FG000|NOT COMPLETED|Overall Study||15||
59673725|NCT01301833|75792735|FG001|NOT COMPLETED|Overall Study||8||
59673726|NCT01301833|75792736|FG002|NOT COMPLETED|Overall Study||7||
59673727|NCT01301833|75792737|FG003|NOT COMPLETED|Overall Study||7||
59673728|NCT01301092|75792750|FG000|STARTED|Overall Study||6||
59673729|NCT01301092|75792751|FG001|STARTED|Overall Study||16||
59673730|NCT01301092|75792752|FG002|STARTED|Overall Study||8||
59673731|NCT01301092|75792750|FG000|COMPLETED|Overall Study||6||
59673732|NCT01301092|75792751|FG001|COMPLETED|Overall Study||16||
59673733|NCT01301092|75792752|FG002|COMPLETED|Overall Study||7||
59673734|NCT01301092|75792750|FG000|NOT COMPLETED|Overall Study||0||
59673735|NCT01301092|75792751|FG001|NOT COMPLETED|Overall Study||0||
59673736|NCT01301092|75792752|FG002|NOT COMPLETED|Overall Study||1||
59673737|NCT01300819|75792767|FG000|STARTED|Overall Study||125||
59673738|NCT01300819|75792768|FG001|STARTED|Overall Study||224||
59673739|NCT01300819|75792767|FG000|COMPLETED|Overall Study||103||
59673740|NCT01300819|75792768|FG001|COMPLETED|Overall Study||180||
59673741|NCT01300819|75792767|FG000|NOT COMPLETED|Overall Study||22||
59673742|NCT01300819|75792768|FG001|NOT COMPLETED|Overall Study||44||
59673743|NCT01300741|75792774|FG000|STARTED|Overall Study||75||
59673744|NCT01300741|75792774|FG000|COMPLETED|Overall Study||72||
59673745|NCT01300741|75792774|FG000|NOT COMPLETED|Overall Study||3||
59673746|NCT01300546|75792782|FG000|STARTED|Overall Study||19||
59673747|NCT01300546|75792783|FG001|STARTED|Overall Study||20||
59673748|NCT01300546|75792782|FG000|COMPLETED|Overall Study||18||
59673749|NCT01300546|75792783|FG001|COMPLETED|Overall Study||14||
59673750|NCT01300546|75792782|FG000|NOT COMPLETED|Overall Study||1||
59673751|NCT01300546|75792783|FG001|NOT COMPLETED|Overall Study||6||
59673752|NCT01300351|75792791|FG000|STARTED|Overall Study||111||
59673753|NCT01300351|75792792|FG001|STARTED|Overall Study||110||
59673754|NCT01300351|75792791|FG000|Received Study Treatment|Overall Study||109||
59673755|NCT01300351|75792792|FG001|Received Study Treatment|Overall Study||110||
59673756|NCT01300351|75792791|FG000|COMPLETED|Overall Study||75||
59673757|NCT01300351|75792792|FG001|COMPLETED|Overall Study||72||
59673758|NCT01300351|75792791|FG000|NOT COMPLETED|Overall Study||36||
59673759|NCT01300351|75792792|FG001|NOT COMPLETED|Overall Study||38||
59673760|NCT01300234|75792800|FG000|STARTED|Overall Study||257||
59673761|NCT01300234|75792801|FG001|STARTED|Overall Study||255||
59673762|NCT01300234|75792800|FG000|COMPLETED|Overall Study||229||
59673763|NCT01300234|75792801|FG001|COMPLETED|Overall Study||228||
59673764|NCT01300234|75792800|FG000|NOT COMPLETED|Overall Study||28||
59673765|NCT01300234|75792801|FG001|NOT COMPLETED|Overall Study||27||
59673766|NCT01299961|75792818|FG000|STARTED|Overall Study||25||
59673767|NCT01299961|75792818|FG000|COMPLETED|Overall Study||19||
59673768|NCT01299961|75792818|FG000|NOT COMPLETED|Overall Study||6||
59673769|NCT01299805|75792824|FG000|STARTED|Overall Study||12||
59673770|NCT01299805|75792825|FG001|STARTED|Overall Study||5||
59673771|NCT01299805|75792824|FG000|COMPLETED|Overall Study||10||
59673772|NCT01299805|75792825|FG001|COMPLETED|Overall Study||5||
59673773|NCT01299805|75792824|FG000|NOT COMPLETED|Overall Study||2||
59673774|NCT01299805|75792825|FG001|NOT COMPLETED|Overall Study||0||
59673775|NCT01299766|75792833|FG000|STARTED|Overall Study||111||
59673776|NCT01299766|75792834|FG001|STARTED|Overall Study||110||
59673777|NCT01299766|75792833|FG000|COMPLETED|Overall Study||77|Provided data at 24 months|
59673778|NCT01299766|75792834|FG001|COMPLETED|Overall Study||87|Provided data at 24 months|
59673779|NCT01299766|75792833|FG000|NOT COMPLETED|Overall Study||34||
59673780|NCT01299766|75792834|FG001|NOT COMPLETED|Overall Study||23||
59673781|NCT01299727|75792843|FG000|STARTED|Overall Study||4||
59673782|NCT01299727|75792844|FG001|STARTED|Overall Study||4||
59673783|NCT01299727|75792845|FG002|STARTED|Overall Study||4||
59673784|NCT01299727|75792843|FG000|COMPLETED|Overall Study||0||
59673785|NCT01299727|75792844|FG001|COMPLETED|Overall Study||0||
59673786|NCT01299727|75792845|FG002|COMPLETED|Overall Study||0||
59673787|NCT01299727|75792843|FG000|NOT COMPLETED|Overall Study||4||
59673788|NCT01299727|75792844|FG001|NOT COMPLETED|Overall Study||4||
59673789|NCT01299727|75792845|FG002|NOT COMPLETED|Overall Study||4||
59673790|NCT01299571|75792853|FG000|STARTED|Overall Study||3977||
59673791|NCT01299571|75792853|FG000|COMPLETED|Overall Study||3870||
59673792|NCT01299571|75792853|FG000|NOT COMPLETED|Overall Study||107||
59673793|NCT01299376|75792860|FG000|STARTED|Double-blind Treatment (Weeks 1 to 8)||141||
59673794|NCT01299376|75792861|FG001|STARTED|Double-blind Treatment (Weeks 1 to 8)||145||
59673795|NCT01299376|75792860|FG000|COMPLETED|Double-blind Treatment (Weeks 1 to 8)||134||
59673796|NCT01299376|75792861|FG001|COMPLETED|Double-blind Treatment (Weeks 1 to 8)||133||
59673797|NCT01299376|75792860|FG000|NOT COMPLETED|Double-blind Treatment (Weeks 1 to 8)||7||
59673798|NCT01299376|75792861|FG001|NOT COMPLETED|Double-blind Treatment (Weeks 1 to 8)||12||
59673799|NCT01299376|75792860|FG000|STARTED|Extension (Weeks 9 to 52)||134||
59673800|NCT01299376|75792861|FG001|STARTED|Extension (Weeks 9 to 52)||133||
59673801|NCT01299376|75792860|FG000|COMPLETED|Extension (Weeks 9 to 52)||124||
59673802|NCT01299376|75792861|FG001|COMPLETED|Extension (Weeks 9 to 52)||118||
59673803|NCT01299376|75792860|FG000|NOT COMPLETED|Extension (Weeks 9 to 52)||10||
59673804|NCT01299376|75792861|FG001|NOT COMPLETED|Extension (Weeks 9 to 52)||15||
59673805|NCT01299025|75792873|FG000|STARTED|Overall Study||42||
59673806|NCT01299025|75792874|FG001|STARTED|Overall Study||42||
59673807|NCT01299025|75792873|FG000|COMPLETED|Overall Study||39||
59673808|NCT01299025|75792874|FG001|COMPLETED|Overall Study||41||
59673809|NCT01299025|75792873|FG000|NOT COMPLETED|Overall Study||3||
59673810|NCT01299025|75792874|FG001|NOT COMPLETED|Overall Study||1||
59673811|NCT01298596|75792882|FG000|STARTED|Overall Study||200||
59546172|NCT01065506|75644783|FG001|COMPLETED|Overall Study||34||
59546173|NCT01065506|75644782|FG000|NOT COMPLETED|Overall Study||32||
59546174|NCT01065506|75644783|FG001|NOT COMPLETED|Overall Study||38||
59546175|NCT01066364|75644791|FG000|STARTED|Overall Study||25||
59546176|NCT01066364|75644792|FG001|STARTED|Overall Study||25||
59673812|NCT01298596|75792883|FG001|STARTED|Overall Study||200||
59673813|NCT01298596|75792882|FG000|COMPLETED|Overall Study||172||
59673814|NCT01298596|75792883|FG001|COMPLETED|Overall Study||167||
59673815|NCT01298596|75792882|FG000|NOT COMPLETED|Overall Study||28||
59673816|NCT01298596|75792883|FG001|NOT COMPLETED|Overall Study||33||
59673817|NCT01298518|75792892|FG000|STARTED|Overall Study||16||
59673818|NCT01298518|75792893|FG001|STARTED|Overall Study||16||
59673819|NCT01298518|75792894|FG002|STARTED|Overall Study||16||
59673820|NCT01298518|75792892|FG000|COMPLETED|Overall Study||16||
59673821|NCT01298518|75792893|FG001|COMPLETED|Overall Study||16||
59673822|NCT01298518|75792894|FG002|COMPLETED|Overall Study||15||
59673823|NCT01298518|75792892|FG000|NOT COMPLETED|Overall Study||0||
59673824|NCT01298518|75792893|FG001|NOT COMPLETED|Overall Study||0||
59673825|NCT01298518|75792894|FG002|NOT COMPLETED|Overall Study||1||
59673826|NCT01298362|75792904|FG000|STARTED|Overall Study||124||
59673827|NCT01298362|75792905|FG001|STARTED|Overall Study||166||
59673828|NCT01298362|75792904|FG000|COMPLETED|Overall Study||86||
59673829|NCT01298362|75792905|FG001|COMPLETED|Overall Study||123||
59673830|NCT01298362|75792904|FG000|NOT COMPLETED|Overall Study||38||
59673831|NCT01298362|75792905|FG001|NOT COMPLETED|Overall Study||43||
59673832|NCT01297504|75792913|FG000|STARTED|Overall Study||464||
59673833|NCT01297504|75792913|FG000|Participants Studied|Overall Study|Six participants were eliminated due to invalid consent, previous palivizumab or no study visits|458||
59673834|NCT01297504|75792913|FG000|COMPLETED|Overall Study||397||
59673835|NCT01297504|75792913|FG000|NOT COMPLETED|Overall Study||67||
59673836|NCT01297465|75792923|FG000|STARTED|Overall Study||99||
59673837|NCT01297465|75792924|FG001|STARTED|Overall Study||103||
59673838|NCT01297465|75792923|FG000|COMPLETED|Overall Study||91||
59673839|NCT01297465|75792924|FG001|COMPLETED|Overall Study||93||
59673840|NCT01297465|75792923|FG000|NOT COMPLETED|Overall Study||8||
59673841|NCT01297465|75792924|FG001|NOT COMPLETED|Overall Study||10||
59546177|NCT01066364|75644791|FG000|COMPLETED|Overall Study||22||
59546178|NCT01066364|75644792|FG001|COMPLETED|Overall Study||23||
59546179|NCT01066364|75644791|FG000|NOT COMPLETED|Overall Study||3||
59546180|NCT01066364|75644792|FG001|NOT COMPLETED|Overall Study||2||
59546181|NCT01066520|75644801|FG000|STARTED|Overall Study||143||
59546182|NCT01066520|75644802|FG001|STARTED|Overall Study||140||
59673842|NCT01297309|75792930|FG000|STARTED|Overall Study||51||
59673843|NCT01297309|75792930|FG000|Treated|Overall Study||49||
59673844|NCT01297309|75792930|FG000|Started Extension Period|Overall Study||46||
59673845|NCT01297309|75792930|FG000|COMPLETED|Overall Study||37||
59673846|NCT01297309|75792930|FG000|NOT COMPLETED|Overall Study||14||
59673847|NCT04518462|75792937|FG000|STARTED|Overall Study||40||
59673848|NCT04518462|75792938|FG001|STARTED|Overall Study||41||
59673849|NCT04518462|75792939|FG002|STARTED|Overall Study||40||
59673850|NCT04518462|75792937|FG000|COMPLETED|Overall Study||39||
59673851|NCT04518462|75792938|FG001|COMPLETED|Overall Study||40||
59673852|NCT04518462|75792939|FG002|COMPLETED|Overall Study||39||
59673853|NCT04518462|75792937|FG000|NOT COMPLETED|Overall Study||1||
59673854|NCT04518462|75792938|FG001|NOT COMPLETED|Overall Study||1||
59673855|NCT04518462|75792939|FG002|NOT COMPLETED|Overall Study||1||
59673856|NCT01297270|75792950|FG000|STARTED|Overall Study||262||
59673857|NCT01297270|75792951|FG001|STARTED|Overall Study||264||
59673858|NCT01297270|75792952|FG002|STARTED|Overall Study||132||
59673859|NCT01297270|75792950|FG000|COMPLETED|Overall Study||217||
59673860|NCT01297270|75792951|FG001|COMPLETED|Overall Study||192||
59673861|NCT01297270|75792952|FG002|COMPLETED|Overall Study||103||
59673862|NCT01297270|75792950|FG000|NOT COMPLETED|Overall Study||45||
59673863|NCT01297270|75792951|FG001|NOT COMPLETED|Overall Study||72||
59673864|NCT01297270|75792952|FG002|NOT COMPLETED|Overall Study||29||
59673865|NCT01296568|75792960|FG000|STARTED|[^14C]LY2603618 Single Dose and Washout||3||
59673866|NCT01296568|75792960|FG000|COMPLETED|[^14C]LY2603618 Single Dose and Washout||3||
59673867|NCT01296568|75792960|FG000|NOT COMPLETED|[^14C]LY2603618 Single Dose and Washout||0||
59673868|NCT01296568|75792960|FG000|STARTED|Continued Access Phase||3||
59673869|NCT01296568|75792960|FG000|COMPLETED|Continued Access Phase|After study discontinuation participants assessed for disease progression (21-day safety follow-up).|0||
59673870|NCT01296568|75792960|FG000|NOT COMPLETED|Continued Access Phase||3||
59673871|NCT01296412|75792968|FG000|STARTED|Overall Study||326||
59673872|NCT01296412|75792969|FG001|STARTED|Overall Study||327||
59673873|NCT01296412|75792968|FG000|COMPLETED|Overall Study||275||
59673874|NCT01296412|75792969|FG001|COMPLETED|Overall Study||257||
59673875|NCT01296412|75792968|FG000|NOT COMPLETED|Overall Study||51||
59673876|NCT01296412|75792969|FG001|NOT COMPLETED|Overall Study||70||
59673877|NCT01295905|75792977|FG000|STARTED|Overall Study||60||
59673878|NCT01295905|75792978|FG001|STARTED|Overall Study||30||
59673879|NCT01295905|75792977|FG000|COMPLETED|Overall Study||58||
59673880|NCT01295905|75792978|FG001|COMPLETED|Overall Study||30||
59673881|NCT01295905|75792977|FG000|NOT COMPLETED|Overall Study||2||
59673882|NCT01295905|75792978|FG001|NOT COMPLETED|Overall Study||0||
59673883|NCT02596035|75792987|FG000|STARTED|Overall Study||97||
59673884|NCT02596035|75792988|FG001|STARTED|Overall Study||44||
59673885|NCT02596035|75792989|FG002|STARTED|Overall Study||1||
59673886|NCT02596035|75792987|FG000|COMPLETED|Overall Study||0||
59673887|NCT02596035|75792988|FG001|COMPLETED|Overall Study||0||
59673888|NCT02596035|75792989|FG002|COMPLETED|Overall Study||0||
59673889|NCT02596035|75792987|FG000|NOT COMPLETED|Overall Study||97||
59673890|NCT02596035|75792988|FG001|NOT COMPLETED|Overall Study||44||
59673891|NCT02596035|75792989|FG002|NOT COMPLETED|Overall Study||1||
59673892|NCT02595372|75792998|FG000|STARTED|Overall Study||42||
59673893|NCT02595372|75792998|FG000|COMPLETED|Overall Study||33||
59673894|NCT02595372|75792998|FG000|NOT COMPLETED|Overall Study||9||
59673895|NCT02597790|75793004|FG000|STARTED|Overall Study||45||
59673896|NCT02597790|75793005|FG001|STARTED|Overall Study||41||
59673897|NCT02597790|75793004|FG000|COMPLETED|Overall Study||36||
59673898|NCT02597790|75793005|FG001|COMPLETED|Overall Study||29||
59673899|NCT02597790|75793004|FG000|NOT COMPLETED|Overall Study||9||
59673900|NCT02597790|75793005|FG001|NOT COMPLETED|Overall Study||12||
59673901|NCT04978454|75793020|FG000|STARTED|Overall Study||12||
59673902|NCT04978454|75793021|FG001|STARTED|Overall Study||10||
59673903|NCT04978454|75793022|FG002|STARTED|Overall Study||36||
59673904|NCT04978454|75793023|FG003|STARTED|Overall Study||2||
59673905|NCT04978454|75793020|FG000|COMPLETED|Overall Study||12||
59673906|NCT04978454|75793021|FG001|COMPLETED|Overall Study||10||
59673907|NCT04978454|75793022|FG002|COMPLETED|Overall Study||36||
59673908|NCT04978454|75793023|FG003|COMPLETED|Overall Study||2||
59673909|NCT04978454|75793020|FG000|NOT COMPLETED|Overall Study||0||
59673910|NCT04978454|75793021|FG001|NOT COMPLETED|Overall Study||0||
59673911|NCT04978454|75793022|FG002|NOT COMPLETED|Overall Study||0||
59673912|NCT04978454|75793023|FG003|NOT COMPLETED|Overall Study||0||
59673913|NCT04829916|75793035|FG000|STARTED|Overall Study||8||
59673914|NCT04829916|75793036|FG001|STARTED|Overall Study||4||
59673915|NCT04829916|75793035|FG000|COMPLETED|Overall Study||7||
59673916|NCT04829916|75793036|FG001|COMPLETED|Overall Study||4||
59673917|NCT04829916|75793035|FG000|NOT COMPLETED|Overall Study||1||
59673918|NCT04829916|75793036|FG001|NOT COMPLETED|Overall Study||0||
59673919|NCT04761822|75793048|FG000|STARTED|Overall Study||227||
59673920|NCT04761822|75793049|FG001|STARTED|Overall Study||219||
59673921|NCT04761822|75793050|FG002|STARTED|Overall Study||117||
59673922|NCT04761822|75793051|FG003|STARTED|Overall Study||123||
59673923|NCT04761822|75793048|FG000|COMPLETED|Overall Study||219||
59673924|NCT04761822|75793049|FG001|COMPLETED|Overall Study||209||
59673925|NCT04761822|75793050|FG002|COMPLETED|Overall Study||113||
59673926|NCT04761822|75793051|FG003|COMPLETED|Overall Study||105||
59673927|NCT04761822|75793048|FG000|NOT COMPLETED|Overall Study||8||
59673928|NCT04761822|75793049|FG001|NOT COMPLETED|Overall Study||10||
59673929|NCT04761822|75793050|FG002|NOT COMPLETED|Overall Study||4||
59673930|NCT04761822|75793051|FG003|NOT COMPLETED|Overall Study||18||
59673931|NCT04709692|75793076|FG000|STARTED|Overall Study||10||
59673932|NCT04709692|75793077|FG001|STARTED|Overall Study||12||
59673933|NCT04709692|75793076|FG000|COMPLETED|Overall Study||10||
59673934|NCT04709692|75793077|FG001|COMPLETED|Overall Study||11||
59673935|NCT04709692|75793076|FG000|NOT COMPLETED|Overall Study||0||
59673936|NCT04709692|75793077|FG001|NOT COMPLETED|Overall Study||1||
59673937|NCT04690855|75793083|FG000|STARTED|Overall Study||1||
59673938|NCT04690855|75793083|FG000|COMPLETED|Overall Study||1||
59673939|NCT04690855|75793083|FG000|NOT COMPLETED|Overall Study||0||
59673940|NCT04596267|75793089|FG000|STARTED|Medication Dispense/Exposure Period 1||4||
59673941|NCT04596267|75793090|FG001|STARTED|Medication Dispense/Exposure Period 1||5||
59673942|NCT04596267|75793089|FG000|COMPLETED|Medication Dispense/Exposure Period 1||3||
59673943|NCT04596267|75793090|FG001|COMPLETED|Medication Dispense/Exposure Period 1||4||
59673944|NCT04596267|75793089|FG000|NOT COMPLETED|Medication Dispense/Exposure Period 1||1||
59673945|NCT04596267|75793090|FG001|NOT COMPLETED|Medication Dispense/Exposure Period 1||1||
59673946|NCT04596267|75793089|FG000|STARTED|Alcohol Self-Administration Trial 1||3||
59673947|NCT04596267|75793090|FG001|STARTED|Alcohol Self-Administration Trial 1||4||
59673948|NCT04596267|75793089|FG000|COMPLETED|Alcohol Self-Administration Trial 1||3||
59673949|NCT04596267|75793090|FG001|COMPLETED|Alcohol Self-Administration Trial 1||4||
59673950|NCT04596267|75793089|FG000|NOT COMPLETED|Alcohol Self-Administration Trial 1||0||
59673951|NCT04596267|75793090|FG001|NOT COMPLETED|Alcohol Self-Administration Trial 1||0||
59673952|NCT04596267|75793089|FG000|STARTED|Medication Dispense/Exposure Period 2||3||
59673953|NCT04596267|75793090|FG001|STARTED|Medication Dispense/Exposure Period 2||4||
59673954|NCT04596267|75793089|FG000|COMPLETED|Medication Dispense/Exposure Period 2||3||
59673955|NCT04596267|75793090|FG001|COMPLETED|Medication Dispense/Exposure Period 2||4||
59673956|NCT04596267|75793089|FG000|NOT COMPLETED|Medication Dispense/Exposure Period 2||0||
59673957|NCT04596267|75793090|FG001|NOT COMPLETED|Medication Dispense/Exposure Period 2||0||
59673958|NCT04596267|75793089|FG000|STARTED|Alcohol Self-Administration Trial 2||3||
59673959|NCT04596267|75793090|FG001|STARTED|Alcohol Self-Administration Trial 2||4||
59673960|NCT04596267|75793089|FG000|COMPLETED|Alcohol Self-Administration Trial 2||3||
59673961|NCT04596267|75793090|FG001|COMPLETED|Alcohol Self-Administration Trial 2||4||
59673962|NCT04596267|75793089|FG000|NOT COMPLETED|Alcohol Self-Administration Trial 2||0||
59673963|NCT04596267|75793090|FG001|NOT COMPLETED|Alcohol Self-Administration Trial 2||0||
59673964|NCT04466228|75793101|FG000|STARTED|Overall Study||20||
59673965|NCT04466228|75793102|FG001|STARTED|Overall Study||20||
59673966|NCT04466228|75793103|FG002|STARTED|Overall Study||20||
59673967|NCT04466228|75793101|FG000|COMPLETED|Overall Study||20||
59673968|NCT04466228|75793102|FG001|COMPLETED|Overall Study||20||
59673969|NCT04466228|75793103|FG002|COMPLETED|Overall Study||20||
59673970|NCT04466228|75793101|FG000|NOT COMPLETED|Overall Study||0||
59673971|NCT04466228|75793102|FG001|NOT COMPLETED|Overall Study||0||
59673972|NCT04466228|75793103|FG002|NOT COMPLETED|Overall Study||0||
59673973|NCT04439903|75793113|FG000|STARTED|Overall Study||18||
59673974|NCT04439903|75793113|FG000|COMPLETED|Overall Study||15||
59673975|NCT04439903|75793113|FG000|NOT COMPLETED|Overall Study||3||
59673976|NCT04280783|75793119|FG000|STARTED|Overall Study||15||
59673977|NCT04280783|75793120|FG001|STARTED|Overall Study||15||
59673978|NCT04280783|75793119|FG000|COMPLETED|Overall Study||14||
59989450|NCT00495131|76104752|FG000|STARTED|Overall Study||154||
59989451|NCT00495131|76104753|FG001|STARTED|Overall Study||154||
59989452|NCT00495131|76104752|FG000|COMPLETED|Overall Study||147||
59989453|NCT00495131|76104753|FG001|COMPLETED|Overall Study||148||
59989454|NCT00495131|76104752|FG000|NOT COMPLETED|Overall Study||7||
59989455|NCT00495131|76104753|FG001|NOT COMPLETED|Overall Study||6||
59989456|NCT02257372|76104759|FG000|STARTED|Overall Study||117||
59989457|NCT02257372|76104760|FG001|STARTED|Overall Study||119||
59989458|NCT02257372|76104759|FG000|COMPLETED|Overall Study||110||
59989459|NCT02257372|76104760|FG001|COMPLETED|Overall Study||109||
59989460|NCT02257372|76104759|FG000|NOT COMPLETED|Overall Study||7||
59989461|NCT02257372|76104760|FG001|NOT COMPLETED|Overall Study||10||
59989462|NCT02256982|76104768|FG000|STARTED|Overall Study||1||
59989463|NCT02256982|76104769|FG001|STARTED|Overall Study||2||
59989464|NCT02256982|76104768|FG000|COMPLETED|Overall Study||1||
59989465|NCT02256982|76104769|FG001|COMPLETED|Overall Study||1||
59989466|NCT02256982|76104768|FG000|NOT COMPLETED|Overall Study||0||
59673979|NCT04280783|75793120|FG001|COMPLETED|Overall Study||14||
59673980|NCT04280783|75793119|FG000|NOT COMPLETED|Overall Study||1||
59673981|NCT04280783|75793120|FG001|NOT COMPLETED|Overall Study||1||
59673982|NCT04177095|75793127|FG000|STARTED|Overall Study||17||
59673983|NCT04177095|75793127|FG000|COMPLETED|Overall Study||10||
59673984|NCT04177095|75793127|FG000|NOT COMPLETED|Overall Study||7||
59673985|NCT04158050|75793133|FG000|STARTED|Overall Study||42||
59673986|NCT04158050|75793134|FG001|STARTED|Overall Study|This is a retrospective evaluation of clinical data|22||
59673987|NCT04158050|75793133|FG000|COMPLETED|Overall Study||33||
59673988|NCT04158050|75793134|FG001|COMPLETED|Overall Study||17||
59673989|NCT04158050|75793133|FG000|NOT COMPLETED|Overall Study||9||
59673990|NCT04158050|75793134|FG001|NOT COMPLETED|Overall Study||5||
59673991|NCT03870334|75793142|FG000|STARTED|Overall Study||12||
59673992|NCT03870334|75793143|FG001|STARTED|Overall Study||11||
59673993|NCT03870334|75793142|FG000|COMPLETED|Overall Study||12||
59673994|NCT03870334|75793143|FG001|COMPLETED|Overall Study||11||
59673995|NCT03870334|75793142|FG000|NOT COMPLETED|Overall Study||0||
59673996|NCT03870334|75793143|FG001|NOT COMPLETED|Overall Study||0||
59989467|NCT02256982|76104769|FG001|NOT COMPLETED|Overall Study||1||
59989468|NCT02736721|76104775|FG000|STARTED|Overall Study||41||
59989469|NCT02736721|76104775|FG000|COMPLETED|Overall Study||25||
59989470|NCT02736721|76104775|FG000|NOT COMPLETED|Overall Study||16||
59989471|NCT04176445|76104779|FG000|STARTED|Overall Study||12||
59673997|NCT03799718|75793149|FG000|STARTED|Overall Study|20 participants underwent bone marrow aspiration. In two participants, autologous bone marrow culture failed to meet specific MSC-NTF cell product release criteria and they did not receive treatment|20||54
59673998|NCT03799718|75793149|FG000|COMPLETED|Overall Study|Of the 20 participants enrolled, 18 were treated, 17 received all three treatments and one received two treatments.|18||53
59989472|NCT04176445|76104780|FG001|STARTED|Overall Study||7||
59989473|NCT04176445|76104779|FG000|COMPLETED|Overall Study||12||
59989474|NCT04176445|76104780|FG001|COMPLETED|Overall Study||5||
59673999|NCT03799718|75793149|FG000|NOT COMPLETED|Overall Study||2||1
59674000|NCT03781791|75793155|FG000|STARTED|Overall Study||93||
59674001|NCT03781791|75793156|FG001|STARTED|Overall Study||58||
59674002|NCT03781791|75793155|FG000|COMPLETED|Overall Study||67||
59674003|NCT03781791|75793156|FG001|COMPLETED|Overall Study||50||
59674004|NCT03781791|75793155|FG000|NOT COMPLETED|Overall Study||26||
59674005|NCT03781791|75793156|FG001|NOT COMPLETED|Overall Study||8||
59674006|NCT03711929|75793165|FG000|STARTED|Double Masked Treatment Period (DMTP)|Units assigned to Arm/Group are whole participants. If participants enrolled both eyes to the study, both eyes received the same assigned intervention.|57||65
59674007|NCT03711929|75793166|FG001|STARTED|Double Masked Treatment Period (DMTP)|Units assigned to Arm/Group are whole participants. If participants enrolled both eyes to the study, both eyes received the same assigned intervention.|59||68
59674008|NCT03711929|75793167|FG002|STARTED|Double Masked Treatment Period (DMTP)|Units assigned to Arm/Group are whole participants. If participants enrolled both eyes to the study, both eyes received the same assigned intervention.|29||32
59674009|NCT03711929|75793165|FG000|COMPLETED|Double Masked Treatment Period (DMTP)|Units assigned to Arm/Group are whole participants. If participants enrolled both eyes to the study, both eyes received the same assigned intervention.|51||59
59674010|NCT03711929|75793166|FG001|COMPLETED|Double Masked Treatment Period (DMTP)|Units assigned to Arm/Group are whole participants. If participants enrolled both eyes to the study, both eyes received the same assigned intervention.|48||55
59674011|NCT03711929|75793167|FG002|COMPLETED|Double Masked Treatment Period (DMTP)|Units assigned to Arm/Group are whole participants. If participants enrolled both eyes to the study, both eyes received the same assigned intervention.|24||27
59674012|NCT03711929|75793165|FG000|NOT COMPLETED|Double Masked Treatment Period (DMTP)||6||6
59674013|NCT03711929|75793166|FG001|NOT COMPLETED|Double Masked Treatment Period (DMTP)||11||13
59674014|NCT03711929|75793167|FG002|NOT COMPLETED|Double Masked Treatment Period (DMTP)||5||5
59674015|NCT03711929|75793165|FG000|STARTED|Open Label Treatment Period (OLTP)|Some participants exited the study or got rescued during Double Masked Treatment Period, hence, less participants entered the Open Label Treatment Period in the Test arm. Units assigned to Arm/Group are whole participants. If participants enrolled both eyes to the study, both eyes received the same assigned intervention.|42||49
59674016|NCT03711929|75793166|FG001|STARTED|Open Label Treatment Period (OLTP)|Some participants exited the study or got rescued during Double Masked Treatment Period, hence, less participants entered the Open Label Treatment Period in the Control arm. Units assigned to Arm/Group are whole participants. If participants enrolled both eyes to the study, both eyes received the same assigned intervention.|40||47
59674017|NCT03711929|75793167|FG002|STARTED|Open Label Treatment Period (OLTP)|Some participants exited the study or got rescued during Double Masked Treatment Period, hence, less participants entered the Open Label Treatment Period in the Dummy arm. Units assigned to Arm/Group are whole participants. If participants enrolled both eyes to the study, both eyes received the same assigned intervention.|21||24
59674018|NCT03711929|75793165|FG000|COMPLETED|Open Label Treatment Period (OLTP)|Units assigned to Arm/Group are whole participants. If participants enrolled both eyes to the study, both eyes received the same assigned intervention.|34||40
59674019|NCT03711929|75793166|FG001|COMPLETED|Open Label Treatment Period (OLTP)|Units assigned to Arm/Group are whole participants. If participants enrolled both eyes to the study, both eyes received the same assigned intervention.|35||41
59674020|NCT03711929|75793167|FG002|COMPLETED|Open Label Treatment Period (OLTP)|Units assigned to Arm/Group are whole participants. If participants enrolled both eyes to the study, both eyes received the same assigned intervention.|15||16
59674021|NCT03711929|75793165|FG000|NOT COMPLETED|Open Label Treatment Period (OLTP)||8||9
59674022|NCT03711929|75793166|FG001|NOT COMPLETED|Open Label Treatment Period (OLTP)||5||6
59674023|NCT03711929|75793167|FG002|NOT COMPLETED|Open Label Treatment Period (OLTP)||6||8
59674024|NCT03697980|75793178|FG000|STARTED|Overall Study||124||
59674025|NCT03697980|75793178|FG000|COMPLETED|Overall Study||119||
59674026|NCT03697980|75793178|FG000|NOT COMPLETED|Overall Study||5||
59674027|NCT03458728|75793184|FG000|STARTED|Overall Study||24||
59674028|NCT03458728|75793185|FG001|STARTED|Overall Study||7||
59674029|NCT03458728|75793184|FG000|Started Treatment|Overall Study||24||
59674030|NCT03458728|75793185|FG001|Started Treatment|Overall Study||7||
59674031|NCT03458728|75793184|FG000|Terminated Treatment|Overall Study||24||
59674032|NCT03458728|75793185|FG001|Terminated Treatment|Overall Study||7||
59674033|NCT03458728|75793184|FG000|COMPLETED|Overall Study||0||
59674034|NCT03458728|75793185|FG001|COMPLETED|Overall Study||0||
59674035|NCT03458728|75793184|FG000|NOT COMPLETED|Overall Study||24||
59674036|NCT03458728|75793185|FG001|NOT COMPLETED|Overall Study||7||
59674037|NCT03220035|75793193|FG000|STARTED|Overall Study||4||
59674038|NCT03220035|75793193|FG000|COMPLETED|Overall Study||0||
59674039|NCT03220035|75793193|FG000|NOT COMPLETED|Overall Study||4||
59674040|NCT03215706|75793199|FG000|STARTED|Randomization||361|= Participants Randomized|
59674041|NCT03215706|75793200|FG001|STARTED|Randomization||358|= Participants Randomized|
59674042|NCT03215706|75793199|FG000|COMPLETED|Randomization||358|= Participants treated|
59674043|NCT03215706|75793200|FG001|COMPLETED|Randomization||349|= Participants treated|
59674044|NCT03215706|75793199|FG000|NOT COMPLETED|Randomization||3||
59674045|NCT03215706|75793200|FG001|NOT COMPLETED|Randomization||9||
59674046|NCT03215706|75793199|FG000|STARTED|Treatment Period||358|= Participants treated|
59674047|NCT03215706|75793200|FG001|STARTED|Treatment Period||349|= Participants treated|
59674048|NCT03215706|75793199|FG000|COMPLETED|Treatment Period||16|= completing treatment|
59674049|NCT03215706|75793200|FG001|COMPLETED|Treatment Period||103|= completing treatment|
59674050|NCT03215706|75793199|FG000|NOT COMPLETED|Treatment Period||342||
59674051|NCT03215706|75793200|FG001|NOT COMPLETED|Treatment Period||246||
59674052|NCT03213691|75793206|FG000|STARTED|Overall Study||21||
59674053|NCT03213691|75793206|FG000|COMPLETED|Overall Study||0||
59674054|NCT03213691|75793206|FG000|NOT COMPLETED|Overall Study||21||
59674055|NCT03213665|75793210|FG000|STARTED|Overall Study||20||
59674056|NCT03213665|75793210|FG000|COMPLETED|Overall Study||1||
59674057|NCT03213665|75793210|FG000|NOT COMPLETED|Overall Study||19||
59674058|NCT03151005|75793216|FG000|STARTED|Overall Study||35||
59674059|NCT03151005|75793217|FG001|STARTED|Overall Study||35||
59674060|NCT03151005|75793216|FG000|COMPLETED|Overall Study||30||
59674061|NCT03151005|75793217|FG001|COMPLETED|Overall Study||30||
59674062|NCT03151005|75793216|FG000|NOT COMPLETED|Overall Study||5||
59674063|NCT03151005|75793217|FG001|NOT COMPLETED|Overall Study||5||
59674064|NCT03143153|75793226|FG000|STARTED|Pre-Treatment||325|Started=Randomized|
59674065|NCT03143153|75793227|FG001|STARTED|Pre-Treatment||321|Started=Randomized|
59674066|NCT03143153|75793228|FG002|STARTED|Pre-Treatment||324|Started=Randomized|
59674067|NCT03143153|75793226|FG000|COMPLETED|Pre-Treatment||322|Completed=Treated|
59674068|NCT03143153|75793227|FG001|COMPLETED|Pre-Treatment||310|Completed=Treated|
59989475|NCT04176445|76104779|FG000|NOT COMPLETED|Overall Study||0||
59674069|NCT03143153|75793228|FG002|COMPLETED|Pre-Treatment||304|Completed=Treated|
59674070|NCT03143153|75793226|FG000|NOT COMPLETED|Pre-Treatment||3||
59674071|NCT03143153|75793227|FG001|NOT COMPLETED|Pre-Treatment||11||
59674072|NCT03143153|75793228|FG002|NOT COMPLETED|Pre-Treatment||20||
59674073|NCT03143153|75793226|FG000|STARTED|Treatment||322||
59674074|NCT03143153|75793227|FG001|STARTED|Treatment||310||
59674075|NCT03143153|75793228|FG002|STARTED|Treatment||304||
59674076|NCT03143153|75793226|FG000|COMPLETED|Treatment||21|Completed=continuing treatment|
59674077|NCT03143153|75793227|FG001|COMPLETED|Treatment||25|Completed=continuing treatment|
59674078|NCT03143153|75793228|FG002|COMPLETED|Treatment||4|Completed=continuing treatment|
59674079|NCT03143153|75793226|FG000|NOT COMPLETED|Treatment||301||
59674080|NCT03143153|75793227|FG001|NOT COMPLETED|Treatment||285||
59674081|NCT03143153|75793228|FG002|NOT COMPLETED|Treatment||300||
59674082|NCT03106779|75793238|FG000|STARTED|Overall Study||157||
59674083|NCT03106779|75793239|FG001|STARTED|Overall Study||76||
59674084|NCT03106779|75793238|FG000|Treated|Overall Study||156||
59674085|NCT03106779|75793239|FG001|Treated|Overall Study||0||
59674086|NCT03106779|75793238|FG000|Not Treated|Overall Study||1|One patient randomized to asciminib was discontinued due to cytopenia as per Investigator's decision and never took medication.|
59674087|NCT03106779|75793239|FG001|Not Treated|Overall Study||0|One patient randomized to asciminib was discontinued due to cytopenia as per Investigator's decision and never took medication.|
59674088|NCT03106779|75793238|FG000|COMPLETED|Overall Study||97|Completed = Patients ongoing at the time of the primary analysis cut-off|
59674089|NCT03106779|75793239|FG001|COMPLETED|Overall Study||22|Completed = Patients ongoing at the time of the primary analysis cut-off|
59674090|NCT03106779|75793238|FG000|NOT COMPLETED|Overall Study||60||
59674091|NCT03106779|75793239|FG001|NOT COMPLETED|Overall Study||54||
59674092|NCT02872116|75793248|FG000|STARTED|Pre-Treatment||789|= Randomized|
59674093|NCT02872116|75793249|FG001|STARTED|Pre-Treatment||833|= Randomized|
59674094|NCT02872116|75793250|FG002|STARTED|Pre-Treatment||409|= Randomized|
59674095|NCT02872116|75793248|FG000|COMPLETED|Pre-Treatment||782|= Moving to treatment period|
59674096|NCT02872116|75793249|FG001|COMPLETED|Pre-Treatment||806|= Moving to treatment period|
59674097|NCT02872116|75793250|FG002|COMPLETED|Pre-Treatment||403|= Moving to treatment period|
59674098|NCT02872116|75793248|FG000|NOT COMPLETED|Pre-Treatment||7||
59674099|NCT02872116|75793249|FG001|NOT COMPLETED|Pre-Treatment||27||
59674100|NCT02872116|75793250|FG002|NOT COMPLETED|Pre-Treatment||6||
59674101|NCT02872116|75793248|FG000|STARTED|Treatment||782|Treated|
59674102|NCT02872116|75793249|FG001|STARTED|Treatment||806|Treated|
59674103|NCT02872116|75793250|FG002|STARTED|Treatment||403|Treated|
59674104|NCT02872116|75793248|FG000|COMPLETED|Treatment||623|Continuing in the study|
59674105|NCT02872116|75793249|FG001|COMPLETED|Treatment||653|Continuing in the study|
59674106|NCT02872116|75793250|FG002|COMPLETED|Treatment||319|Continuing in the study|
59989476|NCT04176445|76104780|FG001|NOT COMPLETED|Overall Study||2||
59674107|NCT02872116|75793248|FG000|NOT COMPLETED|Treatment||159||
59674108|NCT02872116|75793249|FG001|NOT COMPLETED|Treatment||153||
59674109|NCT02872116|75793250|FG002|NOT COMPLETED|Treatment||84||
59674110|NCT02828358|75793264|FG000|STARTED|Overall Study||56||
59674111|NCT02828358|75793265|FG001|STARTED|Overall Study||22||
59674112|NCT02828358|75793264|FG000|COMPLETED|Overall Study||11||
59674113|NCT02828358|75793265|FG001|COMPLETED|Overall Study||0||
59674114|NCT02828358|75793264|FG000|NOT COMPLETED|Overall Study||45||
59674115|NCT02828358|75793265|FG001|NOT COMPLETED|Overall Study||22||
59674116|NCT02592824|75793272|FG000|STARTED|Overall Study|7 patients not completed (Intraoperative exclusion criteria n= 5; Lost CRF n=2)|155||
59674117|NCT02592824|75793273|FG001|STARTED|Overall Study|4 patients not completed ( Intraoperative exclusion criteria n=3; Lost CRF n=1)|159||
59674118|NCT02592824|75793272|FG000|COMPLETED|Overall Study||148||
59674119|NCT02592824|75793273|FG001|COMPLETED|Overall Study||155||
59674120|NCT02592824|75793272|FG000|NOT COMPLETED|Overall Study||7||
59674121|NCT02592824|75793273|FG001|NOT COMPLETED|Overall Study||4||
59674122|NCT02414399|75793281|FG000|STARTED|Overall Study||702||
59674123|NCT02414399|75793282|FG001|STARTED|Overall Study||696||
59674124|NCT02414399|75793281|FG000|COMPLETED|Overall Study||702||
59674125|NCT02414399|75793282|FG001|COMPLETED|Overall Study||696||
59674126|NCT02414399|75793281|FG000|NOT COMPLETED|Overall Study||0||
59674127|NCT02414399|75793282|FG001|NOT COMPLETED|Overall Study||0||
59674128|NCT02348112|75793292|FG000|STARTED|Overall Study||213||
59674129|NCT02348112|75793293|FG001|STARTED|Overall Study||203||
59674130|NCT02348112|75793292|FG000|COMPLETED|Overall Study||140||
59674131|NCT02348112|75793293|FG001|COMPLETED|Overall Study||101||
59674132|NCT02348112|75793292|FG000|NOT COMPLETED|Overall Study||73||
59674133|NCT02348112|75793293|FG001|NOT COMPLETED|Overall Study||102||
59674134|NCT02286726|75793302|FG000|STARTED|Overall Study||16||
59674135|NCT02286726|75793303|FG001|STARTED|Overall Study||24||
59674136|NCT02286726|75793304|FG002|STARTED|Overall Study||16||
59674137|NCT02286726|75793302|FG000|COMPLETED|Overall Study||16||
59674138|NCT02286726|75793303|FG001|COMPLETED|Overall Study||24||
59674139|NCT02286726|75793304|FG002|COMPLETED|Overall Study||16||
59674140|NCT02286726|75793302|FG000|NOT COMPLETED|Overall Study||0||
59674141|NCT02286726|75793303|FG001|NOT COMPLETED|Overall Study||0||
59674142|NCT02286726|75793304|FG002|NOT COMPLETED|Overall Study||0||
59674143|NCT02205034|75793315|FG000|STARTED|Overall Study||6||
59674144|NCT02205034|75793316|FG001|STARTED|Overall Study||6||
59674145|NCT02205034|75793317|FG002|STARTED|Overall Study||6||
59674146|NCT02205034|75793315|FG000|COMPLETED|Overall Study||6||
59674147|NCT02205034|75793316|FG001|COMPLETED|Overall Study||6||
59674148|NCT02205034|75793317|FG002|COMPLETED|Overall Study||6||
59674149|NCT02205034|75793315|FG000|NOT COMPLETED|Overall Study||0||
59674150|NCT02205034|75793316|FG001|NOT COMPLETED|Overall Study||0||
59674151|NCT02205034|75793317|FG002|NOT COMPLETED|Overall Study||0||
59674152|NCT02004691|75793327|FG000|STARTED|PAP: Up to 52 Weeks||18||
59674153|NCT02004691|75793328|FG001|STARTED|PAP: Up to 52 Weeks||18||
59674154|NCT02004691|75793327|FG000|COMPLETED|PAP: Up to 52 Weeks||17||
59674155|NCT02004691|75793328|FG001|COMPLETED|PAP: Up to 52 Weeks||18||
60077953|NCT01506609|76192966|FG003|NOT COMPLETED|Overall Study||99||
60077954|NCT01506609|76192967|FG004|NOT COMPLETED|Overall Study||96||
60077955|NCT01506609|76192968|FG005|NOT COMPLETED|Overall Study||94||
60077956|NCT02087956|76192981|FG000|STARTED|Overall Study||111||
60077957|NCT02087956|76192982|FG001|STARTED|Overall Study||112||
60077958|NCT02087956|76192981|FG000|COMPLETED|Overall Study||105||
60077959|NCT02087956|76192982|FG001|COMPLETED|Overall Study||107||
60077960|NCT02087956|76192981|FG000|NOT COMPLETED|Overall Study||6||
59674156|NCT02004691|75793327|FG000|NOT COMPLETED|PAP: Up to 52 Weeks||1||
59674157|NCT02004691|75793328|FG001|NOT COMPLETED|PAP: Up to 52 Weeks||0||
59674158|NCT02004691|75793327|FG000|STARTED|ETP: Ongoing From Week 52||17||
59674159|NCT02004691|75793328|FG001|STARTED|ETP: Ongoing From Week 52||18||
59674160|NCT02004691|75793327|FG000|COMPLETED|ETP: Ongoing From Week 52||0||
59674161|NCT02004691|75793328|FG001|COMPLETED|ETP: Ongoing From Week 52||0||
59674162|NCT02004691|75793327|FG000|NOT COMPLETED|ETP: Ongoing From Week 52||17||
59674163|NCT02004691|75793328|FG001|NOT COMPLETED|ETP: Ongoing From Week 52||18||
59674164|NCT01613118|75793338|FG000|STARTED|Double-blind||13||
59674165|NCT01613118|75793339|FG001|STARTED|Double-blind||26||
59674166|NCT01613118|75793340|FG002|STARTED|Double-blind||34||
59674167|NCT01613118|75793341|FG003|STARTED|Double-blind||36||
59674168|NCT01613118|75793338|FG000|COMPLETED|Double-blind||13||
59674169|NCT01613118|75793339|FG001|COMPLETED|Double-blind||23||
59674170|NCT01613118|75793340|FG002|COMPLETED|Double-blind||32||
60077961|NCT02087956|76192982|FG001|NOT COMPLETED|Overall Study||5||
59674171|NCT01613118|75793341|FG003|COMPLETED|Double-blind||35||
59674172|NCT01613118|75793338|FG000|NOT COMPLETED|Double-blind||0||
59674173|NCT01613118|75793339|FG001|NOT COMPLETED|Double-blind||3||
59674174|NCT01613118|75793340|FG002|NOT COMPLETED|Double-blind||2||
59674175|NCT01613118|75793341|FG003|NOT COMPLETED|Double-blind||1||
59674176|NCT01613118|75793338|FG000|STARTED|Open-label Extension|Arm includes subjects from the Irbesartan Arm in the Double-blind period.|21||
59674177|NCT01613118|75793339|FG001|STARTED|Open-label Extension|Arm includes subjects from the Irbesartan Arm in the Double-blind period.|42||
59709764|NCT01072149|75828530|FG010|NOT COMPLETED|Treatment Period 1 (28 Days)||1||
59674178|NCT01613118|75793340|FG002|STARTED|Open-label Extension|Arm includes subjects from the Irbesartan Arm in the Double-blind period.|40||
59674179|NCT01613118|75793341|FG003|STARTED|Open-label Extension||0||
59674180|NCT01613118|75793338|FG000|COMPLETED|Open-label Extension|OLE ongoing|0||
59674181|NCT01613118|75793339|FG001|COMPLETED|Open-label Extension|OLE ongoing|0||
59674182|NCT01613118|75793340|FG002|COMPLETED|Open-label Extension|OLE ongoing|0||
59674183|NCT01613118|75793341|FG003|COMPLETED|Open-label Extension||0||
59674184|NCT01613118|75793338|FG000|NOT COMPLETED|Open-label Extension||21||
59674185|NCT01613118|75793339|FG001|NOT COMPLETED|Open-label Extension||42||
59674186|NCT01613118|75793340|FG002|NOT COMPLETED|Open-label Extension||40||
59674187|NCT01613118|75793341|FG003|NOT COMPLETED|Open-label Extension||0||
59674188|NCT00732212|75793356|FG000|STARTED|Overall Study||112||
59674189|NCT00732212|75793357|FG001|STARTED|Overall Study||123||
59674190|NCT00732212|75793356|FG000|Temporarily Suspended|Overall Study|Study was suspended for a 9 month period by the VA DMC because of slow enrollment, then restarted.|50||
59674191|NCT00732212|75793357|FG001|Temporarily Suspended|Overall Study||50||
59674192|NCT00732212|75793356|FG000|COMPLETED|Overall Study||112||
59674193|NCT00732212|75793357|FG001|COMPLETED|Overall Study||123||
59674194|NCT00732212|75793356|FG000|NOT COMPLETED|Overall Study||0||
59674195|NCT00732212|75793357|FG001|NOT COMPLETED|Overall Study||0||
59674196|NCT01248962|75793389|FG000|STARTED|Overall Study||74||
59674197|NCT01248962|75793390|FG001|STARTED|Overall Study||72||
59674198|NCT01248962|75793389|FG000|COMPLETED|Overall Study||58||
59674199|NCT01248962|75793390|FG001|COMPLETED|Overall Study||56||
59674200|NCT01248962|75793389|FG000|NOT COMPLETED|Overall Study||16||
59674201|NCT01248962|75793390|FG001|NOT COMPLETED|Overall Study||16||
59674202|NCT01248455|75793397|FG000|STARTED|Overall Study||9||
59674203|NCT01248455|75793397|FG000|COMPLETED|Overall Study||8||
59674204|NCT01248455|75793397|FG000|NOT COMPLETED|Overall Study||1||
59674205|NCT01247090|75793404|FG000|STARTED|Overall Study||4||
59674206|NCT01247090|75793405|FG001|STARTED|Overall Study||4||
59674207|NCT01247090|75793406|FG002|STARTED|Overall Study||4||
59674208|NCT01247090|75793404|FG000|COMPLETED|Overall Study||3||
59674209|NCT01247090|75793405|FG001|COMPLETED|Overall Study||3||
59674210|NCT01247090|75793406|FG002|COMPLETED|Overall Study||4||
59674211|NCT01247090|75793404|FG000|NOT COMPLETED|Overall Study||1||
59674212|NCT01247090|75793405|FG001|NOT COMPLETED|Overall Study||1||
59674213|NCT01247090|75793406|FG002|NOT COMPLETED|Overall Study||0||
59674214|NCT01249664|75793416|FG000|STARTED|Overall Study||91||
59674215|NCT01249664|75793417|FG001|STARTED|Overall Study||31||
59674216|NCT01249664|75793416|FG000|Participants Received Treatment|Overall Study|Safety population|91||
59674217|NCT01249664|75793417|FG001|Participants Received Treatment|Overall Study|Safety population|31||
59674218|NCT01249664|75793416|FG000|Fulfilled Requirements of FAS Population|Overall Study|Full Analysis Set (FAS) population: Basis of efficacy evaluation|90||
59674219|NCT01249664|75793417|FG001|Fulfilled Requirements of FAS Population|Overall Study|FAS population: Basis of efficacy evaluation|31||
59674220|NCT01249664|75793416|FG000|Completed 24 Weeks Treatment|Overall Study|Withdrawal from treatment does not equal to withdrawal from study.|83||
59674221|NCT01249664|75793417|FG001|Completed 24 Weeks Treatment|Overall Study|Withdrawal from treatment does not equal to withdrawal from study.|25||
59674222|NCT01249664|75793416|FG000|Completed 48 Weeks Treatment|Overall Study||78||
59674223|NCT01249664|75793417|FG001|Completed 48 Weeks Treatment|Overall Study||24||
59674224|NCT01249664|75793416|FG000|COMPLETED|Overall Study|Completers of study visits up to week 48|85||
59674225|NCT01249664|75793417|FG001|COMPLETED|Overall Study|Completers of study visits up to week 48|31||
59674226|NCT01249664|75793416|FG000|NOT COMPLETED|Overall Study||6||
59674227|NCT01249664|75793417|FG001|NOT COMPLETED|Overall Study||0||
59674228|NCT01249274|75793427|FG000|STARTED|Overall Study|all 25 were included in intention-to-treat and safety analyses|25||
59674229|NCT01249274|75793428|FG001|STARTED|Overall Study|all 25 were included in intention-to-treat and safety analyses|25||
59674230|NCT01249274|75793427|FG000|Completed Treatment|Overall Study||21||
59674231|NCT01249274|75793428|FG001|Completed Treatment|Overall Study||19||
59674232|NCT01249274|75793427|FG000|Completed Treatment & Post Trial Visit|Overall Study||20||
59674233|NCT01249274|75793428|FG001|Completed Treatment & Post Trial Visit|Overall Study||17||
59674234|NCT01249274|75793427|FG000|Completed Post Trial Visit But Not tx|Overall Study||1||
59674235|NCT01249274|75793428|FG001|Completed Post Trial Visit But Not tx|Overall Study||2||
60077962|NCT01506453|76192992|FG000|STARTED|Overall Study||25||
59674236|NCT01249274|75793427|FG000|COMPLETED|Overall Study||21||
60077963|NCT01506453|76192993|FG001|STARTED|Overall Study||26||
59674237|NCT01249274|75793428|FG001|COMPLETED|Overall Study||19||
59674238|NCT01249274|75793427|FG000|NOT COMPLETED|Overall Study||4||
59674239|NCT01249274|75793428|FG001|NOT COMPLETED|Overall Study||6||
59674240|NCT01249157|75793436|FG000|STARTED|Overall Study||1||
59674241|NCT01249157|75793436|FG000|COMPLETED|Overall Study|No data displayed because Outcome Measure has zero total participants analyzed.|0||
59674242|NCT01249157|75793436|FG000|NOT COMPLETED|Overall Study||1||
59674243|NCT01249118|75793440|FG000|STARTED|First Intervention Period||2||
59674244|NCT01249118|75793441|FG001|STARTED|First Intervention Period||6||
59674245|NCT01249118|75793442|FG002|STARTED|First Intervention Period||5||
59674246|NCT01249118|75793440|FG000|COMPLETED|First Intervention Period||2||
59674247|NCT01249118|75793441|FG001|COMPLETED|First Intervention Period||6||
59674248|NCT01249118|75793442|FG002|COMPLETED|First Intervention Period||5||
59674249|NCT01249118|75793440|FG000|NOT COMPLETED|First Intervention Period||0||
60077964|NCT01506453|76192992|FG000|COMPLETED|Overall Study||25||
59546183|NCT01066520|75644803|FG002|STARTED|Overall Study||137||
59546184|NCT01066520|75644801|FG000|COMPLETED|Overall Study||143||
59546185|NCT01066520|75644802|FG001|COMPLETED|Overall Study||140||
59546186|NCT01066520|75644803|FG002|COMPLETED|Overall Study||137||
59546187|NCT01066520|75644801|FG000|NOT COMPLETED|Overall Study||0||
59546188|NCT01066520|75644802|FG001|NOT COMPLETED|Overall Study||0||
59546189|NCT01066520|75644803|FG002|NOT COMPLETED|Overall Study||0||
59546190|NCT01067456|75644813|FG000|STARTED|Overall Study||30||
59546191|NCT01067456|75644814|FG001|STARTED|Overall Study||29||
59546192|NCT01067456|75644813|FG000|COMPLETED|Overall Study||30||
59546193|NCT01067456|75644814|FG001|COMPLETED|Overall Study||29||
59546194|NCT01067456|75644813|FG000|NOT COMPLETED|Overall Study||0||
59546195|NCT01067456|75644814|FG001|NOT COMPLETED|Overall Study||0||
59546196|NCT01067768|75644824|FG000|STARTED|Overall Study||604||
59546197|NCT01067768|75644825|FG001|STARTED|Overall Study||605||
59546198|NCT01067768|75644824|FG000|COMPLETED|Overall Study||604||
59546199|NCT01067768|75644825|FG001|COMPLETED|Overall Study||605||
59546200|NCT01067768|75644824|FG000|NOT COMPLETED|Overall Study||0||
59546201|NCT01067768|75644825|FG001|NOT COMPLETED|Overall Study||0||
59546202|NCT01068548|75644833|FG000|STARTED|Overall Study||66||
59546203|NCT01068548|75644834|FG001|STARTED|Overall Study||63||
59546204|NCT01068548|75644833|FG000|COMPLETED|Overall Study||66||
59546205|NCT01068548|75644834|FG001|COMPLETED|Overall Study||63||
59546206|NCT01068548|75644833|FG000|NOT COMPLETED|Overall Study||0||
59546207|NCT01068548|75644834|FG001|NOT COMPLETED|Overall Study||0||
59546208|NCT01069562|75644843|FG000|STARTED|Overall Study||20||
59546209|NCT01069562|75644844|FG001|STARTED|Overall Study||20||
59546210|NCT01069562|75644843|FG000|COMPLETED|Overall Study||20||
59546211|NCT01069562|75644844|FG001|COMPLETED|Overall Study||20||
59546212|NCT01069562|75644843|FG000|NOT COMPLETED|Overall Study||0||
59546213|NCT01069562|75644844|FG001|NOT COMPLETED|Overall Study||0||
60077965|NCT01506453|76192993|FG001|COMPLETED|Overall Study||24||
60077966|NCT01506453|76192992|FG000|NOT COMPLETED|Overall Study||0||
60077967|NCT01506453|76192993|FG001|NOT COMPLETED|Overall Study||2||
60077968|NCT01482429|76193001|FG000|STARTED|Care Usual||0||
59546214|NCT02416908|75644853|FG000|STARTED|Dose Escalation Phase||6||
59546215|NCT02416908|75644854|FG001|STARTED|Dose Escalation Phase||0||
60077969|NCT01482429|76193002|FG001|STARTED|Care Usual||269||
60077970|NCT01482429|76193001|FG000|COMPLETED|Care Usual||0||
60077971|NCT01482429|76193002|FG001|COMPLETED|Care Usual||96||
60077972|NCT01482429|76193001|FG000|NOT COMPLETED|Care Usual||0||
60077973|NCT01482429|76193002|FG001|NOT COMPLETED|Care Usual||173||
60077974|NCT01482429|76193001|FG000|STARTED|Protocol||414||
59546216|NCT02416908|75644855|FG002|STARTED|Dose Escalation Phase||34||
59546217|NCT02416908|75644856|FG003|STARTED|Dose Escalation Phase||0||
59546218|NCT02416908|75644853|FG000|COMPLETED|Dose Escalation Phase||6||
59815903|NCT01107015|75938332|FG000|STARTED|Overall Study||62||
59546219|NCT02416908|75644854|FG001|COMPLETED|Dose Escalation Phase||0||
59546220|NCT02416908|75644855|FG002|COMPLETED|Dose Escalation Phase||30||
59546221|NCT02416908|75644856|FG003|COMPLETED|Dose Escalation Phase||0||
59674250|NCT01249118|75793441|FG001|NOT COMPLETED|First Intervention Period||0||
59674251|NCT01249118|75793442|FG002|NOT COMPLETED|First Intervention Period||0||
59674252|NCT01249118|75793440|FG000|STARTED|First Washout Period||2||
59674253|NCT01249118|75793441|FG001|STARTED|First Washout Period||6||
59674254|NCT01249118|75793442|FG002|STARTED|First Washout Period||5||
59674255|NCT01249118|75793440|FG000|COMPLETED|First Washout Period||2||
59674256|NCT01249118|75793441|FG001|COMPLETED|First Washout Period||5||
59674257|NCT01249118|75793442|FG002|COMPLETED|First Washout Period||5||
59674258|NCT01249118|75793440|FG000|NOT COMPLETED|First Washout Period||0||
59674259|NCT01249118|75793441|FG001|NOT COMPLETED|First Washout Period||1||
59674260|NCT01249118|75793442|FG002|NOT COMPLETED|First Washout Period||0||
59674261|NCT01249118|75793440|FG000|STARTED|Second Intervention Period||2||
59674262|NCT01249118|75793441|FG001|STARTED|Second Intervention Period||5||
59674263|NCT01249118|75793442|FG002|STARTED|Second Intervention Period||5||
59674264|NCT01249118|75793440|FG000|COMPLETED|Second Intervention Period||2||
59674265|NCT01249118|75793441|FG001|COMPLETED|Second Intervention Period||5||
59674266|NCT01249118|75793442|FG002|COMPLETED|Second Intervention Period||5||
59674267|NCT01249118|75793440|FG000|NOT COMPLETED|Second Intervention Period||0||
59674268|NCT01249118|75793441|FG001|NOT COMPLETED|Second Intervention Period||0||
59674269|NCT01249118|75793442|FG002|NOT COMPLETED|Second Intervention Period||0||
59674270|NCT01249118|75793440|FG000|STARTED|Second Washout Period||2||
59674271|NCT01249118|75793441|FG001|STARTED|Second Washout Period||5||
59674272|NCT01249118|75793442|FG002|STARTED|Second Washout Period||5||
59674273|NCT01249118|75793440|FG000|COMPLETED|Second Washout Period||2||
59674274|NCT01249118|75793441|FG001|COMPLETED|Second Washout Period||5||
59674275|NCT01249118|75793442|FG002|COMPLETED|Second Washout Period||5||
59674276|NCT01249118|75793440|FG000|NOT COMPLETED|Second Washout Period||0||
59674277|NCT01249118|75793441|FG001|NOT COMPLETED|Second Washout Period||0||
59674278|NCT01249118|75793442|FG002|NOT COMPLETED|Second Washout Period||0||
59674279|NCT01248884|75793452|FG000|STARTED|Overall Study||240||
59674280|NCT01248884|75793453|FG001|STARTED|Overall Study||242||
59674281|NCT01248884|75793454|FG002|STARTED|Overall Study||239||
59674282|NCT01248884|75793452|FG000|COMPLETED|Overall Study||238||
59674283|NCT01248884|75793453|FG001|COMPLETED|Overall Study||239||
59674284|NCT01248884|75793454|FG002|COMPLETED|Overall Study||238||
59674285|NCT01248884|75793452|FG000|NOT COMPLETED|Overall Study||2||
59674286|NCT01248884|75793453|FG001|NOT COMPLETED|Overall Study||3||
59674287|NCT01248884|75793454|FG002|NOT COMPLETED|Overall Study||1||
59674288|NCT01248728|75793466|FG000|STARTED|Overall Study||19||
59674289|NCT01248728|75793467|FG001|STARTED|Overall Study||19||
59674290|NCT01248728|75793466|FG000|COMPLETED|Overall Study||15||
59674291|NCT01248728|75793467|FG001|COMPLETED|Overall Study||17||
59674292|NCT01248728|75793466|FG000|NOT COMPLETED|Overall Study||4||
59674293|NCT01248728|75793467|FG001|NOT COMPLETED|Overall Study||2||
59674294|NCT01246973|75793477|FG000|STARTED|Overall Study||344||
59674295|NCT01246973|75793478|FG001|STARTED|Overall Study||342||
59674296|NCT01246973|75793477|FG000|COMPLETED|Overall Study||283||
59674297|NCT01246973|75793478|FG001|COMPLETED|Overall Study||295||
59674298|NCT01246973|75793477|FG000|NOT COMPLETED|Overall Study||61||
59674299|NCT01246973|75793478|FG001|NOT COMPLETED|Overall Study||47||
59674300|NCT01246466|75793484|FG000|STARTED|Overall Study||24||
59674301|NCT01246466|75793484|FG000|COMPLETED|Overall Study||22||
59674302|NCT01246466|75793484|FG000|NOT COMPLETED|Overall Study||2||
59674303|NCT01245764|75793493|FG000|STARTED|Study Phase A||80||
59674304|NCT01245764|75793494|FG001|STARTED|Study Phase A||30||
59674305|NCT01245764|75793495|FG002|STARTED|Study Phase A||120||
59674306|NCT01245764|75793496|FG003|STARTED|Study Phase A||20||
59674307|NCT01245764|75793493|FG000|Completed Vaccinations in Study Phase A|Study Phase A||77||
59674308|NCT01245764|75793494|FG001|Completed Vaccinations in Study Phase A|Study Phase A||28||
59674309|NCT01245764|75793495|FG002|Completed Vaccinations in Study Phase A|Study Phase A||117||
59674310|NCT01245764|75793496|FG003|Completed Vaccinations in Study Phase A|Study Phase A||19||
59674311|NCT01245764|75793493|FG000|COMPLETED|Study Phase A||71||
59674312|NCT01245764|75793494|FG001|COMPLETED|Study Phase A||25||
59815904|NCT01107015|75938333|FG001|STARTED|Overall Study||38||
59815905|NCT01107015|75938334|FG002|STARTED|Overall Study||33||
59674313|NCT01245764|75793495|FG002|COMPLETED|Study Phase A||110||
59674314|NCT01245764|75793496|FG003|COMPLETED|Study Phase A||17||
59674315|NCT01245764|75793493|FG000|NOT COMPLETED|Study Phase A||9||
59674316|NCT01245764|75793494|FG001|NOT COMPLETED|Study Phase A||5||
59674317|NCT01245764|75793495|FG002|NOT COMPLETED|Study Phase A||10||
59674318|NCT01245764|75793496|FG003|NOT COMPLETED|Study Phase A||3||
59674319|NCT01245764|75793493|FG000|STARTED|Study Phase B||0||
59674320|NCT01245764|75793494|FG001|STARTED|Study Phase B||0||
59674321|NCT01245764|75793495|FG002|STARTED|Study Phase B||0||
59674322|NCT01245764|75793496|FG003|STARTED|Study Phase B||17||
59674323|NCT01245764|75793493|FG000|Completed Vaccinations in Study Phase B|Study Phase B||0||
59674324|NCT01245764|75793494|FG001|Completed Vaccinations in Study Phase B|Study Phase B||0||
59674325|NCT01245764|75793495|FG002|Completed Vaccinations in Study Phase B|Study Phase B||0||
59674326|NCT01245764|75793496|FG003|Completed Vaccinations in Study Phase B|Study Phase B||17||
59674327|NCT01245764|75793493|FG000|COMPLETED|Study Phase B||0||
59674328|NCT01245764|75793494|FG001|COMPLETED|Study Phase B||0||
59674329|NCT01245764|75793495|FG002|COMPLETED|Study Phase B||0||
59674330|NCT01245764|75793496|FG003|COMPLETED|Study Phase B||17||
59674331|NCT01245764|75793493|FG000|NOT COMPLETED|Study Phase B||0||
59674332|NCT01245764|75793494|FG001|NOT COMPLETED|Study Phase B||0||
59674333|NCT01245764|75793495|FG002|NOT COMPLETED|Study Phase B||0||
59674334|NCT01245764|75793496|FG003|NOT COMPLETED|Study Phase B||0||
59674335|NCT01245140|75793516|FG000|STARTED|Overall Study||9||
59674336|NCT01245140|75793517|FG001|STARTED|Overall Study||24||
59674337|NCT01245140|75793516|FG000|COMPLETED|Overall Study||6||
59674338|NCT01245140|75793517|FG001|COMPLETED|Overall Study||14||
59674339|NCT01245140|75793516|FG000|NOT COMPLETED|Overall Study||3||
59674340|NCT01245140|75793517|FG001|NOT COMPLETED|Overall Study||10||
59674341|NCT01245101|75793525|FG000|STARTED|Period 1 (Treatment)||15||
59674342|NCT01245101|75793526|FG001|STARTED|Period 1 (Treatment)||0||
59674343|NCT01245101|75793525|FG000|COMPLETED|Period 1 (Treatment)||13||
59674344|NCT01245101|75793526|FG001|COMPLETED|Period 1 (Treatment)||0||
59674345|NCT01245101|75793525|FG000|NOT COMPLETED|Period 1 (Treatment)||2||
59674346|NCT01245101|75793526|FG001|NOT COMPLETED|Period 1 (Treatment)||0||
59674347|NCT01245101|75793525|FG000|STARTED|Period 2 (Washout)||13||
59674348|NCT01245101|75793526|FG001|STARTED|Period 2 (Washout)||0||
59674349|NCT01245101|75793525|FG000|COMPLETED|Period 2 (Washout)||12||
59674350|NCT01245101|75793526|FG001|COMPLETED|Period 2 (Washout)||0||
59674351|NCT01245101|75793525|FG000|NOT COMPLETED|Period 2 (Washout)||1||
59674352|NCT01245101|75793526|FG001|NOT COMPLETED|Period 2 (Washout)||0||
59674353|NCT01245101|75793525|FG000|STARTED|Period 3 (Treatment)||12||
59674354|NCT01245101|75793526|FG001|STARTED|Period 3 (Treatment)||0||
59674355|NCT01245101|75793525|FG000|COMPLETED|Period 3 (Treatment)||11||
59674356|NCT01245101|75793526|FG001|COMPLETED|Period 3 (Treatment)||0||
59674357|NCT01245101|75793525|FG000|NOT COMPLETED|Period 3 (Treatment)||1||
59674358|NCT01245101|75793526|FG001|NOT COMPLETED|Period 3 (Treatment)||0||
59674359|NCT01245062|75793534|FG000|STARTED|Randomization and Crossover Phase||214|Par. randomized onto study.|
59674360|NCT01245062|75793535|FG001|STARTED|Randomization and Crossover Phase||108|Par. randomized onto study.|
59674361|NCT01245062|75793536|FG002|STARTED|Randomization and Crossover Phase||0|Par. randomized onto study.|
59674362|NCT01245062|75793534|FG000|COMPLETED|Randomization and Crossover Phase||173|Par. completed the study as they died during the conduct of the study.|
59674363|NCT01245062|75793535|FG001|COMPLETED|Randomization and Crossover Phase||77|Par. completed the study as they died during the conduct of the study.|
59674364|NCT01245062|75793536|FG002|COMPLETED|Randomization and Crossover Phase||0|Par. completed the study as they died during the conduct of the study.|
59674365|NCT01245062|75793534|FG000|NOT COMPLETED|Randomization and Crossover Phase||41||
59674366|NCT01245062|75793535|FG001|NOT COMPLETED|Randomization and Crossover Phase||31||
59674367|NCT01245062|75793536|FG002|NOT COMPLETED|Randomization and Crossover Phase||0||
59674368|NCT01245062|75793534|FG000|STARTED|Cross-over Phase||0||
59674369|NCT01245062|75793535|FG001|STARTED|Cross-over Phase||0||
59674370|NCT01245062|75793536|FG002|STARTED|Cross-over Phase|As of the data cut on December 16, 2016, 70 of 108 participants crossed over from CT to trametinib.|70||
59674371|NCT01245062|75793534|FG000|COMPLETED|Cross-over Phase||0|Par. completed the study as they died during the conduct of the study.|
59674372|NCT01245062|75793535|FG001|COMPLETED|Cross-over Phase||0|Par. completed the study as they died during the conduct of the study.|
59674373|NCT01245062|75793536|FG002|COMPLETED|Cross-over Phase||53|Par. completed the study as they died during the conduct of the study.|
59674374|NCT01245062|75793534|FG000|NOT COMPLETED|Cross-over Phase||0||
59674375|NCT01245062|75793535|FG001|NOT COMPLETED|Cross-over Phase||0||
59674376|NCT01245062|75793536|FG002|NOT COMPLETED|Cross-over Phase||17||
59674377|NCT01244984|75793547|FG000|STARTED|Overall Study||60||
59674378|NCT01244984|75793548|FG001|STARTED|Overall Study||93||
59674379|NCT01244984|75793549|FG002|STARTED|Overall Study||90||
59674380|NCT01244984|75793547|FG000|COMPLETED|Overall Study||55||
59674381|NCT01244984|75793548|FG001|COMPLETED|Overall Study||79||
59674382|NCT01244984|75793549|FG002|COMPLETED|Overall Study||86||
59674383|NCT01244984|75793547|FG000|NOT COMPLETED|Overall Study||5||
59674384|NCT01244984|75793548|FG001|NOT COMPLETED|Overall Study||14||
59674385|NCT01244984|75793549|FG002|NOT COMPLETED|Overall Study||4||
59989477|NCT02738203|76104788|FG000|STARTED|Overall Study||110||
59989478|NCT02738203|76104789|FG001|STARTED|Overall Study||110||
59989479|NCT02738203|76104788|FG000|COMPLETED|Overall Study||108||
59674386|NCT01244516|75793561|FG000|STARTED|Period 1 (Baseline to 1-week Visit)||170||
59674387|NCT01244516|75793562|FG001|STARTED|Period 1 (Baseline to 1-week Visit)||177||
59674388|NCT01244516|75793563|FG002|STARTED|Period 1 (Baseline to 1-week Visit)||173||
59674389|NCT01244516|75793561|FG000|COMPLETED|Period 1 (Baseline to 1-week Visit)||166||
59674390|NCT01244516|75793562|FG001|COMPLETED|Period 1 (Baseline to 1-week Visit)||171||
59674391|NCT01244516|75793563|FG002|COMPLETED|Period 1 (Baseline to 1-week Visit)||170||
59674392|NCT01244516|75793561|FG000|NOT COMPLETED|Period 1 (Baseline to 1-week Visit)||4||
59674393|NCT01244516|75793562|FG001|NOT COMPLETED|Period 1 (Baseline to 1-week Visit)||6||
59815906|NCT01107015|75938335|FG003|STARTED|Overall Study||80||
59989480|NCT02738203|76104789|FG001|COMPLETED|Overall Study||107||
59989481|NCT02738203|76104788|FG000|NOT COMPLETED|Overall Study||2||
59989482|NCT02738203|76104789|FG001|NOT COMPLETED|Overall Study||3||
59989483|NCT02452034|76104801|FG000|STARTED|Overall Study||16||
59674394|NCT01244516|75793563|FG002|NOT COMPLETED|Period 1 (Baseline to 1-week Visit)||3||
59674395|NCT01244516|75793561|FG000|STARTED|Period 2 (1-week to 2-week Visit)||166||
59674396|NCT01244516|75793562|FG001|STARTED|Period 2 (1-week to 2-week Visit)||171||
59674397|NCT01244516|75793563|FG002|STARTED|Period 2 (1-week to 2-week Visit)||170||
59674398|NCT01244516|75793561|FG000|COMPLETED|Period 2 (1-week to 2-week Visit)||163||
59674399|NCT01244516|75793562|FG001|COMPLETED|Period 2 (1-week to 2-week Visit)||170||
59674400|NCT01244516|75793563|FG002|COMPLETED|Period 2 (1-week to 2-week Visit)||168||
59674401|NCT01244516|75793561|FG000|NOT COMPLETED|Period 2 (1-week to 2-week Visit)||3||
59674402|NCT01244516|75793562|FG001|NOT COMPLETED|Period 2 (1-week to 2-week Visit)||1||
59674403|NCT01244516|75793563|FG002|NOT COMPLETED|Period 2 (1-week to 2-week Visit)||2||
59674404|NCT01244126|75793575|FG000|STARTED|Overall Study||59||
59674405|NCT01244126|75793576|FG001|STARTED|Overall Study||55||
59674406|NCT01244126|75793577|FG002|STARTED|Overall Study||57||
59674407|NCT01244126|75793575|FG000|COMPLETED|Overall Study||56||
59674408|NCT01244126|75793576|FG001|COMPLETED|Overall Study||52||
59674409|NCT01244126|75793577|FG002|COMPLETED|Overall Study||48||
59674410|NCT01244126|75793575|FG000|NOT COMPLETED|Overall Study||3||
59674411|NCT01244126|75793576|FG001|NOT COMPLETED|Overall Study||3||
59674412|NCT01244126|75793577|FG002|NOT COMPLETED|Overall Study||9||
59674413|NCT01243892|75793587|FG000|STARTED|Overall Study||15||
59674414|NCT01243892|75793588|FG001|STARTED|Overall Study||3||
59674415|NCT01243892|75793587|FG000|COMPLETED|Overall Study||13||
59674416|NCT01243892|75793588|FG001|COMPLETED|Overall Study||3||
59674417|NCT01243892|75793587|FG000|NOT COMPLETED|Overall Study||2||
59674418|NCT01243892|75793588|FG001|NOT COMPLETED|Overall Study||0||
59674419|NCT01243775|75793594|FG000|STARTED|Overall Study||33||
59674420|NCT01243775|75793594|FG000|COMPLETED|Overall Study||31||
59674421|NCT01243775|75793594|FG000|NOT COMPLETED|Overall Study||2||
59674422|NCT01243268|75793598|FG000|STARTED|Overall Study||674||
59674423|NCT01243268|75793598|FG000|COMPLETED|Overall Study||610||
59674424|NCT01243268|75793598|FG000|NOT COMPLETED|Overall Study||64||
59674425|NCT01242371|75793604|FG000|STARTED|Overall Study||33||
59674426|NCT01242371|75793605|FG001|STARTED|Overall Study||32||
59674427|NCT01242371|75793604|FG000|COMPLETED|Overall Study||31||
59674428|NCT01242371|75793605|FG001|COMPLETED|Overall Study||27||
59674429|NCT01242371|75793604|FG000|NOT COMPLETED|Overall Study||2||
59674430|NCT01242371|75793605|FG001|NOT COMPLETED|Overall Study||5||
59674431|NCT01242176|75793611|FG000|STARTED|First Intervention||12||
59674432|NCT01242176|75793612|FG001|STARTED|First Intervention||12||
59674433|NCT01242176|75793611|FG000|COMPLETED|First Intervention||12||
59674434|NCT01242176|75793612|FG001|COMPLETED|First Intervention||12||
59674435|NCT01242176|75793611|FG000|NOT COMPLETED|First Intervention||0||
59674436|NCT01242176|75793612|FG001|NOT COMPLETED|First Intervention||0||
59674437|NCT01242176|75793611|FG000|STARTED|Washout Period of 7 Days||12||
59674438|NCT01242176|75793612|FG001|STARTED|Washout Period of 7 Days||12||
59674439|NCT01242176|75793611|FG000|COMPLETED|Washout Period of 7 Days||11||
59674440|NCT01242176|75793612|FG001|COMPLETED|Washout Period of 7 Days||10||
59674441|NCT01242176|75793611|FG000|NOT COMPLETED|Washout Period of 7 Days||1||
59674442|NCT01242176|75793612|FG001|NOT COMPLETED|Washout Period of 7 Days||2||
59674443|NCT01242176|75793611|FG000|STARTED|Second Intervention||11||
59674444|NCT01242176|75793612|FG001|STARTED|Second Intervention||10||
59674445|NCT01242176|75793611|FG000|COMPLETED|Second Intervention||11||
59674446|NCT01242176|75793612|FG001|COMPLETED|Second Intervention||10||
59674447|NCT01242176|75793611|FG000|NOT COMPLETED|Second Intervention||0||
59674448|NCT01242176|75793612|FG001|NOT COMPLETED|Second Intervention||0||
59674449|NCT01242020|75793620|FG000|STARTED|Overall Study||6||
59674450|NCT01242020|75793621|FG001|STARTED|Overall Study||0||
59674451|NCT01242020|75793620|FG000|COMPLETED|Overall Study||3||
59674452|NCT01242020|75793621|FG001|COMPLETED|Overall Study||0||
59674453|NCT01242020|75793620|FG000|NOT COMPLETED|Overall Study||3||
59674454|NCT01242020|75793621|FG001|NOT COMPLETED|Overall Study||0||
59674455|NCT01241786|75793627|FG000|STARTED|Overall Study||5||
59674456|NCT01241786|75793627|FG000|COMPLETED|Overall Study||0||
59674457|NCT01241786|75793627|FG000|NOT COMPLETED|Overall Study||5||
59674458|NCT01241318|75793634|FG000|STARTED|Overall Study|Women enrolled|19629||
59674459|NCT01241318|75793635|FG001|STARTED|Overall Study|Women enrolled|20050||
59674460|NCT01241318|75793634|FG000|Liveborn Infant|Overall Study|Infants|18510||
59674461|NCT01241318|75793635|FG001|Liveborn Infant|Overall Study|Infants|19346||
59674462|NCT01241318|75793634|FG000|COMPLETED|Overall Study|Infants|18450||
59674463|NCT01241318|75793635|FG001|COMPLETED|Overall Study|Infants|19308||
59674464|NCT01241318|75793634|FG000|NOT COMPLETED|Overall Study||1179||
59674465|NCT01241318|75793635|FG001|NOT COMPLETED|Overall Study||742||
59674466|NCT01241279|75793646|FG000|STARTED|Overall Study||4||
59674467|NCT01241279|75793647|FG001|STARTED|Overall Study||2||
59674468|NCT01241279|75793646|FG000|COMPLETED|Overall Study||4||
59674469|NCT01241279|75793647|FG001|COMPLETED|Overall Study||1||
59674470|NCT01241279|75793646|FG000|NOT COMPLETED|Overall Study||0||
59674471|NCT01241279|75793647|FG001|NOT COMPLETED|Overall Study||1||
59674472|NCT01241240|75793655|FG000|STARTED|Overall Study||94||
59674473|NCT01241240|75793656|FG001|STARTED|Overall Study||98||
59674474|NCT01241240|75793655|FG000|COMPLETED|Overall Study||86||
59674475|NCT01241240|75793656|FG001|COMPLETED|Overall Study||89||
59674476|NCT01241240|75793655|FG000|NOT COMPLETED|Overall Study||8||
59674477|NCT01241240|75793656|FG001|NOT COMPLETED|Overall Study||9||
59674478|NCT01240811|75793665|FG000|STARTED|Overall Study||8||
59674479|NCT01240811|75793666|FG001|STARTED|Overall Study||17||
59674480|NCT01240811|75793667|FG002|STARTED|Overall Study||17||
59674481|NCT01240811|75793665|FG000|COMPLETED|Overall Study||8||
59674482|NCT01240811|75793666|FG001|COMPLETED|Overall Study||16||
59674483|NCT01240811|75793667|FG002|COMPLETED|Overall Study||16||
59674484|NCT01240811|75793665|FG000|NOT COMPLETED|Overall Study||0||
59674485|NCT01240811|75793666|FG001|NOT COMPLETED|Overall Study||1||
59674486|NCT01240811|75793667|FG002|NOT COMPLETED|Overall Study||1||
59674487|NCT01240382|75793679|FG000|STARTED|Overall Study||144||
59674488|NCT01240382|75793680|FG001|STARTED|Overall Study||143||
59674489|NCT01240382|75793679|FG000|COMPLETED|Overall Study||142||
59674490|NCT01240382|75793680|FG001|COMPLETED|Overall Study||139||
59674491|NCT01240382|75793679|FG000|NOT COMPLETED|Overall Study||2||
59674492|NCT01240382|75793680|FG001|NOT COMPLETED|Overall Study||4||
59674493|NCT01244828|75793686|FG000|STARTED|Overall Study|Received study drug|157||
59674494|NCT01244828|75793686|FG000|COMPLETED|Overall Study||79||
59674495|NCT01244828|75793686|FG000|NOT COMPLETED|Overall Study||78||
59674496|NCT01249833|75793692|FG000|STARTED|Overall Study||59||
59674497|NCT01249833|75793693|FG001|STARTED|Overall Study||63||
59674498|NCT01249833|75793692|FG000|COMPLETED|Overall Study||59||
59674499|NCT01249833|75793693|FG001|COMPLETED|Overall Study||62||
59674500|NCT01249833|75793692|FG000|NOT COMPLETED|Overall Study||0||
59674501|NCT01249833|75793693|FG001|NOT COMPLETED|Overall Study||1||
59674502|NCT01249404|75793702|FG000|STARTED|Overall Study||127||
59674503|NCT01249404|75793703|FG001|STARTED|Overall Study||129||
59674504|NCT01249404|75793704|FG002|STARTED|Overall Study||132||
59674505|NCT01249404|75793702|FG000|COMPLETED|Overall Study||120||
59674506|NCT01249404|75793703|FG001|COMPLETED|Overall Study||121||
59674507|NCT01249404|75793704|FG002|COMPLETED|Overall Study||125||
59674508|NCT01249404|75793702|FG000|NOT COMPLETED|Overall Study||7||
59674509|NCT01249404|75793703|FG001|NOT COMPLETED|Overall Study||8||
59674510|NCT01249404|75793704|FG002|NOT COMPLETED|Overall Study||7||
59674511|NCT01249365|75793712|FG000|STARTED|Overall Study||199||
59674512|NCT01249365|75793712|FG000|COMPLETED|Overall Study||198||
59674513|NCT01249365|75793712|FG000|NOT COMPLETED|Overall Study||1||
59674514|NCT01249131|75793716|FG000|STARTED|First Intervention||3||
59674515|NCT01249131|75793717|FG001|STARTED|First Intervention||3||
59674516|NCT01249131|75793718|FG002|STARTED|First Intervention||4||
59674517|NCT01249131|75793719|FG003|STARTED|First Intervention||3||
59674518|NCT01249131|75793720|FG004|STARTED|First Intervention||3||
59674519|NCT01249131|75793721|FG005|STARTED|First Intervention||4||
59674520|NCT01249131|75793716|FG000|COMPLETED|First Intervention||3||
59674521|NCT01249131|75793717|FG001|COMPLETED|First Intervention||3||
59674522|NCT01249131|75793718|FG002|COMPLETED|First Intervention||4||
59674523|NCT01249131|75793719|FG003|COMPLETED|First Intervention||3||
59674524|NCT01249131|75793720|FG004|COMPLETED|First Intervention||3||
59674525|NCT01249131|75793721|FG005|COMPLETED|First Intervention||4||
59674526|NCT01249131|75793716|FG000|NOT COMPLETED|First Intervention||0||
59674527|NCT01249131|75793717|FG001|NOT COMPLETED|First Intervention||0||
59674528|NCT01249131|75793718|FG002|NOT COMPLETED|First Intervention||0||
59674529|NCT01249131|75793719|FG003|NOT COMPLETED|First Intervention||0||
59674530|NCT01249131|75793720|FG004|NOT COMPLETED|First Intervention||0||
59674531|NCT01249131|75793721|FG005|NOT COMPLETED|First Intervention||0||
59674532|NCT01249131|75793716|FG000|STARTED|Washout Period of 10 Days||3||
59815907|NCT01107015|75938332|FG000|COMPLETED|Overall Study||56||
59815908|NCT01107015|75938333|FG001|COMPLETED|Overall Study||23||
59674533|NCT01249131|75793717|FG001|STARTED|Washout Period of 10 Days||3||
59674534|NCT01249131|75793718|FG002|STARTED|Washout Period of 10 Days||4||
59674535|NCT01249131|75793719|FG003|STARTED|Washout Period of 10 Days||3||
59674536|NCT01249131|75793720|FG004|STARTED|Washout Period of 10 Days||3||
59674537|NCT01249131|75793721|FG005|STARTED|Washout Period of 10 Days||4||
59674538|NCT01249131|75793716|FG000|COMPLETED|Washout Period of 10 Days||3||
59674539|NCT01249131|75793717|FG001|COMPLETED|Washout Period of 10 Days||3||
59674540|NCT01249131|75793718|FG002|COMPLETED|Washout Period of 10 Days||4||
59674541|NCT01249131|75793719|FG003|COMPLETED|Washout Period of 10 Days||3||
59674542|NCT01249131|75793720|FG004|COMPLETED|Washout Period of 10 Days||2||
59674543|NCT01249131|75793721|FG005|COMPLETED|Washout Period of 10 Days||4||
59674544|NCT01249131|75793716|FG000|NOT COMPLETED|Washout Period of 10 Days||0||
59674545|NCT01249131|75793717|FG001|NOT COMPLETED|Washout Period of 10 Days||0||
59674546|NCT01249131|75793718|FG002|NOT COMPLETED|Washout Period of 10 Days||0||
59674547|NCT01249131|75793719|FG003|NOT COMPLETED|Washout Period of 10 Days||0||
59674548|NCT01249131|75793720|FG004|NOT COMPLETED|Washout Period of 10 Days||1||
59674549|NCT01249131|75793721|FG005|NOT COMPLETED|Washout Period of 10 Days||0||
59674550|NCT01249131|75793716|FG000|STARTED|Second Intervention||3||
59674551|NCT01249131|75793717|FG001|STARTED|Second Intervention||3||
59674552|NCT01249131|75793718|FG002|STARTED|Second Intervention||4||
59674553|NCT01249131|75793719|FG003|STARTED|Second Intervention||3||
59674554|NCT01249131|75793720|FG004|STARTED|Second Intervention||2||
59674555|NCT01249131|75793721|FG005|STARTED|Second Intervention||4||
59674556|NCT01249131|75793716|FG000|COMPLETED|Second Intervention||3||
59674557|NCT01249131|75793717|FG001|COMPLETED|Second Intervention||3||
59674558|NCT01249131|75793718|FG002|COMPLETED|Second Intervention||4||
59674559|NCT01249131|75793719|FG003|COMPLETED|Second Intervention||3||
59674560|NCT01249131|75793720|FG004|COMPLETED|Second Intervention||2||
59674561|NCT01249131|75793721|FG005|COMPLETED|Second Intervention||4||
59674562|NCT01249131|75793716|FG000|NOT COMPLETED|Second Intervention||0||
59674563|NCT01249131|75793717|FG001|NOT COMPLETED|Second Intervention||0||
59674564|NCT01249131|75793718|FG002|NOT COMPLETED|Second Intervention||0||
59674565|NCT01249131|75793719|FG003|NOT COMPLETED|Second Intervention||0||
59674566|NCT01249131|75793720|FG004|NOT COMPLETED|Second Intervention||0||
59674567|NCT01249131|75793721|FG005|NOT COMPLETED|Second Intervention||0||
59674568|NCT01249131|75793716|FG000|STARTED|Washout Period of 10 Days||3||
59674569|NCT01249131|75793717|FG001|STARTED|Washout Period of 10 Days||3||
59674570|NCT01249131|75793718|FG002|STARTED|Washout Period of 10 Days||4||
59674571|NCT01249131|75793719|FG003|STARTED|Washout Period of 10 Days||3||
59674572|NCT01249131|75793720|FG004|STARTED|Washout Period of 10 Days||2||
59674573|NCT01249131|75793721|FG005|STARTED|Washout Period of 10 Days||4||
59674574|NCT01249131|75793716|FG000|COMPLETED|Washout Period of 10 Days||3||
59674575|NCT01249131|75793717|FG001|COMPLETED|Washout Period of 10 Days||3||
59674576|NCT01249131|75793718|FG002|COMPLETED|Washout Period of 10 Days||4||
59674577|NCT01249131|75793719|FG003|COMPLETED|Washout Period of 10 Days||3||
59674578|NCT01249131|75793720|FG004|COMPLETED|Washout Period of 10 Days||2||
59674579|NCT01249131|75793721|FG005|COMPLETED|Washout Period of 10 Days||4||
59674580|NCT01249131|75793716|FG000|NOT COMPLETED|Washout Period of 10 Days||0||
59674581|NCT01249131|75793717|FG001|NOT COMPLETED|Washout Period of 10 Days||0||
59674582|NCT01249131|75793718|FG002|NOT COMPLETED|Washout Period of 10 Days||0||
59674583|NCT01249131|75793719|FG003|NOT COMPLETED|Washout Period of 10 Days||0||
59674584|NCT01249131|75793720|FG004|NOT COMPLETED|Washout Period of 10 Days||0||
59674585|NCT01249131|75793721|FG005|NOT COMPLETED|Washout Period of 10 Days||0||
59674586|NCT01249131|75793716|FG000|STARTED|Third Intervention||3||
59674587|NCT01249131|75793717|FG001|STARTED|Third Intervention||3||
59674588|NCT01249131|75793718|FG002|STARTED|Third Intervention||4||
59674589|NCT01249131|75793719|FG003|STARTED|Third Intervention||3||
59674590|NCT01249131|75793720|FG004|STARTED|Third Intervention||2||
59674591|NCT01249131|75793721|FG005|STARTED|Third Intervention||4||
59674592|NCT01249131|75793716|FG000|COMPLETED|Third Intervention||3||
59674593|NCT01249131|75793717|FG001|COMPLETED|Third Intervention||3||
59674594|NCT01249131|75793718|FG002|COMPLETED|Third Intervention||4||
59674595|NCT01249131|75793719|FG003|COMPLETED|Third Intervention||3||
59674596|NCT01249131|75793720|FG004|COMPLETED|Third Intervention||2||
59674597|NCT01249131|75793721|FG005|COMPLETED|Third Intervention||4||
59674598|NCT01249131|75793716|FG000|NOT COMPLETED|Third Intervention||0||
59674599|NCT01249131|75793717|FG001|NOT COMPLETED|Third Intervention||0||
59674600|NCT01249131|75793718|FG002|NOT COMPLETED|Third Intervention||0||
59674601|NCT01249131|75793719|FG003|NOT COMPLETED|Third Intervention||0||
59674602|NCT01249131|75793720|FG004|NOT COMPLETED|Third Intervention||0||
59674603|NCT01249131|75793721|FG005|NOT COMPLETED|Third Intervention||0||
59674604|NCT01249092|75793729|FG000|STARTED|Overall Study||20||
59674605|NCT01249092|75793729|FG000|COMPLETED|Overall Study||18||
59674606|NCT01249092|75793729|FG000|NOT COMPLETED|Overall Study||2||
59674607|NCT01248936|75793735|FG000|STARTED|Overall Study||374||
59674608|NCT01248936|75793735|FG000|COMPLETED|Overall Study||0||
59674609|NCT01248936|75793735|FG000|NOT COMPLETED|Overall Study||374||
59989484|NCT02452034|76104802|FG001|STARTED|Overall Study||21||
59674610|NCT01248780|75793742|FG000|STARTED|Overall Study||132||
59674611|NCT01248780|75793743|FG001|STARTED|Overall Study||132||
59674612|NCT01248780|75793742|FG000|COMPLETED|Overall Study||123||
59674613|NCT01248780|75793743|FG001|COMPLETED|Overall Study||117||
59674614|NCT01248780|75793742|FG000|NOT COMPLETED|Overall Study||9||
59674615|NCT01248780|75793743|FG001|NOT COMPLETED|Overall Study||15||
59674616|NCT01248468|75793752|FG000|STARTED|Overall Study||299||
59674617|NCT01248468|75793753|FG001|STARTED|Overall Study||304||
59674618|NCT01248468|75793754|FG002|STARTED|Overall Study||149||
59674619|NCT01248468|75793752|FG000|Safety Population|Overall Study||266||
59989485|NCT02452034|76104803|FG002|STARTED|Overall Study||15||
59674620|NCT01248468|75793753|FG001|Safety Population|Overall Study||271||
59674621|NCT01248468|75793754|FG002|Safety Population|Overall Study||133||
59674622|NCT01248468|75793752|FG000|ITT Population|Overall Study||256||
59674623|NCT01248468|75793753|FG001|ITT Population|Overall Study||261||
59674624|NCT01248468|75793754|FG002|ITT Population|Overall Study||125||
59674625|NCT01248468|75793752|FG000|COMPLETED|Overall Study||284||
59674626|NCT01248468|75793753|FG001|COMPLETED|Overall Study||290||
59674627|NCT01248468|75793754|FG002|COMPLETED|Overall Study||145||
59674628|NCT01248468|75793752|FG000|NOT COMPLETED|Overall Study||15||
59674629|NCT01248468|75793753|FG001|NOT COMPLETED|Overall Study||14||
59674630|NCT01248468|75793754|FG002|NOT COMPLETED|Overall Study||4||
59674631|NCT01247922|75793762|FG000|STARTED|Overall Study||4||
59674632|NCT01247922|75793762|FG000|Treated|Overall Study||4||
59989486|NCT02452034|76104804|FG003|STARTED|Overall Study||17||
59989487|NCT02452034|76104805|FG004|STARTED|Overall Study||20||
59989488|NCT02452034|76104806|FG005|STARTED|Overall Study||29||
59674633|NCT01247922|75793762|FG000|COMPLETED|Overall Study||0||
59674634|NCT01247922|75793762|FG000|NOT COMPLETED|Overall Study||4||
59674635|NCT01246206|75793766|FG000|STARTED|Overall Study||21||
59674636|NCT01246206|75793766|FG000|COMPLETED|Overall Study||20||
59674637|NCT01246206|75793766|FG000|NOT COMPLETED|Overall Study||1||
59674638|NCT01246011|75793773|FG000|STARTED|Overall Study||0||
59674639|NCT01246011|75793774|FG001|STARTED|Overall Study||0||
59674640|NCT01246011|75793775|FG002|STARTED|Overall Study||9||
59674641|NCT01246011|75793773|FG000|COMPLETED|Overall Study||0||
59674642|NCT01246011|75793774|FG001|COMPLETED|Overall Study||0||
59674643|NCT01246011|75793775|FG002|COMPLETED|Overall Study||5||
59674644|NCT01246011|75793773|FG000|NOT COMPLETED|Overall Study||0||
59674645|NCT01246011|75793774|FG001|NOT COMPLETED|Overall Study||0||
59674646|NCT01246011|75793775|FG002|NOT COMPLETED|Overall Study||4||
59674647|NCT01244490|75793787|FG000|STARTED|Overall Study||111||
59674648|NCT01244490|75793788|FG001|STARTED|Overall Study||115||
59674649|NCT01244490|75793789|FG002|STARTED|Overall Study||112||
59674650|NCT01244490|75793787|FG000|COMPLETED|Overall Study||92||
59674651|NCT01244490|75793788|FG001|COMPLETED|Overall Study||91||
59674652|NCT01244490|75793789|FG002|COMPLETED|Overall Study||89||
59674653|NCT01244490|75793787|FG000|NOT COMPLETED|Overall Study||19||
59674654|NCT01244490|75793788|FG001|NOT COMPLETED|Overall Study||24||
59674655|NCT01244490|75793789|FG002|NOT COMPLETED|Overall Study||23||
59674656|NCT01243944|75793799|FG000|STARTED|Overall Study||110||
59674657|NCT01243944|75793800|FG001|STARTED|Overall Study|One participant withdrew consent 5 days after randomization to BAT & wasn't treated while on study.|112||
59674658|NCT01243944|75793799|FG000|Treated|Overall Study||110||
59674659|NCT01243944|75793800|FG001|Treated|Overall Study||111||
59674660|NCT01243944|75793799|FG000|Followed for Survival|Overall Study||22||
59674661|NCT01243944|75793800|FG001|Followed for Survival|Overall Study||21||
59674662|NCT01243944|75793799|FG000|COMPLETED|Overall Study||65||
59674663|NCT01243944|75793800|FG001|COMPLETED|Overall Study|Study evaluation completion is reported for participants that were treated & those never treatment.|61||
59674664|NCT01243944|75793799|FG000|NOT COMPLETED|Overall Study||45||
59674665|NCT01243944|75793800|FG001|NOT COMPLETED|Overall Study||51||
59674666|NCT01243242|75793809|FG000|STARTED|Overall Study||60||
59674667|NCT01243242|75793810|FG001|STARTED|Overall Study||60||
59674668|NCT01243242|75793809|FG000|COMPLETED|Overall Study||57||
59674669|NCT01243242|75793810|FG001|COMPLETED|Overall Study||56||
59674670|NCT01243242|75793809|FG000|NOT COMPLETED|Overall Study||3||
59674671|NCT01243242|75793810|FG001|NOT COMPLETED|Overall Study||4||
59674672|NCT01242813|75793816|FG000|STARTED|Overall Study||20||
59674673|NCT01242813|75793816|FG000|COMPLETED|Overall Study||18||
59674674|NCT01242813|75793816|FG000|NOT COMPLETED|Overall Study||2||
59674675|NCT01242111|75793820|FG000|STARTED|Overall Study||20||
59674676|NCT01242111|75793820|FG000|COMPLETED|Overall Study||17||
59674677|NCT01242111|75793820|FG000|NOT COMPLETED|Overall Study||3||
59674678|NCT01241604|75793824|FG000|STARTED|Screening Period||11||
59674679|NCT01241604|75793825|FG001|STARTED|Screening Period||0||
59674680|NCT01241604|75793826|FG002|STARTED|Screening Period||0||
59674681|NCT01241604|75793824|FG000|COMPLETED|Screening Period||8||
59674682|NCT01241604|75793825|FG001|COMPLETED|Screening Period||0||
59674683|NCT01241604|75793826|FG002|COMPLETED|Screening Period||0||
59674684|NCT01241604|75793824|FG000|NOT COMPLETED|Screening Period||3||
59674685|NCT01241604|75793825|FG001|NOT COMPLETED|Screening Period||0||
59674686|NCT01241604|75793826|FG002|NOT COMPLETED|Screening Period||0||
59674687|NCT01241604|75793824|FG000|STARTED|Study Period||0||
59674688|NCT01241604|75793825|FG001|STARTED|Study Period||5||
59674689|NCT01241604|75793826|FG002|STARTED|Study Period||3||
59674690|NCT01241604|75793824|FG000|COMPLETED|Study Period||0||
59674691|NCT01241604|75793825|FG001|COMPLETED|Study Period||5||
59674692|NCT01241604|75793826|FG002|COMPLETED|Study Period||3||
59674693|NCT01241604|75793824|FG000|NOT COMPLETED|Study Period||0||
59674694|NCT01241604|75793825|FG001|NOT COMPLETED|Study Period||0||
59674695|NCT01241604|75793826|FG002|NOT COMPLETED|Study Period||0||
59674696|NCT01241292|75793835|FG000|STARTED|Overall Study||3||
59674697|NCT01241292|75793836|FG001|STARTED|Overall Study||3||
59674698|NCT01241292|75793835|FG000|Entered Treatment Period|Overall Study||3||
59674699|NCT01241292|75793836|FG001|Entered Treatment Period|Overall Study||3||
59674700|NCT01241292|75793835|FG000|COMPLETED|Overall Study|completed=treatment on-going|0||
59674701|NCT01241292|75793836|FG001|COMPLETED|Overall Study|completed=treatment on-going|0||
59674702|NCT01241292|75793835|FG000|NOT COMPLETED|Overall Study||3||
59674703|NCT01241292|75793836|FG001|NOT COMPLETED|Overall Study||3||
59674704|NCT01240863|75793848|FG000|STARTED|Open-label Titration Period||391||
59674705|NCT01240863|75793849|FG001|STARTED|Open-label Titration Period||0||
59674706|NCT01240863|75793850|FG002|STARTED|Open-label Titration Period||0||
59674707|NCT01240863|75793848|FG000|Safety Analysis Set|Open-label Titration Period||389||
59674708|NCT01240863|75793849|FG001|Safety Analysis Set|Open-label Titration Period||0||
59674709|NCT01240863|75793850|FG002|Safety Analysis Set|Open-label Titration Period||0||
59815909|NCT01107015|75938334|FG002|COMPLETED|Overall Study||22||
59674710|NCT01240863|75793848|FG000|COMPLETED|Open-label Titration Period||294||
59674711|NCT01240863|75793849|FG001|COMPLETED|Open-label Titration Period||0||
59815910|NCT01107015|75938335|FG003|COMPLETED|Overall Study||62||
59546222|NCT02416908|75644853|FG000|NOT COMPLETED|Dose Escalation Phase||0||
59546223|NCT02416908|75644854|FG001|NOT COMPLETED|Dose Escalation Phase||0||
59546224|NCT02416908|75644855|FG002|NOT COMPLETED|Dose Escalation Phase||4||
59546225|NCT02416908|75644856|FG003|NOT COMPLETED|Dose Escalation Phase||0||
59546226|NCT02416908|75644853|FG000|STARTED|Maintenance Phase||0||
59546227|NCT02416908|75644854|FG001|STARTED|Maintenance Phase||0||
59546228|NCT02416908|75644855|FG002|STARTED|Maintenance Phase||0||
59546229|NCT02416908|75644856|FG003|STARTED|Maintenance Phase||2||
59546230|NCT02416908|75644853|FG000|COMPLETED|Maintenance Phase||0||
59546231|NCT02416908|75644854|FG001|COMPLETED|Maintenance Phase||0||
59546232|NCT02416908|75644855|FG002|COMPLETED|Maintenance Phase||0||
59546233|NCT02416908|75644856|FG003|COMPLETED|Maintenance Phase||2||
59546234|NCT02416908|75644853|FG000|NOT COMPLETED|Maintenance Phase||0||
59546235|NCT02416908|75644854|FG001|NOT COMPLETED|Maintenance Phase||0||
59546236|NCT02416908|75644855|FG002|NOT COMPLETED|Maintenance Phase||0||
59546237|NCT02416908|75644856|FG003|NOT COMPLETED|Maintenance Phase||0||
59546238|NCT01070810|75644865|FG000|STARTED|Overall Study||45||
59546239|NCT01070810|75644866|FG001|STARTED|Overall Study||43||
59546240|NCT01070810|75644865|FG000|COMPLETED|Overall Study||45||
59546241|NCT01070810|75644866|FG001|COMPLETED|Overall Study||43||
59546242|NCT01070810|75644865|FG000|NOT COMPLETED|Overall Study||0||
59546243|NCT01070810|75644866|FG001|NOT COMPLETED|Overall Study||0||
59546244|NCT01071044|75644876|FG000|STARTED|Overall Study||15||
59546245|NCT01071044|75644877|FG001|STARTED|Overall Study||11||
59546246|NCT01071044|75644876|FG000|COMPLETED|Overall Study||13||
59546247|NCT01071044|75644877|FG001|COMPLETED|Overall Study||11||
59546248|NCT01071044|75644876|FG000|NOT COMPLETED|Overall Study||2||
59546249|NCT01071044|75644877|FG001|NOT COMPLETED|Overall Study||0||
59546250|NCT01071356|75644888|FG000|STARTED|Overall Study||111||
59546251|NCT01071356|75644889|FG001|STARTED|Overall Study||106||
59674712|NCT01240863|75793850|FG002|COMPLETED|Open-label Titration Period||0||
59674713|NCT01240863|75793848|FG000|NOT COMPLETED|Open-label Titration Period||97||
59674714|NCT01240863|75793849|FG001|NOT COMPLETED|Open-label Titration Period||0||
59674715|NCT01240863|75793850|FG002|NOT COMPLETED|Open-label Titration Period||0||
59674716|NCT01240863|75793848|FG000|STARTED|Double-blind Treatment Period (12 Weeks)||0||
59674717|NCT01240863|75793849|FG001|STARTED|Double-blind Treatment Period (12 Weeks)||148||
59674718|NCT01240863|75793850|FG002|STARTED|Double-blind Treatment Period (12 Weeks)||146||
59674719|NCT01240863|75793848|FG000|Full Analysis and Safety Analysis Sets|Double-blind Treatment Period (12 Weeks)||0||
59674720|NCT01240863|75793849|FG001|Full Analysis and Safety Analysis Sets|Double-blind Treatment Period (12 Weeks)||147||
59674721|NCT01240863|75793850|FG002|Full Analysis and Safety Analysis Sets|Double-blind Treatment Period (12 Weeks)||146||
59674722|NCT01240863|75793848|FG000|COMPLETED|Double-blind Treatment Period (12 Weeks)||0||
59674723|NCT01240863|75793849|FG001|COMPLETED|Double-blind Treatment Period (12 Weeks)||102||
59674724|NCT01240863|75793850|FG002|COMPLETED|Double-blind Treatment Period (12 Weeks)||94||
59674725|NCT01240863|75793848|FG000|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||0||
59674726|NCT01240863|75793849|FG001|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||46||
59674727|NCT01240863|75793850|FG002|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||52||
59674728|NCT01240746|75793865|FG000|STARTED|Overall Study||736||
59674729|NCT01240746|75793866|FG001|STARTED|Overall Study||725||
59674730|NCT01240746|75793867|FG002|STARTED|Overall Study||2902||
59674731|NCT01240746|75793865|FG000|COMPLETED|Overall Study||677||
59674732|NCT01240746|75793866|FG001|COMPLETED|Overall Study||677||
59674733|NCT01240746|75793867|FG002|COMPLETED|Overall Study||2659||
59674734|NCT01240746|75793865|FG000|NOT COMPLETED|Overall Study||59||
59674735|NCT01240746|75793866|FG001|NOT COMPLETED|Overall Study||48||
59674736|NCT01240746|75793867|FG002|NOT COMPLETED|Overall Study||243||
59674737|NCT01240590|75793880|FG000|STARTED|Phase I||0||
59674738|NCT01240590|75793881|FG001|STARTED|Phase I||6||
59674739|NCT01240590|75793882|FG002|STARTED|Phase I||3||
59674740|NCT01240590|75793883|FG003|STARTED|Phase I||0||
59674741|NCT01240590|75793884|FG004|STARTED|Phase I||0||
59674742|NCT01240590|75793880|FG000|COMPLETED|Phase I||0||
59674743|NCT01240590|75793881|FG001|COMPLETED|Phase I||6||
59674744|NCT01240590|75793882|FG002|COMPLETED|Phase I||0||
59674745|NCT01240590|75793883|FG003|COMPLETED|Phase I||0||
59674746|NCT01240590|75793884|FG004|COMPLETED|Phase I||0||
59674747|NCT01240590|75793880|FG000|NOT COMPLETED|Phase I||0||
59674748|NCT01240590|75793881|FG001|NOT COMPLETED|Phase I||0||
59674749|NCT01240590|75793882|FG002|NOT COMPLETED|Phase I||3||
59674750|NCT01240590|75793883|FG003|NOT COMPLETED|Phase I||0||
59674751|NCT01240590|75793884|FG004|NOT COMPLETED|Phase I||0||
59674752|NCT01240590|75793880|FG000|STARTED|Phase II||0||
59674753|NCT01240590|75793881|FG001|STARTED|Phase II||0||
59674754|NCT01240590|75793882|FG002|STARTED|Phase II||0||
59674755|NCT01240590|75793883|FG003|STARTED|Phase II||17||
59674756|NCT01240590|75793884|FG004|STARTED|Phase II||1||
59674757|NCT01240590|75793880|FG000|COMPLETED|Phase II||0||
59674758|NCT01240590|75793881|FG001|COMPLETED|Phase II||0||
59674759|NCT01240590|75793882|FG002|COMPLETED|Phase II||0||
59674760|NCT01240590|75793883|FG003|COMPLETED|Phase II||15||
59674761|NCT01240590|75793884|FG004|COMPLETED|Phase II||0||
59674762|NCT01240590|75793880|FG000|NOT COMPLETED|Phase II||0||
59674763|NCT01240590|75793881|FG001|NOT COMPLETED|Phase II||0||
59674764|NCT01240590|75793882|FG002|NOT COMPLETED|Phase II||0||
59674765|NCT01240590|75793883|FG003|NOT COMPLETED|Phase II||2||
59674766|NCT01240590|75793884|FG004|NOT COMPLETED|Phase II||1||
59674767|NCT01240200|75793912|FG000|STARTED|12-week Crossover Phase - Period 1||25||
59674768|NCT01240200|75793913|FG001|STARTED|12-week Crossover Phase - Period 1||24||
59674769|NCT01240200|75793912|FG000|COMPLETED|12-week Crossover Phase - Period 1||23||
59674770|NCT01240200|75793913|FG001|COMPLETED|12-week Crossover Phase - Period 1||23||
59674771|NCT01240200|75793912|FG000|NOT COMPLETED|12-week Crossover Phase - Period 1||2||
59674772|NCT01240200|75793913|FG001|NOT COMPLETED|12-week Crossover Phase - Period 1||1||
59674773|NCT01240200|75793912|FG000|STARTED|12-week Crossover Phase - Period 2||23||
59674774|NCT01240200|75793913|FG001|STARTED|12-week Crossover Phase - Period 2||23||
59674775|NCT01240200|75793912|FG000|COMPLETED|12-week Crossover Phase - Period 2||23||
59674776|NCT01240200|75793913|FG001|COMPLETED|12-week Crossover Phase - Period 2||23||
59674777|NCT01240200|75793912|FG000|NOT COMPLETED|12-week Crossover Phase - Period 2||0||
59674778|NCT01240200|75793913|FG001|NOT COMPLETED|12-week Crossover Phase - Period 2||0||
59674779|NCT01356966|75793924|FG000|STARTED|Overall Study||18||
59674780|NCT01356966|75793925|FG001|STARTED|Overall Study||14||
59674781|NCT01356966|75793924|FG000|COMPLETED|Overall Study||16||
59674782|NCT01356966|75793925|FG001|COMPLETED|Overall Study||12||
59674783|NCT01356966|75793924|FG000|NOT COMPLETED|Overall Study||2||
59674784|NCT01356966|75793925|FG001|NOT COMPLETED|Overall Study||2||
59674785|NCT00530868|75793933|FG000|STARTED|Overall Study||50||
59674786|NCT00530868|75793934|FG001|STARTED|Overall Study||25||
59674787|NCT00530868|75793933|FG000|COMPLETED|Overall Study||50||
59674788|NCT00530868|75793934|FG001|COMPLETED|Overall Study||25||
59674789|NCT00530868|75793933|FG000|NOT COMPLETED|Overall Study||0||
59674790|NCT00530868|75793934|FG001|NOT COMPLETED|Overall Study||0||
59674791|NCT05319912|75793948|FG000|STARTED|Overall Study||3||
59674792|NCT05319912|75793949|FG001|STARTED|Overall Study||3||
59674793|NCT05319912|75793950|FG002|STARTED|Overall Study||3||
59674794|NCT05319912|75793951|FG003|STARTED|Overall Study||3||
59674795|NCT05319912|75793952|FG004|STARTED|Overall Study||3||
59674796|NCT05319912|75793953|FG005|STARTED|Overall Study||3||
59674797|NCT05319912|75793948|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3||
59674798|NCT05319912|75793949|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3||
59674799|NCT05319912|75793950|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3||
59674800|NCT05319912|75793951|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3||
59674801|NCT05319912|75793952|FG004|Received at Least 1 Dose of Study Drug|Overall Study||3||
59674802|NCT05319912|75793953|FG005|Received at Least 1 Dose of Study Drug|Overall Study||3||
59674803|NCT05319912|75793948|FG000|COMPLETED|Overall Study||3||
59674804|NCT05319912|75793949|FG001|COMPLETED|Overall Study||3||
59674805|NCT05319912|75793950|FG002|COMPLETED|Overall Study||3||
59674806|NCT05319912|75793951|FG003|COMPLETED|Overall Study||3||
59674807|NCT05319912|75793952|FG004|COMPLETED|Overall Study||3||
59674808|NCT05319912|75793953|FG005|COMPLETED|Overall Study||3||
59674809|NCT05319912|75793948|FG000|NOT COMPLETED|Overall Study||0||
59674810|NCT05319912|75793949|FG001|NOT COMPLETED|Overall Study||0||
59674811|NCT05319912|75793950|FG002|NOT COMPLETED|Overall Study||0||
59674812|NCT05319912|75793951|FG003|NOT COMPLETED|Overall Study||0||
59674813|NCT05319912|75793952|FG004|NOT COMPLETED|Overall Study||0||
59674814|NCT05319912|75793953|FG005|NOT COMPLETED|Overall Study||0||
59674815|NCT05289271|75793963|FG000|STARTED|Overall Study||86|Allocated participants|
59674816|NCT05289271|75793964|FG001|STARTED|Overall Study||82|Allocated participants|
59674817|NCT05289271|75793963|FG000|Treated|Overall Study||85||
59674818|NCT05289271|75793964|FG001|Treated|Overall Study||82||
59674819|NCT05289271|75793963|FG000|COMPLETED|Overall Study||85||
59674820|NCT05289271|75793964|FG001|COMPLETED|Overall Study||82||
59674821|NCT05289271|75793963|FG000|NOT COMPLETED|Overall Study||1||
59674822|NCT05289271|75793964|FG001|NOT COMPLETED|Overall Study||0||
59674823|NCT05248399|75793972|FG000|STARTED|Overall Study||101||
59674824|NCT05248399|75793973|FG001|STARTED|Overall Study||99||
59674825|NCT05248399|75793972|FG000|COMPLETED|Overall Study||84||
59674826|NCT05248399|75793973|FG001|COMPLETED|Overall Study||82||
59674827|NCT05248399|75793972|FG000|NOT COMPLETED|Overall Study||17||
59674828|NCT05248399|75793973|FG001|NOT COMPLETED|Overall Study||17||
59674829|NCT05223478|75793983|FG000|STARTED|Overall Study||11||
59674830|NCT05223478|75793984|FG001|STARTED|Overall Study||12||
59674831|NCT05223478|75793983|FG000|COMPLETED|Overall Study||11||
59674832|NCT05223478|75793984|FG001|COMPLETED|Overall Study||12||
59674833|NCT05223478|75793983|FG000|NOT COMPLETED|Overall Study||0||
59674834|NCT05223478|75793984|FG001|NOT COMPLETED|Overall Study||0||
59674835|NCT05149287|75793992|FG000|STARTED|Overall Study||3||
59674836|NCT05149287|75793993|FG001|STARTED|Overall Study||2||
59674837|NCT05149287|75793992|FG000|COMPLETED|Overall Study||3||
59674838|NCT05149287|75793993|FG001|COMPLETED|Overall Study||2||
59674839|NCT05149287|75793992|FG000|NOT COMPLETED|Overall Study||0||
59674840|NCT05149287|75793993|FG001|NOT COMPLETED|Overall Study||0||
59674841|NCT05110781|75793999|FG000|STARTED|Overall Study||1||
59674842|NCT05110781|75793999|FG000|COMPLETED|Overall Study||1||
59674843|NCT05110781|75793999|FG000|NOT COMPLETED|Overall Study||0||
59674844|NCT05080660|75794005|FG000|STARTED|Overall Study||107||
59674845|NCT05080660|75794006|FG001|STARTED|Overall Study||53||
59674846|NCT05080660|75794005|FG000|Received at Least One Dose of Study Drug|Overall Study||107||
59674847|NCT05080660|75794006|FG001|Received at Least One Dose of Study Drug|Overall Study||53||
59674848|NCT05080660|75794005|FG000|COMPLETED|Overall Study||94||
59674849|NCT05080660|75794006|FG001|COMPLETED|Overall Study||51||
59674850|NCT05080660|75794005|FG000|NOT COMPLETED|Overall Study||13||
59674851|NCT05080660|75794006|FG001|NOT COMPLETED|Overall Study||2||
59674852|NCT05005312|75794014|FG000|STARTED|Overall Study||8||
59674853|NCT05005312|75794015|FG001|STARTED|Overall Study||9||
59674854|NCT05005312|75794014|FG000|Treated|Overall Study||8||
59674855|NCT05005312|75794015|FG001|Treated|Overall Study||8||
59674856|NCT05005312|75794014|FG000|COMPLETED|Overall Study||8||
59674857|NCT05005312|75794015|FG001|COMPLETED|Overall Study|One participant in the moderate hepatic impairment group was excluded from the safety and PK analysis set as this participant was randomized but was discontinued due to difficulty in venous access for blood draws on Day 1 prior to dosing with study treatment PF-07321332.|8||
59674858|NCT05005312|75794014|FG000|NOT COMPLETED|Overall Study||0||
59674859|NCT05005312|75794015|FG001|NOT COMPLETED|Overall Study||1||
59674860|NCT04955444|75794023|FG000|STARTED|Overall Study||160||
59674861|NCT04955444|75794024|FG001|STARTED|Overall Study||80||
59674862|NCT04955444|75794023|FG000|COMPLETED|Overall Study||160||
59674863|NCT04955444|75794024|FG001|COMPLETED|Overall Study||80||
59674864|NCT04955444|75794023|FG000|NOT COMPLETED|Overall Study||0||
59674865|NCT04955444|75794024|FG001|NOT COMPLETED|Overall Study||0||
59674866|NCT04867902|75794030|FG000|STARTED|Overall Study||12||
59674867|NCT04867902|75794030|FG000|COMPLETED|Overall Study||8||
59674868|NCT04867902|75794030|FG000|NOT COMPLETED|Overall Study||4||
59674869|NCT04677179|75794037|FG000|STARTED|Induction Treatment Period||32||
59674870|NCT04677179|75794038|FG001|STARTED|Induction Treatment Period||35||
59674871|NCT04677179|75794039|FG002|STARTED|Induction Treatment Period||14||
59674872|NCT04677179|75794040|FG003|STARTED|Induction Treatment Period||0||
59674873|NCT04677179|75794041|FG004|STARTED|Induction Treatment Period||0||
59674874|NCT04677179|75794042|FG005|STARTED|Induction Treatment Period||0||
59674875|NCT04677179|75794043|FG006|STARTED|Induction Treatment Period||0||
59674876|NCT04677179|75794044|FG007|STARTED|Induction Treatment Period||0||
59674877|NCT04677179|75794045|FG008|STARTED|Induction Treatment Period||0||
59674878|NCT04677179|75794046|FG009|STARTED|Induction Treatment Period||0||
59674879|NCT04677179|75794037|FG000|Received at Least One Dose of Study Drug|Induction Treatment Period||32||
59674880|NCT04677179|75794038|FG001|Received at Least One Dose of Study Drug|Induction Treatment Period||35||
59674881|NCT04677179|75794039|FG002|Received at Least One Dose of Study Drug|Induction Treatment Period||14||
59674882|NCT04677179|75794040|FG003|Received at Least One Dose of Study Drug|Induction Treatment Period||0||
59989489|NCT02452034|76104801|FG000|Treated|Overall Study||14||
59989490|NCT02452034|76104802|FG001|Treated|Overall Study||21||
59989491|NCT02452034|76104803|FG002|Treated|Overall Study||15||
59546252|NCT01071356|75644888|FG000|COMPLETED|Overall Study||104||
59546253|NCT01071356|75644889|FG001|COMPLETED|Overall Study||97||
59546254|NCT01071356|75644888|FG000|NOT COMPLETED|Overall Study||7||
59546255|NCT01071356|75644889|FG001|NOT COMPLETED|Overall Study||9||
59546256|NCT01072136|75644897|FG000|STARTED|Overall Study||44||
59546257|NCT01072136|75644898|FG001|STARTED|Overall Study||43||
59546258|NCT01072136|75644897|FG000|Met All Enrollment Criteria|Overall Study|Some eligibility test results were not available until after randomization.|30||
59674883|NCT04677179|75794041|FG004|Received at Least One Dose of Study Drug|Induction Treatment Period||0||
59674884|NCT04677179|75794042|FG005|Received at Least One Dose of Study Drug|Induction Treatment Period||0||
59674885|NCT04677179|75794043|FG006|Received at Least One Dose of Study Drug|Induction Treatment Period||0||
59674886|NCT04677179|75794044|FG007|Received at Least One Dose of Study Drug|Induction Treatment Period||0||
59674887|NCT04677179|75794045|FG008|Received at Least One Dose of Study Drug|Induction Treatment Period||0||
59674888|NCT04677179|75794046|FG009|Received at Least One Dose of Study Drug|Induction Treatment Period||0||
59674889|NCT04677179|75794037|FG000|COMPLETED|Induction Treatment Period||19||
59674890|NCT04677179|75794038|FG001|COMPLETED|Induction Treatment Period||22||
59674891|NCT04677179|75794039|FG002|COMPLETED|Induction Treatment Period||12||
59674892|NCT04677179|75794040|FG003|COMPLETED|Induction Treatment Period||0||
59674893|NCT04677179|75794041|FG004|COMPLETED|Induction Treatment Period||0||
59674894|NCT04677179|75794042|FG005|COMPLETED|Induction Treatment Period||0||
59674895|NCT04677179|75794043|FG006|COMPLETED|Induction Treatment Period||0||
59674896|NCT04677179|75794044|FG007|COMPLETED|Induction Treatment Period||0||
59674897|NCT04677179|75794045|FG008|COMPLETED|Induction Treatment Period||0||
59674898|NCT04677179|75794046|FG009|COMPLETED|Induction Treatment Period||0||
59674899|NCT04677179|75794037|FG000|NOT COMPLETED|Induction Treatment Period||13||
59674900|NCT04677179|75794038|FG001|NOT COMPLETED|Induction Treatment Period||13||
59989492|NCT02452034|76104804|FG003|Treated|Overall Study||16||
59989493|NCT02452034|76104805|FG004|Treated|Overall Study||20||
59989494|NCT02452034|76104806|FG005|Treated|Overall Study||29||
59989495|NCT02452034|76104801|FG000|COMPLETED|Overall Study||14||
59989496|NCT02452034|76104802|FG001|COMPLETED|Overall Study||20||
59674901|NCT04677179|75794039|FG002|NOT COMPLETED|Induction Treatment Period||2||
59674902|NCT04677179|75794040|FG003|NOT COMPLETED|Induction Treatment Period||0||
59674903|NCT04677179|75794041|FG004|NOT COMPLETED|Induction Treatment Period||0||
59674904|NCT04677179|75794042|FG005|NOT COMPLETED|Induction Treatment Period||0||
59674905|NCT04677179|75794043|FG006|NOT COMPLETED|Induction Treatment Period||0||
59674906|NCT04677179|75794044|FG007|NOT COMPLETED|Induction Treatment Period||0||
60077975|NCT01482429|76193002|FG001|STARTED|Protocol||0||
60077976|NCT01482429|76193001|FG000|COMPLETED|Protocol||139||
60077977|NCT01482429|76193002|FG001|COMPLETED|Protocol||0||
59546259|NCT01072136|75644898|FG001|Met All Enrollment Criteria|Overall Study||25||
59546260|NCT01072136|75644897|FG000|COMPLETED|Overall Study||21||
59546261|NCT01072136|75644898|FG001|COMPLETED|Overall Study||12||
59546262|NCT01072136|75644897|FG000|NOT COMPLETED|Overall Study||23||
59546263|NCT01072136|75644898|FG001|NOT COMPLETED|Overall Study||31||
59546264|NCT01074164|75644909|FG000|STARTED|Overall Study||7||
59546265|NCT01074164|75644910|FG001|STARTED|Overall Study||8||
59674907|NCT04677179|75794045|FG008|NOT COMPLETED|Induction Treatment Period||0||
59674908|NCT04677179|75794046|FG009|NOT COMPLETED|Induction Treatment Period||0||
59674909|NCT04677179|75794037|FG000|STARTED|Maintenance Treatment Period|Induction treatment period arm.|0||
59674910|NCT04677179|75794038|FG001|STARTED|Maintenance Treatment Period|Induction treatment period arm.|0||
59674911|NCT04677179|75794039|FG002|STARTED|Maintenance Treatment Period|Induction treatment period arm.|0||
59674912|NCT04677179|75794040|FG003|STARTED|Maintenance Treatment Period|Only week 12 induction treatment responders entered the maintenance treatment period.|8||
59674913|NCT04677179|75794041|FG004|STARTED|Maintenance Treatment Period|Only week 12 induction treatment responders entered the maintenance treatment period.|10||
59674914|NCT04677179|75794042|FG005|STARTED|Maintenance Treatment Period|Only week 12 induction treatment responders entered the maintenance treatment period.|5||
59989497|NCT02452034|76104803|FG002|COMPLETED|Overall Study||14||
59989498|NCT02452034|76104804|FG003|COMPLETED|Overall Study||16||
59989499|NCT02452034|76104805|FG004|COMPLETED|Overall Study||19||
59989500|NCT02452034|76104806|FG005|COMPLETED|Overall Study||26||
59546266|NCT01074164|75644909|FG000|COMPLETED|Overall Study||4||
59546267|NCT01074164|75644910|FG001|COMPLETED|Overall Study||7||
59546268|NCT01074164|75644909|FG000|NOT COMPLETED|Overall Study||3||
59546269|NCT01074164|75644910|FG001|NOT COMPLETED|Overall Study||1||
60077978|NCT01482429|76193001|FG000|NOT COMPLETED|Protocol||275||
60077979|NCT01482429|76193002|FG001|NOT COMPLETED|Protocol||0||
59674915|NCT04677179|75794043|FG006|STARTED|Maintenance Treatment Period||0||
59674916|NCT04677179|75794044|FG007|STARTED|Maintenance Treatment Period||0||
59674917|NCT04677179|75794045|FG008|STARTED|Maintenance Treatment Period||0||
59815911|NCT01107015|75938332|FG000|NOT COMPLETED|Overall Study||6||
59815912|NCT01107015|75938333|FG001|NOT COMPLETED|Overall Study||15||
60077980|NCT01504971|76193008|FG000|STARTED|Overall Study||95||
60077981|NCT01504971|76193008|FG000|COMPLETED|Overall Study||82||
60077982|NCT01504971|76193008|FG000|NOT COMPLETED|Overall Study||13||
60077983|NCT01479777|76193016|FG000|STARTED|Overall Study||12||
60077984|NCT01479777|76193016|FG000|COMPLETED|Overall Study||10||
60077985|NCT01479777|76193016|FG000|NOT COMPLETED|Overall Study||2||
60077986|NCT01479621|76193026|FG000|STARTED|Pre-Assignment Period (Run-In Placebo)||909||
60077987|NCT01479621|76193027|FG001|STARTED|Pre-Assignment Period (Run-In Placebo)||0||
60077988|NCT01479621|76193028|FG002|STARTED|Pre-Assignment Period (Run-In Placebo)||0||
60077989|NCT01479621|76193029|FG003|STARTED|Pre-Assignment Period (Run-In Placebo)||0||
60077990|NCT01479621|76193030|FG004|STARTED|Pre-Assignment Period (Run-In Placebo)||0||
60077991|NCT01479621|76193031|FG005|STARTED|Pre-Assignment Period (Run-In Placebo)||0||
59546270|NCT03041324|75644919|FG000|STARTED|Overall Study||2||
59546271|NCT03041324|75644920|FG001|STARTED|Overall Study||2||
59546272|NCT03041324|75644921|FG002|STARTED|Overall Study||5||
59546273|NCT03041324|75644919|FG000|COMPLETED|Overall Study||2||
59546274|NCT03041324|75644920|FG001|COMPLETED|Overall Study||2||
59546275|NCT03041324|75644921|FG002|COMPLETED|Overall Study||5||
59546276|NCT03041324|75644919|FG000|NOT COMPLETED|Overall Study||0||
59546277|NCT03041324|75644920|FG001|NOT COMPLETED|Overall Study||0||
60077992|NCT01479621|76193032|FG006|STARTED|Pre-Assignment Period (Run-In Placebo)||0||
60077993|NCT01479621|76193026|FG000|COMPLETED|Pre-Assignment Period (Run-In Placebo)||622||
59546278|NCT03041324|75644921|FG002|NOT COMPLETED|Overall Study||0||
59546279|NCT01076270|75644932|FG000|STARTED|Overall Study||1||
60077994|NCT01479621|76193027|FG001|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0||
60077995|NCT01479621|76193028|FG002|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0||
60077996|NCT01479621|76193029|FG003|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0||
59674918|NCT04677179|75794046|FG009|STARTED|Maintenance Treatment Period||0||
59815913|NCT01107015|75938334|FG002|NOT COMPLETED|Overall Study||11||
59674919|NCT04677179|75794037|FG000|COMPLETED|Maintenance Treatment Period||0||
59674920|NCT04677179|75794038|FG001|COMPLETED|Maintenance Treatment Period||0||
59674921|NCT04677179|75794039|FG002|COMPLETED|Maintenance Treatment Period||0||
59674922|NCT04677179|75794040|FG003|COMPLETED|Maintenance Treatment Period||0||
59674923|NCT04677179|75794041|FG004|COMPLETED|Maintenance Treatment Period||0||
59674924|NCT04677179|75794042|FG005|COMPLETED|Maintenance Treatment Period||0||
59674925|NCT04677179|75794043|FG006|COMPLETED|Maintenance Treatment Period||0||
59674926|NCT04677179|75794044|FG007|COMPLETED|Maintenance Treatment Period||0||
59674927|NCT04677179|75794045|FG008|COMPLETED|Maintenance Treatment Period||0||
59546280|NCT01076270|75644932|FG000|COMPLETED|Overall Study||1||
59546281|NCT01076270|75644932|FG000|NOT COMPLETED|Overall Study||0||
59546282|NCT01076348|75644936|FG000|STARTED|Overall Study||73||
59546283|NCT01076348|75644936|FG000|COMPLETED|Overall Study||51||
59674928|NCT04677179|75794046|FG009|COMPLETED|Maintenance Treatment Period||0||
59674929|NCT04677179|75794037|FG000|NOT COMPLETED|Maintenance Treatment Period||0||
59674930|NCT04677179|75794038|FG001|NOT COMPLETED|Maintenance Treatment Period||0||
59674931|NCT04677179|75794039|FG002|NOT COMPLETED|Maintenance Treatment Period||0||
59674932|NCT04677179|75794040|FG003|NOT COMPLETED|Maintenance Treatment Period||8||
59674933|NCT04677179|75794041|FG004|NOT COMPLETED|Maintenance Treatment Period||10||
59674934|NCT04677179|75794042|FG005|NOT COMPLETED|Maintenance Treatment Period||5||
59674935|NCT04677179|75794043|FG006|NOT COMPLETED|Maintenance Treatment Period||0||
59674936|NCT04677179|75794044|FG007|NOT COMPLETED|Maintenance Treatment Period||0||
59674937|NCT04677179|75794045|FG008|NOT COMPLETED|Maintenance Treatment Period||0||
59674938|NCT04677179|75794046|FG009|NOT COMPLETED|Maintenance Treatment Period||0||
59674939|NCT04677179|75794037|FG000|STARTED|Extension Treatment Period||0||
59674940|NCT04677179|75794038|FG001|STARTED|Extension Treatment Period||0||
59674941|NCT04677179|75794039|FG002|STARTED|Extension Treatment Period||0||
59674942|NCT04677179|75794040|FG003|STARTED|Extension Treatment Period||0||
59674943|NCT04677179|75794041|FG004|STARTED|Extension Treatment Period||0||
59674944|NCT04677179|75794042|FG005|STARTED|Extension Treatment Period||0||
59674945|NCT04677179|75794043|FG006|STARTED|Extension Treatment Period|Only week 12 induction treatment non-responders entered the extension treatment period.|26||
59674946|NCT04677179|75794044|FG007|STARTED|Extension Treatment Period||0||
59674947|NCT04677179|75794045|FG008|STARTED|Extension Treatment Period||0||
59674948|NCT04677179|75794046|FG009|STARTED|Extension Treatment Period||0||
59674949|NCT04677179|75794037|FG000|COMPLETED|Extension Treatment Period||0||
59674950|NCT04677179|75794038|FG001|COMPLETED|Extension Treatment Period||0||
59674951|NCT04677179|75794039|FG002|COMPLETED|Extension Treatment Period||0||
59674952|NCT04677179|75794040|FG003|COMPLETED|Extension Treatment Period||0||
59674953|NCT04677179|75794041|FG004|COMPLETED|Extension Treatment Period||0||
59674954|NCT04677179|75794042|FG005|COMPLETED|Extension Treatment Period||0||
59674955|NCT04677179|75794043|FG006|COMPLETED|Extension Treatment Period||0||
59674956|NCT04677179|75794044|FG007|COMPLETED|Extension Treatment Period||0||
59674957|NCT04677179|75794045|FG008|COMPLETED|Extension Treatment Period||0||
59674958|NCT04677179|75794046|FG009|COMPLETED|Extension Treatment Period||0||
59674959|NCT04677179|75794037|FG000|NOT COMPLETED|Extension Treatment Period||0||
59674960|NCT04677179|75794038|FG001|NOT COMPLETED|Extension Treatment Period||0||
59674961|NCT04677179|75794039|FG002|NOT COMPLETED|Extension Treatment Period||0||
59674962|NCT04677179|75794040|FG003|NOT COMPLETED|Extension Treatment Period||0||
59546284|NCT01076348|75644936|FG000|NOT COMPLETED|Overall Study||22||
59546285|NCT01076504|75644940|FG000|STARTED|Overall Study||80||
59546286|NCT01076504|75644940|FG000|COMPLETED|Overall Study|Patients remained on study until disease progression or withdrawal for any other reason|0||
59546287|NCT01076504|75644940|FG000|NOT COMPLETED|Overall Study||80||
59546288|NCT02453256|75644946|FG000|STARTED|Double Blind Period||106||
59546289|NCT02453256|75644947|FG001|STARTED|Double Blind Period||104||
59546290|NCT02453256|75644946|FG000|COMPLETED|Double Blind Period||93||
59546291|NCT02453256|75644947|FG001|COMPLETED|Double Blind Period||95||
59674963|NCT04677179|75794041|FG004|NOT COMPLETED|Extension Treatment Period||0||
59674964|NCT04677179|75794042|FG005|NOT COMPLETED|Extension Treatment Period||0||
59674965|NCT04677179|75794043|FG006|NOT COMPLETED|Extension Treatment Period||26||
59674966|NCT04677179|75794044|FG007|NOT COMPLETED|Extension Treatment Period||0||
59674967|NCT04677179|75794045|FG008|NOT COMPLETED|Extension Treatment Period||0||
59674968|NCT04677179|75794046|FG009|NOT COMPLETED|Extension Treatment Period||0||
59546292|NCT02453256|75644946|FG000|NOT COMPLETED|Double Blind Period||13||
59546293|NCT02453256|75644947|FG001|NOT COMPLETED|Double Blind Period||9||
59546294|NCT02453256|75644946|FG000|STARTED|Open Label Period||89||
59674969|NCT04677179|75794037|FG000|STARTED|Post-Treatment Follow-up Period||0||
59674970|NCT04677179|75794038|FG001|STARTED|Post-Treatment Follow-up Period||0||
59674971|NCT04677179|75794039|FG002|STARTED|Post-Treatment Follow-up Period||0||
59674972|NCT04677179|75794040|FG003|STARTED|Post-Treatment Follow-up Period||0||
59674973|NCT04677179|75794041|FG004|STARTED|Post-Treatment Follow-up Period||0||
59674974|NCT04677179|75794042|FG005|STARTED|Post-Treatment Follow-up Period||0||
59674975|NCT04677179|75794043|FG006|STARTED|Post-Treatment Follow-up Period||0||
59546295|NCT02453256|75644947|FG001|STARTED|Open Label Period||92||
59546296|NCT02453256|75644946|FG000|COMPLETED|Open Label Period||82||
59674976|NCT04677179|75794044|FG007|STARTED|Post-Treatment Follow-up Period|Participants entered the post-treatment follow-up period from induction or maintenance, or extension treatment periods.|25||
59674977|NCT04677179|75794045|FG008|STARTED|Post-Treatment Follow-up Period|Participants entered the post-treatment follow-up period from induction or maintenance, or extension treatment periods.|30||
59674978|NCT04677179|75794046|FG009|STARTED|Post-Treatment Follow-up Period|Participants entered the post-treatment follow-up period from induction or maintenance, or extension treatment periods.|11||
59674979|NCT04677179|75794037|FG000|COMPLETED|Post-Treatment Follow-up Period||0||
59674980|NCT04677179|75794038|FG001|COMPLETED|Post-Treatment Follow-up Period||0||
59674981|NCT04677179|75794039|FG002|COMPLETED|Post-Treatment Follow-up Period||0||
59674982|NCT04677179|75794040|FG003|COMPLETED|Post-Treatment Follow-up Period||0||
59674983|NCT04677179|75794041|FG004|COMPLETED|Post-Treatment Follow-up Period||0||
59674984|NCT04677179|75794042|FG005|COMPLETED|Post-Treatment Follow-up Period||0||
59674985|NCT04677179|75794043|FG006|COMPLETED|Post-Treatment Follow-up Period||0||
59674986|NCT04677179|75794044|FG007|COMPLETED|Post-Treatment Follow-up Period||0||
59674987|NCT04677179|75794045|FG008|COMPLETED|Post-Treatment Follow-up Period||0||
59674988|NCT04677179|75794046|FG009|COMPLETED|Post-Treatment Follow-up Period||0||
59674989|NCT04677179|75794037|FG000|NOT COMPLETED|Post-Treatment Follow-up Period||0||
59674990|NCT04677179|75794038|FG001|NOT COMPLETED|Post-Treatment Follow-up Period||0||
59674991|NCT04677179|75794039|FG002|NOT COMPLETED|Post-Treatment Follow-up Period||0||
59674992|NCT04677179|75794040|FG003|NOT COMPLETED|Post-Treatment Follow-up Period||0||
59674993|NCT04677179|75794041|FG004|NOT COMPLETED|Post-Treatment Follow-up Period||0||
59674994|NCT04677179|75794042|FG005|NOT COMPLETED|Post-Treatment Follow-up Period||0||
59674995|NCT04677179|75794043|FG006|NOT COMPLETED|Post-Treatment Follow-up Period||0||
59674996|NCT04677179|75794044|FG007|NOT COMPLETED|Post-Treatment Follow-up Period||25||
59674997|NCT04677179|75794045|FG008|NOT COMPLETED|Post-Treatment Follow-up Period||30||
59674998|NCT04677179|75794046|FG009|NOT COMPLETED|Post-Treatment Follow-up Period||11||
59674999|NCT04590937|75794063|FG000|STARTED|Period 1 - Cocktail||15||
59675000|NCT04590937|75794063|FG000|COMPLETED|Period 1 - Cocktail||15|"completed refers to: not prematurely discontinued from trial medication"|
59675001|NCT04590937|75794063|FG000|NOT COMPLETED|Period 1 - Cocktail||0||
59675002|NCT04590937|75794063|FG000|STARTED|Period 2 - BI 730357+Cocktail||15||
59675003|NCT04590937|75794063|FG000|Treated at Least One Dose of BI|Period 2 - BI 730357+Cocktail||15||
59675004|NCT04590937|75794063|FG000|Treated at Least One Dose of Cocktail+BI|Period 2 - BI 730357+Cocktail||14||
59675005|NCT04590937|75794063|FG000|COMPLETED|Period 2 - BI 730357+Cocktail||14|"completed refers to: not prematurely discontinued from trial medication"|
59675006|NCT04590937|75794063|FG000|NOT COMPLETED|Period 2 - BI 730357+Cocktail||1||
59675007|NCT04576897|75794077|FG000|STARTED|Overall Study||70||
59675008|NCT04576897|75794077|FG000|COMPLETED|Overall Study||33||
59675009|NCT04576897|75794077|FG000|NOT COMPLETED|Overall Study||37||
59675010|NCT04301778|75794084|FG000|STARTED|Overall Study||5||
59675011|NCT04301778|75794084|FG000|COMPLETED|Overall Study||5||
59675012|NCT04301778|75794084|FG000|NOT COMPLETED|Overall Study||0||
59675013|NCT04247074|75794092|FG000|STARTED|Overall Study||126||
59675014|NCT04247074|75794093|FG001|STARTED|Overall Study||59||
59675015|NCT04247074|75794094|FG002|STARTED|Overall Study||113||
59675016|NCT04247074|75794095|FG003|STARTED|Overall Study||115||
59675017|NCT04247074|75794092|FG000|COMPLETED|Overall Study||121||
59675018|NCT04247074|75794093|FG001|COMPLETED|Overall Study||52||
59675019|NCT04247074|75794094|FG002|COMPLETED|Overall Study||106||
59675020|NCT04247074|75794095|FG003|COMPLETED|Overall Study||107||
59675021|NCT04247074|75794092|FG000|NOT COMPLETED|Overall Study||5||
59675022|NCT04247074|75794093|FG001|NOT COMPLETED|Overall Study||7||
59675023|NCT04247074|75794094|FG002|NOT COMPLETED|Overall Study||7||
59675024|NCT04247074|75794095|FG003|NOT COMPLETED|Overall Study||8||
59675025|NCT04166435|75794109|FG000|STARTED|Overall Study||11||
59675026|NCT04166435|75794109|FG000|COMPLETED|Overall Study||9||
59675027|NCT04166435|75794109|FG000|NOT COMPLETED|Overall Study||2||
59675028|NCT04124965|75794115|FG000|STARTED|Overall Study||35||
59675029|NCT04124965|75794116|FG001|STARTED|Overall Study||36||
59675030|NCT04124965|75794115|FG000|Safety Set|Overall Study||35|Received at least 1 dose of investigational medicinal product|
59675031|NCT04124965|75794116|FG001|Safety Set|Overall Study||35|Received at least 1 dose of investigational medicinal product|
59675032|NCT04124965|75794115|FG000|COMPLETED|Overall Study||5||
59675033|NCT04124965|75794116|FG001|COMPLETED|Overall Study||3||
59675034|NCT04124965|75794115|FG000|NOT COMPLETED|Overall Study||30||
59675035|NCT04124965|75794116|FG001|NOT COMPLETED|Overall Study||33||
59675036|NCT04098068|75794122|FG000|STARTED|Overall Study||12||
59675037|NCT04098068|75794122|FG000|COMPLETED|Overall Study||2||
59675038|NCT04098068|75794122|FG000|NOT COMPLETED|Overall Study||10||
59675039|NCT04021862|75794129|FG000|STARTED|Placebo Controlled Period (Week 0-16)||29||
59675040|NCT04021862|75794130|FG001|STARTED|Placebo Controlled Period (Week 0-16)||29||
59675041|NCT04021862|75794131|FG002|STARTED|Placebo Controlled Period (Week 0-16)||29||
59675042|NCT04021862|75794132|FG003|STARTED|Placebo Controlled Period (Week 0-16)||0||
59675043|NCT04021862|75794133|FG004|STARTED|Placebo Controlled Period (Week 0-16)||0||
59675044|NCT04021862|75794134|FG005|STARTED|Placebo Controlled Period (Week 0-16)||0||
59675045|NCT04021862|75794129|FG000|COMPLETED|Placebo Controlled Period (Week 0-16)||27||
59675046|NCT04021862|75794130|FG001|COMPLETED|Placebo Controlled Period (Week 0-16)||28||
59815914|NCT01107015|75938335|FG003|NOT COMPLETED|Overall Study||18||
59675047|NCT04021862|75794131|FG002|COMPLETED|Placebo Controlled Period (Week 0-16)||27||
59675048|NCT04021862|75794132|FG003|COMPLETED|Placebo Controlled Period (Week 0-16)||0||
59675049|NCT04021862|75794133|FG004|COMPLETED|Placebo Controlled Period (Week 0-16)||0||
59675050|NCT04021862|75794134|FG005|COMPLETED|Placebo Controlled Period (Week 0-16)||0||
59675051|NCT04021862|75794129|FG000|NOT COMPLETED|Placebo Controlled Period (Week 0-16)||2||
59675052|NCT04021862|75794130|FG001|NOT COMPLETED|Placebo Controlled Period (Week 0-16)||1||
59675053|NCT04021862|75794131|FG002|NOT COMPLETED|Placebo Controlled Period (Week 0-16)||2||
59675054|NCT04021862|75794132|FG003|NOT COMPLETED|Placebo Controlled Period (Week 0-16)||0||
59675055|NCT04021862|75794133|FG004|NOT COMPLETED|Placebo Controlled Period (Week 0-16)||0||
59675056|NCT04021862|75794134|FG005|NOT COMPLETED|Placebo Controlled Period (Week 0-16)||0||
59675057|NCT04021862|75794129|FG000|STARTED|Active Treatment Period (Week 16-32)||0||
59675058|NCT04021862|75794130|FG001|STARTED|Active Treatment Period (Week 16-32)||0||
59675059|NCT04021862|75794131|FG002|STARTED|Active Treatment Period (Week 16-32)||0||
59675060|NCT04021862|75794132|FG003|STARTED|Active Treatment Period (Week 16-32)||27||
59675061|NCT04021862|75794133|FG004|STARTED|Active Treatment Period (Week 16-32)||28||
59675062|NCT04021862|75794134|FG005|STARTED|Active Treatment Period (Week 16-32)||27||
59675063|NCT04021862|75794129|FG000|COMPLETED|Active Treatment Period (Week 16-32)||0||
59675064|NCT04021862|75794130|FG001|COMPLETED|Active Treatment Period (Week 16-32)||0||
59675065|NCT04021862|75794131|FG002|COMPLETED|Active Treatment Period (Week 16-32)||0||
59675066|NCT04021862|75794132|FG003|COMPLETED|Active Treatment Period (Week 16-32)||26||
59675067|NCT04021862|75794133|FG004|COMPLETED|Active Treatment Period (Week 16-32)||28||
59675068|NCT04021862|75794134|FG005|COMPLETED|Active Treatment Period (Week 16-32)||27||
59675069|NCT04021862|75794129|FG000|NOT COMPLETED|Active Treatment Period (Week 16-32)||0||
59675070|NCT04021862|75794130|FG001|NOT COMPLETED|Active Treatment Period (Week 16-32)||0||
59675071|NCT04021862|75794131|FG002|NOT COMPLETED|Active Treatment Period (Week 16-32)||0||
59675072|NCT04021862|75794132|FG003|NOT COMPLETED|Active Treatment Period (Week 16-32)||1||
59675073|NCT04021862|75794133|FG004|NOT COMPLETED|Active Treatment Period (Week 16-32)||0||
59675074|NCT04021862|75794134|FG005|NOT COMPLETED|Active Treatment Period (Week 16-32)||0||
59675075|NCT04003155|75794151|FG000|STARTED|Double-Blind (DB) Period (12 Weeks)||175||
59675076|NCT04003155|75794152|FG001|STARTED|Double-Blind (DB) Period (12 Weeks)||176||
59675077|NCT04003155|75794153|FG002|STARTED|Double-Blind (DB) Period (12 Weeks)||176||
59675078|NCT04003155|75794154|FG003|STARTED|Double-Blind (DB) Period (12 Weeks)||0||
59675079|NCT04003155|75794155|FG004|STARTED|Double-Blind (DB) Period (12 Weeks)||0||
59675080|NCT04003155|75794151|FG000|Full Analysis Set|Double-Blind (DB) Period (12 Weeks)||175||
59675081|NCT04003155|75794152|FG001|Full Analysis Set|Double-Blind (DB) Period (12 Weeks)||173||
59675082|NCT04003155|75794153|FG002|Full Analysis Set|Double-Blind (DB) Period (12 Weeks)||174||
59675083|NCT04003155|75794154|FG003|Full Analysis Set|Double-Blind (DB) Period (12 Weeks)||0||
59675084|NCT04003155|75794155|FG004|Full Analysis Set|Double-Blind (DB) Period (12 Weeks)||0||
59675085|NCT04003155|75794151|FG000|Safety Analysis Set|Double-Blind (DB) Period (12 Weeks)||175||
59675086|NCT04003155|75794152|FG001|Safety Analysis Set|Double-Blind (DB) Period (12 Weeks)|1 participant who was randomized to fezolinetant 45 mg received fezolinetant 30 mg during the 12-week study period. This participant was included in the fezolinetant 30 mg group for the Safety Analysis Set|174||
59675087|NCT04003155|75794153|FG002|Safety Analysis Set|Double-Blind (DB) Period (12 Weeks)||173||
59675088|NCT04003155|75794154|FG003|Safety Analysis Set|Double-Blind (DB) Period (12 Weeks)||0||
59675089|NCT04003155|75794155|FG004|Safety Analysis Set|Double-Blind (DB) Period (12 Weeks)||0||
59675090|NCT04003155|75794151|FG000|Treated|Double-Blind (DB) Period (12 Weeks)||175||
59675091|NCT04003155|75794152|FG001|Treated|Double-Blind (DB) Period (12 Weeks)||173||
59675092|NCT04003155|75794153|FG002|Treated|Double-Blind (DB) Period (12 Weeks)|1 participant who was randomized in this arm actually received 30mg fezolinetant.|174||
59675093|NCT04003155|75794154|FG003|Treated|Double-Blind (DB) Period (12 Weeks)||0||
59675094|NCT04003155|75794155|FG004|Treated|Double-Blind (DB) Period (12 Weeks)||0||
59675095|NCT04003155|75794151|FG000|COMPLETED|Double-Blind (DB) Period (12 Weeks)||152||
59675096|NCT04003155|75794152|FG001|COMPLETED|Double-Blind (DB) Period (12 Weeks)||142||
59989501|NCT02452034|76104801|FG000|NOT COMPLETED|Overall Study||2||
59989502|NCT02452034|76104802|FG001|NOT COMPLETED|Overall Study||1||
59989503|NCT02452034|76104803|FG002|NOT COMPLETED|Overall Study||1||
59989504|NCT02452034|76104804|FG003|NOT COMPLETED|Overall Study||1||
59675097|NCT04003155|75794153|FG002|COMPLETED|Double-Blind (DB) Period (12 Weeks)||161||
59989505|NCT02452034|76104805|FG004|NOT COMPLETED|Overall Study||1||
60077997|NCT01479621|76193030|FG004|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0||
60077998|NCT01479621|76193031|FG005|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0||
60077999|NCT01479621|76193032|FG006|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0||
59675098|NCT04003155|75794154|FG003|COMPLETED|Double-Blind (DB) Period (12 Weeks)||0||
59675099|NCT04003155|75794155|FG004|COMPLETED|Double-Blind (DB) Period (12 Weeks)||0||
59675100|NCT04003155|75794151|FG000|NOT COMPLETED|Double-Blind (DB) Period (12 Weeks)||23||
59675101|NCT04003155|75794152|FG001|NOT COMPLETED|Double-Blind (DB) Period (12 Weeks)||34||
59675102|NCT04003155|75794153|FG002|NOT COMPLETED|Double-Blind (DB) Period (12 Weeks)||15||
59989506|NCT02452034|76104806|FG005|NOT COMPLETED|Overall Study||3||
59989507|NCT00513617|76104823|FG000|STARTED|Overall Study||36||
60078000|NCT01479621|76193026|FG000|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||287||
59675103|NCT04003155|75794154|FG003|NOT COMPLETED|Double-Blind (DB) Period (12 Weeks)||0||
59675104|NCT04003155|75794155|FG004|NOT COMPLETED|Double-Blind (DB) Period (12 Weeks)||0||
59675105|NCT04003155|75794151|FG000|STARTED|Extension Period (EP) (40 Weeks)|Participants who received placebo in double-blind period were moved to fezolinetant 30/45 mg arms in extension treatment period|0||
59675106|NCT04003155|75794152|FG001|STARTED|Extension Period (EP) (40 Weeks)|"1 participant who completed DB discontinued study before entering EP.~1 participant who was randomized to 45 mg but received 30 mg in DB, was then moved to 30mg in EP."|142||
59675107|NCT04003155|75794153|FG002|STARTED|Extension Period (EP) (40 Weeks)|Two participants who completed double-blind period discontinued the study before entering the extension treatment period|158||
59675108|NCT04003155|75794154|FG003|STARTED|Extension Period (EP) (40 Weeks)|Participants who received placebo in double-blind period were randomized to fezolinetant 30 mg arms|76||
59675109|NCT04003155|75794155|FG004|STARTED|Extension Period (EP) (40 Weeks)|Participants who received placebo in double-blind period were randomized to fezolinetant 45 mg arms|76||
59675110|NCT04003155|75794151|FG000|COMPLETED|Extension Period (EP) (40 Weeks)||0||
59675111|NCT04003155|75794152|FG001|COMPLETED|Extension Period (EP) (40 Weeks)||124||
59675112|NCT04003155|75794153|FG002|COMPLETED|Extension Period (EP) (40 Weeks)||143||
59675113|NCT04003155|75794154|FG003|COMPLETED|Extension Period (EP) (40 Weeks)||62||
59675114|NCT04003155|75794155|FG004|COMPLETED|Extension Period (EP) (40 Weeks)||67||
59675115|NCT04003155|75794151|FG000|NOT COMPLETED|Extension Period (EP) (40 Weeks)||0||
59675116|NCT04003155|75794152|FG001|NOT COMPLETED|Extension Period (EP) (40 Weeks)||18||
59675117|NCT04003155|75794153|FG002|NOT COMPLETED|Extension Period (EP) (40 Weeks)||15||
59675118|NCT04003155|75794154|FG003|NOT COMPLETED|Extension Period (EP) (40 Weeks)||14||
59675119|NCT04003155|75794155|FG004|NOT COMPLETED|Extension Period (EP) (40 Weeks)||9||
59675120|NCT04003142|75794176|FG000|STARTED|Double-blind Period (12 Weeks)||168||
59675121|NCT04003142|75794177|FG001|STARTED|Double-blind Period (12 Weeks)||166||
59675122|NCT04003142|75794178|FG002|STARTED|Double-blind Period (12 Weeks)||167||
59675123|NCT04003142|75794179|FG003|STARTED|Double-blind Period (12 Weeks)||0||
59675124|NCT04003142|75794180|FG004|STARTED|Double-blind Period (12 Weeks)||0||
59675125|NCT04003142|75794176|FG000|Treated|Double-blind Period (12 Weeks)||167||
59675126|NCT04003142|75794177|FG001|Treated|Double-blind Period (12 Weeks)||166||
59675127|NCT04003142|75794178|FG002|Treated|Double-blind Period (12 Weeks)||167||
59675128|NCT04003142|75794179|FG003|Treated|Double-blind Period (12 Weeks)||0||
59675129|NCT04003142|75794180|FG004|Treated|Double-blind Period (12 Weeks)||0||
59675130|NCT04003142|75794176|FG000|COMPLETED|Double-blind Period (12 Weeks)||151||
59675131|NCT04003142|75794177|FG001|COMPLETED|Double-blind Period (12 Weeks)||152||
59675132|NCT04003142|75794178|FG002|COMPLETED|Double-blind Period (12 Weeks)||155||
59675133|NCT04003142|75794179|FG003|COMPLETED|Double-blind Period (12 Weeks)||0||
59675134|NCT04003142|75794180|FG004|COMPLETED|Double-blind Period (12 Weeks)||0||
59675135|NCT04003142|75794176|FG000|NOT COMPLETED|Double-blind Period (12 Weeks)||17||
59675136|NCT04003142|75794177|FG001|NOT COMPLETED|Double-blind Period (12 Weeks)||14||
59675137|NCT04003142|75794178|FG002|NOT COMPLETED|Double-blind Period (12 Weeks)||12||
59675138|NCT04003142|75794179|FG003|NOT COMPLETED|Double-blind Period (12 Weeks)||0||
59675139|NCT04003142|75794180|FG004|NOT COMPLETED|Double-blind Period (12 Weeks)||0||
59675140|NCT04003142|75794176|FG000|STARTED|Extension Period (40 Weeks)|Participants who received placebo in double-blind period were moved to fezolinetant 30/45 mg arms in extension treatment period|0||
59675141|NCT04003142|75794177|FG001|STARTED|Extension Period (40 Weeks)||152||
59675142|NCT04003142|75794178|FG002|STARTED|Extension Period (40 Weeks)|One participant who completed double-blind period discontinued the study before entering the extension treatment period.|154||
59675143|NCT04003142|75794179|FG003|STARTED|Extension Period (40 Weeks)|Participants who received placebo in double-blind period were randomized to fezolinetant 30 mg arms|76||
59675144|NCT04003142|75794180|FG004|STARTED|Extension Period (40 Weeks)|Participants who received placebo in double-blind period were randomized to fezolinetant 45 mg arms|75||
59675145|NCT04003142|75794176|FG000|COMPLETED|Extension Period (40 Weeks)||0||
59675146|NCT04003142|75794177|FG001|COMPLETED|Extension Period (40 Weeks)||125||
59675147|NCT04003142|75794178|FG002|COMPLETED|Extension Period (40 Weeks)||132||
59675148|NCT04003142|75794179|FG003|COMPLETED|Extension Period (40 Weeks)||63||
59675149|NCT04003142|75794180|FG004|COMPLETED|Extension Period (40 Weeks)||63||
59675150|NCT04003142|75794176|FG000|NOT COMPLETED|Extension Period (40 Weeks)||0||
59675151|NCT04003142|75794177|FG001|NOT COMPLETED|Extension Period (40 Weeks)||27||
59675152|NCT04003142|75794178|FG002|NOT COMPLETED|Extension Period (40 Weeks)||22||
59675153|NCT04003142|75794179|FG003|NOT COMPLETED|Extension Period (40 Weeks)||13||
59675154|NCT04003142|75794180|FG004|NOT COMPLETED|Extension Period (40 Weeks)||12||
59675155|NCT03971422|75794201|FG000|STARTED|Overall Study||67||
59675156|NCT03971422|75794202|FG001|STARTED|Overall Study||66||
59675157|NCT03971422|75794203|FG002|STARTED|Overall Study||67||
59675158|NCT03971422|75794201|FG000|COMPLETED|Overall Study||42||
59675159|NCT03971422|75794202|FG001|COMPLETED|Overall Study||43||
59675160|NCT03971422|75794203|FG002|COMPLETED|Overall Study||43||
59675161|NCT03971422|75794201|FG000|NOT COMPLETED|Overall Study||25||
59675162|NCT03971422|75794202|FG001|NOT COMPLETED|Overall Study||23||
59675163|NCT03971422|75794203|FG002|NOT COMPLETED|Overall Study||24||
59675164|NCT03831477|75794211|FG000|STARTED|Overall Study||15||
59675165|NCT03831477|75794211|FG000|COMPLETED|Overall Study||13||
59675166|NCT03831477|75794211|FG000|NOT COMPLETED|Overall Study||2||
59675167|NCT03770260|75794218|FG000|STARTED|Overall Study||3||
59675168|NCT03770260|75794219|FG001|STARTED|Overall Study||4||
59675169|NCT03770260|75794220|FG002|STARTED|Overall Study||1||
59675170|NCT03770260|75794221|FG003|STARTED|Overall Study||0||
59675171|NCT03770260|75794218|FG000|COMPLETED|Overall Study||3||
59675172|NCT03770260|75794219|FG001|COMPLETED|Overall Study||3||
59675173|NCT03770260|75794220|FG002|COMPLETED|Overall Study||1||
59675174|NCT03770260|75794221|FG003|COMPLETED|Overall Study||0||
59675175|NCT03770260|75794218|FG000|NOT COMPLETED|Overall Study||0||
59675176|NCT03770260|75794219|FG001|NOT COMPLETED|Overall Study||1||
59675177|NCT03770260|75794220|FG002|NOT COMPLETED|Overall Study||0||
59675178|NCT03770260|75794221|FG003|NOT COMPLETED|Overall Study||0||
59675179|NCT03737110|75794232|FG000|STARTED|Run-in (RI) Period||86||
59675180|NCT03737110|75794233|FG001|STARTED|Run-in (RI) Period||0||
59675181|NCT03737110|75794234|FG002|STARTED|Run-in (RI) Period||0||
59675182|NCT03737110|75794235|FG003|STARTED|Run-in (RI) Period||0||
59675183|NCT03737110|75794236|FG004|STARTED|Run-in (RI) Period||0||
59675184|NCT03737110|75794237|FG005|STARTED|Run-in (RI) Period||0||
59675185|NCT03737110|75794232|FG000|Continue to RW Period|Run-in (RI) Period||61||
59675186|NCT03737110|75794233|FG001|Continue to RW Period|Run-in (RI) Period||0||
59675187|NCT03737110|75794234|FG002|Continue to RW Period|Run-in (RI) Period||0||
59675188|NCT03737110|75794235|FG003|Continue to RW Period|Run-in (RI) Period||0||
59675189|NCT03737110|75794236|FG004|Continue to RW Period|Run-in (RI) Period||0||
59675190|NCT03737110|75794237|FG005|Continue to RW Period|Run-in (RI) Period||0||
59675191|NCT03737110|75794232|FG000|Continue Directly to LTE Period|Run-in (RI) Period||15||
59675192|NCT03737110|75794233|FG001|Continue Directly to LTE Period|Run-in (RI) Period||0||
59675193|NCT03737110|75794234|FG002|Continue Directly to LTE Period|Run-in (RI) Period||0||
59675194|NCT03737110|75794235|FG003|Continue Directly to LTE Period|Run-in (RI) Period||0||
59675195|NCT03737110|75794236|FG004|Continue Directly to LTE Period|Run-in (RI) Period||0||
59675196|NCT03737110|75794237|FG005|Continue Directly to LTE Period|Run-in (RI) Period||0||
59675197|NCT03737110|75794232|FG000|COMPLETED|Run-in (RI) Period||76||
59675198|NCT03737110|75794233|FG001|COMPLETED|Run-in (RI) Period||0||
59675199|NCT03737110|75794234|FG002|COMPLETED|Run-in (RI) Period||0||
59675200|NCT03737110|75794235|FG003|COMPLETED|Run-in (RI) Period||0||
59675201|NCT03737110|75794236|FG004|COMPLETED|Run-in (RI) Period||0||
59675202|NCT03737110|75794237|FG005|COMPLETED|Run-in (RI) Period||0||
59675203|NCT03737110|75794232|FG000|NOT COMPLETED|Run-in (RI) Period||10||
59675204|NCT03737110|75794233|FG001|NOT COMPLETED|Run-in (RI) Period||0||
59675205|NCT03737110|75794234|FG002|NOT COMPLETED|Run-in (RI) Period||0||
59675206|NCT03737110|75794235|FG003|NOT COMPLETED|Run-in (RI) Period||0||
59675207|NCT03737110|75794236|FG004|NOT COMPLETED|Run-in (RI) Period||0||
59675208|NCT03737110|75794237|FG005|NOT COMPLETED|Run-in (RI) Period||0||
59675209|NCT03737110|75794232|FG000|STARTED|Randomized Withdrawal (RW) Period||0|Met protocol-defined clinical response criteria and entered into RW Period.|
59675210|NCT03737110|75794233|FG001|STARTED|Randomized Withdrawal (RW) Period||30|Met protocol-defined clinical response criteria and entered into RW Period.|
59675211|NCT03737110|75794234|FG002|STARTED|Randomized Withdrawal (RW) Period||31|Met protocol-defined clinical response criteria and entered into RW Period.|
59675212|NCT03737110|75794235|FG003|STARTED|Randomized Withdrawal (RW) Period||0|Met protocol-defined clinical response criteria and entered into RW Period.|
59675213|NCT03737110|75794236|FG004|STARTED|Randomized Withdrawal (RW) Period||0|Met protocol-defined clinical response criteria and entered into RW Period.|
59675214|NCT03737110|75794237|FG005|STARTED|Randomized Withdrawal (RW) Period||0|Met protocol-defined clinical response criteria and entered into RW Period.|
59675215|NCT03737110|75794232|FG000|COMPLETED|Randomized Withdrawal (RW) Period||0|Completed, Continuing into LTE|
59675216|NCT03737110|75794233|FG001|COMPLETED|Randomized Withdrawal (RW) Period||29|Completed, Continuing into LTE|
59675217|NCT03737110|75794234|FG002|COMPLETED|Randomized Withdrawal (RW) Period||30|Completed, Continuing into LTE|
59675218|NCT03737110|75794235|FG003|COMPLETED|Randomized Withdrawal (RW) Period||0|Completed, Continuing into LTE|
59675219|NCT03737110|75794236|FG004|COMPLETED|Randomized Withdrawal (RW) Period||0|Completed, Continuing into LTE|
59675220|NCT03737110|75794237|FG005|COMPLETED|Randomized Withdrawal (RW) Period||0|Completed, Continuing into LTE|
59675221|NCT03737110|75794232|FG000|NOT COMPLETED|Randomized Withdrawal (RW) Period||0||
59675222|NCT03737110|75794233|FG001|NOT COMPLETED|Randomized Withdrawal (RW) Period||1||
59675223|NCT03737110|75794234|FG002|NOT COMPLETED|Randomized Withdrawal (RW) Period||1||
59675224|NCT03737110|75794235|FG003|NOT COMPLETED|Randomized Withdrawal (RW) Period||0||
59675225|NCT03737110|75794236|FG004|NOT COMPLETED|Randomized Withdrawal (RW) Period||0||
59675226|NCT03737110|75794237|FG005|NOT COMPLETED|Randomized Withdrawal (RW) Period||0||
59675227|NCT03737110|75794232|FG000|STARTED|Long-Term Extension (LTE) Period|Participants who entered the LTE directly from RI after protocol-specified 22 adjudicated pericarditis recurrence events had accrued.|0||
59675228|NCT03737110|75794233|FG001|STARTED|Long-Term Extension (LTE) Period|1 participant withdrew consent prior to entering LTE.|0||
59675229|NCT03737110|75794234|FG002|STARTED|Long-Term Extension (LTE) Period||0||
59675230|NCT03737110|75794235|FG003|STARTED|Long-Term Extension (LTE) Period||15||
59675231|NCT03737110|75794236|FG004|STARTED|Long-Term Extension (LTE) Period||25||
59675232|NCT03737110|75794237|FG005|STARTED|Long-Term Extension (LTE) Period||34||
59675233|NCT03737110|75794232|FG000|COMPLETED|Long-Term Extension (LTE) Period||0||
59675234|NCT03737110|75794233|FG001|COMPLETED|Long-Term Extension (LTE) Period||0||
59675235|NCT03737110|75794234|FG002|COMPLETED|Long-Term Extension (LTE) Period||0||
59675236|NCT03737110|75794235|FG003|COMPLETED|Long-Term Extension (LTE) Period||13||
59675237|NCT03737110|75794236|FG004|COMPLETED|Long-Term Extension (LTE) Period||24||
59675238|NCT03737110|75794237|FG005|COMPLETED|Long-Term Extension (LTE) Period||32||
59675239|NCT03737110|75794232|FG000|NOT COMPLETED|Long-Term Extension (LTE) Period||0||
59675240|NCT03737110|75794233|FG001|NOT COMPLETED|Long-Term Extension (LTE) Period||0||
59675241|NCT03737110|75794234|FG002|NOT COMPLETED|Long-Term Extension (LTE) Period||0||
59675242|NCT03737110|75794235|FG003|NOT COMPLETED|Long-Term Extension (LTE) Period||2||
59675243|NCT03737110|75794236|FG004|NOT COMPLETED|Long-Term Extension (LTE) Period||1||
59675244|NCT03737110|75794237|FG005|NOT COMPLETED|Long-Term Extension (LTE) Period||2||
59675245|NCT03723590|75794265|FG000|STARTED|Overall Study||5||
59675246|NCT03723590|75794265|FG000|COMPLETED|Overall Study|Study was stopped due to business decision. Baseline information, Subject packets and data were not collected for analysis. Numbers were given based on discussion with the sites. I can change all to zero if needed.|0||
59675247|NCT03723590|75794265|FG000|NOT COMPLETED|Overall Study||5||
59675248|NCT03592771|75794272|FG000|STARTED|Overall Study||104||
59675249|NCT03592771|75794273|FG001|STARTED|Overall Study||98||
59675250|NCT03592771|75794274|FG002|STARTED|Overall Study||102||
59675251|NCT03592771|75794272|FG000|COMPLETED|Overall Study||97||
59675252|NCT03592771|75794273|FG001|COMPLETED|Overall Study||84||
59675253|NCT03592771|75794274|FG002|COMPLETED|Overall Study||85||
59675254|NCT03592771|75794272|FG000|NOT COMPLETED|Overall Study||7||
59675255|NCT03592771|75794273|FG001|NOT COMPLETED|Overall Study||14||
59675256|NCT03592771|75794274|FG002|NOT COMPLETED|Overall Study||17||
59675257|NCT03495154|75794282|FG000|STARTED|Overall Study|There were 145 subjects screened and consented.|145||
59675258|NCT03495154|75794282|FG000|Full Analysis Set|Overall Study|Full Analysis Set (FAS) includes any enrolled subject who received study device. Results are based on Full Analysis Set subjects.|125||
59675259|NCT03495154|75794282|FG000|COMPLETED|Overall Study|Number of subjects that completed the study|104||
59675260|NCT03495154|75794282|FG000|NOT COMPLETED|Overall Study||41||
59675261|NCT03466918|75794286|FG000|STARTED|Overall Study||58||
59675262|NCT03466918|75794286|FG000|Analysis Population|Overall Study||50|8/58 patients were roll-in patients. Roll-in patients were not included in the analysis.|
59675263|NCT03466918|75794286|FG000|COMPLETED|Overall Study|All 58 patients completed the 30-day primary endpoint.|58||
59675264|NCT03466918|75794286|FG000|NOT COMPLETED|Overall Study||0||
59675265|NCT03421691|75794291|FG000|STARTED|Overall Study||16||
59675266|NCT03421691|75794291|FG000|COMPLETED|Overall Study||10||
59675267|NCT03421691|75794291|FG000|NOT COMPLETED|Overall Study||6||
59675268|NCT03390296|75794301|FG000|STARTED|Overall Study||4||
59675269|NCT03390296|75794302|FG001|STARTED|Overall Study||21||
59675270|NCT03390296|75794303|FG002|STARTED|Overall Study||7||
59675271|NCT03390296|75794304|FG003|STARTED|Overall Study||13||
59675272|NCT03390296|75794305|FG004|STARTED|Overall Study||0||
59675273|NCT03390296|75794306|FG005|STARTED|Overall Study||5||
59675274|NCT03390296|75794301|FG000|COMPLETED|Overall Study||4||
59675275|NCT03390296|75794302|FG001|COMPLETED|Overall Study||21||
59675276|NCT03390296|75794303|FG002|COMPLETED|Overall Study||7||
59675277|NCT03390296|75794304|FG003|COMPLETED|Overall Study||13||
59675278|NCT03390296|75794305|FG004|COMPLETED|Overall Study||0||
59675279|NCT03390296|75794306|FG005|COMPLETED|Overall Study||5||
59675280|NCT03390296|75794301|FG000|NOT COMPLETED|Overall Study||0||
59675281|NCT03390296|75794302|FG001|NOT COMPLETED|Overall Study||0||
59675282|NCT03390296|75794303|FG002|NOT COMPLETED|Overall Study||0||
59675283|NCT03390296|75794304|FG003|NOT COMPLETED|Overall Study||0||
59675284|NCT03390296|75794305|FG004|NOT COMPLETED|Overall Study||0||
59675285|NCT03390296|75794306|FG005|NOT COMPLETED|Overall Study||0||
59675286|NCT03334253|75794322|FG000|STARTED|Overall Study||125||
59675287|NCT03334253|75794323|FG001|STARTED|Overall Study||62||
59675288|NCT03334253|75794322|FG000|COMPLETED|Overall Study||118||
59675289|NCT03334253|75794323|FG001|COMPLETED|Overall Study||57||
59675290|NCT03334253|75794322|FG000|NOT COMPLETED|Overall Study||7||
59675291|NCT03334253|75794323|FG001|NOT COMPLETED|Overall Study||5||
59675292|NCT03314857|75794329|FG000|STARTED|Overall Study||67||
59675293|NCT03314857|75794329|FG000|Analysis Population|Overall Study||61|6/67 patients were roll-in patients. Roll-in patients were not included in the analysis.|
59675294|NCT03314857|75794329|FG000|COMPLETED|Overall Study|62/67 patients completed the 30-day primary endpoint visit.|62||
59675295|NCT03314857|75794329|FG000|NOT COMPLETED|Overall Study||5||
59675296|NCT03302156|75794335|FG000|STARTED|Overall Study||2||
59675297|NCT03302156|75794336|FG001|STARTED|Overall Study||13||
59675298|NCT03302156|75794337|FG002|STARTED|Overall Study||0||
59675299|NCT03302156|75794335|FG000|Analysis Population|Overall Study||2||
59675300|NCT03302156|75794336|FG001|Analysis Population|Overall Study||12||
59675301|NCT03302156|75794337|FG002|Analysis Population|Overall Study||0||
59675302|NCT03302156|75794335|FG000|Participants With Confirmed Ovarian Cancer With PSMA Uptake|Overall Study||0||
59675303|NCT03302156|75794336|FG001|Participants With Confirmed Ovarian Cancer With PSMA Uptake|Overall Study||1||
59675304|NCT03302156|75794337|FG002|Participants With Confirmed Ovarian Cancer With PSMA Uptake|Overall Study||0||
59675305|NCT03302156|75794335|FG000|COMPLETED|Overall Study||2||
59675306|NCT03302156|75794336|FG001|COMPLETED|Overall Study||12||
59675307|NCT03302156|75794337|FG002|COMPLETED|Overall Study||0||
59675308|NCT03302156|75794335|FG000|NOT COMPLETED|Overall Study||0||
59675309|NCT03302156|75794336|FG001|NOT COMPLETED|Overall Study||1||
59675310|NCT03302156|75794337|FG002|NOT COMPLETED|Overall Study||0||
59675311|NCT03235739|75794346|FG000|STARTED|Overall Study||69||
59675312|NCT03235739|75794347|FG001|STARTED|Overall Study||67||
59675313|NCT03235739|75794346|FG000|COMPLETED|Overall Study||67||
59675314|NCT03235739|75794347|FG001|COMPLETED|Overall Study||64||
59675315|NCT03235739|75794346|FG000|NOT COMPLETED|Overall Study||2||
59675316|NCT03235739|75794347|FG001|NOT COMPLETED|Overall Study||3||
59675317|NCT03176771|75794356|FG000|STARTED|Double-Blind Placebo-Controlled Period||85||
59675318|NCT03176771|75794357|FG001|STARTED|Double-Blind Placebo-Controlled Period||86||
59675319|NCT03176771|75794358|FG002|STARTED|Double-Blind Placebo-Controlled Period||85||
59675320|NCT03176771|75794359|FG003|STARTED|Double-Blind Placebo-Controlled Period||0||
59675321|NCT03176771|75794360|FG004|STARTED|Double-Blind Placebo-Controlled Period||0||
59675322|NCT03176771|75794356|FG000|COMPLETED|Double-Blind Placebo-Controlled Period||80||
59675323|NCT03176771|75794357|FG001|COMPLETED|Double-Blind Placebo-Controlled Period||71||
59675324|NCT03176771|75794358|FG002|COMPLETED|Double-Blind Placebo-Controlled Period||60||
59675325|NCT03176771|75794359|FG003|COMPLETED|Double-Blind Placebo-Controlled Period||0||
59675326|NCT03176771|75794360|FG004|COMPLETED|Double-Blind Placebo-Controlled Period||0||
59675327|NCT03176771|75794356|FG000|NOT COMPLETED|Double-Blind Placebo-Controlled Period||5||
59675328|NCT03176771|75794357|FG001|NOT COMPLETED|Double-Blind Placebo-Controlled Period||15||
59675329|NCT03176771|75794358|FG002|NOT COMPLETED|Double-Blind Placebo-Controlled Period||25||
59675330|NCT03176771|75794359|FG003|NOT COMPLETED|Double-Blind Placebo-Controlled Period||0||
59675331|NCT03176771|75794360|FG004|NOT COMPLETED|Double-Blind Placebo-Controlled Period||0||
59675332|NCT03176771|75794356|FG000|STARTED|Double-Blind Extension Period|Of the 80 placebo subjects who remained in the study at Week 6, 41 were re-randomized to MT-5199 40 mg (Double-Blind Extension Period) and 39 were re-randomized to MT-5199 80 mg (Double-Blind Extension Period).|0||
59675333|NCT03176771|75794357|FG001|STARTED|Double-Blind Extension Period|All MT-5199 40 mg 71 subjects who completed Double-Blind Placebo-Controlled Period entered to MT-5199 40 mg Double-Blind Extension Period.|0||
59675334|NCT03176771|75794358|FG002|STARTED|Double-Blind Extension Period|All MT-5199 80 mg 60 subjects who completed Double-Blind Placebo-Controlled Period entered to MT-5199 80 mg Double-Blind Extension Period.|0||
59675335|NCT03176771|75794359|FG003|STARTED|Double-Blind Extension Period|Of the 112 subject who entered the MT-5199 40 mg (Double-Blind Extension Period), 41 were previously in the placebo group and 71 were in the 40 mg group during the Double-Blind Placebo-Controlled Period.|112||
59675336|NCT03176771|75794360|FG004|STARTED|Double-Blind Extension Period|Of the 99 subjects who entered the MT-5199 80 mg (Double-Blind Extension Period), 39 were previously in the placebo group and 60 were in the 80 mg group during the Double-Blind Placebo-Controlled Period.|99||
59675337|NCT03176771|75794356|FG000|COMPLETED|Double-Blind Extension Period||0||
59675338|NCT03176771|75794357|FG001|COMPLETED|Double-Blind Extension Period||0||
59675339|NCT03176771|75794358|FG002|COMPLETED|Double-Blind Extension Period||0||
59675340|NCT03176771|75794359|FG003|COMPLETED|Double-Blind Extension Period||67||
59675341|NCT03176771|75794360|FG004|COMPLETED|Double-Blind Extension Period||50||
59675342|NCT03176771|75794356|FG000|NOT COMPLETED|Double-Blind Extension Period||0||
59675343|NCT03176771|75794357|FG001|NOT COMPLETED|Double-Blind Extension Period||0||
59675344|NCT03176771|75794358|FG002|NOT COMPLETED|Double-Blind Extension Period||0||
59675345|NCT03176771|75794359|FG003|NOT COMPLETED|Double-Blind Extension Period||45||
59675346|NCT03176771|75794360|FG004|NOT COMPLETED|Double-Blind Extension Period||49||
59675347|NCT02971956|75794370|FG000|STARTED|Overall Study||49||
59675348|NCT02971956|75794370|FG000|COMPLETED|Overall Study||49||
59675349|NCT02971956|75794370|FG000|NOT COMPLETED|Overall Study||0||
59675350|NCT02829918|75794374|FG000|STARTED|Overall Study||54||
59675351|NCT02829918|75794374|FG000|COMPLETED|Overall Study||46||
59675352|NCT02829918|75794374|FG000|NOT COMPLETED|Overall Study||8||
59675353|NCT02789020|75794380|FG000|STARTED|Overall Study||45||
59675354|NCT02789020|75794381|FG001|STARTED|Overall Study||45||
59675355|NCT02789020|75794380|FG000|COMPLETED|Overall Study||39||
59675356|NCT02789020|75794381|FG001|COMPLETED|Overall Study||40||
59675357|NCT02789020|75794380|FG000|NOT COMPLETED|Overall Study||6||
59675358|NCT02789020|75794381|FG001|NOT COMPLETED|Overall Study||5||
59675359|NCT02579161|75794389|FG000|STARTED|Overall Study||49||
59675360|NCT02579161|75794390|FG001|STARTED|Overall Study||49||
59675361|NCT02579161|75794389|FG000|COMPLETED|Overall Study||49||
59675362|NCT02579161|75794390|FG001|COMPLETED|Overall Study||49||
59675363|NCT02579161|75794389|FG000|NOT COMPLETED|Overall Study||0||
59675364|NCT02579161|75794390|FG001|NOT COMPLETED|Overall Study||0||
59675365|NCT02536170|75794399|FG000|STARTED|Overall Study||36||
59675366|NCT02536170|75794400|FG001|STARTED|Overall Study||36||
59675367|NCT02536170|75794401|FG002|STARTED|Overall Study||36||
60078001|NCT01479621|76193027|FG001|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0||
60078002|NCT01479621|76193028|FG002|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0||
60078003|NCT01479621|76193029|FG003|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0||
59675368|NCT02536170|75794399|FG000|COMPLETED|Overall Study||36||
59675369|NCT02536170|75794400|FG001|COMPLETED|Overall Study||36||
59675370|NCT02536170|75794401|FG002|COMPLETED|Overall Study||36||
59675371|NCT02536170|75794399|FG000|NOT COMPLETED|Overall Study||0||
59675372|NCT02536170|75794400|FG001|NOT COMPLETED|Overall Study||0||
59675373|NCT02536170|75794401|FG002|NOT COMPLETED|Overall Study||0||
60078004|NCT01479621|76193030|FG004|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0||
60078005|NCT01479621|76193031|FG005|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0||
59675374|NCT02431897|75794411|FG000|STARTED|Overall Study||102||
59675375|NCT02431897|75794412|FG001|STARTED|Overall Study||97||
59675376|NCT02431897|75794411|FG000|COMPLETED|Overall Study||93||
59675377|NCT02431897|75794412|FG001|COMPLETED|Overall Study||93||
59675378|NCT02431897|75794411|FG000|NOT COMPLETED|Overall Study||9||
59675379|NCT02431897|75794412|FG001|NOT COMPLETED|Overall Study||4||
59675380|NCT02427841|75794418|FG000|STARTED|Overall Study||19|20 participants enrolled who agreed to participate in the study following completion of the informed consent process. 19 started is the number of participants who were assigned to each Arm/Group. One subject withdrew prior to treatment resulting in a total of 19 subjects enrolled and started treatment.|
59675381|NCT02427841|75794418|FG000|COMPLETED|Overall Study||11||
59675382|NCT02427841|75794418|FG000|NOT COMPLETED|Overall Study||8||
59675383|NCT02348216|75794430|FG000|STARTED|Overall Study||8||
59675384|NCT02348216|75794431|FG001|STARTED|Overall Study||81||
59675385|NCT02348216|75794432|FG002|STARTED|Overall Study||30||
59675386|NCT02348216|75794433|FG003|STARTED|Overall Study||42||
59675387|NCT02348216|75794434|FG004|STARTED|Overall Study||46||
59675388|NCT02348216|75794435|FG005|STARTED|Overall Study||58||
59675389|NCT02348216|75794436|FG006|STARTED|Overall Study||42||
59675390|NCT02348216|75794430|FG000|COMPLETED|Overall Study||0||
59675391|NCT02348216|75794431|FG001|COMPLETED|Overall Study||0||
59675392|NCT02348216|75794432|FG002|COMPLETED|Overall Study||0||
59675393|NCT02348216|75794433|FG003|COMPLETED|Overall Study||0||
59675394|NCT02348216|75794434|FG004|COMPLETED|Overall Study||0||
59675395|NCT02348216|75794435|FG005|COMPLETED|Overall Study||0||
59675396|NCT02348216|75794436|FG006|COMPLETED|Overall Study||0||
59675397|NCT02348216|75794430|FG000|NOT COMPLETED|Overall Study||8||
59675398|NCT02348216|75794431|FG001|NOT COMPLETED|Overall Study||81||
59675399|NCT02348216|75794432|FG002|NOT COMPLETED|Overall Study||30||
59675400|NCT02348216|75794433|FG003|NOT COMPLETED|Overall Study||42||
59675401|NCT02348216|75794434|FG004|NOT COMPLETED|Overall Study||46||
59675402|NCT02348216|75794435|FG005|NOT COMPLETED|Overall Study||58||
59675403|NCT02348216|75794436|FG006|NOT COMPLETED|Overall Study||42||
59675404|NCT02037529|75794476|FG000|STARTED|Overall Study||101||
59675405|NCT02037529|75794477|FG001|STARTED|Overall Study||100||
59675406|NCT02037529|75794476|FG000|COMPLETED|Overall Study||100||
59675407|NCT02037529|75794477|FG001|COMPLETED|Overall Study||96||
59675408|NCT02037529|75794476|FG000|NOT COMPLETED|Overall Study||1||
59675409|NCT02037529|75794477|FG001|NOT COMPLETED|Overall Study||4||
59675410|NCT02030028|75794484|FG000|STARTED|Overall Study||18||
59675411|NCT02030028|75794484|FG000|COMPLETED|Overall Study||13||
59675412|NCT02030028|75794484|FG000|NOT COMPLETED|Overall Study||5||
59675413|NCT01956123|75794490|FG000|STARTED|COS Cycle 2||252||
59675414|NCT01956123|75794491|FG001|STARTED|COS Cycle 2||261||
59675415|NCT01956123|75794492|FG002|STARTED|COS Cycle 2||0||
59675416|NCT01956123|75794493|FG003|STARTED|COS Cycle 2||0||
59675417|NCT01956123|75794490|FG000|COMPLETED|COS Cycle 2||238||
59675418|NCT01956123|75794491|FG001|COMPLETED|COS Cycle 2||254||
59675419|NCT01956123|75794492|FG002|COMPLETED|COS Cycle 2||0||
59675420|NCT01956123|75794493|FG003|COMPLETED|COS Cycle 2||0||
59675421|NCT01956123|75794490|FG000|NOT COMPLETED|COS Cycle 2||14||
59675422|NCT01956123|75794491|FG001|NOT COMPLETED|COS Cycle 2||7||
59675423|NCT01956123|75794492|FG002|NOT COMPLETED|COS Cycle 2||0||
59675424|NCT01956123|75794493|FG003|NOT COMPLETED|COS Cycle 2||0||
59675425|NCT01956123|75794490|FG000|STARTED|COS Cycle 3||0||
59675426|NCT01956123|75794491|FG001|STARTED|COS Cycle 3||0||
59675427|NCT01956123|75794492|FG002|STARTED|COS Cycle 3|Participants in COS cycle 2 who failed to achieve an ongoing pregnancy could undergo COS cycle 3|95||
59675428|NCT01956123|75794493|FG003|STARTED|COS Cycle 3|Participants in COS cycle 2 who failed to achieve an ongoing pregnancy could undergo COS cycle 3|93||
59675429|NCT01956123|75794490|FG000|COMPLETED|COS Cycle 3||0||
59675430|NCT01956123|75794491|FG001|COMPLETED|COS Cycle 3||0||
59675431|NCT01956123|75794492|FG002|COMPLETED|COS Cycle 3||89||
59675432|NCT01956123|75794493|FG003|COMPLETED|COS Cycle 3||91||
59675433|NCT01956123|75794490|FG000|NOT COMPLETED|COS Cycle 3||0||
59675434|NCT01956123|75794491|FG001|NOT COMPLETED|COS Cycle 3||0||
59675435|NCT01956123|75794492|FG002|NOT COMPLETED|COS Cycle 3||6||
59675436|NCT01956123|75794493|FG003|NOT COMPLETED|COS Cycle 3||2||
59675437|NCT01452269|75794506|FG000|STARTED|Overall Study||48||
59675438|NCT01452269|75794507|FG001|STARTED|Overall Study||56||
59675439|NCT01452269|75794506|FG000|COMPLETED|Overall Study||47||
59675440|NCT01452269|75794507|FG001|COMPLETED|Overall Study||51||
59675441|NCT01452269|75794506|FG000|NOT COMPLETED|Overall Study||1||
59675442|NCT01452269|75794507|FG001|NOT COMPLETED|Overall Study||5||
59675443|NCT01191697|75794513|FG000|STARTED|Overall Study||37||
59675444|NCT01191697|75794513|FG000|Analyzed Popopulation|Overall Study|1 participant withdrew consent prior to starting threapy.|36||
59675445|NCT01191697|75794513|FG000|COMPLETED|Overall Study||0||
59675446|NCT01191697|75794513|FG000|NOT COMPLETED|Overall Study||37||
59675447|NCT01044745|75794517|FG000|STARTED|Overall Study||20||
59675448|NCT01044745|75794517|FG000|COMPLETED|Overall Study||18||
59675449|NCT01044745|75794517|FG000|NOT COMPLETED|Overall Study||2||
59675450|NCT01295827|75794534|FG000|STARTED|Overall Study||4||
59675451|NCT01295827|75794535|FG001|STARTED|Overall Study||3||
59675452|NCT01295827|75794536|FG002|STARTED|Overall Study||12||
59675453|NCT01295827|75794537|FG003|STARTED|Overall Study||4||
59675454|NCT01295827|75794538|FG004|STARTED|Overall Study||3||
59675455|NCT01295827|75794539|FG005|STARTED|Overall Study||6||
59675456|NCT01295827|75794540|FG006|STARTED|Overall Study||164||
59675457|NCT01295827|75794541|FG007|STARTED|Overall Study||321||
59675458|NCT01295827|75794542|FG008|STARTED|Overall Study||183||
59675459|NCT01295827|75794543|FG009|STARTED|Overall Study||61||
59675460|NCT01295827|75794544|FG010|STARTED|Overall Study||296||
59675461|NCT01295827|75794545|FG011|STARTED|Overall Study||203||
59675462|NCT01295827|75794546|FG012|STARTED|Overall Study||0||
59675463|NCT01295827|75794547|FG013|STARTED|Overall Study||0||
59675464|NCT01295827|75794548|FG014|STARTED|Overall Study||0||
59675465|NCT01295827|75794534|FG000|Treated (All Treated Population)|Overall Study||4||
59675466|NCT01295827|75794535|FG001|Treated (All Treated Population)|Overall Study||3||
59675467|NCT01295827|75794536|FG002|Treated (All Treated Population)|Overall Study||10||
59675468|NCT01295827|75794537|FG003|Treated (All Treated Population)|Overall Study||4||
59675469|NCT01295827|75794538|FG004|Treated (All Treated Population)|Overall Study||3||
59675470|NCT01295827|75794539|FG005|Treated (All Treated Population)|Overall Study||6||
59675471|NCT01295827|75794540|FG006|Treated (All Treated Population)|Overall Study||162||
59675472|NCT01295827|75794541|FG007|Treated (All Treated Population)|Overall Study||313||
59675473|NCT01295827|75794542|FG008|Treated (All Treated Population)|Overall Study||180||
59675474|NCT01295827|75794543|FG009|Treated (All Treated Population)|Overall Study||61||
59675475|NCT01295827|75794544|FG010|Treated (All Treated Population)|Overall Study||287||
59675476|NCT01295827|75794545|FG011|Treated (All Treated Population)|Overall Study||202||
59675477|NCT01295827|75794546|FG012|Treated (All Treated Population)|Overall Study||0||
59675478|NCT01295827|75794547|FG013|Treated (All Treated Population)|Overall Study||0||
59675479|NCT01295827|75794548|FG014|Treated (All Treated Population)|Overall Study||0||
59675480|NCT01295827|75794534|FG000|COMPLETED|Overall Study||0||
59675481|NCT01295827|75794535|FG001|COMPLETED|Overall Study||0||
59675482|NCT01295827|75794536|FG002|COMPLETED|Overall Study||0||
59675483|NCT01295827|75794537|FG003|COMPLETED|Overall Study||0||
59675484|NCT01295827|75794538|FG004|COMPLETED|Overall Study||1||
59675485|NCT01295827|75794539|FG005|COMPLETED|Overall Study||0||
59675486|NCT01295827|75794540|FG006|COMPLETED|Overall Study||18||
59675487|NCT01295827|75794541|FG007|COMPLETED|Overall Study||24||
59675488|NCT01295827|75794542|FG008|COMPLETED|Overall Study||14||
59675489|NCT01295827|75794543|FG009|COMPLETED|Overall Study||6||
59675490|NCT01295827|75794544|FG010|COMPLETED|Overall Study||20||
59675491|NCT01295827|75794545|FG011|COMPLETED|Overall Study||17||
59675492|NCT01295827|75794546|FG012|COMPLETED|Overall Study||0||
59675493|NCT01295827|75794547|FG013|COMPLETED|Overall Study||0||
59675494|NCT01295827|75794548|FG014|COMPLETED|Overall Study||0||
59675495|NCT01295827|75794534|FG000|NOT COMPLETED|Overall Study||4||
59675496|NCT01295827|75794535|FG001|NOT COMPLETED|Overall Study||3||
59675497|NCT01295827|75794536|FG002|NOT COMPLETED|Overall Study||12||
59675498|NCT01295827|75794537|FG003|NOT COMPLETED|Overall Study||4||
59675499|NCT01295827|75794538|FG004|NOT COMPLETED|Overall Study||2||
59675500|NCT01295827|75794539|FG005|NOT COMPLETED|Overall Study||6||
59675501|NCT01295827|75794540|FG006|NOT COMPLETED|Overall Study||146||
59675502|NCT01295827|75794541|FG007|NOT COMPLETED|Overall Study||297||
59675503|NCT01295827|75794542|FG008|NOT COMPLETED|Overall Study||169||
59675504|NCT01295827|75794543|FG009|NOT COMPLETED|Overall Study||55||
59675505|NCT01295827|75794544|FG010|NOT COMPLETED|Overall Study||276||
59675506|NCT01295827|75794545|FG011|NOT COMPLETED|Overall Study||186||
59675507|NCT01295827|75794546|FG012|NOT COMPLETED|Overall Study||0||
59675508|NCT01295827|75794547|FG013|NOT COMPLETED|Overall Study||0||
59675509|NCT01295827|75794548|FG014|NOT COMPLETED|Overall Study||0||
59675510|NCT01295671|75794604|FG000|STARTED|Overall Study||67||
59675511|NCT01295671|75794605|FG001|STARTED|Overall Study||67||
59675512|NCT01295671|75794606|FG002|STARTED|Overall Study||69||
59675513|NCT01295671|75794604|FG000|COMPLETED|Overall Study||60||
59675514|NCT01295671|75794605|FG001|COMPLETED|Overall Study||60||
59675515|NCT01295671|75794606|FG002|COMPLETED|Overall Study||66||
59675516|NCT01295671|75794604|FG000|NOT COMPLETED|Overall Study||7||
59675517|NCT01295671|75794605|FG001|NOT COMPLETED|Overall Study||7||
59675518|NCT01295671|75794606|FG002|NOT COMPLETED|Overall Study||3||
59675519|NCT01295320|75794614|FG000|STARTED|Overall Study||129||
59675520|NCT01295320|75794614|FG000|COMPLETED|Overall Study||119||
59675521|NCT01295320|75794614|FG000|NOT COMPLETED|Overall Study||10||
59675522|NCT01295281|75794620|FG000|STARTED|First Intervention (7 Days)||53||
59675523|NCT01295281|75794621|FG001|STARTED|First Intervention (7 Days)||52||
59675524|NCT01295281|75794620|FG000|COMPLETED|First Intervention (7 Days)||53||
59675525|NCT01295281|75794621|FG001|COMPLETED|First Intervention (7 Days)||51||
59675526|NCT01295281|75794620|FG000|NOT COMPLETED|First Intervention (7 Days)||0||
59675527|NCT01295281|75794621|FG001|NOT COMPLETED|First Intervention (7 Days)||1||
59675528|NCT01295281|75794620|FG000|STARTED|Second Intervention (7days)||53||
59675529|NCT01295281|75794621|FG001|STARTED|Second Intervention (7days)||51||
59675530|NCT01295281|75794620|FG000|COMPLETED|Second Intervention (7days)||53||
59675531|NCT01295281|75794621|FG001|COMPLETED|Second Intervention (7days)||51||
59675532|NCT01295281|75794620|FG000|NOT COMPLETED|Second Intervention (7days)||0||
59675533|NCT01295281|75794621|FG001|NOT COMPLETED|Second Intervention (7days)||0||
59675534|NCT01294696|75794629|FG000|STARTED|Overall Study||1261||
59675535|NCT01294696|75794629|FG000|COMPLETED|Overall Study||1187||
59675536|NCT01294696|75794629|FG000|NOT COMPLETED|Overall Study||74||
59675537|NCT01294579|75794634|FG000|STARTED|Overall Study||49||
59675538|NCT01294579|75794634|FG000|COMPLETED|Overall Study||14||
59675539|NCT01294579|75794634|FG000|NOT COMPLETED|Overall Study||35||
59675540|NCT01294462|75794640|FG000|STARTED|Overall Study||401||
59675541|NCT01294462|75794641|FG001|STARTED|Overall Study||400||
59675542|NCT01294462|75794640|FG000|Received Randomized Treatment|Overall Study||387||
59675543|NCT01294462|75794641|FG001|Received Randomized Treatment|Overall Study||380||
59675544|NCT01294462|75794640|FG000|COMPLETED|Overall Study||335||
59675545|NCT01294462|75794641|FG001|COMPLETED|Overall Study||337||
59675546|NCT01294462|75794640|FG000|NOT COMPLETED|Overall Study||66||
59675547|NCT01294462|75794641|FG001|NOT COMPLETED|Overall Study||63||
59675548|NCT01294423|75794650|FG000|STARTED|Overall Study||86||
59675549|NCT01294423|75794651|FG001|STARTED|Overall Study||88||
59675550|NCT01294423|75794652|FG002|STARTED|Overall Study||87||
59675551|NCT01294423|75794650|FG000|COMPLETED|Overall Study||81||
59675552|NCT01294423|75794651|FG001|COMPLETED|Overall Study||79||
59675553|NCT01294423|75794652|FG002|COMPLETED|Overall Study||79||
59675554|NCT01294423|75794650|FG000|NOT COMPLETED|Overall Study||5||
59675555|NCT01294423|75794651|FG001|NOT COMPLETED|Overall Study||9||
59675556|NCT01294423|75794652|FG002|NOT COMPLETED|Overall Study||8||
59675557|NCT01294150|75794662|FG000|STARTED|Overall Study||140||
59675558|NCT01294150|75794663|FG001|STARTED|Overall Study||66||
59675559|NCT01294150|75794662|FG000|COMPLETED|Overall Study||138||
59675560|NCT01294150|75794663|FG001|COMPLETED|Overall Study||64||
59675561|NCT01294150|75794662|FG000|NOT COMPLETED|Overall Study||2||
59675562|NCT01294150|75794663|FG001|NOT COMPLETED|Overall Study||2||
59675563|NCT01292473|75794675|FG000|STARTED|Overall Study||79||
59675564|NCT01292473|75794676|FG001|STARTED|Overall Study||82||
59675565|NCT01292473|75794677|FG002|STARTED|Overall Study||83||
59675566|NCT01292473|75794678|FG003|STARTED|Overall Study||79||
59675567|NCT01292473|75794675|FG000|COMPLETED|Overall Study||74||
59675568|NCT01292473|75794676|FG001|COMPLETED|Overall Study||75||
59675569|NCT01292473|75794677|FG002|COMPLETED|Overall Study||74||
59675570|NCT01292473|75794678|FG003|COMPLETED|Overall Study||67||
59675571|NCT01292473|75794675|FG000|NOT COMPLETED|Overall Study||5||
59675572|NCT01292473|75794676|FG001|NOT COMPLETED|Overall Study||7||
59675573|NCT01292473|75794677|FG002|NOT COMPLETED|Overall Study||9||
59675574|NCT01292473|75794678|FG003|NOT COMPLETED|Overall Study||12||
59675575|NCT01292239|75794694|FG000|STARTED|Overall Study||123||
59675576|NCT01292239|75794695|FG001|STARTED|Overall Study||60||
59675577|NCT01292239|75794694|FG000|COMPLETED|Overall Study||119||
59675578|NCT01292239|75794695|FG001|COMPLETED|Overall Study||53||
59675579|NCT01292239|75794694|FG000|NOT COMPLETED|Overall Study||4||
59675580|NCT01292239|75794695|FG001|NOT COMPLETED|Overall Study||7||
59675581|NCT01291225|75794703|FG000|STARTED|Overall Study||151||
59675582|NCT01291225|75794704|FG001|STARTED|Overall Study||160||
59675583|NCT01291225|75794703|FG000|COMPLETED|Overall Study||66||
59675584|NCT01291225|75794704|FG001|COMPLETED|Overall Study||121||
59675585|NCT01291225|75794703|FG000|NOT COMPLETED|Overall Study||85||
59675586|NCT01291225|75794704|FG001|NOT COMPLETED|Overall Study||39||
59675587|NCT01290796|75794714|FG000|STARTED|Overall Study||153||
59675588|NCT01290796|75794714|FG000|COMPLETED|Overall Study||123||
59675589|NCT01290796|75794714|FG000|NOT COMPLETED|Overall Study||30||
59675590|NCT01290757|75794720|FG000|STARTED|Overall Study||90||
59675591|NCT01290757|75794721|FG001|STARTED|Overall Study||90||
59675592|NCT01290757|75794720|FG000|COMPLETED|Overall Study||88||
59675593|NCT01290757|75794721|FG001|COMPLETED|Overall Study||88||
59675594|NCT01290757|75794720|FG000|NOT COMPLETED|Overall Study||2||
59675595|NCT01290757|75794721|FG001|NOT COMPLETED|Overall Study||2||
59675596|NCT01290718|75794727|FG000|STARTED|Overall Study||4||
59675597|NCT01290718|75794727|FG000|COMPLETED|Overall Study||0||
59675598|NCT01290718|75794727|FG000|NOT COMPLETED|Overall Study||4||
59675599|NCT01290679|75794733|FG000|STARTED|Overall Study|Not including 1 participant was randomized to this group, but never received treatment.|257||
59675600|NCT01290679|75794734|FG001|STARTED|Overall Study|Not including 1 participant was randomized to this group, but never received treatment.|134||
59675601|NCT01290679|75794733|FG000|COMPLETED|Overall Study||241||
59815915|NCT00999037|75938347|FG000|STARTED|Overall Study||9||
59989508|NCT00513617|76104824|FG001|STARTED|Overall Study||35||
59989509|NCT00513617|76104825|FG002|STARTED|Overall Study||38||
59675602|NCT01290679|75794734|FG001|COMPLETED|Overall Study||113||
59675603|NCT01290679|75794733|FG000|NOT COMPLETED|Overall Study||16||
59675604|NCT01290679|75794734|FG001|NOT COMPLETED|Overall Study||21||
59675605|NCT01290601|75794742|FG000|STARTED|Overall Study||46||
59675606|NCT01290601|75794743|FG001|STARTED|Overall Study||24||
59675607|NCT01290601|75794744|FG002|STARTED|Overall Study||0||
59675608|NCT01290601|75794745|FG003|STARTED|Overall Study||0||
59675609|NCT01290601|75794742|FG000|COMPLETED|Overall Study||35||
59675610|NCT01290601|75794743|FG001|COMPLETED|Overall Study||19||
59675611|NCT01290601|75794744|FG002|COMPLETED|Overall Study||0||
59675612|NCT01290601|75794745|FG003|COMPLETED|Overall Study||0||
59675613|NCT01290601|75794742|FG000|NOT COMPLETED|Overall Study||11||
59675614|NCT01290601|75794743|FG001|NOT COMPLETED|Overall Study||5||
59675615|NCT01290601|75794744|FG002|NOT COMPLETED|Overall Study||0||
59989510|NCT00513617|76104823|FG000|COMPLETED|Overall Study||25||
59675616|NCT01290601|75794745|FG003|NOT COMPLETED|Overall Study||0||
59675617|NCT01290523|75794751|FG000|STARTED|Overall Study||14||
59675618|NCT01290523|75794751|FG000|COMPLETED|Overall Study||11||
59675619|NCT01290523|75794751|FG000|NOT COMPLETED|Overall Study||3||
59675620|NCT01290094|75794755|FG000|STARTED|Overall Study||41||
59675621|NCT01290094|75794755|FG000|COMPLETED|Overall Study||35||
59675622|NCT01290094|75794755|FG000|NOT COMPLETED|Overall Study||6||
59546297|NCT02453256|75644947|FG001|COMPLETED|Open Label Period||85||
59546298|NCT02453256|75644946|FG000|NOT COMPLETED|Open Label Period||7||
59546299|NCT02453256|75644947|FG001|NOT COMPLETED|Open Label Period||7||
59546300|NCT02442804|75644962|FG000|STARTED|Overall Study||8||
59546301|NCT02442804|75644963|FG001|STARTED|Overall Study||8||
59546302|NCT02442804|75644962|FG000|COMPLETED|Overall Study||7||
59675623|NCT04688346|75794761|FG000|STARTED|Overall Study||6||6
59675624|NCT04688346|75794762|FG001|STARTED|Overall Study||7||7
59675625|NCT04688346|75794761|FG000|First Intervention|Overall Study||6||6
59675626|NCT04688346|75794762|FG001|First Intervention|Overall Study||7||7
59675627|NCT04688346|75794761|FG000|Second Intervention|Overall Study||6||6
59675628|NCT04688346|75794762|FG001|Second Intervention|Overall Study||7||7
59675629|NCT04688346|75794761|FG000|COMPLETED|Overall Study||6||6
59675630|NCT04688346|75794762|FG001|COMPLETED|Overall Study||7||7
59675631|NCT04688346|75794761|FG000|NOT COMPLETED|Overall Study||0||0
59675632|NCT04688346|75794762|FG001|NOT COMPLETED|Overall Study||0||0
59675633|NCT01289821|75794768|FG000|STARTED|Treatment Period||54||
59675634|NCT01289821|75794768|FG000|Participants Received Regorafenib|Treatment Period||54||
59675635|NCT01289821|75794768|FG000|COMPLETED|Treatment Period||0||
59675636|NCT01289821|75794768|FG000|NOT COMPLETED|Treatment Period||54||
59675637|NCT01289821|75794768|FG000|STARTED|Safety Follow-up Period||54||
59675638|NCT01289821|75794768|FG000|COMPLETED|Safety Follow-up Period||49||
59675639|NCT01289821|75794768|FG000|NOT COMPLETED|Safety Follow-up Period||5||
59675640|NCT01289821|75794768|FG000|STARTED|Survival Follow-up Period||52||
59675641|NCT01289821|75794768|FG000|COMPLETED|Survival Follow-up Period|34 participants died and completed survival follow-up period.|34||
59675642|NCT01289821|75794768|FG000|NOT COMPLETED|Survival Follow-up Period||18||
59675643|NCT01289782|75794774|FG000|STARTED|Overall Study||264||
59675644|NCT01289782|75794775|FG001|STARTED|Overall Study|Not including 1 participant was randomized to this group, but never received treatment.|130||
59675645|NCT01289782|75794774|FG000|COMPLETED|Overall Study||239||
59675646|NCT01289782|75794775|FG001|COMPLETED|Overall Study||118||
59675647|NCT01289782|75794774|FG000|NOT COMPLETED|Overall Study||25||
59675648|NCT01289782|75794775|FG001|NOT COMPLETED|Overall Study||12||
59675649|NCT01289353|75794781|FG000|STARTED|Overall Study||92||
59675650|NCT01289353|75794781|FG000|COMPLETED|Overall Study||90||
59675651|NCT01289353|75794781|FG000|NOT COMPLETED|Overall Study||2||
59675652|NCT01289119|75794791|FG000|STARTED|Overall Study||93||
59675653|NCT01289119|75794792|FG001|STARTED|Overall Study||92||
59675654|NCT01289119|75794793|FG002|STARTED|Overall Study||98||
59675655|NCT01289119|75794794|FG003|STARTED|Overall Study||99||
59675656|NCT01289119|75794795|FG004|STARTED|Overall Study||63||
59675657|NCT01289119|75794796|FG005|STARTED|Overall Study||61||
59675658|NCT01289119|75794791|FG000|Treated|Overall Study|Patients who took at least one dose of double-blind study drug.|92||
59675659|NCT01289119|75794792|FG001|Treated|Overall Study||92||
59675660|NCT01289119|75794793|FG002|Treated|Overall Study||98||
59675661|NCT01289119|75794794|FG003|Treated|Overall Study||99||
59675662|NCT01289119|75794795|FG004|Treated|Overall Study||63||
59675663|NCT01289119|75794796|FG005|Treated|Overall Study||61||
59675664|NCT01289119|75794791|FG000|COMPLETED|Overall Study||84||
59675665|NCT01289119|75794792|FG001|COMPLETED|Overall Study||83||
59675666|NCT01289119|75794793|FG002|COMPLETED|Overall Study||89||
59675667|NCT01289119|75794794|FG003|COMPLETED|Overall Study||93||
59675668|NCT01289119|75794795|FG004|COMPLETED|Overall Study||58||
59675669|NCT01289119|75794796|FG005|COMPLETED|Overall Study||57||
59675670|NCT01289119|75794791|FG000|NOT COMPLETED|Overall Study||9||
59675671|NCT01289119|75794792|FG001|NOT COMPLETED|Overall Study||9||
59675672|NCT01289119|75794793|FG002|NOT COMPLETED|Overall Study||9||
59675673|NCT01289119|75794794|FG003|NOT COMPLETED|Overall Study||6||
59675674|NCT01289119|75794795|FG004|NOT COMPLETED|Overall Study||5||
59675675|NCT01289119|75794796|FG005|NOT COMPLETED|Overall Study||4||
59675676|NCT01289041|75794810|FG000|STARTED|Overall Study||70||
59675677|NCT01289041|75794810|FG000|COMPLETED|Overall Study||0||
59675678|NCT01289041|75794810|FG000|NOT COMPLETED|Overall Study||70||
59675679|NCT01288729|75794818|FG000|STARTED|Overall Study||10||
59546303|NCT02442804|75644963|FG001|COMPLETED|Overall Study||7||
59546304|NCT02442804|75644962|FG000|NOT COMPLETED|Overall Study||1||
59546305|NCT02442804|75644963|FG001|NOT COMPLETED|Overall Study||1||
59546306|NCT01076972|75644969|FG000|STARTED|Overall Study||1184||
59675680|NCT01288729|75794819|FG001|STARTED|Overall Study||10||
59675681|NCT01288729|75794818|FG000|COMPLETED|Overall Study||9||
59675682|NCT01288729|75794819|FG001|COMPLETED|Overall Study||10||
59675683|NCT01288729|75794818|FG000|NOT COMPLETED|Overall Study||1||
59546307|NCT01076972|75644969|FG000|COMPLETED|Overall Study||1184||
59546308|NCT01076972|75644969|FG000|NOT COMPLETED|Overall Study||0||
59675684|NCT01288729|75794819|FG001|NOT COMPLETED|Overall Study||0||
59546309|NCT02174198|75644985|FG000|STARTED|Overall Study||16||
59675685|NCT01288612|75794828|FG000|STARTED|Overall Study||150||
59675686|NCT01288612|75794829|FG001|STARTED|Overall Study||151||
59675687|NCT01288612|75794830|FG002|STARTED|Overall Study||158||
59675688|NCT01288612|75794828|FG000|Contacted|Overall Study||139||
59675689|NCT01288612|75794829|FG001|Contacted|Overall Study||135||
59675690|NCT01288612|75794830|FG002|Contacted|Overall Study||138||
59675691|NCT01288612|75794828|FG000|Agreed to Take Part|Overall Study||61||
59675692|NCT01288612|75794829|FG001|Agreed to Take Part|Overall Study||72||
59675693|NCT01288612|75794830|FG002|Agreed to Take Part|Overall Study||76||
59675694|NCT01288612|75794828|FG000|COMPLETED|Overall Study||61||
59675695|NCT01288612|75794829|FG001|COMPLETED|Overall Study||69||
59675696|NCT01288612|75794830|FG002|COMPLETED|Overall Study||76||
59675697|NCT01288612|75794828|FG000|NOT COMPLETED|Overall Study||89||
59675698|NCT01288612|75794829|FG001|NOT COMPLETED|Overall Study||82||
59675699|NCT01288612|75794830|FG002|NOT COMPLETED|Overall Study||82||
59675700|NCT01287832|75794840|FG000|STARTED|Overall Study||6||
59675701|NCT01287832|75794841|FG001|STARTED|Overall Study||5||
59675702|NCT01287832|75794840|FG000|COMPLETED|Overall Study||5||
59675703|NCT01287832|75794841|FG001|COMPLETED|Overall Study||4||
59675704|NCT01287832|75794840|FG000|NOT COMPLETED|Overall Study||1||
59675705|NCT01287832|75794841|FG001|NOT COMPLETED|Overall Study||1||
59675706|NCT01287754|75794849|FG000|STARTED|Overall Study||3||
59675707|NCT01287754|75794850|FG001|STARTED|Overall Study||21||
59675708|NCT01287754|75794849|FG000|COMPLETED|Overall Study||0||
59675709|NCT01287754|75794850|FG001|COMPLETED|Overall Study||0||
59675710|NCT01287754|75794849|FG000|NOT COMPLETED|Overall Study||3||
59675711|NCT01287754|75794850|FG001|NOT COMPLETED|Overall Study||21||
59675712|NCT01287520|75794865|FG000|STARTED|Overall Study||3||
59675713|NCT01287520|75794866|FG001|STARTED|Overall Study|One participant who received study drug but did not complete Cycle 1 was replaced.|7||
59675714|NCT01287520|75794867|FG002|STARTED|Overall Study||5||
59675715|NCT01287520|75794868|FG003|STARTED|Overall Study|One participant who received study drug but did not complete Cycle 1 was replaced.|7||
59675716|NCT01287520|75794869|FG004|STARTED|Overall Study||3||
59675717|NCT01287520|75794870|FG005|STARTED|Overall Study||4||
59675718|NCT01287520|75794871|FG006|STARTED|Overall Study||2||
59675719|NCT01287520|75794872|FG007|STARTED|Overall Study||5||
59675720|NCT01287520|75794873|FG008|STARTED|Overall Study||5||
59675721|NCT01287520|75794865|FG000|COMPLETED|Overall Study||0||
59675722|NCT01287520|75794866|FG001|COMPLETED|Overall Study||0||
59675723|NCT01287520|75794867|FG002|COMPLETED|Overall Study||0||
59675724|NCT01287520|75794868|FG003|COMPLETED|Overall Study||0||
59675725|NCT01287520|75794869|FG004|COMPLETED|Overall Study||0||
59675726|NCT01287520|75794870|FG005|COMPLETED|Overall Study||0||
59675727|NCT01287520|75794871|FG006|COMPLETED|Overall Study||0||
59675728|NCT01287520|75794872|FG007|COMPLETED|Overall Study||0||
59675729|NCT01287520|75794873|FG008|COMPLETED|Overall Study||0||
59675730|NCT01287520|75794865|FG000|NOT COMPLETED|Overall Study||3||
59675731|NCT01287520|75794866|FG001|NOT COMPLETED|Overall Study||7||
59675732|NCT01287520|75794867|FG002|NOT COMPLETED|Overall Study||5||
59675733|NCT01287520|75794868|FG003|NOT COMPLETED|Overall Study||7||
59675734|NCT01287520|75794869|FG004|NOT COMPLETED|Overall Study||3||
59675735|NCT01287520|75794870|FG005|NOT COMPLETED|Overall Study||4||
59675736|NCT01287520|75794871|FG006|NOT COMPLETED|Overall Study||2||
59675737|NCT01287520|75794872|FG007|NOT COMPLETED|Overall Study||5||
59675738|NCT01287520|75794873|FG008|NOT COMPLETED|Overall Study||5||
59675739|NCT01287403|75794922|FG000|STARTED|Diet Restriction (7 Days)||14||
59675740|NCT01287403|75794922|FG000|COMPLETED|Diet Restriction (7 Days)||14||
59675741|NCT01287403|75794922|FG000|NOT COMPLETED|Diet Restriction (7 Days)||0||
59675742|NCT01287403|75794922|FG000|STARTED|1st Intervention (1 Day)||14||
59675743|NCT01287403|75794922|FG000|COMPLETED|1st Intervention (1 Day)|"The adverse event was linked to the intake of refined wheat flour"|13||
59675744|NCT01287403|75794922|FG000|NOT COMPLETED|1st Intervention (1 Day)||1||
59675745|NCT01287403|75794922|FG000|STARTED|Washout 7 Days||13||
59675746|NCT01287403|75794922|FG000|COMPLETED|Washout 7 Days||13||
59675747|NCT01287403|75794922|FG000|NOT COMPLETED|Washout 7 Days||0||
59675748|NCT01287403|75794922|FG000|STARTED|2nd Intervention (1 Day)||13||
59675749|NCT01287403|75794922|FG000|COMPLETED|2nd Intervention (1 Day)||13||
59675750|NCT01287403|75794922|FG000|NOT COMPLETED|2nd Intervention (1 Day)||0||
59675751|NCT01287403|75794922|FG000|STARTED|Washout (7 Days)||13||
59675752|NCT01287403|75794922|FG000|COMPLETED|Washout (7 Days)||13||
59675753|NCT01287403|75794922|FG000|NOT COMPLETED|Washout (7 Days)||0||
59675754|NCT01287403|75794922|FG000|STARTED|3rd Intervention (1 Day)||13||
59675755|NCT01287403|75794922|FG000|COMPLETED|3rd Intervention (1 Day)||13||
59675756|NCT01287403|75794922|FG000|NOT COMPLETED|3rd Intervention (1 Day)||0||
59675757|NCT01287403|75794922|FG000|STARTED|Washout (7 Days)||13||
59675758|NCT01287403|75794922|FG000|COMPLETED|Washout (7 Days)||13||
59675759|NCT01287403|75794922|FG000|NOT COMPLETED|Washout (7 Days)||0||
59675760|NCT01287403|75794922|FG000|STARTED|4th Intervention (1 Day)||13||
59675761|NCT01287403|75794922|FG000|COMPLETED|4th Intervention (1 Day)||13||
59815916|NCT00999037|75938348|FG001|STARTED|Overall Study||9||
59675762|NCT01287403|75794922|FG000|NOT COMPLETED|4th Intervention (1 Day)||0||
59675763|NCT01287403|75794922|FG000|STARTED|Washout (7 Days)||13||
59675764|NCT01287403|75794922|FG000|COMPLETED|Washout (7 Days)||13||
59675765|NCT01287403|75794922|FG000|NOT COMPLETED|Washout (7 Days)||0||
59675766|NCT01287403|75794922|FG000|STARTED|5th Intervention (1 Day)||13||
59675767|NCT01287403|75794922|FG000|COMPLETED|5th Intervention (1 Day)||13||
59675768|NCT01287403|75794922|FG000|NOT COMPLETED|5th Intervention (1 Day)||0||
59675769|NCT01287403|75794922|FG000|STARTED|Washout (7 Days)||13||
59675770|NCT01287403|75794922|FG000|COMPLETED|Washout (7 Days)||13||
59675771|NCT01287403|75794922|FG000|NOT COMPLETED|Washout (7 Days)||0||
59675772|NCT01287403|75794922|FG000|STARTED|6th and Last Intervention (1 Day)||13||
59675773|NCT01287403|75794922|FG000|COMPLETED|6th and Last Intervention (1 Day)||13||
59675774|NCT01287403|75794922|FG000|NOT COMPLETED|6th and Last Intervention (1 Day)||0||
59675775|NCT01287364|75794938|FG000|STARTED|Overall Study||94||
59675776|NCT01287364|75794939|FG001|STARTED|Overall Study||91||
59675777|NCT01287364|75794938|FG000|COMPLETED|Overall Study||85||
59675778|NCT01287364|75794939|FG001|COMPLETED|Overall Study||81||
59675779|NCT01287364|75794938|FG000|NOT COMPLETED|Overall Study||9||
59675780|NCT01287364|75794939|FG001|NOT COMPLETED|Overall Study||10||
59675781|NCT02889835|75794958|FG000|STARTED|Overall Study||53|A total of 53 patients were enrolled. Each patient received in different teeth, one restoration of each intervention except for 3 patients who received two restorations of each intervention for a total of 56 teeth per intervention.|56
59675782|NCT02889835|75794959|FG001|STARTED|Overall Study||53|A total of 53 patients were enrolled. Each patient received in different teeth, one restoration of each intervention except for 3 patients who received two restorations of each intervention for a total of 56 teeth per intervention.|56
59675783|NCT02889835|75794960|FG002|STARTED|Overall Study||53|A total of 53 patients were enrolled. Each patient received in different teeth, one restoration of each intervention except for 3 patients who received two restorations of each intervention for a total of 56 teeth per intervention.|56
59675784|NCT02889835|75794958|FG000|COMPLETED|Overall Study||35||37
59675785|NCT02889835|75794959|FG001|COMPLETED|Overall Study||35||37
59675786|NCT02889835|75794960|FG002|COMPLETED|Overall Study||35||37
59675787|NCT02889835|75794958|FG000|NOT COMPLETED|Overall Study||18||19
59675788|NCT02889835|75794959|FG001|NOT COMPLETED|Overall Study||18||19
59675789|NCT02889835|75794960|FG002|NOT COMPLETED|Overall Study||18||19
59675790|NCT01287013|75794971|FG000|STARTED|Overall Study||32||
59675791|NCT01287013|75794972|FG001|STARTED|Overall Study||34||
59675792|NCT01287013|75794973|FG002|STARTED|Overall Study||21||
59675793|NCT01287013|75794971|FG000|COMPLETED|Overall Study||29||
59675794|NCT01287013|75794972|FG001|COMPLETED|Overall Study||29||
59675795|NCT01287013|75794973|FG002|COMPLETED|Overall Study||0||
59675796|NCT01287013|75794971|FG000|NOT COMPLETED|Overall Study||3||
59675797|NCT01287013|75794972|FG001|NOT COMPLETED|Overall Study||5||
59675798|NCT01287013|75794973|FG002|NOT COMPLETED|Overall Study||21||
59675799|NCT01286779|75794981|FG000|STARTED|Overall Study||115||
59675800|NCT01286779|75794981|FG000|COMPLETED|Overall Study||96||
59675801|NCT01286779|75794981|FG000|NOT COMPLETED|Overall Study||19||
59675802|NCT01286740|75794995|FG000|STARTED|Overall Study||50||
59675803|NCT01286740|75794995|FG000|Enrolled and Treated|Overall Study||49||
59675804|NCT01286740|75794995|FG000|Week 12 (Primary Endpoint)|Overall Study||49||
59675805|NCT01286740|75794995|FG000|COMPLETED|Overall Study||48||
59675806|NCT01286740|75794995|FG000|NOT COMPLETED|Overall Study||2||
59675807|NCT01286311|75795001|FG000|STARTED|Overall Study|218 patients (of the 14 physician randomized to the intervention) started the study.|232||
59675808|NCT01286311|75795002|FG001|STARTED|Overall Study|217 patients (of the 15 physician randomized to the intervention) started the study.|232||
59675809|NCT01286311|75795001|FG000|COMPLETED|Overall Study|204 patients (of the 14 physician randomized to the intervention) completed the study.|218||
59675810|NCT01286311|75795002|FG001|COMPLETED|Overall Study|217 patients (of the 15 physician randomized to the intervention) completed the study.|232||
59675811|NCT01286311|75795001|FG000|NOT COMPLETED|Overall Study||14||
59675812|NCT01286311|75795002|FG001|NOT COMPLETED|Overall Study||0||
59675813|NCT01286077|75795010|FG000|STARTED|Overall Study|One patient did not start treatment and was excluded from the Intent to Treat (ITT) population.|51||
59675814|NCT01286077|75795011|FG001|STARTED|Overall Study|One patient did not have any post-baseline assessment and was excluded from the ITT population.|53||
59675815|NCT01286077|75795010|FG000|COMPLETED|Overall Study||41||
59675816|NCT01286077|75795011|FG001|COMPLETED|Overall Study||46||
59675817|NCT01286077|75795010|FG000|NOT COMPLETED|Overall Study||10||
59675818|NCT01286077|75795011|FG001|NOT COMPLETED|Overall Study||7||
59675819|NCT01285960|75795017|FG000|STARTED|Overall Study|2 subjects receiving fewer than 10 sonications were added to the 106 for safety population of 108|108||
59675820|NCT01285960|75795017|FG000|COMPLETED|Overall Study|An additional 2 subjects receiving fewer than 10 sonications were included in the safety population|102||
59675821|NCT01285960|75795017|FG000|NOT COMPLETED|Overall Study||6||
59675822|NCT02665143|75795021|FG000|STARTED|Phase 1||6||
59675823|NCT02665143|75795021|FG000|COMPLETED|Phase 1||6||
59675824|NCT02665143|75795021|FG000|NOT COMPLETED|Phase 1||0||
59675825|NCT02665143|75795021|FG000|STARTED|Phase 2|19 Participants were enrolled in Phase 2.|19||
59675826|NCT02665143|75795021|FG000|Completed 0 Cycles|Phase 2||1||
59675827|NCT02665143|75795021|FG000|Completed 1 Cycle|Phase 2||12||
59675828|NCT02665143|75795021|FG000|Completed 2 Cycles|Phase 2||3||
59675829|NCT02665143|75795021|FG000|Completed 3 Cycles|Phase 2||3||
59675830|NCT02665143|75795021|FG000|COMPLETED|Phase 2||19||
59675831|NCT02665143|75795021|FG000|NOT COMPLETED|Phase 2||0||
59675832|NCT01285609|75795028|FG000|STARTED|Randomized|Represents participants randomized to this arm prior to 1st dose of chemotherapy treatment|479|Started = Randomized|
59675833|NCT01285609|75795029|FG001|STARTED|Randomized|Represents participants randomized to this arm prior to 1st dose of chemotherapy treatment|477|Started = Randomized|
59675834|NCT01285609|75795028|FG000|Treated With Chemotherapy (1st Dose)|Randomized||475||
59675835|NCT01285609|75795029|FG001|Treated With Chemotherapy (1st Dose)|Randomized||473||
59675836|NCT01285609|75795028|FG000|COMPLETED|Randomized||388|Completed = Continued to Blinded Therapy|
59675837|NCT01285609|75795029|FG001|COMPLETED|Randomized||361|Completed = Continued to Blinded Therapy|
59675838|NCT01285609|75795028|FG000|NOT COMPLETED|Randomized||91||
59675839|NCT01285609|75795029|FG001|NOT COMPLETED|Randomized||116||
59675840|NCT01285609|75795028|FG000|STARTED|Treated With Blinded Therapy||388|Started = Received at least one dose of Blinded Therapy|
59675841|NCT01285609|75795029|FG001|STARTED|Treated With Blinded Therapy||361|Started = Received at least one dose of Blinded Therapy|
59675842|NCT01285609|75795028|FG000|COMPLETED|Treated With Blinded Therapy||1|Completed = Completed the Blinded Therapy treatment phase|
59675843|NCT01285609|75795029|FG001|COMPLETED|Treated With Blinded Therapy||2|Completed = Completed the Blinded Therapy treatment phase|
59675844|NCT01285609|75795028|FG000|NOT COMPLETED|Treated With Blinded Therapy||387||
59675845|NCT01285609|75795029|FG001|NOT COMPLETED|Treated With Blinded Therapy||359||
59675846|NCT01285492|75795039|FG000|STARTED|Overall Study|All patients randomized to this group|121||
59675847|NCT01285492|75795040|FG001|STARTED|Overall Study|All patients randomized to this group|39||
59675848|NCT01285492|75795039|FG000|Safety Set (for Demographics)|Overall Study|All patients who took study drug; 2 patients did not|119||
59675849|NCT01285492|75795040|FG001|Safety Set (for Demographics)|Overall Study|All patients who took study drug|39||
59675850|NCT01285492|75795039|FG000|COMPLETED|Overall Study||104||
59675851|NCT01285492|75795040|FG001|COMPLETED|Overall Study||38||
59675852|NCT01285492|75795039|FG000|NOT COMPLETED|Overall Study||17||
59675853|NCT01285492|75795040|FG001|NOT COMPLETED|Overall Study||1||
59675854|NCT01284634|75795050|FG000|STARTED|Overall Study||7||
59675855|NCT01284634|75795051|FG001|STARTED|Overall Study||6||
59675856|NCT01284634|75795052|FG002|STARTED|Overall Study||7||
59675857|NCT01284634|75795053|FG003|STARTED|Overall Study||5||
59675858|NCT01284634|75795050|FG000|Received at Least 1 Dose of Study Drug|Overall Study||7|Safety analysis set; analyzed as per actual treatment received.|
59675859|NCT01284634|75795051|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6|Safety analysis set; analyzed as per actual treatment received.|
59675860|NCT01284634|75795052|FG002|Received at Least 1 Dose of Study Drug|Overall Study||7|Safety analysis set; analyzed as per actual treatment received.|
59675861|NCT01284634|75795053|FG003|Received at Least 1 Dose of Study Drug|Overall Study||5|Safety analysis set; analyzed as per actual treatment received.|
59675862|NCT01284634|75795050|FG000|Intent to Treat (ITT) Analysis Set|Overall Study||7|Randomized and received at least one dose of study medication and had on-treatment efficacy data.|
59675863|NCT01284634|75795051|FG001|Intent to Treat (ITT) Analysis Set|Overall Study||6|Randomized and received at least one dose of study medication and had on-treatment efficacy data.|
59675864|NCT01284634|75795052|FG002|Intent to Treat (ITT) Analysis Set|Overall Study||7|Randomized and received at least one dose of study medication and had on-treatment efficacy data.|
59675865|NCT01284634|75795053|FG003|Intent to Treat (ITT) Analysis Set|Overall Study||5|Randomized and received at least one dose of study medication and had on-treatment efficacy data.|
59675866|NCT01284634|75795050|FG000|COMPLETED|Overall Study||6||
59675867|NCT01284634|75795051|FG001|COMPLETED|Overall Study||6||
59675868|NCT01284634|75795052|FG002|COMPLETED|Overall Study||5||
59675869|NCT01284634|75795053|FG003|COMPLETED|Overall Study||4||
59675870|NCT01284634|75795050|FG000|NOT COMPLETED|Overall Study||1||
59675871|NCT01284634|75795051|FG001|NOT COMPLETED|Overall Study||0||
59675872|NCT01284634|75795052|FG002|NOT COMPLETED|Overall Study||2||
59675873|NCT01284634|75795053|FG003|NOT COMPLETED|Overall Study||1||
59675874|NCT01284361|75795063|FG000|STARTED|Overall Study||91||
59675875|NCT01284361|75795063|FG000|COMPLETED|Overall Study||82||
59675876|NCT01284361|75795063|FG000|NOT COMPLETED|Overall Study||9||
59675877|NCT01284127|75795070|FG000|STARTED|Overall Study||38||
59675878|NCT01284127|75795070|FG000|COMPLETED|Overall Study||31||
59675879|NCT01284127|75795070|FG000|NOT COMPLETED|Overall Study||7||
59675880|NCT01283971|75795076|FG000|STARTED|Overall Study||48||
59675881|NCT01283971|75795077|FG001|STARTED|Overall Study||48||
59675882|NCT01283971|75795076|FG000|Intent to Treat Population|Overall Study||46||
59675883|NCT01283971|75795077|FG001|Intent to Treat Population|Overall Study||48||
59675884|NCT01283971|75795076|FG000|COMPLETED|Overall Study||33||
59675885|NCT01283971|75795077|FG001|COMPLETED|Overall Study||36||
59675886|NCT01283971|75795076|FG000|NOT COMPLETED|Overall Study||15||
59675887|NCT01283971|75795077|FG001|NOT COMPLETED|Overall Study||12||
59675888|NCT01283581|75795086|FG000|STARTED|Overall Study||81||
59675889|NCT01283581|75795087|FG001|STARTED|Overall Study||77||
59675890|NCT01283581|75795088|FG002|STARTED|Overall Study||98||
59675891|NCT01283581|75795086|FG000|COMPLETED|Overall Study||69||
59675892|NCT01283581|75795087|FG001|COMPLETED|Overall Study||63||
59675893|NCT01283581|75795088|FG002|COMPLETED|Overall Study||78||
59675894|NCT01283581|75795086|FG000|NOT COMPLETED|Overall Study||12||
59675895|NCT01283581|75795087|FG001|NOT COMPLETED|Overall Study||14||
59675896|NCT01283581|75795088|FG002|NOT COMPLETED|Overall Study||20||
59675897|NCT01283542|75795099|FG000|STARTED|Main Phase||20||
59989511|NCT00513617|76104824|FG001|COMPLETED|Overall Study||25||
59989512|NCT00513617|76104825|FG002|COMPLETED|Overall Study||30||
59989513|NCT00513617|76104823|FG000|NOT COMPLETED|Overall Study||11||
59675898|NCT01283542|75795099|FG000|Full Analysis Set (FAS)|Main Phase||20|received at least 1 dose of study medication|
59675899|NCT01283542|75795099|FG000|Safety Analysis Set|Main Phase||20|rec'd at least 1 dose of drug + 1 at least one post-BL safety assessment|
59675900|NCT01283542|75795099|FG000|COMPLETED|Main Phase||13||
59675901|NCT01283542|75795099|FG000|NOT COMPLETED|Main Phase||7||
59675902|NCT01283542|75795099|FG000|STARTED|Extension Phase||13||
59675903|NCT01283542|75795099|FG000|Full Analysis Set (FAS)|Extension Phase||13|received at least 1 dose of study drug|
59675904|NCT01283542|75795099|FG000|Safety Analysis Set|Extension Phase||13|rec'd at least 1 dose of drug + 1 at least one post-BL safety assessment|
59675905|NCT01283542|75795099|FG000|COMPLETED|Extension Phase||10||
59675906|NCT01283542|75795099|FG000|NOT COMPLETED|Extension Phase||3||
59675907|NCT01283386|75795123|FG000|STARTED|Overall Study||10||
59675908|NCT01283386|75795124|FG001|STARTED|Overall Study||16||
59675909|NCT01283386|75795123|FG000|COMPLETED|Overall Study||2||
59675910|NCT01283386|75795124|FG001|COMPLETED|Overall Study||4||
59675911|NCT01283386|75795123|FG000|NOT COMPLETED|Overall Study||8||
59675912|NCT01283386|75795124|FG001|NOT COMPLETED|Overall Study||12||
59675913|NCT01283152|75795132|FG000|STARTED|Overall Study||25||
59675914|NCT01283152|75795133|FG001|STARTED|Overall Study||25||
59675915|NCT01283152|75795132|FG000|ITT Population|Overall Study||25||
59675916|NCT01283152|75795133|FG001|ITT Population|Overall Study||25||
59675917|NCT01283152|75795132|FG000|Study Treatment Received|Overall Study||25||
59675918|NCT01283152|75795133|FG001|Study Treatment Received|Overall Study||25||
59675919|NCT01283152|75795132|FG000|24-hr HESA Attempted|Overall Study||25||
59675920|NCT01283152|75795133|FG001|24-hr HESA Attempted|Overall Study||25||
59675921|NCT01283152|75795132|FG000|COMPLETED|Overall Study||23||
59675922|NCT01283152|75795133|FG001|COMPLETED|Overall Study||25||
59675923|NCT01283152|75795132|FG000|NOT COMPLETED|Overall Study||2||
59675924|NCT01283152|75795133|FG001|NOT COMPLETED|Overall Study||0||
59675925|NCT01283035|75795139|FG000|STARTED|Overall Study||6||
59675926|NCT01283035|75795139|FG000|COMPLETED|Overall Study||5||
59675927|NCT01283035|75795139|FG000|NOT COMPLETED|Overall Study||1||
59675928|NCT01283464|75795145|FG000|STARTED|Overall Study||12||
59675929|NCT01283464|75795146|FG001|STARTED|Overall Study||12||
59675930|NCT01283464|75795145|FG000|COMPLETED|Overall Study||10||
59675931|NCT01283464|75795146|FG001|COMPLETED|Overall Study||11||
59675932|NCT01283464|75795145|FG000|NOT COMPLETED|Overall Study||2||
59675933|NCT01283464|75795146|FG001|NOT COMPLETED|Overall Study||1||
59675934|NCT01282801|75795154|FG000|STARTED|First Intervention||9||
59675935|NCT01282801|75795155|FG001|STARTED|First Intervention||9||
59675936|NCT01282801|75795154|FG000|COMPLETED|First Intervention||9||
59675937|NCT01282801|75795155|FG001|COMPLETED|First Intervention||9||
59675938|NCT01282801|75795154|FG000|NOT COMPLETED|First Intervention||0||
59989514|NCT00513617|76104824|FG001|NOT COMPLETED|Overall Study||10||
59989515|NCT00513617|76104825|FG002|NOT COMPLETED|Overall Study||8||
59989516|NCT02482298|76104833|FG000|STARTED|Overall Study||30||
59989517|NCT02482298|76104834|FG001|STARTED|Overall Study||27||
59675939|NCT01282801|75795155|FG001|NOT COMPLETED|First Intervention||0||
59675940|NCT01282801|75795154|FG000|STARTED|Washout of 7 Days||9||
59675941|NCT01282801|75795155|FG001|STARTED|Washout of 7 Days||9||
59675942|NCT01282801|75795154|FG000|COMPLETED|Washout of 7 Days||9||
59675943|NCT01282801|75795155|FG001|COMPLETED|Washout of 7 Days||9||
59675944|NCT01282801|75795154|FG000|NOT COMPLETED|Washout of 7 Days||0||
59675945|NCT01282801|75795155|FG001|NOT COMPLETED|Washout of 7 Days||0||
59675946|NCT01282801|75795154|FG000|STARTED|Second Intervention||9||
59675947|NCT01282801|75795155|FG001|STARTED|Second Intervention||9||
59675948|NCT01282801|75795154|FG000|COMPLETED|Second Intervention||9||
59675949|NCT01282801|75795155|FG001|COMPLETED|Second Intervention||8||
59675950|NCT01282801|75795154|FG000|NOT COMPLETED|Second Intervention||0||
59675951|NCT01282801|75795155|FG001|NOT COMPLETED|Second Intervention||1||
59675952|NCT01282372|75795161|FG000|STARTED|Overall Study||500||
59675953|NCT01282372|75795161|FG000|COMPLETED|Overall Study||421||
59675954|NCT01282372|75795161|FG000|NOT COMPLETED|Overall Study||79||
59675955|NCT01282294|75795172|FG000|STARTED|Overall Study||100||
59675956|NCT01282294|75795172|FG000|Intra-operative|Overall Study||99||
59675957|NCT01282294|75795172|FG000|Post-operative|Overall Study||99||
59675958|NCT01282294|75795172|FG000|6 Weeks|Overall Study||95||
59675959|NCT01282294|75795172|FG000|3 Months|Overall Study||95||
59675960|NCT01282294|75795172|FG000|6 Months|Overall Study||94||
59675961|NCT01282294|75795172|FG000|12 Months|Overall Study||86||
59675962|NCT01282294|75795172|FG000|COMPLETED|Overall Study||81||
59675963|NCT01282294|75795172|FG000|NOT COMPLETED|Overall Study||19||
59675964|NCT01282216|75795178|FG000|STARTED|Overall Study||18||
59989518|NCT02482298|76104835|FG002|STARTED|Overall Study||30||
59989519|NCT02482298|76104833|FG000|COMPLETED|Overall Study||28||
59675965|NCT01282216|75795179|FG001|STARTED|Overall Study||26||
59675966|NCT01282216|75795180|FG002|STARTED|Overall Study||52||
59675967|NCT01282216|75795181|FG003|STARTED|Overall Study||8||
59675968|NCT01282216|75795178|FG000|COMPLETED|Overall Study||18||
59989520|NCT02482298|76104834|FG001|COMPLETED|Overall Study||24||
59675969|NCT01282216|75795179|FG001|COMPLETED|Overall Study||26||
59675970|NCT01282216|75795180|FG002|COMPLETED|Overall Study||19||
59675971|NCT01282216|75795181|FG003|COMPLETED|Overall Study||0||
59675972|NCT01282216|75795178|FG000|NOT COMPLETED|Overall Study||0||
59675973|NCT01282216|75795179|FG001|NOT COMPLETED|Overall Study||0||
59675974|NCT01282216|75795180|FG002|NOT COMPLETED|Overall Study||33||
59675975|NCT01282216|75795181|FG003|NOT COMPLETED|Overall Study||8||
59675976|NCT01281865|75795189|FG000|STARTED|Overall Study||12||
59675977|NCT01281865|75795190|FG001|STARTED|Overall Study||2||
59675978|NCT01281865|75795189|FG000|COMPLETED|Overall Study||9||
59675979|NCT01281865|75795190|FG001|COMPLETED|Overall Study||1||
59675980|NCT01281865|75795189|FG000|NOT COMPLETED|Overall Study||3||
59675981|NCT01281865|75795190|FG001|NOT COMPLETED|Overall Study||1||
59675982|NCT01281202|75795198|FG000|STARTED|Overall Study||103||
59675983|NCT01281202|75795199|FG001|STARTED|Overall Study||104||
59675984|NCT01281202|75795198|FG000|COMPLETED|Overall Study||75||
59675985|NCT01281202|75795199|FG001|COMPLETED|Overall Study||68||
59675986|NCT01281202|75795198|FG000|NOT COMPLETED|Overall Study||28||
59675987|NCT01281202|75795199|FG001|NOT COMPLETED|Overall Study||36||
59675988|NCT01281124|75795207|FG000|STARTED|Overall Study||1||
59675989|NCT01281124|75795207|FG000|COMPLETED|Overall Study||0||
59675990|NCT01281124|75795207|FG000|NOT COMPLETED|Overall Study||1||
59675991|NCT01280968|75795215|FG000|STARTED|Overall Study||45||
59675992|NCT01280968|75795216|FG001|STARTED|Overall Study||7||
59675993|NCT01280968|75795215|FG000|COMPLETED|Overall Study||27||
59675994|NCT01280968|75795216|FG001|COMPLETED|Overall Study||4||
59675995|NCT01280968|75795215|FG000|NOT COMPLETED|Overall Study||18||
59675996|NCT01280968|75795216|FG001|NOT COMPLETED|Overall Study||3||
59675997|NCT01280812|75795226|FG000|STARTED|Overall Study||70||
59675998|NCT01280812|75795227|FG001|STARTED|Overall Study||71||
59675999|NCT01280812|75795228|FG002|STARTED|Overall Study||69||
59676000|NCT01280812|75795226|FG000|COMPLETED|Overall Study||67||
59676001|NCT01280812|75795227|FG001|COMPLETED|Overall Study||69||
59676002|NCT01280812|75795228|FG002|COMPLETED|Overall Study||68||
59676003|NCT01280812|75795226|FG000|NOT COMPLETED|Overall Study||3||
59676004|NCT01280812|75795227|FG001|NOT COMPLETED|Overall Study||2||
59676005|NCT01280812|75795228|FG002|NOT COMPLETED|Overall Study||1||
59676006|NCT01280656|75795240|FG000|STARTED|Overall Study||62||
59676007|NCT01280656|75795241|FG001|STARTED|Overall Study||312||
59676008|NCT01280656|75795242|FG002|STARTED|Overall Study||286||
59676009|NCT01280656|75795240|FG000|COMPLETED|Overall Study||59||
59676010|NCT01280656|75795241|FG001|COMPLETED|Overall Study||265||
59676011|NCT01280656|75795242|FG002|COMPLETED|Overall Study||223||
59676012|NCT01280656|75795240|FG000|NOT COMPLETED|Overall Study||3||
59676013|NCT01280656|75795241|FG001|NOT COMPLETED|Overall Study||47||
59676014|NCT01280656|75795242|FG002|NOT COMPLETED|Overall Study||63||
59676015|NCT01280617|75795252|FG000|STARTED|Overall Study||23||
59676016|NCT01280617|75795253|FG001|STARTED|Overall Study||21||
59676017|NCT01280617|75795252|FG000|COMPLETED|Overall Study||23||
59676018|NCT01280617|75795253|FG001|COMPLETED|Overall Study||20||
59676019|NCT01280617|75795252|FG000|NOT COMPLETED|Overall Study||0||
59676020|NCT01280617|75795253|FG001|NOT COMPLETED|Overall Study||1||
59676021|NCT01280266|75795261|FG000|STARTED|First Intervention (Week 1-4)||15||
59676022|NCT01280266|75795262|FG001|STARTED|First Intervention (Week 1-4)||14||
59676023|NCT01280266|75795261|FG000|COMPLETED|First Intervention (Week 1-4)||14||
59676024|NCT01280266|75795262|FG001|COMPLETED|First Intervention (Week 1-4)||12||
59676025|NCT01280266|75795261|FG000|NOT COMPLETED|First Intervention (Week 1-4)||1||
59676026|NCT01280266|75795262|FG001|NOT COMPLETED|First Intervention (Week 1-4)||2||
59676027|NCT01280266|75795261|FG000|STARTED|Washout Period (Week 4-5)||14||
59676028|NCT01280266|75795262|FG001|STARTED|Washout Period (Week 4-5)||12||
59676029|NCT01280266|75795261|FG000|COMPLETED|Washout Period (Week 4-5)||14||
59676030|NCT01280266|75795262|FG001|COMPLETED|Washout Period (Week 4-5)||12||
59676031|NCT01280266|75795261|FG000|NOT COMPLETED|Washout Period (Week 4-5)||0||
59676032|NCT01280266|75795262|FG001|NOT COMPLETED|Washout Period (Week 4-5)||0||
59676033|NCT01280266|75795261|FG000|STARTED|Second Intervention (Week 5-9)||14||
59676034|NCT01280266|75795262|FG001|STARTED|Second Intervention (Week 5-9)||12||
59676035|NCT01280266|75795261|FG000|COMPLETED|Second Intervention (Week 5-9)||14||
59676036|NCT01280266|75795262|FG001|COMPLETED|Second Intervention (Week 5-9)||12||
59676037|NCT01280266|75795261|FG000|NOT COMPLETED|Second Intervention (Week 5-9)||0||
59676038|NCT01280266|75795262|FG001|NOT COMPLETED|Second Intervention (Week 5-9)||0||
59676039|NCT01279447|75795274|FG000|STARTED|Overall Study||34||
59676040|NCT01279447|75795275|FG001|STARTED|Overall Study||34||
59815917|NCT00999037|75938347|FG000|COMPLETED|Overall Study||9||
59676041|NCT01279447|75795274|FG000|COMPLETED|Overall Study||31||
59676042|NCT01279447|75795275|FG001|COMPLETED|Overall Study||33||
59676043|NCT01279447|75795274|FG000|NOT COMPLETED|Overall Study||3||
59676044|NCT01279447|75795275|FG001|NOT COMPLETED|Overall Study||1||
59676045|NCT03792737|75795284|FG000|STARTED|Overall Study||166|Participated in randomization|
59676046|NCT03792737|75795285|FG001|STARTED|Overall Study||167|Participated in randomization|
59676047|NCT03792737|75795286|FG002|STARTED|Overall Study||167|Participated in randomization|
59676048|NCT03792737|75795284|FG000|Safety Analysis Set|Overall Study||162|subjects who received investigational product treatment and had post-baseline follow-up data|
59676049|NCT03792737|75795285|FG001|Safety Analysis Set|Overall Study|one subject didn't participate screen visit or randomize, but receive IP treatment by mistake.|161|subjects who received investigational product treatment and had post-baseline follow-up data|
59676050|NCT03792737|75795286|FG002|Safety Analysis Set|Overall Study||162|subjects who received investigational product treatment and had post-baseline follow-up data|
59676051|NCT03792737|75795284|FG000|Full Analysis Set|Overall Study||162|Subjects who were randomized and received corresponding investigational product(IP) treatment, with at least one data to evaluate the post-baseline effectiveness.|
59676052|NCT03792737|75795285|FG001|Full Analysis Set|Overall Study||160|Subjects who were randomized and received corresponding investigational product(IP) treatment, with at least one data to evaluate the post-baseline effectiveness.|
59676053|NCT03792737|75795286|FG002|Full Analysis Set|Overall Study||162|Subjects who were randomized and received corresponding investigational product(IP) treatment, with at least one data to evaluate the post-baseline effectiveness.|
59676054|NCT03792737|75795284|FG000|COMPLETED|Overall Study||160|Completed all the study visits|
59676055|NCT03792737|75795285|FG001|COMPLETED|Overall Study||159|Completed all the study visits|
59676056|NCT03792737|75795286|FG002|COMPLETED|Overall Study||158|Completed all the study visits|
59676057|NCT03792737|75795284|FG000|NOT COMPLETED|Overall Study||6||
59676058|NCT03792737|75795285|FG001|NOT COMPLETED|Overall Study||8||
59676059|NCT03792737|75795286|FG002|NOT COMPLETED|Overall Study||9||
59676060|NCT01276639|75795297|FG000|STARTED|Week 0 to 16||363||
59676061|NCT01276639|75795298|FG001|STARTED|Week 0 to 16||361||
59676062|NCT01276639|75795299|FG002|STARTED|Week 0 to 16||177||
59676063|NCT01276639|75795300|FG003|STARTED|Week 0 to 16||0||
59676064|NCT01276639|75795301|FG004|STARTED|Week 0 to 16||0||
59676065|NCT01276639|75795297|FG000|Treated|Week 0 to 16||363||
59676066|NCT01276639|75795298|FG001|Treated|Week 0 to 16||360||
59676067|NCT01276639|75795299|FG002|Treated|Week 0 to 16||177||
59676068|NCT01276639|75795300|FG003|Treated|Week 0 to 16||0||
59676069|NCT01276639|75795301|FG004|Treated|Week 0 to 16||0||
59676070|NCT01276639|75795297|FG000|COMPLETED|Week 0 to 16||313||
59676071|NCT01276639|75795298|FG001|COMPLETED|Week 0 to 16||320||
59676072|NCT01276639|75795299|FG002|COMPLETED|Week 0 to 16||132||
59676073|NCT01276639|75795300|FG003|COMPLETED|Week 0 to 16||0||
59676074|NCT01276639|75795301|FG004|COMPLETED|Week 0 to 16||0||
59676075|NCT01276639|75795297|FG000|NOT COMPLETED|Week 0 to 16||50||
59676076|NCT01276639|75795298|FG001|NOT COMPLETED|Week 0 to 16||41||
59676077|NCT01276639|75795299|FG002|NOT COMPLETED|Week 0 to 16||45||
59676078|NCT01276639|75795300|FG003|NOT COMPLETED|Week 0 to 16||0||
59676079|NCT01276639|75795301|FG004|NOT COMPLETED|Week 0 to 16||0||
59676080|NCT01276639|75795297|FG000|STARTED|Week 16 to 52||313||
59676081|NCT01276639|75795298|FG001|STARTED|Week 16 to 52||320||
59676082|NCT01276639|75795299|FG002|STARTED|Week 16 to 52||0||
59676083|NCT01276639|75795300|FG003|STARTED|Week 16 to 52||66||
59676084|NCT01276639|75795301|FG004|STARTED|Week 16 to 52||66||
59676085|NCT01276639|75795297|FG000|COMPLETED|Week 16 to 52||186||
59676086|NCT01276639|75795298|FG001|COMPLETED|Week 16 to 52||219||
59676087|NCT01276639|75795299|FG002|COMPLETED|Week 16 to 52||0||
59676088|NCT01276639|75795300|FG003|COMPLETED|Week 16 to 52||50||
59676089|NCT01276639|75795301|FG004|COMPLETED|Week 16 to 52||45||
59676090|NCT01276639|75795297|FG000|NOT COMPLETED|Week 16 to 52||127||
59676091|NCT01276639|75795298|FG001|NOT COMPLETED|Week 16 to 52||101||
59676092|NCT01276639|75795299|FG002|NOT COMPLETED|Week 16 to 52||0||
59676093|NCT01276639|75795300|FG003|NOT COMPLETED|Week 16 to 52||16||
59676094|NCT01276639|75795301|FG004|NOT COMPLETED|Week 16 to 52||21||
59676095|NCT01275625|75795316|FG000|STARTED|Overall Study||77||
59676096|NCT01275625|75795316|FG000|Treated|Overall Study||77||
59676097|NCT01275625|75795316|FG000|COMPLETED|Overall Study||64||
59676098|NCT01275625|75795316|FG000|NOT COMPLETED|Overall Study||13||
59676099|NCT01272193|75795322|FG000|STARTED|Overall Study||147||
59676100|NCT01272193|75795323|FG001|STARTED|Overall Study||149||
59676101|NCT01272193|75795322|FG000|COMPLETED|Overall Study||137||
59676102|NCT01272193|75795323|FG001|COMPLETED|Overall Study||137||
59676103|NCT01272193|75795322|FG000|NOT COMPLETED|Overall Study||10||
59676104|NCT01272193|75795323|FG001|NOT COMPLETED|Overall Study||12||
59676105|NCT04019613|75795329|FG000|STARTED|Overall Study||4||
59676106|NCT04019613|75795329|FG000|COMPLETED|Overall Study||4||
59676107|NCT04019613|75795329|FG000|NOT COMPLETED|Overall Study||0||
59676108|NCT01270828|75795335|FG000|STARTED|Pregabalin CR SB||0||
59676109|NCT01270828|75795336|FG001|STARTED|Pregabalin CR SB||0||
59676110|NCT01270828|75795337|FG002|STARTED|Pregabalin CR SB||806||
59676111|NCT01270828|75795335|FG000|COMPLETED|Pregabalin CR SB||0||
59676112|NCT01270828|75795336|FG001|COMPLETED|Pregabalin CR SB||0||
59676113|NCT01270828|75795337|FG002|COMPLETED|Pregabalin CR SB||660||
59676114|NCT01270828|75795335|FG000|NOT COMPLETED|Pregabalin CR SB||0||
59676115|NCT01270828|75795336|FG001|NOT COMPLETED|Pregabalin CR SB||0||
59676116|NCT01270828|75795337|FG002|NOT COMPLETED|Pregabalin CR SB||146||
59676117|NCT01270828|75795335|FG000|STARTED|Double Blind Phase||208||
59676118|NCT01270828|75795336|FG001|STARTED|Double Blind Phase||205||
59676119|NCT01270828|75795337|FG002|STARTED|Double Blind Phase||0||
59676120|NCT01270828|75795335|FG000|COMPLETED|Double Blind Phase||182||
59676121|NCT01270828|75795336|FG001|COMPLETED|Double Blind Phase||160||
59676122|NCT01270828|75795337|FG002|COMPLETED|Double Blind Phase||0||
59676123|NCT01270828|75795335|FG000|NOT COMPLETED|Double Blind Phase||26||
59676124|NCT01270828|75795336|FG001|NOT COMPLETED|Double Blind Phase||45||
59676125|NCT01270828|75795337|FG002|NOT COMPLETED|Double Blind Phase||0||
59676126|NCT01269385|75795345|FG000|STARTED|Overall Study||4||
59676127|NCT01269385|75795346|FG001|STARTED|Overall Study||4||
59676128|NCT01269385|75795347|FG002|STARTED|Overall Study||6||
59676129|NCT01269385|75795348|FG003|STARTED|Overall Study||8||
59676130|NCT01269385|75795345|FG000|COMPLETED|Overall Study||3||
59676131|NCT01269385|75795346|FG001|COMPLETED|Overall Study||3||
59676132|NCT01269385|75795347|FG002|COMPLETED|Overall Study||6||
59676133|NCT01269385|75795348|FG003|COMPLETED|Overall Study||8||
59676134|NCT01269385|75795345|FG000|NOT COMPLETED|Overall Study||1||
59676135|NCT01269385|75795346|FG001|NOT COMPLETED|Overall Study||1||
59676136|NCT01269385|75795347|FG002|NOT COMPLETED|Overall Study||0||
59676137|NCT01269385|75795348|FG003|NOT COMPLETED|Overall Study||0||
59676138|NCT01268683|75795358|FG000|STARTED|Overall Study||10||
59676139|NCT01268683|75795358|FG000|COMPLETED|Overall Study||8||
59676140|NCT01268683|75795358|FG000|NOT COMPLETED|Overall Study||2||
59676141|NCT01268566|75795362|FG000|STARTED|Overall Study||56||
59676142|NCT01268566|75795362|FG000|COMPLETED|Overall Study||13||
59676143|NCT01268566|75795362|FG000|NOT COMPLETED|Overall Study||43||
59676144|NCT01268488|75795366|FG000|STARTED|Overall Study||98||
59676145|NCT01268488|75795366|FG000|COMPLETED|Overall Study||93||
59676146|NCT01268488|75795366|FG000|NOT COMPLETED|Overall Study||5||
59676147|NCT01268098|75795373|FG000|STARTED|Overall Study||19||
59676148|NCT01268098|75795374|FG001|STARTED|Overall Study||23||
59676149|NCT01268098|75795373|FG000|COMPLETED|Overall Study||18||
59676150|NCT01268098|75795374|FG001|COMPLETED|Overall Study||23||
59676151|NCT01268098|75795373|FG000|NOT COMPLETED|Overall Study||1||
59676152|NCT01268098|75795374|FG001|NOT COMPLETED|Overall Study||0||
59676153|NCT01268059|75795384|FG000|STARTED|Overall Study||40||
59676154|NCT01268059|75795385|FG001|STARTED|Overall Study|Arm applicable for both dose-determination (Phase 1b) and randomization phase (Phase 2) of study.|45||
59676155|NCT01268059|75795386|FG002|STARTED|Overall Study||6||
59676156|NCT01268059|75795387|FG003|STARTED|Overall Study||8||
59676157|NCT01268059|75795384|FG000|COMPLETED|Overall Study|End of study defined as 14 months from the last participant enrolled, or sponsor stopped the study.|12||
59676158|NCT01268059|75795385|FG001|COMPLETED|Overall Study|End of study defined as 14 months from the last participant enrolled, or sponsor stopped the study.|10||
59676159|NCT01268059|75795386|FG002|COMPLETED|Overall Study|End of study defined as 14 months from the last participant enrolled, or sponsor stopped the study.|3||
59676160|NCT01268059|75795387|FG003|COMPLETED|Overall Study|End of study defined as 14 months from the last participant enrolled, or sponsor stopped the study.|3||
59676161|NCT01268059|75795384|FG000|NOT COMPLETED|Overall Study||28||
59676162|NCT01268059|75795385|FG001|NOT COMPLETED|Overall Study||35||
59676163|NCT01268059|75795386|FG002|NOT COMPLETED|Overall Study||3||
59676164|NCT01268059|75795387|FG003|NOT COMPLETED|Overall Study||5||
59676165|NCT01267825|75795402|FG000|STARTED|Overall Study||1||
59676166|NCT01267825|75795403|FG001|STARTED|Overall Study||0||
59676167|NCT01267825|75795402|FG000|COMPLETED|Overall Study||0||
59676168|NCT01267825|75795403|FG001|COMPLETED|Overall Study||0||
59676169|NCT01267825|75795402|FG000|NOT COMPLETED|Overall Study||1||
59676170|NCT01267825|75795403|FG001|NOT COMPLETED|Overall Study||0||
59676171|NCT01260181|75795409|FG000|STARTED|Overall Study||30||
59676172|NCT01260181|75795409|FG000|COMPLETED|Overall Study||29||
59676173|NCT01260181|75795409|FG000|NOT COMPLETED|Overall Study||1||
59676174|NCT01260142|75795419|FG000|STARTED|Treatment Period 1||6||
59676175|NCT01260142|75795420|FG001|STARTED|Treatment Period 1||6||
59676176|NCT01260142|75795421|FG002|STARTED|Treatment Period 1||6||
59676177|NCT01260142|75795422|FG003|STARTED|Treatment Period 1||6||
59676178|NCT01260142|75795423|FG004|STARTED|Treatment Period 1||6||
59676179|NCT01260142|75795424|FG005|STARTED|Treatment Period 1||6||
59676180|NCT01260142|75795419|FG000|COMPLETED|Treatment Period 1||5||
59676181|NCT01260142|75795420|FG001|COMPLETED|Treatment Period 1||5||
59676182|NCT01260142|75795421|FG002|COMPLETED|Treatment Period 1||6||
59676183|NCT01260142|75795422|FG003|COMPLETED|Treatment Period 1||6||
59676184|NCT01260142|75795423|FG004|COMPLETED|Treatment Period 1||4||
59676185|NCT01260142|75795424|FG005|COMPLETED|Treatment Period 1||3||
59676186|NCT01260142|75795419|FG000|NOT COMPLETED|Treatment Period 1||1||
59676187|NCT01260142|75795420|FG001|NOT COMPLETED|Treatment Period 1||1||
59676188|NCT01260142|75795421|FG002|NOT COMPLETED|Treatment Period 1||0||
59676189|NCT01260142|75795422|FG003|NOT COMPLETED|Treatment Period 1||0||
59676190|NCT01260142|75795423|FG004|NOT COMPLETED|Treatment Period 1||2||
59676191|NCT01260142|75795424|FG005|NOT COMPLETED|Treatment Period 1||3||
59676192|NCT01260142|75795419|FG000|STARTED|Treatment Period 2||5||
59989521|NCT02482298|76104835|FG002|COMPLETED|Overall Study||27||
59989522|NCT02482298|76104833|FG000|NOT COMPLETED|Overall Study||2||
59989523|NCT02482298|76104834|FG001|NOT COMPLETED|Overall Study||3||
59676193|NCT01260142|75795420|FG001|STARTED|Treatment Period 2||5||
59676194|NCT01260142|75795421|FG002|STARTED|Treatment Period 2||6||
59676195|NCT01260142|75795422|FG003|STARTED|Treatment Period 2||6||
59676196|NCT01260142|75795423|FG004|STARTED|Treatment Period 2||4||
59676197|NCT01260142|75795424|FG005|STARTED|Treatment Period 2||3||
59676198|NCT01260142|75795419|FG000|COMPLETED|Treatment Period 2||5||
59676199|NCT01260142|75795420|FG001|COMPLETED|Treatment Period 2||5||
59676200|NCT01260142|75795421|FG002|COMPLETED|Treatment Period 2||6||
59676201|NCT01260142|75795422|FG003|COMPLETED|Treatment Period 2||6||
59676202|NCT01260142|75795423|FG004|COMPLETED|Treatment Period 2||4||
59676203|NCT01260142|75795424|FG005|COMPLETED|Treatment Period 2||3||
59676204|NCT01260142|75795419|FG000|NOT COMPLETED|Treatment Period 2||0||
59676205|NCT01260142|75795420|FG001|NOT COMPLETED|Treatment Period 2||0||
59676206|NCT01260142|75795421|FG002|NOT COMPLETED|Treatment Period 2||0||
59676207|NCT01260142|75795422|FG003|NOT COMPLETED|Treatment Period 2||0||
59676208|NCT01260142|75795423|FG004|NOT COMPLETED|Treatment Period 2||0||
59676209|NCT01260142|75795424|FG005|NOT COMPLETED|Treatment Period 2||0||
59676210|NCT01259869|75795444|FG000|STARTED|Overall Study||34||
59676211|NCT01259869|75795444|FG000|COMPLETED|Overall Study||33||
59676212|NCT01259869|75795444|FG000|NOT COMPLETED|Overall Study||1||
59676213|NCT01259713|75795450|FG000|STARTED|Overall Study||237||
59676214|NCT01259713|75795451|FG001|STARTED|Overall Study||118||
59676215|NCT01259713|75795450|FG000|COMPLETED|Overall Study||142||
59676216|NCT01259713|75795451|FG001|COMPLETED|Overall Study||77||
59676217|NCT01259713|75795450|FG000|NOT COMPLETED|Overall Study||95||
59676218|NCT01259713|75795451|FG001|NOT COMPLETED|Overall Study||41||
59676219|NCT01259401|75795459|FG000|STARTED|End of 4-week Intervention||21||
59676220|NCT01259401|75795460|FG001|STARTED|End of 4-week Intervention||21||
59676221|NCT01259401|75795459|FG000|COMPLETED|End of 4-week Intervention||21||
59676222|NCT01259401|75795460|FG001|COMPLETED|End of 4-week Intervention||21||
59676223|NCT01259401|75795459|FG000|NOT COMPLETED|End of 4-week Intervention||0||
59676224|NCT01259401|75795460|FG001|NOT COMPLETED|End of 4-week Intervention||0||
59676225|NCT01259401|75795459|FG000|STARTED|4-month Follow-up||21||
59676226|NCT01259401|75795460|FG001|STARTED|4-month Follow-up||21||
59676227|NCT01259401|75795459|FG000|COMPLETED|4-month Follow-up||21||
59676228|NCT01259401|75795460|FG001|COMPLETED|4-month Follow-up||19||
59676229|NCT01259401|75795459|FG000|NOT COMPLETED|4-month Follow-up||0||
59676230|NCT01259401|75795460|FG001|NOT COMPLETED|4-month Follow-up||2||
59676231|NCT03135067|75795468|FG000|STARTED|Overall Study||1063||33
59676232|NCT03135067|75795469|FG001|STARTED|Overall Study||1039||33
59676233|NCT03135067|75795468|FG000|COMPLETED|Overall Study||1019||33
59676234|NCT03135067|75795469|FG001|COMPLETED|Overall Study||991||33
59676235|NCT03135067|75795468|FG000|NOT COMPLETED|Overall Study||44||0
59676236|NCT03135067|75795469|FG001|NOT COMPLETED|Overall Study||48||0
59676237|NCT01313923|75795475|FG000|STARTED|Overall Study||3||
59676238|NCT01313923|75795475|FG000|COMPLETED|Overall Study||0||
59676239|NCT01313923|75795475|FG000|NOT COMPLETED|Overall Study||3||
59676240|NCT01313884|75795479|FG000|STARTED|Overall Study||3||
59676241|NCT01313884|75795479|FG000|COMPLETED|Overall Study||2||
59676242|NCT01313884|75795479|FG000|NOT COMPLETED|Overall Study||1||
59676243|NCT01135459|75795485|FG000|STARTED|Overall Study||92||
59676244|NCT01135459|75795486|FG001|STARTED|Overall Study||91||
59676245|NCT01135459|75795485|FG000|Received at Least 1 Dose of Study Drug|Overall Study||92||
59676246|NCT01135459|75795486|FG001|Received at Least 1 Dose of Study Drug|Overall Study||91||
59676247|NCT01135459|75795485|FG000|COMPLETED|Overall Study||71||
59676248|NCT01135459|75795486|FG001|COMPLETED|Overall Study||71||
59676249|NCT01135459|75795485|FG000|NOT COMPLETED|Overall Study||21||
59676250|NCT01135459|75795486|FG001|NOT COMPLETED|Overall Study||20||
59676251|NCT01259284|75795495|FG000|STARTED|Overall Study||2||
59676252|NCT01259284|75795496|FG001|STARTED|Overall Study||0||
59676253|NCT01259284|75795497|FG002|STARTED|Overall Study||0||
59676254|NCT01259284|75795495|FG000|COMPLETED|Overall Study||0||
59676255|NCT01259284|75795496|FG001|COMPLETED|Overall Study||0||
59676256|NCT01259284|75795497|FG002|COMPLETED|Overall Study||0||
59676257|NCT01259284|75795495|FG000|NOT COMPLETED|Overall Study||2||
59676258|NCT01259284|75795496|FG001|NOT COMPLETED|Overall Study||0||
59676259|NCT01259284|75795497|FG002|NOT COMPLETED|Overall Study||0||
59676260|NCT01259245|75795507|FG000|STARTED|Overall Study||98||
59676261|NCT01259245|75795508|FG001|STARTED|Overall Study||94||
59676262|NCT01259245|75795507|FG000|COMPLETED|Overall Study|27 were lost to follow-up and 1 deceased|70||
59676263|NCT01259245|75795508|FG001|COMPLETED|Overall Study|24 discontinued intervention and 2 deceased|68||
59676264|NCT01259245|75795507|FG000|NOT COMPLETED|Overall Study||28||
59676265|NCT01259245|75795508|FG001|NOT COMPLETED|Overall Study||26||
59676266|NCT01259089|75795516|FG000|STARTED|Reached First Response at 4 Weeks||3||
59676267|NCT01259089|75795517|FG001|STARTED|Reached First Response at 4 Weeks||3||
59676268|NCT01259089|75795518|FG002|STARTED|Reached First Response at 4 Weeks||3||
59676269|NCT01259089|75795519|FG003|STARTED|Reached First Response at 4 Weeks||3||
59676270|NCT01259089|75795520|FG004|STARTED|Reached First Response at 4 Weeks||6||
59676271|NCT01259089|75795521|FG005|STARTED|Reached First Response at 4 Weeks||20||
59676272|NCT01259089|75795516|FG000|Started Treatment on Study|Reached First Response at 4 Weeks||3||
59676273|NCT01259089|75795517|FG001|Started Treatment on Study|Reached First Response at 4 Weeks||3||
59676274|NCT01259089|75795518|FG002|Started Treatment on Study|Reached First Response at 4 Weeks||3||
59676275|NCT01259089|75795519|FG003|Started Treatment on Study|Reached First Response at 4 Weeks||3||
59676276|NCT01259089|75795520|FG004|Started Treatment on Study|Reached First Response at 4 Weeks||6||
59676277|NCT01259089|75795521|FG005|Started Treatment on Study|Reached First Response at 4 Weeks||19||
59676278|NCT01259089|75795516|FG000|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||3||
59676279|NCT01259089|75795517|FG001|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||3||
59676280|NCT01259089|75795518|FG002|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||3||
59676281|NCT01259089|75795519|FG003|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||3||
59676282|NCT01259089|75795520|FG004|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||6||
59676283|NCT01259089|75795521|FG005|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||18||
59676284|NCT01259089|75795516|FG000|COMPLETED|Reached First Response at 4 Weeks||3||
59676285|NCT01259089|75795517|FG001|COMPLETED|Reached First Response at 4 Weeks||3||
59676286|NCT01259089|75795518|FG002|COMPLETED|Reached First Response at 4 Weeks||3||
59676287|NCT01259089|75795519|FG003|COMPLETED|Reached First Response at 4 Weeks||3||
59676288|NCT01259089|75795520|FG004|COMPLETED|Reached First Response at 4 Weeks||6||
59676289|NCT01259089|75795521|FG005|COMPLETED|Reached First Response at 4 Weeks||18||
59676290|NCT01259089|75795516|FG000|NOT COMPLETED|Reached First Response at 4 Weeks||0||
59676291|NCT01259089|75795517|FG001|NOT COMPLETED|Reached First Response at 4 Weeks||0||
59676292|NCT01259089|75795518|FG002|NOT COMPLETED|Reached First Response at 4 Weeks||0||
59676293|NCT01259089|75795519|FG003|NOT COMPLETED|Reached First Response at 4 Weeks||0||
59676294|NCT01259089|75795520|FG004|NOT COMPLETED|Reached First Response at 4 Weeks||0||
59676295|NCT01259089|75795521|FG005|NOT COMPLETED|Reached First Response at 4 Weeks||2||
59676296|NCT01259089|75795516|FG000|STARTED|Confirmed Response at 8 Weeks||3||
59676297|NCT01259089|75795517|FG001|STARTED|Confirmed Response at 8 Weeks||3||
59676298|NCT01259089|75795518|FG002|STARTED|Confirmed Response at 8 Weeks||3||
59676299|NCT01259089|75795519|FG003|STARTED|Confirmed Response at 8 Weeks||3||
59676300|NCT01259089|75795520|FG004|STARTED|Confirmed Response at 8 Weeks||6||
59676301|NCT01259089|75795521|FG005|STARTED|Confirmed Response at 8 Weeks||18||
59676302|NCT01259089|75795516|FG000|COMPLETED|Confirmed Response at 8 Weeks||3||
59676303|NCT01259089|75795517|FG001|COMPLETED|Confirmed Response at 8 Weeks||3||
59676304|NCT01259089|75795518|FG002|COMPLETED|Confirmed Response at 8 Weeks||2||
59676305|NCT01259089|75795519|FG003|COMPLETED|Confirmed Response at 8 Weeks||2||
59676306|NCT01259089|75795520|FG004|COMPLETED|Confirmed Response at 8 Weeks||2||
59676307|NCT01259089|75795521|FG005|COMPLETED|Confirmed Response at 8 Weeks||8||
59676308|NCT01259089|75795516|FG000|NOT COMPLETED|Confirmed Response at 8 Weeks||0||
59676309|NCT01259089|75795517|FG001|NOT COMPLETED|Confirmed Response at 8 Weeks||0||
59676310|NCT01259089|75795518|FG002|NOT COMPLETED|Confirmed Response at 8 Weeks||1||
59676311|NCT01259089|75795519|FG003|NOT COMPLETED|Confirmed Response at 8 Weeks||1||
59676312|NCT01259089|75795520|FG004|NOT COMPLETED|Confirmed Response at 8 Weeks||4||
59676313|NCT01259089|75795521|FG005|NOT COMPLETED|Confirmed Response at 8 Weeks||10||
59676314|NCT01259089|75795516|FG000|STARTED|Continued Treatment After 8 Weeks||3||
59676315|NCT01259089|75795517|FG001|STARTED|Continued Treatment After 8 Weeks||3||
59676316|NCT01259089|75795518|FG002|STARTED|Continued Treatment After 8 Weeks||2||
59676317|NCT01259089|75795519|FG003|STARTED|Continued Treatment After 8 Weeks||2||
59676318|NCT01259089|75795520|FG004|STARTED|Continued Treatment After 8 Weeks||2||
59676319|NCT01259089|75795521|FG005|STARTED|Continued Treatment After 8 Weeks||8||
59676320|NCT01259089|75795516|FG000|COMPLETED|Continued Treatment After 8 Weeks||1||
59676321|NCT01259089|75795517|FG001|COMPLETED|Continued Treatment After 8 Weeks||2||
59676322|NCT01259089|75795518|FG002|COMPLETED|Continued Treatment After 8 Weeks||1||
59676323|NCT01259089|75795519|FG003|COMPLETED|Continued Treatment After 8 Weeks||1||
59676324|NCT01259089|75795520|FG004|COMPLETED|Continued Treatment After 8 Weeks||0||
59676325|NCT01259089|75795521|FG005|COMPLETED|Continued Treatment After 8 Weeks||7||
59676326|NCT01259089|75795516|FG000|NOT COMPLETED|Continued Treatment After 8 Weeks||2||
59676327|NCT01259089|75795517|FG001|NOT COMPLETED|Continued Treatment After 8 Weeks||1||
59676328|NCT01259089|75795518|FG002|NOT COMPLETED|Continued Treatment After 8 Weeks||1||
59676329|NCT01259089|75795519|FG003|NOT COMPLETED|Continued Treatment After 8 Weeks||1||
59676330|NCT01259089|75795520|FG004|NOT COMPLETED|Continued Treatment After 8 Weeks||2||
59676331|NCT01259089|75795521|FG005|NOT COMPLETED|Continued Treatment After 8 Weeks||1||
59676332|NCT01259089|75795516|FG000|STARTED|Survival Follow up for Two Years||3|All patients that are treated on study go into follow up once they finish treatment.|
59676333|NCT01259089|75795517|FG001|STARTED|Survival Follow up for Two Years||3|All patients that are treated on study go into follow up once they finish treatment.|
59676334|NCT01259089|75795518|FG002|STARTED|Survival Follow up for Two Years||3|All patients that are treated on study go into follow up once they finish treatment.|
59676335|NCT01259089|75795519|FG003|STARTED|Survival Follow up for Two Years||3|All patients that are treated on study go into follow up once they finish treatment.|
59676336|NCT01259089|75795520|FG004|STARTED|Survival Follow up for Two Years||6|All patients that are treated on study go into follow up once they finish treatment.|
59676337|NCT01259089|75795521|FG005|STARTED|Survival Follow up for Two Years||19|All patients that are treated on study go into follow up once they finish treatment.|
59676338|NCT01259089|75795516|FG000|COMPLETED|Survival Follow up for Two Years||0||
59676339|NCT01259089|75795517|FG001|COMPLETED|Survival Follow up for Two Years||1||
59676340|NCT01259089|75795518|FG002|COMPLETED|Survival Follow up for Two Years||1||
59676341|NCT01259089|75795519|FG003|COMPLETED|Survival Follow up for Two Years||0||
59676342|NCT01259089|75795520|FG004|COMPLETED|Survival Follow up for Two Years||0||
59676343|NCT01259089|75795521|FG005|COMPLETED|Survival Follow up for Two Years||0||
59676344|NCT01259089|75795516|FG000|NOT COMPLETED|Survival Follow up for Two Years||3||
59676345|NCT01259089|75795517|FG001|NOT COMPLETED|Survival Follow up for Two Years||2||
59815918|NCT00999037|75938348|FG001|COMPLETED|Overall Study||9||
59676346|NCT01259089|75795518|FG002|NOT COMPLETED|Survival Follow up for Two Years||2||
59676347|NCT01259089|75795519|FG003|NOT COMPLETED|Survival Follow up for Two Years||3||
59676348|NCT01259089|75795520|FG004|NOT COMPLETED|Survival Follow up for Two Years||6||
59676349|NCT01259089|75795521|FG005|NOT COMPLETED|Survival Follow up for Two Years||19||
59676350|NCT01258738|75795537|FG000|STARTED|Double-blind Period||111||
59676351|NCT01258738|75795538|FG001|STARTED|Double-blind Period||114||
59676352|NCT01258738|75795537|FG000|Treated|Double-blind Period||111||
59676353|NCT01258738|75795538|FG001|Treated|Double-blind Period||113||
59676354|NCT01258738|75795537|FG000|COMPLETED|Double-blind Period||102||
59676355|NCT01258738|75795538|FG001|COMPLETED|Double-blind Period|Only 106 participants entered the open label period.|107||
59676356|NCT01258738|75795537|FG000|NOT COMPLETED|Double-blind Period||9||
59676357|NCT01258738|75795538|FG001|NOT COMPLETED|Double-blind Period||7||
59676358|NCT01258738|75795537|FG000|STARTED|Open-label Period||102||
59676359|NCT01258738|75795538|FG001|STARTED|Open-label Period||106||
59676360|NCT01258738|75795537|FG000|COMPLETED|Open-label Period||85||
59676361|NCT01258738|75795538|FG001|COMPLETED|Open-label Period||85||
59676362|NCT01258738|75795537|FG000|NOT COMPLETED|Open-label Period||17||
59676363|NCT01258738|75795538|FG001|NOT COMPLETED|Open-label Period||21||
59676364|NCT01258660|75795546|FG000|STARTED|Overall Study|randomized and received at least one dose of treatment|86||
59676365|NCT01258660|75795547|FG001|STARTED|Overall Study|randomized and received at least one dose of treatment|86||
59676366|NCT01258660|75795546|FG000|Received Treatment|Overall Study||79||
59676367|NCT01258660|75795547|FG001|Received Treatment|Overall Study||82||
59676368|NCT01258660|75795546|FG000|Completed Treatment|Overall Study||79||
59676369|NCT01258660|75795547|FG001|Completed Treatment|Overall Study||81||
59676370|NCT01258660|75795546|FG000|COMPLETED|Overall Study|completed and valid for primary analysis data set|75||
59676371|NCT01258660|75795547|FG001|COMPLETED|Overall Study|completed and valid for primary analysis data set|75||
59676372|NCT01258660|75795546|FG000|NOT COMPLETED|Overall Study||11||
59676373|NCT01258660|75795547|FG001|NOT COMPLETED|Overall Study||11||
59676374|NCT01258348|75795554|FG000|STARTED|Overall Study||1||
59676375|NCT01258348|75795555|FG001|STARTED|Overall Study||5||
59676376|NCT01258348|75795556|FG002|STARTED|Overall Study||3||
59676377|NCT01258348|75795557|FG003|STARTED|Overall Study||6||
59676378|NCT01258348|75795558|FG004|STARTED|Overall Study||6||
59676379|NCT01258348|75795554|FG000|Received at Least 1 Dose of Study Drug|Overall Study||1||
59676380|NCT01258348|75795555|FG001|Received at Least 1 Dose of Study Drug|Overall Study||5||
59676381|NCT01258348|75795556|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3||
59676382|NCT01258348|75795557|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6||
59676383|NCT01258348|75795558|FG004|Received at Least 1 Dose of Study Drug|Overall Study||6||
59676384|NCT01258348|75795554|FG000|COMPLETED|Overall Study||0||
59676385|NCT01258348|75795555|FG001|COMPLETED|Overall Study||0||
59676386|NCT01258348|75795556|FG002|COMPLETED|Overall Study||0||
59676387|NCT01258348|75795557|FG003|COMPLETED|Overall Study||0||
59676388|NCT01258348|75795558|FG004|COMPLETED|Overall Study||0||
59676389|NCT01258348|75795554|FG000|NOT COMPLETED|Overall Study||1||
59676390|NCT01258348|75795555|FG001|NOT COMPLETED|Overall Study||5||
59676391|NCT01258348|75795556|FG002|NOT COMPLETED|Overall Study||3||
59676392|NCT01258348|75795557|FG003|NOT COMPLETED|Overall Study||6||
59676393|NCT01258348|75795558|FG004|NOT COMPLETED|Overall Study||6||
59676394|NCT01258075|75795574|FG000|STARTED|Overall Study||141||
59676395|NCT01258075|75795575|FG001|STARTED|Overall Study||95||
59676396|NCT01258075|75795574|FG000|COMPLETED|Overall Study||99||
59676397|NCT01258075|75795575|FG001|COMPLETED|Overall Study||72||
59676398|NCT01258075|75795574|FG000|NOT COMPLETED|Overall Study||42||
59676399|NCT01258075|75795575|FG001|NOT COMPLETED|Overall Study||23||
59676400|NCT01257568|75795581|FG000|STARTED|Overall Study||40||42
59676401|NCT01257568|75795581|FG000|COMPLETED|Overall Study||7||9
59676402|NCT01257568|75795581|FG000|NOT COMPLETED|Overall Study||33||33
59989524|NCT02482298|76104835|FG002|NOT COMPLETED|Overall Study||3||
59989525|NCT00440531|76104846|FG000|STARTED|Overall Study||185||
59989526|NCT00440531|76104847|FG001|STARTED|Overall Study||183||
59989527|NCT00440531|76104848|FG002|STARTED|Overall Study||172||
59989528|NCT00440531|76104846|FG000|Vaccination 1|Overall Study||183||
59676403|NCT01256788|75795590|FG000|STARTED|Overall Study||12||
59676404|NCT01256788|75795591|FG001|STARTED|Overall Study||14||
59676405|NCT01256788|75795592|FG002|STARTED|Overall Study||8||
59676406|NCT01256788|75795590|FG000|COMPLETED|Overall Study||7||
59676407|NCT01256788|75795591|FG001|COMPLETED|Overall Study||6||
59676408|NCT01256788|75795592|FG002|COMPLETED|Overall Study||5||
59989529|NCT00440531|76104847|FG001|Vaccination 1|Overall Study||183||
59989530|NCT00440531|76104848|FG002|Vaccination 1|Overall Study||172||
59989531|NCT00440531|76104846|FG000|Vaccination 2|Overall Study||181||
59676409|NCT01256788|75795590|FG000|NOT COMPLETED|Overall Study||5||
59676410|NCT01256788|75795591|FG001|NOT COMPLETED|Overall Study||8||
59676411|NCT01256788|75795592|FG002|NOT COMPLETED|Overall Study||3||
59676412|NCT01256671|75795600|FG000|STARTED|Overall Study||530||
59676413|NCT01256671|75795600|FG000|Safety Population|Overall Study||521||
59676414|NCT01256671|75795600|FG000|COMPLETED|Overall Study||435||
59676415|NCT01256671|75795600|FG000|NOT COMPLETED|Overall Study||95||
59989532|NCT00440531|76104847|FG001|Vaccination 2|Overall Study||182||
59989533|NCT00440531|76104848|FG002|Vaccination 2|Overall Study||171||
59676416|NCT01256476|75795606|FG000|STARTED|Overall Study||164||
59676417|NCT01256476|75795607|FG001|STARTED|Overall Study||164||
59676418|NCT01256476|75795606|FG000|COMPLETED|Overall Study||158||
59676419|NCT01256476|75795607|FG001|COMPLETED|Overall Study||157||
59676420|NCT01256476|75795606|FG000|NOT COMPLETED|Overall Study||6||
59676421|NCT01256476|75795607|FG001|NOT COMPLETED|Overall Study||7||
59676422|NCT01256008|75795616|FG000|STARTED|Overall Study||98||
59676423|NCT01256008|75795617|FG001|STARTED|Overall Study||98||
59676424|NCT01256008|75795618|FG002|STARTED|Overall Study||196||
59676425|NCT01256008|75795616|FG000|COMPLETED|Overall Study||90||
59676426|NCT01256008|75795617|FG001|COMPLETED|Overall Study||91||
59676427|NCT01256008|75795618|FG002|COMPLETED|Overall Study||175||
59676428|NCT01256008|75795616|FG000|NOT COMPLETED|Overall Study||8||
59676429|NCT01256008|75795617|FG001|NOT COMPLETED|Overall Study||7||
59676430|NCT01256008|75795618|FG002|NOT COMPLETED|Overall Study||21||
59676431|NCT01255423|75795630|FG000|STARTED|Overall Study||104||
59676432|NCT01255423|75795631|FG001|STARTED|Overall Study||102||
59676433|NCT01255423|75795630|FG000|COMPLETED|Overall Study||101||
59676434|NCT01255423|75795631|FG001|COMPLETED|Overall Study||99||
59676435|NCT01255423|75795630|FG000|NOT COMPLETED|Overall Study||3||
59676436|NCT01255423|75795631|FG001|NOT COMPLETED|Overall Study||3||
59676437|NCT01255306|75795639|FG000|STARTED|Overall Study||26||
59676438|NCT01255306|75795640|FG001|STARTED|Overall Study||33||
59676439|NCT01255306|75795639|FG000|COMPLETED|Overall Study||25||
59676440|NCT01255306|75795640|FG001|COMPLETED|Overall Study||32||
59676441|NCT01255306|75795639|FG000|NOT COMPLETED|Overall Study||1||
59676442|NCT01255306|75795640|FG001|NOT COMPLETED|Overall Study||1||
59676443|NCT01254721|75795651|FG000|STARTED|Overall Study|Seroquel XR: 300mg|67||
59676444|NCT01254721|75795652|FG001|STARTED|Overall Study|Seroquel XR: 300mg Lithium: 900mg|64||
59676445|NCT01254721|75795651|FG000|COMPLETED|Overall Study||52||
59676446|NCT01254721|75795652|FG001|COMPLETED|Overall Study||42||
59676447|NCT01254721|75795651|FG000|NOT COMPLETED|Overall Study||15||
59676448|NCT01254721|75795652|FG001|NOT COMPLETED|Overall Study||22||
59676449|NCT01254643|75795658|FG000|STARTED|Overall Study||100||
59676450|NCT01254643|75795658|FG000|Vaccination 1|Overall Study||100||
59676451|NCT01254643|75795658|FG000|Vaccination 2|Overall Study||99||
59676452|NCT01254643|75795658|FG000|Vaccination 3|Overall Study||99||
59676453|NCT01254643|75795658|FG000|COMPLETED|Overall Study||99||
59676454|NCT01254643|75795658|FG000|NOT COMPLETED|Overall Study||1||
59676455|NCT01254604|75795664|FG000|STARTED|Overall Study||95||
59676456|NCT01254604|75795665|FG001|STARTED|Overall Study||95||
59676457|NCT01254604|75795664|FG000|Treated|Overall Study|"The 2 out of 95 started who did not take study drug discontinued due to Withdrawal by Subject"|93||
59676458|NCT01254604|75795665|FG001|Treated|Overall Study|"The 1 out of 95 started who did not take study drug discontinued due to Withdrawal by Subject"|94||
59676459|NCT01254604|75795664|FG000|COMPLETED|Overall Study||87||
59676460|NCT01254604|75795665|FG001|COMPLETED|Overall Study||86||
59676461|NCT01254604|75795664|FG000|NOT COMPLETED|Overall Study||8||
59676462|NCT01254604|75795665|FG001|NOT COMPLETED|Overall Study||9||
59676463|NCT01254565|75795677|FG000|STARTED|Overall Study||5||
59676464|NCT01254565|75795678|FG001|STARTED|Overall Study||7||
59676465|NCT01254565|75795679|FG002|STARTED|Overall Study||21||
59676466|NCT01254565|75795680|FG003|STARTED|Overall Study||21||
59676467|NCT01254565|75795681|FG004|STARTED|Overall Study||16||
59676468|NCT01254565|75795682|FG005|STARTED|Overall Study||17||
59676469|NCT01254565|75795677|FG000|Received Treatment|Overall Study||4||
59676470|NCT01254565|75795678|FG001|Received Treatment|Overall Study||6||
59676471|NCT01254565|75795679|FG002|Received Treatment|Overall Study||21||
59676472|NCT01254565|75795680|FG003|Received Treatment|Overall Study||21||
59676473|NCT01254565|75795681|FG004|Received Treatment|Overall Study||13||
59676474|NCT01254565|75795682|FG005|Received Treatment|Overall Study||13||
59676475|NCT01254565|75795677|FG000|COMPLETED|Overall Study||4||
59676476|NCT01254565|75795678|FG001|COMPLETED|Overall Study||6||
59676477|NCT01254565|75795679|FG002|COMPLETED|Overall Study||21||
59676478|NCT01254565|75795680|FG003|COMPLETED|Overall Study||20||
59676479|NCT01254565|75795681|FG004|COMPLETED|Overall Study||12||
59676480|NCT01254565|75795682|FG005|COMPLETED|Overall Study||13||
59676481|NCT01254565|75795677|FG000|NOT COMPLETED|Overall Study||1||
59676482|NCT01254565|75795678|FG001|NOT COMPLETED|Overall Study||1||
59676483|NCT01254565|75795679|FG002|NOT COMPLETED|Overall Study||0||
59676484|NCT01254565|75795680|FG003|NOT COMPLETED|Overall Study||1||
59676485|NCT01254565|75795681|FG004|NOT COMPLETED|Overall Study||4||
59676486|NCT01254565|75795682|FG005|NOT COMPLETED|Overall Study||4||
59676487|NCT01254409|75795700|FG000|STARTED|Overall Study||6||
59676488|NCT01254409|75795701|FG001|STARTED|Overall Study||6||
59676489|NCT01254409|75795702|FG002|STARTED|Overall Study||5||
59676490|NCT01254409|75795703|FG003|STARTED|Overall Study||4||
59676491|NCT01254409|75795700|FG000|COMPLETED|Overall Study||6||
59676492|NCT01254409|75795701|FG001|COMPLETED|Overall Study||5||
59676493|NCT01254409|75795702|FG002|COMPLETED|Overall Study||5||
59676494|NCT01254409|75795703|FG003|COMPLETED|Overall Study||4||
59676495|NCT01254409|75795700|FG000|NOT COMPLETED|Overall Study||0||
59676496|NCT01254409|75795701|FG001|NOT COMPLETED|Overall Study||1||
59676497|NCT01254409|75795702|FG002|NOT COMPLETED|Overall Study||0||
59676498|NCT01254409|75795703|FG003|NOT COMPLETED|Overall Study||0||
59676499|NCT01254331|75795716|FG000|STARTED|Initial Phase||51||
59676500|NCT01254331|75795716|FG000|COMPLETED|Initial Phase||46||
59676501|NCT01254331|75795716|FG000|NOT COMPLETED|Initial Phase||5||
59676502|NCT01254331|75795716|FG000|STARTED|Extension Phase|1 participant withdrew consent after completing initial phase and did not enter the extension phase|45||
59676503|NCT01254331|75795716|FG000|COMPLETED|Extension Phase||41||
59676504|NCT01254331|75795716|FG000|NOT COMPLETED|Extension Phase||4||
59676505|NCT04218279|75795722|FG000|STARTED|Overall Study||316||16
59676506|NCT04218279|75795723|FG001|STARTED|Overall Study||362||20
59676507|NCT04218279|75795722|FG000|COMPLETED|Overall Study||211||15
59676508|NCT04218279|75795723|FG001|COMPLETED|Overall Study||225||20
59676509|NCT04218279|75795722|FG000|NOT COMPLETED|Overall Study||105||1
59676510|NCT04218279|75795723|FG001|NOT COMPLETED|Overall Study||137||0
59676511|NCT01254292|75795731|FG000|STARTED|Comparative Phase||282||
59676512|NCT01254292|75795732|FG001|STARTED|Comparative Phase||285||
59676513|NCT01254292|75795731|FG000|Participants Received Treatment|Comparative Phase|safety population|279||
59676514|NCT01254292|75795732|FG001|Participants Received Treatment|Comparative Phase|safety population|281||
59676515|NCT01254292|75795731|FG000|COMPLETED|Comparative Phase||227||
59676516|NCT01254292|75795732|FG001|COMPLETED|Comparative Phase||204||
59676517|NCT01254292|75795731|FG000|NOT COMPLETED|Comparative Phase||55||
59676518|NCT01254292|75795732|FG001|NOT COMPLETED|Comparative Phase||81||
59676519|NCT01254292|75795731|FG000|STARTED|LCS12 Extension Phase|A total of 200 participants elected to enter this optional Extension Phase.|200||
59676520|NCT01254292|75795732|FG001|STARTED|LCS12 Extension Phase|Optional Extension Phase was for LCS12 group only.|0||
59676521|NCT01254292|75795731|FG000|COMPLETED|LCS12 Extension Phase||163||
59676522|NCT01254292|75795732|FG001|COMPLETED|LCS12 Extension Phase||0||
59676523|NCT01254292|75795731|FG000|NOT COMPLETED|LCS12 Extension Phase||37||
59676524|NCT01254292|75795732|FG001|NOT COMPLETED|LCS12 Extension Phase||0||
59676525|NCT01254019|75795741|FG000|STARTED|Overall Study||61||
59676526|NCT01254019|75795742|FG001|STARTED|Overall Study||125||
59676527|NCT01254019|75795741|FG000|COMPLETED|Overall Study||60||
59676528|NCT01254019|75795742|FG001|COMPLETED|Overall Study||121||
59676529|NCT01254019|75795741|FG000|NOT COMPLETED|Overall Study||1||
59676530|NCT01254019|75795742|FG001|NOT COMPLETED|Overall Study||4||
59676531|NCT01253317|75795751|FG000|STARTED|Overall Study||12||
59676532|NCT01253317|75795751|FG000|COMPLETED|Overall Study||10||
59676533|NCT01253317|75795751|FG000|NOT COMPLETED|Overall Study||2||
59676534|NCT01253200|75795764|FG000|STARTED|Overall Study||125||
59676535|NCT01253200|75795765|FG001|STARTED|Overall Study||125||
59676536|NCT01253200|75795766|FG002|STARTED|Overall Study||30||
59676537|NCT01253200|75795767|FG003|STARTED|Overall Study||17||
59676538|NCT01253200|75795768|FG004|STARTED|Overall Study||5||
59676539|NCT01253200|75795764|FG000|Procedure|Overall Study||109||
59676540|NCT01253200|75795765|FG001|Procedure|Overall Study||111||
59676541|NCT01253200|75795766|FG002|Procedure|Overall Study||28||
59676542|NCT01253200|75795767|FG003|Procedure|Overall Study||12||
59676543|NCT01253200|75795768|FG004|Procedure|Overall Study||0||
59676544|NCT01253200|75795764|FG000|10 Day Follow-up|Overall Study||106||
59676545|NCT01253200|75795765|FG001|10 Day Follow-up|Overall Study||111||
59676546|NCT01253200|75795766|FG002|10 Day Follow-up|Overall Study||28||
59676547|NCT01253200|75795767|FG003|10 Day Follow-up|Overall Study||12||
59676548|NCT01253200|75795768|FG004|10 Day Follow-up|Overall Study||0||
59676549|NCT01253200|75795764|FG000|3 Month Follow-up|Overall Study||104||
59676550|NCT01253200|75795765|FG001|3 Month Follow-up|Overall Study||106||
59676551|NCT01253200|75795766|FG002|3 Month Follow-up|Overall Study||28||
59676552|NCT01253200|75795767|FG003|3 Month Follow-up|Overall Study||12||
59676553|NCT01253200|75795768|FG004|3 Month Follow-up|Overall Study||0||
59676554|NCT01253200|75795764|FG000|COMPLETED|Overall Study||104||
59676555|NCT01253200|75795765|FG001|COMPLETED|Overall Study||106||
59676556|NCT01253200|75795766|FG002|COMPLETED|Overall Study||28||
59676557|NCT01253200|75795767|FG003|COMPLETED|Overall Study||12||
59676558|NCT01253200|75795768|FG004|COMPLETED|Overall Study||0||
59676559|NCT01253200|75795764|FG000|NOT COMPLETED|Overall Study||21||
59676560|NCT01253200|75795765|FG001|NOT COMPLETED|Overall Study||19||
59676561|NCT01253200|75795766|FG002|NOT COMPLETED|Overall Study||2||
59676562|NCT01253200|75795767|FG003|NOT COMPLETED|Overall Study||5||
59676563|NCT01253200|75795768|FG004|NOT COMPLETED|Overall Study||5||
59676564|NCT01253044|75795779|FG000|STARTED|Overall Study||80||
59676565|NCT01253044|75795780|FG001|STARTED|Overall Study||80||
59676566|NCT01253044|75795779|FG000|COMPLETED|Overall Study||42||
59676567|NCT01253044|75795780|FG001|COMPLETED|Overall Study||51||
59676568|NCT01253044|75795779|FG000|NOT COMPLETED|Overall Study||38||
59676569|NCT01253044|75795780|FG001|NOT COMPLETED|Overall Study||29||
59676570|NCT01252966|75795788|FG000|STARTED|Overall Study||108||
59676571|NCT01252966|75795789|FG001|STARTED|Overall Study||105||
59676572|NCT01252966|75795788|FG000|COMPLETED|Overall Study||85||
59676573|NCT01252966|75795789|FG001|COMPLETED|Overall Study||92||
59676574|NCT01252966|75795788|FG000|NOT COMPLETED|Overall Study||23||
59676575|NCT01252966|75795789|FG001|NOT COMPLETED|Overall Study||13||
59676576|NCT01252810|75795799|FG000|STARTED|Overall Study||142||
59676577|NCT01252810|75795800|FG001|STARTED|Overall Study||142||
59676578|NCT01252810|75795799|FG000|COMPLETED|Overall Study||128||
59676579|NCT01252810|75795800|FG001|COMPLETED|Overall Study||139||
59676580|NCT01252810|75795799|FG000|NOT COMPLETED|Overall Study||14||
59676581|NCT01252810|75795800|FG001|NOT COMPLETED|Overall Study||3||
59676582|NCT01252186|75795809|FG000|STARTED|Overall Study||87||
59676583|NCT01252186|75795810|FG001|STARTED|Overall Study||91||
59676584|NCT01252186|75795811|FG002|STARTED|Overall Study||87||
59676585|NCT01252186|75795809|FG000|Received Study Drug|Overall Study||83||
59676586|NCT01252186|75795810|FG001|Received Study Drug|Overall Study||89||
59676587|NCT01252186|75795811|FG002|Received Study Drug|Overall Study||80||
59676588|NCT01252186|75795809|FG000|COMPLETED|Overall Study||57||
59676589|NCT01252186|75795810|FG001|COMPLETED|Overall Study||59||
59676590|NCT01252186|75795811|FG002|COMPLETED|Overall Study||53||
59676591|NCT01252186|75795809|FG000|NOT COMPLETED|Overall Study||30||
59676592|NCT01252186|75795810|FG001|NOT COMPLETED|Overall Study||32||
59676593|NCT01252186|75795811|FG002|NOT COMPLETED|Overall Study||34||
59676594|NCT03988335|75795821|FG000|STARTED|Overall Study||16||
59676595|NCT03988335|75795822|FG001|STARTED|Overall Study||19||
59676596|NCT03988335|75795821|FG000|COMPLETED|Overall Study||14||
59676597|NCT03988335|75795822|FG001|COMPLETED|Overall Study||18||
59676598|NCT03988335|75795821|FG000|NOT COMPLETED|Overall Study||2||
59676599|NCT03988335|75795822|FG001|NOT COMPLETED|Overall Study||1||
59676600|NCT04320316|75795828|FG000|STARTED|Overall Study|1|1|Patient started on Burosumab and the dose was adjusted upwards every 4 weeks because of still having relatively low Phsophorus level.|
59676601|NCT04320316|75795828|FG000|COMPLETED|Overall Study||1||
59676602|NCT04320316|75795828|FG000|NOT COMPLETED|Overall Study||0||
59676603|NCT01731782|75795839|FG000|STARTED|Overall Study||41||
59676604|NCT01731782|75795840|FG001|STARTED|Overall Study||38||
59676605|NCT01731782|75795839|FG000|COMPLETED|Overall Study||41||
59676606|NCT01731782|75795840|FG001|COMPLETED|Overall Study||38||
59676607|NCT01731782|75795839|FG000|NOT COMPLETED|Overall Study||0||
59676608|NCT01731782|75795840|FG001|NOT COMPLETED|Overall Study||0||
59676609|NCT01251952|75795846|FG000|STARTED|Overall Study||2||
59676610|NCT01251952|75795846|FG000|COMPLETED|Overall Study||1||
59676611|NCT01251952|75795846|FG000|NOT COMPLETED|Overall Study||1||
59676612|NCT01251367|75795850|FG000|STARTED|Overall Study||345||
59676613|NCT01251367|75795850|FG000|Cycle 1|Overall Study||345||
59676614|NCT01251367|75795850|FG000|Cycle 2|Overall Study||297||
59676615|NCT01251367|75795850|FG000|Cycle 3|Overall Study||224||
59676616|NCT01251367|75795850|FG000|Cycle 4|Overall Study||139||
59676617|NCT01251367|75795850|FG000|COMPLETED|Overall Study||269||
59676618|NCT01251367|75795850|FG000|NOT COMPLETED|Overall Study||76||
59676619|NCT01250509|75795856|FG000|STARTED|Overall Study||24||
59676620|NCT01250509|75795857|FG001|STARTED|Overall Study||23||
59676621|NCT01250509|75795856|FG000|COMPLETED|Overall Study||19||
59676622|NCT01250509|75795857|FG001|COMPLETED|Overall Study||21||
59676623|NCT01250509|75795856|FG000|NOT COMPLETED|Overall Study||5||
59676624|NCT01250509|75795857|FG001|NOT COMPLETED|Overall Study||2||
59676625|NCT01250119|75795865|FG000|STARTED|Diagnostic Phase||688||
59676626|NCT01250119|75795866|FG001|STARTED|Diagnostic Phase||0||
59676627|NCT01250119|75795865|FG000|COMPLETED|Diagnostic Phase|Completed refers to participants with both positive and negative EGFR mutation test result.|575||
59676628|NCT01250119|75795866|FG001|COMPLETED|Diagnostic Phase||0||
59676629|NCT01250119|75795865|FG000|NOT COMPLETED|Diagnostic Phase||113||
59676630|NCT01250119|75795866|FG001|NOT COMPLETED|Diagnostic Phase||0||
59676631|NCT01250119|75795865|FG000|STARTED|Treatment Phase||0||
59676632|NCT01250119|75795866|FG001|STARTED|Treatment Phase|Out of 52 participants with positive EGFR mutation test result, only 41 participants were treated.|41||
59676633|NCT01250119|75795865|FG000|COMPLETED|Treatment Phase||0||
59676634|NCT01250119|75795866|FG001|COMPLETED|Treatment Phase||0||
59676635|NCT01250119|75795865|FG000|NOT COMPLETED|Treatment Phase||0||
59676636|NCT01250119|75795866|FG001|NOT COMPLETED|Treatment Phase||41||
59676637|NCT01250002|75795875|FG000|STARTED|Overall Study||35||
59676638|NCT01250002|75795876|FG001|STARTED|Overall Study||35||
59676639|NCT01250002|75795875|FG000|COMPLETED|Overall Study||31||
59676640|NCT01250002|75795876|FG001|COMPLETED|Overall Study||32||
59676641|NCT01250002|75795875|FG000|NOT COMPLETED|Overall Study||4||
59676642|NCT01250002|75795876|FG001|NOT COMPLETED|Overall Study||3||
59676643|NCT01246960|75795884|FG000|STARTED|Overall Study||84||
59676644|NCT01246960|75795885|FG001|STARTED|Overall Study||84||
59676645|NCT01246960|75795884|FG000|Received Any Quantity of Study Drug|Overall Study||82||
59676646|NCT01246960|75795885|FG001|Received Any Quantity of Study Drug|Overall Study||80||
59676647|NCT01246960|75795884|FG000|COMPLETED|Overall Study||78||
59676648|NCT01246960|75795885|FG001|COMPLETED|Overall Study||80||
59676649|NCT01246960|75795884|FG000|NOT COMPLETED|Overall Study||6||
59676650|NCT01246960|75795885|FG001|NOT COMPLETED|Overall Study||4||
59676651|NCT01244620|75795891|FG000|STARTED|Overall Study||4||
59676652|NCT01244620|75795892|FG001|STARTED|Overall Study||4||
59676653|NCT01244620|75795893|FG002|STARTED|Overall Study||4||
59676654|NCT01244620|75795894|FG003|STARTED|Overall Study||4||
59676655|NCT01244620|75795891|FG000|COMPLETED|Overall Study||0||
59676656|NCT01244620|75795892|FG001|COMPLETED|Overall Study||0||
59676657|NCT01244620|75795893|FG002|COMPLETED|Overall Study||0||
59676658|NCT01244620|75795894|FG003|COMPLETED|Overall Study||0||
59676659|NCT01244620|75795891|FG000|NOT COMPLETED|Overall Study||4||
59676660|NCT01244620|75795892|FG001|NOT COMPLETED|Overall Study||4||
59676661|NCT01244620|75795893|FG002|NOT COMPLETED|Overall Study||4||
59676662|NCT01244620|75795894|FG003|NOT COMPLETED|Overall Study||4||
59676663|NCT01267201|75795904|FG000|STARTED|First Intervention Period||4||
59676664|NCT01267201|75795905|FG001|STARTED|First Intervention Period||4||
59676665|NCT01267201|75795906|FG002|STARTED|First Intervention Period||4||
59676666|NCT01267201|75795907|FG003|STARTED|First Intervention Period||4||
59676667|NCT01267201|75795908|FG004|STARTED|First Intervention Period||4||
59676668|NCT01267201|75795909|FG005|STARTED|First Intervention Period||4||
59676669|NCT01267201|75795904|FG000|COMPLETED|First Intervention Period||3||
59676670|NCT01267201|75795905|FG001|COMPLETED|First Intervention Period||4||
59676671|NCT01267201|75795906|FG002|COMPLETED|First Intervention Period||4||
59676672|NCT01267201|75795907|FG003|COMPLETED|First Intervention Period||4||
59676673|NCT01267201|75795908|FG004|COMPLETED|First Intervention Period||4||
59676674|NCT01267201|75795909|FG005|COMPLETED|First Intervention Period||4||
59676675|NCT01267201|75795904|FG000|NOT COMPLETED|First Intervention Period||1||
59676676|NCT01267201|75795905|FG001|NOT COMPLETED|First Intervention Period||0||
59676677|NCT01267201|75795906|FG002|NOT COMPLETED|First Intervention Period||0||
59676678|NCT01267201|75795907|FG003|NOT COMPLETED|First Intervention Period||0||
59676679|NCT01267201|75795908|FG004|NOT COMPLETED|First Intervention Period||0||
59676680|NCT01267201|75795909|FG005|NOT COMPLETED|First Intervention Period||0||
59676681|NCT01267201|75795904|FG000|STARTED|Washout Period (At Least 2 Days)||3||
59676682|NCT01267201|75795905|FG001|STARTED|Washout Period (At Least 2 Days)||4||
59676683|NCT01267201|75795906|FG002|STARTED|Washout Period (At Least 2 Days)||4||
59676684|NCT01267201|75795907|FG003|STARTED|Washout Period (At Least 2 Days)||4||
59676685|NCT01267201|75795908|FG004|STARTED|Washout Period (At Least 2 Days)||4||
59676686|NCT01267201|75795909|FG005|STARTED|Washout Period (At Least 2 Days)||4||
59676687|NCT01267201|75795904|FG000|COMPLETED|Washout Period (At Least 2 Days)||3||
59676688|NCT01267201|75795905|FG001|COMPLETED|Washout Period (At Least 2 Days)||4||
59676689|NCT01267201|75795906|FG002|COMPLETED|Washout Period (At Least 2 Days)||4||
59676690|NCT01267201|75795907|FG003|COMPLETED|Washout Period (At Least 2 Days)||4||
59676691|NCT01267201|75795908|FG004|COMPLETED|Washout Period (At Least 2 Days)||4||
59676692|NCT01267201|75795909|FG005|COMPLETED|Washout Period (At Least 2 Days)||4||
59676693|NCT01267201|75795904|FG000|NOT COMPLETED|Washout Period (At Least 2 Days)||0||
59676694|NCT01267201|75795905|FG001|NOT COMPLETED|Washout Period (At Least 2 Days)||0||
59676695|NCT01267201|75795906|FG002|NOT COMPLETED|Washout Period (At Least 2 Days)||0||
59676696|NCT01267201|75795907|FG003|NOT COMPLETED|Washout Period (At Least 2 Days)||0||
59676697|NCT01267201|75795908|FG004|NOT COMPLETED|Washout Period (At Least 2 Days)||0||
59676698|NCT01267201|75795909|FG005|NOT COMPLETED|Washout Period (At Least 2 Days)||0||
59676699|NCT01267201|75795904|FG000|STARTED|Second Intervention Period||3||
59676700|NCT01267201|75795905|FG001|STARTED|Second Intervention Period||4||
59676701|NCT01267201|75795906|FG002|STARTED|Second Intervention Period||4||
59676702|NCT01267201|75795907|FG003|STARTED|Second Intervention Period||4||
59676703|NCT01267201|75795908|FG004|STARTED|Second Intervention Period||4||
59676704|NCT01267201|75795909|FG005|STARTED|Second Intervention Period||4||
59676705|NCT01267201|75795904|FG000|COMPLETED|Second Intervention Period||3||
59676706|NCT01267201|75795905|FG001|COMPLETED|Second Intervention Period||3||
59676707|NCT01267201|75795906|FG002|COMPLETED|Second Intervention Period||4||
59676708|NCT01267201|75795907|FG003|COMPLETED|Second Intervention Period||4||
59676709|NCT01267201|75795908|FG004|COMPLETED|Second Intervention Period||4||
59676710|NCT01267201|75795909|FG005|COMPLETED|Second Intervention Period||4||
59676711|NCT01267201|75795904|FG000|NOT COMPLETED|Second Intervention Period||0||
59676712|NCT01267201|75795905|FG001|NOT COMPLETED|Second Intervention Period||1||
59676713|NCT01267201|75795906|FG002|NOT COMPLETED|Second Intervention Period||0||
59676714|NCT01267201|75795907|FG003|NOT COMPLETED|Second Intervention Period||0||
59676715|NCT01267201|75795908|FG004|NOT COMPLETED|Second Intervention Period||0||
59676716|NCT01267201|75795909|FG005|NOT COMPLETED|Second Intervention Period||0||
59676717|NCT01267201|75795904|FG000|STARTED|Washout Period (At Least 2 Days)||3||
59676718|NCT01267201|75795905|FG001|STARTED|Washout Period (At Least 2 Days)||3||
59676719|NCT01267201|75795906|FG002|STARTED|Washout Period (At Least 2 Days)||4||
59676720|NCT01267201|75795907|FG003|STARTED|Washout Period (At Least 2 Days)||4||
59676721|NCT01267201|75795908|FG004|STARTED|Washout Period (At Least 2 Days)||4||
59676722|NCT01267201|75795909|FG005|STARTED|Washout Period (At Least 2 Days)||4||
59676723|NCT01267201|75795904|FG000|COMPLETED|Washout Period (At Least 2 Days)||3||
59676724|NCT01267201|75795905|FG001|COMPLETED|Washout Period (At Least 2 Days)||3||
59676725|NCT01267201|75795906|FG002|COMPLETED|Washout Period (At Least 2 Days)||4||
59676726|NCT01267201|75795907|FG003|COMPLETED|Washout Period (At Least 2 Days)||4||
59676727|NCT01267201|75795908|FG004|COMPLETED|Washout Period (At Least 2 Days)||4||
59676728|NCT01267201|75795909|FG005|COMPLETED|Washout Period (At Least 2 Days)||4||
59676729|NCT01267201|75795904|FG000|NOT COMPLETED|Washout Period (At Least 2 Days)||0||
59676730|NCT01267201|75795905|FG001|NOT COMPLETED|Washout Period (At Least 2 Days)||0||
59676731|NCT01267201|75795906|FG002|NOT COMPLETED|Washout Period (At Least 2 Days)||0||
59676732|NCT01267201|75795907|FG003|NOT COMPLETED|Washout Period (At Least 2 Days)||0||
59676733|NCT01267201|75795908|FG004|NOT COMPLETED|Washout Period (At Least 2 Days)||0||
59676734|NCT01267201|75795909|FG005|NOT COMPLETED|Washout Period (At Least 2 Days)||0||
59676735|NCT01267201|75795904|FG000|STARTED|Third Intervention Period||3||
59676736|NCT01267201|75795905|FG001|STARTED|Third Intervention Period||3||
59676737|NCT01267201|75795906|FG002|STARTED|Third Intervention Period||4||
59676738|NCT01267201|75795907|FG003|STARTED|Third Intervention Period||4||
59676739|NCT01267201|75795908|FG004|STARTED|Third Intervention Period||4||
59676740|NCT01267201|75795909|FG005|STARTED|Third Intervention Period||4||
59676741|NCT01267201|75795904|FG000|COMPLETED|Third Intervention Period||3||
59676742|NCT01267201|75795905|FG001|COMPLETED|Third Intervention Period||3||
59676743|NCT01267201|75795906|FG002|COMPLETED|Third Intervention Period||4||
59676744|NCT01267201|75795907|FG003|COMPLETED|Third Intervention Period||4||
59676745|NCT01267201|75795908|FG004|COMPLETED|Third Intervention Period||4||
59676746|NCT01267201|75795909|FG005|COMPLETED|Third Intervention Period||4||
59676747|NCT01267201|75795904|FG000|NOT COMPLETED|Third Intervention Period||0||
59676748|NCT01267201|75795905|FG001|NOT COMPLETED|Third Intervention Period||0||
59676749|NCT01267201|75795906|FG002|NOT COMPLETED|Third Intervention Period||0||
59676750|NCT01267201|75795907|FG003|NOT COMPLETED|Third Intervention Period||0||
59676751|NCT01267201|75795908|FG004|NOT COMPLETED|Third Intervention Period||0||
59676752|NCT01267201|75795909|FG005|NOT COMPLETED|Third Intervention Period||0||
59676753|NCT01266967|75795919|FG000|STARTED|Overall Study||89||
59676754|NCT01266967|75795920|FG001|STARTED|Overall Study||83||
59676755|NCT01266967|75795919|FG000|COMPLETED|Overall Study||0||
59676756|NCT01266967|75795920|FG001|COMPLETED|Overall Study||0||
59676757|NCT01266967|75795919|FG000|NOT COMPLETED|Overall Study||89||
59676758|NCT01266967|75795920|FG001|NOT COMPLETED|Overall Study||83||
59676759|NCT01266850|75795934|FG000|STARTED|Overall Study||242||
59676760|NCT01266850|75795935|FG001|STARTED|Overall Study||248||
59676761|NCT01266850|75795936|FG002|STARTED|Overall Study||238||
59676762|NCT01266850|75795937|FG003|STARTED|Overall Study||329||
59676763|NCT01266850|75795938|FG004|STARTED|Overall Study||327||
59676764|NCT01266850|75795934|FG000|Received Second Vaccine|Overall Study||231||
59676765|NCT01266850|75795935|FG001|Received Second Vaccine|Overall Study||233||
59676766|NCT01266850|75795936|FG002|Received Second Vaccine|Overall Study||227||
59676767|NCT01266850|75795937|FG003|Received Second Vaccine|Overall Study||311||
59676768|NCT01266850|75795938|FG004|Received Second Vaccine|Overall Study||307||
59676769|NCT01266850|75795934|FG000|Received Third Vaccine|Overall Study||221||
60078006|NCT01479621|76193032|FG006|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0||
60078007|NCT01479621|76193026|FG000|STARTED|Treatment Period||0||
60078008|NCT01479621|76193027|FG001|STARTED|Treatment Period||103||
59676770|NCT01266850|75795935|FG001|Received Third Vaccine|Overall Study||221||
59676771|NCT01266850|75795936|FG002|Received Third Vaccine|Overall Study||217||
59676772|NCT01266850|75795937|FG003|Received Third Vaccine|Overall Study||0||
59676773|NCT01266850|75795938|FG004|Received Third Vaccine|Overall Study||299||
59676774|NCT01266850|75795934|FG000|COMPLETED|Overall Study||212||
59676775|NCT01266850|75795935|FG001|COMPLETED|Overall Study||212||
59676776|NCT01266850|75795936|FG002|COMPLETED|Overall Study||214||
59676777|NCT01266850|75795937|FG003|COMPLETED|Overall Study||301||
59676778|NCT01266850|75795938|FG004|COMPLETED|Overall Study||297||
59676779|NCT01266850|75795934|FG000|NOT COMPLETED|Overall Study||30||
59676780|NCT01266850|75795935|FG001|NOT COMPLETED|Overall Study||36||
59676781|NCT01266850|75795936|FG002|NOT COMPLETED|Overall Study||24||
59676782|NCT01266850|75795937|FG003|NOT COMPLETED|Overall Study||28||
59676783|NCT01266850|75795938|FG004|NOT COMPLETED|Overall Study||30||
59676784|NCT01266460|75795950|FG000|STARTED|Overall Study||50||
59676785|NCT01266460|75795950|FG000|COMPLETED|Overall Study||16||
59676786|NCT01266460|75795950|FG000|NOT COMPLETED|Overall Study||34||
59676787|NCT01266265|75795956|FG000|STARTED|Overall Study||666||
59676788|NCT01266265|75795957|FG001|STARTED|Overall Study||667||
59676789|NCT01266265|75795956|FG000|COMPLETED|Overall Study||461||
59676790|NCT01266265|75795957|FG001|COMPLETED|Overall Study||477||
59676791|NCT01266265|75795956|FG000|NOT COMPLETED|Overall Study||205||
60078009|NCT01479621|76193028|FG002|STARTED|Treatment Period||104||
59676792|NCT01266265|75795957|FG001|NOT COMPLETED|Overall Study||190||
59676793|NCT03268382|75795967|FG000|STARTED|Overall Study||28||
59676794|NCT03268382|75795968|FG001|STARTED|Overall Study||3||
59676795|NCT03268382|75795969|FG002|STARTED|Overall Study||2||
59676796|NCT03268382|75795970|FG003|STARTED|Overall Study||3||
59676797|NCT03268382|75795967|FG000|COMPLETED|Overall Study||28||
59676798|NCT03268382|75795968|FG001|COMPLETED|Overall Study||3||
59676799|NCT03268382|75795969|FG002|COMPLETED|Overall Study||2||
59676800|NCT03268382|75795970|FG003|COMPLETED|Overall Study||3||
59676801|NCT03268382|75795967|FG000|NOT COMPLETED|Overall Study||0||
59676802|NCT03268382|75795968|FG001|NOT COMPLETED|Overall Study||0||
59676803|NCT03268382|75795969|FG002|NOT COMPLETED|Overall Study||0||
60078010|NCT01479621|76193029|FG003|STARTED|Treatment Period||104||
60078011|NCT01479621|76193030|FG004|STARTED|Treatment Period||103||
60078012|NCT01479621|76193031|FG005|STARTED|Treatment Period||104||
59676804|NCT03268382|75795970|FG003|NOT COMPLETED|Overall Study||0||
59676805|NCT01266148|75795982|FG000|STARTED|Overall Study||56||
59676806|NCT01266148|75795983|FG001|STARTED|Overall Study||59||
59676807|NCT01266148|75795982|FG000|COMPLETED|Overall Study||49||
59676808|NCT01266148|75795983|FG001|COMPLETED|Overall Study||56||
59676809|NCT01266148|75795982|FG000|NOT COMPLETED|Overall Study||7||
59676810|NCT01266148|75795983|FG001|NOT COMPLETED|Overall Study||3||
59676811|NCT01266070|75795989|FG000|STARTED|Overall Study||6||
59676812|NCT01266070|75795989|FG000|COMPLETED|Overall Study||2||
59676813|NCT01266070|75795989|FG000|NOT COMPLETED|Overall Study||4||
59676814|NCT01265992|75795993|FG000|STARTED|Overall Study||50||
59676815|NCT01265992|75795993|FG000|Received Treatment|Overall Study||49||
59676816|NCT01265992|75795993|FG000|COMPLETED|Overall Study||41||
59676817|NCT01265992|75795993|FG000|NOT COMPLETED|Overall Study||9||
59676818|NCT01265953|75795999|FG000|STARTED|Overall Study||50||
59676819|NCT01265953|75796000|FG001|STARTED|Overall Study||48||
59676820|NCT01265953|75795999|FG000|COMPLETED|Overall Study||45||
59676821|NCT01265953|75796000|FG001|COMPLETED|Overall Study||45||
59676822|NCT01265953|75795999|FG000|NOT COMPLETED|Overall Study||5||
59676823|NCT01265953|75796000|FG001|NOT COMPLETED|Overall Study||3||
59676824|NCT01265875|75796006|FG000|STARTED|Overall Study||12||
59676825|NCT01265875|75796006|FG000|COMPLETED|Overall Study||11||
59676826|NCT01265875|75796006|FG000|NOT COMPLETED|Overall Study||1||
59676827|NCT01265797|75796013|FG000|STARTED|Run-in Month||34||
59676828|NCT01265797|75796014|FG001|STARTED|Run-in Month||34||
59676829|NCT01265797|75796013|FG000|COMPLETED|Run-in Month||34||
59676830|NCT01265797|75796014|FG001|COMPLETED|Run-in Month||29||
59676831|NCT01265797|75796013|FG000|NOT COMPLETED|Run-in Month||0||
59676832|NCT01265797|75796014|FG001|NOT COMPLETED|Run-in Month||5||
59676833|NCT01265797|75796013|FG000|STARTED|Blinded Month||34||
59676834|NCT01265797|75796014|FG001|STARTED|Blinded Month||29||
59676835|NCT01265797|75796013|FG000|COMPLETED|Blinded Month||24||
59676836|NCT01265797|75796014|FG001|COMPLETED|Blinded Month||27||
59676837|NCT01265797|75796013|FG000|NOT COMPLETED|Blinded Month||10||
59676838|NCT01265797|75796014|FG001|NOT COMPLETED|Blinded Month||2||
59676839|NCT01265797|75796013|FG000|STARTED|Open Label Month||24||
59676840|NCT01265797|75796014|FG001|STARTED|Open Label Month||27||
59676841|NCT01265797|75796013|FG000|COMPLETED|Open Label Month||24||
59676842|NCT01265797|75796014|FG001|COMPLETED|Open Label Month||26||
59676843|NCT01265797|75796013|FG000|NOT COMPLETED|Open Label Month||0||
59676844|NCT01265797|75796014|FG001|NOT COMPLETED|Open Label Month||1||
59676845|NCT01265719|75796024|FG000|STARTED|Overall Study||102||
59676846|NCT01265719|75796025|FG001|STARTED|Overall Study||73||
59676847|NCT01265719|75796024|FG000|COMPLETED|Overall Study||88||
59676848|NCT01265719|75796025|FG001|COMPLETED|Overall Study||60||
59676849|NCT01265719|75796024|FG000|NOT COMPLETED|Overall Study||14||
59676850|NCT01265719|75796025|FG001|NOT COMPLETED|Overall Study||13||
59676851|NCT03148496|75796035|FG000|STARTED|Overall Study||27||
59676852|NCT03148496|75796036|FG001|STARTED|Overall Study||28||
59676853|NCT03148496|75796037|FG002|STARTED|Overall Study||25||
59676854|NCT03148496|75796038|FG003|STARTED|Overall Study||27||
59676855|NCT03148496|75796035|FG000|COMPLETED|Overall Study||20||
59676856|NCT03148496|75796036|FG001|COMPLETED|Overall Study||19||
59676857|NCT03148496|75796037|FG002|COMPLETED|Overall Study||19||
59676858|NCT03148496|75796038|FG003|COMPLETED|Overall Study||26||
59676859|NCT03148496|75796035|FG000|NOT COMPLETED|Overall Study||7||
59676860|NCT03148496|75796036|FG001|NOT COMPLETED|Overall Study||9||
59676861|NCT03148496|75796037|FG002|NOT COMPLETED|Overall Study||6||
59676862|NCT03148496|75796038|FG003|NOT COMPLETED|Overall Study||1||
59676863|NCT01265563|75796057|FG000|STARTED|Overall Study||16||
59676864|NCT01265563|75796058|FG001|STARTED|Overall Study||13||
59676865|NCT01265563|75796059|FG002|STARTED|Overall Study||17||
59676866|NCT01265563|75796060|FG003|STARTED|Overall Study||16||
59676867|NCT01265563|75796061|FG004|STARTED|Overall Study||16||
59676868|NCT01265563|75796057|FG000|COMPLETED|Overall Study||16||
59676869|NCT01265563|75796058|FG001|COMPLETED|Overall Study||12||
59676870|NCT01265563|75796059|FG002|COMPLETED|Overall Study||16||
59676871|NCT01265563|75796060|FG003|COMPLETED|Overall Study||16||
59676872|NCT01265563|75796061|FG004|COMPLETED|Overall Study||14||
59676873|NCT01265563|75796057|FG000|NOT COMPLETED|Overall Study||0||
59676874|NCT01265563|75796058|FG001|NOT COMPLETED|Overall Study||1||
59676875|NCT01265563|75796059|FG002|NOT COMPLETED|Overall Study||1||
59676876|NCT01265563|75796060|FG003|NOT COMPLETED|Overall Study||0||
59676877|NCT01265563|75796061|FG004|NOT COMPLETED|Overall Study||2||
59676878|NCT01265056|75796080|FG000|STARTED|Initial Study Period||26||
59676879|NCT01265056|75796081|FG001|STARTED|Initial Study Period||27||
59676880|NCT01265056|75796080|FG000|COMPLETED|Initial Study Period||24||
59676881|NCT01265056|75796081|FG001|COMPLETED|Initial Study Period||25||
59676882|NCT01265056|75796080|FG000|NOT COMPLETED|Initial Study Period||2||
59676883|NCT01265056|75796081|FG001|NOT COMPLETED|Initial Study Period||2||
59676884|NCT01265056|75796080|FG000|STARTED|Follow up||26||
59676885|NCT01265056|75796081|FG001|STARTED|Follow up||27||
59676886|NCT01265056|75796080|FG000|COMPLETED|Follow up||19||
59676887|NCT01265056|75796081|FG001|COMPLETED|Follow up||24||
59676888|NCT01265056|75796080|FG000|NOT COMPLETED|Follow up||7||
59676889|NCT01265056|75796081|FG001|NOT COMPLETED|Follow up||3||
59676890|NCT01264939|75796089|FG000|STARTED|Overall Study||84||
59676891|NCT01264939|75796090|FG001|STARTED|Overall Study||252||
59676892|NCT01264939|75796089|FG000|COMPLETED|Overall Study||66||
59676893|NCT01264939|75796090|FG001|COMPLETED|Overall Study||224||
59676894|NCT01264939|75796089|FG000|NOT COMPLETED|Overall Study||18||
59676895|NCT01264939|75796090|FG001|NOT COMPLETED|Overall Study||28||
59676896|NCT01264081|75796096|FG000|STARTED|Participants Screened||34||
59676897|NCT01264081|75796096|FG000|COMPLETED|Participants Screened||4||
59676898|NCT01264081|75796096|FG000|NOT COMPLETED|Participants Screened||30||
59676899|NCT01264081|75796096|FG000|STARTED|Started Treatment||4||
59676900|NCT01264081|75796096|FG000|COMPLETED|Started Treatment||2||
59676901|NCT01264081|75796096|FG000|NOT COMPLETED|Started Treatment||2||
59676902|NCT01264081|75796096|FG000|STARTED|Analysis||2||
59676903|NCT01264081|75796096|FG000|COMPLETED|Analysis||2||
59676904|NCT01264081|75796096|FG000|NOT COMPLETED|Analysis||0||
59676905|NCT01263925|75796102|FG000|STARTED|Overall Study||276||
59676906|NCT01263925|75796103|FG001|STARTED|Overall Study||285||
59676907|NCT01263925|75796102|FG000|Full Analysis Set|Overall Study||269||
59676908|NCT01263925|75796103|FG001|Full Analysis Set|Overall Study||272||
59676909|NCT01263925|75796102|FG000|COMPLETED|Overall Study||225||
59676910|NCT01263925|75796103|FG001|COMPLETED|Overall Study||233||
59676911|NCT01263925|75796102|FG000|NOT COMPLETED|Overall Study||51||
59676912|NCT01263925|75796103|FG001|NOT COMPLETED|Overall Study||52||
59676913|NCT01263691|75796115|FG000|STARTED|Overall Study||18||
59676914|NCT01263691|75796116|FG001|STARTED|Overall Study||18||
59676915|NCT01263691|75796117|FG002|STARTED|Overall Study||17||
60078013|NCT01479621|76193032|FG006|STARTED|Treatment Period||104||
60078014|NCT01479621|76193026|FG000|Safety Population|Treatment Period||0||
59676916|NCT01263691|75796118|FG003|STARTED|Overall Study||19||
59676917|NCT01263691|75796119|FG004|STARTED|Overall Study||18||
59676918|NCT01263691|75796120|FG005|STARTED|Overall Study||15||
59676919|NCT01263691|75796115|FG000|COMPLETED|Overall Study||15||
59676920|NCT01263691|75796116|FG001|COMPLETED|Overall Study||18||
59676921|NCT01263691|75796117|FG002|COMPLETED|Overall Study||16||
59676922|NCT01263691|75796118|FG003|COMPLETED|Overall Study||18||
59676923|NCT01263691|75796119|FG004|COMPLETED|Overall Study||18||
59676924|NCT01263691|75796120|FG005|COMPLETED|Overall Study||15||
59676925|NCT01263691|75796115|FG000|NOT COMPLETED|Overall Study||3||
59676926|NCT01263691|75796116|FG001|NOT COMPLETED|Overall Study||0||
59676927|NCT01263691|75796117|FG002|NOT COMPLETED|Overall Study||1||
59676928|NCT01263691|75796118|FG003|NOT COMPLETED|Overall Study||1||
59676929|NCT01263691|75796119|FG004|NOT COMPLETED|Overall Study||0||
59676930|NCT01263691|75796120|FG005|NOT COMPLETED|Overall Study||0||
59676931|NCT01808456|75796157|FG000|STARTED|Overall Study||30||
59676932|NCT01808456|75796158|FG001|STARTED|Overall Study||32||
59676933|NCT01808456|75796157|FG000|COMPLETED|Overall Study||26||
59676934|NCT01808456|75796158|FG001|COMPLETED|Overall Study||30||
59676935|NCT01808456|75796157|FG000|NOT COMPLETED|Overall Study||4||
59676936|NCT01808456|75796158|FG001|NOT COMPLETED|Overall Study||2||
59676937|NCT00659711|75796172|FG000|STARTED|Overall Study||12||
59676938|NCT00659711|75796173|FG001|STARTED|Overall Study||10||
59676939|NCT00659711|75796172|FG000|COMPLETED|Overall Study||12||
59676940|NCT00659711|75796173|FG001|COMPLETED|Overall Study||10||
59676941|NCT00659711|75796172|FG000|NOT COMPLETED|Overall Study||0||
59676942|NCT00659711|75796173|FG001|NOT COMPLETED|Overall Study||0||
59676943|NCT02581007|75796179|FG000|STARTED|Overall Study||25||
59676944|NCT02581007|75796179|FG000|COMPLETED|Overall Study||25||
59676945|NCT02581007|75796179|FG000|NOT COMPLETED|Overall Study||0||
59676946|NCT02540330|75796185|FG000|STARTED|Overall Study||2||
59676947|NCT02540330|75796186|FG001|STARTED|Overall Study||1||
59676948|NCT02540330|75796185|FG000|COMPLETED|Overall Study||2||
59676949|NCT02540330|75796186|FG001|COMPLETED|Overall Study||1||
59676950|NCT02540330|75796185|FG000|NOT COMPLETED|Overall Study||0||
59676951|NCT02540330|75796186|FG001|NOT COMPLETED|Overall Study||0||
59676952|NCT01263496|75796197|FG000|STARTED|Enrolled - Long-Term Extension Study||72||
59676953|NCT01263496|75796198|FG001|STARTED|Enrolled - Long-Term Extension Study||75||
59676954|NCT01263496|75796199|FG002|STARTED|Enrolled - Long-Term Extension Study||72||
59676955|NCT01263496|75796200|FG003|STARTED|Enrolled - Long-Term Extension Study||75||
59676956|NCT01263496|75796201|FG004|STARTED|Enrolled - Long-Term Extension Study||74||
59676957|NCT01263496|75796202|FG005|STARTED|Enrolled - Long-Term Extension Study||17||
59676958|NCT01263496|75796203|FG006|STARTED|Enrolled - Long-Term Extension Study||17||
59676959|NCT01263496|75796204|FG007|STARTED|Enrolled - Long-Term Extension Study||18||
59676960|NCT01263496|75796205|FG008|STARTED|Enrolled - Long-Term Extension Study||18||
59676961|NCT01263496|75796197|FG000|COMPLETED|Enrolled - Long-Term Extension Study||71||
59676962|NCT01263496|75796198|FG001|COMPLETED|Enrolled - Long-Term Extension Study||75||
59676963|NCT01263496|75796199|FG002|COMPLETED|Enrolled - Long-Term Extension Study||72||
59676964|NCT01263496|75796200|FG003|COMPLETED|Enrolled - Long-Term Extension Study||74||
59676965|NCT01263496|75796201|FG004|COMPLETED|Enrolled - Long-Term Extension Study||72||
59676966|NCT01263496|75796202|FG005|COMPLETED|Enrolled - Long-Term Extension Study||17||
59676967|NCT01263496|75796203|FG006|COMPLETED|Enrolled - Long-Term Extension Study||17||
59676968|NCT01263496|75796204|FG007|COMPLETED|Enrolled - Long-Term Extension Study||18||
59676969|NCT01263496|75796205|FG008|COMPLETED|Enrolled - Long-Term Extension Study||18||
59676970|NCT01263496|75796197|FG000|NOT COMPLETED|Enrolled - Long-Term Extension Study||1||
60078015|NCT01479621|76193027|FG001|Safety Population|Treatment Period||103||
59676971|NCT01263496|75796198|FG001|NOT COMPLETED|Enrolled - Long-Term Extension Study||0||
59676972|NCT01263496|75796199|FG002|NOT COMPLETED|Enrolled - Long-Term Extension Study||0||
59676973|NCT01263496|75796200|FG003|NOT COMPLETED|Enrolled - Long-Term Extension Study||1||
59676974|NCT01263496|75796201|FG004|NOT COMPLETED|Enrolled - Long-Term Extension Study||2||
59676975|NCT01263496|75796202|FG005|NOT COMPLETED|Enrolled - Long-Term Extension Study||0||
59676976|NCT01263496|75796203|FG006|NOT COMPLETED|Enrolled - Long-Term Extension Study||0||
59676977|NCT01263496|75796204|FG007|NOT COMPLETED|Enrolled - Long-Term Extension Study||0||
59676978|NCT01263496|75796205|FG008|NOT COMPLETED|Enrolled - Long-Term Extension Study||0||
59676979|NCT01263496|75796197|FG000|STARTED|Entered - Long-Term Extension Study||71||
59676980|NCT01263496|75796198|FG001|STARTED|Entered - Long-Term Extension Study|3 participants did not enter from previous period (1 voluntary withdraw; 2 did not meet criteria).|72||
59676981|NCT01263496|75796199|FG002|STARTED|Entered - Long-Term Extension Study||72||
59676982|NCT01263496|75796200|FG003|STARTED|Entered - Long-Term Extension Study||74||
59546310|NCT02174198|75644986|FG001|STARTED|Overall Study||16||
59546311|NCT02174198|75644985|FG000|COMPLETED|Overall Study||16||
59546312|NCT02174198|75644986|FG001|COMPLETED|Overall Study||16||
59676983|NCT01263496|75796201|FG004|STARTED|Entered - Long-Term Extension Study|1 participant did not enter from previous period (voluntary withdraw).|71||
59676984|NCT01263496|75796202|FG005|STARTED|Entered - Long-Term Extension Study||17||
59676985|NCT01263496|75796203|FG006|STARTED|Entered - Long-Term Extension Study||17||
59676986|NCT01263496|75796204|FG007|STARTED|Entered - Long-Term Extension Study|1 participant did not enter from previous period (voluntary withdraw).|17||
59676987|NCT01263496|75796205|FG008|STARTED|Entered - Long-Term Extension Study||18||
59676988|NCT01263496|75796197|FG000|COMPLETED|Entered - Long-Term Extension Study||62||
59676989|NCT01263496|75796198|FG001|COMPLETED|Entered - Long-Term Extension Study||59||
59676990|NCT01263496|75796199|FG002|COMPLETED|Entered - Long-Term Extension Study||62||
59676991|NCT01263496|75796200|FG003|COMPLETED|Entered - Long-Term Extension Study||68||
59676992|NCT01263496|75796201|FG004|COMPLETED|Entered - Long-Term Extension Study||61||
59676993|NCT01263496|75796202|FG005|COMPLETED|Entered - Long-Term Extension Study||16||
59676994|NCT01263496|75796203|FG006|COMPLETED|Entered - Long-Term Extension Study||16||
59676995|NCT01263496|75796204|FG007|COMPLETED|Entered - Long-Term Extension Study||16||
59676996|NCT01263496|75796205|FG008|COMPLETED|Entered - Long-Term Extension Study||15||
59676997|NCT01263496|75796197|FG000|NOT COMPLETED|Entered - Long-Term Extension Study||9||
59676998|NCT01263496|75796198|FG001|NOT COMPLETED|Entered - Long-Term Extension Study||13||
59676999|NCT01263496|75796199|FG002|NOT COMPLETED|Entered - Long-Term Extension Study||10||
59677000|NCT01263496|75796200|FG003|NOT COMPLETED|Entered - Long-Term Extension Study||6||
59677001|NCT01263496|75796201|FG004|NOT COMPLETED|Entered - Long-Term Extension Study||10||
59677002|NCT01263496|75796202|FG005|NOT COMPLETED|Entered - Long-Term Extension Study||1||
59677003|NCT01263496|75796203|FG006|NOT COMPLETED|Entered - Long-Term Extension Study||1||
59677004|NCT01263496|75796204|FG007|NOT COMPLETED|Entered - Long-Term Extension Study||1||
59677005|NCT01263496|75796205|FG008|NOT COMPLETED|Entered - Long-Term Extension Study||3||
59677006|NCT01263223|75796217|FG000|STARTED|Period 1||12||
59677007|NCT01263223|75796218|FG001|STARTED|Period 1||12||
59677008|NCT01263223|75796217|FG000|COMPLETED|Period 1||12||
59677009|NCT01263223|75796218|FG001|COMPLETED|Period 1||12||
59677010|NCT01263223|75796217|FG000|NOT COMPLETED|Period 1||0||
59677011|NCT01263223|75796218|FG001|NOT COMPLETED|Period 1||0||
59677012|NCT01263223|75796217|FG000|STARTED|3-Day Washout||12||
59677013|NCT01263223|75796218|FG001|STARTED|3-Day Washout||12||
59677014|NCT01263223|75796217|FG000|COMPLETED|3-Day Washout||12||
59677015|NCT01263223|75796218|FG001|COMPLETED|3-Day Washout||12||
59677016|NCT01263223|75796217|FG000|NOT COMPLETED|3-Day Washout||0||
59677017|NCT01263223|75796218|FG001|NOT COMPLETED|3-Day Washout||0||
59677018|NCT01263223|75796217|FG000|STARTED|Period 2||12||
59677019|NCT01263223|75796218|FG001|STARTED|Period 2||12||
59677020|NCT01263223|75796217|FG000|COMPLETED|Period 2||12||
59677021|NCT01263223|75796218|FG001|COMPLETED|Period 2||11||
59677022|NCT01263223|75796217|FG000|NOT COMPLETED|Period 2||0||
59546313|NCT02174198|75644985|FG000|NOT COMPLETED|Overall Study||0||
59546314|NCT02174198|75644986|FG001|NOT COMPLETED|Overall Study||0||
59546315|NCT02174432|75644992|FG000|STARTED|Overall Study||36||
59546316|NCT02174432|75644992|FG000|COMPLETED|Overall Study||16||
59546317|NCT02174432|75644992|FG000|NOT COMPLETED|Overall Study||20||
59546318|NCT02176382|75644998|FG000|STARTED|DATA-HD Study||39||
59546319|NCT02176382|75644999|FG001|STARTED|DATA-HD Study||37||
59546320|NCT02176382|75644998|FG000|COMPLETED|DATA-HD Study||31||
59546321|NCT02176382|75644999|FG001|COMPLETED|DATA-HD Study||29||
59546322|NCT02176382|75644998|FG000|NOT COMPLETED|DATA-HD Study||8||
59546323|NCT02176382|75644999|FG001|NOT COMPLETED|DATA-HD Study||8||
59677023|NCT01263223|75796218|FG001|NOT COMPLETED|Period 2||1||
59677024|NCT01263223|75796217|FG000|STARTED|Period 3||12||
59677025|NCT01263223|75796218|FG001|STARTED|Period 3||11||
59546324|NCT02176382|75644998|FG000|STARTED|DATA-HD Extension||27|7 subjects completed DATA-HD but did not enroll in extension study.|
59677026|NCT01263223|75796217|FG000|COMPLETED|Period 3||12||
59677027|NCT01263223|75796218|FG001|COMPLETED|Period 3||11||
59677028|NCT01263223|75796217|FG000|NOT COMPLETED|Period 3||0||
59546325|NCT02176382|75644999|FG001|STARTED|DATA-HD Extension||26|7 subjects completed DATA-HD but did not enroll in extension study.|
59546326|NCT02176382|75644998|FG000|COMPLETED|DATA-HD Extension||26||
59677029|NCT01263223|75796218|FG001|NOT COMPLETED|Period 3||0||
59677030|NCT01263223|75796217|FG000|STARTED|7-day Follow-up||12||
59677031|NCT01263223|75796218|FG001|STARTED|7-day Follow-up||11||
59677032|NCT01263223|75796217|FG000|COMPLETED|7-day Follow-up|One participant who did not complete received Placebo in Period 3.|11||
59677033|NCT01263223|75796218|FG001|COMPLETED|7-day Follow-up|One participant who did not complete received 36-mg LY2216684 in Period 3.|10||
59677034|NCT01263223|75796217|FG000|NOT COMPLETED|7-day Follow-up||1||
59677035|NCT01263223|75796218|FG001|NOT COMPLETED|7-day Follow-up||1||
59677036|NCT01263106|75796227|FG000|STARTED|Period 1 (7 Days)||11||
59677037|NCT01263106|75796228|FG001|STARTED|Period 1 (7 Days)||10||
59677038|NCT01263106|75796227|FG000|COMPLETED|Period 1 (7 Days)|Period 1: 1 participant took theophylline alone but was not given LY + theophylline.|11||
59677039|NCT01263106|75796228|FG001|COMPLETED|Period 1 (7 Days)|Period 1: 1 participant took LY + theophylline but was not given theophylline alone.|10||
59677040|NCT01263106|75796227|FG000|NOT COMPLETED|Period 1 (7 Days)||0||
59677041|NCT01263106|75796228|FG001|NOT COMPLETED|Period 1 (7 Days)||0||
59677042|NCT01263106|75796227|FG000|STARTED|Washout (at Least 7 Days)||11||
59677043|NCT01263106|75796228|FG001|STARTED|Washout (at Least 7 Days)||10||
59677044|NCT01263106|75796227|FG000|COMPLETED|Washout (at Least 7 Days)||10||
59677045|NCT01263106|75796228|FG001|COMPLETED|Washout (at Least 7 Days)||9||
59677046|NCT01263106|75796227|FG000|NOT COMPLETED|Washout (at Least 7 Days)||1||
59677047|NCT01263106|75796228|FG001|NOT COMPLETED|Washout (at Least 7 Days)||1||
59677048|NCT01263106|75796227|FG000|STARTED|Period 2 (7 Days)||10||
59677049|NCT01263106|75796228|FG001|STARTED|Period 2 (7 Days)||9||
59677050|NCT01263106|75796227|FG000|COMPLETED|Period 2 (7 Days)||10||
59677051|NCT01263106|75796228|FG001|COMPLETED|Period 2 (7 Days)||9||
59677052|NCT01263106|75796227|FG000|NOT COMPLETED|Period 2 (7 Days)||0||
59677053|NCT01263106|75796228|FG001|NOT COMPLETED|Period 2 (7 Days)||0||
59677054|NCT01263028|75796237|FG000|STARTED|Overall Study||6||
59677055|NCT01263028|75796237|FG000|COMPLETED|Overall Study||0||
59677056|NCT01263028|75796237|FG000|NOT COMPLETED|Overall Study||6||
59677057|NCT01262989|75796241|FG000|STARTED|Period 1||20||
59677058|NCT01262989|75796242|FG001|STARTED|Period 1||20||
59677059|NCT01262989|75796241|FG000|COMPLETED|Period 1||19||
59677060|NCT01262989|75796242|FG001|COMPLETED|Period 1||17||
59677061|NCT01262989|75796241|FG000|NOT COMPLETED|Period 1||1||
59677062|NCT01262989|75796242|FG001|NOT COMPLETED|Period 1||3||
59677063|NCT01262989|75796241|FG000|STARTED|7-Day Washout Period||19||
59677064|NCT01262989|75796242|FG001|STARTED|7-Day Washout Period||17||
59677065|NCT01262989|75796241|FG000|COMPLETED|7-Day Washout Period||19||
59677066|NCT01262989|75796242|FG001|COMPLETED|7-Day Washout Period||17||
59677067|NCT01262989|75796241|FG000|NOT COMPLETED|7-Day Washout Period||0||
59677068|NCT01262989|75796242|FG001|NOT COMPLETED|7-Day Washout Period||0||
59677069|NCT01262989|75796241|FG000|STARTED|Period 2||19||
59677070|NCT01262989|75796242|FG001|STARTED|Period 2||17||
59677071|NCT01262989|75796241|FG000|COMPLETED|Period 2||19||
59677072|NCT01262989|75796242|FG001|COMPLETED|Period 2||16||
59677073|NCT01262989|75796241|FG000|NOT COMPLETED|Period 2||0||
59677074|NCT01262989|75796242|FG001|NOT COMPLETED|Period 2||1||
59677075|NCT01262872|75796256|FG000|STARTED|Step 1||60||
59677076|NCT01262872|75796257|FG001|STARTED|Step 1||60||
59677077|NCT01262872|75796258|FG002|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0||
59677078|NCT01262872|75796259|FG003|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0||
59677079|NCT01262872|75796260|FG004|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0||
59677080|NCT01262872|75796261|FG005|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0||
59677081|NCT01262872|75796262|FG006|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0||
59677082|NCT01262872|75796263|FG007|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0||
59677083|NCT01262872|75796256|FG000|COMPLETED|Step 1||60||
59677084|NCT01262872|75796257|FG001|COMPLETED|Step 1||60||
59677085|NCT01262872|75796258|FG002|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0||
59677086|NCT01262872|75796259|FG003|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone|0||
59677087|NCT01262872|75796260|FG004|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0||
59677088|NCT01262872|75796261|FG005|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0||
59677089|NCT01262872|75796262|FG006|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0||
59677090|NCT01262872|75796263|FG007|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0||
59677091|NCT01262872|75796256|FG000|NOT COMPLETED|Step 1||0||
59677092|NCT01262872|75796257|FG001|NOT COMPLETED|Step 1||0||
59677093|NCT01262872|75796258|FG002|NOT COMPLETED|Step 1||0||
59677094|NCT01262872|75796259|FG003|NOT COMPLETED|Step 1||0||
59677095|NCT01262872|75796260|FG004|NOT COMPLETED|Step 1||0||
59677096|NCT01262872|75796261|FG005|NOT COMPLETED|Step 1||0||
59677097|NCT01262872|75796262|FG006|NOT COMPLETED|Step 1||0||
59677098|NCT01262872|75796263|FG007|NOT COMPLETED|Step 1||0||
59677099|NCT01262872|75796256|FG000|STARTED|Step 2|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0||
59677100|NCT01262872|75796257|FG001|STARTED|Step 2|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0||
59677101|NCT01262872|75796258|FG002|STARTED|Step 2||200||
59677102|NCT01262872|75796259|FG003|STARTED|Step 2||200||
59677103|NCT01262872|75796260|FG004|STARTED|Step 2||200||
59677104|NCT01262872|75796261|FG005|STARTED|Step 2||200||
59677105|NCT01262872|75796262|FG006|STARTED|Step 2||200||
59677106|NCT01262872|75796263|FG007|STARTED|Step 2||200||
59677107|NCT01262872|75796256|FG000|COMPLETED|Step 2|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0||
59677108|NCT01262872|75796257|FG001|COMPLETED|Step 2|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0||
59677109|NCT01262872|75796258|FG002|COMPLETED|Step 2||191||
59677110|NCT01262872|75796259|FG003|COMPLETED|Step 2||190||
59677111|NCT01262872|75796260|FG004|COMPLETED|Step 2||195||
59677112|NCT01262872|75796261|FG005|COMPLETED|Step 2||191||
59677113|NCT01262872|75796262|FG006|COMPLETED|Step 2||191||
59677114|NCT01262872|75796263|FG007|COMPLETED|Step 2||194||
59677115|NCT01262872|75796256|FG000|NOT COMPLETED|Step 2||0||
59677116|NCT01262872|75796257|FG001|NOT COMPLETED|Step 2||0||
59677117|NCT01262872|75796258|FG002|NOT COMPLETED|Step 2||9||
59677118|NCT01262872|75796259|FG003|NOT COMPLETED|Step 2||10||
59677119|NCT01262872|75796260|FG004|NOT COMPLETED|Step 2||5||
59677120|NCT01262872|75796261|FG005|NOT COMPLETED|Step 2||9||
59677121|NCT01262872|75796262|FG006|NOT COMPLETED|Step 2||9||
59677122|NCT01262872|75796263|FG007|NOT COMPLETED|Step 2||6||
59677123|NCT01262677|75796300|FG000|STARTED|Overall Study||100||
59677124|NCT01262677|75796301|FG001|STARTED|Overall Study||113||
59677125|NCT01262677|75796302|FG002|STARTED|Overall Study||110||
59677126|NCT01262677|75796300|FG000|COMPLETED|Overall Study||91||
59677127|NCT01262677|75796301|FG001|COMPLETED|Overall Study||98||
59677128|NCT01262677|75796302|FG002|COMPLETED|Overall Study||98||
59677129|NCT01262677|75796300|FG000|NOT COMPLETED|Overall Study||9||
59677130|NCT01262677|75796301|FG001|NOT COMPLETED|Overall Study||15||
59677131|NCT01262677|75796302|FG002|NOT COMPLETED|Overall Study||12||
59677132|NCT01262638|75796314|FG000|STARTED|Overall Study||45||
59677133|NCT01262638|75796315|FG001|STARTED|Overall Study||44||
59677134|NCT01262638|75796316|FG002|STARTED|Overall Study||44||
59677135|NCT01262638|75796317|FG003|STARTED|Overall Study||44||
59677136|NCT01262638|75796314|FG000|COMPLETED|Overall Study||38||
59677137|NCT01262638|75796315|FG001|COMPLETED|Overall Study||38||
59677138|NCT01262638|75796316|FG002|COMPLETED|Overall Study||38||
59677139|NCT01262638|75796317|FG003|COMPLETED|Overall Study||37||
59677140|NCT01262638|75796314|FG000|NOT COMPLETED|Overall Study||7||
59677141|NCT01262638|75796315|FG001|NOT COMPLETED|Overall Study||6||
59677142|NCT01262638|75796316|FG002|NOT COMPLETED|Overall Study||6||
59677143|NCT01262638|75796317|FG003|NOT COMPLETED|Overall Study||7||
59677144|NCT01262560|75796333|FG000|STARTED|Overall Study||53||
59677145|NCT01262560|75796334|FG001|STARTED|Overall Study||54||
59677146|NCT01262560|75796335|FG002|STARTED|Overall Study||56||
59677147|NCT01262560|75796333|FG000|COMPLETED|Overall Study|Randomized eligible patients who received protocol treatment.|53||
59677148|NCT01262560|75796334|FG001|COMPLETED|Overall Study|Randomized eligible patients who received protocol treatment.|53||
59677149|NCT01262560|75796335|FG002|COMPLETED|Overall Study|Randomized eligible patients who received protocol treatment.|54||
59677150|NCT01262560|75796333|FG000|NOT COMPLETED|Overall Study||0||
59677151|NCT01262560|75796334|FG001|NOT COMPLETED|Overall Study||1||
59677152|NCT01262560|75796335|FG002|NOT COMPLETED|Overall Study||2||
59677153|NCT01262365|75796346|FG000|STARTED|Overall Study||266||
59677154|NCT01262365|75796347|FG001|STARTED|Overall Study||262||
59677155|NCT01262365|75796348|FG002|STARTED|Overall Study||265||
59677156|NCT01262365|75796346|FG000|COMPLETED|Overall Study||176||
59677157|NCT01262365|75796347|FG001|COMPLETED|Overall Study||181||
59677158|NCT01262365|75796348|FG002|COMPLETED|Overall Study||171||
59677159|NCT01262365|75796346|FG000|NOT COMPLETED|Overall Study||90||
59677160|NCT01262365|75796347|FG001|NOT COMPLETED|Overall Study||81||
59677161|NCT01262365|75796348|FG002|NOT COMPLETED|Overall Study||94||
59677162|NCT03932812|75796358|FG000|STARTED|Overall Study||42||
59677163|NCT03932812|75796359|FG001|STARTED|Overall Study||40||
59677164|NCT03932812|75796358|FG000|Baseline Interview|Overall Study||42||
59677165|NCT03932812|75796359|FG001|Baseline Interview|Overall Study||40||
59677166|NCT03932812|75796358|FG000|3 Month Survey|Overall Study||29||
59677167|NCT03932812|75796359|FG001|3 Month Survey|Overall Study||26||
59677168|NCT03932812|75796358|FG000|6 Month Survey|Overall Study||25||
59677169|NCT03932812|75796359|FG001|6 Month Survey|Overall Study||25||
59677170|NCT03932812|75796358|FG000|COMPLETED|Overall Study||25||
59677171|NCT03932812|75796359|FG001|COMPLETED|Overall Study||25||
59677172|NCT03932812|75796358|FG000|NOT COMPLETED|Overall Study||17||
59677173|NCT03932812|75796359|FG001|NOT COMPLETED|Overall Study||15||
59677174|NCT01262287|75796368|FG000|STARTED|Overall Study||20||
59677175|NCT01262287|75796369|FG001|STARTED|Overall Study||19||
59677176|NCT01262287|75796368|FG000|COMPLETED|Overall Study||18||
59677177|NCT01262287|75796369|FG001|COMPLETED|Overall Study||18||
59677178|NCT01262287|75796368|FG000|NOT COMPLETED|Overall Study||2||
59677179|NCT01262287|75796369|FG001|NOT COMPLETED|Overall Study||1||
60078016|NCT01479621|76193028|FG002|Safety Population|Treatment Period||104||
60078017|NCT01479621|76193029|FG003|Safety Population|Treatment Period||104||
60078018|NCT01479621|76193030|FG004|Safety Population|Treatment Period||103||
60078019|NCT01479621|76193031|FG005|Safety Population|Treatment Period||104||
60078020|NCT01479621|76193032|FG006|Safety Population|Treatment Period||104||
60078021|NCT01479621|76193026|FG000|Full Analysis Set|Treatment Period||0||
60078022|NCT01479621|76193027|FG001|Full Analysis Set|Treatment Period||102||
60078023|NCT01479621|76193028|FG002|Full Analysis Set|Treatment Period||101||
60078024|NCT01479621|76193029|FG003|Full Analysis Set|Treatment Period||102||
60078025|NCT01479621|76193030|FG004|Full Analysis Set|Treatment Period||102||
60078026|NCT01479621|76193031|FG005|Full Analysis Set|Treatment Period||102||
60078027|NCT01479621|76193032|FG006|Full Analysis Set|Treatment Period||102||
60078028|NCT01479621|76193026|FG000|COMPLETED|Treatment Period||0||
60078029|NCT01479621|76193027|FG001|COMPLETED|Treatment Period||79||
60078030|NCT01479621|76193028|FG002|COMPLETED|Treatment Period||83||
59677180|NCT01262092|75796381|FG000|STARTED|Buprenorphine+Gabapentin/Plac Induction||16||
59677181|NCT01262092|75796382|FG001|STARTED|Buprenorphine+Gabapentin/Plac Induction||14||
59677182|NCT01262092|75796381|FG000|COMPLETED|Buprenorphine+Gabapentin/Plac Induction||13||
59677183|NCT01262092|75796382|FG001|COMPLETED|Buprenorphine+Gabapentin/Plac Induction||13||
59677184|NCT01262092|75796381|FG000|NOT COMPLETED|Buprenorphine+Gabapentin/Plac Induction||3||
59677185|NCT01262092|75796382|FG001|NOT COMPLETED|Buprenorphine+Gabapentin/Plac Induction||1||
59677186|NCT01262092|75796381|FG000|STARTED|Buprenorphine Taper|One left the study prior to starting the taper due to pharmacy error (started taper in wk 2)|12||
59677187|NCT01262092|75796382|FG001|STARTED|Buprenorphine Taper||13||
59677188|NCT01262092|75796381|FG000|COMPLETED|Buprenorphine Taper||11||
59677189|NCT01262092|75796382|FG001|COMPLETED|Buprenorphine Taper||12||
59677190|NCT01262092|75796381|FG000|NOT COMPLETED|Buprenorphine Taper||1||
59677191|NCT01262092|75796382|FG001|NOT COMPLETED|Buprenorphine Taper||1||
59677192|NCT01262092|75796381|FG000|STARTED|Gabapentin Taper|One participant dropped out after the buprenorphine taper but prior to the gabapentin taper|10||
59677193|NCT01262092|75796382|FG001|STARTED|Gabapentin Taper|One participant dropped out after the buprenorphine taper but prior to the gabapentin taper|11||
59677194|NCT01262092|75796381|FG000|COMPLETED|Gabapentin Taper||9||
59677195|NCT01262092|75796382|FG001|COMPLETED|Gabapentin Taper||11||
59677196|NCT01262092|75796381|FG000|NOT COMPLETED|Gabapentin Taper||1||
59677197|NCT01262092|75796382|FG001|NOT COMPLETED|Gabapentin Taper||0||
59677198|NCT01261975|75796388|FG000|STARTED|Overall Study|36 Participants 72 eyes started|36||
59677199|NCT01261975|75796388|FG000|COMPLETED|Overall Study|35 Participants 70 eyes completed|35||
59677200|NCT01261975|75796388|FG000|NOT COMPLETED|Overall Study||1||
59677201|NCT01261780|75796397|FG000|STARTED|Overall Study||7||
59677202|NCT01261780|75796398|FG001|STARTED|Overall Study||7||
59677203|NCT01261780|75796397|FG000|COMPLETED|Overall Study||5||
59677204|NCT01261780|75796398|FG001|COMPLETED|Overall Study||5||
59677205|NCT01261780|75796397|FG000|NOT COMPLETED|Overall Study||2||
59677206|NCT01261780|75796398|FG001|NOT COMPLETED|Overall Study||2||
59677207|NCT01261624|75796406|FG000|STARTED|Week 0 to Week 12||10||
59677208|NCT01261624|75796407|FG001|STARTED|Week 0 to Week 12||6||
59677209|NCT01261624|75796406|FG000|COMPLETED|Week 0 to Week 12||9||
59677210|NCT01261624|75796407|FG001|COMPLETED|Week 0 to Week 12||3||
59677211|NCT01261624|75796406|FG000|NOT COMPLETED|Week 0 to Week 12||1||
59677212|NCT01261624|75796407|FG001|NOT COMPLETED|Week 0 to Week 12||3||
59677213|NCT01261624|75796406|FG000|STARTED|Week 13 to Week 24|Of 9 pts from LDTC: 5 non-responders switched to HDTC; 4 pts responded, but 3 switched to HDTC|1||
59677214|NCT01261624|75796407|FG001|STARTED|Week 13 to Week 24|Of 6 pts of HDTC: 3 non-responders went out of study, 3 continued. 8 swithched from LDTC to HDTC|11||
59677215|NCT01261624|75796406|FG000|COMPLETED|Week 13 to Week 24||1||
59677216|NCT01261624|75796407|FG001|COMPLETED|Week 13 to Week 24||10||
59677217|NCT01261624|75796406|FG000|NOT COMPLETED|Week 13 to Week 24||0||
59677218|NCT01261624|75796407|FG001|NOT COMPLETED|Week 13 to Week 24||1||
59677219|NCT03694522|75796421|FG000|STARTED|Overall Study||77||
59677220|NCT03694522|75796422|FG001|STARTED|Overall Study||78||
59677221|NCT03694522|75796421|FG000|Received Any Study Treatment|Overall Study||76||
59677222|NCT03694522|75796422|FG001|Received Any Study Treatment|Overall Study||77||
59677223|NCT03694522|75796421|FG000|COMPLETED|Overall Study||15||
59677224|NCT03694522|75796422|FG001|COMPLETED|Overall Study||12||
59677225|NCT03694522|75796421|FG000|NOT COMPLETED|Overall Study||62||
59677226|NCT03694522|75796422|FG001|NOT COMPLETED|Overall Study||66||
59677227|NCT01261390|75796432|FG000|STARTED|Overall Study|15 of the 44 participants only had to complete a 6-month follow-up assessment.|44||
59677228|NCT01261390|75796433|FG001|STARTED|Overall Study|15 of the 42 participants only had to complete a 6-month follow-up assessment.|42||
59677229|NCT01261390|75796434|FG002|STARTED|Overall Study|16 of the 42 participants only had to complete a 6-month follow-up assessment.|42||
59677230|NCT01261390|75796435|FG003|STARTED|Overall Study|15 of the 41 participants only had to complete a 6-month follow-up assessment.|41||
59677231|NCT01261390|75796432|FG000|6-Month Visit|Overall Study|For 14 of the 30 participants in this arm, this was their final visit.|37||
59677232|NCT01261390|75796433|FG001|6-Month Visit|Overall Study|For 12 of the 34 participants in this arm, this was their final visit.|34||
59677233|NCT01261390|75796434|FG002|6-Month Visit|Overall Study|For 16 of the 34 participants in this arm, this was their final visit.|34||
59677234|NCT01261390|75796435|FG003|6-Month Visit|Overall Study|For 14 of the 32 participants in this arm, this was their final visit.|32||
59677235|NCT01261390|75796432|FG000|12-Month Visit|Overall Study||23||
59677236|NCT01261390|75796433|FG001|12-Month Visit|Overall Study||21||
59677237|NCT01261390|75796434|FG002|12-Month Visit|Overall Study||19||
59677238|NCT01261390|75796435|FG003|12-Month Visit|Overall Study||19||
59677239|NCT01261390|75796432|FG000|COMPLETED|Overall Study|14 of the 37 participants that completed the study in this arm were under the 6-Month protocol.|37||
59677240|NCT01261390|75796433|FG001|COMPLETED|Overall Study|12 of the 33 participants that completed the study in this arm were under the 6-Month protocol.|33||
59677241|NCT01261390|75796434|FG002|COMPLETED|Overall Study|16 of the 35 participants that completed the study in this arm were under the 6-Month protocol.|35||
59677242|NCT01261390|75796435|FG003|COMPLETED|Overall Study|14 of the 33 participants that completed the study in this arm were under the 6-Month protocol.|33||
59677243|NCT01261390|75796432|FG000|NOT COMPLETED|Overall Study||7||
59677244|NCT01261390|75796433|FG001|NOT COMPLETED|Overall Study||9||
59677245|NCT01261390|75796434|FG002|NOT COMPLETED|Overall Study||7||
59677246|NCT01261390|75796435|FG003|NOT COMPLETED|Overall Study||8||
59677247|NCT03391882|75796456|FG000|STARTED|Study Overall||20||
59677248|NCT03391882|75796457|FG001|STARTED|Study Overall||19||
59677249|NCT03391882|75796458|FG002|STARTED|Study Overall||19||
59677250|NCT03391882|75796459|FG003|STARTED|Study Overall||18||
59677251|NCT03391882|75796460|FG004|STARTED|Study Overall||18||
59677252|NCT03391882|75796461|FG005|STARTED|Study Overall||19||
59677253|NCT03391882|75796456|FG000|Safety Population|Study Overall||20||
59677254|NCT03391882|75796457|FG001|Safety Population|Study Overall||18||
60078031|NCT01479621|76193029|FG003|COMPLETED|Treatment Period||92||
60078032|NCT01479621|76193030|FG004|COMPLETED|Treatment Period||82||
60078033|NCT01479621|76193031|FG005|COMPLETED|Treatment Period||63||
59677255|NCT03391882|75796458|FG002|Safety Population|Study Overall||19||
59677256|NCT03391882|75796459|FG003|Safety Population|Study Overall||18||
60078034|NCT01479621|76193032|FG006|COMPLETED|Treatment Period||84||
60078035|NCT01479621|76193026|FG000|NOT COMPLETED|Treatment Period||0||
60078036|NCT01479621|76193027|FG001|NOT COMPLETED|Treatment Period||24||
60078037|NCT01479621|76193028|FG002|NOT COMPLETED|Treatment Period||21||
60078038|NCT01479621|76193029|FG003|NOT COMPLETED|Treatment Period||12||
60078039|NCT01479621|76193030|FG004|NOT COMPLETED|Treatment Period||21||
59677257|NCT03391882|75796460|FG004|Safety Population|Study Overall||18||
59677258|NCT03391882|75796461|FG005|Safety Population|Study Overall||19||
59677259|NCT03391882|75796456|FG000|Modified Intent-to-Treat Population|Study Overall||20||
59677260|NCT03391882|75796457|FG001|Modified Intent-to-Treat Population|Study Overall||18||
59677261|NCT03391882|75796458|FG002|Modified Intent-to-Treat Population|Study Overall||19||
59677262|NCT03391882|75796459|FG003|Modified Intent-to-Treat Population|Study Overall||18||
59677263|NCT03391882|75796460|FG004|Modified Intent-to-Treat Population|Study Overall||18||
59677264|NCT03391882|75796461|FG005|Modified Intent-to-Treat Population|Study Overall||19||
59677265|NCT03391882|75796456|FG000|COMPLETED|Study Overall||0|The study|
59677266|NCT03391882|75796457|FG001|COMPLETED|Study Overall||0|The study|
59677267|NCT03391882|75796458|FG002|COMPLETED|Study Overall||16|The study|
59677268|NCT03391882|75796459|FG003|COMPLETED|Study Overall||15|The study|
59677269|NCT03391882|75796460|FG004|COMPLETED|Study Overall||14|The study|
59677270|NCT03391882|75796461|FG005|COMPLETED|Study Overall||15|The study|
59677271|NCT03391882|75796456|FG000|NOT COMPLETED|Study Overall||20||
59677272|NCT03391882|75796457|FG001|NOT COMPLETED|Study Overall||19||
59677273|NCT03391882|75796458|FG002|NOT COMPLETED|Study Overall||3||
59677274|NCT03391882|75796459|FG003|NOT COMPLETED|Study Overall||3||
59677275|NCT03391882|75796460|FG004|NOT COMPLETED|Study Overall||4||
59677276|NCT03391882|75796461|FG005|NOT COMPLETED|Study Overall||4||
59677277|NCT03391882|75796456|FG000|STARTED|Part A - Titration Phase||20||
59677278|NCT03391882|75796457|FG001|STARTED|Part A - Titration Phase||19||
60078040|NCT01479621|76193031|FG005|NOT COMPLETED|Treatment Period||41||
60078041|NCT01479621|76193032|FG006|NOT COMPLETED|Treatment Period||20||
60078042|NCT02319304|76193046|FG000|STARTED|Overall Study||3||
60078043|NCT02319304|76193046|FG000|COMPLETED|Overall Study||2||
60078044|NCT02319304|76193046|FG000|NOT COMPLETED|Overall Study||1||
60078045|NCT00885664|76193052|FG000|STARTED|Overall Study||60||
60078046|NCT00885664|76193052|FG000|COMPLETED|Overall Study||48||
60078047|NCT00885664|76193052|FG000|NOT COMPLETED|Overall Study||12||
59677279|NCT03391882|75796458|FG002|STARTED|Part A - Titration Phase||19||
59677280|NCT03391882|75796459|FG003|STARTED|Part A - Titration Phase||18||
59677281|NCT03391882|75796460|FG004|STARTED|Part A - Titration Phase||18||
59677282|NCT03391882|75796461|FG005|STARTED|Part A - Titration Phase||19||
59677283|NCT03391882|75796456|FG000|Safety Population Part A|Part A - Titration Phase||20||
59677284|NCT03391882|75796457|FG001|Safety Population Part A|Part A - Titration Phase||18||
59677285|NCT03391882|75796458|FG002|Safety Population Part A|Part A - Titration Phase||19||
59677286|NCT03391882|75796459|FG003|Safety Population Part A|Part A - Titration Phase||18||
59677287|NCT03391882|75796460|FG004|Safety Population Part A|Part A - Titration Phase||18||
59677288|NCT03391882|75796461|FG005|Safety Population Part A|Part A - Titration Phase||19||
59677289|NCT03391882|75796456|FG000|Modified Intent-to-Treat Population Part A|Part A - Titration Phase||20||
59677290|NCT03391882|75796457|FG001|Modified Intent-to-Treat Population Part A|Part A - Titration Phase||18||
60078048|NCT03364348|76193062|FG000|STARTED|Overall Study||3||
60078049|NCT03364348|76193063|FG001|STARTED|Overall Study||2||
60078050|NCT03364348|76193064|FG002|STARTED|Overall Study||3||
60078051|NCT03364348|76193065|FG003|STARTED|Overall Study||10||
59677291|NCT03391882|75796458|FG002|Modified Intent-to-Treat Population Part A|Part A - Titration Phase||19||
59677292|NCT03391882|75796459|FG003|Modified Intent-to-Treat Population Part A|Part A - Titration Phase||18||
59677293|NCT03391882|75796460|FG004|Modified Intent-to-Treat Population Part A|Part A - Titration Phase||18||
59677294|NCT03391882|75796461|FG005|Modified Intent-to-Treat Population Part A|Part A - Titration Phase||19||
59815919|NCT00999037|75938347|FG000|NOT COMPLETED|Overall Study||0||
59677295|NCT03391882|75796456|FG000|COMPLETED|Part A - Titration Phase||2|Part A|
59677296|NCT03391882|75796457|FG001|COMPLETED|Part A - Titration Phase||3|Part A|
59677297|NCT03391882|75796458|FG002|COMPLETED|Part A - Titration Phase||19|Part A|
59677298|NCT03391882|75796459|FG003|COMPLETED|Part A - Titration Phase||18|Part A|
59677299|NCT03391882|75796460|FG004|COMPLETED|Part A - Titration Phase||18|Part A|
59677300|NCT03391882|75796461|FG005|COMPLETED|Part A - Titration Phase||19|Part A|
59677301|NCT03391882|75796456|FG000|NOT COMPLETED|Part A - Titration Phase||18||
59677302|NCT03391882|75796457|FG001|NOT COMPLETED|Part A - Titration Phase||16||
59677303|NCT03391882|75796458|FG002|NOT COMPLETED|Part A - Titration Phase||0||
59677304|NCT03391882|75796459|FG003|NOT COMPLETED|Part A - Titration Phase||0||
59677305|NCT03391882|75796460|FG004|NOT COMPLETED|Part A - Titration Phase||0||
59677306|NCT03391882|75796461|FG005|NOT COMPLETED|Part A - Titration Phase||0||
59677307|NCT03391882|75796456|FG000|STARTED|Post Part A / Pre Part B||2||
59677308|NCT03391882|75796457|FG001|STARTED|Post Part A / Pre Part B||3||
59677309|NCT03391882|75796458|FG002|STARTED|Post Part A / Pre Part B||19||
59677310|NCT03391882|75796459|FG003|STARTED|Post Part A / Pre Part B||18||
59677311|NCT03391882|75796460|FG004|STARTED|Post Part A / Pre Part B||18||
59677312|NCT03391882|75796461|FG005|STARTED|Post Part A / Pre Part B||19||
59677313|NCT03391882|75796456|FG000|COMPLETED|Post Part A / Pre Part B||0||
59677314|NCT03391882|75796457|FG001|COMPLETED|Post Part A / Pre Part B||0||
59677315|NCT03391882|75796458|FG002|COMPLETED|Post Part A / Pre Part B||19||
59677316|NCT03391882|75796459|FG003|COMPLETED|Post Part A / Pre Part B||18||
59677317|NCT03391882|75796460|FG004|COMPLETED|Post Part A / Pre Part B||18||
59677318|NCT03391882|75796461|FG005|COMPLETED|Post Part A / Pre Part B||19||
59677319|NCT03391882|75796456|FG000|NOT COMPLETED|Post Part A / Pre Part B||2||
59677320|NCT03391882|75796457|FG001|NOT COMPLETED|Post Part A / Pre Part B||3||
59677321|NCT03391882|75796458|FG002|NOT COMPLETED|Post Part A / Pre Part B||0||
59677322|NCT03391882|75796459|FG003|NOT COMPLETED|Post Part A / Pre Part B||0||
59677323|NCT03391882|75796460|FG004|NOT COMPLETED|Post Part A / Pre Part B||0||
59677324|NCT03391882|75796461|FG005|NOT COMPLETED|Post Part A / Pre Part B||0||
59677325|NCT03391882|75796456|FG000|STARTED|Part B - Treatment Phase||0||
59677326|NCT03391882|75796457|FG001|STARTED|Part B - Treatment Phase||0||
59677327|NCT03391882|75796458|FG002|STARTED|Part B - Treatment Phase||19||
59677328|NCT03391882|75796459|FG003|STARTED|Part B - Treatment Phase||18||
59677329|NCT03391882|75796460|FG004|STARTED|Part B - Treatment Phase||18||
59677330|NCT03391882|75796461|FG005|STARTED|Part B - Treatment Phase||19||
59677331|NCT03391882|75796456|FG000|Safety Population Part B|Part B - Treatment Phase||0||
59677332|NCT03391882|75796457|FG001|Safety Population Part B|Part B - Treatment Phase||0||
59677333|NCT03391882|75796458|FG002|Safety Population Part B|Part B - Treatment Phase||19||
59677334|NCT03391882|75796459|FG003|Safety Population Part B|Part B - Treatment Phase||18||
59677335|NCT03391882|75796460|FG004|Safety Population Part B|Part B - Treatment Phase||18||
59677336|NCT03391882|75796461|FG005|Safety Population Part B|Part B - Treatment Phase||19||
59677337|NCT03391882|75796456|FG000|Modified Intent-to-Treat Population Part B|Part B - Treatment Phase||0||
59677338|NCT03391882|75796457|FG001|Modified Intent-to-Treat Population Part B|Part B - Treatment Phase||0||
59677339|NCT03391882|75796458|FG002|Modified Intent-to-Treat Population Part B|Part B - Treatment Phase||19||
59677340|NCT03391882|75796459|FG003|Modified Intent-to-Treat Population Part B|Part B - Treatment Phase||18||
59677341|NCT03391882|75796460|FG004|Modified Intent-to-Treat Population Part B|Part B - Treatment Phase||18||
59677342|NCT03391882|75796461|FG005|Modified Intent-to-Treat Population Part B|Part B - Treatment Phase||19||
59677343|NCT03391882|75796456|FG000|COMPLETED|Part B - Treatment Phase||0|Part B|
59677344|NCT03391882|75796457|FG001|COMPLETED|Part B - Treatment Phase||0|Part B|
59677345|NCT03391882|75796458|FG002|COMPLETED|Part B - Treatment Phase||16|Part B|
59677346|NCT03391882|75796459|FG003|COMPLETED|Part B - Treatment Phase||15|Part B|
59677347|NCT03391882|75796460|FG004|COMPLETED|Part B - Treatment Phase||14|Part B|
59677348|NCT03391882|75796461|FG005|COMPLETED|Part B - Treatment Phase||15|Part B|
59677349|NCT03391882|75796456|FG000|NOT COMPLETED|Part B - Treatment Phase||0||
59546327|NCT02176382|75644999|FG001|COMPLETED|DATA-HD Extension||26||
59677350|NCT03391882|75796457|FG001|NOT COMPLETED|Part B - Treatment Phase||0||
59677351|NCT03391882|75796458|FG002|NOT COMPLETED|Part B - Treatment Phase||3||
59546328|NCT02176382|75644998|FG000|NOT COMPLETED|DATA-HD Extension||1||
59546329|NCT02176382|75644999|FG001|NOT COMPLETED|DATA-HD Extension||0||
59546330|NCT01077596|75645017|FG000|STARTED|Overall Study||350||
59546331|NCT01077596|75645018|FG001|STARTED|Overall Study||1050||
59546332|NCT01077596|75645019|FG002|STARTED|Overall Study||457||
59546333|NCT01077596|75645020|FG003|STARTED|Overall Study||1370||
59546334|NCT01077596|75645021|FG004|STARTED|Overall Study||294||
59546335|NCT01077596|75645022|FG005|STARTED|Overall Study||882||
59546336|NCT01077596|75645023|FG006|STARTED|Overall Study||308||
59677352|NCT03391882|75796459|FG003|NOT COMPLETED|Part B - Treatment Phase||3||
59546337|NCT01077596|75645024|FG007|STARTED|Overall Study||837||
59546338|NCT01077596|75645025|FG008|STARTED|Overall Study||2842||
59546339|NCT01077596|75645026|FG009|STARTED|Overall Study||28420||
59546340|NCT01077596|75645027|FG010|STARTED|Overall Study||2215||
59546341|NCT01077596|75645028|FG011|STARTED|Overall Study||22150||
59546342|NCT01077596|75645017|FG000|COMPLETED|Overall Study||350||
59546343|NCT01077596|75645018|FG001|COMPLETED|Overall Study||1050||
59677353|NCT03391882|75796460|FG004|NOT COMPLETED|Part B - Treatment Phase||4||
59677354|NCT03391882|75796461|FG005|NOT COMPLETED|Part B - Treatment Phase||4||
59677355|NCT01261000|75796471|FG000|STARTED|Overall Study||8||
59677356|NCT01261000|75796471|FG000|COMPLETED|Overall Study||7||
59677357|NCT01261000|75796471|FG000|NOT COMPLETED|Overall Study||1||
59677358|NCT01099449|75796478|FG000|STARTED|Overall Study||118|Nine patients were deemed ineligible or withdrew prior to randomization.|
59677359|NCT01099449|75796479|FG001|STARTED|Overall Study||119|Nine patients were deemed ineligible or withdrew prior to randomization.|
59677360|NCT01099449|75796480|FG002|STARTED|Overall Study||116|Nine patients were deemed ineligible or withdrew prior to randomization.|
59677361|NCT01099449|75796478|FG000|COMPLETED|Overall Study||118||
59677362|NCT01099449|75796479|FG001|COMPLETED|Overall Study||119||
59677363|NCT01099449|75796480|FG002|COMPLETED|Overall Study||116||
59677364|NCT01099449|75796478|FG000|NOT COMPLETED|Overall Study||0||
59677365|NCT01099449|75796479|FG001|NOT COMPLETED|Overall Study||0||
59677366|NCT01099449|75796480|FG002|NOT COMPLETED|Overall Study||0||
59677367|NCT01234402|75796504|FG000|STARTED|Overall Study||52||
59677368|NCT01234402|75796505|FG001|STARTED|Overall Study||51||
59677369|NCT01234402|75796506|FG002|STARTED|Overall Study||50||
59677370|NCT01234402|75796504|FG000|Received at Least One Dose of Study Drug|Overall Study||52||
59677371|NCT01234402|75796505|FG001|Received at Least One Dose of Study Drug|Overall Study||49||
59677372|NCT01234402|75796506|FG002|Received at Least One Dose of Study Drug|Overall Study||49||
59677373|NCT01234402|75796504|FG000|Capecitabine Crossover to Ramucirumab|Overall Study||0||
59677374|NCT01234402|75796505|FG001|Capecitabine Crossover to Ramucirumab|Overall Study||0||
59677375|NCT01234402|75796506|FG002|Capecitabine Crossover to Ramucirumab|Overall Study||29||
59677376|NCT01234402|75796504|FG000|Capecitabine Crossover to Icrucumab|Overall Study||0||
59677377|NCT01234402|75796505|FG001|Capecitabine Crossover to Icrucumab|Overall Study||0||
59677378|NCT01234402|75796506|FG002|Capecitabine Crossover to Icrucumab|Overall Study||1||
59677379|NCT01234402|75796504|FG000|COMPLETED|Overall Study||51||
59677380|NCT01234402|75796505|FG001|COMPLETED|Overall Study||45||
59677381|NCT01234402|75796506|FG002|COMPLETED|Overall Study||42||
59677382|NCT01234402|75796504|FG000|NOT COMPLETED|Overall Study||1||
59677383|NCT01234402|75796505|FG001|NOT COMPLETED|Overall Study||6||
59677384|NCT01234402|75796506|FG002|NOT COMPLETED|Overall Study||8||
59677385|NCT01260922|75796518|FG000|STARTED|First Intervention||13||
59677386|NCT01260922|75796519|FG001|STARTED|First Intervention||13||
59677387|NCT01260922|75796518|FG000|COMPLETED|First Intervention||13||
59677388|NCT01260922|75796519|FG001|COMPLETED|First Intervention||12||
59677389|NCT01260922|75796518|FG000|NOT COMPLETED|First Intervention||0||
59677390|NCT01260922|75796519|FG001|NOT COMPLETED|First Intervention||1||
59677391|NCT01260922|75796518|FG000|STARTED|Washout of 28 Days||13||
59677392|NCT01260922|75796519|FG001|STARTED|Washout of 28 Days||12||
59677393|NCT01260922|75796518|FG000|COMPLETED|Washout of 28 Days||9||
59677394|NCT01260922|75796519|FG001|COMPLETED|Washout of 28 Days||10||
59677395|NCT01260922|75796518|FG000|NOT COMPLETED|Washout of 28 Days||4||
59677396|NCT01260922|75796519|FG001|NOT COMPLETED|Washout of 28 Days||2||
59677397|NCT01260922|75796518|FG000|STARTED|Second Intervention||9||
59677398|NCT01260922|75796519|FG001|STARTED|Second Intervention||10||
59677399|NCT01260922|75796518|FG000|COMPLETED|Second Intervention||9||
59677400|NCT01260922|75796519|FG001|COMPLETED|Second Intervention||8||
59677401|NCT01260922|75796518|FG000|NOT COMPLETED|Second Intervention||0||
59677402|NCT01260922|75796519|FG001|NOT COMPLETED|Second Intervention||2||
59677403|NCT01233817|75796525|FG000|STARTED|Overall Study||12||
59677404|NCT01233817|75796525|FG000|COMPLETED|Overall Study||9||
59677405|NCT01233817|75796525|FG000|NOT COMPLETED|Overall Study||3||
59677406|NCT01233232|75796532|FG000|STARTED|Overall Study||29||
59677407|NCT01233232|75796533|FG001|STARTED|Overall Study||30||
59677408|NCT01233232|75796534|FG002|STARTED|Overall Study||28||
59677409|NCT01233232|75796532|FG000|COMPLETED|Overall Study||28||
59677410|NCT01233232|75796533|FG001|COMPLETED|Overall Study||30||
59677411|NCT01233232|75796534|FG002|COMPLETED|Overall Study||28||
59677412|NCT01233232|75796532|FG000|NOT COMPLETED|Overall Study||1||
59677413|NCT01233232|75796533|FG001|NOT COMPLETED|Overall Study||0||
59677414|NCT01233232|75796534|FG002|NOT COMPLETED|Overall Study||0||
59677415|NCT01233076|75796544|FG000|STARTED|Period 1, One Week||30||
59677416|NCT01233076|75796545|FG001|STARTED|Period 1, One Week||30||
59677417|NCT01233076|75796544|FG000|COMPLETED|Period 1, One Week||30||
59677418|NCT01233076|75796545|FG001|COMPLETED|Period 1, One Week||30||
59677419|NCT01233076|75796544|FG000|NOT COMPLETED|Period 1, One Week||0||
59677420|NCT01233076|75796545|FG001|NOT COMPLETED|Period 1, One Week||0||
59677421|NCT01233076|75796544|FG000|STARTED|Period 2, One Week||30||
59677422|NCT01233076|75796545|FG001|STARTED|Period 2, One Week||30||
59677423|NCT01233076|75796544|FG000|COMPLETED|Period 2, One Week||29||
59677424|NCT01233076|75796545|FG001|COMPLETED|Period 2, One Week||30||
59677425|NCT01233076|75796544|FG000|NOT COMPLETED|Period 2, One Week||1||
59677426|NCT01233076|75796545|FG001|NOT COMPLETED|Period 2, One Week||0||
59677427|NCT01212094|75796554|FG000|STARTED|Year 1: Baseline Monitoring||43||
59677428|NCT01212094|75796555|FG001|STARTED|Year 1: Baseline Monitoring||0||
59677429|NCT01212094|75796556|FG002|STARTED|Year 1: Baseline Monitoring||0||
59677430|NCT01212094|75796554|FG000|COMPLETED|Year 1: Baseline Monitoring||27||
59677431|NCT01212094|75796555|FG001|COMPLETED|Year 1: Baseline Monitoring||0||
59677432|NCT01212094|75796556|FG002|COMPLETED|Year 1: Baseline Monitoring||0||
59677433|NCT01212094|75796554|FG000|NOT COMPLETED|Year 1: Baseline Monitoring||16||
59677434|NCT01212094|75796555|FG001|NOT COMPLETED|Year 1: Baseline Monitoring||0||
59677435|NCT01212094|75796556|FG002|NOT COMPLETED|Year 1: Baseline Monitoring||0||
59677436|NCT01212094|75796554|FG000|STARTED|Years 2 & 3: Treatment Randomization||0||
59677437|NCT01212094|75796555|FG001|STARTED|Years 2 & 3: Treatment Randomization||9||
59677438|NCT01212094|75796556|FG002|STARTED|Years 2 & 3: Treatment Randomization||18||
59677439|NCT01212094|75796554|FG000|COMPLETED|Years 2 & 3: Treatment Randomization||0||
59677440|NCT01212094|75796555|FG001|COMPLETED|Years 2 & 3: Treatment Randomization||5||
59677441|NCT01212094|75796556|FG002|COMPLETED|Years 2 & 3: Treatment Randomization||7||
59677442|NCT01212094|75796554|FG000|NOT COMPLETED|Years 2 & 3: Treatment Randomization||0||
59677443|NCT01212094|75796555|FG001|NOT COMPLETED|Years 2 & 3: Treatment Randomization||4||
59677444|NCT01212094|75796556|FG002|NOT COMPLETED|Years 2 & 3: Treatment Randomization||11||
59677445|NCT01232569|75796565|FG000|STARTED|Double-blind Treatment Period||438||
59677446|NCT01232569|75796566|FG001|STARTED|Double-blind Treatment Period||218||
59677447|NCT01232569|75796567|FG002|STARTED|Double-blind Treatment Period|There were no participants in this reporting group in this period.|0||
59677448|NCT01232569|75796568|FG003|STARTED|Double-blind Treatment Period|There were no participants in this reporting group in this period.|0||
59677449|NCT01232569|75796565|FG000|COMPLETED|Double-blind Treatment Period||410||
59677450|NCT01232569|75796566|FG001|COMPLETED|Double-blind Treatment Period||209||
59677451|NCT01232569|75796567|FG002|COMPLETED|Double-blind Treatment Period||0||
59677452|NCT01232569|75796568|FG003|COMPLETED|Double-blind Treatment Period||0||
59677453|NCT01232569|75796565|FG000|NOT COMPLETED|Double-blind Treatment Period||28||
59677454|NCT01232569|75796566|FG001|NOT COMPLETED|Double-blind Treatment Period||9||
59677455|NCT01232569|75796567|FG002|NOT COMPLETED|Double-blind Treatment Period||0||
59677456|NCT01232569|75796568|FG003|NOT COMPLETED|Double-blind Treatment Period||0||
59677457|NCT01232569|75796565|FG000|STARTED|Open-label Extension Period|There were no participants in this reporting group in this period.|0||
59677458|NCT01232569|75796566|FG001|STARTED|Open-label Extension Period|There were no participants in this reporting group in this period.|0||
59677459|NCT01232569|75796567|FG002|STARTED|Open-label Extension Period|Some participants who completed the double-blind period did not enter the open-label period.|230||
59677460|NCT01232569|75796568|FG003|STARTED|Open-label Extension Period|Some participants who completed the double-blind period did not enter the open-label period.|227||
59677461|NCT01232569|75796565|FG000|COMPLETED|Open-label Extension Period||0||
59677462|NCT01232569|75796566|FG001|COMPLETED|Open-label Extension Period||0||
59677463|NCT01232569|75796567|FG002|COMPLETED|Open-label Extension Period||203||
59677464|NCT01232569|75796568|FG003|COMPLETED|Open-label Extension Period||200||
59677465|NCT01232569|75796565|FG000|NOT COMPLETED|Open-label Extension Period||0||
59677466|NCT01232569|75796566|FG001|NOT COMPLETED|Open-label Extension Period||0||
59677467|NCT01232569|75796567|FG002|NOT COMPLETED|Open-label Extension Period||27||
59677468|NCT01232569|75796568|FG003|NOT COMPLETED|Open-label Extension Period||27||
59677469|NCT01211665|75796579|FG000|STARTED|Overall Study||2||
59677470|NCT01211665|75796580|FG001|STARTED|Overall Study||1||
59677471|NCT01211665|75796579|FG000|COMPLETED|Overall Study||0||
59677472|NCT01211665|75796580|FG001|COMPLETED|Overall Study|completed treatment with study drug|1||
59677473|NCT01211665|75796579|FG000|NOT COMPLETED|Overall Study||2||
59677474|NCT01211665|75796580|FG001|NOT COMPLETED|Overall Study||0||
59677475|NCT01232491|75796588|FG000|STARTED|Overall Study||306||
59677476|NCT01232491|75796589|FG001|STARTED|Overall Study||305||
59677477|NCT01232491|75796588|FG000|Exposed (Safety Analysis Set)|Overall Study|One subject withdrew prior to exposure to trial drug.|305||
59677478|NCT01232491|75796589|FG001|Exposed (Safety Analysis Set)|Overall Study|Four subjects withdrew prior to exposure to trial drug.|301||
59677479|NCT01232491|75796588|FG000|COMPLETED|Overall Study||246||
59677480|NCT01232491|75796589|FG001|COMPLETED|Overall Study||242||
59677481|NCT01232491|75796588|FG000|NOT COMPLETED|Overall Study||60||
59677482|NCT01232491|75796589|FG001|NOT COMPLETED|Overall Study||63||
59677483|NCT01232452|75796597|FG000|STARTED|Overall Study||87||
59677484|NCT01232452|75796598|FG001|STARTED|Overall Study||85||
59546344|NCT01077596|75645019|FG002|COMPLETED|Overall Study||457||
59546345|NCT01077596|75645020|FG003|COMPLETED|Overall Study||1370||
59546346|NCT01077596|75645021|FG004|COMPLETED|Overall Study||294||
59546347|NCT01077596|75645022|FG005|COMPLETED|Overall Study||882||
59546348|NCT01077596|75645023|FG006|COMPLETED|Overall Study||308||
59546349|NCT01077596|75645024|FG007|COMPLETED|Overall Study||837||
59546350|NCT01077596|75645025|FG008|COMPLETED|Overall Study||2842||
59546351|NCT01077596|75645026|FG009|COMPLETED|Overall Study||28420||
59546352|NCT01077596|75645027|FG010|COMPLETED|Overall Study||2215||
59677485|NCT01232452|75796597|FG000|Received at Least One Dose of Study Drug|Overall Study||85||
59677486|NCT01232452|75796598|FG001|Received at Least One Dose of Study Drug|Overall Study||81||
59677487|NCT01232452|75796597|FG000|COMPLETED|Overall Study||48||
59677488|NCT01232452|75796598|FG001|COMPLETED|Overall Study||46||
59677489|NCT01232452|75796597|FG000|NOT COMPLETED|Overall Study||39||
59677490|NCT01232452|75796598|FG001|NOT COMPLETED|Overall Study||39||
59546353|NCT01077596|75645028|FG011|COMPLETED|Overall Study||22150||
59546354|NCT01077596|75645017|FG000|NOT COMPLETED|Overall Study||0||
59677491|NCT01211197|75796604|FG000|STARTED|Treatment Period 1 (1 Day)||3||
59677492|NCT01211197|75796605|FG001|STARTED|Treatment Period 1 (1 Day)||3||
59677493|NCT01211197|75796606|FG002|STARTED|Treatment Period 1 (1 Day)||3||
59677494|NCT01211197|75796607|FG003|STARTED|Treatment Period 1 (1 Day)||3||
59677495|NCT01211197|75796608|FG004|STARTED|Treatment Period 1 (1 Day)||2||
59677496|NCT01211197|75796609|FG005|STARTED|Treatment Period 1 (1 Day)||2||
59989534|NCT00440531|76104846|FG000|Vaccination 3|Overall Study||176||
59546355|NCT01077596|75645018|FG001|NOT COMPLETED|Overall Study||0||
59546356|NCT01077596|75645019|FG002|NOT COMPLETED|Overall Study||0||
59546357|NCT01077596|75645020|FG003|NOT COMPLETED|Overall Study||0||
59546358|NCT01077596|75645021|FG004|NOT COMPLETED|Overall Study||0||
59546359|NCT01077596|75645022|FG005|NOT COMPLETED|Overall Study||0||
59546360|NCT01077596|75645023|FG006|NOT COMPLETED|Overall Study||0||
59546361|NCT01077596|75645024|FG007|NOT COMPLETED|Overall Study||0||
59546362|NCT01077596|75645025|FG008|NOT COMPLETED|Overall Study||0||
59546363|NCT01077596|75645026|FG009|NOT COMPLETED|Overall Study||0||
59546364|NCT01077596|75645027|FG010|NOT COMPLETED|Overall Study||0||
59546365|NCT01077596|75645028|FG011|NOT COMPLETED|Overall Study||0||
59546366|NCT02414958|75645052|FG000|STARTED|Overall Study||243||
59546367|NCT02414958|75645053|FG001|STARTED|Overall Study||243||
59546368|NCT02414958|75645054|FG002|STARTED|Overall Study||244||
59546369|NCT02414958|75645052|FG000|COMPLETED|Overall Study||211||
59546370|NCT02414958|75645053|FG001|COMPLETED|Overall Study||223||
59546371|NCT02414958|75645054|FG002|COMPLETED|Overall Study||230||
59546372|NCT02414958|75645052|FG000|NOT COMPLETED|Overall Study||32||
59546373|NCT02414958|75645053|FG001|NOT COMPLETED|Overall Study||20||
59546374|NCT02414958|75645054|FG002|NOT COMPLETED|Overall Study||14||
59546375|NCT01078220|75645062|FG000|STARTED|Overall Study||189629||
59546376|NCT01078220|75645062|FG000|COMPLETED|Overall Study||189629||
59546377|NCT01078220|75645062|FG000|NOT COMPLETED|Overall Study||0||
59546378|NCT01078376|75645073|FG000|STARTED|Overall Study||9||
59546379|NCT01078376|75645074|FG001|STARTED|Overall Study||9||
59546380|NCT01078376|75645075|FG002|STARTED|Overall Study||8||
59546381|NCT01078376|75645076|FG003|STARTED|Overall Study||3||
59546382|NCT01078376|75645073|FG000|COMPLETED|Overall Study||9||
59546383|NCT01078376|75645074|FG001|COMPLETED|Overall Study||9||
59546384|NCT01078376|75645075|FG002|COMPLETED|Overall Study||8||
59546385|NCT01078376|75645076|FG003|COMPLETED|Overall Study||3||
59546386|NCT01078376|75645073|FG000|NOT COMPLETED|Overall Study||0||
59546387|NCT01078376|75645074|FG001|NOT COMPLETED|Overall Study||0||
59546388|NCT01078376|75645075|FG002|NOT COMPLETED|Overall Study||0||
59546389|NCT01078376|75645076|FG003|NOT COMPLETED|Overall Study||0||
59546390|NCT01079390|75645092|FG000|STARTED|Overall Study||15||
59546391|NCT01079390|75645093|FG001|STARTED|Overall Study||15||
59546392|NCT01079390|75645094|FG002|STARTED|Overall Study||14||
59546393|NCT01079390|75645092|FG000|COMPLETED|Overall Study||10||
59546394|NCT01079390|75645093|FG001|COMPLETED|Overall Study||10||
59546395|NCT01079390|75645094|FG002|COMPLETED|Overall Study||10||
59546396|NCT01079390|75645092|FG000|NOT COMPLETED|Overall Study||5||
59546397|NCT01079390|75645093|FG001|NOT COMPLETED|Overall Study||5||
59546398|NCT01079390|75645094|FG002|NOT COMPLETED|Overall Study||4||
59546399|NCT01080248|75645104|FG000|STARTED|Overall Study||2||
59546400|NCT01080248|75645104|FG000|COMPLETED|Overall Study||2||
59546401|NCT01080248|75645104|FG000|NOT COMPLETED|Overall Study||0||
59546402|NCT01080794|75645112|FG000|STARTED|Overall Study||20||
59546403|NCT01080794|75645113|FG001|STARTED|Overall Study||14||
59546404|NCT01080794|75645114|FG002|STARTED|Overall Study||12||
59546405|NCT01080794|75645115|FG003|STARTED|Overall Study||15||
59546406|NCT01080794|75645112|FG000|COMPLETED|Overall Study||15||
59546407|NCT01080794|75645113|FG001|COMPLETED|Overall Study||12||
59546408|NCT01080794|75645114|FG002|COMPLETED|Overall Study||10||
59546409|NCT01080794|75645115|FG003|COMPLETED|Overall Study||13||
59546410|NCT01080794|75645112|FG000|NOT COMPLETED|Overall Study||5||
59546411|NCT01080794|75645113|FG001|NOT COMPLETED|Overall Study||2||
59546412|NCT01080794|75645114|FG002|NOT COMPLETED|Overall Study||2||
59546413|NCT01080794|75645115|FG003|NOT COMPLETED|Overall Study||2||
59546414|NCT02452476|75645127|FG000|STARTED|Overall Study||64||
59546415|NCT02452476|75645128|FG001|STARTED|Overall Study||59||
59989535|NCT00440531|76104847|FG001|Vaccination 3|Overall Study||178||
60078052|NCT03364348|76193062|FG000|COMPLETED|Overall Study||3||
59546416|NCT02452476|75645127|FG000|COMPLETED|Overall Study||53||
59546417|NCT02452476|75645128|FG001|COMPLETED|Overall Study||49||
59546418|NCT02452476|75645127|FG000|NOT COMPLETED|Overall Study||11||
59546419|NCT02452476|75645128|FG001|NOT COMPLETED|Overall Study||10||
59546420|NCT01082588|75645136|FG000|STARTED|Overall Study||30||
59546421|NCT01082588|75645137|FG001|STARTED|Overall Study||30||
59546422|NCT01082588|75645136|FG000|COMPLETED|Overall Study||24||
59546423|NCT01082588|75645137|FG001|COMPLETED|Overall Study||25||
59546424|NCT01082588|75645136|FG000|NOT COMPLETED|Overall Study||6||
59546425|NCT01082588|75645137|FG001|NOT COMPLETED|Overall Study||5||
59546426|NCT02442336|75645143|FG000|STARTED|Overall Study||80||
59546427|NCT02442336|75645143|FG000|Developmental Phase|Overall Study||6||
59546428|NCT02442336|75645143|FG000|Evaluation Phase|Overall Study||74||
59565816|NCT02335242|75668230|FG001|STARTED|Follow-up Period (12 Weeks)||11||
59677497|NCT01211197|75796604|FG000|COMPLETED|Treatment Period 1 (1 Day)||3||
59677498|NCT01211197|75796605|FG001|COMPLETED|Treatment Period 1 (1 Day)||3||
59677499|NCT01211197|75796606|FG002|COMPLETED|Treatment Period 1 (1 Day)||3||
59677500|NCT01211197|75796607|FG003|COMPLETED|Treatment Period 1 (1 Day)||3||
59677501|NCT01211197|75796608|FG004|COMPLETED|Treatment Period 1 (1 Day)||2||
59677502|NCT01211197|75796609|FG005|COMPLETED|Treatment Period 1 (1 Day)||2||
59677503|NCT01211197|75796604|FG000|NOT COMPLETED|Treatment Period 1 (1 Day)||0||
59677504|NCT01211197|75796605|FG001|NOT COMPLETED|Treatment Period 1 (1 Day)||0||
59677505|NCT01211197|75796606|FG002|NOT COMPLETED|Treatment Period 1 (1 Day)||0||
59677506|NCT01211197|75796607|FG003|NOT COMPLETED|Treatment Period 1 (1 Day)||0||
59677507|NCT01211197|75796608|FG004|NOT COMPLETED|Treatment Period 1 (1 Day)||0||
59677508|NCT01211197|75796609|FG005|NOT COMPLETED|Treatment Period 1 (1 Day)||0||
59677509|NCT01211197|75796604|FG000|STARTED|Washout Period 1 (7 Days)||3||
59677510|NCT01211197|75796605|FG001|STARTED|Washout Period 1 (7 Days)||3||
59677511|NCT01211197|75796606|FG002|STARTED|Washout Period 1 (7 Days)||3||
59677512|NCT01211197|75796607|FG003|STARTED|Washout Period 1 (7 Days)||3||
59677513|NCT01211197|75796608|FG004|STARTED|Washout Period 1 (7 Days)||2||
59677514|NCT01211197|75796609|FG005|STARTED|Washout Period 1 (7 Days)||2||
59677515|NCT01211197|75796604|FG000|COMPLETED|Washout Period 1 (7 Days)||3||
59677516|NCT01211197|75796605|FG001|COMPLETED|Washout Period 1 (7 Days)||3||
59677517|NCT01211197|75796606|FG002|COMPLETED|Washout Period 1 (7 Days)||2||
59677518|NCT01211197|75796607|FG003|COMPLETED|Washout Period 1 (7 Days)||3||
59677519|NCT01211197|75796608|FG004|COMPLETED|Washout Period 1 (7 Days)||2||
59677520|NCT01211197|75796609|FG005|COMPLETED|Washout Period 1 (7 Days)||2||
59677521|NCT01211197|75796604|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0||
59677522|NCT01211197|75796605|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0||
59677523|NCT01211197|75796606|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||1||
59677524|NCT01211197|75796607|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0||
59677525|NCT01211197|75796608|FG004|NOT COMPLETED|Washout Period 1 (7 Days)||0||
59677526|NCT01211197|75796609|FG005|NOT COMPLETED|Washout Period 1 (7 Days)||0||
59677527|NCT01211197|75796604|FG000|STARTED|Treatment Period 2 (1 Day)||3||
59677528|NCT01211197|75796605|FG001|STARTED|Treatment Period 2 (1 Day)||3||
59677529|NCT01211197|75796606|FG002|STARTED|Treatment Period 2 (1 Day)||2||
59677530|NCT01211197|75796607|FG003|STARTED|Treatment Period 2 (1 Day)||3||
59677531|NCT01211197|75796608|FG004|STARTED|Treatment Period 2 (1 Day)||2||
59677532|NCT01211197|75796609|FG005|STARTED|Treatment Period 2 (1 Day)||2||
59677533|NCT01211197|75796604|FG000|COMPLETED|Treatment Period 2 (1 Day)||3||
59677534|NCT01211197|75796605|FG001|COMPLETED|Treatment Period 2 (1 Day)||3||
59677535|NCT01211197|75796606|FG002|COMPLETED|Treatment Period 2 (1 Day)||2||
59677536|NCT01211197|75796607|FG003|COMPLETED|Treatment Period 2 (1 Day)||3||
59677537|NCT01211197|75796608|FG004|COMPLETED|Treatment Period 2 (1 Day)||2||
59677538|NCT01211197|75796609|FG005|COMPLETED|Treatment Period 2 (1 Day)||2||
59677539|NCT01211197|75796604|FG000|NOT COMPLETED|Treatment Period 2 (1 Day)||0||
59677540|NCT01211197|75796605|FG001|NOT COMPLETED|Treatment Period 2 (1 Day)||0||
59677541|NCT01211197|75796606|FG002|NOT COMPLETED|Treatment Period 2 (1 Day)||0||
59677542|NCT01211197|75796607|FG003|NOT COMPLETED|Treatment Period 2 (1 Day)||0||
59677543|NCT01211197|75796608|FG004|NOT COMPLETED|Treatment Period 2 (1 Day)||0||
59677544|NCT01211197|75796609|FG005|NOT COMPLETED|Treatment Period 2 (1 Day)||0||
59677545|NCT01211197|75796604|FG000|STARTED|Washout Period 2 (7 Days)||3||
59677546|NCT01211197|75796605|FG001|STARTED|Washout Period 2 (7 Days)||3||
59677547|NCT01211197|75796606|FG002|STARTED|Washout Period 2 (7 Days)||2||
59677548|NCT01211197|75796607|FG003|STARTED|Washout Period 2 (7 Days)||3||
59677549|NCT01211197|75796608|FG004|STARTED|Washout Period 2 (7 Days)||2||
59677550|NCT01211197|75796609|FG005|STARTED|Washout Period 2 (7 Days)||2||
59677551|NCT01211197|75796604|FG000|COMPLETED|Washout Period 2 (7 Days)||2||
59677552|NCT01211197|75796605|FG001|COMPLETED|Washout Period 2 (7 Days)||3||
59677553|NCT01211197|75796606|FG002|COMPLETED|Washout Period 2 (7 Days)||2||
59677554|NCT01211197|75796607|FG003|COMPLETED|Washout Period 2 (7 Days)||3||
59677555|NCT01211197|75796608|FG004|COMPLETED|Washout Period 2 (7 Days)||2||
59677556|NCT01211197|75796609|FG005|COMPLETED|Washout Period 2 (7 Days)||2||
59677557|NCT01211197|75796604|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||1||
59677558|NCT01211197|75796605|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0||
59677559|NCT01211197|75796606|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0||
59677560|NCT01211197|75796607|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0||
59677561|NCT01211197|75796608|FG004|NOT COMPLETED|Washout Period 2 (7 Days)||0||
59677562|NCT01211197|75796609|FG005|NOT COMPLETED|Washout Period 2 (7 Days)||0||
59677563|NCT01211197|75796604|FG000|STARTED|Treatment Period 3 (1 Day)||2||
59677564|NCT01211197|75796605|FG001|STARTED|Treatment Period 3 (1 Day)||3||
59677565|NCT01211197|75796606|FG002|STARTED|Treatment Period 3 (1 Day)||2||
59677566|NCT01211197|75796607|FG003|STARTED|Treatment Period 3 (1 Day)||3||
59677567|NCT01211197|75796608|FG004|STARTED|Treatment Period 3 (1 Day)||2||
59677568|NCT01211197|75796609|FG005|STARTED|Treatment Period 3 (1 Day)||2||
59677569|NCT01211197|75796604|FG000|COMPLETED|Treatment Period 3 (1 Day)||2||
59677570|NCT01211197|75796605|FG001|COMPLETED|Treatment Period 3 (1 Day)||3||
59677571|NCT01211197|75796606|FG002|COMPLETED|Treatment Period 3 (1 Day)||2||
59677572|NCT01211197|75796607|FG003|COMPLETED|Treatment Period 3 (1 Day)||3||
59677573|NCT01211197|75796608|FG004|COMPLETED|Treatment Period 3 (1 Day)||2||
59677574|NCT01211197|75796609|FG005|COMPLETED|Treatment Period 3 (1 Day)||2||
59677575|NCT01211197|75796604|FG000|NOT COMPLETED|Treatment Period 3 (1 Day)||0||
59677576|NCT01211197|75796605|FG001|NOT COMPLETED|Treatment Period 3 (1 Day)||0||
59677577|NCT01211197|75796606|FG002|NOT COMPLETED|Treatment Period 3 (1 Day)||0||
59677578|NCT01211197|75796607|FG003|NOT COMPLETED|Treatment Period 3 (1 Day)||0||
59677579|NCT01211197|75796608|FG004|NOT COMPLETED|Treatment Period 3 (1 Day)||0||
59677580|NCT01211197|75796609|FG005|NOT COMPLETED|Treatment Period 3 (1 Day)||0||
59677581|NCT01232296|75796619|FG000|STARTED|Overall Study||82||
59677582|NCT01232296|75796620|FG001|STARTED|Overall Study||83||
59677583|NCT01232296|75796619|FG000|Full Analysis Set|Overall Study||82||
59677584|NCT01232296|75796620|FG001|Full Analysis Set|Overall Study||83||
59677585|NCT01232296|75796619|FG000|Safety Set|Overall Study|The Safety Set includes all patients who received at least one dose of study medication|79||
59677586|NCT01232296|75796620|FG001|Safety Set|Overall Study||83||
59677587|NCT01232296|75796619|FG000|COMPLETED|Overall Study||0||
59677588|NCT01232296|75796620|FG001|COMPLETED|Overall Study||0||
59677589|NCT01232296|75796619|FG000|NOT COMPLETED|Overall Study||82||
59677590|NCT01232296|75796620|FG001|NOT COMPLETED|Overall Study||83||
59677591|NCT01231984|75796628|FG000|STARTED|Study Period 1||69||
59677592|NCT01231984|75796629|FG001|STARTED|Study Period 1||70||
59677593|NCT01231984|75796630|FG002|STARTED|Study Period 1||66||
59677594|NCT01231984|75796631|FG003|STARTED|Study Period 1||69||
59677595|NCT01231984|75796628|FG000|COMPLETED|Study Period 1||57||
59677596|NCT01231984|75796629|FG001|COMPLETED|Study Period 1||63||
59677597|NCT01231984|75796630|FG002|COMPLETED|Study Period 1||59||
59677598|NCT01231984|75796631|FG003|COMPLETED|Study Period 1||60||
59677599|NCT01231984|75796628|FG000|NOT COMPLETED|Study Period 1||12||
59677600|NCT01231984|75796629|FG001|NOT COMPLETED|Study Period 1||7||
59677601|NCT01231984|75796630|FG002|NOT COMPLETED|Study Period 1||7||
59677602|NCT01231984|75796631|FG003|NOT COMPLETED|Study Period 1||9||
59677603|NCT01231984|75796628|FG000|STARTED|Study Period 2||57||
59677604|NCT01231984|75796629|FG001|STARTED|Study Period 2||63||
59677605|NCT01231984|75796630|FG002|STARTED|Study Period 2||59||
59677606|NCT01231984|75796631|FG003|STARTED|Study Period 2||60||
59677607|NCT01231984|75796628|FG000|COMPLETED|Study Period 2||54||
59677608|NCT01231984|75796629|FG001|COMPLETED|Study Period 2||61||
59677609|NCT01231984|75796630|FG002|COMPLETED|Study Period 2||59||
59677610|NCT01231984|75796631|FG003|COMPLETED|Study Period 2||56||
59677611|NCT01231984|75796628|FG000|NOT COMPLETED|Study Period 2||3||
59677612|NCT01231984|75796629|FG001|NOT COMPLETED|Study Period 2||2||
59677613|NCT01231984|75796630|FG002|NOT COMPLETED|Study Period 2||0||
59677614|NCT01231984|75796631|FG003|NOT COMPLETED|Study Period 2||4||
59677615|NCT01210807|75796651|FG000|STARTED|Overall Study||36||
59677616|NCT01210807|75796652|FG001|STARTED|Overall Study||34||
59677617|NCT01210807|75796651|FG000|COMPLETED|Overall Study||33||
59677618|NCT01210807|75796652|FG001|COMPLETED|Overall Study||31||
59677619|NCT01210807|75796651|FG000|NOT COMPLETED|Overall Study||3||
59677620|NCT01210807|75796652|FG001|NOT COMPLETED|Overall Study||3||
59677621|NCT01231555|75796661|FG000|STARTED|Overall Study||8||
59677622|NCT01231555|75796662|FG001|STARTED|Overall Study||7||
59677623|NCT01231555|75796663|FG002|STARTED|Overall Study||8||
59677624|NCT01231555|75796661|FG000|COMPLETED|Overall Study||0||
59677625|NCT01231555|75796662|FG001|COMPLETED|Overall Study||0||
59677626|NCT01231555|75796663|FG002|COMPLETED|Overall Study||0||
59677627|NCT01231555|75796661|FG000|NOT COMPLETED|Overall Study||8||
59677628|NCT01231555|75796662|FG001|NOT COMPLETED|Overall Study||7||
59677629|NCT01231555|75796663|FG002|NOT COMPLETED|Overall Study||8||
59677630|NCT01210690|75796671|FG000|STARTED|Overall Study||101||
59677631|NCT01210690|75796671|FG000|COMPLETED|Overall Study||75||
59677632|NCT01210690|75796671|FG000|NOT COMPLETED|Overall Study||26||
59677633|NCT01210651|75796678|FG000|STARTED|Overall Study|Number randomized to intervention, but not number who started intervention by attending 1st session.|20||
59677634|NCT01210651|75796679|FG001|STARTED|Overall Study|Number randomized to intervention, but not number who started intervention by attending 1st session.|18||
59677635|NCT01210651|75796678|FG000|Number Attending 1st Assigned Session|Overall Study||18||
59677636|NCT01210651|75796679|FG001|Number Attending 1st Assigned Session|Overall Study||12||
59677637|NCT01210651|75796678|FG000|COMPLETED|Overall Study||15||
59677638|NCT01210651|75796679|FG001|COMPLETED|Overall Study||10||
59677639|NCT01210651|75796678|FG000|NOT COMPLETED|Overall Study||5||
59677640|NCT01210651|75796679|FG001|NOT COMPLETED|Overall Study||8||
59677641|NCT03850535|75796693|FG000|STARTED|Overall Study||4||
59677642|NCT03850535|75796694|FG001|STARTED|Overall Study||9||
59677643|NCT03850535|75796695|FG002|STARTED|Overall Study||6||
59677644|NCT03850535|75796696|FG003|STARTED|Overall Study||4||
59677645|NCT03850535|75796693|FG000|COMPLETED|Overall Study||0||
59677646|NCT03850535|75796694|FG001|COMPLETED|Overall Study||0||
59677647|NCT03850535|75796695|FG002|COMPLETED|Overall Study||0||
59677648|NCT03850535|75796696|FG003|COMPLETED|Overall Study||0||
59677649|NCT03850535|75796693|FG000|NOT COMPLETED|Overall Study||4||
59677650|NCT03850535|75796694|FG001|NOT COMPLETED|Overall Study||9||
59677651|NCT03850535|75796695|FG002|NOT COMPLETED|Overall Study||6||
59677652|NCT03850535|75796696|FG003|NOT COMPLETED|Overall Study||4||
59677653|NCT03187379|75796708|FG000|STARTED|Overall Study||50||
59677654|NCT03187379|75796709|FG001|STARTED|Overall Study||52||
59677655|NCT03187379|75796708|FG000|COMPLETED|Overall Study||50||
59677656|NCT03187379|75796709|FG001|COMPLETED|Overall Study||52||
59677657|NCT03187379|75796708|FG000|NOT COMPLETED|Overall Study||0||
59677658|NCT03187379|75796709|FG001|NOT COMPLETED|Overall Study||0||
59677659|NCT03077360|75796718|FG000|STARTED|Overall Study||17||
59677660|NCT03077360|75796719|FG001|STARTED|Overall Study||17||
59677661|NCT03077360|75796720|FG002|STARTED|Overall Study||14||
59677662|NCT03077360|75796718|FG000|COMPLETED|Overall Study||17||
59677663|NCT03077360|75796719|FG001|COMPLETED|Overall Study||16||
59677664|NCT03077360|75796720|FG002|COMPLETED|Overall Study||12||
59677665|NCT03077360|75796718|FG000|NOT COMPLETED|Overall Study||0||
59677666|NCT03077360|75796719|FG001|NOT COMPLETED|Overall Study||1||
59677667|NCT03077360|75796720|FG002|NOT COMPLETED|Overall Study||2||
59677668|NCT02837042|75796729|FG000|STARTED|Overall Study||6||
59677669|NCT02837042|75796729|FG000|COMPLETED|Overall Study||6||
59677670|NCT02837042|75796729|FG000|NOT COMPLETED|Overall Study||0||
59677671|NCT03368196|75796733|FG000|STARTED|Overall Study||12||
59677672|NCT03368196|75796733|FG000|COMPLETED|Overall Study||12|Ongoing as of data cutoff 14 Sept 2018|
59677673|NCT03368196|75796733|FG000|NOT COMPLETED|Overall Study||0||
59677674|NCT03048552|75796741|FG000|STARTED|Overall Study||4||
59677675|NCT03048552|75796742|FG001|STARTED|Overall Study||18||
59677676|NCT03048552|75796743|FG002|STARTED|Overall Study||4||
59677677|NCT03048552|75796744|FG003|STARTED|Overall Study|Fewer caregivers were enrolled in Family CONNECT arm than youth as 2 caregivers had multiple children in the Family CONNECT arm: one caregiver had n=2 children and 1 caregiver had n=3 children.|15||
59677678|NCT03048552|75796741|FG000|COMPLETED|Overall Study||4||
59677679|NCT03048552|75796742|FG001|COMPLETED|Overall Study||18||
59677680|NCT03048552|75796743|FG002|COMPLETED|Overall Study||4||
59677681|NCT03048552|75796744|FG003|COMPLETED|Overall Study||15||
59677682|NCT03048552|75796741|FG000|NOT COMPLETED|Overall Study||0||
59677683|NCT03048552|75796742|FG001|NOT COMPLETED|Overall Study||0||
59677684|NCT03048552|75796743|FG002|NOT COMPLETED|Overall Study||0||
59677685|NCT03048552|75796744|FG003|NOT COMPLETED|Overall Study||0||
59677686|NCT01210495|75796758|FG000|STARTED|Overall Study||15||
59677687|NCT01210495|75796759|FG001|STARTED|Overall Study||7||
59677688|NCT01210495|75796760|FG002|STARTED|Overall Study||134||
59677689|NCT01210495|75796761|FG003|STARTED|Overall Study||68||
59677690|NCT01210495|75796758|FG000|COMPLETED|Overall Study||0||
59677691|NCT01210495|75796759|FG001|COMPLETED|Overall Study||0||
59677692|NCT01210495|75796760|FG002|COMPLETED|Overall Study||0||
59677693|NCT01210495|75796761|FG003|COMPLETED|Overall Study||0||
59677694|NCT01210495|75796758|FG000|NOT COMPLETED|Overall Study||15||
59677695|NCT01210495|75796759|FG001|NOT COMPLETED|Overall Study||7||
59677696|NCT01210495|75796760|FG002|NOT COMPLETED|Overall Study||134||
59677697|NCT01210495|75796761|FG003|NOT COMPLETED|Overall Study||68||
59677698|NCT01231516|75796773|FG000|STARTED|Double-blind Phase (Up to Week [Wk] 48)||360|Randomized|
59677699|NCT01231516|75796774|FG001|STARTED|Double-blind Phase (Up to Week [Wk] 48)||364|Randomized|
59677700|NCT01231516|75796773|FG000|ITT-E Population|Double-blind Phase (Up to Week [Wk] 48)||357||
59677701|NCT01231516|75796774|FG001|ITT-E Population|Double-blind Phase (Up to Week [Wk] 48)||362||
59677702|NCT01231516|75796773|FG000|Modified (m)ITT-E Population|Double-blind Phase (Up to Week [Wk] 48)||354||
59677703|NCT01231516|75796774|FG001|Modified (m)ITT-E Population|Double-blind Phase (Up to Week [Wk] 48)||361||
59677704|NCT01231516|75796773|FG000|COMPLETED|Double-blind Phase (Up to Week [Wk] 48)||299||
59989536|NCT00440531|76104848|FG002|Vaccination 3|Overall Study||166||
59677705|NCT01231516|75796774|FG001|COMPLETED|Double-blind Phase (Up to Week [Wk] 48)||283||
59677706|NCT01231516|75796773|FG000|NOT COMPLETED|Double-blind Phase (Up to Week [Wk] 48)||61||
59677707|NCT01231516|75796774|FG001|NOT COMPLETED|Double-blind Phase (Up to Week [Wk] 48)||81||
59677708|NCT01231516|75796773|FG000|STARTED|Open-label Phase:From Wk 48 up to Wk 480|4 participants completed the Double-blind Phase but did not enter the Open-label Phase.|295||
59677709|NCT01231516|75796774|FG001|STARTED|Open-label Phase:From Wk 48 up to Wk 480|157 participants completed the Double-blind Phase but did not enter the Open-label Phase.|126||
59677710|NCT01231516|75796773|FG000|COMPLETED|Open-label Phase:From Wk 48 up to Wk 480||227||
59677711|NCT01231516|75796774|FG001|COMPLETED|Open-label Phase:From Wk 48 up to Wk 480||109||
59677712|NCT01231516|75796773|FG000|NOT COMPLETED|Open-label Phase:From Wk 48 up to Wk 480||68||
59677713|NCT01231516|75796774|FG001|NOT COMPLETED|Open-label Phase:From Wk 48 up to Wk 480||17||
59677714|NCT01231321|75796780|FG000|STARTED|Overall Study||100||
59677715|NCT01231321|75796780|FG000|COMPLETED|Overall Study||95||
59677716|NCT01231321|75796780|FG000|NOT COMPLETED|Overall Study||5||
59989537|NCT00440531|76104846|FG000|COMPLETED|Overall Study||175||
59677717|NCT01210222|75796790|FG000|STARTED|Overall Study||35||
59677718|NCT01210222|75796790|FG000|COMPLETED|Overall Study||32||
59677719|NCT01210222|75796790|FG000|NOT COMPLETED|Overall Study||3||
59677720|NCT01210144|75796802|FG000|STARTED|Overall Study||13||
59989538|NCT00440531|76104847|FG001|COMPLETED|Overall Study||178||
59677721|NCT01210144|75796803|FG001|STARTED|Overall Study||11||
59677722|NCT01210144|75796802|FG000|COMPLETED|Overall Study||10||
59677723|NCT01210144|75796803|FG001|COMPLETED|Overall Study||11||
59677724|NCT01210144|75796802|FG000|NOT COMPLETED|Overall Study||3||
59677725|NCT01210144|75796803|FG001|NOT COMPLETED|Overall Study||0||
59989539|NCT00440531|76104848|FG002|COMPLETED|Overall Study||165||
59677726|NCT01209949|75796810|FG000|STARTED|Overall Study||30||
59677727|NCT01209949|75796810|FG000|COMPLETED|Overall Study||27||
59677728|NCT01209949|75796810|FG000|NOT COMPLETED|Overall Study||3||
59677729|NCT01209832|75796814|FG000|STARTED|Period 1||11||
59677730|NCT01209832|75796814|FG000|Received At Least 1 Dose of Study Drug|Period 1||10||
59677731|NCT01209832|75796814|FG000|COMPLETED|Period 1||10||
59677732|NCT01209832|75796814|FG000|NOT COMPLETED|Period 1||1||
59677733|NCT01209832|75796814|FG000|STARTED|Period 2||10||
59677734|NCT01209832|75796814|FG000|COMPLETED|Period 2||9||
59677735|NCT01209832|75796814|FG000|NOT COMPLETED|Period 2||1||
59677736|NCT01209832|75796814|FG000|STARTED|Maintenance Period 1 (M1)|Five participants who completed Period 2 did not enroll into Maintenance Period.|4||
59989540|NCT00440531|76104846|FG000|NOT COMPLETED|Overall Study||10||
59989541|NCT00440531|76104847|FG001|NOT COMPLETED|Overall Study||5||
59989542|NCT00440531|76104848|FG002|NOT COMPLETED|Overall Study||7||
59989543|NCT02513732|76104854|FG000|STARTED|Overall Study||100||
59546429|NCT02442336|75645143|FG000|Provided Access to Intervention|Overall Study||55|55 participants were provided access to My Journey AHead. 44 participants logged in and viewed the program, whereas 11 participants did not log in or access the program.|
59546430|NCT02442336|75645143|FG000|COMPLETED|Overall Study||44||
59546431|NCT02442336|75645143|FG000|NOT COMPLETED|Overall Study||36||
59546432|NCT02452398|75645147|FG000|STARTED|Overall Study|Study was halted prematurely. No results analysis completed.|79||
59546433|NCT02452398|75645147|FG000|COMPLETED|Overall Study|Study was halted prematurely. No results analysis completed.|38||
59546434|NCT02452398|75645147|FG000|NOT COMPLETED|Overall Study||41||
59546435|NCT02413398|75645153|FG000|STARTED|Overall Study||160||
59546436|NCT02413398|75645154|FG001|STARTED|Overall Study||161||
59546437|NCT02413398|75645153|FG000|COMPLETED|Overall Study||156||
59546438|NCT02413398|75645154|FG001|COMPLETED|Overall Study||154||
59546439|NCT02413398|75645153|FG000|NOT COMPLETED|Overall Study||4||
59546440|NCT02413398|75645154|FG001|NOT COMPLETED|Overall Study||7||
59546441|NCT02441946|75645163|FG000|STARTED|Cycle 1 Period 1 (2 Weeks)||74||
59546442|NCT02441946|75645164|FG001|STARTED|Cycle 1 Period 1 (2 Weeks)||76||
59546443|NCT02441946|75645165|FG002|STARTED|Cycle 1 Period 1 (2 Weeks)||74||
59546444|NCT02441946|75645163|FG000|Received at Least One Dose of Study Drug|Cycle 1 Period 1 (2 Weeks)||74||
59546445|NCT02441946|75645164|FG001|Received at Least One Dose of Study Drug|Cycle 1 Period 1 (2 Weeks)|1 participant did not receive drug due to an error in randomization.|75||
59677737|NCT01209832|75796814|FG000|COMPLETED|Maintenance Period 1 (M1)||4||
59677738|NCT01209832|75796814|FG000|NOT COMPLETED|Maintenance Period 1 (M1)||0||
59677739|NCT01209832|75796814|FG000|STARTED|Maintenance Period 2 (M1)|One participant who completed maintenance period 1 did not enter maintenance period 2.|3||
59989544|NCT02513732|76104854|FG000|COMPLETED|Overall Study||78||
59989545|NCT02513732|76104854|FG000|NOT COMPLETED|Overall Study||22||
59989546|NCT00429923|76104861|FG000|STARTED|Overall Study||57||
59989547|NCT00429923|76104862|FG001|STARTED|Overall Study||55||
59989548|NCT00429923|76104863|FG002|STARTED|Overall Study||107||
59989549|NCT00429923|76104861|FG000|COMPLETED|Overall Study||52||
59989550|NCT00429923|76104862|FG001|COMPLETED|Overall Study||51||
59677740|NCT01209832|75796814|FG000|COMPLETED|Maintenance Period 2 (M1)||3||
59677741|NCT01209832|75796814|FG000|NOT COMPLETED|Maintenance Period 2 (M1)||0||
59677742|NCT01230892|75796827|FG000|STARTED|Overall Study||15||
59677743|NCT01230892|75796828|FG001|STARTED|Overall Study||14||
59677744|NCT01230892|75796827|FG000|COMPLETED|Overall Study||12||
59677745|NCT01230892|75796828|FG001|COMPLETED|Overall Study||13||
59677746|NCT01230892|75796827|FG000|NOT COMPLETED|Overall Study||3||
59677747|NCT01230892|75796828|FG001|NOT COMPLETED|Overall Study||1||
59546446|NCT02441946|75645165|FG002|Received at Least One Dose of Study Drug|Cycle 1 Period 1 (2 Weeks)||74||
59546447|NCT02441946|75645163|FG000|COMPLETED|Cycle 1 Period 1 (2 Weeks)||72||
59546448|NCT02441946|75645164|FG001|COMPLETED|Cycle 1 Period 1 (2 Weeks)||71||
59546449|NCT02441946|75645165|FG002|COMPLETED|Cycle 1 Period 1 (2 Weeks)||74||
59546450|NCT02441946|75645163|FG000|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||2||
59546451|NCT02441946|75645164|FG001|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||5||
59546452|NCT02441946|75645165|FG002|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0||
59546453|NCT02441946|75645163|FG000|STARTED|Cycle 2-5 Period 2 (14 Weeks)|All 217 participants were assigned to abemaciclib + anastrozole post cycle 1.|217||
59546454|NCT02441946|75645164|FG001|STARTED|Cycle 2-5 Period 2 (14 Weeks)|All 217 participants were assigned abemaciclib + anastrozole post cycle 1.|0||
59546455|NCT02441946|75645165|FG002|STARTED|Cycle 2-5 Period 2 (14 Weeks)|All 217 participants were assigned abemaciclib + anastrozole post cycle 1.|0||
59546456|NCT02441946|75645163|FG000|Received at Least One Dose of Study Drug|Cycle 2-5 Period 2 (14 Weeks)||217||
59546457|NCT02441946|75645164|FG001|Received at Least One Dose of Study Drug|Cycle 2-5 Period 2 (14 Weeks)||0||
59546458|NCT02441946|75645165|FG002|Received at Least One Dose of Study Drug|Cycle 2-5 Period 2 (14 Weeks)||0||
59546459|NCT02441946|75645163|FG000|Progressive Disease|Cycle 2-5 Period 2 (14 Weeks)||5||
59546460|NCT02441946|75645164|FG001|Progressive Disease|Cycle 2-5 Period 2 (14 Weeks)||0||
59546461|NCT02441946|75645165|FG002|Progressive Disease|Cycle 2-5 Period 2 (14 Weeks)||0||
59546462|NCT02441946|75645163|FG000|COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||190||
59546463|NCT02441946|75645164|FG001|COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||0||
59546464|NCT02441946|75645165|FG002|COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||0||
59546465|NCT02441946|75645163|FG000|NOT COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||27||
59546466|NCT02441946|75645164|FG001|NOT COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||0||
59546467|NCT02441946|75645165|FG002|NOT COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||0||
59546468|NCT02441946|75645163|FG000|STARTED|Extension Period (8 Weeks)|All participants who did not discontinue continued to the extension period.|42||
59546469|NCT02441946|75645164|FG001|STARTED|Extension Period (8 Weeks)||0||
59546470|NCT02441946|75645165|FG002|STARTED|Extension Period (8 Weeks)||0||
59546471|NCT02441946|75645163|FG000|COMPLETED|Extension Period (8 Weeks)||40||
59546472|NCT02441946|75645164|FG001|COMPLETED|Extension Period (8 Weeks)||0||
59546473|NCT02441946|75645165|FG002|COMPLETED|Extension Period (8 Weeks)||0||
59546474|NCT02441946|75645163|FG000|NOT COMPLETED|Extension Period (8 Weeks)||2||
59546475|NCT02441946|75645164|FG001|NOT COMPLETED|Extension Period (8 Weeks)||0||
59546476|NCT02441946|75645165|FG002|NOT COMPLETED|Extension Period (8 Weeks)||0||
59546477|NCT01083368|75645178|FG000|STARTED|Dose Escalation Weeks 1-4||0||
59546478|NCT01083368|75645179|FG001|STARTED|Dose Escalation Weeks 1-4||0||
59546479|NCT01083368|75645180|FG002|STARTED|Dose Escalation Weeks 1-4||4||
59546480|NCT01083368|75645181|FG003|STARTED|Dose Escalation Weeks 1-4||0||
59546481|NCT01083368|75645178|FG000|Disease Progression|Dose Escalation Weeks 1-4||0||
59546482|NCT01083368|75645179|FG001|Disease Progression|Dose Escalation Weeks 1-4||0||
59546483|NCT01083368|75645180|FG002|Disease Progression|Dose Escalation Weeks 1-4||1||
59546484|NCT01083368|75645181|FG003|Disease Progression|Dose Escalation Weeks 1-4||0||
59546485|NCT01083368|75645178|FG000|COMPLETED|Dose Escalation Weeks 1-4||0||
59546486|NCT01083368|75645179|FG001|COMPLETED|Dose Escalation Weeks 1-4||0||
59546487|NCT01083368|75645180|FG002|COMPLETED|Dose Escalation Weeks 1-4||4||
59546488|NCT01083368|75645181|FG003|COMPLETED|Dose Escalation Weeks 1-4||0||
59546489|NCT01083368|75645178|FG000|NOT COMPLETED|Dose Escalation Weeks 1-4||0||
59546490|NCT01083368|75645179|FG001|NOT COMPLETED|Dose Escalation Weeks 1-4||0||
59546491|NCT01083368|75645180|FG002|NOT COMPLETED|Dose Escalation Weeks 1-4||0||
59546492|NCT01083368|75645181|FG003|NOT COMPLETED|Dose Escalation Weeks 1-4||0||
59546493|NCT01083368|75645178|FG000|STARTED|Dose Escalation Weeks 5-9||0||
59546494|NCT01083368|75645179|FG001|STARTED|Dose Escalation Weeks 5-9||0||
59677748|NCT01230814|75796836|FG000|STARTED|Overall Study||118||
59677749|NCT01230814|75796837|FG001|STARTED|Overall Study||116||
59677750|NCT01230814|75796836|FG000|COMPLETED|Overall Study||105||
59677751|NCT01230814|75796837|FG001|COMPLETED|Overall Study||112||
59677752|NCT01230814|75796836|FG000|NOT COMPLETED|Overall Study||13||
59677753|NCT01230814|75796837|FG001|NOT COMPLETED|Overall Study||4||
59677754|NCT01230307|75796845|FG000|STARTED|Overall Study||6||
59677755|NCT01230307|75796846|FG001|STARTED|Overall Study||6||
59546495|NCT01083368|75645180|FG002|STARTED|Dose Escalation Weeks 5-9|Participant on DL1 did not move to dose level 2 because of disease progression.|1||
59546496|NCT01083368|75645181|FG003|STARTED|Dose Escalation Weeks 5-9||6||
59546497|NCT01083368|75645178|FG000|COMPLETED|Dose Escalation Weeks 5-9||0||
59546498|NCT01083368|75645179|FG001|COMPLETED|Dose Escalation Weeks 5-9||0||
59546499|NCT01083368|75645180|FG002|COMPLETED|Dose Escalation Weeks 5-9||1||
59546500|NCT01083368|75645181|FG003|COMPLETED|Dose Escalation Weeks 5-9|3 participants on dose level 1 moved to dose level 2, 3 more new participants joined.|6||
59677756|NCT01230307|75796845|FG000|COMPLETED|Overall Study||6||
59677757|NCT01230307|75796846|FG001|COMPLETED|Overall Study||4||
59677758|NCT01230307|75796845|FG000|NOT COMPLETED|Overall Study||0||
59677759|NCT01230307|75796846|FG001|NOT COMPLETED|Overall Study||2||
59677760|NCT01209598|75796854|FG000|STARTED|Overall Study||30||
59677761|NCT01209598|75796855|FG001|STARTED|Overall Study||60||
59677762|NCT01209598|75796854|FG000|COMPLETED|Overall Study||29||
59677763|NCT01209598|75796855|FG001|COMPLETED|Overall Study||60||
59677764|NCT01209598|75796854|FG000|NOT COMPLETED|Overall Study||1||
59677765|NCT01209598|75796855|FG001|NOT COMPLETED|Overall Study||0||
59677766|NCT01209520|75796862|FG000|STARTED|Overall Study||6||
59677767|NCT01209520|75796862|FG000|COMPLETED|Overall Study||3||
59677768|NCT01209520|75796862|FG000|NOT COMPLETED|Overall Study||3||
59677769|NCT01209325|75796866|FG000|STARTED|Overall Study||149|Enrolled|
59677770|NCT01209325|75796866|FG000|Eligible|Overall Study||145||
59677771|NCT01209325|75796866|FG000|Received First Vaccine Injection|Overall Study||144||
59677772|NCT01209325|75796866|FG000|Received Second Vaccine Injection|Overall Study||141||
59677773|NCT01209325|75796866|FG000|Received Third Vaccine Infjection|Overall Study||138||
59677774|NCT01209325|75796866|FG000|Returned After Week 28|Overall Study||124||
59677775|NCT01209325|75796866|FG000|COMPLETED|Overall Study||106||
59677776|NCT01209325|75796866|FG000|NOT COMPLETED|Overall Study||43||
59677777|NCT04415073|75796894|FG000|STARTED|Overall Study||0||
59677778|NCT04415073|75796895|FG001|STARTED|Overall Study||0||
59677779|NCT04415073|75796894|FG000|COMPLETED|Overall Study||0||
59677780|NCT04415073|75796895|FG001|COMPLETED|Overall Study||0||
59677781|NCT04415073|75796894|FG000|NOT COMPLETED|Overall Study||0||
59677782|NCT04415073|75796895|FG001|NOT COMPLETED|Overall Study||0||
59677783|NCT01209286|75796904|FG000|STARTED|Overall Study||7||
59677784|NCT01209286|75796905|FG001|STARTED|Overall Study||23||
59677785|NCT01209286|75796906|FG002|STARTED|Overall Study||6||
59677786|NCT01209286|75796904|FG000|COMPLETED|Overall Study||2||
59677787|NCT01209286|75796905|FG001|COMPLETED|Overall Study||13||
59677788|NCT01209286|75796906|FG002|COMPLETED|Overall Study||3||
59677789|NCT01209286|75796904|FG000|NOT COMPLETED|Overall Study||5||
59677790|NCT01209286|75796905|FG001|NOT COMPLETED|Overall Study||10||
59677791|NCT01209286|75796906|FG002|NOT COMPLETED|Overall Study||3||
59677792|NCT05097144|75796923|FG000|STARTED|Period 1 (One Month)||18||
59677793|NCT05097144|75796924|FG001|STARTED|Period 1 (One Month)||18||
59677794|NCT05097144|75796923|FG000|COMPLETED|Period 1 (One Month)||18||
59677795|NCT05097144|75796924|FG001|COMPLETED|Period 1 (One Month)||18||
59677796|NCT05097144|75796923|FG000|NOT COMPLETED|Period 1 (One Month)||0||
59677797|NCT05097144|75796924|FG001|NOT COMPLETED|Period 1 (One Month)||0||
59677798|NCT05097144|75796923|FG000|STARTED|Period 2 (One Month)||18||
59677799|NCT05097144|75796924|FG001|STARTED|Period 2 (One Month)||18||
59677800|NCT05097144|75796923|FG000|COMPLETED|Period 2 (One Month)||18||
59677801|NCT05097144|75796924|FG001|COMPLETED|Period 2 (One Month)||18||
60078053|NCT03364348|76193063|FG001|COMPLETED|Overall Study||2||
60078054|NCT03364348|76193064|FG002|COMPLETED|Overall Study||3||
60078055|NCT03364348|76193065|FG003|COMPLETED|Overall Study||10||
60078056|NCT03364348|76193062|FG000|NOT COMPLETED|Overall Study||0||
60078057|NCT03364348|76193063|FG001|NOT COMPLETED|Overall Study||0||
60078058|NCT03364348|76193064|FG002|NOT COMPLETED|Overall Study||0||
60078059|NCT03364348|76193065|FG003|NOT COMPLETED|Overall Study||0||
60078060|NCT01479465|76193080|FG000|STARTED|Overall Study||11||
60078061|NCT01479465|76193081|FG001|STARTED|Overall Study||84||
60078062|NCT01479465|76193082|FG002|STARTED|Overall Study||86||
60078063|NCT01479465|76193083|FG003|STARTED|Overall Study||85||
59677802|NCT05097144|75796923|FG000|NOT COMPLETED|Period 2 (One Month)||0||
59677803|NCT05097144|75796924|FG001|NOT COMPLETED|Period 2 (One Month)||0||
59677804|NCT05048719|75796939|FG000|STARTED|Overall Study||55||
59677805|NCT05048719|75796940|FG001|STARTED|Overall Study||51||
59677806|NCT05048719|75796941|FG002|STARTED|Overall Study||56||
59677807|NCT05048719|75796942|FG003|STARTED|Overall Study||47||
59677808|NCT05048719|75796943|FG004|STARTED|Overall Study||27||
59677809|NCT05048719|75796944|FG005|STARTED|Overall Study||34||
59677810|NCT05048719|75796945|FG006|STARTED|Overall Study||31||
59677811|NCT05048719|75796946|FG007|STARTED|Overall Study||32||
59677812|NCT05048719|75796947|FG008|STARTED|Overall Study||50||
59677813|NCT05048719|75796939|FG000|Received At Least One Dose of Study Drug|Overall Study||55||
59677814|NCT05048719|75796940|FG001|Received At Least One Dose of Study Drug|Overall Study||51||
59677815|NCT05048719|75796941|FG002|Received At Least One Dose of Study Drug|Overall Study||56||
59677816|NCT05048719|75796942|FG003|Received At Least One Dose of Study Drug|Overall Study||47||
59677817|NCT05048719|75796943|FG004|Received At Least One Dose of Study Drug|Overall Study||27||
59677818|NCT05048719|75796944|FG005|Received At Least One Dose of Study Drug|Overall Study||34||
59677819|NCT05048719|75796945|FG006|Received At Least One Dose of Study Drug|Overall Study||31||
59677820|NCT05048719|75796946|FG007|Received At Least One Dose of Study Drug|Overall Study||32||
60078064|NCT01479465|76193080|FG000|COMPLETED|Overall Study||0||
59677821|NCT05048719|75796947|FG008|Received At Least One Dose of Study Drug|Overall Study||50||
59677822|NCT05048719|75796939|FG000|COMPLETED|Overall Study||51||
59677823|NCT05048719|75796940|FG001|COMPLETED|Overall Study||47||
59677824|NCT05048719|75796941|FG002|COMPLETED|Overall Study||50||
59677825|NCT05048719|75796942|FG003|COMPLETED|Overall Study||42||
59677826|NCT05048719|75796943|FG004|COMPLETED|Overall Study||25||
59677827|NCT05048719|75796944|FG005|COMPLETED|Overall Study||30||
59677828|NCT05048719|75796945|FG006|COMPLETED|Overall Study||29||
59677829|NCT05048719|75796946|FG007|COMPLETED|Overall Study||29||
59677830|NCT05048719|75796947|FG008|COMPLETED|Overall Study||49||
59677831|NCT05048719|75796939|FG000|NOT COMPLETED|Overall Study||4||
59677832|NCT05048719|75796940|FG001|NOT COMPLETED|Overall Study||4||
59677833|NCT05048719|75796941|FG002|NOT COMPLETED|Overall Study||6||
59677834|NCT05048719|75796942|FG003|NOT COMPLETED|Overall Study||5||
59677835|NCT05048719|75796943|FG004|NOT COMPLETED|Overall Study||2||
59677836|NCT05048719|75796944|FG005|NOT COMPLETED|Overall Study||4||
59677837|NCT05048719|75796945|FG006|NOT COMPLETED|Overall Study||2||
59677838|NCT05048719|75796946|FG007|NOT COMPLETED|Overall Study||3||
59677839|NCT05048719|75796947|FG008|NOT COMPLETED|Overall Study||1||
59677840|NCT04949802|75796972|FG000|STARTED|Overall Study||15||22
59815920|NCT00999037|75938348|FG001|NOT COMPLETED|Overall Study||0||
59815921|NCT00833664|75938358|FG000|STARTED|First Intervention||11||
59815922|NCT00833664|75938359|FG001|STARTED|First Intervention||11||
59815923|NCT00833664|75938358|FG000|COMPLETED|First Intervention||11||
59815924|NCT00833664|75938359|FG001|COMPLETED|First Intervention||11||
59815925|NCT00833664|75938358|FG000|NOT COMPLETED|First Intervention||0||
59989551|NCT00429923|76104863|FG002|COMPLETED|Overall Study||68||
59989552|NCT00429923|76104861|FG000|NOT COMPLETED|Overall Study||5||
59989553|NCT00429923|76104862|FG001|NOT COMPLETED|Overall Study||4||
59989554|NCT00429923|76104863|FG002|NOT COMPLETED|Overall Study||39||
59989555|NCT02256436|76104870|FG000|STARTED|Overall Study||272||
60078065|NCT01479465|76193081|FG001|COMPLETED|Overall Study||0||
60078066|NCT01479465|76193082|FG002|COMPLETED|Overall Study||0||
59546501|NCT01083368|75645178|FG000|NOT COMPLETED|Dose Escalation Weeks 5-9||0||
59546502|NCT01083368|75645179|FG001|NOT COMPLETED|Dose Escalation Weeks 5-9||0||
59815926|NCT00833664|75938359|FG001|NOT COMPLETED|First Intervention||0||
59815927|NCT00833664|75938358|FG000|STARTED|Washout: 14 Days||11||
59815928|NCT00833664|75938359|FG001|STARTED|Washout: 14 Days||11||
59815929|NCT00833664|75938358|FG000|COMPLETED|Washout: 14 Days||10||
59815930|NCT00833664|75938359|FG001|COMPLETED|Washout: 14 Days||11||
59815931|NCT00833664|75938358|FG000|NOT COMPLETED|Washout: 14 Days||1||
59815932|NCT00833664|75938359|FG001|NOT COMPLETED|Washout: 14 Days||0||
59815933|NCT00833664|75938358|FG000|STARTED|Second Intervention||10||
59815934|NCT00833664|75938359|FG001|STARTED|Second Intervention||11||
59815935|NCT00833664|75938358|FG000|COMPLETED|Second Intervention||10||
59815936|NCT00833664|75938359|FG001|COMPLETED|Second Intervention||11||
59546503|NCT01083368|75645180|FG002|NOT COMPLETED|Dose Escalation Weeks 5-9||0||
59546504|NCT01083368|75645181|FG003|NOT COMPLETED|Dose Escalation Weeks 5-9||0||
59546505|NCT01083368|75645178|FG000|STARTED|Phase II - Efficacy/Safety||0||
59546506|NCT01083368|75645179|FG001|STARTED|Phase II - Efficacy/Safety||0||
59546507|NCT01083368|75645180|FG002|STARTED|Phase II - Efficacy/Safety||0||
59546508|NCT01083368|75645181|FG003|STARTED|Phase II - Efficacy/Safety||20||
59546509|NCT01083368|75645178|FG000|COMPLETED|Phase II - Efficacy/Safety||0||
59546510|NCT01083368|75645179|FG001|COMPLETED|Phase II - Efficacy/Safety||0||
59546511|NCT01083368|75645180|FG002|COMPLETED|Phase II - Efficacy/Safety||0||
59546512|NCT01083368|75645181|FG003|COMPLETED|Phase II - Efficacy/Safety|14 plus 6 participants from previous period|20||
59546513|NCT01083368|75645178|FG000|NOT COMPLETED|Phase II - Efficacy/Safety||0||
59546514|NCT01083368|75645179|FG001|NOT COMPLETED|Phase II - Efficacy/Safety||0||
59546515|NCT01083368|75645180|FG002|NOT COMPLETED|Phase II - Efficacy/Safety||0||
59546516|NCT01083368|75645181|FG003|NOT COMPLETED|Phase II - Efficacy/Safety||0||
59546517|NCT01083758|75645189|FG000|STARTED|Overall Study||31||
59546518|NCT01083758|75645189|FG000|COMPLETED|Overall Study||29||
59677841|NCT04949802|75796972|FG000|COMPLETED|Overall Study||12||18
59677842|NCT04949802|75796972|FG000|NOT COMPLETED|Overall Study||3||4
59677843|NCT04718870|75796979|FG000|STARTED|Overall Study||18||
59815937|NCT00833664|75938358|FG000|NOT COMPLETED|Second Intervention||0||
59989556|NCT02256436|76104871|FG001|STARTED|Overall Study||270||
59989557|NCT02256436|76104870|FG000|Treated|Overall Study||255||
59677844|NCT04718870|75796980|FG001|STARTED|Overall Study||23||
59677845|NCT04718870|75796979|FG000|COMPLETED|Overall Study||18||
59677846|NCT04718870|75796980|FG001|COMPLETED|Overall Study||23||
59677847|NCT04718870|75796979|FG000|NOT COMPLETED|Overall Study||0||
59677848|NCT04718870|75796980|FG001|NOT COMPLETED|Overall Study||0||
59677849|NCT04626297|75796988|FG000|STARTED|Overall Study||127||
59677850|NCT04626297|75796989|FG001|STARTED|Overall Study||127||
59677851|NCT04626297|75796988|FG000|Received at Least 1 Dose of Study Drug|Overall Study||127||
59677852|NCT04626297|75796989|FG001|Received at Least 1 Dose of Study Drug|Overall Study||127||
59677853|NCT04626297|75796988|FG000|COMPLETED|Overall Study||88||
59677854|NCT04626297|75796989|FG001|COMPLETED|Overall Study||113||
59677855|NCT04626297|75796988|FG000|NOT COMPLETED|Overall Study||39||
59677856|NCT04626297|75796989|FG001|NOT COMPLETED|Overall Study||14||
59677857|NCT04567407|75796995|FG000|STARTED|Overall Study||45||
59677858|NCT04567407|75796995|FG000|COMPLETED|Overall Study||40||
59677859|NCT04567407|75796995|FG000|NOT COMPLETED|Overall Study||5||
59677860|NCT04154189|75797001|FG000|STARTED|Overall Study||40||
59677861|NCT04154189|75797002|FG001|STARTED|Overall Study||41||
59677862|NCT04154189|75797001|FG000|Treated (Safety Analysis Set)|Overall Study||39||
59677863|NCT04154189|75797002|FG001|Treated (Safety Analysis Set)|Overall Study||39||
59677864|NCT04154189|75797001|FG000|Optional Lenvatinib Treatment (Arm B Only)|Overall Study||0|Participants from Treatment Arm B: Ifosfamide + Etoposide who had PD per RECIST v1.1 were eligible to receive an optional lenvatinib treatment plus any remaining cycles of chemotherapy (ifosfamide + etoposide) if 5 cycles were not completed prior to PD.|
59677865|NCT04154189|75797002|FG001|Optional Lenvatinib Treatment (Arm B Only)|Overall Study||14|Participants from Treatment Arm B: Ifosfamide + Etoposide who had PD per RECIST v1.1 were eligible to receive an optional lenvatinib treatment plus any remaining cycles of chemotherapy (ifosfamide + etoposide) if 5 cycles were not completed prior to PD.|
59677866|NCT04154189|75797001|FG000|COMPLETED|Overall Study||0||
59677867|NCT04154189|75797002|FG001|COMPLETED|Overall Study||0||
59677868|NCT04154189|75797001|FG000|NOT COMPLETED|Overall Study||40||
59677869|NCT04154189|75797002|FG001|NOT COMPLETED|Overall Study||41||
59677870|NCT03949673|75797013|FG000|STARTED|Overall Study||2||
59677871|NCT03949673|75797014|FG001|STARTED|Overall Study||5||
59677872|NCT03949673|75797015|FG002|STARTED|Overall Study||13||
59677873|NCT03949673|75797013|FG000|COMPLETED|Overall Study||2||
59677874|NCT03949673|75797014|FG001|COMPLETED|Overall Study||5||
59677875|NCT03949673|75797015|FG002|COMPLETED|Overall Study||13||
59677876|NCT03949673|75797013|FG000|NOT COMPLETED|Overall Study||0||
59677877|NCT03949673|75797014|FG001|NOT COMPLETED|Overall Study||0||
59677878|NCT03949673|75797015|FG002|NOT COMPLETED|Overall Study||0||
59677879|NCT03905512|75797025|FG000|STARTED|Overall Study||83||
59677880|NCT03905512|75797026|FG001|STARTED|Overall Study||87||
59677881|NCT03905512|75797025|FG000|Received At Least 1 Dose of Study Drug|Overall Study||83||
59677882|NCT03905512|75797026|FG001|Received At Least 1 Dose of Study Drug|Overall Study||87||
59677883|NCT03905512|75797025|FG000|COMPLETED|Overall Study||62||
59677884|NCT03905512|75797026|FG001|COMPLETED|Overall Study||70||
59677885|NCT03905512|75797025|FG000|NOT COMPLETED|Overall Study||21||
59677886|NCT03905512|75797026|FG001|NOT COMPLETED|Overall Study||17||
59677887|NCT03891875|75797035|FG000|STARTED|Overall Study||117||
59677888|NCT03891875|75797036|FG001|STARTED|Overall Study||59||
59677889|NCT03891875|75797035|FG000|COMPLETED|Overall Study||83||
59677890|NCT03891875|75797036|FG001|COMPLETED|Overall Study||51||
59677891|NCT03891875|75797035|FG000|NOT COMPLETED|Overall Study||34||
59677892|NCT03891875|75797036|FG001|NOT COMPLETED|Overall Study||8||
59677893|NCT03830164|75797045|FG000|STARTED|Overall Study||5||
59677894|NCT03830164|75797046|FG001|STARTED|Overall Study||8||
59677895|NCT03830164|75797047|FG002|STARTED|Overall Study||1||
59677896|NCT03830164|75797045|FG000|COMPLETED|Overall Study||3||
59677897|NCT03830164|75797046|FG001|COMPLETED|Overall Study||0||
59677898|NCT03830164|75797047|FG002|COMPLETED|Overall Study||1||
59677899|NCT03830164|75797045|FG000|NOT COMPLETED|Overall Study||2||
59677900|NCT03830164|75797046|FG001|NOT COMPLETED|Overall Study||8||
59677901|NCT03830164|75797047|FG002|NOT COMPLETED|Overall Study||0||
59677902|NCT03769181|75797059|FG000|STARTED|Overall Study||18||
59677903|NCT03769181|75797060|FG001|STARTED|Overall Study||12||
59677904|NCT03769181|75797061|FG002|STARTED|Overall Study||17||
59677905|NCT03769181|75797062|FG003|STARTED|Overall Study||11||
59677906|NCT03769181|75797059|FG000|COMPLETED|Overall Study||5|Participants who completed study treatment.|
59677907|NCT03769181|75797060|FG001|COMPLETED|Overall Study||4|Participants who completed study treatment.|
59677908|NCT03769181|75797061|FG002|COMPLETED|Overall Study||0|Participants who completed study treatment.|
59677909|NCT03769181|75797062|FG003|COMPLETED|Overall Study||0|Participants who completed study treatment.|
59677910|NCT03769181|75797059|FG000|NOT COMPLETED|Overall Study||13||
59677911|NCT03769181|75797060|FG001|NOT COMPLETED|Overall Study||8||
59677912|NCT03769181|75797061|FG002|NOT COMPLETED|Overall Study||17||
59677913|NCT03769181|75797062|FG003|NOT COMPLETED|Overall Study||11||
59677914|NCT03722407|75797097|FG000|STARTED|Overall Study||29||
59677915|NCT03722407|75797097|FG000|COMPLETED|Overall Study||29||
59677916|NCT03722407|75797097|FG000|NOT COMPLETED|Overall Study||0||
59677917|NCT03621696|75797105|FG000|STARTED|Overall Study||21||
59677918|NCT03621696|75797106|FG001|STARTED|Overall Study||31||
59677919|NCT03621696|75797107|FG002|STARTED|Overall Study||6||
59677920|NCT03621696|75797108|FG003|STARTED|Overall Study||5||
59677921|NCT03621696|75797105|FG000|COMPLETED|Overall Study||20||
59677922|NCT03621696|75797106|FG001|COMPLETED|Overall Study||30||
59677923|NCT03621696|75797107|FG002|COMPLETED|Overall Study||4||
59677924|NCT03621696|75797108|FG003|COMPLETED|Overall Study||0||
59677925|NCT03621696|75797105|FG000|NOT COMPLETED|Overall Study||1||
59677926|NCT03621696|75797106|FG001|NOT COMPLETED|Overall Study||1||
59677927|NCT03621696|75797107|FG002|NOT COMPLETED|Overall Study||2||
59677928|NCT03621696|75797108|FG003|NOT COMPLETED|Overall Study||5||
59677929|NCT03594747|75797119|FG000|STARTED|Overall Study||120||
59677930|NCT03594747|75797120|FG001|STARTED|Overall Study||119||
59677931|NCT03594747|75797121|FG002|STARTED|Overall Study||121||
59677932|NCT03594747|75797119|FG000|Randomized But Not Treated|Overall Study||0||
59677933|NCT03594747|75797120|FG001|Randomized But Not Treated|Overall Study||1||
59677934|NCT03594747|75797121|FG002|Randomized But Not Treated|Overall Study||4||
59677935|NCT03594747|75797119|FG000|COMPLETED|Overall Study||0||
59677936|NCT03594747|75797120|FG001|COMPLETED|Overall Study||0||
59677937|NCT03594747|75797121|FG002|COMPLETED|Overall Study||0||
59677938|NCT03594747|75797119|FG000|NOT COMPLETED|Overall Study||120||
59677939|NCT03594747|75797120|FG001|NOT COMPLETED|Overall Study||119||
59677940|NCT03594747|75797121|FG002|NOT COMPLETED|Overall Study||121||
59677941|NCT03592641|75797129|FG000|STARTED|Overall Study||5||
59677942|NCT03592641|75797129|FG000|COMPLETED|Overall Study||4||
59677943|NCT03592641|75797129|FG000|NOT COMPLETED|Overall Study||1||
59677944|NCT03468985|75797137|FG000|STARTED|Overall Study||0||
59677945|NCT03468985|75797138|FG001|STARTED|Overall Study||2||
59677946|NCT03468985|75797139|FG002|STARTED|Overall Study||0||
59677947|NCT03468985|75797140|FG003|STARTED|Overall Study||1||
59677948|NCT03468985|75797137|FG000|COMPLETED|Overall Study||0||
59677949|NCT03468985|75797138|FG001|COMPLETED|Overall Study||0||
59677950|NCT03468985|75797139|FG002|COMPLETED|Overall Study||0||
59677951|NCT03468985|75797140|FG003|COMPLETED|Overall Study||0||
59677952|NCT03468985|75797137|FG000|NOT COMPLETED|Overall Study||0||
59677953|NCT03468985|75797138|FG001|NOT COMPLETED|Overall Study||2||
59677954|NCT03468985|75797139|FG002|NOT COMPLETED|Overall Study||0||
59677955|NCT03468985|75797140|FG003|NOT COMPLETED|Overall Study||1||
59677956|NCT03447912|75797152|FG000|STARTED|Overall Study||1481||14
59677957|NCT03447912|75797153|FG001|STARTED|Overall Study||1443||14
59677958|NCT03447912|75797152|FG000|Community Members Who Completed the Baseline Survey|Overall Study||732||14
59677959|NCT03447912|75797153|FG001|Community Members Who Completed the Baseline Survey|Overall Study||724||14
59677960|NCT03447912|75797152|FG000|Community Members Who Completed the Follow-up Survey|Overall Study||749||14
59677961|NCT03447912|75797153|FG001|Community Members Who Completed the Follow-up Survey|Overall Study||719||14
59677962|NCT03447912|75797152|FG000|COMPLETED|Overall Study||1481||14
59677963|NCT03447912|75797153|FG001|COMPLETED|Overall Study||1443||14
59677964|NCT03447912|75797152|FG000|NOT COMPLETED|Overall Study||0||0
59677965|NCT03447912|75797153|FG001|NOT COMPLETED|Overall Study||0||0
59677966|NCT03434418|75797159|FG000|STARTED|Overall Study||17||
59677967|NCT03434418|75797159|FG000|COMPLETED|Overall Study||2||
59677968|NCT03434418|75797159|FG000|NOT COMPLETED|Overall Study||15||
59677969|NCT03376659|75797163|FG000|STARTED|Overall Study||4||
59677970|NCT03376659|75797164|FG001|STARTED|Overall Study||4||
59677971|NCT03376659|75797163|FG000|COMPLETED|Overall Study||4||
59677972|NCT03376659|75797164|FG001|COMPLETED|Overall Study||4||
59677973|NCT03376659|75797163|FG000|NOT COMPLETED|Overall Study||0||
59677974|NCT03376659|75797164|FG001|NOT COMPLETED|Overall Study||0||
59677975|NCT03366103|75797174|FG000|STARTED|Overall Study||9||
59677976|NCT03366103|75797175|FG001|STARTED|Overall Study||5||
59677977|NCT03366103|75797176|FG002|STARTED|Overall Study||1||
59677978|NCT03366103|75797174|FG000|COMPLETED|Overall Study||6||
59677979|NCT03366103|75797175|FG001|COMPLETED|Overall Study||3||
59677980|NCT03366103|75797176|FG002|COMPLETED|Overall Study||1||
59677981|NCT03366103|75797174|FG000|NOT COMPLETED|Overall Study||3||
59677982|NCT03366103|75797175|FG001|NOT COMPLETED|Overall Study||2||
59677983|NCT03366103|75797176|FG002|NOT COMPLETED|Overall Study||0||
59677984|NCT03253679|75797187|FG000|STARTED|Overall Study||31||
59677985|NCT03253679|75797187|FG000|COMPLETED|Overall Study||30||
59677986|NCT03253679|75797187|FG000|NOT COMPLETED|Overall Study||1||
59677987|NCT03149822|75797194|FG000|STARTED|Overall Study||5||
59677988|NCT03149822|75797195|FG001|STARTED|Overall Study||3||
59677989|NCT03149822|75797196|FG002|STARTED|Overall Study||37||
59677990|NCT03149822|75797194|FG000|COMPLETED|Overall Study||5||
59677991|NCT03149822|75797195|FG001|COMPLETED|Overall Study||3||
59677992|NCT03149822|75797196|FG002|COMPLETED|Overall Study||37||
59677993|NCT03149822|75797194|FG000|NOT COMPLETED|Overall Study||0||
59677994|NCT03149822|75797195|FG001|NOT COMPLETED|Overall Study||0||
59677995|NCT03149822|75797196|FG002|NOT COMPLETED|Overall Study||0||
59677996|NCT03099148|75797208|FG000|STARTED|Period 1||7||
59677997|NCT03099148|75797209|FG001|STARTED|Period 1||7||
59677998|NCT03099148|75797210|FG002|STARTED|Period 1||7||
59677999|NCT03099148|75797211|FG003|STARTED|Period 1||8||
59678000|NCT03099148|75797208|FG000|Received at Least 1 Dose of Study Drug|Period 1||7||
59678001|NCT03099148|75797209|FG001|Received at Least 1 Dose of Study Drug|Period 1||7||
59678002|NCT03099148|75797210|FG002|Received at Least 1 Dose of Study Drug|Period 1||7||
59678003|NCT03099148|75797211|FG003|Received at Least 1 Dose of Study Drug|Period 1||8||
59678004|NCT03099148|75797208|FG000|COMPLETED|Period 1||7||
59678005|NCT03099148|75797209|FG001|COMPLETED|Period 1||7||
59678006|NCT03099148|75797210|FG002|COMPLETED|Period 1||7||
59678007|NCT03099148|75797211|FG003|COMPLETED|Period 1||8||
59678008|NCT03099148|75797208|FG000|NOT COMPLETED|Period 1||0||
59678009|NCT03099148|75797209|FG001|NOT COMPLETED|Period 1||0||
59678010|NCT03099148|75797210|FG002|NOT COMPLETED|Period 1||0||
59678011|NCT03099148|75797211|FG003|NOT COMPLETED|Period 1||0||
59678012|NCT03099148|75797208|FG000|STARTED|Wash-out||7||
59678013|NCT03099148|75797209|FG001|STARTED|Wash-out||7||
59678014|NCT03099148|75797210|FG002|STARTED|Wash-out||7||
59678015|NCT03099148|75797211|FG003|STARTED|Wash-out||8||
59678016|NCT03099148|75797208|FG000|COMPLETED|Wash-out||7||
59815938|NCT00833664|75938359|FG001|NOT COMPLETED|Second Intervention||0||
59815939|NCT00380367|75938363|FG000|STARTED|Overall Study||110||
59815940|NCT00380367|75938363|FG000|COMPLETED|Overall Study||108||
59815941|NCT00380367|75938363|FG000|NOT COMPLETED|Overall Study||2||
59546519|NCT01083758|75645189|FG000|NOT COMPLETED|Overall Study||2||
59546520|NCT02387580|75645199|FG000|STARTED|Overall Study||8||
59546521|NCT02387580|75645200|FG001|STARTED|Overall Study||8||
59546522|NCT02387580|75645201|FG002|STARTED|Overall Study||8||
59546523|NCT02387580|75645202|FG003|STARTED|Overall Study||8||
59546524|NCT02387580|75645203|FG004|STARTED|Overall Study||8||
59546525|NCT02387580|75645204|FG005|STARTED|Overall Study||8||
59546526|NCT02387580|75645199|FG000|COMPLETED|Overall Study||8||
59546527|NCT02387580|75645200|FG001|COMPLETED|Overall Study||8||
59546528|NCT02387580|75645201|FG002|COMPLETED|Overall Study||8||
59546529|NCT02387580|75645202|FG003|COMPLETED|Overall Study||7||
59546530|NCT02387580|75645203|FG004|COMPLETED|Overall Study||8||
59546531|NCT02387580|75645204|FG005|COMPLETED|Overall Study||8||
59546532|NCT02387580|75645199|FG000|NOT COMPLETED|Overall Study||0||
59546533|NCT02387580|75645200|FG001|NOT COMPLETED|Overall Study||0||
59546534|NCT02387580|75645201|FG002|NOT COMPLETED|Overall Study||0||
59546535|NCT02387580|75645202|FG003|NOT COMPLETED|Overall Study||1||
59546536|NCT02387580|75645203|FG004|NOT COMPLETED|Overall Study||0||
59546537|NCT02387580|75645204|FG005|NOT COMPLETED|Overall Study||0||
59546538|NCT02440854|75645220|FG000|STARTED|Overall Study||80|Enrolled|
59546539|NCT02440854|75645220|FG000|Analyzed|Overall Study||77||
59546540|NCT02440854|75645220|FG000|COMPLETED|Overall Study||0|Completed 48 month follow up|
59546541|NCT02440854|75645220|FG000|NOT COMPLETED|Overall Study||80||
59546542|NCT01084148|75645226|FG000|STARTED|Overall Study||118||
59546543|NCT01084148|75645227|FG001|STARTED|Overall Study|Among those 118 patients randomized into V0034 CR 01B vehicle arm, one patient not treated.|118||
59546544|NCT01084148|75645226|FG000|Treated Patients|Overall Study||118||
59546545|NCT01084148|75645227|FG001|Treated Patients|Overall Study|Patients who received test product at least once|117||
59546546|NCT01084148|75645226|FG000|COMPLETED|Overall Study||88||
59546547|NCT01084148|75645227|FG001|COMPLETED|Overall Study||102||
59546548|NCT01084148|75645226|FG000|NOT COMPLETED|Overall Study||30||
59546549|NCT01084148|75645227|FG001|NOT COMPLETED|Overall Study||16||
59546550|NCT01085006|75645237|FG000|STARTED|Overall Study||50||
59546551|NCT01085006|75645238|FG001|STARTED|Overall Study||50||
59546552|NCT01085006|75645237|FG000|COMPLETED|Overall Study||50||
59546553|NCT01085006|75645238|FG001|COMPLETED|Overall Study||50||
59546554|NCT01085006|75645237|FG000|NOT COMPLETED|Overall Study||0||
59546555|NCT01085006|75645238|FG001|NOT COMPLETED|Overall Study||0||
59546556|NCT01085318|75645246|FG000|STARTED|Overall Study||23||
59546557|NCT01085318|75645247|FG001|STARTED|Overall Study||15||
59546558|NCT01085318|75645246|FG000|COMPLETED|Overall Study||21||
59546559|NCT01085318|75645247|FG001|COMPLETED|Overall Study||15||
59546560|NCT01085318|75645246|FG000|NOT COMPLETED|Overall Study||2||
59546561|NCT01085318|75645247|FG001|NOT COMPLETED|Overall Study||0||
59546562|NCT01085786|75645255|FG000|STARTED|Overall Study||123||
59546563|NCT01085786|75645256|FG001|STARTED|Overall Study||117||
59546564|NCT01085786|75645255|FG000|COMPLETED|Overall Study||123||
59546565|NCT01085786|75645256|FG001|COMPLETED|Overall Study||117||
59546566|NCT01085786|75645255|FG000|NOT COMPLETED|Overall Study||0||
59546567|NCT01085786|75645256|FG001|NOT COMPLETED|Overall Study||0||
59546568|NCT01035788|75645264|FG000|STARTED|Overall Study|23 couples = 23 Veterans + 23 partners; only data for Veterans will be included for primary outcome.|23||
59546569|NCT01035788|75645265|FG001|STARTED|Overall Study|23 couples = 23 Veterans + 23 partners; only data for Veterans will be included for primary outcome.|23||
59546570|NCT01035788|75645264|FG000|COMPLETED|Overall Study||17||
59546571|NCT01035788|75645265|FG001|COMPLETED|Overall Study||9||
59546572|NCT01035788|75645264|FG000|NOT COMPLETED|Overall Study||6||
59546573|NCT01035788|75645265|FG001|NOT COMPLETED|Overall Study||14||
59546574|NCT02412852|75645275|FG000|STARTED|Overall Study||4||
59546575|NCT02412852|75645276|FG001|STARTED|Overall Study||8||
59546576|NCT02412852|75645277|FG002|STARTED|Overall Study||5||
59546577|NCT02412852|75645278|FG003|STARTED|Overall Study||9||
59546578|NCT02412852|75645275|FG000|COMPLETED|Overall Study||4||
59546579|NCT02412852|75645276|FG001|COMPLETED|Overall Study||7||
59546580|NCT02412852|75645277|FG002|COMPLETED|Overall Study||5||
59546581|NCT02412852|75645278|FG003|COMPLETED|Overall Study||8||
59546582|NCT02412852|75645275|FG000|NOT COMPLETED|Overall Study||0||
59546583|NCT02412852|75645276|FG001|NOT COMPLETED|Overall Study||1||
59546584|NCT02412852|75645277|FG002|NOT COMPLETED|Overall Study||0||
59546585|NCT02412852|75645278|FG003|NOT COMPLETED|Overall Study||1||
59546586|NCT02170220|75645288|FG000|STARTED|Overall Study||6||
59546587|NCT02170220|75645289|FG001|STARTED|Overall Study||6||
59546588|NCT02170220|75645288|FG000|COMPLETED|Overall Study||6||
59546589|NCT02170220|75645289|FG001|COMPLETED|Overall Study||6||
59546590|NCT02170220|75645288|FG000|NOT COMPLETED|Overall Study||0||
59546591|NCT02170220|75645289|FG001|NOT COMPLETED|Overall Study||0||
59546592|NCT01036490|75645297|FG000|STARTED|Overall Study||18||
59678017|NCT03099148|75797209|FG001|COMPLETED|Wash-out||6||
59815942|NCT00531050|75938373|FG000|STARTED|Part 1: Period 1||4||
59815943|NCT00531050|75938374|FG001|STARTED|Part 1: Period 1||5||
59815944|NCT00531050|75938375|FG002|STARTED|Part 1: Period 1||4||
59546593|NCT01036490|75645298|FG001|STARTED|Overall Study||18||
59678018|NCT03099148|75797210|FG002|COMPLETED|Wash-out||7||
59678019|NCT03099148|75797211|FG003|COMPLETED|Wash-out||8||
59678020|NCT03099148|75797208|FG000|NOT COMPLETED|Wash-out||0||
59989558|NCT02256436|76104871|FG001|Treated|Overall Study||266||
59989559|NCT02256436|76104870|FG000|Switched Over to Pembrolizumab|Overall Study||13||
59989560|NCT02256436|76104871|FG001|Switched Over to Pembrolizumab|Overall Study||0||
59989561|NCT02256436|76104870|FG000|COMPLETED|Overall Study||0||
59989562|NCT02256436|76104871|FG001|COMPLETED|Overall Study||0||
59989563|NCT02256436|76104870|FG000|NOT COMPLETED|Overall Study||272||
59989564|NCT02256436|76104871|FG001|NOT COMPLETED|Overall Study||270||
59989565|NCT00326183|76104880|FG000|STARTED|Overall Study||1453||
59546594|NCT01036490|75645297|FG000|COMPLETED|Overall Study||14||
59678021|NCT03099148|75797209|FG001|NOT COMPLETED|Wash-out||1||
59678022|NCT03099148|75797210|FG002|NOT COMPLETED|Wash-out||0||
59678023|NCT03099148|75797211|FG003|NOT COMPLETED|Wash-out||0||
59678024|NCT03099148|75797208|FG000|STARTED|Period 2||7||
59678025|NCT03099148|75797209|FG001|STARTED|Period 2||6||
59678026|NCT03099148|75797210|FG002|STARTED|Period 2||7||
59678027|NCT03099148|75797211|FG003|STARTED|Period 2||8||
59678028|NCT03099148|75797208|FG000|COMPLETED|Period 2||7||
59678029|NCT03099148|75797209|FG001|COMPLETED|Period 2||6||
59678030|NCT03099148|75797210|FG002|COMPLETED|Period 2||7||
59678031|NCT03099148|75797211|FG003|COMPLETED|Period 2||8||
59678032|NCT03099148|75797208|FG000|NOT COMPLETED|Period 2||0||
59678033|NCT03099148|75797209|FG001|NOT COMPLETED|Period 2||0||
59678034|NCT03099148|75797210|FG002|NOT COMPLETED|Period 2||0||
59678035|NCT03099148|75797211|FG003|NOT COMPLETED|Period 2||0||
59678036|NCT03099148|75797208|FG000|STARTED|Wash-out||7||
59678037|NCT03099148|75797209|FG001|STARTED|Wash-out||6||
59678038|NCT03099148|75797210|FG002|STARTED|Wash-out||7||
59678039|NCT03099148|75797211|FG003|STARTED|Wash-out||8||
59678040|NCT03099148|75797208|FG000|COMPLETED|Wash-out||7||
59678041|NCT03099148|75797209|FG001|COMPLETED|Wash-out||5||
59678042|NCT03099148|75797210|FG002|COMPLETED|Wash-out||7||
59678043|NCT03099148|75797211|FG003|COMPLETED|Wash-out||8||
59678044|NCT03099148|75797208|FG000|NOT COMPLETED|Wash-out||0||
59546595|NCT01036490|75645298|FG001|COMPLETED|Overall Study||18||
59546596|NCT01036490|75645297|FG000|NOT COMPLETED|Overall Study||4||
59546597|NCT01036490|75645298|FG001|NOT COMPLETED|Overall Study||0||
59546598|NCT01036802|75645306|FG000|STARTED|Overall Study||2||
59546599|NCT01036802|75645307|FG001|STARTED|Overall Study||1||
59546600|NCT01036802|75645306|FG000|COMPLETED|Overall Study||2||
59546601|NCT01036802|75645307|FG001|COMPLETED|Overall Study|Patient was taken off study after 7 months as she required hip replacement surgery.|1||
59546602|NCT01036802|75645306|FG000|NOT COMPLETED|Overall Study||0||
59546603|NCT01036802|75645307|FG001|NOT COMPLETED|Overall Study||0||
59546604|NCT01037192|75645316|FG000|STARTED|Overall Study||3||
59546605|NCT01037192|75645317|FG001|STARTED|Overall Study||1||
59546606|NCT01037192|75645316|FG000|COMPLETED|Overall Study||3||
59546607|NCT01037192|75645317|FG001|COMPLETED|Overall Study||1||
59546608|NCT01037192|75645316|FG000|NOT COMPLETED|Overall Study||0||
59546609|NCT01037192|75645317|FG001|NOT COMPLETED|Overall Study||0||
59546610|NCT01088672|75645325|FG000|STARTED|Overall Study||60||
59546611|NCT01088672|75645325|FG000|COMPLETED|Overall Study||60||
59678045|NCT03099148|75797209|FG001|NOT COMPLETED|Wash-out||1||
59678046|NCT03099148|75797210|FG002|NOT COMPLETED|Wash-out||0||
59678047|NCT03099148|75797211|FG003|NOT COMPLETED|Wash-out||0||
59678048|NCT03099148|75797208|FG000|STARTED|Period 3||7||
59678049|NCT03099148|75797209|FG001|STARTED|Period 3||5||
59678050|NCT03099148|75797210|FG002|STARTED|Period 3||7||
59678051|NCT03099148|75797211|FG003|STARTED|Period 3||8||
59678052|NCT03099148|75797208|FG000|COMPLETED|Period 3||7||
59678053|NCT03099148|75797209|FG001|COMPLETED|Period 3||5||
59678054|NCT03099148|75797210|FG002|COMPLETED|Period 3||7||
59678055|NCT03099148|75797211|FG003|COMPLETED|Period 3||8||
59678056|NCT03099148|75797208|FG000|NOT COMPLETED|Period 3||0||
59678057|NCT03099148|75797209|FG001|NOT COMPLETED|Period 3||0||
59678058|NCT03099148|75797210|FG002|NOT COMPLETED|Period 3||0||
59989566|NCT00326183|76104881|FG001|STARTED|Overall Study||347||
59546612|NCT01088672|75645325|FG000|NOT COMPLETED|Overall Study||0||
59546613|NCT02386098|75645334|FG000|STARTED|Stage 1 (96 Weeks)||43||
59546614|NCT02386098|75645335|FG001|STARTED|Stage 1 (96 Weeks)||43||
59678059|NCT03099148|75797211|FG003|NOT COMPLETED|Period 3||0||
59678060|NCT03099148|75797208|FG000|STARTED|Wash-out||7||
59678061|NCT03099148|75797209|FG001|STARTED|Wash-out||5||
59678062|NCT03099148|75797210|FG002|STARTED|Wash-out||7||
59678063|NCT03099148|75797211|FG003|STARTED|Wash-out||8||
59678064|NCT03099148|75797208|FG000|COMPLETED|Wash-out||7||
59678065|NCT03099148|75797209|FG001|COMPLETED|Wash-out||5||
59678066|NCT03099148|75797210|FG002|COMPLETED|Wash-out||7||
59546615|NCT02386098|75645336|FG002|STARTED|Stage 1 (96 Weeks)||0||
59546616|NCT02386098|75645337|FG003|STARTED|Stage 1 (96 Weeks)||0||
59546617|NCT02386098|75645338|FG004|STARTED|Stage 1 (96 Weeks)||0||
59546618|NCT02386098|75645334|FG000|COMPLETED|Stage 1 (96 Weeks)||0||
59678067|NCT03099148|75797211|FG003|COMPLETED|Wash-out||8||
59678068|NCT03099148|75797208|FG000|NOT COMPLETED|Wash-out||0||
59678069|NCT03099148|75797209|FG001|NOT COMPLETED|Wash-out||0||
59678070|NCT03099148|75797210|FG002|NOT COMPLETED|Wash-out||0||
59678071|NCT03099148|75797211|FG003|NOT COMPLETED|Wash-out||0||
59678072|NCT03099148|75797208|FG000|STARTED|Period 4||7||
59678073|NCT03099148|75797209|FG001|STARTED|Period 4||5||
59678074|NCT03099148|75797210|FG002|STARTED|Period 4||7||
59678075|NCT03099148|75797211|FG003|STARTED|Period 4||8||
59678076|NCT03099148|75797208|FG000|COMPLETED|Period 4||7||
59678077|NCT03099148|75797209|FG001|COMPLETED|Period 4||5||
59678078|NCT03099148|75797210|FG002|COMPLETED|Period 4||7||
59678079|NCT03099148|75797211|FG003|COMPLETED|Period 4||8||
59678080|NCT03099148|75797208|FG000|NOT COMPLETED|Period 4||0||
59678081|NCT03099148|75797209|FG001|NOT COMPLETED|Period 4||0||
59678082|NCT03099148|75797210|FG002|NOT COMPLETED|Period 4||0||
59678083|NCT03099148|75797211|FG003|NOT COMPLETED|Period 4||0||
59678084|NCT03088813|75797226|FG000|STARTED|Part 1: Dose Evaluation (Up to Week 172)||5||
59678085|NCT03088813|75797227|FG001|STARTED|Part 1: Dose Evaluation (Up to Week 172)||25||
59678086|NCT03088813|75797228|FG002|STARTED|Part 1: Dose Evaluation (Up to Week 172)||0||
59678087|NCT03088813|75797229|FG003|STARTED|Part 1: Dose Evaluation (Up to Week 172)||0||
59678088|NCT03088813|75797226|FG000|COMPLETED|Part 1: Dose Evaluation (Up to Week 172)||4||
59678089|NCT03088813|75797227|FG001|COMPLETED|Part 1: Dose Evaluation (Up to Week 172)||22||
59678090|NCT03088813|75797228|FG002|COMPLETED|Part 1: Dose Evaluation (Up to Week 172)||0||
59678091|NCT03088813|75797229|FG003|COMPLETED|Part 1: Dose Evaluation (Up to Week 172)||0||
59678092|NCT03088813|75797226|FG000|NOT COMPLETED|Part 1: Dose Evaluation (Up to Week 172)||1||
59678093|NCT03088813|75797227|FG001|NOT COMPLETED|Part 1: Dose Evaluation (Up to Week 172)||3||
59678094|NCT03088813|75797228|FG002|NOT COMPLETED|Part 1: Dose Evaluation (Up to Week 172)||0||
59678095|NCT03088813|75797229|FG003|NOT COMPLETED|Part 1: Dose Evaluation (Up to Week 172)||0||
59678096|NCT03088813|75797226|FG000|STARTED|Part 2: Randomized Study (Upto Week 197)||0||
59678097|NCT03088813|75797227|FG001|STARTED|Part 2: Randomized Study (Upto Week 197)||0||
59678098|NCT03088813|75797228|FG002|STARTED|Part 2: Randomized Study (Upto Week 197)||229||
59678099|NCT03088813|75797229|FG003|STARTED|Part 2: Randomized Study (Upto Week 197)||232||
59678100|NCT03088813|75797226|FG000|COMPLETED|Part 2: Randomized Study (Upto Week 197)||0||
59678101|NCT03088813|75797227|FG001|COMPLETED|Part 2: Randomized Study (Upto Week 197)||0||
59678102|NCT03088813|75797228|FG002|COMPLETED|Part 2: Randomized Study (Upto Week 197)||179||
59678103|NCT03088813|75797229|FG003|COMPLETED|Part 2: Randomized Study (Upto Week 197)||174||
59678104|NCT03088813|75797226|FG000|NOT COMPLETED|Part 2: Randomized Study (Upto Week 197)||0||
59678105|NCT03088813|75797227|FG001|NOT COMPLETED|Part 2: Randomized Study (Upto Week 197)||0||
59678106|NCT03088813|75797228|FG002|NOT COMPLETED|Part 2: Randomized Study (Upto Week 197)||50||
59678107|NCT03088813|75797229|FG003|NOT COMPLETED|Part 2: Randomized Study (Upto Week 197)||58||
59678108|NCT03061474|75797242|FG000|STARTED|Overall Study||24||
59546619|NCT02386098|75645335|FG001|COMPLETED|Stage 1 (96 Weeks)||0||
59546620|NCT02386098|75645336|FG002|COMPLETED|Stage 1 (96 Weeks)||0||
59546621|NCT02386098|75645337|FG003|COMPLETED|Stage 1 (96 Weeks)||0||
59546622|NCT02386098|75645338|FG004|COMPLETED|Stage 1 (96 Weeks)||0||
59546623|NCT02386098|75645334|FG000|NOT COMPLETED|Stage 1 (96 Weeks)||43||
59546624|NCT02386098|75645335|FG001|NOT COMPLETED|Stage 1 (96 Weeks)||43||
59546625|NCT02386098|75645336|FG002|NOT COMPLETED|Stage 1 (96 Weeks)||0||
59546626|NCT02386098|75645337|FG003|NOT COMPLETED|Stage 1 (96 Weeks)||0||
59546627|NCT02386098|75645338|FG004|NOT COMPLETED|Stage 1 (96 Weeks)||0||
59546628|NCT02386098|75645334|FG000|STARTED|Stage 2 (96 Weeks)||0||
59546629|NCT02386098|75645335|FG001|STARTED|Stage 2 (96 Weeks)||0||
59546630|NCT02386098|75645336|FG002|STARTED|Stage 2 (96 Weeks)||0||
59546631|NCT02386098|75645337|FG003|STARTED|Stage 2 (96 Weeks)||0||
59546632|NCT02386098|75645338|FG004|STARTED|Stage 2 (96 Weeks)||0||
59546633|NCT02386098|75645334|FG000|COMPLETED|Stage 2 (96 Weeks)||0||
59546634|NCT02386098|75645335|FG001|COMPLETED|Stage 2 (96 Weeks)||0||
59546635|NCT02386098|75645336|FG002|COMPLETED|Stage 2 (96 Weeks)||0||
59546636|NCT02386098|75645337|FG003|COMPLETED|Stage 2 (96 Weeks)||0||
59546637|NCT02386098|75645338|FG004|COMPLETED|Stage 2 (96 Weeks)||0||
59546638|NCT02386098|75645334|FG000|NOT COMPLETED|Stage 2 (96 Weeks)||0||
59546639|NCT02386098|75645335|FG001|NOT COMPLETED|Stage 2 (96 Weeks)||0||
59678109|NCT03061474|75797243|FG001|STARTED|Overall Study|22 participants received treatment therapy.|22||
59678110|NCT03061474|75797242|FG000|COMPLETED|Overall Study||22||
59678111|NCT03061474|75797243|FG001|COMPLETED|Overall Study||18||
59678112|NCT03061474|75797242|FG000|NOT COMPLETED|Overall Study||2||
59678113|NCT03061474|75797243|FG001|NOT COMPLETED|Overall Study||4||
59678114|NCT03040726|75797251|FG000|STARTED|Overall Study||31||
59678115|NCT03040726|75797252|FG001|STARTED|Overall Study||15||
59678116|NCT03040726|75797251|FG000|Started Placebo run-in Phase|Overall Study||31||
59678117|NCT03040726|75797252|FG001|Started Placebo run-in Phase|Overall Study||15||
59678118|NCT03040726|75797251|FG000|Started Blinded Phase|Overall Study||22||
59678119|NCT03040726|75797252|FG001|Started Blinded Phase|Overall Study||11||
59546640|NCT02386098|75645336|FG002|NOT COMPLETED|Stage 2 (96 Weeks)||0||
59546641|NCT02386098|75645337|FG003|NOT COMPLETED|Stage 2 (96 Weeks)||0||
59546642|NCT02386098|75645338|FG004|NOT COMPLETED|Stage 2 (96 Weeks)||0||
59546643|NCT01089062|75645356|FG000|STARTED|Visit 2 (Randomization)||4||
59546644|NCT01089062|75645357|FG001|STARTED|Visit 2 (Randomization)||4||
59546645|NCT01089062|75645358|FG002|STARTED|Visit 2 (Randomization)||4||
60078067|NCT01479465|76193083|FG003|COMPLETED|Overall Study||0||
60078068|NCT01479465|76193080|FG000|NOT COMPLETED|Overall Study||11||
60078069|NCT01479465|76193081|FG001|NOT COMPLETED|Overall Study||84||
60078070|NCT01479465|76193082|FG002|NOT COMPLETED|Overall Study||86||
60078071|NCT01479465|76193083|FG003|NOT COMPLETED|Overall Study||85||
60078072|NCT02090374|76193101|FG000|STARTED|Overall Study||8||
59678120|NCT03040726|75797251|FG000|COMPLETED|Overall Study||21||
59678121|NCT03040726|75797252|FG001|COMPLETED|Overall Study||9||
59678122|NCT03040726|75797251|FG000|NOT COMPLETED|Overall Study||10||
59678123|NCT03040726|75797252|FG001|NOT COMPLETED|Overall Study||6||
59678124|NCT02899728|75797261|FG000|STARTED|Overall Study|0|5||
59678125|NCT02899728|75797262|FG001|STARTED|Overall Study||3||
59678126|NCT02899728|75797261|FG000|COMPLETED|Overall Study||4||
59678127|NCT02899728|75797262|FG001|COMPLETED|Overall Study||2||
59678128|NCT02899728|75797261|FG000|NOT COMPLETED|Overall Study||1||
59678129|NCT02899728|75797262|FG001|NOT COMPLETED|Overall Study||1||
59678130|NCT02899065|75797270|FG000|STARTED|Randomization to 7 Day Follow Up Contact|Procalcitonin results available: n=93 Procalcitonin results not available: n=7|100||
59678131|NCT02899065|75797271|FG001|STARTED|Randomization to 7 Day Follow Up Contact|Procalcitonin results available: n=33 Procalcitonin results not available: n=67|100||
59678132|NCT02899065|75797270|FG000|COMPLETED|Randomization to 7 Day Follow Up Contact||99||
59678133|NCT02899065|75797271|FG001|COMPLETED|Randomization to 7 Day Follow Up Contact||95||
59678134|NCT02899065|75797270|FG000|NOT COMPLETED|Randomization to 7 Day Follow Up Contact||1||
59678135|NCT02899065|75797271|FG001|NOT COMPLETED|Randomization to 7 Day Follow Up Contact||5||
59678136|NCT02899065|75797270|FG000|STARTED|Day 7 to 4 Week Follow Up Contact||99||
59678137|NCT02899065|75797271|FG001|STARTED|Day 7 to 4 Week Follow Up Contact||95||
59678138|NCT02899065|75797270|FG000|COMPLETED|Day 7 to 4 Week Follow Up Contact||75||
59678139|NCT02899065|75797271|FG001|COMPLETED|Day 7 to 4 Week Follow Up Contact||79||
59678140|NCT02899065|75797270|FG000|NOT COMPLETED|Day 7 to 4 Week Follow Up Contact||24||
59678141|NCT02899065|75797271|FG001|NOT COMPLETED|Day 7 to 4 Week Follow Up Contact||16||
59678142|NCT02893930|75797277|FG000|STARTED|Overall Study||13||
59678143|NCT02893930|75797277|FG000|Eligible and Treated|Overall Study||12||
59678144|NCT02893930|75797277|FG000|COMPLETED|Overall Study||0||
59678145|NCT02893930|75797277|FG000|NOT COMPLETED|Overall Study||13||
59678146|NCT02780804|75797284|FG000|STARTED|Overall Study||6||
59678147|NCT02780804|75797285|FG001|STARTED|Overall Study||9||
59678148|NCT02780804|75797286|FG002|STARTED|Overall Study||6||
59678149|NCT02780804|75797284|FG000|COMPLETED|Overall Study||0||
59678150|NCT02780804|75797285|FG001|COMPLETED|Overall Study||0||
59678151|NCT02780804|75797286|FG002|COMPLETED|Overall Study||0||
59678152|NCT02780804|75797284|FG000|NOT COMPLETED|Overall Study||6||
59678153|NCT02780804|75797285|FG001|NOT COMPLETED|Overall Study||9||
59678154|NCT02780804|75797286|FG002|NOT COMPLETED|Overall Study||6||
59678155|NCT02629393|75797295|FG000|STARTED|Overall Study||5||
59678156|NCT02629393|75797295|FG000|COMPLETED|Overall Study||2||
59678157|NCT02629393|75797295|FG000|NOT COMPLETED|Overall Study||3||
59678158|NCT02604459|75797304|FG000|STARTED|Overall Study||56||
59678159|NCT02604459|75797305|FG001|STARTED|Overall Study||53||
59678160|NCT02604459|75797306|FG002|STARTED|Overall Study||22||
59678161|NCT02604459|75797307|FG003|STARTED|Overall Study||14||
59678162|NCT02604459|75797304|FG000|COMPLETED|Overall Study||56||
59678163|NCT02604459|75797305|FG001|COMPLETED|Overall Study||53||
60078073|NCT02090374|76193102|FG001|STARTED|Overall Study||4||
60078074|NCT02090374|76193103|FG002|STARTED|Overall Study||4||
60078075|NCT02090374|76193104|FG003|STARTED|Overall Study||9||
60078076|NCT02090374|76193105|FG004|STARTED|Overall Study||35||
60078077|NCT02090374|76193106|FG005|STARTED|Overall Study||15||
60078078|NCT02090374|76193107|FG006|STARTED|Overall Study||16||
60078079|NCT02090374|76193108|FG007|STARTED|Overall Study||2||
59678164|NCT02604459|75797306|FG002|COMPLETED|Overall Study||22||
60078080|NCT02090374|76193101|FG000|COMPLETED|Overall Study||8||
60078081|NCT02090374|76193102|FG001|COMPLETED|Overall Study||4||
59678165|NCT02604459|75797307|FG003|COMPLETED|Overall Study||14||
59678166|NCT02604459|75797304|FG000|NOT COMPLETED|Overall Study||0||
59678167|NCT02604459|75797305|FG001|NOT COMPLETED|Overall Study||0||
59678168|NCT02604459|75797306|FG002|NOT COMPLETED|Overall Study||0||
59678169|NCT02604459|75797307|FG003|NOT COMPLETED|Overall Study||0||
59678170|NCT02535338|75797321|FG000|STARTED|Overall Study||3||
59678171|NCT02535338|75797322|FG001|STARTED|Overall Study||8||
59678172|NCT02535338|75797321|FG000|COMPLETED|Overall Study||3||
59678173|NCT02535338|75797322|FG001|COMPLETED|Overall Study||8||
59678174|NCT02535338|75797321|FG000|NOT COMPLETED|Overall Study||0||
60078082|NCT02090374|76193103|FG002|COMPLETED|Overall Study||4||
60078083|NCT02090374|76193104|FG003|COMPLETED|Overall Study||9||
60078084|NCT02090374|76193105|FG004|COMPLETED|Overall Study||35||
59678175|NCT02535338|75797322|FG001|NOT COMPLETED|Overall Study||0||
59678176|NCT02500797|75797342|FG000|STARTED|Overall Study||43||
59678177|NCT02500797|75797343|FG001|STARTED|Overall Study||42||
59678178|NCT02500797|75797344|FG002|STARTED|Overall Study||15||
59678179|NCT02500797|75797345|FG003|STARTED|Overall Study||14||
59678180|NCT02500797|75797346|FG004|STARTED|Overall Study||14||
59678181|NCT02500797|75797347|FG005|STARTED|Overall Study||15||
59678182|NCT02500797|75797348|FG006|STARTED|Overall Study||10||
59678183|NCT02500797|75797349|FG007|STARTED|Overall Study||11||
59678184|NCT02500797|75797342|FG000|Arm I Crossover|Overall Study||4|Arm I Patients who progress after 10 weeks on single agent nivolumab and cross over to Arm II.|
59678185|NCT02500797|75797343|FG001|Arm I Crossover|Overall Study||0|Arm I Patients who progress after 10 weeks on single agent nivolumab and cross over to Arm II.|
59678186|NCT02500797|75797344|FG002|Arm I Crossover|Overall Study||6|Arm I Patients who progress after 10 weeks on single agent nivolumab and cross over to Arm II.|
59678187|NCT02500797|75797345|FG003|Arm I Crossover|Overall Study||0|Arm I Patients who progress after 10 weeks on single agent nivolumab and cross over to Arm II.|
59678188|NCT02500797|75797346|FG004|Arm I Crossover|Overall Study||1|Arm I Patients who progress after 10 weeks on single agent nivolumab and cross over to Arm II.|
59678189|NCT02500797|75797347|FG005|Arm I Crossover|Overall Study||0|Arm I Patients who progress after 10 weeks on single agent nivolumab and cross over to Arm II.|
59678190|NCT02500797|75797348|FG006|Arm I Crossover|Overall Study||2|Arm I Patients who progress after 10 weeks on single agent nivolumab and cross over to Arm II.|
59678191|NCT02500797|75797349|FG007|Arm I Crossover|Overall Study||0|Arm I Patients who progress after 10 weeks on single agent nivolumab and cross over to Arm II.|
59678192|NCT02500797|75797342|FG000|COMPLETED|Overall Study||42||
59678193|NCT02500797|75797343|FG001|COMPLETED|Overall Study||42||
59678194|NCT02500797|75797344|FG002|COMPLETED|Overall Study||15||
59678195|NCT02500797|75797345|FG003|COMPLETED|Overall Study||14||
59678196|NCT02500797|75797346|FG004|COMPLETED|Overall Study||13||
59678197|NCT02500797|75797347|FG005|COMPLETED|Overall Study||14||
59678198|NCT02500797|75797348|FG006|COMPLETED|Overall Study||10||
59678199|NCT02500797|75797349|FG007|COMPLETED|Overall Study||11||
59678200|NCT02500797|75797342|FG000|NOT COMPLETED|Overall Study||1||
59678201|NCT02500797|75797343|FG001|NOT COMPLETED|Overall Study||0||
59678202|NCT02500797|75797344|FG002|NOT COMPLETED|Overall Study||0||
59678203|NCT02500797|75797345|FG003|NOT COMPLETED|Overall Study||0||
59678204|NCT02500797|75797346|FG004|NOT COMPLETED|Overall Study||1||
59678205|NCT02500797|75797347|FG005|NOT COMPLETED|Overall Study||1||
59678206|NCT02500797|75797348|FG006|NOT COMPLETED|Overall Study||0||
59678207|NCT02500797|75797349|FG007|NOT COMPLETED|Overall Study||0||
59678208|NCT02047461|75797374|FG000|STARTED|Overall Study||8||
59678209|NCT02047461|75797374|FG000|COMPLETED|Overall Study||8||
59678210|NCT02047461|75797374|FG000|NOT COMPLETED|Overall Study||0||
59678211|NCT02017704|75797382|FG000|STARTED|Overall Study||4||
59678212|NCT02017704|75797383|FG001|STARTED|Overall Study||5||
59678213|NCT02017704|75797382|FG000|COMPLETED|Overall Study||2||
59678214|NCT02017704|75797383|FG001|COMPLETED|Overall Study||5||
59678215|NCT02017704|75797382|FG000|NOT COMPLETED|Overall Study||2||
59678216|NCT02017704|75797383|FG001|NOT COMPLETED|Overall Study||0||
59678217|NCT02005471|75797393|FG000|STARTED|Main Study||195||
59678218|NCT02005471|75797394|FG001|STARTED|Main Study||194||
59678219|NCT02005471|75797395|FG002|STARTED|Main Study||0||
59678220|NCT02005471|75797396|FG003|STARTED|Main Study||0||
59678221|NCT02005471|75797393|FG000|Safety Evaluable (SE) Population|Main Study||188|SE population included all randomized participants who received at least one dose of study treatment with participants grouped according to the actual treatment received.|
59678222|NCT02005471|75797394|FG001|Safety Evaluable (SE) Population|Main Study||194|SE population included all randomized participants who received at least one dose of study treatment with participants grouped according to the actual treatment received.|
59678223|NCT02005471|75797395|FG002|Safety Evaluable (SE) Population|Main Study||0|SE population included all randomized participants who received at least one dose of study treatment with participants grouped according to the actual treatment received.|
59678224|NCT02005471|75797396|FG003|Safety Evaluable (SE) Population|Main Study||0|SE population included all randomized participants who received at least one dose of study treatment with participants grouped according to the actual treatment received.|
59678225|NCT02005471|75797393|FG000|COMPLETED|Main Study||71||
59678226|NCT02005471|75797394|FG001|COMPLETED|Main Study||118||
59678227|NCT02005471|75797395|FG002|COMPLETED|Main Study||0||
60078085|NCT02090374|76193106|FG005|COMPLETED|Overall Study||15||
60078086|NCT02090374|76193107|FG006|COMPLETED|Overall Study||16||
59678228|NCT02005471|75797396|FG003|COMPLETED|Main Study||0||
59678229|NCT02005471|75797393|FG000|NOT COMPLETED|Main Study||124||
59678230|NCT02005471|75797394|FG001|NOT COMPLETED|Main Study||76||
59678231|NCT02005471|75797395|FG002|NOT COMPLETED|Main Study||0||
59678232|NCT02005471|75797396|FG003|NOT COMPLETED|Main Study||0||
59678233|NCT02005471|75797393|FG000|STARTED|Re-Treatment/Crossover (R/C) Substudy|Following the end of main study, participants who had progressed clinically and were in need of therapy participated in the Re-Treatment/Crossover Substudy at the discretion of the investigator.|0||
60078087|NCT02090374|76193108|FG007|COMPLETED|Overall Study||2||
60078088|NCT02090374|76193101|FG000|NOT COMPLETED|Overall Study||0||
60078089|NCT02090374|76193102|FG001|NOT COMPLETED|Overall Study||0||
59678234|NCT02005471|75797394|FG001|STARTED|Re-Treatment/Crossover (R/C) Substudy|Following the end of main study, participants who had progressed clinically and were in need of therapy participated in the Re-Treatment/Crossover Substudy at the discretion of the investigator.|0||
59678235|NCT02005471|75797395|FG002|STARTED|Re-Treatment/Crossover (R/C) Substudy|9 participants from BR arm entered R/C substudy.|9||
60078090|NCT02090374|76193103|FG002|NOT COMPLETED|Overall Study||0||
59678236|NCT02005471|75797396|FG003|STARTED|Re-Treatment/Crossover (R/C) Substudy|25 participants from VR arm entered R/C substudy.|25||
59678237|NCT02005471|75797393|FG000|COMPLETED|Re-Treatment/Crossover (R/C) Substudy||0||
59678238|NCT02005471|75797394|FG001|COMPLETED|Re-Treatment/Crossover (R/C) Substudy||0||
59678239|NCT02005471|75797395|FG002|COMPLETED|Re-Treatment/Crossover (R/C) Substudy||7||
59678240|NCT02005471|75797396|FG003|COMPLETED|Re-Treatment/Crossover (R/C) Substudy||15||
59678241|NCT02005471|75797393|FG000|NOT COMPLETED|Re-Treatment/Crossover (R/C) Substudy||0||
59678242|NCT02005471|75797394|FG001|NOT COMPLETED|Re-Treatment/Crossover (R/C) Substudy||0||
59678243|NCT02005471|75797395|FG002|NOT COMPLETED|Re-Treatment/Crossover (R/C) Substudy||2||
59678244|NCT02005471|75797396|FG003|NOT COMPLETED|Re-Treatment/Crossover (R/C) Substudy||10||
59678245|NCT01977651|75797407|FG000|STARTED|4 Month Treatment Period||423||
59678246|NCT01977651|75797407|FG000|COMPLETED|4 Month Treatment Period||322||
59678247|NCT01977651|75797407|FG000|NOT COMPLETED|4 Month Treatment Period||101||
59678248|NCT01977651|75797407|FG000|STARTED|1 Year Extension Period|Participants who benefited from enzalutamide treatment continued in the 1 year extension period|287||
59678249|NCT01977651|75797407|FG000|COMPLETED|1 Year Extension Period||157||
59678250|NCT01977651|75797407|FG000|NOT COMPLETED|1 Year Extension Period||130||
59678251|NCT01977651|75797407|FG000|STARTED|Post 1 Year Extension Period|Participants who benefited from enzalutamide treatment continued in the post 1 year extension period|145||
59678252|NCT01977651|75797407|FG000|COMPLETED|Post 1 Year Extension Period||1||
59678253|NCT01977651|75797407|FG000|NOT COMPLETED|Post 1 Year Extension Period||144||
59678254|NCT01949311|75797411|FG000|STARTED|Overall Study||2677||
59678255|NCT01949311|75797411|FG000|COMPLETED|Overall Study||1297||
59678256|NCT01949311|75797411|FG000|NOT COMPLETED|Overall Study||1380||
59678257|NCT01933932|75797418|FG000|STARTED|Overall Study||254||
59678258|NCT01933932|75797419|FG001|STARTED|Overall Study||256||
59678259|NCT01933932|75797418|FG000|COMPLETED|Overall Study|These were the number of patients who were still ongoing at data cut-off|70||
59678260|NCT01933932|75797419|FG001|COMPLETED|Overall Study|These were the number of patients who were still ongoing at data cut-off|78||
59678261|NCT01933932|75797418|FG000|NOT COMPLETED|Overall Study||184||
59678262|NCT01933932|75797419|FG001|NOT COMPLETED|Overall Study||178||
59678263|NCT01892722|75797427|FG000|STARTED|Overall Study||107||
59678264|NCT01892722|75797428|FG001|STARTED|Overall Study||108||
59678265|NCT01892722|75797427|FG000|Full Analysis Set|Overall Study||107||
59678266|NCT01892722|75797428|FG001|Full Analysis Set|Overall Study||107||
59678267|NCT01892722|75797427|FG000|COMPLETED|Overall Study||100||
59678268|NCT01892722|75797428|FG001|COMPLETED|Overall Study||88||
59678269|NCT01892722|75797427|FG000|NOT COMPLETED|Overall Study||7||
59678270|NCT01892722|75797428|FG001|NOT COMPLETED|Overall Study||20||
59678271|NCT01711658|75797436|FG000|STARTED|Overall Study||64||
59678272|NCT01711658|75797437|FG001|STARTED|Overall Study||63||
59678273|NCT01711658|75797436|FG000|Participants Who Started Protocol Treatment|Overall Study||59||
59678274|NCT01711658|75797437|FG001|Participants Who Started Protocol Treatment|Overall Study||60||
59678275|NCT01711658|75797436|FG000|COMPLETED|Overall Study||64|Participants contributing data to results are considered to have completed the study.|
59678276|NCT01711658|75797437|FG001|COMPLETED|Overall Study||63|Participants contributing data to results are considered to have completed the study.|
59678277|NCT01711658|75797436|FG000|NOT COMPLETED|Overall Study||0||
59678278|NCT01711658|75797437|FG001|NOT COMPLETED|Overall Study||0||
59678279|NCT01698008|75797446|FG000|STARTED|Overall Study||3||
59678280|NCT01698008|75797447|FG001|STARTED|Overall Study||2||
59678281|NCT01698008|75797446|FG000|COMPLETED|Overall Study||2||
59678282|NCT01698008|75797447|FG001|COMPLETED|Overall Study||0||
59678283|NCT01698008|75797446|FG000|NOT COMPLETED|Overall Study||1||
59678284|NCT01698008|75797447|FG001|NOT COMPLETED|Overall Study||2||
59678285|NCT01622868|75797455|FG000|STARTED|Overall Study||72||
59678286|NCT01622868|75797456|FG001|STARTED|Overall Study||71||
59678287|NCT01622868|75797455|FG000|Eligible|Overall Study||65||
59678288|NCT01622868|75797456|FG001|Eligible|Overall Study||71||
59678289|NCT01622868|75797455|FG000|Eligible, Started Study Treatment, Has Adverse Event Data|Overall Study||63||
59678290|NCT01622868|75797456|FG001|Eligible, Started Study Treatment, Has Adverse Event Data|Overall Study||71||
59678291|NCT01622868|75797455|FG000|COMPLETED|Overall Study||65|Participants contributing data to results are considered to have completed the study|
59678292|NCT01622868|75797456|FG001|COMPLETED|Overall Study||71|Participants contributing data to results are considered to have completed the study|
59678293|NCT01622868|75797455|FG000|NOT COMPLETED|Overall Study||7||
59678294|NCT01622868|75797456|FG001|NOT COMPLETED|Overall Study||0||
59678295|NCT00566345|75797464|FG000|STARTED|Overall Study||1829||
59678296|NCT00566345|75797465|FG001|STARTED|Overall Study||1841||
59678297|NCT00566345|75797464|FG000|COMPLETED|Overall Study||1656||
59678298|NCT00566345|75797465|FG001|COMPLETED|Overall Study||1694||
59678299|NCT00566345|75797464|FG000|NOT COMPLETED|Overall Study||173||
59678300|NCT00566345|75797465|FG001|NOT COMPLETED|Overall Study||147||
59678301|NCT00317720|75797474|FG000|STARTED|Overall Study||40||
59678302|NCT00317720|75797475|FG001|STARTED|Overall Study||7||
59678303|NCT00317720|75797474|FG000|COMPLETED|Overall Study||40||
59678304|NCT00317720|75797475|FG001|COMPLETED|Overall Study||7||
59678305|NCT00317720|75797474|FG000|NOT COMPLETED|Overall Study||0||
59678306|NCT00317720|75797475|FG001|NOT COMPLETED|Overall Study||0||
59678307|NCT01208233|75797485|FG000|STARTED|Overall Study||11||
59678308|NCT01208233|75797486|FG001|STARTED|Overall Study||9||
59678309|NCT01208233|75797487|FG002|STARTED|Overall Study||11||
59678310|NCT01208233|75797488|FG003|STARTED|Overall Study||10||
59678311|NCT01208233|75797489|FG004|STARTED|Overall Study||70||
59678312|NCT01208233|75797490|FG005|STARTED|Overall Study||67||
59678313|NCT01208233|75797485|FG000|COMPLETED|Overall Study||6||
59678314|NCT01208233|75797486|FG001|COMPLETED|Overall Study||6||
59678315|NCT01208233|75797487|FG002|COMPLETED|Overall Study||7||
59678316|NCT01208233|75797488|FG003|COMPLETED|Overall Study||9||
59678317|NCT01208233|75797489|FG004|COMPLETED|Overall Study||46||
59678318|NCT01208233|75797490|FG005|COMPLETED|Overall Study||46||
59678319|NCT01208233|75797485|FG000|NOT COMPLETED|Overall Study||5||
59678320|NCT01208233|75797486|FG001|NOT COMPLETED|Overall Study||3||
59678321|NCT01208233|75797487|FG002|NOT COMPLETED|Overall Study||4||
59678322|NCT01208233|75797488|FG003|NOT COMPLETED|Overall Study||1||
59678323|NCT01208233|75797489|FG004|NOT COMPLETED|Overall Study||24||
59678324|NCT01208233|75797490|FG005|NOT COMPLETED|Overall Study||21||
59678325|NCT01208038|75797510|FG000|STARTED|Overall Study||22||
59678326|NCT01208038|75797510|FG000|COMPLETED|Overall Study|Patient withdrew before commencing study drug|21||
59678327|NCT01208038|75797510|FG000|NOT COMPLETED|Overall Study||1||
59678328|NCT01207687|75797514|FG000|STARTED|Overall Study||14||
59678329|NCT01207687|75797514|FG000|COMPLETED|Overall Study||12||
59678330|NCT01207687|75797514|FG000|NOT COMPLETED|Overall Study||2||
59678331|NCT01207453|75797526|FG000|STARTED|First Intervention||23||
59678332|NCT01207453|75797527|FG001|STARTED|First Intervention||18||
59678333|NCT01207453|75797526|FG000|COMPLETED|First Intervention||21||
59678334|NCT01207453|75797527|FG001|COMPLETED|First Intervention||17||
59678335|NCT01207453|75797526|FG000|NOT COMPLETED|First Intervention||2||
59678336|NCT01207453|75797527|FG001|NOT COMPLETED|First Intervention||1||
59678337|NCT01207453|75797526|FG000|STARTED|Washout||21||
59678338|NCT01207453|75797527|FG001|STARTED|Washout||17||
59678339|NCT01207453|75797526|FG000|COMPLETED|Washout||19||
59678340|NCT01207453|75797527|FG001|COMPLETED|Washout||17||
59678341|NCT01207453|75797526|FG000|NOT COMPLETED|Washout||2||
59678342|NCT01207453|75797527|FG001|NOT COMPLETED|Washout||0||
59678343|NCT01207453|75797526|FG000|STARTED|2nd Intervention||19||
59678344|NCT01207453|75797527|FG001|STARTED|2nd Intervention||17||
59678345|NCT01207453|75797526|FG000|COMPLETED|2nd Intervention||17||
59678346|NCT01207453|75797527|FG001|COMPLETED|2nd Intervention||15||
59678347|NCT01207453|75797526|FG000|NOT COMPLETED|2nd Intervention||2||
59678348|NCT01207453|75797527|FG001|NOT COMPLETED|2nd Intervention||2||
59678349|NCT01207414|75797538|FG000|STARTED|Overall Study|Includes 1 patient randomized in error.|241||
59678350|NCT01207414|75797539|FG001|STARTED|Overall Study||260||
59678351|NCT01207414|75797538|FG000|Safety Population: Received Study Drug|Overall Study||240||
59678352|NCT01207414|75797539|FG001|Safety Population: Received Study Drug|Overall Study||260||
59678353|NCT01207414|75797538|FG000|COMPLETED|Overall Study||168||
59678354|NCT01207414|75797539|FG001|COMPLETED|Overall Study||178||
59678355|NCT01207414|75797538|FG000|NOT COMPLETED|Overall Study||73||
59678356|NCT01207414|75797539|FG001|NOT COMPLETED|Overall Study||82||
59678357|NCT01207219|75797548|FG000|STARTED|Overall Study||45||
59678358|NCT01207219|75797549|FG001|STARTED|Overall Study||40||
59546646|NCT01089062|75645359|FG003|STARTED|Visit 2 (Randomization)||4||
59546647|NCT01089062|75645360|FG004|STARTED|Visit 2 (Randomization)||4||
59546648|NCT01089062|75645361|FG005|STARTED|Visit 2 (Randomization)||4||
59546649|NCT01089062|75645356|FG000|COMPLETED|Visit 2 (Randomization)||3||
59546650|NCT01089062|75645357|FG001|COMPLETED|Visit 2 (Randomization)||3||
59546651|NCT01089062|75645358|FG002|COMPLETED|Visit 2 (Randomization)||3||
59546652|NCT01089062|75645359|FG003|COMPLETED|Visit 2 (Randomization)||4||
59546653|NCT01089062|75645360|FG004|COMPLETED|Visit 2 (Randomization)||3||
59546654|NCT01089062|75645361|FG005|COMPLETED|Visit 2 (Randomization)||3||
59546655|NCT01089062|75645356|FG000|NOT COMPLETED|Visit 2 (Randomization)||1||
59678359|NCT01207219|75797550|FG002|STARTED|Overall Study||39||
59678360|NCT01207219|75797548|FG000|Included in ITT Analysis|Overall Study||40||
59678361|NCT01207219|75797549|FG001|Included in ITT Analysis|Overall Study||37||
59678362|NCT01207219|75797550|FG002|Included in ITT Analysis|Overall Study||38||
59678363|NCT01207219|75797548|FG000|COMPLETED|Overall Study||34||
59678364|NCT01207219|75797549|FG001|COMPLETED|Overall Study||29||
59678365|NCT01207219|75797550|FG002|COMPLETED|Overall Study||32||
59678366|NCT01207219|75797548|FG000|NOT COMPLETED|Overall Study||11||
59678367|NCT01207219|75797549|FG001|NOT COMPLETED|Overall Study||11||
59678368|NCT01207219|75797550|FG002|NOT COMPLETED|Overall Study||7||
59678369|NCT01206517|75797564|FG000|STARTED|Overall Study||6||
59678370|NCT01206517|75797565|FG001|STARTED|Overall Study||6||
59678371|NCT01206517|75797566|FG002|STARTED|Overall Study||6||
59678372|NCT01206517|75797567|FG003|STARTED|Overall Study||4||
59546656|NCT01089062|75645357|FG001|NOT COMPLETED|Visit 2 (Randomization)||1||
59678373|NCT01206517|75797568|FG004|STARTED|Overall Study||4||
59678374|NCT01206517|75797569|FG005|STARTED|Overall Study||4||
59678375|NCT01206517|75797564|FG000|COMPLETED|Overall Study||6||
59678376|NCT01206517|75797565|FG001|COMPLETED|Overall Study||6||
59678377|NCT01206517|75797566|FG002|COMPLETED|Overall Study||4||
59678378|NCT01206517|75797567|FG003|COMPLETED|Overall Study||4||
59678379|NCT01206517|75797568|FG004|COMPLETED|Overall Study||3||
59678380|NCT01206517|75797569|FG005|COMPLETED|Overall Study||4||
59678381|NCT01206517|75797564|FG000|NOT COMPLETED|Overall Study||0||
59678382|NCT01206517|75797565|FG001|NOT COMPLETED|Overall Study||0||
59678383|NCT01206517|75797566|FG002|NOT COMPLETED|Overall Study||2||
59678384|NCT01206517|75797567|FG003|NOT COMPLETED|Overall Study||0||
59678385|NCT01206517|75797568|FG004|NOT COMPLETED|Overall Study||1||
59678386|NCT01206517|75797569|FG005|NOT COMPLETED|Overall Study||0||
59678387|NCT01206439|75797580|FG000|STARTED|Overall Study||2||
59678388|NCT01206439|75797580|FG000|COMPLETED|Overall Study||1||
59678389|NCT01206439|75797580|FG000|NOT COMPLETED|Overall Study||1||
59678390|NCT01206322|75797586|FG000|STARTED|Overall Study||4||
59678391|NCT01206322|75797587|FG001|STARTED|Overall Study||11||
59678392|NCT01206322|75797588|FG002|STARTED|Overall Study||9||
59678393|NCT01206322|75797589|FG003|STARTED|Overall Study||6||
59678394|NCT01206322|75797586|FG000|COMPLETED|Overall Study||4||
59678395|NCT01206322|75797587|FG001|COMPLETED|Overall Study||11||
59815945|NCT00531050|75938376|FG003|STARTED|Part 1: Period 1||5||
59678396|NCT01206322|75797588|FG002|COMPLETED|Overall Study||9||
59678397|NCT01206322|75797589|FG003|COMPLETED|Overall Study||5||
59678398|NCT01206322|75797586|FG000|NOT COMPLETED|Overall Study||0||
59678399|NCT01206322|75797587|FG001|NOT COMPLETED|Overall Study||0||
59678400|NCT01206322|75797588|FG002|NOT COMPLETED|Overall Study||0||
59678401|NCT01206322|75797589|FG003|NOT COMPLETED|Overall Study||1||
59678402|NCT01206166|75797601|FG000|STARTED|Overall Study||73||
59678403|NCT01206166|75797602|FG001|STARTED|Overall Study||52||
59678404|NCT01206166|75797601|FG000|COMPLETED|Overall Study||71||
59678405|NCT01206166|75797602|FG001|COMPLETED|Overall Study||49||
59678406|NCT01206166|75797601|FG000|NOT COMPLETED|Overall Study||2||
59678407|NCT01206166|75797602|FG001|NOT COMPLETED|Overall Study||3||
59678408|NCT01207102|75797611|FG000|STARTED|Overall Study||10||
59678409|NCT01207102|75797611|FG000|COMPLETED|Overall Study||0||
59678410|NCT01207102|75797611|FG000|NOT COMPLETED|Overall Study||10||
59678411|NCT03014622|75797617|FG000|STARTED|Overall Study||201||
59678412|NCT03014622|75797618|FG001|STARTED|Overall Study||102||
59678413|NCT03014622|75797617|FG000|COMPLETED|Overall Study||182||
59678414|NCT03014622|75797618|FG001|COMPLETED|Overall Study||93||
59678415|NCT03014622|75797617|FG000|NOT COMPLETED|Overall Study||19||
59678416|NCT03014622|75797618|FG001|NOT COMPLETED|Overall Study||9||
59678417|NCT01205776|75797627|FG000|STARTED|Overall Study||948||
59678418|NCT01205776|75797628|FG001|STARTED|Overall Study||957||
59678419|NCT01205776|75797627|FG000|COMPLETED|Overall Study||884||
59678420|NCT01205776|75797628|FG001|COMPLETED|Overall Study||862||
59678421|NCT01205776|75797627|FG000|NOT COMPLETED|Overall Study||64||
59678422|NCT01205776|75797628|FG001|NOT COMPLETED|Overall Study||95||
59678423|NCT01205581|75797640|FG000|STARTED|Overall Study||14||
59678424|NCT01205581|75797641|FG001|STARTED|Overall Study||13||
59678425|NCT01205581|75797642|FG002|STARTED|Overall Study||8||
59678426|NCT01205581|75797643|FG003|STARTED|Overall Study||9||
59678427|NCT01205581|75797644|FG004|STARTED|Overall Study||20||
59678428|NCT01205581|75797645|FG005|STARTED|Overall Study||20||
59678429|NCT01205581|75797640|FG000|COMPLETED|Overall Study||13||
59678430|NCT01205581|75797641|FG001|COMPLETED|Overall Study||13||
59678431|NCT01205581|75797642|FG002|COMPLETED|Overall Study||8||
59678432|NCT01205581|75797643|FG003|COMPLETED|Overall Study||9||
59678433|NCT01205581|75797644|FG004|COMPLETED|Overall Study||20||
59678434|NCT01205581|75797645|FG005|COMPLETED|Overall Study||20||
59678435|NCT01205581|75797640|FG000|NOT COMPLETED|Overall Study||1||
59678436|NCT01205581|75797641|FG001|NOT COMPLETED|Overall Study||0||
60078091|NCT02090374|76193104|FG003|NOT COMPLETED|Overall Study||0||
60078092|NCT02090374|76193105|FG004|NOT COMPLETED|Overall Study||0||
60078093|NCT02090374|76193106|FG005|NOT COMPLETED|Overall Study||0||
59678437|NCT01205581|75797642|FG002|NOT COMPLETED|Overall Study||0||
59678438|NCT01205581|75797643|FG003|NOT COMPLETED|Overall Study||0||
59678439|NCT01205581|75797644|FG004|NOT COMPLETED|Overall Study||0||
59678440|NCT01205581|75797645|FG005|NOT COMPLETED|Overall Study||0||
59678441|NCT01205269|75797676|FG000|STARTED|Period 1 - First Intervention||4||
59678442|NCT01205269|75797677|FG001|STARTED|Period 1 - First Intervention||4||
59815946|NCT00531050|75938377|FG004|STARTED|Part 1: Period 1||4||
59678443|NCT01205269|75797678|FG002|STARTED|Period 1 - First Intervention||4||
59678444|NCT01205269|75797679|FG003|STARTED|Period 1 - First Intervention||6||
59678445|NCT01205269|75797680|FG004|STARTED|Period 1 - First Intervention||5||
59678446|NCT01205269|75797681|FG005|STARTED|Period 1 - First Intervention||5||
59678447|NCT01205269|75797676|FG000|COMPLETED|Period 1 - First Intervention||4||
59678448|NCT01205269|75797677|FG001|COMPLETED|Period 1 - First Intervention||4||
59678449|NCT01205269|75797678|FG002|COMPLETED|Period 1 - First Intervention||4||
59815947|NCT00531050|75938378|FG005|STARTED|Part 1: Period 1||5||
59678450|NCT01205269|75797679|FG003|COMPLETED|Period 1 - First Intervention||6||
59678451|NCT01205269|75797680|FG004|COMPLETED|Period 1 - First Intervention||5||
59678452|NCT01205269|75797681|FG005|COMPLETED|Period 1 - First Intervention||5||
59678453|NCT01205269|75797676|FG000|NOT COMPLETED|Period 1 - First Intervention||0||
59678454|NCT01205269|75797677|FG001|NOT COMPLETED|Period 1 - First Intervention||0||
59678455|NCT01205269|75797678|FG002|NOT COMPLETED|Period 1 - First Intervention||0||
59678456|NCT01205269|75797679|FG003|NOT COMPLETED|Period 1 - First Intervention||0||
59678457|NCT01205269|75797680|FG004|NOT COMPLETED|Period 1 - First Intervention||0||
59678458|NCT01205269|75797681|FG005|NOT COMPLETED|Period 1 - First Intervention||0||
59678459|NCT01205269|75797676|FG000|STARTED|Period 2 - Washout||4||
59678460|NCT01205269|75797677|FG001|STARTED|Period 2 - Washout||4||
59678461|NCT01205269|75797678|FG002|STARTED|Period 2 - Washout||4||
59678462|NCT01205269|75797679|FG003|STARTED|Period 2 - Washout||6||
59678463|NCT01205269|75797680|FG004|STARTED|Period 2 - Washout||5||
59678464|NCT01205269|75797681|FG005|STARTED|Period 2 - Washout||5||
59678465|NCT01205269|75797676|FG000|COMPLETED|Period 2 - Washout||4||
59678466|NCT01205269|75797677|FG001|COMPLETED|Period 2 - Washout||4||
59678467|NCT01205269|75797678|FG002|COMPLETED|Period 2 - Washout||4||
59678468|NCT01205269|75797679|FG003|COMPLETED|Period 2 - Washout||6||
59678469|NCT01205269|75797680|FG004|COMPLETED|Period 2 - Washout||5||
59678470|NCT01205269|75797681|FG005|COMPLETED|Period 2 - Washout||5||
59678471|NCT01205269|75797676|FG000|NOT COMPLETED|Period 2 - Washout||0||
59678472|NCT01205269|75797677|FG001|NOT COMPLETED|Period 2 - Washout||0||
59678473|NCT01205269|75797678|FG002|NOT COMPLETED|Period 2 - Washout||0||
59678474|NCT01205269|75797679|FG003|NOT COMPLETED|Period 2 - Washout||0||
59678475|NCT01205269|75797680|FG004|NOT COMPLETED|Period 2 - Washout||0||
59678476|NCT01205269|75797681|FG005|NOT COMPLETED|Period 2 - Washout||0||
59678477|NCT01205269|75797676|FG000|STARTED|Period 3 - Second Intervention||4||
59678478|NCT01205269|75797677|FG001|STARTED|Period 3 - Second Intervention||4||
59678479|NCT01205269|75797678|FG002|STARTED|Period 3 - Second Intervention||4||
59678480|NCT01205269|75797679|FG003|STARTED|Period 3 - Second Intervention||6||
59678481|NCT01205269|75797680|FG004|STARTED|Period 3 - Second Intervention||5||
59678482|NCT01205269|75797681|FG005|STARTED|Period 3 - Second Intervention||5||
59678483|NCT01205269|75797676|FG000|COMPLETED|Period 3 - Second Intervention||4||
59678484|NCT01205269|75797677|FG001|COMPLETED|Period 3 - Second Intervention||4||
59678485|NCT01205269|75797678|FG002|COMPLETED|Period 3 - Second Intervention||4||
59678486|NCT01205269|75797679|FG003|COMPLETED|Period 3 - Second Intervention||6||
59678487|NCT01205269|75797680|FG004|COMPLETED|Period 3 - Second Intervention||5||
59678488|NCT01205269|75797681|FG005|COMPLETED|Period 3 - Second Intervention||5||
59678489|NCT01205269|75797676|FG000|NOT COMPLETED|Period 3 - Second Intervention||0||
59678490|NCT01205269|75797677|FG001|NOT COMPLETED|Period 3 - Second Intervention||0||
59678491|NCT01205269|75797678|FG002|NOT COMPLETED|Period 3 - Second Intervention||0||
59678492|NCT01205269|75797679|FG003|NOT COMPLETED|Period 3 - Second Intervention||0||
59678493|NCT01205269|75797680|FG004|NOT COMPLETED|Period 3 - Second Intervention||0||
59678494|NCT01205269|75797681|FG005|NOT COMPLETED|Period 3 - Second Intervention||0||
59678495|NCT01205269|75797676|FG000|STARTED|Period 4 - Washout||4||
59678496|NCT01205269|75797677|FG001|STARTED|Period 4 - Washout||4||
59678497|NCT01205269|75797678|FG002|STARTED|Period 4 - Washout||4||
59678498|NCT01205269|75797679|FG003|STARTED|Period 4 - Washout||6||
59678499|NCT01205269|75797680|FG004|STARTED|Period 4 - Washout||5||
59678500|NCT01205269|75797681|FG005|STARTED|Period 4 - Washout||5||
59678501|NCT01205269|75797676|FG000|COMPLETED|Period 4 - Washout||4||
59678502|NCT01205269|75797677|FG001|COMPLETED|Period 4 - Washout||4||
59678503|NCT01205269|75797678|FG002|COMPLETED|Period 4 - Washout||4||
59678504|NCT01205269|75797679|FG003|COMPLETED|Period 4 - Washout||5||
59678505|NCT01205269|75797680|FG004|COMPLETED|Period 4 - Washout||5||
59678506|NCT01205269|75797681|FG005|COMPLETED|Period 4 - Washout||5||
59678507|NCT01205269|75797676|FG000|NOT COMPLETED|Period 4 - Washout||0||
59678508|NCT01205269|75797677|FG001|NOT COMPLETED|Period 4 - Washout||0||
59678509|NCT01205269|75797678|FG002|NOT COMPLETED|Period 4 - Washout||0||
59678510|NCT01205269|75797679|FG003|NOT COMPLETED|Period 4 - Washout||1||
59678511|NCT01205269|75797680|FG004|NOT COMPLETED|Period 4 - Washout||0||
59678512|NCT01205269|75797681|FG005|NOT COMPLETED|Period 4 - Washout||0||
59678513|NCT01205269|75797676|FG000|STARTED|Period 5 - Third Intervention||4||
59678514|NCT01205269|75797677|FG001|STARTED|Period 5 - Third Intervention||4||
59678515|NCT01205269|75797678|FG002|STARTED|Period 5 - Third Intervention||4||
59678516|NCT01205269|75797679|FG003|STARTED|Period 5 - Third Intervention||5||
59678517|NCT01205269|75797680|FG004|STARTED|Period 5 - Third Intervention||5||
59678518|NCT01205269|75797681|FG005|STARTED|Period 5 - Third Intervention||5||
59678519|NCT01205269|75797676|FG000|COMPLETED|Period 5 - Third Intervention||4||
59678520|NCT01205269|75797677|FG001|COMPLETED|Period 5 - Third Intervention||4||
59678521|NCT01205269|75797678|FG002|COMPLETED|Period 5 - Third Intervention||4||
59678522|NCT01205269|75797679|FG003|COMPLETED|Period 5 - Third Intervention||5||
59678523|NCT01205269|75797680|FG004|COMPLETED|Period 5 - Third Intervention||5||
59678524|NCT01205269|75797681|FG005|COMPLETED|Period 5 - Third Intervention||5||
59678525|NCT01205269|75797676|FG000|NOT COMPLETED|Period 5 - Third Intervention||0||
59678526|NCT01205269|75797677|FG001|NOT COMPLETED|Period 5 - Third Intervention||0||
59546657|NCT01089062|75645358|FG002|NOT COMPLETED|Visit 2 (Randomization)||1||
59546658|NCT01089062|75645359|FG003|NOT COMPLETED|Visit 2 (Randomization)||0||
59546659|NCT01089062|75645360|FG004|NOT COMPLETED|Visit 2 (Randomization)||1||
59546660|NCT01089062|75645361|FG005|NOT COMPLETED|Visit 2 (Randomization)||1||
59546661|NCT01089062|75645356|FG000|STARTED|Visit 3||3||
59546662|NCT01089062|75645357|FG001|STARTED|Visit 3||3||
59546663|NCT01089062|75645358|FG002|STARTED|Visit 3||3||
59546664|NCT01089062|75645359|FG003|STARTED|Visit 3||4||
59546665|NCT01089062|75645360|FG004|STARTED|Visit 3||3||
59546666|NCT01089062|75645361|FG005|STARTED|Visit 3||3||
59546667|NCT01089062|75645356|FG000|COMPLETED|Visit 3||3||
59546668|NCT01089062|75645357|FG001|COMPLETED|Visit 3||3||
59546669|NCT01089062|75645358|FG002|COMPLETED|Visit 3||3||
59546670|NCT01089062|75645359|FG003|COMPLETED|Visit 3||3||
59546671|NCT01089062|75645360|FG004|COMPLETED|Visit 3||3||
59546672|NCT01089062|75645361|FG005|COMPLETED|Visit 3||3||
59546673|NCT01089062|75645356|FG000|NOT COMPLETED|Visit 3||0||
59546674|NCT01089062|75645357|FG001|NOT COMPLETED|Visit 3||0||
59546675|NCT01089062|75645358|FG002|NOT COMPLETED|Visit 3||0||
59546676|NCT01089062|75645359|FG003|NOT COMPLETED|Visit 3||1||
59546677|NCT01089062|75645360|FG004|NOT COMPLETED|Visit 3||0||
59546678|NCT01089062|75645361|FG005|NOT COMPLETED|Visit 3||0||
59546679|NCT01089062|75645356|FG000|STARTED|Visit 4||3||
59546680|NCT01089062|75645357|FG001|STARTED|Visit 4||3||
59546681|NCT01089062|75645358|FG002|STARTED|Visit 4||3||
59546682|NCT01089062|75645359|FG003|STARTED|Visit 4||3||
59546683|NCT01089062|75645360|FG004|STARTED|Visit 4||3||
59546684|NCT01089062|75645361|FG005|STARTED|Visit 4||3||
59546685|NCT01089062|75645356|FG000|COMPLETED|Visit 4||3||
59546686|NCT01089062|75645357|FG001|COMPLETED|Visit 4||3||
59546687|NCT01089062|75645358|FG002|COMPLETED|Visit 4||3||
59546688|NCT01089062|75645359|FG003|COMPLETED|Visit 4||3||
59546689|NCT01089062|75645360|FG004|COMPLETED|Visit 4||3||
59546690|NCT01089062|75645361|FG005|COMPLETED|Visit 4||3||
59546691|NCT01089062|75645356|FG000|NOT COMPLETED|Visit 4||0||
59546692|NCT01089062|75645357|FG001|NOT COMPLETED|Visit 4||0||
59546693|NCT01089062|75645358|FG002|NOT COMPLETED|Visit 4||0||
59546694|NCT01089062|75645359|FG003|NOT COMPLETED|Visit 4||0||
59546695|NCT01089062|75645360|FG004|NOT COMPLETED|Visit 4||0||
59546696|NCT01089062|75645361|FG005|NOT COMPLETED|Visit 4||0||
59546697|NCT01089062|75645356|FG000|STARTED|Follow-up Visit (Final Visit)||3||
59546698|NCT01089062|75645357|FG001|STARTED|Follow-up Visit (Final Visit)||3||
59546699|NCT01089062|75645358|FG002|STARTED|Follow-up Visit (Final Visit)||3||
59546700|NCT01089062|75645359|FG003|STARTED|Follow-up Visit (Final Visit)||3||
59546701|NCT01089062|75645360|FG004|STARTED|Follow-up Visit (Final Visit)||3||
59546702|NCT01089062|75645361|FG005|STARTED|Follow-up Visit (Final Visit)||3||
59546703|NCT01089062|75645356|FG000|COMPLETED|Follow-up Visit (Final Visit)||3||
59546704|NCT01089062|75645357|FG001|COMPLETED|Follow-up Visit (Final Visit)||3||
59546705|NCT01089062|75645358|FG002|COMPLETED|Follow-up Visit (Final Visit)||3||
59678527|NCT01205269|75797678|FG002|NOT COMPLETED|Period 5 - Third Intervention||0||
59678528|NCT01205269|75797679|FG003|NOT COMPLETED|Period 5 - Third Intervention||0||
59678529|NCT01205269|75797680|FG004|NOT COMPLETED|Period 5 - Third Intervention||0||
59678530|NCT01205269|75797681|FG005|NOT COMPLETED|Period 5 - Third Intervention||0||
59678531|NCT02015832|75797689|FG000|STARTED|Overall Study||454||
59678532|NCT02015832|75797689|FG000|COMPLETED|Overall Study||443||
59678533|NCT02015832|75797689|FG000|NOT COMPLETED|Overall Study||11||
59678534|NCT01240915|75797706|FG000|STARTED|Overall Study||2||
59678535|NCT01240915|75797707|FG001|STARTED|Overall Study||3||
59678536|NCT01240915|75797708|FG002|STARTED|Overall Study||2||
59678537|NCT01240915|75797709|FG003|STARTED|Overall Study||4||
59678538|NCT01240915|75797710|FG004|STARTED|Overall Study||6||
59678539|NCT01240915|75797711|FG005|STARTED|Overall Study||23||
59678540|NCT01240915|75797712|FG006|STARTED|Overall Study||25||
59678541|NCT01240915|75797713|FG007|STARTED|Overall Study||19||
59546706|NCT01089062|75645359|FG003|COMPLETED|Follow-up Visit (Final Visit)||3||
59546707|NCT01089062|75645360|FG004|COMPLETED|Follow-up Visit (Final Visit)||3||
59546708|NCT01089062|75645361|FG005|COMPLETED|Follow-up Visit (Final Visit)||3||
59546709|NCT01089062|75645356|FG000|NOT COMPLETED|Follow-up Visit (Final Visit)||0||
59546710|NCT01089062|75645357|FG001|NOT COMPLETED|Follow-up Visit (Final Visit)||0||
59678542|NCT01240915|75797714|FG008|STARTED|Overall Study||21||
59546711|NCT01089062|75645358|FG002|NOT COMPLETED|Follow-up Visit (Final Visit)||0||
59546712|NCT01089062|75645359|FG003|NOT COMPLETED|Follow-up Visit (Final Visit)||0||
59546713|NCT01089062|75645360|FG004|NOT COMPLETED|Follow-up Visit (Final Visit)||0||
59546714|NCT01089062|75645361|FG005|NOT COMPLETED|Follow-up Visit (Final Visit)||0||
59546715|NCT01109108|75645372|FG000|STARTED|Overall Study||4035||
59546716|NCT01109108|75645373|FG001|STARTED|Overall Study||4755||
59678543|NCT01240915|75797706|FG000|COMPLETED|Overall Study||0||
59678544|NCT01240915|75797707|FG001|COMPLETED|Overall Study||2||
59678545|NCT01240915|75797708|FG002|COMPLETED|Overall Study||2||
59678546|NCT01240915|75797709|FG003|COMPLETED|Overall Study||1||
59678547|NCT01240915|75797710|FG004|COMPLETED|Overall Study||2||
59546717|NCT01109108|75645372|FG000|COMPLETED|Overall Study||4035||
59546718|NCT01109108|75645373|FG001|COMPLETED|Overall Study||4755||
59546719|NCT01109108|75645372|FG000|NOT COMPLETED|Overall Study||0||
59546720|NCT01109108|75645373|FG001|NOT COMPLETED|Overall Study||0||
59678548|NCT01240915|75797711|FG005|COMPLETED|Overall Study||13||
59678549|NCT01240915|75797712|FG006|COMPLETED|Overall Study||17||
59678550|NCT01240915|75797713|FG007|COMPLETED|Overall Study||15||
59678551|NCT01240915|75797714|FG008|COMPLETED|Overall Study||13||
59678552|NCT01240915|75797706|FG000|NOT COMPLETED|Overall Study||2||
59678553|NCT01240915|75797707|FG001|NOT COMPLETED|Overall Study||1||
59678554|NCT01240915|75797708|FG002|NOT COMPLETED|Overall Study||0||
59678555|NCT01240915|75797709|FG003|NOT COMPLETED|Overall Study||3||
59678556|NCT01240915|75797710|FG004|NOT COMPLETED|Overall Study||4||
59678557|NCT01240915|75797711|FG005|NOT COMPLETED|Overall Study||10||
59678558|NCT01240915|75797712|FG006|NOT COMPLETED|Overall Study||8||
59678559|NCT01240915|75797713|FG007|NOT COMPLETED|Overall Study||4||
59678560|NCT01240915|75797714|FG008|NOT COMPLETED|Overall Study||8||
59678561|NCT01239745|75797736|FG000|STARTED|Overall Study||46||
59678562|NCT01239745|75797736|FG000|COMPLETED|Overall Study||0||
59678563|NCT01239745|75797736|FG000|NOT COMPLETED|Overall Study||46||
59678564|NCT01239472|75797742|FG000|STARTED|Overall Study||15||
59678565|NCT01239472|75797743|FG001|STARTED|Overall Study||15||
59678566|NCT01239472|75797742|FG000|COMPLETED|Overall Study||10||
59678567|NCT01239472|75797743|FG001|COMPLETED|Overall Study||12||
59678568|NCT01239472|75797742|FG000|NOT COMPLETED|Overall Study||5||
59678569|NCT01239472|75797743|FG001|NOT COMPLETED|Overall Study||3||
59678570|NCT01229449|75797756|FG000|STARTED|Overall Study||173||
59678571|NCT01229449|75797757|FG001|STARTED|Overall Study||168||
59678572|NCT01229449|75797758|FG002|STARTED|Overall Study||169||
59678573|NCT01229449|75797759|FG003|STARTED|Overall Study||113||
59678574|NCT01229449|75797760|FG004|STARTED|Overall Study||55||
59678575|NCT01229449|75797756|FG000|COMPLETED|Overall Study||172||
59678576|NCT01229449|75797757|FG001|COMPLETED|Overall Study||164||
59678577|NCT01229449|75797758|FG002|COMPLETED|Overall Study||167||
59678578|NCT01229449|75797759|FG003|COMPLETED|Overall Study||112||
59678579|NCT01229449|75797760|FG004|COMPLETED|Overall Study||54||
59678580|NCT01229449|75797756|FG000|NOT COMPLETED|Overall Study||1||
59678581|NCT01229449|75797757|FG001|NOT COMPLETED|Overall Study||4||
59678582|NCT01229449|75797758|FG002|NOT COMPLETED|Overall Study||2||
59678583|NCT01229449|75797759|FG003|NOT COMPLETED|Overall Study||1||
59678584|NCT01229449|75797760|FG004|NOT COMPLETED|Overall Study||1||
59678585|NCT01239316|75797772|FG000|STARTED|Overall Study||12||
59678586|NCT01239316|75797772|FG000|COMPLETED|Overall Study||0||
59678587|NCT01239316|75797772|FG000|NOT COMPLETED|Overall Study||12||
59678588|NCT01239160|75797778|FG000|STARTED|Overall Study||114|"Of the 238 patients started, 64 APCD and 66 SPCD had reached the 12 week visit milestone at the time of the outcome analysis reported below. Results presented include 130 subjects who had completed the 12 week follow up (or who withdrew within 12 weeks) prior to the 26Oct2011 dataset."|
59678589|NCT01239160|75797779|FG001|STARTED|Overall Study||114|"Of the 238 patients started, 64 APCD and 66 SPCD had reached the 12 week visit milestone at the time of the outcome analysis reported below. Results presented include 130 subjects who had completed the 12 week follow up (or who withdrew within 12 weeks) prior to the 26Oct2011 dataset."|
59678590|NCT01239160|75797780|FG002|STARTED|Overall Study||10|"Of the 238 patients started, 64 APCD and 66 SPCD had reached the 12 week visit milestone at the time of the outcome analysis reported below. Results presented include 130 subjects who had completed the 12 week follow up (or who withdrew within 12 weeks) prior to the 26Oct2011 dataset."|
59678591|NCT01239160|75797778|FG000|COMPLETED|Overall Study||89||
59678592|NCT01239160|75797779|FG001|COMPLETED|Overall Study||95||
59678593|NCT01239160|75797780|FG002|COMPLETED|Overall Study||0||
59678594|NCT01239160|75797778|FG000|NOT COMPLETED|Overall Study||25||
59678595|NCT01239160|75797779|FG001|NOT COMPLETED|Overall Study||19||
59678596|NCT01239160|75797780|FG002|NOT COMPLETED|Overall Study||10||
59678597|NCT01239121|75797789|FG000|STARTED|Overall Study||188||
59678598|NCT01239121|75797790|FG001|STARTED|Overall Study||199||
59678599|NCT01239121|75797791|FG002|STARTED|Overall Study||15||
59678600|NCT01239121|75797789|FG000|COMPLETED|Overall Study||186||
59678601|NCT01239121|75797790|FG001|COMPLETED|Overall Study||195||
59678602|NCT01239121|75797791|FG002|COMPLETED|Overall Study||15||
59678603|NCT01239121|75797789|FG000|NOT COMPLETED|Overall Study||2||
59678604|NCT01239121|75797790|FG001|NOT COMPLETED|Overall Study||4||
59678605|NCT01239121|75797791|FG002|NOT COMPLETED|Overall Study||0||
59678606|NCT01239043|75797801|FG000|STARTED|Overall Study|For safety analysis number includes 1 participant randomized to Menactra who received Menomune.|36||
59678607|NCT01239043|75797802|FG001|STARTED|Overall Study||103||
59678608|NCT01239043|75797801|FG000|COMPLETED|Overall Study||34||
59678609|NCT01239043|75797802|FG001|COMPLETED|Overall Study||102||
59678610|NCT01239043|75797801|FG000|NOT COMPLETED|Overall Study||2||
59678611|NCT01239043|75797802|FG001|NOT COMPLETED|Overall Study||1||
59678612|NCT01238848|75797810|FG000|STARTED|Overall Study||50||
59678613|NCT01238848|75797811|FG001|STARTED|Overall Study||50||
59678614|NCT01238848|75797810|FG000|COMPLETED|Overall Study||37||
59678615|NCT01238848|75797811|FG001|COMPLETED|Overall Study||45||
59678616|NCT01238848|75797810|FG000|NOT COMPLETED|Overall Study||13||
59678617|NCT01238848|75797811|FG001|NOT COMPLETED|Overall Study||5||
59678618|NCT01238575|75797819|FG000|STARTED|Overall Study||30||
59678619|NCT01238575|75797820|FG001|STARTED|Overall Study||32||
59678620|NCT01238575|75797819|FG000|COMPLETED|Overall Study||26||
59678621|NCT01238575|75797820|FG001|COMPLETED|Overall Study||28||
59678622|NCT01238575|75797819|FG000|NOT COMPLETED|Overall Study||4||
59678623|NCT01238575|75797820|FG001|NOT COMPLETED|Overall Study||4||
59678624|NCT05537428|75797826|FG000|STARTED|Overall Study||39||
59678625|NCT05537428|75797826|FG000|COMPLETED|Overall Study||35||
59678626|NCT05537428|75797826|FG000|NOT COMPLETED|Overall Study||4||
59678627|NCT05376215|75797832|FG000|STARTED|Overall Study||23||
59678628|NCT05376215|75797833|FG001|STARTED|Overall Study||21||
59678629|NCT05376215|75797832|FG000|Completed First Assigned Fitting Method|Overall Study||22||
59678630|NCT05376215|75797833|FG001|Completed First Assigned Fitting Method|Overall Study||20||
59678631|NCT05376215|75797832|FG000|Completed Second Fitting Method|Overall Study||21||
59678632|NCT05376215|75797833|FG001|Completed Second Fitting Method|Overall Study||19||
59678633|NCT05376215|75797832|FG000|COMPLETED|Overall Study||21||
59678634|NCT05376215|75797833|FG001|COMPLETED|Overall Study||19||
59678635|NCT05376215|75797832|FG000|NOT COMPLETED|Overall Study||2||
59678636|NCT05376215|75797833|FG001|NOT COMPLETED|Overall Study||2||
59678637|NCT04482036|75797843|FG000|STARTED|Overall Study||5||
59678638|NCT04482036|75797844|FG001|STARTED|Overall Study||5||
59678639|NCT04482036|75797845|FG002|STARTED|Overall Study||5||
59678640|NCT04482036|75797846|FG003|STARTED|Overall Study||5||
59678641|NCT04482036|75797843|FG000|COMPLETED|Overall Study||2||
59678642|NCT04482036|75797844|FG001|COMPLETED|Overall Study||2||
59678643|NCT04482036|75797845|FG002|COMPLETED|Overall Study||0||
59678644|NCT04482036|75797846|FG003|COMPLETED|Overall Study||0||
59678645|NCT04482036|75797843|FG000|NOT COMPLETED|Overall Study||3||
59678646|NCT04482036|75797844|FG001|NOT COMPLETED|Overall Study||3||
59678647|NCT04482036|75797845|FG002|NOT COMPLETED|Overall Study||5||
59678648|NCT04482036|75797846|FG003|NOT COMPLETED|Overall Study||5||
59678649|NCT04447794|75797862|FG000|STARTED|Overall Study||64||
59678650|NCT04447794|75797863|FG001|STARTED|Overall Study||64||
59678651|NCT04447794|75797864|FG002|STARTED|Overall Study||63||
59678652|NCT04447794|75797862|FG000|COMPLETED|Overall Study||61||
59678653|NCT04447794|75797863|FG001|COMPLETED|Overall Study||60||
59678654|NCT04447794|75797864|FG002|COMPLETED|Overall Study||55||
59678655|NCT04447794|75797862|FG000|NOT COMPLETED|Overall Study||3||
59678656|NCT04447794|75797863|FG001|NOT COMPLETED|Overall Study||4||
59678657|NCT04447794|75797864|FG002|NOT COMPLETED|Overall Study||8||
59678658|NCT04170764|75797873|FG000|STARTED|Overall Study||664||
59678659|NCT04170764|75797873|FG000|COMPLETED|Overall Study||571||
59678660|NCT04170764|75797873|FG000|NOT COMPLETED|Overall Study||93||
59678661|NCT04138576|75797877|FG000|STARTED|Overall Study||381||
59678662|NCT04138576|75797877|FG000|COMPLETED|Overall Study||365||
59678663|NCT04138576|75797877|FG000|NOT COMPLETED|Overall Study||16||
59678664|NCT04089488|75797883|FG000|STARTED|Overall Study||175||
59678665|NCT04089488|75797883|FG000|COMPLETED|Overall Study||175||
59678666|NCT04089488|75797883|FG000|NOT COMPLETED|Overall Study||0||
59678667|NCT04009291|75797891|FG000|STARTED|Blinded Period (Weeks 0 to 4)||14||
59678668|NCT04009291|75797892|FG001|STARTED|Blinded Period (Weeks 0 to 4)||15||
59678669|NCT04009291|75797893|FG002|STARTED|Blinded Period (Weeks 0 to 4)||15||
59678670|NCT04009291|75797894|FG003|STARTED|Blinded Period (Weeks 0 to 4)||15||
59678671|NCT04009291|75797895|FG004|STARTED|Blinded Period (Weeks 0 to 4)||0||
59678672|NCT04009291|75797891|FG000|COMPLETED|Blinded Period (Weeks 0 to 4)||14||
59678673|NCT04009291|75797892|FG001|COMPLETED|Blinded Period (Weeks 0 to 4)||15||
59678674|NCT04009291|75797893|FG002|COMPLETED|Blinded Period (Weeks 0 to 4)||15||
59678675|NCT04009291|75797894|FG003|COMPLETED|Blinded Period (Weeks 0 to 4)||15||
59678676|NCT04009291|75797895|FG004|COMPLETED|Blinded Period (Weeks 0 to 4)||0||
59678677|NCT04009291|75797891|FG000|NOT COMPLETED|Blinded Period (Weeks 0 to 4)||0||
59678678|NCT04009291|75797892|FG001|NOT COMPLETED|Blinded Period (Weeks 0 to 4)||0||
59678679|NCT04009291|75797893|FG002|NOT COMPLETED|Blinded Period (Weeks 0 to 4)||0||
59678680|NCT04009291|75797894|FG003|NOT COMPLETED|Blinded Period (Weeks 0 to 4)||0||
59678681|NCT04009291|75797895|FG004|NOT COMPLETED|Blinded Period (Weeks 0 to 4)||0||
59678682|NCT04009291|75797891|FG000|STARTED|Open-Label Period (Weeks 4 to 266)||0||
59678683|NCT04009291|75797892|FG001|STARTED|Open-Label Period (Weeks 4 to 266)||0||
59678684|NCT04009291|75797893|FG002|STARTED|Open-Label Period (Weeks 4 to 266)||0||
59678685|NCT04009291|75797894|FG003|STARTED|Open-Label Period (Weeks 4 to 266)||0||
59678686|NCT04009291|75797895|FG004|STARTED|Open-Label Period (Weeks 4 to 266)||59||
59678687|NCT04009291|75797891|FG000|COMPLETED|Open-Label Period (Weeks 4 to 266)||0||
59678688|NCT04009291|75797892|FG001|COMPLETED|Open-Label Period (Weeks 4 to 266)||0||
59678689|NCT04009291|75797893|FG002|COMPLETED|Open-Label Period (Weeks 4 to 266)||0||
59678690|NCT04009291|75797894|FG003|COMPLETED|Open-Label Period (Weeks 4 to 266)||0||
59678691|NCT04009291|75797895|FG004|COMPLETED|Open-Label Period (Weeks 4 to 266)||0||
59678692|NCT04009291|75797891|FG000|NOT COMPLETED|Open-Label Period (Weeks 4 to 266)||0||
59678693|NCT04009291|75797892|FG001|NOT COMPLETED|Open-Label Period (Weeks 4 to 266)||0||
59678694|NCT04009291|75797893|FG002|NOT COMPLETED|Open-Label Period (Weeks 4 to 266)||0||
59678695|NCT04009291|75797894|FG003|NOT COMPLETED|Open-Label Period (Weeks 4 to 266)||0||
59678696|NCT04009291|75797895|FG004|NOT COMPLETED|Open-Label Period (Weeks 4 to 266)||59||
59678697|NCT03811340|75797906|FG000|STARTED|Overall Study||1105||
59678698|NCT03811340|75797906|FG000|COMPLETED|Overall Study||1015||
59678699|NCT03811340|75797906|FG000|NOT COMPLETED|Overall Study||90||
59678700|NCT03790280|75797912|FG000|STARTED|Overall Study||8||
59678701|NCT03790280|75797913|FG001|STARTED|Overall Study||9||
59678702|NCT03790280|75797912|FG000|COMPLETED|Overall Study||7||
59678703|NCT03790280|75797913|FG001|COMPLETED|Overall Study||9||
59678704|NCT03790280|75797912|FG000|NOT COMPLETED|Overall Study||1||
59678705|NCT03790280|75797913|FG001|NOT COMPLETED|Overall Study||0||
59678706|NCT03668119|75797921|FG000|STARTED|Pre-treatment||136|Randomized|
59678707|NCT03668119|75797922|FG001|STARTED|Pre-treatment||76|Randomized|
59678708|NCT03668119|75797921|FG000|bTMB-H Started|Pre-treatment||80|Randomized in a salvage setting|
59678709|NCT03668119|75797922|FG001|bTMB-H Started|Pre-treatment||45|Randomized in a salvage setting|
59678710|NCT03668119|75797921|FG000|tTMB-H Started|Pre-treatment||88|Randomized in a salvage setting|
59678711|NCT03668119|75797922|FG001|tTMB-H Started|Pre-treatment||47|Randomized in a salvage setting|
59678712|NCT03668119|75797921|FG000|COMPLETED|Pre-treatment||135|Treated|
59678713|NCT03668119|75797922|FG001|COMPLETED|Pre-treatment||76|Treated|
59678714|NCT03668119|75797921|FG000|NOT COMPLETED|Pre-treatment||1||
59678715|NCT03668119|75797922|FG001|NOT COMPLETED|Pre-treatment||0||
59678716|NCT03668119|75797921|FG000|STARTED|Treatment||135|Treated|
59678717|NCT03668119|75797922|FG001|STARTED|Treatment||76|Treated|
59678718|NCT03668119|75797921|FG000|bTMB-H Started|Treatment||83|Treated|
59678719|NCT03668119|75797922|FG001|bTMB-H Started|Treatment||47|Treated|
59678720|NCT03668119|75797921|FG000|tTMB-H Started|Treatment||94|Treated|
59678721|NCT03668119|75797922|FG001|tTMB-H Started|Treatment||50|Treated|
59678722|NCT03668119|75797921|FG000|Arm B Rollover|Treatment||0||
59678723|NCT03668119|75797922|FG001|Arm B Rollover|Treatment||21||
59678724|NCT03668119|75797921|FG000|COMPLETED|Treatment||8|Continuing in the treatment period|
59678725|NCT03668119|75797922|FG001|COMPLETED|Treatment||4|Continuing in the treatment period|
59678726|NCT03668119|75797921|FG000|NOT COMPLETED|Treatment||127||
59678727|NCT03668119|75797922|FG001|NOT COMPLETED|Treatment||72||
59678728|NCT03379246|75797930|FG000|STARTED|Overall Study||236||
59678729|NCT03379246|75797930|FG000|COMPLETED|Overall Study||236||
59678730|NCT03379246|75797930|FG000|NOT COMPLETED|Overall Study||0||
59678731|NCT03224819|75797948|FG000|STARTED|Overall Study||1||
59678732|NCT03224819|75797949|FG001|STARTED|Overall Study||1||
59678733|NCT03224819|75797950|FG002|STARTED|Overall Study||3||
59678734|NCT03224819|75797951|FG003|STARTED|Overall Study||3||
59678735|NCT03224819|75797952|FG004|STARTED|Overall Study||3||
59678736|NCT03224819|75797953|FG005|STARTED|Overall Study||3||
59678737|NCT03224819|75797954|FG006|STARTED|Overall Study||3||
59678738|NCT03224819|75797955|FG007|STARTED|Overall Study||3||
59678739|NCT03224819|75797956|FG008|STARTED|Overall Study||4||
59678740|NCT03224819|75797957|FG009|STARTED|Overall Study||6||
59678741|NCT03224819|75797958|FG010|STARTED|Overall Study||4||
59678742|NCT03224819|75797959|FG011|STARTED|Overall Study||4||
59678743|NCT03224819|75797960|FG012|STARTED|Overall Study||5||
59678744|NCT03224819|75797961|FG013|STARTED|Overall Study||3||
59678745|NCT03224819|75797948|FG000|COMPLETED|Overall Study||1||
59678746|NCT03224819|75797949|FG001|COMPLETED|Overall Study||0||
59678747|NCT03224819|75797950|FG002|COMPLETED|Overall Study||3||
59678748|NCT03224819|75797951|FG003|COMPLETED|Overall Study||2||
59678749|NCT03224819|75797952|FG004|COMPLETED|Overall Study||2||
59678750|NCT03224819|75797953|FG005|COMPLETED|Overall Study||1||
59678751|NCT03224819|75797954|FG006|COMPLETED|Overall Study||2||
59678752|NCT03224819|75797955|FG007|COMPLETED|Overall Study||1||
59678753|NCT03224819|75797956|FG008|COMPLETED|Overall Study||2||
59678754|NCT03224819|75797957|FG009|COMPLETED|Overall Study||4||
59678755|NCT03224819|75797958|FG010|COMPLETED|Overall Study||3||
59678756|NCT03224819|75797959|FG011|COMPLETED|Overall Study||2||
59678757|NCT03224819|75797960|FG012|COMPLETED|Overall Study||3||
59678758|NCT03224819|75797961|FG013|COMPLETED|Overall Study||3||
59678759|NCT03224819|75797948|FG000|NOT COMPLETED|Overall Study||0||
59678760|NCT03224819|75797949|FG001|NOT COMPLETED|Overall Study||1||
59678761|NCT03224819|75797950|FG002|NOT COMPLETED|Overall Study||0||
59678762|NCT03224819|75797951|FG003|NOT COMPLETED|Overall Study||1||
59678763|NCT03224819|75797952|FG004|NOT COMPLETED|Overall Study||1||
59678764|NCT03224819|75797953|FG005|NOT COMPLETED|Overall Study||2||
59678765|NCT03224819|75797954|FG006|NOT COMPLETED|Overall Study||1||
59678766|NCT03224819|75797955|FG007|NOT COMPLETED|Overall Study||2||
59678767|NCT03224819|75797956|FG008|NOT COMPLETED|Overall Study||2||
59678768|NCT03224819|75797957|FG009|NOT COMPLETED|Overall Study||2||
59678769|NCT03224819|75797958|FG010|NOT COMPLETED|Overall Study||1||
59678770|NCT03224819|75797959|FG011|NOT COMPLETED|Overall Study||2||
59678771|NCT03224819|75797960|FG012|NOT COMPLETED|Overall Study||2||
59678772|NCT03224819|75797961|FG013|NOT COMPLETED|Overall Study||0||
59678773|NCT02783950|75797995|FG000|STARTED|Overall Study||182||
59678774|NCT02783950|75797996|FG001|STARTED|Overall Study||174||
59678775|NCT02783950|75797995|FG000|COMPLETED|Overall Study||175|Includes all patients who were followed for at least 18 months or had an event prior to 18 months|
59678776|NCT02783950|75797996|FG001|COMPLETED|Overall Study||165|Includes all patients who were followed for at least 18 months or had an event prior to 18 months|
59678777|NCT02783950|75797995|FG000|NOT COMPLETED|Overall Study||7||
59678778|NCT02783950|75797996|FG001|NOT COMPLETED|Overall Study||9||
59678779|NCT02549573|75798004|FG000|STARTED|Overall Study||6||
59678780|NCT02549573|75798005|FG001|STARTED|Overall Study||7||
59678781|NCT02549573|75798004|FG000|COMPLETED|Overall Study||6||
59678782|NCT02549573|75798005|FG001|COMPLETED|Overall Study||4||
59678783|NCT02549573|75798004|FG000|NOT COMPLETED|Overall Study||0||
59678784|NCT02549573|75798005|FG001|NOT COMPLETED|Overall Study||3||
59678785|NCT02378181|75798013|FG000|STARTED|Overall Study||21||
59678786|NCT02378181|75798014|FG001|STARTED|Overall Study||28||
59678787|NCT02378181|75798013|FG000|6 Week Assessment|Overall Study||18||
59678788|NCT02378181|75798014|FG001|6 Week Assessment|Overall Study||16||
59678789|NCT02378181|75798013|FG000|3 Month Assessment|Overall Study||18||
59678790|NCT02378181|75798014|FG001|3 Month Assessment|Overall Study||21||
59678791|NCT02378181|75798013|FG000|COMPLETED|Overall Study||18||
59678792|NCT02378181|75798014|FG001|COMPLETED|Overall Study||21||
59678793|NCT02378181|75798013|FG000|NOT COMPLETED|Overall Study||3||
59678794|NCT02378181|75798014|FG001|NOT COMPLETED|Overall Study||7||
59678795|NCT02201108|75798022|FG000|STARTED|Double-blind Period (up to Week 96)||57|Randomized and treated participants.|
59678796|NCT02201108|75798023|FG001|STARTED|Double-blind Period (up to Week 96)||109|Randomized and treated participants.|
59678797|NCT02201108|75798022|FG000|COMPLETED|Double-blind Period (up to Week 96)||53||
59678798|NCT02201108|75798023|FG001|COMPLETED|Double-blind Period (up to Week 96)||102||
59678799|NCT02201108|75798022|FG000|NOT COMPLETED|Double-blind Period (up to Week 96)||4||
59678800|NCT02201108|75798023|FG001|NOT COMPLETED|Double-blind Period (up to Week 96)||7||
59678801|NCT02201108|75798022|FG000|STARTED|Open Label Period (up to Week 192)||52|Post completion of DB treatment period, only eligible participants entered OL treatment period.|
59678802|NCT02201108|75798023|FG001|STARTED|Open Label Period (up to Week 192)||100|Post completion of DB treatment period, only eligible participants entered OL treatment period.|
59678803|NCT02201108|75798022|FG000|COMPLETED|Open Label Period (up to Week 192)||31||
59678804|NCT02201108|75798023|FG001|COMPLETED|Open Label Period (up to Week 192)||73||
59678805|NCT02201108|75798022|FG000|NOT COMPLETED|Open Label Period (up to Week 192)||21||
59678806|NCT02201108|75798023|FG001|NOT COMPLETED|Open Label Period (up to Week 192)||27||
59678807|NCT02180243|75798044|FG000|STARTED|Overall Study||75||
59678808|NCT02180243|75798045|FG001|STARTED|Overall Study||74||
59678809|NCT02180243|75798044|FG000|COMPLETED|Overall Study||51||
59678810|NCT02180243|75798045|FG001|COMPLETED|Overall Study||60||
59678811|NCT02180243|75798044|FG000|NOT COMPLETED|Overall Study||24||
59678812|NCT02180243|75798045|FG001|NOT COMPLETED|Overall Study||14||
59678813|NCT01772563|75798052|FG000|STARTED|Cycle 1||28||
59678814|NCT01772563|75798052|FG000|Treated With 300 mg Volasertib|Cycle 1||3||
59678815|NCT01772563|75798052|FG000|Treated With 250 mg of Volasertib|Cycle 1||25||
59678816|NCT01772563|75798052|FG000|COMPLETED|Cycle 1||24|Patients continuing to >=Cycle 2|
59678817|NCT01772563|75798052|FG000|NOT COMPLETED|Cycle 1||4||
59678818|NCT01772563|75798052|FG000|STARTED|Cycle 2 and Beyond||24|Patients started mono-therapy (Cycle 2 and beyond)|
59678819|NCT01772563|75798052|FG000|Treated With 300 mg Volasertib in Cycle 2|Cycle 2 and Beyond||1||
59678820|NCT01772563|75798052|FG000|Treated With 250 mg Volasertib in Cycle 2|Cycle 2 and Beyond||21||
59678821|NCT01772563|75798052|FG000|Treated With 200 mg Volasertib in Cycle 2|Cycle 2 and Beyond||1||
59678822|NCT01772563|75798052|FG000|COMPLETED|Cycle 2 and Beyond||1||
59678823|NCT01772563|75798052|FG000|NOT COMPLETED|Cycle 2 and Beyond||23||
59678824|NCT01445171|75798058|FG000|STARTED|Overall Study||295||
59678825|NCT01445171|75798058|FG000|Implanted With Study Device|Overall Study||287||
59678826|NCT01445171|75798058|FG000|COMPLETED|Overall Study||200||
59678827|NCT01445171|75798058|FG000|NOT COMPLETED|Overall Study||95||
59678828|NCT00492050|75798064|FG000|STARTED|Overall Study||37|(Additonal cycle 3); Bortezomib 1.6 mg/m2, Rituximab 375 mg/m2 (1 additional cycle)|
59678829|NCT00492050|75798064|FG000|Inadequate Response to First Two Cycles|Overall Study||25||
59678830|NCT00492050|75798064|FG000|Inadequate Response to First 3 Cycles|Overall Study||12|Rituximab 375 mg/m^2, Cyclophosphamide 100 mg/m^2, Doborubicine 9 mg/m^2/day, dexamethasone 40 mg/day (2 cycles)|
59678831|NCT00492050|75798064|FG000|If Adequate Response to First Two Cycles-participants Proceed to Stem Cell Collection|Overall Study||30|+ 1 cycle of 2CdA 3.0 mg/m2, cyclophosphamide 60 mg/m2, rituximab 375 mg/m2|
59678832|NCT00492050|75798064|FG000|COMPLETED|Overall Study||28||
59678833|NCT00492050|75798064|FG000|NOT COMPLETED|Overall Study||9||
59815948|NCT00531050|75938373|FG000|COMPLETED|Part 1: Period 1||4||
59815949|NCT00531050|75938374|FG001|COMPLETED|Part 1: Period 1||4||
59815950|NCT00531050|75938375|FG002|COMPLETED|Part 1: Period 1||4||
59678834|NCT01237951|75798068|FG000|STARTED|Overall Study||75||
59678835|NCT01237951|75798068|FG000|COMPLETED|Overall Study||74||
59678836|NCT01237951|75798068|FG000|NOT COMPLETED|Overall Study||1||
59678837|NCT01239394|75798072|FG000|STARTED|Overall Study||42||
59678838|NCT01239394|75798072|FG000|COMPLETED|Overall Study||41||
59678839|NCT01239394|75798072|FG000|NOT COMPLETED|Overall Study||1||
59678840|NCT01237678|75798079|FG000|STARTED|Phase I - IMGN901+Carboplatin+Etoposide||33||
59678841|NCT01237678|75798080|FG001|STARTED|Phase I - IMGN901+Carboplatin+Etoposide||0||
59678842|NCT01237678|75798081|FG002|STARTED|Phase I - IMGN901+Carboplatin+Etoposide||0||
59678843|NCT01237678|75798079|FG000|Received Intervention|Phase I - IMGN901+Carboplatin+Etoposide||33||
59678844|NCT01237678|75798080|FG001|Received Intervention|Phase I - IMGN901+Carboplatin+Etoposide||0||
59678845|NCT01237678|75798081|FG002|Received Intervention|Phase I - IMGN901+Carboplatin+Etoposide||0||
59678846|NCT01237678|75798079|FG000|COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||0||
59678847|NCT01237678|75798080|FG001|COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||0||
59815951|NCT00531050|75938376|FG003|COMPLETED|Part 1: Period 1||4||
59815952|NCT00531050|75938377|FG004|COMPLETED|Part 1: Period 1||4||
59815953|NCT00531050|75938378|FG005|COMPLETED|Part 1: Period 1||5||
59678848|NCT01237678|75798081|FG002|COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||0||
59678849|NCT01237678|75798079|FG000|NOT COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||33||
59678850|NCT01237678|75798080|FG001|NOT COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||0||
59678851|NCT01237678|75798081|FG002|NOT COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||0||
59678852|NCT01237678|75798079|FG000|STARTED|Phase II||0||
59678853|NCT01237678|75798080|FG001|STARTED|Phase II|98 subjects were randomized, 94 subjects treated|98||
59678854|NCT01237678|75798081|FG002|STARTED|Phase II|50 subjects were randomized, 47 subjects treated|50||
59678855|NCT01237678|75798079|FG000|Received Intervention|Phase II||0||
59678856|NCT01237678|75798080|FG001|Received Intervention|Phase II||94||
59678857|NCT01237678|75798081|FG002|Received Intervention|Phase II||47||
59678858|NCT01237678|75798079|FG000|COMPLETED|Phase II||0||
59678859|NCT01237678|75798080|FG001|COMPLETED|Phase II||0||
59678860|NCT01237678|75798081|FG002|COMPLETED|Phase II||0||
59678861|NCT01237678|75798079|FG000|NOT COMPLETED|Phase II||0||
59678862|NCT01237678|75798080|FG001|NOT COMPLETED|Phase II||98||
59678863|NCT01237678|75798081|FG002|NOT COMPLETED|Phase II||50||
59678864|NCT04684992|75798096|FG000|STARTED|Overall Study||36||
59678865|NCT04684992|75798096|FG000|COMPLETED|Overall Study||34||
59678866|NCT04684992|75798096|FG000|NOT COMPLETED|Overall Study||2||
59678867|NCT01229371|75798104|FG000|STARTED|Overall Study||109||
59678868|NCT01229371|75798105|FG001|STARTED|Overall Study||111||
59678869|NCT01229371|75798106|FG002|STARTED|Overall Study||110||
59678870|NCT01229371|75798107|FG003|STARTED|Overall Study||110||
59678871|NCT01229371|75798104|FG000|COMPLETED|Overall Study||109||
59678872|NCT01229371|75798105|FG001|COMPLETED|Overall Study||110||
59678873|NCT01229371|75798106|FG002|COMPLETED|Overall Study||110||
59678874|NCT01229371|75798107|FG003|COMPLETED|Overall Study||110||
59678875|NCT01229371|75798104|FG000|NOT COMPLETED|Overall Study||0||
59678876|NCT01229371|75798105|FG001|NOT COMPLETED|Overall Study||1||
59678877|NCT01229371|75798106|FG002|NOT COMPLETED|Overall Study||0||
59678878|NCT01229371|75798107|FG003|NOT COMPLETED|Overall Study||0||
59678879|NCT01237327|75798119|FG000|STARTED|Overall Study||43||
59678880|NCT01237327|75798120|FG001|STARTED|Overall Study||41||
59678881|NCT01237327|75798119|FG000|Stopped Treatment in Core Study (D/C)|Overall Study|Continued in Extension Study for follow-up only; not treated with study medication.|22||
59678882|NCT01237327|75798120|FG001|Stopped Treatment in Core Study (D/C)|Overall Study|Continued in Extension Study for follow-up only; not treated with study medication.|24||
59678883|NCT01237327|75798119|FG000|Completed Treatment in Core Study|Overall Study|Completed 26 weeks of treatment in Core Study; continued in Extension Study for follow-up only.|3||
59678884|NCT01237327|75798120|FG001|Completed Treatment in Core Study|Overall Study|Completed 26 weeks of treatment in Core Study; continued in Extension Study for follow-up only.|2||
59678885|NCT01237327|75798119|FG000|Continued Treatment in Extension Study|Overall Study||21||
59678886|NCT01237327|75798120|FG001|Continued Treatment in Extension Study|Overall Study||17||
59678887|NCT01237327|75798119|FG000|COMPLETED|Overall Study|On treatment at Extension Study cut-off date.|1||
59678888|NCT01237327|75798120|FG001|COMPLETED|Overall Study|On treatment at Extension Study cut-off date.|1||
59678889|NCT01237327|75798119|FG000|NOT COMPLETED|Overall Study||42||
59678890|NCT01237327|75798120|FG001|NOT COMPLETED|Overall Study||40||
59678891|NCT01237054|75798126|FG000|STARTED|Overall Study||31||
59678892|NCT01237054|75798126|FG000|COMPLETED|Overall Study||30||
59678893|NCT01237054|75798126|FG000|NOT COMPLETED|Overall Study||1||
59678894|NCT04646291|75798136|FG000|STARTED|Overall Study||272||
59678895|NCT04646291|75798137|FG001|STARTED|Overall Study||70||
59678896|NCT04646291|75798138|FG002|STARTED|Overall Study||8||
59678897|NCT04646291|75798136|FG000|COMPLETED|Overall Study||272||
59678898|NCT04646291|75798137|FG001|COMPLETED|Overall Study||70||
59678899|NCT04646291|75798138|FG002|COMPLETED|Overall Study||8||
59678900|NCT04646291|75798136|FG000|NOT COMPLETED|Overall Study||0||
59678901|NCT04646291|75798137|FG001|NOT COMPLETED|Overall Study||0||
59678902|NCT04646291|75798138|FG002|NOT COMPLETED|Overall Study||0||
59678903|NCT01236352|75798163|FG000|STARTED|Overall Study||4||
59678904|NCT01236352|75798164|FG001|STARTED|Overall Study||4||
59678905|NCT01236352|75798165|FG002|STARTED|Overall Study||4||
59678906|NCT01236352|75798166|FG003|STARTED|Overall Study||4||
59678907|NCT01236352|75798167|FG004|STARTED|Overall Study||4||
59678908|NCT01236352|75798168|FG005|STARTED|Overall Study||4||
59678909|NCT01236352|75798169|FG006|STARTED|Overall Study||8||
59678910|NCT01236352|75798170|FG007|STARTED|Overall Study||7||
59678911|NCT01236352|75798171|FG008|STARTED|Overall Study||3||
59678912|NCT01236352|75798172|FG009|STARTED|Overall Study||22||
59678913|NCT01236352|75798173|FG010|STARTED|Overall Study||20||
59678914|NCT01236352|75798163|FG000|COMPLETED|Overall Study||0||
59678915|NCT01236352|75798164|FG001|COMPLETED|Overall Study||0||
59678916|NCT01236352|75798165|FG002|COMPLETED|Overall Study||0||
59678917|NCT01236352|75798166|FG003|COMPLETED|Overall Study||1||
59678918|NCT01236352|75798167|FG004|COMPLETED|Overall Study||0||
59678919|NCT01236352|75798168|FG005|COMPLETED|Overall Study||0||
59678920|NCT01236352|75798169|FG006|COMPLETED|Overall Study||0||
59678921|NCT01236352|75798170|FG007|COMPLETED|Overall Study||0||
59678922|NCT01236352|75798171|FG008|COMPLETED|Overall Study||0||
59678923|NCT01236352|75798172|FG009|COMPLETED|Overall Study||0||
59678924|NCT01236352|75798173|FG010|COMPLETED|Overall Study||0||
59678925|NCT01236352|75798163|FG000|NOT COMPLETED|Overall Study||4||
59678926|NCT01236352|75798164|FG001|NOT COMPLETED|Overall Study||4||
59678927|NCT01236352|75798165|FG002|NOT COMPLETED|Overall Study||4||
59678928|NCT01236352|75798166|FG003|NOT COMPLETED|Overall Study||3||
59678929|NCT01236352|75798167|FG004|NOT COMPLETED|Overall Study||4||
59678930|NCT01236352|75798168|FG005|NOT COMPLETED|Overall Study||4||
59678931|NCT01236352|75798169|FG006|NOT COMPLETED|Overall Study||8||
59678932|NCT01236352|75798170|FG007|NOT COMPLETED|Overall Study||7||
59678933|NCT01236352|75798171|FG008|NOT COMPLETED|Overall Study||3||
59678934|NCT01236352|75798172|FG009|NOT COMPLETED|Overall Study||22||
59678935|NCT01236352|75798173|FG010|NOT COMPLETED|Overall Study||20||
59678936|NCT01236118|75798200|FG000|STARTED|Overall Study||6||
59678937|NCT01236118|75798201|FG001|STARTED|Overall Study||5||
59678938|NCT01236118|75798202|FG002|STARTED|Overall Study||17||
59678939|NCT01236118|75798200|FG000|COMPLETED|Overall Study||4||
59678940|NCT01236118|75798201|FG001|COMPLETED|Overall Study||4||
59678941|NCT01236118|75798202|FG002|COMPLETED|Overall Study||14||
59678942|NCT01236118|75798200|FG000|NOT COMPLETED|Overall Study||2||
59678943|NCT01236118|75798201|FG001|NOT COMPLETED|Overall Study||1||
59678944|NCT01236118|75798202|FG002|NOT COMPLETED|Overall Study||3||
59678945|NCT01236001|75798212|FG000|STARTED|Overall Study||105||
59678946|NCT01236001|75798213|FG001|STARTED|Overall Study||87||
59678947|NCT01236001|75798212|FG000|COMPLETED|Overall Study||87||
59678948|NCT01236001|75798213|FG001|COMPLETED|Overall Study||65||
59678949|NCT01236001|75798212|FG000|NOT COMPLETED|Overall Study||18||
59678950|NCT01236001|75798213|FG001|NOT COMPLETED|Overall Study||22||
59678951|NCT01229254|75798223|FG000|STARTED|Overall Study||42||
59678952|NCT01229254|75798224|FG001|STARTED|Overall Study||74||
59678953|NCT01229254|75798225|FG002|STARTED|Overall Study||73||
59678954|NCT01229254|75798223|FG000|COMPLETED|Overall Study||27||
59678955|NCT01229254|75798224|FG001|COMPLETED|Overall Study||58||
59678956|NCT01229254|75798225|FG002|COMPLETED|Overall Study||61||
59678957|NCT01229254|75798223|FG000|NOT COMPLETED|Overall Study||15||
59678958|NCT01229254|75798224|FG001|NOT COMPLETED|Overall Study||16||
59678959|NCT01229254|75798225|FG002|NOT COMPLETED|Overall Study||12||
59678960|NCT01235728|75798234|FG000|STARTED|Overall Study||3||
59678961|NCT01235728|75798235|FG001|STARTED|Overall Study||3||
59678962|NCT01235728|75798236|FG002|STARTED|Overall Study||3||
59678963|NCT01235728|75798237|FG003|STARTED|Overall Study||3||
59678964|NCT01235728|75798238|FG004|STARTED|Overall Study||3||
59678965|NCT01235728|75798239|FG005|STARTED|Overall Study||3||
59678966|NCT01235728|75798240|FG006|STARTED|Overall Study||3||
59678967|NCT01235728|75798241|FG007|STARTED|Overall Study||3||
59678968|NCT01235728|75798234|FG000|COMPLETED|Overall Study||3||
59678969|NCT01235728|75798235|FG001|COMPLETED|Overall Study||3||
59678970|NCT01235728|75798236|FG002|COMPLETED|Overall Study||3||
59678971|NCT01235728|75798237|FG003|COMPLETED|Overall Study||2||
59678972|NCT01235728|75798238|FG004|COMPLETED|Overall Study||3||
59678973|NCT01235728|75798239|FG005|COMPLETED|Overall Study||3||
59678974|NCT01235728|75798240|FG006|COMPLETED|Overall Study||3||
59678975|NCT01235728|75798241|FG007|COMPLETED|Overall Study||3||
59678976|NCT01235728|75798234|FG000|NOT COMPLETED|Overall Study||0||
59678977|NCT01235728|75798235|FG001|NOT COMPLETED|Overall Study||0||
59678978|NCT01235728|75798236|FG002|NOT COMPLETED|Overall Study||0||
59678979|NCT01235728|75798237|FG003|NOT COMPLETED|Overall Study||1||
59678980|NCT01235728|75798238|FG004|NOT COMPLETED|Overall Study||0||
59678981|NCT01235728|75798239|FG005|NOT COMPLETED|Overall Study||0||
59678982|NCT01235728|75798240|FG006|NOT COMPLETED|Overall Study||0||
59678983|NCT01235728|75798241|FG007|NOT COMPLETED|Overall Study||0||
59678984|NCT01235689|75798251|FG000|STARTED|Overall Study|Total randomized includes participants who randomized at Week 9 and earlier.|122||
59678985|NCT01235689|75798252|FG001|STARTED|Overall Study|Total randomized includes participants who randomized at Week 9 and earlier.|122||
59678986|NCT01235689|75798251|FG000|Early Randomized (Baseline to Week 9)|Overall Study||63||
59678987|NCT01235689|75798252|FG001|Early Randomized (Baseline to Week 9)|Overall Study||69||
59678988|NCT01235689|75798251|FG000|Randomized at Week 9|Overall Study||59||
59678989|NCT01235689|75798252|FG001|Randomized at Week 9|Overall Study||53||
59678990|NCT01235689|75798251|FG000|COMPLETED|Overall Study||93||
59678991|NCT01235689|75798252|FG001|COMPLETED|Overall Study||90||
59678992|NCT01235689|75798251|FG000|NOT COMPLETED|Overall Study||29||
59678993|NCT01235689|75798252|FG001|NOT COMPLETED|Overall Study||32||
59678994|NCT01229176|75798266|FG000|STARTED|Overall Study||40||
59678995|NCT01229176|75798267|FG001|STARTED|Overall Study||40||
59678996|NCT01229176|75798268|FG002|STARTED|Overall Study||20||
59678997|NCT01229176|75798269|FG003|STARTED|Overall Study||20||
59678998|NCT01229176|75798270|FG004|STARTED|Overall Study||20||
59678999|NCT01229176|75798271|FG005|STARTED|Overall Study||20||
59679000|NCT01229176|75798272|FG006|STARTED|Overall Study||20||
59679001|NCT01229176|75798273|FG007|STARTED|Overall Study||20||
59679002|NCT01229176|75798266|FG000|COMPLETED|Overall Study||40||
59679003|NCT01229176|75798267|FG001|COMPLETED|Overall Study||37||
59679004|NCT01229176|75798268|FG002|COMPLETED|Overall Study||20||
59679005|NCT01229176|75798269|FG003|COMPLETED|Overall Study||19||
59679006|NCT01229176|75798270|FG004|COMPLETED|Overall Study||18||
59679007|NCT01229176|75798271|FG005|COMPLETED|Overall Study||18||
59679008|NCT01229176|75798272|FG006|COMPLETED|Overall Study||20||
59679009|NCT01229176|75798273|FG007|COMPLETED|Overall Study||17||
59679010|NCT01229176|75798266|FG000|NOT COMPLETED|Overall Study||0||
59679011|NCT01229176|75798267|FG001|NOT COMPLETED|Overall Study||3||
59679012|NCT01229176|75798268|FG002|NOT COMPLETED|Overall Study||0||
59679013|NCT01229176|75798269|FG003|NOT COMPLETED|Overall Study||1||
59679014|NCT01229176|75798270|FG004|NOT COMPLETED|Overall Study||2||
59679015|NCT01229176|75798271|FG005|NOT COMPLETED|Overall Study||2||
59679016|NCT01229176|75798272|FG006|NOT COMPLETED|Overall Study||0||
59679017|NCT01229176|75798273|FG007|NOT COMPLETED|Overall Study||3||
59679018|NCT01228747|75798293|FG000|STARTED|Overall Study||125||
59679019|NCT01228747|75798294|FG001|STARTED|Overall Study||126||
59679020|NCT01228747|75798293|FG000|COMPLETED|Overall Study||60||
59679021|NCT01228747|75798294|FG001|COMPLETED|Overall Study||81||
59679022|NCT01228747|75798293|FG000|NOT COMPLETED|Overall Study||65||
59679023|NCT01228747|75798294|FG001|NOT COMPLETED|Overall Study||45||
59679024|NCT01228591|75798300|FG000|STARTED|Baseline||18||
59679025|NCT01228591|75798301|FG001|STARTED|Baseline||18||
59679026|NCT01228591|75798300|FG000|COMPLETED|Baseline||17||
59679027|NCT01228591|75798301|FG001|COMPLETED|Baseline||16||
59679028|NCT01228591|75798300|FG000|NOT COMPLETED|Baseline||1||
59679029|NCT01228591|75798301|FG001|NOT COMPLETED|Baseline||2||
59679030|NCT01228591|75798300|FG000|STARTED|1-Week Follow-Up||17||
59679031|NCT01228591|75798301|FG001|STARTED|1-Week Follow-Up||16||
59679032|NCT01228591|75798300|FG000|COMPLETED|1-Week Follow-Up||17||
59679033|NCT01228591|75798301|FG001|COMPLETED|1-Week Follow-Up||16||
59679034|NCT01228591|75798300|FG000|NOT COMPLETED|1-Week Follow-Up||0||
59679035|NCT01228591|75798301|FG001|NOT COMPLETED|1-Week Follow-Up||0||
59679036|NCT01228591|75798300|FG000|STARTED|Final Visit||17||
59679037|NCT01228591|75798301|FG001|STARTED|Final Visit||16||
59679038|NCT01228591|75798300|FG000|COMPLETED|Final Visit||17||
59679039|NCT01228591|75798301|FG001|COMPLETED|Final Visit||16||
59679040|NCT01228591|75798300|FG000|NOT COMPLETED|Final Visit||0||
59679041|NCT01228591|75798301|FG001|NOT COMPLETED|Final Visit||0||
59679042|NCT01235338|75798313|FG000|STARTED|Overall Study||42||
59679043|NCT01235338|75798314|FG001|STARTED|Overall Study||38||
59679044|NCT01235338|75798313|FG000|COMPLETED|Overall Study||31||
59679045|NCT01235338|75798314|FG001|COMPLETED|Overall Study||33||
59679046|NCT01235338|75798313|FG000|NOT COMPLETED|Overall Study||11||
59679047|NCT01235338|75798314|FG001|NOT COMPLETED|Overall Study||5||
59679048|NCT01234675|75798322|FG000|STARTED|First Intervention (6 Weeks)||10||
59679049|NCT01234675|75798323|FG001|STARTED|First Intervention (6 Weeks)||9||
59679050|NCT01234675|75798322|FG000|COMPLETED|First Intervention (6 Weeks)||9||
59679051|NCT01234675|75798323|FG001|COMPLETED|First Intervention (6 Weeks)||8||
59679052|NCT01234675|75798322|FG000|NOT COMPLETED|First Intervention (6 Weeks)||1||
59679053|NCT01234675|75798323|FG001|NOT COMPLETED|First Intervention (6 Weeks)||1||
59679054|NCT01234675|75798322|FG000|STARTED|Second Intervention (6 Weeks)||9||
59679055|NCT01234675|75798323|FG001|STARTED|Second Intervention (6 Weeks)||8||
59679056|NCT01234675|75798322|FG000|COMPLETED|Second Intervention (6 Weeks)||7||
59679057|NCT01234675|75798323|FG001|COMPLETED|Second Intervention (6 Weeks)||8||
59679058|NCT01234675|75798322|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||2||
59679059|NCT01234675|75798323|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||0||
59679060|NCT01228318|75798331|FG000|STARTED|Overall Study||34||
59679061|NCT01228318|75798332|FG001|STARTED|Overall Study||29||
59679062|NCT01228318|75798331|FG000|COMPLETED|Overall Study||30||
59679063|NCT01228318|75798332|FG001|COMPLETED|Overall Study||22||
59679064|NCT01228318|75798331|FG000|NOT COMPLETED|Overall Study||4||
59679065|NCT01228318|75798332|FG001|NOT COMPLETED|Overall Study||7||
59679066|NCT01227967|75798340|FG000|STARTED|Overall Study||314||
59679067|NCT01227967|75798341|FG001|STARTED|Overall Study||316||
59679068|NCT01227967|75798340|FG000|COMPLETED|Overall Study||298|Results were through database cutoff (10 November 2016) for efficacy analysis (through Day 28 visit)|
59679069|NCT01227967|75798341|FG001|COMPLETED|Overall Study||303|Results were through database cutoff (10 November 2016) for efficacy analysis (through Day 28 visit)|
59679070|NCT01227967|75798340|FG000|NOT COMPLETED|Overall Study||16||
59679071|NCT01227967|75798341|FG001|NOT COMPLETED|Overall Study||13||
59679072|NCT01227928|75798349|FG000|STARTED|Overall Study||72||
59679073|NCT01227928|75798350|FG001|STARTED|Overall Study||73||
59679074|NCT01227928|75798349|FG000|COMPLETED|Overall Study||50||
59679075|NCT01227928|75798350|FG001|COMPLETED|Overall Study||56||
59679076|NCT01227928|75798349|FG000|NOT COMPLETED|Overall Study||22||
59679077|NCT01227928|75798350|FG001|NOT COMPLETED|Overall Study||17||
59679078|NCT01227889|75798358|FG000|STARTED|Randomized Phase (RP)||187||
59679079|NCT01227889|75798359|FG001|STARTED|Randomized Phase (RP)||63||
59679080|NCT01227889|75798358|FG000|COMPLETED|Randomized Phase (RP)||0||
59679081|NCT01227889|75798359|FG001|COMPLETED|Randomized Phase (RP)||0||
59679082|NCT01227889|75798358|FG000|NOT COMPLETED|Randomized Phase (RP)||187||
59679083|NCT01227889|75798359|FG001|NOT COMPLETED|Randomized Phase (RP)||63||
59679084|NCT01227889|75798358|FG000|STARTED|Crossover Phase||0||
59679085|NCT01227889|75798359|FG001|STARTED|Crossover Phase|As of the data cut on December 18, 2012, 36 of 63 participants crossed over from DTIC to GSK2118436.|37||
59679086|NCT01227889|75798358|FG000|COMPLETED|Crossover Phase||0||
59679087|NCT01227889|75798359|FG001|COMPLETED|Crossover Phase||0||
59679088|NCT01227889|75798358|FG000|NOT COMPLETED|Crossover Phase||0||
59679089|NCT01227889|75798359|FG001|NOT COMPLETED|Crossover Phase||37||
59679090|NCT01227577|75798373|FG000|STARTED|Overall Study||128||
59679091|NCT01227577|75798373|FG000|COMPLETED|Overall Study||93||
59679092|NCT01227577|75798373|FG000|NOT COMPLETED|Overall Study||35||
59679093|NCT04634903|75798380|FG000|STARTED|Overall Study||818||
59679094|NCT04634903|75798381|FG001|STARTED|Overall Study||821||
59679095|NCT04634903|75798382|FG002|STARTED|Overall Study||813||
59679096|NCT04634903|75798380|FG000|COMPLETED|Overall Study||669||
59679097|NCT04634903|75798381|FG001|COMPLETED|Overall Study||732||
59679098|NCT04634903|75798382|FG002|COMPLETED|Overall Study||653||
59679099|NCT04634903|75798380|FG000|NOT COMPLETED|Overall Study||149||
59679100|NCT04634903|75798381|FG001|NOT COMPLETED|Overall Study||89||
59679101|NCT04634903|75798382|FG002|NOT COMPLETED|Overall Study||160||
59679102|NCT01227421|75798393|FG000|STARTED|Overall Study||201||
59679103|NCT01227421|75798394|FG001|STARTED|Overall Study||212||
59679104|NCT01227421|75798395|FG002|STARTED|Overall Study||211||
59679105|NCT01227421|75798393|FG000|COMPLETED|Overall Study||190||
59679106|NCT01227421|75798394|FG001|COMPLETED|Overall Study||194||
59679107|NCT01227421|75798395|FG002|COMPLETED|Overall Study||201||
59679108|NCT01227421|75798393|FG000|NOT COMPLETED|Overall Study||11||
59679109|NCT01227421|75798394|FG001|NOT COMPLETED|Overall Study||18||
59679110|NCT01227421|75798395|FG002|NOT COMPLETED|Overall Study||10||
59679111|NCT01227265|75798406|FG000|STARTED|Overall Study||158||
59679112|NCT01227265|75798407|FG001|STARTED|Overall Study||159||
59679113|NCT01227265|75798408|FG002|STARTED|Overall Study||159||
59679114|NCT01227265|75798406|FG000|Treated|Overall Study||157||
59679115|NCT01227265|75798407|FG001|Treated|Overall Study||157||
59679116|NCT01227265|75798408|FG002|Treated|Overall Study||159||
59679117|NCT01227265|75798406|FG000|COMPLETED|Overall Study||139||
59679118|NCT01227265|75798407|FG001|COMPLETED|Overall Study||139||
59679119|NCT01227265|75798408|FG002|COMPLETED|Overall Study||145||
59679120|NCT01227265|75798406|FG000|NOT COMPLETED|Overall Study||19||
59679121|NCT01227265|75798407|FG001|NOT COMPLETED|Overall Study||20||
59679122|NCT01227265|75798408|FG002|NOT COMPLETED|Overall Study||14||
59679123|NCT01226095|75798416|FG000|STARTED|Overall Study||519||
59679124|NCT01226095|75798416|FG000|COMPLETED|Overall Study||518||
59679125|NCT01226095|75798416|FG000|NOT COMPLETED|Overall Study||1||
59679126|NCT01225822|75798432|FG000|STARTED|Overall Study||389||
59679127|NCT01225822|75798433|FG001|STARTED|Overall Study||390||
59679128|NCT01225822|75798434|FG002|STARTED|Overall Study||393||
59679129|NCT01225822|75798435|FG003|STARTED|Overall Study||385||
59679130|NCT01225822|75798436|FG004|STARTED|Overall Study||392||
59679131|NCT01225822|75798432|FG000|COMPLETED|Overall Study||351||
59679132|NCT01225822|75798433|FG001|COMPLETED|Overall Study||334||
59679133|NCT01225822|75798434|FG002|COMPLETED|Overall Study||355||
59679134|NCT01225822|75798435|FG003|COMPLETED|Overall Study||333||
59679135|NCT01225822|75798436|FG004|COMPLETED|Overall Study||361||
59679136|NCT01225822|75798432|FG000|NOT COMPLETED|Overall Study||38||
59679137|NCT01225822|75798433|FG001|NOT COMPLETED|Overall Study||56||
59679138|NCT01225822|75798434|FG002|NOT COMPLETED|Overall Study||38||
59679139|NCT01225822|75798435|FG003|NOT COMPLETED|Overall Study||52||
59679140|NCT01225822|75798436|FG004|NOT COMPLETED|Overall Study||31||
59679141|NCT01225549|75798451|FG000|STARTED|Period 1 - First Treatment Period||1||
59679142|NCT01225549|75798452|FG001|STARTED|Period 1 - First Treatment Period||4||
59679143|NCT01225549|75798453|FG002|STARTED|Period 1 - First Treatment Period||3||
59679144|NCT01225549|75798454|FG003|STARTED|Period 1 - First Treatment Period||1||
59679145|NCT01225549|75798455|FG004|STARTED|Period 1 - First Treatment Period||1||
59679146|NCT01225549|75798456|FG005|STARTED|Period 1 - First Treatment Period||1||
59679147|NCT01225549|75798457|FG006|STARTED|Period 1 - First Treatment Period||3||
59679148|NCT01225549|75798458|FG007|STARTED|Period 1 - First Treatment Period||1||
59679149|NCT01225549|75798459|FG008|STARTED|Period 1 - First Treatment Period||4||
59679150|NCT01225549|75798460|FG009|STARTED|Period 1 - First Treatment Period||1||
59679151|NCT01225549|75798451|FG000|COMPLETED|Period 1 - First Treatment Period||1||
59679152|NCT01225549|75798452|FG001|COMPLETED|Period 1 - First Treatment Period||4||
59679153|NCT01225549|75798453|FG002|COMPLETED|Period 1 - First Treatment Period||3||
59679154|NCT01225549|75798454|FG003|COMPLETED|Period 1 - First Treatment Period||1||
59679155|NCT01225549|75798455|FG004|COMPLETED|Period 1 - First Treatment Period||1||
59679156|NCT01225549|75798456|FG005|COMPLETED|Period 1 - First Treatment Period||1||
59679157|NCT01225549|75798457|FG006|COMPLETED|Period 1 - First Treatment Period||3||
59679158|NCT01225549|75798458|FG007|COMPLETED|Period 1 - First Treatment Period||1||
59679159|NCT01225549|75798459|FG008|COMPLETED|Period 1 - First Treatment Period||4||
59679160|NCT01225549|75798460|FG009|COMPLETED|Period 1 - First Treatment Period||1||
59679161|NCT01225549|75798451|FG000|NOT COMPLETED|Period 1 - First Treatment Period||0||
59679162|NCT01225549|75798452|FG001|NOT COMPLETED|Period 1 - First Treatment Period||0||
59679163|NCT01225549|75798453|FG002|NOT COMPLETED|Period 1 - First Treatment Period||0||
59679164|NCT01225549|75798454|FG003|NOT COMPLETED|Period 1 - First Treatment Period||0||
59679165|NCT01225549|75798455|FG004|NOT COMPLETED|Period 1 - First Treatment Period||0||
59679166|NCT01225549|75798456|FG005|NOT COMPLETED|Period 1 - First Treatment Period||0||
59679167|NCT01225549|75798457|FG006|NOT COMPLETED|Period 1 - First Treatment Period||0||
59679168|NCT01225549|75798458|FG007|NOT COMPLETED|Period 1 - First Treatment Period||0||
59679169|NCT01225549|75798459|FG008|NOT COMPLETED|Period 1 - First Treatment Period||0||
59679170|NCT01225549|75798460|FG009|NOT COMPLETED|Period 1 - First Treatment Period||0||
59679171|NCT01225549|75798451|FG000|STARTED|Period 2 - Washout||1||
59679172|NCT01225549|75798452|FG001|STARTED|Period 2 - Washout||4||
59679173|NCT01225549|75798453|FG002|STARTED|Period 2 - Washout||3||
59679174|NCT01225549|75798454|FG003|STARTED|Period 2 - Washout||1||
59679175|NCT01225549|75798455|FG004|STARTED|Period 2 - Washout||1||
59679176|NCT01225549|75798456|FG005|STARTED|Period 2 - Washout||1||
59679177|NCT01225549|75798457|FG006|STARTED|Period 2 - Washout||3||
59679178|NCT01225549|75798458|FG007|STARTED|Period 2 - Washout||1||
59679179|NCT01225549|75798459|FG008|STARTED|Period 2 - Washout||4||
59679180|NCT01225549|75798460|FG009|STARTED|Period 2 - Washout||1||
59679181|NCT01225549|75798451|FG000|COMPLETED|Period 2 - Washout||1||
59679182|NCT01225549|75798452|FG001|COMPLETED|Period 2 - Washout||4||
59679183|NCT01225549|75798453|FG002|COMPLETED|Period 2 - Washout||3||
59679184|NCT01225549|75798454|FG003|COMPLETED|Period 2 - Washout||1||
59679185|NCT01225549|75798455|FG004|COMPLETED|Period 2 - Washout||1||
59679186|NCT01225549|75798456|FG005|COMPLETED|Period 2 - Washout||1||
59679187|NCT01225549|75798457|FG006|COMPLETED|Period 2 - Washout||3||
59679188|NCT01225549|75798458|FG007|COMPLETED|Period 2 - Washout||1||
59679189|NCT01225549|75798459|FG008|COMPLETED|Period 2 - Washout||4||
59679190|NCT01225549|75798460|FG009|COMPLETED|Period 2 - Washout||1||
59679191|NCT01225549|75798451|FG000|NOT COMPLETED|Period 2 - Washout||0||
59679192|NCT01225549|75798452|FG001|NOT COMPLETED|Period 2 - Washout||0||
59679193|NCT01225549|75798453|FG002|NOT COMPLETED|Period 2 - Washout||0||
59679194|NCT01225549|75798454|FG003|NOT COMPLETED|Period 2 - Washout||0||
59679195|NCT01225549|75798455|FG004|NOT COMPLETED|Period 2 - Washout||0||
59679196|NCT01225549|75798456|FG005|NOT COMPLETED|Period 2 - Washout||0||
59679197|NCT01225549|75798457|FG006|NOT COMPLETED|Period 2 - Washout||0||
59679198|NCT01225549|75798458|FG007|NOT COMPLETED|Period 2 - Washout||0||
59679199|NCT01225549|75798459|FG008|NOT COMPLETED|Period 2 - Washout||0||
59679200|NCT01225549|75798460|FG009|NOT COMPLETED|Period 2 - Washout||0||
59679201|NCT01225549|75798451|FG000|STARTED|Period 3 - Second Treatment Period||1||
59679202|NCT01225549|75798452|FG001|STARTED|Period 3 - Second Treatment Period||4||
59679203|NCT01225549|75798453|FG002|STARTED|Period 3 - Second Treatment Period||3||
59679204|NCT01225549|75798454|FG003|STARTED|Period 3 - Second Treatment Period||1||
59679205|NCT01225549|75798455|FG004|STARTED|Period 3 - Second Treatment Period||1||
59679206|NCT01225549|75798456|FG005|STARTED|Period 3 - Second Treatment Period||1||
59679207|NCT01225549|75798457|FG006|STARTED|Period 3 - Second Treatment Period||3||
59679208|NCT01225549|75798458|FG007|STARTED|Period 3 - Second Treatment Period||1||
59679209|NCT01225549|75798459|FG008|STARTED|Period 3 - Second Treatment Period||4||
59679210|NCT01225549|75798460|FG009|STARTED|Period 3 - Second Treatment Period||1||
59679211|NCT01225549|75798451|FG000|COMPLETED|Period 3 - Second Treatment Period||1||
59679212|NCT01225549|75798452|FG001|COMPLETED|Period 3 - Second Treatment Period||4||
59679213|NCT01225549|75798453|FG002|COMPLETED|Period 3 - Second Treatment Period||3||
59679214|NCT01225549|75798454|FG003|COMPLETED|Period 3 - Second Treatment Period||1||
59679215|NCT01225549|75798455|FG004|COMPLETED|Period 3 - Second Treatment Period||1||
59679216|NCT01225549|75798456|FG005|COMPLETED|Period 3 - Second Treatment Period||1||
59679217|NCT01225549|75798457|FG006|COMPLETED|Period 3 - Second Treatment Period||3||
59679218|NCT01225549|75798458|FG007|COMPLETED|Period 3 - Second Treatment Period||1||
59679219|NCT01225549|75798459|FG008|COMPLETED|Period 3 - Second Treatment Period||4||
59679220|NCT01225549|75798460|FG009|COMPLETED|Period 3 - Second Treatment Period||1||
59679221|NCT01225549|75798451|FG000|NOT COMPLETED|Period 3 - Second Treatment Period||0||
59679222|NCT01225549|75798452|FG001|NOT COMPLETED|Period 3 - Second Treatment Period||0||
59679223|NCT01225549|75798453|FG002|NOT COMPLETED|Period 3 - Second Treatment Period||0||
59679224|NCT01225549|75798454|FG003|NOT COMPLETED|Period 3 - Second Treatment Period||0||
59679225|NCT01225549|75798455|FG004|NOT COMPLETED|Period 3 - Second Treatment Period||0||
59679226|NCT01225549|75798456|FG005|NOT COMPLETED|Period 3 - Second Treatment Period||0||
59679227|NCT01225549|75798457|FG006|NOT COMPLETED|Period 3 - Second Treatment Period||0||
59679228|NCT01225549|75798458|FG007|NOT COMPLETED|Period 3 - Second Treatment Period||0||
59679229|NCT01225549|75798459|FG008|NOT COMPLETED|Period 3 - Second Treatment Period||0||
59679230|NCT01225549|75798460|FG009|NOT COMPLETED|Period 3 - Second Treatment Period||0||
59679231|NCT01225549|75798451|FG000|STARTED|Period 4 - Washout||1||
59679232|NCT01225549|75798452|FG001|STARTED|Period 4 - Washout||4||
59679233|NCT01225549|75798453|FG002|STARTED|Period 4 - Washout||3||
59679234|NCT01225549|75798454|FG003|STARTED|Period 4 - Washout||1||
59679235|NCT01225549|75798455|FG004|STARTED|Period 4 - Washout||1||
59815954|NCT00531050|75938373|FG000|NOT COMPLETED|Part 1: Period 1||0||
59815955|NCT00531050|75938374|FG001|NOT COMPLETED|Part 1: Period 1||1||
59679236|NCT01225549|75798456|FG005|STARTED|Period 4 - Washout||1||
59679237|NCT01225549|75798457|FG006|STARTED|Period 4 - Washout||3||
59679238|NCT01225549|75798458|FG007|STARTED|Period 4 - Washout||1||
59679239|NCT01225549|75798459|FG008|STARTED|Period 4 - Washout||4||
59679240|NCT01225549|75798460|FG009|STARTED|Period 4 - Washout||1||
59679241|NCT01225549|75798451|FG000|COMPLETED|Period 4 - Washout||1||
59679242|NCT01225549|75798452|FG001|COMPLETED|Period 4 - Washout||3||
59679243|NCT01225549|75798453|FG002|COMPLETED|Period 4 - Washout||3||
59679244|NCT01225549|75798454|FG003|COMPLETED|Period 4 - Washout||1||
60078094|NCT02090374|76193107|FG006|NOT COMPLETED|Overall Study||0||
60078095|NCT02090374|76193108|FG007|NOT COMPLETED|Overall Study||0||
59679245|NCT01225549|75798455|FG004|COMPLETED|Period 4 - Washout||1||
59679246|NCT01225549|75798456|FG005|COMPLETED|Period 4 - Washout||1||
59679247|NCT01225549|75798457|FG006|COMPLETED|Period 4 - Washout||3||
59679248|NCT01225549|75798458|FG007|COMPLETED|Period 4 - Washout||1||
59679249|NCT01225549|75798459|FG008|COMPLETED|Period 4 - Washout||4||
59679250|NCT01225549|75798460|FG009|COMPLETED|Period 4 - Washout||1||
59679251|NCT01225549|75798451|FG000|NOT COMPLETED|Period 4 - Washout||0||
59679252|NCT01225549|75798452|FG001|NOT COMPLETED|Period 4 - Washout||1||
59679253|NCT01225549|75798453|FG002|NOT COMPLETED|Period 4 - Washout||0||
59679254|NCT01225549|75798454|FG003|NOT COMPLETED|Period 4 - Washout||0||
59679255|NCT01225549|75798455|FG004|NOT COMPLETED|Period 4 - Washout||0||
59679256|NCT01225549|75798456|FG005|NOT COMPLETED|Period 4 - Washout||0||
59679257|NCT01225549|75798457|FG006|NOT COMPLETED|Period 4 - Washout||0||
59679258|NCT01225549|75798458|FG007|NOT COMPLETED|Period 4 - Washout||0||
59679259|NCT01225549|75798459|FG008|NOT COMPLETED|Period 4 - Washout||0||
59679260|NCT01225549|75798460|FG009|NOT COMPLETED|Period 4 - Washout||0||
59679261|NCT01225549|75798451|FG000|STARTED|Period 5 - Third Treatment Period||1||
59679262|NCT01225549|75798452|FG001|STARTED|Period 5 - Third Treatment Period||3||
59679263|NCT01225549|75798453|FG002|STARTED|Period 5 - Third Treatment Period||3||
59679264|NCT01225549|75798454|FG003|STARTED|Period 5 - Third Treatment Period||1||
59679265|NCT01225549|75798455|FG004|STARTED|Period 5 - Third Treatment Period||1||
59679266|NCT01225549|75798456|FG005|STARTED|Period 5 - Third Treatment Period||1||
59679267|NCT01225549|75798457|FG006|STARTED|Period 5 - Third Treatment Period||3||
59679268|NCT01225549|75798458|FG007|STARTED|Period 5 - Third Treatment Period||1||
59679269|NCT01225549|75798459|FG008|STARTED|Period 5 - Third Treatment Period||4||
59679270|NCT01225549|75798460|FG009|STARTED|Period 5 - Third Treatment Period||1||
59679271|NCT01225549|75798451|FG000|COMPLETED|Period 5 - Third Treatment Period||1||
59679272|NCT01225549|75798452|FG001|COMPLETED|Period 5 - Third Treatment Period||3||
59679273|NCT01225549|75798453|FG002|COMPLETED|Period 5 - Third Treatment Period||3||
59679274|NCT01225549|75798454|FG003|COMPLETED|Period 5 - Third Treatment Period||1||
59679275|NCT01225549|75798455|FG004|COMPLETED|Period 5 - Third Treatment Period||1||
59679276|NCT01225549|75798456|FG005|COMPLETED|Period 5 - Third Treatment Period||1||
59679277|NCT01225549|75798457|FG006|COMPLETED|Period 5 - Third Treatment Period||3||
59679278|NCT01225549|75798458|FG007|COMPLETED|Period 5 - Third Treatment Period||1||
59679279|NCT01225549|75798459|FG008|COMPLETED|Period 5 - Third Treatment Period||4||
59679280|NCT01225549|75798460|FG009|COMPLETED|Period 5 - Third Treatment Period||1||
59679281|NCT01225549|75798451|FG000|NOT COMPLETED|Period 5 - Third Treatment Period||0||
59679282|NCT01225549|75798452|FG001|NOT COMPLETED|Period 5 - Third Treatment Period||0||
59679283|NCT01225549|75798453|FG002|NOT COMPLETED|Period 5 - Third Treatment Period||0||
59679284|NCT01225549|75798454|FG003|NOT COMPLETED|Period 5 - Third Treatment Period||0||
59679285|NCT01225549|75798455|FG004|NOT COMPLETED|Period 5 - Third Treatment Period||0||
59679286|NCT01225549|75798456|FG005|NOT COMPLETED|Period 5 - Third Treatment Period||0||
59679287|NCT01225549|75798457|FG006|NOT COMPLETED|Period 5 - Third Treatment Period||0||
59679288|NCT01225549|75798458|FG007|NOT COMPLETED|Period 5 - Third Treatment Period||0||
59679289|NCT01225549|75798459|FG008|NOT COMPLETED|Period 5 - Third Treatment Period||0||
59679290|NCT01225549|75798460|FG009|NOT COMPLETED|Period 5 - Third Treatment Period||0||
59679291|NCT01225549|75798451|FG000|STARTED|Period 6 - Washout||1||
59679292|NCT01225549|75798452|FG001|STARTED|Period 6 - Washout||3||
59679293|NCT01225549|75798453|FG002|STARTED|Period 6 - Washout||3||
59679294|NCT01225549|75798454|FG003|STARTED|Period 6 - Washout||1||
59679295|NCT01225549|75798455|FG004|STARTED|Period 6 - Washout||1||
59679296|NCT01225549|75798456|FG005|STARTED|Period 6 - Washout||1||
59679297|NCT01225549|75798457|FG006|STARTED|Period 6 - Washout||3||
59679298|NCT01225549|75798458|FG007|STARTED|Period 6 - Washout||1||
60078096|NCT04773028|76193128|FG000|STARTED|Overall Study||24||
60078097|NCT04773028|76193129|FG001|STARTED|Overall Study||24||
60078098|NCT04773028|76193128|FG000|COMPLETED|Overall Study||24||
60078099|NCT04773028|76193129|FG001|COMPLETED|Overall Study||24||
59679299|NCT01225549|75798459|FG008|STARTED|Period 6 - Washout||4||
59679300|NCT01225549|75798460|FG009|STARTED|Period 6 - Washout||1||
59679301|NCT01225549|75798451|FG000|COMPLETED|Period 6 - Washout||1||
59679302|NCT01225549|75798452|FG001|COMPLETED|Period 6 - Washout||3||
59679303|NCT01225549|75798453|FG002|COMPLETED|Period 6 - Washout||3||
59679304|NCT01225549|75798454|FG003|COMPLETED|Period 6 - Washout||0||
59679305|NCT01225549|75798455|FG004|COMPLETED|Period 6 - Washout||1||
59679306|NCT01225549|75798456|FG005|COMPLETED|Period 6 - Washout||1||
59679307|NCT01225549|75798457|FG006|COMPLETED|Period 6 - Washout||3||
59679308|NCT01225549|75798458|FG007|COMPLETED|Period 6 - Washout||1||
59679309|NCT01225549|75798459|FG008|COMPLETED|Period 6 - Washout||4||
59679310|NCT01225549|75798460|FG009|COMPLETED|Period 6 - Washout||1||
59679311|NCT01225549|75798451|FG000|NOT COMPLETED|Period 6 - Washout||0||
59679312|NCT01225549|75798452|FG001|NOT COMPLETED|Period 6 - Washout||0||
59679313|NCT01225549|75798453|FG002|NOT COMPLETED|Period 6 - Washout||0||
59679314|NCT01225549|75798454|FG003|NOT COMPLETED|Period 6 - Washout||1||
59679315|NCT01225549|75798455|FG004|NOT COMPLETED|Period 6 - Washout||0||
59679316|NCT01225549|75798456|FG005|NOT COMPLETED|Period 6 - Washout||0||
59679317|NCT01225549|75798457|FG006|NOT COMPLETED|Period 6 - Washout||0||
59679318|NCT01225549|75798458|FG007|NOT COMPLETED|Period 6 - Washout||0||
59679319|NCT01225549|75798459|FG008|NOT COMPLETED|Period 6 - Washout||0||
59679320|NCT01225549|75798460|FG009|NOT COMPLETED|Period 6 - Washout||0||
59679321|NCT01225549|75798451|FG000|STARTED|Period 7 - Fourth Treatment Period||1||
59679322|NCT01225549|75798452|FG001|STARTED|Period 7 - Fourth Treatment Period||3||
59679323|NCT01225549|75798453|FG002|STARTED|Period 7 - Fourth Treatment Period||3||
59679324|NCT01225549|75798454|FG003|STARTED|Period 7 - Fourth Treatment Period||0||
59679325|NCT01225549|75798455|FG004|STARTED|Period 7 - Fourth Treatment Period||1||
59679326|NCT01225549|75798456|FG005|STARTED|Period 7 - Fourth Treatment Period||1||
59679327|NCT01225549|75798457|FG006|STARTED|Period 7 - Fourth Treatment Period||3||
59679328|NCT01225549|75798458|FG007|STARTED|Period 7 - Fourth Treatment Period||1||
59679329|NCT01225549|75798459|FG008|STARTED|Period 7 - Fourth Treatment Period||4||
59679330|NCT01225549|75798460|FG009|STARTED|Period 7 - Fourth Treatment Period||1||
59679331|NCT01225549|75798451|FG000|COMPLETED|Period 7 - Fourth Treatment Period||1||
59679332|NCT01225549|75798452|FG001|COMPLETED|Period 7 - Fourth Treatment Period||3||
59679333|NCT01225549|75798453|FG002|COMPLETED|Period 7 - Fourth Treatment Period||3||
59679334|NCT01225549|75798454|FG003|COMPLETED|Period 7 - Fourth Treatment Period||0||
59679335|NCT01225549|75798455|FG004|COMPLETED|Period 7 - Fourth Treatment Period||1||
59679336|NCT01225549|75798456|FG005|COMPLETED|Period 7 - Fourth Treatment Period||1||
59679337|NCT01225549|75798457|FG006|COMPLETED|Period 7 - Fourth Treatment Period||3||
59679338|NCT01225549|75798458|FG007|COMPLETED|Period 7 - Fourth Treatment Period||1||
59679339|NCT01225549|75798459|FG008|COMPLETED|Period 7 - Fourth Treatment Period||4||
59679340|NCT01225549|75798460|FG009|COMPLETED|Period 7 - Fourth Treatment Period||1||
59679341|NCT01225549|75798451|FG000|NOT COMPLETED|Period 7 - Fourth Treatment Period||0||
59679342|NCT01225549|75798452|FG001|NOT COMPLETED|Period 7 - Fourth Treatment Period||0||
59679343|NCT01225549|75798453|FG002|NOT COMPLETED|Period 7 - Fourth Treatment Period||0||
59679344|NCT01225549|75798454|FG003|NOT COMPLETED|Period 7 - Fourth Treatment Period||0||
59679345|NCT01225549|75798455|FG004|NOT COMPLETED|Period 7 - Fourth Treatment Period||0||
59679346|NCT01225549|75798456|FG005|NOT COMPLETED|Period 7 - Fourth Treatment Period||0||
59679347|NCT01225549|75798457|FG006|NOT COMPLETED|Period 7 - Fourth Treatment Period||0||
59679348|NCT01225549|75798458|FG007|NOT COMPLETED|Period 7 - Fourth Treatment Period||0||
59679349|NCT01225549|75798459|FG008|NOT COMPLETED|Period 7 - Fourth Treatment Period||0||
59679350|NCT01225549|75798460|FG009|NOT COMPLETED|Period 7 - Fourth Treatment Period||0||
59679351|NCT01225159|75798472|FG000|STARTED|Overall Study||100||
59679352|NCT01225159|75798473|FG001|STARTED|Overall Study||100||
59679353|NCT01225159|75798472|FG000|COMPLETED|Overall Study||99||
59679354|NCT01225159|75798473|FG001|COMPLETED|Overall Study||100||
59679355|NCT01225159|75798472|FG000|NOT COMPLETED|Overall Study||1||
59679356|NCT01225159|75798473|FG001|NOT COMPLETED|Overall Study||0||
59679357|NCT01224925|75798481|FG000|STARTED|Overall Study||37||
59679358|NCT01224925|75798482|FG001|STARTED|Overall Study||33||
59679359|NCT01224925|75798481|FG000|COMPLETED|Overall Study||34||
59679360|NCT01224925|75798482|FG001|COMPLETED|Overall Study||31||
59679361|NCT01224925|75798481|FG000|NOT COMPLETED|Overall Study||3||
59679362|NCT01224925|75798482|FG001|NOT COMPLETED|Overall Study||2||
59679363|NCT01223404|75798490|FG000|STARTED|First Intervention (1 Day)||4||
59679364|NCT01223404|75798491|FG001|STARTED|First Intervention (1 Day)||3||
59679365|NCT01223404|75798492|FG002|STARTED|First Intervention (1 Day)||4||
59679366|NCT01223404|75798493|FG003|STARTED|First Intervention (1 Day)||5||
59679367|NCT01223404|75798494|FG004|STARTED|First Intervention (1 Day)||2||
59679368|NCT01223404|75798495|FG005|STARTED|First Intervention (1 Day)||3||
59679369|NCT01223404|75798490|FG000|COMPLETED|First Intervention (1 Day)||4||
59679370|NCT01223404|75798491|FG001|COMPLETED|First Intervention (1 Day)||3||
59679371|NCT01223404|75798492|FG002|COMPLETED|First Intervention (1 Day)||4||
59679372|NCT01223404|75798493|FG003|COMPLETED|First Intervention (1 Day)||4||
59679373|NCT01223404|75798494|FG004|COMPLETED|First Intervention (1 Day)||2||
59679374|NCT01223404|75798495|FG005|COMPLETED|First Intervention (1 Day)||3||
59679375|NCT01223404|75798490|FG000|NOT COMPLETED|First Intervention (1 Day)||0||
59679376|NCT01223404|75798491|FG001|NOT COMPLETED|First Intervention (1 Day)||0||
59679377|NCT01223404|75798492|FG002|NOT COMPLETED|First Intervention (1 Day)||0||
59815956|NCT00531050|75938375|FG002|NOT COMPLETED|Part 1: Period 1||0||
59546721|NCT02412618|75645381|FG000|STARTED|Overall Study||50||
59546722|NCT02412618|75645382|FG001|STARTED|Overall Study||50||
59546723|NCT02412618|75645381|FG000|COMPLETED|Overall Study||48||
59546724|NCT02412618|75645382|FG001|COMPLETED|Overall Study||48||
59546725|NCT02412618|75645381|FG000|NOT COMPLETED|Overall Study||2||
59546726|NCT02412618|75645382|FG001|NOT COMPLETED|Overall Study||2||
59546727|NCT01040858|75645390|FG000|STARTED|Overall Study||59||
59546728|NCT01040858|75645391|FG001|STARTED|Overall Study||69||
59546729|NCT01040858|75645390|FG000|COMPLETED|Overall Study||50||
59546730|NCT01040858|75645391|FG001|COMPLETED|Overall Study||69||
59546731|NCT01040858|75645390|FG000|NOT COMPLETED|Overall Study||9||
59679378|NCT01223404|75798493|FG003|NOT COMPLETED|First Intervention (1 Day)||1||
59679379|NCT01223404|75798494|FG004|NOT COMPLETED|First Intervention (1 Day)||0||
59679380|NCT01223404|75798495|FG005|NOT COMPLETED|First Intervention (1 Day)||0||
59679381|NCT01223404|75798490|FG000|STARTED|Second Intervention (1 Day)||4||
59679382|NCT01223404|75798491|FG001|STARTED|Second Intervention (1 Day)||3||
59679383|NCT01223404|75798492|FG002|STARTED|Second Intervention (1 Day)||4||
59679384|NCT01223404|75798493|FG003|STARTED|Second Intervention (1 Day)||4||
59679385|NCT01223404|75798494|FG004|STARTED|Second Intervention (1 Day)||2||
59679386|NCT01223404|75798495|FG005|STARTED|Second Intervention (1 Day)||3||
59679387|NCT01223404|75798490|FG000|COMPLETED|Second Intervention (1 Day)||3||
59679388|NCT01223404|75798491|FG001|COMPLETED|Second Intervention (1 Day)||3||
59679389|NCT01223404|75798492|FG002|COMPLETED|Second Intervention (1 Day)||4||
59679390|NCT01223404|75798493|FG003|COMPLETED|Second Intervention (1 Day)||4||
59679391|NCT01223404|75798494|FG004|COMPLETED|Second Intervention (1 Day)||2||
59679392|NCT01223404|75798495|FG005|COMPLETED|Second Intervention (1 Day)||3||
59679393|NCT01223404|75798490|FG000|NOT COMPLETED|Second Intervention (1 Day)||1||
59679394|NCT01223404|75798491|FG001|NOT COMPLETED|Second Intervention (1 Day)||0||
59679395|NCT01223404|75798492|FG002|NOT COMPLETED|Second Intervention (1 Day)||0||
59679396|NCT01223404|75798493|FG003|NOT COMPLETED|Second Intervention (1 Day)||0||
59679397|NCT01223404|75798494|FG004|NOT COMPLETED|Second Intervention (1 Day)||0||
59679398|NCT01223404|75798495|FG005|NOT COMPLETED|Second Intervention (1 Day)||0||
59679399|NCT01223404|75798490|FG000|STARTED|Third Intervention (1 Day)||3||
59679400|NCT01223404|75798491|FG001|STARTED|Third Intervention (1 Day)||3||
59679401|NCT01223404|75798492|FG002|STARTED|Third Intervention (1 Day)||4||
59679402|NCT01223404|75798493|FG003|STARTED|Third Intervention (1 Day)||4||
59679403|NCT01223404|75798494|FG004|STARTED|Third Intervention (1 Day)||2||
59679404|NCT01223404|75798495|FG005|STARTED|Third Intervention (1 Day)||3||
59679405|NCT01223404|75798490|FG000|COMPLETED|Third Intervention (1 Day)||3||
59679406|NCT01223404|75798491|FG001|COMPLETED|Third Intervention (1 Day)||3||
59679407|NCT01223404|75798492|FG002|COMPLETED|Third Intervention (1 Day)||4||
59679408|NCT01223404|75798493|FG003|COMPLETED|Third Intervention (1 Day)||3||
59679409|NCT01223404|75798494|FG004|COMPLETED|Third Intervention (1 Day)||2||
59679410|NCT01223404|75798495|FG005|COMPLETED|Third Intervention (1 Day)||3||
59679411|NCT01223404|75798490|FG000|NOT COMPLETED|Third Intervention (1 Day)||0||
59679412|NCT01223404|75798491|FG001|NOT COMPLETED|Third Intervention (1 Day)||0||
59679413|NCT01223404|75798492|FG002|NOT COMPLETED|Third Intervention (1 Day)||0||
59679414|NCT01223404|75798493|FG003|NOT COMPLETED|Third Intervention (1 Day)||1||
59679415|NCT01223404|75798494|FG004|NOT COMPLETED|Third Intervention (1 Day)||0||
59679416|NCT01223404|75798495|FG005|NOT COMPLETED|Third Intervention (1 Day)||0||
59679417|NCT04680273|75798514|FG000|STARTED|Overall Study||6||
59679418|NCT04680273|75798515|FG001|STARTED|Overall Study||5||
59679419|NCT04680273|75798516|FG002|STARTED|Overall Study||5||
59679420|NCT04680273|75798514|FG000|Part 1: Received the Planned Dose of Study Drug|Overall Study||6||
59679421|NCT04680273|75798515|FG001|Part 1: Received the Planned Dose of Study Drug|Overall Study||0||
59679422|NCT04680273|75798516|FG002|Part 1: Received the Planned Dose of Study Drug|Overall Study||0||
59679423|NCT04680273|75798514|FG000|Part 2: Received All 3 Planned Doses of Study Drug|Overall Study||0||
59679424|NCT04680273|75798515|FG001|Part 2: Received All 3 Planned Doses of Study Drug|Overall Study||5||
59679425|NCT04680273|75798516|FG002|Part 2: Received All 3 Planned Doses of Study Drug|Overall Study||5||
59679426|NCT04680273|75798514|FG000|COMPLETED|Overall Study||6||
59679427|NCT04680273|75798515|FG001|COMPLETED|Overall Study||5||
59679428|NCT04680273|75798516|FG002|COMPLETED|Overall Study||5||
59679429|NCT04680273|75798514|FG000|NOT COMPLETED|Overall Study||0||
59679430|NCT04680273|75798515|FG001|NOT COMPLETED|Overall Study||0||
59679431|NCT04680273|75798516|FG002|NOT COMPLETED|Overall Study||0||
59679432|NCT01223365|75798543|FG000|STARTED|Open-label Titration Period||330||
59679433|NCT01223365|75798543|FG000|Safety Analysis Set|Open-label Titration Period||329||
59679434|NCT01223365|75798543|FG000|Achieved Stable Pain Relief|Open-label Titration Period||294||
59679435|NCT01223365|75798543|FG000|COMPLETED|Open-label Titration Period||291||
59679436|NCT01223365|75798543|FG000|NOT COMPLETED|Open-label Titration Period||39||
59679437|NCT01223365|75798543|FG000|STARTED|Open-label Treatment Period||291||
59679438|NCT01223365|75798543|FG000|COMPLETED|Open-label Treatment Period||189||
59679439|NCT01223365|75798543|FG000|NOT COMPLETED|Open-label Treatment Period||102||
59679440|NCT01222507|75798552|FG000|STARTED|Overall Study||62||
59679441|NCT01222507|75798552|FG000|COMPLETED|Overall Study||60||
59679442|NCT01222507|75798552|FG000|NOT COMPLETED|Overall Study||2||
59679443|NCT01222078|75798556|FG000|STARTED|Overall Study||1||
59679444|NCT01222078|75798556|FG000|COMPLETED|Overall Study||0||
59679445|NCT01222078|75798556|FG000|NOT COMPLETED|Overall Study||1||
59679446|NCT01221727|75798563|FG000|STARTED|Overall Study|Number of subjects randomized into the study|21||
59679447|NCT01221727|75798564|FG001|STARTED|Overall Study|Number of subjects randomized into the study|9||
59679448|NCT01221727|75798563|FG000|Treated|Overall Study|Number of subjects received investigational product|19||
59679449|NCT01221727|75798564|FG001|Treated|Overall Study|Number of subjects received investigational product|8||
59679450|NCT01221727|75798563|FG000|COMPLETED|Overall Study||18||
59679451|NCT01221727|75798564|FG001|COMPLETED|Overall Study||8||
59679452|NCT01221727|75798563|FG000|NOT COMPLETED|Overall Study||3||
59679453|NCT01221727|75798564|FG001|NOT COMPLETED|Overall Study||1||
59679454|NCT01221181|75798576|FG000|STARTED|Overall Study||6||
59679455|NCT01221181|75798576|FG000|COMPLETED|Overall Study||5||
59679456|NCT01221181|75798576|FG000|NOT COMPLETED|Overall Study||1||
59679457|NCT01220557|75798582|FG000|STARTED|Overall Study||81||
59679458|NCT01220557|75798583|FG001|STARTED|Overall Study||79||
59679459|NCT01220557|75798582|FG000|COMPLETED|Overall Study|per protocol analysis including patients which participated in at least 6 out of 12 lessons.|75||
59679460|NCT01220557|75798583|FG001|COMPLETED|Overall Study|per protocol analysis including patients which participated in at least 6 out of 12 lessons.|74||
59679461|NCT01220557|75798582|FG000|NOT COMPLETED|Overall Study||6||
59679462|NCT01220557|75798583|FG001|NOT COMPLETED|Overall Study||5||
59679463|NCT01220401|75798589|FG000|STARTED|Overall Study||21||
59679464|NCT01220401|75798589|FG000|COMPLETED|Overall Study||18||
59679465|NCT01220401|75798589|FG000|NOT COMPLETED|Overall Study||3||
59679466|NCT01220167|75798596|FG000|STARTED|Period 1||6||
59679467|NCT01220167|75798597|FG001|STARTED|Period 1||6||
59679468|NCT01220167|75798598|FG002|STARTED|Period 1||6||
59679469|NCT01220167|75798596|FG000|COMPLETED|Period 1||6||
59679470|NCT01220167|75798597|FG001|COMPLETED|Period 1||6||
59679471|NCT01220167|75798598|FG002|COMPLETED|Period 1||6||
59679472|NCT01220167|75798596|FG000|NOT COMPLETED|Period 1||0||
59679473|NCT01220167|75798597|FG001|NOT COMPLETED|Period 1||0||
59679474|NCT01220167|75798598|FG002|NOT COMPLETED|Period 1||0||
59679475|NCT01220167|75798596|FG000|STARTED|Period 2||6||
59679476|NCT01220167|75798597|FG001|STARTED|Period 2||6||
59679477|NCT01220167|75798598|FG002|STARTED|Period 2||6||
59679478|NCT01220167|75798596|FG000|COMPLETED|Period 2||6||
59679479|NCT01220167|75798597|FG001|COMPLETED|Period 2||6||
59679480|NCT01220167|75798598|FG002|COMPLETED|Period 2||6||
59679481|NCT01220167|75798596|FG000|NOT COMPLETED|Period 2||0||
59679482|NCT01220167|75798597|FG001|NOT COMPLETED|Period 2||0||
59679483|NCT01220167|75798598|FG002|NOT COMPLETED|Period 2||0||
59679484|NCT01220167|75798596|FG000|STARTED|Period 3||6||
59679485|NCT01220167|75798597|FG001|STARTED|Period 3||6||
59679486|NCT01220167|75798598|FG002|STARTED|Period 3||6||
59679487|NCT01220167|75798596|FG000|COMPLETED|Period 3||6||
59679488|NCT01220167|75798597|FG001|COMPLETED|Period 3||5||
59679489|NCT01220167|75798598|FG002|COMPLETED|Period 3||6||
59679490|NCT01220167|75798596|FG000|NOT COMPLETED|Period 3||0||
59679491|NCT01220167|75798597|FG001|NOT COMPLETED|Period 3||1||
59679492|NCT01220167|75798598|FG002|NOT COMPLETED|Period 3||0||
59679493|NCT01220128|75798611|FG000|STARTED|Overall Study||15||
59679494|NCT01220128|75798612|FG001|STARTED|Overall Study||7||
59679495|NCT01220128|75798613|FG002|STARTED|Overall Study||9||
59679496|NCT01220128|75798614|FG003|STARTED|Overall Study||6||
59679497|NCT01220128|75798615|FG004|STARTED|Overall Study||11||
59679498|NCT01220128|75798616|FG005|STARTED|Overall Study||4||
59679499|NCT01220128|75798617|FG006|STARTED|Overall Study||8||
59679500|NCT01220128|75798611|FG000|COMPLETED|Overall Study||11||
59679501|NCT01220128|75798612|FG001|COMPLETED|Overall Study||6||
59679502|NCT01220128|75798613|FG002|COMPLETED|Overall Study||6||
59679503|NCT01220128|75798614|FG003|COMPLETED|Overall Study||6||
59679504|NCT01220128|75798615|FG004|COMPLETED|Overall Study||11||
59679505|NCT01220128|75798616|FG005|COMPLETED|Overall Study||4||
59679506|NCT01220128|75798617|FG006|COMPLETED|Overall Study||3||
59679507|NCT01220128|75798611|FG000|NOT COMPLETED|Overall Study||4||
59679508|NCT01220128|75798612|FG001|NOT COMPLETED|Overall Study||1||
59679509|NCT01220128|75798613|FG002|NOT COMPLETED|Overall Study||3||
59679510|NCT01220128|75798614|FG003|NOT COMPLETED|Overall Study||0||
59679511|NCT01220128|75798615|FG004|NOT COMPLETED|Overall Study||0||
59679512|NCT01220128|75798616|FG005|NOT COMPLETED|Overall Study||0||
59679513|NCT01220128|75798617|FG006|NOT COMPLETED|Overall Study||5||
59679514|NCT01219933|75798634|FG000|STARTED|Overall Study||68||
59679515|NCT01219933|75798634|FG000|COMPLETED|Overall Study||30||
59679516|NCT01219933|75798634|FG000|NOT COMPLETED|Overall Study||38||
59679517|NCT01218802|75798641|FG000|STARTED|Overall Study||72||
59679518|NCT01218802|75798642|FG001|STARTED|Overall Study||75||
59679519|NCT01218802|75798641|FG000|COMPLETED|Overall Study||62||
59679520|NCT01218802|75798642|FG001|COMPLETED|Overall Study||57||
59679521|NCT01218802|75798641|FG000|NOT COMPLETED|Overall Study||10||
59679522|NCT01218802|75798642|FG001|NOT COMPLETED|Overall Study||18||
59679523|NCT01218646|75798652|FG000|STARTED|Overall Study||225||
59679524|NCT01218646|75798653|FG001|STARTED|Overall Study||225||
59679525|NCT01218646|75798654|FG002|STARTED|Overall Study||225||
59679526|NCT01218646|75798655|FG003|STARTED|Overall Study||64||
59679527|NCT01218646|75798652|FG000|COMPLETED|Overall Study||224||
59679528|NCT01218646|75798653|FG001|COMPLETED|Overall Study||225||
59679529|NCT01218646|75798654|FG002|COMPLETED|Overall Study||223||
59679530|NCT01218646|75798655|FG003|COMPLETED|Overall Study||63||
59679531|NCT01218646|75798652|FG000|NOT COMPLETED|Overall Study||1||
59679532|NCT01218646|75798653|FG001|NOT COMPLETED|Overall Study||0||
59679533|NCT01218646|75798654|FG002|NOT COMPLETED|Overall Study||2||
59679534|NCT01218646|75798655|FG003|NOT COMPLETED|Overall Study||1||
59679535|NCT01188772|75798669|FG000|STARTED|Overall Study||48||
59679536|NCT01188772|75798670|FG001|STARTED|Overall Study||48||
59679537|NCT01188772|75798671|FG002|STARTED|Overall Study||26||
59679538|NCT01188772|75798672|FG003|STARTED|Overall Study||25||
59679539|NCT01188772|75798669|FG000|Randomized and Treated|Overall Study||48||
59679540|NCT01188772|75798670|FG001|Randomized and Treated|Overall Study||47||
59679541|NCT01188772|75798671|FG002|Randomized and Treated|Overall Study||26||
59679542|NCT01188772|75798672|FG003|Randomized and Treated|Overall Study||25||
59679543|NCT01188772|75798669|FG000|COMPLETED|Overall Study||43||
59679544|NCT01188772|75798670|FG001|COMPLETED|Overall Study||45||
59679545|NCT01188772|75798671|FG002|COMPLETED|Overall Study||15||
59679546|NCT01188772|75798672|FG003|COMPLETED|Overall Study||24||
59679547|NCT01188772|75798669|FG000|NOT COMPLETED|Overall Study||5||
59679548|NCT01188772|75798670|FG001|NOT COMPLETED|Overall Study||3||
59679549|NCT01188772|75798671|FG002|NOT COMPLETED|Overall Study||11||
59679550|NCT01188772|75798672|FG003|NOT COMPLETED|Overall Study||1||
59679551|NCT01188655|75798685|FG000|STARTED|Overall Study||89||
59679552|NCT01188655|75798685|FG000|COMPLETED|Overall Study||76||
59679553|NCT01188655|75798685|FG000|NOT COMPLETED|Overall Study||13||
59679554|NCT01188538|75798691|FG000|STARTED|Overall Study||20||
59546732|NCT01040858|75645391|FG001|NOT COMPLETED|Overall Study||0||
59546733|NCT01091948|75645402|FG000|STARTED|Overall Study||37||
59546734|NCT01091948|75645403|FG001|STARTED|Overall Study||38||
59546735|NCT01091948|75645402|FG000|COMPLETED|Overall Study||37||
59546736|NCT01091948|75645403|FG001|COMPLETED|Overall Study||38||
59546737|NCT01091948|75645402|FG000|NOT COMPLETED|Overall Study||0||
59546738|NCT01091948|75645403|FG001|NOT COMPLETED|Overall Study||0||
59679555|NCT01188538|75798692|FG001|STARTED|Overall Study||20||
59679556|NCT01188538|75798691|FG000|COMPLETED|Overall Study||20||
59679557|NCT01188538|75798692|FG001|COMPLETED|Overall Study||19||
59679558|NCT01188538|75798691|FG000|NOT COMPLETED|Overall Study||0||
59679559|NCT01188538|75798692|FG001|NOT COMPLETED|Overall Study||1||
59679560|NCT01188343|75798703|FG000|STARTED|Overall Study||102||
59679561|NCT01188343|75798704|FG001|STARTED|Overall Study||219||
59679562|NCT01188343|75798705|FG002|STARTED|Overall Study||221||
59679563|NCT01188343|75798703|FG000|COMPLETED|Overall Study||101||
59679564|NCT01188343|75798704|FG001|COMPLETED|Overall Study||193||
59679565|NCT01188343|75798705|FG002|COMPLETED|Overall Study||220||
59679566|NCT01188343|75798703|FG000|NOT COMPLETED|Overall Study||1||
59679567|NCT01188343|75798704|FG001|NOT COMPLETED|Overall Study||26||
59679568|NCT01188343|75798705|FG002|NOT COMPLETED|Overall Study||1||
59679569|NCT01188226|75798716|FG000|STARTED|Overall Study||10||
59679570|NCT01188226|75798716|FG000|COMPLETED|Overall Study||6||
59679571|NCT01188226|75798716|FG000|NOT COMPLETED|Overall Study||4||
59679572|NCT01218100|75798734|FG000|STARTED|Overall Study||95||
59679573|NCT01218100|75798735|FG001|STARTED|Overall Study||190||
59679574|NCT01218100|75798736|FG002|STARTED|Overall Study||189||
59679575|NCT01218100|75798737|FG003|STARTED|Overall Study||190||
59679576|NCT01218100|75798734|FG000|COMPLETED|Overall Study||71||
59679577|NCT01218100|75798735|FG001|COMPLETED|Overall Study||165||
59679578|NCT01218100|75798736|FG002|COMPLETED|Overall Study||162||
59679579|NCT01218100|75798737|FG003|COMPLETED|Overall Study||156||
59679580|NCT01218100|75798734|FG000|NOT COMPLETED|Overall Study||24||
59679581|NCT01218100|75798735|FG001|NOT COMPLETED|Overall Study||25||
59679582|NCT01218100|75798736|FG002|NOT COMPLETED|Overall Study||27||
59679583|NCT01218100|75798737|FG003|NOT COMPLETED|Overall Study||34||
59679584|NCT04593641|75798751|FG000|STARTED|Overall Study||5||
59679585|NCT04593641|75798752|FG001|STARTED|Overall Study||5||
59679586|NCT04593641|75798753|FG002|STARTED|Overall Study||5||
59679587|NCT04593641|75798754|FG003|STARTED|Overall Study||3||
59679588|NCT04593641|75798751|FG000|COMPLETED|Overall Study||4||
59679589|NCT04593641|75798752|FG001|COMPLETED|Overall Study||5||
59679590|NCT04593641|75798753|FG002|COMPLETED|Overall Study||5||
59679591|NCT04593641|75798754|FG003|COMPLETED|Overall Study||3||
59679592|NCT04593641|75798751|FG000|NOT COMPLETED|Overall Study||1||
59679593|NCT04593641|75798752|FG001|NOT COMPLETED|Overall Study||0||
59679594|NCT04593641|75798753|FG002|NOT COMPLETED|Overall Study||0||
59679595|NCT04593641|75798754|FG003|NOT COMPLETED|Overall Study||0||
59679596|NCT04341441|75798768|FG000|STARTED|Overall Study||197||
59679597|NCT04341441|75798769|FG001|STARTED|Overall Study||201||
59546739|NCT01109576|75645410|FG000|STARTED|Overall Study||13||
59546740|NCT01109576|75645410|FG000|COMPLETED|Overall Study||12||
59679598|NCT04341441|75798770|FG002|STARTED|Overall Study||200||
59679599|NCT04341441|75798771|FG003|STARTED|Overall Study||26||
59679600|NCT04341441|75798768|FG000|COMPLETED|Overall Study||188||
59679601|NCT04341441|75798769|FG001|COMPLETED|Overall Study||199||
59679602|NCT04341441|75798770|FG002|COMPLETED|Overall Study||191||
59679603|NCT04341441|75798771|FG003|COMPLETED|Overall Study||26||
59679604|NCT04341441|75798768|FG000|NOT COMPLETED|Overall Study||9||
59679605|NCT04341441|75798769|FG001|NOT COMPLETED|Overall Study||2||
59679606|NCT04341441|75798770|FG002|NOT COMPLETED|Overall Study||9||
59679607|NCT04341441|75798771|FG003|NOT COMPLETED|Overall Study||0||
59679608|NCT01187953|75798783|FG000|STARTED|Overall Study||268||
59679609|NCT01187953|75798784|FG001|STARTED|Overall Study||275||
59679610|NCT01187953|75798783|FG000|Dosed|Overall Study||266||
59679611|NCT01187953|75798784|FG001|Dosed|Overall Study||271||
59679612|NCT01187953|75798783|FG000|COMPLETED|Overall Study||253||
59546741|NCT01109576|75645410|FG000|NOT COMPLETED|Overall Study||1||
59679613|NCT01187953|75798784|FG001|COMPLETED|Overall Study||254||
59679614|NCT01187953|75798783|FG000|NOT COMPLETED|Overall Study||15||
59679615|NCT01187953|75798784|FG001|NOT COMPLETED|Overall Study||21||
59679616|NCT04262817|75798790|FG000|STARTED|Overall Study||16||
59679617|NCT04262817|75798790|FG000|Freebase Tobacco Flavor Completed|Overall Study||16||
59679618|NCT04262817|75798790|FG000|Freebase Menthol Flavor Completed|Overall Study||16||
59679619|NCT04262817|75798790|FG000|Nicotine Salt Tobacco Flavor Completed|Overall Study||16||
59679620|NCT04262817|75798790|FG000|Nicotine Salt Menthol Flavor Completed|Overall Study||16||
59679621|NCT04262817|75798790|FG000|COMPLETED|Overall Study||16||
59679622|NCT04262817|75798790|FG000|NOT COMPLETED|Overall Study||0||
59679623|NCT01217944|75798800|FG000|STARTED|Overall Study||106||
59679624|NCT01217944|75798801|FG001|STARTED|Overall Study||116||
59679625|NCT01217944|75798802|FG002|STARTED|Overall Study||55||
59679626|NCT01217944|75798800|FG000|Completed 3 Months|Overall Study||105||
59679627|NCT01217944|75798801|FG001|Completed 3 Months|Overall Study||116||
59679628|NCT01217944|75798802|FG002|Completed 3 Months|Overall Study||55||
59679629|NCT01217944|75798800|FG000|Completed 6 Months|Overall Study||103||
59679630|NCT01217944|75798801|FG001|Completed 6 Months|Overall Study||116||
59679631|NCT01217944|75798802|FG002|Completed 6 Months|Overall Study||55||
59679632|NCT01217944|75798800|FG000|COMPLETED|Overall Study||100||
59679633|NCT01217944|75798801|FG001|COMPLETED|Overall Study||112||
59679634|NCT01217944|75798802|FG002|COMPLETED|Overall Study||55||
59679635|NCT01217944|75798800|FG000|NOT COMPLETED|Overall Study||6||
59679636|NCT01217944|75798801|FG001|NOT COMPLETED|Overall Study||4||
59679637|NCT01217944|75798802|FG002|NOT COMPLETED|Overall Study||0||
59679638|NCT01187446|75798814|FG000|STARTED|Overall Study||14||
59679639|NCT01187446|75798815|FG001|STARTED|Overall Study||14||
59679640|NCT01187446|75798814|FG000|COMPLETED|Overall Study||14||
59679641|NCT01187446|75798815|FG001|COMPLETED|Overall Study||13||
59679642|NCT01187446|75798814|FG000|NOT COMPLETED|Overall Study||0||
59679643|NCT01187446|75798815|FG001|NOT COMPLETED|Overall Study||1||
59679644|NCT01187407|75798825|FG000|STARTED|Confirmation (CF) Phase, 3 Weeks||1480||
59679645|NCT01187407|75798826|FG001|STARTED|Confirmation (CF) Phase, 3 Weeks||0||
59679646|NCT01187407|75798827|FG002|STARTED|Confirmation (CF) Phase, 3 Weeks||0||
59679647|NCT01187407|75798828|FG003|STARTED|Confirmation (CF) Phase, 3 Weeks||0||
59679648|NCT01187407|75798829|FG004|STARTED|Confirmation (CF) Phase, 3 Weeks||0||
59679649|NCT01187407|75798825|FG000|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks|Participants who discontinued the CF Phase early had the option to enter the DC Phase.|25||
59679650|NCT01187407|75798826|FG001|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0||
59679651|NCT01187407|75798827|FG002|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0||
59679652|NCT01187407|75798828|FG003|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0||
59679653|NCT01187407|75798829|FG004|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0||
59679654|NCT01187407|75798825|FG000|COMPLETED|Confirmation (CF) Phase, 3 Weeks|Participants who completed the CF Phase entered the Adjunctive Treatment (AT) Phase.|1390||
59679655|NCT01187407|75798826|FG001|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0||
59679656|NCT01187407|75798827|FG002|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0||
59679657|NCT01187407|75798828|FG003|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0||
59679658|NCT01187407|75798829|FG004|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0||
59679659|NCT01187407|75798825|FG000|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||90||
59679660|NCT01187407|75798826|FG001|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0||
59679661|NCT01187407|75798827|FG002|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0||
59679662|NCT01187407|75798828|FG003|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0||
59679663|NCT01187407|75798829|FG004|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0||
59679664|NCT01187407|75798825|FG000|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||0||
59679665|NCT01187407|75798826|FG001|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||232||
59679666|NCT01187407|75798827|FG002|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||226||
59679667|NCT01187407|75798828|FG003|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||231||
59679668|NCT01187407|75798829|FG004|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||701||
59679669|NCT01187407|75798825|FG000|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0||
59679670|NCT01187407|75798826|FG001|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|212||
59679671|NCT01187407|75798827|FG002|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|215||
59679672|NCT01187407|75798828|FG003|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|220||
59679673|NCT01187407|75798829|FG004|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|660||
59679674|NCT01187407|75798825|FG000|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0||
59679675|NCT01187407|75798826|FG001|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||196||
59679676|NCT01187407|75798827|FG002|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||191||
59679677|NCT01187407|75798828|FG003|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||202||
59679678|NCT01187407|75798829|FG004|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||626||
59679679|NCT01187407|75798825|FG000|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0||
59679680|NCT01187407|75798826|FG001|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||36||
59679681|NCT01187407|75798827|FG002|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||35||
59679682|NCT01187407|75798828|FG003|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||29||
59679683|NCT01187407|75798829|FG004|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||75||
59679684|NCT01186978|75798846|FG000|STARTED|Overall Study||63||
59679685|NCT01186978|75798846|FG000|COMPLETED|Overall Study||62||
59679686|NCT01186978|75798846|FG000|NOT COMPLETED|Overall Study||1||
59679687|NCT01186939|75798850|FG000|STARTED|Overall Study||40||
59679688|NCT01186939|75798850|FG000|COMPLETED|Overall Study||0||
59679689|NCT01186939|75798850|FG000|NOT COMPLETED|Overall Study||40||
59679690|NCT04141917|75798856|FG000|STARTED|Surveillance Year 1||63|This is all year 1 participants enrolled during standard surveillance months at their shelter of residence|3
59679691|NCT04141917|75798857|FG001|STARTED|Surveillance Year 1||76|This is all year 1 participants enrolled during standard surveillance months at their shelter of residence|2
59679692|NCT04141917|75798858|FG002|STARTED|Surveillance Year 1||81|This is all year 1 participants enrolled during standard surveillance months at their shelter of residence|2
59679693|NCT04141917|75798859|FG003|STARTED|Surveillance Year 1||324|This is all year 1 participants enrolled during standard surveillance months at their shelter of residence|2
59679694|NCT04141917|75798856|FG000|COMPLETED|Surveillance Year 1||63||3
59679695|NCT04141917|75798857|FG001|COMPLETED|Surveillance Year 1||76||2
59679696|NCT04141917|75798858|FG002|COMPLETED|Surveillance Year 1||81||2
59679697|NCT04141917|75798859|FG003|COMPLETED|Surveillance Year 1||324||2
59679698|NCT04141917|75798856|FG000|NOT COMPLETED|Surveillance Year 1||0||0
59679699|NCT04141917|75798857|FG001|NOT COMPLETED|Surveillance Year 1||0||0
59679700|NCT04141917|75798858|FG002|NOT COMPLETED|Surveillance Year 1||0||0
59679701|NCT04141917|75798859|FG003|NOT COMPLETED|Surveillance Year 1||0||0
59679702|NCT04141917|75798856|FG000|STARTED|Surveillance + Test and Treat Year 1||358|This is all year 1 participants enrolled during standard surveillance + test and treat protocol months at their shelter of residence|3
59679703|NCT04141917|75798857|FG001|STARTED|Surveillance + Test and Treat Year 1||153|This is all year 1 participants enrolled during standard surveillance + test and treat protocol months at their shelter of residence|2
59679704|NCT04141917|75798858|FG002|STARTED|Surveillance + Test and Treat Year 1||82|This is all year 1 participants enrolled during standard surveillance + test and treat protocol months at their shelter of residence|2
59679705|NCT04141917|75798859|FG003|STARTED|Surveillance + Test and Treat Year 1||83|This is all year 1 participants enrolled during standard surveillance + test and treat protocol months at their shelter of residence|2
59679706|NCT04141917|75798856|FG000|COMPLETED|Surveillance + Test and Treat Year 1||358||3
59679707|NCT04141917|75798857|FG001|COMPLETED|Surveillance + Test and Treat Year 1||153||2
59679708|NCT04141917|75798858|FG002|COMPLETED|Surveillance + Test and Treat Year 1||82||2
59679709|NCT04141917|75798859|FG003|COMPLETED|Surveillance + Test and Treat Year 1||83||2
59679710|NCT04141917|75798856|FG000|NOT COMPLETED|Surveillance + Test and Treat Year 1||0||0
59679711|NCT04141917|75798857|FG001|NOT COMPLETED|Surveillance + Test and Treat Year 1||0||0
59679712|NCT04141917|75798858|FG002|NOT COMPLETED|Surveillance + Test and Treat Year 1||0||0
59679713|NCT04141917|75798859|FG003|NOT COMPLETED|Surveillance + Test and Treat Year 1||0||0
59679714|NCT04141917|75798856|FG000|STARTED|Summer Surveillance||73|This is all participants enrolled between 4/1/2020 and 11/1/2020 when only standard surveillance was conducted at all shelters as year 1 of the test and treat protocol took place between 11/15/2019 and 3/31/2020 and year 2 of the protocol took place between 11/2/2020 and 3/31/2021. Enrollments are noted as per their randomized shelter sequence from year 1.|3
59679715|NCT04141917|75798857|FG001|STARTED|Summer Surveillance||39|This is all participants enrolled between 4/1/2020 and 11/1/2020 when only standard surveillance was conducted at all shelters as year 1 of the test and treat protocol took place between 11/15/2019 and 3/31/2020 and year 2 of the protocol took place between 11/2/2020 and 3/31/2021. Enrollments are noted as per their randomized shelter sequence from year 1.|2
59679716|NCT04141917|75798858|FG002|STARTED|Summer Surveillance||54|This is all participants enrolled between 4/1/2020 and 11/1/2020 when only standard surveillance was conducted at all shelters as year 1 of the test and treat protocol took place between 11/15/2019 and 3/31/2020 and year 2 of the protocol took place between 11/2/2020 and 3/31/2021. Enrollments are noted as per their randomized shelter sequence from year 1.|2
59679717|NCT04141917|75798859|FG003|STARTED|Summer Surveillance||20|This is all participants enrolled between 4/1/2020 and 11/1/2020 when only standard surveillance was conducted at all shelters as year 1 of the test and treat protocol took place between 11/15/2019 and 3/31/2020 and year 2 of the protocol took place between 11/2/2020 and 3/31/2021. Enrollments are noted as per their randomized shelter sequence from year 1.|2
59679718|NCT04141917|75798856|FG000|COMPLETED|Summer Surveillance||73||3
59679719|NCT04141917|75798857|FG001|COMPLETED|Summer Surveillance||39||2
59679720|NCT04141917|75798858|FG002|COMPLETED|Summer Surveillance||54||2
59679721|NCT04141917|75798859|FG003|COMPLETED|Summer Surveillance||20||2
59679722|NCT04141917|75798856|FG000|NOT COMPLETED|Summer Surveillance||0||0
59679723|NCT04141917|75798857|FG001|NOT COMPLETED|Summer Surveillance||0||0
59679724|NCT04141917|75798858|FG002|NOT COMPLETED|Summer Surveillance||0||0
59679725|NCT04141917|75798859|FG003|NOT COMPLETED|Summer Surveillance||0||0
59679726|NCT04141917|75798856|FG000|STARTED|Surveillance Year 2||3|This is all year 2 participants enrolled during standard surveillance months at their shelter of residence|3
59679727|NCT04141917|75798857|FG001|STARTED|Surveillance Year 2||3|This is all year 2 participants enrolled during standard surveillance months at their shelter of residence|2
59679728|NCT04141917|75798858|FG002|STARTED|Surveillance Year 2||10|This is all year 2 participants enrolled during standard surveillance months at their shelter of residence|2
59815957|NCT00531050|75938376|FG003|NOT COMPLETED|Part 1: Period 1||1||
59679729|NCT04141917|75798859|FG003|STARTED|Surveillance Year 2||7|This is all year 2 participants enrolled during standard surveillance months at their shelter of residence|2
59679730|NCT04141917|75798856|FG000|COMPLETED|Surveillance Year 2||3||3
59679731|NCT04141917|75798857|FG001|COMPLETED|Surveillance Year 2||3||2
59679732|NCT04141917|75798858|FG002|COMPLETED|Surveillance Year 2||10||2
59679733|NCT04141917|75798859|FG003|COMPLETED|Surveillance Year 2||7||2
59679734|NCT04141917|75798856|FG000|NOT COMPLETED|Surveillance Year 2||0||0
59679735|NCT04141917|75798857|FG001|NOT COMPLETED|Surveillance Year 2||0||0
59679736|NCT04141917|75798858|FG002|NOT COMPLETED|Surveillance Year 2||0||0
59679737|NCT04141917|75798859|FG003|NOT COMPLETED|Surveillance Year 2||0||0
59679738|NCT04141917|75798856|FG000|STARTED|Surveillance + Test and Treat Year 2||62|This is all year 1 participants enrolled during standard surveillance + test and treat protocol months at their shelter of residence|3
59679739|NCT04141917|75798857|FG001|STARTED|Surveillance + Test and Treat Year 2||13|This is all year 1 participants enrolled during standard surveillance + test and treat protocol months at their shelter of residence|2
59679740|NCT04141917|75798858|FG002|STARTED|Surveillance + Test and Treat Year 2||3|This is all year 1 participants enrolled during standard surveillance + test and treat protocol months at their shelter of residence|2
59679741|NCT04141917|75798859|FG003|STARTED|Surveillance + Test and Treat Year 2||3|This is all year 1 participants enrolled during standard surveillance + test and treat protocol months at their shelter of residence|2
59679742|NCT04141917|75798856|FG000|COMPLETED|Surveillance + Test and Treat Year 2||62||3
59679743|NCT04141917|75798857|FG001|COMPLETED|Surveillance + Test and Treat Year 2||13||2
59679744|NCT04141917|75798858|FG002|COMPLETED|Surveillance + Test and Treat Year 2||3||2
59679745|NCT04141917|75798859|FG003|COMPLETED|Surveillance + Test and Treat Year 2||3||2
59679746|NCT04141917|75798856|FG000|NOT COMPLETED|Surveillance + Test and Treat Year 2||0||0
59679747|NCT04141917|75798857|FG001|NOT COMPLETED|Surveillance + Test and Treat Year 2||0||0
59679748|NCT04141917|75798858|FG002|NOT COMPLETED|Surveillance + Test and Treat Year 2||0||0
59679749|NCT04141917|75798859|FG003|NOT COMPLETED|Surveillance + Test and Treat Year 2||0||0
59679750|NCT04381052|75798867|FG000|STARTED|Overall Study||1||
59679751|NCT04381052|75798867|FG000|COMPLETED|Overall Study||1||
59679752|NCT04381052|75798867|FG000|NOT COMPLETED|Overall Study||0||
59679753|NCT04938648|75798875|FG000|STARTED|Overall Study||34||
59679754|NCT04938648|75798876|FG001|STARTED|Overall Study||35||
59679755|NCT04938648|75798875|FG000|COMPLETED|Overall Study||27||
59679756|NCT04938648|75798876|FG001|COMPLETED|Overall Study||28||
59679757|NCT04938648|75798875|FG000|NOT COMPLETED|Overall Study||7||
59679758|NCT04938648|75798876|FG001|NOT COMPLETED|Overall Study||7||
59679759|NCT04564092|75798883|FG000|STARTED|Overall Study||9||
59679760|NCT04564092|75798883|FG000|Safety Population|Overall Study||8|The safety population included all participants who received ioflupane (123I) injection.|
59679761|NCT04564092|75798883|FG000|COMPLETED|Overall Study||8||
59679762|NCT04564092|75798883|FG000|NOT COMPLETED|Overall Study||1||
59679763|NCT02130687|75798890|FG000|STARTED|Washout||36||
59679764|NCT02130687|75798891|FG001|STARTED|Washout||35||
59679765|NCT02130687|75798892|FG002|STARTED|Washout||35||
59679766|NCT02130687|75798890|FG000|COMPLETED|Washout||36||
59679767|NCT02130687|75798891|FG001|COMPLETED|Washout||33||
59679768|NCT02130687|75798892|FG002|COMPLETED|Washout||31||
59679769|NCT02130687|75798890|FG000|NOT COMPLETED|Washout||0||
59679770|NCT02130687|75798891|FG001|NOT COMPLETED|Washout||2||
59679771|NCT02130687|75798892|FG002|NOT COMPLETED|Washout||4||
59679772|NCT02130687|75798890|FG000|STARTED|Drug 1 Only||36||
59679773|NCT02130687|75798891|FG001|STARTED|Drug 1 Only||33||
59679774|NCT02130687|75798892|FG002|STARTED|Drug 1 Only||31||
59679775|NCT02130687|75798890|FG000|COMPLETED|Drug 1 Only||33||
59679776|NCT02130687|75798891|FG001|COMPLETED|Drug 1 Only||30||
59679777|NCT02130687|75798892|FG002|COMPLETED|Drug 1 Only||30||
59679778|NCT02130687|75798890|FG000|NOT COMPLETED|Drug 1 Only||3||
59679779|NCT02130687|75798891|FG001|NOT COMPLETED|Drug 1 Only||3||
59679780|NCT02130687|75798892|FG002|NOT COMPLETED|Drug 1 Only||1||
59679781|NCT02130687|75798890|FG000|STARTED|Crossover Period 1||33||
59679782|NCT02130687|75798891|FG001|STARTED|Crossover Period 1||30||
59679783|NCT02130687|75798892|FG002|STARTED|Crossover Period 1||30||
59679784|NCT02130687|75798890|FG000|COMPLETED|Crossover Period 1||33||
59679785|NCT02130687|75798891|FG001|COMPLETED|Crossover Period 1||30||
59679786|NCT02130687|75798892|FG002|COMPLETED|Crossover Period 1||30||
59679787|NCT02130687|75798890|FG000|NOT COMPLETED|Crossover Period 1||0||
59679788|NCT02130687|75798891|FG001|NOT COMPLETED|Crossover Period 1||0||
59679789|NCT02130687|75798892|FG002|NOT COMPLETED|Crossover Period 1||0||
59679790|NCT02130687|75798890|FG000|STARTED|Drug 1 Only Between Periods 1 and 2||33||
59679791|NCT02130687|75798891|FG001|STARTED|Drug 1 Only Between Periods 1 and 2||30||
59679792|NCT02130687|75798892|FG002|STARTED|Drug 1 Only Between Periods 1 and 2||30||
59679793|NCT02130687|75798890|FG000|COMPLETED|Drug 1 Only Between Periods 1 and 2||33||
59679794|NCT02130687|75798891|FG001|COMPLETED|Drug 1 Only Between Periods 1 and 2||26||
59679795|NCT02130687|75798892|FG002|COMPLETED|Drug 1 Only Between Periods 1 and 2||29||
59679796|NCT02130687|75798890|FG000|NOT COMPLETED|Drug 1 Only Between Periods 1 and 2||0||
59679797|NCT02130687|75798891|FG001|NOT COMPLETED|Drug 1 Only Between Periods 1 and 2||4||
59679798|NCT02130687|75798892|FG002|NOT COMPLETED|Drug 1 Only Between Periods 1 and 2||1||
59679799|NCT02130687|75798890|FG000|STARTED|Crossover Period 2||33||
59679800|NCT02130687|75798891|FG001|STARTED|Crossover Period 2||26||
59679801|NCT02130687|75798892|FG002|STARTED|Crossover Period 2||29||
59679802|NCT02130687|75798890|FG000|COMPLETED|Crossover Period 2||33||
59679803|NCT02130687|75798891|FG001|COMPLETED|Crossover Period 2||26||
59679804|NCT02130687|75798892|FG002|COMPLETED|Crossover Period 2||29||
59679805|NCT02130687|75798890|FG000|NOT COMPLETED|Crossover Period 2||0||
59679806|NCT02130687|75798891|FG001|NOT COMPLETED|Crossover Period 2||0||
59679807|NCT02130687|75798892|FG002|NOT COMPLETED|Crossover Period 2||0||
59679808|NCT02130687|75798890|FG000|STARTED|Drug 1 Only Between Periods 2 and 3||33||
59679809|NCT02130687|75798891|FG001|STARTED|Drug 1 Only Between Periods 2 and 3||26||
59679810|NCT02130687|75798892|FG002|STARTED|Drug 1 Only Between Periods 2 and 3||29||
59679811|NCT02130687|75798890|FG000|COMPLETED|Drug 1 Only Between Periods 2 and 3||33||
59679812|NCT02130687|75798891|FG001|COMPLETED|Drug 1 Only Between Periods 2 and 3||25||
59679813|NCT02130687|75798892|FG002|COMPLETED|Drug 1 Only Between Periods 2 and 3||27||
59679814|NCT02130687|75798890|FG000|NOT COMPLETED|Drug 1 Only Between Periods 2 and 3||0||
59679815|NCT02130687|75798891|FG001|NOT COMPLETED|Drug 1 Only Between Periods 2 and 3||1||
59679816|NCT02130687|75798892|FG002|NOT COMPLETED|Drug 1 Only Between Periods 2 and 3||2||
59679817|NCT02130687|75798890|FG000|STARTED|Crossover Period 3||33||
59679818|NCT02130687|75798891|FG001|STARTED|Crossover Period 3||25||
59679819|NCT02130687|75798892|FG002|STARTED|Crossover Period 3||27||
59679820|NCT02130687|75798890|FG000|COMPLETED|Crossover Period 3||33||
59679821|NCT02130687|75798891|FG001|COMPLETED|Crossover Period 3||25||
59679822|NCT02130687|75798892|FG002|COMPLETED|Crossover Period 3||27||
59679823|NCT02130687|75798890|FG000|NOT COMPLETED|Crossover Period 3||0||
59679824|NCT02130687|75798891|FG001|NOT COMPLETED|Crossover Period 3||0||
59679825|NCT02130687|75798892|FG002|NOT COMPLETED|Crossover Period 3||0||
59679826|NCT03103490|75798918|FG000|STARTED|Overall Study||28||
59679827|NCT03103490|75798918|FG000|COMPLETED|Overall Study||28||
59679828|NCT03103490|75798918|FG000|NOT COMPLETED|Overall Study||0||
59679829|NCT01658826|75798924|FG000|STARTED|Period 1: First Intervention (28 Days)||45||
59679830|NCT01658826|75798925|FG001|STARTED|Period 1: First Intervention (28 Days)||46||
59679831|NCT01658826|75798924|FG000|COMPLETED|Period 1: First Intervention (28 Days)||38||
59679832|NCT01658826|75798925|FG001|COMPLETED|Period 1: First Intervention (28 Days)||36||
59679833|NCT01658826|75798924|FG000|NOT COMPLETED|Period 1: First Intervention (28 Days)||7||
59679834|NCT01658826|75798925|FG001|NOT COMPLETED|Period 1: First Intervention (28 Days)||10||
59679835|NCT01658826|75798924|FG000|STARTED|Washout Period: 28 Days||38||
59679836|NCT01658826|75798925|FG001|STARTED|Washout Period: 28 Days||36||
59679837|NCT01658826|75798924|FG000|COMPLETED|Washout Period: 28 Days||32||
59679838|NCT01658826|75798925|FG001|COMPLETED|Washout Period: 28 Days||32||
59679839|NCT01658826|75798924|FG000|NOT COMPLETED|Washout Period: 28 Days||6||
59679840|NCT01658826|75798925|FG001|NOT COMPLETED|Washout Period: 28 Days||4||
59679841|NCT01658826|75798924|FG000|STARTED|Period 2: Second Intervention (28 Days)||32||
59679842|NCT01658826|75798925|FG001|STARTED|Period 2: Second Intervention (28 Days)||32||
59679843|NCT01658826|75798924|FG000|COMPLETED|Period 2: Second Intervention (28 Days)||29||
59679844|NCT01658826|75798925|FG001|COMPLETED|Period 2: Second Intervention (28 Days)||27||
59679845|NCT01658826|75798924|FG000|NOT COMPLETED|Period 2: Second Intervention (28 Days)||3||
59679846|NCT01658826|75798925|FG001|NOT COMPLETED|Period 2: Second Intervention (28 Days)||5||
59679847|NCT03026504|75798931|FG000|STARTED|Overall Study||15||
59679848|NCT03026504|75798931|FG000|COMPLETED|Overall Study||14||
59679849|NCT03026504|75798931|FG000|NOT COMPLETED|Overall Study||1||
59679850|NCT01186744|75798941|FG000|STARTED|Overall Study||218||
59679851|NCT01186744|75798942|FG001|STARTED|Overall Study||157||
59679852|NCT01186744|75798943|FG002|STARTED|Overall Study||31||
59679853|NCT01186744|75798944|FG003|STARTED|Overall Study||82||
59679854|NCT01186744|75798945|FG004|STARTED|Overall Study||45||
59679855|NCT01186744|75798946|FG005|STARTED|Overall Study||133||
59679856|NCT01186744|75798941|FG000|COMPLETED|Overall Study||10||
59679857|NCT01186744|75798942|FG001|COMPLETED|Overall Study||5||
59679858|NCT01186744|75798943|FG002|COMPLETED|Overall Study||25||
59679859|NCT01186744|75798944|FG003|COMPLETED|Overall Study||70||
59815958|NCT00531050|75938377|FG004|NOT COMPLETED|Part 1: Period 1||0||
59679860|NCT01186744|75798945|FG004|COMPLETED|Overall Study||39||
59815959|NCT00531050|75938378|FG005|NOT COMPLETED|Part 1: Period 1||0||
59815960|NCT00531050|75938373|FG000|STARTED|Part 1: Period 2||4||
59679861|NCT01186744|75798946|FG005|COMPLETED|Overall Study||107||
59679862|NCT01186744|75798941|FG000|NOT COMPLETED|Overall Study||208||
59679863|NCT01186744|75798942|FG001|NOT COMPLETED|Overall Study||152||
59679864|NCT01186744|75798943|FG002|NOT COMPLETED|Overall Study||6||
59679865|NCT01186744|75798944|FG003|NOT COMPLETED|Overall Study||12||
59679866|NCT01186744|75798945|FG004|NOT COMPLETED|Overall Study||6||
59679867|NCT01186744|75798946|FG005|NOT COMPLETED|Overall Study||26||
59679868|NCT01185964|75798984|FG000|STARTED|Phase 1b and Phase 2||15||
59679869|NCT01185964|75798985|FG001|STARTED|Phase 1b and Phase 2||66||
59679870|NCT01185964|75798986|FG002|STARTED|Phase 1b and Phase 2||67||
59679871|NCT01185964|75798987|FG003|STARTED|Phase 1b and Phase 2||0||
59679872|NCT01185964|75798984|FG000|Received at Least 1 Dose of Study Drug|Phase 1b and Phase 2||15||
59679873|NCT01185964|75798985|FG001|Received at Least 1 Dose of Study Drug|Phase 1b and Phase 2||64||
59679874|NCT01185964|75798986|FG002|Received at Least 1 Dose of Study Drug|Phase 1b and Phase 2||65||
59815961|NCT00531050|75938374|FG001|STARTED|Part 1: Period 2||4||
59679875|NCT01185964|75798987|FG003|Received at Least 1 Dose of Study Drug|Phase 1b and Phase 2||0||
59679876|NCT01185964|75798984|FG000|COMPLETED|Phase 1b and Phase 2||13||
59679877|NCT01185964|75798985|FG001|COMPLETED|Phase 1b and Phase 2||56||
59679878|NCT01185964|75798986|FG002|COMPLETED|Phase 1b and Phase 2||58||
59679879|NCT01185964|75798987|FG003|COMPLETED|Phase 1b and Phase 2||0||
59679880|NCT01185964|75798984|FG000|NOT COMPLETED|Phase 1b and Phase 2||2||
59679881|NCT01185964|75798985|FG001|NOT COMPLETED|Phase 1b and Phase 2||10||
59679882|NCT01185964|75798986|FG002|NOT COMPLETED|Phase 1b and Phase 2||9||
59679883|NCT01185964|75798987|FG003|NOT COMPLETED|Phase 1b and Phase 2||0||
59679884|NCT01185964|75798984|FG000|STARTED|Optional Olaratumab Monotherapy on Dox||0||
59679885|NCT01185964|75798985|FG001|STARTED|Optional Olaratumab Monotherapy on Dox||0||
59679886|NCT01185964|75798986|FG002|STARTED|Optional Olaratumab Monotherapy on Dox||0||
59679887|NCT01185964|75798987|FG003|STARTED|Optional Olaratumab Monotherapy on Dox|Participants with disease progression after treatment received olaratumab.|30||
59679888|NCT01185964|75798984|FG000|COMPLETED|Optional Olaratumab Monotherapy on Dox||0||
59679889|NCT01185964|75798985|FG001|COMPLETED|Optional Olaratumab Monotherapy on Dox||0||
59679890|NCT01185964|75798986|FG002|COMPLETED|Optional Olaratumab Monotherapy on Dox||0||
59679891|NCT01185964|75798987|FG003|COMPLETED|Optional Olaratumab Monotherapy on Dox||25||
59679892|NCT01185964|75798984|FG000|NOT COMPLETED|Optional Olaratumab Monotherapy on Dox||0||
59679893|NCT01185964|75798985|FG001|NOT COMPLETED|Optional Olaratumab Monotherapy on Dox||0||
59679894|NCT01185964|75798986|FG002|NOT COMPLETED|Optional Olaratumab Monotherapy on Dox||0||
59679895|NCT01185964|75798987|FG003|NOT COMPLETED|Optional Olaratumab Monotherapy on Dox||5||
59679896|NCT01217476|75799005|FG000|STARTED|Overall Study||105||
59679897|NCT01217476|75799006|FG001|STARTED|Overall Study||102||
59679898|NCT01217476|75799005|FG000|COMPLETED|Overall Study||93||
59679899|NCT01217476|75799006|FG001|COMPLETED|Overall Study||95||
59679900|NCT01217476|75799005|FG000|NOT COMPLETED|Overall Study||12||
59679901|NCT01217476|75799006|FG001|NOT COMPLETED|Overall Study||7||
59679902|NCT02550470|75799015|FG000|STARTED|Overall Study|"time to reach FiO2 of 4 mm Hg was recorded for each absorbent in the anesthesia circuit~Absorbent units other than participants were assigned to Arms/Groups"|||58
59679903|NCT02550470|75799016|FG001|STARTED|Overall Study|"time to reach FiO2 of 4 mm Hg was recorded for each absorbent in the anesthesia circuit~Absorbent units other than participants were assigned to Arms/Groups"|||65
59679904|NCT02550470|75799017|FG002|STARTED|Overall Study|"time to reach FiO2 of 4 mm Hg was recorded for each absorbent in the anesthesia circuit~Absorbent units other than participants were assigned to Arms/Groups"|||63
59679905|NCT02550470|75799015|FG000|COMPLETED|Overall Study|"time to reach FiO2 of 4 mm Hg was recorded for each absorbent in the anesthesia circuit~Absorbent units other than participants were assigned to Arms/Groups"|||58
59679906|NCT02550470|75799016|FG001|COMPLETED|Overall Study|"time to reach FiO2 of 4 mm Hg was recorded for each absorbent in the anesthesia circuit~Absorbent units other than participants were assigned to Arms/Groups"|||65
59679907|NCT02550470|75799017|FG002|COMPLETED|Overall Study|"time to reach FiO2 of 4 mm Hg was recorded for each absorbent in the anesthesia circuit~Absorbent units other than participants were assigned to Arms/Groups"|||63
59679908|NCT02550470|75799015|FG000|NOT COMPLETED|Overall Study||||0
59679909|NCT02550470|75799016|FG001|NOT COMPLETED|Overall Study||||0
59679910|NCT02550470|75799017|FG002|NOT COMPLETED|Overall Study||||0
59679911|NCT01217437|75799027|FG000|STARTED|Overall Study||55||
59679912|NCT01217437|75799028|FG001|STARTED|Overall Study||53||
59679913|NCT01217437|75799027|FG000|COMPLETED|Overall Study||12||
59679914|NCT01217437|75799028|FG001|COMPLETED|Overall Study||12||
59679915|NCT01217437|75799027|FG000|NOT COMPLETED|Overall Study||43||
59679916|NCT01217437|75799028|FG001|NOT COMPLETED|Overall Study||41||
59679917|NCT05155566|75799036|FG000|STARTED|Overall Study||574||
59679918|NCT05155566|75799037|FG001|STARTED|Overall Study||273||
59679919|NCT05155566|75799036|FG000|COMPLETED|Overall Study||574||
59679920|NCT05155566|75799037|FG001|COMPLETED|Overall Study||273||
59679921|NCT05155566|75799036|FG000|NOT COMPLETED|Overall Study||0||
59679922|NCT05155566|75799037|FG001|NOT COMPLETED|Overall Study||0||
59679923|NCT05055570|75799045|FG000|STARTED|Overall Study||25||
59679924|NCT05055570|75799046|FG001|STARTED|Overall Study||63||
59679925|NCT05055570|75799045|FG000|COMPLETED|Overall Study||25||
59679926|NCT05055570|75799046|FG001|COMPLETED|Overall Study||63||
59679927|NCT05055570|75799045|FG000|NOT COMPLETED|Overall Study||0||
59679928|NCT05055570|75799046|FG001|NOT COMPLETED|Overall Study||0||
59679929|NCT04531904|75799052|FG000|STARTED|Overall Study||102|Enrolled, attempted and had EmboVAC procedure performed.|
59679930|NCT04531904|75799052|FG000|Attempted EmboVac Procedure But Not Performed|Overall Study|Participants who were not included in the device effectiveness analysis.|2||
59679931|NCT04531904|75799052|FG000|COMPLETED|Overall Study||87||
59679932|NCT04531904|75799052|FG000|NOT COMPLETED|Overall Study||15||
59679933|NCT04137380|75799063|FG000|STARTED|Overall Study||6||
59679934|NCT04137380|75799064|FG001|STARTED|Overall Study||10||
59679935|NCT04137380|75799065|FG002|STARTED|Overall Study||10||
59679936|NCT04137380|75799066|FG003|STARTED|Overall Study||10||
59679937|NCT04137380|75799067|FG004|STARTED|Overall Study||4||
59679938|NCT04137380|75799068|FG005|STARTED|Overall Study||10||
59679939|NCT04137380|75799069|FG006|STARTED|Overall Study||10||
59679940|NCT04137380|75799063|FG000|Received at Least One Dose of Study Drug|Overall Study||6||
59679941|NCT04137380|75799064|FG001|Received at Least One Dose of Study Drug|Overall Study||10||
59679942|NCT04137380|75799065|FG002|Received at Least One Dose of Study Drug|Overall Study||10||
59679943|NCT04137380|75799066|FG003|Received at Least One Dose of Study Drug|Overall Study||10||
59679944|NCT04137380|75799067|FG004|Received at Least One Dose of Study Drug|Overall Study||4||
59679945|NCT04137380|75799068|FG005|Received at Least One Dose of Study Drug|Overall Study||10||
59679946|NCT04137380|75799069|FG006|Received at Least One Dose of Study Drug|Overall Study||10||
59679947|NCT04137380|75799063|FG000|COMPLETED|Overall Study||6||
59679948|NCT04137380|75799064|FG001|COMPLETED|Overall Study||10||
59679949|NCT04137380|75799065|FG002|COMPLETED|Overall Study||10||
59679950|NCT04137380|75799066|FG003|COMPLETED|Overall Study||9||
59679951|NCT04137380|75799067|FG004|COMPLETED|Overall Study||4||
59679952|NCT04137380|75799068|FG005|COMPLETED|Overall Study||10||
59679953|NCT04137380|75799069|FG006|COMPLETED|Overall Study||10||
59679954|NCT04137380|75799063|FG000|NOT COMPLETED|Overall Study||0||
59679955|NCT04137380|75799064|FG001|NOT COMPLETED|Overall Study||0||
59679956|NCT04137380|75799065|FG002|NOT COMPLETED|Overall Study||0||
59679957|NCT04137380|75799066|FG003|NOT COMPLETED|Overall Study||1||
59679958|NCT04137380|75799067|FG004|NOT COMPLETED|Overall Study||0||
59679959|NCT04137380|75799068|FG005|NOT COMPLETED|Overall Study||0||
59679960|NCT04137380|75799069|FG006|NOT COMPLETED|Overall Study||0||
59679961|NCT02927301|75799093|FG000|STARTED|Overall Study||181||
59679962|NCT02927301|75799093|FG000|COMPLETED|Overall Study||171||
59679963|NCT02927301|75799093|FG000|NOT COMPLETED|Overall Study||10||
59679964|NCT02653976|75799097|FG000|STARTED|Overall Study||65||
59679965|NCT02653976|75799097|FG000|COMPLETED|Overall Study||56||
59679966|NCT02653976|75799097|FG000|NOT COMPLETED|Overall Study||9||
59679967|NCT02611037|75799101|FG000|STARTED|Overall Study||7||
59679968|NCT02611037|75799102|FG001|STARTED|Overall Study||27||
59679969|NCT02611037|75799101|FG000|COMPLETED|Overall Study||5||
59679970|NCT02611037|75799102|FG001|COMPLETED|Overall Study||27||
59679971|NCT02611037|75799101|FG000|NOT COMPLETED|Overall Study||2||
59679972|NCT02611037|75799102|FG001|NOT COMPLETED|Overall Study||0||
59679973|NCT02446236|75799110|FG000|STARTED|Overall Study||5||
59679974|NCT02446236|75799111|FG001|STARTED|Overall Study||3||
59679975|NCT02446236|75799112|FG002|STARTED|Overall Study||19||
59815962|NCT00531050|75938375|FG002|STARTED|Part 1: Period 2||4||
59815963|NCT00531050|75938376|FG003|STARTED|Part 1: Period 2||4||
59815964|NCT00531050|75938377|FG004|STARTED|Part 1: Period 2||4||
59815965|NCT00531050|75938378|FG005|STARTED|Part 1: Period 2||5||
59815966|NCT00531050|75938373|FG000|COMPLETED|Part 1: Period 2||4||
59679976|NCT02446236|75799110|FG000|COMPLETED|Overall Study||4||
59679977|NCT02446236|75799111|FG001|COMPLETED|Overall Study||3||
59679978|NCT02446236|75799112|FG002|COMPLETED|Overall Study||17||
59679979|NCT02446236|75799110|FG000|NOT COMPLETED|Overall Study||1||
59679980|NCT02446236|75799111|FG001|NOT COMPLETED|Overall Study||0||
59679981|NCT02446236|75799112|FG002|NOT COMPLETED|Overall Study||2||
59679982|NCT01566695|75799120|FG000|STARTED|Overall Study||107||
59679983|NCT01566695|75799121|FG001|STARTED|Overall Study||109||
59679984|NCT01566695|75799120|FG000|COMPLETED|Overall Study||12|Completed = participants on treatment as of data cut off date of 25 Jan 2019|
59679985|NCT01566695|75799121|FG001|COMPLETED|Overall Study||10|Completed = participants on treatment as of data cut off date of 25 Jan 2019|
59679986|NCT01566695|75799120|FG000|NOT COMPLETED|Overall Study||95||
59679987|NCT01566695|75799121|FG001|NOT COMPLETED|Overall Study||99||
59679988|NCT01081951|75799129|FG000|STARTED|Overall Study||81||
59679989|NCT01081951|75799130|FG001|STARTED|Overall Study||81||
59679990|NCT01081951|75799129|FG000|Received Study Treatment|Overall Study||81||
59679991|NCT01081951|75799130|FG001|Received Study Treatment|Overall Study||75||
59679992|NCT01081951|75799129|FG000|Entered Maintenance Phase|Overall Study||66||
59815967|NCT00531050|75938374|FG001|COMPLETED|Part 1: Period 2||4||
59815968|NCT00531050|75938375|FG002|COMPLETED|Part 1: Period 2||4||
59815969|NCT00531050|75938376|FG003|COMPLETED|Part 1: Period 2||4||
59815970|NCT00531050|75938377|FG004|COMPLETED|Part 1: Period 2||4||
59679993|NCT01081951|75799130|FG001|Entered Maintenance Phase|Overall Study||55||
59679994|NCT01081951|75799129|FG000|Ongoing Study Treatment at Data Cut-off|Overall Study||11||
59679995|NCT01081951|75799130|FG001|Ongoing Study Treatment at Data Cut-off|Overall Study||0||
59679996|NCT01081951|75799129|FG000|COMPLETED|Overall Study|Completed is ongoing study at DCO (Data cut-off),either on-treatment or in survival follow-up|25||
59679997|NCT01081951|75799130|FG001|COMPLETED|Overall Study|Completed is ongoing study at DCO (Data cut-off), either on-treatment or in survival follow-up|26||
59679998|NCT01081951|75799129|FG000|NOT COMPLETED|Overall Study||56||
59679999|NCT01081951|75799130|FG001|NOT COMPLETED|Overall Study||55||
59680000|NCT00736385|75799138|FG000|STARTED|Overall Study||4||
59680001|NCT00736385|75799139|FG001|STARTED|Overall Study||5||
59680002|NCT00736385|75799138|FG000|COMPLETED|Overall Study||2||
59680003|NCT00736385|75799139|FG001|COMPLETED|Overall Study||2||
59680004|NCT00736385|75799138|FG000|NOT COMPLETED|Overall Study||2||
59680005|NCT00736385|75799139|FG001|NOT COMPLETED|Overall Study||3||
59815971|NCT00531050|75938378|FG005|COMPLETED|Part 1: Period 2||5||
59680006|NCT00392327|75799153|FG000|STARTED|Overall Study||87||
59680007|NCT00392327|75799154|FG001|STARTED|Overall Study||93||
59680008|NCT00392327|75799155|FG002|STARTED|Overall Study||56||
59680009|NCT00392327|75799156|FG003|STARTED|Overall Study||58||
59680010|NCT00392327|75799157|FG004|STARTED|Overall Study||23||
59815972|NCT00531050|75938373|FG000|NOT COMPLETED|Part 1: Period 2||0||
60078100|NCT04773028|76193128|FG000|NOT COMPLETED|Overall Study||0||
60078101|NCT04773028|76193129|FG001|NOT COMPLETED|Overall Study||0||
59680011|NCT00392327|75799158|FG005|STARTED|Overall Study||19||
59680012|NCT00392327|75799159|FG006|STARTED|Overall Study||21||
59680013|NCT00392327|75799160|FG007|STARTED|Overall Study||22||
59680014|NCT00392327|75799153|FG000|COMPLETED|Overall Study||72||
59680015|NCT00392327|75799154|FG001|COMPLETED|Overall Study||74||
59680016|NCT00392327|75799155|FG002|COMPLETED|Overall Study||36||
59680017|NCT00392327|75799156|FG003|COMPLETED|Overall Study||42||
59680018|NCT00392327|75799157|FG004|COMPLETED|Overall Study||20||
59680019|NCT00392327|75799158|FG005|COMPLETED|Overall Study||14||
59680020|NCT00392327|75799159|FG006|COMPLETED|Overall Study||12||
59680021|NCT00392327|75799160|FG007|COMPLETED|Overall Study||11||
59680022|NCT00392327|75799153|FG000|NOT COMPLETED|Overall Study||15||
59680023|NCT00392327|75799154|FG001|NOT COMPLETED|Overall Study||19||
59680024|NCT00392327|75799155|FG002|NOT COMPLETED|Overall Study||20||
59680025|NCT00392327|75799156|FG003|NOT COMPLETED|Overall Study||16||
59680026|NCT00392327|75799157|FG004|NOT COMPLETED|Overall Study||3||
59680027|NCT00392327|75799158|FG005|NOT COMPLETED|Overall Study||5||
59680028|NCT00392327|75799159|FG006|NOT COMPLETED|Overall Study||9||
59680029|NCT00392327|75799160|FG007|NOT COMPLETED|Overall Study||11||
59680030|NCT00352534|75799180|FG000|STARTED|Initial Staging||211||
59680031|NCT00352534|75799181|FG001|STARTED|Initial Staging||597||
59815973|NCT00531050|75938374|FG001|NOT COMPLETED|Part 1: Period 2||0||
59815974|NCT00531050|75938375|FG002|NOT COMPLETED|Part 1: Period 2||0||
59815975|NCT00531050|75938376|FG003|NOT COMPLETED|Part 1: Period 2||0||
59815976|NCT00531050|75938377|FG004|NOT COMPLETED|Part 1: Period 2||0||
59815977|NCT00531050|75938378|FG005|NOT COMPLETED|Part 1: Period 2||0||
59815978|NCT00531050|75938373|FG000|STARTED|Part 1: Period 3||4||
60078102|NCT01503021|76193137|FG000|STARTED|Overall Study||360||
59815979|NCT00531050|75938374|FG001|STARTED|Part 1: Period 3||4||
59815980|NCT00531050|75938375|FG002|STARTED|Part 1: Period 3||4||
59815981|NCT00531050|75938376|FG003|STARTED|Part 1: Period 3||4||
59815982|NCT00531050|75938377|FG004|STARTED|Part 1: Period 3||4||
59815983|NCT00531050|75938378|FG005|STARTED|Part 1: Period 3||5||
60078103|NCT01503021|76193138|FG001|STARTED|Overall Study||358||
60078104|NCT01503021|76193137|FG000|Dosed|Overall Study||351||
60078105|NCT01503021|76193138|FG001|Dosed|Overall Study||352||
60078106|NCT01503021|76193137|FG000|Completed Treatment|Overall Study||333||
60078107|NCT01503021|76193138|FG001|Completed Treatment|Overall Study|One patient completed the treatment period but discontinued prior to completing the follow-up visit.|333||
60078108|NCT01503021|76193137|FG000|COMPLETED|Overall Study||333||
60078109|NCT01503021|76193138|FG001|COMPLETED|Overall Study||332||
60078110|NCT01503021|76193137|FG000|NOT COMPLETED|Overall Study||27||
60078111|NCT01503021|76193138|FG001|NOT COMPLETED|Overall Study||26||
60078112|NCT01531725|76193149|FG000|STARTED|Overall Study|5 patients with protocol violation were excluded.|202||
60078113|NCT01531725|76193149|FG000|COMPLETED|Overall Study||197||
60078114|NCT01531725|76193149|FG000|NOT COMPLETED|Overall Study||5||
60078115|NCT01478373|76193153|FG000|STARTED|Treatment Phase||39||
60078116|NCT01478373|76193153|FG000|COMPLETED|Treatment Phase||38||
59546742|NCT01041248|75645414|FG000|STARTED|Overall Study|January 2010|1||
59546743|NCT01041248|75645414|FG000|COMPLETED|Overall Study||1||
59546744|NCT01041248|75645414|FG000|NOT COMPLETED|Overall Study||0||
59546745|NCT02179892|75645421|FG000|STARTED|Overall Study||5||
59546746|NCT02179892|75645422|FG001|STARTED|Overall Study||4||
59546747|NCT02179892|75645421|FG000|COMPLETED|Overall Study||5||
59546748|NCT02179892|75645422|FG001|COMPLETED|Overall Study||4||
59546749|NCT02179892|75645421|FG000|NOT COMPLETED|Overall Study||0||
59546750|NCT02179892|75645422|FG001|NOT COMPLETED|Overall Study||0||
59546751|NCT01092338|75645430|FG000|STARTED|Overall Study||22||
59546752|NCT01092338|75645431|FG001|STARTED|Overall Study||22||
59546753|NCT01092338|75645430|FG000|COMPLETED|Overall Study||21||
59546754|NCT01092338|75645431|FG001|COMPLETED|Overall Study||21||
59546755|NCT01092338|75645430|FG000|NOT COMPLETED|Overall Study||1||
59546756|NCT01092338|75645431|FG001|NOT COMPLETED|Overall Study||1||
59546757|NCT01110434|75645439|FG000|STARTED|Overall Study||40||
59546758|NCT01110434|75645440|FG001|STARTED|Overall Study||26||
59546759|NCT01110434|75645439|FG000|COMPLETED|Overall Study||29||
59546760|NCT01110434|75645440|FG001|COMPLETED|Overall Study||20||
59546761|NCT01110434|75645439|FG000|NOT COMPLETED|Overall Study||11||
59546762|NCT01110434|75645440|FG001|NOT COMPLETED|Overall Study||6||
59546763|NCT01042496|75645448|FG000|STARTED|Overall Study||29||
59546764|NCT01042496|75645449|FG001|STARTED|Overall Study||33||
59546765|NCT01042496|75645448|FG000|COMPLETED|Overall Study||29||
59546766|NCT01042496|75645449|FG001|COMPLETED|Overall Study||33||
59546767|NCT01042496|75645448|FG000|NOT COMPLETED|Overall Study||0||
59546768|NCT01042496|75645449|FG001|NOT COMPLETED|Overall Study||0||
59546769|NCT01111058|75645461|FG000|STARTED|Overall Study||28||
59680032|NCT00352534|75799182|FG002|STARTED|Initial Staging||0||
59815984|NCT00531050|75938373|FG000|COMPLETED|Part 1: Period 3||3||
59546770|NCT01111058|75645462|FG001|STARTED|Overall Study||24||
59546771|NCT01111058|75645461|FG000|COMPLETED|Overall Study||28||
59546772|NCT01111058|75645462|FG001|COMPLETED|Overall Study||24||
59680033|NCT00352534|75799183|FG003|STARTED|Initial Staging||0||
59815985|NCT00531050|75938374|FG001|COMPLETED|Part 1: Period 3||4||
60078117|NCT01478373|76193153|FG000|NOT COMPLETED|Treatment Phase||1||
60078118|NCT01478373|76193153|FG000|STARTED|Survival Phase||38||
59680034|NCT00352534|75799184|FG004|STARTED|Initial Staging||0||
59680035|NCT00352534|75799185|FG005|STARTED|Initial Staging||0||
59680036|NCT00352534|75799186|FG006|STARTED|Initial Staging||0||
59680037|NCT00352534|75799180|FG000|COMPLETED|Initial Staging||203||
59680038|NCT00352534|75799181|FG001|COMPLETED|Initial Staging||588||
59680039|NCT00352534|75799182|FG002|COMPLETED|Initial Staging||0||
59680040|NCT00352534|75799183|FG003|COMPLETED|Initial Staging||0||
59680041|NCT00352534|75799184|FG004|COMPLETED|Initial Staging||0||
59680042|NCT00352534|75799185|FG005|COMPLETED|Initial Staging||0||
59680043|NCT00352534|75799186|FG006|COMPLETED|Initial Staging||0||
59680044|NCT00352534|75799180|FG000|NOT COMPLETED|Initial Staging||8||
59680045|NCT00352534|75799181|FG001|NOT COMPLETED|Initial Staging||9||
60078119|NCT01478373|76193153|FG000|COMPLETED|Survival Phase||0||
60078120|NCT01478373|76193153|FG000|NOT COMPLETED|Survival Phase||38||
60078121|NCT01502709|76193159|FG000|STARTED|Overall Study||5||
60078122|NCT01502709|76193160|FG001|STARTED|Overall Study||0||
60078123|NCT01502709|76193159|FG000|COMPLETED|Overall Study||1||
60078124|NCT01502709|76193160|FG001|COMPLETED|Overall Study||0||
60078125|NCT01502709|76193159|FG000|NOT COMPLETED|Overall Study||4||
60078126|NCT01502709|76193160|FG001|NOT COMPLETED|Overall Study||0||
60078127|NCT01477749|76193167|FG000|STARTED|Overall Study||47||
60078128|NCT01477749|76193167|FG000|COMPLETED|Overall Study||43||
60078129|NCT01477749|76193167|FG000|NOT COMPLETED|Overall Study||4||
60078130|NCT00054028|76193173|FG000|STARTED|Overall Study||31||
60078131|NCT00054028|76193173|FG000|Phase I|Overall Study||9||
60078132|NCT00054028|76193173|FG000|Phase II|Overall Study||22||
60078133|NCT00054028|76193173|FG000|COMPLETED|Overall Study||31||
60078134|NCT00054028|76193173|FG000|NOT COMPLETED|Overall Study||0||
60078135|NCT00058240|76193182|FG000|STARTED|First Dose Level||20||
60078136|NCT00058240|76193183|FG001|STARTED|First Dose Level||3||
60078137|NCT00058240|76193184|FG002|STARTED|First Dose Level||17||
60078138|NCT00058240|76193185|FG003|STARTED|First Dose Level||12||
60078139|NCT00058240|76193182|FG000|Treated|First Dose Level||20||
60078140|NCT00058240|76193183|FG001|Treated|First Dose Level||3||
60078141|NCT00058240|76193184|FG002|Treated|First Dose Level||17||
60078142|NCT00058240|76193185|FG003|Treated|First Dose Level||12||
60078143|NCT00058240|76193182|FG000|COMPLETED|First Dose Level||20||
60078144|NCT00058240|76193183|FG001|COMPLETED|First Dose Level||3||
59546773|NCT01111058|75645461|FG000|NOT COMPLETED|Overall Study||0||
59546774|NCT01111058|75645462|FG001|NOT COMPLETED|Overall Study||0||
59546775|NCT01111370|75645468|FG000|STARTED|Overall Study||60||
59546776|NCT01111370|75645468|FG000|COMPLETED|Overall Study||58||
59546777|NCT01111370|75645468|FG000|NOT COMPLETED|Overall Study||2||
59546778|NCT01112228|75645472|FG000|STARTED|Overall Study||600||
59546779|NCT01112228|75645472|FG000|COMPLETED|Overall Study||600||
59546780|NCT01112228|75645472|FG000|NOT COMPLETED|Overall Study||0||
59546781|NCT01043432|75645482|FG000|STARTED|Overall Study||22||
59546782|NCT01043432|75645483|FG001|STARTED|Overall Study||51||
59546783|NCT01043432|75645484|FG002|STARTED|Overall Study||12||
59546784|NCT01043432|75645485|FG003|STARTED|Overall Study||48||
59546785|NCT01043432|75645482|FG000|COMPLETED|Overall Study||22||
59546786|NCT01043432|75645483|FG001|COMPLETED|Overall Study||51||
59546787|NCT01043432|75645484|FG002|COMPLETED|Overall Study||12||
59546788|NCT01043432|75645485|FG003|COMPLETED|Overall Study||48||
59546789|NCT01043432|75645482|FG000|NOT COMPLETED|Overall Study||0||
59546790|NCT01043432|75645483|FG001|NOT COMPLETED|Overall Study||0||
59546791|NCT01043432|75645484|FG002|NOT COMPLETED|Overall Study||0||
59546792|NCT01043432|75645485|FG003|NOT COMPLETED|Overall Study||0||
59546793|NCT01112696|75645492|FG000|STARTED|Overall Study||100||
59546794|NCT01112696|75645492|FG000|COMPLETED|Overall Study||98||
59546795|NCT01112696|75645492|FG000|NOT COMPLETED|Overall Study||2||
59680046|NCT00352534|75799182|FG002|NOT COMPLETED|Initial Staging||0||
59546796|NCT01094522|75645499|FG000|STARTED|Overall Study||20||
59546797|NCT01094522|75645500|FG001|STARTED|Overall Study||20||
59680047|NCT00352534|75799183|FG003|NOT COMPLETED|Initial Staging||0||
60078145|NCT00058240|76193184|FG002|COMPLETED|First Dose Level||17||
60078146|NCT00058240|76193185|FG003|COMPLETED|First Dose Level||12||
60078147|NCT00058240|76193182|FG000|NOT COMPLETED|First Dose Level||0||
60078148|NCT00058240|76193183|FG001|NOT COMPLETED|First Dose Level||0||
59680048|NCT00352534|75799184|FG004|NOT COMPLETED|Initial Staging||0||
59680049|NCT00352534|75799185|FG005|NOT COMPLETED|Initial Staging||0||
59680050|NCT00352534|75799186|FG006|NOT COMPLETED|Initial Staging||0||
59680051|NCT00352534|75799180|FG000|STARTED|Final Risk Group Assignment||0||
59680052|NCT00352534|75799181|FG001|STARTED|Final Risk Group Assignment||0||
59680053|NCT00352534|75799182|FG002|STARTED|Final Risk Group Assignment||119||
59680054|NCT00352534|75799183|FG003|STARTED|Final Risk Group Assignment||52||
59680055|NCT00352534|75799184|FG004|STARTED|Final Risk Group Assignment||32||
59680056|NCT00352534|75799185|FG005|STARTED|Final Risk Group Assignment||548||
59680057|NCT00352534|75799186|FG006|STARTED|Final Risk Group Assignment||40||
59680058|NCT00352534|75799180|FG000|COMPLETED|Final Risk Group Assignment||0||
59680059|NCT00352534|75799181|FG001|COMPLETED|Final Risk Group Assignment||0||
59680060|NCT00352534|75799182|FG002|COMPLETED|Final Risk Group Assignment||116||
60078149|NCT00058240|76193184|FG002|NOT COMPLETED|First Dose Level||0||
60078150|NCT00058240|76193185|FG003|NOT COMPLETED|First Dose Level||0||
60078151|NCT00058240|76193182|FG000|STARTED|Second Dose Level||0||
60078152|NCT00058240|76193183|FG001|STARTED|Second Dose Level||0||
60078153|NCT00058240|76193184|FG002|STARTED|Second Dose Level|2 patients were previously treated at Dose level 1, relapsed, and retreated at Dose level 3.|2||
60078154|NCT00058240|76193185|FG003|STARTED|Second Dose Level|4 patients previously relapsed on a different Dose level and were retreated at Dose level 4.|4||
60078155|NCT00058240|76193182|FG000|COMPLETED|Second Dose Level||0||
60078156|NCT00058240|76193183|FG001|COMPLETED|Second Dose Level||0||
60078157|NCT00058240|76193184|FG002|COMPLETED|Second Dose Level||2||
60078158|NCT00058240|76193185|FG003|COMPLETED|Second Dose Level||4||
60078159|NCT00058240|76193182|FG000|NOT COMPLETED|Second Dose Level||0||
60078160|NCT00058240|76193183|FG001|NOT COMPLETED|Second Dose Level||0||
60078161|NCT00058240|76193184|FG002|NOT COMPLETED|Second Dose Level||0||
60078162|NCT00058240|76193185|FG003|NOT COMPLETED|Second Dose Level||0||
60078163|NCT01502631|76193197|FG000|STARTED|Overall Study||30||
60078164|NCT01502631|76193198|FG001|STARTED|Overall Study||31||
60078165|NCT01502631|76193197|FG000|COMPLETED|Overall Study||10||
60078166|NCT01502631|76193198|FG001|COMPLETED|Overall Study||11||
60078167|NCT01502631|76193197|FG000|NOT COMPLETED|Overall Study||20||
60078168|NCT01502631|76193198|FG001|NOT COMPLETED|Overall Study||20||
60078169|NCT00060424|76193204|FG000|STARTED|Overall Study||21||
60078170|NCT00060424|76193204|FG000|COMPLETED|Overall Study||21||
60078171|NCT00060424|76193204|FG000|NOT COMPLETED|Overall Study||0||
60078172|NCT00062764|76193208|FG000|STARTED|Overall Study||18||
60078173|NCT00062764|76193208|FG000|COMPLETED|Overall Study||18||
60078174|NCT00062764|76193208|FG000|NOT COMPLETED|Overall Study||0||
60078175|NCT00063232|76193212|FG000|STARTED|Overall Study||26||
60078176|NCT00063232|76193212|FG000|COMPLETED|Overall Study||26||
60078177|NCT00063232|76193212|FG000|NOT COMPLETED|Overall Study||0||
60078178|NCT00063622|76193219|FG000|STARTED|Overall Study||80||
60078179|NCT00063622|76193220|FG001|STARTED|Overall Study||84||
60078180|NCT00063622|76193221|FG002|STARTED|Overall Study||83||
60078181|NCT00063622|76193219|FG000|COMPLETED|Overall Study|All randomized patients were included in analysis of primary outcome|70||
60078182|NCT00063622|76193220|FG001|COMPLETED|Overall Study|All randomized patients were included in analysis of primary outcome|80||
60078183|NCT00063622|76193221|FG002|COMPLETED|Overall Study|All randomized patients were included in analysis of primary outcome|72||
60078184|NCT00063622|76193219|FG000|NOT COMPLETED|Overall Study||10||
60078185|NCT00063622|76193220|FG001|NOT COMPLETED|Overall Study||4||
60078186|NCT00063622|76193221|FG002|NOT COMPLETED|Overall Study||11||
60078187|NCT00153166|76193232|FG000|STARTED|Overall Study||11||
59680061|NCT00352534|75799183|FG003|COMPLETED|Final Risk Group Assignment||49||
59680062|NCT00352534|75799184|FG004|COMPLETED|Final Risk Group Assignment||31||
59680063|NCT00352534|75799185|FG005|COMPLETED|Final Risk Group Assignment||503||
59680064|NCT00352534|75799186|FG006|COMPLETED|Final Risk Group Assignment||1||
59680065|NCT00352534|75799180|FG000|NOT COMPLETED|Final Risk Group Assignment||0||
59680066|NCT00352534|75799181|FG001|NOT COMPLETED|Final Risk Group Assignment||0||
59680067|NCT00352534|75799182|FG002|NOT COMPLETED|Final Risk Group Assignment||3||
59680068|NCT00352534|75799183|FG003|NOT COMPLETED|Final Risk Group Assignment||3||
60078188|NCT00153166|76193233|FG001|STARTED|Overall Study||37||
60078189|NCT00153166|76193234|FG002|STARTED|Overall Study||28||
60078190|NCT00153166|76193232|FG000|Received Atorvastatin and Pioglitazone|Overall Study||3||
60078191|NCT00153166|76193233|FG001|Received Atorvastatin and Pioglitazone|Overall Study||9||
60078192|NCT00153166|76193234|FG002|Received Atorvastatin and Pioglitazone|Overall Study||7||
60078193|NCT00153166|76193232|FG000|Received Atorvastatin and Placebo|Overall Study||2||
59680069|NCT00352534|75799184|FG004|NOT COMPLETED|Final Risk Group Assignment||1||
59680070|NCT00352534|75799185|FG005|NOT COMPLETED|Final Risk Group Assignment||45||
59680071|NCT00352534|75799186|FG006|NOT COMPLETED|Final Risk Group Assignment||39||
59709765|NCT01072149|75828531|FG011|NOT COMPLETED|Treatment Period 1 (28 Days)||0||
60078194|NCT00153166|76193233|FG001|Received Atorvastatin and Placebo|Overall Study||9||
60078195|NCT00153166|76193234|FG002|Received Atorvastatin and Placebo|Overall Study||7||
60078196|NCT00153166|76193232|FG000|Received Placebo and Pioglitazone|Overall Study||3||
60078197|NCT00153166|76193233|FG001|Received Placebo and Pioglitazone|Overall Study||10||
60078198|NCT00153166|76193234|FG002|Received Placebo and Pioglitazone|Overall Study||7||
60078199|NCT00153166|76193232|FG000|Received Placebo and Placebo|Overall Study||3||
60078200|NCT00153166|76193233|FG001|Received Placebo and Placebo|Overall Study||9||
60078201|NCT00153166|76193234|FG002|Received Placebo and Placebo|Overall Study||7||
59680072|NCT01217047|75799200|FG000|STARTED|Overall Study||3||
59680073|NCT01217047|75799201|FG001|STARTED|Overall Study||4||
59680074|NCT01217047|75799202|FG002|STARTED|Overall Study||3||
60078202|NCT00153166|76193232|FG000|COMPLETED|Overall Study||11||
60078203|NCT00153166|76193233|FG001|COMPLETED|Overall Study||37||
60078204|NCT00153166|76193234|FG002|COMPLETED|Overall Study||28||
60078205|NCT00153166|76193232|FG000|NOT COMPLETED|Overall Study||0||
60078206|NCT00153166|76193233|FG001|NOT COMPLETED|Overall Study||0||
60078207|NCT00153166|76193234|FG002|NOT COMPLETED|Overall Study||0||
60078208|NCT00156910|76193245|FG000|STARTED|Double-Blind Phase (DB)||341||
60078209|NCT00156910|76193246|FG001|STARTED|Double-Blind Phase (DB)||338||
60078210|NCT00156910|76193245|FG000|COMPLETED|Double-Blind Phase (DB)|Completed Week 24|296||
60078211|NCT00156910|76193246|FG001|COMPLETED|Double-Blind Phase (DB)|Completed Week 24|295||
60078212|NCT00156910|76193245|FG000|NOT COMPLETED|Double-Blind Phase (DB)||45||
60078213|NCT00156910|76193246|FG001|NOT COMPLETED|Double-Blind Phase (DB)||43||
60078214|NCT00156910|76193245|FG000|STARTED|Open-Label Phase (OL)|Number of DB Botulinum toxin type A patients who rolled into OL phase|285||
60078215|NCT00156910|76193246|FG001|STARTED|Open-Label Phase (OL)|Number of DB Placebo patients who rolled into OL Phase|286||
60078216|NCT00156910|76193245|FG000|COMPLETED|Open-Label Phase (OL)||252||
60078217|NCT00156910|76193246|FG001|COMPLETED|Open-Label Phase (OL)||231||
60078218|NCT00156910|76193245|FG000|NOT COMPLETED|Open-Label Phase (OL)||33||
60078219|NCT00156910|76193246|FG001|NOT COMPLETED|Open-Label Phase (OL)||55||
59546798|NCT01094522|75645499|FG000|COMPLETED|Overall Study||20||
59546799|NCT01094522|75645500|FG001|COMPLETED|Overall Study||20||
59546800|NCT01094522|75645499|FG000|NOT COMPLETED|Overall Study||0||
59546801|NCT01094522|75645500|FG001|NOT COMPLETED|Overall Study||0||
59546802|NCT02178800|75645509|FG000|STARTED|Overall Study||151||
60078220|NCT01475721|76193254|FG000|STARTED|Overall Study||5834||
60078221|NCT01475721|76193255|FG001|STARTED|Overall Study||5845||
60078222|NCT01475721|76193254|FG000|COMPLETED|Overall Study||5823||
60078223|NCT01475721|76193255|FG001|COMPLETED|Overall Study||5831||
59546803|NCT02178800|75645510|FG001|STARTED|Overall Study||48||
59546804|NCT02178800|75645509|FG000|COMPLETED|Overall Study|Number of participants who weren't terminated at week 41|131||
59546805|NCT02178800|75645510|FG001|COMPLETED|Overall Study|Number of participants who weren't terminated at week 41|42||
59546806|NCT02178800|75645509|FG000|NOT COMPLETED|Overall Study||20||
59546807|NCT02178800|75645510|FG001|NOT COMPLETED|Overall Study||6||
59546808|NCT01044212|75645526|FG000|STARTED|Overall Study||35||
59546809|NCT01044212|75645527|FG001|STARTED|Overall Study||37||
59546810|NCT01044212|75645526|FG000|COMPLETED|Overall Study||30||
59546811|NCT01044212|75645527|FG001|COMPLETED|Overall Study||30||
59546812|NCT01044212|75645526|FG000|NOT COMPLETED|Overall Study||5||
59546813|NCT01044212|75645527|FG001|NOT COMPLETED|Overall Study||7||
59546814|NCT02174510|75645537|FG000|STARTED|Overall Study||8||
59546815|NCT02174510|75645538|FG001|STARTED|Overall Study||8||
60078224|NCT01475721|76193254|FG000|NOT COMPLETED|Overall Study||11||
59546816|NCT02174510|75645539|FG002|STARTED|Overall Study||12||
59546817|NCT02174510|75645540|FG003|STARTED|Overall Study||9||
59546818|NCT02174510|75645537|FG000|COMPLETED|Overall Study||8||
59546819|NCT02174510|75645538|FG001|COMPLETED|Overall Study||8||
59546820|NCT02174510|75645539|FG002|COMPLETED|Overall Study||12||
59546821|NCT02174510|75645540|FG003|COMPLETED|Overall Study||9||
59546822|NCT02174510|75645537|FG000|NOT COMPLETED|Overall Study||0||
59546823|NCT02174510|75645538|FG001|NOT COMPLETED|Overall Study||0||
59546824|NCT02174510|75645539|FG002|NOT COMPLETED|Overall Study||0||
59546825|NCT02174510|75645540|FG003|NOT COMPLETED|Overall Study||0||
59546826|NCT01113008|75645551|FG000|STARTED|Overall Study||133||
59546827|NCT01113008|75645552|FG001|STARTED|Overall Study||133||
59680075|NCT01217047|75799200|FG000|COMPLETED|Overall Study||3||
59680076|NCT01217047|75799201|FG001|COMPLETED|Overall Study||3||
59546828|NCT01113008|75645551|FG000|COMPLETED|Overall Study||133||
59546829|NCT01113008|75645552|FG001|COMPLETED|Overall Study||133||
59546830|NCT01113008|75645551|FG000|NOT COMPLETED|Overall Study||0||
59546831|NCT01113008|75645552|FG001|NOT COMPLETED|Overall Study||0||
59546832|NCT00585195|75645579|FG000|STARTED|Overall Study||3||
59546833|NCT00585195|75645580|FG001|STARTED|Overall Study||4||
60078225|NCT01475721|76193255|FG001|NOT COMPLETED|Overall Study||14||
60078226|NCT00065806|76193263|FG000|STARTED|Overall Study||113||
60078227|NCT00065806|76193264|FG001|STARTED|Overall Study||108||
60078228|NCT00065806|76193263|FG000|COMPLETED|Overall Study||93||
60078229|NCT00065806|76193264|FG001|COMPLETED|Overall Study||89||
60078230|NCT00065806|76193263|FG000|NOT COMPLETED|Overall Study||20||
60078231|NCT00065806|76193264|FG001|NOT COMPLETED|Overall Study||19||
60078232|NCT02091466|76193272|FG000|STARTED|Overall Study||20||
60078233|NCT02091466|76193273|FG001|STARTED|Overall Study||20||
60078234|NCT02091466|76193272|FG000|COMPLETED|Overall Study||20||
60078235|NCT02091466|76193273|FG001|COMPLETED|Overall Study||20||
60078236|NCT02091466|76193272|FG000|NOT COMPLETED|Overall Study||0||
60078237|NCT02091466|76193273|FG001|NOT COMPLETED|Overall Study||0||
60078238|NCT01530087|76193279|FG000|STARTED|Overall Study||3||
59546834|NCT00585195|75645581|FG002|STARTED|Overall Study||9||
59546835|NCT00585195|75645582|FG003|STARTED|Overall Study||7||
59546836|NCT00585195|75645583|FG004|STARTED|Overall Study||9||
59546837|NCT00585195|75645584|FG005|STARTED|Overall Study||6||
59546838|NCT00585195|75645585|FG006|STARTED|Overall Study||7||
59546839|NCT00585195|75645586|FG007|STARTED|Overall Study||5||
59680077|NCT01217047|75799202|FG002|COMPLETED|Overall Study||3||
59680078|NCT01217047|75799200|FG000|NOT COMPLETED|Overall Study||0||
59680079|NCT01217047|75799201|FG001|NOT COMPLETED|Overall Study||1||
60078239|NCT01530087|76193279|FG000|COMPLETED|Overall Study||1||
60078240|NCT01530087|76193279|FG000|NOT COMPLETED|Overall Study||2||
60078241|NCT00068770|76193286|FG000|STARTED|Overall Study||13||
60078242|NCT00068770|76193287|FG001|STARTED|Overall Study||22||
60078243|NCT00068770|76193286|FG000|COMPLETED|Overall Study||13||
60078244|NCT00068770|76193287|FG001|COMPLETED|Overall Study||22||
60078245|NCT00068770|76193286|FG000|NOT COMPLETED|Overall Study||0||
60078246|NCT00068770|76193287|FG001|NOT COMPLETED|Overall Study||0||
60078247|NCT01475487|76193297|FG000|STARTED|Overall Study||25||
60078248|NCT01475487|76193298|FG001|STARTED|Overall Study||25||
60078249|NCT01475487|76193297|FG000|COMPLETED|Overall Study||23||
60078250|NCT01475487|76193298|FG001|COMPLETED|Overall Study||24||
60078251|NCT01475487|76193297|FG000|NOT COMPLETED|Overall Study||2||
60078252|NCT01475487|76193298|FG001|NOT COMPLETED|Overall Study||1||
60078253|NCT01475331|76193306|FG000|STARTED|Overall Study||23||
60078254|NCT01475331|76193307|FG001|STARTED|Overall Study||23||
60078255|NCT01475331|76193306|FG000|COMPLETED|Overall Study||18||
60078256|NCT01475331|76193307|FG001|COMPLETED|Overall Study||21||
60078257|NCT01475331|76193306|FG000|NOT COMPLETED|Overall Study||5||
60078258|NCT01475331|76193307|FG001|NOT COMPLETED|Overall Study||2||
60078259|NCT01500213|76193315|FG000|STARTED|Overall Study|Number of randomized patients|278||
60078260|NCT01500213|76193316|FG001|STARTED|Overall Study||277||
60078261|NCT01500213|76193315|FG000|COMPLETED|Overall Study|Number of patients who completed 6 cycles|61||
60078262|NCT01500213|76193316|FG001|COMPLETED|Overall Study||53||
60078263|NCT01500213|76193315|FG000|NOT COMPLETED|Overall Study||217||
60078264|NCT01500213|76193316|FG001|NOT COMPLETED|Overall Study||224||
60078265|NCT00069160|76193324|FG000|STARTED|Overall Study||23||
60078266|NCT00069160|76193325|FG001|STARTED|Overall Study||25||
60078267|NCT00069160|76193324|FG000|COMPLETED|Overall Study||23||
60078268|NCT00069160|76193325|FG001|COMPLETED|Overall Study||25||
59546840|NCT00585195|75645587|FG008|STARTED|Overall Study||3||
59546841|NCT00585195|75645588|FG009|STARTED|Overall Study||6||
59546842|NCT00585195|75645589|FG010|STARTED|Overall Study||11||
60078269|NCT00069160|76193324|FG000|NOT COMPLETED|Overall Study||0||
60078270|NCT00069160|76193325|FG001|NOT COMPLETED|Overall Study||0||
60078271|NCT00071890|76193336|FG000|STARTED|Overall Study|3 patients did not received Interleukin-2|81||
60078272|NCT00071890|76193337|FG001|STARTED|Overall Study|1 patients stopped HAART at week 0|67||
60078273|NCT00071890|76193336|FG000|COMPLETED|Overall Study|"1 withdrawal~1 death 81 patients analysed"|81||
60078274|NCT00071890|76193337|FG001|COMPLETED|Overall Study|"1 withdrawal~1 lost of follow-up~1 death 67 patients analysed"|67||
60078275|NCT00071890|76193336|FG000|NOT COMPLETED|Overall Study||0||
60078276|NCT00071890|76193337|FG001|NOT COMPLETED|Overall Study||0||
60078277|NCT01475253|76193346|FG000|STARTED|Randomized, Blinded Study||47||
60078278|NCT01475253|76193347|FG001|STARTED|Randomized, Blinded Study||46||
60078279|NCT01475253|76193348|FG002|STARTED|Randomized, Blinded Study||11||
60078280|NCT01475253|76193349|FG003|STARTED|Randomized, Blinded Study||0||
60078281|NCT01475253|76193346|FG000|COMPLETED|Randomized, Blinded Study||45||
60078282|NCT01475253|76193347|FG001|COMPLETED|Randomized, Blinded Study||45||
60078283|NCT01475253|76193348|FG002|COMPLETED|Randomized, Blinded Study||11||
60078284|NCT01475253|76193349|FG003|COMPLETED|Randomized, Blinded Study||0||
59546843|NCT00585195|75645590|FG011|STARTED|Overall Study||53||
59546844|NCT00585195|75645591|FG012|STARTED|Overall Study||85||
59546845|NCT00585195|75645592|FG013|STARTED|Overall Study||41||
59546846|NCT00585195|75645593|FG014|STARTED|Overall Study||48||
59546847|NCT00585195|75645594|FG015|STARTED|Overall Study||19||
59546848|NCT00585195|75645595|FG016|STARTED|Overall Study||154||
60078285|NCT01475253|76193346|FG000|NOT COMPLETED|Randomized, Blinded Study||2||
60078286|NCT01475253|76193347|FG001|NOT COMPLETED|Randomized, Blinded Study||1||
60078287|NCT01475253|76193348|FG002|NOT COMPLETED|Randomized, Blinded Study||0||
60078288|NCT01475253|76193349|FG003|NOT COMPLETED|Randomized, Blinded Study||0||
60078289|NCT01475253|76193346|FG000|STARTED|Open Label Extension||0||
60078290|NCT01475253|76193347|FG001|STARTED|Open Label Extension||0||
60078291|NCT01475253|76193348|FG002|STARTED|Open Label Extension||0||
60078292|NCT01475253|76193349|FG003|STARTED|Open Label Extension||56||
60078293|NCT01475253|76193346|FG000|COMPLETED|Open Label Extension||0||
60078294|NCT01475253|76193347|FG001|COMPLETED|Open Label Extension||0||
60078295|NCT01475253|76193348|FG002|COMPLETED|Open Label Extension||0||
59546849|NCT00585195|75645596|FG017|STARTED|Overall Study||67||
59546850|NCT00585195|75645597|FG018|STARTED|Overall Study||21||
60078296|NCT01475253|76193349|FG003|COMPLETED|Open Label Extension||56||
60078297|NCT01475253|76193346|FG000|NOT COMPLETED|Open Label Extension||0||
59546851|NCT00585195|75645598|FG019|STARTED|Overall Study||18||
59546852|NCT00585195|75645599|FG020|STARTED|Overall Study||14||
60078298|NCT01475253|76193347|FG001|NOT COMPLETED|Open Label Extension||0||
60078299|NCT01475253|76193348|FG002|NOT COMPLETED|Open Label Extension||0||
60078300|NCT01475253|76193349|FG003|NOT COMPLETED|Open Label Extension||0||
60078301|NCT00072514|76193357|FG000|STARTED|Overall Study||55||
60078302|NCT00072514|76193357|FG000|COMPLETED|Overall Study||51||
60078303|NCT00072514|76193357|FG000|NOT COMPLETED|Overall Study||4||
60078304|NCT00074308|76193363|FG000|STARTED|Overall Study||3||
60078305|NCT00074308|76193364|FG001|STARTED|Overall Study||3||
60078306|NCT00074308|76193365|FG002|STARTED|Overall Study||3||
60078307|NCT00074308|76193366|FG003|STARTED|Overall Study||8||
60078308|NCT00074308|76193367|FG004|STARTED|Overall Study||23||
60078309|NCT00074308|76193363|FG000|COMPLETED|Overall Study||3||
60078310|NCT00074308|76193364|FG001|COMPLETED|Overall Study||3||
60078311|NCT00074308|76193365|FG002|COMPLETED|Overall Study||3||
60078312|NCT00074308|76193366|FG003|COMPLETED|Overall Study||8||
60078313|NCT00074308|76193367|FG004|COMPLETED|Overall Study||23||
60078314|NCT00074308|76193363|FG000|NOT COMPLETED|Overall Study||0||
60078315|NCT00074308|76193364|FG001|NOT COMPLETED|Overall Study||0||
60078316|NCT00074308|76193365|FG002|NOT COMPLETED|Overall Study||0||
60078317|NCT00074308|76193366|FG003|NOT COMPLETED|Overall Study||0||
60078318|NCT00074308|76193367|FG004|NOT COMPLETED|Overall Study||0||
60078319|NCT00159250|76193379|FG000|STARTED|Overall Study||2||
60078320|NCT00159250|76193380|FG001|STARTED|Overall Study||5||
60078321|NCT00159250|76193379|FG000|COMPLETED|Overall Study||2||
60078322|NCT00159250|76193380|FG001|COMPLETED|Overall Study||5||
60078323|NCT00159250|76193379|FG000|NOT COMPLETED|Overall Study||0||
60078324|NCT00159250|76193380|FG001|NOT COMPLETED|Overall Study||0||
60078325|NCT00165958|76193388|FG000|STARTED|Overall Study||19||
60078326|NCT00165958|76193389|FG001|STARTED|Overall Study||21||
60078327|NCT00165958|76193388|FG000|COMPLETED|Overall Study||18||
60078328|NCT00165958|76193389|FG001|COMPLETED|Overall Study||19||
60078329|NCT00165958|76193388|FG000|NOT COMPLETED|Overall Study||1||
60078330|NCT00165958|76193389|FG001|NOT COMPLETED|Overall Study||2||
60078331|NCT00166036|76193397|FG000|STARTED|Overall Study||17||
60078332|NCT00166036|76193398|FG001|STARTED|Overall Study||19||
60078333|NCT00166036|76193397|FG000|COMPLETED|Overall Study||17||
60078334|NCT00166036|76193398|FG001|COMPLETED|Overall Study||19||
60078335|NCT00166036|76193397|FG000|NOT COMPLETED|Overall Study||0||
60078336|NCT00166036|76193398|FG001|NOT COMPLETED|Overall Study||0||
60078337|NCT01500135|76193407|FG000|STARTED|Overall Study||100||
60078338|NCT01500135|76193408|FG001|STARTED|Overall Study||50||
60078339|NCT01500135|76193407|FG000|COMPLETED|Overall Study||83||
60078340|NCT01500135|76193408|FG001|COMPLETED|Overall Study||39||
60078341|NCT01500135|76193407|FG000|NOT COMPLETED|Overall Study||17||
60078342|NCT01500135|76193408|FG001|NOT COMPLETED|Overall Study||11||
60078343|NCT00167206|76193414|FG000|STARTED|Overall Study||16||
60078344|NCT00167206|76193414|FG000|COMPLETED|Overall Study||16||
60078345|NCT00167206|76193414|FG000|NOT COMPLETED|Overall Study||0||
60078346|NCT01475097|76193420|FG000|STARTED|Overall Study||128||
60078347|NCT01475097|76193421|FG001|STARTED|Overall Study||127||
60078348|NCT01475097|76193420|FG000|COMPLETED|Overall Study||127||
60078349|NCT01475097|76193421|FG001|COMPLETED|Overall Study||126||
60078350|NCT01475097|76193420|FG000|NOT COMPLETED|Overall Study||1||
60078351|NCT01475097|76193421|FG001|NOT COMPLETED|Overall Study||1||
60078352|NCT01529385|76193429|FG000|STARTED|Overall Study||40||
60078353|NCT01529385|76193430|FG001|STARTED|Overall Study||40||
60078354|NCT01529385|76193429|FG000|Received Intervention|Overall Study|1 participant failed to show up to treatment allocation visit and was subsequently lost to follow up|39||
60078355|NCT01529385|76193430|FG001|Received Intervention|Overall Study||40||
60078356|NCT01529385|76193429|FG000|COMPLETED|Overall Study||38||
60078357|NCT01529385|76193430|FG001|COMPLETED|Overall Study||39||
60078358|NCT01529385|76193429|FG000|NOT COMPLETED|Overall Study||2||
59546853|NCT00585195|75645579|FG000|Treated|Overall Study||3||
60078359|NCT01529385|76193430|FG001|NOT COMPLETED|Overall Study||1||
60078360|NCT01474551|76193436|FG000|STARTED|Overall Study||2||
60078361|NCT01474551|76193436|FG000|COMPLETED|Overall Study||1||
60078362|NCT01474551|76193436|FG000|NOT COMPLETED|Overall Study||1||
60078363|NCT02094586|76193444|FG000|STARTED|Overall Study||927||
59546854|NCT00585195|75645580|FG001|Treated|Overall Study||4||
60078364|NCT02094586|76193445|FG001|STARTED|Overall Study||933||
60078365|NCT02094586|76193446|FG002|STARTED|Overall Study||935||
60078366|NCT02094586|76193447|FG003|STARTED|Overall Study||351||
60078367|NCT02094586|76193444|FG000|COMPLETED|Overall Study||848|Study Completion (Day 181) - Completion of study is based upon the Study Completion/Early Term eCRF|
60078368|NCT02094586|76193445|FG001|COMPLETED|Overall Study||866|Study Completion (Day 181) - Completion of study is based upon the Study Completion/Early Term eCRF|
59546855|NCT00585195|75645581|FG002|Treated|Overall Study||8||
60078369|NCT02094586|76193446|FG002|COMPLETED|Overall Study||876|Study Completion (Day 181) - Completion of study is based upon the Study Completion/Early Term eCRF|
60078370|NCT02094586|76193447|FG003|COMPLETED|Overall Study||331|Study Completion (Day 181) - Completion of study is based upon the Study Completion/Early Term eCRF|
60078371|NCT02094586|76193444|FG000|NOT COMPLETED|Overall Study||79||
60078372|NCT02094586|76193445|FG001|NOT COMPLETED|Overall Study||67||
60078373|NCT02094586|76193446|FG002|NOT COMPLETED|Overall Study||59||
60078374|NCT02094586|76193447|FG003|NOT COMPLETED|Overall Study||20||
60078375|NCT01500057|76193471|FG000|STARTED|Overall Study||31||
60078376|NCT01500057|76193472|FG001|STARTED|Overall Study||35||
60078377|NCT01500057|76193471|FG000|COMPLETED|Overall Study||25||
60078378|NCT01500057|76193472|FG001|COMPLETED|Overall Study||31||
60078379|NCT01500057|76193471|FG000|NOT COMPLETED|Overall Study||6||
60078380|NCT01500057|76193472|FG001|NOT COMPLETED|Overall Study||4||
60078381|NCT02094664|76193480|FG000|STARTED|Overall Study||16||
60078382|NCT02094664|76193481|FG001|STARTED|Overall Study||16||
60078383|NCT02094664|76193480|FG000|COMPLETED|Overall Study||16||
60078384|NCT02094664|76193481|FG001|COMPLETED|Overall Study||16||
60078385|NCT02094664|76193480|FG000|NOT COMPLETED|Overall Study||0||
60078386|NCT02094664|76193481|FG001|NOT COMPLETED|Overall Study||0||
60078387|NCT01499667|76193490|FG000|STARTED|Overall Study|"Started indicates randomized as well as safety population."|50||
60078388|NCT01499667|76193491|FG001|STARTED|Overall Study||42||
60078389|NCT01499667|76193492|FG002|STARTED|Overall Study||50||
60078390|NCT01499667|76193490|FG000|Full Analysis Set (FAS)|Overall Study|One randomized patient did not receive natalizumub at screening, which was a requirement for FAS.|49||
60078391|NCT01499667|76193491|FG001|Full Analysis Set (FAS)|Overall Study||42||
60078392|NCT01499667|76193492|FG002|Full Analysis Set (FAS)|Overall Study||50||
60078393|NCT01499667|76193490|FG000|Modified Full Analysis Set|Overall Study|mFAS included all FAS patients who completed 8 wks of fingolimod treatment with MRI scan|41||
59680080|NCT01217047|75799202|FG002|NOT COMPLETED|Overall Study||0||
59680081|NCT01185340|75799214|FG000|STARTED|Confirmation (CF) Phase, 3 Weeks||1056||
59680082|NCT01185340|75799215|FG001|STARTED|Confirmation (CF) Phase, 3 Weeks||0||
59680083|NCT01185340|75799216|FG002|STARTED|Confirmation (CF) Phase, 3 Weeks||0||
59680084|NCT01185340|75799217|FG003|STARTED|Confirmation (CF) Phase, 3 Weeks||0||
59680085|NCT01185340|75799214|FG000|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks|Participants who discontinued the CF Phase early had the option to enter the DC Phase.|18||
59680086|NCT01185340|75799215|FG001|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0||
59680087|NCT01185340|75799216|FG002|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0||
59680088|NCT01185340|75799217|FG003|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0||
59680089|NCT01185340|75799214|FG000|COMPLETED|Confirmation (CF) Phase, 3 Weeks|Participants who completed the CF Phase entered the Adjunctive Treatment (AT) Phase.|968||
59680090|NCT01185340|75799215|FG001|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0||
59680091|NCT01185340|75799216|FG002|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0||
59680092|NCT01185340|75799217|FG003|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0||
59680093|NCT01185340|75799214|FG000|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||88||
59680094|NCT01185340|75799215|FG001|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0||
59680095|NCT01185340|75799216|FG002|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0||
59680096|NCT01185340|75799217|FG003|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0||
59680097|NCT01185340|75799214|FG000|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||0||
59680098|NCT01185340|75799215|FG001|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||230||
59680099|NCT01185340|75799216|FG002|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||219||
59680100|NCT01185340|75799217|FG003|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||519||
59680101|NCT01185340|75799214|FG000|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0||
59680102|NCT01185340|75799215|FG001|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|206||
59680103|NCT01185340|75799216|FG002|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|204||
60078394|NCT01499667|76193491|FG001|Modified Full Analysis Set|Overall Study||29||
60078395|NCT01499667|76193492|FG002|Modified Full Analysis Set|Overall Study||39||
60078396|NCT01499667|76193490|FG000|COMPLETED|Overall Study||41||
60078397|NCT01499667|76193491|FG001|COMPLETED|Overall Study||31||
60078398|NCT01499667|76193492|FG002|COMPLETED|Overall Study||40||
60078399|NCT01499667|76193490|FG000|NOT COMPLETED|Overall Study||9||
60078400|NCT01499667|76193491|FG001|NOT COMPLETED|Overall Study||11||
59680104|NCT01185340|75799217|FG003|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|483||
59680105|NCT01185340|75799214|FG000|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0||
59680106|NCT01185340|75799215|FG001|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||195||
59680107|NCT01185340|75799216|FG002|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||186||
59680108|NCT01185340|75799217|FG003|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||458||
59680109|NCT01185340|75799214|FG000|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0||
59680110|NCT01185340|75799215|FG001|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||35||
60078401|NCT01499667|76193492|FG002|NOT COMPLETED|Overall Study||10||
60078402|NCT01499511|76193502|FG000|STARTED|Overall Study||885||
60078403|NCT01499511|76193503|FG001|STARTED|Overall Study||833||
59680111|NCT01185340|75799216|FG002|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||33||
59680112|NCT01185340|75799217|FG003|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||61||
59680113|NCT01216189|75799231|FG000|STARTED|Overall Study||110||
59680114|NCT01216189|75799232|FG001|STARTED|Overall Study||32||
59680115|NCT01216189|75799231|FG000|COMPLETED|Overall Study||85||
59680116|NCT01216189|75799232|FG001|COMPLETED|Overall Study||27||
59680117|NCT01216189|75799231|FG000|NOT COMPLETED|Overall Study||25||
59680118|NCT01216189|75799232|FG001|NOT COMPLETED|Overall Study||5||
59680119|NCT01185301|75799242|FG000|STARTED|Overall Study||98||
59680120|NCT01185301|75799243|FG001|STARTED|Overall Study||100||
59680121|NCT01185301|75799244|FG002|STARTED|Overall Study||99||
59680122|NCT01185301|75799245|FG003|STARTED|Overall Study||98||
59680123|NCT01185301|75799242|FG000|COMPLETED|Overall Study||83||
59680124|NCT01185301|75799243|FG001|COMPLETED|Overall Study||93||
60078404|NCT01499511|76193502|FG000|COMPLETED|Overall Study||884||
60078405|NCT01499511|76193503|FG001|COMPLETED|Overall Study||833||
60078406|NCT01499511|76193502|FG000|NOT COMPLETED|Overall Study||1||
60078407|NCT01499511|76193503|FG001|NOT COMPLETED|Overall Study||0||
60078408|NCT00168298|76193513|FG000|STARTED|Double-Blind Period||226||
60078409|NCT00168298|76193514|FG001|STARTED|Double-Blind Period||218||
60078410|NCT00168298|76193515|FG002|STARTED|Double-Blind Period||224||
60078411|NCT00168298|76193513|FG000|COMPLETED|Double-Blind Period||214||
60078412|NCT00168298|76193514|FG001|COMPLETED|Double-Blind Period||206||
59680125|NCT01185301|75799244|FG002|COMPLETED|Overall Study||93||
59680126|NCT01185301|75799245|FG003|COMPLETED|Overall Study||89||
59680127|NCT01185301|75799242|FG000|NOT COMPLETED|Overall Study||15||
59680128|NCT01185301|75799243|FG001|NOT COMPLETED|Overall Study||7||
59680129|NCT01185301|75799244|FG002|NOT COMPLETED|Overall Study||6||
59680130|NCT01185301|75799245|FG003|NOT COMPLETED|Overall Study||9||
59680131|NCT01216072|75799257|FG000|STARTED|Open-Label Core Period ( 6 Months)||790||
59680132|NCT01216072|75799258|FG001|STARTED|Open-Label Core Period ( 6 Months)||263||
59680133|NCT01216072|75799257|FG000|Full Analysis Set|Open-Label Core Period ( 6 Months)|One patient was randomized in error and was not included in FAS.|789||
59680134|NCT01216072|75799258|FG001|Full Analysis Set|Open-Label Core Period ( 6 Months)||263||
59680135|NCT01216072|75799257|FG000|Safety Set|Open-Label Core Period ( 6 Months)||783||
59680136|NCT01216072|75799258|FG001|Safety Set|Open-Label Core Period ( 6 Months)||245||
60078413|NCT00168298|76193515|FG002|COMPLETED|Double-Blind Period||209||
60078414|NCT00168298|76193513|FG000|NOT COMPLETED|Double-Blind Period||12||
60078415|NCT00168298|76193514|FG001|NOT COMPLETED|Double-Blind Period||12||
60078416|NCT00168298|76193515|FG002|NOT COMPLETED|Double-Blind Period||15||
60078417|NCT00168298|76193513|FG000|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|179||
60078418|NCT00168298|76193514|FG001|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|173||
60078419|NCT00168298|76193515|FG002|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|168||
60078420|NCT00168298|76193513|FG000|COMPLETED|Open-Label Period||172||
60078421|NCT00168298|76193514|FG001|COMPLETED|Open-Label Period||168||
60078422|NCT00168298|76193515|FG002|COMPLETED|Open-Label Period||160||
60078423|NCT00168298|76193513|FG000|NOT COMPLETED|Open-Label Period||7||
60078424|NCT00168298|76193514|FG001|NOT COMPLETED|Open-Label Period||5||
60078425|NCT00168298|76193515|FG002|NOT COMPLETED|Open-Label Period||8||
60078426|NCT01474317|76193523|FG000|STARTED|Overall Study||226||
60078427|NCT01474317|76193523|FG000|COMPLETED|Overall Study||224||
60078428|NCT01474317|76193523|FG000|NOT COMPLETED|Overall Study||2||
60078429|NCT00075088|76193529|FG000|STARTED|Overall Study||403||
60078430|NCT00075088|76193530|FG001|STARTED|Overall Study||391||
60078431|NCT00075088|76193529|FG000|COMPLETED|Overall Study||403||
59680137|NCT01216072|75799257|FG000|COMPLETED|Open-Label Core Period ( 6 Months)||714||
59680138|NCT01216072|75799258|FG001|COMPLETED|Open-Label Core Period ( 6 Months)||229||
59680139|NCT01216072|75799257|FG000|NOT COMPLETED|Open-Label Core Period ( 6 Months)||76||
59680140|NCT01216072|75799258|FG001|NOT COMPLETED|Open-Label Core Period ( 6 Months)||34||
59680141|NCT01216072|75799257|FG000|STARTED|Open-Label Extension Period (3 Months)||0||
59680142|NCT01216072|75799258|FG001|STARTED|Open-Label Extension Period (3 Months)|Only DMT patients, who completed the core study, were eligible for fingolimod.|195||
59680143|NCT01216072|75799257|FG000|Safety Set|Open-Label Extension Period (3 Months)||0||
59680144|NCT01216072|75799258|FG001|Safety Set|Open-Label Extension Period (3 Months)||193||
59680145|NCT01216072|75799257|FG000|COMPLETED|Open-Label Extension Period (3 Months)||0||
59815986|NCT00531050|75938375|FG002|COMPLETED|Part 1: Period 3||4||
60078432|NCT00075088|76193530|FG001|COMPLETED|Overall Study||391||
60078433|NCT00075088|76193529|FG000|NOT COMPLETED|Overall Study||0||
60078434|NCT00075088|76193530|FG001|NOT COMPLETED|Overall Study||0||
60078435|NCT00076258|76193539|FG000|STARTED|Overall Study||62||
60078436|NCT00076258|76193540|FG001|STARTED|Overall Study||64||
60078437|NCT00076258|76193539|FG000|COMPLETED|Overall Study||61||
60078438|NCT00076258|76193540|FG001|COMPLETED|Overall Study||61||
60078439|NCT00076258|76193539|FG000|NOT COMPLETED|Overall Study||1||
60078440|NCT00076258|76193540|FG001|NOT COMPLETED|Overall Study||3||
60078441|NCT00078286|76193548|FG000|STARTED|Overall Study||234||
60078442|NCT00078286|76193549|FG001|STARTED|Overall Study||235||
60078443|NCT00078286|76193548|FG000|COMPLETED|Overall Study||138||
60078444|NCT00078286|76193549|FG001|COMPLETED|Overall Study||152||
60078445|NCT00078286|76193548|FG000|NOT COMPLETED|Overall Study||96||
60078446|NCT00078286|76193549|FG001|NOT COMPLETED|Overall Study||83||
60078447|NCT00078754|76193558|FG000|STARTED|Overall Study||29||
60078448|NCT00078754|76193559|FG001|STARTED|Overall Study||30||
60078449|NCT00078754|76193560|FG002|STARTED|Overall Study||31||
60078450|NCT00078754|76193558|FG000|COMPLETED|Overall Study||14||
60078451|NCT00078754|76193559|FG001|COMPLETED|Overall Study||11||
60078452|NCT00078754|76193560|FG002|COMPLETED|Overall Study||16||
60078453|NCT00078754|76193558|FG000|NOT COMPLETED|Overall Study||15||
60078454|NCT00078754|76193559|FG001|NOT COMPLETED|Overall Study||19||
60078455|NCT00078754|76193560|FG002|NOT COMPLETED|Overall Study||15||
60078456|NCT00080470|76193573|FG000|STARTED|Overall Study||45||
60078457|NCT00080470|76193574|FG001|STARTED|Overall Study||42||
59546856|NCT00585195|75645582|FG003|Treated|Overall Study||7||
59546857|NCT00585195|75645583|FG004|Treated|Overall Study||8||
59546858|NCT00585195|75645584|FG005|Treated|Overall Study||6||
59546859|NCT00585195|75645585|FG006|Treated|Overall Study||6||
59815987|NCT00531050|75938376|FG003|COMPLETED|Part 1: Period 3||4||
59815988|NCT00531050|75938377|FG004|COMPLETED|Part 1: Period 3||4||
59815989|NCT00531050|75938378|FG005|COMPLETED|Part 1: Period 3||5||
59815990|NCT00531050|75938373|FG000|NOT COMPLETED|Part 1: Period 3||1||
59815991|NCT00531050|75938374|FG001|NOT COMPLETED|Part 1: Period 3||0||
59815992|NCT00531050|75938375|FG002|NOT COMPLETED|Part 1: Period 3||0||
59815993|NCT00531050|75938376|FG003|NOT COMPLETED|Part 1: Period 3||0||
59815994|NCT00531050|75938377|FG004|NOT COMPLETED|Part 1: Period 3||0||
59815995|NCT00531050|75938378|FG005|NOT COMPLETED|Part 1: Period 3||0||
59815996|NCT00531050|75938373|FG000|STARTED|Part 2: Period 1||3||
59815997|NCT00531050|75938374|FG001|STARTED|Part 2: Period 1||4||
59815998|NCT00531050|75938375|FG002|STARTED|Part 2: Period 1||4||
59815999|NCT00531050|75938376|FG003|STARTED|Part 2: Period 1||4||
59816000|NCT00531050|75938377|FG004|STARTED|Part 2: Period 1||4||
59816001|NCT00531050|75938378|FG005|STARTED|Part 2: Period 1||5||
59816002|NCT00531050|75938373|FG000|COMPLETED|Part 2: Period 1||3||
59816003|NCT00531050|75938374|FG001|COMPLETED|Part 2: Period 1||4||
59816004|NCT00531050|75938375|FG002|COMPLETED|Part 2: Period 1||4||
59816005|NCT00531050|75938376|FG003|COMPLETED|Part 2: Period 1||4||
59816006|NCT00531050|75938377|FG004|COMPLETED|Part 2: Period 1||4||
59816007|NCT00531050|75938378|FG005|COMPLETED|Part 2: Period 1||4||
59816008|NCT00531050|75938373|FG000|NOT COMPLETED|Part 2: Period 1||0||
59816009|NCT00531050|75938374|FG001|NOT COMPLETED|Part 2: Period 1||0||
59816010|NCT00531050|75938375|FG002|NOT COMPLETED|Part 2: Period 1||0||
59816011|NCT00531050|75938376|FG003|NOT COMPLETED|Part 2: Period 1||0||
59816012|NCT00531050|75938377|FG004|NOT COMPLETED|Part 2: Period 1||0||
59816013|NCT00531050|75938378|FG005|NOT COMPLETED|Part 2: Period 1||1||
59816014|NCT00531050|75938373|FG000|STARTED|Part 2: Period 2||3||
59816015|NCT00531050|75938374|FG001|STARTED|Part 2: Period 2||4||
59816016|NCT00531050|75938375|FG002|STARTED|Part 2: Period 2||4||
59816017|NCT00531050|75938376|FG003|STARTED|Part 2: Period 2||4||
59816018|NCT00531050|75938377|FG004|STARTED|Part 2: Period 2||4||
60078458|NCT00080470|76193573|FG000|COMPLETED|Overall Study||11||
60078459|NCT00080470|76193574|FG001|COMPLETED|Overall Study||14||
60078460|NCT00080470|76193573|FG000|NOT COMPLETED|Overall Study||34||
60078461|NCT00080470|76193574|FG001|NOT COMPLETED|Overall Study||28||
60078462|NCT00081328|76193585|FG000|STARTED|Overall Study||232||
60078463|NCT00081328|76193586|FG001|STARTED|Overall Study||233||
60078464|NCT00081328|76193587|FG002|STARTED|Overall Study||234||
59816019|NCT00531050|75938378|FG005|STARTED|Part 2: Period 2||4||
59816020|NCT00531050|75938373|FG000|COMPLETED|Part 2: Period 2||3||
59816021|NCT00531050|75938374|FG001|COMPLETED|Part 2: Period 2||4||
59816022|NCT00531050|75938375|FG002|COMPLETED|Part 2: Period 2||4||
59816023|NCT00531050|75938376|FG003|COMPLETED|Part 2: Period 2||4||
59816024|NCT00531050|75938377|FG004|COMPLETED|Part 2: Period 2||4||
59816025|NCT00531050|75938378|FG005|COMPLETED|Part 2: Period 2||4||
60078465|NCT00081328|76193585|FG000|COMPLETED|Overall Study||232||
60078466|NCT00081328|76193586|FG001|COMPLETED|Overall Study||233||
60078467|NCT00081328|76193587|FG002|COMPLETED|Overall Study||234||
60078468|NCT00081328|76193585|FG000|NOT COMPLETED|Overall Study||0||
60078469|NCT00081328|76193586|FG001|NOT COMPLETED|Overall Study||0||
60078470|NCT00081328|76193587|FG002|NOT COMPLETED|Overall Study||0||
60078471|NCT00082342|76193598|FG000|STARTED|Overall Study||13||
60078472|NCT00082342|76193599|FG001|STARTED|Overall Study||12||
60078473|NCT00082342|76193598|FG000|COMPLETED|Overall Study||13||
60078474|NCT00082342|76193599|FG001|COMPLETED|Overall Study||12||
60078475|NCT00082342|76193598|FG000|NOT COMPLETED|Overall Study||0||
59546860|NCT00585195|75645586|FG007|Treated|Overall Study||5||
60078476|NCT00082342|76193599|FG001|NOT COMPLETED|Overall Study||0||
60078477|NCT01499355|76193619|FG000|STARTED|Run-In Period||276||
60078478|NCT01499355|76193620|FG001|STARTED|Run-In Period||0||
60078479|NCT01499355|76193621|FG002|STARTED|Run-In Period||0||
60078480|NCT01499355|76193622|FG003|STARTED|Run-In Period||0||
59816026|NCT00531050|75938373|FG000|NOT COMPLETED|Part 2: Period 2||0||
59816027|NCT00531050|75938374|FG001|NOT COMPLETED|Part 2: Period 2||0||
59816028|NCT00531050|75938375|FG002|NOT COMPLETED|Part 2: Period 2||0||
60078481|NCT01499355|76193619|FG000|COMPLETED|Run-In Period||245||
60078482|NCT01499355|76193620|FG001|COMPLETED|Run-In Period||0||
60078483|NCT01499355|76193621|FG002|COMPLETED|Run-In Period||0||
60078484|NCT01499355|76193622|FG003|COMPLETED|Run-In Period||0||
60078485|NCT01499355|76193619|FG000|NOT COMPLETED|Run-In Period||31||
60078486|NCT01499355|76193620|FG001|NOT COMPLETED|Run-In Period||0||
60078487|NCT01499355|76193621|FG002|NOT COMPLETED|Run-In Period||0||
60078488|NCT01499355|76193622|FG003|NOT COMPLETED|Run-In Period||0||
60078489|NCT01499355|76193619|FG000|STARTED|Double-Blind Period||0||
60078490|NCT01499355|76193620|FG001|STARTED|Double-Blind Period||63||
60078491|NCT01499355|76193621|FG002|STARTED|Double-Blind Period||63||
60078492|NCT01499355|76193622|FG003|STARTED|Double-Blind Period||62||
59680146|NCT01216072|75799258|FG001|COMPLETED|Open-Label Extension Period (3 Months)||181||
59680147|NCT01216072|75799257|FG000|NOT COMPLETED|Open-Label Extension Period (3 Months)||0||
59680148|NCT01216072|75799258|FG001|NOT COMPLETED|Open-Label Extension Period (3 Months)||14||
59680149|NCT01184989|75799267|FG000|STARTED|Overall Study|Treated Patients|112||
59816029|NCT00531050|75938376|FG003|NOT COMPLETED|Part 2: Period 2||0||
59816030|NCT00531050|75938377|FG004|NOT COMPLETED|Part 2: Period 2||0||
60078493|NCT01499355|76193619|FG000|COMPLETED|Double-Blind Period||0||
60078494|NCT01499355|76193620|FG001|COMPLETED|Double-Blind Period||40||
60078495|NCT01499355|76193621|FG002|COMPLETED|Double-Blind Period||38||
60078496|NCT01499355|76193622|FG003|COMPLETED|Double-Blind Period||39||
60078497|NCT01499355|76193619|FG000|NOT COMPLETED|Double-Blind Period||0||
60078498|NCT01499355|76193620|FG001|NOT COMPLETED|Double-Blind Period||23||
60078499|NCT01499355|76193621|FG002|NOT COMPLETED|Double-Blind Period||25||
60078500|NCT01499355|76193622|FG003|NOT COMPLETED|Double-Blind Period||23||
59816031|NCT00531050|75938378|FG005|NOT COMPLETED|Part 2: Period 2||0||
60078501|NCT00083122|76193634|FG000|STARTED|Overall Study||40||
60078502|NCT00083122|76193635|FG001|STARTED|Overall Study||5||
60078503|NCT00083122|76193634|FG000|COMPLETED|Overall Study||40||
60078504|NCT00083122|76193635|FG001|COMPLETED|Overall Study||5||
60078505|NCT00083122|76193634|FG000|NOT COMPLETED|Overall Study||0||
60078506|NCT00083122|76193635|FG001|NOT COMPLETED|Overall Study||0||
60078507|NCT01474239|76193643|FG000|STARTED|Overall Study||59||
60078508|NCT01474239|76193644|FG001|STARTED|Overall Study||32||
60078509|NCT01474239|76193643|FG000|COMPLETED|Overall Study||0||
60078510|NCT01474239|76193644|FG001|COMPLETED|Overall Study||0||
60078511|NCT01474239|76193643|FG000|NOT COMPLETED|Overall Study||59||
60078512|NCT01474239|76193644|FG001|NOT COMPLETED|Overall Study||32||
60078513|NCT01473381|76193654|FG000|STARTED|Overall Study||290||
60078514|NCT01473381|76193655|FG001|STARTED|Overall Study||292||
60078515|NCT01473381|76193656|FG002|STARTED|Overall Study||291||
60078516|NCT01473381|76193657|FG003|STARTED|Overall Study||289||
60078517|NCT01473381|76193654|FG000|Safety Population|Overall Study||281||
60078518|NCT01473381|76193655|FG001|Safety Population|Overall Study||288||
60078519|NCT01473381|76193656|FG002|Safety Population|Overall Study||287||
60078520|NCT01473381|76193657|FG003|Safety Population|Overall Study||282||
60078521|NCT01473381|76193654|FG000|COMPLETED|Overall Study||210||
59546861|NCT00585195|75645587|FG008|Treated|Overall Study||3||
60078522|NCT01473381|76193655|FG001|COMPLETED|Overall Study||199||
59546862|NCT00585195|75645588|FG009|Treated|Overall Study||6||
59546863|NCT00585195|75645589|FG010|Treated|Overall Study||9||
59546864|NCT00585195|75645590|FG011|Treated|Overall Study||53||
59546865|NCT00585195|75645591|FG012|Treated|Overall Study||85||
59546866|NCT00585195|75645592|FG013|Treated|Overall Study||41||
59546867|NCT00585195|75645593|FG014|Treated|Overall Study||48||
59546868|NCT00585195|75645594|FG015|Treated|Overall Study||18||
59680150|NCT01184989|75799267|FG000|COMPLETED|Overall Study||100||
59680151|NCT01184989|75799267|FG000|NOT COMPLETED|Overall Study||12||
59680152|NCT01215955|75799275|FG000|STARTED|Overall Study||268||
59680153|NCT01215955|75799276|FG001|STARTED|Overall Study||263||
59680154|NCT01215955|75799277|FG002|STARTED|Overall Study|Three (3) participants from 1 site were excluded due to quality issues and validity of data.|292||
59680155|NCT01215955|75799278|FG003|STARTED|Overall Study|Two (2) participants from 1 site were excluded due to quality issues and validity of the data.|294||
59680156|NCT01215955|75799275|FG000|Received at Least 1 Dose of Study Drug|Overall Study||267||
59680157|NCT01215955|75799276|FG001|Received at Least 1 Dose of Study Drug|Overall Study||261||
59680158|NCT01215955|75799277|FG002|Received at Least 1 Dose of Study Drug|Overall Study||288||
59680159|NCT01215955|75799278|FG003|Received at Least 1 Dose of Study Drug|Overall Study||290||
59680160|NCT01215955|75799275|FG000|COMPLETED|Overall Study||223||
59680161|NCT01215955|75799276|FG001|COMPLETED|Overall Study||210||
59680162|NCT01215955|75799277|FG002|COMPLETED|Overall Study||244||
59680163|NCT01215955|75799278|FG003|COMPLETED|Overall Study||241||
59680164|NCT01215955|75799275|FG000|NOT COMPLETED|Overall Study||45||
59680165|NCT01215955|75799276|FG001|NOT COMPLETED|Overall Study||53||
59680166|NCT01215955|75799277|FG002|NOT COMPLETED|Overall Study||48||
59680167|NCT01215955|75799278|FG003|NOT COMPLETED|Overall Study||53||
59680168|NCT04673214|75799293|FG000|STARTED|Overall Study||67||
59680169|NCT04673214|75799294|FG001|STARTED|Overall Study||47||
59709766|NCT01072149|75828532|FG012|NOT COMPLETED|Treatment Period 1 (28 Days)||0||
59709767|NCT01072149|75828533|FG013|NOT COMPLETED|Treatment Period 1 (28 Days)||0||
59709768|NCT01072149|75828534|FG014|NOT COMPLETED|Treatment Period 1 (28 Days)||0||
59709769|NCT01072149|75828535|FG015|NOT COMPLETED|Treatment Period 1 (28 Days)||0||
59709770|NCT01072149|75828536|FG016|NOT COMPLETED|Treatment Period 1 (28 Days)||0||
59816032|NCT00531050|75938373|FG000|STARTED|Part 2: Period 3||3||
59816033|NCT00531050|75938374|FG001|STARTED|Part 2: Period 3||4||
59816034|NCT00531050|75938375|FG002|STARTED|Part 2: Period 3||4||
60078523|NCT01473381|76193656|FG002|COMPLETED|Overall Study||189||
60078524|NCT01473381|76193657|FG003|COMPLETED|Overall Study||200||
59680170|NCT04673214|75799293|FG000|Lost to Follow up|Overall Study|These patients were discontinued, given in the first days of their follow-up by video call, they presented major symptoms such as dyspnea of movement, dyspnea at rest, and chest pain; Following the protocol's follow-up criteria, patients were informed of their clinical care at the hospital level immediately, and the protocol was no longer followed. Subsequently, when capturing information in the data analysis, the clinical status of the patients is searched, registering their death.|2||
59709771|NCT01072149|75828537|FG017|NOT COMPLETED|Treatment Period 1 (28 Days)||1||
59709772|NCT01072149|75828520|FG000|STARTED|Washout Period 1 (14 Days)||3||
59816035|NCT00531050|75938376|FG003|STARTED|Part 2: Period 3||4||
59816036|NCT00531050|75938377|FG004|STARTED|Part 2: Period 3||4||
60078525|NCT01473381|76193654|FG000|NOT COMPLETED|Overall Study||80||
60078526|NCT01473381|76193655|FG001|NOT COMPLETED|Overall Study||93||
60078527|NCT01473381|76193656|FG002|NOT COMPLETED|Overall Study||102||
60078528|NCT01473381|76193657|FG003|NOT COMPLETED|Overall Study||89||
60078529|NCT00168454|76193674|FG000|STARTED|Overall Study||44||
60078530|NCT00168454|76193675|FG001|STARTED|Overall Study||57||
60078531|NCT00168454|76193676|FG002|STARTED|Overall Study||54||
60078532|NCT00168454|76193677|FG003|STARTED|Overall Study||49||
60078533|NCT00168454|76193678|FG004|STARTED|Overall Study||53||
60078534|NCT00168454|76193679|FG005|STARTED|Overall Study||56||
60078535|NCT00168454|76193674|FG000|COMPLETED|Overall Study||37||
60078536|NCT00168454|76193675|FG001|COMPLETED|Overall Study||50||
60078537|NCT00168454|76193676|FG002|COMPLETED|Overall Study||48||
60078538|NCT00168454|76193677|FG003|COMPLETED|Overall Study||40||
60078539|NCT00168454|76193678|FG004|COMPLETED|Overall Study||47||
60078540|NCT00168454|76193679|FG005|COMPLETED|Overall Study||50||
60078541|NCT00168454|76193674|FG000|NOT COMPLETED|Overall Study||7||
60078542|NCT00168454|76193675|FG001|NOT COMPLETED|Overall Study||7||
60078543|NCT00168454|76193676|FG002|NOT COMPLETED|Overall Study||6||
60078544|NCT00168454|76193677|FG003|NOT COMPLETED|Overall Study||9||
60078545|NCT00168454|76193678|FG004|NOT COMPLETED|Overall Study||6||
60078546|NCT00168454|76193679|FG005|NOT COMPLETED|Overall Study||6||
60078547|NCT00175006|76193693|FG000|STARTED|Overall Study||13||
60078548|NCT00175006|76193693|FG000|COMPLETED|Overall Study||13||
60078549|NCT00175006|76193693|FG000|NOT COMPLETED|Overall Study||0||
60078550|NCT01499277|76193699|FG000|STARTED|Overall Study||506||
60078551|NCT01499277|76193700|FG001|STARTED|Overall Study||255||
60078552|NCT01499277|76193699|FG000|COMPLETED|Overall Study||459||
60078553|NCT01499277|76193700|FG001|COMPLETED|Overall Study||223||
60078554|NCT01499277|76193699|FG000|NOT COMPLETED|Overall Study||47||
60078555|NCT01499277|76193700|FG001|NOT COMPLETED|Overall Study||32||
59709773|NCT01072149|75828521|FG001|STARTED|Washout Period 1 (14 Days)||3||
59709774|NCT01072149|75828522|FG002|STARTED|Washout Period 1 (14 Days)||2||
59709775|NCT01072149|75828523|FG003|STARTED|Washout Period 1 (14 Days)||3||
59816037|NCT00531050|75938378|FG005|STARTED|Part 2: Period 3||4||
59816038|NCT00531050|75938373|FG000|COMPLETED|Part 2: Period 3||2||
59816039|NCT00531050|75938374|FG001|COMPLETED|Part 2: Period 3||4||
59816040|NCT00531050|75938375|FG002|COMPLETED|Part 2: Period 3||4||
60078556|NCT00176800|76193706|FG000|STARTED|Overall Study||69||
60078557|NCT00176800|76193706|FG000|COMPLETED|Overall Study||69||
60078558|NCT00176800|76193706|FG000|NOT COMPLETED|Overall Study||0||
59709776|NCT01072149|75828524|FG004|STARTED|Washout Period 1 (14 Days)||3||
59816041|NCT00531050|75938376|FG003|COMPLETED|Part 2: Period 3||4||
60078559|NCT00176878|76193710|FG000|STARTED|Overall Study||10||
60078560|NCT00176878|76193710|FG000|COMPLETED|Overall Study||10||
60078561|NCT00176878|76193710|FG000|NOT COMPLETED|Overall Study||0||
60078562|NCT02338336|76193716|FG000|STARTED|Overall Study||26||
60078563|NCT02338336|76193717|FG001|STARTED|Overall Study||17||
60078564|NCT02338336|76193718|FG002|STARTED|Overall Study||7||
60078565|NCT02338336|76193719|FG003|STARTED|Overall Study||4||
60078566|NCT02338336|76193716|FG000|COMPLETED|Overall Study||24||
60078567|NCT02338336|76193717|FG001|COMPLETED|Overall Study||17||
60078568|NCT02338336|76193718|FG002|COMPLETED|Overall Study||7||
60078569|NCT02338336|76193719|FG003|COMPLETED|Overall Study||4||
60078570|NCT02338336|76193716|FG000|NOT COMPLETED|Overall Study||2||
60078571|NCT02338336|76193717|FG001|NOT COMPLETED|Overall Study||0||
60078572|NCT02338336|76193718|FG002|NOT COMPLETED|Overall Study||0||
60078573|NCT02338336|76193719|FG003|NOT COMPLETED|Overall Study||0||
60078574|NCT01499199|76193725|FG000|STARTED|Overall Study||13||
60078575|NCT01499199|76193725|FG000|COMPLETED|Overall Study||11||
60078576|NCT01499199|76193725|FG000|NOT COMPLETED|Overall Study||2||
60078577|NCT01499043|76193729|FG000|STARTED|Overall Study||6||
60078578|NCT01499043|76193729|FG000|COMPLETED|Overall Study||0||
60078579|NCT01499043|76193729|FG000|NOT COMPLETED|Overall Study||6||
60078580|NCT00087022|76193740|FG000|STARTED|Overall Study||433|ITT Population|
60078581|NCT00087022|76193741|FG001|STARTED|Overall Study||431|ITT Population|
60078582|NCT00087022|76193740|FG000|Treated (Safety Population)|Overall Study||431||
60078583|NCT00087022|76193741|FG001|Treated (Safety Population)|Overall Study||424||
60078584|NCT00087022|76193740|FG000|COMPLETED|Overall Study||379||
60078585|NCT00087022|76193741|FG001|COMPLETED|Overall Study||376||
60078586|NCT00087022|76193740|FG000|NOT COMPLETED|Overall Study||54||
60078587|NCT00087022|76193741|FG001|NOT COMPLETED|Overall Study||55||
60078588|NCT00179998|76193749|FG000|STARTED|Initial Period - 6 Months||12||
60078589|NCT00179998|76193750|FG001|STARTED|Initial Period - 6 Months||12||
60078590|NCT00179998|76193749|FG000|COMPLETED|Initial Period - 6 Months||12||
60078591|NCT00179998|76193750|FG001|COMPLETED|Initial Period - 6 Months||12||
60078592|NCT00179998|76193749|FG000|NOT COMPLETED|Initial Period - 6 Months||0||
60078593|NCT00179998|76193750|FG001|NOT COMPLETED|Initial Period - 6 Months||0||
60078594|NCT00179998|76193749|FG000|STARTED|Crossover Period - 6 Months||12||
60078595|NCT00179998|76193750|FG001|STARTED|Crossover Period - 6 Months||12||
60078596|NCT00179998|76193749|FG000|COMPLETED|Crossover Period - 6 Months||12||
60078597|NCT00179998|76193750|FG001|COMPLETED|Crossover Period - 6 Months||10||
60078598|NCT00179998|76193749|FG000|NOT COMPLETED|Crossover Period - 6 Months||0||
60078599|NCT00179998|76193750|FG001|NOT COMPLETED|Crossover Period - 6 Months||2||
59680171|NCT04673214|75799294|FG001|Lost to Follow up|Overall Study|This patient was stopped being followed up in the first days of his follow-up by video call. He presented major symptoms such as dyspnea of movement, dyspnea at rest, and chest pain; With the follow-up criteria of the protocol, the patient was informed of their clinical care at the hospital level immediately, and the protocol was no longer followed. Subsequently, when capturing information in the data analysis, the clinical status of the patient is searched, registering death.|1||
59680172|NCT04673214|75799293|FG000|COMPLETED|Overall Study||65|Analyzed|
59680173|NCT04673214|75799294|FG001|COMPLETED|Overall Study||46|Analyzed|
59680174|NCT04673214|75799293|FG000|NOT COMPLETED|Overall Study||2||
59680175|NCT04673214|75799294|FG001|NOT COMPLETED|Overall Study||1||
59680176|NCT01215916|75799313|FG000|STARTED|Overall Study||1||
59680177|NCT01215916|75799314|FG001|STARTED|Overall Study||5||
59680178|NCT01215916|75799315|FG002|STARTED|Overall Study||3||
59680179|NCT01215916|75799316|FG003|STARTED|Overall Study||6||
59680180|NCT01215916|75799317|FG004|STARTED|Overall Study||6||
59680181|NCT01215916|75799318|FG005|STARTED|Overall Study||4||
59680182|NCT01215916|75799319|FG006|STARTED|Overall Study||9||
59680183|NCT01215916|75799320|FG007|STARTED|Overall Study||3||
59680184|NCT01215916|75799321|FG008|STARTED|Overall Study||2||
59680185|NCT01215916|75799313|FG000|Received at Least 1 Dose of Either Drug|Overall Study||1||
59680186|NCT01215916|75799314|FG001|Received at Least 1 Dose of Either Drug|Overall Study||5||
59680187|NCT01215916|75799315|FG002|Received at Least 1 Dose of Either Drug|Overall Study||3||
59680188|NCT01215916|75799316|FG003|Received at Least 1 Dose of Either Drug|Overall Study||6||
59680189|NCT01215916|75799317|FG004|Received at Least 1 Dose of Either Drug|Overall Study||6||
60078600|NCT00181168|76193762|FG000|STARTED|Overall Study||30||
60078601|NCT00181168|76193763|FG001|STARTED|Overall Study||33||
60078602|NCT00181168|76193762|FG000|COMPLETED|Overall Study||30||
60078603|NCT00181168|76193763|FG001|COMPLETED|Overall Study||33||
60078604|NCT00181168|76193762|FG000|NOT COMPLETED|Overall Study||0||
60078605|NCT00181168|76193763|FG001|NOT COMPLETED|Overall Study||0||
60078606|NCT02151526|76193771|FG000|STARTED|Overall Study||3||
60078607|NCT02151526|76193772|FG001|STARTED|Overall Study||4||
60078608|NCT02151526|76193771|FG000|COMPLETED|Overall Study||3||
60078609|NCT02151526|76193772|FG001|COMPLETED|Overall Study||4||
60078610|NCT02151526|76193771|FG000|NOT COMPLETED|Overall Study||0||
60078611|NCT02151526|76193772|FG001|NOT COMPLETED|Overall Study||0||
60078612|NCT00089752|76193782|FG000|STARTED|Overall Study||141||
60078613|NCT00089752|76193783|FG001|STARTED|Overall Study||140||
60078614|NCT00089752|76193782|FG000|COMPLETED|Overall Study||121||
60078615|NCT00089752|76193783|FG001|COMPLETED|Overall Study||118||
60078616|NCT00089752|76193782|FG000|NOT COMPLETED|Overall Study||20||
60078617|NCT00089752|76193783|FG001|NOT COMPLETED|Overall Study||22||
60078618|NCT00090844|76193793|FG000|STARTED|Overall Study||27||
59680190|NCT01215916|75799318|FG005|Received at Least 1 Dose of Either Drug|Overall Study||4||
60078619|NCT00090844|76193794|FG001|STARTED|Overall Study||22||
60078620|NCT00090844|76193793|FG000|COMPLETED|Overall Study||26||
60078621|NCT00090844|76193794|FG001|COMPLETED|Overall Study||21||
60078622|NCT00090844|76193793|FG000|NOT COMPLETED|Overall Study||1||
60078623|NCT00090844|76193794|FG001|NOT COMPLETED|Overall Study||1||
60078624|NCT01498887|76193803|FG000|STARTED|Overall Study||200||
60078625|NCT01498887|76193804|FG001|STARTED|Overall Study||147||
60078626|NCT01498887|76193803|FG000|Safety Set|Overall Study||200||
60078627|NCT01498887|76193804|FG001|Safety Set|Overall Study||147||
60078628|NCT01498887|76193803|FG000|Intent-to-treat|Overall Study||185||
60078629|NCT01498887|76193804|FG001|Intent-to-treat|Overall Study||135||
60078630|NCT01498887|76193803|FG000|COMPLETED|Overall Study||184||
60078631|NCT01498887|76193804|FG001|COMPLETED|Overall Study||136||
60078632|NCT01498887|76193803|FG000|NOT COMPLETED|Overall Study||16||
60078633|NCT01498887|76193804|FG001|NOT COMPLETED|Overall Study||11||
60078634|NCT01498653|76193813|FG000|STARTED|Overall Study||155||
60078635|NCT01498653|76193814|FG001|STARTED|Overall Study||154||
60078636|NCT01498653|76193813|FG000|COMPLETED|Overall Study||136||
60078637|NCT01498653|76193814|FG001|COMPLETED|Overall Study||119||
60078638|NCT01498653|76193813|FG000|NOT COMPLETED|Overall Study||19||
60078639|NCT01498653|76193814|FG001|NOT COMPLETED|Overall Study||35||
60078640|NCT01498575|76193822|FG000|STARTED|Overall Sample||610||
60078641|NCT01498575|76193823|FG001|STARTED|Overall Sample||414||
60078642|NCT01498575|76193822|FG000|COMPLETED|Overall Sample||550||
60078643|NCT01498575|76193823|FG001|COMPLETED|Overall Sample||400||
60078644|NCT01498575|76193822|FG000|NOT COMPLETED|Overall Sample||60||
60078645|NCT01498575|76193823|FG001|NOT COMPLETED|Overall Sample||14||
60078646|NCT01498575|76193822|FG000|STARTED|On the Road Driving Assessment (ODA)||128||
60078647|NCT01498575|76193823|FG001|STARTED|On the Road Driving Assessment (ODA)||89||
60078648|NCT01498575|76193822|FG000|COMPLETED|On the Road Driving Assessment (ODA)||86||
60078649|NCT01498575|76193823|FG001|COMPLETED|On the Road Driving Assessment (ODA)||65||
60078650|NCT01498575|76193822|FG000|NOT COMPLETED|On the Road Driving Assessment (ODA)||42||
60078651|NCT01498575|76193823|FG001|NOT COMPLETED|On the Road Driving Assessment (ODA)||24||
60078652|NCT01498185|76193834|FG000|STARTED|Overall Study||13||
60078653|NCT01498185|76193835|FG001|STARTED|Overall Study||13||
60078654|NCT01498185|76193836|FG002|STARTED|Overall Study||15||
60078655|NCT01498185|76193837|FG003|STARTED|Overall Study||14||
60078656|NCT01498185|76193838|FG004|STARTED|Overall Study||15||
60078657|NCT01498185|76193834|FG000|COMPLETED|Overall Study||12||
60078658|NCT01498185|76193835|FG001|COMPLETED|Overall Study||12||
60078659|NCT01498185|76193836|FG002|COMPLETED|Overall Study||15||
60078660|NCT01498185|76193837|FG003|COMPLETED|Overall Study||11||
60078661|NCT01498185|76193838|FG004|COMPLETED|Overall Study||12||
60078662|NCT01498185|76193834|FG000|NOT COMPLETED|Overall Study||1||
60078663|NCT01498185|76193835|FG001|NOT COMPLETED|Overall Study||1||
60078664|NCT01498185|76193836|FG002|NOT COMPLETED|Overall Study||0||
60078665|NCT01498185|76193837|FG003|NOT COMPLETED|Overall Study||3||
60078666|NCT01498185|76193838|FG004|NOT COMPLETED|Overall Study||3||
60078667|NCT01528605|76193860|FG000|STARTED|Overall Study||28||
60078668|NCT01528605|76193861|FG001|STARTED|Overall Study||28||
60078669|NCT01528605|76193862|FG002|STARTED|Overall Study||28||
60078670|NCT01528605|76193863|FG003|STARTED|Overall Study||28||
59680191|NCT01215916|75799319|FG006|Received at Least 1 Dose of Either Drug|Overall Study||9||
59680192|NCT01215916|75799320|FG007|Received at Least 1 Dose of Either Drug|Overall Study||3||
59680193|NCT01215916|75799321|FG008|Received at Least 1 Dose of Either Drug|Overall Study||2||
59680194|NCT01215916|75799313|FG000|COMPLETED|Overall Study||0||
59680195|NCT01215916|75799314|FG001|COMPLETED|Overall Study||0||
59680196|NCT01215916|75799315|FG002|COMPLETED|Overall Study||0||
59680197|NCT01215916|75799316|FG003|COMPLETED|Overall Study||0||
59680198|NCT01215916|75799317|FG004|COMPLETED|Overall Study||0||
59680199|NCT01215916|75799318|FG005|COMPLETED|Overall Study||0||
59680200|NCT01215916|75799319|FG006|COMPLETED|Overall Study||0||
59680201|NCT01215916|75799320|FG007|COMPLETED|Overall Study||0||
59680202|NCT01215916|75799321|FG008|COMPLETED|Overall Study||0||
59816042|NCT00531050|75938377|FG004|COMPLETED|Part 2: Period 3||4||
60078671|NCT01528605|76193864|FG004|STARTED|Overall Study||28||
60078672|NCT01528605|76193865|FG005|STARTED|Overall Study||28||
60078673|NCT01528605|76193860|FG000|COMPLETED|Overall Study||26||
60078674|NCT01528605|76193861|FG001|COMPLETED|Overall Study||28||
60078675|NCT01528605|76193862|FG002|COMPLETED|Overall Study||27||
59546869|NCT00585195|75645595|FG016|Treated|Overall Study||154||
59546870|NCT00585195|75645596|FG017|Treated|Overall Study||66||
59546871|NCT00585195|75645597|FG018|Treated|Overall Study||18||
59546872|NCT00585195|75645598|FG019|Treated|Overall Study||18||
59546873|NCT00585195|75645599|FG020|Treated|Overall Study||12||
59546874|NCT00585195|75645579|FG000|COMPLETED|Overall Study||0||
59546875|NCT00585195|75645580|FG001|COMPLETED|Overall Study||0||
59546876|NCT00585195|75645581|FG002|COMPLETED|Overall Study||0||
59546877|NCT00585195|75645582|FG003|COMPLETED|Overall Study||0||
59546878|NCT00585195|75645583|FG004|COMPLETED|Overall Study||0||
59546879|NCT00585195|75645584|FG005|COMPLETED|Overall Study||0||
59546880|NCT00585195|75645585|FG006|COMPLETED|Overall Study||0||
59546881|NCT00585195|75645586|FG007|COMPLETED|Overall Study||0||
59546882|NCT00585195|75645587|FG008|COMPLETED|Overall Study||0||
59546883|NCT00585195|75645588|FG009|COMPLETED|Overall Study||0||
59546884|NCT00585195|75645589|FG010|COMPLETED|Overall Study||0||
60078676|NCT01528605|76193863|FG003|COMPLETED|Overall Study||27||
60078677|NCT01528605|76193864|FG004|COMPLETED|Overall Study||28||
59546885|NCT00585195|75645590|FG011|COMPLETED|Overall Study||0||
59546886|NCT00585195|75645591|FG012|COMPLETED|Overall Study||0||
59546887|NCT00585195|75645592|FG013|COMPLETED|Overall Study||0||
59546888|NCT00585195|75645593|FG014|COMPLETED|Overall Study||0||
59546889|NCT00585195|75645594|FG015|COMPLETED|Overall Study||0||
59546890|NCT00585195|75645595|FG016|COMPLETED|Overall Study||0||
59546891|NCT00585195|75645596|FG017|COMPLETED|Overall Study||0||
59546892|NCT00585195|75645597|FG018|COMPLETED|Overall Study||0||
59546893|NCT00585195|75645598|FG019|COMPLETED|Overall Study||0||
59546894|NCT00585195|75645599|FG020|COMPLETED|Overall Study||0||
59680203|NCT01215916|75799313|FG000|NOT COMPLETED|Overall Study||1||
59680204|NCT01215916|75799314|FG001|NOT COMPLETED|Overall Study||5||
60078678|NCT01528605|76193865|FG005|COMPLETED|Overall Study||28||
60078679|NCT01528605|76193860|FG000|NOT COMPLETED|Overall Study||2||
60078680|NCT01528605|76193861|FG001|NOT COMPLETED|Overall Study||0||
60078681|NCT01528605|76193862|FG002|NOT COMPLETED|Overall Study||1||
60078682|NCT01528605|76193863|FG003|NOT COMPLETED|Overall Study||1||
60078683|NCT01528605|76193864|FG004|NOT COMPLETED|Overall Study||0||
60078684|NCT01528605|76193865|FG005|NOT COMPLETED|Overall Study||0||
59680205|NCT01215916|75799315|FG002|NOT COMPLETED|Overall Study||3||
59680206|NCT01215916|75799316|FG003|NOT COMPLETED|Overall Study||6||
59680207|NCT01215916|75799317|FG004|NOT COMPLETED|Overall Study||6||
59680208|NCT01215916|75799318|FG005|NOT COMPLETED|Overall Study||4||
59680209|NCT01215916|75799319|FG006|NOT COMPLETED|Overall Study||9||
59680210|NCT01215916|75799320|FG007|NOT COMPLETED|Overall Study||3||
59680211|NCT01215916|75799321|FG008|NOT COMPLETED|Overall Study||2||
59680212|NCT01184872|75799347|FG000|STARTED|Overall Study|"Started indicates randomized and full analysis set."|81||
59680213|NCT01184872|75799348|FG001|STARTED|Overall Study||39||
59680214|NCT01184872|75799347|FG000|Safety Set|Overall Study|One patient randomized to Daptomycin received Vancomycin.|80||
59680215|NCT01184872|75799348|FG001|Safety Set|Overall Study||40||
59680216|NCT01184872|75799347|FG000|Clinical Evaluable Set (CES)|Overall Study||73||
59680217|NCT01184872|75799348|FG001|Clinical Evaluable Set (CES)|Overall Study||30||
60078685|NCT01528215|76193881|FG000|STARTED|Enrollment to 1 Year Follow-up||59||
60078686|NCT01528215|76193882|FG001|STARTED|Enrollment to 1 Year Follow-up||61||
60078687|NCT01528215|76193881|FG000|COMPLETED|Enrollment to 1 Year Follow-up||55||
60078688|NCT01528215|76193882|FG001|COMPLETED|Enrollment to 1 Year Follow-up||60||
60078689|NCT01528215|76193881|FG000|NOT COMPLETED|Enrollment to 1 Year Follow-up||4||
60078690|NCT01528215|76193882|FG001|NOT COMPLETED|Enrollment to 1 Year Follow-up||1||
60078691|NCT01528215|76193881|FG000|STARTED|1 Year Follow-up to 5 Year Follow-up||55||
60078692|NCT01528215|76193882|FG001|STARTED|1 Year Follow-up to 5 Year Follow-up||60||
60078693|NCT01528215|76193881|FG000|COMPLETED|1 Year Follow-up to 5 Year Follow-up||40||
60078694|NCT01528215|76193882|FG001|COMPLETED|1 Year Follow-up to 5 Year Follow-up||45||
60078695|NCT01528215|76193881|FG000|NOT COMPLETED|1 Year Follow-up to 5 Year Follow-up||15||
60078696|NCT01528215|76193882|FG001|NOT COMPLETED|1 Year Follow-up to 5 Year Follow-up||15||
59680218|NCT01184872|75799347|FG000|Microbiologically Evaluable Set (MES)|Overall Study||65||
59680219|NCT01184872|75799348|FG001|Microbiologically Evaluable Set (MES)|Overall Study||27||
59680220|NCT01184872|75799347|FG000|COMPLETED|Overall Study||71||
60078697|NCT01527357|76193890|FG000|STARTED|Overall Study||482||
60078698|NCT01527357|76193891|FG001|STARTED|Overall Study||239||
60078699|NCT01527357|76193890|FG000|Efficacy Population|Overall Study|Two participants did not receive study treatment.|480||
60078700|NCT01527357|76193891|FG001|Efficacy Population|Overall Study||239||
60078701|NCT01527357|76193890|FG000|COMPLETED|Overall Study||465||
60078702|NCT01527357|76193891|FG001|COMPLETED|Overall Study||230||
60078703|NCT01527357|76193890|FG000|NOT COMPLETED|Overall Study||17||
60078704|NCT01527357|76193891|FG001|NOT COMPLETED|Overall Study||9||
60078705|NCT00093964|76193899|FG000|STARTED|Overall Study||41||
60078706|NCT00093964|76193900|FG001|STARTED|Overall Study||40||
60078707|NCT00093964|76193899|FG000|COMPLETED|Overall Study||41||
60078708|NCT00093964|76193900|FG001|COMPLETED|Overall Study||40||
60078709|NCT00093964|76193899|FG000|NOT COMPLETED|Overall Study||0||
60078710|NCT00093964|76193900|FG001|NOT COMPLETED|Overall Study||0||
60078711|NCT01526889|76193910|FG000|STARTED|Treatment Period||18||
60078712|NCT01526889|76193911|FG001|STARTED|Treatment Period||7||
60078713|NCT01526889|76193910|FG000|COMPLETED|Treatment Period||16||
60078714|NCT01526889|76193911|FG001|COMPLETED|Treatment Period||7||
60078715|NCT01526889|76193910|FG000|NOT COMPLETED|Treatment Period||2||
60078716|NCT01526889|76193911|FG001|NOT COMPLETED|Treatment Period||0||
60078717|NCT01526889|76193910|FG000|STARTED|Treatment Extension Period||5||
60078718|NCT01526889|76193911|FG001|STARTED|Treatment Extension Period||0||
60078719|NCT01526889|76193910|FG000|COMPLETED|Treatment Extension Period||4||
60078720|NCT01526889|76193911|FG001|COMPLETED|Treatment Extension Period||0||
59680221|NCT01184872|75799348|FG001|COMPLETED|Overall Study||31||
59680222|NCT01184872|75799347|FG000|NOT COMPLETED|Overall Study||10||
59680223|NCT01184872|75799348|FG001|NOT COMPLETED|Overall Study||8||
59680224|NCT01215721|75799354|FG000|STARTED|Overall Study||40||
59680225|NCT01215721|75799354|FG000|COMPLETED|Overall Study||38||
59680226|NCT01215721|75799354|FG000|NOT COMPLETED|Overall Study||2||
59680227|NCT01184326|75799361|FG000|STARTED|Overall Study||3||
59680228|NCT01184326|75799362|FG001|STARTED|Overall Study||6||
60078721|NCT01526889|76193910|FG000|NOT COMPLETED|Treatment Extension Period||1||
60078722|NCT01526889|76193911|FG001|NOT COMPLETED|Treatment Extension Period||0||
60078723|NCT00181714|76193917|FG000|STARTED|Signed Consent/Enrolled||203||
60078724|NCT00181714|76193917|FG000|COMPLETED|Signed Consent/Enrolled||154||
60078725|NCT00181714|76193917|FG000|NOT COMPLETED|Signed Consent/Enrolled||49||
59680229|NCT01184326|75799363|FG002|STARTED|Overall Study||14||
59680230|NCT01184326|75799361|FG000|COMPLETED|Overall Study||0|Given treatment duration is not fixed, all participants are considered as 'Non Completed'.|
59680231|NCT01184326|75799362|FG001|COMPLETED|Overall Study||0|Given treatment duration is not fixed, all participants are considered as 'Non Completed'.|
59680232|NCT01184326|75799363|FG002|COMPLETED|Overall Study||0|Given treatment duration is not fixed, all participants are considered as 'Non Completed'.|
59680233|NCT01184326|75799361|FG000|NOT COMPLETED|Overall Study||3||
59680234|NCT01184326|75799362|FG001|NOT COMPLETED|Overall Study||6||
59680235|NCT01184326|75799363|FG002|NOT COMPLETED|Overall Study||14||
60078726|NCT00181714|76193917|FG000|STARTED|Began Treatment With OROS-MPH||154||
60078727|NCT00181714|76193917|FG000|COMPLETED|Began Treatment With OROS-MPH||30||
60078728|NCT00181714|76193917|FG000|NOT COMPLETED|Began Treatment With OROS-MPH||124||
60078729|NCT01472835|76193923|FG000|STARTED|Overall Study||37||
60078730|NCT01472835|76193924|FG001|STARTED|Overall Study||36||
60078731|NCT01472835|76193923|FG000|COMPLETED|Overall Study||35||
60078732|NCT01472835|76193924|FG001|COMPLETED|Overall Study||36||
60078733|NCT01472835|76193923|FG000|NOT COMPLETED|Overall Study||2||
60078734|NCT01472835|76193924|FG001|NOT COMPLETED|Overall Study||0||
60078735|NCT00185692|76193933|FG000|STARTED|Overall Study||16||
60078736|NCT00185692|76193933|FG000|COMPLETED|Overall Study||0||
60078737|NCT00185692|76193933|FG000|NOT COMPLETED|Overall Study||16||
60078738|NCT01526733|76193937|FG000|STARTED|Phase 1||12||
60078739|NCT01526733|76193938|FG001|STARTED|Phase 1|One participant discontinued after receiving insulin-sham and before receiving insulin-rHuPH20.|13||
60078740|NCT01526733|76193937|FG000|Received at Least 1 Dose of Study Drug|Phase 1||12||
60078741|NCT01526733|76193938|FG001|Received at Least 1 Dose of Study Drug|Phase 1||13||
60078742|NCT01526733|76193937|FG000|COMPLETED|Phase 1||10||
60078743|NCT01526733|76193938|FG001|COMPLETED|Phase 1||12||
59680236|NCT01215253|75799376|FG000|STARTED|Overall Study||510||
59680237|NCT01215253|75799377|FG001|STARTED|Overall Study||502||
59680238|NCT01215253|75799376|FG000|COMPLETED|Overall Study||424||
59680239|NCT01215253|75799377|FG001|COMPLETED|Overall Study||439||
59680240|NCT01215253|75799376|FG000|NOT COMPLETED|Overall Study||86||
59680241|NCT01215253|75799377|FG001|NOT COMPLETED|Overall Study||63||
59680242|NCT01184053|75799384|FG000|STARTED|Overall Study||3||
59680243|NCT01184053|75799384|FG000|COMPLETED|Overall Study||0||
59680244|NCT01184053|75799384|FG000|NOT COMPLETED|Overall Study||3||
59680245|NCT01183975|75799389|FG000|STARTED|Overall Study||517||
60078744|NCT01526733|76193937|FG000|NOT COMPLETED|Phase 1||2||
60078745|NCT01526733|76193938|FG001|NOT COMPLETED|Phase 1||1||
60078746|NCT01526733|76193937|FG000|STARTED|Washout Period of 5 to 21 Days||10||
60078747|NCT01526733|76193938|FG001|STARTED|Washout Period of 5 to 21 Days||12||
60078748|NCT01526733|76193937|FG000|COMPLETED|Washout Period of 5 to 21 Days||10||
60078749|NCT01526733|76193938|FG001|COMPLETED|Washout Period of 5 to 21 Days||12||
60078750|NCT01526733|76193937|FG000|NOT COMPLETED|Washout Period of 5 to 21 Days||0||
60078751|NCT01526733|76193938|FG001|NOT COMPLETED|Washout Period of 5 to 21 Days||0||
60078752|NCT01526733|76193937|FG000|STARTED|Phase 2||10||
60078753|NCT01526733|76193938|FG001|STARTED|Phase 2||12||
60078754|NCT01526733|76193937|FG000|COMPLETED|Phase 2||10||
60078755|NCT01526733|76193938|FG001|COMPLETED|Phase 2||12||
60078756|NCT01526733|76193937|FG000|NOT COMPLETED|Phase 2||0||
60078757|NCT01526733|76193938|FG001|NOT COMPLETED|Phase 2||0||
60078758|NCT00094900|76193945|FG000|STARTED|Overall Study||11||
60078759|NCT00094900|76193945|FG000|COMPLETED|Overall Study||10||
60078760|NCT00094900|76193945|FG000|NOT COMPLETED|Overall Study||1||
60078761|NCT00096460|76193951|FG000|STARTED|Overall Study||22||
60078762|NCT00096460|76193952|FG001|STARTED|Overall Study||8||
59680246|NCT01183975|75799389|FG000|COMPLETED|Overall Study||444||
59680247|NCT01183975|75799389|FG000|NOT COMPLETED|Overall Study||73||
60078763|NCT00096460|76193951|FG000|COMPLETED|Overall Study||15||
60078764|NCT00096460|76193952|FG001|COMPLETED|Overall Study||7||
60078765|NCT00096460|76193951|FG000|NOT COMPLETED|Overall Study||7||
60078766|NCT00096460|76193952|FG001|NOT COMPLETED|Overall Study||1||
60078767|NCT00006178|76193958|FG000|STARTED|Overall Study||12||
60078768|NCT00006178|76193958|FG000|COMPLETED|Overall Study||12||
60078769|NCT00006178|76193958|FG000|NOT COMPLETED|Overall Study||0||
60078770|NCT00097708|76193965|FG000|STARTED|Overall Study||173||
60078771|NCT00097708|76193966|FG001|STARTED|Overall Study||176||
60078772|NCT00097708|76193967|FG002|STARTED|Overall Study||162||
60078773|NCT00097708|76193965|FG000|Intent-to-Treat (ITT)|Overall Study||165||
60078774|NCT00097708|76193966|FG001|Intent-to-Treat (ITT)|Overall Study||169||
60078775|NCT00097708|76193967|FG002|Intent-to-Treat (ITT)|Overall Study||149||
60078776|NCT00097708|76193965|FG000|Treated|Overall Study||171||
60078777|NCT00097708|76193966|FG001|Treated|Overall Study||176||
60078778|NCT00097708|76193967|FG002|Treated|Overall Study||160||
60078779|NCT00097708|76193965|FG000|COMPLETED|Overall Study||109||
60078780|NCT00097708|76193966|FG001|COMPLETED|Overall Study||120||
60078781|NCT00097708|76193967|FG002|COMPLETED|Overall Study||97||
60078782|NCT00097708|76193965|FG000|NOT COMPLETED|Overall Study||64||
59680248|NCT01183858|75799395|FG000|STARTED|Overall Study||154||
59680249|NCT01183858|75799396|FG001|STARTED|Overall Study||159||
59680250|NCT01183858|75799395|FG000|Safety Population|Overall Study||154||
60078783|NCT00097708|76193966|FG001|NOT COMPLETED|Overall Study||56||
59680251|NCT01183858|75799396|FG001|Safety Population|Overall Study||158||
59680252|NCT01183858|75799395|FG000|COMPLETED|Overall Study||1||
60078784|NCT00097708|76193967|FG002|NOT COMPLETED|Overall Study||65||
60078785|NCT00098956|76193975|FG000|STARTED|Overall Study||19||
60078786|NCT00098956|76193975|FG000|COMPLETED|Overall Study||19||
60078787|NCT00098956|76193975|FG000|NOT COMPLETED|Overall Study||0||
60078788|NCT01472757|76193983|FG000|STARTED|Overall Study||91||
60078789|NCT01472757|76193984|FG001|STARTED|Overall Study||93||
60078790|NCT01472757|76193985|FG002|STARTED|Overall Study||95||
60078791|NCT01472757|76193986|FG003|STARTED|Overall Study||94||
59680253|NCT01183858|75799396|FG001|COMPLETED|Overall Study||3||
59680254|NCT01183858|75799395|FG000|NOT COMPLETED|Overall Study||153||
59680255|NCT01183858|75799396|FG001|NOT COMPLETED|Overall Study||156||
59680256|NCT01215175|75799407|FG000|STARTED|Overall Study||30||
60078792|NCT01472757|76193983|FG000|Full Analysis Set|Overall Study||91|Five subjects had no post-dose efficacy assessments and were excluded from the Full Analysis Set.|
60078793|NCT01472757|76193984|FG001|Full Analysis Set|Overall Study||93|Five subjects had no post-dose efficacy assessments and were excluded from the Full Analysis Set.|
60078794|NCT01472757|76193985|FG002|Full Analysis Set|Overall Study||92|Five subjects had no post-dose efficacy assessments and were excluded from the Full Analysis Set.|
60078795|NCT01472757|76193986|FG003|Full Analysis Set|Overall Study||92|Five subjects had no post-dose efficacy assessments and were excluded from the Full Analysis Set.|
60078796|NCT01472757|76193983|FG000|COMPLETED|Overall Study||61||
60078797|NCT01472757|76193984|FG001|COMPLETED|Overall Study||80||
60078798|NCT01472757|76193985|FG002|COMPLETED|Overall Study||76||
60078799|NCT01472757|76193986|FG003|COMPLETED|Overall Study||75||
60078800|NCT01472757|76193983|FG000|NOT COMPLETED|Overall Study||30||
60078801|NCT01472757|76193984|FG001|NOT COMPLETED|Overall Study||13||
60078802|NCT01472757|76193985|FG002|NOT COMPLETED|Overall Study||19||
60078803|NCT01472757|76193986|FG003|NOT COMPLETED|Overall Study||19||
60078804|NCT00187720|76193998|FG000|STARTED|Overall Study||9||
60078805|NCT00187720|76193999|FG001|STARTED|Overall Study||14||
60078806|NCT00187720|76193998|FG000|COMPLETED|Overall Study||9||
60078807|NCT00187720|76193999|FG001|COMPLETED|Overall Study||14||
60078808|NCT00187720|76193998|FG000|NOT COMPLETED|Overall Study||0||
60078809|NCT00187720|76193999|FG001|NOT COMPLETED|Overall Study||0||
60078810|NCT01472289|76194005|FG000|STARTED|Overall Study||17||
60078811|NCT01472289|76194005|FG000|COMPLETED|Overall Study||15||
60078812|NCT01472289|76194005|FG000|NOT COMPLETED|Overall Study||2||
60078813|NCT00006244|76194009|FG000|STARTED|Overall Study||36||
60078814|NCT00006244|76194009|FG000|COMPLETED|Overall Study||36||
60078815|NCT00006244|76194009|FG000|NOT COMPLETED|Overall Study||0||
60078816|NCT00187876|76194015|FG000|STARTED|Overall Study||24||
60078817|NCT00187876|76194016|FG001|STARTED|Overall Study||43||
60078818|NCT00187876|76194015|FG000|COMPLETED|Overall Study||24||
59546895|NCT00585195|75645579|FG000|NOT COMPLETED|Overall Study||3||
59680257|NCT01215175|75799408|FG001|STARTED|Overall Study||30||
59680258|NCT01215175|75799409|FG002|STARTED|Overall Study||33||
59680259|NCT01215175|75799410|FG003|STARTED|Overall Study||29||
59680260|NCT01215175|75799411|FG004|STARTED|Overall Study||28||
59680261|NCT01215175|75799407|FG000|Treated|Overall Study||30||
59680262|NCT01215175|75799408|FG001|Treated|Overall Study||30||
59680263|NCT01215175|75799409|FG002|Treated|Overall Study||33||
59680264|NCT01215175|75799410|FG003|Treated|Overall Study||29||
59680265|NCT01215175|75799411|FG004|Treated|Overall Study||28||
59680266|NCT01215175|75799407|FG000|COMPLETED|Overall Study||30||
59680267|NCT01215175|75799408|FG001|COMPLETED|Overall Study||29||
59680268|NCT01215175|75799409|FG002|COMPLETED|Overall Study||33||
60078819|NCT00187876|76194016|FG001|COMPLETED|Overall Study||43||
60078820|NCT00187876|76194015|FG000|NOT COMPLETED|Overall Study||0||
60078821|NCT00187876|76194016|FG001|NOT COMPLETED|Overall Study||0||
60078822|NCT01525875|76194024|FG000|STARTED|Placebo-controlled Period||22||
60078823|NCT01525875|76194025|FG001|STARTED|Placebo-controlled Period||22||
60078824|NCT01525875|76194024|FG000|COMPLETED|Placebo-controlled Period||21||
60078825|NCT01525875|76194025|FG001|COMPLETED|Placebo-controlled Period||20||
60078826|NCT01525875|76194024|FG000|NOT COMPLETED|Placebo-controlled Period||1||
60078827|NCT01525875|76194025|FG001|NOT COMPLETED|Placebo-controlled Period||2||
59546896|NCT00585195|75645580|FG001|NOT COMPLETED|Overall Study||4||
59546897|NCT00585195|75645581|FG002|NOT COMPLETED|Overall Study||9||
59546898|NCT00585195|75645582|FG003|NOT COMPLETED|Overall Study||7||
59546899|NCT00585195|75645583|FG004|NOT COMPLETED|Overall Study||9||
59546900|NCT00585195|75645584|FG005|NOT COMPLETED|Overall Study||6||
59546901|NCT00585195|75645585|FG006|NOT COMPLETED|Overall Study||7||
59546902|NCT00585195|75645586|FG007|NOT COMPLETED|Overall Study||5||
59546903|NCT00585195|75645587|FG008|NOT COMPLETED|Overall Study||3||
59546904|NCT00585195|75645588|FG009|NOT COMPLETED|Overall Study||6||
60078828|NCT01525875|76194024|FG000|STARTED|Open-label Period||21||
60078829|NCT01525875|76194025|FG001|STARTED|Open-label Period||20||
60078830|NCT01525875|76194024|FG000|COMPLETED|Open-label Period||21||
60078831|NCT01525875|76194025|FG001|COMPLETED|Open-label Period||18||
60078832|NCT01525875|76194024|FG000|NOT COMPLETED|Open-label Period||0||
60078833|NCT01525875|76194025|FG001|NOT COMPLETED|Open-label Period||2||
59546905|NCT00585195|75645589|FG010|NOT COMPLETED|Overall Study||11||
59546906|NCT00585195|75645590|FG011|NOT COMPLETED|Overall Study||53||
59546907|NCT00585195|75645591|FG012|NOT COMPLETED|Overall Study||85||
59680269|NCT01215175|75799410|FG003|COMPLETED|Overall Study||28||
60078834|NCT01525641|76194031|FG000|STARTED|Overall Study||615||
60078835|NCT01525641|76194031|FG000|COMPLETED|Overall Study||435||
60078836|NCT01525641|76194031|FG000|NOT COMPLETED|Overall Study||180||
60078837|NCT00006400|76194037|FG000|STARTED|Overall Study||96||
59546908|NCT00585195|75645592|FG013|NOT COMPLETED|Overall Study||41||
60078838|NCT00006400|76194038|FG001|STARTED|Overall Study||97||
60078839|NCT00006400|76194037|FG000|COMPLETED|Overall Study||83||
59680270|NCT01215175|75799411|FG004|COMPLETED|Overall Study||28||
59680271|NCT01215175|75799407|FG000|NOT COMPLETED|Overall Study||0||
59680272|NCT01215175|75799408|FG001|NOT COMPLETED|Overall Study||1||
59680273|NCT01215175|75799409|FG002|NOT COMPLETED|Overall Study||0||
59680274|NCT01215175|75799410|FG003|NOT COMPLETED|Overall Study||1||
59680275|NCT01215175|75799411|FG004|NOT COMPLETED|Overall Study||0||
59680276|NCT01215097|75799425|FG000|STARTED|Overall Study|Patients who are randomised and treated with placebo. 1 patient was not treated then not included.|100||
60078840|NCT00006400|76194038|FG001|COMPLETED|Overall Study||84||
60078841|NCT00006400|76194037|FG000|NOT COMPLETED|Overall Study||13||
60078842|NCT00006400|76194038|FG001|NOT COMPLETED|Overall Study||13||
60078843|NCT01496469|76194046|FG000|STARTED|Overall Study||60||
60078844|NCT01496469|76194047|FG001|STARTED|Overall Study||61||
60078845|NCT01496469|76194046|FG000|COMPLETED|Overall Study||50||
60078846|NCT01496469|76194047|FG001|COMPLETED|Overall Study||53||
60078847|NCT01496469|76194046|FG000|NOT COMPLETED|Overall Study||10||
60078848|NCT01496469|76194047|FG001|NOT COMPLETED|Overall Study||8||
60078849|NCT00189436|76194055|FG000|STARTED|Overall Study||31||
60078850|NCT00189436|76194056|FG001|STARTED|Overall Study||30||
60078851|NCT00189436|76194055|FG000|COMPLETED|Overall Study||23||
60078852|NCT00189436|76194056|FG001|COMPLETED|Overall Study||25||
60078853|NCT00189436|76194055|FG000|NOT COMPLETED|Overall Study||8||
60078854|NCT00189436|76194056|FG001|NOT COMPLETED|Overall Study||5||
60078855|NCT01471353|76194062|FG000|STARTED|Overall Study||42||
60078856|NCT01471353|76194062|FG000|COMPLETED|Overall Study||39||
60078857|NCT01471353|76194062|FG000|NOT COMPLETED|Overall Study||3||
60078858|NCT01525407|76194068|FG000|STARTED|Overall Study||41||
60078859|NCT01525407|76194069|FG001|STARTED|Overall Study||42||
60078860|NCT01525407|76194068|FG000|COMPLETED|Overall Study||38||
60078861|NCT01525407|76194069|FG001|COMPLETED|Overall Study||38||
60078862|NCT01525407|76194068|FG000|NOT COMPLETED|Overall Study||3||
60078863|NCT01525407|76194069|FG001|NOT COMPLETED|Overall Study||4||
60078864|NCT01471197|76194077|FG000|STARTED|Overall Study||6||
60078865|NCT01471197|76194078|FG001|STARTED|Overall Study||2||
60078866|NCT01471197|76194077|FG000|COMPLETED|Overall Study||0||
60078867|NCT01471197|76194078|FG001|COMPLETED|Overall Study||0||
59680277|NCT01215097|75799426|FG001|STARTED|Overall Study|Patients who are randomised and treated with linagliptin.|205||
59680278|NCT01215097|75799425|FG000|COMPLETED|Overall Study||88||
59680279|NCT01215097|75799426|FG001|COMPLETED|Overall Study||191||
59680280|NCT01215097|75799425|FG000|NOT COMPLETED|Overall Study||12||
59680281|NCT01215097|75799426|FG001|NOT COMPLETED|Overall Study||14||
59680282|NCT03303339|75799444|FG000|STARTED|Overall Study||3||
59680283|NCT03303339|75799445|FG001|STARTED|Overall Study||3||
59680284|NCT03303339|75799446|FG002|STARTED|Overall Study||3||
59680285|NCT03303339|75799447|FG003|STARTED|Overall Study||3||
59680286|NCT03303339|75799448|FG004|STARTED|Overall Study||5||
60078868|NCT01471197|76194077|FG000|NOT COMPLETED|Overall Study||6||
60078869|NCT01471197|76194078|FG001|NOT COMPLETED|Overall Study||2||
60078870|NCT00011986|76194089|FG000|STARTED|Overall Study||864||
60078871|NCT00011986|76194090|FG001|STARTED|Overall Study||864||
60078872|NCT00011986|76194091|FG002|STARTED|Overall Study||862||
60078873|NCT00011986|76194092|FG003|STARTED|Overall Study||861||
60078874|NCT00011986|76194093|FG004|STARTED|Overall Study||861||
60078875|NCT00011986|76194089|FG000|Initiated Treatment|Overall Study||862||
60078876|NCT00011986|76194090|FG001|Initiated Treatment|Overall Study||860||
60078877|NCT00011986|76194091|FG002|Initiated Treatment|Overall Study||854||
60078878|NCT00011986|76194092|FG003|Initiated Treatment|Overall Study||846||
60078879|NCT00011986|76194093|FG004|Initiated Treatment|Overall Study||851||
60078880|NCT00011986|76194089|FG000|COMPLETED|Overall Study||864||
60078881|NCT00011986|76194090|FG001|COMPLETED|Overall Study||864||
60078882|NCT00011986|76194091|FG002|COMPLETED|Overall Study||862||
60078883|NCT00011986|76194092|FG003|COMPLETED|Overall Study||861||
60078884|NCT00011986|76194093|FG004|COMPLETED|Overall Study||861||
60078885|NCT00011986|76194089|FG000|NOT COMPLETED|Overall Study||0||
60078886|NCT00011986|76194090|FG001|NOT COMPLETED|Overall Study||0||
60078887|NCT00011986|76194091|FG002|NOT COMPLETED|Overall Study||0||
60078888|NCT00011986|76194092|FG003|NOT COMPLETED|Overall Study||0||
60078889|NCT00011986|76194093|FG004|NOT COMPLETED|Overall Study||0||
60078890|NCT01524783|76194112|FG000|STARTED|Blinded Period||205||
59680287|NCT03303339|75799449|FG005|STARTED|Overall Study||4||
59680288|NCT03303339|75799450|FG006|STARTED|Overall Study||3||
59680289|NCT03303339|75799451|FG007|STARTED|Overall Study||3||
59680290|NCT03303339|75799452|FG008|STARTED|Overall Study||4||
59680291|NCT03303339|75799453|FG009|STARTED|Overall Study||3||
59680292|NCT03303339|75799454|FG010|STARTED|Overall Study||6||
59680293|NCT03303339|75799455|FG011|STARTED|Overall Study||32||
60078891|NCT01524783|76194113|FG001|STARTED|Blinded Period||97||
60078892|NCT01524783|76194114|FG002|STARTED|Blinded Period||0||
60078893|NCT01524783|76194112|FG000|COMPLETED|Blinded Period||26|Participants who entered the open-label part of the study|
60078894|NCT01524783|76194113|FG001|COMPLETED|Blinded Period||6|Participants who entered the open-label part of the study|
60078895|NCT01524783|76194114|FG002|COMPLETED|Blinded Period||0|Participants who entered the open-label part of the study|
60078896|NCT01524783|76194112|FG000|NOT COMPLETED|Blinded Period||179||
59680294|NCT03303339|75799444|FG000|COMPLETED|Overall Study||0||
60078897|NCT01524783|76194113|FG001|NOT COMPLETED|Blinded Period||91||
60078898|NCT01524783|76194114|FG002|NOT COMPLETED|Blinded Period||0||
60078899|NCT01524783|76194112|FG000|STARTED|Open-label Period||26||
60078900|NCT01524783|76194113|FG001|STARTED|Open-label Period||0||
60078901|NCT01524783|76194114|FG002|STARTED|Open-label Period||6||
60078902|NCT01524783|76194112|FG000|COMPLETED|Open-label Period||0||
60078903|NCT01524783|76194113|FG001|COMPLETED|Open-label Period||0||
60078904|NCT01524783|76194114|FG002|COMPLETED|Open-label Period||0||
60078905|NCT01524783|76194112|FG000|NOT COMPLETED|Open-label Period||26||
60078906|NCT01524783|76194113|FG001|NOT COMPLETED|Open-label Period||0||
60078907|NCT01524783|76194114|FG002|NOT COMPLETED|Open-label Period||6||
59680295|NCT03303339|75799445|FG001|COMPLETED|Overall Study||1||
59680296|NCT03303339|75799446|FG002|COMPLETED|Overall Study||1||
59680297|NCT03303339|75799447|FG003|COMPLETED|Overall Study||2||
59680298|NCT03303339|75799448|FG004|COMPLETED|Overall Study||0||
59680299|NCT03303339|75799449|FG005|COMPLETED|Overall Study||1||
59680300|NCT03303339|75799450|FG006|COMPLETED|Overall Study||0||
59680301|NCT03303339|75799451|FG007|COMPLETED|Overall Study||1||
59680302|NCT03303339|75799452|FG008|COMPLETED|Overall Study||0||
59680303|NCT03303339|75799453|FG009|COMPLETED|Overall Study||0||
59680304|NCT03303339|75799454|FG010|COMPLETED|Overall Study||1||
59680305|NCT03303339|75799455|FG011|COMPLETED|Overall Study||4||
59680306|NCT03303339|75799444|FG000|NOT COMPLETED|Overall Study||3||
59680307|NCT03303339|75799445|FG001|NOT COMPLETED|Overall Study||2||
59680308|NCT03303339|75799446|FG002|NOT COMPLETED|Overall Study||2||
59680309|NCT03303339|75799447|FG003|NOT COMPLETED|Overall Study||1||
59680310|NCT03303339|75799448|FG004|NOT COMPLETED|Overall Study||5||
59680311|NCT03303339|75799449|FG005|NOT COMPLETED|Overall Study||3||
59680312|NCT03303339|75799450|FG006|NOT COMPLETED|Overall Study||3||
59680313|NCT03303339|75799451|FG007|NOT COMPLETED|Overall Study||2||
59680314|NCT03303339|75799452|FG008|NOT COMPLETED|Overall Study||4||
59680315|NCT03303339|75799453|FG009|NOT COMPLETED|Overall Study||3||
59680316|NCT03303339|75799454|FG010|NOT COMPLETED|Overall Study||5||
59680317|NCT03303339|75799455|FG011|NOT COMPLETED|Overall Study||28||
59680318|NCT01183780|75799500|FG000|STARTED|Overall Study||536||
60078908|NCT01494987|76194128|FG000|STARTED|Overall Study||216||
60078909|NCT01494987|76194129|FG001|STARTED|Overall Study||215||
60078910|NCT01494987|76194128|FG000|COMPLETED|Overall Study||188||
60078911|NCT01494987|76194129|FG001|COMPLETED|Overall Study||187||
60078912|NCT01494987|76194128|FG000|NOT COMPLETED|Overall Study||28||
60078913|NCT01494987|76194129|FG001|NOT COMPLETED|Overall Study||28||
60078914|NCT01524627|76194137|FG000|STARTED|Overall Study||22||
60078915|NCT01524627|76194138|FG001|STARTED|Overall Study||21||
60078916|NCT01524627|76194137|FG000|COMPLETED|Overall Study||21||
60078917|NCT01524627|76194138|FG001|COMPLETED|Overall Study||19||
59680319|NCT01183780|75799501|FG001|STARTED|Overall Study||536||
59680320|NCT01183780|75799500|FG000|Received at Least 1 Dose of Study Drug|Overall Study||528||
59680321|NCT01183780|75799501|FG001|Received at Least 1 Dose of Study Drug|Overall Study||529||
59680322|NCT01183780|75799500|FG000|COMPLETED|Overall Study||505||
59680323|NCT01183780|75799501|FG001|COMPLETED|Overall Study||511||
59680324|NCT01183780|75799500|FG000|NOT COMPLETED|Overall Study||31||
59680325|NCT01183780|75799501|FG001|NOT COMPLETED|Overall Study||25||
59680326|NCT01183468|75799511|FG000|STARTED|Overall Study||8||
59680327|NCT01183468|75799512|FG001|STARTED|Overall Study||9||
59680328|NCT01183468|75799513|FG002|STARTED|Overall Study||0||
59680329|NCT01183468|75799514|FG003|STARTED|Overall Study||0||
59680330|NCT01183468|75799511|FG000|COMPLETED|Overall Study||5||
59680331|NCT01183468|75799512|FG001|COMPLETED|Overall Study||7||
60078918|NCT01524627|76194137|FG000|NOT COMPLETED|Overall Study||1||
60078919|NCT01524627|76194138|FG001|NOT COMPLETED|Overall Study||2||
60078920|NCT01469637|76194146|FG000|STARTED|First Intervention||22||
60078921|NCT01469637|76194147|FG001|STARTED|First Intervention||22||
60078922|NCT01469637|76194146|FG000|COMPLETED|First Intervention||22||
60078923|NCT01469637|76194147|FG001|COMPLETED|First Intervention||21||
60078924|NCT01469637|76194146|FG000|NOT COMPLETED|First Intervention||0||
60078925|NCT01469637|76194147|FG001|NOT COMPLETED|First Intervention||1||
60078926|NCT01469637|76194146|FG000|STARTED|Second Intervention||22||
60078927|NCT01469637|76194147|FG001|STARTED|Second Intervention||21||
60078928|NCT01469637|76194146|FG000|COMPLETED|Second Intervention||21||
60078929|NCT01469637|76194147|FG001|COMPLETED|Second Intervention||21||
60078930|NCT01469637|76194146|FG000|NOT COMPLETED|Second Intervention||1||
59680332|NCT01183468|75799513|FG002|COMPLETED|Overall Study||0||
59680333|NCT01183468|75799514|FG003|COMPLETED|Overall Study||0||
59680334|NCT01183468|75799511|FG000|NOT COMPLETED|Overall Study||3||
59680335|NCT01183468|75799512|FG001|NOT COMPLETED|Overall Study||2||
59680336|NCT01183468|75799513|FG002|NOT COMPLETED|Overall Study||0||
59680337|NCT01183468|75799514|FG003|NOT COMPLETED|Overall Study||0||
59680338|NCT01183390|75799524|FG000|STARTED|First Intervention||11||
59680339|NCT01183390|75799525|FG001|STARTED|First Intervention||11||
59680340|NCT01183390|75799524|FG000|COMPLETED|First Intervention||11||
59680341|NCT01183390|75799525|FG001|COMPLETED|First Intervention||10||
59680342|NCT01183390|75799524|FG000|NOT COMPLETED|First Intervention||0||
59680343|NCT01183390|75799525|FG001|NOT COMPLETED|First Intervention||1||
59680344|NCT01183390|75799524|FG000|STARTED|Washout of 21 Days||11||
59680345|NCT01183390|75799525|FG001|STARTED|Washout of 21 Days||10||
59680346|NCT01183390|75799524|FG000|COMPLETED|Washout of 21 Days||11||
59680347|NCT01183390|75799525|FG001|COMPLETED|Washout of 21 Days||10||
59680348|NCT01183390|75799524|FG000|NOT COMPLETED|Washout of 21 Days||0||
59680349|NCT01183390|75799525|FG001|NOT COMPLETED|Washout of 21 Days||0||
59680350|NCT01183390|75799524|FG000|STARTED|Second Intervention||11||
59680351|NCT01183390|75799525|FG001|STARTED|Second Intervention||10||
59680352|NCT01183390|75799524|FG000|COMPLETED|Second Intervention||11||
59680353|NCT01183390|75799525|FG001|COMPLETED|Second Intervention||10||
59680354|NCT01183390|75799524|FG000|NOT COMPLETED|Second Intervention||0||
59680355|NCT01183390|75799525|FG001|NOT COMPLETED|Second Intervention||0||
59680356|NCT01214668|75799537|FG000|STARTED|Overall Study||4||
59680357|NCT01214668|75799538|FG001|STARTED|Overall Study||3||
59680358|NCT01214668|75799539|FG002|STARTED|Overall Study||6||
59680359|NCT01214668|75799540|FG003|STARTED|Overall Study||6||
59680360|NCT01214668|75799541|FG004|STARTED|Overall Study||6||
59680361|NCT01214668|75799542|FG005|STARTED|Overall Study||6||
59680362|NCT01214668|75799537|FG000|Received at Least One Dose of Study Drug|Overall Study||4||
59680363|NCT01214668|75799538|FG001|Received at Least One Dose of Study Drug|Overall Study||3||
59680364|NCT01214668|75799539|FG002|Received at Least One Dose of Study Drug|Overall Study||6||
59680365|NCT01214668|75799540|FG003|Received at Least One Dose of Study Drug|Overall Study||6||
59680366|NCT01214668|75799541|FG004|Received at Least One Dose of Study Drug|Overall Study||6||
59680367|NCT01214668|75799542|FG005|Received at Least One Dose of Study Drug|Overall Study||6||
59680368|NCT01214668|75799537|FG000|COMPLETED|Overall Study||0||
59680369|NCT01214668|75799538|FG001|COMPLETED|Overall Study||0||
59680370|NCT01214668|75799539|FG002|COMPLETED|Overall Study||0||
59680371|NCT01214668|75799540|FG003|COMPLETED|Overall Study||0||
59680372|NCT01214668|75799541|FG004|COMPLETED|Overall Study||0||
59680373|NCT01214668|75799542|FG005|COMPLETED|Overall Study||0||
59680374|NCT01214668|75799537|FG000|NOT COMPLETED|Overall Study||4||
59680375|NCT01214668|75799538|FG001|NOT COMPLETED|Overall Study||3||
59680376|NCT01214668|75799539|FG002|NOT COMPLETED|Overall Study||6||
59680377|NCT01214668|75799540|FG003|NOT COMPLETED|Overall Study||6||
59680378|NCT01214668|75799541|FG004|NOT COMPLETED|Overall Study||6||
59680379|NCT01214668|75799542|FG005|NOT COMPLETED|Overall Study||6||
59680380|NCT01191268|75799560|FG000|STARTED|Overall Study||295||
59680381|NCT01191268|75799561|FG001|STARTED|Overall Study||293||
59680382|NCT01191268|75799562|FG002|STARTED|Overall Study||296||
59680383|NCT01191268|75799560|FG000|Received at Least One Dose of Study Drug|Overall Study||295||
59680384|NCT01191268|75799561|FG001|Received at Least One Dose of Study Drug|Overall Study||293||
60078931|NCT01469637|76194147|FG001|NOT COMPLETED|Second Intervention||0||
60078932|NCT00012298|76194160|FG000|STARTED|Overall Study||11||
60078933|NCT00012298|76194161|FG001|STARTED|Overall Study||7||
60078934|NCT00012298|76194162|FG002|STARTED|Overall Study||9||
60078935|NCT00012298|76194163|FG003|STARTED|Overall Study||4||
60078936|NCT00012298|76194164|FG004|STARTED|Overall Study||5||
60078937|NCT00012298|76194165|FG005|STARTED|Overall Study||6||
60078938|NCT00012298|76194166|FG006|STARTED|Overall Study||39||
60078939|NCT00012298|76194160|FG000|COMPLETED|Overall Study||11||
60078940|NCT00012298|76194161|FG001|COMPLETED|Overall Study||7||
60078941|NCT00012298|76194162|FG002|COMPLETED|Overall Study||9||
60078942|NCT00012298|76194163|FG003|COMPLETED|Overall Study||4||
60078943|NCT00012298|76194164|FG004|COMPLETED|Overall Study||5||
60078944|NCT00012298|76194165|FG005|COMPLETED|Overall Study||6||
60078945|NCT00012298|76194166|FG006|COMPLETED|Overall Study||39||
60078946|NCT00012298|76194160|FG000|NOT COMPLETED|Overall Study||0||
60078947|NCT00012298|76194161|FG001|NOT COMPLETED|Overall Study||0||
60078948|NCT00012298|76194162|FG002|NOT COMPLETED|Overall Study||0||
59680385|NCT01191268|75799562|FG002|Received at Least One Dose of Study Drug|Overall Study||296||
59680386|NCT01191268|75799560|FG000|COMPLETED|Overall Study||237||
59680387|NCT01191268|75799561|FG001|COMPLETED|Overall Study||238||
59680388|NCT01191268|75799562|FG002|COMPLETED|Overall Study||244||
59680389|NCT01191268|75799560|FG000|NOT COMPLETED|Overall Study||58||
59680390|NCT01191268|75799561|FG001|NOT COMPLETED|Overall Study||55||
59680391|NCT01191268|75799562|FG002|NOT COMPLETED|Overall Study||52||
59680392|NCT01191190|75799571|FG000|STARTED|Overall Study||21||
59680393|NCT01191190|75799571|FG000|COMPLETED|Overall Study||20||
59680394|NCT01191190|75799571|FG000|NOT COMPLETED|Overall Study||1||
59680395|NCT05751629|75799575|FG000|STARTED|Overall Study||41||
59680396|NCT05751629|75799575|FG000|COMPLETED|Overall Study||0||
59680397|NCT05751629|75799575|FG000|NOT COMPLETED|Overall Study||41||
59680398|NCT05306977|75799579|FG000|STARTED|Overall Study||5||
59680399|NCT05306977|75799579|FG000|COMPLETED|Overall Study||4||
59680400|NCT05306977|75799579|FG000|NOT COMPLETED|Overall Study||1||
59680401|NCT05086276|75799585|FG000|STARTED|Overall Study||70||
59680402|NCT05086276|75799586|FG001|STARTED|Overall Study||72||
59680403|NCT05086276|75799585|FG000|COMPLETED|Overall Study||69||
60078949|NCT00012298|76194163|FG003|NOT COMPLETED|Overall Study||0||
60078950|NCT00012298|76194164|FG004|NOT COMPLETED|Overall Study||0||
60078951|NCT00012298|76194165|FG005|NOT COMPLETED|Overall Study||0||
60078952|NCT00012298|76194166|FG006|NOT COMPLETED|Overall Study||0||
59680404|NCT05086276|75799586|FG001|COMPLETED|Overall Study||71||
59680405|NCT05086276|75799585|FG000|NOT COMPLETED|Overall Study||1||
59680406|NCT05086276|75799586|FG001|NOT COMPLETED|Overall Study||1||
60078953|NCT00193258|76194184|FG000|STARTED|Overall Study||94||
60078954|NCT00193258|76194184|FG000|COMPLETED|Overall Study||94||
60078955|NCT00193258|76194184|FG000|NOT COMPLETED|Overall Study||0||
59680407|NCT04870710|75799592|FG000|STARTED|Overall Study||6||
59680408|NCT04870710|75799592|FG000|Transcranial Direct Current Stimulation (tDCS) Baseline Assessment|Overall Study||6||
59680409|NCT04870710|75799592|FG000|Transcranial Direct Current Stimulation (tDCS) Five Day Follow-up Assessment|Overall Study||6||
59680410|NCT04870710|75799592|FG000|Transcranial Direct Current Stimulation (tDCS) 1 Month Follow-up Assessment|Overall Study||5||
59680411|NCT04870710|75799592|FG000|Transcranial Alternating Current Stimulation (tACS) Baseline Assessment|Overall Study||4||
59680412|NCT04870710|75799592|FG000|Transcranial Alternating Current Stimulation (tACS) 5 Day Follow up Assessment|Overall Study||4||
59680413|NCT04870710|75799592|FG000|Transcranial Alternating Current Stimulation (tACS) 1 Month Follow up Assessment|Overall Study||3||
59680414|NCT04870710|75799592|FG000|COMPLETED|Overall Study||3||
59680415|NCT04870710|75799592|FG000|NOT COMPLETED|Overall Study||3||
59680416|NCT04858802|75799598|FG000|STARTED|Overall Study||80||80
59680417|NCT04858802|75799599|FG001|STARTED|Overall Study||80||80
60078956|NCT00029536|76194192|FG000|STARTED|Overall Study||85||
59680418|NCT04858802|75799598|FG000|Completed Day 45 Follow-up Visit|Overall Study||80||80
59680419|NCT04858802|75799599|FG001|Completed Day 45 Follow-up Visit|Overall Study||80||80
59680420|NCT04858802|75799598|FG000|COMPLETED|Overall Study||78||78
59680421|NCT04858802|75799599|FG001|COMPLETED|Overall Study||78||78
59680422|NCT04858802|75799598|FG000|NOT COMPLETED|Overall Study||2||2
59680423|NCT04858802|75799599|FG001|NOT COMPLETED|Overall Study||2||2
59680424|NCT04787055|75799607|FG000|STARTED|Overall Study||18||
59680425|NCT04787055|75799608|FG001|STARTED|Overall Study||17||
59680426|NCT04787055|75799607|FG000|COMPLETED|Overall Study||15||
59680427|NCT04787055|75799608|FG001|COMPLETED|Overall Study||11||
59680428|NCT04787055|75799607|FG000|NOT COMPLETED|Overall Study||3||
59680429|NCT04787055|75799608|FG001|NOT COMPLETED|Overall Study||6||
59680430|NCT04562090|75799617|FG000|STARTED|Overall Study||84||
59680431|NCT04562090|75799618|FG001|STARTED|Overall Study||165||
59680432|NCT04562090|75799617|FG000|Participants (Never-Up Titrated)|Overall Study||44||
59680433|NCT04562090|75799618|FG001|Participants (Never-Up Titrated)|Overall Study||0||
59680434|NCT04562090|75799617|FG000|Participants (Up Titrated to 50 mg)|Overall Study||39||
59680435|NCT04562090|75799618|FG001|Participants (Up Titrated to 50 mg)|Overall Study||0||
59680436|NCT04562090|75799617|FG000|Treated|Overall Study||83||
59680437|NCT04562090|75799618|FG001|Treated|Overall Study||165||
59680438|NCT04562090|75799617|FG000|COMPLETED|Overall Study||78||
59680439|NCT04562090|75799618|FG001|COMPLETED|Overall Study||153||
59680440|NCT04562090|75799617|FG000|NOT COMPLETED|Overall Study||6||
59680441|NCT04562090|75799618|FG001|NOT COMPLETED|Overall Study||12||
59680442|NCT04557189|75799629|FG000|STARTED|Overall Study||44||
59680443|NCT04557189|75799630|FG001|STARTED|Overall Study||45||
59680444|NCT04557189|75799629|FG000|Full Analysis Set (FAS)|Overall Study||41|FAS included all participants who were randomized to treatment and received both doses of double-blind study drug before and during surgery.|
59709777|NCT01072149|75828525|FG005|STARTED|Washout Period 1 (14 Days)||3||
59816043|NCT00531050|75938378|FG005|COMPLETED|Part 2: Period 3||3||
59816044|NCT00531050|75938373|FG000|NOT COMPLETED|Part 2: Period 3||1||
59816045|NCT00531050|75938374|FG001|NOT COMPLETED|Part 2: Period 3||0||
59816046|NCT00531050|75938375|FG002|NOT COMPLETED|Part 2: Period 3||0||
59816047|NCT00531050|75938376|FG003|NOT COMPLETED|Part 2: Period 3||0||
59816048|NCT00531050|75938377|FG004|NOT COMPLETED|Part 2: Period 3||0||
59816049|NCT00531050|75938378|FG005|NOT COMPLETED|Part 2: Period 3||1||
59816050|NCT00530348|75938397|FG000|STARTED|Overall Study|Randomized.|195||
59816051|NCT00530348|75938398|FG001|STARTED|Overall Study|Randomized.|386||
59816052|NCT00530348|75938397|FG000|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug.|187||
59816053|NCT00530348|75938398|FG001|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug.|376||
59816054|NCT00530348|75938397|FG000|COMPLETED|Overall Study||173||
59816055|NCT00530348|75938398|FG001|COMPLETED|Overall Study||367||
59816056|NCT00530348|75938397|FG000|NOT COMPLETED|Overall Study||22||
59816057|NCT00530348|75938398|FG001|NOT COMPLETED|Overall Study||19||
59816058|NCT03886220|75938406|FG000|STARTED|Treatment Period||28||
59816059|NCT03886220|75938407|FG001|STARTED|Treatment Period||54||
59816060|NCT03886220|75938406|FG000|COMPLETED|Treatment Period||23|Completed study drug treatment.|
59816061|NCT03886220|75938407|FG001|COMPLETED|Treatment Period||42|Completed study drug treatment.|
60078957|NCT00029536|76194193|FG001|STARTED|Overall Study||45||
60078958|NCT00029536|76194194|FG002|STARTED|Overall Study||105||
60078959|NCT00029536|76194195|FG003|STARTED|Overall Study||59||
59709778|NCT01072149|75828526|FG006|STARTED|Washout Period 1 (14 Days)||3||
59709779|NCT01072149|75828527|FG007|STARTED|Washout Period 1 (14 Days)||3||
59709780|NCT01072149|75828528|FG008|STARTED|Washout Period 1 (14 Days)||3||
59709781|NCT01072149|75828529|FG009|STARTED|Washout Period 1 (14 Days)||3||
59709782|NCT01072149|75828530|FG010|STARTED|Washout Period 1 (14 Days)||2||
59709783|NCT01072149|75828531|FG011|STARTED|Washout Period 1 (14 Days)||3||
59709784|NCT01072149|75828532|FG012|STARTED|Washout Period 1 (14 Days)||3||
59709785|NCT01072149|75828533|FG013|STARTED|Washout Period 1 (14 Days)||3||
59709786|NCT01072149|75828534|FG014|STARTED|Washout Period 1 (14 Days)||3||
59709787|NCT01072149|75828535|FG015|STARTED|Washout Period 1 (14 Days)||3||
59709788|NCT01072149|75828536|FG016|STARTED|Washout Period 1 (14 Days)||3||
59680445|NCT04557189|75799630|FG001|Full Analysis Set (FAS)|Overall Study||39|FAS included all participants who were randomized to treatment and received both doses of double-blind study drug before and during surgery.|
59680446|NCT04557189|75799629|FG000|Pharmacokinetic (PK) Set|Overall Study||0|PK Set included all participants who received study drug and had at least 1 evaluable PK sample. Due to dosing error, an unintended mis-dose of TAK-951 redacted mg was administered to 18 participants from the TAK-951 4 mg group. Data for these participants were collected and reported separately.|
59680447|NCT04557189|75799630|FG001|Pharmacokinetic (PK) Set|Overall Study||21|PK Set included all participants who received study drug and had at least 1 evaluable PK sample. Due to dosing error, an unintended mis-dose of TAK-951 redacted mg was administered to 18 participants from the TAK-951 4 mg group. Data for these participants were collected and reported separately.|
59680448|NCT04557189|75799629|FG000|Immunogenicity Set|Overall Study||0|Immunogenicity Set included all participants who received at least 1 dose of study drug, had an ADA status assessment at baseline, and at least 1 postbaseline sample. Due to dosing error, an unintended mis-dose of TAK-951 redacted mg was administered to 18 participants from the TAK-951 4 mg group. Data for these participants were collected and reported separately.|
59680449|NCT04557189|75799630|FG001|Immunogenicity Set|Overall Study||21|Immunogenicity Set included all participants who received at least 1 dose of study drug, had an ADA status assessment at baseline, and at least 1 postbaseline sample. Due to dosing error, an unintended mis-dose of TAK-951 redacted mg was administered to 18 participants from the TAK-951 4 mg group. Data for these participants were collected and reported separately.|
59680450|NCT04557189|75799629|FG000|Unintended Mis-dose Due to Dosing Error|Overall Study||0|Of the 39 participants in the TAK-951 4 mg SC group, 18 participants received an unintended mis-dose of TAK-951 redacted mg.|
59680451|NCT04557189|75799630|FG001|Unintended Mis-dose Due to Dosing Error|Overall Study||18|Of the 39 participants in the TAK-951 4 mg SC group, 18 participants received an unintended mis-dose of TAK-951 redacted mg.|
59680452|NCT04557189|75799629|FG000|COMPLETED|Overall Study||38||
59680453|NCT04557189|75799630|FG001|COMPLETED|Overall Study||36||
59680454|NCT04557189|75799629|FG000|NOT COMPLETED|Overall Study||6||
59680455|NCT04557189|75799630|FG001|NOT COMPLETED|Overall Study||9||
59680456|NCT04530838|75799643|FG000|STARTED|Overall Study||225||
59680457|NCT04530838|75799644|FG001|STARTED|Overall Study||224||
59680458|NCT04530838|75799645|FG002|STARTED|Overall Study||217||
59680459|NCT04530838|75799643|FG000|COMPLETED|Overall Study||217||
59680460|NCT04530838|75799644|FG001|COMPLETED|Overall Study||220||
59680461|NCT04530838|75799645|FG002|COMPLETED|Overall Study||211||
60078960|NCT00029536|76194192|FG000|COMPLETED|Overall Study||85||
60078961|NCT00029536|76194193|FG001|COMPLETED|Overall Study||45||
60078962|NCT00029536|76194194|FG002|COMPLETED|Overall Study||105||
60078963|NCT00029536|76194195|FG003|COMPLETED|Overall Study||59||
60078964|NCT00029536|76194192|FG000|NOT COMPLETED|Overall Study||0||
60078965|NCT00029536|76194193|FG001|NOT COMPLETED|Overall Study||0||
60078966|NCT00029536|76194194|FG002|NOT COMPLETED|Overall Study||0||
60078967|NCT00029536|76194195|FG003|NOT COMPLETED|Overall Study||0||
60078968|NCT00193492|76194209|FG000|STARTED|Overall Study||31||
60078969|NCT00193492|76194210|FG001|STARTED|Overall Study||29||
60078970|NCT00193492|76194209|FG000|COMPLETED|Overall Study||14||
60078971|NCT00193492|76194210|FG001|COMPLETED|Overall Study||14||
60078972|NCT00193492|76194209|FG000|NOT COMPLETED|Overall Study||17||
60078973|NCT00193492|76194210|FG001|NOT COMPLETED|Overall Study||15||
60078974|NCT00194116|76194218|FG000|STARTED|Overall Study||26||
60078975|NCT00194116|76194219|FG001|STARTED|Overall Study||28||
60078976|NCT00194116|76194218|FG000|COMPLETED|Overall Study||13||
60078977|NCT00194116|76194219|FG001|COMPLETED|Overall Study||13||
60078978|NCT00194116|76194218|FG000|NOT COMPLETED|Overall Study||13||
60078979|NCT00194116|76194219|FG001|NOT COMPLETED|Overall Study||15||
60078980|NCT02096458|76194225|FG000|STARTED|Overall Study||8||
60078981|NCT02096458|76194225|FG000|COMPLETED|Overall Study||8||
60078982|NCT02096458|76194225|FG000|NOT COMPLETED|Overall Study||0||
60078983|NCT02096692|76194229|FG000|STARTED|Overall Study||154||
60078984|NCT02096692|76194229|FG000|COMPLETED|Overall Study||150||
60078985|NCT02096692|76194229|FG000|NOT COMPLETED|Overall Study||4||
60078986|NCT00194896|76194237|FG000|STARTED|Overall Study||15||
60078987|NCT00194896|76194238|FG001|STARTED|Overall Study||15||
60078988|NCT00194896|76194239|FG002|STARTED|Overall Study||13||
60078989|NCT00194896|76194240|FG003|STARTED|Overall Study||21||
60078990|NCT00194896|76194237|FG000|COMPLETED|Overall Study||4||
60078991|NCT00194896|76194238|FG001|COMPLETED|Overall Study||10||
60078992|NCT00194896|76194239|FG002|COMPLETED|Overall Study||7||
60078993|NCT00194896|76194240|FG003|COMPLETED|Overall Study||9||
60078994|NCT00194896|76194237|FG000|NOT COMPLETED|Overall Study||11||
60078995|NCT00194896|76194238|FG001|NOT COMPLETED|Overall Study||5||
60078996|NCT00194896|76194239|FG002|NOT COMPLETED|Overall Study||6||
60078997|NCT00194896|76194240|FG003|NOT COMPLETED|Overall Study||12||
60078998|NCT00197392|76194252|FG000|STARTED|Overall Study||214||
60078999|NCT00197392|76194253|FG001|STARTED|Overall Study||220||
60079000|NCT00197392|76194252|FG000|Safety Population|Overall Study||214||
60079001|NCT00197392|76194253|FG001|Safety Population|Overall Study||220||
60079002|NCT00197392|76194252|FG000|Modified Intent to Treat|Overall Study||209||
60079003|NCT00197392|76194253|FG001|Modified Intent to Treat|Overall Study||210||
60079004|NCT00197392|76194252|FG000|Evaluable|Overall Study||176||
60079005|NCT00197392|76194253|FG001|Evaluable|Overall Study||181||
60079006|NCT00197392|76194252|FG000|Per Protocol|Overall Study||126||
60079007|NCT00197392|76194253|FG001|Per Protocol|Overall Study||134||
60079008|NCT00197392|76194252|FG000|COMPLETED|Overall Study||126||
60079009|NCT00197392|76194253|FG001|COMPLETED|Overall Study||134||
60079010|NCT00197392|76194252|FG000|NOT COMPLETED|Overall Study||88||
60079011|NCT00197392|76194253|FG001|NOT COMPLETED|Overall Study||86||
60079012|NCT00107536|76194275|FG000|STARTED|Overall Study||26||
60079013|NCT00107536|76194275|FG000|COMPLETED|Overall Study||26||
60079014|NCT00107536|76194275|FG000|NOT COMPLETED|Overall Study||0||
60079015|NCT00108550|76194281|FG000|STARTED|Overall Study||55||
60079016|NCT00108550|76194282|FG001|STARTED|Overall Study||53||
60079017|NCT00108550|76194281|FG000|COMPLETED|Overall Study||39||
60079018|NCT00108550|76194282|FG001|COMPLETED|Overall Study||37||
60079019|NCT00108550|76194281|FG000|NOT COMPLETED|Overall Study||16||
60079020|NCT00108550|76194282|FG001|NOT COMPLETED|Overall Study||16||
60079021|NCT00109876|76194288|FG000|STARTED|Overall Study||51||
59680462|NCT04530838|75799643|FG000|NOT COMPLETED|Overall Study||8||
59680463|NCT04530838|75799644|FG001|NOT COMPLETED|Overall Study||4||
59680464|NCT04530838|75799645|FG002|NOT COMPLETED|Overall Study||6||
59680465|NCT04474054|75799653|FG000|STARTED|Overall Study||15||
59680466|NCT04474054|75799653|FG000|COMPLETED|Overall Study||15||
59680467|NCT04474054|75799653|FG000|NOT COMPLETED|Overall Study||0||
59680468|NCT04424901|75799659|FG000|STARTED|Overall Study||21||
59680469|NCT04424901|75799660|FG001|STARTED|Overall Study||20||
59680470|NCT04424901|75799659|FG000|COMPLETED|Overall Study||4||
59680471|NCT04424901|75799660|FG001|COMPLETED|Overall Study||4||
59680472|NCT04424901|75799659|FG000|NOT COMPLETED|Overall Study||17||
59680473|NCT04424901|75799660|FG001|NOT COMPLETED|Overall Study||16||
59680474|NCT04410445|75799668|FG000|STARTED|Overall Study||378||
59680475|NCT04410445|75799669|FG001|STARTED|Overall Study||387||
59680476|NCT04410445|75799668|FG000|COMPLETED|Overall Study||348||
59680477|NCT04410445|75799669|FG001|COMPLETED|Overall Study||363||
59546909|NCT00585195|75645593|FG014|NOT COMPLETED|Overall Study||48||
59546910|NCT00585195|75645594|FG015|NOT COMPLETED|Overall Study||19||
59546911|NCT00585195|75645595|FG016|NOT COMPLETED|Overall Study||154||
59546912|NCT00585195|75645596|FG017|NOT COMPLETED|Overall Study||67||
59546913|NCT00585195|75645597|FG018|NOT COMPLETED|Overall Study||21||
59680478|NCT04410445|75799668|FG000|NOT COMPLETED|Overall Study||30||
59680479|NCT04410445|75799669|FG001|NOT COMPLETED|Overall Study||24||
59680480|NCT04158908|75799677|FG000|STARTED|Overall Study||11||
59680481|NCT04158908|75799678|FG001|STARTED|Overall Study||9||
59680482|NCT04158908|75799677|FG000|COMPLETED|Overall Study||10||
59680483|NCT04158908|75799678|FG001|COMPLETED|Overall Study||8||
59680484|NCT04158908|75799677|FG000|NOT COMPLETED|Overall Study||1||
59680485|NCT04158908|75799678|FG001|NOT COMPLETED|Overall Study||1||
59680486|NCT04129086|75799686|FG000|STARTED|Overall Study||144||
59680487|NCT04129086|75799687|FG001|STARTED|Overall Study||156||
59680488|NCT04129086|75799686|FG000|COMPLETED|Overall Study||144||
59680489|NCT04129086|75799687|FG001|COMPLETED|Overall Study||156||
59680490|NCT04129086|75799686|FG000|NOT COMPLETED|Overall Study||0||
59680491|NCT04129086|75799687|FG001|NOT COMPLETED|Overall Study||0||
59680492|NCT04062448|75799693|FG000|STARTED|Overall Study||16||
59680493|NCT04062448|75799693|FG000|COMPLETED|Overall Study||0||
59680494|NCT04062448|75799693|FG000|NOT COMPLETED|Overall Study||16||
59680495|NCT03970733|75799700|FG000|STARTED|Main Study Phase (18 Months)||97||
59680496|NCT03970733|75799701|FG001|STARTED|Main Study Phase (18 Months)||98||
59680497|NCT03970733|75799702|FG002|STARTED|Main Study Phase (18 Months)||51||
59680498|NCT03970733|75799703|FG003|STARTED|Main Study Phase (18 Months)||0||
59680499|NCT03970733|75799704|FG004|STARTED|Main Study Phase (18 Months)||0||
59680500|NCT03970733|75799700|FG000|COMPLETED|Main Study Phase (18 Months)||89|Participants who completed Day 545 (Month 18)|
59680501|NCT03970733|75799701|FG001|COMPLETED|Main Study Phase (18 Months)||84|Participants who completed Day 545 (Month 18)|
59680502|NCT03970733|75799702|FG002|COMPLETED|Main Study Phase (18 Months)||46|Participants who completed Day 545 (Month 18)|
59680503|NCT03970733|75799703|FG003|COMPLETED|Main Study Phase (18 Months)|No participants were enrolled in this arm during the main study phase.|0|Participants who completed Day 545 (Month 18)|
59680504|NCT03970733|75799704|FG004|COMPLETED|Main Study Phase (18 Months)|No participants were enrolled in this arm during the main study phase.|0|Participants who completed Day 545 (Month 18)|
59680505|NCT03970733|75799700|FG000|NOT COMPLETED|Main Study Phase (18 Months)||8||
59680506|NCT03970733|75799701|FG001|NOT COMPLETED|Main Study Phase (18 Months)||14||
59680507|NCT03970733|75799702|FG002|NOT COMPLETED|Main Study Phase (18 Months)||5||
59680508|NCT03970733|75799703|FG003|NOT COMPLETED|Main Study Phase (18 Months)||0||
59680509|NCT03970733|75799704|FG004|NOT COMPLETED|Main Study Phase (18 Months)||0||
59680510|NCT03970733|75799700|FG000|STARTED|Booster Phase (Approx. 12 Months)|Participants did not continue booster phase.|0||
59680511|NCT03970733|75799701|FG001|STARTED|Booster Phase (Approx. 12 Months)|Participants who continued to booster phase are reported under booster phase arms.|0||
60079022|NCT00109876|76194288|FG000|COMPLETED|Overall Study||51||
60079023|NCT00109876|76194288|FG000|NOT COMPLETED|Overall Study||0||
60079024|NCT02093962|76194294|FG000|STARTED|Overall Study||134||
60079025|NCT02093962|76194295|FG001|STARTED|Overall Study||131||
60079026|NCT02093962|76194294|FG000|Received Treatment|Overall Study||130||
60079027|NCT02093962|76194295|FG001|Received Treatment|Overall Study||130||
60079028|NCT02093962|76194294|FG000|COMPLETED|Overall Study||0||
59546914|NCT00585195|75645598|FG019|NOT COMPLETED|Overall Study||18||
59680512|NCT03970733|75799702|FG002|STARTED|Booster Phase (Approx. 12 Months)|Participants did not continue booster phase.|0||
59680513|NCT03970733|75799703|FG003|STARTED|Booster Phase (Approx. 12 Months)||39||
59680514|NCT03970733|75799704|FG004|STARTED|Booster Phase (Approx. 12 Months)||19||
59680515|NCT03970733|75799700|FG000|COMPLETED|Booster Phase (Approx. 12 Months)||0||
59680516|NCT03970733|75799701|FG001|COMPLETED|Booster Phase (Approx. 12 Months)||0||
59680517|NCT03970733|75799702|FG002|COMPLETED|Booster Phase (Approx. 12 Months)||0||
59680518|NCT03970733|75799703|FG003|COMPLETED|Booster Phase (Approx. 12 Months)||39||
59680519|NCT03970733|75799704|FG004|COMPLETED|Booster Phase (Approx. 12 Months)||18||
59680520|NCT03970733|75799700|FG000|NOT COMPLETED|Booster Phase (Approx. 12 Months)||0||
59680521|NCT03970733|75799701|FG001|NOT COMPLETED|Booster Phase (Approx. 12 Months)||0||
59680522|NCT03970733|75799702|FG002|NOT COMPLETED|Booster Phase (Approx. 12 Months)||0||
59680523|NCT03970733|75799703|FG003|NOT COMPLETED|Booster Phase (Approx. 12 Months)||0||
59680524|NCT03970733|75799704|FG004|NOT COMPLETED|Booster Phase (Approx. 12 Months)||1||
59680525|NCT03921411|75799716|FG000|STARTED|Overall Study||20||
59680526|NCT03921411|75799716|FG000|Treated|Overall Study||18||
59680527|NCT03921411|75799716|FG000|COMPLETED|Overall Study||15||
59680528|NCT03921411|75799716|FG000|NOT COMPLETED|Overall Study||5||
59680529|NCT03728582|75799720|FG000|STARTED|Intervention Period 1 (up to 6 Weeks)||3||
59680530|NCT03728582|75799721|FG001|STARTED|Intervention Period 1 (up to 6 Weeks)||5||
59680531|NCT03728582|75799720|FG000|COMPLETED|Intervention Period 1 (up to 6 Weeks)||3||
59680532|NCT03728582|75799721|FG001|COMPLETED|Intervention Period 1 (up to 6 Weeks)||4||
59680533|NCT03728582|75799720|FG000|NOT COMPLETED|Intervention Period 1 (up to 6 Weeks)||0||
59680534|NCT03728582|75799721|FG001|NOT COMPLETED|Intervention Period 1 (up to 6 Weeks)||1||
59680535|NCT03728582|75799720|FG000|STARTED|Washout (8 Weeks)||3||
59680536|NCT03728582|75799721|FG001|STARTED|Washout (8 Weeks)||4||
59680537|NCT03728582|75799720|FG000|COMPLETED|Washout (8 Weeks)||2||
59680538|NCT03728582|75799721|FG001|COMPLETED|Washout (8 Weeks)||4||
59680539|NCT03728582|75799720|FG000|NOT COMPLETED|Washout (8 Weeks)||1||
59546915|NCT00585195|75645599|FG020|NOT COMPLETED|Overall Study||14||
59546916|NCT01113398|75645682|FG000|STARTED|Overall Study||36||
59546917|NCT01113398|75645682|FG000|COMPLETED|Overall Study|Completed= Discontinued study drug due to disease progression, death, toxicity or any other reason|36||
59546918|NCT01113398|75645682|FG000|NOT COMPLETED|Overall Study||0||
59546919|NCT01113632|75645688|FG000|STARTED|Overall Study||33||
59546920|NCT01113632|75645689|FG001|STARTED|Overall Study||44||
59546921|NCT01113632|75645688|FG000|COMPLETED|Overall Study||2||
59546922|NCT01113632|75645689|FG001|COMPLETED|Overall Study||19||
59546923|NCT01113632|75645688|FG000|NOT COMPLETED|Overall Study||31||
59546924|NCT01113632|75645689|FG001|NOT COMPLETED|Overall Study||25||
59546925|NCT01114334|75645697|FG000|STARTED|Overall Study||88||
59680540|NCT03728582|75799721|FG001|NOT COMPLETED|Washout (8 Weeks)||0||
59546926|NCT01114334|75645698|FG001|STARTED|Overall Study||80||
59546927|NCT01114334|75645697|FG000|COMPLETED|Overall Study||67||
59546928|NCT01114334|75645698|FG001|COMPLETED|Overall Study||58||
59546929|NCT01114334|75645697|FG000|NOT COMPLETED|Overall Study||21||
59546930|NCT01114334|75645698|FG001|NOT COMPLETED|Overall Study||22||
59546931|NCT00458835|75645711|FG000|STARTED|Overall Study||5||
59546932|NCT00458835|75645712|FG001|STARTED|Overall Study||5||
59546933|NCT00458835|75645713|FG002|STARTED|Overall Study||5||
59546934|NCT00458835|75645714|FG003|STARTED|Overall Study||5||
59546935|NCT00458835|75645715|FG004|STARTED|Overall Study||5||
59546936|NCT00458835|75645716|FG005|STARTED|Overall Study||5||
59546937|NCT00458835|75645711|FG000|COMPLETED|Overall Study||5||
59546938|NCT00458835|75645712|FG001|COMPLETED|Overall Study||5||
59546939|NCT00458835|75645713|FG002|COMPLETED|Overall Study||5||
59546940|NCT00458835|75645714|FG003|COMPLETED|Overall Study||5||
59546941|NCT00458835|75645715|FG004|COMPLETED|Overall Study||5||
59546942|NCT00458835|75645716|FG005|COMPLETED|Overall Study||4||
59546943|NCT00458835|75645711|FG000|NOT COMPLETED|Overall Study||0||
59546944|NCT00458835|75645712|FG001|NOT COMPLETED|Overall Study||0||
59546945|NCT00458835|75645713|FG002|NOT COMPLETED|Overall Study||0||
59546946|NCT00458835|75645714|FG003|NOT COMPLETED|Overall Study||0||
59546947|NCT00458835|75645715|FG004|NOT COMPLETED|Overall Study||0||
59546948|NCT00458835|75645716|FG005|NOT COMPLETED|Overall Study||1||
59546949|NCT01044758|75645731|FG000|STARTED|Overall Study||12||
59546950|NCT01044758|75645732|FG001|STARTED|Overall Study||12||
59546951|NCT01044758|75645733|FG002|STARTED|Overall Study||11||
59546952|NCT01044758|75645734|FG003|STARTED|Overall Study||12||
59546953|NCT01044758|75645735|FG004|STARTED|Overall Study||11||
59546954|NCT01044758|75645736|FG005|STARTED|Overall Study||11||
59546955|NCT01044758|75645737|FG006|STARTED|Overall Study||27||
59546956|NCT01044758|75645731|FG000|COMPLETED|Overall Study||8||
59546957|NCT01044758|75645732|FG001|COMPLETED|Overall Study||12||
59546958|NCT01044758|75645733|FG002|COMPLETED|Overall Study||7||
59546959|NCT01044758|75645734|FG003|COMPLETED|Overall Study||10||
59546960|NCT01044758|75645735|FG004|COMPLETED|Overall Study||9||
59546961|NCT01044758|75645736|FG005|COMPLETED|Overall Study||8||
59546962|NCT01044758|75645737|FG006|COMPLETED|Overall Study||17||
59546963|NCT01044758|75645731|FG000|NOT COMPLETED|Overall Study||4||
59546964|NCT01044758|75645732|FG001|NOT COMPLETED|Overall Study||0||
59546965|NCT01044758|75645733|FG002|NOT COMPLETED|Overall Study||4||
59680541|NCT03728582|75799720|FG000|STARTED|Intervention Period 2 (Up to 6 Weeks)||2||
59680542|NCT03728582|75799721|FG001|STARTED|Intervention Period 2 (Up to 6 Weeks)||4||
59680543|NCT03728582|75799720|FG000|COMPLETED|Intervention Period 2 (Up to 6 Weeks)||2||
59680544|NCT03728582|75799721|FG001|COMPLETED|Intervention Period 2 (Up to 6 Weeks)||4||
59680545|NCT03728582|75799720|FG000|NOT COMPLETED|Intervention Period 2 (Up to 6 Weeks)||0||
59680546|NCT03728582|75799721|FG001|NOT COMPLETED|Intervention Period 2 (Up to 6 Weeks)||0||
59680547|NCT03456882|75799729|FG000|STARTED|Overall Study||74||
59680548|NCT03456882|75799730|FG001|STARTED|Overall Study||73||
59680549|NCT03456882|75799729|FG000|COMPLETED|Overall Study||60||
59680550|NCT03456882|75799730|FG001|COMPLETED|Overall Study||50||
59680551|NCT03456882|75799729|FG000|NOT COMPLETED|Overall Study||14||
59680552|NCT03456882|75799730|FG001|NOT COMPLETED|Overall Study||23||
59680553|NCT03416179|75799740|FG000|STARTED|Overall Study||201||
59680554|NCT03416179|75799741|FG001|STARTED|Overall Study||203||
59680555|NCT03416179|75799742|FG002|STARTED|Overall Study||163||
59680556|NCT03416179|75799743|FG003|STARTED|Overall Study||162||
59680557|NCT03416179|75799740|FG000|Treated|Overall Study||198||
59680558|NCT03416179|75799741|FG001|Treated|Overall Study||201||
59680559|NCT03416179|75799742|FG002|Treated|Overall Study||162||
59680560|NCT03416179|75799743|FG003|Treated|Overall Study||160||
59680561|NCT03416179|75799740|FG000|COMPLETED|Overall Study||0||
59680562|NCT03416179|75799741|FG001|COMPLETED|Overall Study||1||
59680563|NCT03416179|75799742|FG002|COMPLETED|Overall Study||13||
59680564|NCT03416179|75799743|FG003|COMPLETED|Overall Study||6||
59680565|NCT03416179|75799740|FG000|NOT COMPLETED|Overall Study||201||
59680566|NCT03416179|75799741|FG001|NOT COMPLETED|Overall Study||202||
59680567|NCT03416179|75799742|FG002|NOT COMPLETED|Overall Study||150||
59680568|NCT03416179|75799743|FG003|NOT COMPLETED|Overall Study||156||
59680569|NCT03156660|75799756|FG000|STARTED|Overall Study||109||
59680570|NCT03156660|75799757|FG001|STARTED|Overall Study||110||
59680571|NCT03156660|75799758|FG002|STARTED|Overall Study||86||
59680572|NCT03156660|75799756|FG000|COMPLETED|Overall Study||95||
59680573|NCT03156660|75799757|FG001|COMPLETED|Overall Study||100||
59680574|NCT03156660|75799758|FG002|COMPLETED|Overall Study||78||
59680575|NCT03156660|75799756|FG000|NOT COMPLETED|Overall Study||14||
59680576|NCT03156660|75799757|FG001|NOT COMPLETED|Overall Study||10||
59680577|NCT03156660|75799758|FG002|NOT COMPLETED|Overall Study||8||
59680578|NCT02932332|75799770|FG000|STARTED|Overall Study||5||
59680579|NCT02932332|75799771|FG001|STARTED|Overall Study||4||
59680580|NCT02932332|75799772|FG002|STARTED|Overall Study||5||
59680581|NCT02932332|75799773|FG003|STARTED|Overall Study||5||
59680582|NCT02932332|75799770|FG000|Intervention 1|Overall Study||4||
59680583|NCT02932332|75799771|FG001|Intervention 1|Overall Study||4||
59680584|NCT02932332|75799772|FG002|Intervention 1|Overall Study||5||
59680585|NCT02932332|75799773|FG003|Intervention 1|Overall Study||4||
59680586|NCT02932332|75799770|FG000|Intervention 2|Overall Study||4||
59680587|NCT02932332|75799771|FG001|Intervention 2|Overall Study||3||
59680588|NCT02932332|75799772|FG002|Intervention 2|Overall Study||4||
59680589|NCT02932332|75799773|FG003|Intervention 2|Overall Study||4||
59680590|NCT02932332|75799770|FG000|Intervention 3|Overall Study||3||
59680591|NCT02932332|75799771|FG001|Intervention 3|Overall Study||2||
59680592|NCT02932332|75799772|FG002|Intervention 3|Overall Study||4||
59680593|NCT02932332|75799773|FG003|Intervention 3|Overall Study||3||
59680594|NCT02932332|75799770|FG000|Intervention 4|Overall Study||3||
59680595|NCT02932332|75799771|FG001|Intervention 4|Overall Study||1||
59680596|NCT02932332|75799772|FG002|Intervention 4|Overall Study||4||
59680597|NCT02932332|75799773|FG003|Intervention 4|Overall Study||3||
59680598|NCT02932332|75799770|FG000|COMPLETED|Overall Study||3||
59680599|NCT02932332|75799771|FG001|COMPLETED|Overall Study||1||
59680600|NCT02932332|75799772|FG002|COMPLETED|Overall Study||4||
59680601|NCT02932332|75799773|FG003|COMPLETED|Overall Study||3||
59680602|NCT02932332|75799770|FG000|NOT COMPLETED|Overall Study||2||
59680603|NCT02932332|75799771|FG001|NOT COMPLETED|Overall Study||3||
59680604|NCT02932332|75799772|FG002|NOT COMPLETED|Overall Study||1||
59680605|NCT02932332|75799773|FG003|NOT COMPLETED|Overall Study||2||
59680606|NCT02918409|75799786|FG000|STARTED|Overall Study||16||
59680607|NCT02918409|75799787|FG001|STARTED|Overall Study||10||
59680608|NCT02918409|75799788|FG002|STARTED|Overall Study||25||
59680609|NCT02918409|75799786|FG000|COMPLETED|Overall Study||15||
59680610|NCT02918409|75799787|FG001|COMPLETED|Overall Study||10||
59680611|NCT02918409|75799788|FG002|COMPLETED|Overall Study||24||
59680612|NCT02918409|75799786|FG000|NOT COMPLETED|Overall Study||1||
59680613|NCT02918409|75799787|FG001|NOT COMPLETED|Overall Study||0||
59680614|NCT02918409|75799788|FG002|NOT COMPLETED|Overall Study||1||
59680615|NCT02901574|75799796|FG000|STARTED|Intervention Period 1 (up to 5 Weeks)||14||
59680616|NCT02901574|75799797|FG001|STARTED|Intervention Period 1 (up to 5 Weeks)||14||
59680617|NCT02901574|75799796|FG000|COMPLETED|Intervention Period 1 (up to 5 Weeks)||11||
59680618|NCT02901574|75799797|FG001|COMPLETED|Intervention Period 1 (up to 5 Weeks)||13||
59680619|NCT02901574|75799796|FG000|NOT COMPLETED|Intervention Period 1 (up to 5 Weeks)||3||
59680620|NCT02901574|75799797|FG001|NOT COMPLETED|Intervention Period 1 (up to 5 Weeks)||1||
59680621|NCT02901574|75799796|FG000|STARTED|Wash Out ( 8 Weeks)||11||
59680622|NCT02901574|75799797|FG001|STARTED|Wash Out ( 8 Weeks)||13||
59680623|NCT02901574|75799796|FG000|COMPLETED|Wash Out ( 8 Weeks)||10||
59680624|NCT02901574|75799797|FG001|COMPLETED|Wash Out ( 8 Weeks)||12||
59680625|NCT02901574|75799796|FG000|NOT COMPLETED|Wash Out ( 8 Weeks)||1||
59680626|NCT02901574|75799797|FG001|NOT COMPLETED|Wash Out ( 8 Weeks)||1||
59680627|NCT02901574|75799796|FG000|STARTED|Intervention Period 2 (up to 5 Weeks)||10||
59680628|NCT02901574|75799797|FG001|STARTED|Intervention Period 2 (up to 5 Weeks)||12||
59680629|NCT02901574|75799796|FG000|COMPLETED|Intervention Period 2 (up to 5 Weeks)||10||
59680630|NCT02901574|75799797|FG001|COMPLETED|Intervention Period 2 (up to 5 Weeks)||12||
59680631|NCT02901574|75799796|FG000|NOT COMPLETED|Intervention Period 2 (up to 5 Weeks)||0||
59680632|NCT02901574|75799797|FG001|NOT COMPLETED|Intervention Period 2 (up to 5 Weeks)||0||
59680633|NCT02820623|75799807|FG000|STARTED|Overall Study||41||
59680634|NCT02820623|75799808|FG001|STARTED|Overall Study||42||
59680635|NCT02820623|75799809|FG002|STARTED|Overall Study||43||
59680636|NCT02820623|75799807|FG000|COMPLETED|Overall Study||36||
59680637|NCT02820623|75799808|FG001|COMPLETED|Overall Study||35||
59680638|NCT02820623|75799809|FG002|COMPLETED|Overall Study||32||
59680639|NCT02820623|75799807|FG000|NOT COMPLETED|Overall Study||5||
59680640|NCT02820623|75799808|FG001|NOT COMPLETED|Overall Study||7||
59680641|NCT02820623|75799809|FG002|NOT COMPLETED|Overall Study||11||
59680642|NCT02774005|75799817|FG000|STARTED|Overall Study|A total of 199 patients were enrolled in the study. 198 received treatment and were included in the Safety Population. There were 196 patients in the Intent-to-Treat (ITT) population. A total of 181 patients were included in the modified Intent-to-Treat (mITT) population.|199||
59680643|NCT02774005|75799817|FG000|Safety Population|Overall Study||198||
59680644|NCT02774005|75799817|FG000|Intent-to-Treat (ITT) Population|Overall Study||196||
59680645|NCT02774005|75799817|FG000|Modified Intent-to-Treat (mITT) Population|Overall Study||181||
59680646|NCT02774005|75799817|FG000|COMPLETED|Overall Study||138||
59680647|NCT02774005|75799817|FG000|NOT COMPLETED|Overall Study||61||
59680648|NCT02747849|75799823|FG000|STARTED|Overall Study||13||
59680649|NCT02747849|75799824|FG001|STARTED|Overall Study||14||
59680650|NCT02747849|75799823|FG000|COMPLETED|Overall Study||12||
59680651|NCT02747849|75799824|FG001|COMPLETED|Overall Study||14||
59680652|NCT02747849|75799823|FG000|NOT COMPLETED|Overall Study||1||
59680653|NCT02747849|75799824|FG001|NOT COMPLETED|Overall Study||0||
59680654|NCT02695771|75799835|FG000|STARTED|Overall Study||29||
59680655|NCT02695771|75799836|FG001|STARTED|Overall Study||26||
59680656|NCT02695771|75799837|FG002|STARTED|Overall Study||27||
59680657|NCT02695771|75799835|FG000|COMPLETED|Overall Study||29||
59680658|NCT02695771|75799836|FG001|COMPLETED|Overall Study||26||
59680659|NCT02695771|75799837|FG002|COMPLETED|Overall Study||27||
59680660|NCT02695771|75799835|FG000|NOT COMPLETED|Overall Study||0||
59680661|NCT02695771|75799836|FG001|NOT COMPLETED|Overall Study||0||
59680662|NCT02695771|75799837|FG002|NOT COMPLETED|Overall Study||0||
59680663|NCT01975428|75799847|FG000|STARTED|Overall Study||85||
59680664|NCT01975428|75799848|FG001|STARTED|Overall Study||97||
59680665|NCT01975428|75799847|FG000|COMPLETED|Overall Study||65||
59680666|NCT01975428|75799848|FG001|COMPLETED|Overall Study||83||
59680667|NCT01975428|75799847|FG000|NOT COMPLETED|Overall Study||20||
59680668|NCT01975428|75799848|FG001|NOT COMPLETED|Overall Study||14||
59680669|NCT01669915|75799858|FG000|STARTED|Overall Study||844||
59680670|NCT01669915|75799859|FG001|STARTED|Overall Study||866||
59680671|NCT01669915|75799860|FG002|STARTED|Overall Study||855||
59680672|NCT01669915|75799861|FG003|STARTED|Overall Study||859||
59680673|NCT01669915|75799858|FG000|COMPLETED|Overall Study||844||
59680674|NCT01669915|75799859|FG001|COMPLETED|Overall Study||866||
59680675|NCT01669915|75799860|FG002|COMPLETED|Overall Study||855||
59680676|NCT01669915|75799861|FG003|COMPLETED|Overall Study||859||
59680677|NCT01669915|75799858|FG000|NOT COMPLETED|Overall Study||0||
59680678|NCT01669915|75799859|FG001|NOT COMPLETED|Overall Study||0||
59680679|NCT01669915|75799860|FG002|NOT COMPLETED|Overall Study||0||
59680680|NCT01669915|75799861|FG003|NOT COMPLETED|Overall Study||0||
59680681|NCT01549587|75799877|FG000|STARTED|Overall Study||373||
59680682|NCT01549587|75799878|FG001|STARTED|Overall Study||373||
59680683|NCT01549587|75799877|FG000|COMPLETED|Overall Study||334||
59680684|NCT01549587|75799878|FG001|COMPLETED|Overall Study||336||
59680685|NCT01549587|75799877|FG000|NOT COMPLETED|Overall Study||39||
59680686|NCT01549587|75799878|FG001|NOT COMPLETED|Overall Study||37||
59680687|NCT01047540|75799889|FG000|STARTED|Overall Study||34||
59680688|NCT01047540|75799890|FG001|STARTED|Overall Study||32||
59680689|NCT01047540|75799891|FG002|STARTED|Overall Study||29||
59680690|NCT01047540|75799892|FG003|STARTED|Overall Study||31||
59680691|NCT01047540|75799893|FG004|STARTED|Overall Study||30||
59680692|NCT01047540|75799889|FG000|Full Analysis Set|Overall Study||33||
59680693|NCT01047540|75799890|FG001|Full Analysis Set|Overall Study||32||
59680694|NCT01047540|75799891|FG002|Full Analysis Set|Overall Study||29||
59680695|NCT01047540|75799892|FG003|Full Analysis Set|Overall Study||31||
59680696|NCT01047540|75799893|FG004|Full Analysis Set|Overall Study||30||
59680697|NCT01047540|75799889|FG000|COMPLETED|Overall Study||29||
59680698|NCT01047540|75799890|FG001|COMPLETED|Overall Study||32||
59680699|NCT01047540|75799891|FG002|COMPLETED|Overall Study||26||
59680700|NCT01047540|75799892|FG003|COMPLETED|Overall Study||31||
59680701|NCT01047540|75799893|FG004|COMPLETED|Overall Study||29||
59680702|NCT01047540|75799889|FG000|NOT COMPLETED|Overall Study||5||
59680703|NCT01047540|75799890|FG001|NOT COMPLETED|Overall Study||0||
59680704|NCT01047540|75799891|FG002|NOT COMPLETED|Overall Study||3||
59680705|NCT01047540|75799892|FG003|NOT COMPLETED|Overall Study||0||
59680706|NCT01047540|75799893|FG004|NOT COMPLETED|Overall Study||1||
59680707|NCT00521222|75799909|FG000|STARTED|Overall Study||15||
59680708|NCT00521222|75799910|FG001|STARTED|Overall Study||18||
59680709|NCT00521222|75799911|FG002|STARTED|Overall Study||16||
59680710|NCT00521222|75799912|FG003|STARTED|Overall Study||18||
59680711|NCT00521222|75799909|FG000|COMPLETED|Overall Study||15||
59680712|NCT00521222|75799910|FG001|COMPLETED|Overall Study||17||
59680713|NCT00521222|75799911|FG002|COMPLETED|Overall Study||13||
59680714|NCT00521222|75799912|FG003|COMPLETED|Overall Study||16||
59680715|NCT00521222|75799909|FG000|NOT COMPLETED|Overall Study||0||
59680716|NCT00521222|75799910|FG001|NOT COMPLETED|Overall Study||1||
59680717|NCT00521222|75799911|FG002|NOT COMPLETED|Overall Study||3||
59680718|NCT00521222|75799912|FG003|NOT COMPLETED|Overall Study||2||
59680719|NCT04637997|75799924|FG000|STARTED|Overall Study||9||
59680720|NCT04637997|75799925|FG001|STARTED|Overall Study||9||
59680721|NCT04637997|75799924|FG000|COMPLETED|Overall Study||9||
59680722|NCT04637997|75799925|FG001|COMPLETED|Overall Study||9||
59680723|NCT04637997|75799924|FG000|NOT COMPLETED|Overall Study||0||
59680724|NCT04637997|75799925|FG001|NOT COMPLETED|Overall Study||0||
59680725|NCT01214629|75799946|FG000|STARTED|Overall Study||1||
59680726|NCT01214629|75799947|FG001|STARTED|Overall Study||1||
59680727|NCT01214629|75799948|FG002|STARTED|Overall Study||1||
59680728|NCT01214629|75799949|FG003|STARTED|Overall Study||3||
59680729|NCT01214629|75799950|FG004|STARTED|Overall Study||3||
59680730|NCT01214629|75799951|FG005|STARTED|Overall Study||13||
59680731|NCT01214629|75799952|FG006|STARTED|Overall Study||5||
59680732|NCT01214629|75799953|FG007|STARTED|Overall Study||3||
59680733|NCT01214629|75799954|FG008|STARTED|Overall Study||3||
59680734|NCT01214629|75799955|FG009|STARTED|Overall Study||18||
59680735|NCT01214629|75799956|FG010|STARTED|Overall Study||3||
59680736|NCT01214629|75799946|FG000|Received at Least 1 Dose of Study Drug|Overall Study||1||
59680737|NCT01214629|75799947|FG001|Received at Least 1 Dose of Study Drug|Overall Study||1||
59680738|NCT01214629|75799948|FG002|Received at Least 1 Dose of Study Drug|Overall Study||1||
59680739|NCT01214629|75799949|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3||
59680740|NCT01214629|75799950|FG004|Received at Least 1 Dose of Study Drug|Overall Study||3||
59680741|NCT01214629|75799951|FG005|Received at Least 1 Dose of Study Drug|Overall Study||13||
59680742|NCT01214629|75799952|FG006|Received at Least 1 Dose of Study Drug|Overall Study||5||
59680743|NCT01214629|75799953|FG007|Received at Least 1 Dose of Study Drug|Overall Study||3||
60079029|NCT02093962|76194295|FG001|COMPLETED|Overall Study||0||
60079030|NCT02093962|76194294|FG000|NOT COMPLETED|Overall Study||134||
60079031|NCT02093962|76194295|FG001|NOT COMPLETED|Overall Study||131||
60079032|NCT02094118|76194303|FG000|STARTED|Overall Study||85||
60079033|NCT02094118|76194304|FG001|STARTED|Overall Study||86||
60079034|NCT02094118|76194303|FG000|COMPLETED|Overall Study||73||
60079035|NCT02094118|76194304|FG001|COMPLETED|Overall Study||81||
60079036|NCT02094118|76194303|FG000|NOT COMPLETED|Overall Study||12||
60079037|NCT02094118|76194304|FG001|NOT COMPLETED|Overall Study||5||
60079038|NCT00200902|76194317|FG000|STARTED|Overall Study||39|Overall for this study, n=67 assessed for many measures in Results section.|
59680744|NCT01214629|75799954|FG008|Received at Least 1 Dose of Study Drug|Overall Study||3||
59680745|NCT01214629|75799955|FG009|Received at Least 1 Dose of Study Drug|Overall Study||18||
59680746|NCT01214629|75799956|FG010|Received at Least 1 Dose of Study Drug|Overall Study||3||
59680747|NCT01214629|75799946|FG000|COMPLETED|Overall Study||0||
59680748|NCT01214629|75799947|FG001|COMPLETED|Overall Study||0||
59680749|NCT01214629|75799948|FG002|COMPLETED|Overall Study||1||
59680750|NCT01214629|75799949|FG003|COMPLETED|Overall Study||1||
59680751|NCT01214629|75799950|FG004|COMPLETED|Overall Study||1||
59680752|NCT01214629|75799951|FG005|COMPLETED|Overall Study||9||
59680753|NCT01214629|75799952|FG006|COMPLETED|Overall Study||4||
59680754|NCT01214629|75799953|FG007|COMPLETED|Overall Study||2||
59680755|NCT01214629|75799954|FG008|COMPLETED|Overall Study||2||
59680756|NCT01214629|75799955|FG009|COMPLETED|Overall Study||11||
59680757|NCT01214629|75799956|FG010|COMPLETED|Overall Study||1||
59680758|NCT01214629|75799946|FG000|NOT COMPLETED|Overall Study||1||
59680759|NCT01214629|75799947|FG001|NOT COMPLETED|Overall Study||1||
59680760|NCT01214629|75799948|FG002|NOT COMPLETED|Overall Study||0||
60079039|NCT00200902|76194318|FG001|STARTED|Overall Study||29|Overall for this study, n=67 assessed for many measures in Results section.|
59680761|NCT01214629|75799949|FG003|NOT COMPLETED|Overall Study||2||
59680762|NCT01214629|75799950|FG004|NOT COMPLETED|Overall Study||2||
59680763|NCT01214629|75799951|FG005|NOT COMPLETED|Overall Study||4||
59680764|NCT01214629|75799952|FG006|NOT COMPLETED|Overall Study||1||
59680765|NCT01214629|75799953|FG007|NOT COMPLETED|Overall Study||1||
59680766|NCT01214629|75799954|FG008|NOT COMPLETED|Overall Study||1||
59680767|NCT01214629|75799955|FG009|NOT COMPLETED|Overall Study||7||
59680768|NCT01214629|75799956|FG010|NOT COMPLETED|Overall Study||2||
59680769|NCT01214434|75799996|FG000|STARTED|Overall Study||15||
59680770|NCT01214434|75799997|FG001|STARTED|Overall Study||27||
59680771|NCT01214434|75799996|FG000|COMPLETED|Overall Study||11||
59680772|NCT01214434|75799997|FG001|COMPLETED|Overall Study||25||
59680773|NCT01214434|75799996|FG000|NOT COMPLETED|Overall Study||4||
59680774|NCT01214434|75799997|FG001|NOT COMPLETED|Overall Study||2||
59680775|NCT01214395|75800003|FG000|STARTED|Overall Study||5||
59680776|NCT01214395|75800003|FG000|COMPLETED|Overall Study||0||
59680777|NCT01214395|75800003|FG000|NOT COMPLETED|Overall Study||5||
59680778|NCT01214239|75800010|FG000|STARTED|Overall Study|patients who were randomised and treated with placebo|99||
59680779|NCT01214239|75800011|FG001|STARTED|Overall Study|patients who were randomised and treated with placebo. 1 patient was not treated then not included|200||
59680780|NCT01214239|75800010|FG000|COMPLETED|Overall Study||87||
59680781|NCT01214239|75800011|FG001|COMPLETED|Overall Study||182||
59680782|NCT01214239|75800010|FG000|NOT COMPLETED|Overall Study||12||
59680783|NCT01214239|75800011|FG001|NOT COMPLETED|Overall Study||18||
59680784|NCT01214200|75800017|FG000|STARTED|Overall Study||20||
59680785|NCT01214200|75800017|FG000|COMPLETED|Overall Study||9||
59680786|NCT01214200|75800017|FG000|NOT COMPLETED|Overall Study||11||
59680787|NCT01214044|75800023|FG000|STARTED|Visit 1: Screening and Consent, Washout||31||
59680788|NCT01214044|75800023|FG000|COMPLETED|Visit 1: Screening and Consent, Washout||19||
59680789|NCT01214044|75800023|FG000|NOT COMPLETED|Visit 1: Screening and Consent, Washout||12||
59680790|NCT01214044|75800023|FG000|STARTED|Visit 2: End Washout & Start Placebo||19||
59680791|NCT01214044|75800023|FG000|COMPLETED|Visit 2: End Washout & Start Placebo|2 subjects dropped out during the placebo week (between study visits 2 & 3)|17||
59680792|NCT01214044|75800023|FG000|NOT COMPLETED|Visit 2: End Washout & Start Placebo||2||
59680793|NCT01214044|75800023|FG000|STARTED|Visits 3-5: Escitalopram 10 mg Daily||17||
59680794|NCT01214044|75800023|FG000|COMPLETED|Visits 3-5: Escitalopram 10 mg Daily||14||
59680795|NCT01214044|75800023|FG000|NOT COMPLETED|Visits 3-5: Escitalopram 10 mg Daily||3||
59680796|NCT01214044|75800023|FG000|STARTED|Visits 6-11: Escitalopram 20 mg Daily||14||
59680797|NCT01214044|75800023|FG000|COMPLETED|Visits 6-11: Escitalopram 20 mg Daily||10||
59680798|NCT01214044|75800023|FG000|NOT COMPLETED|Visits 6-11: Escitalopram 20 mg Daily||4||
59680799|NCT01213966|75800035|FG000|STARTED|Overall Study||20||
59680800|NCT01213966|75800036|FG001|STARTED|Overall Study||20||
59680801|NCT01213966|75800037|FG002|STARTED|Overall Study||20||
59680802|NCT01213966|75800038|FG003|STARTED|Overall Study||21||
59680803|NCT01213966|75800035|FG000|COMPLETED|Overall Study||19||
60079040|NCT00200902|76194319|FG002|STARTED|Overall Study||20|Overall for this study, n=67 assessed for many measures in Results section.|
60079041|NCT00200902|76194317|FG000|COMPLETED|Overall Study||29||
60079042|NCT00200902|76194318|FG001|COMPLETED|Overall Study||26||
60079043|NCT00200902|76194319|FG002|COMPLETED|Overall Study||12||
60079044|NCT00200902|76194317|FG000|NOT COMPLETED|Overall Study||10||
60079045|NCT00200902|76194318|FG001|NOT COMPLETED|Overall Study||3||
60079046|NCT00200902|76194319|FG002|NOT COMPLETED|Overall Study||8||
60079047|NCT00201448|76194335|FG000|STARTED|Overall Study||42||
60079048|NCT00201448|76194336|FG001|STARTED|Overall Study||40||
60079049|NCT00201448|76194335|FG000|COMPLETED|Overall Study||42||
60079050|NCT00201448|76194336|FG001|COMPLETED|Overall Study||40||
60079051|NCT00201448|76194335|FG000|NOT COMPLETED|Overall Study||0||
60079052|NCT00201448|76194336|FG001|NOT COMPLETED|Overall Study||0||
60079053|NCT00201760|76194346|FG000|STARTED|Overall Study||5||
60079054|NCT00201760|76194347|FG001|STARTED|Overall Study||5||
60079055|NCT00201760|76194346|FG000|COMPLETED|Overall Study||5||
60079056|NCT00201760|76194347|FG001|COMPLETED|Overall Study||5||
60079057|NCT00201760|76194346|FG000|NOT COMPLETED|Overall Study||0||
60079058|NCT00201760|76194347|FG001|NOT COMPLETED|Overall Study||0||
60079059|NCT00201838|76194355|FG000|STARTED|Overall Study||30||
60079060|NCT00201838|76194356|FG001|STARTED|Overall Study||8||
60079061|NCT00201838|76194355|FG000|Treatment Cohort|Overall Study||30||
60079062|NCT00201838|76194356|FG001|Treatment Cohort|Overall Study||8||
60079063|NCT00201838|76194355|FG000|COMPLETED|Overall Study||30||
60079064|NCT00201838|76194356|FG001|COMPLETED|Overall Study||8||
60079065|NCT00201838|76194355|FG000|NOT COMPLETED|Overall Study||0||
60079066|NCT00201838|76194356|FG001|NOT COMPLETED|Overall Study||0||
59680804|NCT01213966|75800036|FG001|COMPLETED|Overall Study||20||
59680805|NCT01213966|75800037|FG002|COMPLETED|Overall Study||17||
59680806|NCT01213966|75800038|FG003|COMPLETED|Overall Study||20||
59680807|NCT01213966|75800035|FG000|NOT COMPLETED|Overall Study||1||
60079067|NCT00040846|76194374|FG000|STARTED|Overall Study||60||
60079068|NCT00040846|76194375|FG001|STARTED|Overall Study||0||
59680808|NCT01213966|75800036|FG001|NOT COMPLETED|Overall Study||0||
59680809|NCT01213966|75800037|FG002|NOT COMPLETED|Overall Study||3||
59680810|NCT01213966|75800038|FG003|NOT COMPLETED|Overall Study||1||
60079069|NCT00040846|76194376|FG002|STARTED|Overall Study||0||
60079070|NCT00040846|76194377|FG003|STARTED|Overall Study||0||
60079071|NCT00040846|76194378|FG004|STARTED|Overall Study||0||
60079072|NCT00040846|76194379|FG005|STARTED|Overall Study||0||
60079073|NCT00040846|76194374|FG000|COMPLETED|Overall Study||60||
60079074|NCT00040846|76194375|FG001|COMPLETED|Overall Study||0||
59680811|NCT01213264|75800051|FG000|STARTED|Overall Study||155||
59680812|NCT01213264|75800052|FG001|STARTED|Overall Study||177||
59680813|NCT01213264|75800053|FG002|STARTED|Overall Study||327||
59680814|NCT01213264|75800051|FG000|COMPLETED|Overall Study||153||
59680815|NCT01213264|75800052|FG001|COMPLETED|Overall Study||175||
59680816|NCT01213264|75800053|FG002|COMPLETED|Overall Study||321||
59680817|NCT01213264|75800051|FG000|NOT COMPLETED|Overall Study||2||
59680818|NCT01213264|75800052|FG001|NOT COMPLETED|Overall Study||2||
59680819|NCT01213264|75800053|FG002|NOT COMPLETED|Overall Study||6||
59680820|NCT01212991|75800066|FG000|STARTED|Double-blind||872||
59680821|NCT01212991|75800067|FG001|STARTED|Double-blind||845||
59680822|NCT01212991|75800068|FG002|STARTED|Double-blind||0||
59680823|NCT01212991|75800066|FG000|Safety Population|Double-blind||871||
59680824|NCT01212991|75800067|FG001|Safety Population|Double-blind||844||
59680825|NCT01212991|75800068|FG002|Safety Population|Double-blind||0||
59680826|NCT01212991|75800066|FG000|COMPLETED|Double-blind||0||
59680827|NCT01212991|75800067|FG001|COMPLETED|Double-blind||234||
59680828|NCT01212991|75800068|FG002|COMPLETED|Double-blind||0||
59680829|NCT01212991|75800066|FG000|NOT COMPLETED|Double-blind||872||
59680830|NCT01212991|75800067|FG001|NOT COMPLETED|Double-blind||611||
59680831|NCT01212991|75800068|FG002|NOT COMPLETED|Double-blind||0||
59680832|NCT01212991|75800066|FG000|STARTED|Open-label||0||
59680833|NCT01212991|75800067|FG001|STARTED|Open-label|participants were given the opportunity to receive open-label access to enzalutamide|0||
59680834|NCT01212991|75800068|FG002|STARTED|Open-label|previous placebo treated participants were given the opportunity to receive enzalutamide|234||
59680835|NCT01212991|75800066|FG000|COMPLETED|Open-label||0||
59680836|NCT01212991|75800067|FG001|COMPLETED|Open-label||0||
59680837|NCT01212991|75800068|FG002|COMPLETED|Open-label||0||
59680838|NCT01212991|75800066|FG000|NOT COMPLETED|Open-label||0||
59680839|NCT01212991|75800067|FG001|NOT COMPLETED|Open-label||0||
59680840|NCT01212991|75800068|FG002|NOT COMPLETED|Open-label||234||
59680841|NCT01212757|75800079|FG000|STARTED|Placebo-controlled Phase (Week 0 - 24)||162||
59680842|NCT01212757|75800080|FG001|STARTED|Placebo-controlled Phase (Week 0 - 24)||163||
59680843|NCT01212757|75800081|FG002|STARTED|Placebo-controlled Phase (Week 0 - 24)||163||
59680844|NCT01212757|75800082|FG003|STARTED|Placebo-controlled Phase (Week 0 - 24)||0||
59680845|NCT01212757|75800083|FG004|STARTED|Placebo-controlled Phase (Week 0 - 24)||0||
59680846|NCT01212757|75800084|FG005|STARTED|Placebo-controlled Phase (Week 0 - 24)||0||
59680847|NCT01212757|75800085|FG006|STARTED|Placebo-controlled Phase (Week 0 - 24)||0||
59680848|NCT01212757|75800086|FG007|STARTED|Placebo-controlled Phase (Week 0 - 24)||0||
59680849|NCT01212757|75800087|FG008|STARTED|Placebo-controlled Phase (Week 0 - 24)||0||
59680850|NCT01212757|75800079|FG000|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||159||
59680851|NCT01212757|75800080|FG001|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||163||
59680852|NCT01212757|75800081|FG002|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||162||
59680853|NCT01212757|75800082|FG003|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0||
59680854|NCT01212757|75800083|FG004|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0||
59680855|NCT01212757|75800084|FG005|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0||
59680856|NCT01212757|75800085|FG006|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0||
59680857|NCT01212757|75800086|FG007|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0||
59680858|NCT01212757|75800087|FG008|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0||
59680859|NCT01212757|75800079|FG000|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||148||
59680860|NCT01212757|75800080|FG001|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||151||
59680861|NCT01212757|75800081|FG002|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||149||
59680862|NCT01212757|75800082|FG003|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0||
59680863|NCT01212757|75800083|FG004|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0||
59680864|NCT01212757|75800084|FG005|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0||
59680865|NCT01212757|75800085|FG006|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0||
59680866|NCT01212757|75800086|FG007|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0||
59680867|NCT01212757|75800087|FG008|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0||
59680868|NCT01212757|75800079|FG000|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|Two participants who escaped early did not complete Week 24|88||
59680869|NCT01212757|75800080|FG001|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|Three participants who escaped early did not complete Week 24|59||
59680870|NCT01212757|75800081|FG002|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||64||
59680871|NCT01212757|75800082|FG003|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0||
59680872|NCT01212757|75800083|FG004|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0||
59680873|NCT01212757|75800084|FG005|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0||
59680874|NCT01212757|75800085|FG006|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0||
59680875|NCT01212757|75800086|FG007|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0||
59680876|NCT01212757|75800087|FG008|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0||
60079075|NCT00040846|76194376|FG002|COMPLETED|Overall Study||0||
60079076|NCT00040846|76194377|FG003|COMPLETED|Overall Study||0||
60079077|NCT00040846|76194378|FG004|COMPLETED|Overall Study||0||
60079078|NCT00040846|76194379|FG005|COMPLETED|Overall Study||0||
59680877|NCT01212757|75800079|FG000|COMPLETED|Placebo-controlled Phase (Week 0 - 24)|Two participants who completed Week 24 did not enter the active treatment phase|143||
59680878|NCT01212757|75800080|FG001|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||143||
59680879|NCT01212757|75800081|FG002|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||142||
59680880|NCT01212757|75800082|FG003|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0||
59680881|NCT01212757|75800083|FG004|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0||
59680882|NCT01212757|75800084|FG005|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0||
59680883|NCT01212757|75800085|FG006|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0||
59680884|NCT01212757|75800086|FG007|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0||
59680885|NCT01212757|75800087|FG008|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0||
59680886|NCT01212757|75800079|FG000|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||19||
59680887|NCT01212757|75800080|FG001|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||20||
59680888|NCT01212757|75800081|FG002|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||21||
59680889|NCT01212757|75800082|FG003|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0||
59680890|NCT01212757|75800083|FG004|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0||
59680891|NCT01212757|75800084|FG005|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0||
59680892|NCT01212757|75800085|FG006|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0||
59680893|NCT01212757|75800086|FG007|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0||
59680894|NCT01212757|75800087|FG008|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0||
59680895|NCT01212757|75800079|FG000|STARTED|Active Treatment Phase (Weeks 24 - 52)||0||
59680896|NCT01212757|75800080|FG001|STARTED|Active Treatment Phase (Weeks 24 - 52)|6 participants who completed Week 24 did not enter the Week 24-52 active treatment phase|137||
59680897|NCT01212757|75800081|FG002|STARTED|Active Treatment Phase (Weeks 24 - 52)|8 participants who completed Week 24 did not enter the Week 24-52 active treatment phase|134||
59680898|NCT01212757|75800082|FG003|STARTED|Active Treatment Phase (Weeks 24 - 52)||43||
59680899|NCT01212757|75800083|FG004|STARTED|Active Treatment Phase (Weeks 24 - 52)||27||
59680900|NCT01212757|75800084|FG005|STARTED|Active Treatment Phase (Weeks 24 - 52)|2 participants who EE and completed Week 24 did not enter the Week 24-52 active treatment phase|41||
59680901|NCT01212757|75800085|FG006|STARTED|Active Treatment Phase (Weeks 24 - 52)||28||
59680902|NCT01212757|75800086|FG007|STARTED|Active Treatment Phase (Weeks 24 - 52)||0||
59680903|NCT01212757|75800087|FG008|STARTED|Active Treatment Phase (Weeks 24 - 52)||0||
59680904|NCT01212757|75800079|FG000|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0||
59680905|NCT01212757|75800080|FG001|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||125||
59680906|NCT01212757|75800081|FG002|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||114||
59680907|NCT01212757|75800082|FG003|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||35||
59680908|NCT01212757|75800083|FG004|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||25||
59680909|NCT01212757|75800084|FG005|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||34||
59680910|NCT01212757|75800085|FG006|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||28||
59680911|NCT01212757|75800086|FG007|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0||
59680912|NCT01212757|75800087|FG008|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0||
59680913|NCT01212757|75800079|FG000|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0||
59680914|NCT01212757|75800080|FG001|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||12||
59680915|NCT01212757|75800081|FG002|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||20||
59680916|NCT01212757|75800082|FG003|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||8||
59680917|NCT01212757|75800083|FG004|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||2||
59680918|NCT01212757|75800084|FG005|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||7||
59680919|NCT01212757|75800085|FG006|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0||
59680920|NCT01212757|75800086|FG007|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0||
59680921|NCT01212757|75800087|FG008|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0||
59680922|NCT01212757|75800079|FG000|STARTED|Long-Term Safety Phase (Year 2)||0||
59680923|NCT01212757|75800080|FG001|STARTED|Long-Term Safety Phase (Year 2)|6 participants who completed Week 52 did not enter the long-term safety phase|119||
59680924|NCT01212757|75800081|FG002|STARTED|Long-Term Safety Phase (Year 2)|5 participants who completed Week 52 did not enter the long-term safety phase|109||
59680925|NCT01212757|75800082|FG003|STARTED|Long-Term Safety Phase (Year 2)||0||
59680926|NCT01212757|75800083|FG004|STARTED|Long-Term Safety Phase (Year 2)||0||
59680927|NCT01212757|75800084|FG005|STARTED|Long-Term Safety Phase (Year 2)||0||
59680928|NCT01212757|75800085|FG006|STARTED|Long-Term Safety Phase (Year 2)||0||
59680929|NCT01212757|75800086|FG007|STARTED|Long-Term Safety Phase (Year 2)|Combined PBO-APR 20EE+XO;2 participants who completed Week 52 did not enter long-term safety phase|58||
59680930|NCT01212757|75800087|FG008|STARTED|Long-Term Safety Phase (Year 2)|Combined PBO-APR 30EE+XO;2 participants who completed Week 52 did not enter long-term safety phase|60||
59680931|NCT01212757|75800079|FG000|COMPLETED|Long-Term Safety Phase (Year 2)||0||
59680932|NCT01212757|75800080|FG001|COMPLETED|Long-Term Safety Phase (Year 2)||107||
59680933|NCT01212757|75800081|FG002|COMPLETED|Long-Term Safety Phase (Year 2)||95||
59680934|NCT01212757|75800082|FG003|COMPLETED|Long-Term Safety Phase (Year 2)||0||
59680935|NCT01212757|75800083|FG004|COMPLETED|Long-Term Safety Phase (Year 2)||0||
59680936|NCT01212757|75800084|FG005|COMPLETED|Long-Term Safety Phase (Year 2)||0||
59680937|NCT01212757|75800085|FG006|COMPLETED|Long-Term Safety Phase (Year 2)||0||
59680938|NCT01212757|75800086|FG007|COMPLETED|Long-Term Safety Phase (Year 2)||48||
59680939|NCT01212757|75800087|FG008|COMPLETED|Long-Term Safety Phase (Year 2)||51||
59680940|NCT01212757|75800079|FG000|NOT COMPLETED|Long-Term Safety Phase (Year 2)||0||
59680941|NCT01212757|75800080|FG001|NOT COMPLETED|Long-Term Safety Phase (Year 2)||12||
59680942|NCT01212757|75800081|FG002|NOT COMPLETED|Long-Term Safety Phase (Year 2)||14||
59680943|NCT01212757|75800082|FG003|NOT COMPLETED|Long-Term Safety Phase (Year 2)||0||
59680944|NCT01212757|75800083|FG004|NOT COMPLETED|Long-Term Safety Phase (Year 2)||0||
59680945|NCT01212757|75800084|FG005|NOT COMPLETED|Long-Term Safety Phase (Year 2)||0||
59680946|NCT01212757|75800085|FG006|NOT COMPLETED|Long-Term Safety Phase (Year 2)||0||
59680947|NCT01212757|75800086|FG007|NOT COMPLETED|Long-Term Safety Phase (Year 2)||10||
59680948|NCT01212757|75800087|FG008|NOT COMPLETED|Long-Term Safety Phase (Year 2)||9||
59680949|NCT01212757|75800079|FG000|STARTED|Long-Term Safety Phase (Year 3)||0||
59680950|NCT01212757|75800080|FG001|STARTED|Long-Term Safety Phase (Year 3)||107||
59680951|NCT01212757|75800081|FG002|STARTED|Long-Term Safety Phase (Year 3)||95||
59680952|NCT01212757|75800082|FG003|STARTED|Long-Term Safety Phase (Year 3)||0||
59680953|NCT01212757|75800083|FG004|STARTED|Long-Term Safety Phase (Year 3)||0||
59680954|NCT01212757|75800084|FG005|STARTED|Long-Term Safety Phase (Year 3)||0||
59680955|NCT01212757|75800085|FG006|STARTED|Long-Term Safety Phase (Year 3)||0||
59680956|NCT01212757|75800086|FG007|STARTED|Long-Term Safety Phase (Year 3)||48||
59680957|NCT01212757|75800087|FG008|STARTED|Long-Term Safety Phase (Year 3)||51||
59680958|NCT01212757|75800079|FG000|COMPLETED|Long-Term Safety Phase (Year 3)||0||
59680959|NCT01212757|75800080|FG001|COMPLETED|Long-Term Safety Phase (Year 3)||89||
59680960|NCT01212757|75800081|FG002|COMPLETED|Long-Term Safety Phase (Year 3)||84||
59680961|NCT01212757|75800082|FG003|COMPLETED|Long-Term Safety Phase (Year 3)||0||
59680962|NCT01212757|75800083|FG004|COMPLETED|Long-Term Safety Phase (Year 3)||0||
59680963|NCT01212757|75800084|FG005|COMPLETED|Long-Term Safety Phase (Year 3)||0||
59680964|NCT01212757|75800085|FG006|COMPLETED|Long-Term Safety Phase (Year 3)||0||
59680965|NCT01212757|75800086|FG007|COMPLETED|Long-Term Safety Phase (Year 3)||42||
59680966|NCT01212757|75800087|FG008|COMPLETED|Long-Term Safety Phase (Year 3)||46||
59680967|NCT01212757|75800079|FG000|NOT COMPLETED|Long-Term Safety Phase (Year 3)||0||
59680968|NCT01212757|75800080|FG001|NOT COMPLETED|Long-Term Safety Phase (Year 3)||18||
59680969|NCT01212757|75800081|FG002|NOT COMPLETED|Long-Term Safety Phase (Year 3)||11||
59680970|NCT01212757|75800082|FG003|NOT COMPLETED|Long-Term Safety Phase (Year 3)||0||
59680971|NCT01212757|75800083|FG004|NOT COMPLETED|Long-Term Safety Phase (Year 3)||0||
59680972|NCT01212757|75800084|FG005|NOT COMPLETED|Long-Term Safety Phase (Year 3)||0||
59680973|NCT01212757|75800085|FG006|NOT COMPLETED|Long-Term Safety Phase (Year 3)||0||
59680974|NCT01212757|75800086|FG007|NOT COMPLETED|Long-Term Safety Phase (Year 3)||6||
59680975|NCT01212757|75800087|FG008|NOT COMPLETED|Long-Term Safety Phase (Year 3)||5||
59680976|NCT01212757|75800079|FG000|STARTED|Long-Term Safety Phase (Year 4)||0||
59680977|NCT01212757|75800080|FG001|STARTED|Long-Term Safety Phase (Year 4)||89||
59680978|NCT01212757|75800081|FG002|STARTED|Long-Term Safety Phase (Year 4)||84||
59680979|NCT01212757|75800082|FG003|STARTED|Long-Term Safety Phase (Year 4)||0||
59680980|NCT01212757|75800083|FG004|STARTED|Long-Term Safety Phase (Year 4)||0||
59680981|NCT01212757|75800084|FG005|STARTED|Long-Term Safety Phase (Year 4)||0||
59680982|NCT01212757|75800085|FG006|STARTED|Long-Term Safety Phase (Year 4)||0||
59680983|NCT01212757|75800086|FG007|STARTED|Long-Term Safety Phase (Year 4)|1 participant who completed Year 3 did not continue treatment in Year 4|41||
59680984|NCT01212757|75800087|FG008|STARTED|Long-Term Safety Phase (Year 4)||46||
59680985|NCT01212757|75800079|FG000|COMPLETED|Long-Term Safety Phase (Year 4)||0||
59680986|NCT01212757|75800080|FG001|COMPLETED|Long-Term Safety Phase (Year 4)||80||
59680987|NCT01212757|75800081|FG002|COMPLETED|Long-Term Safety Phase (Year 4)||77||
59546966|NCT01044758|75645734|FG003|NOT COMPLETED|Overall Study||2||
59546967|NCT01044758|75645735|FG004|NOT COMPLETED|Overall Study||2||
59546968|NCT01044758|75645736|FG005|NOT COMPLETED|Overall Study||3||
59546969|NCT01044758|75645737|FG006|NOT COMPLETED|Overall Study||10||
59546970|NCT02440659|75645758|FG000|STARTED|Overall Study||1997||
59680988|NCT01212757|75800082|FG003|COMPLETED|Long-Term Safety Phase (Year 4)||0||
59680989|NCT01212757|75800083|FG004|COMPLETED|Long-Term Safety Phase (Year 4)||0||
59680990|NCT01212757|75800084|FG005|COMPLETED|Long-Term Safety Phase (Year 4)||0||
59680991|NCT01212757|75800085|FG006|COMPLETED|Long-Term Safety Phase (Year 4)||0||
59680992|NCT01212757|75800086|FG007|COMPLETED|Long-Term Safety Phase (Year 4)||37||
59680993|NCT01212757|75800087|FG008|COMPLETED|Long-Term Safety Phase (Year 4)||39||
59680994|NCT01212757|75800079|FG000|NOT COMPLETED|Long-Term Safety Phase (Year 4)||0||
59680995|NCT01212757|75800080|FG001|NOT COMPLETED|Long-Term Safety Phase (Year 4)||9||
59680996|NCT01212757|75800081|FG002|NOT COMPLETED|Long-Term Safety Phase (Year 4)||7||
59680997|NCT01212757|75800082|FG003|NOT COMPLETED|Long-Term Safety Phase (Year 4)||0||
59680998|NCT01212757|75800083|FG004|NOT COMPLETED|Long-Term Safety Phase (Year 4)||0||
59680999|NCT01212757|75800084|FG005|NOT COMPLETED|Long-Term Safety Phase (Year 4)||0||
59681000|NCT01212757|75800085|FG006|NOT COMPLETED|Long-Term Safety Phase (Year 4)||0||
59681001|NCT01212757|75800086|FG007|NOT COMPLETED|Long-Term Safety Phase (Year 4)||4||
59681002|NCT01212757|75800087|FG008|NOT COMPLETED|Long-Term Safety Phase (Year 4)||7||
59681003|NCT01212757|75800079|FG000|STARTED|Long-Term Safety Phase (Year 5)||0||
59681004|NCT01212757|75800080|FG001|STARTED|Long-Term Safety Phase (Year 5)||80||
59681005|NCT01212757|75800081|FG002|STARTED|Long-Term Safety Phase (Year 5)||77||
59681006|NCT01212757|75800082|FG003|STARTED|Long-Term Safety Phase (Year 5)||0||
59681007|NCT01212757|75800083|FG004|STARTED|Long-Term Safety Phase (Year 5)||0||
59681008|NCT01212757|75800084|FG005|STARTED|Long-Term Safety Phase (Year 5)||0||
59681009|NCT01212757|75800085|FG006|STARTED|Long-Term Safety Phase (Year 5)||0||
59681010|NCT01212757|75800086|FG007|STARTED|Long-Term Safety Phase (Year 5)|1 participant was only counted in year 5 but not in 4 year due to late APR dispensing|38||
59681011|NCT01212757|75800087|FG008|STARTED|Long-Term Safety Phase (Year 5)||39||
59681012|NCT01212757|75800079|FG000|COMPLETED|Long-Term Safety Phase (Year 5)||0||
59681013|NCT01212757|75800080|FG001|COMPLETED|Long-Term Safety Phase (Year 5)||72||
59681014|NCT01212757|75800081|FG002|COMPLETED|Long-Term Safety Phase (Year 5)||69||
59681015|NCT01212757|75800082|FG003|COMPLETED|Long-Term Safety Phase (Year 5)||0||
59681016|NCT01212757|75800083|FG004|COMPLETED|Long-Term Safety Phase (Year 5)||0||
59681017|NCT01212757|75800084|FG005|COMPLETED|Long-Term Safety Phase (Year 5)||0||
59681018|NCT01212757|75800085|FG006|COMPLETED|Long-Term Safety Phase (Year 5)||0||
59681019|NCT01212757|75800086|FG007|COMPLETED|Long-Term Safety Phase (Year 5)||33||
59681020|NCT01212757|75800087|FG008|COMPLETED|Long-Term Safety Phase (Year 5)||37||
59681021|NCT01212757|75800079|FG000|NOT COMPLETED|Long-Term Safety Phase (Year 5)||0||
59681022|NCT01212757|75800080|FG001|NOT COMPLETED|Long-Term Safety Phase (Year 5)||8||
59681023|NCT01212757|75800081|FG002|NOT COMPLETED|Long-Term Safety Phase (Year 5)||8||
59681024|NCT01212757|75800082|FG003|NOT COMPLETED|Long-Term Safety Phase (Year 5)||0||
59681025|NCT01212757|75800083|FG004|NOT COMPLETED|Long-Term Safety Phase (Year 5)||0||
59681026|NCT01212757|75800084|FG005|NOT COMPLETED|Long-Term Safety Phase (Year 5)||0||
59681027|NCT01212757|75800085|FG006|NOT COMPLETED|Long-Term Safety Phase (Year 5)||0||
59681028|NCT01212757|75800086|FG007|NOT COMPLETED|Long-Term Safety Phase (Year 5)||5||
59681029|NCT01212757|75800087|FG008|NOT COMPLETED|Long-Term Safety Phase (Year 5)||2||
59681030|NCT01190410|75800107|FG000|STARTED|Overall Study||4|16|
59681031|NCT01190410|75800108|FG001|STARTED|Overall Study||12|16|
59681032|NCT01190410|75800107|FG000|Re-Induction|Overall Study||0||
59681033|NCT01190410|75800108|FG001|Re-Induction|Overall Study||2||
59681034|NCT01190410|75800107|FG000|COMPLETED|Overall Study||3|6|
59681035|NCT01190410|75800108|FG001|COMPLETED|Overall Study||3|6|
59681036|NCT01190410|75800107|FG000|NOT COMPLETED|Overall Study||1||
59681037|NCT01190410|75800108|FG001|NOT COMPLETED|Overall Study||9||
59681038|NCT01190254|75800123|FG000|STARTED|Overall Study||102||
59681039|NCT01190254|75800124|FG001|STARTED|Overall Study||98||
59681040|NCT01190254|75800125|FG002|STARTED|Overall Study||106||
59681041|NCT01190254|75800123|FG000|Treated|Overall Study||102||
59681042|NCT01190254|75800124|FG001|Treated|Overall Study||98||
59681043|NCT01190254|75800125|FG002|Treated|Overall Study||106||
59681044|NCT01190254|75800123|FG000|COMPLETED|Overall Study||81||
59816062|NCT03886220|75938406|FG000|NOT COMPLETED|Treatment Period||5||
59816063|NCT03886220|75938407|FG001|NOT COMPLETED|Treatment Period||12||
59816064|NCT03886220|75938406|FG000|STARTED|Post-Treatment Follow-Up Period||25|Entered the post-treatment follow-up period (includes some participants who discontinued study drug during the treatment period).|
59989567|NCT00326183|76104880|FG000|Vaccination 1 + Safety Follow-up|Overall Study||1453||
59989568|NCT00326183|76104881|FG001|Vaccination 1 + Safety Follow-up|Overall Study||347||
59989569|NCT00326183|76104880|FG000|Postvaccination 1 Post-safety Follow-up|Overall Study||1393||
59989570|NCT00326183|76104881|FG001|Postvaccination 1 Post-safety Follow-up|Overall Study||325||
59989571|NCT00326183|76104880|FG000|Vaccination 2 + Safety Follow-up|Overall Study||1301||
59989572|NCT00326183|76104881|FG001|Vaccination 2 + Safety Follow-up|Overall Study||292||
59989573|NCT00326183|76104880|FG000|Postvaccination 2 Post-safety Follow-up|Overall Study||1265||
59989574|NCT00326183|76104881|FG001|Postvaccination 2 Post-safety Follow-up|Overall Study||271||
59989575|NCT00326183|76104880|FG000|COMPLETED|Overall Study||1253||
59989576|NCT00326183|76104881|FG001|COMPLETED|Overall Study||264||
59989577|NCT00326183|76104880|FG000|NOT COMPLETED|Overall Study||200||
59989578|NCT00326183|76104881|FG001|NOT COMPLETED|Overall Study||83||
59989579|NCT02481050|76104885|FG000|STARTED|Overall Study||58||
59989580|NCT02481050|76104885|FG000|COMPLETED|Overall Study||0||
59681045|NCT01190254|75800124|FG001|COMPLETED|Overall Study||81||
59681046|NCT01190254|75800125|FG002|COMPLETED|Overall Study||84||
59681047|NCT01190254|75800123|FG000|NOT COMPLETED|Overall Study||21||
59681048|NCT01190254|75800124|FG001|NOT COMPLETED|Overall Study||17||
59681049|NCT01190254|75800125|FG002|NOT COMPLETED|Overall Study||22||
59681050|NCT01190839|75800135|FG000|STARTED|Overall Study||150||
59681051|NCT01190839|75800136|FG001|STARTED|Overall Study||147||
59681052|NCT01190839|75800135|FG000|Treated|Overall Study||148||
59681053|NCT01190839|75800136|FG001|Treated|Overall Study||143||
59681054|NCT01190839|75800135|FG000|COMPLETED|Overall Study||0||
59681055|NCT01190839|75800136|FG001|COMPLETED|Overall Study||0||
59681056|NCT01190839|75800135|FG000|NOT COMPLETED|Overall Study||150||
59681057|NCT01190839|75800136|FG001|NOT COMPLETED|Overall Study||147||
59681058|NCT01190215|75800146|FG000|STARTED|Up to Day 28||38||
59681059|NCT01190215|75800147|FG001|STARTED|Up to Day 28||39||
59681060|NCT01190215|75800146|FG000|COMPLETED|Up to Day 28||38||
59681061|NCT01190215|75800147|FG001|COMPLETED|Up to Day 28||39||
59681062|NCT01190215|75800146|FG000|NOT COMPLETED|Up to Day 28||0||
59681063|NCT01190215|75800147|FG001|NOT COMPLETED|Up to Day 28||0||
59681064|NCT01190215|75800146|FG000|STARTED|Up to Month 6||38||
59681065|NCT01190215|75800147|FG001|STARTED|Up to Month 6||39||
59681066|NCT01190215|75800146|FG000|COMPLETED|Up to Month 6||36||
59681067|NCT01190215|75800147|FG001|COMPLETED|Up to Month 6||39||
59681068|NCT01190215|75800146|FG000|NOT COMPLETED|Up to Month 6||2||
59681069|NCT01190215|75800147|FG001|NOT COMPLETED|Up to Month 6||0||
59681070|NCT01190449|75800155|FG000|STARTED|Overall Study||15||
59681071|NCT01190449|75800156|FG001|STARTED|Overall Study||36||
59681072|NCT01190449|75800155|FG000|COMPLETED|Overall Study||15||
59681073|NCT01190449|75800156|FG001|COMPLETED|Overall Study||32||
59681074|NCT01190449|75800155|FG000|NOT COMPLETED|Overall Study||0||
59681075|NCT01190449|75800156|FG001|NOT COMPLETED|Overall Study||4||
59681076|NCT01190176|75800162|FG000|STARTED|Overall Study||32||
59681077|NCT01190176|75800162|FG000|COMPLETED|Overall Study||30||
59681078|NCT01190176|75800162|FG000|NOT COMPLETED|Overall Study||2||
59681079|NCT01190098|75800168|FG000|STARTED|Overall Study||42||
59681080|NCT01190098|75800169|FG001|STARTED|Overall Study||10||
59681081|NCT01190098|75800168|FG000|COMPLETED|Overall Study||39||
59681082|NCT01190098|75800169|FG001|COMPLETED|Overall Study||8||
59681083|NCT01190098|75800168|FG000|NOT COMPLETED|Overall Study||3||
59681084|NCT01190098|75800169|FG001|NOT COMPLETED|Overall Study||2||
59681085|NCT01190020|75800177|FG000|STARTED|Overall Study||29||
59681086|NCT01190020|75800178|FG001|STARTED|Overall Study||12||
59681087|NCT01190020|75800177|FG000|COMPLETED|Overall Study||22||
59681088|NCT01190020|75800178|FG001|COMPLETED|Overall Study||12||
59681089|NCT01190020|75800177|FG000|NOT COMPLETED|Overall Study||7||
59681090|NCT01190020|75800178|FG001|NOT COMPLETED|Overall Study||0||
59681091|NCT01189435|75800184|FG000|STARTED|Overall Study||2||
59681092|NCT01189435|75800184|FG000|COMPLETED|Overall Study||0||
59681093|NCT01189435|75800184|FG000|NOT COMPLETED|Overall Study||2||
59681094|NCT01165996|75800188|FG000|STARTED|Overall Study||25||
59681095|NCT01165996|75800188|FG000|Induction Phase|Overall Study||25||
59681096|NCT01165996|75800188|FG000|Maintenance Phase|Overall Study||23||
59681097|NCT01165996|75800188|FG000|COMPLETED|Overall Study||23||
59681098|NCT01165996|75800188|FG000|NOT COMPLETED|Overall Study||2||
59681099|NCT01165684|75800195|FG000|STARTED|Overall Study||201||
59681100|NCT01165684|75800196|FG001|STARTED|Overall Study||200||
59681101|NCT01165684|75800195|FG000|Exposed|Overall Study|3 subjects withdrew prior to exposure to trial drug|198||
59681102|NCT01165684|75800196|FG001|Exposed|Overall Study|1 subject withdrew prior to exposure to trial drug|199||
59681103|NCT01165684|75800195|FG000|COMPLETED|Overall Study||173||
59681104|NCT01165684|75800196|FG001|COMPLETED|Overall Study||148||
59681105|NCT01165684|75800195|FG000|NOT COMPLETED|Overall Study||28||
59681106|NCT01165684|75800196|FG001|NOT COMPLETED|Overall Study||52||
59681107|NCT01189201|75800202|FG000|STARTED|Overall Study||42||
59681108|NCT01189201|75800202|FG000|Received Empa/Linagliptin FDC A1(Fasted)|Overall Study||42||
59681109|NCT01189201|75800202|FG000|Rec. Empa/Linagliptin Ind.Tablet(Fasted)|Overall Study||41||
59681110|NCT01189201|75800202|FG000|Received Empa/Linagliptin FDC A1 (Fed)|Overall Study||18||
59681111|NCT01189201|75800202|FG000|Received Empa/Linagliptin FDC A3(Fasted)|Overall Study||24||
59681112|NCT01189201|75800202|FG000|COMPLETED|Overall Study||41||
59681113|NCT01189201|75800202|FG000|NOT COMPLETED|Overall Study||1||
59681114|NCT01188967|75800219|FG000|STARTED|Overall Study||10||
59681115|NCT01188967|75800220|FG001|STARTED|Overall Study||8||
59681116|NCT01188967|75800219|FG000|COMPLETED|Overall Study||5||
59681117|NCT01188967|75800220|FG001|COMPLETED|Overall Study||4||
59681118|NCT01188967|75800219|FG000|NOT COMPLETED|Overall Study||5||
59681119|NCT01188967|75800220|FG001|NOT COMPLETED|Overall Study||4||
59681120|NCT01188811|75800230|FG000|STARTED|Overall Study||28||
59681121|NCT01188811|75800231|FG001|STARTED|Overall Study||26||
59681122|NCT01188811|75800230|FG000|COMPLETED|Overall Study||22||
59681123|NCT01188811|75800231|FG001|COMPLETED|Overall Study||24||
59681124|NCT01188811|75800230|FG000|NOT COMPLETED|Overall Study||6||
59681125|NCT01188811|75800231|FG001|NOT COMPLETED|Overall Study||2||
59681126|NCT01183234|75800239|FG000|STARTED|First Intervention||14||
59681127|NCT01183234|75800240|FG001|STARTED|First Intervention||14||
59681128|NCT01183234|75800239|FG000|COMPLETED|First Intervention||13||
59681129|NCT01183234|75800240|FG001|COMPLETED|First Intervention||14||
59681130|NCT01183234|75800239|FG000|NOT COMPLETED|First Intervention||1||
59681131|NCT01183234|75800240|FG001|NOT COMPLETED|First Intervention||0||
59681132|NCT01183234|75800239|FG000|STARTED|Washout||13||
59681133|NCT01183234|75800240|FG001|STARTED|Washout||14||
59681134|NCT01183234|75800239|FG000|COMPLETED|Washout||13||
59681135|NCT01183234|75800240|FG001|COMPLETED|Washout||14||
59681136|NCT01183234|75800239|FG000|NOT COMPLETED|Washout||0||
59681137|NCT01183234|75800240|FG001|NOT COMPLETED|Washout||0||
59681138|NCT01183234|75800239|FG000|STARTED|Second Intervention||13||
59681139|NCT01183234|75800240|FG001|STARTED|Second Intervention||14||
59681140|NCT01183234|75800239|FG000|COMPLETED|Second Intervention||13||
59681141|NCT01183234|75800240|FG001|COMPLETED|Second Intervention||14||
59681142|NCT01183234|75800239|FG000|NOT COMPLETED|Second Intervention||0||
59681143|NCT01183234|75800240|FG001|NOT COMPLETED|Second Intervention||0||
59681144|NCT01165216|75800248|FG000|STARTED|Overall Study|Participants who received any study drug|8||
59681145|NCT01165216|75800249|FG001|STARTED|Overall Study|Participants who received any study drug|7||
59681146|NCT01165216|75800248|FG000|Received at Least 1 Dose of Ipilimumab|Overall Study||6||
59681147|NCT01165216|75800249|FG001|Received at Least 1 Dose of Ipilimumab|Overall Study||6||
59681148|NCT01165216|75800248|FG000|COMPLETED|Overall Study|Completed=still on study drug|0||
59546971|NCT02440659|75645759|FG001|STARTED|Overall Study||949||
59546972|NCT02440659|75645758|FG000|COMPLETED|Overall Study||1346||
59546973|NCT02440659|75645759|FG001|COMPLETED|Overall Study||614||
59546974|NCT02440659|75645758|FG000|NOT COMPLETED|Overall Study||651||
59546975|NCT02440659|75645759|FG001|NOT COMPLETED|Overall Study||335||
59546976|NCT02439216|75645771|FG000|STARTED|PartA(7 Day Open-Label Treatment Period)||5||
59546977|NCT02439216|75645772|FG001|STARTED|PartA(7 Day Open-Label Treatment Period)||6||
59546978|NCT02439216|75645773|FG002|STARTED|PartA(7 Day Open-Label Treatment Period)||6||
59546979|NCT02439216|75645774|FG003|STARTED|PartA(7 Day Open-Label Treatment Period)||0||
59546980|NCT02439216|75645775|FG004|STARTED|PartA(7 Day Open-Label Treatment Period)||0||
59546981|NCT02439216|75645776|FG005|STARTED|PartA(7 Day Open-Label Treatment Period)||0||
59546982|NCT02439216|75645777|FG006|STARTED|PartA(7 Day Open-Label Treatment Period)||0||
59546983|NCT02439216|75645778|FG007|STARTED|PartA(7 Day Open-Label Treatment Period)||0||
59546984|NCT02439216|75645779|FG008|STARTED|PartA(7 Day Open-Label Treatment Period)||0||
59546985|NCT02439216|75645771|FG000|COMPLETED|PartA(7 Day Open-Label Treatment Period)||4||
59546986|NCT02439216|75645772|FG001|COMPLETED|PartA(7 Day Open-Label Treatment Period)||6||
59546987|NCT02439216|75645773|FG002|COMPLETED|PartA(7 Day Open-Label Treatment Period)||6||
59546988|NCT02439216|75645774|FG003|COMPLETED|PartA(7 Day Open-Label Treatment Period)||0||
59546989|NCT02439216|75645775|FG004|COMPLETED|PartA(7 Day Open-Label Treatment Period)||0||
59546990|NCT02439216|75645776|FG005|COMPLETED|PartA(7 Day Open-Label Treatment Period)||0||
59546991|NCT02439216|75645777|FG006|COMPLETED|PartA(7 Day Open-Label Treatment Period)||0||
59546992|NCT02439216|75645778|FG007|COMPLETED|PartA(7 Day Open-Label Treatment Period)||0||
59546993|NCT02439216|75645779|FG008|COMPLETED|PartA(7 Day Open-Label Treatment Period)||0||
59546994|NCT02439216|75645771|FG000|NOT COMPLETED|PartA(7 Day Open-Label Treatment Period)||1||
59546995|NCT02439216|75645772|FG001|NOT COMPLETED|PartA(7 Day Open-Label Treatment Period)||0||
59546996|NCT02439216|75645773|FG002|NOT COMPLETED|PartA(7 Day Open-Label Treatment Period)||0||
59546997|NCT02439216|75645774|FG003|NOT COMPLETED|PartA(7 Day Open-Label Treatment Period)||0||
59546998|NCT02439216|75645775|FG004|NOT COMPLETED|PartA(7 Day Open-Label Treatment Period)||0||
59546999|NCT02439216|75645776|FG005|NOT COMPLETED|PartA(7 Day Open-Label Treatment Period)||0||
59547000|NCT02439216|75645777|FG006|NOT COMPLETED|PartA(7 Day Open-Label Treatment Period)||0||
59547001|NCT02439216|75645778|FG007|NOT COMPLETED|PartA(7 Day Open-Label Treatment Period)||0||
59547002|NCT02439216|75645779|FG008|NOT COMPLETED|PartA(7 Day Open-Label Treatment Period)||0||
59547003|NCT02439216|75645771|FG000|STARTED|Part B (12-week Double Blind)||0|It includes 16 Subjects who completed Part A and continued to Part B plus 15 New subjects who entered Part B|
59547004|NCT02439216|75645772|FG001|STARTED|Part B (12-week Double Blind)||0|It includes 16 Subjects who completed Part A and continued to Part B plus 15 New subjects who entered Part B|
59547005|NCT02439216|75645773|FG002|STARTED|Part B (12-week Double Blind)||0|It includes 16 Subjects who completed Part A and continued to Part B plus 15 New subjects who entered Part B|
59565817|NCT02335242|75668229|FG000|COMPLETED|Follow-up Period (12 Weeks)||4||
59565818|NCT02335242|75668230|FG001|COMPLETED|Follow-up Period (12 Weeks)||10||
59565819|NCT02335242|75668229|FG000|NOT COMPLETED|Follow-up Period (12 Weeks)||2||
59565820|NCT02335242|75668230|FG001|NOT COMPLETED|Follow-up Period (12 Weeks)||1||
59565821|NCT02334384|75668242|FG000|STARTED|Overall Study||4||
59565822|NCT02334384|75668243|FG001|STARTED|Overall Study||2||
59565823|NCT02334384|75668242|FG000|COMPLETED|Overall Study||3||
59565824|NCT02334384|75668243|FG001|COMPLETED|Overall Study||1||
59565825|NCT02334384|75668242|FG000|NOT COMPLETED|Overall Study||1||
59565826|NCT02334384|75668243|FG001|NOT COMPLETED|Overall Study||1||
59565827|NCT02334306|75668251|FG000|STARTED|Double-blind Period||16||
59565828|NCT02334306|75668252|FG001|STARTED|Double-blind Period||16||
59565829|NCT02334306|75668251|FG000|COMPLETED|Double-blind Period||15||
59565830|NCT02334306|75668252|FG001|COMPLETED|Double-blind Period||14||
59565831|NCT02334306|75668251|FG000|NOT COMPLETED|Double-blind Period||1||
59565832|NCT02334306|75668252|FG001|NOT COMPLETED|Double-blind Period||2||
59565833|NCT02334306|75668251|FG000|STARTED|Open-label Period||15||
59565834|NCT02334306|75668252|FG001|STARTED|Open-label Period||14||
59565835|NCT02334306|75668251|FG000|COMPLETED|Open-label Period||15||
59565836|NCT02334306|75668252|FG001|COMPLETED|Open-label Period||14||
59565837|NCT02334306|75668251|FG000|NOT COMPLETED|Open-label Period||0||
59565838|NCT02334306|75668252|FG001|NOT COMPLETED|Open-label Period||0||
59565839|NCT02305758|75668261|FG000|STARTED|Overall Study||65||
59565840|NCT02305758|75668262|FG001|STARTED|Overall Study||65||
59547006|NCT02439216|75645774|FG003|STARTED|Part B (12-week Double Blind)|4 New subjects plus 6 subjects who completed Part A|10|It includes 16 Subjects who completed Part A and continued to Part B plus 15 New subjects who entered Part B|
59547007|NCT02439216|75645775|FG004|STARTED|Part B (12-week Double Blind)|4 New subjects plus 6 subjects who completed Part A|10|It includes 16 Subjects who completed Part A and continued to Part B plus 15 New subjects who entered Part B|
59547008|NCT02439216|75645776|FG005|STARTED|Part B (12-week Double Blind)|3 New subjects plus 2 subjects who completed Part A|5|It includes 16 Subjects who completed Part A and continued to Part B plus 15 New subjects who entered Part B|
59547009|NCT02439216|75645777|FG006|STARTED|Part B (12-week Double Blind)|4 New subjects plus 2 subjects who completed Part A|6|It includes 16 Subjects who completed Part A and continued to Part B plus 15 New subjects who entered Part B|
59681149|NCT01165216|75800249|FG001|COMPLETED|Overall Study|Completed=still on study drug|0||
59681150|NCT01165216|75800248|FG000|NOT COMPLETED|Overall Study||8||
59681151|NCT01165216|75800249|FG001|NOT COMPLETED|Overall Study||7||
59681152|NCT04616430|75800260|FG000|STARTED|Overall Study||30||
59681153|NCT04616430|75800261|FG001|STARTED|Overall Study||30||
59681154|NCT04616430|75800262|FG002|STARTED|Overall Study||30||
59681155|NCT04616430|75800260|FG000|COMPLETED|Overall Study||23||
59681156|NCT04616430|75800261|FG001|COMPLETED|Overall Study||2||
59681157|NCT04616430|75800262|FG002|COMPLETED|Overall Study||0||
59681158|NCT04616430|75800260|FG000|NOT COMPLETED|Overall Study||7||
59681159|NCT04616430|75800261|FG001|NOT COMPLETED|Overall Study||28||
59681160|NCT04616430|75800262|FG002|NOT COMPLETED|Overall Study||30||
59681161|NCT04545476|75800274|FG000|STARTED|Overall Study||11||
59681162|NCT04545476|75800275|FG001|STARTED|Overall Study||10||
59681163|NCT04545476|75800276|FG002|STARTED|Overall Study||8||
59681164|NCT04545476|75800277|FG003|STARTED|Overall Study||8||
59681165|NCT04545476|75800274|FG000|COMPLETED|Overall Study||10||
59681166|NCT04545476|75800275|FG001|COMPLETED|Overall Study||9||
59681167|NCT04545476|75800276|FG002|COMPLETED|Overall Study||8||
59681168|NCT04545476|75800277|FG003|COMPLETED|Overall Study||8||
59681169|NCT04545476|75800274|FG000|NOT COMPLETED|Overall Study||1||
59681170|NCT04545476|75800275|FG001|NOT COMPLETED|Overall Study||1||
59681171|NCT04545476|75800276|FG002|NOT COMPLETED|Overall Study||0||
59681172|NCT04545476|75800277|FG003|NOT COMPLETED|Overall Study||0||
59681173|NCT01969838|75800292|FG000|STARTED|Double-blind Phase|The MMB group is only applicable to the double-blind phase. Participants who complete the double-blind phase and continue to receive MMB in the open-label phase constitute the MMB to MMB group.|215||
59681174|NCT01969838|75800293|FG001|STARTED|Double-blind Phase|The RUX group is only applicable to the double-blind phase. Participants who complete the double-blind phase and begin receiving MMB in the open-label phase constitute the RUX to MMB group.|217||
59681175|NCT01969838|75800294|FG002|STARTED|Double-blind Phase|The MMB to MMB group is only applicable to the open-label phase.|0||
59681176|NCT01969838|75800295|FG003|STARTED|Double-blind Phase|The RUX to MMB group is only applicable to the open-label phase.|0||
59681177|NCT01969838|75800292|FG000|COMPLETED|Double-blind Phase||188||
59681178|NCT01969838|75800293|FG001|COMPLETED|Double-blind Phase||208||
59681179|NCT01969838|75800294|FG002|COMPLETED|Double-blind Phase||0||
59681180|NCT01969838|75800295|FG003|COMPLETED|Double-blind Phase||0||
59681181|NCT01969838|75800292|FG000|NOT COMPLETED|Double-blind Phase||27||
59681182|NCT01969838|75800293|FG001|NOT COMPLETED|Double-blind Phase||9||
59681183|NCT01969838|75800294|FG002|NOT COMPLETED|Double-blind Phase||0||
59681184|NCT01969838|75800295|FG003|NOT COMPLETED|Double-blind Phase||0||
59681185|NCT01969838|75800292|FG000|STARTED|Open-label Phase|The MMB group is only applicable to the double-blind phase. Participants who complete the double-blind phase and continue to receive MMB in the open-label phase constitute the MMB to MMB group.|0||
59547010|NCT02439216|75645778|FG007|STARTED|Part B (12-week Double Blind)||0|It includes 16 Subjects who completed Part A and continued to Part B plus 15 New subjects who entered Part B|
59547011|NCT02439216|75645779|FG008|STARTED|Part B (12-week Double Blind)||0|It includes 16 Subjects who completed Part A and continued to Part B plus 15 New subjects who entered Part B|
59547012|NCT02439216|75645771|FG000|COMPLETED|Part B (12-week Double Blind)||0||
59681186|NCT01969838|75800293|FG001|STARTED|Open-label Phase|The RUX group is only applicable to the double-blind phase. Participants who complete the double-blind phase and begin receiving MMB in the open-label phase constitute the RUX to MMB group.|0||
59681187|NCT01969838|75800294|FG002|STARTED|Open-label Phase|Of 188 participants in the MMB group who completed the double-blind phase, 171 entered the open-label phase to continue receiving MMB.|171||
59681188|NCT01969838|75800295|FG003|STARTED|Open-label Phase|Of 208 participants in the RUX group who completed the double-blind phase, 197 entered the open-label phase to begin receiving MMB.|197||
59681189|NCT01969838|75800292|FG000|COMPLETED|Open-label Phase||0|Defined as completing survival follow-up for a period of up to 5 years from randomization.|
59681190|NCT01969838|75800293|FG001|COMPLETED|Open-label Phase||0|Defined as completing survival follow-up for a period of up to 5 years from randomization.|
59681191|NCT01969838|75800294|FG002|COMPLETED|Open-label Phase|The Sponsor terminated the study prior to subjects completing the 5 years of follow-up with the exception of a single subject. Subjects receiving MMB at the time of study termination were eligible to transition to an extended access study (SRA-MMB-4365) to continue MMB treatment.|1|Defined as completing survival follow-up for a period of up to 5 years from randomization.|
59681192|NCT01969838|75800295|FG003|COMPLETED|Open-label Phase||0|Defined as completing survival follow-up for a period of up to 5 years from randomization.|
59681193|NCT01969838|75800292|FG000|NOT COMPLETED|Open-label Phase||0||
59547013|NCT02439216|75645772|FG001|COMPLETED|Part B (12-week Double Blind)||0||
59547014|NCT02439216|75645773|FG002|COMPLETED|Part B (12-week Double Blind)||0||
59547015|NCT02439216|75645774|FG003|COMPLETED|Part B (12-week Double Blind)||10||
59547016|NCT02439216|75645775|FG004|COMPLETED|Part B (12-week Double Blind)||10||
59681194|NCT01969838|75800293|FG001|NOT COMPLETED|Open-label Phase||0||
59681195|NCT01969838|75800294|FG002|NOT COMPLETED|Open-label Phase||170||
59681196|NCT01969838|75800295|FG003|NOT COMPLETED|Open-label Phase||197||
59547017|NCT02439216|75645776|FG005|COMPLETED|Part B (12-week Double Blind)||5||
59547018|NCT02439216|75645777|FG006|COMPLETED|Part B (12-week Double Blind)||6||
59547019|NCT02439216|75645778|FG007|COMPLETED|Part B (12-week Double Blind)||0||
59547020|NCT02439216|75645779|FG008|COMPLETED|Part B (12-week Double Blind)||0||
59547021|NCT02439216|75645771|FG000|NOT COMPLETED|Part B (12-week Double Blind)||0||
59681197|NCT01165177|75800306|FG000|STARTED|Overall Study||7695||
59681198|NCT01165177|75800307|FG001|STARTED|Overall Study||7710||
59681199|NCT01165177|75800306|FG000|COMPLETED|Overall Study||6773||
59681200|NCT01165177|75800307|FG001|COMPLETED|Overall Study||6808||
59681201|NCT01165177|75800306|FG000|NOT COMPLETED|Overall Study||922||
59681202|NCT01165177|75800307|FG001|NOT COMPLETED|Overall Study||902||
59681203|NCT01165138|75800324|FG000|STARTED|Overall Study||0||
59681204|NCT01165138|75800325|FG001|STARTED|Overall Study||203||
59681205|NCT01165138|75800326|FG002|STARTED|Overall Study||205||
59681206|NCT01165138|75800327|FG003|STARTED|Overall Study||201||
59681207|NCT01165138|75800324|FG000|COMPLETED|Overall Study||0||
59681208|NCT01165138|75800325|FG001|COMPLETED|Overall Study||151||
59681209|NCT01165138|75800326|FG002|COMPLETED|Overall Study||185||
59681210|NCT01165138|75800327|FG003|COMPLETED|Overall Study||179||
59681211|NCT01165138|75800324|FG000|NOT COMPLETED|Overall Study||0||
59681212|NCT01165138|75800325|FG001|NOT COMPLETED|Overall Study||52||
59681213|NCT01165138|75800326|FG002|NOT COMPLETED|Overall Study||20||
59681214|NCT01165138|75800327|FG003|NOT COMPLETED|Overall Study||22||
59681215|NCT01165021|75800335|FG000|STARTED|Overall Study||19||
59681216|NCT01165021|75800335|FG000|≥1 Dose Chemo|Overall Study||19||
59681217|NCT01165021|75800335|FG000|≥1 Dose Chemo, Baseline, Cy 3 Assessment|Overall Study||17||
59681218|NCT01165021|75800335|FG000|3 Cycles of Chemo, Then Surgery|Overall Study||15||
59681219|NCT01165021|75800335|FG000|COMPLETED|Overall Study||18||
59681220|NCT01165021|75800335|FG000|NOT COMPLETED|Overall Study||1||
59681221|NCT01182844|75800341|FG000|STARTED|Overall Study||15||
59681222|NCT01182844|75800342|FG001|STARTED|Overall Study||15||
59681223|NCT01182844|75800341|FG000|COMPLETED|Overall Study||15||
59681224|NCT01182844|75800342|FG001|COMPLETED|Overall Study||13||
59681225|NCT01182844|75800341|FG000|NOT COMPLETED|Overall Study||0||
59681226|NCT01182844|75800342|FG001|NOT COMPLETED|Overall Study||2||
59681227|NCT01164865|75800350|FG000|STARTED|Overall Study||39||
59681228|NCT01164865|75800351|FG001|STARTED|Overall Study||39||
59681229|NCT01164865|75800350|FG000|COMPLETED|Overall Study||37||
59681230|NCT01164865|75800351|FG001|COMPLETED|Overall Study||38||
59681231|NCT01164865|75800350|FG000|NOT COMPLETED|Overall Study||2||
59547022|NCT02439216|75645772|FG001|NOT COMPLETED|Part B (12-week Double Blind)||0||
59547023|NCT02439216|75645773|FG002|NOT COMPLETED|Part B (12-week Double Blind)||0||
59681232|NCT01164865|75800351|FG001|NOT COMPLETED|Overall Study||1||
59681233|NCT01164475|75800359|FG000|STARTED|Overall Study||30||
59681234|NCT01164475|75800360|FG001|STARTED|Overall Study||31||
59681235|NCT01164475|75800359|FG000|COMPLETED|Overall Study||28||
59681236|NCT01164475|75800360|FG001|COMPLETED|Overall Study||29||
59681237|NCT01164475|75800359|FG000|NOT COMPLETED|Overall Study||2||
59681238|NCT01164475|75800360|FG001|NOT COMPLETED|Overall Study||2||
59681239|NCT01164007|75800366|FG000|STARTED|Overall Study||40||
59681240|NCT01164007|75800366|FG000|Treated|Overall Study||37||
59681241|NCT01164007|75800366|FG000|COMPLETED|Overall Study||0||
59681242|NCT01164007|75800366|FG000|NOT COMPLETED|Overall Study||40||
59681243|NCT01163851|75800372|FG000|STARTED|Overall Study||13||
59681244|NCT01163851|75800373|FG001|STARTED|Overall Study||12||
59681245|NCT01163851|75800372|FG000|Treated|Overall Study||12||
59681246|NCT01163851|75800373|FG001|Treated|Overall Study||12||
59681247|NCT01163851|75800372|FG000|COMPLETED|Overall Study||12||
59681248|NCT01163851|75800373|FG001|COMPLETED|Overall Study||11||
59681249|NCT01163851|75800372|FG000|NOT COMPLETED|Overall Study||1||
59681250|NCT01163851|75800373|FG001|NOT COMPLETED|Overall Study||1||
59681251|NCT01163617|75800379|FG000|STARTED|Phase A (User Experience), Weeks 0 and 2||19||
59681252|NCT01163617|75800380|FG001|STARTED|Phase A (User Experience), Weeks 0 and 2||23||
59681253|NCT01163617|75800381|FG002|STARTED|Phase A (User Experience), Weeks 0 and 2||21||
59681254|NCT01163617|75800382|FG003|STARTED|Phase A (User Experience), Weeks 0 and 2||21||
59681255|NCT01163617|75800383|FG004|STARTED|Phase A (User Experience), Weeks 0 and 2||0||
59681256|NCT01163617|75800384|FG005|STARTED|Phase A (User Experience), Weeks 0 and 2||0||
59681257|NCT01163617|75800385|FG006|STARTED|Phase A (User Experience), Weeks 0 and 2||0||
59681258|NCT01163617|75800386|FG007|STARTED|Phase A (User Experience), Weeks 0 and 2||0||
59681259|NCT01163617|75800379|FG000|COMPLETED|Phase A (User Experience), Weeks 0 and 2||19||
59681260|NCT01163617|75800380|FG001|COMPLETED|Phase A (User Experience), Weeks 0 and 2||21||
59681261|NCT01163617|75800381|FG002|COMPLETED|Phase A (User Experience), Weeks 0 and 2||20||
59681262|NCT01163617|75800382|FG003|COMPLETED|Phase A (User Experience), Weeks 0 and 2||21||
59681263|NCT01163617|75800383|FG004|COMPLETED|Phase A (User Experience), Weeks 0 and 2||0||
59681264|NCT01163617|75800384|FG005|COMPLETED|Phase A (User Experience), Weeks 0 and 2||0||
59681265|NCT01163617|75800385|FG006|COMPLETED|Phase A (User Experience), Weeks 0 and 2||0||
59681266|NCT01163617|75800386|FG007|COMPLETED|Phase A (User Experience), Weeks 0 and 2||0||
59681267|NCT01163617|75800379|FG000|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0||
59681268|NCT01163617|75800380|FG001|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||2||
59681269|NCT01163617|75800381|FG002|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||1||
59681270|NCT01163617|75800382|FG003|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0||
59681271|NCT01163617|75800383|FG004|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0||
59681272|NCT01163617|75800384|FG005|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0||
59989581|NCT02481050|76104885|FG000|NOT COMPLETED|Overall Study||58||
59681273|NCT01163617|75800385|FG006|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0||
59681274|NCT01163617|75800386|FG007|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0||
59681275|NCT01163617|75800379|FG000|STARTED|Phase B (Injection Time), Week 4||0||
59681276|NCT01163617|75800380|FG001|STARTED|Phase B (Injection Time), Week 4||0||
59681277|NCT01163617|75800381|FG002|STARTED|Phase B (Injection Time), Week 4||0||
59681278|NCT01163617|75800382|FG003|STARTED|Phase B (Injection Time), Week 4||0||
59681279|NCT01163617|75800383|FG004|STARTED|Phase B (Injection Time), Week 4||18||
59681280|NCT01163617|75800384|FG005|STARTED|Phase B (Injection Time), Week 4||27||
59681281|NCT01163617|75800385|FG006|STARTED|Phase B (Injection Time), Week 4||16||
59681282|NCT01163617|75800386|FG007|STARTED|Phase B (Injection Time), Week 4||20||
59681283|NCT01163617|75800379|FG000|COMPLETED|Phase B (Injection Time), Week 4||0||
59681284|NCT01163617|75800380|FG001|COMPLETED|Phase B (Injection Time), Week 4||0||
59681285|NCT01163617|75800381|FG002|COMPLETED|Phase B (Injection Time), Week 4||0||
59681286|NCT01163617|75800382|FG003|COMPLETED|Phase B (Injection Time), Week 4||0||
59681287|NCT01163617|75800383|FG004|COMPLETED|Phase B (Injection Time), Week 4||18||
59681288|NCT01163617|75800384|FG005|COMPLETED|Phase B (Injection Time), Week 4||27||
59681289|NCT01163617|75800385|FG006|COMPLETED|Phase B (Injection Time), Week 4||16||
59681290|NCT01163617|75800386|FG007|COMPLETED|Phase B (Injection Time), Week 4||20||
59681291|NCT01163617|75800379|FG000|NOT COMPLETED|Phase B (Injection Time), Week 4||0||
59681292|NCT01163617|75800380|FG001|NOT COMPLETED|Phase B (Injection Time), Week 4||0||
59681293|NCT01163617|75800381|FG002|NOT COMPLETED|Phase B (Injection Time), Week 4||0||
59681294|NCT01163617|75800382|FG003|NOT COMPLETED|Phase B (Injection Time), Week 4||0||
59681295|NCT01163617|75800383|FG004|NOT COMPLETED|Phase B (Injection Time), Week 4||0||
59681296|NCT01163617|75800384|FG005|NOT COMPLETED|Phase B (Injection Time), Week 4||0||
59681297|NCT01163617|75800385|FG006|NOT COMPLETED|Phase B (Injection Time), Week 4||0||
59681298|NCT01163617|75800386|FG007|NOT COMPLETED|Phase B (Injection Time), Week 4||0||
59681299|NCT01182337|75800408|FG000|STARTED|Overall Study||22||
59681300|NCT01182337|75800409|FG001|STARTED|Overall Study||9||
59681301|NCT01182337|75800408|FG000|COMPLETED|Overall Study||19||
59681302|NCT01182337|75800409|FG001|COMPLETED|Overall Study||7||
59681303|NCT01182337|75800408|FG000|NOT COMPLETED|Overall Study||3||
59681304|NCT01182337|75800409|FG001|NOT COMPLETED|Overall Study||2||
59681305|NCT01182298|75800416|FG000|STARTED|Overall Study||10||
59681306|NCT01182298|75800416|FG000|COMPLETED|Overall Study||4||
59681307|NCT01182298|75800416|FG000|NOT COMPLETED|Overall Study||6||
59681308|NCT01163266|75800423|FG000|STARTED|Overall Study||157||
59681309|NCT01163266|75800424|FG001|STARTED|Overall Study||155||
59681310|NCT01163266|75800425|FG002|STARTED|Overall Study||150||
59681311|NCT01163266|75800423|FG000|Treated|Overall Study||157||
59681312|NCT01163266|75800424|FG001|Treated|Overall Study||155||
59681313|NCT01163266|75800425|FG002|Treated|Overall Study||150||
59681314|NCT01163266|75800423|FG000|COMPLETED|Overall Study||139||
59681315|NCT01163266|75800424|FG001|COMPLETED|Overall Study||124||
59681316|NCT01163266|75800425|FG002|COMPLETED|Overall Study||122||
59681317|NCT01163266|75800423|FG000|NOT COMPLETED|Overall Study||18||
59681318|NCT01163266|75800424|FG001|NOT COMPLETED|Overall Study||31||
59681319|NCT01163266|75800425|FG002|NOT COMPLETED|Overall Study||28||
59681320|NCT00565461|75800437|FG000|STARTED|Overall Study||40||
60079079|NCT00040846|76194374|FG000|NOT COMPLETED|Overall Study||0||
60079080|NCT00040846|76194375|FG001|NOT COMPLETED|Overall Study||0||
59681321|NCT00565461|75800438|FG001|STARTED|Overall Study||40||
59681322|NCT00565461|75800439|FG002|STARTED|Overall Study||40||
59681323|NCT00565461|75800440|FG003|STARTED|Overall Study||40||
59681324|NCT00565461|75800437|FG000|COMPLETED|Overall Study||40||
59681325|NCT00565461|75800438|FG001|COMPLETED|Overall Study||39||
59681326|NCT00565461|75800439|FG002|COMPLETED|Overall Study||39||
59681327|NCT00565461|75800440|FG003|COMPLETED|Overall Study||37||
59681328|NCT00565461|75800437|FG000|NOT COMPLETED|Overall Study||0||
59681329|NCT00565461|75800438|FG001|NOT COMPLETED|Overall Study||1||
59681330|NCT00565461|75800439|FG002|NOT COMPLETED|Overall Study||1||
59681331|NCT00565461|75800440|FG003|NOT COMPLETED|Overall Study||3||
59681332|NCT01516346|75800459|FG000|STARTED|Overall Study||13||
59681333|NCT01516346|75800460|FG001|STARTED|Overall Study||15||
59681334|NCT01516346|75800461|FG002|STARTED|Overall Study||16||
59681335|NCT01516346|75800459|FG000|COMPLETED|Overall Study||7||
59681336|NCT01516346|75800460|FG001|COMPLETED|Overall Study||9||
60079081|NCT00040846|76194376|FG002|NOT COMPLETED|Overall Study||0||
60079082|NCT00040846|76194377|FG003|NOT COMPLETED|Overall Study||0||
60079083|NCT00040846|76194378|FG004|NOT COMPLETED|Overall Study||0||
60079084|NCT00040846|76194379|FG005|NOT COMPLETED|Overall Study||0||
59681337|NCT01516346|75800461|FG002|COMPLETED|Overall Study||11||
59681338|NCT01516346|75800459|FG000|NOT COMPLETED|Overall Study||6||
59681339|NCT01516346|75800460|FG001|NOT COMPLETED|Overall Study||6||
59681340|NCT01516346|75800461|FG002|NOT COMPLETED|Overall Study||5||
59681341|NCT01303796|75800471|FG000|STARTED|Lead In Phase||21||
59681342|NCT01303796|75800472|FG001|STARTED|Lead In Phase|Intend-to-Treat study subject population|0||
59681343|NCT01303796|75800473|FG002|STARTED|Lead In Phase|Intend-to-Treat study subject population|0||
59681344|NCT01303796|75800471|FG000|COMPLETED|Lead In Phase||21||
60079085|NCT00041938|76194395|FG000|STARTED|Overall Study||1163||
60079086|NCT00041938|76194396|FG001|STARTED|Overall Study||1142||
59681345|NCT01303796|75800472|FG001|COMPLETED|Lead In Phase||0||
59681346|NCT01303796|75800473|FG002|COMPLETED|Lead In Phase||0||
59681347|NCT01303796|75800471|FG000|NOT COMPLETED|Lead In Phase||0||
59681348|NCT01303796|75800472|FG001|NOT COMPLETED|Lead In Phase||0||
59681349|NCT01303796|75800473|FG002|NOT COMPLETED|Lead In Phase||0||
59681350|NCT01303796|75800471|FG000|STARTED|Randomized Phase III||0||
59681351|NCT01303796|75800472|FG001|STARTED|Randomized Phase III||241||
59681352|NCT01303796|75800473|FG002|STARTED|Randomized Phase III||241||
59681353|NCT01303796|75800471|FG000|COMPLETED|Randomized Phase III||0||
59681354|NCT01303796|75800472|FG001|COMPLETED|Randomized Phase III||241||
59681355|NCT01303796|75800473|FG002|COMPLETED|Randomized Phase III||241||
59681356|NCT01303796|75800471|FG000|NOT COMPLETED|Randomized Phase III||0||
59681357|NCT01303796|75800472|FG001|NOT COMPLETED|Randomized Phase III||0||
59681358|NCT01303796|75800473|FG002|NOT COMPLETED|Randomized Phase III||0||
59681359|NCT01163149|75800483|FG000|STARTED|Primary Treatment Period||7||
59681360|NCT01163149|75800484|FG001|STARTED|Primary Treatment Period||6||
59681361|NCT01163149|75800485|FG002|STARTED|Primary Treatment Period||6||
59681362|NCT01163149|75800483|FG000|COMPLETED|Primary Treatment Period||7||
59681363|NCT01163149|75800484|FG001|COMPLETED|Primary Treatment Period||6||
59681364|NCT01163149|75800485|FG002|COMPLETED|Primary Treatment Period||6||
59681365|NCT01163149|75800483|FG000|NOT COMPLETED|Primary Treatment Period||0||
59681366|NCT01163149|75800484|FG001|NOT COMPLETED|Primary Treatment Period||0||
59681367|NCT01163149|75800485|FG002|NOT COMPLETED|Primary Treatment Period||0||
59681368|NCT01163149|75800483|FG000|STARTED|Extension Treatment Period||7||
59681369|NCT01163149|75800484|FG001|STARTED|Extension Treatment Period||6||
59681370|NCT01163149|75800485|FG002|STARTED|Extension Treatment Period||6||
59681371|NCT01163149|75800483|FG000|COMPLETED|Extension Treatment Period||5||
59681372|NCT01163149|75800484|FG001|COMPLETED|Extension Treatment Period||5||
59681373|NCT01163149|75800485|FG002|COMPLETED|Extension Treatment Period||4||
59681374|NCT01163149|75800483|FG000|NOT COMPLETED|Extension Treatment Period||2||
59681375|NCT01163149|75800484|FG001|NOT COMPLETED|Extension Treatment Period||1||
59681376|NCT01163149|75800485|FG002|NOT COMPLETED|Extension Treatment Period||2||
59681377|NCT01163032|75800510|FG000|STARTED|Randomization Phase||42||
59681378|NCT01163032|75800511|FG001|STARTED|Randomization Phase||42||
59681379|NCT01163032|75800512|FG002|STARTED|Randomization Phase|Not applicable for Randomized Phase|0||
59681380|NCT01163032|75800510|FG000|COMPLETED|Randomization Phase||32||
59681381|NCT01163032|75800511|FG001|COMPLETED|Randomization Phase||30||
59681382|NCT01163032|75800512|FG002|COMPLETED|Randomization Phase|Not applicable for Randomized Phase|0||
59681383|NCT01163032|75800510|FG000|NOT COMPLETED|Randomization Phase||10||
59681384|NCT01163032|75800511|FG001|NOT COMPLETED|Randomization Phase||12||
59681385|NCT01163032|75800512|FG002|NOT COMPLETED|Randomization Phase||0||
59681386|NCT01163032|75800510|FG000|STARTED|Open Label Extension Phase|Not applicable for Open Label Extension Phase|0||
59681387|NCT01163032|75800511|FG001|STARTED|Open Label Extension Phase|Not applicable for Open Label Extension Phase|0||
59681388|NCT01163032|75800512|FG002|STARTED|Open Label Extension Phase|3 randomized patients rolled into extension (2 randomized to tasimelteon and one to placebo)|55||
59681389|NCT01163032|75800510|FG000|COMPLETED|Open Label Extension Phase|Not applicable for Open Label Extension Phase|0||
59681390|NCT01163032|75800511|FG001|COMPLETED|Open Label Extension Phase|Not applicable for Open Label Extension Phase|0||
59681391|NCT01163032|75800512|FG002|COMPLETED|Open Label Extension Phase||39||
59681392|NCT01163032|75800510|FG000|NOT COMPLETED|Open Label Extension Phase||0||
59681393|NCT01163032|75800511|FG001|NOT COMPLETED|Open Label Extension Phase||0||
59681394|NCT01163032|75800512|FG002|NOT COMPLETED|Open Label Extension Phase||16||
59681395|NCT01162486|75800525|FG000|STARTED|Overall Study||8||
59681396|NCT01162486|75800526|FG001|STARTED|Overall Study||6||
59681397|NCT01162486|75800527|FG002|STARTED|Overall Study||6||
59681398|NCT01162486|75800528|FG003|STARTED|Overall Study||7||
59681399|NCT01162486|75800529|FG004|STARTED|Overall Study||6||
59681400|NCT01162486|75800525|FG000|Took at Least One Dose Study Drug|Overall Study||8||
59681401|NCT01162486|75800526|FG001|Took at Least One Dose Study Drug|Overall Study||6||
59681402|NCT01162486|75800527|FG002|Took at Least One Dose Study Drug|Overall Study||6||
59681403|NCT01162486|75800528|FG003|Took at Least One Dose Study Drug|Overall Study||7||
59681404|NCT01162486|75800529|FG004|Took at Least One Dose Study Drug|Overall Study||6||
59681405|NCT01162486|75800525|FG000|COMPLETED|Overall Study||6||
59681406|NCT01162486|75800526|FG001|COMPLETED|Overall Study||6||
59681407|NCT01162486|75800527|FG002|COMPLETED|Overall Study||5||
59681408|NCT01162486|75800528|FG003|COMPLETED|Overall Study||6||
59681409|NCT01162486|75800529|FG004|COMPLETED|Overall Study||6||
59681410|NCT01162486|75800525|FG000|NOT COMPLETED|Overall Study||2||
59547024|NCT02439216|75645774|FG003|NOT COMPLETED|Part B (12-week Double Blind)||0||
59547025|NCT02439216|75645775|FG004|NOT COMPLETED|Part B (12-week Double Blind)||0||
59681411|NCT01162486|75800526|FG001|NOT COMPLETED|Overall Study||0||
59681412|NCT01162486|75800527|FG002|NOT COMPLETED|Overall Study||1||
59681413|NCT01162486|75800528|FG003|NOT COMPLETED|Overall Study||1||
59681414|NCT01162486|75800529|FG004|NOT COMPLETED|Overall Study||0||
59681415|NCT01162135|75800545|FG000|STARTED|Overall Study||16||
59681416|NCT01162135|75800545|FG000|COMPLETED|Overall Study||13||
59681417|NCT01162135|75800545|FG000|NOT COMPLETED|Overall Study||3||
59681418|NCT01161628|75800549|FG000|STARTED|Overall Study||25||
59681419|NCT01161628|75800549|FG000|COMPLETED|Overall Study||17||
59681420|NCT01161628|75800549|FG000|NOT COMPLETED|Overall Study||8||
59681421|NCT01161472|75800553|FG000|STARTED|First Intervention Period||5||
59681422|NCT01161472|75800554|FG001|STARTED|First Intervention Period||5||
59681423|NCT01161472|75800555|FG002|STARTED|First Intervention Period||5||
59681424|NCT01161472|75800556|FG003|STARTED|First Intervention Period||5||
59681425|NCT01161472|75800553|FG000|Treated|First Intervention Period||5||
59681426|NCT01161472|75800554|FG001|Treated|First Intervention Period||5||
59681427|NCT01161472|75800555|FG002|Treated|First Intervention Period||5||
59681428|NCT01161472|75800556|FG003|Treated|First Intervention Period||5||
59681429|NCT01161472|75800553|FG000|COMPLETED|First Intervention Period||5||
59681430|NCT01161472|75800554|FG001|COMPLETED|First Intervention Period||5||
59681431|NCT01161472|75800555|FG002|COMPLETED|First Intervention Period||5||
59681432|NCT01161472|75800556|FG003|COMPLETED|First Intervention Period||5||
59681433|NCT01161472|75800553|FG000|NOT COMPLETED|First Intervention Period||0||
59681434|NCT01161472|75800554|FG001|NOT COMPLETED|First Intervention Period||0||
59681435|NCT01161472|75800555|FG002|NOT COMPLETED|First Intervention Period||0||
59681436|NCT01161472|75800556|FG003|NOT COMPLETED|First Intervention Period||0||
59681437|NCT01161472|75800553|FG000|STARTED|Washout Period (At Least 3 to 6 Days)||5||
59681438|NCT01161472|75800554|FG001|STARTED|Washout Period (At Least 3 to 6 Days)||5||
59681439|NCT01161472|75800555|FG002|STARTED|Washout Period (At Least 3 to 6 Days)||5||
59681440|NCT01161472|75800556|FG003|STARTED|Washout Period (At Least 3 to 6 Days)||5||
59681441|NCT01161472|75800553|FG000|COMPLETED|Washout Period (At Least 3 to 6 Days)||5||
59681442|NCT01161472|75800554|FG001|COMPLETED|Washout Period (At Least 3 to 6 Days)||5||
59681443|NCT01161472|75800555|FG002|COMPLETED|Washout Period (At Least 3 to 6 Days)||5||
59681444|NCT01161472|75800556|FG003|COMPLETED|Washout Period (At Least 3 to 6 Days)||5||
59681445|NCT01161472|75800553|FG000|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0||
59681446|NCT01161472|75800554|FG001|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0||
59681447|NCT01161472|75800555|FG002|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0||
59681448|NCT01161472|75800556|FG003|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0||
59681449|NCT01161472|75800553|FG000|STARTED|Second Intervention Period||5||
59681450|NCT01161472|75800554|FG001|STARTED|Second Intervention Period||5||
59681451|NCT01161472|75800555|FG002|STARTED|Second Intervention Period||5||
59681452|NCT01161472|75800556|FG003|STARTED|Second Intervention Period||5||
59681453|NCT01161472|75800553|FG000|COMPLETED|Second Intervention Period||5||
59681454|NCT01161472|75800554|FG001|COMPLETED|Second Intervention Period||5||
59681455|NCT01161472|75800555|FG002|COMPLETED|Second Intervention Period||5||
59681456|NCT01161472|75800556|FG003|COMPLETED|Second Intervention Period||5||
59681457|NCT01161472|75800553|FG000|NOT COMPLETED|Second Intervention Period||0||
59681458|NCT01161472|75800554|FG001|NOT COMPLETED|Second Intervention Period||0||
59681459|NCT01161472|75800555|FG002|NOT COMPLETED|Second Intervention Period||0||
59681460|NCT01161472|75800556|FG003|NOT COMPLETED|Second Intervention Period||0||
59681461|NCT01161472|75800553|FG000|STARTED|Washout Period (At Least 3 to 6 Days)||5||
59681462|NCT01161472|75800554|FG001|STARTED|Washout Period (At Least 3 to 6 Days)||5||
59681463|NCT01161472|75800555|FG002|STARTED|Washout Period (At Least 3 to 6 Days)||5||
59681464|NCT01161472|75800556|FG003|STARTED|Washout Period (At Least 3 to 6 Days)||5||
59681465|NCT01161472|75800553|FG000|COMPLETED|Washout Period (At Least 3 to 6 Days)||4||
59681466|NCT01161472|75800554|FG001|COMPLETED|Washout Period (At Least 3 to 6 Days)||5||
59681467|NCT01161472|75800555|FG002|COMPLETED|Washout Period (At Least 3 to 6 Days)||5||
59681468|NCT01161472|75800556|FG003|COMPLETED|Washout Period (At Least 3 to 6 Days)||5||
59681469|NCT01161472|75800553|FG000|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||1||
59681470|NCT01161472|75800554|FG001|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0||
59681471|NCT01161472|75800555|FG002|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0||
59681472|NCT01161472|75800556|FG003|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0||
59681473|NCT01161472|75800553|FG000|STARTED|Third Intervention Period||4||
59681474|NCT01161472|75800554|FG001|STARTED|Third Intervention Period||5||
59681475|NCT01161472|75800555|FG002|STARTED|Third Intervention Period||5||
59681476|NCT01161472|75800556|FG003|STARTED|Third Intervention Period||5||
59681477|NCT01161472|75800553|FG000|COMPLETED|Third Intervention Period||4||
59681478|NCT01161472|75800554|FG001|COMPLETED|Third Intervention Period||5||
59681479|NCT01161472|75800555|FG002|COMPLETED|Third Intervention Period||5||
59681480|NCT01161472|75800556|FG003|COMPLETED|Third Intervention Period||5||
59681481|NCT01161472|75800553|FG000|NOT COMPLETED|Third Intervention Period||0||
59681482|NCT01161472|75800554|FG001|NOT COMPLETED|Third Intervention Period||0||
59681483|NCT01161472|75800555|FG002|NOT COMPLETED|Third Intervention Period||0||
59681484|NCT01161472|75800556|FG003|NOT COMPLETED|Third Intervention Period||0||
59681485|NCT01161472|75800553|FG000|STARTED|Washout Period (At Least 3 to 6 Days)||4||
59681486|NCT01161472|75800554|FG001|STARTED|Washout Period (At Least 3 to 6 Days)||5||
59681487|NCT01161472|75800555|FG002|STARTED|Washout Period (At Least 3 to 6 Days)||5||
59681488|NCT01161472|75800556|FG003|STARTED|Washout Period (At Least 3 to 6 Days)||5||
59681489|NCT01161472|75800553|FG000|COMPLETED|Washout Period (At Least 3 to 6 Days)||4||
59681490|NCT01161472|75800554|FG001|COMPLETED|Washout Period (At Least 3 to 6 Days)||5||
59681491|NCT01161472|75800555|FG002|COMPLETED|Washout Period (At Least 3 to 6 Days)||5||
59681492|NCT01161472|75800556|FG003|COMPLETED|Washout Period (At Least 3 to 6 Days)||5||
59681493|NCT01161472|75800553|FG000|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0||
59681494|NCT01161472|75800554|FG001|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0||
59681495|NCT01161472|75800555|FG002|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0||
59681496|NCT01161472|75800556|FG003|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0||
59681497|NCT01161472|75800553|FG000|STARTED|Fourth Intervention Period||4||
59681498|NCT01161472|75800554|FG001|STARTED|Fourth Intervention Period||5||
59681499|NCT01161472|75800555|FG002|STARTED|Fourth Intervention Period||5||
59681500|NCT01161472|75800556|FG003|STARTED|Fourth Intervention Period||5||
59681501|NCT01161472|75800553|FG000|COMPLETED|Fourth Intervention Period||4||
59681502|NCT01161472|75800554|FG001|COMPLETED|Fourth Intervention Period||5||
59681503|NCT01161472|75800555|FG002|COMPLETED|Fourth Intervention Period||5||
59681504|NCT01161472|75800556|FG003|COMPLETED|Fourth Intervention Period||5||
59681505|NCT01161472|75800553|FG000|NOT COMPLETED|Fourth Intervention Period||0||
59681506|NCT01161472|75800554|FG001|NOT COMPLETED|Fourth Intervention Period||0||
59681507|NCT01161472|75800555|FG002|NOT COMPLETED|Fourth Intervention Period||0||
59681508|NCT01161472|75800556|FG003|NOT COMPLETED|Fourth Intervention Period||0||
59681509|NCT01161043|75800566|FG000|STARTED|Overall Study||83||
59681510|NCT01161043|75800566|FG000|COMPLETED|Overall Study||80||
59681511|NCT01161043|75800566|FG000|NOT COMPLETED|Overall Study||3||
59681512|NCT01160770|75800570|FG000|STARTED|Overall Study||267||
59681513|NCT01160770|75800570|FG000|COMPLETED|Overall Study||188||
59681514|NCT01160770|75800570|FG000|NOT COMPLETED|Overall Study||79||
59681515|NCT01160614|75800576|FG000|STARTED|Overall Study||5||
59681516|NCT01160614|75800577|FG001|STARTED|Overall Study||25||
59681517|NCT01160614|75800576|FG000|COMPLETED|Overall Study||5||
59681518|NCT01160614|75800577|FG001|COMPLETED|Overall Study||23||
59681519|NCT01160614|75800576|FG000|NOT COMPLETED|Overall Study||0||
59681520|NCT01160614|75800577|FG001|NOT COMPLETED|Overall Study||2||
59681521|NCT01159912|75800604|FG000|STARTED|Overall Study||115||
59681522|NCT01159912|75800605|FG001|STARTED|Overall Study||114||
59681523|NCT01159912|75800606|FG002|STARTED|Overall Study||114||
59681524|NCT01159912|75800604|FG000|COMPLETED|Overall Study||75||
59681525|NCT01159912|75800605|FG001|COMPLETED|Overall Study||92||
59681526|NCT01159912|75800606|FG002|COMPLETED|Overall Study||88||
59681527|NCT01159912|75800604|FG000|NOT COMPLETED|Overall Study||40||
59681528|NCT01159912|75800605|FG001|NOT COMPLETED|Overall Study||22||
59681529|NCT01159912|75800606|FG002|NOT COMPLETED|Overall Study||26||
59681530|NCT01159600|75800622|FG000|STARTED|Overall Study||207||
59681531|NCT01159600|75800623|FG001|STARTED|Overall Study||217||
59681532|NCT01159600|75800624|FG002|STARTED|Overall Study||214||
59681533|NCT01159600|75800625|FG003|STARTED|Overall Study||69||
59681534|NCT01159600|75800626|FG004|STARTED|Overall Study||225||
59681535|NCT01159600|75800627|FG005|STARTED|Overall Study||226||
59681536|NCT01159600|75800628|FG006|STARTED|Overall Study||218||
59681537|NCT01159600|75800629|FG007|STARTED|Overall Study||103||
59681538|NCT01159600|75800622|FG000|COMPLETED|Overall Study||186||
59681539|NCT01159600|75800623|FG001|COMPLETED|Overall Study||209||
59681540|NCT01159600|75800624|FG002|COMPLETED|Overall Study||196||
59681541|NCT01159600|75800625|FG003|COMPLETED|Overall Study||58||
59681542|NCT01159600|75800626|FG004|COMPLETED|Overall Study||201||
59681543|NCT01159600|75800627|FG005|COMPLETED|Overall Study||208||
59681544|NCT01159600|75800628|FG006|COMPLETED|Overall Study||199||
59681545|NCT01159600|75800629|FG007|COMPLETED|Overall Study||85||
59681546|NCT01159600|75800622|FG000|NOT COMPLETED|Overall Study||21||
59681547|NCT01159600|75800623|FG001|NOT COMPLETED|Overall Study||8||
59681548|NCT01159600|75800624|FG002|NOT COMPLETED|Overall Study||18||
59681549|NCT01159600|75800625|FG003|NOT COMPLETED|Overall Study||11||
59681550|NCT01159600|75800626|FG004|NOT COMPLETED|Overall Study||24||
59681551|NCT01159600|75800627|FG005|NOT COMPLETED|Overall Study||18||
59681552|NCT01159600|75800628|FG006|NOT COMPLETED|Overall Study||19||
59681553|NCT01159600|75800629|FG007|NOT COMPLETED|Overall Study||18||
59681554|NCT01159171|75800648|FG000|STARTED|Overall Study||50||
59681555|NCT01159171|75800648|FG000|COMPLETED|Overall Study||0||
59681556|NCT01159171|75800648|FG000|NOT COMPLETED|Overall Study||50||
59681557|NCT01158118|75800655|FG000|STARTED|Overall Study||24||
59681558|NCT01158118|75800656|FG001|STARTED|Overall Study||24||
59681559|NCT01158118|75800655|FG000|COMPLETED|Overall Study||23||
59681560|NCT01158118|75800656|FG001|COMPLETED|Overall Study||21||
59681561|NCT01158118|75800655|FG000|NOT COMPLETED|Overall Study||1||
59681562|NCT01158118|75800656|FG001|NOT COMPLETED|Overall Study||3||
59681563|NCT01157845|75800662|FG000|STARTED|Overall Study||165||
59681564|NCT01157845|75800662|FG000|COMPLETED|Overall Study||130||
59681565|NCT01157845|75800662|FG000|NOT COMPLETED|Overall Study||35||
59681566|NCT01157377|75800673|FG000|STARTED|Overall Study||23||
59681567|NCT01157377|75800674|FG001|STARTED|Overall Study||23||
59681568|NCT01157377|75800675|FG002|STARTED|Overall Study||27||
59681569|NCT01157377|75800676|FG003|STARTED|Overall Study||15||
59681570|NCT01157377|75800677|FG004|STARTED|Overall Study||20||
59681571|NCT01157377|75800678|FG005|STARTED|Overall Study||19||
59681572|NCT01157377|75800679|FG006|STARTED|Overall Study||29||
59681573|NCT01157377|75800673|FG000|COMPLETED|Overall Study||21||
59681574|NCT01157377|75800674|FG001|COMPLETED|Overall Study||20||
59681575|NCT01157377|75800675|FG002|COMPLETED|Overall Study||26||
59681576|NCT01157377|75800676|FG003|COMPLETED|Overall Study||14||
59681577|NCT01157377|75800677|FG004|COMPLETED|Overall Study||18||
59681578|NCT01157377|75800678|FG005|COMPLETED|Overall Study||16||
59681579|NCT01157377|75800679|FG006|COMPLETED|Overall Study||27||
59681580|NCT01157377|75800673|FG000|NOT COMPLETED|Overall Study||2||
59681581|NCT01157377|75800674|FG001|NOT COMPLETED|Overall Study||3||
59681582|NCT01157377|75800675|FG002|NOT COMPLETED|Overall Study||1||
59681583|NCT01157377|75800676|FG003|NOT COMPLETED|Overall Study||1||
59681584|NCT01157377|75800677|FG004|NOT COMPLETED|Overall Study||2||
59681585|NCT01157377|75800678|FG005|NOT COMPLETED|Overall Study||3||
59681586|NCT01157377|75800679|FG006|NOT COMPLETED|Overall Study||2||
59681587|NCT01157182|75800697|FG000|STARTED|First Intervention||18||
59681588|NCT01157182|75800698|FG001|STARTED|First Intervention||18||
59681589|NCT01157182|75800697|FG000|COMPLETED|First Intervention||18||
59681590|NCT01157182|75800698|FG001|COMPLETED|First Intervention||18||
59681591|NCT01157182|75800697|FG000|NOT COMPLETED|First Intervention||0||
59681592|NCT01157182|75800698|FG001|NOT COMPLETED|First Intervention||0||
59681593|NCT01157182|75800697|FG000|STARTED|Washout of 28 Days||18||
59681594|NCT01157182|75800698|FG001|STARTED|Washout of 28 Days||18||
59681595|NCT01157182|75800697|FG000|COMPLETED|Washout of 28 Days||16||
59681596|NCT01157182|75800698|FG001|COMPLETED|Washout of 28 Days||18||
59547026|NCT02439216|75645776|FG005|NOT COMPLETED|Part B (12-week Double Blind)||0||
59547027|NCT02439216|75645777|FG006|NOT COMPLETED|Part B (12-week Double Blind)||0||
59547028|NCT02439216|75645778|FG007|NOT COMPLETED|Part B (12-week Double Blind)||0||
59547029|NCT02439216|75645779|FG008|NOT COMPLETED|Part B (12-week Double Blind)||0||
59547030|NCT02439216|75645771|FG000|STARTED|Part C (138-week, Open-label Treatment)||0|It has Subjects completed Part B|
59547031|NCT02439216|75645772|FG001|STARTED|Part C (138-week, Open-label Treatment)||0|It has Subjects completed Part B|
59547032|NCT02439216|75645773|FG002|STARTED|Part C (138-week, Open-label Treatment)||0|It has Subjects completed Part B|
59547033|NCT02439216|75645774|FG003|STARTED|Part C (138-week, Open-label Treatment)||0|It has Subjects completed Part B|
59547034|NCT02439216|75645775|FG004|STARTED|Part C (138-week, Open-label Treatment)||0|It has Subjects completed Part B|
59547035|NCT02439216|75645776|FG005|STARTED|Part C (138-week, Open-label Treatment)||0|It has Subjects completed Part B|
59547036|NCT02439216|75645777|FG006|STARTED|Part C (138-week, Open-label Treatment)||0|It has Subjects completed Part B|
59547037|NCT02439216|75645778|FG007|STARTED|Part C (138-week, Open-label Treatment)||15|It has Subjects completed Part B|
59547038|NCT02439216|75645779|FG008|STARTED|Part C (138-week, Open-label Treatment)||16|It has Subjects completed Part B|
59547039|NCT02439216|75645771|FG000|COMPLETED|Part C (138-week, Open-label Treatment)||0||
59681597|NCT01157182|75800697|FG000|NOT COMPLETED|Washout of 28 Days||2||
59681598|NCT01157182|75800698|FG001|NOT COMPLETED|Washout of 28 Days||0||
59681599|NCT01157182|75800697|FG000|STARTED|Second Intervention||16||
59681600|NCT01157182|75800698|FG001|STARTED|Second Intervention||18||
59681601|NCT01157182|75800697|FG000|COMPLETED|Second Intervention||16||
59681602|NCT01157182|75800698|FG001|COMPLETED|Second Intervention||18||
59681603|NCT01157182|75800697|FG000|NOT COMPLETED|Second Intervention||0||
59681604|NCT01157182|75800698|FG001|NOT COMPLETED|Second Intervention||0||
59681605|NCT01157065|75800706|FG000|STARTED|Overall Study||38||
59681606|NCT01157065|75800707|FG001|STARTED|Overall Study||11||
59681607|NCT01157065|75800706|FG000|COMPLETED|Overall Study||38||
59681608|NCT01157065|75800707|FG001|COMPLETED|Overall Study||10||
59681609|NCT01157065|75800706|FG000|NOT COMPLETED|Overall Study||0||
59681610|NCT01157065|75800707|FG001|NOT COMPLETED|Overall Study||1||
59681611|NCT01156792|75800713|FG000|STARTED|Overall Study||162||
59681612|NCT01156792|75800713|FG000|COMPLETED|Overall Study||93||
59681613|NCT01156792|75800713|FG000|NOT COMPLETED|Overall Study||69||
59681614|NCT01156714|75800731|FG000|STARTED|Overall Study||20||
59681615|NCT01156714|75800732|FG001|STARTED|Overall Study||19||
59681616|NCT01156714|75800733|FG002|STARTED|Overall Study||20||
59681617|NCT01156714|75800731|FG000|COMPLETED|Overall Study||11||
59681618|NCT01156714|75800732|FG001|COMPLETED|Overall Study||15||
60079087|NCT00041938|76194395|FG000|Completed Follow-up|Overall Study||761||
60079088|NCT00041938|76194396|FG001|Completed Follow-up|Overall Study||745||
60079089|NCT00041938|76194395|FG000|Primary Endpoint|Overall Study||320||
60079090|NCT00041938|76194396|FG001|Primary Endpoint|Overall Study||302||
60079091|NCT00041938|76194395|FG000|Only Vital Status Known|Overall Study||44||
60079092|NCT00041938|76194396|FG001|Only Vital Status Known|Overall Study||46||
60079093|NCT00041938|76194395|FG000|Lost to Follow-up|Overall Study||18||
60079094|NCT00041938|76194396|FG001|Lost to Follow-up|Overall Study||17||
60079095|NCT00041938|76194395|FG000|Withdrew Consent|Overall Study||20||
60079096|NCT00041938|76194396|FG001|Withdrew Consent|Overall Study||14||
60079097|NCT00041938|76194395|FG000|COMPLETED|Overall Study||1125||
59681619|NCT01156714|75800733|FG002|COMPLETED|Overall Study||17||
59681620|NCT01156714|75800731|FG000|NOT COMPLETED|Overall Study||9||
59681621|NCT01156714|75800732|FG001|NOT COMPLETED|Overall Study||4||
59681622|NCT01156714|75800733|FG002|NOT COMPLETED|Overall Study||3||
59681623|NCT01156675|75800747|FG000|STARTED|Overall Study||107||
59681624|NCT01156675|75800748|FG001|STARTED|Overall Study||106||
59681625|NCT01156675|75800749|FG002|STARTED|Overall Study||2||
59681626|NCT01156675|75800747|FG000|COMPLETED|Overall Study||73||
59681627|NCT01156675|75800748|FG001|COMPLETED|Overall Study||81||
59681628|NCT01156675|75800749|FG002|COMPLETED|Overall Study||0||
59681629|NCT01156675|75800747|FG000|NOT COMPLETED|Overall Study||34||
59681630|NCT01156675|75800748|FG001|NOT COMPLETED|Overall Study||25||
59681631|NCT01156675|75800749|FG002|NOT COMPLETED|Overall Study||2||
59681632|NCT01156480|75800760|FG000|STARTED|Overall Study||0||
59681633|NCT01156480|75800761|FG001|STARTED|Overall Study||2||
59681634|NCT01156480|75800760|FG000|COMPLETED|Overall Study||0||
59681635|NCT01156480|75800761|FG001|COMPLETED|Overall Study||1||
59681636|NCT01156480|75800760|FG000|NOT COMPLETED|Overall Study||0||
59681637|NCT01156480|75800761|FG001|NOT COMPLETED|Overall Study||1||
59681638|NCT01156363|75800769|FG000|STARTED|Overall Study||86||
59681639|NCT01156363|75800769|FG000|COMPLETED|Overall Study||64||
59681640|NCT01156363|75800769|FG000|NOT COMPLETED|Overall Study||22||
59681641|NCT01156051|75800782|FG000|STARTED|Overall Study||12||
59681642|NCT01156051|75800783|FG001|STARTED|Overall Study||17||
59681643|NCT01156051|75800782|FG000|COMPLETED|Overall Study||11||
59681644|NCT01156051|75800783|FG001|COMPLETED|Overall Study||16||
59681645|NCT01156051|75800782|FG000|NOT COMPLETED|Overall Study||1||
59681646|NCT01156051|75800783|FG001|NOT COMPLETED|Overall Study||1||
59681647|NCT01156012|75800791|FG000|STARTED|Overall Study||213||
59681648|NCT01156012|75800792|FG001|STARTED|Overall Study||189||
59681649|NCT01156012|75800791|FG000|COMPLETED|Overall Study||206||
59681650|NCT01156012|75800792|FG001|COMPLETED|Overall Study||186||
59681651|NCT01156012|75800791|FG000|NOT COMPLETED|Overall Study||7||
59681652|NCT01156012|75800792|FG001|NOT COMPLETED|Overall Study||3||
59681653|NCT01155661|75800798|FG000|STARTED|Overall Study||608||
59681654|NCT01155661|75800798|FG000|COMPLETED|Overall Study||328||
59681655|NCT01155661|75800798|FG000|NOT COMPLETED|Overall Study||280||
59681656|NCT01155583|75800813|FG000|STARTED|Phase I||3||
59681657|NCT01155583|75800814|FG001|STARTED|Phase I||3||
59681658|NCT01155583|75800815|FG002|STARTED|Phase I||4||
59681659|NCT01155583|75800816|FG003|STARTED|Phase I||6||
60079098|NCT00041938|76194396|FG001|COMPLETED|Overall Study||1111||
59681660|NCT01155583|75800817|FG004|STARTED|Phase I||7||
59681661|NCT01155583|75800818|FG005|STARTED|Phase I||0||
59681662|NCT01155583|75800819|FG006|STARTED|Phase I||3||
59681663|NCT01155583|75800820|FG007|STARTED|Phase I||8||
59681664|NCT01155583|75800821|FG008|STARTED|Phase I||0||
59681665|NCT01155583|75800813|FG000|COMPLETED|Phase I||3||
59681666|NCT01155583|75800814|FG001|COMPLETED|Phase I||3||
60079099|NCT00041938|76194395|FG000|NOT COMPLETED|Overall Study||38||
60079100|NCT00041938|76194396|FG001|NOT COMPLETED|Overall Study||31||
59681667|NCT01155583|75800815|FG002|COMPLETED|Phase I||4||
59681668|NCT01155583|75800816|FG003|COMPLETED|Phase I||6||
59681669|NCT01155583|75800817|FG004|COMPLETED|Phase I||6||
59681670|NCT01155583|75800818|FG005|COMPLETED|Phase I||0||
59681671|NCT01155583|75800819|FG006|COMPLETED|Phase I||3||
59681672|NCT01155583|75800820|FG007|COMPLETED|Phase I||5||
59681673|NCT01155583|75800821|FG008|COMPLETED|Phase I||0||
59681674|NCT01155583|75800813|FG000|NOT COMPLETED|Phase I||0||
59681675|NCT01155583|75800814|FG001|NOT COMPLETED|Phase I||0||
59681676|NCT01155583|75800815|FG002|NOT COMPLETED|Phase I||0||
59681677|NCT01155583|75800816|FG003|NOT COMPLETED|Phase I||0||
59681678|NCT01155583|75800817|FG004|NOT COMPLETED|Phase I||1||
59681679|NCT01155583|75800818|FG005|NOT COMPLETED|Phase I||0||
60079101|NCT00202930|76194402|FG000|STARTED|Overall Study||4||
59681680|NCT01155583|75800819|FG006|NOT COMPLETED|Phase I||0||
59681681|NCT01155583|75800820|FG007|NOT COMPLETED|Phase I||3||
59681682|NCT01155583|75800821|FG008|NOT COMPLETED|Phase I||0||
59681683|NCT01155583|75800813|FG000|STARTED|Phase II - Expansion Phase||0||
59681684|NCT01155583|75800814|FG001|STARTED|Phase II - Expansion Phase||0||
59681685|NCT01155583|75800815|FG002|STARTED|Phase II - Expansion Phase||0||
59681686|NCT01155583|75800816|FG003|STARTED|Phase II - Expansion Phase||0||
59681687|NCT01155583|75800817|FG004|STARTED|Phase II - Expansion Phase||0||
59681688|NCT01155583|75800818|FG005|STARTED|Phase II - Expansion Phase||0||
59681689|NCT01155583|75800819|FG006|STARTED|Phase II - Expansion Phase||0||
59681690|NCT01155583|75800820|FG007|STARTED|Phase II - Expansion Phase||0||
59681691|NCT01155583|75800821|FG008|STARTED|Phase II - Expansion Phase||11||
59681692|NCT01155583|75800813|FG000|COMPLETED|Phase II - Expansion Phase||0||
59681693|NCT01155583|75800814|FG001|COMPLETED|Phase II - Expansion Phase||0||
59681694|NCT01155583|75800815|FG002|COMPLETED|Phase II - Expansion Phase||0||
59681695|NCT01155583|75800816|FG003|COMPLETED|Phase II - Expansion Phase||0||
59681696|NCT01155583|75800817|FG004|COMPLETED|Phase II - Expansion Phase||0||
59681697|NCT01155583|75800818|FG005|COMPLETED|Phase II - Expansion Phase||0||
59681698|NCT01155583|75800819|FG006|COMPLETED|Phase II - Expansion Phase||0||
59681699|NCT01155583|75800820|FG007|COMPLETED|Phase II - Expansion Phase||0||
59681700|NCT01155583|75800821|FG008|COMPLETED|Phase II - Expansion Phase||11||
59681701|NCT01155583|75800813|FG000|NOT COMPLETED|Phase II - Expansion Phase||0||
59681702|NCT01155583|75800814|FG001|NOT COMPLETED|Phase II - Expansion Phase||0||
59681703|NCT01155583|75800815|FG002|NOT COMPLETED|Phase II - Expansion Phase||0||
59681704|NCT01155583|75800816|FG003|NOT COMPLETED|Phase II - Expansion Phase||0||
59681705|NCT01155583|75800817|FG004|NOT COMPLETED|Phase II - Expansion Phase||0||
59681706|NCT01155583|75800818|FG005|NOT COMPLETED|Phase II - Expansion Phase||0||
59681707|NCT01155583|75800819|FG006|NOT COMPLETED|Phase II - Expansion Phase||0||
59681708|NCT01155583|75800820|FG007|NOT COMPLETED|Phase II - Expansion Phase||0||
59681709|NCT01155583|75800821|FG008|NOT COMPLETED|Phase II - Expansion Phase||0||
59681710|NCT01155466|75800842|FG000|STARTED|Overall Study||156||
59681711|NCT01155466|75800843|FG001|STARTED|Overall Study||155||
59681712|NCT01155466|75800844|FG002|STARTED|Overall Study||156||
59681713|NCT01155466|75800845|FG003|STARTED|Overall Study||155||
59681714|NCT01155466|75800846|FG004|STARTED|Overall Study||156||
59681715|NCT01155466|75800842|FG000|Treated|Overall Study||154||
59681716|NCT01155466|75800843|FG001|Treated|Overall Study||153||
59681717|NCT01155466|75800844|FG002|Treated|Overall Study||153||
59681718|NCT01155466|75800845|FG003|Treated|Overall Study||155||
59681719|NCT01155466|75800846|FG004|Treated|Overall Study||154||
59681720|NCT01155466|75800842|FG000|COMPLETED|Overall Study|Completed treatment phase|134||
59681721|NCT01155466|75800843|FG001|COMPLETED|Overall Study|Completed treatment phase|130||
59681722|NCT01155466|75800844|FG002|COMPLETED|Overall Study|Completed treatment phase|136||
59681723|NCT01155466|75800845|FG003|COMPLETED|Overall Study|Completed treatment phase|134||
59681724|NCT01155466|75800846|FG004|COMPLETED|Overall Study|Completed treatment phase|129||
59681725|NCT01155466|75800842|FG000|NOT COMPLETED|Overall Study||22||
59681726|NCT01155466|75800843|FG001|NOT COMPLETED|Overall Study||25||
59681727|NCT01155466|75800844|FG002|NOT COMPLETED|Overall Study||20||
59681728|NCT01155466|75800845|FG003|NOT COMPLETED|Overall Study||21||
59681729|NCT01155466|75800846|FG004|NOT COMPLETED|Overall Study||27||
59681730|NCT01155388|75800860|FG000|STARTED|Overall Study||8|Data are for the combined AMAG-FER-CKD-251 and AMAG-FER-CKD-252 studies.|
59681731|NCT01155388|75800861|FG001|STARTED|Overall Study||6|Data are for the combined AMAG-FER-CKD-251 and AMAG-FER-CKD-252 studies.|
59681732|NCT01155388|75800860|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8||
59681733|NCT01155388|75800861|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6||
59681734|NCT01155388|75800860|FG000|COMPLETED|Overall Study||7||
59681735|NCT01155388|75800861|FG001|COMPLETED|Overall Study||6||
59681736|NCT01155388|75800860|FG000|NOT COMPLETED|Overall Study||1||
59681737|NCT01155388|75800861|FG001|NOT COMPLETED|Overall Study||0||
59681738|NCT01154452|75800872|FG000|STARTED|Phase Ib||6||
59681739|NCT01154452|75800873|FG001|STARTED|Phase Ib||4||
59681740|NCT01154452|75800874|FG002|STARTED|Phase Ib||0||
59681741|NCT01154452|75800875|FG003|STARTED|Phase Ib||0||
59681742|NCT01154452|75800872|FG000|COMPLETED|Phase Ib||3||
59681743|NCT01154452|75800873|FG001|COMPLETED|Phase Ib||3||
59681744|NCT01154452|75800874|FG002|COMPLETED|Phase Ib||0||
59681745|NCT01154452|75800875|FG003|COMPLETED|Phase Ib||0||
59681746|NCT01154452|75800872|FG000|NOT COMPLETED|Phase Ib||3||
59681747|NCT01154452|75800873|FG001|NOT COMPLETED|Phase Ib||1||
59681748|NCT01154452|75800874|FG002|NOT COMPLETED|Phase Ib||0||
59681749|NCT01154452|75800875|FG003|NOT COMPLETED|Phase Ib||0||
59681750|NCT01154452|75800872|FG000|STARTED|Phase II||0||
59681751|NCT01154452|75800873|FG001|STARTED|Phase II||0||
59681752|NCT01154452|75800874|FG002|STARTED|Phase II||35||
59681753|NCT01154452|75800875|FG003|STARTED|Phase II||33||
59681754|NCT01154452|75800872|FG000|COMPLETED|Phase II||0||
59681755|NCT01154452|75800873|FG001|COMPLETED|Phase II||0||
59681756|NCT01154452|75800874|FG002|COMPLETED|Phase II||30||
59681757|NCT01154452|75800875|FG003|COMPLETED|Phase II||27||
59681758|NCT01154452|75800872|FG000|NOT COMPLETED|Phase II||0||
59681759|NCT01154452|75800873|FG001|NOT COMPLETED|Phase II||0||
59681760|NCT01154452|75800874|FG002|NOT COMPLETED|Phase II||5||
59681761|NCT01154452|75800875|FG003|NOT COMPLETED|Phase II||6||
59681762|NCT01154296|75800890|FG000|STARTED|Randomization and Intervention||2505||
59681763|NCT01154296|75800891|FG001|STARTED|Randomization and Intervention||2507||
59681764|NCT01154296|75800890|FG000|COMPLETED|Randomization and Intervention||2500||
59681765|NCT01154296|75800891|FG001|COMPLETED|Randomization and Intervention||2505||
59681766|NCT01154296|75800890|FG000|NOT COMPLETED|Randomization and Intervention||5||
59681767|NCT01154296|75800891|FG001|NOT COMPLETED|Randomization and Intervention||2||
59681768|NCT01154296|75800890|FG000|STARTED|6-month Follow-up||2505||
59681769|NCT01154296|75800891|FG001|STARTED|6-month Follow-up||2507||
59681770|NCT01154296|75800890|FG000|COMPLETED|6-month Follow-up||2177||
59681771|NCT01154296|75800891|FG001|COMPLETED|6-month Follow-up||2179||
59681772|NCT01154296|75800890|FG000|NOT COMPLETED|6-month Follow-up||328||
59681773|NCT01154296|75800891|FG001|NOT COMPLETED|6-month Follow-up||328||
59681774|NCT01154218|75800897|FG000|STARTED|First Intervention Period||9||
59681775|NCT01154218|75800898|FG001|STARTED|First Intervention Period||9||
59681776|NCT01154218|75800899|FG002|STARTED|First Intervention Period||9||
59681777|NCT01154218|75800900|FG003|STARTED|First Intervention Period||9||
59681778|NCT01154218|75800897|FG000|COMPLETED|First Intervention Period||9||
59681779|NCT01154218|75800898|FG001|COMPLETED|First Intervention Period||9||
59681780|NCT01154218|75800899|FG002|COMPLETED|First Intervention Period||9||
59681781|NCT01154218|75800900|FG003|COMPLETED|First Intervention Period||9||
59681782|NCT01154218|75800897|FG000|NOT COMPLETED|First Intervention Period||0||
59681783|NCT01154218|75800898|FG001|NOT COMPLETED|First Intervention Period||0||
59681784|NCT01154218|75800899|FG002|NOT COMPLETED|First Intervention Period||0||
59681785|NCT01154218|75800900|FG003|NOT COMPLETED|First Intervention Period||0||
59681786|NCT01154218|75800897|FG000|STARTED|Washout Period (at Least 14 Days)||9||
59681787|NCT01154218|75800898|FG001|STARTED|Washout Period (at Least 14 Days)||9||
59681788|NCT01154218|75800899|FG002|STARTED|Washout Period (at Least 14 Days)||9||
59681789|NCT01154218|75800900|FG003|STARTED|Washout Period (at Least 14 Days)||9||
59681790|NCT01154218|75800897|FG000|COMPLETED|Washout Period (at Least 14 Days)||9||
59681791|NCT01154218|75800898|FG001|COMPLETED|Washout Period (at Least 14 Days)||9||
59681792|NCT01154218|75800899|FG002|COMPLETED|Washout Period (at Least 14 Days)||9||
59681793|NCT01154218|75800900|FG003|COMPLETED|Washout Period (at Least 14 Days)||9||
59681794|NCT01154218|75800897|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0||
59681795|NCT01154218|75800898|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0||
59681796|NCT01154218|75800899|FG002|NOT COMPLETED|Washout Period (at Least 14 Days)||0||
59681797|NCT01154218|75800900|FG003|NOT COMPLETED|Washout Period (at Least 14 Days)||0||
59681798|NCT01154218|75800897|FG000|STARTED|Second Intervention Period||9||
59681799|NCT01154218|75800898|FG001|STARTED|Second Intervention Period||9||
59681800|NCT01154218|75800899|FG002|STARTED|Second Intervention Period||9||
59681801|NCT01154218|75800900|FG003|STARTED|Second Intervention Period||9||
59681802|NCT01154218|75800897|FG000|COMPLETED|Second Intervention Period||9||
59681803|NCT01154218|75800898|FG001|COMPLETED|Second Intervention Period||9||
59681804|NCT01154218|75800899|FG002|COMPLETED|Second Intervention Period||9||
59681805|NCT01154218|75800900|FG003|COMPLETED|Second Intervention Period||9||
59681806|NCT01154218|75800897|FG000|NOT COMPLETED|Second Intervention Period||0||
59681807|NCT01154218|75800898|FG001|NOT COMPLETED|Second Intervention Period||0||
59681808|NCT01154218|75800899|FG002|NOT COMPLETED|Second Intervention Period||0||
59681809|NCT01154218|75800900|FG003|NOT COMPLETED|Second Intervention Period||0||
59681810|NCT01154218|75800897|FG000|STARTED|Washout Period (at Least 14 Days)||9||
59681811|NCT01154218|75800898|FG001|STARTED|Washout Period (at Least 14 Days)||9||
59681812|NCT01154218|75800899|FG002|STARTED|Washout Period (at Least 14 Days)||9||
59681813|NCT01154218|75800900|FG003|STARTED|Washout Period (at Least 14 Days)||9||
59681814|NCT01154218|75800897|FG000|COMPLETED|Washout Period (at Least 14 Days)||9||
59681815|NCT01154218|75800898|FG001|COMPLETED|Washout Period (at Least 14 Days)||9||
59681816|NCT01154218|75800899|FG002|COMPLETED|Washout Period (at Least 14 Days)||9||
59681817|NCT01154218|75800900|FG003|COMPLETED|Washout Period (at Least 14 Days)||9||
59681818|NCT01154218|75800897|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0||
59681819|NCT01154218|75800898|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0||
59681820|NCT01154218|75800899|FG002|NOT COMPLETED|Washout Period (at Least 14 Days)||0||
59681821|NCT01154218|75800900|FG003|NOT COMPLETED|Washout Period (at Least 14 Days)||0||
59681822|NCT01154218|75800897|FG000|STARTED|Third Intervention Period||9||
59681823|NCT01154218|75800898|FG001|STARTED|Third Intervention Period||9||
59681824|NCT01154218|75800899|FG002|STARTED|Third Intervention Period||9||
59681825|NCT01154218|75800900|FG003|STARTED|Third Intervention Period||9||
59681826|NCT01154218|75800897|FG000|COMPLETED|Third Intervention Period||9||
59681827|NCT01154218|75800898|FG001|COMPLETED|Third Intervention Period||8||
59681828|NCT01154218|75800899|FG002|COMPLETED|Third Intervention Period||9||
59681829|NCT01154218|75800900|FG003|COMPLETED|Third Intervention Period||9||
59681830|NCT01154218|75800897|FG000|NOT COMPLETED|Third Intervention Period||0||
59681831|NCT01154218|75800898|FG001|NOT COMPLETED|Third Intervention Period||1||
59681832|NCT01154218|75800899|FG002|NOT COMPLETED|Third Intervention Period||0||
59681833|NCT01154218|75800900|FG003|NOT COMPLETED|Third Intervention Period||0||
59681834|NCT01154218|75800897|FG000|STARTED|Washout Period (at Least 14 Days)||9||
59681835|NCT01154218|75800898|FG001|STARTED|Washout Period (at Least 14 Days)||8||
59547040|NCT02439216|75645772|FG001|COMPLETED|Part C (138-week, Open-label Treatment)||0||
59547041|NCT02439216|75645773|FG002|COMPLETED|Part C (138-week, Open-label Treatment)||0||
59547042|NCT02439216|75645774|FG003|COMPLETED|Part C (138-week, Open-label Treatment)||0||
59547043|NCT02439216|75645775|FG004|COMPLETED|Part C (138-week, Open-label Treatment)||0||
59547044|NCT02439216|75645776|FG005|COMPLETED|Part C (138-week, Open-label Treatment)||0||
59547045|NCT02439216|75645777|FG006|COMPLETED|Part C (138-week, Open-label Treatment)||0||
59547046|NCT02439216|75645778|FG007|COMPLETED|Part C (138-week, Open-label Treatment)||8||
59547047|NCT02439216|75645779|FG008|COMPLETED|Part C (138-week, Open-label Treatment)||5||
59547048|NCT02439216|75645771|FG000|NOT COMPLETED|Part C (138-week, Open-label Treatment)||0||
59547049|NCT02439216|75645772|FG001|NOT COMPLETED|Part C (138-week, Open-label Treatment)||0||
59547050|NCT02439216|75645773|FG002|NOT COMPLETED|Part C (138-week, Open-label Treatment)||0||
59547051|NCT02439216|75645774|FG003|NOT COMPLETED|Part C (138-week, Open-label Treatment)||0||
59547052|NCT02439216|75645775|FG004|NOT COMPLETED|Part C (138-week, Open-label Treatment)||0||
59547053|NCT02439216|75645776|FG005|NOT COMPLETED|Part C (138-week, Open-label Treatment)||0||
59547054|NCT02439216|75645777|FG006|NOT COMPLETED|Part C (138-week, Open-label Treatment)||0||
59547055|NCT02439216|75645778|FG007|NOT COMPLETED|Part C (138-week, Open-label Treatment)||7||
59547056|NCT02439216|75645779|FG008|NOT COMPLETED|Part C (138-week, Open-label Treatment)||11||
59547057|NCT02439138|75645803|FG000|STARTED|Overall Study||5||
59547058|NCT02439138|75645803|FG000|COMPLETED|Overall Study||2||
59547059|NCT02439138|75645803|FG000|NOT COMPLETED|Overall Study||3||
59547060|NCT01097642|75645809|FG000|STARTED|Overall Study||15||
59547061|NCT01097642|75645810|FG001|STARTED|Overall Study||25||
59547062|NCT01097642|75645809|FG000|COMPLETED|Overall Study||15||
59547063|NCT01097642|75645810|FG001|COMPLETED|Overall Study||25||
59547064|NCT01097642|75645809|FG000|NOT COMPLETED|Overall Study||0||
59547065|NCT01097642|75645810|FG001|NOT COMPLETED|Overall Study||0||
59547066|NCT02442687|75645819|FG000|STARTED|Overall Study||21||
59547067|NCT02442687|75645820|FG001|STARTED|Overall Study||22||
59547068|NCT02442687|75645821|FG002|STARTED|Overall Study||22||
59547069|NCT02442687|75645819|FG000|COMPLETED|Overall Study||13||
59547070|NCT02442687|75645820|FG001|COMPLETED|Overall Study||11||
59547071|NCT02442687|75645821|FG002|COMPLETED|Overall Study||19||
59547072|NCT02442687|75645819|FG000|NOT COMPLETED|Overall Study||8||
59547073|NCT02442687|75645820|FG001|NOT COMPLETED|Overall Study||11||
59547074|NCT02442687|75645821|FG002|NOT COMPLETED|Overall Study||3||
59547075|NCT01115660|75645832|FG000|STARTED|Overall Study||20||
59547076|NCT01115660|75645833|FG001|STARTED|Overall Study||10||
59547077|NCT01115660|75645832|FG000|COMPLETED|Overall Study||19||
59547078|NCT01115660|75645833|FG001|COMPLETED|Overall Study||10||
59547079|NCT01115660|75645832|FG000|NOT COMPLETED|Overall Study||1||
59547080|NCT01115660|75645833|FG001|NOT COMPLETED|Overall Study||0||
59547081|NCT01048424|75645841|FG000|STARTED|Overall Study||10||
59547082|NCT01048424|75645842|FG001|STARTED|Overall Study||10||
59547083|NCT01048424|75645841|FG000|COMPLETED|Overall Study||8||
59547084|NCT01048424|75645842|FG001|COMPLETED|Overall Study||10||
59547085|NCT01048424|75645841|FG000|NOT COMPLETED|Overall Study||2||
59547086|NCT01048424|75645842|FG001|NOT COMPLETED|Overall Study||0||
59681836|NCT01154218|75800899|FG002|STARTED|Washout Period (at Least 14 Days)||9||
59681837|NCT01154218|75800900|FG003|STARTED|Washout Period (at Least 14 Days)||9||
59681838|NCT01154218|75800897|FG000|COMPLETED|Washout Period (at Least 14 Days)||9||
59681839|NCT01154218|75800898|FG001|COMPLETED|Washout Period (at Least 14 Days)||8||
59681840|NCT01154218|75800899|FG002|COMPLETED|Washout Period (at Least 14 Days)||9||
59681841|NCT01154218|75800900|FG003|COMPLETED|Washout Period (at Least 14 Days)||8||
59681842|NCT01154218|75800897|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0||
59681843|NCT01154218|75800898|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0||
59547087|NCT02444715|75645851|FG000|STARTED|Overall Study||46||
59547088|NCT02444715|75645852|FG001|STARTED|Overall Study||48||
59547089|NCT02444715|75645851|FG000|COMPLETED|Overall Study||36||
59547090|NCT02444715|75645852|FG001|COMPLETED|Overall Study||32||
59547091|NCT02444715|75645851|FG000|NOT COMPLETED|Overall Study||10||
59547092|NCT02444715|75645852|FG001|NOT COMPLETED|Overall Study||16||
59547093|NCT01048658|75645861|FG000|STARTED|Overall Study||80||
59547094|NCT01048658|75645862|FG001|STARTED|Overall Study||80||
59547095|NCT01048658|75645861|FG000|COMPLETED|Overall Study||80||
59547096|NCT01048658|75645862|FG001|COMPLETED|Overall Study||80||
59547097|NCT01048658|75645861|FG000|NOT COMPLETED|Overall Study||0||
59547098|NCT01048658|75645862|FG001|NOT COMPLETED|Overall Study||0||
59547099|NCT02445807|75645870|FG000|STARTED|Overall Study||176||
59547100|NCT02445807|75645871|FG001|STARTED|Overall Study||89||
59547101|NCT02445807|75645870|FG000|COMPLETED|Overall Study||176||
59547102|NCT02445807|75645871|FG001|COMPLETED|Overall Study||89||
59547103|NCT02445807|75645870|FG000|NOT COMPLETED|Overall Study||0||
59547104|NCT02445807|75645871|FG001|NOT COMPLETED|Overall Study||0||
59547105|NCT01116986|75645909|FG000|STARTED|Overall Study||24||
59547106|NCT01116986|75645910|FG001|STARTED|Overall Study||19||
59547107|NCT01116986|75645911|FG002|STARTED|Overall Study||18||
59547108|NCT01116986|75645912|FG003|STARTED|Overall Study||22||
59547109|NCT01116986|75645913|FG004|STARTED|Overall Study||24||
59547110|NCT01116986|75645914|FG005|STARTED|Overall Study||22||
59681844|NCT01154218|75800899|FG002|NOT COMPLETED|Washout Period (at Least 14 Days)||0||
59681845|NCT01154218|75800900|FG003|NOT COMPLETED|Washout Period (at Least 14 Days)||1||
59681846|NCT01154218|75800897|FG000|STARTED|Fourth Intervention Period||9||
59681847|NCT01154218|75800898|FG001|STARTED|Fourth Intervention Period||8||
59681848|NCT01154218|75800899|FG002|STARTED|Fourth Intervention Period||9||
59681849|NCT01154218|75800900|FG003|STARTED|Fourth Intervention Period||8||
59681850|NCT01154218|75800897|FG000|COMPLETED|Fourth Intervention Period||8||
59681851|NCT01154218|75800898|FG001|COMPLETED|Fourth Intervention Period||8||
59681852|NCT01154218|75800899|FG002|COMPLETED|Fourth Intervention Period||9||
59681853|NCT01154218|75800900|FG003|COMPLETED|Fourth Intervention Period||8||
59681854|NCT01154218|75800897|FG000|NOT COMPLETED|Fourth Intervention Period||1||
59681855|NCT01154218|75800898|FG001|NOT COMPLETED|Fourth Intervention Period||0||
59681856|NCT01154218|75800899|FG002|NOT COMPLETED|Fourth Intervention Period||0||
59681857|NCT01154218|75800900|FG003|NOT COMPLETED|Fourth Intervention Period||0||
59681858|NCT04625426|75800913|FG000|STARTED|Overall Study||23||
59681859|NCT04625426|75800914|FG001|STARTED|Overall Study||37||
59681860|NCT04625426|75800915|FG002|STARTED|Overall Study||24||
59681861|NCT04625426|75800913|FG000|COMPLETED|Overall Study||9||
59681862|NCT04625426|75800914|FG001|COMPLETED|Overall Study||12||
59681863|NCT04625426|75800915|FG002|COMPLETED|Overall Study||12||
59681864|NCT04625426|75800913|FG000|NOT COMPLETED|Overall Study||14||
59681865|NCT04625426|75800914|FG001|NOT COMPLETED|Overall Study||25||
59681866|NCT04625426|75800915|FG002|NOT COMPLETED|Overall Study||12||
59681867|NCT01154140|75800925|FG000|STARTED|Overall Study||172||
59681868|NCT01154140|75800926|FG001|STARTED|Overall Study||171||
59681869|NCT01154140|75800925|FG000|Treated|Overall Study||171||
59681870|NCT01154140|75800926|FG001|Treated|Overall Study||169||
59681871|NCT01154140|75800925|FG000|COMPLETED|Overall Study||81||
59681872|NCT01154140|75800926|FG001|COMPLETED|Overall Study||69||
59681873|NCT01154140|75800925|FG000|NOT COMPLETED|Overall Study||91||
59681874|NCT01154140|75800926|FG001|NOT COMPLETED|Overall Study||102||
59681875|NCT01154101|75800937|FG000|STARTED|Overall Study||7||
59681876|NCT01154101|75800938|FG001|STARTED|Overall Study||9||
59681877|NCT01154101|75800939|FG002|STARTED|Overall Study||12||
59681878|NCT01154101|75800940|FG003|STARTED|Overall Study||11||
59681879|NCT01154101|75800941|FG004|STARTED|Overall Study||1||
59681880|NCT01154101|75800937|FG000|COMPLETED|Overall Study||7||
59681881|NCT01154101|75800938|FG001|COMPLETED|Overall Study||5||
59681882|NCT01154101|75800939|FG002|COMPLETED|Overall Study||9||
59681883|NCT01154101|75800940|FG003|COMPLETED|Overall Study||9||
59681884|NCT01154101|75800941|FG004|COMPLETED|Overall Study||0||
59681885|NCT01154101|75800937|FG000|NOT COMPLETED|Overall Study||0||
59681886|NCT01154101|75800938|FG001|NOT COMPLETED|Overall Study||4||
59681887|NCT01154101|75800939|FG002|NOT COMPLETED|Overall Study||3||
59681888|NCT01154101|75800940|FG003|NOT COMPLETED|Overall Study||2||
59681889|NCT01154101|75800941|FG004|NOT COMPLETED|Overall Study||1||
59681890|NCT01153984|75800958|FG000|STARTED|Overall Study||23||
59681891|NCT01153984|75800958|FG000|COMPLETED|Overall Study||21||
59681892|NCT01153984|75800958|FG000|NOT COMPLETED|Overall Study||2||
59681893|NCT01153633|75800964|FG000|STARTED|Overall Study||17||
59681894|NCT01153633|75800965|FG001|STARTED|Overall Study||17||
59681895|NCT01153633|75800964|FG000|COMPLETED|Overall Study||13||
59681896|NCT01153633|75800965|FG001|COMPLETED|Overall Study||13||
59681897|NCT01153633|75800964|FG000|NOT COMPLETED|Overall Study||4||
59681898|NCT01153633|75800965|FG001|NOT COMPLETED|Overall Study||4||
59681899|NCT01153516|75800975|FG000|STARTED|Overall Study||12||
59681900|NCT01153516|75800976|FG001|STARTED|Overall Study||10||
59681901|NCT01153516|75800975|FG000|COMPLETED|Overall Study||10||
59681902|NCT01153516|75800976|FG001|COMPLETED|Overall Study||10||
59681903|NCT01153516|75800975|FG000|NOT COMPLETED|Overall Study||2||
59681904|NCT01153516|75800976|FG001|NOT COMPLETED|Overall Study||0||
59681905|NCT01153321|75800984|FG000|STARTED|Overall Study||22||
59681906|NCT01153321|75800985|FG001|STARTED|Overall Study||22||
59681907|NCT01153321|75800984|FG000|COMPLETED|Overall Study||21||
59681908|NCT01153321|75800985|FG001|COMPLETED|Overall Study||19||
59681909|NCT01153321|75800984|FG000|NOT COMPLETED|Overall Study||1||
59681910|NCT01153321|75800985|FG001|NOT COMPLETED|Overall Study||3||
59681911|NCT01153009|75800995|FG000|STARTED|Overall Study||161||
59681912|NCT01153009|75800996|FG001|STARTED|Overall Study||147||
59681913|NCT01153009|75800997|FG002|STARTED|Overall Study||154||
59681914|NCT01153009|75800998|FG003|STARTED|Overall Study||152||
59681915|NCT01153009|75800995|FG000|Treated|Overall Study||159||
59681916|NCT01153009|75800996|FG001|Treated|Overall Study||147||
59681917|NCT01153009|75800997|FG002|Treated|Overall Study||154||
59681918|NCT01153009|75800998|FG003|Treated|Overall Study||150||
59681919|NCT01153009|75800995|FG000|COMPLETED|Overall Study||129||
59681920|NCT01153009|75800996|FG001|COMPLETED|Overall Study||113||
59681921|NCT01153009|75800997|FG002|COMPLETED|Overall Study||113||
59681922|NCT01153009|75800998|FG003|COMPLETED|Overall Study||115||
59681923|NCT01153009|75800995|FG000|NOT COMPLETED|Overall Study||32||
59681924|NCT01153009|75800996|FG001|NOT COMPLETED|Overall Study||34||
59681925|NCT01153009|75800997|FG002|NOT COMPLETED|Overall Study||41||
59681926|NCT01153009|75800998|FG003|NOT COMPLETED|Overall Study||37||
59681927|NCT01152814|75801008|FG000|STARTED|Overall Study||64||
59681928|NCT01152814|75801008|FG000|COMPLETED|Overall Study||62||
59681929|NCT01152814|75801008|FG000|NOT COMPLETED|Overall Study||2||
59681930|NCT01152580|75801014|FG000|STARTED|Overall Study||5||
59681931|NCT01152580|75801015|FG001|STARTED|Overall Study||14||
59681932|NCT01152580|75801014|FG000|COMPLETED|Overall Study||5||
59681933|NCT01152580|75801015|FG001|COMPLETED|Overall Study||13||
59681934|NCT01152580|75801014|FG000|NOT COMPLETED|Overall Study||0||
59681935|NCT01152580|75801015|FG001|NOT COMPLETED|Overall Study||1||
59681936|NCT01152385|75801025|FG000|STARTED|Overall Study||55||
59681937|NCT01152385|75801026|FG001|STARTED|Overall Study||58||
59681938|NCT01152385|75801027|FG002|STARTED|Overall Study||56||
59681939|NCT01152385|75801028|FG003|STARTED|Overall Study||55||
59681940|NCT01152385|75801025|FG000|COMPLETED|Overall Study||46||
59681941|NCT01152385|75801026|FG001|COMPLETED|Overall Study||52||
59681942|NCT01152385|75801027|FG002|COMPLETED|Overall Study||51||
59681943|NCT01152385|75801028|FG003|COMPLETED|Overall Study||50||
59681944|NCT01152385|75801025|FG000|NOT COMPLETED|Overall Study||9||
59681945|NCT01152385|75801026|FG001|NOT COMPLETED|Overall Study||6||
59681946|NCT01152385|75801027|FG002|NOT COMPLETED|Overall Study||5||
59681947|NCT01152385|75801028|FG003|NOT COMPLETED|Overall Study||5||
59681948|NCT01152190|75801044|FG000|STARTED|Overall Study||50||
59681949|NCT01152190|75801045|FG001|STARTED|Overall Study||47||
59681950|NCT01152190|75801044|FG000|Received at Least 1 Dose of Study Drug|Overall Study||50||
59681951|NCT01152190|75801045|FG001|Received at Least 1 Dose of Study Drug|Overall Study||47||
59681952|NCT01152190|75801044|FG000|COMPLETED|Overall Study||45||
59681953|NCT01152190|75801045|FG001|COMPLETED|Overall Study||39||
59681954|NCT01152190|75801044|FG000|NOT COMPLETED|Overall Study||5||
59681955|NCT01152190|75801045|FG001|NOT COMPLETED|Overall Study||8||
59681956|NCT01151410|75801053|FG000|STARTED|Overall Study||104||
59681957|NCT01151410|75801054|FG001|STARTED|Overall Study||104||
59681958|NCT01151410|75801053|FG000|Safety Set (SAF)|Overall Study||105||
59681959|NCT01151410|75801054|FG001|Safety Set (SAF)|Overall Study|Number of patients in SAF differed due to kit dispensing error in 1 patient at Visit 12|103||
59681960|NCT01151410|75801053|FG000|COMPLETED|Overall Study||93||
59681961|NCT01151410|75801054|FG001|COMPLETED|Overall Study||89||
59681962|NCT01151410|75801053|FG000|NOT COMPLETED|Overall Study||11||
59681963|NCT01151410|75801054|FG001|NOT COMPLETED|Overall Study||15||
59681964|NCT01151215|75801063|FG000|STARTED|Overall Study||120||
59681965|NCT01151215|75801064|FG001|STARTED|Overall Study||118||
59681966|NCT01151215|75801065|FG002|STARTED|Overall Study||121||
59681967|NCT01151215|75801063|FG000|COMPLETED|Overall Study|This is number of patients who were continuing at cut off (ie not withdrawn)|100||
59681968|NCT01151215|75801064|FG001|COMPLETED|Overall Study|This is number of patients who were continuing at cut off (ie not withdrawn)|95||
59681969|NCT01151215|75801065|FG002|COMPLETED|Overall Study|This is number of patients who were continuing at cut off (ie not withdrawn)|102||
59681970|NCT01151215|75801063|FG000|NOT COMPLETED|Overall Study||20||
59681971|NCT01151215|75801064|FG001|NOT COMPLETED|Overall Study||23||
59681972|NCT01151215|75801065|FG002|NOT COMPLETED|Overall Study||19||
59681973|NCT01151137|75801075|FG000|STARTED|Overall Study||1617||
59681974|NCT01151137|75801076|FG001|STARTED|Overall Study||1619||
59681975|NCT01151137|75801075|FG000|Treated|Overall Study|One participant randomized to the placebo group received Dronedarone for 7 days by mistake|1610||
59681976|NCT01151137|75801076|FG001|Treated|Overall Study||1613||
59681977|NCT01151137|75801075|FG000|Discontinued Treatment|Overall Study||171||
59681978|NCT01151137|75801076|FG001|Discontinued Treatment|Overall Study||342||
59681979|NCT01151137|75801075|FG000|COMPLETED|Overall Study||1601||
59681980|NCT01151137|75801076|FG001|COMPLETED|Overall Study||1591||
59681981|NCT01151137|75801075|FG000|NOT COMPLETED|Overall Study||16||
59681982|NCT01151137|75801076|FG001|NOT COMPLETED|Overall Study||28||
59681983|NCT01151098|75801082|FG000|STARTED|Overall Study|Extension Safety Population|189||
59681984|NCT01151098|75801082|FG000|COMPLETED|Overall Study||72||
59681985|NCT01151098|75801082|FG000|NOT COMPLETED|Overall Study||117||
59681986|NCT01151020|75801086|FG000|STARTED|Overall Study||110||
59681987|NCT01151020|75801086|FG000|30-day|Overall Study||110||
59681988|NCT01151020|75801086|FG000|COMPLETED|Overall Study||56||
59681989|NCT01151020|75801086|FG000|NOT COMPLETED|Overall Study||54||
59681990|NCT01150474|75801092|FG000|STARTED|Overall Study||51||
59681991|NCT01150474|75801093|FG001|STARTED|Overall Study||52||
59681992|NCT01150474|75801092|FG000|COMPLETED|Overall Study||41||
59681993|NCT01150474|75801093|FG001|COMPLETED|Overall Study||49||
59681994|NCT01150474|75801092|FG000|NOT COMPLETED|Overall Study||10||
59681995|NCT01150474|75801093|FG001|NOT COMPLETED|Overall Study||3||
59681996|NCT01150357|75801102|FG000|STARTED|Dose Response Phase (Phase 1)||108||
59681997|NCT01150357|75801103|FG001|STARTED|Dose Response Phase (Phase 1)||54||
59681998|NCT01150357|75801104|FG002|STARTED|Dose Response Phase (Phase 1)||105||
59681999|NCT01150357|75801102|FG000|COMPLETED|Dose Response Phase (Phase 1)||107||
59682000|NCT01150357|75801103|FG001|COMPLETED|Dose Response Phase (Phase 1)||51||
59682001|NCT01150357|75801104|FG002|COMPLETED|Dose Response Phase (Phase 1)||102||
59682002|NCT01150357|75801102|FG000|NOT COMPLETED|Dose Response Phase (Phase 1)||1||
59682003|NCT01150357|75801103|FG001|NOT COMPLETED|Dose Response Phase (Phase 1)||3||
59682004|NCT01150357|75801104|FG002|NOT COMPLETED|Dose Response Phase (Phase 1)||3||
59682005|NCT01150357|75801102|FG000|STARTED|Placebo-controlled Withdrawal (Phase 2)||107||
59682006|NCT01150357|75801103|FG001|STARTED|Placebo-controlled Withdrawal (Phase 2)||51||
59682007|NCT01150357|75801104|FG002|STARTED|Placebo-controlled Withdrawal (Phase 2)||102||
59682008|NCT01150357|75801102|FG000|Started Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||50||
59682009|NCT01150357|75801103|FG001|Started Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||30||
59682010|NCT01150357|75801104|FG002|Started Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||50||
59682011|NCT01150357|75801102|FG000|Completed Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||50||
59682012|NCT01150357|75801103|FG001|Completed Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||30||
59682013|NCT01150357|75801104|FG002|Completed Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||49||
59682014|NCT01150357|75801102|FG000|Started Placebo Treatment|Placebo-controlled Withdrawal (Phase 2)||57||
59682015|NCT01150357|75801103|FG001|Started Placebo Treatment|Placebo-controlled Withdrawal (Phase 2)||21||
59682016|NCT01150357|75801104|FG002|Started Placebo Treatment|Placebo-controlled Withdrawal (Phase 2)||52||
59682017|NCT01150357|75801102|FG000|Completed Placebo Treament|Placebo-controlled Withdrawal (Phase 2)||54||
59682018|NCT01150357|75801103|FG001|Completed Placebo Treament|Placebo-controlled Withdrawal (Phase 2)||21||
59682019|NCT01150357|75801104|FG002|Completed Placebo Treament|Placebo-controlled Withdrawal (Phase 2)||51||
59682020|NCT01150357|75801102|FG000|COMPLETED|Placebo-controlled Withdrawal (Phase 2)||104||
59682021|NCT01150357|75801103|FG001|COMPLETED|Placebo-controlled Withdrawal (Phase 2)||51||
59682022|NCT01150357|75801104|FG002|COMPLETED|Placebo-controlled Withdrawal (Phase 2)||100||
59682023|NCT01150357|75801102|FG000|NOT COMPLETED|Placebo-controlled Withdrawal (Phase 2)||3||
59682024|NCT01150357|75801103|FG001|NOT COMPLETED|Placebo-controlled Withdrawal (Phase 2)||0||
59682025|NCT01150357|75801104|FG002|NOT COMPLETED|Placebo-controlled Withdrawal (Phase 2)||2||
59682026|NCT04617509|75801124|FG000|STARTED|Period 1: Part 1 Formulation A||14||
59682027|NCT04617509|75801125|FG001|STARTED|Period 1: Part 1 Formulation A||0||
59682028|NCT04617509|75801126|FG002|STARTED|Period 1: Part 1 Formulation A|Subjects were expected to participate in both Part I and Part II, seven visits in total. Subject 112 was prematurely withdrawn from the study due to self-reported Covid-19-like symptoms via phone after Visit 5, i.e. after receiving both GS-248 formulations but prior to the food interaction part. This means subject 112 was withdrawn after Part I Formulation B but before Part II which cannot be visualized in the Period section. The correct number of subjects started Part II is thus 13.|0||
59682029|NCT04617509|75801124|FG000|COMPLETED|Period 1: Part 1 Formulation A||14||
59682030|NCT04617509|75801125|FG001|COMPLETED|Period 1: Part 1 Formulation A||0||
59682031|NCT04617509|75801126|FG002|COMPLETED|Period 1: Part 1 Formulation A||0||
59682032|NCT04617509|75801124|FG000|NOT COMPLETED|Period 1: Part 1 Formulation A||0||
59682033|NCT04617509|75801125|FG001|NOT COMPLETED|Period 1: Part 1 Formulation A||0||
59682034|NCT04617509|75801126|FG002|NOT COMPLETED|Period 1: Part 1 Formulation A||0||
59682035|NCT04617509|75801124|FG000|STARTED|Period 2: Part 1 Formulation B||0||
59682036|NCT04617509|75801125|FG001|STARTED|Period 2: Part 1 Formulation B||14||
59682037|NCT04617509|75801126|FG002|STARTED|Period 2: Part 1 Formulation B||0||
59682038|NCT04617509|75801124|FG000|COMPLETED|Period 2: Part 1 Formulation B||0||
59682039|NCT04617509|75801125|FG001|COMPLETED|Period 2: Part 1 Formulation B||14||
59682040|NCT04617509|75801126|FG002|COMPLETED|Period 2: Part 1 Formulation B||0||
59682041|NCT04617509|75801124|FG000|NOT COMPLETED|Period 2: Part 1 Formulation B||0||
59682042|NCT04617509|75801125|FG001|NOT COMPLETED|Period 2: Part 1 Formulation B||0||
59682043|NCT04617509|75801126|FG002|NOT COMPLETED|Period 2: Part 1 Formulation B||0||
59682044|NCT04617509|75801124|FG000|STARTED|Period 3: Part 2 Formulation A Fed Cond.||0||
59682045|NCT04617509|75801125|FG001|STARTED|Period 3: Part 2 Formulation A Fed Cond.||0||
59682046|NCT04617509|75801126|FG002|STARTED|Period 3: Part 2 Formulation A Fed Cond.||14||
59682047|NCT04617509|75801124|FG000|COMPLETED|Period 3: Part 2 Formulation A Fed Cond.||0||
59682048|NCT04617509|75801125|FG001|COMPLETED|Period 3: Part 2 Formulation A Fed Cond.||0||
59682049|NCT04617509|75801126|FG002|COMPLETED|Period 3: Part 2 Formulation A Fed Cond.||13||
59682050|NCT04617509|75801124|FG000|NOT COMPLETED|Period 3: Part 2 Formulation A Fed Cond.||0||
59682051|NCT04617509|75801125|FG001|NOT COMPLETED|Period 3: Part 2 Formulation A Fed Cond.||0||
59682052|NCT04617509|75801126|FG002|NOT COMPLETED|Period 3: Part 2 Formulation A Fed Cond.||1||
59682053|NCT01150123|75801154|FG000|STARTED|Overall Study||40||
59682054|NCT01150123|75801155|FG001|STARTED|Overall Study||40||
59682055|NCT01150123|75801156|FG002|STARTED|Overall Study||39||
59682056|NCT01150123|75801157|FG003|STARTED|Overall Study||40||
59682057|NCT01150123|75801158|FG004|STARTED|Overall Study||40||
59682058|NCT01150123|75801159|FG005|STARTED|Overall Study||40||
59682059|NCT01150123|75801160|FG006|STARTED|Overall Study||39||
59682060|NCT01150123|75801161|FG007|STARTED|Overall Study||40||
59682061|NCT01150123|75801162|FG008|STARTED|Overall Study||20||
59682062|NCT01150123|75801163|FG009|STARTED|Overall Study||40||
59682063|NCT01150123|75801164|FG010|STARTED|Overall Study||40||
59682064|NCT01150123|75801165|FG011|STARTED|Overall Study||40||
59682065|NCT01150123|75801166|FG012|STARTED|Overall Study||40||
59682066|NCT01150123|75801167|FG013|STARTED|Overall Study||40||
59682067|NCT01150123|75801168|FG014|STARTED|Overall Study||40||
59682068|NCT01150123|75801169|FG015|STARTED|Overall Study||40||
59682069|NCT01150123|75801170|FG016|STARTED|Overall Study||40||
59682070|NCT01150123|75801171|FG017|STARTED|Overall Study||20||
59682071|NCT01150123|75801154|FG000|COMPLETED|Overall Study||37||
59682072|NCT01150123|75801155|FG001|COMPLETED|Overall Study||38||
59682073|NCT01150123|75801156|FG002|COMPLETED|Overall Study||35||
59682074|NCT01150123|75801157|FG003|COMPLETED|Overall Study||37||
59682075|NCT01150123|75801158|FG004|COMPLETED|Overall Study||37||
59682076|NCT01150123|75801159|FG005|COMPLETED|Overall Study||34||
59682077|NCT01150123|75801160|FG006|COMPLETED|Overall Study||39||
59682078|NCT01150123|75801161|FG007|COMPLETED|Overall Study||37||
59682079|NCT01150123|75801162|FG008|COMPLETED|Overall Study||15||
59682080|NCT01150123|75801163|FG009|COMPLETED|Overall Study||39||
59682081|NCT01150123|75801164|FG010|COMPLETED|Overall Study||38||
59682082|NCT01150123|75801165|FG011|COMPLETED|Overall Study||39||
59682083|NCT01150123|75801166|FG012|COMPLETED|Overall Study||37||
59682084|NCT01150123|75801167|FG013|COMPLETED|Overall Study||40||
59682085|NCT01150123|75801168|FG014|COMPLETED|Overall Study||40||
59682086|NCT01150123|75801169|FG015|COMPLETED|Overall Study||39||
59682087|NCT01150123|75801170|FG016|COMPLETED|Overall Study||40||
59682088|NCT01150123|75801171|FG017|COMPLETED|Overall Study||19||
59682089|NCT01150123|75801154|FG000|NOT COMPLETED|Overall Study||3||
59682090|NCT01150123|75801155|FG001|NOT COMPLETED|Overall Study||2||
59682091|NCT01150123|75801156|FG002|NOT COMPLETED|Overall Study||4||
59682092|NCT01150123|75801157|FG003|NOT COMPLETED|Overall Study||3||
59682093|NCT01150123|75801158|FG004|NOT COMPLETED|Overall Study||3||
59682094|NCT01150123|75801159|FG005|NOT COMPLETED|Overall Study||6||
59682095|NCT01150123|75801160|FG006|NOT COMPLETED|Overall Study||0||
59682096|NCT01150123|75801161|FG007|NOT COMPLETED|Overall Study||3||
59682097|NCT01150123|75801162|FG008|NOT COMPLETED|Overall Study||5||
59682098|NCT01150123|75801163|FG009|NOT COMPLETED|Overall Study||1||
59682099|NCT01150123|75801164|FG010|NOT COMPLETED|Overall Study||2||
59682100|NCT01150123|75801165|FG011|NOT COMPLETED|Overall Study||1||
59682101|NCT01150123|75801166|FG012|NOT COMPLETED|Overall Study||3||
59682102|NCT01150123|75801167|FG013|NOT COMPLETED|Overall Study||0||
59682103|NCT01150123|75801168|FG014|NOT COMPLETED|Overall Study||0||
59682104|NCT01150123|75801169|FG015|NOT COMPLETED|Overall Study||1||
59682105|NCT01150123|75801170|FG016|NOT COMPLETED|Overall Study||0||
59682106|NCT01150123|75801171|FG017|NOT COMPLETED|Overall Study||1||
59682107|NCT01149655|75801230|FG000|STARTED|Period 1 - Conversion Phase||186||
59682108|NCT01149655|75801231|FG001|STARTED|Period 1 - Conversion Phase||0||
59682109|NCT01149655|75801232|FG002|STARTED|Period 1 - Conversion Phase||0||
59682110|NCT01149655|75801233|FG003|STARTED|Period 1 - Conversion Phase||0||
59682111|NCT01149655|75801230|FG000|COMPLETED|Period 1 - Conversion Phase||168||
59682112|NCT01149655|75801231|FG001|COMPLETED|Period 1 - Conversion Phase||0||
59682113|NCT01149655|75801232|FG002|COMPLETED|Period 1 - Conversion Phase||0||
59682114|NCT01149655|75801233|FG003|COMPLETED|Period 1 - Conversion Phase||0||
59682115|NCT01149655|75801230|FG000|NOT COMPLETED|Period 1 - Conversion Phase||18||
59682116|NCT01149655|75801231|FG001|NOT COMPLETED|Period 1 - Conversion Phase||0||
59682117|NCT01149655|75801232|FG002|NOT COMPLETED|Period 1 - Conversion Phase||0||
59682118|NCT01149655|75801233|FG003|NOT COMPLETED|Period 1 - Conversion Phase||0||
59682119|NCT01149655|75801230|FG000|STARTED|Period 2-Stabilization Phase||0||
59682120|NCT01149655|75801231|FG001|STARTED|Period 2-Stabilization Phase||183||
59682121|NCT01149655|75801232|FG002|STARTED|Period 2-Stabilization Phase||0||
59682122|NCT01149655|75801233|FG003|STARTED|Period 2-Stabilization Phase||0||
59682123|NCT01149655|75801230|FG000|COMPLETED|Period 2-Stabilization Phase||0||
59682124|NCT01149655|75801231|FG001|COMPLETED|Period 2-Stabilization Phase||146||
59682125|NCT01149655|75801232|FG002|COMPLETED|Period 2-Stabilization Phase||0||
59682126|NCT01149655|75801233|FG003|COMPLETED|Period 2-Stabilization Phase||0||
59682127|NCT01149655|75801230|FG000|NOT COMPLETED|Period 2-Stabilization Phase||0||
59682128|NCT01149655|75801231|FG001|NOT COMPLETED|Period 2-Stabilization Phase||37||
59682129|NCT01149655|75801232|FG002|NOT COMPLETED|Period 2-Stabilization Phase||0||
59682130|NCT01149655|75801233|FG003|NOT COMPLETED|Period 2-Stabilization Phase||0||
59682131|NCT01149655|75801230|FG000|STARTED|Period 3-DB Maintenance Phase||0||
59682132|NCT01149655|75801231|FG001|STARTED|Period 3-DB Maintenance Phase||0||
59682133|NCT01149655|75801232|FG002|STARTED|Period 3-DB Maintenance Phase||98||
59682134|NCT01149655|75801233|FG003|STARTED|Period 3-DB Maintenance Phase||48||
59682135|NCT01149655|75801230|FG000|COMPLETED|Period 3-DB Maintenance Phase||0||
59682136|NCT01149655|75801231|FG001|COMPLETED|Period 3-DB Maintenance Phase||0||
59682137|NCT01149655|75801232|FG002|COMPLETED|Period 3-DB Maintenance Phase||15||
59682138|NCT01149655|75801233|FG003|COMPLETED|Period 3-DB Maintenance Phase||6||
59682139|NCT01149655|75801230|FG000|NOT COMPLETED|Period 3-DB Maintenance Phase||0||
59682140|NCT01149655|75801231|FG001|NOT COMPLETED|Period 3-DB Maintenance Phase||0||
59682141|NCT01149655|75801232|FG002|NOT COMPLETED|Period 3-DB Maintenance Phase||83||
59682142|NCT01149655|75801233|FG003|NOT COMPLETED|Period 3-DB Maintenance Phase||42||
59682143|NCT01149538|75801243|FG000|STARTED|Overall Study||31||
59682144|NCT01149538|75801244|FG001|STARTED|Overall Study||29||
59682145|NCT01149538|75801243|FG000|COMPLETED|Overall Study||26||
59682146|NCT01149538|75801244|FG001|COMPLETED|Overall Study||25||
59682147|NCT01149538|75801243|FG000|NOT COMPLETED|Overall Study||5||
59682148|NCT01149538|75801244|FG001|NOT COMPLETED|Overall Study||4||
59682149|NCT01149460|75801252|FG000|STARTED|Overall Study||18||
59682150|NCT01149460|75801253|FG001|STARTED|Overall Study||18||
59682151|NCT01149460|75801252|FG000|COMPLETED|Overall Study||18||
59682152|NCT01149460|75801253|FG001|COMPLETED|Overall Study||16||
59682153|NCT01149460|75801252|FG000|NOT COMPLETED|Overall Study||0||
59682154|NCT01149460|75801253|FG001|NOT COMPLETED|Overall Study||2||
59682155|NCT01149421|75801262|FG000|STARTED|Overall Study||251||
59682156|NCT01149421|75801263|FG001|STARTED|Overall Study||254||
59682157|NCT01149421|75801264|FG002|STARTED|Overall Study||250||
59682158|NCT01149421|75801262|FG000|Received at Least One Dose of Study Drug|Overall Study||251||
59682159|NCT01149421|75801263|FG001|Received at Least One Dose of Study Drug|Overall Study||254||
59682160|NCT01149421|75801264|FG002|Received at Least One Dose of Study Drug|Overall Study||250||
59682161|NCT01149421|75801262|FG000|COMPLETED|Overall Study||199||
59682162|NCT01149421|75801263|FG001|COMPLETED|Overall Study||225||
59682163|NCT01149421|75801264|FG002|COMPLETED|Overall Study||206||
59682164|NCT01149421|75801262|FG000|NOT COMPLETED|Overall Study||52||
59682165|NCT01149421|75801263|FG001|NOT COMPLETED|Overall Study||29||
59682166|NCT01149421|75801264|FG002|NOT COMPLETED|Overall Study||44||
59682167|NCT04599959|75801272|FG000|STARTED|Overall Study||151||
59682168|NCT04599959|75801272|FG000|COMPLETED|Overall Study||151||
59682169|NCT04599959|75801272|FG000|NOT COMPLETED|Overall Study||0||
59682170|NCT01149343|75801282|FG000|STARTED|Overall Study||20|107 patients were treated, 106 patients have 1 dose of vaccine assigned in the randomization system|
59682171|NCT01149343|75801283|FG001|STARTED|Overall Study||24|107 patients were treated, 106 patients have 1 dose of vaccine assigned in the randomization system|
59682172|NCT01149343|75801284|FG002|STARTED|Overall Study||22|107 patients were treated, 106 patients have 1 dose of vaccine assigned in the randomization system|
59682173|NCT01149343|75801285|FG003|STARTED|Overall Study||40|107 patients were treated, 106 patients have 1 dose of vaccine assigned in the randomization system|
59682174|NCT01149343|75801282|FG000|COMPLETED|Overall Study||0||
59682175|NCT01149343|75801283|FG001|COMPLETED|Overall Study||0||
59682176|NCT01149343|75801284|FG002|COMPLETED|Overall Study||0||
59682177|NCT01149343|75801285|FG003|COMPLETED|Overall Study||0||
59682178|NCT01149343|75801282|FG000|NOT COMPLETED|Overall Study||20||
59682179|NCT01149343|75801283|FG001|NOT COMPLETED|Overall Study||24||
59682180|NCT01149343|75801284|FG002|NOT COMPLETED|Overall Study||22||
59682181|NCT01149343|75801285|FG003|NOT COMPLETED|Overall Study||40||
59682182|NCT01149148|75801301|FG000|STARTED|Overall Study||12||
59682183|NCT01149148|75801302|FG001|STARTED|Overall Study||13||
59682184|NCT01149148|75801301|FG000|COMPLETED|Overall Study||10||
59682185|NCT01149148|75801302|FG001|COMPLETED|Overall Study||11||
59682186|NCT01149148|75801301|FG000|NOT COMPLETED|Overall Study||2||
59682187|NCT01149148|75801302|FG001|NOT COMPLETED|Overall Study||2||
59682188|NCT01148017|75801313|FG000|STARTED|Overall Study||214||
59682189|NCT01148017|75801314|FG001|STARTED|Overall Study||121||
59682190|NCT01148017|75801315|FG002|STARTED|Overall Study||53||
59682191|NCT01148017|75801316|FG003|STARTED|Overall Study||45||
59682192|NCT01148017|75801313|FG000|COMPLETED|Overall Study||134||
59682193|NCT01148017|75801314|FG001|COMPLETED|Overall Study||87||
59682194|NCT01148017|75801315|FG002|COMPLETED|Overall Study||53||
59682195|NCT01148017|75801316|FG003|COMPLETED|Overall Study||45||
59682196|NCT01148017|75801313|FG000|NOT COMPLETED|Overall Study||80||
59682197|NCT01148017|75801314|FG001|NOT COMPLETED|Overall Study||34||
59682198|NCT01148017|75801315|FG002|NOT COMPLETED|Overall Study||0||
59682199|NCT01148017|75801316|FG003|NOT COMPLETED|Overall Study||0||
59682200|NCT01147900|75801330|FG000|STARTED|At Year 8.5||54||
59682201|NCT01147900|75801331|FG001|STARTED|At Year 8.5||60||
59989582|NCT02511782|76104892|FG000|STARTED|Overall Study||51||
59989583|NCT02511782|76104893|FG001|STARTED|Overall Study||2||
59989584|NCT02511782|76104894|FG002|STARTED|Overall Study||10||
59682202|NCT01147900|75801332|FG002|STARTED|At Year 8.5||66||
59682203|NCT01147900|75801330|FG000|COMPLETED|At Year 8.5||54||
59682204|NCT01147900|75801331|FG001|COMPLETED|At Year 8.5||60||
59682205|NCT01147900|75801332|FG002|COMPLETED|At Year 8.5||66||
59682206|NCT01147900|75801330|FG000|NOT COMPLETED|At Year 8.5||0||
59682207|NCT01147900|75801331|FG001|NOT COMPLETED|At Year 8.5||0||
59682208|NCT01147900|75801332|FG002|NOT COMPLETED|At Year 8.5||0||
59682209|NCT01147900|75801330|FG000|STARTED|At Year 10|At Year 10, a total of 177 subjects (out of the 180 planned) were enrolled|55||
59682210|NCT01147900|75801331|FG001|STARTED|At Year 10||60||
59682211|NCT01147900|75801332|FG002|STARTED|At Year 10|At Year 10, a total of 177 subjects (out of the 180 planned) were enrolled.|62||
59682212|NCT01147900|75801330|FG000|COMPLETED|At Year 10||55||
59682213|NCT01147900|75801331|FG001|COMPLETED|At Year 10||59||
59682214|NCT01147900|75801332|FG002|COMPLETED|At Year 10||62||
59682215|NCT01147900|75801330|FG000|NOT COMPLETED|At Year 10||0||
59682216|NCT01147900|75801331|FG001|NOT COMPLETED|At Year 10||1||
59682217|NCT01147900|75801332|FG002|NOT COMPLETED|At Year 10||0||
59682218|NCT01147744|75801347|FG000|STARTED|Overall Study||100||
59682219|NCT01147744|75801348|FG001|STARTED|Overall Study||99||
59682220|NCT01147744|75801349|FG002|STARTED|Overall Study||100||
59682221|NCT01147744|75801350|FG003|STARTED|Overall Study||100||
59682222|NCT01147744|75801351|FG004|STARTED|Overall Study||101||
59682223|NCT01147744|75801352|FG005|STARTED|Overall Study||103||
59682224|NCT01147744|75801353|FG006|STARTED|Overall Study||97||
59682225|NCT01147744|75801347|FG000|COMPLETED|Overall Study||71||
59682226|NCT01147744|75801348|FG001|COMPLETED|Overall Study||76||
59682227|NCT01147744|75801349|FG002|COMPLETED|Overall Study||82||
59682228|NCT01147744|75801350|FG003|COMPLETED|Overall Study||82||
59682229|NCT01147744|75801351|FG004|COMPLETED|Overall Study||76||
59682230|NCT01147744|75801352|FG005|COMPLETED|Overall Study||83||
59682231|NCT01147744|75801353|FG006|COMPLETED|Overall Study||78||
59682232|NCT01147744|75801347|FG000|NOT COMPLETED|Overall Study||29||
59682233|NCT01147744|75801348|FG001|NOT COMPLETED|Overall Study||23||
59682234|NCT01147744|75801349|FG002|NOT COMPLETED|Overall Study||18||
59682235|NCT01147744|75801350|FG003|NOT COMPLETED|Overall Study||18||
59682236|NCT01147744|75801351|FG004|NOT COMPLETED|Overall Study||25||
59682237|NCT01147744|75801352|FG005|NOT COMPLETED|Overall Study||20||
59682238|NCT01147744|75801353|FG006|NOT COMPLETED|Overall Study||19||
59682239|NCT01147471|75801377|FG000|STARTED|Through Initial Hospital Discharge||13||
59682240|NCT01147471|75801378|FG001|STARTED|Through Initial Hospital Discharge||11||
59682241|NCT01147471|75801377|FG000|COMPLETED|Through Initial Hospital Discharge||13||
59682242|NCT01147471|75801378|FG001|COMPLETED|Through Initial Hospital Discharge||11||
59682243|NCT01147471|75801377|FG000|NOT COMPLETED|Through Initial Hospital Discharge||0||
59682244|NCT01147471|75801378|FG001|NOT COMPLETED|Through Initial Hospital Discharge||0||
59682245|NCT01147471|75801377|FG000|STARTED|Post-discharge Follow Up (Approx 2 Wks)||13||
59682246|NCT01147471|75801378|FG001|STARTED|Post-discharge Follow Up (Approx 2 Wks)||11||
59682247|NCT01147471|75801377|FG000|COMPLETED|Post-discharge Follow Up (Approx 2 Wks)||13||
59682248|NCT01147471|75801378|FG001|COMPLETED|Post-discharge Follow Up (Approx 2 Wks)||8||
59682249|NCT01147471|75801377|FG000|NOT COMPLETED|Post-discharge Follow Up (Approx 2 Wks)||0||
59682250|NCT01147471|75801378|FG001|NOT COMPLETED|Post-discharge Follow Up (Approx 2 Wks)||3||
59682251|NCT01147471|75801377|FG000|STARTED|3 Month Follow Up||13||
59682252|NCT01147471|75801378|FG001|STARTED|3 Month Follow Up||8||
59682253|NCT01147471|75801377|FG000|COMPLETED|3 Month Follow Up||12||
59682254|NCT01147471|75801378|FG001|COMPLETED|3 Month Follow Up||6||
59682255|NCT01147471|75801377|FG000|NOT COMPLETED|3 Month Follow Up||1||
59682256|NCT01147471|75801378|FG001|NOT COMPLETED|3 Month Follow Up||2||
59682257|NCT01147471|75801377|FG000|STARTED|6 Month Follow Up||12||
59682258|NCT01147471|75801378|FG001|STARTED|6 Month Follow Up||6||
59682259|NCT01147471|75801377|FG000|COMPLETED|6 Month Follow Up||8||
59682260|NCT01147471|75801378|FG001|COMPLETED|6 Month Follow Up||4||
59682261|NCT01147471|75801377|FG000|NOT COMPLETED|6 Month Follow Up||4||
59682262|NCT01147471|75801378|FG001|NOT COMPLETED|6 Month Follow Up||2||
59682263|NCT01147393|75801384|FG000|STARTED|Dose Level 1||3||
59682264|NCT01147393|75801384|FG000|COMPLETED|Dose Level 1||1||
59682265|NCT01147393|75801384|FG000|NOT COMPLETED|Dose Level 1||2||
59682266|NCT01147393|75801384|FG000|STARTED|Dose Level -1||1||
59682267|NCT01147393|75801384|FG000|COMPLETED|Dose Level -1||0||
59682268|NCT01147393|75801384|FG000|NOT COMPLETED|Dose Level -1||1||
59682269|NCT01146652|75801391|FG000|STARTED|Overall Study||1912||
59682270|NCT01146652|75801392|FG001|STARTED|Overall Study||111||
59682271|NCT01146652|75801391|FG000|Treated|Overall Study||1910||
59682272|NCT01146652|75801392|FG001|Treated|Overall Study||111||
59682273|NCT01146652|75801391|FG000|Enrolled in the Sub-study|Overall Study||110|Participants who were eligible and entered sub-study from Week 24 of main study.|
59682274|NCT01146652|75801392|FG001|Enrolled in the Sub-study|Overall Study||14|Participants who were eligible and entered sub-study from Week 24 of main study.|
59682275|NCT01146652|75801391|FG000|Discontinued From the Sub-study|Overall Study||1|Sub-study discontinued participants were included in the discontinuation count of the main study.|
59682276|NCT01146652|75801392|FG001|Discontinued From the Sub-study|Overall Study||2|Sub-study discontinued participants were included in the discontinuation count of the main study.|
59682277|NCT01146652|75801391|FG000|Switched Back to Main Study|Overall Study||108|Participants who were willing to switch back to the main study regardless of if they completed the sub-study.|
59682278|NCT01146652|75801392|FG001|Switched Back to Main Study|Overall Study||13|Participants who were willing to switch back to the main study regardless of if they completed the sub-study.|
59682279|NCT01146652|75801391|FG000|COMPLETED|Overall Study||961||
59682280|NCT01146652|75801392|FG001|COMPLETED|Overall Study||66||
59682281|NCT01146652|75801391|FG000|NOT COMPLETED|Overall Study||951||
59682282|NCT01146652|75801392|FG001|NOT COMPLETED|Overall Study||45||
59682283|NCT01146613|75801407|FG000|STARTED|Overall Study||99||
59682284|NCT01146613|75801408|FG001|STARTED|Overall Study||101||
59682285|NCT01146613|75801407|FG000|COMPLETED|Overall Study||92||
59682286|NCT01146613|75801408|FG001|COMPLETED|Overall Study||89||
59682287|NCT01146613|75801407|FG000|NOT COMPLETED|Overall Study||7||
59682288|NCT01146613|75801408|FG001|NOT COMPLETED|Overall Study||12||
59682289|NCT01145755|75801417|FG000|STARTED|Overall Study||40||
59682290|NCT01145755|75801418|FG001|STARTED|Overall Study||47||
59682291|NCT01145755|75801419|FG002|STARTED|Overall Study||44||
59682292|NCT01145755|75801417|FG000|COMPLETED|Overall Study||20||
59682293|NCT01145755|75801418|FG001|COMPLETED|Overall Study||19||
59682294|NCT01145755|75801419|FG002|COMPLETED|Overall Study||19||
59682295|NCT01145755|75801417|FG000|NOT COMPLETED|Overall Study||20||
59682296|NCT01145755|75801418|FG001|NOT COMPLETED|Overall Study||28||
59682297|NCT01145755|75801419|FG002|NOT COMPLETED|Overall Study||25||
59682298|NCT01145560|75801430|FG000|STARTED|Overall Study||100||
59682299|NCT01145560|75801431|FG001|STARTED|Overall Study||100||
59682300|NCT01145560|75801432|FG002|STARTED|Overall Study||100||
59682301|NCT01145560|75801430|FG000|Received Treatment|Overall Study||99||
59682302|NCT01145560|75801431|FG001|Received Treatment|Overall Study||98||
59682303|NCT01145560|75801432|FG002|Received Treatment|Overall Study||99||
59682304|NCT01145560|75801430|FG000|Completed Treatment|Overall Study|9 patients died during the treatment period without completing the full course of treatment.|69||
59682305|NCT01145560|75801431|FG001|Completed Treatment|Overall Study|8 patients died during the treatment period without completing the full course of treatment.|85||
59682306|NCT01145560|75801432|FG002|Completed Treatment|Overall Study|7 patients died during the treatment period without completing the full course of treatment.|78||
59682307|NCT01145560|75801430|FG000|COMPLETED|Overall Study|20 patients died during the study. Death was not a reason for treatment or study discontinuation.|96||
59682308|NCT01145560|75801431|FG001|COMPLETED|Overall Study|33 patients died during the study. Death was not a reason for treatment or study discontinuation.|96||
59682309|NCT01145560|75801432|FG002|COMPLETED|Overall Study|27 patients died during the study. Death was not a reason for treatment or study discontinuation.|98||
59682310|NCT01145560|75801430|FG000|NOT COMPLETED|Overall Study||4||
59682311|NCT01145560|75801431|FG001|NOT COMPLETED|Overall Study||4||
59682312|NCT01145560|75801432|FG002|NOT COMPLETED|Overall Study||2||
59682313|NCT01145482|75801442|FG000|STARTED|First Intervention (1 Day)||6||
59682314|NCT01145482|75801443|FG001|STARTED|First Intervention (1 Day)||6||
59682315|NCT01145482|75801442|FG000|COMPLETED|First Intervention (1 Day)||6||
59682316|NCT01145482|75801443|FG001|COMPLETED|First Intervention (1 Day)||5||
59682317|NCT01145482|75801442|FG000|NOT COMPLETED|First Intervention (1 Day)||0||
59682318|NCT01145482|75801443|FG001|NOT COMPLETED|First Intervention (1 Day)||1||
59682319|NCT01145482|75801442|FG000|STARTED|Second Intervention (1 Day)||5||
59682320|NCT01145482|75801443|FG001|STARTED|Second Intervention (1 Day)||6||
59682321|NCT01145482|75801442|FG000|COMPLETED|Second Intervention (1 Day)||5||
59682322|NCT01145482|75801443|FG001|COMPLETED|Second Intervention (1 Day)||6||
59682323|NCT01145482|75801442|FG000|NOT COMPLETED|Second Intervention (1 Day)||0||
59682324|NCT01145482|75801443|FG001|NOT COMPLETED|Second Intervention (1 Day)||0||
59682325|NCT01145053|75801449|FG000|STARTED|Overall Study||341||
59682326|NCT01145053|75801449|FG000|COMPLETED|Overall Study||248||
59682327|NCT01145053|75801449|FG000|NOT COMPLETED|Overall Study||93||
59682328|NCT01144663|75801457|FG000|STARTED|Primary Vaccination Phase||528||
59682329|NCT01144663|75801458|FG001|STARTED|Primary Vaccination Phase||524||
59682330|NCT01144663|75801459|FG002|STARTED|Primary Vaccination Phase||516||
59682331|NCT01144663|75801460|FG003|STARTED|Primary Vaccination Phase||527||
59682332|NCT01144663|75801457|FG000|COMPLETED|Primary Vaccination Phase||508||
59682333|NCT01144663|75801458|FG001|COMPLETED|Primary Vaccination Phase||517||
59682334|NCT01144663|75801459|FG002|COMPLETED|Primary Vaccination Phase||508||
59682335|NCT01144663|75801460|FG003|COMPLETED|Primary Vaccination Phase||509||
59682336|NCT01144663|75801457|FG000|NOT COMPLETED|Primary Vaccination Phase||20||
59682337|NCT01144663|75801458|FG001|NOT COMPLETED|Primary Vaccination Phase||7||
59682338|NCT01144663|75801459|FG002|NOT COMPLETED|Primary Vaccination Phase||8||
59682339|NCT01144663|75801460|FG003|NOT COMPLETED|Primary Vaccination Phase||18||
59682340|NCT01144663|75801457|FG000|STARTED|Booster Vaccination Phase||497||
59682341|NCT01144663|75801458|FG001|STARTED|Booster Vaccination Phase||511||
59682342|NCT01144663|75801459|FG002|STARTED|Booster Vaccination Phase||503||
59682343|NCT01144663|75801460|FG003|STARTED|Booster Vaccination Phase||506||
59682344|NCT01144663|75801457|FG000|COMPLETED|Booster Vaccination Phase||494||
59682345|NCT01144663|75801458|FG001|COMPLETED|Booster Vaccination Phase||509||
59682346|NCT01144663|75801459|FG002|COMPLETED|Booster Vaccination Phase||498||
59682347|NCT01144663|75801460|FG003|COMPLETED|Booster Vaccination Phase||505||
59682348|NCT01144663|75801457|FG000|NOT COMPLETED|Booster Vaccination Phase||3||
59682349|NCT01144663|75801458|FG001|NOT COMPLETED|Booster Vaccination Phase||2||
59682350|NCT01144663|75801459|FG002|NOT COMPLETED|Booster Vaccination Phase||5||
59682351|NCT01144663|75801460|FG003|NOT COMPLETED|Booster Vaccination Phase||1||
59682352|NCT01144663|75801457|FG000|STARTED|Extended Safety Follow-Up (ESFU)||497||
59682353|NCT01144663|75801458|FG001|STARTED|Extended Safety Follow-Up (ESFU)||511||
59682354|NCT01144663|75801459|FG002|STARTED|Extended Safety Follow-Up (ESFU)||503||
59682355|NCT01144663|75801460|FG003|STARTED|Extended Safety Follow-Up (ESFU)||506||
59682356|NCT01144663|75801457|FG000|COMPLETED|Extended Safety Follow-Up (ESFU)||492||
59682357|NCT01144663|75801458|FG001|COMPLETED|Extended Safety Follow-Up (ESFU)||502||
59682358|NCT01144663|75801459|FG002|COMPLETED|Extended Safety Follow-Up (ESFU)||496||
59816065|NCT03886220|75938407|FG001|STARTED|Post-Treatment Follow-Up Period||41|Entered the post-treatment follow-up period (includes some participants who discontinued study drug during the treatment period).|
59682359|NCT01144663|75801460|FG003|COMPLETED|Extended Safety Follow-Up (ESFU)||505||
59682360|NCT01144663|75801457|FG000|NOT COMPLETED|Extended Safety Follow-Up (ESFU)||5||
59682361|NCT01144663|75801458|FG001|NOT COMPLETED|Extended Safety Follow-Up (ESFU)||9||
59682362|NCT01144663|75801459|FG002|NOT COMPLETED|Extended Safety Follow-Up (ESFU)||7||
59682363|NCT01144663|75801460|FG003|NOT COMPLETED|Extended Safety Follow-Up (ESFU)||1||
59682364|NCT01143337|75801472|FG000|STARTED|Overall Study||49||
59682365|NCT01143337|75801473|FG001|STARTED|Overall Study||50||
59682366|NCT01143337|75801474|FG002|STARTED|Overall Study||13||
59682367|NCT01143337|75801472|FG000|COMPLETED|Overall Study||39||
59682368|NCT01143337|75801473|FG001|COMPLETED|Overall Study||39||
59682369|NCT01143337|75801474|FG002|COMPLETED|Overall Study|Frequency of this arm AE was higher than assumption before study initiation.|1||
59682370|NCT01143337|75801472|FG000|NOT COMPLETED|Overall Study||10||
59682371|NCT01143337|75801473|FG001|NOT COMPLETED|Overall Study||11||
59682372|NCT01143337|75801474|FG002|NOT COMPLETED|Overall Study||12||
59682373|NCT04313023|75801482|FG000|STARTED|Overall Study||108||
59682374|NCT04313023|75801483|FG001|STARTED|Overall Study||109||
59682375|NCT04313023|75801482|FG000|COMPLETED|Overall Study||100||
59682376|NCT04313023|75801483|FG001|COMPLETED|Overall Study||107||
59682377|NCT04313023|75801482|FG000|NOT COMPLETED|Overall Study||8||
59682378|NCT04313023|75801483|FG001|NOT COMPLETED|Overall Study||2||
59682379|NCT01143259|75801491|FG000|STARTED|Overall Study||136||
59682380|NCT01143259|75801492|FG001|STARTED|Overall Study||138||
59682381|NCT01143259|75801491|FG000|COMPLETED|Overall Study||113||
59547111|NCT01116986|75645915|FG006|STARTED|Overall Study||22||
59547112|NCT01116986|75645916|FG007|STARTED|Overall Study||22||
59547113|NCT01116986|75645917|FG008|STARTED|Overall Study||20||
59547114|NCT01116986|75645918|FG009|STARTED|Overall Study||23||
59547115|NCT01116986|75645919|FG010|STARTED|Overall Study||19||
59682382|NCT01143259|75801492|FG001|COMPLETED|Overall Study||118||
59682383|NCT01143259|75801491|FG000|NOT COMPLETED|Overall Study||23||
59682384|NCT01143259|75801492|FG001|NOT COMPLETED|Overall Study||20||
59682385|NCT01142791|75801498|FG000|STARTED|Overall Study||115||
59682386|NCT01142791|75801499|FG001|STARTED|Overall Study|6 participants receiving only 1 sonication were included only in adverse events reporting.|6||
59682387|NCT01142791|75801498|FG000|Safety|Overall Study||115||
59682388|NCT01142791|75801499|FG001|Safety|Overall Study|Safety data only was reported for 6 participants receiving only 1 sonication.|6||
59682389|NCT01142791|75801498|FG000|COMPLETED|Overall Study||108||
59682390|NCT01142791|75801499|FG001|COMPLETED|Overall Study||0||
59682391|NCT01142791|75801498|FG000|NOT COMPLETED|Overall Study||7||
59682392|NCT01142791|75801499|FG001|NOT COMPLETED|Overall Study||6||
59682393|NCT01142596|75801505|FG000|STARTED|Overall Study||44||
59682394|NCT01142596|75801506|FG001|STARTED|Overall Study||157||
59682395|NCT01142596|75801505|FG000|COMPLETED|Overall Study||15||
59682396|NCT01142596|75801506|FG001|COMPLETED|Overall Study||71||
59682397|NCT01142596|75801505|FG000|NOT COMPLETED|Overall Study||29||
59682398|NCT01142596|75801506|FG001|NOT COMPLETED|Overall Study||86||
59682399|NCT01142128|75801516|FG000|STARTED|Overall Study||8||
59989585|NCT02511782|76104892|FG000|COMPLETED|Overall Study||50||
59989586|NCT02511782|76104893|FG001|COMPLETED|Overall Study||2||
59989587|NCT02511782|76104894|FG002|COMPLETED|Overall Study||10||
59989588|NCT02511782|76104892|FG000|NOT COMPLETED|Overall Study||1||
59989589|NCT02511782|76104893|FG001|NOT COMPLETED|Overall Study||0||
59989590|NCT02511782|76104894|FG002|NOT COMPLETED|Overall Study||0||
59989591|NCT02480114|76104904|FG000|STARTED|Overall Study||41||
59989592|NCT02480114|76104905|FG001|STARTED|Overall Study||38||
59989593|NCT02480114|76104904|FG000|COMPLETED|Overall Study||32||
59989594|NCT02480114|76104905|FG001|COMPLETED|Overall Study||30||
59989595|NCT02480114|76104904|FG000|NOT COMPLETED|Overall Study||9||
60079102|NCT00202930|76194402|FG000|COMPLETED|Overall Study||4||
59547116|NCT01116986|75645920|FG011|STARTED|Overall Study||20||
59547117|NCT01116986|75645921|FG012|STARTED|Overall Study||17||
59547118|NCT01116986|75645922|FG013|STARTED|Overall Study||19||
59547119|NCT01116986|75645923|FG014|STARTED|Overall Study||17||
59682400|NCT01142128|75801516|FG000|Nexium Alone|Overall Study||3||
59682401|NCT01142128|75801516|FG000|Placebo to Nexium, Alone|Overall Study||3||
59682402|NCT01142128|75801516|FG000|Viokase 16 Plus Nexium|Overall Study||2||
59682403|NCT01142128|75801516|FG000|Viokase 16 Plus Placebo to Nexium|Overall Study||0||
59682404|NCT01142128|75801516|FG000|COMPLETED|Overall Study||4||
59682405|NCT01142128|75801516|FG000|NOT COMPLETED|Overall Study||4||
59682406|NCT01142089|75801528|FG000|STARTED|Overall Study||65||
59682407|NCT01142089|75801529|FG001|STARTED|Overall Study||199||
59682408|NCT01142089|75801528|FG000|COMPLETED|Overall Study||53||
59682409|NCT01142089|75801529|FG001|COMPLETED|Overall Study||178||
59682410|NCT01142089|75801528|FG000|NOT COMPLETED|Overall Study||12||
59682411|NCT01142089|75801529|FG001|NOT COMPLETED|Overall Study||21||
59682412|NCT01141660|75801537|FG000|STARTED|Overall Study||71||
59682413|NCT01141660|75801538|FG001|STARTED|Overall Study||60||
59989596|NCT02480114|76104905|FG001|NOT COMPLETED|Overall Study||8||
59989597|NCT02479880|76104913|FG000|STARTED|Overall Study||15||
59989598|NCT02479880|76104914|FG001|STARTED|Overall Study||15||
60079103|NCT00202930|76194402|FG000|NOT COMPLETED|Overall Study||0||
59547120|NCT01116986|75645924|FG015|STARTED|Overall Study||21||
59547121|NCT01116986|75645925|FG016|STARTED|Overall Study||16||
59547122|NCT01116986|75645926|FG017|STARTED|Overall Study||24||
59547123|NCT01116986|75645927|FG018|STARTED|Overall Study||23||
59547124|NCT01116986|75645928|FG019|STARTED|Overall Study||15||
59547125|NCT01116986|75645929|FG020|STARTED|Overall Study||24||
59547126|NCT01116986|75645930|FG021|STARTED|Overall Study||20||
59547127|NCT01116986|75645931|FG022|STARTED|Overall Study||23||
59682414|NCT01141660|75801537|FG000|COMPLETED|Overall Study||71||
59682415|NCT01141660|75801538|FG001|COMPLETED|Overall Study||48||
59682416|NCT01141660|75801537|FG000|NOT COMPLETED|Overall Study||0||
59682417|NCT01141660|75801538|FG001|NOT COMPLETED|Overall Study||12||
59682418|NCT01140880|75801546|FG000|STARTED|Overall Study||70||
59682419|NCT01140880|75801547|FG001|STARTED|Overall Study||100||
59682420|NCT01140880|75801546|FG000|COMPLETED|Overall Study||56||
59682421|NCT01140880|75801547|FG001|COMPLETED|Overall Study||56||
59682422|NCT01140880|75801546|FG000|NOT COMPLETED|Overall Study||14||
59682423|NCT01140880|75801547|FG001|NOT COMPLETED|Overall Study||44||
59682424|NCT01140646|75801553|FG000|STARTED|Overall Study||43||
59682425|NCT01140646|75801553|FG000|COMPLETED|Overall Study||34||
59682426|NCT01140646|75801553|FG000|NOT COMPLETED|Overall Study||9||
59682427|NCT01140568|75801557|FG000|STARTED|Overall Study||38|Patients who signed study consent|
59682428|NCT01140568|75801557|FG000|Screen Fail|Overall Study||4||
59682429|NCT01140568|75801557|FG000|Treated With Study Drug|Overall Study||34||
59682430|NCT01140568|75801557|FG000|COMPLETED|Overall Study||2|Patients who were still on study at the time of closure|
59682431|NCT01140568|75801557|FG000|NOT COMPLETED|Overall Study||36||
59682432|NCT01140451|75801563|FG000|STARTED|Overall Study||95|The first week of Study 009e was Total Study Week 48 for Studies 009 and 009e combined.|
59682433|NCT01140451|75801564|FG001|STARTED|Overall Study||96|The first week of Study 009e was Total Study Week 48 for Studies 009 and 009e combined.|
59682434|NCT01140451|75801563|FG000|Completed 24 Weeks|Overall Study||89|Week 24 of Study 009e was Total Study Week 72|
59682435|NCT01140451|75801564|FG001|Completed 24 Weeks|Overall Study||86|Week 24 of Study 009e was Total Study Week 72|
59682436|NCT01140451|75801563|FG000|Completed 48 Weeks|Overall Study||78|Week 48 of Study 009e was Total Study Week 96|
59682437|NCT01140451|75801564|FG001|Completed 48 Weeks|Overall Study||70|Week 48 of Study 009e was Total Study Week 96|
59682438|NCT01140451|75801563|FG000|Completed 72 Weeks|Overall Study||63|Week 72 of Study 009e was Total Study Week 120|
59682439|NCT01140451|75801564|FG001|Completed 72 Weeks|Overall Study||62|Week 72 of Study 009e was Total Study Week 120|
59682440|NCT01140451|75801563|FG000|Completed 96 Weeks|Overall Study||57|Week 96 of Study 009e was Total Study Week 144|
59682441|NCT01140451|75801564|FG001|Completed 96 Weeks|Overall Study||54|Week 96 of Study 009e was Total Study Week 144|
59682442|NCT01140451|75801563|FG000|As-Treated Population|Overall Study||95|Received at least 1 dose of study drug in Study 009e|
59682443|NCT01140451|75801564|FG001|As-Treated Population|Overall Study||96|Received at least 1 dose of study drug in Study 009e|
59682444|NCT01140451|75801563|FG000|96-Week Completer Population|Overall Study||78|Completed 48 weeks of treatment in both Study 009 and Study 009e|
59682445|NCT01140451|75801564|FG001|96-Week Completer Population|Overall Study||70|Completed 48 weeks of treatment in both Study 009 and Study 009e|
59682446|NCT01140451|75801563|FG000|144-Week Completer Population|Overall Study||57|Completed 48 weeks of treatment in Study 009 and 96 weeks in Study 009e|
59682447|NCT01140451|75801564|FG001|144-Week Completer Population|Overall Study||54|Completed 48 weeks of treatment in Study 009 and 96 weeks in Study 009e|
59682448|NCT01140451|75801563|FG000|COMPLETED|Overall Study||57|Study completion for Study 009e was Week 100 (Total Study Week 148)|
59682449|NCT01140451|75801564|FG001|COMPLETED|Overall Study||54|Study completion for Study 009e was Week 100 (Total Study Week 148)|
59682450|NCT01140451|75801563|FG000|NOT COMPLETED|Overall Study||38||
59682451|NCT01140451|75801564|FG001|NOT COMPLETED|Overall Study||42||
59682452|NCT01140061|75801581|FG000|STARTED|Part I|Includes 1 replacement participant|7||
59682453|NCT01140061|75801582|FG001|STARTED|Part I||2||
59682454|NCT01140061|75801583|FG002|STARTED|Part I||0||
59682455|NCT01140061|75801584|FG003|STARTED|Part I||0||
59682456|NCT01140061|75801585|FG004|STARTED|Part I||0||
59682457|NCT01140061|75801586|FG005|STARTED|Part I||0||
59682458|NCT01140061|75801587|FG006|STARTED|Part I||0||
59682459|NCT01140061|75801588|FG007|STARTED|Part I||0||
59682460|NCT01140061|75801589|FG008|STARTED|Part I||0||
59682461|NCT01140061|75801590|FG009|STARTED|Part I||0||
59682462|NCT01140061|75801581|FG000|COMPLETED|Part I||6||
59816066|NCT03886220|75938406|FG000|COMPLETED|Post-Treatment Follow-Up Period||23||
59989599|NCT02479880|76104913|FG000|COMPLETED|Overall Study||2||
59989600|NCT02479880|76104914|FG001|COMPLETED|Overall Study||2||
59682463|NCT01140061|75801582|FG001|COMPLETED|Part I||2||
59682464|NCT01140061|75801583|FG002|COMPLETED|Part I||0||
59682465|NCT01140061|75801584|FG003|COMPLETED|Part I||0||
59682466|NCT01140061|75801585|FG004|COMPLETED|Part I||0||
59682467|NCT01140061|75801586|FG005|COMPLETED|Part I||0||
59682468|NCT01140061|75801587|FG006|COMPLETED|Part I||0||
59682469|NCT01140061|75801588|FG007|COMPLETED|Part I||0||
59682470|NCT01140061|75801589|FG008|COMPLETED|Part I||0||
59682471|NCT01140061|75801590|FG009|COMPLETED|Part I||0||
59682472|NCT01140061|75801581|FG000|NOT COMPLETED|Part I||1||
59682473|NCT01140061|75801582|FG001|NOT COMPLETED|Part I||0||
59682474|NCT01140061|75801583|FG002|NOT COMPLETED|Part I||0||
59682475|NCT01140061|75801584|FG003|NOT COMPLETED|Part I||0||
59682476|NCT01140061|75801585|FG004|NOT COMPLETED|Part I||0||
59682477|NCT01140061|75801586|FG005|NOT COMPLETED|Part I||0||
59682478|NCT01140061|75801587|FG006|NOT COMPLETED|Part I||0||
59682479|NCT01140061|75801588|FG007|NOT COMPLETED|Part I||0||
59682480|NCT01140061|75801589|FG008|NOT COMPLETED|Part I||0||
59682481|NCT01140061|75801590|FG009|NOT COMPLETED|Part I||0||
59989601|NCT02479880|76104913|FG000|NOT COMPLETED|Overall Study||13||
59989602|NCT02479880|76104914|FG001|NOT COMPLETED|Overall Study||13||
59989603|NCT02479802|76104920|FG000|STARTED|Overall Study||13||
59682482|NCT01140061|75801581|FG000|STARTED|Part II||0||
59682483|NCT01140061|75801582|FG001|STARTED|Part II||0||
59682484|NCT01140061|75801583|FG002|STARTED|Part II||6||
59682485|NCT01140061|75801584|FG003|STARTED|Part II||2||
59682486|NCT01140061|75801585|FG004|STARTED|Part II||6||
59682487|NCT01140061|75801586|FG005|STARTED|Part II||2||
59682488|NCT01140061|75801587|FG006|STARTED|Part II||6||
59682489|NCT01140061|75801588|FG007|STARTED|Part II||2||
59682490|NCT01140061|75801589|FG008|STARTED|Part II||0||
59682491|NCT01140061|75801590|FG009|STARTED|Part II||0||
59682492|NCT01140061|75801581|FG000|COMPLETED|Part II||0||
59682493|NCT01140061|75801582|FG001|COMPLETED|Part II||0||
59682494|NCT01140061|75801583|FG002|COMPLETED|Part II||6||
59682495|NCT01140061|75801584|FG003|COMPLETED|Part II||2||
59682496|NCT01140061|75801585|FG004|COMPLETED|Part II||6||
59682497|NCT01140061|75801586|FG005|COMPLETED|Part II||2||
59682498|NCT01140061|75801587|FG006|COMPLETED|Part II||6||
59682499|NCT01140061|75801588|FG007|COMPLETED|Part II||2||
59682500|NCT01140061|75801589|FG008|COMPLETED|Part II||0||
59682501|NCT01140061|75801590|FG009|COMPLETED|Part II||0||
59682502|NCT01140061|75801581|FG000|NOT COMPLETED|Part II||0||
59682503|NCT01140061|75801582|FG001|NOT COMPLETED|Part II||0||
59682504|NCT01140061|75801583|FG002|NOT COMPLETED|Part II||0||
59682505|NCT01140061|75801584|FG003|NOT COMPLETED|Part II||0||
59682506|NCT01140061|75801585|FG004|NOT COMPLETED|Part II||0||
59682507|NCT01140061|75801586|FG005|NOT COMPLETED|Part II||0||
59682508|NCT01140061|75801587|FG006|NOT COMPLETED|Part II||0||
59682509|NCT01140061|75801588|FG007|NOT COMPLETED|Part II||0||
59682510|NCT01140061|75801589|FG008|NOT COMPLETED|Part II||0||
59682511|NCT01140061|75801590|FG009|NOT COMPLETED|Part II||0||
59682512|NCT01140061|75801581|FG000|STARTED|Part III||0||
59682513|NCT01140061|75801582|FG001|STARTED|Part III||0||
59682514|NCT01140061|75801583|FG002|STARTED|Part III||0||
59682515|NCT01140061|75801584|FG003|STARTED|Part III||0||
59682516|NCT01140061|75801585|FG004|STARTED|Part III||0||
59682517|NCT01140061|75801586|FG005|STARTED|Part III||0||
59682518|NCT01140061|75801587|FG006|STARTED|Part III||0||
59682519|NCT01140061|75801588|FG007|STARTED|Part III||0||
59682520|NCT01140061|75801589|FG008|STARTED|Part III||7||
59682521|NCT01140061|75801590|FG009|STARTED|Part III|Includes 1 replacement participant|2||
59682522|NCT01140061|75801581|FG000|COMPLETED|Part III||0||
59682523|NCT01140061|75801582|FG001|COMPLETED|Part III||0||
59682524|NCT01140061|75801583|FG002|COMPLETED|Part III||0||
59682525|NCT01140061|75801584|FG003|COMPLETED|Part III||0||
59682526|NCT01140061|75801585|FG004|COMPLETED|Part III||0||
59682527|NCT01140061|75801586|FG005|COMPLETED|Part III||0||
59682528|NCT01140061|75801587|FG006|COMPLETED|Part III||0||
59682529|NCT01140061|75801588|FG007|COMPLETED|Part III||0||
59682530|NCT01140061|75801589|FG008|COMPLETED|Part III||7||
59682531|NCT01140061|75801590|FG009|COMPLETED|Part III||2||
59682532|NCT01140061|75801581|FG000|NOT COMPLETED|Part III||0||
59682533|NCT01140061|75801582|FG001|NOT COMPLETED|Part III||0||
59682534|NCT01140061|75801583|FG002|NOT COMPLETED|Part III||0||
59682535|NCT01140061|75801584|FG003|NOT COMPLETED|Part III||0||
59682536|NCT01140061|75801585|FG004|NOT COMPLETED|Part III||0||
59682537|NCT01140061|75801586|FG005|NOT COMPLETED|Part III||0||
59682538|NCT01140061|75801587|FG006|NOT COMPLETED|Part III||0||
59682539|NCT01140061|75801588|FG007|NOT COMPLETED|Part III||0||
59682540|NCT01140061|75801589|FG008|NOT COMPLETED|Part III||0||
59682541|NCT01140061|75801590|FG009|NOT COMPLETED|Part III||0||
59682542|NCT01140061|75801581|FG000|STARTED|Extension||0||
59682543|NCT01140061|75801582|FG001|STARTED|Extension||0||
59682544|NCT01140061|75801583|FG002|STARTED|Extension||0||
59682545|NCT01140061|75801584|FG003|STARTED|Extension||0||
59682546|NCT01140061|75801585|FG004|STARTED|Extension||0||
59682547|NCT01140061|75801586|FG005|STARTED|Extension||0||
59682548|NCT01140061|75801587|FG006|STARTED|Extension||0||
60079104|NCT00044044|76194411|FG000|STARTED|Overall Study||71||
59682549|NCT01140061|75801588|FG007|STARTED|Extension||0||
59682550|NCT01140061|75801589|FG008|STARTED|Extension||7||
60079105|NCT00044044|76194412|FG001|STARTED|Overall Study||69||
60079106|NCT00044044|76194413|FG002|STARTED|Overall Study||71||
59682551|NCT01140061|75801590|FG009|STARTED|Extension||2||
59682552|NCT01140061|75801581|FG000|COMPLETED|Extension||0||
59682553|NCT01140061|75801582|FG001|COMPLETED|Extension||0||
59682554|NCT01140061|75801583|FG002|COMPLETED|Extension||0||
59682555|NCT01140061|75801584|FG003|COMPLETED|Extension||0||
59682556|NCT01140061|75801585|FG004|COMPLETED|Extension||0||
59682557|NCT01140061|75801586|FG005|COMPLETED|Extension||0||
59682558|NCT01140061|75801587|FG006|COMPLETED|Extension||0||
59682559|NCT01140061|75801588|FG007|COMPLETED|Extension||0||
59682560|NCT01140061|75801589|FG008|COMPLETED|Extension||7||
59682561|NCT01140061|75801590|FG009|COMPLETED|Extension||1||
59682562|NCT01140061|75801581|FG000|NOT COMPLETED|Extension||0||
59682563|NCT01140061|75801582|FG001|NOT COMPLETED|Extension||0||
59682564|NCT01140061|75801583|FG002|NOT COMPLETED|Extension||0||
59682565|NCT01140061|75801584|FG003|NOT COMPLETED|Extension||0||
59682566|NCT01140061|75801585|FG004|NOT COMPLETED|Extension||0||
60079107|NCT00044044|76194414|FG003|STARTED|Overall Study||73||
60079108|NCT00044044|76194415|FG004|STARTED|Overall Study||72||
60079109|NCT00044044|76194411|FG000|COMPLETED|Overall Study||27||
59682567|NCT01140061|75801586|FG005|NOT COMPLETED|Extension||0||
59682568|NCT01140061|75801587|FG006|NOT COMPLETED|Extension||0||
59682569|NCT01140061|75801588|FG007|NOT COMPLETED|Extension||0||
59682570|NCT01140061|75801589|FG008|NOT COMPLETED|Extension||0||
59682571|NCT01140061|75801590|FG009|NOT COMPLETED|Extension||1||
59682572|NCT01139164|75801608|FG000|STARTED|Overall Study||4||
59682573|NCT01139164|75801609|FG001|STARTED|Overall Study||67||
59682574|NCT01139164|75801610|FG002|STARTED|Overall Study||7||
59682575|NCT01139164|75801608|FG000|COMPLETED|Overall Study||4||
59682576|NCT01139164|75801609|FG001|COMPLETED|Overall Study||65||
59682577|NCT01139164|75801610|FG002|COMPLETED|Overall Study||7||
59682578|NCT01139164|75801608|FG000|NOT COMPLETED|Overall Study||0||
59682579|NCT01139164|75801609|FG001|NOT COMPLETED|Overall Study||2||
59682580|NCT01139164|75801610|FG002|NOT COMPLETED|Overall Study||0||
59682581|NCT01139125|75801618|FG000|STARTED|Overall Study||3||
59682582|NCT01139125|75801618|FG000|COMPLETED|Overall Study||2||
59682583|NCT01139125|75801618|FG000|NOT COMPLETED|Overall Study||1||
59682584|NCT01139047|75801622|FG000|STARTED|Overall Study||77||
59682585|NCT01139047|75801622|FG000|COMPLETED|Overall Study||76||
59682586|NCT01139047|75801622|FG000|NOT COMPLETED|Overall Study||1||
59682587|NCT01139008|75801629|FG000|STARTED|Overall Study||80||
59682588|NCT01139008|75801629|FG000|COMPLETED|Overall Study||74||
59682589|NCT01139008|75801629|FG000|NOT COMPLETED|Overall Study||6||
59682590|NCT01138657|75801638|FG000|STARTED|Overall Study||120||
59682591|NCT01138657|75801639|FG001|STARTED|Overall Study||119||
59682592|NCT01138657|75801638|FG000|Enrolled in Main Study|Overall Study||112||
59682593|NCT01138657|75801639|FG001|Enrolled in Main Study|Overall Study||111||
59682594|NCT01138657|75801638|FG000|Enrolled in Japan Sub-study|Overall Study||8||
59682595|NCT01138657|75801639|FG001|Enrolled in Japan Sub-study|Overall Study||8||
59682596|NCT01138657|75801638|FG000|COMPLETED|Overall Study||112||
59682597|NCT01138657|75801639|FG001|COMPLETED|Overall Study||101||
59682598|NCT01138657|75801638|FG000|NOT COMPLETED|Overall Study||8||
59682599|NCT01138657|75801639|FG001|NOT COMPLETED|Overall Study||18||
59682600|NCT01138501|75801647|FG000|STARTED|Overall Study|Two subjects withdrew consent after being enrolled but before receiving any trial product.|65||
59682601|NCT01138501|75801647|FG000|Exposed|Overall Study||63||
59682602|NCT01138501|75801647|FG000|COMPLETED|Overall Study||60||
59989604|NCT02479802|76104920|FG000|COMPLETED|Overall Study||11||
59989605|NCT02479802|76104920|FG000|NOT COMPLETED|Overall Study||2||
59989606|NCT02479412|76104933|FG000|STARTED|Overall Study||6||
59989607|NCT02479412|76104934|FG001|STARTED|Overall Study||6||
59989608|NCT02479412|76104935|FG002|STARTED|Overall Study||6||
59989609|NCT02479412|76104936|FG003|STARTED|Overall Study||7||
59989610|NCT02479412|76104937|FG004|STARTED|Overall Study||6||
59547128|NCT01116986|75645932|FG023|STARTED|Overall Study||21||
59547129|NCT01116986|75645933|FG024|STARTED|Overall Study||18||
59547130|NCT01116986|75645934|FG025|STARTED|Overall Study||19||
59547131|NCT01116986|75645935|FG026|STARTED|Overall Study||18||
59547132|NCT01116986|75645936|FG027|STARTED|Overall Study||19||
59547133|NCT01116986|75645937|FG028|STARTED|Overall Study||17||
59547134|NCT01116986|75645938|FG029|STARTED|Overall Study||17||
59547135|NCT01116986|75645939|FG030|STARTED|Overall Study||17||
59547136|NCT01116986|75645940|FG031|STARTED|Overall Study||17||
59547137|NCT01116986|75645909|FG000|COMPLETED|Overall Study||22||
59547138|NCT01116986|75645910|FG001|COMPLETED|Overall Study||16||
59547139|NCT01116986|75645911|FG002|COMPLETED|Overall Study||16||
59547140|NCT01116986|75645912|FG003|COMPLETED|Overall Study||20||
59547141|NCT01116986|75645913|FG004|COMPLETED|Overall Study||20||
59547142|NCT01116986|75645914|FG005|COMPLETED|Overall Study||20||
59547143|NCT01116986|75645915|FG006|COMPLETED|Overall Study||20||
59547144|NCT01116986|75645916|FG007|COMPLETED|Overall Study||20||
59547145|NCT01116986|75645917|FG008|COMPLETED|Overall Study||19||
59547146|NCT01116986|75645918|FG009|COMPLETED|Overall Study||19||
59989611|NCT02479412|76104938|FG005|STARTED|Overall Study||5||
59547147|NCT01116986|75645919|FG010|COMPLETED|Overall Study||18||
59547148|NCT01116986|75645920|FG011|COMPLETED|Overall Study||20||
59547149|NCT01116986|75645921|FG012|COMPLETED|Overall Study||16||
59547150|NCT01116986|75645922|FG013|COMPLETED|Overall Study||16||
59547151|NCT01116986|75645923|FG014|COMPLETED|Overall Study||17||
59547152|NCT01116986|75645924|FG015|COMPLETED|Overall Study||15||
59547153|NCT01116986|75645925|FG016|COMPLETED|Overall Study||13||
59547154|NCT01116986|75645926|FG017|COMPLETED|Overall Study||19||
59547155|NCT01116986|75645927|FG018|COMPLETED|Overall Study||20||
59682603|NCT01138501|75801647|FG000|NOT COMPLETED|Overall Study||5||
59682604|NCT01138150|75801653|FG000|STARTED|Overall Study||18||
59682605|NCT01138150|75801654|FG001|STARTED|Overall Study||18||
59989612|NCT02479412|76104939|FG006|STARTED|Overall Study||6||
59682606|NCT01138150|75801653|FG000|COMPLETED|Overall Study||17||
59682607|NCT01138150|75801654|FG001|COMPLETED|Overall Study||17||
59682608|NCT01138150|75801653|FG000|NOT COMPLETED|Overall Study||1||
59682609|NCT01138150|75801654|FG001|NOT COMPLETED|Overall Study||1||
59682610|NCT01138111|75801670|FG000|STARTED|Overall Study||45||
59682611|NCT01138111|75801670|FG000|COMPLETED|Overall Study||36||
59682612|NCT01138111|75801670|FG000|NOT COMPLETED|Overall Study||9||
59682613|NCT01137955|75801701|FG000|STARTED|Overall Study||25||
59682614|NCT01137955|75801702|FG001|STARTED|Overall Study||25||
59682615|NCT01137955|75801701|FG000|COMPLETED|Overall Study||20||
59682616|NCT01137955|75801702|FG001|COMPLETED|Overall Study||21||
59682617|NCT01137955|75801701|FG000|NOT COMPLETED|Overall Study||5||
59682618|NCT01137955|75801702|FG001|NOT COMPLETED|Overall Study||4||
59682619|NCT01137682|75801712|FG000|STARTED|Overall Study||65||
59682620|NCT01137682|75801713|FG001|STARTED|Overall Study||65||
59682621|NCT01137682|75801714|FG002|STARTED|Overall Study||68||
59682622|NCT01137682|75801712|FG000|Not Treated|Overall Study||2||
59682623|NCT01137682|75801713|FG001|Not Treated|Overall Study||2||
59682624|NCT01137682|75801714|FG002|Not Treated|Overall Study||1||
59682625|NCT01137682|75801712|FG000|Treated|Overall Study||63||
59682626|NCT01137682|75801713|FG001|Treated|Overall Study||63||
59682627|NCT01137682|75801714|FG002|Treated|Overall Study||67||
59682628|NCT01137682|75801712|FG000|Completed 24-Week Core Phase|Overall Study||59||
59682629|NCT01137682|75801713|FG001|Completed 24-Week Core Phase|Overall Study||57||
59682630|NCT01137682|75801714|FG002|Completed 24-Week Core Phase|Overall Study||65||
59682631|NCT01137682|75801712|FG000|Not Continuing Into Extension|Overall Study||2||
59682632|NCT01137682|75801713|FG001|Not Continuing Into Extension|Overall Study||3||
59682633|NCT01137682|75801714|FG002|Not Continuing Into Extension|Overall Study||2||
59682634|NCT01137682|75801712|FG000|Continuing Into Extension|Overall Study||57||
59682635|NCT01137682|75801713|FG001|Continuing Into Extension|Overall Study||54||
59682636|NCT01137682|75801714|FG002|Continuing Into Extension|Overall Study||63||
59682637|NCT01137682|75801712|FG000|Safety Set - CORE|Overall Study|2 patients never received drug.|63||
59682638|NCT01137682|75801713|FG001|Safety Set - CORE|Overall Study|2 patients never received drug. 1 patient had no post baseline safety assement.|62||
59682639|NCT01137682|75801714|FG002|Safety Set - CORE|Overall Study|2 patients never received drug.|66||
59682640|NCT01137682|75801712|FG000|Safety Set - Extension|Overall Study||57||
59682641|NCT01137682|75801713|FG001|Safety Set - Extension|Overall Study||54||
59682642|NCT01137682|75801714|FG002|Safety Set - Extension|Overall Study|1 patient did not receive study treatment|62||
59682643|NCT01137682|75801712|FG000|COMPLETED|Overall Study||28||
59682644|NCT01137682|75801713|FG001|COMPLETED|Overall Study||25||
59682645|NCT01137682|75801714|FG002|COMPLETED|Overall Study||34||
59682646|NCT01137682|75801712|FG000|NOT COMPLETED|Overall Study||37||
59682647|NCT01137682|75801713|FG001|NOT COMPLETED|Overall Study||40||
59682648|NCT01137682|75801714|FG002|NOT COMPLETED|Overall Study||34||
59682649|NCT03452397|75801730|FG000|STARTED|Overall Study||41||
59682650|NCT03452397|75801731|FG001|STARTED|Overall Study||41||
59682651|NCT03452397|75801732|FG002|STARTED|Overall Study||41||
59682652|NCT03452397|75801733|FG003|STARTED|Overall Study||42||
59682653|NCT03452397|75801730|FG000|COMPLETED|Overall Study||40||
59682654|NCT03452397|75801731|FG001|COMPLETED|Overall Study||41||
59682655|NCT03452397|75801732|FG002|COMPLETED|Overall Study||39||
59682656|NCT03452397|75801733|FG003|COMPLETED|Overall Study||41||
59682657|NCT03452397|75801730|FG000|NOT COMPLETED|Overall Study||1||
59682658|NCT03452397|75801731|FG001|NOT COMPLETED|Overall Study||0||
59682659|NCT03452397|75801732|FG002|NOT COMPLETED|Overall Study||2||
59682660|NCT03452397|75801733|FG003|NOT COMPLETED|Overall Study||1||
59682661|NCT03453684|75801745|FG000|STARTED|Overall Study||60||
59682662|NCT03453684|75801745|FG000|COMPLETED|Overall Study||60||
59682663|NCT03453684|75801745|FG000|NOT COMPLETED|Overall Study||0||
59682664|NCT03458130|75801752|FG000|STARTED|Overall Study||16||
59682665|NCT03458130|75801753|FG001|STARTED|Overall Study||16||
59682666|NCT03458130|75801754|FG002|STARTED|Overall Study||17||
59682667|NCT03458130|75801752|FG000|Screening|Overall Study||16||
59682668|NCT03458130|75801753|FG001|Screening|Overall Study||16||
59682669|NCT03458130|75801754|FG002|Screening|Overall Study||17||
59682670|NCT03458130|75801752|FG000|Double Blind Treatment|Overall Study||16||
59682671|NCT03458130|75801753|FG001|Double Blind Treatment|Overall Study||16||
59682672|NCT03458130|75801754|FG002|Double Blind Treatment|Overall Study||17||
59682673|NCT03458130|75801752|FG000|Follow-Up|Overall Study||16||
59682674|NCT03458130|75801753|FG001|Follow-Up|Overall Study||16||
59682675|NCT03458130|75801754|FG002|Follow-Up|Overall Study||17||
59682676|NCT03458130|75801752|FG000|COMPLETED|Overall Study||16||
59682677|NCT03458130|75801753|FG001|COMPLETED|Overall Study||16||
59682678|NCT03458130|75801754|FG002|COMPLETED|Overall Study||17||
59682679|NCT03458130|75801752|FG000|NOT COMPLETED|Overall Study||0||
59682680|NCT03458130|75801753|FG001|NOT COMPLETED|Overall Study||0||
59682681|NCT03458130|75801754|FG002|NOT COMPLETED|Overall Study||0||
59682682|NCT00199875|75801767|FG000|STARTED|Overall Study||3||
59682683|NCT00199875|75801768|FG001|STARTED|Overall Study||3||
59682684|NCT00199875|75801769|FG002|STARTED|Overall Study||6||
59682685|NCT00199875|75801770|FG003|STARTED|Overall Study||3||
59682686|NCT00199875|75801771|FG004|STARTED|Overall Study||3||
59682687|NCT00199875|75801767|FG000|COMPLETED|Overall Study||3||
59682688|NCT00199875|75801768|FG001|COMPLETED|Overall Study||3||
59682689|NCT00199875|75801769|FG002|COMPLETED|Overall Study||6||
59682690|NCT00199875|75801770|FG003|COMPLETED|Overall Study||3||
59682691|NCT00199875|75801771|FG004|COMPLETED|Overall Study||2||
59682692|NCT00199875|75801767|FG000|NOT COMPLETED|Overall Study||0||
59682693|NCT00199875|75801768|FG001|NOT COMPLETED|Overall Study||0||
59682694|NCT00199875|75801769|FG002|NOT COMPLETED|Overall Study||0||
59682695|NCT00199875|75801770|FG003|NOT COMPLETED|Overall Study||0||
59682696|NCT00199875|75801771|FG004|NOT COMPLETED|Overall Study||1||
59682697|NCT00199836|75801783|FG000|STARTED|Overall Study||14||
59682698|NCT00199836|75801783|FG000|COMPLETED|Overall Study||8||
59682699|NCT00199836|75801783|FG000|NOT COMPLETED|Overall Study||6||
59682700|NCT00199797|75801788|FG000|STARTED|Overall Study||20||
59682701|NCT00199797|75801788|FG000|COMPLETED|Overall Study||17||
59682702|NCT00199797|75801788|FG000|NOT COMPLETED|Overall Study||3||
59682703|NCT01137604|75801797|FG000|STARTED|Overall Study|39 participants were randomized but 1 participant died prior to receiving treatment.|38||
59682704|NCT01137604|75801798|FG001|STARTED|Overall Study||42||
59682705|NCT01137604|75801799|FG002|STARTED|Overall Study||39||
59682706|NCT01137604|75801800|FG003|STARTED|Overall Study||32||
59682707|NCT01137604|75801797|FG000|Treatment Discontinued Due to Disease Progression|Overall Study||34||
59682708|NCT01137604|75801798|FG001|Treatment Discontinued Due to Disease Progression|Overall Study||32||
59682709|NCT01137604|75801799|FG002|Treatment Discontinued Due to Disease Progression|Overall Study||26||
59682710|NCT01137604|75801800|FG003|Treatment Discontinued Due to Disease Progression|Overall Study||21||
59682711|NCT01137604|75801797|FG000|COMPLETED|Overall Study||34||
59682712|NCT01137604|75801798|FG001|COMPLETED|Overall Study||32||
59682713|NCT01137604|75801799|FG002|COMPLETED|Overall Study||26||
59682714|NCT01137604|75801800|FG003|COMPLETED|Overall Study||21||
59682715|NCT01137604|75801797|FG000|NOT COMPLETED|Overall Study||4||
59682716|NCT01137604|75801798|FG001|NOT COMPLETED|Overall Study||10||
59682717|NCT01137604|75801799|FG002|NOT COMPLETED|Overall Study||13||
59682718|NCT01137604|75801800|FG003|NOT COMPLETED|Overall Study||11||
59682719|NCT00198822|75801813|FG000|STARTED|Overall Study|No. of consenting pregnant women in the placebo arm of trial cohort|19876||
59682720|NCT00198822|75801814|FG001|STARTED|Overall Study|No. of consenting pregnant women in the vitamin A arm of trial cohort|19826||
59682721|NCT00198822|75801815|FG002|STARTED|Overall Study|No. of consenting pregnant women in the beta-catorene arm of trial cohort|20019||
59682722|NCT00198822|75801813|FG000|COMPLETED|Overall Study|No. of consented pregnant women in placebo arm with vital status known at 12 weeks postpartum|19862||
59682723|NCT00198822|75801814|FG001|COMPLETED|Overall Study|No. of consented pregnant women in vitamin A arm with vital status known at 12 weeks postpartum|19806||
59682724|NCT00198822|75801815|FG002|COMPLETED|Overall Study|No. of consented pregnant women in beta-catorene arm with vital status known at 12 weeks postpartum|19998||
59682725|NCT00198822|75801813|FG000|NOT COMPLETED|Overall Study||14||
59682726|NCT00198822|75801814|FG001|NOT COMPLETED|Overall Study||20||
59682727|NCT00198822|75801815|FG002|NOT COMPLETED|Overall Study||21||
59682728|NCT01137292|75801823|FG000|STARTED|Overall Study||177||
59682729|NCT01137292|75801823|FG000|COMPLETED|Overall Study||123||
59682730|NCT01137292|75801823|FG000|NOT COMPLETED|Overall Study||54||
59682731|NCT00197496|75801829|FG000|STARTED|Baseline to Discharge||14||
59682732|NCT00197496|75801830|FG001|STARTED|Baseline to Discharge||7||
59682733|NCT00197496|75801829|FG000|COMPLETED|Baseline to Discharge||12||
59682734|NCT00197496|75801830|FG001|COMPLETED|Baseline to Discharge||5||
59682735|NCT00197496|75801829|FG000|NOT COMPLETED|Baseline to Discharge||2||
59682736|NCT00197496|75801830|FG001|NOT COMPLETED|Baseline to Discharge||2||
59682737|NCT00197496|75801829|FG000|STARTED|Follow-up||12||
59682738|NCT00197496|75801830|FG001|STARTED|Follow-up||5||
59682739|NCT00197496|75801829|FG000|COMPLETED|Follow-up||10||
59682740|NCT00197496|75801830|FG001|COMPLETED|Follow-up||4||
59682741|NCT00197496|75801829|FG000|NOT COMPLETED|Follow-up||2||
59682742|NCT00197496|75801830|FG001|NOT COMPLETED|Follow-up||1||
59682743|NCT00197145|75801838|FG000|STARTED|Period 1: Randomized Treatment Phase||13||
59682744|NCT00197145|75801839|FG001|STARTED|Period 1: Randomized Treatment Phase||11||
59682745|NCT00197145|75801838|FG000|COMPLETED|Period 1: Randomized Treatment Phase||0||
59682746|NCT00197145|75801839|FG001|COMPLETED|Period 1: Randomized Treatment Phase||0||
59682747|NCT00197145|75801838|FG000|NOT COMPLETED|Period 1: Randomized Treatment Phase||13||
59682748|NCT00197145|75801839|FG001|NOT COMPLETED|Period 1: Randomized Treatment Phase||11||
59682749|NCT00197145|75801838|FG000|STARTED|Period 2 : Open Label Phase||10||
59682750|NCT00197145|75801839|FG001|STARTED|Period 2 : Open Label Phase||0||
59682751|NCT00197145|75801838|FG000|COMPLETED|Period 2 : Open Label Phase||0||
59682752|NCT00197145|75801839|FG001|COMPLETED|Period 2 : Open Label Phase||0||
59682753|NCT00197145|75801838|FG000|NOT COMPLETED|Period 2 : Open Label Phase||10||
59682754|NCT00197145|75801839|FG001|NOT COMPLETED|Period 2 : Open Label Phase||0||
59682755|NCT01136785|75801848|FG000|STARTED|Overall Study||15||
59682756|NCT01136785|75801849|FG001|STARTED|Overall Study||7||
59682757|NCT01136785|75801848|FG000|COMPLETED|Overall Study||13||
59682758|NCT01136785|75801849|FG001|COMPLETED|Overall Study||6||
59682759|NCT01136785|75801848|FG000|NOT COMPLETED|Overall Study||2||
59682760|NCT01136785|75801849|FG001|NOT COMPLETED|Overall Study||1||
59682761|NCT00197106|75801861|FG000|STARTED|4-Week Run-In Period||257||
59682762|NCT00197106|75801862|FG001|STARTED|4-Week Run-In Period||0||
59682763|NCT00197106|75801863|FG002|STARTED|4-Week Run-In Period||0||
59682764|NCT00197106|75801861|FG000|COMPLETED|4-Week Run-In Period||158||
59682765|NCT00197106|75801862|FG001|COMPLETED|4-Week Run-In Period||0||
59682766|NCT00197106|75801863|FG002|COMPLETED|4-Week Run-In Period||0||
59682767|NCT00197106|75801861|FG000|NOT COMPLETED|4-Week Run-In Period||99||
59682768|NCT00197106|75801862|FG001|NOT COMPLETED|4-Week Run-In Period||0||
59682769|NCT00197106|75801863|FG002|NOT COMPLETED|4-Week Run-In Period||0||
59682770|NCT00197106|75801861|FG000|STARTED|Overall Treatment Period||0||
59682771|NCT00197106|75801862|FG001|STARTED|Overall Treatment Period||78||
59682772|NCT00197106|75801863|FG002|STARTED|Overall Treatment Period||80||
59682773|NCT00197106|75801861|FG000|COMPLETED|Overall Treatment Period||0||
59682774|NCT00197106|75801862|FG001|COMPLETED|Overall Treatment Period||77||
59682775|NCT00197106|75801863|FG002|COMPLETED|Overall Treatment Period||74||
59682776|NCT00197106|75801861|FG000|NOT COMPLETED|Overall Treatment Period||0||
59682777|NCT00197106|75801862|FG001|NOT COMPLETED|Overall Treatment Period||1||
59682778|NCT00197106|75801863|FG002|NOT COMPLETED|Overall Treatment Period||6||
59682779|NCT01136746|75801871|FG000|STARTED|Overall Study||9||
59682780|NCT01136746|75801872|FG001|STARTED|Overall Study||7||
59682781|NCT01136746|75801871|FG000|COMPLETED|Overall Study||6||
59682782|NCT01136746|75801872|FG001|COMPLETED|Overall Study||4||
59682783|NCT01136746|75801871|FG000|NOT COMPLETED|Overall Study||3||
59682784|NCT01136746|75801872|FG001|NOT COMPLETED|Overall Study||3||
59682785|NCT01136356|75801878|FG000|STARTED|First Intervention||6||
59989613|NCT02479412|76104940|FG007|STARTED|Overall Study||5||
59989614|NCT02479412|76104941|FG008|STARTED|Overall Study||7||
59989615|NCT02479412|76104933|FG000|COMPLETED|Overall Study||6||
59989616|NCT02479412|76104934|FG001|COMPLETED|Overall Study||6||
59682786|NCT01136356|75801879|FG001|STARTED|First Intervention||6||
59682787|NCT01136356|75801878|FG000|COMPLETED|First Intervention||6||
59682788|NCT01136356|75801879|FG001|COMPLETED|First Intervention||6||
59682789|NCT01136356|75801878|FG000|NOT COMPLETED|First Intervention||0||
59682790|NCT01136356|75801879|FG001|NOT COMPLETED|First Intervention||0||
59682791|NCT01136356|75801878|FG000|STARTED|First 18-day Withdrawal||6||
59682792|NCT01136356|75801879|FG001|STARTED|First 18-day Withdrawal||6||
59682793|NCT01136356|75801878|FG000|COMPLETED|First 18-day Withdrawal||2||
59682794|NCT01136356|75801879|FG001|COMPLETED|First 18-day Withdrawal||6||
59682795|NCT01136356|75801878|FG000|NOT COMPLETED|First 18-day Withdrawal||4||
59682796|NCT01136356|75801879|FG001|NOT COMPLETED|First 18-day Withdrawal||0||
59682797|NCT01136356|75801878|FG000|STARTED|Second Intervention||2||
59682798|NCT01136356|75801879|FG001|STARTED|Second Intervention||6||
59682799|NCT01136356|75801878|FG000|COMPLETED|Second Intervention||2||
59682800|NCT01136356|75801879|FG001|COMPLETED|Second Intervention||6||
59682801|NCT01136356|75801878|FG000|NOT COMPLETED|Second Intervention||0||
59682802|NCT01136356|75801879|FG001|NOT COMPLETED|Second Intervention||0||
59682803|NCT01136356|75801878|FG000|STARTED|Second 18-day Withdrawal||2||
59682804|NCT01136356|75801879|FG001|STARTED|Second 18-day Withdrawal||6||
59682805|NCT01136356|75801878|FG000|COMPLETED|Second 18-day Withdrawal||2||
59682806|NCT01136356|75801879|FG001|COMPLETED|Second 18-day Withdrawal||5||
59682807|NCT01136356|75801878|FG000|NOT COMPLETED|Second 18-day Withdrawal||0||
59682808|NCT01136356|75801879|FG001|NOT COMPLETED|Second 18-day Withdrawal||1||
59682809|NCT00196326|75801884|FG000|STARTED|Overall Study|Took at least one dose of study medication|2235||
59682810|NCT00196326|75801884|FG000|Safety Population|Overall Study|Treated participants|2185||
59682811|NCT00196326|75801884|FG000|Pregnancy Intent-to-treat Cohort (PITT)|Overall Study|Completed one cycle and 18-35 years old|1735||
59682812|NCT00196326|75801884|FG000|COMPLETED|Overall Study||1249||
59682813|NCT00196326|75801884|FG000|NOT COMPLETED|Overall Study||986||
59682814|NCT00195663|75801891|FG000|STARTED|2-year Double-blind Treatment Period||257||
59682815|NCT00195663|75801892|FG001|STARTED|2-year Double-blind Treatment Period||274||
59682816|NCT00195663|75801893|FG002|STARTED|2-year Double-blind Treatment Period||268||
59682817|NCT00195663|75801891|FG000|COMPLETED|2-year Double-blind Treatment Period||164||
59682818|NCT00195663|75801892|FG001|COMPLETED|2-year Double-blind Treatment Period||166||
59989617|NCT02479412|76104935|FG002|COMPLETED|Overall Study||4||
59989618|NCT02479412|76104936|FG003|COMPLETED|Overall Study||6||
59989619|NCT02479412|76104937|FG004|COMPLETED|Overall Study||5||
59989620|NCT02479412|76104938|FG005|COMPLETED|Overall Study||5||
59989621|NCT02479412|76104939|FG006|COMPLETED|Overall Study||6||
59989622|NCT02479412|76104940|FG007|COMPLETED|Overall Study||4||
59989623|NCT02479412|76104941|FG008|COMPLETED|Overall Study||6||
59989624|NCT02479412|76104933|FG000|NOT COMPLETED|Overall Study||0||
59682819|NCT00195663|75801893|FG002|COMPLETED|2-year Double-blind Treatment Period||196||
59682820|NCT00195663|75801891|FG000|NOT COMPLETED|2-year Double-blind Treatment Period||93||
59682821|NCT00195663|75801892|FG001|NOT COMPLETED|2-year Double-blind Treatment Period||108||
59682822|NCT00195663|75801893|FG002|NOT COMPLETED|2-year Double-blind Treatment Period||72||
59682823|NCT00195663|75801891|FG000|STARTED|Open-Label Extension Period||155||
59682824|NCT00195663|75801892|FG001|STARTED|Open-Label Extension Period||159||
59682825|NCT00195663|75801893|FG002|STARTED|Open-Label Extension Period||183||
59682826|NCT00195663|75801891|FG000|COMPLETED|Open-Label Extension Period||79||
59989625|NCT02479412|76104934|FG001|NOT COMPLETED|Overall Study||0||
59989626|NCT02479412|76104935|FG002|NOT COMPLETED|Overall Study||2||
59682827|NCT00195663|75801892|FG001|COMPLETED|Open-Label Extension Period||85||
59682828|NCT00195663|75801893|FG002|COMPLETED|Open-Label Extension Period||86||
59682829|NCT00195663|75801891|FG000|NOT COMPLETED|Open-Label Extension Period||76||
59682830|NCT00195663|75801892|FG001|NOT COMPLETED|Open-Label Extension Period||74||
59682831|NCT00195663|75801893|FG002|NOT COMPLETED|Open-Label Extension Period||97||
59682832|NCT01135498|75801911|FG000|STARTED|Overall Study||90||
59682833|NCT01135498|75801911|FG000|COMPLETED|Overall Study||0||
59682834|NCT01135498|75801911|FG000|NOT COMPLETED|Overall Study||90||
59682835|NCT00195507|75801918|FG000|STARTED|Overall Study||357||
59682836|NCT00195507|75801919|FG001|STARTED|Overall Study||363||
59682837|NCT00195507|75801918|FG000|COMPLETED|Overall Study||258||
59682838|NCT00195507|75801919|FG001|COMPLETED|Overall Study||245||
59682839|NCT00195507|75801918|FG000|NOT COMPLETED|Overall Study||99||
59682840|NCT00195507|75801919|FG001|NOT COMPLETED|Overall Study||118||
59682841|NCT01134562|75801930|FG000|STARTED|Overall Study||4||
59682842|NCT01134562|75801931|FG001|STARTED|Overall Study||4||
59682843|NCT01134562|75801932|FG002|STARTED|Overall Study||4||
59682844|NCT01134562|75801933|FG003|STARTED|Overall Study||8||
59682845|NCT01134562|75801934|FG004|STARTED|Overall Study||8||
59682846|NCT01134562|75801930|FG000|COMPLETED|Overall Study||4||
59682847|NCT01134562|75801931|FG001|COMPLETED|Overall Study||3||
59682848|NCT01134562|75801932|FG002|COMPLETED|Overall Study||4||
59682849|NCT01134562|75801933|FG003|COMPLETED|Overall Study||8||
59682850|NCT01134562|75801934|FG004|COMPLETED|Overall Study||8||
59682851|NCT01134562|75801930|FG000|NOT COMPLETED|Overall Study||0||
59682852|NCT01134562|75801931|FG001|NOT COMPLETED|Overall Study||1||
59682853|NCT01134562|75801932|FG002|NOT COMPLETED|Overall Study||0||
59682854|NCT01134562|75801933|FG003|NOT COMPLETED|Overall Study||0||
59682855|NCT01134562|75801934|FG004|NOT COMPLETED|Overall Study||0||
59682856|NCT04610489|75801954|FG000|STARTED|Overall Study||117||
59682857|NCT04610489|75801954|FG000|COMPLETED|Overall Study||117||
59682858|NCT04610489|75801954|FG000|NOT COMPLETED|Overall Study||0||
59682859|NCT00195351|75801961|FG000|STARTED|Overall Study||236||
59682860|NCT00195351|75801962|FG001|STARTED|Overall Study||231||
59682861|NCT00195351|75801961|FG000|COMPLETED|Overall Study||215||
59682862|NCT00195351|75801962|FG001|COMPLETED|Overall Study||215||
59682863|NCT00195351|75801961|FG000|NOT COMPLETED|Overall Study||21||
59682864|NCT00195351|75801962|FG001|NOT COMPLETED|Overall Study||16||
59682865|NCT00195273|75801970|FG000|STARTED|Overall Study||31||
59682866|NCT00195273|75801971|FG001|STARTED|Overall Study||30||
59682867|NCT00195273|75801970|FG000|COMPLETED|Overall Study||10||
59682868|NCT00195273|75801971|FG001|COMPLETED|Overall Study||16||
59682869|NCT00195273|75801970|FG000|NOT COMPLETED|Overall Study||21||
59682870|NCT00195273|75801971|FG001|NOT COMPLETED|Overall Study||14||
59682871|NCT00193479|75801977|FG000|STARTED|Induction Chemotherapy||51||
59682872|NCT00193479|75801977|FG000|COMPLETED|Induction Chemotherapy||48||
59682873|NCT00193479|75801977|FG000|NOT COMPLETED|Induction Chemotherapy||3||
59682874|NCT00193479|75801977|FG000|STARTED|Maintenance Rituximab||48||
59682875|NCT00193479|75801977|FG000|COMPLETED|Maintenance Rituximab||44||
59682876|NCT00193479|75801977|FG000|NOT COMPLETED|Maintenance Rituximab||4||
59682877|NCT00193206|75801981|FG000|STARTED|Preoperative Therapy||123||
59682878|NCT00193206|75801981|FG000|COMPLETED|Preoperative Therapy||116||
59682879|NCT00193206|75801981|FG000|NOT COMPLETED|Preoperative Therapy||7||
59682880|NCT00193206|75801981|FG000|STARTED|Surgery||116||
59682881|NCT00193206|75801981|FG000|COMPLETED|Surgery||116||
59682882|NCT00193206|75801981|FG000|NOT COMPLETED|Surgery||0||
59682883|NCT00193206|75801981|FG000|STARTED|Postoperative Therapy||116||
59682884|NCT00193206|75801981|FG000|COMPLETED|Postoperative Therapy||102||
59682885|NCT00193206|75801981|FG000|NOT COMPLETED|Postoperative Therapy||14||
59682886|NCT00193050|75801985|FG000|STARTED|Neoadjuvant Treatment||110||
59682887|NCT00193050|75801985|FG000|COMPLETED|Neoadjuvant Treatment||101||
59682888|NCT00193050|75801985|FG000|NOT COMPLETED|Neoadjuvant Treatment||9||
59682889|NCT00193050|75801985|FG000|STARTED|Surgery|2 patients had surgery after 2 cycles of neoadjuvant treatment|103||
59682890|NCT00193050|75801985|FG000|COMPLETED|Surgery||103||
59682891|NCT00193050|75801985|FG000|NOT COMPLETED|Surgery||0||
59682892|NCT00193050|75801985|FG000|STARTED|Adjuvant|16 patients never initiated postoperative adjuvant therapy|87||
59682893|NCT00193050|75801985|FG000|COMPLETED|Adjuvant||77||
59682894|NCT00193050|75801985|FG000|NOT COMPLETED|Adjuvant||10||
59682895|NCT00192504|75801994|FG000|STARTED|Overall Study||5||
59682896|NCT00192504|75801995|FG001|STARTED|Overall Study||5||
59682897|NCT00192504|75801996|FG002|STARTED|Overall Study|Baseline demographics are not available on one patient who did not receive study drug.|6||
59682898|NCT00192504|75801997|FG003|STARTED|Overall Study||15||
59682899|NCT00192504|75801994|FG000|COMPLETED|Overall Study||4||
59682900|NCT00192504|75801995|FG001|COMPLETED|Overall Study||5||
59682901|NCT00192504|75801996|FG002|COMPLETED|Overall Study||5||
59682902|NCT00192504|75801997|FG003|COMPLETED|Overall Study||15||
59682903|NCT00192504|75801994|FG000|NOT COMPLETED|Overall Study||1||
59682904|NCT00192504|75801995|FG001|NOT COMPLETED|Overall Study||0||
59682905|NCT00192504|75801996|FG002|NOT COMPLETED|Overall Study||1||
59682906|NCT00192504|75801997|FG003|NOT COMPLETED|Overall Study||0||
59682907|NCT00192114|75802007|FG000|STARTED|Overall Study||28||
59682908|NCT00192114|75802007|FG000|Received at Least 1 Dose of Study Drug|Overall Study||28||
59682909|NCT00192114|75802007|FG000|COMPLETED|Overall Study||4||
59682910|NCT00192114|75802007|FG000|NOT COMPLETED|Overall Study||24||
59682911|NCT00192075|75802013|FG000|STARTED|Overall Study||42||
59682912|NCT00192075|75802014|FG001|STARTED|Overall Study||42||
59682913|NCT00192075|75802013|FG000|COMPLETED|Overall Study||3||
59682914|NCT00192075|75802014|FG001|COMPLETED|Overall Study||23||
59682915|NCT00192075|75802013|FG000|NOT COMPLETED|Overall Study||39||
59682916|NCT00192075|75802014|FG001|NOT COMPLETED|Overall Study||19||
59682917|NCT00192036|75802025|FG000|STARTED|Overall Study||49||
59682918|NCT00192036|75802025|FG000|COMPLETED|Overall Study||28||
59682919|NCT00192036|75802025|FG000|NOT COMPLETED|Overall Study||21||
59682920|NCT00191724|75802034|FG000|STARTED|Overall Study||6||
59682921|NCT00191724|75802035|FG001|STARTED|Overall Study||9||
59682922|NCT00191724|75802036|FG002|STARTED|Overall Study||9||
59682923|NCT00191724|75802037|FG003|STARTED|Overall Study||8||
59682924|NCT00191724|75802038|FG004|STARTED|Overall Study||15||
59682925|NCT00191724|75802034|FG000|COMPLETED|Overall Study||5||
59682926|NCT00191724|75802035|FG001|COMPLETED|Overall Study||8||
59682927|NCT00191724|75802036|FG002|COMPLETED|Overall Study||8||
59682928|NCT00191724|75802037|FG003|COMPLETED|Overall Study||5||
59682929|NCT00191724|75802038|FG004|COMPLETED|Overall Study||12||
59682930|NCT00191724|75802034|FG000|NOT COMPLETED|Overall Study||1||
59682931|NCT00191724|75802035|FG001|NOT COMPLETED|Overall Study||1||
59682932|NCT00191724|75802036|FG002|NOT COMPLETED|Overall Study||1||
59682933|NCT00191724|75802037|FG003|NOT COMPLETED|Overall Study||3||
59682934|NCT00191724|75802038|FG004|NOT COMPLETED|Overall Study||3||
59682935|NCT00191646|75802052|FG000|STARTED|Overall Study||417||
59682936|NCT00191646|75802053|FG001|STARTED|Overall Study||414||
59682937|NCT00191646|75802052|FG000|Received Induction Therapy|Overall Study||411||
59682938|NCT00191646|75802053|FG001|Received Induction Therapy|Overall Study||409||
59682939|NCT00191646|75802052|FG000|Received Consolidation Therapy|Overall Study||169||
59682940|NCT00191646|75802053|FG001|Received Consolidation Therapy|Overall Study||183||
59682941|NCT00191646|75802052|FG000|Received Crossover Therapy|Overall Study||77||
59682942|NCT00191646|75802053|FG001|Received Crossover Therapy|Overall Study||78||
59682943|NCT00191646|75802052|FG000|COMPLETED|Overall Study|Completed was defined as the patients treated in either consolidation therapy or crossover therapy.|246||
59682944|NCT00191646|75802053|FG001|COMPLETED|Overall Study|Completed was defined as the patients treated in either consolidation therapy or crossover therapy.|261||
59682945|NCT00191646|75802052|FG000|NOT COMPLETED|Overall Study||171||
59682946|NCT00191646|75802053|FG001|NOT COMPLETED|Overall Study||153||
59682947|NCT00191451|75802070|FG000|STARTED|Overall Study||50||
59682948|NCT00191451|75802071|FG001|STARTED|Overall Study||51||
59682949|NCT00191451|75802072|FG002|STARTED|Overall Study||49||
59682950|NCT00191451|75802070|FG000|Received at Least One Dose of Study Drug|Overall Study||50||
59682951|NCT00191451|75802071|FG001|Received at Least One Dose of Study Drug|Overall Study||48||
59682952|NCT00191451|75802072|FG002|Received at Least One Dose of Study Drug|Overall Study||47||
59682953|NCT00191451|75802070|FG000|COMPLETED|Overall Study||43||
59682954|NCT00191451|75802071|FG001|COMPLETED|Overall Study||37||
59682955|NCT00191451|75802072|FG002|COMPLETED|Overall Study||35||
59682956|NCT00191451|75802070|FG000|NOT COMPLETED|Overall Study||7||
59682957|NCT00191451|75802071|FG001|NOT COMPLETED|Overall Study||14||
59682958|NCT00191451|75802072|FG002|NOT COMPLETED|Overall Study||14||
59682959|NCT00191334|75802080|FG000|STARTED|Overall Study||50||
59682960|NCT00191334|75802080|FG000|COMPLETED|Overall Study||33||
59682961|NCT00191334|75802080|FG000|NOT COMPLETED|Overall Study||17||
59682962|NCT00191139|75802086|FG000|STARTED|Overall Study||32||
59682963|NCT00191139|75802087|FG001|STARTED|Overall Study||32||
59682964|NCT00191139|75802086|FG000|COMPLETED|Overall Study||27||
59682965|NCT00191139|75802087|FG001|COMPLETED|Overall Study||20||
59682966|NCT00191139|75802086|FG000|NOT COMPLETED|Overall Study||5||
59816067|NCT03886220|75938407|FG001|COMPLETED|Post-Treatment Follow-Up Period||39||
59816068|NCT03886220|75938406|FG000|NOT COMPLETED|Post-Treatment Follow-Up Period||2||
59816069|NCT03886220|75938407|FG001|NOT COMPLETED|Post-Treatment Follow-Up Period||2||
59816070|NCT00530270|75938415|FG000|STARTED|Overall Study||6||
59816071|NCT00530270|75938416|FG001|STARTED|Overall Study||6||
59682967|NCT00191139|75802087|FG001|NOT COMPLETED|Overall Study||12||
59682968|NCT00190983|75802093|FG000|STARTED|Overall Study||29||
59682969|NCT00190983|75802093|FG000|COMPLETED|Overall Study|Completed means patient received treatment and was evaluable for response.|27||
59682970|NCT00190983|75802093|FG000|NOT COMPLETED|Overall Study||2||
59682971|NCT00190749|75802099|FG000|STARTED|Overall Study||68||
59682972|NCT00190749|75802100|FG001|STARTED|Overall Study||62||
59682973|NCT00190749|75802099|FG000|COMPLETED|Overall Study||42||
59682974|NCT00190749|75802100|FG001|COMPLETED|Overall Study||31||
59682975|NCT00190749|75802099|FG000|NOT COMPLETED|Overall Study||26||
59682976|NCT00190749|75802100|FG001|NOT COMPLETED|Overall Study||31||
59682977|NCT00190671|75802108|FG000|STARTED|Overall Study||42||
59682978|NCT00190671|75802109|FG001|STARTED|Overall Study||61||
59682979|NCT00190671|75802108|FG000|COMPLETED|Overall Study||15||
59682980|NCT00190671|75802109|FG001|COMPLETED|Overall Study||19||
59682981|NCT00190671|75802108|FG000|NOT COMPLETED|Overall Study||27||
59816072|NCT00530270|75938415|FG000|COMPLETED|Overall Study||5||
59816073|NCT00530270|75938416|FG001|COMPLETED|Overall Study||6||
59682982|NCT00190671|75802109|FG001|NOT COMPLETED|Overall Study||42||
59682983|NCT00199914|75802118|FG000|STARTED|Overall Study||53||
59682984|NCT00199914|75802119|FG001|STARTED|Overall Study||60||
59682985|NCT00199914|75802118|FG000|COMPLETED|Overall Study||50||
59682986|NCT00199914|75802119|FG001|COMPLETED|Overall Study||54||
59682987|NCT00199914|75802118|FG000|NOT COMPLETED|Overall Study||3||
59682988|NCT00199914|75802119|FG001|NOT COMPLETED|Overall Study||6||
59682989|NCT04607291|75802125|FG000|STARTED|Overall Study||183||
59682990|NCT04607291|75802125|FG000|COMPLETED|Overall Study||183||
59682991|NCT04607291|75802125|FG000|NOT COMPLETED|Overall Study||0||
59682992|NCT00477165|75802131|FG000|STARTED|Overall Study||27||
59682993|NCT00477165|75802132|FG001|STARTED|Overall Study||27||
59682994|NCT00477165|75802131|FG000|COMPLETED|Overall Study||20||
59682995|NCT00477165|75802132|FG001|COMPLETED|Overall Study||25||
59682996|NCT00477165|75802131|FG000|NOT COMPLETED|Overall Study||7||
59682997|NCT00477165|75802132|FG001|NOT COMPLETED|Overall Study||2||
59682998|NCT00476229|75802138|FG000|STARTED|Overall Study||20||
59682999|NCT00476229|75802138|FG000|COMPLETED|Overall Study||19||
59683000|NCT00476229|75802138|FG000|NOT COMPLETED|Overall Study||1||
59683001|NCT00476151|75802144|FG000|STARTED|Overall Study||112||
59683002|NCT00476151|75802145|FG001|STARTED|Overall Study||114||
59683003|NCT00476151|75802144|FG000|COMPLETED|Overall Study||109||
59683004|NCT00476151|75802145|FG001|COMPLETED|Overall Study||107||
59683005|NCT00476151|75802144|FG000|NOT COMPLETED|Overall Study||3||
59683006|NCT00476151|75802145|FG001|NOT COMPLETED|Overall Study||7||
59683007|NCT00475644|75802151|FG000|STARTED|Overall Study||66||
59683008|NCT00475644|75802151|FG000|Received at Least One Dose of Study Drug|Overall Study||66||
59683009|NCT00475644|75802151|FG000|COMPLETED|Overall Study||53||
59683010|NCT00475644|75802151|FG000|NOT COMPLETED|Overall Study||13||
59683011|NCT00474903|75802158|FG000|STARTED|Overall Study||30||
59683012|NCT00474903|75802159|FG001|STARTED|Overall Study||47||
59683013|NCT00474903|75802160|FG002|STARTED|Overall Study||45||
59683014|NCT00474903|75802158|FG000|COMPLETED|Overall Study||29||
59683015|NCT00474903|75802159|FG001|COMPLETED|Overall Study||42||
59683016|NCT00474903|75802160|FG002|COMPLETED|Overall Study||43||
59683017|NCT00474903|75802158|FG000|NOT COMPLETED|Overall Study||1||
59683018|NCT00474903|75802159|FG001|NOT COMPLETED|Overall Study||5||
59683019|NCT00474903|75802160|FG002|NOT COMPLETED|Overall Study||2||
59683020|NCT01134055|75802175|FG000|STARTED|Overall Study||73||
59683021|NCT01134055|75802176|FG001|STARTED|Overall Study||72||
59683022|NCT01134055|75802177|FG002|STARTED|Overall Study||74||
59683023|NCT01134055|75802178|FG003|STARTED|Overall Study||73||
59683024|NCT01134055|75802179|FG004|STARTED|Overall Study||73||
59683025|NCT01134055|75802180|FG005|STARTED|Overall Study||72||
59683026|NCT01134055|75802181|FG006|STARTED|Overall Study||73||
59683027|NCT01134055|75802175|FG000|COMPLETED|Overall Study||65||
59683028|NCT01134055|75802176|FG001|COMPLETED|Overall Study||66||
59683029|NCT01134055|75802177|FG002|COMPLETED|Overall Study||71||
59683030|NCT01134055|75802178|FG003|COMPLETED|Overall Study||67||
59683031|NCT01134055|75802179|FG004|COMPLETED|Overall Study||67||
59683032|NCT01134055|75802180|FG005|COMPLETED|Overall Study||65||
59683033|NCT01134055|75802181|FG006|COMPLETED|Overall Study||62||
59683034|NCT01134055|75802175|FG000|NOT COMPLETED|Overall Study||8||
59683035|NCT01134055|75802176|FG001|NOT COMPLETED|Overall Study||6||
59683036|NCT01134055|75802177|FG002|NOT COMPLETED|Overall Study||3||
59683037|NCT01134055|75802178|FG003|NOT COMPLETED|Overall Study||6||
59683038|NCT01134055|75802179|FG004|NOT COMPLETED|Overall Study||6||
59683039|NCT01134055|75802180|FG005|NOT COMPLETED|Overall Study||7||
59683040|NCT01134055|75802181|FG006|NOT COMPLETED|Overall Study||11||
59683041|NCT00474708|75802205|FG000|STARTED|Overall Study||791||
59683042|NCT00474708|75802206|FG001|STARTED|Overall Study||367||
59683043|NCT00474708|75802205|FG000|COMPLETED|Overall Study||734||
59683044|NCT00474708|75802206|FG001|COMPLETED|Overall Study||342||
59683045|NCT00474708|75802205|FG000|NOT COMPLETED|Overall Study||57||
59683046|NCT00474708|75802206|FG001|NOT COMPLETED|Overall Study||25||
59683047|NCT00474240|75802218|FG000|STARTED|Overall Study||27||
59683048|NCT00474240|75802219|FG001|STARTED|Overall Study||26||
59683049|NCT00474240|75802220|FG002|STARTED|Overall Study||26||
59683050|NCT00474240|75802221|FG003|STARTED|Overall Study||26||
59683051|NCT00474240|75802222|FG004|STARTED|Overall Study||26||
59683052|NCT00474240|75802223|FG005|STARTED|Overall Study||26||
59683053|NCT00474240|75802218|FG000|COMPLETED|Overall Study||26||
59683054|NCT00474240|75802219|FG001|COMPLETED|Overall Study||25||
59683055|NCT00474240|75802220|FG002|COMPLETED|Overall Study||17||
59683056|NCT00474240|75802221|FG003|COMPLETED|Overall Study||10||
59683057|NCT00474240|75802222|FG004|COMPLETED|Overall Study||18||
59683058|NCT00474240|75802223|FG005|COMPLETED|Overall Study||8||
59683059|NCT00474240|75802218|FG000|NOT COMPLETED|Overall Study||1||
59683060|NCT00474240|75802219|FG001|NOT COMPLETED|Overall Study||1||
59683061|NCT00474240|75802220|FG002|NOT COMPLETED|Overall Study||9||
59683062|NCT00474240|75802221|FG003|NOT COMPLETED|Overall Study||16||
59683063|NCT00474240|75802222|FG004|NOT COMPLETED|Overall Study||8||
59683064|NCT00474240|75802223|FG005|NOT COMPLETED|Overall Study||18||
59683065|NCT00473889|75802239|FG000|STARTED|Overall Study||126||
59683066|NCT00473889|75802240|FG001|STARTED|Overall Study||127||
59683067|NCT00473889|75802239|FG000|COMPLETED|Overall Study||43||
59683068|NCT00473889|75802240|FG001|COMPLETED|Overall Study||63||
59989627|NCT02479412|76104936|FG003|NOT COMPLETED|Overall Study||1||
59989628|NCT02479412|76104937|FG004|NOT COMPLETED|Overall Study||1||
59989629|NCT02479412|76104938|FG005|NOT COMPLETED|Overall Study||0||
59989630|NCT02479412|76104939|FG006|NOT COMPLETED|Overall Study||0||
59989631|NCT02479412|76104940|FG007|NOT COMPLETED|Overall Study||1||
59989632|NCT02479412|76104941|FG008|NOT COMPLETED|Overall Study||1||
59989633|NCT00224003|76104957|FG000|STARTED|Overall Study|First patient in: April 2, 2003|23||
59989634|NCT00224003|76104957|FG000|COMPLETED|Overall Study|Last patient out: March 31, 2004|16||
59989635|NCT00224003|76104957|FG000|NOT COMPLETED|Overall Study||7||
59989636|NCT02450552|76104963|FG000|STARTED|Overall Study||19||
59989637|NCT02450552|76104964|FG001|STARTED|Overall Study||23||
59989638|NCT02450552|76104965|FG002|STARTED|Overall Study||23||
59989639|NCT02450552|76104963|FG000|COMPLETED|Overall Study||14||
59989640|NCT02450552|76104964|FG001|COMPLETED|Overall Study||23||
59989641|NCT02450552|76104965|FG002|COMPLETED|Overall Study||18||
59989642|NCT02450552|76104963|FG000|NOT COMPLETED|Overall Study||5||
59989643|NCT02450552|76104964|FG001|NOT COMPLETED|Overall Study||0||
59989644|NCT02450552|76104965|FG002|NOT COMPLETED|Overall Study||5||
60079110|NCT00044044|76194412|FG001|COMPLETED|Overall Study||28||
60079111|NCT00044044|76194413|FG002|COMPLETED|Overall Study||31||
60079112|NCT00044044|76194414|FG003|COMPLETED|Overall Study||29||
60079113|NCT00044044|76194415|FG004|COMPLETED|Overall Study||36||
60079114|NCT00044044|76194411|FG000|NOT COMPLETED|Overall Study||44||
60079115|NCT00044044|76194412|FG001|NOT COMPLETED|Overall Study||41||
60079116|NCT00044044|76194413|FG002|NOT COMPLETED|Overall Study||40||
60079117|NCT00044044|76194414|FG003|NOT COMPLETED|Overall Study||44||
60079118|NCT00044044|76194415|FG004|NOT COMPLETED|Overall Study||36||
59683069|NCT00473889|75802239|FG000|NOT COMPLETED|Overall Study||83||
60079119|NCT00112918|76194430|FG000|STARTED|Overall Study||1151||
60079120|NCT00112918|76194431|FG001|STARTED|Overall Study||1155||
60079121|NCT00112918|76194432|FG002|STARTED|Overall Study||1145||
60079122|NCT00112918|76194430|FG000|Received Treatment|Overall Study||1126||
60079123|NCT00112918|76194431|FG001|Received Treatment|Overall Study|Includes two patients from FOLFOX4 who received Bv and were assigned to FOLFOX4+Bv safety analysis|1145||
60079124|NCT00112918|76194432|FG002|Received Treatment|Overall Study||1135||
60079125|NCT00112918|76194430|FG000|Stage III Disease Population|Overall Study||955||
60079126|NCT00112918|76194431|FG001|Stage III Disease Population|Overall Study||960||
60079127|NCT00112918|76194432|FG002|Stage III Disease Population|Overall Study||952||
60079128|NCT00112918|76194430|FG000|COMPLETED|Overall Study|Represents patients alive in follow-up at the time of final data cut-off (30 June 2012)|854||
60079129|NCT00112918|76194431|FG001|COMPLETED|Overall Study|Represents patients alive in follow-up at the time of final data cut-off (30 June 2012)|810||
60079130|NCT00112918|76194432|FG002|COMPLETED|Overall Study|Represents patients alive in follow-up at the time of final data cut-off (30 June 2012)|846||
59989645|NCT02508428|76104975|FG000|STARTED|Overall Study||114||116
59989646|NCT02508428|76104976|FG001|STARTED|Overall Study||111||114
59989647|NCT02508428|76104975|FG000|COMPLETED|Overall Study||62||64
59989648|NCT02508428|76104976|FG001|COMPLETED|Overall Study||44||46
59989649|NCT02508428|76104975|FG000|NOT COMPLETED|Overall Study||52||52
59989650|NCT02508428|76104976|FG001|NOT COMPLETED|Overall Study||67||68
59989651|NCT02448680|76104984|FG000|STARTED|Overall Study||12||
59989652|NCT02448680|76104985|FG001|STARTED|Overall Study||13||
59989653|NCT02448680|76104984|FG000|COMPLETED|Overall Study||11||
59989654|NCT02448680|76104985|FG001|COMPLETED|Overall Study||10||
59989655|NCT02448680|76104984|FG000|NOT COMPLETED|Overall Study||1||
59989656|NCT02448680|76104985|FG001|NOT COMPLETED|Overall Study||3||
59989657|NCT02448446|76104995|FG000|STARTED|Overall Study||13||
59989658|NCT02448446|76104996|FG001|STARTED|Overall Study||12||
59989659|NCT02448446|76104995|FG000|COMPLETED|Overall Study||12||
60079131|NCT00112918|76194430|FG000|NOT COMPLETED|Overall Study||297||
60079132|NCT00112918|76194431|FG001|NOT COMPLETED|Overall Study||345||
60079133|NCT00112918|76194432|FG002|NOT COMPLETED|Overall Study||299||
60079134|NCT00205348|76194440|FG000|STARTED|Overall Study||146||
59989660|NCT02448446|76104996|FG001|COMPLETED|Overall Study||12||
59989661|NCT02448446|76104995|FG000|NOT COMPLETED|Overall Study||1||
59989662|NCT02448446|76104996|FG001|NOT COMPLETED|Overall Study||0||
59989663|NCT02447744|76105004|FG000|STARTED|Overall Study|6 subjects are enrolled in the mindfulness program after serving on the waiting list control group|21||
59989664|NCT02447744|76105005|FG001|STARTED|Overall Study||22||
59989665|NCT02447744|76105004|FG000|COMPLETED|Overall Study||15||
59989666|NCT02447744|76105005|FG001|COMPLETED|Overall Study||21||
59989667|NCT02447744|76105004|FG000|NOT COMPLETED|Overall Study||6||
59989668|NCT02447744|76105005|FG001|NOT COMPLETED|Overall Study||1||
59989669|NCT02478632|76105013|FG000|STARTED|Early Switch Phase (Up to Week 52)||53||
60079135|NCT00205348|76194440|FG000|COMPLETED|Overall Study||116||
59683070|NCT00473889|75802240|FG001|NOT COMPLETED|Overall Study||64||
59683071|NCT00473694|75802250|FG000|STARTED|Overall Study||48||
59683072|NCT00473694|75802251|FG001|STARTED|Overall Study|Includes 1 participant randomized to vecuronium+sugammadex but treated with rocuronium+neostigmine|41||
59683073|NCT00473694|75802252|FG002|STARTED|Overall Study||51||
59683074|NCT00473694|75802253|FG003|STARTED|Overall Study||42||
59683075|NCT00473694|75802250|FG000|Treated|Overall Study|Number of participants treated was based on actual treatment received.|37||
59683076|NCT00473694|75802251|FG001|Treated|Overall Study|Number of participants treated was based on actual treatment received.|38||
59683077|NCT00473694|75802252|FG002|Treated|Overall Study|Number of participants treated was based on actual treatment received.|46||
59683078|NCT00473694|75802253|FG003|Treated|Overall Study|Number of participants treated was based on actual treatment received.|36||
59683079|NCT00473694|75802250|FG000|COMPLETED|Overall Study|Number of participants completed was based on actual treatment received.|37||
59683080|NCT00473694|75802251|FG001|COMPLETED|Overall Study|Number of participants completed was based on actual treatment received.|37||
59683081|NCT00473694|75802252|FG002|COMPLETED|Overall Study|Number of participants completed was based on actual treatment received.|46||
59683082|NCT00473694|75802253|FG003|COMPLETED|Overall Study|Number of participants completed was based on actual treatment received.|35||
59683083|NCT00473694|75802250|FG000|NOT COMPLETED|Overall Study||11||
59683084|NCT00473694|75802251|FG001|NOT COMPLETED|Overall Study||4||
59683085|NCT00473694|75802252|FG002|NOT COMPLETED|Overall Study||5||
59683086|NCT00473694|75802253|FG003|NOT COMPLETED|Overall Study||7||
59683087|NCT00473655|75802269|FG000|STARTED|Overall Study|Just participants with TG above 200 mg/dl entered this period|111||
59683088|NCT00473655|75802270|FG001|STARTED|Overall Study|Just participants with TG above 200 mg/dl entered this period|112||
59683089|NCT00473655|75802271|FG002|STARTED|Overall Study|Just participants with TG above 200 mg/dl entered this period|111||
59683090|NCT00473655|75802269|FG000|COMPLETED|Overall Study|9 participants were lost of follow up|102||
59683091|NCT00473655|75802270|FG001|COMPLETED|Overall Study|5 participants were lost of follow up|107||
59683092|NCT00473655|75802271|FG002|COMPLETED|Overall Study|8 participants were lost of follow up|103||
59683093|NCT00473655|75802269|FG000|NOT COMPLETED|Overall Study||9||
59683094|NCT00473655|75802270|FG001|NOT COMPLETED|Overall Study||5||
59683095|NCT00473655|75802271|FG002|NOT COMPLETED|Overall Study||8||
59683096|NCT00473382|75802282|FG000|STARTED|Core Study||130||
59683097|NCT00473382|75802283|FG001|STARTED|Core Study||125||
59683098|NCT00473382|75802284|FG002|STARTED|Core Study||127||
59683099|NCT00473382|75802282|FG000|COMPLETED|Core Study||102||
59683100|NCT00473382|75802283|FG001|COMPLETED|Core Study||98||
59683101|NCT00473382|75802284|FG002|COMPLETED|Core Study||98||
59683102|NCT00473382|75802282|FG000|NOT COMPLETED|Core Study||28||
59683103|NCT00473382|75802283|FG001|NOT COMPLETED|Core Study||27||
59683104|NCT00473382|75802284|FG002|NOT COMPLETED|Core Study||29||
59683105|NCT00473382|75802282|FG000|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|88||
59683106|NCT00473382|75802283|FG001|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|83||
59683107|NCT00473382|75802284|FG002|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|84||
59683108|NCT00473382|75802282|FG000|COMPLETED|Open-label Extension Through Month 48||38||
59683109|NCT00473382|75802283|FG001|COMPLETED|Open-label Extension Through Month 48||42||
59683110|NCT00473382|75802284|FG002|COMPLETED|Open-label Extension Through Month 48||37||
59683111|NCT00473382|75802282|FG000|NOT COMPLETED|Open-label Extension Through Month 48||50||
59683112|NCT00473382|75802283|FG001|NOT COMPLETED|Open-label Extension Through Month 48||41||
59683113|NCT00473382|75802284|FG002|NOT COMPLETED|Open-label Extension Through Month 48||47||
59683114|NCT00473382|75802282|FG000|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|88||
59683115|NCT00473382|75802283|FG001|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|83||
59683116|NCT00473382|75802284|FG002|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|84||
59683117|NCT00473382|75802282|FG000|COMPLETED|Open-label Extension Through Month 60||2||
59683118|NCT00473382|75802283|FG001|COMPLETED|Open-label Extension Through Month 60||1||
59683119|NCT00473382|75802284|FG002|COMPLETED|Open-label Extension Through Month 60||2||
59683120|NCT00473382|75802282|FG000|NOT COMPLETED|Open-label Extension Through Month 60||86||
59683121|NCT00473382|75802283|FG001|NOT COMPLETED|Open-label Extension Through Month 60||82||
60079136|NCT00205348|76194440|FG000|NOT COMPLETED|Overall Study||30||
60079137|NCT00046228|76194447|FG000|STARTED|90 Days||806||
60079138|NCT00046228|76194448|FG001|STARTED|90 Days||818||
60079139|NCT00046228|76194449|FG002|STARTED|90 Days||828||
60079140|NCT00046228|76194447|FG000|COMPLETED|90 Days|The number completed includes subjects who died or were seen for a visit within specified window.|793||
60079141|NCT00046228|76194448|FG001|COMPLETED|90 Days|The number completed includes subjects who died or were seen for a visit within specified window.|810||
60079142|NCT00046228|76194449|FG002|COMPLETED|90 Days|The number completed includes subjects who died or were seen for a visit within specified window.|813||
59683122|NCT00473382|75802284|FG002|NOT COMPLETED|Open-label Extension Through Month 60||82||
59683123|NCT00473265|75802310|FG000|STARTED|Overall Study||68||
60079143|NCT00046228|76194447|FG000|NOT COMPLETED|90 Days||13||
59683124|NCT00473265|75802310|FG000|COMPLETED|Overall Study||48||
59683125|NCT00473265|75802310|FG000|NOT COMPLETED|Overall Study||20||
59683126|NCT00472641|75802314|FG000|STARTED|Overall Study||25||
59683127|NCT00472641|75802314|FG000|COMPLETED|Overall Study||18||
59683128|NCT00472641|75802314|FG000|NOT COMPLETED|Overall Study||7||
59683129|NCT01133977|75802323|FG000|STARTED|Overall Study|Treated|3||
59683130|NCT01133977|75802324|FG001|STARTED|Overall Study|Treated|7||
59683131|NCT01133977|75802325|FG002|STARTED|Overall Study|Treated|6||
59683132|NCT01133977|75802326|FG003|STARTED|Overall Study|Treated|42||
59683133|NCT01133977|75802327|FG004|STARTED|Overall Study|Treated|39||
59683134|NCT01133977|75802323|FG000|COMPLETED|Overall Study||0||
59683135|NCT01133977|75802324|FG001|COMPLETED|Overall Study||0||
59683136|NCT01133977|75802325|FG002|COMPLETED|Overall Study||0||
59683137|NCT01133977|75802326|FG003|COMPLETED|Overall Study||3||
59683138|NCT01133977|75802327|FG004|COMPLETED|Overall Study||1||
59683139|NCT01133977|75802323|FG000|NOT COMPLETED|Overall Study||3||
59683140|NCT01133977|75802324|FG001|NOT COMPLETED|Overall Study||7||
59683141|NCT01133977|75802325|FG002|NOT COMPLETED|Overall Study||6||
59683142|NCT01133977|75802326|FG003|NOT COMPLETED|Overall Study||39||
59683143|NCT01133977|75802327|FG004|NOT COMPLETED|Overall Study||38||
59683144|NCT01133821|75802344|FG000|STARTED|Overall Study||45||
59683145|NCT01133821|75802345|FG001|STARTED|Overall Study||47||
59683146|NCT01133821|75802344|FG000|COMPLETED|Overall Study||27||
59683147|NCT01133821|75802345|FG001|COMPLETED|Overall Study||28||
59683148|NCT01133821|75802344|FG000|NOT COMPLETED|Overall Study||18||
59683149|NCT01133821|75802345|FG001|NOT COMPLETED|Overall Study||19||
59683150|NCT00472446|75802355|FG000|STARTED|Overall Study||46||
59683151|NCT00472446|75802356|FG001|STARTED|Overall Study||47||
59683152|NCT00472446|75802357|FG002|STARTED|Overall Study||45||
59683153|NCT00472446|75802358|FG003|STARTED|Overall Study||45||
59683154|NCT00472446|75802355|FG000|COMPLETED|Overall Study||41||
59683155|NCT00472446|75802356|FG001|COMPLETED|Overall Study||41||
59683156|NCT00472446|75802357|FG002|COMPLETED|Overall Study||38||
59683157|NCT00472446|75802358|FG003|COMPLETED|Overall Study||39||
59683158|NCT00472446|75802355|FG000|NOT COMPLETED|Overall Study||5||
59683159|NCT00472446|75802356|FG001|NOT COMPLETED|Overall Study||6||
59683160|NCT00472446|75802357|FG002|NOT COMPLETED|Overall Study||7||
59683161|NCT00472446|75802358|FG003|NOT COMPLETED|Overall Study||6||
59683162|NCT00472290|75802368|FG000|STARTED|Overall Study||72||
59683163|NCT00472290|75802368|FG000|COMPLETED|Overall Study||0||
59683164|NCT00472290|75802368|FG000|NOT COMPLETED|Overall Study||72||
59683165|NCT01133704|75802374|FG000|STARTED|Overall Study||65||
59683166|NCT01133704|75802375|FG001|STARTED|Overall Study||33||
59683167|NCT01133704|75802374|FG000|COMPLETED|Overall Study|(including 3 year follow-up)|16||
59683168|NCT01133704|75802375|FG001|COMPLETED|Overall Study|(including 3 year follow-up)|7||
59683169|NCT01133704|75802374|FG000|NOT COMPLETED|Overall Study||49||
59683170|NCT01133704|75802375|FG001|NOT COMPLETED|Overall Study||26||
59683171|NCT01133665|75802381|FG000|STARTED|Overall Study||42||
59683172|NCT01133665|75802381|FG000|COMPLETED|Overall Study||40||
59683173|NCT01133665|75802381|FG000|NOT COMPLETED|Overall Study||2||
59683174|NCT01133626|75802388|FG000|STARTED|Overall Study||50||
59683175|NCT01133626|75802389|FG001|STARTED|Overall Study||46||
59683176|NCT01133626|75802390|FG002|STARTED|Overall Study||11||
59683177|NCT01133626|75802388|FG000|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|50||
59683178|NCT01133626|75802389|FG001|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|46||
59683179|NCT01133626|75802390|FG002|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|11||
59683180|NCT01133626|75802388|FG000|Per Protocol Population|Overall Study|Received >=1 dose of study drug and >=1 post-baseline assessment prior to major protocol deviation.|48||
59683181|NCT01133626|75802389|FG001|Per Protocol Population|Overall Study|Received >=1 dose of study drug and >=1 post-baseline assessment prior to major protocol deviation.|41||
59683182|NCT01133626|75802390|FG002|Per Protocol Population|Overall Study|Received >=1 dose of study drug and >=1 post-baseline assessment prior to major protocol deviation.|9||
59683183|NCT01133626|75802388|FG000|COMPLETED|Overall Study||49||
59683184|NCT01133626|75802389|FG001|COMPLETED|Overall Study||41||
59683185|NCT01133626|75802390|FG002|COMPLETED|Overall Study||9||
59683186|NCT01133626|75802388|FG000|NOT COMPLETED|Overall Study||1||
59683187|NCT01133626|75802389|FG001|NOT COMPLETED|Overall Study||5||
59683188|NCT01133626|75802390|FG002|NOT COMPLETED|Overall Study||2||
59683189|NCT01133392|75802400|FG000|STARTED|First Intervention (1 Day )||20||
59683190|NCT01133392|75802401|FG001|STARTED|First Intervention (1 Day )||18||
59683191|NCT01133392|75802400|FG000|COMPLETED|First Intervention (1 Day )||20||
59683192|NCT01133392|75802401|FG001|COMPLETED|First Intervention (1 Day )||18||
59683193|NCT01133392|75802400|FG000|NOT COMPLETED|First Intervention (1 Day )||0||
59683194|NCT01133392|75802401|FG001|NOT COMPLETED|First Intervention (1 Day )||0||
59683195|NCT01133392|75802400|FG000|STARTED|Interval Between Dosing (4-7 Days)||20||
59683196|NCT01133392|75802401|FG001|STARTED|Interval Between Dosing (4-7 Days)||18||
59683197|NCT01133392|75802400|FG000|COMPLETED|Interval Between Dosing (4-7 Days)||20||
59683198|NCT01133392|75802401|FG001|COMPLETED|Interval Between Dosing (4-7 Days)||17||
59683199|NCT01133392|75802400|FG000|NOT COMPLETED|Interval Between Dosing (4-7 Days)||0||
59683200|NCT01133392|75802401|FG001|NOT COMPLETED|Interval Between Dosing (4-7 Days)||1||
59683201|NCT01133392|75802400|FG000|STARTED|Second Intervention (1 Day)||20||
59683202|NCT01133392|75802401|FG001|STARTED|Second Intervention (1 Day)||17||
59683203|NCT01133392|75802400|FG000|COMPLETED|Second Intervention (1 Day)||20||
59683204|NCT01133392|75802401|FG001|COMPLETED|Second Intervention (1 Day)||17||
59683205|NCT01133392|75802400|FG000|NOT COMPLETED|Second Intervention (1 Day)||0||
59683206|NCT01133392|75802401|FG001|NOT COMPLETED|Second Intervention (1 Day)||0||
59683207|NCT01133392|75802400|FG000|STARTED|Interval Between Dosing (4-7 Days)||20||
59683208|NCT01133392|75802401|FG001|STARTED|Interval Between Dosing (4-7 Days)||17||
59683209|NCT01133392|75802400|FG000|COMPLETED|Interval Between Dosing (4-7 Days)||20||
59683210|NCT01133392|75802401|FG001|COMPLETED|Interval Between Dosing (4-7 Days)||17||
59683211|NCT01133392|75802400|FG000|NOT COMPLETED|Interval Between Dosing (4-7 Days)||0||
59683212|NCT01133392|75802401|FG001|NOT COMPLETED|Interval Between Dosing (4-7 Days)||0||
59683213|NCT01133392|75802400|FG000|STARTED|Third Intervention (1 Day)||20||
59683214|NCT01133392|75802401|FG001|STARTED|Third Intervention (1 Day)||17||
59683215|NCT01133392|75802400|FG000|COMPLETED|Third Intervention (1 Day)||20||
59683216|NCT01133392|75802401|FG001|COMPLETED|Third Intervention (1 Day)||17||
59683217|NCT01133392|75802400|FG000|NOT COMPLETED|Third Intervention (1 Day)||0||
59683218|NCT01133392|75802401|FG001|NOT COMPLETED|Third Intervention (1 Day)||0||
59683219|NCT01133392|75802400|FG000|STARTED|Interval Between Dosing (4-7 Days)||20||
59683220|NCT01133392|75802401|FG001|STARTED|Interval Between Dosing (4-7 Days)||17||
59683221|NCT01133392|75802400|FG000|COMPLETED|Interval Between Dosing (4-7 Days)||20||
59683222|NCT01133392|75802401|FG001|COMPLETED|Interval Between Dosing (4-7 Days)||16||
59683223|NCT01133392|75802400|FG000|NOT COMPLETED|Interval Between Dosing (4-7 Days)||0||
59683224|NCT01133392|75802401|FG001|NOT COMPLETED|Interval Between Dosing (4-7 Days)||1||
59683225|NCT01133392|75802400|FG000|STARTED|Fourth Intervention (1 Day)||20||
59683226|NCT01133392|75802401|FG001|STARTED|Fourth Intervention (1 Day)||16||
59683227|NCT01133392|75802400|FG000|COMPLETED|Fourth Intervention (1 Day)||20||
59683228|NCT01133392|75802401|FG001|COMPLETED|Fourth Intervention (1 Day)||16||
59683229|NCT01133392|75802400|FG000|NOT COMPLETED|Fourth Intervention (1 Day)||0||
59683230|NCT01133392|75802401|FG001|NOT COMPLETED|Fourth Intervention (1 Day)||0||
59683231|NCT00471354|75802407|FG000|STARTED|Overall Study||228||
59683232|NCT00471354|75802407|FG000|COMPLETED|Overall Study||176||
59683233|NCT00471354|75802407|FG000|NOT COMPLETED|Overall Study||52||
59683234|NCT00471315|75802411|FG000|STARTED|Overall Study||18||
59683235|NCT00471315|75802411|FG000|COMPLETED|Overall Study||10||
59683236|NCT00471315|75802411|FG000|NOT COMPLETED|Overall Study||8||
59683237|NCT00471237|75802422|FG000|STARTED|Overall Study||90||
59683238|NCT00471237|75802423|FG001|STARTED|Overall Study||87||
59683239|NCT00471237|75802424|FG002|STARTED|Overall Study||82||
59683240|NCT00471237|75802425|FG003|STARTED|Overall Study||88||
59683241|NCT00471237|75802426|FG004|STARTED|Overall Study||87||
59683242|NCT00471237|75802427|FG005|STARTED|Overall Study||89||
59683243|NCT00471237|75802428|FG006|STARTED|Overall Study||41||
59683244|NCT00471237|75802422|FG000|COMPLETED|Overall Study||49||
59683245|NCT00471237|75802423|FG001|COMPLETED|Overall Study||45||
59683246|NCT00471237|75802424|FG002|COMPLETED|Overall Study||48||
59683247|NCT00471237|75802425|FG003|COMPLETED|Overall Study||43||
59683248|NCT00471237|75802426|FG004|COMPLETED|Overall Study||46||
59683249|NCT00471237|75802427|FG005|COMPLETED|Overall Study||50||
59683250|NCT00471237|75802428|FG006|COMPLETED|Overall Study||38||
59683251|NCT00471237|75802422|FG000|NOT COMPLETED|Overall Study||41||
59683252|NCT00471237|75802423|FG001|NOT COMPLETED|Overall Study||42||
59683253|NCT00471237|75802424|FG002|NOT COMPLETED|Overall Study||34||
59683254|NCT00471237|75802425|FG003|NOT COMPLETED|Overall Study||45||
59683255|NCT00471237|75802426|FG004|NOT COMPLETED|Overall Study||41||
59683256|NCT00471237|75802427|FG005|NOT COMPLETED|Overall Study||39||
59683257|NCT00471237|75802428|FG006|NOT COMPLETED|Overall Study||3||
59683258|NCT00471081|75802450|FG000|STARTED|Active Phase||160||
59683259|NCT00471081|75802451|FG001|STARTED|Active Phase||189||
59683260|NCT00471081|75802450|FG000|COMPLETED|Active Phase||158||
59683261|NCT00471081|75802451|FG001|COMPLETED|Active Phase||176||
59683262|NCT00471081|75802450|FG000|NOT COMPLETED|Active Phase||2||
59683263|NCT00471081|75802451|FG001|NOT COMPLETED|Active Phase||13||
59683264|NCT00471081|75802450|FG000|STARTED|Extended Safety Follow-Up||160||
59683265|NCT00471081|75802451|FG001|STARTED|Extended Safety Follow-Up||189||
59683266|NCT00471081|75802450|FG000|COMPLETED|Extended Safety Follow-Up||158||
59683267|NCT00471081|75802451|FG001|COMPLETED|Extended Safety Follow-Up||176||
59683268|NCT00471081|75802450|FG000|NOT COMPLETED|Extended Safety Follow-Up||2||
59683269|NCT00471081|75802451|FG001|NOT COMPLETED|Extended Safety Follow-Up||13||
59683270|NCT00470847|75802458|FG000|STARTED|Overall Study||35||
59683271|NCT00470847|75802458|FG000|COMPLETED|Overall Study||34||
59683272|NCT00470847|75802458|FG000|NOT COMPLETED|Overall Study||1||
59683273|NCT00470535|75802464|FG000|STARTED|Overall Study||18||
59683274|NCT00470535|75802464|FG000|COMPLETED|Overall Study||0||
59683275|NCT00470535|75802464|FG000|NOT COMPLETED|Overall Study||18||
59683276|NCT00470418|75802470|FG000|STARTED|Overall Study||7||
59816074|NCT00530270|75938415|FG000|NOT COMPLETED|Overall Study||1||
59683277|NCT00470418|75802471|FG001|STARTED|Overall Study||3||
59683278|NCT00470418|75802470|FG000|COMPLETED|Overall Study||6||
59683279|NCT00470418|75802471|FG001|COMPLETED|Overall Study||3||
59683280|NCT00470418|75802470|FG000|NOT COMPLETED|Overall Study||1||
59683281|NCT00470418|75802471|FG001|NOT COMPLETED|Overall Study||0||
59683282|NCT01133275|75802477|FG000|STARTED|Overall Study||28||
59683283|NCT01133275|75802477|FG000|COMPLETED|Overall Study||26||
59683284|NCT01133275|75802477|FG000|NOT COMPLETED|Overall Study||2||
59683285|NCT00470184|75802481|FG000|STARTED|Overall Study||41||
59683286|NCT00470184|75802481|FG000|Treated With Study Therapy|Overall Study||36||
59683287|NCT00470184|75802481|FG000|COMPLETED|Overall Study||19||
59683288|NCT00470184|75802481|FG000|NOT COMPLETED|Overall Study||22||
59683289|NCT00470067|75802486|FG000|STARTED|Overall Study||9||
59683290|NCT00470067|75802486|FG000|COMPLETED|Overall Study||2||
59683291|NCT00470067|75802486|FG000|NOT COMPLETED|Overall Study||7||
59683292|NCT00475020|75802490|FG000|STARTED|Overall Study||63||
59683293|NCT00475020|75802490|FG000|COMPLETED|Overall Study||58||
59683294|NCT00475020|75802490|FG000|NOT COMPLETED|Overall Study||5||
59683295|NCT02484456|75802496|FG000|STARTED|First Treatment Period: Week 1||10||
59683296|NCT02484456|75802497|FG001|STARTED|First Treatment Period: Week 1||9||
59683297|NCT02484456|75802496|FG000|COMPLETED|First Treatment Period: Week 1||10||
59683298|NCT02484456|75802497|FG001|COMPLETED|First Treatment Period: Week 1||9||
59683299|NCT02484456|75802496|FG000|NOT COMPLETED|First Treatment Period: Week 1||0||
59683300|NCT02484456|75802497|FG001|NOT COMPLETED|First Treatment Period: Week 1||0||
59683301|NCT02484456|75802496|FG000|STARTED|First Treatment Period: Week 2||10||
59683302|NCT02484456|75802497|FG001|STARTED|First Treatment Period: Week 2||9||
59683303|NCT02484456|75802496|FG000|COMPLETED|First Treatment Period: Week 2||10||
59683304|NCT02484456|75802497|FG001|COMPLETED|First Treatment Period: Week 2||9||
59683305|NCT02484456|75802496|FG000|NOT COMPLETED|First Treatment Period: Week 2||0||
59683306|NCT02484456|75802497|FG001|NOT COMPLETED|First Treatment Period: Week 2||0||
59683307|NCT02484456|75802496|FG000|STARTED|Washout Period||10||
59683308|NCT02484456|75802497|FG001|STARTED|Washout Period||9||
59683309|NCT02484456|75802496|FG000|COMPLETED|Washout Period||10||
59683310|NCT02484456|75802497|FG001|COMPLETED|Washout Period||8||
59683311|NCT02484456|75802496|FG000|NOT COMPLETED|Washout Period||0||
59683312|NCT02484456|75802497|FG001|NOT COMPLETED|Washout Period||1||
59683313|NCT02484456|75802496|FG000|STARTED|Second Treatment Period: Week 1||10||
59683314|NCT02484456|75802497|FG001|STARTED|Second Treatment Period: Week 1||8||
59683315|NCT02484456|75802496|FG000|COMPLETED|Second Treatment Period: Week 1||9||
60079144|NCT00046228|76194448|FG001|NOT COMPLETED|90 Days||8||
60079145|NCT00046228|76194449|FG002|NOT COMPLETED|90 Days||15||
60079146|NCT00046228|76194447|FG000|STARTED|1 Year|This is the number of participants that were originally randomized to the trial.|806||
60079147|NCT00046228|76194448|FG001|STARTED|1 Year|This is the number of participants that were originally randomized to the trial.|818||
60079148|NCT00046228|76194449|FG002|STARTED|1 Year|This is the number of participants that were originally randomized to the trial.|828||
60079149|NCT00046228|76194447|FG000|COMPLETED|1 Year|The number completed includes subjects who died or were seen for a visit within specified window.|787||
59683316|NCT02484456|75802497|FG001|COMPLETED|Second Treatment Period: Week 1||7||
59683317|NCT02484456|75802496|FG000|NOT COMPLETED|Second Treatment Period: Week 1||1||
59683318|NCT02484456|75802497|FG001|NOT COMPLETED|Second Treatment Period: Week 1||1||
59683319|NCT02484456|75802496|FG000|STARTED|Second Treatment Period: Week 2||9||
59683320|NCT02484456|75802497|FG001|STARTED|Second Treatment Period: Week 2||7||
59683321|NCT02484456|75802496|FG000|COMPLETED|Second Treatment Period: Week 2||9||
59683322|NCT02484456|75802497|FG001|COMPLETED|Second Treatment Period: Week 2||6||
59683323|NCT02484456|75802496|FG000|NOT COMPLETED|Second Treatment Period: Week 2||0||
60079150|NCT00046228|76194448|FG001|COMPLETED|1 Year|The number completed includes subjects who died or were seen for a visit within specified window.|804||
60079151|NCT00046228|76194449|FG002|COMPLETED|1 Year|The number completed includes subjects who died or were seen for a visit within specified window|816||
60079152|NCT00046228|76194447|FG000|NOT COMPLETED|1 Year||19||
60079153|NCT00046228|76194448|FG001|NOT COMPLETED|1 Year||14||
59683324|NCT02484456|75802497|FG001|NOT COMPLETED|Second Treatment Period: Week 2||1||
59683325|NCT01132807|75802504|FG000|STARTED|Initial ABVD Treatment (2 Cycles)||15||
59683326|NCT01132807|75802505|FG001|STARTED|Initial ABVD Treatment (2 Cycles)||135||
59683327|NCT01132807|75802506|FG002|STARTED|Initial ABVD Treatment (2 Cycles)||14||
59683328|NCT01132807|75802504|FG000|COMPLETED|Initial ABVD Treatment (2 Cycles)||0||
59683329|NCT01132807|75802505|FG001|COMPLETED|Initial ABVD Treatment (2 Cycles)||135||
59683330|NCT01132807|75802506|FG002|COMPLETED|Initial ABVD Treatment (2 Cycles)||14||
59683331|NCT01132807|75802504|FG000|NOT COMPLETED|Initial ABVD Treatment (2 Cycles)||15||
59683332|NCT01132807|75802505|FG001|NOT COMPLETED|Initial ABVD Treatment (2 Cycles)||0||
59683333|NCT01132807|75802506|FG002|NOT COMPLETED|Initial ABVD Treatment (2 Cycles)||0||
59683334|NCT01132807|75802504|FG000|STARTED|Post-Cycle 2 PET Assessment||0||
59683335|NCT01132807|75802505|FG001|STARTED|Post-Cycle 2 PET Assessment||135||
59683336|NCT01132807|75802506|FG002|STARTED|Post-Cycle 2 PET Assessment||14||
59683337|NCT01132807|75802504|FG000|COMPLETED|Post-Cycle 2 PET Assessment||0||
59683338|NCT01132807|75802505|FG001|COMPLETED|Post-Cycle 2 PET Assessment||135||
59683339|NCT01132807|75802506|FG002|COMPLETED|Post-Cycle 2 PET Assessment||14||
60079154|NCT00046228|76194449|FG002|NOT COMPLETED|1 Year||12||
60079155|NCT00205504|76194459|FG000|STARTED|Overall Study||21||
60079156|NCT00205504|76194460|FG001|STARTED|Overall Study||15||
59683340|NCT01132807|75802504|FG000|NOT COMPLETED|Post-Cycle 2 PET Assessment||0||
59683341|NCT01132807|75802505|FG001|NOT COMPLETED|Post-Cycle 2 PET Assessment||0||
59683342|NCT01132807|75802506|FG002|NOT COMPLETED|Post-Cycle 2 PET Assessment||0||
59683343|NCT01132651|75802516|FG000|STARTED|Overall Study||4||
59683344|NCT01132651|75802517|FG001|STARTED|Overall Study||5||
59683345|NCT01132651|75802516|FG000|COMPLETED|Overall Study||3||
59683346|NCT01132651|75802517|FG001|COMPLETED|Overall Study||4||
59683347|NCT01132651|75802516|FG000|NOT COMPLETED|Overall Study||1||
59683348|NCT01132651|75802517|FG001|NOT COMPLETED|Overall Study||1||
59683349|NCT01089543|75802527|FG000|STARTED|Overall Study||84||
59683350|NCT01089543|75802528|FG001|STARTED|Overall Study||85||
59683351|NCT01089543|75802529|FG002|STARTED|Overall Study||84||
59683352|NCT01089543|75802530|FG003|STARTED|Overall Study||85||
59683353|NCT01089543|75802527|FG000|COMPLETED|Overall Study||81||
59683354|NCT01089543|75802528|FG001|COMPLETED|Overall Study||81||
59683355|NCT01089543|75802529|FG002|COMPLETED|Overall Study||81||
59683356|NCT01089543|75802530|FG003|COMPLETED|Overall Study||83||
59683357|NCT01089543|75802527|FG000|NOT COMPLETED|Overall Study||3||
59683358|NCT01089543|75802528|FG001|NOT COMPLETED|Overall Study||4||
59683359|NCT01089543|75802529|FG002|NOT COMPLETED|Overall Study||3||
59683360|NCT01089543|75802530|FG003|NOT COMPLETED|Overall Study||2||
59683361|NCT01089504|75802542|FG000|STARTED|Overall Study||8||
59683362|NCT01089504|75802543|FG001|STARTED|Overall Study||5||
59683363|NCT01089504|75802542|FG000|COMPLETED|Overall Study||5||
59683364|NCT01089504|75802543|FG001|COMPLETED|Overall Study||4||
59683365|NCT01089504|75802542|FG000|NOT COMPLETED|Overall Study||3||
59683366|NCT01089504|75802543|FG001|NOT COMPLETED|Overall Study||1||
59683367|NCT01088997|75802551|FG000|STARTED|Overall Study||7||
59683368|NCT01088997|75802552|FG001|STARTED|Overall Study||5||
59683369|NCT01088997|75802551|FG000|COMPLETED|Overall Study||4||
59683370|NCT01088997|75802552|FG001|COMPLETED|Overall Study||2||
59683371|NCT01088997|75802551|FG000|NOT COMPLETED|Overall Study||3||
59683372|NCT01088997|75802552|FG001|NOT COMPLETED|Overall Study||3||
59683373|NCT01088529|75802563|FG000|STARTED|Overall Study||44||
59683374|NCT01088529|75802564|FG001|STARTED|Overall Study||22||
59683375|NCT01088529|75802563|FG000|Received Treatment|Overall Study||44||
59683376|NCT01088529|75802564|FG001|Received Treatment|Overall Study||21||
59683377|NCT01088529|75802563|FG000|COMPLETED|Overall Study||44||
59683378|NCT01088529|75802564|FG001|COMPLETED|Overall Study||21||
59683379|NCT01088529|75802563|FG000|NOT COMPLETED|Overall Study||0||
59683380|NCT01088529|75802564|FG001|NOT COMPLETED|Overall Study||1||
59683381|NCT01087944|75802570|FG000|STARTED|Period 1 (Week 1-3)||30||
59683382|NCT01087944|75802571|FG001|STARTED|Period 1 (Week 1-3)||30||
59683383|NCT01087944|75802570|FG000|COMPLETED|Period 1 (Week 1-3)||29||
59683384|NCT01087944|75802571|FG001|COMPLETED|Period 1 (Week 1-3)||30||
59683385|NCT01087944|75802570|FG000|NOT COMPLETED|Period 1 (Week 1-3)||1||
59683386|NCT01087944|75802571|FG001|NOT COMPLETED|Period 1 (Week 1-3)||0||
59683387|NCT01087944|75802570|FG000|STARTED|Period 2 (Week 4-6)||29||
59683388|NCT01087944|75802571|FG001|STARTED|Period 2 (Week 4-6)||30||
59683389|NCT01087944|75802570|FG000|COMPLETED|Period 2 (Week 4-6)||29||
59683390|NCT01087944|75802571|FG001|COMPLETED|Period 2 (Week 4-6)||28||
59683391|NCT01087944|75802570|FG000|NOT COMPLETED|Period 2 (Week 4-6)||0||
59683392|NCT01087944|75802571|FG001|NOT COMPLETED|Period 2 (Week 4-6)||2||
59683393|NCT01132612|75802580|FG000|STARTED|Overall Study||46||
59683394|NCT01132612|75802581|FG001|STARTED|Overall Study||42||
59683395|NCT01132612|75802582|FG002|STARTED|Overall Study||187||
59683396|NCT01132612|75802580|FG000|COMPLETED|Overall Study||6||
59547156|NCT01116986|75645928|FG019|COMPLETED|Overall Study||13||
59547157|NCT01116986|75645929|FG020|COMPLETED|Overall Study||22||
59547158|NCT01116986|75645930|FG021|COMPLETED|Overall Study||18||
59547159|NCT01116986|75645931|FG022|COMPLETED|Overall Study||19||
59547160|NCT01116986|75645932|FG023|COMPLETED|Overall Study||19||
59547161|NCT01116986|75645933|FG024|COMPLETED|Overall Study||15||
59547162|NCT01116986|75645934|FG025|COMPLETED|Overall Study||19||
59547163|NCT01116986|75645935|FG026|COMPLETED|Overall Study||14||
59547164|NCT01116986|75645936|FG027|COMPLETED|Overall Study||18||
59547165|NCT01116986|75645937|FG028|COMPLETED|Overall Study||17||
59547166|NCT01116986|75645938|FG029|COMPLETED|Overall Study||17||
59547167|NCT01116986|75645939|FG030|COMPLETED|Overall Study||16||
59683397|NCT01132612|75802581|FG001|COMPLETED|Overall Study||7||
59683398|NCT01132612|75802582|FG002|COMPLETED|Overall Study||17||
59683399|NCT01132612|75802580|FG000|NOT COMPLETED|Overall Study||40||
59683400|NCT01132612|75802581|FG001|NOT COMPLETED|Overall Study||35||
59683401|NCT01132612|75802582|FG002|NOT COMPLETED|Overall Study||170||
59683402|NCT01132495|75802594|FG000|STARTED|Overall Study||447||
59547168|NCT01116986|75645940|FG031|COMPLETED|Overall Study||14||
59683403|NCT01132495|75802595|FG001|STARTED|Overall Study||441||
59683404|NCT01132495|75802596|FG002|STARTED|Overall Study||166||
59683405|NCT01132495|75802597|FG003|STARTED|Overall Study||116||
59683406|NCT01132495|75802594|FG000|COMPLETED|Overall Study||407||
59683407|NCT01132495|75802595|FG001|COMPLETED|Overall Study||403||
59683408|NCT01132495|75802596|FG002|COMPLETED|Overall Study||146||
59683409|NCT01132495|75802597|FG003|COMPLETED|Overall Study||104||
59683410|NCT01132495|75802594|FG000|NOT COMPLETED|Overall Study||40||
59683411|NCT01132495|75802595|FG001|NOT COMPLETED|Overall Study||38||
59683412|NCT01132495|75802596|FG002|NOT COMPLETED|Overall Study||20||
59683413|NCT01132495|75802597|FG003|NOT COMPLETED|Overall Study||12||
59683414|NCT01087905|75802616|FG000|STARTED|Overall Study||119||
59683415|NCT01087905|75802617|FG001|STARTED|Overall Study||126||
59683416|NCT01087905|75802618|FG002|STARTED|Overall Study||123||
59683417|NCT01087905|75802619|FG003|STARTED|Overall Study||122||
59683418|NCT01087905|75802620|FG004|STARTED|Overall Study||122||
59683419|NCT01087905|75802621|FG005|STARTED|Overall Study||127||
59683420|NCT01087905|75802622|FG006|STARTED|Overall Study||121||
59683421|NCT01087905|75802623|FG007|STARTED|Overall Study||127||
59683422|NCT01087905|75802616|FG000|COMPLETED|Overall Study||90||
59683423|NCT01087905|75802617|FG001|COMPLETED|Overall Study||94||
59683424|NCT01087905|75802618|FG002|COMPLETED|Overall Study||101||
59683425|NCT01087905|75802619|FG003|COMPLETED|Overall Study||86||
59683426|NCT01087905|75802620|FG004|COMPLETED|Overall Study||91||
59683427|NCT01087905|75802621|FG005|COMPLETED|Overall Study||99||
59683428|NCT01087905|75802622|FG006|COMPLETED|Overall Study||98||
59683429|NCT01087905|75802623|FG007|COMPLETED|Overall Study||98||
59683430|NCT01087905|75802616|FG000|NOT COMPLETED|Overall Study||29||
59683431|NCT01087905|75802617|FG001|NOT COMPLETED|Overall Study||32||
59683432|NCT01087905|75802618|FG002|NOT COMPLETED|Overall Study||22||
59683433|NCT01087905|75802619|FG003|NOT COMPLETED|Overall Study||36||
59683434|NCT01087905|75802620|FG004|NOT COMPLETED|Overall Study||31||
59683435|NCT01087905|75802621|FG005|NOT COMPLETED|Overall Study||28||
59683436|NCT01087905|75802622|FG006|NOT COMPLETED|Overall Study||23||
59683437|NCT01087905|75802623|FG007|NOT COMPLETED|Overall Study||29||
60079157|NCT00205504|76194459|FG000|COMPLETED|Overall Study||14||
60079158|NCT00205504|76194460|FG001|COMPLETED|Overall Study||15||
60079159|NCT00205504|76194459|FG000|NOT COMPLETED|Overall Study||7||
60079160|NCT00205504|76194460|FG001|NOT COMPLETED|Overall Study||0||
60079161|NCT00205660|76194472|FG000|STARTED|Overall Study||14||
60079162|NCT00205660|76194473|FG001|STARTED|Overall Study||37||
59547169|NCT01116986|75645909|FG000|NOT COMPLETED|Overall Study||2||
59547170|NCT01116986|75645910|FG001|NOT COMPLETED|Overall Study||3||
59547171|NCT01116986|75645911|FG002|NOT COMPLETED|Overall Study||2||
59547172|NCT01116986|75645912|FG003|NOT COMPLETED|Overall Study||2||
59547173|NCT01116986|75645913|FG004|NOT COMPLETED|Overall Study||4||
59547174|NCT01116986|75645914|FG005|NOT COMPLETED|Overall Study||2||
59547175|NCT01116986|75645915|FG006|NOT COMPLETED|Overall Study||2||
59547176|NCT01116986|75645916|FG007|NOT COMPLETED|Overall Study||2||
59547177|NCT01116986|75645917|FG008|NOT COMPLETED|Overall Study||1||
59547178|NCT01116986|75645918|FG009|NOT COMPLETED|Overall Study||4||
59547179|NCT01116986|75645919|FG010|NOT COMPLETED|Overall Study||1||
59547180|NCT01116986|75645920|FG011|NOT COMPLETED|Overall Study||0||
59547181|NCT01116986|75645921|FG012|NOT COMPLETED|Overall Study||1||
59547182|NCT01116986|75645922|FG013|NOT COMPLETED|Overall Study||3||
59547183|NCT01116986|75645923|FG014|NOT COMPLETED|Overall Study||0||
59547184|NCT01116986|75645924|FG015|NOT COMPLETED|Overall Study||6||
59547185|NCT01116986|75645925|FG016|NOT COMPLETED|Overall Study||3||
59547186|NCT01116986|75645926|FG017|NOT COMPLETED|Overall Study||5||
59547187|NCT01116986|75645927|FG018|NOT COMPLETED|Overall Study||3||
59547188|NCT01116986|75645928|FG019|NOT COMPLETED|Overall Study||2||
59547189|NCT01116986|75645929|FG020|NOT COMPLETED|Overall Study||2||
59547190|NCT01116986|75645930|FG021|NOT COMPLETED|Overall Study||2||
59547191|NCT01116986|75645931|FG022|NOT COMPLETED|Overall Study||4||
59547192|NCT01116986|75645932|FG023|NOT COMPLETED|Overall Study||2||
59547193|NCT01116986|75645933|FG024|NOT COMPLETED|Overall Study||3||
59547194|NCT01116986|75645934|FG025|NOT COMPLETED|Overall Study||0||
59547195|NCT01116986|75645935|FG026|NOT COMPLETED|Overall Study||4||
59547196|NCT01116986|75645936|FG027|NOT COMPLETED|Overall Study||1||
59547197|NCT01116986|75645937|FG028|NOT COMPLETED|Overall Study||0||
59547198|NCT01116986|75645938|FG029|NOT COMPLETED|Overall Study||0||
59547199|NCT01116986|75645939|FG030|NOT COMPLETED|Overall Study||1||
59547200|NCT01116986|75645940|FG031|NOT COMPLETED|Overall Study||3||
59547201|NCT01098422|75645960|FG000|STARTED|Overall Study||10||
59547202|NCT01098422|75645960|FG000|COMPLETED|Overall Study||9||
59683438|NCT01087788|75802642|FG000|STARTED|24-weeks Double-blind Period||136||
59683439|NCT01087788|75802643|FG001|STARTED|24-weeks Double-blind Period||138||
59683440|NCT01087788|75802644|FG002|STARTED|24-weeks Double-blind Period||135||
59709789|NCT01072149|75828537|FG017|STARTED|Washout Period 1 (14 Days)||2||
60079163|NCT00205660|76194472|FG000|COMPLETED|Overall Study||12||
60079164|NCT00205660|76194473|FG001|COMPLETED|Overall Study||35||
60079165|NCT00205660|76194472|FG000|NOT COMPLETED|Overall Study||2||
60079166|NCT00205660|76194473|FG001|NOT COMPLETED|Overall Study||2||
59547203|NCT01098422|75645960|FG000|NOT COMPLETED|Overall Study||1||
59547204|NCT01098500|75645964|FG000|STARTED|Overall Study||3800||
59547205|NCT01098500|75645964|FG000|COMPLETED|Overall Study||3800||
59547206|NCT01098500|75645964|FG000|NOT COMPLETED|Overall Study||0||
59547207|NCT01098578|75645968|FG000|STARTED|Overall Study||20||
59547208|NCT01098578|75645968|FG000|COMPLETED|Overall Study||20||
59547209|NCT01098578|75645968|FG000|NOT COMPLETED|Overall Study||0||
59547210|NCT01099202|75645976|FG000|STARTED|Overall Study||55||
60079167|NCT00113230|76194480|FG000|STARTED|Overall Study||25||
59683441|NCT01087788|75802642|FG000|Received CZP 200 mg Q2W at 16 Weeks|24-weeks Double-blind Period|30 subjects left the Placebo group and were re-randomized to CZP 200 mg Q2W on Week 16.|30||
59683442|NCT01087788|75802643|FG001|Received CZP 200 mg Q2W at 16 Weeks|24-weeks Double-blind Period|not applicable for this arm|0||
59683443|NCT01087788|75802644|FG002|Received CZP 200 mg Q2W at 16 Weeks|24-weeks Double-blind Period|not applicable for this arm|0||
59683444|NCT01087788|75802642|FG000|Received CZP 400 mg Q4W at 16 Weeks|24-weeks Double-blind Period|29 subjects left the Placebo group and were re-randomized to CZP 400 mg Q4W on Week 16.|29||
59683445|NCT01087788|75802643|FG001|Received CZP 400 mg Q4W at 16 Weeks|24-weeks Double-blind Period|not applicable for this arm|0||
59683446|NCT01087788|75802644|FG002|Received CZP 400 mg Q4W at 16 Weeks|24-weeks Double-blind Period|not applicable for this arm|0||
59683447|NCT01087788|75802642|FG000|COMPLETED|24-weeks Double-blind Period||120||
59683448|NCT01087788|75802643|FG001|COMPLETED|24-weeks Double-blind Period||128||
59683449|NCT01087788|75802644|FG002|COMPLETED|24-weeks Double-blind Period||120||
59683450|NCT01087788|75802642|FG000|NOT COMPLETED|24-weeks Double-blind Period||16||
59683451|NCT01087788|75802643|FG001|NOT COMPLETED|24-weeks Double-blind Period||10||
59683452|NCT01087788|75802644|FG002|NOT COMPLETED|24-weeks Double-blind Period||15||
59683453|NCT01087788|75802642|FG000|STARTED|24-weeks Dose-blind Period||120||
59683454|NCT01087788|75802643|FG001|STARTED|24-weeks Dose-blind Period||128||
59683455|NCT01087788|75802644|FG002|STARTED|24-weeks Dose-blind Period||120||
59683456|NCT01087788|75802642|FG000|Received CZP 200 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|Sum of subjects re-randomized to CZP 200mg Q2W at week 16 (30 subjects) and at week 24 (30 subjects)|60||
59683457|NCT01087788|75802643|FG001|Received CZP 200 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|not applicable for this arm|0||
59683458|NCT01087788|75802644|FG002|Received CZP 200 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|not applicable for this arm|0||
59683459|NCT01087788|75802642|FG000|Received CZP 400 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|Sum of subjects re-randomized to CZP 400mg Q2W at week 16 (29 subjects) and at week 24 (31 subjects)|60||
59683460|NCT01087788|75802643|FG001|Received CZP 400 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|not applicable for this arm|0||
59683461|NCT01087788|75802644|FG002|Received CZP 400 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|not applicable for this arm|0||
59683462|NCT01087788|75802642|FG000|COMPLETED|24-weeks Dose-blind Period||113||
59683463|NCT01087788|75802643|FG001|COMPLETED|24-weeks Dose-blind Period||123||
59683464|NCT01087788|75802644|FG002|COMPLETED|24-weeks Dose-blind Period||114||
59683465|NCT01087788|75802642|FG000|NOT COMPLETED|24-weeks Dose-blind Period||7||
59683466|NCT01087788|75802643|FG001|NOT COMPLETED|24-weeks Dose-blind Period||5||
59683467|NCT01087788|75802644|FG002|NOT COMPLETED|24-weeks Dose-blind Period||6||
59683468|NCT01087788|75802642|FG000|STARTED|Open-Label Period (OL-P)|2 subj. completed the Dose-Blind Period, then withdrew from the study rather than entering the OL-P.|111||
59683469|NCT01087788|75802643|FG001|STARTED|Open-Label Period (OL-P)|2 subj. completed the Dose-Blind Period, then withdrew from the study rather than entering the OL-P.|121||
59683470|NCT01087788|75802644|FG002|STARTED|Open-Label Period (OL-P)||114||
59683471|NCT01087788|75802642|FG000|COMPLETED|Open-Label Period (OL-P)||81||
59683472|NCT01087788|75802643|FG001|COMPLETED|Open-Label Period (OL-P)||97||
59683473|NCT01087788|75802644|FG002|COMPLETED|Open-Label Period (OL-P)||86||
59683474|NCT01087788|75802642|FG000|NOT COMPLETED|Open-Label Period (OL-P)||30||
59683475|NCT01087788|75802643|FG001|NOT COMPLETED|Open-Label Period (OL-P)||24||
59683476|NCT01087788|75802644|FG002|NOT COMPLETED|Open-Label Period (OL-P)||28||
59683477|NCT01086969|75802656|FG000|STARTED|Overall Study||100||
59683478|NCT01086969|75802657|FG001|STARTED|Overall Study||100||
59683479|NCT01086969|75802658|FG002|STARTED|Overall Study||100||
59683480|NCT01086969|75802656|FG000|COMPLETED|Overall Study||99||
59683481|NCT01086969|75802657|FG001|COMPLETED|Overall Study||98||
59683482|NCT01086969|75802658|FG002|COMPLETED|Overall Study||100||
59683483|NCT01086969|75802656|FG000|NOT COMPLETED|Overall Study||1||
59683484|NCT01086969|75802657|FG001|NOT COMPLETED|Overall Study||2||
59683485|NCT01086969|75802658|FG002|NOT COMPLETED|Overall Study||0||
59683486|NCT01086423|75802669|FG000|STARTED|Overall Study||330||
59683487|NCT01086423|75802670|FG001|STARTED|Overall Study||324||
59683488|NCT01086423|75802671|FG002|STARTED|Overall Study||330||
59683489|NCT01086423|75802669|FG000|COMPLETED|Overall Study||320||
59683490|NCT01086423|75802670|FG001|COMPLETED|Overall Study||321||
59683491|NCT01086423|75802671|FG002|COMPLETED|Overall Study||321||
59683492|NCT01086423|75802669|FG000|NOT COMPLETED|Overall Study||10||
59683493|NCT01086423|75802670|FG001|NOT COMPLETED|Overall Study||3||
59683494|NCT01086423|75802671|FG002|NOT COMPLETED|Overall Study||9||
59683495|NCT01086150|75802682|FG000|STARTED|Overall Study||11||
59683496|NCT01086150|75802683|FG001|STARTED|Overall Study||27||
59683497|NCT01086150|75802684|FG002|STARTED|Overall Study||13||
59683498|NCT01086150|75802682|FG000|COMPLETED|Overall Study||11||
59683499|NCT01086150|75802683|FG001|COMPLETED|Overall Study||21||
59683500|NCT01086150|75802684|FG002|COMPLETED|Overall Study||12||
59683501|NCT01086150|75802682|FG000|NOT COMPLETED|Overall Study||0||
59683502|NCT01086150|75802683|FG001|NOT COMPLETED|Overall Study||6||
59683503|NCT01086150|75802684|FG002|NOT COMPLETED|Overall Study||1||
59683504|NCT01086033|75802692|FG000|STARTED|Overall Study||566||
59683505|NCT01086033|75802692|FG000|COMPLETED|Overall Study||262||
59683506|NCT01086033|75802692|FG000|NOT COMPLETED|Overall Study||304||
59683507|NCT01085682|75802701|FG000|STARTED|Overall Study||31||
59683508|NCT01085682|75802702|FG001|STARTED|Overall Study||28||
59683509|NCT01085682|75802701|FG000|COMPLETED|Overall Study||6||
59683510|NCT01085682|75802702|FG001|COMPLETED|Overall Study||3||
59683511|NCT01085682|75802701|FG000|NOT COMPLETED|Overall Study||25||
59683512|NCT01085682|75802702|FG001|NOT COMPLETED|Overall Study||25||
59683513|NCT01085214|75802708|FG000|STARTED|Overall Study||37||
59683514|NCT01085214|75802708|FG000|COMPLETED|Overall Study||36||
59683515|NCT01085214|75802708|FG000|NOT COMPLETED|Overall Study||1||
59683516|NCT01085136|75802712|FG000|STARTED|Part A||1154||
59683517|NCT01085136|75802713|FG001|STARTED|Part A|Only Afatinib monotherapy administered in Part A|0||
59683518|NCT01085136|75802714|FG002|STARTED|Part A||0||
59683519|NCT01085136|75802712|FG000|Randomized to Part B|Part A|Discontinued Part A -Randomized to Part B|206||
59683520|NCT01085136|75802713|FG001|Randomized to Part B|Part A||0||
59683521|NCT01085136|75802714|FG002|Randomized to Part B|Part A||0||
59683522|NCT01085136|75802712|FG000|COMPLETED|Part A|Randomized to Part B & completed trial as per protocol, had PD, clinical progression.|831||
59683523|NCT01085136|75802713|FG001|COMPLETED|Part A||0||
59683524|NCT01085136|75802714|FG002|COMPLETED|Part A||0||
59683525|NCT01085136|75802712|FG000|NOT COMPLETED|Part A||323||
59683526|NCT01085136|75802713|FG001|NOT COMPLETED|Part A||0||
59683527|NCT01085136|75802714|FG002|NOT COMPLETED|Part A||0||
59683528|NCT01085136|75802712|FG000|STARTED|Part B|Afatinib monotherapy not administered in Part B|0||
59683529|NCT01085136|75802713|FG001|STARTED|Part B||138||
59683530|NCT01085136|75802714|FG002|STARTED|Part B||68||
59683531|NCT01085136|75802712|FG000|COMPLETED|Part B|Afatinib monotherapy not administered in Part B|0||
59683532|NCT01085136|75802713|FG001|COMPLETED|Part B|Completed trial as per protocol, had progressive disease, clinical signs or symptoms of progression|87||
59683533|NCT01085136|75802714|FG002|COMPLETED|Part B|Completed trial as per protocol, had progressive disease, clinical signs or symptoms of progression|42||
59683534|NCT01085136|75802712|FG000|NOT COMPLETED|Part B||0||
59683535|NCT01085136|75802713|FG001|NOT COMPLETED|Part B||51||
59683536|NCT01085136|75802714|FG002|NOT COMPLETED|Part B||26||
59683537|NCT01084707|75802724|FG000|STARTED|Overall Study||40||
59683538|NCT01084707|75802724|FG000|COMPLETED|Overall Study||34||
59683539|NCT01084707|75802724|FG000|NOT COMPLETED|Overall Study||6||
59683540|NCT01084668|75802736|FG000|STARTED|Overall Study|Three participants who took Humira prior to study entry have been excluded from the database.|42||
59683541|NCT01084668|75802736|FG000|COMPLETED|Overall Study||33||
59683542|NCT01084668|75802736|FG000|NOT COMPLETED|Overall Study||9||
59683543|NCT01084551|75802745|FG000|STARTED|Overall Study||95||
59683544|NCT01084551|75802746|FG001|STARTED|Overall Study||95||
59683545|NCT01084551|75802747|FG002|STARTED|Overall Study||94||
59683546|NCT01084551|75802745|FG000|COMPLETED|Overall Study||86||
59683547|NCT01084551|75802746|FG001|COMPLETED|Overall Study||81||
59683548|NCT01084551|75802747|FG002|COMPLETED|Overall Study||86||
59683549|NCT01084551|75802745|FG000|NOT COMPLETED|Overall Study||9||
59683550|NCT01084551|75802746|FG001|NOT COMPLETED|Overall Study||14||
59683551|NCT01084551|75802747|FG002|NOT COMPLETED|Overall Study||8||
59683552|NCT01084005|75802757|FG000|STARTED|Overall Study||79||
59989670|NCT02478632|76105014|FG001|STARTED|Early Switch Phase (Up to Week 52)||49||
59989671|NCT02478632|76105013|FG000|COMPLETED|Early Switch Phase (Up to Week 52)||49||
59989672|NCT02478632|76105014|FG001|COMPLETED|Early Switch Phase (Up to Week 52)||44||
59989673|NCT02478632|76105013|FG000|NOT COMPLETED|Early Switch Phase (Up to Week 52)||4||
59683553|NCT01084005|75802758|FG001|STARTED|Overall Study||162||
59683554|NCT01084005|75802757|FG000|COMPLETED|Overall Study||74||
59683555|NCT01084005|75802758|FG001|COMPLETED|Overall Study||146||
59683556|NCT01084005|75802757|FG000|NOT COMPLETED|Overall Study||5||
59683557|NCT01084005|75802758|FG001|NOT COMPLETED|Overall Study||16||
59683558|NCT01083810|75802767|FG000|STARTED|Overall Study||137||
59683559|NCT01083810|75802768|FG001|STARTED|Overall Study||92||
59683560|NCT01083810|75802769|FG002|STARTED|Overall Study||55||
59683561|NCT01083810|75802767|FG000|COMPLETED|Overall Study||72||
59683562|NCT01083810|75802768|FG001|COMPLETED|Overall Study||47||
59683563|NCT01083810|75802769|FG002|COMPLETED|Overall Study||35||
59683564|NCT01083810|75802767|FG000|NOT COMPLETED|Overall Study||65||
59683565|NCT01083810|75802768|FG001|NOT COMPLETED|Overall Study||45||
59683566|NCT01083810|75802769|FG002|NOT COMPLETED|Overall Study||20||
59683567|NCT01083771|75802775|FG000|STARTED|Overall Study||21||
59683568|NCT01083771|75802775|FG000|COMPLETED|Overall Study||16||
59683569|NCT01083771|75802775|FG000|NOT COMPLETED|Overall Study||5||
59683570|NCT01083693|75802782|FG000|STARTED|Overall Study||93||
59683571|NCT01083693|75802783|FG001|STARTED|Overall Study||28||
59683572|NCT01083693|75802784|FG002|STARTED|Overall Study||40||
59683573|NCT01083693|75802782|FG000|COMPLETED|Overall Study||73||
59683574|NCT01083693|75802783|FG001|COMPLETED|Overall Study||22||
59683575|NCT01083693|75802784|FG002|COMPLETED|Overall Study||33||
59683576|NCT01083693|75802782|FG000|NOT COMPLETED|Overall Study||20||
59683577|NCT01083693|75802783|FG001|NOT COMPLETED|Overall Study||6||
59683578|NCT01083693|75802784|FG002|NOT COMPLETED|Overall Study||7||
59683579|NCT01083576|75802798|FG000|STARTED|Overall Study||15||
59683580|NCT01083576|75802799|FG001|STARTED|Overall Study||15||
59683581|NCT01083576|75802798|FG000|COMPLETED|Overall Study||9||
59683582|NCT01083576|75802799|FG001|COMPLETED|Overall Study||14||
59989674|NCT02478632|76105014|FG001|NOT COMPLETED|Early Switch Phase (Up to Week 52)||5||
59989675|NCT02478632|76105013|FG000|STARTED|Late Switch Phase (Week 52 to Week 148)||49||
59989676|NCT02478632|76105014|FG001|STARTED|Late Switch Phase (Week 52 to Week 148)||44||
60079168|NCT00113230|76194480|FG000|COMPLETED|Overall Study||25||
59683583|NCT01083576|75802798|FG000|NOT COMPLETED|Overall Study||6||
59683584|NCT01083576|75802799|FG001|NOT COMPLETED|Overall Study||1||
59683585|NCT01083186|75802806|FG000|STARTED|Overall Study||500||
59683586|NCT01083186|75802806|FG000|COMPLETED|Overall Study||406||
59683587|NCT01083186|75802806|FG000|NOT COMPLETED|Overall Study||94||
59683588|NCT01082640|75802833|FG000|STARTED|Overall Study||32||
59683589|NCT01082640|75802834|FG001|STARTED|Overall Study||32||
59683590|NCT01082640|75802835|FG002|STARTED|Overall Study||32||
59683591|NCT01082640|75802833|FG000|COMPLETED|Overall Study||15||
59683592|NCT01082640|75802834|FG001|COMPLETED|Overall Study||17||
59683593|NCT01082640|75802835|FG002|COMPLETED|Overall Study||24||
59683594|NCT01082640|75802833|FG000|NOT COMPLETED|Overall Study||17||
59683595|NCT01082640|75802834|FG001|NOT COMPLETED|Overall Study||15||
59683596|NCT01082640|75802835|FG002|NOT COMPLETED|Overall Study||8||
59683597|NCT01082367|75802848|FG000|STARTED|Double-blind Period||26||
59683598|NCT01082367|75802849|FG001|STARTED|Double-blind Period||25||
59683599|NCT01082367|75802848|FG000|Stage 1:1st Treatment (tx) Cycle|Double-blind Period||26||
59683600|NCT01082367|75802849|FG001|Stage 1:1st Treatment (tx) Cycle|Double-blind Period|1 participant discontinued after cycle 1 due to an SAE|25||
59683601|NCT01082367|75802848|FG000|Stage 2:no tx|Double-blind Period||0||
59683602|NCT01082367|75802849|FG001|Stage 2:no tx|Double-blind Period||0||
59683603|NCT01082367|75802848|FG000|Entered OL TOBI|Double-blind Period||4||
59683604|NCT01082367|75802849|FG001|Entered OL TOBI|Double-blind Period||18||
59683605|NCT01082367|75802848|FG000|P.A-free,Day 29 w/ no Cross-over|Double-blind Period||9||
59683606|NCT01082367|75802849|FG001|P.A-free,Day 29 w/ no Cross-over|Double-blind Period||0||
59683607|NCT01082367|75802848|FG000|Stage 3: Cross-over (co) tx|Double-blind Period||13||
59683608|NCT01082367|75802849|FG001|Stage 3: Cross-over (co) tx|Double-blind Period||6||
59683609|NCT01082367|75802848|FG000|Stage 4:no tx for Patients Not in co|Double-blind Period||0||
59683610|NCT01082367|75802849|FG001|Stage 4:no tx for Patients Not in co|Double-blind Period||0||
59683611|NCT01082367|75802848|FG000|COMPLETED|Double-blind Period||21||
59683612|NCT01082367|75802849|FG001|COMPLETED|Double-blind Period||12||
59683613|NCT01082367|75802848|FG000|NOT COMPLETED|Double-blind Period||5||
59683614|NCT01082367|75802849|FG001|NOT COMPLETED|Double-blind Period||13||
59683615|NCT01082367|75802848|FG000|STARTED|Follow-up (F-U) Period||19||
59683616|NCT01082367|75802849|FG001|STARTED|Follow-up (F-U) Period||10||
59683617|NCT01082367|75802848|FG000|Treated in F-U|Follow-up (F-U) Period||5||
59683618|NCT01082367|75802849|FG001|Treated in F-U|Follow-up (F-U) Period||5||
59683619|NCT01082367|75802848|FG000|COMPLETED|Follow-up (F-U) Period||17||
59683620|NCT01082367|75802849|FG001|COMPLETED|Follow-up (F-U) Period||9||
59683621|NCT01082367|75802848|FG000|NOT COMPLETED|Follow-up (F-U) Period||2||
59683622|NCT01082367|75802849|FG001|NOT COMPLETED|Follow-up (F-U) Period||1||
59683623|NCT01082211|75802859|FG000|STARTED|Overall Study||65||
59683624|NCT01082211|75802859|FG000|Has Baseline PT QOL Data|Overall Study||46|Eligible patients who consented to QOL study & have patient-reported baseline data|
59683625|NCT01082211|75802859|FG000|Has Baseline MD QOL Data|Overall Study||44|Eligible patients who consented to QOL study & have physician-assessed baseline data|
59683626|NCT01082211|75802859|FG000|Has Baseline/12-month PT QOL Data|Overall Study||36|Eligible patients who consented to QOL study & have patient-reported baseline/12-month data|
59683627|NCT01082211|75802859|FG000|Has Baseline/12-Month MD QOL Data|Overall Study||35|Eligible patients who consented to QOL study & have physician-assessed baseline/12-month data|
59683628|NCT01082211|75802859|FG000|Has Baseline/36-month PT QOL Data|Overall Study||32|Eligible patients who consented to QOL study & have patient-reported baseline/36-month data|
59683629|NCT01082211|75802859|FG000|Has Baseline/36-Month MD QOL Data|Overall Study||27|Eligible patients who consented to QOL study & have physician-assessed baseline/36-month data|
59683630|NCT01082211|75802859|FG000|All Eligible Patients|Overall Study||58||
59683631|NCT01082211|75802859|FG000|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|58||
59683632|NCT01082211|75802859|FG000|NOT COMPLETED|Overall Study||7||
59683633|NCT01081665|75802866|FG000|STARTED|Overall Study||237||
59683634|NCT01081665|75802866|FG000|Full Analysis Set|Overall Study||237||
59683635|NCT01081665|75802866|FG000|Evaluable Population|Overall Study|Participants with baseline and at least 2 post-baseline parathormone measurements at 24 months.|212||
59683636|NCT01081665|75802866|FG000|COMPLETED|Overall Study||142||
59683637|NCT01081665|75802866|FG000|NOT COMPLETED|Overall Study||95||
59683638|NCT01081626|75802872|FG000|STARTED|Overall Study||155||
59683639|NCT01081626|75802873|FG001|STARTED|Overall Study||155||
59683640|NCT01081626|75802872|FG000|Assessed for Efficacy|Overall Study||122||
59683641|NCT01081626|75802873|FG001|Assessed for Efficacy|Overall Study||125||
59683642|NCT01081626|75802872|FG000|COMPLETED|Overall Study||95||
59683643|NCT01081626|75802873|FG001|COMPLETED|Overall Study||94||
59683644|NCT01081626|75802872|FG000|NOT COMPLETED|Overall Study||60||
59683645|NCT01081626|75802873|FG001|NOT COMPLETED|Overall Study||61||
59683646|NCT01080768|75802881|FG000|STARTED|Overall Study||14||
59683647|NCT01080768|75802882|FG001|STARTED|Overall Study||17||
59683648|NCT01080768|75802881|FG000|COMPLETED|Overall Study||12||
59683649|NCT01080768|75802882|FG001|COMPLETED|Overall Study||16||
59683650|NCT01080768|75802881|FG000|NOT COMPLETED|Overall Study||2||
60079169|NCT00113230|76194480|FG000|NOT COMPLETED|Overall Study||0||
59683651|NCT01080768|75802882|FG001|NOT COMPLETED|Overall Study||1||
60079170|NCT00049036|76194486|FG000|STARTED|Overall Study||51||
59683652|NCT01080300|75802890|FG000|STARTED|Overall Study|302 subjects were randomized, but only 300 received study treatment.|300||
59683653|NCT01080300|75802891|FG001|STARTED|Overall Study|298 subjects were randomized, but only 295 received study treatment.|295||
59683654|NCT01080300|75802890|FG000|COMPLETED|Overall Study||206||
59683655|NCT01080300|75802891|FG001|COMPLETED|Overall Study||191||
59683656|NCT01080300|75802890|FG000|NOT COMPLETED|Overall Study||94||
59683657|NCT01080300|75802891|FG001|NOT COMPLETED|Overall Study||104||
59683658|NCT01085097|75802902|FG000|STARTED|Overall Study||15||
59683659|NCT01085097|75802903|FG001|STARTED|Overall Study||16||
59683660|NCT01085097|75802904|FG002|STARTED|Overall Study||15||
59683661|NCT01085097|75802902|FG000|Received at Least 1 Dose of Study Drug|Overall Study||15||
59683662|NCT01085097|75802903|FG001|Received at Least 1 Dose of Study Drug|Overall Study||16||
59683663|NCT01085097|75802904|FG002|Received at Least 1 Dose of Study Drug|Overall Study||15||
59683664|NCT01085097|75802902|FG000|COMPLETED|Overall Study||13||
59683665|NCT01085097|75802903|FG001|COMPLETED|Overall Study||16||
59683666|NCT01085097|75802904|FG002|COMPLETED|Overall Study||13||
59683667|NCT01085097|75802902|FG000|NOT COMPLETED|Overall Study||2||
59683668|NCT01085097|75802903|FG001|NOT COMPLETED|Overall Study||0||
59683669|NCT01085097|75802904|FG002|NOT COMPLETED|Overall Study||2||
59683670|NCT01088802|75802912|FG000|STARTED|Overall Study||60||
59683671|NCT01088802|75802912|FG000|COMPLETED|Overall Study||60||
59683672|NCT01088802|75802912|FG000|NOT COMPLETED|Overall Study||0||
59683673|NCT03450629|75802918|FG000|STARTED|Overall Study||341||
59683674|NCT03450629|75802919|FG001|STARTED|Overall Study||341||
59683675|NCT03450629|75802918|FG000|COMPLETED|Overall Study||293|Completed Visit 5|
59683676|NCT03450629|75802919|FG001|COMPLETED|Overall Study||307|Completed Visit 5|
59683677|NCT03450629|75802918|FG000|NOT COMPLETED|Overall Study||48||
59683678|NCT03450629|75802919|FG001|NOT COMPLETED|Overall Study||34||
59683679|NCT00198029|75802925|FG000|STARTED|Overall Study||32||
59683680|NCT00198029|75802925|FG000|COMPLETED|Overall Study||28||
59683681|NCT00198029|75802925|FG000|NOT COMPLETED|Overall Study||4||
59683682|NCT00197054|75802932|FG000|STARTED|Overall Study||85||
59683683|NCT00197054|75802933|FG001|STARTED|Overall Study||85||
59547211|NCT01099202|75645977|FG001|STARTED|Overall Study||54||
59547212|NCT01099202|75645976|FG000|COMPLETED|Overall Study||55||
59547213|NCT01099202|75645977|FG001|COMPLETED|Overall Study||54||
59683684|NCT00197054|75802934|FG002|STARTED|Overall Study||85||
59683685|NCT00197054|75802932|FG000|COMPLETED|Overall Study||68||
59683686|NCT00197054|75802933|FG001|COMPLETED|Overall Study||64||
59683687|NCT00197054|75802934|FG002|COMPLETED|Overall Study||73||
59683688|NCT00197054|75802932|FG000|NOT COMPLETED|Overall Study||17||
59683689|NCT00197054|75802933|FG001|NOT COMPLETED|Overall Study||21||
59683690|NCT00197054|75802934|FG002|NOT COMPLETED|Overall Study||12||
59683691|NCT00197015|75802955|FG000|STARTED|Overall Study||324||
59683692|NCT00197015|75802956|FG001|STARTED|Overall Study||455||
59683693|NCT00197015|75802957|FG002|STARTED|Overall Study||462||
59683694|NCT00197015|75802955|FG000|COMPLETED|Overall Study||274||
59683695|NCT00197015|75802956|FG001|COMPLETED|Overall Study||366||
59683696|NCT00197015|75802957|FG002|COMPLETED|Overall Study||385||
59683697|NCT00197015|75802955|FG000|NOT COMPLETED|Overall Study||50||
59683698|NCT00197015|75802956|FG001|NOT COMPLETED|Overall Study||89||
59683699|NCT00197015|75802957|FG002|NOT COMPLETED|Overall Study||77||
59683700|NCT00196976|75802979|FG000|STARTED|Primary Study||39||
59683701|NCT00196976|75802980|FG001|STARTED|Primary Study||41||
59683702|NCT00196976|75802981|FG002|STARTED|Primary Study||41||
59683703|NCT00196976|75802982|FG003|STARTED|Primary Study||40||
59683704|NCT00196976|75802983|FG004|STARTED|Primary Study||40||
59683705|NCT00196976|75802984|FG005|STARTED|Primary Study||54||
59816075|NCT00530270|75938416|FG001|NOT COMPLETED|Overall Study||0||
59683706|NCT00196976|75802985|FG006|STARTED|Primary Study||50||
59683707|NCT00196976|75802986|FG007|STARTED|Primary Study||52||
59683708|NCT00196976|75802987|FG008|STARTED|Primary Study||52||
59683709|NCT00196976|75802988|FG009|STARTED|Primary Study||52||
59683710|NCT00196976|75802989|FG010|STARTED|Primary Study||0||
59683711|NCT00196976|75802990|FG011|STARTED|Primary Study||0||
59683712|NCT00196976|75802991|FG012|STARTED|Primary Study||0||
59683713|NCT00196976|75802992|FG013|STARTED|Primary Study||0||
59683714|NCT00196976|75802979|FG000|COMPLETED|Primary Study||38||
59683715|NCT00196976|75802980|FG001|COMPLETED|Primary Study||40||
59683716|NCT00196976|75802981|FG002|COMPLETED|Primary Study||37||
59683717|NCT00196976|75802982|FG003|COMPLETED|Primary Study||39||
59683718|NCT00196976|75802983|FG004|COMPLETED|Primary Study||37||
59683719|NCT00196976|75802984|FG005|COMPLETED|Primary Study||52||
59683720|NCT00196976|75802985|FG006|COMPLETED|Primary Study||50||
59683721|NCT00196976|75802986|FG007|COMPLETED|Primary Study||49||
59683722|NCT00196976|75802987|FG008|COMPLETED|Primary Study||52||
59683723|NCT00196976|75802988|FG009|COMPLETED|Primary Study||51||
59683724|NCT00196976|75802989|FG010|COMPLETED|Primary Study||0||
59683725|NCT00196976|75802990|FG011|COMPLETED|Primary Study||0||
59683726|NCT00196976|75802991|FG012|COMPLETED|Primary Study||0||
59683727|NCT00196976|75802992|FG013|COMPLETED|Primary Study||0||
59683728|NCT00196976|75802979|FG000|NOT COMPLETED|Primary Study||1||
59683729|NCT00196976|75802980|FG001|NOT COMPLETED|Primary Study||1||
59683730|NCT00196976|75802981|FG002|NOT COMPLETED|Primary Study||4||
59816076|NCT03885596|75938426|FG000|STARTED|Overall Study||9||
59683731|NCT00196976|75802982|FG003|NOT COMPLETED|Primary Study||1||
59683732|NCT00196976|75802983|FG004|NOT COMPLETED|Primary Study||3||
59683733|NCT00196976|75802984|FG005|NOT COMPLETED|Primary Study||2||
59683734|NCT00196976|75802985|FG006|NOT COMPLETED|Primary Study||0||
59683735|NCT00196976|75802986|FG007|NOT COMPLETED|Primary Study||3||
59683736|NCT00196976|75802987|FG008|NOT COMPLETED|Primary Study||0||
59683737|NCT00196976|75802988|FG009|NOT COMPLETED|Primary Study||1||
59683738|NCT00196976|75802989|FG010|NOT COMPLETED|Primary Study||0||
59683739|NCT00196976|75802990|FG011|NOT COMPLETED|Primary Study||0||
59683740|NCT00196976|75802991|FG012|NOT COMPLETED|Primary Study||0||
59683741|NCT00196976|75802992|FG013|NOT COMPLETED|Primary Study||0||
59683742|NCT00196976|75802979|FG000|STARTED|Booster Study||0||
59683743|NCT00196976|75802980|FG001|STARTED|Booster Study||0||
59683744|NCT00196976|75802981|FG002|STARTED|Booster Study||0||
59683745|NCT00196976|75802982|FG003|STARTED|Booster Study||0||
59683746|NCT00196976|75802983|FG004|STARTED|Booster Study||0||
59683747|NCT00196976|75802984|FG005|STARTED|Booster Study||0||
59683748|NCT00196976|75802985|FG006|STARTED|Booster Study||0||
59683749|NCT00196976|75802986|FG007|STARTED|Booster Study||0||
59683750|NCT00196976|75802987|FG008|STARTED|Booster Study||0||
59683751|NCT00196976|75802988|FG009|STARTED|Booster Study||0||
59683752|NCT00196976|75802989|FG010|STARTED|Booster Study||33||
59683753|NCT00196976|75802990|FG011|STARTED|Booster Study||32||
59683754|NCT00196976|75802991|FG012|STARTED|Booster Study||45||
59683755|NCT00196976|75802992|FG013|STARTED|Booster Study||43||
59683756|NCT00196976|75802979|FG000|COMPLETED|Booster Study||0||
59683757|NCT00196976|75802980|FG001|COMPLETED|Booster Study||0||
59683758|NCT00196976|75802981|FG002|COMPLETED|Booster Study||0||
59683759|NCT00196976|75802982|FG003|COMPLETED|Booster Study||0||
59683760|NCT00196976|75802983|FG004|COMPLETED|Booster Study||0||
59683761|NCT00196976|75802984|FG005|COMPLETED|Booster Study||0||
59683762|NCT00196976|75802985|FG006|COMPLETED|Booster Study||0||
59683763|NCT00196976|75802986|FG007|COMPLETED|Booster Study||0||
59683764|NCT00196976|75802987|FG008|COMPLETED|Booster Study||0||
59683765|NCT00196976|75802988|FG009|COMPLETED|Booster Study||0||
59683766|NCT00196976|75802989|FG010|COMPLETED|Booster Study||31||
59683767|NCT00196976|75802990|FG011|COMPLETED|Booster Study||30||
59683768|NCT00196976|75802991|FG012|COMPLETED|Booster Study||45||
59683769|NCT00196976|75802992|FG013|COMPLETED|Booster Study||43||
59683770|NCT00196976|75802979|FG000|NOT COMPLETED|Booster Study||0||
59683771|NCT00196976|75802980|FG001|NOT COMPLETED|Booster Study||0||
59683772|NCT00196976|75802981|FG002|NOT COMPLETED|Booster Study||0||
59683773|NCT00196976|75802982|FG003|NOT COMPLETED|Booster Study||0||
59683774|NCT00196976|75802983|FG004|NOT COMPLETED|Booster Study||0||
59683775|NCT00196976|75802984|FG005|NOT COMPLETED|Booster Study||0||
59683776|NCT00196976|75802985|FG006|NOT COMPLETED|Booster Study||0||
59683777|NCT00196976|75802986|FG007|NOT COMPLETED|Booster Study||0||
59683778|NCT00196976|75802987|FG008|NOT COMPLETED|Booster Study||0||
59683779|NCT00196976|75802988|FG009|NOT COMPLETED|Booster Study||0||
59683780|NCT00196976|75802989|FG010|NOT COMPLETED|Booster Study||2||
59683781|NCT00196976|75802990|FG011|NOT COMPLETED|Booster Study||2||
59683782|NCT00196976|75802991|FG012|NOT COMPLETED|Booster Study||0||
59683783|NCT00196976|75802992|FG013|NOT COMPLETED|Booster Study||0||
59683784|NCT00196313|75803034|FG000|STARTED|Overall Study||47||
59683785|NCT00196313|75803035|FG001|STARTED|Overall Study||48||
59683786|NCT00196313|75803034|FG000|COMPLETED|Overall Study||36||
59683787|NCT00196313|75803035|FG001|COMPLETED|Overall Study||40||
59683788|NCT00196313|75803034|FG000|NOT COMPLETED|Overall Study||11||
59683789|NCT00196313|75803035|FG001|NOT COMPLETED|Overall Study||8||
59683790|NCT00196196|75803042|FG000|STARTED|Overall Study||274||
59683791|NCT00196196|75803042|FG000|COMPLETED|Overall Study||267||
59683792|NCT00196196|75803042|FG000|NOT COMPLETED|Overall Study||7||
59683793|NCT00195650|75803046|FG000|STARTED|Overall Study|Participants who received at least 1 adalimumab dose in study;3 enrolled did not receive adalimumab.|846||
59683794|NCT00195650|75803046|FG000|COMPLETED|Overall Study||321||
59683795|NCT00195650|75803046|FG000|NOT COMPLETED|Overall Study||525||
59683796|NCT00195494|75803052|FG000|STARTED|Year 1||0||
59683797|NCT00195494|75803053|FG001|STARTED|Year 1||0||
59683798|NCT00195494|75803054|FG002|STARTED|Year 1||0||
59683799|NCT00195494|75803055|FG003|STARTED|Year 1||0||
59683800|NCT00195494|75803056|FG004|STARTED|Year 1||268||
59683801|NCT00195494|75803057|FG005|STARTED|Year 1||274||
59683802|NCT00195494|75803052|FG000|COMPLETED|Year 1||0||
59683803|NCT00195494|75803053|FG001|COMPLETED|Year 1||0||
59683804|NCT00195494|75803054|FG002|COMPLETED|Year 1||0||
59683805|NCT00195494|75803055|FG003|COMPLETED|Year 1||0||
59683806|NCT00195494|75803056|FG004|COMPLETED|Year 1||189||
59683807|NCT00195494|75803057|FG005|COMPLETED|Year 1||221||
59683808|NCT00195494|75803052|FG000|NOT COMPLETED|Year 1||0||
59683809|NCT00195494|75803053|FG001|NOT COMPLETED|Year 1||0||
59683810|NCT00195494|75803054|FG002|NOT COMPLETED|Year 1||0||
59683811|NCT00195494|75803055|FG003|NOT COMPLETED|Year 1||0||
59683812|NCT00195494|75803056|FG004|NOT COMPLETED|Year 1||79||
59683813|NCT00195494|75803057|FG005|NOT COMPLETED|Year 1||53||
59683814|NCT00195494|75803052|FG000|STARTED|Year 2|A patient with Year 1 termination had taken drug briefly during Year 2 and thus counted in the data.|111||
59683815|NCT00195494|75803053|FG001|STARTED|Year 2||90||
59683816|NCT00195494|75803054|FG002|STARTED|Year 2|A patient with Year 1 termination had taken drug briefly during Year 2 and thus counted in the data.|111||
59683817|NCT00195494|75803055|FG003|STARTED|Year 2||99||
59683818|NCT00195494|75803056|FG004|STARTED|Year 2||0||
59683819|NCT00195494|75803057|FG005|STARTED|Year 2||0||
59683820|NCT00195494|75803052|FG000|COMPLETED|Year 2||104||
59683821|NCT00195494|75803053|FG001|COMPLETED|Year 2||74||
59683822|NCT00195494|75803054|FG002|COMPLETED|Year 2||93||
59683823|NCT00195494|75803055|FG003|COMPLETED|Year 2||76||
59683824|NCT00195494|75803056|FG004|COMPLETED|Year 2||0||
59683825|NCT00195494|75803057|FG005|COMPLETED|Year 2||0||
59683826|NCT00195494|75803052|FG000|NOT COMPLETED|Year 2||7||
59683827|NCT00195494|75803053|FG001|NOT COMPLETED|Year 2||16||
59683828|NCT00195494|75803054|FG002|NOT COMPLETED|Year 2||18||
59683829|NCT00195494|75803055|FG003|NOT COMPLETED|Year 2||23||
59683830|NCT00195494|75803056|FG004|NOT COMPLETED|Year 2||0||
59683831|NCT00195494|75803057|FG005|NOT COMPLETED|Year 2||0||
59683832|NCT00194987|75803075|FG000|STARTED|Overall Study||51||
59683833|NCT00194987|75803076|FG001|STARTED|Overall Study||51||
59683834|NCT00194987|75803075|FG000|COMPLETED|Overall Study||51||
59683835|NCT00194987|75803076|FG001|COMPLETED|Overall Study|"3 women chose to withdraw because they felt the study was too inconvenient."|48||
59683836|NCT00194987|75803075|FG000|NOT COMPLETED|Overall Study||0||
59683837|NCT00194987|75803076|FG001|NOT COMPLETED|Overall Study||3||
59683838|NCT00194792|75803084|FG000|STARTED|Overall Study||28||
59683839|NCT00194792|75803084|FG000|COMPLETED|Overall Study||27||
59683840|NCT00194792|75803084|FG000|NOT COMPLETED|Overall Study||1||
59683841|NCT02486367|75803090|FG000|STARTED|Overall Study||30||
59683842|NCT02486367|75803091|FG001|STARTED|Overall Study||30||
59683843|NCT02486367|75803090|FG000|COMPLETED|Overall Study||30||
59683844|NCT02486367|75803091|FG001|COMPLETED|Overall Study||30||
59683845|NCT02486367|75803090|FG000|NOT COMPLETED|Overall Study||0||
59683846|NCT02486367|75803091|FG001|NOT COMPLETED|Overall Study||0||
59683847|NCT00194675|75803099|FG000|STARTED|Overall Study||27||
59683848|NCT00194675|75803100|FG001|STARTED|Overall Study||26||
59683849|NCT00194675|75803099|FG000|COMPLETED|Overall Study||22||
59683850|NCT00194675|75803100|FG001|COMPLETED|Overall Study||24||
59683851|NCT00194675|75803099|FG000|NOT COMPLETED|Overall Study||5||
59683852|NCT00194675|75803100|FG001|NOT COMPLETED|Overall Study||2||
59683853|NCT00194012|75803110|FG000|STARTED|Randomized Phase||31||
59683854|NCT00194012|75803111|FG001|STARTED|Randomized Phase||31||
59683855|NCT00194012|75803110|FG000|Received More Than One Dose|Randomized Phase||30||
59683856|NCT00194012|75803111|FG001|Received More Than One Dose|Randomized Phase||29||
59683857|NCT00194012|75803110|FG000|COMPLETED|Randomized Phase||15||
59683858|NCT00194012|75803111|FG001|COMPLETED|Randomized Phase||6||
59683859|NCT00194012|75803110|FG000|NOT COMPLETED|Randomized Phase||16||
59683860|NCT00194012|75803111|FG001|NOT COMPLETED|Randomized Phase||25||
59683861|NCT00194012|75803110|FG000|STARTED|Open Label Extension (OLE)|Participants from aripiprazole group started OLE (eligible even if randomized period not completed).|22||
59683862|NCT00194012|75803111|FG001|STARTED|Open Label Extension (OLE)|Participants from placebo group started OLE (eligible even if randomized period not completed).|21||
59683863|NCT00194012|75803110|FG000|COMPLETED|Open Label Extension (OLE)||17||
59683864|NCT00194012|75803111|FG001|COMPLETED|Open Label Extension (OLE)||15||
59683865|NCT00194012|75803110|FG000|NOT COMPLETED|Open Label Extension (OLE)||5||
59683866|NCT00194012|75803111|FG001|NOT COMPLETED|Open Label Extension (OLE)||6||
59683867|NCT00192647|75803125|FG000|STARTED|Overall Study||448||
59683868|NCT00192647|75803126|FG001|STARTED|Overall Study||448||
59683869|NCT00192647|75803125|FG000|Treated|Overall Study||433||
59683870|NCT00192647|75803126|FG001|Treated|Overall Study||438||
59683871|NCT00192647|75803125|FG000|COMPLETED|Overall Study||320||
59683872|NCT00192647|75803126|FG001|COMPLETED|Overall Study||302||
59683873|NCT00192647|75803125|FG000|NOT COMPLETED|Overall Study||128||
59683874|NCT00192647|75803126|FG001|NOT COMPLETED|Overall Study||146||
59683875|NCT00192296|75803136|FG000|STARTED|Overall Study||6||
59683876|NCT00192296|75803137|FG001|STARTED|Overall Study||6||
59683877|NCT00192296|75803138|FG002|STARTED|Overall Study||6||
59683878|NCT00192296|75803139|FG003|STARTED|Overall Study||6||
59683879|NCT00192296|75803136|FG000|COMPLETED|Overall Study||6||
59683880|NCT00192296|75803137|FG001|COMPLETED|Overall Study||5||
59683881|NCT00192296|75803138|FG002|COMPLETED|Overall Study||6||
59683882|NCT00192296|75803139|FG003|COMPLETED|Overall Study||6||
59683883|NCT00192296|75803136|FG000|NOT COMPLETED|Overall Study||0||
59683884|NCT00192296|75803137|FG001|NOT COMPLETED|Overall Study||1||
59683885|NCT00192296|75803138|FG002|NOT COMPLETED|Overall Study||0||
59683886|NCT00192296|75803139|FG003|NOT COMPLETED|Overall Study||0||
59683887|NCT00192023|75803151|FG000|STARTED|Period III - Double-Blind||107||
59683888|NCT00192023|75803152|FG001|STARTED|Period III - Double-Blind||32||
59683889|NCT00192023|75803151|FG000|COMPLETED|Period III - Double-Blind|6 patients who completed the protocol did not enter optional open-label period.|100||
59683890|NCT00192023|75803152|FG001|COMPLETED|Period III - Double-Blind|2 patients who completed the protocol did not enter the optional open-label period.|32||
59683891|NCT00192023|75803151|FG000|NOT COMPLETED|Period III - Double-Blind||7||
59683892|NCT00192023|75803152|FG001|NOT COMPLETED|Period III - Double-Blind||0||
59683893|NCT00192023|75803151|FG000|STARTED|Period IV - Optional Open-Label||124||
59709790|NCT01072149|75828520|FG000|COMPLETED|Washout Period 1 (14 Days)||3||
59683894|NCT00192023|75803152|FG001|STARTED|Period IV - Optional Open-Label|Placebo patients received atomoxetine during the optional open-label period.|0||
59683895|NCT00192023|75803151|FG000|COMPLETED|Period IV - Optional Open-Label||49||
59683896|NCT00192023|75803152|FG001|COMPLETED|Period IV - Optional Open-Label||0||
59683897|NCT00192023|75803151|FG000|NOT COMPLETED|Period IV - Optional Open-Label||75||
59683898|NCT00192023|75803152|FG001|NOT COMPLETED|Period IV - Optional Open-Label||0||
59683899|NCT00191984|75803158|FG000|STARTED|Overall Study||46||
59683900|NCT00191984|75803158|FG000|COMPLETED|Overall Study||7||
59683901|NCT00191984|75803158|FG000|NOT COMPLETED|Overall Study||39||
59683902|NCT00191906|75803166|FG000|STARTED|Study Period II||39||
59683903|NCT00191906|75803167|FG001|STARTED|Study Period II||37||
59683904|NCT00191906|75803168|FG002|STARTED|Study Period II||27||
59683905|NCT00191906|75803169|FG003|STARTED|Study Period II||18||
59683906|NCT00191906|75803166|FG000|COMPLETED|Study Period II||39||
59683907|NCT00191906|75803167|FG001|COMPLETED|Study Period II||32||
59683908|NCT00191906|75803168|FG002|COMPLETED|Study Period II||26||
59683909|NCT00191906|75803169|FG003|COMPLETED|Study Period II||18||
59683910|NCT00191906|75803166|FG000|NOT COMPLETED|Study Period II||0||
59683911|NCT00191906|75803167|FG001|NOT COMPLETED|Study Period II||5||
59683912|NCT00191906|75803168|FG002|NOT COMPLETED|Study Period II||1||
59683913|NCT00191906|75803169|FG003|NOT COMPLETED|Study Period II||0||
59683914|NCT00191906|75803166|FG000|STARTED|Study Period III|These are patients who continued in optional open-label period (1 country). All received atomoxetine|14||
59683915|NCT00191906|75803167|FG001|STARTED|Study Period III|These are patients who continued in optional open-label period (1 country). All received atomoxetine|11||
59683916|NCT00191906|75803168|FG002|STARTED|Study Period III||0||
59683917|NCT00191906|75803169|FG003|STARTED|Study Period III||0||
59683918|NCT00191906|75803166|FG000|COMPLETED|Study Period III||9||
59683919|NCT00191906|75803167|FG001|COMPLETED|Study Period III||7||
59683920|NCT00191906|75803168|FG002|COMPLETED|Study Period III||0||
59683921|NCT00191906|75803169|FG003|COMPLETED|Study Period III||0||
59683922|NCT00191906|75803166|FG000|NOT COMPLETED|Study Period III||5||
59683923|NCT00191906|75803167|FG001|NOT COMPLETED|Study Period III||4||
59683924|NCT00191906|75803168|FG002|NOT COMPLETED|Study Period III||0||
59683925|NCT00191906|75803169|FG003|NOT COMPLETED|Study Period III||0||
59683926|NCT00191789|75803185|FG000|STARTED|Overall Study||65||
59683927|NCT00191789|75803185|FG000|COMPLETED|Overall Study||40||
59683928|NCT00191789|75803185|FG000|NOT COMPLETED|Overall Study||25||
59683929|NCT00191282|75803191|FG000|STARTED|Overall Study||558||
59683930|NCT00191282|75803192|FG001|STARTED|Overall Study||558||
59683931|NCT00191282|75803191|FG000|COMPLETED|Overall Study||338||
59683932|NCT00191282|75803192|FG001|COMPLETED|Overall Study||346||
59683933|NCT00191282|75803191|FG000|NOT COMPLETED|Overall Study||220||
59683934|NCT00191282|75803192|FG001|NOT COMPLETED|Overall Study||212||
59683935|NCT00191165|75803200|FG000|STARTED|Overall Study||14||
59683936|NCT00191165|75803201|FG001|STARTED|Overall Study||13||
59683937|NCT00191165|75803200|FG000|COMPLETED|Overall Study||12||
59683938|NCT00191165|75803201|FG001|COMPLETED|Overall Study||11||
59683939|NCT00191165|75803200|FG000|NOT COMPLETED|Overall Study||2||
59683940|NCT00191165|75803201|FG001|NOT COMPLETED|Overall Study||2||
59683941|NCT00190775|75803209|FG000|STARTED|Overall Study||268||
59683942|NCT00190775|75803210|FG001|STARTED|Overall Study||234||
59683943|NCT00190775|75803209|FG000|Received Study Drug|Overall Study||266||
59683944|NCT00190775|75803210|FG001|Received Study Drug|Overall Study||234||
59683945|NCT00190775|75803209|FG000|COMPLETED|Overall Study||119||
59683946|NCT00190775|75803210|FG001|COMPLETED|Overall Study||134||
59683947|NCT00190775|75803209|FG000|NOT COMPLETED|Overall Study||149||
59683948|NCT00190775|75803210|FG001|NOT COMPLETED|Overall Study||100||
59683949|NCT00199901|75803225|FG000|STARTED|Overall Study||56||
59683950|NCT00199901|75803226|FG001|STARTED|Overall Study||54||
59683951|NCT00199901|75803225|FG000|COMPLETED|Overall Study||29||
59683952|NCT00199901|75803226|FG001|COMPLETED|Overall Study||30||
59683953|NCT00199901|75803225|FG000|NOT COMPLETED|Overall Study||27||
59683954|NCT00199901|75803226|FG001|NOT COMPLETED|Overall Study||24||
59683955|NCT00198107|75803236|FG000|STARTED|Double-Blind Period||41||
59683956|NCT00198107|75803237|FG001|STARTED|Double-Blind Period||40||
59683957|NCT00198107|75803238|FG002|STARTED|Double-Blind Period||0||
59683958|NCT00198107|75803236|FG000|1 or More Follow-up Visits|Double-Blind Period||40||
59683959|NCT00198107|75803237|FG001|1 or More Follow-up Visits|Double-Blind Period||38||
59683960|NCT00198107|75803238|FG002|1 or More Follow-up Visits|Double-Blind Period||0||
59816077|NCT03885596|75938427|FG001|STARTED|Overall Study||9||
59816078|NCT03885596|75938428|FG002|STARTED|Overall Study||9||
59816079|NCT03885596|75938429|FG003|STARTED|Overall Study||9||
59683961|NCT00198107|75803236|FG000|COMPLETED|Double-Blind Period||35||
59683962|NCT00198107|75803237|FG001|COMPLETED|Double-Blind Period||37||
59683963|NCT00198107|75803238|FG002|COMPLETED|Double-Blind Period||0||
59816080|NCT03885596|75938426|FG000|COMPLETED|Overall Study||7||
59683964|NCT00198107|75803236|FG000|NOT COMPLETED|Double-Blind Period||6||
59683965|NCT00198107|75803237|FG001|NOT COMPLETED|Double-Blind Period||3||
59683966|NCT00198107|75803238|FG002|NOT COMPLETED|Double-Blind Period||0||
59683967|NCT00198107|75803236|FG000|STARTED|Pilot Add-On Aripiprazole +D-cycloserine||0||
59816081|NCT03885596|75938427|FG001|COMPLETED|Overall Study||8||
59816082|NCT03885596|75938428|FG002|COMPLETED|Overall Study||9||
59683968|NCT00198107|75803237|FG001|STARTED|Pilot Add-On Aripiprazole +D-cycloserine||0||
60079171|NCT00049036|76194487|FG001|STARTED|Overall Study||55||
60079172|NCT00049036|76194486|FG000|COMPLETED|Overall Study||51||
60079173|NCT00049036|76194487|FG001|COMPLETED|Overall Study||55||
60079174|NCT00049036|76194486|FG000|NOT COMPLETED|Overall Study||0||
60079175|NCT00049036|76194487|FG001|NOT COMPLETED|Overall Study||0||
60079176|NCT00212446|76194493|FG000|STARTED|Overall Study||8||
60079177|NCT00212446|76194493|FG000|COMPLETED|Overall Study||8||
60079178|NCT00212446|76194493|FG000|NOT COMPLETED|Overall Study||0||
60079179|NCT00049504|76194497|FG000|STARTED|Overall Study||55||
60079180|NCT00049504|76194497|FG000|COMPLETED|Overall Study||55||
59683969|NCT00198107|75803238|FG002|STARTED|Pilot Add-On Aripiprazole +D-cycloserine||10||
59683970|NCT00198107|75803236|FG000|COMPLETED|Pilot Add-On Aripiprazole +D-cycloserine||0||
59683971|NCT00198107|75803237|FG001|COMPLETED|Pilot Add-On Aripiprazole +D-cycloserine||0||
59683972|NCT00198107|75803238|FG002|COMPLETED|Pilot Add-On Aripiprazole +D-cycloserine||8||
59683973|NCT00198107|75803236|FG000|NOT COMPLETED|Pilot Add-On Aripiprazole +D-cycloserine||0||
59683974|NCT00198107|75803237|FG001|NOT COMPLETED|Pilot Add-On Aripiprazole +D-cycloserine||0||
59683975|NCT00198107|75803238|FG002|NOT COMPLETED|Pilot Add-On Aripiprazole +D-cycloserine||2||
59683976|NCT00179660|75803246|FG000|STARTED|Overall Study||50||
59683977|NCT00179660|75803246|FG000|Received Study Drug|Overall Study||49||
59683978|NCT00179660|75803246|FG000|Completed 12 Cycles of Treatment|Overall Study||12||
59683979|NCT00179660|75803246|FG000|COMPLETED|Overall Study|Completed refers to participants ongoing in the study at the time of analysis.|0||
59683980|NCT00179660|75803246|FG000|NOT COMPLETED|Overall Study||50||
59683981|NCT00178256|75803250|FG000|STARTED|Overall Study||10||
59683982|NCT00178256|75803251|FG001|STARTED|Overall Study||7||
59683983|NCT00178256|75803252|FG002|STARTED|Overall Study||6||
59683984|NCT00178256|75803253|FG003|STARTED|Overall Study||18||
59683985|NCT00178256|75803250|FG000|COMPLETED|Overall Study||6||
59683986|NCT00178256|75803251|FG001|COMPLETED|Overall Study||6||
59683987|NCT00178256|75803252|FG002|COMPLETED|Overall Study||6||
59683988|NCT00178256|75803253|FG003|COMPLETED|Overall Study||16||
59683989|NCT00178256|75803250|FG000|NOT COMPLETED|Overall Study||4||
59683990|NCT00178256|75803251|FG001|NOT COMPLETED|Overall Study||1||
59683991|NCT00178256|75803252|FG002|NOT COMPLETED|Overall Study||0||
59683992|NCT00178256|75803253|FG003|NOT COMPLETED|Overall Study||2||
59683993|NCT00177164|75803262|FG000|STARTED|Overall Study||23||
59683994|NCT00177164|75803263|FG001|STARTED|Overall Study||25||
59683995|NCT00177164|75803262|FG000|COMPLETED|Overall Study||14||
59683996|NCT00177164|75803263|FG001|COMPLETED|Overall Study||9||
59683997|NCT00177164|75803262|FG000|NOT COMPLETED|Overall Study||9||
59683998|NCT00177164|75803263|FG001|NOT COMPLETED|Overall Study||16||
59683999|NCT02487251|75803273|FG000|STARTED|Overall Study||434|Sample sizes reflect parent-child dyads enrolled in each study arm. The sample size for dyads equals that number of parents and that number of children. Among those who started per arm: 434 parents/434 children (Phase 1 Usual Exposure); 65 parents/65 children (Phase 2 Mealtime Support Activities); 152 parents/152 children (Phase 2 Usual Exposure); 159 parents/159 children (Phase 2 Meal Delivery and Receipt of Cookware).|
59684000|NCT02487251|75803274|FG001|STARTED|Overall Study||65|Sample sizes reflect parent-child dyads enrolled in each study arm. The sample size for dyads equals that number of parents and that number of children. Among those who started per arm: 434 parents/434 children (Phase 1 Usual Exposure); 65 parents/65 children (Phase 2 Mealtime Support Activities); 152 parents/152 children (Phase 2 Usual Exposure); 159 parents/159 children (Phase 2 Meal Delivery and Receipt of Cookware).|
59684001|NCT02487251|75803275|FG002|STARTED|Overall Study||152|Sample sizes reflect parent-child dyads enrolled in each study arm. The sample size for dyads equals that number of parents and that number of children. Among those who started per arm: 434 parents/434 children (Phase 1 Usual Exposure); 65 parents/65 children (Phase 2 Mealtime Support Activities); 152 parents/152 children (Phase 2 Usual Exposure); 159 parents/159 children (Phase 2 Meal Delivery and Receipt of Cookware).|
59684002|NCT02487251|75803276|FG003|STARTED|Overall Study||159|Sample sizes reflect parent-child dyads enrolled in each study arm. The sample size for dyads equals that number of parents and that number of children. Among those who started per arm: 434 parents/434 children (Phase 1 Usual Exposure); 65 parents/65 children (Phase 2 Mealtime Support Activities); 152 parents/152 children (Phase 2 Usual Exposure); 159 parents/159 children (Phase 2 Meal Delivery and Receipt of Cookware).|
59684003|NCT02487251|75803273|FG000|COMPLETED|Overall Study||366|Sample sizes reflect parent-child dyads enrolled in each study arm. The sample size for dyads equals that number of parents and that number of children. Among those who completed per arm: 366 parents/366 children (Phase 1 Usual Exposure); 55 parents/55 children (Phase 2 Mealtime Support Activities); 125 parents/125 children (Phase 2 Usual Exposure); 134 parents/134 children (Phase 2 Meal Delivery and Receipt of Cookware).|
59684004|NCT02487251|75803274|FG001|COMPLETED|Overall Study||55|Sample sizes reflect parent-child dyads enrolled in each study arm. The sample size for dyads equals that number of parents and that number of children. Among those who completed per arm: 366 parents/366 children (Phase 1 Usual Exposure); 55 parents/55 children (Phase 2 Mealtime Support Activities); 125 parents/125 children (Phase 2 Usual Exposure); 134 parents/134 children (Phase 2 Meal Delivery and Receipt of Cookware).|
60079181|NCT00049504|76194497|FG000|NOT COMPLETED|Overall Study||0||
60079182|NCT00050986|76194501|FG000|STARTED|Overall Study||55||
60079183|NCT00050986|76194501|FG000|COMPLETED|Overall Study|Two participants had withdrawn consents before the study treatment was initiated.|53||
60079184|NCT00050986|76194501|FG000|NOT COMPLETED|Overall Study||2||
60079185|NCT00214786|76194505|FG000|STARTED|Overall Study||4||
60079186|NCT00214786|76194505|FG000|COMPLETED|Overall Study||1||
60079187|NCT00214786|76194505|FG000|NOT COMPLETED|Overall Study||3||
60079188|NCT00118144|76194509|FG000|STARTED|Overall Study||42||
59709791|NCT01072149|75828521|FG001|COMPLETED|Washout Period 1 (14 Days)||3||
59709792|NCT01072149|75828522|FG002|COMPLETED|Washout Period 1 (14 Days)||2||
60079189|NCT00118144|76194509|FG000|COMPLETED|Overall Study||41||
60079190|NCT00118144|76194509|FG000|NOT COMPLETED|Overall Study||1||
60079191|NCT00118378|76194516|FG000|STARTED|Overall Study||62||
60079192|NCT00118378|76194517|FG001|STARTED|Overall Study||53||
60079193|NCT00118378|76194516|FG000|COMPLETED|Overall Study||60||
59547214|NCT01099202|75645976|FG000|NOT COMPLETED|Overall Study||0||
59547215|NCT01099202|75645977|FG001|NOT COMPLETED|Overall Study||0||
59547216|NCT02448303|75645986|FG000|STARTED|Overall Study||38||
59547217|NCT02448303|75645987|FG001|STARTED|Overall Study||36||
59547218|NCT02448303|75645986|FG000|Enrolled|Overall Study||38||
59547219|NCT02448303|75645987|FG001|Enrolled|Overall Study||36||
59547220|NCT02448303|75645986|FG000|Received Study Medication|Overall Study||33||
59547221|NCT02448303|75645987|FG001|Received Study Medication|Overall Study||35||
59547222|NCT02448303|75645986|FG000|Discontinued Study|Overall Study||38||
59547223|NCT02448303|75645987|FG001|Discontinued Study|Overall Study||36||
59547224|NCT02448303|75645986|FG000|COMPLETED|Overall Study||0||
59547225|NCT02448303|75645987|FG001|COMPLETED|Overall Study||0||
59547226|NCT02448303|75645986|FG000|NOT COMPLETED|Overall Study||38||
59547227|NCT02448303|75645987|FG001|NOT COMPLETED|Overall Study||36||
59547228|NCT02415855|75645995|FG000|STARTED|Overall Study||37||
59547229|NCT02415855|75645996|FG001|STARTED|Overall Study||64||
59547230|NCT02415855|75645995|FG000|COMPLETED|Overall Study||34||
59547231|NCT02415855|75645996|FG001|COMPLETED|Overall Study||62||
59547232|NCT02415855|75645995|FG000|NOT COMPLETED|Overall Study||3||
59547233|NCT02415855|75645996|FG001|NOT COMPLETED|Overall Study||2||
59547234|NCT02449473|75646004|FG000|STARTED|Overall Study||39||
59547235|NCT02449473|75646005|FG001|STARTED|Overall Study||40||
59547236|NCT02449473|75646004|FG000|COMPLETED|Overall Study||39||
59547237|NCT02449473|75646005|FG001|COMPLETED|Overall Study||40||
59547238|NCT02449473|75646004|FG000|NOT COMPLETED|Overall Study||0||
59547239|NCT02449473|75646005|FG001|NOT COMPLETED|Overall Study||0||
59547240|NCT02450799|75646014|FG000|STARTED|Overall Study||31||
59547241|NCT02450799|75646015|FG001|STARTED|Overall Study||37||
59547242|NCT02450799|75646016|FG002|STARTED|Overall Study||30||
59547243|NCT02450799|75646014|FG000|COMPLETED|Overall Study||31||
59547244|NCT02450799|75646015|FG001|COMPLETED|Overall Study||37||
59547245|NCT02450799|75646016|FG002|COMPLETED|Overall Study||30||
59547246|NCT02450799|75646014|FG000|NOT COMPLETED|Overall Study||0||
59547247|NCT02450799|75646015|FG001|NOT COMPLETED|Overall Study||0||
59547248|NCT02450799|75646016|FG002|NOT COMPLETED|Overall Study||0||
59547249|NCT02416713|75646031|FG000|STARTED|Overall Study||8||
59547250|NCT02416713|75646032|FG001|STARTED|Overall Study||9||
59547251|NCT02416713|75646033|FG002|STARTED|Overall Study||8||
59547252|NCT02416713|75646034|FG003|STARTED|Overall Study||10||
59547253|NCT02416713|75646031|FG000|COMPLETED|Overall Study||8||
59547254|NCT02416713|75646032|FG001|COMPLETED|Overall Study||9||
59547255|NCT02416713|75646033|FG002|COMPLETED|Overall Study||8||
59547256|NCT02416713|75646034|FG003|COMPLETED|Overall Study||10||
59547257|NCT02416713|75646031|FG000|NOT COMPLETED|Overall Study||0||
59547258|NCT02416713|75646032|FG001|NOT COMPLETED|Overall Study||0||
59547259|NCT02416713|75646033|FG002|NOT COMPLETED|Overall Study||0||
59547260|NCT02416713|75646034|FG003|NOT COMPLETED|Overall Study||0||
59547261|NCT02419521|75646044|FG000|STARTED|Overall Study||75||
59547262|NCT02419521|75646044|FG000|COMPLETED|Overall Study||74||
59547263|NCT02419521|75646044|FG000|NOT COMPLETED|Overall Study||1||
59547264|NCT02423577|75646050|FG000|STARTED|Overall Study||53||
59547265|NCT02423577|75646051|FG001|STARTED|Overall Study||26||
59547266|NCT02423577|75646050|FG000|COMPLETED|Overall Study||53||
59547267|NCT02423577|75646051|FG001|COMPLETED|Overall Study||26||
59547268|NCT02423577|75646050|FG000|NOT COMPLETED|Overall Study||0||
59547269|NCT02423577|75646051|FG001|NOT COMPLETED|Overall Study||0||
59547270|NCT02424357|75646059|FG000|STARTED|Overall Study||35||
59547271|NCT02424357|75646060|FG001|STARTED|Overall Study||30||
59547272|NCT02424357|75646059|FG000|COMPLETED|Overall Study||35||
59547273|NCT02424357|75646060|FG001|COMPLETED|Overall Study||30||
59709793|NCT01072149|75828523|FG003|COMPLETED|Washout Period 1 (14 Days)||3||
59547274|NCT02424357|75646059|FG000|NOT COMPLETED|Overall Study||0||
59547275|NCT02424357|75646060|FG001|NOT COMPLETED|Overall Study||0||
59547276|NCT02425449|75646073|FG000|STARTED|Overall Study||0||
59547277|NCT02425449|75646074|FG001|STARTED|Overall Study||4||
59547278|NCT02425449|75646075|FG002|STARTED|Overall Study||5||
59547279|NCT02425449|75646076|FG003|STARTED|Overall Study||5||
59547280|NCT02425449|75646077|FG004|STARTED|Overall Study||5||
59547281|NCT02425449|75646073|FG000|COMPLETED|Overall Study||0||
59547282|NCT02425449|75646074|FG001|COMPLETED|Overall Study||4||
59547283|NCT02425449|75646075|FG002|COMPLETED|Overall Study||5||
59547284|NCT02425449|75646076|FG003|COMPLETED|Overall Study||5||
59547285|NCT02425449|75646077|FG004|COMPLETED|Overall Study||5||
60079194|NCT00118378|76194517|FG001|COMPLETED|Overall Study||45||
60079195|NCT00118378|76194516|FG000|NOT COMPLETED|Overall Study||2||
60079196|NCT00118378|76194517|FG001|NOT COMPLETED|Overall Study||8||
60079197|NCT00217438|76194527|FG000|STARTED|Overall Study||66||
60079198|NCT00217438|76194528|FG001|STARTED|Overall Study||64||
59684005|NCT02487251|75803275|FG002|COMPLETED|Overall Study||125|Sample sizes reflect parent-child dyads enrolled in each study arm. The sample size for dyads equals that number of parents and that number of children. Among those who completed per arm: 366 parents/366 children (Phase 1 Usual Exposure); 55 parents/55 children (Phase 2 Mealtime Support Activities); 125 parents/125 children (Phase 2 Usual Exposure); 134 parents/134 children (Phase 2 Meal Delivery and Receipt of Cookware).|
59684006|NCT02487251|75803276|FG003|COMPLETED|Overall Study||134|Sample sizes reflect parent-child dyads enrolled in each study arm. The sample size for dyads equals that number of parents and that number of children. Among those who completed per arm: 366 parents/366 children (Phase 1 Usual Exposure); 55 parents/55 children (Phase 2 Mealtime Support Activities); 125 parents/125 children (Phase 2 Usual Exposure); 134 parents/134 children (Phase 2 Meal Delivery and Receipt of Cookware).|
59684007|NCT02487251|75803273|FG000|NOT COMPLETED|Overall Study||68||
59684008|NCT02487251|75803274|FG001|NOT COMPLETED|Overall Study||10||
59684009|NCT02487251|75803275|FG002|NOT COMPLETED|Overall Study||27||
59684010|NCT02487251|75803276|FG003|NOT COMPLETED|Overall Study||25||
59684011|NCT02489942|75803286|FG000|STARTED|Overall Study||8145||
59684012|NCT02489942|75803286|FG000|Case Report Form (CRF) Collected|Overall Study||8059||
59684013|NCT02489942|75803286|FG000|Treated|Overall Study||8057||
59684014|NCT02489942|75803286|FG000|COMPLETED|Overall Study||4729||
59684015|NCT02489942|75803286|FG000|NOT COMPLETED|Overall Study||3416||
59684016|NCT00176462|75803292|FG000|STARTED|Induction (4 Weeks)||21||
59684017|NCT00176462|75803293|FG001|STARTED|Induction (4 Weeks)||39||
59684018|NCT00176462|75803292|FG000|COMPLETED|Induction (4 Weeks)||20||
59684019|NCT00176462|75803293|FG001|COMPLETED|Induction (4 Weeks)||34||
59684020|NCT00176462|75803292|FG000|NOT COMPLETED|Induction (4 Weeks)||1||
59684021|NCT00176462|75803293|FG001|NOT COMPLETED|Induction (4 Weeks)||5||
59684022|NCT00176462|75803292|FG000|STARTED|Consolidation (12 Weeks)||20||
59684023|NCT00176462|75803293|FG001|STARTED|Consolidation (12 Weeks)||34||
59684024|NCT00176462|75803292|FG000|COMPLETED|Consolidation (12 Weeks)||20||
59684025|NCT00176462|75803293|FG001|COMPLETED|Consolidation (12 Weeks)||29||
59684026|NCT00176462|75803292|FG000|NOT COMPLETED|Consolidation (12 Weeks)||0||
59684027|NCT00176462|75803293|FG001|NOT COMPLETED|Consolidation (12 Weeks)||5||
59684028|NCT00176462|75803292|FG000|STARTED|Delayed Intensification (8 Weeks)||20||
59684029|NCT00176462|75803293|FG001|STARTED|Delayed Intensification (8 Weeks)||29||
59684030|NCT00176462|75803292|FG000|COMPLETED|Delayed Intensification (8 Weeks)||20||
59684031|NCT00176462|75803293|FG001|COMPLETED|Delayed Intensification (8 Weeks)||29||
59684032|NCT00176462|75803292|FG000|NOT COMPLETED|Delayed Intensification (8 Weeks)||0||
59684033|NCT00176462|75803293|FG001|NOT COMPLETED|Delayed Intensification (8 Weeks)||0||
59684034|NCT00176462|75803292|FG000|STARTED|Intensive Continuation (8X8-week Cycles)||20||
59684035|NCT00176462|75803293|FG001|STARTED|Intensive Continuation (8X8-week Cycles)||29||
59684036|NCT00176462|75803292|FG000|COMPLETED|Intensive Continuation (8X8-week Cycles)||19||
59684037|NCT00176462|75803293|FG001|COMPLETED|Intensive Continuation (8X8-week Cycles)||26||
59684038|NCT00176462|75803292|FG000|NOT COMPLETED|Intensive Continuation (8X8-week Cycles)||1||
59684039|NCT00176462|75803293|FG001|NOT COMPLETED|Intensive Continuation (8X8-week Cycles)||3||
59684040|NCT00176462|75803292|FG000|STARTED|Continuation -up to 30mos Post Remission||19||
59684041|NCT00176462|75803293|FG001|STARTED|Continuation -up to 30mos Post Remission||26||
59684042|NCT00176462|75803292|FG000|COMPLETED|Continuation -up to 30mos Post Remission||19||
59684043|NCT00176462|75803293|FG001|COMPLETED|Continuation -up to 30mos Post Remission||26||
59684044|NCT00176462|75803292|FG000|NOT COMPLETED|Continuation -up to 30mos Post Remission||0||
59684045|NCT00176462|75803293|FG001|NOT COMPLETED|Continuation -up to 30mos Post Remission||0||
59684046|NCT00175019|75803303|FG000|STARTED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|606||
59684047|NCT00175019|75803304|FG001|STARTED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|388||
59684048|NCT00175019|75803305|FG002|STARTED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|92||
59684049|NCT00175019|75803303|FG000|COMPLETED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|412||
59684050|NCT00175019|75803304|FG001|COMPLETED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|217||
59684051|NCT00175019|75803305|FG002|COMPLETED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|35||
59684052|NCT00175019|75803303|FG000|NOT COMPLETED|Overall Study||194||
60079199|NCT00217438|76194527|FG000|COMPLETED|Overall Study||66||
60079200|NCT00217438|76194528|FG001|COMPLETED|Overall Study|One patient did not complete Day 80-120 evaluation tests after returning to referring physician.|63||
60079201|NCT00217438|76194527|FG000|NOT COMPLETED|Overall Study||0||
60079202|NCT00217438|76194528|FG001|NOT COMPLETED|Overall Study||1||
60079203|NCT00217594|76194534|FG000|STARTED|Overall Study||31||
60079204|NCT00217594|76194534|FG000|COMPLETED|Overall Study||31||
60079205|NCT00217594|76194534|FG000|NOT COMPLETED|Overall Study||0||
60079206|NCT00118534|76194540|FG000|STARTED|Overall Study||472||
60079207|NCT00118534|76194541|FG001|STARTED|Overall Study||471||
60079208|NCT00118534|76194540|FG000|COMPLETED|Overall Study||472||
59684053|NCT00175019|75803304|FG001|NOT COMPLETED|Overall Study||171||
59684054|NCT00175019|75803305|FG002|NOT COMPLETED|Overall Study||57||
59709794|NCT01072149|75828524|FG004|COMPLETED|Washout Period 1 (14 Days)||3||
60079209|NCT00118534|76194541|FG001|COMPLETED|Overall Study||471||
59684055|NCT00174941|75803316|FG000|STARTED|Overall Study|Subjects started on febuxostat 80mg. Number of subjects based on Final Stable Dose after titration.|8||
59684056|NCT00174941|75803317|FG001|STARTED|Overall Study|Subjects started on febuxostat 80mg. Number of subjects based on Final Stable Dose after titration.|79||
59684057|NCT00174941|75803318|FG002|STARTED|Overall Study|Subjects started on febuxostat 80mg. Number of subjects based on Final Stable Dose after titration.|29||
59684058|NCT00174941|75803319|FG003|STARTED|Overall Study||116||
59684059|NCT00174941|75803316|FG000|COMPLETED|Overall Study||6||
59684060|NCT00174941|75803317|FG001|COMPLETED|Overall Study||41||
59684061|NCT00174941|75803318|FG002|COMPLETED|Overall Study||11||
59684062|NCT00174941|75803319|FG003|COMPLETED|Overall Study||58||
59684063|NCT00174941|75803316|FG000|NOT COMPLETED|Overall Study||2||
59684064|NCT00174941|75803317|FG001|NOT COMPLETED|Overall Study||38||
59684065|NCT00174941|75803318|FG002|NOT COMPLETED|Overall Study||18||
59684066|NCT00174941|75803319|FG003|NOT COMPLETED|Overall Study||58||
59684067|NCT00171704|75803331|FG000|STARTED|Overall Study||133||
59684068|NCT00171704|75803332|FG001|STARTED|Overall Study||130||
59684069|NCT00171704|75803331|FG000|COMPLETED|Overall Study||89||
59684070|NCT00171704|75803332|FG001|COMPLETED|Overall Study||81||
59684071|NCT00171704|75803331|FG000|NOT COMPLETED|Overall Study||44||
59684072|NCT00171704|75803332|FG001|NOT COMPLETED|Overall Study||49||
59684073|NCT00171314|75803340|FG000|STARTED|Overall Study|2 patients in each arm were randomized but not treated.|263||
59684074|NCT00171314|75803341|FG001|STARTED|Overall Study||264||
59684075|NCT00171314|75803340|FG000|Safety Population|Overall Study|"Treatment Actually Received = 251 from upfront Arm and 3 from delayed Arm"|254||
59684076|NCT00171314|75803341|FG001|Safety Population|Overall Study|"Treatment Actually Received = 10 from upfront Arm and 259 from delayed Arm"|269||
59684077|NCT00171314|75803340|FG000|COMPLETED|Overall Study||172||
59684078|NCT00171314|75803341|FG001|COMPLETED|Overall Study||186||
59684079|NCT00171314|75803340|FG000|NOT COMPLETED|Overall Study||91||
59684080|NCT00171314|75803341|FG001|NOT COMPLETED|Overall Study||78||
59684081|NCT00171158|75803347|FG000|STARTED|Core Study||260||
59684082|NCT00171158|75803347|FG000|COMPLETED|Core Study||21||
59684083|NCT00171158|75803347|FG000|NOT COMPLETED|Core Study||239||
59684084|NCT00171158|75803347|FG000|STARTED|E2 Extension||8|Participants that completed the core study entered the Extension 1 (E1) of the study, of which 13 participants discontinued the study. 8 participants entered Extension (E2).|
59684085|NCT00171158|75803347|FG000|COMPLETED|E2 Extension||1||
59684086|NCT00171158|75803347|FG000|NOT COMPLETED|E2 Extension||7||
59684087|NCT00170846|75803354|FG000|STARTED|Overall Study||123||
59684088|NCT00170846|75803355|FG001|STARTED|Overall Study||127||
59684089|NCT00170846|75803356|FG002|STARTED|Overall Study||144||
59684090|NCT00170846|75803354|FG000|COMPLETED|Overall Study||112||
59684091|NCT00170846|75803355|FG001|COMPLETED|Overall Study||108||
59684092|NCT00170846|75803356|FG002|COMPLETED|Overall Study||131||
59684093|NCT00170846|75803354|FG000|NOT COMPLETED|Overall Study||11||
59684094|NCT00170846|75803355|FG001|NOT COMPLETED|Overall Study||19||
59684095|NCT00170846|75803356|FG002|NOT COMPLETED|Overall Study||13||
59684096|NCT00479882|75803368|FG000|STARTED|Precrossover: Periods I/II (Weeks 1-12)||610||
59684097|NCT00479882|75803369|FG001|STARTED|Precrossover: Periods I/II (Weeks 1-12)||602||
59684098|NCT00479882|75803370|FG002|STARTED|Precrossover: Periods I/II (Weeks 1-12)||597||
59684099|NCT00479882|75803371|FG003|STARTED|Precrossover: Periods I/II (Weeks 1-12)||605||
59684100|NCT00479882|75803368|FG000|COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||472||
59684101|NCT00479882|75803369|FG001|COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||440||
59684102|NCT00479882|75803370|FG002|COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||440||
59684103|NCT00479882|75803371|FG003|COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||465||
59684104|NCT00479882|75803368|FG000|NOT COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||138||
59684105|NCT00479882|75803369|FG001|NOT COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||162||
59684106|NCT00479882|75803370|FG002|NOT COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||157||
59684107|NCT00479882|75803371|FG003|NOT COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||140||
59684108|NCT00479882|75803368|FG000|STARTED|Crossover: Period III (Weeks 13-20)||472||
59684109|NCT00479882|75803369|FG001|STARTED|Crossover: Period III (Weeks 13-20)||440||
59684110|NCT00479882|75803370|FG002|STARTED|Crossover: Period III (Weeks 13-20)||440||
59684111|NCT00479882|75803371|FG003|STARTED|Crossover: Period III (Weeks 13-20)||465||
59684112|NCT00479882|75803368|FG000|COMPLETED|Crossover: Period III (Weeks 13-20)||447||
59684113|NCT00479882|75803369|FG001|COMPLETED|Crossover: Period III (Weeks 13-20)||419||
59684114|NCT00479882|75803370|FG002|COMPLETED|Crossover: Period III (Weeks 13-20)||420||
59684115|NCT00479882|75803371|FG003|COMPLETED|Crossover: Period III (Weeks 13-20)||447||
59684116|NCT00479882|75803368|FG000|NOT COMPLETED|Crossover: Period III (Weeks 13-20)||25||
59684117|NCT00479882|75803369|FG001|NOT COMPLETED|Crossover: Period III (Weeks 13-20)||21||
59684118|NCT00479882|75803370|FG002|NOT COMPLETED|Crossover: Period III (Weeks 13-20)||20||
59684119|NCT00479882|75803371|FG003|NOT COMPLETED|Crossover: Period III (Weeks 13-20)||18||
59684120|NCT00479765|75803397|FG000|STARTED|Overall Study||4||
59684121|NCT00479765|75803397|FG000|COMPLETED|Overall Study||0||
59684122|NCT00479765|75803397|FG000|NOT COMPLETED|Overall Study||4||
59684123|NCT00479687|75803403|FG000|STARTED|Ph 1: Blinded, Randomized, Controlled||150||
59684124|NCT00479687|75803404|FG001|STARTED|Ph 1: Blinded, Randomized, Controlled||150||
59684125|NCT00479687|75803405|FG002|STARTED|Ph 1: Blinded, Randomized, Controlled||0||
59684126|NCT00479687|75803403|FG000|COMPLETED|Ph 1: Blinded, Randomized, Controlled||125||
59684127|NCT00479687|75803404|FG001|COMPLETED|Ph 1: Blinded, Randomized, Controlled||131||
59684128|NCT00479687|75803405|FG002|COMPLETED|Ph 1: Blinded, Randomized, Controlled||0||
59684129|NCT00479687|75803403|FG000|NOT COMPLETED|Ph 1: Blinded, Randomized, Controlled||25||
59684130|NCT00479687|75803404|FG001|NOT COMPLETED|Ph 1: Blinded, Randomized, Controlled||19||
59684131|NCT00479687|75803405|FG002|NOT COMPLETED|Ph 1: Blinded, Randomized, Controlled||0||
59684132|NCT00479687|75803403|FG000|STARTED|Ph 2: Open Label, Single (Supartz) Arm||0||
59684133|NCT00479687|75803404|FG001|STARTED|Ph 2: Open Label, Single (Supartz) Arm||0||
59684134|NCT00479687|75803405|FG002|STARTED|Ph 2: Open Label, Single (Supartz) Arm|Four did not continue to Ph2; 224 received at least 1 inj. and 28 received no trt. (only follow-up)|224||
59684135|NCT00479687|75803403|FG000|COMPLETED|Ph 2: Open Label, Single (Supartz) Arm||0||
59684136|NCT00479687|75803404|FG001|COMPLETED|Ph 2: Open Label, Single (Supartz) Arm||0||
59684137|NCT00479687|75803405|FG002|COMPLETED|Ph 2: Open Label, Single (Supartz) Arm||215||
59684138|NCT00479687|75803403|FG000|NOT COMPLETED|Ph 2: Open Label, Single (Supartz) Arm||0||
59684139|NCT00479687|75803404|FG001|NOT COMPLETED|Ph 2: Open Label, Single (Supartz) Arm||0||
59684140|NCT00479687|75803405|FG002|NOT COMPLETED|Ph 2: Open Label, Single (Supartz) Arm||9||
59684141|NCT00479336|75803416|FG000|STARTED|Overall Study||27||
59684142|NCT00479336|75803417|FG001|STARTED|Overall Study||26||
59684143|NCT00479336|75803418|FG002|STARTED|Overall Study||25||
59684144|NCT00479336|75803419|FG003|STARTED|Overall Study||26||
59684145|NCT00479336|75803416|FG000|COMPLETED|Overall Study||23||
59684146|NCT00479336|75803417|FG001|COMPLETED|Overall Study||20||
59684147|NCT00479336|75803418|FG002|COMPLETED|Overall Study||24||
59684148|NCT00479336|75803419|FG003|COMPLETED|Overall Study||21||
59684149|NCT00479336|75803416|FG000|NOT COMPLETED|Overall Study||4||
59684150|NCT00479336|75803417|FG001|NOT COMPLETED|Overall Study||6||
59684151|NCT00479336|75803418|FG002|NOT COMPLETED|Overall Study||1||
59684152|NCT00479336|75803419|FG003|NOT COMPLETED|Overall Study||5||
59684153|NCT00478244|75803429|FG000|STARTED|Overall Study||7||
59684154|NCT00478244|75803429|FG000|COMPLETED|Overall Study||6||
59547286|NCT02425449|75646073|FG000|NOT COMPLETED|Overall Study||0||
59547287|NCT02425449|75646074|FG001|NOT COMPLETED|Overall Study||0||
59547288|NCT02425449|75646075|FG002|NOT COMPLETED|Overall Study||0||
59547289|NCT02425449|75646076|FG003|NOT COMPLETED|Overall Study||0||
59684155|NCT00478244|75803429|FG000|NOT COMPLETED|Overall Study||1||
59684156|NCT00478205|75803435|FG000|STARTED|Overall Study||981||
59684157|NCT00478205|75803436|FG001|STARTED|Overall Study||486||
59684158|NCT00478205|75803435|FG000|COMPLETED|Overall Study||685||
59684159|NCT00478205|75803436|FG001|COMPLETED|Overall Study||399||
59684160|NCT00478205|75803435|FG000|NOT COMPLETED|Overall Study||296||
59684161|NCT00478205|75803436|FG001|NOT COMPLETED|Overall Study||87||
59684162|NCT00477971|75803444|FG000|STARTED|Overall Study||34||
59684163|NCT00477971|75803445|FG001|STARTED|Overall Study||55||
59684164|NCT00477971|75803444|FG000|COMPLETED|Overall Study||17||
59684165|NCT00477971|75803445|FG001|COMPLETED|Overall Study||49||
59684166|NCT00477971|75803444|FG000|NOT COMPLETED|Overall Study||17||
59684167|NCT00477971|75803445|FG001|NOT COMPLETED|Overall Study||6||
59684168|NCT00477464|75803451|FG000|STARTED|Overall Study||51||
59684169|NCT00477464|75803451|FG000|COMPLETED|Overall Study||0||
59684170|NCT00477464|75803451|FG000|NOT COMPLETED|Overall Study||51||
59684171|NCT00477386|75803459|FG000|STARTED|Overall Study||11||
59684172|NCT00477386|75803460|FG001|STARTED|Overall Study||17||
59684173|NCT00477386|75803459|FG000|COMPLETED|Overall Study||0||
59684174|NCT00477386|75803460|FG001|COMPLETED|Overall Study||0||
59684175|NCT00477386|75803459|FG000|NOT COMPLETED|Overall Study||11||
59684176|NCT00477386|75803460|FG001|NOT COMPLETED|Overall Study||17||
59684177|NCT00477269|75803468|FG000|STARTED|Core Study||28||
59684178|NCT00477269|75803469|FG001|STARTED|Core Study||31||
59684179|NCT00477269|75803470|FG002|STARTED|Core Study||0||
59684180|NCT00477269|75803468|FG000|COMPLETED|Core Study||19||
59684181|NCT00477269|75803469|FG001|COMPLETED|Core Study||23||
60079210|NCT00118534|76194540|FG000|NOT COMPLETED|Overall Study||0||
60079211|NCT00118534|76194541|FG001|NOT COMPLETED|Overall Study||0||
60079212|NCT00052078|76194552|FG000|STARTED|Overall Study||133||
59547290|NCT02425449|75646077|FG004|NOT COMPLETED|Overall Study||0||
59684182|NCT00477269|75803470|FG002|COMPLETED|Core Study||0||
59684183|NCT00477269|75803468|FG000|NOT COMPLETED|Core Study||9||
59684184|NCT00477269|75803469|FG001|NOT COMPLETED|Core Study||8||
59684185|NCT00477269|75803470|FG002|NOT COMPLETED|Core Study||0||
60079213|NCT00052078|76194553|FG001|STARTED|Overall Study||139||
60079214|NCT00052078|76194554|FG002|STARTED|Overall Study||140||
59547291|NCT02429115|75646095|FG000|STARTED|Overall Study||52|Includes patient participants and caregiver participants|
59684186|NCT00477269|75803468|FG000|STARTED|Open Label Extension|Arm in the Core study not extension|0||
59684187|NCT00477269|75803469|FG001|STARTED|Open Label Extension|Arm in the Core study not extension|0||
59684188|NCT00477269|75803470|FG002|STARTED|Open Label Extension||22||
59684189|NCT00477269|75803468|FG000|COMPLETED|Open Label Extension|Arm in the Core study not extension|0||
59684190|NCT00477269|75803469|FG001|COMPLETED|Open Label Extension|Arm in the Core study not extension|0||
59684191|NCT00477269|75803470|FG002|COMPLETED|Open Label Extension||9||
59684192|NCT00477269|75803468|FG000|NOT COMPLETED|Open Label Extension||0||
60079215|NCT00052078|76194555|FG003|STARTED|Overall Study||76||
59684193|NCT00477269|75803469|FG001|NOT COMPLETED|Open Label Extension||0||
59684194|NCT00477269|75803470|FG002|NOT COMPLETED|Open Label Extension||13||
59684195|NCT00477152|75803478|FG000|STARTED|Overall Study|One patient withdrawn prior to treatment, so not included in analyses.|52||
59684196|NCT00477152|75803478|FG000|COMPLETED|Overall Study|Two patients treated, but assessments incomplete. All available data included in analyses for these.|49||
59684197|NCT00477152|75803478|FG000|NOT COMPLETED|Overall Study||3||
59684198|NCT00476996|75803485|FG000|STARTED|Blinded Treatment Phase (up to Week 48)||277||
59684199|NCT00476996|75803486|FG001|STARTED|Blinded Treatment Phase (up to Week 48)||277||
59684200|NCT00476996|75803487|FG002|STARTED|Blinded Treatment Phase (up to Week 48)||282||
59684201|NCT00476996|75803488|FG003|STARTED|Blinded Treatment Phase (up to Week 48)||0||
59684202|NCT00476996|75803485|FG000|COMPLETED|Blinded Treatment Phase (up to Week 48)||205||
59684203|NCT00476996|75803486|FG001|COMPLETED|Blinded Treatment Phase (up to Week 48)||222||
59684204|NCT00476996|75803487|FG002|COMPLETED|Blinded Treatment Phase (up to Week 48)||237||
59684205|NCT00476996|75803488|FG003|COMPLETED|Blinded Treatment Phase (up to Week 48)||0||
59684206|NCT00476996|75803485|FG000|NOT COMPLETED|Blinded Treatment Phase (up to Week 48)||72||
59684207|NCT00476996|75803486|FG001|NOT COMPLETED|Blinded Treatment Phase (up to Week 48)||55||
59684208|NCT00476996|75803487|FG002|NOT COMPLETED|Blinded Treatment Phase (up to Week 48)||45||
59684209|NCT00476996|75803488|FG003|NOT COMPLETED|Blinded Treatment Phase (up to Week 48)||0||
59684210|NCT00476996|75803485|FG000|STARTED|OLE Phase (From Week 48)||0||
59684211|NCT00476996|75803486|FG001|STARTED|OLE Phase (From Week 48)||0||
59684212|NCT00476996|75803487|FG002|STARTED|OLE Phase (From Week 48)||0||
59684213|NCT00476996|75803488|FG003|STARTED|OLE Phase (From Week 48)||664||
59684214|NCT00476996|75803485|FG000|COMPLETED|OLE Phase (From Week 48)||0||
59684215|NCT00476996|75803486|FG001|COMPLETED|OLE Phase (From Week 48)||0||
59684216|NCT00476996|75803487|FG002|COMPLETED|OLE Phase (From Week 48)||0||
59684217|NCT00476996|75803488|FG003|COMPLETED|OLE Phase (From Week 48)||0||
59684218|NCT00476996|75803485|FG000|NOT COMPLETED|OLE Phase (From Week 48)||0||
59684219|NCT00476996|75803486|FG001|NOT COMPLETED|OLE Phase (From Week 48)||0||
59684220|NCT00476996|75803487|FG002|NOT COMPLETED|OLE Phase (From Week 48)||0||
59684221|NCT00476996|75803488|FG003|NOT COMPLETED|OLE Phase (From Week 48)||664||
59684222|NCT00476957|75803499|FG000|STARTED|Overall Study||4357||
59684223|NCT00476957|75803500|FG001|STARTED|Overall Study||4352||
59684224|NCT00476957|75803499|FG000|COMPLETED|Overall Study||4181||
60079216|NCT00052078|76194552|FG000|COMPLETED|Overall Study||110||
60079217|NCT00052078|76194553|FG001|COMPLETED|Overall Study||133||
60079218|NCT00052078|76194554|FG002|COMPLETED|Overall Study||127||
59684225|NCT00476957|75803500|FG001|COMPLETED|Overall Study||4159||
59684226|NCT00476957|75803499|FG000|NOT COMPLETED|Overall Study||176||
59684227|NCT00476957|75803500|FG001|NOT COMPLETED|Overall Study||193||
59684228|NCT00475865|75803509|FG000|STARTED|Overall Study|randomized|41||
59684229|NCT00475865|75803510|FG001|STARTED|Overall Study|randomized|42||
59684230|NCT00475865|75803511|FG002|STARTED|Overall Study|randomized|40||
59684231|NCT00475865|75803509|FG000|Treated|Overall Study|completed treatment period|41||
59684232|NCT00475865|75803510|FG001|Treated|Overall Study||42||
59684233|NCT00475865|75803511|FG002|Treated|Overall Study||40||
59684234|NCT00475865|75803509|FG000|COMPLETED|Overall Study||39||
59684235|NCT00475865|75803510|FG001|COMPLETED|Overall Study|completed treatment period|37||
59684236|NCT00475865|75803511|FG002|COMPLETED|Overall Study|completed treatment period|34||
59684237|NCT00475865|75803509|FG000|NOT COMPLETED|Overall Study||2||
60079219|NCT00052078|76194555|FG003|COMPLETED|Overall Study||61||
60079220|NCT00052078|76194552|FG000|NOT COMPLETED|Overall Study||23||
60079221|NCT00052078|76194553|FG001|NOT COMPLETED|Overall Study||6||
60079222|NCT00052078|76194554|FG002|NOT COMPLETED|Overall Study||13||
59684238|NCT00475865|75803510|FG001|NOT COMPLETED|Overall Study||5||
59684239|NCT00475865|75803511|FG002|NOT COMPLETED|Overall Study||6||
59684240|NCT00475709|75803521|FG000|STARTED|Overall Study||1022||
59684241|NCT00475709|75803521|FG000|Eligible of Analysis|Overall Study|Excludes eight ineligible subjects|1014||
59684242|NCT00475709|75803521|FG000|COMPLETED|Overall Study||946||
59684243|NCT00475709|75803521|FG000|NOT COMPLETED|Overall Study||76||
59684244|NCT00475670|75803527|FG000|STARTED|Overall Study||3||
60079223|NCT00052078|76194555|FG003|NOT COMPLETED|Overall Study||15||
60079224|NCT04842747|76194567|FG000|STARTED|Overall Study||134||
60079225|NCT04842747|76194568|FG001|STARTED|Overall Study||70||
60079226|NCT04842747|76194567|FG000|COMPLETED|Overall Study||125||
60079227|NCT04842747|76194568|FG001|COMPLETED|Overall Study||66||
60079228|NCT04842747|76194567|FG000|NOT COMPLETED|Overall Study||9||
59684245|NCT00475670|75803528|FG001|STARTED|Overall Study||41||
59684246|NCT00475670|75803527|FG000|COMPLETED|Overall Study|This cohort was closed prematurely (with only 3 participants) because of enrollment difficulties.|0||
59684247|NCT00475670|75803528|FG001|COMPLETED|Overall Study||0||
59684248|NCT00475670|75803527|FG000|NOT COMPLETED|Overall Study||3||
59684249|NCT00475670|75803528|FG001|NOT COMPLETED|Overall Study||41||
59684250|NCT00474968|75803536|FG000|STARTED|Overall Study||366||
59684251|NCT00474968|75803537|FG001|STARTED|Overall Study||371||
59684252|NCT00474968|75803536|FG000|COMPLETED|Overall Study||348||
59684253|NCT00474968|75803537|FG001|COMPLETED|Overall Study||355||
60079229|NCT04842747|76194568|FG001|NOT COMPLETED|Overall Study||4||
60079230|NCT04810481|76194576|FG000|STARTED|Overall Study||86||
60079231|NCT04810481|76194577|FG001|STARTED|Overall Study||84||
59684254|NCT00474968|75803536|FG000|NOT COMPLETED|Overall Study||18||
59684255|NCT00474968|75803537|FG001|NOT COMPLETED|Overall Study||16||
59684256|NCT00474929|75803548|FG000|STARTED|Overall Study||6||
59684257|NCT00474929|75803549|FG001|STARTED|Overall Study||6||
59684258|NCT00474929|75803550|FG002|STARTED|Overall Study||7||
59684259|NCT00474929|75803551|FG003|STARTED|Overall Study||7||
59684260|NCT00474929|75803552|FG004|STARTED|Overall Study||77||
59684261|NCT00474929|75803548|FG000|COMPLETED|Overall Study||6||
59684262|NCT00474929|75803549|FG001|COMPLETED|Overall Study||5||
59684263|NCT00474929|75803550|FG002|COMPLETED|Overall Study||5||
59684264|NCT00474929|75803551|FG003|COMPLETED|Overall Study||5||
59684265|NCT00474929|75803552|FG004|COMPLETED|Overall Study||77||
59684266|NCT00474929|75803548|FG000|NOT COMPLETED|Overall Study||0||
59684267|NCT00474929|75803549|FG001|NOT COMPLETED|Overall Study||1||
59684268|NCT00474929|75803550|FG002|NOT COMPLETED|Overall Study||2||
59684269|NCT00474929|75803551|FG003|NOT COMPLETED|Overall Study||2||
59684270|NCT00474929|75803552|FG004|NOT COMPLETED|Overall Study||0||
59684271|NCT00474812|75803565|FG000|STARTED|Overall Study||51||
59684272|NCT00474812|75803565|FG000|COMPLETED|Overall Study||44||
59684273|NCT00474812|75803565|FG000|NOT COMPLETED|Overall Study||7||
59684274|NCT00474383|75803569|FG000|STARTED|Main Study||47||
59684275|NCT00474383|75803570|FG001|STARTED|Main Study||0||
59684276|NCT00474383|75803569|FG000|COMPLETED|Main Study||11||
59684277|NCT00474383|75803570|FG001|COMPLETED|Main Study||0||
59684278|NCT00474383|75803569|FG000|NOT COMPLETED|Main Study||36||
59684279|NCT00474383|75803570|FG001|NOT COMPLETED|Main Study||0||
59684280|NCT00474383|75803569|FG000|STARTED|Between Main Study and Extension||11||
59684281|NCT00474383|75803570|FG001|STARTED|Between Main Study and Extension||0||
59684282|NCT00474383|75803569|FG000|COMPLETED|Between Main Study and Extension||5||
59684283|NCT00474383|75803570|FG001|COMPLETED|Between Main Study and Extension||0||
59684284|NCT00474383|75803569|FG000|NOT COMPLETED|Between Main Study and Extension||6||
59684285|NCT00474383|75803570|FG001|NOT COMPLETED|Between Main Study and Extension||0||
59684286|NCT00474383|75803569|FG000|STARTED|Extension||0||
59684287|NCT00474383|75803570|FG001|STARTED|Extension||5||
59684288|NCT00474383|75803569|FG000|COMPLETED|Extension||0||
59684289|NCT00474383|75803570|FG001|COMPLETED|Extension||0||
59684290|NCT00474383|75803569|FG000|NOT COMPLETED|Extension||0||
59684291|NCT00474383|75803570|FG001|NOT COMPLETED|Extension||5||
59684292|NCT00474266|75803578|FG000|STARTED|Overall Study||375||
59684293|NCT00474266|75803579|FG001|STARTED|Overall Study||374||
59684294|NCT00474266|75803580|FG002|STARTED|Overall Study||126||
59684295|NCT00474266|75803581|FG003|STARTED|Overall Study||125||
59684296|NCT00474266|75803578|FG000|COMPLETED|Overall Study||368||
59684297|NCT00474266|75803579|FG001|COMPLETED|Overall Study||354||
59684298|NCT00474266|75803580|FG002|COMPLETED|Overall Study||122||
59684299|NCT00474266|75803581|FG003|COMPLETED|Overall Study||118||
59684300|NCT00474266|75803578|FG000|NOT COMPLETED|Overall Study||7||
59684301|NCT00474266|75803579|FG001|NOT COMPLETED|Overall Study||20||
59684302|NCT00474266|75803580|FG002|NOT COMPLETED|Overall Study||4||
59684303|NCT00474266|75803581|FG003|NOT COMPLETED|Overall Study||7||
59684304|NCT00473564|75803594|FG000|STARTED|Overall Study||170||
59684305|NCT00473564|75803594|FG000|COMPLETED|Overall Study||147||
59684306|NCT00473564|75803594|FG000|NOT COMPLETED|Overall Study||23||
59684307|NCT00472199|75803600|FG000|STARTED|Overall Study||166||
59684308|NCT00472199|75803601|FG001|STARTED|Overall Study||163||
59684309|NCT00472199|75803600|FG000|COMPLETED|Overall Study||131||
59684310|NCT00472199|75803601|FG001|COMPLETED|Overall Study||103||
59684311|NCT00472199|75803600|FG000|NOT COMPLETED|Overall Study||35||
59684312|NCT00472199|75803601|FG001|NOT COMPLETED|Overall Study||60||
59684313|NCT00472082|75803607|FG000|STARTED|Overall Study||5||
59684314|NCT00472082|75803607|FG000|COMPLETED|Overall Study||0||
59547292|NCT02429115|75646096|FG001|STARTED|Overall Study||52|Includes patient participants and caregiver participants|
59547293|NCT02429115|75646097|FG002|STARTED|Overall Study||51|Includes patient participants and caregiver participants|
59547294|NCT02429115|75646098|FG003|STARTED|Overall Study||29|Includes patient participants and caregiver participants|
59547295|NCT02429115|75646099|FG004|STARTED|Overall Study||29|Includes patient participants and caregiver participants|
59547296|NCT02429115|75646100|FG005|STARTED|Overall Study||28|Includes patient participants and caregiver participants|
59547297|NCT02429115|75646095|FG000|COMPLETED|Overall Study||40||
59547298|NCT02429115|75646096|FG001|COMPLETED|Overall Study||42||
59547299|NCT02429115|75646097|FG002|COMPLETED|Overall Study||35||
59547300|NCT02429115|75646098|FG003|COMPLETED|Overall Study||21||
59547301|NCT02429115|75646099|FG004|COMPLETED|Overall Study||22||
59547302|NCT02429115|75646100|FG005|COMPLETED|Overall Study||27||
59547303|NCT02429115|75646095|FG000|NOT COMPLETED|Overall Study||12||
59547304|NCT02429115|75646096|FG001|NOT COMPLETED|Overall Study||10||
59547305|NCT02429115|75646097|FG002|NOT COMPLETED|Overall Study||16||
59684315|NCT00472082|75803607|FG000|NOT COMPLETED|Overall Study||5||
59684316|NCT00471887|75803611|FG000|STARTED|Overall Study||32||
59684317|NCT00471887|75803611|FG000|COMPLETED|Overall Study||23||
59684318|NCT00471887|75803611|FG000|NOT COMPLETED|Overall Study||9||
59684319|NCT00471536|75803615|FG000|STARTED|Overall Study||19||
59684320|NCT00471536|75803615|FG000|COMPLETED|Overall Study||18||
59684321|NCT00471536|75803615|FG000|NOT COMPLETED|Overall Study||1||
59684322|NCT00470834|75803621|FG000|STARTED|Treatment Period (18 Months)||65||
59684323|NCT00470834|75803622|FG001|STARTED|Treatment Period (18 Months)||62||
59684324|NCT00470834|75803621|FG000|COMPLETED|Treatment Period (18 Months)||27||
59684325|NCT00470834|75803622|FG001|COMPLETED|Treatment Period (18 Months)||31||
59684326|NCT00470834|75803621|FG000|NOT COMPLETED|Treatment Period (18 Months)||38||
59684327|NCT00470834|75803622|FG001|NOT COMPLETED|Treatment Period (18 Months)||31||
59684328|NCT00470834|75803621|FG000|STARTED|Extension Period (24 Months)|One participant who completed the Treatment Period did not participate in the Extension Period.|26||
59684329|NCT00470834|75803622|FG001|STARTED|Extension Period (24 Months)|One participant who completed the Treatment Period did not participate in the Extension Period.|30||
59684330|NCT00470834|75803621|FG000|COMPLETED|Extension Period (24 Months)||11||
59684331|NCT00470834|75803622|FG001|COMPLETED|Extension Period (24 Months)||7||
59684332|NCT00470834|75803621|FG000|NOT COMPLETED|Extension Period (24 Months)||15||
59684333|NCT00470834|75803622|FG001|NOT COMPLETED|Extension Period (24 Months)||23||
59684334|NCT00470366|75803628|FG000|STARTED|Overall Study||60||
59684335|NCT00470366|75803628|FG000|COMPLETED|Overall Study||56||
59684336|NCT00470366|75803628|FG000|NOT COMPLETED|Overall Study||4||
59684337|NCT00470093|75803632|FG000|STARTED|Overall Study||2||
59684338|NCT00470093|75803632|FG000|COMPLETED|Overall Study||0||
59684339|NCT00470093|75803632|FG000|NOT COMPLETED|Overall Study||2||
59684340|NCT00470054|75803636|FG000|STARTED|Overall Study||44||
59684341|NCT00470054|75803636|FG000|COMPLETED|Overall Study||43||
59684342|NCT00470054|75803636|FG000|NOT COMPLETED|Overall Study||1||
59684343|NCT00474188|75803640|FG000|STARTED|Overall Study||26||
59684344|NCT00474188|75803640|FG000|COMPLETED|Overall Study|Disease progression=15, adverse event=4, death=1|20||
59684345|NCT00474188|75803640|FG000|NOT COMPLETED|Overall Study||6||
59684346|NCT00475982|75803645|FG000|STARTED|Overall Study||23||
59684347|NCT00475982|75803646|FG001|STARTED|Overall Study||21||
59684348|NCT00475982|75803645|FG000|COMPLETED|Overall Study||16||
59684349|NCT00475982|75803646|FG001|COMPLETED|Overall Study||18||
59684350|NCT00475982|75803645|FG000|NOT COMPLETED|Overall Study||7||
59684351|NCT00475982|75803646|FG001|NOT COMPLETED|Overall Study||3||
59684352|NCT01089647|75803654|FG000|STARTED|Overall Study||17||
59684353|NCT01089647|75803655|FG001|STARTED|Overall Study||17||
59684354|NCT01089647|75803654|FG000|COMPLETED|Overall Study||13||
59684355|NCT01089647|75803655|FG001|COMPLETED|Overall Study||13||
59684356|NCT01089647|75803654|FG000|NOT COMPLETED|Overall Study||4||
59684357|NCT01089647|75803655|FG001|NOT COMPLETED|Overall Study||4||
59684358|NCT01089608|75803663|FG000|STARTED|Overall Study||43||
59684359|NCT01089608|75803664|FG001|STARTED|Overall Study||50||
59684360|NCT01089608|75803663|FG000|COMPLETED|Overall Study||43||
59684361|NCT01089608|75803664|FG001|COMPLETED|Overall Study||44||
59684362|NCT01089608|75803663|FG000|NOT COMPLETED|Overall Study||0||
59684363|NCT01089608|75803664|FG001|NOT COMPLETED|Overall Study||6||
59684364|NCT01089413|75803673|FG000|STARTED|Overall Study||201||
59684365|NCT01089413|75803673|FG000|Received Bevacizumab in First Line|Overall Study||199||
59684366|NCT01089413|75803673|FG000|COMPLETED|Overall Study||0||
59684367|NCT01089413|75803673|FG000|NOT COMPLETED|Overall Study||201||
59684368|NCT01089023|75803683|FG000|STARTED|Overall Study||95||
59684369|NCT01089023|75803683|FG000|COMPLETED|Overall Study||88||
59989677|NCT02478632|76105013|FG000|COMPLETED|Late Switch Phase (Week 52 to Week 148)||42||
59989678|NCT02478632|76105014|FG001|COMPLETED|Late Switch Phase (Week 52 to Week 148)||40||
59989679|NCT02478632|76105013|FG000|NOT COMPLETED|Late Switch Phase (Week 52 to Week 148)||7||
59684370|NCT01089023|75803683|FG000|NOT COMPLETED|Overall Study||7||
59684371|NCT01088984|75803689|FG000|STARTED|Phase 1||5||
59684372|NCT01088984|75803690|FG001|STARTED|Phase 1||6||
59684373|NCT01088984|75803689|FG000|COMPLETED|Phase 1|completed follow-up up to 12 month from last dose of study drug|0||
59684374|NCT01088984|75803690|FG001|COMPLETED|Phase 1|completed follow-up up to 12 month from last dose of study drug|0||
59684375|NCT01088984|75803689|FG000|NOT COMPLETED|Phase 1||5||
59684376|NCT01088984|75803690|FG001|NOT COMPLETED|Phase 1||6||
59684377|NCT01088984|75803689|FG000|STARTED|Phase 2||0||
59684378|NCT01088984|75803690|FG001|STARTED|Phase 2||32||
59684379|NCT01088984|75803689|FG000|COMPLETED|Phase 2|completed follow-up up to 12 month from last dose of study drug|0||
59684380|NCT01088984|75803690|FG001|COMPLETED|Phase 2|completed follow-up up to 12 month from last dose of study drug|0||
59989680|NCT02478632|76105014|FG001|NOT COMPLETED|Late Switch Phase (Week 52 to Week 148)||4||
59989681|NCT02478398|76105025|FG000|STARTED|Overall Study||513||
59989682|NCT02478398|76105026|FG001|STARTED|Overall Study||512||
59684381|NCT01088984|75803689|FG000|NOT COMPLETED|Phase 2||0||
59684382|NCT01088984|75803690|FG001|NOT COMPLETED|Phase 2||32||
59684383|NCT01088438|75803701|FG000|STARTED|Overall Study||94||
59684384|NCT01088438|75803702|FG001|STARTED|Overall Study||95||
59684385|NCT01088438|75803701|FG000|COMPLETED|Overall Study||65||
59684386|NCT01088438|75803702|FG001|COMPLETED|Overall Study||59||
59684387|NCT01088438|75803701|FG000|NOT COMPLETED|Overall Study||29||
59684388|NCT01088438|75803702|FG001|NOT COMPLETED|Overall Study||36||
59684389|NCT01088243|75803710|FG000|STARTED|Overall Study||13||
59989683|NCT02478398|76105025|FG000|Treated|Overall Study||512||
59989684|NCT02478398|76105026|FG001|Treated|Overall Study||510||
59684390|NCT01088243|75803711|FG001|STARTED|Overall Study||5||
59684391|NCT01088243|75803710|FG000|COMPLETED|Overall Study||12||
59684392|NCT01088243|75803711|FG001|COMPLETED|Overall Study||5||
59684393|NCT01088243|75803710|FG000|NOT COMPLETED|Overall Study||1||
59684394|NCT01088243|75803711|FG001|NOT COMPLETED|Overall Study||0||
59684395|NCT01088048|75803727|FG000|STARTED|Overall Study||51||
59684396|NCT01088048|75803728|FG001|STARTED|Overall Study||51||
59684397|NCT01088048|75803729|FG002|STARTED|Overall Study||18||
59684398|NCT01088048|75803730|FG003|STARTED|Overall Study||18||
59684399|NCT01088048|75803731|FG004|STARTED|Overall Study||33||
59684400|NCT01088048|75803732|FG005|STARTED|Overall Study||21||
59684401|NCT01088048|75803733|FG006|STARTED|Overall Study||12||
59684402|NCT01088048|75803734|FG007|STARTED|Overall Study||15||
59684403|NCT01088048|75803735|FG008|STARTED|Overall Study||15||
59684404|NCT01088048|75803736|FG009|STARTED|Overall Study||7||
59684405|NCT01088048|75803727|FG000|Participants With CLL|Overall Study||19||
59684406|NCT01088048|75803728|FG001|Participants With CLL|Overall Study||18||
59684407|NCT01088048|75803729|FG002|Participants With CLL|Overall Study||0||
59684408|NCT01088048|75803730|FG003|Participants With CLL|Overall Study||0||
59684409|NCT01088048|75803731|FG004|Participants With CLL|Overall Study||15||
59684410|NCT01088048|75803732|FG005|Participants With CLL|Overall Study||21||
59684411|NCT01088048|75803733|FG006|Participants With CLL|Overall Study||12||
59684412|NCT01088048|75803734|FG007|Participants With CLL|Overall Study||15||
59684413|NCT01088048|75803735|FG008|Participants With CLL|Overall Study||14||
59684414|NCT01088048|75803736|FG009|Participants With CLL|Overall Study||1||
59684415|NCT01088048|75803727|FG000|Participants With Indolent NHL|Overall Study||32||
59684416|NCT01088048|75803728|FG001|Participants With Indolent NHL|Overall Study||33||
59684417|NCT01088048|75803729|FG002|Participants With Indolent NHL|Overall Study||0||
59684418|NCT01088048|75803730|FG003|Participants With Indolent NHL|Overall Study||0||
59684419|NCT01088048|75803731|FG004|Participants With Indolent NHL|Overall Study||14||
59684420|NCT01088048|75803732|FG005|Participants With Indolent NHL|Overall Study||0||
59684421|NCT01088048|75803733|FG006|Participants With Indolent NHL|Overall Study||0||
59684422|NCT01088048|75803734|FG007|Participants With Indolent NHL|Overall Study||0||
59684423|NCT01088048|75803735|FG008|Participants With Indolent NHL|Overall Study||1||
59684424|NCT01088048|75803736|FG009|Participants With Indolent NHL|Overall Study||6||
59684425|NCT01088048|75803727|FG000|Participants With MCL|Overall Study||0||
59684426|NCT01088048|75803728|FG001|Participants With MCL|Overall Study||0||
59684427|NCT01088048|75803729|FG002|Participants With MCL|Overall Study||18||
59684428|NCT01088048|75803730|FG003|Participants With MCL|Overall Study||18||
59684429|NCT01088048|75803731|FG004|Participants With MCL|Overall Study||4||
59684430|NCT01088048|75803732|FG005|Participants With MCL|Overall Study||0||
59684431|NCT01088048|75803733|FG006|Participants With MCL|Overall Study||0||
59684432|NCT01088048|75803734|FG007|Participants With MCL|Overall Study||0||
59684433|NCT01088048|75803735|FG008|Participants With MCL|Overall Study||0||
59684434|NCT01088048|75803736|FG009|Participants With MCL|Overall Study||0||
59684435|NCT01088048|75803727|FG000|COMPLETED|Overall Study||29||
59684436|NCT01088048|75803728|FG001|COMPLETED|Overall Study||24||
59684437|NCT01088048|75803729|FG002|COMPLETED|Overall Study||4||
59684438|NCT01088048|75803730|FG003|COMPLETED|Overall Study||4||
59684439|NCT01088048|75803731|FG004|COMPLETED|Overall Study||16||
59684440|NCT01088048|75803732|FG005|COMPLETED|Overall Study||10||
59684441|NCT01088048|75803733|FG006|COMPLETED|Overall Study||6||
59684442|NCT01088048|75803734|FG007|COMPLETED|Overall Study||10||
59684443|NCT01088048|75803735|FG008|COMPLETED|Overall Study||8||
59684444|NCT01088048|75803736|FG009|COMPLETED|Overall Study||3||
59684445|NCT01088048|75803727|FG000|NOT COMPLETED|Overall Study||22||
59684446|NCT01088048|75803728|FG001|NOT COMPLETED|Overall Study||27||
59684447|NCT01088048|75803729|FG002|NOT COMPLETED|Overall Study||14||
59684448|NCT01088048|75803730|FG003|NOT COMPLETED|Overall Study||14||
59684449|NCT01088048|75803731|FG004|NOT COMPLETED|Overall Study||17||
59684450|NCT01088048|75803732|FG005|NOT COMPLETED|Overall Study||11||
59684451|NCT01088048|75803733|FG006|NOT COMPLETED|Overall Study||6||
59684452|NCT01088048|75803734|FG007|NOT COMPLETED|Overall Study||5||
59684453|NCT01088048|75803735|FG008|NOT COMPLETED|Overall Study||7||
59684454|NCT01088048|75803736|FG009|NOT COMPLETED|Overall Study||4||
59684455|NCT01087970|75803769|FG000|STARTED|Overall Study||69||
59684456|NCT01087970|75803769|FG000|Received ≥1 Dose of Any Study Drug|Overall Study||69||
59684457|NCT01087970|75803769|FG000|Completed 6 Cycles|Overall Study||69||
59684458|NCT01087970|75803769|FG000|Efficacy Population|Overall Study|All treated participants excluding those from a noncompliant study site.|58||
59684459|NCT01087970|75803769|FG000|Received Carboplatin|Overall Study||63||
59684460|NCT01087970|75803769|FG000|COMPLETED|Overall Study||67||
59684461|NCT01087970|75803769|FG000|NOT COMPLETED|Overall Study||2||
59684462|NCT01087814|75803776|FG000|STARTED|First Intervention (5 Days)||8||
59684463|NCT01087814|75803777|FG001|STARTED|First Intervention (5 Days)||7||
59684464|NCT01087814|75803776|FG000|COMPLETED|First Intervention (5 Days)||5||
59684465|NCT01087814|75803777|FG001|COMPLETED|First Intervention (5 Days)||6||
59684466|NCT01087814|75803776|FG000|NOT COMPLETED|First Intervention (5 Days)||3||
59684467|NCT01087814|75803777|FG001|NOT COMPLETED|First Intervention (5 Days)||1||
59684468|NCT01087814|75803776|FG000|STARTED|Second Intervention (5 Days)||5||
59684469|NCT01087814|75803777|FG001|STARTED|Second Intervention (5 Days)||6||
59684470|NCT01087814|75803776|FG000|COMPLETED|Second Intervention (5 Days)||4||
59684471|NCT01087814|75803777|FG001|COMPLETED|Second Intervention (5 Days)||6||
59684472|NCT01087814|75803776|FG000|NOT COMPLETED|Second Intervention (5 Days)||1||
59684473|NCT01087814|75803777|FG001|NOT COMPLETED|Second Intervention (5 Days)||0||
59684474|NCT01087775|75803783|FG000|STARTED|Overall Study||25||
59684475|NCT01087775|75803783|FG000|COMPLETED|Overall Study|2 subjects were found to be ineligible for the study|23||
59684476|NCT01087775|75803783|FG000|NOT COMPLETED|Overall Study||2||
59684477|NCT01087502|75803790|FG000|STARTED|Up to Interim Analysis (Week 12)||123||
59684478|NCT01087502|75803791|FG001|STARTED|Up to Interim Analysis (Week 12)||118||
59684479|NCT01087502|75803790|FG000|COMPLETED|Up to Interim Analysis (Week 12)||114||
59684480|NCT01087502|75803791|FG001|COMPLETED|Up to Interim Analysis (Week 12)||110||
59684481|NCT01087502|75803790|FG000|NOT COMPLETED|Up to Interim Analysis (Week 12)||9||
59684482|NCT01087502|75803791|FG001|NOT COMPLETED|Up to Interim Analysis (Week 12)||8||
59684483|NCT01087502|75803790|FG000|STARTED|Up to Final Analysis (Week 52)||123||
59684484|NCT01087502|75803791|FG001|STARTED|Up to Final Analysis (Week 52)||118||
59684485|NCT01087502|75803790|FG000|COMPLETED|Up to Final Analysis (Week 52)||90||
59684486|NCT01087502|75803791|FG001|COMPLETED|Up to Final Analysis (Week 52)||95||
59684487|NCT01087502|75803790|FG000|NOT COMPLETED|Up to Final Analysis (Week 52)||33||
59684488|NCT01087502|75803791|FG001|NOT COMPLETED|Up to Final Analysis (Week 52)||23||
59684489|NCT01086410|75803803|FG000|STARTED|Overall Study||58||
59684490|NCT01086410|75803804|FG001|STARTED|Overall Study||56||
59684491|NCT01086410|75803805|FG002|STARTED|Overall Study||56||
59684492|NCT01086410|75803806|FG003|STARTED|Overall Study||15||
59684493|NCT01086410|75803803|FG000|COMPLETED|Overall Study||55||
59684494|NCT01086410|75803804|FG001|COMPLETED|Overall Study||54||
59684495|NCT01086410|75803805|FG002|COMPLETED|Overall Study||55||
59684496|NCT01086410|75803806|FG003|COMPLETED|Overall Study||13||
59684497|NCT01086410|75803803|FG000|NOT COMPLETED|Overall Study||3||
59684498|NCT01086410|75803804|FG001|NOT COMPLETED|Overall Study||2||
59684499|NCT01086410|75803805|FG002|NOT COMPLETED|Overall Study||1||
59684500|NCT01086410|75803806|FG003|NOT COMPLETED|Overall Study||2||
59684501|NCT04553679|75803818|FG000|STARTED|Overall Study||13||
59684502|NCT04553679|75803819|FG001|STARTED|Overall Study||3||
59684503|NCT04553679|75803818|FG000|COMPLETED|Overall Study||11||
59684504|NCT04553679|75803819|FG001|COMPLETED|Overall Study||2||
59684505|NCT04553679|75803818|FG000|NOT COMPLETED|Overall Study||2||
59684506|NCT04553679|75803819|FG001|NOT COMPLETED|Overall Study||1||
59684507|NCT01086215|75803833|FG000|STARTED|Overall Study||212||
59684508|NCT01086215|75803834|FG001|STARTED|Overall Study||201||
59684509|NCT01086215|75803835|FG002|STARTED|Overall Study||73||
59684510|NCT01086215|75803836|FG003|STARTED|Overall Study||14||
59684511|NCT01086215|75803833|FG000|3 Month Follow Up|Overall Study|7 LTF; 4 Deaths|201||
59684512|NCT01086215|75803834|FG001|3 Month Follow Up|Overall Study|10 LTF; 4 Deaths|187||
59684513|NCT01086215|75803835|FG002|3 Month Follow Up|Overall Study|5 LTF; 4 Deaths|64||
59684514|NCT01086215|75803836|FG003|3 Month Follow Up|Overall Study|1 LTF; 0 Deaths|13||
59684515|NCT01086215|75803833|FG000|6 Month Follow Up|Overall Study|5 LTF; 4 Deaths|192||
59684516|NCT01086215|75803834|FG001|6 Month Follow Up|Overall Study|13 LTF; 2 Deaths|172||
59684517|NCT01086215|75803835|FG002|6 Month Follow Up|Overall Study|4 LTF; 0 Deaths|60||
59684518|NCT01086215|75803836|FG003|6 Month Follow Up|Overall Study|1 LTF; 0 Deaths|12||
59684519|NCT01086215|75803833|FG000|12 Month Follow Up|Overall Study|10 LTF; 6 Deaths|176||
59684520|NCT01086215|75803834|FG001|12 Month Follow Up|Overall Study|16 LTF; 2 Deaths|154||
59684521|NCT01086215|75803835|FG002|12 Month Follow Up|Overall Study|9 LTF; 4 Deaths|47||
59684522|NCT01086215|75803836|FG003|12 Month Follow Up|Overall Study|0 LTF; 1 Death|11||
59684523|NCT01086215|75803833|FG000|COMPLETED|Overall Study||176||
59684524|NCT01086215|75803834|FG001|COMPLETED|Overall Study||154||
59684525|NCT01086215|75803835|FG002|COMPLETED|Overall Study||47||
60079232|NCT04810481|76194576|FG000|COMPLETED|Overall Study||76||
60079233|NCT04810481|76194577|FG001|COMPLETED|Overall Study||56||
60079234|NCT04810481|76194576|FG000|NOT COMPLETED|Overall Study||10||
60079235|NCT04810481|76194577|FG001|NOT COMPLETED|Overall Study||28||
59684526|NCT01086215|75803836|FG003|COMPLETED|Overall Study||11||
59684527|NCT01086215|75803833|FG000|NOT COMPLETED|Overall Study||36||
59684528|NCT01086215|75803834|FG001|NOT COMPLETED|Overall Study||47||
59684529|NCT01086215|75803835|FG002|NOT COMPLETED|Overall Study||26||
59684530|NCT01086215|75803836|FG003|NOT COMPLETED|Overall Study||3||
59684531|NCT01085591|75803849|FG000|STARTED|Overall Study||69||
59684532|NCT01085591|75803850|FG001|STARTED|Overall Study||71||
59684533|NCT01085591|75803851|FG002|STARTED|Overall Study||70||
59684534|NCT01085591|75803849|FG000|Received at Least 1 Dose of Study Drug|Overall Study||68||
59684535|NCT01085591|75803850|FG001|Received at Least 1 Dose of Study Drug|Overall Study||69||
59684536|NCT01085591|75803851|FG002|Received at Least 1 Dose of Study Drug|Overall Study||70||
59684537|NCT01085591|75803849|FG000|COMPLETED|Overall Study||66||
60079236|NCT04762719|76194586|FG000|STARTED|Overall Study||4||
60079237|NCT04762719|76194587|FG001|STARTED|Overall Study||4||
60079238|NCT04762719|76194588|FG002|STARTED|Overall Study||4||
60079239|NCT04762719|76194586|FG000|COMPLETED|Overall Study||4||
60079240|NCT04762719|76194587|FG001|COMPLETED|Overall Study||4||
59684538|NCT01085591|75803850|FG001|COMPLETED|Overall Study||65||
59684539|NCT01085591|75803851|FG002|COMPLETED|Overall Study||63||
59684540|NCT01085591|75803849|FG000|NOT COMPLETED|Overall Study||3||
59684541|NCT01085591|75803850|FG001|NOT COMPLETED|Overall Study||6||
59684542|NCT01085591|75803851|FG002|NOT COMPLETED|Overall Study||7||
59684543|NCT01085357|75803862|FG000|STARTED|Overall Study||374||
59684544|NCT01085357|75803863|FG001|STARTED|Overall Study||131||
59684545|NCT01085357|75803862|FG000|COMPLETED|Overall Study||355||
59684546|NCT01085357|75803863|FG001|COMPLETED|Overall Study||125||
59684547|NCT01085357|75803862|FG000|NOT COMPLETED|Overall Study||19||
59684548|NCT01085357|75803863|FG001|NOT COMPLETED|Overall Study||6||
59684549|NCT01085201|75803874|FG000|STARTED|Overall Study||18||
59684550|NCT01085201|75803875|FG001|STARTED|Overall Study||7||
59684551|NCT01085201|75803876|FG002|STARTED|Overall Study||5||
59684552|NCT01085201|75803877|FG003|STARTED|Overall Study||6||
59684553|NCT01085201|75803878|FG004|STARTED|Overall Study||3||
59684554|NCT01085201|75803874|FG000|COMPLETED|Overall Study||15||
59684555|NCT01085201|75803875|FG001|COMPLETED|Overall Study||6||
59684556|NCT01085201|75803876|FG002|COMPLETED|Overall Study||3||
59684557|NCT01085201|75803877|FG003|COMPLETED|Overall Study||6||
59684558|NCT01085201|75803878|FG004|COMPLETED|Overall Study||3||
59684559|NCT01085201|75803874|FG000|NOT COMPLETED|Overall Study||3||
59684560|NCT01085201|75803875|FG001|NOT COMPLETED|Overall Study||1||
59684561|NCT01085201|75803876|FG002|NOT COMPLETED|Overall Study||2||
59684562|NCT01085201|75803877|FG003|NOT COMPLETED|Overall Study||0||
59684563|NCT01085201|75803878|FG004|NOT COMPLETED|Overall Study||0||
59684564|NCT01085084|75803898|FG000|STARTED|Overall Study||26||
59684565|NCT01085084|75803899|FG001|STARTED|Overall Study||28||
59684566|NCT01085084|75803900|FG002|STARTED|Overall Study||28||
59684567|NCT01085084|75803898|FG000|Received at Least 1 Dose of Study Drug|Overall Study||26||
59684568|NCT01085084|75803899|FG001|Received at Least 1 Dose of Study Drug|Overall Study||28||
59684569|NCT01085084|75803900|FG002|Received at Least 1 Dose of Study Drug|Overall Study||28||
59684570|NCT01085084|75803898|FG000|Safety Analysis Set|Overall Study||25||
59684571|NCT01085084|75803899|FG001|Safety Analysis Set|Overall Study|1 participant was assigned to placebo but received laquinimod 0.5 mg by mistake.|29||
59684572|NCT01085084|75803900|FG002|Safety Analysis Set|Overall Study||28||
59684573|NCT01085084|75803898|FG000|COMPLETED|Overall Study||19||
59684574|NCT01085084|75803899|FG001|COMPLETED|Overall Study||23||
59684575|NCT01085084|75803900|FG002|COMPLETED|Overall Study||19||
59684576|NCT01085084|75803898|FG000|NOT COMPLETED|Overall Study||7||
59684577|NCT01085084|75803899|FG001|NOT COMPLETED|Overall Study||5||
59684578|NCT01085084|75803900|FG002|NOT COMPLETED|Overall Study||9||
59684579|NCT01085045|75803908|FG000|STARTED|Part A||122||
59684580|NCT01085045|75803908|FG000|GFF MDI 72/9.6mcg|Part A||40||
59684581|NCT01085045|75803908|FG000|GFF MDI 36/9.6 µg (PT003)|Part A||42||
59684582|NCT01085045|75803908|FG000|GP MDI 36 µg (PT001)|Part A||40||
59684583|NCT01085045|75803908|FG000|Spiriva 18 µg|Part A||58||
59684584|NCT01085045|75803908|FG000|FF MDI 9.6 µg (PT005)|Part A||20||
59684585|NCT01085045|75803908|FG000|FF MDI 7.2 µg (PT005)|Part A||21||
59684586|NCT01085045|75803908|FG000|Placebo MDI|Part A||5||
59684587|NCT01085045|75803908|FG000|Foradil 12 µg|Part A||14||
59684588|NCT01085045|75803908|FG000|COMPLETED|Part A||104||
59684589|NCT01085045|75803908|FG000|NOT COMPLETED|Part A||18||
59684590|NCT01085045|75803908|FG000|STARTED|Part B||104||
59684591|NCT01085045|75803908|FG000|GFF MDI 72/9.6mcg (PT003)|Part B||0||
59684592|NCT01085045|75803908|FG000|GFF MDI 36/9.6 µg|Part B||0||
59684593|NCT01085045|75803908|FG000|Spiriva 18 µg|Part B||0||
59684594|NCT01085045|75803908|FG000|FF MDI 9.6 µg (PT005)|Part B||43||
59684595|NCT01085045|75803908|FG000|FF MDI 7.2 µg (PT005)|Part B||43||
59684596|NCT01085045|75803908|FG000|Placebo MDI|Part B||47||
59684597|NCT01085045|75803908|FG000|Foradil 12 µg|Part B||41||
59684598|NCT01085045|75803908|FG000|GP MDI 36 µg (PT001)|Part B||0||
59684599|NCT01085045|75803908|FG000|COMPLETED|Part B||89||
59684600|NCT01085045|75803908|FG000|NOT COMPLETED|Part B||15||
59684601|NCT01084772|75803930|FG000|STARTED|Baseline||68||
59684602|NCT01084772|75803931|FG001|STARTED|Baseline||66||
59684603|NCT01084772|75803930|FG000|COMPLETED|Baseline||61||
59684604|NCT01084772|75803931|FG001|COMPLETED|Baseline||60||
59684605|NCT01084772|75803930|FG000|NOT COMPLETED|Baseline||7||
59684606|NCT01084772|75803931|FG001|NOT COMPLETED|Baseline||6||
59684607|NCT01084772|75803930|FG000|STARTED|3 Months||61||
59684608|NCT01084772|75803931|FG001|STARTED|3 Months||60||
59684609|NCT01084772|75803930|FG000|COMPLETED|3 Months||58||
59684610|NCT01084772|75803931|FG001|COMPLETED|3 Months||58||
59684611|NCT01084772|75803930|FG000|NOT COMPLETED|3 Months||3||
59684612|NCT01084772|75803931|FG001|NOT COMPLETED|3 Months||2||
59684613|NCT01084772|75803930|FG000|STARTED|1 Year||58||
59684614|NCT01084772|75803931|FG001|STARTED|1 Year||58||
59684615|NCT01084772|75803930|FG000|COMPLETED|1 Year||55||
59684616|NCT01084772|75803931|FG001|COMPLETED|1 Year||50||
59684617|NCT01084772|75803930|FG000|NOT COMPLETED|1 Year||3||
59684618|NCT01084772|75803931|FG001|NOT COMPLETED|1 Year||8||
59684619|NCT01084772|75803930|FG000|STARTED|2 Years||55||
59684620|NCT01084772|75803931|FG001|STARTED|2 Years||50||
59684621|NCT01084772|75803930|FG000|COMPLETED|2 Years||46||
59684622|NCT01084772|75803931|FG001|COMPLETED|2 Years||46||
59684623|NCT01084772|75803930|FG000|NOT COMPLETED|2 Years||9||
59684624|NCT01084772|75803931|FG001|NOT COMPLETED|2 Years||4||
59684625|NCT00179673|75803937|FG000|STARTED|Overall Study||43||
59684626|NCT00179673|75803937|FG000|Received Study Drug|Overall Study||43||
59684627|NCT00179673|75803937|FG000|COMPLETED|Overall Study|Completed refers to participants ongoing in the study at the time of analysis.|0||
59684628|NCT00179673|75803937|FG000|NOT COMPLETED|Overall Study||43||
59684629|NCT01084655|75803944|FG000|STARTED|Overall Study||6||
59684630|NCT01084655|75803945|FG001|STARTED|Overall Study||8||
59684631|NCT01084655|75803946|FG002|STARTED|Overall Study||24||
59684632|NCT01084655|75803944|FG000|Treated|Overall Study||6||
59684633|NCT01084655|75803945|FG001|Treated|Overall Study||8||
59684634|NCT01084655|75803946|FG002|Treated|Overall Study||23||
59684635|NCT01084655|75803944|FG000|COMPLETED|Overall Study||0||
59684636|NCT01084655|75803945|FG001|COMPLETED|Overall Study||2||
59684637|NCT01084655|75803946|FG002|COMPLETED|Overall Study||5||
59684638|NCT01084655|75803944|FG000|NOT COMPLETED|Overall Study||6||
59684639|NCT01084655|75803945|FG001|NOT COMPLETED|Overall Study||6||
59684640|NCT01084655|75803946|FG002|NOT COMPLETED|Overall Study||19||
59684641|NCT01084538|75803958|FG000|STARTED|Overall Study||181||
59684642|NCT01084538|75803958|FG000|COMPLETED|Overall Study||113||
59684643|NCT01084538|75803958|FG000|NOT COMPLETED|Overall Study||68||
59684644|NCT01083680|75803962|FG000|STARTED|Overall Study||4107||
59684645|NCT01083680|75803962|FG000|Full Analysis Set (FAS), Efficacy|Overall Study||1621||
59684646|NCT01083680|75803962|FG000|COMPLETED|Overall Study||263||
59684647|NCT01083680|75803962|FG000|NOT COMPLETED|Overall Study||3844||
59684648|NCT00179517|75803968|FG000|STARTED|Overall Study||20||
59684649|NCT00179517|75803969|FG001|STARTED|Overall Study||20||
59684650|NCT00179517|75803968|FG000|COMPLETED|Overall Study||18||
59684651|NCT00179517|75803969|FG001|COMPLETED|Overall Study||19||
59684652|NCT00179517|75803968|FG000|NOT COMPLETED|Overall Study||2||
59684653|NCT00179517|75803969|FG001|NOT COMPLETED|Overall Study||1||
59684654|NCT01083641|75803975|FG000|STARTED|Overall Study||17||
59684655|NCT01083641|75803975|FG000|COMPLETED|Overall Study||15||
59684656|NCT01083641|75803975|FG000|NOT COMPLETED|Overall Study||2||
59684657|NCT00179010|75803981|FG000|STARTED|Overall Study||6||
59684658|NCT00179010|75803982|FG001|STARTED|Overall Study||7||
59684659|NCT00179010|75803981|FG000|COMPLETED|Overall Study||5||
59684660|NCT00179010|75803982|FG001|COMPLETED|Overall Study||5||
59684661|NCT00179010|75803981|FG000|NOT COMPLETED|Overall Study||1||
59684662|NCT00179010|75803982|FG001|NOT COMPLETED|Overall Study||2||
59684663|NCT01083602|75803989|FG000|STARTED|Overall Study||55||
59684664|NCT01083602|75803989|FG000|COMPLETED|Overall Study||0||
59684665|NCT01083602|75803989|FG000|NOT COMPLETED|Overall Study||55||
59684666|NCT00178464|75803993|FG000|STARTED|Overall Study||11||
59684667|NCT00178464|75803993|FG000|COMPLETED|Overall Study||9||
59684668|NCT00178464|75803993|FG000|NOT COMPLETED|Overall Study||2||
60079241|NCT04762719|76194588|FG002|COMPLETED|Overall Study||4||
60079242|NCT04762719|76194586|FG000|NOT COMPLETED|Overall Study||0||
60079243|NCT04762719|76194587|FG001|NOT COMPLETED|Overall Study||0||
60079244|NCT04762719|76194588|FG002|NOT COMPLETED|Overall Study||0||
60079245|NCT04755231|76194596|FG000|STARTED|Overall Study||144||288
60079246|NCT04755231|76194596|FG000|Attempted Implantation, First Eye|Overall Study||144||144
60079247|NCT04755231|76194596|FG000|Attempted Implantation Second Eye|Overall Study||142||142
60079248|NCT04755231|76194596|FG000|Successful Implantation, First Eye|Overall Study||144||144
60079249|NCT04755231|76194596|FG000|Successful Implantation Second Eye|Overall Study||142||142
60079250|NCT04755231|76194596|FG000|COMPLETED|Overall Study||134||268
60079251|NCT04755231|76194596|FG000|NOT COMPLETED|Overall Study||10||20
60079252|NCT04664400|76194609|FG000|STARTED|Overall Study||10||
60079253|NCT04664400|76194609|FG000|COMPLETED|Overall Study||8||
60079254|NCT04664400|76194609|FG000|NOT COMPLETED|Overall Study||2||
60079255|NCT04657770|76194614|FG000|STARTED|Overall Study||19||
59547306|NCT02429115|75646098|FG003|NOT COMPLETED|Overall Study||8||
59547307|NCT02429115|75646099|FG004|NOT COMPLETED|Overall Study||7||
59684669|NCT01083485|75803999|FG000|STARTED|Overall Study||70||
59684670|NCT01083485|75804000|FG001|STARTED|Overall Study||67||
59684671|NCT01083485|75803999|FG000|COMPLETED|Overall Study||63||
59684672|NCT01083485|75804000|FG001|COMPLETED|Overall Study||64||
59816083|NCT03885596|75938429|FG003|COMPLETED|Overall Study||9||
60079256|NCT04657770|76194614|FG000|COMPLETED|Overall Study||15||
60079257|NCT04657770|76194614|FG000|NOT COMPLETED|Overall Study||4||
60079258|NCT04496453|76194618|FG000|STARTED|Overall Study||17||
60079259|NCT04496453|76194618|FG000|COMPLETED|Overall Study||11||
60079260|NCT04496453|76194618|FG000|NOT COMPLETED|Overall Study||6||
59684673|NCT01083485|75803999|FG000|NOT COMPLETED|Overall Study||7||
59684674|NCT01083485|75804000|FG001|NOT COMPLETED|Overall Study||3||
59684675|NCT01083173|75804008|FG000|STARTED|Main Surveillance: Safety Group||595||
59684676|NCT01083173|75804009|FG001|STARTED|Main Surveillance: Safety Group||0||
59684677|NCT01083173|75804008|FG000|COMPLETED|Main Surveillance: Safety Group||580||
59684678|NCT01083173|75804009|FG001|COMPLETED|Main Surveillance: Safety Group||0||
59684679|NCT01083173|75804008|FG000|NOT COMPLETED|Main Surveillance: Safety Group||15||
59684680|NCT01083173|75804009|FG001|NOT COMPLETED|Main Surveillance: Safety Group||0||
59684681|NCT01083173|75804008|FG000|STARTED|Main Surveillance: Effectiveness Group||580||
59684682|NCT01083173|75804009|FG001|STARTED|Main Surveillance: Effectiveness Group||0||
59684683|NCT01083173|75804008|FG000|COMPLETED|Main Surveillance: Effectiveness Group||198||
59684684|NCT01083173|75804009|FG001|COMPLETED|Main Surveillance: Effectiveness Group||0||
59684685|NCT01083173|75804008|FG000|NOT COMPLETED|Main Surveillance: Effectiveness Group||382||
59684686|NCT01083173|75804009|FG001|NOT COMPLETED|Main Surveillance: Effectiveness Group||0||
59684687|NCT01083173|75804008|FG000|STARTED|Long-term Surveillance: Safety Group||0||
59684688|NCT01083173|75804009|FG001|STARTED|Long-term Surveillance: Safety Group||595||
59684689|NCT01083173|75804008|FG000|COMPLETED|Long-term Surveillance: Safety Group||0||
59684690|NCT01083173|75804009|FG001|COMPLETED|Long-term Surveillance: Safety Group||479||
59684691|NCT01083173|75804008|FG000|NOT COMPLETED|Long-term Surveillance: Safety Group||0||
59684692|NCT01083173|75804009|FG001|NOT COMPLETED|Long-term Surveillance: Safety Group||116||
59684693|NCT01083173|75804008|FG000|STARTED|Long-term Surveillance: Effectiveness Gr||0||
59684694|NCT01083173|75804009|FG001|STARTED|Long-term Surveillance: Effectiveness Gr||479||
59684695|NCT01083173|75804008|FG000|COMPLETED|Long-term Surveillance: Effectiveness Gr||0||
59684696|NCT01083173|75804009|FG001|COMPLETED|Long-term Surveillance: Effectiveness Gr||102||
59684697|NCT01083173|75804008|FG000|NOT COMPLETED|Long-term Surveillance: Effectiveness Gr||0||
59684698|NCT01083173|75804009|FG001|NOT COMPLETED|Long-term Surveillance: Effectiveness Gr||377||
59684699|NCT00177294|75804020|FG000|STARTED|Overall Study||60||
59684700|NCT00177294|75804021|FG001|STARTED|Overall Study||64||
59684701|NCT00177294|75804020|FG000|COMPLETED|Overall Study||53||
59684702|NCT00177294|75804021|FG001|COMPLETED|Overall Study||59||
59684703|NCT00177294|75804020|FG000|NOT COMPLETED|Overall Study||7||
59684704|NCT00177294|75804021|FG001|NOT COMPLETED|Overall Study||5||
59684705|NCT01082081|75804030|FG000|STARTED|Overall Study||121||
59684706|NCT01082081|75804031|FG001|STARTED|Overall Study||119||
59684707|NCT01082081|75804032|FG002|STARTED|Overall Study||60||
59684708|NCT01082081|75804030|FG000|COMPLETED|Overall Study||121||
59684709|NCT01082081|75804031|FG001|COMPLETED|Overall Study||118||
59684710|NCT01082081|75804032|FG002|COMPLETED|Overall Study||58||
59684711|NCT01082081|75804030|FG000|NOT COMPLETED|Overall Study||0||
59684712|NCT01082081|75804031|FG001|NOT COMPLETED|Overall Study||1||
59684713|NCT01082081|75804032|FG002|NOT COMPLETED|Overall Study||2||
59684714|NCT00177216|75804043|FG000|STARTED|Overall Study||26||
59684715|NCT00177216|75804044|FG001|STARTED|Overall Study||23||
59684716|NCT00177216|75804045|FG002|STARTED|Overall Study||20||
59684717|NCT00177216|75804043|FG000|COMPLETED|Overall Study||20||
59684718|NCT00177216|75804044|FG001|COMPLETED|Overall Study||20||
59684719|NCT00177216|75804045|FG002|COMPLETED|Overall Study||19||
59684720|NCT00177216|75804043|FG000|NOT COMPLETED|Overall Study||6||
59684721|NCT00177216|75804044|FG001|NOT COMPLETED|Overall Study||3||
59684722|NCT00177216|75804045|FG002|NOT COMPLETED|Overall Study||1||
59684723|NCT01081886|75804059|FG000|STARTED|Overall Study||11||
59684724|NCT01081886|75804060|FG001|STARTED|Overall Study||13||
59684725|NCT01081886|75804059|FG000|COMPLETED|Overall Study||0||
59684726|NCT01081886|75804060|FG001|COMPLETED|Overall Study||0||
59684727|NCT01081886|75804059|FG000|NOT COMPLETED|Overall Study||11||
59684728|NCT01081886|75804060|FG001|NOT COMPLETED|Overall Study||13||
59684729|NCT01081769|75804068|FG000|STARTED|Whole Intent-to-Treat||376||
59684730|NCT01081769|75804069|FG001|STARTED|Whole Intent-to-Treat||388||
59684731|NCT01081769|75804068|FG000|COMPLETED|Whole Intent-to-Treat||352||
59684732|NCT01081769|75804069|FG001|COMPLETED|Whole Intent-to-Treat||363||
59684733|NCT01081769|75804068|FG000|NOT COMPLETED|Whole Intent-to-Treat||24||
59684734|NCT01081769|75804069|FG001|NOT COMPLETED|Whole Intent-to-Treat||25||
59684735|NCT01081769|75804068|FG000|STARTED|CORE Intent-To-Treat||352||
59684736|NCT01081769|75804069|FG001|STARTED|CORE Intent-To-Treat||363||
59684737|NCT01081769|75804068|FG000|COMPLETED|CORE Intent-To-Treat||272||
59684738|NCT01081769|75804069|FG001|COMPLETED|CORE Intent-To-Treat||266||
59684739|NCT01081769|75804068|FG000|NOT COMPLETED|CORE Intent-To-Treat||80||
59684740|NCT01081769|75804069|FG001|NOT COMPLETED|CORE Intent-To-Treat||97||
59684741|NCT01081301|75804075|FG000|STARTED|Overall Study||36||
59684742|NCT01081301|75804075|FG000|COMPLETED|Overall Study||22||
59684743|NCT01081301|75804075|FG000|NOT COMPLETED|Overall Study||14||
59684744|NCT00174954|75804096|FG000|STARTED|Overall Study||32||
59684745|NCT00174954|75804096|FG000|COMPLETED|Overall Study||28||
59816084|NCT03885596|75938426|FG000|NOT COMPLETED|Overall Study||2||
59684746|NCT00174954|75804096|FG000|NOT COMPLETED|Overall Study||4||
59684747|NCT01081145|75804100|FG000|STARTED|Open-Label Phase||528||
59684748|NCT01081145|75804101|FG001|STARTED|Open-Label Phase||0||
59684749|NCT01081145|75804100|FG000|COMPLETED|Open-Label Phase||316||
59816085|NCT03885596|75938427|FG001|NOT COMPLETED|Overall Study||1||
59684750|NCT01081145|75804101|FG001|COMPLETED|Open-Label Phase||0||
59684751|NCT01081145|75804100|FG000|NOT COMPLETED|Open-Label Phase||212||
59684752|NCT01081145|75804101|FG001|NOT COMPLETED|Open-Label Phase||0||
59684753|NCT01081145|75804100|FG000|STARTED|Double-Blind Randomized-Withdrawal Phase||157||
59684754|NCT01081145|75804101|FG001|STARTED|Double-Blind Randomized-Withdrawal Phase||159||
59684755|NCT01081145|75804100|FG000|COMPLETED|Double-Blind Randomized-Withdrawal Phase||76||
59684756|NCT01081145|75804101|FG001|COMPLETED|Double-Blind Randomized-Withdrawal Phase||53||
59684757|NCT01081145|75804100|FG000|NOT COMPLETED|Double-Blind Randomized-Withdrawal Phase||81||
59684758|NCT01081145|75804101|FG001|NOT COMPLETED|Double-Blind Randomized-Withdrawal Phase||106||
59684759|NCT00174915|75804114|FG000|STARTED|Overall Study||267||
59684760|NCT00174915|75804115|FG001|STARTED|Overall Study||269||
59684761|NCT00174915|75804116|FG002|STARTED|Overall Study||134||
59684762|NCT00174915|75804117|FG003|STARTED|Overall Study||268||
59684763|NCT00174915|75804118|FG004|STARTED|Overall Study||134||
59684764|NCT00174915|75804114|FG000|COMPLETED|Overall Study||174||
59684765|NCT00174915|75804115|FG001|COMPLETED|Overall Study||200||
59684766|NCT00174915|75804116|FG002|COMPLETED|Overall Study||86||
59684767|NCT00174915|75804117|FG003|COMPLETED|Overall Study||211||
59684768|NCT00174915|75804118|FG004|COMPLETED|Overall Study||101||
59684769|NCT00174915|75804114|FG000|NOT COMPLETED|Overall Study||93||
59684770|NCT00174915|75804115|FG001|NOT COMPLETED|Overall Study||69||
59684771|NCT00174915|75804116|FG002|NOT COMPLETED|Overall Study||48||
59684772|NCT00174915|75804117|FG003|NOT COMPLETED|Overall Study||57||
59684773|NCT00174915|75804118|FG004|NOT COMPLETED|Overall Study||33||
59684774|NCT01080716|75804134|FG000|STARTED|Part 1||14||
59684775|NCT01080716|75804135|FG001|STARTED|Part 1||6||
59684776|NCT01080716|75804136|FG002|STARTED|Part 1||0||
59684777|NCT01080716|75804137|FG003|STARTED|Part 1||0||
59684778|NCT01080716|75804134|FG000|COMPLETED|Part 1||13||
59684779|NCT01080716|75804135|FG001|COMPLETED|Part 1||6||
59684780|NCT01080716|75804136|FG002|COMPLETED|Part 1||0||
59684781|NCT01080716|75804137|FG003|COMPLETED|Part 1||0||
59684782|NCT01080716|75804134|FG000|NOT COMPLETED|Part 1||1||
60079261|NCT04440163|76194630|FG000|STARTED|Vaccination Phase (Approx. 7 Months)||552||
60079262|NCT04440163|76194631|FG001|STARTED|Vaccination Phase (Approx. 7 Months)||276||
60079263|NCT04440163|76194632|FG002|STARTED|Vaccination Phase (Approx. 7 Months)||528||
60079264|NCT04440163|76194633|FG003|STARTED|Vaccination Phase (Approx. 7 Months)|One participant initially randomized to group 3 was included in group 4 as participant received the wrong vaccination (Trumenba + saline).|261||
60079265|NCT04440163|76194634|FG004|STARTED|Vaccination Phase (Approx. 7 Months)||544||
60079266|NCT04440163|76194635|FG005|STARTED|Vaccination Phase (Approx. 7 Months)||57||
59684783|NCT01080716|75804135|FG001|NOT COMPLETED|Part 1||0||
59684784|NCT01080716|75804136|FG002|NOT COMPLETED|Part 1||0||
59684785|NCT01080716|75804137|FG003|NOT COMPLETED|Part 1||0||
59684786|NCT01080716|75804134|FG000|STARTED|Part 2||0||
59684787|NCT01080716|75804135|FG001|STARTED|Part 2||0||
59684788|NCT01080716|75804136|FG002|STARTED|Part 2||10||
59684789|NCT01080716|75804137|FG003|STARTED|Part 2||10||
59684790|NCT01080716|75804134|FG000|COMPLETED|Part 2||0||
59684791|NCT01080716|75804135|FG001|COMPLETED|Part 2||0||
59684792|NCT01080716|75804136|FG002|COMPLETED|Part 2||10||
59684793|NCT01080716|75804137|FG003|COMPLETED|Part 2||10||
59684794|NCT01080716|75804134|FG000|NOT COMPLETED|Part 2||0||
59684795|NCT01080716|75804135|FG001|NOT COMPLETED|Part 2||0||
59684796|NCT01080716|75804136|FG002|NOT COMPLETED|Part 2||0||
59684797|NCT01080716|75804137|FG003|NOT COMPLETED|Part 2||0||
59684798|NCT00172185|75804155|FG000|STARTED|Overall Study||6||
59684799|NCT00172185|75804156|FG001|STARTED|Overall Study||7||
59684800|NCT00172185|75804157|FG002|STARTED|Overall Study||25||
59684801|NCT00172185|75804158|FG003|STARTED|Overall Study||27||
59684802|NCT00172185|75804155|FG000|COMPLETED|Overall Study||6||
59684803|NCT00172185|75804156|FG001|COMPLETED|Overall Study||5||
59684804|NCT00172185|75804157|FG002|COMPLETED|Overall Study||20||
59684805|NCT00172185|75804158|FG003|COMPLETED|Overall Study||23||
59684806|NCT00172185|75804155|FG000|NOT COMPLETED|Overall Study||0||
59684807|NCT00172185|75804156|FG001|NOT COMPLETED|Overall Study||2||
60079267|NCT04440163|76194636|FG006|STARTED|Vaccination Phase (Approx. 7 Months)||154||
60079268|NCT04440163|76194637|FG007|STARTED|Vaccination Phase (Approx. 7 Months)||59||
59816086|NCT03885596|75938428|FG002|NOT COMPLETED|Overall Study||0||
59684808|NCT00172185|75804157|FG002|NOT COMPLETED|Overall Study||5||
59684809|NCT00172185|75804158|FG003|NOT COMPLETED|Overall Study||4||
59684810|NCT01080326|75804172|FG000|STARTED|Overall Study||7||
59684811|NCT01080326|75804172|FG000|COMPLETED|Overall Study||3||
59684812|NCT01080326|75804172|FG000|NOT COMPLETED|Overall Study||4||
59684813|NCT00171951|75804176|FG000|STARTED|Overall Study||19||
59684814|NCT00171951|75804176|FG000|COMPLETED|Overall Study||3||
59684815|NCT00171951|75804176|FG000|NOT COMPLETED|Overall Study||16||
59684816|NCT01080131|75804185|FG000|STARTED|Core Study (0- 12 Weeks)||112||
59684817|NCT01080131|75804186|FG001|STARTED|Core Study (0- 12 Weeks)||114||
59684818|NCT01080131|75804185|FG000|COMPLETED|Core Study (0- 12 Weeks)||99||
59684819|NCT01080131|75804186|FG001|COMPLETED|Core Study (0- 12 Weeks)||103||
59684820|NCT01080131|75804185|FG000|NOT COMPLETED|Core Study (0- 12 Weeks)||13||
59684821|NCT01080131|75804186|FG001|NOT COMPLETED|Core Study (0- 12 Weeks)||11||
59684822|NCT01080131|75804185|FG000|STARTED|Extension Study 1 (12 -24 Weeks)||84||
59684823|NCT01080131|75804186|FG001|STARTED|Extension Study 1 (12 -24 Weeks)||76||
59684824|NCT01080131|75804185|FG000|COMPLETED|Extension Study 1 (12 -24 Weeks)||78||
59684825|NCT01080131|75804186|FG001|COMPLETED|Extension Study 1 (12 -24 Weeks)||72||
59684826|NCT01080131|75804185|FG000|NOT COMPLETED|Extension Study 1 (12 -24 Weeks)||6||
59684827|NCT01080131|75804186|FG001|NOT COMPLETED|Extension Study 1 (12 -24 Weeks)||4||
59684828|NCT01080131|75804185|FG000|STARTED|Extension Study 2 (25-72 Weeks)||72||
59684829|NCT01080131|75804186|FG001|STARTED|Extension Study 2 (25-72 Weeks)||65||
59684830|NCT01080131|75804185|FG000|Re-treated With or Switch to Canakinumab|Extension Study 2 (25-72 Weeks)|Includes patients re-treated with canakinumab at any time during the 72 weeks|62||
59684831|NCT01080131|75804186|FG001|Re-treated With or Switch to Canakinumab|Extension Study 2 (25-72 Weeks)|Includes patients switched to canakinumab from Week 25 - Week 72|41||
59684832|NCT01080131|75804185|FG000|COMPLETED|Extension Study 2 (25-72 Weeks)||64||
59684833|NCT01080131|75804186|FG001|COMPLETED|Extension Study 2 (25-72 Weeks)||54||
59684834|NCT01080131|75804185|FG000|NOT COMPLETED|Extension Study 2 (25-72 Weeks)||8||
59684835|NCT01080131|75804186|FG001|NOT COMPLETED|Extension Study 2 (25-72 Weeks)||11||
59684836|NCT00171873|75804212|FG000|STARTED|Overall Study||42||
59684837|NCT00171873|75804213|FG001|STARTED|Overall Study||43||
59684838|NCT00171873|75804212|FG000|COMPLETED|Overall Study||33||
59684839|NCT00171873|75804213|FG001|COMPLETED|Overall Study||40||
59684840|NCT00171873|75804212|FG000|NOT COMPLETED|Overall Study||9||
59684841|NCT00171873|75804213|FG001|NOT COMPLETED|Overall Study||3||
59684842|NCT00171834|75804226|FG000|STARTED|Overall Study||6||
59684843|NCT00171834|75804227|FG001|STARTED|Overall Study||12||
59684844|NCT00171834|75804228|FG002|STARTED|Overall Study||12||
59684845|NCT00171834|75804229|FG003|STARTED|Overall Study||12||
59684846|NCT00171834|75804230|FG004|STARTED|Overall Study||8||
59684847|NCT00171834|75804231|FG005|STARTED|Overall Study||35||
59684848|NCT00171834|75804232|FG006|STARTED|Overall Study||4||
59684849|NCT00171834|75804226|FG000|Completed 6 Cycles of Treatment|Overall Study||0||
59684850|NCT00171834|75804227|FG001|Completed 6 Cycles of Treatment|Overall Study||0||
59684851|NCT00171834|75804228|FG002|Completed 6 Cycles of Treatment|Overall Study||1||
59684852|NCT00171834|75804229|FG003|Completed 6 Cycles of Treatment|Overall Study||0||
59684853|NCT00171834|75804230|FG004|Completed 6 Cycles of Treatment|Overall Study||2||
59684854|NCT00171834|75804231|FG005|Completed 6 Cycles of Treatment|Overall Study||1||
59684855|NCT00171834|75804232|FG006|Completed 6 Cycles of Treatment|Overall Study||0||
59684856|NCT00171834|75804226|FG000|COMPLETED|Overall Study||0||
59684857|NCT00171834|75804227|FG001|COMPLETED|Overall Study||0||
59684858|NCT00171834|75804228|FG002|COMPLETED|Overall Study||0||
59684859|NCT00171834|75804229|FG003|COMPLETED|Overall Study||0||
59684860|NCT00171834|75804230|FG004|COMPLETED|Overall Study||0||
59684861|NCT00171834|75804231|FG005|COMPLETED|Overall Study||0||
59684862|NCT00171834|75804232|FG006|COMPLETED|Overall Study||0||
59684863|NCT00171834|75804226|FG000|NOT COMPLETED|Overall Study||6||
59684864|NCT00171834|75804227|FG001|NOT COMPLETED|Overall Study||12||
59684865|NCT00171834|75804228|FG002|NOT COMPLETED|Overall Study||12||
59684866|NCT00171834|75804229|FG003|NOT COMPLETED|Overall Study||12||
59684867|NCT00171834|75804230|FG004|NOT COMPLETED|Overall Study||8||
59684868|NCT00171834|75804231|FG005|NOT COMPLETED|Overall Study||35||
59684869|NCT00171834|75804232|FG006|NOT COMPLETED|Overall Study||4||
59684870|NCT00171249|75804262|FG000|STARTED|Overall Study||77||
59684871|NCT00171249|75804263|FG001|STARTED|Overall Study||5||
59684872|NCT00171249|75804264|FG002|STARTED|Overall Study||5||
59684873|NCT00171249|75804265|FG003|STARTED|Overall Study||158||
59684874|NCT00171249|75804266|FG004|STARTED|Overall Study||3||
59684875|NCT00171249|75804267|FG005|STARTED|Overall Study||43||
59684876|NCT00171249|75804268|FG006|STARTED|Overall Study||2||
59684877|NCT00171249|75804262|FG000|Completed Part 1|Overall Study||50||
59684878|NCT00171249|75804263|FG001|Completed Part 1|Overall Study||0||
59684879|NCT00171249|75804264|FG002|Completed Part 1|Overall Study||1||
59684880|NCT00171249|75804265|FG003|Completed Part 1|Overall Study||125||
59684881|NCT00171249|75804266|FG004|Completed Part 1|Overall Study||2||
59684882|NCT00171249|75804267|FG005|Completed Part 1|Overall Study||6||
59684883|NCT00171249|75804268|FG006|Completed Part 1|Overall Study||0||
59684884|NCT00171249|75804262|FG000|COMPLETED|Overall Study||1||
59684885|NCT00171249|75804263|FG001|COMPLETED|Overall Study||0||
59684886|NCT00171249|75804264|FG002|COMPLETED|Overall Study||0||
59684887|NCT00171249|75804265|FG003|COMPLETED|Overall Study||6||
59684888|NCT00171249|75804266|FG004|COMPLETED|Overall Study||0||
59684889|NCT00171249|75804267|FG005|COMPLETED|Overall Study||0||
59684890|NCT00171249|75804268|FG006|COMPLETED|Overall Study||0||
59684891|NCT00171249|75804262|FG000|NOT COMPLETED|Overall Study||76||
59684892|NCT00171249|75804263|FG001|NOT COMPLETED|Overall Study||5||
59684893|NCT00171249|75804264|FG002|NOT COMPLETED|Overall Study||5||
59684894|NCT00171249|75804265|FG003|NOT COMPLETED|Overall Study||152||
59684895|NCT00171249|75804266|FG004|NOT COMPLETED|Overall Study||3||
59684896|NCT00171249|75804267|FG005|NOT COMPLETED|Overall Study||43||
59684897|NCT00171249|75804268|FG006|NOT COMPLETED|Overall Study||2||
59684898|NCT01085630|75804279|FG000|STARTED|Overall Study||26||
59684899|NCT01085630|75804280|FG001|STARTED|Overall Study||27||
59684900|NCT01085630|75804279|FG000|COMPLETED|Overall Study||22||
59684901|NCT01085630|75804280|FG001|COMPLETED|Overall Study||27||
59684902|NCT01085630|75804279|FG000|NOT COMPLETED|Overall Study||4||
59684903|NCT01085630|75804280|FG001|NOT COMPLETED|Overall Study||0||
59684904|NCT00171210|75804288|FG000|STARTED|Overall Study||259||
59684905|NCT00171210|75804289|FG001|STARTED|Overall Study||296||
59684906|NCT00171210|75804288|FG000|STARTED EXTENSION STUDY|Overall Study||259||
59684907|NCT00171210|75804289|FG001|STARTED EXTENSION STUDY|Overall Study||247||
59684908|NCT00171210|75804288|FG000|COMPLETED|Overall Study||190||
59684909|NCT00171210|75804289|FG001|COMPLETED|Overall Study||181||
59684910|NCT00171210|75804288|FG000|NOT COMPLETED|Overall Study||69||
59684911|NCT00171210|75804289|FG001|NOT COMPLETED|Overall Study||115||
59684912|NCT00171054|75804297|FG000|STARTED|Overall Study||63||
59684913|NCT00171054|75804298|FG001|STARTED|Overall Study||62||
59684914|NCT00171054|75804297|FG000|COMPLETED|Overall Study||53||
59684915|NCT00171054|75804298|FG001|COMPLETED|Overall Study||50||
59684916|NCT00171054|75804297|FG000|NOT COMPLETED|Overall Study||10||
59684917|NCT00171054|75804298|FG001|NOT COMPLETED|Overall Study||12||
59684918|NCT01084694|75804306|FG000|STARTED|Overall Study||50||
59684919|NCT01084694|75804307|FG001|STARTED|Overall Study||50||
59684920|NCT01084694|75804306|FG000|COMPLETED|Overall Study||44||
59684921|NCT01084694|75804307|FG001|COMPLETED|Overall Study||30||
59684922|NCT01084694|75804306|FG000|NOT COMPLETED|Overall Study||6||
59684923|NCT01084694|75804307|FG001|NOT COMPLETED|Overall Study||20||
59684924|NCT00479856|75804321|FG000|STARTED|Overall Study||9||
59684925|NCT00479856|75804321|FG000|COMPLETED|Overall Study||6||
59684926|NCT00479856|75804321|FG000|NOT COMPLETED|Overall Study||3||
59684927|NCT00479466|75804331|FG000|STARTED|Overall Study||57||
59684928|NCT00479466|75804332|FG001|STARTED|Overall Study||57||
59684929|NCT00479466|75804333|FG002|STARTED|Overall Study||57||
59684930|NCT00479466|75804334|FG003|STARTED|Overall Study||58||
59684931|NCT00479466|75804335|FG004|STARTED|Overall Study||56||
59684932|NCT00479466|75804336|FG005|STARTED|Overall Study||57||
59684933|NCT00479466|75804331|FG000|COMPLETED|Overall Study||44||
59684934|NCT00479466|75804332|FG001|COMPLETED|Overall Study||49||
59684935|NCT00479466|75804333|FG002|COMPLETED|Overall Study||54||
59684936|NCT00479466|75804334|FG003|COMPLETED|Overall Study||55||
59684937|NCT00479466|75804335|FG004|COMPLETED|Overall Study||48||
59684938|NCT00479466|75804336|FG005|COMPLETED|Overall Study||53||
59684939|NCT00479466|75804331|FG000|NOT COMPLETED|Overall Study||13||
59684940|NCT00479466|75804332|FG001|NOT COMPLETED|Overall Study||8||
59684941|NCT00479466|75804333|FG002|NOT COMPLETED|Overall Study||3||
59684942|NCT00479466|75804334|FG003|NOT COMPLETED|Overall Study||3||
59684943|NCT00479466|75804335|FG004|NOT COMPLETED|Overall Study||8||
59684944|NCT00479466|75804336|FG005|NOT COMPLETED|Overall Study||4||
59684945|NCT00479388|75804352|FG000|STARTED|Overall Study||606||
59684946|NCT00479388|75804353|FG001|STARTED|Overall Study||610||
59684947|NCT00479388|75804352|FG000|COMPLETED|Overall Study||474||
59547308|NCT02429115|75646100|FG005|NOT COMPLETED|Overall Study||1||
59547309|NCT02454075|75646114|FG000|STARTED|Overall Study||3||
59547310|NCT02454075|75646114|FG000|COMPLETED|Overall Study||3||
59547311|NCT02454075|75646114|FG000|NOT COMPLETED|Overall Study||0||
59547312|NCT02454153|75646122|FG000|STARTED|Overall Study||92||
59547313|NCT02454153|75646123|FG001|STARTED|Overall Study||92||
59547314|NCT02454153|75646122|FG000|COMPLETED|Overall Study||92||
59547315|NCT02454153|75646123|FG001|COMPLETED|Overall Study||92||
59547316|NCT02454153|75646122|FG000|NOT COMPLETED|Overall Study||0||
59547317|NCT02454153|75646123|FG001|NOT COMPLETED|Overall Study||0||
59547318|NCT02431299|75646132|FG000|STARTED|Overall Study||236||
59547319|NCT02431299|75646133|FG001|STARTED|Overall Study||63||
59547320|NCT02431299|75646132|FG000|COMPLETED|Overall Study||183||
59547321|NCT02431299|75646133|FG001|COMPLETED|Overall Study||62||
59547322|NCT02431299|75646132|FG000|NOT COMPLETED|Overall Study||53||
59547323|NCT02431299|75646133|FG001|NOT COMPLETED|Overall Study||1||
59547324|NCT02455167|75646139|FG000|STARTED|Overall Study||4||
59547325|NCT02455167|75646139|FG000|COMPLETED|Overall Study||4||
59684948|NCT00479388|75804353|FG001|COMPLETED|Overall Study||537||
59684949|NCT00479388|75804352|FG000|NOT COMPLETED|Overall Study||132||
59684950|NCT00479388|75804353|FG001|NOT COMPLETED|Overall Study||73||
59684951|NCT00479232|75804361|FG000|STARTED|Overall Study||3||
59684952|NCT00479232|75804362|FG001|STARTED|Overall Study||3||
59684953|NCT00479232|75804363|FG002|STARTED|Overall Study||28||
59684954|NCT00479232|75804364|FG003|STARTED|Overall Study||3||
59684955|NCT00479232|75804365|FG004|STARTED|Overall Study||4||
59684956|NCT00479232|75804366|FG005|STARTED|Overall Study||30||
59684957|NCT00479232|75804361|FG000|COMPLETED|Overall Study||0||
59684958|NCT00479232|75804362|FG001|COMPLETED|Overall Study||0||
59684959|NCT00479232|75804363|FG002|COMPLETED|Overall Study||0||
59684960|NCT00479232|75804364|FG003|COMPLETED|Overall Study||0||
59684961|NCT00479232|75804365|FG004|COMPLETED|Overall Study||0||
59684962|NCT00479232|75804366|FG005|COMPLETED|Overall Study||0||
59684963|NCT00479232|75804361|FG000|NOT COMPLETED|Overall Study||3||
59684964|NCT00479232|75804362|FG001|NOT COMPLETED|Overall Study||3||
59684965|NCT00479232|75804363|FG002|NOT COMPLETED|Overall Study||28||
59684966|NCT00479232|75804364|FG003|NOT COMPLETED|Overall Study||3||
59684967|NCT00479232|75804365|FG004|NOT COMPLETED|Overall Study||4||
59684968|NCT00479232|75804366|FG005|NOT COMPLETED|Overall Study||30||
59684969|NCT00478881|75804386|FG000|STARTED|Overall Study||199||
59684970|NCT00478881|75804387|FG001|STARTED|Overall Study||198||
59684971|NCT00478881|75804386|FG000|Received Medication|Overall Study||198||
59684972|NCT00478881|75804387|FG001|Received Medication|Overall Study||198||
59684973|NCT00478881|75804386|FG000|COMPLETED|Overall Study||160||
59684974|NCT00478881|75804387|FG001|COMPLETED|Overall Study||176||
59684975|NCT00478881|75804386|FG000|NOT COMPLETED|Overall Study||39||
59684976|NCT00478881|75804387|FG001|NOT COMPLETED|Overall Study||22||
59684977|NCT00478647|75804393|FG000|STARTED|Overall Study||40||
59684978|NCT00478647|75804393|FG000|COMPLETED|Overall Study|Intent-to-Treat (ITT)=participants who have received at least 1 full or partial dose of study drug.|38||
59684979|NCT00478647|75804393|FG000|NOT COMPLETED|Overall Study||2||
59684980|NCT00478608|75804397|FG000|STARTED|Overall Study||79||
59684981|NCT00478608|75804397|FG000|COMPLETED|Overall Study||59||
59684982|NCT00478608|75804397|FG000|NOT COMPLETED|Overall Study||20||
59684983|NCT00478257|75804403|FG000|STARTED|Overall Study||23||
59684984|NCT00478257|75804404|FG001|STARTED|Overall Study||16||
59684985|NCT00478257|75804403|FG000|COMPLETED|Overall Study||15||
59684986|NCT00478257|75804404|FG001|COMPLETED|Overall Study||13||
59684987|NCT00478257|75804403|FG000|NOT COMPLETED|Overall Study||8||
59684988|NCT00478257|75804404|FG001|NOT COMPLETED|Overall Study||3||
59684989|NCT00478140|75804410|FG000|STARTED|Overall Study||4||
59684990|NCT00478140|75804410|FG000|COMPLETED|Overall Study||3||
59684991|NCT00478140|75804410|FG000|NOT COMPLETED|Overall Study||1||
59684992|NCT00478023|75804419|FG000|STARTED|Overall Study||170||
59684993|NCT00478023|75804420|FG001|STARTED|Overall Study||168||
59684994|NCT00478023|75804421|FG002|STARTED|Overall Study||171||
59684995|NCT00478023|75804422|FG003|STARTED|Overall Study||176||
59684996|NCT00478023|75804423|FG004|STARTED|Overall Study||169||
59684997|NCT00478023|75804419|FG000|COMPLETED|Overall Study||135||
59684998|NCT00478023|75804420|FG001|COMPLETED|Overall Study||144||
59684999|NCT00478023|75804421|FG002|COMPLETED|Overall Study||151||
59685000|NCT00478023|75804422|FG003|COMPLETED|Overall Study||146||
59685001|NCT00478023|75804423|FG004|COMPLETED|Overall Study||114||
59685002|NCT00478023|75804419|FG000|NOT COMPLETED|Overall Study||35||
59685003|NCT00478023|75804420|FG001|NOT COMPLETED|Overall Study||24||
59685004|NCT00478023|75804421|FG002|NOT COMPLETED|Overall Study||20||
59685005|NCT00478023|75804422|FG003|NOT COMPLETED|Overall Study||30||
59685006|NCT00478023|75804423|FG004|NOT COMPLETED|Overall Study||55||
59685007|NCT00477750|75804435|FG000|STARTED|Overall Study||26||
59685008|NCT00477750|75804435|FG000|COMPLETED|Overall Study||15||
59685009|NCT00477750|75804435|FG000|NOT COMPLETED|Overall Study||11||
59685010|NCT00477672|75804444|FG000|STARTED|Overall Study||98||
59685011|NCT00477672|75804445|FG001|STARTED|Overall Study||101||
59989685|NCT02478398|76105025|FG000|COMPLETED|Overall Study||461||
59989686|NCT02478398|76105026|FG001|COMPLETED|Overall Study||491||
59989687|NCT02478398|76105025|FG000|NOT COMPLETED|Overall Study||52||
59989688|NCT02478398|76105026|FG001|NOT COMPLETED|Overall Study||21||
59989689|NCT02478164|76105033|FG000|STARTED|Overall Study|17 participants enrolled. 15 of 17 received ponatinib as 2 participants withdrew prior to ponatinib.|15||
59989690|NCT02478164|76105033|FG000|COMPLETED|Overall Study||0||
59989691|NCT02478164|76105033|FG000|NOT COMPLETED|Overall Study||15||
59685012|NCT00477672|75804446|FG002|STARTED|Overall Study||99||
59989692|NCT02476994|76105039|FG000|STARTED|Overall Study||1||
60079269|NCT04440163|76194630|FG000|Vaccination 1|Vaccination Phase (Approx. 7 Months)||547||
60079270|NCT04440163|76194631|FG001|Vaccination 1|Vaccination Phase (Approx. 7 Months)||274||
59685013|NCT00477672|75804444|FG000|COMPLETED|Overall Study||91||
59685014|NCT00477672|75804445|FG001|COMPLETED|Overall Study||85||
59685015|NCT00477672|75804446|FG002|COMPLETED|Overall Study||83||
59685016|NCT00477672|75804444|FG000|NOT COMPLETED|Overall Study||7||
59685017|NCT00477672|75804445|FG001|NOT COMPLETED|Overall Study||16||
59685018|NCT00477672|75804446|FG002|NOT COMPLETED|Overall Study||16||
59685019|NCT00477633|75804454|FG000|STARTED|Overall Study||1700||
59685020|NCT00477633|75804454|FG000|COMPLETED|Overall Study||991||
59685021|NCT00477633|75804454|FG000|NOT COMPLETED|Overall Study||709||
59685022|NCT04548531|75804460|FG000|STARTED|Intervention Period||400||
59685023|NCT04548531|75804461|FG001|STARTED|Intervention Period||400||
59685024|NCT04548531|75804460|FG000|COMPLETED|Intervention Period||399||
59685025|NCT04548531|75804461|FG001|COMPLETED|Intervention Period||399||
59685026|NCT04548531|75804460|FG000|NOT COMPLETED|Intervention Period||1||
59685027|NCT04548531|75804461|FG001|NOT COMPLETED|Intervention Period||1||
59816087|NCT03885596|75938429|FG003|NOT COMPLETED|Overall Study||0||
59685028|NCT04548531|75804460|FG000|STARTED|8-week Follow-up Survey|A random subset (n=252) of the 399 patients in each arm were selected to be mailed a survey to assess the intervention about 8 weeks later.|252||
59685029|NCT04548531|75804461|FG001|STARTED|8-week Follow-up Survey|A random subset (n=252) of the 399 patients in each arm were selected to be mailed a survey to assess the intervention about 8 weeks later.|252||
59685030|NCT04548531|75804460|FG000|COMPLETED|8-week Follow-up Survey||124||
59685031|NCT04548531|75804461|FG001|COMPLETED|8-week Follow-up Survey||119||
59685032|NCT04548531|75804460|FG000|NOT COMPLETED|8-week Follow-up Survey||128||
59685033|NCT04548531|75804461|FG001|NOT COMPLETED|8-week Follow-up Survey||133||
59685034|NCT01131676|75804470|FG000|STARTED|Discontinuation From Treatment|Randomised|2337||
59685035|NCT01131676|75804471|FG001|STARTED|Discontinuation From Treatment|Randomised|2347||
59685036|NCT01131676|75804472|FG002|STARTED|Discontinuation From Treatment|Randomised|2344||
59685037|NCT01131676|75804470|FG000|COMPLETED|Discontinuation From Treatment|Not prematurely discontinued from trial medication|1650||
59685038|NCT01131676|75804471|FG001|COMPLETED|Discontinuation From Treatment|Not prematurely discontinued from trial medication|1790||
59685039|NCT01131676|75804472|FG002|COMPLETED|Discontinuation From Treatment|Not prematurely discontinued from trial medication|1800||
59685040|NCT01131676|75804470|FG000|NOT COMPLETED|Discontinuation From Treatment||687||
59685041|NCT01131676|75804471|FG001|NOT COMPLETED|Discontinuation From Treatment||557||
59685042|NCT01131676|75804472|FG002|NOT COMPLETED|Discontinuation From Treatment||544||
59685043|NCT01131676|75804470|FG000|STARTED|Discontinuation From Study (Treated Set)||2333||
59685044|NCT01131676|75804471|FG001|STARTED|Discontinuation From Study (Treated Set)||2345||
59685045|NCT01131676|75804472|FG002|STARTED|Discontinuation From Study (Treated Set)||2342||
59685046|NCT01131676|75804470|FG000|Final Vital Status (VS) Available|Discontinuation From Study (Treated Set)||2316||
59685047|NCT01131676|75804471|FG001|Final Vital Status (VS) Available|Discontinuation From Study (Treated Set)||2324||
59685048|NCT01131676|75804472|FG002|Final Vital Status (VS) Available|Discontinuation From Study (Treated Set)||2327||
59685049|NCT01131676|75804470|FG000|COMPLETED|Discontinuation From Study (Treated Set)|Completed the trial or died|2266||
59685050|NCT01131676|75804471|FG001|COMPLETED|Discontinuation From Study (Treated Set)|Completed the trial or died|2264||
59685051|NCT01131676|75804472|FG002|COMPLETED|Discontinuation From Study (Treated Set)|Completed the trial or died|2279||
59685052|NCT01131676|75804470|FG000|NOT COMPLETED|Discontinuation From Study (Treated Set)||67||
59685053|NCT01131676|75804471|FG001|NOT COMPLETED|Discontinuation From Study (Treated Set)||81||
59685054|NCT01131676|75804472|FG002|NOT COMPLETED|Discontinuation From Study (Treated Set)||63||
59685055|NCT04560374|75804483|FG000|STARTED|Overall Study||50||
59685056|NCT04560374|75804484|FG001|STARTED|Overall Study||50||
59685057|NCT04560374|75804483|FG000|COMPLETED|Overall Study||50||
59685058|NCT04560374|75804484|FG001|COMPLETED|Overall Study||50||
59685059|NCT04560374|75804483|FG000|NOT COMPLETED|Overall Study||0||
59685060|NCT04560374|75804484|FG001|NOT COMPLETED|Overall Study||0||
59685061|NCT01131520|75804494|FG000|STARTED|Overall Study||180||
59685062|NCT01131520|75804495|FG001|STARTED|Overall Study||180||
59685063|NCT01131520|75804494|FG000|COMPLETED|Overall Study||179||
59685064|NCT01131520|75804495|FG001|COMPLETED|Overall Study||176||
59685065|NCT01131520|75804494|FG000|NOT COMPLETED|Overall Study||1||
59685066|NCT01131520|75804495|FG001|NOT COMPLETED|Overall Study||4||
59685067|NCT01131325|75804501|FG000|STARTED|Overall Study||3||
59685068|NCT01131325|75804501|FG000|COMPLETED|Overall Study||0||
59685069|NCT01131325|75804501|FG000|NOT COMPLETED|Overall Study||3||
59685070|NCT01131130|75804505|FG000|STARTED|Period 1 - Baseline||118||
59685071|NCT01131130|75804505|FG000|COMPLETED|Period 1 - Baseline|Participant was discontinued 1 day following dispensing and not reported in result tables|117||
59685072|NCT01131130|75804505|FG000|NOT COMPLETED|Period 1 - Baseline||1||
59685073|NCT01131130|75804505|FG000|STARTED|Period 2 - Crossover||117||
59685074|NCT01131130|75804505|FG000|COMPLETED|Period 2 - Crossover||117||
59685075|NCT01131130|75804505|FG000|NOT COMPLETED|Period 2 - Crossover||0||
59685076|NCT01131130|75804505|FG000|STARTED|Period 3- Crossover||117||
59685077|NCT01131130|75804505|FG000|COMPLETED|Period 3- Crossover||116||
59685078|NCT01131130|75804505|FG000|NOT COMPLETED|Period 3- Crossover||1||
59685079|NCT01130974|75804515|FG000|STARTED|Overall Study||100||
59685080|NCT01130974|75804516|FG001|STARTED|Overall Study||100||
59685081|NCT01130974|75804515|FG000|COMPLETED|Overall Study||85||
59685082|NCT01130974|75804516|FG001|COMPLETED|Overall Study||87||
59685083|NCT01130974|75804515|FG000|NOT COMPLETED|Overall Study||15||
59685084|NCT01130974|75804516|FG001|NOT COMPLETED|Overall Study||13||
59685085|NCT01130272|75804528|FG000|STARTED|Overall Study||107||
59685086|NCT01130272|75804529|FG001|STARTED|Overall Study||173||
59685087|NCT01130272|75804530|FG002|STARTED|Overall Study||169||
59685088|NCT01130272|75804531|FG003|STARTED|Overall Study||171||
59685089|NCT01130272|75804532|FG004|STARTED|Overall Study||169||
59685090|NCT01130272|75804528|FG000|Safety Analysis Set: as Randomized|Overall Study||105|All participants who received study drug as per randomized dose assignment.|
59685091|NCT01130272|75804529|FG001|Safety Analysis Set: as Randomized|Overall Study||171|All participants who received study drug as per randomized dose assignment.|
59685092|NCT01130272|75804530|FG002|Safety Analysis Set: as Randomized|Overall Study||166|All participants who received study drug as per randomized dose assignment.|
59685093|NCT01130272|75804531|FG003|Safety Analysis Set: as Randomized|Overall Study||167|All participants who received study drug as per randomized dose assignment.|
59685094|NCT01130272|75804532|FG004|Safety Analysis Set: as Randomized|Overall Study||162|All participants who received study drug as per randomized dose assignment.|
59685095|NCT01130272|75804528|FG000|Safety Analysis Set: Highest Dose Level|Overall Study|105 total represents 1 patient in from Placebo arm; 1 patient out to 200 mg arm.|105|Reflects the reassignment of patients randomized more than once to the highest dose level arm.|
59685096|NCT01130272|75804529|FG001|Safety Analysis Set: Highest Dose Level|Overall Study|170 total represents 2 patients in from Placebo arm; 3 patients out to 200 mg arm.|170|Reflects the reassignment of patients randomized more than once to the highest dose level arm.|
59685097|NCT01130272|75804530|FG002|Safety Analysis Set: Highest Dose Level|Overall Study|165 total represents 1 patient out to 200 mg arm.|165|Reflects the reassignment of patients randomized more than once to the highest dose level arm.|
59685098|NCT01130272|75804531|FG003|Safety Analysis Set: Highest Dose Level|Overall Study|172 total represents 1 patient in from 5 mg; 3 patients in from 25 mg;1 patient in from 100 mg arms.|172|Reflects the reassignment of patients randomized more than once to the highest dose level arm.|
59685099|NCT01130272|75804532|FG004|Safety Analysis Set: Highest Dose Level|Overall Study|159 total represents 2 patients out to 25 mg arm; 1 patient out to 5 mg arm.|159|Reflects the reassignment of patients randomized more than once to the highest dose level arm.|
59685100|NCT01130272|75804528|FG000|COMPLETED|Overall Study||48||
59685101|NCT01130272|75804529|FG001|COMPLETED|Overall Study||131||
59685102|NCT01130272|75804530|FG002|COMPLETED|Overall Study||121||
59685103|NCT01130272|75804531|FG003|COMPLETED|Overall Study||103||
59685104|NCT01130272|75804532|FG004|COMPLETED|Overall Study||117||
59685105|NCT01130272|75804528|FG000|NOT COMPLETED|Overall Study||59||
59685106|NCT01130272|75804529|FG001|NOT COMPLETED|Overall Study||42||
59685107|NCT01130272|75804530|FG002|NOT COMPLETED|Overall Study||48||
59685108|NCT01130272|75804531|FG003|NOT COMPLETED|Overall Study||68||
59685109|NCT01130272|75804532|FG004|NOT COMPLETED|Overall Study||52||
59685110|NCT01129960|75804548|FG000|STARTED|Overall Study||84||
59685111|NCT01129960|75804549|FG001|STARTED|Overall Study||83||
59685112|NCT01129960|75804550|FG002|STARTED|Overall Study||82||
59685113|NCT01129960|75804551|FG003|STARTED|Overall Study||83||
59685114|NCT01129960|75804548|FG000|Safety|Overall Study||84||
59685115|NCT01129960|75804549|FG001|Safety|Overall Study||83||
59685116|NCT01129960|75804550|FG002|Safety|Overall Study|One subject was randomized to placebo, but was dispensed in error with an ESL 800 mg kit at DB Visit|83||
59685117|NCT01129960|75804551|FG003|Safety|Overall Study||82||
59685118|NCT01129960|75804548|FG000|Intent-to-Treat|Overall Study||84||
59685119|NCT01129960|75804549|FG001|Intent-to-Treat|Overall Study||83||
59685120|NCT01129960|75804550|FG002|Intent-to-Treat|Overall Study||82||
59685121|NCT01129960|75804551|FG003|Intent-to-Treat|Overall Study||83||
59685122|NCT01129960|75804548|FG000|Per-Protocol|Overall Study||34||
59685123|NCT01129960|75804549|FG001|Per-Protocol|Overall Study||52||
59685124|NCT01129960|75804550|FG002|Per-Protocol|Overall Study||49||
59685125|NCT01129960|75804551|FG003|Per-Protocol|Overall Study||55||
59685126|NCT01129960|75804548|FG000|Full Analysis Set (FAS|Overall Study||71||
59685127|NCT01129960|75804549|FG001|Full Analysis Set (FAS|Overall Study||67||
59685128|NCT01129960|75804550|FG002|Full Analysis Set (FAS|Overall Study||68||
59685129|NCT01129960|75804551|FG003|Full Analysis Set (FAS|Overall Study||71||
59685130|NCT01129960|75804548|FG000|COMPLETED|Overall Study||54||
59685131|NCT01129960|75804549|FG001|COMPLETED|Overall Study||61||
59685132|NCT01129960|75804550|FG002|COMPLETED|Overall Study||56||
59685133|NCT01129960|75804551|FG003|COMPLETED|Overall Study||70||
59685134|NCT01129960|75804548|FG000|NOT COMPLETED|Overall Study||30||
59685135|NCT01129960|75804549|FG001|NOT COMPLETED|Overall Study||22||
59685136|NCT01129960|75804550|FG002|NOT COMPLETED|Overall Study||26||
59685137|NCT01129960|75804551|FG003|NOT COMPLETED|Overall Study||13||
59685138|NCT01129921|75804563|FG000|STARTED|Prior to Sham Cross-over, 6-12 Weeks||20||
59685139|NCT01129921|75804564|FG001|STARTED|Prior to Sham Cross-over, 6-12 Weeks||20||
59685140|NCT01129921|75804563|FG000|COMPLETED|Prior to Sham Cross-over, 6-12 Weeks||20||
59685141|NCT01129921|75804564|FG001|COMPLETED|Prior to Sham Cross-over, 6-12 Weeks||20||
59685142|NCT01129921|75804563|FG000|NOT COMPLETED|Prior to Sham Cross-over, 6-12 Weeks||0||
59685143|NCT01129921|75804564|FG001|NOT COMPLETED|Prior to Sham Cross-over, 6-12 Weeks||0||
59685144|NCT01129921|75804563|FG000|STARTED|After Sham Cross-over to Mild, One Year||20||
59685145|NCT01129921|75804564|FG001|STARTED|After Sham Cross-over to Mild, One Year||20||
59685146|NCT01129921|75804563|FG000|COMPLETED|After Sham Cross-over to Mild, One Year|All 20 completed Wk 6-12 Intent to Treat analysis. Eighteen reported Year 1 outcomes.|18||
59685147|NCT01129921|75804564|FG001|COMPLETED|After Sham Cross-over to Mild, One Year|All 20 completed Wk 6-12 Intent to Treat analysis prior to x-over. After x-over 13 reported Year 1.|13||
59685148|NCT01129921|75804563|FG000|NOT COMPLETED|After Sham Cross-over to Mild, One Year||2||
59685149|NCT01129921|75804564|FG001|NOT COMPLETED|After Sham Cross-over to Mild, One Year||7||
59685150|NCT04311697|75804576|FG000|STARTED|Overall Study||136||
59685151|NCT04311697|75804577|FG001|STARTED|Overall Study||67||
59685152|NCT04311697|75804576|FG000|COMPLETED|Overall Study||85||
59685153|NCT04311697|75804577|FG001|COMPLETED|Overall Study||35||
59685154|NCT04311697|75804576|FG000|NOT COMPLETED|Overall Study||51||
59685155|NCT04311697|75804577|FG001|NOT COMPLETED|Overall Study||32||
59685156|NCT01129882|75804583|FG000|STARTED|Overall Study||709||
59685157|NCT01129882|75804583|FG000|Received at Least 1 Dose of Study Drug|Overall Study||709||
59685158|NCT01129882|75804583|FG000|COMPLETED|Overall Study||431||
59685159|NCT01129882|75804583|FG000|NOT COMPLETED|Overall Study||278||
59685160|NCT01129102|75804590|FG000|STARTED|Overall Study||110||
59685161|NCT01129102|75804591|FG001|STARTED|Overall Study||50||
59685162|NCT01129102|75804592|FG002|STARTED|Overall Study||55||
59685163|NCT01129102|75804590|FG000|COMPLETED|Overall Study||102||
59685164|NCT01129102|75804591|FG001|COMPLETED|Overall Study||44||
59685165|NCT01129102|75804592|FG002|COMPLETED|Overall Study||48||
59685166|NCT01129102|75804590|FG000|NOT COMPLETED|Overall Study||8||
59685167|NCT01129102|75804591|FG001|NOT COMPLETED|Overall Study||6||
59685168|NCT01129102|75804592|FG002|NOT COMPLETED|Overall Study||7||
59685169|NCT01129024|75804599|FG000|STARTED|Overall Study||19||
59685170|NCT01129024|75804599|FG000|COMPLETED|Overall Study||0||
59685171|NCT01129024|75804599|FG000|NOT COMPLETED|Overall Study||19||
59685172|NCT01128946|75804603|FG000|STARTED|Period I||20||
59685173|NCT01128946|75804604|FG001|STARTED|Period I||21||
59685174|NCT01128946|75804605|FG002|STARTED|Period I||21||
59685175|NCT01128946|75804606|FG003|STARTED|Period I||21||
59685176|NCT01128946|75804603|FG000|COMPLETED|Period I||20||
59685177|NCT01128946|75804604|FG001|COMPLETED|Period I||20||
59685178|NCT01128946|75804605|FG002|COMPLETED|Period I||20||
59685179|NCT01128946|75804606|FG003|COMPLETED|Period I||20||
59685180|NCT01128946|75804603|FG000|NOT COMPLETED|Period I||0||
59685181|NCT01128946|75804604|FG001|NOT COMPLETED|Period I||1||
59685182|NCT01128946|75804605|FG002|NOT COMPLETED|Period I||1||
59685183|NCT01128946|75804606|FG003|NOT COMPLETED|Period I||1||
59685184|NCT01128946|75804603|FG000|STARTED|Period II|Due to crossover design, different set of participants received this treatment compared to Period I|20||
59685185|NCT01128946|75804604|FG001|STARTED|Period II|Due to crossover design, different set of participants received this treatment compared to Period I|20||
59685186|NCT01128946|75804605|FG002|STARTED|Period II|Due to crossover design, different set of participants received this treatment compared to Period I|20||
59685187|NCT01128946|75804606|FG003|STARTED|Period II|Due to crossover design, different set of participants received this treatment compared to Period I|20||
59685188|NCT01128946|75804603|FG000|COMPLETED|Period II||20||
59685189|NCT01128946|75804604|FG001|COMPLETED|Period II||19||
59685190|NCT01128946|75804605|FG002|COMPLETED|Period II||20||
59685191|NCT01128946|75804606|FG003|COMPLETED|Period II||19||
59685192|NCT01128946|75804603|FG000|NOT COMPLETED|Period II||0||
59685193|NCT01128946|75804604|FG001|NOT COMPLETED|Period II||1||
59685194|NCT01128946|75804605|FG002|NOT COMPLETED|Period II||0||
59685195|NCT01128946|75804606|FG003|NOT COMPLETED|Period II||1||
59685196|NCT01128946|75804603|FG000|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|20||
59685197|NCT01128946|75804604|FG001|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|19||
59685198|NCT01128946|75804605|FG002|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|20||
59685199|NCT01128946|75804606|FG003|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|19||
59685200|NCT01128946|75804603|FG000|COMPLETED|Period III||19||
59685201|NCT01128946|75804604|FG001|COMPLETED|Period III||19||
59685202|NCT01128946|75804605|FG002|COMPLETED|Period III||20||
59685203|NCT01128946|75804606|FG003|COMPLETED|Period III||19||
59685204|NCT01128946|75804603|FG000|NOT COMPLETED|Period III||1||
59685205|NCT01128946|75804604|FG001|NOT COMPLETED|Period III||0||
59685206|NCT01128946|75804605|FG002|NOT COMPLETED|Period III||0||
59685207|NCT01128946|75804606|FG003|NOT COMPLETED|Period III||0||
59685208|NCT01128946|75804603|FG000|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|19||
59685209|NCT01128946|75804604|FG001|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|20||
59685210|NCT01128946|75804605|FG002|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|19||
59685211|NCT01128946|75804606|FG003|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|19||
59685212|NCT01128946|75804603|FG000|COMPLETED|Period IV||19||
59685213|NCT01128946|75804604|FG001|COMPLETED|Period IV||20||
59685214|NCT01128946|75804605|FG002|COMPLETED|Period IV||19||
59685215|NCT01128946|75804606|FG003|COMPLETED|Period IV||19||
59685216|NCT01128946|75804603|FG000|NOT COMPLETED|Period IV||0||
59685217|NCT01128946|75804604|FG001|NOT COMPLETED|Period IV||0||
59685218|NCT01128946|75804605|FG002|NOT COMPLETED|Period IV||0||
59685219|NCT01128946|75804606|FG003|NOT COMPLETED|Period IV||0||
59685220|NCT01128595|75804617|FG000|STARTED|Treatment Period 1||7||
59685221|NCT01128595|75804618|FG001|STARTED|Treatment Period 1||6||
59685222|NCT01128595|75804619|FG002|STARTED|Treatment Period 1||7||
59685223|NCT01128595|75804620|FG003|STARTED|Treatment Period 1||7||
59685224|NCT01128595|75804617|FG000|COMPLETED|Treatment Period 1||7||
59685225|NCT01128595|75804618|FG001|COMPLETED|Treatment Period 1||6||
59685226|NCT01128595|75804619|FG002|COMPLETED|Treatment Period 1||7||
59685227|NCT01128595|75804620|FG003|COMPLETED|Treatment Period 1||7||
59816088|NCT00529100|75938445|FG000|STARTED|Overall Study||16||
59685228|NCT01128595|75804617|FG000|NOT COMPLETED|Treatment Period 1||0||
59685229|NCT01128595|75804618|FG001|NOT COMPLETED|Treatment Period 1||0||
59685230|NCT01128595|75804619|FG002|NOT COMPLETED|Treatment Period 1||0||
59816089|NCT00529100|75938446|FG001|STARTED|Overall Study||33||
60079271|NCT04440163|76194632|FG002|Vaccination 1|Vaccination Phase (Approx. 7 Months)||526||
59685231|NCT01128595|75804620|FG003|NOT COMPLETED|Treatment Period 1||0||
59685232|NCT01128595|75804617|FG000|STARTED|Washout Period 1||7||
59816090|NCT00529100|75938445|FG000|Received at Least 1 Dose of Study Drug|Overall Study||16||
59816091|NCT00529100|75938446|FG001|Received at Least 1 Dose of Study Drug|Overall Study||33||
60079272|NCT04440163|76194633|FG003|Vaccination 1|Vaccination Phase (Approx. 7 Months)||261||
60079273|NCT04440163|76194634|FG004|Vaccination 1|Vaccination Phase (Approx. 7 Months)||537||
60079274|NCT04440163|76194635|FG005|Vaccination 1|Vaccination Phase (Approx. 7 Months)||56||
60079275|NCT04440163|76194636|FG006|Vaccination 1|Vaccination Phase (Approx. 7 Months)||153||
60079276|NCT04440163|76194637|FG007|Vaccination 1|Vaccination Phase (Approx. 7 Months)||59||
60079277|NCT04440163|76194630|FG000|Vaccination 2|Vaccination Phase (Approx. 7 Months)||500||
60079278|NCT04440163|76194631|FG001|Vaccination 2|Vaccination Phase (Approx. 7 Months)||254||
60079279|NCT04440163|76194632|FG002|Vaccination 2|Vaccination Phase (Approx. 7 Months)||453||
60079280|NCT04440163|76194633|FG003|Vaccination 2|Vaccination Phase (Approx. 7 Months)||218||
60079281|NCT04440163|76194634|FG004|Vaccination 2|Vaccination Phase (Approx. 7 Months)||481||
60079282|NCT04440163|76194635|FG005|Vaccination 2|Vaccination Phase (Approx. 7 Months)||46||
60079283|NCT04440163|76194636|FG006|Vaccination 2|Vaccination Phase (Approx. 7 Months)||123||
60079284|NCT04440163|76194637|FG007|Vaccination 2|Vaccination Phase (Approx. 7 Months)||45||
60079285|NCT04440163|76194630|FG000|COMPLETED|Vaccination Phase (Approx. 7 Months)||490||
60079286|NCT04440163|76194631|FG001|COMPLETED|Vaccination Phase (Approx. 7 Months)||248||
60079287|NCT04440163|76194632|FG002|COMPLETED|Vaccination Phase (Approx. 7 Months)||440||
60079288|NCT04440163|76194633|FG003|COMPLETED|Vaccination Phase (Approx. 7 Months)||209||
60079289|NCT04440163|76194634|FG004|COMPLETED|Vaccination Phase (Approx. 7 Months)||476||
60079290|NCT04440163|76194635|FG005|COMPLETED|Vaccination Phase (Approx. 7 Months)||45||
60079291|NCT04440163|76194636|FG006|COMPLETED|Vaccination Phase (Approx. 7 Months)||122||
60079292|NCT04440163|76194637|FG007|COMPLETED|Vaccination Phase (Approx. 7 Months)||44||
60079293|NCT04440163|76194630|FG000|NOT COMPLETED|Vaccination Phase (Approx. 7 Months)||62||
60079294|NCT04440163|76194631|FG001|NOT COMPLETED|Vaccination Phase (Approx. 7 Months)||28||
60079295|NCT04440163|76194632|FG002|NOT COMPLETED|Vaccination Phase (Approx. 7 Months)||88||
60079296|NCT04440163|76194633|FG003|NOT COMPLETED|Vaccination Phase (Approx. 7 Months)||52||
60079297|NCT04440163|76194634|FG004|NOT COMPLETED|Vaccination Phase (Approx. 7 Months)||68||
60079298|NCT04440163|76194635|FG005|NOT COMPLETED|Vaccination Phase (Approx. 7 Months)||12||
60079299|NCT04440163|76194636|FG006|NOT COMPLETED|Vaccination Phase (Approx. 7 Months)||32||
60079300|NCT04440163|76194637|FG007|NOT COMPLETED|Vaccination Phase (Approx. 7 Months)||15||
60079301|NCT04440163|76194630|FG000|STARTED|Follow-up Phase (Approx. 5 Months)||490||
60079302|NCT04440163|76194631|FG001|STARTED|Follow-up Phase (Approx. 5 Months)||248||
60079303|NCT04440163|76194632|FG002|STARTED|Follow-up Phase (Approx. 5 Months)||440||
60079304|NCT04440163|76194633|FG003|STARTED|Follow-up Phase (Approx. 5 Months)||209||
59547326|NCT02455167|75646139|FG000|NOT COMPLETED|Overall Study||0||
59547327|NCT02457897|75646143|FG000|STARTED|Part 1 Short-term (2 Weeks) Study||7||
59547328|NCT02457897|75646143|FG000|COMPLETED|Part 1 Short-term (2 Weeks) Study||7||
59547329|NCT02457897|75646143|FG000|NOT COMPLETED|Part 1 Short-term (2 Weeks) Study||0||
59547330|NCT02457897|75646143|FG000|STARTED|Part 2 Long-term (6 Month) Study|Two patients were not eligible for Part 2 study because their HbA1c was less than 7.|5||
59547331|NCT02457897|75646143|FG000|COMPLETED|Part 2 Long-term (6 Month) Study||5||
59547332|NCT02457897|75646143|FG000|NOT COMPLETED|Part 2 Long-term (6 Month) Study||0||
59547333|NCT02431455|75646149|FG000|STARTED|Overall Study||112||
59547334|NCT02431455|75646150|FG001|STARTED|Overall Study||112||
59547335|NCT02431455|75646149|FG000|COMPLETED|Overall Study||112||
59547336|NCT02431455|75646150|FG001|COMPLETED|Overall Study||112||
59547337|NCT02431455|75646149|FG000|NOT COMPLETED|Overall Study||0||
59547338|NCT02431455|75646150|FG001|NOT COMPLETED|Overall Study||0||
59547339|NCT02458365|75646158|FG000|STARTED|Overall Study||2000||
59547340|NCT02458365|75646159|FG001|STARTED|Overall Study||1901||
59547341|NCT02458365|75646158|FG000|COMPLETED|Overall Study||1723||
59547342|NCT02458365|75646159|FG001|COMPLETED|Overall Study||1607||
59547343|NCT02458365|75646158|FG000|NOT COMPLETED|Overall Study||277||
59547344|NCT02458365|75646159|FG001|NOT COMPLETED|Overall Study||294||
59547345|NCT02434497|75646166|FG000|STARTED|Overall Study||9||
59547346|NCT02434497|75646166|FG000|COMPLETED|Overall Study||4||
59547347|NCT02434497|75646166|FG000|NOT COMPLETED|Overall Study||5||
59816092|NCT00529100|75938445|FG000|COMPLETED|Overall Study||16||
60079305|NCT04440163|76194634|FG004|STARTED|Follow-up Phase (Approx. 5 Months)||476||
60079306|NCT04440163|76194635|FG005|STARTED|Follow-up Phase (Approx. 5 Months)||45||
60079307|NCT04440163|76194636|FG006|STARTED|Follow-up Phase (Approx. 5 Months)||122||
60079308|NCT04440163|76194637|FG007|STARTED|Follow-up Phase (Approx. 5 Months)||44||
60079309|NCT04440163|76194630|FG000|COMPLETED|Follow-up Phase (Approx. 5 Months)||487||
60079310|NCT04440163|76194631|FG001|COMPLETED|Follow-up Phase (Approx. 5 Months)||243||
60079311|NCT04440163|76194632|FG002|COMPLETED|Follow-up Phase (Approx. 5 Months)||440||
60079312|NCT04440163|76194633|FG003|COMPLETED|Follow-up Phase (Approx. 5 Months)||208||
60079313|NCT04440163|76194634|FG004|COMPLETED|Follow-up Phase (Approx. 5 Months)||475||
59547348|NCT02435901|75646172|FG000|STARTED|Overall Study||29||
59547349|NCT02435901|75646172|FG000|COMPLETED|Overall Study||29||
59547350|NCT02435901|75646172|FG000|NOT COMPLETED|Overall Study||0||
59547351|NCT02438826|75646179|FG000|STARTED|Double-Blind Treatment Phase||123||
59547352|NCT02438826|75646180|FG001|STARTED|Double-Blind Treatment Phase||117||
59816093|NCT00529100|75938446|FG001|COMPLETED|Overall Study||24||
59685233|NCT01128595|75804618|FG001|STARTED|Washout Period 1||6||
59685234|NCT01128595|75804619|FG002|STARTED|Washout Period 1||7||
59685235|NCT01128595|75804620|FG003|STARTED|Washout Period 1||7||
59685236|NCT01128595|75804617|FG000|COMPLETED|Washout Period 1||7||
59685237|NCT01128595|75804618|FG001|COMPLETED|Washout Period 1||6||
59685238|NCT01128595|75804619|FG002|COMPLETED|Washout Period 1||7||
59685239|NCT01128595|75804620|FG003|COMPLETED|Washout Period 1||7||
59685240|NCT01128595|75804617|FG000|NOT COMPLETED|Washout Period 1||0||
59685241|NCT01128595|75804618|FG001|NOT COMPLETED|Washout Period 1||0||
59685242|NCT01128595|75804619|FG002|NOT COMPLETED|Washout Period 1||0||
59685243|NCT01128595|75804620|FG003|NOT COMPLETED|Washout Period 1||0||
59685244|NCT01128595|75804617|FG000|STARTED|Treatment Period 2||7||
59685245|NCT01128595|75804618|FG001|STARTED|Treatment Period 2||6||
59685246|NCT01128595|75804619|FG002|STARTED|Treatment Period 2||7||
59685247|NCT01128595|75804620|FG003|STARTED|Treatment Period 2||7||
59685248|NCT01128595|75804617|FG000|COMPLETED|Treatment Period 2||7||
59685249|NCT01128595|75804618|FG001|COMPLETED|Treatment Period 2||6||
59685250|NCT01128595|75804619|FG002|COMPLETED|Treatment Period 2||7||
59685251|NCT01128595|75804620|FG003|COMPLETED|Treatment Period 2||7||
59685252|NCT01128595|75804617|FG000|NOT COMPLETED|Treatment Period 2||0||
59685253|NCT01128595|75804618|FG001|NOT COMPLETED|Treatment Period 2||0||
59685254|NCT01128595|75804619|FG002|NOT COMPLETED|Treatment Period 2||0||
59685255|NCT01128595|75804620|FG003|NOT COMPLETED|Treatment Period 2||0||
59685256|NCT01128595|75804617|FG000|STARTED|Washout Period 2||7||
59685257|NCT01128595|75804618|FG001|STARTED|Washout Period 2||6||
59685258|NCT01128595|75804619|FG002|STARTED|Washout Period 2||7||
59685259|NCT01128595|75804620|FG003|STARTED|Washout Period 2||7||
59685260|NCT01128595|75804617|FG000|COMPLETED|Washout Period 2||7||
59685261|NCT01128595|75804618|FG001|COMPLETED|Washout Period 2||6||
59685262|NCT01128595|75804619|FG002|COMPLETED|Washout Period 2||7||
59685263|NCT01128595|75804620|FG003|COMPLETED|Washout Period 2||7||
59685264|NCT01128595|75804617|FG000|NOT COMPLETED|Washout Period 2||0||
59685265|NCT01128595|75804618|FG001|NOT COMPLETED|Washout Period 2||0||
59685266|NCT01128595|75804619|FG002|NOT COMPLETED|Washout Period 2||0||
59685267|NCT01128595|75804620|FG003|NOT COMPLETED|Washout Period 2||0||
59685268|NCT01128595|75804617|FG000|STARTED|Treatment Period 3||7||
59685269|NCT01128595|75804618|FG001|STARTED|Treatment Period 3||6||
59685270|NCT01128595|75804619|FG002|STARTED|Treatment Period 3||7||
59685271|NCT01128595|75804620|FG003|STARTED|Treatment Period 3||7||
59685272|NCT01128595|75804617|FG000|COMPLETED|Treatment Period 3||7||
59685273|NCT01128595|75804618|FG001|COMPLETED|Treatment Period 3||5||
59685274|NCT01128595|75804619|FG002|COMPLETED|Treatment Period 3||7||
59685275|NCT01128595|75804620|FG003|COMPLETED|Treatment Period 3||7||
59685276|NCT01128595|75804617|FG000|NOT COMPLETED|Treatment Period 3||0||
59685277|NCT01128595|75804618|FG001|NOT COMPLETED|Treatment Period 3||1||
59685278|NCT01128595|75804619|FG002|NOT COMPLETED|Treatment Period 3||0||
59685279|NCT01128595|75804620|FG003|NOT COMPLETED|Treatment Period 3||0||
59685280|NCT01128595|75804617|FG000|STARTED|Washout Period 3||7||
59685281|NCT01128595|75804618|FG001|STARTED|Washout Period 3||5||
59685282|NCT01128595|75804619|FG002|STARTED|Washout Period 3||7||
59685283|NCT01128595|75804620|FG003|STARTED|Washout Period 3||7||
59685284|NCT01128595|75804617|FG000|COMPLETED|Washout Period 3||7||
59685285|NCT01128595|75804618|FG001|COMPLETED|Washout Period 3||5||
59685286|NCT01128595|75804619|FG002|COMPLETED|Washout Period 3||7||
59685287|NCT01128595|75804620|FG003|COMPLETED|Washout Period 3||7||
59685288|NCT01128595|75804617|FG000|NOT COMPLETED|Washout Period 3||0||
59685289|NCT01128595|75804618|FG001|NOT COMPLETED|Washout Period 3||0||
59685290|NCT01128595|75804619|FG002|NOT COMPLETED|Washout Period 3||0||
59685291|NCT01128595|75804620|FG003|NOT COMPLETED|Washout Period 3||0||
59685292|NCT01128595|75804617|FG000|STARTED|Treatment Period 4||7||
59685293|NCT01128595|75804618|FG001|STARTED|Treatment Period 4||5||
59685294|NCT01128595|75804619|FG002|STARTED|Treatment Period 4||7||
59685295|NCT01128595|75804620|FG003|STARTED|Treatment Period 4||7||
59685296|NCT01128595|75804617|FG000|COMPLETED|Treatment Period 4||7||
59685297|NCT01128595|75804618|FG001|COMPLETED|Treatment Period 4||5||
59685298|NCT01128595|75804619|FG002|COMPLETED|Treatment Period 4||7||
59685299|NCT01128595|75804620|FG003|COMPLETED|Treatment Period 4||7||
59685300|NCT01128595|75804617|FG000|NOT COMPLETED|Treatment Period 4||0||
59685301|NCT01128595|75804618|FG001|NOT COMPLETED|Treatment Period 4||0||
59685302|NCT01128595|75804619|FG002|NOT COMPLETED|Treatment Period 4||0||
59685303|NCT01128595|75804620|FG003|NOT COMPLETED|Treatment Period 4||0||
59685304|NCT01129336|75804633|FG000|STARTED|Overall Study||15||
59685305|NCT01129336|75804634|FG001|STARTED|Overall Study||29||
59685306|NCT01129336|75804633|FG000|Completed Treatment|Overall Study||1||
59685307|NCT01129336|75804634|FG001|Completed Treatment|Overall Study||3||
59685308|NCT01129336|75804633|FG000|COMPLETED|Overall Study|Completed indicates Completed Study as per protocol.|3||
59685309|NCT01129336|75804634|FG001|COMPLETED|Overall Study|Completed indicates Completed Study as per protocol.|13||
59685310|NCT01129336|75804633|FG000|NOT COMPLETED|Overall Study||12||
59685311|NCT01129336|75804634|FG001|NOT COMPLETED|Overall Study||16||
59685312|NCT01128400|75804643|FG000|STARTED|Overall Study||8||
59685313|NCT01128400|75804644|FG001|STARTED|Overall Study||9||
59685314|NCT01128400|75804645|FG002|STARTED|Overall Study||23||
59685315|NCT01128400|75804643|FG000|COMPLETED|Overall Study||6||
59685316|NCT01128400|75804644|FG001|COMPLETED|Overall Study||8||
59685317|NCT01128400|75804645|FG002|COMPLETED|Overall Study||7||
59685318|NCT01128400|75804643|FG000|NOT COMPLETED|Overall Study||2||
59685319|NCT01128400|75804644|FG001|NOT COMPLETED|Overall Study||1||
59685320|NCT01128400|75804645|FG002|NOT COMPLETED|Overall Study||16||
59685321|NCT01128361|75804655|FG000|STARTED|Overall Study||39||
59685322|NCT01128361|75804656|FG001|STARTED|Overall Study||37||
59685323|NCT01128361|75804655|FG000|COMPLETED|Overall Study||34||
59685324|NCT01128361|75804656|FG001|COMPLETED|Overall Study||34||
59685325|NCT01128361|75804655|FG000|NOT COMPLETED|Overall Study||5||
59685326|NCT01128361|75804656|FG001|NOT COMPLETED|Overall Study||3||
59685327|NCT01128244|75804662|FG000|STARTED|Overall Study||13||
59685328|NCT01128244|75804662|FG000|COMPLETED|Overall Study||10||
59685329|NCT01128244|75804662|FG000|NOT COMPLETED|Overall Study||3||
59685330|NCT01127893|75804670|FG000|STARTED|Overall Study||1||
59685331|NCT01127893|75804670|FG000|COMPLETED|Overall Study||0||
59685332|NCT01127893|75804670|FG000|NOT COMPLETED|Overall Study||1||
59685333|NCT01126879|75804676|FG000|STARTED|Overall Study||8||
59685334|NCT01126879|75804677|FG001|STARTED|Overall Study||4||
59685335|NCT01126879|75804676|FG000|Started 3 Months of Genistein/Placebo|Overall Study||8||
59685336|NCT01126879|75804677|FG001|Started 3 Months of Genistein/Placebo|Overall Study||4||
59685337|NCT01126879|75804676|FG000|Prostatectomy or Radiation|Overall Study||8||
59685338|NCT01126879|75804677|FG001|Prostatectomy or Radiation|Overall Study||4||
59685339|NCT01126879|75804676|FG000|Completed 3 Months Genistein/Placebo|Overall Study||4||
59685340|NCT01126879|75804677|FG001|Completed 3 Months Genistein/Placebo|Overall Study||2||
59685341|NCT01126879|75804676|FG000|COMPLETED|Overall Study||3||
59685342|NCT01126879|75804677|FG001|COMPLETED|Overall Study||2||
59685343|NCT01126879|75804676|FG000|NOT COMPLETED|Overall Study||5||
59685344|NCT01126879|75804677|FG001|NOT COMPLETED|Overall Study||2||
59685345|NCT01126060|75804685|FG000|STARTED|Overall Study||40||
59685346|NCT01126060|75804686|FG001|STARTED|Overall Study||40||
59685347|NCT01126060|75804685|FG000|COMPLETED|Overall Study||40||
59685348|NCT01126060|75804686|FG001|COMPLETED|Overall Study||38||
59685349|NCT01126060|75804685|FG000|NOT COMPLETED|Overall Study||0||
59685350|NCT01126060|75804686|FG001|NOT COMPLETED|Overall Study||2||
59685351|NCT01125748|75804694|FG000|STARTED|Overall Study||88||
59685352|NCT01125748|75804695|FG001|STARTED|Overall Study||88||
59685353|NCT01125748|75804694|FG000|COMPLETED|Overall Study||78||
59685354|NCT01125748|75804695|FG001|COMPLETED|Overall Study||74||
59685355|NCT01125748|75804694|FG000|NOT COMPLETED|Overall Study||10||
59685356|NCT01125748|75804695|FG001|NOT COMPLETED|Overall Study||14||
59685357|NCT01125514|75804701|FG000|STARTED|Treatment Period 1 (Day 1 - Day 7)|Randomized and safety population|37||
59685358|NCT01125514|75804701|FG000|COMPLETED|Treatment Period 1 (Day 1 - Day 7)||35||
59685359|NCT01125514|75804701|FG000|NOT COMPLETED|Treatment Period 1 (Day 1 - Day 7)||2||
59685360|NCT01125514|75804701|FG000|STARTED|Treatment Period 2 (Day 8 - Day 17)||35||
59685361|NCT01125514|75804701|FG000|Pharmacokinetic (PK) Analysis Set|Treatment Period 2 (Day 8 - Day 17)||33||
59685362|NCT01125514|75804701|FG000|Pharmacodynamics (PD) Analysis Set|Treatment Period 2 (Day 8 - Day 17)||33||
59685363|NCT01125514|75804701|FG000|COMPLETED|Treatment Period 2 (Day 8 - Day 17)||32||
59685364|NCT01125514|75804701|FG000|NOT COMPLETED|Treatment Period 2 (Day 8 - Day 17)||3||
59685365|NCT01125514|75804701|FG000|STARTED|Treatment Period2(Day9-Day27) and Day 28||32||
59685366|NCT01125514|75804701|FG000|COMPLETED|Treatment Period2(Day9-Day27) and Day 28||28||
59685367|NCT01125514|75804701|FG000|NOT COMPLETED|Treatment Period2(Day9-Day27) and Day 28||4||
59685368|NCT01125358|75804719|FG000|STARTED|Overall Study||21||
59685369|NCT01125358|75804720|FG001|STARTED|Overall Study||21||
59685370|NCT01125358|75804721|FG002|STARTED|Overall Study||20||
59685371|NCT01125358|75804722|FG003|STARTED|Overall Study||20||
59685372|NCT01125358|75804719|FG000|Received at Least 1 Dose of Study Drug|Overall Study||21||
59685373|NCT01125358|75804720|FG001|Received at Least 1 Dose of Study Drug|Overall Study||21||
59685374|NCT01125358|75804721|FG002|Received at Least 1 Dose of Study Drug|Overall Study||20||
59685375|NCT01125358|75804722|FG003|Received at Least 1 Dose of Study Drug|Overall Study||20||
59685376|NCT01125358|75804719|FG000|Placebo Responder|Overall Study||1||
59685377|NCT01125358|75804720|FG001|Placebo Responder|Overall Study||0||
59685378|NCT01125358|75804721|FG002|Placebo Responder|Overall Study||0||
59685379|NCT01125358|75804722|FG003|Placebo Responder|Overall Study||0||
59685380|NCT01125358|75804719|FG000|COMPLETED|Overall Study||9||
59685381|NCT01125358|75804720|FG001|COMPLETED|Overall Study||17||
59685382|NCT01125358|75804721|FG002|COMPLETED|Overall Study||11||
59685383|NCT01125358|75804722|FG003|COMPLETED|Overall Study||12||
59685384|NCT01125358|75804719|FG000|NOT COMPLETED|Overall Study||12||
59685385|NCT01125358|75804720|FG001|NOT COMPLETED|Overall Study||4||
59685386|NCT01125358|75804721|FG002|NOT COMPLETED|Overall Study||9||
59685387|NCT01125358|75804722|FG003|NOT COMPLETED|Overall Study||8||
59685388|NCT01125046|75804732|FG000|STARTED|First 6 Months of Treatment||50||
59685389|NCT01125046|75804732|FG000|COMPLETED|First 6 Months of Treatment||36||
59685390|NCT01125046|75804732|FG000|NOT COMPLETED|First 6 Months of Treatment||14||
59685391|NCT01125046|75804732|FG000|STARTED|Continued Treatment After 6 Months||36||
59685392|NCT01125046|75804732|FG000|COMPLETED|Continued Treatment After 6 Months||33||
59685393|NCT01125046|75804732|FG000|NOT COMPLETED|Continued Treatment After 6 Months||3||
59685394|NCT01125046|75804732|FG000|STARTED|Follow-up/Data Cut Off Point||49|All patients treated on the study go into follow up period.|
59685395|NCT01125046|75804732|FG000|COMPLETED|Follow-up/Data Cut Off Point||16||
59685396|NCT01125046|75804732|FG000|NOT COMPLETED|Follow-up/Data Cut Off Point||33||
59685397|NCT01124734|75804736|FG000|STARTED|Overall Study||17||
59685398|NCT01124734|75804736|FG000|Completion of Course 1 Cycle 1|Overall Study|All 17 participants successfully completed Course 1 Cycle 1|17||
59685399|NCT01124734|75804736|FG000|Initiation of Course 1 Cycle 2|Overall Study||17||
59685400|NCT01124734|75804736|FG000|COMPLETED|Overall Study|Closed to accrual|0||
59685401|NCT01124734|75804736|FG000|NOT COMPLETED|Overall Study||17||
59685402|NCT01124617|75804747|FG000|STARTED|Overall Study||60||
59685403|NCT01124617|75804748|FG001|STARTED|Overall Study||31||
59685404|NCT01124617|75804747|FG000|COMPLETED|Overall Study||41||
59685405|NCT01124617|75804748|FG001|COMPLETED|Overall Study||25||
59685406|NCT01124617|75804747|FG000|NOT COMPLETED|Overall Study||19||
59685407|NCT01124617|75804748|FG001|NOT COMPLETED|Overall Study||6||
59685408|NCT01124422|75804756|FG000|STARTED|4-Week Open-label Run-in Phase||338||
59685409|NCT01124422|75804757|FG001|STARTED|4-Week Open-label Run-in Phase||0||
59685410|NCT01124422|75804758|FG002|STARTED|4-Week Open-label Run-in Phase||0||
59685411|NCT01124422|75804756|FG000|COMPLETED|4-Week Open-label Run-in Phase||255||
59685412|NCT01124422|75804757|FG001|COMPLETED|4-Week Open-label Run-in Phase||0||
59685413|NCT01124422|75804758|FG002|COMPLETED|4-Week Open-label Run-in Phase||0||
59685414|NCT01124422|75804756|FG000|NOT COMPLETED|4-Week Open-label Run-in Phase||83||
59685415|NCT01124422|75804757|FG001|NOT COMPLETED|4-Week Open-label Run-in Phase||0||
59685416|NCT01124422|75804758|FG002|NOT COMPLETED|4-Week Open-label Run-in Phase||0||
59685417|NCT01124422|75804756|FG000|STARTED|4-Week Double-blind Treatment Phase||0||
59685418|NCT01124422|75804757|FG001|STARTED|4-Week Double-blind Treatment Phase||131||
59685419|NCT01124422|75804758|FG002|STARTED|4-Week Double-blind Treatment Phase||124||
59685420|NCT01124422|75804756|FG000|COMPLETED|4-Week Double-blind Treatment Phase||0||
59685421|NCT01124422|75804757|FG001|COMPLETED|4-Week Double-blind Treatment Phase||120||
59685422|NCT01124422|75804758|FG002|COMPLETED|4-Week Double-blind Treatment Phase||115||
59685423|NCT01124422|75804756|FG000|NOT COMPLETED|4-Week Double-blind Treatment Phase||0||
59685424|NCT01124422|75804757|FG001|NOT COMPLETED|4-Week Double-blind Treatment Phase||11||
59685425|NCT01124422|75804758|FG002|NOT COMPLETED|4-Week Double-blind Treatment Phase||9||
59685426|NCT01124149|75804765|FG000|STARTED|Acute Phase||722||
59685427|NCT01124149|75804765|FG000|COMPLETED|Acute Phase||639||
59685428|NCT01124149|75804765|FG000|NOT COMPLETED|Acute Phase||83||
59685429|NCT01124149|75804765|FG000|STARTED|Maintenance Phase||469||
59685430|NCT01124149|75804765|FG000|COMPLETED|Maintenance Phase||373||
59685431|NCT01124149|75804765|FG000|NOT COMPLETED|Maintenance Phase||96||
59685432|NCT01123642|75804772|FG000|STARTED|Overall Study||345||
59685433|NCT01123642|75804772|FG000|COMPLETED|Overall Study||277||
59685434|NCT01123642|75804772|FG000|NOT COMPLETED|Overall Study||68||
59685435|NCT01122862|75804777|FG000|STARTED|Period 1||8||
59685436|NCT01122862|75804778|FG001|STARTED|Period 1||8||
59685437|NCT01122862|75804779|FG002|STARTED|Period 1||7||
59685438|NCT01122862|75804777|FG000|COMPLETED|Period 1||8||
59816094|NCT00529100|75938445|FG000|NOT COMPLETED|Overall Study||0||
59816095|NCT00529100|75938446|FG001|NOT COMPLETED|Overall Study||9||
59685439|NCT01122862|75804778|FG001|COMPLETED|Period 1||7||
59685440|NCT01122862|75804779|FG002|COMPLETED|Period 1||7||
59685441|NCT01122862|75804777|FG000|NOT COMPLETED|Period 1||0||
59685442|NCT01122862|75804778|FG001|NOT COMPLETED|Period 1||1||
59685443|NCT01122862|75804779|FG002|NOT COMPLETED|Period 1||0||
59685444|NCT01122862|75804777|FG000|STARTED|Period 2|Due to crossover design,a different set of participants received this treatment compared to Period 1|8||
59685445|NCT01122862|75804778|FG001|STARTED|Period 2|Due to crossover design,a different set of participants received this treatment compared to Period 1|7||
59685446|NCT01122862|75804779|FG002|STARTED|Period 2|Due to crossover design,a different set of participants received this treatment compared to Period 1|7||
59685447|NCT01122862|75804777|FG000|COMPLETED|Period 2||8||
59685448|NCT01122862|75804778|FG001|COMPLETED|Period 2||7||
59685449|NCT01122862|75804779|FG002|COMPLETED|Period 2||6||
59685450|NCT01122862|75804777|FG000|NOT COMPLETED|Period 2||0||
59685451|NCT01122862|75804778|FG001|NOT COMPLETED|Period 2||0||
59685452|NCT01122862|75804779|FG002|NOT COMPLETED|Period 2||1||
59685453|NCT01122862|75804777|FG000|STARTED|Period 3|Due to crossover design,a different set of participants received this treatment compared to Period 2|6||
59685454|NCT01122862|75804778|FG001|STARTED|Period 3|Due to crossover design,a different set of participants received this treatment compared to Period 2|7||
59685455|NCT01122862|75804779|FG002|STARTED|Period 3|Due to crossover design,a different set of participants received this treatment compared to Period 2|8||
59685456|NCT01122862|75804777|FG000|COMPLETED|Period 3||6||
59685457|NCT01122862|75804778|FG001|COMPLETED|Period 3||7||
59685458|NCT01122862|75804779|FG002|COMPLETED|Period 3||8||
59685459|NCT01122862|75804777|FG000|NOT COMPLETED|Period 3||0||
59685460|NCT01122862|75804778|FG001|NOT COMPLETED|Period 3||0||
59685461|NCT01122862|75804779|FG002|NOT COMPLETED|Period 3||0||
59685462|NCT01122394|75804790|FG000|STARTED|Overall Study||66||
59685463|NCT01122394|75804791|FG001|STARTED|Overall Study||74||
59816096|NCT03878108|75938458|FG000|STARTED|Overall Study||11||
59816097|NCT03878108|75938459|FG001|STARTED|Overall Study||10||
59685464|NCT01122394|75804790|FG000|COMPLETED|Overall Study||63||
59685465|NCT01122394|75804791|FG001|COMPLETED|Overall Study||70||
59685466|NCT01122394|75804790|FG000|NOT COMPLETED|Overall Study||3||
59685467|NCT01122394|75804791|FG001|NOT COMPLETED|Overall Study||4||
59685468|NCT01121926|75804799|FG000|STARTED|First Intervention Period||15||
59685469|NCT01121926|75804800|FG001|STARTED|First Intervention Period||15||
59685470|NCT01121926|75804799|FG000|COMPLETED|First Intervention Period||14||
59685471|NCT01121926|75804800|FG001|COMPLETED|First Intervention Period||15||
59685472|NCT01121926|75804799|FG000|NOT COMPLETED|First Intervention Period||1||
59685473|NCT01121926|75804800|FG001|NOT COMPLETED|First Intervention Period||0||
59685474|NCT01121926|75804799|FG000|STARTED|Washout Period||14||
59685475|NCT01121926|75804800|FG001|STARTED|Washout Period||15||
59685476|NCT01121926|75804799|FG000|COMPLETED|Washout Period||14||
59685477|NCT01121926|75804800|FG001|COMPLETED|Washout Period||13||
59685478|NCT01121926|75804799|FG000|NOT COMPLETED|Washout Period||0||
59685479|NCT01121926|75804800|FG001|NOT COMPLETED|Washout Period||2||
59685480|NCT01121926|75804799|FG000|STARTED|Second Intervention Period||14||
59685481|NCT01121926|75804800|FG001|STARTED|Second Intervention Period||13||
59685482|NCT01121926|75804799|FG000|COMPLETED|Second Intervention Period||14||
59685483|NCT01121926|75804800|FG001|COMPLETED|Second Intervention Period||13||
59685484|NCT01121926|75804799|FG000|NOT COMPLETED|Second Intervention Period||0||
59685485|NCT01121926|75804800|FG001|NOT COMPLETED|Second Intervention Period||0||
59685486|NCT00579995|75804808|FG000|STARTED|Overall Study||18||
59685487|NCT00579995|75804809|FG001|STARTED|Overall Study||23||
59685488|NCT00579995|75804808|FG000|COMPLETED|Overall Study||18||
59685489|NCT00579995|75804809|FG001|COMPLETED|Overall Study||23||
59685490|NCT00579995|75804808|FG000|NOT COMPLETED|Overall Study||0||
59685491|NCT00579995|75804809|FG001|NOT COMPLETED|Overall Study||0||
59685492|NCT01121575|75804821|FG000|STARTED|Overall Study||14||
59685493|NCT01121575|75804822|FG001|STARTED|Overall Study||6||
59685494|NCT01121575|75804823|FG002|STARTED|Overall Study||7||
59685495|NCT01121575|75804824|FG003|STARTED|Overall Study||6||
59685496|NCT01121575|75804825|FG004|STARTED|Overall Study||25||
59685497|NCT01121575|75804826|FG005|STARTED|Overall Study||12||
59685498|NCT01121575|75804821|FG000|Treated|Overall Study||14||
59685499|NCT01121575|75804822|FG001|Treated|Overall Study||6||
59685500|NCT01121575|75804823|FG002|Treated|Overall Study||7||
59685501|NCT01121575|75804824|FG003|Treated|Overall Study||6||
59685502|NCT01121575|75804825|FG004|Treated|Overall Study||25||
59685503|NCT01121575|75804826|FG005|Treated|Overall Study||12||
59685504|NCT01121575|75804821|FG000|COMPLETED|Overall Study||0||
59685505|NCT01121575|75804822|FG001|COMPLETED|Overall Study||0||
59685506|NCT01121575|75804823|FG002|COMPLETED|Overall Study||0||
59685507|NCT01121575|75804824|FG003|COMPLETED|Overall Study||0||
59685508|NCT01121575|75804825|FG004|COMPLETED|Overall Study||0||
59685509|NCT01121575|75804826|FG005|COMPLETED|Overall Study||0||
59685510|NCT01121575|75804821|FG000|NOT COMPLETED|Overall Study||14||
59685511|NCT01121575|75804822|FG001|NOT COMPLETED|Overall Study||6||
59685512|NCT01121575|75804823|FG002|NOT COMPLETED|Overall Study||7||
59685513|NCT01121575|75804824|FG003|NOT COMPLETED|Overall Study||6||
59685514|NCT01121575|75804825|FG004|NOT COMPLETED|Overall Study||25||
59685515|NCT01121575|75804826|FG005|NOT COMPLETED|Overall Study||12||
59685516|NCT04530591|75804845|FG000|STARTED|Overall Study||97||
59685517|NCT04530591|75804845|FG000|COMPLETED|Overall Study||97||
59685518|NCT04530591|75804845|FG000|NOT COMPLETED|Overall Study||0||
59685519|NCT01121536|75804849|FG000|STARTED|Overall Study||867||
59685520|NCT01121536|75804849|FG000|Safety Population|Overall Study|Participants treated|863||
59685521|NCT01121536|75804849|FG000|Full Analysis Population|Overall Study|Treated participants who had at least 1 post-baseline efficacy assessment.|859||
59685522|NCT01121536|75804849|FG000|COMPLETED|Overall Study|One participant 'completed' early due to study closeout.|506||
59685523|NCT01121536|75804849|FG000|NOT COMPLETED|Overall Study||361||
59685524|NCT01121263|75804855|FG000|STARTED|Overall Study||200||
59685525|NCT01121263|75804856|FG001|STARTED|Overall Study||98||
59685526|NCT01121263|75804855|FG000|COMPLETED|Overall Study||175||
59685527|NCT01121263|75804856|FG001|COMPLETED|Overall Study||83||
59685528|NCT01121263|75804855|FG000|NOT COMPLETED|Overall Study||25||
59685529|NCT01121263|75804856|FG001|NOT COMPLETED|Overall Study||15||
59685530|NCT01121185|75804866|FG000|STARTED|Overall Study||7||
59685531|NCT01121185|75804867|FG001|STARTED|Overall Study||6||
59685532|NCT01121185|75804866|FG000|Infused|Overall Study||7||
59685533|NCT01121185|75804867|FG001|Infused|Overall Study|Excluded medical condition identified in one subject after randomization but before study infusion.|5||
59685534|NCT01121185|75804866|FG000|Transplanted|Overall Study|One subject initiated the first study infusion, but transplant surgery was subsequently cancelled.|6||
59685535|NCT01121185|75804867|FG001|Transplanted|Overall Study||5||
59685536|NCT01121185|75804866|FG000|COMPLETED|Overall Study||6||
59685537|NCT01121185|75804867|FG001|COMPLETED|Overall Study||5||
59685538|NCT01121185|75804866|FG000|NOT COMPLETED|Overall Study||1||
59685539|NCT01121185|75804867|FG001|NOT COMPLETED|Overall Study||1||
59685540|NCT01121146|75804875|FG000|STARTED|Overall Study||116||
59685541|NCT01121146|75804876|FG001|STARTED|Overall Study||114||
59685542|NCT01121146|75804875|FG000|COMPLETED|Overall Study|The 90 hips include those that were not revised and had a minimum 9-year questionnaire or radiograph|90||
59685543|NCT01121146|75804876|FG001|COMPLETED|Overall Study|The 72 hips include those that were not revised and had a minimum 9-year questionnaire or radiograph|72||
59685544|NCT01121146|75804875|FG000|NOT COMPLETED|Overall Study||26||
59685545|NCT01121146|75804876|FG001|NOT COMPLETED|Overall Study||42||
59685546|NCT01120756|75804885|FG000|STARTED|Overall Study||21||
59685547|NCT01120756|75804886|FG001|STARTED|Overall Study||14||
59685548|NCT01120756|75804885|FG000|COMPLETED|Overall Study||20||
59685549|NCT01120756|75804886|FG001|COMPLETED|Overall Study||13||
59685550|NCT01120756|75804885|FG000|NOT COMPLETED|Overall Study||1||
59685551|NCT01120756|75804886|FG001|NOT COMPLETED|Overall Study||1||
59685552|NCT01120717|75804894|FG000|STARTED|Overall Study||226||
59685553|NCT01120717|75804895|FG001|STARTED|Overall Study||113||
59685554|NCT01120717|75804894|FG000|Safety Population: Received Study Drug|Overall Study||225||
59685555|NCT01120717|75804895|FG001|Safety Population: Received Study Drug|Overall Study||113||
59685556|NCT01120717|75804894|FG000|COMPLETED|Overall Study||194||
59685557|NCT01120717|75804895|FG001|COMPLETED|Overall Study||89||
59685558|NCT01120717|75804894|FG000|NOT COMPLETED|Overall Study||32||
59685559|NCT01120717|75804895|FG001|NOT COMPLETED|Overall Study||24||
59685560|NCT01120600|75804903|FG000|STARTED|Overall Study||147||
59685561|NCT01120600|75804904|FG001|STARTED|Overall Study||147||
59685562|NCT01120600|75804903|FG000|Treated|Overall Study||146||
59685563|NCT01120600|75804904|FG001|Treated|Overall Study||146||
59685564|NCT01120600|75804903|FG000|COMPLETED|Overall Study||128||
59685565|NCT01120600|75804904|FG001|COMPLETED|Overall Study||115||
59685566|NCT01120600|75804903|FG000|NOT COMPLETED|Overall Study||19||
59685567|NCT01120600|75804904|FG001|NOT COMPLETED|Overall Study||32||
59685568|NCT01120210|75804912|FG000|STARTED|MAIN INFUSION||16||
59685569|NCT01120210|75804913|FG001|STARTED|MAIN INFUSION||46||
59685570|NCT01120210|75804912|FG000|COMPLETED|MAIN INFUSION||15||
59685571|NCT01120210|75804913|FG001|COMPLETED|MAIN INFUSION||45||
59685572|NCT01120210|75804912|FG000|NOT COMPLETED|MAIN INFUSION||1||
59685573|NCT01120210|75804913|FG001|NOT COMPLETED|MAIN INFUSION||1||
59685574|NCT01120210|75804912|FG000|STARTED|18-HOUR EXTENDED INFUSION SUBSTUDY||3||
59685575|NCT01120210|75804913|FG001|STARTED|18-HOUR EXTENDED INFUSION SUBSTUDY||7||
59685576|NCT01120210|75804912|FG000|COMPLETED|18-HOUR EXTENDED INFUSION SUBSTUDY||3||
59685577|NCT01120210|75804913|FG001|COMPLETED|18-HOUR EXTENDED INFUSION SUBSTUDY||7||
59685578|NCT01120210|75804912|FG000|NOT COMPLETED|18-HOUR EXTENDED INFUSION SUBSTUDY||0||
59685579|NCT01120210|75804913|FG001|NOT COMPLETED|18-HOUR EXTENDED INFUSION SUBSTUDY||0||
59685580|NCT01120093|75804919|FG000|STARTED|Treatment Period 1||18||
59685581|NCT01120093|75804920|FG001|STARTED|Treatment Period 1||14||
59685582|NCT01120093|75804921|FG002|STARTED|Treatment Period 1||17||
59685583|NCT01120093|75804922|FG003|STARTED|Treatment Period 1||14||
59685584|NCT01120093|75804923|FG004|STARTED|Treatment Period 1||16||
59685585|NCT01120093|75804919|FG000|COMPLETED|Treatment Period 1||18||
59685586|NCT01120093|75804920|FG001|COMPLETED|Treatment Period 1||13||
59685587|NCT01120093|75804921|FG002|COMPLETED|Treatment Period 1||16||
59685588|NCT01120093|75804922|FG003|COMPLETED|Treatment Period 1||14||
59685589|NCT01120093|75804923|FG004|COMPLETED|Treatment Period 1||15||
59685590|NCT01120093|75804919|FG000|NOT COMPLETED|Treatment Period 1||0||
59685591|NCT01120093|75804920|FG001|NOT COMPLETED|Treatment Period 1||1||
59685592|NCT01120093|75804921|FG002|NOT COMPLETED|Treatment Period 1||1||
59685593|NCT01120093|75804922|FG003|NOT COMPLETED|Treatment Period 1||0||
59685594|NCT01120093|75804923|FG004|NOT COMPLETED|Treatment Period 1||1||
59685595|NCT01120093|75804919|FG000|STARTED|Treatment Period 2||18||
59685596|NCT01120093|75804920|FG001|STARTED|Treatment Period 2||13||
59685597|NCT01120093|75804921|FG002|STARTED|Treatment Period 2||16||
59685598|NCT01120093|75804922|FG003|STARTED|Treatment Period 2||14||
59685599|NCT01120093|75804923|FG004|STARTED|Treatment Period 2||15||
59685600|NCT01120093|75804919|FG000|COMPLETED|Treatment Period 2||18||
59685601|NCT01120093|75804920|FG001|COMPLETED|Treatment Period 2||13||
59685602|NCT01120093|75804921|FG002|COMPLETED|Treatment Period 2||16||
59685603|NCT01120093|75804922|FG003|COMPLETED|Treatment Period 2||13||
59685604|NCT01120093|75804923|FG004|COMPLETED|Treatment Period 2||14||
59685605|NCT01120093|75804919|FG000|NOT COMPLETED|Treatment Period 2||0||
59816098|NCT03878108|75938458|FG000|Completed First Phase|Overall Study||10||
59685606|NCT01120093|75804920|FG001|NOT COMPLETED|Treatment Period 2||0||
59685607|NCT01120093|75804921|FG002|NOT COMPLETED|Treatment Period 2||0||
59816099|NCT03878108|75938459|FG001|Completed First Phase|Overall Study||10||
59816100|NCT03878108|75938458|FG000|COMPLETED|Overall Study||10||
59685608|NCT01120093|75804922|FG003|NOT COMPLETED|Treatment Period 2||1||
59685609|NCT01120093|75804923|FG004|NOT COMPLETED|Treatment Period 2||1||
59685610|NCT01120093|75804919|FG000|STARTED|Treatment Period 3||18||
59685611|NCT01120093|75804920|FG001|STARTED|Treatment Period 3||13||
59685612|NCT01120093|75804921|FG002|STARTED|Treatment Period 3||16||
59685613|NCT01120093|75804922|FG003|STARTED|Treatment Period 3||13||
59685614|NCT01120093|75804923|FG004|STARTED|Treatment Period 3||14||
59685615|NCT01120093|75804919|FG000|COMPLETED|Treatment Period 3||18||
59685616|NCT01120093|75804920|FG001|COMPLETED|Treatment Period 3||13||
59685617|NCT01120093|75804921|FG002|COMPLETED|Treatment Period 3||15||
59816101|NCT03878108|75938459|FG001|COMPLETED|Overall Study||10||
59816102|NCT03878108|75938458|FG000|NOT COMPLETED|Overall Study||1||
59685618|NCT01120093|75804922|FG003|COMPLETED|Treatment Period 3||12||
59685619|NCT01120093|75804923|FG004|COMPLETED|Treatment Period 3||13||
59685620|NCT01120093|75804919|FG000|NOT COMPLETED|Treatment Period 3||0||
59685621|NCT01120093|75804920|FG001|NOT COMPLETED|Treatment Period 3||0||
59685622|NCT01120093|75804921|FG002|NOT COMPLETED|Treatment Period 3||1||
59685623|NCT01120093|75804922|FG003|NOT COMPLETED|Treatment Period 3||1||
59685624|NCT01120093|75804923|FG004|NOT COMPLETED|Treatment Period 3||1||
59685625|NCT01120093|75804919|FG000|STARTED|Treatment Period 4||18||
59685626|NCT01120093|75804920|FG001|STARTED|Treatment Period 4||13||
59685627|NCT01120093|75804921|FG002|STARTED|Treatment Period 4||15||
59685628|NCT01120093|75804922|FG003|STARTED|Treatment Period 4||12||
59685629|NCT01120093|75804923|FG004|STARTED|Treatment Period 4||13||
59685630|NCT01120093|75804919|FG000|COMPLETED|Treatment Period 4||17||
59685631|NCT01120093|75804920|FG001|COMPLETED|Treatment Period 4||13||
59685632|NCT01120093|75804921|FG002|COMPLETED|Treatment Period 4||15||
59685633|NCT01120093|75804922|FG003|COMPLETED|Treatment Period 4||12||
59685634|NCT01120093|75804923|FG004|COMPLETED|Treatment Period 4||13||
59685635|NCT01120093|75804919|FG000|NOT COMPLETED|Treatment Period 4||1||
59685636|NCT01120093|75804920|FG001|NOT COMPLETED|Treatment Period 4||0||
59685637|NCT01120093|75804921|FG002|NOT COMPLETED|Treatment Period 4||0||
59685638|NCT01120093|75804922|FG003|NOT COMPLETED|Treatment Period 4||0||
59685639|NCT01120093|75804923|FG004|NOT COMPLETED|Treatment Period 4||0||
59685640|NCT01120093|75804919|FG000|STARTED|Treatment Period 5||17||
59685641|NCT01120093|75804920|FG001|STARTED|Treatment Period 5||13||
59685642|NCT01120093|75804921|FG002|STARTED|Treatment Period 5||15||
59685643|NCT01120093|75804922|FG003|STARTED|Treatment Period 5||12||
59685644|NCT01120093|75804923|FG004|STARTED|Treatment Period 5||13||
59685645|NCT01120093|75804919|FG000|COMPLETED|Treatment Period 5||17||
59685646|NCT01120093|75804920|FG001|COMPLETED|Treatment Period 5||12||
59685647|NCT01120093|75804921|FG002|COMPLETED|Treatment Period 5||15||
59685648|NCT01120093|75804922|FG003|COMPLETED|Treatment Period 5||11||
59685649|NCT01120093|75804923|FG004|COMPLETED|Treatment Period 5||13||
59685650|NCT01120093|75804919|FG000|NOT COMPLETED|Treatment Period 5||0||
59685651|NCT01120093|75804920|FG001|NOT COMPLETED|Treatment Period 5||1||
59685652|NCT01120093|75804921|FG002|NOT COMPLETED|Treatment Period 5||0||
59685653|NCT01120093|75804922|FG003|NOT COMPLETED|Treatment Period 5||1||
59685654|NCT01120093|75804923|FG004|NOT COMPLETED|Treatment Period 5||0||
59685655|NCT01119937|75804937|FG000|STARTED|Overall Study||123||
59685656|NCT01119937|75804938|FG001|STARTED|Overall Study||40||
59685657|NCT01119937|75804937|FG000|COMPLETED|Overall Study||104||
59685658|NCT01119937|75804938|FG001|COMPLETED|Overall Study||33||
59685659|NCT01119937|75804937|FG000|NOT COMPLETED|Overall Study||19||
59685660|NCT01119937|75804938|FG001|NOT COMPLETED|Overall Study||7||
59685661|NCT01119898|75804946|FG000|STARTED|Overall Study||131||
59685662|NCT01119898|75804947|FG001|STARTED|Overall Study||129||
59685663|NCT01119898|75804946|FG000|Received Study Drug (mITT)|Overall Study||130||
59685664|NCT01119898|75804947|FG001|Received Study Drug (mITT)|Overall Study||129||
59685665|NCT01119898|75804946|FG000|COMPLETED|Overall Study||123||
59685666|NCT01119898|75804947|FG001|COMPLETED|Overall Study||117||
59685667|NCT01119898|75804946|FG000|NOT COMPLETED|Overall Study||8||
59989693|NCT02476994|76105040|FG001|STARTED|Overall Study||0||
59989694|NCT02476994|76105039|FG000|COMPLETED|Overall Study||0||
59989695|NCT02476994|76105040|FG001|COMPLETED|Overall Study||0||
59989696|NCT02476994|76105039|FG000|NOT COMPLETED|Overall Study||1||
59989697|NCT02476994|76105040|FG001|NOT COMPLETED|Overall Study||0||
59685668|NCT01119898|75804947|FG001|NOT COMPLETED|Overall Study||12||
59685669|NCT01119859|75804955|FG000|STARTED|Overall Study||163||
59685670|NCT01119859|75804956|FG001|STARTED|Overall Study||163||
59685671|NCT01119859|75804955|FG000|COMPLETED|Overall Study||139||
59685672|NCT01119859|75804956|FG001|COMPLETED|Overall Study||133||
59685673|NCT01119859|75804955|FG000|NOT COMPLETED|Overall Study||24||
59685674|NCT01119859|75804956|FG001|NOT COMPLETED|Overall Study||30||
59685675|NCT01119703|75804964|FG000|STARTED|Overall Study||30||
59685676|NCT01119703|75804965|FG001|STARTED|Overall Study||144||
59685677|NCT01119703|75804964|FG000|COMPLETED|Overall Study||30||
59685678|NCT01119703|75804965|FG001|COMPLETED|Overall Study||143||
59685679|NCT01119703|75804964|FG000|NOT COMPLETED|Overall Study||0||
59685680|NCT01119703|75804965|FG001|NOT COMPLETED|Overall Study||1||
59685681|NCT01119625|75804972|FG000|STARTED|Overall Study||118||
59685682|NCT01119625|75804973|FG001|STARTED|Overall Study||120||
59685683|NCT01119625|75804972|FG000|COMPLETED|Overall Study||115||
59685684|NCT01119625|75804973|FG001|COMPLETED|Overall Study||116||
59685685|NCT01119625|75804972|FG000|NOT COMPLETED|Overall Study||3||
59685686|NCT01119625|75804973|FG001|NOT COMPLETED|Overall Study||4||
59685687|NCT01119118|75804979|FG000|STARTED|Overall Study||6||
59685688|NCT01119118|75804979|FG000|COMPLETED|Overall Study||5||
59685689|NCT01119118|75804979|FG000|NOT COMPLETED|Overall Study||1||
59685690|NCT01119001|75804983|FG000|STARTED|Overall Study||13||
59685691|NCT01119001|75804983|FG000|COMPLETED|Overall Study||11||
59685692|NCT01119001|75804983|FG000|NOT COMPLETED|Overall Study||2||
59685693|NCT01118962|75804989|FG000|STARTED|Overall Study||39||
59685694|NCT01118962|75804989|FG000|COMPLETED|Overall Study||29||
59685695|NCT01118962|75804989|FG000|NOT COMPLETED|Overall Study||10||
59685696|NCT01118728|75804993|FG000|STARTED|Overall Study||223||
59685697|NCT01118728|75804993|FG000|COMPLETED|Overall Study||0||
59685698|NCT01118728|75804993|FG000|NOT COMPLETED|Overall Study||223||
59685699|NCT01118455|75804999|FG000|STARTED|Baseline [Visits 1 & 2]||66||
59685700|NCT01118455|75805000|FG001|STARTED|Baseline [Visits 1 & 2]||69||
59685701|NCT01118455|75804999|FG000|Actual Patients Treated|Baseline [Visits 1 & 2]||65||
59685702|NCT01118455|75805000|FG001|Actual Patients Treated|Baseline [Visits 1 & 2]||69||
59685703|NCT01118455|75804999|FG000|COMPLETED|Baseline [Visits 1 & 2]||65||
59685704|NCT01118455|75805000|FG001|COMPLETED|Baseline [Visits 1 & 2]||69||
59685705|NCT01118455|75804999|FG000|NOT COMPLETED|Baseline [Visits 1 & 2]||1||
59685706|NCT01118455|75805000|FG001|NOT COMPLETED|Baseline [Visits 1 & 2]||0||
59685707|NCT01118455|75804999|FG000|STARTED|Treatment Phase (VNS/AED) [Visits 3-10]||65||
59685708|NCT01118455|75805000|FG001|STARTED|Treatment Phase (VNS/AED) [Visits 3-10]||69||
59685709|NCT01118455|75804999|FG000|COMPLETED|Treatment Phase (VNS/AED) [Visits 3-10]||65||
59685710|NCT01118455|75805000|FG001|COMPLETED|Treatment Phase (VNS/AED) [Visits 3-10]||69||
59685711|NCT01118455|75804999|FG000|NOT COMPLETED|Treatment Phase (VNS/AED) [Visits 3-10]||0||
59685712|NCT01118455|75805000|FG001|NOT COMPLETED|Treatment Phase (VNS/AED) [Visits 3-10]||0||
59685713|NCT01118377|75805014|FG000|STARTED|Overall Study||45||
59685714|NCT01118377|75805014|FG000|COMPLETED|Overall Study||3||
59685715|NCT01118377|75805014|FG000|NOT COMPLETED|Overall Study||42||
59685716|NCT01118299|75805020|FG000|STARTED|Overall Study||68||
59685717|NCT01118299|75805021|FG001|STARTED|Overall Study||29||
59685718|NCT01118299|75805020|FG000|COMPLETED|Overall Study||45||
59685719|NCT01118299|75805021|FG001|COMPLETED|Overall Study||0||
59685720|NCT01118299|75805020|FG000|NOT COMPLETED|Overall Study||23||
59685721|NCT01118299|75805021|FG001|NOT COMPLETED|Overall Study||29||
59685722|NCT01118143|75805028|FG000|STARTED|Overall Study||64||
59685723|NCT01118143|75805029|FG001|STARTED|Overall Study||69||
59685724|NCT01118143|75805028|FG000|COMPLETED|Overall Study||62||
59685725|NCT01118143|75805029|FG001|COMPLETED|Overall Study||64||
59685726|NCT01118143|75805028|FG000|NOT COMPLETED|Overall Study||2||
59685727|NCT01118143|75805029|FG001|NOT COMPLETED|Overall Study||5||
59685728|NCT01117987|75805039|FG000|STARTED|Overall Study||66||
59685729|NCT01117987|75805040|FG001|STARTED|Overall Study||78||
59685730|NCT01117987|75805039|FG000|COMPLETED|Overall Study||5||
59685731|NCT01117987|75805040|FG001|COMPLETED|Overall Study||4||
59685732|NCT01117987|75805039|FG000|NOT COMPLETED|Overall Study||61||
59685733|NCT01117987|75805040|FG001|NOT COMPLETED|Overall Study||74||
59685734|NCT01117870|75805048|FG000|STARTED|Overall Study||15||
59685735|NCT01117870|75805049|FG001|STARTED|Overall Study||16||
59685736|NCT01117870|75805048|FG000|COMPLETED|Overall Study|One did not receive the allocated intervention; (degenerate spine/inability to place needle).|14||
59685737|NCT01117870|75805049|FG001|COMPLETED|Overall Study||16||
59685738|NCT01117870|75805048|FG000|NOT COMPLETED|Overall Study||1||
59685739|NCT01117870|75805049|FG001|NOT COMPLETED|Overall Study||0||
59685740|NCT01117792|75805059|FG000|STARTED|Overall Study||55||
59685741|NCT01117792|75805059|FG000|COMPLETED|Overall Study||51||
59685742|NCT01117792|75805059|FG000|NOT COMPLETED|Overall Study||4||
59685743|NCT02219490|75805063|FG000|STARTED|Overall Study||1596||
59685744|NCT02219490|75805063|FG000|COMPLETED|Overall Study||1258||
59685745|NCT02219490|75805063|FG000|NOT COMPLETED|Overall Study||338||
59685746|NCT01117480|75805071|FG000|STARTED|Overall Study||1013||
59685747|NCT01117480|75805071|FG000|COMPLETED|Overall Study||985||
59685748|NCT01117480|75805071|FG000|NOT COMPLETED|Overall Study||28||
59685749|NCT01117051|75805077|FG000|STARTED|Overall Study||86||
59685750|NCT01117051|75805078|FG001|STARTED|Overall Study||88||
59685751|NCT01117051|75805077|FG000|COMPLETED|Overall Study||73||
59685752|NCT01117051|75805078|FG001|COMPLETED|Overall Study||77||
59989698|NCT02508194|76105048|FG000|STARTED|Overall Study||949||
60079314|NCT04440163|76194635|FG005|COMPLETED|Follow-up Phase (Approx. 5 Months)||45||
59685753|NCT01117051|75805077|FG000|NOT COMPLETED|Overall Study||13||
59685754|NCT01117051|75805078|FG001|NOT COMPLETED|Overall Study||11||
59685755|NCT02211417|75805087|FG000|STARTED|Overall Study||51||
59685756|NCT02211417|75805088|FG001|STARTED|Overall Study||51||
59685757|NCT02211417|75805087|FG000|COMPLETED|Overall Study||36||
59685758|NCT02211417|75805088|FG001|COMPLETED|Overall Study||35||
59685759|NCT02211417|75805087|FG000|NOT COMPLETED|Overall Study||15||
59685760|NCT02211417|75805088|FG001|NOT COMPLETED|Overall Study||16||
59685761|NCT02218164|75805095|FG000|STARTED|Overall Study||8||
59685762|NCT02218164|75805095|FG000|COMPLETED|Overall Study||8||
59685763|NCT02218164|75805095|FG000|NOT COMPLETED|Overall Study||0||
59685764|NCT01117012|75805101|FG000|STARTED|Overall Study||89||
59685765|NCT01117012|75805102|FG001|STARTED|Overall Study||103||
59685766|NCT01117012|75805101|FG000|COMPLETED|Overall Study||81||
59685767|NCT01117012|75805102|FG001|COMPLETED|Overall Study||98||
59685768|NCT01117012|75805101|FG000|NOT COMPLETED|Overall Study||8||
59685769|NCT01117012|75805102|FG001|NOT COMPLETED|Overall Study||5||
59685770|NCT01116739|75805110|FG000|STARTED|Overall Study||1056||
59685771|NCT01116739|75805111|FG001|STARTED|Overall Study||1004||
59685772|NCT01116739|75805110|FG000|COMPLETED|Overall Study||926||
59685773|NCT01116739|75805111|FG001|COMPLETED|Overall Study||868||
59685774|NCT01116739|75805110|FG000|NOT COMPLETED|Overall Study||130||
59989699|NCT02508194|76105049|FG001|STARTED|Overall Study||951||
59685775|NCT01116739|75805111|FG001|NOT COMPLETED|Overall Study||136||
59685776|NCT01116544|75805119|FG000|STARTED|Overall Study||23||
59685777|NCT01116544|75805120|FG001|STARTED|Overall Study||23||
59685778|NCT01116544|75805119|FG000|COMPLETED|Overall Study||21||
59685779|NCT01116544|75805120|FG001|COMPLETED|Overall Study||22||
59685780|NCT01116544|75805119|FG000|NOT COMPLETED|Overall Study||2||
59685781|NCT01116544|75805120|FG001|NOT COMPLETED|Overall Study||1||
59685782|NCT01116427|75805128|FG000|STARTED|Core Phase||44||
59685783|NCT01116427|75805129|FG001|STARTED|Core Phase||21||
59685784|NCT01116427|75805128|FG000|COMPLETED|Core Phase||39||
59685785|NCT01116427|75805129|FG001|COMPLETED|Core Phase||20||
59685786|NCT01116427|75805128|FG000|NOT COMPLETED|Core Phase||5||
59685787|NCT01116427|75805129|FG001|NOT COMPLETED|Core Phase||1||
59685788|NCT01116427|75805128|FG000|STARTED|Extension Phase|One participant that completed core phase did not meet eligibility for Extension Phase|38||
59685789|NCT01116427|75805129|FG001|STARTED|Extension Phase||20||
59685790|NCT01116427|75805128|FG000|COMPLETED|Extension Phase||29||
59685791|NCT01116427|75805129|FG001|COMPLETED|Extension Phase||18||
59685792|NCT01116427|75805128|FG000|NOT COMPLETED|Extension Phase||9||
59685793|NCT01116427|75805129|FG001|NOT COMPLETED|Extension Phase||2||
59685794|NCT01116232|75805139|FG000|STARTED|Overall Study||4||
59685795|NCT01116232|75805139|FG000|COMPLETED|Overall Study||0||
59685796|NCT01116232|75805139|FG000|NOT COMPLETED|Overall Study||4||
59685797|NCT01115998|75805148|FG000|STARTED|Overall Study||17||
59685798|NCT01115998|75805149|FG001|STARTED|Overall Study||17||
59685799|NCT01115998|75805148|FG000|COMPLETED|Overall Study||11||
59685800|NCT01115998|75805149|FG001|COMPLETED|Overall Study||11||
59685801|NCT01115998|75805148|FG000|NOT COMPLETED|Overall Study||6||
59685802|NCT01115998|75805149|FG001|NOT COMPLETED|Overall Study||6||
59685803|NCT01205230|75805157|FG000|STARTED|Overall Study||21||
59685804|NCT01205230|75805158|FG001|STARTED|Overall Study||13||
59685805|NCT01205230|75805157|FG000|Combination Therapy|Overall Study||21||
59685806|NCT01205230|75805158|FG001|Combination Therapy|Overall Study||13||
59685807|NCT01205230|75805157|FG000|COMPLETED|Overall Study||16||
59685808|NCT01205230|75805158|FG001|COMPLETED|Overall Study||13||
59685809|NCT01205230|75805157|FG000|NOT COMPLETED|Overall Study||5||
59685810|NCT01205230|75805158|FG001|NOT COMPLETED|Overall Study||0||
59685811|NCT01205152|75805169|FG000|STARTED|Overall Study||10||
59685812|NCT01205152|75805169|FG000|COMPLETED|Overall Study||9||
59685813|NCT01205152|75805169|FG000|NOT COMPLETED|Overall Study||1||
59685814|NCT01205035|75805177|FG000|STARTED|Overall Study||3||
59685815|NCT01205035|75805178|FG001|STARTED|Overall Study||3||
59685816|NCT01205035|75805177|FG000|COMPLETED|Overall Study||1||
59685817|NCT01205035|75805178|FG001|COMPLETED|Overall Study||3||
59685818|NCT01205035|75805177|FG000|NOT COMPLETED|Overall Study||2||
59685819|NCT01205035|75805178|FG001|NOT COMPLETED|Overall Study||0||
59685820|NCT01204918|75805187|FG000|STARTED|Overall Study||25||
59816103|NCT03878108|75938459|FG001|NOT COMPLETED|Overall Study||0||
59685821|NCT01204918|75805188|FG001|STARTED|Overall Study||39||
59685822|NCT01204918|75805189|FG002|STARTED|Overall Study||40||
59685823|NCT01204918|75805187|FG000|Stage 1 Begin|Overall Study||25||
59685824|NCT01204918|75805188|FG001|Stage 1 Begin|Overall Study||39||
59685825|NCT01204918|75805189|FG002|Stage 1 Begin|Overall Study||40||
59685826|NCT01204918|75805187|FG000|Stage 1 End|Overall Study||22||
59685827|NCT01204918|75805188|FG001|Stage 1 End|Overall Study||35||
59685828|NCT01204918|75805189|FG002|Stage 1 End|Overall Study||36||
59685829|NCT01204918|75805187|FG000|Stage 2 Begin|Overall Study||22||
59685830|NCT01204918|75805188|FG001|Stage 2 Begin|Overall Study||35||
59685831|NCT01204918|75805189|FG002|Stage 2 Begin|Overall Study||36||
59685832|NCT01204918|75805187|FG000|Stage 2 End|Overall Study||21||
59685833|NCT01204918|75805188|FG001|Stage 2 End|Overall Study||29||
59685834|NCT01204918|75805189|FG002|Stage 2 End|Overall Study||35||
59685835|NCT01204918|75805187|FG000|COMPLETED|Overall Study||21||
59685836|NCT01204918|75805188|FG001|COMPLETED|Overall Study||29||
59685837|NCT01204918|75805189|FG002|COMPLETED|Overall Study||35||
59685838|NCT01204918|75805187|FG000|NOT COMPLETED|Overall Study||4||
59685839|NCT01204918|75805188|FG001|NOT COMPLETED|Overall Study||10||
59685840|NCT01204918|75805189|FG002|NOT COMPLETED|Overall Study||5||
59685841|NCT01204294|75805204|FG000|STARTED|Overall Study||82||
59685842|NCT01204294|75805205|FG001|STARTED|Overall Study||66||
59685843|NCT01204294|75805206|FG002|STARTED|Overall Study||74||
59685844|NCT01204294|75805207|FG003|STARTED|Overall Study||143||
59685845|NCT01204294|75805208|FG004|STARTED|Overall Study||85||
59685846|NCT01204294|75805209|FG005|STARTED|Overall Study||63||
59685847|NCT01204294|75805210|FG006|STARTED|Overall Study||61||
59685848|NCT01204294|75805204|FG000|COMPLETED|Overall Study||79||
59685849|NCT01204294|75805205|FG001|COMPLETED|Overall Study||58||
59685850|NCT01204294|75805206|FG002|COMPLETED|Overall Study||69||
59685851|NCT01204294|75805207|FG003|COMPLETED|Overall Study||132||
59685852|NCT01204294|75805208|FG004|COMPLETED|Overall Study||83||
59685853|NCT01204294|75805209|FG005|COMPLETED|Overall Study||58||
59685854|NCT01204294|75805210|FG006|COMPLETED|Overall Study||59||
59685855|NCT01204294|75805204|FG000|NOT COMPLETED|Overall Study||3||
59685856|NCT01204294|75805205|FG001|NOT COMPLETED|Overall Study||8||
59685857|NCT01204294|75805206|FG002|NOT COMPLETED|Overall Study||5||
59685858|NCT01204294|75805207|FG003|NOT COMPLETED|Overall Study||11||
59685859|NCT01204294|75805208|FG004|NOT COMPLETED|Overall Study||2||
59685860|NCT01204294|75805209|FG005|NOT COMPLETED|Overall Study||5||
59685861|NCT01204294|75805210|FG006|NOT COMPLETED|Overall Study||2||
59685862|NCT01182181|75805228|FG000|STARTED|First Intervention||11||
59685863|NCT01182181|75805229|FG001|STARTED|First Intervention||11||
59685864|NCT01182181|75805228|FG000|COMPLETED|First Intervention||10||
59685865|NCT01182181|75805229|FG001|COMPLETED|First Intervention||11||
59685866|NCT01182181|75805228|FG000|NOT COMPLETED|First Intervention||1||
59685867|NCT01182181|75805229|FG001|NOT COMPLETED|First Intervention||0||
59685868|NCT01182181|75805228|FG000|STARTED|Washout of 21 Days||10||
59685869|NCT01182181|75805229|FG001|STARTED|Washout of 21 Days||11||
59685870|NCT01182181|75805228|FG000|COMPLETED|Washout of 21 Days||10||
59685871|NCT01182181|75805229|FG001|COMPLETED|Washout of 21 Days||10||
59685872|NCT01182181|75805228|FG000|NOT COMPLETED|Washout of 21 Days||0||
59685873|NCT01182181|75805229|FG001|NOT COMPLETED|Washout of 21 Days||1||
59685874|NCT01182181|75805228|FG000|STARTED|Second Intervention||10||
59685875|NCT01182181|75805229|FG001|STARTED|Second Intervention||10||
59685876|NCT01182181|75805228|FG000|COMPLETED|Second Intervention||10||
59685877|NCT01182181|75805229|FG001|COMPLETED|Second Intervention||10||
59685878|NCT01182181|75805228|FG000|NOT COMPLETED|Second Intervention||0||
59685879|NCT01182181|75805229|FG001|NOT COMPLETED|Second Intervention||0||
59685880|NCT01181986|75805237|FG000|STARTED|Phase 1||19||
59685881|NCT01181986|75805238|FG001|STARTED|Phase 1||23||
59685882|NCT01181986|75805239|FG002|STARTED|Phase 1||34||
59685883|NCT01181986|75805237|FG000|Saline+Exenatide|Phase 1|N/A for this arm|0||
59685884|NCT01181986|75805238|FG001|Saline+Exenatide|Phase 1|N/A for this arm|0||
59685885|NCT01181986|75805239|FG002|Saline+Exenatide|Phase 1||32||
59685886|NCT01181986|75805237|FG000|Saline+Placebo|Phase 1|N/A for this arm|0||
59685887|NCT01181986|75805238|FG001|Saline+Placebo|Phase 1|N/A for this arm|0||
59685888|NCT01181986|75805239|FG002|Saline+Placebo|Phase 1||33||
59685889|NCT01181986|75805237|FG000|Exendin-9+Exenatide|Phase 1|N/A for this arm|0||
59685890|NCT01181986|75805238|FG001|Exendin-9+Exenatide|Phase 1|N/A for this arm|0||
59685891|NCT01181986|75805239|FG002|Exendin-9+Exenatide|Phase 1||33||
59685892|NCT01181986|75805237|FG000|COMPLETED|Phase 1||18||
59685893|NCT01181986|75805238|FG001|COMPLETED|Phase 1||22||
59685894|NCT01181986|75805239|FG002|COMPLETED|Phase 1||32||
59685895|NCT01181986|75805237|FG000|NOT COMPLETED|Phase 1||1||
59685896|NCT01181986|75805238|FG001|NOT COMPLETED|Phase 1||1||
59685897|NCT01181986|75805239|FG002|NOT COMPLETED|Phase 1||2||
59685898|NCT01181986|75805237|FG000|STARTED|Phase 2||18||
59685899|NCT01181986|75805238|FG001|STARTED|Phase 2||22||
59685900|NCT01181986|75805239|FG002|STARTED|Phase 2|N/A for Sub-study 2|0||
59685901|NCT01181986|75805237|FG000|COMPLETED|Phase 2||18||
59685902|NCT01181986|75805238|FG001|COMPLETED|Phase 2||18||
59685903|NCT01181986|75805239|FG002|COMPLETED|Phase 2||0||
59685904|NCT01181986|75805237|FG000|NOT COMPLETED|Phase 2||0||
59685905|NCT01181986|75805238|FG001|NOT COMPLETED|Phase 2||4||
59685906|NCT01181986|75805239|FG002|NOT COMPLETED|Phase 2||0||
59685907|NCT01181167|75805255|FG000|STARTED|Overall Study||307||
59685908|NCT01181167|75805256|FG001|STARTED|Overall Study||303||
59685909|NCT01181167|75805255|FG000|Efficacy Analysis Population|Overall Study||255||
59685910|NCT01181167|75805256|FG001|Efficacy Analysis Population|Overall Study||248||
59685911|NCT01181167|75805255|FG000|COMPLETED|Overall Study||284||
59685912|NCT01181167|75805256|FG001|COMPLETED|Overall Study||271||
59685913|NCT01181167|75805255|FG000|NOT COMPLETED|Overall Study||23||
59685914|NCT01181167|75805256|FG001|NOT COMPLETED|Overall Study||32||
59685915|NCT01181128|75805265|FG000|STARTED|Overall Study||118||
59685916|NCT01181128|75805266|FG001|STARTED|Overall Study||24||
59685917|NCT01181128|75805267|FG002|STARTED|Overall Study||23||
59685918|NCT01181128|75805265|FG000|Pharmacokinetic (PK) Subgroup|Overall Study||30||
59685919|NCT01181128|75805266|FG001|Pharmacokinetic (PK) Subgroup|Overall Study||0||
59685920|NCT01181128|75805267|FG002|Pharmacokinetic (PK) Subgroup|Overall Study||0||
59685921|NCT01181128|75805265|FG000|Perioperative Management Subgroup|Overall Study|Participants who underwent major surgery.|8||
59685922|NCT01181128|75805266|FG001|Perioperative Management Subgroup|Overall Study|Participants who underwent major surgery.|1||
59685923|NCT01181128|75805267|FG002|Perioperative Management Subgroup|Overall Study|Participants who underwent major surgery.|0||
59685924|NCT01181128|75805265|FG000|COMPLETED|Overall Study||112||
59685925|NCT01181128|75805266|FG001|COMPLETED|Overall Study||19||
59685926|NCT01181128|75805267|FG002|COMPLETED|Overall Study||22||
59685927|NCT01181128|75805265|FG000|NOT COMPLETED|Overall Study||6||
59685928|NCT01181128|75805266|FG001|NOT COMPLETED|Overall Study||5||
59685929|NCT01181128|75805267|FG002|NOT COMPLETED|Overall Study||1||
59685930|NCT01203787|75805289|FG000|STARTED|Overall Study||63||
59685931|NCT01203787|75805290|FG001|STARTED|Overall Study||57||
59685932|NCT01203787|75805289|FG000|COMPLETED|Overall Study||32||
59685933|NCT01203787|75805290|FG001|COMPLETED|Overall Study||30||
59685934|NCT01203787|75805289|FG000|NOT COMPLETED|Overall Study||31||
59685935|NCT01203787|75805290|FG001|NOT COMPLETED|Overall Study||27||
59685936|NCT01181011|75805298|FG000|STARTED|Overall Study||28||
59685937|NCT01181011|75805298|FG000|Received Telmisartan 80mg|Overall Study||27||
59685938|NCT01181011|75805298|FG000|Received Telmisartan 80mg,Amlodipine 5mg|Overall Study||27||
59685939|NCT01181011|75805298|FG000|Received Amlodipine 5mg|Overall Study||26||
59685940|NCT01181011|75805298|FG000|COMPLETED|Overall Study||25||
59685941|NCT01181011|75805298|FG000|NOT COMPLETED|Overall Study||3||
59685942|NCT01180777|75805307|FG000|STARTED|Overall Study||92||
59685943|NCT01180777|75805307|FG000|COMPLETED|Overall Study||80||
59685944|NCT01180777|75805307|FG000|NOT COMPLETED|Overall Study||12||
59685945|NCT01648023|75805315|FG000|STARTED|Overall Study||25||
59685946|NCT01648023|75805316|FG001|STARTED|Overall Study||24||
59685947|NCT01648023|75805315|FG000|COMPLETED|Overall Study||24||
59685948|NCT01648023|75805316|FG001|COMPLETED|Overall Study||22||
59685949|NCT01648023|75805315|FG000|NOT COMPLETED|Overall Study||1||
59685950|NCT01648023|75805316|FG001|NOT COMPLETED|Overall Study||2||
59685951|NCT04547036|75805322|FG000|STARTED|Overall Study||129||155
59685952|NCT04547036|75805322|FG000|COMPLETED|Overall Study||129||155
59685953|NCT04547036|75805322|FG000|NOT COMPLETED|Overall Study||0||0
59685954|NCT02756208|75805330|FG000|STARTED|Overall Study||18||
59685955|NCT02756208|75805331|FG001|STARTED|Overall Study||16||
59685956|NCT02756208|75805332|FG002|STARTED|Overall Study||15||
59685957|NCT02756208|75805333|FG003|STARTED|Overall Study||16||
59685958|NCT02756208|75805330|FG000|COMPLETED|Overall Study||13||
59685959|NCT02756208|75805331|FG001|COMPLETED|Overall Study||14||
59685960|NCT02756208|75805332|FG002|COMPLETED|Overall Study||13||
59685961|NCT02756208|75805333|FG003|COMPLETED|Overall Study||12||
59685962|NCT02756208|75805330|FG000|NOT COMPLETED|Overall Study||5||
59685963|NCT02756208|75805331|FG001|NOT COMPLETED|Overall Study||2||
59685964|NCT02756208|75805332|FG002|NOT COMPLETED|Overall Study||2||
59685965|NCT02756208|75805333|FG003|NOT COMPLETED|Overall Study||4||
59685966|NCT02756013|75805343|FG000|STARTED|Overall Study||3||
59685967|NCT02756013|75805343|FG000|COMPLETED|Overall Study||1||
59685968|NCT02756013|75805343|FG000|NOT COMPLETED|Overall Study||2||
59685969|NCT01202773|75805350|FG000|STARTED|Overall Study||153||
59685970|NCT01202773|75805351|FG001|STARTED|Overall Study||148||
59685971|NCT01202773|75805352|FG002|STARTED|Overall Study||155||
59685972|NCT01202773|75805350|FG000|Received at Least 1 Dose of Study Drug|Overall Study||153||
59685973|NCT01202773|75805351|FG001|Received at Least 1 Dose of Study Drug|Overall Study||147||
59685974|NCT01202773|75805352|FG002|Received at Least 1 Dose of Study Drug|Overall Study||154||
59685975|NCT01202773|75805350|FG000|Week 16 NR|Overall Study||23||
59685976|NCT01202773|75805351|FG001|Week 16 NR|Overall Study||33||
59685977|NCT01202773|75805352|FG002|Week 16 NR|Overall Study||37||
59685978|NCT01202773|75805350|FG000|Post-Treatment Follow-Up Population|Overall Study||46||
59685979|NCT01202773|75805351|FG001|Post-Treatment Follow-Up Population|Overall Study||36||
59685980|NCT01202773|75805352|FG002|Post-Treatment Follow-Up Population|Overall Study||51||
59685981|NCT01202773|75805350|FG000|COMPLETED|Overall Study|Those who completed 24-week treatment period including both Week 16 responders and NR.|96||
59685982|NCT01202773|75805351|FG001|COMPLETED|Overall Study|Those who completed 24-week treatment period including both Week 16 responders and NR.|105||
59685983|NCT01202773|75805352|FG002|COMPLETED|Overall Study|Those who completed 24-week treatment period including both Week 16 responders and NR.|100||
59685984|NCT01202773|75805350|FG000|NOT COMPLETED|Overall Study||57||
59685985|NCT01202773|75805351|FG001|NOT COMPLETED|Overall Study||43||
59685986|NCT01202773|75805352|FG002|NOT COMPLETED|Overall Study||55||
59685987|NCT01180660|75805372|FG000|STARTED|Overall Study||25||
59685988|NCT01180660|75805373|FG001|STARTED|Overall Study||26||
59685989|NCT01180660|75805372|FG000|COMPLETED|Overall Study||24||
59685990|NCT01180660|75805373|FG001|COMPLETED|Overall Study||26||
59685991|NCT01180660|75805372|FG000|NOT COMPLETED|Overall Study||1||
59685992|NCT01180660|75805373|FG001|NOT COMPLETED|Overall Study||0||
59685993|NCT01202227|75805379|FG000|STARTED|Overall Study|Treated|103||
59685994|NCT01202227|75805379|FG000|COMPLETED|Overall Study||84||
59685995|NCT01202227|75805379|FG000|NOT COMPLETED|Overall Study||19||
59685996|NCT01202188|75805388|FG000|STARTED|Overall Study||475||
59685997|NCT01202188|75805389|FG001|STARTED|Overall Study||477||
59685998|NCT01202188|75805390|FG002|STARTED|Overall Study||475||
59685999|NCT01202188|75805391|FG003|STARTED|Overall Study||483||
59686000|NCT01202188|75805392|FG004|STARTED|Overall Study||234||
59686001|NCT01202188|75805388|FG000|Safety Set; Received Study Drug|Overall Study||474||
59686002|NCT01202188|75805389|FG001|Safety Set; Received Study Drug|Overall Study||476||
59686003|NCT01202188|75805390|FG002|Safety Set; Received Study Drug|Overall Study||473||
59686004|NCT01202188|75805391|FG003|Safety Set; Received Study Drug|Overall Study||480||
59686005|NCT01202188|75805392|FG004|Safety Set; Received Study Drug|Overall Study||232||
59686006|NCT01202188|75805388|FG000|COMPLETED|Overall Study||437||
59686007|NCT01202188|75805389|FG001|COMPLETED|Overall Study||421||
59686008|NCT01202188|75805390|FG002|COMPLETED|Overall Study||422||
59686009|NCT01202188|75805391|FG003|COMPLETED|Overall Study||441||
59686010|NCT01202188|75805392|FG004|COMPLETED|Overall Study||189||
59686011|NCT01202188|75805388|FG000|NOT COMPLETED|Overall Study||38||
59686012|NCT01202188|75805389|FG001|NOT COMPLETED|Overall Study||56||
59686013|NCT01202188|75805390|FG002|NOT COMPLETED|Overall Study||53||
59686014|NCT01202188|75805391|FG003|NOT COMPLETED|Overall Study||42||
59686015|NCT01202188|75805392|FG004|NOT COMPLETED|Overall Study||45||
59686016|NCT01201915|75805413|FG000|STARTED|Overall Study||24||
59686017|NCT01201915|75805414|FG001|STARTED|Overall Study||25||
59686018|NCT01201915|75805415|FG002|STARTED|Overall Study||25||
59686019|NCT01201915|75805413|FG000|COMPLETED|Overall Study||16||
59686020|NCT01201915|75805414|FG001|COMPLETED|Overall Study||14||
59686021|NCT01201915|75805415|FG002|COMPLETED|Overall Study||19||
59686022|NCT01201915|75805413|FG000|NOT COMPLETED|Overall Study||8||
59686023|NCT01201915|75805414|FG001|NOT COMPLETED|Overall Study||11||
59686024|NCT01201915|75805415|FG002|NOT COMPLETED|Overall Study||6||
59686025|NCT01179919|75805423|FG000|STARTED|Overall Study||21||
59686026|NCT01179919|75805423|FG000|COMPLETED|Overall Study||19||
59686027|NCT01179919|75805423|FG000|NOT COMPLETED|Overall Study||2||
59686028|NCT01201798|75805429|FG000|STARTED|Overall Study||56||
59686029|NCT01201798|75805430|FG001|STARTED|Overall Study||54||
59686030|NCT01201798|75805429|FG000|COMPLETED|Overall Study||47||
59686031|NCT01201798|75805430|FG001|COMPLETED|Overall Study||39||
59686032|NCT01201798|75805429|FG000|NOT COMPLETED|Overall Study||9||
59686033|NCT01201798|75805430|FG001|NOT COMPLETED|Overall Study||15||
59686034|NCT01201759|75805438|FG000|STARTED|Visit 1 Wash-in ( Untreated)||10||
59686035|NCT01201759|75805439|FG001|STARTED|Visit 1 Wash-in ( Untreated)||8||
59686036|NCT01201759|75805438|FG000|COMPLETED|Visit 1 Wash-in ( Untreated)||8||
59686037|NCT01201759|75805439|FG001|COMPLETED|Visit 1 Wash-in ( Untreated)||7||
59686038|NCT01201759|75805438|FG000|NOT COMPLETED|Visit 1 Wash-in ( Untreated)||2||
59686039|NCT01201759|75805439|FG001|NOT COMPLETED|Visit 1 Wash-in ( Untreated)||1||
59686040|NCT01201759|75805438|FG000|STARTED|Visit 2||8||
59686041|NCT01201759|75805439|FG001|STARTED|Visit 2||7||
59686042|NCT01201759|75805438|FG000|COMPLETED|Visit 2||8||
59686043|NCT01201759|75805439|FG001|COMPLETED|Visit 2||7||
59686044|NCT01201759|75805438|FG000|NOT COMPLETED|Visit 2||0||
59686045|NCT01201759|75805439|FG001|NOT COMPLETED|Visit 2||0||
59686046|NCT01201759|75805438|FG000|STARTED|Visit 3 - Washout||8||
59686047|NCT01201759|75805439|FG001|STARTED|Visit 3 - Washout||7||
59686048|NCT01201759|75805438|FG000|COMPLETED|Visit 3 - Washout||7||
59686049|NCT01201759|75805439|FG001|COMPLETED|Visit 3 - Washout||4||
59686050|NCT01201759|75805438|FG000|NOT COMPLETED|Visit 3 - Washout||1||
59686051|NCT01201759|75805439|FG001|NOT COMPLETED|Visit 3 - Washout||3||
59686052|NCT01201759|75805438|FG000|STARTED|Visit 4 Crossover||7||
59686053|NCT01201759|75805439|FG001|STARTED|Visit 4 Crossover||4||
59686054|NCT01201759|75805438|FG000|COMPLETED|Visit 4 Crossover||7||
59686055|NCT01201759|75805439|FG001|COMPLETED|Visit 4 Crossover||3||
59686056|NCT01201759|75805438|FG000|NOT COMPLETED|Visit 4 Crossover||0||
59686057|NCT01201759|75805439|FG001|NOT COMPLETED|Visit 4 Crossover||1||
59686058|NCT01201759|75805438|FG000|STARTED|Visit 5||7||
59686059|NCT01201759|75805439|FG001|STARTED|Visit 5||3||
59686060|NCT01201759|75805438|FG000|COMPLETED|Visit 5||7||
59686061|NCT01201759|75805439|FG001|COMPLETED|Visit 5||3||
59686062|NCT01201759|75805438|FG000|NOT COMPLETED|Visit 5||0||
59686063|NCT01201759|75805439|FG001|NOT COMPLETED|Visit 5||0||
59686064|NCT01200589|75805449|FG000|STARTED|Overall Study||219||
59686065|NCT01200589|75805450|FG001|STARTED|Overall Study||219||
59686066|NCT01200589|75805449|FG000|Intent-to-treat (ITT) Analysis Set|Overall Study||219||
59686067|NCT01200589|75805450|FG001|Intent-to-treat (ITT) Analysis Set|Overall Study||219||
59686068|NCT01200589|75805449|FG000|Safety Set|Overall Study||217||
59686069|NCT01200589|75805450|FG001|Safety Set|Overall Study||218||
59686070|NCT01200589|75805449|FG000|COMPLETED|Overall Study||29||
59686071|NCT01200589|75805450|FG001|COMPLETED|Overall Study||30||
59686072|NCT01200589|75805449|FG000|NOT COMPLETED|Overall Study||190||
59686073|NCT01200589|75805450|FG001|NOT COMPLETED|Overall Study||189||
59686074|NCT01200511|75805456|FG000|STARTED|Overall Study||49||
60079315|NCT04440163|76194636|FG006|COMPLETED|Follow-up Phase (Approx. 5 Months)||120||
59686075|NCT01200511|75805456|FG000|COMPLETED|Overall Study||44||
59686076|NCT01200511|75805456|FG000|NOT COMPLETED|Overall Study||5||
59686077|NCT01179334|75805464|FG000|STARTED|Treatment Period||12||
59686078|NCT01179334|75805465|FG001|STARTED|Treatment Period||6||
59686079|NCT01179334|75805464|FG000|Participants Received Treatment|Treatment Period||12||
59686080|NCT01179334|75805465|FG001|Participants Received Treatment|Treatment Period||6||
59686081|NCT01179334|75805464|FG000|COMPLETED|Treatment Period||11||
59686082|NCT01179334|75805465|FG001|COMPLETED|Treatment Period||6||
59686083|NCT01179334|75805464|FG000|NOT COMPLETED|Treatment Period||1||
59686084|NCT01179334|75805465|FG001|NOT COMPLETED|Treatment Period||0||
59686085|NCT01179334|75805464|FG000|STARTED|Long-term Extension (LTE) Period||11||
59686086|NCT01179334|75805465|FG001|STARTED|Long-term Extension (LTE) Period||6||
59686087|NCT01179334|75805464|FG000|COMPLETED|Long-term Extension (LTE) Period|LTE phase was terminated by sponsor|0||
59686088|NCT01179334|75805465|FG001|COMPLETED|Long-term Extension (LTE) Period|LTE phase was terminated by sponsor|0||
59686089|NCT01179334|75805464|FG000|NOT COMPLETED|Long-term Extension (LTE) Period||11||
59686090|NCT01179334|75805465|FG001|NOT COMPLETED|Long-term Extension (LTE) Period||6||
59686091|NCT01178671|75805473|FG000|STARTED|Overall Study||18||
59686092|NCT01178671|75805474|FG001|STARTED|Overall Study||18||
59686093|NCT01178671|75805473|FG000|COMPLETED|Overall Study||6||
59686094|NCT01178671|75805474|FG001|COMPLETED|Overall Study||3||
59686095|NCT01178671|75805473|FG000|NOT COMPLETED|Overall Study||12||
59686096|NCT01178671|75805474|FG001|NOT COMPLETED|Overall Study||15||
59686097|NCT01178125|75805480|FG000|STARTED|Overall Study|Number enrolled.|2858||
59686098|NCT01178125|75805480|FG000|Safety Population|Overall Study|Received at least 1 dose of DR-102.|2765||
59686099|NCT01178125|75805480|FG000|Intent to Treat (ITT) Population|Overall Study|Completed at least one 28-day cycle of investigational product.|2607||
59686100|NCT01178125|75805480|FG000|Pregnancy ITT (PITT) Population|Overall Study|Participants in the ITT population between the ages of 18 and 35, inclusive.|2401||
59686101|NCT01178125|75805480|FG000|COMPLETED|Overall Study||1680||
59686102|NCT01178125|75805480|FG000|NOT COMPLETED|Overall Study||1178||
59686103|NCT01649505|75805491|FG000|STARTED|Overall Study||1||
59686104|NCT01649505|75805492|FG001|STARTED|Overall Study||1||
59686105|NCT01649505|75805491|FG000|COMPLETED|Overall Study||0||
59686106|NCT01649505|75805492|FG001|COMPLETED|Overall Study||0||
59686107|NCT01649505|75805491|FG000|NOT COMPLETED|Overall Study||1||
59686108|NCT01649505|75805492|FG001|NOT COMPLETED|Overall Study||1||
59686109|NCT01178086|75805502|FG000|STARTED|Overall Study|Safety analysis set: participants who received at least one dose of rituximab.|681||
59686110|NCT01178086|75805502|FG000|Effectiveness Analysis Set (EAS)|Overall Study|who received at least 1 dose of rituximab and had data from baseline and at least 1 follow-up visit.|661||
59686111|NCT01178086|75805502|FG000|COMPLETED|Overall Study||349||
59686112|NCT01178086|75805502|FG000|NOT COMPLETED|Overall Study||332||
59686113|NCT01177969|75805510|FG000|STARTED|Overall Study||19||
59686114|NCT01177969|75805511|FG001|STARTED|Overall Study||14||
59686115|NCT01177969|75805510|FG000|COMPLETED|Overall Study||16||
59686116|NCT01177969|75805511|FG001|COMPLETED|Overall Study||11||
59686117|NCT01177969|75805510|FG000|NOT COMPLETED|Overall Study||3||
59686118|NCT01177969|75805511|FG001|NOT COMPLETED|Overall Study||3||
59686119|NCT01177813|75805522|FG000|STARTED|Overall Study||228||
59686120|NCT01177813|75805523|FG001|STARTED|Overall Study||224||
59686121|NCT01177813|75805524|FG002|STARTED|Overall Study||224||
59686122|NCT01177813|75805525|FG003|STARTED|Overall Study||223||
59686123|NCT01177813|75805526|FG004|STARTED|Overall Study||87||
59686124|NCT01177813|75805522|FG000|COMPLETED|Overall Study||187||
59686125|NCT01177813|75805523|FG001|COMPLETED|Overall Study||206||
59686126|NCT01177813|75805524|FG002|COMPLETED|Overall Study||204||
59686127|NCT01177813|75805525|FG003|COMPLETED|Overall Study||206||
59686128|NCT01177813|75805526|FG004|COMPLETED|Overall Study||78||
59686129|NCT01177813|75805522|FG000|NOT COMPLETED|Overall Study||41||
59686130|NCT01177813|75805523|FG001|NOT COMPLETED|Overall Study||18||
59686131|NCT01177813|75805524|FG002|NOT COMPLETED|Overall Study||20||
59686132|NCT01177813|75805525|FG003|NOT COMPLETED|Overall Study||17||
59686133|NCT01177813|75805526|FG004|NOT COMPLETED|Overall Study||9||
59686134|NCT01200394|75805540|FG000|STARTED|Overall Study||64||
59686135|NCT01200394|75805541|FG001|STARTED|Overall Study||192||
59686136|NCT01200394|75805540|FG000|COMPLETED|Overall Study||62||
59686137|NCT01200394|75805541|FG001|COMPLETED|Overall Study||164||
59686138|NCT01200394|75805540|FG000|NOT COMPLETED|Overall Study||2||
59686139|NCT01200394|75805541|FG001|NOT COMPLETED|Overall Study||28||
59686140|NCT01200355|75805550|FG000|STARTED|Overall Study||58||
59686141|NCT01200355|75805551|FG001|STARTED|Overall Study||55||
59686142|NCT01200355|75805550|FG000|COMPLETED|Overall Study||51||
59686143|NCT01200355|75805551|FG001|COMPLETED|Overall Study||53||
59686144|NCT01200355|75805550|FG000|NOT COMPLETED|Overall Study||7||
59686145|NCT01200355|75805551|FG001|NOT COMPLETED|Overall Study||2||
59686146|NCT01200238|75805559|FG000|STARTED|Overall Study||7||
59686147|NCT01200238|75805560|FG001|STARTED|Overall Study||10||
59686148|NCT01200238|75805559|FG000|COMPLETED|Overall Study||0||
59686149|NCT01200238|75805560|FG001|COMPLETED|Overall Study||0||
59686150|NCT01200238|75805559|FG000|NOT COMPLETED|Overall Study||7||
59686151|NCT01200238|75805560|FG001|NOT COMPLETED|Overall Study||10||
59709795|NCT01072149|75828525|FG005|COMPLETED|Washout Period 1 (14 Days)||3||
59709796|NCT01072149|75828526|FG006|COMPLETED|Washout Period 1 (14 Days)||3||
59709797|NCT01072149|75828527|FG007|COMPLETED|Washout Period 1 (14 Days)||3||
59709798|NCT01072149|75828528|FG008|COMPLETED|Washout Period 1 (14 Days)||3||
59709799|NCT01072149|75828529|FG009|COMPLETED|Washout Period 1 (14 Days)||3||
59709800|NCT01072149|75828530|FG010|COMPLETED|Washout Period 1 (14 Days)||2||
59709801|NCT01072149|75828531|FG011|COMPLETED|Washout Period 1 (14 Days)||3||
59709802|NCT01072149|75828532|FG012|COMPLETED|Washout Period 1 (14 Days)||3||
59709803|NCT01072149|75828533|FG013|COMPLETED|Washout Period 1 (14 Days)||3||
59709804|NCT01072149|75828534|FG014|COMPLETED|Washout Period 1 (14 Days)||3||
59709805|NCT01072149|75828535|FG015|COMPLETED|Washout Period 1 (14 Days)||3||
59709806|NCT01072149|75828536|FG016|COMPLETED|Washout Period 1 (14 Days)||3||
59709807|NCT01072149|75828537|FG017|COMPLETED|Washout Period 1 (14 Days)||2||
59709808|NCT01072149|75828520|FG000|NOT COMPLETED|Washout Period 1 (14 Days)||0||
59709809|NCT01072149|75828521|FG001|NOT COMPLETED|Washout Period 1 (14 Days)||0||
59709810|NCT01072149|75828522|FG002|NOT COMPLETED|Washout Period 1 (14 Days)||0||
59709811|NCT01072149|75828523|FG003|NOT COMPLETED|Washout Period 1 (14 Days)||0||
59709812|NCT01072149|75828524|FG004|NOT COMPLETED|Washout Period 1 (14 Days)||0||
59709813|NCT01072149|75828525|FG005|NOT COMPLETED|Washout Period 1 (14 Days)||0||
59709814|NCT01072149|75828526|FG006|NOT COMPLETED|Washout Period 1 (14 Days)||0||
59709815|NCT01072149|75828527|FG007|NOT COMPLETED|Washout Period 1 (14 Days)||0||
59709816|NCT01072149|75828528|FG008|NOT COMPLETED|Washout Period 1 (14 Days)||0||
59709817|NCT01072149|75828529|FG009|NOT COMPLETED|Washout Period 1 (14 Days)||0||
59709818|NCT01072149|75828530|FG010|NOT COMPLETED|Washout Period 1 (14 Days)||0||
59709819|NCT01072149|75828531|FG011|NOT COMPLETED|Washout Period 1 (14 Days)||0||
59709820|NCT01072149|75828532|FG012|NOT COMPLETED|Washout Period 1 (14 Days)||0||
59709821|NCT01072149|75828533|FG013|NOT COMPLETED|Washout Period 1 (14 Days)||0||
59686152|NCT01199731|75805569|FG000|STARTED|Overall Study||9||
59686153|NCT01199731|75805570|FG001|STARTED|Overall Study||11||
59686154|NCT01199731|75805571|FG002|STARTED|Overall Study||10||
59686155|NCT01199731|75805569|FG000|COMPLETED|Overall Study||0||
59686156|NCT01199731|75805570|FG001|COMPLETED|Overall Study||0||
59686157|NCT01199731|75805571|FG002|COMPLETED|Overall Study||0||
59686158|NCT01199731|75805569|FG000|NOT COMPLETED|Overall Study||9||
59686159|NCT01199731|75805570|FG001|NOT COMPLETED|Overall Study||11||
59686160|NCT01199731|75805571|FG002|NOT COMPLETED|Overall Study||10||
59686161|NCT01199263|75805581|FG000|STARTED|Overall Study||54||
59686162|NCT01199263|75805582|FG001|STARTED|Overall Study||54||
59686163|NCT01199263|75805581|FG000|COMPLETED|Overall Study||48||
59686164|NCT01199263|75805582|FG001|COMPLETED|Overall Study||52||
59686165|NCT01199263|75805581|FG000|NOT COMPLETED|Overall Study||6||
59686166|NCT01199263|75805582|FG001|NOT COMPLETED|Overall Study||2||
59686167|NCT01199068|75805593|FG000|STARTED|Overall Study||3||
59686168|NCT01199068|75805594|FG001|STARTED|Overall Study||3||
59686169|NCT01199068|75805595|FG002|STARTED|Overall Study||9||
59686170|NCT01199068|75805593|FG000|Received Treatment|Overall Study||3||
59686171|NCT01199068|75805594|FG001|Received Treatment|Overall Study||3||
59686172|NCT01199068|75805595|FG002|Received Treatment|Overall Study||8||
59686173|NCT01199068|75805593|FG000|COMPLETED|Overall Study||0||
59686174|NCT01199068|75805594|FG001|COMPLETED|Overall Study||0||
59686175|NCT01199068|75805595|FG002|COMPLETED|Overall Study||0||
59686176|NCT01199068|75805593|FG000|NOT COMPLETED|Overall Study||3||
59686177|NCT01199068|75805594|FG001|NOT COMPLETED|Overall Study||3||
59686178|NCT01199068|75805595|FG002|NOT COMPLETED|Overall Study||9||
59686179|NCT01198873|75805612|FG000|STARTED|Overall Study||41||
59686180|NCT01198873|75805613|FG001|STARTED|Overall Study||35||
59686181|NCT01198873|75805612|FG000|Treated|Overall Study||41||
59686182|NCT01198873|75805613|FG001|Treated|Overall Study||35||
59686183|NCT01198873|75805612|FG000|Evaluable for Efficacy|Overall Study|8 participants discontinued before completing 3-month treatment and were not assessed post-baseline|33||
59686184|NCT01198873|75805613|FG001|Evaluable for Efficacy|Overall Study|9 participants discontinued before completing 3-month treatment and were not assessed post-baseline|26||
59686185|NCT01198873|75805612|FG000|COMPLETED|Overall Study||4||
59686186|NCT01198873|75805613|FG001|COMPLETED|Overall Study||3||
59686187|NCT01198873|75805612|FG000|NOT COMPLETED|Overall Study||37||
59686188|NCT01198873|75805613|FG001|NOT COMPLETED|Overall Study||32||
59686189|NCT01198795|75805619|FG000|STARTED|Overall Study||162||
59686190|NCT01198795|75805619|FG000|COMPLETED|Overall Study||80||
59686191|NCT01198795|75805619|FG000|NOT COMPLETED|Overall Study||82||
59686192|NCT01198756|75805627|FG000|STARTED|Overall Study||932||
59686193|NCT01198756|75805628|FG001|STARTED|Overall Study||929||
59686194|NCT01198756|75805629|FG002|STARTED|Overall Study||932||
59547353|NCT02438826|75646181|FG002|STARTED|Double-Blind Treatment Phase||0||
59547354|NCT02438826|75646182|FG003|STARTED|Double-Blind Treatment Phase||0||
59547355|NCT02438826|75646179|FG000|Received at Least 1 Dose of Study Drug|Double-Blind Treatment Phase||120||
59547356|NCT02438826|75646180|FG001|Received at Least 1 Dose of Study Drug|Double-Blind Treatment Phase||117||
59686195|NCT01198756|75805630|FG003|STARTED|Overall Study||301||
59686196|NCT01198756|75805627|FG000|COMPLETED|Overall Study||894||
59686197|NCT01198756|75805628|FG001|COMPLETED|Overall Study||889||
59686198|NCT01198756|75805629|FG002|COMPLETED|Overall Study||902||
59686199|NCT01198756|75805630|FG003|COMPLETED|Overall Study||275||
59686200|NCT01198756|75805627|FG000|NOT COMPLETED|Overall Study||38||
59686201|NCT01198756|75805628|FG001|NOT COMPLETED|Overall Study||40||
59686202|NCT01198756|75805629|FG002|NOT COMPLETED|Overall Study||30||
59547357|NCT02438826|75646181|FG002|Received at Least 1 Dose of Study Drug|Double-Blind Treatment Phase||0||
59547358|NCT02438826|75646182|FG003|Received at Least 1 Dose of Study Drug|Double-Blind Treatment Phase||0||
59547359|NCT02438826|75646179|FG000|COMPLETED|Double-Blind Treatment Phase||117||
59547360|NCT02438826|75646180|FG001|COMPLETED|Double-Blind Treatment Phase||113||
59547361|NCT02438826|75646181|FG002|COMPLETED|Double-Blind Treatment Phase||0||
59547362|NCT02438826|75646182|FG003|COMPLETED|Double-Blind Treatment Phase||0||
59547363|NCT02438826|75646179|FG000|NOT COMPLETED|Double-Blind Treatment Phase||6||
59547364|NCT02438826|75646180|FG001|NOT COMPLETED|Double-Blind Treatment Phase||4||
59547365|NCT02438826|75646181|FG002|NOT COMPLETED|Double-Blind Treatment Phase||0||
59547366|NCT02438826|75646182|FG003|NOT COMPLETED|Double-Blind Treatment Phase||0||
59547367|NCT02438826|75646179|FG000|STARTED|Open-Label Treatment Phase|This period is optional phase, one participant chose not to enter the open-label phase.|116||
59547368|NCT02438826|75646180|FG001|STARTED|Open-Label Treatment Phase||113||
59547369|NCT02438826|75646181|FG002|STARTED|Open-Label Treatment Phase||0||
59547370|NCT02438826|75646182|FG003|STARTED|Open-Label Treatment Phase||0||
59547371|NCT02438826|75646179|FG000|COMPLETED|Open-Label Treatment Phase||72||
59686203|NCT01198756|75805630|FG003|NOT COMPLETED|Overall Study||26||
59686204|NCT01198600|75805647|FG000|STARTED|Phase 1: Period One, 30 Days of Wear||35||
59686205|NCT01198600|75805648|FG001|STARTED|Phase 1: Period One, 30 Days of Wear||37||
59686206|NCT01198600|75805649|FG002|STARTED|Phase 1: Period One, 30 Days of Wear||0||
59686207|NCT01198600|75805650|FG003|STARTED|Phase 1: Period One, 30 Days of Wear||0||
59686208|NCT01198600|75805647|FG000|COMPLETED|Phase 1: Period One, 30 Days of Wear||33||
59686209|NCT01198600|75805648|FG001|COMPLETED|Phase 1: Period One, 30 Days of Wear||36||
60079316|NCT04440163|76194637|FG007|COMPLETED|Follow-up Phase (Approx. 5 Months)||43||
60079317|NCT04440163|76194630|FG000|NOT COMPLETED|Follow-up Phase (Approx. 5 Months)||3||
59686210|NCT01198600|75805649|FG002|COMPLETED|Phase 1: Period One, 30 Days of Wear||0||
59686211|NCT01198600|75805650|FG003|COMPLETED|Phase 1: Period One, 30 Days of Wear||0||
59686212|NCT01198600|75805647|FG000|NOT COMPLETED|Phase 1: Period One, 30 Days of Wear||2||
59686213|NCT01198600|75805648|FG001|NOT COMPLETED|Phase 1: Period One, 30 Days of Wear||1||
59686214|NCT01198600|75805649|FG002|NOT COMPLETED|Phase 1: Period One, 30 Days of Wear||0||
59686215|NCT01198600|75805650|FG003|NOT COMPLETED|Phase 1: Period One, 30 Days of Wear||0||
59686216|NCT01198600|75805647|FG000|STARTED|Phase 1: Period Two, 30 Days of Wear|One participant discontinued between Period One and Period Two due to unconvenience.|32||
59686217|NCT01198600|75805648|FG001|STARTED|Phase 1: Period Two, 30 Days of Wear||36||
59686218|NCT01198600|75805649|FG002|STARTED|Phase 1: Period Two, 30 Days of Wear||0||
59686219|NCT01198600|75805650|FG003|STARTED|Phase 1: Period Two, 30 Days of Wear||0||
59686220|NCT01198600|75805647|FG000|COMPLETED|Phase 1: Period Two, 30 Days of Wear||32||
59686221|NCT01198600|75805648|FG001|COMPLETED|Phase 1: Period Two, 30 Days of Wear||35||
59686222|NCT01198600|75805649|FG002|COMPLETED|Phase 1: Period Two, 30 Days of Wear||0||
59686223|NCT01198600|75805650|FG003|COMPLETED|Phase 1: Period Two, 30 Days of Wear||0||
59686224|NCT01198600|75805647|FG000|NOT COMPLETED|Phase 1: Period Two, 30 Days of Wear||0||
59686225|NCT01198600|75805648|FG001|NOT COMPLETED|Phase 1: Period Two, 30 Days of Wear||1||
59686226|NCT01198600|75805649|FG002|NOT COMPLETED|Phase 1: Period Two, 30 Days of Wear||0||
59686227|NCT01198600|75805650|FG003|NOT COMPLETED|Phase 1: Period Two, 30 Days of Wear||0||
59686228|NCT01198600|75805647|FG000|STARTED|Phase 2: 56 Days of Wear||0||
59686229|NCT01198600|75805648|FG001|STARTED|Phase 2: 56 Days of Wear||0||
59686230|NCT01198600|75805649|FG002|STARTED|Phase 2: 56 Days of Wear||67||
59686231|NCT01198600|75805650|FG003|STARTED|Phase 2: 56 Days of Wear||0||
59686232|NCT01198600|75805647|FG000|COMPLETED|Phase 2: 56 Days of Wear||0||
59686233|NCT01198600|75805648|FG001|COMPLETED|Phase 2: 56 Days of Wear||0||
59686234|NCT01198600|75805649|FG002|COMPLETED|Phase 2: 56 Days of Wear||62||
59686235|NCT01198600|75805650|FG003|COMPLETED|Phase 2: 56 Days of Wear||0||
59686236|NCT01198600|75805647|FG000|NOT COMPLETED|Phase 2: 56 Days of Wear||0||
59686237|NCT01198600|75805648|FG001|NOT COMPLETED|Phase 2: 56 Days of Wear||0||
59686238|NCT01198600|75805649|FG002|NOT COMPLETED|Phase 2: 56 Days of Wear||5||
59686239|NCT01198600|75805650|FG003|NOT COMPLETED|Phase 2: 56 Days of Wear||0||
59686240|NCT01198600|75805647|FG000|STARTED|Phase 3: 43 Days of Wear||0||
59686241|NCT01198600|75805648|FG001|STARTED|Phase 3: 43 Days of Wear||0||
59686242|NCT01198600|75805649|FG002|STARTED|Phase 3: 43 Days of Wear||0||
59686243|NCT01198600|75805650|FG003|STARTED|Phase 3: 43 Days of Wear||38||
59686244|NCT01198600|75805647|FG000|COMPLETED|Phase 3: 43 Days of Wear||0||
59686245|NCT01198600|75805648|FG001|COMPLETED|Phase 3: 43 Days of Wear||0||
59686246|NCT01198600|75805649|FG002|COMPLETED|Phase 3: 43 Days of Wear||0||
59686247|NCT01198600|75805650|FG003|COMPLETED|Phase 3: 43 Days of Wear||38||
59686248|NCT01198600|75805647|FG000|NOT COMPLETED|Phase 3: 43 Days of Wear||0||
59686249|NCT01198600|75805648|FG001|NOT COMPLETED|Phase 3: 43 Days of Wear||0||
59686250|NCT01198600|75805649|FG002|NOT COMPLETED|Phase 3: 43 Days of Wear||0||
59686251|NCT01198600|75805650|FG003|NOT COMPLETED|Phase 3: 43 Days of Wear||0||
59686252|NCT01198132|75805660|FG000|STARTED|Overall Study||63||
59686253|NCT01198132|75805661|FG001|STARTED|Overall Study||66||
59686254|NCT01198132|75805660|FG000|COMPLETED|Overall Study||45||
59686255|NCT01198132|75805661|FG001|COMPLETED|Overall Study||45||
59686256|NCT01198132|75805660|FG000|NOT COMPLETED|Overall Study||18||
59686257|NCT01198132|75805661|FG001|NOT COMPLETED|Overall Study||21||
59686258|NCT01197508|75805673|FG000|STARTED|Overall Study||174||
59686259|NCT01197508|75805674|FG001|STARTED|Overall Study||174||
59686260|NCT01197508|75805675|FG002|STARTED|Overall Study||174||
59686261|NCT01197508|75805676|FG003|STARTED|Overall Study||174||
59686262|NCT01197508|75805673|FG000|Received Treatment|Overall Study||174||
59686263|NCT01197508|75805674|FG001|Received Treatment|Overall Study||174||
59686264|NCT01197508|75805675|FG002|Received Treatment|Overall Study||171||
59686265|NCT01197508|75805676|FG003|Received Treatment|Overall Study||174||
59686266|NCT01197508|75805673|FG000|COMPLETED|Overall Study||151||
60079318|NCT04440163|76194631|FG001|NOT COMPLETED|Follow-up Phase (Approx. 5 Months)||5||
60079319|NCT04440163|76194632|FG002|NOT COMPLETED|Follow-up Phase (Approx. 5 Months)||0||
60079320|NCT04440163|76194633|FG003|NOT COMPLETED|Follow-up Phase (Approx. 5 Months)||1||
60079321|NCT04440163|76194634|FG004|NOT COMPLETED|Follow-up Phase (Approx. 5 Months)||1||
59686267|NCT01197508|75805674|FG001|COMPLETED|Overall Study||144||
59686268|NCT01197508|75805675|FG002|COMPLETED|Overall Study||125||
59686269|NCT01197508|75805676|FG003|COMPLETED|Overall Study||158||
59686270|NCT01197508|75805673|FG000|NOT COMPLETED|Overall Study||23||
59686271|NCT01197508|75805674|FG001|NOT COMPLETED|Overall Study||30||
59686272|NCT01197508|75805675|FG002|NOT COMPLETED|Overall Study||49||
59686273|NCT01197508|75805676|FG003|NOT COMPLETED|Overall Study||16||
59686274|NCT04534764|75805686|FG000|STARTED|Period 1||18||
59686275|NCT04534764|75805687|FG001|STARTED|Period 1||17||
59686276|NCT04534764|75805686|FG000|COMPLETED|Period 1||18||
59686277|NCT04534764|75805687|FG001|COMPLETED|Period 1||17||
59686278|NCT04534764|75805686|FG000|NOT COMPLETED|Period 1||0||
59686279|NCT04534764|75805687|FG001|NOT COMPLETED|Period 1||0||
59686280|NCT04534764|75805686|FG000|STARTED|Period 2||18||
59686281|NCT04534764|75805687|FG001|STARTED|Period 2||17||
59686282|NCT04534764|75805686|FG000|COMPLETED|Period 2||18||
59686283|NCT04534764|75805687|FG001|COMPLETED|Period 2||17||
59686284|NCT04534764|75805686|FG000|NOT COMPLETED|Period 2||0||
59686285|NCT04534764|75805687|FG001|NOT COMPLETED|Period 2||0||
59686286|NCT01196416|75805693|FG000|STARTED|Overall Study||14||
59686287|NCT01196416|75805693|FG000|COMPLETED|Overall Study||12||
59686288|NCT01196416|75805693|FG000|NOT COMPLETED|Overall Study||2||
59686289|NCT01196104|75805699|FG000|STARTED|Overall Study||19||
59686290|NCT01196104|75805700|FG001|STARTED|Overall Study||20||
59686291|NCT01196104|75805699|FG000|COMPLETED|Overall Study||15||
59686292|NCT01196104|75805700|FG001|COMPLETED|Overall Study||15||
59686293|NCT01196104|75805699|FG000|NOT COMPLETED|Overall Study||4||
59686294|NCT01196104|75805700|FG001|NOT COMPLETED|Overall Study||5||
59686295|NCT03113955|75805708|FG000|STARTED|Overall Study||109||
59686296|NCT03113955|75805708|FG000|COMPLETED|Overall Study||92||
59686297|NCT03113955|75805708|FG000|NOT COMPLETED|Overall Study||17||
59686298|NCT01196026|75805718|FG000|STARTED|Overall Study||10||
59686299|NCT01196026|75805719|FG001|STARTED|Overall Study||44||
59686300|NCT01196026|75805720|FG002|STARTED|Overall Study||23||
59686301|NCT01196026|75805721|FG003|STARTED|Overall Study||10||
59686302|NCT01196026|75805722|FG004|STARTED|Overall Study||43||
59686303|NCT01196026|75805723|FG005|STARTED|Overall Study||24||
59686304|NCT01196026|75805718|FG000|Completed at Day 28|Overall Study||9||
59686305|NCT01196026|75805719|FG001|Completed at Day 28|Overall Study||41||
59686306|NCT01196026|75805720|FG002|Completed at Day 28|Overall Study||23||
59686307|NCT01196026|75805721|FG003|Completed at Day 28|Overall Study||10||
59686308|NCT01196026|75805722|FG004|Completed at Day 28|Overall Study||42||
59686309|NCT01196026|75805723|FG005|Completed at Day 28|Overall Study||24||
59686310|NCT01196026|75805718|FG000|COMPLETED|Overall Study||9||
59686311|NCT01196026|75805719|FG001|COMPLETED|Overall Study||36||
59686312|NCT01196026|75805720|FG002|COMPLETED|Overall Study||23||
59686313|NCT01196026|75805721|FG003|COMPLETED|Overall Study||10||
59686314|NCT01196026|75805722|FG004|COMPLETED|Overall Study||42||
59686315|NCT01196026|75805723|FG005|COMPLETED|Overall Study||24||
59686316|NCT01196026|75805718|FG000|NOT COMPLETED|Overall Study||1||
59686317|NCT01196026|75805719|FG001|NOT COMPLETED|Overall Study||8||
59547372|NCT02438826|75646180|FG001|COMPLETED|Open-Label Treatment Phase||80||
59547373|NCT02438826|75646181|FG002|COMPLETED|Open-Label Treatment Phase||0||
59547374|NCT02438826|75646182|FG003|COMPLETED|Open-Label Treatment Phase||0||
59547375|NCT02438826|75646179|FG000|NOT COMPLETED|Open-Label Treatment Phase||44||
59547376|NCT02438826|75646180|FG001|NOT COMPLETED|Open-Label Treatment Phase||33||
59547377|NCT02438826|75646181|FG002|NOT COMPLETED|Open-Label Treatment Phase||0||
59547378|NCT02438826|75646182|FG003|NOT COMPLETED|Open-Label Treatment Phase||0||
59547379|NCT02438826|75646179|FG000|STARTED|Post-Treatment Phase|Participants who discontinued Open-Label Treatment also had the option to enter Post-Treatment Phase|93||
59547380|NCT02438826|75646180|FG001|STARTED|Post-Treatment Phase|Participants who discontinued Open-Label Treatment also had the option to enter Post-Treatment Phase|93||
59547381|NCT02438826|75646181|FG002|STARTED|Post-Treatment Phase|Participants entered from Double-Blind Treatment Phase.|2||
59547382|NCT02438826|75646182|FG003|STARTED|Post-Treatment Phase|Participants entered from Double-Blind Treatment Phase.|4||
59547383|NCT02438826|75646179|FG000|COMPLETED|Post-Treatment Phase||84||
59547384|NCT02438826|75646180|FG001|COMPLETED|Post-Treatment Phase||92||
59547385|NCT02438826|75646181|FG002|COMPLETED|Post-Treatment Phase||2||
59547386|NCT02438826|75646182|FG003|COMPLETED|Post-Treatment Phase||4||
59547387|NCT02438826|75646179|FG000|NOT COMPLETED|Post-Treatment Phase||9||
59547388|NCT02438826|75646180|FG001|NOT COMPLETED|Post-Treatment Phase||1||
59547389|NCT02438826|75646181|FG002|NOT COMPLETED|Post-Treatment Phase||0||
59547390|NCT02438826|75646182|FG003|NOT COMPLETED|Post-Treatment Phase||0||
59547391|NCT02438280|75646199|FG000|STARTED|Overall Study||14||
59547392|NCT02438280|75646200|FG001|STARTED|Overall Study||13||
59547393|NCT02438280|75646199|FG000|COMPLETED|Overall Study||13||
59547394|NCT02438280|75646200|FG001|COMPLETED|Overall Study||13||
59547395|NCT02438280|75646199|FG000|NOT COMPLETED|Overall Study||1||
59547396|NCT02438280|75646200|FG001|NOT COMPLETED|Overall Study||0||
59547397|NCT02437383|75646209|FG000|STARTED|Overall Study||100||
59547398|NCT02437383|75646210|FG001|STARTED|Overall Study||100||
59547399|NCT02437383|75646209|FG000|COMPLETED|Overall Study||87||
59547400|NCT02437383|75646210|FG001|COMPLETED|Overall Study||87||
59547401|NCT02437383|75646209|FG000|NOT COMPLETED|Overall Study||13||
59547402|NCT02437383|75646210|FG001|NOT COMPLETED|Overall Study||13||
59547403|NCT02385708|75646218|FG000|STARTED|Overall Study||81||
59686318|NCT01196026|75805720|FG002|NOT COMPLETED|Overall Study||0||
59686319|NCT01196026|75805721|FG003|NOT COMPLETED|Overall Study||0||
59686320|NCT01196026|75805722|FG004|NOT COMPLETED|Overall Study||1||
59686321|NCT01196026|75805723|FG005|NOT COMPLETED|Overall Study||0||
59686322|NCT01195948|75805742|FG000|STARTED|Overall Study||10||
59686323|NCT01195948|75805743|FG001|STARTED|Overall Study||10||
59686324|NCT01195948|75805744|FG002|STARTED|Overall Study||11||
59686325|NCT01195948|75805742|FG000|Week 24|Overall Study||10||
59686326|NCT01195948|75805743|FG001|Week 24|Overall Study||10||
59686327|NCT01195948|75805744|FG002|Week 24|Overall Study||10||
59686328|NCT01195948|75805742|FG000|COMPLETED|Overall Study||10||
59686329|NCT01195948|75805743|FG001|COMPLETED|Overall Study||9||
59686330|NCT01195948|75805744|FG002|COMPLETED|Overall Study||9||
59686331|NCT01195948|75805742|FG000|NOT COMPLETED|Overall Study||0||
59686332|NCT01195948|75805743|FG001|NOT COMPLETED|Overall Study||1||
59686333|NCT01195948|75805744|FG002|NOT COMPLETED|Overall Study||2||
59686334|NCT01195831|75805757|FG000|STARTED|Overall Study||120||
59686335|NCT01195831|75805758|FG001|STARTED|Overall Study||124||
59686336|NCT01195831|75805757|FG000|COMPLETED|Overall Study||112||
59686337|NCT01195831|75805758|FG001|COMPLETED|Overall Study||114||
59686338|NCT01195831|75805757|FG000|NOT COMPLETED|Overall Study||8||
59686339|NCT01195831|75805758|FG001|NOT COMPLETED|Overall Study||10||
59547404|NCT02385708|75646219|FG001|STARTED|Overall Study||82||
59547405|NCT02385708|75646218|FG000|Intervention Started|Overall Study||81||
59547406|NCT02385708|75646219|FG001|Intervention Started|Overall Study||82||
59547407|NCT02385708|75646218|FG000|COMPLETED|Overall Study||73||
59547408|NCT02385708|75646219|FG001|COMPLETED|Overall Study||67||
59547409|NCT02385708|75646218|FG000|NOT COMPLETED|Overall Study||8||
59547410|NCT02385708|75646219|FG001|NOT COMPLETED|Overall Study||15||
59547411|NCT01099358|75646225|FG000|STARTED|Overall Study||4||
59686340|NCT01195675|75805764|FG000|STARTED|Overall Study||30||
59686341|NCT01195675|75805764|FG000|Received Empa 25mg|Overall Study||28||
59686342|NCT01195675|75805764|FG000|Received Empa 200mg|Overall Study||30||
59686343|NCT01195675|75805764|FG000|Received Moxifloxacin|Overall Study||29||
59686344|NCT01195675|75805764|FG000|Received Placebo 1|Overall Study||29||
59686345|NCT01195675|75805764|FG000|Received Placebo 2|Overall Study||28||
59686346|NCT01195675|75805764|FG000|COMPLETED|Overall Study||27||
59686347|NCT01195675|75805764|FG000|NOT COMPLETED|Overall Study||3||
59686348|NCT01195636|75805781|FG000|STARTED|First Intervention (3 Weeks)||35||
59686349|NCT01195636|75805782|FG001|STARTED|First Intervention (3 Weeks)||35||
59686350|NCT01195636|75805781|FG000|Received at Least 1 Dose of Drug|First Intervention (3 Weeks)||33||
59686351|NCT01195636|75805782|FG001|Received at Least 1 Dose of Drug|First Intervention (3 Weeks)||35||
59686352|NCT01195636|75805781|FG000|COMPLETED|First Intervention (3 Weeks)||30||
59686353|NCT01195636|75805782|FG001|COMPLETED|First Intervention (3 Weeks)||32||
59686354|NCT01195636|75805781|FG000|NOT COMPLETED|First Intervention (3 Weeks)||5||
59686355|NCT01195636|75805782|FG001|NOT COMPLETED|First Intervention (3 Weeks)||3||
59686356|NCT01195636|75805781|FG000|STARTED|Washout Period (2 Weeks)||30||
59686357|NCT01195636|75805782|FG001|STARTED|Washout Period (2 Weeks)||32||
59686358|NCT01195636|75805781|FG000|COMPLETED|Washout Period (2 Weeks)||28||
59686359|NCT01195636|75805782|FG001|COMPLETED|Washout Period (2 Weeks)||29||
59686360|NCT01195636|75805781|FG000|NOT COMPLETED|Washout Period (2 Weeks)||2||
59686361|NCT01195636|75805782|FG001|NOT COMPLETED|Washout Period (2 Weeks)||3||
59686362|NCT01195636|75805781|FG000|STARTED|Second Intervention (3 Weeks)||28||
59686363|NCT01195636|75805782|FG001|STARTED|Second Intervention (3 Weeks)||29||
59686364|NCT01195636|75805781|FG000|COMPLETED|Second Intervention (3 Weeks)||27||
59686365|NCT01195636|75805782|FG001|COMPLETED|Second Intervention (3 Weeks)||27||
59686366|NCT01195636|75805781|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||1||
59686367|NCT01195636|75805782|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||2||
59686368|NCT01195363|75805790|FG000|STARTED|Overall Study||15||
59686369|NCT01195363|75805791|FG001|STARTED|Overall Study||13||
59686370|NCT01195363|75805790|FG000|COMPLETED|Overall Study||4||
59686371|NCT01195363|75805791|FG001|COMPLETED|Overall Study||4||
59686372|NCT01195363|75805790|FG000|NOT COMPLETED|Overall Study||11||
59686373|NCT01195363|75805791|FG001|NOT COMPLETED|Overall Study||9||
59686374|NCT01195090|75805799|FG000|STARTED|Overall Study||60||
59686375|NCT01195090|75805800|FG001|STARTED|Overall Study||60||
59686376|NCT01195090|75805799|FG000|COMPLETED|Overall Study||54||
59686377|NCT01195090|75805800|FG001|COMPLETED|Overall Study||52||
59686378|NCT01195090|75805799|FG000|NOT COMPLETED|Overall Study||6||
59686379|NCT01195090|75805800|FG001|NOT COMPLETED|Overall Study||8||
59686380|NCT01194973|75805806|FG000|STARTED|Screening Period||44||
59547412|NCT01099358|75646226|FG001|STARTED|Overall Study||6||
59686381|NCT01194973|75805806|FG000|COMPLETED|Screening Period||41||
59686382|NCT01194973|75805806|FG000|NOT COMPLETED|Screening Period||3||
59686383|NCT01194973|75805806|FG000|STARTED|26 Week Treatment Period||41||
59686384|NCT01194973|75805806|FG000|COMPLETED|26 Week Treatment Period||38||
59686385|NCT01194973|75805806|FG000|NOT COMPLETED|26 Week Treatment Period||3||
59686386|NCT02218697|75805812|FG000|STARTED|Overall Study||179||
59686387|NCT02218697|75805813|FG001|STARTED|Overall Study||177||
59686388|NCT02218697|75805812|FG000|COMPLETED|Overall Study||177||
59686389|NCT02218697|75805813|FG001|COMPLETED|Overall Study||171||
59686390|NCT02218697|75805812|FG000|NOT COMPLETED|Overall Study||2||
59686391|NCT02218697|75805813|FG001|NOT COMPLETED|Overall Study||6||
59686392|NCT01177540|75805821|FG000|STARTED|Overall Study||11||
59686393|NCT01177540|75805822|FG001|STARTED|Overall Study||14||
59686394|NCT01177540|75805821|FG000|COMPLETED|Overall Study||10||
59686395|NCT01177540|75805822|FG001|COMPLETED|Overall Study||14||
59686396|NCT01177540|75805821|FG000|NOT COMPLETED|Overall Study||1||
59686397|NCT01177540|75805822|FG001|NOT COMPLETED|Overall Study||0||
59686398|NCT01177384|75805830|FG000|STARTED|Overall Study||191||
59686399|NCT01177384|75805831|FG001|STARTED|Overall Study|Includes the second randomization of a participant|190||
59686400|NCT01177384|75805830|FG000|COMPLETED|Overall Study||177||
59686401|NCT01177384|75805831|FG001|COMPLETED|Overall Study||164||
59686402|NCT01177384|75805830|FG000|NOT COMPLETED|Overall Study||14||
59686403|NCT01177384|75805831|FG001|NOT COMPLETED|Overall Study||26||
59686404|NCT01194154|75805839|FG000|STARTED|Overall Study||117||
59686405|NCT01194154|75805840|FG001|STARTED|Overall Study||124||
59686406|NCT01194154|75805839|FG000|Full Analysis Set|Overall Study||115||
59686407|NCT01194154|75805840|FG001|Full Analysis Set|Overall Study||120||
59686408|NCT01194154|75805839|FG000|Safety Analysis Set|Overall Study|3 participants randomized to placebo but received MIRCERA and included in MIRCERA arm (as treated).|118||
59686409|NCT01194154|75805840|FG001|Safety Analysis Set|Overall Study|3 participants randomized to placebo but received MIRCERA and included in MIRCERA arm (as treated).|117||
59686410|NCT01194154|75805839|FG000|COMPLETED|Overall Study||68||
59686411|NCT01194154|75805840|FG001|COMPLETED|Overall Study||91||
59686412|NCT01194154|75805839|FG000|NOT COMPLETED|Overall Study||49||
59686413|NCT01194154|75805840|FG001|NOT COMPLETED|Overall Study||33||
59686414|NCT05431478|75805850|FG000|STARTED|Period 1, Approximately 14 Days||34||68
59686415|NCT05431478|75805851|FG001|STARTED|Period 1, Approximately 14 Days||34||68
59686416|NCT05431478|75805850|FG000|COMPLETED|Period 1, Approximately 14 Days||34||68
59686417|NCT05431478|75805851|FG001|COMPLETED|Period 1, Approximately 14 Days||34||68
59686418|NCT05431478|75805850|FG000|NOT COMPLETED|Period 1, Approximately 14 Days||0||0
59686419|NCT05431478|75805851|FG001|NOT COMPLETED|Period 1, Approximately 14 Days||0||0
59686420|NCT05431478|75805850|FG000|STARTED|Period 2, Approximately 14 Days||34||68
59686421|NCT05431478|75805851|FG001|STARTED|Period 2, Approximately 14 Days||34||68
59686422|NCT05431478|75805850|FG000|COMPLETED|Period 2, Approximately 14 Days||34||68
59686423|NCT05431478|75805851|FG001|COMPLETED|Period 2, Approximately 14 Days||34||68
59686424|NCT05431478|75805850|FG000|NOT COMPLETED|Period 2, Approximately 14 Days||0||0
59686425|NCT05431478|75805851|FG001|NOT COMPLETED|Period 2, Approximately 14 Days||0||0
59686426|NCT05034731|75805862|FG000|STARTED|Overall Study||13||
59686427|NCT05034731|75805863|FG001|STARTED|Overall Study||6||
59686428|NCT05034731|75805862|FG000|COMPLETED|Overall Study||12||
59686429|NCT05034731|75805863|FG001|COMPLETED|Overall Study||5||
59686430|NCT05034731|75805862|FG000|NOT COMPLETED|Overall Study||1||
59686431|NCT05034731|75805863|FG001|NOT COMPLETED|Overall Study||1||
59686432|NCT04984993|75805873|FG000|STARTED|Overall Study||96||
59686433|NCT04984993|75805874|FG001|STARTED|Overall Study||96||
59686434|NCT04984993|75805873|FG000|Received Treatment|Overall Study||94||
59686435|NCT04984993|75805874|FG001|Received Treatment|Overall Study||94||
59686436|NCT04984993|75805873|FG000|COMPLETED|Overall Study||82||
59686437|NCT04984993|75805874|FG001|COMPLETED|Overall Study||92||
59686438|NCT04984993|75805873|FG000|NOT COMPLETED|Overall Study||14||
59686439|NCT04984993|75805874|FG001|NOT COMPLETED|Overall Study||4||
59686440|NCT04880161|75805881|FG000|STARTED|Overall Study||16||
59686441|NCT04880161|75805882|FG001|STARTED|Overall Study||16||
59686442|NCT04880161|75805881|FG000|COMPLETED|Overall Study||14||
59686443|NCT04880161|75805882|FG001|COMPLETED|Overall Study||13||
59686444|NCT04880161|75805881|FG000|NOT COMPLETED|Overall Study||2||
59686445|NCT04880161|75805882|FG001|NOT COMPLETED|Overall Study||3||
59686446|NCT04809220|75805890|FG000|STARTED|Overall Study||395||
59686447|NCT04809220|75805891|FG001|STARTED|Overall Study||196||
59686448|NCT04809220|75805890|FG000|Received at Least 1 Dose of Study Intervention|Overall Study||395||
59686449|NCT04809220|75805891|FG001|Received at Least 1 Dose of Study Intervention|Overall Study||196||
59686450|NCT04809220|75805890|FG000|COMPLETED|Overall Study||377||
59686451|NCT04809220|75805891|FG001|COMPLETED|Overall Study||190||
59686452|NCT04809220|75805890|FG000|NOT COMPLETED|Overall Study||18||
59686453|NCT04809220|75805891|FG001|NOT COMPLETED|Overall Study||6||
59686454|NCT04740827|75805900|FG000|STARTED|Double-blind Treatment (Up to Week 12)||158||
59686455|NCT04740827|75805901|FG001|STARTED|Double-blind Treatment (Up to Week 12)||157||
59686456|NCT04740827|75805900|FG000|Safety Population|Double-blind Treatment (Up to Week 12)||157|Safety population consisted of all participants who received at least 1 dose of study intervention.|
59686457|NCT04740827|75805901|FG001|Safety Population|Double-blind Treatment (Up to Week 12)||156|Safety population consisted of all participants who received at least 1 dose of study intervention.|
59686458|NCT04740827|75805900|FG000|Modified Intent-to-Treat (mITT) Population|Double-blind Treatment (Up to Week 12)||154|mITT population consisted of all randomized participants who received at least 1 dose of study intervention, had an evaluable baseline period of eDiary data, and had at least 1 evaluable postbaseline 4-week period (Weeks 1 to 4, 5 to 8, and 9 to 12) of eDiary data during the double-blind treatment period.|
59686459|NCT04740827|75805901|FG001|Modified Intent-to-Treat (mITT) Population|Double-blind Treatment (Up to Week 12)||151|mITT population consisted of all randomized participants who received at least 1 dose of study intervention, had an evaluable baseline period of eDiary data, and had at least 1 evaluable postbaseline 4-week period (Weeks 1 to 4, 5 to 8, and 9 to 12) of eDiary data during the double-blind treatment period.|
59686460|NCT04740827|75805900|FG000|Off-treatment Hypothetical Estimand (OTHE) Population|Double-blind Treatment (Up to Week 12)||155|OTHE population consisted of all randomized participants who received at least 1 dose of study intervention, had an evaluable baseline period of eDiary data, and had at least 1 evaluable postbaseline 4-week period (Weeks 1 to 4, 5 to 8, 9 to 12) of eDiary data, regardless of whether on study intervention or off study intervention.|
59709822|NCT01072149|75828534|FG014|NOT COMPLETED|Washout Period 1 (14 Days)||0||
59709823|NCT01072149|75828535|FG015|NOT COMPLETED|Washout Period 1 (14 Days)||0||
59709824|NCT01072149|75828536|FG016|NOT COMPLETED|Washout Period 1 (14 Days)||0||
59709825|NCT01072149|75828537|FG017|NOT COMPLETED|Washout Period 1 (14 Days)||0||
59686461|NCT04740827|75805901|FG001|Off-treatment Hypothetical Estimand (OTHE) Population|Double-blind Treatment (Up to Week 12)||154|OTHE population consisted of all randomized participants who received at least 1 dose of study intervention, had an evaluable baseline period of eDiary data, and had at least 1 evaluable postbaseline 4-week period (Weeks 1 to 4, 5 to 8, 9 to 12) of eDiary data, regardless of whether on study intervention or off study intervention.|
59686462|NCT04740827|75805900|FG000|COMPLETED|Double-blind Treatment (Up to Week 12)||151||
59686463|NCT04740827|75805901|FG001|COMPLETED|Double-blind Treatment (Up to Week 12)||144||
59686464|NCT04740827|75805900|FG000|NOT COMPLETED|Double-blind Treatment (Up to Week 12)||7||
59686465|NCT04740827|75805901|FG001|NOT COMPLETED|Double-blind Treatment (Up to Week 12)||13||
59686466|NCT04740827|75805900|FG000|STARTED|Follow-up Period (Week 13 to Week 16)||43|Of 295 participants who completed the double-blind period 87 participants entered the follow-up period. Participants who rolled over directly at Week 12 to study 3101-312-002 [NCT04686136] did not enter the safety-follow up period.|
59686467|NCT04740827|75805901|FG001|STARTED|Follow-up Period (Week 13 to Week 16)||44|Of 295 participants who completed the double-blind period 87 participants entered the follow-up period. Participants who rolled over directly at Week 12 to study 3101-312-002 [NCT04686136] did not enter the safety-follow up period.|
59686468|NCT04740827|75805900|FG000|COMPLETED|Follow-up Period (Week 13 to Week 16)||42||
59686469|NCT04740827|75805901|FG001|COMPLETED|Follow-up Period (Week 13 to Week 16)||44||
59686470|NCT04740827|75805900|FG000|NOT COMPLETED|Follow-up Period (Week 13 to Week 16)||1||
59686471|NCT04740827|75805901|FG001|NOT COMPLETED|Follow-up Period (Week 13 to Week 16)||0||
59686472|NCT04725240|75805907|FG000|STARTED|Overall Study||18||
59686473|NCT04725240|75805907|FG000|COMPLETED|Overall Study||16||
59686474|NCT04725240|75805907|FG000|NOT COMPLETED|Overall Study||2||
59686475|NCT04633551|75805913|FG000|STARTED|Overall Study||6||
59686476|NCT04633551|75805914|FG001|STARTED|Overall Study||3||
59686477|NCT04633551|75805913|FG000|COMPLETED|Overall Study||5||
59686478|NCT04633551|75805914|FG001|COMPLETED|Overall Study||3||
59686479|NCT04633551|75805913|FG000|NOT COMPLETED|Overall Study||1||
59686480|NCT04633551|75805914|FG001|NOT COMPLETED|Overall Study||0||
59686481|NCT04620746|75805922|FG000|STARTED|Overall Study||139||
59686482|NCT04620746|75805923|FG001|STARTED|Overall Study||145||
59686483|NCT04620746|75805922|FG000|COMPLETED|Overall Study||136||
59686484|NCT04620746|75805923|FG001|COMPLETED|Overall Study||144||
59686485|NCT04620746|75805922|FG000|NOT COMPLETED|Overall Study||3||
59686486|NCT04620746|75805923|FG001|NOT COMPLETED|Overall Study||1||
59686487|NCT04557787|75805933|FG000|STARTED|Overall Study||3||
59686488|NCT04557787|75805934|FG001|STARTED|Overall Study||2||
59686489|NCT04557787|75805935|FG002|STARTED|Overall Study||3||
59686490|NCT04557787|75805936|FG003|STARTED|Overall Study||2||
59686491|NCT04557787|75805937|FG004|STARTED|Overall Study||3||
59686492|NCT04557787|75805938|FG005|STARTED|Overall Study||2||
59686493|NCT04557787|75805933|FG000|COMPLETED|Overall Study||3||
59686494|NCT04557787|75805934|FG001|COMPLETED|Overall Study||2||
59686495|NCT04557787|75805935|FG002|COMPLETED|Overall Study||3||
59686496|NCT04557787|75805936|FG003|COMPLETED|Overall Study||2||
59686497|NCT04557787|75805937|FG004|COMPLETED|Overall Study||3||
59686498|NCT04557787|75805938|FG005|COMPLETED|Overall Study||2||
59686499|NCT04557787|75805933|FG000|NOT COMPLETED|Overall Study||0||
59686500|NCT04557787|75805934|FG001|NOT COMPLETED|Overall Study||0||
59686501|NCT04557787|75805935|FG002|NOT COMPLETED|Overall Study||0||
59686502|NCT04557787|75805936|FG003|NOT COMPLETED|Overall Study||0||
59686503|NCT04557787|75805937|FG004|NOT COMPLETED|Overall Study||0||
59686504|NCT04557787|75805938|FG005|NOT COMPLETED|Overall Study||0||
59686505|NCT04547998|75805946|FG000|STARTED|Overall Study||25||25
59686506|NCT04547998|75805947|FG001|STARTED|Overall Study||25||25
59686507|NCT04547998|75805946|FG000|COMPLETED|Overall Study||25||25
59686508|NCT04547998|75805947|FG001|COMPLETED|Overall Study||25||25
59686509|NCT04547998|75805946|FG000|NOT COMPLETED|Overall Study||0||0
59686510|NCT04547998|75805947|FG001|NOT COMPLETED|Overall Study||0||0
59686511|NCT04524858|75805954|FG000|STARTED|Overall Study||1||
59686512|NCT04524858|75805954|FG000|COMPLETED|Overall Study||0||
59686513|NCT04524858|75805954|FG000|NOT COMPLETED|Overall Study||1||
59686514|NCT04464265|75805958|FG000|STARTED|Overall Study||32||
59686515|NCT04464265|75805958|FG000|COMPLETED|Overall Study||30||
59686516|NCT04464265|75805958|FG000|NOT COMPLETED|Overall Study||2||
59686517|NCT04406389|75805964|FG000|STARTED|Overall Study||4||
59686518|NCT04406389|75805965|FG001|STARTED|Overall Study||10||
59686519|NCT04406389|75805964|FG000|COMPLETED|Overall Study||4||
59686520|NCT04406389|75805965|FG001|COMPLETED|Overall Study||10||
59686521|NCT04406389|75805964|FG000|NOT COMPLETED|Overall Study||0||
59686522|NCT04406389|75805965|FG001|NOT COMPLETED|Overall Study||0||
59686523|NCT04326231|75805971|FG000|STARTED|Overall Study|Child/Caregiver pair|10|10 subjects represents Child/Caregiver pair|
59686524|NCT04326231|75805971|FG000|COMPLETED|Overall Study|COVID Withdrawn|0|10 subjects represents Child/Caregiver pair|
59686525|NCT04326231|75805971|FG000|NOT COMPLETED|Overall Study||10||
59686526|NCT04275336|75805978|FG000|STARTED|Overall Study||120||
59686527|NCT04275336|75805979|FG001|STARTED|Overall Study||118||
59686528|NCT04275336|75805980|FG002|STARTED|Overall Study||116||
59686529|NCT04275336|75805978|FG000|COMPLETED|Overall Study||103||
59816104|NCT00529958|75938468|FG000|STARTED|2-Year Follow-up||110||
59686530|NCT04275336|75805979|FG001|COMPLETED|Overall Study||96||
59686531|NCT04275336|75805980|FG002|COMPLETED|Overall Study||100||
59686532|NCT04275336|75805978|FG000|NOT COMPLETED|Overall Study||17||
59686533|NCT04275336|75805979|FG001|NOT COMPLETED|Overall Study||22||
59686534|NCT04275336|75805980|FG002|NOT COMPLETED|Overall Study||16||
59686535|NCT04266717|75805993|FG000|STARTED|Overall Study||10||
59686536|NCT04266717|75805994|FG001|STARTED|Overall Study||10||
59686537|NCT04266717|75805993|FG000|COMPLETED|Overall Study||10||
59686538|NCT04266717|75805994|FG001|COMPLETED|Overall Study||10||
59686539|NCT04266717|75805993|FG000|NOT COMPLETED|Overall Study||0||
59686540|NCT04266717|75805994|FG001|NOT COMPLETED|Overall Study||0||
59686541|NCT04251910|75806006|FG000|STARTED|Overall Study||16||
59686542|NCT04251910|75806007|FG001|STARTED|Overall Study||20||
59686543|NCT04251910|75806008|FG002|STARTED|Overall Study||4||
59686544|NCT04251910|75806009|FG003|STARTED|Overall Study||14||
59686545|NCT04251910|75806010|FG004|STARTED|Overall Study||23||
59686546|NCT04251910|75806011|FG005|STARTED|Overall Study||23||
59686547|NCT04251910|75806006|FG000|COMPLETED|Overall Study||16||
59686548|NCT04251910|75806007|FG001|COMPLETED|Overall Study||15||
59686549|NCT04251910|75806008|FG002|COMPLETED|Overall Study||4||
59686550|NCT04251910|75806009|FG003|COMPLETED|Overall Study||10||
59686551|NCT04251910|75806010|FG004|COMPLETED|Overall Study||22||
59686552|NCT04251910|75806011|FG005|COMPLETED|Overall Study||23||
59686553|NCT04251910|75806006|FG000|NOT COMPLETED|Overall Study||0||
59686554|NCT04251910|75806007|FG001|NOT COMPLETED|Overall Study||5||
59686555|NCT04251910|75806008|FG002|NOT COMPLETED|Overall Study||0||
59686556|NCT04251910|75806009|FG003|NOT COMPLETED|Overall Study||4||
59686557|NCT04251910|75806010|FG004|NOT COMPLETED|Overall Study||1||
59686558|NCT04251910|75806011|FG005|NOT COMPLETED|Overall Study||0||
59686559|NCT04248491|75806030|FG000|STARTED|Overall Study||6||
59686560|NCT04248491|75806031|FG001|STARTED|Overall Study||5||
59686561|NCT04248491|75806030|FG000|COMPLETED|Overall Study||5||
59686562|NCT04248491|75806031|FG001|COMPLETED|Overall Study||5||
59686563|NCT04248491|75806030|FG000|NOT COMPLETED|Overall Study||1||
59686564|NCT04248491|75806031|FG001|NOT COMPLETED|Overall Study||0||
59686565|NCT04193293|75806037|FG000|STARTED|Overall Study||0||
59686566|NCT04193293|75806037|FG000|COMPLETED|Overall Study||0||
59686567|NCT04193293|75806037|FG000|NOT COMPLETED|Overall Study||0||
59686568|NCT04126187|75806041|FG000|STARTED|Overall Study||30||
59686569|NCT04126187|75806041|FG000|COMPLETED|Overall Study||30||
59686570|NCT04126187|75806041|FG000|NOT COMPLETED|Overall Study||0||
59686571|NCT04101318|75806045|FG000|STARTED|First Intervention (42 +/- 3 Days)||34||
59686572|NCT04101318|75806046|FG001|STARTED|First Intervention (42 +/- 3 Days)||38||
59686573|NCT04101318|75806045|FG000|Received Allocated Intervention|First Intervention (42 +/- 3 Days)||34||
59686574|NCT04101318|75806046|FG001|Received Allocated Intervention|First Intervention (42 +/- 3 Days)||36||
59686575|NCT04101318|75806045|FG000|COMPLETED|First Intervention (42 +/- 3 Days)||34||
59686576|NCT04101318|75806046|FG001|COMPLETED|First Intervention (42 +/- 3 Days)||36||
59686577|NCT04101318|75806045|FG000|NOT COMPLETED|First Intervention (42 +/- 3 Days)||0||
59686578|NCT04101318|75806046|FG001|NOT COMPLETED|First Intervention (42 +/- 3 Days)||2||
59686579|NCT04101318|75806045|FG000|STARTED|Second Intervention (42 +/- 3 Days)||34||
59686580|NCT04101318|75806046|FG001|STARTED|Second Intervention (42 +/- 3 Days)||36||
59686581|NCT04101318|75806045|FG000|Received Allocated Intervention|Second Intervention (42 +/- 3 Days)||33||
59686582|NCT04101318|75806046|FG001|Received Allocated Intervention|Second Intervention (42 +/- 3 Days)||35||
59686583|NCT04101318|75806045|FG000|COMPLETED|Second Intervention (42 +/- 3 Days)||33||
59686584|NCT04101318|75806046|FG001|COMPLETED|Second Intervention (42 +/- 3 Days)||35||
59686585|NCT04101318|75806045|FG000|NOT COMPLETED|Second Intervention (42 +/- 3 Days)||1||
59686586|NCT04101318|75806046|FG001|NOT COMPLETED|Second Intervention (42 +/- 3 Days)||1||
59686587|NCT04091672|75806054|FG000|STARTED|Overall Study||65||65
59686588|NCT04091672|75806055|FG001|STARTED|Overall Study||65||65
59686589|NCT04091672|75806054|FG000|COMPLETED|Overall Study||47||47
59686590|NCT04091672|75806055|FG001|COMPLETED|Overall Study||47||47
59686591|NCT04091672|75806054|FG000|NOT COMPLETED|Overall Study||18||18
59686592|NCT04091672|75806055|FG001|NOT COMPLETED|Overall Study||18||18
59686593|NCT04054375|75806061|FG000|STARTED|Overall Study||20||
59686594|NCT04054375|75806061|FG000|COMPLETED|Overall Study|Due to COVID-19, some participants were not able to come to our site to complete all outcome measurements. Our study team worked with individuals to make them feel safe and collect as much data as we possibly could. This is the reason why some outcome metrics have less than 20 data points. All 20 patients completed the study and took the medication for all 24 weeks.|20||
59686595|NCT04054375|75806061|FG000|NOT COMPLETED|Overall Study||0||
59686596|NCT04003389|75806071|FG000|STARTED|Overall Study||611||
59686597|NCT04003389|75806072|FG001|STARTED|Overall Study||611||
59686598|NCT04003389|75806073|FG002|STARTED|Overall Study||609||
59686599|NCT04003389|75806071|FG000|Treated|Overall Study||610||
59686600|NCT04003389|75806072|FG001|Treated|Overall Study||611||
59686601|NCT04003389|75806073|FG002|Treated|Overall Study||609||
59686602|NCT04003389|75806071|FG000|COMPLETED|Overall Study||410||
59686603|NCT04003389|75806072|FG001|COMPLETED|Overall Study||451||
59686604|NCT04003389|75806073|FG002|COMPLETED|Overall Study||444||
59686605|NCT04003389|75806071|FG000|NOT COMPLETED|Overall Study||201||
59686606|NCT04003389|75806072|FG001|NOT COMPLETED|Overall Study||160||
59686607|NCT04003389|75806073|FG002|NOT COMPLETED|Overall Study||165||
59686608|NCT03960437|75806081|FG000|STARTED|Overall Study||22||
59686609|NCT03960437|75806081|FG000|COMPLETED|Overall Study||13||
59686610|NCT03960437|75806081|FG000|NOT COMPLETED|Overall Study||9||
59686611|NCT03959488|75806090|FG000|STARTED|Season 1||616||
59686612|NCT03959488|75806091|FG001|STARTED|Season 1||309||
59686613|NCT03959488|75806092|FG002|STARTED|Season 1||0||
59686614|NCT03959488|75806093|FG003|STARTED|Season 1||0||
59686615|NCT03959488|75806094|FG004|STARTED|Season 1||0||
59686616|NCT03959488|75806090|FG000|COMPLETED|Season 1||543||
59686617|NCT03959488|75806091|FG001|COMPLETED|Season 1||263||
59686618|NCT03959488|75806092|FG002|COMPLETED|Season 1||0||
59686619|NCT03959488|75806093|FG003|COMPLETED|Season 1||0||
59686620|NCT03959488|75806094|FG004|COMPLETED|Season 1||0||
59686621|NCT03959488|75806090|FG000|NOT COMPLETED|Season 1||73||
59686622|NCT03959488|75806091|FG001|NOT COMPLETED|Season 1||46||
59686623|NCT03959488|75806092|FG002|NOT COMPLETED|Season 1||0||
59686624|NCT03959488|75806093|FG003|NOT COMPLETED|Season 1||0||
59686625|NCT03959488|75806094|FG004|NOT COMPLETED|Season 1||0||
59686626|NCT03959488|75806090|FG000|STARTED|Season 2||0|Only CHD/CLD subjects who completed Season 1 continued into Season 2 phase of the study|
59686627|NCT03959488|75806091|FG001|STARTED|Season 2||0|Only CHD/CLD subjects who completed Season 1 continued into Season 2 phase of the study|
59686628|NCT03959488|75806092|FG002|STARTED|Season 2||180|Only CHD/CLD subjects who completed Season 1 continued into Season 2 phase of the study|
59686629|NCT03959488|75806093|FG003|STARTED|Season 2||40|Only CHD/CLD subjects who completed Season 1 continued into Season 2 phase of the study|
59686630|NCT03959488|75806094|FG004|STARTED|Season 2||42|Only CHD/CLD subjects who completed Season 1 continued into Season 2 phase of the study|
59686631|NCT03959488|75806090|FG000|COMPLETED|Season 2||0||
59686632|NCT03959488|75806091|FG001|COMPLETED|Season 2||0||
59686633|NCT03959488|75806092|FG002|COMPLETED|Season 2||174||
59686634|NCT03959488|75806093|FG003|COMPLETED|Season 2||39||
59686635|NCT03959488|75806094|FG004|COMPLETED|Season 2||40||
59686636|NCT03959488|75806090|FG000|NOT COMPLETED|Season 2||0||
59686637|NCT03959488|75806091|FG001|NOT COMPLETED|Season 2||0||
59686638|NCT03959488|75806092|FG002|NOT COMPLETED|Season 2||6||
59686639|NCT03959488|75806093|FG003|NOT COMPLETED|Season 2||1||
59686640|NCT03959488|75806094|FG004|NOT COMPLETED|Season 2||2||
59686641|NCT03847194|75806115|FG000|STARTED|Overall Study||85||
59686642|NCT03847194|75806116|FG001|STARTED|Overall Study||87||
59686643|NCT03847194|75806115|FG000|COMPLETED|Overall Study||82||
59686644|NCT03847194|75806116|FG001|COMPLETED|Overall Study||79||
59686645|NCT03847194|75806115|FG000|NOT COMPLETED|Overall Study||3||
59686646|NCT03847194|75806116|FG001|NOT COMPLETED|Overall Study||8||
59686647|NCT03828747|75806124|FG000|STARTED|Double-Blind Treatment Period||135||
59686648|NCT03828747|75806125|FG001|STARTED|Double-Blind Treatment Period||132||
59686649|NCT03828747|75806124|FG000|Cohort 1|Double-Blind Treatment Period||78|Participants who completed the double-blind treatment period (before implementation of Protocol Version 3), or participants who completed the double-blind study drug treatment through Week 45 without any missed doses of study drug (after implementation of Protocol Version 4), were assigned to Cohort 1. In Cohort 1, the double-blind treatment period has a duration of 48 weeks.|
59686650|NCT03828747|75806125|FG001|Cohort 1|Double-Blind Treatment Period||86|Participants who completed the double-blind treatment period (before implementation of Protocol Version 3), or participants who completed the double-blind study drug treatment through Week 45 without any missed doses of study drug (after implementation of Protocol Version 4), were assigned to Cohort 1. In Cohort 1, the double-blind treatment period has a duration of 48 weeks.|
59686651|NCT03828747|75806124|FG000|Cohort 2|Double-Blind Treatment Period||57|Participants who were active in the double-blind treatment period (after implementation of Protocol Version 3) or participants who missed one or more study drug dose (after implementation of Protocol version 4) were assigned to Cohort 2. In Cohort 2, the double-blind treatment period has a duration of 60 weeks.|
59686652|NCT03828747|75806125|FG001|Cohort 2|Double-Blind Treatment Period||46|Participants who were active in the double-blind treatment period (after implementation of Protocol Version 3) or participants who missed one or more study drug dose (after implementation of Protocol version 4) were assigned to Cohort 2. In Cohort 2, the double-blind treatment period has a duration of 60 weeks.|
59686653|NCT03828747|75806124|FG000|COMPLETED|Double-Blind Treatment Period||104||
59686654|NCT03828747|75806125|FG001|COMPLETED|Double-Blind Treatment Period||96||
59686655|NCT03828747|75806124|FG000|NOT COMPLETED|Double-Blind Treatment Period||31||
59686656|NCT03828747|75806125|FG001|NOT COMPLETED|Double-Blind Treatment Period||36||
59686657|NCT03828747|75806124|FG000|STARTED|Open-Label Extension||104||
59686658|NCT03828747|75806125|FG001|STARTED|Open-Label Extension||95||
59686659|NCT03828747|75806124|FG000|COMPLETED|Open-Label Extension||0||
59686660|NCT03828747|75806125|FG001|COMPLETED|Open-Label Extension||0||
59686661|NCT03828747|75806124|FG000|NOT COMPLETED|Open-Label Extension||104||
59686662|NCT03828747|75806125|FG001|NOT COMPLETED|Open-Label Extension||95||
59686663|NCT03825315|75806135|FG000|STARTED|Overall Study||49||
59686664|NCT03825315|75806136|FG001|STARTED|Overall Study||54||
59686665|NCT03825315|75806137|FG002|STARTED|Overall Study||52||
59686666|NCT03825315|75806135|FG000|COMPLETED|Overall Study||42||
59686667|NCT03825315|75806136|FG001|COMPLETED|Overall Study||48||
59686668|NCT03825315|75806137|FG002|COMPLETED|Overall Study||46||
59686669|NCT03825315|75806135|FG000|NOT COMPLETED|Overall Study||7||
59686670|NCT03825315|75806136|FG001|NOT COMPLETED|Overall Study||6||
59686671|NCT03825315|75806137|FG002|NOT COMPLETED|Overall Study||6||
59686672|NCT03821402|75806150|FG000|STARTED|Overall Study||22||
60079322|NCT04440163|76194635|FG005|NOT COMPLETED|Follow-up Phase (Approx. 5 Months)||0||
60079323|NCT04440163|76194636|FG006|NOT COMPLETED|Follow-up Phase (Approx. 5 Months)||2||
59686673|NCT03821402|75806151|FG001|STARTED|Overall Study||19||
59686674|NCT03821402|75806152|FG002|STARTED|Overall Study||18||
59686675|NCT03821402|75806153|FG003|STARTED|Overall Study||24||
59686676|NCT03821402|75806150|FG000|COMPLETED|Overall Study||15||
59686677|NCT03821402|75806151|FG001|COMPLETED|Overall Study||12||
59686678|NCT03821402|75806152|FG002|COMPLETED|Overall Study||15||
59686679|NCT03821402|75806153|FG003|COMPLETED|Overall Study||18||
59686680|NCT03821402|75806150|FG000|NOT COMPLETED|Overall Study||7||
59686681|NCT03821402|75806151|FG001|NOT COMPLETED|Overall Study||7||
59686682|NCT03821402|75806152|FG002|NOT COMPLETED|Overall Study||3||
59686683|NCT03821402|75806153|FG003|NOT COMPLETED|Overall Study||6||
59686684|NCT03816176|75806163|FG000|STARTED|Overall Study||31|31|
59686685|NCT03816176|75806163|FG000|COMPLETED|Overall Study||19||
59686686|NCT03816176|75806163|FG000|NOT COMPLETED|Overall Study||12||
59686687|NCT03752242|75806167|FG000|STARTED|Overall Study||2||
59686688|NCT03752242|75806167|FG000|COMPLETED|Overall Study||2||
59686689|NCT03752242|75806167|FG000|NOT COMPLETED|Overall Study||0||
59686690|NCT03712098|75806175|FG000|STARTED|Overall Study||19||
59686691|NCT03712098|75806176|FG001|STARTED|Overall Study||21||
59686692|NCT03712098|75806175|FG000|COMPLETED|Overall Study||5||
59686693|NCT03712098|75806176|FG001|COMPLETED|Overall Study||9||
59686694|NCT03712098|75806175|FG000|NOT COMPLETED|Overall Study||14||
59686695|NCT03712098|75806176|FG001|NOT COMPLETED|Overall Study||12||
59686696|NCT03704688|75806188|FG000|STARTED|Overall Study||0||
59686697|NCT03704688|75806189|FG001|STARTED|Overall Study||0||
59686698|NCT03704688|75806190|FG002|STARTED|Overall Study||0||
59686699|NCT03704688|75806191|FG003|STARTED|Overall Study||7||
59686700|NCT03704688|75806192|FG004|STARTED|Overall Study||5||
59686701|NCT03704688|75806193|FG005|STARTED|Overall Study||0||
59686702|NCT03704688|75806188|FG000|COMPLETED|Overall Study||0||
59686703|NCT03704688|75806189|FG001|COMPLETED|Overall Study||0||
59686704|NCT03704688|75806190|FG002|COMPLETED|Overall Study||0||
59686705|NCT03704688|75806191|FG003|COMPLETED|Overall Study||0||
59686706|NCT03704688|75806192|FG004|COMPLETED|Overall Study||0||
59686707|NCT03704688|75806193|FG005|COMPLETED|Overall Study||0||
59686708|NCT03704688|75806188|FG000|NOT COMPLETED|Overall Study||0||
59686709|NCT03704688|75806189|FG001|NOT COMPLETED|Overall Study||0||
59686710|NCT03704688|75806190|FG002|NOT COMPLETED|Overall Study||0||
59686711|NCT03704688|75806191|FG003|NOT COMPLETED|Overall Study||7||
59686712|NCT03704688|75806192|FG004|NOT COMPLETED|Overall Study||5||
59686713|NCT03704688|75806193|FG005|NOT COMPLETED|Overall Study||0||
59686714|NCT03683394|75806210|FG000|STARTED|Overall Study||82||
59686715|NCT03683394|75806211|FG001|STARTED|Overall Study||90||
59686716|NCT03683394|75806210|FG000|COMPLETED|Overall Study||68||
59989700|NCT02508194|76105048|FG000|COMPLETED|Overall Study||897||
59686717|NCT03683394|75806211|FG001|COMPLETED|Overall Study||81||
59686718|NCT03683394|75806210|FG000|NOT COMPLETED|Overall Study||14||
59686719|NCT03683394|75806211|FG001|NOT COMPLETED|Overall Study||9||
59686720|NCT03656510|75806223|FG000|STARTED|Overall Study||50||
59686721|NCT03656510|75806224|FG001|STARTED|Overall Study||49||
59686722|NCT03656510|75806225|FG002|STARTED|Overall Study||48||
59686723|NCT03656510|75806226|FG003|STARTED|Overall Study||34||
59686724|NCT03656510|75806227|FG004|STARTED|Overall Study||34||
59686725|NCT03656510|75806228|FG005|STARTED|Overall Study||31||
59686726|NCT03656510|75806223|FG000|COMPLETED|Overall Study||48||
59686727|NCT03656510|75806224|FG001|COMPLETED|Overall Study||48||
59686728|NCT03656510|75806225|FG002|COMPLETED|Overall Study||48||
59686729|NCT03656510|75806226|FG003|COMPLETED|Overall Study||33||
59686730|NCT03656510|75806227|FG004|COMPLETED|Overall Study||34||
59686731|NCT03656510|75806228|FG005|COMPLETED|Overall Study||31||
59686732|NCT03656510|75806223|FG000|NOT COMPLETED|Overall Study||2||
59989701|NCT02508194|76105049|FG001|COMPLETED|Overall Study||907||
59989702|NCT02508194|76105048|FG000|NOT COMPLETED|Overall Study||52||
59989703|NCT02508194|76105049|FG001|NOT COMPLETED|Overall Study||44||
59989704|NCT02508116|76105057|FG000|STARTED|Overall Study||252||
59989705|NCT02508116|76105058|FG001|STARTED|Overall Study||257||
59989706|NCT02508116|76105057|FG000|Received Intervention as Randomized|Overall Study||249||
59686733|NCT03656510|75806224|FG001|NOT COMPLETED|Overall Study||1||
59686734|NCT03656510|75806225|FG002|NOT COMPLETED|Overall Study||0||
59686735|NCT03656510|75806226|FG003|NOT COMPLETED|Overall Study||1||
59686736|NCT03656510|75806227|FG004|NOT COMPLETED|Overall Study||0||
59686737|NCT03656510|75806228|FG005|NOT COMPLETED|Overall Study||0||
59686738|NCT03586583|75806249|FG000|STARTED|Overall Study||600||
59686739|NCT03586583|75806249|FG000|COMPLETED|Overall Study||600||
59686740|NCT03586583|75806249|FG000|NOT COMPLETED|Overall Study||0||
59686741|NCT03539081|75806257|FG000|STARTED|Overall Study||5||
59686742|NCT03539081|75806258|FG001|STARTED|Overall Study||10||
59686743|NCT03539081|75806259|FG002|STARTED|Overall Study||0||
59686744|NCT03539081|75806257|FG000|COMPLETED|Overall Study||2||
59686745|NCT03539081|75806258|FG001|COMPLETED|Overall Study||7||
59686746|NCT03539081|75806259|FG002|COMPLETED|Overall Study||0||
59686747|NCT03539081|75806257|FG000|NOT COMPLETED|Overall Study||3||
59686748|NCT03539081|75806258|FG001|NOT COMPLETED|Overall Study||3||
59686749|NCT03539081|75806259|FG002|NOT COMPLETED|Overall Study||0||
59989707|NCT02508116|76105058|FG001|Received Intervention as Randomized|Overall Study||255||
59686750|NCT03538626|75806278|FG000|STARTED|Overall Study||3||
59686751|NCT03538626|75806279|FG001|STARTED|Overall Study||4||
59686752|NCT03538626|75806280|FG002|STARTED|Overall Study||3||
59686753|NCT03538626|75806281|FG003|STARTED|Overall Study||3||
59686754|NCT03538626|75806282|FG004|STARTED|Overall Study||5||
59686755|NCT03538626|75806283|FG005|STARTED|Overall Study||5||
59686756|NCT03538626|75806284|FG006|STARTED|Overall Study||5||
59686757|NCT03538626|75806285|FG007|STARTED|Overall Study||5||
59686758|NCT03538626|75806278|FG000|Received First Product Administration|Overall Study||3||
59686759|NCT03538626|75806279|FG001|Received First Product Administration|Overall Study|One Group 2 participant withdrew from the study prior to product administration.|3||
59686760|NCT03538626|75806280|FG002|Received First Product Administration|Overall Study||3||
59686761|NCT03538626|75806281|FG003|Received First Product Administration|Overall Study||3||
59686762|NCT03538626|75806282|FG004|Received First Product Administration|Overall Study||5||
59686763|NCT03538626|75806283|FG005|Received First Product Administration|Overall Study||5||
59686764|NCT03538626|75806284|FG006|Received First Product Administration|Overall Study||5||
59686765|NCT03538626|75806285|FG007|Received First Product Administration|Overall Study||5||
59686766|NCT03538626|75806278|FG000|Received All Product Administrations|Overall Study||3||
59686767|NCT03538626|75806279|FG001|Received All Product Administrations|Overall Study||3||
59686768|NCT03538626|75806280|FG002|Received All Product Administrations|Overall Study||3||
59686769|NCT03538626|75806281|FG003|Received All Product Administrations|Overall Study||3||
59686770|NCT03538626|75806282|FG004|Received All Product Administrations|Overall Study||5||
59686771|NCT03538626|75806283|FG005|Received All Product Administrations|Overall Study||5||
59686772|NCT03538626|75806284|FG006|Received All Product Administrations|Overall Study||5||
59686773|NCT03538626|75806285|FG007|Received All Product Administrations|Overall Study||5||
59686774|NCT03538626|75806278|FG000|COMPLETED|Overall Study||3||
59686775|NCT03538626|75806279|FG001|COMPLETED|Overall Study||3||
59686776|NCT03538626|75806280|FG002|COMPLETED|Overall Study||3||
59686777|NCT03538626|75806281|FG003|COMPLETED|Overall Study||3||
59686778|NCT03538626|75806282|FG004|COMPLETED|Overall Study||5||
59686779|NCT03538626|75806283|FG005|COMPLETED|Overall Study||5||
59686780|NCT03538626|75806284|FG006|COMPLETED|Overall Study|One Group 7 participant was lost to follow up after the product administration was completed.|4||
59686781|NCT03538626|75806285|FG007|COMPLETED|Overall Study||5||
59686782|NCT03538626|75806278|FG000|NOT COMPLETED|Overall Study||0||
59686783|NCT03538626|75806279|FG001|NOT COMPLETED|Overall Study||1||
59686784|NCT03538626|75806280|FG002|NOT COMPLETED|Overall Study||0||
59686785|NCT03538626|75806281|FG003|NOT COMPLETED|Overall Study||0||
59686786|NCT03538626|75806282|FG004|NOT COMPLETED|Overall Study||0||
59686787|NCT03538626|75806283|FG005|NOT COMPLETED|Overall Study||0||
59686788|NCT03538626|75806284|FG006|NOT COMPLETED|Overall Study||1||
59686789|NCT03538626|75806285|FG007|NOT COMPLETED|Overall Study||0||
59686790|NCT03518203|75806303|FG000|STARTED|Overall Study||23||
59686791|NCT03518203|75806303|FG000|COMPLETED|Overall Study||21||
59686792|NCT03518203|75806303|FG000|NOT COMPLETED|Overall Study||2||
59686793|NCT03501693|75806307|FG000|STARTED|First Reading Session||75||
59686794|NCT03501693|75806308|FG001|STARTED|First Reading Session||75||
59686795|NCT03501693|75806307|FG000|COMPLETED|First Reading Session||75||
59686796|NCT03501693|75806308|FG001|COMPLETED|First Reading Session||75||
59686797|NCT03501693|75806307|FG000|NOT COMPLETED|First Reading Session||0||
59686798|NCT03501693|75806308|FG001|NOT COMPLETED|First Reading Session||0||
59686799|NCT03501693|75806307|FG000|STARTED|4 Week Memory Washout Period||75||
59686800|NCT03501693|75806308|FG001|STARTED|4 Week Memory Washout Period||75||
59686801|NCT03501693|75806307|FG000|COMPLETED|4 Week Memory Washout Period||75||
59686802|NCT03501693|75806308|FG001|COMPLETED|4 Week Memory Washout Period||75||
59686803|NCT03501693|75806307|FG000|NOT COMPLETED|4 Week Memory Washout Period||0||
59686804|NCT03501693|75806308|FG001|NOT COMPLETED|4 Week Memory Washout Period||0||
59686805|NCT03501693|75806307|FG000|STARTED|Second Reading Session||75||
59686806|NCT03501693|75806308|FG001|STARTED|Second Reading Session||75||
59686807|NCT03501693|75806307|FG000|COMPLETED|Second Reading Session||75||
59686808|NCT03501693|75806308|FG001|COMPLETED|Second Reading Session||75||
59686809|NCT03501693|75806307|FG000|NOT COMPLETED|Second Reading Session||0||
59686810|NCT03501693|75806308|FG001|NOT COMPLETED|Second Reading Session||0||
59686811|NCT03500172|75806317|FG000|STARTED|Period 1: Baseline Randomization||0||
59686812|NCT03500172|75806318|FG001|STARTED|Period 1: Baseline Randomization||0||
59686813|NCT03500172|75806319|FG002|STARTED|Period 1: Baseline Randomization||0||
59686814|NCT03500172|75806320|FG003|STARTED|Period 1: Baseline Randomization||0||
59686815|NCT03500172|75806321|FG004|STARTED|Period 1: Baseline Randomization||0||
59686816|NCT03500172|75806322|FG005|STARTED|Period 1: Baseline Randomization||0||
59686817|NCT03500172|75806323|FG006|STARTED|Period 1: Baseline Randomization||0||
59686818|NCT03500172|75806324|FG007|STARTED|Period 1: Baseline Randomization||0||
59686819|NCT03500172|75806325|FG008|STARTED|Period 1: Baseline Randomization||614||
59686820|NCT03500172|75806326|FG009|STARTED|Period 1: Baseline Randomization||390||
59686821|NCT03500172|75806327|FG010|STARTED|Period 1: Baseline Randomization||387||
59686822|NCT03500172|75806317|FG000|COMPLETED|Period 1: Baseline Randomization||0||
59686823|NCT03500172|75806318|FG001|COMPLETED|Period 1: Baseline Randomization||0||
59817936|NCT04488770|75940336|FG010|COMPLETED|Part 1-Cohort 2: Period 2 (Up to 5 Days)||0||
59686824|NCT03500172|75806319|FG002|COMPLETED|Period 1: Baseline Randomization||0||
59686825|NCT03500172|75806320|FG003|COMPLETED|Period 1: Baseline Randomization||0||
59686826|NCT03500172|75806321|FG004|COMPLETED|Period 1: Baseline Randomization||0||
59686827|NCT03500172|75806322|FG005|COMPLETED|Period 1: Baseline Randomization||0||
59686828|NCT03500172|75806323|FG006|COMPLETED|Period 1: Baseline Randomization||0||
59686829|NCT03500172|75806324|FG007|COMPLETED|Period 1: Baseline Randomization||0||
59686830|NCT03500172|75806325|FG008|COMPLETED|Period 1: Baseline Randomization||614||
59686831|NCT03500172|75806326|FG009|COMPLETED|Period 1: Baseline Randomization||387||
59686832|NCT03500172|75806327|FG010|COMPLETED|Period 1: Baseline Randomization||387||
59686833|NCT03500172|75806317|FG000|NOT COMPLETED|Period 1: Baseline Randomization||0||
59686834|NCT03500172|75806318|FG001|NOT COMPLETED|Period 1: Baseline Randomization||0||
59686835|NCT03500172|75806319|FG002|NOT COMPLETED|Period 1: Baseline Randomization||0||
59686836|NCT03500172|75806320|FG003|NOT COMPLETED|Period 1: Baseline Randomization||0||
59686837|NCT03500172|75806321|FG004|NOT COMPLETED|Period 1: Baseline Randomization||0||
59686838|NCT03500172|75806322|FG005|NOT COMPLETED|Period 1: Baseline Randomization||0||
59686839|NCT03500172|75806323|FG006|NOT COMPLETED|Period 1: Baseline Randomization||0||
59686840|NCT03500172|75806324|FG007|NOT COMPLETED|Period 1: Baseline Randomization||0||
59686841|NCT03500172|75806325|FG008|NOT COMPLETED|Period 1: Baseline Randomization||0||
59686842|NCT03500172|75806326|FG009|NOT COMPLETED|Period 1: Baseline Randomization||3||
59547413|NCT01099358|75646227|FG002|STARTED|Overall Study||21||
59547414|NCT01099358|75646228|FG003|STARTED|Overall Study||16||
59547415|NCT01099358|75646225|FG000|Received at Least One Dose of Study Drug|Overall Study||3||
59547416|NCT01099358|75646226|FG001|Received at Least One Dose of Study Drug|Overall Study||6||
59547417|NCT01099358|75646227|FG002|Received at Least One Dose of Study Drug|Overall Study||20||
59547418|NCT01099358|75646228|FG003|Received at Least One Dose of Study Drug|Overall Study||15||
59547419|NCT01099358|75646225|FG000|COMPLETED|Overall Study||1||
59686843|NCT03500172|75806327|FG010|NOT COMPLETED|Period 1: Baseline Randomization||0||
59686844|NCT03500172|75806317|FG000|STARTED|Period 2: Re-Randomization||27||
59686845|NCT03500172|75806318|FG001|STARTED|Period 2: Re-Randomization||24||
59686846|NCT03500172|75806319|FG002|STARTED|Period 2: Re-Randomization||171||
59686847|NCT03500172|75806320|FG003|STARTED|Period 2: Re-Randomization||165||
59686848|NCT03500172|75806321|FG004|STARTED|Period 2: Re-Randomization||20||
59686849|NCT03500172|75806322|FG005|STARTED|Period 2: Re-Randomization||27||
59686850|NCT03500172|75806323|FG006|STARTED|Period 2: Re-Randomization||177||
59686851|NCT03500172|75806324|FG007|STARTED|Period 2: Re-Randomization||163||
59686852|NCT03500172|75806325|FG008|STARTED|Period 2: Re-Randomization||614||
59686853|NCT03500172|75806326|FG009|STARTED|Period 2: Re-Randomization||0||
59686854|NCT03500172|75806327|FG010|STARTED|Period 2: Re-Randomization||0||
59686855|NCT03500172|75806317|FG000|COMPLETED|Period 2: Re-Randomization||19||
59686856|NCT03500172|75806318|FG001|COMPLETED|Period 2: Re-Randomization||18||
59686857|NCT03500172|75806319|FG002|COMPLETED|Period 2: Re-Randomization||84||
59686858|NCT03500172|75806320|FG003|COMPLETED|Period 2: Re-Randomization||93||
59686859|NCT03500172|75806321|FG004|COMPLETED|Period 2: Re-Randomization||14||
59686860|NCT03500172|75806322|FG005|COMPLETED|Period 2: Re-Randomization||21||
59686861|NCT03500172|75806323|FG006|COMPLETED|Period 2: Re-Randomization||109||
59686862|NCT03500172|75806324|FG007|COMPLETED|Period 2: Re-Randomization||87||
59686863|NCT03500172|75806325|FG008|COMPLETED|Period 2: Re-Randomization||614||
59686864|NCT03500172|75806326|FG009|COMPLETED|Period 2: Re-Randomization||0||
59686865|NCT03500172|75806327|FG010|COMPLETED|Period 2: Re-Randomization||0||
59686866|NCT03500172|75806317|FG000|NOT COMPLETED|Period 2: Re-Randomization||8||
59686867|NCT03500172|75806318|FG001|NOT COMPLETED|Period 2: Re-Randomization||6||
59686868|NCT03500172|75806319|FG002|NOT COMPLETED|Period 2: Re-Randomization||87||
59686869|NCT03500172|75806320|FG003|NOT COMPLETED|Period 2: Re-Randomization||72||
59686870|NCT03500172|75806321|FG004|NOT COMPLETED|Period 2: Re-Randomization||6||
59686871|NCT03500172|75806322|FG005|NOT COMPLETED|Period 2: Re-Randomization||6||
59686872|NCT03500172|75806323|FG006|NOT COMPLETED|Period 2: Re-Randomization||68||
59686873|NCT03500172|75806324|FG007|NOT COMPLETED|Period 2: Re-Randomization||76||
59686874|NCT03500172|75806325|FG008|NOT COMPLETED|Period 2: Re-Randomization||0||
59686875|NCT03500172|75806326|FG009|NOT COMPLETED|Period 2: Re-Randomization||0||
60079324|NCT04440163|76194637|FG007|NOT COMPLETED|Follow-up Phase (Approx. 5 Months)||1||
60079325|NCT04312997|76194657|FG000|STARTED|Overall Study||51||
60079326|NCT04312997|76194658|FG001|STARTED|Overall Study||50||
59686876|NCT03500172|75806327|FG010|NOT COMPLETED|Period 2: Re-Randomization||0||
59686877|NCT03470922|75806345|FG000|STARTED|Overall Study||355||
59686878|NCT03470922|75806346|FG001|STARTED|Overall Study||359||
59686879|NCT03470922|75806345|FG000|COMPLETED|Overall Study||237|Continuing in the study|
59686880|NCT03470922|75806346|FG001|COMPLETED|Overall Study||227|Continuing in the study|
59686881|NCT03470922|75806345|FG000|NOT COMPLETED|Overall Study||118||
59686882|NCT03470922|75806346|FG001|NOT COMPLETED|Overall Study||132||
59686883|NCT03440814|75806354|FG000|STARTED|Overall Study||84||
59686884|NCT03440814|75806355|FG001|STARTED|Overall Study||42||
59686885|NCT03440814|75806354|FG000|Randomized (May or May Not Have Taken Study Drug)|Overall Study||85||
60079327|NCT04312997|76194657|FG000|COMPLETED|Overall Study||45||
59547420|NCT01099358|75646226|FG001|COMPLETED|Overall Study||5||
59686886|NCT03440814|75806355|FG001|Randomized (May or May Not Have Taken Study Drug)|Overall Study||42||
59686887|NCT03440814|75806354|FG000|Intent-to-Treat (ITT) Population|Overall Study||82|Double-Blind Treatment Period: Randomized subjects who took at least one dose of study drug and had at least one post-Baseline HQ-CT value.|
59686888|NCT03440814|75806355|FG001|Intent-to-Treat (ITT) Population|Overall Study||42|Double-Blind Treatment Period: Randomized subjects who took at least one dose of study drug and had at least one post-Baseline HQ-CT value.|
59686889|NCT03440814|75806354|FG000|COMPLETED|Overall Study||79||
59686890|NCT03440814|75806355|FG001|COMPLETED|Overall Study||41||
59686891|NCT03440814|75806354|FG000|NOT COMPLETED|Overall Study||5||
59686892|NCT03440814|75806355|FG001|NOT COMPLETED|Overall Study||1||
59686893|NCT03427814|75806363|FG000|STARTED|Overall Study||71||
59686894|NCT03427814|75806364|FG001|STARTED|Overall Study||65||
59686895|NCT03427814|75806363|FG000|COMPLETED|Overall Study||0||
59686896|NCT03427814|75806364|FG001|COMPLETED|Overall Study||0||
59686897|NCT03427814|75806363|FG000|NOT COMPLETED|Overall Study||71||
59686898|NCT03427814|75806364|FG001|NOT COMPLETED|Overall Study||65||
59686899|NCT03418493|75806381|FG000|STARTED|Overall Study||11||
59686900|NCT03418493|75806382|FG001|STARTED|Overall Study||3||
59686901|NCT03418493|75806383|FG002|STARTED|Overall Study||3||
59686902|NCT03418493|75806384|FG003|STARTED|Overall Study||6||
59686903|NCT03418493|75806385|FG004|STARTED|Overall Study||6||
59686904|NCT03418493|75806386|FG005|STARTED|Overall Study||6||
59686905|NCT03418493|75806387|FG006|STARTED|Overall Study||6||
59686906|NCT03418493|75806388|FG007|STARTED|Overall Study||6||
59686907|NCT03418493|75806389|FG008|STARTED|Overall Study||2||
59686908|NCT03418493|75806390|FG009|STARTED|Overall Study||6||
59686909|NCT03418493|75806391|FG010|STARTED|Overall Study||8||
59686910|NCT03418493|75806381|FG000|COMPLETED|Overall Study||10||
59686911|NCT03418493|75806382|FG001|COMPLETED|Overall Study||3||
59686912|NCT03418493|75806383|FG002|COMPLETED|Overall Study||3||
59686913|NCT03418493|75806384|FG003|COMPLETED|Overall Study||6||
59686914|NCT03418493|75806385|FG004|COMPLETED|Overall Study||6||
59686915|NCT03418493|75806386|FG005|COMPLETED|Overall Study||6||
59686916|NCT03418493|75806387|FG006|COMPLETED|Overall Study||6||
59686917|NCT03418493|75806388|FG007|COMPLETED|Overall Study||6||
59686918|NCT03418493|75806389|FG008|COMPLETED|Overall Study||2||
59686919|NCT03418493|75806390|FG009|COMPLETED|Overall Study||5||
59686920|NCT03418493|75806391|FG010|COMPLETED|Overall Study||8||
59547421|NCT01099358|75646227|FG002|COMPLETED|Overall Study||13||
59547422|NCT01099358|75646228|FG003|COMPLETED|Overall Study||12||
59547423|NCT01099358|75646225|FG000|NOT COMPLETED|Overall Study||3||
59547424|NCT01099358|75646226|FG001|NOT COMPLETED|Overall Study||1||
59547425|NCT01099358|75646227|FG002|NOT COMPLETED|Overall Study||8||
59547426|NCT01099358|75646228|FG003|NOT COMPLETED|Overall Study||4||
60079328|NCT04312997|76194658|FG001|COMPLETED|Overall Study||47||
59547427|NCT01118624|75646239|FG000|STARTED|Overall Study||22||
59547428|NCT01118624|75646239|FG000|COMPLETED|Overall Study||0||
59547429|NCT01118624|75646239|FG000|NOT COMPLETED|Overall Study||22||
59547430|NCT02461563|75646247|FG000|STARTED|Overall Study||3||
59547431|NCT02461563|75646248|FG001|STARTED|Overall Study||3||
59547432|NCT02461563|75646249|FG002|STARTED|Overall Study||3||
59547433|NCT02461563|75646250|FG003|STARTED|Overall Study||3||
59547434|NCT02461563|75646247|FG000|COMPLETED|Overall Study||3||
59547435|NCT02461563|75646248|FG001|COMPLETED|Overall Study||3||
59547436|NCT02461563|75646249|FG002|COMPLETED|Overall Study||3||
59686921|NCT03418493|75806381|FG000|NOT COMPLETED|Overall Study||1||
59686922|NCT03418493|75806382|FG001|NOT COMPLETED|Overall Study||0||
59686923|NCT03418493|75806383|FG002|NOT COMPLETED|Overall Study||0||
59686924|NCT03418493|75806384|FG003|NOT COMPLETED|Overall Study||0||
59686925|NCT03418493|75806385|FG004|NOT COMPLETED|Overall Study||0||
59686926|NCT03418493|75806386|FG005|NOT COMPLETED|Overall Study||0||
59686927|NCT03418493|75806387|FG006|NOT COMPLETED|Overall Study||0||
59686928|NCT03418493|75806388|FG007|NOT COMPLETED|Overall Study||0||
59686929|NCT03418493|75806389|FG008|NOT COMPLETED|Overall Study||0||
59547437|NCT02461563|75646250|FG003|COMPLETED|Overall Study||3||
59686930|NCT03418493|75806390|FG009|NOT COMPLETED|Overall Study||1||
59686931|NCT03418493|75806391|FG010|NOT COMPLETED|Overall Study||0||
59686932|NCT03368664|75806424|FG000|STARTED|Phase1: Prior DMT:Month -4 to Month 0||16||
59686933|NCT03368664|75806424|FG000|COMPLETED|Phase1: Prior DMT:Month -4 to Month 0||12||
59686934|NCT03368664|75806424|FG000|NOT COMPLETED|Phase1: Prior DMT:Month -4 to Month 0||4||
59989708|NCT02508116|76105057|FG000|COMPLETED|Overall Study||244||
59989709|NCT02508116|76105058|FG001|COMPLETED|Overall Study||250||
59989710|NCT02508116|76105057|FG000|NOT COMPLETED|Overall Study||8||
59547438|NCT02461563|75646247|FG000|NOT COMPLETED|Overall Study||0||
59989711|NCT02508116|76105058|FG001|NOT COMPLETED|Overall Study||7||
59989712|NCT01653782|76105067|FG000|STARTED|Overall Study||52||
59547439|NCT02461563|75646248|FG001|NOT COMPLETED|Overall Study||0||
59547440|NCT02461563|75646249|FG002|NOT COMPLETED|Overall Study||0||
59989713|NCT01653782|76105068|FG001|STARTED|Overall Study||55||
59686935|NCT03368664|75806424|FG000|STARTED|Phase2:AlemtuzumabTreatment:Month 0 to 8|Out of 12 participants who had completed Phase 1, one participant did not enter Phase 2.|11||
59686936|NCT03368664|75806424|FG000|Treated|Phase2:AlemtuzumabTreatment:Month 0 to 8||11||
59686937|NCT03368664|75806424|FG000|COMPLETED|Phase2:AlemtuzumabTreatment:Month 0 to 8||11||
59686938|NCT03368664|75806424|FG000|NOT COMPLETED|Phase2:AlemtuzumabTreatment:Month 0 to 8||0||
59686939|NCT03343054|75806435|FG000|STARTED|Dose Escalation Period (Up to 286 Days)||3||
59686940|NCT03343054|75806436|FG001|STARTED|Dose Escalation Period (Up to 286 Days)||6||
59686941|NCT03343054|75806437|FG002|STARTED|Dose Escalation Period (Up to 286 Days)|Dose escalation and Dose expansion were separate populations.|0||
59686942|NCT03343054|75806435|FG000|COMPLETED|Dose Escalation Period (Up to 286 Days)||0||
59686943|NCT03343054|75806436|FG001|COMPLETED|Dose Escalation Period (Up to 286 Days)||0||
59686944|NCT03343054|75806437|FG002|COMPLETED|Dose Escalation Period (Up to 286 Days)||0||
59686945|NCT03343054|75806435|FG000|NOT COMPLETED|Dose Escalation Period (Up to 286 Days)||3||
59686946|NCT03343054|75806436|FG001|NOT COMPLETED|Dose Escalation Period (Up to 286 Days)||6||
59547441|NCT02461563|75646250|FG003|NOT COMPLETED|Overall Study||0||
59547442|NCT02438475|75646268|FG000|STARTED|Overall Study||104||
59547443|NCT02438475|75646269|FG001|STARTED|Overall Study||104||
59547444|NCT02438475|75646268|FG000|COMPLETED|Overall Study||102||
59547445|NCT02438475|75646269|FG001|COMPLETED|Overall Study||104||
59547446|NCT02438475|75646268|FG000|NOT COMPLETED|Overall Study||2||
59547447|NCT02438475|75646269|FG001|NOT COMPLETED|Overall Study||0||
59547448|NCT02439879|75646277|FG000|STARTED|Overall Study||16||
59547449|NCT02439879|75646278|FG001|STARTED|Overall Study||17||
59547450|NCT02439879|75646277|FG000|COMPLETED|Overall Study||16||
59686947|NCT03343054|75806437|FG002|NOT COMPLETED|Dose Escalation Period (Up to 286 Days)||0||
59686948|NCT03343054|75806435|FG000|STARTED|Dose Expansion Period (Up to 502 Days)||0||
59686949|NCT03343054|75806436|FG001|STARTED|Dose Expansion Period (Up to 502 Days)||0||
59686950|NCT03343054|75806437|FG002|STARTED|Dose Expansion Period (Up to 502 Days)|Dose escalation and Dose expansion were separate populations.|19||
59686951|NCT03343054|75806435|FG000|COMPLETED|Dose Expansion Period (Up to 502 Days)||0||
59686952|NCT03343054|75806436|FG001|COMPLETED|Dose Expansion Period (Up to 502 Days)||0||
59686953|NCT03343054|75806437|FG002|COMPLETED|Dose Expansion Period (Up to 502 Days)||0||
59686954|NCT03343054|75806435|FG000|NOT COMPLETED|Dose Expansion Period (Up to 502 Days)||0||
59686955|NCT03343054|75806436|FG001|NOT COMPLETED|Dose Expansion Period (Up to 502 Days)||0||
59686956|NCT03343054|75806437|FG002|NOT COMPLETED|Dose Expansion Period (Up to 502 Days)||19||
59686957|NCT03322358|75806452|FG000|STARTED|Overall Study||77||
59686958|NCT03322358|75806453|FG001|STARTED|Overall Study||75||
59686959|NCT03322358|75806454|FG002|STARTED|Overall Study||75||
59686960|NCT03322358|75806455|FG003|STARTED|Overall Study||74||
59686961|NCT03322358|75806456|FG004|STARTED|Overall Study||75||
59686962|NCT03322358|75806457|FG005|STARTED|Overall Study||76||
59686963|NCT03322358|75806452|FG000|COMPLETED|Overall Study||77||
59686964|NCT03322358|75806453|FG001|COMPLETED|Overall Study||75||
59686965|NCT03322358|75806454|FG002|COMPLETED|Overall Study||75||
59686966|NCT03322358|75806455|FG003|COMPLETED|Overall Study||74||
59686967|NCT03322358|75806456|FG004|COMPLETED|Overall Study||75||
59686968|NCT03322358|75806457|FG005|COMPLETED|Overall Study||76||
59686969|NCT03322358|75806452|FG000|NOT COMPLETED|Overall Study||0||
59686970|NCT03322358|75806453|FG001|NOT COMPLETED|Overall Study||0||
59686971|NCT03322358|75806454|FG002|NOT COMPLETED|Overall Study||0||
59686972|NCT03322358|75806455|FG003|NOT COMPLETED|Overall Study||0||
59686973|NCT03322358|75806456|FG004|NOT COMPLETED|Overall Study||0||
59686974|NCT03322358|75806457|FG005|NOT COMPLETED|Overall Study||0||
59686975|NCT03309878|75806475|FG000|STARTED|Overall Study||4||
59686976|NCT03309878|75806476|FG001|STARTED|Overall Study||4||
59686977|NCT03309878|75806477|FG002|STARTED|Overall Study||0||
59686978|NCT03309878|75806478|FG003|STARTED|Overall Study||0||
59686979|NCT03309878|75806475|FG000|COMPLETED|Overall Study||1||
59686980|NCT03309878|75806476|FG001|COMPLETED|Overall Study||2||
59686981|NCT03309878|75806477|FG002|COMPLETED|Overall Study||0||
59686982|NCT03309878|75806478|FG003|COMPLETED|Overall Study||0||
59686983|NCT03309878|75806475|FG000|NOT COMPLETED|Overall Study||3||
59686984|NCT03309878|75806476|FG001|NOT COMPLETED|Overall Study||2||
59686985|NCT03309878|75806477|FG002|NOT COMPLETED|Overall Study||0||
59686986|NCT03309878|75806478|FG003|NOT COMPLETED|Overall Study||0||
59686987|NCT03226691|75806488|FG000|STARTED|Overall Study||15||
59686988|NCT03226691|75806488|FG000|COMPLETED|Overall Study||15||
59686989|NCT03226691|75806488|FG000|NOT COMPLETED|Overall Study||0||
59686990|NCT03202628|75806492|FG000|STARTED|Overall Study||8||
59686991|NCT03202628|75806492|FG000|COMPLETED|Overall Study||8||
59686992|NCT03202628|75806492|FG000|NOT COMPLETED|Overall Study||0||
59686993|NCT03200704|75806496|FG000|STARTED|Overall Study||152||
59686994|NCT03200704|75806496|FG000|COMPLETED|Overall Study||151||
59686995|NCT03200704|75806496|FG000|NOT COMPLETED|Overall Study||1||
59686996|NCT03176472|75806502|FG000|STARTED|Double Blind Treatment Period||142||
59686997|NCT03176472|75806503|FG001|STARTED|Double Blind Treatment Period||140||
59686998|NCT03176472|75806502|FG000|COMPLETED|Double Blind Treatment Period||132||
59686999|NCT03176472|75806503|FG001|COMPLETED|Double Blind Treatment Period||124||
59547451|NCT02439879|75646278|FG001|COMPLETED|Overall Study||17||
59547452|NCT02439879|75646277|FG000|NOT COMPLETED|Overall Study||0||
59687000|NCT03176472|75806502|FG000|NOT COMPLETED|Double Blind Treatment Period||10||
59687001|NCT03176472|75806503|FG001|NOT COMPLETED|Double Blind Treatment Period||16||
59687002|NCT03176472|75806502|FG000|STARTED|Open Label Extension||131||
59687003|NCT03176472|75806503|FG001|STARTED|Open Label Extension||121||
59687004|NCT03176472|75806502|FG000|COMPLETED|Open Label Extension||123||
59687005|NCT03176472|75806503|FG001|COMPLETED|Open Label Extension||109||
59687006|NCT03176472|75806502|FG000|NOT COMPLETED|Open Label Extension||8||
59687007|NCT03176472|75806503|FG001|NOT COMPLETED|Open Label Extension||12||
59687008|NCT03067571|75806510|FG000|STARTED|Overall Study||7||
59687009|NCT03067571|75806510|FG000|COMPLETED|Overall Study||7||
59687010|NCT03067571|75806510|FG000|NOT COMPLETED|Overall Study||0||
59687011|NCT03060096|75806517|FG000|STARTED|Overall Study||19||
59687012|NCT03060096|75806518|FG001|STARTED|Overall Study||15||
59687013|NCT03060096|75806519|FG002|STARTED|Overall Study||34||
59687014|NCT03060096|75806517|FG000|COMPLETED|Overall Study||16||
59687015|NCT03060096|75806518|FG001|COMPLETED|Overall Study||12||
59687016|NCT03060096|75806519|FG002|COMPLETED|Overall Study||32||
59687017|NCT03060096|75806517|FG000|NOT COMPLETED|Overall Study||3||
59687018|NCT03060096|75806518|FG001|NOT COMPLETED|Overall Study||3||
59687019|NCT03060096|75806519|FG002|NOT COMPLETED|Overall Study||2||
59687020|NCT05764785|75806532|FG000|STARTED|Overall Study||25||
59687021|NCT05764785|75806533|FG001|STARTED|Overall Study||38||
59687022|NCT05764785|75806532|FG000|COMPLETED|Overall Study||23||
59687023|NCT05764785|75806533|FG001|COMPLETED|Overall Study||30||
59687024|NCT05764785|75806532|FG000|NOT COMPLETED|Overall Study||2||
59687025|NCT05764785|75806533|FG001|NOT COMPLETED|Overall Study||8||
59687026|NCT05130047|75806541|FG000|STARTED|Overall Study||15||
59687027|NCT05130047|75806542|FG001|STARTED|Overall Study||15||
59687028|NCT05130047|75806541|FG000|COMPLETED|Overall Study||15||
59687029|NCT05130047|75806542|FG001|COMPLETED|Overall Study||15||
59687030|NCT05130047|75806541|FG000|NOT COMPLETED|Overall Study||0||
59687031|NCT05130047|75806542|FG001|NOT COMPLETED|Overall Study||0||
59687032|NCT04910139|75806548|FG000|STARTED|Overall Study||50||
59687033|NCT04910139|75806548|FG000|COMPLETED|Overall Study||50||
59687034|NCT04910139|75806548|FG000|NOT COMPLETED|Overall Study||0||
59687035|NCT04876599|75806554|FG000|STARTED|Overall Study||32||
59687036|NCT04876599|75806555|FG001|STARTED|Overall Study||32||
59687037|NCT04876599|75806554|FG000|Follow up Survey #1|Overall Study||31||
59687038|NCT04876599|75806555|FG001|Follow up Survey #1|Overall Study||31||
59687039|NCT04876599|75806554|FG000|Exit Interview|Overall Study||29||
59687040|NCT04876599|75806555|FG001|Exit Interview|Overall Study||30||
59687041|NCT04876599|75806554|FG000|Follow up Survey #2|Overall Study||29||
59687042|NCT04876599|75806555|FG001|Follow up Survey #2|Overall Study||29||
59687043|NCT04876599|75806554|FG000|COMPLETED|Overall Study|Within the IN FOCUS arm, one participant missed the deadline to complete the T1 survey, two participants declined the exit interview and T2 survey (time constraints), and an additional participant missed the exit interview and T2 survey.|28||
59687044|NCT04876599|75806555|FG001|COMPLETED|Overall Study|Within the Usual Care Control arm, one participant declined study participation (dissatisfaction with randomization), one participant declined the exit interview and T2 survey (time constraints), and one participant declined the T2 survey.|29||
59687045|NCT04876599|75806554|FG000|NOT COMPLETED|Overall Study||4||
59687046|NCT04876599|75806555|FG001|NOT COMPLETED|Overall Study||3||
59687047|NCT04730947|75806564|FG000|STARTED|Overall Study||21||
59687048|NCT04730947|75806565|FG001|STARTED|Overall Study||17||
60079329|NCT04312997|76194657|FG000|NOT COMPLETED|Overall Study||6||
60079330|NCT04312997|76194658|FG001|NOT COMPLETED|Overall Study||3||
59547453|NCT02439879|75646278|FG001|NOT COMPLETED|Overall Study||0||
59687049|NCT04730947|75806564|FG000|COMPLETED|Overall Study||21||
59687050|NCT04730947|75806565|FG001|COMPLETED|Overall Study||16||
59687051|NCT04730947|75806564|FG000|NOT COMPLETED|Overall Study||0||
59687052|NCT04730947|75806565|FG001|NOT COMPLETED|Overall Study||1||
59687053|NCT04660799|75806573|FG000|STARTED|Overall Study||24||
59687054|NCT04660799|75806574|FG001|STARTED|Overall Study||26||
59687055|NCT04660799|75806573|FG000|COMPLETED|Overall Study||17||
59687056|NCT04660799|75806574|FG001|COMPLETED|Overall Study||18||
59687057|NCT04660799|75806573|FG000|NOT COMPLETED|Overall Study||7||
59687058|NCT04660799|75806574|FG001|NOT COMPLETED|Overall Study||8||
59687059|NCT04625517|75806581|FG000|STARTED|Overall Study||6||
59687060|NCT04625517|75806581|FG000|COMPLETED|Overall Study||3||
59687061|NCT04625517|75806581|FG000|NOT COMPLETED|Overall Study||3||
60079331|NCT04304508|76194668|FG000|STARTED|Overall Study||455|Full analysis set (FAS)|
60079332|NCT04304508|76194669|FG001|STARTED|Overall Study||450|Full analysis set (FAS)|
59687062|NCT04598321|75806585|FG000|STARTED|Overall Study||1||
59687063|NCT04598321|75806585|FG000|COMPLETED|Overall Study||1||
59687064|NCT04598321|75806585|FG000|NOT COMPLETED|Overall Study||0||
59687065|NCT04553471|75806589|FG000|STARTED|Overall Study||70||
59687066|NCT04553471|75806589|FG000|COMPLETED|Overall Study||66||
59687067|NCT04553471|75806589|FG000|NOT COMPLETED|Overall Study||4||
59687068|NCT04484831|75806595|FG000|STARTED|Overall Study||20||
59687069|NCT04484831|75806596|FG001|STARTED|Overall Study||20||
59687070|NCT04484831|75806595|FG000|COMPLETED|Overall Study||19||
59687071|NCT04484831|75806596|FG001|COMPLETED|Overall Study||20||
59687072|NCT04484831|75806595|FG000|NOT COMPLETED|Overall Study||1||
59687073|NCT04484831|75806596|FG001|NOT COMPLETED|Overall Study||0||
59687074|NCT04415281|75806604|FG000|STARTED|Overall Study||7||
59687075|NCT04415281|75806605|FG001|STARTED|Overall Study||6||
59687076|NCT04415281|75806604|FG000|COMPLETED|Overall Study||7||
59687077|NCT04415281|75806605|FG001|COMPLETED|Overall Study||6||
59687078|NCT04415281|75806604|FG000|NOT COMPLETED|Overall Study||0||
59687079|NCT04415281|75806605|FG001|NOT COMPLETED|Overall Study||0||
59687080|NCT04247100|75806613|FG000|STARTED|Overall Study||5||
59687081|NCT04247100|75806614|FG001|STARTED|Overall Study||5||
59687082|NCT04247100|75806613|FG000|COMPLETED|Overall Study||4||
59687083|NCT04247100|75806614|FG001|COMPLETED|Overall Study||4||
59687084|NCT04247100|75806613|FG000|NOT COMPLETED|Overall Study||1||
59687085|NCT04247100|75806614|FG001|NOT COMPLETED|Overall Study||1||
59687086|NCT04116112|75806624|FG000|STARTED|Overall Study||40||
59687087|NCT04116112|75806625|FG001|STARTED|Overall Study||40||
59687088|NCT04116112|75806626|FG002|STARTED|Overall Study||40||
59687089|NCT04116112|75806624|FG000|COMPLETED|Overall Study||39||
59687090|NCT04116112|75806625|FG001|COMPLETED|Overall Study||36||
59687091|NCT04116112|75806626|FG002|COMPLETED|Overall Study||38||
59687092|NCT04116112|75806624|FG000|NOT COMPLETED|Overall Study||1||
59687093|NCT04116112|75806625|FG001|NOT COMPLETED|Overall Study||4||
59687094|NCT04116112|75806626|FG002|NOT COMPLETED|Overall Study||2||
59687095|NCT04063787|75806634|FG000|STARTED|Overall Study||46||
59687096|NCT04063787|75806634|FG000|COMPLETED|Overall Study||37||
59687097|NCT04063787|75806634|FG000|NOT COMPLETED|Overall Study||9||
59687098|NCT04040400|75806638|FG000|STARTED|Cohort 1||5||
59687099|NCT04040400|75806639|FG001|STARTED|Cohort 1||0||
59687100|NCT04040400|75806640|FG002|STARTED|Cohort 1||0||
59687101|NCT04040400|75806638|FG000|COMPLETED|Cohort 1||5||
59687102|NCT04040400|75806639|FG001|COMPLETED|Cohort 1||0||
59687103|NCT04040400|75806640|FG002|COMPLETED|Cohort 1||0||
59687104|NCT04040400|75806638|FG000|NOT COMPLETED|Cohort 1||0||
59687105|NCT04040400|75806639|FG001|NOT COMPLETED|Cohort 1||0||
59687106|NCT04040400|75806640|FG002|NOT COMPLETED|Cohort 1||0||
59687107|NCT04040400|75806638|FG000|STARTED|Cohort 1:||5||
59687108|NCT04040400|75806639|FG001|STARTED|Cohort 1:||0||
59687109|NCT04040400|75806640|FG002|STARTED|Cohort 1:||0||
59687110|NCT04040400|75806638|FG000|COMPLETED|Cohort 1:||4|1 participant died of respiratory failure unrelated to treatment.|
59687111|NCT04040400|75806639|FG001|COMPLETED|Cohort 1:||0|1 participant died of respiratory failure unrelated to treatment.|
59687112|NCT04040400|75806640|FG002|COMPLETED|Cohort 1:||0|1 participant died of respiratory failure unrelated to treatment.|
59687113|NCT04040400|75806638|FG000|NOT COMPLETED|Cohort 1:||1||
59687114|NCT04040400|75806639|FG001|NOT COMPLETED|Cohort 1:||0||
59687115|NCT04040400|75806640|FG002|NOT COMPLETED|Cohort 1:||0||
59687116|NCT03995316|75806648|FG000|STARTED|Overall Study||96||
59687117|NCT03995316|75806649|FG001|STARTED|Overall Study||95||
59687118|NCT03995316|75806648|FG000|COMPLETED|Overall Study||86||
59687119|NCT03995316|75806649|FG001|COMPLETED|Overall Study||92||
59687120|NCT03995316|75806648|FG000|NOT COMPLETED|Overall Study||10||
59687121|NCT03995316|75806649|FG001|NOT COMPLETED|Overall Study||3||
59687122|NCT03927690|75806658|FG000|STARTED|Overall Study||28||
59687123|NCT03927690|75806659|FG001|STARTED|Overall Study||30||
59687124|NCT03927690|75806660|FG002|STARTED|Overall Study||33||
59687125|NCT03927690|75806658|FG000|COMPLETED|Overall Study||21||
59687126|NCT03927690|75806659|FG001|COMPLETED|Overall Study||27||
59687127|NCT03927690|75806660|FG002|COMPLETED|Overall Study||31||
59989714|NCT01653782|76105069|FG002|STARTED|Overall Study||52||
59989715|NCT01653782|76105067|FG000|COMPLETED|Overall Study||36||
59989716|NCT01653782|76105068|FG001|COMPLETED|Overall Study||37||
59989717|NCT01653782|76105069|FG002|COMPLETED|Overall Study||46||
59989718|NCT01653782|76105067|FG000|NOT COMPLETED|Overall Study||16||
59989719|NCT01653782|76105068|FG001|NOT COMPLETED|Overall Study||18||
59687128|NCT03927690|75806658|FG000|NOT COMPLETED|Overall Study||7||
59687129|NCT03927690|75806659|FG001|NOT COMPLETED|Overall Study||3||
59687130|NCT03927690|75806660|FG002|NOT COMPLETED|Overall Study||2||
59687131|NCT03793842|75806672|FG000|STARTED|Randomization-Intervention 1 (~6 Hrs)||8|Randomized|
59687132|NCT03793842|75806673|FG001|STARTED|Randomization-Intervention 1 (~6 Hrs)||8|Randomized|
59687133|NCT03793842|75806672|FG000|Intervention 1 Started|Randomization-Intervention 1 (~6 Hrs)||6||
59687134|NCT03793842|75806673|FG001|Intervention 1 Started|Randomization-Intervention 1 (~6 Hrs)||6||
59687135|NCT03793842|75806672|FG000|COMPLETED|Randomization-Intervention 1 (~6 Hrs)||6||
59687136|NCT03793842|75806673|FG001|COMPLETED|Randomization-Intervention 1 (~6 Hrs)||6||
59687137|NCT03793842|75806672|FG000|NOT COMPLETED|Randomization-Intervention 1 (~6 Hrs)||2||
59687138|NCT03793842|75806673|FG001|NOT COMPLETED|Randomization-Intervention 1 (~6 Hrs)||2||
59687139|NCT03793842|75806672|FG000|STARTED|Intervention 2 (14-18 Hours)||6||
59687140|NCT03793842|75806673|FG001|STARTED|Intervention 2 (14-18 Hours)||6||
59687141|NCT03793842|75806672|FG000|COMPLETED|Intervention 2 (14-18 Hours)||6||
59687142|NCT03793842|75806673|FG001|COMPLETED|Intervention 2 (14-18 Hours)||6||
59989720|NCT01653782|76105069|FG002|NOT COMPLETED|Overall Study||6||
59989721|NCT02318329|76105087|FG000|STARTED|Overall Study||3||
59989722|NCT02318329|76105088|FG001|STARTED|Overall Study||4||
59989723|NCT02318329|76105089|FG002|STARTED|Overall Study||3||
59989724|NCT02318329|76105090|FG003|STARTED|Overall Study||3||
59989725|NCT02318329|76105091|FG004|STARTED|Overall Study||3||
59687143|NCT03793842|75806672|FG000|NOT COMPLETED|Intervention 2 (14-18 Hours)||0||
59687144|NCT03793842|75806673|FG001|NOT COMPLETED|Intervention 2 (14-18 Hours)||0||
59687145|NCT03597100|75806679|FG000|STARTED|Overall Study||263||
59687146|NCT03597100|75806679|FG000|COMPLETED|Overall Study||205||
59687147|NCT03597100|75806679|FG000|NOT COMPLETED|Overall Study||58||
59687148|NCT03555695|75806683|FG000|STARTED|Overall Study||19||
59687149|NCT03555695|75806683|FG000|COMPLETED|Overall Study||15||
59687150|NCT03555695|75806683|FG000|NOT COMPLETED|Overall Study||4||
59687151|NCT03538691|75806687|FG000|STARTED|Phase A: Acute Treatment (up to 8 Weeks)||1149||
59687152|NCT03538691|75806688|FG001|STARTED|Phase A: Acute Treatment (up to 8 Weeks)||0||
59687153|NCT03538691|75806689|FG002|STARTED|Phase A: Acute Treatment (up to 8 Weeks)||0||
59687154|NCT03538691|75806690|FG003|STARTED|Phase A: Acute Treatment (up to 8 Weeks)||0||
59687155|NCT03538691|75806687|FG000|Phase A Safety Sample|Phase A: Acute Treatment (up to 8 Weeks)||1136|The Phase A Safety Sample included all participants who received at least 1 dose of brexpiprazole in Phase A.|
59687156|NCT03538691|75806688|FG001|Phase A Safety Sample|Phase A: Acute Treatment (up to 8 Weeks)||0|The Phase A Safety Sample included all participants who received at least 1 dose of brexpiprazole in Phase A.|
59687157|NCT03538691|75806689|FG002|Phase A Safety Sample|Phase A: Acute Treatment (up to 8 Weeks)||0|The Phase A Safety Sample included all participants who received at least 1 dose of brexpiprazole in Phase A.|
59687158|NCT03538691|75806690|FG003|Phase A Safety Sample|Phase A: Acute Treatment (up to 8 Weeks)||0|The Phase A Safety Sample included all participants who received at least 1 dose of brexpiprazole in Phase A.|
59687159|NCT03538691|75806687|FG000|COMPLETED|Phase A: Acute Treatment (up to 8 Weeks)||766||
59687160|NCT03538691|75806688|FG001|COMPLETED|Phase A: Acute Treatment (up to 8 Weeks)||0||
59687161|NCT03538691|75806689|FG002|COMPLETED|Phase A: Acute Treatment (up to 8 Weeks)||0||
59687162|NCT03538691|75806690|FG003|COMPLETED|Phase A: Acute Treatment (up to 8 Weeks)||0||
59687163|NCT03538691|75806687|FG000|NOT COMPLETED|Phase A: Acute Treatment (up to 8 Weeks)||383||
59687164|NCT03538691|75806688|FG001|NOT COMPLETED|Phase A: Acute Treatment (up to 8 Weeks)||0||
59687165|NCT03538691|75806689|FG002|NOT COMPLETED|Phase A: Acute Treatment (up to 8 Weeks)||0||
59687166|NCT03538691|75806690|FG003|NOT COMPLETED|Phase A: Acute Treatment (up to 8 Weeks)||0||
59687167|NCT03538691|75806687|FG000|STARTED|Phase B: Stabilization (12 Weeks)||0||
59687168|NCT03538691|75806688|FG001|STARTED|Phase B: Stabilization (12 Weeks)||766||
59687169|NCT03538691|75806689|FG002|STARTED|Phase B: Stabilization (12 Weeks)||0||
59687170|NCT03538691|75806690|FG003|STARTED|Phase B: Stabilization (12 Weeks)||0||
59687171|NCT03538691|75806687|FG000|Phase B Safety Sample|Phase B: Stabilization (12 Weeks)||0|The Phase B Safety Sample included all participants who received at least 1 dose of brexpiprazole in Phase B.|
59687172|NCT03538691|75806688|FG001|Phase B Safety Sample|Phase B: Stabilization (12 Weeks)||765|The Phase B Safety Sample included all participants who received at least 1 dose of brexpiprazole in Phase B.|
59687173|NCT03538691|75806689|FG002|Phase B Safety Sample|Phase B: Stabilization (12 Weeks)||0|The Phase B Safety Sample included all participants who received at least 1 dose of brexpiprazole in Phase B.|
59687174|NCT03538691|75806690|FG003|Phase B Safety Sample|Phase B: Stabilization (12 Weeks)||0|The Phase B Safety Sample included all participants who received at least 1 dose of brexpiprazole in Phase B.|
59687175|NCT03538691|75806687|FG000|COMPLETED|Phase B: Stabilization (12 Weeks)||0||
59687176|NCT03538691|75806688|FG001|COMPLETED|Phase B: Stabilization (12 Weeks)||489||
59687177|NCT03538691|75806689|FG002|COMPLETED|Phase B: Stabilization (12 Weeks)||0||
59687178|NCT03538691|75806690|FG003|COMPLETED|Phase B: Stabilization (12 Weeks)||0||
59687179|NCT03538691|75806687|FG000|NOT COMPLETED|Phase B: Stabilization (12 Weeks)||0||
59687180|NCT03538691|75806688|FG001|NOT COMPLETED|Phase B: Stabilization (12 Weeks)||277||
59687181|NCT03538691|75806689|FG002|NOT COMPLETED|Phase B: Stabilization (12 Weeks)||0||
59687182|NCT03538691|75806690|FG003|NOT COMPLETED|Phase B: Stabilization (12 Weeks)||0||
59687183|NCT03538691|75806687|FG000|STARTED|Phase C:Randomized Withdrawal (26 Weeks)||0||
59687184|NCT03538691|75806688|FG001|STARTED|Phase C:Randomized Withdrawal (26 Weeks)||0||
59687185|NCT03538691|75806689|FG002|STARTED|Phase C:Randomized Withdrawal (26 Weeks)||240||
59687186|NCT03538691|75806690|FG003|STARTED|Phase C:Randomized Withdrawal (26 Weeks)||249||
59687187|NCT03538691|75806687|FG000|Phase C Safety Sample|Phase C:Randomized Withdrawal (26 Weeks)||0|The Phase C Safety Sample included all participants who were randomized to double-blind treatment and received at least 1 dose of double-blind trial medication in Phase C.|
59687188|NCT03538691|75806688|FG001|Phase C Safety Sample|Phase C:Randomized Withdrawal (26 Weeks)||0|The Phase C Safety Sample included all participants who were randomized to double-blind treatment and received at least 1 dose of double-blind trial medication in Phase C.|
59687189|NCT03538691|75806689|FG002|Phase C Safety Sample|Phase C:Randomized Withdrawal (26 Weeks)||240|The Phase C Safety Sample included all participants who were randomized to double-blind treatment and received at least 1 dose of double-blind trial medication in Phase C.|
59687190|NCT03538691|75806690|FG003|Phase C Safety Sample|Phase C:Randomized Withdrawal (26 Weeks)||248|The Phase C Safety Sample included all participants who were randomized to double-blind treatment and received at least 1 dose of double-blind trial medication in Phase C.|
59687191|NCT03538691|75806687|FG000|COMPLETED|Phase C:Randomized Withdrawal (26 Weeks)||0||
59687192|NCT03538691|75806688|FG001|COMPLETED|Phase C:Randomized Withdrawal (26 Weeks)||0||
59687193|NCT03538691|75806689|FG002|COMPLETED|Phase C:Randomized Withdrawal (26 Weeks)||120||
59687194|NCT03538691|75806690|FG003|COMPLETED|Phase C:Randomized Withdrawal (26 Weeks)||131||
59687195|NCT03538691|75806687|FG000|NOT COMPLETED|Phase C:Randomized Withdrawal (26 Weeks)||0||
59687196|NCT03538691|75806688|FG001|NOT COMPLETED|Phase C:Randomized Withdrawal (26 Weeks)||0||
59687197|NCT03538691|75806689|FG002|NOT COMPLETED|Phase C:Randomized Withdrawal (26 Weeks)||120||
59687198|NCT03538691|75806690|FG003|NOT COMPLETED|Phase C:Randomized Withdrawal (26 Weeks)||118||
59687199|NCT03511664|75806700|FG000|STARTED|Overall Study||551|All randomized patients were included in the Full Analysis Set (FAS). Patients were included in the treatment arm to which they were randomized regardless of actual treatment received.|
59687200|NCT03511664|75806701|FG001|STARTED|Overall Study||280|All randomized patients were included in the Full Analysis Set (FAS). Patients were included in the treatment arm to which they were randomized regardless of actual treatment received.|
59687201|NCT03511664|75806700|FG000|FAS Safety Analysis Set|Overall Study||529||
59687202|NCT03511664|75806701|FG001|FAS Safety Analysis Set|Overall Study||205||
59687203|NCT03511664|75806700|FG000|Progression-Free Survival (PFS) Full Analysis Set (PFS-FAS)|Overall Study||385||
59687204|NCT03511664|75806701|FG001|Progression-Free Survival (PFS) Full Analysis Set (PFS-FAS)|Overall Study||196||
59687205|NCT03511664|75806700|FG000|Response Evaluable Analysis Set|Overall Study||319||
59687206|NCT03511664|75806701|FG001|Response Evaluable Analysis Set|Overall Study||120||
59687207|NCT03511664|75806700|FG000|COMPLETED|Overall Study||329||
59687208|NCT03511664|75806701|FG001|COMPLETED|Overall Study||167||
59687209|NCT03511664|75806700|FG000|NOT COMPLETED|Overall Study||222||
59687210|NCT03511664|75806701|FG001|NOT COMPLETED|Overall Study||113||
59687211|NCT03490760|75806707|FG000|STARTED|Overall Study||9||
59687212|NCT03490760|75806707|FG000|COMPLETED|Overall Study||7||
59687213|NCT03490760|75806707|FG000|NOT COMPLETED|Overall Study||2||
59687214|NCT03180398|75806711|FG000|STARTED|Overall Study||9||
59687215|NCT03180398|75806711|FG000|COMPLETED|Overall Study|Study closed due to lack of accrual.|9||
59687216|NCT03180398|75806711|FG000|NOT COMPLETED|Overall Study||0||
59687217|NCT03120949|75806718|FG000|STARTED|Overall Study|One subject was randomized in error and did not receive any dose of study drug.|1058||
59687218|NCT03120949|75806719|FG001|STARTED|Overall Study||1047||
59687219|NCT03120949|75806718|FG000|mITT|Overall Study||1057||
59687220|NCT03120949|75806719|FG001|mITT|Overall Study||1047||
59687221|NCT03120949|75806718|FG000|Safety Population|Overall Study|Subjects in the safety population were analyzed according to the treatment they actually received during the OLE study. (14 patients had been assigned to q4w group but actually received the treatment according to the q2w group).|1043||
59687222|NCT03120949|75806719|FG001|Safety Population|Overall Study|Subjects in the safety population were analyzed according to the treatment they actually received during the OLE study. (14 patients had been assigned to q4w group but actually received the treatment according to the q2w group).|1061||
59687223|NCT03120949|75806718|FG000|COMPLETED|Overall Study||830||
59687224|NCT03120949|75806719|FG001|COMPLETED|Overall Study||844||
59687225|NCT03120949|75806718|FG000|NOT COMPLETED|Overall Study||228||
59687226|NCT03120949|75806719|FG001|NOT COMPLETED|Overall Study||203||
59687227|NCT03104855|75806731|FG000|STARTED|Overall Study||5||
59687228|NCT03104855|75806732|FG001|STARTED|Overall Study||5||
59687229|NCT03104855|75806731|FG000|COMPLETED|Overall Study||5||
59687230|NCT03104855|75806732|FG001|COMPLETED|Overall Study||5||
59687231|NCT03104855|75806731|FG000|NOT COMPLETED|Overall Study||0||
59687232|NCT03104855|75806732|FG001|NOT COMPLETED|Overall Study||0||
59687233|NCT02921256|75806742|FG000|STARTED|Arm 1a v. Arm II||88||
59687234|NCT02921256|75806743|FG001|STARTED|Arm 1a v. Arm II||90||
59687235|NCT02921256|75806744|FG002|STARTED|Arm 1a v. Arm II||0||
59687236|NCT02921256|75806742|FG000|COMPLETED|Arm 1a v. Arm II||72||
59687237|NCT02921256|75806743|FG001|COMPLETED|Arm 1a v. Arm II||57||
59687238|NCT02921256|75806744|FG002|COMPLETED|Arm 1a v. Arm II||0||
59687239|NCT02921256|75806742|FG000|NOT COMPLETED|Arm 1a v. Arm II||16||
59687240|NCT02921256|75806743|FG001|NOT COMPLETED|Arm 1a v. Arm II||33||
59687241|NCT02921256|75806744|FG002|NOT COMPLETED|Arm 1a v. Arm II||0||
59687242|NCT02921256|75806742|FG000|STARTED|Arm Ib v Arm III||95||
59687243|NCT02921256|75806743|FG001|STARTED|Arm Ib v Arm III||0||
59687244|NCT02921256|75806744|FG002|STARTED|Arm Ib v Arm III||90||
59687245|NCT02921256|75806742|FG000|COMPLETED|Arm Ib v Arm III||71||
59687246|NCT02921256|75806743|FG001|COMPLETED|Arm Ib v Arm III||0||
59687247|NCT02921256|75806744|FG002|COMPLETED|Arm Ib v Arm III||75||
59687248|NCT02921256|75806742|FG000|NOT COMPLETED|Arm Ib v Arm III||24||
59687249|NCT02921256|75806743|FG001|NOT COMPLETED|Arm Ib v Arm III||0||
59687250|NCT02921256|75806744|FG002|NOT COMPLETED|Arm Ib v Arm III||15||
59687251|NCT02757885|75806758|FG000|STARTED|Overall Study||10||
59687252|NCT02757885|75806758|FG000|COMPLETED|Overall Study||6||
59687253|NCT02757885|75806758|FG000|NOT COMPLETED|Overall Study||4||
59687254|NCT02670811|75806764|FG000|STARTED|Overall Study||18||
59687255|NCT02670811|75806765|FG001|STARTED|Overall Study||18||
59687256|NCT02670811|75806764|FG000|COMPLETED|Overall Study||17||
59687257|NCT02670811|75806765|FG001|COMPLETED|Overall Study||18||
59687258|NCT02670811|75806764|FG000|NOT COMPLETED|Overall Study||1||
59687259|NCT02670811|75806765|FG001|NOT COMPLETED|Overall Study||0||
59687260|NCT02635867|75806776|FG000|STARTED|Overall Study||25||30
59687261|NCT02635867|75806777|FG001|STARTED|Overall Study||27||30
59687262|NCT02635867|75806778|FG002|STARTED|Overall Study||27||30
59687263|NCT02635867|75806779|FG003|STARTED|Overall Study||10||10
59687264|NCT02635867|75806780|FG004|STARTED|Overall Study||9||9
59687265|NCT02635867|75806776|FG000|COMPLETED|Overall Study||21||25
59687266|NCT02635867|75806777|FG001|COMPLETED|Overall Study||24||27
59687267|NCT02635867|75806778|FG002|COMPLETED|Overall Study||24||27
59687268|NCT02635867|75806779|FG003|COMPLETED|Overall Study||6||6
59687269|NCT02635867|75806780|FG004|COMPLETED|Overall Study||8||8
59687270|NCT02635867|75806776|FG000|NOT COMPLETED|Overall Study||4||5
59687271|NCT02635867|75806777|FG001|NOT COMPLETED|Overall Study||3||3
59687272|NCT02635867|75806778|FG002|NOT COMPLETED|Overall Study||3||3
59687273|NCT02635867|75806779|FG003|NOT COMPLETED|Overall Study||4||4
59687274|NCT02635867|75806780|FG004|NOT COMPLETED|Overall Study||1||1
59687275|NCT02426658|75806797|FG000|STARTED|Overall Study||16||
59687276|NCT02426658|75806797|FG000|COMPLETED|Overall Study||13||
59687277|NCT02426658|75806797|FG000|NOT COMPLETED|Overall Study||3||
59687278|NCT02158091|75806804|FG000|STARTED|Overall Study||6||
59687279|NCT02158091|75806805|FG001|STARTED|Overall Study||6||
59687280|NCT02158091|75806806|FG002|STARTED|Overall Study||20||
59687281|NCT02158091|75806804|FG000|COMPLETED|Overall Study||4||
59687282|NCT02158091|75806805|FG001|COMPLETED|Overall Study||5||
59687283|NCT02158091|75806806|FG002|COMPLETED|Overall Study||20||
59687284|NCT02158091|75806804|FG000|NOT COMPLETED|Overall Study||2||
59687285|NCT02158091|75806805|FG001|NOT COMPLETED|Overall Study||1||
59687286|NCT02158091|75806806|FG002|NOT COMPLETED|Overall Study||0||
59687287|NCT01460654|75806817|FG000|STARTED|Overall Study||19||
59687288|NCT01460654|75806818|FG001|STARTED|Overall Study||10||
59687289|NCT01460654|75806819|FG002|STARTED|Overall Study||15||
59687290|NCT01460654|75806817|FG000|COMPLETED|Overall Study||14||
59687291|NCT01460654|75806818|FG001|COMPLETED|Overall Study||9||
59687292|NCT01460654|75806819|FG002|COMPLETED|Overall Study||13||
59687293|NCT01460654|75806817|FG000|NOT COMPLETED|Overall Study||5||
59687294|NCT01460654|75806818|FG001|NOT COMPLETED|Overall Study||1||
59687295|NCT01460654|75806819|FG002|NOT COMPLETED|Overall Study||2||
59687296|NCT02996266|75806829|FG000|STARTED|Overall Study||339||
59687297|NCT02996266|75806830|FG001|STARTED|Overall Study||338||
59687298|NCT02996266|75806829|FG000|COMPLETED|Overall Study||211||
59687299|NCT02996266|75806830|FG001|COMPLETED|Overall Study||222||
59687300|NCT02996266|75806829|FG000|NOT COMPLETED|Overall Study||128||
59687301|NCT02996266|75806830|FG001|NOT COMPLETED|Overall Study||116||
59687302|NCT02903420|75806836|FG000|STARTED|Overall Study||28||
59687303|NCT02903420|75806836|FG000|COMPLETED|Overall Study||25||
59687304|NCT02903420|75806836|FG000|NOT COMPLETED|Overall Study||3||
59687305|NCT02831933|75806840|FG000|STARTED|Overall Study||11||
59687306|NCT02831933|75806840|FG000|COMPLETED|Overall Study||0||
59687307|NCT02831933|75806840|FG000|NOT COMPLETED|Overall Study||11||
59687308|NCT02813668|75806844|FG000|STARTED|Overall Study||2108||
59687309|NCT02813668|75806844|FG000|COMPLETED|Overall Study||1358||
59687310|NCT02813668|75806844|FG000|NOT COMPLETED|Overall Study||750||
59687311|NCT02763566|75806852|FG000|STARTED|Overall Study||207||
59687312|NCT02763566|75806853|FG001|STARTED|Overall Study||99||
59687313|NCT02763566|75806854|FG002|STARTED|Overall Study||104||
59687314|NCT02763566|75806855|FG003|STARTED|Overall Study||53||
59687315|NCT02763566|75806852|FG000|COMPLETED|Overall Study||89||
59687316|NCT02763566|75806853|FG001|COMPLETED|Overall Study||60||
59687317|NCT02763566|75806854|FG002|COMPLETED|Overall Study||50||
59687318|NCT02763566|75806855|FG003|COMPLETED|Overall Study||39||
59687319|NCT02763566|75806852|FG000|NOT COMPLETED|Overall Study||118||
59687320|NCT02763566|75806853|FG001|NOT COMPLETED|Overall Study||39||
59687321|NCT02763566|75806854|FG002|NOT COMPLETED|Overall Study||54||
59687322|NCT02763566|75806855|FG003|NOT COMPLETED|Overall Study||14||
59687323|NCT02760433|75806874|FG000|STARTED|Overall Study||161||
59687324|NCT02760433|75806875|FG001|STARTED|Overall Study||138||
59687325|NCT02760433|75806876|FG002|STARTED|Overall Study||26||
59687326|NCT02760433|75806877|FG003|STARTED|Overall Study||32||
59687327|NCT02760433|75806878|FG004|STARTED|Overall Study||11||
59687328|NCT02760433|75806874|FG000|COMPLETED|Overall Study||134||
59687329|NCT02760433|75806875|FG001|COMPLETED|Overall Study||128||
59687330|NCT02760433|75806876|FG002|COMPLETED|Overall Study||25||
59687331|NCT02760433|75806877|FG003|COMPLETED|Overall Study||30||
59687332|NCT02760433|75806878|FG004|COMPLETED|Overall Study||1||
59687333|NCT02760433|75806874|FG000|NOT COMPLETED|Overall Study||27||
59687334|NCT02760433|75806875|FG001|NOT COMPLETED|Overall Study||10||
59687335|NCT02760433|75806876|FG002|NOT COMPLETED|Overall Study||1||
59687336|NCT02760433|75806877|FG003|NOT COMPLETED|Overall Study||2||
59687337|NCT02760433|75806878|FG004|NOT COMPLETED|Overall Study||10||
59687338|NCT02760407|75806898|FG000|STARTED|Overall Study||479||
59687339|NCT02760407|75806899|FG001|STARTED|Overall Study||464||
59687340|NCT02760407|75806900|FG002|STARTED|Overall Study||462||
59687341|NCT02760407|75806901|FG003|STARTED|Overall Study||243||
59687342|NCT02760407|75806898|FG000|COMPLETED|Overall Study||443||
59687343|NCT02760407|75806899|FG001|COMPLETED|Overall Study||421||
59687344|NCT02760407|75806900|FG002|COMPLETED|Overall Study||412||
59687345|NCT02760407|75806901|FG003|COMPLETED|Overall Study||207||
59687346|NCT02760407|75806898|FG000|NOT COMPLETED|Overall Study||36||
59687347|NCT02760407|75806899|FG001|NOT COMPLETED|Overall Study||43||
59687348|NCT02760407|75806900|FG002|NOT COMPLETED|Overall Study||50||
59687349|NCT02760407|75806901|FG003|NOT COMPLETED|Overall Study||36||
59687350|NCT02760368|75806917|FG000|STARTED|Overall Study||142||
59687351|NCT02760368|75806918|FG001|STARTED|Overall Study||143||
59687352|NCT02760368|75806919|FG002|STARTED|Overall Study||143||
59687353|NCT02760368|75806917|FG000|COMPLETED|Overall Study||134||
59687354|NCT02760368|75806918|FG001|COMPLETED|Overall Study||130||
59687355|NCT02760368|75806919|FG002|COMPLETED|Overall Study||132||
59547454|NCT03371108|75646286|FG000|STARTED|Safety Analysis Set||284||
59547455|NCT03371108|75646287|FG001|STARTED|Safety Analysis Set||283||
59547456|NCT03371108|75646286|FG000|COMPLETED|Safety Analysis Set||281||
59547457|NCT03371108|75646287|FG001|COMPLETED|Safety Analysis Set||282||
59547458|NCT03371108|75646286|FG000|NOT COMPLETED|Safety Analysis Set||3||
59547459|NCT03371108|75646287|FG001|NOT COMPLETED|Safety Analysis Set||1||
59547460|NCT03371108|75646286|FG000|STARTED|Completers||281||
59547461|NCT03371108|75646287|FG001|STARTED|Completers||282||
59547462|NCT03371108|75646286|FG000|COMPLETED|Completers||259||
59547463|NCT03371108|75646287|FG001|COMPLETED|Completers||256||
59687356|NCT02760368|75806917|FG000|NOT COMPLETED|Overall Study||8||
59687357|NCT02760368|75806918|FG001|NOT COMPLETED|Overall Study||13||
59687358|NCT02760368|75806919|FG002|NOT COMPLETED|Overall Study||11||
59687359|NCT02747004|75806933|FG000|STARTED|Overall Study||78||
59687360|NCT02747004|75806934|FG001|STARTED|Overall Study||79||
59687361|NCT02747004|75806935|FG002|STARTED|Overall Study||77||
59687362|NCT02747004|75806933|FG000|Received at Least One Dose of Study Drug|Overall Study||78||
59687363|NCT02747004|75806934|FG001|Received at Least One Dose of Study Drug|Overall Study||79||
59687364|NCT02747004|75806935|FG002|Received at Least One Dose of Study Drug|Overall Study||77||
59687365|NCT02747004|75806933|FG000|COMPLETED|Overall Study||21||
59687366|NCT02747004|75806934|FG001|COMPLETED|Overall Study||30||
59687367|NCT02747004|75806935|FG002|COMPLETED|Overall Study||30||
59687368|NCT02747004|75806933|FG000|NOT COMPLETED|Overall Study||57||
59687369|NCT02747004|75806934|FG001|NOT COMPLETED|Overall Study||49||
59687370|NCT02747004|75806935|FG002|NOT COMPLETED|Overall Study||47||
59687371|NCT02741570|75806945|FG000|STARTED|Pre-Treatment Period||472||
59687372|NCT02741570|75806946|FG001|STARTED|Pre-Treatment Period||475||
59687373|NCT02741570|75806945|FG000|COMPLETED|Pre-Treatment Period||468|Continuing into treatment period|
59687374|NCT02741570|75806946|FG001|COMPLETED|Pre-Treatment Period||441|Continuing into treatment period|
59687375|NCT02741570|75806945|FG000|NOT COMPLETED|Pre-Treatment Period||4||
59687376|NCT02741570|75806946|FG001|NOT COMPLETED|Pre-Treatment Period||34||
59687377|NCT02741570|75806945|FG000|STARTED|Treatment Period||468||
59687378|NCT02741570|75806946|FG001|STARTED|Treatment Period||441||
59687379|NCT02741570|75806945|FG000|COMPLETED|Treatment Period||0|Participants continuing in the treatment period|
59687380|NCT02741570|75806946|FG001|COMPLETED|Treatment Period||0|Participants continuing in the treatment period|
59687381|NCT02741570|75806945|FG000|NOT COMPLETED|Treatment Period||468||
59687382|NCT02741570|75806946|FG001|NOT COMPLETED|Treatment Period||441||
59687383|NCT02706197|75806954|FG000|STARTED|Overall Study||18||
59687384|NCT02706197|75806955|FG001|STARTED|Overall Study||6||
59687385|NCT02706197|75806954|FG000|COMPLETED|Overall Study||18||
59687386|NCT02706197|75806955|FG001|COMPLETED|Overall Study||6||
59687387|NCT02706197|75806954|FG000|NOT COMPLETED|Overall Study||0||
59687388|NCT02706197|75806955|FG001|NOT COMPLETED|Overall Study||0||
59687389|NCT02685566|75806961|FG000|STARTED|First Reading Session||50||
59687390|NCT02685566|75806962|FG001|STARTED|First Reading Session||50||
59687391|NCT02685566|75806961|FG000|COMPLETED|First Reading Session||50||
59547464|NCT03371108|75646286|FG000|NOT COMPLETED|Completers||22||
59687392|NCT02685566|75806962|FG001|COMPLETED|First Reading Session||50||
59687393|NCT02685566|75806961|FG000|NOT COMPLETED|First Reading Session||0||
59687394|NCT02685566|75806962|FG001|NOT COMPLETED|First Reading Session||0||
59687395|NCT02685566|75806961|FG000|STARTED|4 Week Memory Washout Period||50||
59687396|NCT02685566|75806962|FG001|STARTED|4 Week Memory Washout Period||50||
59687397|NCT02685566|75806961|FG000|COMPLETED|4 Week Memory Washout Period||50||
59687398|NCT02685566|75806962|FG001|COMPLETED|4 Week Memory Washout Period||50||
59687399|NCT02685566|75806961|FG000|NOT COMPLETED|4 Week Memory Washout Period||0||
59687400|NCT02685566|75806962|FG001|NOT COMPLETED|4 Week Memory Washout Period||0||
59687401|NCT02685566|75806961|FG000|STARTED|Second Reading Session||50||
59687402|NCT02685566|75806962|FG001|STARTED|Second Reading Session||50||
59547465|NCT03371108|75646287|FG001|NOT COMPLETED|Completers||26||
59547466|NCT02517567|75646293|FG000|STARTED|First Exposure (8 Hours)||6||
59687403|NCT02685566|75806961|FG000|COMPLETED|Second Reading Session||50||
59687404|NCT02685566|75806962|FG001|COMPLETED|Second Reading Session||50||
59687405|NCT02685566|75806961|FG000|NOT COMPLETED|Second Reading Session||0||
59687406|NCT02685566|75806962|FG001|NOT COMPLETED|Second Reading Session||0||
59687407|NCT02675231|75806973|FG000|STARTED|Overall Study||79||
59687408|NCT02675231|75806974|FG001|STARTED|Overall Study||79||
59687409|NCT02675231|75806975|FG002|STARTED|Overall Study||79||
59687410|NCT02675231|75806973|FG000|Received at Least One Dose of Drug|Overall Study||78||
59687411|NCT02675231|75806974|FG001|Received at Least One Dose of Drug|Overall Study||77||
59687412|NCT02675231|75806975|FG002|Received at Least One Dose of Drug|Overall Study||72||
59687413|NCT02675231|75806973|FG000|COMPLETED|Overall Study||53||
59687414|NCT02675231|75806974|FG001|COMPLETED|Overall Study||43||
59687415|NCT02675231|75806975|FG002|COMPLETED|Overall Study||53||
59687416|NCT02675231|75806973|FG000|NOT COMPLETED|Overall Study||26||
59687417|NCT02675231|75806974|FG001|NOT COMPLETED|Overall Study||36||
59687418|NCT02675231|75806975|FG002|NOT COMPLETED|Overall Study||26||
59687419|NCT02641483|75806984|FG000|STARTED|Overall Study||2||
59687420|NCT02641483|75806984|FG000|COMPLETED|Overall Study||2||
59687421|NCT02641483|75806984|FG000|NOT COMPLETED|Overall Study||0||
59687422|NCT02603887|75806988|FG000|STARTED|Stage 1||12||
59687423|NCT02603887|75806988|FG000|Cycle 1|Stage 1||12||
59687424|NCT02603887|75806988|FG000|Cycle 8|Stage 1||7||
59687425|NCT02603887|75806988|FG000|COMPLETED|Stage 1||7||
59687426|NCT02603887|75806988|FG000|NOT COMPLETED|Stage 1||5||
59687427|NCT02603887|75806988|FG000|STARTED|Stage 2||1||
59687428|NCT02603887|75806988|FG000|Cycle 1|Stage 2||1||
59687429|NCT02603887|75806988|FG000|Cycle 8|Stage 2||0||
59687430|NCT02603887|75806988|FG000|COMPLETED|Stage 2||0||
59687431|NCT02603887|75806988|FG000|NOT COMPLETED|Stage 2||1||
59687432|NCT02554279|75806994|FG000|STARTED|Overall Study||311||
59687433|NCT02554279|75806995|FG001|STARTED|Overall Study||309||
59687434|NCT02554279|75806994|FG000|Treated|Overall Study||310||
59687435|NCT02554279|75806995|FG001|Treated|Overall Study||309||
59687436|NCT02554279|75806994|FG000|Completed Day 6 of Stimulation|Overall Study||308||
59687437|NCT02554279|75806995|FG001|Completed Day 6 of Stimulation|Overall Study||309||
59687438|NCT02554279|75806994|FG000|Received Trigger|Overall Study||293||
59687439|NCT02554279|75806995|FG001|Received Trigger|Overall Study||307||
59687440|NCT02554279|75806994|FG000|Completed Oocyte Retrieval|Overall Study||292||
59687441|NCT02554279|75806995|FG001|Completed Oocyte Retrieval|Overall Study||306||
59687442|NCT02554279|75806994|FG000|Completed Fresh Blastocyst Transfer|Overall Study||201||
59687443|NCT02554279|75806995|FG001|Completed Fresh Blastocyst Transfer|Overall Study||191||
59687444|NCT02554279|75806994|FG000|COMPLETED|Overall Study||279||
59687445|NCT02554279|75806995|FG001|COMPLETED|Overall Study||291||
59687446|NCT02554279|75806994|FG000|NOT COMPLETED|Overall Study||32||
59687447|NCT02554279|75806995|FG001|NOT COMPLETED|Overall Study||18||
59687448|NCT02542293|75807010|FG000|STARTED|Overall Study||474|Randomized in overall study|
59687449|NCT02542293|75807011|FG001|STARTED|Overall Study||479|Randomized in overall study|
59687450|NCT02542293|75807010|FG000|Randomized in Global Cohort|Overall Study||410||
59687451|NCT02542293|75807011|FG001|Randomized in Global Cohort|Overall Study||413||
59687452|NCT02542293|75807010|FG000|Received Treatment in Global Cohort|Overall Study||410||
59687453|NCT02542293|75807011|FG001|Received Treatment in Global Cohort|Overall Study||399||
59687454|NCT02542293|75807010|FG000|Randomized in China Cohort|Overall Study||78||
59687455|NCT02542293|75807011|FG001|Randomized in China Cohort|Overall Study||82||
59687456|NCT02542293|75807010|FG000|Received Treatment in China Cohort|Overall Study||77||
59687457|NCT02542293|75807011|FG001|Received Treatment in China Cohort|Overall Study||78||
59687458|NCT02542293|75807010|FG000|Included in Both Cohorts (Global and China)|Overall Study||14||
59687459|NCT02542293|75807011|FG001|Included in Both Cohorts (Global and China)|Overall Study||16||
59687460|NCT02542293|75807010|FG000|Ongoing in Study at DCO for Final Analysis in Global Cohort|Overall Study||75||
59687461|NCT02542293|75807011|FG001|Ongoing in Study at DCO for Final Analysis in Global Cohort|Overall Study||67||
59687462|NCT02542293|75807010|FG000|Ongoing in Study at DCO for Final Analysis in China Cohort|Overall Study||27||
59687463|NCT02542293|75807011|FG001|Ongoing in Study at DCO for Final Analysis in China Cohort|Overall Study||18||
59687464|NCT02542293|75807010|FG000|COMPLETED|Overall Study||99|Ongoing in overall study at DCO for final analysis.|
59687465|NCT02542293|75807011|FG001|COMPLETED|Overall Study||83|Ongoing in overall study at DCO for final analysis.|
59687466|NCT02542293|75807010|FG000|NOT COMPLETED|Overall Study||375||
59687467|NCT02542293|75807011|FG001|NOT COMPLETED|Overall Study||396||
59687468|NCT02511730|75807024|FG000|STARTED|First Reading Session||50||
59687469|NCT02511730|75807025|FG001|STARTED|First Reading Session||50||
59687470|NCT02511730|75807024|FG000|COMPLETED|First Reading Session||50||
59687471|NCT02511730|75807025|FG001|COMPLETED|First Reading Session||50||
59687472|NCT02511730|75807024|FG000|NOT COMPLETED|First Reading Session||0||
59687473|NCT02511730|75807025|FG001|NOT COMPLETED|First Reading Session||0||
59687474|NCT02511730|75807024|FG000|STARTED|4 Week Memory Washout Period||50||
59687475|NCT02511730|75807025|FG001|STARTED|4 Week Memory Washout Period||50||
59687476|NCT02511730|75807024|FG000|COMPLETED|4 Week Memory Washout Period||50||
59687477|NCT02511730|75807025|FG001|COMPLETED|4 Week Memory Washout Period||50||
59687478|NCT02511730|75807024|FG000|NOT COMPLETED|4 Week Memory Washout Period||0||
59687479|NCT02511730|75807025|FG001|NOT COMPLETED|4 Week Memory Washout Period||0||
59687480|NCT02511730|75807024|FG000|STARTED|Session Reading Session||50||
59687481|NCT02511730|75807025|FG001|STARTED|Session Reading Session||50||
59687482|NCT02511730|75807024|FG000|COMPLETED|Session Reading Session||50||
59687483|NCT02511730|75807025|FG001|COMPLETED|Session Reading Session||50||
59687484|NCT02511730|75807024|FG000|NOT COMPLETED|Session Reading Session||0||
59687485|NCT02511730|75807025|FG001|NOT COMPLETED|Session Reading Session||0||
59687486|NCT02456194|75807031|FG000|STARTED|Overall Study||30||
59687487|NCT02456194|75807031|FG000|COMPLETED|Overall Study||29||
59687488|NCT02456194|75807031|FG000|NOT COMPLETED|Overall Study||1||
59687489|NCT02439450|75807039|FG000|STARTED|Overall Study||47||
59687490|NCT02439450|75807040|FG001|STARTED|Overall Study||68||
59687491|NCT02439450|75807041|FG002|STARTED|Overall Study||2||
59687492|NCT02439450|75807042|FG003|STARTED|Overall Study||4||
59687493|NCT02439450|75807039|FG000|COMPLETED|Overall Study||21||
59687494|NCT02439450|75807040|FG001|COMPLETED|Overall Study||24||
59687495|NCT02439450|75807041|FG002|COMPLETED|Overall Study||0||
59687496|NCT02439450|75807042|FG003|COMPLETED|Overall Study||0||
59687497|NCT02439450|75807039|FG000|NOT COMPLETED|Overall Study||26||
59547467|NCT02517567|75646294|FG001|STARTED|First Exposure (8 Hours)||8||
59547468|NCT02517567|75646295|FG002|STARTED|First Exposure (8 Hours)||7||
59547469|NCT02517567|75646296|FG003|STARTED|First Exposure (8 Hours)||8||
59547470|NCT02517567|75646293|FG000|COMPLETED|First Exposure (8 Hours)||6||
59547471|NCT02517567|75646294|FG001|COMPLETED|First Exposure (8 Hours)||8||
59547472|NCT02517567|75646295|FG002|COMPLETED|First Exposure (8 Hours)||7||
59547473|NCT02517567|75646296|FG003|COMPLETED|First Exposure (8 Hours)||8||
59547474|NCT02517567|75646293|FG000|NOT COMPLETED|First Exposure (8 Hours)||0||
59547475|NCT02517567|75646294|FG001|NOT COMPLETED|First Exposure (8 Hours)||0||
59547476|NCT02517567|75646295|FG002|NOT COMPLETED|First Exposure (8 Hours)||0||
59547477|NCT02517567|75646296|FG003|NOT COMPLETED|First Exposure (8 Hours)||0||
59547478|NCT02517567|75646293|FG000|STARTED|Second Exposure (8 Hours)||6||
59547479|NCT02517567|75646294|FG001|STARTED|Second Exposure (8 Hours)||8||
59547480|NCT02517567|75646295|FG002|STARTED|Second Exposure (8 Hours)||7||
59687498|NCT02439450|75807040|FG001|NOT COMPLETED|Overall Study||44||
59687499|NCT02439450|75807041|FG002|NOT COMPLETED|Overall Study||2||
59687500|NCT02439450|75807042|FG003|NOT COMPLETED|Overall Study||4||
59687501|NCT02403778|75807054|FG000|STARTED|Overall Study||6||
59687502|NCT02403778|75807055|FG001|STARTED|Overall Study||4||
59687503|NCT02403778|75807054|FG000|COMPLETED|Overall Study||6||
59989726|NCT02318329|76105092|FG005|STARTED|Overall Study||3||
59989727|NCT02318329|76105093|FG006|STARTED|Overall Study||1||
59547481|NCT02517567|75646296|FG003|STARTED|Second Exposure (8 Hours)||8||
59687504|NCT02403778|75807055|FG001|COMPLETED|Overall Study||4||
59687505|NCT02403778|75807054|FG000|NOT COMPLETED|Overall Study||0||
59687506|NCT02403778|75807055|FG001|NOT COMPLETED|Overall Study||0||
59687507|NCT02312258|75807063|FG000|STARTED|Overall Study||281||
59687508|NCT02312258|75807064|FG001|STARTED|Overall Study||425||
59687509|NCT02312258|75807063|FG000|Safety Population|Overall Study||276|"The safety population was defined as all participants who received at least 1 dose of ixazomib or placebo.~Three placebo participants who erroneously received a single dose of ixazomib were included in the ixazomib arm of the safety population."|
59687510|NCT02312258|75807064|FG001|Safety Population|Overall Study||426|"The safety population was defined as all participants who received at least 1 dose of ixazomib or placebo.~Three placebo participants who erroneously received a single dose of ixazomib were included in the ixazomib arm of the safety population."|
59687511|NCT02312258|75807063|FG000|COMPLETED|Overall Study||0||
59687512|NCT02312258|75807064|FG001|COMPLETED|Overall Study||0||
59687513|NCT02312258|75807063|FG000|NOT COMPLETED|Overall Study||281||
59687514|NCT02312258|75807064|FG001|NOT COMPLETED|Overall Study||425||
59687515|NCT02276274|75807074|FG000|STARTED|First Intervention Period||6||
59687516|NCT02276274|75807075|FG001|STARTED|First Intervention Period||6||
59687517|NCT02276274|75807074|FG000|COMPLETED|First Intervention Period||6||
59687518|NCT02276274|75807075|FG001|COMPLETED|First Intervention Period||6||
59687519|NCT02276274|75807074|FG000|NOT COMPLETED|First Intervention Period||0||
59687520|NCT02276274|75807075|FG001|NOT COMPLETED|First Intervention Period||0||
59687521|NCT02276274|75807074|FG000|STARTED|Washout Period (at Least 15 Days)||6||
59687522|NCT02276274|75807075|FG001|STARTED|Washout Period (at Least 15 Days)||6||
59687523|NCT02276274|75807074|FG000|COMPLETED|Washout Period (at Least 15 Days)||6||
59687524|NCT02276274|75807075|FG001|COMPLETED|Washout Period (at Least 15 Days)||6||
59687525|NCT02276274|75807074|FG000|NOT COMPLETED|Washout Period (at Least 15 Days)||0||
59687526|NCT02276274|75807075|FG001|NOT COMPLETED|Washout Period (at Least 15 Days)||0||
59687527|NCT02276274|75807074|FG000|STARTED|Second Intervention Period||6||
59687528|NCT02276274|75807075|FG001|STARTED|Second Intervention Period||6||
59687529|NCT02276274|75807074|FG000|COMPLETED|Second Intervention Period||6||
59687530|NCT02276274|75807075|FG001|COMPLETED|Second Intervention Period||6||
59687531|NCT02276274|75807074|FG000|NOT COMPLETED|Second Intervention Period||0||
59687532|NCT02276274|75807075|FG001|NOT COMPLETED|Second Intervention Period||0||
59687533|NCT02164734|75807083|FG000|STARTED|Overall Study||42||
59687534|NCT02164734|75807084|FG001|STARTED|Overall Study||51||
59687535|NCT02164734|75807083|FG000|COMPLETED|Overall Study||42|Intention-to-treat analysis|
59687536|NCT02164734|75807084|FG001|COMPLETED|Overall Study||51|Intention-to-treat analysis|
59687537|NCT02164734|75807083|FG000|NOT COMPLETED|Overall Study||0||
59687538|NCT02164734|75807084|FG001|NOT COMPLETED|Overall Study||0||
59687539|NCT02110069|75807092|FG000|STARTED|Overall Study||2||
59687540|NCT02110069|75807093|FG001|STARTED|Overall Study||2||
59687541|NCT02110069|75807092|FG000|COMPLETED|Overall Study|subject was switched to sirolimus at maintenance course 7 for failure on Vincristine|0|second subject came off study at maintenance course 6 as family moved out of the country|
59989728|NCT02318329|76105094|FG007|STARTED|Overall Study||1||
59547482|NCT02517567|75646293|FG000|COMPLETED|Second Exposure (8 Hours)||6||
59547483|NCT02517567|75646294|FG001|COMPLETED|Second Exposure (8 Hours)||8||
59709826|NCT01072149|75828520|FG000|STARTED|Treatment Period 2 (28 Days)||3||
59989729|NCT02318329|76105095|FG008|STARTED|Overall Study||6||
59547484|NCT02517567|75646295|FG002|COMPLETED|Second Exposure (8 Hours)||7||
59687542|NCT02110069|75807093|FG001|COMPLETED|Overall Study|1 subject was takend off protocol treatment at 10 months of maintenance for disease response.|2|second subject came off study at maintenance course 6 as family moved out of the country|
59687543|NCT02110069|75807092|FG000|NOT COMPLETED|Overall Study||2||
59687544|NCT02110069|75807093|FG001|NOT COMPLETED|Overall Study||0||
59687545|NCT02049515|75807101|FG000|STARTED|Overall Study||90||
59687546|NCT02049515|75807102|FG001|STARTED|Overall Study||9||
59687547|NCT02049515|75807101|FG000|Received at Least 1 Dose of Study Drug|Overall Study||90|All-treated analysis set: all participants who received any amount of study drug (IPI-145 or ofatumumab).|
59687548|NCT02049515|75807102|FG001|Received at Least 1 Dose of Study Drug|Overall Study||9|All-treated analysis set: all participants who received any amount of study drug (IPI-145 or ofatumumab).|
59687549|NCT02049515|75807101|FG000|COMPLETED|Overall Study||0||
59687550|NCT02049515|75807102|FG001|COMPLETED|Overall Study||3||
59687551|NCT02049515|75807101|FG000|NOT COMPLETED|Overall Study||90||
59687552|NCT02049515|75807102|FG001|NOT COMPLETED|Overall Study||6||
59687553|NCT02039401|75807110|FG000|STARTED|Overall Study||9||
59687554|NCT02039401|75807111|FG001|STARTED|Overall Study||9||
59687555|NCT02039401|75807110|FG000|COMPLETED|Overall Study||9||
59687556|NCT02039401|75807111|FG001|COMPLETED|Overall Study||8||
59687557|NCT02039401|75807110|FG000|NOT COMPLETED|Overall Study||0||
59687558|NCT02039401|75807111|FG001|NOT COMPLETED|Overall Study||1||
59687559|NCT02004522|75807120|FG000|STARTED|Overall Study||160|Number of subjects randomized.|
59687560|NCT02004522|75807121|FG001|STARTED|Overall Study||159|Number of subjects randomized.|
59687561|NCT02004522|75807120|FG000|Number of Subjects Treated|Overall Study||158|Number of subjects exposed to treatment.|
59687562|NCT02004522|75807121|FG001|Number of Subjects Treated|Overall Study||155|Number of subjects exposed to treatment.|
59687563|NCT02004522|75807120|FG000|COMPLETED|Overall Study|Completed defined here as still on treatment.|34||
59687564|NCT02004522|75807121|FG001|COMPLETED|Overall Study|Completed defined here as still on treatment.|0||
59687565|NCT02004522|75807120|FG000|NOT COMPLETED|Overall Study||126||
59687566|NCT02004522|75807121|FG001|NOT COMPLETED|Overall Study||159||
59687567|NCT01959139|75807131|FG000|STARTED|Phase I: Cohort 1||5||
59687568|NCT01959139|75807132|FG001|STARTED|Phase I: Cohort 1||0||
59687569|NCT01959139|75807133|FG002|STARTED|Phase I: Cohort 1||0||
59687570|NCT01959139|75807134|FG003|STARTED|Phase I: Cohort 1||0||
59687571|NCT01959139|75807131|FG000|COMPLETED|Phase I: Cohort 1||5||
59687572|NCT01959139|75807132|FG001|COMPLETED|Phase I: Cohort 1||0||
59687573|NCT01959139|75807133|FG002|COMPLETED|Phase I: Cohort 1||0||
59687574|NCT01959139|75807134|FG003|COMPLETED|Phase I: Cohort 1||0||
59687575|NCT01959139|75807131|FG000|NOT COMPLETED|Phase I: Cohort 1||0||
59687576|NCT01959139|75807132|FG001|NOT COMPLETED|Phase I: Cohort 1||0||
59687577|NCT01959139|75807133|FG002|NOT COMPLETED|Phase I: Cohort 1||0||
59687578|NCT01959139|75807134|FG003|NOT COMPLETED|Phase I: Cohort 1||0||
59687579|NCT01959139|75807131|FG000|STARTED|Phase I: Cohort 2||0||
59687580|NCT01959139|75807132|FG001|STARTED|Phase I: Cohort 2||6||
59687581|NCT01959139|75807133|FG002|STARTED|Phase I: Cohort 2||0||
59687582|NCT01959139|75807134|FG003|STARTED|Phase I: Cohort 2||0||
59687583|NCT01959139|75807131|FG000|COMPLETED|Phase I: Cohort 2||0||
59687584|NCT01959139|75807132|FG001|COMPLETED|Phase I: Cohort 2||6||
59687585|NCT01959139|75807133|FG002|COMPLETED|Phase I: Cohort 2||0||
59687586|NCT01959139|75807134|FG003|COMPLETED|Phase I: Cohort 2||0||
59687587|NCT01959139|75807131|FG000|NOT COMPLETED|Phase I: Cohort 2||0||
59687588|NCT01959139|75807132|FG001|NOT COMPLETED|Phase I: Cohort 2||0||
59687589|NCT01959139|75807133|FG002|NOT COMPLETED|Phase I: Cohort 2||0||
59687590|NCT01959139|75807134|FG003|NOT COMPLETED|Phase I: Cohort 2||0||
59687591|NCT01959139|75807131|FG000|STARTED|Phase II||0||
59687592|NCT01959139|75807132|FG001|STARTED|Phase II||0||
59687593|NCT01959139|75807133|FG002|STARTED|Phase II||56||
59687594|NCT01959139|75807134|FG003|STARTED|Phase II||55||
59687595|NCT01959139|75807131|FG000|Assessed for AEs|Phase II||0||
59687596|NCT01959139|75807132|FG001|Assessed for AEs|Phase II||0||
59687597|NCT01959139|75807133|FG002|Assessed for AEs|Phase II||54||
59687598|NCT01959139|75807134|FG003|Assessed for AEs|Phase II||51||
59687599|NCT01959139|75807131|FG000|COMPLETED|Phase II||0||
59687600|NCT01959139|75807132|FG001|COMPLETED|Phase II||0||
59816105|NCT00529958|75938469|FG001|STARTED|2-Year Follow-up|110 randomized to HT, but there was (n=1) cross-over from the DB group|110||
59687601|NCT01959139|75807133|FG002|COMPLETED|Phase II||0||
59687602|NCT01959139|75807134|FG003|COMPLETED|Phase II||0||
59687603|NCT01959139|75807131|FG000|NOT COMPLETED|Phase II||0||
59687604|NCT01959139|75807132|FG001|NOT COMPLETED|Phase II||0||
59687605|NCT01959139|75807133|FG002|NOT COMPLETED|Phase II||56||
59687606|NCT01959139|75807134|FG003|NOT COMPLETED|Phase II||55||
59687607|NCT01932697|75807151|FG000|STARTED|Overall Study||38||
59687608|NCT01932697|75807152|FG001|STARTED|Overall Study||43||
59687609|NCT01932697|75807151|FG000|COMPLETED|Overall Study||36||
59687610|NCT01932697|75807152|FG001|COMPLETED|Overall Study||43||
59687611|NCT01932697|75807151|FG000|NOT COMPLETED|Overall Study||2||
59687612|NCT01932697|75807152|FG001|NOT COMPLETED|Overall Study||0||
59687613|NCT01803854|75807163|FG000|STARTED|Overall Study||1275||
59687614|NCT01803854|75807163|FG000|COMPLETED|Overall Study||1275||
59687615|NCT01803854|75807163|FG000|NOT COMPLETED|Overall Study||0||
59687616|NCT01752049|75807168|FG000|STARTED|Overall Study||5||15
59687617|NCT01752049|75807169|FG001|STARTED|Overall Study||5||5
59687618|NCT01752049|75807168|FG000|COMPLETED|Overall Study||5||15
59687619|NCT01752049|75807169|FG001|COMPLETED|Overall Study||5||5
59687620|NCT01752049|75807168|FG000|NOT COMPLETED|Overall Study||0||0
59687621|NCT01752049|75807169|FG001|NOT COMPLETED|Overall Study||0||0
59687622|NCT01747447|75807179|FG000|STARTED|Overall Study||193||
59687623|NCT01747447|75807180|FG001|STARTED|Overall Study||195||
59687624|NCT01747447|75807181|FG002|STARTED|Overall Study||195||
59687625|NCT01747447|75807182|FG003|STARTED|Overall Study||188||
59687626|NCT01747447|75807179|FG000|COMPLETED|Overall Study||170||
59989730|NCT02318329|76105096|FG009|STARTED|Overall Study||52||
59989731|NCT02318329|76105087|FG000|COMPLETED|Overall Study||0||
59989732|NCT02318329|76105088|FG001|COMPLETED|Overall Study||0||
59687627|NCT01747447|75807180|FG001|COMPLETED|Overall Study||177||
59687628|NCT01747447|75807181|FG002|COMPLETED|Overall Study||176||
59687629|NCT01747447|75807182|FG003|COMPLETED|Overall Study||164||
59687630|NCT01747447|75807179|FG000|NOT COMPLETED|Overall Study||23||
59687631|NCT01747447|75807180|FG001|NOT COMPLETED|Overall Study||18||
59687632|NCT01747447|75807181|FG002|NOT COMPLETED|Overall Study||19||
59687633|NCT01747447|75807182|FG003|NOT COMPLETED|Overall Study||24||
59687634|NCT01739309|75807198|FG000|STARTED|Overall Study||28||
59687635|NCT01739309|75807198|FG000|Received at Least One Dose of Study Drug|Overall Study||28||
59687636|NCT01739309|75807198|FG000|COMPLETED|Overall Study||26||
59687637|NCT01739309|75807198|FG000|NOT COMPLETED|Overall Study||2||
59687638|NCT01659658|75807209|FG000|STARTED|Overall Study||90||
59687639|NCT01659658|75807210|FG001|STARTED|Overall Study||26||
59687640|NCT01659658|75807211|FG002|STARTED|Overall Study||10||
59687641|NCT01659658|75807212|FG003|STARTED|Overall Study||2||
59687642|NCT01659658|75807213|FG004|STARTED|Overall Study||49||
59687643|NCT01659658|75807209|FG000|COMPLETED|Overall Study||0||
59687644|NCT01659658|75807210|FG001|COMPLETED|Overall Study||0||
59687645|NCT01659658|75807211|FG002|COMPLETED|Overall Study||0||
59687646|NCT01659658|75807212|FG003|COMPLETED|Overall Study||0||
59687647|NCT01659658|75807213|FG004|COMPLETED|Overall Study||0||
59687648|NCT01659658|75807209|FG000|NOT COMPLETED|Overall Study||90||
59687649|NCT01659658|75807210|FG001|NOT COMPLETED|Overall Study||26||
59687650|NCT01659658|75807211|FG002|NOT COMPLETED|Overall Study||10||
59687651|NCT01659658|75807212|FG003|NOT COMPLETED|Overall Study||2||
59687652|NCT01659658|75807213|FG004|NOT COMPLETED|Overall Study||49||
59687653|NCT01517243|75807226|FG000|STARTED|Overall Study|Defined as those participants that signed consent and started treatment|19||
59687654|NCT01517243|75807226|FG000|COMPLETED|Overall Study||19||
59687655|NCT01517243|75807226|FG000|NOT COMPLETED|Overall Study||0||
59687656|NCT01357161|75807233|FG000|STARTED|Part 1 (Open Label Run-in)||15||
59687657|NCT01357161|75807234|FG001|STARTED|Part 1 (Open Label Run-in)||0||
59687658|NCT01357161|75807235|FG002|STARTED|Part 1 (Open Label Run-in)||0||
59687659|NCT01357161|75807233|FG000|COMPLETED|Part 1 (Open Label Run-in)||0||
59687660|NCT01357161|75807234|FG001|COMPLETED|Part 1 (Open Label Run-in)||0||
59687661|NCT01357161|75807235|FG002|COMPLETED|Part 1 (Open Label Run-in)||0||
59687662|NCT01357161|75807233|FG000|NOT COMPLETED|Part 1 (Open Label Run-in)||15||
59687663|NCT01357161|75807234|FG001|NOT COMPLETED|Part 1 (Open Label Run-in)||0||
59687664|NCT01357161|75807235|FG002|NOT COMPLETED|Part 1 (Open Label Run-in)||0||
59687665|NCT01357161|75807233|FG000|STARTED|Part 2 (Double-Blind Comparison)||0||
59687666|NCT01357161|75807234|FG001|STARTED|Part 2 (Double-Blind Comparison)|New participants enrolled in Part 2.|59||
59687667|NCT01357161|75807235|FG002|STARTED|Part 2 (Double-Blind Comparison)|New participants enrolled in Part 2.|62||
59687668|NCT01357161|75807233|FG000|Treated|Part 2 (Double-Blind Comparison)||0||
59687669|NCT01357161|75807234|FG001|Treated|Part 2 (Double-Blind Comparison)||59||
59687670|NCT01357161|75807235|FG002|Treated|Part 2 (Double-Blind Comparison)||60||
59687671|NCT01357161|75807233|FG000|COMPLETED|Part 2 (Double-Blind Comparison)||0||
59687672|NCT01357161|75807234|FG001|COMPLETED|Part 2 (Double-Blind Comparison)||0||
59687673|NCT01357161|75807235|FG002|COMPLETED|Part 2 (Double-Blind Comparison)||0||
59687674|NCT01357161|75807233|FG000|NOT COMPLETED|Part 2 (Double-Blind Comparison)||0||
59687675|NCT01357161|75807234|FG001|NOT COMPLETED|Part 2 (Double-Blind Comparison)||59||
59989733|NCT02318329|76105089|FG002|COMPLETED|Overall Study||0||
59989734|NCT02318329|76105090|FG003|COMPLETED|Overall Study||0||
59687676|NCT01357161|75807235|FG002|NOT COMPLETED|Part 2 (Double-Blind Comparison)||62||
59687677|NCT01321073|75807243|FG000|STARTED|Overall Study||64||
59687678|NCT01321073|75807243|FG000|COMPLETED|Overall Study||57||
59687679|NCT01321073|75807243|FG000|NOT COMPLETED|Overall Study||7||
59687680|NCT01276704|75807249|FG000|STARTED|Overall Study||115||
59687681|NCT01276704|75807250|FG001|STARTED|Overall Study||62||
59687682|NCT01276704|75807249|FG000|COMPLETED|Overall Study||101||
59687683|NCT01276704|75807250|FG001|COMPLETED|Overall Study||51||
59687684|NCT01276704|75807249|FG000|NOT COMPLETED|Overall Study||14||
59687685|NCT01276704|75807250|FG001|NOT COMPLETED|Overall Study||11||
59687686|NCT01190930|75807258|FG000|STARTED|Induction||9298||
59687687|NCT01190930|75807259|FG001|STARTED|Induction||52||
59687688|NCT01190930|75807260|FG002|STARTED|Induction||0||
59687689|NCT01190930|75807261|FG003|STARTED|Induction||0||
59687690|NCT01190930|75807262|FG004|STARTED|Induction||0||
59687691|NCT01190930|75807263|FG005|STARTED|Induction||0||
59687692|NCT01190930|75807264|FG006|STARTED|Induction||0||
59687693|NCT01190930|75807265|FG007|STARTED|Induction||0||
59687694|NCT01190930|75807266|FG008|STARTED|Induction||0||
59687695|NCT01190930|75807267|FG009|STARTED|Induction||0||
59687696|NCT01190930|75807258|FG000|COMPLETED|Induction||3949||
59687697|NCT01190930|75807259|FG001|COMPLETED|Induction||43||
59687698|NCT01190930|75807260|FG002|COMPLETED|Induction||0||
59687699|NCT01190930|75807261|FG003|COMPLETED|Induction||0||
59687700|NCT01190930|75807262|FG004|COMPLETED|Induction||0||
59687701|NCT01190930|75807263|FG005|COMPLETED|Induction||0||
59687702|NCT01190930|75807264|FG006|COMPLETED|Induction||0||
59687703|NCT01190930|75807265|FG007|COMPLETED|Induction||0||
59687704|NCT01190930|75807266|FG008|COMPLETED|Induction||0||
59687705|NCT01190930|75807267|FG009|COMPLETED|Induction||0||
59687706|NCT01190930|75807258|FG000|NOT COMPLETED|Induction||5349||
59687707|NCT01190930|75807259|FG001|NOT COMPLETED|Induction||9||
59687708|NCT01190930|75807260|FG002|NOT COMPLETED|Induction||0||
59687709|NCT01190930|75807261|FG003|NOT COMPLETED|Induction||0||
59687710|NCT01190930|75807262|FG004|NOT COMPLETED|Induction||0||
59687711|NCT01190930|75807263|FG005|NOT COMPLETED|Induction||0||
59687712|NCT01190930|75807264|FG006|NOT COMPLETED|Induction||0||
59687713|NCT01190930|75807265|FG007|NOT COMPLETED|Induction||0||
59687714|NCT01190930|75807266|FG008|NOT COMPLETED|Induction||0||
59687715|NCT01190930|75807267|FG009|NOT COMPLETED|Induction||0||
59687716|NCT01190930|75807258|FG000|STARTED|Post Induction Pre-Maintenance||0||
59687717|NCT01190930|75807259|FG001|STARTED|Post Induction Pre-Maintenance||43||
59687718|NCT01190930|75807260|FG002|STARTED|Post Induction Pre-Maintenance||3122||
59687719|NCT01190930|75807261|FG003|STARTED|Post Induction Pre-Maintenance||224||
59687720|NCT01190930|75807262|FG004|STARTED|Post Induction Pre-Maintenance||301||
59687721|NCT01190930|75807263|FG005|STARTED|Post Induction Pre-Maintenance||302||
59687722|NCT01190930|75807264|FG006|STARTED|Post Induction Pre-Maintenance||0||
59687723|NCT01190930|75807265|FG007|STARTED|Post Induction Pre-Maintenance||0||
59687724|NCT01190930|75807266|FG008|STARTED|Post Induction Pre-Maintenance||0||
59687725|NCT01190930|75807267|FG009|STARTED|Post Induction Pre-Maintenance||0||
59687726|NCT01190930|75807258|FG000|COMPLETED|Post Induction Pre-Maintenance||0||
59687727|NCT01190930|75807259|FG001|COMPLETED|Post Induction Pre-Maintenance||37||
59687728|NCT01190930|75807260|FG002|COMPLETED|Post Induction Pre-Maintenance||2364||
59687729|NCT01190930|75807261|FG003|COMPLETED|Post Induction Pre-Maintenance||207||
59687730|NCT01190930|75807262|FG004|COMPLETED|Post Induction Pre-Maintenance||296||
59687731|NCT01190930|75807263|FG005|COMPLETED|Post Induction Pre-Maintenance||296||
59687732|NCT01190930|75807264|FG006|COMPLETED|Post Induction Pre-Maintenance||0||
59687733|NCT01190930|75807265|FG007|COMPLETED|Post Induction Pre-Maintenance||0||
59687734|NCT01190930|75807266|FG008|COMPLETED|Post Induction Pre-Maintenance||0||
59687735|NCT01190930|75807267|FG009|COMPLETED|Post Induction Pre-Maintenance||0||
59687736|NCT01190930|75807258|FG000|NOT COMPLETED|Post Induction Pre-Maintenance||0||
59687737|NCT01190930|75807259|FG001|NOT COMPLETED|Post Induction Pre-Maintenance||6||
59687738|NCT01190930|75807260|FG002|NOT COMPLETED|Post Induction Pre-Maintenance||758||
59687739|NCT01190930|75807261|FG003|NOT COMPLETED|Post Induction Pre-Maintenance||17||
59687740|NCT01190930|75807262|FG004|NOT COMPLETED|Post Induction Pre-Maintenance||5||
59687741|NCT01190930|75807263|FG005|NOT COMPLETED|Post Induction Pre-Maintenance||6||
59687742|NCT01190930|75807264|FG006|NOT COMPLETED|Post Induction Pre-Maintenance||0||
59687743|NCT01190930|75807265|FG007|NOT COMPLETED|Post Induction Pre-Maintenance||0||
59687744|NCT01190930|75807266|FG008|NOT COMPLETED|Post Induction Pre-Maintenance||0||
59687745|NCT01190930|75807267|FG009|NOT COMPLETED|Post Induction Pre-Maintenance||0||
59687746|NCT01190930|75807258|FG000|STARTED|Maintenance||0||
59687747|NCT01190930|75807259|FG001|STARTED|Maintenance||37||
59687748|NCT01190930|75807260|FG002|STARTED|Maintenance||0||
59687749|NCT01190930|75807261|FG003|STARTED|Maintenance||207||
59687750|NCT01190930|75807262|FG004|STARTED|Maintenance||296||
59687751|NCT01190930|75807263|FG005|STARTED|Maintenance||296||
59687752|NCT01190930|75807264|FG006|STARTED|Maintenance||600||
59687753|NCT01190930|75807265|FG007|STARTED|Maintenance||586||
59687754|NCT01190930|75807266|FG008|STARTED|Maintenance||586||
59687755|NCT01190930|75807267|FG009|STARTED|Maintenance||592||
59687756|NCT01190930|75807258|FG000|COMPLETED|Maintenance||0||
59687757|NCT01190930|75807259|FG001|COMPLETED|Maintenance||27||
59687758|NCT01190930|75807260|FG002|COMPLETED|Maintenance||0||
60079333|NCT04304508|76194670|FG002|STARTED|Overall Study||447|Full analysis set (FAS)|
59687759|NCT01190930|75807261|FG003|COMPLETED|Maintenance||167||
59687760|NCT01190930|75807262|FG004|COMPLETED|Maintenance||287||
59687761|NCT01190930|75807263|FG005|COMPLETED|Maintenance||284||
59687762|NCT01190930|75807264|FG006|COMPLETED|Maintenance||574||
59687763|NCT01190930|75807265|FG007|COMPLETED|Maintenance||540||
59687764|NCT01190930|75807266|FG008|COMPLETED|Maintenance||540||
59687765|NCT01190930|75807267|FG009|COMPLETED|Maintenance||555||
59687766|NCT01190930|75807258|FG000|NOT COMPLETED|Maintenance||0||
59687767|NCT01190930|75807259|FG001|NOT COMPLETED|Maintenance||10||
59687768|NCT01190930|75807260|FG002|NOT COMPLETED|Maintenance||0||
59687769|NCT01190930|75807261|FG003|NOT COMPLETED|Maintenance||40||
59687770|NCT01190930|75807262|FG004|NOT COMPLETED|Maintenance||9||
59687771|NCT01190930|75807263|FG005|NOT COMPLETED|Maintenance||12||
59687772|NCT01190930|75807264|FG006|NOT COMPLETED|Maintenance||26||
59687773|NCT01190930|75807265|FG007|NOT COMPLETED|Maintenance||46||
59687774|NCT01190930|75807266|FG008|NOT COMPLETED|Maintenance||46||
59687775|NCT01190930|75807267|FG009|NOT COMPLETED|Maintenance||37||
59687776|NCT01169259|75807295|FG000|STARTED|Overall Study||6463||
59687777|NCT01169259|75807296|FG001|STARTED|Overall Study||6464||
59687778|NCT01169259|75807297|FG002|STARTED|Overall Study||6470||
59687779|NCT01169259|75807298|FG003|STARTED|Overall Study||6474||
59687780|NCT01169259|75807295|FG000|COMPLETED|Overall Study||6463||
59687781|NCT01169259|75807296|FG001|COMPLETED|Overall Study||6464||
59687782|NCT01169259|75807297|FG002|COMPLETED|Overall Study||6470||
59687783|NCT01169259|75807298|FG003|COMPLETED|Overall Study||6474||
59687784|NCT01169259|75807295|FG000|NOT COMPLETED|Overall Study||0||
59687785|NCT01169259|75807296|FG001|NOT COMPLETED|Overall Study||0||
59687786|NCT01169259|75807297|FG002|NOT COMPLETED|Overall Study||0||
59687787|NCT01169259|75807298|FG003|NOT COMPLETED|Overall Study||0||
59687788|NCT01163682|75807316|FG000|STARTED|Overall Study||31||
59687789|NCT01163682|75807317|FG001|STARTED|Overall Study||32||
59687790|NCT01163682|75807316|FG000|COMPLETED|Overall Study||25||
59687791|NCT01163682|75807317|FG001|COMPLETED|Overall Study||23||
59687792|NCT01163682|75807316|FG000|NOT COMPLETED|Overall Study||6||
59687793|NCT01163682|75807317|FG001|NOT COMPLETED|Overall Study||9||
59687794|NCT01047007|75807327|FG000|STARTED|Overall Study||3||
59687795|NCT01047007|75807328|FG001|STARTED|Overall Study||6||
59687796|NCT01047007|75807329|FG002|STARTED|Overall Study||2||
59687797|NCT01047007|75807330|FG003|STARTED|Overall Study||0||
59687798|NCT01047007|75807327|FG000|Treated|Overall Study||3||
59687799|NCT01047007|75807328|FG001|Treated|Overall Study||6||
59687800|NCT01047007|75807329|FG002|Treated|Overall Study||2||
59687801|NCT01047007|75807330|FG003|Treated|Overall Study||0||
59687802|NCT01047007|75807327|FG000|COMPLETED|Overall Study||1||
59687803|NCT01047007|75807328|FG001|COMPLETED|Overall Study||0||
59687804|NCT01047007|75807329|FG002|COMPLETED|Overall Study||0||
59687805|NCT01047007|75807330|FG003|COMPLETED|Overall Study||0||
59687806|NCT01047007|75807327|FG000|NOT COMPLETED|Overall Study||2||
59687807|NCT01047007|75807328|FG001|NOT COMPLETED|Overall Study||6||
59687808|NCT01047007|75807329|FG002|NOT COMPLETED|Overall Study||2||
59687809|NCT01047007|75807330|FG003|NOT COMPLETED|Overall Study||0||
59687810|NCT01002872|75807342|FG000|STARTED|Overall Study||10||
59687811|NCT01002872|75807343|FG001|STARTED|Overall Study||9||
59687812|NCT01002872|75807342|FG000|COMPLETED|Overall Study||10||
59687813|NCT01002872|75807343|FG001|COMPLETED|Overall Study||9||
59687814|NCT01002872|75807342|FG000|NOT COMPLETED|Overall Study||0||
59687815|NCT01002872|75807343|FG001|NOT COMPLETED|Overall Study||0||
59687816|NCT00848588|75807349|FG000|STARTED|Overall Study||404||
59687817|NCT00848588|75807349|FG000|COMPLETED|Overall Study||404||
59687818|NCT00848588|75807349|FG000|NOT COMPLETED|Overall Study||0||
59687819|NCT00648648|75807381|FG000|STARTED|Overall Study||3|Started = Randomized|
59687820|NCT00648648|75807382|FG001|STARTED|Overall Study||3|Started = Randomized|
59687821|NCT00648648|75807383|FG002|STARTED|Overall Study||3|Started = Randomized|
59687822|NCT00648648|75807384|FG003|STARTED|Overall Study|Does not include two Part 1 participants who were randomized to this arm.|4|Started = Randomized|
59687823|NCT00648648|75807385|FG004|STARTED|Overall Study||9|Started = Randomized|
59687824|NCT00648648|75807386|FG005|STARTED|Overall Study|Does not include two Part 1 participants who were randomized to this arm.|1|Started = Randomized|
59687825|NCT00648648|75807387|FG006|STARTED|Overall Study|Does not include one Part 1 participant who was randomized to this arm.|10|Started = Randomized|
59687826|NCT00648648|75807388|FG007|STARTED|Overall Study|Does not include two Part 1 participants who were randomized to this arm.|1|Started = Randomized|
59687827|NCT00648648|75807389|FG008|STARTED|Overall Study|Does not include one Part 1 participant who was randomized to this arm.|3|Started = Randomized|
59687828|NCT00648648|75807390|FG009|STARTED|Overall Study||10|Started = Randomized|
59687829|NCT00648648|75807391|FG010|STARTED|Overall Study||6|Started = Randomized|
59687830|NCT00648648|75807392|FG011|STARTED|Overall Study||13|Started = Randomized|
59687831|NCT00648648|75807393|FG012|STARTED|Overall Study||6|Started = Randomized|
59687832|NCT00648648|75807394|FG013|STARTED|Overall Study||5|Started = Randomized|
59687833|NCT00648648|75807395|FG014|STARTED|Overall Study||4|Started = Randomized|
59687834|NCT00648648|75807396|FG015|STARTED|Overall Study||11|Started = Randomized|
59687835|NCT00648648|75807397|FG016|STARTED|Overall Study||16|Started = Randomized|
59687836|NCT00648648|75807398|FG017|STARTED|Overall Study||6|Started = Randomized|
59687837|NCT00648648|75807399|FG018|STARTED|Overall Study||5|Started = Randomized|
59687838|NCT00648648|75807400|FG019|STARTED|Overall Study||7|Started = Randomized|
59687839|NCT00648648|75807401|FG020|STARTED|Overall Study||6|Started = Randomized|
59687840|NCT00648648|75807402|FG021|STARTED|Overall Study||10|Started = Randomized|
59687841|NCT00648648|75807403|FG022|STARTED|Overall Study||14|Started = Randomized|
59687842|NCT00648648|75807404|FG023|STARTED|Overall Study||4|Started = Randomized|
59687843|NCT00648648|75807405|FG024|STARTED|Overall Study||4|Started = Randomized|
59687844|NCT00648648|75807406|FG025|STARTED|Overall Study||4|Started = Randomized|
59687845|NCT00648648|75807407|FG026|STARTED|Overall Study||26|Started = Randomized|
59687846|NCT00648648|75807408|FG027|STARTED|Overall Study||12|Started = Randomized|
59687847|NCT00648648|75807381|FG000|Treated|Overall Study||3||
59687848|NCT00648648|75807382|FG001|Treated|Overall Study||3||
59687849|NCT00648648|75807383|FG002|Treated|Overall Study||3||
59709827|NCT01072149|75828521|FG001|STARTED|Treatment Period 2 (28 Days)||3||
59687850|NCT00648648|75807384|FG003|Treated|Overall Study|Does not include two Part 1 participants who were treated in this arm.|4||
59687851|NCT00648648|75807385|FG004|Treated|Overall Study||8||
59687852|NCT00648648|75807386|FG005|Treated|Overall Study|Does not include two Part 1 participants who were treated in this arm.|1||
59687853|NCT00648648|75807387|FG006|Treated|Overall Study|Does not include one treated participant who was excluded from analysis.|9||
59687854|NCT00648648|75807388|FG007|Treated|Overall Study|Does not include two Part 1 participants who were treated in this arm.|1||
59687855|NCT00648648|75807389|FG008|Treated|Overall Study|Does not include one Part 1 participant who was treated in this arm.|3||
59687856|NCT00648648|75807390|FG009|Treated|Overall Study|Does not include one treated participant who was excluded from analysis.|9||
59687857|NCT00648648|75807391|FG010|Treated|Overall Study||6||
59687858|NCT00648648|75807392|FG011|Treated|Overall Study||13||
59687859|NCT00648648|75807393|FG012|Treated|Overall Study||6||
59687860|NCT00648648|75807394|FG013|Treated|Overall Study||5||
59687861|NCT00648648|75807395|FG014|Treated|Overall Study||4||
59687862|NCT00648648|75807396|FG015|Treated|Overall Study||11||
59687863|NCT00648648|75807397|FG016|Treated|Overall Study||16||
59687864|NCT00648648|75807398|FG017|Treated|Overall Study||6||
59687865|NCT00648648|75807399|FG018|Treated|Overall Study||4||
59687866|NCT00648648|75807400|FG019|Treated|Overall Study||7||
59687867|NCT00648648|75807401|FG020|Treated|Overall Study||6||
59687868|NCT00648648|75807402|FG021|Treated|Overall Study||10||
59687869|NCT00648648|75807403|FG022|Treated|Overall Study||14||
59687870|NCT00648648|75807404|FG023|Treated|Overall Study||4||
59687871|NCT00648648|75807405|FG024|Treated|Overall Study||4||
59687872|NCT00648648|75807406|FG025|Treated|Overall Study||4||
59687873|NCT00648648|75807407|FG026|Treated|Overall Study||26||
59687874|NCT00648648|75807408|FG027|Treated|Overall Study||12||
59687875|NCT00648648|75807381|FG000|COMPLETED|Overall Study||3||
59687876|NCT00648648|75807382|FG001|COMPLETED|Overall Study||3||
59687877|NCT00648648|75807383|FG002|COMPLETED|Overall Study||3||
59687878|NCT00648648|75807384|FG003|COMPLETED|Overall Study||0||
59687879|NCT00648648|75807385|FG004|COMPLETED|Overall Study||0||
59687880|NCT00648648|75807386|FG005|COMPLETED|Overall Study||0||
59687881|NCT00648648|75807387|FG006|COMPLETED|Overall Study||0||
59687882|NCT00648648|75807388|FG007|COMPLETED|Overall Study||0||
59687883|NCT00648648|75807389|FG008|COMPLETED|Overall Study||0||
59687884|NCT00648648|75807390|FG009|COMPLETED|Overall Study||0||
59687885|NCT00648648|75807391|FG010|COMPLETED|Overall Study||0||
59687886|NCT00648648|75807392|FG011|COMPLETED|Overall Study||0||
59687887|NCT00648648|75807393|FG012|COMPLETED|Overall Study||0||
59687888|NCT00648648|75807394|FG013|COMPLETED|Overall Study||0||
59687889|NCT00648648|75807395|FG014|COMPLETED|Overall Study||0||
59687890|NCT00648648|75807396|FG015|COMPLETED|Overall Study||0||
59687891|NCT00648648|75807397|FG016|COMPLETED|Overall Study||2||
59687892|NCT00648648|75807398|FG017|COMPLETED|Overall Study||0||
59687893|NCT00648648|75807399|FG018|COMPLETED|Overall Study||0||
59687894|NCT00648648|75807400|FG019|COMPLETED|Overall Study||0||
59687895|NCT00648648|75807401|FG020|COMPLETED|Overall Study||0||
59687896|NCT00648648|75807402|FG021|COMPLETED|Overall Study||0||
59687897|NCT00648648|75807403|FG022|COMPLETED|Overall Study||0||
59687898|NCT00648648|75807404|FG023|COMPLETED|Overall Study||0||
59687899|NCT00648648|75807405|FG024|COMPLETED|Overall Study||0||
59687900|NCT00648648|75807406|FG025|COMPLETED|Overall Study||0||
59687901|NCT00648648|75807407|FG026|COMPLETED|Overall Study||0||
59687902|NCT00648648|75807408|FG027|COMPLETED|Overall Study||0||
59687903|NCT00648648|75807381|FG000|NOT COMPLETED|Overall Study||0||
59687904|NCT00648648|75807382|FG001|NOT COMPLETED|Overall Study||0||
59687905|NCT00648648|75807383|FG002|NOT COMPLETED|Overall Study||0||
59687906|NCT00648648|75807384|FG003|NOT COMPLETED|Overall Study||4||
59687907|NCT00648648|75807385|FG004|NOT COMPLETED|Overall Study||9||
59687908|NCT00648648|75807386|FG005|NOT COMPLETED|Overall Study||1||
59687909|NCT00648648|75807387|FG006|NOT COMPLETED|Overall Study||10||
59687910|NCT00648648|75807388|FG007|NOT COMPLETED|Overall Study||1||
59687911|NCT00648648|75807389|FG008|NOT COMPLETED|Overall Study||3||
59687912|NCT00648648|75807390|FG009|NOT COMPLETED|Overall Study||10||
59687913|NCT00648648|75807391|FG010|NOT COMPLETED|Overall Study||6||
59687914|NCT00648648|75807392|FG011|NOT COMPLETED|Overall Study||13||
59687915|NCT00648648|75807393|FG012|NOT COMPLETED|Overall Study||6||
59687916|NCT00648648|75807394|FG013|NOT COMPLETED|Overall Study||5||
59687917|NCT00648648|75807395|FG014|NOT COMPLETED|Overall Study||4||
59687918|NCT00648648|75807396|FG015|NOT COMPLETED|Overall Study||11||
59687919|NCT00648648|75807397|FG016|NOT COMPLETED|Overall Study||14||
59687920|NCT00648648|75807398|FG017|NOT COMPLETED|Overall Study||6||
59687921|NCT00648648|75807399|FG018|NOT COMPLETED|Overall Study||5||
59687922|NCT00648648|75807400|FG019|NOT COMPLETED|Overall Study||7||
59687923|NCT00648648|75807401|FG020|NOT COMPLETED|Overall Study||6||
59687924|NCT00648648|75807402|FG021|NOT COMPLETED|Overall Study||10||
59687925|NCT00648648|75807403|FG022|NOT COMPLETED|Overall Study||14||
59687926|NCT00648648|75807404|FG023|NOT COMPLETED|Overall Study||4||
59687927|NCT00648648|75807405|FG024|NOT COMPLETED|Overall Study||4||
59687928|NCT00648648|75807406|FG025|NOT COMPLETED|Overall Study||4||
59687929|NCT00648648|75807407|FG026|NOT COMPLETED|Overall Study||26||
59687930|NCT00648648|75807408|FG027|NOT COMPLETED|Overall Study||12||
59687931|NCT00614172|75807466|FG000|STARTED|Overall Study||50||
59687932|NCT00614172|75807466|FG000|COMPLETED|Overall Study||50||
59687933|NCT00614172|75807466|FG000|NOT COMPLETED|Overall Study||0||
59687934|NCT00546351|75807470|FG000|STARTED|Overall Study||621||
59687935|NCT00546351|75807470|FG000|COMPLETED|Overall Study||385||
59687936|NCT00546351|75807470|FG000|NOT COMPLETED|Overall Study||236||
59687937|NCT00536172|75807476|FG000|STARTED|Overall Study||74||
59687938|NCT00536172|75807477|FG001|STARTED|Overall Study||74||
59687939|NCT00536172|75807476|FG000|COMPLETED|Overall Study||60||
59687940|NCT00536172|75807477|FG001|COMPLETED|Overall Study||65||
59687941|NCT00536172|75807476|FG000|NOT COMPLETED|Overall Study||14||
59687942|NCT00536172|75807477|FG001|NOT COMPLETED|Overall Study||9||
59687943|NCT00003838|75807486|FG000|STARTED|Overall Study||102||
59687944|NCT00003838|75807487|FG001|STARTED|Overall Study||43||
59687945|NCT00003838|75807488|FG002|STARTED|Overall Study||57||
59687946|NCT00003838|75807486|FG000|COMPLETED|Overall Study||102||
59687947|NCT00003838|75807487|FG001|COMPLETED|Overall Study||18||
59687948|NCT00003838|75807488|FG002|COMPLETED|Overall Study||49||
59687949|NCT00003838|75807486|FG000|NOT COMPLETED|Overall Study||0||
59687950|NCT00003838|75807487|FG001|NOT COMPLETED|Overall Study||25||
59687951|NCT00003838|75807488|FG002|NOT COMPLETED|Overall Study||8||
59687952|NCT04852055|75807497|FG000|STARTED|Overall Study||1270||80
59687953|NCT04852055|75807498|FG001|STARTED|Overall Study||1341||80
59687954|NCT04852055|75807497|FG000|COMPLETED|Overall Study||1138||79
59687955|NCT04852055|75807498|FG001|COMPLETED|Overall Study||1205||80
59687956|NCT04852055|75807497|FG000|NOT COMPLETED|Overall Study||132||1
59687957|NCT04852055|75807498|FG001|NOT COMPLETED|Overall Study||136||0
59687958|NCT04724291|75807504|FG000|STARTED|Overall Study||43||
59687959|NCT04724291|75807504|FG000|COMPLETED|Overall Study||40||
59687960|NCT04724291|75807504|FG000|NOT COMPLETED|Overall Study||3||
59687961|NCT04620213|75807510|FG000|STARTED|Overall Study||94||
59687962|NCT04620213|75807511|FG001|STARTED|Overall Study||91||
59687963|NCT04620213|75807510|FG000|COMPLETED|Overall Study||94||
59687964|NCT04620213|75807511|FG001|COMPLETED|Overall Study||91||
59687965|NCT04620213|75807510|FG000|NOT COMPLETED|Overall Study||0||
59687966|NCT04620213|75807511|FG001|NOT COMPLETED|Overall Study||0||
59687967|NCT04276883|75807520|FG000|STARTED|Overall Study||127||
59687968|NCT04276883|75807521|FG001|STARTED|Overall Study||127||
59687969|NCT04276883|75807522|FG002|STARTED|Overall Study||126||
59687970|NCT04276883|75807520|FG000|COMPLETED|Overall Study||123||
59687971|NCT04276883|75807521|FG001|COMPLETED|Overall Study||119||
59687972|NCT04276883|75807522|FG002|COMPLETED|Overall Study||120||
59687973|NCT04276883|75807520|FG000|NOT COMPLETED|Overall Study||4||
59687974|NCT04276883|75807521|FG001|NOT COMPLETED|Overall Study||8||
59687975|NCT04276883|75807522|FG002|NOT COMPLETED|Overall Study||6||
59687976|NCT04099888|75807532|FG000|STARTED|Overall Study||21||
59687977|NCT04099888|75807533|FG001|STARTED|Overall Study||20||
59687978|NCT04099888|75807532|FG000|COMPLETED|Overall Study||0||
59687979|NCT04099888|75807533|FG001|COMPLETED|Overall Study||0||
59687980|NCT04099888|75807532|FG000|NOT COMPLETED|Overall Study||21||
59687981|NCT04099888|75807533|FG001|NOT COMPLETED|Overall Study||20||
59687982|NCT04081389|75807543|FG000|STARTED|Overall Study||1||
59687983|NCT04081389|75807544|FG001|STARTED|Overall Study||1||
59687984|NCT04081389|75807545|FG002|STARTED|Overall Study||4||
59687985|NCT04081389|75807546|FG003|STARTED|Overall Study||3||
59687986|NCT04081389|75807543|FG000|COMPLETED|Overall Study||1||
59687987|NCT04081389|75807544|FG001|COMPLETED|Overall Study||1||
59687988|NCT04081389|75807545|FG002|COMPLETED|Overall Study||3||
59687989|NCT04081389|75807546|FG003|COMPLETED|Overall Study||3||
59687990|NCT04081389|75807543|FG000|NOT COMPLETED|Overall Study||0||
59687991|NCT04081389|75807544|FG001|NOT COMPLETED|Overall Study||0||
59687992|NCT04081389|75807545|FG002|NOT COMPLETED|Overall Study||1||
59687993|NCT04081389|75807546|FG003|NOT COMPLETED|Overall Study||0||
59687994|NCT04032080|75807556|FG000|STARTED|Overall Study||10||
59687995|NCT04032080|75807556|FG000|COMPLETED|Overall Study||4||
59687996|NCT04032080|75807556|FG000|NOT COMPLETED|Overall Study||6||
59687997|NCT03912818|75807562|FG000|STARTED|Overall Study||3||
59687998|NCT03912818|75807563|FG001|STARTED|Overall Study||0||
59687999|NCT03912818|75807564|FG002|STARTED|Overall Study||3||
59688000|NCT03912818|75807562|FG000|COMPLETED|Overall Study||3||
59688001|NCT03912818|75807563|FG001|COMPLETED|Overall Study||0||
59688002|NCT03912818|75807564|FG002|COMPLETED|Overall Study||3||
59688003|NCT03912818|75807562|FG000|NOT COMPLETED|Overall Study||0||
59688004|NCT03912818|75807563|FG001|NOT COMPLETED|Overall Study||0||
59688005|NCT03912818|75807564|FG002|NOT COMPLETED|Overall Study||0||
59688006|NCT03781323|75807570|FG000|STARTED|Overall Study||12||
59688007|NCT03781323|75807570|FG000|COMPLETED|Overall Study||11||
59688008|NCT03781323|75807570|FG000|NOT COMPLETED|Overall Study||1||
59688009|NCT03729362|75807576|FG000|STARTED|Overall Study||85||
59688010|NCT03729362|75807577|FG001|STARTED|Overall Study|Two subjects randomized to this group never dosed because genotyping did not confirm diagnosis of Pompe disease.|40||
59688011|NCT03729362|75807576|FG000|Received at Least 1 Dose of Study Drug|Overall Study||85||
59688012|NCT03729362|75807577|FG001|Received at Least 1 Dose of Study Drug|Overall Study||38||
59688013|NCT03729362|75807576|FG000|COMPLETED|Overall Study||80||
59688014|NCT03729362|75807577|FG001|COMPLETED|Overall Study||37||
59688015|NCT03729362|75807576|FG000|NOT COMPLETED|Overall Study||5||
59688016|NCT03729362|75807577|FG001|NOT COMPLETED|Overall Study||3||
59688017|NCT03453385|75807594|FG000|STARTED|Overall Study||211||
59688018|NCT03453385|75807595|FG001|STARTED|Overall Study||427||
59688019|NCT03453385|75807594|FG000|COMPLETED|Overall Study||211||
59688020|NCT03453385|75807595|FG001|COMPLETED|Overall Study||427||
59688021|NCT03453385|75807594|FG000|NOT COMPLETED|Overall Study||0||
59688022|NCT03453385|75807595|FG001|NOT COMPLETED|Overall Study||0||
59688023|NCT03340766|75807604|FG000|STARTED|Overall Study||12||
59688024|NCT03340766|75807605|FG001|STARTED|Overall Study||10||
59688025|NCT03340766|75807606|FG002|STARTED|Overall Study||9||
59688026|NCT03340766|75807604|FG000|Received Blinatumomab|Overall Study||12||
59688027|NCT03340766|75807605|FG001|Received Blinatumomab|Overall Study||10||
59688028|NCT03340766|75807606|FG002|Received Blinatumomab|Overall Study||9||
59688029|NCT03340766|75807604|FG000|Received Pembrolizumab|Overall Study||10||
59688030|NCT03340766|75807605|FG001|Received Pembrolizumab|Overall Study||7||
59688031|NCT03340766|75807606|FG002|Received Pembrolizumab|Overall Study||7||
59688032|NCT03340766|75807604|FG000|COMPLETED|Overall Study||1||
59688033|NCT03340766|75807605|FG001|COMPLETED|Overall Study||0||
59688034|NCT03340766|75807606|FG002|COMPLETED|Overall Study||0||
59688035|NCT03340766|75807604|FG000|NOT COMPLETED|Overall Study||11||
59688036|NCT03340766|75807605|FG001|NOT COMPLETED|Overall Study||10||
59688037|NCT03340766|75807606|FG002|NOT COMPLETED|Overall Study||9||
59688038|NCT03190265|75807622|FG000|STARTED|Overall Study||31||
59688039|NCT03190265|75807623|FG001|STARTED|Overall Study||30||
59688040|NCT03190265|75807622|FG000|COMPLETED|Overall Study||11||
59688041|NCT03190265|75807623|FG001|COMPLETED|Overall Study||8||
59688042|NCT03190265|75807622|FG000|NOT COMPLETED|Overall Study||20||
59688043|NCT03190265|75807623|FG001|NOT COMPLETED|Overall Study||22||
59688044|NCT03057119|75807632|FG000|STARTED|Overall Study||17||
59688045|NCT03057119|75807633|FG001|STARTED|Overall Study||17||
59688046|NCT03057119|75807634|FG002|STARTED|Overall Study||52||
59688047|NCT03057119|75807632|FG000|Completed T1|Overall Study||17||
59688048|NCT03057119|75807633|FG001|Completed T1|Overall Study||17||
59688049|NCT03057119|75807634|FG002|Completed T1|Overall Study||45||
59688050|NCT03057119|75807632|FG000|Completed T2|Overall Study||9||
59688051|NCT03057119|75807633|FG001|Completed T2|Overall Study||5||
59688052|NCT03057119|75807634|FG002|Completed T2|Overall Study||30||
59688053|NCT03057119|75807632|FG000|Completed T3|Overall Study||4||
59688054|NCT03057119|75807633|FG001|Completed T3|Overall Study||3||
59688055|NCT03057119|75807634|FG002|Completed T3|Overall Study||35||
59688056|NCT03057119|75807632|FG000|COMPLETED|Overall Study||4|Completed all 3 assessments|
59688057|NCT03057119|75807633|FG001|COMPLETED|Overall Study||3|Completed all 3 assessments|
59688058|NCT03057119|75807634|FG002|COMPLETED|Overall Study||13|Completed all 3 assessments|
59688059|NCT03057119|75807632|FG000|NOT COMPLETED|Overall Study||13||
59688060|NCT03057119|75807633|FG001|NOT COMPLETED|Overall Study||14||
59688061|NCT03057119|75807634|FG002|NOT COMPLETED|Overall Study||39||
59688062|NCT02711852|75807642|FG000|STARTED|Overall Study||19||
59688063|NCT02711852|75807642|FG000|Received At Least 1 Dose of Study Drug|Overall Study||19||
59688064|NCT02711852|75807642|FG000|COMPLETED|Overall Study||9||
59688065|NCT02711852|75807642|FG000|NOT COMPLETED|Overall Study||10||
59688066|NCT02573779|75807648|FG000|STARTED|Overall Study||74||
59688067|NCT02573779|75807649|FG001|STARTED|Overall Study||43||
59688068|NCT02573779|75807648|FG000|COMPLETED|Overall Study||74||
59688069|NCT02573779|75807649|FG001|COMPLETED|Overall Study||43||
59688070|NCT02573779|75807648|FG000|NOT COMPLETED|Overall Study||0||
59688071|NCT02573779|75807649|FG001|NOT COMPLETED|Overall Study||0||
59688072|NCT02221934|75807657|FG000|STARTED|Screening||0||
59688073|NCT02221934|75807658|FG001|STARTED|Screening||0||
59688074|NCT02221934|75807659|FG002|STARTED|Screening||607||
59688075|NCT02221934|75807657|FG000|COMPLETED|Screening||0||
59688076|NCT02221934|75807658|FG001|COMPLETED|Screening||0||
59688077|NCT02221934|75807659|FG002|COMPLETED|Screening||183||
59688078|NCT02221934|75807657|FG000|NOT COMPLETED|Screening||0||
59688079|NCT02221934|75807658|FG001|NOT COMPLETED|Screening||0||
59688080|NCT02221934|75807659|FG002|NOT COMPLETED|Screening||424||
59688081|NCT02221934|75807657|FG000|STARTED|Device Activation||0||
59688082|NCT02221934|75807658|FG001|STARTED|Device Activation||0||
59688083|NCT02221934|75807659|FG002|STARTED|Device Activation||183||
59688084|NCT02221934|75807657|FG000|Primary Safety Analysis Cohort|Device Activation||0||
59688085|NCT02221934|75807658|FG001|Primary Safety Analysis Cohort|Device Activation||0||
59688086|NCT02221934|75807659|FG002|Primary Safety Analysis Cohort|Device Activation||183||
59688087|NCT02221934|75807657|FG000|Successful Implant|Device Activation||0||
59688088|NCT02221934|75807658|FG001|Successful Implant|Device Activation||0||
59688089|NCT02221934|75807659|FG002|Successful Implant|Device Activation||180||
59688090|NCT02221934|75807657|FG000|COMPLETED|Device Activation||0||
59688091|NCT02221934|75807658|FG001|COMPLETED|Device Activation||0||
59688092|NCT02221934|75807659|FG002|COMPLETED|Device Activation||178||
59688093|NCT02221934|75807657|FG000|NOT COMPLETED|Device Activation||0||
59688094|NCT02221934|75807658|FG001|NOT COMPLETED|Device Activation||0||
59688095|NCT02221934|75807659|FG002|NOT COMPLETED|Device Activation||5||
59688096|NCT02221934|75807657|FG000|STARTED|Randomized Testing (Month 1 to Month 3)||87||
59688097|NCT02221934|75807658|FG001|STARTED|Randomized Testing (Month 1 to Month 3)||91||
59688098|NCT02221934|75807659|FG002|STARTED|Randomized Testing (Month 1 to Month 3)||0||
59688099|NCT02221934|75807657|FG000|Successful Randomization|Randomized Testing (Month 1 to Month 3)||87||
59688100|NCT02221934|75807658|FG001|Successful Randomization|Randomized Testing (Month 1 to Month 3)||91||
59688101|NCT02221934|75807659|FG002|Successful Randomization|Randomized Testing (Month 1 to Month 3)||0||
59688102|NCT02221934|75807657|FG000|Successful Device Use (Primary Effectiveness Analysis Cohort)|Randomized Testing (Month 1 to Month 3)||85||
59688103|NCT02221934|75807658|FG001|Successful Device Use (Primary Effectiveness Analysis Cohort)|Randomized Testing (Month 1 to Month 3)||85||
59688104|NCT02221934|75807659|FG002|Successful Device Use (Primary Effectiveness Analysis Cohort)|Randomized Testing (Month 1 to Month 3)||0||
59688105|NCT02221934|75807657|FG000|COMPLETED|Randomized Testing (Month 1 to Month 3)||82||
59688106|NCT02221934|75807658|FG001|COMPLETED|Randomized Testing (Month 1 to Month 3)||83||
59688107|NCT02221934|75807659|FG002|COMPLETED|Randomized Testing (Month 1 to Month 3)||0||
59688108|NCT02221934|75807657|FG000|NOT COMPLETED|Randomized Testing (Month 1 to Month 3)||5||
59688109|NCT02221934|75807658|FG001|NOT COMPLETED|Randomized Testing (Month 1 to Month 3)||8||
59688110|NCT02221934|75807659|FG002|NOT COMPLETED|Randomized Testing (Month 1 to Month 3)||0||
59688111|NCT02221934|75807657|FG000|STARTED|Follow-up (Month 3 to Month 12)||82||
59688112|NCT02221934|75807658|FG001|STARTED|Follow-up (Month 3 to Month 12)||83||
59688113|NCT02221934|75807659|FG002|STARTED|Follow-up (Month 3 to Month 12)||0||
59688114|NCT02221934|75807657|FG000|COMPLETED|Follow-up (Month 3 to Month 12)||74||
59688115|NCT02221934|75807658|FG001|COMPLETED|Follow-up (Month 3 to Month 12)||75||
59688116|NCT02221934|75807659|FG002|COMPLETED|Follow-up (Month 3 to Month 12)||0||
59688117|NCT02221934|75807657|FG000|NOT COMPLETED|Follow-up (Month 3 to Month 12)||8||
59688118|NCT02221934|75807658|FG001|NOT COMPLETED|Follow-up (Month 3 to Month 12)||8||
59688119|NCT02221934|75807659|FG002|NOT COMPLETED|Follow-up (Month 3 to Month 12)||0||
59688120|NCT02143128|75807668|FG000|STARTED|Overall Study||409||
59688121|NCT02143128|75807669|FG001|STARTED|Overall Study||417||
59688122|NCT02143128|75807670|FG002|STARTED|Overall Study||326||
59688123|NCT02143128|75807668|FG000|COMPLETED|Overall Study||409||
59688124|NCT02143128|75807669|FG001|COMPLETED|Overall Study||417||
59688125|NCT02143128|75807670|FG002|COMPLETED|Overall Study||326||
59688126|NCT02143128|75807668|FG000|NOT COMPLETED|Overall Study||0||
59688127|NCT02143128|75807669|FG001|NOT COMPLETED|Overall Study||0||
59688128|NCT02143128|75807670|FG002|NOT COMPLETED|Overall Study||0||
59688129|NCT01977417|75807680|FG000|STARTED|Overall Study||8||
59688130|NCT01977417|75807681|FG001|STARTED|Overall Study||13||
59688131|NCT01977417|75807680|FG000|COMPLETED|Overall Study||5||
59688132|NCT01977417|75807681|FG001|COMPLETED|Overall Study||7||
59688133|NCT01977417|75807680|FG000|NOT COMPLETED|Overall Study||3||
59688134|NCT01977417|75807681|FG001|NOT COMPLETED|Overall Study||6||
59688135|NCT01951885|75807689|FG000|STARTED|Overall Study||50||
59688136|NCT01951885|75807690|FG001|STARTED|Overall Study||51||
59688137|NCT01951885|75807689|FG000|COMPLETED|Overall Study||49||
59688138|NCT01951885|75807690|FG001|COMPLETED|Overall Study||47||
59688139|NCT01951885|75807689|FG000|NOT COMPLETED|Overall Study||1||
59688140|NCT01951885|75807690|FG001|NOT COMPLETED|Overall Study||4||
59688141|NCT00626990|75807700|FG000|STARTED|Overall Study||189||
59688142|NCT00626990|75807701|FG001|STARTED|Overall Study||188||
59688143|NCT00626990|75807702|FG002|STARTED|Overall Study||186||
59688144|NCT00626990|75807703|FG003|STARTED|Overall Study||188||
59688145|NCT00626990|75807700|FG000|COMPLETED|Overall Study||175||
59688146|NCT00626990|75807701|FG001|COMPLETED|Overall Study||163||
59688147|NCT00626990|75807702|FG002|COMPLETED|Overall Study||109||
59688148|NCT00626990|75807703|FG003|COMPLETED|Overall Study||93||
59688149|NCT00626990|75807700|FG000|NOT COMPLETED|Overall Study||14||
59688150|NCT00626990|75807701|FG001|NOT COMPLETED|Overall Study||25||
59688151|NCT00626990|75807702|FG002|NOT COMPLETED|Overall Study||77||
59688152|NCT00626990|75807703|FG003|NOT COMPLETED|Overall Study||95||
59688153|NCT00107198|75807717|FG000|STARTED|Overall Study||188||
59688154|NCT00107198|75807717|FG000|COMPLETED|Overall Study||136||
59688155|NCT00107198|75807717|FG000|NOT COMPLETED|Overall Study||52||
59688156|NCT02754557|75807723|FG000|STARTED|Overall Study||27||
59688157|NCT02754557|75807724|FG001|STARTED|Overall Study||38||
59688158|NCT02754557|75807723|FG000|Completed Post-treatment Assessment at Week 4|Overall Study||27||
59688159|NCT02754557|75807724|FG001|Completed Post-treatment Assessment at Week 4|Overall Study||38||
59688160|NCT02754557|75807723|FG000|Completed One-month Post-treatment Assessment at Week 8|Overall Study||19||
59688161|NCT02754557|75807724|FG001|Completed One-month Post-treatment Assessment at Week 8|Overall Study||32||
59688162|NCT02754557|75807723|FG000|COMPLETED|Overall Study||27|Completed the primary aim of the study which was the post-treatment follow up assessment at Week 4.|
59688163|NCT02754557|75807724|FG001|COMPLETED|Overall Study||38|Completed the primary aim of the study which was the post-treatment follow up assessment at Week 4.|
59688164|NCT02754557|75807723|FG000|NOT COMPLETED|Overall Study||0||
59688165|NCT02754557|75807724|FG001|NOT COMPLETED|Overall Study||0||
59688166|NCT01193920|75807740|FG000|STARTED|Overall Study||40||
59688167|NCT01193920|75807741|FG001|STARTED|Overall Study||20||
59688168|NCT01193920|75807742|FG002|STARTED|Overall Study||80||
59688169|NCT01193920|75807743|FG003|STARTED|Overall Study||80||
59688170|NCT01193920|75807744|FG004|STARTED|Overall Study||80||
59688171|NCT01193920|75807745|FG005|STARTED|Overall Study||80||
59688172|NCT01193920|75807746|FG006|STARTED|Overall Study||80||
59688173|NCT01193920|75807747|FG007|STARTED|Overall Study||80||
59688174|NCT01193920|75807748|FG008|STARTED|Overall Study||76||
59688175|NCT01193920|75807749|FG009|STARTED|Overall Study||81||
59688176|NCT01193920|75807740|FG000|COMPLETED|Overall Study||37||
59688177|NCT01193920|75807741|FG001|COMPLETED|Overall Study||20||
59688178|NCT01193920|75807742|FG002|COMPLETED|Overall Study||74||
59688179|NCT01193920|75807743|FG003|COMPLETED|Overall Study||76||
59688180|NCT01193920|75807744|FG004|COMPLETED|Overall Study||74||
59688181|NCT01193920|75807745|FG005|COMPLETED|Overall Study||76||
59688182|NCT01193920|75807746|FG006|COMPLETED|Overall Study||74||
59688183|NCT01193920|75807747|FG007|COMPLETED|Overall Study||76||
59688184|NCT01193920|75807748|FG008|COMPLETED|Overall Study||71||
59688185|NCT01193920|75807749|FG009|COMPLETED|Overall Study||74||
59688186|NCT01193920|75807740|FG000|NOT COMPLETED|Overall Study||3||
59688187|NCT01193920|75807741|FG001|NOT COMPLETED|Overall Study||0||
59688188|NCT01193920|75807742|FG002|NOT COMPLETED|Overall Study||6||
59688189|NCT01193920|75807743|FG003|NOT COMPLETED|Overall Study||4||
59688190|NCT01193920|75807744|FG004|NOT COMPLETED|Overall Study||6||
59688191|NCT01193920|75807745|FG005|NOT COMPLETED|Overall Study||4||
59688192|NCT01193920|75807746|FG006|NOT COMPLETED|Overall Study||6||
59688193|NCT01193920|75807747|FG007|NOT COMPLETED|Overall Study||4||
59688194|NCT01193920|75807748|FG008|NOT COMPLETED|Overall Study||5||
59688195|NCT01193920|75807749|FG009|NOT COMPLETED|Overall Study||7||
59688196|NCT01193686|75807774|FG000|STARTED|Overall Study||15||
59688197|NCT01193686|75807775|FG001|STARTED|Overall Study||9||
59547485|NCT02517567|75646296|FG003|COMPLETED|Second Exposure (8 Hours)||8||
59547486|NCT02517567|75646293|FG000|NOT COMPLETED|Second Exposure (8 Hours)||0||
59547487|NCT02517567|75646294|FG001|NOT COMPLETED|Second Exposure (8 Hours)||0||
59547488|NCT02517567|75646295|FG002|NOT COMPLETED|Second Exposure (8 Hours)||0||
59547489|NCT02517567|75646296|FG003|NOT COMPLETED|Second Exposure (8 Hours)||0||
59688198|NCT01193686|75807774|FG000|Completed Baseline Assessment|Overall Study||15||
59688199|NCT01193686|75807775|FG001|Completed Baseline Assessment|Overall Study||9||
59688200|NCT01193686|75807774|FG000|Completed Mentor Training|Overall Study||9||
59688201|NCT01193686|75807775|FG001|Completed Mentor Training|Overall Study|Not applicable. Recipients were not required to complete training.|0||
59688202|NCT01193686|75807774|FG000|Completed Visits and Final Assessment|Overall Study||8||
59688203|NCT01193686|75807775|FG001|Completed Visits and Final Assessment|Overall Study||8||
59688204|NCT01193686|75807774|FG000|COMPLETED|Overall Study||8||
59688205|NCT01193686|75807775|FG001|COMPLETED|Overall Study||8||
59688206|NCT01193686|75807774|FG000|NOT COMPLETED|Overall Study||7||
59688207|NCT01193686|75807775|FG001|NOT COMPLETED|Overall Study||1||
59688208|NCT01193608|75807788|FG000|STARTED|Overall Study||6||
59688209|NCT01193608|75807789|FG001|STARTED|Overall Study||6||
59688210|NCT01193608|75807790|FG002|STARTED|Overall Study||16||
59688211|NCT01193608|75807791|FG003|STARTED|Overall Study||17||
59688212|NCT01193608|75807792|FG004|STARTED|Overall Study||24||
59688213|NCT01193608|75807793|FG005|STARTED|Overall Study||19||
59688214|NCT01193608|75807788|FG000|COMPLETED|Overall Study||6||
59688215|NCT01193608|75807789|FG001|COMPLETED|Overall Study||4||
59688216|NCT01193608|75807790|FG002|COMPLETED|Overall Study||14||
59688217|NCT01193608|75807791|FG003|COMPLETED|Overall Study||14||
59688218|NCT01193608|75807792|FG004|COMPLETED|Overall Study||19||
59688219|NCT01193608|75807793|FG005|COMPLETED|Overall Study||17||
59688220|NCT01193608|75807788|FG000|NOT COMPLETED|Overall Study||0||
59688221|NCT01193608|75807789|FG001|NOT COMPLETED|Overall Study||2||
59688222|NCT01193608|75807790|FG002|NOT COMPLETED|Overall Study||2||
59688223|NCT01193608|75807791|FG003|NOT COMPLETED|Overall Study||3||
59688224|NCT01193608|75807792|FG004|NOT COMPLETED|Overall Study||5||
59688225|NCT01193608|75807793|FG005|NOT COMPLETED|Overall Study||2||
59688226|NCT01177228|75807816|FG000|STARTED|Overall Study||9||
59688227|NCT01177228|75807817|FG001|STARTED|Overall Study||13||
59688228|NCT01177228|75807818|FG002|STARTED|Overall Study||14||
59688229|NCT01177228|75807819|FG003|STARTED|Overall Study||11||
59688230|NCT01177228|75807816|FG000|Received Treatment|Overall Study||9||
59688231|NCT01177228|75807817|FG001|Received Treatment|Overall Study||12||
59688232|NCT01177228|75807818|FG002|Received Treatment|Overall Study||14||
59688233|NCT01177228|75807819|FG003|Received Treatment|Overall Study||11||
59688234|NCT01177228|75807816|FG000|COMPLETED|Overall Study||8||
59688235|NCT01177228|75807817|FG001|COMPLETED|Overall Study||11||
59688236|NCT01177228|75807818|FG002|COMPLETED|Overall Study||14||
59688237|NCT01177228|75807819|FG003|COMPLETED|Overall Study||11||
59688238|NCT01177228|75807816|FG000|NOT COMPLETED|Overall Study||1||
59688239|NCT01177228|75807817|FG001|NOT COMPLETED|Overall Study||2||
59688240|NCT01177228|75807818|FG002|NOT COMPLETED|Overall Study||0||
59688241|NCT01177228|75807819|FG003|NOT COMPLETED|Overall Study||0||
59688242|NCT01193530|75807836|FG000|STARTED|Overall Study||4||
59688243|NCT01193530|75807837|FG001|STARTED|Overall Study||8||
59688244|NCT01193530|75807836|FG000|COMPLETED|Overall Study||1||
59688245|NCT01193530|75807837|FG001|COMPLETED|Overall Study||3||
59688246|NCT01193530|75807836|FG000|NOT COMPLETED|Overall Study||3||
59688247|NCT01193530|75807837|FG001|NOT COMPLETED|Overall Study||5||
59688248|NCT00107172|75807845|FG000|STARTED|Overall Study||114||
59688249|NCT00107172|75807846|FG001|STARTED|Overall Study||108||
59688250|NCT00107172|75807845|FG000|COMPLETED|Overall Study||109||
59688251|NCT00107172|75807846|FG001|COMPLETED|Overall Study||103||
59688252|NCT00107172|75807845|FG000|NOT COMPLETED|Overall Study||5||
59688253|NCT00107172|75807846|FG001|NOT COMPLETED|Overall Study||5||
59688254|NCT01684826|75807852|FG000|STARTED|Overall Study||49||
59688255|NCT01684826|75807852|FG000|Collected Dose and Image Information|Overall Study||39||
59688256|NCT01684826|75807852|FG000|COMPLETED|Overall Study||39||
59688257|NCT01684826|75807852|FG000|NOT COMPLETED|Overall Study||10||
59688258|NCT01680965|75807860|FG000|STARTED|Overall Study||3||
59688259|NCT01680965|75807861|FG001|STARTED|Overall Study||3||
59688260|NCT01680965|75807862|FG002|STARTED|Overall Study||6||
59688261|NCT01680965|75807863|FG003|STARTED|Overall Study||32||
59688262|NCT01680965|75807860|FG000|COMPLETED|Overall Study||3||
59688263|NCT01680965|75807861|FG001|COMPLETED|Overall Study||3||
59688264|NCT01680965|75807862|FG002|COMPLETED|Overall Study||6||
59688265|NCT01680965|75807863|FG003|COMPLETED|Overall Study||26||
59688266|NCT01680965|75807860|FG000|NOT COMPLETED|Overall Study||0||
59688267|NCT01680965|75807861|FG001|NOT COMPLETED|Overall Study||0||
59688268|NCT01680965|75807862|FG002|NOT COMPLETED|Overall Study||0||
59688269|NCT01680965|75807863|FG003|NOT COMPLETED|Overall Study||6||
59688270|NCT01339923|75807878|FG000|STARTED|Overall Study||253||
59688271|NCT01339923|75807879|FG001|STARTED|Overall Study||250||
59688272|NCT01339923|75807880|FG002|STARTED|Overall Study||251||
59688273|NCT01339923|75807881|FG003|STARTED|Overall Study||104||
59688274|NCT01339923|75807882|FG004|STARTED|Overall Study||300||
59688275|NCT01339923|75807883|FG005|STARTED|Overall Study||126||
59688276|NCT01339923|75807884|FG006|STARTED|Overall Study||125||
59688277|NCT01339923|75807878|FG000|COMPLETED|Overall Study||239||
59688278|NCT01339923|75807879|FG001|COMPLETED|Overall Study||234||
59688279|NCT01339923|75807880|FG002|COMPLETED|Overall Study||243||
59688280|NCT01339923|75807881|FG003|COMPLETED|Overall Study||100||
59688281|NCT01339923|75807882|FG004|COMPLETED|Overall Study||295||
59688282|NCT01339923|75807883|FG005|COMPLETED|Overall Study||117||
59688283|NCT01339923|75807884|FG006|COMPLETED|Overall Study||111||
59688284|NCT01339923|75807878|FG000|NOT COMPLETED|Overall Study||14||
59688285|NCT01339923|75807879|FG001|NOT COMPLETED|Overall Study||16||
59688286|NCT01339923|75807880|FG002|NOT COMPLETED|Overall Study||8||
59688287|NCT01339923|75807881|FG003|NOT COMPLETED|Overall Study||4||
59688288|NCT01339923|75807882|FG004|NOT COMPLETED|Overall Study||5||
59688289|NCT01339923|75807883|FG005|NOT COMPLETED|Overall Study||9||
59688290|NCT01339923|75807884|FG006|NOT COMPLETED|Overall Study||14||
59688291|NCT04615832|75807913|FG000|STARTED|Overall Study||44||
59688292|NCT04615832|75807913|FG000|COMPLETED|Overall Study||44||
59688293|NCT04615832|75807913|FG000|NOT COMPLETED|Overall Study||0||
59688294|NCT01380093|75807917|FG000|STARTED|Naloxone Challenge Phase||80||
59688295|NCT01380093|75807918|FG001|STARTED|Naloxone Challenge Phase||0||
59688296|NCT01380093|75807919|FG002|STARTED|Naloxone Challenge Phase||0||
59688297|NCT01380093|75807920|FG003|STARTED|Naloxone Challenge Phase||0||
59688298|NCT01380093|75807921|FG004|STARTED|Naloxone Challenge Phase||0||
59688299|NCT01380093|75807922|FG005|STARTED|Naloxone Challenge Phase||0||
59688300|NCT01380093|75807923|FG006|STARTED|Naloxone Challenge Phase||0||
59688301|NCT01380093|75807924|FG007|STARTED|Naloxone Challenge Phase||0||
59688302|NCT01380093|75807925|FG008|STARTED|Naloxone Challenge Phase||0||
59688303|NCT01380093|75807917|FG000|TREATED|Naloxone Challenge Phase||59||
59688304|NCT01380093|75807918|FG001|TREATED|Naloxone Challenge Phase||0||
59688305|NCT01380093|75807919|FG002|TREATED|Naloxone Challenge Phase||0||
59688306|NCT01380093|75807920|FG003|TREATED|Naloxone Challenge Phase||0||
59688307|NCT01380093|75807921|FG004|TREATED|Naloxone Challenge Phase||0||
59688308|NCT01380093|75807922|FG005|TREATED|Naloxone Challenge Phase||0||
59688309|NCT01380093|75807923|FG006|TREATED|Naloxone Challenge Phase||0||
59688310|NCT01380093|75807924|FG007|TREATED|Naloxone Challenge Phase||0||
59688311|NCT01380093|75807925|FG008|TREATED|Naloxone Challenge Phase||0||
59688312|NCT01380093|75807917|FG000|COMPLETED|Naloxone Challenge Phase||59||
59688313|NCT01380093|75807918|FG001|COMPLETED|Naloxone Challenge Phase||0||
59688314|NCT01380093|75807919|FG002|COMPLETED|Naloxone Challenge Phase||0||
59688315|NCT01380093|75807920|FG003|COMPLETED|Naloxone Challenge Phase||0||
59688316|NCT01380093|75807921|FG004|COMPLETED|Naloxone Challenge Phase||0||
59688317|NCT01380093|75807922|FG005|COMPLETED|Naloxone Challenge Phase||0||
59688318|NCT01380093|75807923|FG006|COMPLETED|Naloxone Challenge Phase||0||
59688319|NCT01380093|75807924|FG007|COMPLETED|Naloxone Challenge Phase||0||
59688320|NCT01380093|75807925|FG008|COMPLETED|Naloxone Challenge Phase||0||
59688321|NCT01380093|75807917|FG000|NOT COMPLETED|Naloxone Challenge Phase||21||
59688322|NCT01380093|75807918|FG001|NOT COMPLETED|Naloxone Challenge Phase||0||
59688323|NCT01380093|75807919|FG002|NOT COMPLETED|Naloxone Challenge Phase||0||
59688324|NCT01380093|75807920|FG003|NOT COMPLETED|Naloxone Challenge Phase||0||
59688325|NCT01380093|75807921|FG004|NOT COMPLETED|Naloxone Challenge Phase||0||
59688326|NCT01380093|75807922|FG005|NOT COMPLETED|Naloxone Challenge Phase||0||
59688327|NCT01380093|75807923|FG006|NOT COMPLETED|Naloxone Challenge Phase||0||
59688328|NCT01380093|75807924|FG007|NOT COMPLETED|Naloxone Challenge Phase||0||
59688329|NCT01380093|75807925|FG008|NOT COMPLETED|Naloxone Challenge Phase||0||
59688330|NCT01380093|75807917|FG000|STARTED|Drug Discrimination Phase: Day 1||0||
59688331|NCT01380093|75807918|FG001|STARTED|Drug Discrimination Phase: Day 1||30||
59688332|NCT01380093|75807919|FG002|STARTED|Drug Discrimination Phase: Day 1||29||
59688333|NCT01380093|75807920|FG003|STARTED|Drug Discrimination Phase: Day 1||0||
59688334|NCT01380093|75807921|FG004|STARTED|Drug Discrimination Phase: Day 1||0||
59688335|NCT01380093|75807922|FG005|STARTED|Drug Discrimination Phase: Day 1||0||
59688336|NCT01380093|75807923|FG006|STARTED|Drug Discrimination Phase: Day 1||0||
59688337|NCT01380093|75807924|FG007|STARTED|Drug Discrimination Phase: Day 1||0||
59688338|NCT01380093|75807925|FG008|STARTED|Drug Discrimination Phase: Day 1||0||
59688339|NCT01380093|75807917|FG000|COMPLETED|Drug Discrimination Phase: Day 1||0||
59688340|NCT01380093|75807918|FG001|COMPLETED|Drug Discrimination Phase: Day 1||29||
59688341|NCT01380093|75807919|FG002|COMPLETED|Drug Discrimination Phase: Day 1||29||
59688342|NCT01380093|75807920|FG003|COMPLETED|Drug Discrimination Phase: Day 1||0||
59688343|NCT01380093|75807921|FG004|COMPLETED|Drug Discrimination Phase: Day 1||0||
59688344|NCT01380093|75807922|FG005|COMPLETED|Drug Discrimination Phase: Day 1||0||
59688345|NCT01380093|75807923|FG006|COMPLETED|Drug Discrimination Phase: Day 1||0||
59688346|NCT01380093|75807924|FG007|COMPLETED|Drug Discrimination Phase: Day 1||0||
59688347|NCT01380093|75807925|FG008|COMPLETED|Drug Discrimination Phase: Day 1||0||
59688348|NCT01380093|75807917|FG000|NOT COMPLETED|Drug Discrimination Phase: Day 1||0||
59688349|NCT01380093|75807918|FG001|NOT COMPLETED|Drug Discrimination Phase: Day 1||1||
59688350|NCT01380093|75807919|FG002|NOT COMPLETED|Drug Discrimination Phase: Day 1||0||
59688351|NCT01380093|75807920|FG003|NOT COMPLETED|Drug Discrimination Phase: Day 1||0||
59688352|NCT01380093|75807921|FG004|NOT COMPLETED|Drug Discrimination Phase: Day 1||0||
59688353|NCT01380093|75807922|FG005|NOT COMPLETED|Drug Discrimination Phase: Day 1||0||
59688354|NCT01380093|75807923|FG006|NOT COMPLETED|Drug Discrimination Phase: Day 1||0||
59688355|NCT01380093|75807924|FG007|NOT COMPLETED|Drug Discrimination Phase: Day 1||0||
59688356|NCT01380093|75807925|FG008|NOT COMPLETED|Drug Discrimination Phase: Day 1||0||
59688357|NCT01380093|75807917|FG000|STARTED|Drug Discrimination Phase: Day 2||0||
59688358|NCT01380093|75807918|FG001|STARTED|Drug Discrimination Phase: Day 2||29||
59688359|NCT01380093|75807919|FG002|STARTED|Drug Discrimination Phase: Day 2||29||
59688360|NCT01380093|75807920|FG003|STARTED|Drug Discrimination Phase: Day 2||0||
59688361|NCT01380093|75807921|FG004|STARTED|Drug Discrimination Phase: Day 2||0||
59688362|NCT01380093|75807922|FG005|STARTED|Drug Discrimination Phase: Day 2||0||
59688363|NCT01380093|75807923|FG006|STARTED|Drug Discrimination Phase: Day 2||0||
59688364|NCT01380093|75807924|FG007|STARTED|Drug Discrimination Phase: Day 2||0||
59688365|NCT01380093|75807925|FG008|STARTED|Drug Discrimination Phase: Day 2||0||
59688366|NCT01380093|75807917|FG000|COMPLETED|Drug Discrimination Phase: Day 2||0||
59688367|NCT01380093|75807918|FG001|COMPLETED|Drug Discrimination Phase: Day 2||20||
59688368|NCT01380093|75807919|FG002|COMPLETED|Drug Discrimination Phase: Day 2||16||
59688369|NCT01380093|75807920|FG003|COMPLETED|Drug Discrimination Phase: Day 2||0||
59688370|NCT01380093|75807921|FG004|COMPLETED|Drug Discrimination Phase: Day 2||0||
59688371|NCT01380093|75807922|FG005|COMPLETED|Drug Discrimination Phase: Day 2||0||
59688372|NCT01380093|75807923|FG006|COMPLETED|Drug Discrimination Phase: Day 2||0||
59688373|NCT01380093|75807924|FG007|COMPLETED|Drug Discrimination Phase: Day 2||0||
59688374|NCT01380093|75807925|FG008|COMPLETED|Drug Discrimination Phase: Day 2||0||
59688375|NCT01380093|75807917|FG000|NOT COMPLETED|Drug Discrimination Phase: Day 2||0||
59688376|NCT01380093|75807918|FG001|NOT COMPLETED|Drug Discrimination Phase: Day 2||9||
59688377|NCT01380093|75807919|FG002|NOT COMPLETED|Drug Discrimination Phase: Day 2||13||
59688378|NCT01380093|75807920|FG003|NOT COMPLETED|Drug Discrimination Phase: Day 2||0||
59688379|NCT01380093|75807921|FG004|NOT COMPLETED|Drug Discrimination Phase: Day 2||0||
59688380|NCT01380093|75807922|FG005|NOT COMPLETED|Drug Discrimination Phase: Day 2||0||
59688381|NCT01380093|75807923|FG006|NOT COMPLETED|Drug Discrimination Phase: Day 2||0||
59688382|NCT01380093|75807924|FG007|NOT COMPLETED|Drug Discrimination Phase: Day 2||0||
59688383|NCT01380093|75807925|FG008|NOT COMPLETED|Drug Discrimination Phase: Day 2||0||
59688384|NCT01380093|75807917|FG000|STARTED|Treatment Phase: First Intervention||0||
59688385|NCT01380093|75807918|FG001|STARTED|Treatment Phase: First Intervention||0||
59688386|NCT01380093|75807919|FG002|STARTED|Treatment Phase: First Intervention||0||
59688387|NCT01380093|75807920|FG003|STARTED|Treatment Phase: First Intervention||6||
59688388|NCT01380093|75807921|FG004|STARTED|Treatment Phase: First Intervention||6||
59688389|NCT01380093|75807922|FG005|STARTED|Treatment Phase: First Intervention||6||
59688390|NCT01380093|75807923|FG006|STARTED|Treatment Phase: First Intervention||6||
59688391|NCT01380093|75807924|FG007|STARTED|Treatment Phase: First Intervention||6||
59688392|NCT01380093|75807925|FG008|STARTED|Treatment Phase: First Intervention||6||
59688393|NCT01380093|75807917|FG000|COMPLETED|Treatment Phase: First Intervention||0||
59688394|NCT01380093|75807918|FG001|COMPLETED|Treatment Phase: First Intervention||0||
59688395|NCT01380093|75807919|FG002|COMPLETED|Treatment Phase: First Intervention||0||
59688396|NCT01380093|75807920|FG003|COMPLETED|Treatment Phase: First Intervention||6||
59688397|NCT01380093|75807921|FG004|COMPLETED|Treatment Phase: First Intervention||6||
59688398|NCT01380093|75807922|FG005|COMPLETED|Treatment Phase: First Intervention||6||
59688399|NCT01380093|75807923|FG006|COMPLETED|Treatment Phase: First Intervention||6||
59688400|NCT01380093|75807924|FG007|COMPLETED|Treatment Phase: First Intervention||6||
59688401|NCT01380093|75807925|FG008|COMPLETED|Treatment Phase: First Intervention||6||
59688402|NCT01380093|75807917|FG000|NOT COMPLETED|Treatment Phase: First Intervention||0||
59688403|NCT01380093|75807918|FG001|NOT COMPLETED|Treatment Phase: First Intervention||0||
59688404|NCT01380093|75807919|FG002|NOT COMPLETED|Treatment Phase: First Intervention||0||
59688405|NCT01380093|75807920|FG003|NOT COMPLETED|Treatment Phase: First Intervention||0||
59688406|NCT01380093|75807921|FG004|NOT COMPLETED|Treatment Phase: First Intervention||0||
59688407|NCT01380093|75807922|FG005|NOT COMPLETED|Treatment Phase: First Intervention||0||
59688408|NCT01380093|75807923|FG006|NOT COMPLETED|Treatment Phase: First Intervention||0||
59688409|NCT01380093|75807924|FG007|NOT COMPLETED|Treatment Phase: First Intervention||0||
59688410|NCT01380093|75807925|FG008|NOT COMPLETED|Treatment Phase: First Intervention||0||
59688411|NCT01380093|75807917|FG000|STARTED|Treatment Phase: Washout Period||0||
59688412|NCT01380093|75807918|FG001|STARTED|Treatment Phase: Washout Period||0||
59688413|NCT01380093|75807919|FG002|STARTED|Treatment Phase: Washout Period||0||
59688414|NCT01380093|75807920|FG003|STARTED|Treatment Phase: Washout Period||6||
59688415|NCT01380093|75807921|FG004|STARTED|Treatment Phase: Washout Period||6||
59688416|NCT01380093|75807922|FG005|STARTED|Treatment Phase: Washout Period||6||
59688417|NCT01380093|75807923|FG006|STARTED|Treatment Phase: Washout Period||6||
59688418|NCT01380093|75807924|FG007|STARTED|Treatment Phase: Washout Period||6||
59688419|NCT01380093|75807925|FG008|STARTED|Treatment Phase: Washout Period||6||
59688420|NCT01380093|75807917|FG000|COMPLETED|Treatment Phase: Washout Period||0||
59688421|NCT01380093|75807918|FG001|COMPLETED|Treatment Phase: Washout Period||0||
59688422|NCT01380093|75807919|FG002|COMPLETED|Treatment Phase: Washout Period||0||
59688423|NCT01380093|75807920|FG003|COMPLETED|Treatment Phase: Washout Period||6||
59688424|NCT01380093|75807921|FG004|COMPLETED|Treatment Phase: Washout Period||6||
59688425|NCT01380093|75807922|FG005|COMPLETED|Treatment Phase: Washout Period||6||
59688426|NCT01380093|75807923|FG006|COMPLETED|Treatment Phase: Washout Period||6||
59688427|NCT01380093|75807924|FG007|COMPLETED|Treatment Phase: Washout Period||6||
59688428|NCT01380093|75807925|FG008|COMPLETED|Treatment Phase: Washout Period||6||
59688429|NCT01380093|75807917|FG000|NOT COMPLETED|Treatment Phase: Washout Period||0||
59688430|NCT01380093|75807918|FG001|NOT COMPLETED|Treatment Phase: Washout Period||0||
59688431|NCT01380093|75807919|FG002|NOT COMPLETED|Treatment Phase: Washout Period||0||
59688432|NCT01380093|75807920|FG003|NOT COMPLETED|Treatment Phase: Washout Period||0||
59688433|NCT01380093|75807921|FG004|NOT COMPLETED|Treatment Phase: Washout Period||0||
59688434|NCT01380093|75807922|FG005|NOT COMPLETED|Treatment Phase: Washout Period||0||
59688435|NCT01380093|75807923|FG006|NOT COMPLETED|Treatment Phase: Washout Period||0||
59688436|NCT01380093|75807924|FG007|NOT COMPLETED|Treatment Phase: Washout Period||0||
59688437|NCT01380093|75807925|FG008|NOT COMPLETED|Treatment Phase: Washout Period||0||
59688438|NCT01380093|75807917|FG000|STARTED|Treatment Phase: Second Intervention||0||
59688439|NCT01380093|75807918|FG001|STARTED|Treatment Phase: Second Intervention||0||
59688440|NCT01380093|75807919|FG002|STARTED|Treatment Phase: Second Intervention||0||
59688441|NCT01380093|75807920|FG003|STARTED|Treatment Phase: Second Intervention||6||
59688442|NCT01380093|75807921|FG004|STARTED|Treatment Phase: Second Intervention||6||
59688443|NCT01380093|75807922|FG005|STARTED|Treatment Phase: Second Intervention||6||
59688444|NCT01380093|75807923|FG006|STARTED|Treatment Phase: Second Intervention||6||
59688445|NCT01380093|75807924|FG007|STARTED|Treatment Phase: Second Intervention||6||
59688446|NCT01380093|75807925|FG008|STARTED|Treatment Phase: Second Intervention||6||
59688447|NCT01380093|75807917|FG000|COMPLETED|Treatment Phase: Second Intervention||0||
59688448|NCT01380093|75807918|FG001|COMPLETED|Treatment Phase: Second Intervention||0||
59688449|NCT01380093|75807919|FG002|COMPLETED|Treatment Phase: Second Intervention||0||
59688450|NCT01380093|75807920|FG003|COMPLETED|Treatment Phase: Second Intervention||5||
59688451|NCT01380093|75807921|FG004|COMPLETED|Treatment Phase: Second Intervention||6||
59688452|NCT01380093|75807922|FG005|COMPLETED|Treatment Phase: Second Intervention||6||
59688453|NCT01380093|75807923|FG006|COMPLETED|Treatment Phase: Second Intervention||6||
59816106|NCT00529958|75938470|FG002|STARTED|2-Year Follow-up|110 randomized to DB, but there was (n=1) cross-over to the HT group|110||
59816107|NCT00529958|75938468|FG000|COMPLETED|2-Year Follow-up||106||
59816108|NCT00529958|75938469|FG001|COMPLETED|2-Year Follow-up|108 HT patients analyzed excludes n=1 cross-over patient (analyzed on intention-to-treat basis).|108||
59816109|NCT00529958|75938470|FG002|COMPLETED|2-Year Follow-up|108 DB patients analyzed include 1 cross-over with HT graft (analyzed on intention-to-treat basis).|108||
59989735|NCT02318329|76105091|FG004|COMPLETED|Overall Study||0||
59989736|NCT02318329|76105092|FG005|COMPLETED|Overall Study||0||
59989737|NCT02318329|76105093|FG006|COMPLETED|Overall Study||0||
59989738|NCT02318329|76105094|FG007|COMPLETED|Overall Study||0||
59989739|NCT02318329|76105095|FG008|COMPLETED|Overall Study||0||
59989740|NCT02318329|76105096|FG009|COMPLETED|Overall Study||0||
59688454|NCT01380093|75807924|FG007|COMPLETED|Treatment Phase: Second Intervention||6||
59688455|NCT01380093|75807925|FG008|COMPLETED|Treatment Phase: Second Intervention||6||
59688456|NCT01380093|75807917|FG000|NOT COMPLETED|Treatment Phase: Second Intervention||0||
59688457|NCT01380093|75807918|FG001|NOT COMPLETED|Treatment Phase: Second Intervention||0||
59688458|NCT01380093|75807919|FG002|NOT COMPLETED|Treatment Phase: Second Intervention||0||
59688459|NCT01380093|75807920|FG003|NOT COMPLETED|Treatment Phase: Second Intervention||1||
59688460|NCT01380093|75807921|FG004|NOT COMPLETED|Treatment Phase: Second Intervention||0||
59688461|NCT01380093|75807922|FG005|NOT COMPLETED|Treatment Phase: Second Intervention||0||
59688462|NCT01380093|75807923|FG006|NOT COMPLETED|Treatment Phase: Second Intervention||0||
59688463|NCT01380093|75807924|FG007|NOT COMPLETED|Treatment Phase: Second Intervention||0||
59688464|NCT01380093|75807925|FG008|NOT COMPLETED|Treatment Phase: Second Intervention||0||
59688465|NCT01380093|75807917|FG000|STARTED|Treatment Phase: Washout Period||0||
59688466|NCT01380093|75807918|FG001|STARTED|Treatment Phase: Washout Period||0||
59688467|NCT01380093|75807919|FG002|STARTED|Treatment Phase: Washout Period||0||
59688468|NCT01380093|75807920|FG003|STARTED|Treatment Phase: Washout Period||5||
59688469|NCT01380093|75807921|FG004|STARTED|Treatment Phase: Washout Period||6||
59688470|NCT01380093|75807922|FG005|STARTED|Treatment Phase: Washout Period||6||
59688471|NCT01380093|75807923|FG006|STARTED|Treatment Phase: Washout Period||6||
59688472|NCT01380093|75807924|FG007|STARTED|Treatment Phase: Washout Period||6||
59688473|NCT01380093|75807925|FG008|STARTED|Treatment Phase: Washout Period||6||
59688474|NCT01380093|75807917|FG000|COMPLETED|Treatment Phase: Washout Period||0||
59688475|NCT01380093|75807918|FG001|COMPLETED|Treatment Phase: Washout Period||0||
59688476|NCT01380093|75807919|FG002|COMPLETED|Treatment Phase: Washout Period||0||
59688477|NCT01380093|75807920|FG003|COMPLETED|Treatment Phase: Washout Period||5||
59688478|NCT01380093|75807921|FG004|COMPLETED|Treatment Phase: Washout Period||6||
59688479|NCT01380093|75807922|FG005|COMPLETED|Treatment Phase: Washout Period||6||
59688480|NCT01380093|75807923|FG006|COMPLETED|Treatment Phase: Washout Period||6||
59688481|NCT01380093|75807924|FG007|COMPLETED|Treatment Phase: Washout Period||6||
59688482|NCT01380093|75807925|FG008|COMPLETED|Treatment Phase: Washout Period||6||
59688483|NCT01380093|75807917|FG000|NOT COMPLETED|Treatment Phase: Washout Period||0||
59688484|NCT01380093|75807918|FG001|NOT COMPLETED|Treatment Phase: Washout Period||0||
59688485|NCT01380093|75807919|FG002|NOT COMPLETED|Treatment Phase: Washout Period||0||
59688486|NCT01380093|75807920|FG003|NOT COMPLETED|Treatment Phase: Washout Period||0||
59688487|NCT01380093|75807921|FG004|NOT COMPLETED|Treatment Phase: Washout Period||0||
59688488|NCT01380093|75807922|FG005|NOT COMPLETED|Treatment Phase: Washout Period||0||
59688489|NCT01380093|75807923|FG006|NOT COMPLETED|Treatment Phase: Washout Period||0||
59688490|NCT01380093|75807924|FG007|NOT COMPLETED|Treatment Phase: Washout Period||0||
59688491|NCT01380093|75807925|FG008|NOT COMPLETED|Treatment Phase: Washout Period||0||
59688492|NCT01380093|75807917|FG000|STARTED|Treatment Phase: Third Intervention||0||
59688493|NCT01380093|75807918|FG001|STARTED|Treatment Phase: Third Intervention||0||
59688494|NCT01380093|75807919|FG002|STARTED|Treatment Phase: Third Intervention||0||
59688495|NCT01380093|75807920|FG003|STARTED|Treatment Phase: Third Intervention||5||
59688496|NCT01380093|75807921|FG004|STARTED|Treatment Phase: Third Intervention||6||
59688497|NCT01380093|75807922|FG005|STARTED|Treatment Phase: Third Intervention||6||
59688498|NCT01380093|75807923|FG006|STARTED|Treatment Phase: Third Intervention||6||
59688499|NCT01380093|75807924|FG007|STARTED|Treatment Phase: Third Intervention||6||
59688500|NCT01380093|75807925|FG008|STARTED|Treatment Phase: Third Intervention||6||
59989741|NCT02318329|76105087|FG000|NOT COMPLETED|Overall Study||3||
59688501|NCT01380093|75807917|FG000|COMPLETED|Treatment Phase: Third Intervention||0||
59688502|NCT01380093|75807918|FG001|COMPLETED|Treatment Phase: Third Intervention||0||
59688503|NCT01380093|75807919|FG002|COMPLETED|Treatment Phase: Third Intervention||0||
59688504|NCT01380093|75807920|FG003|COMPLETED|Treatment Phase: Third Intervention||5||
59688505|NCT01380093|75807921|FG004|COMPLETED|Treatment Phase: Third Intervention||6||
59688506|NCT01380093|75807922|FG005|COMPLETED|Treatment Phase: Third Intervention||6||
59688507|NCT01380093|75807923|FG006|COMPLETED|Treatment Phase: Third Intervention||6||
59688508|NCT01380093|75807924|FG007|COMPLETED|Treatment Phase: Third Intervention||6||
59688509|NCT01380093|75807925|FG008|COMPLETED|Treatment Phase: Third Intervention||4||
59688510|NCT01380093|75807917|FG000|NOT COMPLETED|Treatment Phase: Third Intervention||0||
59688511|NCT01380093|75807918|FG001|NOT COMPLETED|Treatment Phase: Third Intervention||0||
59688512|NCT01380093|75807919|FG002|NOT COMPLETED|Treatment Phase: Third Intervention||0||
59688513|NCT01380093|75807920|FG003|NOT COMPLETED|Treatment Phase: Third Intervention||0||
59688514|NCT01380093|75807921|FG004|NOT COMPLETED|Treatment Phase: Third Intervention||0||
59688515|NCT01380093|75807922|FG005|NOT COMPLETED|Treatment Phase: Third Intervention||0||
59688516|NCT01380093|75807923|FG006|NOT COMPLETED|Treatment Phase: Third Intervention||0||
59688517|NCT01380093|75807924|FG007|NOT COMPLETED|Treatment Phase: Third Intervention||0||
59688518|NCT01380093|75807925|FG008|NOT COMPLETED|Treatment Phase: Third Intervention||2||
59688519|NCT01379937|75807943|FG000|STARTED|Overall Study||156||
59688520|NCT01379937|75807944|FG001|STARTED|Overall Study||156||
59688521|NCT01379937|75807945|FG002|STARTED|Overall Study||104||
59688522|NCT01379937|75807946|FG003|STARTED|Overall Study||104||
59688523|NCT01379937|75807943|FG000|COMPLETED|Overall Study||155||
59688524|NCT01379937|75807944|FG001|COMPLETED|Overall Study||153||
59688525|NCT01379937|75807945|FG002|COMPLETED|Overall Study||102||
59688526|NCT01379937|75807946|FG003|COMPLETED|Overall Study||103||
59688527|NCT01379937|75807943|FG000|NOT COMPLETED|Overall Study||1||
59688528|NCT01379937|75807944|FG001|NOT COMPLETED|Overall Study||3||
59688529|NCT01379937|75807945|FG002|NOT COMPLETED|Overall Study||2||
59688530|NCT01379937|75807946|FG003|NOT COMPLETED|Overall Study||1||
59688531|NCT03720392|75807963|FG000|STARTED|Overall Study||3||
59688532|NCT03720392|75807964|FG001|STARTED|Overall Study||3||
59989742|NCT02318329|76105088|FG001|NOT COMPLETED|Overall Study||4||
59989743|NCT02318329|76105089|FG002|NOT COMPLETED|Overall Study||3||
59989744|NCT02318329|76105090|FG003|NOT COMPLETED|Overall Study||3||
59688533|NCT03720392|75807963|FG000|COMPLETED|Overall Study||3||
59688534|NCT03720392|75807964|FG001|COMPLETED|Overall Study||3||
59688535|NCT03720392|75807963|FG000|NOT COMPLETED|Overall Study||0||
59688536|NCT03720392|75807964|FG001|NOT COMPLETED|Overall Study||0||
59688537|NCT01379781|75807972|FG000|STARTED|Overall Study||27||
59688538|NCT01379781|75807973|FG001|STARTED|Overall Study||27||
59688539|NCT01379781|75807972|FG000|COMPLETED|Overall Study||16||
59688540|NCT01379781|75807973|FG001|COMPLETED|Overall Study||19||
59688541|NCT01379781|75807972|FG000|NOT COMPLETED|Overall Study||11||
59688542|NCT01379781|75807973|FG001|NOT COMPLETED|Overall Study||8||
59688543|NCT01379703|75807979|FG000|STARTED|Study Start Through 9 Months|Participants taking lopinavir/ritonavir tablets/capsules or oral solution during the study (66/2288)|66||
59688544|NCT01379703|75807980|FG001|STARTED|Study Start Through 9 Months|Participants taking the lopinavir/ritonavir capsule formulation (only) during study (1206/2288)|1206||
59688545|NCT01379703|75807981|FG002|STARTED|Study Start Through 9 Months|Participants taking the lopinavir/ritonavir tablet formulation (only) during study (1016/2288)|1016||
59688546|NCT01379703|75807979|FG000|COMPLETED|Study Start Through 9 Months||62||
59688547|NCT01379703|75807980|FG001|COMPLETED|Study Start Through 9 Months|Participants taking the capsule formulation were followed for an additional 9 months (up to 18 mos).|1084||
59688548|NCT01379703|75807981|FG002|COMPLETED|Study Start Through 9 Months||873||
59688549|NCT01379703|75807979|FG000|NOT COMPLETED|Study Start Through 9 Months||4||
59688550|NCT01379703|75807980|FG001|NOT COMPLETED|Study Start Through 9 Months||122||
59688551|NCT01379703|75807981|FG002|NOT COMPLETED|Study Start Through 9 Months||143||
59688552|NCT01379703|75807979|FG000|STARTED|9 Months Through 18 Months|Participants in this subgroup were followed for 9 months.|0||
59688553|NCT01379703|75807980|FG001|STARTED|9 Months Through 18 Months|Participants taking the capsule formulation were followed for an additional 9 months (up to 18 mos).|1084||
59688554|NCT01379703|75807981|FG002|STARTED|9 Months Through 18 Months|Participants in this subgroup were followed for 9 months.|0||
59688555|NCT01379703|75807979|FG000|COMPLETED|9 Months Through 18 Months||0||
59688556|NCT01379703|75807980|FG001|COMPLETED|9 Months Through 18 Months||854||
59688557|NCT01379703|75807981|FG002|COMPLETED|9 Months Through 18 Months||0||
59688558|NCT01379703|75807979|FG000|NOT COMPLETED|9 Months Through 18 Months||0||
59688559|NCT01379703|75807980|FG001|NOT COMPLETED|9 Months Through 18 Months||230||
59688560|NCT01379703|75807981|FG002|NOT COMPLETED|9 Months Through 18 Months||0||
59688561|NCT01335477|75807992|FG000|STARTED|Overall Study||220||
59688562|NCT01335477|75807993|FG001|STARTED|Overall Study||331||
59688563|NCT01335477|75807992|FG000|COMPLETED|Overall Study||179||
59688564|NCT01335477|75807993|FG001|COMPLETED|Overall Study||272||
59688565|NCT01335477|75807992|FG000|NOT COMPLETED|Overall Study||41||
59688566|NCT01335477|75807993|FG001|NOT COMPLETED|Overall Study||59||
59688567|NCT01371825|75807999|FG000|STARTED|Overall Study||9||
59688568|NCT01371825|75807999|FG000|Received at Least 1 Dose of Study Drug|Overall Study||9||
59688569|NCT01371825|75807999|FG000|COMPLETED|Overall Study||5||
59688570|NCT01371825|75807999|FG000|NOT COMPLETED|Overall Study||4||
59688571|NCT01371747|75808009|FG000|STARTED|Overall Study||74||
59688572|NCT01371747|75808010|FG001|STARTED|Overall Study||74||
59989745|NCT02318329|76105091|FG004|NOT COMPLETED|Overall Study||3||
59688573|NCT01371747|75808011|FG002|STARTED|Overall Study||74||
59688574|NCT01371747|75808012|FG003|STARTED|Overall Study||26||
59688575|NCT01371747|75808013|FG004|STARTED|Overall Study||28||
59688576|NCT01371747|75808014|FG005|STARTED|Overall Study||30||
59688577|NCT01371747|75808009|FG000|COMPLETED|Overall Study||56||
59688578|NCT01371747|75808010|FG001|COMPLETED|Overall Study||51||
59688579|NCT01371747|75808011|FG002|COMPLETED|Overall Study||50||
59688580|NCT01371747|75808012|FG003|COMPLETED|Overall Study||17||
59688581|NCT01371747|75808013|FG004|COMPLETED|Overall Study||21||
59688582|NCT01371747|75808014|FG005|COMPLETED|Overall Study||16||
59688583|NCT01371747|75808009|FG000|NOT COMPLETED|Overall Study||18||
59688584|NCT01371747|75808010|FG001|NOT COMPLETED|Overall Study||23||
59989746|NCT02318329|76105092|FG005|NOT COMPLETED|Overall Study||3||
59688585|NCT01371747|75808011|FG002|NOT COMPLETED|Overall Study||24||
59688586|NCT01371747|75808012|FG003|NOT COMPLETED|Overall Study||9||
59688587|NCT01371747|75808013|FG004|NOT COMPLETED|Overall Study||7||
59688588|NCT01371747|75808014|FG005|NOT COMPLETED|Overall Study||14||
59688589|NCT03321617|75808033|FG000|STARTED|Overall Study||3||
59688590|NCT03321617|75808034|FG001|STARTED|Overall Study||3||
59688591|NCT03321617|75808035|FG002|STARTED|Overall Study||2||
59688592|NCT03321617|75808036|FG003|STARTED|Overall Study||3||
59688593|NCT03321617|75808033|FG000|COMPLETED|Overall Study||2||
59688594|NCT03321617|75808034|FG001|COMPLETED|Overall Study||3||
59688595|NCT03321617|75808035|FG002|COMPLETED|Overall Study||2||
59688596|NCT03321617|75808036|FG003|COMPLETED|Overall Study||2||
59688597|NCT03321617|75808033|FG000|NOT COMPLETED|Overall Study||1||
59688598|NCT03321617|75808034|FG001|NOT COMPLETED|Overall Study||0||
59688599|NCT03321617|75808035|FG002|NOT COMPLETED|Overall Study||0||
59688600|NCT03321617|75808036|FG003|NOT COMPLETED|Overall Study||1||
59688601|NCT01371708|75808049|FG000|STARTED|Overall Study||92||
59688602|NCT01371708|75808050|FG001|STARTED|Overall Study||93||
59688603|NCT01371708|75808051|FG002|STARTED|Overall Study||98||
59688604|NCT01371708|75808049|FG000|Received Treatment|Overall Study||91||
59688605|NCT01371708|75808050|FG001|Received Treatment|Overall Study||93||
59688606|NCT01371708|75808051|FG002|Received Treatment|Overall Study||97||
59688607|NCT01371708|75808049|FG000|COMPLETED|Overall Study||66||
59688608|NCT01371708|75808050|FG001|COMPLETED|Overall Study||63||
59688609|NCT01371708|75808051|FG002|COMPLETED|Overall Study||59||
59688610|NCT01371708|75808049|FG000|NOT COMPLETED|Overall Study||26||
59688611|NCT01371708|75808050|FG001|NOT COMPLETED|Overall Study||30||
59688612|NCT01371708|75808051|FG002|NOT COMPLETED|Overall Study||39||
59688613|NCT01335399|75808063|FG000|STARTED|Pre-treatment Period||374|Started = randomized|
59688614|NCT01335399|75808064|FG001|STARTED|Pre-treatment Period||374|Started = randomized|
59688615|NCT01335399|75808063|FG000|COMPLETED|Pre-treatment Period||371|Completed = continued to the treatment period|
59688616|NCT01335399|75808064|FG001|COMPLETED|Pre-treatment Period||371|Completed = continued to the treatment period|
59688617|NCT01335399|75808063|FG000|NOT COMPLETED|Pre-treatment Period||3||
59688618|NCT01335399|75808064|FG001|NOT COMPLETED|Pre-treatment Period||3||
59688619|NCT01335399|75808063|FG000|STARTED|Treatment Period||371||
59688620|NCT01335399|75808064|FG001|STARTED|Treatment Period||371||
59688621|NCT01335399|75808063|FG000|COMPLETED|Treatment Period||0||
59688622|NCT01335399|75808064|FG001|COMPLETED|Treatment Period||0||
59688623|NCT01335399|75808063|FG000|NOT COMPLETED|Treatment Period||371||
59688624|NCT01335399|75808064|FG001|NOT COMPLETED|Treatment Period||371||
59688625|NCT01366521|75808074|FG000|STARTED|Overall Study||21||
59688626|NCT01366521|75808075|FG001|STARTED|Overall Study||15||
59688627|NCT01366521|75808076|FG002|STARTED|Overall Study||23||
59688628|NCT01366521|75808077|FG003|STARTED|Overall Study||11||
59688629|NCT01366521|75808074|FG000|COMPLETED|Overall Study||20||
59688630|NCT01366521|75808075|FG001|COMPLETED|Overall Study||14||
59688631|NCT01366521|75808076|FG002|COMPLETED|Overall Study||21||
59688632|NCT01366521|75808077|FG003|COMPLETED|Overall Study||11||
59688633|NCT01366521|75808074|FG000|NOT COMPLETED|Overall Study||1||
59688634|NCT01366521|75808075|FG001|NOT COMPLETED|Overall Study||1||
59688635|NCT01366521|75808076|FG002|NOT COMPLETED|Overall Study||2||
59688636|NCT01366521|75808077|FG003|NOT COMPLETED|Overall Study||0||
59688637|NCT01335009|75808091|FG000|STARTED|Overall Study||40||
59688638|NCT01335009|75808092|FG001|STARTED|Overall Study||36||
59688639|NCT01335009|75808091|FG000|COMPLETED|Overall Study||9||
59688640|NCT01335009|75808092|FG001|COMPLETED|Overall Study||3||
59688641|NCT01335009|75808091|FG000|NOT COMPLETED|Overall Study||31||
59688642|NCT01335009|75808092|FG001|NOT COMPLETED|Overall Study||33||
59688643|NCT04824365|75808100|FG000|STARTED|Overall Study||15||
59688644|NCT04824365|75808101|FG001|STARTED|Overall Study||15||
59688645|NCT04824365|75808100|FG000|COMPLETED|Overall Study||15||
59688646|NCT04824365|75808101|FG001|COMPLETED|Overall Study||15||
59688647|NCT04824365|75808100|FG000|NOT COMPLETED|Overall Study||0||
59688648|NCT04824365|75808101|FG001|NOT COMPLETED|Overall Study||0||
59688649|NCT01366443|75808107|FG000|STARTED|Overall Study||288||
59688650|NCT01366443|75808107|FG000|COMPLETED|Overall Study||285||
59688651|NCT01366443|75808107|FG000|NOT COMPLETED|Overall Study||3||
59688652|NCT01332630|75808112|FG000|STARTED|Overall Study||24||
59688653|NCT01332630|75808112|FG000|COMPLETED|Overall Study||21||
59688654|NCT01332630|75808112|FG000|NOT COMPLETED|Overall Study||3||
59688655|NCT01366209|75808118|FG000|STARTED|Overall Study||278||
59688656|NCT01366209|75808119|FG001|STARTED|Overall Study||277||
59688657|NCT01366209|75808118|FG000|COMPLETED|Overall Study|Participants completing study assessment at Week 52 were completers, even if treatment was withdrawn|243||
59688658|NCT01366209|75808119|FG001|COMPLETED|Overall Study||241||
59688659|NCT01366209|75808118|FG000|NOT COMPLETED|Overall Study||35||
59688660|NCT01366209|75808119|FG001|NOT COMPLETED|Overall Study||36||
59688661|NCT01365546|75808125|FG000|STARTED|Overall Study|in this study 41 patients were screened but only 30 patients completed the study.|41||
59688662|NCT01365546|75808125|FG000|COMPLETED|Overall Study||30||
59688663|NCT01365546|75808125|FG000|NOT COMPLETED|Overall Study||11||
59688664|NCT01365507|75808135|FG000|STARTED|Overall Study||136||
59688665|NCT01365507|75808136|FG001|STARTED|Overall Study||140||
59688666|NCT01365507|75808135|FG000|Exposed|Overall Study|Two subjects withdrew before exposure to trial drug|134||
59688667|NCT01365507|75808136|FG001|Exposed|Overall Study||140||
59688668|NCT01365507|75808135|FG000|COMPLETED|Overall Study||127||
59688669|NCT01365507|75808136|FG001|COMPLETED|Overall Study||131||
59688670|NCT01365507|75808135|FG000|NOT COMPLETED|Overall Study||9||
59688671|NCT01365507|75808136|FG001|NOT COMPLETED|Overall Study||9||
59688672|NCT02995694|75808145|FG000|STARTED|Overall Study||215||
59688673|NCT02995694|75808146|FG001|STARTED|Overall Study||211||
59688674|NCT02995694|75808147|FG002|STARTED|Overall Study||109||
59688675|NCT02995694|75808145|FG000|COMPLETED|Overall Study||181||
59688676|NCT02995694|75808146|FG001|COMPLETED|Overall Study||183||
59688677|NCT02995694|75808147|FG002|COMPLETED|Overall Study||94||
59688678|NCT02995694|75808145|FG000|NOT COMPLETED|Overall Study||34||
59688679|NCT02995694|75808146|FG001|NOT COMPLETED|Overall Study||28||
59688680|NCT02995694|75808147|FG002|NOT COMPLETED|Overall Study||15||
59688681|NCT01365468|75808160|FG000|STARTED|Overall Study||4||
59688682|NCT01365468|75808161|FG001|STARTED|Overall Study||5||
59688683|NCT01365468|75808160|FG000|COMPLETED|Overall Study||0||
59688684|NCT01365468|75808161|FG001|COMPLETED|Overall Study||5||
59688685|NCT01365468|75808160|FG000|NOT COMPLETED|Overall Study||4||
59688686|NCT01365468|75808161|FG001|NOT COMPLETED|Overall Study||0||
59688687|NCT01357980|75808172|FG000|STARTED|Overall Study||16||
59688688|NCT01357980|75808173|FG001|STARTED|Overall Study||7||
59688689|NCT01357980|75808174|FG002|STARTED|Overall Study||17||
59688690|NCT01357980|75808175|FG003|STARTED|Overall Study||7||
59688691|NCT01357980|75808172|FG000|COMPLETED|Overall Study||16||
59688692|NCT01357980|75808173|FG001|COMPLETED|Overall Study||6||
59688693|NCT01357980|75808174|FG002|COMPLETED|Overall Study||16||
59688694|NCT01357980|75808175|FG003|COMPLETED|Overall Study||7||
59688695|NCT01357980|75808172|FG000|NOT COMPLETED|Overall Study||0||
59688696|NCT01357980|75808173|FG001|NOT COMPLETED|Overall Study||1||
59688697|NCT01357980|75808174|FG002|NOT COMPLETED|Overall Study||1||
59688698|NCT01357980|75808175|FG003|NOT COMPLETED|Overall Study||0||
59688699|NCT01332318|75808189|FG000|STARTED|Overall Study||34||
59688700|NCT01332318|75808190|FG001|STARTED|Overall Study||32||
59688701|NCT01332318|75808191|FG002|STARTED|Overall Study||34||
59688702|NCT01332318|75808192|FG003|STARTED|Overall Study||30||
59688703|NCT01332318|75808189|FG000|COMPLETED|Overall Study||32||
59688704|NCT01332318|75808190|FG001|COMPLETED|Overall Study||28||
59688705|NCT01332318|75808191|FG002|COMPLETED|Overall Study||33||
59688706|NCT01332318|75808192|FG003|COMPLETED|Overall Study||28||
59688707|NCT01332318|75808189|FG000|NOT COMPLETED|Overall Study||2||
59688708|NCT01332318|75808190|FG001|NOT COMPLETED|Overall Study||4||
59989747|NCT02318329|76105093|FG006|NOT COMPLETED|Overall Study||1||
59688709|NCT01332318|75808191|FG002|NOT COMPLETED|Overall Study||1||
59688710|NCT01332318|75808192|FG003|NOT COMPLETED|Overall Study||2||
59688711|NCT02071901|75808203|FG000|STARTED|Overall Study||31||
59688712|NCT02071901|75808203|FG000|COMPLETED|Overall Study||31||
59688713|NCT02071901|75808203|FG000|NOT COMPLETED|Overall Study||0||
59688714|NCT01331109|75808207|FG000|STARTED|Overall Study||57||
59688715|NCT01331109|75808207|FG000|COMPLETED|Overall Study||0||
59688716|NCT01331109|75808207|FG000|NOT COMPLETED|Overall Study||57||
59688717|NCT01357551|75808213|FG000|STARTED|Overall Study||110||
59688718|NCT01357551|75808214|FG001|STARTED|Overall Study||112||
59688719|NCT01357551|75808213|FG000|COMPLETED|Overall Study||88||
59688720|NCT01357551|75808214|FG001|COMPLETED|Overall Study||101||
59688721|NCT01357551|75808213|FG000|NOT COMPLETED|Overall Study||22||
59688722|NCT01357551|75808214|FG001|NOT COMPLETED|Overall Study||11||
59989748|NCT02318329|76105094|FG007|NOT COMPLETED|Overall Study||1||
59688723|NCT01357239|75808227|FG000|STARTED|Stratum: All Patients||31||
59688724|NCT01357239|75808228|FG001|STARTED|Stratum: All Patients||27||
59688725|NCT01357239|75808229|FG002|STARTED|Stratum: All Patients||39||
59688726|NCT01357239|75808230|FG003|STARTED|Stratum: All Patients||42||
59688727|NCT01357239|75808227|FG000|COMPLETED|Stratum: All Patients||31||
59688728|NCT01357239|75808228|FG001|COMPLETED|Stratum: All Patients||27||
59688729|NCT01357239|75808229|FG002|COMPLETED|Stratum: All Patients||37||
59688730|NCT01357239|75808230|FG003|COMPLETED|Stratum: All Patients||40||
59688731|NCT01357239|75808227|FG000|NOT COMPLETED|Stratum: All Patients||0||
59688732|NCT01357239|75808228|FG001|NOT COMPLETED|Stratum: All Patients||0||
60079334|NCT04304508|76194671|FG003|STARTED|Overall Study||456|Full analysis set (FAS)|
60079335|NCT04304508|76194668|FG000|Treated|Overall Study||445|Safety analysis set (SAF)|
60079336|NCT04304508|76194669|FG001|Treated|Overall Study||446|Safety analysis set (SAF)|
60079337|NCT04304508|76194670|FG002|Treated|Overall Study||443|Safety analysis set (SAF)|
60079338|NCT04304508|76194671|FG003|Treated|Overall Study||452|Safety analysis set (SAF)|
60079339|NCT04304508|76194668|FG000|COMPLETED|Overall Study|Treatment completed|335||
60079340|NCT04304508|76194669|FG001|COMPLETED|Overall Study|Treatment completed|329||
60079341|NCT04304508|76194670|FG002|COMPLETED|Overall Study|Treatment completed|313||
60079342|NCT04304508|76194671|FG003|COMPLETED|Overall Study|Treatment completed|314||
60079343|NCT04304508|76194668|FG000|NOT COMPLETED|Overall Study||120||
60079344|NCT04304508|76194669|FG001|NOT COMPLETED|Overall Study||121||
60079345|NCT04304508|76194670|FG002|NOT COMPLETED|Overall Study||134||
60079346|NCT04304508|76194671|FG003|NOT COMPLETED|Overall Study||142||
59688733|NCT01357239|75808229|FG002|NOT COMPLETED|Stratum: All Patients||2||
59688734|NCT01357239|75808230|FG003|NOT COMPLETED|Stratum: All Patients||2||
59688735|NCT01357239|75808227|FG000|STARTED|Stratum I: Fully-Methylated||8||
59688736|NCT01357239|75808228|FG001|STARTED|Stratum I: Fully-Methylated||6||
59688737|NCT01357239|75808229|FG002|STARTED|Stratum I: Fully-Methylated||17||
59688738|NCT01357239|75808230|FG003|STARTED|Stratum I: Fully-Methylated||22||
59688739|NCT01357239|75808227|FG000|COMPLETED|Stratum I: Fully-Methylated||8||
59688740|NCT01357239|75808228|FG001|COMPLETED|Stratum I: Fully-Methylated||6||
59688741|NCT01357239|75808229|FG002|COMPLETED|Stratum I: Fully-Methylated||16||
59688742|NCT01357239|75808230|FG003|COMPLETED|Stratum I: Fully-Methylated||22||
59688743|NCT01357239|75808227|FG000|NOT COMPLETED|Stratum I: Fully-Methylated||0||
59688744|NCT01357239|75808228|FG001|NOT COMPLETED|Stratum I: Fully-Methylated||0||
59688745|NCT01357239|75808229|FG002|NOT COMPLETED|Stratum I: Fully-Methylated||1||
59688746|NCT01357239|75808230|FG003|NOT COMPLETED|Stratum I: Fully-Methylated||0||
59688747|NCT01357239|75808227|FG000|STARTED|Stratum II: Partially-Methylated||23||
59688748|NCT01357239|75808228|FG001|STARTED|Stratum II: Partially-Methylated||21||
59688749|NCT01357239|75808229|FG002|STARTED|Stratum II: Partially-Methylated||22||
59688750|NCT01357239|75808230|FG003|STARTED|Stratum II: Partially-Methylated||20||
59688751|NCT01357239|75808227|FG000|COMPLETED|Stratum II: Partially-Methylated||23||
59688752|NCT01357239|75808228|FG001|COMPLETED|Stratum II: Partially-Methylated||21||
59688753|NCT01357239|75808229|FG002|COMPLETED|Stratum II: Partially-Methylated||21||
59688754|NCT01357239|75808230|FG003|COMPLETED|Stratum II: Partially-Methylated||18||
59688755|NCT01357239|75808227|FG000|NOT COMPLETED|Stratum II: Partially-Methylated||0||
59688756|NCT01357239|75808228|FG001|NOT COMPLETED|Stratum II: Partially-Methylated||0||
59688757|NCT01357239|75808229|FG002|NOT COMPLETED|Stratum II: Partially-Methylated||1||
59688758|NCT01357239|75808230|FG003|NOT COMPLETED|Stratum II: Partially-Methylated||2||
59688759|NCT01351350|75808248|FG000|STARTED|Overall Study||8|Here, started indicates the participants who were enrolled.|
59688760|NCT01351350|75808249|FG001|STARTED|Overall Study||29|Here, started indicates the participants who were enrolled.|
59688761|NCT01351350|75808250|FG002|STARTED|Overall Study||11|Here, started indicates the participants who were enrolled.|
59688762|NCT01351350|75808251|FG003|STARTED|Overall Study||13|Here, started indicates the participants who were enrolled.|
59688763|NCT01351350|75808252|FG004|STARTED|Overall Study||7|Here, started indicates the participants who were enrolled.|
59688764|NCT01351350|75808248|FG000|Treated|Overall Study||8||
59688765|NCT01351350|75808249|FG001|Treated|Overall Study||29||
59688766|NCT01351350|75808250|FG002|Treated|Overall Study||10||
59688767|NCT01351350|75808251|FG003|Treated|Overall Study||13||
59688768|NCT01351350|75808252|FG004|Treated|Overall Study||7||
59688769|NCT01351350|75808248|FG000|Dose-escalation Evaluable|Overall Study||7||
59688770|NCT01351350|75808249|FG001|Dose-escalation Evaluable|Overall Study||23||
59688771|NCT01351350|75808250|FG002|Dose-escalation Evaluable|Overall Study||10||
59688772|NCT01351350|75808251|FG003|Dose-escalation Evaluable|Overall Study||0||
59688773|NCT01351350|75808252|FG004|Dose-escalation Evaluable|Overall Study||0||
59688774|NCT01351350|75808248|FG000|COMPLETED|Overall Study||0||
59688775|NCT01351350|75808249|FG001|COMPLETED|Overall Study||0||
59688776|NCT01351350|75808250|FG002|COMPLETED|Overall Study||0||
59688777|NCT01351350|75808251|FG003|COMPLETED|Overall Study||0||
59688778|NCT01351350|75808252|FG004|COMPLETED|Overall Study||0||
59688779|NCT01351350|75808248|FG000|NOT COMPLETED|Overall Study||8||
59688780|NCT01351350|75808249|FG001|NOT COMPLETED|Overall Study||29||
59688781|NCT01351350|75808250|FG002|NOT COMPLETED|Overall Study||11||
59688782|NCT01351350|75808251|FG003|NOT COMPLETED|Overall Study||13||
59688783|NCT01351350|75808252|FG004|NOT COMPLETED|Overall Study||7||
59688784|NCT01350999|75808280|FG000|STARTED|Overall Study||165||
60079347|NCT04206332|76194700|FG000|STARTED|Part A||4||
59816110|NCT00529958|75938468|FG000|NOT COMPLETED|2-Year Follow-up||4||
59816111|NCT00529958|75938469|FG001|NOT COMPLETED|2-Year Follow-up||2||
60079348|NCT04206332|76194701|FG001|STARTED|Part A||4||
60079349|NCT04206332|76194702|FG002|STARTED|Part A||5||
60079350|NCT04206332|76194703|FG003|STARTED|Part A||5||
60079351|NCT04206332|76194704|FG004|STARTED|Part A||3||
59688785|NCT01350999|75808281|FG001|STARTED|Overall Study||171||
59688786|NCT01350999|75808282|FG002|STARTED|Overall Study||167||
59816112|NCT00529958|75938470|FG002|NOT COMPLETED|2-Year Follow-up||2||
59688787|NCT01350999|75808280|FG000|Treated|Overall Study||165||
59688788|NCT01350999|75808281|FG001|Treated|Overall Study||171||
59688789|NCT01350999|75808282|FG002|Treated|Overall Study||167||
59688790|NCT01350999|75808280|FG000|COMPLETED|Overall Study||157||
59688791|NCT01350999|75808281|FG001|COMPLETED|Overall Study||157||
59688792|NCT01350999|75808282|FG002|COMPLETED|Overall Study||146||
59688793|NCT01350999|75808280|FG000|NOT COMPLETED|Overall Study||8||
59688794|NCT01350999|75808281|FG001|NOT COMPLETED|Overall Study||14||
59688795|NCT01350999|75808282|FG002|NOT COMPLETED|Overall Study||21||
59688796|NCT02275559|75808292|FG000|STARTED|Overall Study||115||
59688797|NCT02275559|75808293|FG001|STARTED|Overall Study||118||
59688798|NCT02275559|75808292|FG000|COMPLETED|Overall Study||115||
59688799|NCT02275559|75808293|FG001|COMPLETED|Overall Study||118||
59688800|NCT02275559|75808292|FG000|NOT COMPLETED|Overall Study||0||
59688801|NCT02275559|75808293|FG001|NOT COMPLETED|Overall Study||0||
59688802|NCT01330914|75808301|FG000|STARTED|Overall Study||55||
59688803|NCT01330914|75808301|FG000|COMPLETED|Overall Study||48||
59688804|NCT01330914|75808301|FG000|NOT COMPLETED|Overall Study||7||
59688805|NCT01350804|75808309|FG000|STARTED|Core Study||138||
59688806|NCT01350804|75808310|FG001|STARTED|Core Study||137||
59688807|NCT01350804|75808311|FG002|STARTED|Core Study||138||
59688808|NCT01350804|75808312|FG003|STARTED|Core Study||138||
59688809|NCT01350804|75808309|FG000|Safety Set|Core Study|1 participant actually received placebo; participant was reassigned to placebo for safety analysis.|137||
59688810|NCT01350804|75808310|FG001|Safety Set|Core Study|1 participant did not receive treatment; therefore participant was not counted in safety analysis.|136||
59688811|NCT01350804|75808311|FG002|Safety Set|Core Study|1 participant actually received placebo; participant was reassigned to placebo for safety analysis.|139||
59688812|NCT01350804|75808312|FG003|Safety Set|Core Study|1 participant did not receive treatment; therefore participant was not counted in safety analysis.|137||
59688813|NCT01350804|75808309|FG000|Tratment Switch to AIN457 at Week 16|Core Study||0||
59688814|NCT01350804|75808310|FG001|Tratment Switch to AIN457 at Week 16|Core Study||0||
59688815|NCT01350804|75808311|FG002|Tratment Switch to AIN457 at Week 16|Core Study|15 participantsdiscontinued prior to the treatment switch|78||
59688816|NCT01350804|75808312|FG003|Tratment Switch to AIN457 at Week 16|Core Study||0||
59688817|NCT01350804|75808309|FG000|Treatment Switch to AIN457 at Week 24|Core Study||0||
59688818|NCT01350804|75808310|FG001|Treatment Switch to AIN457 at Week 24|Core Study||0||
59688819|NCT01350804|75808311|FG002|Treatment Switch to AIN457 at Week 24|Core Study||45||
59688820|NCT01350804|75808312|FG003|Treatment Switch to AIN457 at Week 24|Core Study||37||
59688821|NCT01350804|75808309|FG000|Full Analysis Set|Core Study||138||
59688822|NCT01350804|75808310|FG001|Full Analysis Set|Core Study||137||
59688823|NCT01350804|75808311|FG002|Full Analysis Set|Core Study||138||
59688824|NCT01350804|75808312|FG003|Full Analysis Set|Core Study||138||
59688825|NCT01350804|75808309|FG000|COMPLETED|Core Study||97||
59688826|NCT01350804|75808310|FG001|COMPLETED|Core Study||90||
59688827|NCT01350804|75808311|FG002|COMPLETED|Core Study||91||
59688828|NCT01350804|75808312|FG003|COMPLETED|Core Study||112||
59688829|NCT01350804|75808309|FG000|NOT COMPLETED|Core Study||41||
59688830|NCT01350804|75808310|FG001|NOT COMPLETED|Core Study||47||
59688831|NCT01350804|75808311|FG002|NOT COMPLETED|Core Study||47||
59688832|NCT01350804|75808312|FG003|NOT COMPLETED|Core Study||26||
59688833|NCT01350804|75808309|FG000|STARTED|Extension Study, Weeks 52 - 260||80||
59688834|NCT01350804|75808310|FG001|STARTED|Extension Study, Weeks 52 - 260||79||
59688835|NCT01350804|75808311|FG002|STARTED|Extension Study, Weeks 52 - 260|During the extension, these participants received AIN457.|72||
59688836|NCT01350804|75808312|FG003|STARTED|Extension Study, Weeks 52 - 260|During the extension, these participants received AIN457.|23||
59688837|NCT01350804|75808309|FG000|COMPLETED|Extension Study, Weeks 52 - 260||0||
59688838|NCT01350804|75808310|FG001|COMPLETED|Extension Study, Weeks 52 - 260||0||
59688839|NCT01350804|75808311|FG002|COMPLETED|Extension Study, Weeks 52 - 260||0||
59688840|NCT01350804|75808312|FG003|COMPLETED|Extension Study, Weeks 52 - 260||0||
59688841|NCT01350804|75808309|FG000|NOT COMPLETED|Extension Study, Weeks 52 - 260||80||
59688842|NCT01350804|75808310|FG001|NOT COMPLETED|Extension Study, Weeks 52 - 260||79||
59688843|NCT01350804|75808311|FG002|NOT COMPLETED|Extension Study, Weeks 52 - 260||72||
59688844|NCT01350804|75808312|FG003|NOT COMPLETED|Extension Study, Weeks 52 - 260||23||
59688845|NCT01350492|75808334|FG000|STARTED|Intervention||28||
59688846|NCT01350492|75808335|FG001|STARTED|Intervention||26||
59688847|NCT01350492|75808334|FG000|6-week MRI Scan|Intervention||24||
59688848|NCT01350492|75808335|FG001|6-week MRI Scan|Intervention||22||
59688849|NCT01350492|75808334|FG000|11-week MRI Scan|Intervention||23||
59688850|NCT01350492|75808335|FG001|11-week MRI Scan|Intervention||21||
59688851|NCT01350492|75808334|FG000|COMPLETED|Intervention||23||
59688852|NCT01350492|75808335|FG001|COMPLETED|Intervention||20||
59688853|NCT01350492|75808334|FG000|NOT COMPLETED|Intervention||5||
59688854|NCT01350492|75808335|FG001|NOT COMPLETED|Intervention||6||
59688855|NCT01350492|75808334|FG000|STARTED|Post Intervention Follow-Up||23||
59688856|NCT01350492|75808335|FG001|STARTED|Post Intervention Follow-Up||20||
59688857|NCT01350492|75808334|FG000|6-month MRI Scan|Post Intervention Follow-Up||20||
59688858|NCT01350492|75808335|FG001|6-month MRI Scan|Post Intervention Follow-Up||20||
59688859|NCT01350492|75808334|FG000|COMPLETED|Post Intervention Follow-Up||17||
59688860|NCT01350492|75808335|FG001|COMPLETED|Post Intervention Follow-Up||18||
59688861|NCT01350492|75808334|FG000|NOT COMPLETED|Post Intervention Follow-Up||6||
59688862|NCT01350492|75808335|FG001|NOT COMPLETED|Post Intervention Follow-Up||2||
59688863|NCT02270957|75808343|FG000|STARTED|Overall Study||31||
59688864|NCT02270957|75808344|FG001|STARTED|Overall Study||35||
59688865|NCT02270957|75808343|FG000|COMPLETED|Overall Study||27||
59688866|NCT02270957|75808344|FG001|COMPLETED|Overall Study||31||
59688867|NCT02270957|75808343|FG000|NOT COMPLETED|Overall Study||4||
59688868|NCT02270957|75808344|FG001|NOT COMPLETED|Overall Study||4||
59688869|NCT01350414|75808351|FG000|STARTED|Overall Study||181||
59688870|NCT01350414|75808351|FG000|Year 2|Overall Study||165||
59688871|NCT01350414|75808351|FG000|Year 3|Overall Study||162||
59688872|NCT01350414|75808351|FG000|Year 4|Overall Study||159||
59688873|NCT01350414|75808351|FG000|Year 5|Overall Study||162||
59688874|NCT01350414|75808351|FG000|COMPLETED|Overall Study||162||
59688875|NCT01350414|75808351|FG000|NOT COMPLETED|Overall Study||19||
59688876|NCT01350336|75808361|FG000|STARTED|Overall Study||284||279
59688877|NCT01350336|75808361|FG000|COMPLETED|Overall Study||227||227
59688878|NCT01350336|75808361|FG000|NOT COMPLETED|Overall Study||57||52
59688879|NCT01349049|75808419|FG000|STARTED|Overall Study||3||
59688880|NCT01349049|75808420|FG001|STARTED|Overall Study||7||
59688881|NCT01349049|75808421|FG002|STARTED|Overall Study||3||
59688882|NCT01349049|75808422|FG003|STARTED|Overall Study||3||
59688883|NCT01349049|75808423|FG004|STARTED|Overall Study||3||
59688884|NCT01349049|75808424|FG005|STARTED|Overall Study||6||
59688885|NCT01349049|75808425|FG006|STARTED|Overall Study||5||
59688886|NCT01349049|75808426|FG007|STARTED|Overall Study||4||
59688887|NCT01349049|75808427|FG008|STARTED|Overall Study||56||
59688888|NCT01349049|75808419|FG000|COMPLETED|Overall Study||0||
59688889|NCT01349049|75808420|FG001|COMPLETED|Overall Study||0||
59688890|NCT01349049|75808421|FG002|COMPLETED|Overall Study||0||
59688891|NCT01349049|75808422|FG003|COMPLETED|Overall Study||0||
59688892|NCT01349049|75808423|FG004|COMPLETED|Overall Study||0||
59688893|NCT01349049|75808424|FG005|COMPLETED|Overall Study||0||
59688894|NCT01349049|75808425|FG006|COMPLETED|Overall Study||0||
59688895|NCT01349049|75808426|FG007|COMPLETED|Overall Study||0||
59688896|NCT01349049|75808427|FG008|COMPLETED|Overall Study||1||
59688897|NCT01349049|75808419|FG000|NOT COMPLETED|Overall Study||3||
59688898|NCT01349049|75808420|FG001|NOT COMPLETED|Overall Study||7||
59688899|NCT01349049|75808421|FG002|NOT COMPLETED|Overall Study||3||
59688900|NCT01349049|75808422|FG003|NOT COMPLETED|Overall Study||3||
59688901|NCT01349049|75808423|FG004|NOT COMPLETED|Overall Study||3||
59688902|NCT01349049|75808424|FG005|NOT COMPLETED|Overall Study||6||
59688903|NCT01349049|75808425|FG006|NOT COMPLETED|Overall Study||5||
59688904|NCT01349049|75808426|FG007|NOT COMPLETED|Overall Study||4||
59688905|NCT01349049|75808427|FG008|NOT COMPLETED|Overall Study||55||
59688906|NCT01348854|75808461|FG000|STARTED|Overall Study|53 eyes of 34 participants|34||
59688907|NCT01348854|75808462|FG001|STARTED|Overall Study|10 eyes of 6 participants|6||
59688908|NCT01348854|75808461|FG000|COMPLETED|Overall Study|47 eyes of 31 participants|31||
59688909|NCT01348854|75808462|FG001|COMPLETED|Overall Study|9 eyes of 5 participants|5||
59688910|NCT01348854|75808461|FG000|NOT COMPLETED|Overall Study||3||
59688911|NCT01348854|75808462|FG001|NOT COMPLETED|Overall Study||1||
59688912|NCT01348776|75808468|FG000|STARTED|Overall Study|3 subjects were lost to follow-up: 2 after the 1-month follow-up, 1 after performing 4 treatments|87||
59688913|NCT01348776|75808468|FG000|COMPLETED|Overall Study||84||
59688914|NCT01348776|75808468|FG000|NOT COMPLETED|Overall Study||3||
60079352|NCT04206332|76194705|FG005|STARTED|Part A||8||
60079353|NCT04206332|76194706|FG006|STARTED|Part A||0||
60079354|NCT04206332|76194707|FG007|STARTED|Part A||0||
60079355|NCT04206332|76194708|FG008|STARTED|Part A||0||
59688915|NCT01348698|75808481|FG000|STARTED|Overall Study||74||
59688916|NCT01348698|75808481|FG000|COMPLETED|Overall Study||2||
59688917|NCT01348698|75808481|FG000|NOT COMPLETED|Overall Study||72||
59688918|NCT01348542|75808487|FG000|STARTED|Overall Study||13||
59688919|NCT01348542|75808488|FG001|STARTED|Overall Study||11||
59688920|NCT01348542|75808487|FG000|COMPLETED|Overall Study||10||
59688921|NCT01348542|75808488|FG001|COMPLETED|Overall Study||11||
59688922|NCT01348542|75808487|FG000|NOT COMPLETED|Overall Study||3||
59688923|NCT01348542|75808488|FG001|NOT COMPLETED|Overall Study||0||
59688924|NCT01346709|75808494|FG000|STARTED|Overall Study||5450||
59688925|NCT01346709|75808494|FG000|COMPLETED|Overall Study||5099||
59688926|NCT01346709|75808494|FG000|NOT COMPLETED|Overall Study||351||
59688927|NCT01346592|75808501|FG000|STARTED|Overall Study||3136||
60079356|NCT04206332|76194709|FG009|STARTED|Part A||0||
60079357|NCT04206332|76194710|FG010|STARTED|Part A||0||
59688928|NCT01346592|75808502|FG001|STARTED|Overall Study||1478||
59688929|NCT01346592|75808503|FG002|STARTED|Overall Study||1486||
59688930|NCT01346592|75808501|FG000|COMPLETED|Overall Study||2983||
59688931|NCT01346592|75808502|FG001|COMPLETED|Overall Study||1389||
59688932|NCT01346592|75808503|FG002|COMPLETED|Overall Study||1408||
59688933|NCT01346592|75808501|FG000|NOT COMPLETED|Overall Study||153||
59688934|NCT01346592|75808502|FG001|NOT COMPLETED|Overall Study||89||
59688935|NCT01346592|75808503|FG002|NOT COMPLETED|Overall Study||78||
59688936|NCT01346514|75808530|FG000|STARTED|Overall Study||91||
59688937|NCT01346514|75808531|FG001|STARTED|Overall Study||90||
59688938|NCT01346514|75808530|FG000|3 Month Assessment|Overall Study||83||
60079358|NCT04206332|76194711|FG011|STARTED|Part A||0||
59688939|NCT01346514|75808531|FG001|3 Month Assessment|Overall Study||68||
59989749|NCT02318329|76105095|FG008|NOT COMPLETED|Overall Study||6||
59989750|NCT02318329|76105096|FG009|NOT COMPLETED|Overall Study||52||
59989751|NCT02255656|76105137|FG000|STARTED|Overall Study||1062||
59989752|NCT02255656|76105137|FG000|COMPLETED|Overall Study||592||
60079359|NCT04206332|76194712|FG012|STARTED|Part A||0||
59547490|NCT02517567|75646293|FG000|STARTED|Third Exposure (8 Hours)||6||
59688940|NCT01346514|75808530|FG000|6 Month Assessment|Overall Study||74||
59688941|NCT01346514|75808531|FG001|6 Month Assessment|Overall Study||61||
59688942|NCT01346514|75808530|FG000|9 Month Assessment|Overall Study||67||
59688943|NCT01346514|75808531|FG001|9 Month Assessment|Overall Study||59||
59688944|NCT01346514|75808530|FG000|12 Month Assessment|Overall Study||62||
59688945|NCT01346514|75808531|FG001|12 Month Assessment|Overall Study||53||
59688946|NCT01346514|75808530|FG000|COMPLETED|Overall Study|Number of patients completing BL-12 months|62||
59688947|NCT01346514|75808531|FG001|COMPLETED|Overall Study|Number of patients completing BL-12 months.|53||
59688948|NCT01346514|75808530|FG000|NOT COMPLETED|Overall Study||29||
59688949|NCT01346514|75808531|FG001|NOT COMPLETED|Overall Study||37||
59688950|NCT01193335|75808541|FG000|STARTED|Infant Series||100||
59688951|NCT01193335|75808542|FG001|STARTED|Infant Series||100||
59688952|NCT01193335|75808541|FG000|COMPLETED|Infant Series||100||
59688953|NCT01193335|75808542|FG001|COMPLETED|Infant Series||100||
59688954|NCT01193335|75808541|FG000|NOT COMPLETED|Infant Series||0||
59688955|NCT01193335|75808542|FG001|NOT COMPLETED|Infant Series||0||
59688956|NCT01193335|75808541|FG000|STARTED|After Infant Series||100||
59688957|NCT01193335|75808542|FG001|STARTED|After Infant Series||100||
59688958|NCT01193335|75808541|FG000|COMPLETED|After Infant Series||99||
59688959|NCT01193335|75808542|FG001|COMPLETED|After Infant Series||97||
59688960|NCT01193335|75808541|FG000|NOT COMPLETED|After Infant Series||1||
59688961|NCT01193335|75808542|FG001|NOT COMPLETED|After Infant Series||3||
59688962|NCT01193335|75808541|FG000|STARTED|Toddler Dose||99||
59688963|NCT01193335|75808542|FG001|STARTED|Toddler Dose||97||
59688964|NCT01193335|75808541|FG000|COMPLETED|Toddler Dose||99||
59688965|NCT01193335|75808542|FG001|COMPLETED|Toddler Dose||97||
59688966|NCT01193335|75808541|FG000|NOT COMPLETED|Toddler Dose||0||
59688967|NCT01193335|75808542|FG001|NOT COMPLETED|Toddler Dose||0||
59688968|NCT01193335|75808541|FG000|STARTED|1-Year Follow-up||99||
59688969|NCT01193335|75808542|FG001|STARTED|1-Year Follow-up||97||
59688970|NCT01193335|75808541|FG000|COMPLETED|1-Year Follow-up||88||
59688971|NCT01193335|75808542|FG001|COMPLETED|1-Year Follow-up||88||
59688972|NCT01193335|75808541|FG000|NOT COMPLETED|1-Year Follow-up||11||
59688973|NCT01193335|75808542|FG001|NOT COMPLETED|1-Year Follow-up||9||
59688974|NCT01193335|75808541|FG000|STARTED|2-Year Follow-up||88||
59688975|NCT01193335|75808542|FG001|STARTED|2-Year Follow-up||88||
59688976|NCT01193335|75808541|FG000|COMPLETED|2-Year Follow-up||81||
59688977|NCT01193335|75808542|FG001|COMPLETED|2-Year Follow-up||80||
59688978|NCT01193335|75808541|FG000|NOT COMPLETED|2-Year Follow-up||7||
59688979|NCT01193335|75808542|FG001|NOT COMPLETED|2-Year Follow-up||8||
59688980|NCT01342887|75808564|FG000|STARTED|Overall Study||6||
59688981|NCT01342887|75808564|FG000|COMPLETED|Overall Study||4||
59688982|NCT01342887|75808564|FG000|NOT COMPLETED|Overall Study||2||
59688983|NCT01342341|75808570|FG000|STARTED|Overall Study||24||
59688984|NCT01342341|75808571|FG001|STARTED|Overall Study||24||
59688985|NCT01342341|75808570|FG000|COMPLETED|Overall Study||20||
59688986|NCT01342341|75808571|FG001|COMPLETED|Overall Study||20||
59688987|NCT01342341|75808570|FG000|NOT COMPLETED|Overall Study||4||
59547491|NCT02517567|75646294|FG001|STARTED|Third Exposure (8 Hours)||8||
59547492|NCT02517567|75646295|FG002|STARTED|Third Exposure (8 Hours)||7||
59547493|NCT02517567|75646296|FG003|STARTED|Third Exposure (8 Hours)||8||
59547494|NCT02517567|75646293|FG000|COMPLETED|Third Exposure (8 Hours)||6||
59547495|NCT02517567|75646294|FG001|COMPLETED|Third Exposure (8 Hours)||8||
59547496|NCT02517567|75646295|FG002|COMPLETED|Third Exposure (8 Hours)||7||
59688988|NCT01342341|75808571|FG001|NOT COMPLETED|Overall Study||4||
59989753|NCT02255656|76105137|FG000|NOT COMPLETED|Overall Study||470||
59989754|NCT02255500|76105150|FG000|STARTED|Overall Study||16||
59547497|NCT02517567|75646296|FG003|COMPLETED|Third Exposure (8 Hours)||8||
59547498|NCT02517567|75646293|FG000|NOT COMPLETED|Third Exposure (8 Hours)||0||
59816113|NCT00529958|75938468|FG000|STARTED|5-Year Follow-up||106||
60079360|NCT04206332|76194713|FG013|STARTED|Part A||0||
59547499|NCT02517567|75646294|FG001|NOT COMPLETED|Third Exposure (8 Hours)||0||
59547500|NCT02517567|75646295|FG002|NOT COMPLETED|Third Exposure (8 Hours)||0||
59547501|NCT02517567|75646296|FG003|NOT COMPLETED|Third Exposure (8 Hours)||0||
59547502|NCT02517567|75646293|FG000|STARTED|Fourth Exposure (8 Hours)||6||
59688989|NCT01340664|75808580|FG000|STARTED|Overall Study||93||
59688990|NCT01340664|75808581|FG001|STARTED|Overall Study||93||
59688991|NCT01340664|75808582|FG002|STARTED|Overall Study||93||
59688992|NCT01340664|75808580|FG000|COMPLETED|Overall Study||86||
59688993|NCT01340664|75808581|FG001|COMPLETED|Overall Study||85||
59688994|NCT01340664|75808582|FG002|COMPLETED|Overall Study||80||
59688995|NCT01340664|75808580|FG000|NOT COMPLETED|Overall Study||7||
59989755|NCT02255500|76105151|FG001|STARTED|Overall Study||7||
59989756|NCT02255500|76105150|FG000|COMPLETED|Overall Study||15||
59989757|NCT02255500|76105151|FG001|COMPLETED|Overall Study||7||
60079361|NCT04206332|76194714|FG014|STARTED|Part A||0||
59688996|NCT01340664|75808581|FG001|NOT COMPLETED|Overall Study||8||
59688997|NCT01340664|75808582|FG002|NOT COMPLETED|Overall Study||13||
59688998|NCT01340625|75808592|FG000|STARTED|First Intervention||18||
59688999|NCT01340625|75808593|FG001|STARTED|First Intervention||18||
59689000|NCT01340625|75808592|FG000|COMPLETED|First Intervention||17||
59689001|NCT01340625|75808593|FG001|COMPLETED|First Intervention||18||
59689002|NCT01340625|75808592|FG000|NOT COMPLETED|First Intervention||1||
59689003|NCT01340625|75808593|FG001|NOT COMPLETED|First Intervention||0||
59689004|NCT01340625|75808592|FG000|STARTED|Washout Period of 28 Days||17||
59689005|NCT01340625|75808593|FG001|STARTED|Washout Period of 28 Days||18||
59689006|NCT01340625|75808592|FG000|COMPLETED|Washout Period of 28 Days||16||
59689007|NCT01340625|75808593|FG001|COMPLETED|Washout Period of 28 Days||18||
59689008|NCT01340625|75808592|FG000|NOT COMPLETED|Washout Period of 28 Days||1||
59689009|NCT01340625|75808593|FG001|NOT COMPLETED|Washout Period of 28 Days||0||
59689010|NCT01340625|75808592|FG000|STARTED|Second Intervention||16||
59689011|NCT01340625|75808593|FG001|STARTED|Second Intervention||18||
59689012|NCT01340625|75808592|FG000|COMPLETED|Second Intervention||16||
59689013|NCT01340625|75808593|FG001|COMPLETED|Second Intervention||18||
59689014|NCT01340625|75808592|FG000|NOT COMPLETED|Second Intervention||0||
59689015|NCT01340625|75808593|FG001|NOT COMPLETED|Second Intervention||0||
59689016|NCT01340196|75808599|FG000|STARTED|Treat. Period 1 (Tenofovir)||16||
59689017|NCT01340196|75808599|FG000|COMPLETED|Treat. Period 1 (Tenofovir)||16||
59989758|NCT02255500|76105150|FG000|NOT COMPLETED|Overall Study||1||
59989759|NCT02255500|76105151|FG001|NOT COMPLETED|Overall Study||0||
59989760|NCT02505542|76105157|FG000|STARTED|Part A: Open-Label Period||736||
59989761|NCT02505542|76105158|FG001|STARTED|Part A: Open-Label Period||0||
59989762|NCT02505542|76105159|FG002|STARTED|Part A: Open-Label Period||0||
59989763|NCT02505542|76105160|FG003|STARTED|Part A: Open-Label Period||0||
59989764|NCT02505542|76105157|FG000|COMPLETED|Part A: Open-Label Period||659||
59989765|NCT02505542|76105158|FG001|COMPLETED|Part A: Open-Label Period||0||
59989766|NCT02505542|76105159|FG002|COMPLETED|Part A: Open-Label Period||0||
59989767|NCT02505542|76105160|FG003|COMPLETED|Part A: Open-Label Period||0||
59989768|NCT02505542|76105157|FG000|NOT COMPLETED|Part A: Open-Label Period||77||
59989769|NCT02505542|76105158|FG001|NOT COMPLETED|Part A: Open-Label Period||0||
59989770|NCT02505542|76105159|FG002|NOT COMPLETED|Part A: Open-Label Period||0||
59989771|NCT02505542|76105160|FG003|NOT COMPLETED|Part A: Open-Label Period||0||
59989772|NCT02505542|76105157|FG000|STARTED|Completed Part A, Did Not Enter Part B||659||
59989773|NCT02505542|76105158|FG001|STARTED|Completed Part A, Did Not Enter Part B||0||
59989774|NCT02505542|76105159|FG002|STARTED|Completed Part A, Did Not Enter Part B||0||
59989775|NCT02505542|76105160|FG003|STARTED|Completed Part A, Did Not Enter Part B||0||
59989776|NCT02505542|76105157|FG000|COMPLETED|Completed Part A, Did Not Enter Part B||313||
59989777|NCT02505542|76105158|FG001|COMPLETED|Completed Part A, Did Not Enter Part B||0||
60079362|NCT04206332|76194715|FG015|STARTED|Part A||0||
60079363|NCT04206332|76194716|FG016|STARTED|Part A||0||
60079364|NCT04206332|76194700|FG000|Received Product Administration|Part A||4||
60079365|NCT04206332|76194701|FG001|Received Product Administration|Part A||4||
60079366|NCT04206332|76194702|FG002|Received Product Administration|Part A||5||
60079367|NCT04206332|76194703|FG003|Received Product Administration|Part A||5||
60079368|NCT04206332|76194704|FG004|Received Product Administration|Part A||3||
60079369|NCT04206332|76194705|FG005|Received Product Administration|Part A||0||
59689018|NCT01340196|75808599|FG000|NOT COMPLETED|Treat. Period 1 (Tenofovir)||0||
59689019|NCT01340196|75808599|FG000|STARTED|Treat. Period 2 (Tenofovir/Faldaprevir)||16||
59689020|NCT01340196|75808599|FG000|COMPLETED|Treat. Period 2 (Tenofovir/Faldaprevir)||16||
59989778|NCT02505542|76105159|FG002|COMPLETED|Completed Part A, Did Not Enter Part B||0||
59989779|NCT02505542|76105160|FG003|COMPLETED|Completed Part A, Did Not Enter Part B||0||
59989780|NCT02505542|76105157|FG000|NOT COMPLETED|Completed Part A, Did Not Enter Part B||346||
59989781|NCT02505542|76105158|FG001|NOT COMPLETED|Completed Part A, Did Not Enter Part B||0||
59989782|NCT02505542|76105159|FG002|NOT COMPLETED|Completed Part A, Did Not Enter Part B||0||
59989783|NCT02505542|76105160|FG003|NOT COMPLETED|Completed Part A, Did Not Enter Part B||0||
59989784|NCT02505542|76105157|FG000|STARTED|Part B: Double-Blind Period||0||
59989785|NCT02505542|76105158|FG001|STARTED|Part B: Double-Blind Period||104||
59989786|NCT02505542|76105159|FG002|STARTED|Part B: Double-Blind Period||104||
60079370|NCT04206332|76194706|FG006|Received Product Administration|Part A||0||
60079371|NCT04206332|76194707|FG007|Received Product Administration|Part A||0||
59689021|NCT01340196|75808599|FG000|NOT COMPLETED|Treat. Period 2 (Tenofovir/Faldaprevir)||0||
59689022|NCT01340196|75808599|FG000|STARTED|Treat. Period 3 (Faldaprevir)||16||
59689023|NCT01340196|75808599|FG000|COMPLETED|Treat. Period 3 (Faldaprevir)||14||
59689024|NCT01340196|75808599|FG000|NOT COMPLETED|Treat. Period 3 (Faldaprevir)||2||
59689025|NCT01327599|75808608|FG000|STARTED|Overall Study||60||
59689026|NCT01327599|75808608|FG000|COMPLETED|Overall Study||57||
59689027|NCT01327599|75808608|FG000|NOT COMPLETED|Overall Study||3||
59689028|NCT01193257|75808614|FG000|STARTED|Overall Study||365||
59689029|NCT01193257|75808615|FG001|STARTED|Overall Study||734||
59689030|NCT01193257|75808614|FG000|Treated|Overall Study||363||
59689031|NCT01193257|75808615|FG001|Treated|Overall Study||732||
59689032|NCT01193257|75808614|FG000|COMPLETED|Overall Study||0||
59689033|NCT01193257|75808615|FG001|COMPLETED|Overall Study||0||
59689034|NCT01193257|75808614|FG000|NOT COMPLETED|Overall Study||365||
59689035|NCT01193257|75808615|FG001|NOT COMPLETED|Overall Study||734||
59689036|NCT01193218|75808626|FG000|STARTED|0-12 Weeks|It is actually placebo group|109||
59689037|NCT01193218|75808627|FG001|STARTED|0-12 Weeks|It is actually N/A|0||
59689038|NCT01193218|75808628|FG002|STARTED|0-12 Weeks|It is actually empa 5mg group|110||
59689039|NCT01193218|75808629|FG003|STARTED|0-12 Weeks|It is actually N/A|0||
59689040|NCT01193218|75808630|FG004|STARTED|0-12 Weeks||109||
59689041|NCT01193218|75808631|FG005|STARTED|0-12 Weeks||109||
59689042|NCT01193218|75808632|FG006|STARTED|0-12 Weeks|It is actually empa 50mg group|110||
59689043|NCT01193218|75808633|FG007|STARTED|0-12 Weeks|It is actually N/A|0||
59689044|NCT01193218|75808626|FG000|COMPLETED|0-12 Weeks||100||
59689045|NCT01193218|75808627|FG001|COMPLETED|0-12 Weeks||0||
59689046|NCT01193218|75808628|FG002|COMPLETED|0-12 Weeks||107||
59689047|NCT01193218|75808629|FG003|COMPLETED|0-12 Weeks||0||
59689048|NCT01193218|75808630|FG004|COMPLETED|0-12 Weeks||108||
59689049|NCT01193218|75808631|FG005|COMPLETED|0-12 Weeks||106||
59689050|NCT01193218|75808632|FG006|COMPLETED|0-12 Weeks||107||
59689051|NCT01193218|75808633|FG007|COMPLETED|0-12 Weeks||0||
59689052|NCT01193218|75808626|FG000|NOT COMPLETED|0-12 Weeks||9||
59689053|NCT01193218|75808627|FG001|NOT COMPLETED|0-12 Weeks||0||
59689054|NCT01193218|75808628|FG002|NOT COMPLETED|0-12 Weeks||3||
59689055|NCT01193218|75808629|FG003|NOT COMPLETED|0-12 Weeks||0||
59689056|NCT01193218|75808630|FG004|NOT COMPLETED|0-12 Weeks||1||
59689057|NCT01193218|75808631|FG005|NOT COMPLETED|0-12 Weeks||3||
59689058|NCT01193218|75808632|FG006|NOT COMPLETED|0-12 Weeks||3||
59689059|NCT01193218|75808633|FG007|NOT COMPLETED|0-12 Weeks||0||
59689060|NCT01193218|75808626|FG000|STARTED|12-52 Weeks||50||
59689061|NCT01193218|75808627|FG001|STARTED|12-52 Weeks||50||
59689062|NCT01193218|75808628|FG002|STARTED|12-52 Weeks||54||
59689063|NCT01193218|75808629|FG003|STARTED|12-52 Weeks||53||
59689064|NCT01193218|75808630|FG004|STARTED|12-52 Weeks||108||
59689065|NCT01193218|75808631|FG005|STARTED|12-52 Weeks||106||
59689066|NCT01193218|75808632|FG006|STARTED|12-52 Weeks||54||
59689067|NCT01193218|75808633|FG007|STARTED|12-52 Weeks||53||
59689068|NCT01193218|75808626|FG000|COMPLETED|12-52 Weeks||45||
59689069|NCT01193218|75808627|FG001|COMPLETED|12-52 Weeks||50||
59689070|NCT01193218|75808628|FG002|COMPLETED|12-52 Weeks||50||
59689071|NCT01193218|75808629|FG003|COMPLETED|12-52 Weeks||50||
59689072|NCT01193218|75808630|FG004|COMPLETED|12-52 Weeks||104||
59689073|NCT01193218|75808631|FG005|COMPLETED|12-52 Weeks||101||
59689074|NCT01193218|75808632|FG006|COMPLETED|12-52 Weeks||51||
59689075|NCT01193218|75808633|FG007|COMPLETED|12-52 Weeks||49||
59689076|NCT01193218|75808626|FG000|NOT COMPLETED|12-52 Weeks||5||
59689077|NCT01193218|75808627|FG001|NOT COMPLETED|12-52 Weeks||0||
59689078|NCT01193218|75808628|FG002|NOT COMPLETED|12-52 Weeks||4||
59689079|NCT01193218|75808629|FG003|NOT COMPLETED|12-52 Weeks||3||
59689080|NCT01193218|75808630|FG004|NOT COMPLETED|12-52 Weeks||4||
59689081|NCT01193218|75808631|FG005|NOT COMPLETED|12-52 Weeks||5||
59689082|NCT01193218|75808632|FG006|NOT COMPLETED|12-52 Weeks||3||
59689083|NCT01193218|75808633|FG007|NOT COMPLETED|12-52 Weeks||4||
59689084|NCT01193101|75808653|FG000|STARTED|Overall Study||100||
59689085|NCT01193101|75808654|FG001|STARTED|Overall Study||101||
59689086|NCT01193101|75808655|FG002|STARTED|Overall Study||96||
59689087|NCT01193101|75808656|FG003|STARTED|Overall Study||92||
59689088|NCT01193101|75808653|FG000|Full Analysis Set|Overall Study||100||
59689089|NCT01193101|75808654|FG001|Full Analysis Set|Overall Study||101||
59689090|NCT01193101|75808655|FG002|Full Analysis Set|Overall Study||96||
59689091|NCT01193101|75808656|FG003|Full Analysis Set|Overall Study||92||
59689092|NCT01193101|75808653|FG000|Placebo Withdrawal Set|Overall Study||95||
59689093|NCT01193101|75808654|FG001|Placebo Withdrawal Set|Overall Study||94||
59689094|NCT01193101|75808655|FG002|Placebo Withdrawal Set|Overall Study||93||
59689095|NCT01193101|75808656|FG003|Placebo Withdrawal Set|Overall Study||80||
59689096|NCT01193101|75808653|FG000|COMPLETED|Overall Study||95||
59689097|NCT01193101|75808654|FG001|COMPLETED|Overall Study||94||
59689098|NCT01193101|75808655|FG002|COMPLETED|Overall Study||93||
59689099|NCT01193101|75808656|FG003|COMPLETED|Overall Study||80||
59689100|NCT01193101|75808653|FG000|NOT COMPLETED|Overall Study||5||
59689101|NCT01193101|75808654|FG001|NOT COMPLETED|Overall Study||7||
59689102|NCT01193101|75808655|FG002|NOT COMPLETED|Overall Study||3||
59689103|NCT01193101|75808656|FG003|NOT COMPLETED|Overall Study||12||
59689104|NCT01192516|75808669|FG000|STARTED|Overall Study|Indicates number of people initially randomized to group|66||
59689105|NCT01192516|75808670|FG001|STARTED|Overall Study|Indicates number of people initially randomized to group|66||
59689106|NCT01192516|75808671|FG002|STARTED|Overall Study|Indicates number of people initially randomized to group|63||
59689107|NCT01192516|75808669|FG000|COMPLETED|Overall Study||46||
59689108|NCT01192516|75808670|FG001|COMPLETED|Overall Study||49||
59689109|NCT01192516|75808671|FG002|COMPLETED|Overall Study||55||
59689110|NCT01192516|75808669|FG000|NOT COMPLETED|Overall Study||20||
59689111|NCT01192516|75808670|FG001|NOT COMPLETED|Overall Study||17||
59689112|NCT01192516|75808671|FG002|NOT COMPLETED|Overall Study||8||
59689113|NCT01192399|75808683|FG000|STARTED|Overall Study||29||
59689114|NCT01192399|75808683|FG000|COMPLETED|Overall Study||27||
59689115|NCT01192399|75808683|FG000|NOT COMPLETED|Overall Study||2||
59689116|NCT01176916|75808687|FG000|STARTED|Overall Study||564||
59689117|NCT01176916|75808687|FG000|Treated|Overall Study||558||
59689118|NCT01176916|75808687|FG000|Assigne But Not Treated|Overall Study||6||
59689119|NCT01176916|75808687|FG000|COMPLETED|Overall Study||397||
59689120|NCT01176916|75808687|FG000|NOT COMPLETED|Overall Study||167||
59689121|NCT01192204|75808693|FG000|STARTED|Overall Study||23||
59689122|NCT01192204|75808694|FG001|STARTED|Overall Study||18||
59689123|NCT01192204|75808693|FG000|COMPLETED|Overall Study||22||
59689124|NCT01192204|75808694|FG001|COMPLETED|Overall Study||18||
59689125|NCT01192204|75808693|FG000|NOT COMPLETED|Overall Study||1||
59689126|NCT01192204|75808694|FG001|NOT COMPLETED|Overall Study||0||
59689127|NCT01192126|75808701|FG000|STARTED|First Intervention (1 Week)||51||
59689128|NCT01192126|75808702|FG001|STARTED|First Intervention (1 Week)||51||
59689129|NCT01192126|75808701|FG000|COMPLETED|First Intervention (1 Week)||49||
59689130|NCT01192126|75808702|FG001|COMPLETED|First Intervention (1 Week)||50||
59689131|NCT01192126|75808701|FG000|NOT COMPLETED|First Intervention (1 Week)||2||
59689132|NCT01192126|75808702|FG001|NOT COMPLETED|First Intervention (1 Week)||1||
59689133|NCT01192126|75808701|FG000|STARTED|Second Intervention (1 Week)||49||
59689134|NCT01192126|75808702|FG001|STARTED|Second Intervention (1 Week)||50||
59689135|NCT01192126|75808701|FG000|COMPLETED|Second Intervention (1 Week)||49||
59689136|NCT01192126|75808702|FG001|COMPLETED|Second Intervention (1 Week)||50||
59689137|NCT01192126|75808701|FG000|NOT COMPLETED|Second Intervention (1 Week)||0||
59689138|NCT01192126|75808702|FG001|NOT COMPLETED|Second Intervention (1 Week)||0||
59689139|NCT01327482|75808708|FG000|STARTED|Overall Study||10||
59689140|NCT01327482|75808708|FG000|COMPLETED|Overall Study|The 10th participant completed 2/3 visits|9||
59689141|NCT01327482|75808708|FG000|NOT COMPLETED|Overall Study||1||
59689142|NCT01176565|75808714|FG000|STARTED|Overall Study||500||
59689143|NCT01176565|75808715|FG001|STARTED|Overall Study||500||
59689144|NCT01176565|75808714|FG000|COMPLETED|Overall Study||480||
59689145|NCT01176565|75808715|FG001|COMPLETED|Overall Study||481||
59689146|NCT01176565|75808714|FG000|NOT COMPLETED|Overall Study||20||
59689147|NCT01176565|75808715|FG001|NOT COMPLETED|Overall Study||19||
59689148|NCT01176292|75808723|FG000|STARTED|Overall Study||71||
59689149|NCT01176292|75808724|FG001|STARTED|Overall Study||71||
59689150|NCT01176292|75808723|FG000|COMPLETED|Overall Study||66||
59689151|NCT01176292|75808724|FG001|COMPLETED|Overall Study||62||
59689152|NCT01176292|75808723|FG000|NOT COMPLETED|Overall Study||5||
59689153|NCT01176292|75808724|FG001|NOT COMPLETED|Overall Study||9||
59689154|NCT01113541|75808730|FG000|STARTED|Overall Study||13||
59689155|NCT01113541|75808730|FG000|COMPLETED|Overall Study||0||
59689156|NCT01113541|75808730|FG000|NOT COMPLETED|Overall Study||13||
59689157|NCT04450823|75808734|FG000|STARTED|Overall Study||61||
59689158|NCT04450823|75808734|FG000|COMPLETED|Overall Study||58||
59689159|NCT04450823|75808734|FG000|NOT COMPLETED|Overall Study||3||
59689160|NCT01113502|75808743|FG000|STARTED|Overall Study||4||
59689161|NCT01113502|75808744|FG001|STARTED|Overall Study||3||
59689162|NCT01113502|75808745|FG002|STARTED|Overall Study||7||
59689163|NCT01113502|75808746|FG003|STARTED|Overall Study||9||
59689164|NCT01113502|75808747|FG004|STARTED|Overall Study||21||
59689165|NCT01113502|75808743|FG000|COMPLETED|Overall Study||3||
59689166|NCT01113502|75808744|FG001|COMPLETED|Overall Study||3||
59689167|NCT01113502|75808745|FG002|COMPLETED|Overall Study||3||
59689168|NCT01113502|75808746|FG003|COMPLETED|Overall Study||6||
59689169|NCT01113502|75808747|FG004|COMPLETED|Overall Study||21||
59689170|NCT01113502|75808743|FG000|NOT COMPLETED|Overall Study||1||
59689171|NCT01113502|75808744|FG001|NOT COMPLETED|Overall Study||0||
59689172|NCT01113502|75808745|FG002|NOT COMPLETED|Overall Study||4||
59689173|NCT01113502|75808746|FG003|NOT COMPLETED|Overall Study||3||
59689174|NCT01113502|75808747|FG004|NOT COMPLETED|Overall Study||0||
59689175|NCT01113463|75808760|FG000|STARTED|Overall Study||17||
59689176|NCT01113463|75808760|FG000|COMPLETED|Overall Study||12||
59689177|NCT01113463|75808760|FG000|NOT COMPLETED|Overall Study||5||
59689178|NCT01112917|75808764|FG000|STARTED|Overall Study||96||
59689179|NCT01112917|75808765|FG001|STARTED|Overall Study||53||
59689180|NCT01112917|75808764|FG000|COMPLETED|Overall Study||89||
59689181|NCT01112917|75808765|FG001|COMPLETED|Overall Study||38||
59689182|NCT01112917|75808764|FG000|NOT COMPLETED|Overall Study||7||
59689183|NCT01112917|75808765|FG001|NOT COMPLETED|Overall Study||15||
59689184|NCT01176058|75808771|FG000|STARTED|Overall Study||9||
59689185|NCT01176058|75808772|FG001|STARTED|Overall Study||8||
59689186|NCT01176058|75808771|FG000|COMPLETED|Overall Study||5||
59689187|NCT01176058|75808772|FG001|COMPLETED|Overall Study||5||
59689188|NCT01176058|75808771|FG000|NOT COMPLETED|Overall Study||4||
59689189|NCT01176058|75808772|FG001|NOT COMPLETED|Overall Study||3||
59689190|NCT01175824|75808780|FG000|STARTED|Overall Study||236||
59689191|NCT01175824|75808781|FG001|STARTED|Overall Study||242||
59689192|NCT01175824|75808780|FG000|Received at Least 1 Dose of Study Drug|Overall Study||236||
59689193|NCT01175824|75808781|FG001|Received at Least 1 Dose of Study Drug|Overall Study||240||
59689194|NCT01175824|75808780|FG000|COMPLETED|Overall Study||220||
59689195|NCT01175824|75808781|FG001|COMPLETED|Overall Study||220||
59689196|NCT01175824|75808780|FG000|NOT COMPLETED|Overall Study||16||
59689197|NCT01175824|75808781|FG001|NOT COMPLETED|Overall Study||22||
59689198|NCT01175707|75808789|FG000|STARTED|Overall Study||40||
59689199|NCT01175707|75808790|FG001|STARTED|Overall Study||40||
59689200|NCT01175707|75808789|FG000|COMPLETED|Overall Study||36||
59689201|NCT01175707|75808790|FG001|COMPLETED|Overall Study||34||
59689202|NCT01175707|75808789|FG000|NOT COMPLETED|Overall Study||4||
59689203|NCT01175707|75808790|FG001|NOT COMPLETED|Overall Study||6||
59689204|NCT01112059|75808799|FG000|STARTED|Overall Study||20||
59689205|NCT01112059|75808800|FG001|STARTED|Overall Study||20||
59689206|NCT01112059|75808799|FG000|COMPLETED|Overall Study||19||
59689207|NCT01112059|75808800|FG001|COMPLETED|Overall Study||20||
59689208|NCT01112059|75808799|FG000|NOT COMPLETED|Overall Study||1||
59689209|NCT01112059|75808800|FG001|NOT COMPLETED|Overall Study||0||
59689210|NCT01175668|75808811|FG000|STARTED|Overall Study||34||
59689211|NCT01175668|75808812|FG001|STARTED|Overall Study||34||
59689212|NCT01175668|75808811|FG000|COMPLETED|Overall Study||32||
59689213|NCT01175668|75808812|FG001|COMPLETED|Overall Study||34||
59689214|NCT01175668|75808811|FG000|NOT COMPLETED|Overall Study||2||
59689215|NCT01175668|75808812|FG001|NOT COMPLETED|Overall Study||0||
59689216|NCT01111825|75808822|FG000|STARTED|Overall Study||8||
59689217|NCT01111825|75808823|FG001|STARTED|Overall Study||6||
59689218|NCT01111825|75808824|FG002|STARTED|Overall Study||37||
59689219|NCT01111825|75808825|FG003|STARTED|Overall Study||48||
59689220|NCT01111825|75808822|FG000|COMPLETED|Overall Study||5|Completed means completed study or died.|
59689221|NCT01111825|75808823|FG001|COMPLETED|Overall Study||5|Completed means completed study or died.|
59689222|NCT01111825|75808824|FG002|COMPLETED|Overall Study||29|Completed means completed study or died.|
59689223|NCT01111825|75808825|FG003|COMPLETED|Overall Study||27|Completed means completed study or died.|
59689224|NCT01111825|75808822|FG000|NOT COMPLETED|Overall Study||3||
59689225|NCT01111825|75808823|FG001|NOT COMPLETED|Overall Study||1||
59689226|NCT01111825|75808824|FG002|NOT COMPLETED|Overall Study||8||
59689227|NCT01111825|75808825|FG003|NOT COMPLETED|Overall Study||21||
59689228|NCT01175590|75808837|FG000|STARTED|Overall Study||347||
59689229|NCT01175590|75808838|FG001|STARTED|Overall Study||171||
59689230|NCT01175590|75808837|FG000|Modified Intent to Treat Population|Overall Study||212||
59689231|NCT01175590|75808838|FG001|Modified Intent to Treat Population|Overall Study||87||
59689232|NCT01175590|75808837|FG000|Safety Population|Overall Study||344||
59689233|NCT01175590|75808838|FG001|Safety Population|Overall Study||170||
59689234|NCT01175590|75808837|FG000|COMPLETED|Overall Study||335||
59689235|NCT01175590|75808838|FG001|COMPLETED|Overall Study||161||
59689236|NCT01175590|75808837|FG000|NOT COMPLETED|Overall Study||12||
59689237|NCT01175590|75808838|FG001|NOT COMPLETED|Overall Study||10||
59689238|NCT01175473|75808847|FG000|STARTED|Overall Study|Randomized and treated.|77||
59689239|NCT01175473|75808848|FG001|STARTED|Overall Study||71||
59689240|NCT01175473|75808847|FG000|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|77||
59689241|NCT01175473|75808848|FG001|Safety Population|Overall Study||71||
59689242|NCT01175473|75808847|FG000|Pharmacodynamic (PD) Population|Overall Study|All patients who received at least 1 dose; had baseline and at least 1 post-baseline PD assessment.|75||
59689243|NCT01175473|75808848|FG001|Pharmacodynamic (PD) Population|Overall Study||68||
59689244|NCT01175473|75808847|FG000|COMPLETED|Overall Study||75||
59689245|NCT01175473|75808848|FG001|COMPLETED|Overall Study||69||
59689246|NCT01175473|75808847|FG000|NOT COMPLETED|Overall Study||2||
59689247|NCT01175473|75808848|FG001|NOT COMPLETED|Overall Study||2||
59689248|NCT01111552|75808854|FG000|STARTED|Phase B (Day 1 to Week 8)||237||
59689249|NCT01111552|75808855|FG001|STARTED|Phase B (Day 1 to Week 8)||0||
59689250|NCT01111552|75808856|FG002|STARTED|Phase B (Day 1 to Week 8)||0||
59689251|NCT01111552|75808857|FG003|STARTED|Phase B (Day 1 to Week 8)||0||
59689252|NCT01111552|75808858|FG004|STARTED|Phase B (Day 1 to Week 8)||0||
59689253|NCT01111552|75808854|FG000|COMPLETED|Phase B (Day 1 to Week 8)||120||
59689254|NCT01111552|75808855|FG001|COMPLETED|Phase B (Day 1 to Week 8)||0||
59689255|NCT01111552|75808856|FG002|COMPLETED|Phase B (Day 1 to Week 8)||0||
59689256|NCT01111552|75808857|FG003|COMPLETED|Phase B (Day 1 to Week 8)||0||
59689257|NCT01111552|75808858|FG004|COMPLETED|Phase B (Day 1 to Week 8)||0||
59689258|NCT01111552|75808854|FG000|NOT COMPLETED|Phase B (Day 1 to Week 8)||117||
59689259|NCT01111552|75808855|FG001|NOT COMPLETED|Phase B (Day 1 to Week 8)||0||
59689260|NCT01111552|75808856|FG002|NOT COMPLETED|Phase B (Day 1 to Week 8)||0||
59689261|NCT01111552|75808857|FG003|NOT COMPLETED|Phase B (Day 1 to Week 8)||0||
59689262|NCT01111552|75808858|FG004|NOT COMPLETED|Phase B (Day 1 to Week 8)||0||
59689263|NCT01111552|75808854|FG000|STARTED|Phase B+ and Phase C (Weeks 9 to 14)||0||
59689264|NCT01111552|75808855|FG001|STARTED|Phase B+ and Phase C (Weeks 9 to 14)||54||
59689265|NCT01111552|75808856|FG002|STARTED|Phase B+ and Phase C (Weeks 9 to 14)||22||
59689266|NCT01111552|75808857|FG003|STARTED|Phase B+ and Phase C (Weeks 9 to 14)||21||
59689267|NCT01111552|75808858|FG004|STARTED|Phase B+ and Phase C (Weeks 9 to 14)||23||
59689268|NCT01111552|75808854|FG000|COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||0||
59689269|NCT01111552|75808855|FG001|COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||45||
59689270|NCT01111552|75808856|FG002|COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||17||
59689271|NCT01111552|75808857|FG003|COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||17||
59689272|NCT01111552|75808858|FG004|COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||18||
59689273|NCT01111552|75808854|FG000|NOT COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||0||
59689274|NCT01111552|75808855|FG001|NOT COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||9||
59689275|NCT01111552|75808856|FG002|NOT COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||5||
59689276|NCT01111552|75808857|FG003|NOT COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||4||
59689277|NCT01111552|75808858|FG004|NOT COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||5||
59689278|NCT01175083|75808874|FG000|STARTED|Primary Epoch||50||
59689279|NCT01175083|75808875|FG001|STARTED|Primary Epoch||50||
59689280|NCT01175083|75808876|FG002|STARTED|Primary Epoch||50||
59689281|NCT01175083|75808877|FG003|STARTED|Primary Epoch||50||
59689282|NCT01175083|75808878|FG004|STARTED|Primary Epoch||50||
59689283|NCT01175083|75808879|FG005|STARTED|Primary Epoch||50||
59689284|NCT01175083|75808874|FG000|COMPLETED|Primary Epoch||50||
59689285|NCT01175083|75808875|FG001|COMPLETED|Primary Epoch||50||
59689286|NCT01175083|75808876|FG002|COMPLETED|Primary Epoch||50||
59689287|NCT01175083|75808877|FG003|COMPLETED|Primary Epoch||50||
59689288|NCT01175083|75808878|FG004|COMPLETED|Primary Epoch||50||
59689289|NCT01175083|75808879|FG005|COMPLETED|Primary Epoch||47||
59689290|NCT01175083|75808874|FG000|NOT COMPLETED|Primary Epoch||0||
59689291|NCT01175083|75808875|FG001|NOT COMPLETED|Primary Epoch||0||
59689292|NCT01175083|75808876|FG002|NOT COMPLETED|Primary Epoch||0||
59689293|NCT01175083|75808877|FG003|NOT COMPLETED|Primary Epoch||0||
59689294|NCT01175083|75808878|FG004|NOT COMPLETED|Primary Epoch||0||
59689295|NCT01175083|75808879|FG005|NOT COMPLETED|Primary Epoch||3||
59689296|NCT01175083|75808874|FG000|STARTED|Booster Epoch|One subject died between both Epochs and hence did not participate in the Booster Epoch.|49||
59709828|NCT01072149|75828522|FG002|STARTED|Treatment Period 2 (28 Days)||2||
59689297|NCT01175083|75808875|FG001|STARTED|Booster Epoch|One subject died between both Epochs and hence did not participate in the Booster Epoch.|49||
59689298|NCT01175083|75808876|FG002|STARTED|Booster Epoch||50||
59689299|NCT01175083|75808877|FG003|STARTED|Booster Epoch||50||
59689300|NCT01175083|75808878|FG004|STARTED|Booster Epoch|No subjects participated in the Booster Epoch, as no booster dose was planned per protocol.|0||
59689301|NCT01175083|75808879|FG005|STARTED|Booster Epoch|No subjects participated in the Booster Epoch, as no booster dose was planned per protocol.|0||
59689302|NCT01175083|75808874|FG000|COMPLETED|Booster Epoch||49||
59689303|NCT01175083|75808875|FG001|COMPLETED|Booster Epoch||49||
59689304|NCT01175083|75808876|FG002|COMPLETED|Booster Epoch||49||
59689305|NCT01175083|75808877|FG003|COMPLETED|Booster Epoch||49||
59689306|NCT01175083|75808878|FG004|COMPLETED|Booster Epoch||0||
59689307|NCT01175083|75808879|FG005|COMPLETED|Booster Epoch||0||
59689308|NCT01175083|75808874|FG000|NOT COMPLETED|Booster Epoch||0||
59689309|NCT01175083|75808875|FG001|NOT COMPLETED|Booster Epoch||0||
59689310|NCT01175083|75808876|FG002|NOT COMPLETED|Booster Epoch||1||
59689311|NCT01175083|75808877|FG003|NOT COMPLETED|Booster Epoch||1||
59689312|NCT01175083|75808878|FG004|NOT COMPLETED|Booster Epoch||0||
59689313|NCT01175083|75808879|FG005|NOT COMPLETED|Booster Epoch||0||
59689314|NCT01174459|75808897|FG000|STARTED|Overall Study|Registered patients|571||
59689315|NCT01174459|75808897|FG000|COMPLETED|Overall Study|Case report form (CRF) collected|566||
59689316|NCT01174459|75808897|FG000|NOT COMPLETED|Overall Study||5||
59689317|NCT01174342|75808901|FG000|STARTED|Overall Study||30||
59689318|NCT01174342|75808901|FG000|COMPLETED|Overall Study||26||
59689319|NCT01174342|75808901|FG000|NOT COMPLETED|Overall Study||4||
59689320|NCT01111474|75808905|FG000|STARTED|Overall Study|593 teeth from 74 participants: 296 teeth treated with cyanoacrylate and 297 teeth with LILT|74||
59689321|NCT01111474|75808905|FG000|COMPLETED|Overall Study|434 teeth from 62 participants: 218 teeth teated with cyanoacrylate and 216 teeth with LILT|62||
59689322|NCT01111474|75808905|FG000|NOT COMPLETED|Overall Study||12||
59689323|NCT01174264|75808914|FG000|STARTED|Single Dose Pharmacokinetics||23||
59689324|NCT01174264|75808915|FG001|STARTED|Single Dose Pharmacokinetics||20||
59689325|NCT01174264|75808916|FG002|STARTED|Single Dose Pharmacokinetics||20||
59689326|NCT01174264|75808914|FG000|COMPLETED|Single Dose Pharmacokinetics||22||
59689327|NCT01174264|75808915|FG001|COMPLETED|Single Dose Pharmacokinetics||20||
59689328|NCT01174264|75808916|FG002|COMPLETED|Single Dose Pharmacokinetics||18||
59689329|NCT01174264|75808914|FG000|NOT COMPLETED|Single Dose Pharmacokinetics||1||
59689330|NCT01174264|75808915|FG001|NOT COMPLETED|Single Dose Pharmacokinetics||0||
59689331|NCT01174264|75808916|FG002|NOT COMPLETED|Single Dose Pharmacokinetics||2||
59689332|NCT01174264|75808914|FG000|STARTED|Steady-state Pharmacokinetics|Includes 22 patients from period 1 fasting arm and 9 patients from period 1 high-fat arm|31||
59689333|NCT01174264|75808915|FG001|STARTED|Steady-state Pharmacokinetics|Patients in period 2 were randomized to fasting vs. fed state only.|0||
59689334|NCT01174264|75808916|FG002|STARTED|Steady-state Pharmacokinetics|Includes 11 patients from period 1 high-fat arm and 18 patients from period 1 low-fat arm|29||
59689335|NCT01174264|75808914|FG000|COMPLETED|Steady-state Pharmacokinetics||25||
59689336|NCT01174264|75808915|FG001|COMPLETED|Steady-state Pharmacokinetics||0||
59689337|NCT01174264|75808916|FG002|COMPLETED|Steady-state Pharmacokinetics||27||
59689338|NCT01174264|75808914|FG000|NOT COMPLETED|Steady-state Pharmacokinetics||6||
59689339|NCT01174264|75808915|FG001|NOT COMPLETED|Steady-state Pharmacokinetics||0||
59689340|NCT01174264|75808916|FG002|NOT COMPLETED|Steady-state Pharmacokinetics||2||
59689341|NCT01174186|75808926|FG000|STARTED|Overall Study|Patients were included over three years|15||
59689342|NCT01174186|75808927|FG001|STARTED|Overall Study||15||
59689343|NCT01174186|75808926|FG000|COMPLETED|Overall Study||15||
59689344|NCT01174186|75808927|FG001|COMPLETED|Overall Study||12||
59689345|NCT01174186|75808926|FG000|NOT COMPLETED|Overall Study||0||
59689346|NCT01174186|75808927|FG001|NOT COMPLETED|Overall Study||3||
59689347|NCT01173718|75808933|FG000|STARTED|Overall Study||138||
59689348|NCT01173718|75808933|FG000|COMPLETED|Overall Study||94||
59689349|NCT01173718|75808933|FG000|NOT COMPLETED|Overall Study||44||
59689350|NCT01111240|75808937|FG000|STARTED|Overall Study||4635||
59689351|NCT01111240|75808937|FG000|COMPLETED|Overall Study||3569||
59689352|NCT01111240|75808937|FG000|NOT COMPLETED|Overall Study||1066||
59689353|NCT01111123|75808943|FG000|STARTED|Open- Label Phase||55||
59689354|NCT01111123|75808944|FG001|STARTED|Open- Label Phase||0||
59689355|NCT01111123|75808943|FG000|COMPLETED|Open- Label Phase||41||
59689356|NCT01111123|75808944|FG001|COMPLETED|Open- Label Phase||0||
59689357|NCT01111123|75808943|FG000|NOT COMPLETED|Open- Label Phase||14||
59689358|NCT01111123|75808944|FG001|NOT COMPLETED|Open- Label Phase||0||
59689359|NCT01111123|75808943|FG000|STARTED|Maintenance Phase||21||
59689360|NCT01111123|75808944|FG001|STARTED|Maintenance Phase||20||
59689361|NCT01111123|75808943|FG000|COMPLETED|Maintenance Phase||21||
59689362|NCT01111123|75808944|FG001|COMPLETED|Maintenance Phase||18||
59689363|NCT01111123|75808943|FG000|NOT COMPLETED|Maintenance Phase||0||
59689364|NCT01111123|75808944|FG001|NOT COMPLETED|Maintenance Phase||2||
59689365|NCT01173679|75808952|FG000|STARTED|Overall Study||10||
59689366|NCT01173679|75808952|FG000|COMPLETED|Overall Study||9||
59689367|NCT01173679|75808952|FG000|NOT COMPLETED|Overall Study||1||
59689368|NCT01110382|75808959|FG000|STARTED|Overall Study||31||
59689369|NCT01110382|75808960|FG001|STARTED|Overall Study||10||
59689370|NCT01110382|75808959|FG000|COMPLETED|Overall Study||31||
59689371|NCT01110382|75808960|FG001|COMPLETED|Overall Study||8||
59689372|NCT01110382|75808959|FG000|NOT COMPLETED|Overall Study||0||
59689373|NCT01110382|75808960|FG001|NOT COMPLETED|Overall Study||2||
59689374|NCT01173601|75808970|FG000|STARTED|Confirmation (CF) Phase, 3 Weeks||1416||
59689375|NCT01173601|75808971|FG001|STARTED|Confirmation (CF) Phase, 3 Weeks||0||
59689376|NCT01173601|75808972|FG002|STARTED|Confirmation (CF) Phase, 3 Weeks||0||
59689377|NCT01173601|75808973|FG003|STARTED|Confirmation (CF) Phase, 3 Weeks||0||
59689378|NCT01173601|75808974|FG004|STARTED|Confirmation (CF) Phase, 3 Weeks||0||
59689379|NCT01173601|75808970|FG000|Entered Discontinuation Phase|Confirmation (CF) Phase, 3 Weeks|Participants who discontinued the CF Phase had the option to enter the DC phase.|21||
59689380|NCT01173601|75808971|FG001|Entered Discontinuation Phase|Confirmation (CF) Phase, 3 Weeks||0||
59689381|NCT01173601|75808972|FG002|Entered Discontinuation Phase|Confirmation (CF) Phase, 3 Weeks||0||
59689382|NCT01173601|75808973|FG003|Entered Discontinuation Phase|Confirmation (CF) Phase, 3 Weeks||0||
59689383|NCT01173601|75808974|FG004|Entered Discontinuation Phase|Confirmation (CF) Phase, 3 Weeks||0||
59689384|NCT01173601|75808970|FG000|COMPLETED|Confirmation (CF) Phase, 3 Weeks|Participants who completed the CF Phase entered the AT Phase.|1328||
59689385|NCT01173601|75808971|FG001|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0||
59689386|NCT01173601|75808972|FG002|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0||
59689387|NCT01173601|75808973|FG003|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0||
59689388|NCT01173601|75808974|FG004|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0||
59689389|NCT01173601|75808970|FG000|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||88||
59689390|NCT01173601|75808971|FG001|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0||
59689391|NCT01173601|75808972|FG002|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0||
59689392|NCT01173601|75808973|FG003|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0||
59689393|NCT01173601|75808974|FG004|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0||
59689394|NCT01173601|75808970|FG000|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||0||
59689395|NCT01173601|75808971|FG001|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||231||
59689396|NCT01173601|75808972|FG002|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||230||
59689397|NCT01173601|75808973|FG003|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||240||
59689398|NCT01173601|75808974|FG004|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||627||
59689399|NCT01173601|75808970|FG000|Entered Taper Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0||
59689400|NCT01173601|75808971|FG001|Entered Taper Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the taper DC Phase.|100||
59689401|NCT01173601|75808972|FG002|Entered Taper Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the taper DC Phase.|107||
59689402|NCT01173601|75808973|FG003|Entered Taper Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0||
59689403|NCT01173601|75808974|FG004|Entered Taper Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0||
59689404|NCT01173601|75808970|FG000|Entered Abrupt Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0||
59689405|NCT01173601|75808971|FG001|Entered Abrupt Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the abrupt DC Phase.|100||
59689406|NCT01173601|75808972|FG002|Entered Abrupt Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the abrupt DC Phase.|108||
59689407|NCT01173601|75808973|FG003|Entered Abrupt Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the abrupt DC Phase.|221||
59689408|NCT01173601|75808974|FG004|Entered Abrupt Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the abrupt DC Phase.|586||
59689409|NCT01173601|75808970|FG000|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0||
59689410|NCT01173601|75808971|FG001|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||196||
59689411|NCT01173601|75808972|FG002|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||197||
59689412|NCT01173601|75808973|FG003|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||210||
59689413|NCT01173601|75808974|FG004|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||559||
59689414|NCT01173601|75808970|FG000|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0||
59689415|NCT01173601|75808971|FG001|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||35||
59689416|NCT01173601|75808972|FG002|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||33||
59689417|NCT01173601|75808973|FG003|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||30||
59689418|NCT01173601|75808974|FG004|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||68||
59689419|NCT01173523|75808994|FG000|STARTED|Overall Study||13||
59689420|NCT01173523|75808995|FG001|STARTED|Overall Study||12||
59689421|NCT01173523|75808994|FG000|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0||
59689422|NCT01173523|75808995|FG001|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0||
59689423|NCT01173523|75808994|FG000|NOT COMPLETED|Overall Study||13||
59689424|NCT01173523|75808995|FG001|NOT COMPLETED|Overall Study||12||
59689425|NCT01173055|75809003|FG000|STARTED|Period 1 - Day 1 to 49||10||
59689426|NCT01173055|75809004|FG001|STARTED|Period 1 - Day 1 to 49||12||
59689427|NCT01173055|75809003|FG000|COMPLETED|Period 1 - Day 1 to 49||8||
59689428|NCT01173055|75809004|FG001|COMPLETED|Period 1 - Day 1 to 49||10||
59689429|NCT01173055|75809003|FG000|NOT COMPLETED|Period 1 - Day 1 to 49||2||
59689430|NCT01173055|75809004|FG001|NOT COMPLETED|Period 1 - Day 1 to 49||2||
59689431|NCT01173055|75809003|FG000|STARTED|Placebo Washout Period - Day 50 to 63||8||
59689432|NCT01173055|75809004|FG001|STARTED|Placebo Washout Period - Day 50 to 63||10||
59689433|NCT01173055|75809003|FG000|COMPLETED|Placebo Washout Period - Day 50 to 63||8||
59689434|NCT01173055|75809004|FG001|COMPLETED|Placebo Washout Period - Day 50 to 63||10||
59689435|NCT01173055|75809003|FG000|NOT COMPLETED|Placebo Washout Period - Day 50 to 63||0||
59689436|NCT01173055|75809004|FG001|NOT COMPLETED|Placebo Washout Period - Day 50 to 63||0||
59689437|NCT01173055|75809003|FG000|STARTED|Period 2 - Day 64 to 112||8||
59689438|NCT01173055|75809004|FG001|STARTED|Period 2 - Day 64 to 112||10||
59689439|NCT01173055|75809003|FG000|COMPLETED|Period 2 - Day 64 to 112||8||
59689440|NCT01173055|75809004|FG001|COMPLETED|Period 2 - Day 64 to 112||9||
59689441|NCT01173055|75809003|FG000|NOT COMPLETED|Period 2 - Day 64 to 112||0||
59689442|NCT01173055|75809004|FG001|NOT COMPLETED|Period 2 - Day 64 to 112||1||
59689443|NCT01172938|75809013|FG000|STARTED|Placebo-controlled Phase (Week 0-24)||168||
59689444|NCT01172938|75809014|FG001|STARTED|Placebo-controlled Phase (Week 0-24)||168||
59689445|NCT01172938|75809015|FG002|STARTED|Placebo-controlled Phase (Week 0-24)||168||
59689446|NCT01172938|75809016|FG003|STARTED|Placebo-controlled Phase (Week 0-24)||0||
59689447|NCT01172938|75809017|FG004|STARTED|Placebo-controlled Phase (Week 0-24)||0||
59689448|NCT01172938|75809018|FG005|STARTED|Placebo-controlled Phase (Week 0-24)||0||
59689449|NCT01172938|75809019|FG006|STARTED|Placebo-controlled Phase (Week 0-24)||0||
59547503|NCT02517567|75646294|FG001|STARTED|Fourth Exposure (8 Hours)||8||
59547504|NCT02517567|75646295|FG002|STARTED|Fourth Exposure (8 Hours)|One subject discontinued between Period 3 and Period 4 (withdrawal by subject)|6||
59547505|NCT02517567|75646296|FG003|STARTED|Fourth Exposure (8 Hours)||8||
59689450|NCT01172938|75809020|FG007|STARTED|Placebo-controlled Phase (Week 0-24)||0||
59689451|NCT01172938|75809021|FG008|STARTED|Placebo-controlled Phase (Week 0-24)||0||
59689452|NCT01172938|75809013|FG000|Received Treatment|Placebo-controlled Phase (Week 0-24)||168||
59689453|NCT01172938|75809014|FG001|Received Treatment|Placebo-controlled Phase (Week 0-24)||168||
59689454|NCT01172938|75809015|FG002|Received Treatment|Placebo-controlled Phase (Week 0-24)||168||
59689455|NCT01172938|75809016|FG003|Received Treatment|Placebo-controlled Phase (Week 0-24)||0||
59689456|NCT01172938|75809017|FG004|Received Treatment|Placebo-controlled Phase (Week 0-24)||0||
59689457|NCT01172938|75809018|FG005|Received Treatment|Placebo-controlled Phase (Week 0-24)||0||
59689458|NCT01172938|75809019|FG006|Received Treatment|Placebo-controlled Phase (Week 0-24)||0||
59689459|NCT01172938|75809020|FG007|Received Treatment|Placebo-controlled Phase (Week 0-24)||0||
59689460|NCT01172938|75809021|FG008|Received Treatment|Placebo-controlled Phase (Week 0-24)||0||
59547506|NCT02517567|75646293|FG000|COMPLETED|Fourth Exposure (8 Hours)||6||
59547507|NCT02517567|75646294|FG001|COMPLETED|Fourth Exposure (8 Hours)||8||
59547508|NCT02517567|75646295|FG002|COMPLETED|Fourth Exposure (8 Hours)||6||
59547509|NCT02517567|75646296|FG003|COMPLETED|Fourth Exposure (8 Hours)||8||
59547510|NCT02517567|75646293|FG000|NOT COMPLETED|Fourth Exposure (8 Hours)||0||
59547511|NCT02517567|75646294|FG001|NOT COMPLETED|Fourth Exposure (8 Hours)||0||
59547512|NCT02517567|75646295|FG002|NOT COMPLETED|Fourth Exposure (8 Hours)||0||
59547513|NCT02517567|75646296|FG003|NOT COMPLETED|Fourth Exposure (8 Hours)||0||
59547514|NCT01100606|75646305|FG000|STARTED|First Treatment Period||8||
59547515|NCT01100606|75646306|FG001|STARTED|First Treatment Period||7||
59547516|NCT01100606|75646305|FG000|COMPLETED|First Treatment Period|Due to difficulty with syringe nurser,1 participant completed study with apple sauce,not apple juice|8||
59547517|NCT01100606|75646306|FG001|COMPLETED|First Treatment Period||7||
59547518|NCT01100606|75646305|FG000|NOT COMPLETED|First Treatment Period||0||
59547519|NCT01100606|75646306|FG001|NOT COMPLETED|First Treatment Period||0||
59547520|NCT01100606|75646305|FG000|STARTED|Second Treatment Period||8||
59689461|NCT01172938|75809013|FG000|Completed Week 16|Placebo-controlled Phase (Week 0-24)||158||
59689462|NCT01172938|75809014|FG001|Completed Week 16|Placebo-controlled Phase (Week 0-24)||158||
59689463|NCT01172938|75809015|FG002|Completed Week 16|Placebo-controlled Phase (Week 0-24)||154||
59689464|NCT01172938|75809016|FG003|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0||
59689465|NCT01172938|75809017|FG004|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0||
59689466|NCT01172938|75809018|FG005|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0||
59689467|NCT01172938|75809019|FG006|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0||
59689468|NCT01172938|75809020|FG007|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0||
59689469|NCT01172938|75809021|FG008|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0||
59689470|NCT01172938|75809013|FG000|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)|Five participants who escaped early did not complete Week 24|107||
59689471|NCT01172938|75809014|FG001|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)|Six participants who escaped early did not complete Week 24|78||
59689472|NCT01172938|75809015|FG002|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||58||
59689473|NCT01172938|75809016|FG003|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0||
59689474|NCT01172938|75809017|FG004|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0||
59689475|NCT01172938|75809018|FG005|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0||
59689476|NCT01172938|75809019|FG006|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0||
59689477|NCT01172938|75809020|FG007|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0||
59689478|NCT01172938|75809021|FG008|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0||
59689479|NCT01172938|75809013|FG000|COMPLETED|Placebo-controlled Phase (Week 0-24)|One participant who completed Week 24 did not enter the active treatment phase|150||
59689480|NCT01172938|75809014|FG001|COMPLETED|Placebo-controlled Phase (Week 0-24)||146||
59689481|NCT01172938|75809015|FG002|COMPLETED|Placebo-controlled Phase (Week 0-24)||148||
59689482|NCT01172938|75809016|FG003|COMPLETED|Placebo-controlled Phase (Week 0-24)||0||
59689483|NCT01172938|75809017|FG004|COMPLETED|Placebo-controlled Phase (Week 0-24)||0||
59689484|NCT01172938|75809018|FG005|COMPLETED|Placebo-controlled Phase (Week 0-24)||0||
59689485|NCT01172938|75809019|FG006|COMPLETED|Placebo-controlled Phase (Week 0-24)||0||
59689486|NCT01172938|75809020|FG007|COMPLETED|Placebo-controlled Phase (Week 0-24)||0||
59689487|NCT01172938|75809021|FG008|COMPLETED|Placebo-controlled Phase (Week 0-24)||0||
59689488|NCT01172938|75809013|FG000|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||18||
59689489|NCT01172938|75809014|FG001|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||22||
59689490|NCT01172938|75809015|FG002|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||20||
59689491|NCT01172938|75809016|FG003|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0||
59689492|NCT01172938|75809017|FG004|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0||
59689493|NCT01172938|75809018|FG005|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0||
59689494|NCT01172938|75809019|FG006|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0||
59689495|NCT01172938|75809020|FG007|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0||
59689496|NCT01172938|75809021|FG008|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0||
59689497|NCT01172938|75809013|FG000|STARTED|Active Treatment Phase (Weeks 25-52)||0||
59689498|NCT01172938|75809014|FG001|STARTED|Active Treatment Phase (Weeks 25-52)|Ten participants who completed Week 24 did not enter the active treatment phase|136||
59689499|NCT01172938|75809015|FG002|STARTED|Active Treatment Phase (Weeks 25-52)|Three participants who completed Week 24 did not enter the active treatment phase|145||
59689500|NCT01172938|75809016|FG003|STARTED|Active Treatment Phase (Weeks 25-52)|One participant who escaped early and completed Week 24 did not enter the active treatment phase|51||
59689501|NCT01172938|75809017|FG004|STARTED|Active Treatment Phase (Weeks 25-52)||23||
59689502|NCT01172938|75809018|FG005|STARTED|Active Treatment Phase (Weeks 25-52)|One participant who escaped early and completed Week 24 did not enter the active treatment phase|49||
59689503|NCT01172938|75809019|FG006|STARTED|Active Treatment Phase (Weeks 25-52)||24||
59689504|NCT01172938|75809020|FG007|STARTED|Active Treatment Phase (Weeks 25-52)||0||
59689505|NCT01172938|75809021|FG008|STARTED|Active Treatment Phase (Weeks 25-52)||0||
59689506|NCT01172938|75809013|FG000|COMPLETED|Active Treatment Phase (Weeks 25-52)||0||
59689507|NCT01172938|75809014|FG001|COMPLETED|Active Treatment Phase (Weeks 25-52)||124||
59689508|NCT01172938|75809015|FG002|COMPLETED|Active Treatment Phase (Weeks 25-52)||130||
59689509|NCT01172938|75809016|FG003|COMPLETED|Active Treatment Phase (Weeks 25-52)||44||
59689510|NCT01172938|75809017|FG004|COMPLETED|Active Treatment Phase (Weeks 25-52)||19||
59689511|NCT01172938|75809018|FG005|COMPLETED|Active Treatment Phase (Weeks 25-52)||34||
59689512|NCT01172938|75809019|FG006|COMPLETED|Active Treatment Phase (Weeks 25-52)||22||
59689513|NCT01172938|75809020|FG007|COMPLETED|Active Treatment Phase (Weeks 25-52)||0||
59689514|NCT01172938|75809021|FG008|COMPLETED|Active Treatment Phase (Weeks 25-52)||0||
59689515|NCT01172938|75809013|FG000|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||0||
59689516|NCT01172938|75809014|FG001|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||12||
59689517|NCT01172938|75809015|FG002|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||15||
59689518|NCT01172938|75809016|FG003|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||7||
59816114|NCT00529958|75938469|FG001|STARTED|5-Year Follow-up|108 HT patients available for 5-year follow-up excludes n=1 cross-over patient from the DB group|108||
59816115|NCT00529958|75938470|FG002|STARTED|5-Year Follow-up|108 DB patients available for 5-year follow-up includes n=1 cross-over with a single-bundle HT graft|108||
59816116|NCT00529958|75938468|FG000|COMPLETED|5-Year Follow-up||103||
59689519|NCT01172938|75809017|FG004|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||4||
59689520|NCT01172938|75809018|FG005|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||15||
59689521|NCT01172938|75809019|FG006|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||2||
59689522|NCT01172938|75809020|FG007|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||0||
59689523|NCT01172938|75809021|FG008|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||0||
59689524|NCT01172938|75809013|FG000|STARTED|Active-Treatment Phase (Weeks 52-104)||0||
59689525|NCT01172938|75809014|FG001|STARTED|Active-Treatment Phase (Weeks 52-104)|Six participants who completed Week 52 did not enter the next year of active treatment phase|118||
59689526|NCT01172938|75809015|FG002|STARTED|Active-Treatment Phase (Weeks 52-104)|Nine participants who completed Week 52 did not enter the next year of active treatment phase|121||
59689527|NCT01172938|75809016|FG003|STARTED|Active-Treatment Phase (Weeks 52-104)||0||
59689528|NCT01172938|75809017|FG004|STARTED|Active-Treatment Phase (Weeks 52-104)||0||
59689529|NCT01172938|75809018|FG005|STARTED|Active-Treatment Phase (Weeks 52-104)||0||
59689530|NCT01172938|75809019|FG006|STARTED|Active-Treatment Phase (Weeks 52-104)||0||
59689531|NCT01172938|75809020|FG007|STARTED|Active-Treatment Phase (Weeks 52-104)||61||
59689532|NCT01172938|75809021|FG008|STARTED|Active-Treatment Phase (Weeks 52-104)||49||
59689533|NCT01172938|75809013|FG000|COMPLETED|Active-Treatment Phase (Weeks 52-104)||0||
59689534|NCT01172938|75809014|FG001|COMPLETED|Active-Treatment Phase (Weeks 52-104)||95||
59689535|NCT01172938|75809015|FG002|COMPLETED|Active-Treatment Phase (Weeks 52-104)||100||
59689536|NCT01172938|75809016|FG003|COMPLETED|Active-Treatment Phase (Weeks 52-104)||0||
59689537|NCT01172938|75809017|FG004|COMPLETED|Active-Treatment Phase (Weeks 52-104)||0||
59689538|NCT01172938|75809018|FG005|COMPLETED|Active-Treatment Phase (Weeks 52-104)||0||
59689539|NCT01172938|75809019|FG006|COMPLETED|Active-Treatment Phase (Weeks 52-104)||0||
59689540|NCT01172938|75809020|FG007|COMPLETED|Active-Treatment Phase (Weeks 52-104)||46||
59689541|NCT01172938|75809021|FG008|COMPLETED|Active-Treatment Phase (Weeks 52-104)||45||
59689542|NCT01172938|75809013|FG000|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||0||
59689543|NCT01172938|75809014|FG001|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||23||
59689544|NCT01172938|75809015|FG002|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||21||
59689545|NCT01172938|75809016|FG003|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||0||
59689546|NCT01172938|75809017|FG004|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||0||
59689547|NCT01172938|75809018|FG005|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||0||
59689548|NCT01172938|75809019|FG006|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||0||
59689549|NCT01172938|75809020|FG007|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||15||
59689550|NCT01172938|75809021|FG008|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||4||
59689551|NCT01172938|75809013|FG000|STARTED|Active-Treatment Phase Weeks (104-156)||0||
59689552|NCT01172938|75809014|FG001|STARTED|Active-Treatment Phase Weeks (104-156)||95||
59689553|NCT01172938|75809015|FG002|STARTED|Active-Treatment Phase Weeks (104-156)||100||
59689554|NCT01172938|75809016|FG003|STARTED|Active-Treatment Phase Weeks (104-156)||0||
59689555|NCT01172938|75809017|FG004|STARTED|Active-Treatment Phase Weeks (104-156)||0||
59689556|NCT01172938|75809018|FG005|STARTED|Active-Treatment Phase Weeks (104-156)||0||
59689557|NCT01172938|75809019|FG006|STARTED|Active-Treatment Phase Weeks (104-156)||0||
59689558|NCT01172938|75809020|FG007|STARTED|Active-Treatment Phase Weeks (104-156)||46||
59689559|NCT01172938|75809021|FG008|STARTED|Active-Treatment Phase Weeks (104-156)||45||
59689560|NCT01172938|75809013|FG000|COMPLETED|Active-Treatment Phase Weeks (104-156)||0||
59689561|NCT01172938|75809014|FG001|COMPLETED|Active-Treatment Phase Weeks (104-156)||84||
59689562|NCT01172938|75809015|FG002|COMPLETED|Active-Treatment Phase Weeks (104-156)||93||
59689563|NCT01172938|75809016|FG003|COMPLETED|Active-Treatment Phase Weeks (104-156)||0||
59689564|NCT01172938|75809017|FG004|COMPLETED|Active-Treatment Phase Weeks (104-156)||0||
59689565|NCT01172938|75809018|FG005|COMPLETED|Active-Treatment Phase Weeks (104-156)||0||
59689566|NCT01172938|75809019|FG006|COMPLETED|Active-Treatment Phase Weeks (104-156)||0||
59689567|NCT01172938|75809020|FG007|COMPLETED|Active-Treatment Phase Weeks (104-156)||41||
59689568|NCT01172938|75809021|FG008|COMPLETED|Active-Treatment Phase Weeks (104-156)||41||
59689569|NCT01172938|75809013|FG000|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||0||
59689570|NCT01172938|75809014|FG001|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||11||
59689571|NCT01172938|75809015|FG002|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||7||
59689572|NCT01172938|75809016|FG003|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||0||
59689573|NCT01172938|75809017|FG004|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||0||
59689574|NCT01172938|75809018|FG005|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||0||
59689575|NCT01172938|75809019|FG006|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||0||
59689576|NCT01172938|75809020|FG007|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||5||
59689577|NCT01172938|75809021|FG008|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||4||
59689578|NCT01172938|75809013|FG000|STARTED|Active-Treatment Phase (Weeks 156-208)||0||
59689579|NCT01172938|75809014|FG001|STARTED|Active-Treatment Phase (Weeks 156-208)||84||
59689580|NCT01172938|75809015|FG002|STARTED|Active-Treatment Phase (Weeks 156-208)||93||
59689581|NCT01172938|75809016|FG003|STARTED|Active-Treatment Phase (Weeks 156-208)||0||
59689582|NCT01172938|75809017|FG004|STARTED|Active-Treatment Phase (Weeks 156-208)||0||
59689583|NCT01172938|75809018|FG005|STARTED|Active-Treatment Phase (Weeks 156-208)||0||
59689584|NCT01172938|75809019|FG006|STARTED|Active-Treatment Phase (Weeks 156-208)||0||
59689585|NCT01172938|75809020|FG007|STARTED|Active-Treatment Phase (Weeks 156-208)||41||
59689586|NCT01172938|75809021|FG008|STARTED|Active-Treatment Phase (Weeks 156-208)||41||
59689587|NCT01172938|75809013|FG000|COMPLETED|Active-Treatment Phase (Weeks 156-208)||0||
59689588|NCT01172938|75809014|FG001|COMPLETED|Active-Treatment Phase (Weeks 156-208)||75||
59689589|NCT01172938|75809015|FG002|COMPLETED|Active-Treatment Phase (Weeks 156-208)||88||
59689590|NCT01172938|75809016|FG003|COMPLETED|Active-Treatment Phase (Weeks 156-208)||0||
59689591|NCT01172938|75809017|FG004|COMPLETED|Active-Treatment Phase (Weeks 156-208)||0||
59689592|NCT01172938|75809018|FG005|COMPLETED|Active-Treatment Phase (Weeks 156-208)||0||
59689593|NCT01172938|75809019|FG006|COMPLETED|Active-Treatment Phase (Weeks 156-208)||0||
59689594|NCT01172938|75809020|FG007|COMPLETED|Active-Treatment Phase (Weeks 156-208)||32||
59689595|NCT01172938|75809021|FG008|COMPLETED|Active-Treatment Phase (Weeks 156-208)||34||
59689596|NCT01172938|75809013|FG000|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||0||
59689597|NCT01172938|75809014|FG001|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||9||
59689598|NCT01172938|75809015|FG002|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||5||
59689599|NCT01172938|75809016|FG003|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||0||
59689600|NCT01172938|75809017|FG004|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||0||
59689601|NCT01172938|75809018|FG005|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||0||
59689602|NCT01172938|75809019|FG006|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||0||
59689603|NCT01172938|75809020|FG007|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||9||
59689604|NCT01172938|75809021|FG008|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||7||
59689605|NCT01172938|75809013|FG000|STARTED|Active-Treatment Phase (Weeks 208-260)||0||
59689606|NCT01172938|75809014|FG001|STARTED|Active-Treatment Phase (Weeks 208-260)||75||
59689607|NCT01172938|75809015|FG002|STARTED|Active-Treatment Phase (Weeks 208-260)||88||
59689608|NCT01172938|75809016|FG003|STARTED|Active-Treatment Phase (Weeks 208-260)||0||
59689609|NCT01172938|75809017|FG004|STARTED|Active-Treatment Phase (Weeks 208-260)||0||
59689610|NCT01172938|75809018|FG005|STARTED|Active-Treatment Phase (Weeks 208-260)||0||
59689611|NCT01172938|75809019|FG006|STARTED|Active-Treatment Phase (Weeks 208-260)||0||
59689612|NCT01172938|75809020|FG007|STARTED|Active-Treatment Phase (Weeks 208-260)||32||
59689613|NCT01172938|75809021|FG008|STARTED|Active-Treatment Phase (Weeks 208-260)||34||
59689614|NCT01172938|75809013|FG000|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0||
59689615|NCT01172938|75809014|FG001|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0||
59689616|NCT01172938|75809015|FG002|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0||
59689617|NCT01172938|75809016|FG003|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0||
59689618|NCT01172938|75809017|FG004|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0||
59689619|NCT01172938|75809018|FG005|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0||
59689620|NCT01172938|75809019|FG006|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0||
59689621|NCT01172938|75809020|FG007|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||25||
59689622|NCT01172938|75809021|FG008|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0||
59689623|NCT01172938|75809013|FG000|COMPLETED|Active-Treatment Phase (Weeks 208-260)||0||
59689624|NCT01172938|75809014|FG001|COMPLETED|Active-Treatment Phase (Weeks 208-260)||72||
59689625|NCT01172938|75809015|FG002|COMPLETED|Active-Treatment Phase (Weeks 208-260)||80||
59689626|NCT01172938|75809016|FG003|COMPLETED|Active-Treatment Phase (Weeks 208-260)||0||
59689627|NCT01172938|75809017|FG004|COMPLETED|Active-Treatment Phase (Weeks 208-260)||0||
59689628|NCT01172938|75809018|FG005|COMPLETED|Active-Treatment Phase (Weeks 208-260)||0||
59689629|NCT01172938|75809019|FG006|COMPLETED|Active-Treatment Phase (Weeks 208-260)||0||
59689630|NCT01172938|75809020|FG007|COMPLETED|Active-Treatment Phase (Weeks 208-260)||29||
59689631|NCT01172938|75809021|FG008|COMPLETED|Active-Treatment Phase (Weeks 208-260)||32||
59689632|NCT01172938|75809013|FG000|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||0||
59689633|NCT01172938|75809014|FG001|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||3||
59689634|NCT01172938|75809015|FG002|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||8||
59689635|NCT01172938|75809016|FG003|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||0||
59689636|NCT01172938|75809017|FG004|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||0||
59689637|NCT01172938|75809018|FG005|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||0||
59689638|NCT01172938|75809019|FG006|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||0||
59689639|NCT01172938|75809020|FG007|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||3||
59689640|NCT01172938|75809021|FG008|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||2||
59689641|NCT01109992|75809041|FG000|STARTED|Overall Study||11|Subjects screened|
59689642|NCT01109992|75809042|FG001|STARTED|Overall Study||32|Subjects screened|
59689643|NCT01109992|75809041|FG000|Subjects Enrolled|Overall Study||11||
59689644|NCT01109992|75809042|FG001|Subjects Enrolled|Overall Study||32||
59689645|NCT01109992|75809041|FG000|COMPLETED|Overall Study||11||
59689646|NCT01109992|75809042|FG001|COMPLETED|Overall Study||30||
59689647|NCT01109992|75809041|FG000|NOT COMPLETED|Overall Study||0||
59689648|NCT01109992|75809042|FG001|NOT COMPLETED|Overall Study||2||
59689649|NCT01109524|75809051|FG000|STARTED|Overall Study||60||
59689650|NCT01109524|75809051|FG000|COMPLETED|Overall Study||3||
59689651|NCT01109524|75809051|FG000|NOT COMPLETED|Overall Study||57||
59689652|NCT04347564|75809055|FG000|STARTED|Overall Study||45||
59689653|NCT04347564|75809055|FG000|COMPLETED|Overall Study||45||
59689654|NCT04347564|75809055|FG000|NOT COMPLETED|Overall Study||0||
59689655|NCT01109173|75809066|FG000|STARTED|Overall Study||851||
59689656|NCT01109173|75809067|FG001|STARTED|Overall Study||845||
59689657|NCT01109173|75809068|FG002|STARTED|Overall Study||211||
59689658|NCT01109173|75809069|FG003|STARTED|Overall Study||213||
59689659|NCT01109173|75809066|FG000|COMPLETED|Overall Study||763||
59689660|NCT01109173|75809067|FG001|COMPLETED|Overall Study||759||
59689661|NCT01109173|75809068|FG002|COMPLETED|Overall Study||110||
59689662|NCT01109173|75809069|FG003|COMPLETED|Overall Study||120||
59689663|NCT01109173|75809066|FG000|NOT COMPLETED|Overall Study||88||
59689664|NCT01109173|75809067|FG001|NOT COMPLETED|Overall Study||86||
59689665|NCT01109173|75809068|FG002|NOT COMPLETED|Overall Study||101||
59689666|NCT01109173|75809069|FG003|NOT COMPLETED|Overall Study||93||
59689667|NCT01172821|75809083|FG000|STARTED|Overall Study|Entered and Treated|254||
59689668|NCT01172821|75809084|FG001|STARTED|Overall Study|Entered and Treated|257||
59689669|NCT01172821|75809085|FG002|STARTED|Overall Study|Entered and Treated|253||
59689670|NCT01172821|75809086|FG003|STARTED|Overall Study|Entered and Treated|266||
59689671|NCT01172821|75809083|FG000|COMPLETED|Overall Study||240||
59689672|NCT01172821|75809084|FG001|COMPLETED|Overall Study||245||
59689673|NCT01172821|75809085|FG002|COMPLETED|Overall Study||240||
59689674|NCT01172821|75809086|FG003|COMPLETED|Overall Study||249||
59689675|NCT01172821|75809083|FG000|NOT COMPLETED|Overall Study||14||
59689676|NCT01172821|75809084|FG001|NOT COMPLETED|Overall Study||12||
59689677|NCT01172821|75809085|FG002|NOT COMPLETED|Overall Study||13||
59689678|NCT01172821|75809086|FG003|NOT COMPLETED|Overall Study||17||
59689679|NCT01172275|75809098|FG000|STARTED|Overall Study||5||
59689680|NCT01172275|75809099|FG001|STARTED|Overall Study||6||
59689681|NCT01172275|75809098|FG000|COMPLETED|Overall Study||3||
59689682|NCT01172275|75809099|FG001|COMPLETED|Overall Study||6||
59689683|NCT01172275|75809098|FG000|NOT COMPLETED|Overall Study||2||
59689684|NCT01172275|75809099|FG001|NOT COMPLETED|Overall Study||0||
59689685|NCT01108510|75809107|FG000|STARTED|Overall Study||349||
59689686|NCT01108510|75809108|FG001|STARTED|Overall Study||349||
59689687|NCT01108510|75809107|FG000|COMPLETED|Overall Study||70||
59689688|NCT01108510|75809108|FG001|COMPLETED|Overall Study||81||
59689689|NCT01108510|75809107|FG000|NOT COMPLETED|Overall Study||279||
59689690|NCT01108510|75809108|FG001|NOT COMPLETED|Overall Study||268||
59689691|NCT01340027|75809126|FG000|STARTED|Overall Study||81||
59689692|NCT01340027|75809127|FG001|STARTED|Overall Study||78||
59689693|NCT01340027|75809128|FG002|STARTED|Overall Study||79||
59689694|NCT01340027|75809129|FG003|STARTED|Overall Study||79||
59689695|NCT01340027|75809130|FG004|STARTED|Overall Study||156||
59689696|NCT01340027|75809131|FG005|STARTED|Overall Study||78||
59689697|NCT01340027|75809132|FG006|STARTED|Overall Study||149||
59689698|NCT01340027|75809133|FG007|STARTED|Overall Study||149||
59689699|NCT01340027|75809134|FG008|STARTED|Overall Study||144||
59689700|NCT01340027|75809135|FG009|STARTED|Overall Study||152||
59689701|NCT01340027|75809136|FG010|STARTED|Overall Study||81||
59689702|NCT01340027|75809137|FG011|STARTED|Overall Study||81||
59689703|NCT01340027|75809126|FG000|Received Treatment|Overall Study||81||
59689704|NCT01340027|75809127|FG001|Received Treatment|Overall Study||78||
59689705|NCT01340027|75809128|FG002|Received Treatment|Overall Study||78||
59689706|NCT01340027|75809129|FG003|Received Treatment|Overall Study||79||
59689707|NCT01340027|75809130|FG004|Received Treatment|Overall Study||156||
59689708|NCT01340027|75809131|FG005|Received Treatment|Overall Study||78||
59689709|NCT01340027|75809132|FG006|Received Treatment|Overall Study||149||
59689710|NCT01340027|75809133|FG007|Received Treatment|Overall Study||149||
59689711|NCT01340027|75809134|FG008|Received Treatment|Overall Study||144||
59689712|NCT01340027|75809135|FG009|Received Treatment|Overall Study||152||
59689713|NCT01340027|75809136|FG010|Received Treatment|Overall Study||81||
59689714|NCT01340027|75809137|FG011|Received Treatment|Overall Study||81||
59689715|NCT01340027|75809126|FG000|COMPLETED|Overall Study||76||
59689716|NCT01340027|75809127|FG001|COMPLETED|Overall Study||71||
59689717|NCT01340027|75809128|FG002|COMPLETED|Overall Study||75||
59689718|NCT01340027|75809129|FG003|COMPLETED|Overall Study||75||
59689719|NCT01340027|75809130|FG004|COMPLETED|Overall Study||146||
59689720|NCT01340027|75809131|FG005|COMPLETED|Overall Study||74||
59989787|NCT02505542|76105160|FG003|STARTED|Part B: Double-Blind Period||105||
59689721|NCT01340027|75809132|FG006|COMPLETED|Overall Study||142||
59689722|NCT01340027|75809133|FG007|COMPLETED|Overall Study||142||
59689723|NCT01340027|75809134|FG008|COMPLETED|Overall Study||136||
59689724|NCT01340027|75809135|FG009|COMPLETED|Overall Study||146||
59689725|NCT01340027|75809136|FG010|COMPLETED|Overall Study||79||
59689726|NCT01340027|75809137|FG011|COMPLETED|Overall Study||77||
59689727|NCT01340027|75809126|FG000|NOT COMPLETED|Overall Study||5||
59689728|NCT01340027|75809127|FG001|NOT COMPLETED|Overall Study||7||
59689729|NCT01340027|75809128|FG002|NOT COMPLETED|Overall Study||4||
59689730|NCT01340027|75809129|FG003|NOT COMPLETED|Overall Study||4||
59689731|NCT01340027|75809130|FG004|NOT COMPLETED|Overall Study||10||
59689732|NCT01340027|75809131|FG005|NOT COMPLETED|Overall Study||4||
59689733|NCT01340027|75809132|FG006|NOT COMPLETED|Overall Study||7||
59689734|NCT01340027|75809133|FG007|NOT COMPLETED|Overall Study||7||
59689735|NCT01340027|75809134|FG008|NOT COMPLETED|Overall Study||8||
59689736|NCT01340027|75809135|FG009|NOT COMPLETED|Overall Study||6||
59689737|NCT01340027|75809136|FG010|NOT COMPLETED|Overall Study||2||
59689738|NCT01340027|75809137|FG011|NOT COMPLETED|Overall Study||4||
59547521|NCT01100606|75646306|FG001|STARTED|Second Treatment Period||7||
59547522|NCT01100606|75646305|FG000|COMPLETED|Second Treatment Period|Due to intolerance to apple sauce & apple juice,1 participant completed study with banana-based food|8||
59547523|NCT01100606|75646306|FG001|COMPLETED|Second Treatment Period|Due to difficulty with syringe nurser, 1 participant completed study using apple sauce|7||
59689739|NCT01327053|75809165|FG000|STARTED|Overall Study||79||
59689740|NCT01327053|75809166|FG001|STARTED|Overall Study||151||
59689741|NCT01327053|75809165|FG000|Untreated|Overall Study||0||
59689742|NCT01327053|75809166|FG001|Untreated|Overall Study|one patient randomized to LDE225 (sonidegib) 800 mg did not receive study treatment|1||
59689743|NCT01327053|75809165|FG000|Patients Cont. to Next Phase of Trial|Overall Study||52||
59689744|NCT01327053|75809166|FG001|Patients Cont. to Next Phase of Trial|Overall Study||89||
59689745|NCT01327053|75809165|FG000|Survival Follow-up|Overall Study||33||
59689746|NCT01327053|75809166|FG001|Survival Follow-up|Overall Study||49||
59689747|NCT01327053|75809165|FG000|Post-treatment Follow-up|Overall Study||19||
59689748|NCT01327053|75809166|FG001|Post-treatment Follow-up|Overall Study||40||
59689749|NCT01327053|75809165|FG000|COMPLETED|Overall Study||0||
59689750|NCT01327053|75809166|FG001|COMPLETED|Overall Study||0||
59689751|NCT01327053|75809165|FG000|NOT COMPLETED|Overall Study||79||
59689752|NCT01327053|75809166|FG001|NOT COMPLETED|Overall Study||151||
59689753|NCT01107925|75809180|FG000|STARTED|Period 1-Randomization up Through Day 12||34||
59689754|NCT01107925|75809181|FG001|STARTED|Period 1-Randomization up Through Day 12||0||
59689755|NCT01107925|75809182|FG002|STARTED|Period 1-Randomization up Through Day 12||0||
59689756|NCT01107925|75809183|FG003|STARTED|Period 1-Randomization up Through Day 12||0||
59689757|NCT01107925|75809184|FG004|STARTED|Period 1-Randomization up Through Day 12||38||
59689758|NCT01107925|75809185|FG005|STARTED|Period 1-Randomization up Through Day 12||0||
59689759|NCT01107925|75809180|FG000|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||34||
59689760|NCT01107925|75809181|FG001|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||0||
59689761|NCT01107925|75809182|FG002|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||0||
59689762|NCT01107925|75809183|FG003|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||0||
59689763|NCT01107925|75809184|FG004|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||38||
59689764|NCT01107925|75809185|FG005|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||0||
59689765|NCT01107925|75809180|FG000|COMPLETED|Period 1-Randomization up Through Day 12||33||
59689766|NCT01107925|75809181|FG001|COMPLETED|Period 1-Randomization up Through Day 12||0||
59689767|NCT01107925|75809182|FG002|COMPLETED|Period 1-Randomization up Through Day 12||0||
59689768|NCT01107925|75809183|FG003|COMPLETED|Period 1-Randomization up Through Day 12||0||
59689769|NCT01107925|75809184|FG004|COMPLETED|Period 1-Randomization up Through Day 12||37||
59689770|NCT01107925|75809185|FG005|COMPLETED|Period 1-Randomization up Through Day 12||0||
59689771|NCT01107925|75809180|FG000|NOT COMPLETED|Period 1-Randomization up Through Day 12||1||
59689772|NCT01107925|75809181|FG001|NOT COMPLETED|Period 1-Randomization up Through Day 12||0||
59689773|NCT01107925|75809182|FG002|NOT COMPLETED|Period 1-Randomization up Through Day 12||0||
59689774|NCT01107925|75809183|FG003|NOT COMPLETED|Period 1-Randomization up Through Day 12||0||
59689775|NCT01107925|75809184|FG004|NOT COMPLETED|Period 1-Randomization up Through Day 12||1||
59989788|NCT02505542|76105157|FG000|Started Escape Period|Part B: Double-Blind Period||0||
59989789|NCT02505542|76105158|FG001|Started Escape Period|Part B: Double-Blind Period||73||
59989790|NCT02505542|76105159|FG002|Started Escape Period|Part B: Double-Blind Period||7||
59989791|NCT02505542|76105160|FG003|Started Escape Period|Part B: Double-Blind Period||15||
59989792|NCT02505542|76105157|FG000|COMPLETED|Part B: Double-Blind Period||0||
59989793|NCT02505542|76105158|FG001|COMPLETED|Part B: Double-Blind Period||92||
59989794|NCT02505542|76105159|FG002|COMPLETED|Part B: Double-Blind Period||95||
59989795|NCT02505542|76105160|FG003|COMPLETED|Part B: Double-Blind Period||98||
59989796|NCT02505542|76105157|FG000|NOT COMPLETED|Part B: Double-Blind Period||0||
59989797|NCT02505542|76105158|FG001|NOT COMPLETED|Part B: Double-Blind Period||12||
59989798|NCT02505542|76105159|FG002|NOT COMPLETED|Part B: Double-Blind Period||9||
59689776|NCT01107925|75809185|FG005|NOT COMPLETED|Period 1-Randomization up Through Day 12||0||
59689777|NCT01107925|75809180|FG000|STARTED|Period 2|5 mg prasugrel (Period 1, LBW treatment) switched to 10 mg prasugrel or 75 mg clopidogrel (Period 2)|0||
59689778|NCT01107925|75809181|FG001|STARTED|Period 2||16||
59689779|NCT01107925|75809182|FG002|STARTED|Period 2||17||
59689780|NCT01107925|75809183|FG003|STARTED|Period 2||20||
59689781|NCT01107925|75809184|FG004|STARTED|Period 2|10 mg prasugrel (Period 1, HBW treatment) switched to 5 mg prasugrel or 75 mg clopidogrel (Period 2)|0||
59689782|NCT01107925|75809185|FG005|STARTED|Period 2||17||
59689783|NCT01107925|75809180|FG000|Took at Least 1 Dose of Study Drug|Period 2||0||
59689784|NCT01107925|75809181|FG001|Took at Least 1 Dose of Study Drug|Period 2||16||
59689785|NCT01107925|75809182|FG002|Took at Least 1 Dose of Study Drug|Period 2||17||
59689786|NCT01107925|75809183|FG003|Took at Least 1 Dose of Study Drug|Period 2||20||
59689787|NCT01107925|75809184|FG004|Took at Least 1 Dose of Study Drug|Period 2||0||
59689788|NCT01107925|75809185|FG005|Took at Least 1 Dose of Study Drug|Period 2||17||
59689789|NCT01107925|75809180|FG000|COMPLETED|Period 2||0||
59689790|NCT01107925|75809181|FG001|COMPLETED|Period 2||15||
59689791|NCT01107925|75809182|FG002|COMPLETED|Period 2||17||
59689792|NCT01107925|75809183|FG003|COMPLETED|Period 2||20||
59689793|NCT01107925|75809184|FG004|COMPLETED|Period 2||0||
59689794|NCT01107925|75809185|FG005|COMPLETED|Period 2||16||
59689795|NCT01107925|75809180|FG000|NOT COMPLETED|Period 2||0||
59689796|NCT01107925|75809181|FG001|NOT COMPLETED|Period 2||1||
59689797|NCT01107925|75809182|FG002|NOT COMPLETED|Period 2||0||
59689798|NCT01107925|75809183|FG003|NOT COMPLETED|Period 2||0||
59689799|NCT01107925|75809184|FG004|NOT COMPLETED|Period 2||0||
59689800|NCT01107925|75809185|FG005|NOT COMPLETED|Period 2||1||
59689801|NCT01107925|75809180|FG000|STARTED|Period 3||0||
59689802|NCT01107925|75809181|FG001|STARTED|Period 3|75 mg clopidogrel (Period 2, LBW treatment sequence) crossed over to 10 mg prasugrel (Period 3).|17||
59689803|NCT01107925|75809182|FG002|STARTED|Period 3|10 mg prasugrel (Period 2, LBW treatment sequence) crossed over to 75 mg clopidogrel (Period 3).|15||
59689804|NCT01107925|75809183|FG003|STARTED|Period 3|75 mg clopidogrel (Period 2, HBW treatment sequence) crossed over to 5 mg prasugrel (Period 3).|16||
59689805|NCT01107925|75809184|FG004|STARTED|Period 3||0||
59689806|NCT01107925|75809185|FG005|STARTED|Period 3|5 mg prasugrel (Period 2, HBW treatment sequence) crossed over to 75 mg clopidogrel (Period 3).|20||
59689807|NCT01107925|75809180|FG000|Took at Least 1 Dose of Study Drug|Period 3||0||
59689808|NCT01107925|75809181|FG001|Took at Least 1 Dose of Study Drug|Period 3||17||
59689809|NCT01107925|75809182|FG002|Took at Least 1 Dose of Study Drug|Period 3||15||
59689810|NCT01107925|75809183|FG003|Took at Least 1 Dose of Study Drug|Period 3||16||
59689811|NCT01107925|75809184|FG004|Took at Least 1 Dose of Study Drug|Period 3||0||
59689812|NCT01107925|75809185|FG005|Took at Least 1 Dose of Study Drug|Period 3||20||
59689813|NCT01107925|75809180|FG000|COMPLETED|Period 3||0||
59689814|NCT01107925|75809181|FG001|COMPLETED|Period 3||17||
59689815|NCT01107925|75809182|FG002|COMPLETED|Period 3||15||
59689816|NCT01107925|75809183|FG003|COMPLETED|Period 3||16||
59689817|NCT01107925|75809184|FG004|COMPLETED|Period 3||0||
59689818|NCT01107925|75809185|FG005|COMPLETED|Period 3||20||
59689819|NCT01107925|75809180|FG000|NOT COMPLETED|Period 3||0||
59689820|NCT01107925|75809181|FG001|NOT COMPLETED|Period 3||0||
59689821|NCT01107925|75809182|FG002|NOT COMPLETED|Period 3||0||
59689822|NCT01107925|75809183|FG003|NOT COMPLETED|Period 3||0||
59689823|NCT01107925|75809184|FG004|NOT COMPLETED|Period 3||0||
59689824|NCT01107925|75809185|FG005|NOT COMPLETED|Period 3||0||
59689825|NCT01339832|75809213|FG000|STARTED|Overall Study||51||
59689826|NCT01339832|75809213|FG000|COMPLETED|Overall Study||37||
59689827|NCT01339832|75809213|FG000|NOT COMPLETED|Overall Study||14||
59689828|NCT01339559|75809217|FG000|STARTED|Overall Study||766||
59689829|NCT01339559|75809217|FG000|COMPLETED|Overall Study||368||
59689830|NCT01339559|75809217|FG000|NOT COMPLETED|Overall Study||398||
59689831|NCT00107900|75809228|FG000|STARTED|Overall Study||85||
59689832|NCT00107900|75809229|FG001|STARTED|Overall Study||75||
59689833|NCT00107900|75809230|FG002|STARTED|Overall Study||129||
59689834|NCT00107900|75809231|FG003|STARTED|Overall Study||99||
59689835|NCT00107900|75809232|FG004|STARTED|Overall Study||115||
59689836|NCT00107900|75809233|FG005|STARTED|Overall Study||103||
59689837|NCT00107900|75809228|FG000|COMPLETED|Overall Study||75||
59689838|NCT00107900|75809229|FG001|COMPLETED|Overall Study||72||
59689839|NCT00107900|75809230|FG002|COMPLETED|Overall Study||104||
59689840|NCT00107900|75809231|FG003|COMPLETED|Overall Study||87||
59689841|NCT00107900|75809232|FG004|COMPLETED|Overall Study||94||
59689842|NCT00107900|75809233|FG005|COMPLETED|Overall Study||94||
59689843|NCT00107900|75809228|FG000|NOT COMPLETED|Overall Study||10||
59689844|NCT00107900|75809229|FG001|NOT COMPLETED|Overall Study||3||
59689845|NCT00107900|75809230|FG002|NOT COMPLETED|Overall Study||25||
59689846|NCT00107900|75809231|FG003|NOT COMPLETED|Overall Study||12||
59689847|NCT00107900|75809232|FG004|NOT COMPLETED|Overall Study||21||
59689848|NCT00107900|75809233|FG005|NOT COMPLETED|Overall Study||9||
59689849|NCT01339052|75809249|FG000|STARTED|Overall Study||15||
59689850|NCT01339052|75809250|FG001|STARTED|Overall Study||50||
59689851|NCT01339052|75809249|FG000|Measurable Disease|Overall Study||11|Measurable disease post-surgery for Cohort 1 participants.|
59689852|NCT01339052|75809250|FG001|Measurable Disease|Overall Study|Radiographic response evaluated on participants with measurable disease only.|40|Measurable disease post-surgery for Cohort 1 participants.|
59689853|NCT01339052|75809249|FG000|Evaluable Tumor Sample at Surgery|Overall Study||14||
59689854|NCT01339052|75809250|FG001|Evaluable Tumor Sample at Surgery|Overall Study|Milestone is not relevant for non-surgical cohort.|0||
59689855|NCT01339052|75809249|FG000|Evaluable Plasma Sample at Surgery|Overall Study||13||
59816117|NCT00529958|75938469|FG001|COMPLETED|5-Year Follow-up||105||
59689856|NCT01339052|75809250|FG001|Evaluable Plasma Sample at Surgery|Overall Study|Milestone is not relevant for non-surgical cohort.|0||
59689857|NCT01339052|75809249|FG000|COMPLETED|Overall Study||0|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|
59689858|NCT01339052|75809250|FG001|COMPLETED|Overall Study||0|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|
59689859|NCT01339052|75809249|FG000|NOT COMPLETED|Overall Study||15||
59689860|NCT01339052|75809250|FG001|NOT COMPLETED|Overall Study||50||
59689861|NCT00107315|75809259|FG000|STARTED|Overall Study||16||
59689862|NCT00107315|75809259|FG000|COMPLETED|Overall Study||1||
59689863|NCT00107315|75809259|FG000|NOT COMPLETED|Overall Study||15||
59689864|NCT01335971|75809266|FG000|STARTED|Overall Study||31||
59689865|NCT01335971|75809267|FG001|STARTED|Overall Study||29||
59689866|NCT01335971|75809268|FG002|STARTED|Overall Study||29||
59689867|NCT01335971|75809266|FG000|COMPLETED|Overall Study||29||
59689868|NCT01335971|75809267|FG001|COMPLETED|Overall Study||28||
59689869|NCT01335971|75809268|FG002|COMPLETED|Overall Study||28||
59689870|NCT01335971|75809266|FG000|NOT COMPLETED|Overall Study||2||
59689871|NCT01335971|75809267|FG001|NOT COMPLETED|Overall Study||1||
59689872|NCT01335971|75809268|FG002|NOT COMPLETED|Overall Study||1||
59689873|NCT00107276|75809276|FG000|STARTED|Overall Study||112||
59689874|NCT00107276|75809276|FG000|Eligible|Overall Study||96||
59689875|NCT00107276|75809276|FG000|COMPLETED|Overall Study||40||
59689876|NCT00107276|75809276|FG000|NOT COMPLETED|Overall Study||72||
59689877|NCT01335698|75809286|FG000|STARTED|Treatment Stage 1||23||
59689878|NCT01335698|75809287|FG001|STARTED|Treatment Stage 1||12||
59689879|NCT01335698|75809288|FG002|STARTED|Treatment Stage 1||21||
59689880|NCT01335698|75809289|FG003|STARTED|Treatment Stage 1||35||
59689881|NCT01335698|75809290|FG004|STARTED|Treatment Stage 1||8||
59689882|NCT01335698|75809286|FG000|COMPLETED|Treatment Stage 1||15||
59689883|NCT01335698|75809287|FG001|COMPLETED|Treatment Stage 1||4||
59689884|NCT01335698|75809288|FG002|COMPLETED|Treatment Stage 1||16||
59689885|NCT01335698|75809289|FG003|COMPLETED|Treatment Stage 1||26||
59689886|NCT01335698|75809290|FG004|COMPLETED|Treatment Stage 1||6||
59689887|NCT01335698|75809286|FG000|NOT COMPLETED|Treatment Stage 1||8||
59689888|NCT01335698|75809287|FG001|NOT COMPLETED|Treatment Stage 1||8||
59689889|NCT01335698|75809288|FG002|NOT COMPLETED|Treatment Stage 1||5||
59689890|NCT01335698|75809289|FG003|NOT COMPLETED|Treatment Stage 1||9||
59689891|NCT01335698|75809290|FG004|NOT COMPLETED|Treatment Stage 1||2||
59689892|NCT01335698|75809286|FG000|STARTED|Treatment Stage 2||15||
59689893|NCT01335698|75809287|FG001|STARTED|Treatment Stage 2||4||
59689894|NCT01335698|75809288|FG002|STARTED|Treatment Stage 2||16||
59689895|NCT01335698|75809289|FG003|STARTED|Treatment Stage 2||26||
59689896|NCT01335698|75809290|FG004|STARTED|Treatment Stage 2||6||
59689897|NCT01335698|75809286|FG000|COMPLETED|Treatment Stage 2||4||
59689898|NCT01335698|75809287|FG001|COMPLETED|Treatment Stage 2||1||
59689899|NCT01335698|75809288|FG002|COMPLETED|Treatment Stage 2||11||
59689900|NCT01335698|75809289|FG003|COMPLETED|Treatment Stage 2||18||
59689901|NCT01335698|75809290|FG004|COMPLETED|Treatment Stage 2||5||
59689902|NCT01335698|75809286|FG000|NOT COMPLETED|Treatment Stage 2||11||
59689903|NCT01335698|75809287|FG001|NOT COMPLETED|Treatment Stage 2||3||
59689904|NCT01335698|75809288|FG002|NOT COMPLETED|Treatment Stage 2||5||
59689905|NCT01335698|75809289|FG003|NOT COMPLETED|Treatment Stage 2||8||
59689906|NCT01335698|75809290|FG004|NOT COMPLETED|Treatment Stage 2||1||
59689907|NCT00107120|75809306|FG000|STARTED|Overall Study|Safety Population defined as all patients who took at least one dose of double-blind study drug|155||
59689908|NCT00107120|75809307|FG001|STARTED|Overall Study|Safety Population defined as all patients who took at least one dose of double-blind study drug|157||
59689909|NCT00107120|75809306|FG000|COMPLETED|Overall Study||126||
59689910|NCT00107120|75809307|FG001|COMPLETED|Overall Study||133||
59689911|NCT00107120|75809306|FG000|NOT COMPLETED|Overall Study||29||
59689912|NCT00107120|75809307|FG001|NOT COMPLETED|Overall Study||24||
59689913|NCT01335464|75809315|FG000|STARTED|Overall Study||206||
59689914|NCT01335464|75809316|FG001|STARTED|Overall Study||309||
59689915|NCT01335464|75809315|FG000|COMPLETED|Overall Study||174||
59689916|NCT01335464|75809316|FG001|COMPLETED|Overall Study||260||
59689917|NCT01335464|75809315|FG000|NOT COMPLETED|Overall Study||32||
59689918|NCT01335464|75809316|FG001|NOT COMPLETED|Overall Study||49||
60079372|NCT04206332|76194708|FG008|Received Product Administration|Part A||0||
60079373|NCT04206332|76194709|FG009|Received Product Administration|Part A||0||
60079374|NCT04206332|76194710|FG010|Received Product Administration|Part A||0||
60079375|NCT04206332|76194711|FG011|Received Product Administration|Part A||0||
59689919|NCT00107042|75809324|FG000|STARTED|Overall Study||60||
59689920|NCT00107042|75809325|FG001|STARTED|Overall Study||63||
59689921|NCT00107042|75809324|FG000|COMPLETED|Overall Study||38||
59689922|NCT00107042|75809325|FG001|COMPLETED|Overall Study||47||
59689923|NCT00107042|75809324|FG000|NOT COMPLETED|Overall Study||22||
59689924|NCT00107042|75809325|FG001|NOT COMPLETED|Overall Study||16||
59689925|NCT00106964|75809376|FG000|STARTED|Overall Study||118||
59689926|NCT00106964|75809377|FG001|STARTED|Overall Study||126||
60079376|NCT04206332|76194712|FG012|Received Product Administration|Part A||0||
60079377|NCT04206332|76194713|FG013|Received Product Administration|Part A||0||
60079378|NCT04206332|76194714|FG014|Received Product Administration|Part A||0||
59689927|NCT00106964|75809378|FG002|STARTED|Overall Study||127||
59689928|NCT00106964|75809376|FG000|COMPLETED|Overall Study|The number of those those who completed the vaccine series was 105.|105||
59689929|NCT00106964|75809377|FG001|COMPLETED|Overall Study|The number of those who completed the vaccine series was 111.|111||
59689930|NCT00106964|75809378|FG002|COMPLETED|Overall Study|The number of those who completed the vaccine series was 120.|120||
59689931|NCT00106964|75809376|FG000|NOT COMPLETED|Overall Study||13||
59689932|NCT00106964|75809377|FG001|NOT COMPLETED|Overall Study||15||
59689933|NCT00106964|75809378|FG002|NOT COMPLETED|Overall Study||7||
59689934|NCT00106184|75809397|FG000|STARTED|Overall Study||96||
59689935|NCT00106184|75809398|FG001|STARTED|Overall Study||104||
59689936|NCT00106184|75809397|FG000|Treated|Overall Study|96 subjects were randomized.|93||
59689937|NCT00106184|75809398|FG001|Treated|Overall Study|104 subjects were randomized.|102||
59689938|NCT00106184|75809397|FG000|COMPLETED|Overall Study||93||
59689939|NCT00106184|75809398|FG001|COMPLETED|Overall Study||102||
59689940|NCT00106184|75809397|FG000|NOT COMPLETED|Overall Study||3||
59689941|NCT00106184|75809398|FG001|NOT COMPLETED|Overall Study||2||
59689942|NCT01334918|75809408|FG000|STARTED|Overall Study||63||
59689943|NCT01334918|75809409|FG001|STARTED|Overall Study||61||
59689944|NCT01334918|75809408|FG000|Randomized + 1 Stress Scan|Overall Study|Equates to Safety Analysis Set (SAF)|57||
59689945|NCT01334918|75809409|FG001|Randomized + 1 Stress Scan|Overall Study|Equates to Safety Analysis Set (SAF)|61||
59689946|NCT01334918|75809408|FG000|COMPLETED|Overall Study||55||
59689947|NCT01334918|75809409|FG001|COMPLETED|Overall Study||60||
59689948|NCT01334918|75809408|FG000|NOT COMPLETED|Overall Study||8||
59689949|NCT01334918|75809409|FG001|NOT COMPLETED|Overall Study||1||
59689950|NCT01332968|75809428|FG000|STARTED|Induction Period||699||
59689951|NCT01332968|75809429|FG001|STARTED|Induction Period||702||
59689952|NCT01332968|75809430|FG002|STARTED|Induction Period||0||
59689953|NCT01332968|75809431|FG003|STARTED|Induction Period||0||
59689954|NCT01332968|75809432|FG004|STARTED|Induction Period||0||
59689955|NCT01332968|75809433|FG005|STARTED|Induction Period||0||
59689956|NCT01332968|75809434|FG006|STARTED|Induction Period||0||
59689957|NCT01332968|75809435|FG007|STARTED|Induction Period||0||
59689958|NCT01332968|75809428|FG000|COMPLETED|Induction Period||641||
59689959|NCT01332968|75809429|FG001|COMPLETED|Induction Period||646||
59689960|NCT01332968|75809430|FG002|COMPLETED|Induction Period||0||
59689961|NCT01332968|75809431|FG003|COMPLETED|Induction Period||0||
59689962|NCT01332968|75809432|FG004|COMPLETED|Induction Period||0||
59689963|NCT01332968|75809433|FG005|COMPLETED|Induction Period||0||
59689964|NCT01332968|75809434|FG006|COMPLETED|Induction Period||0||
59689965|NCT01332968|75809435|FG007|COMPLETED|Induction Period||0||
59689966|NCT01332968|75809428|FG000|NOT COMPLETED|Induction Period||58||
59689967|NCT01332968|75809429|FG001|NOT COMPLETED|Induction Period||56||
59689968|NCT01332968|75809430|FG002|NOT COMPLETED|Induction Period||0||
59689969|NCT01332968|75809431|FG003|NOT COMPLETED|Induction Period||0||
59689970|NCT01332968|75809432|FG004|NOT COMPLETED|Induction Period||0||
59689971|NCT01332968|75809433|FG005|NOT COMPLETED|Induction Period||0||
59689972|NCT01332968|75809434|FG006|NOT COMPLETED|Induction Period||0||
59689973|NCT01332968|75809435|FG007|NOT COMPLETED|Induction Period||0||
59689974|NCT01332968|75809428|FG000|STARTED|Maintenance/Observation Period||0||
59689975|NCT01332968|75809429|FG001|STARTED|Maintenance/Observation Period||0||
59689976|NCT01332968|75809430|FG002|STARTED|Maintenance/Observation Period||612||
59689977|NCT01332968|75809431|FG003|STARTED|Maintenance/Observation Period||624||
59689978|NCT01332968|75809432|FG004|STARTED|Maintenance/Observation Period||12||
59689979|NCT01332968|75809433|FG005|STARTED|Maintenance/Observation Period||11||
59689980|NCT01332968|75809434|FG006|STARTED|Maintenance/Observation Period||0||
59689981|NCT01332968|75809435|FG007|STARTED|Maintenance/Observation Period||0||
59689982|NCT01332968|75809428|FG000|COMPLETED|Maintenance/Observation Period||0||
59689983|NCT01332968|75809429|FG001|COMPLETED|Maintenance/Observation Period||0||
59689984|NCT01332968|75809430|FG002|COMPLETED|Maintenance/Observation Period||451||
59689985|NCT01332968|75809431|FG003|COMPLETED|Maintenance/Observation Period||475||
59689986|NCT01332968|75809432|FG004|COMPLETED|Maintenance/Observation Period||12||
59689987|NCT01332968|75809433|FG005|COMPLETED|Maintenance/Observation Period||10||
59689988|NCT01332968|75809434|FG006|COMPLETED|Maintenance/Observation Period||0||
59689989|NCT01332968|75809435|FG007|COMPLETED|Maintenance/Observation Period||0||
59689990|NCT01332968|75809428|FG000|NOT COMPLETED|Maintenance/Observation Period||0||
59689991|NCT01332968|75809429|FG001|NOT COMPLETED|Maintenance/Observation Period||0||
59689992|NCT01332968|75809430|FG002|NOT COMPLETED|Maintenance/Observation Period||161||
59689993|NCT01332968|75809431|FG003|NOT COMPLETED|Maintenance/Observation Period||149||
59689994|NCT01332968|75809432|FG004|NOT COMPLETED|Maintenance/Observation Period||0||
59689995|NCT01332968|75809433|FG005|NOT COMPLETED|Maintenance/Observation Period||1||
59689996|NCT01332968|75809434|FG006|NOT COMPLETED|Maintenance/Observation Period||0||
59689997|NCT01332968|75809435|FG007|NOT COMPLETED|Maintenance/Observation Period||0||
59689998|NCT01332968|75809428|FG000|STARTED|Follow-Up Period||0||
59689999|NCT01332968|75809429|FG001|STARTED|Follow-Up Period||0||
59690000|NCT01332968|75809430|FG002|STARTED|Follow-Up Period||0||
59690001|NCT01332968|75809431|FG003|STARTED|Follow-Up Period||0||
59690002|NCT01332968|75809432|FG004|STARTED|Follow-Up Period||0||
59690003|NCT01332968|75809433|FG005|STARTED|Follow-Up Period||0||
59690004|NCT01332968|75809434|FG006|STARTED|Follow-Up Period||554||
59690005|NCT01332968|75809435|FG007|STARTED|Follow-Up Period||602||
59690006|NCT01332968|75809428|FG000|COMPLETED|Follow-Up Period||0||
59690007|NCT01332968|75809429|FG001|COMPLETED|Follow-Up Period||0||
59690008|NCT01332968|75809430|FG002|COMPLETED|Follow-Up Period||0||
59690009|NCT01332968|75809431|FG003|COMPLETED|Follow-Up Period||0||
59690010|NCT01332968|75809432|FG004|COMPLETED|Follow-Up Period||0||
59690011|NCT01332968|75809433|FG005|COMPLETED|Follow-Up Period||0||
59690012|NCT01332968|75809434|FG006|COMPLETED|Follow-Up Period||324||
59690013|NCT01332968|75809435|FG007|COMPLETED|Follow-Up Period||367||
59690014|NCT01332968|75809428|FG000|NOT COMPLETED|Follow-Up Period||0||
59690015|NCT01332968|75809429|FG001|NOT COMPLETED|Follow-Up Period||0||
59690016|NCT01332968|75809430|FG002|NOT COMPLETED|Follow-Up Period||0||
59690017|NCT01332968|75809431|FG003|NOT COMPLETED|Follow-Up Period||0||
59690018|NCT01332968|75809432|FG004|NOT COMPLETED|Follow-Up Period||0||
59690019|NCT01332968|75809433|FG005|NOT COMPLETED|Follow-Up Period||0||
59690020|NCT01332968|75809434|FG006|NOT COMPLETED|Follow-Up Period||230||
59690021|NCT01332968|75809435|FG007|NOT COMPLETED|Follow-Up Period||235||
59690022|NCT01332851|75809445|FG000|STARTED|Overall Study||124||
59690023|NCT01332851|75809446|FG001|STARTED|Overall Study||123||
59690024|NCT01332851|75809445|FG000|Completed Intervention|Overall Study|9 no intervention, 8 <full dose, 107 full dose; 3 new caregivers enrolled-initial parent dropped out|107|Intent-to-treat: we attempted to retain all participants, regardless of intervention completion.|
59690025|NCT01332851|75809446|FG001|Completed Intervention|Overall Study|4 no intervention, 9 <full dose, 110 full dose; 4 new caregivers enrolled-initial parent dropped out|110|Intent-to-treat: we attempted to retain all participants, regardless of intervention completion.|
59690026|NCT01332851|75809445|FG000|Completed Follow up 1|Overall Study||116|Attempted to retain all participants regardless of intervention completion|
59690027|NCT01332851|75809446|FG001|Completed Follow up 1|Overall Study|Includes 1 new caregiver enrolled due to initial parent no longer parenting|112|Attempted to retain all participants regardless of intervention completion|
59690028|NCT01332851|75809445|FG000|Completed Follow up 2|Overall Study|Includes 1 new caregiver enrolled due to initial parent no longer parenting|111|Attempted to retain all participants regardless of intervention and/or follow up 1 completion|
59690029|NCT01332851|75809446|FG001|Completed Follow up 2|Overall Study|Includes 4 new caregivers enrolled due to initial parent no longer parenting|111|Attempted to retain all participants regardless of intervention and/or follow up 1 completion|
59690030|NCT01332851|75809445|FG000|Completed Follow up 3|Overall Study|Includes 3 new caregivers enrolled due to initial parent no longer parenting|113|Attempted to retain all participants regardless of intervention and/or follow up 1 & 2 completion|
59690031|NCT01332851|75809446|FG001|Completed Follow up 3|Overall Study|Includes 3 new caregivers enrolled due to initial parent no longer parenting|110|Attempted to retain all participants regardless of intervention and/or follow up 1 & 2 completion|
59690032|NCT01332851|75809445|FG000|COMPLETED|Overall Study||113||
59547524|NCT01100606|75646305|FG000|NOT COMPLETED|Second Treatment Period||0||
59547525|NCT01100606|75646306|FG001|NOT COMPLETED|Second Treatment Period||0||
59547526|NCT01100762|75646316|FG000|STARTED|Overall Study||10||
59547527|NCT01100762|75646316|FG000|COMPLETED|Overall Study||10||
59547528|NCT01100762|75646316|FG000|NOT COMPLETED|Overall Study||0||
59547529|NCT02462967|75646325|FG000|STARTED|Overall Study||54||
59690033|NCT01332851|75809446|FG001|COMPLETED|Overall Study||110||
59690034|NCT01332851|75809445|FG000|NOT COMPLETED|Overall Study||11||
59690035|NCT01332851|75809446|FG001|NOT COMPLETED|Overall Study||13||
59690036|NCT01332305|75809461|FG000|STARTED|Overall Study||41||
59690037|NCT01332305|75809462|FG001|STARTED|Overall Study||48||
59690038|NCT01332305|75809463|FG002|STARTED|Overall Study||45||
59690039|NCT01332305|75809464|FG003|STARTED|Overall Study||38||
59690040|NCT01332305|75809465|FG004|STARTED|Overall Study||45||
59690041|NCT01332305|75809461|FG000|COMPLETED|Overall Study||31||
59690042|NCT01332305|75809462|FG001|COMPLETED|Overall Study||34||
59690043|NCT01332305|75809463|FG002|COMPLETED|Overall Study||31||
59690044|NCT01332305|75809464|FG003|COMPLETED|Overall Study||30||
59690045|NCT01332305|75809465|FG004|COMPLETED|Overall Study||33||
59690046|NCT01332305|75809461|FG000|NOT COMPLETED|Overall Study||10||
59690047|NCT01332305|75809462|FG001|NOT COMPLETED|Overall Study||14||
59690048|NCT01332305|75809463|FG002|NOT COMPLETED|Overall Study||14||
59690049|NCT01332305|75809464|FG003|NOT COMPLETED|Overall Study||8||
59690050|NCT01332305|75809465|FG004|NOT COMPLETED|Overall Study||12||
59690051|NCT01332227|75809479|FG000|STARTED|Overall Study|Participants who received treatment|72||
59690052|NCT01332227|75809480|FG001|STARTED|Overall Study|Participants who received treatment|37||
59690053|NCT01332227|75809479|FG000|COMPLETED|Overall Study||56||
59690054|NCT01332227|75809480|FG001|COMPLETED|Overall Study||32||
59690055|NCT01332227|75809479|FG000|NOT COMPLETED|Overall Study||16||
59690056|NCT01332227|75809480|FG001|NOT COMPLETED|Overall Study||5||
59690057|NCT01332149|75809488|FG000|STARTED|Overall Study|Assigned to study treatment.|314||
59690058|NCT01332149|75809489|FG001|STARTED|Overall Study|Assigned to study treatment.|309||
59547530|NCT02462967|75646326|FG001|STARTED|Overall Study||54||
59547531|NCT02462967|75646327|FG002|STARTED|Overall Study||54||
59547532|NCT02462967|75646325|FG000|COMPLETED|Overall Study||52||
59547533|NCT02462967|75646326|FG001|COMPLETED|Overall Study||48||
59547534|NCT02462967|75646327|FG002|COMPLETED|Overall Study||51||
59547535|NCT02462967|75646325|FG000|NOT COMPLETED|Overall Study||2||
59547536|NCT02462967|75646326|FG001|NOT COMPLETED|Overall Study||6||
59547537|NCT02462967|75646327|FG002|NOT COMPLETED|Overall Study||3||
59547538|NCT01119716|75646335|FG000|STARTED|Overall Study||4658||
59547539|NCT01119716|75646335|FG000|COMPLETED|Overall Study||4658||
59547540|NCT01119716|75646335|FG000|NOT COMPLETED|Overall Study||0||
59547541|NCT02518191|75646345|FG000|STARTED|Overall Study||171||
59547542|NCT02518191|75646346|FG001|STARTED|Overall Study||174||
59547543|NCT02518191|75646345|FG000|COMPLETED|Overall Study||165||
59547544|NCT02518191|75646346|FG001|COMPLETED|Overall Study||165||
59547545|NCT02518191|75646345|FG000|NOT COMPLETED|Overall Study||6||
59690059|NCT01332149|75809488|FG000|Treated|Overall Study||313||
59690060|NCT01332149|75809489|FG001|Treated|Overall Study||307||
59690061|NCT01332149|75809488|FG000|COMPLETED|Overall Study||284||
59690062|NCT01332149|75809489|FG001|COMPLETED|Overall Study||271||
59690063|NCT01332149|75809488|FG000|NOT COMPLETED|Overall Study||30||
59690064|NCT01332149|75809489|FG001|NOT COMPLETED|Overall Study||38||
59690065|NCT01330628|75809497|FG000|STARTED|Overall Study||170||
59690066|NCT01330628|75809498|FG001|STARTED|Overall Study||82||
59690067|NCT01330628|75809497|FG000|30 Day Follow-up|Overall Study||165||
59690068|NCT01330628|75809498|FG001|30 Day Follow-up|Overall Study||73||
59690069|NCT01330628|75809497|FG000|6 Month Follow-up|Overall Study||135||
59690070|NCT01330628|75809498|FG001|6 Month Follow-up|Overall Study||60||
59690071|NCT01330628|75809497|FG000|COMPLETED|Overall Study||100||
59690072|NCT01330628|75809498|FG001|COMPLETED|Overall Study||42||
59690073|NCT01330628|75809497|FG000|NOT COMPLETED|Overall Study||70||
59690074|NCT01330628|75809498|FG001|NOT COMPLETED|Overall Study||40||
59690075|NCT01330433|75809506|FG000|STARTED|Overall Study||16||
59690076|NCT01330433|75809507|FG001|STARTED|Overall Study||19||
59690077|NCT01330433|75809506|FG000|COMPLETED|Overall Study||14||
59690078|NCT01330433|75809507|FG001|COMPLETED|Overall Study||16||
59690079|NCT01330433|75809506|FG000|NOT COMPLETED|Overall Study||2||
59690080|NCT01330433|75809507|FG001|NOT COMPLETED|Overall Study||3||
59690081|NCT01330316|75809515|FG000|STARTED|Overall Study||43||
59690082|NCT01330316|75809516|FG001|STARTED|Overall Study||75||
59690083|NCT01330316|75809515|FG000|COMPLETED|Overall Study||41||
59690084|NCT01330316|75809516|FG001|COMPLETED|Overall Study||60||
59690085|NCT01330316|75809515|FG000|NOT COMPLETED|Overall Study||2||
59690086|NCT01330316|75809516|FG001|NOT COMPLETED|Overall Study||15||
59690087|NCT01326702|75809529|FG000|STARTED|Overall Study||3||
59690088|NCT01326702|75809530|FG001|STARTED|Overall Study||3||
59690089|NCT01326702|75809531|FG002|STARTED|Overall Study||6||
59690090|NCT01326702|75809532|FG003|STARTED|Overall Study||4||
59690091|NCT01326702|75809533|FG004|STARTED|Overall Study||5||
59690092|NCT01326702|75809534|FG005|STARTED|Overall Study||15||
59690093|NCT01326702|75809535|FG006|STARTED|Overall Study||7||
59690094|NCT01326702|75809529|FG000|COMPLETED|Overall Study||1||
59690095|NCT01326702|75809530|FG001|COMPLETED|Overall Study||1||
59690096|NCT01326702|75809531|FG002|COMPLETED|Overall Study||1||
59690097|NCT01326702|75809532|FG003|COMPLETED|Overall Study||1||
59690098|NCT01326702|75809533|FG004|COMPLETED|Overall Study||1||
59690099|NCT01326702|75809534|FG005|COMPLETED|Overall Study||7||
59690100|NCT01326702|75809535|FG006|COMPLETED|Overall Study||0||
59690101|NCT01326702|75809529|FG000|NOT COMPLETED|Overall Study||2||
59690102|NCT01326702|75809530|FG001|NOT COMPLETED|Overall Study||2||
59690103|NCT01326702|75809531|FG002|NOT COMPLETED|Overall Study||5||
59690104|NCT01326702|75809532|FG003|NOT COMPLETED|Overall Study||3||
59690105|NCT01326702|75809533|FG004|NOT COMPLETED|Overall Study||4||
59690106|NCT01326702|75809534|FG005|NOT COMPLETED|Overall Study||8||
59690107|NCT01326702|75809535|FG006|NOT COMPLETED|Overall Study||7||
59690108|NCT01327703|75809554|FG000|STARTED|First Treatment Period||42||
59690109|NCT01327703|75809555|FG001|STARTED|First Treatment Period||45||
59690110|NCT01327703|75809554|FG000|COMPLETED|First Treatment Period||42||
59690111|NCT01327703|75809555|FG001|COMPLETED|First Treatment Period||45||
59690112|NCT01327703|75809554|FG000|NOT COMPLETED|First Treatment Period||0||
59690113|NCT01327703|75809555|FG001|NOT COMPLETED|First Treatment Period||0||
59690114|NCT01327703|75809554|FG000|STARTED|Second Treatment Period|Two participants discontinued between first and second treatment periods due to adverse event.|40||
59690115|NCT01327703|75809555|FG001|STARTED|Second Treatment Period|One participant discontinued between first and second treatment periods due to adverse event.|44||
59690116|NCT01327703|75809554|FG000|COMPLETED|Second Treatment Period||39||
59690117|NCT01327703|75809555|FG001|COMPLETED|Second Treatment Period||42||
59690118|NCT01327703|75809554|FG000|NOT COMPLETED|Second Treatment Period||1||
59690119|NCT01327703|75809555|FG001|NOT COMPLETED|Second Treatment Period||2||
59690120|NCT01380080|75809566|FG000|STARTED|Overall Study||424||
59690121|NCT01380080|75809567|FG001|STARTED|Overall Study||426||
59690122|NCT01380080|75809566|FG000|COMPLETED|Overall Study||339||
59690123|NCT01380080|75809567|FG001|COMPLETED|Overall Study||343||
59690124|NCT01380080|75809566|FG000|NOT COMPLETED|Overall Study||85||
59690125|NCT01380080|75809567|FG001|NOT COMPLETED|Overall Study||83||
59690126|NCT01379768|75809576|FG000|STARTED|Overall Study||23||
59690127|NCT01379768|75809577|FG001|STARTED|Overall Study||22||
59690128|NCT01379768|75809578|FG002|STARTED|Overall Study||20||
59690129|NCT01379768|75809576|FG000|COMPLETED|Overall Study||20||
59690130|NCT01379768|75809577|FG001|COMPLETED|Overall Study||21||
59690131|NCT01379768|75809578|FG002|COMPLETED|Overall Study||20||
59690132|NCT01379768|75809576|FG000|NOT COMPLETED|Overall Study||3||
59690133|NCT01379768|75809577|FG001|NOT COMPLETED|Overall Study||1||
59690134|NCT01379768|75809578|FG002|NOT COMPLETED|Overall Study||0||
59690135|NCT01379573|75809586|FG000|STARTED|Overall Study||74||
59690136|NCT01379573|75809586|FG000|COMPLETED|Overall Study||63||
59690137|NCT01379573|75809586|FG000|NOT COMPLETED|Overall Study||11||
59690138|NCT01379534|75809592|FG000|STARTED|Treatment Phase||22||
59690139|NCT01379534|75809593|FG001|STARTED|Treatment Phase||31||
59690140|NCT01379534|75809592|FG000|COMPLETED|Treatment Phase||0||
59690141|NCT01379534|75809593|FG001|COMPLETED|Treatment Phase||0||
59690142|NCT01379534|75809592|FG000|NOT COMPLETED|Treatment Phase||22||
59690143|NCT01379534|75809593|FG001|NOT COMPLETED|Treatment Phase||31||
59690144|NCT01379534|75809592|FG000|STARTED|Tumor Assessment Follow-up (f/u) Phase|All participants discontinued the Treatment Phase. Of these, only 6 qualified for f/u tumor assess..|4||
59690145|NCT01379534|75809593|FG001|STARTED|Tumor Assessment Follow-up (f/u) Phase||2||
59690146|NCT01379534|75809592|FG000|COMPLETED|Tumor Assessment Follow-up (f/u) Phase||0||
59690147|NCT01379534|75809593|FG001|COMPLETED|Tumor Assessment Follow-up (f/u) Phase||0||
59690148|NCT01379534|75809592|FG000|NOT COMPLETED|Tumor Assessment Follow-up (f/u) Phase||4||
59690149|NCT01379534|75809593|FG001|NOT COMPLETED|Tumor Assessment Follow-up (f/u) Phase||2||
59690150|NCT01371851|75809601|FG000|STARTED|Overall Study|Eligible participants who showed up on day 1 of week 1 and received at least one dose of study med.|11||
59690151|NCT01371851|75809602|FG001|STARTED|Overall Study|Eligible participants who showed up on day 1 of week 1 and received at least one dose of study med.|11||
59690152|NCT01371851|75809601|FG000|COMPLETED|Overall Study||3||
59690153|NCT01371851|75809602|FG001|COMPLETED|Overall Study||2||
59690154|NCT01371851|75809601|FG000|NOT COMPLETED|Overall Study||8||
59690155|NCT01371851|75809602|FG001|NOT COMPLETED|Overall Study||9||
59690156|NCT01371734|75809611|FG000|STARTED|Overall Study||120||
59690157|NCT01371734|75809612|FG001|STARTED|Overall Study||122||
59690158|NCT01371734|75809613|FG002|STARTED|Overall Study||121||
59690159|NCT01371734|75809611|FG000|COMPLETED|Overall Study||97||
59690160|NCT01371734|75809612|FG001|COMPLETED|Overall Study||103||
59690161|NCT01371734|75809613|FG002|COMPLETED|Overall Study||104||
59690162|NCT01371734|75809611|FG000|NOT COMPLETED|Overall Study||23||
59690163|NCT01371734|75809612|FG001|NOT COMPLETED|Overall Study||19||
59690164|NCT01371734|75809613|FG002|NOT COMPLETED|Overall Study||17||
59690165|NCT01365494|75809623|FG000|STARTED|Overall Study||126||
59690166|NCT01365494|75809624|FG001|STARTED|Overall Study||124||
59690167|NCT01365494|75809623|FG000|COMPLETED|Overall Study||124||
59690168|NCT01365494|75809624|FG001|COMPLETED|Overall Study||121||
59690169|NCT01365494|75809623|FG000|NOT COMPLETED|Overall Study||2||
59690170|NCT01365494|75809624|FG001|NOT COMPLETED|Overall Study||3||
59690171|NCT01357889|75809633|FG000|STARTED|Single-dose Phase (BE Phase: 28 Days)||86||
59690172|NCT01357889|75809634|FG001|STARTED|Single-dose Phase (BE Phase: 28 Days)||81||
59690173|NCT01357889|75809633|FG000|COMPLETED|Single-dose Phase (BE Phase: 28 Days)||82||
59690174|NCT01357889|75809634|FG001|COMPLETED|Single-dose Phase (BE Phase: 28 Days)||79||
59690175|NCT01357889|75809633|FG000|NOT COMPLETED|Single-dose Phase (BE Phase: 28 Days)||4||
59690176|NCT01357889|75809634|FG001|NOT COMPLETED|Single-dose Phase (BE Phase: 28 Days)||2||
59690177|NCT01357889|75809633|FG000|STARTED|Multiple-dose Phase (MDP) (Overall)|After completion of the BE Phase, additional participants were randomized to the Overall Phase.|141||
59690178|NCT01357889|75809634|FG001|STARTED|Multiple-dose Phase (MDP) (Overall)|After completion of the BE Phase, additional participants were randomized to the Overall Phase.|142||
59690179|NCT01357889|75809633|FG000|COMPLETED|Multiple-dose Phase (MDP) (Overall)||125||
59690180|NCT01357889|75809634|FG001|COMPLETED|Multiple-dose Phase (MDP) (Overall)||126||
59690181|NCT01357889|75809633|FG000|NOT COMPLETED|Multiple-dose Phase (MDP) (Overall)||16||
59690182|NCT01357889|75809634|FG001|NOT COMPLETED|Multiple-dose Phase (MDP) (Overall)||16||
59690183|NCT01357889|75809633|FG000|STARTED|Follow-up Phase (FUP) (8 Weeks)|All participants who started the MDP entered the FUP, regardless of MDP completion status.|141||
59690184|NCT01357889|75809634|FG001|STARTED|Follow-up Phase (FUP) (8 Weeks)|All participants who started the MDP entered the FUP, regardless of MDP completion status.|142||
59690185|NCT01357889|75809633|FG000|COMPLETED|Follow-up Phase (FUP) (8 Weeks)||138||
59690186|NCT01357889|75809634|FG001|COMPLETED|Follow-up Phase (FUP) (8 Weeks)||138||
59690187|NCT01357889|75809633|FG000|NOT COMPLETED|Follow-up Phase (FUP) (8 Weeks)||3||
59690188|NCT01357889|75809634|FG001|NOT COMPLETED|Follow-up Phase (FUP) (8 Weeks)||4||
59690189|NCT01357850|75809646|FG000|STARTED|Overall Study||30||
59690190|NCT01357850|75809647|FG001|STARTED|Overall Study||12||
59690191|NCT01357850|75809648|FG002|STARTED|Overall Study||13||
59690192|NCT01357850|75809649|FG003|STARTED|Overall Study||27||
59690193|NCT01357850|75809646|FG000|COMPLETED|Overall Study||29||
59690194|NCT01357850|75809647|FG001|COMPLETED|Overall Study||12||
59690195|NCT01357850|75809648|FG002|COMPLETED|Overall Study||13||
59690196|NCT01357850|75809649|FG003|COMPLETED|Overall Study||27||
59690197|NCT01357850|75809646|FG000|NOT COMPLETED|Overall Study||1||
59690198|NCT01357850|75809647|FG001|NOT COMPLETED|Overall Study||0||
59690199|NCT01357850|75809648|FG002|NOT COMPLETED|Overall Study||0||
59690200|NCT01357850|75809649|FG003|NOT COMPLETED|Overall Study||0||
59690201|NCT01357655|75809662|FG000|STARTED|Overall Study||66||
59690202|NCT01357655|75809663|FG001|STARTED|Overall Study||0||
59690203|NCT01357655|75809662|FG000|COMPLETED|Overall Study||0||
59690204|NCT01357655|75809663|FG001|COMPLETED|Overall Study||0||
59690205|NCT01357655|75809662|FG000|NOT COMPLETED|Overall Study||66||
59690206|NCT01357655|75809663|FG001|NOT COMPLETED|Overall Study||0||
59690207|NCT01357616|75809670|FG000|STARTED|Overall Study||166||
59690208|NCT01357616|75809671|FG001|STARTED|Overall Study||162||
59690209|NCT01357616|75809670|FG000|COMPLETED|Overall Study||156||
59690210|NCT01357616|75809671|FG001|COMPLETED|Overall Study||153||
59690211|NCT01357616|75809670|FG000|NOT COMPLETED|Overall Study||10||
59690212|NCT01357616|75809671|FG001|NOT COMPLETED|Overall Study||9||
59690213|NCT01357577|75809679|FG000|STARTED|Overall Study||64||
59690214|NCT01357577|75809680|FG001|STARTED|Overall Study||65||
59690215|NCT01357577|75809679|FG000|Post-Treatment Assessment Completed|Overall Study||24||
59690216|NCT01357577|75809680|FG001|Post-Treatment Assessment Completed|Overall Study||39||
59690217|NCT01357577|75809679|FG000|COMPLETED|Overall Study||27|Completed Milestone is defined at 6-month assessment completed|
59690218|NCT01357577|75809680|FG001|COMPLETED|Overall Study||39|Completed Milestone is defined at 6-month assessment completed|
59690219|NCT01357577|75809679|FG000|NOT COMPLETED|Overall Study||37||
59690220|NCT01357577|75809680|FG001|NOT COMPLETED|Overall Study||26||
59690221|NCT01351025|75809689|FG000|STARTED|Week 0 - 20||46||
59690222|NCT01351025|75809690|FG001|STARTED|Week 0 - 20||48||
59690223|NCT01351025|75809689|FG000|COMPLETED|Week 0 - 20||43||
59690224|NCT01351025|75809690|FG001|COMPLETED|Week 0 - 20||47||
59690225|NCT01351025|75809689|FG000|NOT COMPLETED|Week 0 - 20||3||
59690226|NCT01351025|75809690|FG001|NOT COMPLETED|Week 0 - 20||1||
59690227|NCT01351025|75809689|FG000|STARTED|Week 20 - 24||43||
59690228|NCT01351025|75809690|FG001|STARTED|Week 20 - 24||47||
59690229|NCT01351025|75809689|FG000|COMPLETED|Week 20 - 24||43||
59690230|NCT01351025|75809690|FG001|COMPLETED|Week 20 - 24||47||
59690231|NCT01351025|75809689|FG000|NOT COMPLETED|Week 20 - 24||0||
59690232|NCT01351025|75809690|FG001|NOT COMPLETED|Week 20 - 24||0||
59690233|NCT01351025|75809689|FG000|STARTED|Week 24 - 44||43||
59690234|NCT01351025|75809690|FG001|STARTED|Week 24 - 44||47||
59690235|NCT01351025|75809689|FG000|COMPLETED|Week 24 - 44||42||
59690236|NCT01351025|75809690|FG001|COMPLETED|Week 24 - 44||43||
59690237|NCT01351025|75809689|FG000|NOT COMPLETED|Week 24 - 44||1||
59690238|NCT01351025|75809690|FG001|NOT COMPLETED|Week 24 - 44||4||
59690239|NCT01351025|75809689|FG000|STARTED|Week 44 - 48||42||
59690240|NCT01351025|75809690|FG001|STARTED|Week 44 - 48||43||
59690241|NCT01351025|75809689|FG000|COMPLETED|Week 44 - 48||42||
59690242|NCT01351025|75809690|FG001|COMPLETED|Week 44 - 48||43||
59690243|NCT01351025|75809689|FG000|NOT COMPLETED|Week 44 - 48||0||
59690244|NCT01351025|75809690|FG001|NOT COMPLETED|Week 44 - 48||0||
59690245|NCT01349036|75809704|FG000|STARTED|Overall Study||14||
59690246|NCT01349036|75809705|FG001|STARTED|Overall Study||24||
59690247|NCT01349036|75809704|FG000|COMPLETED|Overall Study||0||
59690248|NCT01349036|75809705|FG001|COMPLETED|Overall Study||0||
59690249|NCT01349036|75809704|FG000|NOT COMPLETED|Overall Study||14||
59690250|NCT01349036|75809705|FG001|NOT COMPLETED|Overall Study||24||
59690251|NCT01348763|75809715|FG000|STARTED|With Tenofovir/Emtricitabine (10 Days)||13||
59690252|NCT01348763|75809715|FG000|COMPLETED|With Tenofovir/Emtricitabine (10 Days)||11||
59690253|NCT01348763|75809715|FG000|NOT COMPLETED|With Tenofovir/Emtricitabine (10 Days)||2||
59690254|NCT01348763|75809715|FG000|STARTED|Without Tenofovir/Emtricitabine (11 Day)||11||
59690255|NCT01348763|75809715|FG000|COMPLETED|Without Tenofovir/Emtricitabine (11 Day)||11||
59690256|NCT01348763|75809715|FG000|NOT COMPLETED|Without Tenofovir/Emtricitabine (11 Day)||0||
59690257|NCT01346969|75809723|FG000|STARTED|Overall Study||28||
59690258|NCT01346969|75809724|FG001|STARTED|Overall Study||14||
59690259|NCT01346969|75809725|FG002|STARTED|Overall Study||13||
59690260|NCT01346969|75809726|FG003|STARTED|Overall Study||13||
59690261|NCT01346969|75809723|FG000|Safety Population|Overall Study||27||
59690262|NCT01346969|75809724|FG001|Safety Population|Overall Study||14||
59690263|NCT01346969|75809725|FG002|Safety Population|Overall Study||13||
59690264|NCT01346969|75809726|FG003|Safety Population|Overall Study||13||
59690265|NCT01346969|75809723|FG000|COMPLETED|Overall Study||26||
59690266|NCT01346969|75809724|FG001|COMPLETED|Overall Study||14||
59690267|NCT01346969|75809725|FG002|COMPLETED|Overall Study||10||
59690268|NCT01346969|75809726|FG003|COMPLETED|Overall Study||12||
59690269|NCT01346969|75809723|FG000|NOT COMPLETED|Overall Study||2||
59690270|NCT01346969|75809724|FG001|NOT COMPLETED|Overall Study||0||
59690271|NCT01346969|75809725|FG002|NOT COMPLETED|Overall Study||3||
59690272|NCT01346969|75809726|FG003|NOT COMPLETED|Overall Study||1||
59690273|NCT01346774|75809738|FG000|STARTED|Overall Study||80||
59690274|NCT01346774|75809739|FG001|STARTED|Overall Study||80||
59690275|NCT01346774|75809738|FG000|COMPLETED|Overall Study||67||
59690276|NCT01346774|75809739|FG001|COMPLETED|Overall Study||63||
59690277|NCT01346774|75809738|FG000|NOT COMPLETED|Overall Study||13||
59690278|NCT01346774|75809739|FG001|NOT COMPLETED|Overall Study||17||
59690279|NCT01346696|75809745|FG000|STARTED|Overall Study||45||94
59690280|NCT01346696|75809745|FG000|COMPLETED|Overall Study||44||90
59690281|NCT01346696|75809745|FG000|NOT COMPLETED|Overall Study||1||4
59690282|NCT01346540|75809751|FG000|STARTED|Overall Study||4||
59690283|NCT01346540|75809752|FG001|STARTED|Overall Study||12||
59690284|NCT01346540|75809751|FG000|COMPLETED|Overall Study||1||
59690285|NCT01346540|75809752|FG001|COMPLETED|Overall Study||0||
59690286|NCT01346540|75809751|FG000|NOT COMPLETED|Overall Study||3||
59690287|NCT01346540|75809752|FG001|NOT COMPLETED|Overall Study||12||
59690288|NCT01342913|75809761|FG000|STARTED|2-week Run-in Period||702||
59690289|NCT01342913|75809762|FG001|STARTED|2-week Run-in Period||0||
59690290|NCT01342913|75809763|FG002|STARTED|2-week Run-in Period||0||
59690291|NCT01342913|75809761|FG000|COMPLETED|2-week Run-in Period||528||
59690292|NCT01342913|75809762|FG001|COMPLETED|2-week Run-in Period||0||
59690293|NCT01342913|75809763|FG002|COMPLETED|2-week Run-in Period||0||
59690294|NCT01342913|75809761|FG000|NOT COMPLETED|2-week Run-in Period||174||
59690295|NCT01342913|75809762|FG001|NOT COMPLETED|2-week Run-in Period||0||
59816118|NCT00529958|75938470|FG002|COMPLETED|5-Year Follow-up||107||
59690296|NCT01342913|75809763|FG002|NOT COMPLETED|2-week Run-in Period||0||
59690297|NCT01342913|75809761|FG000|STARTED|Double-Blind Treatment Period||0||
59690298|NCT01342913|75809762|FG001|STARTED|Double-Blind Treatment Period||262||
59690299|NCT01342913|75809763|FG002|STARTED|Double-Blind Treatment Period||266||
59690300|NCT01342913|75809761|FG000|COMPLETED|Double-Blind Treatment Period||0||
59690301|NCT01342913|75809762|FG001|COMPLETED|Double-Blind Treatment Period||246||
59690302|NCT01342913|75809763|FG002|COMPLETED|Double-Blind Treatment Period||243||
59690303|NCT01342913|75809761|FG000|NOT COMPLETED|Double-Blind Treatment Period||0||
59690304|NCT01342913|75809762|FG001|NOT COMPLETED|Double-Blind Treatment Period||16||
59690305|NCT01342913|75809763|FG002|NOT COMPLETED|Double-Blind Treatment Period||23||
59690306|NCT01342796|75809771|FG000|STARTED|Overall Study||43||
59690307|NCT01342796|75809772|FG001|STARTED|Overall Study||41||
59690308|NCT01342796|75809771|FG000|COMPLETED|Overall Study||40||
59690309|NCT01342796|75809772|FG001|COMPLETED|Overall Study||38||
59690310|NCT01342796|75809771|FG000|NOT COMPLETED|Overall Study||3||
59690311|NCT01342796|75809772|FG001|NOT COMPLETED|Overall Study||3||
59690312|NCT01342640|75809778|FG000|STARTED|Overall Study||70||
59690313|NCT01342640|75809778|FG000|COMPLETED|Overall Study||29||
59690314|NCT01342640|75809778|FG000|NOT COMPLETED|Overall Study||41||
59690315|NCT01342484|75809785|FG000|STARTED|Overall Study||15||
59690316|NCT01342484|75809786|FG001|STARTED|Overall Study||10||
59690317|NCT01342484|75809787|FG002|STARTED|Overall Study||14||
59690318|NCT01342484|75809785|FG000|COMPLETED|Overall Study||13||
59690319|NCT01342484|75809786|FG001|COMPLETED|Overall Study||10||
59690320|NCT01342484|75809787|FG002|COMPLETED|Overall Study||13||
59690321|NCT01342484|75809785|FG000|NOT COMPLETED|Overall Study||2||
59690322|NCT01342484|75809786|FG001|NOT COMPLETED|Overall Study||0||
59690323|NCT01342484|75809787|FG002|NOT COMPLETED|Overall Study||1||
59690324|NCT01342445|75809797|FG000|STARTED|Overall Study||26||
59690325|NCT01342445|75809798|FG001|STARTED|Overall Study||24||
59690326|NCT01342445|75809797|FG000|COMPLETED|Overall Study||26||
59690327|NCT01342445|75809798|FG001|COMPLETED|Overall Study||22||
59690328|NCT01342445|75809797|FG000|NOT COMPLETED|Overall Study||0||
59690329|NCT01342445|75809798|FG001|NOT COMPLETED|Overall Study||2||
59690330|NCT01342211|75809813|FG000|STARTED|Overall Study||19||
59690331|NCT01342211|75809814|FG001|STARTED|Overall Study||19||
59690332|NCT01342211|75809815|FG002|STARTED|Overall Study||18||
59690333|NCT01342211|75809816|FG003|STARTED|Overall Study||19||
59690334|NCT01342211|75809817|FG004|STARTED|Overall Study||18||
59690335|NCT01342211|75809813|FG000|Treated|Overall Study||19||
59690336|NCT01342211|75809814|FG001|Treated|Overall Study||17||
59690337|NCT01342211|75809815|FG002|Treated|Overall Study||18||
59690338|NCT01342211|75809816|FG003|Treated|Overall Study||19||
59690339|NCT01342211|75809817|FG004|Treated|Overall Study||17||
59690340|NCT01342211|75809813|FG000|COMPLETED|Overall Study||19||
59690341|NCT01342211|75809814|FG001|COMPLETED|Overall Study||17||
59690342|NCT01342211|75809815|FG002|COMPLETED|Overall Study||18||
59690343|NCT01342211|75809816|FG003|COMPLETED|Overall Study||17||
59690344|NCT01342211|75809817|FG004|COMPLETED|Overall Study||16||
59690345|NCT01342211|75809813|FG000|NOT COMPLETED|Overall Study||0||
59690346|NCT01342211|75809814|FG001|NOT COMPLETED|Overall Study||2||
59690347|NCT01342211|75809815|FG002|NOT COMPLETED|Overall Study||0||
59690348|NCT01342211|75809816|FG003|NOT COMPLETED|Overall Study||2||
59690349|NCT01342211|75809817|FG004|NOT COMPLETED|Overall Study||2||
59690350|NCT01342094|75809835|FG000|STARTED|Overall Study||82||
59690351|NCT01342094|75809836|FG001|STARTED|Overall Study||84||
59690352|NCT01342094|75809835|FG000|COMPLETED|Overall Study||77||
59690353|NCT01342094|75809836|FG001|COMPLETED|Overall Study||81||
59690354|NCT01342094|75809835|FG000|NOT COMPLETED|Overall Study||5||
59690355|NCT01342094|75809836|FG001|NOT COMPLETED|Overall Study||3||
59690356|NCT01340768|75809844|FG000|STARTED|Overall Study||436||
59690357|NCT01340768|75809845|FG001|STARTED|Overall Study||434||
59690358|NCT01340768|75809844|FG000|COMPLETED|Overall Study||419||
59690359|NCT01340768|75809845|FG001|COMPLETED|Overall Study||429||
59690360|NCT01340768|75809844|FG000|NOT COMPLETED|Overall Study||17||
59690361|NCT01340768|75809845|FG001|NOT COMPLETED|Overall Study||5||
59690362|NCT01340651|75809851|FG000|STARTED|Overall Study||41||
59690363|NCT01340651|75809851|FG000|COMPLETED|Overall Study||24||
59690364|NCT01340651|75809851|FG000|NOT COMPLETED|Overall Study||17||
59690365|NCT01340495|75809857|FG000|STARTED|Overall Study||70||
59690366|NCT01340495|75809857|FG000|COMPLETED|Overall Study||69||
59690367|NCT01340495|75809857|FG000|NOT COMPLETED|Overall Study||1||
59690368|NCT01340300|75809865|FG000|STARTED|Overall Study||35||
59690369|NCT01340300|75809866|FG001|STARTED|Overall Study||35||
59690370|NCT01340300|75809867|FG002|STARTED|Overall Study||35||
59690371|NCT01340300|75809868|FG003|STARTED|Overall Study||34||
59690372|NCT01340300|75809865|FG000|Baseline Blood Sample|Overall Study||33||
59690373|NCT01340300|75809866|FG001|Baseline Blood Sample|Overall Study||34||
59690374|NCT01340300|75809867|FG002|Baseline Blood Sample|Overall Study||32||
59690375|NCT01340300|75809868|FG003|Baseline Blood Sample|Overall Study||29||
59690376|NCT01340300|75809865|FG000|Follow-up Blood Sample|Overall Study||25||
59690377|NCT01340300|75809866|FG001|Follow-up Blood Sample|Overall Study||26||
59690378|NCT01340300|75809867|FG002|Follow-up Blood Sample|Overall Study||19||
59690379|NCT01340300|75809868|FG003|Follow-up Blood Sample|Overall Study||18||
59690380|NCT01340300|75809865|FG000|COMPLETED|Overall Study||26|Complete treatment and required follow-ups|
59690381|NCT01340300|75809866|FG001|COMPLETED|Overall Study||26|Complete treatment and required follow-ups|
59690382|NCT01340300|75809867|FG002|COMPLETED|Overall Study||20|Complete treatment and required follow-ups|
59690383|NCT01340300|75809868|FG003|COMPLETED|Overall Study||20|Complete treatment and required follow-ups|
59690384|NCT01340300|75809865|FG000|NOT COMPLETED|Overall Study||9||
59690385|NCT01340300|75809866|FG001|NOT COMPLETED|Overall Study||9||
59690386|NCT01340300|75809867|FG002|NOT COMPLETED|Overall Study||15||
59690387|NCT01340300|75809868|FG003|NOT COMPLETED|Overall Study||14||
59690388|NCT01340066|75809880|FG000|STARTED|Placebo Run in Period||94||
59690389|NCT01340066|75809881|FG001|STARTED|Placebo Run in Period||0||
59690390|NCT01340066|75809882|FG002|STARTED|Placebo Run in Period||0||
59690391|NCT01340066|75809880|FG000|COMPLETED|Placebo Run in Period|Completed run in period and were eligible for randomization|67||
59690392|NCT01340066|75809881|FG001|COMPLETED|Placebo Run in Period||0||
59690393|NCT01340066|75809882|FG002|COMPLETED|Placebo Run in Period||0||
59690394|NCT01340066|75809880|FG000|NOT COMPLETED|Placebo Run in Period||27||
59690395|NCT01340066|75809881|FG001|NOT COMPLETED|Placebo Run in Period||0||
59690396|NCT01340066|75809882|FG002|NOT COMPLETED|Placebo Run in Period||0||
59690397|NCT01340066|75809880|FG000|STARTED|5 Week Double Blind Randomization Period||0||
59690398|NCT01340066|75809881|FG001|STARTED|5 Week Double Blind Randomization Period||33||
59690399|NCT01340066|75809882|FG002|STARTED|5 Week Double Blind Randomization Period||34||
59690400|NCT01340066|75809880|FG000|COMPLETED|5 Week Double Blind Randomization Period||0||
59690401|NCT01340066|75809881|FG001|COMPLETED|5 Week Double Blind Randomization Period||28||
59690402|NCT01340066|75809882|FG002|COMPLETED|5 Week Double Blind Randomization Period||31||
59690403|NCT01340066|75809880|FG000|NOT COMPLETED|5 Week Double Blind Randomization Period||0||
59690404|NCT01340066|75809881|FG001|NOT COMPLETED|5 Week Double Blind Randomization Period||5||
59690405|NCT01340066|75809882|FG002|NOT COMPLETED|5 Week Double Blind Randomization Period||3||
59690406|NCT01107535|75809889|FG000|STARTED|Overall Study||82||
59690407|NCT01107535|75809889|FG000|Number of Participants Analyzed|Overall Study||82||
59690408|NCT01107535|75809889|FG000|COMPLETED|Overall Study||77||
59690409|NCT01107535|75809889|FG000|NOT COMPLETED|Overall Study||5||
59690410|NCT01326546|75809895|FG000|STARTED|Overall Study||189||
59690411|NCT01326546|75809896|FG001|STARTED|Overall Study||189||
59690412|NCT01326546|75809895|FG000|COMPLETED|Overall Study||172||
59690413|NCT01326546|75809896|FG001|COMPLETED|Overall Study||176||
59690414|NCT01326546|75809895|FG000|NOT COMPLETED|Overall Study||17||
59690415|NCT01326546|75809896|FG001|NOT COMPLETED|Overall Study||13||
59690416|NCT01325532|75809904|FG000|STARTED|Overall Study||17||
59690417|NCT01325532|75809905|FG001|STARTED|Overall Study||13||
59690418|NCT01325532|75809904|FG000|COMPLETED|Overall Study||15||
59690419|NCT01325532|75809905|FG001|COMPLETED|Overall Study||13||
59690420|NCT01325532|75809904|FG000|NOT COMPLETED|Overall Study||2||
59690421|NCT01325532|75809905|FG001|NOT COMPLETED|Overall Study||0||
59690422|NCT01171963|75809913|FG000|STARTED|Overall Study||1666||
59690423|NCT01171963|75809914|FG001|STARTED|Overall Study||1667||
59690424|NCT01171963|75809913|FG000|COMPLETED|Overall Study||1518||
59690425|NCT01171963|75809914|FG001|COMPLETED|Overall Study||1499||
59816119|NCT00529958|75938468|FG000|NOT COMPLETED|5-Year Follow-up||3||
59690426|NCT01171963|75809913|FG000|NOT COMPLETED|Overall Study||148||
59690427|NCT01171963|75809914|FG001|NOT COMPLETED|Overall Study||168||
59690428|NCT01171183|75809925|FG000|STARTED|Residential Facility (Weeks 1-2)|Those who were admitted to the residential facility and received at least one dose of study med.|15||
59690429|NCT01171183|75809926|FG001|STARTED|Residential Facility (Weeks 1-2)|Subjects receiving at least one dose of study med. One did not due to BP outside study parameters.|16||
59690430|NCT01171183|75809925|FG000|COMPLETED|Residential Facility (Weeks 1-2)||13||
59690431|NCT01171183|75809926|FG001|COMPLETED|Residential Facility (Weeks 1-2)||10||
59690432|NCT01171183|75809925|FG000|NOT COMPLETED|Residential Facility (Weeks 1-2)||2||
59690433|NCT01171183|75809926|FG001|NOT COMPLETED|Residential Facility (Weeks 1-2)||6||
59690434|NCT01171183|75809925|FG000|STARTED|Outpatient Participation (Weeks 3-10)|One subject completed the residential stay but withdrew prior to starting the outpatient phase.|12||
59816120|NCT00529958|75938469|FG001|NOT COMPLETED|5-Year Follow-up||3||
59816121|NCT00529958|75938470|FG002|NOT COMPLETED|5-Year Follow-up||1||
59816122|NCT00529802|75938478|FG000|STARTED|Evaluable for Primary Endpoint|60 patients started trial|60||
59690435|NCT01171183|75809926|FG001|STARTED|Outpatient Participation (Weeks 3-10)|One subject completed the residential stay but was discharged due to protocol noncompliance.|9||
59690436|NCT01171183|75809925|FG000|COMPLETED|Outpatient Participation (Weeks 3-10)||2||
59690437|NCT01171183|75809926|FG001|COMPLETED|Outpatient Participation (Weeks 3-10)||4||
59690438|NCT01171183|75809925|FG000|NOT COMPLETED|Outpatient Participation (Weeks 3-10)||10||
59690439|NCT01171183|75809926|FG001|NOT COMPLETED|Outpatient Participation (Weeks 3-10)||5||
59690440|NCT01170091|75809932|FG000|STARTED|Overall Study||651||
59690441|NCT01170091|75809932|FG000|COMPLETED|Overall Study||627||
59690442|NCT01170091|75809932|FG000|NOT COMPLETED|Overall Study||24||
59690443|NCT01169779|75809938|FG000|STARTED|Overall Study|Randomized.|195||
59690444|NCT01169779|75809939|FG001|STARTED|Overall Study||196||
59690445|NCT01169779|75809938|FG000|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|194||
59690446|NCT01169779|75809939|FG001|Treated/Safety Population|Overall Study||196||
59690447|NCT01169779|75809938|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|193||
59690448|NCT01169779|75809939|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||195||
59690449|NCT01169779|75809938|FG000|Subgroup for Standardized Meal Test|Overall Study|Patients at selected sites where standardized meal test was performed.|130||
59690450|NCT01169779|75809939|FG001|Subgroup for Standardized Meal Test|Overall Study||121||
59690451|NCT01169779|75809938|FG000|COMPLETED|Overall Study||184||
59690452|NCT01169779|75809939|FG001|COMPLETED|Overall Study||179||
59690453|NCT01169779|75809938|FG000|NOT COMPLETED|Overall Study||11||
59690454|NCT01169779|75809939|FG001|NOT COMPLETED|Overall Study||17||
59690455|NCT01169701|75809947|FG000|STARTED|Overall Study||36||
59690456|NCT01169701|75809948|FG001|STARTED|Overall Study||35||
59690457|NCT01169701|75809947|FG000|Safety Set|Overall Study||36||
59690458|NCT01169701|75809948|FG001|Safety Set|Overall Study||35||
59690459|NCT01169701|75809947|FG000|Intent to Treat (ITT) Set|Overall Study||32||
59690460|NCT01169701|75809948|FG001|Intent to Treat (ITT) Set|Overall Study||28||
59690461|NCT01169701|75809947|FG000|COMPLETED|Overall Study||31||
59690462|NCT01169701|75809948|FG001|COMPLETED|Overall Study||25||
59690463|NCT01169701|75809947|FG000|NOT COMPLETED|Overall Study||5||
59690464|NCT01169701|75809948|FG001|NOT COMPLETED|Overall Study||10||
59690465|NCT01168999|75809958|FG000|STARTED|Overall Study||28||
59690466|NCT01168999|75809959|FG001|STARTED|Overall Study||27||
59690467|NCT01168999|75809960|FG002|STARTED|Overall Study||27||
59690468|NCT01168999|75809961|FG003|STARTED|Overall Study||28||
59690469|NCT01168999|75809958|FG000|COMPLETED|Overall Study||26||
59690470|NCT01168999|75809959|FG001|COMPLETED|Overall Study||26||
59690471|NCT01168999|75809960|FG002|COMPLETED|Overall Study||27||
59690472|NCT01168999|75809961|FG003|COMPLETED|Overall Study||28||
59690473|NCT01168999|75809958|FG000|NOT COMPLETED|Overall Study||2||
59690474|NCT01168999|75809959|FG001|NOT COMPLETED|Overall Study||1||
59690475|NCT01168999|75809960|FG002|NOT COMPLETED|Overall Study||0||
59690476|NCT01168999|75809961|FG003|NOT COMPLETED|Overall Study||0||
59690477|NCT01167907|75809973|FG000|STARTED|Overall Study||17||
59690478|NCT01167907|75809974|FG001|STARTED|Overall Study||15||
59690479|NCT01167907|75809973|FG000|COMPLETED|Overall Study||15||
59690480|NCT01167907|75809974|FG001|COMPLETED|Overall Study||14||
59690481|NCT01167907|75809973|FG000|NOT COMPLETED|Overall Study||2||
59690482|NCT01167907|75809974|FG001|NOT COMPLETED|Overall Study||1||
59690483|NCT01166659|75809980|FG000|STARTED|Overall Study||48||
59690484|NCT01166659|75809980|FG000|COMPLETED|Overall Study||35||
59690485|NCT01166659|75809980|FG000|NOT COMPLETED|Overall Study||13||
59690486|NCT01115491|75809985|FG000|STARTED|Overall Study||32||
59690487|NCT01115491|75809985|FG000|COMPLETED|Overall Study||2||
59690488|NCT01115491|75809985|FG000|NOT COMPLETED|Overall Study||30||
59690489|NCT01113931|75809991|FG000|STARTED|Overall Study||247||
59690490|NCT01113931|75809992|FG001|STARTED|Overall Study||248||
59690491|NCT01113931|75809991|FG000|Safety Population|Overall Study|1 subject did not take any study medication|246||
59690492|NCT01113931|75809992|FG001|Safety Population|Overall Study||248||
59690493|NCT01113931|75809991|FG000|mITT Population|Overall Study||188||
59690494|NCT01113931|75809992|FG001|mITT Population|Overall Study||190||
59690495|NCT01113931|75809991|FG000|COMPLETED|Overall Study||228||
59690496|NCT01113931|75809992|FG001|COMPLETED|Overall Study||231||
59690497|NCT01113931|75809991|FG000|NOT COMPLETED|Overall Study||19||
59690498|NCT01113931|75809992|FG001|NOT COMPLETED|Overall Study||17||
59690499|NCT01107379|75809998|FG000|STARTED|Overall Study||203||
59690500|NCT01107379|75809998|FG000|COMPLETED|Overall Study||182||
59690501|NCT01107379|75809998|FG000|NOT COMPLETED|Overall Study||21||
59690502|NCT01106911|75810002|FG000|STARTED|Overall Study||1085||
59690503|NCT01106911|75810002|FG000|COMPLETED|Overall Study||1080||
59690504|NCT01106911|75810002|FG000|NOT COMPLETED|Overall Study||5||
59690505|NCT01106677|75810010|FG000|STARTED|Core Period: Baseline to Week 26||183||
59690506|NCT01106677|75810011|FG001|STARTED|Core Period: Baseline to Week 26||368||
59690507|NCT01106677|75810012|FG002|STARTED|Core Period: Baseline to Week 26||367||
59690508|NCT01106677|75810013|FG003|STARTED|Core Period: Baseline to Week 26||366||
59690509|NCT01106677|75810010|FG000|COMPLETED|Core Period: Baseline to Week 26||155||
59690510|NCT01106677|75810011|FG001|COMPLETED|Core Period: Baseline to Week 26||322||
59690511|NCT01106677|75810012|FG002|COMPLETED|Core Period: Baseline to Week 26||323||
59690512|NCT01106677|75810013|FG003|COMPLETED|Core Period: Baseline to Week 26||319||
59690513|NCT01106677|75810010|FG000|NOT COMPLETED|Core Period: Baseline to Week 26||28||
59690514|NCT01106677|75810011|FG001|NOT COMPLETED|Core Period: Baseline to Week 26||46||
59690515|NCT01106677|75810012|FG002|NOT COMPLETED|Core Period: Baseline to Week 26||44||
59690516|NCT01106677|75810013|FG003|NOT COMPLETED|Core Period: Baseline to Week 26||47||
59690517|NCT01106677|75810010|FG000|STARTED|Extension Period: Week 26 to Week 52|2 pts completed core but did not enter ext: protcol violation(1), lost to f/u(1).|153||
59690518|NCT01106677|75810011|FG001|STARTED|Extension Period: Week 26 to Week 52|6 pts completed core but did not enter ext: not specified(5), withdrawal by subject(1).|316||
59690519|NCT01106677|75810012|FG002|STARTED|Extension Period: Week 26 to Week 52|2 pts completed core but did not enter ext: not specified(1), withdrawal by subject(1).|321||
59690520|NCT01106677|75810013|FG003|STARTED|Extension Period: Week 26 to Week 52|6 pts completed core but did not enter ext: not specified(3), physician decision(2), lost to f/u(1).|313||
59690521|NCT01106677|75810010|FG000|COMPLETED|Extension Period: Week 26 to Week 52||138||
59690522|NCT01106677|75810011|FG001|COMPLETED|Extension Period: Week 26 to Week 52||298||
59690523|NCT01106677|75810012|FG002|COMPLETED|Extension Period: Week 26 to Week 52||299||
59690524|NCT01106677|75810013|FG003|COMPLETED|Extension Period: Week 26 to Week 52||285||
59690525|NCT01106677|75810010|FG000|NOT COMPLETED|Extension Period: Week 26 to Week 52||15||
59690526|NCT01106677|75810011|FG001|NOT COMPLETED|Extension Period: Week 26 to Week 52||18||
59690527|NCT01106677|75810012|FG002|NOT COMPLETED|Extension Period: Week 26 to Week 52||22||
59690528|NCT01106677|75810013|FG003|NOT COMPLETED|Extension Period: Week 26 to Week 52||28||
59690529|NCT01106287|75810034|FG000|STARTED|Overall Study|One participant that discontinued the study due to a pre-treatment adverse event was replaced.|4||
59690530|NCT01106287|75810035|FG001|STARTED|Overall Study||3||
59690531|NCT01106287|75810036|FG002|STARTED|Overall Study||3||
59690532|NCT01106287|75810037|FG003|STARTED|Overall Study||3||
59690533|NCT01106287|75810034|FG000|COMPLETED|Overall Study||3||
59690534|NCT01106287|75810035|FG001|COMPLETED|Overall Study||3||
59690535|NCT01106287|75810036|FG002|COMPLETED|Overall Study||3||
59690536|NCT01106287|75810037|FG003|COMPLETED|Overall Study||3||
59690537|NCT01106287|75810034|FG000|NOT COMPLETED|Overall Study||1||
59690538|NCT01106287|75810035|FG001|NOT COMPLETED|Overall Study||0||
59690539|NCT01106287|75810036|FG002|NOT COMPLETED|Overall Study||0||
59690540|NCT01106287|75810037|FG003|NOT COMPLETED|Overall Study||0||
59690541|NCT01104493|75810053|FG000|STARTED|Overall Study||240||
59690542|NCT01104493|75810054|FG001|STARTED|Overall Study||60||
59690543|NCT01104493|75810053|FG000|COMPLETED|Overall Study||240||
59690544|NCT01104493|75810054|FG001|COMPLETED|Overall Study||58||
59690545|NCT01104493|75810053|FG000|NOT COMPLETED|Overall Study||0||
59690546|NCT01104493|75810054|FG001|NOT COMPLETED|Overall Study||2||
59690547|NCT01104415|75810060|FG000|STARTED|Core Phase||15||
59690548|NCT01104415|75810061|FG001|STARTED|Core Phase||0||
59690549|NCT01104415|75810060|FG000|COMPLETED|Core Phase||14||
59690550|NCT01104415|75810061|FG001|COMPLETED|Core Phase||0||
59690551|NCT01104415|75810060|FG000|NOT COMPLETED|Core Phase||1||
59690552|NCT01104415|75810061|FG001|NOT COMPLETED|Core Phase||0||
59690553|NCT01104415|75810060|FG000|STARTED|Extension Period||0||
59690554|NCT01104415|75810061|FG001|STARTED|Extension Period|Out of 14 participants who completed Core Phase, 3 were not eligible to enter the Extension Period.|11||
59690555|NCT01104415|75810060|FG000|COMPLETED|Extension Period||0||
59690556|NCT01104415|75810061|FG001|COMPLETED|Extension Period||0||
59690557|NCT01104415|75810060|FG000|NOT COMPLETED|Extension Period||0||
59690558|NCT01104415|75810061|FG001|NOT COMPLETED|Extension Period||11||
59690559|NCT01099579|75810071|FG000|STARTED|Stage 1 (ATV Powder Formulation)||21||
59690560|NCT01099579|75810072|FG001|STARTED|Stage 1 (ATV Powder Formulation)||19||
59690561|NCT01099579|75810073|FG002|STARTED|Stage 1 (ATV Powder Formulation)||16||
59690562|NCT01099579|75810071|FG000|COMPLETED|Stage 1 (ATV Powder Formulation)|Completed Stage 1|17||
59690563|NCT01099579|75810072|FG001|COMPLETED|Stage 1 (ATV Powder Formulation)|Completed Stage 1|14||
59690564|NCT01099579|75810073|FG002|COMPLETED|Stage 1 (ATV Powder Formulation)|Completed Stage 1|15||
59690565|NCT01099579|75810071|FG000|NOT COMPLETED|Stage 1 (ATV Powder Formulation)||4||
59690566|NCT01099579|75810072|FG001|NOT COMPLETED|Stage 1 (ATV Powder Formulation)||5||
59690567|NCT01099579|75810073|FG002|NOT COMPLETED|Stage 1 (ATV Powder Formulation)||1||
59690568|NCT01099579|75810071|FG000|STARTED|Stage 2 (ATV Capsule)||16||
59690569|NCT01099579|75810072|FG001|STARTED|Stage 2 (ATV Capsule)||14||
59690570|NCT01099579|75810073|FG002|STARTED|Stage 2 (ATV Capsule)||15||
59690571|NCT01099579|75810071|FG000|COMPLETED|Stage 2 (ATV Capsule)||10||
59690572|NCT01099579|75810072|FG001|COMPLETED|Stage 2 (ATV Capsule)||9||
59690573|NCT01099579|75810073|FG002|COMPLETED|Stage 2 (ATV Capsule)||9||
59690574|NCT01099579|75810071|FG000|NOT COMPLETED|Stage 2 (ATV Capsule)||6||
59690575|NCT01099579|75810072|FG001|NOT COMPLETED|Stage 2 (ATV Capsule)||5||
59690576|NCT01099579|75810073|FG002|NOT COMPLETED|Stage 2 (ATV Capsule)||6||
59690577|NCT01103713|75810083|FG000|STARTED|Overall Study||168||
59690578|NCT01103713|75810083|FG000|COMPLETED|Overall Study||155||
59690579|NCT01103713|75810083|FG000|NOT COMPLETED|Overall Study||13||
59690580|NCT01103479|75810093|FG000|STARTED|Overall Study||168||
59690581|NCT01103479|75810094|FG001|STARTED|Overall Study||210||
59690582|NCT01103479|75810095|FG002|STARTED|Overall Study||188||
59690583|NCT01103479|75810093|FG000|COMPLETED|Overall Study||163||
59690584|NCT01103479|75810094|FG001|COMPLETED|Overall Study||201||
59690585|NCT01103479|75810095|FG002|COMPLETED|Overall Study||174||
59690586|NCT01103479|75810093|FG000|NOT COMPLETED|Overall Study||5||
59690587|NCT01103479|75810094|FG001|NOT COMPLETED|Overall Study||9||
59690588|NCT01103479|75810095|FG002|NOT COMPLETED|Overall Study||14||
59690589|NCT01103323|75810106|FG000|STARTED|Without/Before Drug Switch||505||
59690590|NCT01103323|75810107|FG001|STARTED|Without/Before Drug Switch||255||
59690591|NCT01103323|75810106|FG000|Participants Received Treatment|Without/Before Drug Switch||500||
59690592|NCT01103323|75810107|FG001|Participants Received Treatment|Without/Before Drug Switch||253||
59690593|NCT01103323|75810106|FG000|COMPLETED|Without/Before Drug Switch||429||
59690594|NCT01103323|75810107|FG001|COMPLETED|Without/Before Drug Switch||237||
59690595|NCT01103323|75810106|FG000|NOT COMPLETED|Without/Before Drug Switch||76||
59690596|NCT01103323|75810107|FG001|NOT COMPLETED|Without/Before Drug Switch||18||
59690597|NCT01103323|75810106|FG000|STARTED|Switched From Placebo to Regorafenib||0||
59690598|NCT01103323|75810107|FG001|STARTED|Switched From Placebo to Regorafenib|Participants in the placebo+BSC group switched to Regorafenib treatment after unblinding.|4||
59690599|NCT01103323|75810106|FG000|COMPLETED|Switched From Placebo to Regorafenib||0||
59690600|NCT01103323|75810107|FG001|COMPLETED|Switched From Placebo to Regorafenib||3||
59690601|NCT01103323|75810106|FG000|NOT COMPLETED|Switched From Placebo to Regorafenib||0||
59690602|NCT01103323|75810107|FG001|NOT COMPLETED|Switched From Placebo to Regorafenib||1||
59690603|NCT01103245|75810118|FG000|STARTED|Overall Study||13||
59690604|NCT01103245|75810119|FG001|STARTED|Overall Study||7||
59690605|NCT01103245|75810120|FG002|STARTED|Overall Study||12||
59690606|NCT01103245|75810121|FG003|STARTED|Overall Study||6||
59690607|NCT01103245|75810118|FG000|COMPLETED|Overall Study||10||
59690608|NCT01103245|75810119|FG001|COMPLETED|Overall Study||5||
59690609|NCT01103245|75810120|FG002|COMPLETED|Overall Study||8||
59690610|NCT01103245|75810121|FG003|COMPLETED|Overall Study||6||
59690611|NCT01103245|75810118|FG000|NOT COMPLETED|Overall Study||3||
59690612|NCT01103245|75810119|FG001|NOT COMPLETED|Overall Study||2||
59690613|NCT01103245|75810120|FG002|NOT COMPLETED|Overall Study||4||
59690614|NCT01103245|75810121|FG003|NOT COMPLETED|Overall Study||0||
59690615|NCT01099267|75810131|FG000|STARTED|MDS-003 Study|This information duplicates results in NCT00065156.|148||
59690616|NCT01099267|75810131|FG000|COMPLETED|MDS-003 Study||24||
59690617|NCT01099267|75810131|FG000|NOT COMPLETED|MDS-003 Study||124||
59690618|NCT01099267|75810131|FG000|STARTED|MDS-009 Extension Follow-up|Participants from MDS-003 (including some who did not complete) at sites participating in MDS-009.|54||
59690619|NCT01099267|75810131|FG000|Informed Consent Given|MDS-009 Extension Follow-up||33||
59690620|NCT01099267|75810131|FG000|Other Source of Follow-up Info Used|MDS-009 Extension Follow-up|Social Security Death Index, public records, verbal reports from health providers and next of kin.|21||
59690621|NCT01099267|75810131|FG000|COMPLETED|MDS-009 Extension Follow-up||54||
59690622|NCT01099267|75810131|FG000|NOT COMPLETED|MDS-009 Extension Follow-up||0||
59690623|NCT01098487|75810135|FG000|STARTED|Overall Study||162||
59690624|NCT01098487|75810135|FG000|COMPLETED|Overall Study||118||
59690625|NCT01098487|75810135|FG000|NOT COMPLETED|Overall Study||44||
59690626|NCT01098097|75810139|FG000|STARTED|Overall Study||963||
59690627|NCT01098097|75810139|FG000|COMPLETED|Overall Study|Participants completing the study received at least 12 weeks of treatment|881||
59690628|NCT01098097|75810139|FG000|NOT COMPLETED|Overall Study||82||
59690629|NCT01097863|75810146|FG000|STARTED|Overall Study||90||
59690630|NCT01097863|75810147|FG001|STARTED|Overall Study||98||
59690631|NCT01097863|75810148|FG002|STARTED|Overall Study||91||
59690632|NCT01097863|75810146|FG000|COMPLETED|Overall Study||89||
59690633|NCT01097863|75810147|FG001|COMPLETED|Overall Study||98||
59690634|NCT01097863|75810148|FG002|COMPLETED|Overall Study||89||
59690635|NCT01097863|75810146|FG000|NOT COMPLETED|Overall Study||1||
59690636|NCT01097863|75810147|FG001|NOT COMPLETED|Overall Study||0||
59690637|NCT01097863|75810148|FG002|NOT COMPLETED|Overall Study||2||
59690638|NCT01326962|75810156|FG000|STARTED|Overall Study||28||
59690639|NCT01326962|75810156|FG000|COMPLETED|Overall Study||21||
59690640|NCT01326962|75810156|FG000|NOT COMPLETED|Overall Study||7||
59690641|NCT01326728|75810162|FG000|STARTED|Overall Study||47||
59690642|NCT01326728|75810163|FG001|STARTED|Overall Study||9||
59690643|NCT01326728|75810162|FG000|COMPLETED|Overall Study||0||
59690644|NCT01326728|75810163|FG001|COMPLETED|Overall Study||0||
59690645|NCT01326728|75810162|FG000|NOT COMPLETED|Overall Study||47||
59690646|NCT01326728|75810163|FG001|NOT COMPLETED|Overall Study||9||
59690647|NCT01097707|75810173|FG000|STARTED|Overall Study||83||
59690648|NCT01097707|75810174|FG001|STARTED|Overall Study||80||
59690649|NCT01097707|75810175|FG002|STARTED|Overall Study||82||
59690650|NCT01097707|75810176|FG003|STARTED|Overall Study||84||
59690651|NCT01097707|75810177|FG004|STARTED|Overall Study||85||
59690652|NCT01097707|75810173|FG000|COMPLETED|Overall Study||39||
59690653|NCT01097707|75810174|FG001|COMPLETED|Overall Study||37||
59690654|NCT01097707|75810175|FG002|COMPLETED|Overall Study||37||
59690655|NCT01097707|75810176|FG003|COMPLETED|Overall Study||40||
59690656|NCT01097707|75810177|FG004|COMPLETED|Overall Study||35||
59690657|NCT01097707|75810173|FG000|NOT COMPLETED|Overall Study||44||
59690658|NCT01097707|75810174|FG001|NOT COMPLETED|Overall Study||43||
59690659|NCT01097707|75810175|FG002|NOT COMPLETED|Overall Study||45||
59690660|NCT01097707|75810176|FG003|NOT COMPLETED|Overall Study||44||
59690661|NCT01097707|75810177|FG004|NOT COMPLETED|Overall Study||50||
59690662|NCT01326104|75810191|FG000|STARTED|Overall Study||7||
59690663|NCT01326104|75810192|FG001|STARTED|Overall Study||19||
59690664|NCT01326104|75810191|FG000|COMPLETED|Overall Study||7||
59690665|NCT01326104|75810192|FG001|COMPLETED|Overall Study||15||
59690666|NCT01326104|75810191|FG000|NOT COMPLETED|Overall Study||0||
59690667|NCT01326104|75810192|FG001|NOT COMPLETED|Overall Study||4||
59690668|NCT01326026|75810200|FG000|STARTED|Overall Study||111||
59690669|NCT01326026|75810201|FG001|STARTED|Overall Study||111||
59690670|NCT01326026|75810200|FG000|Exposed|Overall Study|One subject withdrew before exposure to trial drug|110||
59690671|NCT01326026|75810201|FG001|Exposed|Overall Study||111||
59690672|NCT01326026|75810200|FG000|COMPLETED|Overall Study||99||
59690673|NCT01326026|75810201|FG001|COMPLETED|Overall Study||98||
59690674|NCT01326026|75810200|FG000|NOT COMPLETED|Overall Study||12||
59690675|NCT01326026|75810201|FG001|NOT COMPLETED|Overall Study||13||
59690676|NCT01097629|75810210|FG000|STARTED|Double-Blind (DB) Treatment (TRT) Phase||240||
59690677|NCT01097629|75810211|FG001|STARTED|Double-Blind (DB) Treatment (TRT) Phase||392||
59690678|NCT01097629|75810212|FG002|STARTED|Double-Blind (DB) Treatment (TRT) Phase||387||
59690679|NCT01097629|75810213|FG003|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0||
59690680|NCT01097629|75810214|FG004|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0||
59690681|NCT01097629|75810215|FG005|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0||
59690682|NCT01097629|75810216|FG006|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0||
59690683|NCT01097629|75810217|FG007|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0||
59690684|NCT01097629|75810210|FG000|Treated|Double-Blind (DB) Treatment (TRT) Phase||239||
59690685|NCT01097629|75810211|FG001|Treated|Double-Blind (DB) Treatment (TRT) Phase||387||
59690686|NCT01097629|75810212|FG002|Treated|Double-Blind (DB) Treatment (TRT) Phase||383||
59690687|NCT01097629|75810213|FG003|Treated|Double-Blind (DB) Treatment (TRT) Phase||0||
59690688|NCT01097629|75810214|FG004|Treated|Double-Blind (DB) Treatment (TRT) Phase||0||
59690689|NCT01097629|75810215|FG005|Treated|Double-Blind (DB) Treatment (TRT) Phase||0||
59690690|NCT01097629|75810216|FG006|Treated|Double-Blind (DB) Treatment (TRT) Phase||0||
59690691|NCT01097629|75810217|FG007|Treated|Double-Blind (DB) Treatment (TRT) Phase||0||
59690692|NCT01097629|75810210|FG000|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||205||
59690693|NCT01097629|75810211|FG001|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|2 did not continue into RO|346||
59690694|NCT01097629|75810212|FG002|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|3 did not continue into RO|330||
59690695|NCT01097629|75810213|FG003|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0||
59690696|NCT01097629|75810214|FG004|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0||
59690697|NCT01097629|75810215|FG005|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0||
59690698|NCT01097629|75810216|FG006|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0||
59690699|NCT01097629|75810217|FG007|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0||
59690700|NCT01097629|75810210|FG000|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||35||
59690701|NCT01097629|75810211|FG001|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||46||
59690702|NCT01097629|75810212|FG002|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||57||
59690703|NCT01097629|75810213|FG003|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0||
59690704|NCT01097629|75810214|FG004|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0||
59690705|NCT01097629|75810215|FG005|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0||
59690706|NCT01097629|75810216|FG006|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0||
59690707|NCT01097629|75810217|FG007|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0||
59690708|NCT01097629|75810210|FG000|STARTED|DB RO Phase||0||
59690709|NCT01097629|75810211|FG001|STARTED|DB RO Phase||0||
59690710|NCT01097629|75810212|FG002|STARTED|DB RO Phase||0||
59690711|NCT01097629|75810213|FG003|STARTED|DB RO Phase||97||
59690712|NCT01097629|75810214|FG004|STARTED|DB RO Phase||108||
59690713|NCT01097629|75810215|FG005|STARTED|DB RO Phase||173||
59690714|NCT01097629|75810216|FG006|STARTED|DB RO Phase||171||
59690715|NCT01097629|75810217|FG007|STARTED|DB RO Phase||327||
59690716|NCT01097629|75810210|FG000|COMPLETED|DB RO Phase||0||
59690717|NCT01097629|75810211|FG001|COMPLETED|DB RO Phase||0||
59690718|NCT01097629|75810212|FG002|COMPLETED|DB RO Phase||0||
59690719|NCT01097629|75810213|FG003|COMPLETED|DB RO Phase||96||
59690720|NCT01097629|75810214|FG004|COMPLETED|DB RO Phase||108||
59690721|NCT01097629|75810215|FG005|COMPLETED|DB RO Phase||172||
59690722|NCT01097629|75810216|FG006|COMPLETED|DB RO Phase||168||
59690723|NCT01097629|75810217|FG007|COMPLETED|DB RO Phase||326||
59690724|NCT01097629|75810210|FG000|NOT COMPLETED|DB RO Phase||0||
59690725|NCT01097629|75810211|FG001|NOT COMPLETED|DB RO Phase||0||
59690726|NCT01097629|75810212|FG002|NOT COMPLETED|DB RO Phase||0||
59690727|NCT01097629|75810213|FG003|NOT COMPLETED|DB RO Phase||1||
59690728|NCT01097629|75810214|FG004|NOT COMPLETED|DB RO Phase||0||
59690729|NCT01097629|75810215|FG005|NOT COMPLETED|DB RO Phase||1||
59690730|NCT01097629|75810216|FG006|NOT COMPLETED|DB RO Phase||3||
59690731|NCT01097629|75810217|FG007|NOT COMPLETED|DB RO Phase||1||
59690732|NCT01324622|75810242|FG000|STARTED|Overall Study||13||
59690733|NCT01324622|75810243|FG001|STARTED|Overall Study||11||
59690734|NCT01324622|75810242|FG000|COMPLETED|Overall Study||4||
59690735|NCT01324622|75810243|FG001|COMPLETED|Overall Study||4||
59690736|NCT01324622|75810242|FG000|NOT COMPLETED|Overall Study||9||
59690737|NCT01324622|75810243|FG001|NOT COMPLETED|Overall Study||7||
59690738|NCT01097005|75810250|FG000|STARTED|Overall Study|number of participants who were enrolled for this study.|466||
59690739|NCT01097005|75810250|FG000|Analysis of Safety|Overall Study|number of participants who could be measured for Adverse Events|441||
59690740|NCT01097005|75810250|FG000|Analysis of NTM Lung Disease|Overall Study|number of participants who contributed to the Baseline data|340||
59690741|NCT01097005|75810250|FG000|Analysis of Bacilli Negative Conversion|Overall Study|number of participants who were analysed for bacilli negative conversion|285||
59690742|NCT01097005|75810250|FG000|Analysis of CGI|Overall Study|number of participants who were measured for Clinical Global Improvement (CGI)|249||
59690743|NCT01097005|75810250|FG000|COMPLETED|Overall Study||101||
59690744|NCT01097005|75810250|FG000|NOT COMPLETED|Overall Study||365||
59690745|NCT01096849|75810259|FG000|STARTED|Overall Study||22||
59690746|NCT01096849|75810260|FG001|STARTED|Overall Study||76||
59690747|NCT01096849|75810261|FG002|STARTED|Overall Study||47||
59690748|NCT01096849|75810259|FG000|COMPLETED|Overall Study||20||
59690749|NCT01096849|75810260|FG001|COMPLETED|Overall Study||64||
59690750|NCT01096849|75810261|FG002|COMPLETED|Overall Study||41||
59690751|NCT01096849|75810259|FG000|NOT COMPLETED|Overall Study||2||
59690752|NCT01096849|75810260|FG001|NOT COMPLETED|Overall Study||12||
59690753|NCT01096849|75810261|FG002|NOT COMPLETED|Overall Study||6||
59690754|NCT01324388|75810272|FG000|STARTED|Part 1 of Study||23||
59690755|NCT01324388|75810273|FG001|STARTED|Part 1 of Study||8||
59690756|NCT01324388|75810274|FG002|STARTED|Part 1 of Study||0||
59690757|NCT01324388|75810275|FG003|STARTED|Part 1 of Study||0||
59690758|NCT01324388|75810272|FG000|Received at Least 1 Dose|Part 1 of Study||23||
59690759|NCT01324388|75810273|FG001|Received at Least 1 Dose|Part 1 of Study||8||
59690760|NCT01324388|75810274|FG002|Received at Least 1 Dose|Part 1 of Study||0||
59690761|NCT01324388|75810275|FG003|Received at Least 1 Dose|Part 1 of Study||0||
59690762|NCT01324388|75810272|FG000|COMPLETED|Part 1 of Study||19||
59690763|NCT01324388|75810273|FG001|COMPLETED|Part 1 of Study||6||
59690764|NCT01324388|75810274|FG002|COMPLETED|Part 1 of Study||0||
59690765|NCT01324388|75810275|FG003|COMPLETED|Part 1 of Study||0||
59690766|NCT01324388|75810272|FG000|NOT COMPLETED|Part 1 of Study||4||
59690767|NCT01324388|75810273|FG001|NOT COMPLETED|Part 1 of Study||2||
59690768|NCT01324388|75810274|FG002|NOT COMPLETED|Part 1 of Study||0||
59690769|NCT01324388|75810275|FG003|NOT COMPLETED|Part 1 of Study||0||
59690770|NCT01324388|75810272|FG000|STARTED|Part 2 of Study: First Intervention||0||
59690771|NCT01324388|75810273|FG001|STARTED|Part 2 of Study: First Intervention||0||
59690772|NCT01324388|75810274|FG002|STARTED|Part 2 of Study: First Intervention||10||
59690773|NCT01324388|75810275|FG003|STARTED|Part 2 of Study: First Intervention||10||
59690774|NCT01324388|75810272|FG000|COMPLETED|Part 2 of Study: First Intervention||0||
59690775|NCT01324388|75810273|FG001|COMPLETED|Part 2 of Study: First Intervention||0||
59690776|NCT01324388|75810274|FG002|COMPLETED|Part 2 of Study: First Intervention||10||
59690777|NCT01324388|75810275|FG003|COMPLETED|Part 2 of Study: First Intervention||9||
59690778|NCT01324388|75810272|FG000|NOT COMPLETED|Part 2 of Study: First Intervention||0||
59690779|NCT01324388|75810273|FG001|NOT COMPLETED|Part 2 of Study: First Intervention||0||
59690780|NCT01324388|75810274|FG002|NOT COMPLETED|Part 2 of Study: First Intervention||0||
59690781|NCT01324388|75810275|FG003|NOT COMPLETED|Part 2 of Study: First Intervention||1||
59690782|NCT01324388|75810272|FG000|STARTED|Part 2: Washout of at Least 21 Days||0||
59690783|NCT01324388|75810273|FG001|STARTED|Part 2: Washout of at Least 21 Days||0||
59690784|NCT01324388|75810274|FG002|STARTED|Part 2: Washout of at Least 21 Days||10||
59690785|NCT01324388|75810275|FG003|STARTED|Part 2: Washout of at Least 21 Days||9||
59690786|NCT01324388|75810272|FG000|COMPLETED|Part 2: Washout of at Least 21 Days||0||
59690787|NCT01324388|75810273|FG001|COMPLETED|Part 2: Washout of at Least 21 Days||0||
59690788|NCT01324388|75810274|FG002|COMPLETED|Part 2: Washout of at Least 21 Days||10||
59690789|NCT01324388|75810275|FG003|COMPLETED|Part 2: Washout of at Least 21 Days||9||
59690790|NCT01324388|75810272|FG000|NOT COMPLETED|Part 2: Washout of at Least 21 Days||0||
59690791|NCT01324388|75810273|FG001|NOT COMPLETED|Part 2: Washout of at Least 21 Days||0||
59690792|NCT01324388|75810274|FG002|NOT COMPLETED|Part 2: Washout of at Least 21 Days||0||
59690793|NCT01324388|75810275|FG003|NOT COMPLETED|Part 2: Washout of at Least 21 Days||0||
59690794|NCT01324388|75810272|FG000|STARTED|Part 2 of Study: Second Intervention||0||
59690795|NCT01324388|75810273|FG001|STARTED|Part 2 of Study: Second Intervention||0||
59690796|NCT01324388|75810274|FG002|STARTED|Part 2 of Study: Second Intervention||10||
59690797|NCT01324388|75810275|FG003|STARTED|Part 2 of Study: Second Intervention||9||
59690798|NCT01324388|75810272|FG000|COMPLETED|Part 2 of Study: Second Intervention||0||
59690799|NCT01324388|75810273|FG001|COMPLETED|Part 2 of Study: Second Intervention||0||
59690800|NCT01324388|75810274|FG002|COMPLETED|Part 2 of Study: Second Intervention||9||
59690801|NCT01324388|75810275|FG003|COMPLETED|Part 2 of Study: Second Intervention||9||
59690802|NCT01324388|75810272|FG000|NOT COMPLETED|Part 2 of Study: Second Intervention||0||
59690803|NCT01324388|75810273|FG001|NOT COMPLETED|Part 2 of Study: Second Intervention||0||
59690804|NCT01324388|75810274|FG002|NOT COMPLETED|Part 2 of Study: Second Intervention||1||
59690805|NCT01324388|75810275|FG003|NOT COMPLETED|Part 2 of Study: Second Intervention||0||
59690806|NCT01102777|75810289|FG000|STARTED|Overall Study||84||
59690807|NCT01102777|75810290|FG001|STARTED|Overall Study||155||
59690808|NCT01102777|75810289|FG000|COMPLETED|Overall Study||75||
59690809|NCT01102777|75810290|FG001|COMPLETED|Overall Study||139||
59690810|NCT01102777|75810289|FG000|NOT COMPLETED|Overall Study||9||
59690811|NCT01102777|75810290|FG001|NOT COMPLETED|Overall Study||16||
59690812|NCT01324310|75810297|FG000|STARTED|Overall Study||15||
59690813|NCT01324310|75810297|FG000|COMPLETED|Overall Study||13||
59690814|NCT01324310|75810297|FG000|NOT COMPLETED|Overall Study||2||
59690815|NCT01102231|75810303|FG000|STARTED|Overall Study||106||
59690816|NCT01102231|75810303|FG000|COMPLETED|Overall Study||91||
59690817|NCT01102231|75810303|FG000|NOT COMPLETED|Overall Study||15||
59690818|NCT01094743|75810308|FG000|STARTED|Period 1||52||
59690819|NCT01094743|75810308|FG000|COMPLETED|Period 1||50||
59690820|NCT01094743|75810308|FG000|NOT COMPLETED|Period 1||2||
59690821|NCT01094743|75810308|FG000|STARTED|Period 2||50||
59690822|NCT01094743|75810308|FG000|COMPLETED|Period 2||50||
59690823|NCT01094743|75810308|FG000|NOT COMPLETED|Period 2||0||
59690824|NCT01095835|75810316|FG000|STARTED|Overall Study||51||
59690825|NCT01095835|75810317|FG001|STARTED|Overall Study||52||
59690826|NCT01095835|75810318|FG002|STARTED|Overall Study||25||
59690827|NCT01095835|75810316|FG000|COMPLETED|Overall Study||41||
59690828|NCT01095835|75810317|FG001|COMPLETED|Overall Study||40||
59690829|NCT01095835|75810318|FG002|COMPLETED|Overall Study||17||
59690830|NCT01095835|75810316|FG000|NOT COMPLETED|Overall Study||10||
59690831|NCT01095835|75810317|FG001|NOT COMPLETED|Overall Study||12||
59690832|NCT01095835|75810318|FG002|NOT COMPLETED|Overall Study||8||
59690833|NCT01324232|75810331|FG000|STARTED|Overall Study||49||
59690834|NCT01324232|75810332|FG001|STARTED|Overall Study||53||
59690835|NCT01324232|75810333|FG002|STARTED|Overall Study||54||
59690836|NCT01324232|75810334|FG003|STARTED|Overall Study||53||
59690837|NCT01324232|75810331|FG000|COMPLETED|Overall Study||44||
59690838|NCT01324232|75810332|FG001|COMPLETED|Overall Study||42||
59690839|NCT01324232|75810333|FG002|COMPLETED|Overall Study||41||
59690840|NCT01324232|75810334|FG003|COMPLETED|Overall Study||42||
59690841|NCT01324232|75810331|FG000|NOT COMPLETED|Overall Study||5||
59690842|NCT01324232|75810332|FG001|NOT COMPLETED|Overall Study||11||
59690843|NCT01324232|75810333|FG002|NOT COMPLETED|Overall Study||13||
59690844|NCT01324232|75810334|FG003|NOT COMPLETED|Overall Study||11||
59690845|NCT01094119|75810351|FG000|STARTED|Overall Study||34||
59690846|NCT01094119|75810352|FG001|STARTED|Overall Study||36||
59690847|NCT01094119|75810351|FG000|COMPLETED|Overall Study||32||
59690848|NCT01094119|75810352|FG001|COMPLETED|Overall Study||32||
59690849|NCT01094119|75810351|FG000|NOT COMPLETED|Overall Study||2||
59690850|NCT01094119|75810352|FG001|NOT COMPLETED|Overall Study||4||
59690851|NCT01323920|75810358|FG000|STARTED|Overall Study||35||
59690852|NCT01323920|75810358|FG000|COMPLETED|Overall Study||29||
59690853|NCT01323920|75810358|FG000|NOT COMPLETED|Overall Study||6||
59690854|NCT01093885|75810362|FG000|STARTED|Overall Study||15||
59690855|NCT01093885|75810362|FG000|COMPLETED|Overall Study||10||
59690856|NCT01093885|75810362|FG000|NOT COMPLETED|Overall Study||5||
59690857|NCT01101997|75810367|FG000|STARTED|Overall Study||60||
59690858|NCT01101997|75810367|FG000|COMPLETED|Overall Study||58||
59690859|NCT01101997|75810367|FG000|NOT COMPLETED|Overall Study||2||
59690860|NCT00597597|75810373|FG000|STARTED|Overall Study||11||
59690861|NCT00597597|75810373|FG000|COMPLETED|Overall Study||11||
59690862|NCT00597597|75810373|FG000|NOT COMPLETED|Overall Study||0||
59690863|NCT01324830|75810397|FG000|STARTED|Overall Study||3||
59690864|NCT01324830|75810398|FG001|STARTED|Overall Study||3||
59690865|NCT01324830|75810399|FG002|STARTED|Overall Study||3||
59690866|NCT01324830|75810400|FG003|STARTED|Overall Study||3||
59690867|NCT01324830|75810401|FG004|STARTED|Overall Study||7||
59690868|NCT01324830|75810402|FG005|STARTED|Overall Study||7||
59690869|NCT01324830|75810403|FG006|STARTED|Overall Study||3||
59690870|NCT01324830|75810404|FG007|STARTED|Overall Study||3||
59690871|NCT01324830|75810405|FG008|STARTED|Overall Study||5||
59690872|NCT01324830|75810406|FG009|STARTED|Overall Study||6||
59690873|NCT01324830|75810407|FG010|STARTED|Overall Study||4||
59690874|NCT01324830|75810408|FG011|STARTED|Overall Study||1||
59690875|NCT01324830|75810409|FG012|STARTED|Overall Study||1||
59690876|NCT01324830|75810410|FG013|STARTED|Overall Study||1||
59690877|NCT01324830|75810411|FG014|STARTED|Overall Study||1||
59690878|NCT01324830|75810412|FG015|STARTED|Overall Study||3||
59690879|NCT01324830|75810413|FG016|STARTED|Overall Study||3||
59690880|NCT01324830|75810414|FG017|STARTED|Overall Study||6||
59690881|NCT01324830|75810415|FG018|STARTED|Overall Study||6||
59690882|NCT01324830|75810397|FG000|COMPLETED|Overall Study||0||
59690883|NCT01324830|75810398|FG001|COMPLETED|Overall Study||0||
59690884|NCT01324830|75810399|FG002|COMPLETED|Overall Study||0||
59690885|NCT01324830|75810400|FG003|COMPLETED|Overall Study||0||
59690886|NCT01324830|75810401|FG004|COMPLETED|Overall Study||0||
59690887|NCT01324830|75810402|FG005|COMPLETED|Overall Study||0||
59690888|NCT01324830|75810403|FG006|COMPLETED|Overall Study||0||
59690889|NCT01324830|75810404|FG007|COMPLETED|Overall Study||0||
59690890|NCT01324830|75810405|FG008|COMPLETED|Overall Study||0||
59690891|NCT01324830|75810406|FG009|COMPLETED|Overall Study||0||
59690892|NCT01324830|75810407|FG010|COMPLETED|Overall Study||0||
59690893|NCT01324830|75810408|FG011|COMPLETED|Overall Study||0||
59690894|NCT01324830|75810409|FG012|COMPLETED|Overall Study||0||
59690895|NCT01324830|75810410|FG013|COMPLETED|Overall Study||0||
59690896|NCT01324830|75810411|FG014|COMPLETED|Overall Study||0||
59690897|NCT01324830|75810412|FG015|COMPLETED|Overall Study||0||
59690898|NCT01324830|75810413|FG016|COMPLETED|Overall Study||0||
59690899|NCT01324830|75810414|FG017|COMPLETED|Overall Study||0||
59690900|NCT01324830|75810415|FG018|COMPLETED|Overall Study||0||
59690901|NCT01324830|75810397|FG000|NOT COMPLETED|Overall Study||3||
59690902|NCT01324830|75810398|FG001|NOT COMPLETED|Overall Study||3||
59690903|NCT01324830|75810399|FG002|NOT COMPLETED|Overall Study||3||
59690904|NCT01324830|75810400|FG003|NOT COMPLETED|Overall Study||3||
59690905|NCT01324830|75810401|FG004|NOT COMPLETED|Overall Study||7||
59690906|NCT01324830|75810402|FG005|NOT COMPLETED|Overall Study||7||
59690907|NCT01324830|75810403|FG006|NOT COMPLETED|Overall Study||3||
59690908|NCT01324830|75810404|FG007|NOT COMPLETED|Overall Study||3||
59690909|NCT01324830|75810405|FG008|NOT COMPLETED|Overall Study||5||
59690910|NCT01324830|75810406|FG009|NOT COMPLETED|Overall Study||6||
59690911|NCT01324830|75810407|FG010|NOT COMPLETED|Overall Study||4||
59690912|NCT01324830|75810408|FG011|NOT COMPLETED|Overall Study||1||
59690913|NCT01324830|75810409|FG012|NOT COMPLETED|Overall Study||1||
59690914|NCT01324830|75810410|FG013|NOT COMPLETED|Overall Study||1||
59690915|NCT01324830|75810411|FG014|NOT COMPLETED|Overall Study||1||
59690916|NCT01324830|75810412|FG015|NOT COMPLETED|Overall Study||3||
59690917|NCT01324830|75810413|FG016|NOT COMPLETED|Overall Study||3||
59690918|NCT01324830|75810414|FG017|NOT COMPLETED|Overall Study||6||
59690919|NCT01324830|75810415|FG018|NOT COMPLETED|Overall Study||6||
59690920|NCT01324440|75810463|FG000|STARTED|Overall Study||32||
59690921|NCT01324440|75810464|FG001|STARTED|Overall Study||32||
59690922|NCT01324440|75810463|FG000|COMPLETED|Overall Study||32||
59690923|NCT01324440|75810464|FG001|COMPLETED|Overall Study||31||
59690924|NCT01324440|75810463|FG000|NOT COMPLETED|Overall Study||0||
59690925|NCT01324440|75810464|FG001|NOT COMPLETED|Overall Study||1||
59690926|NCT01325493|75810472|FG000|STARTED|Overall Study||30||
59690927|NCT01325493|75810473|FG001|STARTED|Overall Study||24||
59690928|NCT01325493|75810472|FG000|COMPLETED|Overall Study||29||
59690929|NCT01325493|75810473|FG001|COMPLETED|Overall Study||21||
59690930|NCT01325493|75810472|FG000|NOT COMPLETED|Overall Study||1||
59690931|NCT01325493|75810473|FG001|NOT COMPLETED|Overall Study||3||
59690932|NCT01323972|75810483|FG000|STARTED|Overall Study||81||
59690933|NCT01323972|75810484|FG001|STARTED|Overall Study||79||
59690934|NCT01323972|75810485|FG002|STARTED|Overall Study||80||
59690935|NCT01323972|75810486|FG003|STARTED|Overall Study||80||
59690936|NCT01323972|75810483|FG000|COMPLETED|Overall Study||79||
59690937|NCT01323972|75810484|FG001|COMPLETED|Overall Study||76||
59690938|NCT01323972|75810485|FG002|COMPLETED|Overall Study||78||
59690939|NCT01323972|75810486|FG003|COMPLETED|Overall Study||79||
59690940|NCT01323972|75810483|FG000|NOT COMPLETED|Overall Study||2||
59690941|NCT01323972|75810484|FG001|NOT COMPLETED|Overall Study||3||
59690942|NCT01323972|75810485|FG002|NOT COMPLETED|Overall Study||2||
59690943|NCT01323972|75810486|FG003|NOT COMPLETED|Overall Study||1||
59690944|NCT01325337|75810503|FG000|STARTED|Overall Study||61||
59690945|NCT01325337|75810504|FG001|STARTED|Overall Study||61||
59690946|NCT01325337|75810505|FG002|STARTED|Overall Study||62||
59690947|NCT01325337|75810506|FG003|STARTED|Overall Study||62||
59690948|NCT01325337|75810507|FG004|STARTED|Overall Study||61||
59690949|NCT01325337|75810503|FG000|COMPLETED|Overall Study||56||
59690950|NCT01325337|75810504|FG001|COMPLETED|Overall Study||52||
59690951|NCT01325337|75810505|FG002|COMPLETED|Overall Study||53||
59690952|NCT01325337|75810506|FG003|COMPLETED|Overall Study||52||
59690953|NCT01325337|75810507|FG004|COMPLETED|Overall Study||53||
59690954|NCT01325337|75810503|FG000|NOT COMPLETED|Overall Study||5||
59690955|NCT01325337|75810504|FG001|NOT COMPLETED|Overall Study||9||
59690956|NCT01325337|75810505|FG002|NOT COMPLETED|Overall Study||9||
59690957|NCT01325337|75810506|FG003|NOT COMPLETED|Overall Study||10||
59690958|NCT01325337|75810507|FG004|NOT COMPLETED|Overall Study||8||
59690959|NCT01324947|75810519|FG000|STARTED|Overall Study||74||
59690960|NCT01324947|75810519|FG000|Safety Population|Overall Study|Safety Population includes those who were enrolled and received at least one dose of study drug|73||
59690961|NCT01324947|75810519|FG000|Efficacy Evaluable Population (EEP)|Overall Study|Participants who received ≥ 1 dose of study drug and had at least 1 postbaseline efficacy assessment|64||
59690962|NCT01324947|75810519|FG000|COMPLETED|Overall Study||0||
59690963|NCT01324947|75810519|FG000|NOT COMPLETED|Overall Study||74||
59690964|NCT01101841|75810527|FG000|STARTED|Overall Study||285||
59690965|NCT01101841|75810528|FG001|STARTED|Overall Study||285||
59690966|NCT01101841|75810527|FG000|COMPLETED|Overall Study||235||
59690967|NCT01101841|75810528|FG001|COMPLETED|Overall Study||218||
59690968|NCT01101841|75810527|FG000|NOT COMPLETED|Overall Study||50||
59690969|NCT01101841|75810528|FG001|NOT COMPLETED|Overall Study||67||
59690970|NCT01324401|75810537|FG000|STARTED|Overall Study||4||
59690971|NCT01324401|75810538|FG001|STARTED|Overall Study|3 excluded from ITT analysis: 1 screen fail, 2 voluntary withdrawal pre-treatment|26||
59690972|NCT01324401|75810537|FG000|COMPLETED|Overall Study|one (1) could not tolerate minimum starting dose|3||
59690973|NCT01324401|75810538|FG001|COMPLETED|Overall Study|three (3) unable to complete due to adverse events|20||
59690974|NCT01324401|75810537|FG000|NOT COMPLETED|Overall Study||1||
59690975|NCT01324401|75810538|FG001|NOT COMPLETED|Overall Study||6||
59690976|NCT01323660|75810544|FG000|STARTED|Treatment Period 1 (12 Weeks)||84||
59690977|NCT01323660|75810545|FG001|STARTED|Treatment Period 1 (12 Weeks)||22||
59690978|NCT01323660|75810546|FG002|STARTED|Treatment Period 1 (12 Weeks)||24||
59690979|NCT01323660|75810547|FG003|STARTED|Treatment Period 1 (12 Weeks)||36||
59690980|NCT01323660|75810548|FG004|STARTED|Treatment Period 1 (12 Weeks)||71||
59690981|NCT01323660|75810549|FG005|STARTED|Treatment Period 1 (12 Weeks)||70||
59690982|NCT01323660|75810544|FG000|COMPLETED|Treatment Period 1 (12 Weeks)||65||
59690983|NCT01323660|75810545|FG001|COMPLETED|Treatment Period 1 (12 Weeks)||21||
59690984|NCT01323660|75810546|FG002|COMPLETED|Treatment Period 1 (12 Weeks)||19||
59690985|NCT01323660|75810547|FG003|COMPLETED|Treatment Period 1 (12 Weeks)||31||
59690986|NCT01323660|75810548|FG004|COMPLETED|Treatment Period 1 (12 Weeks)||61||
59690987|NCT01323660|75810549|FG005|COMPLETED|Treatment Period 1 (12 Weeks)||61||
59690988|NCT01323660|75810544|FG000|NOT COMPLETED|Treatment Period 1 (12 Weeks)||19||
59690989|NCT01323660|75810545|FG001|NOT COMPLETED|Treatment Period 1 (12 Weeks)||1||
59690990|NCT01323660|75810546|FG002|NOT COMPLETED|Treatment Period 1 (12 Weeks)||5||
59690991|NCT01323660|75810547|FG003|NOT COMPLETED|Treatment Period 1 (12 Weeks)||5||
59690992|NCT01323660|75810548|FG004|NOT COMPLETED|Treatment Period 1 (12 Weeks)||10||
59690993|NCT01323660|75810549|FG005|NOT COMPLETED|Treatment Period 1 (12 Weeks)||9||
59690994|NCT01323660|75810544|FG000|STARTED|Washout Period (14 Days)||65||
59690995|NCT01323660|75810545|FG001|STARTED|Washout Period (14 Days)||21||
59690996|NCT01323660|75810546|FG002|STARTED|Washout Period (14 Days)||19||
59690997|NCT01323660|75810547|FG003|STARTED|Washout Period (14 Days)||31||
59690998|NCT01323660|75810548|FG004|STARTED|Washout Period (14 Days)||61||
59690999|NCT01323660|75810549|FG005|STARTED|Washout Period (14 Days)||61||
59691000|NCT01323660|75810544|FG000|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|65||
59691001|NCT01323660|75810545|FG001|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|21||
59691002|NCT01323660|75810546|FG002|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|18||
59691003|NCT01323660|75810547|FG003|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|28||
59691004|NCT01323660|75810548|FG004|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|58||
59691005|NCT01323660|75810549|FG005|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|59||
59691006|NCT01323660|75810544|FG000|NOT COMPLETED|Washout Period (14 Days)||0||
59691007|NCT01323660|75810545|FG001|NOT COMPLETED|Washout Period (14 Days)||0||
59691008|NCT01323660|75810546|FG002|NOT COMPLETED|Washout Period (14 Days)||1||
59691009|NCT01323660|75810547|FG003|NOT COMPLETED|Washout Period (14 Days)||3||
59691010|NCT01323660|75810548|FG004|NOT COMPLETED|Washout Period (14 Days)||3||
59691011|NCT01323660|75810549|FG005|NOT COMPLETED|Washout Period (14 Days)||2||
59691012|NCT01323660|75810544|FG000|STARTED|Treatment Period 2 (12 Weeks)|"By crossover design, participants were assigned to a different treatment arm in each period."|67||
59691013|NCT01323660|75810545|FG001|STARTED|Treatment Period 2 (12 Weeks)|"By crossover design, participants were assigned to a different treatment arm in each period."|18||
59691014|NCT01323660|75810546|FG002|STARTED|Treatment Period 2 (12 Weeks)|"By crossover design, participants were assigned to a different treatment arm in each period."|17||
59691015|NCT01323660|75810547|FG003|STARTED|Treatment Period 2 (12 Weeks)|"By crossover design, participants were assigned to a different treatment arm in each period."|28||
59691016|NCT01323660|75810548|FG004|STARTED|Treatment Period 2 (12 Weeks)|"By crossover design, participants were assigned to a different treatment arm in each period."|59||
59691017|NCT01323660|75810549|FG005|STARTED|Treatment Period 2 (12 Weeks)|"By crossover design, participants were assigned to a different treatment arm in each period."|58||
59691018|NCT01323660|75810544|FG000|COMPLETED|Treatment Period 2 (12 Weeks)||55||
59691019|NCT01323660|75810545|FG001|COMPLETED|Treatment Period 2 (12 Weeks)||17||
59691020|NCT01323660|75810546|FG002|COMPLETED|Treatment Period 2 (12 Weeks)||14||
59691021|NCT01323660|75810547|FG003|COMPLETED|Treatment Period 2 (12 Weeks)||25||
59691022|NCT01323660|75810548|FG004|COMPLETED|Treatment Period 2 (12 Weeks)||55||
59691023|NCT01323660|75810549|FG005|COMPLETED|Treatment Period 2 (12 Weeks)||51||
59691024|NCT01323660|75810544|FG000|NOT COMPLETED|Treatment Period 2 (12 Weeks)||12||
59691025|NCT01323660|75810545|FG001|NOT COMPLETED|Treatment Period 2 (12 Weeks)||1||
59691026|NCT01323660|75810546|FG002|NOT COMPLETED|Treatment Period 2 (12 Weeks)||3||
59691027|NCT01323660|75810547|FG003|NOT COMPLETED|Treatment Period 2 (12 Weeks)||3||
59691028|NCT01323660|75810548|FG004|NOT COMPLETED|Treatment Period 2 (12 Weeks)||4||
59691029|NCT01323660|75810549|FG005|NOT COMPLETED|Treatment Period 2 (12 Weeks)||7||
59691030|NCT01092637|75810565|FG000|STARTED|Overall Study||145||
59691031|NCT01092637|75810566|FG001|STARTED|Overall Study||135||
59691032|NCT01092637|75810565|FG000|COMPLETED|Overall Study||98||
59691033|NCT01092637|75810566|FG001|COMPLETED|Overall Study||86||
59691034|NCT01092637|75810565|FG000|NOT COMPLETED|Overall Study||47||
59691035|NCT01092637|75810566|FG001|NOT COMPLETED|Overall Study||49||
59691036|NCT01324323|75810573|FG000|STARTED|Overall Study||14||
59691037|NCT01324323|75810573|FG000|COMPLETED|Overall Study||13||
59691038|NCT01324323|75810573|FG000|NOT COMPLETED|Overall Study||1||
59691039|NCT01323582|75810587|FG000|STARTED|Weeks 1-4 (First Period)||12||
59691040|NCT01323582|75810588|FG001|STARTED|Weeks 1-4 (First Period)||14||
59691041|NCT01323582|75810587|FG000|COMPLETED|Weeks 1-4 (First Period)||10||
59691042|NCT01323582|75810588|FG001|COMPLETED|Weeks 1-4 (First Period)||12||
59691043|NCT01323582|75810587|FG000|NOT COMPLETED|Weeks 1-4 (First Period)||2||
59691044|NCT01323582|75810588|FG001|NOT COMPLETED|Weeks 1-4 (First Period)||2||
59691045|NCT01323582|75810587|FG000|STARTED|Weeks 5-7 (Washout)||10||
59691046|NCT01323582|75810588|FG001|STARTED|Weeks 5-7 (Washout)||12||
59691047|NCT01323582|75810587|FG000|COMPLETED|Weeks 5-7 (Washout)||10||
59691048|NCT01323582|75810588|FG001|COMPLETED|Weeks 5-7 (Washout)||11||
59691049|NCT01323582|75810587|FG000|NOT COMPLETED|Weeks 5-7 (Washout)||0||
59691050|NCT01323582|75810588|FG001|NOT COMPLETED|Weeks 5-7 (Washout)||1||
59691051|NCT01323582|75810587|FG000|STARTED|Weeks 8-11 (Period 2)||10||
59691052|NCT01323582|75810588|FG001|STARTED|Weeks 8-11 (Period 2)||11||
59691053|NCT01323582|75810587|FG000|COMPLETED|Weeks 8-11 (Period 2)||10||
59691054|NCT01323582|75810588|FG001|COMPLETED|Weeks 8-11 (Period 2)||10||
59691055|NCT01323582|75810587|FG000|NOT COMPLETED|Weeks 8-11 (Period 2)||0||
59691056|NCT01323582|75810588|FG001|NOT COMPLETED|Weeks 8-11 (Period 2)||1||
59691057|NCT01323621|75810598|FG000|STARTED|2-week, Single-blind Run In Period||739||
59691058|NCT01323621|75810599|FG001|STARTED|2-week, Single-blind Run In Period||0||
59691059|NCT01323621|75810600|FG002|STARTED|2-week, Single-blind Run In Period||0||
59691060|NCT01323621|75810598|FG000|COMPLETED|2-week, Single-blind Run In Period||511||
59691061|NCT01323621|75810599|FG001|COMPLETED|2-week, Single-blind Run In Period||0||
59691062|NCT01323621|75810600|FG002|COMPLETED|2-week, Single-blind Run In Period||0||
59691063|NCT01323621|75810598|FG000|NOT COMPLETED|2-week, Single-blind Run In Period||228||
59691064|NCT01323621|75810599|FG001|NOT COMPLETED|2-week, Single-blind Run In Period||0||
59691065|NCT01323621|75810600|FG002|NOT COMPLETED|2-week, Single-blind Run In Period||0||
59691066|NCT01323621|75810598|FG000|STARTED|12-week, Double-blind Treatment Period||0||
59691067|NCT01323621|75810599|FG001|STARTED|12-week, Double-blind Treatment Period||252||
59691068|NCT01323621|75810600|FG002|STARTED|12-week, Double-blind Treatment Period||259||
59691069|NCT01323621|75810598|FG000|COMPLETED|12-week, Double-blind Treatment Period||0||
59691070|NCT01323621|75810599|FG001|COMPLETED|12-week, Double-blind Treatment Period||237||
59691071|NCT01323621|75810600|FG002|COMPLETED|12-week, Double-blind Treatment Period||239||
59691072|NCT01323621|75810598|FG000|NOT COMPLETED|12-week, Double-blind Treatment Period||0||
59691073|NCT01323621|75810599|FG001|NOT COMPLETED|12-week, Double-blind Treatment Period||15||
59691074|NCT01323621|75810600|FG002|NOT COMPLETED|12-week, Double-blind Treatment Period||20||
59691075|NCT01323192|75810608|FG000|STARTED|Overall Study||143||
59691076|NCT01323192|75810609|FG001|STARTED|Overall Study||141||
59691077|NCT01323192|75810608|FG000|COMPLETED|Overall Study||134||
59691078|NCT01323192|75810609|FG001|COMPLETED|Overall Study||135||
59691079|NCT01323192|75810608|FG000|NOT COMPLETED|Overall Study||9||
59691080|NCT01323192|75810609|FG001|NOT COMPLETED|Overall Study||6||
59691081|NCT01323387|75810615|FG000|STARTED|Overall Study||178||
59691082|NCT01323387|75810615|FG000|COMPLETED|Overall Study||94||
59691083|NCT01323387|75810615|FG000|NOT COMPLETED|Overall Study||84||
59691084|NCT01321749|75810623|FG000|STARTED|Overall Study||51||
59691085|NCT01321749|75810624|FG001|STARTED|Overall Study||52||
59691086|NCT01321749|75810623|FG000|COMPLETED|Overall Study||38||
59691087|NCT01321749|75810624|FG001|COMPLETED|Overall Study||30||
59691088|NCT01321749|75810623|FG000|NOT COMPLETED|Overall Study||13||
59691089|NCT01321749|75810624|FG001|NOT COMPLETED|Overall Study||22||
59691090|NCT01320735|75810630|FG000|STARTED|Overall Study||300||
59691091|NCT01320735|75810630|FG000|COMPLETED|Overall Study||194||
59691092|NCT01320735|75810630|FG000|NOT COMPLETED|Overall Study||106||
59691093|NCT01320033|75810637|FG000|STARTED|Overall Study||216||
59691094|NCT01320033|75810638|FG001|STARTED|Overall Study||224||
60079379|NCT04206332|76194715|FG015|Received Product Administration|Part A||0||
60079380|NCT04206332|76194716|FG016|Received Product Administration|Part A||0||
60079381|NCT04206332|76194700|FG000|Completed Controlled Human Malaria Infection (CHMI)|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0||
60103616|NCT01291108|76221867|FG004|NOT COMPLETED|Month 1 (Monotherapy)||0||
59691095|NCT01320033|75810639|FG002|STARTED|Overall Study||222||
59691096|NCT01320033|75810637|FG000|COMPLETED|Overall Study||158||
59691097|NCT01320033|75810638|FG001|COMPLETED|Overall Study||160||
59691098|NCT01320033|75810639|FG002|COMPLETED|Overall Study||169||
59691099|NCT01320033|75810637|FG000|NOT COMPLETED|Overall Study||58||
59691100|NCT01320033|75810638|FG001|NOT COMPLETED|Overall Study||64||
59691101|NCT01320033|75810639|FG002|NOT COMPLETED|Overall Study||53||
59691102|NCT01101061|75810653|FG000|STARTED|Overall Study||6||
59691103|NCT01101061|75810654|FG001|STARTED|Overall Study||6||
59691104|NCT01101061|75810655|FG002|STARTED|Overall Study||7||
59691105|NCT01101061|75810656|FG003|STARTED|Overall Study||6||
59691106|NCT01101061|75810657|FG004|STARTED|Overall Study||2||
59691107|NCT01101061|75810658|FG005|STARTED|Overall Study||4||
59691108|NCT01101061|75810653|FG000|Received Study Drug|Overall Study||6||
59691109|NCT01101061|75810654|FG001|Received Study Drug|Overall Study||6||
59691110|NCT01101061|75810655|FG002|Received Study Drug|Overall Study||6||
59691111|NCT01101061|75810656|FG003|Received Study Drug|Overall Study||6||
59691112|NCT01101061|75810657|FG004|Received Study Drug|Overall Study||2||
59691113|NCT01101061|75810658|FG005|Received Study Drug|Overall Study||4||
59691114|NCT01101061|75810653|FG000|COMPLETED|Overall Study||6||
59691115|NCT01101061|75810654|FG001|COMPLETED|Overall Study||6||
59691116|NCT01101061|75810655|FG002|COMPLETED|Overall Study||6||
59691117|NCT01101061|75810656|FG003|COMPLETED|Overall Study||6||
59691118|NCT01101061|75810657|FG004|COMPLETED|Overall Study||2||
59691119|NCT01101061|75810658|FG005|COMPLETED|Overall Study||4||
59691120|NCT01101061|75810653|FG000|NOT COMPLETED|Overall Study||0||
59691121|NCT01101061|75810654|FG001|NOT COMPLETED|Overall Study||0||
59691122|NCT01101061|75810655|FG002|NOT COMPLETED|Overall Study||1||
59691123|NCT01101061|75810656|FG003|NOT COMPLETED|Overall Study||0||
59691124|NCT01101061|75810657|FG004|NOT COMPLETED|Overall Study||0||
59691125|NCT01101061|75810658|FG005|NOT COMPLETED|Overall Study||0||
59691126|NCT01317615|75810676|FG000|STARTED|Overall Study||49||
59691127|NCT01317615|75810676|FG000|COMPLETED|Overall Study||0||
59691128|NCT01317615|75810676|FG000|NOT COMPLETED|Overall Study||49||
59691129|NCT01078675|75810682|FG000|STARTED|Overall Study||250||
59691130|NCT01078675|75810683|FG001|STARTED|Overall Study||65||
59691131|NCT01078675|75810682|FG000|Patients Treated|Overall Study||198||
59691132|NCT01078675|75810683|FG001|Patients Treated|Overall Study||0||
59691133|NCT01078675|75810682|FG000|COMPLETED|Overall Study||182||
59691134|NCT01078675|75810683|FG001|COMPLETED|Overall Study|Healthy siblings did not participate in investigational product administration.|59||
59691135|NCT01078675|75810682|FG000|NOT COMPLETED|Overall Study||68||
59691136|NCT01078675|75810683|FG001|NOT COMPLETED|Overall Study||6||
59691137|NCT01100437|75810689|FG000|STARTED|Screening||4||
59691138|NCT01100437|75810690|FG001|STARTED|Screening||2||
59691139|NCT01100437|75810691|FG002|STARTED|Screening||8||
59691140|NCT01100437|75810689|FG000|COMPLETED|Screening||4||
59691141|NCT01100437|75810690|FG001|COMPLETED|Screening||2||
59691142|NCT01100437|75810691|FG002|COMPLETED|Screening||8||
59691143|NCT01100437|75810689|FG000|NOT COMPLETED|Screening||0||
59691144|NCT01100437|75810690|FG001|NOT COMPLETED|Screening||0||
59691145|NCT01100437|75810691|FG002|NOT COMPLETED|Screening||0||
59691146|NCT01100437|75810689|FG000|STARTED|Titration/Stabilization||4||
59691147|NCT01100437|75810690|FG001|STARTED|Titration/Stabilization||2||
59691148|NCT01100437|75810691|FG002|STARTED|Titration/Stabilization||8||
59691149|NCT01100437|75810689|FG000|COMPLETED|Titration/Stabilization||4||
59691150|NCT01100437|75810690|FG001|COMPLETED|Titration/Stabilization||2||
59691151|NCT01100437|75810691|FG002|COMPLETED|Titration/Stabilization||2||
59691152|NCT01100437|75810689|FG000|NOT COMPLETED|Titration/Stabilization||0||
59691153|NCT01100437|75810690|FG001|NOT COMPLETED|Titration/Stabilization||0||
59691154|NCT01100437|75810691|FG002|NOT COMPLETED|Titration/Stabilization||6||
59691155|NCT01100437|75810689|FG000|STARTED|Maintenance||4||
59691156|NCT01100437|75810690|FG001|STARTED|Maintenance||2||
59691157|NCT01100437|75810691|FG002|STARTED|Maintenance||2||
59691158|NCT01100437|75810689|FG000|COMPLETED|Maintenance||4||
59691159|NCT01100437|75810690|FG001|COMPLETED|Maintenance||2||
59691160|NCT01100437|75810691|FG002|COMPLETED|Maintenance||0||
59691161|NCT01100437|75810689|FG000|NOT COMPLETED|Maintenance||0||
59691162|NCT01100437|75810690|FG001|NOT COMPLETED|Maintenance||0||
59691163|NCT01100437|75810691|FG002|NOT COMPLETED|Maintenance||2||
59691164|NCT01100437|75810689|FG000|STARTED|Treatment 1||4||
59691165|NCT01100437|75810690|FG001|STARTED|Treatment 1||2||
59691166|NCT01100437|75810691|FG002|STARTED|Treatment 1||0||
59691167|NCT01100437|75810689|FG000|COMPLETED|Treatment 1||4||
59691168|NCT01100437|75810690|FG001|COMPLETED|Treatment 1||2||
60079382|NCT04206332|76194701|FG001|Completed Controlled Human Malaria Infection (CHMI)|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0||
59691169|NCT01100437|75810691|FG002|COMPLETED|Treatment 1||0||
59691170|NCT01100437|75810689|FG000|NOT COMPLETED|Treatment 1||0||
59691171|NCT01100437|75810690|FG001|NOT COMPLETED|Treatment 1||0||
59691172|NCT01100437|75810691|FG002|NOT COMPLETED|Treatment 1||0||
59691173|NCT01100437|75810689|FG000|STARTED|Washout (4 Days)||4||
59691174|NCT01100437|75810690|FG001|STARTED|Washout (4 Days)||2||
59691175|NCT01100437|75810691|FG002|STARTED|Washout (4 Days)||0||
59691176|NCT01100437|75810689|FG000|COMPLETED|Washout (4 Days)||4||
59691177|NCT01100437|75810690|FG001|COMPLETED|Washout (4 Days)||2||
59691178|NCT01100437|75810691|FG002|COMPLETED|Washout (4 Days)||0||
59691179|NCT01100437|75810689|FG000|NOT COMPLETED|Washout (4 Days)||0||
59691180|NCT01100437|75810690|FG001|NOT COMPLETED|Washout (4 Days)||0||
59691181|NCT01100437|75810691|FG002|NOT COMPLETED|Washout (4 Days)||0||
59691182|NCT01100437|75810689|FG000|STARTED|Treatment 2||4||
59691183|NCT01100437|75810690|FG001|STARTED|Treatment 2||2||
59691184|NCT01100437|75810691|FG002|STARTED|Treatment 2||0||
59691185|NCT01100437|75810689|FG000|COMPLETED|Treatment 2||4||
59691186|NCT01100437|75810690|FG001|COMPLETED|Treatment 2||2||
59691187|NCT01100437|75810691|FG002|COMPLETED|Treatment 2||0||
59691188|NCT01100437|75810689|FG000|NOT COMPLETED|Treatment 2||0||
59691189|NCT01100437|75810690|FG001|NOT COMPLETED|Treatment 2||0||
59691190|NCT01100437|75810691|FG002|NOT COMPLETED|Treatment 2||0||
59691191|NCT01322490|75810703|FG000|STARTED|Treatment Period||432||
59691192|NCT01322490|75810704|FG001|STARTED|Treatment Period||432||
59691193|NCT01322490|75810705|FG002|STARTED|Treatment Period||433||
59691194|NCT01322490|75810703|FG000|Treated|Treatment Period||429||
59691195|NCT01322490|75810704|FG001|Treated|Treatment Period||429||
59691196|NCT01322490|75810705|FG002|Treated|Treatment Period||428||
59691197|NCT01322490|75810703|FG000|COMPLETED|Treatment Period||300||
59691198|NCT01322490|75810704|FG001|COMPLETED|Treatment Period||279||
59691199|NCT01322490|75810705|FG002|COMPLETED|Treatment Period||280||
59691200|NCT01322490|75810703|FG000|NOT COMPLETED|Treatment Period||132||
59691201|NCT01322490|75810704|FG001|NOT COMPLETED|Treatment Period||153||
59691202|NCT01322490|75810705|FG002|NOT COMPLETED|Treatment Period||153||
59691203|NCT01322490|75810703|FG000|STARTED|Long Term Follow-up Period|You did not have to complete treatment to enter follow up.|409||
59691204|NCT01322490|75810704|FG001|STARTED|Long Term Follow-up Period|You did not have to complete treatment to enter follow up.|408||
59691205|NCT01322490|75810705|FG002|STARTED|Long Term Follow-up Period|You did not have to complete treatment to enter follow up.|413||
59691206|NCT01322490|75810703|FG000|COMPLETED|Long Term Follow-up Period||0||
59691207|NCT01322490|75810704|FG001|COMPLETED|Long Term Follow-up Period||0||
59691208|NCT01322490|75810705|FG002|COMPLETED|Long Term Follow-up Period||0||
59691209|NCT01322490|75810703|FG000|NOT COMPLETED|Long Term Follow-up Period||409||
59691210|NCT01322490|75810704|FG001|NOT COMPLETED|Long Term Follow-up Period||408||
59691211|NCT01322490|75810705|FG002|NOT COMPLETED|Long Term Follow-up Period||413||
59691212|NCT01314261|75810717|FG000|STARTED|Overall Study||9||
59691213|NCT01314261|75810718|FG001|STARTED|Overall Study||9||
59691214|NCT01314261|75810719|FG002|STARTED|Overall Study||10||
59691215|NCT01314261|75810720|FG003|STARTED|Overall Study||9||
59691216|NCT01314261|75810717|FG000|Discontinued ABT-267 or Placebo|Overall Study||1||
59691217|NCT01314261|75810718|FG001|Discontinued ABT-267 or Placebo|Overall Study||0||
59691218|NCT01314261|75810719|FG002|Discontinued ABT-267 or Placebo|Overall Study||1||
59691219|NCT01314261|75810720|FG003|Discontinued ABT-267 or Placebo|Overall Study||0||
59691220|NCT01314261|75810717|FG000|Discontinued pegIFN/RBV|Overall Study||1||
59691221|NCT01314261|75810718|FG001|Discontinued pegIFN/RBV|Overall Study||4||
59691222|NCT01314261|75810719|FG002|Discontinued pegIFN/RBV|Overall Study||5||
59691223|NCT01314261|75810720|FG003|Discontinued pegIFN/RBV|Overall Study||1||
59691224|NCT01314261|75810717|FG000|COMPLETED|Overall Study||7||
59691225|NCT01314261|75810718|FG001|COMPLETED|Overall Study||5||
59691226|NCT01314261|75810719|FG002|COMPLETED|Overall Study||7||
59691227|NCT01314261|75810720|FG003|COMPLETED|Overall Study||6||
59691228|NCT01314261|75810717|FG000|NOT COMPLETED|Overall Study||2||
59691229|NCT01314261|75810718|FG001|NOT COMPLETED|Overall Study||4||
59691230|NCT01314261|75810719|FG002|NOT COMPLETED|Overall Study||3||
59691231|NCT01314261|75810720|FG003|NOT COMPLETED|Overall Study||3||
59691232|NCT01321710|75810733|FG000|STARTED|Overall Study||50||
59691233|NCT01321710|75810734|FG001|STARTED|Overall Study||58||
59691234|NCT01321710|75810735|FG002|STARTED|Overall Study||44||
59691235|NCT01321710|75810733|FG000|COMPLETED|Overall Study||46||
59691236|NCT01321710|75810734|FG001|COMPLETED|Overall Study||53||
59691237|NCT01321710|75810735|FG002|COMPLETED|Overall Study||44||
59691238|NCT01321710|75810733|FG000|NOT COMPLETED|Overall Study||4||
59691239|NCT01321710|75810734|FG001|NOT COMPLETED|Overall Study||5||
59691240|NCT01321710|75810735|FG002|NOT COMPLETED|Overall Study||0||
59691241|NCT01321008|75810745|FG000|STARTED|Overall Study||1||
59691242|NCT01321008|75810745|FG000|COMPLETED|Overall Study||0||
59691243|NCT01321008|75810745|FG000|NOT COMPLETED|Overall Study||1||
59691244|NCT01320150|75810751|FG000|STARTED|Overall Study||311||
59691245|NCT01320150|75810751|FG000|PPP|Overall Study||34|Subjects with Persistent Post-Operative Pain (PPP)|
59691246|NCT01320150|75810751|FG000|Non-PPP|Overall Study||211|Subjects without Persistent Post-Operative Pain (Non-PPP)|
59691247|NCT01320150|75810751|FG000|COMPLETED|Overall Study||245||
59691248|NCT01320150|75810751|FG000|NOT COMPLETED|Overall Study||66||
59691249|NCT01323530|75810762|FG000|STARTED|Phase 1b (Dose Escalation Phase)||8||
59691250|NCT01323530|75810763|FG001|STARTED|Phase 1b (Dose Escalation Phase)||6||
59691251|NCT01323530|75810764|FG002|STARTED|Phase 1b (Dose Escalation Phase)||5||
59691252|NCT01323530|75810765|FG003|STARTED|Phase 1b (Dose Escalation Phase)||3||
59691253|NCT01323530|75810766|FG004|STARTED|Phase 1b (Dose Escalation Phase)||6||
59691254|NCT01323530|75810767|FG005|STARTED|Phase 1b (Dose Escalation Phase)||6||
59691255|NCT01323530|75810768|FG006|STARTED|Phase 1b (Dose Escalation Phase)||0||
59989799|NCT02505542|76105160|FG003|NOT COMPLETED|Part B: Double-Blind Period||7||
59691256|NCT01323530|75810762|FG000|COMPLETED|Phase 1b (Dose Escalation Phase)||5||
59691257|NCT01323530|75810763|FG001|COMPLETED|Phase 1b (Dose Escalation Phase)||4||
59691258|NCT01323530|75810764|FG002|COMPLETED|Phase 1b (Dose Escalation Phase)||4||
59691259|NCT01323530|75810765|FG003|COMPLETED|Phase 1b (Dose Escalation Phase)||3||
59989800|NCT04456153|76105188|FG000|STARTED|Overall Study||19||
59989801|NCT04456153|76105189|FG001|STARTED|Overall Study||41||
59989802|NCT04456153|76105188|FG000|COMPLETED|Overall Study||19||
59989803|NCT04456153|76105189|FG001|COMPLETED|Overall Study||41||
59989804|NCT04456153|76105188|FG000|NOT COMPLETED|Overall Study||0||
59989805|NCT04456153|76105189|FG001|NOT COMPLETED|Overall Study||0||
59989806|NCT02475980|76105209|FG000|STARTED|Overall Study||13||
59989807|NCT02475980|76105209|FG000|COMPLETED|Overall Study||8||
59989808|NCT02475980|76105209|FG000|NOT COMPLETED|Overall Study||5||
59989809|NCT02447432|76105215|FG000|STARTED|Epoch 001||160||
59989810|NCT02447432|76105216|FG001|STARTED|Epoch 001||160||
59989811|NCT02447432|76105215|FG000|COMPLETED|Epoch 001||155||
59989812|NCT02447432|76105216|FG001|COMPLETED|Epoch 001||147||
60103617|NCT01291108|76221868|FG005|NOT COMPLETED|Month 1 (Monotherapy)||0||
59691260|NCT01323530|75810766|FG004|COMPLETED|Phase 1b (Dose Escalation Phase)||3||
59691261|NCT01323530|75810767|FG005|COMPLETED|Phase 1b (Dose Escalation Phase)||3||
59691262|NCT01323530|75810768|FG006|COMPLETED|Phase 1b (Dose Escalation Phase)||0||
59691263|NCT01323530|75810762|FG000|NOT COMPLETED|Phase 1b (Dose Escalation Phase)||3||
59691264|NCT01323530|75810763|FG001|NOT COMPLETED|Phase 1b (Dose Escalation Phase)||2||
59691265|NCT01323530|75810764|FG002|NOT COMPLETED|Phase 1b (Dose Escalation Phase)||1||
59691266|NCT01323530|75810765|FG003|NOT COMPLETED|Phase 1b (Dose Escalation Phase)||0||
59691267|NCT01323530|75810766|FG004|NOT COMPLETED|Phase 1b (Dose Escalation Phase)||3||
59691268|NCT01323530|75810767|FG005|NOT COMPLETED|Phase 1b (Dose Escalation Phase)||3||
59691269|NCT01323530|75810768|FG006|NOT COMPLETED|Phase 1b (Dose Escalation Phase)||0||
59691270|NCT01323530|75810762|FG000|STARTED|Phase 2 (Dose-confirmation Phase)||0||
59691271|NCT01323530|75810763|FG001|STARTED|Phase 2 (Dose-confirmation Phase)||0||
59691272|NCT01323530|75810764|FG002|STARTED|Phase 2 (Dose-confirmation Phase)||0||
59691273|NCT01323530|75810765|FG003|STARTED|Phase 2 (Dose-confirmation Phase)||0||
59691274|NCT01323530|75810766|FG004|STARTED|Phase 2 (Dose-confirmation Phase)||0||
59691275|NCT01323530|75810767|FG005|STARTED|Phase 2 (Dose-confirmation Phase)||0||
59691276|NCT01323530|75810768|FG006|STARTED|Phase 2 (Dose-confirmation Phase)||42||
59691277|NCT01323530|75810762|FG000|COMPLETED|Phase 2 (Dose-confirmation Phase)||0||
59691278|NCT01323530|75810763|FG001|COMPLETED|Phase 2 (Dose-confirmation Phase)||0||
59691279|NCT01323530|75810764|FG002|COMPLETED|Phase 2 (Dose-confirmation Phase)||0||
59691280|NCT01323530|75810765|FG003|COMPLETED|Phase 2 (Dose-confirmation Phase)||0||
59691281|NCT01323530|75810766|FG004|COMPLETED|Phase 2 (Dose-confirmation Phase)||0||
59691282|NCT01323530|75810767|FG005|COMPLETED|Phase 2 (Dose-confirmation Phase)||0||
59691283|NCT01323530|75810768|FG006|COMPLETED|Phase 2 (Dose-confirmation Phase)||25||
59691284|NCT01323530|75810762|FG000|NOT COMPLETED|Phase 2 (Dose-confirmation Phase)||0||
59691285|NCT01323530|75810763|FG001|NOT COMPLETED|Phase 2 (Dose-confirmation Phase)||0||
59691286|NCT01323530|75810764|FG002|NOT COMPLETED|Phase 2 (Dose-confirmation Phase)||0||
59691287|NCT01323530|75810765|FG003|NOT COMPLETED|Phase 2 (Dose-confirmation Phase)||0||
59691288|NCT01323530|75810766|FG004|NOT COMPLETED|Phase 2 (Dose-confirmation Phase)||0||
59691289|NCT01323530|75810767|FG005|NOT COMPLETED|Phase 2 (Dose-confirmation Phase)||0||
59691290|NCT01323530|75810768|FG006|NOT COMPLETED|Phase 2 (Dose-confirmation Phase)||17||
59691291|NCT01313637|75810789|FG000|STARTED|Overall Study||275||
59691292|NCT01313637|75810790|FG001|STARTED|Overall Study||407||
59691293|NCT01313637|75810791|FG002|STARTED|Overall Study||404||
59691294|NCT01313637|75810792|FG003|STARTED|Overall Study||403||
59691295|NCT01313637|75810789|FG000|COMPLETED|Overall Study||183||
59691296|NCT01313637|75810790|FG001|COMPLETED|Overall Study||312||
59691297|NCT01313637|75810791|FG002|COMPLETED|Overall Study||298||
59691298|NCT01313637|75810792|FG003|COMPLETED|Overall Study||325||
59691299|NCT01313637|75810789|FG000|NOT COMPLETED|Overall Study||92||
59691300|NCT01313637|75810790|FG001|NOT COMPLETED|Overall Study||95||
59691301|NCT01313637|75810791|FG002|NOT COMPLETED|Overall Study||106||
59691302|NCT01313637|75810792|FG003|NOT COMPLETED|Overall Study||78||
59691303|NCT01320722|75810807|FG000|STARTED|Overall Study||46||
59691304|NCT01320722|75810808|FG001|STARTED|Overall Study||47||
59691305|NCT01320722|75810809|FG002|STARTED|Overall Study||47||
59691306|NCT01320722|75810810|FG003|STARTED|Overall Study||49||
59691307|NCT01320722|75810811|FG004|STARTED|Overall Study||53||
59691308|NCT01320722|75810807|FG000|Received Intervention|Overall Study||43||
59691309|NCT01320722|75810808|FG001|Received Intervention|Overall Study||45||
59691310|NCT01320722|75810809|FG002|Received Intervention|Overall Study||46||
59691311|NCT01320722|75810810|FG003|Received Intervention|Overall Study||48||
59691312|NCT01320722|75810811|FG004|Received Intervention|Overall Study||51||
59691313|NCT01320722|75810807|FG000|COMPLETED|Overall Study||43||
59691314|NCT01320722|75810808|FG001|COMPLETED|Overall Study||41||
59691315|NCT01320722|75810809|FG002|COMPLETED|Overall Study||40||
59691316|NCT01320722|75810810|FG003|COMPLETED|Overall Study||35||
59691317|NCT01320722|75810811|FG004|COMPLETED|Overall Study||45||
59691318|NCT01320722|75810807|FG000|NOT COMPLETED|Overall Study||3||
59691319|NCT01320722|75810808|FG001|NOT COMPLETED|Overall Study||6||
59691320|NCT01320722|75810809|FG002|NOT COMPLETED|Overall Study||7||
59691321|NCT01320722|75810810|FG003|NOT COMPLETED|Overall Study||14||
59691322|NCT01320722|75810811|FG004|NOT COMPLETED|Overall Study||8||
59691323|NCT01313559|75810828|FG000|STARTED|Overall Study||4||
59691324|NCT01313559|75810829|FG001|STARTED|Overall Study||2||
59691325|NCT01313559|75810828|FG000|COMPLETED|Overall Study||0||
59691326|NCT01313559|75810829|FG001|COMPLETED|Overall Study||0||
59691327|NCT01313559|75810828|FG000|NOT COMPLETED|Overall Study||4||
59691328|NCT01313559|75810829|FG001|NOT COMPLETED|Overall Study||2||
59691329|NCT01312779|75810835|FG000|STARTED|Overall Study||39||
59691330|NCT01312779|75810835|FG000|Implanted With Device|Overall Study||12||
59816123|NCT00529802|75938478|FG000|COMPLETED|Evaluable for Primary Endpoint|Evaluable for primary endpoint|50||
59691331|NCT01312779|75810835|FG000|COMPLETED|Overall Study||7||
59691332|NCT01312779|75810835|FG000|NOT COMPLETED|Overall Study||32||
59691333|NCT01312467|75810848|FG000|STARTED|Overall Study||45||
59691334|NCT01312467|75810848|FG000|COMPLETED|Overall Study||32||
59691335|NCT01312467|75810848|FG000|NOT COMPLETED|Overall Study||13||
59691336|NCT01310127|75810855|FG000|STARTED|Overall Study||12||
59691337|NCT01310127|75810856|FG001|STARTED|Overall Study||11||
59691338|NCT01310127|75810855|FG000|COMPLETED|Overall Study||10||
59691339|NCT01310127|75810856|FG001|COMPLETED|Overall Study||10||
59691340|NCT01310127|75810855|FG000|NOT COMPLETED|Overall Study||2||
59691341|NCT01310127|75810856|FG001|NOT COMPLETED|Overall Study||1||
59691342|NCT01309893|75810862|FG000|STARTED|Week 1 - First Intervention||33||
59691343|NCT01309893|75810863|FG001|STARTED|Week 1 - First Intervention||33||
59691344|NCT01309893|75810862|FG000|COMPLETED|Week 1 - First Intervention||33||
59691345|NCT01309893|75810863|FG001|COMPLETED|Week 1 - First Intervention||33||
59691346|NCT01309893|75810862|FG000|NOT COMPLETED|Week 1 - First Intervention||0||
59691347|NCT01309893|75810863|FG001|NOT COMPLETED|Week 1 - First Intervention||0||
59691348|NCT01309893|75810862|FG000|STARTED|Week 2 - Crossover Intervention||33||
59691349|NCT01309893|75810863|FG001|STARTED|Week 2 - Crossover Intervention||33||
59691350|NCT01309893|75810862|FG000|COMPLETED|Week 2 - Crossover Intervention||32||
59691351|NCT01309893|75810863|FG001|COMPLETED|Week 2 - Crossover Intervention||32||
59691352|NCT01309893|75810862|FG000|NOT COMPLETED|Week 2 - Crossover Intervention||1||
59691353|NCT01309893|75810863|FG001|NOT COMPLETED|Week 2 - Crossover Intervention||1||
59691354|NCT01318902|75810873|FG000|STARTED|Overall Study||6||
59691355|NCT01318902|75810874|FG001|STARTED|Overall Study||5||
59691356|NCT01318902|75810875|FG002|STARTED|Overall Study||5||
59691357|NCT01318902|75810876|FG003|STARTED|Overall Study||11||
59691358|NCT01318902|75810873|FG000|COMPLETED|Overall Study||5|Completed=participants who completed maximum cycles per protocol and who had progressive disease.|
59691359|NCT01318902|75810874|FG001|COMPLETED|Overall Study||2|Completed=participants who completed maximum cycles per protocol and who had progressive disease.|
59691360|NCT01318902|75810875|FG002|COMPLETED|Overall Study||3|Completed=participants who completed maximum cycles per protocol and who had progressive disease.|
59691361|NCT01318902|75810876|FG003|COMPLETED|Overall Study||5|Completed=participants who completed maximum cycles per protocol and who had progressive disease.|
59691362|NCT01318902|75810873|FG000|NOT COMPLETED|Overall Study||1||
59691363|NCT01318902|75810874|FG001|NOT COMPLETED|Overall Study||3||
59691364|NCT01318902|75810875|FG002|NOT COMPLETED|Overall Study||2||
59691365|NCT01318902|75810876|FG003|NOT COMPLETED|Overall Study||6||
59691366|NCT01313858|75810891|FG000|STARTED|Overall Study||524||
59691367|NCT01313858|75810892|FG001|STARTED|Overall Study||546||
59691368|NCT01313858|75810893|FG002|STARTED|Overall Study||543||
59691369|NCT01313858|75810891|FG000|COMPLETED|Overall Study||238||
59691370|NCT01313858|75810892|FG001|COMPLETED|Overall Study||276||
59691371|NCT01313858|75810893|FG002|COMPLETED|Overall Study||305||
59691372|NCT01313858|75810891|FG000|NOT COMPLETED|Overall Study||286||
59691373|NCT01313858|75810892|FG001|NOT COMPLETED|Overall Study||270||
59691374|NCT01313858|75810893|FG002|NOT COMPLETED|Overall Study||238||
59691375|NCT01090765|75810905|FG000|STARTED|Overall Study||3||
59691376|NCT01090765|75810906|FG001|STARTED|Overall Study||3||
59691377|NCT01090765|75810907|FG002|STARTED|Overall Study||3||
59691378|NCT01090765|75810908|FG003|STARTED|Overall Study||2||
59691379|NCT01090765|75810909|FG004|STARTED|Overall Study||6||
60103783|NCT03915574|76222055|FG000|COMPLETED|Overall Study|70 mother-infant dyads completed the study (total participants = 140)|70||
59547546|NCT02518191|75646346|FG001|NOT COMPLETED|Overall Study||9||
59547547|NCT02524119|75646354|FG000|STARTED|Overall Study||5||
59547548|NCT02524119|75646354|FG000|COMPLETED|Overall Study||5||
59547549|NCT02524119|75646354|FG000|NOT COMPLETED|Overall Study||0||
59547550|NCT01119794|75646358|FG000|STARTED|Overall Study||10||
59547551|NCT01119794|75646358|FG000|COMPLETED|Overall Study||10||
59547552|NCT01119794|75646358|FG000|NOT COMPLETED|Overall Study||0||
59547553|NCT02464449|75646364|FG000|STARTED|Overall Study||166||
59547554|NCT02464449|75646365|FG001|STARTED|Overall Study||112||
59547555|NCT02464449|75646364|FG000|COMPLETED|Overall Study||151||
59547556|NCT02464449|75646365|FG001|COMPLETED|Overall Study||100||
59547557|NCT02464449|75646364|FG000|NOT COMPLETED|Overall Study||15||
59547558|NCT02464449|75646365|FG001|NOT COMPLETED|Overall Study||12||
59547559|NCT02464917|75646373|FG000|STARTED|Overall Study||35||
59547560|NCT02464917|75646374|FG001|STARTED|Overall Study||35||
59547561|NCT02464917|75646373|FG000|COMPLETED|Overall Study||35||
59547562|NCT02464917|75646374|FG001|COMPLETED|Overall Study||35||
59547563|NCT02464917|75646373|FG000|NOT COMPLETED|Overall Study||0||
59691380|NCT01090765|75810910|FG005|STARTED|Overall Study||4||
59691381|NCT01090765|75810905|FG000|COMPLETED|Overall Study||3||
59691382|NCT01090765|75810906|FG001|COMPLETED|Overall Study||3||
59691383|NCT01090765|75810907|FG002|COMPLETED|Overall Study||3||
59691384|NCT01090765|75810908|FG003|COMPLETED|Overall Study||1||
59691385|NCT01090765|75810909|FG004|COMPLETED|Overall Study||4||
59691386|NCT01090765|75810910|FG005|COMPLETED|Overall Study||3||
59691387|NCT01090765|75810905|FG000|NOT COMPLETED|Overall Study||0||
59691388|NCT01090765|75810906|FG001|NOT COMPLETED|Overall Study||0||
59691389|NCT01090765|75810907|FG002|NOT COMPLETED|Overall Study||0||
59691390|NCT01090765|75810908|FG003|NOT COMPLETED|Overall Study||1||
59547564|NCT02464917|75646374|FG001|NOT COMPLETED|Overall Study||0||
59547565|NCT01120808|75646380|FG000|STARTED|Overall Study||136||
59547566|NCT01120808|75646380|FG000|COMPLETED|Overall Study||90||
59547567|NCT01120808|75646380|FG000|NOT COMPLETED|Overall Study||46||
59691391|NCT01090765|75810909|FG004|NOT COMPLETED|Overall Study||2||
59547568|NCT02465073|75646387|FG000|STARTED|Overall Study||17||
59691392|NCT01090765|75810910|FG005|NOT COMPLETED|Overall Study||1||
59691393|NCT01313780|75810927|FG000|STARTED|Overall Study|FAS|58||
59691394|NCT01313780|75810928|FG001|STARTED|Overall Study|FAS|59||
59691395|NCT01313780|75810927|FG000|COMPLETED|Overall Study|PPS|33||
59691396|NCT01313780|75810928|FG001|COMPLETED|Overall Study|PPS|31||
59691397|NCT01313780|75810927|FG000|NOT COMPLETED|Overall Study||25||
59691398|NCT01313780|75810928|FG001|NOT COMPLETED|Overall Study||28||
59691399|NCT01090453|75810936|FG000|STARTED|Overall Study||238||
59691400|NCT01090453|75810937|FG001|STARTED|Overall Study||242||
59691401|NCT01090453|75810936|FG000|COMPLETED|Overall Study||225||
59691402|NCT01090453|75810937|FG001|COMPLETED|Overall Study||228||
59691403|NCT01090453|75810936|FG000|NOT COMPLETED|Overall Study||13||
59691404|NCT01090453|75810937|FG001|NOT COMPLETED|Overall Study||14||
59691405|NCT01171612|75810943|FG000|STARTED|Overall Study||483||
59691406|NCT01171612|75810943|FG000|COMPLETED|Overall Study||432||
59691407|NCT01171612|75810943|FG000|NOT COMPLETED|Overall Study||51||
59691408|NCT01171534|75810952|FG000|STARTED|Overall Study|retrospective arm never performed on study|0||
59691409|NCT01171534|75810953|FG001|STARTED|Overall Study||7||
59691410|NCT01171534|75810952|FG000|COMPLETED|Overall Study||0||
59691411|NCT01171534|75810953|FG001|COMPLETED|Overall Study||4||
59691412|NCT01171534|75810952|FG000|NOT COMPLETED|Overall Study||0||
59691413|NCT01171534|75810953|FG001|NOT COMPLETED|Overall Study||3||
59691414|NCT01170598|75810959|FG000|STARTED|Overall Study||35||
59691415|NCT01170598|75810959|FG000|COMPLETED|Overall Study||29||
59691416|NCT01170598|75810959|FG000|NOT COMPLETED|Overall Study||6||
59691417|NCT01170364|75810965|FG000|STARTED|Overall Study||8||
59691418|NCT01170364|75810966|FG001|STARTED|Overall Study||6||
59691419|NCT01170364|75810965|FG000|COMPLETED|Overall Study||4||
59691420|NCT01170364|75810966|FG001|COMPLETED|Overall Study|One participant was unable to begin the second testing period due to scheduling conflicts.|5||
59691421|NCT01170364|75810965|FG000|NOT COMPLETED|Overall Study||4||
59691422|NCT01170364|75810966|FG001|NOT COMPLETED|Overall Study||1||
59691423|NCT01076179|75810972|FG000|STARTED|Overall Study||502||
59691424|NCT01076179|75810972|FG000|COMPLETED|Overall Study||501||
59691425|NCT01076179|75810972|FG000|NOT COMPLETED|Overall Study||1||
59691426|NCT01170208|75810980|FG000|STARTED|Overall Study||20||
59691427|NCT01170208|75810981|FG001|STARTED|Overall Study||20||
59691428|NCT01170208|75810982|FG002|STARTED|Overall Study||6||
59691429|NCT01170208|75810980|FG000|COMPLETED|Overall Study||14||
59691430|NCT01170208|75810981|FG001|COMPLETED|Overall Study||20||
59691431|NCT01170208|75810982|FG002|COMPLETED|Overall Study||4||
59691432|NCT01170208|75810980|FG000|NOT COMPLETED|Overall Study||6||
59691433|NCT01170208|75810981|FG001|NOT COMPLETED|Overall Study||0||
59691434|NCT01170208|75810982|FG002|NOT COMPLETED|Overall Study||2||
59691435|NCT01313624|75810995|FG000|STARTED|Double-Blind Phase||134||
59691436|NCT01313624|75810996|FG001|STARTED|Double-Blind Phase||132||
59691437|NCT01313624|75810995|FG000|COMPLETED|Double-Blind Phase||96||
59691438|NCT01313624|75810996|FG001|COMPLETED|Double-Blind Phase||122||
59691439|NCT01313624|75810995|FG000|NOT COMPLETED|Double-Blind Phase||38||
59691440|NCT01313624|75810996|FG001|NOT COMPLETED|Double-Blind Phase||10||
59691441|NCT01313624|75810995|FG000|STARTED|Open-Label Phase||96||
59691442|NCT01313624|75810996|FG001|STARTED|Open-Label Phase||122||
59691443|NCT01313624|75810995|FG000|COMPLETED|Open-Label Phase||92||
59691444|NCT01313624|75810996|FG001|COMPLETED|Open-Label Phase||109||
59691445|NCT01313624|75810995|FG000|NOT COMPLETED|Open-Label Phase||4||
59691446|NCT01313624|75810996|FG001|NOT COMPLETED|Open-Label Phase||13||
59691447|NCT01169350|75811004|FG000|STARTED|Overall Study||8||
59691448|NCT01169350|75811004|FG000|COMPLETED|Overall Study||3||
59691449|NCT01169350|75811004|FG000|NOT COMPLETED|Overall Study||5||
59691450|NCT01169038|75811008|FG000|STARTED|Overall Study||15||
59691451|NCT01169038|75811008|FG000|COMPLETED|Overall Study||8||
59691452|NCT01169038|75811008|FG000|NOT COMPLETED|Overall Study||7||
59691453|NCT01167634|75811016|FG000|STARTED|Overall Study||33||
59691454|NCT01167634|75811017|FG001|STARTED|Overall Study||33||
59691455|NCT01167634|75811018|FG002|STARTED|Overall Study||33||
59691456|NCT01167634|75811019|FG003|STARTED|Overall Study||33||
59691457|NCT01167634|75811016|FG000|COMPLETED|Overall Study||31||
59691458|NCT01167634|75811017|FG001|COMPLETED|Overall Study||29||
59691459|NCT01167634|75811018|FG002|COMPLETED|Overall Study||30||
59691460|NCT01167634|75811019|FG003|COMPLETED|Overall Study||29||
59691461|NCT01167634|75811016|FG000|NOT COMPLETED|Overall Study||2||
59691462|NCT01167634|75811017|FG001|NOT COMPLETED|Overall Study||4||
59691463|NCT01167634|75811018|FG002|NOT COMPLETED|Overall Study||3||
59691464|NCT01167634|75811019|FG003|NOT COMPLETED|Overall Study||4||
59691465|NCT01166386|75811031|FG000|STARTED|Overall Study||82||
59691466|NCT01166386|75811032|FG001|STARTED|Overall Study||83||
59691467|NCT01166386|75811031|FG000|COMPLETED|Overall Study||79||
59691468|NCT01166386|75811032|FG001|COMPLETED|Overall Study||78||
59691469|NCT01166386|75811031|FG000|NOT COMPLETED|Overall Study||3||
59691470|NCT01166386|75811032|FG001|NOT COMPLETED|Overall Study||5||
59691471|NCT01114828|75811040|FG000|STARTED|Overall Study||19||
59691472|NCT01114828|75811041|FG001|STARTED|Overall Study||21||
59691473|NCT01114828|75811040|FG000|COMPLETED|Overall Study||16||
59691474|NCT01114828|75811041|FG001|COMPLETED|Overall Study||17||
59691475|NCT01114828|75811040|FG000|NOT COMPLETED|Overall Study||3||
59691476|NCT01114828|75811041|FG001|NOT COMPLETED|Overall Study||4||
59691477|NCT01313312|75811047|FG000|STARTED|Overall Study||258||
59691478|NCT01313312|75811047|FG000|Cycle 1|Overall Study||254||
59691479|NCT01313312|75811047|FG000|Cycle 2|Overall Study||229||
59691480|NCT01313312|75811047|FG000|Cycle 3|Overall Study||175||
59691481|NCT01313312|75811047|FG000|Cycle 4|Overall Study||81||
59691482|NCT01313312|75811047|FG000|Cycle 5|Overall Study||11||
59691483|NCT01313312|75811047|FG000|COMPLETED|Overall Study||222||
59691484|NCT01313312|75811047|FG000|NOT COMPLETED|Overall Study||36||
59691485|NCT01114672|75811053|FG000|STARTED|Overall Study||25||
59691486|NCT01114672|75811054|FG001|STARTED|Overall Study||25||
59691487|NCT01114672|75811053|FG000|COMPLETED|Overall Study||21||
59691488|NCT01114672|75811054|FG001|COMPLETED|Overall Study||23||
59691489|NCT01114672|75811053|FG000|NOT COMPLETED|Overall Study||4||
59691490|NCT01114672|75811054|FG001|NOT COMPLETED|Overall Study||2||
59691491|NCT01114516|75811062|FG000|STARTED|Overall Study||26||
59691492|NCT01114516|75811063|FG001|STARTED|Overall Study||27||
59691493|NCT01114516|75811062|FG000|COMPLETED|Overall Study||24||
59691494|NCT01114516|75811063|FG001|COMPLETED|Overall Study||26||
59691495|NCT01114516|75811062|FG000|NOT COMPLETED|Overall Study||2||
59691496|NCT01114516|75811063|FG001|NOT COMPLETED|Overall Study||1||
59691497|NCT01114438|75811069|FG000|STARTED|Overall Study||45||
59691498|NCT01114438|75811069|FG000|COMPLETED|Overall Study||31||
59691499|NCT01114438|75811069|FG000|NOT COMPLETED|Overall Study||14||
59691500|NCT01313078|75811078|FG000|STARTED|Overall Study||4||
59691501|NCT01313078|75811078|FG000|COMPLETED|Overall Study||1||
59691502|NCT01313078|75811078|FG000|NOT COMPLETED|Overall Study||3||
59691503|NCT01114360|75811082|FG000|STARTED|Intervention 1 (4 Weeks)||18||
59691504|NCT01114360|75811083|FG001|STARTED|Intervention 1 (4 Weeks)||19||
59691505|NCT01114360|75811082|FG000|COMPLETED|Intervention 1 (4 Weeks)||18||
59691506|NCT01114360|75811083|FG001|COMPLETED|Intervention 1 (4 Weeks)||18||
59691507|NCT01114360|75811082|FG000|NOT COMPLETED|Intervention 1 (4 Weeks)||0||
59691508|NCT01114360|75811083|FG001|NOT COMPLETED|Intervention 1 (4 Weeks)||1||
59691509|NCT01114360|75811082|FG000|STARTED|Intervention 2 (4 Weeks)||18||
59691510|NCT01114360|75811083|FG001|STARTED|Intervention 2 (4 Weeks)||18||
59691511|NCT01114360|75811082|FG000|COMPLETED|Intervention 2 (4 Weeks)||18||
59691512|NCT01114360|75811083|FG001|COMPLETED|Intervention 2 (4 Weeks)||18||
59691513|NCT01114360|75811082|FG000|NOT COMPLETED|Intervention 2 (4 Weeks)||0||
59691514|NCT01114360|75811083|FG001|NOT COMPLETED|Intervention 2 (4 Weeks)||0||
59691515|NCT01310036|75811103|FG000|STARTED|Overall Study||208||
59691516|NCT01310036|75811103|FG000|COMPLETED|Overall Study||6||
59691517|NCT01310036|75811103|FG000|NOT COMPLETED|Overall Study||202||
59691518|NCT01309100|75811107|FG000|STARTED|Overall Study||144||
59691519|NCT01309100|75811107|FG000|COMPLETED|Overall Study||142||
59691520|NCT01309100|75811107|FG000|NOT COMPLETED|Overall Study||2||
59691521|NCT01308788|75811116|FG000|STARTED|6-month Treatment||14||
59691522|NCT01308788|75811117|FG001|STARTED|6-month Treatment||21||
60079383|NCT04206332|76194702|FG002|Completed Controlled Human Malaria Infection (CHMI)|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0||
60079384|NCT04206332|76194703|FG003|Completed Controlled Human Malaria Infection (CHMI)|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0||
60079385|NCT04206332|76194704|FG004|Completed Controlled Human Malaria Infection (CHMI)|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0||
60079386|NCT04206332|76194705|FG005|Completed Controlled Human Malaria Infection (CHMI)|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0||
60079387|NCT04206332|76194706|FG006|Completed Controlled Human Malaria Infection (CHMI)|Part A||0||
60079388|NCT04206332|76194707|FG007|Completed Controlled Human Malaria Infection (CHMI)|Part A||0||
60079389|NCT04206332|76194708|FG008|Completed Controlled Human Malaria Infection (CHMI)|Part A||0||
60079390|NCT04206332|76194709|FG009|Completed Controlled Human Malaria Infection (CHMI)|Part A||0||
60079391|NCT04206332|76194710|FG010|Completed Controlled Human Malaria Infection (CHMI)|Part A||0||
59691523|NCT01308788|75811116|FG000|COMPLETED|6-month Treatment||14||
59691524|NCT01308788|75811117|FG001|COMPLETED|6-month Treatment||21||
59691525|NCT01308788|75811116|FG000|NOT COMPLETED|6-month Treatment||0||
59691526|NCT01308788|75811117|FG001|NOT COMPLETED|6-month Treatment||0||
59691527|NCT01308788|75811116|FG000|STARTED|2-year Treatment||14||
59691528|NCT01308788|75811117|FG001|STARTED|2-year Treatment||21||
59691529|NCT01308788|75811116|FG000|COMPLETED|2-year Treatment||10||
59691530|NCT01308788|75811117|FG001|COMPLETED|2-year Treatment||10||
59691531|NCT01308788|75811116|FG000|NOT COMPLETED|2-year Treatment||4||
59691532|NCT01308788|75811117|FG001|NOT COMPLETED|2-year Treatment||11||
59691533|NCT01075321|75811123|FG000|STARTED|Overall Study||7||
59691534|NCT01075321|75811124|FG001|STARTED|Overall Study||9||
59691535|NCT01075321|75811125|FG002|STARTED|Overall Study||9||
59691536|NCT01075321|75811126|FG003|STARTED|Overall Study||33||
59691537|NCT01075321|75811123|FG000|COMPLETED|Overall Study||6||
59691538|NCT01075321|75811124|FG001|COMPLETED|Overall Study||9||
59691539|NCT01075321|75811125|FG002|COMPLETED|Overall Study||7||
59691540|NCT01075321|75811126|FG003|COMPLETED|Overall Study||31||
59691541|NCT01075321|75811123|FG000|NOT COMPLETED|Overall Study||1||
59691542|NCT01075321|75811124|FG001|NOT COMPLETED|Overall Study||0||
59691543|NCT01075321|75811125|FG002|NOT COMPLETED|Overall Study||2||
59691544|NCT01075321|75811126|FG003|NOT COMPLETED|Overall Study||2||
59691545|NCT01114204|75811140|FG000|STARTED|Overall Study||406||
59691546|NCT01114204|75811141|FG001|STARTED|Overall Study||199||
59691547|NCT01114204|75811140|FG000|Received at Least 1 Dose of Study Drug|Overall Study||406||
59691548|NCT01114204|75811141|FG001|Received at Least 1 Dose of Study Drug|Overall Study||199||
59691549|NCT01114204|75811140|FG000|COMPLETED|Overall Study||385|Completed is defined as had study drug and Week 5 visit.|
59691550|NCT01114204|75811141|FG001|COMPLETED|Overall Study||191|Completed is defined as had study drug and Week 5 visit.|
59691551|NCT01114204|75811140|FG000|NOT COMPLETED|Overall Study||21||
59691552|NCT01114204|75811141|FG001|NOT COMPLETED|Overall Study||8||
59691553|NCT01075243|75811150|FG000|STARTED|Overall Study||163||
59691554|NCT01075243|75811151|FG001|STARTED|Overall Study||158||
59691555|NCT01075243|75811152|FG002|STARTED|Overall Study||80||
59691556|NCT01075243|75811150|FG000|COMPLETED|Overall Study||157||
59691557|NCT01075243|75811151|FG001|COMPLETED|Overall Study||155||
59691558|NCT01075243|75811152|FG002|COMPLETED|Overall Study||80||
59691559|NCT01075243|75811150|FG000|NOT COMPLETED|Overall Study||6||
59691560|NCT01075243|75811151|FG001|NOT COMPLETED|Overall Study||3||
59691561|NCT01075243|75811152|FG002|NOT COMPLETED|Overall Study||0||
59691562|NCT01308476|75811164|FG000|STARTED|Overall Study|Entered and treated.|48||
59691563|NCT01308476|75811165|FG001|STARTED|Overall Study|Entered and treated.|47||
59691564|NCT01308476|75811164|FG000|COMPLETED|Overall Study||45||
59691565|NCT01308476|75811165|FG001|COMPLETED|Overall Study||45||
59691566|NCT01308476|75811164|FG000|NOT COMPLETED|Overall Study||3||
59691567|NCT01308476|75811165|FG001|NOT COMPLETED|Overall Study||2||
59691568|NCT01078441|75811171|FG000|STARTED|Overall Study||2||
59691569|NCT01078441|75811171|FG000|COMPLETED|Overall Study||1||
59691570|NCT01078441|75811171|FG000|NOT COMPLETED|Overall Study||1||
59691571|NCT01308008|75811177|FG000|STARTED|4 Weeks||71||
59691572|NCT01308008|75811178|FG001|STARTED|4 Weeks||73||
59691573|NCT01308008|75811177|FG000|COMPLETED|4 Weeks||62||
59691574|NCT01308008|75811178|FG001|COMPLETED|4 Weeks||71||
59691575|NCT01308008|75811177|FG000|NOT COMPLETED|4 Weeks||9||
59691576|NCT01308008|75811178|FG001|NOT COMPLETED|4 Weeks||2||
59691577|NCT01308008|75811177|FG000|STARTED|6 Months||62||
59691578|NCT01308008|75811178|FG001|STARTED|6 Months||71||
59691579|NCT01308008|75811177|FG000|COMPLETED|6 Months||54||
59691580|NCT01308008|75811178|FG001|COMPLETED|6 Months||62||
59691581|NCT01308008|75811177|FG000|NOT COMPLETED|6 Months||8||
59691582|NCT01308008|75811178|FG001|NOT COMPLETED|6 Months||9||
59691583|NCT01308008|75811177|FG000|STARTED|12 Months||54||
59691584|NCT01308008|75811178|FG001|STARTED|12 Months||62||
59691585|NCT01308008|75811177|FG000|COMPLETED|12 Months||46||
59691586|NCT01308008|75811178|FG001|COMPLETED|12 Months||58||
59691587|NCT01308008|75811177|FG000|NOT COMPLETED|12 Months||8||
59691588|NCT01308008|75811178|FG001|NOT COMPLETED|12 Months||4||
59691589|NCT01113892|75811186|FG000|STARTED|Overall Study||101||
59691590|NCT01113892|75811187|FG001|STARTED|Overall Study||106||
59691591|NCT01113892|75811186|FG000|COMPLETED|Overall Study||87||
59691592|NCT01113892|75811187|FG001|COMPLETED|Overall Study||90||
59691593|NCT01113892|75811186|FG000|NOT COMPLETED|Overall Study||14||
59691594|NCT01113892|75811187|FG001|NOT COMPLETED|Overall Study||16||
59691595|NCT01090063|75811193|FG000|STARTED|Screen||28||
59691596|NCT01090063|75811193|FG000|COMPLETED|Screen||24||
59691597|NCT01090063|75811193|FG000|NOT COMPLETED|Screen||4||
59691598|NCT01090063|75811193|FG000|STARTED|Treatment||24||
59691599|NCT01090063|75811193|FG000|COMPLETED|Treatment||20||
59691600|NCT01090063|75811193|FG000|NOT COMPLETED|Treatment||4||
59691601|NCT01113580|75811209|FG000|STARTED|Overall Study||60||
59691602|NCT01113580|75811210|FG001|STARTED|Overall Study||60||
59691603|NCT01113580|75811209|FG000|COMPLETED|Overall Study||59||
59691604|NCT01113580|75811210|FG001|COMPLETED|Overall Study||60||
59691605|NCT01113580|75811209|FG000|NOT COMPLETED|Overall Study||1||
59691606|NCT01113580|75811210|FG001|NOT COMPLETED|Overall Study||0||
59691607|NCT01306214|75811219|FG000|STARTED|Overall Study||189||
59691608|NCT01306214|75811220|FG001|STARTED|Overall Study||187||
59691609|NCT01306214|75811221|FG002|STARTED|Overall Study||190||
59691610|NCT01306214|75811219|FG000|COMPLETED|Overall Study||161||
59691611|NCT01306214|75811220|FG001|COMPLETED|Overall Study||159||
59691612|NCT01306214|75811221|FG002|COMPLETED|Overall Study||168||
59691613|NCT01306214|75811219|FG000|NOT COMPLETED|Overall Study||28||
59691614|NCT01306214|75811220|FG001|NOT COMPLETED|Overall Study||28||
59691615|NCT01306214|75811221|FG002|NOT COMPLETED|Overall Study||22||
59691616|NCT01077739|75811231|FG000|STARTED|Overall Study||25||
59691617|NCT01077739|75811232|FG001|STARTED|Overall Study||50||
59691618|NCT01077739|75811231|FG000|COMPLETED|Overall Study||20||
59691619|NCT01077739|75811232|FG001|COMPLETED|Overall Study||40||
59691620|NCT01077739|75811231|FG000|NOT COMPLETED|Overall Study||5||
59691621|NCT01077739|75811232|FG001|NOT COMPLETED|Overall Study||10||
59691622|NCT01306058|75811238|FG000|STARTED|Overall Study||27||
59691623|NCT01306058|75811238|FG000|COMPLETED|Overall Study||25||
59691624|NCT01306058|75811238|FG000|NOT COMPLETED|Overall Study||2||
59691625|NCT01305200|75811245|FG000|STARTED|Overall Study||111||
59691626|NCT01305200|75811246|FG001|STARTED|Overall Study||112||
59691627|NCT01305200|75811247|FG002|STARTED|Overall Study||3||
59691628|NCT01305200|75811245|FG000|COMPLETED|Overall Study||82||
59691629|NCT01305200|75811246|FG001|COMPLETED|Overall Study||81||
59691630|NCT01305200|75811247|FG002|COMPLETED|Overall Study||0||
59691631|NCT01305200|75811245|FG000|NOT COMPLETED|Overall Study||29||
59691632|NCT01305200|75811246|FG001|NOT COMPLETED|Overall Study||31||
59691633|NCT01305200|75811247|FG002|NOT COMPLETED|Overall Study||3||
59691634|NCT01077271|75811257|FG000|STARTED|Overall Study||124||
59691635|NCT01077271|75811257|FG000|Participants Treated With Palivizumab|Overall Study||120||
59691636|NCT01077271|75811257|FG000|Number of Participants Analyzed|Overall Study||120||
59691637|NCT01077271|75811257|FG000|COMPLETED|Overall Study||102||
59691638|NCT01077271|75811257|FG000|NOT COMPLETED|Overall Study||22||
59691639|NCT01305044|75811271|FG000|STARTED|Overall Study||32||
59691640|NCT01305044|75811272|FG001|STARTED|Overall Study||31||
59691641|NCT01305044|75811271|FG000|COMPLETED|Overall Study||29||
59691642|NCT01305044|75811272|FG001|COMPLETED|Overall Study||25||
59691643|NCT01305044|75811271|FG000|NOT COMPLETED|Overall Study||3||
59691644|NCT01305044|75811272|FG001|NOT COMPLETED|Overall Study||6||
59691645|NCT01304498|75811280|FG000|STARTED|Overall Study||300||
59691646|NCT01304498|75811281|FG001|STARTED|Overall Study||300||
59691647|NCT01304498|75811280|FG000|Received ≥1 Dose|Overall Study||300||
59691648|NCT01304498|75811281|FG001|Received ≥1 Dose|Overall Study||300||
59691649|NCT01304498|75811280|FG000|COMPLETED|Overall Study||294||
59691650|NCT01304498|75811281|FG001|COMPLETED|Overall Study||295||
59691651|NCT01304498|75811280|FG000|NOT COMPLETED|Overall Study||6||
59691652|NCT01304498|75811281|FG001|NOT COMPLETED|Overall Study||5||
59691653|NCT01077193|75811287|FG000|STARTED|Overall Study||44||
59691654|NCT01077193|75811287|FG000|COMPLETED|Overall Study||0||
59691655|NCT01077193|75811287|FG000|NOT COMPLETED|Overall Study||44||
59691656|NCT01074931|75811291|FG000|STARTED|Overall Study||98||
59691657|NCT01074931|75811291|FG000|COMPLETED|Overall Study||92||
59691658|NCT01074931|75811291|FG000|NOT COMPLETED|Overall Study||6||
59691659|NCT01303172|75811301|FG000|STARTED|Overall Study||75||
59691660|NCT01303172|75811302|FG001|STARTED|Overall Study||35||
59691661|NCT01303172|75811301|FG000|COMPLETED|Overall Study||12||
59691662|NCT01303172|75811302|FG001|COMPLETED|Overall Study||1||
59691663|NCT01303172|75811301|FG000|NOT COMPLETED|Overall Study||63||
59691664|NCT01303172|75811302|FG001|NOT COMPLETED|Overall Study||34||
59691665|NCT01302938|75811311|FG000|STARTED|Overall Study||12||
59691666|NCT01302938|75811312|FG001|STARTED|Overall Study||6||
59691667|NCT01302938|75811311|FG000|COMPLETED|Overall Study||10||
59691668|NCT01302938|75811312|FG001|COMPLETED|Overall Study||6||
59691669|NCT01302938|75811311|FG000|NOT COMPLETED|Overall Study||2||
59691670|NCT01302938|75811312|FG001|NOT COMPLETED|Overall Study||0||
59691671|NCT01302548|75811321|FG000|STARTED|Overall Study||14||
59691672|NCT01302548|75811322|FG001|STARTED|Overall Study||19||
59547569|NCT02465073|75646388|FG001|STARTED|Overall Study||16||
59547570|NCT02465073|75646389|FG002|STARTED|Overall Study||16||
59691673|NCT01302548|75811321|FG000|COMPLETED|Overall Study||12||
59691674|NCT01302548|75811322|FG001|COMPLETED|Overall Study||18||
59691675|NCT01302548|75811321|FG000|NOT COMPLETED|Overall Study||2||
59691676|NCT01302548|75811322|FG001|NOT COMPLETED|Overall Study||1||
59691677|NCT01076959|75811328|FG000|STARTED|Overall Study||7740||
59691678|NCT01076959|75811328|FG000|COMPLETED|Overall Study||5490||
59691679|NCT01076959|75811328|FG000|NOT COMPLETED|Overall Study||2250||
59691680|NCT01302392|75811347|FG000|STARTED|Overall Study||158||
59691681|NCT01302392|75811348|FG001|STARTED|Overall Study||157||
59691682|NCT01302392|75811347|FG000|Treated|Overall Study||153||
59691683|NCT01302392|75811348|FG001|Treated|Overall Study||157||
59691684|NCT01302392|75811347|FG000|COMPLETED|Overall Study||151||
59691685|NCT01302392|75811348|FG001|COMPLETED|Overall Study||156||
59691686|NCT01302392|75811347|FG000|NOT COMPLETED|Overall Study||7||
59691687|NCT01302392|75811348|FG001|NOT COMPLETED|Overall Study||1||
59691688|NCT01076647|75811356|FG000|STARTED|Overall Study||233||
59691689|NCT01076647|75811357|FG001|STARTED|Overall Study||234||
59691690|NCT01076647|75811356|FG000|COMPLETED|Overall Study||208||
59691691|NCT01076647|75811357|FG001|COMPLETED|Overall Study||209||
59547571|NCT02465073|75646387|FG000|COMPLETED|Overall Study||15||
59691692|NCT01076647|75811356|FG000|NOT COMPLETED|Overall Study||25||
59691693|NCT01076647|75811357|FG001|NOT COMPLETED|Overall Study||25||
59691694|NCT01074307|75811365|FG000|STARTED|Overall Study||66||
59691695|NCT01074307|75811366|FG001|STARTED|Overall Study||114||
59691696|NCT01074307|75811365|FG000|COMPLETED|Overall Study||44||
59691697|NCT01074307|75811366|FG001|COMPLETED|Overall Study||102||
59691698|NCT01074307|75811365|FG000|NOT COMPLETED|Overall Study||22||
59691699|NCT01074307|75811366|FG001|NOT COMPLETED|Overall Study||12||
59691700|NCT01076335|75811372|FG000|STARTED|Overall Study||40||
59691701|NCT01076335|75811372|FG000|COMPLETED|Overall Study||36||
59691702|NCT01076335|75811372|FG000|NOT COMPLETED|Overall Study||4||
59691703|NCT01309737|75811379|FG000|STARTED|Week 0 to 16||383||
59691704|NCT01309737|75811380|FG001|STARTED|Week 0 to 16||381||
59691705|NCT01309737|75811381|FG002|STARTED|Week 0 to 16||196||
59691706|NCT01309737|75811382|FG003|STARTED|Week 0 to 16||0||
59691707|NCT01309737|75811383|FG004|STARTED|Week 0 to 16||0||
59691708|NCT01309737|75811379|FG000|Treated|Week 0 to 16||382||
59691709|NCT01309737|75811380|FG001|Treated|Week 0 to 16||381||
59691710|NCT01309737|75811381|FG002|Treated|Week 0 to 16||196||
59691711|NCT01309737|75811382|FG003|Treated|Week 0 to 16||0||
59691712|NCT01309737|75811383|FG004|Treated|Week 0 to 16||0||
59691713|NCT01309737|75811379|FG000|COMPLETED|Week 0 to 16||331||
59691714|NCT01309737|75811380|FG001|COMPLETED|Week 0 to 16||341||
59691715|NCT01309737|75811381|FG002|COMPLETED|Week 0 to 16||152||
59691716|NCT01309737|75811382|FG003|COMPLETED|Week 0 to 16||0||
59691717|NCT01309737|75811383|FG004|COMPLETED|Week 0 to 16||0||
59691718|NCT01309737|75811379|FG000|NOT COMPLETED|Week 0 to 16||52||
59691719|NCT01309737|75811380|FG001|NOT COMPLETED|Week 0 to 16||40||
59691720|NCT01309737|75811381|FG002|NOT COMPLETED|Week 0 to 16||44||
59691721|NCT01309737|75811382|FG003|NOT COMPLETED|Week 0 to 16||0||
59691722|NCT01309737|75811383|FG004|NOT COMPLETED|Week 0 to 16||0||
59691723|NCT01309737|75811379|FG000|STARTED|Week 16 to 52||331||
59691724|NCT01309737|75811380|FG001|STARTED|Week 16 to 52||341||
59691725|NCT01309737|75811381|FG002|STARTED|Week 16 to 52||0||
59691726|NCT01309737|75811382|FG003|STARTED|Week 16 to 52||75||
59691727|NCT01309737|75811383|FG004|STARTED|Week 16 to 52||77||
59691728|NCT01309737|75811379|FG000|COMPLETED|Week 16 to 52||198||
59691729|NCT01309737|75811380|FG001|COMPLETED|Week 16 to 52||238||
59691730|NCT01309737|75811381|FG002|COMPLETED|Week 16 to 52||0||
59691731|NCT01309737|75811382|FG003|COMPLETED|Week 16 to 52||41||
59691732|NCT01309737|75811383|FG004|COMPLETED|Week 16 to 52||44||
59691733|NCT01309737|75811379|FG000|NOT COMPLETED|Week 16 to 52||133||
59691734|NCT01309737|75811380|FG001|NOT COMPLETED|Week 16 to 52||103||
59691735|NCT01309737|75811381|FG002|NOT COMPLETED|Week 16 to 52||0||
59691736|NCT01309737|75811382|FG003|NOT COMPLETED|Week 16 to 52||34||
59691737|NCT01309737|75811383|FG004|NOT COMPLETED|Week 16 to 52||33||
59691738|NCT01074229|75811409|FG000|STARTED|Overall Study||25||
59691739|NCT01074229|75811410|FG001|STARTED|Overall Study||25||
59691740|NCT01074229|75811411|FG002|STARTED|Overall Study||25||
59691741|NCT01074229|75811409|FG000|COMPLETED|Overall Study||23||
59691742|NCT01074229|75811410|FG001|COMPLETED|Overall Study||22||
59691743|NCT01074229|75811411|FG002|COMPLETED|Overall Study||21||
59691744|NCT01074229|75811409|FG000|NOT COMPLETED|Overall Study||2||
59691745|NCT01074229|75811410|FG001|NOT COMPLETED|Overall Study||3||
59691746|NCT01074229|75811411|FG002|NOT COMPLETED|Overall Study||4||
59691747|NCT01106014|75811423|FG000|STARTED|Overall Study||574||
59691748|NCT01106014|75811424|FG001|STARTED|Overall Study||582||
59691749|NCT01106014|75811423|FG000|COMPLETED|Overall Study||289||
59691750|NCT01106014|75811424|FG001|COMPLETED|Overall Study||252||
59691751|NCT01106014|75811423|FG000|NOT COMPLETED|Overall Study||285||
59691752|NCT01106014|75811424|FG001|NOT COMPLETED|Overall Study||330||
59691753|NCT01073605|75811433|FG000|STARTED|Overall Study||68||
59691754|NCT01073605|75811434|FG001|STARTED|Overall Study||71||
59691755|NCT01073605|75811435|FG002|STARTED|Overall Study||69||
59691756|NCT01073605|75811433|FG000|Received Treatment|Overall Study||68||
59691757|NCT01073605|75811434|FG001|Received Treatment|Overall Study||70||
59691758|NCT01073605|75811435|FG002|Received Treatment|Overall Study||68||
59691759|NCT01073605|75811433|FG000|COMPLETED|Overall Study|Corresponds to follow-up until final height|6||
59691760|NCT01073605|75811434|FG001|COMPLETED|Overall Study|Corresponds to follow-up until final height|4||
59691761|NCT01073605|75811435|FG002|COMPLETED|Overall Study|Corresponds to follow-up until final height|8||
59691762|NCT01073605|75811433|FG000|NOT COMPLETED|Overall Study||62||
59691763|NCT01073605|75811434|FG001|NOT COMPLETED|Overall Study||67||
59691764|NCT01073605|75811435|FG002|NOT COMPLETED|Overall Study||61||
59691765|NCT01073293|75811445|FG000|STARTED|Overall Study||526||
59691766|NCT01073293|75811446|FG001|STARTED|Overall Study||528||
59691767|NCT01073293|75811445|FG000|COMPLETED|Overall Study||521||
59691768|NCT01073293|75811446|FG001|COMPLETED|Overall Study||517||
59691769|NCT01073293|75811445|FG000|NOT COMPLETED|Overall Study||5||
59691770|NCT01073293|75811446|FG001|NOT COMPLETED|Overall Study||11||
59691771|NCT01105936|75811452|FG000|STARTED|Period 1||8||
59691772|NCT01105936|75811453|FG001|STARTED|Period 1||8||
59691773|NCT01105936|75811454|FG002|STARTED|Period 1||7||
59691774|NCT01105936|75811455|FG003|STARTED|Period 1||8||
59691775|NCT01105936|75811452|FG000|COMPLETED|Period 1||8||
59691776|NCT01105936|75811453|FG001|COMPLETED|Period 1||8||
59691777|NCT01105936|75811454|FG002|COMPLETED|Period 1||7||
59691778|NCT01105936|75811455|FG003|COMPLETED|Period 1||7||
59691779|NCT01105936|75811452|FG000|NOT COMPLETED|Period 1||0||
59691780|NCT01105936|75811453|FG001|NOT COMPLETED|Period 1||0||
59691781|NCT01105936|75811454|FG002|NOT COMPLETED|Period 1||0||
59691782|NCT01105936|75811455|FG003|NOT COMPLETED|Period 1||1||
59691783|NCT01105936|75811452|FG000|STARTED|Wash-out Period 1||8||
59691784|NCT01105936|75811453|FG001|STARTED|Wash-out Period 1||8||
59691785|NCT01105936|75811454|FG002|STARTED|Wash-out Period 1||7||
59691786|NCT01105936|75811455|FG003|STARTED|Wash-out Period 1||7||
59691787|NCT01105936|75811452|FG000|COMPLETED|Wash-out Period 1||8||
59691788|NCT01105936|75811453|FG001|COMPLETED|Wash-out Period 1||8||
59691789|NCT01105936|75811454|FG002|COMPLETED|Wash-out Period 1||7||
59691790|NCT01105936|75811455|FG003|COMPLETED|Wash-out Period 1||7||
59691791|NCT01105936|75811452|FG000|NOT COMPLETED|Wash-out Period 1||0||
59691792|NCT01105936|75811453|FG001|NOT COMPLETED|Wash-out Period 1||0||
59691793|NCT01105936|75811454|FG002|NOT COMPLETED|Wash-out Period 1||0||
59691794|NCT01105936|75811455|FG003|NOT COMPLETED|Wash-out Period 1||0||
59691795|NCT01105936|75811452|FG000|STARTED|Period 2||8||
59691796|NCT01105936|75811453|FG001|STARTED|Period 2||8||
59691797|NCT01105936|75811454|FG002|STARTED|Period 2||7||
59691798|NCT01105936|75811455|FG003|STARTED|Period 2||7||
59691799|NCT01105936|75811452|FG000|COMPLETED|Period 2||7||
59691800|NCT01105936|75811453|FG001|COMPLETED|Period 2||8||
59691801|NCT01105936|75811454|FG002|COMPLETED|Period 2||7||
59691802|NCT01105936|75811455|FG003|COMPLETED|Period 2||7||
59691803|NCT01105936|75811452|FG000|NOT COMPLETED|Period 2||1||
59691804|NCT01105936|75811453|FG001|NOT COMPLETED|Period 2||0||
59691805|NCT01105936|75811454|FG002|NOT COMPLETED|Period 2||0||
59691806|NCT01105936|75811455|FG003|NOT COMPLETED|Period 2||0||
59691807|NCT01105936|75811452|FG000|STARTED|Wash-out Period 2||7||
59691808|NCT01105936|75811453|FG001|STARTED|Wash-out Period 2||8||
59691809|NCT01105936|75811454|FG002|STARTED|Wash-out Period 2||7||
59691810|NCT01105936|75811455|FG003|STARTED|Wash-out Period 2||7||
59691811|NCT01105936|75811452|FG000|COMPLETED|Wash-out Period 2||7||
59691812|NCT01105936|75811453|FG001|COMPLETED|Wash-out Period 2||8||
59691813|NCT01105936|75811454|FG002|COMPLETED|Wash-out Period 2||7||
59691814|NCT01105936|75811455|FG003|COMPLETED|Wash-out Period 2||7||
59691815|NCT01105936|75811452|FG000|NOT COMPLETED|Wash-out Period 2||0||
59691816|NCT01105936|75811453|FG001|NOT COMPLETED|Wash-out Period 2||0||
59691817|NCT01105936|75811454|FG002|NOT COMPLETED|Wash-out Period 2||0||
59691818|NCT01105936|75811455|FG003|NOT COMPLETED|Wash-out Period 2||0||
59691819|NCT01105936|75811452|FG000|STARTED|Period 3||7||
59691820|NCT01105936|75811453|FG001|STARTED|Period 3||8||
59691821|NCT01105936|75811454|FG002|STARTED|Period 3||7||
59691822|NCT01105936|75811455|FG003|STARTED|Period 3||7||
59691823|NCT01105936|75811452|FG000|COMPLETED|Period 3||7||
59691824|NCT01105936|75811453|FG001|COMPLETED|Period 3||6||
59691825|NCT01105936|75811454|FG002|COMPLETED|Period 3||7||
59691826|NCT01105936|75811455|FG003|COMPLETED|Period 3||7||
59691827|NCT01105936|75811452|FG000|NOT COMPLETED|Period 3||0||
59691828|NCT01105936|75811453|FG001|NOT COMPLETED|Period 3||2||
59691829|NCT01105936|75811454|FG002|NOT COMPLETED|Period 3||0||
59691830|NCT01105936|75811455|FG003|NOT COMPLETED|Period 3||0||
59691831|NCT01309659|75811466|FG000|STARTED|Overall Study||9||
59691832|NCT01309659|75811467|FG001|STARTED|Overall Study||10||
59691833|NCT01309659|75811466|FG000|COMPLETED|Overall Study||9||
59691834|NCT01309659|75811467|FG001|COMPLETED|Overall Study||9||
59691835|NCT01309659|75811466|FG000|NOT COMPLETED|Overall Study||0||
59691836|NCT01309659|75811467|FG001|NOT COMPLETED|Overall Study||1||
59691837|NCT01104766|75811477|FG000|STARTED|Overall Study||153||
59816124|NCT00529802|75938478|FG000|NOT COMPLETED|Evaluable for Primary Endpoint||10||
59816125|NCT00529802|75938478|FG000|STARTED|Evaluable for Secondary Endpoint||50||
59691838|NCT01104766|75811478|FG001|STARTED|Overall Study||155||
59691839|NCT01104766|75811479|FG002|STARTED|Overall Study||157||
59691840|NCT01104766|75811480|FG003|STARTED|Overall Study||152||
59691841|NCT01104766|75811477|FG000|COMPLETED|Overall Study||95||
59691842|NCT01104766|75811478|FG001|COMPLETED|Overall Study||104||
59691843|NCT01104766|75811479|FG002|COMPLETED|Overall Study||97||
59691844|NCT01104766|75811480|FG003|COMPLETED|Overall Study||114||
59691845|NCT01104766|75811477|FG000|NOT COMPLETED|Overall Study||58||
59691846|NCT01104766|75811478|FG001|NOT COMPLETED|Overall Study||51||
59816126|NCT00529802|75938478|FG000|COMPLETED|Evaluable for Secondary Endpoint||48||
59816127|NCT00529802|75938478|FG000|NOT COMPLETED|Evaluable for Secondary Endpoint||2||
59691847|NCT01104766|75811479|FG002|NOT COMPLETED|Overall Study||60||
59691848|NCT01104766|75811480|FG003|NOT COMPLETED|Overall Study||38||
59691849|NCT01104376|75811490|FG000|STARTED|Overall Study||89||
59691850|NCT01104376|75811490|FG000|COMPLETED|Overall Study||61||
59691851|NCT01104376|75811490|FG000|NOT COMPLETED|Overall Study||28||
59691852|NCT01072357|75811496|FG000|STARTED|Overall Study||15||
59691853|NCT01072357|75811497|FG001|STARTED|Overall Study||15||
59691854|NCT01072357|75811496|FG000|COMPLETED|Overall Study||15||
59691855|NCT01072357|75811497|FG001|COMPLETED|Overall Study||14||
59691856|NCT01072357|75811496|FG000|NOT COMPLETED|Overall Study||0||
59691857|NCT01072357|75811497|FG001|NOT COMPLETED|Overall Study||1||
59691858|NCT01072201|75811505|FG000|STARTED|Overall Study||30||
59691859|NCT01072201|75811506|FG001|STARTED|Overall Study||30||
59691860|NCT01072201|75811505|FG000|COMPLETED|Overall Study||30||
59691861|NCT01072201|75811506|FG001|COMPLETED|Overall Study||29||
59691862|NCT01072201|75811505|FG000|NOT COMPLETED|Overall Study||0||
59691863|NCT01072201|75811506|FG001|NOT COMPLETED|Overall Study||1||
59691864|NCT01103362|75811512|FG000|STARTED|Overall Study||596||
59691865|NCT01103362|75811512|FG000|COMPLETED|Overall Study||0||
59691866|NCT01103362|75811512|FG000|NOT COMPLETED|Overall Study||596||
59691867|NCT01103284|75811518|FG000|STARTED|Overall Study||236||
59691868|NCT01103284|75811519|FG001|STARTED|Overall Study||239||
59691869|NCT01103284|75811518|FG000|Treated|Overall Study||236||
59691870|NCT01103284|75811519|FG001|Treated|Overall Study||238||
59691871|NCT01103284|75811518|FG000|At Least One Post-baseline Visit (FAS)|Overall Study|Patients reaching this milestone were included in the Full Analysis Set (FAS) population|233||
59691872|NCT01103284|75811519|FG001|At Least One Post-baseline Visit (FAS)|Overall Study|Patients reaching this milestone were included in the Full Analysis Set (FAS)|235||
59691873|NCT01103284|75811518|FG000|COMPLETED|Overall Study||194||
59691874|NCT01103284|75811519|FG001|COMPLETED|Overall Study||195||
59691875|NCT01103284|75811518|FG000|NOT COMPLETED|Overall Study||42||
59691876|NCT01103284|75811519|FG001|NOT COMPLETED|Overall Study||44||
59691877|NCT01070953|75811525|FG000|STARTED|Participants for Safety Evaluation||4467||
59691878|NCT01070953|75811525|FG000|COMPLETED|Participants for Safety Evaluation||3536||
59691879|NCT01070953|75811525|FG000|NOT COMPLETED|Participants for Safety Evaluation||931||
59691880|NCT01070953|75811525|FG000|STARTED|Participants for Efficacy Evaluation||3536||
59691881|NCT01070953|75811525|FG000|COMPLETED|Participants for Efficacy Evaluation||3309||
59691882|NCT01070953|75811525|FG000|NOT COMPLETED|Participants for Efficacy Evaluation||227||
59691883|NCT01089361|75811537|FG000|STARTED|Overall Study||9||
59691884|NCT01089361|75811538|FG001|STARTED|Overall Study||10||
59691885|NCT01089361|75811537|FG000|COMPLETED|Overall Study||8||
59691886|NCT01089361|75811538|FG001|COMPLETED|Overall Study||10||
59691887|NCT01089361|75811537|FG000|NOT COMPLETED|Overall Study||1||
59691888|NCT01089361|75811538|FG001|NOT COMPLETED|Overall Study||0||
59691889|NCT01102972|75811548|FG000|STARTED|Overall Study|"297 PAR enrolled. 1 PAR withdrew before taking investigational product and didn't start the study."|199||
59691890|NCT01102972|75811549|FG001|STARTED|Overall Study|"297 PAR enrolled. 1 PAR withdrew before taking investigational product and didn't start the study."|97||
59691891|NCT01102972|75811548|FG000|Completed Week 24|Overall Study||180||
59691892|NCT01102972|75811549|FG001|Completed Week 24|Overall Study||88||
59691893|NCT01102972|75811548|FG000|COMPLETED|Overall Study|These participants completed Study Week 48.|170||
59691894|NCT01102972|75811549|FG001|COMPLETED|Overall Study|These participants completed Study Week 48.|83||
59691895|NCT01102972|75811548|FG000|NOT COMPLETED|Overall Study||29||
59691896|NCT01102972|75811549|FG001|NOT COMPLETED|Overall Study||14||
59691897|NCT01309269|75811555|FG000|STARTED|Overall Study||1085||
59691898|NCT01309269|75811555|FG000|Treated|Overall Study||978||
59691899|NCT01309269|75811555|FG000|COMPLETED|Overall Study||245||
59691900|NCT01309269|75811555|FG000|NOT COMPLETED|Overall Study||840||
59691901|NCT01088503|75811562|FG000|STARTED|Overall Study||3123||
59691902|NCT01088503|75811563|FG001|STARTED|Overall Study||8846||
59691903|NCT01088503|75811564|FG002|STARTED|Overall Study||258||
59691904|NCT01088503|75811562|FG000|COMPLETED|Overall Study||2941||
59691905|NCT01088503|75811563|FG001|COMPLETED|Overall Study||8161||
59691906|NCT01088503|75811564|FG002|COMPLETED|Overall Study||241||
59691907|NCT01088503|75811562|FG000|NOT COMPLETED|Overall Study||182||
59989813|NCT02447432|76105215|FG000|NOT COMPLETED|Epoch 001||5||
59989814|NCT02447432|76105216|FG001|NOT COMPLETED|Epoch 001||13||
59989815|NCT02447432|76105215|FG000|STARTED|Epoch 002||152||
59691908|NCT01088503|75811563|FG001|NOT COMPLETED|Overall Study||685||
59691909|NCT01088503|75811564|FG002|NOT COMPLETED|Overall Study||17||
59691910|NCT01087489|75811570|FG000|STARTED|Overall Study||19||
59691911|NCT01087489|75811571|FG001|STARTED|Overall Study||34||
59691912|NCT01087489|75811570|FG000|COMPLETED|Overall Study||19||
59691913|NCT01087489|75811571|FG001|COMPLETED|Overall Study||31||
59691914|NCT01087489|75811570|FG000|NOT COMPLETED|Overall Study||0||
59691915|NCT01087489|75811571|FG001|NOT COMPLETED|Overall Study||3||
59989816|NCT02447432|76105216|FG001|STARTED|Epoch 002||145||
59989817|NCT02447432|76105215|FG000|COMPLETED|Epoch 002||152||
59691916|NCT01082965|75811579|FG000|STARTED|Overall Study||10||
59691917|NCT01082965|75811580|FG001|STARTED|Overall Study||8||
59691918|NCT01082965|75811579|FG000|COMPLETED|Overall Study||9||
59691919|NCT01082965|75811580|FG001|COMPLETED|Overall Study||6||
59691920|NCT01082965|75811579|FG000|NOT COMPLETED|Overall Study||1||
59691921|NCT01082965|75811580|FG001|NOT COMPLETED|Overall Study||2||
59691922|NCT01102426|75811588|FG000|STARTED|Overall Study||171||
59691923|NCT01102426|75811589|FG001|STARTED|Overall Study||84||
59691924|NCT01102426|75811588|FG000|COMPLETED|Overall Study||6||
59691925|NCT01102426|75811589|FG001|COMPLETED|Overall Study||3||
59691926|NCT01102426|75811588|FG000|NOT COMPLETED|Overall Study||165||
59691927|NCT01102426|75811589|FG001|NOT COMPLETED|Overall Study||81||
59691928|NCT01101334|75811597|FG000|STARTED|Overall Study||45||
59691929|NCT01101334|75811598|FG001|STARTED|Overall Study||45||
59691930|NCT01101334|75811597|FG000|Received Study Treatment|Overall Study||44||
59989818|NCT02447432|76105216|FG001|COMPLETED|Epoch 002||145||
59989819|NCT02447432|76105215|FG000|NOT COMPLETED|Epoch 002||0||
59691931|NCT01101334|75811598|FG001|Received Study Treatment|Overall Study||45||
59691932|NCT01101334|75811597|FG000|COMPLETED|Overall Study||0||
59691933|NCT01101334|75811598|FG001|COMPLETED|Overall Study||0||
59691934|NCT01101334|75811597|FG000|NOT COMPLETED|Overall Study||45||
59691935|NCT01101334|75811598|FG001|NOT COMPLETED|Overall Study||45||
59691936|NCT01327547|75811606|FG000|STARTED|Overall Study||70||
59691937|NCT01327547|75811607|FG001|STARTED|Overall Study||67||
59691938|NCT01327547|75811606|FG000|Randomized and Not Treated|Overall Study||0||
59691939|NCT01327547|75811607|FG001|Randomized and Not Treated|Overall Study|Randomized but was withdrawn prior to receiving treatment due to poor venous access.|1||
59691940|NCT01327547|75811606|FG000|COMPLETED|Overall Study||50||
59691941|NCT01327547|75811607|FG001|COMPLETED|Overall Study||45||
59691942|NCT01327547|75811606|FG000|NOT COMPLETED|Overall Study||20||
59691943|NCT01327547|75811607|FG001|NOT COMPLETED|Overall Study||22||
59691944|NCT04386785|75811622|FG000|STARTED|Overall Study||27||30
59691945|NCT04386785|75811622|FG000|COMPLETED|Overall Study||27||30
59691946|NCT04386785|75811622|FG000|NOT COMPLETED|Overall Study||0||0
59691947|NCT01308567|75811629|FG000|STARTED|Overall Study|Randomized|391||
59691948|NCT01308567|75811630|FG001|STARTED|Overall Study|Randomized|389||
59691949|NCT01308567|75811631|FG002|STARTED|Overall Study|Randomized|388||
59691950|NCT01308567|75811629|FG000|Treated|Overall Study|For 1 participant, actual treatment received was Cabazitaxel 25 mg/m^2.|388||
59691951|NCT01308567|75811630|FG001|Treated|Overall Study|For 15 participants, actual treatment received was Cabazitaxel 25 mg/m^2.|382||
59691952|NCT01308567|75811631|FG002|Treated|Overall Study|For 2 participants, actual treatment received was Cabazitaxel 20 mg/m^2.|377||
59691953|NCT01308567|75811629|FG000|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival.|389||
59691954|NCT01308567|75811630|FG001|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival.|385||
59691955|NCT01308567|75811631|FG002|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival.|384||
59691956|NCT01308567|75811629|FG000|NOT COMPLETED|Overall Study||2||
59691957|NCT01308567|75811630|FG001|NOT COMPLETED|Overall Study||4||
59691958|NCT01308567|75811631|FG002|NOT COMPLETED|Overall Study||4||
59691959|NCT01307319|75811642|FG000|STARTED|Overall Study|Randomized|239||
59691960|NCT01307319|75811643|FG001|STARTED|Overall Study|Randomized|242||
59691961|NCT01307319|75811644|FG002|STARTED|Overall Study|Randomized|234||
59691962|NCT01307319|75811642|FG000|Safety Population|Overall Study||239||
59691963|NCT01307319|75811643|FG001|Safety Population|Overall Study|One participant was randomized in error and did not receive study medication.|241||
59691964|NCT01307319|75811644|FG002|Safety Population|Overall Study||234||
59691965|NCT01307319|75811642|FG000|ITT Population|Overall Study|One participant provided no post-baseline assessment.|238||
59691966|NCT01307319|75811643|FG001|ITT Population|Overall Study||241||
59691967|NCT01307319|75811644|FG002|ITT Population|Overall Study||234||
59691968|NCT01307319|75811642|FG000|COMPLETED|Overall Study||235||
59691969|NCT01307319|75811643|FG001|COMPLETED|Overall Study||234||
59691970|NCT01307319|75811644|FG002|COMPLETED|Overall Study||227||
59691971|NCT01307319|75811642|FG000|NOT COMPLETED|Overall Study||4||
59691972|NCT01307319|75811643|FG001|NOT COMPLETED|Overall Study||8||
59691973|NCT01307319|75811644|FG002|NOT COMPLETED|Overall Study||7||
59691974|NCT01080391|75811654|FG000|STARTED|Overall Study||396||
59691975|NCT01080391|75811655|FG001|STARTED|Overall Study||396||
59691976|NCT01080391|75811654|FG000|Treated|Overall Study||389||
59691977|NCT01080391|75811655|FG001|Treated|Overall Study||392||
59691978|NCT01080391|75811654|FG000|COMPLETED|Overall Study||389|Completed represents patients who discontinued treatment as of 05 December 2017|
59691979|NCT01080391|75811655|FG001|COMPLETED|Overall Study||392|Completed represents patients who discontinued treatment as of 05 December 2017|
59691980|NCT01080391|75811654|FG000|NOT COMPLETED|Overall Study||7||
59691981|NCT01080391|75811655|FG001|NOT COMPLETED|Overall Study||4||
59691982|NCT01070329|75811663|FG000|STARTED|Overall Study||261||
59691983|NCT01070329|75811664|FG001|STARTED|Overall Study||266||
59691984|NCT01070329|75811663|FG000|COMPLETED|Overall Study||209||
59691985|NCT01070329|75811664|FG001|COMPLETED|Overall Study||217||
59691986|NCT01070329|75811663|FG000|NOT COMPLETED|Overall Study||52||
59989820|NCT02447432|76105216|FG001|NOT COMPLETED|Epoch 002||0||
59989821|NCT02446886|76105224|FG000|STARTED|Overall Study||8||
59691987|NCT01070329|75811664|FG001|NOT COMPLETED|Overall Study||49||
59691988|NCT01069861|75811670|FG000|STARTED|Overall Study||4||
59691989|NCT01069861|75811670|FG000|COMPLETED|Overall Study||1||
59691990|NCT01069861|75811670|FG000|NOT COMPLETED|Overall Study||3||
59691991|NCT01306929|75811674|FG000|STARTED|Overall Study||134||
59691992|NCT01306929|75811674|FG000|COMPLETED|Overall Study||40||
59691993|NCT01306929|75811674|FG000|NOT COMPLETED|Overall Study||94||
59691994|NCT01064401|75811680|FG000|STARTED|Overall Study||922||
59691995|NCT01064401|75811681|FG001|STARTED|Overall Study||919||
59691996|NCT01064401|75811680|FG000|COMPLETED|Overall Study||694||
59691997|NCT01064401|75811681|FG001|COMPLETED|Overall Study||724||
59691998|NCT01064401|75811680|FG000|NOT COMPLETED|Overall Study||228||
59691999|NCT01064401|75811681|FG001|NOT COMPLETED|Overall Study||195||
59692000|NCT01306617|75811691|FG000|STARTED|Overall Study||19||
59692001|NCT01306617|75811692|FG001|STARTED|Overall Study||14||
59692002|NCT01306617|75811693|FG002|STARTED|Overall Study||17||
59692003|NCT01306617|75811691|FG000|COMPLETED|Overall Study|The number of participants who completed study drug|18||
59692004|NCT01306617|75811692|FG001|COMPLETED|Overall Study|The number of participants who completed study drug|13||
59692005|NCT01306617|75811693|FG002|COMPLETED|Overall Study|The number of participants who completed study drug|12||
59692006|NCT01306617|75811691|FG000|NOT COMPLETED|Overall Study||1||
59692007|NCT01306617|75811692|FG001|NOT COMPLETED|Overall Study||1||
59692008|NCT01306617|75811693|FG002|NOT COMPLETED|Overall Study||5||
59692009|NCT01306305|75811703|FG000|STARTED|Overall Study||55||
59692010|NCT01306305|75811704|FG001|STARTED|Overall Study||55||
59692011|NCT01306305|75811703|FG000|COMPLETED|Overall Study||53||
59692012|NCT01306305|75811704|FG001|COMPLETED|Overall Study||55||
59692013|NCT01306305|75811703|FG000|NOT COMPLETED|Overall Study||2||
59692014|NCT01306305|75811704|FG001|NOT COMPLETED|Overall Study||0||
59692015|NCT01038427|75811713|FG000|STARTED|Overall Study||317||
59692016|NCT01038427|75811714|FG001|STARTED|Overall Study||320||
59692017|NCT01038427|75811715|FG002|STARTED|Overall Study||158||
59692018|NCT01038427|75811713|FG000|Per-Protocol (PPP) Population|Overall Study||306|All participants who satisfied the criteria set forth in the protocol in terms of dosing compliance, number of available post-randomization evaluations and absence of significant protocol violations.|
59692019|NCT01038427|75811714|FG001|Per-Protocol (PPP) Population|Overall Study||307|All participants who satisfied the criteria set forth in the protocol in terms of dosing compliance, number of available post-randomization evaluations and absence of significant protocol violations.|
59692020|NCT01038427|75811715|FG002|Per-Protocol (PPP) Population|Overall Study||150|All participants who satisfied the criteria set forth in the protocol in terms of dosing compliance, number of available post-randomization evaluations and absence of significant protocol violations.|
59692021|NCT01038427|75811713|FG000|Intent-to-Treat (ITT) Population|Overall Study||314|All participants in the PPP as well as all participants who administered at least one dose of randomized study drug and had at least one post-randomization evaluation.|
59692022|NCT01038427|75811714|FG001|Intent-to-Treat (ITT) Population|Overall Study||314|All participants in the PPP as well as all participants who administered at least one dose of randomized study drug and had at least one post-randomization evaluation.|
59692023|NCT01038427|75811715|FG002|Intent-to-Treat (ITT) Population|Overall Study||156|All participants in the PPP as well as all participants who administered at least one dose of randomized study drug and had at least one post-randomization evaluation.|
59692024|NCT01038427|75811713|FG000|COMPLETED|Overall Study||314||
59692025|NCT01038427|75811714|FG001|COMPLETED|Overall Study||314||
59692026|NCT01038427|75811715|FG002|COMPLETED|Overall Study||154||
59692027|NCT01038427|75811713|FG000|NOT COMPLETED|Overall Study||3||
59692028|NCT01038427|75811714|FG001|NOT COMPLETED|Overall Study||6||
59692029|NCT01038427|75811715|FG002|NOT COMPLETED|Overall Study||4||
59692030|NCT01037413|75811723|FG000|STARTED|Part A: Skin Testing||25||
59692031|NCT01037413|75811724|FG001|STARTED|Part A: Skin Testing||0||
59692032|NCT01037413|75811723|FG000|COMPLETED|Part A: Skin Testing||23||
59692033|NCT01037413|75811724|FG001|COMPLETED|Part A: Skin Testing||0||
59692034|NCT01037413|75811723|FG000|NOT COMPLETED|Part A: Skin Testing||2||
59692035|NCT01037413|75811724|FG001|NOT COMPLETED|Part A: Skin Testing||0||
59692036|NCT01037413|75811723|FG000|STARTED|Part B: Scar Revision|Participants who tested negative for skin sensitization proceeded to Part B of the study. .|0||
59692037|NCT01037413|75811724|FG001|STARTED|Part B: Scar Revision|Participants who completed Part A of the study and were negative for skin sensitization.|23||
59692038|NCT01037413|75811723|FG000|Treated|Part B: Scar Revision||0||
59692039|NCT01037413|75811724|FG001|Treated|Part B: Scar Revision||22||
59692040|NCT01037413|75811723|FG000|COMPLETED|Part B: Scar Revision||0||
59692041|NCT01037413|75811724|FG001|COMPLETED|Part B: Scar Revision||21||
59692042|NCT01037413|75811723|FG000|NOT COMPLETED|Part B: Scar Revision||0||
59692043|NCT01037413|75811724|FG001|NOT COMPLETED|Part B: Scar Revision||2||
59692044|NCT01326845|75811739|FG000|STARTED|Overall Study||7||
59692045|NCT01326845|75811740|FG001|STARTED|Overall Study||5||
59692046|NCT01326845|75811739|FG000|COMPLETED|Overall Study|Study terminated early|0||
59692047|NCT01326845|75811740|FG001|COMPLETED|Overall Study|Study terminated early|0||
59692048|NCT01326845|75811739|FG000|NOT COMPLETED|Overall Study||7||
59692049|NCT01326845|75811740|FG001|NOT COMPLETED|Overall Study||5||
59692050|NCT01062763|75811748|FG000|STARTED|Overall Study|119 randomized.|58||
59692051|NCT01062763|75811749|FG001|STARTED|Overall Study||61||
59692052|NCT01062763|75811748|FG000|COMPLETED|Overall Study||55||
59692053|NCT01062763|75811749|FG001|COMPLETED|Overall Study||57||
59692054|NCT01062763|75811748|FG000|NOT COMPLETED|Overall Study||3||
59692055|NCT01062763|75811749|FG001|NOT COMPLETED|Overall Study||4||
59692056|NCT01048099|75811755|FG000|STARTED|Patients Enrolled and Blood Collected|Patients enrolled|283||
59692057|NCT01048099|75811755|FG000|COMPLETED|Patients Enrolled and Blood Collected|Patients with circulating tumor cells (CTCs)|226||
59692058|NCT01048099|75811755|FG000|NOT COMPLETED|Patients Enrolled and Blood Collected||57||
59692059|NCT01048099|75811755|FG000|STARTED|Patients Evaluated by PRO Onc Assay|Patients with CTCs who were evaluated by PRO Onc Assay|226||
59692060|NCT01048099|75811755|FG000|COMPLETED|Patients Evaluated by PRO Onc Assay|Patients evaluated by PRO Onc Assay with HER2 overexpression/activation detected|24||
59692061|NCT01048099|75811755|FG000|NOT COMPLETED|Patients Evaluated by PRO Onc Assay||202||
59692062|NCT01048099|75811755|FG000|STARTED|Pts w/ HER2 Overexpression/Activation|Patients with detected HER2 activation and/or overexpression|24||
59692063|NCT01048099|75811755|FG000|COMPLETED|Pts w/ HER2 Overexpression/Activation|Patients who proceeded to treatment|14||
59692064|NCT01048099|75811755|FG000|NOT COMPLETED|Pts w/ HER2 Overexpression/Activation||10||
59692065|NCT01048099|75811755|FG000|STARTED|Treatment Per Protocol||14||
59692066|NCT01048099|75811755|FG000|COMPLETED|Treatment Per Protocol|Patients continued treatment until disease progression or coming off-study for any other reason|0||
59692067|NCT01048099|75811755|FG000|NOT COMPLETED|Treatment Per Protocol||14||
59692068|NCT01303965|75811763|FG000|STARTED|Overall Study||3||
59692069|NCT01303965|75811764|FG001|STARTED|Overall Study||11||
59692070|NCT01303965|75811763|FG000|COMPLETED|Overall Study||0||
59692071|NCT01303965|75811764|FG001|COMPLETED|Overall Study||1||
59692072|NCT01303965|75811763|FG000|NOT COMPLETED|Overall Study||3||
59692073|NCT01303965|75811764|FG001|NOT COMPLETED|Overall Study||10||
59692074|NCT01045993|75811774|FG000|STARTED|Overall Study||26||
59692075|NCT01045993|75811775|FG001|STARTED|Overall Study||5||
59692076|NCT01045993|75811776|FG002|STARTED|Overall Study||5||
59692077|NCT01045993|75811777|FG003|STARTED|Overall Study||25||
59692078|NCT01045993|75811774|FG000|COMPLETED|Overall Study||26||
59692079|NCT01045993|75811775|FG001|COMPLETED|Overall Study||4||
59692080|NCT01045993|75811776|FG002|COMPLETED|Overall Study||5||
59692081|NCT01045993|75811777|FG003|COMPLETED|Overall Study||25||
59692082|NCT01045993|75811774|FG000|NOT COMPLETED|Overall Study||0||
59692083|NCT01045993|75811775|FG001|NOT COMPLETED|Overall Study||1||
59692084|NCT01045993|75811776|FG002|NOT COMPLETED|Overall Study||0||
59692085|NCT01045993|75811777|FG003|NOT COMPLETED|Overall Study||0||
59692086|NCT01303419|75811787|FG000|STARTED|Overall Study|Subjects who met all Inclusion and none of the Exclusion criteria|224||
59692087|NCT01303419|75811787|FG000|COMPLETED|Overall Study||128||
59692088|NCT01303419|75811787|FG000|NOT COMPLETED|Overall Study||96||
59692089|NCT01326533|75811793|FG000|STARTED|Overall Study||17||
59692090|NCT01326533|75811794|FG001|STARTED|Overall Study||15||
60079392|NCT04206332|76194711|FG011|Completed Controlled Human Malaria Infection (CHMI)|Part A||0||
60079393|NCT04206332|76194712|FG012|Completed Controlled Human Malaria Infection (CHMI)|Part A||0||
60079394|NCT04206332|76194713|FG013|Completed Controlled Human Malaria Infection (CHMI)|Part A||0||
60079395|NCT04206332|76194714|FG014|Completed Controlled Human Malaria Infection (CHMI)|Part A||0||
59692091|NCT01326533|75811793|FG000|COMPLETED|Overall Study||13||
59692092|NCT01326533|75811794|FG001|COMPLETED|Overall Study||15||
59692093|NCT01326533|75811793|FG000|NOT COMPLETED|Overall Study||4||
59692094|NCT01326533|75811794|FG001|NOT COMPLETED|Overall Study||0||
59692095|NCT01045447|75811802|FG000|STARTED|Overall Study||232||
59692096|NCT01045447|75811803|FG001|STARTED|Overall Study||233||
59692097|NCT01045447|75811802|FG000|Exposed|Overall Study|Two subjects withdrew prior to exposure to trial drug|230||
59692098|NCT01045447|75811803|FG001|Exposed|Overall Study||233||
59692099|NCT01045447|75811802|FG000|COMPLETED|Overall Study||196||
59692100|NCT01045447|75811803|FG001|COMPLETED|Overall Study||205||
59692101|NCT01045447|75811802|FG000|NOT COMPLETED|Overall Study||36||
59692102|NCT01045447|75811803|FG001|NOT COMPLETED|Overall Study||28||
59692103|NCT01301625|75811809|FG000|STARTED|Overall Study||78||
59692104|NCT01301625|75811809|FG000|COMPLETED|Overall Study||43||
59692105|NCT01301625|75811809|FG000|NOT COMPLETED|Overall Study||35||
59692106|NCT01301391|75811813|FG000|STARTED|Overall Study|On treatment until disease progression, patient withdrawal of consent, or unacceptable toxicity.|30||
59692107|NCT01301391|75811813|FG000|COMPLETED|Overall Study||4|Follow up for survival: up to the end of study or for no more than 2 years from end of treatment.|
60079396|NCT04206332|76194715|FG015|Completed Controlled Human Malaria Infection (CHMI)|Part A||0||
60079397|NCT04206332|76194716|FG016|Completed Controlled Human Malaria Infection (CHMI)|Part A||0||
60079398|NCT04206332|76194700|FG000|COMPLETED|Part A||4||
60079399|NCT04206332|76194701|FG001|COMPLETED|Part A||3||
60079400|NCT04206332|76194702|FG002|COMPLETED|Part A||5||
59692108|NCT01301391|75811813|FG000|NOT COMPLETED|Overall Study||26||
59692109|NCT01036321|75811819|FG000|STARTED|Overall Study||36||
59692110|NCT01036321|75811820|FG001|STARTED|Overall Study||35||
59692111|NCT01036321|75811819|FG000|COMPLETED|Overall Study||31||
59692112|NCT01036321|75811820|FG001|COMPLETED|Overall Study||31||
59692113|NCT01036321|75811819|FG000|NOT COMPLETED|Overall Study||5||
59692114|NCT01036321|75811820|FG001|NOT COMPLETED|Overall Study||4||
59692115|NCT01061359|75811826|FG000|STARTED|Overall Study||1972||
59692116|NCT01061359|75811826|FG000|COMPLETED|Overall Study|Completed 5 years of follow-up: 668 Disease free and 2 Relapsed|670||
60079401|NCT04206332|76194703|FG003|COMPLETED|Part A||5||
59692117|NCT01061359|75811826|FG000|NOT COMPLETED|Overall Study||1302||
59692118|NCT01301079|75811832|FG000|STARTED|Overall Study||30||
59692119|NCT01301079|75811833|FG001|STARTED|Overall Study||30||
59692120|NCT01301079|75811832|FG000|COMPLETED|Overall Study||28||
59692121|NCT01301079|75811833|FG001|COMPLETED|Overall Study||28||
59692122|NCT01301079|75811832|FG000|NOT COMPLETED|Overall Study||2||
59692123|NCT01301079|75811833|FG001|NOT COMPLETED|Overall Study||2||
59692124|NCT01036165|75811843|FG000|STARTED|Overall Study||103||
59692125|NCT01036165|75811843|FG000|COMPLETED|Overall Study||88||
59692126|NCT01036165|75811843|FG000|NOT COMPLETED|Overall Study||15||
59692127|NCT01301001|75811847|FG000|STARTED|First Intervention||44||
59692128|NCT01301001|75811848|FG001|STARTED|First Intervention||45||
59692129|NCT01301001|75811847|FG000|COMPLETED|First Intervention||34||
59692130|NCT01301001|75811848|FG001|COMPLETED|First Intervention||36||
59692131|NCT01301001|75811847|FG000|NOT COMPLETED|First Intervention||10||
59692132|NCT01301001|75811848|FG001|NOT COMPLETED|First Intervention||9||
59692133|NCT01301001|75811847|FG000|STARTED|Washout (2 Weeks)||34||
59692134|NCT01301001|75811848|FG001|STARTED|Washout (2 Weeks)||36||
59692135|NCT01301001|75811847|FG000|COMPLETED|Washout (2 Weeks)||34||
59692136|NCT01301001|75811848|FG001|COMPLETED|Washout (2 Weeks)||36||
59692137|NCT01301001|75811847|FG000|NOT COMPLETED|Washout (2 Weeks)||0||
59692138|NCT01301001|75811848|FG001|NOT COMPLETED|Washout (2 Weeks)||0||
59692139|NCT01301001|75811847|FG000|STARTED|Second Intervention||34||
59692140|NCT01301001|75811848|FG001|STARTED|Second Intervention||36||
59692141|NCT01301001|75811847|FG000|COMPLETED|Second Intervention||30||
59692142|NCT01301001|75811848|FG001|COMPLETED|Second Intervention||36||
59692143|NCT01301001|75811847|FG000|NOT COMPLETED|Second Intervention||4||
59692144|NCT01301001|75811848|FG001|NOT COMPLETED|Second Intervention||0||
59692145|NCT01300923|75811855|FG000|STARTED|Overall Study||12||
59692146|NCT01300923|75811856|FG001|STARTED|Overall Study||2||
59692147|NCT01300923|75811855|FG000|COMPLETED|Overall Study||12||
59692148|NCT01300923|75811856|FG001|COMPLETED|Overall Study||0||
59692149|NCT01300923|75811855|FG000|NOT COMPLETED|Overall Study||0||
59692150|NCT01300923|75811856|FG001|NOT COMPLETED|Overall Study||2||
59692151|NCT01300767|75811861|FG000|STARTED|Overall Study||74||
59692152|NCT01300767|75811861|FG000|COMPLETED|Overall Study||70||
59692153|NCT01300767|75811861|FG000|NOT COMPLETED|Overall Study||4||
59692154|NCT01300455|75811869|FG000|STARTED|Period 1||13||
59692155|NCT01300455|75811870|FG001|STARTED|Period 1||13||
59692156|NCT01300455|75811869|FG000|COMPLETED|Period 1||13||
59692157|NCT01300455|75811870|FG001|COMPLETED|Period 1||13||
59692158|NCT01300455|75811869|FG000|NOT COMPLETED|Period 1||0||
59692159|NCT01300455|75811870|FG001|NOT COMPLETED|Period 1||0||
59692160|NCT01300455|75811869|FG000|STARTED|Washout||13||
59692161|NCT01300455|75811870|FG001|STARTED|Washout||13||
59692162|NCT01300455|75811869|FG000|COMPLETED|Washout||12||
59692163|NCT01300455|75811870|FG001|COMPLETED|Washout||13||
59692164|NCT01300455|75811869|FG000|NOT COMPLETED|Washout||1||
59692165|NCT01300455|75811870|FG001|NOT COMPLETED|Washout||0||
59692166|NCT01300455|75811869|FG000|STARTED|Period 2||12||
59692167|NCT01300455|75811870|FG001|STARTED|Period 2||13||
59692168|NCT01300455|75811869|FG000|COMPLETED|Period 2||12||
59692169|NCT01300455|75811870|FG001|COMPLETED|Period 2||13||
59692170|NCT01300455|75811869|FG000|NOT COMPLETED|Period 2||0||
59692171|NCT01300455|75811870|FG001|NOT COMPLETED|Period 2||0||
59692172|NCT01107418|75811880|FG000|STARTED|Overall Study||52||
59692173|NCT01107418|75811880|FG000|COMPLETED|Overall Study||0||
59692174|NCT01107418|75811880|FG000|NOT COMPLETED|Overall Study||52||
59692175|NCT01101178|75811895|FG000|STARTED|Period 1||40||
59692176|NCT01101178|75811896|FG001|STARTED|Period 1||39||
59692177|NCT01101178|75811895|FG000|COMPLETED|Period 1||36||
59692178|NCT01101178|75811896|FG001|COMPLETED|Period 1||35||
59692179|NCT01101178|75811895|FG000|NOT COMPLETED|Period 1||4||
59692180|NCT01101178|75811896|FG001|NOT COMPLETED|Period 1||4||
59692181|NCT01101178|75811895|FG000|STARTED|Period 2||36||
59692182|NCT01101178|75811896|FG001|STARTED|Period 2||35||
59692183|NCT01101178|75811895|FG000|COMPLETED|Period 2||36||
59692184|NCT01101178|75811896|FG001|COMPLETED|Period 2||34||
59692185|NCT01101178|75811895|FG000|NOT COMPLETED|Period 2||0||
59692186|NCT01101178|75811896|FG001|NOT COMPLETED|Period 2||1||
59692187|NCT01101022|75811905|FG000|STARTED|Overall Study||79||
59692188|NCT01101022|75811906|FG001|STARTED|Overall Study||80||
59692189|NCT01101022|75811905|FG000|COMPLETED|Overall Study||62||
59692190|NCT01101022|75811906|FG001|COMPLETED|Overall Study||53||
59692191|NCT01101022|75811905|FG000|NOT COMPLETED|Overall Study||17||
59692192|NCT01101022|75811906|FG001|NOT COMPLETED|Overall Study||27||
59692193|NCT01299909|75811915|FG000|STARTED|Overall Study||68||
59692194|NCT01299909|75811916|FG001|STARTED|Overall Study||67||
59692195|NCT01299909|75811917|FG002|STARTED|Overall Study||40||
59692196|NCT01299909|75811915|FG000|COMPLETED|Overall Study||46||
59692197|NCT01299909|75811916|FG001|COMPLETED|Overall Study||49||
59692198|NCT01299909|75811917|FG002|COMPLETED|Overall Study||23||
59692199|NCT01299909|75811915|FG000|NOT COMPLETED|Overall Study||22||
59692200|NCT01299909|75811916|FG001|NOT COMPLETED|Overall Study||18||
59692201|NCT01299909|75811917|FG002|NOT COMPLETED|Overall Study||17||
59692202|NCT01298661|75811927|FG000|STARTED|Overall Study||33||
59692203|NCT01298661|75811928|FG001|STARTED|Overall Study||24||
59692204|NCT01298661|75811929|FG002|STARTED|Overall Study||34||
59692205|NCT01298661|75811927|FG000|COMPLETED|Overall Study||31||
59692206|NCT01298661|75811928|FG001|COMPLETED|Overall Study||24||
59692207|NCT01298661|75811929|FG002|COMPLETED|Overall Study||32||
59692208|NCT01298661|75811927|FG000|NOT COMPLETED|Overall Study||2||
59692209|NCT01298661|75811928|FG001|NOT COMPLETED|Overall Study||0||
59692210|NCT01298661|75811929|FG002|NOT COMPLETED|Overall Study||2||
59692211|NCT01100944|75811938|FG000|STARTED|Dose Escalation Phase 1 Dose Level 1||6||
59692212|NCT01100944|75811939|FG001|STARTED|Dose Escalation Phase 1 Dose Level 1||0||
59692213|NCT01100944|75811940|FG002|STARTED|Dose Escalation Phase 1 Dose Level 1||0||
59692214|NCT01100944|75811938|FG000|COMPLETED|Dose Escalation Phase 1 Dose Level 1||2||
59692215|NCT01100944|75811939|FG001|COMPLETED|Dose Escalation Phase 1 Dose Level 1||0||
59692216|NCT01100944|75811940|FG002|COMPLETED|Dose Escalation Phase 1 Dose Level 1||0||
59692217|NCT01100944|75811938|FG000|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 1||4||
59692218|NCT01100944|75811939|FG001|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 1||0||
59692219|NCT01100944|75811940|FG002|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 1||0||
59692220|NCT01100944|75811938|FG000|STARTED|Dose Escalation Phase 1 Dose Level 2||0||
59692221|NCT01100944|75811939|FG001|STARTED|Dose Escalation Phase 1 Dose Level 2||2||
59692222|NCT01100944|75811940|FG002|STARTED|Dose Escalation Phase 1 Dose Level 2||0||
59692223|NCT01100944|75811938|FG000|COMPLETED|Dose Escalation Phase 1 Dose Level 2||0||
59692224|NCT01100944|75811939|FG001|COMPLETED|Dose Escalation Phase 1 Dose Level 2||0||
59692225|NCT01100944|75811940|FG002|COMPLETED|Dose Escalation Phase 1 Dose Level 2||0||
59692226|NCT01100944|75811938|FG000|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 2||0||
59692227|NCT01100944|75811939|FG001|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 2||2||
59692228|NCT01100944|75811940|FG002|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 2||0||
59692229|NCT01100944|75811938|FG000|STARTED|Expansion Phase - Phase 2||0||
59692230|NCT01100944|75811939|FG001|STARTED|Expansion Phase - Phase 2||0||
59692231|NCT01100944|75811940|FG002|STARTED|Expansion Phase - Phase 2||18||
59692232|NCT01100944|75811938|FG000|COMPLETED|Expansion Phase - Phase 2||0||
59692233|NCT01100944|75811939|FG001|COMPLETED|Expansion Phase - Phase 2||0||
59692234|NCT01100944|75811940|FG002|COMPLETED|Expansion Phase - Phase 2||18||
59692235|NCT01100944|75811938|FG000|NOT COMPLETED|Expansion Phase - Phase 2||0||
59692236|NCT01100944|75811939|FG001|NOT COMPLETED|Expansion Phase - Phase 2||0||
59692237|NCT01100944|75811940|FG002|NOT COMPLETED|Expansion Phase - Phase 2||0||
59692238|NCT01100320|75811961|FG000|STARTED|Period 1||43||
59692239|NCT01100320|75811962|FG001|STARTED|Period 1||45||
59692240|NCT01100320|75811961|FG000|COMPLETED|Period 1||38||
59692241|NCT01100320|75811962|FG001|COMPLETED|Period 1||38||
59692242|NCT01100320|75811961|FG000|NOT COMPLETED|Period 1||5||
59692243|NCT01100320|75811962|FG001|NOT COMPLETED|Period 1||7||
59692244|NCT01100320|75811961|FG000|STARTED|Period 2||38||
59692245|NCT01100320|75811962|FG001|STARTED|Period 2||38||
59692246|NCT01100320|75811961|FG000|COMPLETED|Period 2||37||
59692247|NCT01100320|75811962|FG001|COMPLETED|Period 2||37||
59692248|NCT01100320|75811961|FG000|NOT COMPLETED|Period 2||1||
59692249|NCT01100320|75811962|FG001|NOT COMPLETED|Period 2||1||
59692250|NCT01100086|75811968|FG000|STARTED|Period 1||43||
59692251|NCT01100086|75811969|FG001|STARTED|Period 1||41||
59692252|NCT01100086|75811968|FG000|COMPLETED|Period 1||42||
59692253|NCT01100086|75811969|FG001|COMPLETED|Period 1||41||
59692254|NCT01100086|75811968|FG000|NOT COMPLETED|Period 1||1||
59692255|NCT01100086|75811969|FG001|NOT COMPLETED|Period 1||0||
59692256|NCT01100086|75811968|FG000|STARTED|Period 2||42||
59692257|NCT01100086|75811969|FG001|STARTED|Period 2||41||
59692258|NCT01100086|75811968|FG000|COMPLETED|Period 2||42||
59692259|NCT01100086|75811969|FG001|COMPLETED|Period 2||41||
59692260|NCT01100086|75811968|FG000|NOT COMPLETED|Period 2||0||
59692261|NCT01100086|75811969|FG001|NOT COMPLETED|Period 2||0||
59692262|NCT01297959|75811977|FG000|STARTED|Overall Study||261||
59692263|NCT01297959|75811978|FG001|STARTED|Overall Study||242||
59692264|NCT01297959|75811977|FG000|COMPLETED|Overall Study||241||
59692265|NCT01297959|75811978|FG001|COMPLETED|Overall Study||226||
59692266|NCT01297959|75811977|FG000|NOT COMPLETED|Overall Study||20||
59692267|NCT01297959|75811978|FG001|NOT COMPLETED|Overall Study||16||
59692268|NCT01035229|75811986|FG000|STARTED|Overall Study||362||
59692269|NCT01035229|75811987|FG001|STARTED|Overall Study||184||
59692270|NCT01035229|75811986|FG000|COMPLETED|Overall Study||0||
59692271|NCT01035229|75811987|FG001|COMPLETED|Overall Study||0||
59692272|NCT01035229|75811986|FG000|NOT COMPLETED|Overall Study||362||
59692273|NCT01035229|75811987|FG001|NOT COMPLETED|Overall Study||184||
59692274|NCT01106404|75811997|FG000|STARTED|Period I (First 6 Weeks)||36||
59692275|NCT01106404|75811998|FG001|STARTED|Period I (First 6 Weeks)||40||
59692276|NCT01106404|75811997|FG000|COMPLETED|Period I (First 6 Weeks)||33||
59692277|NCT01106404|75811998|FG001|COMPLETED|Period I (First 6 Weeks)||38||
59692278|NCT01106404|75811997|FG000|NOT COMPLETED|Period I (First 6 Weeks)||3||
59692279|NCT01106404|75811998|FG001|NOT COMPLETED|Period I (First 6 Weeks)||2||
59692280|NCT01106404|75811997|FG000|STARTED|Period II (Second 6 Weeks)||33||
59692281|NCT01106404|75811998|FG001|STARTED|Period II (Second 6 Weeks)||38||
59692282|NCT01106404|75811997|FG000|COMPLETED|Period II (Second 6 Weeks)||33||
59692283|NCT01106404|75811998|FG001|COMPLETED|Period II (Second 6 Weeks)||38||
59692284|NCT01106404|75811997|FG000|NOT COMPLETED|Period II (Second 6 Weeks)||0||
59692285|NCT01106404|75811998|FG001|NOT COMPLETED|Period II (Second 6 Weeks)||0||
59692286|NCT01059799|75812012|FG000|STARTED|Overall Study||289||
59692287|NCT01059799|75812013|FG001|STARTED|Overall Study||146||
59692288|NCT01059799|75812012|FG000|Exposed|Overall Study|Five subjects withdrew before exposure to trial drug|284||
59692289|NCT01059799|75812013|FG001|Exposed|Overall Study||146||
59692290|NCT01059799|75812012|FG000|COMPLETED|Overall Study||258||
59692291|NCT01059799|75812013|FG001|COMPLETED|Overall Study||136||
59692292|NCT01059799|75812012|FG000|NOT COMPLETED|Overall Study||31||
59692293|NCT01059799|75812013|FG001|NOT COMPLETED|Overall Study||10||
59692294|NCT01106248|75812019|FG000|STARTED|Overall Study||26||
59692295|NCT01106248|75812019|FG000|COMPLETED|Overall Study||23||
59692296|NCT01106248|75812019|FG000|NOT COMPLETED|Overall Study||3||
59692297|NCT01059175|75812025|FG000|STARTED|Overall Study||43||
59692298|NCT01059175|75812026|FG001|STARTED|Overall Study||41||
59692299|NCT01059175|75812025|FG000|COMPLETED|Overall Study|17 patients deceased 4 additional patients were prematurely exited|22||
59692300|NCT01059175|75812026|FG001|COMPLETED|Overall Study|17 patients deceased 3 patients were prematurely exited|21||
59692301|NCT01059175|75812025|FG000|NOT COMPLETED|Overall Study||21||
59692302|NCT01059175|75812026|FG001|NOT COMPLETED|Overall Study||20||
59692303|NCT01297491|75812034|FG000|STARTED|Overall Study||30||
59692304|NCT01297491|75812035|FG001|STARTED|Overall Study||33||
59692305|NCT01297491|75812034|FG000|COMPLETED|Overall Study||0||
59692306|NCT01297491|75812035|FG001|COMPLETED|Overall Study||0||
59692307|NCT01297491|75812034|FG000|NOT COMPLETED|Overall Study||30||
59692308|NCT01297491|75812035|FG001|NOT COMPLETED|Overall Study||33||
59692309|NCT01106092|75812045|FG000|STARTED|Overall Study||78||
59692310|NCT01106092|75812046|FG001|STARTED|Overall Study||78||
59692311|NCT01106092|75812047|FG002|STARTED|Overall Study||78||
59692312|NCT01106092|75812048|FG003|STARTED|Overall Study||78||
59692313|NCT01106092|75812045|FG000|COMPLETED|Overall Study||78||
59692314|NCT01106092|75812046|FG001|COMPLETED|Overall Study||78||
59692315|NCT01106092|75812047|FG002|COMPLETED|Overall Study||78||
59692316|NCT01106092|75812048|FG003|COMPLETED|Overall Study||77||
59692317|NCT01106092|75812045|FG000|NOT COMPLETED|Overall Study||0||
59692318|NCT01106092|75812046|FG001|NOT COMPLETED|Overall Study||0||
59692319|NCT01106092|75812047|FG002|NOT COMPLETED|Overall Study||0||
59692320|NCT01106092|75812048|FG003|NOT COMPLETED|Overall Study||1||
59692321|NCT01097668|75812060|FG000|STARTED|Overall Study||21||
59692322|NCT01097668|75812061|FG001|STARTED|Overall Study||22||
59692323|NCT01097668|75812060|FG000|Week 20|Overall Study|Patient evaluability time point = week 20|21||
59692324|NCT01097668|75812061|FG001|Week 20|Overall Study|Patient evaluability time point = week 20|22||
59692325|NCT01097668|75812060|FG000|Week 48|Overall Study||19||
59692326|NCT01097668|75812061|FG001|Week 48|Overall Study||20||
59692327|NCT01097668|75812060|FG000|COMPLETED|Overall Study||19||
59692328|NCT01097668|75812061|FG001|COMPLETED|Overall Study||20||
59692329|NCT01097668|75812060|FG000|NOT COMPLETED|Overall Study||2||
59692330|NCT01097668|75812061|FG001|NOT COMPLETED|Overall Study||2||
59692331|NCT01325207|75812077|FG000|STARTED|Completed 4 Weeks/1 Cycle of Treatment||3||
59692332|NCT01325207|75812078|FG001|STARTED|Completed 4 Weeks/1 Cycle of Treatment||3||
59692333|NCT01325207|75812079|FG002|STARTED|Completed 4 Weeks/1 Cycle of Treatment||1||
59692334|NCT01325207|75812080|FG003|STARTED|Completed 4 Weeks/1 Cycle of Treatment||1||
59692335|NCT01325207|75812081|FG004|STARTED|Completed 4 Weeks/1 Cycle of Treatment||7||
59692336|NCT01325207|75812082|FG005|STARTED|Completed 4 Weeks/1 Cycle of Treatment||19||
59692337|NCT01325207|75812077|FG000|COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||3||
59692338|NCT01325207|75812078|FG001|COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||3||
59692339|NCT01325207|75812079|FG002|COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||1||
59692340|NCT01325207|75812080|FG003|COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||1||
59692341|NCT01325207|75812081|FG004|COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||5||
59692342|NCT01325207|75812082|FG005|COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||19||
59692343|NCT01325207|75812077|FG000|NOT COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||0||
59692344|NCT01325207|75812078|FG001|NOT COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||0||
59692345|NCT01325207|75812079|FG002|NOT COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||0||
59692346|NCT01325207|75812080|FG003|NOT COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||0||
59692347|NCT01325207|75812081|FG004|NOT COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||2||
59692348|NCT01325207|75812082|FG005|NOT COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||0||
59692349|NCT01325207|75812077|FG000|STARTED|Completed 8 Weeks/2 Cycles of Treatment||3||
59692350|NCT01325207|75812078|FG001|STARTED|Completed 8 Weeks/2 Cycles of Treatment||3||
59692351|NCT01325207|75812079|FG002|STARTED|Completed 8 Weeks/2 Cycles of Treatment||1||
59692352|NCT01325207|75812080|FG003|STARTED|Completed 8 Weeks/2 Cycles of Treatment||1||
59692353|NCT01325207|75812081|FG004|STARTED|Completed 8 Weeks/2 Cycles of Treatment||5||
59692354|NCT01325207|75812082|FG005|STARTED|Completed 8 Weeks/2 Cycles of Treatment||19||
59692355|NCT01325207|75812077|FG000|COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||2||
59692356|NCT01325207|75812078|FG001|COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||2||
59692357|NCT01325207|75812079|FG002|COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||1||
59692358|NCT01325207|75812080|FG003|COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||1||
59692359|NCT01325207|75812081|FG004|COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||3||
59692360|NCT01325207|75812082|FG005|COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||14||
59692361|NCT01325207|75812077|FG000|NOT COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||1||
59692362|NCT01325207|75812078|FG001|NOT COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||1||
59692363|NCT01325207|75812079|FG002|NOT COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||0||
59692364|NCT01325207|75812080|FG003|NOT COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||0||
59692365|NCT01325207|75812081|FG004|NOT COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||2||
59692366|NCT01325207|75812082|FG005|NOT COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||5||
59692367|NCT01325207|75812077|FG000|STARTED|Started 9th Week/Cycle 3 of Treatment||2||
59692368|NCT01325207|75812078|FG001|STARTED|Started 9th Week/Cycle 3 of Treatment||2||
59692369|NCT01325207|75812079|FG002|STARTED|Started 9th Week/Cycle 3 of Treatment||1||
59692370|NCT01325207|75812080|FG003|STARTED|Started 9th Week/Cycle 3 of Treatment||1||
59692371|NCT01325207|75812081|FG004|STARTED|Started 9th Week/Cycle 3 of Treatment||3||
59692372|NCT01325207|75812082|FG005|STARTED|Started 9th Week/Cycle 3 of Treatment||14||
59692373|NCT01325207|75812077|FG000|COMPLETED|Started 9th Week/Cycle 3 of Treatment||1||
59692374|NCT01325207|75812078|FG001|COMPLETED|Started 9th Week/Cycle 3 of Treatment||0||
59692375|NCT01325207|75812079|FG002|COMPLETED|Started 9th Week/Cycle 3 of Treatment||0||
59692376|NCT01325207|75812080|FG003|COMPLETED|Started 9th Week/Cycle 3 of Treatment||0||
59692377|NCT01325207|75812081|FG004|COMPLETED|Started 9th Week/Cycle 3 of Treatment||3||
59547572|NCT02465073|75646388|FG001|COMPLETED|Overall Study||15||
59692378|NCT01325207|75812082|FG005|COMPLETED|Started 9th Week/Cycle 3 of Treatment||9||
59692379|NCT01325207|75812077|FG000|NOT COMPLETED|Started 9th Week/Cycle 3 of Treatment||1||
59692380|NCT01325207|75812078|FG001|NOT COMPLETED|Started 9th Week/Cycle 3 of Treatment||2||
59692381|NCT01325207|75812079|FG002|NOT COMPLETED|Started 9th Week/Cycle 3 of Treatment||1||
59692382|NCT01325207|75812080|FG003|NOT COMPLETED|Started 9th Week/Cycle 3 of Treatment||1||
59692383|NCT01325207|75812081|FG004|NOT COMPLETED|Started 9th Week/Cycle 3 of Treatment||0||
59692384|NCT01325207|75812082|FG005|NOT COMPLETED|Started 9th Week/Cycle 3 of Treatment||5||
59692385|NCT01325207|75812077|FG000|STARTED|Follow-up Every 3 Months Until Death||3|All patients treated on study went into the follow up period.|
59692386|NCT01325207|75812078|FG001|STARTED|Follow-up Every 3 Months Until Death||3|All patients treated on study went into the follow up period.|
59692387|NCT01325207|75812079|FG002|STARTED|Follow-up Every 3 Months Until Death||1|All patients treated on study went into the follow up period.|
59692388|NCT01325207|75812080|FG003|STARTED|Follow-up Every 3 Months Until Death||1|All patients treated on study went into the follow up period.|
59692389|NCT01325207|75812081|FG004|STARTED|Follow-up Every 3 Months Until Death||7|All patients treated on study went into the follow up period.|
59692390|NCT01325207|75812082|FG005|STARTED|Follow-up Every 3 Months Until Death||19|All patients treated on study went into the follow up period.|
59692391|NCT01325207|75812077|FG000|COMPLETED|Follow-up Every 3 Months Until Death||3||
59692392|NCT01325207|75812078|FG001|COMPLETED|Follow-up Every 3 Months Until Death||3||
59692393|NCT01325207|75812079|FG002|COMPLETED|Follow-up Every 3 Months Until Death||1||
59692394|NCT01325207|75812080|FG003|COMPLETED|Follow-up Every 3 Months Until Death||1||
59692395|NCT01325207|75812081|FG004|COMPLETED|Follow-up Every 3 Months Until Death||6||
59692396|NCT01325207|75812082|FG005|COMPLETED|Follow-up Every 3 Months Until Death||18||
59692397|NCT01325207|75812077|FG000|NOT COMPLETED|Follow-up Every 3 Months Until Death||0||
59692398|NCT01325207|75812078|FG001|NOT COMPLETED|Follow-up Every 3 Months Until Death||0||
59692399|NCT01325207|75812079|FG002|NOT COMPLETED|Follow-up Every 3 Months Until Death||0||
59692400|NCT01325207|75812080|FG003|NOT COMPLETED|Follow-up Every 3 Months Until Death||0||
59692401|NCT01325207|75812081|FG004|NOT COMPLETED|Follow-up Every 3 Months Until Death||1||
59692402|NCT01325207|75812082|FG005|NOT COMPLETED|Follow-up Every 3 Months Until Death||1||
59692403|NCT01324349|75812099|FG000|STARTED|Overall Study||32||
59692404|NCT01324349|75812100|FG001|STARTED|Overall Study||18||
59692405|NCT01324349|75812099|FG000|COMPLETED|Overall Study||31||
59692406|NCT01324349|75812100|FG001|COMPLETED|Overall Study||16||
59692407|NCT01324349|75812099|FG000|NOT COMPLETED|Overall Study||1||
59692408|NCT01324349|75812100|FG001|NOT COMPLETED|Overall Study||2||
59692409|NCT01095250|75812110|FG000|STARTED|Overall Study||8||
59692410|NCT01095250|75812111|FG001|STARTED|Overall Study||10||
59692411|NCT01095250|75812112|FG002|STARTED|Overall Study||8||
59692412|NCT01095250|75812113|FG003|STARTED|Overall Study||5||
59692413|NCT01095250|75812110|FG000|COMPLETED|Overall Study||0||
59692414|NCT01095250|75812111|FG001|COMPLETED|Overall Study||0||
59692415|NCT01095250|75812112|FG002|COMPLETED|Overall Study||0||
59692416|NCT01095250|75812113|FG003|COMPLETED|Overall Study||0||
59547573|NCT02465073|75646389|FG002|COMPLETED|Overall Study||15||
59547574|NCT02465073|75646387|FG000|NOT COMPLETED|Overall Study||2||
59547575|NCT02465073|75646388|FG001|NOT COMPLETED|Overall Study||1||
59547576|NCT02465073|75646389|FG002|NOT COMPLETED|Overall Study||1||
59547577|NCT02524977|75646399|FG000|STARTED|Overall Study||738||
59547578|NCT02524977|75646400|FG001|STARTED|Overall Study||846||
59547579|NCT02524977|75646399|FG000|COMPLETED|Overall Study||692||
59547580|NCT02524977|75646400|FG001|COMPLETED|Overall Study||801||
59547581|NCT02524977|75646399|FG000|NOT COMPLETED|Overall Study||46||
59547582|NCT02524977|75646400|FG001|NOT COMPLETED|Overall Study||45||
59547583|NCT01103414|75646413|FG000|STARTED|Overall Study||72||
59547584|NCT01103414|75646414|FG001|STARTED|Overall Study||71||
59692417|NCT01095250|75812110|FG000|NOT COMPLETED|Overall Study||8||
59692418|NCT01095250|75812111|FG001|NOT COMPLETED|Overall Study||10||
59692419|NCT01095250|75812112|FG002|NOT COMPLETED|Overall Study||8||
59692420|NCT01095250|75812113|FG003|NOT COMPLETED|Overall Study||5||
59692421|NCT01324271|75812123|FG000|STARTED|Overall Study||57||
59692422|NCT01324271|75812124|FG001|STARTED|Overall Study||28||
59692423|NCT01324271|75812123|FG000|COMPLETED|Overall Study||53||
59692424|NCT01324271|75812124|FG001|COMPLETED|Overall Study||28||
59692425|NCT01324271|75812123|FG000|NOT COMPLETED|Overall Study||4||
59692426|NCT01324271|75812124|FG001|NOT COMPLETED|Overall Study||0||
59692427|NCT01095094|75812130|FG000|STARTED|Overall Study||19||
59692428|NCT01095094|75812130|FG000|COMPLETED|Overall Study||16||
59692429|NCT01095094|75812130|FG000|NOT COMPLETED|Overall Study||3||
59692430|NCT01323647|75812136|FG000|STARTED|Overall Study||470||
59692431|NCT01323647|75812137|FG001|STARTED|Overall Study||487||
59692432|NCT01323647|75812136|FG000|COMPLETED|Overall Study||461||
59692433|NCT01323647|75812137|FG001|COMPLETED|Overall Study||487||
59692434|NCT01323647|75812136|FG000|NOT COMPLETED|Overall Study||9||
59692435|NCT01323647|75812137|FG001|NOT COMPLETED|Overall Study||0||
59692436|NCT01094782|75812149|FG000|STARTED|Overall Study||39||
59692437|NCT01094782|75812150|FG001|STARTED|Overall Study||39||
59692438|NCT01094782|75812151|FG002|STARTED|Overall Study||34||
59692439|NCT01094782|75812152|FG003|STARTED|Overall Study||56||
59692440|NCT01094782|75812153|FG004|STARTED|Overall Study||42||
59692441|NCT01094782|75812154|FG005|STARTED|Overall Study||38||
59692442|NCT01094782|75812149|FG000|COMPLETED|Overall Study||31||
59692443|NCT01094782|75812150|FG001|COMPLETED|Overall Study||29||
59692444|NCT01094782|75812151|FG002|COMPLETED|Overall Study||31||
59692445|NCT01094782|75812152|FG003|COMPLETED|Overall Study||45||
59692446|NCT01094782|75812153|FG004|COMPLETED|Overall Study||31||
59692447|NCT01094782|75812154|FG005|COMPLETED|Overall Study||30||
59692448|NCT01094782|75812149|FG000|NOT COMPLETED|Overall Study||8||
59692449|NCT01094782|75812150|FG001|NOT COMPLETED|Overall Study||10||
59692450|NCT01094782|75812151|FG002|NOT COMPLETED|Overall Study||3||
59692451|NCT01094782|75812152|FG003|NOT COMPLETED|Overall Study||11||
59692452|NCT01094782|75812153|FG004|NOT COMPLETED|Overall Study||11||
59692453|NCT01094782|75812154|FG005|NOT COMPLETED|Overall Study||8||
59692454|NCT01097044|75812170|FG000|STARTED|Overall Study||39||
59692455|NCT01097044|75812171|FG001|STARTED|Overall Study||38||
59692456|NCT01097044|75812170|FG000|COMPLETED|Overall Study||34||
59692457|NCT01097044|75812171|FG001|COMPLETED|Overall Study||33||
59692458|NCT01097044|75812170|FG000|NOT COMPLETED|Overall Study||5||
59692459|NCT01097044|75812171|FG001|NOT COMPLETED|Overall Study||5||
59692460|NCT01322009|75812181|FG000|STARTED|Overall Study||7||
59692461|NCT01322009|75812182|FG001|STARTED|Overall Study||7||
59692462|NCT01322009|75812181|FG000|COMPLETED|Overall Study||7||
59692463|NCT01322009|75812182|FG001|COMPLETED|Overall Study||4||
59547585|NCT01103414|75646415|FG002|STARTED|Overall Study||71||
59547586|NCT01103414|75646416|FG003|STARTED|Overall Study||71||
59547587|NCT01103414|75646417|FG004|STARTED|Overall Study||71||
59547588|NCT01103414|75646413|FG000|COMPLETED|Overall Study||59||
59692464|NCT01322009|75812181|FG000|NOT COMPLETED|Overall Study||0||
59692465|NCT01322009|75812182|FG001|NOT COMPLETED|Overall Study||3||
59547589|NCT01103414|75646414|FG001|COMPLETED|Overall Study||62||
59547590|NCT01103414|75646415|FG002|COMPLETED|Overall Study||56||
59692466|NCT01321697|75812188|FG000|STARTED|Overall Study||7||
59692467|NCT01321697|75812188|FG000|COMPLETED|Overall Study||0||
59692468|NCT01321697|75812188|FG000|NOT COMPLETED|Overall Study||7||
59692469|NCT01320683|75812192|FG000|STARTED|Overall Study||1||
59692470|NCT01320683|75812192|FG000|COMPLETED|Overall Study||0||
59692471|NCT01320683|75812192|FG000|NOT COMPLETED|Overall Study||1||
59692472|NCT01320293|75812196|FG000|STARTED|Overall Study||18||
59692473|NCT01320293|75812196|FG000|COMPLETED|Overall Study||16||
59692474|NCT01320293|75812196|FG000|NOT COMPLETED|Overall Study||2||
59692475|NCT01318811|75812202|FG000|STARTED|Overall Study||4||
59692476|NCT01318811|75812203|FG001|STARTED|Overall Study||8||
59692477|NCT01318811|75812202|FG000|COMPLETED|Overall Study||3||
59692478|NCT01318811|75812203|FG001|COMPLETED|Overall Study||4||
59692479|NCT01318811|75812202|FG000|NOT COMPLETED|Overall Study||1||
59692480|NCT01318811|75812203|FG001|NOT COMPLETED|Overall Study||4||
59692481|NCT01093846|75812212|FG000|STARTED|Overall Study||19||
59692482|NCT01093846|75812213|FG001|STARTED|Overall Study||18||
59692483|NCT01093846|75812214|FG002|STARTED|Overall Study||22||
59692484|NCT01093846|75812212|FG000|COMPLETED|Overall Study||0||
59692485|NCT01093846|75812213|FG001|COMPLETED|Overall Study||0||
59692486|NCT01093846|75812214|FG002|COMPLETED|Overall Study||1||
59692487|NCT01093846|75812212|FG000|NOT COMPLETED|Overall Study||19||
59692488|NCT01093846|75812213|FG001|NOT COMPLETED|Overall Study||18||
59692489|NCT01093846|75812214|FG002|NOT COMPLETED|Overall Study||21||
59692490|NCT01315847|75812222|FG000|STARTED|Part I, Period 1|Subjects who participated in Part I did not participate in Part III.|5||
59692491|NCT01315847|75812223|FG001|STARTED|Part I, Period 1||0||
59692492|NCT01315847|75812222|FG000|Received Telcagepant|Part I, Period 1||5||
59692493|NCT01315847|75812223|FG001|Received Telcagepant|Part I, Period 1||0||
59692494|NCT01315847|75812222|FG000|Received [11C]MK-4232|Part I, Period 1|One of these participants received [11C]MK-4232 only at baseline.|5||
59692495|NCT01315847|75812223|FG001|Received [11C]MK-4232|Part I, Period 1||0||
59692496|NCT01315847|75812222|FG000|COMPLETED|Part I, Period 1||2||
59692497|NCT01315847|75812223|FG001|COMPLETED|Part I, Period 1||0||
59692498|NCT01315847|75812222|FG000|NOT COMPLETED|Part I, Period 1||3||
59692499|NCT01315847|75812223|FG001|NOT COMPLETED|Part I, Period 1||0||
59692500|NCT01315847|75812222|FG000|STARTED|Part I, Period 2|One of these subjects did not participate in Part I, Period 1.|3||
59692501|NCT01315847|75812223|FG001|STARTED|Part I, Period 2||0||
59692502|NCT01315847|75812222|FG000|Received Telcagepant|Part I, Period 2||3||
59692503|NCT01315847|75812223|FG001|Received Telcagepant|Part I, Period 2||0||
59692504|NCT01315847|75812222|FG000|Received [11C]MK-4232|Part I, Period 2||3||
59692505|NCT01315847|75812223|FG001|Received [11C]MK-4232|Part I, Period 2||0||
59692506|NCT01315847|75812222|FG000|COMPLETED|Part I, Period 2||3||
59692507|NCT01315847|75812223|FG001|COMPLETED|Part I, Period 2||0||
59692508|NCT01315847|75812222|FG000|NOT COMPLETED|Part I, Period 2||0||
59692509|NCT01315847|75812223|FG001|NOT COMPLETED|Part I, Period 2||0||
59692510|NCT01315847|75812222|FG000|STARTED|Part III, Period 1||0||
59692511|NCT01315847|75812223|FG001|STARTED|Part III, Period 1|Subjects who participated in Part III did not participate in Part I.|4||
59692512|NCT01315847|75812222|FG000|Received Telcagepant|Part III, Period 1||0||
59692513|NCT01315847|75812223|FG001|Received Telcagepant|Part III, Period 1||4||
59692514|NCT01315847|75812222|FG000|Received [11C]MK-4232|Part III, Period 1||0||
59692515|NCT01315847|75812223|FG001|Received [11C]MK-4232|Part III, Period 1|One of these participants received [11C]MK-4232 only at baseline.|4||
59692516|NCT01315847|75812222|FG000|COMPLETED|Part III, Period 1||0||
59692517|NCT01315847|75812223|FG001|COMPLETED|Part III, Period 1||3||
59692518|NCT01315847|75812222|FG000|NOT COMPLETED|Part III, Period 1||0||
59692519|NCT01315847|75812223|FG001|NOT COMPLETED|Part III, Period 1||1||
59692520|NCT01315847|75812222|FG000|STARTED|Part III, Period 2||0||
59692521|NCT01315847|75812223|FG001|STARTED|Part III, Period 2||3||
59692522|NCT01315847|75812222|FG000|Received Telcagepant|Part III, Period 2||0||
59692523|NCT01315847|75812223|FG001|Received Telcagepant|Part III, Period 2||3||
59816128|NCT00528866|75938484|FG000|STARTED|Overall Study||80||
59816129|NCT00528866|75938484|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|74||
59816130|NCT00528866|75938484|FG000|NOT COMPLETED|Overall Study||6||
59816131|NCT00614393|75938494|FG000|STARTED|Overall Study||180||
59816132|NCT00614393|75938495|FG001|STARTED|Overall Study||8||
59816133|NCT00614393|75938496|FG002|STARTED|Overall Study||10||
59816134|NCT00614393|75938497|FG003|STARTED|Overall Study||180||
59816135|NCT00614393|75938498|FG004|STARTED|Overall Study||180||
59816136|NCT00614393|75938494|FG000|Treated|Overall Study||180||
59989822|NCT02446886|76105225|FG001|STARTED|Overall Study||7||
59989823|NCT02446886|76105224|FG000|COMPLETED|Overall Study||6||
59989824|NCT02446886|76105225|FG001|COMPLETED|Overall Study||3||
59989825|NCT02446886|76105224|FG000|NOT COMPLETED|Overall Study||2||
59547591|NCT01103414|75646416|FG003|COMPLETED|Overall Study||64||
59547592|NCT01103414|75646417|FG004|COMPLETED|Overall Study||56||
59547593|NCT01103414|75646413|FG000|NOT COMPLETED|Overall Study||13||
59547594|NCT01103414|75646414|FG001|NOT COMPLETED|Overall Study||9||
59547595|NCT01103414|75646415|FG002|NOT COMPLETED|Overall Study||15||
59547596|NCT01103414|75646416|FG003|NOT COMPLETED|Overall Study||7||
59547597|NCT01103414|75646417|FG004|NOT COMPLETED|Overall Study||15||
59547598|NCT01103492|75646429|FG000|STARTED|Overall Study||1||
59547599|NCT01103492|75646429|FG000|COMPLETED|Overall Study||1||
59547600|NCT01103492|75646429|FG000|NOT COMPLETED|Overall Study||0||
59547601|NCT02525055|75646439|FG000|STARTED|Overall Study||6||
59547602|NCT02525055|75646440|FG001|STARTED|Overall Study||6||
59547603|NCT02525055|75646441|FG002|STARTED|Overall Study||6||
59547604|NCT02525055|75646442|FG003|STARTED|Overall Study||6||
59547605|NCT02525055|75646443|FG004|STARTED|Overall Study||6||
59547606|NCT02525055|75646444|FG005|STARTED|Overall Study||16||
59547607|NCT02525055|75646439|FG000|COMPLETED|Overall Study||6||
59547608|NCT02525055|75646440|FG001|COMPLETED|Overall Study||6||
59692524|NCT01315847|75812222|FG000|Received [11C]MK-4232|Part III, Period 2||0||
59692525|NCT01315847|75812223|FG001|Received [11C]MK-4232|Part III, Period 2||3||
59692526|NCT01315847|75812222|FG000|COMPLETED|Part III, Period 2||0||
59692527|NCT01315847|75812223|FG001|COMPLETED|Part III, Period 2||3||
59692528|NCT01315847|75812222|FG000|NOT COMPLETED|Part III, Period 2||0||
59692529|NCT01315847|75812223|FG001|NOT COMPLETED|Part III, Period 2||0||
59692530|NCT01093534|75812232|FG000|STARTED|Overall Study||186||
59692531|NCT01093534|75812233|FG001|STARTED|Overall Study||183||
59692532|NCT01093534|75812234|FG002|STARTED|Overall Study||178||
59692533|NCT01093534|75812232|FG000|Received Study Treatment|Overall Study||186||
59692534|NCT01093534|75812233|FG001|Received Study Treatment|Overall Study||182||
59692535|NCT01093534|75812234|FG002|Received Study Treatment|Overall Study||175||
59692536|NCT01093534|75812232|FG000|COMPLETED|Overall Study||176||
59692537|NCT01093534|75812233|FG001|COMPLETED|Overall Study||167||
59692538|NCT01093534|75812234|FG002|COMPLETED|Overall Study||169||
59692539|NCT01093534|75812232|FG000|NOT COMPLETED|Overall Study||10||
59692540|NCT01093534|75812233|FG001|NOT COMPLETED|Overall Study||16||
59692541|NCT01093534|75812234|FG002|NOT COMPLETED|Overall Study||9||
59692542|NCT01314911|75812245|FG000|STARTED|Overall Study||278||
59692543|NCT01314911|75812246|FG001|STARTED|Overall Study||280||
59692544|NCT01314911|75812245|FG000|COMPLETED|Overall Study||273|Data were locked on July 12, 2018 and were retrieved on August 14, 2018.|
59692545|NCT01314911|75812246|FG001|COMPLETED|Overall Study||274|Data were locked on July 12, 2018 and were retrieved on August 14, 2018.|
59692546|NCT01314911|75812245|FG000|NOT COMPLETED|Overall Study||5||
59692547|NCT01314911|75812246|FG001|NOT COMPLETED|Overall Study||6||
59692548|NCT01093222|75812252|FG000|STARTED|Overall Study||40||
59692549|NCT01093222|75812252|FG000|Eligible and Began Protocol Therapy|Overall Study||34||
59692550|NCT01093222|75812252|FG000|COMPLETED|Overall Study||0||
59692551|NCT01093222|75812252|FG000|NOT COMPLETED|Overall Study||40||
59692552|NCT01313663|75812258|FG000|STARTED|Overall Study||9||
59692553|NCT01313663|75812259|FG001|STARTED|Overall Study||11||
59692554|NCT01313663|75812258|FG000|COMPLETED|Overall Study||5||
59692555|NCT01313663|75812259|FG001|COMPLETED|Overall Study||3||
59692556|NCT01313663|75812258|FG000|NOT COMPLETED|Overall Study||4||
59692557|NCT01313663|75812259|FG001|NOT COMPLETED|Overall Study||8||
59692558|NCT01092832|75812267|FG000|STARTED|Overall Study||14||
59692559|NCT01092832|75812268|FG001|STARTED|Overall Study||8||
59692560|NCT01092832|75812267|FG000|COMPLETED|Overall Study||13||
59692561|NCT01092832|75812268|FG001|COMPLETED|Overall Study||8||
59692562|NCT01092832|75812267|FG000|NOT COMPLETED|Overall Study||1||
59692563|NCT01092832|75812268|FG001|NOT COMPLETED|Overall Study||0||
59692564|NCT01313273|75812276|FG000|STARTED|Overall Study||2||
59692565|NCT01313273|75812277|FG001|STARTED|Overall Study||1||
59692566|NCT01313273|75812276|FG000|COMPLETED|Overall Study||0||
59692567|NCT01313273|75812277|FG001|COMPLETED|Overall Study||0||
59692568|NCT01313273|75812276|FG000|NOT COMPLETED|Overall Study||2||
59692569|NCT01313273|75812277|FG001|NOT COMPLETED|Overall Study||1||
59692570|NCT01091974|75812287|FG000|STARTED|Overall Study||24||
59692571|NCT01091974|75812288|FG001|STARTED|Overall Study||23||
59692572|NCT01091974|75812289|FG002|STARTED|Overall Study||25||
59692573|NCT01091974|75812290|FG003|STARTED|Overall Study||24||
59692574|NCT01091974|75812287|FG000|COMPLETED|Overall Study||19||
59692575|NCT01091974|75812288|FG001|COMPLETED|Overall Study||18||
59692576|NCT01091974|75812289|FG002|COMPLETED|Overall Study||19||
59692577|NCT01091974|75812290|FG003|COMPLETED|Overall Study||17||
59692578|NCT01091974|75812287|FG000|NOT COMPLETED|Overall Study||5||
59692579|NCT01091974|75812288|FG001|NOT COMPLETED|Overall Study||5||
59692580|NCT01091974|75812289|FG002|NOT COMPLETED|Overall Study||6||
59692581|NCT01091974|75812290|FG003|NOT COMPLETED|Overall Study||7||
59692582|NCT01313117|75812300|FG000|STARTED|Cohort 1: Dose Level 1 (ALA 300mg Daily)||2||
59692583|NCT01313117|75812300|FG000|COMPLETED|Cohort 1: Dose Level 1 (ALA 300mg Daily)||2||
59692584|NCT01313117|75812300|FG000|NOT COMPLETED|Cohort 1: Dose Level 1 (ALA 300mg Daily)||0||
59692585|NCT01313117|75812300|FG000|STARTED|Cohort 2: Dose Level 2 (ALA 600mg Daily)||2||
59692586|NCT01313117|75812300|FG000|COMPLETED|Cohort 2: Dose Level 2 (ALA 600mg Daily)||1||
59692587|NCT01313117|75812300|FG000|NOT COMPLETED|Cohort 2: Dose Level 2 (ALA 600mg Daily)||1||
59692588|NCT01313117|75812300|FG000|STARTED|Cohort 3: Dose Level 3 (ALA 400mg Daily)||2||
59692589|NCT01313117|75812300|FG000|COMPLETED|Cohort 3: Dose Level 3 (ALA 400mg Daily)||2||
59692590|NCT01313117|75812300|FG000|NOT COMPLETED|Cohort 3: Dose Level 3 (ALA 400mg Daily)||0||
59692591|NCT01313117|75812300|FG000|STARTED|Cohort 4: Dose Level 4 (ALA 500mg Daily)||2||
59692592|NCT01313117|75812300|FG000|COMPLETED|Cohort 4: Dose Level 4 (ALA 500mg Daily)||2||
59692593|NCT01313117|75812300|FG000|NOT COMPLETED|Cohort 4: Dose Level 4 (ALA 500mg Daily)||0||
59692594|NCT01313117|75812300|FG000|STARTED|Cohort 5: Dose Level 2 (ALA 600mg Daily)||1||
59692595|NCT01313117|75812300|FG000|COMPLETED|Cohort 5: Dose Level 2 (ALA 600mg Daily)||0||
59692596|NCT01313117|75812300|FG000|NOT COMPLETED|Cohort 5: Dose Level 2 (ALA 600mg Daily)||1||
59692597|NCT01313039|75812305|FG000|STARTED|Overall Study||4||
59692598|NCT01313039|75812305|FG000|COMPLETED|Overall Study||2||
59692599|NCT01313039|75812305|FG000|NOT COMPLETED|Overall Study||2||
59692600|NCT01091662|75812311|FG000|STARTED|Overall Study||58||
59692601|NCT01091662|75812312|FG001|STARTED|Overall Study||114||
59692602|NCT01091662|75812311|FG000|COMPLETED|Overall Study||41||
59692603|NCT01091662|75812312|FG001|COMPLETED|Overall Study||80||
59692604|NCT01091662|75812311|FG000|NOT COMPLETED|Overall Study||17||
59692605|NCT01091662|75812312|FG001|NOT COMPLETED|Overall Study||34||
59989826|NCT02446886|76105225|FG001|NOT COMPLETED|Overall Study||4||
59989827|NCT04351243|76105234|FG000|STARTED|Overall Study||114||
59989828|NCT04351243|76105235|FG001|STARTED|Overall Study||113||
59989829|NCT04351243|76105234|FG000|Completed Baseline Assessment|Overall Study||113||
59989830|NCT04351243|76105235|FG001|Completed Baseline Assessment|Overall Study||112||
59989831|NCT04351243|76105234|FG000|COMPLETED|Overall Study||74||
59989832|NCT04351243|76105235|FG001|COMPLETED|Overall Study||75||
59989833|NCT04351243|76105234|FG000|NOT COMPLETED|Overall Study||40||
59989834|NCT04351243|76105235|FG001|NOT COMPLETED|Overall Study||38||
59989835|NCT03448939|76105243|FG000|STARTED|Overall Study||243||
59989836|NCT03448939|76105244|FG001|STARTED|Overall Study||118||
59989837|NCT03448939|76105243|FG000|Received at Least 1 Dose of Study Drug|Overall Study||239||
59989838|NCT03448939|76105244|FG001|Received at Least 1 Dose of Study Drug|Overall Study||113||
59989839|NCT03448939|76105243|FG000|COMPLETED|Overall Study||222||
59989840|NCT03448939|76105244|FG001|COMPLETED|Overall Study||107||
59989841|NCT03448939|76105243|FG000|NOT COMPLETED|Overall Study||21||
59989842|NCT03448939|76105244|FG001|NOT COMPLETED|Overall Study||11||
59989843|NCT03851107|76105250|FG000|STARTED|Overall Study||9||
59692606|NCT01312961|75812325|FG000|STARTED|Overall Study||52||
59692607|NCT01312961|75812326|FG001|STARTED|Overall Study||52||
59692608|NCT01312961|75812325|FG000|Treated|Overall Study||52||
59692609|NCT01312961|75812326|FG001|Treated|Overall Study||52||
59692610|NCT01312961|75812325|FG000|COMPLETED|Overall Study||35||
59692611|NCT01312961|75812326|FG001|COMPLETED|Overall Study||45||
59692612|NCT01312961|75812325|FG000|NOT COMPLETED|Overall Study||17||
59692613|NCT01312961|75812326|FG001|NOT COMPLETED|Overall Study||7||
59692614|NCT01311557|75812335|FG000|STARTED|Overall Study||651||
59692615|NCT01311557|75812336|FG001|STARTED|Overall Study||651||
59692616|NCT01311557|75812335|FG000|COMPLETED|Overall Study||646||
59692617|NCT01311557|75812336|FG001|COMPLETED|Overall Study||645||
59692618|NCT01311557|75812335|FG000|NOT COMPLETED|Overall Study||5||
59692619|NCT01311557|75812336|FG001|NOT COMPLETED|Overall Study||6||
59692620|NCT01310777|75812345|FG000|STARTED|Overall Study||193||
59989844|NCT03851107|76105250|FG000|COMPLETED|Overall Study||7||
59989845|NCT03851107|76105250|FG000|NOT COMPLETED|Overall Study||2||
59692621|NCT01310777|75812346|FG001|STARTED|Overall Study||192||
59692622|NCT01310777|75812347|FG002|STARTED|Overall Study||175||
59692623|NCT01310777|75812345|FG000|COMPLETED|Overall Study||160||
59692624|NCT01310777|75812346|FG001|COMPLETED|Overall Study||178||
59692625|NCT01310777|75812347|FG002|COMPLETED|Overall Study||145||
59692626|NCT01310777|75812345|FG000|NOT COMPLETED|Overall Study||33||
59692627|NCT01310777|75812346|FG001|NOT COMPLETED|Overall Study||14||
59692628|NCT01310777|75812347|FG002|NOT COMPLETED|Overall Study||30||
59692629|NCT01310699|75812357|FG000|STARTED|Overall Study||132||
59692630|NCT01310699|75812358|FG001|STARTED|Overall Study||149||
59692631|NCT01310699|75812357|FG000|COMPLETED|Overall Study||128||
59692632|NCT01310699|75812358|FG001|COMPLETED|Overall Study||143||
59692633|NCT01310699|75812357|FG000|NOT COMPLETED|Overall Study||4||
59692634|NCT01310699|75812358|FG001|NOT COMPLETED|Overall Study||6||
59692635|NCT01310075|75812368|FG000|STARTED|Overall Study||45||
59692636|NCT01310075|75812369|FG001|STARTED|Overall Study||45||
59692637|NCT01310075|75812368|FG000|COMPLETED|Overall Study||31||
59692638|NCT01310075|75812369|FG001|COMPLETED|Overall Study||35||
59692639|NCT01310075|75812368|FG000|NOT COMPLETED|Overall Study||14||
59692640|NCT01310075|75812369|FG001|NOT COMPLETED|Overall Study||10||
59692641|NCT01309997|75812377|FG000|STARTED|Overall Study||35||
59692642|NCT01309997|75812378|FG001|STARTED|Overall Study||37||
59692643|NCT01309997|75812377|FG000|Remained on First Arm Only|Overall Study||16||
59692644|NCT01309997|75812378|FG001|Remained on First Arm Only|Overall Study||14||
59692645|NCT01309997|75812377|FG000|Crossed Over to Second Arm|Overall Study||19||
59692646|NCT01309997|75812378|FG001|Crossed Over to Second Arm|Overall Study||23||
59692647|NCT01309997|75812377|FG000|COMPLETED|Overall Study||30||
59692648|NCT01309997|75812378|FG001|COMPLETED|Overall Study||31||
59692649|NCT01309997|75812377|FG000|NOT COMPLETED|Overall Study||5||
59692650|NCT01309997|75812378|FG001|NOT COMPLETED|Overall Study||6||
59692651|NCT01309919|75812397|FG000|STARTED|Overall Study||75||
59692652|NCT01309919|75812398|FG001|STARTED|Overall Study||75||
59989846|NCT02504294|76105262|FG000|STARTED|Overall Study||212||
59989847|NCT02504294|76105263|FG001|STARTED|Overall Study||206||
59989848|NCT02504294|76105262|FG000|COMPLETED|Overall Study||156||
59989849|NCT02504294|76105263|FG001|COMPLETED|Overall Study||158||
59989850|NCT02504294|76105262|FG000|NOT COMPLETED|Overall Study||56||
59692653|NCT01309919|75812397|FG000|COMPLETED|Overall Study||58||
59692654|NCT01309919|75812398|FG001|COMPLETED|Overall Study||27||
59692655|NCT01309919|75812397|FG000|NOT COMPLETED|Overall Study||17||
59692656|NCT01309919|75812398|FG001|NOT COMPLETED|Overall Study||48||
59989851|NCT02504294|76105263|FG001|NOT COMPLETED|Overall Study||48||
59692657|NCT01309841|75812407|FG000|STARTED|Overall Study||217||
59692658|NCT01309841|75812408|FG001|STARTED|Overall Study||218||
59692659|NCT01309841|75812409|FG002|STARTED|Overall Study||217||
59692660|NCT01309841|75812407|FG000|COMPLETED|Overall Study||178||
59692661|NCT01309841|75812408|FG001|COMPLETED|Overall Study||177||
59692662|NCT01309841|75812409|FG002|COMPLETED|Overall Study||180||
59692663|NCT01309841|75812407|FG000|NOT COMPLETED|Overall Study||39||
59692664|NCT01309841|75812408|FG001|NOT COMPLETED|Overall Study||41||
59692665|NCT01309841|75812409|FG002|NOT COMPLETED|Overall Study||37||
59692666|NCT01308749|75812419|FG000|STARTED|Period 1: Double Blind Treatment||12||
59692667|NCT01308749|75812420|FG001|STARTED|Period 1: Double Blind Treatment||13||
59692668|NCT01308749|75812419|FG000|COMPLETED|Period 1: Double Blind Treatment||11||
59692669|NCT01308749|75812420|FG001|COMPLETED|Period 1: Double Blind Treatment||13||
59692670|NCT01308749|75812419|FG000|NOT COMPLETED|Period 1: Double Blind Treatment||1||
59692671|NCT01308749|75812420|FG001|NOT COMPLETED|Period 1: Double Blind Treatment||0||
59692672|NCT01308749|75812419|FG000|STARTED|Period 2: Open Label Treatment||11||
59692673|NCT01308749|75812420|FG001|STARTED|Period 2: Open Label Treatment||13||
59692674|NCT01308749|75812419|FG000|COMPLETED|Period 2: Open Label Treatment||11||
59692675|NCT01308749|75812420|FG001|COMPLETED|Period 2: Open Label Treatment||11||
59692676|NCT01308749|75812419|FG000|NOT COMPLETED|Period 2: Open Label Treatment||0||
59692677|NCT01308749|75812420|FG001|NOT COMPLETED|Period 2: Open Label Treatment||2||
59692678|NCT01307891|75812442|FG000|STARTED|Overall Study||42||
59692679|NCT01307891|75812443|FG001|STARTED|Overall Study||22||
59692680|NCT01307891|75812442|FG000|COMPLETED|Overall Study||39||
59692681|NCT01307891|75812443|FG001|COMPLETED|Overall Study||21||
59692682|NCT01307891|75812442|FG000|NOT COMPLETED|Overall Study||3||
59692683|NCT01307891|75812443|FG001|NOT COMPLETED|Overall Study||1||
59692684|NCT01307579|75812451|FG000|STARTED|Overall Study||257||
59692685|NCT01307579|75812452|FG001|STARTED|Overall Study||260||
59692686|NCT01307579|75812451|FG000|COMPLETED|Overall Study||117||
59692687|NCT01307579|75812452|FG001|COMPLETED|Overall Study||115||
59692688|NCT01307579|75812451|FG000|NOT COMPLETED|Overall Study||140||
59692689|NCT01307579|75812452|FG001|NOT COMPLETED|Overall Study||145||
59692690|NCT01057693|75812458|FG000|STARTED|Single-Blind Phase (Up to Week 6)||665||
59692691|NCT01057693|75812459|FG001|STARTED|Single-Blind Phase (Up to Week 6)||0||
59692692|NCT01057693|75812460|FG002|STARTED|Single-Blind Phase (Up to Week 6)||0||
59692693|NCT01057693|75812458|FG000|COMPLETED|Single-Blind Phase (Up to Week 6)||566||
59692694|NCT01057693|75812459|FG001|COMPLETED|Single-Blind Phase (Up to Week 6)||0||
59692695|NCT01057693|75812460|FG002|COMPLETED|Single-Blind Phase (Up to Week 6)||0||
59692696|NCT01057693|75812458|FG000|NOT COMPLETED|Single-Blind Phase (Up to Week 6)||99||
59692697|NCT01057693|75812459|FG001|NOT COMPLETED|Single-Blind Phase (Up to Week 6)||0||
59692698|NCT01057693|75812460|FG002|NOT COMPLETED|Single-Blind Phase (Up to Week 6)||0||
59692699|NCT01057693|75812458|FG000|STARTED|Between Single-Blind and Double-Blind||566||
59692700|NCT01057693|75812459|FG001|STARTED|Between Single-Blind and Double-Blind||0||
59692701|NCT01057693|75812460|FG002|STARTED|Between Single-Blind and Double-Blind||0||
59692702|NCT01057693|75812458|FG000|COMPLETED|Between Single-Blind and Double-Blind||296||
59692703|NCT01057693|75812459|FG001|COMPLETED|Between Single-Blind and Double-Blind||0||
59692704|NCT01057693|75812460|FG002|COMPLETED|Between Single-Blind and Double-Blind||0||
59692705|NCT01057693|75812458|FG000|NOT COMPLETED|Between Single-Blind and Double-Blind||270||
59692706|NCT01057693|75812459|FG001|NOT COMPLETED|Between Single-Blind and Double-Blind||0||
59692707|NCT01057693|75812460|FG002|NOT COMPLETED|Between Single-Blind and Double-Blind||0||
59692708|NCT01057693|75812458|FG000|STARTED|Double-Blind Phase (Week 7 to Week 19)||0||
59692709|NCT01057693|75812459|FG001|STARTED|Double-Blind Phase (Week 7 to Week 19)||147||
59692710|NCT01057693|75812460|FG002|STARTED|Double-Blind Phase (Week 7 to Week 19)||149||
59692711|NCT01057693|75812458|FG000|Treated|Double-Blind Phase (Week 7 to Week 19)||0||
59692712|NCT01057693|75812459|FG001|Treated|Double-Blind Phase (Week 7 to Week 19)||147||
59692713|NCT01057693|75812460|FG002|Treated|Double-Blind Phase (Week 7 to Week 19)||147||
59692714|NCT01057693|75812458|FG000|COMPLETED|Double-Blind Phase (Week 7 to Week 19)||0||
59692715|NCT01057693|75812459|FG001|COMPLETED|Double-Blind Phase (Week 7 to Week 19)||125||
59816137|NCT00614393|75938495|FG001|Treated|Overall Study||8||
59692716|NCT01057693|75812460|FG002|COMPLETED|Double-Blind Phase (Week 7 to Week 19)||113||
59692717|NCT01057693|75812458|FG000|NOT COMPLETED|Double-Blind Phase (Week 7 to Week 19)||0||
59692718|NCT01057693|75812459|FG001|NOT COMPLETED|Double-Blind Phase (Week 7 to Week 19)||22||
59692719|NCT01057693|75812460|FG002|NOT COMPLETED|Double-Blind Phase (Week 7 to Week 19)||36||
59692720|NCT01307501|75812468|FG000|STARTED|Overall Study||40||60
59692721|NCT01307501|75812468|FG000|Intent-to-Treat (ITT) Population|Overall Study||40|Participants for whom cryoablation via Galil Medical Cryoablation System was attempted or performed.|60
59692722|NCT01307501|75812468|FG000|COMPLETED|Overall Study||17||23
59692723|NCT01307501|75812468|FG000|NOT COMPLETED|Overall Study||23||37
59692724|NCT01034137|75812475|FG000|STARTED|Overall Study||106||
59692725|NCT01034137|75812476|FG001|STARTED|Overall Study||103||
59692726|NCT01034137|75812477|FG002|STARTED|Overall Study||108||
59692727|NCT01034137|75812475|FG000|COMPLETED|Overall Study||78||
59692728|NCT01034137|75812476|FG001|COMPLETED|Overall Study||81||
59692729|NCT01034137|75812477|FG002|COMPLETED|Overall Study||78||
59692730|NCT01034137|75812475|FG000|NOT COMPLETED|Overall Study||28||
59692731|NCT01034137|75812476|FG001|NOT COMPLETED|Overall Study||22||
59692732|NCT01034137|75812477|FG002|NOT COMPLETED|Overall Study||30||
59692733|NCT01056289|75812486|FG000|STARTED|Open-label Phase||480||
59692734|NCT01056289|75812487|FG001|STARTED|Open-label Phase||0||
59692735|NCT01056289|75812488|FG002|STARTED|Open-label Phase||0||
59692736|NCT01056289|75812489|FG003|STARTED|Open-label Phase||0||
59692737|NCT01056289|75812486|FG000|COMPLETED|Open-label Phase|Participants transitioned to Double-blind phase|361||
59692738|NCT01056289|75812487|FG001|COMPLETED|Open-label Phase||0||
59692739|NCT01056289|75812488|FG002|COMPLETED|Open-label Phase||0||
59692740|NCT01056289|75812489|FG003|COMPLETED|Open-label Phase||0||
59692741|NCT01056289|75812486|FG000|NOT COMPLETED|Open-label Phase||119||
59692742|NCT01056289|75812487|FG001|NOT COMPLETED|Open-label Phase||0||
59692743|NCT01056289|75812488|FG002|NOT COMPLETED|Open-label Phase||0||
59692744|NCT01056289|75812489|FG003|NOT COMPLETED|Open-label Phase||0||
59692745|NCT01056289|75812486|FG000|STARTED|Double-blind Phase||0||
59692746|NCT01056289|75812487|FG001|STARTED|Double-blind Phase||73||
59692747|NCT01056289|75812488|FG002|STARTED|Double-blind Phase||140||
59692748|NCT01056289|75812489|FG003|STARTED|Double-blind Phase||148||
59692749|NCT01056289|75812486|FG000|COMPLETED|Double-blind Phase||0||
59692750|NCT01056289|75812487|FG001|COMPLETED|Double-blind Phase||69||
59692751|NCT01056289|75812488|FG002|COMPLETED|Double-blind Phase||127||
59692752|NCT01056289|75812489|FG003|COMPLETED|Double-blind Phase||138||
59692753|NCT01056289|75812486|FG000|NOT COMPLETED|Double-blind Phase||0||
59692754|NCT01056289|75812487|FG001|NOT COMPLETED|Double-blind Phase||4||
59692755|NCT01056289|75812488|FG002|NOT COMPLETED|Double-blind Phase||13||
59692756|NCT01056289|75812489|FG003|NOT COMPLETED|Double-blind Phase||10||
59692757|NCT01039675|75812501|FG000|STARTED|Overall Study||9||
59692758|NCT01039675|75812502|FG001|STARTED|Overall Study||42||
59692759|NCT01039675|75812501|FG000|COMPLETED|Overall Study||9||
59692760|NCT01039675|75812502|FG001|COMPLETED|Overall Study||35||
59692761|NCT01039675|75812501|FG000|NOT COMPLETED|Overall Study||0||
59692762|NCT01039675|75812502|FG001|NOT COMPLETED|Overall Study||7||
59692763|NCT01033825|75812515|FG000|STARTED|Overall Study||51||
59692764|NCT01033825|75812516|FG001|STARTED|Overall Study||60||
59692765|NCT01033825|75812517|FG002|STARTED|Overall Study||57||
59692766|NCT01033825|75812518|FG003|STARTED|Overall Study||48||
59692767|NCT01033825|75812519|FG004|STARTED|Overall Study||58||
59692768|NCT01033825|75812520|FG005|STARTED|Overall Study||18||
59692769|NCT01033825|75812521|FG006|STARTED|Overall Study||18||
59692770|NCT01033825|75812515|FG000|COMPLETED|Overall Study||48||
59692771|NCT01033825|75812516|FG001|COMPLETED|Overall Study||57||
59692772|NCT01033825|75812517|FG002|COMPLETED|Overall Study||55||
59692773|NCT01033825|75812518|FG003|COMPLETED|Overall Study||46||
59692774|NCT01033825|75812519|FG004|COMPLETED|Overall Study||56||
59692775|NCT01033825|75812520|FG005|COMPLETED|Overall Study||18||
59692776|NCT01033825|75812521|FG006|COMPLETED|Overall Study||18||
59692777|NCT01033825|75812515|FG000|NOT COMPLETED|Overall Study||3||
59692778|NCT01033825|75812516|FG001|NOT COMPLETED|Overall Study||3||
59692779|NCT01033825|75812517|FG002|NOT COMPLETED|Overall Study||2||
59692780|NCT01033825|75812518|FG003|NOT COMPLETED|Overall Study||2||
59692781|NCT01033825|75812519|FG004|NOT COMPLETED|Overall Study||2||
59692782|NCT01033825|75812520|FG005|NOT COMPLETED|Overall Study||0||
59692783|NCT01033825|75812521|FG006|NOT COMPLETED|Overall Study||0||
59692784|NCT01033747|75812541|FG000|STARTED|Overall Study||51||
59692785|NCT01033747|75812542|FG001|STARTED|Overall Study||19||
59692786|NCT01033747|75812541|FG000|COMPLETED|Overall Study||14||
59692787|NCT01033747|75812542|FG001|COMPLETED|Overall Study||4||
59692788|NCT01033747|75812541|FG000|NOT COMPLETED|Overall Study||37||
59692789|NCT01033747|75812542|FG001|NOT COMPLETED|Overall Study||15||
59692790|NCT01091428|75812552|FG000|STARTED|Phase 1||38||
59692791|NCT01091428|75812553|FG001|STARTED|Phase 1||11||
59692792|NCT01091428|75812554|FG002|STARTED|Phase 1||0||
59692793|NCT01091428|75812555|FG003|STARTED|Phase 1||0||
59692794|NCT01091428|75812552|FG000|COMPLETED|Phase 1|Completed = participants who completed the treatment.|0||
59692795|NCT01091428|75812553|FG001|COMPLETED|Phase 1||0||
59692796|NCT01091428|75812554|FG002|COMPLETED|Phase 1||0||
59692797|NCT01091428|75812555|FG003|COMPLETED|Phase 1||0||
59692798|NCT01091428|75812552|FG000|NOT COMPLETED|Phase 1||38||
59692799|NCT01091428|75812553|FG001|NOT COMPLETED|Phase 1||11||
59692800|NCT01091428|75812554|FG002|NOT COMPLETED|Phase 1||0||
59692801|NCT01091428|75812555|FG003|NOT COMPLETED|Phase 1||0||
59692802|NCT01091428|75812552|FG000|STARTED|Phase 2||0||
59692803|NCT01091428|75812553|FG001|STARTED|Phase 2||0||
59692804|NCT01091428|75812554|FG002|STARTED|Phase 2||73||
59692805|NCT01091428|75812555|FG003|STARTED|Phase 2||69||
59692806|NCT01091428|75812552|FG000|COMPLETED|Phase 2||0||
59692807|NCT01091428|75812553|FG001|COMPLETED|Phase 2||0||
59692808|NCT01091428|75812554|FG002|COMPLETED|Phase 2||0||
59692809|NCT01091428|75812555|FG003|COMPLETED|Phase 2||0||
59692810|NCT01091428|75812552|FG000|NOT COMPLETED|Phase 2||0||
59692811|NCT01091428|75812553|FG001|NOT COMPLETED|Phase 2||0||
59692812|NCT01091428|75812554|FG002|NOT COMPLETED|Phase 2||73||
59692813|NCT01091428|75812555|FG003|NOT COMPLETED|Phase 2||69||
59692814|NCT01096342|75812574|FG000|STARTED|Overall Study||16||
59692815|NCT01096342|75812574|FG000|COMPLETED|Overall Study||15||
59692816|NCT01096342|75812574|FG000|NOT COMPLETED|Overall Study||1||
59692817|NCT01039519|75812578|FG000|STARTED|Treatment||27||
59692818|NCT01039519|75812578|FG000|COMPLETED|Treatment|Reason not completed represents reason for terminating treatment.|0||
59692819|NCT01039519|75812578|FG000|NOT COMPLETED|Treatment||27||
59692820|NCT01039519|75812578|FG000|STARTED|Survival Follow-up||27||
59692821|NCT01039519|75812578|FG000|COMPLETED|Survival Follow-up||0||
59692822|NCT01039519|75812578|FG000|NOT COMPLETED|Survival Follow-up||27||
59692823|NCT01096186|75812582|FG000|STARTED|Overall Study||617||
59692824|NCT01096186|75812582|FG000|COMPLETED|Overall Study||567||
59692825|NCT01096186|75812582|FG000|NOT COMPLETED|Overall Study||50||
59692826|NCT01032889|75812589|FG000|STARTED|Overall Study||41||
59692827|NCT01032889|75812590|FG001|STARTED|Overall Study||43||
59692828|NCT01032889|75812591|FG002|STARTED|Overall Study||45||
59692829|NCT01032889|75812589|FG000|Received Treatment|Overall Study||41||
59692830|NCT01032889|75812590|FG001|Received Treatment|Overall Study||43||
59692831|NCT01032889|75812591|FG002|Received Treatment|Overall Study||45||
59692832|NCT01032889|75812589|FG000|COMPLETED|Overall Study||33||
59692833|NCT01032889|75812590|FG001|COMPLETED|Overall Study||28||
59692834|NCT01032889|75812591|FG002|COMPLETED|Overall Study||42||
59692835|NCT01032889|75812589|FG000|NOT COMPLETED|Overall Study||8||
59692836|NCT01032889|75812590|FG001|NOT COMPLETED|Overall Study||15||
59692837|NCT01032889|75812591|FG002|NOT COMPLETED|Overall Study||3||
59692838|NCT01049503|75812605|FG000|STARTED|Overall Study||52||
59692839|NCT01049503|75812606|FG001|STARTED|Overall Study||48||
59692840|NCT01049503|75812607|FG002|STARTED|Overall Study||56||
59692841|NCT01049503|75812608|FG003|STARTED|Overall Study||55||
59692842|NCT01049503|75812609|FG004|STARTED|Overall Study||56||
59692843|NCT01049503|75812610|FG005|STARTED|Overall Study||48||
59692844|NCT01049503|75812605|FG000|COMPLETED|Overall Study||41||
59692845|NCT01049503|75812606|FG001|COMPLETED|Overall Study||36||
59692846|NCT01049503|75812607|FG002|COMPLETED|Overall Study||32||
59692847|NCT01049503|75812608|FG003|COMPLETED|Overall Study||29||
59692848|NCT01049503|75812609|FG004|COMPLETED|Overall Study||29||
59692849|NCT01049503|75812610|FG005|COMPLETED|Overall Study||40||
59692850|NCT01049503|75812605|FG000|NOT COMPLETED|Overall Study||11||
59692851|NCT01049503|75812606|FG001|NOT COMPLETED|Overall Study||12||
59692852|NCT01049503|75812607|FG002|NOT COMPLETED|Overall Study||24||
59692853|NCT01049503|75812608|FG003|NOT COMPLETED|Overall Study||26||
59692854|NCT01049503|75812609|FG004|NOT COMPLETED|Overall Study||27||
59692855|NCT01049503|75812610|FG005|NOT COMPLETED|Overall Study||8||
59692856|NCT01029925|75812633|FG000|STARTED|Completion of Cycle 1 (28 Days)||7||
59692857|NCT01029925|75812633|FG000|COMPLETED|Completion of Cycle 1 (28 Days)||3||
59692858|NCT01029925|75812633|FG000|NOT COMPLETED|Completion of Cycle 1 (28 Days)||4||
59692859|NCT01029925|75812633|FG000|STARTED|Completion of Cycle 2 (56 Days)||3||
59692860|NCT01029925|75812633|FG000|COMPLETED|Completion of Cycle 2 (56 Days)||2||
59692861|NCT01029925|75812633|FG000|NOT COMPLETED|Completion of Cycle 2 (56 Days)||1||
59692862|NCT01029691|75812640|FG000|STARTED|APAP Initiation to Week 1 or Delivery||20|Assignment to APAP or Standard, not actual beginning of use of APAP vs. standard of care|
59692863|NCT01029691|75812641|FG001|STARTED|APAP Initiation to Week 1 or Delivery|4 delivered before APAP initiation 7 elected not to have APAP following baseline study|27|Assignment to APAP or Standard, not actual beginning of use of APAP vs. standard of care|
59692864|NCT01029691|75812642|FG002|STARTED|APAP Initiation to Week 1 or Delivery||77|Assignment to APAP or Standard, not actual beginning of use of APAP vs. standard of care|
59692865|NCT01029691|75812640|FG000|Baseline Sleep Study|APAP Initiation to Week 1 or Delivery||20||
59692866|NCT01029691|75812641|FG001|Baseline Sleep Study|APAP Initiation to Week 1 or Delivery||23||
59692867|NCT01029691|75812642|FG002|Baseline Sleep Study|APAP Initiation to Week 1 or Delivery||77||
59692868|NCT01029691|75812640|FG000|Began Actual APAP Use|APAP Initiation to Week 1 or Delivery||20||
59692869|NCT01029691|75812641|FG001|Began Actual APAP Use|APAP Initiation to Week 1 or Delivery||16||
59692870|NCT01029691|75812642|FG002|Began Actual APAP Use|APAP Initiation to Week 1 or Delivery||77||
59692871|NCT01029691|75812640|FG000|COMPLETED|APAP Initiation to Week 1 or Delivery||20|Women in APAP arm who reached the 1 week blood pressure measure|
59692872|NCT01029691|75812641|FG001|COMPLETED|APAP Initiation to Week 1 or Delivery||16|Women in APAP arm who reached the 1 week blood pressure measure|
59692873|NCT01029691|75812642|FG002|COMPLETED|APAP Initiation to Week 1 or Delivery||77|Women in APAP arm who reached the 1 week blood pressure measure|
59692874|NCT01029691|75812640|FG000|NOT COMPLETED|APAP Initiation to Week 1 or Delivery||0||
59692875|NCT01029691|75812641|FG001|NOT COMPLETED|APAP Initiation to Week 1 or Delivery||11||
59692876|NCT01029691|75812642|FG002|NOT COMPLETED|APAP Initiation to Week 1 or Delivery||0||
59692877|NCT01029691|75812640|FG000|STARTED|Continued APAP to Delivery||20||
59692878|NCT01029691|75812641|FG001|STARTED|Continued APAP to Delivery||16||
59692879|NCT01029691|75812642|FG002|STARTED|Continued APAP to Delivery||77||
59692880|NCT01029691|75812640|FG000|COMPLETED|Continued APAP to Delivery||20||
59692881|NCT01029691|75812641|FG001|COMPLETED|Continued APAP to Delivery||16||
59692882|NCT01029691|75812642|FG002|COMPLETED|Continued APAP to Delivery||76||
59692883|NCT01029691|75812640|FG000|NOT COMPLETED|Continued APAP to Delivery||0||
59692884|NCT01029691|75812641|FG001|NOT COMPLETED|Continued APAP to Delivery||0||
59692885|NCT01029691|75812642|FG002|NOT COMPLETED|Continued APAP to Delivery||1||
59692886|NCT01029535|75812651|FG000|STARTED|Overall Study||103||
59692887|NCT01029535|75812651|FG000|COMPLETED|Overall Study||72||
59692888|NCT01029535|75812651|FG000|NOT COMPLETED|Overall Study||31||
59692889|NCT01028053|75812656|FG000|STARTED|Overall Study||365||
59692890|NCT01028053|75812656|FG000|COMPLETED|Overall Study||232||
59692891|NCT01028053|75812656|FG000|NOT COMPLETED|Overall Study||133||
59692892|NCT01023217|75812664|FG000|STARTED|Overall Study||45||
59692893|NCT01023217|75812665|FG001|STARTED|Overall Study||45||
59692894|NCT01023217|75812664|FG000|COMPLETED|Overall Study||44||
59692895|NCT01023217|75812665|FG001|COMPLETED|Overall Study||45||
59692896|NCT01023217|75812664|FG000|NOT COMPLETED|Overall Study||1||
59692897|NCT01023217|75812665|FG001|NOT COMPLETED|Overall Study||0||
59692898|NCT01095796|75812673|FG000|STARTED|Overall Study||353||
59692899|NCT01095796|75812674|FG001|STARTED|Overall Study||354||
59692900|NCT01095796|75812673|FG000|COMPLETED|Overall Study||58||
59692901|NCT01095796|75812674|FG001|COMPLETED|Overall Study||65||
59692902|NCT01095796|75812673|FG000|NOT COMPLETED|Overall Study||295||
59692903|NCT01095796|75812674|FG001|NOT COMPLETED|Overall Study||289||
59692904|NCT01023061|75812680|FG000|STARTED|Overall Study||24||
59692905|NCT01023061|75812680|FG000|COMPLETED|Overall Study||22|2 patients enrolled but withdrew from study prior to receiving study therapy|
59692906|NCT01023061|75812680|FG000|NOT COMPLETED|Overall Study||2||
59692907|NCT01027897|75812684|FG000|STARTED|Overall Study||30||
59692908|NCT01027897|75812684|FG000|COMPLETED|Overall Study||28||
59692909|NCT01027897|75812684|FG000|NOT COMPLETED|Overall Study||2||
59692910|NCT01027351|75812694|FG000|STARTED|Overall Study||29||
59692911|NCT01027351|75812695|FG001|STARTED|Overall Study||19||
59692912|NCT01027351|75812696|FG002|STARTED|Overall Study||14||
59692913|NCT01027351|75812697|FG003|STARTED|Overall Study||8||
59692914|NCT01027351|75812698|FG004|STARTED|Overall Study||43||
59692915|NCT01027351|75812699|FG005|STARTED|Overall Study||50||
59692916|NCT01027351|75812694|FG000|COMPLETED|Overall Study||26||
59692917|NCT01027351|75812695|FG001|COMPLETED|Overall Study||18||
59692918|NCT01027351|75812696|FG002|COMPLETED|Overall Study||13||
59692919|NCT01027351|75812697|FG003|COMPLETED|Overall Study||6||
59692920|NCT01027351|75812698|FG004|COMPLETED|Overall Study||32||
59692921|NCT01027351|75812699|FG005|COMPLETED|Overall Study||45||
59692922|NCT01027351|75812694|FG000|NOT COMPLETED|Overall Study||3||
59692923|NCT01027351|75812695|FG001|NOT COMPLETED|Overall Study||1||
59692924|NCT01027351|75812696|FG002|NOT COMPLETED|Overall Study||1||
59692925|NCT01027351|75812697|FG003|NOT COMPLETED|Overall Study||2||
59692926|NCT01027351|75812698|FG004|NOT COMPLETED|Overall Study||11||
59692927|NCT01027351|75812699|FG005|NOT COMPLETED|Overall Study||5||
59692928|NCT01027273|75812722|FG000|STARTED|Overall Study||301||
59692929|NCT01027273|75812723|FG001|STARTED|Overall Study||299||
59692930|NCT01027273|75812722|FG000|COMPLETED|Overall Study||242||
59692931|NCT01027273|75812723|FG001|COMPLETED|Overall Study||266||
59692932|NCT01027273|75812722|FG000|NOT COMPLETED|Overall Study||59||
59692933|NCT01027273|75812723|FG001|NOT COMPLETED|Overall Study||33||
59692934|NCT01022203|75812731|FG000|STARTED|PreTreatment Assessment||58||
59692935|NCT01022203|75812732|FG001|STARTED|PreTreatment Assessment||56||
59692936|NCT01022203|75812731|FG000|COMPLETED|PreTreatment Assessment||58||
59692937|NCT01022203|75812732|FG001|COMPLETED|PreTreatment Assessment||56||
59692938|NCT01022203|75812731|FG000|NOT COMPLETED|PreTreatment Assessment||0||
59692939|NCT01022203|75812732|FG001|NOT COMPLETED|PreTreatment Assessment||0||
59692940|NCT01022203|75812731|FG000|STARTED|Post Treatment Assessment||58||
59692941|NCT01022203|75812732|FG001|STARTED|Post Treatment Assessment||56||
59692942|NCT01022203|75812731|FG000|COMPLETED|Post Treatment Assessment||44||
59692943|NCT01022203|75812732|FG001|COMPLETED|Post Treatment Assessment||42||
59692944|NCT01022203|75812731|FG000|NOT COMPLETED|Post Treatment Assessment||14||
59692945|NCT01022203|75812732|FG001|NOT COMPLETED|Post Treatment Assessment||14||
59692946|NCT01022203|75812731|FG000|STARTED|Follow-Up Assessment||44||
59692947|NCT01022203|75812732|FG001|STARTED|Follow-Up Assessment||42||
59692948|NCT01022203|75812731|FG000|COMPLETED|Follow-Up Assessment||42||
59692949|NCT01022203|75812732|FG001|COMPLETED|Follow-Up Assessment||40||
59692950|NCT01022203|75812731|FG000|NOT COMPLETED|Follow-Up Assessment||2||
59692951|NCT01022203|75812732|FG001|NOT COMPLETED|Follow-Up Assessment||2||
59692952|NCT01296711|75812749|FG000|STARTED|Overall Study||20||
59692953|NCT01296711|75812750|FG001|STARTED|Overall Study||20||
59692954|NCT01296711|75812751|FG002|STARTED|Overall Study||21||
59692955|NCT01296711|75812752|FG003|STARTED|Overall Study||20||
59692956|NCT01296711|75812753|FG004|STARTED|Overall Study||17||
59692957|NCT01296711|75812754|FG005|STARTED|Overall Study||16||
59692958|NCT01296711|75812755|FG006|STARTED|Overall Study||40||
59692959|NCT01296711|75812756|FG007|STARTED|Overall Study||36||
59692960|NCT01296711|75812749|FG000|COMPLETED|Overall Study||4||
59692961|NCT01296711|75812750|FG001|COMPLETED|Overall Study||12||
59692962|NCT01296711|75812751|FG002|COMPLETED|Overall Study||8||
59692963|NCT01296711|75812752|FG003|COMPLETED|Overall Study||7||
59692964|NCT01296711|75812753|FG004|COMPLETED|Overall Study||7||
59692965|NCT01296711|75812754|FG005|COMPLETED|Overall Study||5||
59692966|NCT01296711|75812755|FG006|COMPLETED|Overall Study||9||
59692967|NCT01296711|75812756|FG007|COMPLETED|Overall Study||15||
59692968|NCT01296711|75812749|FG000|NOT COMPLETED|Overall Study||16||
59692969|NCT01296711|75812750|FG001|NOT COMPLETED|Overall Study||8||
59692970|NCT01296711|75812751|FG002|NOT COMPLETED|Overall Study||13||
59692971|NCT01296711|75812752|FG003|NOT COMPLETED|Overall Study||13||
59692972|NCT01296711|75812753|FG004|NOT COMPLETED|Overall Study||10||
59692973|NCT01296711|75812754|FG005|NOT COMPLETED|Overall Study||11||
59692974|NCT01296711|75812755|FG006|NOT COMPLETED|Overall Study||31||
59692975|NCT01296711|75812756|FG007|NOT COMPLETED|Overall Study||21||
59692976|NCT01294917|75812774|FG000|STARTED|Overall Study||42||
59692977|NCT01294917|75812774|FG000|Received Investigational MPS|Overall Study||36||
59692978|NCT01294917|75812774|FG000|Received Clear Care|Overall Study||36||
59692979|NCT01294917|75812774|FG000|Received OptiFree RepleniSH MPS|Overall Study||36||
59692980|NCT01294917|75812774|FG000|COMPLETED|Overall Study||36||
59692981|NCT01294917|75812774|FG000|NOT COMPLETED|Overall Study||6||
59692982|NCT01294683|75812782|FG000|STARTED|Precrossover (Periods I/II)||489||
59692983|NCT01294683|75812783|FG001|STARTED|Precrossover (Periods I/II)||488||
59692984|NCT01294683|75812782|FG000|Treated|Precrossover (Periods I/II)||486||
59692985|NCT01294683|75812783|FG001|Treated|Precrossover (Periods I/II)||486||
59692986|NCT01294683|75812782|FG000|COMPLETED|Precrossover (Periods I/II)||232||
59692987|NCT01294683|75812783|FG001|COMPLETED|Precrossover (Periods I/II)||222||
59692988|NCT01294683|75812782|FG000|NOT COMPLETED|Precrossover (Periods I/II)||257||
59692989|NCT01294683|75812783|FG001|NOT COMPLETED|Precrossover (Periods I/II)||266||
59692990|NCT01294683|75812782|FG000|STARTED|Post Crossover (Period III)||232||
59692991|NCT01294683|75812783|FG001|STARTED|Post Crossover (Period III)||222||
59692992|NCT01294683|75812782|FG000|COMPLETED|Post Crossover (Period III)||199||
59692993|NCT01294683|75812783|FG001|COMPLETED|Post Crossover (Period III)||190||
59692994|NCT01294683|75812782|FG000|NOT COMPLETED|Post Crossover (Period III)||33||
59692995|NCT01294683|75812783|FG001|NOT COMPLETED|Post Crossover (Period III)||32||
59692996|NCT01294449|75812797|FG000|STARTED|Overall Study||156||
59692997|NCT01294449|75812798|FG001|STARTED|Overall Study||252||
59692998|NCT01294449|75812797|FG000|Consent to Registry|Overall Study||149||
59692999|NCT01294449|75812798|FG001|Consent to Registry|Overall Study||245||
59693000|NCT01294449|75812797|FG000|COMPLETED|Overall Study||144||
59693001|NCT01294449|75812798|FG001|COMPLETED|Overall Study||237||
59693002|NCT01294449|75812797|FG000|NOT COMPLETED|Overall Study||12||
59693003|NCT01294449|75812798|FG001|NOT COMPLETED|Overall Study||15||
59693004|NCT01294371|75812804|FG000|STARTED|Overall Study||391||
59693005|NCT01294371|75812804|FG000|Treated|Overall Study||390||
59693006|NCT01294371|75812804|FG000|COMPLETED|Overall Study||357||
59693007|NCT01294371|75812804|FG000|NOT COMPLETED|Overall Study||34||
59693008|NCT01293123|75812813|FG000|STARTED|Overall Study||1||
59693009|NCT01293123|75812814|FG001|STARTED|Overall Study||1||
59693010|NCT01293123|75812813|FG000|COMPLETED|Overall Study||1||
59693011|NCT01293123|75812814|FG001|COMPLETED|Overall Study||0||
59693012|NCT01293123|75812813|FG000|NOT COMPLETED|Overall Study||0||
59693013|NCT01293123|75812814|FG001|NOT COMPLETED|Overall Study||1||
59693014|NCT01292187|75812822|FG000|STARTED|Overall Study||86||
59693015|NCT01292187|75812823|FG001|STARTED|Overall Study||43||
59693016|NCT01292187|75812822|FG000|COMPLETED|Overall Study||69||
59693017|NCT01292187|75812823|FG001|COMPLETED|Overall Study||30||
59693018|NCT01292187|75812822|FG000|NOT COMPLETED|Overall Study||17||
59693019|NCT01292187|75812823|FG001|NOT COMPLETED|Overall Study||13||
59693020|NCT01026493|75812838|FG000|STARTED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|8||
59693021|NCT01026493|75812839|FG001|STARTED|Overall Study||7||
59693022|NCT01026493|75812840|FG002|STARTED|Overall Study||9||
59547609|NCT02525055|75646441|FG002|COMPLETED|Overall Study||6||
59693023|NCT01026493|75812841|FG003|STARTED|Overall Study||8||
59693024|NCT01026493|75812842|FG004|STARTED|Overall Study||75||
59693025|NCT01026493|75812843|FG005|STARTED|Overall Study||76||
59693026|NCT01026493|75812844|FG006|STARTED|Overall Study||36||
59693027|NCT01026493|75812845|FG007|STARTED|Overall Study||38||
59693028|NCT01026493|75812838|FG000|COMPLETED|Overall Study||8||
59693029|NCT01026493|75812839|FG001|COMPLETED|Overall Study||6||
59693030|NCT01026493|75812840|FG002|COMPLETED|Overall Study||9||
59693031|NCT01026493|75812841|FG003|COMPLETED|Overall Study||8||
59693032|NCT01026493|75812842|FG004|COMPLETED|Overall Study||73||
59693033|NCT01026493|75812843|FG005|COMPLETED|Overall Study||73||
59693034|NCT01026493|75812844|FG006|COMPLETED|Overall Study||32||
59693035|NCT01026493|75812845|FG007|COMPLETED|Overall Study||37||
59693036|NCT01026493|75812838|FG000|NOT COMPLETED|Overall Study||0||
59693037|NCT01026493|75812839|FG001|NOT COMPLETED|Overall Study||1||
59693038|NCT01026493|75812840|FG002|NOT COMPLETED|Overall Study||0||
59693039|NCT01026493|75812841|FG003|NOT COMPLETED|Overall Study||0||
59693040|NCT01026493|75812842|FG004|NOT COMPLETED|Overall Study||2||
59693041|NCT01026493|75812843|FG005|NOT COMPLETED|Overall Study||3||
59693042|NCT01026493|75812844|FG006|NOT COMPLETED|Overall Study||4||
59693043|NCT01026493|75812845|FG007|NOT COMPLETED|Overall Study||1||
59693044|NCT01026103|75812863|FG000|STARTED|Overall Study||30||
59693045|NCT01026103|75812863|FG000|Consented|Overall Study||30||
59693046|NCT01026103|75812863|FG000|COMPLETED|Overall Study||28||
59693047|NCT01026103|75812863|FG000|NOT COMPLETED|Overall Study||2||
59693048|NCT01291173|75812871|FG000|STARTED|Overall Study||64||
59693049|NCT01291173|75812872|FG001|STARTED|Overall Study||66||
59693050|NCT01291173|75812873|FG002|STARTED|Overall Study||65||
59693051|NCT01291173|75812874|FG003|STARTED|Overall Study||65||
59693052|NCT01291173|75812871|FG000|COMPLETED|Overall Study||47||
59693053|NCT01291173|75812872|FG001|COMPLETED|Overall Study||51||
59693054|NCT01291173|75812873|FG002|COMPLETED|Overall Study||52||
59693055|NCT01291173|75812874|FG003|COMPLETED|Overall Study||52||
59693056|NCT01291173|75812871|FG000|NOT COMPLETED|Overall Study||17||
59693057|NCT01291173|75812872|FG001|NOT COMPLETED|Overall Study||15||
59693058|NCT01291173|75812873|FG002|NOT COMPLETED|Overall Study||13||
59693059|NCT01291173|75812874|FG003|NOT COMPLETED|Overall Study||13||
59693060|NCT01291017|75812884|FG000|STARTED|Overall Study||19||
59693061|NCT01291017|75812884|FG000|COMPLETED|Overall Study||14||
59693062|NCT01291017|75812884|FG000|NOT COMPLETED|Overall Study||5||
59693063|NCT01290315|75812892|FG000|STARTED|Overall Study||14||
59693064|NCT01290315|75812893|FG001|STARTED|Overall Study||12||
59693065|NCT01290315|75812894|FG002|STARTED|Overall Study||10||
59693066|NCT01290315|75812895|FG003|STARTED|Overall Study||13||
59693067|NCT01290315|75812892|FG000|COMPLETED|Overall Study||11||
59693068|NCT01290315|75812893|FG001|COMPLETED|Overall Study||9||
59693069|NCT01290315|75812894|FG002|COMPLETED|Overall Study||10||
59693070|NCT01290315|75812895|FG003|COMPLETED|Overall Study||8||
59693071|NCT01290315|75812892|FG000|NOT COMPLETED|Overall Study||3||
59693072|NCT01290315|75812893|FG001|NOT COMPLETED|Overall Study||3||
59693073|NCT01290315|75812894|FG002|NOT COMPLETED|Overall Study||0||
59693074|NCT01290315|75812895|FG003|NOT COMPLETED|Overall Study||5||
59693075|NCT01289847|75812904|FG000|STARTED|Overall Study||25||
59693076|NCT01289847|75812904|FG000|COMPLETED|Overall Study||24||
59693077|NCT01289847|75812904|FG000|NOT COMPLETED|Overall Study||1||
59693078|NCT01079182|75812908|FG000|STARTED|Overall Study||4681||
59693079|NCT01079182|75812908|FG000|COMPLETED|Overall Study||1962||
59693080|NCT01079182|75812908|FG000|NOT COMPLETED|Overall Study||2719||
59693081|NCT01021813|75812914|FG000|STARTED|DB Treatment Phase||522||
59693082|NCT01021813|75812915|FG001|STARTED|DB Treatment Phase||259||
59693083|NCT01021813|75812916|FG002|STARTED|DB Treatment Phase||0||
59693084|NCT01021813|75812917|FG003|STARTED|DB Treatment Phase||0||
59693085|NCT01021813|75812918|FG004|STARTED|DB Treatment Phase||0||
59693086|NCT01021813|75812914|FG000|Treated|DB Treatment Phase||521||
59693087|NCT01021813|75812915|FG001|Treated|DB Treatment Phase||258||
59693088|NCT01021813|75812916|FG002|Treated|DB Treatment Phase||0||
59693089|NCT01021813|75812917|FG003|Treated|DB Treatment Phase||0||
59693090|NCT01021813|75812918|FG004|Treated|DB Treatment Phase||0||
59693091|NCT01021813|75812914|FG000|COMPLETED|DB Treatment Phase||322||
59693092|NCT01021813|75812915|FG001|COMPLETED|DB Treatment Phase||162||
59693093|NCT01021813|75812916|FG002|COMPLETED|DB Treatment Phase||0||
59693094|NCT01021813|75812917|FG003|COMPLETED|DB Treatment Phase||0||
59693095|NCT01021813|75812918|FG004|COMPLETED|DB Treatment Phase||0||
59693096|NCT01021813|75812914|FG000|NOT COMPLETED|DB Treatment Phase||200||
59693097|NCT01021813|75812915|FG001|NOT COMPLETED|DB Treatment Phase||97||
59693098|NCT01021813|75812916|FG002|NOT COMPLETED|DB Treatment Phase||0||
59693099|NCT01021813|75812917|FG003|NOT COMPLETED|DB Treatment Phase||0||
59693100|NCT01021813|75812918|FG004|NOT COMPLETED|DB Treatment Phase||0||
59693101|NCT01021813|75812914|FG000|STARTED|DB Randomized Discontinuation Phase||0||
59693102|NCT01021813|75812915|FG001|STARTED|DB Randomized Discontinuation Phase||0||
59693103|NCT01021813|75812916|FG002|STARTED|DB Randomized Discontinuation Phase||156||
59693104|NCT01021813|75812917|FG003|STARTED|DB Randomized Discontinuation Phase||166||
59693105|NCT01021813|75812918|FG004|STARTED|DB Randomized Discontinuation Phase||162||
59693106|NCT01021813|75812914|FG000|COMPLETED|DB Randomized Discontinuation Phase||0||
59693107|NCT01021813|75812915|FG001|COMPLETED|DB Randomized Discontinuation Phase||0||
59693108|NCT01021813|75812916|FG002|COMPLETED|DB Randomized Discontinuation Phase||152||
59693109|NCT01021813|75812917|FG003|COMPLETED|DB Randomized Discontinuation Phase||161||
59693110|NCT01021813|75812918|FG004|COMPLETED|DB Randomized Discontinuation Phase||157||
59693111|NCT01021813|75812914|FG000|NOT COMPLETED|DB Randomized Discontinuation Phase||0||
59693112|NCT01021813|75812915|FG001|NOT COMPLETED|DB Randomized Discontinuation Phase||0||
59693113|NCT01021813|75812916|FG002|NOT COMPLETED|DB Randomized Discontinuation Phase||4||
59693114|NCT01021813|75812917|FG003|NOT COMPLETED|DB Randomized Discontinuation Phase||5||
59693115|NCT01021813|75812918|FG004|NOT COMPLETED|DB Randomized Discontinuation Phase||5||
59693116|NCT01025635|75812937|FG000|STARTED|Overall Study||198||
59693117|NCT01025635|75812938|FG001|STARTED|Overall Study||203||
59693118|NCT01025635|75812937|FG000|COMPLETED|Overall Study||175||
59693119|NCT01025635|75812938|FG001|COMPLETED|Overall Study||178||
59693120|NCT01025635|75812937|FG000|NOT COMPLETED|Overall Study||23||
59693121|NCT01025635|75812938|FG001|NOT COMPLETED|Overall Study||25||
59693122|NCT01021423|75812946|FG000|STARTED|Overall Study|One participant discontinued treatment (continued in the study) due to an AE|4||
59693123|NCT01021423|75812947|FG001|STARTED|Overall Study|One participant discontinued treatment (continued in the study) due to disease progression|5||
59693124|NCT01021423|75812946|FG000|COMPLETED|Overall Study||0||
59693125|NCT01021423|75812947|FG001|COMPLETED|Overall Study||0||
59693126|NCT01021423|75812946|FG000|NOT COMPLETED|Overall Study||4||
59693127|NCT01021423|75812947|FG001|NOT COMPLETED|Overall Study||5||
59693128|NCT01020877|75812955|FG000|STARTED|First Intervention||19||
59693129|NCT01020877|75812956|FG001|STARTED|First Intervention||19||
59693130|NCT01020877|75812955|FG000|COMPLETED|First Intervention||19||
59693131|NCT01020877|75812956|FG001|COMPLETED|First Intervention||19||
59693132|NCT01020877|75812955|FG000|NOT COMPLETED|First Intervention||0||
59693133|NCT01020877|75812956|FG001|NOT COMPLETED|First Intervention||0||
59693134|NCT01020877|75812955|FG000|STARTED|Washout of 7 Days||19||
59693135|NCT01020877|75812956|FG001|STARTED|Washout of 7 Days||19||
59693136|NCT01020877|75812955|FG000|COMPLETED|Washout of 7 Days||19||
59693137|NCT01020877|75812956|FG001|COMPLETED|Washout of 7 Days||19||
59693138|NCT01020877|75812955|FG000|NOT COMPLETED|Washout of 7 Days||0||
59693139|NCT01020877|75812956|FG001|NOT COMPLETED|Washout of 7 Days||0||
59693140|NCT01020877|75812955|FG000|STARTED|Second Intervention||19||
59693141|NCT01020877|75812956|FG001|STARTED|Second Intervention||19||
59693142|NCT01020877|75812955|FG000|COMPLETED|Second Intervention||18||
59693143|NCT01020877|75812956|FG001|COMPLETED|Second Intervention||19||
59693144|NCT01020877|75812955|FG000|NOT COMPLETED|Second Intervention||1||
59693145|NCT01020877|75812956|FG001|NOT COMPLETED|Second Intervention||0||
59693146|NCT01020799|75812965|FG000|STARTED|Overall Study||98||
59693147|NCT01020799|75812966|FG001|STARTED|Overall Study||99||
59693148|NCT01020799|75812967|FG002|STARTED|Overall Study||50||
59693149|NCT01020799|75812965|FG000|Patients Received Treatment|Overall Study||96||
59693150|NCT01020799|75812966|FG001|Patients Received Treatment|Overall Study||99||
59693151|NCT01020799|75812967|FG002|Patients Received Treatment|Overall Study||50||
59693152|NCT01020799|75812965|FG000|Full Analysis Set|Overall Study||91||
59693153|NCT01020799|75812966|FG001|Full Analysis Set|Overall Study||94||
59693154|NCT01020799|75812967|FG002|Full Analysis Set|Overall Study||49||
59693155|NCT01020799|75812965|FG000|COMPLETED|Overall Study||79||
59693156|NCT01020799|75812966|FG001|COMPLETED|Overall Study||85||
59693157|NCT01020799|75812967|FG002|COMPLETED|Overall Study||43||
59693158|NCT01020799|75812965|FG000|NOT COMPLETED|Overall Study||19||
59693159|NCT01020799|75812966|FG001|NOT COMPLETED|Overall Study||14||
59693160|NCT01020799|75812967|FG002|NOT COMPLETED|Overall Study||7||
59693161|NCT01288989|75812980|FG000|STARTED|Overall Study||6||
59693162|NCT01288989|75812981|FG001|STARTED|Overall Study||3||
59693163|NCT01288989|75812982|FG002|STARTED|Overall Study||3||
59693164|NCT01288989|75812983|FG003|STARTED|Overall Study||11||
59693165|NCT01288989|75812984|FG004|STARTED|Overall Study||21||
59693166|NCT01288989|75812980|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6||
59693167|NCT01288989|75812981|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3||
59693168|NCT01288989|75812982|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3||
59693169|NCT01288989|75812983|FG003|Received at Least 1 Dose of Study Drug|Overall Study||11||
59693170|NCT01288989|75812984|FG004|Received at Least 1 Dose of Study Drug|Overall Study||21||
59693171|NCT01288989|75812980|FG000|COMPLETED|Overall Study||5||
59693172|NCT01288989|75812981|FG001|COMPLETED|Overall Study||3||
59693173|NCT01288989|75812982|FG002|COMPLETED|Overall Study||3||
59693174|NCT01288989|75812983|FG003|COMPLETED|Overall Study||10||
59693175|NCT01288989|75812984|FG004|COMPLETED|Overall Study||15||
59693176|NCT01288989|75812980|FG000|NOT COMPLETED|Overall Study||1||
59693177|NCT01288989|75812981|FG001|NOT COMPLETED|Overall Study||0||
59693178|NCT01288989|75812982|FG002|NOT COMPLETED|Overall Study||0||
59693179|NCT01288989|75812983|FG003|NOT COMPLETED|Overall Study||1||
59693180|NCT01288989|75812984|FG004|NOT COMPLETED|Overall Study||6||
59693181|NCT01020487|75813005|FG000|STARTED|Part 1||12||
59693182|NCT01020487|75813006|FG001|STARTED|Part 1||0||
59693183|NCT01020487|75813007|FG002|STARTED|Part 1||0||
59693184|NCT01020487|75813005|FG000|COMPLETED|Part 1||12||
59693185|NCT01020487|75813006|FG001|COMPLETED|Part 1||0||
59693186|NCT01020487|75813007|FG002|COMPLETED|Part 1||0||
59693187|NCT01020487|75813005|FG000|NOT COMPLETED|Part 1||0||
59693188|NCT01020487|75813006|FG001|NOT COMPLETED|Part 1||0||
59693189|NCT01020487|75813007|FG002|NOT COMPLETED|Part 1||0||
59693190|NCT01020487|75813005|FG000|STARTED|Part 2 Double-blind Treatment Period||0||
59816138|NCT00614393|75938496|FG002|Treated|Overall Study||10||
59693191|NCT01020487|75813006|FG001|STARTED|Part 2 Double-blind Treatment Period|Includes one participant who enrolled in Part 2 after completing Part 1|18||
59693192|NCT01020487|75813007|FG002|STARTED|Part 2 Double-blind Treatment Period|Includes one participant who enrolled in Part 2 after completing Part 1|19||
59693193|NCT01020487|75813005|FG000|Received Treatment|Part 2 Double-blind Treatment Period||0||
59693194|NCT01020487|75813006|FG001|Received Treatment|Part 2 Double-blind Treatment Period||18||
59693195|NCT01020487|75813007|FG002|Received Treatment|Part 2 Double-blind Treatment Period||18||
59693196|NCT01020487|75813005|FG000|COMPLETED|Part 2 Double-blind Treatment Period||0||
59693197|NCT01020487|75813006|FG001|COMPLETED|Part 2 Double-blind Treatment Period||16||
59693198|NCT01020487|75813007|FG002|COMPLETED|Part 2 Double-blind Treatment Period||13||
59693199|NCT01020487|75813005|FG000|NOT COMPLETED|Part 2 Double-blind Treatment Period||0||
59693200|NCT01020487|75813006|FG001|NOT COMPLETED|Part 2 Double-blind Treatment Period||2||
59693201|NCT01020487|75813007|FG002|NOT COMPLETED|Part 2 Double-blind Treatment Period||6||
59693202|NCT01020487|75813005|FG000|STARTED|Part 2 Open-label Period||0||
59693203|NCT01020487|75813006|FG001|STARTED|Part 2 Open-label Period||16||
59693204|NCT01020487|75813007|FG002|STARTED|Part 2 Open-label Period||13||
59693205|NCT01020487|75813005|FG000|COMPLETED|Part 2 Open-label Period||0||
59693206|NCT01020487|75813006|FG001|COMPLETED|Part 2 Open-label Period||12||
59989852|NCT02446418|76105271|FG000|STARTED|Overall Study||210||
59989853|NCT02446418|76105272|FG001|STARTED|Overall Study||210||
59989854|NCT02446418|76105271|FG000|COMPLETED|Overall Study||192||
59989855|NCT02446418|76105272|FG001|COMPLETED|Overall Study||194||
59989856|NCT02446418|76105271|FG000|NOT COMPLETED|Overall Study||18||
59989857|NCT02446418|76105272|FG001|NOT COMPLETED|Overall Study||16||
59989858|NCT02445794|76105282|FG000|STARTED|Overall Study||6||
60079402|NCT04206332|76194704|FG004|COMPLETED|Part A||3||
60079403|NCT04206332|76194705|FG005|COMPLETED|Part A||0||
60079404|NCT04206332|76194706|FG006|COMPLETED|Part A||0||
60079405|NCT04206332|76194707|FG007|COMPLETED|Part A||0||
59693207|NCT01020487|75813007|FG002|COMPLETED|Part 2 Open-label Period||12||
59989859|NCT02445794|76105283|FG001|STARTED|Overall Study||3||
59989860|NCT02445794|76105284|FG002|STARTED|Overall Study||7||
59989861|NCT02445794|76105285|FG003|STARTED|Overall Study||3||
59989862|NCT02445794|76105282|FG000|COMPLETED|Overall Study||6||
59989863|NCT02445794|76105283|FG001|COMPLETED|Overall Study||3||
59989864|NCT02445794|76105284|FG002|COMPLETED|Overall Study||5||
59989865|NCT02445794|76105285|FG003|COMPLETED|Overall Study||3||
59989866|NCT02445794|76105282|FG000|NOT COMPLETED|Overall Study||0||
59989867|NCT02445794|76105283|FG001|NOT COMPLETED|Overall Study||0||
59989868|NCT02445794|76105284|FG002|NOT COMPLETED|Overall Study||2||
59989869|NCT02445794|76105285|FG003|NOT COMPLETED|Overall Study||0||
59989870|NCT02475278|76105300|FG000|STARTED|Overall Study||50||
59989871|NCT02475278|76105300|FG000|COMPLETED|Overall Study||48||
59989872|NCT02475278|76105300|FG000|NOT COMPLETED|Overall Study||2||
59989873|NCT02254486|76105306|FG000|STARTED|Overall Study||311||
59989874|NCT02254486|76105307|FG001|STARTED|Overall Study||310||
59989875|NCT02254486|76105306|FG000|COMPLETED|Overall Study||261||
59989876|NCT02254486|76105307|FG001|COMPLETED|Overall Study||255||
60079406|NCT04206332|76194708|FG008|COMPLETED|Part A||0||
60079407|NCT04206332|76194709|FG009|COMPLETED|Part A||0||
60079408|NCT04206332|76194710|FG010|COMPLETED|Part A||0||
59693208|NCT01020487|75813005|FG000|NOT COMPLETED|Part 2 Open-label Period||0||
59693209|NCT01020487|75813006|FG001|NOT COMPLETED|Part 2 Open-label Period||4||
59693210|NCT01020487|75813007|FG002|NOT COMPLETED|Part 2 Open-label Period||1||
59693211|NCT01024855|75813017|FG000|STARTED|Overall Study|30 subjects enrolled in a paired/split-eye evaluation; each subject used both study treatments|30||
59989877|NCT02254486|76105306|FG000|NOT COMPLETED|Overall Study||50||
59989878|NCT02254486|76105307|FG001|NOT COMPLETED|Overall Study||55||
59989879|NCT01641640|76105313|FG000|STARTED|Overall Study||328||
59693212|NCT01024855|75813017|FG000|COMPLETED|Overall Study|One subject of the 30 seen for baseline did not meet the inclusion/exclusion criteria|29||
59693213|NCT01024855|75813017|FG000|NOT COMPLETED|Overall Study||1||
59693214|NCT01014013|75813024|FG000|STARTED|Overall Study||135||
59693215|NCT01014013|75813025|FG001|STARTED|Overall Study||136||
59693216|NCT01014013|75813024|FG000|Adverse Event Reporting|Overall Study|Patients who received at least 1 dose of MK0826 parenteral therapy|132||
59693217|NCT01014013|75813025|FG001|Adverse Event Reporting|Overall Study|Patients who received at least 1 dose of Ceftriaxone parenteral therapy|135||
59693218|NCT01014013|75813024|FG000|Completed Parenteral Therapy|Overall Study|"Patients completing MK0826 as a single daily dose of 1.0g intravenous~infusion at least 3 days"|87||
59709829|NCT01072149|75828523|FG003|STARTED|Treatment Period 2 (28 Days)||3||
59816139|NCT00614393|75938497|FG003|Treated|Overall Study||180||
59989880|NCT01641640|76105313|FG000|Enrolled and Treated|Overall Study||327||
59989881|NCT01641640|76105313|FG000|COMPLETED|Overall Study||292||
59989882|NCT01641640|76105313|FG000|NOT COMPLETED|Overall Study||36||
59989883|NCT01639144|76105319|FG000|STARTED|Overall Study||260||
59989884|NCT01639144|76105320|FG001|STARTED|Overall Study||255||
59989885|NCT01639144|76105319|FG000|COMPLETED|Overall Study||250||
60079409|NCT04206332|76194711|FG011|COMPLETED|Part A||0||
60079410|NCT04206332|76194712|FG012|COMPLETED|Part A||0||
60079411|NCT04206332|76194713|FG013|COMPLETED|Part A||0||
60079412|NCT04206332|76194714|FG014|COMPLETED|Part A||0||
60079413|NCT04206332|76194715|FG015|COMPLETED|Part A||0||
60079414|NCT04206332|76194716|FG016|COMPLETED|Part A||0||
59693219|NCT01014013|75813025|FG001|Completed Parenteral Therapy|Overall Study|Patients completing Ceftriaxone as a single daily dose of 2.0g intravenous infusion at least 3 days|88||
59693220|NCT01014013|75813024|FG000|COMPLETED|Overall Study|Patients who completed 7 days therapy including minimum 3 days of MK0826 parentheral therapy|84||
59693221|NCT01014013|75813025|FG001|COMPLETED|Overall Study|Patients who completed 7 days therapy including minimum 3 days of Ceftriaxone parentheral therapy|80||
59693222|NCT01014013|75813024|FG000|NOT COMPLETED|Overall Study||51||
59693223|NCT01014013|75813025|FG001|NOT COMPLETED|Overall Study||56||
59693224|NCT01013701|75813033|FG000|STARTED|Overall Study||7||
59547610|NCT02525055|75646442|FG003|COMPLETED|Overall Study||6||
59547611|NCT02525055|75646443|FG004|COMPLETED|Overall Study||6||
59547612|NCT02525055|75646444|FG005|COMPLETED|Overall Study||16||
59547613|NCT02525055|75646439|FG000|NOT COMPLETED|Overall Study||0||
59547614|NCT02525055|75646440|FG001|NOT COMPLETED|Overall Study||0||
59547615|NCT02525055|75646441|FG002|NOT COMPLETED|Overall Study||0||
59547616|NCT02525055|75646442|FG003|NOT COMPLETED|Overall Study||0||
59547617|NCT02525055|75646443|FG004|NOT COMPLETED|Overall Study||0||
59547618|NCT02525055|75646444|FG005|NOT COMPLETED|Overall Study||0||
59547619|NCT02180828|75646460|FG000|STARTED|Overall Study||120||
59547620|NCT02180828|75646461|FG001|STARTED|Overall Study||120||
59547621|NCT02180828|75646460|FG000|COMPLETED|Overall Study||115||
59547622|NCT02180828|75646461|FG001|COMPLETED|Overall Study||113||
59547623|NCT02180828|75646460|FG000|NOT COMPLETED|Overall Study||5||
59547624|NCT02180828|75646461|FG001|NOT COMPLETED|Overall Study||7||
59547625|NCT02466087|75646467|FG000|STARTED|First Intervention: Weeks 1-6||62||
59547626|NCT02466087|75646468|FG001|STARTED|First Intervention: Weeks 1-6||64||
59547627|NCT02466087|75646467|FG000|COMPLETED|First Intervention: Weeks 1-6||55||
59547628|NCT02466087|75646468|FG001|COMPLETED|First Intervention: Weeks 1-6||57||
59547629|NCT02466087|75646467|FG000|NOT COMPLETED|First Intervention: Weeks 1-6||7||
59547630|NCT02466087|75646468|FG001|NOT COMPLETED|First Intervention: Weeks 1-6||7||
59547631|NCT02466087|75646467|FG000|STARTED|Second Intervention: Weeks 7-12||55||
59547632|NCT02466087|75646468|FG001|STARTED|Second Intervention: Weeks 7-12||57||
59547633|NCT02466087|75646467|FG000|COMPLETED|Second Intervention: Weeks 7-12||55||
59547634|NCT02466087|75646468|FG001|COMPLETED|Second Intervention: Weeks 7-12||57||
59547635|NCT02466087|75646467|FG000|NOT COMPLETED|Second Intervention: Weeks 7-12||0||
59547636|NCT02466087|75646468|FG001|NOT COMPLETED|Second Intervention: Weeks 7-12||0||
59547637|NCT01105754|75646477|FG000|STARTED|Overall Study||319||
59547638|NCT01105754|75646478|FG001|STARTED|Overall Study||319||
59547639|NCT01105754|75646477|FG000|COMPLETED|Overall Study||304||
59547640|NCT01105754|75646478|FG001|COMPLETED|Overall Study||307||
59693225|NCT01013701|75813033|FG000|COMPLETED|Overall Study||0||
59693226|NCT01013701|75813033|FG000|NOT COMPLETED|Overall Study||7||
59547641|NCT01105754|75646477|FG000|NOT COMPLETED|Overall Study||15||
59547642|NCT01105754|75646478|FG001|NOT COMPLETED|Overall Study||12||
59547643|NCT02525523|75646486|FG000|STARTED|Overall Study||69||
59547644|NCT02525523|75646487|FG001|STARTED|Overall Study||69||
59547645|NCT02525523|75646486|FG000|COMPLETED|Overall Study||46||
59547646|NCT02525523|75646487|FG001|COMPLETED|Overall Study||44||
59693227|NCT01020019|75813040|FG000|STARTED|Overall Study||61||
59693228|NCT01020019|75813041|FG001|STARTED|Overall Study||61||
59693229|NCT01020019|75813040|FG000|COMPLETED|Overall Study||35||
59693230|NCT01020019|75813041|FG001|COMPLETED|Overall Study||32||
59693231|NCT01020019|75813040|FG000|NOT COMPLETED|Overall Study||26||
59693232|NCT01020019|75813041|FG001|NOT COMPLETED|Overall Study||29||
59693233|NCT01024465|75813047|FG000|STARTED|Overall Study||26||
59693234|NCT01024465|75813047|FG000|COMPLETED|Overall Study||23||
59693235|NCT01024465|75813047|FG000|NOT COMPLETED|Overall Study||3||
59693236|NCT01024387|75813051|FG000|STARTED|Overall Study||60||
59693237|NCT01024387|75813051|FG000|Evaluable for PFS|Overall Study||54|One of the patients uneval for resp was incl in PFS eval dataset which included follow-up for death.|
59693238|NCT01024387|75813051|FG000|Evaluable for Response|Overall Study||53|symptomatic deterioration (n=2), patient or MD decision (n=2 each), hypersensitivity reaction (n=1)|
59693239|NCT01024387|75813051|FG000|COMPLETED|Overall Study||0|Given treatment duration is not fixed, all patients are considered as 'Non Completed'.|
59693240|NCT01024387|75813051|FG000|NOT COMPLETED|Overall Study||60||
59693241|NCT01019317|75813055|FG000|STARTED|Overall Study||151||
59693242|NCT01019317|75813055|FG000|COMPLETED|Overall Study||147||
59693243|NCT01019317|75813055|FG000|NOT COMPLETED|Overall Study||4||
59693244|NCT01024309|75813061|FG000|STARTED|Overall Study||35||
59693245|NCT01024309|75813062|FG001|STARTED|Overall Study||31||
59693246|NCT01024309|75813061|FG000|COMPLETED|Overall Study||27||
59693247|NCT01024309|75813062|FG001|COMPLETED|Overall Study||27||
59693248|NCT01024309|75813061|FG000|NOT COMPLETED|Overall Study||8||
59693249|NCT01024309|75813062|FG001|NOT COMPLETED|Overall Study||4||
59693250|NCT01090492|75813076|FG000|STARTED|First Intervention Period (4 Weeks)||27||
59693251|NCT01090492|75813077|FG001|STARTED|First Intervention Period (4 Weeks)||29||
59693252|NCT01090492|75813078|FG002|STARTED|First Intervention Period (4 Weeks)||29||
59693253|NCT01090492|75813079|FG003|STARTED|First Intervention Period (4 Weeks)||28||
59693254|NCT01090492|75813080|FG004|STARTED|First Intervention Period (4 Weeks)||33||
59693255|NCT01090492|75813081|FG005|STARTED|First Intervention Period (4 Weeks)||32||
59693256|NCT01090492|75813082|FG006|STARTED|First Intervention Period (4 Weeks)||32||
59693257|NCT01090492|75813083|FG007|STARTED|First Intervention Period (4 Weeks)||33||
59693258|NCT01090492|75813076|FG000|COMPLETED|First Intervention Period (4 Weeks)||26||
59693259|NCT01090492|75813077|FG001|COMPLETED|First Intervention Period (4 Weeks)||24||
59693260|NCT01090492|75813078|FG002|COMPLETED|First Intervention Period (4 Weeks)||26||
59693261|NCT01090492|75813079|FG003|COMPLETED|First Intervention Period (4 Weeks)||22||
59693262|NCT01090492|75813080|FG004|COMPLETED|First Intervention Period (4 Weeks)||29||
59693263|NCT01090492|75813081|FG005|COMPLETED|First Intervention Period (4 Weeks)||30||
59693264|NCT01090492|75813082|FG006|COMPLETED|First Intervention Period (4 Weeks)||31||
59693265|NCT01090492|75813083|FG007|COMPLETED|First Intervention Period (4 Weeks)||27||
59693266|NCT01090492|75813076|FG000|NOT COMPLETED|First Intervention Period (4 Weeks)||1||
59693267|NCT01090492|75813077|FG001|NOT COMPLETED|First Intervention Period (4 Weeks)||5||
59693268|NCT01090492|75813078|FG002|NOT COMPLETED|First Intervention Period (4 Weeks)||3||
59693269|NCT01090492|75813079|FG003|NOT COMPLETED|First Intervention Period (4 Weeks)||6||
59693270|NCT01090492|75813080|FG004|NOT COMPLETED|First Intervention Period (4 Weeks)||4||
59693271|NCT01090492|75813081|FG005|NOT COMPLETED|First Intervention Period (4 Weeks)||2||
59693272|NCT01090492|75813082|FG006|NOT COMPLETED|First Intervention Period (4 Weeks)||1||
59693273|NCT01090492|75813083|FG007|NOT COMPLETED|First Intervention Period (4 Weeks)||6||
59693274|NCT01090492|75813076|FG000|STARTED|Placebo Washout Period ( 2 Weeks)||26||
59693275|NCT01090492|75813077|FG001|STARTED|Placebo Washout Period ( 2 Weeks)||24||
59693276|NCT01090492|75813078|FG002|STARTED|Placebo Washout Period ( 2 Weeks)||26||
59693277|NCT01090492|75813079|FG003|STARTED|Placebo Washout Period ( 2 Weeks)||22||
59693278|NCT01090492|75813080|FG004|STARTED|Placebo Washout Period ( 2 Weeks)||29||
59693279|NCT01090492|75813081|FG005|STARTED|Placebo Washout Period ( 2 Weeks)||30||
59693280|NCT01090492|75813082|FG006|STARTED|Placebo Washout Period ( 2 Weeks)||31||
59693281|NCT01090492|75813083|FG007|STARTED|Placebo Washout Period ( 2 Weeks)||27||
59693282|NCT01090492|75813076|FG000|COMPLETED|Placebo Washout Period ( 2 Weeks)||26||
59693283|NCT01090492|75813077|FG001|COMPLETED|Placebo Washout Period ( 2 Weeks)||24||
59693284|NCT01090492|75813078|FG002|COMPLETED|Placebo Washout Period ( 2 Weeks)||26||
59693285|NCT01090492|75813079|FG003|COMPLETED|Placebo Washout Period ( 2 Weeks)||22||
59693286|NCT01090492|75813080|FG004|COMPLETED|Placebo Washout Period ( 2 Weeks)||29||
59693287|NCT01090492|75813081|FG005|COMPLETED|Placebo Washout Period ( 2 Weeks)||30||
59693288|NCT01090492|75813082|FG006|COMPLETED|Placebo Washout Period ( 2 Weeks)||31||
59693289|NCT01090492|75813083|FG007|COMPLETED|Placebo Washout Period ( 2 Weeks)||27||
59693290|NCT01090492|75813076|FG000|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0||
59693291|NCT01090492|75813077|FG001|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0||
59693292|NCT01090492|75813078|FG002|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0||
59693293|NCT01090492|75813079|FG003|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0||
59693294|NCT01090492|75813080|FG004|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0||
59693295|NCT01090492|75813081|FG005|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0||
59693296|NCT01090492|75813082|FG006|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0||
59693297|NCT01090492|75813083|FG007|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0||
59693298|NCT01090492|75813076|FG000|STARTED|Second Intervention Period (4 Weeks)||26||
59693299|NCT01090492|75813077|FG001|STARTED|Second Intervention Period (4 Weeks)||24||
59693300|NCT01090492|75813078|FG002|STARTED|Second Intervention Period (4 Weeks)||26||
59693301|NCT01090492|75813079|FG003|STARTED|Second Intervention Period (4 Weeks)||22||
59693302|NCT01090492|75813080|FG004|STARTED|Second Intervention Period (4 Weeks)||29||
59693303|NCT01090492|75813081|FG005|STARTED|Second Intervention Period (4 Weeks)||30||
59693304|NCT01090492|75813082|FG006|STARTED|Second Intervention Period (4 Weeks)||31||
59693305|NCT01090492|75813083|FG007|STARTED|Second Intervention Period (4 Weeks)||27||
59693306|NCT01090492|75813076|FG000|COMPLETED|Second Intervention Period (4 Weeks)||25||
59693307|NCT01090492|75813077|FG001|COMPLETED|Second Intervention Period (4 Weeks)||22||
59693308|NCT01090492|75813078|FG002|COMPLETED|Second Intervention Period (4 Weeks)||24||
59693309|NCT01090492|75813079|FG003|COMPLETED|Second Intervention Period (4 Weeks)||22||
59693310|NCT01090492|75813080|FG004|COMPLETED|Second Intervention Period (4 Weeks)||27||
59693311|NCT01090492|75813081|FG005|COMPLETED|Second Intervention Period (4 Weeks)||29||
59693312|NCT01090492|75813082|FG006|COMPLETED|Second Intervention Period (4 Weeks)||22||
59693313|NCT01090492|75813083|FG007|COMPLETED|Second Intervention Period (4 Weeks)||25||
59693314|NCT01090492|75813076|FG000|NOT COMPLETED|Second Intervention Period (4 Weeks)||1||
59693315|NCT01090492|75813077|FG001|NOT COMPLETED|Second Intervention Period (4 Weeks)||2||
59693316|NCT01090492|75813078|FG002|NOT COMPLETED|Second Intervention Period (4 Weeks)||2||
59693317|NCT01090492|75813079|FG003|NOT COMPLETED|Second Intervention Period (4 Weeks)||0||
59693318|NCT01090492|75813080|FG004|NOT COMPLETED|Second Intervention Period (4 Weeks)||2||
59693319|NCT01090492|75813081|FG005|NOT COMPLETED|Second Intervention Period (4 Weeks)||1||
59693320|NCT01090492|75813082|FG006|NOT COMPLETED|Second Intervention Period (4 Weeks)||9||
59693321|NCT01090492|75813083|FG007|NOT COMPLETED|Second Intervention Period (4 Weeks)||2||
59693322|NCT01288911|75813104|FG000|STARTED|Double-blind Period||184||
59693323|NCT01288911|75813105|FG001|STARTED|Double-blind Period||191||
59693324|NCT01288911|75813104|FG000|Received Treatment|Double-blind Period||183||
59693325|NCT01288911|75813105|FG001|Received Treatment|Double-blind Period||189||
59693326|NCT01288911|75813104|FG000|COMPLETED|Double-blind Period|Indicates participants were still receiving treatment at the data cut-off date of 19 October 2014.|42||
59693327|NCT01288911|75813105|FG001|COMPLETED|Double-blind Period|Indicates participants were still receiving treatment at the data cut-off date of 19 October 2014.|9||
59693328|NCT01288911|75813104|FG000|NOT COMPLETED|Double-blind Period||142||
59693329|NCT01288911|75813105|FG001|NOT COMPLETED|Double-blind Period||182||
59693330|NCT01288911|75813104|FG000|STARTED|Open-label Period (All Enzalutamide)||42||
59693331|NCT01288911|75813105|FG001|STARTED|Open-label Period (All Enzalutamide)||9||
59693332|NCT01288911|75813104|FG000|Received Treatment|Open-label Period (All Enzalutamide)||42||
59693333|NCT01288911|75813105|FG001|Received Treatment|Open-label Period (All Enzalutamide)||9||
59693334|NCT01288911|75813104|FG000|COMPLETED|Open-label Period (All Enzalutamide)||0||
59693335|NCT01288911|75813105|FG001|COMPLETED|Open-label Period (All Enzalutamide)||0||
59693336|NCT01288911|75813104|FG000|NOT COMPLETED|Open-label Period (All Enzalutamide)||42||
59693337|NCT01288911|75813105|FG001|NOT COMPLETED|Open-label Period (All Enzalutamide)||9||
59693338|NCT01288443|75813120|FG000|STARTED|Overall Study|Randomized|31||
59693339|NCT01288443|75813121|FG001|STARTED|Overall Study|Randomized|30||
59693340|NCT01288443|75813122|FG002|STARTED|Overall Study|Randomized|31||
59693341|NCT01288443|75813123|FG003|STARTED|Overall Study|Randomized|31||
59693342|NCT01288443|75813124|FG004|STARTED|Overall Study|Randomized|30||
59693343|NCT01288443|75813125|FG005|STARTED|Overall Study|Randomized|30||
59693344|NCT01288443|75813120|FG000|Treated|Overall Study||31||
59693345|NCT01288443|75813121|FG001|Treated|Overall Study||30||
59693346|NCT01288443|75813122|FG002|Treated|Overall Study||31||
59693347|NCT01288443|75813123|FG003|Treated|Overall Study||31||
59693348|NCT01288443|75813124|FG004|Treated|Overall Study||29||
59693349|NCT01288443|75813125|FG005|Treated|Overall Study||30||
59693350|NCT01288443|75813120|FG000|COMPLETED|Overall Study||31||
59693351|NCT01288443|75813121|FG001|COMPLETED|Overall Study||29||
59693352|NCT01288443|75813122|FG002|COMPLETED|Overall Study||30||
59693353|NCT01288443|75813123|FG003|COMPLETED|Overall Study||27||
59693354|NCT01288443|75813124|FG004|COMPLETED|Overall Study||23||
59693355|NCT01288443|75813125|FG005|COMPLETED|Overall Study||25||
59693356|NCT01288443|75813120|FG000|NOT COMPLETED|Overall Study||0||
59693357|NCT01288443|75813121|FG001|NOT COMPLETED|Overall Study||1||
59693358|NCT01288443|75813122|FG002|NOT COMPLETED|Overall Study||1||
59693359|NCT01288443|75813123|FG003|NOT COMPLETED|Overall Study||4||
59693360|NCT01288443|75813124|FG004|NOT COMPLETED|Overall Study||7||
59693361|NCT01288443|75813125|FG005|NOT COMPLETED|Overall Study||5||
59693362|NCT01288287|75813139|FG000|STARTED|Overall Study||149||
59693363|NCT01288287|75813139|FG000|Safety Set|Overall Study||147||
59693364|NCT01288287|75813139|FG000|Full Analysis Set|Overall Study||111||
59693365|NCT01288287|75813139|FG000|COMPLETED|Overall Study||103||
59693366|NCT01288287|75813139|FG000|NOT COMPLETED|Overall Study||46||
59693367|NCT01288209|75813146|FG000|STARTED|Overall Study||53||
59693368|NCT01288209|75813147|FG001|STARTED|Overall Study||53||
59693369|NCT01288209|75813146|FG000|COMPLETED|Overall Study||51||
59693370|NCT01288209|75813147|FG001|COMPLETED|Overall Study||50||
59693371|NCT01288209|75813146|FG000|NOT COMPLETED|Overall Study||2||
59693372|NCT01288209|75813147|FG001|NOT COMPLETED|Overall Study||3||
59693373|NCT01288053|75813153|FG000|STARTED|Overall Study||9||
59693374|NCT01288053|75813153|FG000|COMPLETED|Overall Study||8||
59693375|NCT01288053|75813153|FG000|NOT COMPLETED|Overall Study||1||
59693376|NCT01287195|75813157|FG000|STARTED|Overall Study||6||
59693377|NCT01287195|75813157|FG000|COMPLETED|Overall Study||4||
59693378|NCT01287195|75813157|FG000|NOT COMPLETED|Overall Study||2||
59693379|NCT01287117|75813165|FG000|STARTED|Overall Study||80||
59693380|NCT01287117|75813166|FG001|STARTED|Overall Study||78||
59693381|NCT01287117|75813167|FG002|STARTED|Overall Study||80||
59693382|NCT01287117|75813168|FG003|STARTED|Overall Study||81||
59693383|NCT01287117|75813165|FG000|Received Treatment|Overall Study||80||
59693384|NCT01287117|75813166|FG001|Received Treatment|Overall Study||77||
59693385|NCT01287117|75813167|FG002|Received Treatment|Overall Study||80||
59693386|NCT01287117|75813168|FG003|Received Treatment|Overall Study||81||
59693387|NCT01287117|75813165|FG000|COMPLETED|Overall Study||65||
59693388|NCT01287117|75813166|FG001|COMPLETED|Overall Study||64||
59693389|NCT01287117|75813167|FG002|COMPLETED|Overall Study||64||
59693390|NCT01287117|75813168|FG003|COMPLETED|Overall Study||69||
59693391|NCT01287117|75813165|FG000|NOT COMPLETED|Overall Study||15||
59693392|NCT01287117|75813166|FG001|NOT COMPLETED|Overall Study||14||
59693393|NCT01287117|75813167|FG002|NOT COMPLETED|Overall Study||16||
59693394|NCT01287117|75813168|FG003|NOT COMPLETED|Overall Study||12||
59693395|NCT01287039|75813180|FG000|STARTED|Overall Study||244||
59693396|NCT01287039|75813181|FG001|STARTED|Overall Study||245||
59693397|NCT01287039|75813180|FG000|COMPLETED|Overall Study||215||
59693398|NCT01287039|75813181|FG001|COMPLETED|Overall Study||218||
59693399|NCT01287039|75813180|FG000|NOT COMPLETED|Overall Study||29||
59693400|NCT01287039|75813181|FG001|NOT COMPLETED|Overall Study||27||
59693401|NCT01285401|75813189|FG000|STARTED|Overall Study||115||
59693402|NCT01285401|75813190|FG001|STARTED|Overall Study||117||
59693403|NCT01285401|75813189|FG000|Treated|Overall Study||113||
59693404|NCT01285401|75813190|FG001|Treated|Overall Study||116||
59693405|NCT01285401|75813189|FG000|COMPLETED|Overall Study||98||
59693406|NCT01285401|75813190|FG001|COMPLETED|Overall Study||88||
59693407|NCT01285401|75813189|FG000|NOT COMPLETED|Overall Study||17||
59693408|NCT01285401|75813190|FG001|NOT COMPLETED|Overall Study||29||
59693409|NCT01285323|75813198|FG000|STARTED|Overall Study||232||
59693410|NCT01285323|75813199|FG001|STARTED|Overall Study||232||
59693411|NCT01285323|75813198|FG000|Full Analysis Set|Overall Study|Randomized participants who received at least 1 dose of study drug|232||
59693412|NCT01285323|75813199|FG001|Full Analysis Set|Overall Study||232||
59693413|NCT01285323|75813198|FG000|Safety Analysis Set|Overall Study|Participants who received at least 1 dose of study drug|232||
59693414|NCT01285323|75813199|FG001|Safety Analysis Set|Overall Study||232||
59693415|NCT01285323|75813198|FG000|COMPLETED|Overall Study||199||
59693416|NCT01285323|75813199|FG001|COMPLETED|Overall Study||202||
59693417|NCT01285323|75813198|FG000|NOT COMPLETED|Overall Study||33||
59693418|NCT01285323|75813199|FG001|NOT COMPLETED|Overall Study||30||
59693419|NCT01284621|75813205|FG000|STARTED|First Intervention (8 Days)||3||
59693420|NCT01284621|75813206|FG001|STARTED|First Intervention (8 Days)||4||
59693421|NCT01284621|75813207|FG002|STARTED|First Intervention (8 Days)||4||
59693422|NCT01284621|75813208|FG003|STARTED|First Intervention (8 Days)||4||
59693423|NCT01284621|75813209|FG004|STARTED|First Intervention (8 Days)||4||
59693424|NCT01284621|75813210|FG005|STARTED|First Intervention (8 Days)||4||
59693425|NCT01284621|75813205|FG000|COMPLETED|First Intervention (8 Days)||3||
59693426|NCT01284621|75813206|FG001|COMPLETED|First Intervention (8 Days)||4||
59693427|NCT01284621|75813207|FG002|COMPLETED|First Intervention (8 Days)||4||
59693428|NCT01284621|75813208|FG003|COMPLETED|First Intervention (8 Days)||4||
59693429|NCT01284621|75813209|FG004|COMPLETED|First Intervention (8 Days)||4||
59693430|NCT01284621|75813210|FG005|COMPLETED|First Intervention (8 Days)||4||
59693431|NCT01284621|75813205|FG000|NOT COMPLETED|First Intervention (8 Days)||0||
59693432|NCT01284621|75813206|FG001|NOT COMPLETED|First Intervention (8 Days)||0||
59693433|NCT01284621|75813207|FG002|NOT COMPLETED|First Intervention (8 Days)||0||
59693434|NCT01284621|75813208|FG003|NOT COMPLETED|First Intervention (8 Days)||0||
59693435|NCT01284621|75813209|FG004|NOT COMPLETED|First Intervention (8 Days)||0||
59693436|NCT01284621|75813210|FG005|NOT COMPLETED|First Intervention (8 Days)||0||
59693437|NCT01284621|75813205|FG000|STARTED|Washout Period 1 (7 Days)||3||
59693438|NCT01284621|75813206|FG001|STARTED|Washout Period 1 (7 Days)||4||
59693439|NCT01284621|75813207|FG002|STARTED|Washout Period 1 (7 Days)||4||
59693440|NCT01284621|75813208|FG003|STARTED|Washout Period 1 (7 Days)||4||
59693441|NCT01284621|75813209|FG004|STARTED|Washout Period 1 (7 Days)||4||
59693442|NCT01284621|75813210|FG005|STARTED|Washout Period 1 (7 Days)||4||
59693443|NCT01284621|75813205|FG000|COMPLETED|Washout Period 1 (7 Days)||3||
59693444|NCT01284621|75813206|FG001|COMPLETED|Washout Period 1 (7 Days)||4||
59693445|NCT01284621|75813207|FG002|COMPLETED|Washout Period 1 (7 Days)||4||
59693446|NCT01284621|75813208|FG003|COMPLETED|Washout Period 1 (7 Days)||4||
59693447|NCT01284621|75813209|FG004|COMPLETED|Washout Period 1 (7 Days)||3||
59693448|NCT01284621|75813210|FG005|COMPLETED|Washout Period 1 (7 Days)||4||
59693449|NCT01284621|75813205|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0||
59693450|NCT01284621|75813206|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0||
59693451|NCT01284621|75813207|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0||
59693452|NCT01284621|75813208|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0||
59693453|NCT01284621|75813209|FG004|NOT COMPLETED|Washout Period 1 (7 Days)||1||
59693454|NCT01284621|75813210|FG005|NOT COMPLETED|Washout Period 1 (7 Days)||0||
59693455|NCT01284621|75813205|FG000|STARTED|Second Intervention (8 Days)||3||
59693456|NCT01284621|75813206|FG001|STARTED|Second Intervention (8 Days)||4||
59693457|NCT01284621|75813207|FG002|STARTED|Second Intervention (8 Days)||4||
59547647|NCT02525523|75646486|FG000|NOT COMPLETED|Overall Study||23||
59547648|NCT02525523|75646487|FG001|NOT COMPLETED|Overall Study||25||
59547649|NCT02528409|75646495|FG000|STARTED|Overall Study||40||
59547650|NCT02528409|75646496|FG001|STARTED|Overall Study||40||
59693458|NCT01284621|75813208|FG003|STARTED|Second Intervention (8 Days)||4||
59693459|NCT01284621|75813209|FG004|STARTED|Second Intervention (8 Days)||3||
59693460|NCT01284621|75813210|FG005|STARTED|Second Intervention (8 Days)||4||
59693461|NCT01284621|75813205|FG000|COMPLETED|Second Intervention (8 Days)||3||
59693462|NCT01284621|75813206|FG001|COMPLETED|Second Intervention (8 Days)||4||
59693463|NCT01284621|75813207|FG002|COMPLETED|Second Intervention (8 Days)||4||
59693464|NCT01284621|75813208|FG003|COMPLETED|Second Intervention (8 Days)||4||
59693465|NCT01284621|75813209|FG004|COMPLETED|Second Intervention (8 Days)||3||
59693466|NCT01284621|75813210|FG005|COMPLETED|Second Intervention (8 Days)||4||
59693467|NCT01284621|75813205|FG000|NOT COMPLETED|Second Intervention (8 Days)||0||
59693468|NCT01284621|75813206|FG001|NOT COMPLETED|Second Intervention (8 Days)||0||
59693469|NCT01284621|75813207|FG002|NOT COMPLETED|Second Intervention (8 Days)||0||
59693470|NCT01284621|75813208|FG003|NOT COMPLETED|Second Intervention (8 Days)||0||
59693471|NCT01284621|75813209|FG004|NOT COMPLETED|Second Intervention (8 Days)||0||
59693472|NCT01284621|75813210|FG005|NOT COMPLETED|Second Intervention (8 Days)||0||
59693473|NCT01284621|75813205|FG000|STARTED|Washout Period 2 (7 Days)||3||
59693474|NCT01284621|75813206|FG001|STARTED|Washout Period 2 (7 Days)||4||
59693475|NCT01284621|75813207|FG002|STARTED|Washout Period 2 (7 Days)||4||
59693476|NCT01284621|75813208|FG003|STARTED|Washout Period 2 (7 Days)||4||
59693477|NCT01284621|75813209|FG004|STARTED|Washout Period 2 (7 Days)||3||
59693478|NCT01284621|75813210|FG005|STARTED|Washout Period 2 (7 Days)||4||
59693479|NCT01284621|75813205|FG000|COMPLETED|Washout Period 2 (7 Days)||3||
59693480|NCT01284621|75813206|FG001|COMPLETED|Washout Period 2 (7 Days)||4||
59693481|NCT01284621|75813207|FG002|COMPLETED|Washout Period 2 (7 Days)||4||
59693482|NCT01284621|75813208|FG003|COMPLETED|Washout Period 2 (7 Days)||4||
59693483|NCT01284621|75813209|FG004|COMPLETED|Washout Period 2 (7 Days)||3||
59693484|NCT01284621|75813210|FG005|COMPLETED|Washout Period 2 (7 Days)||4||
59693485|NCT01284621|75813205|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0||
59693486|NCT01284621|75813206|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0||
59693487|NCT01284621|75813207|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0||
59693488|NCT01284621|75813208|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0||
59693489|NCT01284621|75813209|FG004|NOT COMPLETED|Washout Period 2 (7 Days)||0||
59693490|NCT01284621|75813210|FG005|NOT COMPLETED|Washout Period 2 (7 Days)||0||
59693491|NCT01284621|75813205|FG000|STARTED|Third Intervention (8 Days)||3||
59693492|NCT01284621|75813206|FG001|STARTED|Third Intervention (8 Days)||4||
59693493|NCT01284621|75813207|FG002|STARTED|Third Intervention (8 Days)||4||
59693494|NCT01284621|75813208|FG003|STARTED|Third Intervention (8 Days)||4||
59693495|NCT01284621|75813209|FG004|STARTED|Third Intervention (8 Days)||3||
59693496|NCT01284621|75813210|FG005|STARTED|Third Intervention (8 Days)||4||
59693497|NCT01284621|75813205|FG000|COMPLETED|Third Intervention (8 Days)||3||
59693498|NCT01284621|75813206|FG001|COMPLETED|Third Intervention (8 Days)||4||
59693499|NCT01284621|75813207|FG002|COMPLETED|Third Intervention (8 Days)||4||
59693500|NCT01284621|75813208|FG003|COMPLETED|Third Intervention (8 Days)||4||
59693501|NCT01284621|75813209|FG004|COMPLETED|Third Intervention (8 Days)||3||
59693502|NCT01284621|75813210|FG005|COMPLETED|Third Intervention (8 Days)||4||
59693503|NCT01284621|75813205|FG000|NOT COMPLETED|Third Intervention (8 Days)||0||
59693504|NCT01284621|75813206|FG001|NOT COMPLETED|Third Intervention (8 Days)||0||
59693505|NCT01284621|75813207|FG002|NOT COMPLETED|Third Intervention (8 Days)||0||
59816140|NCT00614393|75938498|FG004|Treated|Overall Study||178||
59816141|NCT00614393|75938494|FG000|COMPLETED|Overall Study||0||
59816142|NCT00614393|75938495|FG001|COMPLETED|Overall Study||0||
59547651|NCT02528409|75646495|FG000|COMPLETED|Overall Study||18||
59547652|NCT02528409|75646496|FG001|COMPLETED|Overall Study||24||
59547653|NCT02528409|75646495|FG000|NOT COMPLETED|Overall Study||22||
59547654|NCT02528409|75646496|FG001|NOT COMPLETED|Overall Study||16||
59547655|NCT02467179|75646504|FG000|STARTED|Overall Study||25||
59547656|NCT02467179|75646505|FG001|STARTED|Overall Study||25||
59547657|NCT02467179|75646504|FG000|COMPLETED|Overall Study||25||
59693506|NCT01284621|75813208|FG003|NOT COMPLETED|Third Intervention (8 Days)||0||
59693507|NCT01284621|75813209|FG004|NOT COMPLETED|Third Intervention (8 Days)||0||
59693508|NCT01284621|75813210|FG005|NOT COMPLETED|Third Intervention (8 Days)||0||
59693509|NCT01283139|75813224|FG000|STARTED|Overall Study||108||
59693510|NCT01283139|75813225|FG001|STARTED|Overall Study||108||
59693511|NCT01283139|75813226|FG002|STARTED|Overall Study||109||
59693512|NCT01283139|75813227|FG003|STARTED|Overall Study||107||
59693513|NCT01283139|75813224|FG000|COMPLETED|Overall Study||91||
59693514|NCT01283139|75813225|FG001|COMPLETED|Overall Study||90||
59693515|NCT01283139|75813226|FG002|COMPLETED|Overall Study||91||
59693516|NCT01283139|75813227|FG003|COMPLETED|Overall Study||92||
59693517|NCT01283139|75813224|FG000|NOT COMPLETED|Overall Study||17||
59693518|NCT01283139|75813225|FG001|NOT COMPLETED|Overall Study||18||
59693519|NCT01283139|75813226|FG002|NOT COMPLETED|Overall Study||18||
59693520|NCT01283139|75813227|FG003|NOT COMPLETED|Overall Study||15||
59693521|NCT01282203|75813237|FG000|STARTED|Overall Study||1122||
59693522|NCT01282203|75813237|FG000|COMPLETED|Overall Study||1121||
59693523|NCT01282203|75813237|FG000|NOT COMPLETED|Overall Study||1||
59693524|NCT01281969|75813246|FG000|STARTED|Overall Study||18||
59693525|NCT01281969|75813247|FG001|STARTED|Overall Study||18||
59693526|NCT01281969|75813248|FG002|STARTED|Overall Study||12||
59693527|NCT01281969|75813246|FG000|COMPLETED|Overall Study||17||
59693528|NCT01281969|75813247|FG001|COMPLETED|Overall Study||18||
59693529|NCT01281969|75813248|FG002|COMPLETED|Overall Study||0||
59693530|NCT01281969|75813246|FG000|NOT COMPLETED|Overall Study||1||
59693531|NCT01281969|75813247|FG001|NOT COMPLETED|Overall Study||0||
59693532|NCT01281969|75813248|FG002|NOT COMPLETED|Overall Study||12||
59693533|NCT01281813|75813259|FG000|STARTED|Overall Study||4||
59693534|NCT01281813|75813260|FG001|STARTED|Overall Study||4||
59693535|NCT01281813|75813261|FG002|STARTED|Overall Study||137||
59693536|NCT01281813|75813259|FG000|COMPLETED|Overall Study||0||
59693537|NCT01281813|75813260|FG001|COMPLETED|Overall Study||0||
59693538|NCT01281813|75813261|FG002|COMPLETED|Overall Study||0||
59693539|NCT01281813|75813259|FG000|NOT COMPLETED|Overall Study||4||
59693540|NCT01281813|75813260|FG001|NOT COMPLETED|Overall Study||4||
59693541|NCT01281813|75813261|FG002|NOT COMPLETED|Overall Study||137||
59693542|NCT01090414|75813273|FG000|STARTED|Parent Studies||191||
59693543|NCT01090414|75813274|FG001|STARTED|Parent Studies||241||
59693544|NCT01090414|75813275|FG002|STARTED|Parent Studies||64||
59693545|NCT01090414|75813276|FG003|STARTED|Parent Studies||18||
59693546|NCT01090414|75813273|FG000|COMPLETED|Parent Studies||50|Study completion was defined as participants who completed through Week 48 of parent study.|
59693547|NCT01090414|75813274|FG001|COMPLETED|Parent Studies||114|Study completion was defined as participants who completed through Week 48 of parent study.|
59693548|NCT01090414|75813275|FG002|COMPLETED|Parent Studies||43|Study completion was defined as participants who completed through Week 48 of parent study.|
59693549|NCT01090414|75813276|FG003|COMPLETED|Parent Studies||5|Study completion was defined as participants who completed through Week 48 of parent study.|
59693550|NCT01090414|75813273|FG000|NOT COMPLETED|Parent Studies||141||
59693551|NCT01090414|75813274|FG001|NOT COMPLETED|Parent Studies||127||
59693552|NCT01090414|75813275|FG002|NOT COMPLETED|Parent Studies||21||
59693553|NCT01090414|75813276|FG003|NOT COMPLETED|Parent Studies||13||
59693554|NCT01090414|75813273|FG000|STARTED|Study 101-99|50 participants completed the parent study, but only 48 participants enrolled into Study 101-99.|48||
59693555|NCT01090414|75813274|FG001|STARTED|Study 101-99|114 participants completed the parent study, but only 108 participants enrolled into Study 101-99.|108||
59693556|NCT01090414|75813275|FG002|STARTED|Study 101-99|43 participants completed the parent study, but only 41 participants enrolled into Study 101-99.|41||
59693557|NCT01090414|75813276|FG003|STARTED|Study 101-99||5||
59693558|NCT01090414|75813273|FG000|COMPLETED|Study 101-99||0||
59693559|NCT01090414|75813274|FG001|COMPLETED|Study 101-99||0||
59693560|NCT01090414|75813275|FG002|COMPLETED|Study 101-99||0||
59693561|NCT01090414|75813276|FG003|COMPLETED|Study 101-99||0||
59693562|NCT01090414|75813273|FG000|NOT COMPLETED|Study 101-99||48||
59693563|NCT01090414|75813274|FG001|NOT COMPLETED|Study 101-99||108||
59693564|NCT01090414|75813275|FG002|NOT COMPLETED|Study 101-99||41||
59693565|NCT01090414|75813276|FG003|NOT COMPLETED|Study 101-99||5||
59693566|NCT01090102|75813300|FG000|STARTED|First 12 Weeks||15||
59693567|NCT01090102|75813301|FG001|STARTED|First 12 Weeks||18||
59693568|NCT01090102|75813300|FG000|COMPLETED|First 12 Weeks||11||
59693569|NCT01090102|75813301|FG001|COMPLETED|First 12 Weeks||16||
59693570|NCT01090102|75813300|FG000|NOT COMPLETED|First 12 Weeks||4||
59693571|NCT01090102|75813301|FG001|NOT COMPLETED|First 12 Weeks||2||
59693572|NCT01090102|75813300|FG000|STARTED|Second 12 Weeks||11||
59693573|NCT01090102|75813301|FG001|STARTED|Second 12 Weeks||16||
59693574|NCT01090102|75813300|FG000|COMPLETED|Second 12 Weeks||11||
59693575|NCT01090102|75813301|FG001|COMPLETED|Second 12 Weeks||15||
59547658|NCT02467179|75646505|FG001|COMPLETED|Overall Study||25||
59693576|NCT01090102|75813300|FG000|NOT COMPLETED|Second 12 Weeks||0||
59693577|NCT01090102|75813301|FG001|NOT COMPLETED|Second 12 Weeks||1||
59693578|NCT01287897|75813311|FG000|STARTED|Overall Study||70||
59693579|NCT01287897|75813312|FG001|STARTED|Overall Study||69||
59693580|NCT01287897|75813313|FG002|STARTED|Overall Study||71||
59693581|NCT01287897|75813314|FG003|STARTED|Overall Study|Enrollment was halted before reaching the planned sample size due to safety findings in NCT01405196.|40||
59693582|NCT01287897|75813311|FG000|Treated|Overall Study||69||
59693583|NCT01287897|75813312|FG001|Treated|Overall Study||67||
59693584|NCT01287897|75813313|FG002|Treated|Overall Study||71||
59693585|NCT01287897|75813314|FG003|Treated|Overall Study||40||
59693586|NCT01287897|75813311|FG000|Completed Treatment Period|Overall Study||58||
59693587|NCT01287897|75813312|FG001|Completed Treatment Period|Overall Study||52||
59693588|NCT01287897|75813313|FG002|Completed Treatment Period|Overall Study||58||
59693589|NCT01287897|75813314|FG003|Completed Treatment Period|Overall Study||29||
59693590|NCT01287897|75813311|FG000|Completed Follow-up Period|Overall Study||3||
59693591|NCT01287897|75813312|FG001|Completed Follow-up Period|Overall Study||8||
59693592|NCT01287897|75813313|FG002|Completed Follow-up Period|Overall Study||3||
59693593|NCT01287897|75813314|FG003|Completed Follow-up Period|Overall Study||4||
59693594|NCT01287897|75813311|FG000|Enrolled in NCT01345318|Overall Study||56||
59693595|NCT01287897|75813312|FG001|Enrolled in NCT01345318|Overall Study||50||
59693596|NCT01287897|75813313|FG002|Enrolled in NCT01345318|Overall Study||56||
59693597|NCT01287897|75813314|FG003|Enrolled in NCT01345318|Overall Study||29||
59693598|NCT01287897|75813311|FG000|COMPLETED|Overall Study|Include participants who completed the follow-up period or enrolled in NCT01345318.|59||
59693599|NCT01287897|75813312|FG001|COMPLETED|Overall Study|Include participants who completed the follow-up period or enrolled in NCT01345318.|58||
59693600|NCT01287897|75813313|FG002|COMPLETED|Overall Study|Include participants who completed the follow-up period or enrolled in NCT01345318.|59||
59693601|NCT01287897|75813314|FG003|COMPLETED|Overall Study|Include participants who completed the follow-up period or enrolled in NCT01345318.|33||
59693602|NCT01287897|75813311|FG000|NOT COMPLETED|Overall Study||11||
59693603|NCT01287897|75813312|FG001|NOT COMPLETED|Overall Study||11||
59693604|NCT01287897|75813313|FG002|NOT COMPLETED|Overall Study||12||
59693605|NCT01287897|75813314|FG003|NOT COMPLETED|Overall Study||7||
59693606|NCT01090024|75813328|FG000|STARTED|Period 1||6||
59693607|NCT01090024|75813329|FG001|STARTED|Period 1||6||
59693608|NCT01090024|75813330|FG002|STARTED|Period 1||6||
59693609|NCT01090024|75813331|FG003|STARTED|Period 1||6||
59693610|NCT01090024|75813332|FG004|STARTED|Period 1||6||
59693611|NCT01090024|75813333|FG005|STARTED|Period 1||6||
59693612|NCT01090024|75813334|FG006|STARTED|Period 1||6||
59693613|NCT01090024|75813335|FG007|STARTED|Period 1||6||
59693614|NCT01090024|75813336|FG008|STARTED|Period 1||6||
59693615|NCT01090024|75813337|FG009|STARTED|Period 1||6||
59693616|NCT01090024|75813338|FG010|STARTED|Period 1||6||
59693617|NCT01090024|75813339|FG011|STARTED|Period 1||6||
59693618|NCT01090024|75813340|FG012|STARTED|Period 1||6||
59693619|NCT01090024|75813341|FG013|STARTED|Period 1||6||
59693620|NCT01090024|75813342|FG014|STARTED|Period 1||6||
59693621|NCT01090024|75813343|FG015|STARTED|Period 1||6||
59693622|NCT01090024|75813344|FG016|STARTED|Period 1||6||
59693623|NCT01090024|75813345|FG017|STARTED|Period 1||6||
59693624|NCT01090024|75813328|FG000|COMPLETED|Period 1||6||
59693625|NCT01090024|75813329|FG001|COMPLETED|Period 1||5||
59693626|NCT01090024|75813330|FG002|COMPLETED|Period 1||6||
59693627|NCT01090024|75813331|FG003|COMPLETED|Period 1||5||
59693628|NCT01090024|75813332|FG004|COMPLETED|Period 1||6||
59693629|NCT01090024|75813333|FG005|COMPLETED|Period 1||6||
59693630|NCT01090024|75813334|FG006|COMPLETED|Period 1||6||
59693631|NCT01090024|75813335|FG007|COMPLETED|Period 1||6||
59693632|NCT01090024|75813336|FG008|COMPLETED|Period 1||6||
59693633|NCT01090024|75813337|FG009|COMPLETED|Period 1||5||
59693634|NCT01090024|75813338|FG010|COMPLETED|Period 1||6||
59693635|NCT01090024|75813339|FG011|COMPLETED|Period 1||5||
59693636|NCT01090024|75813340|FG012|COMPLETED|Period 1||6||
59693637|NCT01090024|75813341|FG013|COMPLETED|Period 1||6||
59693638|NCT01090024|75813342|FG014|COMPLETED|Period 1||5||
59693639|NCT01090024|75813343|FG015|COMPLETED|Period 1||6||
59693640|NCT01090024|75813344|FG016|COMPLETED|Period 1||6||
59693641|NCT01090024|75813345|FG017|COMPLETED|Period 1||5||
59693642|NCT01090024|75813328|FG000|NOT COMPLETED|Period 1||0||
59693643|NCT01090024|75813329|FG001|NOT COMPLETED|Period 1||1||
59693644|NCT01090024|75813330|FG002|NOT COMPLETED|Period 1||0||
59693645|NCT01090024|75813331|FG003|NOT COMPLETED|Period 1||1||
59693646|NCT01090024|75813332|FG004|NOT COMPLETED|Period 1||0||
59693647|NCT01090024|75813333|FG005|NOT COMPLETED|Period 1||0||
59693648|NCT01090024|75813334|FG006|NOT COMPLETED|Period 1||0||
59693649|NCT01090024|75813335|FG007|NOT COMPLETED|Period 1||0||
59693650|NCT01090024|75813336|FG008|NOT COMPLETED|Period 1||0||
59693651|NCT01090024|75813337|FG009|NOT COMPLETED|Period 1||1||
59693652|NCT01090024|75813338|FG010|NOT COMPLETED|Period 1||0||
59693653|NCT01090024|75813339|FG011|NOT COMPLETED|Period 1||1||
59693654|NCT01090024|75813340|FG012|NOT COMPLETED|Period 1||0||
59693655|NCT01090024|75813341|FG013|NOT COMPLETED|Period 1||0||
59693656|NCT01090024|75813342|FG014|NOT COMPLETED|Period 1||1||
59693657|NCT01090024|75813343|FG015|NOT COMPLETED|Period 1||0||
59693658|NCT01090024|75813344|FG016|NOT COMPLETED|Period 1||0||
59693659|NCT01090024|75813345|FG017|NOT COMPLETED|Period 1||1||
59693660|NCT01090024|75813328|FG000|STARTED|Period 2||6||
59693661|NCT01090024|75813329|FG001|STARTED|Period 2||5||
59693662|NCT01090024|75813330|FG002|STARTED|Period 2||6||
59693663|NCT01090024|75813331|FG003|STARTED|Period 2||5||
59693664|NCT01090024|75813332|FG004|STARTED|Period 2||6||
59693665|NCT01090024|75813333|FG005|STARTED|Period 2||6||
59693666|NCT01090024|75813334|FG006|STARTED|Period 2||6||
59693667|NCT01090024|75813335|FG007|STARTED|Period 2||6||
59693668|NCT01090024|75813336|FG008|STARTED|Period 2||6||
59693669|NCT01090024|75813337|FG009|STARTED|Period 2||5||
59693670|NCT01090024|75813338|FG010|STARTED|Period 2||6||
59693671|NCT01090024|75813339|FG011|STARTED|Period 2||5||
59693672|NCT01090024|75813340|FG012|STARTED|Period 2||6||
59693673|NCT01090024|75813341|FG013|STARTED|Period 2||6||
59693674|NCT01090024|75813342|FG014|STARTED|Period 2||5||
59693675|NCT01090024|75813343|FG015|STARTED|Period 2||6||
59693676|NCT01090024|75813344|FG016|STARTED|Period 2||6||
59693677|NCT01090024|75813345|FG017|STARTED|Period 2||5||
59693678|NCT01090024|75813328|FG000|COMPLETED|Period 2||5||
59693679|NCT01090024|75813329|FG001|COMPLETED|Period 2||5||
59693680|NCT01090024|75813330|FG002|COMPLETED|Period 2||6||
59693681|NCT01090024|75813331|FG003|COMPLETED|Period 2||4||
59693682|NCT01090024|75813332|FG004|COMPLETED|Period 2||6||
59693683|NCT01090024|75813333|FG005|COMPLETED|Period 2||6||
59693684|NCT01090024|75813334|FG006|COMPLETED|Period 2||6||
59693685|NCT01090024|75813335|FG007|COMPLETED|Period 2||6||
59693686|NCT01090024|75813336|FG008|COMPLETED|Period 2||6||
59693687|NCT01090024|75813337|FG009|COMPLETED|Period 2||5||
59693688|NCT01090024|75813338|FG010|COMPLETED|Period 2||6||
59693689|NCT01090024|75813339|FG011|COMPLETED|Period 2||5||
59693690|NCT01090024|75813340|FG012|COMPLETED|Period 2||6||
59693691|NCT01090024|75813341|FG013|COMPLETED|Period 2||6||
59693692|NCT01090024|75813342|FG014|COMPLETED|Period 2||5||
59693693|NCT01090024|75813343|FG015|COMPLETED|Period 2||6||
59693694|NCT01090024|75813344|FG016|COMPLETED|Period 2||6||
59693695|NCT01090024|75813345|FG017|COMPLETED|Period 2||5||
59693696|NCT01090024|75813328|FG000|NOT COMPLETED|Period 2||1||
59693697|NCT01090024|75813329|FG001|NOT COMPLETED|Period 2||0||
59693698|NCT01090024|75813330|FG002|NOT COMPLETED|Period 2||0||
59693699|NCT01090024|75813331|FG003|NOT COMPLETED|Period 2||1||
59693700|NCT01090024|75813332|FG004|NOT COMPLETED|Period 2||0||
59693701|NCT01090024|75813333|FG005|NOT COMPLETED|Period 2||0||
59693702|NCT01090024|75813334|FG006|NOT COMPLETED|Period 2||0||
59693703|NCT01090024|75813335|FG007|NOT COMPLETED|Period 2||0||
59693704|NCT01090024|75813336|FG008|NOT COMPLETED|Period 2||0||
59693705|NCT01090024|75813337|FG009|NOT COMPLETED|Period 2||0||
59693706|NCT01090024|75813338|FG010|NOT COMPLETED|Period 2||0||
59693707|NCT01090024|75813339|FG011|NOT COMPLETED|Period 2||0||
59693708|NCT01090024|75813340|FG012|NOT COMPLETED|Period 2||0||
59693709|NCT01090024|75813341|FG013|NOT COMPLETED|Period 2||0||
59693710|NCT01090024|75813342|FG014|NOT COMPLETED|Period 2||0||
59693711|NCT01090024|75813343|FG015|NOT COMPLETED|Period 2||0||
59693712|NCT01090024|75813344|FG016|NOT COMPLETED|Period 2||0||
59693713|NCT01090024|75813345|FG017|NOT COMPLETED|Period 2||0||
59693714|NCT01090024|75813328|FG000|STARTED|Period 3||5||
59693715|NCT01090024|75813329|FG001|STARTED|Period 3||5||
59693716|NCT01090024|75813330|FG002|STARTED|Period 3||6||
59693717|NCT01090024|75813331|FG003|STARTED|Period 3||4||
59693718|NCT01090024|75813332|FG004|STARTED|Period 3||6||
59693719|NCT01090024|75813333|FG005|STARTED|Period 3||6||
59693720|NCT01090024|75813334|FG006|STARTED|Period 3||6||
59693721|NCT01090024|75813335|FG007|STARTED|Period 3||6||
59693722|NCT01090024|75813336|FG008|STARTED|Period 3||6||
59693723|NCT01090024|75813337|FG009|STARTED|Period 3||5||
59693724|NCT01090024|75813338|FG010|STARTED|Period 3||6||
59693725|NCT01090024|75813339|FG011|STARTED|Period 3||5||
59693726|NCT01090024|75813340|FG012|STARTED|Period 3||6||
59693727|NCT01090024|75813341|FG013|STARTED|Period 3||6||
59693728|NCT01090024|75813342|FG014|STARTED|Period 3||5||
59693729|NCT01090024|75813343|FG015|STARTED|Period 3||6||
59693730|NCT01090024|75813344|FG016|STARTED|Period 3||6||
59693731|NCT01090024|75813345|FG017|STARTED|Period 3||5||
59693732|NCT01090024|75813328|FG000|Treated|Period 3||5||
59693733|NCT01090024|75813329|FG001|Treated|Period 3||5||
59693734|NCT01090024|75813330|FG002|Treated|Period 3||6||
59693735|NCT01090024|75813331|FG003|Treated|Period 3||4||
59693736|NCT01090024|75813332|FG004|Treated|Period 3||6||
59693737|NCT01090024|75813333|FG005|Treated|Period 3||6||
59693738|NCT01090024|75813334|FG006|Treated|Period 3||6||
59693739|NCT01090024|75813335|FG007|Treated|Period 3||6||
59693740|NCT01090024|75813336|FG008|Treated|Period 3||6||
59693741|NCT01090024|75813337|FG009|Treated|Period 3||5||
59693742|NCT01090024|75813338|FG010|Treated|Period 3||6||
59693743|NCT01090024|75813339|FG011|Treated|Period 3||5||
59693744|NCT01090024|75813340|FG012|Treated|Period 3||6||
59693745|NCT01090024|75813341|FG013|Treated|Period 3||6||
59693746|NCT01090024|75813342|FG014|Treated|Period 3||5||
59693747|NCT01090024|75813343|FG015|Treated|Period 3||5||
59693748|NCT01090024|75813344|FG016|Treated|Period 3||6||
59693749|NCT01090024|75813345|FG017|Treated|Period 3||5||
59693750|NCT01090024|75813328|FG000|COMPLETED|Period 3||5||
59693751|NCT01090024|75813329|FG001|COMPLETED|Period 3||5||
59693752|NCT01090024|75813330|FG002|COMPLETED|Period 3||6||
59693753|NCT01090024|75813331|FG003|COMPLETED|Period 3||4||
59693754|NCT01090024|75813332|FG004|COMPLETED|Period 3||6||
59693755|NCT01090024|75813333|FG005|COMPLETED|Period 3||5||
59693756|NCT01090024|75813334|FG006|COMPLETED|Period 3||6||
59693757|NCT01090024|75813335|FG007|COMPLETED|Period 3||6||
59693758|NCT01090024|75813336|FG008|COMPLETED|Period 3||5||
59693759|NCT01090024|75813337|FG009|COMPLETED|Period 3||5||
59693760|NCT01090024|75813338|FG010|COMPLETED|Period 3||6||
59693761|NCT01090024|75813339|FG011|COMPLETED|Period 3||5||
59693762|NCT01090024|75813340|FG012|COMPLETED|Period 3||6||
59693763|NCT01090024|75813341|FG013|COMPLETED|Period 3||6||
59693764|NCT01090024|75813342|FG014|COMPLETED|Period 3||5||
59693765|NCT01090024|75813343|FG015|COMPLETED|Period 3||5||
59693766|NCT01090024|75813344|FG016|COMPLETED|Period 3||6||
59693767|NCT01090024|75813345|FG017|COMPLETED|Period 3||5||
59693768|NCT01090024|75813328|FG000|NOT COMPLETED|Period 3||0||
59693769|NCT01090024|75813329|FG001|NOT COMPLETED|Period 3||0||
59693770|NCT01090024|75813330|FG002|NOT COMPLETED|Period 3||0||
59693771|NCT01090024|75813331|FG003|NOT COMPLETED|Period 3||0||
59693772|NCT01090024|75813332|FG004|NOT COMPLETED|Period 3||0||
59693773|NCT01090024|75813333|FG005|NOT COMPLETED|Period 3||1||
59693774|NCT01090024|75813334|FG006|NOT COMPLETED|Period 3||0||
59693775|NCT01090024|75813335|FG007|NOT COMPLETED|Period 3||0||
59693776|NCT01090024|75813336|FG008|NOT COMPLETED|Period 3||1||
59693777|NCT01090024|75813337|FG009|NOT COMPLETED|Period 3||0||
59693778|NCT01090024|75813338|FG010|NOT COMPLETED|Period 3||0||
60079415|NCT04206332|76194700|FG000|NOT COMPLETED|Part A||0||
60079416|NCT04206332|76194701|FG001|NOT COMPLETED|Part A||1||
60079417|NCT04206332|76194702|FG002|NOT COMPLETED|Part A||0||
60079418|NCT04206332|76194703|FG003|NOT COMPLETED|Part A||0||
60079419|NCT04206332|76194704|FG004|NOT COMPLETED|Part A||0||
60079420|NCT04206332|76194705|FG005|NOT COMPLETED|Part A||8||
59693779|NCT01090024|75813339|FG011|NOT COMPLETED|Period 3||0||
59693780|NCT01090024|75813340|FG012|NOT COMPLETED|Period 3||0||
59693781|NCT01090024|75813341|FG013|NOT COMPLETED|Period 3||0||
59693782|NCT01090024|75813342|FG014|NOT COMPLETED|Period 3||0||
59693783|NCT01090024|75813343|FG015|NOT COMPLETED|Period 3||1||
59693784|NCT01090024|75813344|FG016|NOT COMPLETED|Period 3||0||
59693785|NCT01090024|75813345|FG017|NOT COMPLETED|Period 3||0||
59693786|NCT04868890|75813357|FG000|STARTED|Overall Study||64||
59693787|NCT04868890|75813358|FG001|STARTED|Overall Study||65||
59693788|NCT04868890|75813357|FG000|COMPLETED|Overall Study||61||
59693789|NCT04868890|75813358|FG001|COMPLETED|Overall Study||59||
59693790|NCT04868890|75813357|FG000|NOT COMPLETED|Overall Study||3||
59693791|NCT04868890|75813358|FG001|NOT COMPLETED|Overall Study||6||
59693792|NCT01281189|75813366|FG000|STARTED|Overall Study||468||
59693793|NCT01281189|75813367|FG001|STARTED|Overall Study||474||
59693794|NCT01281189|75813366|FG000|COMPLETED|Overall Study||321||
59693795|NCT01281189|75813367|FG001|COMPLETED|Overall Study||331||
59693796|NCT01281189|75813366|FG000|NOT COMPLETED|Overall Study||147||
59693797|NCT01281189|75813367|FG001|NOT COMPLETED|Overall Study||143||
59693798|NCT01280955|75813373|FG000|STARTED|Overall Study||30||
59693799|NCT01280955|75813373|FG000|COMPLETED|Overall Study||27||
59693800|NCT01280955|75813373|FG000|NOT COMPLETED|Overall Study||3||
59693801|NCT01280721|75813379|FG000|STARTED|Overall Study||135||
59693802|NCT01280721|75813379|FG000|COMPLETED|Overall Study||113||
59693803|NCT01280721|75813379|FG000|NOT COMPLETED|Overall Study||22||
59693804|NCT01087762|75813397|FG000|STARTED|Double Blind Period (Weeks 0-24)|Completed 24-weeks Double-blind Period|107||
59693805|NCT01087762|75813398|FG001|STARTED|Double Blind Period (Weeks 0-24)|Completed 24-weeks Double-blind Period|111||
59693806|NCT01087762|75813399|FG002|STARTED|Double Blind Period (Weeks 0-24)|Completed 24-weeks Double-blind Period|107||
59693807|NCT01087762|75813400|FG003|STARTED|Double Blind Period (Weeks 0-24)||0||
59693808|NCT01087762|75813401|FG004|STARTED|Double Blind Period (Weeks 0-24)||0||
59693809|NCT01087762|75813397|FG000|COMPLETED|Double Blind Period (Weeks 0-24)||95||
59693810|NCT01087762|75813398|FG001|COMPLETED|Double Blind Period (Weeks 0-24)||105||
59693811|NCT01087762|75813399|FG002|COMPLETED|Double Blind Period (Weeks 0-24)||98||
59693812|NCT01087762|75813400|FG003|COMPLETED|Double Blind Period (Weeks 0-24)||0||
59693813|NCT01087762|75813401|FG004|COMPLETED|Double Blind Period (Weeks 0-24)||0||
59693814|NCT01087762|75813397|FG000|NOT COMPLETED|Double Blind Period (Weeks 0-24)||12||
59693815|NCT01087762|75813398|FG001|NOT COMPLETED|Double Blind Period (Weeks 0-24)||6||
59693816|NCT01087762|75813399|FG002|NOT COMPLETED|Double Blind Period (Weeks 0-24)||9||
59693817|NCT01087762|75813400|FG003|NOT COMPLETED|Double Blind Period (Weeks 0-24)||0||
59693818|NCT01087762|75813401|FG004|NOT COMPLETED|Double Blind Period (Weeks 0-24)||0||
59693819|NCT01087762|75813397|FG000|STARTED|Open-Label Period (Weeks 48-204)||0||
59693820|NCT01087762|75813398|FG001|STARTED|Open-Label Period (Weeks 48-204)||0||
59693821|NCT01087762|75813399|FG002|STARTED|Open-Label Period (Weeks 48-204)||0||
60079421|NCT04206332|76194706|FG006|NOT COMPLETED|Part A||0||
60079422|NCT04206332|76194707|FG007|NOT COMPLETED|Part A||0||
60079423|NCT04206332|76194708|FG008|NOT COMPLETED|Part A||0||
59693822|NCT01087762|75813400|FG003|STARTED|Open-Label Period (Weeks 48-204)||158||
59693823|NCT01087762|75813401|FG004|STARTED|Open-Label Period (Weeks 48-204)||157||
59693824|NCT01087762|75813397|FG000|COMPLETED|Open-Label Period (Weeks 48-204)||0||
59693825|NCT01087762|75813398|FG001|COMPLETED|Open-Label Period (Weeks 48-204)||0||
60079424|NCT04206332|76194709|FG009|NOT COMPLETED|Part A||0||
60079425|NCT04206332|76194710|FG010|NOT COMPLETED|Part A||0||
59693826|NCT01087762|75813399|FG002|COMPLETED|Open-Label Period (Weeks 48-204)||0||
59693827|NCT01087762|75813400|FG003|COMPLETED|Open-Label Period (Weeks 48-204)||99||
59693828|NCT01087762|75813401|FG004|COMPLETED|Open-Label Period (Weeks 48-204)||100||
59693829|NCT01087762|75813397|FG000|NOT COMPLETED|Open-Label Period (Weeks 48-204)||0||
59693830|NCT01087762|75813398|FG001|NOT COMPLETED|Open-Label Period (Weeks 48-204)||0||
59693831|NCT01087762|75813399|FG002|NOT COMPLETED|Open-Label Period (Weeks 48-204)||0||
59693832|NCT01087762|75813400|FG003|NOT COMPLETED|Open-Label Period (Weeks 48-204)||59||
59693833|NCT01087762|75813401|FG004|NOT COMPLETED|Open-Label Period (Weeks 48-204)||57||
59693834|NCT01078168|75813413|FG000|STARTED|Overall Study||11||
59693835|NCT01078168|75813414|FG001|STARTED|Overall Study||11||
59693836|NCT01078168|75813413|FG000|COMPLETED|Overall Study||11||
59693837|NCT01078168|75813414|FG001|COMPLETED|Overall Study||10||
59693838|NCT01078168|75813413|FG000|NOT COMPLETED|Overall Study||0||
59693839|NCT01078168|75813414|FG001|NOT COMPLETED|Overall Study||1||
59693840|NCT01086358|75813420|FG000|STARTED|First Intervention|30 subjects enrolled.|30||
59693841|NCT01086358|75813421|FG001|STARTED|First Intervention|30 subjects enrolled, 1 withdrew before randomization|29||
59693842|NCT01086358|75813420|FG000|COMPLETED|First Intervention||21||
59693843|NCT01086358|75813421|FG001|COMPLETED|First Intervention||24||
59693844|NCT01086358|75813420|FG000|NOT COMPLETED|First Intervention||9||
59693845|NCT01086358|75813421|FG001|NOT COMPLETED|First Intervention||5||
59693846|NCT01086358|75813420|FG000|STARTED|Second Intervention||21||
59693847|NCT01086358|75813421|FG001|STARTED|Second Intervention||24||
59693848|NCT01086358|75813420|FG000|COMPLETED|Second Intervention||17||
59693849|NCT01086358|75813421|FG001|COMPLETED|Second Intervention||20||
59693850|NCT01086358|75813420|FG000|NOT COMPLETED|Second Intervention||4||
59693851|NCT01086358|75813421|FG001|NOT COMPLETED|Second Intervention||4||
59693852|NCT01277601|75813431|FG000|STARTED|Overall Study||188||
59693853|NCT01277601|75813432|FG001|STARTED|Overall Study||187||
59693854|NCT01277601|75813433|FG002|STARTED|Overall Study||190||
59693855|NCT01277601|75813434|FG003|STARTED|Overall Study||186||
59693856|NCT01277601|75813431|FG000|COMPLETED|Overall Study||151||
59693857|NCT01277601|75813432|FG001|COMPLETED|Overall Study||139||
59693858|NCT01277601|75813433|FG002|COMPLETED|Overall Study||163||
59693859|NCT01277601|75813434|FG003|COMPLETED|Overall Study||150||
59693860|NCT01277601|75813431|FG000|NOT COMPLETED|Overall Study||37||
59693861|NCT01277601|75813432|FG001|NOT COMPLETED|Overall Study||48||
59693862|NCT01277601|75813433|FG002|NOT COMPLETED|Overall Study||27||
59693863|NCT01277601|75813434|FG003|NOT COMPLETED|Overall Study||36||
59693864|NCT01277523|75813464|FG000|STARTED|Overall Study||135||
59693865|NCT01277523|75813465|FG001|STARTED|Overall Study||127||
59693866|NCT01277523|75813466|FG002|STARTED|Overall Study||130||
59693867|NCT01277523|75813464|FG000|COMPLETED|Overall Study||132||
59693868|NCT01277523|75813465|FG001|COMPLETED|Overall Study||126||
59693869|NCT01277523|75813466|FG002|COMPLETED|Overall Study||130||
59693870|NCT01277523|75813464|FG000|NOT COMPLETED|Overall Study||3||
59693871|NCT01277523|75813465|FG001|NOT COMPLETED|Overall Study||1||
59693872|NCT01277523|75813466|FG002|NOT COMPLETED|Overall Study||0||
59693873|NCT01081834|75813479|FG000|STARTED|Core Period: Baseline to Week 26||192||
59693874|NCT01081834|75813480|FG001|STARTED|Core Period: Baseline to Week 26||195||
59693875|NCT01081834|75813481|FG002|STARTED|Core Period: Baseline to Week 26||197||
59693876|NCT01081834|75813482|FG003|STARTED|Core Period: Baseline to Week 26||47||
59693877|NCT01081834|75813483|FG004|STARTED|Core Period: Baseline to Week 26||44||
59693878|NCT01081834|75813479|FG000|COMPLETED|Core Period: Baseline to Week 26||160||
59693879|NCT01081834|75813480|FG001|COMPLETED|Core Period: Baseline to Week 26||172||
59693880|NCT01081834|75813481|FG002|COMPLETED|Core Period: Baseline to Week 26||175||
59693881|NCT01081834|75813482|FG003|COMPLETED|Core Period: Baseline to Week 26||40||
59693882|NCT01081834|75813483|FG004|COMPLETED|Core Period: Baseline to Week 26||40||
59693883|NCT01081834|75813479|FG000|NOT COMPLETED|Core Period: Baseline to Week 26||32||
59693884|NCT01081834|75813480|FG001|NOT COMPLETED|Core Period: Baseline to Week 26||23||
59693885|NCT01081834|75813481|FG002|NOT COMPLETED|Core Period: Baseline to Week 26||22||
59693886|NCT01081834|75813482|FG003|NOT COMPLETED|Core Period: Baseline to Week 26||7||
59693887|NCT01081834|75813483|FG004|NOT COMPLETED|Core Period: Baseline to Week 26||4||
59693888|NCT01081834|75813479|FG000|STARTED|Extension Period: Week 26 to Week 52|5 pts discontinued on last day of core: lack of efficacy on rescue (2), not specified (NS) (3).|155||
59693889|NCT01081834|75813480|FG001|STARTED|Extension Period: Week 26 to Week 52|2 pts discontinued on last day of core: adverse event (AE) (1), protocol violation (PV) (1).|170||
59693890|NCT01081834|75813481|FG002|STARTED|Extension Period: Week 26 to Week 52|5 pts discontinued last day of core: AE (1), lost f/u (1), PV (1), NS (1), physician decision (1).|170||
59693891|NCT01081834|75813482|FG003|STARTED|Extension Period: Week 26 to Week 52|The treatment duration for the High Glycemic Substudy was 26 weeks only.|0||
59693892|NCT01081834|75813483|FG004|STARTED|Extension Period: Week 26 to Week 52|The treatment duration for the High Glycemic Substudy was 26 weeks only.|0||
59693893|NCT01081834|75813479|FG000|COMPLETED|Extension Period: Week 26 to Week 52||135||
59693894|NCT01081834|75813480|FG001|COMPLETED|Extension Period: Week 26 to Week 52||152||
59693895|NCT01081834|75813481|FG002|COMPLETED|Extension Period: Week 26 to Week 52||165||
59693896|NCT01081834|75813482|FG003|COMPLETED|Extension Period: Week 26 to Week 52||0||
59693897|NCT01081834|75813483|FG004|COMPLETED|Extension Period: Week 26 to Week 52||0||
59693898|NCT01081834|75813479|FG000|NOT COMPLETED|Extension Period: Week 26 to Week 52||20||
59693899|NCT01081834|75813480|FG001|NOT COMPLETED|Extension Period: Week 26 to Week 52||18||
59693900|NCT01081834|75813481|FG002|NOT COMPLETED|Extension Period: Week 26 to Week 52||5||
59693901|NCT01081834|75813482|FG003|NOT COMPLETED|Extension Period: Week 26 to Week 52||0||
59693902|NCT01081834|75813483|FG004|NOT COMPLETED|Extension Period: Week 26 to Week 52||0||
59693903|NCT01276509|75813506|FG000|STARTED|Overall Study||66||
59693904|NCT01276509|75813507|FG001|STARTED|Overall Study||65||
59693905|NCT01276509|75813508|FG002|STARTED|Overall Study||68||
59693906|NCT01276509|75813509|FG003|STARTED|Overall Study||63||
59693907|NCT01276509|75813506|FG000|COMPLETED|Overall Study||53||
59693908|NCT01276509|75813507|FG001|COMPLETED|Overall Study||53||
59693909|NCT01276509|75813508|FG002|COMPLETED|Overall Study||63||
59693910|NCT01276509|75813509|FG003|COMPLETED|Overall Study||58||
59693911|NCT01276509|75813506|FG000|NOT COMPLETED|Overall Study||13||
59693912|NCT01276509|75813507|FG001|NOT COMPLETED|Overall Study||12||
59693913|NCT01276509|75813508|FG002|NOT COMPLETED|Overall Study||5||
59693914|NCT01276509|75813509|FG003|NOT COMPLETED|Overall Study||5||
59693915|NCT01079962|75813521|FG000|STARTED|Overall Study||105||
59693916|NCT01079962|75813522|FG001|STARTED|Overall Study||104||
59693917|NCT01079962|75813521|FG000|COMPLETED|Overall Study||90||
59693918|NCT01079962|75813522|FG001|COMPLETED|Overall Study||89||
59693919|NCT01079962|75813521|FG000|NOT COMPLETED|Overall Study||15||
59693920|NCT01079962|75813522|FG001|NOT COMPLETED|Overall Study||15||
59693921|NCT01274637|75813530|FG000|STARTED|Overall Study||30||
59693922|NCT01274637|75813531|FG001|STARTED|Overall Study||32||
59693923|NCT01274637|75813530|FG000|COMPLETED|Overall Study||30||
59693924|NCT01274637|75813531|FG001|COMPLETED|Overall Study||30||
59693925|NCT01274637|75813530|FG000|NOT COMPLETED|Overall Study||0||
59693926|NCT01274637|75813531|FG001|NOT COMPLETED|Overall Study||2||
59693927|NCT01079806|75813539|FG000|STARTED|Day 1 to Week 96||120||
59693928|NCT01079806|75813540|FG001|STARTED|Day 1 to Week 96||60||
59693929|NCT01079806|75813539|FG000|Received Treatment|Day 1 to Week 96||120||
59693930|NCT01079806|75813540|FG001|Received Treatment|Day 1 to Week 96||60||
59693931|NCT01079806|75813539|FG000|Primary Endpoint Cohort|Day 1 to Week 96||82||
59693932|NCT01079806|75813540|FG001|Primary Endpoint Cohort|Day 1 to Week 96||41||
59693933|NCT01079806|75813539|FG000|COMPLETED|Day 1 to Week 96||113||
59693934|NCT01079806|75813540|FG001|COMPLETED|Day 1 to Week 96||53||
59693935|NCT01079806|75813539|FG000|NOT COMPLETED|Day 1 to Week 96||7||
59693936|NCT01079806|75813540|FG001|NOT COMPLETED|Day 1 to Week 96||7||
59693937|NCT01079806|75813539|FG000|STARTED|Long-term Follow-up: Day 1-End of Study||111|Entered from start to end of long-term follow-up|
59693938|NCT01079806|75813540|FG001|STARTED|Long-term Follow-up: Day 1-End of Study||58|Entered from start to end of long-term follow-up|
59693939|NCT01079806|75813539|FG000|COMPLETED|Long-term Follow-up: Day 1-End of Study||92||
59693940|NCT01079806|75813540|FG001|COMPLETED|Long-term Follow-up: Day 1-End of Study||43||
59693941|NCT01079806|75813539|FG000|NOT COMPLETED|Long-term Follow-up: Day 1-End of Study||19||
59693942|NCT01079806|75813540|FG001|NOT COMPLETED|Long-term Follow-up: Day 1-End of Study||15||
59693943|NCT01078090|75813548|FG000|STARTED|Overall Study||5745||
59693944|NCT01078090|75813548|FG000|COMPLETED|Overall Study||1152||
59693945|NCT01078090|75813548|FG000|NOT COMPLETED|Overall Study||4593||
59693946|NCT01077622|75813566|FG000|STARTED|Overall Study||10||
59693947|NCT01077622|75813566|FG000|COMPLETED|Overall Study||7||
59693948|NCT01077622|75813566|FG000|NOT COMPLETED|Overall Study||3||
59693949|NCT01313676|75813574|FG000|STARTED|Overall Study||4131||
59693950|NCT01313676|75813575|FG001|STARTED|Overall Study||4157||
59693951|NCT01313676|75813576|FG002|STARTED|Overall Study||4140||
59693952|NCT01313676|75813577|FG003|STARTED|Overall Study||4140||
59693953|NCT01313676|75813574|FG000|COMPLETED|Overall Study||2881||
59693954|NCT01313676|75813575|FG001|COMPLETED|Overall Study||3044||
59693955|NCT01313676|75813576|FG002|COMPLETED|Overall Study||3052||
59693956|NCT01313676|75813577|FG003|COMPLETED|Overall Study||3146||
59693957|NCT01313676|75813574|FG000|NOT COMPLETED|Overall Study||1250||
59693958|NCT01313676|75813575|FG001|NOT COMPLETED|Overall Study||1113||
59693959|NCT01313676|75813576|FG002|NOT COMPLETED|Overall Study||1088||
59693960|NCT01313676|75813577|FG003|NOT COMPLETED|Overall Study||994||
59693961|NCT01313286|75813588|FG000|STARTED|Period 1||8||
59693962|NCT01313286|75813589|FG001|STARTED|Period 1||8||
59693963|NCT01313286|75813588|FG000|COMPLETED|Period 1||6||
59693964|NCT01313286|75813589|FG001|COMPLETED|Period 1||8||
59693965|NCT01313286|75813588|FG000|NOT COMPLETED|Period 1||2||
59693966|NCT01313286|75813589|FG001|NOT COMPLETED|Period 1||0||
59693967|NCT01313286|75813588|FG000|STARTED|Period 2||6||
59693968|NCT01313286|75813589|FG001|STARTED|Period 2||8||
59693969|NCT01313286|75813588|FG000|COMPLETED|Period 2||6||
59693970|NCT01313286|75813589|FG001|COMPLETED|Period 2||8||
59693971|NCT01313286|75813588|FG000|NOT COMPLETED|Period 2||0||
59693972|NCT01313286|75813589|FG001|NOT COMPLETED|Period 2||0||
59693973|NCT01313208|75813597|FG000|STARTED|Double-blind Phase (Weeks 1 - 12)||104||
59693974|NCT01313208|75813598|FG001|STARTED|Double-blind Phase (Weeks 1 - 12)||106||
59693975|NCT01313208|75813597|FG000|COMPLETED|Double-blind Phase (Weeks 1 - 12)||98||
59693976|NCT01313208|75813598|FG001|COMPLETED|Double-blind Phase (Weeks 1 - 12)||101||
59693977|NCT01313208|75813597|FG000|NOT COMPLETED|Double-blind Phase (Weeks 1 - 12)||6||
59693978|NCT01313208|75813598|FG001|NOT COMPLETED|Double-blind Phase (Weeks 1 - 12)||5||
59816143|NCT00614393|75938496|FG002|COMPLETED|Overall Study||0||
59693979|NCT01313208|75813597|FG000|STARTED|Open-label Phase (Weeks 13 - 24)||98||
59693980|NCT01313208|75813598|FG001|STARTED|Open-label Phase (Weeks 13 - 24)||101||
59693981|NCT01313208|75813597|FG000|COMPLETED|Open-label Phase (Weeks 13 - 24)||92||
59693982|NCT01313208|75813598|FG001|COMPLETED|Open-label Phase (Weeks 13 - 24)||98||
59693983|NCT01313208|75813597|FG000|NOT COMPLETED|Open-label Phase (Weeks 13 - 24)||6||
59693984|NCT01313208|75813598|FG001|NOT COMPLETED|Open-label Phase (Weeks 13 - 24)||3||
59693985|NCT01312428|75813608|FG000|STARTED|Overall Study||3||
59693986|NCT01312428|75813609|FG001|STARTED|Overall Study||4||
59693987|NCT01312428|75813608|FG000|COMPLETED|Overall Study||0||
59693988|NCT01312428|75813609|FG001|COMPLETED|Overall Study||0||
59693989|NCT01312428|75813608|FG000|NOT COMPLETED|Overall Study||3||
59693990|NCT01312428|75813609|FG001|NOT COMPLETED|Overall Study||4||
59693991|NCT01075984|75813622|FG000|STARTED|Treatment Phase||10||
59693992|NCT01075984|75813623|FG001|STARTED|Treatment Phase||11||
59693993|NCT01075984|75813624|FG002|STARTED|Treatment Phase||21||
59693994|NCT01075984|75813625|FG003|STARTED|Treatment Phase||24||
59693995|NCT01075984|75813626|FG004|STARTED|Treatment Phase||213||
59693996|NCT01075984|75813622|FG000|COMPLETED|Treatment Phase||10||
59693997|NCT01075984|75813623|FG001|COMPLETED|Treatment Phase||10||
59693998|NCT01075984|75813624|FG002|COMPLETED|Treatment Phase||14||
59693999|NCT01075984|75813625|FG003|COMPLETED|Treatment Phase||17||
59694000|NCT01075984|75813626|FG004|COMPLETED|Treatment Phase||153||
59694001|NCT01075984|75813622|FG000|NOT COMPLETED|Treatment Phase||0||
59694002|NCT01075984|75813623|FG001|NOT COMPLETED|Treatment Phase||1||
59694003|NCT01075984|75813624|FG002|NOT COMPLETED|Treatment Phase||7||
59694004|NCT01075984|75813625|FG003|NOT COMPLETED|Treatment Phase||7||
59694005|NCT01075984|75813626|FG004|NOT COMPLETED|Treatment Phase||60||
59694006|NCT01075984|75813622|FG000|STARTED|Follow-up Phase||10||
59694007|NCT01075984|75813623|FG001|STARTED|Follow-up Phase||10||
59694008|NCT01075984|75813624|FG002|STARTED|Follow-up Phase|One participant did not start the follow-up phase for reasons unrelated to study procedures.|20||
59694009|NCT01075984|75813625|FG003|STARTED|Follow-up Phase|Three participants did not start the follow-up phase: one died and two were lost to follow-up.|21||
59694010|NCT01075984|75813626|FG004|STARTED|Follow-up Phase|One participant withdrew consent before the start of the follow-up phase.|212||
59694011|NCT01075984|75813622|FG000|COMPLETED|Follow-up Phase||10||
59694012|NCT01075984|75813623|FG001|COMPLETED|Follow-up Phase||10||
59694013|NCT01075984|75813624|FG002|COMPLETED|Follow-up Phase||19||
59694014|NCT01075984|75813625|FG003|COMPLETED|Follow-up Phase||19||
59694015|NCT01075984|75813626|FG004|COMPLETED|Follow-up Phase||165||
59694016|NCT01075984|75813622|FG000|NOT COMPLETED|Follow-up Phase||0||
59694017|NCT01075984|75813623|FG001|NOT COMPLETED|Follow-up Phase||0||
59694018|NCT01075984|75813624|FG002|NOT COMPLETED|Follow-up Phase||1||
59694019|NCT01075984|75813625|FG003|NOT COMPLETED|Follow-up Phase||2||
59694020|NCT01075984|75813626|FG004|NOT COMPLETED|Follow-up Phase||47||
59694021|NCT01024231|75813645|FG000|STARTED|Overall Study||14||
59694022|NCT01024231|75813646|FG001|STARTED|Overall Study||17||
59694023|NCT01024231|75813647|FG002|STARTED|Overall Study||16||
59694024|NCT01024231|75813648|FG003|STARTED|Overall Study||6||
59694025|NCT01024231|75813649|FG004|STARTED|Overall Study||17||
59694026|NCT01024231|75813650|FG005|STARTED|Overall Study||16||
59694027|NCT01024231|75813651|FG006|STARTED|Overall Study||41||
59694028|NCT01024231|75813645|FG000|COMPLETED|Overall Study||2||
59694029|NCT01024231|75813646|FG001|COMPLETED|Overall Study||2||
59694030|NCT01024231|75813647|FG002|COMPLETED|Overall Study||6||
59694031|NCT01024231|75813648|FG003|COMPLETED|Overall Study||1||
59694032|NCT01024231|75813649|FG004|COMPLETED|Overall Study||0||
59694033|NCT01024231|75813650|FG005|COMPLETED|Overall Study||0||
59694034|NCT01024231|75813651|FG006|COMPLETED|Overall Study||20||
59694035|NCT01024231|75813645|FG000|NOT COMPLETED|Overall Study||12||
59694036|NCT01024231|75813646|FG001|NOT COMPLETED|Overall Study||15||
59694037|NCT01024231|75813647|FG002|NOT COMPLETED|Overall Study||10||
59694038|NCT01024231|75813648|FG003|NOT COMPLETED|Overall Study||5||
59694039|NCT01024231|75813649|FG004|NOT COMPLETED|Overall Study||17||
59694040|NCT01024231|75813650|FG005|NOT COMPLETED|Overall Study||16||
59694041|NCT01024231|75813651|FG006|NOT COMPLETED|Overall Study||21||
59694042|NCT01077544|75813674|FG000|STARTED|Overall Study||8||
59694043|NCT01077544|75813675|FG001|STARTED|Overall Study||7||
59694044|NCT01077544|75813674|FG000|COMPLETED|Overall Study||5||
59694045|NCT01077544|75813675|FG001|COMPLETED|Overall Study||2||
59694046|NCT01077544|75813674|FG000|NOT COMPLETED|Overall Study||3||
59816144|NCT00614393|75938497|FG003|COMPLETED|Overall Study||0||
59694047|NCT01077544|75813675|FG001|NOT COMPLETED|Overall Study||5||
59694048|NCT01075516|75813683|FG000|STARTED|Overall Study||107||
59694049|NCT01075516|75813684|FG001|STARTED|Overall Study||102||
59816145|NCT00614393|75938498|FG004|COMPLETED|Overall Study||0||
59694050|NCT01075516|75813683|FG000|COMPLETED|Overall Study||89||
59694051|NCT01075516|75813684|FG001|COMPLETED|Overall Study||86||
59694052|NCT01075516|75813683|FG000|NOT COMPLETED|Overall Study||18||
59816146|NCT00614393|75938494|FG000|NOT COMPLETED|Overall Study||180||
59694053|NCT01075516|75813684|FG001|NOT COMPLETED|Overall Study||16||
59694054|NCT01012999|75813690|FG000|STARTED|Overall Study||16||
59694055|NCT01012999|75813690|FG000|COMPLETED|Overall Study||15||
59694056|NCT01012999|75813690|FG000|NOT COMPLETED|Overall Study||1||
59694057|NCT01017601|75813696|FG000|STARTED|Overall Study||26||
59694058|NCT01017601|75813697|FG001|STARTED|Overall Study||24||
59694059|NCT01017601|75813696|FG000|COMPLETED|Overall Study||14||
59694060|NCT01017601|75813697|FG001|COMPLETED|Overall Study||11||
59694061|NCT01017601|75813696|FG000|NOT COMPLETED|Overall Study||12||
59694062|NCT01017601|75813697|FG001|NOT COMPLETED|Overall Study||13||
59694063|NCT01016977|75813705|FG000|STARTED|Overall Study||20||
59694064|NCT01016977|75813706|FG001|STARTED|Overall Study||20||
59694065|NCT01016977|75813705|FG000|COMPLETED|Overall Study||17||
59694066|NCT01016977|75813706|FG001|COMPLETED|Overall Study||18||
59694067|NCT01016977|75813705|FG000|NOT COMPLETED|Overall Study||3||
59694068|NCT01016977|75813706|FG001|NOT COMPLETED|Overall Study||2||
59694069|NCT01012765|75813715|FG000|STARTED|Treatment Period 1||20||
59694070|NCT01012765|75813716|FG001|STARTED|Treatment Period 1||21||
59694071|NCT01012765|75813717|FG002|STARTED|Treatment Period 1||23||
59694072|NCT01012765|75813718|FG003|STARTED|Treatment Period 1||18||
59694073|NCT01012765|75813719|FG004|STARTED|Treatment Period 1||22||
59694074|NCT01012765|75813720|FG005|STARTED|Treatment Period 1||25||
59694075|NCT01012765|75813715|FG000|COMPLETED|Treatment Period 1||17||
59694076|NCT01012765|75813716|FG001|COMPLETED|Treatment Period 1||21||
59694077|NCT01012765|75813717|FG002|COMPLETED|Treatment Period 1||21||
59694078|NCT01012765|75813718|FG003|COMPLETED|Treatment Period 1||15||
59694079|NCT01012765|75813719|FG004|COMPLETED|Treatment Period 1||19||
59694080|NCT01012765|75813720|FG005|COMPLETED|Treatment Period 1||25||
59694081|NCT01012765|75813715|FG000|NOT COMPLETED|Treatment Period 1||3||
59694082|NCT01012765|75813716|FG001|NOT COMPLETED|Treatment Period 1||0||
59694083|NCT01012765|75813717|FG002|NOT COMPLETED|Treatment Period 1||2||
59694084|NCT01012765|75813718|FG003|NOT COMPLETED|Treatment Period 1||3||
59694085|NCT01012765|75813719|FG004|NOT COMPLETED|Treatment Period 1||3||
59694086|NCT01012765|75813720|FG005|NOT COMPLETED|Treatment Period 1||0||
59694087|NCT01012765|75813715|FG000|STARTED|Treatment Period 2||17||
59694088|NCT01012765|75813716|FG001|STARTED|Treatment Period 2||21||
59694089|NCT01012765|75813717|FG002|STARTED|Treatment Period 2||21||
59694090|NCT01012765|75813718|FG003|STARTED|Treatment Period 2||15||
59694091|NCT01012765|75813719|FG004|STARTED|Treatment Period 2||19||
59694092|NCT01012765|75813720|FG005|STARTED|Treatment Period 2||25||
59694093|NCT01012765|75813715|FG000|COMPLETED|Treatment Period 2||16||
59694094|NCT01012765|75813716|FG001|COMPLETED|Treatment Period 2||19||
59694095|NCT01012765|75813717|FG002|COMPLETED|Treatment Period 2||18||
59694096|NCT01012765|75813718|FG003|COMPLETED|Treatment Period 2||15||
59694097|NCT01012765|75813719|FG004|COMPLETED|Treatment Period 2||18||
59694098|NCT01012765|75813720|FG005|COMPLETED|Treatment Period 2||24||
59694099|NCT01012765|75813715|FG000|NOT COMPLETED|Treatment Period 2||1||
59694100|NCT01012765|75813716|FG001|NOT COMPLETED|Treatment Period 2||2||
59694101|NCT01012765|75813717|FG002|NOT COMPLETED|Treatment Period 2||3||
59694102|NCT01012765|75813718|FG003|NOT COMPLETED|Treatment Period 2||0||
59694103|NCT01012765|75813719|FG004|NOT COMPLETED|Treatment Period 2||1||
59694104|NCT01012765|75813720|FG005|NOT COMPLETED|Treatment Period 2||1||
59694105|NCT01012765|75813715|FG000|STARTED|Treatment Period 3||16||
59694106|NCT01012765|75813716|FG001|STARTED|Treatment Period 3||19||
59694107|NCT01012765|75813717|FG002|STARTED|Treatment Period 3||18||
59694108|NCT01012765|75813718|FG003|STARTED|Treatment Period 3||15||
59694109|NCT01012765|75813719|FG004|STARTED|Treatment Period 3||18||
59694110|NCT01012765|75813720|FG005|STARTED|Treatment Period 3||24||
59694111|NCT01012765|75813715|FG000|COMPLETED|Treatment Period 3||16||
59694112|NCT01012765|75813716|FG001|COMPLETED|Treatment Period 3||19||
59694113|NCT01012765|75813717|FG002|COMPLETED|Treatment Period 3||18||
59694114|NCT01012765|75813718|FG003|COMPLETED|Treatment Period 3||15||
59694115|NCT01012765|75813719|FG004|COMPLETED|Treatment Period 3||18||
59694116|NCT01012765|75813720|FG005|COMPLETED|Treatment Period 3||24||
59694117|NCT01012765|75813715|FG000|NOT COMPLETED|Treatment Period 3||0||
59694118|NCT01012765|75813716|FG001|NOT COMPLETED|Treatment Period 3||0||
59694119|NCT01012765|75813717|FG002|NOT COMPLETED|Treatment Period 3||0||
59694120|NCT01012765|75813718|FG003|NOT COMPLETED|Treatment Period 3||0||
59694121|NCT01012765|75813719|FG004|NOT COMPLETED|Treatment Period 3||0||
59694122|NCT01012765|75813720|FG005|NOT COMPLETED|Treatment Period 3||0||
59694123|NCT01010503|75813728|FG000|STARTED|Overall Study||32||
59694124|NCT01010503|75813728|FG000|COMPLETED|Overall Study||30||
59694125|NCT01010503|75813728|FG000|NOT COMPLETED|Overall Study||2||
59694126|NCT01006291|75813735|FG000|STARTED|Overall Study||229||
59694127|NCT01006291|75813736|FG001|STARTED|Overall Study||228||
59694128|NCT01006291|75813737|FG002|STARTED|Overall Study||230||
59694129|NCT01006291|75813735|FG000|Exposed|Overall Study|1 subject withdrew before exposure to drug. 2 subjects randomised to IDeg OD received IDeg OD FF|230||
59694130|NCT01006291|75813736|FG001|Exposed|Overall Study|2 subjects received IDeg OD FF|226||
59694131|NCT01006291|75813737|FG002|Exposed|Overall Study|1 subject withdrew prior to exposure to trial drug|229||
59694132|NCT01006291|75813735|FG000|COMPLETED|Overall Study||203||
59694133|NCT01006291|75813736|FG001|COMPLETED|Overall Study||204||
59694134|NCT01006291|75813737|FG002|COMPLETED|Overall Study||203||
59694135|NCT01006291|75813735|FG000|NOT COMPLETED|Overall Study||26||
59694136|NCT01006291|75813736|FG001|NOT COMPLETED|Overall Study||24||
59694137|NCT01006291|75813737|FG002|NOT COMPLETED|Overall Study||27||
59694138|NCT01006135|75813745|FG000|STARTED|Overall Study||4852||
59694139|NCT01006135|75813745|FG000|COMPLETED|Overall Study||4712||
59694140|NCT01006135|75813745|FG000|NOT COMPLETED|Overall Study||140||
59694141|NCT01012609|75813751|FG000|STARTED|Overall Study||21||
59694142|NCT01012609|75813752|FG001|STARTED|Overall Study||26||
59694143|NCT01012609|75813751|FG000|COMPLETED|Overall Study||20||
59547659|NCT02467179|75646504|FG000|NOT COMPLETED|Overall Study||0||
59547660|NCT02467179|75646505|FG001|NOT COMPLETED|Overall Study||0||
59547661|NCT01122446|75646513|FG000|STARTED|Overall Study||25||
59547662|NCT01122446|75646514|FG001|STARTED|Overall Study||25||
59547663|NCT01122446|75646513|FG000|COMPLETED|Overall Study||25||
59989886|NCT01639144|76105320|FG001|COMPLETED|Overall Study||250||
59989887|NCT01639144|76105319|FG000|NOT COMPLETED|Overall Study||10||
59989888|NCT01639144|76105320|FG001|NOT COMPLETED|Overall Study||5||
59989889|NCT01601626|76105329|FG000|STARTED|Overall Study||24||
59989890|NCT01601626|76105330|FG001|STARTED|Overall Study||24||
59989891|NCT01601626|76105331|FG002|STARTED|Overall Study||23||
59989892|NCT01601626|76105329|FG000|COMPLETED|Overall Study||21||
59989893|NCT01601626|76105330|FG001|COMPLETED|Overall Study||19||
59989894|NCT01601626|76105331|FG002|COMPLETED|Overall Study||21||
59989895|NCT01601626|76105329|FG000|NOT COMPLETED|Overall Study||3||
59989896|NCT01601626|76105330|FG001|NOT COMPLETED|Overall Study||5||
59989897|NCT01601626|76105331|FG002|NOT COMPLETED|Overall Study||2||
60079426|NCT04206332|76194711|FG011|NOT COMPLETED|Part A||0||
60079427|NCT04206332|76194712|FG012|NOT COMPLETED|Part A||0||
60079428|NCT04206332|76194713|FG013|NOT COMPLETED|Part A||0||
60079429|NCT04206332|76194714|FG014|NOT COMPLETED|Part A||0||
60079430|NCT04206332|76194715|FG015|NOT COMPLETED|Part A||0||
60079431|NCT04206332|76194716|FG016|NOT COMPLETED|Part A||0||
60079432|NCT04206332|76194700|FG000|STARTED|Part B||0||
60079433|NCT04206332|76194701|FG001|STARTED|Part B||0||
60079434|NCT04206332|76194702|FG002|STARTED|Part B||0||
60079435|NCT04206332|76194703|FG003|STARTED|Part B||0||
60079436|NCT04206332|76194704|FG004|STARTED|Part B||0||
60079437|NCT04206332|76194705|FG005|STARTED|Part B||0||
60079438|NCT04206332|76194706|FG006|STARTED|Part B||0||
60079439|NCT04206332|76194707|FG007|STARTED|Part B|Seven (7) participants from Part A enrolled in Part B, Group 7: CIS43LS (20 mg/kg IV). Of the 7 participants who enrolled in Part B, only 4 received a second product administration.|7||
60079440|NCT04206332|76194708|FG008|STARTED|Part B|Two (2) participants from Part A enrolled in Part B, Group 8: CHMI.|2||
60079441|NCT04206332|76194709|FG009|STARTED|Part B||4||
60079442|NCT04206332|76194710|FG010|STARTED|Part B|One (1) participant from Part A enrolled in Part B, Group 10: CHMI.|8||
60079443|NCT04206332|76194711|FG011|STARTED|Part B||0||
60079444|NCT04206332|76194712|FG012|STARTED|Part B||0||
60079445|NCT04206332|76194713|FG013|STARTED|Part B||0||
60079446|NCT04206332|76194714|FG014|STARTED|Part B||0||
60079447|NCT04206332|76194715|FG015|STARTED|Part B||0||
60079448|NCT04206332|76194716|FG016|STARTED|Part B||0||
60079449|NCT04206332|76194700|FG000|Received Product Administration|Part B||0||
60079450|NCT04206332|76194701|FG001|Received Product Administration|Part B||0||
60079451|NCT04206332|76194702|FG002|Received Product Administration|Part B||0||
60079452|NCT04206332|76194703|FG003|Received Product Administration|Part B||0||
59694144|NCT01012609|75813752|FG001|COMPLETED|Overall Study||25||
59694145|NCT01012609|75813751|FG000|NOT COMPLETED|Overall Study||1||
59694146|NCT01012609|75813752|FG001|NOT COMPLETED|Overall Study||1||
59694147|NCT01012219|75813759|FG000|STARTED|Period 1|Number randomized|36||
59694148|NCT01012219|75813759|FG000|COMPLETED|Period 1||35||
59694149|NCT01012219|75813759|FG000|NOT COMPLETED|Period 1||1||
59694150|NCT01012219|75813759|FG000|STARTED|Period 2|Number who completed Period 1|35||
59694151|NCT01012219|75813759|FG000|COMPLETED|Period 2||34||
59694152|NCT01012219|75813759|FG000|NOT COMPLETED|Period 2||1||
59816147|NCT00614393|75938495|FG001|NOT COMPLETED|Overall Study||8||
59816148|NCT00614393|75938496|FG002|NOT COMPLETED|Overall Study||10||
59816149|NCT00614393|75938497|FG003|NOT COMPLETED|Overall Study||180||
59816150|NCT00614393|75938498|FG004|NOT COMPLETED|Overall Study||180||
59816151|NCT00612677|75938510|FG000|STARTED|Overall Study||1||
59989898|NCT02737501|76105341|FG000|STARTED|Randomized Phase||137||
59989899|NCT02737501|76105342|FG001|STARTED|Randomized Phase||138||
59989900|NCT02737501|76105343|FG002|STARTED|Randomized Phase||0||
59989901|NCT02737501|76105341|FG000|Safety Analysis Set|Randomized Phase||136||
59989902|NCT02737501|76105342|FG001|Safety Analysis Set|Randomized Phase||137||
59989903|NCT02737501|76105343|FG002|Safety Analysis Set|Randomized Phase||0||
60079453|NCT04206332|76194704|FG004|Received Product Administration|Part B||0||
60079454|NCT04206332|76194705|FG005|Received Product Administration|Part B||0||
60079455|NCT04206332|76194706|FG006|Received Product Administration|Part B||0||
60079456|NCT04206332|76194707|FG007|Received Product Administration|Part B||4||
60079457|NCT04206332|76194708|FG008|Received Product Administration|Part B||0||
60079458|NCT04206332|76194709|FG009|Received Product Administration|Part B||4||
60079459|NCT04206332|76194710|FG010|Received Product Administration|Part B||0||
59816152|NCT00612677|75938510|FG000|COMPLETED|Overall Study||0||
59989904|NCT02737501|76105341|FG000|COMPLETED|Randomized Phase||20||
59989905|NCT02737501|76105342|FG001|COMPLETED|Randomized Phase||84||
59989906|NCT02737501|76105343|FG002|COMPLETED|Randomized Phase||0||
59989907|NCT02737501|76105341|FG000|NOT COMPLETED|Randomized Phase||117||
59694153|NCT01012219|75813759|FG000|STARTED|Period 3|of the 36 who started Period 1|20||
59694154|NCT01012219|75813759|FG000|COMPLETED|Period 3||20||
59694155|NCT01012219|75813759|FG000|NOT COMPLETED|Period 3||0||
59694156|NCT01011907|75813768|FG000|STARTED|Overall Study||31||
59694157|NCT01011907|75813769|FG001|STARTED|Overall Study||33||
59694158|NCT01011907|75813768|FG000|COMPLETED|Overall Study||17||
59694159|NCT01011907|75813769|FG001|COMPLETED|Overall Study||18||
59694160|NCT01011907|75813768|FG000|NOT COMPLETED|Overall Study||14||
59694161|NCT01011907|75813769|FG001|NOT COMPLETED|Overall Study||15||
59694162|NCT01011673|75813777|FG000|STARTED|Randomized||62||
59694163|NCT01011673|75813778|FG001|STARTED|Randomized||61||
59694164|NCT01011673|75813777|FG000|COMPLETED|Randomized|2 patients were randomized but not included in analyses bc they did not truly meet study criteria.|60||
59694165|NCT01011673|75813778|FG001|COMPLETED|Randomized|1 patient was randomized but not included in analyses bc they did not truly meet study criteria.|60||
59694166|NCT01011673|75813777|FG000|NOT COMPLETED|Randomized||2||
59694167|NCT01011673|75813778|FG001|NOT COMPLETED|Randomized||1||
59694168|NCT01011673|75813777|FG000|STARTED|Emergency Department Portion||60||
59694169|NCT01011673|75813778|FG001|STARTED|Emergency Department Portion||60||
59694170|NCT01011673|75813777|FG000|COMPLETED|Emergency Department Portion||60||
59694171|NCT01011673|75813778|FG001|COMPLETED|Emergency Department Portion||60||
59694172|NCT01011673|75813777|FG000|NOT COMPLETED|Emergency Department Portion||0||
59694173|NCT01011673|75813778|FG001|NOT COMPLETED|Emergency Department Portion||0||
59694174|NCT01011673|75813777|FG000|STARTED|24 Hour Follow-up||60||
59694175|NCT01011673|75813778|FG001|STARTED|24 Hour Follow-up||60||
59694176|NCT01011673|75813777|FG000|COMPLETED|24 Hour Follow-up||57||
59694177|NCT01011673|75813778|FG001|COMPLETED|24 Hour Follow-up||57||
59694178|NCT01011673|75813777|FG000|NOT COMPLETED|24 Hour Follow-up||3||
59694179|NCT01011673|75813778|FG001|NOT COMPLETED|24 Hour Follow-up||3||
59694180|NCT01011439|75813784|FG000|STARTED|Overall Study||72||
59694181|NCT01011439|75813784|FG000|COMPLETED|Overall Study||15||
59694182|NCT01011439|75813784|FG000|NOT COMPLETED|Overall Study||57||
59694183|NCT01311024|75813791|FG000|STARTED|Overall Study||1530||
59694184|NCT01311024|75813792|FG001|STARTED|Overall Study||811||
59694185|NCT01311024|75813791|FG000|COMPLETED|Overall Study||1495||
59694186|NCT01311024|75813792|FG001|COMPLETED|Overall Study||789||
59694187|NCT01311024|75813791|FG000|NOT COMPLETED|Overall Study||35||
59694188|NCT01311024|75813792|FG001|NOT COMPLETED|Overall Study||22||
59694189|NCT01310868|75813798|FG000|STARTED|Overall Study||72||
59694190|NCT01310868|75813798|FG000|COMPLETED|Overall Study||59||
59694191|NCT01310868|75813798|FG000|NOT COMPLETED|Overall Study||13||
59694192|NCT01273155|75813806|FG000|STARTED|Overall Study||14||
59694193|NCT01273155|75813807|FG001|STARTED|Overall Study||12||
59694194|NCT01273155|75813808|FG002|STARTED|Overall Study||18||
59694195|NCT01273155|75813809|FG003|STARTED|Overall Study||5||
59694196|NCT01273155|75813810|FG004|STARTED|Overall Study||5||
59694197|NCT01273155|75813811|FG005|STARTED|Overall Study||10||
59694198|NCT01273155|75813812|FG006|STARTED|Overall Study||8||
59989908|NCT02737501|76105342|FG001|NOT COMPLETED|Randomized Phase||54||
59989909|NCT02737501|76105343|FG002|NOT COMPLETED|Randomized Phase||0||
59989910|NCT02737501|76105341|FG000|STARTED|Crossover Phase||0||
59694199|NCT01273155|75813806|FG000|COMPLETED|Overall Study||12||
59694200|NCT01273155|75813807|FG001|COMPLETED|Overall Study||8||
59694201|NCT01273155|75813808|FG002|COMPLETED|Overall Study||6||
59694202|NCT01273155|75813809|FG003|COMPLETED|Overall Study||4||
59694203|NCT01273155|75813810|FG004|COMPLETED|Overall Study||3||
59694204|NCT01273155|75813811|FG005|COMPLETED|Overall Study||5||
59694205|NCT01273155|75813812|FG006|COMPLETED|Overall Study||2||
59694206|NCT01273155|75813806|FG000|NOT COMPLETED|Overall Study||2||
59694207|NCT01273155|75813807|FG001|NOT COMPLETED|Overall Study||4||
59694208|NCT01273155|75813808|FG002|NOT COMPLETED|Overall Study||12||
59694209|NCT01273155|75813809|FG003|NOT COMPLETED|Overall Study||1||
59694210|NCT01273155|75813810|FG004|NOT COMPLETED|Overall Study||2||
59694211|NCT01273155|75813811|FG005|NOT COMPLETED|Overall Study||5||
59694212|NCT01273155|75813812|FG006|NOT COMPLETED|Overall Study||6||
59694213|NCT01005901|75813837|FG000|STARTED|Overall Study||552||
59694214|NCT01005901|75813838|FG001|STARTED|Overall Study||270||
59694215|NCT01005901|75813837|FG000|Safety Population|Overall Study||550||
59694216|NCT01005901|75813838|FG001|Safety Population|Overall Study||267||
59694217|NCT01005901|75813837|FG000|Full Analysis Set|Overall Study||534||
59694218|NCT01005901|75813838|FG001|Full Analysis Set|Overall Study||260||
59694219|NCT01005901|75813837|FG000|COMPLETED|Overall Study||450||
59694220|NCT01005901|75813838|FG001|COMPLETED|Overall Study||212||
59989911|NCT02737501|76105342|FG001|STARTED|Crossover Phase||0||
59989912|NCT02737501|76105343|FG002|STARTED|Crossover Phase||65||
59694221|NCT01005901|75813837|FG000|NOT COMPLETED|Overall Study||102||
59694222|NCT01005901|75813838|FG001|NOT COMPLETED|Overall Study||58||
59694223|NCT04968925|75813846|FG000|STARTED|Phase I- Period 1||35||
59694224|NCT04968925|75813847|FG001|STARTED|Phase I- Period 1||40||
59694225|NCT04968925|75813848|FG002|STARTED|Phase I- Period 1||0||
59694226|NCT04968925|75813849|FG003|STARTED|Phase I- Period 1||0||
59694227|NCT04968925|75813846|FG000|COMPLETED|Phase I- Period 1||34||
59694228|NCT04968925|75813847|FG001|COMPLETED|Phase I- Period 1||38||
59694229|NCT04968925|75813848|FG002|COMPLETED|Phase I- Period 1||0||
59694230|NCT04968925|75813849|FG003|COMPLETED|Phase I- Period 1||0||
59694231|NCT04968925|75813846|FG000|NOT COMPLETED|Phase I- Period 1||1||
59694232|NCT04968925|75813847|FG001|NOT COMPLETED|Phase I- Period 1||2||
59694233|NCT04968925|75813848|FG002|NOT COMPLETED|Phase I- Period 1||0||
59694234|NCT04968925|75813849|FG003|NOT COMPLETED|Phase I- Period 1||0||
59694235|NCT04968925|75813846|FG000|STARTED|Phase I- Period 2||34||
59694236|NCT04968925|75813847|FG001|STARTED|Phase I- Period 2||38||
59694237|NCT04968925|75813848|FG002|STARTED|Phase I- Period 2||0||
59694238|NCT04968925|75813849|FG003|STARTED|Phase I- Period 2||0||
59694239|NCT04968925|75813846|FG000|COMPLETED|Phase I- Period 2||34||
59694240|NCT04968925|75813847|FG001|COMPLETED|Phase I- Period 2||38||
59694241|NCT04968925|75813848|FG002|COMPLETED|Phase I- Period 2||0||
59694242|NCT04968925|75813849|FG003|COMPLETED|Phase I- Period 2||0||
59694243|NCT04968925|75813846|FG000|NOT COMPLETED|Phase I- Period 2||0||
59694244|NCT04968925|75813847|FG001|NOT COMPLETED|Phase I- Period 2||0||
59694245|NCT04968925|75813848|FG002|NOT COMPLETED|Phase I- Period 2||0||
59694246|NCT04968925|75813849|FG003|NOT COMPLETED|Phase I- Period 2||0||
59694247|NCT04968925|75813846|FG000|STARTED|Phase II- Period 1||0||
59694248|NCT04968925|75813847|FG001|STARTED|Phase II- Period 1||0||
59694249|NCT04968925|75813848|FG002|STARTED|Phase II- Period 1||112||
59694250|NCT04968925|75813849|FG003|STARTED|Phase II- Period 1||115||
59694251|NCT04968925|75813846|FG000|COMPLETED|Phase II- Period 1||0||
59694252|NCT04968925|75813847|FG001|COMPLETED|Phase II- Period 1||0||
59694253|NCT04968925|75813848|FG002|COMPLETED|Phase II- Period 1||105||
59694254|NCT04968925|75813849|FG003|COMPLETED|Phase II- Period 1||109||
59694255|NCT04968925|75813846|FG000|NOT COMPLETED|Phase II- Period 1||0||
59694256|NCT04968925|75813847|FG001|NOT COMPLETED|Phase II- Period 1||0||
59694257|NCT04968925|75813848|FG002|NOT COMPLETED|Phase II- Period 1||7||
59694258|NCT04968925|75813849|FG003|NOT COMPLETED|Phase II- Period 1||6||
59694259|NCT04968925|75813846|FG000|STARTED|Phase II -Period 2||0||
59694260|NCT04968925|75813847|FG001|STARTED|Phase II -Period 2||0||
59694261|NCT04968925|75813848|FG002|STARTED|Phase II -Period 2||105||
59694262|NCT04968925|75813849|FG003|STARTED|Phase II -Period 2||109||
59694263|NCT04968925|75813846|FG000|COMPLETED|Phase II -Period 2||0||
59694264|NCT04968925|75813847|FG001|COMPLETED|Phase II -Period 2||0||
59694265|NCT04968925|75813848|FG002|COMPLETED|Phase II -Period 2||101||
59694266|NCT04968925|75813849|FG003|COMPLETED|Phase II -Period 2||105||
59694267|NCT04968925|75813846|FG000|NOT COMPLETED|Phase II -Period 2||0||
59694268|NCT04968925|75813847|FG001|NOT COMPLETED|Phase II -Period 2||0||
59694269|NCT04968925|75813848|FG002|NOT COMPLETED|Phase II -Period 2||4||
59694270|NCT04968925|75813849|FG003|NOT COMPLETED|Phase II -Period 2||4||
59694271|NCT01266993|75813861|FG000|STARTED|Persistence Phase (Month 32-44)||199||
59694272|NCT01266993|75813862|FG001|STARTED|Persistence Phase (Month 32-44)||72||
59694273|NCT01266993|75813861|FG000|COMPLETED|Persistence Phase (Month 32-44)||199||
59694274|NCT01266993|75813862|FG001|COMPLETED|Persistence Phase (Month 32-44)||72||
59694275|NCT01266993|75813861|FG000|NOT COMPLETED|Persistence Phase (Month 32-44)||0||
59694276|NCT01266993|75813862|FG001|NOT COMPLETED|Persistence Phase (Month 32-44)||0||
59694277|NCT01266993|75813861|FG000|STARTED|Persistence Phase (Month 44-56)||193||
59694278|NCT01266993|75813862|FG001|STARTED|Persistence Phase (Month 44-56)||68||
59694279|NCT01266993|75813861|FG000|COMPLETED|Persistence Phase (Month 44-56)||193||
59694280|NCT01266993|75813862|FG001|COMPLETED|Persistence Phase (Month 44-56)||68||
59694281|NCT01266993|75813861|FG000|NOT COMPLETED|Persistence Phase (Month 44-56)||0||
59694282|NCT01266993|75813862|FG001|NOT COMPLETED|Persistence Phase (Month 44-56)||0||
59694283|NCT01266993|75813861|FG000|STARTED|Persistence Phase (Month 56-68)||193||
59694284|NCT01266993|75813862|FG001|STARTED|Persistence Phase (Month 56-68)||67||
59694285|NCT01266993|75813861|FG000|COMPLETED|Persistence Phase (Month 56-68)||193||
59694286|NCT01266993|75813862|FG001|COMPLETED|Persistence Phase (Month 56-68)||67||
59694287|NCT01266993|75813861|FG000|NOT COMPLETED|Persistence Phase (Month 56-68)||0||
59989913|NCT02737501|76105341|FG000|COMPLETED|Crossover Phase||0||
59694288|NCT01266993|75813862|FG001|NOT COMPLETED|Persistence Phase (Month 56-68)||0||
59694289|NCT01266993|75813861|FG000|STARTED|Booster Phase (Month 68-69)||179||
59694290|NCT01266993|75813862|FG001|STARTED|Booster Phase (Month 68-69)||62||
59694291|NCT01266993|75813861|FG000|COMPLETED|Booster Phase (Month 68-69)||174||
59694292|NCT01266993|75813862|FG001|COMPLETED|Booster Phase (Month 68-69)||60||
59694293|NCT01266993|75813861|FG000|NOT COMPLETED|Booster Phase (Month 68-69)||5||
59694294|NCT01266993|75813862|FG001|NOT COMPLETED|Booster Phase (Month 68-69)||2||
59694295|NCT01309386|75813870|FG000|STARTED|Overall Study||50||
59694296|NCT01309386|75813871|FG001|STARTED|Overall Study||50||
59694297|NCT01309386|75813870|FG000|COMPLETED|Overall Study||28||
59694298|NCT01309386|75813871|FG001|COMPLETED|Overall Study||29||
59989914|NCT02737501|76105342|FG001|COMPLETED|Crossover Phase||0||
59989915|NCT02737501|76105343|FG002|COMPLETED|Crossover Phase||10||
59989916|NCT02737501|76105341|FG000|NOT COMPLETED|Crossover Phase||0||
59989917|NCT02737501|76105342|FG001|NOT COMPLETED|Crossover Phase||0||
59989918|NCT02737501|76105343|FG002|NOT COMPLETED|Crossover Phase||55||
59989919|NCT01640314|76105353|FG000|STARTED|Overall Study||63||
59989920|NCT01640314|76105354|FG001|STARTED|Overall Study||63||
59694299|NCT01309386|75813870|FG000|NOT COMPLETED|Overall Study||22||
59694300|NCT01309386|75813871|FG001|NOT COMPLETED|Overall Study||21||
59694301|NCT01266603|75813877|FG000|STARTED|Overall Study||44||
59694302|NCT01266603|75813877|FG000|MAGE-A3 Positive Tumor|Overall Study||18||
59694303|NCT01266603|75813877|FG000|Patients Evaluable for Safety|Overall Study||17||
59694304|NCT01266603|75813877|FG000|Patients Evaluable for Response|Overall Study||16||
59694305|NCT01266603|75813877|FG000|Continued to Maintenance- MAGE-A3|Overall Study||4||
59694306|NCT01266603|75813877|FG000|Maintenance Completion|Overall Study||2||
59694307|NCT01266603|75813877|FG000|COMPLETED|Overall Study||2||
59694308|NCT01266603|75813877|FG000|NOT COMPLETED|Overall Study||42||
59694309|NCT01309308|75813883|FG000|STARTED|Overall Study||75||
59694310|NCT01309308|75813884|FG001|STARTED|Overall Study||75||
59694311|NCT01309308|75813883|FG000|COMPLETED|Overall Study||69||
59694312|NCT01309308|75813884|FG001|COMPLETED|Overall Study||71||
59694313|NCT01309308|75813883|FG000|NOT COMPLETED|Overall Study||6||
59694314|NCT01309308|75813884|FG001|NOT COMPLETED|Overall Study||4||
59694315|NCT01266291|75813890|FG000|STARTED|Overall Study||1||
59694316|NCT01266291|75813890|FG000|COMPLETED|Overall Study||0||
59694317|NCT01266291|75813890|FG000|NOT COMPLETED|Overall Study||1||
59694318|NCT01004263|75813894|FG000|STARTED|Overall Study|Participants who took study drug|606||
59694319|NCT01004263|75813894|FG000|COMPLETED|Overall Study||427||
59694320|NCT01004263|75813894|FG000|NOT COMPLETED|Overall Study||179||
59694321|NCT01308762|75813901|FG000|STARTED|Overall Study||6||
59694322|NCT01308762|75813902|FG001|STARTED|Overall Study||7||
59694323|NCT01308762|75813903|FG002|STARTED|Overall Study||6||
59694324|NCT01308762|75813901|FG000|COMPLETED|Overall Study||6||
60079460|NCT04206332|76194711|FG011|Received Product Administration|Part B||0||
60079461|NCT04206332|76194712|FG012|Received Product Administration|Part B||0||
60079462|NCT04206332|76194713|FG013|Received Product Administration|Part B||0||
60079463|NCT04206332|76194714|FG014|Received Product Administration|Part B||0||
60079464|NCT04206332|76194715|FG015|Received Product Administration|Part B||0||
60079465|NCT04206332|76194716|FG016|Received Product Administration|Part B||0||
60079466|NCT04206332|76194700|FG000|Completed Controlled Human Malaria Infection (CHMI)|Part B||0||
60079467|NCT04206332|76194701|FG001|Completed Controlled Human Malaria Infection (CHMI)|Part B||0||
60079468|NCT04206332|76194702|FG002|Completed Controlled Human Malaria Infection (CHMI)|Part B||0||
60079469|NCT04206332|76194703|FG003|Completed Controlled Human Malaria Infection (CHMI)|Part B||0||
60079470|NCT04206332|76194704|FG004|Completed Controlled Human Malaria Infection (CHMI)|Part B||0||
59694325|NCT01308762|75813902|FG001|COMPLETED|Overall Study|One patient was withdrawn as they were retrospecively found to have been ineligible at study entry|6||
59694326|NCT01308762|75813903|FG002|COMPLETED|Overall Study||6||
59694327|NCT01308762|75813901|FG000|NOT COMPLETED|Overall Study||0||
59694328|NCT01308762|75813902|FG001|NOT COMPLETED|Overall Study||1||
59694329|NCT01308762|75813903|FG002|NOT COMPLETED|Overall Study||0||
59694330|NCT01265823|75813914|FG000|STARTED|Overall Study||150||
59694331|NCT01265823|75813914|FG000|COMPLETED|Overall Study||143||
59694332|NCT01265823|75813914|FG000|NOT COMPLETED|Overall Study||7||
59694333|NCT01004185|75813924|FG000|STARTED|Overall Study||19||
59694334|NCT01004185|75813925|FG001|STARTED|Overall Study||20||
59694335|NCT01004185|75813924|FG000|COMPLETED|Overall Study||10||
59694336|NCT01004185|75813925|FG001|COMPLETED|Overall Study||11||
59694337|NCT01004185|75813924|FG000|NOT COMPLETED|Overall Study||9||
59694338|NCT01004185|75813925|FG001|NOT COMPLETED|Overall Study||9||
59694339|NCT01265511|75813933|FG000|STARTED|Overall Study||2||
59694340|NCT01265511|75813934|FG001|STARTED|Overall Study||8||
59694341|NCT01265511|75813933|FG000|COMPLETED|Overall Study||0||
59694342|NCT01265511|75813934|FG001|COMPLETED|Overall Study||5||
59694343|NCT01265511|75813933|FG000|NOT COMPLETED|Overall Study||2||
59694344|NCT01265511|75813934|FG001|NOT COMPLETED|Overall Study||3||
59694345|NCT01264965|75813940|FG000|STARTED|Overall Study||25||
59694346|NCT01264965|75813940|FG000|COMPLETED|Overall Study||15||
59694347|NCT01264965|75813940|FG000|NOT COMPLETED|Overall Study||10||
59694348|NCT01264887|75813944|FG000|STARTED|Overall Study||31||
59694349|NCT01264887|75813944|FG000|COMPLETED|Overall Study||0||
59694350|NCT01264887|75813944|FG000|NOT COMPLETED|Overall Study||31||
59694351|NCT01306968|75813954|FG000|STARTED|Overall Study||7||
59694352|NCT01306968|75813955|FG001|STARTED|Overall Study||23||
59694353|NCT01306968|75813956|FG002|STARTED|Overall Study||24||
59694354|NCT01306968|75813957|FG003|STARTED|Overall Study|2 participants withdrew before chamber sessions were initiated|25||
59694355|NCT01306968|75813954|FG000|COMPLETED|Overall Study||6||
59694356|NCT01306968|75813955|FG001|COMPLETED|Overall Study||20||
59694357|NCT01306968|75813956|FG002|COMPLETED|Overall Study||23||
59694358|NCT01306968|75813957|FG003|COMPLETED|Overall Study||21||
59694359|NCT01306968|75813954|FG000|NOT COMPLETED|Overall Study||1||
59694360|NCT01306968|75813955|FG001|NOT COMPLETED|Overall Study||3||
59694361|NCT01306968|75813956|FG002|NOT COMPLETED|Overall Study||1||
59694362|NCT01306968|75813957|FG003|NOT COMPLETED|Overall Study||4||
59694363|NCT01264419|75813969|FG000|STARTED|Overall Study||75||
59694364|NCT01264419|75813969|FG000|COMPLETED|Overall Study||72||
59694365|NCT01264419|75813969|FG000|NOT COMPLETED|Overall Study||3||
59694366|NCT01263873|75813975|FG000|STARTED|Overall Study||30||
59694367|NCT01263873|75813976|FG001|STARTED|Overall Study||30||
59694368|NCT01263873|75813975|FG000|COMPLETED|Overall Study||29||
59694369|NCT01263873|75813976|FG001|COMPLETED|Overall Study||29||
59694370|NCT01263873|75813975|FG000|NOT COMPLETED|Overall Study||1||
59694371|NCT01263873|75813976|FG001|NOT COMPLETED|Overall Study||1||
59694372|NCT01263639|75813984|FG000|STARTED|Overall Study||107||
59694373|NCT01263639|75813985|FG001|STARTED|Overall Study||121||
59694374|NCT01263639|75813984|FG000|COMPLETED|Overall Study||34||
59694375|NCT01263639|75813985|FG001|COMPLETED|Overall Study||42||
59694376|NCT01263639|75813984|FG000|NOT COMPLETED|Overall Study||73||
59694377|NCT01263639|75813985|FG001|NOT COMPLETED|Overall Study||79||
59694378|NCT01011283|75813993|FG000|STARTED|Overall Study||13||
59694379|NCT01011283|75813994|FG001|STARTED|Overall Study||13||
59694380|NCT01011283|75813993|FG000|COMPLETED|Overall Study||2||
59694381|NCT01011283|75813994|FG001|COMPLETED|Overall Study||2||
59694382|NCT01011283|75813993|FG000|NOT COMPLETED|Overall Study||11||
59694383|NCT01011283|75813994|FG001|NOT COMPLETED|Overall Study||11||
59694384|NCT01263561|75814002|FG000|STARTED|Overall Study||31||
59694385|NCT01263561|75814003|FG001|STARTED|Overall Study||33||
59694386|NCT01263561|75814002|FG000|COMPLETED|Overall Study||30||
59694387|NCT01263561|75814003|FG001|COMPLETED|Overall Study||31||
59694388|NCT01263561|75814002|FG000|NOT COMPLETED|Overall Study||1||
59694389|NCT01263561|75814003|FG001|NOT COMPLETED|Overall Study||2||
59694390|NCT01009099|75814011|FG000|STARTED|Overall Study||58||
59694391|NCT01009099|75814012|FG001|STARTED|Overall Study||61||
59694392|NCT01009099|75814011|FG000|COMPLETED|Overall Study||53||
59694393|NCT01009099|75814012|FG001|COMPLETED|Overall Study||57||
59694394|NCT01009099|75814011|FG000|NOT COMPLETED|Overall Study||5||
59694395|NCT01009099|75814012|FG001|NOT COMPLETED|Overall Study||4||
59694396|NCT01263483|75814021|FG000|STARTED|Overall Study||75||
59694397|NCT01263483|75814022|FG001|STARTED|Overall Study||76||
59694398|NCT01263483|75814023|FG002|STARTED|Overall Study||79||
59694399|NCT01263483|75814021|FG000|COMPLETED|Overall Study||68||
59694400|NCT01263483|75814022|FG001|COMPLETED|Overall Study||74||
59694401|NCT01263483|75814023|FG002|COMPLETED|Overall Study||74||
59694402|NCT01263483|75814021|FG000|NOT COMPLETED|Overall Study||7||
59694403|NCT01263483|75814022|FG001|NOT COMPLETED|Overall Study||2||
59694404|NCT01263483|75814023|FG002|NOT COMPLETED|Overall Study||5||
59694405|NCT01306890|75814031|FG000|STARTED|Overall Study||1976||
59694406|NCT01306890|75814031|FG000|COMPLETED|Overall Study|Subjects were alive at the end of the study and had completed at least 3 years of follow up.|457||
59694407|NCT01306890|75814031|FG000|NOT COMPLETED|Overall Study||1519||
59694408|NCT01011049|75814039|FG000|STARTED|Overall Study||507||
59694409|NCT01011049|75814040|FG001|STARTED|Overall Study||252||
59694410|NCT01011049|75814041|FG002|STARTED|Overall Study||243||
59694411|NCT01011049|75814042|FG003|STARTED|Overall Study||246||
59694412|NCT01011049|75814039|FG000|COMPLETED|Overall Study||506||
59694413|NCT01011049|75814040|FG001|COMPLETED|Overall Study||250||
59694414|NCT01011049|75814041|FG002|COMPLETED|Overall Study||239||
59694415|NCT01011049|75814042|FG003|COMPLETED|Overall Study||246||
59694416|NCT01011049|75814039|FG000|NOT COMPLETED|Overall Study||1||
59694417|NCT01011049|75814040|FG001|NOT COMPLETED|Overall Study||2||
59694418|NCT01011049|75814041|FG002|NOT COMPLETED|Overall Study||4||
59694419|NCT01011049|75814042|FG003|NOT COMPLETED|Overall Study||0||
59694420|NCT01263093|75814054|FG000|STARTED|Period 1||24||
59694421|NCT01263093|75814055|FG001|STARTED|Period 1||23||
59694422|NCT01263093|75814054|FG000|COMPLETED|Period 1||24||
59694423|NCT01263093|75814055|FG001|COMPLETED|Period 1||23||
59694424|NCT01263093|75814054|FG000|NOT COMPLETED|Period 1||0||
59694425|NCT01263093|75814055|FG001|NOT COMPLETED|Period 1||0||
59694426|NCT01263093|75814054|FG000|STARTED|Washout||24||
59694427|NCT01263093|75814055|FG001|STARTED|Washout||23||
59694428|NCT01263093|75814054|FG000|COMPLETED|Washout||23||
59694429|NCT01263093|75814055|FG001|COMPLETED|Washout||23||
59694430|NCT01263093|75814054|FG000|NOT COMPLETED|Washout||1||
59694431|NCT01263093|75814055|FG001|NOT COMPLETED|Washout||0||
59694432|NCT01263093|75814054|FG000|STARTED|Period 2||23||
59694433|NCT01263093|75814055|FG001|STARTED|Period 2||23||
59694434|NCT01263093|75814054|FG000|COMPLETED|Period 2||22||
59694435|NCT01263093|75814055|FG001|COMPLETED|Period 2||23||
59694436|NCT01263093|75814054|FG000|NOT COMPLETED|Period 2||1||
59694437|NCT01263093|75814055|FG001|NOT COMPLETED|Period 2||0||
59694438|NCT01010971|75814065|FG000|STARTED|Overall Study||225||
59694439|NCT01010971|75814066|FG001|STARTED|Overall Study||226||
59694440|NCT01010971|75814067|FG002|STARTED|Overall Study||220||
59694441|NCT01010971|75814065|FG000|COMPLETED|Overall Study||222||
59694442|NCT01010971|75814066|FG001|COMPLETED|Overall Study||218||
59694443|NCT01010971|75814067|FG002|COMPLETED|Overall Study||207||
59694444|NCT01010971|75814065|FG000|NOT COMPLETED|Overall Study||3||
59694445|NCT01010971|75814066|FG001|NOT COMPLETED|Overall Study||8||
59694446|NCT01010971|75814067|FG002|NOT COMPLETED|Overall Study||13||
59694447|NCT01306656|75814077|FG000|STARTED|Overall Study||7||
59694448|NCT01306656|75814078|FG001|STARTED|Overall Study||2||
59694449|NCT01306656|75814077|FG000|COMPLETED|Overall Study||6||
59694450|NCT01306656|75814078|FG001|COMPLETED|Overall Study||2||
59694451|NCT01306656|75814077|FG000|NOT COMPLETED|Overall Study||1||
59694452|NCT01306656|75814078|FG001|NOT COMPLETED|Overall Study||0||
59694453|NCT01008943|75814086|FG000|STARTED|Overall Study||16||
59694454|NCT01008943|75814086|FG000|COMPLETED|Overall Study||15||
59694455|NCT01008943|75814086|FG000|NOT COMPLETED|Overall Study||1||
59694456|NCT01003639|75814092|FG000|STARTED|Overall Study||86||
59694457|NCT01003639|75814093|FG001|STARTED|Overall Study||79||
59694458|NCT01003639|75814092|FG000|COMPLETED|Overall Study||69||
59694459|NCT01003639|75814093|FG001|COMPLETED|Overall Study||57||
59694460|NCT01003639|75814092|FG000|NOT COMPLETED|Overall Study||17||
59694461|NCT01003639|75814093|FG001|NOT COMPLETED|Overall Study||22||
59694462|NCT01003249|75814099|FG000|STARTED|First Intervention (4 Weeks)||7||
59694463|NCT01003249|75814100|FG001|STARTED|First Intervention (4 Weeks)||5||
59694464|NCT01003249|75814099|FG000|Received Intervention|First Intervention (4 Weeks)||7||
59694465|NCT01003249|75814100|FG001|Received Intervention|First Intervention (4 Weeks)||5||
59694466|NCT01003249|75814099|FG000|COMPLETED|First Intervention (4 Weeks)||5||
59694467|NCT01003249|75814100|FG001|COMPLETED|First Intervention (4 Weeks)||3||
59694468|NCT01003249|75814099|FG000|NOT COMPLETED|First Intervention (4 Weeks)||2||
59694469|NCT01003249|75814100|FG001|NOT COMPLETED|First Intervention (4 Weeks)||2||
59694470|NCT01003249|75814099|FG000|STARTED|Washout (3 Weeks)||4||
59694471|NCT01003249|75814100|FG001|STARTED|Washout (3 Weeks)||3||
59694472|NCT01003249|75814099|FG000|COMPLETED|Washout (3 Weeks)||4||
59694473|NCT01003249|75814100|FG001|COMPLETED|Washout (3 Weeks)||3||
59694474|NCT01003249|75814099|FG000|NOT COMPLETED|Washout (3 Weeks)||0||
59694475|NCT01003249|75814100|FG001|NOT COMPLETED|Washout (3 Weeks)||0||
59694476|NCT01003249|75814099|FG000|STARTED|Second Intervention (4 Weeks)||4||
59694477|NCT01003249|75814100|FG001|STARTED|Second Intervention (4 Weeks)||3||
59694478|NCT01003249|75814099|FG000|COMPLETED|Second Intervention (4 Weeks)||3||
59694479|NCT01003249|75814100|FG001|COMPLETED|Second Intervention (4 Weeks)||2||
59694480|NCT01003249|75814099|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||1||
59694481|NCT01003249|75814100|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||1||
59694482|NCT01001767|75814112|FG000|STARTED|Overall Study||18||
59694483|NCT01001767|75814113|FG001|STARTED|Overall Study||17||
59694484|NCT01001767|75814112|FG000|COMPLETED|Overall Study||14||
59694485|NCT01001767|75814113|FG001|COMPLETED|Overall Study||17||
59694486|NCT01001767|75814112|FG000|NOT COMPLETED|Overall Study||4||
59694487|NCT01001767|75814113|FG001|NOT COMPLETED|Overall Study||0||
59694488|NCT01306032|75814125|FG000|STARTED|First Intervention||22||
59694489|NCT01306032|75814126|FG001|STARTED|First Intervention|Not all participants on the Cyclophosphamide Alone Arm met eligibility criteria to crossover.|20||
59694490|NCT01306032|75814127|FG002|STARTED|First Intervention||37||
59694491|NCT01306032|75814128|FG003|STARTED|First Intervention|Not all participants on the Cyclophosphamide Alone Arm met eligibility criteria to crossover.|38||
59694492|NCT01306032|75814129|FG004|STARTED|First Intervention||2||
59694493|NCT01306032|75814130|FG005|STARTED|First Intervention||2||
59694494|NCT01306032|75814125|FG000|COMPLETED|First Intervention||21||
59694495|NCT01306032|75814126|FG001|COMPLETED|First Intervention||18||
59694496|NCT01306032|75814127|FG002|COMPLETED|First Intervention||35||
59694497|NCT01306032|75814128|FG003|COMPLETED|First Intervention||37||
59694498|NCT01306032|75814129|FG004|COMPLETED|First Intervention||0||
59694499|NCT01306032|75814130|FG005|COMPLETED|First Intervention||0||
59694500|NCT01306032|75814125|FG000|NOT COMPLETED|First Intervention||1||
59694501|NCT01306032|75814126|FG001|NOT COMPLETED|First Intervention||2||
59694502|NCT01306032|75814127|FG002|NOT COMPLETED|First Intervention||2||
59694503|NCT01306032|75814128|FG003|NOT COMPLETED|First Intervention||1||
59694504|NCT01306032|75814129|FG004|NOT COMPLETED|First Intervention||2||
59694505|NCT01306032|75814130|FG005|NOT COMPLETED|First Intervention||2||
59694506|NCT01306032|75814125|FG000|STARTED|Disease Progression/Crossover||0||
59694507|NCT01306032|75814126|FG001|STARTED|Disease Progression/Crossover||16||
59694508|NCT01306032|75814127|FG002|STARTED|Disease Progression/Crossover||0||
59694509|NCT01306032|75814128|FG003|STARTED|Disease Progression/Crossover||29||
59694510|NCT01306032|75814129|FG004|STARTED|Disease Progression/Crossover||0||
59694511|NCT01306032|75814130|FG005|STARTED|Disease Progression/Crossover||0||
59694512|NCT01306032|75814125|FG000|COMPLETED|Disease Progression/Crossover||0||
59694513|NCT01306032|75814126|FG001|COMPLETED|Disease Progression/Crossover||14||
59694514|NCT01306032|75814127|FG002|COMPLETED|Disease Progression/Crossover||0||
59694515|NCT01306032|75814128|FG003|COMPLETED|Disease Progression/Crossover||26||
59694516|NCT01306032|75814129|FG004|COMPLETED|Disease Progression/Crossover||0||
59694517|NCT01306032|75814130|FG005|COMPLETED|Disease Progression/Crossover||0||
59694518|NCT01306032|75814125|FG000|NOT COMPLETED|Disease Progression/Crossover||0||
59694519|NCT01306032|75814126|FG001|NOT COMPLETED|Disease Progression/Crossover||2||
59694520|NCT01306032|75814127|FG002|NOT COMPLETED|Disease Progression/Crossover||0||
59694521|NCT01306032|75814128|FG003|NOT COMPLETED|Disease Progression/Crossover||3||
59694522|NCT01306032|75814129|FG004|NOT COMPLETED|Disease Progression/Crossover||0||
59694523|NCT01306032|75814130|FG005|NOT COMPLETED|Disease Progression/Crossover||0||
59694524|NCT01263015|75814158|FG000|STARTED|Double-blind Phase: 96 Weeks Duration||414||
59694525|NCT01263015|75814159|FG001|STARTED|Double-blind Phase: 96 Weeks Duration||419||
59694526|NCT01263015|75814158|FG000|COMPLETED|Double-blind Phase: 96 Weeks Duration||342||
59694527|NCT01263015|75814159|FG001|COMPLETED|Double-blind Phase: 96 Weeks Duration||310||
59694528|NCT01263015|75814158|FG000|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||72||
59694529|NCT01263015|75814159|FG001|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||109||
59694530|NCT01263015|75814158|FG000|STARTED|Open-label Phase: 48 Weeks Duration||341||
59694531|NCT01263015|75814159|FG001|STARTED|Open-label Phase: 48 Weeks Duration||309||
59694532|NCT01263015|75814158|FG000|COMPLETED|Open-label Phase: 48 Weeks Duration||317||
59694533|NCT01263015|75814159|FG001|COMPLETED|Open-label Phase: 48 Weeks Duration||278||
59694534|NCT01263015|75814158|FG000|NOT COMPLETED|Open-label Phase: 48 Weeks Duration||24||
59694535|NCT01263015|75814159|FG001|NOT COMPLETED|Open-label Phase: 48 Weeks Duration||31||
59694536|NCT01305564|75814165|FG000|STARTED|Overall Study||200||
59694537|NCT01305564|75814165|FG000|COMPLETED|Overall Study||163||
59694538|NCT01305564|75814165|FG000|NOT COMPLETED|Overall Study||37||
59694539|NCT01305408|75814182|FG000|STARTED|Overall Study||199||
59694540|NCT01305408|75814183|FG001|STARTED|Overall Study||200||
59694541|NCT01305408|75814182|FG000|Safety Population|Overall Study|Treated participants. One participant was randomized but not treated.|198||
59694542|NCT01305408|75814183|FG001|Safety Population|Overall Study|Treated participants.|200||
59694543|NCT01305408|75814182|FG000|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|196||
59694544|NCT01305408|75814183|FG001|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|197||
59694545|NCT01305408|75814182|FG000|COMPLETED|Overall Study||167||
59694546|NCT01305408|75814183|FG001|COMPLETED|Overall Study||169||
59694547|NCT01305408|75814182|FG000|NOT COMPLETED|Overall Study||32||
59694548|NCT01305408|75814183|FG001|NOT COMPLETED|Overall Study||31||
59694549|NCT01304940|75814191|FG000|STARTED|Overall Study||25||
59694550|NCT01304940|75814192|FG001|STARTED|Overall Study||25||
59694551|NCT01304940|75814191|FG000|Completed Study|Overall Study|recruitment ended when 25 participants completed study procedures|25||
59694552|NCT01304940|75814192|FG001|Completed Study|Overall Study|recruitment ended when 25 participants completed study procedures|25||
59694553|NCT01304940|75814191|FG000|COMPLETED|Overall Study|these participants met severity requirement and were included in study analyses|22||
59694554|NCT01304940|75814192|FG001|COMPLETED|Overall Study||25||
59694555|NCT01304940|75814191|FG000|NOT COMPLETED|Overall Study||3||
59694556|NCT01304940|75814192|FG001|NOT COMPLETED|Overall Study||0||
59694557|NCT01261611|75814201|FG000|STARTED|Treatment Cycle 1||156||
59694558|NCT01261611|75814202|FG001|STARTED|Treatment Cycle 1||159||
59694559|NCT01261611|75814203|FG002|STARTED|Treatment Cycle 1||54||
59694560|NCT01261611|75814201|FG000|COMPLETED|Treatment Cycle 1||152||
59694561|NCT01261611|75814202|FG001|COMPLETED|Treatment Cycle 1||156||
59694562|NCT01261611|75814203|FG002|COMPLETED|Treatment Cycle 1||52||
59694563|NCT01261611|75814201|FG000|NOT COMPLETED|Treatment Cycle 1||4||
59694564|NCT01261611|75814202|FG001|NOT COMPLETED|Treatment Cycle 1||3||
59694565|NCT01261611|75814203|FG002|NOT COMPLETED|Treatment Cycle 1||2||
59694566|NCT01261611|75814201|FG000|STARTED|Treatment Cycle 2|All but 1 who completed DB period entered the open label period. This subject remained at Cycle 1.|359||
59694567|NCT01261611|75814202|FG001|STARTED|Treatment Cycle 2||0||
59694568|NCT01261611|75814203|FG002|STARTED|Treatment Cycle 2||0||
59694569|NCT01261611|75814201|FG000|COMPLETED|Treatment Cycle 2||346||
59694570|NCT01261611|75814202|FG001|COMPLETED|Treatment Cycle 2||0||
59694571|NCT01261611|75814203|FG002|COMPLETED|Treatment Cycle 2||0||
59694572|NCT01261611|75814201|FG000|NOT COMPLETED|Treatment Cycle 2||13||
59694573|NCT01261611|75814202|FG001|NOT COMPLETED|Treatment Cycle 2||0||
59694574|NCT01261611|75814203|FG002|NOT COMPLETED|Treatment Cycle 2||0||
59694575|NCT01261611|75814201|FG000|STARTED|Treatment Cycle 3||346||
59694576|NCT01261611|75814202|FG001|STARTED|Treatment Cycle 3||0||
59694577|NCT01261611|75814203|FG002|STARTED|Treatment Cycle 3||0||
59694578|NCT01261611|75814201|FG000|COMPLETED|Treatment Cycle 3||316||
59694579|NCT01261611|75814202|FG001|COMPLETED|Treatment Cycle 3||0||
59694580|NCT01261611|75814203|FG002|COMPLETED|Treatment Cycle 3||0||
59694581|NCT01261611|75814201|FG000|NOT COMPLETED|Treatment Cycle 3||30||
59694582|NCT01261611|75814202|FG001|NOT COMPLETED|Treatment Cycle 3||0||
59694583|NCT01261611|75814203|FG002|NOT COMPLETED|Treatment Cycle 3||0||
59694584|NCT01261611|75814201|FG000|STARTED|Treatment Cycle 4||316||
59694585|NCT01261611|75814202|FG001|STARTED|Treatment Cycle 4||0||
59694586|NCT01261611|75814203|FG002|STARTED|Treatment Cycle 4||0||
59694587|NCT01261611|75814201|FG000|COMPLETED|Treatment Cycle 4||220||
59694588|NCT01261611|75814202|FG001|COMPLETED|Treatment Cycle 4||0||
59694589|NCT01261611|75814203|FG002|COMPLETED|Treatment Cycle 4||0||
59694590|NCT01261611|75814201|FG000|NOT COMPLETED|Treatment Cycle 4||96||
59694591|NCT01261611|75814202|FG001|NOT COMPLETED|Treatment Cycle 4||0||
59694592|NCT01261611|75814203|FG002|NOT COMPLETED|Treatment Cycle 4||0||
59816153|NCT00612677|75938510|FG000|NOT COMPLETED|Overall Study||1||
59694593|NCT01261611|75814201|FG000|STARTED|Treatment Cycle 5||220||
59694594|NCT01261611|75814202|FG001|STARTED|Treatment Cycle 5||0||
59694595|NCT01261611|75814203|FG002|STARTED|Treatment Cycle 5||0||
59694596|NCT01261611|75814201|FG000|COMPLETED|Treatment Cycle 5||217||
59694597|NCT01261611|75814202|FG001|COMPLETED|Treatment Cycle 5||0||
59694598|NCT01261611|75814203|FG002|COMPLETED|Treatment Cycle 5||0||
59694599|NCT01261611|75814201|FG000|NOT COMPLETED|Treatment Cycle 5||3||
59694600|NCT01261611|75814202|FG001|NOT COMPLETED|Treatment Cycle 5||0||
59694601|NCT01261611|75814203|FG002|NOT COMPLETED|Treatment Cycle 5||0||
59816154|NCT00613925|75938516|FG000|STARTED|Overall Study||37||
59816155|NCT00613925|75938517|FG001|STARTED|Overall Study||33||
59694602|NCT01304706|75814215|FG000|STARTED|Overall Study||121||
59694603|NCT01304706|75814215|FG000|COMPLETED|Overall Study||104||
59694604|NCT01304706|75814215|FG000|NOT COMPLETED|Overall Study||17||
59694605|NCT01303380|75814219|FG000|STARTED|Overall Study||9||
59694606|NCT01303380|75814219|FG000|COMPLETED|Overall Study||8||
59694607|NCT01303380|75814219|FG000|NOT COMPLETED|Overall Study||1||
59694608|NCT01008553|75814223|FG000|STARTED|Period 1 (Titration Period)||258||
59694609|NCT01008553|75814224|FG001|STARTED|Period 1 (Titration Period)||0||
59694610|NCT01008553|75814225|FG002|STARTED|Period 1 (Titration Period)||0||
59694611|NCT01008553|75814223|FG000|COMPLETED|Period 1 (Titration Period)||163||
59694612|NCT01008553|75814224|FG001|COMPLETED|Period 1 (Titration Period)||0||
59694613|NCT01008553|75814225|FG002|COMPLETED|Period 1 (Titration Period)||0||
59694614|NCT01008553|75814223|FG000|NOT COMPLETED|Period 1 (Titration Period)||95||
59694615|NCT01008553|75814224|FG001|NOT COMPLETED|Period 1 (Titration Period)||0||
59694616|NCT01008553|75814225|FG002|NOT COMPLETED|Period 1 (Titration Period)||0||
59694617|NCT01008553|75814223|FG000|STARTED|Period 2 (Double-Blind Period)||0||
59694618|NCT01008553|75814224|FG001|STARTED|Period 2 (Double-Blind Period)||84||
59694619|NCT01008553|75814225|FG002|STARTED|Period 2 (Double-Blind Period)||79||
59694620|NCT01008553|75814223|FG000|COMPLETED|Period 2 (Double-Blind Period)||0||
59694621|NCT01008553|75814224|FG001|COMPLETED|Period 2 (Double-Blind Period)||47||
59694622|NCT01008553|75814225|FG002|COMPLETED|Period 2 (Double-Blind Period)||28||
59694623|NCT01008553|75814223|FG000|NOT COMPLETED|Period 2 (Double-Blind Period)||0||
59694624|NCT01008553|75814224|FG001|NOT COMPLETED|Period 2 (Double-Blind Period)||37||
59694625|NCT01008553|75814225|FG002|NOT COMPLETED|Period 2 (Double-Blind Period)||51||
59694626|NCT01259115|75814234|FG000|STARTED|Period 1||10||
59694627|NCT01259115|75814235|FG001|STARTED|Period 1||10||
59694628|NCT01259115|75814234|FG000|COMPLETED|Period 1||7||
59694629|NCT01259115|75814235|FG001|COMPLETED|Period 1||9||
59694630|NCT01259115|75814234|FG000|NOT COMPLETED|Period 1||3||
59694631|NCT01259115|75814235|FG001|NOT COMPLETED|Period 1||1||
59694632|NCT01259115|75814234|FG000|STARTED|Period: Washout Period of 4 to 18 Days||7||
59694633|NCT01259115|75814235|FG001|STARTED|Period: Washout Period of 4 to 18 Days||9||
59694634|NCT01259115|75814234|FG000|COMPLETED|Period: Washout Period of 4 to 18 Days||7||
59694635|NCT01259115|75814235|FG001|COMPLETED|Period: Washout Period of 4 to 18 Days||9||
59694636|NCT01259115|75814234|FG000|NOT COMPLETED|Period: Washout Period of 4 to 18 Days||0||
59694637|NCT01259115|75814235|FG001|NOT COMPLETED|Period: Washout Period of 4 to 18 Days||0||
59694638|NCT01259115|75814234|FG000|STARTED|Period 2||7||
59694639|NCT01259115|75814235|FG001|STARTED|Period 2||9||
59694640|NCT01259115|75814234|FG000|COMPLETED|Period 2||6||
59694641|NCT01259115|75814235|FG001|COMPLETED|Period 2||9||
59694642|NCT01259115|75814234|FG000|NOT COMPLETED|Period 2||1||
59694643|NCT01259115|75814235|FG001|NOT COMPLETED|Period 2||0||
59694644|NCT01302366|75814246|FG000|STARTED|Overall Study||20||
59694645|NCT01302366|75814246|FG000|COMPLETED|Overall Study||15||
59694646|NCT01302366|75814246|FG000|NOT COMPLETED|Overall Study||5||
59694647|NCT01302054|75814250|FG000|STARTED|Tolterodine Open-Label Run-In Phase||990||
59694648|NCT01302054|75814251|FG001|STARTED|Tolterodine Open-Label Run-In Phase||0||
59694649|NCT01302054|75814252|FG002|STARTED|Tolterodine Open-Label Run-In Phase||0||
59694650|NCT01302054|75814250|FG000|COMPLETED|Tolterodine Open-Label Run-In Phase||611||
59694651|NCT01302054|75814251|FG001|COMPLETED|Tolterodine Open-Label Run-In Phase||0||
59694652|NCT01302054|75814252|FG002|COMPLETED|Tolterodine Open-Label Run-In Phase||0||
59694653|NCT01302054|75814250|FG000|NOT COMPLETED|Tolterodine Open-Label Run-In Phase||379||
59694654|NCT01302054|75814251|FG001|NOT COMPLETED|Tolterodine Open-Label Run-In Phase||0||
59694655|NCT01302054|75814252|FG002|NOT COMPLETED|Tolterodine Open-Label Run-In Phase||0||
59694656|NCT01302054|75814250|FG000|STARTED|Between Open-Label and Double Blind||611||
59694657|NCT01302054|75814251|FG001|STARTED|Between Open-Label and Double Blind||0||
59989921|NCT01640314|76105353|FG000|COMPLETED|Overall Study||63||
59694658|NCT01302054|75814252|FG002|STARTED|Between Open-Label and Double Blind||0||
59694659|NCT01302054|75814250|FG000|COMPLETED|Between Open-Label and Double Blind||609||
59694660|NCT01302054|75814251|FG001|COMPLETED|Between Open-Label and Double Blind||0||
59694661|NCT01302054|75814252|FG002|COMPLETED|Between Open-Label and Double Blind||0||
59694662|NCT01302054|75814250|FG000|NOT COMPLETED|Between Open-Label and Double Blind||2||
59694663|NCT01302054|75814251|FG001|NOT COMPLETED|Between Open-Label and Double Blind||0||
59694664|NCT01302054|75814252|FG002|NOT COMPLETED|Between Open-Label and Double Blind||0||
59694665|NCT01302054|75814250|FG000|STARTED|Double-Blind Treatment Phase||0||
59694666|NCT01302054|75814251|FG001|STARTED|Double-Blind Treatment Phase||308||
59694667|NCT01302054|75814252|FG002|STARTED|Double-Blind Treatment Phase||301||
59694668|NCT01302054|75814250|FG000|COMPLETED|Double-Blind Treatment Phase||0||
59694669|NCT01302054|75814251|FG001|COMPLETED|Double-Blind Treatment Phase||281||
59694670|NCT01302054|75814252|FG002|COMPLETED|Double-Blind Treatment Phase||255||
59694671|NCT01302054|75814250|FG000|NOT COMPLETED|Double-Blind Treatment Phase||0||
59989922|NCT01640314|76105354|FG001|COMPLETED|Overall Study||62||
59694672|NCT01302054|75814251|FG001|NOT COMPLETED|Double-Blind Treatment Phase||27||
59694673|NCT01302054|75814252|FG002|NOT COMPLETED|Double-Blind Treatment Phase||46||
59694674|NCT01301508|75814263|FG000|STARTED|Overall Study||21||
59694675|NCT01301508|75814264|FG001|STARTED|Overall Study||25||
59694676|NCT01301508|75814263|FG000|COMPLETED|Overall Study||20||
59694677|NCT01301508|75814264|FG001|COMPLETED|Overall Study||22||
59694678|NCT01301508|75814263|FG000|NOT COMPLETED|Overall Study||1||
59694679|NCT01301508|75814264|FG001|NOT COMPLETED|Overall Study||3||
59694680|NCT01301274|75814272|FG000|STARTED|Overall Study||34||
59694681|NCT01301274|75814273|FG001|STARTED|Overall Study||32||
59694682|NCT01301274|75814272|FG000|COMPLETED|Overall Study||32||
59694683|NCT01301274|75814273|FG001|COMPLETED|Overall Study||31||
59694684|NCT01301274|75814272|FG000|NOT COMPLETED|Overall Study||2||
59694685|NCT01301274|75814273|FG001|NOT COMPLETED|Overall Study||1||
59694686|NCT01300650|75814284|FG000|STARTED|Overall Study||8||
59694687|NCT01300650|75814284|FG000|COMPLETED|Overall Study||7||
59694688|NCT01300650|75814284|FG000|NOT COMPLETED|Overall Study||1||
59694689|NCT01300572|75814289|FG000|STARTED|Overall Study||16||
59694690|NCT01300572|75814289|FG000|COMPLETED|Overall Study||15||
59694691|NCT01300572|75814289|FG000|NOT COMPLETED|Overall Study||1||
59694692|NCT01077154|75814296|FG000|STARTED|Overall Study||2253||
59694693|NCT01077154|75814297|FG001|STARTED|Overall Study||2256||
59694694|NCT01077154|75814296|FG000|Received Study Drug|Overall Study||2229||
59694695|NCT01077154|75814297|FG001|Received Study Drug|Overall Study||2230||
59694696|NCT01077154|75814296|FG000|COMPLETED|Overall Study||27||
59694697|NCT01077154|75814297|FG001|COMPLETED|Overall Study||28||
59694698|NCT01077154|75814296|FG000|NOT COMPLETED|Overall Study||2226||
59694699|NCT01077154|75814297|FG001|NOT COMPLETED|Overall Study||2228||
59694700|NCT01258101|75814307|FG000|STARTED|Overall Study||151||
59694701|NCT01258101|75814308|FG001|STARTED|Overall Study||144||
59694702|NCT01258101|75814309|FG002|STARTED|Overall Study||33||
59694703|NCT01258101|75814310|FG003|STARTED|Overall Study||52||
59694704|NCT01258101|75814307|FG000|Safety Analysis Population|Overall Study||144||
59694705|NCT01258101|75814308|FG001|Safety Analysis Population|Overall Study||141||
59694706|NCT01258101|75814309|FG002|Safety Analysis Population|Overall Study||30||
59694707|NCT01258101|75814310|FG003|Safety Analysis Population|Overall Study||48||
59694708|NCT01258101|75814307|FG000|Standard Analysis Population|Overall Study||115||
59694709|NCT01258101|75814308|FG001|Standard Analysis Population|Overall Study||110||
59694710|NCT01258101|75814309|FG002|Standard Analysis Population|Overall Study||21||
59694711|NCT01258101|75814310|FG003|Standard Analysis Population|Overall Study||26||
59694712|NCT01258101|75814307|FG000|COMPLETED|Overall Study||118||
59694713|NCT01258101|75814308|FG001|COMPLETED|Overall Study||110||
59694714|NCT01258101|75814309|FG002|COMPLETED|Overall Study||22||
59694715|NCT01258101|75814310|FG003|COMPLETED|Overall Study||27||
59694716|NCT01258101|75814307|FG000|NOT COMPLETED|Overall Study||33||
59694717|NCT01258101|75814308|FG001|NOT COMPLETED|Overall Study||34||
59694718|NCT01258101|75814309|FG002|NOT COMPLETED|Overall Study||11||
59694719|NCT01258101|75814310|FG003|NOT COMPLETED|Overall Study||25||
59694720|NCT01300338|75814322|FG000|STARTED|Overall Study||25||
59694721|NCT01300338|75814323|FG001|STARTED|Overall Study||25||
59694722|NCT01300338|75814322|FG000|COMPLETED|Overall Study||20||
59694723|NCT01300338|75814323|FG001|COMPLETED|Overall Study||25||
59694724|NCT01300338|75814322|FG000|NOT COMPLETED|Overall Study||5||
59694725|NCT01300338|75814323|FG001|NOT COMPLETED|Overall Study||0||
59694726|NCT01300260|75814331|FG000|STARTED|Period 1 of Study: First Intervention||15||
59694727|NCT01300260|75814332|FG001|STARTED|Period 1 of Study: First Intervention||17||
59694728|NCT01300260|75814331|FG000|Received at Least 1 Dose of Study Drug|Period 1 of Study: First Intervention||15||
59694729|NCT01300260|75814332|FG001|Received at Least 1 Dose of Study Drug|Period 1 of Study: First Intervention||17||
59989923|NCT01640314|76105353|FG000|NOT COMPLETED|Overall Study||0||
59989924|NCT01640314|76105354|FG001|NOT COMPLETED|Overall Study||1||
59989925|NCT03377803|76105362|FG000|STARTED|Overall Study||150||
59989926|NCT03377803|76105363|FG001|STARTED|Overall Study||112||
59694730|NCT01300260|75814331|FG000|COMPLETED|Period 1 of Study: First Intervention||14||
59694731|NCT01300260|75814332|FG001|COMPLETED|Period 1 of Study: First Intervention||16||
59694732|NCT01300260|75814331|FG000|NOT COMPLETED|Period 1 of Study: First Intervention||1||
59694733|NCT01300260|75814332|FG001|NOT COMPLETED|Period 1 of Study: First Intervention||1||
59694734|NCT01300260|75814331|FG000|STARTED|Washout Period of at Least 28 Days||14||
59694735|NCT01300260|75814332|FG001|STARTED|Washout Period of at Least 28 Days||16||
59694736|NCT01300260|75814331|FG000|COMPLETED|Washout Period of at Least 28 Days||14||
59694737|NCT01300260|75814332|FG001|COMPLETED|Washout Period of at Least 28 Days||16||
59694738|NCT01300260|75814331|FG000|NOT COMPLETED|Washout Period of at Least 28 Days||0||
59989927|NCT03377803|76105362|FG000|COMPLETED|Overall Study||139||
59989928|NCT03377803|76105363|FG001|COMPLETED|Overall Study||108||
59694739|NCT01300260|75814332|FG001|NOT COMPLETED|Washout Period of at Least 28 Days||0||
59694740|NCT01300260|75814331|FG000|STARTED|Period 2 of Study: Second Intervention||14||
59694741|NCT01300260|75814332|FG001|STARTED|Period 2 of Study: Second Intervention||16||
59694742|NCT01300260|75814331|FG000|COMPLETED|Period 2 of Study: Second Intervention||14||
59694743|NCT01300260|75814332|FG001|COMPLETED|Period 2 of Study: Second Intervention||15||
59694744|NCT01300260|75814331|FG000|NOT COMPLETED|Period 2 of Study: Second Intervention||0||
59694745|NCT01300260|75814332|FG001|NOT COMPLETED|Period 2 of Study: Second Intervention||1||
59694746|NCT01256385|75814351|FG000|STARTED|Overall Study||43||
59694747|NCT01256385|75814352|FG001|STARTED|Overall Study||43||
59694748|NCT01256385|75814351|FG000|Crossover From Arm B to Arm A|Overall Study||0||
59694749|NCT01256385|75814352|FG001|Crossover From Arm B to Arm A|Overall Study||15||
59694750|NCT01256385|75814351|FG000|COMPLETED|Overall Study||40||
59694751|NCT01256385|75814352|FG001|COMPLETED|Overall Study||40||
59694752|NCT01256385|75814351|FG000|NOT COMPLETED|Overall Study||3||
59694753|NCT01256385|75814352|FG001|NOT COMPLETED|Overall Study||3||
59694754|NCT01298778|75814360|FG000|STARTED|Overall Study||33||
59694755|NCT01298778|75814361|FG001|STARTED|Overall Study||36||
59694756|NCT01298778|75814360|FG000|COMPLETED|Overall Study||30||
59694757|NCT01298778|75814361|FG001|COMPLETED|Overall Study||30||
59694758|NCT01298778|75814360|FG000|NOT COMPLETED|Overall Study||3||
59694759|NCT01298778|75814361|FG001|NOT COMPLETED|Overall Study||6||
59694760|NCT01298700|75814371|FG000|STARTED|Overall Study||403||
59694761|NCT01298700|75814372|FG001|STARTED|Overall Study||403||
59694762|NCT01298700|75814371|FG000|Safety Population: Received Study Drug|Overall Study||400||
59694763|NCT01298700|75814372|FG001|Safety Population: Received Study Drug|Overall Study||398||
59694764|NCT01298700|75814371|FG000|COMPLETED|Overall Study||302||
59694765|NCT01298700|75814372|FG001|COMPLETED|Overall Study||303||
59694766|NCT01298700|75814371|FG000|NOT COMPLETED|Overall Study||101||
59694767|NCT01298700|75814372|FG001|NOT COMPLETED|Overall Study||100||
59694768|NCT01297920|75814381|FG000|STARTED|Overall Study||221||
59694769|NCT01297920|75814382|FG001|STARTED|Overall Study||234||
59694770|NCT01297920|75814383|FG002|STARTED|Overall Study||235||
59694771|NCT01297920|75814381|FG000|COMPLETED|Overall Study||163||
59694772|NCT01297920|75814382|FG001|COMPLETED|Overall Study||207||
59694773|NCT01297920|75814383|FG002|COMPLETED|Overall Study||178||
59694774|NCT01297920|75814381|FG000|NOT COMPLETED|Overall Study||58||
59694775|NCT01297920|75814382|FG001|NOT COMPLETED|Overall Study||27||
59694776|NCT01297920|75814383|FG002|NOT COMPLETED|Overall Study||57||
59694777|NCT01255761|75814393|FG000|STARTED|Overall Study||369||
59694778|NCT01255761|75814394|FG001|STARTED|Overall Study||367||
59694779|NCT01255761|75814393|FG000|COMPLETED|Overall Study||187||
59694780|NCT01255761|75814394|FG001|COMPLETED|Overall Study||192||
59694781|NCT01255761|75814393|FG000|NOT COMPLETED|Overall Study||182||
59694782|NCT01255761|75814394|FG001|NOT COMPLETED|Overall Study||175||
59694783|NCT01297062|75814406|FG000|STARTED|Overall Study||15||
59694784|NCT01297062|75814407|FG001|STARTED|Overall Study||14||
59694785|NCT01297062|75814408|FG002|STARTED|Overall Study||14||
59694786|NCT01297062|75814409|FG003|STARTED|Overall Study||14||
59694787|NCT01297062|75814410|FG004|STARTED|Overall Study||15||
59694788|NCT01297062|75814411|FG005|STARTED|Overall Study||14||
59694789|NCT01297062|75814412|FG006|STARTED|Overall Study||8||
59694790|NCT01297062|75814406|FG000|Intent to Treat (ITT)|Overall Study||15||
59694791|NCT01297062|75814407|FG001|Intent to Treat (ITT)|Overall Study||14||
59694792|NCT01297062|75814408|FG002|Intent to Treat (ITT)|Overall Study||14||
59694793|NCT01297062|75814409|FG003|Intent to Treat (ITT)|Overall Study||14||
59694794|NCT01297062|75814410|FG004|Intent to Treat (ITT)|Overall Study||15||
59694795|NCT01297062|75814411|FG005|Intent to Treat (ITT)|Overall Study||14||
59694796|NCT01297062|75814412|FG006|Intent to Treat (ITT)|Overall Study||0||
59694797|NCT01297062|75814406|FG000|Evaluable Population|Overall Study||11||
59694798|NCT01297062|75814407|FG001|Evaluable Population|Overall Study||12||
59694799|NCT01297062|75814408|FG002|Evaluable Population|Overall Study||12||
59694800|NCT01297062|75814409|FG003|Evaluable Population|Overall Study||13||
59694801|NCT01297062|75814410|FG004|Evaluable Population|Overall Study||13||
59694802|NCT01297062|75814411|FG005|Evaluable Population|Overall Study||13||
59694803|NCT01297062|75814412|FG006|Evaluable Population|Overall Study||0||
59694804|NCT01297062|75814406|FG000|COMPLETED|Overall Study||11||
59694805|NCT01297062|75814407|FG001|COMPLETED|Overall Study||13||
59694806|NCT01297062|75814408|FG002|COMPLETED|Overall Study||12||
59694807|NCT01297062|75814409|FG003|COMPLETED|Overall Study||13||
59694808|NCT01297062|75814410|FG004|COMPLETED|Overall Study||13||
59694809|NCT01297062|75814411|FG005|COMPLETED|Overall Study||13||
59694810|NCT01297062|75814412|FG006|COMPLETED|Overall Study||0||
59694811|NCT01297062|75814406|FG000|NOT COMPLETED|Overall Study||4||
59694812|NCT01297062|75814407|FG001|NOT COMPLETED|Overall Study||1||
59694813|NCT01297062|75814408|FG002|NOT COMPLETED|Overall Study||2||
59694814|NCT01297062|75814409|FG003|NOT COMPLETED|Overall Study||1||
59694815|NCT01297062|75814410|FG004|NOT COMPLETED|Overall Study||2||
59694816|NCT01297062|75814411|FG005|NOT COMPLETED|Overall Study||1||
59694817|NCT01297062|75814412|FG006|NOT COMPLETED|Overall Study||8||
59694818|NCT01254747|75814424|FG000|STARTED|Overall Study||40||
59694819|NCT01254747|75814425|FG001|STARTED|Overall Study||29||
59694820|NCT01254747|75814426|FG002|STARTED|Overall Study||30||
59694821|NCT01254747|75814427|FG003|STARTED|Overall Study||30||
59694822|NCT01254747|75814424|FG000|COMPLETED|Overall Study||40||
59694823|NCT01254747|75814425|FG001|COMPLETED|Overall Study||23||
59694824|NCT01254747|75814426|FG002|COMPLETED|Overall Study||26||
59694825|NCT01254747|75814427|FG003|COMPLETED|Overall Study||28||
59694826|NCT01254747|75814424|FG000|NOT COMPLETED|Overall Study||0||
59694827|NCT01254747|75814425|FG001|NOT COMPLETED|Overall Study||6||
59694828|NCT01254747|75814426|FG002|NOT COMPLETED|Overall Study||4||
59694829|NCT01254747|75814427|FG003|NOT COMPLETED|Overall Study||2||
59694830|NCT01296672|75814439|FG000|STARTED|Overall Study||306||
59694831|NCT01296672|75814440|FG001|STARTED|Overall Study||77||
59694832|NCT01296672|75814439|FG000|COMPLETED|Overall Study||233||
59694833|NCT01296672|75814440|FG001|COMPLETED|Overall Study||59||
59694834|NCT01296672|75814439|FG000|NOT COMPLETED|Overall Study||73||
59694835|NCT01296672|75814440|FG001|NOT COMPLETED|Overall Study||18||
59694836|NCT01254669|75814450|FG000|STARTED|Overall Study||100||
59694837|NCT01254669|75814451|FG001|STARTED|Overall Study||100||
59694838|NCT01254669|75814450|FG000|COMPLETED|Overall Study||97||
59694839|NCT01254669|75814451|FG001|COMPLETED|Overall Study||96||
59694840|NCT01254669|75814450|FG000|NOT COMPLETED|Overall Study||3||
59694841|NCT01254669|75814451|FG001|NOT COMPLETED|Overall Study||4||
59694842|NCT01295814|75814461|FG000|STARTED|Overall Study||22||
59694843|NCT01295814|75814462|FG001|STARTED|Overall Study||21||
59694844|NCT01295814|75814461|FG000|COMPLETED|Overall Study||20||
59694845|NCT01295814|75814462|FG001|COMPLETED|Overall Study||19||
59694846|NCT01295814|75814461|FG000|NOT COMPLETED|Overall Study||2||
59694847|NCT01295814|75814462|FG001|NOT COMPLETED|Overall Study||2||
59694848|NCT01254045|75814468|FG000|STARTED|First/Baseline (1 Day at Week 1 )|One completed all baseline measures including administration of placebo, but then lost to follow-up.|2||
59694849|NCT01254045|75814469|FG001|STARTED|First/Baseline (1 Day at Week 1 )||2||
59694850|NCT01254045|75814470|FG002|STARTED|First/Baseline (1 Day at Week 1 )||2||
59694851|NCT01254045|75814471|FG003|STARTED|First/Baseline (1 Day at Week 1 )||1||
59694852|NCT01254045|75814472|FG004|STARTED|First/Baseline (1 Day at Week 1 )||1||
59694853|NCT01254045|75814473|FG005|STARTED|First/Baseline (1 Day at Week 1 )||1||
59694854|NCT01254045|75814468|FG000|COMPLETED|First/Baseline (1 Day at Week 1 )||1||
59694855|NCT01254045|75814469|FG001|COMPLETED|First/Baseline (1 Day at Week 1 )||2||
59694856|NCT01254045|75814470|FG002|COMPLETED|First/Baseline (1 Day at Week 1 )||2||
59694857|NCT01254045|75814471|FG003|COMPLETED|First/Baseline (1 Day at Week 1 )||1||
59694858|NCT01254045|75814472|FG004|COMPLETED|First/Baseline (1 Day at Week 1 )||1||
59694859|NCT01254045|75814473|FG005|COMPLETED|First/Baseline (1 Day at Week 1 )||1||
59694860|NCT01254045|75814468|FG000|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||1||
59694861|NCT01254045|75814469|FG001|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0||
59694862|NCT01254045|75814470|FG002|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0||
59694863|NCT01254045|75814471|FG003|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0||
59694864|NCT01254045|75814472|FG004|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0||
59694865|NCT01254045|75814473|FG005|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0||
59694866|NCT01254045|75814468|FG000|STARTED|Second/Time 2 (1 Day at Week 2)||1||
59694867|NCT01254045|75814469|FG001|STARTED|Second/Time 2 (1 Day at Week 2)||2||
59694868|NCT01254045|75814470|FG002|STARTED|Second/Time 2 (1 Day at Week 2)||2||
59694869|NCT01254045|75814471|FG003|STARTED|Second/Time 2 (1 Day at Week 2)||1||
59694870|NCT01254045|75814472|FG004|STARTED|Second/Time 2 (1 Day at Week 2)||1||
59694871|NCT01254045|75814473|FG005|STARTED|Second/Time 2 (1 Day at Week 2)||1||
59694872|NCT01254045|75814468|FG000|COMPLETED|Second/Time 2 (1 Day at Week 2)||1||
59694873|NCT01254045|75814469|FG001|COMPLETED|Second/Time 2 (1 Day at Week 2)||2||
59694874|NCT01254045|75814470|FG002|COMPLETED|Second/Time 2 (1 Day at Week 2)||2||
59694875|NCT01254045|75814471|FG003|COMPLETED|Second/Time 2 (1 Day at Week 2)||1||
59694876|NCT01254045|75814472|FG004|COMPLETED|Second/Time 2 (1 Day at Week 2)||1||
59694877|NCT01254045|75814473|FG005|COMPLETED|Second/Time 2 (1 Day at Week 2)||1||
59694878|NCT01254045|75814468|FG000|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0||
59694879|NCT01254045|75814469|FG001|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0||
59694880|NCT01254045|75814470|FG002|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0||
59694881|NCT01254045|75814471|FG003|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0||
59694882|NCT01254045|75814472|FG004|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0||
59694883|NCT01254045|75814473|FG005|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0||
59694884|NCT01254045|75814468|FG000|STARTED|Third/Time 3 (1 Day at Week 3)||1||
59694885|NCT01254045|75814469|FG001|STARTED|Third/Time 3 (1 Day at Week 3)||2||
59694886|NCT01254045|75814470|FG002|STARTED|Third/Time 3 (1 Day at Week 3)||2||
59694887|NCT01254045|75814471|FG003|STARTED|Third/Time 3 (1 Day at Week 3)||1||
59694888|NCT01254045|75814472|FG004|STARTED|Third/Time 3 (1 Day at Week 3)||1||
59694889|NCT01254045|75814473|FG005|STARTED|Third/Time 3 (1 Day at Week 3)||1||
59694890|NCT01254045|75814468|FG000|COMPLETED|Third/Time 3 (1 Day at Week 3)||1||
59694891|NCT01254045|75814469|FG001|COMPLETED|Third/Time 3 (1 Day at Week 3)||2||
59694892|NCT01254045|75814470|FG002|COMPLETED|Third/Time 3 (1 Day at Week 3)||2||
59694893|NCT01254045|75814471|FG003|COMPLETED|Third/Time 3 (1 Day at Week 3)||1||
59694894|NCT01254045|75814472|FG004|COMPLETED|Third/Time 3 (1 Day at Week 3)||1||
59694895|NCT01254045|75814473|FG005|COMPLETED|Third/Time 3 (1 Day at Week 3)||1||
59694896|NCT01254045|75814468|FG000|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0||
59694897|NCT01254045|75814469|FG001|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0||
59694898|NCT01254045|75814470|FG002|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0||
59694899|NCT01254045|75814471|FG003|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0||
59694900|NCT01254045|75814472|FG004|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0||
59694901|NCT01254045|75814473|FG005|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0||
59694902|NCT01075282|75814486|FG000|STARTED|Overall Study||273||
59694903|NCT01075282|75814487|FG001|STARTED|Overall Study||272||
59694904|NCT01075282|75814488|FG002|STARTED|Overall Study|Of 265 participants randomized to Insulin Glargine, 3 chose not to take study drug.|265||
59694905|NCT01075282|75814486|FG000|Received at Least One Dose of Study Drug|Overall Study||273||
59694906|NCT01075282|75814487|FG001|Received at Least One Dose of Study Drug|Overall Study||272||
59694907|NCT01075282|75814488|FG002|Received at Least One Dose of Study Drug|Overall Study||262||
59694908|NCT01075282|75814486|FG000|COMPLETED|Overall Study||242||
59694909|NCT01075282|75814487|FG001|COMPLETED|Overall Study||243||
59694910|NCT01075282|75814488|FG002|COMPLETED|Overall Study||238||
59694911|NCT01075282|75814486|FG000|NOT COMPLETED|Overall Study||31||
59694912|NCT01075282|75814487|FG001|NOT COMPLETED|Overall Study||29||
59694913|NCT01075282|75814488|FG002|NOT COMPLETED|Overall Study||27||
59694914|NCT01253811|75814497|FG000|STARTED|Overall Study||6||
59694915|NCT01253811|75814497|FG000|Exposed|Overall Study||6||
59694916|NCT01253811|75814497|FG000|COMPLETED|Overall Study||5||
59694917|NCT01253811|75814497|FG000|NOT COMPLETED|Overall Study||1||
59694918|NCT01295580|75814503|FG000|STARTED|Overall Study||174||
59694919|NCT01295580|75814504|FG001|STARTED|Overall Study||175||
59694920|NCT01295580|75814503|FG000|COMPLETED|Overall Study||164||
59694921|NCT01295580|75814504|FG001|COMPLETED|Overall Study||167||
59694922|NCT01295580|75814503|FG000|NOT COMPLETED|Overall Study||10||
59694923|NCT01295580|75814504|FG001|NOT COMPLETED|Overall Study||8||
59694924|NCT01253577|75814510|FG000|STARTED|Overall Study||105||
59694925|NCT01253577|75814510|FG000|COMPLETED|Overall Study||102||
59694926|NCT01253577|75814510|FG000|NOT COMPLETED|Overall Study||3||
59694927|NCT01295034|75814518|FG000|STARTED|Overall Study||32||
59694928|NCT01295034|75814519|FG001|STARTED|Overall Study||30||
59694929|NCT01295034|75814518|FG000|COMPLETED|Overall Study||27||
59694930|NCT01295034|75814519|FG001|COMPLETED|Overall Study||25||
59694931|NCT01295034|75814518|FG000|NOT COMPLETED|Overall Study||5||
59694932|NCT01295034|75814519|FG001|NOT COMPLETED|Overall Study||5||
59694933|NCT01253421|75814530|FG000|STARTED|Assessment and Scheduling||159|Enrolled for screening visit|
60079471|NCT04206332|76194705|FG005|Completed Controlled Human Malaria Infection (CHMI)|Part B||0||
60079472|NCT04206332|76194706|FG006|Completed Controlled Human Malaria Infection (CHMI)|Part B||0||
60079473|NCT04206332|76194707|FG007|Completed Controlled Human Malaria Infection (CHMI)|Part B||4||
60079474|NCT04206332|76194708|FG008|Completed Controlled Human Malaria Infection (CHMI)|Part B||2||
60079475|NCT04206332|76194709|FG009|Completed Controlled Human Malaria Infection (CHMI)|Part B||3||
59694934|NCT01253421|75814531|FG001|STARTED|Assessment and Scheduling|Arm has no participants until randomization.|0|Enrolled for screening visit|
59694935|NCT01253421|75814532|FG002|STARTED|Assessment and Scheduling|Arm has no participants until randomization.|0|Enrolled for screening visit|
59694936|NCT01253421|75814533|FG003|STARTED|Assessment and Scheduling|Arm has no participants until randomization.|0|Enrolled for screening visit|
59694937|NCT01253421|75814534|FG004|STARTED|Assessment and Scheduling|Arm has no participants until randomization.|0|Enrolled for screening visit|
59694938|NCT01253421|75814530|FG000|Eligible After Screening Visit|Assessment and Scheduling||85||
59694939|NCT01253421|75814531|FG001|Eligible After Screening Visit|Assessment and Scheduling||0||
59694940|NCT01253421|75814532|FG002|Eligible After Screening Visit|Assessment and Scheduling||0||
59694941|NCT01253421|75814533|FG003|Eligible After Screening Visit|Assessment and Scheduling||0||
59694942|NCT01253421|75814534|FG004|Eligible After Screening Visit|Assessment and Scheduling||0||
59694943|NCT01253421|75814530|FG000|Returned for Drug+Scanning Visit|Assessment and Scheduling||60|This milestone accounts for participants who were lost to follow up or withdrew for other reasons.|
59694944|NCT01253421|75814531|FG001|Returned for Drug+Scanning Visit|Assessment and Scheduling||0|This milestone accounts for participants who were lost to follow up or withdrew for other reasons.|
59694945|NCT01253421|75814532|FG002|Returned for Drug+Scanning Visit|Assessment and Scheduling||0|This milestone accounts for participants who were lost to follow up or withdrew for other reasons.|
59694946|NCT01253421|75814533|FG003|Returned for Drug+Scanning Visit|Assessment and Scheduling||0|This milestone accounts for participants who were lost to follow up or withdrew for other reasons.|
59694947|NCT01253421|75814534|FG004|Returned for Drug+Scanning Visit|Assessment and Scheduling||0|This milestone accounts for participants who were lost to follow up or withdrew for other reasons.|
59694948|NCT01253421|75814530|FG000|COMPLETED|Assessment and Scheduling||60|These 60 participants enter Period 2.|
59694949|NCT01253421|75814531|FG001|COMPLETED|Assessment and Scheduling||0|These 60 participants enter Period 2.|
59694950|NCT01253421|75814532|FG002|COMPLETED|Assessment and Scheduling||0|These 60 participants enter Period 2.|
60079476|NCT04206332|76194710|FG010|Completed Controlled Human Malaria Infection (CHMI)|Part B||6||
60079477|NCT04206332|76194711|FG011|Completed Controlled Human Malaria Infection (CHMI)|Part B||0||
60079478|NCT04206332|76194712|FG012|Completed Controlled Human Malaria Infection (CHMI)|Part B||0||
60079479|NCT04206332|76194713|FG013|Completed Controlled Human Malaria Infection (CHMI)|Part B||0||
59694951|NCT01253421|75814533|FG003|COMPLETED|Assessment and Scheduling||0|These 60 participants enter Period 2.|
59694952|NCT01253421|75814534|FG004|COMPLETED|Assessment and Scheduling||0|These 60 participants enter Period 2.|
59694953|NCT01253421|75814530|FG000|NOT COMPLETED|Assessment and Scheduling||99||
59694954|NCT01253421|75814531|FG001|NOT COMPLETED|Assessment and Scheduling||0||
59694955|NCT01253421|75814532|FG002|NOT COMPLETED|Assessment and Scheduling||0||
59694956|NCT01253421|75814533|FG003|NOT COMPLETED|Assessment and Scheduling||0||
59694957|NCT01253421|75814534|FG004|NOT COMPLETED|Assessment and Scheduling||0||
59694958|NCT01253421|75814530|FG000|STARTED|Drug+Scanning Visit|Arm has no participants once randomization has occurred.|0|At the start of this period, all 60 active participants are randomized to a drug-X-condition arm|
59694959|NCT01253421|75814531|FG001|STARTED|Drug+Scanning Visit||15|At the start of this period, all 60 active participants are randomized to a drug-X-condition arm|
59694960|NCT01253421|75814532|FG002|STARTED|Drug+Scanning Visit||14|At the start of this period, all 60 active participants are randomized to a drug-X-condition arm|
59694961|NCT01253421|75814533|FG003|STARTED|Drug+Scanning Visit||16|At the start of this period, all 60 active participants are randomized to a drug-X-condition arm|
59694962|NCT01253421|75814534|FG004|STARTED|Drug+Scanning Visit||15|At the start of this period, all 60 active participants are randomized to a drug-X-condition arm|
59694963|NCT01253421|75814530|FG000|Received Drug Challenge|Drug+Scanning Visit||0||
59694964|NCT01253421|75814531|FG001|Received Drug Challenge|Drug+Scanning Visit||15||
59694965|NCT01253421|75814532|FG002|Received Drug Challenge|Drug+Scanning Visit||14||
59694966|NCT01253421|75814533|FG003|Received Drug Challenge|Drug+Scanning Visit||16||
59694967|NCT01253421|75814534|FG004|Received Drug Challenge|Drug+Scanning Visit||15||
59694968|NCT01253421|75814530|FG000|COMPLETED|Drug+Scanning Visit||0||
59694969|NCT01253421|75814531|FG001|COMPLETED|Drug+Scanning Visit||15||
59694970|NCT01253421|75814532|FG002|COMPLETED|Drug+Scanning Visit||14||
59694971|NCT01253421|75814533|FG003|COMPLETED|Drug+Scanning Visit||16||
59694972|NCT01253421|75814534|FG004|COMPLETED|Drug+Scanning Visit||14||
59694973|NCT01253421|75814530|FG000|NOT COMPLETED|Drug+Scanning Visit||0||
59694974|NCT01253421|75814531|FG001|NOT COMPLETED|Drug+Scanning Visit||0||
59694975|NCT01253421|75814532|FG002|NOT COMPLETED|Drug+Scanning Visit||0||
59694976|NCT01253421|75814533|FG003|NOT COMPLETED|Drug+Scanning Visit||0||
59694977|NCT01253421|75814534|FG004|NOT COMPLETED|Drug+Scanning Visit||1||
59694978|NCT01077076|75814544|FG000|STARTED|First Intervention||5||
59694979|NCT01077076|75814545|FG001|STARTED|First Intervention||5||
59694980|NCT01077076|75814546|FG002|STARTED|First Intervention||5||
59694981|NCT01077076|75814547|FG003|STARTED|First Intervention||5||
59694982|NCT01077076|75814548|FG004|STARTED|First Intervention||5||
59694983|NCT01077076|75814549|FG005|STARTED|First Intervention||5||
59694984|NCT01077076|75814544|FG000|COMPLETED|First Intervention||4||
59694985|NCT01077076|75814545|FG001|COMPLETED|First Intervention||5||
59694986|NCT01077076|75814546|FG002|COMPLETED|First Intervention||5||
59694987|NCT01077076|75814547|FG003|COMPLETED|First Intervention||5||
59694988|NCT01077076|75814548|FG004|COMPLETED|First Intervention||5||
59694989|NCT01077076|75814549|FG005|COMPLETED|First Intervention||5||
59694990|NCT01077076|75814544|FG000|NOT COMPLETED|First Intervention||1||
59694991|NCT01077076|75814545|FG001|NOT COMPLETED|First Intervention||0||
59694992|NCT01077076|75814546|FG002|NOT COMPLETED|First Intervention||0||
59694993|NCT01077076|75814547|FG003|NOT COMPLETED|First Intervention||0||
59694994|NCT01077076|75814548|FG004|NOT COMPLETED|First Intervention||0||
59694995|NCT01077076|75814549|FG005|NOT COMPLETED|First Intervention||0||
59694996|NCT01077076|75814544|FG000|STARTED|Washout Period of 2 Weeks||4||
59694997|NCT01077076|75814545|FG001|STARTED|Washout Period of 2 Weeks||5||
59694998|NCT01077076|75814546|FG002|STARTED|Washout Period of 2 Weeks||5||
59694999|NCT01077076|75814547|FG003|STARTED|Washout Period of 2 Weeks||5||
59695000|NCT01077076|75814548|FG004|STARTED|Washout Period of 2 Weeks||5||
59695001|NCT01077076|75814549|FG005|STARTED|Washout Period of 2 Weeks||5||
59695002|NCT01077076|75814544|FG000|COMPLETED|Washout Period of 2 Weeks||4||
59695003|NCT01077076|75814545|FG001|COMPLETED|Washout Period of 2 Weeks||5||
59695004|NCT01077076|75814546|FG002|COMPLETED|Washout Period of 2 Weeks||5||
59695005|NCT01077076|75814547|FG003|COMPLETED|Washout Period of 2 Weeks||5||
59695006|NCT01077076|75814548|FG004|COMPLETED|Washout Period of 2 Weeks||5||
59695007|NCT01077076|75814549|FG005|COMPLETED|Washout Period of 2 Weeks||5||
59695008|NCT01077076|75814544|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0||
59695009|NCT01077076|75814545|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0||
59695010|NCT01077076|75814546|FG002|NOT COMPLETED|Washout Period of 2 Weeks||0||
59695011|NCT01077076|75814547|FG003|NOT COMPLETED|Washout Period of 2 Weeks||0||
59695012|NCT01077076|75814548|FG004|NOT COMPLETED|Washout Period of 2 Weeks||0||
59695013|NCT01077076|75814549|FG005|NOT COMPLETED|Washout Period of 2 Weeks||0||
59695014|NCT01077076|75814544|FG000|STARTED|Second Intervention||4||
59695015|NCT01077076|75814545|FG001|STARTED|Second Intervention||5||
59695016|NCT01077076|75814546|FG002|STARTED|Second Intervention||5||
59695017|NCT01077076|75814547|FG003|STARTED|Second Intervention||5||
59695018|NCT01077076|75814548|FG004|STARTED|Second Intervention||5||
59695019|NCT01077076|75814549|FG005|STARTED|Second Intervention||5||
59695020|NCT01077076|75814544|FG000|COMPLETED|Second Intervention||4||
59695021|NCT01077076|75814545|FG001|COMPLETED|Second Intervention||5||
59695022|NCT01077076|75814546|FG002|COMPLETED|Second Intervention||5||
59695023|NCT01077076|75814547|FG003|COMPLETED|Second Intervention||5||
59695024|NCT01077076|75814548|FG004|COMPLETED|Second Intervention||5||
59695025|NCT01077076|75814549|FG005|COMPLETED|Second Intervention||5||
59695026|NCT01077076|75814544|FG000|NOT COMPLETED|Second Intervention||0||
59695027|NCT01077076|75814545|FG001|NOT COMPLETED|Second Intervention||0||
59695028|NCT01077076|75814546|FG002|NOT COMPLETED|Second Intervention||0||
59695029|NCT01077076|75814547|FG003|NOT COMPLETED|Second Intervention||0||
59695030|NCT01077076|75814548|FG004|NOT COMPLETED|Second Intervention||0||
59695031|NCT01077076|75814549|FG005|NOT COMPLETED|Second Intervention||0||
59695032|NCT01077076|75814544|FG000|STARTED|Washout Period of 2 Weeks||4||
59695033|NCT01077076|75814545|FG001|STARTED|Washout Period of 2 Weeks||5||
59695034|NCT01077076|75814546|FG002|STARTED|Washout Period of 2 Weeks||5||
59695035|NCT01077076|75814547|FG003|STARTED|Washout Period of 2 Weeks||5||
59695036|NCT01077076|75814548|FG004|STARTED|Washout Period of 2 Weeks||5||
59695037|NCT01077076|75814549|FG005|STARTED|Washout Period of 2 Weeks||5||
59695038|NCT01077076|75814544|FG000|COMPLETED|Washout Period of 2 Weeks||4||
59695039|NCT01077076|75814545|FG001|COMPLETED|Washout Period of 2 Weeks||5||
59695040|NCT01077076|75814546|FG002|COMPLETED|Washout Period of 2 Weeks||5||
59695041|NCT01077076|75814547|FG003|COMPLETED|Washout Period of 2 Weeks||5||
59695042|NCT01077076|75814548|FG004|COMPLETED|Washout Period of 2 Weeks||5||
59695043|NCT01077076|75814549|FG005|COMPLETED|Washout Period of 2 Weeks||5||
59695044|NCT01077076|75814544|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0||
59695045|NCT01077076|75814545|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0||
59695046|NCT01077076|75814546|FG002|NOT COMPLETED|Washout Period of 2 Weeks||0||
59695047|NCT01077076|75814547|FG003|NOT COMPLETED|Washout Period of 2 Weeks||0||
59695048|NCT01077076|75814548|FG004|NOT COMPLETED|Washout Period of 2 Weeks||0||
59695049|NCT01077076|75814549|FG005|NOT COMPLETED|Washout Period of 2 Weeks||0||
59695050|NCT01077076|75814544|FG000|STARTED|Third Intervention||4||
59695051|NCT01077076|75814545|FG001|STARTED|Third Intervention||5||
59695052|NCT01077076|75814546|FG002|STARTED|Third Intervention||5||
59695053|NCT01077076|75814547|FG003|STARTED|Third Intervention||5||
59695054|NCT01077076|75814548|FG004|STARTED|Third Intervention||5||
59695055|NCT01077076|75814549|FG005|STARTED|Third Intervention||5||
59695056|NCT01077076|75814544|FG000|COMPLETED|Third Intervention||4||
59695057|NCT01077076|75814545|FG001|COMPLETED|Third Intervention||5||
59695058|NCT01077076|75814546|FG002|COMPLETED|Third Intervention||5||
59695059|NCT01077076|75814547|FG003|COMPLETED|Third Intervention||5||
59695060|NCT01077076|75814548|FG004|COMPLETED|Third Intervention||5||
59695061|NCT01077076|75814549|FG005|COMPLETED|Third Intervention||4||
59695062|NCT01077076|75814544|FG000|NOT COMPLETED|Third Intervention||0||
59695063|NCT01077076|75814545|FG001|NOT COMPLETED|Third Intervention||0||
59695064|NCT01077076|75814546|FG002|NOT COMPLETED|Third Intervention||0||
59695065|NCT01077076|75814547|FG003|NOT COMPLETED|Third Intervention||0||
59695066|NCT01077076|75814548|FG004|NOT COMPLETED|Third Intervention||0||
59695067|NCT01077076|75814549|FG005|NOT COMPLETED|Third Intervention||1||
59695068|NCT01294800|75814561|FG000|STARTED|Overall Study||111||
59695069|NCT01294800|75814562|FG001|STARTED|Overall Study||113||
59695070|NCT01294800|75814563|FG002|STARTED|Overall Study||113||
59695071|NCT01294800|75814564|FG003|STARTED|Overall Study||113||
59695072|NCT01294800|75814561|FG000|COMPLETED|Overall Study||100||
59695073|NCT01294800|75814562|FG001|COMPLETED|Overall Study||103||
59695074|NCT01294800|75814563|FG002|COMPLETED|Overall Study||96||
59695075|NCT01294800|75814564|FG003|COMPLETED|Overall Study||97||
59695076|NCT01294800|75814561|FG000|NOT COMPLETED|Overall Study||11||
59695077|NCT01294800|75814562|FG001|NOT COMPLETED|Overall Study||10||
59695078|NCT01294800|75814563|FG002|NOT COMPLETED|Overall Study||17||
59695079|NCT01294800|75814564|FG003|NOT COMPLETED|Overall Study||16||
59695080|NCT01294644|75814577|FG000|STARTED|Overall Study||121||
59695081|NCT01294644|75814578|FG001|STARTED|Overall Study||122||
59695082|NCT01294644|75814579|FG002|STARTED|Overall Study||117||
59695083|NCT01294644|75814577|FG000|Received Treatment|Overall Study||118||
59695084|NCT01294644|75814578|FG001|Received Treatment|Overall Study||122||
59695085|NCT01294644|75814579|FG002|Received Treatment|Overall Study||114||
59695086|NCT01294644|75814577|FG000|COMPLETED|Overall Study||111||
59695087|NCT01294644|75814578|FG001|COMPLETED|Overall Study||112||
59695088|NCT01294644|75814579|FG002|COMPLETED|Overall Study||103||
59695089|NCT01294644|75814577|FG000|NOT COMPLETED|Overall Study||10||
59695090|NCT01294644|75814578|FG001|NOT COMPLETED|Overall Study||10||
59695091|NCT01294644|75814579|FG002|NOT COMPLETED|Overall Study||14||
59695092|NCT01293240|75814587|FG000|STARTED|Overall Study||117||
59695093|NCT01293240|75814587|FG000|COMPLETED|Overall Study||115||
59695094|NCT01293240|75814587|FG000|NOT COMPLETED|Overall Study||2||
59547664|NCT01122446|75646514|FG001|COMPLETED|Overall Study||25||
59547665|NCT01122446|75646513|FG000|NOT COMPLETED|Overall Study||0||
59547666|NCT01122446|75646514|FG001|NOT COMPLETED|Overall Study||0||
59547667|NCT02530281|75646522|FG000|STARTED|Overall Study||229||
59547668|NCT02530281|75646523|FG001|STARTED|Overall Study||115||
59547669|NCT02530281|75646522|FG000|COMPLETED|Overall Study||208||
59547670|NCT02530281|75646523|FG001|COMPLETED|Overall Study||112||
59547671|NCT02530281|75646522|FG000|NOT COMPLETED|Overall Study||21||
59695095|NCT01253265|75814596|FG000|STARTED|Overall Study||6||
59695096|NCT01253265|75814597|FG001|STARTED|Overall Study||6||
59695097|NCT01253265|75814598|FG002|STARTED|Overall Study||6||
59695098|NCT01253265|75814599|FG003|STARTED|Overall Study||6||
59695099|NCT01253265|75814600|FG004|STARTED|Overall Study||8||
59695100|NCT01253265|75814596|FG000|COMPLETED|Overall Study||5||
59695101|NCT01253265|75814597|FG001|COMPLETED|Overall Study||6||
59695102|NCT01253265|75814598|FG002|COMPLETED|Overall Study||6||
59695103|NCT01253265|75814599|FG003|COMPLETED|Overall Study||6||
59547672|NCT02530281|75646523|FG001|NOT COMPLETED|Overall Study||3||
59547673|NCT02467491|75646531|FG000|STARTED|Overall Study||12||
59547674|NCT02467491|75646531|FG000|COMPLETED|Overall Study||12||
59547675|NCT02467491|75646531|FG000|NOT COMPLETED|Overall Study||0||
59547676|NCT01106456|75646537|FG000|STARTED|Overall Study||243||
59547677|NCT01106456|75646538|FG001|STARTED|Overall Study||220||
59547678|NCT01106456|75646537|FG000|COMPLETED|Overall Study||140||
59547679|NCT01106456|75646538|FG001|COMPLETED|Overall Study||96||
59547680|NCT01106456|75646537|FG000|NOT COMPLETED|Overall Study||103||
59547681|NCT01106456|75646538|FG001|NOT COMPLETED|Overall Study||124||
59547682|NCT02530515|75646547|FG000|STARTED|Overall Study||0||
59547683|NCT02530515|75646548|FG001|STARTED|Overall Study||0||
59547684|NCT02530515|75646549|FG002|STARTED|Overall Study||8||
59547685|NCT02530515|75646547|FG000|COMPLETED|Overall Study||0||
59547686|NCT02530515|75646548|FG001|COMPLETED|Overall Study||0||
59547687|NCT02530515|75646549|FG002|COMPLETED|Overall Study||8||
59547688|NCT02530515|75646547|FG000|NOT COMPLETED|Overall Study||0||
59547689|NCT02530515|75646548|FG001|NOT COMPLETED|Overall Study||0||
59547690|NCT02530515|75646549|FG002|NOT COMPLETED|Overall Study||0||
59547691|NCT02532933|75646559|FG000|STARTED|Overall Study||22||
59547692|NCT02532933|75646560|FG001|STARTED|Overall Study||22||
59547693|NCT02532933|75646559|FG000|COMPLETED|Overall Study||16||
59547694|NCT02532933|75646560|FG001|COMPLETED|Overall Study||16||
59547695|NCT02532933|75646559|FG000|NOT COMPLETED|Overall Study||6||
59547696|NCT02532933|75646560|FG001|NOT COMPLETED|Overall Study||6||
59547697|NCT01123928|75646568|FG000|STARTED|Overall Study||212||
59547698|NCT01123928|75646569|FG001|STARTED|Overall Study||222||
59547699|NCT01123928|75646568|FG000|COMPLETED|Overall Study||212||
59547700|NCT01123928|75646569|FG001|COMPLETED|Overall Study||222||
59547701|NCT01123928|75646568|FG000|NOT COMPLETED|Overall Study||0||
59547702|NCT01123928|75646569|FG001|NOT COMPLETED|Overall Study||0||
59547703|NCT02469597|75646577|FG000|STARTED|Overall Study||22||
59547704|NCT02469597|75646578|FG001|STARTED|Overall Study||24||
59547705|NCT02469597|75646577|FG000|COMPLETED|Overall Study||22||
59547706|NCT02469597|75646578|FG001|COMPLETED|Overall Study||24||
59547707|NCT02469597|75646577|FG000|NOT COMPLETED|Overall Study||0||
59547708|NCT02469597|75646578|FG001|NOT COMPLETED|Overall Study||0||
59695104|NCT01253265|75814600|FG004|COMPLETED|Overall Study||7||
59695105|NCT01253265|75814596|FG000|NOT COMPLETED|Overall Study||1||
59547709|NCT02183792|75646586|FG000|STARTED|Overall Study||18||
59547710|NCT02183792|75646587|FG001|STARTED|Overall Study||15||
59547711|NCT02183792|75646586|FG000|COMPLETED|Overall Study||18||
59547712|NCT02183792|75646587|FG001|COMPLETED|Overall Study||15||
59547713|NCT02183792|75646586|FG000|NOT COMPLETED|Overall Study||0||
59547714|NCT02183792|75646587|FG001|NOT COMPLETED|Overall Study||0||
59547715|NCT02533089|75646595|FG000|STARTED|Overall Study||605||51
59547716|NCT02533089|75646596|FG001|STARTED|Overall Study||548||52
59565841|NCT02305758|75668261|FG000|COMPLETED|Overall Study||0||
59565842|NCT02305758|75668262|FG001|COMPLETED|Overall Study||0||
59565843|NCT02305758|75668261|FG000|NOT COMPLETED|Overall Study||65||
59565844|NCT02305758|75668262|FG001|NOT COMPLETED|Overall Study||65||
59565845|NCT02305446|75668268|FG000|STARTED|Overall Study||55||
59565846|NCT02305446|75668268|FG000|COMPLETED|Overall Study||54||
59565847|NCT02305446|75668268|FG000|NOT COMPLETED|Overall Study||1||
59565848|NCT04392219|75668290|FG000|STARTED|Overall Study||16||
59695106|NCT01253265|75814597|FG001|NOT COMPLETED|Overall Study||0||
59695107|NCT01253265|75814598|FG002|NOT COMPLETED|Overall Study||0||
59695108|NCT01253265|75814599|FG003|NOT COMPLETED|Overall Study||0||
59695109|NCT01253265|75814600|FG004|NOT COMPLETED|Overall Study||1||
59695110|NCT01293084|75814612|FG000|STARTED|Overall Study||17||
59695111|NCT01293084|75814612|FG000|COMPLETED|Overall Study||12||
59695112|NCT01293084|75814612|FG000|NOT COMPLETED|Overall Study||5||
59695113|NCT01293006|75814622|FG000|STARTED|Period 1||11||
59695114|NCT01293006|75814623|FG001|STARTED|Period 1||2||
59695115|NCT01293006|75814624|FG002|STARTED|Period 1||9||
59695116|NCT01293006|75814625|FG003|STARTED|Period 1||3||
59695117|NCT01293006|75814622|FG000|COMPLETED|Period 1||11||
59695118|NCT01293006|75814623|FG001|COMPLETED|Period 1||2||
59695119|NCT01293006|75814624|FG002|COMPLETED|Period 1||9||
59695120|NCT01293006|75814625|FG003|COMPLETED|Period 1||3||
59695121|NCT01293006|75814622|FG000|NOT COMPLETED|Period 1||0||
59695122|NCT01293006|75814623|FG001|NOT COMPLETED|Period 1||0||
59695123|NCT01293006|75814624|FG002|NOT COMPLETED|Period 1||0||
59695124|NCT01293006|75814625|FG003|NOT COMPLETED|Period 1||0||
59695125|NCT01293006|75814622|FG000|STARTED|Washout||11||
59695126|NCT01293006|75814623|FG001|STARTED|Washout||2||
59695127|NCT01293006|75814624|FG002|STARTED|Washout||9||
59695128|NCT01293006|75814625|FG003|STARTED|Washout||3||
59695129|NCT01293006|75814622|FG000|COMPLETED|Washout||11||
59695130|NCT01293006|75814623|FG001|COMPLETED|Washout||2||
59695131|NCT01293006|75814624|FG002|COMPLETED|Washout||9||
59695132|NCT01293006|75814625|FG003|COMPLETED|Washout||3||
59695133|NCT01293006|75814622|FG000|NOT COMPLETED|Washout||0||
59695134|NCT01293006|75814623|FG001|NOT COMPLETED|Washout||0||
59695135|NCT01293006|75814624|FG002|NOT COMPLETED|Washout||0||
59695136|NCT01293006|75814625|FG003|NOT COMPLETED|Washout||0||
59695137|NCT01293006|75814622|FG000|STARTED|Period 2||11||
59695138|NCT01293006|75814623|FG001|STARTED|Period 2||2||
59695139|NCT01293006|75814624|FG002|STARTED|Period 2||9||
59695140|NCT01293006|75814625|FG003|STARTED|Period 2||3||
59695141|NCT01293006|75814622|FG000|COMPLETED|Period 2||10||
59695142|NCT01293006|75814623|FG001|COMPLETED|Period 2||2||
59695143|NCT01293006|75814624|FG002|COMPLETED|Period 2||9||
59695144|NCT01293006|75814625|FG003|COMPLETED|Period 2||3||
59695145|NCT01293006|75814622|FG000|NOT COMPLETED|Period 2||1||
59695146|NCT01293006|75814623|FG001|NOT COMPLETED|Period 2||0||
59695147|NCT01293006|75814624|FG002|NOT COMPLETED|Period 2||0||
59695148|NCT01293006|75814625|FG003|NOT COMPLETED|Period 2||0||
59695149|NCT02335749|75814640|FG000|STARTED|Overall Study||40||
59695150|NCT02335749|75814640|FG000|COMPLETED|Overall Study||40||
59695151|NCT02335749|75814640|FG000|NOT COMPLETED|Overall Study||0||
59695152|NCT01253187|75814644|FG000|STARTED|Period 1||7||
59695153|NCT01253187|75814645|FG001|STARTED|Period 1||8||
59695154|NCT01253187|75814646|FG002|STARTED|Period 1||7||
59695155|NCT01253187|75814647|FG003|STARTED|Period 1||7||
59695156|NCT01253187|75814648|FG004|STARTED|Period 1||9||
59695157|NCT01253187|75814649|FG005|STARTED|Period 1||6||
59695158|NCT01253187|75814644|FG000|COMPLETED|Period 1||7||
59695159|NCT01253187|75814645|FG001|COMPLETED|Period 1||8||
59695160|NCT01253187|75814646|FG002|COMPLETED|Period 1||7||
59695161|NCT01253187|75814647|FG003|COMPLETED|Period 1||7||
59695162|NCT01253187|75814648|FG004|COMPLETED|Period 1||9||
59695163|NCT01253187|75814649|FG005|COMPLETED|Period 1||6||
59695164|NCT01253187|75814644|FG000|NOT COMPLETED|Period 1||0||
59695165|NCT01253187|75814645|FG001|NOT COMPLETED|Period 1||0||
59695166|NCT01253187|75814646|FG002|NOT COMPLETED|Period 1||0||
59695167|NCT01253187|75814647|FG003|NOT COMPLETED|Period 1||0||
59695168|NCT01253187|75814648|FG004|NOT COMPLETED|Period 1||0||
59695169|NCT01253187|75814649|FG005|NOT COMPLETED|Period 1||0||
59695170|NCT01253187|75814644|FG000|STARTED|Period 2||7||
59989929|NCT03377803|76105362|FG000|NOT COMPLETED|Overall Study||11||
59695171|NCT01253187|75814645|FG001|STARTED|Period 2||8||
59695172|NCT01253187|75814646|FG002|STARTED|Period 2||7||
59695173|NCT01253187|75814647|FG003|STARTED|Period 2||7||
59989930|NCT03377803|76105363|FG001|NOT COMPLETED|Overall Study||4||
59989931|NCT03751007|76105381|FG000|STARTED|Overall Study||2||
59989932|NCT03751007|76105382|FG001|STARTED|Overall Study||5||
59989933|NCT03751007|76105383|FG002|STARTED|Overall Study||2||
59695174|NCT01253187|75814648|FG004|STARTED|Period 2||9||
59695175|NCT01253187|75814649|FG005|STARTED|Period 2||6||
59695176|NCT01253187|75814644|FG000|COMPLETED|Period 2||7||
59695177|NCT01253187|75814645|FG001|COMPLETED|Period 2||8||
59695178|NCT01253187|75814646|FG002|COMPLETED|Period 2||7||
59695179|NCT01253187|75814647|FG003|COMPLETED|Period 2||7||
59695180|NCT01253187|75814648|FG004|COMPLETED|Period 2||8||
59695181|NCT01253187|75814649|FG005|COMPLETED|Period 2||6||
59695182|NCT01253187|75814644|FG000|NOT COMPLETED|Period 2||0||
59695183|NCT01253187|75814645|FG001|NOT COMPLETED|Period 2||0||
59695184|NCT01253187|75814646|FG002|NOT COMPLETED|Period 2||0||
59695185|NCT01253187|75814647|FG003|NOT COMPLETED|Period 2||0||
59695186|NCT01253187|75814648|FG004|NOT COMPLETED|Period 2||1||
59695187|NCT01253187|75814649|FG005|NOT COMPLETED|Period 2||0||
59695188|NCT01253187|75814644|FG000|STARTED|Period 3||7||
59695189|NCT01253187|75814645|FG001|STARTED|Period 3||8||
59695190|NCT01253187|75814646|FG002|STARTED|Period 3||7||
59695191|NCT01253187|75814647|FG003|STARTED|Period 3||7||
59695192|NCT01253187|75814648|FG004|STARTED|Period 3||8||
59695193|NCT01253187|75814649|FG005|STARTED|Period 3||6||
59695194|NCT01253187|75814644|FG000|COMPLETED|Period 3||6||
59695195|NCT01253187|75814645|FG001|COMPLETED|Period 3||7||
59695196|NCT01253187|75814646|FG002|COMPLETED|Period 3||7||
59695197|NCT01253187|75814647|FG003|COMPLETED|Period 3||7||
59695198|NCT01253187|75814648|FG004|COMPLETED|Period 3||7||
59695199|NCT01253187|75814649|FG005|COMPLETED|Period 3||6||
59695200|NCT01253187|75814644|FG000|NOT COMPLETED|Period 3||1||
59695201|NCT01253187|75814645|FG001|NOT COMPLETED|Period 3||1||
59695202|NCT01253187|75814646|FG002|NOT COMPLETED|Period 3||0||
59695203|NCT01253187|75814647|FG003|NOT COMPLETED|Period 3||0||
59695204|NCT01253187|75814648|FG004|NOT COMPLETED|Period 3||1||
59695205|NCT01253187|75814649|FG005|NOT COMPLETED|Period 3||0||
59695206|NCT01252563|75814660|FG000|STARTED|Overall Study||13775||
59695207|NCT01252563|75814660|FG000|COMPLETED|Overall Study||13343||
59695208|NCT01252563|75814660|FG000|NOT COMPLETED|Overall Study||432||
59695209|NCT01292226|75814695|FG000|STARTED|Overall Study||45||
59695210|NCT01292226|75814695|FG000|COMPLETED|Overall Study||32||
59695211|NCT01292226|75814695|FG000|NOT COMPLETED|Overall Study||13||
59695212|NCT01290822|75814699|FG000|STARTED|Overall Study||12||
59695213|NCT01290822|75814699|FG000|COMPLETED|Overall Study||1||
59695214|NCT01290822|75814699|FG000|NOT COMPLETED|Overall Study||11||
59695215|NCT01075048|75814706|FG000|STARTED|Overall Study||9||
59695216|NCT01075048|75814707|FG001|STARTED|Overall Study||60||
59695217|NCT01075048|75814708|FG002|STARTED|Overall Study||62||
59695218|NCT01075048|75814706|FG000|Did Not Receive Treatment|Overall Study||0||
59695219|NCT01075048|75814707|FG001|Did Not Receive Treatment|Overall Study||1||
59695220|NCT01075048|75814708|FG002|Did Not Receive Treatment|Overall Study||0||
59695221|NCT01075048|75814706|FG000|COMPLETED|Overall Study||0||
59695222|NCT01075048|75814707|FG001|COMPLETED|Overall Study||0||
59695223|NCT01075048|75814708|FG002|COMPLETED|Overall Study||0||
59695224|NCT01075048|75814706|FG000|NOT COMPLETED|Overall Study||9||
59695225|NCT01075048|75814707|FG001|NOT COMPLETED|Overall Study||60||
59695226|NCT01075048|75814708|FG002|NOT COMPLETED|Overall Study||62||
59695227|NCT01290666|75814719|FG000|STARTED|Overall Study||93||
59695228|NCT01290666|75814719|FG000|COMPLETED|Overall Study||55||
59695229|NCT01290666|75814719|FG000|NOT COMPLETED|Overall Study||38||
59695230|NCT01252251|75814723|FG000|STARTED|Overall Study||14||
59695231|NCT01252251|75814723|FG000|COMPLETED|Overall Study||13||
59695232|NCT01252251|75814723|FG000|NOT COMPLETED|Overall Study||1||
59695233|NCT01289574|75814730|FG000|STARTED|Overall Study||58||
59695234|NCT01289574|75814731|FG001|STARTED|Overall Study||60||
59695235|NCT01289574|75814732|FG002|STARTED|Overall Study||63||
59695236|NCT01289574|75814730|FG000|COMPLETED|Overall Study||51||
59695237|NCT01289574|75814731|FG001|COMPLETED|Overall Study||57||
59695238|NCT01289574|75814732|FG002|COMPLETED|Overall Study||60||
59695239|NCT01289574|75814730|FG000|NOT COMPLETED|Overall Study||7||
59695240|NCT01289574|75814731|FG001|NOT COMPLETED|Overall Study||3||
59695241|NCT01289574|75814732|FG002|NOT COMPLETED|Overall Study||3||
59695242|NCT01252095|75814743|FG000|STARTED|Overall Study||3||
59695243|NCT01252095|75814744|FG001|STARTED|Overall Study||1||
59695244|NCT01252095|75814743|FG000|COMPLETED|Overall Study||2||
59695245|NCT01252095|75814744|FG001|COMPLETED|Overall Study||1||
59695246|NCT01252095|75814743|FG000|NOT COMPLETED|Overall Study||1||
59695247|NCT01252095|75814744|FG001|NOT COMPLETED|Overall Study||0||
59695248|NCT01289418|75814753|FG000|STARTED|Day 8 Survey||6525||
59695249|NCT01289418|75814753|FG000|COMPLETED|Day 8 Survey||4307||
59695250|NCT01289418|75814753|FG000|NOT COMPLETED|Day 8 Survey||2218||
59695251|NCT01289418|75814753|FG000|STARTED|Day 29 Survey||6525||
59695252|NCT01289418|75814753|FG000|COMPLETED|Day 29 Survey||4057||
59695253|NCT01289418|75814753|FG000|NOT COMPLETED|Day 29 Survey||2468||
59695254|NCT01074658|75814759|FG000|STARTED|Overall Study||1015||
59695255|NCT01074658|75814759|FG000|Attempted Implant|Overall Study||996||
59695256|NCT01074658|75814759|FG000|COMPLETED|Overall Study||996||
59695257|NCT01074658|75814759|FG000|NOT COMPLETED|Overall Study||19||
59695258|NCT01074502|75814763|FG000|STARTED|Overall Study||3||
59695259|NCT01074502|75814763|FG000|COMPLETED|Overall Study||2||
59989934|NCT03751007|76105384|FG003|STARTED|Overall Study||5||
59695260|NCT01074502|75814763|FG000|NOT COMPLETED|Overall Study||1||
59695261|NCT01289028|75814767|FG000|STARTED|Overall Study||125||
59695262|NCT01289028|75814767|FG000|COMPLETED|Overall Study||42||
59695263|NCT01289028|75814767|FG000|NOT COMPLETED|Overall Study||83||
59695264|NCT01250925|75814776|FG000|STARTED|Overall Study||31||
59695265|NCT01250925|75814777|FG001|STARTED|Overall Study||31||
59695266|NCT01250925|75814778|FG002|STARTED|Overall Study||32||
59695267|NCT01250925|75814776|FG000|COMPLETED|Overall Study||26||
59695268|NCT01250925|75814777|FG001|COMPLETED|Overall Study||28||
59695269|NCT01250925|75814778|FG002|COMPLETED|Overall Study||30||
59695270|NCT01250925|75814776|FG000|NOT COMPLETED|Overall Study||5||
59695271|NCT01250925|75814777|FG001|NOT COMPLETED|Overall Study||3||
59695272|NCT01250925|75814778|FG002|NOT COMPLETED|Overall Study||2||
59695273|NCT01285908|75814786|FG000|STARTED|Baseline Measurement||6||
59695274|NCT01285908|75814787|FG001|STARTED|Baseline Measurement||0||
59695275|NCT01285908|75814788|FG002|STARTED|Baseline Measurement||0||
59695276|NCT01285908|75814786|FG000|COMPLETED|Baseline Measurement||3||
59695277|NCT01285908|75814787|FG001|COMPLETED|Baseline Measurement||0||
59695278|NCT01285908|75814788|FG002|COMPLETED|Baseline Measurement||0||
59695279|NCT01285908|75814786|FG000|NOT COMPLETED|Baseline Measurement||3||
59695280|NCT01285908|75814787|FG001|NOT COMPLETED|Baseline Measurement||0||
59695281|NCT01285908|75814788|FG002|NOT COMPLETED|Baseline Measurement||0||
59695282|NCT01285908|75814786|FG000|STARTED|Treatment Crossover||0||
59695283|NCT01285908|75814787|FG001|STARTED|Treatment Crossover|One subject in treatment crossover did not complete baseline testing as unable to complete tasks|2||
59695284|NCT01285908|75814788|FG002|STARTED|Treatment Crossover||2||
59695285|NCT01285908|75814786|FG000|COMPLETED|Treatment Crossover||0||
59695286|NCT01285908|75814787|FG001|COMPLETED|Treatment Crossover||2||
59695287|NCT01285908|75814788|FG002|COMPLETED|Treatment Crossover||2||
59695288|NCT01285908|75814786|FG000|NOT COMPLETED|Treatment Crossover||0||
59695289|NCT01285908|75814787|FG001|NOT COMPLETED|Treatment Crossover||0||
59695290|NCT01285908|75814788|FG002|NOT COMPLETED|Treatment Crossover||0||
59695291|NCT01250769|75814822|FG000|STARTED|Overall Study||11||
59695292|NCT01250769|75814823|FG001|STARTED|Overall Study||73||
59695293|NCT01250769|75814824|FG002|STARTED|Overall Study||75||
59695294|NCT01250769|75814825|FG003|STARTED|Overall Study||11||
59695295|NCT01250769|75814822|FG000|Day 14|Overall Study||11||
59695296|NCT01250769|75814823|FG001|Day 14|Overall Study||72||
59695297|NCT01250769|75814824|FG002|Day 14|Overall Study||74||
59695298|NCT01250769|75814825|FG003|Day 14|Overall Study||11||
59695299|NCT01250769|75814822|FG000|COMPLETED|Overall Study||11||
59695300|NCT01250769|75814823|FG001|COMPLETED|Overall Study||72||
59695301|NCT01250769|75814824|FG002|COMPLETED|Overall Study||73||
59695302|NCT01250769|75814825|FG003|COMPLETED|Overall Study||11||
59695303|NCT01250769|75814822|FG000|NOT COMPLETED|Overall Study||0||
59695304|NCT01250769|75814823|FG001|NOT COMPLETED|Overall Study||1||
59695305|NCT01250769|75814824|FG002|NOT COMPLETED|Overall Study||2||
59695306|NCT01250769|75814825|FG003|NOT COMPLETED|Overall Study||0||
59695307|NCT01074268|75814837|FG000|STARTED|Main: Week 0 to 26 (NN1250-3585)||303||
59695308|NCT01074268|75814838|FG001|STARTED|Main: Week 0 to 26 (NN1250-3585)||153||
59695309|NCT01074268|75814837|FG000|Full Analysis Set|Main: Week 0 to 26 (NN1250-3585)|One subject was withdrawn because the subject was randomised in error (screening failure)|302||
59695310|NCT01074268|75814838|FG001|Full Analysis Set|Main: Week 0 to 26 (NN1250-3585)||153||
59695311|NCT01074268|75814837|FG000|Exposed|Main: Week 0 to 26 (NN1250-3585)|Two subjects withdrew prior to exposure to trial drugs|301||
59695312|NCT01074268|75814838|FG001|Exposed|Main: Week 0 to 26 (NN1250-3585)|One subject withdrew prior to exposure to trial drugs|152||
59695313|NCT01074268|75814837|FG000|COMPLETED|Main: Week 0 to 26 (NN1250-3585)||283||
59695314|NCT01074268|75814838|FG001|COMPLETED|Main: Week 0 to 26 (NN1250-3585)||138||
59695315|NCT01074268|75814837|FG000|NOT COMPLETED|Main: Week 0 to 26 (NN1250-3585)||20||
59695316|NCT01074268|75814838|FG001|NOT COMPLETED|Main: Week 0 to 26 (NN1250-3585)||15||
59695317|NCT01074268|75814837|FG000|STARTED|Extension: Week 27 to 52 (NN1250-3725)|Thirty five subjects from main trial did not continue into the extension|248||
59695318|NCT01074268|75814838|FG001|STARTED|Extension: Week 27 to 52 (NN1250-3725)|Sixteen subjects from main trial did not continue into the extension|122||
59695319|NCT01074268|75814837|FG000|COMPLETED|Extension: Week 27 to 52 (NN1250-3725)||242||
59695320|NCT01074268|75814838|FG001|COMPLETED|Extension: Week 27 to 52 (NN1250-3725)||115||
59695321|NCT01074268|75814837|FG000|NOT COMPLETED|Extension: Week 27 to 52 (NN1250-3725)||6||
59695322|NCT01074268|75814838|FG001|NOT COMPLETED|Extension: Week 27 to 52 (NN1250-3725)||7||
59695323|NCT01074190|75814847|FG000|STARTED|Overall Study||115||
59695324|NCT01074190|75814848|FG001|STARTED|Overall Study||115||
59695325|NCT01074190|75814849|FG002|STARTED|Overall Study||115||
59695326|NCT01074190|75814847|FG000|COMPLETED|Overall Study||111||
59695327|NCT01074190|75814848|FG001|COMPLETED|Overall Study||109||
59695328|NCT01074190|75814849|FG002|COMPLETED|Overall Study||112||
59695329|NCT01074190|75814847|FG000|NOT COMPLETED|Overall Study||4||
59695330|NCT01074190|75814848|FG001|NOT COMPLETED|Overall Study||6||
59695331|NCT01074190|75814849|FG002|NOT COMPLETED|Overall Study||3||
59695332|NCT01073566|75814862|FG000|STARTED|Period 1 (6 Weeks)||19||
59695333|NCT01073566|75814863|FG001|STARTED|Period 1 (6 Weeks)||19||
59695334|NCT01073566|75814862|FG000|COMPLETED|Period 1 (6 Weeks)||19||
59695335|NCT01073566|75814863|FG001|COMPLETED|Period 1 (6 Weeks)||19||
59695336|NCT01073566|75814862|FG000|NOT COMPLETED|Period 1 (6 Weeks)||0||
59695337|NCT01073566|75814863|FG001|NOT COMPLETED|Period 1 (6 Weeks)||0||
59695338|NCT01073566|75814862|FG000|STARTED|Period 2 (6 Weeks)||19||
59695339|NCT01073566|75814863|FG001|STARTED|Period 2 (6 Weeks)||19||
59695340|NCT01073566|75814862|FG000|COMPLETED|Period 2 (6 Weeks)||18||
59695341|NCT01073566|75814863|FG001|COMPLETED|Period 2 (6 Weeks)||19||
59695342|NCT01073566|75814862|FG000|NOT COMPLETED|Period 2 (6 Weeks)||1||
59695343|NCT01073566|75814863|FG001|NOT COMPLETED|Period 2 (6 Weeks)||0||
59695344|NCT01072396|75814871|FG000|STARTED|Period One||63||
59695345|NCT01072396|75814872|FG001|STARTED|Period One||63||
59695346|NCT01072396|75814871|FG000|COMPLETED|Period One||58||
59695347|NCT01072396|75814872|FG001|COMPLETED|Period One||61||
59695348|NCT01072396|75814871|FG000|NOT COMPLETED|Period One||5||
59695349|NCT01072396|75814872|FG001|NOT COMPLETED|Period One||2||
59695350|NCT01072396|75814871|FG000|STARTED|Washout Period||58||
59695351|NCT01072396|75814872|FG001|STARTED|Washout Period||61||
59695352|NCT01072396|75814871|FG000|COMPLETED|Washout Period||58||
59695353|NCT01072396|75814872|FG001|COMPLETED|Washout Period||60||
59695354|NCT01072396|75814871|FG000|NOT COMPLETED|Washout Period||0||
59695355|NCT01072396|75814872|FG001|NOT COMPLETED|Washout Period||1||
59695356|NCT01072396|75814871|FG000|STARTED|Period Two||58||
59695357|NCT01072396|75814872|FG001|STARTED|Period Two||60||
59695358|NCT01072396|75814871|FG000|COMPLETED|Period Two||57||
59695359|NCT01072396|75814872|FG001|COMPLETED|Period Two||57||
59695360|NCT01072396|75814871|FG000|NOT COMPLETED|Period Two||1||
59695361|NCT01072396|75814872|FG001|NOT COMPLETED|Period Two||3||
59695362|NCT01045096|75814881|FG000|STARTED|Overall Study||12||
59695363|NCT01045096|75814882|FG001|STARTED|Overall Study||12||
59695364|NCT01045096|75814883|FG002|STARTED|Overall Study||12||
59695365|NCT01045096|75814881|FG000|Pharmacokinetic Set|Overall Study|All patients with at least one estimable PK parameter for dexlansoprazole on Day 7.|9||
59695366|NCT01045096|75814882|FG001|Pharmacokinetic Set|Overall Study||11||
59695367|NCT01045096|75814883|FG002|Pharmacokinetic Set|Overall Study||11||
59695368|NCT01045096|75814881|FG000|COMPLETED|Overall Study||9||
59695369|NCT01045096|75814882|FG001|COMPLETED|Overall Study||12||
59695370|NCT01045096|75814883|FG002|COMPLETED|Overall Study||12||
59695371|NCT01045096|75814881|FG000|NOT COMPLETED|Overall Study||3||
59695372|NCT01045096|75814882|FG001|NOT COMPLETED|Overall Study||0||
59695373|NCT01045096|75814883|FG002|NOT COMPLETED|Overall Study||0||
59695374|NCT01285518|75814899|FG000|STARTED|Overall Study||10||
59695375|NCT01285518|75814900|FG001|STARTED|Overall Study||10||
59695376|NCT01285518|75814901|FG002|STARTED|Overall Study||10||
59695377|NCT01285518|75814902|FG003|STARTED|Overall Study||10||
59695378|NCT01285518|75814903|FG004|STARTED|Overall Study||10||
59695379|NCT01285518|75814904|FG005|STARTED|Overall Study||10||
59695380|NCT01285518|75814905|FG006|STARTED|Overall Study||10||
59695381|NCT01285518|75814906|FG007|STARTED|Overall Study||14||
59695382|NCT01285518|75814899|FG000|COMPLETED|Overall Study||10||
59695383|NCT01285518|75814900|FG001|COMPLETED|Overall Study||10||
59695384|NCT01285518|75814901|FG002|COMPLETED|Overall Study||10||
59695385|NCT01285518|75814902|FG003|COMPLETED|Overall Study||10||
59695386|NCT01285518|75814903|FG004|COMPLETED|Overall Study||10||
59695387|NCT01285518|75814904|FG005|COMPLETED|Overall Study||9||
59695388|NCT01285518|75814905|FG006|COMPLETED|Overall Study||10||
59695389|NCT01285518|75814906|FG007|COMPLETED|Overall Study||14||
59695390|NCT01285518|75814899|FG000|NOT COMPLETED|Overall Study||0||
59695391|NCT01285518|75814900|FG001|NOT COMPLETED|Overall Study||0||
59695392|NCT01285518|75814901|FG002|NOT COMPLETED|Overall Study||0||
59695393|NCT01285518|75814902|FG003|NOT COMPLETED|Overall Study||0||
59695394|NCT01285518|75814903|FG004|NOT COMPLETED|Overall Study||0||
59695395|NCT01285518|75814904|FG005|NOT COMPLETED|Overall Study||1||
59695396|NCT01285518|75814905|FG006|NOT COMPLETED|Overall Study||0||
59695397|NCT01285518|75814906|FG007|NOT COMPLETED|Overall Study||0||
59695398|NCT01073020|75814929|FG000|STARTED|Overall Study||23||
59695399|NCT01073020|75814930|FG001|STARTED|Overall Study||22||
59695400|NCT01073020|75814931|FG002|STARTED|Overall Study||22||
59695401|NCT01073020|75814932|FG003|STARTED|Overall Study||21||
59695402|NCT01073020|75814929|FG000|COMPLETED|Overall Study||16||
59695403|NCT01073020|75814930|FG001|COMPLETED|Overall Study||17||
59695404|NCT01073020|75814931|FG002|COMPLETED|Overall Study||19||
59695405|NCT01073020|75814932|FG003|COMPLETED|Overall Study||19||
59695406|NCT01073020|75814929|FG000|NOT COMPLETED|Overall Study||7||
59695407|NCT01073020|75814930|FG001|NOT COMPLETED|Overall Study||5||
59695408|NCT01073020|75814931|FG002|NOT COMPLETED|Overall Study||3||
59695409|NCT01073020|75814932|FG003|NOT COMPLETED|Overall Study||2||
59695410|NCT01284114|75814942|FG000|STARTED|Overall Study||23||
59695411|NCT01284114|75814942|FG000|COMPLETED|Overall Study||19||
59695412|NCT01284114|75814942|FG000|NOT COMPLETED|Overall Study||4||
59695413|NCT01283334|75814947|FG000|STARTED|Overall Study||20||
59695414|NCT01283334|75814947|FG000|COMPLETED|Overall Study||13||
59695415|NCT01283334|75814947|FG000|NOT COMPLETED|Overall Study||7||
59695416|NCT01282866|75814953|FG000|STARTED|Overall Study||35||
59816156|NCT00613925|75938516|FG000|COMPLETED|Overall Study||37||
59989935|NCT03751007|76105385|FG004|STARTED|Overall Study||2||
59695417|NCT01282866|75814953|FG000|COMPLETED|Overall Study||34||
59695418|NCT01282866|75814953|FG000|NOT COMPLETED|Overall Study||1||
59695419|NCT01071070|75814959|FG000|STARTED|Overall Study||108||
59695420|NCT01071070|75814960|FG001|STARTED|Overall Study||108||
59695421|NCT01071070|75814959|FG000|COMPLETED|Overall Study||104||
59695422|NCT01071070|75814960|FG001|COMPLETED|Overall Study||105||
59695423|NCT01071070|75814959|FG000|NOT COMPLETED|Overall Study||4||
59816157|NCT00613925|75938517|FG001|COMPLETED|Overall Study||32||
59695424|NCT01071070|75814960|FG001|NOT COMPLETED|Overall Study||3||
59695425|NCT01282476|75814966|FG000|STARTED|Overall Study||18||
59695426|NCT01282476|75814966|FG000|COMPLETED|Overall Study||7||
59695427|NCT01282476|75814966|FG000|NOT COMPLETED|Overall Study||11||
59695428|NCT01282164|75814972|FG000|STARTED|Overall Study||29||
59695429|NCT01282164|75814973|FG001|STARTED|Overall Study||14||
59695430|NCT01282164|75814972|FG000|COMPLETED|Overall Study||28||
59695431|NCT01282164|75814973|FG001|COMPLETED|Overall Study||14||
59695432|NCT01282164|75814972|FG000|NOT COMPLETED|Overall Study||1||
59695433|NCT01282164|75814973|FG001|NOT COMPLETED|Overall Study||0||
59695434|NCT01250379|75814989|FG000|STARTED|Overall Study||247||
59695435|NCT01250379|75814990|FG001|STARTED|Overall Study||247||
59695436|NCT01250379|75814989|FG000|COMPLETED|Overall Study|Participants under study follow-up as of Data Cutoff 30 April 2015 were considered as completers.|45||
59695437|NCT01250379|75814990|FG001|COMPLETED|Overall Study|Participants under study follow-up as of Data Cutoff 30 April 2015 were considered as completers.|54||
59695438|NCT01250379|75814989|FG000|NOT COMPLETED|Overall Study||202||
59695439|NCT01250379|75814990|FG001|NOT COMPLETED|Overall Study||193||
59695440|NCT01072630|75814999|FG000|STARTED|Overall Study||230||
59695441|NCT01072630|75815000|FG001|STARTED|Overall Study||232||
59695442|NCT01072630|75815001|FG002|STARTED|Overall Study||30||
59695443|NCT01072630|75814999|FG000|Safety Population|Overall Study|Treated participants. One participant was randomized but not treated.|229||
59695444|NCT01072630|75815000|FG001|Safety Population|Overall Study|Treated participants. One participant was randomized but not treated.|231||
59695445|NCT01072630|75815001|FG002|Safety Population|Overall Study|Treated participants.|30||
59695446|NCT01072630|75814999|FG000|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|224||
59695447|NCT01072630|75815000|FG001|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|230||
59695448|NCT01072630|75815001|FG002|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|28||
59695449|NCT01072630|75814999|FG000|COMPLETED|Overall Study||175||
59695450|NCT01072630|75815000|FG001|COMPLETED|Overall Study||172||
59695451|NCT01072630|75815001|FG002|COMPLETED|Overall Study||17||
59695452|NCT01072630|75814999|FG000|NOT COMPLETED|Overall Study||55||
59695453|NCT01072630|75815000|FG001|NOT COMPLETED|Overall Study||60||
59695454|NCT01072630|75815001|FG002|NOT COMPLETED|Overall Study||13||
59695455|NCT01281306|75815017|FG000|STARTED|Overall Study||144||
59695456|NCT01281306|75815018|FG001|STARTED|Overall Study||145||
59695457|NCT01281306|75815019|FG002|STARTED|Overall Study||141||
59695458|NCT01281306|75815020|FG003|STARTED|Overall Study||134||
59695459|NCT01281306|75815021|FG004|STARTED|Overall Study||143||
59695460|NCT01281306|75815022|FG005|STARTED|Overall Study||142||
59695461|NCT01281306|75815023|FG006|STARTED|Overall Study||58||
59695462|NCT01281306|75815017|FG000|Full Analysis Set|Overall Study||143||
59695463|NCT01281306|75815018|FG001|Full Analysis Set|Overall Study||145||
59695464|NCT01281306|75815019|FG002|Full Analysis Set|Overall Study||141||
59695465|NCT01281306|75815020|FG003|Full Analysis Set|Overall Study||133||
59695466|NCT01281306|75815021|FG004|Full Analysis Set|Overall Study||143||
59695467|NCT01281306|75815022|FG005|Full Analysis Set|Overall Study||142||
59695468|NCT01281306|75815023|FG006|Full Analysis Set|Overall Study||58||
59695469|NCT01281306|75815017|FG000|Safety Set|Overall Study||143||
59695470|NCT01281306|75815018|FG001|Safety Set|Overall Study||145||
59695471|NCT01281306|75815019|FG002|Safety Set|Overall Study||141||
59695472|NCT01281306|75815020|FG003|Safety Set|Overall Study||133||
59695473|NCT01281306|75815021|FG004|Safety Set|Overall Study||143||
59695474|NCT01281306|75815022|FG005|Safety Set|Overall Study||142||
59695475|NCT01281306|75815023|FG006|Safety Set|Overall Study||58||
59695476|NCT01281306|75815017|FG000|Ambulatory Blood Pressure Monitoring Set|Overall Study||95||
59695477|NCT01281306|75815018|FG001|Ambulatory Blood Pressure Monitoring Set|Overall Study||99||
59695478|NCT01281306|75815019|FG002|Ambulatory Blood Pressure Monitoring Set|Overall Study||92||
59695479|NCT01281306|75815020|FG003|Ambulatory Blood Pressure Monitoring Set|Overall Study||95||
59695480|NCT01281306|75815021|FG004|Ambulatory Blood Pressure Monitoring Set|Overall Study||93||
59695481|NCT01281306|75815022|FG005|Ambulatory Blood Pressure Monitoring Set|Overall Study||91||
59695482|NCT01281306|75815023|FG006|Ambulatory Blood Pressure Monitoring Set|Overall Study||35||
59695483|NCT01281306|75815017|FG000|COMPLETED|Overall Study||136||
59695484|NCT01281306|75815018|FG001|COMPLETED|Overall Study||141||
59695485|NCT01281306|75815019|FG002|COMPLETED|Overall Study||133||
59695486|NCT01281306|75815020|FG003|COMPLETED|Overall Study||123||
59695487|NCT01281306|75815021|FG004|COMPLETED|Overall Study||134||
59695488|NCT01281306|75815022|FG005|COMPLETED|Overall Study||135||
59695489|NCT01281306|75815023|FG006|COMPLETED|Overall Study||51||
59816158|NCT00613925|75938516|FG000|NOT COMPLETED|Overall Study||0||
59816159|NCT00613925|75938517|FG001|NOT COMPLETED|Overall Study||1||
59816160|NCT00613301|75938523|FG000|STARTED|Overall Study||416||
59816161|NCT00613301|75938523|FG000|COMPLETED|Overall Study||188||
59989936|NCT03751007|76105386|FG005|STARTED|Overall Study||4||
59989937|NCT03751007|76105387|FG006|STARTED|Overall Study||2||
59989938|NCT03751007|76105388|FG007|STARTED|Overall Study||5||
59989939|NCT03751007|76105389|FG008|STARTED|Overall Study||10||
59989940|NCT03751007|76105390|FG009|STARTED|Overall Study||2||
59989941|NCT03751007|76105391|FG010|STARTED|Overall Study||5||
59989942|NCT03751007|76105392|FG011|STARTED|Overall Study||1||
59695490|NCT01281306|75815017|FG000|NOT COMPLETED|Overall Study||8||
59695491|NCT01281306|75815018|FG001|NOT COMPLETED|Overall Study||4||
59695492|NCT01281306|75815019|FG002|NOT COMPLETED|Overall Study||8||
59695493|NCT01281306|75815020|FG003|NOT COMPLETED|Overall Study||11||
59695494|NCT01281306|75815021|FG004|NOT COMPLETED|Overall Study||9||
59695495|NCT01281306|75815022|FG005|NOT COMPLETED|Overall Study||7||
59695496|NCT01281306|75815023|FG006|NOT COMPLETED|Overall Study||7||
59695497|NCT01250145|75815041|FG000|STARTED|Overall Study||41||
59816162|NCT00613301|75938523|FG000|NOT COMPLETED|Overall Study||228||
59989943|NCT03751007|76105381|FG000|COMPLETED|Overall Study||2||
59695498|NCT01250145|75815042|FG001|STARTED|Overall Study||210||
59695499|NCT01250145|75815041|FG000|COMPLETED|Overall Study||39||
59695500|NCT01250145|75815042|FG001|COMPLETED|Overall Study||205||
59695501|NCT01250145|75815041|FG000|NOT COMPLETED|Overall Study||2||
59695502|NCT01250145|75815042|FG001|NOT COMPLETED|Overall Study||5||
59695503|NCT01067326|75815064|FG000|STARTED|Overall Study||14||
59695504|NCT01067326|75815065|FG001|STARTED|Overall Study||8||
59695505|NCT01067326|75815064|FG000|COMPLETED|Overall Study||12||
59695506|NCT01067326|75815065|FG001|COMPLETED|Overall Study||5||
59695507|NCT01067326|75815064|FG000|NOT COMPLETED|Overall Study||2||
59695508|NCT01067326|75815065|FG001|NOT COMPLETED|Overall Study||3||
59695509|NCT01279200|75815073|FG000|STARTED|Overall Study||10||
59695510|NCT01279200|75815074|FG001|STARTED|Overall Study||11||
59695511|NCT01279200|75815073|FG000|COMPLETED|Overall Study||8||
59695512|NCT01279200|75815074|FG001|COMPLETED|Overall Study||4||
59695513|NCT01279200|75815073|FG000|NOT COMPLETED|Overall Study||2||
60079480|NCT04206332|76194714|FG014|Completed Controlled Human Malaria Infection (CHMI)|Part B||0||
60079481|NCT04206332|76194715|FG015|Completed Controlled Human Malaria Infection (CHMI)|Part B||0||
60079482|NCT04206332|76194716|FG016|Completed Controlled Human Malaria Infection (CHMI)|Part B||0||
60079483|NCT04206332|76194700|FG000|COMPLETED|Part B||0||
60079484|NCT04206332|76194701|FG001|COMPLETED|Part B||0||
60079485|NCT04206332|76194702|FG002|COMPLETED|Part B||0||
60079486|NCT04206332|76194703|FG003|COMPLETED|Part B||0||
60079487|NCT04206332|76194704|FG004|COMPLETED|Part B||0||
60079488|NCT04206332|76194705|FG005|COMPLETED|Part B||0||
60079489|NCT04206332|76194706|FG006|COMPLETED|Part B||0||
60079490|NCT04206332|76194707|FG007|COMPLETED|Part B||4||
60079491|NCT04206332|76194708|FG008|COMPLETED|Part B||2||
60079492|NCT04206332|76194709|FG009|COMPLETED|Part B||4||
60079493|NCT04206332|76194710|FG010|COMPLETED|Part B||6||
60079494|NCT04206332|76194711|FG011|COMPLETED|Part B||0||
60079495|NCT04206332|76194712|FG012|COMPLETED|Part B||0||
60079496|NCT04206332|76194713|FG013|COMPLETED|Part B||0||
60079497|NCT04206332|76194714|FG014|COMPLETED|Part B||0||
60079498|NCT04206332|76194715|FG015|COMPLETED|Part B||0||
60079499|NCT04206332|76194716|FG016|COMPLETED|Part B||0||
60079500|NCT04206332|76194700|FG000|NOT COMPLETED|Part B||0||
60079501|NCT04206332|76194701|FG001|NOT COMPLETED|Part B||0||
60079502|NCT04206332|76194702|FG002|NOT COMPLETED|Part B||0||
60079503|NCT04206332|76194703|FG003|NOT COMPLETED|Part B||0||
60079504|NCT04206332|76194704|FG004|NOT COMPLETED|Part B||0||
59565849|NCT04392219|75668291|FG001|STARTED|Overall Study||6||
59695514|NCT01279200|75815074|FG001|NOT COMPLETED|Overall Study||7||
59695515|NCT01273818|75815083|FG000|STARTED|Overall Study||100||
59695516|NCT01273818|75815084|FG001|STARTED|Overall Study||100||
59695517|NCT01273818|75815085|FG002|STARTED|Overall Study||100||
59695518|NCT01273818|75815083|FG000|COMPLETED|Overall Study||87||
59695519|NCT01273818|75815084|FG001|COMPLETED|Overall Study||98||
59695520|NCT01273818|75815085|FG002|COMPLETED|Overall Study||91||
59695521|NCT01273818|75815083|FG000|NOT COMPLETED|Overall Study||13||
60079505|NCT04206332|76194705|FG005|NOT COMPLETED|Part B||0||
59565850|NCT04392219|75668292|FG002|STARTED|Overall Study||6||
59565851|NCT04392219|75668293|FG003|STARTED|Overall Study||6||
59565852|NCT04392219|75668294|FG004|STARTED|Overall Study||6||
59565853|NCT04392219|75668295|FG005|STARTED|Overall Study||6||
59565854|NCT04392219|75668296|FG006|STARTED|Overall Study||6||
59565855|NCT04392219|75668297|FG007|STARTED|Overall Study||6||
59565856|NCT04392219|75668298|FG008|STARTED|Overall Study||6||
59565857|NCT04392219|75668299|FG009|STARTED|Overall Study||10||
59565858|NCT04392219|75668300|FG010|STARTED|Overall Study||14||
59565859|NCT04392219|75668301|FG011|STARTED|Overall Study||6||
59565860|NCT04392219|75668302|FG012|STARTED|Overall Study||6||
59565861|NCT04392219|75668303|FG013|STARTED|Overall Study||6||
59565862|NCT04392219|75668304|FG014|STARTED|Overall Study||6||
59565863|NCT04392219|75668305|FG015|STARTED|Overall Study||6||
59565864|NCT04392219|75668306|FG016|STARTED|Overall Study||6||
59565865|NCT04392219|75668307|FG017|STARTED|Overall Study||6||
59565866|NCT04392219|75668290|FG000|COMPLETED|Overall Study||16||
59565867|NCT04392219|75668291|FG001|COMPLETED|Overall Study||6||
59547717|NCT02533089|75646595|FG000|COMPLETED|Overall Study|4 HC accrued no eligable patients 11 HC no patients with outcome data 241 cases missing outcome|364||36
59547718|NCT02533089|75646596|FG001|COMPLETED|Overall Study|6 HC accrued no eligible patients 8 HC no patients with outcome data 114 cases missing outcome|434||38
59695522|NCT01273818|75815084|FG001|NOT COMPLETED|Overall Study||2||
59547719|NCT02533089|75646595|FG000|NOT COMPLETED|Overall Study||241||15
59547720|NCT02533089|75646596|FG001|NOT COMPLETED|Overall Study||114||14
59547721|NCT02533167|75646602|FG000|STARTED|Overall Study||70||
59547722|NCT02533167|75646602|FG000|COMPLETED|Overall Study||55||
59547723|NCT02533167|75646602|FG000|NOT COMPLETED|Overall Study||15||
59547724|NCT02538783|75646609|FG000|STARTED|Overall Study||130||
59547725|NCT02538783|75646610|FG001|STARTED|Overall Study||129||
59547726|NCT02538783|75646609|FG000|COMPLETED|Overall Study||130||
59547727|NCT02538783|75646610|FG001|COMPLETED|Overall Study||128||
59547728|NCT02538783|75646609|FG000|NOT COMPLETED|Overall Study||0||
59547729|NCT02538783|75646610|FG001|NOT COMPLETED|Overall Study||1||
59547730|NCT02471313|75646616|FG000|STARTED|Overall Study||3||
59547731|NCT02471313|75646616|FG000|COMPLETED|Overall Study||3||
59547732|NCT02471313|75646616|FG000|NOT COMPLETED|Overall Study||0||
59547733|NCT02542761|75646620|FG000|STARTED|Acclimation Period 1||5||
59547734|NCT02542761|75646621|FG001|STARTED|Acclimation Period 1||5||
59547735|NCT02542761|75646620|FG000|COMPLETED|Acclimation Period 1||5||
59547736|NCT02542761|75646621|FG001|COMPLETED|Acclimation Period 1||5||
59695523|NCT01273818|75815085|FG002|NOT COMPLETED|Overall Study||9||
59695524|NCT01245387|75815093|FG000|STARTED|Overall Study||1001||
59547737|NCT02542761|75646620|FG000|NOT COMPLETED|Acclimation Period 1||0||
59547738|NCT02542761|75646621|FG001|NOT COMPLETED|Acclimation Period 1||0||
59547739|NCT02542761|75646620|FG000|STARTED|First Intervention||5||
59547740|NCT02542761|75646621|FG001|STARTED|First Intervention||5||
59547741|NCT02542761|75646620|FG000|COMPLETED|First Intervention||5||
59695525|NCT01245387|75815093|FG000|COMPLETED|Overall Study||188||
59695526|NCT01245387|75815093|FG000|NOT COMPLETED|Overall Study||813||
59695527|NCT01037218|75815101|FG000|STARTED|Overall Study||147||
59695528|NCT01037218|75815102|FG001|STARTED|Overall Study||149||
59695529|NCT01037218|75815103|FG002|STARTED|Overall Study||155||
59695530|NCT01037218|75815104|FG003|STARTED|Overall Study||150||
59695531|NCT01037218|75815101|FG000|Safety Population|Overall Study||147||
59695532|NCT01037218|75815102|FG001|Safety Population|Overall Study||148||
59695533|NCT01037218|75815103|FG002|Safety Population|Overall Study||154||
59695534|NCT01037218|75815104|FG003|Safety Population|Overall Study||150||
59695535|NCT01037218|75815101|FG000|mITT Population|Overall Study||141||
59695536|NCT01037218|75815102|FG001|mITT Population|Overall Study||140||
59695537|NCT01037218|75815103|FG002|mITT Population|Overall Study||147||
59695538|NCT01037218|75815104|FG003|mITT Population|Overall Study||141||
59695539|NCT01037218|75815101|FG000|COMPLETED|Overall Study||131||
59547742|NCT02542761|75646621|FG001|COMPLETED|First Intervention||5||
59547743|NCT02542761|75646620|FG000|NOT COMPLETED|First Intervention||0||
59547744|NCT02542761|75646621|FG001|NOT COMPLETED|First Intervention||0||
59547745|NCT02542761|75646620|FG000|STARTED|Acclimation Period 2||5||
59547746|NCT02542761|75646621|FG001|STARTED|Acclimation Period 2||5||
59547747|NCT02542761|75646620|FG000|COMPLETED|Acclimation Period 2||5||
59695540|NCT01037218|75815102|FG001|COMPLETED|Overall Study||128||
59695541|NCT01037218|75815103|FG002|COMPLETED|Overall Study||134||
59695542|NCT01037218|75815104|FG003|COMPLETED|Overall Study||134||
59695543|NCT01037218|75815101|FG000|NOT COMPLETED|Overall Study||16||
59695544|NCT01037218|75815102|FG001|NOT COMPLETED|Overall Study||21||
59695545|NCT01037218|75815103|FG002|NOT COMPLETED|Overall Study||21||
59695546|NCT01037218|75815104|FG003|NOT COMPLETED|Overall Study||16||
59695547|NCT01038856|75815114|FG000|STARTED|Overall Study||5||
59695548|NCT01038856|75815114|FG000|COMPLETED|Overall Study||3||
59695549|NCT01038856|75815114|FG000|NOT COMPLETED|Overall Study||2||
59695550|NCT01066546|75815120|FG000|STARTED|Overall Study||5||
59695551|NCT01066546|75815120|FG000|COMPLETED|Overall Study||0||
59695552|NCT01066546|75815120|FG000|NOT COMPLETED|Overall Study||5||
59695553|NCT01272804|75815130|FG000|STARTED|Overall Study||9||
59816163|NCT00609947|75938528|FG000|STARTED|Overall Study||241||
59547748|NCT02542761|75646621|FG001|COMPLETED|Acclimation Period 2||5||
59547749|NCT02542761|75646620|FG000|NOT COMPLETED|Acclimation Period 2||0||
59547750|NCT02542761|75646621|FG001|NOT COMPLETED|Acclimation Period 2||0||
59547751|NCT02542761|75646620|FG000|STARTED|Second Intervention||5||
59695554|NCT01272804|75815131|FG001|STARTED|Overall Study||9||
59695555|NCT01272804|75815132|FG002|STARTED|Overall Study||9||
59695556|NCT01272804|75815133|FG003|STARTED|Overall Study||9||
59695557|NCT01272804|75815134|FG004|STARTED|Overall Study||9||
59695558|NCT01272804|75815135|FG005|STARTED|Overall Study||16||
59695559|NCT01272804|75815130|FG000|COMPLETED|Overall Study||8||
59695560|NCT01272804|75815131|FG001|COMPLETED|Overall Study||9||
59695561|NCT01272804|75815132|FG002|COMPLETED|Overall Study||9||
59695562|NCT01272804|75815133|FG003|COMPLETED|Overall Study||9||
59695563|NCT01272804|75815134|FG004|COMPLETED|Overall Study||7||
59695564|NCT01272804|75815135|FG005|COMPLETED|Overall Study||15||
59695565|NCT01272804|75815130|FG000|NOT COMPLETED|Overall Study||1||
59695566|NCT01272804|75815131|FG001|NOT COMPLETED|Overall Study||0||
59695567|NCT01272804|75815132|FG002|NOT COMPLETED|Overall Study||0||
59695568|NCT01272804|75815133|FG003|NOT COMPLETED|Overall Study||0||
59695569|NCT01272804|75815134|FG004|NOT COMPLETED|Overall Study||2||
59695570|NCT01272804|75815135|FG005|NOT COMPLETED|Overall Study||1||
59695571|NCT01269918|75815151|FG000|STARTED|Overall Study||71||
59695572|NCT01269918|75815152|FG001|STARTED|Overall Study||71||
59695573|NCT01269918|75815151|FG000|COMPLETED|Overall Study||71||
59695574|NCT01269918|75815152|FG001|COMPLETED|Overall Study||68||
59695575|NCT01269918|75815151|FG000|NOT COMPLETED|Overall Study||0||
59695576|NCT01269918|75815152|FG001|NOT COMPLETED|Overall Study||3||
59695577|NCT01036594|75815158|FG000|STARTED|Run-In: Ketoconazole Only (200 mg)||32||
59695578|NCT01036594|75815159|FG001|STARTED|Run-In: Ketoconazole Only (200 mg)|Dexamethasone not introduced as treatment option until after Week 12 evaluation|0||
59695579|NCT01036594|75815158|FG000|COMPLETED|Run-In: Ketoconazole Only (200 mg)||31||
59695580|NCT01036594|75815159|FG001|COMPLETED|Run-In: Ketoconazole Only (200 mg)||0||
59695581|NCT01036594|75815158|FG000|NOT COMPLETED|Run-In: Ketoconazole Only (200 mg)||1||
59547752|NCT02542761|75646621|FG001|STARTED|Second Intervention||5||
59695582|NCT01036594|75815159|FG001|NOT COMPLETED|Run-In: Ketoconazole Only (200 mg)||0||
59695583|NCT01036594|75815158|FG000|STARTED|First Treatment Regimen||31||
59695584|NCT01036594|75815159|FG001|STARTED|First Treatment Regimen|Dexamethasone not introduced as treatment option until after Week 12 evaluation|0||
59695585|NCT01036594|75815158|FG000|COMPLETED|First Treatment Regimen||30||
59695586|NCT01036594|75815159|FG001|COMPLETED|First Treatment Regimen||0||
59695587|NCT01036594|75815158|FG000|NOT COMPLETED|First Treatment Regimen||1||
59695588|NCT01036594|75815159|FG001|NOT COMPLETED|First Treatment Regimen||0||
59695589|NCT01036594|75815158|FG000|STARTED|Week 12 Evaluation||30||
59547753|NCT02542761|75646620|FG000|COMPLETED|Second Intervention||5||
59547754|NCT02542761|75646621|FG001|COMPLETED|Second Intervention||5||
59695590|NCT01036594|75815159|FG001|STARTED|Week 12 Evaluation|Dexamethasone not introduced as treatment option until after Week 12 evaluation|0||
59695591|NCT01036594|75815158|FG000|COMPLETED|Week 12 Evaluation||24||
59816164|NCT00609947|75938528|FG000|COMPLETED|Overall Study|One death due to automobile accident.|240||
59695592|NCT01036594|75815159|FG001|COMPLETED|Week 12 Evaluation||0||
59695593|NCT01036594|75815158|FG000|NOT COMPLETED|Week 12 Evaluation||6||
59695594|NCT01036594|75815159|FG001|NOT COMPLETED|Week 12 Evaluation||0||
59695595|NCT01036594|75815158|FG000|STARTED|Treatment Regiments Post Week 12||15||
59695596|NCT01036594|75815159|FG001|STARTED|Treatment Regiments Post Week 12||9||
59695597|NCT01036594|75815158|FG000|COMPLETED|Treatment Regiments Post Week 12||13||
59695598|NCT01036594|75815159|FG001|COMPLETED|Treatment Regiments Post Week 12||5||
59695599|NCT01036594|75815158|FG000|NOT COMPLETED|Treatment Regiments Post Week 12||2||
59695600|NCT01036594|75815159|FG001|NOT COMPLETED|Treatment Regiments Post Week 12||4||
59695601|NCT01036438|75815167|FG000|STARTED|Overall Study||101||
59695602|NCT01036438|75815168|FG001|STARTED|Overall Study||100||
59695603|NCT01036438|75815167|FG000|COMPLETED|Overall Study||91||
59695604|NCT01036438|75815168|FG001|COMPLETED|Overall Study||90||
59695605|NCT01036438|75815167|FG000|NOT COMPLETED|Overall Study||10||
59695606|NCT01036438|75815168|FG001|NOT COMPLETED|Overall Study||10||
59695607|NCT01268046|75815178|FG000|STARTED|Overall Study||13||
59695608|NCT01268046|75815179|FG001|STARTED|Overall Study||9||
59695609|NCT01268046|75815180|FG002|STARTED|Overall Study||8||
59695610|NCT01268046|75815181|FG003|STARTED|Overall Study||8||
59695611|NCT01268046|75815178|FG000|COMPLETED|Overall Study||12||
59695612|NCT01268046|75815179|FG001|COMPLETED|Overall Study||9||
59695613|NCT01268046|75815180|FG002|COMPLETED|Overall Study||7||
59695614|NCT01268046|75815181|FG003|COMPLETED|Overall Study||7||
59695615|NCT01268046|75815178|FG000|NOT COMPLETED|Overall Study||1||
59695616|NCT01268046|75815179|FG001|NOT COMPLETED|Overall Study||0||
59695617|NCT01268046|75815180|FG002|NOT COMPLETED|Overall Study||1||
59695618|NCT01268046|75815181|FG003|NOT COMPLETED|Overall Study||1||
59695619|NCT01267266|75815191|FG000|STARTED|Enrollment Phase||33||
59695620|NCT01267266|75815192|FG001|STARTED|Enrollment Phase||0||
59695621|NCT01267266|75815191|FG000|COMPLETED|Enrollment Phase|Two patients signed consent but did not proceed to treatment.|31||
59695622|NCT01267266|75815192|FG001|COMPLETED|Enrollment Phase||0||
59695623|NCT01267266|75815191|FG000|NOT COMPLETED|Enrollment Phase||2||
59695624|NCT01267266|75815192|FG001|NOT COMPLETED|Enrollment Phase||0||
59695625|NCT01267266|75815191|FG000|STARTED|Lead-in Phase||31||
59695626|NCT01267266|75815192|FG001|STARTED|Lead-in Phase||0||
59695627|NCT01267266|75815191|FG000|COMPLETED|Lead-in Phase|12 patients had radiographic progression, 8 clinical progression, 2 toxicity, 1 withdrawal.|8||
59695628|NCT01267266|75815192|FG001|COMPLETED|Lead-in Phase||0||
59695629|NCT01267266|75815191|FG000|NOT COMPLETED|Lead-in Phase||23||
59695630|NCT01267266|75815192|FG001|NOT COMPLETED|Lead-in Phase||0||
59695631|NCT01267266|75815191|FG000|STARTED|Randomized Phase|3 of 8 patients randomized to saracatinib.|3||
59695632|NCT01267266|75815192|FG001|STARTED|Randomized Phase|5 of 8 patients randomized to placebo.|5||
59695633|NCT01267266|75815191|FG000|COMPLETED|Randomized Phase||3||
59695634|NCT01267266|75815192|FG001|COMPLETED|Randomized Phase||5||
59695635|NCT01267266|75815191|FG000|NOT COMPLETED|Randomized Phase||0||
59547755|NCT02542761|75646620|FG000|NOT COMPLETED|Second Intervention||0||
59547756|NCT02542761|75646621|FG001|NOT COMPLETED|Second Intervention||0||
59547757|NCT02474901|75646629|FG000|STARTED|Overall Study||45||
59547758|NCT02474901|75646630|FG001|STARTED|Overall Study||56||
59547759|NCT02474901|75646629|FG000|COMPLETED|Overall Study||44||
59547760|NCT02474901|75646630|FG001|COMPLETED|Overall Study||56||
59547761|NCT02474901|75646629|FG000|NOT COMPLETED|Overall Study||1||
59547762|NCT02474901|75646630|FG001|NOT COMPLETED|Overall Study||0||
59547763|NCT02475837|75646638|FG000|STARTED|Overall Study||6||
59547764|NCT02475837|75646639|FG001|STARTED|Overall Study||7||
59547765|NCT02475837|75646638|FG000|COMPLETED|Overall Study||6||
59547766|NCT02475837|75646639|FG001|COMPLETED|Overall Study||7||
59547767|NCT02475837|75646638|FG000|NOT COMPLETED|Overall Study||0||
59547768|NCT02475837|75646639|FG001|NOT COMPLETED|Overall Study||0||
59547769|NCT02545101|75646645|FG000|STARTED|Overall Study||100||
59547770|NCT02545101|75646645|FG000|COMPLETED|Overall Study||100||
59547771|NCT02545101|75646645|FG000|NOT COMPLETED|Overall Study||0||
59547772|NCT02477319|75646653|FG000|STARTED|Overall Study||55||
59547773|NCT02477319|75646654|FG001|STARTED|Overall Study||40||
59547774|NCT02477319|75646655|FG002|STARTED|Overall Study||164||
59547775|NCT02477319|75646656|FG003|STARTED|Overall Study||193||
59547776|NCT02477319|75646653|FG000|COMPLETED|Overall Study||55||
59547777|NCT02477319|75646654|FG001|COMPLETED|Overall Study||37||
59547778|NCT02477319|75646655|FG002|COMPLETED|Overall Study||149||
59547779|NCT02477319|75646656|FG003|COMPLETED|Overall Study||171||
59547780|NCT02477319|75646653|FG000|NOT COMPLETED|Overall Study||0||
59547781|NCT02477319|75646654|FG001|NOT COMPLETED|Overall Study||3||
59547782|NCT02477319|75646655|FG002|NOT COMPLETED|Overall Study||15||
59547783|NCT02477319|75646656|FG003|NOT COMPLETED|Overall Study||22||
59547784|NCT02548845|75646663|FG000|STARTED|Overall Study||70||
59695636|NCT01267266|75815192|FG001|NOT COMPLETED|Randomized Phase||0||
59695637|NCT01034176|75815203|FG000|STARTED|Overall Study||22||
59695638|NCT01034176|75815204|FG001|STARTED|Overall Study||21||
59816165|NCT00609947|75938528|FG000|NOT COMPLETED|Overall Study||1||
59695639|NCT01034176|75815203|FG000|COMPLETED|Overall Study||20||
59695640|NCT01034176|75815204|FG001|COMPLETED|Overall Study||19||
59816166|NCT00609869|75938533|FG000|STARTED|Overall Study||29||
59547785|NCT02548845|75646663|FG000|COMPLETED|Overall Study||70||
59695641|NCT01034176|75815203|FG000|NOT COMPLETED|Overall Study||2||
59695642|NCT01034176|75815204|FG001|NOT COMPLETED|Overall Study||2||
59695643|NCT01033942|75815213|FG000|STARTED|Overall Study||20||
59695644|NCT01033942|75815214|FG001|STARTED|Overall Study||19||
59695645|NCT01033942|75815215|FG002|STARTED|Overall Study||19||
59695646|NCT01033942|75815213|FG000|COMPLETED|Overall Study||18||
59695647|NCT01033942|75815214|FG001|COMPLETED|Overall Study||15||
59695648|NCT01033942|75815215|FG002|COMPLETED|Overall Study||18||
59695649|NCT01033942|75815213|FG000|NOT COMPLETED|Overall Study||2||
59695650|NCT01033942|75815214|FG001|NOT COMPLETED|Overall Study||4||
59695651|NCT01033942|75815215|FG002|NOT COMPLETED|Overall Study||1||
59695652|NCT01062256|75815228|FG000|STARTED|Overall Study||55||
59695653|NCT01062256|75815229|FG001|STARTED|Overall Study||103||
59695654|NCT01062256|75815230|FG002|STARTED|Overall Study||107||
59695655|NCT01062256|75815228|FG000|COMPLETED|Overall Study||52||
59695656|NCT01062256|75815229|FG001|COMPLETED|Overall Study||96||
59695657|NCT01062256|75815230|FG002|COMPLETED|Overall Study||103||
59695658|NCT01062256|75815228|FG000|NOT COMPLETED|Overall Study||3||
59695659|NCT01062256|75815229|FG001|NOT COMPLETED|Overall Study||7||
59695660|NCT01062256|75815230|FG002|NOT COMPLETED|Overall Study||4||
59695661|NCT01029886|75815240|FG000|STARTED|Overall Study||461||
59695662|NCT01029886|75815241|FG001|STARTED|Overall Study||451||
59695663|NCT01029886|75815240|FG000|Intent to Treat (ITT)|Overall Study||461||
59695664|NCT01029886|75815241|FG001|Intent to Treat (ITT)|Overall Study||450||
59695665|NCT01029886|75815240|FG000|COMPLETED|Overall Study||400||
59695666|NCT01029886|75815241|FG001|COMPLETED|Overall Study||391||
59695667|NCT01029886|75815240|FG000|NOT COMPLETED|Overall Study||61||
59695668|NCT01029886|75815241|FG001|NOT COMPLETED|Overall Study||60||
59695669|NCT01244763|75815257|FG000|STARTED|Overall Study||24||
59695670|NCT01244763|75815258|FG001|STARTED|Overall Study||24||
59695671|NCT01244763|75815259|FG002|STARTED|Overall Study||24||
59695672|NCT01244763|75815260|FG003|STARTED|Overall Study||24||
59695673|NCT01244763|75815261|FG004|STARTED|Overall Study||24||
59695674|NCT01244763|75815262|FG005|STARTED|Overall Study||25||
59695675|NCT01244763|75815257|FG000|Safety Population|Overall Study||24|All participants who received any dose of study drug.|
59695676|NCT01244763|75815258|FG001|Safety Population|Overall Study||24|All participants who received any dose of study drug.|
59695677|NCT01244763|75815259|FG002|Safety Population|Overall Study||24|All participants who received any dose of study drug.|
59695678|NCT01244763|75815260|FG003|Safety Population|Overall Study||24|All participants who received any dose of study drug.|
59695679|NCT01244763|75815261|FG004|Safety Population|Overall Study||24|All participants who received any dose of study drug.|
59695680|NCT01244763|75815262|FG005|Safety Population|Overall Study||25|All participants who received any dose of study drug.|
59695681|NCT01244763|75815257|FG000|Efficacy Evaluable (EE) Population|Overall Study||23|All participants who received at least 2 weeks of study drug with a hemoglobin (Hb) Baseline (BL) and a valid post-BL value at 2 weeks into study.|
59547786|NCT02548845|75646663|FG000|NOT COMPLETED|Overall Study||0||
59695682|NCT01244763|75815258|FG001|Efficacy Evaluable (EE) Population|Overall Study||24|All participants who received at least 2 weeks of study drug with a hemoglobin (Hb) Baseline (BL) and a valid post-BL value at 2 weeks into study.|
59695683|NCT01244763|75815259|FG002|Efficacy Evaluable (EE) Population|Overall Study||23|All participants who received at least 2 weeks of study drug with a hemoglobin (Hb) Baseline (BL) and a valid post-BL value at 2 weeks into study.|
60079506|NCT04206332|76194706|FG006|NOT COMPLETED|Part B||0||
60079507|NCT04206332|76194707|FG007|NOT COMPLETED|Part B||3||
60079508|NCT04206332|76194708|FG008|NOT COMPLETED|Part B||0||
60079509|NCT04206332|76194709|FG009|NOT COMPLETED|Part B||0||
60079510|NCT04206332|76194710|FG010|NOT COMPLETED|Part B||2||
60079511|NCT04206332|76194711|FG011|NOT COMPLETED|Part B||0||
60079512|NCT04206332|76194712|FG012|NOT COMPLETED|Part B||0||
60079513|NCT04206332|76194713|FG013|NOT COMPLETED|Part B||0||
59695684|NCT01244763|75815260|FG003|Efficacy Evaluable (EE) Population|Overall Study||24|All participants who received at least 2 weeks of study drug with a hemoglobin (Hb) Baseline (BL) and a valid post-BL value at 2 weeks into study.|
59695685|NCT01244763|75815261|FG004|Efficacy Evaluable (EE) Population|Overall Study||24|All participants who received at least 2 weeks of study drug with a hemoglobin (Hb) Baseline (BL) and a valid post-BL value at 2 weeks into study.|
59695686|NCT01244763|75815262|FG005|Efficacy Evaluable (EE) Population|Overall Study||25|All participants who received at least 2 weeks of study drug with a hemoglobin (Hb) Baseline (BL) and a valid post-BL value at 2 weeks into study.|
60079514|NCT04206332|76194714|FG014|NOT COMPLETED|Part B||0||
60079515|NCT04206332|76194715|FG015|NOT COMPLETED|Part B||0||
60079516|NCT04206332|76194716|FG016|NOT COMPLETED|Part B||0||
59695687|NCT01244763|75815257|FG000|COMPLETED|Overall Study||21||
59695688|NCT01244763|75815258|FG001|COMPLETED|Overall Study||21||
59695689|NCT01244763|75815259|FG002|COMPLETED|Overall Study||22||
59695690|NCT01244763|75815260|FG003|COMPLETED|Overall Study||23||
59695691|NCT01244763|75815261|FG004|COMPLETED|Overall Study||21||
59695692|NCT01244763|75815262|FG005|COMPLETED|Overall Study||21||
59695693|NCT01244763|75815257|FG000|NOT COMPLETED|Overall Study||3||
59695694|NCT01244763|75815258|FG001|NOT COMPLETED|Overall Study||3||
59695695|NCT01244763|75815259|FG002|NOT COMPLETED|Overall Study||2||
59695696|NCT01244763|75815260|FG003|NOT COMPLETED|Overall Study||1||
59695697|NCT01244763|75815261|FG004|NOT COMPLETED|Overall Study||3||
59695698|NCT01244763|75815262|FG005|NOT COMPLETED|Overall Study||4||
59695699|NCT01244061|75815278|FG000|STARTED|Overall Study||251||
59695700|NCT01244061|75815279|FG001|STARTED|Overall Study||247||
59695701|NCT01244061|75815278|FG000|COMPLETED|Overall Study||169||
59695702|NCT01244061|75815279|FG001|COMPLETED|Overall Study||144||
59695703|NCT01244061|75815278|FG000|NOT COMPLETED|Overall Study||82||
59695704|NCT01244061|75815279|FG001|NOT COMPLETED|Overall Study||103||
59695705|NCT01243671|75815285|FG000|STARTED|Overall Study||20||
59695706|NCT01243671|75815285|FG000|Completed 24 Weeks of Treatment|Overall Study||18||
59695707|NCT01243671|75815285|FG000|Completed 52 Weeks of Treatment|Overall Study||17||
59695708|NCT01243671|75815285|FG000|COMPLETED|Overall Study|Completed 136 weeks of treatment.|15||
59695709|NCT01243671|75815285|FG000|NOT COMPLETED|Overall Study||5||
59695710|NCT01240785|75815291|FG000|STARTED|Overall Study||111||
59695711|NCT01240785|75815292|FG001|STARTED|Overall Study||110||
59989944|NCT03751007|76105382|FG001|COMPLETED|Overall Study||5||
59989945|NCT03751007|76105383|FG002|COMPLETED|Overall Study||2||
59989946|NCT03751007|76105384|FG003|COMPLETED|Overall Study||4||
59989947|NCT03751007|76105385|FG004|COMPLETED|Overall Study||2||
59989948|NCT03751007|76105386|FG005|COMPLETED|Overall Study||4||
59989949|NCT03751007|76105387|FG006|COMPLETED|Overall Study||2||
59989950|NCT03751007|76105388|FG007|COMPLETED|Overall Study||4||
59989951|NCT03751007|76105389|FG008|COMPLETED|Overall Study||10||
59989952|NCT03751007|76105390|FG009|COMPLETED|Overall Study||2||
59989953|NCT03751007|76105391|FG010|COMPLETED|Overall Study||4||
59989954|NCT03751007|76105392|FG011|COMPLETED|Overall Study||0||
59989955|NCT03751007|76105381|FG000|NOT COMPLETED|Overall Study||0||
59695712|NCT01240785|75815291|FG000|COMPLETED|Overall Study|110 women completed in the metformin arm and 107 women completed in the insulin arm.|110||
59695713|NCT01240785|75815292|FG001|COMPLETED|Overall Study||107||
59695714|NCT01240785|75815291|FG000|NOT COMPLETED|Overall Study||1||
59695715|NCT01240785|75815292|FG001|NOT COMPLETED|Overall Study||3||
59695716|NCT01240551|75815300|FG000|STARTED|Overall Study||30||
59989956|NCT03751007|76105382|FG001|NOT COMPLETED|Overall Study||0||
59989957|NCT03751007|76105383|FG002|NOT COMPLETED|Overall Study||0||
59989958|NCT03751007|76105384|FG003|NOT COMPLETED|Overall Study||1||
59989959|NCT03751007|76105385|FG004|NOT COMPLETED|Overall Study||0||
59989960|NCT03751007|76105386|FG005|NOT COMPLETED|Overall Study||0||
59989961|NCT03751007|76105387|FG006|NOT COMPLETED|Overall Study||0||
59989962|NCT03751007|76105388|FG007|NOT COMPLETED|Overall Study||1||
59989963|NCT03751007|76105389|FG008|NOT COMPLETED|Overall Study||0||
59989964|NCT03751007|76105390|FG009|NOT COMPLETED|Overall Study||0||
59989965|NCT03751007|76105391|FG010|NOT COMPLETED|Overall Study||1||
59989966|NCT03751007|76105392|FG011|NOT COMPLETED|Overall Study||1||
59989967|NCT02740049|76105436|FG000|STARTED|Overall Study||9||
59989968|NCT02740049|76105436|FG000|COMPLETED|Overall Study||8||
59989969|NCT02740049|76105436|FG000|NOT COMPLETED|Overall Study||1||
59989970|NCT01601704|76105442|FG000|STARTED|Overall Study||4456|Represents number of participants randomized|
59989971|NCT01601704|76105443|FG001|STARTED|Overall Study||4454|Represents number of participants randomized|
59989972|NCT01601704|76105442|FG000|Treated|Overall Study||4455|Represents number of participants included in the ITT analysis|
59989973|NCT01601704|76105443|FG001|Treated|Overall Study||4450|Represents number of participants included in the ITT analysis|
59989974|NCT01601704|76105442|FG000|COMPLETED|Overall Study||4455|Completed indicates treated participants. Represents number of participants in the ITT analysis.|
59989975|NCT01601704|76105443|FG001|COMPLETED|Overall Study||4450|Completed indicates treated participants. Represents number of participants in the ITT analysis.|
59989976|NCT01601704|76105442|FG000|NOT COMPLETED|Overall Study||1||
59989977|NCT01601704|76105443|FG001|NOT COMPLETED|Overall Study||4||
59989978|NCT01601470|76105449|FG000|STARTED|Period 1 - Sildenafil||28||
59989979|NCT01601470|76105449|FG000|PK Analysis Set|Period 1 - Sildenafil||28||
59989980|NCT01601470|76105449|FG000|Safety Set|Period 1 - Sildenafil||28||
59989981|NCT01601470|76105449|FG000|COMPLETED|Period 1 - Sildenafil||28||
59989982|NCT01601470|76105449|FG000|NOT COMPLETED|Period 1 - Sildenafil||0||
59989983|NCT01601470|76105449|FG000|STARTED|Period 2 - LCZ696||28||
59989984|NCT01601470|76105449|FG000|PK Analysis Set|Period 2 - LCZ696||27||
59989985|NCT01601470|76105449|FG000|Safety Set|Period 2 - LCZ696||27||
60079517|NCT04206332|76194700|FG000|STARTED|Part C||0||
60079518|NCT04206332|76194701|FG001|STARTED|Part C||0||
60079519|NCT04206332|76194702|FG002|STARTED|Part C||0||
59695717|NCT01240551|75815301|FG001|STARTED|Overall Study||30||
59695718|NCT01240551|75815300|FG000|COMPLETED|Overall Study||26||
59695719|NCT01240551|75815301|FG001|COMPLETED|Overall Study||27||
59695720|NCT01240551|75815300|FG000|NOT COMPLETED|Overall Study||4||
59695721|NCT01240551|75815301|FG001|NOT COMPLETED|Overall Study||3||
59695722|NCT01239381|75815307|FG000|STARTED|Overall Study||92||
59695723|NCT01239381|75815307|FG000|COMPLETED|Overall Study||90||
59695724|NCT01239381|75815307|FG000|NOT COMPLETED|Overall Study||2||
59695725|NCT01266876|75815317|FG000|STARTED|Overall Study||15||
59695726|NCT01266876|75815318|FG001|STARTED|Overall Study||15||
59695727|NCT01266876|75815319|FG002|STARTED|Overall Study||16||
59695728|NCT01266876|75815320|FG003|STARTED|Overall Study||15||
59695729|NCT01266876|75815321|FG004|STARTED|Overall Study||16||
59695730|NCT01266876|75815317|FG000|COMPLETED|Overall Study||15||
59695731|NCT01266876|75815318|FG001|COMPLETED|Overall Study||15||
59695732|NCT01266876|75815319|FG002|COMPLETED|Overall Study||16||
59695733|NCT01266876|75815320|FG003|COMPLETED|Overall Study||14||
59695734|NCT01266876|75815321|FG004|COMPLETED|Overall Study||16||
59695735|NCT01266876|75815317|FG000|NOT COMPLETED|Overall Study||0||
59695736|NCT01266876|75815318|FG001|NOT COMPLETED|Overall Study||0||
59695737|NCT01266876|75815319|FG002|NOT COMPLETED|Overall Study||0||
59695738|NCT01266876|75815320|FG003|NOT COMPLETED|Overall Study||1||
59695739|NCT01266876|75815321|FG004|NOT COMPLETED|Overall Study||0||
59695740|NCT01033240|75815336|FG000|STARTED|Overall Study||55||
59695741|NCT01033240|75815337|FG001|STARTED|Overall Study||53||
59695742|NCT01033240|75815338|FG002|STARTED|Overall Study||55||
59695743|NCT01033240|75815336|FG000|COMPLETED|Overall Study||6||
59695744|NCT01033240|75815337|FG001|COMPLETED|Overall Study||3||
59695745|NCT01033240|75815338|FG002|COMPLETED|Overall Study||2||
59695746|NCT01033240|75815336|FG000|NOT COMPLETED|Overall Study||49||
59695747|NCT01033240|75815337|FG001|NOT COMPLETED|Overall Study||50||
59695748|NCT01033240|75815338|FG002|NOT COMPLETED|Overall Study||53||
59695749|NCT01266018|75815346|FG000|STARTED|Overall Study||9||
59695750|NCT01266018|75815347|FG001|STARTED|Overall Study||13||
59695751|NCT01266018|75815346|FG000|COMPLETED|Overall Study|Defined as evaluable for the primary endpoint|8||
59695752|NCT01266018|75815347|FG001|COMPLETED|Overall Study||12||
59695753|NCT01266018|75815346|FG000|NOT COMPLETED|Overall Study||1||
59695754|NCT01266018|75815347|FG001|NOT COMPLETED|Overall Study||1||
59695755|NCT01032382|75815355|FG000|STARTED|Overall Study||16||
59695756|NCT01032382|75815356|FG001|STARTED|Overall Study||14||
59695757|NCT01032382|75815355|FG000|COMPLETED|Overall Study||11||
59695758|NCT01032382|75815356|FG001|COMPLETED|Overall Study||9||
59695759|NCT01032382|75815355|FG000|NOT COMPLETED|Overall Study||5||
59695760|NCT01032382|75815356|FG001|NOT COMPLETED|Overall Study||5||
59695761|NCT01029652|75815364|FG000|STARTED|Core Study (0-12 Weeks)||115||
59695762|NCT01029652|75815365|FG001|STARTED|Core Study (0-12 Weeks)||115||
59695763|NCT01029652|75815364|FG000|Full Analysis Set (FAS), Safety Set|Core Study (0-12 Weeks)||113||
59695764|NCT01029652|75815365|FG001|Full Analysis Set (FAS), Safety Set|Core Study (0-12 Weeks)||115||
59695765|NCT01029652|75815364|FG000|COMPLETED|Core Study (0-12 Weeks)||109||
59695766|NCT01029652|75815365|FG001|COMPLETED|Core Study (0-12 Weeks)||105||
59695767|NCT01029652|75815364|FG000|NOT COMPLETED|Core Study (0-12 Weeks)||6||
59695768|NCT01029652|75815365|FG001|NOT COMPLETED|Core Study (0-12 Weeks)||10||
59695769|NCT01029652|75815364|FG000|STARTED|Extension Study 1 (12-24 Weeks)||90||
59695770|NCT01029652|75815365|FG001|STARTED|Extension Study 1 (12-24 Weeks)||85||
59695771|NCT01029652|75815364|FG000|COMPLETED|Extension Study 1 (12-24 Weeks)||87||
59695772|NCT01029652|75815365|FG001|COMPLETED|Extension Study 1 (12-24 Weeks)||80||
59695773|NCT01029652|75815364|FG000|NOT COMPLETED|Extension Study 1 (12-24 Weeks)||3||
59695774|NCT01029652|75815365|FG001|NOT COMPLETED|Extension Study 1 (12-24 Weeks)||5||
59695775|NCT01029652|75815364|FG000|STARTED|Extension Study 2 (25-72 Weeks)||69||
59695776|NCT01029652|75815365|FG001|STARTED|Extension Study 2 (25-72 Weeks)||66||
59695777|NCT01029652|75815364|FG000|Re-treated With or Switch to Canakinumab|Extension Study 2 (25-72 Weeks)|Includes patients re-treated with canakinumab over 72 weeks study duration overall|69||
59695778|NCT01029652|75815365|FG001|Re-treated With or Switch to Canakinumab|Extension Study 2 (25-72 Weeks)|Includes patients switched to canakinumab from Week 25 - Week 72|39||
59989986|NCT01601470|76105449|FG000|COMPLETED|Period 2 - LCZ696||27||
59695779|NCT01029652|75815364|FG000|COMPLETED|Extension Study 2 (25-72 Weeks)||68||
59695780|NCT01029652|75815365|FG001|COMPLETED|Extension Study 2 (25-72 Weeks)||63||
59695781|NCT01029652|75815364|FG000|NOT COMPLETED|Extension Study 2 (25-72 Weeks)||1||
59695782|NCT01029652|75815365|FG001|NOT COMPLETED|Extension Study 2 (25-72 Weeks)||3||
59695783|NCT01029340|75815394|FG000|STARTED|Part A Treatment Period||14||
59695784|NCT01029340|75815395|FG001|STARTED|Part A Treatment Period||14||
59695785|NCT01029340|75815396|FG002|STARTED|Part A Treatment Period||0||
59695786|NCT01029340|75815397|FG003|STARTED|Part A Treatment Period||0||
59695787|NCT01029340|75815398|FG004|STARTED|Part A Treatment Period||0||
59695788|NCT01029340|75815399|FG005|STARTED|Part A Treatment Period||0||
59695789|NCT01029340|75815394|FG000|Participants Received Treatment|Part A Treatment Period||14||
59695790|NCT01029340|75815395|FG001|Participants Received Treatment|Part A Treatment Period||14||
59695791|NCT01029340|75815396|FG002|Participants Received Treatment|Part A Treatment Period||0||
59695792|NCT01029340|75815397|FG003|Participants Received Treatment|Part A Treatment Period||0||
59695793|NCT01029340|75815398|FG004|Participants Received Treatment|Part A Treatment Period||0||
59695794|NCT01029340|75815399|FG005|Participants Received Treatment|Part A Treatment Period||0||
59695795|NCT01029340|75815394|FG000|Safety Population|Part A Treatment Period|One excluded because receiving Kogenate FS twice.|13||
59695796|NCT01029340|75815395|FG001|Safety Population|Part A Treatment Period||14||
59695797|NCT01029340|75815396|FG002|Safety Population|Part A Treatment Period||0||
59695798|NCT01029340|75815397|FG003|Safety Population|Part A Treatment Period||0||
59695799|NCT01029340|75815398|FG004|Safety Population|Part A Treatment Period||0||
59695800|NCT01029340|75815399|FG005|Safety Population|Part A Treatment Period||0||
59695801|NCT01029340|75815394|FG000|COMPLETED|Part A Treatment Period||14||
59695802|NCT01029340|75815395|FG001|COMPLETED|Part A Treatment Period||14||
59695803|NCT01029340|75815396|FG002|COMPLETED|Part A Treatment Period||0||
59695804|NCT01029340|75815397|FG003|COMPLETED|Part A Treatment Period||0||
59695805|NCT01029340|75815398|FG004|COMPLETED|Part A Treatment Period||0||
59695806|NCT01029340|75815399|FG005|COMPLETED|Part A Treatment Period||0||
59695807|NCT01029340|75815394|FG000|NOT COMPLETED|Part A Treatment Period||0||
59695808|NCT01029340|75815395|FG001|NOT COMPLETED|Part A Treatment Period||0||
59695809|NCT01029340|75815396|FG002|NOT COMPLETED|Part A Treatment Period||0||
59695810|NCT01029340|75815397|FG003|NOT COMPLETED|Part A Treatment Period||0||
59695811|NCT01029340|75815398|FG004|NOT COMPLETED|Part A Treatment Period||0||
59695812|NCT01029340|75815399|FG005|NOT COMPLETED|Part A Treatment Period||0||
59695813|NCT01029340|75815394|FG000|STARTED|Part A Follow up Period||14||
59695814|NCT01029340|75815395|FG001|STARTED|Part A Follow up Period||14||
59695815|NCT01029340|75815396|FG002|STARTED|Part A Follow up Period||0||
59695816|NCT01029340|75815397|FG003|STARTED|Part A Follow up Period||0||
59695817|NCT01029340|75815398|FG004|STARTED|Part A Follow up Period||0||
59695818|NCT01029340|75815399|FG005|STARTED|Part A Follow up Period||0||
59695819|NCT01029340|75815394|FG000|COMPLETED|Part A Follow up Period||14||
59695820|NCT01029340|75815395|FG001|COMPLETED|Part A Follow up Period||14||
59695821|NCT01029340|75815396|FG002|COMPLETED|Part A Follow up Period||0||
59695822|NCT01029340|75815397|FG003|COMPLETED|Part A Follow up Period||0||
59695823|NCT01029340|75815398|FG004|COMPLETED|Part A Follow up Period||0||
59695824|NCT01029340|75815399|FG005|COMPLETED|Part A Follow up Period||0||
59695825|NCT01029340|75815394|FG000|NOT COMPLETED|Part A Follow up Period||0||
59695826|NCT01029340|75815395|FG001|NOT COMPLETED|Part A Follow up Period||0||
59695827|NCT01029340|75815396|FG002|NOT COMPLETED|Part A Follow up Period||0||
59695828|NCT01029340|75815397|FG003|NOT COMPLETED|Part A Follow up Period||0||
59695829|NCT01029340|75815398|FG004|NOT COMPLETED|Part A Follow up Period||0||
59695830|NCT01029340|75815399|FG005|NOT COMPLETED|Part A Follow up Period||0||
59695831|NCT01029340|75815394|FG000|STARTED|Part B Treatment Period||0||
59695832|NCT01029340|75815395|FG001|STARTED|Part B Treatment Period||0||
59695833|NCT01029340|75815396|FG002|STARTED|Part B Treatment Period|Enrolled 4 participants from Arm 1 and 7 participants from Arm 2|31||
59695834|NCT01029340|75815397|FG003|STARTED|Part B Treatment Period|Enrolled 7 participants from Arm 1 and 4 participants from Arm 2|32||
59695835|NCT01029340|75815398|FG004|STARTED|Part B Treatment Period||0||
59695836|NCT01029340|75815399|FG005|STARTED|Part B Treatment Period||0||
59695837|NCT01029340|75815394|FG000|Participants Received Treatment|Part B Treatment Period||0||
59695838|NCT01029340|75815395|FG001|Participants Received Treatment|Part B Treatment Period||0||
59695839|NCT01029340|75815396|FG002|Participants Received Treatment|Part B Treatment Period||30||
59695840|NCT01029340|75815397|FG003|Participants Received Treatment|Part B Treatment Period||32||
59695841|NCT01029340|75815398|FG004|Participants Received Treatment|Part B Treatment Period||0||
59695842|NCT01029340|75815399|FG005|Participants Received Treatment|Part B Treatment Period||0||
59695843|NCT01029340|75815394|FG000|COMPLETED|Part B Treatment Period||0||
59695844|NCT01029340|75815395|FG001|COMPLETED|Part B Treatment Period||0||
59695845|NCT01029340|75815396|FG002|COMPLETED|Part B Treatment Period||29||
59695846|NCT01029340|75815397|FG003|COMPLETED|Part B Treatment Period||32||
59695847|NCT01029340|75815398|FG004|COMPLETED|Part B Treatment Period||0||
59695848|NCT01029340|75815399|FG005|COMPLETED|Part B Treatment Period||0||
59695849|NCT01029340|75815394|FG000|NOT COMPLETED|Part B Treatment Period||0||
59695850|NCT01029340|75815395|FG001|NOT COMPLETED|Part B Treatment Period||0||
59695851|NCT01029340|75815396|FG002|NOT COMPLETED|Part B Treatment Period||2||
59695852|NCT01029340|75815397|FG003|NOT COMPLETED|Part B Treatment Period||0||
59695853|NCT01029340|75815398|FG004|NOT COMPLETED|Part B Treatment Period||0||
59695854|NCT01029340|75815399|FG005|NOT COMPLETED|Part B Treatment Period||0||
59695855|NCT01029340|75815394|FG000|STARTED|Part B Follow up Period||0||
59695856|NCT01029340|75815395|FG001|STARTED|Part B Follow up Period||0||
59695857|NCT01029340|75815396|FG002|STARTED|Part B Follow up Period||29||
59695858|NCT01029340|75815397|FG003|STARTED|Part B Follow up Period||32||
59695859|NCT01029340|75815398|FG004|STARTED|Part B Follow up Period||0||
59695860|NCT01029340|75815399|FG005|STARTED|Part B Follow up Period||0||
59695861|NCT01029340|75815394|FG000|COMPLETED|Part B Follow up Period||0||
59695862|NCT01029340|75815395|FG001|COMPLETED|Part B Follow up Period||0||
59695863|NCT01029340|75815396|FG002|COMPLETED|Part B Follow up Period||29||
59695864|NCT01029340|75815397|FG003|COMPLETED|Part B Follow up Period||32||
59695865|NCT01029340|75815398|FG004|COMPLETED|Part B Follow up Period||0||
59695866|NCT01029340|75815399|FG005|COMPLETED|Part B Follow up Period||0||
59695867|NCT01029340|75815394|FG000|NOT COMPLETED|Part B Follow up Period||0||
59816167|NCT00609869|75938533|FG000|COMPLETED|Overall Study||18||
59695868|NCT01029340|75815395|FG001|NOT COMPLETED|Part B Follow up Period||0||
59695869|NCT01029340|75815396|FG002|NOT COMPLETED|Part B Follow up Period||0||
59695870|NCT01029340|75815397|FG003|NOT COMPLETED|Part B Follow up Period||0||
59695871|NCT01029340|75815398|FG004|NOT COMPLETED|Part B Follow up Period||0||
59695872|NCT01029340|75815399|FG005|NOT COMPLETED|Part B Follow up Period||0||
59695873|NCT01029340|75815394|FG000|STARTED|Extension Period||0||
59695874|NCT01029340|75815395|FG001|STARTED|Extension Period||0||
59695875|NCT01029340|75815396|FG002|STARTED|Extension Period||0||
59695876|NCT01029340|75815397|FG003|STARTED|Extension Period||0||
59695877|NCT01029340|75815398|FG004|STARTED|Extension Period||0||
59695878|NCT01029340|75815399|FG005|STARTED|Extension Period||55||
59695879|NCT01029340|75815394|FG000|COMPLETED|Extension Period||0||
59695880|NCT01029340|75815395|FG001|COMPLETED|Extension Period||0||
59695881|NCT01029340|75815396|FG002|COMPLETED|Extension Period||0||
59695882|NCT01029340|75815397|FG003|COMPLETED|Extension Period||0||
59695883|NCT01029340|75815398|FG004|COMPLETED|Extension Period||0||
59695884|NCT01029340|75815399|FG005|COMPLETED|Extension Period||43||
59695885|NCT01029340|75815394|FG000|NOT COMPLETED|Extension Period||0||
59695886|NCT01029340|75815395|FG001|NOT COMPLETED|Extension Period||0||
59695887|NCT01029340|75815396|FG002|NOT COMPLETED|Extension Period||0||
59695888|NCT01029340|75815397|FG003|NOT COMPLETED|Extension Period||0||
59695889|NCT01029340|75815398|FG004|NOT COMPLETED|Extension Period||0||
59695890|NCT01029340|75815399|FG005|NOT COMPLETED|Extension Period||12||
59695891|NCT01029340|75815394|FG000|STARTED|Part C Treatment Period||0||
59695892|NCT01029340|75815395|FG001|STARTED|Part C Treatment Period||0||
59695893|NCT01029340|75815396|FG002|STARTED|Part C Treatment Period||0||
59695894|NCT01029340|75815397|FG003|STARTED|Part C Treatment Period||0||
59695895|NCT01029340|75815398|FG004|STARTED|Part C Treatment Period||5||
59695896|NCT01029340|75815399|FG005|STARTED|Part C Treatment Period||0||
59695897|NCT01029340|75815394|FG000|Participants Received Treatment|Part C Treatment Period||0||
59695898|NCT01029340|75815395|FG001|Participants Received Treatment|Part C Treatment Period||0||
59695899|NCT01029340|75815396|FG002|Participants Received Treatment|Part C Treatment Period||0||
59695900|NCT01029340|75815397|FG003|Participants Received Treatment|Part C Treatment Period||0||
59695901|NCT01029340|75815398|FG004|Participants Received Treatment|Part C Treatment Period||5||
59695902|NCT01029340|75815399|FG005|Participants Received Treatment|Part C Treatment Period||0||
59695903|NCT01029340|75815394|FG000|COMPLETED|Part C Treatment Period||0||
59695904|NCT01029340|75815395|FG001|COMPLETED|Part C Treatment Period||0||
59695905|NCT01029340|75815396|FG002|COMPLETED|Part C Treatment Period||0||
59695906|NCT01029340|75815397|FG003|COMPLETED|Part C Treatment Period||0||
59695907|NCT01029340|75815398|FG004|COMPLETED|Part C Treatment Period||5||
59695908|NCT01029340|75815399|FG005|COMPLETED|Part C Treatment Period||0||
59695909|NCT01029340|75815394|FG000|NOT COMPLETED|Part C Treatment Period||0||
59695910|NCT01029340|75815395|FG001|NOT COMPLETED|Part C Treatment Period||0||
59695911|NCT01029340|75815396|FG002|NOT COMPLETED|Part C Treatment Period||0||
59695912|NCT01029340|75815397|FG003|NOT COMPLETED|Part C Treatment Period||0||
59695913|NCT01029340|75815398|FG004|NOT COMPLETED|Part C Treatment Period||0||
59695914|NCT01029340|75815399|FG005|NOT COMPLETED|Part C Treatment Period||0||
59695915|NCT01029340|75815394|FG000|STARTED|Part C Follow up Period||0||
59695916|NCT01029340|75815395|FG001|STARTED|Part C Follow up Period||0||
59695917|NCT01029340|75815396|FG002|STARTED|Part C Follow up Period||0||
59695918|NCT01029340|75815397|FG003|STARTED|Part C Follow up Period||0||
59695919|NCT01029340|75815398|FG004|STARTED|Part C Follow up Period||5||
59695920|NCT01029340|75815399|FG005|STARTED|Part C Follow up Period||0||
59695921|NCT01029340|75815394|FG000|COMPLETED|Part C Follow up Period||0||
59695922|NCT01029340|75815395|FG001|COMPLETED|Part C Follow up Period||0||
59695923|NCT01029340|75815396|FG002|COMPLETED|Part C Follow up Period||0||
59695924|NCT01029340|75815397|FG003|COMPLETED|Part C Follow up Period||0||
59695925|NCT01029340|75815398|FG004|COMPLETED|Part C Follow up Period||5||
59695926|NCT01029340|75815399|FG005|COMPLETED|Part C Follow up Period||0||
59695927|NCT01029340|75815394|FG000|NOT COMPLETED|Part C Follow up Period||0||
59695928|NCT01029340|75815395|FG001|NOT COMPLETED|Part C Follow up Period||0||
59695929|NCT01029340|75815396|FG002|NOT COMPLETED|Part C Follow up Period||0||
59695930|NCT01029340|75815397|FG003|NOT COMPLETED|Part C Follow up Period||0||
59695931|NCT01029340|75815398|FG004|NOT COMPLETED|Part C Follow up Period||0||
59695932|NCT01029340|75815399|FG005|NOT COMPLETED|Part C Follow up Period||0||
59695933|NCT01265550|75815416|FG000|STARTED|Pre Randomization||0||
59695934|NCT01265550|75815417|FG001|STARTED|Pre Randomization||0||
59695935|NCT01265550|75815418|FG002|STARTED|Pre Randomization||0||
59695936|NCT01265550|75815419|FG003|STARTED|Pre Randomization||366||
59695937|NCT01265550|75815416|FG000|COMPLETED|Pre Randomization||0||
59695938|NCT01265550|75815417|FG001|COMPLETED|Pre Randomization||0||
59695939|NCT01265550|75815418|FG002|COMPLETED|Pre Randomization||0||
59695940|NCT01265550|75815419|FG003|COMPLETED|Pre Randomization||78||
59695941|NCT01265550|75815416|FG000|NOT COMPLETED|Pre Randomization||0||
59695942|NCT01265550|75815417|FG001|NOT COMPLETED|Pre Randomization||0||
59695943|NCT01265550|75815418|FG002|NOT COMPLETED|Pre Randomization||0||
59695944|NCT01265550|75815419|FG003|NOT COMPLETED|Pre Randomization||288||
59695945|NCT01265550|75815416|FG000|STARTED|Post Randomization||25||
59695946|NCT01265550|75815417|FG001|STARTED|Post Randomization||27||
59695947|NCT01265550|75815418|FG002|STARTED|Post Randomization||26||
59695948|NCT01265550|75815419|FG003|STARTED|Post Randomization||0||
59695949|NCT01265550|75815416|FG000|COMPLETED|Post Randomization||10||
59695950|NCT01265550|75815417|FG001|COMPLETED|Post Randomization||19||
59695951|NCT01265550|75815418|FG002|COMPLETED|Post Randomization||6||
59695952|NCT01265550|75815419|FG003|COMPLETED|Post Randomization||0||
59695953|NCT01265550|75815416|FG000|NOT COMPLETED|Post Randomization||15||
59695954|NCT01265550|75815417|FG001|NOT COMPLETED|Post Randomization||8||
59695955|NCT01265550|75815418|FG002|NOT COMPLETED|Post Randomization||20||
59695956|NCT01265550|75815419|FG003|NOT COMPLETED|Post Randomization||0||
59695957|NCT01265394|75815433|FG000|STARTED|Overall Study||218||
59695958|NCT01265394|75815433|FG000|COMPLETED|Overall Study||181||
59695959|NCT01265394|75815433|FG000|NOT COMPLETED|Overall Study||37||
59695960|NCT01029262|75815440|FG000|STARTED|Overall Study||79||
59695961|NCT01029262|75815441|FG001|STARTED|Overall Study||160||
59695962|NCT01029262|75815440|FG000|COMPLETED|Overall Study||0||
59695963|NCT01029262|75815441|FG001|COMPLETED|Overall Study||0||
59695964|NCT01029262|75815440|FG000|NOT COMPLETED|Overall Study||79||
59695965|NCT01029262|75815441|FG001|NOT COMPLETED|Overall Study||160||
59695966|NCT01028560|75815454|FG000|STARTED|Overall Study|4 of 27 withdrew consent immediately after randomization and are excluded from outcome analysis|27||
59695967|NCT01028560|75815455|FG001|STARTED|Overall Study|4 of 31 withdrew consent immediately after randomization and are excluded from outcome analysis|31||
59695968|NCT01028560|75815454|FG000|Started Study Protocol|Overall Study||23|Only participants who started the study protocol were included in the analysis (total n=50)|
59695969|NCT01028560|75815455|FG001|Started Study Protocol|Overall Study||27|Only participants who started the study protocol were included in the analysis (total n=50)|
59695970|NCT01028560|75815454|FG000|COMPLETED|Overall Study||17||
59695971|NCT01028560|75815455|FG001|COMPLETED|Overall Study||13||
59695972|NCT01028560|75815454|FG000|NOT COMPLETED|Overall Study||10||
59695973|NCT01028560|75815455|FG001|NOT COMPLETED|Overall Study||18||
59695974|NCT01061710|75815462|FG000|STARTED|Overall Study||20||
59695975|NCT01061710|75815462|FG000|COMPLETED|Overall Study||6||
59695976|NCT01061710|75815462|FG000|NOT COMPLETED|Overall Study||14||
59695977|NCT01028014|75815472|FG000|STARTED|Overall Study||10||
59695978|NCT01028014|75815473|FG001|STARTED|Overall Study||10||
59695979|NCT01028014|75815474|FG002|STARTED|Overall Study||10||
59695980|NCT01028014|75815475|FG003|STARTED|Overall Study||10||
59695981|NCT01028014|75815476|FG004|STARTED|Overall Study||10||
59695982|NCT01028014|75815477|FG005|STARTED|Overall Study||6||
59695983|NCT01028014|75815472|FG000|COMPLETED|Overall Study||9||
59695984|NCT01028014|75815473|FG001|COMPLETED|Overall Study||8||
59695985|NCT01028014|75815474|FG002|COMPLETED|Overall Study||10||
59695986|NCT01028014|75815475|FG003|COMPLETED|Overall Study||9||
59695987|NCT01028014|75815476|FG004|COMPLETED|Overall Study||9||
59695988|NCT01028014|75815477|FG005|COMPLETED|Overall Study||4||
59695989|NCT01028014|75815472|FG000|NOT COMPLETED|Overall Study||1||
59695990|NCT01028014|75815473|FG001|NOT COMPLETED|Overall Study||2||
59695991|NCT01028014|75815474|FG002|NOT COMPLETED|Overall Study||0||
59695992|NCT01028014|75815475|FG003|NOT COMPLETED|Overall Study||1||
59695993|NCT01028014|75815476|FG004|NOT COMPLETED|Overall Study||1||
59695994|NCT01028014|75815477|FG005|NOT COMPLETED|Overall Study||2||
59695995|NCT01264770|75815497|FG000|STARTED|Overall Study|Patients who received treatment|54||
59695996|NCT01264770|75815498|FG001|STARTED|Overall Study|Patients who received treatment|48||
59695997|NCT01264770|75815499|FG002|STARTED|Overall Study|Patients who received treatment|57||
59695998|NCT01264770|75815500|FG003|STARTED|Overall Study|Patients who received treatment|54||
59695999|NCT01264770|75815501|FG004|STARTED|Overall Study|Patients who received treatment|27||
59696000|NCT01264770|75815502|FG005|STARTED|Overall Study|Patients who received treatment|25||
59989987|NCT01601470|76105449|FG000|NOT COMPLETED|Period 2 - LCZ696||1||
59989988|NCT01601470|76105449|FG000|STARTED|Period 3 - LCZ696+Sildenafil||27||
59696001|NCT01264770|75815497|FG000|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|2||
59696002|NCT01264770|75815498|FG001|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|5||
59696003|NCT01264770|75815499|FG002|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|2||
59696004|NCT01264770|75815500|FG003|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|3||
59696005|NCT01264770|75815501|FG004|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|2||
59696006|NCT01264770|75815502|FG005|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|0||
59696007|NCT01264770|75815497|FG000|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|36||
59696008|NCT01264770|75815498|FG001|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|38||
59696009|NCT01264770|75815499|FG002|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|41||
59989989|NCT01601470|76105449|FG000|PK Analysis Set|Period 3 - LCZ696+Sildenafil||27||
59816168|NCT00609869|75938533|FG000|NOT COMPLETED|Overall Study||11||
59989990|NCT01601470|76105449|FG000|Safety Set|Period 3 - LCZ696+Sildenafil||27||
59989991|NCT01601470|76105449|FG000|COMPLETED|Period 3 - LCZ696+Sildenafil||27||
59989992|NCT01601470|76105449|FG000|NOT COMPLETED|Period 3 - LCZ696+Sildenafil||0||
59696010|NCT01264770|75815500|FG003|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|48||
59696011|NCT01264770|75815501|FG004|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|19||
59696012|NCT01264770|75815502|FG005|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|19||
59696013|NCT01264770|75815497|FG000|NOT COMPLETED|Overall Study||18||
59696014|NCT01264770|75815498|FG001|NOT COMPLETED|Overall Study||10||
59696015|NCT01264770|75815499|FG002|NOT COMPLETED|Overall Study||16||
59696016|NCT01264770|75815500|FG003|NOT COMPLETED|Overall Study||6||
59696017|NCT01264770|75815501|FG004|NOT COMPLETED|Overall Study||8||
59696018|NCT01264770|75815502|FG005|NOT COMPLETED|Overall Study||6||
59696019|NCT01027702|75815522|FG000|STARTED|Overall Study||4||
59696020|NCT01027702|75815523|FG001|STARTED|Overall Study||4||
59696021|NCT01027702|75815524|FG002|STARTED|Overall Study||3||
59696022|NCT01027702|75815525|FG003|STARTED|Overall Study||14||
59696023|NCT01027702|75815526|FG004|STARTED|Overall Study||10||
59696024|NCT01027702|75815527|FG005|STARTED|Overall Study||1||
59696025|NCT01027702|75815528|FG006|STARTED|Overall Study||2||
59696026|NCT01027702|75815522|FG000|COMPLETED|Overall Study||3||
59696027|NCT01027702|75815523|FG001|COMPLETED|Overall Study||2||
59696028|NCT01027702|75815524|FG002|COMPLETED|Overall Study||2||
59696029|NCT01027702|75815525|FG003|COMPLETED|Overall Study||10||
59696030|NCT01027702|75815526|FG004|COMPLETED|Overall Study||9||
59696031|NCT01027702|75815527|FG005|COMPLETED|Overall Study||1||
59696032|NCT01027702|75815528|FG006|COMPLETED|Overall Study||1||
59696033|NCT01027702|75815522|FG000|NOT COMPLETED|Overall Study||1||
59696034|NCT01027702|75815523|FG001|NOT COMPLETED|Overall Study||2||
59696035|NCT01027702|75815524|FG002|NOT COMPLETED|Overall Study||1||
59696036|NCT01027702|75815525|FG003|NOT COMPLETED|Overall Study||4||
59696037|NCT01027702|75815526|FG004|NOT COMPLETED|Overall Study||1||
59696038|NCT01027702|75815527|FG005|NOT COMPLETED|Overall Study||0||
59696039|NCT01027702|75815528|FG006|NOT COMPLETED|Overall Study||1||
59696040|NCT01302080|75815542|FG000|STARTED|Overall Study|Out of 696 participants, 1 participant started treatment with another antidepressant alone or along with psychotherapy.|696||
59696041|NCT01302080|75815543|FG001|STARTED|Overall Study|Out of 245 participants, 2 participants started treatment with another antidepressant alone or along with psychotherapy.|245||
59696042|NCT01302080|75815542|FG000|COMPLETED|Overall Study||330||
59696043|NCT01302080|75815543|FG001|COMPLETED|Overall Study||102||
59696044|NCT01302080|75815542|FG000|NOT COMPLETED|Overall Study||366||
59696045|NCT01302080|75815543|FG001|NOT COMPLETED|Overall Study||143||
59696046|NCT01238991|75815583|FG000|STARTED|Overall Study||7||
59696047|NCT01238991|75815584|FG001|STARTED|Overall Study||3||
59696048|NCT01238991|75815585|FG002|STARTED|Overall Study||11||
59696049|NCT01238991|75815586|FG003|STARTED|Overall Study||6||
59696050|NCT01238991|75815587|FG004|STARTED|Overall Study||5||
59696051|NCT01238991|75815588|FG005|STARTED|Overall Study||2||
59696052|NCT01238991|75815589|FG006|STARTED|Overall Study||8||
59696053|NCT01238991|75815590|FG007|STARTED|Overall Study||5||
59696054|NCT01238991|75815591|FG008|STARTED|Overall Study||4||
59696055|NCT01238991|75815592|FG009|STARTED|Overall Study||2||
59696056|NCT01238991|75815583|FG000|Received Treatment|Overall Study||7||
59696057|NCT01238991|75815584|FG001|Received Treatment|Overall Study||3||
59696058|NCT01238991|75815585|FG002|Received Treatment|Overall Study||11||
59696059|NCT01238991|75815586|FG003|Received Treatment|Overall Study||6||
59696060|NCT01238991|75815587|FG004|Received Treatment|Overall Study||5||
59696061|NCT01238991|75815588|FG005|Received Treatment|Overall Study||2||
59696062|NCT01238991|75815589|FG006|Received Treatment|Overall Study||8||
59696063|NCT01238991|75815590|FG007|Received Treatment|Overall Study||5||
59696064|NCT01238991|75815591|FG008|Received Treatment|Overall Study||4||
59696065|NCT01238991|75815592|FG009|Received Treatment|Overall Study||2||
59696066|NCT01238991|75815583|FG000|COMPLETED|Overall Study||5||
59696067|NCT01238991|75815584|FG001|COMPLETED|Overall Study||3||
59696068|NCT01238991|75815585|FG002|COMPLETED|Overall Study||5||
59696069|NCT01238991|75815586|FG003|COMPLETED|Overall Study||4||
59696070|NCT01238991|75815587|FG004|COMPLETED|Overall Study||3||
59696071|NCT01238991|75815588|FG005|COMPLETED|Overall Study||2||
59696072|NCT01238991|75815589|FG006|COMPLETED|Overall Study||0||
59696073|NCT01238991|75815590|FG007|COMPLETED|Overall Study||0||
59696074|NCT01238991|75815591|FG008|COMPLETED|Overall Study||0||
59696075|NCT01238991|75815592|FG009|COMPLETED|Overall Study||0||
59696076|NCT01238991|75815583|FG000|NOT COMPLETED|Overall Study||2||
59696077|NCT01238991|75815584|FG001|NOT COMPLETED|Overall Study||0||
59696078|NCT01238991|75815585|FG002|NOT COMPLETED|Overall Study||6||
59696079|NCT01238991|75815586|FG003|NOT COMPLETED|Overall Study||2||
59696080|NCT01238991|75815587|FG004|NOT COMPLETED|Overall Study||2||
59696081|NCT01238991|75815588|FG005|NOT COMPLETED|Overall Study||0||
59696082|NCT01238991|75815589|FG006|NOT COMPLETED|Overall Study||8||
59696083|NCT01238991|75815590|FG007|NOT COMPLETED|Overall Study||5||
59696084|NCT01238991|75815591|FG008|NOT COMPLETED|Overall Study||4||
59696085|NCT01238991|75815592|FG009|NOT COMPLETED|Overall Study||2||
59696086|NCT01238835|75815617|FG000|STARTED|Overall Study||218||
59696087|NCT01238835|75815617|FG000|COMPLETED|Overall Study||82||
59696088|NCT01238835|75815617|FG000|NOT COMPLETED|Overall Study||136||
59696089|NCT01032070|75815623|FG000|STARTED|Overall Study||13||
59696090|NCT01032070|75815624|FG001|STARTED|Overall Study||12||
59696091|NCT01032070|75815623|FG000|COMPLETED|Overall Study||0||
59696092|NCT01032070|75815624|FG001|COMPLETED|Overall Study||0||
59696093|NCT01032070|75815623|FG000|NOT COMPLETED|Overall Study||13||
59696094|NCT01032070|75815624|FG001|NOT COMPLETED|Overall Study||12||
59696095|NCT01237899|75815641|FG000|STARTED|First Dosing Period||1||
59696096|NCT01237899|75815642|FG001|STARTED|First Dosing Period||3||
59696097|NCT01237899|75815643|FG002|STARTED|First Dosing Period||4||
59696098|NCT01237899|75815644|FG003|STARTED|First Dosing Period||3||
59696099|NCT01237899|75815645|FG004|STARTED|First Dosing Period||2||
59696100|NCT01237899|75815646|FG005|STARTED|First Dosing Period||4||
59696101|NCT01237899|75815647|FG006|STARTED|First Dosing Period||1||
59696102|NCT01237899|75815648|FG007|STARTED|First Dosing Period||3||
59696103|NCT01237899|75815649|FG008|STARTED|First Dosing Period||4||
59696104|NCT01237899|75815650|FG009|STARTED|First Dosing Period||3||
59696105|NCT01237899|75815651|FG010|STARTED|First Dosing Period||4||
59696106|NCT01237899|75815641|FG000|COMPLETED|First Dosing Period||1||
59696107|NCT01237899|75815642|FG001|COMPLETED|First Dosing Period||3||
59696108|NCT01237899|75815643|FG002|COMPLETED|First Dosing Period||4||
59696109|NCT01237899|75815644|FG003|COMPLETED|First Dosing Period||3||
59696110|NCT01237899|75815645|FG004|COMPLETED|First Dosing Period||2||
59696111|NCT01237899|75815646|FG005|COMPLETED|First Dosing Period||4||
59696112|NCT01237899|75815647|FG006|COMPLETED|First Dosing Period||1||
59696113|NCT01237899|75815648|FG007|COMPLETED|First Dosing Period||3||
59696114|NCT01237899|75815649|FG008|COMPLETED|First Dosing Period||4||
59696115|NCT01237899|75815650|FG009|COMPLETED|First Dosing Period||3||
59696116|NCT01237899|75815651|FG010|COMPLETED|First Dosing Period||4||
59696117|NCT01237899|75815641|FG000|NOT COMPLETED|First Dosing Period||0||
59696118|NCT01237899|75815642|FG001|NOT COMPLETED|First Dosing Period||0||
59696119|NCT01237899|75815643|FG002|NOT COMPLETED|First Dosing Period||0||
59696120|NCT01237899|75815644|FG003|NOT COMPLETED|First Dosing Period||0||
59696121|NCT01237899|75815645|FG004|NOT COMPLETED|First Dosing Period||0||
59696122|NCT01237899|75815646|FG005|NOT COMPLETED|First Dosing Period||0||
59696123|NCT01237899|75815647|FG006|NOT COMPLETED|First Dosing Period||0||
59696124|NCT01237899|75815648|FG007|NOT COMPLETED|First Dosing Period||0||
59696125|NCT01237899|75815649|FG008|NOT COMPLETED|First Dosing Period||0||
59696126|NCT01237899|75815650|FG009|NOT COMPLETED|First Dosing Period||0||
59696127|NCT01237899|75815651|FG010|NOT COMPLETED|First Dosing Period||0||
59696128|NCT01237899|75815641|FG000|STARTED|Washout Period of at Least 7 Days||1||
59696129|NCT01237899|75815642|FG001|STARTED|Washout Period of at Least 7 Days||3||
59696130|NCT01237899|75815643|FG002|STARTED|Washout Period of at Least 7 Days||4||
59696131|NCT01237899|75815644|FG003|STARTED|Washout Period of at Least 7 Days||3||
59696132|NCT01237899|75815645|FG004|STARTED|Washout Period of at Least 7 Days||2||
59696133|NCT01237899|75815646|FG005|STARTED|Washout Period of at Least 7 Days||4||
59696134|NCT01237899|75815647|FG006|STARTED|Washout Period of at Least 7 Days||1||
59696135|NCT01237899|75815648|FG007|STARTED|Washout Period of at Least 7 Days||3||
59696136|NCT01237899|75815649|FG008|STARTED|Washout Period of at Least 7 Days||4||
59696137|NCT01237899|75815650|FG009|STARTED|Washout Period of at Least 7 Days||3||
59696138|NCT01237899|75815651|FG010|STARTED|Washout Period of at Least 7 Days||4||
59696139|NCT01237899|75815641|FG000|COMPLETED|Washout Period of at Least 7 Days||1||
59696140|NCT01237899|75815642|FG001|COMPLETED|Washout Period of at Least 7 Days||3||
59696141|NCT01237899|75815643|FG002|COMPLETED|Washout Period of at Least 7 Days||3||
59696142|NCT01237899|75815644|FG003|COMPLETED|Washout Period of at Least 7 Days||3||
59696143|NCT01237899|75815645|FG004|COMPLETED|Washout Period of at Least 7 Days||2||
59696144|NCT01237899|75815646|FG005|COMPLETED|Washout Period of at Least 7 Days||4||
59696145|NCT01237899|75815647|FG006|COMPLETED|Washout Period of at Least 7 Days||1||
59696146|NCT01237899|75815648|FG007|COMPLETED|Washout Period of at Least 7 Days||3||
59696147|NCT01237899|75815649|FG008|COMPLETED|Washout Period of at Least 7 Days||4||
59696148|NCT01237899|75815650|FG009|COMPLETED|Washout Period of at Least 7 Days||3||
59696149|NCT01237899|75815651|FG010|COMPLETED|Washout Period of at Least 7 Days||4||
59696150|NCT01237899|75815641|FG000|NOT COMPLETED|Washout Period of at Least 7 Days||0||
59696151|NCT01237899|75815642|FG001|NOT COMPLETED|Washout Period of at Least 7 Days||0||
59696152|NCT01237899|75815643|FG002|NOT COMPLETED|Washout Period of at Least 7 Days||1||
59696153|NCT01237899|75815644|FG003|NOT COMPLETED|Washout Period of at Least 7 Days||0||
59696154|NCT01237899|75815645|FG004|NOT COMPLETED|Washout Period of at Least 7 Days||0||
59696155|NCT01237899|75815646|FG005|NOT COMPLETED|Washout Period of at Least 7 Days||0||
59696156|NCT01237899|75815647|FG006|NOT COMPLETED|Washout Period of at Least 7 Days||0||
59696157|NCT01237899|75815648|FG007|NOT COMPLETED|Washout Period of at Least 7 Days||0||
59696158|NCT01237899|75815649|FG008|NOT COMPLETED|Washout Period of at Least 7 Days||0||
59696159|NCT01237899|75815650|FG009|NOT COMPLETED|Washout Period of at Least 7 Days||0||
59696160|NCT01237899|75815651|FG010|NOT COMPLETED|Washout Period of at Least 7 Days||0||
59696161|NCT01237899|75815641|FG000|STARTED|Second Dosing Period||1||
59696162|NCT01237899|75815642|FG001|STARTED|Second Dosing Period||3||
59696163|NCT01237899|75815643|FG002|STARTED|Second Dosing Period||3||
59696164|NCT01237899|75815644|FG003|STARTED|Second Dosing Period||3||
59696165|NCT01237899|75815645|FG004|STARTED|Second Dosing Period||2||
59696166|NCT01237899|75815646|FG005|STARTED|Second Dosing Period||4||
59696167|NCT01237899|75815647|FG006|STARTED|Second Dosing Period||1||
59696168|NCT01237899|75815648|FG007|STARTED|Second Dosing Period||3||
59696169|NCT01237899|75815649|FG008|STARTED|Second Dosing Period||4||
59696170|NCT01237899|75815650|FG009|STARTED|Second Dosing Period||3||
59696171|NCT01237899|75815651|FG010|STARTED|Second Dosing Period||4||
59696172|NCT01237899|75815641|FG000|COMPLETED|Second Dosing Period||1||
59696173|NCT01237899|75815642|FG001|COMPLETED|Second Dosing Period||3||
59696174|NCT01237899|75815643|FG002|COMPLETED|Second Dosing Period||3||
59696175|NCT01237899|75815644|FG003|COMPLETED|Second Dosing Period||3||
59696176|NCT01237899|75815645|FG004|COMPLETED|Second Dosing Period||2||
59696177|NCT01237899|75815646|FG005|COMPLETED|Second Dosing Period||4||
59696178|NCT01237899|75815647|FG006|COMPLETED|Second Dosing Period||1||
59696179|NCT01237899|75815648|FG007|COMPLETED|Second Dosing Period||3||
59696180|NCT01237899|75815649|FG008|COMPLETED|Second Dosing Period||4||
59696181|NCT01237899|75815650|FG009|COMPLETED|Second Dosing Period||3||
59696182|NCT01237899|75815651|FG010|COMPLETED|Second Dosing Period||4||
59696183|NCT01237899|75815641|FG000|NOT COMPLETED|Second Dosing Period||0||
59696184|NCT01237899|75815642|FG001|NOT COMPLETED|Second Dosing Period||0||
59696185|NCT01237899|75815643|FG002|NOT COMPLETED|Second Dosing Period||0||
59696186|NCT01237899|75815644|FG003|NOT COMPLETED|Second Dosing Period||0||
59696187|NCT01237899|75815645|FG004|NOT COMPLETED|Second Dosing Period||0||
59696188|NCT01237899|75815646|FG005|NOT COMPLETED|Second Dosing Period||0||
59696189|NCT01237899|75815647|FG006|NOT COMPLETED|Second Dosing Period||0||
59696190|NCT01237899|75815648|FG007|NOT COMPLETED|Second Dosing Period||0||
59696191|NCT01237899|75815649|FG008|NOT COMPLETED|Second Dosing Period||0||
59696192|NCT01237899|75815650|FG009|NOT COMPLETED|Second Dosing Period||0||
59696193|NCT01237899|75815651|FG010|NOT COMPLETED|Second Dosing Period||0||
59696194|NCT01264380|75815669|FG000|STARTED|Period A||8||
59696195|NCT01264380|75815670|FG001|STARTED|Period A||8||
59696196|NCT01264380|75815671|FG002|STARTED|Period A||0||
59696197|NCT01264380|75815669|FG000|COMPLETED|Period A||8||
59696198|NCT01264380|75815670|FG001|COMPLETED|Period A||8||
59696199|NCT01264380|75815671|FG002|COMPLETED|Period A||0||
59696200|NCT01264380|75815669|FG000|NOT COMPLETED|Period A||0||
59696201|NCT01264380|75815670|FG001|NOT COMPLETED|Period A||0||
59696202|NCT01264380|75815671|FG002|NOT COMPLETED|Period A||0||
59696203|NCT01264380|75815669|FG000|STARTED|Period B||8||
59696204|NCT01264380|75815670|FG001|STARTED|Period B||8||
59696205|NCT01264380|75815671|FG002|STARTED|Period B||0||
59696206|NCT01264380|75815669|FG000|COMPLETED|Period B||8||
59696207|NCT01264380|75815670|FG001|COMPLETED|Period B||8||
59696208|NCT01264380|75815671|FG002|COMPLETED|Period B||0||
59696209|NCT01264380|75815669|FG000|NOT COMPLETED|Period B||0||
59696210|NCT01264380|75815670|FG001|NOT COMPLETED|Period B||0||
59696211|NCT01264380|75815671|FG002|NOT COMPLETED|Period B||0||
59696212|NCT01264380|75815669|FG000|STARTED|Period C||0||
59696213|NCT01264380|75815670|FG001|STARTED|Period C||0||
59696214|NCT01264380|75815671|FG002|STARTED|Period C||16||
59696215|NCT01264380|75815669|FG000|COMPLETED|Period C||0||
59696216|NCT01264380|75815670|FG001|COMPLETED|Period C||0||
59696217|NCT01264380|75815671|FG002|COMPLETED|Period C||2||
59696218|NCT01264380|75815669|FG000|NOT COMPLETED|Period C||0||
59696219|NCT01264380|75815670|FG001|NOT COMPLETED|Period C||0||
59696220|NCT01264380|75815671|FG002|NOT COMPLETED|Period C||14||
59696221|NCT01263444|75815679|FG000|STARTED|Overall Study||47||
59696222|NCT01263444|75815679|FG000|COMPLETED|Overall Study||37||
59696223|NCT01263444|75815679|FG000|NOT COMPLETED|Overall Study||10||
59696224|NCT01263054|75815685|FG000|STARTED|Overall Study||29||
59696225|NCT01263054|75815686|FG001|STARTED|Overall Study||34||
59696226|NCT01263054|75815685|FG000|COMPLETED|Overall Study||24||
59696227|NCT01263054|75815686|FG001|COMPLETED|Overall Study||28||
59696228|NCT01263054|75815685|FG000|NOT COMPLETED|Overall Study||5||
59696229|NCT01263054|75815686|FG001|NOT COMPLETED|Overall Study||6||
59696230|NCT01031836|75815698|FG000|STARTED|Stage I||5||
59696231|NCT01031836|75815699|FG001|STARTED|Stage I||5||
59696232|NCT01031836|75815700|FG002|STARTED|Stage I||5||
59696233|NCT01031836|75815701|FG003|STARTED|Stage I||5||
59696234|NCT01031836|75815702|FG004|STARTED|Stage I||5||
59696235|NCT01031836|75815703|FG005|STARTED|Stage I||5||
59696236|NCT01031836|75815698|FG000|COMPLETED|Stage I||4||
59696237|NCT01031836|75815699|FG001|COMPLETED|Stage I||3||
59696238|NCT01031836|75815700|FG002|COMPLETED|Stage I||5||
59696239|NCT01031836|75815701|FG003|COMPLETED|Stage I||5||
59696240|NCT01031836|75815702|FG004|COMPLETED|Stage I||5||
59696241|NCT01031836|75815703|FG005|COMPLETED|Stage I||4||
59696242|NCT01031836|75815698|FG000|NOT COMPLETED|Stage I||1||
59696243|NCT01031836|75815699|FG001|NOT COMPLETED|Stage I||2||
59696244|NCT01031836|75815700|FG002|NOT COMPLETED|Stage I||0||
59696245|NCT01031836|75815701|FG003|NOT COMPLETED|Stage I||0||
59696246|NCT01031836|75815702|FG004|NOT COMPLETED|Stage I||0||
59696247|NCT01031836|75815703|FG005|NOT COMPLETED|Stage I||1||
59696248|NCT01031836|75815698|FG000|STARTED|Stage II|1 patient who completed the study treatment in Stage I did not register in Stage II.|3||
59696249|NCT01031836|75815699|FG001|STARTED|Stage II|2 patient who completed the study treatment in Stage I did not register in Stage II.|1||
59696250|NCT01031836|75815700|FG002|STARTED|Stage II|1 patient who completed the study treatment in Stage I did not register in Stage II.|4||
59696251|NCT01031836|75815701|FG003|STARTED|Stage II|1 patient who completed the study treatment in Stage I did not register in Stage II.|4||
59696252|NCT01031836|75815702|FG004|STARTED|Stage II||5||
59696253|NCT01031836|75815703|FG005|STARTED|Stage II||4||
59696254|NCT01031836|75815698|FG000|COMPLETED|Stage II||1||
59696255|NCT01031836|75815699|FG001|COMPLETED|Stage II||1||
59696256|NCT01031836|75815700|FG002|COMPLETED|Stage II||2||
59696257|NCT01031836|75815701|FG003|COMPLETED|Stage II||1||
59696258|NCT01031836|75815702|FG004|COMPLETED|Stage II||3||
59696259|NCT01031836|75815703|FG005|COMPLETED|Stage II||3||
59696260|NCT01031836|75815698|FG000|NOT COMPLETED|Stage II||2||
59696261|NCT01031836|75815699|FG001|NOT COMPLETED|Stage II||0||
59696262|NCT01031836|75815700|FG002|NOT COMPLETED|Stage II||2||
59696263|NCT01031836|75815701|FG003|NOT COMPLETED|Stage II||3||
59696264|NCT01031836|75815702|FG004|NOT COMPLETED|Stage II||2||
59696265|NCT01031836|75815703|FG005|NOT COMPLETED|Stage II||1||
59696266|NCT01237587|75815719|FG000|STARTED|Double Blind Treatment (Acute Phase)||91||
59696267|NCT01237587|75815720|FG001|STARTED|Double Blind Treatment (Acute Phase)||93||
59696268|NCT01237587|75815719|FG000|Received at Least One Dose of Study Drug|Double Blind Treatment (Acute Phase)||91||
59696269|NCT01237587|75815720|FG001|Received at Least One Dose of Study Drug|Double Blind Treatment (Acute Phase)||93||
59696270|NCT01237587|75815719|FG000|COMPLETED|Double Blind Treatment (Acute Phase)||74||
59696271|NCT01237587|75815720|FG001|COMPLETED|Double Blind Treatment (Acute Phase)||75||
59696272|NCT01237587|75815719|FG000|NOT COMPLETED|Double Blind Treatment (Acute Phase)||17||
59696273|NCT01237587|75815720|FG001|NOT COMPLETED|Double Blind Treatment (Acute Phase)||18||
59696274|NCT01237587|75815719|FG000|STARTED|Open Label Treatment (Extension Phase)||74||
59696275|NCT01237587|75815720|FG001|STARTED|Open Label Treatment (Extension Phase)||75||
59696276|NCT01237587|75815719|FG000|Received at Least One Dose of Study Drug|Open Label Treatment (Extension Phase)||74||
59696277|NCT01237587|75815720|FG001|Received at Least One Dose of Study Drug|Open Label Treatment (Extension Phase)||75||
59696278|NCT01237587|75815719|FG000|COMPLETED|Open Label Treatment (Extension Phase)||56||
59696279|NCT01237587|75815720|FG001|COMPLETED|Open Label Treatment (Extension Phase)||50||
59696280|NCT01237587|75815719|FG000|NOT COMPLETED|Open Label Treatment (Extension Phase)||18||
59696281|NCT01237587|75815720|FG001|NOT COMPLETED|Open Label Treatment (Extension Phase)||25||
59696282|NCT01237587|75815719|FG000|STARTED|Taper Phase|Participants who discontinued Acute or Extension phase had an option to enter tapering phase.|36||
59696283|NCT01237587|75815720|FG001|STARTED|Taper Phase|Participants who discontinued Acute or Extension phase had an option to enter tapering phase.|44||
59696284|NCT01237587|75815719|FG000|COMPLETED|Taper Phase||31||
59696285|NCT01237587|75815720|FG001|COMPLETED|Taper Phase||34||
59696286|NCT01237587|75815719|FG000|NOT COMPLETED|Taper Phase||5||
59696287|NCT01237587|75815720|FG001|NOT COMPLETED|Taper Phase||10||
59696288|NCT01031680|75815735|FG000|STARTED|Overall Study|Of the 460 randomized participants only 455 were included in the full analysis set.|460||
59696289|NCT01031680|75815736|FG001|STARTED|Overall Study|Of the 462 randomized participants only 459 were included in the full analysis set.|462||
59696290|NCT01031680|75815735|FG000|COMPLETED|Overall Study||403||
59696291|NCT01031680|75815736|FG001|COMPLETED|Overall Study||404||
59696292|NCT01031680|75815735|FG000|NOT COMPLETED|Overall Study||57||
59696293|NCT01031680|75815736|FG001|NOT COMPLETED|Overall Study||58||
59696294|NCT01031446|75815742|FG000|STARTED|Overall Study||55||
59696295|NCT01031446|75815742|FG000|COMPLETED|Overall Study||0||
59696296|NCT01031446|75815742|FG000|NOT COMPLETED|Overall Study||55||
59696297|NCT01030900|75815748|FG000|STARTED|Overall Study||50||
59696298|NCT01030900|75815748|FG000|COMPLETED|Overall Study||48||
59696299|NCT01030900|75815748|FG000|NOT COMPLETED|Overall Study||2||
59696300|NCT01030822|75815755|FG000|STARTED|Overall Study||100||
59696301|NCT01030822|75815756|FG001|STARTED|Overall Study||95||
59696302|NCT01030822|75815757|FG002|STARTED|Overall Study||87||
59696303|NCT01030822|75815755|FG000|COMPLETED|Overall Study||69||
59696304|NCT01030822|75815756|FG001|COMPLETED|Overall Study||71||
59696305|NCT01030822|75815757|FG002|COMPLETED|Overall Study||61||
59696306|NCT01030822|75815755|FG000|NOT COMPLETED|Overall Study||31||
59696307|NCT01030822|75815756|FG001|NOT COMPLETED|Overall Study||24||
59696308|NCT01030822|75815757|FG002|NOT COMPLETED|Overall Study||26||
59696309|NCT01026454|75815768|FG000|STARTED|First Intervention||18||
59696310|NCT01026454|75815769|FG001|STARTED|First Intervention||14||
59696311|NCT01026454|75815768|FG000|COMPLETED|First Intervention||18||
59696312|NCT01026454|75815769|FG001|COMPLETED|First Intervention||14||
59696313|NCT01026454|75815768|FG000|NOT COMPLETED|First Intervention||0||
59696314|NCT01026454|75815769|FG001|NOT COMPLETED|First Intervention||0||
59696315|NCT01026454|75815768|FG000|STARTED|Washout||18||
59696316|NCT01026454|75815769|FG001|STARTED|Washout||14||
59696317|NCT01026454|75815768|FG000|COMPLETED|Washout||18||
59696318|NCT01026454|75815769|FG001|COMPLETED|Washout||14||
59696319|NCT01026454|75815768|FG000|NOT COMPLETED|Washout||0||
59696320|NCT01026454|75815769|FG001|NOT COMPLETED|Washout||0||
59696321|NCT01026454|75815768|FG000|STARTED|Second Intervention||17||
59696322|NCT01026454|75815769|FG001|STARTED|Second Intervention||14||
59696323|NCT01026454|75815768|FG000|COMPLETED|Second Intervention||16||
59696324|NCT01026454|75815769|FG001|COMPLETED|Second Intervention||13||
59696325|NCT01026454|75815768|FG000|NOT COMPLETED|Second Intervention||1||
59696326|NCT01026454|75815769|FG001|NOT COMPLETED|Second Intervention||1||
59696327|NCT01026220|75815775|FG000|STARTED|Induction||166||
59696328|NCT01026220|75815776|FG001|STARTED|Induction||0||
59696329|NCT01026220|75815777|FG002|STARTED|Induction||0||
59696330|NCT01026220|75815775|FG000|COMPLETED|Induction||141||
59696331|NCT01026220|75815776|FG001|COMPLETED|Induction||0||
59696332|NCT01026220|75815777|FG002|COMPLETED|Induction||0||
59696333|NCT01026220|75815775|FG000|NOT COMPLETED|Induction||25||
59696334|NCT01026220|75815776|FG001|NOT COMPLETED|Induction||0||
59696335|NCT01026220|75815777|FG002|NOT COMPLETED|Induction||0||
59696336|NCT01026220|75815775|FG000|STARTED|Consolidation Maintenance||0||
59696337|NCT01026220|75815776|FG001|STARTED|Consolidation Maintenance||81||
59696338|NCT01026220|75815777|FG002|STARTED|Consolidation Maintenance||80||
59696339|NCT01026220|75815775|FG000|COMPLETED|Consolidation Maintenance||0||
59696340|NCT01026220|75815776|FG001|COMPLETED|Consolidation Maintenance||75||
59696341|NCT01026220|75815777|FG002|COMPLETED|Consolidation Maintenance||66||
59696342|NCT01026220|75815775|FG000|NOT COMPLETED|Consolidation Maintenance||0||
59696343|NCT01026220|75815776|FG001|NOT COMPLETED|Consolidation Maintenance||6||
59696344|NCT01026220|75815777|FG002|NOT COMPLETED|Consolidation Maintenance||14||
59696345|NCT01026142|75815794|FG000|STARTED|Overall Study||224||
59696346|NCT01026142|75815795|FG001|STARTED|Overall Study||228||
59696347|NCT01026142|75815794|FG000|COMPLETED|Overall Study||52||
59696348|NCT01026142|75815795|FG001|COMPLETED|Overall Study||65||
59696349|NCT01026142|75815794|FG000|NOT COMPLETED|Overall Study||172||
59696350|NCT01026142|75815795|FG001|NOT COMPLETED|Overall Study||163||
59696351|NCT05890586|75815803|FG000|STARTED|Overall Study||686||
59696352|NCT05890586|75815804|FG001|STARTED|Overall Study||645||
59696353|NCT05890586|75815803|FG000|COMPLETED|Overall Study||676||
59696354|NCT05890586|75815804|FG001|COMPLETED|Overall Study||615||
59696355|NCT05890586|75815803|FG000|NOT COMPLETED|Overall Study||10||
59696356|NCT05890586|75815804|FG001|NOT COMPLETED|Overall Study||30||
59696357|NCT04615403|75815810|FG000|STARTED|Overall Study||33||
59696358|NCT04615403|75815810|FG000|COMPLETED|Overall Study||32||
59696359|NCT04615403|75815810|FG000|NOT COMPLETED|Overall Study||1||
59696360|NCT04604899|75815814|FG000|STARTED|Overall Study||30||
59696361|NCT04604899|75815814|FG000|COMPLETED|Overall Study||23||
59696362|NCT04604899|75815814|FG000|NOT COMPLETED|Overall Study||7||
59696363|NCT04368429|75815820|FG000|STARTED|Overall Study||180||
59696364|NCT04368429|75815821|FG001|STARTED|Overall Study||180||
59696365|NCT04368429|75815820|FG000|Safety Analysis Set|Overall Study||179|Participants who received at least one dose of the study vaccine and had any safety data available; analyzed according to the vaccine they actually received.|
59696366|NCT04368429|75815821|FG001|Safety Analysis Set|Overall Study||180|Participants who received at least one dose of the study vaccine and had any safety data available; analyzed according to the vaccine they actually received.|
59696367|NCT04368429|75815820|FG000|COMPLETED|Overall Study||179||
59696368|NCT04368429|75815821|FG001|COMPLETED|Overall Study||180||
59696369|NCT04368429|75815820|FG000|NOT COMPLETED|Overall Study||1||
59696370|NCT04368429|75815821|FG001|NOT COMPLETED|Overall Study||0||
59696371|NCT04216017|75815829|FG000|STARTED|Overall Study||5||
59696372|NCT04216017|75815830|FG001|STARTED|Overall Study||4||
59696373|NCT04216017|75815829|FG000|COMPLETED|Overall Study||4||
59696374|NCT04216017|75815830|FG001|COMPLETED|Overall Study||4||
59696375|NCT04216017|75815829|FG000|NOT COMPLETED|Overall Study||1||
59696376|NCT04216017|75815830|FG001|NOT COMPLETED|Overall Study||0||
59696377|NCT04091438|75815838|FG000|STARTED|Treatment Period 1 (1 Day)||14||
59696378|NCT04091438|75815839|FG001|STARTED|Treatment Period 1 (1 Day)||14||
59696379|NCT04091438|75815838|FG000|Treated|Treatment Period 1 (1 Day)||13||
59696380|NCT04091438|75815839|FG001|Treated|Treatment Period 1 (1 Day)||14||
59696381|NCT04091438|75815838|FG000|COMPLETED|Treatment Period 1 (1 Day)||13||
59696382|NCT04091438|75815839|FG001|COMPLETED|Treatment Period 1 (1 Day)||14||
59696383|NCT04091438|75815838|FG000|NOT COMPLETED|Treatment Period 1 (1 Day)||1||
59696384|NCT04091438|75815839|FG001|NOT COMPLETED|Treatment Period 1 (1 Day)||0||
59696385|NCT04091438|75815838|FG000|STARTED|Washout Period (1 Day)||13||
59696386|NCT04091438|75815839|FG001|STARTED|Washout Period (1 Day)||14||
59696387|NCT04091438|75815838|FG000|COMPLETED|Washout Period (1 Day)||13||
59696388|NCT04091438|75815839|FG001|COMPLETED|Washout Period (1 Day)||12||
59696389|NCT04091438|75815838|FG000|NOT COMPLETED|Washout Period (1 Day)||0||
59696390|NCT04091438|75815839|FG001|NOT COMPLETED|Washout Period (1 Day)||2||
59696391|NCT04091438|75815838|FG000|STARTED|Treatment Period 2 (1 Day)||13||
59696392|NCT04091438|75815839|FG001|STARTED|Treatment Period 2 (1 Day)||12||
59696393|NCT04091438|75815838|FG000|COMPLETED|Treatment Period 2 (1 Day)||13||
59696394|NCT04091438|75815839|FG001|COMPLETED|Treatment Period 2 (1 Day)||12||
59696395|NCT04091438|75815838|FG000|NOT COMPLETED|Treatment Period 2 (1 Day)||0||
59696396|NCT04091438|75815839|FG001|NOT COMPLETED|Treatment Period 2 (1 Day)||0||
59696397|NCT04084769|75815851|FG000|STARTED|Overall Study||191||
59696398|NCT04084769|75815852|FG001|STARTED|Overall Study||190||
59696399|NCT04084769|75815853|FG002|STARTED|Overall Study||95||
59696400|NCT04084769|75815854|FG003|STARTED|Overall Study||94||
59696401|NCT04084769|75815851|FG000|Safety Analysis Set (SAfAS)|Overall Study||186|Participants who had received at least one dose of study vaccine in MET59 and had available safety data.|
59696402|NCT04084769|75815852|FG001|Safety Analysis Set (SAfAS)|Overall Study||184|Participants who had received at least one dose of study vaccine in MET59 and had available safety data.|
59696403|NCT04084769|75815853|FG002|Safety Analysis Set (SAfAS)|Overall Study||93|Participants who had received at least one dose of study vaccine in MET59 and had available safety data.|
59696404|NCT04084769|75815854|FG003|Safety Analysis Set (SAfAS)|Overall Study||92|Participants who had received at least one dose of study vaccine in MET59 and had available safety data.|
59696405|NCT04084769|75815851|FG000|Full Analysis Set|Overall Study||191|Participants who had a valid pre-vaccination serology result.|
59696406|NCT04084769|75815852|FG001|Full Analysis Set|Overall Study||190|Participants who had a valid pre-vaccination serology result.|
59696407|NCT04084769|75815853|FG002|Full Analysis Set|Overall Study||95|Participants who had a valid pre-vaccination serology result.|
59696408|NCT04084769|75815854|FG003|Full Analysis Set|Overall Study||94|Participants who had a valid pre-vaccination serology result.|
59696409|NCT04084769|75815851|FG000|Per-Protocol Analysis Set 1 (PPAS1)|Overall Study||46|Participants who received at least 1 dose of the study vaccine in MET59 and had a valid post-vaccination serology result with no relevant protocol deviation; defined for evaluating the immune response of MenACYW vaccine measured by serum bactericidal assay using human complement (hSBA) assessed at Day 06 after vaccination in Groups 1 and 2.|
59696410|NCT04084769|75815852|FG001|Per-Protocol Analysis Set 1 (PPAS1)|Overall Study||45|Participants who received at least 1 dose of the study vaccine in MET59 and had a valid post-vaccination serology result with no relevant protocol deviation; defined for evaluating the immune response of MenACYW vaccine measured by serum bactericidal assay using human complement (hSBA) assessed at Day 06 after vaccination in Groups 1 and 2.|
59696411|NCT04084769|75815853|FG002|Per-Protocol Analysis Set 1 (PPAS1)|Overall Study||0|Participants who received at least 1 dose of the study vaccine in MET59 and had a valid post-vaccination serology result with no relevant protocol deviation; defined for evaluating the immune response of MenACYW vaccine measured by serum bactericidal assay using human complement (hSBA) assessed at Day 06 after vaccination in Groups 1 and 2.|
59696412|NCT04084769|75815854|FG003|Per-Protocol Analysis Set 1 (PPAS1)|Overall Study||0|Participants who received at least 1 dose of the study vaccine in MET59 and had a valid post-vaccination serology result with no relevant protocol deviation; defined for evaluating the immune response of MenACYW vaccine measured by serum bactericidal assay using human complement (hSBA) assessed at Day 06 after vaccination in Groups 1 and 2.|
59696413|NCT04084769|75815851|FG000|Per-Protocol Analysis Set 2 (PPAS2)|Overall Study||174|Participants who received at least 1 dose of the study vaccine in MET59 and had a valid post-vaccination serology result with no relevant protocol deviation; defined for evaluating the immune response of MenACYW vaccine measured by hSBA or serum bactericidal assay using baby rabbit complement (rSBA) assessed at Day 30 after vaccination.|
59696414|NCT04084769|75815852|FG001|Per-Protocol Analysis Set 2 (PPAS2)|Overall Study||176|Participants who received at least 1 dose of the study vaccine in MET59 and had a valid post-vaccination serology result with no relevant protocol deviation; defined for evaluating the immune response of MenACYW vaccine measured by hSBA or serum bactericidal assay using baby rabbit complement (rSBA) assessed at Day 30 after vaccination.|
59696415|NCT04084769|75815853|FG002|Per-Protocol Analysis Set 2 (PPAS2)|Overall Study||90|Participants who received at least 1 dose of the study vaccine in MET59 and had a valid post-vaccination serology result with no relevant protocol deviation; defined for evaluating the immune response of MenACYW vaccine measured by hSBA or serum bactericidal assay using baby rabbit complement (rSBA) assessed at Day 30 after vaccination.|
59696416|NCT04084769|75815854|FG003|Per-Protocol Analysis Set 2 (PPAS2)|Overall Study||89|Participants who received at least 1 dose of the study vaccine in MET59 and had a valid post-vaccination serology result with no relevant protocol deviation; defined for evaluating the immune response of MenACYW vaccine measured by hSBA or serum bactericidal assay using baby rabbit complement (rSBA) assessed at Day 30 after vaccination.|
59696417|NCT04084769|75815851|FG000|COMPLETED|Overall Study||187||
59696418|NCT04084769|75815852|FG001|COMPLETED|Overall Study||186||
59696419|NCT04084769|75815853|FG002|COMPLETED|Overall Study||95||
59696420|NCT04084769|75815854|FG003|COMPLETED|Overall Study||92||
59696421|NCT04084769|75815851|FG000|NOT COMPLETED|Overall Study||4||
59696422|NCT04084769|75815852|FG001|NOT COMPLETED|Overall Study||4||
59696423|NCT04084769|75815853|FG002|NOT COMPLETED|Overall Study||0||
59696424|NCT04084769|75815854|FG003|NOT COMPLETED|Overall Study||2||
59696425|NCT03890367|75815872|FG000|STARTED|Overall Study||232||
59696426|NCT03890367|75815873|FG001|STARTED|Overall Study||235||
59696427|NCT03890367|75815874|FG002|STARTED|Overall Study||240||
59696428|NCT03890367|75815872|FG000|Safety Analysis Set|Overall Study||230|All participants who had received one dose of study vaccine and analyzed according to the vaccine they actually received.|
59696429|NCT03890367|75815873|FG001|Safety Analysis Set|Overall Study||232|All participants who had received one dose of study vaccine and analyzed according to the vaccine they actually received.|
59696430|NCT03890367|75815874|FG002|Safety Analysis Set|Overall Study||239|All participants who had received one dose of study vaccine and analyzed according to the vaccine they actually received.|
59696431|NCT03890367|75815872|FG000|COMPLETED|Overall Study||228||
59696432|NCT03890367|75815873|FG001|COMPLETED|Overall Study||229||
59696433|NCT03890367|75815874|FG002|COMPLETED|Overall Study||239||
59696434|NCT03890367|75815872|FG000|NOT COMPLETED|Overall Study||4||
59696435|NCT03890367|75815873|FG001|NOT COMPLETED|Overall Study||6||
59696436|NCT03890367|75815874|FG002|NOT COMPLETED|Overall Study||1||
59696437|NCT03868124|75815885|FG000|STARTED|Overall Study||185||
59696438|NCT03868124|75815886|FG001|STARTED|Overall Study||183||
59696439|NCT03868124|75815887|FG002|STARTED|Overall Study||192||
59696440|NCT03868124|75815885|FG000|Month 3|Overall Study||182||
59989993|NCT04527328|76105457|FG000|STARTED|Overall Study||5||
59989994|NCT04527328|76105458|FG001|STARTED|Overall Study||5||
59547787|NCT01124786|75646673|FG000|STARTED|Overall Study||182||
59696441|NCT03868124|75815886|FG001|Month 3|Overall Study||182||
59696442|NCT03868124|75815887|FG002|Month 3|Overall Study||190||
59696443|NCT03868124|75815885|FG000|Month 12|Overall Study||176||
59696444|NCT03868124|75815886|FG001|Month 12|Overall Study||180||
59696445|NCT03868124|75815887|FG002|Month 12|Overall Study||183||
59696446|NCT03868124|75815885|FG000|COMPLETED|Overall Study||0||
59696447|NCT03868124|75815886|FG001|COMPLETED|Overall Study||0||
59696448|NCT03868124|75815887|FG002|COMPLETED|Overall Study||0||
59696449|NCT03868124|75815885|FG000|NOT COMPLETED|Overall Study||185||
59696450|NCT03868124|75815886|FG001|NOT COMPLETED|Overall Study||183||
59696451|NCT03868124|75815887|FG002|NOT COMPLETED|Overall Study||192||
59696452|NCT03733249|75815895|FG000|STARTED|Overall Study||184|Patients receiving HSCT graft (HSCT Safety population)|
59696453|NCT03733249|75815895|FG000|Patients Receiving Rivogenlecleucel (BPX-501 Safety Population)|Overall Study||171||
59696454|NCT03733249|75815895|FG000|Intent-to-Treat Population|Overall Study||142|Includes all patients treated with HSCT who received rivogenlecleucel at the dose of 1×10E6 cells/kg.|
59696455|NCT03733249|75815895|FG000|Patients Receiving at Least 1 Dose of Rimiducid|Overall Study||16||
59696456|NCT03733249|75815895|FG000|COMPLETED|Overall Study||149||
59696457|NCT03733249|75815895|FG000|NOT COMPLETED|Overall Study||35||
59696458|NCT03469271|75815907|FG000|STARTED|Overall Study||16||
59696459|NCT03469271|75815908|FG001|STARTED|Overall Study||15||
59696460|NCT03469271|75815909|FG002|STARTED|Overall Study||15||
59696461|NCT03469271|75815910|FG003|STARTED|Overall Study||17||
59696462|NCT03469271|75815907|FG000|COMPLETED|Overall Study||14||
59696463|NCT03469271|75815908|FG001|COMPLETED|Overall Study||15||
59696464|NCT03469271|75815909|FG002|COMPLETED|Overall Study||15||
59696465|NCT03469271|75815910|FG003|COMPLETED|Overall Study||16||
59696466|NCT03469271|75815907|FG000|NOT COMPLETED|Overall Study||2||
59696467|NCT03469271|75815908|FG001|NOT COMPLETED|Overall Study||0||
59696468|NCT03469271|75815909|FG002|NOT COMPLETED|Overall Study||0||
59696469|NCT03469271|75815910|FG003|NOT COMPLETED|Overall Study||1||
59696470|NCT03430921|75815920|FG000|STARTED|Overall Study||4||
59696471|NCT03430921|75815920|FG000|COMPLETED|Overall Study||2||
59696472|NCT03430921|75815920|FG000|NOT COMPLETED|Overall Study||2||
59696473|NCT03302234|75815926|FG000|STARTED|Overall Study||284||
59696474|NCT03302234|75815927|FG001|STARTED|Overall Study||284||
59696475|NCT03302234|75815926|FG000|COMPLETED|Overall Study||0||
59696476|NCT03302234|75815927|FG001|COMPLETED|Overall Study||0||
59696477|NCT03302234|75815926|FG000|NOT COMPLETED|Overall Study||284||
59696478|NCT03302234|75815927|FG001|NOT COMPLETED|Overall Study||284||
59696479|NCT02754596|75815937|FG000|STARTED|Overall Study||51||
59696480|NCT02754596|75815938|FG001|STARTED|Overall Study||54||
59696481|NCT02754596|75815939|FG002|STARTED|Overall Study||49||
59696482|NCT02754596|75815937|FG000|Month 3|Overall Study||51||
59696483|NCT02754596|75815938|FG001|Month 3|Overall Study||54||
59696484|NCT02754596|75815939|FG002|Month 3|Overall Study||49||
59696485|NCT02754596|75815937|FG000|COMPLETED|Overall Study||44||
59696486|NCT02754596|75815938|FG001|COMPLETED|Overall Study||46||
59696487|NCT02754596|75815939|FG002|COMPLETED|Overall Study||45||
59696488|NCT02754596|75815937|FG000|NOT COMPLETED|Overall Study||7||
59696489|NCT02754596|75815938|FG001|NOT COMPLETED|Overall Study||8||
59696490|NCT02754596|75815939|FG002|NOT COMPLETED|Overall Study||4||
59696491|NCT02744898|75815947|FG000|STARTED|Overall Study||23||
59696492|NCT02744898|75815947|FG000|COMPLETED|Overall Study||19||
59696493|NCT02744898|75815947|FG000|NOT COMPLETED|Overall Study||4||
59696494|NCT02095132|75815960|FG000|STARTED|Overall Study||4||
59696495|NCT02095132|75815961|FG001|STARTED|Overall Study||5||
59696496|NCT02095132|75815962|FG002|STARTED|Overall Study||4||
59696497|NCT02095132|75815963|FG003|STARTED|Overall Study||10||
59696498|NCT02095132|75815964|FG004|STARTED|Overall Study||8||
60079520|NCT04206332|76194703|FG003|STARTED|Part C||0||
60079521|NCT04206332|76194704|FG004|STARTED|Part C||0||
59696499|NCT02095132|75815965|FG005|STARTED|Overall Study||6||
59696500|NCT02095132|75815966|FG006|STARTED|Overall Study||19||
59696501|NCT02095132|75815967|FG007|STARTED|Overall Study||10||
59696502|NCT02095132|75815968|FG008|STARTED|Overall Study||10||
59696503|NCT02095132|75815960|FG000|COMPLETED|Overall Study||0||
59696504|NCT02095132|75815961|FG001|COMPLETED|Overall Study||0||
59696505|NCT02095132|75815962|FG002|COMPLETED|Overall Study||0||
59696506|NCT02095132|75815963|FG003|COMPLETED|Overall Study||0||
59696507|NCT02095132|75815964|FG004|COMPLETED|Overall Study||1||
59989995|NCT04527328|76105457|FG000|AKST1210 S-15 or Control|Overall Study||5||
59989996|NCT04527328|76105458|FG001|AKST1210 S-15 or Control|Overall Study||5||
59989997|NCT04527328|76105457|FG000|AKST1210 S-25 or Control|Overall Study||5||
59989998|NCT04527328|76105458|FG001|AKST1210 S-25 or Control|Overall Study||5||
59989999|NCT04527328|76105457|FG000|AKST1210 S-35 or Control|Overall Study||4||
59990000|NCT04527328|76105458|FG001|AKST1210 S-35 or Control|Overall Study||5||
59990001|NCT04527328|76105457|FG000|COMPLETED|Overall Study||3|Subjects who completed the End of Study (follow-up) visit|
59696508|NCT02095132|75815965|FG005|COMPLETED|Overall Study||0||
59696509|NCT02095132|75815966|FG006|COMPLETED|Overall Study||1||
59696510|NCT02095132|75815967|FG007|COMPLETED|Overall Study||1||
59696511|NCT02095132|75815968|FG008|COMPLETED|Overall Study||0||
59696512|NCT02095132|75815960|FG000|NOT COMPLETED|Overall Study||4||
59696513|NCT02095132|75815961|FG001|NOT COMPLETED|Overall Study||5||
60079522|NCT04206332|76194705|FG005|STARTED|Part C||0||
60079523|NCT04206332|76194706|FG006|STARTED|Part C||0||
60079524|NCT04206332|76194707|FG007|STARTED|Part C||0||
59547788|NCT01124786|75646674|FG001|STARTED|Overall Study||185||
59547789|NCT01124786|75646673|FG000|Intent-to-Treat (ITT) Population|Overall Study|All randomized patients (pts)|182||
59696514|NCT02095132|75815962|FG002|NOT COMPLETED|Overall Study||4||
59696515|NCT02095132|75815963|FG003|NOT COMPLETED|Overall Study||10||
59696516|NCT02095132|75815964|FG004|NOT COMPLETED|Overall Study||7||
59696517|NCT02095132|75815965|FG005|NOT COMPLETED|Overall Study||6||
59696518|NCT02095132|75815966|FG006|NOT COMPLETED|Overall Study||18||
59696519|NCT02095132|75815967|FG007|NOT COMPLETED|Overall Study||9||
59696520|NCT02095132|75815968|FG008|NOT COMPLETED|Overall Study||10||
59696521|NCT01867333|75815993|FG000|STARTED|Overall Study||29||
59696522|NCT01867333|75815994|FG001|STARTED|Overall Study||28||
59696523|NCT01867333|75815993|FG000|COMPLETED|Overall Study||21||
59696524|NCT01867333|75815994|FG001|COMPLETED|Overall Study||23||
59696525|NCT01867333|75815993|FG000|NOT COMPLETED|Overall Study||8||
59696526|NCT01867333|75815994|FG001|NOT COMPLETED|Overall Study||5||
59696527|NCT01534494|75816000|FG000|STARTED|Overall Study||10||
59696528|NCT01534494|75816000|FG000|COMPLETED|Overall Study||9||
59696529|NCT01534494|75816000|FG000|NOT COMPLETED|Overall Study||1||
59696530|NCT01428635|75816006|FG000|STARTED|Overall Study||15||
59696531|NCT01428635|75816007|FG001|STARTED|Overall Study||6||
59696532|NCT01428635|75816006|FG000|COMPLETED|Overall Study||15||
59696533|NCT01428635|75816007|FG001|COMPLETED|Overall Study||6||
59696534|NCT01428635|75816006|FG000|NOT COMPLETED|Overall Study||0||
59696535|NCT01428635|75816007|FG001|NOT COMPLETED|Overall Study||0||
59696536|NCT00788671|75816013|FG000|STARTED|Overall Study||57||
59696537|NCT00788671|75816013|FG000|COMPLETED|Overall Study||47||
59696538|NCT00788671|75816013|FG000|NOT COMPLETED|Overall Study||10||
59696539|NCT00602797|75816017|FG000|STARTED|Overall Study||20||
59696540|NCT00602797|75816017|FG000|COMPLETED|Overall Study||19||
59696541|NCT00602797|75816017|FG000|NOT COMPLETED|Overall Study||1||
59696542|NCT00550615|75816024|FG000|STARTED|Overall Study||3||
59696543|NCT00550615|75816025|FG001|STARTED|Overall Study||3||
59696544|NCT00550615|75816026|FG002|STARTED|Overall Study||10||
59696545|NCT00550615|75816027|FG003|STARTED|Overall Study||22||
59696546|NCT00550615|75816024|FG000|COMPLETED|Overall Study||3||
59816169|NCT00529568|75938539|FG000|STARTED|Open-label Pre-Antiviral Treatment Phase||805||
59547790|NCT01124786|75646674|FG001|Intent-to-Treat (ITT) Population|Overall Study||185||
59547791|NCT01124786|75646673|FG000|Safety Population|Overall Study|All pts who received at least one dose of study drug|179||
59816170|NCT00529568|75938540|FG001|STARTED|Open-label Pre-Antiviral Treatment Phase||0||
59547792|NCT01124786|75646674|FG001|Safety Population|Overall Study||181||
59547793|NCT01124786|75646673|FG000|Tumor Evaluable Population|Overall Study|All pts with measurable/evaluable tumor at baseline per RECIST and have received ≥ one dose of drug|178||
59547794|NCT01124786|75646674|FG001|Tumor Evaluable Population|Overall Study||180||
59547795|NCT01124786|75646673|FG000|COMPLETED|Overall Study||178||
59547796|NCT01124786|75646674|FG001|COMPLETED|Overall Study||180||
59547797|NCT01124786|75646673|FG000|NOT COMPLETED|Overall Study||4||
59547798|NCT01124786|75646674|FG001|NOT COMPLETED|Overall Study||5||
59547799|NCT02477709|75646680|FG000|STARTED|Overall Study||6||
59547800|NCT02477709|75646680|FG000|COMPLETED|Overall Study||6||
59547801|NCT02477709|75646680|FG000|NOT COMPLETED|Overall Study||0||
59547802|NCT01108406|75646684|FG000|STARTED|Overall Study||22||
59547803|NCT01108406|75646684|FG000|COMPLETED|Overall Study||22||
59547804|NCT01108406|75646684|FG000|NOT COMPLETED|Overall Study||0||
59547805|NCT01125098|75646692|FG000|STARTED|Overall Study||91||
59547806|NCT01125098|75646693|FG001|STARTED|Overall Study||90||
59547807|NCT01125098|75646692|FG000|COMPLETED|Overall Study||88||
59547808|NCT01125098|75646693|FG001|COMPLETED|Overall Study||90||
59547809|NCT01125098|75646692|FG000|NOT COMPLETED|Overall Study||3||
59547810|NCT01125098|75646693|FG001|NOT COMPLETED|Overall Study||0||
59547811|NCT02179424|75646703|FG000|STARTED|Overall Study||76||
59547812|NCT02179424|75646704|FG001|STARTED|Overall Study||11||
59547813|NCT02179424|75646705|FG002|STARTED|Overall Study||516||
59547814|NCT02179424|75646706|FG003|STARTED|Overall Study||39||
59547815|NCT02179424|75646703|FG000|COMPLETED|Overall Study||76||
59547816|NCT02179424|75646704|FG001|COMPLETED|Overall Study||11||
59696547|NCT00550615|75816025|FG001|COMPLETED|Overall Study||3||
59696548|NCT00550615|75816026|FG002|COMPLETED|Overall Study||6||
59696549|NCT00550615|75816027|FG003|COMPLETED|Overall Study||12||
59696550|NCT00550615|75816024|FG000|NOT COMPLETED|Overall Study||0||
59696551|NCT00550615|75816025|FG001|NOT COMPLETED|Overall Study||0||
59816171|NCT00529568|75938541|FG002|STARTED|Open-label Pre-Antiviral Treatment Phase||0||
59816172|NCT00529568|75938539|FG000|COMPLETED|Open-label Pre-Antiviral Treatment Phase||759||
60079525|NCT04206332|76194708|FG008|STARTED|Part C||0||
60079526|NCT04206332|76194709|FG009|STARTED|Part C||0||
60079527|NCT04206332|76194710|FG010|STARTED|Part C||0||
60079528|NCT04206332|76194711|FG011|STARTED|Part C||7||
59696552|NCT00550615|75816026|FG002|NOT COMPLETED|Overall Study||4||
59696553|NCT00550615|75816027|FG003|NOT COMPLETED|Overall Study||10||
59816173|NCT00529568|75938540|FG001|COMPLETED|Open-label Pre-Antiviral Treatment Phase||0||
60079529|NCT04206332|76194712|FG012|STARTED|Part C||4||
59696554|NCT00471848|75816033|FG000|STARTED|Overall Study||35||
59696555|NCT00471848|75816033|FG000|COMPLETED|Overall Study|35 registered patients received the full 5-day Rabbit Antithymocyte Globulin (RATG) treatment|35||
59696556|NCT00471848|75816033|FG000|NOT COMPLETED|Overall Study||0||
59696557|NCT00006721|75816040|FG000|STARTED|Overall Study||17||
59696558|NCT00006721|75816041|FG001|STARTED|Overall Study||279||
59696559|NCT00006721|75816042|FG002|STARTED|Overall Study||275||
59696560|NCT00006721|75816040|FG000|Eligible|Overall Study||15||
59696561|NCT00006721|75816041|FG001|Eligible|Overall Study||267||
59696562|NCT00006721|75816042|FG002|Eligible|Overall Study||265||
59696563|NCT00006721|75816040|FG000|Eligible and Began Protocol Therapy|Overall Study||14||
59696564|NCT00006721|75816041|FG001|Eligible and Began Protocol Therapy|Overall Study||267||
59696565|NCT00006721|75816042|FG002|Eligible and Began Protocol Therapy|Overall Study||265||
59696566|NCT00006721|75816040|FG000|COMPLETED|Overall Study||13||
59696567|NCT00006721|75816041|FG001|COMPLETED|Overall Study||254||
59696568|NCT00006721|75816042|FG002|COMPLETED|Overall Study||242||
59696569|NCT00006721|75816040|FG000|NOT COMPLETED|Overall Study||4||
59696570|NCT00006721|75816041|FG001|NOT COMPLETED|Overall Study||25||
59696571|NCT00006721|75816042|FG002|NOT COMPLETED|Overall Study||33||
59696572|NCT01030666|75816054|FG000|STARTED|Overall Study||28||
59696573|NCT01030666|75816055|FG001|STARTED|Overall Study||33||
59696574|NCT01030666|75816054|FG000|COMPLETED|Overall Study||25||
59696575|NCT01030666|75816055|FG001|COMPLETED|Overall Study||31||
59696576|NCT01030666|75816054|FG000|NOT COMPLETED|Overall Study||3||
59696577|NCT01030666|75816055|FG001|NOT COMPLETED|Overall Study||2||
59696578|NCT01025752|75816064|FG000|STARTED|Overall Study||62||
59696579|NCT01025752|75816065|FG001|STARTED|Overall Study||63||
59696580|NCT01025752|75816064|FG000|COMPLETED|Overall Study||54||
59696581|NCT01025752|75816065|FG001|COMPLETED|Overall Study||50||
59696582|NCT01025752|75816064|FG000|NOT COMPLETED|Overall Study||8||
59696583|NCT01025752|75816065|FG001|NOT COMPLETED|Overall Study||13||
59696584|NCT01030198|75816073|FG000|STARTED|Overall Study|None recruited|0||
59696585|NCT01030198|75816074|FG001|STARTED|Overall Study||7||
59696586|NCT01030198|75816073|FG000|COMPLETED|Overall Study|None recruited|0||
59696587|NCT01030198|75816074|FG001|COMPLETED|Overall Study|Study terminated due to poor results and lack of enrollment|0||
59696588|NCT01030198|75816073|FG000|NOT COMPLETED|Overall Study||0||
59696589|NCT01030198|75816074|FG001|NOT COMPLETED|Overall Study||7||
59696590|NCT01301456|75816092|FG000|STARTED|Stage 1||15||
59696591|NCT01301456|75816093|FG001|STARTED|Stage 1||5||
59696592|NCT01301456|75816094|FG002|STARTED|Stage 1||6||
59696593|NCT01301456|75816095|FG003|STARTED|Stage 1||6||
59696594|NCT01301456|75816096|FG004|STARTED|Stage 1||7||
59696595|NCT01301456|75816097|FG005|STARTED|Stage 1||5||
59696596|NCT01301456|75816098|FG006|STARTED|Stage 1||8||
59696597|NCT01301456|75816099|FG007|STARTED|Stage 1||0||
59696598|NCT01301456|75816100|FG008|STARTED|Stage 1||0||
59696599|NCT01301456|75816101|FG009|STARTED|Stage 1||0||
59696600|NCT01301456|75816102|FG010|STARTED|Stage 1||0||
59696601|NCT01301456|75816103|FG011|STARTED|Stage 1||0||
59696602|NCT01301456|75816092|FG000|Received Treatment|Stage 1||15||
59696603|NCT01301456|75816093|FG001|Received Treatment|Stage 1||5||
59696604|NCT01301456|75816094|FG002|Received Treatment|Stage 1||6||
59696605|NCT01301456|75816095|FG003|Received Treatment|Stage 1||6||
59696606|NCT01301456|75816096|FG004|Received Treatment|Stage 1||7||
59696607|NCT01301456|75816097|FG005|Received Treatment|Stage 1||5||
59696608|NCT01301456|75816098|FG006|Received Treatment|Stage 1||7||
59696609|NCT01301456|75816099|FG007|Received Treatment|Stage 1||0||
59696610|NCT01301456|75816100|FG008|Received Treatment|Stage 1||0||
59696611|NCT01301456|75816101|FG009|Received Treatment|Stage 1||0||
59696612|NCT01301456|75816102|FG010|Received Treatment|Stage 1||0||
59696613|NCT01301456|75816103|FG011|Received Treatment|Stage 1||0||
59696614|NCT01301456|75816092|FG000|COMPLETED|Stage 1||15||
59696615|NCT01301456|75816093|FG001|COMPLETED|Stage 1||5||
59696616|NCT01301456|75816094|FG002|COMPLETED|Stage 1||5||
59696617|NCT01301456|75816095|FG003|COMPLETED|Stage 1||6||
59696618|NCT01301456|75816096|FG004|COMPLETED|Stage 1||6||
59696619|NCT01301456|75816097|FG005|COMPLETED|Stage 1||5||
59696620|NCT01301456|75816098|FG006|COMPLETED|Stage 1||7||
59696621|NCT01301456|75816099|FG007|COMPLETED|Stage 1||0||
59696622|NCT01301456|75816100|FG008|COMPLETED|Stage 1||0||
59696623|NCT01301456|75816101|FG009|COMPLETED|Stage 1||0||
59696624|NCT01301456|75816102|FG010|COMPLETED|Stage 1||0||
59696625|NCT01301456|75816103|FG011|COMPLETED|Stage 1||0||
59696626|NCT01301456|75816092|FG000|NOT COMPLETED|Stage 1||0||
59696627|NCT01301456|75816093|FG001|NOT COMPLETED|Stage 1||0||
59696628|NCT01301456|75816094|FG002|NOT COMPLETED|Stage 1||1||
59696629|NCT01301456|75816095|FG003|NOT COMPLETED|Stage 1||0||
59696630|NCT01301456|75816096|FG004|NOT COMPLETED|Stage 1||1||
59696631|NCT01301456|75816097|FG005|NOT COMPLETED|Stage 1||0||
59696632|NCT01301456|75816098|FG006|NOT COMPLETED|Stage 1||1||
59696633|NCT01301456|75816099|FG007|NOT COMPLETED|Stage 1||0||
59696634|NCT01301456|75816100|FG008|NOT COMPLETED|Stage 1||0||
59696635|NCT01301456|75816101|FG009|NOT COMPLETED|Stage 1||0||
59696636|NCT01301456|75816102|FG010|NOT COMPLETED|Stage 1||0||
59696637|NCT01301456|75816103|FG011|NOT COMPLETED|Stage 1||0||
59696638|NCT01301456|75816092|FG000|STARTED|Stage 2||0||
59696639|NCT01301456|75816093|FG001|STARTED|Stage 2||0||
59696640|NCT01301456|75816094|FG002|STARTED|Stage 2||0||
59696641|NCT01301456|75816095|FG003|STARTED|Stage 2||0||
59696642|NCT01301456|75816096|FG004|STARTED|Stage 2||0||
59696643|NCT01301456|75816097|FG005|STARTED|Stage 2||0||
59696644|NCT01301456|75816098|FG006|STARTED|Stage 2||0||
59696645|NCT01301456|75816099|FG007|STARTED|Stage 2||7||
59696646|NCT01301456|75816100|FG008|STARTED|Stage 2||5||
59696647|NCT01301456|75816101|FG009|STARTED|Stage 2||7||
59696648|NCT01301456|75816102|FG010|STARTED|Stage 2||7||
59696649|NCT01301456|75816103|FG011|STARTED|Stage 2||6||
59696650|NCT01301456|75816092|FG000|Received Treatment|Stage 2||0||
59696651|NCT01301456|75816093|FG001|Received Treatment|Stage 2||0||
59696652|NCT01301456|75816094|FG002|Received Treatment|Stage 2||0||
59547817|NCT02179424|75646705|FG002|COMPLETED|Overall Study||516||
59696653|NCT01301456|75816095|FG003|Received Treatment|Stage 2||0||
59696654|NCT01301456|75816096|FG004|Received Treatment|Stage 2||0||
59696655|NCT01301456|75816097|FG005|Received Treatment|Stage 2||0||
59696656|NCT01301456|75816098|FG006|Received Treatment|Stage 2||0||
59696657|NCT01301456|75816099|FG007|Received Treatment|Stage 2||7||
59696658|NCT01301456|75816100|FG008|Received Treatment|Stage 2||5||
59696659|NCT01301456|75816101|FG009|Received Treatment|Stage 2||7||
59696660|NCT01301456|75816102|FG010|Received Treatment|Stage 2||7||
59696661|NCT01301456|75816103|FG011|Received Treatment|Stage 2||6||
59696662|NCT01301456|75816092|FG000|COMPLETED|Stage 2||0||
59696663|NCT01301456|75816093|FG001|COMPLETED|Stage 2||0||
59696664|NCT01301456|75816094|FG002|COMPLETED|Stage 2||0||
59696665|NCT01301456|75816095|FG003|COMPLETED|Stage 2||0||
59696666|NCT01301456|75816096|FG004|COMPLETED|Stage 2||0||
59696667|NCT01301456|75816097|FG005|COMPLETED|Stage 2||0||
59696668|NCT01301456|75816098|FG006|COMPLETED|Stage 2||0||
59696669|NCT01301456|75816099|FG007|COMPLETED|Stage 2||7||
59696670|NCT01301456|75816100|FG008|COMPLETED|Stage 2||5||
59696671|NCT01301456|75816101|FG009|COMPLETED|Stage 2||7||
59696672|NCT01301456|75816102|FG010|COMPLETED|Stage 2||6||
59696673|NCT01301456|75816103|FG011|COMPLETED|Stage 2||6||
59696674|NCT01301456|75816092|FG000|NOT COMPLETED|Stage 2||0||
59696675|NCT01301456|75816093|FG001|NOT COMPLETED|Stage 2||0||
59696676|NCT01301456|75816094|FG002|NOT COMPLETED|Stage 2||0||
59696677|NCT01301456|75816095|FG003|NOT COMPLETED|Stage 2||0||
59696678|NCT01301456|75816096|FG004|NOT COMPLETED|Stage 2||0||
59696679|NCT01301456|75816097|FG005|NOT COMPLETED|Stage 2||0||
59696680|NCT01301456|75816098|FG006|NOT COMPLETED|Stage 2||0||
59696681|NCT01301456|75816099|FG007|NOT COMPLETED|Stage 2||0||
59696682|NCT01301456|75816100|FG008|NOT COMPLETED|Stage 2||0||
59547818|NCT02179424|75646706|FG003|COMPLETED|Overall Study||39||
59547819|NCT02179424|75646703|FG000|NOT COMPLETED|Overall Study||0||
59696683|NCT01301456|75816101|FG009|NOT COMPLETED|Stage 2||0||
59696684|NCT01301456|75816102|FG010|NOT COMPLETED|Stage 2||1||
59696685|NCT01301456|75816103|FG011|NOT COMPLETED|Stage 2||0||
59696686|NCT01023256|75816151|FG000|STARTED|Overall Study||25||
59696687|NCT01023256|75816152|FG001|STARTED|Overall Study||22||
59696688|NCT01023256|75816153|FG002|STARTED|Overall Study||24||
59696689|NCT01023256|75816154|FG003|STARTED|Overall Study||27||
59696690|NCT01023256|75816151|FG000|COMPLETED|Overall Study||21||
59696691|NCT01023256|75816152|FG001|COMPLETED|Overall Study||19||
59696692|NCT01023256|75816153|FG002|COMPLETED|Overall Study||23||
59696693|NCT01023256|75816154|FG003|COMPLETED|Overall Study||22||
59696694|NCT01023256|75816151|FG000|NOT COMPLETED|Overall Study||4||
59696695|NCT01023256|75816152|FG001|NOT COMPLETED|Overall Study||3||
59696696|NCT01023256|75816153|FG002|NOT COMPLETED|Overall Study||1||
59696697|NCT01023256|75816154|FG003|NOT COMPLETED|Overall Study||5||
59696698|NCT01023022|75816167|FG000|STARTED|Overall Study|Previous No.: 178 subjects incl. 2 pts who withdraw their approval for processing personal data|176||
59696699|NCT01023022|75816167|FG000|COMPLETED|Overall Study||162||
59696700|NCT01023022|75816167|FG000|NOT COMPLETED|Overall Study||14||
59696701|NCT01058668|75816174|FG000|STARTED|Double-blind Treatment Phase||161||
59696702|NCT01058668|75816175|FG001|STARTED|Double-blind Treatment Phase||167||
59696703|NCT01058668|75816176|FG002|STARTED|Double-blind Treatment Phase||169||
59696704|NCT01058668|75816174|FG000|COMPLETED|Double-blind Treatment Phase||122||
59696705|NCT01058668|75816175|FG001|COMPLETED|Double-blind Treatment Phase||129||
59696706|NCT01058668|75816176|FG002|COMPLETED|Double-blind Treatment Phase||119||
59696707|NCT01058668|75816174|FG000|NOT COMPLETED|Double-blind Treatment Phase||39||
59696708|NCT01058668|75816175|FG001|NOT COMPLETED|Double-blind Treatment Phase||38||
59696709|NCT01058668|75816176|FG002|NOT COMPLETED|Double-blind Treatment Phase||50||
59696710|NCT01058668|75816174|FG000|STARTED|Safety Follow-up|Not all participants entered the Safety-Follow-up|144||
59696711|NCT01058668|75816175|FG001|STARTED|Safety Follow-up||146||
59696712|NCT01058668|75816176|FG002|STARTED|Safety Follow-up||148||
59696713|NCT01058668|75816174|FG000|COMPLETED|Safety Follow-up||139||
59696714|NCT01058668|75816175|FG001|COMPLETED|Safety Follow-up||146||
59696715|NCT01058668|75816176|FG002|COMPLETED|Safety Follow-up||141||
59696716|NCT01058668|75816174|FG000|NOT COMPLETED|Safety Follow-up||5||
59696717|NCT01058668|75816175|FG001|NOT COMPLETED|Safety Follow-up||0||
59696718|NCT01058668|75816176|FG002|NOT COMPLETED|Safety Follow-up||7||
59696719|NCT01301066|75816186|FG000|STARTED|Overall Study||126||
59696720|NCT01301066|75816187|FG001|STARTED|Overall Study||126||
59696721|NCT01301066|75816186|FG000|COMPLETED|Overall Study||99||
59696722|NCT01301066|75816187|FG001|COMPLETED|Overall Study||91||
59696723|NCT01301066|75816186|FG000|NOT COMPLETED|Overall Study||27||
59696724|NCT01301066|75816187|FG001|NOT COMPLETED|Overall Study||35||
59696725|NCT01022398|75816195|FG000|STARTED|Overall Study||2||
59696726|NCT01022398|75816196|FG001|STARTED|Overall Study||2||
59990002|NCT04527328|76105458|FG001|COMPLETED|Overall Study||5|Subjects who completed the End of Study (follow-up) visit|
59990003|NCT04527328|76105457|FG000|NOT COMPLETED|Overall Study||2||
59990004|NCT04527328|76105458|FG001|NOT COMPLETED|Overall Study||0||
59990005|NCT03248375|76105473|FG000|STARTED|Overall Study||29||
59990006|NCT03248375|76105473|FG000|COMPLETED|Overall Study||24||
59990007|NCT03248375|76105473|FG000|NOT COMPLETED|Overall Study||5||
59990008|NCT01637272|76105477|FG000|STARTED|Overall Study||43||
59990009|NCT01637272|76105477|FG000|Completed sc Phase|Overall Study||33||
59990010|NCT01637272|76105477|FG000|Completed Core Phase (sc + LAR)|Overall Study||31||
59696727|NCT01022398|75816195|FG000|COMPLETED|Overall Study||0||
59696728|NCT01022398|75816196|FG001|COMPLETED|Overall Study||0||
59696729|NCT01022398|75816195|FG000|NOT COMPLETED|Overall Study||2||
59696730|NCT01022398|75816196|FG001|NOT COMPLETED|Overall Study||2||
59696731|NCT01262976|75816207|FG000|STARTED|Up to Month 2||40||
59696732|NCT01262976|75816208|FG001|STARTED|Up to Month 2||40||
59696733|NCT01262976|75816209|FG002|STARTED|Up to Month 2||40||
59696734|NCT01262976|75816210|FG003|STARTED|Up to Month 2||40||
59696735|NCT01262976|75816211|FG004|STARTED|Up to Month 2||40||
59696736|NCT01262976|75816212|FG005|STARTED|Up to Month 2||40||
59696737|NCT01262976|75816207|FG000|COMPLETED|Up to Month 2||37||
59696738|NCT01262976|75816208|FG001|COMPLETED|Up to Month 2||39||
59696739|NCT01262976|75816209|FG002|COMPLETED|Up to Month 2||39||
59696740|NCT01262976|75816210|FG003|COMPLETED|Up to Month 2||38||
59696741|NCT01262976|75816211|FG004|COMPLETED|Up to Month 2||38||
59816174|NCT00529568|75938541|FG002|COMPLETED|Open-label Pre-Antiviral Treatment Phase||0||
59990011|NCT01637272|76105477|FG000|Entered Extension Phase|Overall Study||27||
59990012|NCT01637272|76105477|FG000|Completed Core But Did no Enter Ext..|Overall Study||4||
59990013|NCT01637272|76105477|FG000|COMPLETED|Overall Study||23||
59990014|NCT01637272|76105477|FG000|NOT COMPLETED|Overall Study||20||
59990015|NCT01636960|76105496|FG000|STARTED|Induction Phase||9||
59990016|NCT01636960|76105496|FG000|COMPLETED|Induction Phase|Participants continuing into Maintenance Phase|7||
59990017|NCT01636960|76105496|FG000|NOT COMPLETED|Induction Phase||2||
59990018|NCT01636960|76105496|FG000|STARTED|Maintenance Phase||7||
59990019|NCT01636960|76105496|FG000|COMPLETED|Maintenance Phase||0||
59696742|NCT01262976|75816212|FG005|COMPLETED|Up to Month 2||36||
59696743|NCT01262976|75816207|FG000|NOT COMPLETED|Up to Month 2||3||
59696744|NCT01262976|75816208|FG001|NOT COMPLETED|Up to Month 2||1||
59696745|NCT01262976|75816209|FG002|NOT COMPLETED|Up to Month 2||1||
59696746|NCT01262976|75816210|FG003|NOT COMPLETED|Up to Month 2||2||
59696747|NCT01262976|75816211|FG004|NOT COMPLETED|Up to Month 2||2||
59696748|NCT01262976|75816212|FG005|NOT COMPLETED|Up to Month 2||4||
59696749|NCT01262976|75816207|FG000|STARTED|Up to Month 7||40||
59696750|NCT01262976|75816208|FG001|STARTED|Up to Month 7||40||
59696751|NCT01262976|75816209|FG002|STARTED|Up to Month 7||40||
59696752|NCT01262976|75816210|FG003|STARTED|Up to Month 7||40||
59696753|NCT01262976|75816211|FG004|STARTED|Up to Month 7||40||
59696754|NCT01262976|75816212|FG005|STARTED|Up to Month 7||40||
59696755|NCT01262976|75816207|FG000|COMPLETED|Up to Month 7||35||
59990020|NCT01636960|76105496|FG000|NOT COMPLETED|Maintenance Phase||7||
59990021|NCT01636258|76105502|FG000|STARTED|Overall Study||13||
59990022|NCT01636258|76105503|FG001|STARTED|Overall Study||14||
59990023|NCT01636258|76105502|FG000|COMPLETED|Overall Study||12||
59990024|NCT01636258|76105503|FG001|COMPLETED|Overall Study||14||
59990025|NCT01636258|76105502|FG000|NOT COMPLETED|Overall Study||1||
59990026|NCT01636258|76105503|FG001|NOT COMPLETED|Overall Study||0||
59990027|NCT02504216|76105512|FG000|STARTED|Overall Study||3286||
59990028|NCT02504216|76105513|FG001|STARTED|Overall Study||3278||
59990029|NCT02504216|76105512|FG000|Received Treatment|Overall Study||3256||
59990030|NCT02504216|76105513|FG001|Received Treatment|Overall Study||3248||
59990031|NCT02504216|76105512|FG000|COMPLETED|Overall Study||3275|Vital status known at ECOD|
59990032|NCT02504216|76105513|FG001|COMPLETED|Overall Study||3263|Vital status known at ECOD|
59696756|NCT01262976|75816208|FG001|COMPLETED|Up to Month 7||40||
59696757|NCT01262976|75816209|FG002|COMPLETED|Up to Month 7||34||
59696758|NCT01262976|75816210|FG003|COMPLETED|Up to Month 7||34||
59696759|NCT01262976|75816211|FG004|COMPLETED|Up to Month 7||38||
59696760|NCT01262976|75816212|FG005|COMPLETED|Up to Month 7||36||
59696761|NCT01262976|75816207|FG000|NOT COMPLETED|Up to Month 7||5||
59696762|NCT01262976|75816208|FG001|NOT COMPLETED|Up to Month 7||0||
59696763|NCT01262976|75816209|FG002|NOT COMPLETED|Up to Month 7||6||
59696764|NCT01262976|75816210|FG003|NOT COMPLETED|Up to Month 7||6||
59696765|NCT01262976|75816211|FG004|NOT COMPLETED|Up to Month 7||2||
59696766|NCT01262976|75816212|FG005|NOT COMPLETED|Up to Month 7||4||
59696767|NCT01262976|75816207|FG000|STARTED|Up to Year 1||40||
59696768|NCT01262976|75816208|FG001|STARTED|Up to Year 1||40||
59696769|NCT01262976|75816209|FG002|STARTED|Up to Year 1||40||
59696770|NCT01262976|75816210|FG003|STARTED|Up to Year 1||40||
59696771|NCT01262976|75816211|FG004|STARTED|Up to Year 1||40||
59696772|NCT01262976|75816212|FG005|STARTED|Up to Year 1||40||
59696773|NCT01262976|75816207|FG000|COMPLETED|Up to Year 1||31||
59696774|NCT01262976|75816208|FG001|COMPLETED|Up to Year 1||39||
59696775|NCT01262976|75816209|FG002|COMPLETED|Up to Year 1||37||
59696776|NCT01262976|75816210|FG003|COMPLETED|Up to Year 1||36||
59696777|NCT01262976|75816211|FG004|COMPLETED|Up to Year 1||29||
59696778|NCT01262976|75816212|FG005|COMPLETED|Up to Year 1||31||
59696779|NCT01262976|75816207|FG000|NOT COMPLETED|Up to Year 1||9||
59696780|NCT01262976|75816208|FG001|NOT COMPLETED|Up to Year 1||1||
59696781|NCT01262976|75816209|FG002|NOT COMPLETED|Up to Year 1||3||
59696782|NCT01262976|75816210|FG003|NOT COMPLETED|Up to Year 1||4||
59696783|NCT01262976|75816211|FG004|NOT COMPLETED|Up to Year 1||11||
59696784|NCT01262976|75816212|FG005|NOT COMPLETED|Up to Year 1||9||
59696785|NCT01262976|75816207|FG000|STARTED|Up to Year 2||40||
59696786|NCT01262976|75816208|FG001|STARTED|Up to Year 2||40||
59696787|NCT01262976|75816209|FG002|STARTED|Up to Year 2||40||
59696788|NCT01262976|75816210|FG003|STARTED|Up to Year 2||40||
59696789|NCT01262976|75816211|FG004|STARTED|Up to Year 2||40||
59696790|NCT01262976|75816212|FG005|STARTED|Up to Year 2||40||
59696791|NCT01262976|75816207|FG000|COMPLETED|Up to Year 2||35||
59696792|NCT01262976|75816208|FG001|COMPLETED|Up to Year 2||39||
59696793|NCT01262976|75816209|FG002|COMPLETED|Up to Year 2||35||
59696794|NCT01262976|75816210|FG003|COMPLETED|Up to Year 2||36||
59696795|NCT01262976|75816211|FG004|COMPLETED|Up to Year 2||36||
59696796|NCT01262976|75816212|FG005|COMPLETED|Up to Year 2||35||
59696797|NCT01262976|75816207|FG000|NOT COMPLETED|Up to Year 2||5||
59696798|NCT01262976|75816208|FG001|NOT COMPLETED|Up to Year 2||1||
59696799|NCT01262976|75816209|FG002|NOT COMPLETED|Up to Year 2||5||
59696800|NCT01262976|75816210|FG003|NOT COMPLETED|Up to Year 2||4||
59696801|NCT01262976|75816211|FG004|NOT COMPLETED|Up to Year 2||4||
59696802|NCT01262976|75816212|FG005|NOT COMPLETED|Up to Year 2||5||
59696803|NCT01262976|75816207|FG000|STARTED|Up to Year 3||40||
59696804|NCT01262976|75816208|FG001|STARTED|Up to Year 3||40||
59696805|NCT01262976|75816209|FG002|STARTED|Up to Year 3||40||
59696806|NCT01262976|75816210|FG003|STARTED|Up to Year 3||40||
59696807|NCT01262976|75816211|FG004|STARTED|Up to Year 3||40||
59696808|NCT01262976|75816212|FG005|STARTED|Up to Year 3||40||
59696809|NCT01262976|75816207|FG000|COMPLETED|Up to Year 3||34||
59696810|NCT01262976|75816208|FG001|COMPLETED|Up to Year 3||38||
59696811|NCT01262976|75816209|FG002|COMPLETED|Up to Year 3||33||
59990033|NCT02504216|76105512|FG000|NOT COMPLETED|Overall Study||11||
59990034|NCT02504216|76105513|FG001|NOT COMPLETED|Overall Study||15||
59990035|NCT04354870|76105521|FG000|STARTED|Overall Study||83||
59990036|NCT04354870|76105522|FG001|STARTED|Overall Study||47||
59990037|NCT04354870|76105521|FG000|COMPLETED|Overall Study||35||
59990038|NCT04354870|76105522|FG001|COMPLETED|Overall Study||14||
59696812|NCT01262976|75816210|FG003|COMPLETED|Up to Year 3||35||
59696813|NCT01262976|75816211|FG004|COMPLETED|Up to Year 3||38||
59696814|NCT01262976|75816212|FG005|COMPLETED|Up to Year 3||36||
59990039|NCT04354870|76105521|FG000|NOT COMPLETED|Overall Study||48||
59990040|NCT04354870|76105522|FG001|NOT COMPLETED|Overall Study||33||
59990041|NCT02473952|76105530|FG000|STARTED|Overall Study||30||
59990042|NCT02473952|76105531|FG001|STARTED|Overall Study||32||
59990043|NCT02473952|76105530|FG000|COMPLETED|Overall Study||28||
59990044|NCT02473952|76105531|FG001|COMPLETED|Overall Study||24||
59696815|NCT01262976|75816207|FG000|NOT COMPLETED|Up to Year 3||6||
59696816|NCT01262976|75816208|FG001|NOT COMPLETED|Up to Year 3||2||
59696817|NCT01262976|75816209|FG002|NOT COMPLETED|Up to Year 3||7||
59696818|NCT01262976|75816210|FG003|NOT COMPLETED|Up to Year 3||5||
59990045|NCT02473952|76105530|FG000|NOT COMPLETED|Overall Study||2||
59990046|NCT02473952|76105531|FG001|NOT COMPLETED|Overall Study||8||
59990047|NCT02473640|76105537|FG000|STARTED|Treatment Period 1||15||
59990048|NCT02473640|76105537|FG000|COMPLETED|Treatment Period 1||14||
59990049|NCT02473640|76105537|FG000|NOT COMPLETED|Treatment Period 1||1||
59990050|NCT02473640|76105537|FG000|STARTED|Run-in Phase||14||
59990051|NCT02473640|76105537|FG000|COMPLETED|Run-in Phase||14||
59990052|NCT02473640|76105537|FG000|NOT COMPLETED|Run-in Phase||0||
59990053|NCT02473640|76105537|FG000|STARTED|Treatment Period 2||14||
59696819|NCT01262976|75816211|FG004|NOT COMPLETED|Up to Year 3||2||
59696820|NCT01262976|75816212|FG005|NOT COMPLETED|Up to Year 3||4||
59696821|NCT01300286|75816227|FG000|STARTED|Overall Study||23||
59696822|NCT01300286|75816227|FG000|COMPLETED|Overall Study||22||
59696823|NCT01300286|75816227|FG000|NOT COMPLETED|Overall Study||1||
59696824|NCT01300052|75816234|FG000|STARTED|Overall Study||46||
59696825|NCT01300052|75816235|FG001|STARTED|Overall Study||22||
59696826|NCT01300052|75816234|FG000|COMPLETED|Overall Study||40||
59696827|NCT01300052|75816235|FG001|COMPLETED|Overall Study||19||
59696828|NCT01300052|75816234|FG000|NOT COMPLETED|Overall Study||6||
59696829|NCT01300052|75816235|FG001|NOT COMPLETED|Overall Study||3||
59696830|NCT01299896|75816243|FG000|STARTED|Overall Study||319||
59696831|NCT01299896|75816244|FG001|STARTED|Overall Study||314||
59696832|NCT01299896|75816243|FG000|COMPLETED|Overall Study||318||
59696833|NCT01299896|75816244|FG001|COMPLETED|Overall Study||296||
59696834|NCT01299896|75816243|FG000|NOT COMPLETED|Overall Study||1||
59696835|NCT01299896|75816244|FG001|NOT COMPLETED|Overall Study||18||
59696836|NCT01299584|75816250|FG000|STARTED|Overall Study||775||
59696837|NCT01299584|75816250|FG000|COMPLETED|Overall Study||766||
59696838|NCT01299584|75816250|FG000|NOT COMPLETED|Overall Study||9||
60079530|NCT04206332|76194713|FG013|STARTED|Part C||4||
59696839|NCT01236573|75816265|FG000|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||1||
59696840|NCT01236573|75816266|FG001|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||1||
59696841|NCT01236573|75816267|FG002|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||6||
59696842|NCT01236573|75816268|FG003|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||1||
59696843|NCT01236573|75816269|FG004|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0||
59696844|NCT01236573|75816270|FG005|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0||
59696845|NCT01236573|75816271|FG006|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0||
59696846|NCT01236573|75816272|FG007|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0||
59696847|NCT01236573|75816273|FG008|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0||
59696848|NCT01236573|75816274|FG009|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0||
59696849|NCT01236573|75816275|FG010|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0||
59696850|NCT01236573|75816265|FG000|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||1||
59696851|NCT01236573|75816266|FG001|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||1||
59696852|NCT01236573|75816267|FG002|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||6||
59696853|NCT01236573|75816268|FG003|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||1||
59696854|NCT01236573|75816269|FG004|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0||
59696855|NCT01236573|75816270|FG005|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0||
59696856|NCT01236573|75816271|FG006|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0||
59696857|NCT01236573|75816272|FG007|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0||
59696858|NCT01236573|75816273|FG008|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0||
59696859|NCT01236573|75816274|FG009|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0||
59696860|NCT01236573|75816275|FG010|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0||
59696861|NCT01236573|75816265|FG000|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0||
59696862|NCT01236573|75816266|FG001|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0||
59696863|NCT01236573|75816267|FG002|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0||
59696864|NCT01236573|75816268|FG003|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0||
59990054|NCT02473640|76105537|FG000|COMPLETED|Treatment Period 2||14||
59990055|NCT02473640|76105537|FG000|NOT COMPLETED|Treatment Period 2||0||
59990056|NCT01637584|76105546|FG000|STARTED|Overall Study||20||
59990057|NCT01637584|76105547|FG001|STARTED|Overall Study||20||
59990058|NCT01637584|76105546|FG000|COMPLETED|Overall Study||19||
59990059|NCT01637584|76105547|FG001|COMPLETED|Overall Study||17||
59990060|NCT01637584|76105546|FG000|NOT COMPLETED|Overall Study||1||
59990061|NCT01637584|76105547|FG001|NOT COMPLETED|Overall Study||3||
60079531|NCT04206332|76194714|FG014|STARTED|Part C||4||
59696865|NCT01236573|75816269|FG004|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0||
59696866|NCT01236573|75816270|FG005|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0||
59990062|NCT03883906|76105554|FG000|STARTED|Overall Study||30||
59990063|NCT03883906|76105554|FG000|COMPLETED|Overall Study||23||
59696867|NCT01236573|75816271|FG006|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0||
59696868|NCT01236573|75816272|FG007|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0||
59990064|NCT03883906|76105554|FG000|NOT COMPLETED|Overall Study||7||
60079532|NCT04206332|76194715|FG015|STARTED|Part C||4||
59990065|NCT02503202|76105563|FG000|STARTED|Base Study: Up to Month 6||266||
60079533|NCT04206332|76194716|FG016|STARTED|Part C||8||
59990066|NCT02503202|76105564|FG001|STARTED|Base Study: Up to Month 6||265||
59990067|NCT02503202|76105565|FG002|STARTED|Base Study: Up to Month 6||267||
59696869|NCT01236573|75816273|FG008|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0||
59696870|NCT01236573|75816274|FG009|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0||
59696871|NCT01236573|75816275|FG010|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0||
59696872|NCT01236573|75816265|FG000|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0||
59696873|NCT01236573|75816266|FG001|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0||
59696874|NCT01236573|75816267|FG002|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0||
59696875|NCT01236573|75816268|FG003|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0||
59696876|NCT01236573|75816269|FG004|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||1||
59696877|NCT01236573|75816270|FG005|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||4||
59696878|NCT01236573|75816271|FG006|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||3||
59696879|NCT01236573|75816272|FG007|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||3||
59696880|NCT01236573|75816273|FG008|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||4||
59696881|NCT01236573|75816274|FG009|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||4||
59696882|NCT01236573|75816275|FG010|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0||
59696883|NCT01236573|75816265|FG000|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0||
59696884|NCT01236573|75816266|FG001|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0||
59696885|NCT01236573|75816267|FG002|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0||
59696886|NCT01236573|75816268|FG003|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0||
59696887|NCT01236573|75816269|FG004|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||1||
59696888|NCT01236573|75816270|FG005|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||4||
59696889|NCT01236573|75816271|FG006|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||2||
59696890|NCT01236573|75816272|FG007|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||3||
59696891|NCT01236573|75816273|FG008|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||2||
59696892|NCT01236573|75816274|FG009|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||3||
59696893|NCT01236573|75816275|FG010|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0||
59696894|NCT01236573|75816265|FG000|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0||
59696895|NCT01236573|75816266|FG001|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0||
59696896|NCT01236573|75816267|FG002|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0||
59696897|NCT01236573|75816268|FG003|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0||
59696898|NCT01236573|75816269|FG004|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0||
59696899|NCT01236573|75816270|FG005|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0||
59696900|NCT01236573|75816271|FG006|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||1||
59696901|NCT01236573|75816272|FG007|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0||
59696902|NCT01236573|75816273|FG008|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||2||
59696903|NCT01236573|75816274|FG009|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||1||
59696904|NCT01236573|75816275|FG010|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0||
59696905|NCT01236573|75816265|FG000|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0||
59696906|NCT01236573|75816266|FG001|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0||
59696907|NCT01236573|75816267|FG002|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0||
59696908|NCT01236573|75816268|FG003|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0||
59696909|NCT01236573|75816269|FG004|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0||
59990068|NCT02503202|76105566|FG003|STARTED|Base Study: Up to Month 6||266||
59990069|NCT02503202|76105567|FG004|STARTED|Base Study: Up to Month 6||133||
59990070|NCT02503202|76105563|FG000|Vaccinated|Base Study: Up to Month 6||266||
59990071|NCT02503202|76105564|FG001|Vaccinated|Base Study: Up to Month 6||265||
59990072|NCT02503202|76105565|FG002|Vaccinated|Base Study: Up to Month 6||266||
59696910|NCT01236573|75816270|FG005|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0||
59696911|NCT01236573|75816271|FG006|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0||
59696912|NCT01236573|75816272|FG007|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0||
59696913|NCT01236573|75816273|FG008|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0||
59696914|NCT01236573|75816274|FG009|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0||
59696915|NCT01236573|75816275|FG010|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||6||
59696916|NCT01236573|75816265|FG000|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0||
59696917|NCT01236573|75816266|FG001|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0||
59696918|NCT01236573|75816267|FG002|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0||
59696919|NCT01236573|75816268|FG003|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0||
59696920|NCT01236573|75816269|FG004|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0||
59696921|NCT01236573|75816270|FG005|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0||
59696922|NCT01236573|75816271|FG006|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0||
59696923|NCT01236573|75816272|FG007|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0||
59696924|NCT01236573|75816273|FG008|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0||
59696925|NCT01236573|75816274|FG009|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0||
59990073|NCT02503202|76105566|FG003|Vaccinated|Base Study: Up to Month 6||264||
59990074|NCT02503202|76105567|FG004|Vaccinated|Base Study: Up to Month 6||133||
59990075|NCT02503202|76105563|FG000|COMPLETED|Base Study: Up to Month 6||248||
59990076|NCT02503202|76105564|FG001|COMPLETED|Base Study: Up to Month 6||253||
59990077|NCT02503202|76105565|FG002|COMPLETED|Base Study: Up to Month 6||252||
59990078|NCT02503202|76105566|FG003|COMPLETED|Base Study: Up to Month 6||255||
59990079|NCT02503202|76105567|FG004|COMPLETED|Base Study: Up to Month 6||130||
59990080|NCT02503202|76105563|FG000|NOT COMPLETED|Base Study: Up to Month 6||18||
59990081|NCT02503202|76105564|FG001|NOT COMPLETED|Base Study: Up to Month 6||12||
59990082|NCT02503202|76105565|FG002|NOT COMPLETED|Base Study: Up to Month 6||15||
59990083|NCT02503202|76105566|FG003|NOT COMPLETED|Base Study: Up to Month 6||11||
59990084|NCT02503202|76105567|FG004|NOT COMPLETED|Base Study: Up to Month 6||3||
59990085|NCT02503202|76105563|FG000|STARTED|Extension: Month 6 to 24||119|A subset of US participants enrolled in Extension Study|
59990086|NCT02503202|76105564|FG001|STARTED|Extension: Month 6 to 24||130|A subset of US participants enrolled in Extension Study|
59990087|NCT02503202|76105565|FG002|STARTED|Extension: Month 6 to 24||112|A subset of US participants enrolled in Extension Study|
59990088|NCT02503202|76105566|FG003|STARTED|Extension: Month 6 to 24||137|A subset of US participants enrolled in Extension Study|
59990089|NCT02503202|76105567|FG004|STARTED|Extension: Month 6 to 24||68|A subset of US participants enrolled in Extension Study|
59990090|NCT02503202|76105563|FG000|COMPLETED|Extension: Month 6 to 24||108||
59990091|NCT02503202|76105564|FG001|COMPLETED|Extension: Month 6 to 24||114||
59990092|NCT02503202|76105565|FG002|COMPLETED|Extension: Month 6 to 24||103||
59990093|NCT02503202|76105566|FG003|COMPLETED|Extension: Month 6 to 24||119||
59990094|NCT02503202|76105567|FG004|COMPLETED|Extension: Month 6 to 24||67||
59990095|NCT02503202|76105563|FG000|NOT COMPLETED|Extension: Month 6 to 24||11||
59990096|NCT02503202|76105564|FG001|NOT COMPLETED|Extension: Month 6 to 24||16||
59990097|NCT02503202|76105565|FG002|NOT COMPLETED|Extension: Month 6 to 24||9||
59990098|NCT02503202|76105566|FG003|NOT COMPLETED|Extension: Month 6 to 24||18||
59990099|NCT02503202|76105567|FG004|NOT COMPLETED|Extension: Month 6 to 24||1||
59990100|NCT02502734|76105579|FG000|STARTED|Double-blind Treatment Period 1||30||
59990101|NCT02502734|76105580|FG001|STARTED|Double-blind Treatment Period 1||30||
59990102|NCT02502734|76105579|FG000|COMPLETED|Double-blind Treatment Period 1||29||
59990103|NCT02502734|76105580|FG001|COMPLETED|Double-blind Treatment Period 1||30||
59990104|NCT02502734|76105579|FG000|NOT COMPLETED|Double-blind Treatment Period 1||1||
59990105|NCT02502734|76105580|FG001|NOT COMPLETED|Double-blind Treatment Period 1||0||
59990106|NCT02502734|76105579|FG000|STARTED|Washout Period||29||
59990107|NCT02502734|76105580|FG001|STARTED|Washout Period||30||
59990108|NCT02502734|76105579|FG000|COMPLETED|Washout Period||28||
59990109|NCT02502734|76105580|FG001|COMPLETED|Washout Period||30||
59990110|NCT02502734|76105579|FG000|NOT COMPLETED|Washout Period||1||
59990111|NCT02502734|76105580|FG001|NOT COMPLETED|Washout Period||0||
59990112|NCT02502734|76105579|FG000|STARTED|Double-blind Treatment Period 2||28||
59990113|NCT02502734|76105580|FG001|STARTED|Double-blind Treatment Period 2||30||
59990114|NCT02502734|76105579|FG000|COMPLETED|Double-blind Treatment Period 2||28||
59696926|NCT01236573|75816275|FG010|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||5||
59696927|NCT01236573|75816265|FG000|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0||
59696928|NCT01236573|75816266|FG001|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0||
59696929|NCT01236573|75816267|FG002|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0||
59990115|NCT02502734|76105580|FG001|COMPLETED|Double-blind Treatment Period 2||30||
59990116|NCT02502734|76105579|FG000|NOT COMPLETED|Double-blind Treatment Period 2||0||
59990117|NCT02502734|76105580|FG001|NOT COMPLETED|Double-blind Treatment Period 2||0||
59990118|NCT02473250|76105588|FG000|STARTED|Overall Study||40||
59990119|NCT02473250|76105588|FG000|COMPLETED|Overall Study||20||
59990120|NCT02473250|76105588|FG000|NOT COMPLETED|Overall Study||20||
59990121|NCT02706730|76105593|FG000|STARTED|Overall Study||189||
59990122|NCT02706730|76105593|FG000|COMPLETED|Overall Study||156||
59990123|NCT02706730|76105593|FG000|NOT COMPLETED|Overall Study||33||
59696930|NCT01236573|75816268|FG003|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0||
59696931|NCT01236573|75816269|FG004|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0||
59696932|NCT01236573|75816270|FG005|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0||
59696933|NCT01236573|75816271|FG006|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0||
59696934|NCT01236573|75816272|FG007|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0||
59696935|NCT01236573|75816273|FG008|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0||
59696936|NCT01236573|75816274|FG009|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0||
59696937|NCT01236573|75816275|FG010|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||1||
59696938|NCT01236339|75816302|FG000|STARTED|Overall Study||13||
59696939|NCT01236339|75816303|FG001|STARTED|Overall Study||13||
59696940|NCT01236339|75816302|FG000|LVP Crossover to TIPS|Overall Study||0||
59696941|NCT01236339|75816303|FG001|LVP Crossover to TIPS|Overall Study|ONLY patients failing LVP and meeting crossover according to protocol definition|4||
59696942|NCT01236339|75816302|FG000|COMPLETED|Overall Study||2||
59696943|NCT01236339|75816303|FG001|COMPLETED|Overall Study||0||
59696944|NCT01236339|75816302|FG000|NOT COMPLETED|Overall Study||11||
59696945|NCT01236339|75816303|FG001|NOT COMPLETED|Overall Study||13||
59696946|NCT01262898|75816314|FG000|STARTED|Overall Study||21||
59696947|NCT01262898|75816315|FG001|STARTED|Overall Study||18||
59696948|NCT01262898|75816316|FG002|STARTED|Overall Study||18||
59696949|NCT01262898|75816317|FG003|STARTED|Overall Study||22||
59696950|NCT01262898|75816314|FG000|COMPLETED|Overall Study||18||
59990124|NCT02443688|76105600|FG000|STARTED|Overall Study||66||
59990125|NCT02443688|76105601|FG001|STARTED|Overall Study||67||
59990126|NCT02443688|76105602|FG002|STARTED|Overall Study||67||
59990127|NCT02443688|76105600|FG000|COMPLETED|Overall Study||54||
59990128|NCT02443688|76105601|FG001|COMPLETED|Overall Study||58||
59990129|NCT02443688|76105602|FG002|COMPLETED|Overall Study||55||
59990130|NCT02443688|76105600|FG000|NOT COMPLETED|Overall Study||12||
59990131|NCT02443688|76105601|FG001|NOT COMPLETED|Overall Study||9||
59990132|NCT02443688|76105602|FG002|NOT COMPLETED|Overall Study||12||
59990133|NCT02443298|76105616|FG000|STARTED|Overall Study||105||
59696951|NCT01262898|75816315|FG001|COMPLETED|Overall Study||16||
59696952|NCT01262898|75816316|FG002|COMPLETED|Overall Study||18||
59696953|NCT01262898|75816317|FG003|COMPLETED|Overall Study||22||
59696954|NCT01262898|75816314|FG000|NOT COMPLETED|Overall Study||3||
59696955|NCT01262898|75816315|FG001|NOT COMPLETED|Overall Study||2||
59696956|NCT01262898|75816316|FG002|NOT COMPLETED|Overall Study||0||
59696957|NCT01262898|75816317|FG003|NOT COMPLETED|Overall Study||0||
59696958|NCT01262820|75816330|FG000|STARTED|Overall Study||15||
59696959|NCT01262820|75816330|FG000|COMPLETED|Overall Study||0||
59696960|NCT01262820|75816330|FG000|NOT COMPLETED|Overall Study||15||
59696961|NCT01057810|75816336|FG000|STARTED|Overall Study||199||
59696962|NCT01057810|75816337|FG001|STARTED|Overall Study||399||
59696963|NCT01057810|75816336|FG000|COMPLETED|Overall Study||1||
59696964|NCT01057810|75816337|FG001|COMPLETED|Overall Study||1||
59696965|NCT01057810|75816336|FG000|NOT COMPLETED|Overall Study||198||
59696966|NCT01057810|75816337|FG001|NOT COMPLETED|Overall Study||398||
59696967|NCT01262352|75816345|FG000|STARTED|Period 1||11||
59696968|NCT01262352|75816346|FG001|STARTED|Period 1||10||
59990134|NCT02443298|76105617|FG001|STARTED|Overall Study||109||
59990135|NCT02443298|76105616|FG000|COMPLETED|Overall Study||101||
59990136|NCT02443298|76105617|FG001|COMPLETED|Overall Study||104||
59990137|NCT02443298|76105616|FG000|NOT COMPLETED|Overall Study||4||
59990138|NCT02443298|76105617|FG001|NOT COMPLETED|Overall Study||5||
59696969|NCT01262352|75816345|FG000|Dosed|Period 1||10||
59696970|NCT01262352|75816346|FG001|Dosed|Period 1||10||
59696971|NCT01262352|75816345|FG000|COMPLETED|Period 1||10||
59696972|NCT01262352|75816346|FG001|COMPLETED|Period 1||10||
59696973|NCT01262352|75816345|FG000|NOT COMPLETED|Period 1||1||
59696974|NCT01262352|75816346|FG001|NOT COMPLETED|Period 1||0||
59696975|NCT01262352|75816345|FG000|STARTED|Washout||10||
59696976|NCT01262352|75816346|FG001|STARTED|Washout||10||
59696977|NCT01262352|75816345|FG000|COMPLETED|Washout||9||
59696978|NCT01262352|75816346|FG001|COMPLETED|Washout||8||
59696979|NCT01262352|75816345|FG000|NOT COMPLETED|Washout||1||
59696980|NCT01262352|75816346|FG001|NOT COMPLETED|Washout||2||
59696981|NCT01262352|75816345|FG000|STARTED|Period 2||9||
59696982|NCT01262352|75816346|FG001|STARTED|Period 2||8||
59696983|NCT01262352|75816345|FG000|Dosed|Period 2||9||
59696984|NCT01262352|75816346|FG001|Dosed|Period 2||8||
59696985|NCT01262352|75816345|FG000|COMPLETED|Period 2||9||
59696986|NCT01262352|75816346|FG001|COMPLETED|Period 2||8||
59696987|NCT01262352|75816345|FG000|NOT COMPLETED|Period 2||0||
59990139|NCT02500706|76105626|FG000|STARTED|Overall Study||342||
59990140|NCT02500706|76105627|FG001|STARTED|Overall Study||341||
59990141|NCT02500706|76105628|FG002|STARTED|Overall Study||342||
59990142|NCT02500706|76105626|FG000|Exposed|Overall Study||342||
59990143|NCT02500706|76105627|FG001|Exposed|Overall Study||341||
60079534|NCT04206332|76194700|FG000|Received Product Administration|Part C||0||
59696988|NCT01262352|75816346|FG001|NOT COMPLETED|Period 2||0||
59696989|NCT01299272|75816352|FG000|STARTED|Acute Open-label (OL) Period||1249||
59696990|NCT01299272|75816353|FG001|STARTED|Acute Open-label (OL) Period||0||
59696991|NCT01299272|75816354|FG002|STARTED|Acute Open-label (OL) Period||0||
59696992|NCT01299272|75816355|FG003|STARTED|Acute Open-label (OL) Period||0||
59696993|NCT01299272|75816352|FG000|Entered Discontinuation (DC) Period|Acute Open-label (OL) Period|Participants who discontinued the Acute OL Period had the option to enter the DC Period.|271||
59696994|NCT01299272|75816353|FG001|Entered Discontinuation (DC) Period|Acute Open-label (OL) Period||0||
59696995|NCT01299272|75816354|FG002|Entered Discontinuation (DC) Period|Acute Open-label (OL) Period||0||
59696996|NCT01299272|75816355|FG003|Entered Discontinuation (DC) Period|Acute Open-label (OL) Period||0||
59696997|NCT01299272|75816352|FG000|COMPLETED|Acute Open-label (OL) Period|Participants who completed the Acute OL Period entered the Stabilization OL Period.|835||
59696998|NCT01299272|75816353|FG001|COMPLETED|Acute Open-label (OL) Period||0||
59696999|NCT01299272|75816354|FG002|COMPLETED|Acute Open-label (OL) Period||0||
59697000|NCT01299272|75816355|FG003|COMPLETED|Acute Open-label (OL) Period||0||
59697001|NCT01299272|75816352|FG000|NOT COMPLETED|Acute Open-label (OL) Period||414||
59697002|NCT01299272|75816353|FG001|NOT COMPLETED|Acute Open-label (OL) Period||0||
59697003|NCT01299272|75816354|FG002|NOT COMPLETED|Acute Open-label (OL) Period||0||
59697004|NCT01299272|75816355|FG003|NOT COMPLETED|Acute Open-label (OL) Period||0||
59697005|NCT01299272|75816352|FG000|STARTED|Stabilization Open-label (OL) Period||0||
59697006|NCT01299272|75816353|FG001|STARTED|Stabilization Open-label (OL) Period||835||
59697007|NCT01299272|75816354|FG002|STARTED|Stabilization Open-label (OL) Period||0||
59697008|NCT01299272|75816355|FG003|STARTED|Stabilization Open-label (OL) Period||0||
59697009|NCT01299272|75816352|FG000|Entered Discontinuation (DC) Period|Stabilization Open-label (OL) Period||0||
59697010|NCT01299272|75816353|FG001|Entered Discontinuation (DC) Period|Stabilization Open-label (OL) Period|Participants who discontinued the Stabilization OL Period had the option to enter the DC Period.|164||
59990144|NCT02500706|76105628|FG002|Exposed|Overall Study||342||
59697011|NCT01299272|75816354|FG002|Entered Discontinuation (DC) Period|Stabilization Open-label (OL) Period||0||
59697012|NCT01299272|75816355|FG003|Entered Discontinuation (DC) Period|Stabilization Open-label (OL) Period||0||
59697013|NCT01299272|75816352|FG000|COMPLETED|Stabilization Open-label (OL) Period||0||
59697014|NCT01299272|75816353|FG001|COMPLETED|Stabilization Open-label (OL) Period|Participants who completed the Stabilization OL Period were randomized to the DB Period.|586||
59697015|NCT01299272|75816354|FG002|COMPLETED|Stabilization Open-label (OL) Period||0||
59697016|NCT01299272|75816355|FG003|COMPLETED|Stabilization Open-label (OL) Period||0||
59697017|NCT01299272|75816352|FG000|NOT COMPLETED|Stabilization Open-label (OL) Period||0||
59697018|NCT01299272|75816353|FG001|NOT COMPLETED|Stabilization Open-label (OL) Period||249||
59697019|NCT01299272|75816354|FG002|NOT COMPLETED|Stabilization Open-label (OL) Period||0||
59697020|NCT01299272|75816355|FG003|NOT COMPLETED|Stabilization Open-label (OL) Period||0||
59697021|NCT01299272|75816352|FG000|STARTED|Double-blind (DB) Randomized Period||0||
59697022|NCT01299272|75816353|FG001|STARTED|Double-blind (DB) Randomized Period||0||
59697023|NCT01299272|75816354|FG002|STARTED|Double-blind (DB) Randomized Period||294||
59697024|NCT01299272|75816355|FG003|STARTED|Double-blind (DB) Randomized Period||292||
59697025|NCT01299272|75816352|FG000|Entered Taper Discontinuation Period|Double-blind (DB) Randomized Period||0||
59697026|NCT01299272|75816353|FG001|Entered Taper Discontinuation Period|Double-blind (DB) Randomized Period||0||
59697027|NCT01299272|75816354|FG002|Entered Taper Discontinuation Period|Double-blind (DB) Randomized Period|Participants who completed or discontinued the DB Period were randomized to the taper DC Period.|129||
59697028|NCT01299272|75816355|FG003|Entered Taper Discontinuation Period|Double-blind (DB) Randomized Period||0||
59990145|NCT02500706|76105626|FG000|COMPLETED|Overall Study||338||
59990146|NCT02500706|76105627|FG001|COMPLETED|Overall Study||334||
59990147|NCT02500706|76105628|FG002|COMPLETED|Overall Study||335||
59990148|NCT02500706|76105626|FG000|NOT COMPLETED|Overall Study||4||
59990149|NCT02500706|76105627|FG001|NOT COMPLETED|Overall Study||7||
59990150|NCT02500706|76105628|FG002|NOT COMPLETED|Overall Study||7||
59990151|NCT02442830|76105638|FG000|STARTED|Overall Study||42||
59990152|NCT02442830|76105639|FG001|STARTED|Overall Study||45||
59990153|NCT02442830|76105638|FG000|COMPLETED|Overall Study||42||
59990154|NCT02442830|76105639|FG001|COMPLETED|Overall Study||44||
59990155|NCT02442830|76105638|FG000|NOT COMPLETED|Overall Study||0||
59990156|NCT02442830|76105639|FG001|NOT COMPLETED|Overall Study||1||
59990157|NCT02471612|76105646|FG000|STARTED|Overall Study||159||
59990158|NCT02471612|76105646|FG000|COMPLETED|Overall Study||157||
59990159|NCT02471612|76105646|FG000|NOT COMPLETED|Overall Study||2||
59990160|NCT02500550|76105663|FG000|STARTED|Overall Study||15||
59990161|NCT02500550|76105663|FG000|COMPLETED|Overall Study||8||
59990162|NCT02500550|76105663|FG000|NOT COMPLETED|Overall Study||7||
59990163|NCT02499770|76105669|FG000|STARTED|Overall Study||19||
59990164|NCT02499770|76105670|FG001|STARTED|Overall Study||77||
59990165|NCT02499770|76105669|FG000|COMPLETED|Overall Study||0||
59990166|NCT02499770|76105670|FG001|COMPLETED|Overall Study||0||
59990167|NCT02499770|76105669|FG000|NOT COMPLETED|Overall Study||19||
59990168|NCT02499770|76105670|FG001|NOT COMPLETED|Overall Study||77||
60079535|NCT04206332|76194701|FG001|Received Product Administration|Part C||0||
60079536|NCT04206332|76194702|FG002|Received Product Administration|Part C||0||
60079537|NCT04206332|76194703|FG003|Received Product Administration|Part C||0||
60079538|NCT04206332|76194704|FG004|Received Product Administration|Part C||0||
59697029|NCT01299272|75816352|FG000|Entered Abrupt Discontinuation Period|Double-blind (DB) Randomized Period||0||
59697030|NCT01299272|75816353|FG001|Entered Abrupt Discontinuation Period|Double-blind (DB) Randomized Period||0||
59697031|NCT01299272|75816354|FG002|Entered Abrupt Discontinuation Period|Double-blind (DB) Randomized Period|Participants who completed or discontinued the DB Period were randomized to the abrupt DC Period.|132||
59697032|NCT01299272|75816355|FG003|Entered Abrupt Discontinuation Period|Double-blind (DB) Randomized Period|Participants who completed or discontinued the DB Period entered the DC Period.|268||
59697033|NCT01299272|75816352|FG000|COMPLETED|Double-blind (DB) Randomized Period||0||
59697034|NCT01299272|75816353|FG001|COMPLETED|Double-blind (DB) Randomized Period||0||
59697035|NCT01299272|75816354|FG002|COMPLETED|Double-blind (DB) Randomized Period||224||
59697036|NCT01299272|75816355|FG003|COMPLETED|Double-blind (DB) Randomized Period||234||
59697037|NCT01299272|75816352|FG000|NOT COMPLETED|Double-blind (DB) Randomized Period||0||
59697038|NCT01299272|75816353|FG001|NOT COMPLETED|Double-blind (DB) Randomized Period||0||
59697039|NCT01299272|75816354|FG002|NOT COMPLETED|Double-blind (DB) Randomized Period||70||
59697040|NCT01299272|75816355|FG003|NOT COMPLETED|Double-blind (DB) Randomized Period||58||
59697041|NCT01299116|75816372|FG000|STARTED|Overall Study||522||
59697042|NCT01299116|75816373|FG001|STARTED|Overall Study||177||
59697043|NCT01299116|75816374|FG002|STARTED|Overall Study||195||
59697044|NCT01299116|75816372|FG000|COMPLETED|Overall Study||457||
59697045|NCT01299116|75816373|FG001|COMPLETED|Overall Study||168||
59697046|NCT01299116|75816374|FG002|COMPLETED|Overall Study||184||
59697047|NCT01299116|75816372|FG000|NOT COMPLETED|Overall Study||65||
59697048|NCT01299116|75816373|FG001|NOT COMPLETED|Overall Study||9||
59697049|NCT01299116|75816374|FG002|NOT COMPLETED|Overall Study||11||
59697050|NCT01299038|75816387|FG000|STARTED|Overall Study|Consented|10||
59697051|NCT01299038|75816388|FG001|STARTED|Overall Study|Consented|10||
59990169|NCT02442284|76105682|FG000|STARTED|Overall Study||99||
59990170|NCT02442284|76105682|FG000|COMPLETED|Overall Study||92||
59990171|NCT02442284|76105682|FG000|NOT COMPLETED|Overall Study||7||
59990172|NCT03781960|76105686|FG000|STARTED|Overall Study||7||
59990173|NCT03781960|76105686|FG000|COMPLETED|Overall Study||7||
59990174|NCT03781960|76105686|FG000|NOT COMPLETED|Overall Study||0||
59990175|NCT02442206|76105692|FG000|STARTED|Period 1||30||
59990176|NCT02442206|76105693|FG001|STARTED|Period 1||32||
59990177|NCT02442206|76105692|FG000|COMPLETED|Period 1||29||
59990178|NCT02442206|76105693|FG001|COMPLETED|Period 1||29||
59990179|NCT02442206|76105692|FG000|NOT COMPLETED|Period 1||1||
59990180|NCT02442206|76105693|FG001|NOT COMPLETED|Period 1||3||
59990181|NCT02442206|76105692|FG000|STARTED|Period 2||29||
59990182|NCT02442206|76105693|FG001|STARTED|Period 2||29||
59990183|NCT02442206|76105692|FG000|COMPLETED|Period 2||28||
59990184|NCT02442206|76105693|FG001|COMPLETED|Period 2||29||
59990185|NCT02442206|76105692|FG000|NOT COMPLETED|Period 2||1||
59990186|NCT02442206|76105693|FG001|NOT COMPLETED|Period 2||0||
59990187|NCT02499146|76105700|FG000|STARTED|Overall Study||26||
59990188|NCT02499146|76105700|FG000|COMPLETED|Overall Study||0||
59990189|NCT02499146|76105700|FG000|NOT COMPLETED|Overall Study||26||
59990190|NCT03544138|76105704|FG000|STARTED|Overall Study|Number of participants and ears that underwent ear tube placement with HTTS.|258||492
59990191|NCT03544138|76105704|FG000|COMPLETED|Overall Study|Number of participants and ears that completed follow-up at 3-10 weeks post-procedure|229||440
59990192|NCT03544138|76105704|FG000|NOT COMPLETED|Overall Study||29||52
59990193|NCT01634854|76105710|FG000|STARTED|Overall Study||64||
59990194|NCT01634854|76105711|FG001|STARTED|Overall Study||66||
59990195|NCT01634854|76105710|FG000|COMPLETED|Overall Study||62||
59990196|NCT01634854|76105711|FG001|COMPLETED|Overall Study||59||
59697052|NCT01299038|75816387|FG000|COMPLETED|Overall Study|Evaluable|9||
59697053|NCT01299038|75816388|FG001|COMPLETED|Overall Study|Evaluable|10||
59697054|NCT01299038|75816387|FG000|NOT COMPLETED|Overall Study||1||
59697055|NCT01299038|75816388|FG001|NOT COMPLETED|Overall Study||0||
59697056|NCT01298648|75816394|FG000|STARTED|Overall Study||1716||
59697057|NCT01298648|75816394|FG000|COMPLETED|Overall Study||1693||
59697058|NCT01298648|75816394|FG000|NOT COMPLETED|Overall Study||23||
59697059|NCT01261338|75816400|FG000|STARTED|Overall Study|One person in the olestra group started 4 months after the trial began.|14||
59697060|NCT01261338|75816401|FG001|STARTED|Overall Study||14||
59697061|NCT01261338|75816400|FG000|COMPLETED|Overall Study||11||
59697062|NCT01261338|75816401|FG001|COMPLETED|Overall Study||12||
59697063|NCT01261338|75816400|FG000|NOT COMPLETED|Overall Study||3||
59697064|NCT01261338|75816401|FG001|NOT COMPLETED|Overall Study||2||
59697065|NCT01260948|75816409|FG000|STARTED|First Intervention||13||
59697066|NCT01260948|75816410|FG001|STARTED|First Intervention||13||
59697067|NCT01260948|75816409|FG000|COMPLETED|First Intervention||13||
59697068|NCT01260948|75816410|FG001|COMPLETED|First Intervention||13||
59697069|NCT01260948|75816409|FG000|NOT COMPLETED|First Intervention||0||
59697070|NCT01260948|75816410|FG001|NOT COMPLETED|First Intervention||0||
59697071|NCT01260948|75816409|FG000|STARTED|Washout of 28 Days||13||
59697072|NCT01260948|75816410|FG001|STARTED|Washout of 28 Days||13||
59697073|NCT01260948|75816409|FG000|COMPLETED|Washout of 28 Days||12||
59990197|NCT01634854|76105710|FG000|NOT COMPLETED|Overall Study||2||
59990198|NCT01634854|76105711|FG001|NOT COMPLETED|Overall Study||7||
59990199|NCT02469896|76105719|FG000|STARTED|Overall Study||8||
59990200|NCT02469896|76105720|FG001|STARTED|Overall Study||14||
59990201|NCT02469896|76105719|FG000|COMPLETED|Overall Study||6||
59990202|NCT02469896|76105720|FG001|COMPLETED|Overall Study||14||
59697074|NCT01260948|75816410|FG001|COMPLETED|Washout of 28 Days||10||
59697075|NCT01260948|75816409|FG000|NOT COMPLETED|Washout of 28 Days||1||
59816175|NCT00529568|75938539|FG000|NOT COMPLETED|Open-label Pre-Antiviral Treatment Phase||46||
59990203|NCT02469896|76105719|FG000|NOT COMPLETED|Overall Study||2||
59990204|NCT02469896|76105720|FG001|NOT COMPLETED|Overall Study||0||
59990205|NCT02441114|76105730|FG000|STARTED|Period1||10||
59990206|NCT02441114|76105730|FG000|COMPLETED|Period1||10||
59990207|NCT02441114|76105730|FG000|NOT COMPLETED|Period1||0||
59990208|NCT02441114|76105730|FG000|STARTED|Washout1||10||
59990209|NCT02441114|76105730|FG000|COMPLETED|Washout1||10||
59990210|NCT02441114|76105730|FG000|NOT COMPLETED|Washout1||0||
59990211|NCT02441114|76105730|FG000|STARTED|Period2||10||
59990212|NCT02441114|76105730|FG000|COMPLETED|Period2||10||
59990213|NCT02441114|76105730|FG000|NOT COMPLETED|Period2||0||
59990214|NCT02441114|76105730|FG000|STARTED|Washout2||10||
59990215|NCT02441114|76105730|FG000|COMPLETED|Washout2||6||
60079539|NCT04206332|76194705|FG005|Received Product Administration|Part C||0||
59697076|NCT01260948|75816410|FG001|NOT COMPLETED|Washout of 28 Days||3||
59697077|NCT01260948|75816409|FG000|STARTED|Second Intervention||12||
59697078|NCT01260948|75816410|FG001|STARTED|Second Intervention||10||
59697079|NCT01260948|75816409|FG000|COMPLETED|Second Intervention||12||
59697080|NCT01260948|75816410|FG001|COMPLETED|Second Intervention||9||
59697081|NCT01260948|75816409|FG000|NOT COMPLETED|Second Intervention||0||
59816176|NCT00529568|75938540|FG001|NOT COMPLETED|Open-label Pre-Antiviral Treatment Phase||0||
59990216|NCT02441114|76105730|FG000|NOT COMPLETED|Washout2||4||
59697082|NCT01260948|75816410|FG001|NOT COMPLETED|Second Intervention||1||
59990217|NCT02441114|76105730|FG000|STARTED|Period3||6||
59990218|NCT02441114|76105730|FG000|COMPLETED|Period3||6||
59990219|NCT02441114|76105730|FG000|NOT COMPLETED|Period3||0||
59990220|NCT02498678|76105736|FG000|STARTED|Overall Study||25||
59990221|NCT02498678|76105737|FG001|STARTED|Overall Study||25||
59990222|NCT02498678|76105736|FG000|COMPLETED|Overall Study||25||
59990223|NCT02498678|76105737|FG001|COMPLETED|Overall Study||23||
59990224|NCT02498678|76105736|FG000|NOT COMPLETED|Overall Study||0||
59990225|NCT02498678|76105737|FG001|NOT COMPLETED|Overall Study||2||
59990226|NCT02441036|76105748|FG000|STARTED|Overall Study||3||
59990227|NCT02441036|76105749|FG001|STARTED|Overall Study||5||
59990228|NCT02441036|76105750|FG002|STARTED|Overall Study||3||
59990229|NCT02441036|76105751|FG003|STARTED|Overall Study||4||
59990230|NCT02441036|76105752|FG004|STARTED|Overall Study||1||
59990231|NCT02441036|76105748|FG000|Treated|Overall Study||3||
59697083|NCT01025284|75816419|FG000|STARTED|Overall Study||38||
59697084|NCT01025284|75816420|FG001|STARTED|Overall Study||18||
59697085|NCT01025284|75816421|FG002|STARTED|Overall Study||8||
59697086|NCT01025284|75816419|FG000|Received at Least 1 Dose of Study Drug|Overall Study||38||
59697087|NCT01025284|75816420|FG001|Received at Least 1 Dose of Study Drug|Overall Study||18||
59697088|NCT01025284|75816421|FG002|Received at Least 1 Dose of Study Drug|Overall Study||8||
59697089|NCT01025284|75816419|FG000|COMPLETED|Overall Study||38||
59547820|NCT02179424|75646704|FG001|NOT COMPLETED|Overall Study||0||
59697090|NCT01025284|75816420|FG001|COMPLETED|Overall Study||16||
59697091|NCT01025284|75816421|FG002|COMPLETED|Overall Study||8||
59697092|NCT01025284|75816419|FG000|NOT COMPLETED|Overall Study||0||
59697093|NCT01025284|75816420|FG001|NOT COMPLETED|Overall Study||2||
59697094|NCT01025284|75816421|FG002|NOT COMPLETED|Overall Study||0||
59990232|NCT02441036|76105749|FG001|Treated|Overall Study||5||
59990233|NCT02441036|76105750|FG002|Treated|Overall Study||3||
59990234|NCT02441036|76105751|FG003|Treated|Overall Study||4||
59990235|NCT02441036|76105752|FG004|Treated|Overall Study||1||
59990236|NCT02441036|76105748|FG000|Tissue Resected|Overall Study||3||
59990237|NCT02441036|76105749|FG001|Tissue Resected|Overall Study||4||
59990238|NCT02441036|76105750|FG002|Tissue Resected|Overall Study||3||
59990239|NCT02441036|76105751|FG003|Tissue Resected|Overall Study||3||
59990240|NCT02441036|76105752|FG004|Tissue Resected|Overall Study||1||
59990241|NCT02441036|76105748|FG000|COMPLETED|Overall Study||3||
59990242|NCT02441036|76105749|FG001|COMPLETED|Overall Study||4||
59990243|NCT02441036|76105750|FG002|COMPLETED|Overall Study||3||
59990244|NCT02441036|76105751|FG003|COMPLETED|Overall Study||3||
59990245|NCT02441036|76105752|FG004|COMPLETED|Overall Study||1||
59990246|NCT02441036|76105748|FG000|NOT COMPLETED|Overall Study||0||
59990247|NCT02441036|76105749|FG001|NOT COMPLETED|Overall Study||1||
59990248|NCT02441036|76105750|FG002|NOT COMPLETED|Overall Study||0||
59990249|NCT02441036|76105751|FG003|NOT COMPLETED|Overall Study||1||
59990250|NCT02441036|76105752|FG004|NOT COMPLETED|Overall Study||0||
59990251|NCT02498444|76105767|FG000|STARTED|Overall Study||16||
59990252|NCT02498444|76105768|FG001|STARTED|Overall Study||18||
59990253|NCT02498444|76105767|FG000|COMPLETED|Overall Study||12||
59990254|NCT02498444|76105768|FG001|COMPLETED|Overall Study||18||
59990255|NCT02498444|76105767|FG000|NOT COMPLETED|Overall Study||4||
59990256|NCT02498444|76105768|FG001|NOT COMPLETED|Overall Study||0||
59990257|NCT02497976|76105776|FG000|STARTED|Overall Study||28||
59990258|NCT02497976|76105777|FG001|STARTED|Overall Study||14||
59990259|NCT02497976|76105776|FG000|COMPLETED|Overall Study||26||
59990260|NCT02497976|76105777|FG001|COMPLETED|Overall Study||13||
59990261|NCT02497976|76105776|FG000|NOT COMPLETED|Overall Study||2||
59990262|NCT02497976|76105777|FG001|NOT COMPLETED|Overall Study||1||
59697095|NCT01021852|75816439|FG000|STARTED|Treatment Period 1||40||
59697096|NCT01021852|75816440|FG001|STARTED|Treatment Period 1||40||
59697097|NCT01021852|75816441|FG002|STARTED|Treatment Period 1||41||
59697098|NCT01021852|75816442|FG003|STARTED|Treatment Period 1||40||
59697099|NCT01021852|75816443|FG004|STARTED|Treatment Period 1||42||
59990263|NCT03347188|76105785|FG000|STARTED|Double-blind (DB) Period (12 Weeks)||44||
59990264|NCT03347188|76105786|FG001|STARTED|Double-blind (DB) Period (12 Weeks)||43||
59990265|NCT03347188|76105785|FG000|Received at Least 1 Dose of Study Drug|Double-blind (DB) Period (12 Weeks)||43||
59990266|NCT03347188|76105786|FG001|Received at Least 1 Dose of Study Drug|Double-blind (DB) Period (12 Weeks)||43||
59990267|NCT03347188|76105785|FG000|Full Analysis Set (FAS)|Double-blind (DB) Period (12 Weeks)||42|Received at least 1 dose of study drug and had at least 1 post-baseline efficacy assessment on primary endpoint.|
59990268|NCT03347188|76105786|FG001|Full Analysis Set (FAS)|Double-blind (DB) Period (12 Weeks)||43|Received at least 1 dose of study drug and had at least 1 post-baseline efficacy assessment on primary endpoint.|
59990269|NCT03347188|76105785|FG000|COMPLETED|Double-blind (DB) Period (12 Weeks)||29||
59990270|NCT03347188|76105786|FG001|COMPLETED|Double-blind (DB) Period (12 Weeks)||26||
59990271|NCT03347188|76105785|FG000|NOT COMPLETED|Double-blind (DB) Period (12 Weeks)||15||
59990272|NCT03347188|76105786|FG001|NOT COMPLETED|Double-blind (DB) Period (12 Weeks)||17||
59990273|NCT03347188|76105785|FG000|STARTED|Open-label (OL) Period (12 Weeks)||35||
59990274|NCT03347188|76105786|FG001|STARTED|Open-label (OL) Period (12 Weeks)||35||
59990275|NCT03347188|76105785|FG000|Entered in OL Period for Anti-drug Antibody (ADA) Only|Open-label (OL) Period (12 Weeks)||26||
59990276|NCT03347188|76105786|FG001|Entered in OL Period for Anti-drug Antibody (ADA) Only|Open-label (OL) Period (12 Weeks)||28||
59995464|NCT02155946|76111287|FG000|COMPLETED|Overall Study|number completed at primary endpoint|29||
59990277|NCT03347188|76105785|FG000|Received at Least 1 Dose of Study Drug|Open-label (OL) Period (12 Weeks)||9||
59990278|NCT03347188|76105786|FG001|Received at Least 1 Dose of Study Drug|Open-label (OL) Period (12 Weeks)||7||
59990279|NCT03347188|76105785|FG000|COMPLETED|Open-label (OL) Period (12 Weeks)||8||
59990280|NCT03347188|76105786|FG001|COMPLETED|Open-label (OL) Period (12 Weeks)||6||
59990281|NCT03347188|76105785|FG000|NOT COMPLETED|Open-label (OL) Period (12 Weeks)||27||
59990282|NCT03347188|76105786|FG001|NOT COMPLETED|Open-label (OL) Period (12 Weeks)||29||
59990283|NCT02440568|76105796|FG000|STARTED|Overall Study||5||
59990284|NCT02440568|76105797|FG001|STARTED|Overall Study||4||
59990285|NCT02440568|76105798|FG002|STARTED|Overall Study||10||
59990286|NCT02440568|76105799|FG003|STARTED|Overall Study||3||
59990287|NCT02440568|76105796|FG000|COMPLETED|Overall Study||1||
59990288|NCT02440568|76105797|FG001|COMPLETED|Overall Study||1||
59990289|NCT02440568|76105798|FG002|COMPLETED|Overall Study||5||
59990290|NCT02440568|76105799|FG003|COMPLETED|Overall Study||1||
59990291|NCT02440568|76105796|FG000|NOT COMPLETED|Overall Study||4||
59990292|NCT02440568|76105797|FG001|NOT COMPLETED|Overall Study||3||
59990293|NCT02440568|76105798|FG002|NOT COMPLETED|Overall Study||5||
59990294|NCT02440568|76105799|FG003|NOT COMPLETED|Overall Study||2||
59990295|NCT03090191|76105812|FG000|STARTED|Overall Study||8766||
59990296|NCT03090191|76105813|FG001|STARTED|Overall Study||8769||
59990297|NCT03090191|76105812|FG000|Vaccinated at Month 0 (Dose 1)|Overall Study||8723|Among 8766 participants randomized to Clostridium difficile vaccine(Cdif.vac)group(grp),8723 received first dose, 8769 randomized to placebo grp,8717 received first dose. But 2 participants in Cdif.vac grp received placebo,1 participant in placebo grp received Cdif.vac for first dose.So, 8722 received Cdif.vac, 8718 received placebo for first dose. 8722 and 8718=participants in baseline characteristics, safety data summaries since safety population based on actual vaccine received at first dose.|
59990298|NCT03090191|76105813|FG001|Vaccinated at Month 0 (Dose 1)|Overall Study||8717|Among 8766 participants randomized to Clostridium difficile vaccine(Cdif.vac)group(grp),8723 received first dose, 8769 randomized to placebo grp,8717 received first dose. But 2 participants in Cdif.vac grp received placebo,1 participant in placebo grp received Cdif.vac for first dose.So, 8722 received Cdif.vac, 8718 received placebo for first dose. 8722 and 8718=participants in baseline characteristics, safety data summaries since safety population based on actual vaccine received at first dose.|
59990299|NCT03090191|76105812|FG000|Received Clostridium Difficile Vaccine|Overall Study||8721||
59990300|NCT03090191|76105813|FG001|Received Clostridium Difficile Vaccine|Overall Study||1||
59990301|NCT03090191|76105812|FG000|Received Placebo|Overall Study||2||
59990302|NCT03090191|76105813|FG001|Received Placebo|Overall Study||8716||
59990303|NCT03090191|76105812|FG000|Vaccinated at Month 1 (Dose 2)|Overall Study||8311||
59990304|NCT03090191|76105813|FG001|Vaccinated at Month 1 (Dose 2)|Overall Study||8331||
59990305|NCT03090191|76105812|FG000|Received Clostridium Difficile Vaccine|Overall Study||8310||
59990306|NCT03090191|76105813|FG001|Received Clostridium Difficile Vaccine|Overall Study||0||
59990307|NCT03090191|76105812|FG000|Received Placebo|Overall Study||1||
59990308|NCT03090191|76105813|FG001|Received Placebo|Overall Study||8331||
59990309|NCT03090191|76105812|FG000|Vaccinated at Month 6 (Dose 3)|Overall Study||7894||
59990310|NCT03090191|76105813|FG001|Vaccinated at Month 6 (Dose 3)|Overall Study||7967||
59990311|NCT03090191|76105812|FG000|Received Clostridium Difficile Vaccine|Overall Study||7894||
59990312|NCT03090191|76105813|FG001|Received Clostridium Difficile Vaccine|Overall Study||0||
59990313|NCT03090191|76105812|FG000|Received Placebo|Overall Study||0||
59990314|NCT03090191|76105813|FG001|Received Placebo|Overall Study||7967||
59990315|NCT03090191|76105812|FG000|COMPLETED|Overall Study||5533||
59990316|NCT03090191|76105813|FG001|COMPLETED|Overall Study||5574||
59990317|NCT03090191|76105812|FG000|NOT COMPLETED|Overall Study||3233||
59990318|NCT03090191|76105813|FG001|NOT COMPLETED|Overall Study||3195||
59990319|NCT00434434|76105822|FG000|STARTED|Overall Study||23||
59990320|NCT00434434|76105823|FG001|STARTED|Overall Study||24||
59990321|NCT00434434|76105824|FG002|STARTED|Overall Study||14||
59990322|NCT00434434|76105822|FG000|COMPLETED|Overall Study||21||
59990323|NCT00434434|76105823|FG001|COMPLETED|Overall Study||24||
59990324|NCT00434434|76105824|FG002|COMPLETED|Overall Study||13||
59990325|NCT00434434|76105822|FG000|NOT COMPLETED|Overall Study||2||
59990326|NCT00434434|76105823|FG001|NOT COMPLETED|Overall Study||0||
59990327|NCT00434434|76105824|FG002|NOT COMPLETED|Overall Study||1||
59990328|NCT02439320|76105835|FG000|STARTED|Overall Study||744||
59990329|NCT02439320|76105836|FG001|STARTED|Overall Study||745||
59990330|NCT02439320|76105837|FG002|STARTED|Overall Study||742||
59990331|NCT02439320|76105835|FG000|Confirmed Eligibility|Overall Study||710||
59990332|NCT02439320|76105836|FG001|Confirmed Eligibility|Overall Study||695||
59990333|NCT02439320|76105837|FG002|Confirmed Eligibility|Overall Study||705||
59990334|NCT02439320|76105835|FG000|1st Dose (by 4 Hours Migraine Onset)|Overall Study||630|Safety population based on the first dose. Participants received at least 1 dose of study drug.|
59990335|NCT02439320|76105836|FG001|1st Dose (by 4 Hours Migraine Onset)|Overall Study||609|Safety population based on the first dose. Participants received at least 1 dose of study drug.|
59990336|NCT02439320|76105837|FG002|1st Dose (by 4 Hours Migraine Onset)|Overall Study||617|Safety population based on the first dose. Participants received at least 1 dose of study drug.|
59990337|NCT02439320|76105835|FG000|2nd Dose (After 2 Hour Assessment)|Overall Study||289|Participants received second dose of study drug after 4 hours.|
59990338|NCT02439320|76105836|FG001|2nd Dose (After 2 Hour Assessment)|Overall Study||238|Participants received second dose of study drug after 4 hours.|
59990339|NCT02439320|76105837|FG002|2nd Dose (After 2 Hour Assessment)|Overall Study||401|Participants received second dose of study drug after 4 hours.|
59990340|NCT02439320|76105835|FG000|COMPLETED|Overall Study||648|Included participants who received study drug and participants who did not receive study drug.|
59990341|NCT02439320|76105836|FG001|COMPLETED|Overall Study||631|Included participants who received study drug and participants who did not receive study drug.|
59990342|NCT02439320|76105837|FG002|COMPLETED|Overall Study||643|Included participants who received study drug and participants who did not receive study drug.|
59990343|NCT02439320|76105835|FG000|NOT COMPLETED|Overall Study||96||
59990344|NCT02439320|76105836|FG001|NOT COMPLETED|Overall Study||114||
59816177|NCT00529568|75938541|FG002|NOT COMPLETED|Open-label Pre-Antiviral Treatment Phase||0||
59990345|NCT02439320|76105837|FG002|NOT COMPLETED|Overall Study||99||
59990346|NCT02469038|76105853|FG000|STARTED|Overall Study||26||
59990347|NCT02469038|76105854|FG001|STARTED|Overall Study||24||
59990348|NCT02469038|76105853|FG000|COMPLETED|Overall Study||22||
59990349|NCT02469038|76105854|FG001|COMPLETED|Overall Study||19||
59990350|NCT02469038|76105853|FG000|NOT COMPLETED|Overall Study||4||
59990351|NCT02469038|76105854|FG001|NOT COMPLETED|Overall Study||5||
59990352|NCT02468648|76105860|FG000|STARTED|Overall Study||72||
59990353|NCT02468648|76105860|FG000|COMPLETED|Overall Study||71||
59990354|NCT02468648|76105860|FG000|NOT COMPLETED|Overall Study||1||
59990355|NCT02468414|76105866|FG000|STARTED|Overall Study||3||
59990356|NCT02468414|76105867|FG001|STARTED|Overall Study||0||
59990357|NCT02468414|76105866|FG000|Successfully Screened|Overall Study||2||
59990358|NCT02468414|76105867|FG001|Successfully Screened|Overall Study||0||
59990359|NCT02468414|76105866|FG000|Harvesting|Overall Study||1||
59990360|NCT02468414|76105867|FG001|Harvesting|Overall Study||0||
59990361|NCT02468414|76105866|FG000|Implantation|Overall Study||1||
59990362|NCT02468414|76105867|FG001|Implantation|Overall Study||0||
59990363|NCT02468414|76105866|FG000|Safety Follow-up|Overall Study||0||
59990364|NCT02468414|76105867|FG001|Safety Follow-up|Overall Study||0||
59990365|NCT02468414|76105866|FG000|COMPLETED|Overall Study||0||
59990366|NCT02468414|76105867|FG001|COMPLETED|Overall Study||0||
59990367|NCT02468414|76105866|FG000|NOT COMPLETED|Overall Study||3||
59990368|NCT02468414|76105867|FG001|NOT COMPLETED|Overall Study||0||
59990369|NCT02466386|76105873|FG000|STARTED|Overall Study||113||
59990370|NCT02466386|76105873|FG000|COMPLETED|Overall Study||69||
59990371|NCT02466386|76105873|FG000|NOT COMPLETED|Overall Study||44||
59990372|NCT01633060|76105879|FG000|STARTED|Randomization Phase|All randomized patients|289|All randomized patients|
59990373|NCT01633060|76105880|FG001|STARTED|Randomization Phase|All randomized patients|143|All randomized patients|
59990374|NCT01633060|76105879|FG000|COMPLETED|Randomization Phase||288|Randomized and treated|
59990375|NCT01633060|76105880|FG001|COMPLETED|Randomization Phase||140|Randomized and treated|
59990376|NCT01633060|76105879|FG000|NOT COMPLETED|Randomization Phase||1||
59990377|NCT01633060|76105880|FG001|NOT COMPLETED|Randomization Phase||3||
59990378|NCT01633060|76105879|FG000|STARTED|Treatment Phase||288|All patients in FAS that were treated|
59990379|NCT01633060|76105880|FG001|STARTED|Treatment Phase||140|All patients in FAS that were treated|
59990380|NCT01633060|76105879|FG000|FAS - ctDNA PIK3CA Mutant|Treatment Phase||100|All patients in FAS with ctDNA sample and PIK3CA mutation|
59990381|NCT01633060|76105880|FG001|FAS - ctDNA PIK3CA Mutant|Treatment Phase||35|All patients in FAS with ctDNA sample and PIK3CA mutation|
59990382|NCT01633060|76105879|FG000|FAS - ctDNA PIK3CA Non-mutant|Treatment Phase||132|All patients in FAS with ctDNA sample and no PIK3CA mutation|
59990383|NCT01633060|76105880|FG001|FAS - ctDNA PIK3CA Non-mutant|Treatment Phase||81|All patients in FAS with ctDNA sample and no PIK3CA mutation|
59990384|NCT01633060|76105879|FG000|Safety Set (SS)|Treatment Phase||288|At least 1 dose of study treatment and a 1 post baseline safety assessment|
59990385|NCT01633060|76105880|FG001|Safety Set (SS)|Treatment Phase||140|At least 1 dose of study treatment and a 1 post baseline safety assessment|
59990386|NCT01633060|76105879|FG000|Pharmacokinetic Analysis Set (PAS)|Treatment Phase||63|At least one dose of Buparlisib and had at least 1 evaluable buparlisib concentration measurement|
59995465|NCT02155946|76111288|FG001|COMPLETED|Overall Study|number completed at primary endpoint|23||
59816178|NCT00529568|75938539|FG000|STARTED|Double-bilnd Antiviral Treatment Phase||0||
59816179|NCT00529568|75938540|FG001|STARTED|Double-bilnd Antiviral Treatment Phase||253||
59816180|NCT00529568|75938541|FG002|STARTED|Double-bilnd Antiviral Treatment Phase||506||
59990387|NCT01633060|76105880|FG001|Pharmacokinetic Analysis Set (PAS)|Treatment Phase||0|At least one dose of Buparlisib and had at least 1 evaluable buparlisib concentration measurement|
59990388|NCT01633060|76105879|FG000|COMPLETED|Treatment Phase||0||
59990389|NCT01633060|76105880|FG001|COMPLETED|Treatment Phase||0||
59990390|NCT01633060|76105879|FG000|NOT COMPLETED|Treatment Phase||288||
59990391|NCT01633060|76105880|FG001|NOT COMPLETED|Treatment Phase||140||
59990392|NCT01633060|76105879|FG000|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|16|All patients who discontinued treatment and entered Post-Treatment Efficacy Follow-Up Phase|
59990393|NCT01633060|76105880|FG001|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|2|All patients who discontinued treatment and entered Post-Treatment Efficacy Follow-Up Phase|
59990394|NCT01633060|76105879|FG000|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0||
59990395|NCT01633060|76105880|FG001|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0||
59990396|NCT01633060|76105879|FG000|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||16||
59990397|NCT01633060|76105880|FG001|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||2||
59990398|NCT01632904|76105889|FG000|STARTED|Overall Study||54||
59990399|NCT01632904|76105890|FG001|STARTED|Overall Study||56||
59990400|NCT01632904|76105889|FG000|COMPLETED|Overall Study|Patients still in the study as of data cutoff, 27MAR2014.|47||
59990401|NCT01632904|76105890|FG001|COMPLETED|Overall Study|Patients still in the study as of 27MAR2014, including those who crossed over to ruxolitinib|50||
59990402|NCT01632904|76105889|FG000|NOT COMPLETED|Overall Study||7||
59990403|NCT01632904|76105890|FG001|NOT COMPLETED|Overall Study||6||
59990404|NCT03834779|76105898|FG000|STARTED|Overall Study||17||
59990405|NCT03834779|76105899|FG001|STARTED|Overall Study||14||
59990406|NCT03834779|76105898|FG000|COMPLETED|Overall Study||10||
59990407|NCT03834779|76105899|FG001|COMPLETED|Overall Study||8||
59990408|NCT03834779|76105898|FG000|NOT COMPLETED|Overall Study||7||
59990409|NCT03834779|76105899|FG001|NOT COMPLETED|Overall Study||6||
59990410|NCT03726437|76105908|FG000|STARTED|Overall Study||444|Randomized to RealConsent|
59990411|NCT03726437|76105909|FG001|STARTED|Overall Study|Randomized to Attention placebo group|437|Randomized to RealConsent|
59990412|NCT03726437|76105908|FG000|COMPLETED|Overall Study||359|Completed 6-month follow-up assessments.|
59990413|NCT03726437|76105909|FG001|COMPLETED|Overall Study|Completed 6-month follow-up assessment|361|Completed 6-month follow-up assessments.|
59990414|NCT03726437|76105908|FG000|NOT COMPLETED|Overall Study||85||
59990415|NCT03726437|76105909|FG001|NOT COMPLETED|Overall Study||76||
59990416|NCT02465528|76105919|FG000|STARTED|Overall Study||1||
59990417|NCT02465528|76105920|FG001|STARTED|Overall Study||4||
59990418|NCT02465528|76105921|FG002|STARTED|Overall Study||12||
59990419|NCT02465528|76105922|FG003|STARTED|Overall Study||5||
59990420|NCT02465528|76105919|FG000|COMPLETED|Overall Study||0||
59990421|NCT02465528|76105920|FG001|COMPLETED|Overall Study||0||
59990422|NCT02465528|76105921|FG002|COMPLETED|Overall Study||0||
59990423|NCT02465528|76105922|FG003|COMPLETED|Overall Study||0||
59990424|NCT02465528|76105919|FG000|NOT COMPLETED|Overall Study||1||
59990425|NCT02465528|76105920|FG001|NOT COMPLETED|Overall Study||4||
59990426|NCT02465528|76105921|FG002|NOT COMPLETED|Overall Study||12||
59990427|NCT02465528|76105922|FG003|NOT COMPLETED|Overall Study||5||
59990428|NCT02438384|76105937|FG000|STARTED|Overall Study||25||
59990429|NCT02438384|76105938|FG001|STARTED|Overall Study||25||
59990430|NCT02438384|76105939|FG002|STARTED|Overall Study||25||
59990431|NCT02438384|76105937|FG000|COMPLETED|Overall Study||17||
59990432|NCT02438384|76105938|FG001|COMPLETED|Overall Study||19||
59990433|NCT02438384|76105939|FG002|COMPLETED|Overall Study||21||
59990434|NCT02438384|76105937|FG000|NOT COMPLETED|Overall Study||8||
59697100|NCT01021852|75816444|FG005|STARTED|Treatment Period 1||41||
59697101|NCT01021852|75816445|FG006|STARTED|Treatment Period 1||41||
59697102|NCT01021852|75816446|FG007|STARTED|Treatment Period 1||41||
59697103|NCT01021852|75816439|FG000|Treated|Treatment Period 1||40||
59697104|NCT01021852|75816440|FG001|Treated|Treatment Period 1||40||
59697105|NCT01021852|75816441|FG002|Treated|Treatment Period 1||41||
59697106|NCT01021852|75816442|FG003|Treated|Treatment Period 1||38||
59990435|NCT02438384|76105938|FG001|NOT COMPLETED|Overall Study||6||
59990436|NCT02438384|76105939|FG002|NOT COMPLETED|Overall Study||4||
59990437|NCT02463032|76105949|FG000|STARTED|Overall Study||72||
59990438|NCT02463032|76105950|FG001|STARTED|Overall Study||64||
59990439|NCT02463032|76105949|FG000|COMPLETED|Overall Study||1||
59990440|NCT02463032|76105950|FG001|COMPLETED|Overall Study||0||
59697107|NCT01021852|75816443|FG004|Treated|Treatment Period 1||42||
59990441|NCT02463032|76105949|FG000|NOT COMPLETED|Overall Study||71||
59990442|NCT02463032|76105950|FG001|NOT COMPLETED|Overall Study||64||
59990443|NCT02496884|76105960|FG000|STARTED|Overall Study||17||
59990444|NCT02496884|76105961|FG001|STARTED|Overall Study||34||
59697108|NCT01021852|75816444|FG005|Treated|Treatment Period 1|1 participant discontinued Treatment Period 1 (AE) but continued in Placebo Washout|41||
59697109|NCT01021852|75816445|FG006|Treated|Treatment Period 1||41||
59697110|NCT01021852|75816446|FG007|Treated|Treatment Period 1||41||
59697111|NCT01021852|75816439|FG000|COMPLETED|Treatment Period 1||37||
59990445|NCT02496884|76105962|FG002|STARTED|Overall Study||1||
59547821|NCT02179424|75646705|FG002|NOT COMPLETED|Overall Study||0||
59547822|NCT02179424|75646706|FG003|NOT COMPLETED|Overall Study||0||
59547823|NCT02478489|75646719|FG000|STARTED|Overall Study||123||
59547824|NCT02478489|75646720|FG001|STARTED|Overall Study||125||
59547825|NCT02478489|75646719|FG000|COMPLETED|Overall Study||108||
59547826|NCT02478489|75646720|FG001|COMPLETED|Overall Study||109||
59547827|NCT02478489|75646719|FG000|NOT COMPLETED|Overall Study||15||
59547828|NCT02478489|75646720|FG001|NOT COMPLETED|Overall Study||16||
59547829|NCT02480439|75646729|FG000|STARTED|Treatment Period 1||8||
59547830|NCT02480439|75646730|FG001|STARTED|Treatment Period 1||8||
59547831|NCT02480439|75646731|FG002|STARTED|Treatment Period 1||8||
59547832|NCT02480439|75646729|FG000|COMPLETED|Treatment Period 1||8||
59547833|NCT02480439|75646730|FG001|COMPLETED|Treatment Period 1||8||
59547834|NCT02480439|75646731|FG002|COMPLETED|Treatment Period 1||8||
59547835|NCT02480439|75646729|FG000|NOT COMPLETED|Treatment Period 1||0||
59547836|NCT02480439|75646730|FG001|NOT COMPLETED|Treatment Period 1||0||
59547837|NCT02480439|75646731|FG002|NOT COMPLETED|Treatment Period 1||0||
59547838|NCT02480439|75646729|FG000|STARTED|Treatment Period 2||8||
59547839|NCT02480439|75646730|FG001|STARTED|Treatment Period 2|1 Participant was withdrawn due to an Adverse Event after completing Period 1.|7||
59547840|NCT02480439|75646731|FG002|STARTED|Treatment Period 2||8||
59547841|NCT02480439|75646729|FG000|COMPLETED|Treatment Period 2||8||
59547842|NCT02480439|75646730|FG001|COMPLETED|Treatment Period 2||7||
59547843|NCT02480439|75646731|FG002|COMPLETED|Treatment Period 2||8||
59547844|NCT02480439|75646729|FG000|NOT COMPLETED|Treatment Period 2||0||
59547845|NCT02480439|75646730|FG001|NOT COMPLETED|Treatment Period 2||0||
59547846|NCT02480439|75646731|FG002|NOT COMPLETED|Treatment Period 2||0||
59547847|NCT02480439|75646729|FG000|STARTED|Treatment Period 3||8||
59547848|NCT02480439|75646730|FG001|STARTED|Treatment Period 3||7||
59547849|NCT02480439|75646731|FG002|STARTED|Treatment Period 3|1 Participant was withdrawn due to an Adverse Event after completing Period 2.|7||
59547850|NCT02480439|75646729|FG000|COMPLETED|Treatment Period 3||8||
59547851|NCT02480439|75646730|FG001|COMPLETED|Treatment Period 3||7||
59547852|NCT02480439|75646731|FG002|COMPLETED|Treatment Period 3||7||
59547853|NCT02480439|75646729|FG000|NOT COMPLETED|Treatment Period 3||0||
59547854|NCT02480439|75646730|FG001|NOT COMPLETED|Treatment Period 3||0||
59547855|NCT02480439|75646731|FG002|NOT COMPLETED|Treatment Period 3||0||
59547856|NCT02322320|75646742|FG000|STARTED|Overall Study||98||
59547857|NCT02322320|75646743|FG001|STARTED|Overall Study||86||
59547858|NCT02322320|75646744|FG002|STARTED|Overall Study||89||
59547859|NCT02322320|75646742|FG000|COMPLETED|Overall Study||98||
59547860|NCT02322320|75646743|FG001|COMPLETED|Overall Study||86||
59547861|NCT02322320|75646744|FG002|COMPLETED|Overall Study||89||
59547862|NCT02322320|75646742|FG000|NOT COMPLETED|Overall Study||0||
59547863|NCT02322320|75646743|FG001|NOT COMPLETED|Overall Study||0||
59547864|NCT02322320|75646744|FG002|NOT COMPLETED|Overall Study||0||
59547865|NCT02551653|75646754|FG000|STARTED|Overall Study||5||
59547866|NCT02551653|75646755|FG001|STARTED|Overall Study||5||
59547867|NCT02551653|75646754|FG000|COMPLETED|Overall Study||5||
59547868|NCT02551653|75646755|FG001|COMPLETED|Overall Study||5||
59547869|NCT02551653|75646754|FG000|NOT COMPLETED|Overall Study||0||
59547870|NCT02551653|75646755|FG001|NOT COMPLETED|Overall Study||0||
59547871|NCT01163162|75646761|FG000|STARTED|Overall Study||16||
59547872|NCT01163162|75646761|FG000|COMPLETED|Overall Study||16||
59547873|NCT01163162|75646761|FG000|NOT COMPLETED|Overall Study||0||
59547874|NCT01127438|75646771|FG000|STARTED|Overall Study||25||
59547875|NCT01127438|75646772|FG001|STARTED|Overall Study||25||
59547876|NCT01127438|75646773|FG002|STARTED|Overall Study||26||
59547877|NCT01127438|75646774|FG003|STARTED|Overall Study||24||
59547878|NCT01127438|75646775|FG004|STARTED|Overall Study||28||
59547879|NCT01127438|75646776|FG005|STARTED|Overall Study||25||
59547880|NCT01127438|75646771|FG000|COMPLETED|Overall Study||25||
59547881|NCT01127438|75646772|FG001|COMPLETED|Overall Study||25||
59547882|NCT01127438|75646773|FG002|COMPLETED|Overall Study|(n=25) One subject randomized to the approved dose group received a lower dose in error.|26||
59547883|NCT01127438|75646774|FG003|COMPLETED|Overall Study|(n=25) One subject randomized to the approved dose group received a lower dose in error.|24||
59547884|NCT01127438|75646775|FG004|COMPLETED|Overall Study||28||
59547885|NCT01127438|75646776|FG005|COMPLETED|Overall Study||25||
59697112|NCT01021852|75816440|FG001|COMPLETED|Treatment Period 1||39||
59697113|NCT01021852|75816441|FG002|COMPLETED|Treatment Period 1||39||
59697114|NCT01021852|75816442|FG003|COMPLETED|Treatment Period 1||38||
59697115|NCT01021852|75816443|FG004|COMPLETED|Treatment Period 1||39||
59697116|NCT01021852|75816444|FG005|COMPLETED|Treatment Period 1||39||
59697117|NCT01021852|75816445|FG006|COMPLETED|Treatment Period 1||41||
59697118|NCT01021852|75816446|FG007|COMPLETED|Treatment Period 1||40||
59990446|NCT02496884|76105963|FG003|STARTED|Overall Study||4||
59990447|NCT02496884|76105960|FG000|Safety Analysis Set|Overall Study||17||
59990448|NCT02496884|76105961|FG001|Safety Analysis Set|Overall Study||34||
59990449|NCT02496884|76105962|FG002|Safety Analysis Set|Overall Study||1||
59990450|NCT02496884|76105963|FG003|Safety Analysis Set|Overall Study||4||
59990451|NCT02496884|76105960|FG000|Modified Intent to Treat Set (mITT)|Overall Study||17||
59990452|NCT02496884|76105961|FG001|Modified Intent to Treat Set (mITT)|Overall Study||34||
59990453|NCT02496884|76105962|FG002|Modified Intent to Treat Set (mITT)|Overall Study||1||
59990454|NCT02496884|76105963|FG003|Modified Intent to Treat Set (mITT)|Overall Study||4||
59990455|NCT02496884|76105960|FG000|Pharmacokinetic (PK) Analysis Set|Overall Study||0||
59990456|NCT02496884|76105961|FG001|Pharmacokinetic (PK) Analysis Set|Overall Study||33||
59990457|NCT02496884|76105962|FG002|Pharmacokinetic (PK) Analysis Set|Overall Study||0||
59990458|NCT02496884|76105963|FG003|Pharmacokinetic (PK) Analysis Set|Overall Study||4||
59990459|NCT02496884|76105960|FG000|Completed Treatment Per Protocol|Overall Study||16||
59990460|NCT02496884|76105961|FG001|Completed Treatment Per Protocol|Overall Study||27||
59990461|NCT02496884|76105962|FG002|Completed Treatment Per Protocol|Overall Study||1||
59990462|NCT02496884|76105963|FG003|Completed Treatment Per Protocol|Overall Study||3||
59990463|NCT02496884|76105960|FG000|COMPLETED|Overall Study||15||
59990464|NCT02496884|76105961|FG001|COMPLETED|Overall Study||31||
59990465|NCT02496884|76105962|FG002|COMPLETED|Overall Study||1||
59990466|NCT02496884|76105963|FG003|COMPLETED|Overall Study||4||
59990467|NCT02496884|76105960|FG000|NOT COMPLETED|Overall Study||2||
59990468|NCT02496884|76105961|FG001|NOT COMPLETED|Overall Study||3||
59990469|NCT02496884|76105962|FG002|NOT COMPLETED|Overall Study||0||
59990470|NCT02496884|76105963|FG003|NOT COMPLETED|Overall Study||0||
59990471|NCT02462876|76105973|FG000|STARTED|Overall Study||60||
59990472|NCT02462876|76105973|FG000|COMPLETED|Overall Study||33||
59990473|NCT02462876|76105973|FG000|NOT COMPLETED|Overall Study||27||
59990474|NCT03386721|76105992|FG000|STARTED|Overall Study||26||
59990475|NCT03386721|76105993|FG001|STARTED|Overall Study||32||
59990476|NCT03386721|76105994|FG002|STARTED|Overall Study||3||
59990477|NCT03386721|76105995|FG003|STARTED|Overall Study||5||
59990478|NCT03386721|76105996|FG004|STARTED|Overall Study||2||
59990479|NCT03386721|76105997|FG005|STARTED|Overall Study||22||
59990480|NCT03386721|76105998|FG006|STARTED|Overall Study||3||
59990481|NCT03386721|76105999|FG007|STARTED|Overall Study||2||
59990482|NCT03386721|76106000|FG008|STARTED|Overall Study||23||
59990483|NCT03386721|76106001|FG009|STARTED|Overall Study||30||
59990484|NCT03386721|76106002|FG010|STARTED|Overall Study||33||
59990485|NCT03386721|76106003|FG011|STARTED|Overall Study||47||
59990486|NCT03386721|76106004|FG012|STARTED|Overall Study||25||
59990487|NCT03386721|76106005|FG013|STARTED|Overall Study||2||
59990488|NCT03386721|76106006|FG014|STARTED|Overall Study||1||
59990489|NCT03386721|76105992|FG000|Response Evaluable Population|Overall Study||26|Response evaluable population included all participants in the safety population who received at least one dose of simlukafusp alfa/atezolizumab and who had at least one baseline and one on-study tumor assessment.|
59990490|NCT03386721|76105993|FG001|Response Evaluable Population|Overall Study||32|Response evaluable population included all participants in the safety population who received at least one dose of simlukafusp alfa/atezolizumab and who had at least one baseline and one on-study tumor assessment.|
59990491|NCT03386721|76105994|FG002|Response Evaluable Population|Overall Study||3|Response evaluable population included all participants in the safety population who received at least one dose of simlukafusp alfa/atezolizumab and who had at least one baseline and one on-study tumor assessment.|
59990492|NCT03386721|76105995|FG003|Response Evaluable Population|Overall Study||5|Response evaluable population included all participants in the safety population who received at least one dose of simlukafusp alfa/atezolizumab and who had at least one baseline and one on-study tumor assessment.|
59990493|NCT03386721|76105996|FG004|Response Evaluable Population|Overall Study||0|Response evaluable population included all participants in the safety population who received at least one dose of simlukafusp alfa/atezolizumab and who had at least one baseline and one on-study tumor assessment.|
59990494|NCT03386721|76105997|FG005|Response Evaluable Population|Overall Study||21|Response evaluable population included all participants in the safety population who received at least one dose of simlukafusp alfa/atezolizumab and who had at least one baseline and one on-study tumor assessment.|
59990495|NCT03386721|76105998|FG006|Response Evaluable Population|Overall Study||3|Response evaluable population included all participants in the safety population who received at least one dose of simlukafusp alfa/atezolizumab and who had at least one baseline and one on-study tumor assessment.|
59995466|NCT02155946|76111289|FG002|COMPLETED|Overall Study|number completed at primary endpoint|29||
59697119|NCT01021852|75816439|FG000|NOT COMPLETED|Treatment Period 1||3||
59697120|NCT01021852|75816440|FG001|NOT COMPLETED|Treatment Period 1||1||
59697121|NCT01021852|75816441|FG002|NOT COMPLETED|Treatment Period 1||2||
59697122|NCT01021852|75816442|FG003|NOT COMPLETED|Treatment Period 1||2||
59697123|NCT01021852|75816443|FG004|NOT COMPLETED|Treatment Period 1||3||
59990496|NCT03386721|76105999|FG007|Response Evaluable Population|Overall Study||2|Response evaluable population included all participants in the safety population who received at least one dose of simlukafusp alfa/atezolizumab and who had at least one baseline and one on-study tumor assessment.|
59990497|NCT03386721|76106000|FG008|Response Evaluable Population|Overall Study||22|Response evaluable population included all participants in the safety population who received at least one dose of simlukafusp alfa/atezolizumab and who had at least one baseline and one on-study tumor assessment.|
59990498|NCT03386721|76106001|FG009|Response Evaluable Population|Overall Study||28|Response evaluable population included all participants in the safety population who received at least one dose of simlukafusp alfa/atezolizumab and who had at least one baseline and one on-study tumor assessment.|
59990499|NCT03386721|76106002|FG010|Response Evaluable Population|Overall Study||32|Response evaluable population included all participants in the safety population who received at least one dose of simlukafusp alfa/atezolizumab and who had at least one baseline and one on-study tumor assessment.|
59990500|NCT03386721|76106003|FG011|Response Evaluable Population|Overall Study||44|Response evaluable population included all participants in the safety population who received at least one dose of simlukafusp alfa/atezolizumab and who had at least one baseline and one on-study tumor assessment.|
59990501|NCT03386721|76106004|FG012|Response Evaluable Population|Overall Study||25|Response evaluable population included all participants in the safety population who received at least one dose of simlukafusp alfa/atezolizumab and who had at least one baseline and one on-study tumor assessment.|
59990502|NCT03386721|76106005|FG013|Response Evaluable Population|Overall Study||2|Response evaluable population included all participants in the safety population who received at least one dose of simlukafusp alfa/atezolizumab and who had at least one baseline and one on-study tumor assessment.|
59990503|NCT03386721|76106006|FG014|Response Evaluable Population|Overall Study||1|Response evaluable population included all participants in the safety population who received at least one dose of simlukafusp alfa/atezolizumab and who had at least one baseline and one on-study tumor assessment.|
59990504|NCT03386721|76105992|FG000|COMPLETED|Overall Study||4||
59990505|NCT03386721|76105993|FG001|COMPLETED|Overall Study||1||
59990506|NCT03386721|76105994|FG002|COMPLETED|Overall Study||0||
59990507|NCT03386721|76105995|FG003|COMPLETED|Overall Study||0||
59990508|NCT03386721|76105996|FG004|COMPLETED|Overall Study||0||
59990509|NCT03386721|76105997|FG005|COMPLETED|Overall Study||1||
59990510|NCT03386721|76105998|FG006|COMPLETED|Overall Study||0||
59990511|NCT03386721|76105999|FG007|COMPLETED|Overall Study||0||
59990512|NCT03386721|76106000|FG008|COMPLETED|Overall Study||1||
59990513|NCT03386721|76106001|FG009|COMPLETED|Overall Study||0||
59990514|NCT03386721|76106002|FG010|COMPLETED|Overall Study||2||
59990515|NCT03386721|76106003|FG011|COMPLETED|Overall Study||6||
59990516|NCT03386721|76106004|FG012|COMPLETED|Overall Study||0||
59990517|NCT03386721|76106005|FG013|COMPLETED|Overall Study||0||
59990518|NCT03386721|76106006|FG014|COMPLETED|Overall Study||0||
59990519|NCT03386721|76105992|FG000|NOT COMPLETED|Overall Study||22||
59990520|NCT03386721|76105993|FG001|NOT COMPLETED|Overall Study||31||
59990521|NCT03386721|76105994|FG002|NOT COMPLETED|Overall Study||3||
59990522|NCT03386721|76105995|FG003|NOT COMPLETED|Overall Study||5||
59990523|NCT03386721|76105996|FG004|NOT COMPLETED|Overall Study||2||
59990524|NCT03386721|76105997|FG005|NOT COMPLETED|Overall Study||21||
59990525|NCT03386721|76105998|FG006|NOT COMPLETED|Overall Study||3||
59990526|NCT03386721|76105999|FG007|NOT COMPLETED|Overall Study||2||
59990527|NCT03386721|76106000|FG008|NOT COMPLETED|Overall Study||22||
59990528|NCT03386721|76106001|FG009|NOT COMPLETED|Overall Study||30||
59990529|NCT03386721|76106002|FG010|NOT COMPLETED|Overall Study||31||
59990530|NCT03386721|76106003|FG011|NOT COMPLETED|Overall Study||41||
59990531|NCT03386721|76106004|FG012|NOT COMPLETED|Overall Study||25||
59990532|NCT03386721|76106005|FG013|NOT COMPLETED|Overall Study||2||
59990533|NCT03386721|76106006|FG014|NOT COMPLETED|Overall Study||1||
59990534|NCT02462720|76106038|FG000|STARTED|Part 1||18||
59990535|NCT02462720|76106039|FG001|STARTED|Part 1||17||
59990536|NCT02462720|76106038|FG000|COMPLETED|Part 1||18||
59990537|NCT02462720|76106039|FG001|COMPLETED|Part 1||17||
59990538|NCT02462720|76106038|FG000|NOT COMPLETED|Part 1||0||
59990539|NCT02462720|76106039|FG001|NOT COMPLETED|Part 1||0||
59990540|NCT02462720|76106038|FG000|STARTED|Part 2||18||
59990541|NCT02462720|76106039|FG001|STARTED|Part 2||17||
59990542|NCT02462720|76106038|FG000|COMPLETED|Part 2||17||
59990543|NCT02462720|76106039|FG001|COMPLETED|Part 2||16||
59990544|NCT02462720|76106038|FG000|NOT COMPLETED|Part 2||1||
59990545|NCT02462720|76106039|FG001|NOT COMPLETED|Part 2||1||
59990546|NCT02246218|76106049|FG000|STARTED|Overall Study||10||
59990547|NCT02246218|76106050|FG001|STARTED|Overall Study||16||
59990548|NCT02246218|76106049|FG000|COMPLETED|Overall Study||6||
59990549|NCT02246218|76106050|FG001|COMPLETED|Overall Study||10||
59990550|NCT02246218|76106049|FG000|NOT COMPLETED|Overall Study||4||
59990551|NCT02246218|76106050|FG001|NOT COMPLETED|Overall Study||6||
59990552|NCT02244580|76106056|FG000|STARTED|Overall Study||1010||
59990553|NCT02244580|76106056|FG000|COMPLETED|Overall Study|An RT-qPCR assay was performed from breast cancer tissues of 769 out of the 1010 patients.|769||
59990554|NCT02244580|76106056|FG000|NOT COMPLETED|Overall Study||241||
59990555|NCT02244424|76106066|FG000|STARTED|Overall Study|Teens were the participants who received the intervention. Data were collected on the infants.|102|Teen mothers were the participants in the study; data were collected on their infants.|
59995467|NCT02155946|76111290|FG003|COMPLETED|Overall Study|number completed at primary endpoint|24||
59995468|NCT02155946|76111287|FG000|NOT COMPLETED|Overall Study||0||
59995469|NCT02155946|76111288|FG001|NOT COMPLETED|Overall Study||2||
59990556|NCT02244424|76106067|FG001|STARTED|Overall Study|Teen participants received the MIHP standard care. Data were collected on infants.|62|Teen mothers were the participants in the study; data were collected on their infants.|
59990557|NCT02244424|76106066|FG000|Infants|Overall Study|Infants of participants included in the study for collection of demographic and weight data.|51||
59990558|NCT02244424|76106067|FG001|Infants|Overall Study|Infants of participants included in the study for collection of demographic and weight data.|31||
59990559|NCT02244424|76106066|FG000|Mothers|Overall Study||51||
59990560|NCT02244424|76106067|FG001|Mothers|Overall Study||31||
59990561|NCT02244424|76106066|FG000|COMPLETED|Overall Study|Data were collected on all of the infants of the teen moms (n = 41).|82|Numbers include both mothers and infants in the study only.|
59990562|NCT02244424|76106067|FG001|COMPLETED|Overall Study|Data were collected on all of the infants of teen moms (n = 26).|52|Numbers include both mothers and infants in the study only.|
59990563|NCT02244424|76106066|FG000|NOT COMPLETED|Overall Study||20||
59990564|NCT02244424|76106067|FG001|NOT COMPLETED|Overall Study||10||
59990565|NCT00159783|76106076|FG000|STARTED|Overall Study||32||
59990566|NCT00159783|76106077|FG001|STARTED|Overall Study||79||
59990567|NCT00159783|76106078|FG002|STARTED|Overall Study||107||
59990568|NCT00159783|76106076|FG000|COMPLETED|Overall Study||13||
59990569|NCT00159783|76106077|FG001|COMPLETED|Overall Study||52||
59990570|NCT00159783|76106078|FG002|COMPLETED|Overall Study||68||
59990571|NCT00159783|76106076|FG000|NOT COMPLETED|Overall Study||19||
59990572|NCT00159783|76106077|FG001|NOT COMPLETED|Overall Study||27||
59990573|NCT00159783|76106078|FG002|NOT COMPLETED|Overall Study||39||
59990574|NCT00646204|76106089|FG000|STARTED|Overall Study||20||
59990575|NCT00646204|76106090|FG001|STARTED|Overall Study||20||
59990576|NCT00646204|76106089|FG000|COMPLETED|Overall Study||16||
59990577|NCT00646204|76106090|FG001|COMPLETED|Overall Study||20||
59990578|NCT00646204|76106089|FG000|NOT COMPLETED|Overall Study||4||
59990579|NCT00646204|76106090|FG001|NOT COMPLETED|Overall Study||0||
59990580|NCT02936323|76106107|FG000|STARTED|Phase 1 Dose Escalation|Participants in Phase 1 did not advance to Phase 2a.|2||
59990581|NCT02936323|76106108|FG001|STARTED|Phase 1 Dose Escalation|Participants in Phase 1 did not advance to Phase 2a.|3||
59990582|NCT02936323|76106109|FG002|STARTED|Phase 1 Dose Escalation|Participants in Phase 1 did not advance to Phase 2a.|3||
59990583|NCT02936323|76106110|FG003|STARTED|Phase 1 Dose Escalation|Participants in Phase 1 did not advance to Phase 2a.|3||
59990584|NCT02936323|76106111|FG004|STARTED|Phase 1 Dose Escalation|Participants in Phase 1 did not advance to Phase 2a.|3||
59990585|NCT02936323|76106112|FG005|STARTED|Phase 1 Dose Escalation|Participants in Phase 1 did not advance to Phase 2a.|6||
59990586|NCT02936323|76106113|FG006|STARTED|Phase 1 Dose Escalation|Participants in Phase 1 did not advance to Phase 2a.|3||
59990587|NCT02936323|76106114|FG007|STARTED|Phase 1 Dose Escalation||0||
59990588|NCT02936323|76106115|FG008|STARTED|Phase 1 Dose Escalation||0||
59990589|NCT02936323|76106116|FG009|STARTED|Phase 1 Dose Escalation||0||
59990590|NCT02936323|76106107|FG000|COMPLETED|Phase 1 Dose Escalation||0|Participants in the follow-up period of Phase 1 study as of data cut-off date 31 Jul 2020.|
59990591|NCT02936323|76106108|FG001|COMPLETED|Phase 1 Dose Escalation||1|Participants in the follow-up period of Phase 1 study as of data cut-off date 31 Jul 2020.|
59990592|NCT02936323|76106109|FG002|COMPLETED|Phase 1 Dose Escalation||0|Participants in the follow-up period of Phase 1 study as of data cut-off date 31 Jul 2020.|
59990593|NCT02936323|76106110|FG003|COMPLETED|Phase 1 Dose Escalation||1|Participants in the follow-up period of Phase 1 study as of data cut-off date 31 Jul 2020.|
59990594|NCT02936323|76106111|FG004|COMPLETED|Phase 1 Dose Escalation||0|Participants in the follow-up period of Phase 1 study as of data cut-off date 31 Jul 2020.|
59990595|NCT02936323|76106112|FG005|COMPLETED|Phase 1 Dose Escalation||1|Participants in the follow-up period of Phase 1 study as of data cut-off date 31 Jul 2020.|
59990596|NCT02936323|76106113|FG006|COMPLETED|Phase 1 Dose Escalation||0|Participants in the follow-up period of Phase 1 study as of data cut-off date 31 Jul 2020.|
59990597|NCT02936323|76106114|FG007|COMPLETED|Phase 1 Dose Escalation||0|Participants in the follow-up period of Phase 1 study as of data cut-off date 31 Jul 2020.|
59990598|NCT02936323|76106115|FG008|COMPLETED|Phase 1 Dose Escalation||0|Participants in the follow-up period of Phase 1 study as of data cut-off date 31 Jul 2020.|
59990599|NCT02936323|76106116|FG009|COMPLETED|Phase 1 Dose Escalation||0|Participants in the follow-up period of Phase 1 study as of data cut-off date 31 Jul 2020.|
59990600|NCT02936323|76106107|FG000|NOT COMPLETED|Phase 1 Dose Escalation||2||
59990601|NCT02936323|76106108|FG001|NOT COMPLETED|Phase 1 Dose Escalation||2||
59990602|NCT02936323|76106109|FG002|NOT COMPLETED|Phase 1 Dose Escalation||3||
59990603|NCT02936323|76106110|FG003|NOT COMPLETED|Phase 1 Dose Escalation||2||
59990604|NCT02936323|76106111|FG004|NOT COMPLETED|Phase 1 Dose Escalation||3||
59990605|NCT02936323|76106112|FG005|NOT COMPLETED|Phase 1 Dose Escalation||5||
59990606|NCT02936323|76106113|FG006|NOT COMPLETED|Phase 1 Dose Escalation||3||
59990607|NCT02936323|76106114|FG007|NOT COMPLETED|Phase 1 Dose Escalation||0||
59990608|NCT02936323|76106115|FG008|NOT COMPLETED|Phase 1 Dose Escalation||0||
59990609|NCT02936323|76106116|FG009|NOT COMPLETED|Phase 1 Dose Escalation||0||
59990610|NCT02936323|76106107|FG000|STARTED|Phase 2a Dose Expansion||0|Initial Phase 2a PEN-221 start dose at Phase 1 MTD and RP2D of 18 mg flat dose. After review of 19 Phase 2a participants, SRC decreased start dose from 18 mg to 15 mg flat dose due to higher-than-expected treatment discontinuation rate. After review of all Phase 1 and 31 Phase 2a participants, SRC changed 15 mg flat dose to Body Surface Area (BSA) based PEN-221 dose of 8.8 mg/m^2 due to correlation between BSA and drug exposure (AUC) associated with higher rate of participant discontinuation.|
59995059|NCT01675167|76110891|FG002|STARTED|Double-blind Treatment Phase|Subjects were randomized to DB treatment after completing OL titration in the previous period.|257||
59547886|NCT01127438|75646771|FG000|NOT COMPLETED|Overall Study||0||
59547887|NCT01127438|75646772|FG001|NOT COMPLETED|Overall Study||0||
59547888|NCT01127438|75646773|FG002|NOT COMPLETED|Overall Study||0||
59547889|NCT01127438|75646774|FG003|NOT COMPLETED|Overall Study||0||
59547890|NCT01127438|75646775|FG004|NOT COMPLETED|Overall Study||0||
59990611|NCT02936323|76106108|FG001|STARTED|Phase 2a Dose Expansion||0|Initial Phase 2a PEN-221 start dose at Phase 1 MTD and RP2D of 18 mg flat dose. After review of 19 Phase 2a participants, SRC decreased start dose from 18 mg to 15 mg flat dose due to higher-than-expected treatment discontinuation rate. After review of all Phase 1 and 31 Phase 2a participants, SRC changed 15 mg flat dose to Body Surface Area (BSA) based PEN-221 dose of 8.8 mg/m^2 due to correlation between BSA and drug exposure (AUC) associated with higher rate of participant discontinuation.|
59990612|NCT02936323|76106109|FG002|STARTED|Phase 2a Dose Expansion||0|Initial Phase 2a PEN-221 start dose at Phase 1 MTD and RP2D of 18 mg flat dose. After review of 19 Phase 2a participants, SRC decreased start dose from 18 mg to 15 mg flat dose due to higher-than-expected treatment discontinuation rate. After review of all Phase 1 and 31 Phase 2a participants, SRC changed 15 mg flat dose to Body Surface Area (BSA) based PEN-221 dose of 8.8 mg/m^2 due to correlation between BSA and drug exposure (AUC) associated with higher rate of participant discontinuation.|
59990613|NCT02936323|76106110|FG003|STARTED|Phase 2a Dose Expansion||0|Initial Phase 2a PEN-221 start dose at Phase 1 MTD and RP2D of 18 mg flat dose. After review of 19 Phase 2a participants, SRC decreased start dose from 18 mg to 15 mg flat dose due to higher-than-expected treatment discontinuation rate. After review of all Phase 1 and 31 Phase 2a participants, SRC changed 15 mg flat dose to Body Surface Area (BSA) based PEN-221 dose of 8.8 mg/m^2 due to correlation between BSA and drug exposure (AUC) associated with higher rate of participant discontinuation.|
59990614|NCT02936323|76106111|FG004|STARTED|Phase 2a Dose Expansion||0|Initial Phase 2a PEN-221 start dose at Phase 1 MTD and RP2D of 18 mg flat dose. After review of 19 Phase 2a participants, SRC decreased start dose from 18 mg to 15 mg flat dose due to higher-than-expected treatment discontinuation rate. After review of all Phase 1 and 31 Phase 2a participants, SRC changed 15 mg flat dose to Body Surface Area (BSA) based PEN-221 dose of 8.8 mg/m^2 due to correlation between BSA and drug exposure (AUC) associated with higher rate of participant discontinuation.|
59990615|NCT02936323|76106112|FG005|STARTED|Phase 2a Dose Expansion||0|Initial Phase 2a PEN-221 start dose at Phase 1 MTD and RP2D of 18 mg flat dose. After review of 19 Phase 2a participants, SRC decreased start dose from 18 mg to 15 mg flat dose due to higher-than-expected treatment discontinuation rate. After review of all Phase 1 and 31 Phase 2a participants, SRC changed 15 mg flat dose to Body Surface Area (BSA) based PEN-221 dose of 8.8 mg/m^2 due to correlation between BSA and drug exposure (AUC) associated with higher rate of participant discontinuation.|
59990616|NCT02936323|76106113|FG006|STARTED|Phase 2a Dose Expansion||0|Initial Phase 2a PEN-221 start dose at Phase 1 MTD and RP2D of 18 mg flat dose. After review of 19 Phase 2a participants, SRC decreased start dose from 18 mg to 15 mg flat dose due to higher-than-expected treatment discontinuation rate. After review of all Phase 1 and 31 Phase 2a participants, SRC changed 15 mg flat dose to Body Surface Area (BSA) based PEN-221 dose of 8.8 mg/m^2 due to correlation between BSA and drug exposure (AUC) associated with higher rate of participant discontinuation.|
59990617|NCT02936323|76106114|FG007|STARTED|Phase 2a Dose Expansion|Participants in Phase 2a did not participate in Phase 1|32|Initial Phase 2a PEN-221 start dose at Phase 1 MTD and RP2D of 18 mg flat dose. After review of 19 Phase 2a participants, SRC decreased start dose from 18 mg to 15 mg flat dose due to higher-than-expected treatment discontinuation rate. After review of all Phase 1 and 31 Phase 2a participants, SRC changed 15 mg flat dose to Body Surface Area (BSA) based PEN-221 dose of 8.8 mg/m^2 due to correlation between BSA and drug exposure (AUC) associated with higher rate of participant discontinuation.|
59990618|NCT02936323|76106115|FG008|STARTED|Phase 2a Dose Expansion|Participants in Phase 2a did not participate in Phase 1|15|Initial Phase 2a PEN-221 start dose at Phase 1 MTD and RP2D of 18 mg flat dose. After review of 19 Phase 2a participants, SRC decreased start dose from 18 mg to 15 mg flat dose due to higher-than-expected treatment discontinuation rate. After review of all Phase 1 and 31 Phase 2a participants, SRC changed 15 mg flat dose to Body Surface Area (BSA) based PEN-221 dose of 8.8 mg/m^2 due to correlation between BSA and drug exposure (AUC) associated with higher rate of participant discontinuation.|
59995060|NCT01675167|76110889|FG000|COMPLETED|Double-blind Treatment Phase||0||
59995061|NCT01675167|76110890|FG001|COMPLETED|Double-blind Treatment Phase||206||
59995062|NCT01675167|76110891|FG002|COMPLETED|Double-blind Treatment Phase||147||
59995063|NCT01675167|76110889|FG000|NOT COMPLETED|Double-blind Treatment Phase||0||
59995064|NCT01675167|76110890|FG001|NOT COMPLETED|Double-blind Treatment Phase||48||
59995065|NCT01675167|76110891|FG002|NOT COMPLETED|Double-blind Treatment Phase||110||
59995066|NCT01675011|76110901|FG000|STARTED|Overall Study||3||
59995067|NCT01675011|76110902|FG001|STARTED|Overall Study||1||
59995068|NCT01675011|76110901|FG000|COMPLETED|Overall Study||0||
59995069|NCT01675011|76110902|FG001|COMPLETED|Overall Study||0||
59995070|NCT01675011|76110901|FG000|NOT COMPLETED|Overall Study||3||
59995071|NCT01675011|76110902|FG001|NOT COMPLETED|Overall Study||1||
59995072|NCT04208997|76110910|FG000|STARTED|Overall Study||3||
59995073|NCT04208997|76110911|FG001|STARTED|Overall Study||2||
59995074|NCT04208997|76110910|FG000|COMPLETED|Overall Study||3||
59995075|NCT04208997|76110911|FG001|COMPLETED|Overall Study||2||
59995076|NCT04208997|76110910|FG000|NOT COMPLETED|Overall Study||0||
59995077|NCT04208997|76110911|FG001|NOT COMPLETED|Overall Study||0||
59995078|NCT02550093|76110917|FG000|STARTED|Intervention 1||10||
59995079|NCT02550093|76110918|FG001|STARTED|Intervention 1||10||
59547891|NCT01127438|75646776|FG005|NOT COMPLETED|Overall Study||0||
59547892|NCT02481141|75646788|FG000|STARTED|Overall Study||35||
59547893|NCT02481141|75646789|FG001|STARTED|Overall Study||18||
59547894|NCT02481141|75646788|FG000|COMPLETED|Overall Study||26||
59547895|NCT02481141|75646789|FG001|COMPLETED|Overall Study||13||
59547896|NCT02481141|75646788|FG000|NOT COMPLETED|Overall Study||9||
59990619|NCT02936323|76106116|FG009|STARTED|Phase 2a Dose Expansion|Participants in Phase 2a did not participate in Phase 1|19|Initial Phase 2a PEN-221 start dose at Phase 1 MTD and RP2D of 18 mg flat dose. After review of 19 Phase 2a participants, SRC decreased start dose from 18 mg to 15 mg flat dose due to higher-than-expected treatment discontinuation rate. After review of all Phase 1 and 31 Phase 2a participants, SRC changed 15 mg flat dose to Body Surface Area (BSA) based PEN-221 dose of 8.8 mg/m^2 due to correlation between BSA and drug exposure (AUC) associated with higher rate of participant discontinuation.|
59990620|NCT02936323|76106107|FG000|COMPLETED|Phase 2a Dose Expansion||0|Participants in the follow-up period of Phase 2a study as of data cut-off date 31 Jul 2020.|
59990621|NCT02936323|76106108|FG001|COMPLETED|Phase 2a Dose Expansion||0|Participants in the follow-up period of Phase 2a study as of data cut-off date 31 Jul 2020.|
59990622|NCT02936323|76106109|FG002|COMPLETED|Phase 2a Dose Expansion||0|Participants in the follow-up period of Phase 2a study as of data cut-off date 31 Jul 2020.|
59990623|NCT02936323|76106110|FG003|COMPLETED|Phase 2a Dose Expansion||0|Participants in the follow-up period of Phase 2a study as of data cut-off date 31 Jul 2020.|
59990624|NCT02936323|76106111|FG004|COMPLETED|Phase 2a Dose Expansion||0|Participants in the follow-up period of Phase 2a study as of data cut-off date 31 Jul 2020.|
59697124|NCT01021852|75816444|FG005|NOT COMPLETED|Treatment Period 1||2||
59697125|NCT01021852|75816445|FG006|NOT COMPLETED|Treatment Period 1||0||
59697126|NCT01021852|75816446|FG007|NOT COMPLETED|Treatment Period 1||1||
59697127|NCT01021852|75816439|FG000|STARTED|Washout Period-Placebo||37||
59697128|NCT01021852|75816440|FG001|STARTED|Washout Period-Placebo||39||
59697129|NCT01021852|75816441|FG002|STARTED|Washout Period-Placebo||39||
59990625|NCT02936323|76106112|FG005|COMPLETED|Phase 2a Dose Expansion||0|Participants in the follow-up period of Phase 2a study as of data cut-off date 31 Jul 2020.|
59990626|NCT02936323|76106113|FG006|COMPLETED|Phase 2a Dose Expansion||0|Participants in the follow-up period of Phase 2a study as of data cut-off date 31 Jul 2020.|
59990627|NCT02936323|76106114|FG007|COMPLETED|Phase 2a Dose Expansion||15|Participants in the follow-up period of Phase 2a study as of data cut-off date 31 Jul 2020.|
59990628|NCT02936323|76106115|FG008|COMPLETED|Phase 2a Dose Expansion||2|Participants in the follow-up period of Phase 2a study as of data cut-off date 31 Jul 2020.|
59990629|NCT02936323|76106116|FG009|COMPLETED|Phase 2a Dose Expansion||5|Participants in the follow-up period of Phase 2a study as of data cut-off date 31 Jul 2020.|
59990630|NCT02936323|76106107|FG000|NOT COMPLETED|Phase 2a Dose Expansion||0||
59990631|NCT02936323|76106108|FG001|NOT COMPLETED|Phase 2a Dose Expansion||0||
59990632|NCT02936323|76106109|FG002|NOT COMPLETED|Phase 2a Dose Expansion||0||
59990633|NCT02936323|76106110|FG003|NOT COMPLETED|Phase 2a Dose Expansion||0||
59990634|NCT02936323|76106111|FG004|NOT COMPLETED|Phase 2a Dose Expansion||0||
59990635|NCT02936323|76106112|FG005|NOT COMPLETED|Phase 2a Dose Expansion||0||
59990636|NCT02936323|76106113|FG006|NOT COMPLETED|Phase 2a Dose Expansion||0||
59990637|NCT02936323|76106114|FG007|NOT COMPLETED|Phase 2a Dose Expansion||17||
59990638|NCT02936323|76106115|FG008|NOT COMPLETED|Phase 2a Dose Expansion||13||
59990639|NCT02936323|76106116|FG009|NOT COMPLETED|Phase 2a Dose Expansion||14||
59990640|NCT02243176|76106150|FG000|STARTED|Overall Study|3 of the randomized subjects withdrew before taking any medication|244||
59990641|NCT02243176|76106151|FG001|STARTED|Overall Study||244||
59990642|NCT02243176|76106150|FG000|COMPLETED|Overall Study||230||
59990643|NCT02243176|76106151|FG001|COMPLETED|Overall Study||229||
59990644|NCT02243176|76106150|FG000|NOT COMPLETED|Overall Study||14||
59990645|NCT02243176|76106151|FG001|NOT COMPLETED|Overall Study||15||
59990646|NCT00002663|76106162|FG000|STARTED|Overall Study||11||
59990647|NCT00002663|76106163|FG001|STARTED|Overall Study||4||
59547897|NCT02481141|75646789|FG001|NOT COMPLETED|Overall Study||5||
59547898|NCT02481219|75646818|FG000|STARTED|Overall Study||60||
59697130|NCT01021852|75816442|FG003|STARTED|Washout Period-Placebo||38||
59697131|NCT01021852|75816443|FG004|STARTED|Washout Period-Placebo|Includes 1 participant that discontinued Treatment Period 1 (AE).|40||
59697132|NCT01021852|75816444|FG005|STARTED|Washout Period-Placebo|Excludes 1 participant who completed Treatment Period 1 but missed Placebo Washout|39||
59697133|NCT01021852|75816445|FG006|STARTED|Washout Period-Placebo||41||
59697134|NCT01021852|75816446|FG007|STARTED|Washout Period-Placebo||40||
59697135|NCT01021852|75816439|FG000|COMPLETED|Washout Period-Placebo||37||
59697136|NCT01021852|75816440|FG001|COMPLETED|Washout Period-Placebo||39||
59697137|NCT01021852|75816441|FG002|COMPLETED|Washout Period-Placebo||39||
59697138|NCT01021852|75816442|FG003|COMPLETED|Washout Period-Placebo||37||
59697139|NCT01021852|75816443|FG004|COMPLETED|Washout Period-Placebo||39||
59697140|NCT01021852|75816444|FG005|COMPLETED|Washout Period-Placebo||38||
59697141|NCT01021852|75816445|FG006|COMPLETED|Washout Period-Placebo||40||
59697142|NCT01021852|75816446|FG007|COMPLETED|Washout Period-Placebo||40||
59697143|NCT01021852|75816439|FG000|NOT COMPLETED|Washout Period-Placebo||0||
59697144|NCT01021852|75816440|FG001|NOT COMPLETED|Washout Period-Placebo||0||
59697145|NCT01021852|75816441|FG002|NOT COMPLETED|Washout Period-Placebo||0||
59697146|NCT01021852|75816442|FG003|NOT COMPLETED|Washout Period-Placebo||1||
59697147|NCT01021852|75816443|FG004|NOT COMPLETED|Washout Period-Placebo||1||
59697148|NCT01021852|75816444|FG005|NOT COMPLETED|Washout Period-Placebo||1||
59990648|NCT00002663|76106164|FG002|STARTED|Overall Study||2||
59990649|NCT00002663|76106165|FG003|STARTED|Overall Study||5||
59990650|NCT00002663|76106166|FG004|STARTED|Overall Study||1||
59547899|NCT02481219|75646819|FG001|STARTED|Overall Study||62||
59697149|NCT01021852|75816445|FG006|NOT COMPLETED|Washout Period-Placebo||1||
59697150|NCT01021852|75816446|FG007|NOT COMPLETED|Washout Period-Placebo||0||
59697151|NCT01021852|75816439|FG000|STARTED|Washout Period-No Drug|Includes 1 participant who discontinued Treatment Period 1 (AE) and missed Placebo Washout.|38||
59697152|NCT01021852|75816440|FG001|STARTED|Washout Period-No Drug||39||
59697153|NCT01021852|75816441|FG002|STARTED|Washout Period-No Drug||39||
59697154|NCT01021852|75816442|FG003|STARTED|Washout Period-No Drug||37||
59697155|NCT01021852|75816443|FG004|STARTED|Washout Period-No Drug||39||
59697156|NCT01021852|75816444|FG005|STARTED|Washout Period-No Drug|Includes 1 participant who completed Treatment Period 1 but missed Placebo Washout.|39||
59697157|NCT01021852|75816445|FG006|STARTED|Washout Period-No Drug||40||
59697158|NCT01021852|75816446|FG007|STARTED|Washout Period-No Drug||40||
59990651|NCT00002663|76106167|FG005|STARTED|Overall Study||23||
59990652|NCT00002663|76106168|FG006|STARTED|Overall Study||2||
59990653|NCT00002663|76106169|FG007|STARTED|Overall Study||6||
59990654|NCT00002663|76106170|FG008|STARTED|Overall Study||2||
59990655|NCT00002663|76106171|FG009|STARTED|Overall Study||2||
59990656|NCT00002663|76106162|FG000|COMPLETED|Overall Study||4||
59990657|NCT00002663|76106163|FG001|COMPLETED|Overall Study||2||
59990658|NCT00002663|76106164|FG002|COMPLETED|Overall Study||1||
59990659|NCT00002663|76106165|FG003|COMPLETED|Overall Study||3||
59990660|NCT00002663|76106166|FG004|COMPLETED|Overall Study||0||
59990661|NCT00002663|76106167|FG005|COMPLETED|Overall Study||8||
59990662|NCT00002663|76106168|FG006|COMPLETED|Overall Study||1||
59990663|NCT00002663|76106169|FG007|COMPLETED|Overall Study||4||
59990664|NCT00002663|76106170|FG008|COMPLETED|Overall Study||0||
59990665|NCT00002663|76106171|FG009|COMPLETED|Overall Study||0||
59990666|NCT00002663|76106162|FG000|NOT COMPLETED|Overall Study||7||
59990667|NCT00002663|76106163|FG001|NOT COMPLETED|Overall Study||2||
59990668|NCT00002663|76106164|FG002|NOT COMPLETED|Overall Study||1||
59990669|NCT00002663|76106165|FG003|NOT COMPLETED|Overall Study||2||
59990670|NCT00002663|76106166|FG004|NOT COMPLETED|Overall Study||1||
59990671|NCT00002663|76106167|FG005|NOT COMPLETED|Overall Study||15||
59990672|NCT00002663|76106168|FG006|NOT COMPLETED|Overall Study||1||
59990673|NCT00002663|76106169|FG007|NOT COMPLETED|Overall Study||2||
59990674|NCT00002663|76106170|FG008|NOT COMPLETED|Overall Study||2||
59990675|NCT00002663|76106171|FG009|NOT COMPLETED|Overall Study||2||
59990676|NCT02240680|76106182|FG000|STARTED|Overall Study (Up to 24 Weeks)||151||
59990677|NCT02240680|76106183|FG001|STARTED|Overall Study (Up to 24 Weeks)||151||
59990678|NCT02240680|76106184|FG002|STARTED|Overall Study (Up to 24 Weeks)||0||
59990679|NCT02240680|76106185|FG003|STARTED|Overall Study (Up to 24 Weeks)||0||
59990680|NCT02240680|76106182|FG000|COMPLETED|Overall Study (Up to 24 Weeks)||136||
59990681|NCT02240680|76106183|FG001|COMPLETED|Overall Study (Up to 24 Weeks)||143||
59990682|NCT02240680|76106184|FG002|COMPLETED|Overall Study (Up to 24 Weeks)||0||
59990683|NCT02240680|76106185|FG003|COMPLETED|Overall Study (Up to 24 Weeks)||0||
59990684|NCT02240680|76106182|FG000|NOT COMPLETED|Overall Study (Up to 24 Weeks)||15||
59990685|NCT02240680|76106183|FG001|NOT COMPLETED|Overall Study (Up to 24 Weeks)||8||
59990686|NCT02240680|76106184|FG002|NOT COMPLETED|Overall Study (Up to 24 Weeks)||0||
59990687|NCT02240680|76106185|FG003|NOT COMPLETED|Overall Study (Up to 24 Weeks)||0||
59990688|NCT02240680|76106182|FG000|STARTED|Japanese Patients (Up to 52 Weeks)||0||
59990689|NCT02240680|76106183|FG001|STARTED|Japanese Patients (Up to 52 Weeks)||0||
59990690|NCT02240680|76106184|FG002|STARTED|Japanese Patients (Up to 52 Weeks)||50||
59990691|NCT02240680|76106185|FG003|STARTED|Japanese Patients (Up to 52 Weeks)||52||
59990692|NCT02240680|76106182|FG000|COMPLETED|Japanese Patients (Up to 52 Weeks)||0||
59990693|NCT02240680|76106183|FG001|COMPLETED|Japanese Patients (Up to 52 Weeks)||0||
59990694|NCT02240680|76106184|FG002|COMPLETED|Japanese Patients (Up to 52 Weeks)||42||
59990695|NCT02240680|76106185|FG003|COMPLETED|Japanese Patients (Up to 52 Weeks)||45||
59990696|NCT02240680|76106182|FG000|NOT COMPLETED|Japanese Patients (Up to 52 Weeks)||0||
59990697|NCT02240680|76106183|FG001|NOT COMPLETED|Japanese Patients (Up to 52 Weeks)||0||
59990698|NCT02240680|76106184|FG002|NOT COMPLETED|Japanese Patients (Up to 52 Weeks)||8||
59990699|NCT02240680|76106185|FG003|NOT COMPLETED|Japanese Patients (Up to 52 Weeks)||7||
59990700|NCT02240368|76106196|FG000|STARTED|Overall Study||9||
59990701|NCT02240368|76106197|FG001|STARTED|Overall Study||22||
59990702|NCT02240368|76106198|FG002|STARTED|Overall Study||19||
59990703|NCT02240368|76106196|FG000|COMPLETED|Overall Study||8||
59990704|NCT02240368|76106197|FG001|COMPLETED|Overall Study||22||
59990705|NCT02240368|76106198|FG002|COMPLETED|Overall Study||18||
59990706|NCT02240368|76106196|FG000|NOT COMPLETED|Overall Study||1||
59990707|NCT02240368|76106197|FG001|NOT COMPLETED|Overall Study||0||
59990708|NCT02240368|76106198|FG002|NOT COMPLETED|Overall Study||1||
59990709|NCT02239978|76106208|FG000|STARTED|Overall Study||30||
59697159|NCT01021852|75816439|FG000|COMPLETED|Washout Period-No Drug||37||
59697160|NCT01021852|75816440|FG001|COMPLETED|Washout Period-No Drug||39||
59816181|NCT00529568|75938539|FG000|COMPLETED|Double-bilnd Antiviral Treatment Phase||0||
59990710|NCT02239978|76106209|FG001|STARTED|Overall Study||12||
59990711|NCT02239978|76106208|FG000|COMPLETED|Overall Study||28||
59990712|NCT02239978|76106209|FG001|COMPLETED|Overall Study||12||
59990713|NCT02239978|76106208|FG000|NOT COMPLETED|Overall Study||2||
59990714|NCT02239978|76106209|FG001|NOT COMPLETED|Overall Study||0||
59990715|NCT02239510|76106219|FG000|STARTED|Overall Study||5||
59990716|NCT02239510|76106220|FG001|STARTED|Overall Study||4||
59990717|NCT02239510|76106219|FG000|COMPLETED|Overall Study||3||
59697161|NCT01021852|75816441|FG002|COMPLETED|Washout Period-No Drug||39||
59697162|NCT01021852|75816442|FG003|COMPLETED|Washout Period-No Drug||37||
59697163|NCT01021852|75816443|FG004|COMPLETED|Washout Period-No Drug||39||
59697164|NCT01021852|75816444|FG005|COMPLETED|Washout Period-No Drug||38||
59697165|NCT01021852|75816445|FG006|COMPLETED|Washout Period-No Drug||40||
59697166|NCT01021852|75816446|FG007|COMPLETED|Washout Period-No Drug||40||
59697167|NCT01021852|75816439|FG000|NOT COMPLETED|Washout Period-No Drug||1||
59697168|NCT01021852|75816440|FG001|NOT COMPLETED|Washout Period-No Drug||0||
59697169|NCT01021852|75816441|FG002|NOT COMPLETED|Washout Period-No Drug||0||
59697170|NCT01021852|75816442|FG003|NOT COMPLETED|Washout Period-No Drug||0||
59697171|NCT01021852|75816443|FG004|NOT COMPLETED|Washout Period-No Drug||0||
59697172|NCT01021852|75816444|FG005|NOT COMPLETED|Washout Period-No Drug||1||
59697173|NCT01021852|75816445|FG006|NOT COMPLETED|Washout Period-No Drug||0||
59697174|NCT01021852|75816446|FG007|NOT COMPLETED|Washout Period-No Drug||0||
59697175|NCT01021852|75816439|FG000|STARTED|Treatment Period 2||37||
59697176|NCT01021852|75816440|FG001|STARTED|Treatment Period 2||39||
59697177|NCT01021852|75816441|FG002|STARTED|Treatment Period 2||39||
59697178|NCT01021852|75816442|FG003|STARTED|Treatment Period 2||37||
59697179|NCT01021852|75816443|FG004|STARTED|Treatment Period 2||39||
59697180|NCT01021852|75816444|FG005|STARTED|Treatment Period 2||38||
59697181|NCT01021852|75816445|FG006|STARTED|Treatment Period 2||40||
59697182|NCT01021852|75816446|FG007|STARTED|Treatment Period 2||40||
59697183|NCT01021852|75816439|FG000|COMPLETED|Treatment Period 2||37||
59697184|NCT01021852|75816440|FG001|COMPLETED|Treatment Period 2||38||
59697185|NCT01021852|75816441|FG002|COMPLETED|Treatment Period 2||38||
59697186|NCT01021852|75816442|FG003|COMPLETED|Treatment Period 2||37||
59697187|NCT01021852|75816443|FG004|COMPLETED|Treatment Period 2||37||
59697188|NCT01021852|75816444|FG005|COMPLETED|Treatment Period 2||37||
59697189|NCT01021852|75816445|FG006|COMPLETED|Treatment Period 2||37||
59697190|NCT01021852|75816446|FG007|COMPLETED|Treatment Period 2||38||
59697191|NCT01021852|75816439|FG000|NOT COMPLETED|Treatment Period 2||0||
59697192|NCT01021852|75816440|FG001|NOT COMPLETED|Treatment Period 2||1||
59697193|NCT01021852|75816441|FG002|NOT COMPLETED|Treatment Period 2||1||
59697194|NCT01021852|75816442|FG003|NOT COMPLETED|Treatment Period 2||0||
59697195|NCT01021852|75816443|FG004|NOT COMPLETED|Treatment Period 2||2||
59697196|NCT01021852|75816444|FG005|NOT COMPLETED|Treatment Period 2||1||
59697197|NCT01021852|75816445|FG006|NOT COMPLETED|Treatment Period 2||3||
59697198|NCT01021852|75816446|FG007|NOT COMPLETED|Treatment Period 2||2||
59697199|NCT01056718|75816460|FG000|STARTED|Overall Study||53||
59697200|NCT01056718|75816460|FG000|COMPLETED|Overall Study||50||
59697201|NCT01056718|75816460|FG000|NOT COMPLETED|Overall Study||3||
59697202|NCT01298570|75816467|FG000|STARTED|Overall Study||120||
59697203|NCT01298570|75816468|FG001|STARTED|Overall Study||61||
59697204|NCT01298570|75816467|FG000|COMPLETED|Overall Study||0|Patients treated until progression|
59697205|NCT01298570|75816468|FG001|COMPLETED|Overall Study||0|Patients treated until progression|
59697206|NCT01298570|75816467|FG000|NOT COMPLETED|Overall Study||120||
59697207|NCT01298570|75816468|FG001|NOT COMPLETED|Overall Study||61||
59697208|NCT01259856|75816476|FG000|STARTED|Overall Study||82||
59697209|NCT01259856|75816477|FG001|STARTED|Overall Study||86||
59697210|NCT01259856|75816476|FG000|COMPLETED|Overall Study||13||
59697211|NCT01259856|75816477|FG001|COMPLETED|Overall Study||12||
59697212|NCT01259856|75816476|FG000|NOT COMPLETED|Overall Study||69||
59697213|NCT01259856|75816477|FG001|NOT COMPLETED|Overall Study||74||
59697214|NCT01020838|75816483|FG000|STARTED|Overall Study||218||
59697215|NCT01020838|75816483|FG000|Safety Analysis Set|Overall Study|Two patients were excluded from this population because injection of florbetaben was not done.|216||
59697216|NCT01020838|75816483|FG000|Interim Analysis Set (Primary Efficacy)|Overall Study|Primary efficacy analysis of initial study period (tissue-scan matched regional analysis)|41||
59697217|NCT01020838|75816483|FG000|Final Analysis Set (Whole Brain)|Overall Study|Final analysis set comparing PET scans with different histopathological evaluations.|97||
59697218|NCT01020838|75816483|FG000|First Annual Repeat Injection|Overall Study|Patients returning for first follow-up administration and PET-scan.|91||
59697219|NCT01020838|75816483|FG000|Second Annual Repeat Injection|Overall Study|Patients returning for second follow-up administration and PET-scan.|34||
59697220|NCT01020838|75816483|FG000|COMPLETED|Overall Study||35||
59697221|NCT01020838|75816483|FG000|NOT COMPLETED|Overall Study||183||
59697222|NCT01259466|75816498|FG000|STARTED|Overall Study||27||
59697223|NCT01259466|75816499|FG001|STARTED|Overall Study||27||
59697224|NCT01259466|75816498|FG000|COMPLETED|Overall Study||26||
59697225|NCT01259466|75816499|FG001|COMPLETED|Overall Study||18||
59697226|NCT01259466|75816498|FG000|NOT COMPLETED|Overall Study||1||
59697227|NCT01259466|75816499|FG001|NOT COMPLETED|Overall Study||9||
59697228|NCT01259388|75816507|FG000|STARTED|Overall Study||11||
59697229|NCT01259388|75816508|FG001|STARTED|Overall Study||12||
59697230|NCT01259388|75816507|FG000|COMPLETED|Overall Study||6||
59697231|NCT01259388|75816508|FG001|COMPLETED|Overall Study||11||
59697232|NCT01259388|75816507|FG000|NOT COMPLETED|Overall Study||5||
59697233|NCT01259388|75816508|FG001|NOT COMPLETED|Overall Study||1||
59697234|NCT01298492|75816514|FG000|STARTED|Overall Study||268||
59697235|NCT01298492|75816514|FG000|COMPLETED|Overall Study||149||
59697236|NCT01298492|75816514|FG000|NOT COMPLETED|Overall Study||119||
59697237|NCT01297322|75816520|FG000|STARTED|Overall Study||142||
59697238|NCT01297322|75816521|FG001|STARTED|Overall Study||278||
59697239|NCT01297322|75816520|FG000|COMPLETED|Overall Study||141||
59697240|NCT01297322|75816521|FG001|COMPLETED|Overall Study||274||
59697241|NCT01297322|75816520|FG000|NOT COMPLETED|Overall Study||1||
59697242|NCT01297322|75816521|FG001|NOT COMPLETED|Overall Study||4||
59697243|NCT01297244|75816530|FG000|STARTED|Overall Study||90||
59697244|NCT01297244|75816531|FG001|STARTED|Overall Study||15||
59697245|NCT01297244|75816530|FG000|COMPLETED|Overall Study||55||
59697246|NCT01297244|75816531|FG001|COMPLETED|Overall Study||9||
59697247|NCT01297244|75816530|FG000|NOT COMPLETED|Overall Study||35||
59697248|NCT01297244|75816531|FG001|NOT COMPLETED|Overall Study||6||
59697249|NCT05183022|75816538|FG000|STARTED|Overall Study||48||
59697250|NCT05183022|75816538|FG000|COMPLETED|Overall Study||48||
59697251|NCT05183022|75816538|FG000|NOT COMPLETED|Overall Study||0||
59697252|NCT03456726|75816544|FG000|STARTED|Overall Study||17||
59697253|NCT03456726|75816545|FG001|STARTED|Overall Study||3||
59697254|NCT03456726|75816544|FG000|COMPLETED|Overall Study||0||
59697255|NCT03456726|75816545|FG001|COMPLETED|Overall Study||0||
59697256|NCT03456726|75816544|FG000|NOT COMPLETED|Overall Study||17||
59697257|NCT03456726|75816545|FG001|NOT COMPLETED|Overall Study||3||
59697258|NCT03181932|75816553|FG000|STARTED|Period 1 (Double-blind Period)||90|The number of started participants include both age groups (participants 6-21 years and >21 years). The primary efficacy population was the 6-21 years age group. All Outcome Results are presented for the primary age group. The Baseline Characteristics and Safety Results are presented for all participants.|
59697259|NCT03181932|75816554|FG001|STARTED|Period 1 (Double-blind Period)||98|The number of started participants include both age groups (participants 6-21 years and >21 years). The primary efficacy population was the 6-21 years age group. All Outcome Results are presented for the primary age group. The Baseline Characteristics and Safety Results are presented for all participants.|
59697260|NCT03181932|75816553|FG000|COMPLETED|Period 1 (Double-blind Period)||79||
59697261|NCT03181932|75816554|FG001|COMPLETED|Period 1 (Double-blind Period)||85||
59697262|NCT03181932|75816553|FG000|NOT COMPLETED|Period 1 (Double-blind Period)||11||
59697263|NCT03181932|75816554|FG001|NOT COMPLETED|Period 1 (Double-blind Period)||13||
59697264|NCT03181932|75816553|FG000|STARTED|Period 2 (Open-label Period)||75|The numbers refer to the treatment that the participants received during Period 1. 6 participants (4 in the vancomycin group and 2 in the placebo group) who completed Period 1 decided not to participate in Period 2.|
59697265|NCT03181932|75816554|FG001|STARTED|Period 2 (Open-label Period)||83|The numbers refer to the treatment that the participants received during Period 1. 6 participants (4 in the vancomycin group and 2 in the placebo group) who completed Period 1 decided not to participate in Period 2.|
59697266|NCT03181932|75816553|FG000|COMPLETED|Period 2 (Open-label Period)||67||
59697267|NCT03181932|75816554|FG001|COMPLETED|Period 2 (Open-label Period)||70||
59697268|NCT03181932|75816553|FG000|NOT COMPLETED|Period 2 (Open-label Period)||8||
59697269|NCT03181932|75816554|FG001|NOT COMPLETED|Period 2 (Open-label Period)||13||
59697270|NCT02864862|75816564|FG000|STARTED|Overall Study||15||
59697271|NCT02864862|75816565|FG001|STARTED|Overall Study||15||
59697272|NCT02864862|75816566|FG002|STARTED|Overall Study||16||
59697273|NCT02864862|75816564|FG000|Received Intervention|Overall Study||15||
59697274|NCT02864862|75816565|FG001|Received Intervention|Overall Study||15||
59697275|NCT02864862|75816566|FG002|Received Intervention|Overall Study||16||
59697276|NCT02864862|75816564|FG000|3-month Follow up|Overall Study||15||
59697277|NCT02864862|75816565|FG001|3-month Follow up|Overall Study||15||
59697278|NCT02864862|75816566|FG002|3-month Follow up|Overall Study||16||
59697279|NCT02864862|75816564|FG000|6-month Follow up|Overall Study||15||
59697280|NCT02864862|75816565|FG001|6-month Follow up|Overall Study||15||
59697281|NCT02864862|75816566|FG002|6-month Follow up|Overall Study||15||
59697282|NCT02864862|75816564|FG000|12-month Follow up|Overall Study||14||
59697283|NCT02864862|75816565|FG001|12-month Follow up|Overall Study||15||
59697284|NCT02864862|75816566|FG002|12-month Follow up|Overall Study||14||
59697285|NCT02864862|75816564|FG000|COMPLETED|Overall Study||14||
59697286|NCT02864862|75816565|FG001|COMPLETED|Overall Study||15||
59697287|NCT02864862|75816566|FG002|COMPLETED|Overall Study||14||
59697288|NCT02864862|75816564|FG000|NOT COMPLETED|Overall Study||1||
59697289|NCT02864862|75816565|FG001|NOT COMPLETED|Overall Study||0||
59697290|NCT02864862|75816566|FG002|NOT COMPLETED|Overall Study||2||
59697291|NCT01598298|75816578|FG000|STARTED|Overall Study||150||
59697292|NCT01598298|75816579|FG001|STARTED|Overall Study||149||
59697293|NCT01598298|75816578|FG000|Patients Evaluable for Primary Endpoint|Overall Study||127|Patient has an in-window BPI assessment at week 2, 6, or 12.|
59697294|NCT01598298|75816579|FG001|Patients Evaluable for Primary Endpoint|Overall Study||128|Patient has an in-window BPI assessment at week 2, 6, or 12.|
59697295|NCT01598298|75816578|FG000|Patients Evaluable for Adverse Events|Overall Study||138||
59697296|NCT01598298|75816579|FG001|Patients Evaluable for Adverse Events|Overall Study||141||
59697297|NCT01598298|75816578|FG000|COMPLETED|Overall Study||110||
59697298|NCT01598298|75816579|FG001|COMPLETED|Overall Study||108||
59697299|NCT01598298|75816578|FG000|NOT COMPLETED|Overall Study||40||
59697300|NCT01598298|75816579|FG001|NOT COMPLETED|Overall Study||41||
59697301|NCT01235949|75816603|FG000|STARTED|Primary Phase||198||
59697302|NCT01235949|75816604|FG001|STARTED|Primary Phase||198||
59697303|NCT01235949|75816605|FG002|STARTED|Primary Phase||199||
59697304|NCT01235949|75816606|FG003|STARTED|Primary Phase||71||
59697305|NCT01235949|75816607|FG004|STARTED|Primary Phase||72||
59697306|NCT01235949|75816608|FG005|STARTED|Primary Phase||74||
59697307|NCT01235949|75816609|FG006|STARTED|Primary Phase||0||
59697308|NCT01235949|75816610|FG007|STARTED|Primary Phase||0||
59697309|NCT01235949|75816611|FG008|STARTED|Primary Phase||0||
59697310|NCT01235949|75816612|FG009|STARTED|Primary Phase||0||
59697311|NCT01235949|75816613|FG010|STARTED|Primary Phase||0||
59697312|NCT01235949|75816614|FG011|STARTED|Primary Phase||0||
59697313|NCT01235949|75816615|FG012|STARTED|Primary Phase||0||
59697314|NCT01235949|75816616|FG013|STARTED|Primary Phase||0||
59697315|NCT01235949|75816617|FG014|STARTED|Primary Phase||0||
59697316|NCT01235949|75816618|FG015|STARTED|Primary Phase||0||
59697317|NCT01235949|75816619|FG016|STARTED|Primary Phase||0||
59697318|NCT01235949|75816620|FG017|STARTED|Primary Phase||0||
59697319|NCT01235949|75816603|FG000|COMPLETED|Primary Phase|After Primary Phase completion, 7 subjects were not willing to participate in the Booster Phase|194||
59697320|NCT01235949|75816604|FG001|COMPLETED|Primary Phase|After Primary Phase completion, 6 subjects were not willing to participate in the Booster Phase|195||
59697321|NCT01235949|75816605|FG002|COMPLETED|Primary Phase|After Primary Phase completion, 6 subjects were not willing to participate in the Booster Phase|196||
59697322|NCT01235949|75816606|FG003|COMPLETED|Primary Phase|After Primary Phase completion, 2 subjects were not willing to participate in the Booster Phase|69||
59697323|NCT01235949|75816607|FG004|COMPLETED|Primary Phase|After Primary Phase completion, 3 subjects were not willing to participate in the Booster Phase|71||
59697324|NCT01235949|75816608|FG005|COMPLETED|Primary Phase|After Primary Phase completion, all subjects were willing to participate in the Booster Phase|67||
59697325|NCT01235949|75816609|FG006|COMPLETED|Primary Phase||0||
59697326|NCT01235949|75816610|FG007|COMPLETED|Primary Phase||0||
59697327|NCT01235949|75816611|FG008|COMPLETED|Primary Phase||0||
59697328|NCT01235949|75816612|FG009|COMPLETED|Primary Phase||0||
59697329|NCT01235949|75816613|FG010|COMPLETED|Primary Phase||0||
59697330|NCT01235949|75816614|FG011|COMPLETED|Primary Phase||0||
59697331|NCT01235949|75816615|FG012|COMPLETED|Primary Phase||0||
59697332|NCT01235949|75816616|FG013|COMPLETED|Primary Phase||0||
59697333|NCT01235949|75816617|FG014|COMPLETED|Primary Phase||0||
59697334|NCT01235949|75816618|FG015|COMPLETED|Primary Phase||0||
59697335|NCT01235949|75816619|FG016|COMPLETED|Primary Phase||0||
59697336|NCT01235949|75816620|FG017|COMPLETED|Primary Phase||0||
59697337|NCT01235949|75816603|FG000|NOT COMPLETED|Primary Phase||4||
59697338|NCT01235949|75816604|FG001|NOT COMPLETED|Primary Phase||3||
59697339|NCT01235949|75816605|FG002|NOT COMPLETED|Primary Phase||3||
59697340|NCT01235949|75816606|FG003|NOT COMPLETED|Primary Phase||2||
59697341|NCT01235949|75816607|FG004|NOT COMPLETED|Primary Phase||1||
59697342|NCT01235949|75816608|FG005|NOT COMPLETED|Primary Phase||7||
59697343|NCT01235949|75816609|FG006|NOT COMPLETED|Primary Phase||0||
59697344|NCT01235949|75816610|FG007|NOT COMPLETED|Primary Phase||0||
59697345|NCT01235949|75816611|FG008|NOT COMPLETED|Primary Phase||0||
59697346|NCT01235949|75816612|FG009|NOT COMPLETED|Primary Phase||0||
59697347|NCT01235949|75816613|FG010|NOT COMPLETED|Primary Phase||0||
59697348|NCT01235949|75816614|FG011|NOT COMPLETED|Primary Phase||0||
59697349|NCT01235949|75816615|FG012|NOT COMPLETED|Primary Phase||0||
59697350|NCT01235949|75816616|FG013|NOT COMPLETED|Primary Phase||0||
59697351|NCT01235949|75816617|FG014|NOT COMPLETED|Primary Phase||0||
59697352|NCT01235949|75816618|FG015|NOT COMPLETED|Primary Phase||0||
59697353|NCT01235949|75816619|FG016|NOT COMPLETED|Primary Phase||0||
59697354|NCT01235949|75816620|FG017|NOT COMPLETED|Primary Phase||0||
59697355|NCT01235949|75816603|FG000|STARTED|Booster Phase|re-randomized to diverse treatments (IIBU-IIBU, IIBU-DIBU and IIBU-NIBU Groups) in booster phase|0|After Primary Phase completion, 24 subjects were not willing to participate in the Booster Phase|
59697356|NCT01235949|75816604|FG001|STARTED|Booster Phase|re-randomized to diverse treatments (DIBU-IIBU, DIBU-DIBU and DIBU-NIBU Groups) in booster phase|0|After Primary Phase completion, 24 subjects were not willing to participate in the Booster Phase|
59697357|NCT01235949|75816605|FG002|STARTED|Booster Phase|re-randomized to diverse treatments (NIBU-IIBU, NIBU-DIBU and NIBU-NIBU Groups) in booster phase|0|After Primary Phase completion, 24 subjects were not willing to participate in the Booster Phase|
59697358|NCT01235949|75816606|FG003|STARTED|Booster Phase|subjects re-randomized to IPARA-NPARA Group in booster phase|0|After Primary Phase completion, 24 subjects were not willing to participate in the Booster Phase|
59697359|NCT01235949|75816607|FG004|STARTED|Booster Phase|subjects re-randomized to DPARA-IPARA Group in booster phase|0|After Primary Phase completion, 24 subjects were not willing to participate in the Booster Phase|
59697360|NCT01235949|75816608|FG005|STARTED|Booster Phase|subjects re-randomized to NPARA-IPARA Group in booster phase|0|After Primary Phase completion, 24 subjects were not willing to participate in the Booster Phase|
59697361|NCT01235949|75816609|FG006|STARTED|Booster Phase|1/3 of subjects from primary IIBU group re-randomized to receive diverse booster phase treatments|64|After Primary Phase completion, 24 subjects were not willing to participate in the Booster Phase|
59697362|NCT01235949|75816610|FG007|STARTED|Booster Phase|1/3 of subjects from primary IIBU group re-randomized to receive diverse booster phase treatments|60|After Primary Phase completion, 24 subjects were not willing to participate in the Booster Phase|
59990718|NCT02239510|76106220|FG001|COMPLETED|Overall Study||3||
59697363|NCT01235949|75816611|FG008|STARTED|Booster Phase|1/3 of subjects from primary IIBU group re-randomized to receive diverse booster phase treatments|63|After Primary Phase completion, 24 subjects were not willing to participate in the Booster Phase|
59697364|NCT01235949|75816612|FG009|STARTED|Booster Phase|1/3 of subjects from primary DIBU group re-randomized to receive diverse booster phase treatments|63|After Primary Phase completion, 24 subjects were not willing to participate in the Booster Phase|
59697365|NCT01235949|75816613|FG010|STARTED|Booster Phase|1/3 of subjects from primary DIBU group re-randomized to receive diverse booster phase treatments|63|After Primary Phase completion, 24 subjects were not willing to participate in the Booster Phase|
59697366|NCT01235949|75816614|FG011|STARTED|Booster Phase|1/3 of subjects from primary DIBU group re-randomized to receive diverse booster phase treatments|63|After Primary Phase completion, 24 subjects were not willing to participate in the Booster Phase|
59697367|NCT01235949|75816615|FG012|STARTED|Booster Phase|1/3 of subjects from primary NIBU group re-randomized to receive diverse booster phase treatments|63|After Primary Phase completion, 24 subjects were not willing to participate in the Booster Phase|
59697368|NCT01235949|75816616|FG013|STARTED|Booster Phase|1/3 of subjects from primary NIBU group re-randomized to receive diverse booster phase treatments|65|After Primary Phase completion, 24 subjects were not willing to participate in the Booster Phase|
59697369|NCT01235949|75816617|FG014|STARTED|Booster Phase|1/3 of subjects from primary NIBU group re-randomized to receive diverse booster phase treatments|62|After Primary Phase completion, 24 subjects were not willing to participate in the Booster Phase|
59697370|NCT01235949|75816618|FG015|STARTED|Booster Phase|subjects from the primary IPARA group continuing in booster phase with different treatment|67|After Primary Phase completion, 24 subjects were not willing to participate in the Booster Phase|
59697371|NCT01235949|75816619|FG016|STARTED|Booster Phase|subjects from the primary DPARA group continuing in booster phase with different treatment|68|After Primary Phase completion, 24 subjects were not willing to participate in the Booster Phase|
59697372|NCT01235949|75816620|FG017|STARTED|Booster Phase|subjects from the primary NPARA group continuing in booster phase with different treatment|67|After Primary Phase completion, 24 subjects were not willing to participate in the Booster Phase|
59697373|NCT01235949|75816603|FG000|COMPLETED|Booster Phase||0||
59697374|NCT01235949|75816604|FG001|COMPLETED|Booster Phase||0||
59697375|NCT01235949|75816605|FG002|COMPLETED|Booster Phase||0||
59697376|NCT01235949|75816606|FG003|COMPLETED|Booster Phase||0||
59697377|NCT01235949|75816607|FG004|COMPLETED|Booster Phase||0||
59697378|NCT01235949|75816608|FG005|COMPLETED|Booster Phase||0||
59697379|NCT01235949|75816609|FG006|COMPLETED|Booster Phase||64||
59697380|NCT01235949|75816610|FG007|COMPLETED|Booster Phase||59||
59697381|NCT01235949|75816611|FG008|COMPLETED|Booster Phase||61||
59697382|NCT01235949|75816612|FG009|COMPLETED|Booster Phase||62||
59697383|NCT01235949|75816613|FG010|COMPLETED|Booster Phase||61||
59697384|NCT01235949|75816614|FG011|COMPLETED|Booster Phase||60||
59697385|NCT01235949|75816615|FG012|COMPLETED|Booster Phase||60||
59697386|NCT01235949|75816616|FG013|COMPLETED|Booster Phase||65||
59697387|NCT01235949|75816617|FG014|COMPLETED|Booster Phase||60||
59697388|NCT01235949|75816618|FG015|COMPLETED|Booster Phase||66||
59697389|NCT01235949|75816619|FG016|COMPLETED|Booster Phase||68||
59697390|NCT01235949|75816620|FG017|COMPLETED|Booster Phase||65||
59697391|NCT01235949|75816603|FG000|NOT COMPLETED|Booster Phase||0||
59697392|NCT01235949|75816604|FG001|NOT COMPLETED|Booster Phase||0||
59697393|NCT01235949|75816605|FG002|NOT COMPLETED|Booster Phase||0||
59697394|NCT01235949|75816606|FG003|NOT COMPLETED|Booster Phase||0||
59697395|NCT01235949|75816607|FG004|NOT COMPLETED|Booster Phase||0||
59697396|NCT01235949|75816608|FG005|NOT COMPLETED|Booster Phase||0||
59697397|NCT01235949|75816609|FG006|NOT COMPLETED|Booster Phase||0||
59697398|NCT01235949|75816610|FG007|NOT COMPLETED|Booster Phase||1||
59697399|NCT01235949|75816611|FG008|NOT COMPLETED|Booster Phase||2||
59697400|NCT01235949|75816612|FG009|NOT COMPLETED|Booster Phase||1||
59697401|NCT01235949|75816613|FG010|NOT COMPLETED|Booster Phase||2||
59697402|NCT01235949|75816614|FG011|NOT COMPLETED|Booster Phase||3||
59697403|NCT01235949|75816615|FG012|NOT COMPLETED|Booster Phase||3||
59697404|NCT01235949|75816616|FG013|NOT COMPLETED|Booster Phase||0||
59697405|NCT01235949|75816617|FG014|NOT COMPLETED|Booster Phase||2||
59697406|NCT01235949|75816618|FG015|NOT COMPLETED|Booster Phase||1||
59697407|NCT01235949|75816619|FG016|NOT COMPLETED|Booster Phase||0||
59697408|NCT01235949|75816620|FG017|NOT COMPLETED|Booster Phase||2||
59697409|NCT01235793|75816658|FG000|STARTED|Overall Study||11||
59697410|NCT01235793|75816658|FG000|COMPLETED|Overall Study||5||
59697411|NCT01235793|75816658|FG000|NOT COMPLETED|Overall Study||6||
59697412|NCT01258998|75816663|FG000|STARTED|Overall Study||60||
59697413|NCT01258998|75816663|FG000|COMPLETED|Overall Study||59||
59697414|NCT01258998|75816663|FG000|NOT COMPLETED|Overall Study||1||
59697415|NCT01235715|75816669|FG000|STARTED|Overall Study||98||
59697416|NCT01235715|75816670|FG001|STARTED|Overall Study||102||
59697417|NCT01235715|75816669|FG000|COMPLETED|Overall Study||98||
59697418|NCT01235715|75816670|FG001|COMPLETED|Overall Study||100||
59697419|NCT01235715|75816669|FG000|NOT COMPLETED|Overall Study||0||
59697420|NCT01235715|75816670|FG001|NOT COMPLETED|Overall Study||2||
59697421|NCT01235403|75816677|FG000|STARTED|Overall Study||100||
59697422|NCT01235403|75816677|FG000|COMPLETED|Overall Study||74||
59697423|NCT01235403|75816677|FG000|NOT COMPLETED|Overall Study||26||
59697424|NCT01024036|75816683|FG000|STARTED|Blinded Treatment||53||
59697425|NCT01024036|75816684|FG001|STARTED|Blinded Treatment||26||
59697426|NCT01024036|75816683|FG000|COMPLETED|Blinded Treatment||31||
59697427|NCT01024036|75816684|FG001|COMPLETED|Blinded Treatment||6||
59697428|NCT01024036|75816683|FG000|NOT COMPLETED|Blinded Treatment||22||
59697429|NCT01024036|75816684|FG001|NOT COMPLETED|Blinded Treatment||20||
59697430|NCT01024036|75816683|FG000|STARTED|Unblinded Treatment|No participants in this group received treatment during unblinded treatment period|0||
59697431|NCT01024036|75816684|FG001|STARTED|Unblinded Treatment|Placebo participants had an option to receive siltuximab in unblinded treatment period|13||
59697432|NCT01024036|75816683|FG000|COMPLETED|Unblinded Treatment||0||
59697433|NCT01024036|75816684|FG001|COMPLETED|Unblinded Treatment||10||
59697434|NCT01024036|75816683|FG000|NOT COMPLETED|Unblinded Treatment||0||
59697435|NCT01024036|75816684|FG001|NOT COMPLETED|Unblinded Treatment||3||
59697436|NCT01024036|75816683|FG000|STARTED|Follow-Up Period||14|Any participant who discontinued blinded/unblinded treatment could entered Follow-up period|
59697437|NCT01024036|75816684|FG001|STARTED|Follow-Up Period||6|Any participant who discontinued blinded/unblinded treatment could entered Follow-up period|
59697438|NCT01024036|75816683|FG000|COMPLETED|Follow-Up Period||9||
59697439|NCT01024036|75816684|FG001|COMPLETED|Follow-Up Period||3||
59697440|NCT01024036|75816683|FG000|NOT COMPLETED|Follow-Up Period||5||
59697441|NCT01024036|75816684|FG001|NOT COMPLETED|Follow-Up Period||3||
59697442|NCT01234467|75816693|FG000|STARTED|Overall Study||23||
59697443|NCT01234467|75816693|FG000|COMPLETED|Overall Study||11||
59697444|NCT01234467|75816693|FG000|NOT COMPLETED|Overall Study||12||
59697445|NCT01233999|75816697|FG000|STARTED|Overall Study||10||
59697446|NCT01233999|75816697|FG000|COMPLETED|Overall Study||8||
59697447|NCT01233999|75816697|FG000|NOT COMPLETED|Overall Study||2||
59697448|NCT01233687|75816701|FG000|STARTED|Phase I RP2D AMG 102 + Erlotinib||7||
59697449|NCT01233687|75816701|FG000|COMPLETED|Phase I RP2D AMG 102 + Erlotinib||7||
59697450|NCT01233687|75816701|FG000|NOT COMPLETED|Phase I RP2D AMG 102 + Erlotinib||0||
59697451|NCT01233687|75816701|FG000|STARTED|Phase II AMG 102 + Erlotinib|Includes 7 participants from Phase 1 part of study.|49||
59697452|NCT01233687|75816701|FG000|Response-Evaluable|Phase II AMG 102 + Erlotinib||45||
59697453|NCT01233687|75816701|FG000|COMPLETED|Phase II AMG 102 + Erlotinib||45||
59697454|NCT01233687|75816701|FG000|NOT COMPLETED|Phase II AMG 102 + Erlotinib||4||
59697455|NCT01023958|75816705|FG000|STARTED|Overall Study||50||
59697456|NCT01023958|75816705|FG000|COMPLETED|Overall Study||0||
59697457|NCT01023958|75816705|FG000|NOT COMPLETED|Overall Study||50||
59697458|NCT01233609|75816711|FG000|STARTED|Overall Study||46||
59697459|NCT01233609|75816712|FG001|STARTED|Overall Study||44||
59697460|NCT01233609|75816711|FG000|COMPLETED|Overall Study||37||
59697461|NCT01233609|75816712|FG001|COMPLETED|Overall Study||42||
59697462|NCT01233609|75816711|FG000|NOT COMPLETED|Overall Study||9||
59697463|NCT01233609|75816712|FG001|NOT COMPLETED|Overall Study||2||
59697464|NCT01232283|75816728|FG000|STARTED|Placebo Controlled Phase (Weeks 0-16)||275||
59697465|NCT01232283|75816729|FG001|STARTED|Placebo Controlled Phase (Weeks 0-16)||138||
59697466|NCT01232283|75816730|FG002|STARTED|Placebo Controlled Phase (Weeks 0-16)||0||
59697467|NCT01232283|75816731|FG003|STARTED|Placebo Controlled Phase (Weeks 0-16)||0||
59697468|NCT01232283|75816732|FG004|STARTED|Placebo Controlled Phase (Weeks 0-16)||0||
59697469|NCT01232283|75816733|FG005|STARTED|Placebo Controlled Phase (Weeks 0-16)||0||
59697470|NCT01232283|75816734|FG006|STARTED|Placebo Controlled Phase (Weeks 0-16)||0||
59697471|NCT01232283|75816735|FG007|STARTED|Placebo Controlled Phase (Weeks 0-16)||0||
59697472|NCT01232283|75816736|FG008|STARTED|Placebo Controlled Phase (Weeks 0-16)||0||
59697473|NCT01232283|75816737|FG009|STARTED|Placebo Controlled Phase (Weeks 0-16)||0||
59697474|NCT01232283|75816728|FG000|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)|1 protocol violation occurred|272||
59697475|NCT01232283|75816729|FG001|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)|1 protocol violation occurred|136||
59697476|NCT01232283|75816730|FG002|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0||
59697477|NCT01232283|75816731|FG003|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0||
59697478|NCT01232283|75816732|FG004|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0||
59697479|NCT01232283|75816733|FG005|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0||
59697480|NCT01232283|75816734|FG006|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0||
59697481|NCT01232283|75816735|FG007|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0||
59547900|NCT02481219|75646818|FG000|COMPLETED|Overall Study||58||
59547901|NCT02481219|75646819|FG001|COMPLETED|Overall Study||61||
59547902|NCT02481219|75646818|FG000|NOT COMPLETED|Overall Study||2||
59547903|NCT02481219|75646819|FG001|NOT COMPLETED|Overall Study||1||
59697482|NCT01232283|75816736|FG008|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0||
59697483|NCT01232283|75816737|FG009|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0||
59697484|NCT01232283|75816728|FG000|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||239||
59697485|NCT01232283|75816729|FG001|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||112||
59697486|NCT01232283|75816730|FG002|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0||
59697487|NCT01232283|75816731|FG003|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0||
59547904|NCT02481297|75646831|FG000|STARTED|Overall Study||1||
59697488|NCT01232283|75816732|FG004|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0||
59697489|NCT01232283|75816733|FG005|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0||
59697490|NCT01232283|75816734|FG006|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0||
59697491|NCT01232283|75816735|FG007|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0||
59697492|NCT01232283|75816736|FG008|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0||
59697493|NCT01232283|75816737|FG009|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0||
59697494|NCT01232283|75816728|FG000|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||36||
59697495|NCT01232283|75816729|FG001|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||26||
59697496|NCT01232283|75816730|FG002|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0||
59697497|NCT01232283|75816731|FG003|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0||
59697498|NCT01232283|75816732|FG004|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0||
59697499|NCT01232283|75816733|FG005|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0||
59697500|NCT01232283|75816734|FG006|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0||
59697501|NCT01232283|75816735|FG007|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0||
59697502|NCT01232283|75816736|FG008|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0||
59697503|NCT01232283|75816737|FG009|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0||
59697504|NCT01232283|75816728|FG000|STARTED|Maintenance Phase (Weeks16-32)||0||
59697505|NCT01232283|75816729|FG001|STARTED|Maintenance Phase (Weeks16-32)||0||
59697506|NCT01232283|75816730|FG002|STARTED|Maintenance Phase (Weeks16-32)|5 participants discontinued after Week 16 but prior to entry into the Maintenance Phase|234||
59547905|NCT02481297|75646832|FG001|STARTED|Overall Study||6||
59547906|NCT02481297|75646831|FG000|COMPLETED|Overall Study||1||
59547907|NCT02481297|75646832|FG001|COMPLETED|Overall Study||6||
59547908|NCT02481297|75646831|FG000|NOT COMPLETED|Overall Study||0||
59547909|NCT02481297|75646832|FG001|NOT COMPLETED|Overall Study||0||
59547910|NCT02481375|75646842|FG000|STARTED|Overall Study||206||
59547911|NCT02481375|75646843|FG001|STARTED|Overall Study||202||
59547912|NCT02481375|75646844|FG002|STARTED|Overall Study||201||
59547913|NCT02481375|75646845|FG003|STARTED|Overall Study||200||
59547914|NCT02481375|75646842|FG000|COMPLETED|Overall Study||192||
59547915|NCT02481375|75646843|FG001|COMPLETED|Overall Study||191||
59547916|NCT02481375|75646844|FG002|COMPLETED|Overall Study||191||
59547917|NCT02481375|75646845|FG003|COMPLETED|Overall Study||186||
59547918|NCT02481375|75646842|FG000|NOT COMPLETED|Overall Study||14||
59547919|NCT02481375|75646843|FG001|NOT COMPLETED|Overall Study||11||
59547920|NCT02481375|75646844|FG002|NOT COMPLETED|Overall Study||10||
59547921|NCT02481375|75646845|FG003|NOT COMPLETED|Overall Study||14||
59547922|NCT01164098|75646857|FG000|STARTED|Overall Study||15||
59547923|NCT01164098|75646858|FG001|STARTED|Overall Study||15||
59547924|NCT01164098|75646857|FG000|COMPLETED|Overall Study||15||
59547925|NCT01164098|75646858|FG001|COMPLETED|Overall Study||15||
59547926|NCT01164098|75646857|FG000|NOT COMPLETED|Overall Study||0||
59547927|NCT01164098|75646858|FG001|NOT COMPLETED|Overall Study||0||
59547928|NCT02551809|75646867|FG000|STARTED|Overall Study||14||
59547929|NCT02551809|75646868|FG001|STARTED|Overall Study||15||
59547930|NCT02551809|75646869|FG002|STARTED|Overall Study||14||
59547931|NCT02551809|75646867|FG000|COMPLETED|Overall Study||14||
59547932|NCT02551809|75646868|FG001|COMPLETED|Overall Study||14||
59547933|NCT02551809|75646869|FG002|COMPLETED|Overall Study||13||
59547934|NCT02551809|75646867|FG000|NOT COMPLETED|Overall Study||0||
59547935|NCT02551809|75646868|FG001|NOT COMPLETED|Overall Study||1||
59547936|NCT02551809|75646869|FG002|NOT COMPLETED|Overall Study||1||
59547937|NCT01164644|75646879|FG000|STARTED|Overall Study||12||
59547938|NCT01164644|75646880|FG001|STARTED|Overall Study||14||
59547939|NCT01164644|75646879|FG000|COMPLETED|Overall Study||9||
59547940|NCT01164644|75646880|FG001|COMPLETED|Overall Study||13||
59547941|NCT01164644|75646879|FG000|NOT COMPLETED|Overall Study||3||
59990719|NCT02239510|76106219|FG000|NOT COMPLETED|Overall Study||2||
59547942|NCT01164644|75646880|FG001|NOT COMPLETED|Overall Study||1||
59547943|NCT02551887|75646889|FG000|STARTED|Overall Study||301||
59547944|NCT02551887|75646890|FG001|STARTED|Overall Study||124||
59547945|NCT02551887|75646891|FG002|STARTED|Overall Study||222||
59547946|NCT02551887|75646889|FG000|COMPLETED|Overall Study||301||
59547947|NCT02551887|75646890|FG001|COMPLETED|Overall Study||124||
59547948|NCT02551887|75646891|FG002|COMPLETED|Overall Study||222||
59547949|NCT02551887|75646889|FG000|NOT COMPLETED|Overall Study||0||
59547950|NCT02551887|75646890|FG001|NOT COMPLETED|Overall Study||0||
59547951|NCT02551887|75646891|FG002|NOT COMPLETED|Overall Study||0||
59547952|NCT02553135|75646899|FG000|STARTED|Overall Study||6||
59547953|NCT02553135|75646899|FG000|COMPLETED|Overall Study||6||
59547954|NCT02553135|75646899|FG000|NOT COMPLETED|Overall Study||0||
59697507|NCT01232283|75816731|FG003|STARTED|Maintenance Phase (Weeks16-32)|4 participants discontinued after Week 16 but prior to entry into the Maintenance Phase|108||
59697508|NCT01232283|75816732|FG004|STARTED|Maintenance Phase (Weeks16-32)||0||
59697509|NCT01232283|75816733|FG005|STARTED|Maintenance Phase (Weeks16-32)||0||
59697510|NCT01232283|75816734|FG006|STARTED|Maintenance Phase (Weeks16-32)||0||
59697511|NCT01232283|75816735|FG007|STARTED|Maintenance Phase (Weeks16-32)||0||
59697512|NCT01232283|75816736|FG008|STARTED|Maintenance Phase (Weeks16-32)||0||
59697513|NCT01232283|75816737|FG009|STARTED|Maintenance Phase (Weeks16-32)||0||
59697514|NCT01232283|75816728|FG000|COMPLETED|Maintenance Phase (Weeks16-32)||0||
59697515|NCT01232283|75816729|FG001|COMPLETED|Maintenance Phase (Weeks16-32)||0||
59697516|NCT01232283|75816730|FG002|COMPLETED|Maintenance Phase (Weeks16-32)||194||
59697517|NCT01232283|75816731|FG003|COMPLETED|Maintenance Phase (Weeks16-32)||100||
59697518|NCT01232283|75816732|FG004|COMPLETED|Maintenance Phase (Weeks16-32)||0||
59697519|NCT01232283|75816733|FG005|COMPLETED|Maintenance Phase (Weeks16-32)||0||
59697520|NCT01232283|75816734|FG006|COMPLETED|Maintenance Phase (Weeks16-32)||0||
59697521|NCT01232283|75816735|FG007|COMPLETED|Maintenance Phase (Weeks16-32)||0||
59697522|NCT01232283|75816736|FG008|COMPLETED|Maintenance Phase (Weeks16-32)||0||
59697523|NCT01232283|75816737|FG009|COMPLETED|Maintenance Phase (Weeks16-32)||0||
59697524|NCT01232283|75816728|FG000|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0||
59697525|NCT01232283|75816729|FG001|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0||
59697526|NCT01232283|75816730|FG002|NOT COMPLETED|Maintenance Phase (Weeks16-32)||40||
59697527|NCT01232283|75816731|FG003|NOT COMPLETED|Maintenance Phase (Weeks16-32)||8||
59697528|NCT01232283|75816732|FG004|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0||
59697529|NCT01232283|75816733|FG005|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0||
59697530|NCT01232283|75816734|FG006|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0||
59697531|NCT01232283|75816735|FG007|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0||
59697532|NCT01232283|75816736|FG008|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0||
59697533|NCT01232283|75816737|FG009|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0||
59697534|NCT01232283|75816728|FG000|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0||
59697535|NCT01232283|75816729|FG001|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0||
59697536|NCT01232283|75816730|FG002|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0||
59697537|NCT01232283|75816731|FG003|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0||
59697538|NCT01232283|75816732|FG004|STARTED|Randomized Withdrawal Phase(Weeks 32-52)|4 participants discontinued after Week 32 but prior to entry into the Randomized Withdrawal Phase|62||
59697539|NCT01232283|75816733|FG005|STARTED|Randomized Withdrawal Phase(Weeks 32-52)|13 participants discontinued after Week 32 but prior to entry into the Randomized Withdrawal Phase|61||
59697540|NCT01232283|75816734|FG006|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||58||
59697541|NCT01232283|75816735|FG007|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||96||
59697542|NCT01232283|75816736|FG008|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0||
59697543|NCT01232283|75816737|FG009|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0||
59990720|NCT02239510|76106220|FG001|NOT COMPLETED|Overall Study||1||
59990721|NCT02462486|76106229|FG000|STARTED|Overall Study||316||
59990722|NCT02462486|76106230|FG001|STARTED|Overall Study||315||
59990723|NCT02462486|76106231|FG002|STARTED|Overall Study||318||
59990724|NCT02462486|76106229|FG000|COMPLETED|Overall Study||222||
59990725|NCT02462486|76106230|FG001|COMPLETED|Overall Study||223||
59990726|NCT02462486|76106231|FG002|COMPLETED|Overall Study||266||
59990727|NCT02462486|76106229|FG000|NOT COMPLETED|Overall Study||94||
59990728|NCT02462486|76106230|FG001|NOT COMPLETED|Overall Study||92||
59990729|NCT02462486|76106231|FG002|NOT COMPLETED|Overall Study||52||
59697544|NCT01232283|75816728|FG000|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0||
59697545|NCT01232283|75816729|FG001|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0||
59697546|NCT01232283|75816730|FG002|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0||
59697547|NCT01232283|75816731|FG003|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0||
59697548|NCT01232283|75816732|FG004|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0||
59697549|NCT01232283|75816733|FG005|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0||
59697550|NCT01232283|75816734|FG006|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||28||
59697551|NCT01232283|75816735|FG007|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||17||
59697552|NCT01232283|75816736|FG008|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0||
59697553|NCT01232283|75816737|FG009|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0||
59697554|NCT01232283|75816728|FG000|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0||
59990730|NCT02495948|76106239|FG000|STARTED|Period 1, First 30 Days of Wear||83||
59990731|NCT02495948|76106240|FG001|STARTED|Period 1, First 30 Days of Wear||84||
59697555|NCT01232283|75816729|FG001|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0||
59697556|NCT01232283|75816730|FG002|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0||
59697557|NCT01232283|75816731|FG003|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0||
59697558|NCT01232283|75816732|FG004|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||50||
59990732|NCT02495948|76106239|FG000|COMPLETED|Period 1, First 30 Days of Wear||83||
59990733|NCT02495948|76106240|FG001|COMPLETED|Period 1, First 30 Days of Wear||83||
59990734|NCT02495948|76106239|FG000|NOT COMPLETED|Period 1, First 30 Days of Wear||0||
59990735|NCT02495948|76106240|FG001|NOT COMPLETED|Period 1, First 30 Days of Wear||1||
59697559|NCT01232283|75816733|FG005|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||56||
59697560|NCT01232283|75816734|FG006|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||41||
59697561|NCT01232283|75816735|FG007|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||84||
59697562|NCT01232283|75816736|FG008|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0||
59697563|NCT01232283|75816737|FG009|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0||
59697564|NCT01232283|75816728|FG000|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0||
59697565|NCT01232283|75816729|FG001|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0||
59697566|NCT01232283|75816730|FG002|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0||
59697567|NCT01232283|75816731|FG003|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0||
59697568|NCT01232283|75816732|FG004|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||12||
59697569|NCT01232283|75816733|FG005|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||5||
59697570|NCT01232283|75816734|FG006|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||17||
59697571|NCT01232283|75816735|FG007|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||12||
59697572|NCT01232283|75816736|FG008|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0||
59697573|NCT01232283|75816737|FG009|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0||
59697574|NCT01232283|75816728|FG000|STARTED|Long-Term Extension Phase (Weeks 52-260)||0||
59697575|NCT01232283|75816729|FG001|STARTED|Long-Term Extension Phase (Weeks 52-260)||0||
59697576|NCT01232283|75816730|FG002|STARTED|Long-Term Extension Phase (Weeks 52-260)||0||
59697577|NCT01232283|75816731|FG003|STARTED|Long-Term Extension Phase (Weeks 52-260)||0||
59697578|NCT01232283|75816732|FG004|STARTED|Long-Term Extension Phase (Weeks 52-260)||0||
59697579|NCT01232283|75816733|FG005|STARTED|Long-Term Extension Phase (Weeks 52-260)||0||
59697580|NCT01232283|75816734|FG006|STARTED|Long-Term Extension Phase (Weeks 52-260)||0||
59697581|NCT01232283|75816735|FG007|STARTED|Long-Term Extension Phase (Weeks 52-260)||0||
59697582|NCT01232283|75816736|FG008|STARTED|Long-Term Extension Phase (Weeks 52-260)||137||
59697583|NCT01232283|75816737|FG009|STARTED|Long-Term Extension Phase (Weeks 52-260)||80||
59697584|NCT01232283|75816728|FG000|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0||
59697585|NCT01232283|75816729|FG001|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0||
59697586|NCT01232283|75816730|FG002|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0||
59697587|NCT01232283|75816731|FG003|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0||
59697588|NCT01232283|75816732|FG004|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0||
59697589|NCT01232283|75816733|FG005|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0||
59697590|NCT01232283|75816734|FG006|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0||
59697591|NCT01232283|75816735|FG007|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0||
59697592|NCT01232283|75816736|FG008|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||29||
59697593|NCT01232283|75816737|FG009|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||19||
59697594|NCT01232283|75816728|FG000|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0||
59697595|NCT01232283|75816729|FG001|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0||
59697596|NCT01232283|75816730|FG002|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0||
59697597|NCT01232283|75816731|FG003|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0||
59697598|NCT01232283|75816732|FG004|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0||
59697599|NCT01232283|75816733|FG005|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0||
59697600|NCT01232283|75816734|FG006|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0||
59697601|NCT01232283|75816735|FG007|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0||
59697602|NCT01232283|75816736|FG008|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||108||
59697603|NCT01232283|75816737|FG009|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||61||
59697604|NCT01232127|75816759|FG000|STARTED|Period 1: Days 1-10|Participants who received treatment.|25||
59697605|NCT01232127|75816760|FG001|STARTED|Period 1: Days 1-10||0||
59697606|NCT01232127|75816761|FG002|STARTED|Period 1: Days 1-10||0||
59697607|NCT01232127|75816759|FG000|COMPLETED|Period 1: Days 1-10||24||
59697608|NCT01232127|75816760|FG001|COMPLETED|Period 1: Days 1-10||0||
59697609|NCT01232127|75816761|FG002|COMPLETED|Period 1: Days 1-10||0||
59697610|NCT01232127|75816759|FG000|NOT COMPLETED|Period 1: Days 1-10||1||
59697611|NCT01232127|75816760|FG001|NOT COMPLETED|Period 1: Days 1-10||0||
59697612|NCT01232127|75816761|FG002|NOT COMPLETED|Period 1: Days 1-10||0||
59697613|NCT01232127|75816759|FG000|STARTED|Period 2: Days 11-17||0||
59697614|NCT01232127|75816760|FG001|STARTED|Period 2: Days 11-17|Participants who received treatment.|24||
59697615|NCT01232127|75816761|FG002|STARTED|Period 2: Days 11-17||0||
59697616|NCT01232127|75816759|FG000|COMPLETED|Period 2: Days 11-17||0||
59697617|NCT01232127|75816760|FG001|COMPLETED|Period 2: Days 11-17||24||
59697618|NCT01232127|75816761|FG002|COMPLETED|Period 2: Days 11-17||0||
59697619|NCT01232127|75816759|FG000|NOT COMPLETED|Period 2: Days 11-17||0||
59697620|NCT01232127|75816760|FG001|NOT COMPLETED|Period 2: Days 11-17||0||
59697621|NCT01232127|75816761|FG002|NOT COMPLETED|Period 2: Days 11-17||0||
59697622|NCT01232127|75816759|FG000|STARTED|Period 3: Days 18-24||0||
59697623|NCT01232127|75816760|FG001|STARTED|Period 3: Days 18-24||0||
59697624|NCT01232127|75816761|FG002|STARTED|Period 3: Days 18-24|Participants who received treatment.|24||
59697625|NCT01232127|75816759|FG000|COMPLETED|Period 3: Days 18-24||0||
59697626|NCT01232127|75816760|FG001|COMPLETED|Period 3: Days 18-24||0||
59816182|NCT00529568|75938540|FG001|COMPLETED|Double-bilnd Antiviral Treatment Phase||205||
59816183|NCT00529568|75938541|FG002|COMPLETED|Double-bilnd Antiviral Treatment Phase||404||
59697627|NCT01232127|75816761|FG002|COMPLETED|Period 3: Days 18-24||24||
59697628|NCT01232127|75816759|FG000|NOT COMPLETED|Period 3: Days 18-24||0||
59697629|NCT01232127|75816760|FG001|NOT COMPLETED|Period 3: Days 18-24||0||
59697630|NCT01232127|75816761|FG002|NOT COMPLETED|Period 3: Days 18-24||0||
59697631|NCT01258608|75816775|FG000|STARTED|Overall Study||51||
59697632|NCT01258608|75816776|FG001|STARTED|Overall Study||50||
59697633|NCT01258608|75816775|FG000|COMPLETED|Overall Study||30|Completed placebo/mapatumumab treatment defined as treated until radiologic disease progression|
59697634|NCT01258608|75816776|FG001|COMPLETED|Overall Study||31|Completed placebo/mapatumumab treatment defined as treated until radiologic disease progression|
59697635|NCT01258608|75816775|FG000|NOT COMPLETED|Overall Study||21||
59697636|NCT01258608|75816776|FG001|NOT COMPLETED|Overall Study||19||
59697637|NCT01015612|75816783|FG000|STARTED|Overall Study||634||
59697638|NCT01015612|75816783|FG000|COMPLETED|Overall Study||481||
59697639|NCT01015612|75816783|FG000|NOT COMPLETED|Overall Study||153||
59697640|NCT01231659|75816787|FG000|STARTED|Overall Study||72||
59697641|NCT01231659|75816787|FG000|Per Protocol (PP) Set|Overall Study||72|All patients that were treated per protocol and analyzed as 1 group|
59697642|NCT01231659|75816787|FG000|Safety Set|Overall Study||72|All patients who received at least 1 dose of the study drug|
59697643|NCT01231659|75816787|FG000|COMPLETED|Overall Study||0||
59697644|NCT01231659|75816787|FG000|NOT COMPLETED|Overall Study||72||
59697645|NCT01054222|75816791|FG000|STARTED|Overall Study||31||
59697646|NCT01054222|75816791|FG000|COMPLETED|Overall Study||20||
59697647|NCT01054222|75816791|FG000|NOT COMPLETED|Overall Study||11||
59697648|NCT01052428|75816797|FG000|STARTED|Overall Study||19||
59697649|NCT01052428|75816798|FG001|STARTED|Overall Study||19||
59697650|NCT01052428|75816797|FG000|COMPLETED|Overall Study||18||
59697651|NCT01052428|75816798|FG001|COMPLETED|Overall Study||18||
59697652|NCT01052428|75816797|FG000|NOT COMPLETED|Overall Study||1||
59697653|NCT01052428|75816798|FG001|NOT COMPLETED|Overall Study||1||
59697654|NCT01052272|75816808|FG000|STARTED|Overall Study||18||
59697655|NCT01052272|75816809|FG001|STARTED|Overall Study||18||
59697656|NCT01052272|75816810|FG002|STARTED|Overall Study||18||
59697657|NCT01052272|75816811|FG003|STARTED|Overall Study||18||
59697658|NCT01052272|75816808|FG000|COMPLETED|Overall Study||13||
59697659|NCT01052272|75816809|FG001|COMPLETED|Overall Study||11||
59697660|NCT01052272|75816810|FG002|COMPLETED|Overall Study||10||
59697661|NCT01052272|75816811|FG003|COMPLETED|Overall Study||11||
59697662|NCT01052272|75816808|FG000|NOT COMPLETED|Overall Study||5||
59697663|NCT01052272|75816809|FG001|NOT COMPLETED|Overall Study||7||
59697664|NCT01052272|75816810|FG002|NOT COMPLETED|Overall Study||8||
59697665|NCT01052272|75816811|FG003|NOT COMPLETED|Overall Study||7||
59697666|NCT01257204|75816824|FG000|STARTED|Treatment Period (up to Week 24)||50||
59697667|NCT01257204|75816825|FG001|STARTED|Treatment Period (up to Week 24)||50||
59697668|NCT01257204|75816826|FG002|STARTED|Treatment Period (up to Week 24)||51||
59697669|NCT01257204|75816824|FG000|COMPLETED|Treatment Period (up to Week 24)||45||
59697670|NCT01257204|75816825|FG001|COMPLETED|Treatment Period (up to Week 24)||44||
59697671|NCT01257204|75816826|FG002|COMPLETED|Treatment Period (up to Week 24)||42||
59697672|NCT01257204|75816824|FG000|NOT COMPLETED|Treatment Period (up to Week 24)||5||
59697673|NCT01257204|75816825|FG001|NOT COMPLETED|Treatment Period (up to Week 24)||6||
59697674|NCT01257204|75816826|FG002|NOT COMPLETED|Treatment Period (up to Week 24)||9||
59697675|NCT01257204|75816824|FG000|STARTED|Follow-up Period (up to Week 48)|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment.|49||
59697676|NCT01257204|75816825|FG001|STARTED|Follow-up Period (up to Week 48)|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment.|47||
59697677|NCT01257204|75816826|FG002|STARTED|Follow-up Period (up to Week 48)|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment.|49||
59697678|NCT01257204|75816824|FG000|COMPLETED|Follow-up Period (up to Week 48)||48||
59697679|NCT01257204|75816825|FG001|COMPLETED|Follow-up Period (up to Week 48)||41||
59697680|NCT01257204|75816826|FG002|COMPLETED|Follow-up Period (up to Week 48)||39||
59697681|NCT01257204|75816824|FG000|NOT COMPLETED|Follow-up Period (up to Week 48)||1||
59697682|NCT01257204|75816825|FG001|NOT COMPLETED|Follow-up Period (up to Week 48)||6||
59697683|NCT01257204|75816826|FG002|NOT COMPLETED|Follow-up Period (up to Week 48)||10||
59697684|NCT01231581|75816848|FG000|STARTED|Overall Study||80||
59697685|NCT01231581|75816849|FG001|STARTED|Overall Study||80||
59697686|NCT01231581|75816848|FG000|Ongoing|Overall Study|Participant is continuing treatment with trametinib and gemcitabine under roll over study MEK114375.|1||
59697687|NCT01231581|75816849|FG001|Ongoing|Overall Study||0||
59697688|NCT01231581|75816848|FG000|COMPLETED|Overall Study||0||
59697689|NCT01231581|75816849|FG001|COMPLETED|Overall Study||0||
59697690|NCT01231581|75816848|FG000|NOT COMPLETED|Overall Study||80||
59697691|NCT01231581|75816849|FG001|NOT COMPLETED|Overall Study||80||
59697692|NCT01050634|75816855|FG000|STARTED|Overall Study||980||
59697693|NCT01050634|75816855|FG000|Received Treatment|Overall Study||924||
59697694|NCT01050634|75816855|FG000|COMPLETED|Overall Study||852||
59697695|NCT01050634|75816855|FG000|NOT COMPLETED|Overall Study||128||
59697696|NCT01020526|75816859|FG000|STARTED|Overall Study||63||
59697697|NCT01020526|75816859|FG000|COMPLETED|Overall Study||49||
59697698|NCT01020526|75816859|FG000|NOT COMPLETED|Overall Study||14||
59697699|NCT01020448|75816863|FG000|STARTED|Pre-assignment||339||
59697700|NCT01020448|75816863|FG000|COMPLETED|Pre-assignment||326||
59697701|NCT01020448|75816863|FG000|NOT COMPLETED|Pre-assignment||13||
59697702|NCT01020448|75816863|FG000|STARTED|Treatment|One patient was excluded from the safety population as no post-baseline assessment was available|325||
59697703|NCT01020448|75816863|FG000|COMPLETED|Treatment||299||
59697704|NCT01020448|75816863|FG000|NOT COMPLETED|Treatment||26||
59697705|NCT01256658|75816870|FG000|STARTED|Period 1||6817||
59697706|NCT01256658|75816871|FG001|STARTED|Period 1||7258||
59697707|NCT01256658|75816870|FG000|COMPLETED|Period 1||5897||
59697708|NCT01256658|75816871|FG001|COMPLETED|Period 1||6510||
59697709|NCT01256658|75816870|FG000|NOT COMPLETED|Period 1||920||
59697710|NCT01256658|75816871|FG001|NOT COMPLETED|Period 1||748||
59697711|NCT01256658|75816870|FG000|STARTED|Period 2 - Follow up Only - No Treatment|43 participants who completed period 1 did not enroll to continue on period 2|5854||
59697712|NCT01256658|75816871|FG001|STARTED|Period 2 - Follow up Only - No Treatment|138 participants who completed period 1 did not enroll to continue on period 2|6372||
59697713|NCT01256658|75816870|FG000|Lost to Follow up|Period 2 - Follow up Only - No Treatment||71||
59697714|NCT01256658|75816871|FG001|Lost to Follow up|Period 2 - Follow up Only - No Treatment||77||
59697715|NCT01256658|75816870|FG000|Death|Period 2 - Follow up Only - No Treatment||6||
59697716|NCT01256658|75816871|FG001|Death|Period 2 - Follow up Only - No Treatment||8||
59697717|NCT01256658|75816870|FG000|Study Termination|Period 2 - Follow up Only - No Treatment|43 participants who completed period 1 did not enroll to continue on period 2|5777||
59697718|NCT01256658|75816871|FG001|Study Termination|Period 2 - Follow up Only - No Treatment|138 participants who completed period 1 did not enroll to continue on period 2|6287||
59697719|NCT01256658|75816870|FG000|COMPLETED|Period 2 - Follow up Only - No Treatment||0||
59697720|NCT01256658|75816871|FG001|COMPLETED|Period 2 - Follow up Only - No Treatment||0||
59697721|NCT01256658|75816870|FG000|NOT COMPLETED|Period 2 - Follow up Only - No Treatment||5854||
59697722|NCT01256658|75816871|FG001|NOT COMPLETED|Period 2 - Follow up Only - No Treatment||6372||
59697723|NCT01256502|75816880|FG000|STARTED|Overall Study|Implanted with SERI during Stage I breast reconstruction surgery|139||
59697724|NCT01256502|75816880|FG000|COMPLETED|Overall Study||129||
59697725|NCT01256502|75816880|FG000|NOT COMPLETED|Overall Study||10||
59697726|NCT01256190|75816891|FG000|STARTED|Overall Study||39||
59697727|NCT01256190|75816892|FG001|STARTED|Overall Study||17||
59697728|NCT01256190|75816891|FG000|COMPLETED|Overall Study||37||
59697729|NCT01256190|75816892|FG001|COMPLETED|Overall Study||17||
59697730|NCT01256190|75816891|FG000|NOT COMPLETED|Overall Study||2||
59697731|NCT01256190|75816892|FG001|NOT COMPLETED|Overall Study||0||
59697732|NCT01255722|75816901|FG000|STARTED|Overall Study||155||
59697733|NCT01255722|75816902|FG001|STARTED|Overall Study||160||
59697734|NCT01255722|75816903|FG002|STARTED|Overall Study||153||
59697735|NCT01255722|75816901|FG000|COMPLETED|Overall Study||152||
59697736|NCT01255722|75816902|FG001|COMPLETED|Overall Study||159||
59697737|NCT01255722|75816903|FG002|COMPLETED|Overall Study||152||
59697738|NCT01255722|75816901|FG000|NOT COMPLETED|Overall Study||3||
59697739|NCT01255722|75816902|FG001|NOT COMPLETED|Overall Study||1||
59697740|NCT01255722|75816903|FG002|NOT COMPLETED|Overall Study||1||
59697741|NCT01231503|75816920|FG000|STARTED|Overall Study||60||
59697742|NCT01231503|75816921|FG001|STARTED|Overall Study||59||
59697743|NCT01231503|75816922|FG002|STARTED|Overall Study||60||
59697744|NCT01231503|75816923|FG003|STARTED|Overall Study||60||
59697745|NCT01231503|75816924|FG004|STARTED|Overall Study||60||
59697746|NCT01231503|75816925|FG005|STARTED|Overall Study||60||
59697747|NCT01231503|75816926|FG006|STARTED|Overall Study||60||
59697748|NCT01231503|75816927|FG007|STARTED|Overall Study||60||
59697749|NCT01231503|75816920|FG000|COMPLETED|Overall Study||46||
59697750|NCT01231503|75816921|FG001|COMPLETED|Overall Study||46||
59697751|NCT01231503|75816922|FG002|COMPLETED|Overall Study||48||
59697752|NCT01231503|75816923|FG003|COMPLETED|Overall Study||52||
59697753|NCT01231503|75816924|FG004|COMPLETED|Overall Study||50||
59697754|NCT01231503|75816925|FG005|COMPLETED|Overall Study||44||
59697755|NCT01231503|75816926|FG006|COMPLETED|Overall Study||53||
59697756|NCT01231503|75816927|FG007|COMPLETED|Overall Study||52||
59697757|NCT01231503|75816920|FG000|NOT COMPLETED|Overall Study||14||
59697758|NCT01231503|75816921|FG001|NOT COMPLETED|Overall Study||13||
59697759|NCT01231503|75816922|FG002|NOT COMPLETED|Overall Study||12||
59697760|NCT01231503|75816923|FG003|NOT COMPLETED|Overall Study||8||
59697761|NCT01231503|75816924|FG004|NOT COMPLETED|Overall Study||10||
59697762|NCT01231503|75816925|FG005|NOT COMPLETED|Overall Study||16||
59697763|NCT01231503|75816926|FG006|NOT COMPLETED|Overall Study||7||
59697764|NCT01231503|75816927|FG007|NOT COMPLETED|Overall Study||8||
59697765|NCT01230489|75816955|FG000|STARTED|Overall Study||13||
59697766|NCT01230489|75816955|FG000|COMPLETED|Overall Study||8||
59697767|NCT01230489|75816955|FG000|NOT COMPLETED|Overall Study||5||
59816184|NCT00529568|75938539|FG000|NOT COMPLETED|Double-bilnd Antiviral Treatment Phase||0||
59697768|NCT01229397|75816961|FG000|STARTED|Overall Study||103||
59697769|NCT01229397|75816962|FG001|STARTED|Overall Study||102||
59697770|NCT01229397|75816961|FG000|COMPLETED|Overall Study||92||
59697771|NCT01229397|75816962|FG001|COMPLETED|Overall Study||93||
59697772|NCT01229397|75816961|FG000|NOT COMPLETED|Overall Study||11||
59697773|NCT01229397|75816962|FG001|NOT COMPLETED|Overall Study||9||
59697774|NCT01228071|75816972|FG000|STARTED|Overall Study||34||
59697775|NCT01228071|75816972|FG000|COMPLETED|Overall Study||32||
59697776|NCT01228071|75816972|FG000|NOT COMPLETED|Overall Study||2||
59697777|NCT01008475|75816983|FG000|STARTED|Overall Study||3||
59697778|NCT01008475|75816984|FG001|STARTED|Overall Study||3||
59697779|NCT01008475|75816985|FG002|STARTED|Overall Study||7||
59697780|NCT01008475|75816986|FG003|STARTED|Overall Study||3||
59697781|NCT01008475|75816987|FG004|STARTED|Overall Study||72||
59697782|NCT01008475|75816988|FG005|STARTED|Overall Study||73||
59697783|NCT01008475|75816989|FG006|STARTED|Overall Study||71||
59697784|NCT01008475|75816983|FG000|Safety Analysis Set|Overall Study||3||
59697785|NCT01008475|75816984|FG001|Safety Analysis Set|Overall Study||3||
59697786|NCT01008475|75816985|FG002|Safety Analysis Set|Overall Study||7||
59697787|NCT01008475|75816986|FG003|Safety Analysis Set|Overall Study||3||
59697788|NCT01008475|75816987|FG004|Safety Analysis Set|Overall Study|1 subject randomized to EMD525797 1000 mg group received only SoC. Hence, reported under SOC group.|73||
59697789|NCT01008475|75816988|FG005|Safety Analysis Set|Overall Study||72||
59697790|NCT01008475|75816989|FG006|Safety Analysis Set|Overall Study||69||
59697791|NCT01008475|75816983|FG000|COMPLETED|Overall Study||3||
59697792|NCT01008475|75816984|FG001|COMPLETED|Overall Study||3||
59697793|NCT01008475|75816985|FG002|COMPLETED|Overall Study||7||
59697794|NCT01008475|75816986|FG003|COMPLETED|Overall Study||3||
59697795|NCT01008475|75816987|FG004|COMPLETED|Overall Study||67||
59697796|NCT01008475|75816988|FG005|COMPLETED|Overall Study||67||
59697797|NCT01008475|75816989|FG006|COMPLETED|Overall Study||67||
59697798|NCT01008475|75816983|FG000|NOT COMPLETED|Overall Study||0||
59697799|NCT01008475|75816984|FG001|NOT COMPLETED|Overall Study||0||
59697800|NCT01008475|75816985|FG002|NOT COMPLETED|Overall Study||0||
59697801|NCT01008475|75816986|FG003|NOT COMPLETED|Overall Study||0||
59697802|NCT01008475|75816987|FG004|NOT COMPLETED|Overall Study||5||
59697803|NCT01008475|75816988|FG005|NOT COMPLETED|Overall Study||6||
59697804|NCT01008475|75816989|FG006|NOT COMPLETED|Overall Study||4||
59697805|NCT01226745|75817011|FG000|STARTED|Overall Study||80||
59697806|NCT01226745|75817012|FG001|STARTED|Overall Study||87||
59697807|NCT01226745|75817013|FG002|STARTED|Overall Study||89||
59697808|NCT01226745|75817014|FG003|STARTED|Overall Study||29||
59697809|NCT01226745|75817015|FG004|STARTED|Overall Study||26||
59697810|NCT01226745|75817016|FG005|STARTED|Overall Study||29||
59697811|NCT01226745|75817011|FG000|COMPLETED|Overall Study||63||
59697812|NCT01226745|75817012|FG001|COMPLETED|Overall Study||71||
59697813|NCT01226745|75817013|FG002|COMPLETED|Overall Study||69||
59697814|NCT01226745|75817014|FG003|COMPLETED|Overall Study||24||
59697815|NCT01226745|75817015|FG004|COMPLETED|Overall Study||22||
59697816|NCT01226745|75817016|FG005|COMPLETED|Overall Study||24||
59697817|NCT01226745|75817011|FG000|NOT COMPLETED|Overall Study||17||
59697818|NCT01226745|75817012|FG001|NOT COMPLETED|Overall Study||16||
59697819|NCT01226745|75817013|FG002|NOT COMPLETED|Overall Study||20||
59697820|NCT01226745|75817014|FG003|NOT COMPLETED|Overall Study||5||
59697821|NCT01226745|75817015|FG004|NOT COMPLETED|Overall Study||4||
59697822|NCT01226745|75817016|FG005|NOT COMPLETED|Overall Study||5||
59697823|NCT01226511|75817033|FG000|STARTED|Acute Treatment Period|Thirty-one (31) participants who discontinued acute treatment did not enter the taper period.|140||
59697824|NCT01226511|75817034|FG001|STARTED|Acute Treatment Period|Twenty-six (26) participants who discontinued acute treatment did not enter the taper period.|141||
60079540|NCT04206332|76194706|FG006|Received Product Administration|Part C||0||
60079541|NCT04206332|76194707|FG007|Received Product Administration|Part C||0||
60079542|NCT04206332|76194708|FG008|Received Product Administration|Part C||0||
59697825|NCT01226511|75817033|FG000|COMPLETED|Acute Treatment Period||108||
59697826|NCT01226511|75817034|FG001|COMPLETED|Acute Treatment Period||110||
59697827|NCT01226511|75817033|FG000|NOT COMPLETED|Acute Treatment Period||32||
59697828|NCT01226511|75817034|FG001|NOT COMPLETED|Acute Treatment Period||31||
59697829|NCT01226511|75817033|FG000|STARTED|Extension Treatment Period|Nineteen (19) participants who discontinued extension treatment did not enter the taper period.|108||
59697830|NCT01226511|75817034|FG001|STARTED|Extension Treatment Period|Twenty-three (23) participants who discontinued extension treatment did not enter the taper period.|110||
59697831|NCT01226511|75817033|FG000|COMPLETED|Extension Treatment Period|Thirty-nine (39) participants who completed extension treatment did not enter the taper period.|81||
59697832|NCT01226511|75817034|FG001|COMPLETED|Extension Treatment Period|Thirty-five (35) participants who completed extension treatment did not enter the taper period.|83||
60079543|NCT04206332|76194709|FG009|Received Product Administration|Part C||0||
60079544|NCT04206332|76194710|FG010|Received Product Administration|Part C||0||
59697833|NCT01226511|75817033|FG000|NOT COMPLETED|Extension Treatment Period||27||
60079545|NCT04206332|76194711|FG011|Received Product Administration|Part C||7||
60079546|NCT04206332|76194712|FG012|Received Product Administration|Part C||4||
60079547|NCT04206332|76194713|FG013|Received Product Administration|Part C||4||
60079548|NCT04206332|76194714|FG014|Received Product Administration|Part C|One participant enrolled, but product not given: Withdrew consent on day of planned administration|3||
60079549|NCT04206332|76194715|FG015|Received Product Administration|Part C||4||
60079550|NCT04206332|76194716|FG016|Received Product Administration|Part C||0||
59697834|NCT01226511|75817034|FG001|NOT COMPLETED|Extension Treatment Period||27||
59697835|NCT01226511|75817033|FG000|STARTED|Taper Period||51||
59697836|NCT01226511|75817034|FG001|STARTED|Taper Period||57||
59697837|NCT01226511|75817033|FG000|COMPLETED|Taper Period||46||
59697838|NCT01226511|75817034|FG001|COMPLETED|Taper Period||54||
59697839|NCT01226511|75817033|FG000|NOT COMPLETED|Taper Period||5||
59697840|NCT01226511|75817034|FG001|NOT COMPLETED|Taper Period||3||
59697841|NCT01226121|75817049|FG000|STARTED|Overall Study||13||
59697842|NCT01226121|75817050|FG001|STARTED|Overall Study||11||
59697843|NCT01226121|75817051|FG002|STARTED|Overall Study||13||
59697844|NCT01226121|75817049|FG000|30 Day Evaluation|Overall Study||12||
59697845|NCT01226121|75817050|FG001|30 Day Evaluation|Overall Study||11||
59697846|NCT01226121|75817051|FG002|30 Day Evaluation|Overall Study||13||
59697847|NCT01226121|75817049|FG000|COMPLETED|Overall Study||11||
59697848|NCT01226121|75817050|FG001|COMPLETED|Overall Study||11||
59697849|NCT01226121|75817051|FG002|COMPLETED|Overall Study||12||
59697850|NCT01226121|75817049|FG000|NOT COMPLETED|Overall Study||2||
59697851|NCT01226121|75817050|FG001|NOT COMPLETED|Overall Study||0||
59697852|NCT01226121|75817051|FG002|NOT COMPLETED|Overall Study||1||
59697853|NCT01226043|75817061|FG000|STARTED|4-week Crossover Phase - Period 1||202||
59697854|NCT01226043|75817062|FG001|STARTED|4-week Crossover Phase - Period 1||203||
59697855|NCT01226043|75817063|FG002|STARTED|4-week Crossover Phase - Period 1||0||
59697856|NCT01226043|75817064|FG003|STARTED|4-week Crossover Phase - Period 1||0||
59697857|NCT01226043|75817061|FG000|TREATED|4-week Crossover Phase - Period 1||202||
59697858|NCT01226043|75817062|FG001|TREATED|4-week Crossover Phase - Period 1||200||
59697859|NCT01226043|75817063|FG002|TREATED|4-week Crossover Phase - Period 1||0||
59697860|NCT01226043|75817064|FG003|TREATED|4-week Crossover Phase - Period 1||0||
59697861|NCT01226043|75817061|FG000|COMPLETED|4-week Crossover Phase - Period 1||199||
59697862|NCT01226043|75817062|FG001|COMPLETED|4-week Crossover Phase - Period 1||194||
59697863|NCT01226043|75817063|FG002|COMPLETED|4-week Crossover Phase - Period 1||0||
59697864|NCT01226043|75817064|FG003|COMPLETED|4-week Crossover Phase - Period 1||0||
59697865|NCT01226043|75817061|FG000|NOT COMPLETED|4-week Crossover Phase - Period 1||3||
59697866|NCT01226043|75817062|FG001|NOT COMPLETED|4-week Crossover Phase - Period 1||9||
59697867|NCT01226043|75817063|FG002|NOT COMPLETED|4-week Crossover Phase - Period 1||0||
59697868|NCT01226043|75817064|FG003|NOT COMPLETED|4-week Crossover Phase - Period 1||0||
59697869|NCT01226043|75817061|FG000|STARTED|4-week Crossover Phase - Period 2||199||
59697870|NCT01226043|75817062|FG001|STARTED|4-week Crossover Phase - Period 2||194||
59697871|NCT01226043|75817063|FG002|STARTED|4-week Crossover Phase - Period 2||0||
59697872|NCT01226043|75817064|FG003|STARTED|4-week Crossover Phase - Period 2||0||
59697873|NCT01226043|75817061|FG000|TREATED|4-week Crossover Phase - Period 2||199||
59697874|NCT01226043|75817062|FG001|TREATED|4-week Crossover Phase - Period 2||194||
59697875|NCT01226043|75817063|FG002|TREATED|4-week Crossover Phase - Period 2||0||
59697876|NCT01226043|75817064|FG003|TREATED|4-week Crossover Phase - Period 2||0||
59697877|NCT01226043|75817061|FG000|COMPLETED|4-week Crossover Phase - Period 2|28 patients were not re-randomized to the second phase of the study|195||
59697878|NCT01226043|75817062|FG001|COMPLETED|4-week Crossover Phase - Period 2|22 patients were not re-randomized to the second phase of the study|188||
59697879|NCT01226043|75817063|FG002|COMPLETED|4-week Crossover Phase - Period 2||0||
59697880|NCT01226043|75817064|FG003|COMPLETED|4-week Crossover Phase - Period 2||0||
59697881|NCT01226043|75817061|FG000|NOT COMPLETED|4-week Crossover Phase - Period 2||4||
59697882|NCT01226043|75817062|FG001|NOT COMPLETED|4-week Crossover Phase - Period 2||6||
59697883|NCT01226043|75817063|FG002|NOT COMPLETED|4-week Crossover Phase - Period 2||0||
59697884|NCT01226043|75817064|FG003|NOT COMPLETED|4-week Crossover Phase - Period 2||0||
59697885|NCT01226043|75817061|FG000|STARTED|6-week Re-randomization Phase||0||
59697886|NCT01226043|75817062|FG001|STARTED|6-week Re-randomization Phase||0||
59697887|NCT01226043|75817063|FG002|STARTED|6-week Re-randomization Phase||166||
59697888|NCT01226043|75817064|FG003|STARTED|6-week Re-randomization Phase||167||
59697889|NCT01226043|75817061|FG000|TREATED|6-week Re-randomization Phase||0||
59697890|NCT01226043|75817062|FG001|TREATED|6-week Re-randomization Phase||0||
59697891|NCT01226043|75817063|FG002|TREATED|6-week Re-randomization Phase||165||
59697892|NCT01226043|75817064|FG003|TREATED|6-week Re-randomization Phase||165||
59697893|NCT01226043|75817061|FG000|COMPLETED|6-week Re-randomization Phase||0||
59697894|NCT01226043|75817062|FG001|COMPLETED|6-week Re-randomization Phase||0||
59697895|NCT01226043|75817063|FG002|COMPLETED|6-week Re-randomization Phase||159||
59697896|NCT01226043|75817064|FG003|COMPLETED|6-week Re-randomization Phase|3 patients did not enter the observational phase of the study|156||
59697897|NCT01226043|75817061|FG000|NOT COMPLETED|6-week Re-randomization Phase||0||
59697898|NCT01226043|75817062|FG001|NOT COMPLETED|6-week Re-randomization Phase||0||
59697899|NCT01226043|75817063|FG002|NOT COMPLETED|6-week Re-randomization Phase||7||
59697900|NCT01226043|75817064|FG003|NOT COMPLETED|6-week Re-randomization Phase||11||
59697901|NCT01226043|75817061|FG000|STARTED|30-week Observational Phase||0||
59697902|NCT01226043|75817062|FG001|STARTED|30-week Observational Phase||0||
59697903|NCT01226043|75817063|FG002|STARTED|30-week Observational Phase||159||
59697904|NCT01226043|75817064|FG003|STARTED|30-week Observational Phase||153||
59697905|NCT01226043|75817061|FG000|TREATED|30-week Observational Phase||0||
59697906|NCT01226043|75817062|FG001|TREATED|30-week Observational Phase||0||
59697907|NCT01226043|75817063|FG002|TREATED|30-week Observational Phase||159||
59697908|NCT01226043|75817064|FG003|TREATED|30-week Observational Phase||153||
59697909|NCT01226043|75817061|FG000|COMPLETED|30-week Observational Phase||0||
59697910|NCT01226043|75817062|FG001|COMPLETED|30-week Observational Phase||0||
59697911|NCT01226043|75817063|FG002|COMPLETED|30-week Observational Phase||153||
59697912|NCT01226043|75817064|FG003|COMPLETED|30-week Observational Phase||140||
59697913|NCT01226043|75817061|FG000|NOT COMPLETED|30-week Observational Phase||0||
59697914|NCT01226043|75817062|FG001|NOT COMPLETED|30-week Observational Phase||0||
59697915|NCT01226043|75817063|FG002|NOT COMPLETED|30-week Observational Phase||6||
59697916|NCT01226043|75817064|FG003|NOT COMPLETED|30-week Observational Phase||13||
59697917|NCT01001377|75817096|FG000|STARTED|Overall Study||504||
59697918|NCT01001377|75817097|FG001|STARTED|Overall Study||506||
59697919|NCT01001377|75817096|FG000|Received Treatment|Overall Study||500||
59697920|NCT01001377|75817097|FG001|Received Treatment|Overall Study||499||
59697921|NCT01001377|75817096|FG000|COMPLETED|Overall Study|Indicates participants continuing in study|78||
59697922|NCT01001377|75817097|FG001|COMPLETED|Overall Study|Indicates participants continuing in study|85||
59697923|NCT01001377|75817096|FG000|NOT COMPLETED|Overall Study||426||
59697924|NCT01001377|75817097|FG001|NOT COMPLETED|Overall Study||421||
59697925|NCT01225887|75817103|FG000|STARTED|Overall Study||37||
59697926|NCT01225887|75817103|FG000|COMPLETED|Overall Study||32||
59697927|NCT01225887|75817103|FG000|NOT COMPLETED|Overall Study||5||
59697928|NCT01001299|75817107|FG000|STARTED|Overall Study||25||
59697929|NCT01001299|75817107|FG000|COMPLETED|Overall Study||0||
59697930|NCT01001299|75817107|FG000|NOT COMPLETED|Overall Study||25||
59697931|NCT01296932|75817120|FG000|STARTED|Overall Study||3||
59697932|NCT01296932|75817121|FG001|STARTED|Overall Study||3||
59697933|NCT01296932|75817122|FG002|STARTED|Overall Study||6||
59697934|NCT01296932|75817123|FG003|STARTED|Overall Study||6||
59697935|NCT01296932|75817124|FG004|STARTED|Overall Study||3||
59697936|NCT01296932|75817125|FG005|STARTED|Overall Study||3||
59697937|NCT01296932|75817126|FG006|STARTED|Overall Study||6||
59697938|NCT01296932|75817127|FG007|STARTED|Overall Study||3||
59697939|NCT01296932|75817128|FG008|STARTED|Overall Study||4||
59697940|NCT01296932|75817120|FG000|COMPLETED|Overall Study||0||
59697941|NCT01296932|75817121|FG001|COMPLETED|Overall Study||0||
59697942|NCT01296932|75817122|FG002|COMPLETED|Overall Study||0||
59697943|NCT01296932|75817123|FG003|COMPLETED|Overall Study||0||
59697944|NCT01296932|75817124|FG004|COMPLETED|Overall Study||0||
59697945|NCT01296932|75817125|FG005|COMPLETED|Overall Study||0||
59697946|NCT01296932|75817126|FG006|COMPLETED|Overall Study||0||
59697947|NCT01296932|75817127|FG007|COMPLETED|Overall Study||1||
59697948|NCT01296932|75817128|FG008|COMPLETED|Overall Study||0||
59697949|NCT01296932|75817120|FG000|NOT COMPLETED|Overall Study||3||
59697950|NCT01296932|75817121|FG001|NOT COMPLETED|Overall Study||3||
59697951|NCT01296932|75817122|FG002|NOT COMPLETED|Overall Study||6||
59697952|NCT01296932|75817123|FG003|NOT COMPLETED|Overall Study||6||
59697953|NCT01296932|75817124|FG004|NOT COMPLETED|Overall Study||3||
59697954|NCT01296932|75817125|FG005|NOT COMPLETED|Overall Study||3||
59697955|NCT01296932|75817126|FG006|NOT COMPLETED|Overall Study||6||
59697956|NCT01296932|75817127|FG007|NOT COMPLETED|Overall Study||2||
59697957|NCT01296932|75817128|FG008|NOT COMPLETED|Overall Study||4||
59697958|NCT01296698|75817151|FG000|STARTED|Overall Study||244||
59697959|NCT01296698|75817152|FG001|STARTED|Overall Study||13||
59697960|NCT01296698|75817151|FG000|COMPLETED|Overall Study||0||
59697961|NCT01296698|75817152|FG001|COMPLETED|Overall Study||0||
59697962|NCT01296698|75817151|FG000|NOT COMPLETED|Overall Study||244||
59697963|NCT01296698|75817152|FG001|NOT COMPLETED|Overall Study||13||
59697964|NCT01001221|75817162|FG000|STARTED|Overall Study||5||
59697965|NCT01001221|75817163|FG001|STARTED|Overall Study||5||
59697966|NCT01001221|75817164|FG002|STARTED|Overall Study||3||
59697967|NCT01001221|75817165|FG003|STARTED|Overall Study||6||
59697968|NCT01001221|75817166|FG004|STARTED|Overall Study|Inability to determine the MTD during study part 1|0||
59697969|NCT01001221|75817162|FG000|Treated|Overall Study||5||
59697970|NCT01001221|75817163|FG001|Treated|Overall Study||5||
59697971|NCT01001221|75817164|FG002|Treated|Overall Study||2||
59697972|NCT01001221|75817165|FG003|Treated|Overall Study||6||
59697973|NCT01001221|75817166|FG004|Treated|Overall Study||0||
59697974|NCT01001221|75817162|FG000|Completed 1st Treatment Cycle|Overall Study||5||
59697975|NCT01001221|75817163|FG001|Completed 1st Treatment Cycle|Overall Study||5||
59697976|NCT01001221|75817164|FG002|Completed 1st Treatment Cycle|Overall Study||2||
59697977|NCT01001221|75817165|FG003|Completed 1st Treatment Cycle|Overall Study||6||
59697978|NCT01001221|75817166|FG004|Completed 1st Treatment Cycle|Overall Study||0||
59816185|NCT00529568|75938540|FG001|NOT COMPLETED|Double-bilnd Antiviral Treatment Phase||48||
59697979|NCT01001221|75817162|FG000|COMPLETED|Overall Study|Participants treated until disease progression or unacceptable toxicity.|0||
59697980|NCT01001221|75817163|FG001|COMPLETED|Overall Study|Participants treated until disease progression or unacceptable toxicity.|0||
59697981|NCT01001221|75817164|FG002|COMPLETED|Overall Study|Participants treated until disease progression or unacceptable toxicity.|0||
59697982|NCT01001221|75817165|FG003|COMPLETED|Overall Study|Participants treated until disease progression or unacceptable toxicity.|0||
59697983|NCT01001221|75817166|FG004|COMPLETED|Overall Study||0||
59697984|NCT01001221|75817162|FG000|NOT COMPLETED|Overall Study||5||
59697985|NCT01001221|75817163|FG001|NOT COMPLETED|Overall Study||5||
59697986|NCT01001221|75817164|FG002|NOT COMPLETED|Overall Study||3||
59697987|NCT01001221|75817165|FG003|NOT COMPLETED|Overall Study||6||
59697988|NCT01001221|75817166|FG004|NOT COMPLETED|Overall Study||0||
59697989|NCT01296152|75817177|FG000|STARTED|Overall Study||25||
59697990|NCT01296152|75817177|FG000|COMPLETED|Overall Study||24||
59697991|NCT01296152|75817177|FG000|NOT COMPLETED|Overall Study||1||
59697992|NCT01002547|75817184|FG000|STARTED|Overall Study||32||
59697993|NCT01002547|75817185|FG001|STARTED|Overall Study||36||
59697994|NCT01002547|75817186|FG002|STARTED|Overall Study||37||
59697995|NCT01002547|75817184|FG000|COMPLETED|Overall Study||24||
59697996|NCT01002547|75817185|FG001|COMPLETED|Overall Study||33||
59697997|NCT01002547|75817186|FG002|COMPLETED|Overall Study||29||
59697998|NCT01002547|75817184|FG000|NOT COMPLETED|Overall Study||8||
59697999|NCT01002547|75817185|FG001|NOT COMPLETED|Overall Study||3||
59698000|NCT01002547|75817186|FG002|NOT COMPLETED|Overall Study||8||
59698001|NCT01225731|75817199|FG000|STARTED|Part 1||42||
59698002|NCT01225731|75817200|FG001|STARTED|Part 1||92||
59698003|NCT01225731|75817201|FG002|STARTED|Part 1||89||
59698004|NCT01225731|75817202|FG003|STARTED|Part 1||86||
59698005|NCT01225731|75817203|FG004|STARTED|Part 1||46||
59698006|NCT01225731|75817204|FG005|STARTED|Part 1||0||
59698007|NCT01225731|75817205|FG006|STARTED|Part 1||0||
59698008|NCT01225731|75817206|FG007|STARTED|Part 1||0||
59698009|NCT01225731|75817207|FG008|STARTED|Part 1||0||
59698010|NCT01225731|75817208|FG009|STARTED|Part 1||0||
59698011|NCT01225731|75817209|FG010|STARTED|Part 1||0||
59698012|NCT01225731|75817210|FG011|STARTED|Part 1||0||
59698013|NCT01225731|75817211|FG012|STARTED|Part 1||0||
59698014|NCT01225731|75817199|FG000|COMPLETED|Part 1||40||
59698015|NCT01225731|75817200|FG001|COMPLETED|Part 1||87||
59698016|NCT01225731|75817201|FG002|COMPLETED|Part 1||88||
59698017|NCT01225731|75817202|FG003|COMPLETED|Part 1||84||
59698018|NCT01225731|75817203|FG004|COMPLETED|Part 1||40||
59698019|NCT01225731|75817204|FG005|COMPLETED|Part 1||0||
59698020|NCT01225731|75817205|FG006|COMPLETED|Part 1||0||
59698021|NCT01225731|75817206|FG007|COMPLETED|Part 1||0||
59698022|NCT01225731|75817207|FG008|COMPLETED|Part 1||0||
59698023|NCT01225731|75817208|FG009|COMPLETED|Part 1||0||
59698024|NCT01225731|75817209|FG010|COMPLETED|Part 1||0||
59698025|NCT01225731|75817210|FG011|COMPLETED|Part 1||0||
59698026|NCT01225731|75817211|FG012|COMPLETED|Part 1||0||
59698027|NCT01225731|75817199|FG000|NOT COMPLETED|Part 1||2||
59698028|NCT01225731|75817200|FG001|NOT COMPLETED|Part 1||5||
59698029|NCT01225731|75817201|FG002|NOT COMPLETED|Part 1||1||
59698030|NCT01225731|75817202|FG003|NOT COMPLETED|Part 1||2||
59698031|NCT01225731|75817203|FG004|NOT COMPLETED|Part 1||6||
59698032|NCT01225731|75817204|FG005|NOT COMPLETED|Part 1||0||
59698033|NCT01225731|75817205|FG006|NOT COMPLETED|Part 1||0||
59698034|NCT01225731|75817206|FG007|NOT COMPLETED|Part 1||0||
59698035|NCT01225731|75817207|FG008|NOT COMPLETED|Part 1||0||
59698036|NCT01225731|75817208|FG009|NOT COMPLETED|Part 1||0||
59698037|NCT01225731|75817209|FG010|NOT COMPLETED|Part 1||0||
59698038|NCT01225731|75817210|FG011|NOT COMPLETED|Part 1||0||
59698039|NCT01225731|75817211|FG012|NOT COMPLETED|Part 1||0||
59698040|NCT01225731|75817199|FG000|STARTED|Part 2|Participants could progress into Part 2|0||
59698041|NCT01225731|75817200|FG001|STARTED|Part 2|Participants could progress into Part 2|0||
59698042|NCT01225731|75817201|FG002|STARTED|Part 2|Participants could progress into Part 2|0||
59698043|NCT01225731|75817202|FG003|STARTED|Part 2|Participants could progress into Part 2|0||
59698044|NCT01225731|75817203|FG004|STARTED|Part 2|Participants could progress into Part 2; no placebo was given in Part 2|0||
59698045|NCT01225731|75817204|FG005|STARTED|Part 2|Participants were reassigned based on PASI score at Week 16|13||
59698046|NCT01225731|75817205|FG006|STARTED|Part 2|Participants were reassigned based on PASI score at Week 16|94||
59698047|NCT01225731|75817206|FG007|STARTED|Part 2|Participants were reassigned based on PASI score at Week 16|153||
59698048|NCT01225731|75817207|FG008|STARTED|Part 2|Participants were reassigned based on PASI score at Week 16|79||
59698049|NCT01225731|75817208|FG009|STARTED|Part 2||0||
59698050|NCT01225731|75817209|FG010|STARTED|Part 2||0||
59698051|NCT01225731|75817210|FG011|STARTED|Part 2||0||
59698052|NCT01225731|75817211|FG012|STARTED|Part 2||0||
59698053|NCT01225731|75817199|FG000|COMPLETED|Part 2||0||
59698054|NCT01225731|75817200|FG001|COMPLETED|Part 2||0||
59698055|NCT01225731|75817201|FG002|COMPLETED|Part 2||0||
59698056|NCT01225731|75817202|FG003|COMPLETED|Part 2||0||
59698057|NCT01225731|75817203|FG004|COMPLETED|Part 2||0||
59698058|NCT01225731|75817204|FG005|COMPLETED|Part 2||10||
59698059|NCT01225731|75817205|FG006|COMPLETED|Part 2||86||
59698060|NCT01225731|75817206|FG007|COMPLETED|Part 2||128||
59698061|NCT01225731|75817207|FG008|COMPLETED|Part 2||68||
59698062|NCT01225731|75817208|FG009|COMPLETED|Part 2||0||
59698063|NCT01225731|75817209|FG010|COMPLETED|Part 2||0||
59698064|NCT01225731|75817210|FG011|COMPLETED|Part 2||0||
59698065|NCT01225731|75817211|FG012|COMPLETED|Part 2||0||
59698066|NCT01225731|75817199|FG000|NOT COMPLETED|Part 2||0||
59698067|NCT01225731|75817200|FG001|NOT COMPLETED|Part 2||0||
59698068|NCT01225731|75817201|FG002|NOT COMPLETED|Part 2||0||
59698069|NCT01225731|75817202|FG003|NOT COMPLETED|Part 2||0||
59698070|NCT01225731|75817203|FG004|NOT COMPLETED|Part 2||0||
59698071|NCT01225731|75817204|FG005|NOT COMPLETED|Part 2||3||
59698072|NCT01225731|75817205|FG006|NOT COMPLETED|Part 2||8||
59698073|NCT01225731|75817206|FG007|NOT COMPLETED|Part 2||25||
59698074|NCT01225731|75817207|FG008|NOT COMPLETED|Part 2||11||
59698075|NCT01225731|75817208|FG009|NOT COMPLETED|Part 2||0||
59698076|NCT01225731|75817209|FG010|NOT COMPLETED|Part 2||0||
59698077|NCT01225731|75817210|FG011|NOT COMPLETED|Part 2||0||
59698078|NCT01225731|75817211|FG012|NOT COMPLETED|Part 2||0||
59698079|NCT01225731|75817199|FG000|STARTED|Part 3||0||
59698080|NCT01225731|75817200|FG001|STARTED|Part 3||0||
59698081|NCT01225731|75817201|FG002|STARTED|Part 3||0||
59698082|NCT01225731|75817202|FG003|STARTED|Part 3||0||
59698083|NCT01225731|75817203|FG004|STARTED|Part 3||0||
59698084|NCT01225731|75817204|FG005|STARTED|Part 3|Participants could enter the follow-up period|0||
59698085|NCT01225731|75817205|FG006|STARTED|Part 3|Participants could enter the follow-up period|0||
59698086|NCT01225731|75817206|FG007|STARTED|Part 3|Participants could enter the follow-up period|0||
59698087|NCT01225731|75817207|FG008|STARTED|Part 3|Participants could enter the follow-up period|0||
59698088|NCT01225731|75817208|FG009|STARTED|Part 3|Not all participants entered follow-up|10||
59698089|NCT01225731|75817209|FG010|STARTED|Part 3|Not all participants entered follow-up|86||
59698090|NCT01225731|75817210|FG011|STARTED|Part 3|Not all participants entered follow-up|126||
59698091|NCT01225731|75817211|FG012|STARTED|Part 3|Not all participants entered follow-up|67||
59698092|NCT01225731|75817199|FG000|COMPLETED|Part 3||0||
59698093|NCT01225731|75817200|FG001|COMPLETED|Part 3||0||
59698094|NCT01225731|75817201|FG002|COMPLETED|Part 3||0||
59698095|NCT01225731|75817202|FG003|COMPLETED|Part 3||0||
59698096|NCT01225731|75817203|FG004|COMPLETED|Part 3||0||
59698097|NCT01225731|75817204|FG005|COMPLETED|Part 3||0||
59698098|NCT01225731|75817205|FG006|COMPLETED|Part 3||0||
59698099|NCT01225731|75817206|FG007|COMPLETED|Part 3||0||
59698100|NCT01225731|75817207|FG008|COMPLETED|Part 3||0||
59698101|NCT01225731|75817208|FG009|COMPLETED|Part 3||10||
59698102|NCT01225731|75817209|FG010|COMPLETED|Part 3||80||
59698103|NCT01225731|75817210|FG011|COMPLETED|Part 3||116||
59698104|NCT01225731|75817211|FG012|COMPLETED|Part 3||60||
59698105|NCT01225731|75817199|FG000|NOT COMPLETED|Part 3||0||
59698106|NCT01225731|75817200|FG001|NOT COMPLETED|Part 3||0||
59698107|NCT01225731|75817201|FG002|NOT COMPLETED|Part 3||0||
59698108|NCT01225731|75817202|FG003|NOT COMPLETED|Part 3||0||
59698109|NCT01225731|75817203|FG004|NOT COMPLETED|Part 3||0||
59698110|NCT01225731|75817204|FG005|NOT COMPLETED|Part 3||0||
59698111|NCT01225731|75817205|FG006|NOT COMPLETED|Part 3||0||
59698112|NCT01225731|75817206|FG007|NOT COMPLETED|Part 3||0||
59698113|NCT01225731|75817207|FG008|NOT COMPLETED|Part 3||0||
59698114|NCT01225731|75817208|FG009|NOT COMPLETED|Part 3||0||
59698115|NCT01225731|75817209|FG010|NOT COMPLETED|Part 3||6||
59698116|NCT01225731|75817210|FG011|NOT COMPLETED|Part 3||10||
59698117|NCT01225731|75817211|FG012|NOT COMPLETED|Part 3||7||
59698118|NCT01007149|75817242|FG000|STARTED|Overall Study||20||
59698119|NCT01007149|75817243|FG001|STARTED|Overall Study||21||
59698120|NCT01007149|75817242|FG000|COMPLETED|Overall Study||20||
59698121|NCT01007149|75817243|FG001|COMPLETED|Overall Study||20||
59698122|NCT01007149|75817242|FG000|NOT COMPLETED|Overall Study||0||
59698123|NCT01007149|75817243|FG001|NOT COMPLETED|Overall Study||1||
59698124|NCT00998335|75817251|FG000|STARTED|Initial Treatment (Months 0 - 3)||30||
59698125|NCT00998335|75817252|FG001|STARTED|Initial Treatment (Months 0 - 3)||0||
59698126|NCT00998335|75817251|FG000|COMPLETED|Initial Treatment (Months 0 - 3)||30||
59698127|NCT00998335|75817252|FG001|COMPLETED|Initial Treatment (Months 0 - 3)||0||
59698128|NCT00998335|75817251|FG000|NOT COMPLETED|Initial Treatment (Months 0 - 3)||0||
59698129|NCT00998335|75817252|FG001|NOT COMPLETED|Initial Treatment (Months 0 - 3)||0||
59698130|NCT00998335|75817251|FG000|STARTED|Randomized Period (Months 3 to 6)|"All participants started in the Insulin detemir only arm. At month 3 subjects were randomized 2:1."|8||
59698131|NCT00998335|75817252|FG001|STARTED|Randomized Period (Months 3 to 6)|"All participants started in the Insulin detemir only arm. At month 3 subjects were randomized 2:1."|22||
59698132|NCT00998335|75817251|FG000|COMPLETED|Randomized Period (Months 3 to 6)||8||
59698133|NCT00998335|75817252|FG001|COMPLETED|Randomized Period (Months 3 to 6)||20||
59698134|NCT00998335|75817251|FG000|NOT COMPLETED|Randomized Period (Months 3 to 6)||0||
59698135|NCT00998335|75817252|FG001|NOT COMPLETED|Randomized Period (Months 3 to 6)||2||
59698136|NCT01294670|75817269|FG000|STARTED|Overall Study||7||
59698137|NCT01294670|75817270|FG001|STARTED|Overall Study||3||
59698138|NCT01294670|75817271|FG002|STARTED|Overall Study||3||
59698139|NCT01294670|75817272|FG003|STARTED|Overall Study||9||
59698140|NCT01294670|75817273|FG004|STARTED|Overall Study||5||
59698141|NCT01294670|75817269|FG000|COMPLETED|Overall Study||6||
59698142|NCT01294670|75817270|FG001|COMPLETED|Overall Study||3||
59698143|NCT01294670|75817271|FG002|COMPLETED|Overall Study||3||
59698144|NCT01294670|75817272|FG003|COMPLETED|Overall Study||9||
59698145|NCT01294670|75817273|FG004|COMPLETED|Overall Study||5||
59698146|NCT01294670|75817269|FG000|NOT COMPLETED|Overall Study||1||
59698147|NCT01294670|75817270|FG001|NOT COMPLETED|Overall Study||0||
59698148|NCT01294670|75817271|FG002|NOT COMPLETED|Overall Study||0||
59698149|NCT01294670|75817272|FG003|NOT COMPLETED|Overall Study||0||
59698150|NCT01294670|75817273|FG004|NOT COMPLETED|Overall Study||0||
59698151|NCT01006603|75817287|FG000|STARTED|Overall Study|Completed lead-in period and were randomised|360||
59698152|NCT01006603|75817288|FG001|STARTED|Overall Study|Completed lead-in period and were randomised|360||
59698153|NCT01006603|75817287|FG000|COMPLETED|Overall Study||289||
59698154|NCT01006603|75817288|FG001|COMPLETED|Overall Study||285||
59698155|NCT01006603|75817287|FG000|NOT COMPLETED|Overall Study||71||
59698156|NCT01006603|75817288|FG001|NOT COMPLETED|Overall Study||75||
59698157|NCT00997321|75817296|FG000|STARTED|Overall Study||50||
59698158|NCT00997321|75817297|FG001|STARTED|Overall Study||50||
59698159|NCT00997321|75817296|FG000|COMPLETED|Overall Study||50||
59698160|NCT00997321|75817297|FG001|COMPLETED|Overall Study||47||
59698161|NCT00997321|75817296|FG000|NOT COMPLETED|Overall Study||0||
59698162|NCT00997321|75817297|FG001|NOT COMPLETED|Overall Study||3||
59698163|NCT01294592|75817311|FG000|STARTED|Overall Study||369||
59698164|NCT01294592|75817312|FG001|STARTED|Overall Study||373||
59698165|NCT01294592|75817311|FG000|COMPLETED|Overall Study||292||
59698166|NCT01294592|75817312|FG001|COMPLETED|Overall Study||300||
59698167|NCT01294592|75817311|FG000|NOT COMPLETED|Overall Study||77||
59698168|NCT01294592|75817312|FG001|NOT COMPLETED|Overall Study||73||
59698169|NCT00997243|75817321|FG000|STARTED|Overall Study||7||
59698170|NCT00997243|75817321|FG000|COMPLETED|Overall Study||0||
59698171|NCT00997243|75817321|FG000|NOT COMPLETED|Overall Study||7||
59698172|NCT01294514|75817325|FG000|STARTED|Overall Study||27||
59698173|NCT01294514|75817325|FG000|COMPLETED|Overall Study||26||
59698174|NCT01294514|75817325|FG000|NOT COMPLETED|Overall Study||1||
59698175|NCT00999661|75817333|FG000|STARTED|Overall Study||231||
59698176|NCT00999661|75817333|FG000|COMPLETED|Overall Study||161||
59698177|NCT00999661|75817333|FG000|NOT COMPLETED|Overall Study||70||
59698178|NCT01294436|75817339|FG000|STARTED|Overall Study||249||
59698179|NCT01294436|75817340|FG001|STARTED|Overall Study||479||
59698180|NCT01294436|75817339|FG000|COMPLETED|Overall Study||221||
59698181|NCT01294436|75817340|FG001|COMPLETED|Overall Study||409||
59698182|NCT01294436|75817339|FG000|NOT COMPLETED|Overall Study||28||
59698183|NCT01294436|75817340|FG001|NOT COMPLETED|Overall Study||70||
59698184|NCT00995371|75817348|FG000|STARTED|Prior to ESI Cross-over, 6 Weeks||21||
59698185|NCT00995371|75817349|FG001|STARTED|Prior to ESI Cross-over, 6 Weeks||17||
59698186|NCT00995371|75817348|FG000|COMPLETED|Prior to ESI Cross-over, 6 Weeks||21||
59698187|NCT00995371|75817349|FG001|COMPLETED|Prior to ESI Cross-over, 6 Weeks||17||
59698188|NCT00995371|75817348|FG000|NOT COMPLETED|Prior to ESI Cross-over, 6 Weeks||0||
59698189|NCT00995371|75817349|FG001|NOT COMPLETED|Prior to ESI Cross-over, 6 Weeks||0||
59698190|NCT00995371|75817348|FG000|STARTED|After ESI Cross-over to Mild, 26 Weeks||21||
59698191|NCT00995371|75817349|FG001|STARTED|After ESI Cross-over to Mild, 26 Weeks||17||
59698192|NCT00995371|75817348|FG000|COMPLETED|After ESI Cross-over to Mild, 26 Weeks|All 21 completed Wk 6 Intent to Treat analysis. Sixteen reported Week 26 outcomes.|16||
59698193|NCT00995371|75817349|FG001|COMPLETED|After ESI Cross-over to Mild, 26 Weeks|All 17 completed Wk 6 Intent to Treat analysis prior to x-over. After x-over 12 reported Wk 26|12||
59698194|NCT00995371|75817348|FG000|NOT COMPLETED|After ESI Cross-over to Mild, 26 Weeks||5||
59698195|NCT00995371|75817349|FG001|NOT COMPLETED|After ESI Cross-over to Mild, 26 Weeks||5||
59698196|NCT01294358|75817357|FG000|STARTED|Cohort 1: 5/11/11-11/9/11||4||
59698197|NCT01294358|75817358|FG001|STARTED|Cohort 1: 5/11/11-11/9/11||0||
59698198|NCT01294358|75817359|FG002|STARTED|Cohort 1: 5/11/11-11/9/11||0||
59698199|NCT01294358|75817360|FG003|STARTED|Cohort 1: 5/11/11-11/9/11||0||
59698200|NCT01294358|75817361|FG004|STARTED|Cohort 1: 5/11/11-11/9/11||0||
59698201|NCT01294358|75817357|FG000|COMPLETED|Cohort 1: 5/11/11-11/9/11||4||
59698202|NCT01294358|75817358|FG001|COMPLETED|Cohort 1: 5/11/11-11/9/11||0||
59698203|NCT01294358|75817359|FG002|COMPLETED|Cohort 1: 5/11/11-11/9/11||0||
59698204|NCT01294358|75817360|FG003|COMPLETED|Cohort 1: 5/11/11-11/9/11||0||
59698205|NCT01294358|75817361|FG004|COMPLETED|Cohort 1: 5/11/11-11/9/11||0||
59698206|NCT01294358|75817357|FG000|NOT COMPLETED|Cohort 1: 5/11/11-11/9/11||0||
59698207|NCT01294358|75817358|FG001|NOT COMPLETED|Cohort 1: 5/11/11-11/9/11||0||
59698208|NCT01294358|75817359|FG002|NOT COMPLETED|Cohort 1: 5/11/11-11/9/11||0||
59698209|NCT01294358|75817360|FG003|NOT COMPLETED|Cohort 1: 5/11/11-11/9/11||0||
59698210|NCT01294358|75817361|FG004|NOT COMPLETED|Cohort 1: 5/11/11-11/9/11||0||
59698211|NCT01294358|75817357|FG000|STARTED|Cohort 2: 6/9/11-9/17/12||0||
59698212|NCT01294358|75817358|FG001|STARTED|Cohort 2: 6/9/11-9/17/12|4 participants from 18mg move to 36mg and 2 additional participants were enrolled at this dose.|6||
59698213|NCT01294358|75817359|FG002|STARTED|Cohort 2: 6/9/11-9/17/12||0||
59698214|NCT01294358|75817360|FG003|STARTED|Cohort 2: 6/9/11-9/17/12||0||
59698215|NCT01294358|75817361|FG004|STARTED|Cohort 2: 6/9/11-9/17/12||0||
59698216|NCT01294358|75817357|FG000|COMPLETED|Cohort 2: 6/9/11-9/17/12||0||
59698217|NCT01294358|75817358|FG001|COMPLETED|Cohort 2: 6/9/11-9/17/12||4||
59698218|NCT01294358|75817359|FG002|COMPLETED|Cohort 2: 6/9/11-9/17/12||0||
59698219|NCT01294358|75817360|FG003|COMPLETED|Cohort 2: 6/9/11-9/17/12||0||
59698220|NCT01294358|75817361|FG004|COMPLETED|Cohort 2: 6/9/11-9/17/12||0||
59698221|NCT01294358|75817357|FG000|NOT COMPLETED|Cohort 2: 6/9/11-9/17/12||0||
59698222|NCT01294358|75817358|FG001|NOT COMPLETED|Cohort 2: 6/9/11-9/17/12||2||
59698223|NCT01294358|75817359|FG002|NOT COMPLETED|Cohort 2: 6/9/11-9/17/12||0||
59698224|NCT01294358|75817360|FG003|NOT COMPLETED|Cohort 2: 6/9/11-9/17/12||0||
59698225|NCT01294358|75817361|FG004|NOT COMPLETED|Cohort 2: 6/9/11-9/17/12||0||
59698226|NCT01294358|75817357|FG000|STARTED|Cohort 3: 12/1/11-10/6/12||0||
59698227|NCT01294358|75817358|FG001|STARTED|Cohort 3: 12/1/11-10/6/12||0||
59698228|NCT01294358|75817359|FG002|STARTED|Cohort 3: 12/1/11-10/6/12|4 participants from 36mg move to 72mg.|4||
59698229|NCT01294358|75817360|FG003|STARTED|Cohort 3: 12/1/11-10/6/12||0||
59698230|NCT01294358|75817361|FG004|STARTED|Cohort 3: 12/1/11-10/6/12||0||
59698231|NCT01294358|75817357|FG000|COMPLETED|Cohort 3: 12/1/11-10/6/12||0||
59698232|NCT01294358|75817358|FG001|COMPLETED|Cohort 3: 12/1/11-10/6/12||0||
59698233|NCT01294358|75817359|FG002|COMPLETED|Cohort 3: 12/1/11-10/6/12||2||
59698234|NCT01294358|75817360|FG003|COMPLETED|Cohort 3: 12/1/11-10/6/12||0||
59698235|NCT01294358|75817361|FG004|COMPLETED|Cohort 3: 12/1/11-10/6/12||0||
59698236|NCT01294358|75817357|FG000|NOT COMPLETED|Cohort 3: 12/1/11-10/6/12||0||
59698237|NCT01294358|75817358|FG001|NOT COMPLETED|Cohort 3: 12/1/11-10/6/12||0||
59698238|NCT01294358|75817359|FG002|NOT COMPLETED|Cohort 3: 12/1/11-10/6/12||2||
59698239|NCT01294358|75817360|FG003|NOT COMPLETED|Cohort 3: 12/1/11-10/6/12||0||
59698240|NCT01294358|75817361|FG004|NOT COMPLETED|Cohort 3: 12/1/11-10/6/12||0||
59698241|NCT01294358|75817357|FG000|STARTED|Cohort 4: 12/30/11-2/17/17||0||
59698242|NCT01294358|75817358|FG001|STARTED|Cohort 4: 12/30/11-2/17/17||0||
59698243|NCT01294358|75817359|FG002|STARTED|Cohort 4: 12/30/11-2/17/17||0||
59698244|NCT01294358|75817360|FG003|STARTED|Cohort 4: 12/30/11-2/17/17|2 participants from 72mg move to 96mg.|2||
59698245|NCT01294358|75817361|FG004|STARTED|Cohort 4: 12/30/11-2/17/17||0||
59698246|NCT01294358|75817357|FG000|COMPLETED|Cohort 4: 12/30/11-2/17/17||0||
59698247|NCT01294358|75817358|FG001|COMPLETED|Cohort 4: 12/30/11-2/17/17||0||
59698248|NCT01294358|75817359|FG002|COMPLETED|Cohort 4: 12/30/11-2/17/17||0||
59698249|NCT01294358|75817360|FG003|COMPLETED|Cohort 4: 12/30/11-2/17/17||1||
59698250|NCT01294358|75817361|FG004|COMPLETED|Cohort 4: 12/30/11-2/17/17||0||
59698251|NCT01294358|75817357|FG000|NOT COMPLETED|Cohort 4: 12/30/11-2/17/17||0||
59698252|NCT01294358|75817358|FG001|NOT COMPLETED|Cohort 4: 12/30/11-2/17/17||0||
59698253|NCT01294358|75817359|FG002|NOT COMPLETED|Cohort 4: 12/30/11-2/17/17||0||
59698254|NCT01294358|75817360|FG003|NOT COMPLETED|Cohort 4: 12/30/11-2/17/17||1||
59698255|NCT01294358|75817361|FG004|NOT COMPLETED|Cohort 4: 12/30/11-2/17/17||0||
59698256|NCT01294358|75817357|FG000|STARTED|Cohort 5: 3/8/12-3/9/12||0||
59698257|NCT01294358|75817358|FG001|STARTED|Cohort 5: 3/8/12-3/9/12||0||
59698258|NCT01294358|75817359|FG002|STARTED|Cohort 5: 3/8/12-3/9/12||0||
59698259|NCT01294358|75817360|FG003|STARTED|Cohort 5: 3/8/12-3/9/12||0||
59698260|NCT01294358|75817361|FG004|STARTED|Cohort 5: 3/8/12-3/9/12|1 participant from 96mg move to 115mg.|1||
59698261|NCT01294358|75817357|FG000|COMPLETED|Cohort 5: 3/8/12-3/9/12||0||
59698262|NCT01294358|75817358|FG001|COMPLETED|Cohort 5: 3/8/12-3/9/12||0||
59698263|NCT01294358|75817359|FG002|COMPLETED|Cohort 5: 3/8/12-3/9/12||0||
59698264|NCT01294358|75817360|FG003|COMPLETED|Cohort 5: 3/8/12-3/9/12||0||
59698265|NCT01294358|75817361|FG004|COMPLETED|Cohort 5: 3/8/12-3/9/12||0||
59698266|NCT01294358|75817357|FG000|NOT COMPLETED|Cohort 5: 3/8/12-3/9/12||0||
59698267|NCT01294358|75817358|FG001|NOT COMPLETED|Cohort 5: 3/8/12-3/9/12||0||
59698268|NCT01294358|75817359|FG002|NOT COMPLETED|Cohort 5: 3/8/12-3/9/12||0||
59698269|NCT01294358|75817360|FG003|NOT COMPLETED|Cohort 5: 3/8/12-3/9/12||0||
59698270|NCT01294358|75817361|FG004|NOT COMPLETED|Cohort 5: 3/8/12-3/9/12||1||
59698271|NCT00994279|75817380|FG000|STARTED|Overall Study||22||
59698272|NCT00994279|75817381|FG001|STARTED|Overall Study||18||
59698273|NCT00994279|75817380|FG000|COMPLETED|Overall Study||18||
59698274|NCT00994279|75817381|FG001|COMPLETED|Overall Study||13||
59698275|NCT00994279|75817380|FG000|NOT COMPLETED|Overall Study||4||
59698276|NCT00994279|75817381|FG001|NOT COMPLETED|Overall Study||5||
59698277|NCT01294046|75817387|FG000|STARTED|Overall Study||3||
59698278|NCT01294046|75817387|FG000|COMPLETED|Overall Study||0||
59698279|NCT01294046|75817387|FG000|NOT COMPLETED|Overall Study||3||
59698280|NCT01224639|75817402|FG000|STARTED|Overall Study||19||
59698281|NCT01224639|75817403|FG001|STARTED|Overall Study||5||
59698282|NCT01224639|75817404|FG002|STARTED|Overall Study||21||
59698283|NCT01224639|75817405|FG003|STARTED|Overall Study||3||
59698284|NCT01224639|75817406|FG004|STARTED|Overall Study||21||
59698285|NCT01224639|75817407|FG005|STARTED|Overall Study||4||
59698286|NCT01224639|75817408|FG006|STARTED|Overall Study||18||
59698287|NCT01224639|75817409|FG007|STARTED|Overall Study||5||
59698288|NCT01224639|75817402|FG000|COMPLETED|Overall Study||19||
59698289|NCT01224639|75817403|FG001|COMPLETED|Overall Study||5||
59698290|NCT01224639|75817404|FG002|COMPLETED|Overall Study||21||
59698291|NCT01224639|75817405|FG003|COMPLETED|Overall Study||3||
59698292|NCT01224639|75817406|FG004|COMPLETED|Overall Study||19||
59698293|NCT01224639|75817407|FG005|COMPLETED|Overall Study||4||
59990736|NCT02495948|76106239|FG000|STARTED|Period 2, Second 30 Days of Wear||83||
59698294|NCT01224639|75817408|FG006|COMPLETED|Overall Study||17||
59698295|NCT01224639|75817409|FG007|COMPLETED|Overall Study||3||
59698296|NCT01224639|75817402|FG000|NOT COMPLETED|Overall Study||0||
59698297|NCT01224639|75817403|FG001|NOT COMPLETED|Overall Study||0||
59698298|NCT01224639|75817404|FG002|NOT COMPLETED|Overall Study||0||
59698299|NCT01224639|75817405|FG003|NOT COMPLETED|Overall Study||0||
59698300|NCT01224639|75817406|FG004|NOT COMPLETED|Overall Study||2||
59698301|NCT01224639|75817407|FG005|NOT COMPLETED|Overall Study||0||
59698302|NCT01224639|75817408|FG006|NOT COMPLETED|Overall Study||1||
59698303|NCT01224639|75817409|FG007|NOT COMPLETED|Overall Study||2||
59698304|NCT01293968|75817429|FG000|STARTED|Overall Study||20||
59698305|NCT01293968|75817430|FG001|STARTED|Overall Study||17||
59698306|NCT01293968|75817429|FG000|COMPLETED|Overall Study||17||
59990737|NCT02495948|76106240|FG001|STARTED|Period 2, Second 30 Days of Wear||83||
59698307|NCT01293968|75817430|FG001|COMPLETED|Overall Study||14||
59698308|NCT01293968|75817429|FG000|NOT COMPLETED|Overall Study||3||
59698309|NCT01293968|75817430|FG001|NOT COMPLETED|Overall Study||3||
59698310|NCT01293032|75817440|FG000|STARTED|Recurrence Score(RS)Assigned/Randomized||12||
59698311|NCT01293032|75817441|FG001|STARTED|Recurrence Score(RS)Assigned/Randomized||17||
59698312|NCT01293032|75817442|FG002|STARTED|Recurrence Score(RS)Assigned/Randomized||16||
59698313|NCT01293032|75817443|FG003|STARTED|Recurrence Score(RS)Assigned/Randomized||14||
59698314|NCT01293032|75817440|FG000|Assigned/Randomized to Arm|Recurrence Score(RS)Assigned/Randomized||12||
59698315|NCT01293032|75817441|FG001|Assigned/Randomized to Arm|Recurrence Score(RS)Assigned/Randomized||17||
59698316|NCT01293032|75817442|FG002|Assigned/Randomized to Arm|Recurrence Score(RS)Assigned/Randomized||16||
59698317|NCT01293032|75817443|FG003|Assigned/Randomized to Arm|Recurrence Score(RS)Assigned/Randomized||14||
59698318|NCT01293032|75817440|FG000|COMPLETED|Recurrence Score(RS)Assigned/Randomized||12||
59698319|NCT01293032|75817441|FG001|COMPLETED|Recurrence Score(RS)Assigned/Randomized||17||
59698320|NCT01293032|75817442|FG002|COMPLETED|Recurrence Score(RS)Assigned/Randomized|2/5 subjects who refused Arm 2(chemo) were treated with Arm 1(hormonal) and evaluable for response.|11||
59698321|NCT01293032|75817443|FG003|COMPLETED|Recurrence Score(RS)Assigned/Randomized||14||
59698322|NCT01293032|75817440|FG000|NOT COMPLETED|Recurrence Score(RS)Assigned/Randomized||0||
59698323|NCT01293032|75817441|FG001|NOT COMPLETED|Recurrence Score(RS)Assigned/Randomized||0||
59698324|NCT01293032|75817442|FG002|NOT COMPLETED|Recurrence Score(RS)Assigned/Randomized||5||
59698325|NCT01293032|75817443|FG003|NOT COMPLETED|Recurrence Score(RS)Assigned/Randomized||0||
59698326|NCT01293032|75817440|FG000|STARTED|Treatment||12||
59698327|NCT01293032|75817441|FG001|STARTED|Treatment|2/5 subjects who refused Arm 2(chemo) were treated with Arm 1(hormonal) and evaluable for response.|19||
59698328|NCT01293032|75817442|FG002|STARTED|Treatment||11||
59698329|NCT01293032|75817443|FG003|STARTED|Treatment||14||
59698330|NCT01293032|75817440|FG000|COMPLETED|Treatment||10||
59698331|NCT01293032|75817441|FG001|COMPLETED|Treatment||14||
59698332|NCT01293032|75817442|FG002|COMPLETED|Treatment||10||
59698333|NCT01293032|75817443|FG003|COMPLETED|Treatment||13||
59698334|NCT01293032|75817440|FG000|NOT COMPLETED|Treatment||2||
59698335|NCT01293032|75817441|FG001|NOT COMPLETED|Treatment||5||
59698336|NCT01293032|75817442|FG002|NOT COMPLETED|Treatment||1||
59698337|NCT01293032|75817443|FG003|NOT COMPLETED|Treatment||1||
59698338|NCT01292876|75817450|FG000|STARTED|Overall Study||17||
59698339|NCT01292876|75817450|FG000|COMPLETED|Overall Study||13||
59698340|NCT01292876|75817450|FG000|NOT COMPLETED|Overall Study||4||
59698341|NCT01224171|75817458|FG000|STARTED|Overall Study||207||
59698342|NCT01224171|75817459|FG001|STARTED|Overall Study||209||
59698343|NCT01224171|75817458|FG000|TNFα Antagonist Failure Population|Overall Study|Previously failed (inadequate response, loss of response, or intolerance) TNFα antagonist therapy|157||
59698344|NCT01224171|75817459|FG001|TNFα Antagonist Failure Population|Overall Study|Previously failed (inadequate response, loss of response, or intolerance) TNFα antagonist therapy|158||
59698345|NCT01224171|75817458|FG000|COMPLETED|Overall Study|Completed study is defined as patients who completed the Week 10 assessments.|192||
59698346|NCT01224171|75817459|FG001|COMPLETED|Overall Study|Completed study is defined as patients who completed the Week 10 assessments.|196||
59698347|NCT01224171|75817458|FG000|NOT COMPLETED|Overall Study||15||
59698348|NCT01224171|75817459|FG001|NOT COMPLETED|Overall Study||13||
59698349|NCT01292486|75817465|FG000|STARTED|Overall Study||32||
59698350|NCT01292486|75817465|FG000|COMPLETED|Overall Study||26||
59698351|NCT01292486|75817465|FG000|NOT COMPLETED|Overall Study||6||
59698352|NCT01223937|75817472|FG000|STARTED|Overall Study|Intent to treat population: randomized participants regardless if they were exposed to treatment.|131||
59698353|NCT01223937|75817473|FG001|STARTED|Overall Study|Intent to treat population: randomized participants regardless if they were exposed to treatment.|137||
59698354|NCT01223937|75817472|FG000|Full Analysis Set (FAS)|Overall Study|FAS: participants with at least one post-treatment efficacy assessment|128||
59698355|NCT01223937|75817473|FG001|Full Analysis Set (FAS)|Overall Study|FAS: participants with at least one post-treatment efficacy assessment|133||
59698356|NCT01223937|75817472|FG000|Safety Analysis Set (SAS)|Overall Study|SAS: participants with at least one post-treatment safety assessment|126||
59698357|NCT01223937|75817473|FG001|Safety Analysis Set (SAS)|Overall Study|SAS: participants with at least one post-treatment safety assessment|135||
59698358|NCT01223937|75817472|FG000|COMPLETED|Overall Study||114||
59698359|NCT01223937|75817473|FG001|COMPLETED|Overall Study||119||
59698360|NCT01223937|75817472|FG000|NOT COMPLETED|Overall Study||17||
59698361|NCT01223937|75817473|FG001|NOT COMPLETED|Overall Study||18||
59698362|NCT01290224|75817479|FG000|STARTED|Overall Study||10||
59698363|NCT01290224|75817479|FG000|COMPLETED|Overall Study||5||
59698364|NCT01290224|75817479|FG000|NOT COMPLETED|Overall Study||5||
59698365|NCT01223235|75817485|FG000|STARTED|Overall Study||22||
59698366|NCT01223235|75817485|FG000|COMPLETED|Overall Study||21||
59698367|NCT01223235|75817485|FG000|NOT COMPLETED|Overall Study||1||
59698368|NCT01290068|75817491|FG000|STARTED|Overall Study||108||
59698369|NCT01290068|75817492|FG001|STARTED|Overall Study||100||
59698370|NCT01290068|75817491|FG000|Implanted|Overall Study||108||
59698371|NCT01290068|75817492|FG001|Implanted|Overall Study||98||
59698372|NCT01290068|75817491|FG000|COMPLETED|Overall Study||101||
59698373|NCT01290068|75817492|FG001|COMPLETED|Overall Study||94||
59698374|NCT01290068|75817491|FG000|NOT COMPLETED|Overall Study||7||
59816186|NCT00529568|75938541|FG002|NOT COMPLETED|Double-bilnd Antiviral Treatment Phase||102||
59698375|NCT01290068|75817492|FG001|NOT COMPLETED|Overall Study||6||
59698376|NCT00998881|75817500|FG000|STARTED|Overall Study||104||
59698377|NCT00998881|75817501|FG001|STARTED|Overall Study||99||
59698378|NCT00998881|75817500|FG000|COMPLETED|Overall Study||96||
59698379|NCT00998881|75817501|FG001|COMPLETED|Overall Study||97||
59698380|NCT00998881|75817500|FG000|NOT COMPLETED|Overall Study||8||
59698381|NCT00998881|75817501|FG001|NOT COMPLETED|Overall Study||2||
59698382|NCT01222767|75817507|FG000|STARTED|Overall Study||17||
59698383|NCT01222767|75817507|FG000|Received Treatment|Overall Study||16||
59698384|NCT01222767|75817507|FG000|COMPLETED|Overall Study||0||
59698385|NCT01222767|75817507|FG000|NOT COMPLETED|Overall Study||17||
59698386|NCT00993967|75817511|FG000|STARTED|Overall Study||200||
59698387|NCT00993967|75817511|FG000|COMPLETED|Overall Study||139||
59698388|NCT00993967|75817511|FG000|NOT COMPLETED|Overall Study||61||
59698389|NCT01222533|75817515|FG000|STARTED|Overall Study|Entered and treated.|154||
59698390|NCT01222533|75817515|FG000|Received Placebo|Overall Study||147||
59698391|NCT01222533|75817515|FG000|Received Tio R1.25|Overall Study||147||
59698392|NCT01222533|75817515|FG000|Received Tio R2.5|Overall Study||145||
59698393|NCT01222533|75817515|FG000|Received Tio R5|Overall Study||150||
59698394|NCT01222533|75817515|FG000|Received Tio HH18|Overall Study||146||
59698395|NCT01222533|75817515|FG000|COMPLETED|Overall Study|Completed planned observation time (week 21)|140||
59698396|NCT01222533|75817515|FG000|NOT COMPLETED|Overall Study||14||
59698397|NCT01221753|75817527|FG000|STARTED|Overall Study||7||
59698398|NCT01221753|75817527|FG000|COMPLETED|Overall Study||6||
59698399|NCT01221753|75817527|FG000|NOT COMPLETED|Overall Study||1||
59698400|NCT01221597|75817533|FG000|STARTED|Overall Study||277||
59698401|NCT01221597|75817534|FG001|STARTED|Overall Study||140||
59698402|NCT01221597|75817533|FG000|COMPLETED|Overall Study||241||
59698403|NCT01221597|75817534|FG001|COMPLETED|Overall Study||124||
59698404|NCT01221597|75817533|FG000|NOT COMPLETED|Overall Study||36||
59698405|NCT01221597|75817534|FG001|NOT COMPLETED|Overall Study||16||
59698406|NCT01221363|75817543|FG000|STARTED|Overall Study||93||
59698407|NCT01221363|75817544|FG001|STARTED|Overall Study||73||
59698408|NCT01221363|75817543|FG000|COMPLETED|Overall Study||81||
59698409|NCT01221363|75817544|FG001|COMPLETED|Overall Study||68||
59698410|NCT01221363|75817543|FG000|NOT COMPLETED|Overall Study||12||
59698411|NCT01221363|75817544|FG001|NOT COMPLETED|Overall Study||5||
59698412|NCT01221285|75817550|FG000|STARTED|Overall Study||11||
59698413|NCT01221285|75817550|FG000|COMPLETED|Overall Study||10||
59698414|NCT01221285|75817550|FG000|NOT COMPLETED|Overall Study||1||
59698415|NCT01014988|75817560|FG000|STARTED|Overall Study||130||
59698416|NCT01014988|75817561|FG001|STARTED|Overall Study||7||
59698417|NCT01014988|75817562|FG002|STARTED|Overall Study||11||
59698418|NCT01014988|75817563|FG003|STARTED|Overall Study||12||
59698419|NCT01014988|75817564|FG004|STARTED|Overall Study||27||
59698420|NCT01014988|75817565|FG005|STARTED|Overall Study||14||
59698421|NCT01014988|75817560|FG000|COMPLETED|Overall Study||107||
59698422|NCT01014988|75817561|FG001|COMPLETED|Overall Study||7||
59698423|NCT01014988|75817562|FG002|COMPLETED|Overall Study||9||
59698424|NCT01014988|75817563|FG003|COMPLETED|Overall Study||12||
59698425|NCT01014988|75817564|FG004|COMPLETED|Overall Study||26||
59698426|NCT01014988|75817565|FG005|COMPLETED|Overall Study||11||
59698427|NCT01014988|75817560|FG000|NOT COMPLETED|Overall Study||23||
59698428|NCT01014988|75817561|FG001|NOT COMPLETED|Overall Study||0||
59698429|NCT01014988|75817562|FG002|NOT COMPLETED|Overall Study||2||
59698430|NCT01014988|75817563|FG003|NOT COMPLETED|Overall Study||0||
59698431|NCT01014988|75817564|FG004|NOT COMPLETED|Overall Study||1||
59698432|NCT01014988|75817565|FG005|NOT COMPLETED|Overall Study||3||
59698433|NCT01014910|75817589|FG000|STARTED|Overall Study||80||
59698434|NCT01014910|75817590|FG001|STARTED|Overall Study||81||
59698435|NCT01014910|75817589|FG000|COMPLETED|Overall Study||80||
59698436|NCT01014910|75817590|FG001|COMPLETED|Overall Study||79||
59698437|NCT01014910|75817589|FG000|NOT COMPLETED|Overall Study||0||
59698438|NCT01014910|75817590|FG001|NOT COMPLETED|Overall Study||2||
59698439|NCT01019980|75817598|FG000|STARTED|Overall Study|2 patients entered study but did not receive any drug since it was not available in the region.|2||
59698440|NCT01019980|75817599|FG001|STARTED|Overall Study||0||
59816187|NCT00611975|75938552|FG000|STARTED|Overall Study||45||
59816188|NCT00611975|75938553|FG001|STARTED|Overall Study||38||
59816189|NCT00611975|75938552|FG000|COMPLETED|Overall Study||40||
59816190|NCT00611975|75938553|FG001|COMPLETED|Overall Study||30||
59698441|NCT01019980|75817598|FG000|Discontinued|Overall Study||2||
59698442|NCT01019980|75817599|FG001|Discontinued|Overall Study||0||
59698443|NCT01019980|75817598|FG000|COMPLETED|Overall Study||0||
59698444|NCT01019980|75817599|FG001|COMPLETED|Overall Study||0||
59698445|NCT01019980|75817598|FG000|NOT COMPLETED|Overall Study||2||
59698446|NCT01019980|75817599|FG001|NOT COMPLETED|Overall Study||0||
59698447|NCT00993499|75817611|FG000|STARTED|Run-in Period (8 Days)||13||
59698448|NCT00993499|75817612|FG001|STARTED|Run-in Period (8 Days)||12||
59698449|NCT00993499|75817613|FG002|STARTED|Run-in Period (8 Days)||10||
59698450|NCT00993499|75817614|FG003|STARTED|Run-in Period (8 Days)||3||
59816191|NCT00611975|75938552|FG000|NOT COMPLETED|Overall Study||5||
59816192|NCT00611975|75938553|FG001|NOT COMPLETED|Overall Study||8||
59816193|NCT00573131|75938561|FG000|STARTED|Overall Study||72||
59698451|NCT00993499|75817615|FG004|STARTED|Run-in Period (8 Days)||3||
59698452|NCT00993499|75817616|FG005|STARTED|Run-in Period (8 Days)||3||
59698453|NCT00993499|75817611|FG000|COMPLETED|Run-in Period (8 Days)||12||
59698454|NCT00993499|75817612|FG001|COMPLETED|Run-in Period (8 Days)||9||
59698455|NCT00993499|75817613|FG002|COMPLETED|Run-in Period (8 Days)||9||
59698456|NCT00993499|75817614|FG003|COMPLETED|Run-in Period (8 Days)||3||
59698457|NCT00993499|75817615|FG004|COMPLETED|Run-in Period (8 Days)||3||
59698458|NCT00993499|75817616|FG005|COMPLETED|Run-in Period (8 Days)||3||
59698459|NCT00993499|75817611|FG000|NOT COMPLETED|Run-in Period (8 Days)||1||
59698460|NCT00993499|75817612|FG001|NOT COMPLETED|Run-in Period (8 Days)||3||
59698461|NCT00993499|75817613|FG002|NOT COMPLETED|Run-in Period (8 Days)||1||
59698462|NCT00993499|75817614|FG003|NOT COMPLETED|Run-in Period (8 Days)||0||
59698463|NCT00993499|75817615|FG004|NOT COMPLETED|Run-in Period (8 Days)||0||
59698464|NCT00993499|75817616|FG005|NOT COMPLETED|Run-in Period (8 Days)||0||
59698465|NCT00993499|75817611|FG000|STARTED|Discontinued Before Starting Course 3||12||
59698466|NCT00993499|75817612|FG001|STARTED|Discontinued Before Starting Course 3||9||
59698467|NCT00993499|75817613|FG002|STARTED|Discontinued Before Starting Course 3||9||
59698468|NCT00993499|75817614|FG003|STARTED|Discontinued Before Starting Course 3||3||
59698469|NCT00993499|75817615|FG004|STARTED|Discontinued Before Starting Course 3||3||
59698470|NCT00993499|75817616|FG005|STARTED|Discontinued Before Starting Course 3||3||
59698471|NCT00993499|75817611|FG000|COMPLETED|Discontinued Before Starting Course 3||8||
59698472|NCT00993499|75817612|FG001|COMPLETED|Discontinued Before Starting Course 3||5||
59698473|NCT00993499|75817613|FG002|COMPLETED|Discontinued Before Starting Course 3||6||
59698474|NCT00993499|75817614|FG003|COMPLETED|Discontinued Before Starting Course 3||2||
59698475|NCT00993499|75817615|FG004|COMPLETED|Discontinued Before Starting Course 3||3||
59698476|NCT00993499|75817616|FG005|COMPLETED|Discontinued Before Starting Course 3||3||
59698477|NCT00993499|75817611|FG000|NOT COMPLETED|Discontinued Before Starting Course 3||4||
59698478|NCT00993499|75817612|FG001|NOT COMPLETED|Discontinued Before Starting Course 3||4||
59698479|NCT00993499|75817613|FG002|NOT COMPLETED|Discontinued Before Starting Course 3||3||
59698480|NCT00993499|75817614|FG003|NOT COMPLETED|Discontinued Before Starting Course 3||1||
59698481|NCT00993499|75817615|FG004|NOT COMPLETED|Discontinued Before Starting Course 3||0||
59698482|NCT00993499|75817616|FG005|NOT COMPLETED|Discontinued Before Starting Course 3||0||
59698483|NCT00993499|75817611|FG000|STARTED|Discontinued After Starting Course 3||12||
59698484|NCT00993499|75817612|FG001|STARTED|Discontinued After Starting Course 3||9||
59698485|NCT00993499|75817613|FG002|STARTED|Discontinued After Starting Course 3||9||
59698486|NCT00993499|75817614|FG003|STARTED|Discontinued After Starting Course 3||3||
59698487|NCT00993499|75817615|FG004|STARTED|Discontinued After Starting Course 3||3||
59698488|NCT00993499|75817616|FG005|STARTED|Discontinued After Starting Course 3||3||
59698489|NCT00993499|75817611|FG000|COMPLETED|Discontinued After Starting Course 3||4||
59698490|NCT00993499|75817612|FG001|COMPLETED|Discontinued After Starting Course 3||4||
59698491|NCT00993499|75817613|FG002|COMPLETED|Discontinued After Starting Course 3||3||
59698492|NCT00993499|75817614|FG003|COMPLETED|Discontinued After Starting Course 3||1||
59698493|NCT00993499|75817615|FG004|COMPLETED|Discontinued After Starting Course 3||0||
59698494|NCT00993499|75817616|FG005|COMPLETED|Discontinued After Starting Course 3||0||
59698495|NCT00993499|75817611|FG000|NOT COMPLETED|Discontinued After Starting Course 3||8||
59698496|NCT00993499|75817612|FG001|NOT COMPLETED|Discontinued After Starting Course 3||5||
59698497|NCT00993499|75817613|FG002|NOT COMPLETED|Discontinued After Starting Course 3||6||
59698498|NCT00993499|75817614|FG003|NOT COMPLETED|Discontinued After Starting Course 3||2||
59698499|NCT00993499|75817615|FG004|NOT COMPLETED|Discontinued After Starting Course 3||3||
60079551|NCT04206332|76194700|FG000|Completed Controlled Human Malaria Infection (CHMI)|Part C||0||
60079552|NCT04206332|76194701|FG001|Completed Controlled Human Malaria Infection (CHMI)|Part C||0||
60079553|NCT04206332|76194702|FG002|Completed Controlled Human Malaria Infection (CHMI)|Part C||0||
59698500|NCT00993499|75817616|FG005|NOT COMPLETED|Discontinued After Starting Course 3||3||
59698501|NCT01014442|75817632|FG000|STARTED|Overall Study||33||
59698502|NCT01014442|75817633|FG001|STARTED|Overall Study||35||
59698503|NCT01014442|75817632|FG000|COMPLETED|Overall Study||26||
59698504|NCT01014442|75817633|FG001|COMPLETED|Overall Study||16||
59698505|NCT01014442|75817632|FG000|NOT COMPLETED|Overall Study||7||
59698506|NCT01014442|75817633|FG001|NOT COMPLETED|Overall Study||19||
59698507|NCT00996307|75817647|FG000|STARTED|Overall Study||164||
59698508|NCT00996307|75817648|FG001|STARTED|Overall Study||165||
59698509|NCT00996307|75817649|FG002|STARTED|Overall Study||160||
59698510|NCT00996307|75817650|FG003|STARTED|Overall Study||165||
59698511|NCT00996307|75817647|FG000|COMPLETED|Overall Study||144||
59698512|NCT00996307|75817648|FG001|COMPLETED|Overall Study||148||
59698513|NCT00996307|75817649|FG002|COMPLETED|Overall Study||146||
59698514|NCT00996307|75817650|FG003|COMPLETED|Overall Study||144||
59698515|NCT00996307|75817647|FG000|NOT COMPLETED|Overall Study||20||
59698516|NCT00996307|75817648|FG001|NOT COMPLETED|Overall Study||17||
59698517|NCT00996307|75817649|FG002|NOT COMPLETED|Overall Study||14||
59698518|NCT00996307|75817650|FG003|NOT COMPLETED|Overall Study||21||
60079554|NCT04206332|76194703|FG003|Completed Controlled Human Malaria Infection (CHMI)|Part C||0||
59698519|NCT01219959|75817680|FG000|STARTED|Overall Study||127||
59698520|NCT01219959|75817681|FG001|STARTED|Overall Study||124||
59698521|NCT01219959|75817680|FG000|COMPLETED|Overall Study||120||
59698522|NCT01219959|75817681|FG001|COMPLETED|Overall Study||101||
59698523|NCT01219959|75817680|FG000|NOT COMPLETED|Overall Study||7||
59698524|NCT01219959|75817681|FG001|NOT COMPLETED|Overall Study||23||
59698525|NCT00993421|75817694|FG000|STARTED|Overall Study||49||
59698526|NCT00993421|75817695|FG001|STARTED|Overall Study||49||
59698527|NCT00993421|75817696|FG002|STARTED|Overall Study||48||
59698528|NCT00993421|75817697|FG003|STARTED|Overall Study||49||
59698529|NCT00993421|75817698|FG004|STARTED|Overall Study||52||
59698530|NCT00993421|75817699|FG005|STARTED|Overall Study||50||
59698531|NCT00993421|75817700|FG006|STARTED|Overall Study||46||
59698532|NCT00993421|75817694|FG000|COMPLETED|Overall Study||5||
59698533|NCT00993421|75817695|FG001|COMPLETED|Overall Study||4||
59698534|NCT00993421|75817696|FG002|COMPLETED|Overall Study||5||
59698535|NCT00993421|75817697|FG003|COMPLETED|Overall Study||4||
59698536|NCT00993421|75817698|FG004|COMPLETED|Overall Study||6||
59698537|NCT00993421|75817699|FG005|COMPLETED|Overall Study||4||
59698538|NCT00993421|75817700|FG006|COMPLETED|Overall Study||4||
59698539|NCT00993421|75817694|FG000|NOT COMPLETED|Overall Study||44||
59698540|NCT00993421|75817695|FG001|NOT COMPLETED|Overall Study||45||
59698541|NCT00993421|75817696|FG002|NOT COMPLETED|Overall Study||43||
59698542|NCT00993421|75817697|FG003|NOT COMPLETED|Overall Study||45||
59698543|NCT00993421|75817698|FG004|NOT COMPLETED|Overall Study||46||
59698544|NCT00993421|75817699|FG005|NOT COMPLETED|Overall Study||46||
59698545|NCT00993421|75817700|FG006|NOT COMPLETED|Overall Study||42||
59698546|NCT01014208|75817718|FG000|STARTED|Overall Study||225||
59698547|NCT01014208|75817719|FG001|STARTED|Overall Study||222||
59698548|NCT01014208|75817718|FG000|Intent-to-Treat Population|Overall Study||223||
59698549|NCT01014208|75817719|FG001|Intent-to-Treat Population|Overall Study||222||
59698550|NCT01014208|75817718|FG000|COMPLETED|Overall Study||131||
59698551|NCT01014208|75817719|FG001|COMPLETED|Overall Study||122||
59698552|NCT01014208|75817718|FG000|NOT COMPLETED|Overall Study||94||
59698553|NCT01014208|75817719|FG001|NOT COMPLETED|Overall Study||100||
59698554|NCT00991939|75817727|FG000|STARTED|Overall Study||5||
59698555|NCT00991939|75817728|FG001|STARTED|Overall Study||3||
59698556|NCT00991939|75817727|FG000|COMPLETED|Overall Study||0||
59698557|NCT00991939|75817728|FG001|COMPLETED|Overall Study||1||
59698558|NCT00991939|75817727|FG000|NOT COMPLETED|Overall Study||5||
59698559|NCT00991939|75817728|FG001|NOT COMPLETED|Overall Study||2||
59698560|NCT00993265|75817738|FG000|STARTED|Overall Study||20||
59698561|NCT00993265|75817739|FG001|STARTED|Overall Study||19||
59698562|NCT00993265|75817738|FG000|COMPLETED|Overall Study||16||
59698563|NCT00993265|75817739|FG001|COMPLETED|Overall Study||19||
59698564|NCT00993265|75817738|FG000|NOT COMPLETED|Overall Study||4||
59698565|NCT00993265|75817739|FG001|NOT COMPLETED|Overall Study||0||
59698566|NCT04211389|75817747|FG000|STARTED|Overall Study||290||
59698567|NCT04211389|75817748|FG001|STARTED|Overall Study||152||
59698568|NCT04211389|75817747|FG000|COMPLETED|Overall Study||264||
59990738|NCT02495948|76106239|FG000|COMPLETED|Period 2, Second 30 Days of Wear||82||
59990739|NCT02495948|76106240|FG001|COMPLETED|Period 2, Second 30 Days of Wear||82||
59990740|NCT02495948|76106239|FG000|NOT COMPLETED|Period 2, Second 30 Days of Wear||1||
59990741|NCT02495948|76106240|FG001|NOT COMPLETED|Period 2, Second 30 Days of Wear||1||
59698569|NCT04211389|75817748|FG001|COMPLETED|Overall Study||131||
59698570|NCT04211389|75817747|FG000|NOT COMPLETED|Overall Study||26||
59698571|NCT04211389|75817748|FG001|NOT COMPLETED|Overall Study||21||
59698572|NCT00993031|75817756|FG000|STARTED|Overall Study||195||
59698573|NCT00993031|75817757|FG001|STARTED|Overall Study||194||
59698574|NCT00993031|75817756|FG000|Delivered|Overall Study||187||
59698575|NCT00993031|75817757|FG001|Delivered|Overall Study||190||
59698576|NCT00993031|75817756|FG000|COMPLETED|Overall Study||173||
59698577|NCT00993031|75817757|FG001|COMPLETED|Overall Study||175||
59698578|NCT00993031|75817756|FG000|NOT COMPLETED|Overall Study||22||
59698579|NCT00993031|75817757|FG001|NOT COMPLETED|Overall Study||19||
59698580|NCT01010776|75817767|FG000|STARTED|Main Phase||223||
59698581|NCT01010776|75817767|FG000|Treated|Main Phase||218||
59698582|NCT01010776|75817767|FG000|COMPLETED|Main Phase||174||
59698583|NCT01010776|75817767|FG000|NOT COMPLETED|Main Phase||49||
59698584|NCT01010776|75817767|FG000|STARTED|In-Between Main Phase & Extension Phase||174||
59698585|NCT01010776|75817767|FG000|COMPLETED|In-Between Main Phase & Extension Phase||159||
59698586|NCT01010776|75817767|FG000|NOT COMPLETED|In-Between Main Phase & Extension Phase||15||
59698587|NCT01010776|75817767|FG000|STARTED|Extension Phase||159||
59698588|NCT01010776|75817767|FG000|COMPLETED|Extension Phase||156||
59816194|NCT00573131|75938562|FG001|STARTED|Overall Study||65||
59698589|NCT01010776|75817767|FG000|NOT COMPLETED|Extension Phase||3||
59698590|NCT01018810|75817787|FG000|STARTED|Overall Study||4||
59698591|NCT01018810|75817788|FG001|STARTED|Overall Study||1||
59698592|NCT01018810|75817789|FG002|STARTED|Overall Study||1||
59698593|NCT01018810|75817790|FG003|STARTED|Overall Study||1||
59698594|NCT01018810|75817791|FG004|STARTED|Overall Study||1||
59698595|NCT01018810|75817787|FG000|COMPLETED|Overall Study||2||
59698596|NCT01018810|75817788|FG001|COMPLETED|Overall Study||0||
59990742|NCT02461628|76106249|FG000|STARTED|Overall Study||3733||16
59990743|NCT02461628|76106250|FG001|STARTED|Overall Study||3632||16
59698597|NCT01018810|75817789|FG002|COMPLETED|Overall Study||0||
59698598|NCT01018810|75817790|FG003|COMPLETED|Overall Study||0||
59698599|NCT01018810|75817791|FG004|COMPLETED|Overall Study||0||
59698600|NCT01018810|75817787|FG000|NOT COMPLETED|Overall Study||2||
59698601|NCT01018810|75817788|FG001|NOT COMPLETED|Overall Study||1||
59698602|NCT01018810|75817789|FG002|NOT COMPLETED|Overall Study||1||
59698603|NCT01018810|75817790|FG003|NOT COMPLETED|Overall Study||1||
59698604|NCT01018810|75817791|FG004|NOT COMPLETED|Overall Study||1||
59698605|NCT01018732|75817806|FG000|STARTED|Overall Study||50||
59698606|NCT01018732|75817807|FG001|STARTED|Overall Study||51||
59698607|NCT01018732|75817808|FG002|STARTED|Overall Study||54||
59698608|NCT01018732|75817806|FG000|COMPLETED|Overall Study||49||
59698609|NCT01018732|75817807|FG001|COMPLETED|Overall Study||49||
59698610|NCT01018732|75817808|FG002|COMPLETED|Overall Study||50||
59816195|NCT00573131|75938561|FG000|COMPLETED|Overall Study||62||
60079555|NCT04206332|76194704|FG004|Completed Controlled Human Malaria Infection (CHMI)|Part C||0||
60079556|NCT04206332|76194705|FG005|Completed Controlled Human Malaria Infection (CHMI)|Part C||0||
60079557|NCT04206332|76194706|FG006|Completed Controlled Human Malaria Infection (CHMI)|Part C||0||
60079558|NCT04206332|76194707|FG007|Completed Controlled Human Malaria Infection (CHMI)|Part C||0||
60079559|NCT04206332|76194708|FG008|Completed Controlled Human Malaria Infection (CHMI)|Part C||0||
59547955|NCT01165112|75646903|FG000|STARTED|Overall Study||48||
59547956|NCT01165112|75646903|FG000|COMPLETED|Overall Study||48||
59547957|NCT01165112|75646903|FG000|NOT COMPLETED|Overall Study||0||
59547958|NCT02555631|75646907|FG000|STARTED|Overall Study||29||
59547959|NCT02555631|75646907|FG000|COMPLETED|Overall Study||25||
59547960|NCT02555631|75646907|FG000|NOT COMPLETED|Overall Study||4||
59547961|NCT01129778|75646911|FG000|STARTED|Overall Study||22||
59547962|NCT01129778|75646911|FG000|COMPLETED|Overall Study||15||
59547963|NCT01129778|75646911|FG000|NOT COMPLETED|Overall Study||7||
59547964|NCT02484807|75646921|FG000|STARTED|Overall Study||39||
59547965|NCT02484807|75646922|FG001|STARTED|Overall Study||7||
59547966|NCT02484807|75646923|FG002|STARTED|Overall Study||19||
59547967|NCT02484807|75646924|FG003|STARTED|Overall Study||21||
59547968|NCT02484807|75646925|FG004|STARTED|Overall Study||33||
59547969|NCT02484807|75646926|FG005|STARTED|Overall Study||6||
59547970|NCT02484807|75646921|FG000|COMPLETED|Overall Study||39||
59547971|NCT02484807|75646922|FG001|COMPLETED|Overall Study||7||
59547972|NCT02484807|75646923|FG002|COMPLETED|Overall Study||19||
59547973|NCT02484807|75646924|FG003|COMPLETED|Overall Study||21||
59547974|NCT02484807|75646925|FG004|COMPLETED|Overall Study||33||
59547975|NCT02484807|75646926|FG005|COMPLETED|Overall Study||6||
59547976|NCT02484807|75646921|FG000|NOT COMPLETED|Overall Study||0||
59547977|NCT02484807|75646922|FG001|NOT COMPLETED|Overall Study||0||
59547978|NCT02484807|75646923|FG002|NOT COMPLETED|Overall Study||0||
59547979|NCT02484807|75646924|FG003|NOT COMPLETED|Overall Study||0||
59547980|NCT02484807|75646925|FG004|NOT COMPLETED|Overall Study||0||
59547981|NCT02484807|75646926|FG005|NOT COMPLETED|Overall Study||0||
59547982|NCT02556333|75646941|FG000|STARTED|Overall Study||1||
59547983|NCT02556333|75646941|FG000|COMPLETED|Overall Study||1||
59547984|NCT02556333|75646941|FG000|NOT COMPLETED|Overall Study||0||
59547985|NCT01166126|75646945|FG000|STARTED|Overall Study||4||
59698611|NCT01018732|75817806|FG000|NOT COMPLETED|Overall Study||1||
60079560|NCT04206332|76194709|FG009|Completed Controlled Human Malaria Infection (CHMI)|Part C||0||
59547986|NCT01166126|75646945|FG000|COMPLETED|Overall Study||4||
59547987|NCT01166126|75646945|FG000|NOT COMPLETED|Overall Study||0||
59547988|NCT02557035|75646951|FG000|STARTED|Overall Study||225||
59547989|NCT02557035|75646952|FG001|STARTED|Overall Study||215||
59547990|NCT02557035|75646951|FG000|COMPLETED|Overall Study||218||
59547991|NCT02557035|75646952|FG001|COMPLETED|Overall Study||206||
59547992|NCT02557035|75646951|FG000|NOT COMPLETED|Overall Study||7||
59547993|NCT02557035|75646952|FG001|NOT COMPLETED|Overall Study||9||
59547994|NCT02385084|75646958|FG000|STARTED|Period 1||3||
59547995|NCT02385084|75646959|FG001|STARTED|Period 1||3||
59547996|NCT02385084|75646960|FG002|STARTED|Period 1||3||
59547997|NCT02385084|75646961|FG003|STARTED|Period 1||3||
59547998|NCT02385084|75646962|FG004|STARTED|Period 1||3||
59547999|NCT02385084|75646963|FG005|STARTED|Period 1||3||
59548000|NCT02385084|75646958|FG000|Received LY2409021|Period 1||3||
59548001|NCT02385084|75646959|FG001|Received LY2409021|Period 1||3||
59548002|NCT02385084|75646960|FG002|Received LY2409021|Period 1||3||
59548003|NCT02385084|75646961|FG003|Received LY2409021|Period 1||3||
59548004|NCT02385084|75646962|FG004|Received LY2409021|Period 1||3||
59548005|NCT02385084|75646963|FG005|Received LY2409021|Period 1||3||
59548006|NCT02385084|75646958|FG000|Washout|Period 1||3||
59548007|NCT02385084|75646959|FG001|Washout|Period 1||3||
59698612|NCT01018732|75817807|FG001|NOT COMPLETED|Overall Study||2||
59698613|NCT01018732|75817808|FG002|NOT COMPLETED|Overall Study||4||
59698614|NCT01218867|75817827|FG000|STARTED|Overall Study||1||
59698615|NCT01218867|75817828|FG001|STARTED|Overall Study||1||
59698616|NCT01218867|75817829|FG002|STARTED|Overall Study||3||
59698617|NCT01218867|75817830|FG003|STARTED|Overall Study||1||
59698618|NCT01218867|75817831|FG004|STARTED|Overall Study||1||
59698619|NCT01218867|75817832|FG005|STARTED|Overall Study||1||
59698620|NCT01218867|75817833|FG006|STARTED|Overall Study||4||
59698621|NCT01218867|75817834|FG007|STARTED|Overall Study||3||
59698622|NCT01218867|75817835|FG008|STARTED|Overall Study||3||
59698623|NCT01218867|75817836|FG009|STARTED|Overall Study||4||
59698624|NCT01218867|75817837|FG010|STARTED|Overall Study||2||
59698625|NCT01218867|75817827|FG000|COMPLETED|Overall Study||1||
59698626|NCT01218867|75817828|FG001|COMPLETED|Overall Study||1||
59698627|NCT01218867|75817829|FG002|COMPLETED|Overall Study||3||
59698628|NCT01218867|75817830|FG003|COMPLETED|Overall Study||1||
59698629|NCT01218867|75817831|FG004|COMPLETED|Overall Study||1||
59816196|NCT00573131|75938562|FG001|COMPLETED|Overall Study||57||
59990744|NCT02461628|76106249|FG000|Baseline Survey|Overall Study||1038||16
59990745|NCT02461628|76106250|FG001|Baseline Survey|Overall Study||974||16
59990746|NCT02461628|76106249|FG000|6 Month Survey|Overall Study||814||16
59990747|NCT02461628|76106250|FG001|6 Month Survey|Overall Study||832||16
59990748|NCT02461628|76106249|FG000|12 Month Survey|Overall Study||882||16
59990749|NCT02461628|76106250|FG001|12 Month Survey|Overall Study||914||16
59990750|NCT02461628|76106249|FG000|18 Month Survey|Overall Study||995||16
59990751|NCT02461628|76106250|FG001|18 Month Survey|Overall Study||905||16
59990752|NCT02461628|76106249|FG000|COMPLETED|Overall Study||3729||16
59990753|NCT02461628|76106250|FG001|COMPLETED|Overall Study||3625||16
60079561|NCT04206332|76194710|FG010|Completed Controlled Human Malaria Infection (CHMI)|Part C||0||
60079562|NCT04206332|76194711|FG011|Completed Controlled Human Malaria Infection (CHMI)|Part C||7||
60079563|NCT04206332|76194712|FG012|Completed Controlled Human Malaria Infection (CHMI)|Part C||4||
60079564|NCT04206332|76194713|FG013|Completed Controlled Human Malaria Infection (CHMI)|Part C||4||
60079565|NCT04206332|76194714|FG014|Completed Controlled Human Malaria Infection (CHMI)|Part C||3||
60079566|NCT04206332|76194715|FG015|Completed Controlled Human Malaria Infection (CHMI)|Part C||4||
60079567|NCT04206332|76194716|FG016|Completed Controlled Human Malaria Infection (CHMI)|Part C||6||
60079568|NCT04206332|76194700|FG000|COMPLETED|Part C||0||
60079569|NCT04206332|76194701|FG001|COMPLETED|Part C||0||
60079570|NCT04206332|76194702|FG002|COMPLETED|Part C||0||
60079571|NCT04206332|76194703|FG003|COMPLETED|Part C||0||
60079572|NCT04206332|76194704|FG004|COMPLETED|Part C||0||
60079573|NCT04206332|76194705|FG005|COMPLETED|Part C||0||
60079574|NCT04206332|76194706|FG006|COMPLETED|Part C||0||
60079575|NCT04206332|76194707|FG007|COMPLETED|Part C||0||
59548008|NCT02385084|75646960|FG002|Washout|Period 1||3||
59548009|NCT02385084|75646961|FG003|Washout|Period 1||3||
59698630|NCT01218867|75817832|FG005|COMPLETED|Overall Study||1||
59698631|NCT01218867|75817833|FG006|COMPLETED|Overall Study||3||
59698632|NCT01218867|75817834|FG007|COMPLETED|Overall Study||3||
59698633|NCT01218867|75817835|FG008|COMPLETED|Overall Study||3||
59698634|NCT01218867|75817836|FG009|COMPLETED|Overall Study||4||
59698635|NCT01218867|75817837|FG010|COMPLETED|Overall Study||2||
59816197|NCT00573131|75938561|FG000|NOT COMPLETED|Overall Study||10||
59816198|NCT00573131|75938562|FG001|NOT COMPLETED|Overall Study||8||
59816199|NCT00521144|75938573|FG000|STARTED|Overall Study||6||
59816200|NCT00521144|75938574|FG001|STARTED|Overall Study||5||
59816201|NCT00521144|75938575|FG002|STARTED|Overall Study||3||
59816202|NCT00521144|75938576|FG003|STARTED|Overall Study||1||
59816203|NCT00521144|75938577|FG004|STARTED|Overall Study||7||
59816204|NCT00521144|75938573|FG000|COMPLETED|Overall Study||2||
59816205|NCT00521144|75938574|FG001|COMPLETED|Overall Study||2||
59816206|NCT00521144|75938575|FG002|COMPLETED|Overall Study||1||
59816207|NCT00521144|75938576|FG003|COMPLETED|Overall Study||0||
59816208|NCT00521144|75938577|FG004|COMPLETED|Overall Study||0||
59816209|NCT00521144|75938573|FG000|NOT COMPLETED|Overall Study||4||
59816210|NCT00521144|75938574|FG001|NOT COMPLETED|Overall Study||3||
59816211|NCT00521144|75938575|FG002|NOT COMPLETED|Overall Study||2||
59990754|NCT02461628|76106249|FG000|NOT COMPLETED|Overall Study||4||0
59990755|NCT02461628|76106250|FG001|NOT COMPLETED|Overall Study||7||0
59990756|NCT02461160|76106269|FG000|STARTED|Overall Study||8||
59990757|NCT02461160|76106270|FG001|STARTED|Overall Study||6||
59990758|NCT02461160|76106271|FG002|STARTED|Overall Study||6||
60079576|NCT04206332|76194708|FG008|COMPLETED|Part C||0||
60079577|NCT04206332|76194709|FG009|COMPLETED|Part C||0||
60079578|NCT04206332|76194710|FG010|COMPLETED|Part C||0||
60079579|NCT04206332|76194711|FG011|COMPLETED|Part C||7||
60079580|NCT04206332|76194712|FG012|COMPLETED|Part C||4||
60079581|NCT04206332|76194713|FG013|COMPLETED|Part C||4||
60079582|NCT04206332|76194714|FG014|COMPLETED|Part C||2||
60079583|NCT04206332|76194715|FG015|COMPLETED|Part C||4||
60079584|NCT04206332|76194716|FG016|COMPLETED|Part C||6||
60079585|NCT04206332|76194700|FG000|NOT COMPLETED|Part C||0||
60079586|NCT04206332|76194701|FG001|NOT COMPLETED|Part C||0||
59548010|NCT02385084|75646962|FG004|Washout|Period 1||3||
59698636|NCT01218867|75817827|FG000|NOT COMPLETED|Overall Study||0||
59698637|NCT01218867|75817828|FG001|NOT COMPLETED|Overall Study||0||
59698638|NCT01218867|75817829|FG002|NOT COMPLETED|Overall Study||0||
59698639|NCT01218867|75817830|FG003|NOT COMPLETED|Overall Study||0||
59698640|NCT01218867|75817831|FG004|NOT COMPLETED|Overall Study||0||
59698641|NCT01218867|75817832|FG005|NOT COMPLETED|Overall Study||0||
59698642|NCT01218867|75817833|FG006|NOT COMPLETED|Overall Study||1||
59698643|NCT01218867|75817834|FG007|NOT COMPLETED|Overall Study||0||
59698644|NCT01218867|75817835|FG008|NOT COMPLETED|Overall Study||0||
59698645|NCT01218867|75817836|FG009|NOT COMPLETED|Overall Study||0||
59698646|NCT01218867|75817837|FG010|NOT COMPLETED|Overall Study||0||
59698647|NCT01018264|75817874|FG000|STARTED|Overall Study||10||
59698648|NCT01018264|75817875|FG001|STARTED|Overall Study||13||
59698649|NCT01018264|75817874|FG000|COMPLETED|Overall Study||9||
59698650|NCT01018264|75817875|FG001|COMPLETED|Overall Study||12||
59698651|NCT01018264|75817874|FG000|NOT COMPLETED|Overall Study||1||
59698652|NCT01018264|75817875|FG001|NOT COMPLETED|Overall Study||1||
59698653|NCT01018186|75817884|FG000|STARTED|2-week Run-in Period||617||
59698654|NCT01018186|75817885|FG001|STARTED|2-week Run-in Period||0||
59698655|NCT01018186|75817886|FG002|STARTED|2-week Run-in Period||0||
59698656|NCT01018186|75817887|FG003|STARTED|2-week Run-in Period||0||
59698657|NCT01018186|75817884|FG000|COMPLETED|2-week Run-in Period||503||
59698658|NCT01018186|75817885|FG001|COMPLETED|2-week Run-in Period||0||
59698659|NCT01018186|75817886|FG002|COMPLETED|2-week Run-in Period||0||
59698660|NCT01018186|75817887|FG003|COMPLETED|2-week Run-in Period||0||
59698661|NCT01018186|75817884|FG000|NOT COMPLETED|2-week Run-in Period||114||
59698662|NCT01018186|75817885|FG001|NOT COMPLETED|2-week Run-in Period||0||
59698663|NCT01018186|75817886|FG002|NOT COMPLETED|2-week Run-in Period||0||
59698664|NCT01018186|75817887|FG003|NOT COMPLETED|2-week Run-in Period||0||
59698665|NCT01018186|75817884|FG000|STARTED|52-week Double-blind Treatment Period||0||
59698666|NCT01018186|75817885|FG001|STARTED|52-week Double-blind Treatment Period||201||
59698667|NCT01018186|75817886|FG002|STARTED|52-week Double-blind Treatment Period||202||
59698668|NCT01018186|75817887|FG003|STARTED|52-week Double-blind Treatment Period||100||
59698669|NCT01018186|75817884|FG000|COMPLETED|52-week Double-blind Treatment Period||0||
59698670|NCT01018186|75817885|FG001|COMPLETED|52-week Double-blind Treatment Period||161||
59698671|NCT01018186|75817886|FG002|COMPLETED|52-week Double-blind Treatment Period||161||
59698672|NCT01018186|75817887|FG003|COMPLETED|52-week Double-blind Treatment Period||71||
59698673|NCT01018186|75817884|FG000|NOT COMPLETED|52-week Double-blind Treatment Period||0||
59698674|NCT01018186|75817885|FG001|NOT COMPLETED|52-week Double-blind Treatment Period||40||
59698675|NCT01018186|75817886|FG002|NOT COMPLETED|52-week Double-blind Treatment Period||41||
59698676|NCT01018186|75817887|FG003|NOT COMPLETED|52-week Double-blind Treatment Period||29||
59698677|NCT00987337|75817902|FG000|STARTED|Overall Study||96||
59698678|NCT00987337|75817903|FG001|STARTED|Overall Study||96||
59698679|NCT00987337|75817904|FG002|STARTED|Overall Study||96||
59698680|NCT00987337|75817902|FG000|COMPLETED|Overall Study||39||
59698681|NCT00987337|75817903|FG001|COMPLETED|Overall Study||41||
59698682|NCT00987337|75817904|FG002|COMPLETED|Overall Study||45||
59698683|NCT00987337|75817902|FG000|NOT COMPLETED|Overall Study||57||
59698684|NCT00987337|75817903|FG001|NOT COMPLETED|Overall Study||55||
59698685|NCT00987337|75817904|FG002|NOT COMPLETED|Overall Study||51||
59698686|NCT00992407|75817916|FG000|STARTED|Overall Study||37||
59698687|NCT00992407|75817917|FG001|STARTED|Overall Study||38||
59698688|NCT00992407|75817916|FG000|Treated|Overall Study||20||
59698689|NCT00992407|75817917|FG001|Treated|Overall Study||25||
59698690|NCT00992407|75817916|FG000|COMPLETED|Overall Study||6||
59698691|NCT00992407|75817917|FG001|COMPLETED|Overall Study||14||
59698692|NCT00992407|75817916|FG000|NOT COMPLETED|Overall Study||31||
59698693|NCT00992407|75817917|FG001|NOT COMPLETED|Overall Study||24||
59698694|NCT00986479|75817928|FG000|STARTED|Period 1||12||
59698695|NCT00986479|75817929|FG001|STARTED|Period 1||10||
59698696|NCT00986479|75817928|FG000|COMPLETED|Period 1||10||
59698697|NCT00986479|75817929|FG001|COMPLETED|Period 1||10||
59698698|NCT00986479|75817928|FG000|NOT COMPLETED|Period 1||2||
59698699|NCT00986479|75817929|FG001|NOT COMPLETED|Period 1||0||
59698700|NCT00986479|75817928|FG000|STARTED|Period 2||10||
59698701|NCT00986479|75817929|FG001|STARTED|Period 2||10||
59698702|NCT00986479|75817928|FG000|COMPLETED|Period 2||10||
59698703|NCT00986479|75817929|FG001|COMPLETED|Period 2||10||
59698704|NCT00986479|75817928|FG000|NOT COMPLETED|Period 2||0||
59698705|NCT00986479|75817929|FG001|NOT COMPLETED|Period 2||0||
59698706|NCT00986245|75817935|FG000|STARTED|First Intervention||41||
59698707|NCT00986245|75817936|FG001|STARTED|First Intervention||41||
59698708|NCT00986245|75817935|FG000|COMPLETED|First Intervention||31||
59698709|NCT00986245|75817936|FG001|COMPLETED|First Intervention||33||
59698710|NCT00986245|75817935|FG000|NOT COMPLETED|First Intervention||10||
59698711|NCT00986245|75817936|FG001|NOT COMPLETED|First Intervention||8||
59698712|NCT00986245|75817935|FG000|STARTED|Second Intervention||31||
59698713|NCT00986245|75817936|FG001|STARTED|Second Intervention||33||
59698714|NCT00986245|75817935|FG000|COMPLETED|Second Intervention||29||
59698715|NCT00986245|75817936|FG001|COMPLETED|Second Intervention||32||
59698716|NCT00986245|75817935|FG000|NOT COMPLETED|Second Intervention||2||
59698717|NCT00986245|75817936|FG001|NOT COMPLETED|Second Intervention||1||
59698718|NCT00989833|75817950|FG000|STARTED|Overall Study||21||
59698719|NCT00989833|75817951|FG001|STARTED|Overall Study||22||
59698720|NCT00989833|75817952|FG002|STARTED|Overall Study||23||
59698721|NCT00989833|75817950|FG000|COMPLETED|Overall Study||19||
59698722|NCT00989833|75817951|FG001|COMPLETED|Overall Study||19||
59698723|NCT00989833|75817952|FG002|COMPLETED|Overall Study||21||
59698724|NCT00989833|75817950|FG000|NOT COMPLETED|Overall Study||2||
59698725|NCT00989833|75817951|FG001|NOT COMPLETED|Overall Study||3||
59698726|NCT00989833|75817952|FG002|NOT COMPLETED|Overall Study||2||
59698727|NCT01218477|75817964|FG000|STARTED|Overall Study|Participants who received treatment|3||
59698728|NCT01218477|75817965|FG001|STARTED|Overall Study|Participants who received treatment|8||
59698729|NCT01218477|75817966|FG002|STARTED|Overall Study|Participants who received treatment|14||
59698730|NCT01218477|75817967|FG003|STARTED|Overall Study|Participants who received treatment|2||
59698731|NCT01218477|75817964|FG000|COMPLETED|Overall Study|Still receiving study drug|0||
59698732|NCT01218477|75817965|FG001|COMPLETED|Overall Study|Still receiving study drug|0||
59698733|NCT01218477|75817966|FG002|COMPLETED|Overall Study|Still receiving study drug|0||
59698734|NCT01218477|75817967|FG003|COMPLETED|Overall Study|Still receiving study drug|0||
59698735|NCT01218477|75817964|FG000|NOT COMPLETED|Overall Study||3||
59698736|NCT01218477|75817965|FG001|NOT COMPLETED|Overall Study||8||
59698737|NCT01218477|75817966|FG002|NOT COMPLETED|Overall Study||14||
59698738|NCT01218477|75817967|FG003|NOT COMPLETED|Overall Study||2||
59698739|NCT01218243|75817983|FG000|STARTED|Overall Study||50||
59698740|NCT01218243|75817984|FG001|STARTED|Overall Study||50||
59698741|NCT01218243|75817983|FG000|Treatment Completed|Overall Study||45||
59698742|NCT01218243|75817984|FG001|Treatment Completed|Overall Study||42||
59698743|NCT01218243|75817983|FG000|COMPLETED|Overall Study||41||
59698744|NCT01218243|75817984|FG001|COMPLETED|Overall Study||36||
59698745|NCT01218243|75817983|FG000|NOT COMPLETED|Overall Study||9||
59698746|NCT01218243|75817984|FG001|NOT COMPLETED|Overall Study||14||
59698747|NCT00989287|75817992|FG000|STARTED|Overall Study||65||
59698748|NCT00989287|75817993|FG001|STARTED|Overall Study||66||
59698749|NCT00989287|75817992|FG000|COMPLETED|Overall Study||64||
59698750|NCT00989287|75817993|FG001|COMPLETED|Overall Study||65||
59698751|NCT00989287|75817992|FG000|NOT COMPLETED|Overall Study||1||
59698752|NCT00989287|75817993|FG001|NOT COMPLETED|Overall Study||1||
59698753|NCT01218087|75818014|FG000|STARTED|Overall Study||42||
59698754|NCT01218087|75818015|FG001|STARTED|Overall Study||41||
59698755|NCT01218087|75818014|FG000|COMPLETED|Overall Study||27||
59698756|NCT01218087|75818015|FG001|COMPLETED|Overall Study||35||
59698757|NCT01218087|75818014|FG000|NOT COMPLETED|Overall Study||15||
59698758|NCT01218087|75818015|FG001|NOT COMPLETED|Overall Study||6||
59698759|NCT01218009|75818023|FG000|STARTED|Overall Study||166||
59698760|NCT01218009|75818024|FG001|STARTED|Overall Study||165||
59698761|NCT01218009|75818023|FG000|COMPLETED|Overall Study||0||
59698762|NCT01218009|75818024|FG001|COMPLETED|Overall Study||0||
59698763|NCT01218009|75818023|FG000|NOT COMPLETED|Overall Study||166||
59698764|NCT01218009|75818024|FG001|NOT COMPLETED|Overall Study||165||
59698765|NCT00992017|75818030|FG000|STARTED|Overall Study|Two additional women were enrolled but left the clinic before vaccine was administered.|128||
59698766|NCT00992017|75818030|FG000|Received Both Study Vaccinations|Overall Study||124||
59698767|NCT00992017|75818030|FG000|Received Only One Study Vaccination|Overall Study|Reasons: delivered and LFU; moved; no transportation; ineligible - blood transfusion at delivery|4||
59698768|NCT00992017|75818030|FG000|COMPLETED|Overall Study||118||
59698769|NCT00992017|75818030|FG000|NOT COMPLETED|Overall Study||10||
59698770|NCT01217463|75818041|FG000|STARTED|Overall Study||99||
59698771|NCT01217463|75818042|FG001|STARTED|Overall Study||102||
59698772|NCT01217463|75818041|FG000|COMPLETED|Overall Study||86||
59698773|NCT01217463|75818042|FG001|COMPLETED|Overall Study||94||
59698774|NCT01217463|75818041|FG000|NOT COMPLETED|Overall Study||13||
59698775|NCT01217463|75818042|FG001|NOT COMPLETED|Overall Study||8||
59698776|NCT01217307|75818052|FG000|STARTED|Overall Study||191||
59698777|NCT01217307|75818053|FG001|STARTED|Overall Study||189||
59698778|NCT01217307|75818052|FG000|COMPLETED|Overall Study||191||
59698779|NCT01217307|75818053|FG001|COMPLETED|Overall Study||188||
59698780|NCT01217307|75818052|FG000|NOT COMPLETED|Overall Study||0||
59698781|NCT01217307|75818053|FG001|NOT COMPLETED|Overall Study||1||
59698782|NCT01217229|75818059|FG000|STARTED|Overall Study||20||
59698783|NCT01217229|75818059|FG000|COMPLETED|Overall Study||0||
59698784|NCT01217229|75818059|FG000|NOT COMPLETED|Overall Study||20||
59698785|NCT01013740|75818065|FG000|STARTED|Overall Study|13 participants (par.) experiencing PD in the RP elected to enroll in the optional CP.|37||
59698786|NCT01013740|75818066|FG001|STARTED|Overall Study|29 participants experiencing PD in the RP elected to enroll in the optional CP.|75||
59698787|NCT01013740|75818065|FG000|Ongoing|Overall Study||0||
59698788|NCT01013740|75818066|FG001|Ongoing|Overall Study||0||
59698789|NCT01013740|75818065|FG000|COMPLETED|Overall Study|Completion also = 18 mos.of a new anti-cancer therapy initiation +/or progression of disease|26||
59698790|NCT01013740|75818066|FG001|COMPLETED|Overall Study|Completion also = 18 mos.of a new anti-cancer therapy initiation +/or progression of disease|56||
59698791|NCT01013740|75818065|FG000|NOT COMPLETED|Overall Study||11||
59698792|NCT01013740|75818066|FG001|NOT COMPLETED|Overall Study||19||
59698793|NCT01013350|75818076|FG000|STARTED|Overall Study||198||
59698794|NCT01013350|75818077|FG001|STARTED|Overall Study||963||
59698795|NCT01013350|75818076|FG000|Safety Analysis Set|Overall Study||198||
59698796|NCT01013350|75818077|FG001|Safety Analysis Set|Overall Study||950||
59698797|NCT01013350|75818076|FG000|COMPLETED|Overall Study||160||
59698798|NCT01013350|75818077|FG001|COMPLETED|Overall Study||771||
59698799|NCT01013350|75818076|FG000|NOT COMPLETED|Overall Study||38||
59698800|NCT01013350|75818077|FG001|NOT COMPLETED|Overall Study||192||
59698801|NCT01018030|75818087|FG000|STARTED|Overall Study||246||
59698802|NCT01018030|75818088|FG001|STARTED|Overall Study||243||
59698803|NCT01018030|75818089|FG002|STARTED|Overall Study||252||
59698804|NCT01018030|75818087|FG000|COMPLETED|Overall Study||227||
59698805|NCT01018030|75818088|FG001|COMPLETED|Overall Study||232||
59698806|NCT01018030|75818089|FG002|COMPLETED|Overall Study||239||
59698807|NCT01018030|75818087|FG000|NOT COMPLETED|Overall Study||19||
59698808|NCT01018030|75818088|FG001|NOT COMPLETED|Overall Study||11||
59698809|NCT01018030|75818089|FG002|NOT COMPLETED|Overall Study||13||
59698810|NCT01217073|75818105|FG000|STARTED|Base Period||113||
59698811|NCT01217073|75818106|FG001|STARTED|Base Period||115||
59698812|NCT01217073|75818107|FG002|STARTED|Base Period||114||
59698813|NCT01217073|75818108|FG003|STARTED|Base Period||115||
59698814|NCT01217073|75818109|FG004|STARTED|Base Period||114||
59698815|NCT01217073|75818110|FG005|STARTED|Base Period||114||
59698816|NCT01217073|75818111|FG006|STARTED|Base Period||0||
59698817|NCT01217073|75818112|FG007|STARTED|Base Period||0||
59698818|NCT01217073|75818105|FG000|COMPLETED|Base Period||106||
59698819|NCT01217073|75818106|FG001|COMPLETED|Base Period||110||
59698820|NCT01217073|75818107|FG002|COMPLETED|Base Period||107||
59698821|NCT01217073|75818108|FG003|COMPLETED|Base Period||113||
59698822|NCT01217073|75818109|FG004|COMPLETED|Base Period||99||
59698823|NCT01217073|75818110|FG005|COMPLETED|Base Period||105||
59698824|NCT01217073|75818111|FG006|COMPLETED|Base Period||0||
59698825|NCT01217073|75818112|FG007|COMPLETED|Base Period||0||
59698826|NCT01217073|75818105|FG000|NOT COMPLETED|Base Period||7||
59698827|NCT01217073|75818106|FG001|NOT COMPLETED|Base Period||5||
59698828|NCT01217073|75818107|FG002|NOT COMPLETED|Base Period||7||
59698829|NCT01217073|75818108|FG003|NOT COMPLETED|Base Period||2||
59698830|NCT01217073|75818109|FG004|NOT COMPLETED|Base Period||15||
59698831|NCT01217073|75818110|FG005|NOT COMPLETED|Base Period||9||
59698832|NCT01217073|75818111|FG006|NOT COMPLETED|Base Period||0||
59698833|NCT01217073|75818112|FG007|NOT COMPLETED|Base Period||0||
59698834|NCT01217073|75818105|FG000|STARTED|Extension Period||0||
59698835|NCT01217073|75818106|FG001|STARTED|Extension Period||0||
59698836|NCT01217073|75818107|FG002|STARTED|Extension Period||0||
59698837|NCT01217073|75818108|FG003|STARTED|Extension Period||0||
59698838|NCT01217073|75818109|FG004|STARTED|Extension Period||0||
59698839|NCT01217073|75818110|FG005|STARTED|Extension Period||0||
59698840|NCT01217073|75818111|FG006|STARTED|Extension Period||405||
59698841|NCT01217073|75818112|FG007|STARTED|Extension Period||80||
59698842|NCT01217073|75818105|FG000|COMPLETED|Extension Period||0||
59698843|NCT01217073|75818106|FG001|COMPLETED|Extension Period||0||
59698844|NCT01217073|75818107|FG002|COMPLETED|Extension Period||0||
59698845|NCT01217073|75818108|FG003|COMPLETED|Extension Period||0||
59698846|NCT01217073|75818109|FG004|COMPLETED|Extension Period||0||
59698847|NCT01217073|75818110|FG005|COMPLETED|Extension Period||0||
59698848|NCT01217073|75818111|FG006|COMPLETED|Extension Period||314||
59698849|NCT01217073|75818112|FG007|COMPLETED|Extension Period||60||
59698850|NCT01217073|75818105|FG000|NOT COMPLETED|Extension Period||0||
59698851|NCT01217073|75818106|FG001|NOT COMPLETED|Extension Period||0||
59698852|NCT01217073|75818107|FG002|NOT COMPLETED|Extension Period||0||
59698853|NCT01217073|75818108|FG003|NOT COMPLETED|Extension Period||0||
59698854|NCT01217073|75818109|FG004|NOT COMPLETED|Extension Period||0||
59698855|NCT01217073|75818110|FG005|NOT COMPLETED|Extension Period||0||
59698856|NCT01217073|75818111|FG006|NOT COMPLETED|Extension Period||91||
59698857|NCT01217073|75818112|FG007|NOT COMPLETED|Extension Period||20||
59698858|NCT00985621|75818140|FG000|STARTED|Overall Study||142||
59698859|NCT00985621|75818141|FG001|STARTED|Overall Study||161||
59698860|NCT00985621|75818142|FG002|STARTED|Overall Study||152||
59698861|NCT00985621|75818143|FG003|STARTED|Overall Study||159||
59698862|NCT00985621|75818140|FG000|Treated|Overall Study||141||
59698863|NCT00985621|75818141|FG001|Treated|Overall Study||161||
59698864|NCT00985621|75818142|FG002|Treated|Overall Study||150||
60079587|NCT04206332|76194702|FG002|NOT COMPLETED|Part C||0||
59698865|NCT00985621|75818143|FG003|Treated|Overall Study||158||
59698866|NCT00985621|75818140|FG000|COMPLETED|Overall Study||28||
59698867|NCT00985621|75818141|FG001|COMPLETED|Overall Study||30||
59698868|NCT00985621|75818142|FG002|COMPLETED|Overall Study||29||
59698869|NCT00985621|75818143|FG003|COMPLETED|Overall Study||22||
59698870|NCT00985621|75818140|FG000|NOT COMPLETED|Overall Study||114||
59698871|NCT00985621|75818141|FG001|NOT COMPLETED|Overall Study||131||
59698872|NCT00985621|75818142|FG002|NOT COMPLETED|Overall Study||123||
59698873|NCT00985621|75818143|FG003|NOT COMPLETED|Overall Study||137||
59698874|NCT01215981|75818157|FG000|STARTED|Overall Study||35||
59698875|NCT01215981|75818158|FG001|STARTED|Overall Study||33||
59698876|NCT01215981|75818157|FG000|COMPLETED|Overall Study||33||
59698877|NCT01215981|75818158|FG001|COMPLETED|Overall Study||32||
59698878|NCT01215981|75818157|FG000|NOT COMPLETED|Overall Study||2||
59698879|NCT01215981|75818158|FG001|NOT COMPLETED|Overall Study||1||
59698880|NCT01215513|75818164|FG000|STARTED|Overall Study|157 participants were allocated to treatment in CS42 main study (Intent-to-treat analysis set)|157||
59698881|NCT01215513|75818164|FG000|CS42 and CS42A Safety Analysis Set|Overall Study|156 participants received at least 1 dose of degarelix|156||
59698882|NCT01215513|75818164|FG000|CS42 and CS42A Full Analysis Set|Overall Study|155 participants received at least 1 dose of degarelix and had at least 1 efficacy assessment|155||
60079588|NCT04206332|76194703|FG003|NOT COMPLETED|Part C||0||
59698883|NCT01215513|75818164|FG000|CS42A Safety Analysis Set|Overall Study|127 participants were enrolled in the extension study CS42A|127||
59698884|NCT01215513|75818164|FG000|COMPLETED|Overall Study||112||
59698885|NCT01215513|75818164|FG000|NOT COMPLETED|Overall Study||45||
59698886|NCT01215435|75818171|FG000|STARTED|Overall Study||122||
59698887|NCT01215435|75818172|FG001|STARTED|Overall Study||123||
59698888|NCT01215435|75818171|FG000|COMPLETED|Overall Study||103||
59698889|NCT01215435|75818172|FG001|COMPLETED|Overall Study||107||
59698890|NCT01215435|75818171|FG000|NOT COMPLETED|Overall Study||19||
59698891|NCT01215435|75818172|FG001|NOT COMPLETED|Overall Study||16||
59698892|NCT01215357|75818178|FG000|STARTED|Overall Study||34||
59698893|NCT01215357|75818178|FG000|COMPLETED|Overall Study||22||
59698894|NCT01215357|75818178|FG000|NOT COMPLETED|Overall Study||12||
59698895|NCT00984295|75818185|FG000|STARTED|Overall Study|2 patients were incorrectly vaccinated and are excluded from this table.|949||
59698896|NCT00984295|75818186|FG001|STARTED|Overall Study||485||
59698897|NCT00984295|75818187|FG002|STARTED|Overall Study||479||
59698898|NCT00984295|75818185|FG000|Visit 1|Overall Study||949||
59698899|NCT00984295|75818186|FG001|Visit 1|Overall Study||485||
59698900|NCT00984295|75818187|FG002|Visit 1|Overall Study||479||
59698901|NCT00984295|75818185|FG000|Visit 2|Overall Study||909||
59698902|NCT00984295|75818186|FG001|Visit 2|Overall Study||468||
59698903|NCT00984295|75818187|FG002|Visit 2|Overall Study||453||
59698904|NCT00984295|75818185|FG000|COMPLETED|Overall Study||884||
59698905|NCT00984295|75818186|FG001|COMPLETED|Overall Study||453||
59698906|NCT00984295|75818187|FG002|COMPLETED|Overall Study||442||
59698907|NCT00984295|75818185|FG000|NOT COMPLETED|Overall Study||65||
59698908|NCT00984295|75818186|FG001|NOT COMPLETED|Overall Study||32||
59698909|NCT00984295|75818187|FG002|NOT COMPLETED|Overall Study||37||
59698910|NCT01017952|75818199|FG000|STARTED|4-week, Open-label Run-In Period||2092||
59698911|NCT01017952|75818200|FG001|STARTED|4-week, Open-label Run-In Period||0||
59698912|NCT01017952|75818201|FG002|STARTED|4-week, Open-label Run-In Period||0||
59698913|NCT01017952|75818202|FG003|STARTED|4-week, Open-label Run-In Period||0||
59698914|NCT01017952|75818203|FG004|STARTED|4-week, Open-label Run-In Period||0||
59698915|NCT01017952|75818199|FG000|COMPLETED|4-week, Open-label Run-In Period||1633||
59698916|NCT01017952|75818200|FG001|COMPLETED|4-week, Open-label Run-In Period||0||
59698917|NCT01017952|75818201|FG002|COMPLETED|4-week, Open-label Run-In Period||0||
59698918|NCT01017952|75818202|FG003|COMPLETED|4-week, Open-label Run-In Period||0||
59698919|NCT01017952|75818203|FG004|COMPLETED|4-week, Open-label Run-In Period||0||
59698920|NCT01017952|75818199|FG000|NOT COMPLETED|4-week, Open-label Run-In Period||459||
59698921|NCT01017952|75818200|FG001|NOT COMPLETED|4-week, Open-label Run-In Period||0||
59698922|NCT01017952|75818201|FG002|NOT COMPLETED|4-week, Open-label Run-In Period||0||
59698923|NCT01017952|75818202|FG003|NOT COMPLETED|4-week, Open-label Run-In Period||0||
59698924|NCT01017952|75818203|FG004|NOT COMPLETED|4-week, Open-label Run-In Period||0||
59698925|NCT01017952|75818199|FG000|STARTED|52-week, Double-blind Treatment Period||0||
59698926|NCT01017952|75818200|FG001|STARTED|52-week, Double-blind Treatment Period||409||
59698927|NCT01017952|75818201|FG002|STARTED|52-week, Double-blind Treatment Period||412||
59698928|NCT01017952|75818202|FG003|STARTED|52-week, Double-blind Treatment Period||403||
59698929|NCT01017952|75818203|FG004|STARTED|52-week, Double-blind Treatment Period||409||
59698930|NCT01017952|75818199|FG000|Completed the Treatment Period|52-week, Double-blind Treatment Period||0||
59698931|NCT01017952|75818200|FG001|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|285||
59698932|NCT01017952|75818201|FG002|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|305||
59698933|NCT01017952|75818202|FG003|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|293||
59698934|NCT01017952|75818203|FG004|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|307||
59698935|NCT01017952|75818199|FG000|COMPLETED|52-week, Double-blind Treatment Period||0||
59698936|NCT01017952|75818200|FG001|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|284||
59698937|NCT01017952|75818201|FG002|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|303||
59698938|NCT01017952|75818202|FG003|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|291||
59698939|NCT01017952|75818203|FG004|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|306||
59698940|NCT01017952|75818199|FG000|NOT COMPLETED|52-week, Double-blind Treatment Period||0||
59698941|NCT01017952|75818200|FG001|NOT COMPLETED|52-week, Double-blind Treatment Period||125||
59698942|NCT01017952|75818201|FG002|NOT COMPLETED|52-week, Double-blind Treatment Period||109||
59698943|NCT01017952|75818202|FG003|NOT COMPLETED|52-week, Double-blind Treatment Period||112||
59698944|NCT01017952|75818203|FG004|NOT COMPLETED|52-week, Double-blind Treatment Period||103||
59698945|NCT01214655|75818216|FG000|STARTED|Part A|Total on Schedule A, dose days 1,2,3|10||
59698946|NCT01214655|75818217|FG001|STARTED|Part A||0||
59698947|NCT01214655|75818218|FG002|STARTED|Part A||0||
59698948|NCT01214655|75818216|FG000|Received 2 mg Study Drug|Part A||3||
59698949|NCT01214655|75818217|FG001|Received 2 mg Study Drug|Part A||0||
59698950|NCT01214655|75818218|FG002|Received 2 mg Study Drug|Part A||0||
59698951|NCT01214655|75818216|FG000|Escalated From 2 to 4 mg/m²/Day|Part A||3||
59698952|NCT01214655|75818217|FG001|Escalated From 2 to 4 mg/m²/Day|Part A||0||
59698953|NCT01214655|75818218|FG002|Escalated From 2 to 4 mg/m²/Day|Part A||0||
59698954|NCT01214655|75818216|FG000|Joined 4 mg Group|Part A||1|4 participants received 4 mg/m²/day|
59698955|NCT01214655|75818217|FG001|Joined 4 mg Group|Part A||0|4 participants received 4 mg/m²/day|
59698956|NCT01214655|75818218|FG002|Joined 4 mg Group|Part A||0|4 participants received 4 mg/m²/day|
59698957|NCT01214655|75818216|FG000|Escalated From 4 mg Study Drug|Part A||0||
59698958|NCT01214655|75818217|FG001|Escalated From 4 mg Study Drug|Part A||0||
59698959|NCT01214655|75818218|FG002|Escalated From 4 mg Study Drug|Part A||0||
59698960|NCT01214655|75818216|FG000|Joined 5 mg Study Drug|Part A||2|2 participants received 5 mg/m²/day|
59698961|NCT01214655|75818217|FG001|Joined 5 mg Study Drug|Part A||0|2 participants received 5 mg/m²/day|
59698962|NCT01214655|75818218|FG002|Joined 5 mg Study Drug|Part A||0|2 participants received 5 mg/m²/day|
59698963|NCT01214655|75818216|FG000|Escalated From 5 mg Study Drug|Part A||1||
59698964|NCT01214655|75818217|FG001|Escalated From 5 mg Study Drug|Part A||0||
59698965|NCT01214655|75818218|FG002|Escalated From 5 mg Study Drug|Part A||0||
59698966|NCT01214655|75818216|FG000|Joined 6 mg Group|Part A||4||
59698967|NCT01214655|75818217|FG001|Joined 6 mg Group|Part A||0||
59698968|NCT01214655|75818218|FG002|Joined 6 mg Group|Part A||0||
59698969|NCT01214655|75818216|FG000|Received 6 mg Study Drug|Part A||5||
59698970|NCT01214655|75818217|FG001|Received 6 mg Study Drug|Part A||0||
59698971|NCT01214655|75818218|FG002|Received 6 mg Study Drug|Part A||0||
59698972|NCT01214655|75818216|FG000|COMPLETED|Part A||2||
59698973|NCT01214655|75818217|FG001|COMPLETED|Part A||0||
59698974|NCT01214655|75818218|FG002|COMPLETED|Part A||0||
59698975|NCT01214655|75818216|FG000|NOT COMPLETED|Part A||8||
59698976|NCT01214655|75818217|FG001|NOT COMPLETED|Part A||0||
59698977|NCT01214655|75818218|FG002|NOT COMPLETED|Part A||0||
59698978|NCT01214655|75818216|FG000|STARTED|Part B|Part A participants did not enroll in Part B. Participants in A, B, C are considered Cohorts.|0||
59698979|NCT01214655|75818217|FG001|STARTED|Part B|Total on Schedule B, dose days 1,5,9|15||
59698980|NCT01214655|75818218|FG002|STARTED|Part B||0||
59698981|NCT01214655|75818216|FG000|Received at Least 1 Dose of Study Drug|Part B||0||
59698982|NCT01214655|75818217|FG001|Received at Least 1 Dose of Study Drug|Part B||15||
59698983|NCT01214655|75818218|FG002|Received at Least 1 Dose of Study Drug|Part B||0||
59698984|NCT01214655|75818216|FG000|Recieved 8 mg/m²/Day Study Drug|Part B||0||
59698985|NCT01214655|75818217|FG001|Recieved 8 mg/m²/Day Study Drug|Part B||4||
59698986|NCT01214655|75818218|FG002|Recieved 8 mg/m²/Day Study Drug|Part B||0||
59698987|NCT01214655|75818216|FG000|Escalated From 8 to 10 mg/m²/Day|Part B||0||
59698988|NCT01214655|75818217|FG001|Escalated From 8 to 10 mg/m²/Day|Part B||2||
59698989|NCT01214655|75818218|FG002|Escalated From 8 to 10 mg/m²/Day|Part B||0||
59698990|NCT01214655|75818216|FG000|Joined 10 mg/m²/Day Study D|Part B||0|5 participants received 10 mg/m²/day Study Drug|
59698991|NCT01214655|75818217|FG001|Joined 10 mg/m²/Day Study D|Part B||3|5 participants received 10 mg/m²/day Study Drug|
59698992|NCT01214655|75818218|FG002|Joined 10 mg/m²/Day Study D|Part B||0|5 participants received 10 mg/m²/day Study Drug|
59698993|NCT01214655|75818216|FG000|Escalated to 12 mg/m²/Day|Part B||0||
59698994|NCT01214655|75818217|FG001|Escalated to 12 mg/m²/Day|Part B||2||
59698995|NCT01214655|75818218|FG002|Escalated to 12 mg/m²/Day|Part B||0||
59698996|NCT01214655|75818216|FG000|Joined 12 mg/m²/Day|Part B||0|7 participants received 12 mg/m²/day Study Drug|
59698997|NCT01214655|75818217|FG001|Joined 12 mg/m²/Day|Part B||5|7 participants received 12 mg/m²/day Study Drug|
59698998|NCT01214655|75818218|FG002|Joined 12 mg/m²/Day|Part B||0|7 participants received 12 mg/m²/day Study Drug|
59698999|NCT01214655|75818216|FG000|Escalated From 12 to 14 mg/m²/Day|Part B||0||
59699000|NCT01214655|75818217|FG001|Escalated From 12 to 14 mg/m²/Day|Part B||1||
59699001|NCT01214655|75818218|FG002|Escalated From 12 to 14 mg/m²/Day|Part B||0||
59699002|NCT01214655|75818216|FG000|Joined 14 mg/m²/Day|Part B||0|4 participants received 14 mg/m²/day Study Drug|
59699003|NCT01214655|75818217|FG001|Joined 14 mg/m²/Day|Part B||3|4 participants received 14 mg/m²/day Study Drug|
59699004|NCT01214655|75818218|FG002|Joined 14 mg/m²/Day|Part B||0|4 participants received 14 mg/m²/day Study Drug|
59699005|NCT01214655|75818216|FG000|COMPLETED|Part B||0||
59699006|NCT01214655|75818217|FG001|COMPLETED|Part B||2||
59699007|NCT01214655|75818218|FG002|COMPLETED|Part B||0||
59699008|NCT01214655|75818216|FG000|NOT COMPLETED|Part B||0||
59699009|NCT01214655|75818217|FG001|NOT COMPLETED|Part B||13||
59699010|NCT01214655|75818218|FG002|NOT COMPLETED|Part B||0||
59699011|NCT01214655|75818216|FG000|STARTED|Part C||0||
59699012|NCT01214655|75818217|FG001|STARTED|Part C||0||
59699013|NCT01214655|75818218|FG002|STARTED|Part C|Total on Schedule C, dose days 1,2,3|8||
59699014|NCT01214655|75818216|FG000|Received at Least 1 Dose of 5 mg/m²/Day|Part C||0||
59699015|NCT01214655|75818217|FG001|Received at Least 1 Dose of 5 mg/m²/Day|Part C||0||
59699016|NCT01214655|75818218|FG002|Received at Least 1 Dose of 5 mg/m²/Day|Part C||8||
59699017|NCT01214655|75818216|FG000|COMPLETED|Part C||0||
59699018|NCT01214655|75818217|FG001|COMPLETED|Part C||0||
59699019|NCT01214655|75818218|FG002|COMPLETED|Part C||1||
59699020|NCT01214655|75818216|FG000|NOT COMPLETED|Part C||0||
59699021|NCT01214655|75818217|FG001|NOT COMPLETED|Part C||0||
59699022|NCT01214655|75818218|FG002|NOT COMPLETED|Part C||7||
59699023|NCT01017874|75818266|FG000|STARTED|Overall Study||118||
59699024|NCT01017874|75818267|FG001|STARTED|Overall Study||118||
59699025|NCT01017874|75818266|FG000|Received at Least 1 Dose of Study Drug|Overall Study||114||
59699026|NCT01017874|75818267|FG001|Received at Least 1 Dose of Study Drug|Overall Study||118||
59699027|NCT01017874|75818266|FG000|COMPLETED|Overall Study||88||
59699028|NCT01017874|75818267|FG001|COMPLETED|Overall Study||92||
59699029|NCT01017874|75818266|FG000|NOT COMPLETED|Overall Study||30||
59699030|NCT01017874|75818267|FG001|NOT COMPLETED|Overall Study||26||
59699031|NCT01015768|75818273|FG000|STARTED|Overall Study||30||30
59699032|NCT01015768|75818274|FG001|STARTED|Overall Study||30||30
59699033|NCT01015768|75818273|FG000|COMPLETED|Overall Study||26||26
59699034|NCT01015768|75818274|FG001|COMPLETED|Overall Study||26||26
59699035|NCT01015768|75818273|FG000|NOT COMPLETED|Overall Study||4||4
59699036|NCT01015768|75818274|FG001|NOT COMPLETED|Overall Study||4||4
59699037|NCT04426630|75818282|FG000|STARTED|Overall Study||72||
59699038|NCT04426630|75818282|FG000|COMPLETED|Overall Study||66||
59699039|NCT04426630|75818282|FG000|NOT COMPLETED|Overall Study||6||
59699040|NCT01010230|75818288|FG000|STARTED|Overall Study||32||
59699041|NCT01010230|75818289|FG001|STARTED|Overall Study||33||
59699042|NCT01010230|75818288|FG000|COMPLETED|Overall Study||22||
59699043|NCT01010230|75818289|FG001|COMPLETED|Overall Study||26||
59699044|NCT01010230|75818288|FG000|NOT COMPLETED|Overall Study||10||
59699045|NCT01010230|75818289|FG001|NOT COMPLETED|Overall Study||7||
59699046|NCT01009840|75818295|FG000|STARTED|Overall Study||30||
59699047|NCT01009840|75818295|FG000|COMPLETED|Overall Study||16||
59699048|NCT01009840|75818295|FG000|NOT COMPLETED|Overall Study||14||
59699049|NCT00982657|75818303|FG000|STARTED|Overall Study||12||
59699050|NCT00982657|75818304|FG001|STARTED|Overall Study||3||
59699051|NCT00982657|75818305|FG002|STARTED|Overall Study||3||
59699052|NCT00982657|75818306|FG003|STARTED|Overall Study||16||
59699053|NCT00982657|75818303|FG000|COMPLETED|Overall Study||11||
59699054|NCT00982657|75818304|FG001|COMPLETED|Overall Study||3||
59699055|NCT00982657|75818305|FG002|COMPLETED|Overall Study||1||
59699056|NCT00982657|75818306|FG003|COMPLETED|Overall Study||7||
59699057|NCT00982657|75818303|FG000|NOT COMPLETED|Overall Study||1||
59699058|NCT00982657|75818304|FG001|NOT COMPLETED|Overall Study||0||
59699059|NCT00982657|75818305|FG002|NOT COMPLETED|Overall Study||2||
59699060|NCT00982657|75818306|FG003|NOT COMPLETED|Overall Study||9||
59699061|NCT01005316|75818329|FG000|STARTED|Overall Study||50||
59699062|NCT01005316|75818330|FG001|STARTED|Overall Study||97||
59699063|NCT01005316|75818331|FG002|STARTED|Overall Study||16||
59699064|NCT01005316|75818332|FG003|STARTED|Overall Study||127||
59699065|NCT01005316|75818329|FG000|COMPLETED|Overall Study||0||
59699066|NCT01005316|75818330|FG001|COMPLETED|Overall Study||21||
59699067|NCT01005316|75818331|FG002|COMPLETED|Overall Study||5||
59699068|NCT01005316|75818332|FG003|COMPLETED|Overall Study||19||
59699069|NCT01005316|75818329|FG000|NOT COMPLETED|Overall Study||50||
59699070|NCT01005316|75818330|FG001|NOT COMPLETED|Overall Study||76||
59699071|NCT01005316|75818331|FG002|NOT COMPLETED|Overall Study||11||
59699072|NCT01005316|75818332|FG003|NOT COMPLETED|Overall Study||108||
59699073|NCT01004848|75818345|FG000|STARTED|Overall Study||210||
59699074|NCT01004848|75818346|FG001|STARTED|Overall Study||192||
59699075|NCT01004848|75818345|FG000|COMPLETED|Overall Study||155||
59699076|NCT01004848|75818346|FG001|COMPLETED|Overall Study||147||
60079589|NCT04206332|76194704|FG004|NOT COMPLETED|Part C||0||
60079590|NCT04206332|76194705|FG005|NOT COMPLETED|Part C||0||
60079591|NCT04206332|76194706|FG006|NOT COMPLETED|Part C||0||
60079592|NCT04206332|76194707|FG007|NOT COMPLETED|Part C||0||
60079593|NCT04206332|76194708|FG008|NOT COMPLETED|Part C||0||
59699077|NCT01004848|75818345|FG000|NOT COMPLETED|Overall Study||55||
59699078|NCT01004848|75818346|FG001|NOT COMPLETED|Overall Study||45||
59699079|NCT01009294|75818354|FG000|STARTED|Overall Study||6||
59699080|NCT01009294|75818354|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6||
59699081|NCT01009294|75818354|FG000|COMPLETED|Overall Study||0||
59699082|NCT01009294|75818354|FG000|NOT COMPLETED|Overall Study||6||
59699083|NCT01009060|75818360|FG000|STARTED|Overall Study||25||
59699084|NCT01009060|75818361|FG001|STARTED|Overall Study||25||
59699085|NCT01009060|75818360|FG000|COMPLETED|Overall Study||21||
59699086|NCT01009060|75818361|FG001|COMPLETED|Overall Study||20||
59699087|NCT01009060|75818360|FG000|NOT COMPLETED|Overall Study||4||
59699088|NCT01009060|75818361|FG001|NOT COMPLETED|Overall Study||5||
59699089|NCT00988429|75818374|FG000|STARTED|Overall Study||226||
59699090|NCT00988429|75818375|FG001|STARTED|Overall Study||216||
59699091|NCT00988429|75818376|FG002|STARTED|Overall Study||211||
59699092|NCT00988429|75818374|FG000|Safety Population|Overall Study||224||
59699093|NCT00988429|75818375|FG001|Safety Population|Overall Study||216||
59699094|NCT00988429|75818376|FG002|Safety Population|Overall Study||210||
59699095|NCT00988429|75818374|FG000|Intention-to-treat (ITT) Population|Overall Study||220||
59699096|NCT00988429|75818375|FG001|Intention-to-treat (ITT) Population|Overall Study||215||
59699097|NCT00988429|75818376|FG002|Intention-to-treat (ITT) Population|Overall Study||205||
59699098|NCT00988429|75818374|FG000|COMPLETED|Overall Study||189||
59699099|NCT00988429|75818375|FG001|COMPLETED|Overall Study||173||
59699100|NCT00988429|75818376|FG002|COMPLETED|Overall Study||142||
59699101|NCT00988429|75818374|FG000|NOT COMPLETED|Overall Study||37||
59699102|NCT00988429|75818375|FG001|NOT COMPLETED|Overall Study||43||
59699103|NCT00988429|75818376|FG002|NOT COMPLETED|Overall Study||69||
59699104|NCT01008904|75818385|FG000|STARTED|Overall Study||29||
59699105|NCT01008904|75818385|FG000|COMPLETED|Overall Study||25||
59699106|NCT01008904|75818385|FG000|NOT COMPLETED|Overall Study||4||
59699107|NCT01004614|75818393|FG000|STARTED|First Intervention||12||
59699108|NCT01004614|75818394|FG001|STARTED|First Intervention||12||
59699109|NCT01004614|75818395|FG002|STARTED|First Intervention||12||
59699110|NCT01004614|75818396|FG003|STARTED|First Intervention||12||
59699111|NCT01004614|75818393|FG000|COMPLETED|First Intervention||12||
59699112|NCT01004614|75818394|FG001|COMPLETED|First Intervention||12||
59699113|NCT01004614|75818395|FG002|COMPLETED|First Intervention||12||
59699114|NCT01004614|75818396|FG003|COMPLETED|First Intervention||12||
59699115|NCT01004614|75818393|FG000|NOT COMPLETED|First Intervention||0||
59699116|NCT01004614|75818394|FG001|NOT COMPLETED|First Intervention||0||
59699117|NCT01004614|75818395|FG002|NOT COMPLETED|First Intervention||0||
59699118|NCT01004614|75818396|FG003|NOT COMPLETED|First Intervention||0||
59699119|NCT01004614|75818393|FG000|STARTED|Washout||12||
59699120|NCT01004614|75818394|FG001|STARTED|Washout||12||
59699121|NCT01004614|75818395|FG002|STARTED|Washout||12||
59699122|NCT01004614|75818396|FG003|STARTED|Washout||12||
59699123|NCT01004614|75818393|FG000|COMPLETED|Washout||12||
59699124|NCT01004614|75818394|FG001|COMPLETED|Washout||11||
59699125|NCT01004614|75818395|FG002|COMPLETED|Washout||12||
59699126|NCT01004614|75818396|FG003|COMPLETED|Washout||12||
59699127|NCT01004614|75818393|FG000|NOT COMPLETED|Washout||0||
59699128|NCT01004614|75818394|FG001|NOT COMPLETED|Washout||1||
59699129|NCT01004614|75818395|FG002|NOT COMPLETED|Washout||0||
59699130|NCT01004614|75818396|FG003|NOT COMPLETED|Washout||0||
59699131|NCT01004614|75818393|FG000|STARTED|Second Intervention||12||
59699132|NCT01004614|75818394|FG001|STARTED|Second Intervention||11||
59699133|NCT01004614|75818395|FG002|STARTED|Second Intervention||12||
59699134|NCT01004614|75818396|FG003|STARTED|Second Intervention||12||
59699135|NCT01004614|75818393|FG000|COMPLETED|Second Intervention||12||
59699136|NCT01004614|75818394|FG001|COMPLETED|Second Intervention||11||
59699137|NCT01004614|75818395|FG002|COMPLETED|Second Intervention||12||
59699138|NCT01004614|75818396|FG003|COMPLETED|Second Intervention||12||
59699139|NCT01004614|75818393|FG000|NOT COMPLETED|Second Intervention||0||
59699140|NCT01004614|75818394|FG001|NOT COMPLETED|Second Intervention||0||
59699141|NCT01004614|75818395|FG002|NOT COMPLETED|Second Intervention||0||
59699142|NCT01004614|75818396|FG003|NOT COMPLETED|Second Intervention||0||
59699143|NCT00981409|75818408|FG000|STARTED|Overall Study||30||
59699144|NCT00981409|75818409|FG001|STARTED|Overall Study||11||
59699145|NCT00981409|75818408|FG000|COMPLETED|Overall Study||24||
59699146|NCT00981409|75818409|FG001|COMPLETED|Overall Study||10||
59699147|NCT00981409|75818408|FG000|NOT COMPLETED|Overall Study||6||
59699148|NCT00981409|75818409|FG001|NOT COMPLETED|Overall Study||1||
59699149|NCT01008748|75818415|FG000|STARTED|Overall Study||200||
59699150|NCT01008748|75818415|FG000|Baseline|Overall Study||188||
59699151|NCT01008748|75818415|FG000|Week 0|Overall Study||182||
59699152|NCT01008748|75818415|FG000|Week 3|Overall Study||168||
59699153|NCT01008748|75818415|FG000|Week 26|Overall Study||119||
59699154|NCT01008748|75818415|FG000|COMPLETED|Overall Study||119||
59699155|NCT01008748|75818415|FG000|NOT COMPLETED|Overall Study||81||
59699156|NCT01004146|75818421|FG000|STARTED|Overall Study||25||
59699157|NCT01004146|75818422|FG001|STARTED|Overall Study||25||
59699158|NCT01004146|75818421|FG000|Have Incentive Spirometry Data|Overall Study||21||
59699159|NCT01004146|75818422|FG001|Have Incentive Spirometry Data|Overall Study||20||
59699160|NCT01004146|75818421|FG000|COMPLETED|Overall Study||21||
59699161|NCT01004146|75818422|FG001|COMPLETED|Overall Study||20||
59816212|NCT00521144|75938576|FG003|NOT COMPLETED|Overall Study||1||
59990759|NCT02461160|76106272|FG003|STARTED|Overall Study||12||
59990760|NCT02461160|76106273|FG004|STARTED|Overall Study||6||
59990761|NCT02461160|76106274|FG005|STARTED|Overall Study||6||
59990762|NCT02461160|76106275|FG006|STARTED|Overall Study||6||
59990763|NCT02461160|76106276|FG007|STARTED|Overall Study||6||
59990764|NCT02461160|76106277|FG008|STARTED|Overall Study||12||
59699162|NCT01004146|75818421|FG000|NOT COMPLETED|Overall Study||4||
59699163|NCT01004146|75818422|FG001|NOT COMPLETED|Overall Study||5||
59699164|NCT01012414|75818428|FG000|STARTED|Overall Study||10||
59699165|NCT01012414|75818428|FG000|COMPLETED|Overall Study|No subjects completed the study.|0||
59699166|NCT01012414|75818428|FG000|NOT COMPLETED|Overall Study||10||
59699167|NCT00975715|75818436|FG000|STARTED|Titration Period||48||
59699168|NCT00975715|75818437|FG001|STARTED|Titration Period||51||
59699169|NCT00975715|75818436|FG000|COMPLETED|Titration Period||41||
59816213|NCT00521144|75938577|FG004|NOT COMPLETED|Overall Study||7||
59699170|NCT00975715|75818437|FG001|COMPLETED|Titration Period||51||
59699171|NCT00975715|75818436|FG000|NOT COMPLETED|Titration Period||7||
59699172|NCT00975715|75818437|FG001|NOT COMPLETED|Titration Period||0||
59699173|NCT00975715|75818436|FG000|STARTED|Maintenance Period||41||
59699174|NCT00975715|75818437|FG001|STARTED|Maintenance Period||51||
59699175|NCT00975715|75818436|FG000|COMPLETED|Maintenance Period||39||
59699176|NCT00975715|75818437|FG001|COMPLETED|Maintenance Period||50||
59699177|NCT00975715|75818436|FG000|NOT COMPLETED|Maintenance Period||2||
59699178|NCT00975715|75818437|FG001|NOT COMPLETED|Maintenance Period||1||
59990765|NCT02461160|76106278|FG009|STARTED|Overall Study||4||
59990766|NCT02461160|76106279|FG010|STARTED|Overall Study||4||
59699179|NCT03962491|75818445|FG000|STARTED|Overall Study||35||
59699180|NCT03962491|75818446|FG001|STARTED|Overall Study||46||
59699181|NCT03962491|75818445|FG000|COMPLETED|Overall Study||31||
59699182|NCT03962491|75818446|FG001|COMPLETED|Overall Study||41||
59699183|NCT03962491|75818445|FG000|NOT COMPLETED|Overall Study||4||
59699184|NCT03962491|75818446|FG001|NOT COMPLETED|Overall Study||5||
59699185|NCT00978757|75818454|FG000|STARTED|Overall Study|June 2001|22||
59699186|NCT00978757|75818455|FG001|STARTED|Overall Study|June 2001|20||
59699187|NCT00978757|75818454|FG000|COMPLETED|Overall Study|June 2008|21||
59699188|NCT00978757|75818455|FG001|COMPLETED|Overall Study|June 2008|17||
59699189|NCT00978757|75818454|FG000|NOT COMPLETED|Overall Study||1||
59699190|NCT00978757|75818455|FG001|NOT COMPLETED|Overall Study||3||
59699191|NCT01214421|75818465|FG000|STARTED|Overall Study||557||
59699192|NCT01214421|75818466|FG001|STARTED|Overall Study||314||
59699193|NCT01214421|75818467|FG002|STARTED|Overall Study||181||
59699194|NCT01214421|75818468|FG003|STARTED|Overall Study||31||
59699195|NCT01214421|75818465|FG000|COMPLETED|Overall Study||507||
59699196|NCT01214421|75818466|FG001|COMPLETED|Overall Study||256||
59699197|NCT01214421|75818467|FG002|COMPLETED|Overall Study||143||
59699198|NCT01214421|75818468|FG003|COMPLETED|Overall Study||22||
59699199|NCT01214421|75818465|FG000|NOT COMPLETED|Overall Study||50||
59699200|NCT01214421|75818466|FG001|NOT COMPLETED|Overall Study||58||
59699201|NCT01214421|75818467|FG002|NOT COMPLETED|Overall Study||38||
59699202|NCT01214421|75818468|FG003|NOT COMPLETED|Overall Study||9||
59699203|NCT04102111|75818480|FG000|STARTED|Overall Study||18||
59699204|NCT04102111|75818481|FG001|STARTED|Overall Study||30||
59699205|NCT04102111|75818480|FG000|COMPLETED|Overall Study||14||
59699206|NCT04102111|75818481|FG001|COMPLETED|Overall Study||23||
59699207|NCT04102111|75818480|FG000|NOT COMPLETED|Overall Study||4||
59699208|NCT04102111|75818481|FG001|NOT COMPLETED|Overall Study||7||
59699209|NCT01214187|75818489|FG000|STARTED|Overall Study||29||
59699210|NCT01214187|75818490|FG001|STARTED|Overall Study||29||
59699211|NCT01214187|75818489|FG000|COMPLETED|Overall Study||22||
59699212|NCT01214187|75818490|FG001|COMPLETED|Overall Study||23||
59699213|NCT01214187|75818489|FG000|NOT COMPLETED|Overall Study||7||
59699214|NCT01214187|75818490|FG001|NOT COMPLETED|Overall Study||6||
59699215|NCT01003990|75818499|FG000|STARTED|Overall Study||459||
59699216|NCT01003990|75818500|FG001|STARTED|Overall Study||154||
59699217|NCT01003990|75818501|FG002|STARTED|Overall Study||96||
59699218|NCT01003990|75818499|FG000|COMPLETED|Overall Study||367||
59699219|NCT01003990|75818500|FG001|COMPLETED|Overall Study||103||
59699220|NCT01003990|75818501|FG002|COMPLETED|Overall Study||53||
59699221|NCT01003990|75818499|FG000|NOT COMPLETED|Overall Study||92||
59699222|NCT01003990|75818500|FG001|NOT COMPLETED|Overall Study||51||
59699223|NCT01003990|75818501|FG002|NOT COMPLETED|Overall Study||43||
59699224|NCT01003210|75818511|FG000|STARTED|Overall Study||105||
59699225|NCT01003210|75818512|FG001|STARTED|Overall Study||105||
59699226|NCT01003210|75818511|FG000|COMPLETED|Overall Study||104||
59699227|NCT01003210|75818512|FG001|COMPLETED|Overall Study||102||
59699228|NCT01003210|75818511|FG000|NOT COMPLETED|Overall Study||1||
59699229|NCT01003210|75818512|FG001|NOT COMPLETED|Overall Study||3||
59699230|NCT01002820|75818518|FG000|STARTED|Overall Study||11||
59699231|NCT01002820|75818518|FG000|COMPLETED|Overall Study||7||
59699232|NCT01002820|75818518|FG000|NOT COMPLETED|Overall Study||4||
59699233|NCT01012258|75818522|FG000|STARTED|Overall Study||66||
59699234|NCT01012258|75818522|FG000|COMPLETED|Overall Study||0||
59699235|NCT01012258|75818522|FG000|NOT COMPLETED|Overall Study||66||
59699236|NCT01011946|75818527|FG000|STARTED|Overall Study||36||
59699237|NCT01011946|75818527|FG000|COMPLETED|Overall Study||33||
59699238|NCT01011946|75818527|FG000|NOT COMPLETED|Overall Study||3||
59699239|NCT00975481|75818531|FG000|STARTED|First Intervention Period||6||
59699240|NCT00975481|75818532|FG001|STARTED|First Intervention Period||6||
59699241|NCT00975481|75818533|FG002|STARTED|First Intervention Period||6||
59699242|NCT00975481|75818534|FG003|STARTED|First Intervention Period||6||
59699243|NCT00975481|75818535|FG004|STARTED|First Intervention Period||6||
59699244|NCT00975481|75818536|FG005|STARTED|First Intervention Period||6||
59699245|NCT00975481|75818531|FG000|COMPLETED|First Intervention Period||6||
59699246|NCT00975481|75818532|FG001|COMPLETED|First Intervention Period||6||
59699247|NCT00975481|75818533|FG002|COMPLETED|First Intervention Period||6||
59699248|NCT00975481|75818534|FG003|COMPLETED|First Intervention Period||6||
59699249|NCT00975481|75818535|FG004|COMPLETED|First Intervention Period||6||
59699250|NCT00975481|75818536|FG005|COMPLETED|First Intervention Period||6||
59699251|NCT00975481|75818531|FG000|NOT COMPLETED|First Intervention Period||0||
59699252|NCT00975481|75818532|FG001|NOT COMPLETED|First Intervention Period||0||
59699253|NCT00975481|75818533|FG002|NOT COMPLETED|First Intervention Period||0||
59699254|NCT00975481|75818534|FG003|NOT COMPLETED|First Intervention Period||0||
59699255|NCT00975481|75818535|FG004|NOT COMPLETED|First Intervention Period||0||
59699256|NCT00975481|75818536|FG005|NOT COMPLETED|First Intervention Period||0||
59699257|NCT00975481|75818531|FG000|STARTED|Washout Period (at Least 7 Days)||6||
59699258|NCT00975481|75818532|FG001|STARTED|Washout Period (at Least 7 Days)||6||
59699259|NCT00975481|75818533|FG002|STARTED|Washout Period (at Least 7 Days)||6||
59699260|NCT00975481|75818534|FG003|STARTED|Washout Period (at Least 7 Days)||6||
59699261|NCT00975481|75818535|FG004|STARTED|Washout Period (at Least 7 Days)||6||
59699262|NCT00975481|75818536|FG005|STARTED|Washout Period (at Least 7 Days)||6||
59699263|NCT00975481|75818531|FG000|COMPLETED|Washout Period (at Least 7 Days)||6||
59699264|NCT00975481|75818532|FG001|COMPLETED|Washout Period (at Least 7 Days)||6||
59699265|NCT00975481|75818533|FG002|COMPLETED|Washout Period (at Least 7 Days)||6||
59699266|NCT00975481|75818534|FG003|COMPLETED|Washout Period (at Least 7 Days)||6||
59699267|NCT00975481|75818535|FG004|COMPLETED|Washout Period (at Least 7 Days)||6||
59699268|NCT00975481|75818536|FG005|COMPLETED|Washout Period (at Least 7 Days)||6||
59699269|NCT00975481|75818531|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||0||
59699270|NCT00975481|75818532|FG001|NOT COMPLETED|Washout Period (at Least 7 Days)||0||
59699271|NCT00975481|75818533|FG002|NOT COMPLETED|Washout Period (at Least 7 Days)||0||
59699272|NCT00975481|75818534|FG003|NOT COMPLETED|Washout Period (at Least 7 Days)||0||
59699273|NCT00975481|75818535|FG004|NOT COMPLETED|Washout Period (at Least 7 Days)||0||
59699274|NCT00975481|75818536|FG005|NOT COMPLETED|Washout Period (at Least 7 Days)||0||
59699275|NCT00975481|75818531|FG000|STARTED|Second Intervention Period||6||
59699276|NCT00975481|75818532|FG001|STARTED|Second Intervention Period||6||
59699277|NCT00975481|75818533|FG002|STARTED|Second Intervention Period||6||
59699278|NCT00975481|75818534|FG003|STARTED|Second Intervention Period||6||
59699279|NCT00975481|75818535|FG004|STARTED|Second Intervention Period||6||
59699280|NCT00975481|75818536|FG005|STARTED|Second Intervention Period||6||
59699281|NCT00975481|75818531|FG000|COMPLETED|Second Intervention Period||4||
59699282|NCT00975481|75818532|FG001|COMPLETED|Second Intervention Period||5||
59699283|NCT00975481|75818533|FG002|COMPLETED|Second Intervention Period||5||
59699284|NCT00975481|75818534|FG003|COMPLETED|Second Intervention Period||6||
59699285|NCT00975481|75818535|FG004|COMPLETED|Second Intervention Period||6||
59699286|NCT00975481|75818536|FG005|COMPLETED|Second Intervention Period||6||
59699287|NCT00975481|75818531|FG000|NOT COMPLETED|Second Intervention Period||2||
59699288|NCT00975481|75818532|FG001|NOT COMPLETED|Second Intervention Period||1||
59699289|NCT00975481|75818533|FG002|NOT COMPLETED|Second Intervention Period||1||
59699290|NCT00975481|75818534|FG003|NOT COMPLETED|Second Intervention Period||0||
59699291|NCT00975481|75818535|FG004|NOT COMPLETED|Second Intervention Period||0||
59699292|NCT00975481|75818536|FG005|NOT COMPLETED|Second Intervention Period||0||
59699293|NCT00975481|75818531|FG000|STARTED|Washout Period (at Least 7 Days)||4||
59699294|NCT00975481|75818532|FG001|STARTED|Washout Period (at Least 7 Days)||5||
59699295|NCT00975481|75818533|FG002|STARTED|Washout Period (at Least 7 Days)||5||
59699296|NCT00975481|75818534|FG003|STARTED|Washout Period (at Least 7 Days)||6||
59699297|NCT00975481|75818535|FG004|STARTED|Washout Period (at Least 7 Days)||6||
59699298|NCT00975481|75818536|FG005|STARTED|Washout Period (at Least 7 Days)||6||
59699299|NCT00975481|75818531|FG000|COMPLETED|Washout Period (at Least 7 Days)||4||
59699300|NCT00975481|75818532|FG001|COMPLETED|Washout Period (at Least 7 Days)||5||
59699301|NCT00975481|75818533|FG002|COMPLETED|Washout Period (at Least 7 Days)||5||
59699302|NCT00975481|75818534|FG003|COMPLETED|Washout Period (at Least 7 Days)||6||
59699303|NCT00975481|75818535|FG004|COMPLETED|Washout Period (at Least 7 Days)||6||
59548011|NCT02385084|75646963|FG005|Washout|Period 1||3||
59699304|NCT00975481|75818536|FG005|COMPLETED|Washout Period (at Least 7 Days)||6||
59699305|NCT00975481|75818531|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||0||
59548012|NCT02385084|75646958|FG000|COMPLETED|Period 1||3||
59548013|NCT02385084|75646959|FG001|COMPLETED|Period 1||3||
59548014|NCT02385084|75646960|FG002|COMPLETED|Period 1||3||
59548015|NCT02385084|75646961|FG003|COMPLETED|Period 1||3||
59548016|NCT02385084|75646962|FG004|COMPLETED|Period 1||3||
59548017|NCT02385084|75646963|FG005|COMPLETED|Period 1||3||
59548018|NCT02385084|75646958|FG000|NOT COMPLETED|Period 1||0||
59548019|NCT02385084|75646959|FG001|NOT COMPLETED|Period 1||0||
59548020|NCT02385084|75646960|FG002|NOT COMPLETED|Period 1||0||
59548021|NCT02385084|75646961|FG003|NOT COMPLETED|Period 1||0||
59548022|NCT02385084|75646962|FG004|NOT COMPLETED|Period 1||0||
59548023|NCT02385084|75646963|FG005|NOT COMPLETED|Period 1||0||
59548024|NCT02385084|75646958|FG000|STARTED|Period 2|1 participant discontinued after Period 1 - physician decision. Did not enter Period 2.|2||
59548025|NCT02385084|75646959|FG001|STARTED|Period 2||3||
59548026|NCT02385084|75646960|FG002|STARTED|Period 2||3||
59548027|NCT02385084|75646961|FG003|STARTED|Period 2||3||
59548028|NCT02385084|75646962|FG004|STARTED|Period 2||3||
59699306|NCT00975481|75818532|FG001|NOT COMPLETED|Washout Period (at Least 7 Days)||0||
59699307|NCT00975481|75818533|FG002|NOT COMPLETED|Washout Period (at Least 7 Days)||0||
59699308|NCT00975481|75818534|FG003|NOT COMPLETED|Washout Period (at Least 7 Days)||0||
59816214|NCT00520676|75938591|FG000|STARTED|Overall Study||128||
59548029|NCT02385084|75646963|FG005|STARTED|Period 2||3||
59548030|NCT02385084|75646958|FG000|Received LY2409021|Period 2||2||
59548031|NCT02385084|75646959|FG001|Received LY2409021|Period 2||3||
59548032|NCT02385084|75646960|FG002|Received LY2409021|Period 2||3||
59548033|NCT02385084|75646961|FG003|Received LY2409021|Period 2||3||
59548034|NCT02385084|75646962|FG004|Received LY2409021|Period 2||3||
59699309|NCT00975481|75818535|FG004|NOT COMPLETED|Washout Period (at Least 7 Days)||0||
59699310|NCT00975481|75818536|FG005|NOT COMPLETED|Washout Period (at Least 7 Days)||0||
59816215|NCT00520676|75938592|FG001|STARTED|Overall Study||132||
59548035|NCT02385084|75646963|FG005|Received LY2409021|Period 2||3||
59548036|NCT02385084|75646958|FG000|Washout|Period 2||2||
59699311|NCT00975481|75818531|FG000|STARTED|Third Intervention Period||4||
59699312|NCT00975481|75818532|FG001|STARTED|Third Intervention Period||5||
59699313|NCT00975481|75818533|FG002|STARTED|Third Intervention Period||5||
59699314|NCT00975481|75818534|FG003|STARTED|Third Intervention Period||6||
59699315|NCT00975481|75818535|FG004|STARTED|Third Intervention Period||6||
59699316|NCT00975481|75818536|FG005|STARTED|Third Intervention Period||6||
59699317|NCT00975481|75818531|FG000|COMPLETED|Third Intervention Period||4||
59699318|NCT00975481|75818532|FG001|COMPLETED|Third Intervention Period||5||
59699319|NCT00975481|75818533|FG002|COMPLETED|Third Intervention Period||5||
59699320|NCT00975481|75818534|FG003|COMPLETED|Third Intervention Period||6||
59699321|NCT00975481|75818535|FG004|COMPLETED|Third Intervention Period||6||
59699322|NCT00975481|75818536|FG005|COMPLETED|Third Intervention Period||6||
59699323|NCT00975481|75818531|FG000|NOT COMPLETED|Third Intervention Period||0||
59699324|NCT00975481|75818532|FG001|NOT COMPLETED|Third Intervention Period||0||
59699325|NCT00975481|75818533|FG002|NOT COMPLETED|Third Intervention Period||0||
59699326|NCT00975481|75818534|FG003|NOT COMPLETED|Third Intervention Period||0||
59699327|NCT00975481|75818535|FG004|NOT COMPLETED|Third Intervention Period||0||
59699328|NCT00975481|75818536|FG005|NOT COMPLETED|Third Intervention Period||0||
59699329|NCT00975481|75818531|FG000|STARTED|Washout Period (at Least 7 Days)||4||
59699330|NCT00975481|75818532|FG001|STARTED|Washout Period (at Least 7 Days)||5||
59699331|NCT00975481|75818533|FG002|STARTED|Washout Period (at Least 7 Days)||5||
59699332|NCT00975481|75818534|FG003|STARTED|Washout Period (at Least 7 Days)||6||
59699333|NCT00975481|75818535|FG004|STARTED|Washout Period (at Least 7 Days)||6||
59699334|NCT00975481|75818536|FG005|STARTED|Washout Period (at Least 7 Days)||6||
59699335|NCT00975481|75818531|FG000|COMPLETED|Washout Period (at Least 7 Days)||4||
59699336|NCT00975481|75818532|FG001|COMPLETED|Washout Period (at Least 7 Days)||5||
59699337|NCT00975481|75818533|FG002|COMPLETED|Washout Period (at Least 7 Days)||5||
59699338|NCT00975481|75818534|FG003|COMPLETED|Washout Period (at Least 7 Days)||6||
59699339|NCT00975481|75818535|FG004|COMPLETED|Washout Period (at Least 7 Days)||6||
59699340|NCT00975481|75818536|FG005|COMPLETED|Washout Period (at Least 7 Days)||6||
59699341|NCT00975481|75818531|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||0||
59699342|NCT00975481|75818532|FG001|NOT COMPLETED|Washout Period (at Least 7 Days)||0||
59699343|NCT00975481|75818533|FG002|NOT COMPLETED|Washout Period (at Least 7 Days)||0||
59699344|NCT00975481|75818534|FG003|NOT COMPLETED|Washout Period (at Least 7 Days)||0||
59699345|NCT00975481|75818535|FG004|NOT COMPLETED|Washout Period (at Least 7 Days)||0||
59699346|NCT00975481|75818536|FG005|NOT COMPLETED|Washout Period (at Least 7 Days)||0||
59699347|NCT00975481|75818531|FG000|STARTED|Fourth Intervention Period||4||
59699348|NCT00975481|75818532|FG001|STARTED|Fourth Intervention Period||5||
59699349|NCT00975481|75818533|FG002|STARTED|Fourth Intervention Period||5||
59699350|NCT00975481|75818534|FG003|STARTED|Fourth Intervention Period||6||
59699351|NCT00975481|75818535|FG004|STARTED|Fourth Intervention Period||6||
59699352|NCT00975481|75818536|FG005|STARTED|Fourth Intervention Period||6||
59699353|NCT00975481|75818531|FG000|COMPLETED|Fourth Intervention Period||4||
59699354|NCT00975481|75818532|FG001|COMPLETED|Fourth Intervention Period||5||
59699355|NCT00975481|75818533|FG002|COMPLETED|Fourth Intervention Period||4||
59699356|NCT00975481|75818534|FG003|COMPLETED|Fourth Intervention Period||5||
59699357|NCT00975481|75818535|FG004|COMPLETED|Fourth Intervention Period||6||
59699358|NCT00975481|75818536|FG005|COMPLETED|Fourth Intervention Period||6||
59699359|NCT00975481|75818531|FG000|NOT COMPLETED|Fourth Intervention Period||0||
59699360|NCT00975481|75818532|FG001|NOT COMPLETED|Fourth Intervention Period||0||
59699361|NCT00975481|75818533|FG002|NOT COMPLETED|Fourth Intervention Period||1||
59699362|NCT00975481|75818534|FG003|NOT COMPLETED|Fourth Intervention Period||1||
59699363|NCT00975481|75818535|FG004|NOT COMPLETED|Fourth Intervention Period||0||
59699364|NCT00975481|75818536|FG005|NOT COMPLETED|Fourth Intervention Period||0||
59699365|NCT00975481|75818531|FG000|STARTED|Washout Period (at Least 7 Days)||4||
59699366|NCT00975481|75818532|FG001|STARTED|Washout Period (at Least 7 Days)||5||
59699367|NCT00975481|75818533|FG002|STARTED|Washout Period (at Least 7 Days)||4||
59699368|NCT00975481|75818534|FG003|STARTED|Washout Period (at Least 7 Days)||5||
59699369|NCT00975481|75818535|FG004|STARTED|Washout Period (at Least 7 Days)||6||
59990767|NCT02461160|76106280|FG011|STARTED|Overall Study||4||
59699370|NCT00975481|75818536|FG005|STARTED|Washout Period (at Least 7 Days)||6||
59699371|NCT00975481|75818531|FG000|COMPLETED|Washout Period (at Least 7 Days)||4||
59699372|NCT00975481|75818532|FG001|COMPLETED|Washout Period (at Least 7 Days)||5||
59699373|NCT00975481|75818533|FG002|COMPLETED|Washout Period (at Least 7 Days)||4||
59699374|NCT00975481|75818534|FG003|COMPLETED|Washout Period (at Least 7 Days)||5||
59699375|NCT00975481|75818535|FG004|COMPLETED|Washout Period (at Least 7 Days)||6||
59699376|NCT00975481|75818536|FG005|COMPLETED|Washout Period (at Least 7 Days)||6||
59548037|NCT02385084|75646959|FG001|Washout|Period 2||3||
59699377|NCT00975481|75818531|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||0||
59699378|NCT00975481|75818532|FG001|NOT COMPLETED|Washout Period (at Least 7 Days)||0||
59699379|NCT00975481|75818533|FG002|NOT COMPLETED|Washout Period (at Least 7 Days)||0||
59699380|NCT00975481|75818534|FG003|NOT COMPLETED|Washout Period (at Least 7 Days)||0||
59699381|NCT00975481|75818535|FG004|NOT COMPLETED|Washout Period (at Least 7 Days)||0||
59699382|NCT00975481|75818536|FG005|NOT COMPLETED|Washout Period (at Least 7 Days)||0||
59699383|NCT00975481|75818531|FG000|STARTED|Fifth Intervention Period||4||
59699384|NCT00975481|75818532|FG001|STARTED|Fifth Intervention Period||5||
59699385|NCT00975481|75818533|FG002|STARTED|Fifth Intervention Period||4||
59699386|NCT00975481|75818534|FG003|STARTED|Fifth Intervention Period||5||
59699387|NCT00975481|75818535|FG004|STARTED|Fifth Intervention Period||6||
59699388|NCT00975481|75818536|FG005|STARTED|Fifth Intervention Period||6||
59699389|NCT00975481|75818531|FG000|COMPLETED|Fifth Intervention Period||4||
59699390|NCT00975481|75818532|FG001|COMPLETED|Fifth Intervention Period||5||
59699391|NCT00975481|75818533|FG002|COMPLETED|Fifth Intervention Period||4||
59699392|NCT00975481|75818534|FG003|COMPLETED|Fifth Intervention Period||5||
59699393|NCT00975481|75818535|FG004|COMPLETED|Fifth Intervention Period||5||
59699394|NCT00975481|75818536|FG005|COMPLETED|Fifth Intervention Period||6||
59699395|NCT00975481|75818531|FG000|NOT COMPLETED|Fifth Intervention Period||0||
59699396|NCT00975481|75818532|FG001|NOT COMPLETED|Fifth Intervention Period||0||
59699397|NCT00975481|75818533|FG002|NOT COMPLETED|Fifth Intervention Period||0||
59699398|NCT00975481|75818534|FG003|NOT COMPLETED|Fifth Intervention Period||0||
59699399|NCT00975481|75818535|FG004|NOT COMPLETED|Fifth Intervention Period||1||
59699400|NCT00975481|75818536|FG005|NOT COMPLETED|Fifth Intervention Period||0||
59699401|NCT00975481|75818531|FG000|STARTED|Washout Period (at Least 7 Days)||4||
59699402|NCT00975481|75818532|FG001|STARTED|Washout Period (at Least 7 Days)||5||
59699403|NCT00975481|75818533|FG002|STARTED|Washout Period (at Least 7 Days)||4||
59699404|NCT00975481|75818534|FG003|STARTED|Washout Period (at Least 7 Days)||5||
59548038|NCT02385084|75646960|FG002|Washout|Period 2||3||
59548039|NCT02385084|75646961|FG003|Washout|Period 2||3||
59548040|NCT02385084|75646962|FG004|Washout|Period 2||3||
59548041|NCT02385084|75646963|FG005|Washout|Period 2||3||
59548042|NCT02385084|75646958|FG000|COMPLETED|Period 2||2||
59548043|NCT02385084|75646959|FG001|COMPLETED|Period 2||3||
59548044|NCT02385084|75646960|FG002|COMPLETED|Period 2||2||
59548045|NCT02385084|75646961|FG003|COMPLETED|Period 2||3||
59548046|NCT02385084|75646962|FG004|COMPLETED|Period 2||3||
59548047|NCT02385084|75646963|FG005|COMPLETED|Period 2||3||
59548048|NCT02385084|75646958|FG000|NOT COMPLETED|Period 2||0||
59548049|NCT02385084|75646959|FG001|NOT COMPLETED|Period 2||0||
59548050|NCT02385084|75646960|FG002|NOT COMPLETED|Period 2||1||
59548051|NCT02385084|75646961|FG003|NOT COMPLETED|Period 2||0||
59548052|NCT02385084|75646962|FG004|NOT COMPLETED|Period 2||0||
59548053|NCT02385084|75646963|FG005|NOT COMPLETED|Period 2||0||
59548054|NCT02385084|75646958|FG000|STARTED|Period 3||2||
59548055|NCT02385084|75646959|FG001|STARTED|Period 3||3||
59548056|NCT02385084|75646960|FG002|STARTED|Period 3|1 participant discontinued after Period 2 - adverse event. Did not enter Period 3.|1||
59548057|NCT02385084|75646961|FG003|STARTED|Period 3||3||
59548058|NCT02385084|75646962|FG004|STARTED|Period 3|1 participant discontinued after Period 2 - adverse event. Did not enter Period 3.|2||
59548059|NCT02385084|75646963|FG005|STARTED|Period 3||3||
59548060|NCT02385084|75646958|FG000|Received LY2409021|Period 3||2||
59548061|NCT02385084|75646959|FG001|Received LY2409021|Period 3||3||
59548062|NCT02385084|75646960|FG002|Received LY2409021|Period 3||1||
59548063|NCT02385084|75646961|FG003|Received LY2409021|Period 3||3||
59548064|NCT02385084|75646962|FG004|Received LY2409021|Period 3||2||
59548065|NCT02385084|75646963|FG005|Received LY2409021|Period 3||3||
59548066|NCT02385084|75646958|FG000|Washout|Period 3||2||
59548067|NCT02385084|75646959|FG001|Washout|Period 3||3||
59548068|NCT02385084|75646960|FG002|Washout|Period 3||1||
59548069|NCT02385084|75646961|FG003|Washout|Period 3||3||
59548070|NCT02385084|75646962|FG004|Washout|Period 3||2||
59548071|NCT02385084|75646963|FG005|Washout|Period 3||3||
59548072|NCT02385084|75646958|FG000|COMPLETED|Period 3||2||
59699405|NCT00975481|75818535|FG004|STARTED|Washout Period (at Least 7 Days)||5||
59548073|NCT02385084|75646959|FG001|COMPLETED|Period 3||3||
59699406|NCT00975481|75818536|FG005|STARTED|Washout Period (at Least 7 Days)||6||
59699407|NCT00975481|75818531|FG000|COMPLETED|Washout Period (at Least 7 Days)||4||
59548074|NCT02385084|75646960|FG002|COMPLETED|Period 3||1||
59548075|NCT02385084|75646961|FG003|COMPLETED|Period 3||3||
59548076|NCT02385084|75646962|FG004|COMPLETED|Period 3||2||
59548077|NCT02385084|75646963|FG005|COMPLETED|Period 3||3||
59548078|NCT02385084|75646958|FG000|NOT COMPLETED|Period 3||0||
59548079|NCT02385084|75646959|FG001|NOT COMPLETED|Period 3||0||
59548080|NCT02385084|75646960|FG002|NOT COMPLETED|Period 3||0||
59548081|NCT02385084|75646961|FG003|NOT COMPLETED|Period 3||0||
59699408|NCT00975481|75818532|FG001|COMPLETED|Washout Period (at Least 7 Days)||5||
59699409|NCT00975481|75818533|FG002|COMPLETED|Washout Period (at Least 7 Days)||4||
59699410|NCT00975481|75818534|FG003|COMPLETED|Washout Period (at Least 7 Days)||5||
59699411|NCT00975481|75818535|FG004|COMPLETED|Washout Period (at Least 7 Days)||5||
59699412|NCT00975481|75818536|FG005|COMPLETED|Washout Period (at Least 7 Days)||6||
59699413|NCT00975481|75818531|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||0||
59548082|NCT02385084|75646962|FG004|NOT COMPLETED|Period 3||0||
59548083|NCT02385084|75646963|FG005|NOT COMPLETED|Period 3||0||
59548084|NCT02411292|75646972|FG000|STARTED|Overall Study||110||
59548085|NCT02411292|75646972|FG000|COMPLETED|Overall Study||89||
59548086|NCT02411292|75646972|FG000|NOT COMPLETED|Overall Study||21||
59548087|NCT01166984|75646983|FG000|STARTED|Overall Study||5||
59548088|NCT01166984|75646984|FG001|STARTED|Overall Study||5||
59699414|NCT00975481|75818532|FG001|NOT COMPLETED|Washout Period (at Least 7 Days)||0||
59699415|NCT00975481|75818533|FG002|NOT COMPLETED|Washout Period (at Least 7 Days)||0||
59699416|NCT00975481|75818534|FG003|NOT COMPLETED|Washout Period (at Least 7 Days)||0||
59699417|NCT00975481|75818535|FG004|NOT COMPLETED|Washout Period (at Least 7 Days)||0||
59699418|NCT00975481|75818536|FG005|NOT COMPLETED|Washout Period (at Least 7 Days)||0||
59699419|NCT00975481|75818531|FG000|STARTED|Sixth Intervention Period||4||
59699420|NCT00975481|75818532|FG001|STARTED|Sixth Intervention Period||5||
59699421|NCT00975481|75818533|FG002|STARTED|Sixth Intervention Period||4||
59699422|NCT00975481|75818534|FG003|STARTED|Sixth Intervention Period||5||
59699423|NCT00975481|75818535|FG004|STARTED|Sixth Intervention Period||5||
59699424|NCT00975481|75818536|FG005|STARTED|Sixth Intervention Period||6||
59699425|NCT00975481|75818531|FG000|COMPLETED|Sixth Intervention Period||4||
59699426|NCT00975481|75818532|FG001|COMPLETED|Sixth Intervention Period||5||
59699427|NCT00975481|75818533|FG002|COMPLETED|Sixth Intervention Period||4||
59699428|NCT00975481|75818534|FG003|COMPLETED|Sixth Intervention Period||5||
59699429|NCT00975481|75818535|FG004|COMPLETED|Sixth Intervention Period||5||
59699430|NCT00975481|75818536|FG005|COMPLETED|Sixth Intervention Period||6||
59699431|NCT00975481|75818531|FG000|NOT COMPLETED|Sixth Intervention Period||0||
59699432|NCT00975481|75818532|FG001|NOT COMPLETED|Sixth Intervention Period||0||
59699433|NCT00975481|75818533|FG002|NOT COMPLETED|Sixth Intervention Period||0||
59699434|NCT00975481|75818534|FG003|NOT COMPLETED|Sixth Intervention Period||0||
59699435|NCT00975481|75818535|FG004|NOT COMPLETED|Sixth Intervention Period||0||
59699436|NCT00975481|75818536|FG005|NOT COMPLETED|Sixth Intervention Period||0||
59699437|NCT01011868|75818557|FG000|STARTED|After Week 18 Follow-up||170||
59699438|NCT01011868|75818558|FG001|STARTED|After Week 18 Follow-up||169||
59699439|NCT01011868|75818559|FG002|STARTED|After Week 18 Follow-up||155||
59699440|NCT01011868|75818557|FG000|COMPLETED|After Week 18 Follow-up||147||
59699441|NCT01011868|75818558|FG001|COMPLETED|After Week 18 Follow-up||153||
59699442|NCT01011868|75818559|FG002|COMPLETED|After Week 18 Follow-up||129||
59699443|NCT01011868|75818557|FG000|NOT COMPLETED|After Week 18 Follow-up||23||
59699444|NCT01011868|75818558|FG001|NOT COMPLETED|After Week 18 Follow-up||16||
59699445|NCT01011868|75818559|FG002|NOT COMPLETED|After Week 18 Follow-up||26||
59699446|NCT01011868|75818557|FG000|STARTED|After Week 78 Follow-up||170||
59699447|NCT01011868|75818558|FG001|STARTED|After Week 78 Follow-up||169||
59699448|NCT01011868|75818559|FG002|STARTED|After Week 78 Follow-up||155||
59699449|NCT01011868|75818557|FG000|COMPLETED|After Week 78 Follow-up||118||
59699450|NCT01011868|75818558|FG001|COMPLETED|After Week 78 Follow-up||131||
59699451|NCT01011868|75818559|FG002|COMPLETED|After Week 78 Follow-up||111||
59699452|NCT01011868|75818557|FG000|NOT COMPLETED|After Week 78 Follow-up||52||
59699453|NCT01011868|75818558|FG001|NOT COMPLETED|After Week 78 Follow-up||38||
59699454|NCT01011868|75818559|FG002|NOT COMPLETED|After Week 78 Follow-up||44||
59699455|NCT01213251|75818570|FG000|STARTED|Overall Study||40||
59699456|NCT01213251|75818571|FG001|STARTED|Overall Study||41||
59699457|NCT01213251|75818572|FG002|STARTED|Overall Study||45||
59699458|NCT01213251|75818570|FG000|COMPLETED|Overall Study|Patients that had the 18-Month follow-up visit|34||
59699459|NCT01213251|75818571|FG001|COMPLETED|Overall Study|Patients that had the 18-Month follow-up visit|37||
59699460|NCT01213251|75818572|FG002|COMPLETED|Overall Study|Patients that had the 18-Month follow-up visit|34||
59699461|NCT01213251|75818570|FG000|NOT COMPLETED|Overall Study||6||
59699462|NCT01213251|75818571|FG001|NOT COMPLETED|Overall Study||4||
59699463|NCT01213251|75818572|FG002|NOT COMPLETED|Overall Study||11||
59699464|NCT01213173|75818587|FG000|STARTED|Overall Study|Patients who were randomized and received treatment|125||
59699465|NCT01213173|75818588|FG001|STARTED|Overall Study|Patients who were randomized and received treatment|126||
59699466|NCT01213173|75818587|FG000|Patients Included in Safety Population|Overall Study||139||
59699467|NCT01213173|75818588|FG001|Patients Included in Safety Population|Overall Study||112||
59699468|NCT01213173|75818587|FG000|Patients Included in ITT Population|Overall Study||116||
59699469|NCT01213173|75818588|FG001|Patients Included in ITT Population|Overall Study||115||
59699470|NCT01213173|75818587|FG000|Patients Included in PP Population|Overall Study||102||
59699471|NCT01213173|75818588|FG001|Patients Included in PP Population|Overall Study||89||
59699472|NCT01213173|75818587|FG000|COMPLETED|Overall Study|Patients who completed the study|113||
59699473|NCT01213173|75818588|FG001|COMPLETED|Overall Study|Patients who completed the study|110||
59699474|NCT01213173|75818587|FG000|NOT COMPLETED|Overall Study||12||
59699475|NCT01213173|75818588|FG001|NOT COMPLETED|Overall Study||16||
59699476|NCT01212159|75818596|FG000|STARTED|Overall Study||26||
59699477|NCT01212159|75818597|FG001|STARTED|Overall Study||44||
59699478|NCT01212159|75818596|FG000|COMPLETED|Overall Study||14||
59699479|NCT01212159|75818597|FG001|COMPLETED|Overall Study||32||
59699480|NCT01212159|75818596|FG000|NOT COMPLETED|Overall Study||12||
59699481|NCT01212159|75818597|FG001|NOT COMPLETED|Overall Study||12||
59699482|NCT00973765|75818605|FG000|STARTED|Overall Study|96|96||
59699483|NCT00973765|75818606|FG001|STARTED|Overall Study|116|116||
59699484|NCT00973765|75818605|FG000|COMPLETED|Overall Study|88|88||
59699485|NCT00973765|75818606|FG001|COMPLETED|Overall Study|102|102||
59699486|NCT00973765|75818605|FG000|NOT COMPLETED|Overall Study||8||
59699487|NCT00973765|75818606|FG001|NOT COMPLETED|Overall Study||14||
59699488|NCT01211769|75818616|FG000|STARTED|Overall Study||20||
59699489|NCT01211769|75818617|FG001|STARTED|Overall Study||20||
59699490|NCT01211769|75818618|FG002|STARTED|Overall Study||20||
59699491|NCT01211769|75818619|FG003|STARTED|Overall Study||20||
59699492|NCT01211769|75818616|FG000|Participants/Group|Overall Study||20||
59699493|NCT01211769|75818617|FG001|Participants/Group|Overall Study||20||
59699494|NCT01211769|75818618|FG002|Participants/Group|Overall Study||20||
59699495|NCT01211769|75818619|FG003|Participants/Group|Overall Study||20||
59699496|NCT01211769|75818616|FG000|COMPLETED|Overall Study||11||
59699497|NCT01211769|75818617|FG001|COMPLETED|Overall Study||10||
59699498|NCT01211769|75818618|FG002|COMPLETED|Overall Study||12||
59699499|NCT01211769|75818619|FG003|COMPLETED|Overall Study||9||
59699500|NCT01211769|75818616|FG000|NOT COMPLETED|Overall Study||9||
59699501|NCT01211769|75818617|FG001|NOT COMPLETED|Overall Study||10||
59699502|NCT01211769|75818618|FG002|NOT COMPLETED|Overall Study||8||
59699503|NCT01211769|75818619|FG003|NOT COMPLETED|Overall Study||11||
59699504|NCT01211613|75818632|FG000|STARTED|Overall Study||37||
59699505|NCT01211613|75818633|FG001|STARTED|Overall Study||35||
59699506|NCT01211613|75818634|FG002|STARTED|Overall Study||35||
59699507|NCT01211613|75818632|FG000|COMPLETED|Overall Study||34||
59699508|NCT01211613|75818633|FG001|COMPLETED|Overall Study||33||
59699509|NCT01211613|75818634|FG002|COMPLETED|Overall Study||33||
59699510|NCT01211613|75818632|FG000|NOT COMPLETED|Overall Study||3||
59699511|NCT01211613|75818633|FG001|NOT COMPLETED|Overall Study||2||
59699512|NCT01211613|75818634|FG002|NOT COMPLETED|Overall Study||2||
59699513|NCT01211535|75818644|FG000|STARTED|Overall Study||52||
59699514|NCT01211535|75818645|FG001|STARTED|Overall Study||52||
60079594|NCT04206332|76194709|FG009|NOT COMPLETED|Part C||0||
60079595|NCT04206332|76194710|FG010|NOT COMPLETED|Part C||0||
60079596|NCT04206332|76194711|FG011|NOT COMPLETED|Part C||0||
60079597|NCT04206332|76194712|FG012|NOT COMPLETED|Part C||0||
60079598|NCT04206332|76194713|FG013|NOT COMPLETED|Part C||0||
60079599|NCT04206332|76194714|FG014|NOT COMPLETED|Part C||2||
60079600|NCT04206332|76194715|FG015|NOT COMPLETED|Part C||0||
60079601|NCT04206332|76194716|FG016|NOT COMPLETED|Part C||2||
60079602|NCT03948698|76194773|FG000|STARTED|Overall Study||4749072||
60079603|NCT03948698|76194773|FG000|COMPLETED|Overall Study||4749072||
60079604|NCT03948698|76194773|FG000|NOT COMPLETED|Overall Study||0||
60079605|NCT03888287|76194779|FG000|STARTED|Overall Study||131||
60079606|NCT03888287|76194780|FG001|STARTED|Overall Study||0||
60079607|NCT03888287|76194781|FG002|STARTED|Overall Study||266||
60079608|NCT03888287|76194782|FG003|STARTED|Overall Study||80||
59548089|NCT01166984|75646985|FG002|STARTED|Overall Study||5||
59548090|NCT01166984|75646986|FG003|STARTED|Overall Study||5||
59548091|NCT01166984|75646987|FG004|STARTED|Overall Study||5||
59548092|NCT01166984|75646983|FG000|COMPLETED|Overall Study||5||
59548093|NCT01166984|75646984|FG001|COMPLETED|Overall Study||5||
59548094|NCT01166984|75646985|FG002|COMPLETED|Overall Study||5||
59548095|NCT01166984|75646986|FG003|COMPLETED|Overall Study||5||
59699515|NCT01211535|75818644|FG000|COMPLETED|Overall Study||52||
59699516|NCT01211535|75818645|FG001|COMPLETED|Overall Study||51||
59699517|NCT01211535|75818644|FG000|NOT COMPLETED|Overall Study||0||
59699518|NCT01211535|75818645|FG001|NOT COMPLETED|Overall Study||1||
59699519|NCT01011556|75818655|FG000|STARTED|Overall Study||58||
59699520|NCT01011556|75818656|FG001|STARTED|Overall Study||56||
59699521|NCT01011556|75818657|FG002|STARTED|Overall Study||55||
59699522|NCT01011556|75818658|FG003|STARTED|Overall Study||64||
59699523|NCT01011556|75818655|FG000|Received at Least 1 Dose of Study Drug|Overall Study||57||
59699524|NCT01011556|75818656|FG001|Received at Least 1 Dose of Study Drug|Overall Study||56||
59699525|NCT01011556|75818657|FG002|Received at Least 1 Dose of Study Drug|Overall Study||54||
59699526|NCT01011556|75818658|FG003|Received at Least 1 Dose of Study Drug|Overall Study||64||
59699527|NCT01011556|75818655|FG000|COMPLETED|Overall Study||52||
59699528|NCT01011556|75818656|FG001|COMPLETED|Overall Study||48||
59699529|NCT01011556|75818657|FG002|COMPLETED|Overall Study||45||
59699530|NCT01011556|75818658|FG003|COMPLETED|Overall Study||51||
59699531|NCT01011556|75818655|FG000|NOT COMPLETED|Overall Study||6||
59699532|NCT01011556|75818656|FG001|NOT COMPLETED|Overall Study||8||
59699533|NCT01011556|75818657|FG002|NOT COMPLETED|Overall Study||10||
59699534|NCT01011556|75818658|FG003|NOT COMPLETED|Overall Study||13||
59699535|NCT01211145|75818675|FG000|STARTED|Overall Study||296||
60079609|NCT03888287|76194779|FG000|COMPLETED|Overall Study||131||
59548096|NCT01166984|75646987|FG004|COMPLETED|Overall Study||5||
59548097|NCT01166984|75646983|FG000|NOT COMPLETED|Overall Study||0||
60079610|NCT03888287|76194780|FG001|COMPLETED|Overall Study||0||
60079611|NCT03888287|76194781|FG002|COMPLETED|Overall Study||266||
60079612|NCT03888287|76194782|FG003|COMPLETED|Overall Study||80||
60079613|NCT03888287|76194779|FG000|NOT COMPLETED|Overall Study||0||
59548098|NCT01166984|75646984|FG001|NOT COMPLETED|Overall Study||0||
59699536|NCT01211145|75818676|FG001|STARTED|Overall Study||115||
59699537|NCT01211145|75818677|FG002|STARTED|Overall Study||99||
59699538|NCT01211145|75818678|FG003|STARTED|Overall Study||288||
59709830|NCT01072149|75828524|FG004|STARTED|Treatment Period 2 (28 Days)||3||
60079614|NCT03888287|76194780|FG001|NOT COMPLETED|Overall Study||0||
60079615|NCT03888287|76194781|FG002|NOT COMPLETED|Overall Study||0||
60079616|NCT03888287|76194782|FG003|NOT COMPLETED|Overall Study||0||
60079617|NCT03880058|76194793|FG000|STARTED|Part A: Pre-abdominoplasty Injections||22||280
59699539|NCT01211145|75818675|FG000|COMPLETED|Overall Study|1 patient was not counted as completed or discontinued due to incomplete information (N=270-1=269).|270||
59699540|NCT01211145|75818676|FG001|COMPLETED|Overall Study||98||
59699541|NCT01211145|75818677|FG002|COMPLETED|Overall Study||86||
59699542|NCT01211145|75818678|FG003|COMPLETED|Overall Study||268||
59699543|NCT01211145|75818675|FG000|NOT COMPLETED|Overall Study||26||
59699544|NCT01211145|75818676|FG001|NOT COMPLETED|Overall Study||17||
59699545|NCT01211145|75818677|FG002|NOT COMPLETED|Overall Study||13||
59699546|NCT01211145|75818678|FG003|NOT COMPLETED|Overall Study||20||
59699547|NCT00977665|75818690|FG000|STARTED|Overall Study||84||
59699548|NCT00977665|75818691|FG001|STARTED|Overall Study||90||
59699549|NCT00977665|75818690|FG000|COMPLETED|Overall Study||63||
59699550|NCT00977665|75818691|FG001|COMPLETED|Overall Study||75||
59699551|NCT00977665|75818690|FG000|NOT COMPLETED|Overall Study||21||
59699552|NCT00977665|75818691|FG001|NOT COMPLETED|Overall Study||15||
59699553|NCT01210443|75818697|FG000|STARTED|Overall Study||2||
59699554|NCT01210443|75818697|FG000|COMPLETED|Overall Study||0||
59699555|NCT01210443|75818697|FG000|NOT COMPLETED|Overall Study||2||
59699556|NCT01007812|75818701|FG000|STARTED|Period 1, One Week||25||
59699557|NCT01007812|75818702|FG001|STARTED|Period 1, One Week||25||
59699558|NCT01007812|75818701|FG000|COMPLETED|Period 1, One Week||24||
59699559|NCT01007812|75818702|FG001|COMPLETED|Period 1, One Week||24||
59699560|NCT01007812|75818701|FG000|NOT COMPLETED|Period 1, One Week||1||
59699561|NCT01007812|75818702|FG001|NOT COMPLETED|Period 1, One Week||1||
59699562|NCT01007812|75818701|FG000|STARTED|Period 2, One Week||24||
59699563|NCT01007812|75818702|FG001|STARTED|Period 2, One Week||24||
59699564|NCT01007812|75818701|FG000|COMPLETED|Period 2, One Week||24||
59699565|NCT01007812|75818702|FG001|COMPLETED|Period 2, One Week||24||
59699566|NCT01007812|75818701|FG000|NOT COMPLETED|Period 2, One Week||0||
59699567|NCT01007812|75818702|FG001|NOT COMPLETED|Period 2, One Week||0||
59699568|NCT01208961|75818708|FG000|STARTED|Low-Fat Period I||27||
59699569|NCT01208961|75818709|FG001|STARTED|Low-Fat Period I||27||
59699570|NCT01208961|75818708|FG000|COMPLETED|Low-Fat Period I||27||
59699571|NCT01208961|75818709|FG001|COMPLETED|Low-Fat Period I||27||
59699572|NCT01208961|75818708|FG000|NOT COMPLETED|Low-Fat Period I||0||
59699573|NCT01208961|75818709|FG001|NOT COMPLETED|Low-Fat Period I||0||
59699574|NCT01208961|75818708|FG000|STARTED|Low-Fat Period II||26||
59699575|NCT01208961|75818709|FG001|STARTED|Low-Fat Period II||27||
59699576|NCT01208961|75818708|FG000|COMPLETED|Low-Fat Period II||26||
59699577|NCT01208961|75818709|FG001|COMPLETED|Low-Fat Period II||27||
59699578|NCT01208961|75818708|FG000|NOT COMPLETED|Low-Fat Period II||0||
59699579|NCT01208961|75818709|FG001|NOT COMPLETED|Low-Fat Period II||0||
59699580|NCT01208961|75818708|FG000|STARTED|High-Fat Period III||26||
59699581|NCT01208961|75818709|FG001|STARTED|High-Fat Period III||26||
59699582|NCT01208961|75818708|FG000|COMPLETED|High-Fat Period III||25||
59699583|NCT01208961|75818709|FG001|COMPLETED|High-Fat Period III||26||
59699584|NCT01208961|75818708|FG000|NOT COMPLETED|High-Fat Period III||1||
59699585|NCT01208961|75818709|FG001|NOT COMPLETED|High-Fat Period III||0||
59699586|NCT01208961|75818708|FG000|STARTED|High-Fat Period IV||25||
59699587|NCT01208961|75818709|FG001|STARTED|High-Fat Period IV||26||
59699588|NCT01208961|75818708|FG000|COMPLETED|High-Fat Period IV||25||
59699589|NCT01208961|75818709|FG001|COMPLETED|High-Fat Period IV||26||
59699590|NCT01208961|75818708|FG000|NOT COMPLETED|High-Fat Period IV||0||
59699591|NCT01208961|75818709|FG001|NOT COMPLETED|High-Fat Period IV||0||
59699592|NCT01001572|75818716|FG000|STARTED|Single-Blind Valsartan 160 mg||932||
59699593|NCT01001572|75818717|FG001|STARTED|Single-Blind Valsartan 160 mg|Participants did not enroll into this arm during single blind period.|0||
59699594|NCT01001572|75818718|FG002|STARTED|Single-Blind Valsartan 160 mg|Participants did not enroll into this arm during single blind period.|0||
59699595|NCT01001572|75818716|FG000|COMPLETED|Single-Blind Valsartan 160 mg||654||
59699596|NCT01001572|75818717|FG001|COMPLETED|Single-Blind Valsartan 160 mg||0||
59699597|NCT01001572|75818718|FG002|COMPLETED|Single-Blind Valsartan 160 mg||0||
59699598|NCT01001572|75818716|FG000|NOT COMPLETED|Single-Blind Valsartan 160 mg||278||
59699599|NCT01001572|75818717|FG001|NOT COMPLETED|Single-Blind Valsartan 160 mg||0||
59699600|NCT01001572|75818718|FG002|NOT COMPLETED|Single-Blind Valsartan 160 mg||0||
59699601|NCT01001572|75818716|FG000|STARTED|Double-Blind Treatment Phase|This arm is only used for single blind period. So, no enrollment during double blind period.|0||
59699602|NCT01001572|75818717|FG001|STARTED|Double-Blind Treatment Phase||329||
59699603|NCT01001572|75818718|FG002|STARTED|Double-Blind Treatment Phase||325||
59699604|NCT01001572|75818716|FG000|Full Analysis Set (FAS)|Double-Blind Treatment Phase||0||
59699605|NCT01001572|75818717|FG001|Full Analysis Set (FAS)|Double-Blind Treatment Phase|One patient was excluded from full analysis set for having no post-baseline efficacy assessment.|328||
59699606|NCT01001572|75818718|FG002|Full Analysis Set (FAS)|Double-Blind Treatment Phase|Two patients were excluded from full analysis set for having no post-baseline efficacy assessment.|323||
59699607|NCT01001572|75818716|FG000|COMPLETED|Double-Blind Treatment Phase||0||
59699608|NCT01001572|75818717|FG001|COMPLETED|Double-Blind Treatment Phase||319||
59699609|NCT01001572|75818718|FG002|COMPLETED|Double-Blind Treatment Phase||306||
59699610|NCT01001572|75818716|FG000|NOT COMPLETED|Double-Blind Treatment Phase||0||
59699611|NCT01001572|75818717|FG001|NOT COMPLETED|Double-Blind Treatment Phase||10||
59699612|NCT01001572|75818718|FG002|NOT COMPLETED|Double-Blind Treatment Phase||19||
59699613|NCT01208415|75818724|FG000|STARTED|Overall Study||40||
59699614|NCT01208415|75818724|FG000|6 Months|Overall Study||37||
59699615|NCT01208415|75818724|FG000|COMPLETED|Overall Study||0||
59699616|NCT01208415|75818724|FG000|NOT COMPLETED|Overall Study||40||
59699617|NCT01208337|75818728|FG000|STARTED|Overall Study||23||
59699618|NCT01208337|75818728|FG000|One-year Follow-up|Overall Study||23||
59699619|NCT01208337|75818728|FG000|Five-year Follow-up|Overall Study||20||
59699620|NCT01208337|75818728|FG000|COMPLETED|Overall Study||20||
59699621|NCT01208337|75818728|FG000|NOT COMPLETED|Overall Study||3||
59699622|NCT04370548|75818734|FG000|STARTED|Overall Study||204||
59699623|NCT04370548|75818735|FG001|STARTED|Overall Study||103||
59699624|NCT04370548|75818734|FG000|COMPLETED|Overall Study||190||
59699625|NCT04370548|75818735|FG001|COMPLETED|Overall Study||100||
59699626|NCT04370548|75818734|FG000|NOT COMPLETED|Overall Study||14||
59699627|NCT04370548|75818735|FG001|NOT COMPLETED|Overall Study||3||
59699628|NCT01208181|75818744|FG000|STARTED|Part 1||818||
59699629|NCT01208181|75818745|FG001|STARTED|Part 1||468||
59699630|NCT01208181|75818746|FG002|STARTED|Part 1||0||
59699631|NCT01208181|75818747|FG003|STARTED|Part 1||0||
59699632|NCT01208181|75818748|FG004|STARTED|Part 1||118||
59699633|NCT01208181|75818744|FG000|COMPLETED|Part 1|Six participants from this arm did not continue into Part II of the study|719||
59699634|NCT01208181|75818745|FG001|COMPLETED|Part 1|Per protocol, participants in this arm did not continue into Part II of the study|413||
59699635|NCT01208181|75818746|FG002|COMPLETED|Part 1||0||
59699636|NCT01208181|75818747|FG003|COMPLETED|Part 1||0||
59699637|NCT01208181|75818748|FG004|COMPLETED|Part 1|Per protocol, participants in this arm did not continue into Part II of the study|96||
59699638|NCT01208181|75818744|FG000|NOT COMPLETED|Part 1||99||
59699639|NCT01208181|75818745|FG001|NOT COMPLETED|Part 1||55||
59699640|NCT01208181|75818746|FG002|NOT COMPLETED|Part 1||0||
59699641|NCT01208181|75818747|FG003|NOT COMPLETED|Part 1||0||
59699642|NCT01208181|75818748|FG004|NOT COMPLETED|Part 1||22||
59699643|NCT01208181|75818744|FG000|STARTED|Part 2|Per protocol, there were no participants in this arm during Part II of the study|0||
59699644|NCT01208181|75818745|FG001|STARTED|Part 2|Per protocol, there were no participants in this arm during Part II of the study|0||
59699645|NCT01208181|75818746|FG002|STARTED|Part 2|Participants receiving etoricoxib 60 mg in Part I received etoricoxib 60 mg in Part II of the study|350||
59699646|NCT01208181|75818747|FG003|STARTED|Part 2|Participants receiving etoricoxib 60 mg in Part I received etoricoxib 90 mg in Part II of the study|363||
59699647|NCT01208181|75818748|FG004|STARTED|Part 2|Per protocol, participants did not receive placebo during Part II of the study|0||
59699648|NCT01208181|75818744|FG000|COMPLETED|Part 2||0||
59699649|NCT01208181|75818745|FG001|COMPLETED|Part 2||0||
59699650|NCT01208181|75818746|FG002|COMPLETED|Part 2||334||
59699651|NCT01208181|75818747|FG003|COMPLETED|Part 2||343||
59699652|NCT01208181|75818748|FG004|COMPLETED|Part 2||0||
59699653|NCT01208181|75818744|FG000|NOT COMPLETED|Part 2||0||
59699654|NCT01208181|75818745|FG001|NOT COMPLETED|Part 2||0||
59699655|NCT01208181|75818746|FG002|NOT COMPLETED|Part 2||16||
59699656|NCT01208181|75818747|FG003|NOT COMPLETED|Part 2||20||
59699657|NCT01208181|75818748|FG004|NOT COMPLETED|Part 2||0||
59699658|NCT01208103|75818765|FG000|STARTED|Overall Study||30||
59699659|NCT01208103|75818765|FG000|COMPLETED|Overall Study||28||
59699660|NCT01208103|75818765|FG000|NOT COMPLETED|Overall Study||2||
59699661|NCT01206777|75818770|FG000|STARTED|Overall Study||52||
59699662|NCT01206777|75818770|FG000|Discontinued Trial and Deemed Ineligible|Overall Study||2||
59699663|NCT01206777|75818770|FG000|COMPLETED|Overall Study||50||
59699664|NCT01206777|75818770|FG000|NOT COMPLETED|Overall Study||2||
59699665|NCT01001494|75818777|FG000|STARTED|Overall Study|280 patients were randomized, but baseline data was missing from 3 patients in one center|277||
59699666|NCT01001494|75818778|FG001|STARTED|Overall Study|272 patients were randomized, but baseline data was missing from 3 patients in one center|269||
59699667|NCT01001494|75818779|FG002|STARTED|Overall Study|276 patients were randomized, but baseline data was missing from 3 patients in one center|273||
59699668|NCT01001494|75818777|FG000|COMPLETED|Overall Study||253||
59699669|NCT01001494|75818778|FG001|COMPLETED|Overall Study||252||
59699670|NCT01001494|75818779|FG002|COMPLETED|Overall Study||232||
59699671|NCT01001494|75818777|FG000|NOT COMPLETED|Overall Study||24||
59699672|NCT01001494|75818778|FG001|NOT COMPLETED|Overall Study||17||
59699673|NCT01001494|75818779|FG002|NOT COMPLETED|Overall Study||41||
59699674|NCT01205685|75818787|FG000|STARTED|Overall Study||11||
59699675|NCT01205685|75818787|FG000|COMPLETED|Overall Study||0||
59699676|NCT01205685|75818787|FG000|NOT COMPLETED|Overall Study||11||
59699677|NCT01205529|75818791|FG000|STARTED|Overall Study||161||
59699678|NCT01205529|75818791|FG000|COMPLETED|Overall Study||106||
59699679|NCT01205529|75818791|FG000|NOT COMPLETED|Overall Study||55||
59699680|NCT01205451|75818797|FG000|STARTED|Overall Study||53||
59699681|NCT01205451|75818798|FG001|STARTED|Overall Study||56||
59699682|NCT01205451|75818797|FG000|COMPLETED|Overall Study||47||
59699683|NCT01205451|75818798|FG001|COMPLETED|Overall Study||46||
59699684|NCT01205451|75818797|FG000|NOT COMPLETED|Overall Study||6||
59699685|NCT01205451|75818798|FG001|NOT COMPLETED|Overall Study||10||
59699686|NCT01001104|75818808|FG000|STARTED|Overall Study||35||
59699687|NCT01001104|75818809|FG001|STARTED|Overall Study||37||
59699688|NCT01001104|75818810|FG002|STARTED|Overall Study||36||
59699689|NCT01001104|75818811|FG003|STARTED|Overall Study||37||
59699690|NCT01001104|75818808|FG000|COMPLETED|Overall Study||33||
59699691|NCT01001104|75818809|FG001|COMPLETED|Overall Study||36||
59699692|NCT01001104|75818810|FG002|COMPLETED|Overall Study||35||
59699693|NCT01001104|75818811|FG003|COMPLETED|Overall Study||34||
59699694|NCT01001104|75818808|FG000|NOT COMPLETED|Overall Study||2||
59699695|NCT01001104|75818809|FG001|NOT COMPLETED|Overall Study||1||
59699696|NCT01001104|75818810|FG002|NOT COMPLETED|Overall Study||1||
59699697|NCT01001104|75818811|FG003|NOT COMPLETED|Overall Study||3||
59699698|NCT00998764|75818826|FG000|STARTED|Overall Study||216||
59699699|NCT00998764|75818827|FG001|STARTED|Overall Study||276||
59699700|NCT00998764|75818826|FG000|Treated|Overall Study||215||
59699701|NCT00998764|75818827|FG001|Treated|Overall Study||275||
59699702|NCT00998764|75818826|FG000|COMPLETED|Overall Study||0||
59699703|NCT00998764|75818827|FG001|COMPLETED|Overall Study||2||
59699704|NCT00998764|75818826|FG000|NOT COMPLETED|Overall Study||216||
59699705|NCT00998764|75818827|FG001|NOT COMPLETED|Overall Study||274||
59699706|NCT01204671|75818840|FG000|STARTED|Overall Study||1012||
59699707|NCT01204671|75818841|FG001|STARTED|Overall Study||1013||
59699708|NCT01204671|75818842|FG002|STARTED|Overall Study||1011||
59699709|NCT01204671|75818843|FG003|STARTED|Overall Study||1010||
59699710|NCT01204671|75818844|FG004|STARTED|Overall Study||610||
59699711|NCT01204671|75818840|FG000|COMPLETED|Overall Study||998||
59699712|NCT01204671|75818841|FG001|COMPLETED|Overall Study||998||
59699713|NCT01204671|75818842|FG002|COMPLETED|Overall Study||998||
59699714|NCT01204671|75818843|FG003|COMPLETED|Overall Study||997||
59699715|NCT01204671|75818844|FG004|COMPLETED|Overall Study||606||
59699716|NCT01204671|75818840|FG000|NOT COMPLETED|Overall Study||14||
59699717|NCT01204671|75818841|FG001|NOT COMPLETED|Overall Study||15||
59699718|NCT01204671|75818842|FG002|NOT COMPLETED|Overall Study||13||
59699719|NCT01204671|75818843|FG003|NOT COMPLETED|Overall Study||13||
59699720|NCT01204671|75818844|FG004|NOT COMPLETED|Overall Study||4||
59699721|NCT01202955|75818862|FG000|STARTED|Period 1: 10 Days||9||
59699722|NCT01202955|75818863|FG001|STARTED|Period 1: 10 Days||10||
59699723|NCT01202955|75818862|FG000|COMPLETED|Period 1: 10 Days||9||
59699724|NCT01202955|75818863|FG001|COMPLETED|Period 1: 10 Days||8||
59699725|NCT01202955|75818862|FG000|NOT COMPLETED|Period 1: 10 Days||0||
59699726|NCT01202955|75818863|FG001|NOT COMPLETED|Period 1: 10 Days||2||
59699727|NCT01202955|75818862|FG000|STARTED|Period 2: 7 Days (Wash-Out)||9||
59699728|NCT01202955|75818863|FG001|STARTED|Period 2: 7 Days (Wash-Out)||8||
59699729|NCT01202955|75818862|FG000|COMPLETED|Period 2: 7 Days (Wash-Out)||9||
59699730|NCT01202955|75818863|FG001|COMPLETED|Period 2: 7 Days (Wash-Out)||8||
59699731|NCT01202955|75818862|FG000|NOT COMPLETED|Period 2: 7 Days (Wash-Out)||0||
59699732|NCT01202955|75818863|FG001|NOT COMPLETED|Period 2: 7 Days (Wash-Out)||0||
59699733|NCT01202955|75818862|FG000|STARTED|Period 3: 10 Days||9||
59699734|NCT01202955|75818863|FG001|STARTED|Period 3: 10 Days||8||
59699735|NCT01202955|75818862|FG000|COMPLETED|Period 3: 10 Days||9||
59699736|NCT01202955|75818863|FG001|COMPLETED|Period 3: 10 Days||8||
59699737|NCT01202955|75818862|FG000|NOT COMPLETED|Period 3: 10 Days||0||
59699738|NCT01202955|75818863|FG001|NOT COMPLETED|Period 3: 10 Days||0||
59699739|NCT01202877|75818872|FG000|STARTED|Overall Study||6||
59699740|NCT01202877|75818873|FG001|STARTED|Overall Study||8||
59699741|NCT01202877|75818874|FG002|STARTED|Overall Study||40||
59699742|NCT01202877|75818872|FG000|COMPLETED|Overall Study||6||
59699743|NCT01202877|75818873|FG001|COMPLETED|Overall Study||7||
59699744|NCT01202877|75818874|FG002|COMPLETED|Overall Study||34||
59699745|NCT01202877|75818872|FG000|NOT COMPLETED|Overall Study||0||
59699746|NCT01202877|75818873|FG001|NOT COMPLETED|Overall Study||1||
59699747|NCT01202877|75818874|FG002|NOT COMPLETED|Overall Study||6||
59699748|NCT01202409|75818882|FG000|STARTED|Overall Study||19||
59699749|NCT01202409|75818882|FG000|COMPLETED|Overall Study||11||
59699750|NCT01202409|75818882|FG000|NOT COMPLETED|Overall Study||8||
59699751|NCT01202175|75818888|FG000|STARTED|Overall Study||50||
59699752|NCT01202175|75818888|FG000|Nebivolol|Overall Study||25||
59699753|NCT01202175|75818888|FG000|Pacebo|Overall Study||25||
59699754|NCT01202175|75818888|FG000|COMPLETED|Overall Study||45||
59699755|NCT01202175|75818888|FG000|NOT COMPLETED|Overall Study||5||
59699756|NCT01201785|75818893|FG000|STARTED|Overall Study||36||
59699757|NCT01201785|75818893|FG000|COMPLETED|Overall Study||20||
59699758|NCT01201785|75818893|FG000|NOT COMPLETED|Overall Study||16||
59699759|NCT01201317|75818900|FG000|STARTED|Overall Study||48||
59699760|NCT01201317|75818901|FG001|STARTED|Overall Study||45||
59699761|NCT01201317|75818902|FG002|STARTED|Overall Study||41||
59699762|NCT01201317|75818900|FG000|COMPLETED|Overall Study||39||
59699763|NCT01201317|75818901|FG001|COMPLETED|Overall Study||38||
59699764|NCT01201317|75818902|FG002|COMPLETED|Overall Study||33||
59699765|NCT01201317|75818900|FG000|NOT COMPLETED|Overall Study||9||
59699766|NCT01201317|75818901|FG001|NOT COMPLETED|Overall Study||7||
59699767|NCT01201317|75818902|FG002|NOT COMPLETED|Overall Study||8||
59699768|NCT01200069|75818912|FG000|STARTED|Overall Study||8||
59699769|NCT01200069|75818913|FG001|STARTED|Overall Study||6||
59699770|NCT01200069|75818912|FG000|COMPLETED|Overall Study||8||
59699771|NCT01200069|75818913|FG001|COMPLETED|Overall Study||5||
59699772|NCT01200069|75818912|FG000|NOT COMPLETED|Overall Study||0||
59699773|NCT01200069|75818913|FG001|NOT COMPLETED|Overall Study||1||
59699774|NCT01199601|75818964|FG000|STARTED|Overall Study|Control Group|422||
59699775|NCT01199601|75818965|FG001|STARTED|Overall Study|Intervention Group|422||
59699776|NCT01199601|75818964|FG000|COMPLETED|Overall Study||353||
59699777|NCT01199601|75818965|FG001|COMPLETED|Overall Study||344||
59699778|NCT01199601|75818964|FG000|NOT COMPLETED|Overall Study||69||
59699779|NCT01199601|75818965|FG001|NOT COMPLETED|Overall Study||78||
59699780|NCT01199289|75818975|FG000|STARTED|Overall Study||77||
59699781|NCT01199289|75818976|FG001|STARTED|Overall Study||75||
59699782|NCT01199289|75818977|FG002|STARTED|Overall Study||76||
59699783|NCT01199289|75818978|FG003|STARTED|Overall Study||77||
59699784|NCT01199289|75818975|FG000|Participants Who Received Study Treatment|Overall Study||76||
59699785|NCT01199289|75818976|FG001|Participants Who Received Study Treatment|Overall Study||74||
59699786|NCT01199289|75818977|FG002|Participants Who Received Study Treatment|Overall Study||76||
59699787|NCT01199289|75818978|FG003|Participants Who Received Study Treatment|Overall Study||76||
59699788|NCT01199289|75818975|FG000|COMPLETED|Overall Study||68||
59699789|NCT01199289|75818976|FG001|COMPLETED|Overall Study||68||
59699790|NCT01199289|75818977|FG002|COMPLETED|Overall Study||71||
59699791|NCT01199289|75818978|FG003|COMPLETED|Overall Study||65||
59699792|NCT01199289|75818975|FG000|NOT COMPLETED|Overall Study||9||
59699793|NCT01199289|75818976|FG001|NOT COMPLETED|Overall Study||7||
59699794|NCT01199289|75818977|FG002|NOT COMPLETED|Overall Study||5||
59699795|NCT01199289|75818978|FG003|NOT COMPLETED|Overall Study||12||
59699796|NCT01199055|75818994|FG000|STARTED|Overall Study||3||
59699797|NCT01199055|75818995|FG001|STARTED|Overall Study||4||
59699798|NCT01199055|75818996|FG002|STARTED|Overall Study||9||
59699799|NCT01199055|75818994|FG000|COMPLETED|Overall Study||1||
59699800|NCT01199055|75818995|FG001|COMPLETED|Overall Study||1||
59699801|NCT01199055|75818996|FG002|COMPLETED|Overall Study||5||
59699802|NCT01199055|75818994|FG000|NOT COMPLETED|Overall Study||2||
59699803|NCT01199055|75818995|FG001|NOT COMPLETED|Overall Study||3||
59699804|NCT01199055|75818996|FG002|NOT COMPLETED|Overall Study||4||
59699805|NCT01198977|75819008|FG000|STARTED|Overall Study||31||
59699806|NCT01198977|75819009|FG001|STARTED|Overall Study||33||
59699807|NCT01198977|75819008|FG000|COMPLETED|Overall Study||30||
59699808|NCT01198977|75819009|FG001|COMPLETED|Overall Study||33||
59699809|NCT01198977|75819008|FG000|NOT COMPLETED|Overall Study||1||
59699810|NCT01198977|75819009|FG001|NOT COMPLETED|Overall Study||0||
59699811|NCT01198587|75819021|FG000|STARTED|Overall Study||31||
59699812|NCT01198587|75819022|FG001|STARTED|Overall Study||5||
59699813|NCT01198587|75819023|FG002|STARTED|Overall Study||30||
59699814|NCT01198587|75819024|FG003|STARTED|Overall Study||5||
59699815|NCT01198587|75819021|FG000|COMPLETED|Overall Study||23||
59699816|NCT01198587|75819022|FG001|COMPLETED|Overall Study||5||
59699817|NCT01198587|75819023|FG002|COMPLETED|Overall Study||21||
59699818|NCT01198587|75819024|FG003|COMPLETED|Overall Study||5||
59699819|NCT01198587|75819021|FG000|NOT COMPLETED|Overall Study||8||
59699820|NCT01198587|75819022|FG001|NOT COMPLETED|Overall Study||0||
59699821|NCT01198587|75819023|FG002|NOT COMPLETED|Overall Study||9||
59699822|NCT01198587|75819024|FG003|NOT COMPLETED|Overall Study||0||
59990768|NCT02461160|76106281|FG012|STARTED|Overall Study||8||
59990769|NCT02461160|76106269|FG000|COMPLETED|Overall Study||8||
59990770|NCT02461160|76106270|FG001|COMPLETED|Overall Study||6||
59990771|NCT02461160|76106271|FG002|COMPLETED|Overall Study||6||
59699823|NCT01198509|75819045|FG000|STARTED|Overall Study||5||
59699824|NCT01198509|75819046|FG001|STARTED|Overall Study||10||
59699825|NCT01198509|75819047|FG002|STARTED|Overall Study||19||
59699826|NCT01198509|75819048|FG003|STARTED|Overall Study||66||
59699827|NCT01198509|75819049|FG004|STARTED|Overall Study||20||
59699828|NCT01198509|75819050|FG005|STARTED|Overall Study||58||
59699829|NCT01198509|75819045|FG000|COMPLETED|Overall Study|Patient declined further participation after enrollment and allocation to treatment group|4||
59699830|NCT01198509|75819046|FG001|COMPLETED|Overall Study||10||
59699831|NCT01198509|75819047|FG002|COMPLETED|Overall Study||19||
59699832|NCT01198509|75819048|FG003|COMPLETED|Overall Study||66||
59699833|NCT01198509|75819049|FG004|COMPLETED|Overall Study||20||
59699834|NCT01198509|75819050|FG005|COMPLETED|Overall Study||58||
59699835|NCT01198509|75819045|FG000|NOT COMPLETED|Overall Study||1||
59699836|NCT01198509|75819046|FG001|NOT COMPLETED|Overall Study||0||
59699837|NCT01198509|75819047|FG002|NOT COMPLETED|Overall Study||0||
59699838|NCT01198509|75819048|FG003|NOT COMPLETED|Overall Study||0||
59699839|NCT01198509|75819049|FG004|NOT COMPLETED|Overall Study||0||
59699840|NCT01198509|75819050|FG005|NOT COMPLETED|Overall Study||0||
59699841|NCT01198275|75819064|FG000|STARTED|Overall Study||100||
59699842|NCT01198275|75819065|FG001|STARTED|Overall Study||99||
59699843|NCT01198275|75819064|FG000|COMPLETED|Overall Study||94||
59699844|NCT01198275|75819065|FG001|COMPLETED|Overall Study||94||
59699845|NCT01198275|75819064|FG000|NOT COMPLETED|Overall Study||6||
59699846|NCT01198275|75819065|FG001|NOT COMPLETED|Overall Study||5||
59699847|NCT01197417|75819073|FG000|STARTED|Overall Study||104||
59699848|NCT01197417|75819074|FG001|STARTED|Overall Study||104||
59699849|NCT01197417|75819073|FG000|Received Study Drug|Overall Study||101||
59699850|NCT01197417|75819074|FG001|Received Study Drug|Overall Study||103||
59699851|NCT01197417|75819073|FG000|COMPLETED|Overall Study||96||
59699852|NCT01197417|75819074|FG001|COMPLETED|Overall Study||86||
59990772|NCT02461160|76106272|FG003|COMPLETED|Overall Study||12||
59990773|NCT02461160|76106273|FG004|COMPLETED|Overall Study||6||
59699853|NCT01197417|75819073|FG000|NOT COMPLETED|Overall Study||8||
59699854|NCT01197417|75819074|FG001|NOT COMPLETED|Overall Study||18||
59699855|NCT00977431|75819085|FG000|STARTED|Overall Study||7||
59699856|NCT00977431|75819086|FG001|STARTED|Overall Study||6||
59699857|NCT00977431|75819087|FG002|STARTED|Overall Study||7||
59699858|NCT00977431|75819088|FG003|STARTED|Overall Study||3||
59699859|NCT00977431|75819089|FG004|STARTED|Overall Study||13||
59699860|NCT00977431|75819085|FG000|Discontinued Afatinib Before/on Day 42|Overall Study||1|Discontinued afatinib before or at the end of the concomitant treatment period (i.e. on day 42).|
59699861|NCT00977431|75819086|FG001|Discontinued Afatinib Before/on Day 42|Overall Study||0|Discontinued afatinib before or at the end of the concomitant treatment period (i.e. on day 42).|
59699862|NCT00977431|75819087|FG002|Discontinued Afatinib Before/on Day 42|Overall Study||4|Discontinued afatinib before or at the end of the concomitant treatment period (i.e. on day 42).|
59699863|NCT00977431|75819088|FG003|Discontinued Afatinib Before/on Day 42|Overall Study||0|Discontinued afatinib before or at the end of the concomitant treatment period (i.e. on day 42).|
59699864|NCT00977431|75819089|FG004|Discontinued Afatinib Before/on Day 42|Overall Study||3|Discontinued afatinib before or at the end of the concomitant treatment period (i.e. on day 42).|
59699865|NCT00977431|75819085|FG000|COMPLETED|Overall Study||0||
59699866|NCT00977431|75819086|FG001|COMPLETED|Overall Study||0||
59699867|NCT00977431|75819087|FG002|COMPLETED|Overall Study||0||
59699868|NCT00977431|75819088|FG003|COMPLETED|Overall Study||0||
59699869|NCT00977431|75819089|FG004|COMPLETED|Overall Study||0||
59699870|NCT00977431|75819085|FG000|NOT COMPLETED|Overall Study||7||
59699871|NCT00977431|75819086|FG001|NOT COMPLETED|Overall Study||6||
59699872|NCT00977431|75819087|FG002|NOT COMPLETED|Overall Study||7||
59699873|NCT00977431|75819088|FG003|NOT COMPLETED|Overall Study||3||
59699874|NCT00977431|75819089|FG004|NOT COMPLETED|Overall Study||13||
59699875|NCT00977197|75819107|FG000|STARTED|Overall Study||41||
59699876|NCT00977197|75819108|FG001|STARTED|Overall Study||44||
59699877|NCT00977197|75819107|FG000|COMPLETED|Overall Study||32||
59699878|NCT00977197|75819108|FG001|COMPLETED|Overall Study||35||
59699879|NCT00977197|75819107|FG000|NOT COMPLETED|Overall Study||9||
59699880|NCT00977197|75819108|FG001|NOT COMPLETED|Overall Study||9||
59699881|NCT00974311|75819116|FG000|STARTED|DB Phase (up to 24 Months)||800||
59699882|NCT00974311|75819117|FG001|STARTED|DB Phase (up to 24 Months)||399||
59699883|NCT00974311|75819116|FG000|COMPLETED|DB Phase (up to 24 Months)||109||
59699884|NCT00974311|75819117|FG001|COMPLETED|DB Phase (up to 24 Months)||50||
59699885|NCT00974311|75819116|FG000|NOT COMPLETED|DB Phase (up to 24 Months)||691||
59699886|NCT00974311|75819117|FG001|NOT COMPLETED|DB Phase (up to 24 Months)||349||
59699887|NCT00974311|75819116|FG000|STARTED|OLE Phase (up to 77 Months)||109||
59699888|NCT00974311|75819117|FG001|STARTED|OLE Phase (up to 77 Months)||50||
59699889|NCT00974311|75819116|FG000|COMPLETED|OLE Phase (up to 77 Months)||0||
59699890|NCT00974311|75819117|FG001|COMPLETED|OLE Phase (up to 77 Months)||0||
59699891|NCT00974311|75819116|FG000|NOT COMPLETED|OLE Phase (up to 77 Months)||109||
59699892|NCT00974311|75819117|FG001|NOT COMPLETED|OLE Phase (up to 77 Months)||50||
59699893|NCT00974233|75819126|FG000|STARTED|Induction Chemoimmunotherapy||34||
59699894|NCT00974233|75819126|FG000|COMPLETED|Induction Chemoimmunotherapy||19||
59699895|NCT00974233|75819126|FG000|NOT COMPLETED|Induction Chemoimmunotherapy||15||
59699896|NCT00974233|75819126|FG000|STARTED|Maintenance Lenalidomide||19||
59699897|NCT00974233|75819126|FG000|COMPLETED|Maintenance Lenalidomide||6||
59699898|NCT00974233|75819126|FG000|NOT COMPLETED|Maintenance Lenalidomide||13||
59699899|NCT00973921|75819138|FG000|STARTED|Overall Study||40||
59699900|NCT00973921|75819138|FG000|COMPLETED|Overall Study||31||
59699901|NCT00973921|75819138|FG000|NOT COMPLETED|Overall Study||9||
59699902|NCT00972595|75819142|FG000|STARTED|Period 1||23||
59699903|NCT00972595|75819143|FG001|STARTED|Period 1||22||
59699904|NCT00972595|75819142|FG000|COMPLETED|Period 1||22||
59699905|NCT00972595|75819143|FG001|COMPLETED|Period 1||22||
59699906|NCT00972595|75819142|FG000|NOT COMPLETED|Period 1||1||
59699907|NCT00972595|75819143|FG001|NOT COMPLETED|Period 1||0||
59699908|NCT00972595|75819142|FG000|STARTED|Period 2||22||
59699909|NCT00972595|75819143|FG001|STARTED|Period 2||22||
59699910|NCT00972595|75819142|FG000|COMPLETED|Period 2||22||
59699911|NCT00972595|75819143|FG001|COMPLETED|Period 2||22||
59699912|NCT00972595|75819142|FG000|NOT COMPLETED|Period 2||0||
59699913|NCT00972595|75819143|FG001|NOT COMPLETED|Period 2||0||
59699914|NCT01196091|75819152|FG000|STARTED|Overall Study||387||
59699915|NCT01196091|75819153|FG001|STARTED|Overall Study||389||
59699916|NCT01196091|75819154|FG002|STARTED|Overall Study||388||
59699917|NCT01196091|75819152|FG000|Received at Least 1 Dose of Study Drug|Overall Study||386||
59699918|NCT01196091|75819153|FG001|Received at Least 1 Dose of Study Drug|Overall Study||389||
59699919|NCT01196091|75819154|FG002|Received at Least 1 Dose of Study Drug|Overall Study||387||
59699920|NCT01196091|75819152|FG000|ITT-Received Drug and Excluded Sites|Overall Study||381||
59699921|NCT01196091|75819153|FG001|ITT-Received Drug and Excluded Sites|Overall Study||378||
59699922|NCT01196091|75819154|FG002|ITT-Received Drug and Excluded Sites|Overall Study||379||
59699923|NCT01196091|75819152|FG000|Follow-Up|Overall Study||103||
59699924|NCT01196091|75819153|FG001|Follow-Up|Overall Study||105||
59699925|NCT01196091|75819154|FG002|Follow-Up|Overall Study||128||
59699926|NCT01196091|75819152|FG000|COMPLETED|Overall Study||299||
59816216|NCT00520676|75938591|FG000|Received at Least 1 Dose of Study Drug|Overall Study||118||
59699927|NCT01196091|75819153|FG001|COMPLETED|Overall Study||291||
59699928|NCT01196091|75819154|FG002|COMPLETED|Overall Study||284||
59699929|NCT01196091|75819152|FG000|NOT COMPLETED|Overall Study||88||
59699930|NCT01196091|75819153|FG001|NOT COMPLETED|Overall Study||98||
59699931|NCT01196091|75819154|FG002|NOT COMPLETED|Overall Study||104||
59699932|NCT01195623|75819169|FG000|STARTED|Overall Study|166 legs total operated|148||
59699933|NCT01195623|75819170|FG001|STARTED|Overall Study|177 legs total operated|145||
59699934|NCT01195623|75819169|FG000|COMPLETED|Overall Study|127 legs|113||
59699935|NCT01195623|75819170|FG001|COMPLETED|Overall Study|129 legs|108||
59699936|NCT01195623|75819169|FG000|NOT COMPLETED|Overall Study||35||
59699937|NCT01195623|75819170|FG001|NOT COMPLETED|Overall Study||37||
59699938|NCT01195545|75819176|FG000|STARTED|Overall Study||20||
59699939|NCT01195545|75819176|FG000|COMPLETED|Overall Study||16||
59699940|NCT01195545|75819176|FG000|NOT COMPLETED|Overall Study||4||
59699941|NCT01194999|75819180|FG000|STARTED|Overall Study||132||
59699942|NCT01194999|75819180|FG000|COMPLETED|Overall Study||115||
59699943|NCT01194999|75819180|FG000|NOT COMPLETED|Overall Study||17||
59699944|NCT01194531|75819186|FG000|STARTED|Overall Study||29||
59699945|NCT01194531|75819187|FG001|STARTED|Overall Study||30||
59699946|NCT01194531|75819186|FG000|COMPLETED|Overall Study||24||
59699947|NCT01194531|75819187|FG001|COMPLETED|Overall Study||27||
59699948|NCT01194531|75819186|FG000|NOT COMPLETED|Overall Study||5||
59699949|NCT01194531|75819187|FG001|NOT COMPLETED|Overall Study||3||
59699950|NCT00972517|75819193|FG000|STARTED|Overall Study||31||
59699951|NCT00972517|75819194|FG001|STARTED|Overall Study||31||
59699952|NCT00972517|75819195|FG002|STARTED|Overall Study||60||
59699953|NCT00972517|75819196|FG003|STARTED|Overall Study||30||
59699954|NCT00972517|75819197|FG004|STARTED|Overall Study||34||
59699955|NCT00972517|75819198|FG005|STARTED|Overall Study||58||
59699956|NCT00972517|75819193|FG000|COMPLETED|Overall Study||31||
59699957|NCT00972517|75819194|FG001|COMPLETED|Overall Study||30||
59699958|NCT00972517|75819195|FG002|COMPLETED|Overall Study||60||
59699959|NCT00972517|75819196|FG003|COMPLETED|Overall Study||27||
59699960|NCT00972517|75819197|FG004|COMPLETED|Overall Study||33||
59699961|NCT00972517|75819198|FG005|COMPLETED|Overall Study||58||
59699962|NCT00972517|75819193|FG000|NOT COMPLETED|Overall Study||0||
59699963|NCT00972517|75819194|FG001|NOT COMPLETED|Overall Study||1||
59699964|NCT00972517|75819195|FG002|NOT COMPLETED|Overall Study||0||
59699965|NCT00972517|75819196|FG003|NOT COMPLETED|Overall Study||3||
59699966|NCT00972517|75819197|FG004|NOT COMPLETED|Overall Study||1||
59699967|NCT00972517|75819198|FG005|NOT COMPLETED|Overall Study||0||
59699968|NCT00972283|75819220|FG000|STARTED|Main: Week 0 to 52 (NN1250-3582)||755||
59699969|NCT00972283|75819221|FG001|STARTED|Main: Week 0 to 52 (NN1250-3582)||251||
59699970|NCT00972283|75819220|FG000|Full Analysis Set|Main: Week 0 to 52 (NN1250-3582)|11 subjects were excluded due to closure of a site|744||
59699971|NCT00972283|75819221|FG001|Full Analysis Set|Main: Week 0 to 52 (NN1250-3582)|3 subjects were excluded due to closure of a site|248||
59699972|NCT00972283|75819220|FG000|Exposed|Main: Week 0 to 52 (NN1250-3582)|2 subjects were withdrawn prior to exposure to trial products|753||
59699973|NCT00972283|75819221|FG001|Exposed|Main: Week 0 to 52 (NN1250-3582)||251||
59699974|NCT00972283|75819220|FG000|COMPLETED|Main: Week 0 to 52 (NN1250-3582)||618||
59699975|NCT00972283|75819221|FG001|COMPLETED|Main: Week 0 to 52 (NN1250-3582)||211||
59699976|NCT00972283|75819220|FG000|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3582)||137||
59699977|NCT00972283|75819221|FG001|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3582)||40||
59699978|NCT00972283|75819220|FG000|STARTED|Extension: Week 53 to 78 (NN1250-3667)|52 subjects did not continue into the extension from main trial|566||
59699979|NCT00972283|75819221|FG001|STARTED|Extension: Week 53 to 78 (NN1250-3667)|20 subjects did not continue into the extension from main trial|191||
59699980|NCT00972283|75819220|FG000|COMPLETED|Extension: Week 53 to 78 (NN1250-3667)||539||
59699981|NCT00972283|75819221|FG001|COMPLETED|Extension: Week 53 to 78 (NN1250-3667)||183||
59699982|NCT00972283|75819220|FG000|NOT COMPLETED|Extension: Week 53 to 78 (NN1250-3667)||27||
59699983|NCT00972283|75819221|FG001|NOT COMPLETED|Extension: Week 53 to 78 (NN1250-3667)||8||
59699984|NCT00969709|75819231|FG000|STARTED|Overall Study||176||
59699985|NCT00969709|75819232|FG001|STARTED|Overall Study||178||
59699986|NCT00969709|75819233|FG002|STARTED|Overall Study||179||
59699987|NCT00969709|75819234|FG003|STARTED|Overall Study||180||
59699988|NCT00969709|75819231|FG000|COMPLETED|Overall Study||138||
59699989|NCT00969709|75819232|FG001|COMPLETED|Overall Study||130||
59699990|NCT00969709|75819233|FG002|COMPLETED|Overall Study||121||
59699991|NCT00969709|75819234|FG003|COMPLETED|Overall Study||117||
59699992|NCT00969709|75819231|FG000|NOT COMPLETED|Overall Study||38||
59699993|NCT00969709|75819232|FG001|NOT COMPLETED|Overall Study||48||
59699994|NCT00969709|75819233|FG002|NOT COMPLETED|Overall Study||58||
59699995|NCT00969709|75819234|FG003|NOT COMPLETED|Overall Study||63||
59699996|NCT01193517|75819251|FG000|STARTED|Overall Study||3||
59699997|NCT01193517|75819252|FG001|STARTED|Overall Study||12||
59699998|NCT01193517|75819253|FG002|STARTED|Overall Study||11||
59699999|NCT01193517|75819251|FG000|COMPLETED|Overall Study||2||
59700000|NCT01193517|75819252|FG001|COMPLETED|Overall Study||12||
59700001|NCT01193517|75819253|FG002|COMPLETED|Overall Study||11||
59700002|NCT01193517|75819251|FG000|NOT COMPLETED|Overall Study||1||
59700003|NCT01193517|75819252|FG001|NOT COMPLETED|Overall Study||0||
59700004|NCT01193517|75819253|FG002|NOT COMPLETED|Overall Study||0||
59700005|NCT01193283|75819262|FG000|STARTED|Overall Study||22||
59700006|NCT01193283|75819262|FG000|COMPLETED|Overall Study||21||
59700007|NCT01193283|75819262|FG000|NOT COMPLETED|Overall Study||1||
59700008|NCT00971425|75819268|FG000|STARTED|Overall Study||72||
59700009|NCT00971425|75819269|FG001|STARTED|Overall Study||73||
59700010|NCT00971425|75819268|FG000|COMPLETED|Overall Study||71||
59700011|NCT00971425|75819269|FG001|COMPLETED|Overall Study||71||
59700012|NCT00971425|75819268|FG000|NOT COMPLETED|Overall Study||1||
59700013|NCT00971425|75819269|FG001|NOT COMPLETED|Overall Study||2||
59700014|NCT01193127|75819279|FG000|STARTED|Randomized||57||
59700015|NCT01193127|75819280|FG001|STARTED|Randomized||54||
59700016|NCT01193127|75819281|FG002|STARTED|Randomized||55||
59700017|NCT01193127|75819282|FG003|STARTED|Randomized||57||
59700018|NCT01193127|75819279|FG000|COMPLETED|Randomized||57||
59700019|NCT01193127|75819280|FG001|COMPLETED|Randomized||54||
59700020|NCT01193127|75819281|FG002|COMPLETED|Randomized||55||
59700021|NCT01193127|75819282|FG003|COMPLETED|Randomized||56||
59700022|NCT01193127|75819279|FG000|NOT COMPLETED|Randomized||0||
59700023|NCT01193127|75819280|FG001|NOT COMPLETED|Randomized||0||
59700024|NCT01193127|75819281|FG002|NOT COMPLETED|Randomized||0||
59700025|NCT01193127|75819282|FG003|NOT COMPLETED|Randomized||1||
59700026|NCT01193127|75819279|FG000|STARTED|Treated||57||
59700027|NCT01193127|75819280|FG001|STARTED|Treated||54||
59700028|NCT01193127|75819281|FG002|STARTED|Treated||55||
59700029|NCT01193127|75819282|FG003|STARTED|Treated||56||
59700030|NCT01193127|75819279|FG000|COMPLETED|Treated||57||
59700031|NCT01193127|75819280|FG001|COMPLETED|Treated||54||
59700032|NCT01193127|75819281|FG002|COMPLETED|Treated||55||
59700033|NCT01193127|75819282|FG003|COMPLETED|Treated||55||
59700034|NCT01193127|75819279|FG000|NOT COMPLETED|Treated||0||
59700035|NCT01193127|75819280|FG001|NOT COMPLETED|Treated||0||
59700036|NCT01193127|75819281|FG002|NOT COMPLETED|Treated||0||
59700037|NCT01193127|75819282|FG003|NOT COMPLETED|Treated||1||
59700038|NCT01192815|75819294|FG000|STARTED|Overall Study||2||
59700039|NCT01192815|75819294|FG000|COMPLETED|Overall Study||0||
59700040|NCT01192815|75819294|FG000|NOT COMPLETED|Overall Study||2||
59700041|NCT01192347|75819298|FG000|STARTED|Overall Study||175||
59700042|NCT01192347|75819298|FG000|COMPLETED|Overall Study||163||
59700043|NCT01192347|75819298|FG000|NOT COMPLETED|Overall Study||12||
59700044|NCT01192191|75819304|FG000|STARTED|Overall Study||60||
59700045|NCT01192191|75819305|FG001|STARTED|Overall Study||127||
59700046|NCT01192191|75819304|FG000|COMPLETED|Overall Study||49||
59700047|NCT01192191|75819305|FG001|COMPLETED|Overall Study||106||
59700048|NCT01192191|75819304|FG000|NOT COMPLETED|Overall Study||11||
59700049|NCT01192191|75819305|FG001|NOT COMPLETED|Overall Study||21||
59700050|NCT01307267|75819334|FG000|STARTED|Overall Study||4||
59700051|NCT01307267|75819335|FG001|STARTED|Overall Study||3||
59700052|NCT01307267|75819336|FG002|STARTED|Overall Study||6||
59700053|NCT01307267|75819337|FG003|STARTED|Overall Study||4||
59700054|NCT01307267|75819338|FG004|STARTED|Overall Study||3||
59700055|NCT01307267|75819339|FG005|STARTED|Overall Study||42||
59700056|NCT01307267|75819340|FG006|STARTED|Overall Study||3||
59700057|NCT01307267|75819341|FG007|STARTED|Overall Study||4||
59700058|NCT01307267|75819342|FG008|STARTED|Overall Study||31||
59700059|NCT01307267|75819343|FG009|STARTED|Overall Study||5||
59700060|NCT01307267|75819344|FG010|STARTED|Overall Study||6||
59700061|NCT01307267|75819345|FG011|STARTED|Overall Study||11||
59700062|NCT01307267|75819346|FG012|STARTED|Overall Study||3||
59700063|NCT01307267|75819347|FG013|STARTED|Overall Study||3||
59700064|NCT01307267|75819348|FG014|STARTED|Overall Study||4||
59700065|NCT01307267|75819349|FG015|STARTED|Overall Study||3||
59700066|NCT01307267|75819350|FG016|STARTED|Overall Study||3||
59700067|NCT01307267|75819351|FG017|STARTED|Overall Study||3||
59700068|NCT01307267|75819352|FG018|STARTED|Overall Study||4||
59700069|NCT01307267|75819353|FG019|STARTED|Overall Study||32||
59700070|NCT01307267|75819354|FG020|STARTED|Overall Study||3||
59700071|NCT01307267|75819355|FG021|STARTED|Overall Study||5||
59700072|NCT01307267|75819356|FG022|STARTED|Overall Study||4||
59700073|NCT01307267|75819334|FG000|COMPLETED|Overall Study||0||
59700074|NCT01307267|75819335|FG001|COMPLETED|Overall Study||0||
59700075|NCT01307267|75819336|FG002|COMPLETED|Overall Study||1||
59700076|NCT01307267|75819337|FG003|COMPLETED|Overall Study||1||
59700077|NCT01307267|75819338|FG004|COMPLETED|Overall Study||2||
59700078|NCT01307267|75819339|FG005|COMPLETED|Overall Study||1||
59700079|NCT01307267|75819340|FG006|COMPLETED|Overall Study||1||
59700080|NCT01307267|75819341|FG007|COMPLETED|Overall Study||0||
59700081|NCT01307267|75819342|FG008|COMPLETED|Overall Study||1||
59700082|NCT01307267|75819343|FG009|COMPLETED|Overall Study||0||
59700083|NCT01307267|75819344|FG010|COMPLETED|Overall Study||0||
59700084|NCT01307267|75819345|FG011|COMPLETED|Overall Study||0||
59700085|NCT01307267|75819346|FG012|COMPLETED|Overall Study||2||
59700086|NCT01307267|75819347|FG013|COMPLETED|Overall Study||3||
59700087|NCT01307267|75819348|FG014|COMPLETED|Overall Study||2||
59700088|NCT01307267|75819349|FG015|COMPLETED|Overall Study||2||
59700089|NCT01307267|75819350|FG016|COMPLETED|Overall Study||2||
59700090|NCT01307267|75819351|FG017|COMPLETED|Overall Study||2||
59700091|NCT01307267|75819352|FG018|COMPLETED|Overall Study||2||
59700092|NCT01307267|75819353|FG019|COMPLETED|Overall Study||0||
59700093|NCT01307267|75819354|FG020|COMPLETED|Overall Study||0||
59700094|NCT01307267|75819355|FG021|COMPLETED|Overall Study||0||
59700095|NCT01307267|75819356|FG022|COMPLETED|Overall Study||0||
59700096|NCT01307267|75819334|FG000|NOT COMPLETED|Overall Study||4||
59700097|NCT01307267|75819335|FG001|NOT COMPLETED|Overall Study||3||
59700098|NCT01307267|75819336|FG002|NOT COMPLETED|Overall Study||5||
59700099|NCT01307267|75819337|FG003|NOT COMPLETED|Overall Study||3||
59700100|NCT01307267|75819338|FG004|NOT COMPLETED|Overall Study||1||
59700101|NCT01307267|75819339|FG005|NOT COMPLETED|Overall Study||41||
59700102|NCT01307267|75819340|FG006|NOT COMPLETED|Overall Study||2||
59700103|NCT01307267|75819341|FG007|NOT COMPLETED|Overall Study||4||
59700104|NCT01307267|75819342|FG008|NOT COMPLETED|Overall Study||30||
59700105|NCT01307267|75819343|FG009|NOT COMPLETED|Overall Study||5||
59700106|NCT01307267|75819344|FG010|NOT COMPLETED|Overall Study||6||
59700107|NCT01307267|75819345|FG011|NOT COMPLETED|Overall Study||11||
59700108|NCT01307267|75819346|FG012|NOT COMPLETED|Overall Study||1||
59700109|NCT01307267|75819347|FG013|NOT COMPLETED|Overall Study||0||
59700110|NCT01307267|75819348|FG014|NOT COMPLETED|Overall Study||2||
59700111|NCT01307267|75819349|FG015|NOT COMPLETED|Overall Study||1||
59700112|NCT01307267|75819350|FG016|NOT COMPLETED|Overall Study||1||
59700113|NCT01307267|75819351|FG017|NOT COMPLETED|Overall Study||1||
59700114|NCT01307267|75819352|FG018|NOT COMPLETED|Overall Study||2||
59700115|NCT01307267|75819353|FG019|NOT COMPLETED|Overall Study||32||
59700116|NCT01307267|75819354|FG020|NOT COMPLETED|Overall Study||3||
59700117|NCT01307267|75819355|FG021|NOT COMPLETED|Overall Study||5||
59700118|NCT01307267|75819356|FG022|NOT COMPLETED|Overall Study||4||
59700119|NCT01307111|75819418|FG000|STARTED|IUD Insertion||42||
59700120|NCT01307111|75819419|FG001|STARTED|IUD Insertion||40||
59700121|NCT01307111|75819418|FG000|COMPLETED|IUD Insertion||40||
59700122|NCT01307111|75819419|FG001|COMPLETED|IUD Insertion||40||
59700123|NCT01307111|75819418|FG000|NOT COMPLETED|IUD Insertion||2||
59700124|NCT01307111|75819419|FG001|NOT COMPLETED|IUD Insertion||0||
59700125|NCT01307111|75819418|FG000|STARTED|1-2 Week IUD Check up||40||
59700126|NCT01307111|75819419|FG001|STARTED|1-2 Week IUD Check up||40||
59700127|NCT01307111|75819418|FG000|COMPLETED|1-2 Week IUD Check up||38||
59700128|NCT01307111|75819419|FG001|COMPLETED|1-2 Week IUD Check up||38||
59700129|NCT01307111|75819418|FG000|NOT COMPLETED|1-2 Week IUD Check up||2||
59700130|NCT01307111|75819419|FG001|NOT COMPLETED|1-2 Week IUD Check up||2||
59700131|NCT01306877|75819427|FG000|STARTED|Overall Study||78||
59700132|NCT01306877|75819428|FG001|STARTED|Overall Study||71||
59700133|NCT01306877|75819427|FG000|COMPLETED|Overall Study||75||
59700134|NCT01306877|75819428|FG001|COMPLETED|Overall Study||67||
59700135|NCT01306877|75819427|FG000|NOT COMPLETED|Overall Study||3||
59700136|NCT01306877|75819428|FG001|NOT COMPLETED|Overall Study||4||
59700137|NCT01191801|75819436|FG000|STARTED|Overall Study||356||
59700138|NCT01191801|75819437|FG001|STARTED|Overall Study||355||
59700139|NCT01191801|75819436|FG000|COMPLETED|Overall Study||40||
59700140|NCT01191801|75819437|FG001|COMPLETED|Overall Study||18||
59700141|NCT01191801|75819436|FG000|NOT COMPLETED|Overall Study||316||
59700142|NCT01191801|75819437|FG001|NOT COMPLETED|Overall Study||337||
59700143|NCT01306643|75819443|FG000|STARTED|Overall Study||18||
59700144|NCT01306643|75819443|FG000|COMPLETED|Overall Study|Completed Study was defined as participants who completed through Cycle 12 (Week 48) per protocol.|5||
59700145|NCT01306643|75819443|FG000|NOT COMPLETED|Overall Study||13||
59700146|NCT01306331|75819449|FG000|STARTED|Overall Study||1659||
59700147|NCT01306331|75819450|FG001|STARTED|Overall Study||1665||
59700148|NCT01306331|75819449|FG000|COMPLETED|Overall Study||758||
59700149|NCT01306331|75819450|FG001|COMPLETED|Overall Study||788||
59700150|NCT01306331|75819449|FG000|NOT COMPLETED|Overall Study||901||
59700151|NCT01306331|75819450|FG001|NOT COMPLETED|Overall Study||877||
59700152|NCT01306253|75819458|FG000|STARTED|Overall Study||57||
59700153|NCT01306253|75819459|FG001|STARTED|Overall Study||57||
59700154|NCT01306253|75819458|FG000|COMPLETED|Overall Study||56||
59700155|NCT01306253|75819459|FG001|COMPLETED|Overall Study||56||
59700156|NCT01306253|75819458|FG000|NOT COMPLETED|Overall Study||1||
59700157|NCT01306253|75819459|FG001|NOT COMPLETED|Overall Study||1||
59700158|NCT01305941|75819465|FG000|STARTED|Overall Study||32||
59700159|NCT01305941|75819465|FG000|COMPLETED|Overall Study||22||
59700160|NCT01305941|75819465|FG000|NOT COMPLETED|Overall Study||10||
59700161|NCT01305239|75819469|FG000|STARTED|Overall Study||398||
59700162|NCT01305239|75819469|FG000|Safety Set|Overall Study||397||
59700163|NCT01305239|75819469|FG000|Intent to Treat Population|Overall Study||287||
59700164|NCT01305239|75819469|FG000|COMPLETED|Overall Study||375||
59700165|NCT01305239|75819469|FG000|NOT COMPLETED|Overall Study||23||
59700166|NCT01194219|75819475|FG000|STARTED|Placebo-Controlled Phase Weeks 0-16||562||
59700167|NCT01194219|75819476|FG001|STARTED|Placebo-Controlled Phase Weeks 0-16||282||
59700168|NCT01194219|75819477|FG002|STARTED|Placebo-Controlled Phase Weeks 0-16||0||
59700169|NCT01194219|75819478|FG003|STARTED|Placebo-Controlled Phase Weeks 0-16||0||
59700170|NCT01194219|75819479|FG004|STARTED|Placebo-Controlled Phase Weeks 0-16||0||
59700171|NCT01194219|75819480|FG005|STARTED|Placebo-Controlled Phase Weeks 0-16||0||
59700172|NCT01194219|75819481|FG006|STARTED|Placebo-Controlled Phase Weeks 0-16||0||
59700173|NCT01194219|75819482|FG007|STARTED|Placebo-Controlled Phase Weeks 0-16||0||
59700174|NCT01194219|75819483|FG008|STARTED|Placebo-Controlled Phase Weeks 0-16||0||
59700175|NCT01194219|75819484|FG009|STARTED|Placebo-Controlled Phase Weeks 0-16||0||
59700176|NCT01194219|75819475|FG000|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||560||
59700177|NCT01194219|75819476|FG001|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||282||
59700178|NCT01194219|75819477|FG002|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0||
59700179|NCT01194219|75819478|FG003|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0||
59700180|NCT01194219|75819479|FG004|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0||
59700181|NCT01194219|75819480|FG005|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0||
59700182|NCT01194219|75819481|FG006|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0||
59700183|NCT01194219|75819482|FG007|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0||
59700184|NCT01194219|75819483|FG008|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0||
59700185|NCT01194219|75819484|FG009|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0||
59700186|NCT01194219|75819475|FG000|COMPLETED|Placebo-Controlled Phase Weeks 0-16||503||
59700187|NCT01194219|75819476|FG001|COMPLETED|Placebo-Controlled Phase Weeks 0-16||249||
59700188|NCT01194219|75819477|FG002|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0||
59700189|NCT01194219|75819478|FG003|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0||
59700190|NCT01194219|75819479|FG004|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0||
59700191|NCT01194219|75819480|FG005|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0||
59700192|NCT01194219|75819481|FG006|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0||
59700193|NCT01194219|75819482|FG007|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0||
59700194|NCT01194219|75819483|FG008|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0||
59700195|NCT01194219|75819484|FG009|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0||
59700196|NCT01194219|75819475|FG000|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||59||
59700197|NCT01194219|75819476|FG001|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||33||
59700198|NCT01194219|75819477|FG002|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0||
59700199|NCT01194219|75819478|FG003|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0||
59700200|NCT01194219|75819479|FG004|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0||
59700201|NCT01194219|75819480|FG005|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0||
59700202|NCT01194219|75819481|FG006|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0||
59700203|NCT01194219|75819482|FG007|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0||
59700204|NCT01194219|75819483|FG008|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0||
59700205|NCT01194219|75819484|FG009|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0||
59700206|NCT01194219|75819475|FG000|STARTED|Maintenance Phase Weeks16-32||0||
59700207|NCT01194219|75819476|FG001|STARTED|Maintenance Phase Weeks16-32||0||
59700208|NCT01194219|75819477|FG002|STARTED|Maintenance Phase Weeks16-32|9 participants discontinued after Week 16 but prior to entry into the Maintenance Phase|494||
59700209|NCT01194219|75819478|FG003|STARTED|Maintenance Phase Weeks16-32|4 participants discontinued after Week 16 but prior to entry into the Maintenance Phase|245||
59700210|NCT01194219|75819479|FG004|STARTED|Maintenance Phase Weeks16-32||0||
59700211|NCT01194219|75819480|FG005|STARTED|Maintenance Phase Weeks16-32||0||
59700212|NCT01194219|75819481|FG006|STARTED|Maintenance Phase Weeks16-32||0||
59700213|NCT01194219|75819482|FG007|STARTED|Maintenance Phase Weeks16-32||0||
59700214|NCT01194219|75819483|FG008|STARTED|Maintenance Phase Weeks16-32||0||
59700215|NCT01194219|75819484|FG009|STARTED|Maintenance Phase Weeks16-32||0||
59700216|NCT01194219|75819475|FG000|Received Apremilast|Maintenance Phase Weeks16-32||0||
59700217|NCT01194219|75819476|FG001|Received Apremilast|Maintenance Phase Weeks16-32||0||
59700218|NCT01194219|75819477|FG002|Received Apremilast|Maintenance Phase Weeks16-32|1 participant elected not to participate at the time the first dose was dispensed.|493||
59700219|NCT01194219|75819478|FG003|Received Apremilast|Maintenance Phase Weeks16-32|1 participant elected not to participate at the time the first dose was dispensed.|244||
59700220|NCT01194219|75819479|FG004|Received Apremilast|Maintenance Phase Weeks16-32||0||
59700221|NCT01194219|75819480|FG005|Received Apremilast|Maintenance Phase Weeks16-32||0||
59700222|NCT01194219|75819481|FG006|Received Apremilast|Maintenance Phase Weeks16-32||0||
59700223|NCT01194219|75819482|FG007|Received Apremilast|Maintenance Phase Weeks16-32||0||
59700224|NCT01194219|75819483|FG008|Received Apremilast|Maintenance Phase Weeks16-32||0||
59700225|NCT01194219|75819484|FG009|Received Apremilast|Maintenance Phase Weeks16-32||0||
59548099|NCT01166984|75646985|FG002|NOT COMPLETED|Overall Study||0||
59548100|NCT01166984|75646986|FG003|NOT COMPLETED|Overall Study||0||
59548101|NCT01166984|75646987|FG004|NOT COMPLETED|Overall Study||0||
59548102|NCT02486211|75647011|FG000|STARTED|Overall Study||7||
59548103|NCT02486211|75647012|FG001|STARTED|Overall Study||7||
59548104|NCT02486211|75647011|FG000|COMPLETED|Overall Study||6||
59548105|NCT02486211|75647012|FG001|COMPLETED|Overall Study||7||
59548106|NCT02486211|75647011|FG000|NOT COMPLETED|Overall Study||1||
59548107|NCT02486211|75647012|FG001|NOT COMPLETED|Overall Study||0||
59548108|NCT01167452|75647019|FG000|STARTED|Overall Study||36||
59548109|NCT01167452|75647019|FG000|COMPLETED|Overall Study||36||
59700226|NCT01194219|75819475|FG000|COMPLETED|Maintenance Phase Weeks16-32||0||
59548110|NCT01167452|75647019|FG000|NOT COMPLETED|Overall Study||0||
59548111|NCT02487225|75647026|FG000|STARTED|Overall Study||45||
59548112|NCT02487225|75647027|FG001|STARTED|Overall Study||38||
59548113|NCT02487225|75647026|FG000|COMPLETED|Overall Study||18||
59548114|NCT02487225|75647027|FG001|COMPLETED|Overall Study||8||
59548115|NCT02487225|75647026|FG000|NOT COMPLETED|Overall Study||27||
59700227|NCT01194219|75819476|FG001|COMPLETED|Maintenance Phase Weeks16-32||0||
59700228|NCT01194219|75819477|FG002|COMPLETED|Maintenance Phase Weeks16-32||424||
59700229|NCT01194219|75819478|FG003|COMPLETED|Maintenance Phase Weeks16-32||215||
59700230|NCT01194219|75819479|FG004|COMPLETED|Maintenance Phase Weeks16-32||0||
59700231|NCT01194219|75819480|FG005|COMPLETED|Maintenance Phase Weeks16-32||0||
59700232|NCT01194219|75819481|FG006|COMPLETED|Maintenance Phase Weeks16-32||0||
59700233|NCT01194219|75819482|FG007|COMPLETED|Maintenance Phase Weeks16-32||0||
59700234|NCT01194219|75819483|FG008|COMPLETED|Maintenance Phase Weeks16-32||0||
59700235|NCT01194219|75819484|FG009|COMPLETED|Maintenance Phase Weeks16-32||0||
59700236|NCT01194219|75819475|FG000|NOT COMPLETED|Maintenance Phase Weeks16-32||0||
59700237|NCT01194219|75819476|FG001|NOT COMPLETED|Maintenance Phase Weeks16-32||0||
59700238|NCT01194219|75819477|FG002|NOT COMPLETED|Maintenance Phase Weeks16-32||70||
59700239|NCT01194219|75819478|FG003|NOT COMPLETED|Maintenance Phase Weeks16-32||30||
59700240|NCT01194219|75819479|FG004|NOT COMPLETED|Maintenance Phase Weeks16-32||0||
59700241|NCT01194219|75819480|FG005|NOT COMPLETED|Maintenance Phase Weeks16-32||0||
59700242|NCT01194219|75819481|FG006|NOT COMPLETED|Maintenance Phase Weeks16-32||0||
59700243|NCT01194219|75819482|FG007|NOT COMPLETED|Maintenance Phase Weeks16-32||0||
59700244|NCT01194219|75819483|FG008|NOT COMPLETED|Maintenance Phase Weeks16-32||0||
59700245|NCT01194219|75819484|FG009|NOT COMPLETED|Maintenance Phase Weeks16-32||0||
59700246|NCT01194219|75819475|FG000|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0||
59700247|NCT01194219|75819476|FG001|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0||
59700248|NCT01194219|75819477|FG002|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0||
59700249|NCT01194219|75819478|FG003|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0||
59700250|NCT01194219|75819479|FG004|STARTED|Randomized Withdrawal Phase-Weeks 32-52|7 participants discontinued after week 32 but prior to entry into the Randomized withdrawal Phase|77||
59700251|NCT01194219|75819480|FG005|STARTED|Randomized Withdrawal Phase-Weeks 32-52|25 participants discontinued after week 32 but prior to entry into the Randomized withdrawal Phase|77||
59700252|NCT01194219|75819481|FG006|STARTED|Randomized Withdrawal Phase-Weeks 32-52||245||
59700253|NCT01194219|75819482|FG007|STARTED|Randomized Withdrawal Phase-Weeks 32-52||208||
59700254|NCT01194219|75819483|FG008|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0||
59700255|NCT01194219|75819484|FG009|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0||
59700256|NCT01194219|75819475|FG000|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0||
59700257|NCT01194219|75819476|FG001|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0||
59700258|NCT01194219|75819477|FG002|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0||
59700259|NCT01194219|75819478|FG003|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0||
59700260|NCT01194219|75819479|FG004|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0||
59700261|NCT01194219|75819480|FG005|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0||
59700262|NCT01194219|75819481|FG006|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||126||
59700263|NCT01194219|75819482|FG007|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||91||
59700264|NCT01194219|75819483|FG008|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0||
59700265|NCT01194219|75819484|FG009|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0||
59700266|NCT01194219|75819475|FG000|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0||
59700267|NCT01194219|75819476|FG001|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0||
59700268|NCT01194219|75819477|FG002|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0||
59700269|NCT01194219|75819478|FG003|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0||
59700270|NCT01194219|75819479|FG004|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52|1 participant discontinued after Week 52 but prior to entry into the long term extension study|73||
59700271|NCT01194219|75819480|FG005|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52|5 participants discontinued after Week 52 but prior to entry into the long term extension study|73||
59700272|NCT01194219|75819481|FG006|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52|18 participants discontinued after Week 52 but prior to entry into the long term extension study|184||
59700273|NCT01194219|75819482|FG007|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52|10 participants discontinued after Week 52 but prior to entry into the long term extension study|163||
59700274|NCT01194219|75819483|FG008|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0||
59700275|NCT01194219|75819484|FG009|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0||
59700276|NCT01194219|75819475|FG000|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0||
59700277|NCT01194219|75819476|FG001|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0||
59700278|NCT01194219|75819477|FG002|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0||
59700279|NCT01194219|75819478|FG003|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0||
59700280|NCT01194219|75819479|FG004|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||4||
59700281|NCT01194219|75819480|FG005|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||4||
59700282|NCT01194219|75819481|FG006|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||61||
59700283|NCT01194219|75819482|FG007|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||45||
59700284|NCT01194219|75819483|FG008|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0||
59700285|NCT01194219|75819484|FG009|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0||
59700286|NCT01194219|75819475|FG000|STARTED|Long-Term Extension Weeks 52 to 260||0||
59816217|NCT00520676|75938592|FG001|Received at Least 1 Dose of Study Drug|Overall Study||127||
59816218|NCT00520676|75938591|FG000|Qualified Intent-to-treat (Q-ITT)|Overall Study||106||
59700287|NCT01194219|75819476|FG001|STARTED|Long-Term Extension Weeks 52 to 260||0||
59700288|NCT01194219|75819477|FG002|STARTED|Long-Term Extension Weeks 52 to 260||0||
59700289|NCT01194219|75819478|FG003|STARTED|Long-Term Extension Weeks 52 to 260||0||
59700290|NCT01194219|75819479|FG004|STARTED|Long-Term Extension Weeks 52 to 260||0||
59700291|NCT01194219|75819480|FG005|STARTED|Long-Term Extension Weeks 52 to 260||0||
59700292|NCT01194219|75819481|FG006|STARTED|Long-Term Extension Weeks 52 to 260||0||
59700293|NCT01194219|75819482|FG007|STARTED|Long-Term Extension Weeks 52 to 260||0||
59700294|NCT01194219|75819483|FG008|STARTED|Long-Term Extension Weeks 52 to 260||306||
59700295|NCT01194219|75819484|FG009|STARTED|Long-Term Extension Weeks 52 to 260||153||
59700296|NCT01194219|75819475|FG000|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0||
59700297|NCT01194219|75819476|FG001|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0||
59700298|NCT01194219|75819477|FG002|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0||
59700299|NCT01194219|75819478|FG003|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0||
59700300|NCT01194219|75819479|FG004|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0||
59700301|NCT01194219|75819480|FG005|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0||
59700302|NCT01194219|75819481|FG006|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0||
59700303|NCT01194219|75819482|FG007|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0||
59700304|NCT01194219|75819483|FG008|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||304||
59700305|NCT01194219|75819484|FG009|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||153||
59700306|NCT01194219|75819475|FG000|COMPLETED|Long-Term Extension Weeks 52 to 260||0||
59700307|NCT01194219|75819476|FG001|COMPLETED|Long-Term Extension Weeks 52 to 260||0||
59700308|NCT01194219|75819477|FG002|COMPLETED|Long-Term Extension Weeks 52 to 260||0||
59700309|NCT01194219|75819478|FG003|COMPLETED|Long-Term Extension Weeks 52 to 260||0||
59700310|NCT01194219|75819479|FG004|COMPLETED|Long-Term Extension Weeks 52 to 260||0||
59700311|NCT01194219|75819480|FG005|COMPLETED|Long-Term Extension Weeks 52 to 260||0||
59700312|NCT01194219|75819481|FG006|COMPLETED|Long-Term Extension Weeks 52 to 260||0||
59700313|NCT01194219|75819482|FG007|COMPLETED|Long-Term Extension Weeks 52 to 260||0||
59700314|NCT01194219|75819483|FG008|COMPLETED|Long-Term Extension Weeks 52 to 260||86||
59990774|NCT02461160|76106274|FG005|COMPLETED|Overall Study||6||
59990775|NCT02461160|76106275|FG006|COMPLETED|Overall Study||6||
59990776|NCT02461160|76106276|FG007|COMPLETED|Overall Study||5||
59990777|NCT02461160|76106277|FG008|COMPLETED|Overall Study||12||
59700315|NCT01194219|75819484|FG009|COMPLETED|Long-Term Extension Weeks 52 to 260||41||
59700316|NCT01194219|75819475|FG000|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0||
59700317|NCT01194219|75819476|FG001|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0||
59700318|NCT01194219|75819477|FG002|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0||
59700319|NCT01194219|75819478|FG003|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0||
59700320|NCT01194219|75819479|FG004|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0||
59700321|NCT01194219|75819480|FG005|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0||
59700322|NCT01194219|75819481|FG006|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0||
59700323|NCT01194219|75819482|FG007|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0||
59700324|NCT01194219|75819483|FG008|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||220||
59700325|NCT01194219|75819484|FG009|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||112||
59700326|NCT01304693|75819512|FG000|STARTED|Overall Study||10||
59700327|NCT01304693|75819513|FG001|STARTED|Overall Study||35||
59700328|NCT01304693|75819514|FG002|STARTED|Overall Study||48||
59700329|NCT01304693|75819515|FG003|STARTED|Overall Study||40||
59700330|NCT01304693|75819516|FG004|STARTED|Overall Study||61||
59700331|NCT01304693|75819512|FG000|COMPLETED|Overall Study||10||
59700332|NCT01304693|75819513|FG001|COMPLETED|Overall Study||35||
59700333|NCT01304693|75819514|FG002|COMPLETED|Overall Study||47||
59700334|NCT01304693|75819515|FG003|COMPLETED|Overall Study||39||
59700335|NCT01304693|75819516|FG004|COMPLETED|Overall Study||60||
59700336|NCT01304693|75819512|FG000|NOT COMPLETED|Overall Study||0||
59700337|NCT01304693|75819513|FG001|NOT COMPLETED|Overall Study||0||
59700338|NCT01304693|75819514|FG002|NOT COMPLETED|Overall Study||1||
59700339|NCT01304693|75819515|FG003|NOT COMPLETED|Overall Study||1||
59700340|NCT01304693|75819516|FG004|NOT COMPLETED|Overall Study||1||
59700341|NCT01304147|75819528|FG000|STARTED|First Intervention (7days)||10||
59700342|NCT01304147|75819529|FG001|STARTED|First Intervention (7days)||10||
59700343|NCT01304147|75819528|FG000|COMPLETED|First Intervention (7days)||10||
59700344|NCT01304147|75819529|FG001|COMPLETED|First Intervention (7days)||10||
59700345|NCT01304147|75819528|FG000|NOT COMPLETED|First Intervention (7days)||0||
59700346|NCT01304147|75819529|FG001|NOT COMPLETED|First Intervention (7days)||0||
59700347|NCT01304147|75819528|FG000|STARTED|Washout (1 Day)||10||
59700348|NCT01304147|75819529|FG001|STARTED|Washout (1 Day)||10||
59990778|NCT02461160|76106278|FG009|COMPLETED|Overall Study||4||
59990779|NCT02461160|76106279|FG010|COMPLETED|Overall Study||4||
59990780|NCT02461160|76106280|FG011|COMPLETED|Overall Study||4||
59990781|NCT02461160|76106281|FG012|COMPLETED|Overall Study||8||
59700349|NCT01304147|75819528|FG000|COMPLETED|Washout (1 Day)||10||
59700350|NCT01304147|75819529|FG001|COMPLETED|Washout (1 Day)||10||
59700351|NCT01304147|75819528|FG000|NOT COMPLETED|Washout (1 Day)||0||
59700352|NCT01304147|75819529|FG001|NOT COMPLETED|Washout (1 Day)||0||
59700353|NCT01304147|75819528|FG000|STARTED|Second Intervention (7days)||10||
59548116|NCT02487225|75647027|FG001|NOT COMPLETED|Overall Study||30||
59548117|NCT02384850|75647035|FG000|STARTED|Overall Study||4||
59548118|NCT02384850|75647036|FG001|STARTED|Overall Study||6||
59700354|NCT01304147|75819529|FG001|STARTED|Second Intervention (7days)||10||
59700355|NCT01304147|75819528|FG000|COMPLETED|Second Intervention (7days)||9||
59700356|NCT01304147|75819529|FG001|COMPLETED|Second Intervention (7days)||9||
59700357|NCT01304147|75819528|FG000|NOT COMPLETED|Second Intervention (7days)||1||
59700358|NCT01304147|75819529|FG001|NOT COMPLETED|Second Intervention (7days)||1||
59700359|NCT01303445|75819535|FG000|STARTED|First Intervention (7 Days)||30||
59700360|NCT01303445|75819536|FG001|STARTED|First Intervention (7 Days)||30||
59548119|NCT02384850|75647035|FG000|COMPLETED|Overall Study||2||
59548120|NCT02384850|75647036|FG001|COMPLETED|Overall Study||4||
59548121|NCT02384850|75647035|FG000|NOT COMPLETED|Overall Study||2||
59548122|NCT02384850|75647036|FG001|NOT COMPLETED|Overall Study||2||
59548123|NCT01167608|75647042|FG000|STARTED|Overall Study||883||
59548124|NCT01167608|75647042|FG000|COMPLETED|Overall Study||769||
59548125|NCT01167608|75647042|FG000|NOT COMPLETED|Overall Study||114||
59548126|NCT02558829|75647051|FG000|STARTED|Overall Study||21|Safety population (SAF): all randomized subjects who took at least one dose of trial medication.|
59548127|NCT02558829|75647052|FG001|STARTED|Overall Study||21|Safety population (SAF): all randomized subjects who took at least one dose of trial medication.|
59548128|NCT02558829|75647053|FG002|STARTED|Overall Study||24|Safety population (SAF): all randomized subjects who took at least one dose of trial medication.|
59548129|NCT02558829|75647054|FG003|STARTED|Overall Study||18|Safety population (SAF): all randomized subjects who took at least one dose of trial medication.|
59548130|NCT02558829|75647055|FG004|STARTED|Overall Study||18|Safety population (SAF): all randomized subjects who took at least one dose of trial medication.|
59548131|NCT02558829|75647056|FG005|STARTED|Overall Study||26|Safety population (SAF): all randomized subjects who took at least one dose of trial medication.|
59548132|NCT02558829|75647057|FG006|STARTED|Overall Study||18|Safety population (SAF): all randomized subjects who took at least one dose of trial medication.|
59548133|NCT02558829|75647058|FG007|STARTED|Overall Study||11|Safety population (SAF): all randomized subjects who took at least one dose of trial medication.|
59548134|NCT02558829|75647051|FG000|COMPLETED|Overall Study||20|Modified Intention-to-Treat (mITT): randomized subjects with both GHSTs of the cross-over evaluable.|
59548135|NCT02558829|75647052|FG001|COMPLETED|Overall Study||18|Modified Intention-to-Treat (mITT): randomized subjects with both GHSTs of the cross-over evaluable.|
59548136|NCT02558829|75647053|FG002|COMPLETED|Overall Study||21|Modified Intention-to-Treat (mITT): randomized subjects with both GHSTs of the cross-over evaluable.|
59548137|NCT02558829|75647054|FG003|COMPLETED|Overall Study||16|Modified Intention-to-Treat (mITT): randomized subjects with both GHSTs of the cross-over evaluable.|
59548138|NCT02558829|75647055|FG004|COMPLETED|Overall Study||16|Modified Intention-to-Treat (mITT): randomized subjects with both GHSTs of the cross-over evaluable.|
59548139|NCT02558829|75647056|FG005|COMPLETED|Overall Study||24|Modified Intention-to-Treat (mITT): randomized subjects with both GHSTs of the cross-over evaluable.|
59548140|NCT02558829|75647057|FG006|COMPLETED|Overall Study||17|Modified Intention-to-Treat (mITT): randomized subjects with both GHSTs of the cross-over evaluable.|
59548141|NCT02558829|75647058|FG007|COMPLETED|Overall Study||8|Modified Intention-to-Treat (mITT): randomized subjects with both GHSTs of the cross-over evaluable.|
59548142|NCT02558829|75647051|FG000|NOT COMPLETED|Overall Study||1||
59548143|NCT02558829|75647052|FG001|NOT COMPLETED|Overall Study||3||
59548144|NCT02558829|75647053|FG002|NOT COMPLETED|Overall Study||3||
59548145|NCT02558829|75647054|FG003|NOT COMPLETED|Overall Study||2||
59548146|NCT02558829|75647055|FG004|NOT COMPLETED|Overall Study||2||
59548147|NCT02558829|75647056|FG005|NOT COMPLETED|Overall Study||2||
59548148|NCT02558829|75647057|FG006|NOT COMPLETED|Overall Study||1||
59548149|NCT02558829|75647058|FG007|NOT COMPLETED|Overall Study||3||
59548150|NCT01132508|75647080|FG000|STARTED|Overall Study||33||
59548151|NCT01132508|75647080|FG000|Treated at Baseline|Overall Study||33||
59548152|NCT01132508|75647080|FG000|6 Weeks|Overall Study||33||
59548153|NCT01132508|75647080|FG000|12 Weeks|Overall Study||33||
59548154|NCT01132508|75647080|FG000|26 Weeks|Overall Study||33||
59548155|NCT01132508|75647080|FG000|52 Weeks|Overall Study||30||
59548156|NCT01132508|75647080|FG000|78 Weeks|Overall Study||28||
59548157|NCT01132508|75647080|FG000|104 Weeks|Overall Study||27||
59548158|NCT01132508|75647080|FG000|COMPLETED|Overall Study||24||
59548159|NCT01132508|75647080|FG000|NOT COMPLETED|Overall Study||9||
59548160|NCT02487303|75647087|FG000|STARTED|Overall Study||49||
59548161|NCT02487303|75647088|FG001|STARTED|Overall Study||51||
59548162|NCT02487303|75647089|FG002|STARTED|Overall Study||48||
59548163|NCT02487303|75647087|FG000|COMPLETED|Overall Study||47||
59548164|NCT02487303|75647088|FG001|COMPLETED|Overall Study||47||
59548165|NCT02487303|75647089|FG002|COMPLETED|Overall Study||47||
59548166|NCT02487303|75647087|FG000|NOT COMPLETED|Overall Study||2||
59548167|NCT02487303|75647088|FG001|NOT COMPLETED|Overall Study||4||
59548168|NCT02487303|75647089|FG002|NOT COMPLETED|Overall Study||1||
59700361|NCT01303445|75819535|FG000|COMPLETED|First Intervention (7 Days)||29||
59700362|NCT01303445|75819536|FG001|COMPLETED|First Intervention (7 Days)||30||
59548169|NCT02560701|75647102|FG000|STARTED|Overall Study||8060||
59548170|NCT02560701|75647103|FG001|STARTED|Overall Study||89242||
59565868|NCT04392219|75668292|FG002|COMPLETED|Overall Study||6||
59700363|NCT01303445|75819535|FG000|NOT COMPLETED|First Intervention (7 Days)||1||
59700364|NCT01303445|75819536|FG001|NOT COMPLETED|First Intervention (7 Days)||0||
59700365|NCT01303445|75819535|FG000|STARTED|Second Intervention (7 Days)||29||
59700366|NCT01303445|75819536|FG001|STARTED|Second Intervention (7 Days)||30||
59700367|NCT01303445|75819535|FG000|COMPLETED|Second Intervention (7 Days)||28||
59700368|NCT01303445|75819536|FG001|COMPLETED|Second Intervention (7 Days)||28||
59700369|NCT01303445|75819535|FG000|NOT COMPLETED|Second Intervention (7 Days)||1||
59700370|NCT01303445|75819536|FG001|NOT COMPLETED|Second Intervention (7 Days)||2||
59700371|NCT01303445|75819535|FG000|STARTED|Washout (14 Days)||28||
59700372|NCT01303445|75819536|FG001|STARTED|Washout (14 Days)||28||
59700373|NCT01303445|75819535|FG000|COMPLETED|Washout (14 Days)||27||
59700374|NCT01303445|75819536|FG001|COMPLETED|Washout (14 Days)||26||
59700375|NCT01303445|75819535|FG000|NOT COMPLETED|Washout (14 Days)||1||
59700376|NCT01303445|75819536|FG001|NOT COMPLETED|Washout (14 Days)||2||
59700377|NCT01303445|75819535|FG000|STARTED|Third Intervention (7 Days)||27||
59700378|NCT01303445|75819536|FG001|STARTED|Third Intervention (7 Days)||26||
59700379|NCT01303445|75819535|FG000|COMPLETED|Third Intervention (7 Days)||27||
59700380|NCT01303445|75819536|FG001|COMPLETED|Third Intervention (7 Days)||26||
59700381|NCT01303445|75819535|FG000|NOT COMPLETED|Third Intervention (7 Days)||0||
59700382|NCT01303445|75819536|FG001|NOT COMPLETED|Third Intervention (7 Days)||0||
59700383|NCT01303445|75819535|FG000|STARTED|Fourth Intervention (7 Days)||27||
59700384|NCT01303445|75819536|FG001|STARTED|Fourth Intervention (7 Days)||26||
59700385|NCT01303445|75819535|FG000|COMPLETED|Fourth Intervention (7 Days)||26||
59700386|NCT01303445|75819536|FG001|COMPLETED|Fourth Intervention (7 Days)||26||
59700387|NCT01303445|75819535|FG000|NOT COMPLETED|Fourth Intervention (7 Days)||1||
59700388|NCT01303445|75819536|FG001|NOT COMPLETED|Fourth Intervention (7 Days)||0||
59700389|NCT01303445|75819535|FG000|STARTED|Follow-up Period (14 Days)||26||
59700390|NCT01303445|75819536|FG001|STARTED|Follow-up Period (14 Days)||26||
59700391|NCT01303445|75819535|FG000|COMPLETED|Follow-up Period (14 Days)||26||
59700392|NCT01303445|75819536|FG001|COMPLETED|Follow-up Period (14 Days)||25||
59700393|NCT01303445|75819535|FG000|NOT COMPLETED|Follow-up Period (14 Days)||0||
59700394|NCT01303445|75819536|FG001|NOT COMPLETED|Follow-up Period (14 Days)||1||
59700395|NCT01188681|75819550|FG000|STARTED|Overall Study||6||
59700396|NCT01188681|75819551|FG001|STARTED|Overall Study||6||
59700397|NCT01188681|75819552|FG002|STARTED|Overall Study|33 patients enrolled, 32 patients treated. One patient had bladder cancer and was not treated.|33||
59700398|NCT01188681|75819553|FG003|STARTED|Overall Study|34 patients enrolled, 33 patients treated. One patient withdrew consent and was not treated.|34||
59700399|NCT01188681|75819550|FG000|COMPLETED|Overall Study||6||
59700400|NCT01188681|75819551|FG001|COMPLETED|Overall Study||6||
59700401|NCT01188681|75819552|FG002|COMPLETED|Overall Study||32||
59700402|NCT01188681|75819553|FG003|COMPLETED|Overall Study||33||
59700403|NCT01188681|75819550|FG000|NOT COMPLETED|Overall Study||0||
59700404|NCT01188681|75819551|FG001|NOT COMPLETED|Overall Study||0||
59700405|NCT01188681|75819552|FG002|NOT COMPLETED|Overall Study||1||
59700406|NCT01188681|75819553|FG003|NOT COMPLETED|Overall Study||1||
59700407|NCT01302899|75819569|FG000|STARTED|Period 1 (Day 1 to End of Week 6)||4||
59700408|NCT01302899|75819570|FG001|STARTED|Period 1 (Day 1 to End of Week 6)||4||
59700409|NCT01302899|75819569|FG000|COMPLETED|Period 1 (Day 1 to End of Week 6)||4||
59700410|NCT01302899|75819570|FG001|COMPLETED|Period 1 (Day 1 to End of Week 6)||4||
59700411|NCT01302899|75819569|FG000|NOT COMPLETED|Period 1 (Day 1 to End of Week 6)||0||
59700412|NCT01302899|75819570|FG001|NOT COMPLETED|Period 1 (Day 1 to End of Week 6)||0||
59700413|NCT01302899|75819569|FG000|STARTED|Period 2 (Weeks 7 to 12)||4||
59700414|NCT01302899|75819570|FG001|STARTED|Period 2 (Weeks 7 to 12)||4||
59700415|NCT01302899|75819569|FG000|COMPLETED|Period 2 (Weeks 7 to 12)||3||
59700416|NCT01302899|75819570|FG001|COMPLETED|Period 2 (Weeks 7 to 12)||3||
59700417|NCT01302899|75819569|FG000|NOT COMPLETED|Period 2 (Weeks 7 to 12)||1||
59700418|NCT01302899|75819570|FG001|NOT COMPLETED|Period 2 (Weeks 7 to 12)||1||
59700419|NCT01302899|75819569|FG000|STARTED|Period 3 (Weeks 13 to 18)||3||
59700420|NCT01302899|75819570|FG001|STARTED|Period 3 (Weeks 13 to 18)||3||
59700421|NCT01302899|75819569|FG000|COMPLETED|Period 3 (Weeks 13 to 18)||3||
59700422|NCT01302899|75819570|FG001|COMPLETED|Period 3 (Weeks 13 to 18)||3||
59700423|NCT01302899|75819569|FG000|NOT COMPLETED|Period 3 (Weeks 13 to 18)||0||
59700424|NCT01302899|75819570|FG001|NOT COMPLETED|Period 3 (Weeks 13 to 18)||0||
59700425|NCT01302899|75819569|FG000|STARTED|Period 4 (Weeks 19 to 26)||3||
59700426|NCT01302899|75819570|FG001|STARTED|Period 4 (Weeks 19 to 26)||3||
59700427|NCT01302899|75819569|FG000|COMPLETED|Period 4 (Weeks 19 to 26)||3||
59700428|NCT01302899|75819570|FG001|COMPLETED|Period 4 (Weeks 19 to 26)||3||
59700429|NCT01302899|75819569|FG000|NOT COMPLETED|Period 4 (Weeks 19 to 26)||0||
59700430|NCT01302899|75819570|FG001|NOT COMPLETED|Period 4 (Weeks 19 to 26)||0||
59700431|NCT01187901|75819582|FG000|STARTED|Overall Study||46||
59700432|NCT01187901|75819583|FG001|STARTED|Overall Study||46||
59700433|NCT01187901|75819582|FG000|COMPLETED|Overall Study||37||
59700434|NCT01187901|75819583|FG001|COMPLETED|Overall Study||36||
59700435|NCT01187901|75819582|FG000|NOT COMPLETED|Overall Study||9||
59700436|NCT01187901|75819583|FG001|NOT COMPLETED|Overall Study||10||
59700437|NCT01302119|75819591|FG000|STARTED|Overall Study||399||
59700438|NCT01302119|75819592|FG001|STARTED|Overall Study||205||
59700439|NCT01302119|75819591|FG000|COMPLETED|Overall Study||349||
59700440|NCT01302119|75819592|FG001|COMPLETED|Overall Study||177||
59700441|NCT01302119|75819591|FG000|NOT COMPLETED|Overall Study||50||
59700442|NCT01302119|75819592|FG001|NOT COMPLETED|Overall Study||28||
59700443|NCT05038982|75819600|FG000|STARTED|Overall Study||10||
59700444|NCT05038982|75819601|FG001|STARTED|Overall Study||10||
59700445|NCT05038982|75819600|FG000|End of Intervention Period. Week 12: Per Protocol Population|Overall Study||10||
59700446|NCT05038982|75819601|FG001|End of Intervention Period. Week 12: Per Protocol Population|Overall Study||10||
59700447|NCT05038982|75819600|FG000|Follow-up Period (4 Weeks)|Overall Study||10||
59700448|NCT05038982|75819601|FG001|Follow-up Period (4 Weeks)|Overall Study||8||
59700449|NCT05038982|75819600|FG000|COMPLETED|Overall Study||10||
59700450|NCT05038982|75819601|FG001|COMPLETED|Overall Study||8||
59700451|NCT05038982|75819600|FG000|NOT COMPLETED|Overall Study||0||
59700452|NCT05038982|75819601|FG001|NOT COMPLETED|Overall Study||2||
59700453|NCT04983797|75819608|FG000|STARTED|Overall Study||31||
59700454|NCT04983797|75819608|FG000|COMPLETED|Overall Study||31||
59700455|NCT04983797|75819608|FG000|NOT COMPLETED|Overall Study||0||
59700456|NCT04867785|75819620|FG000|STARTED|Overall Study||45||
59700457|NCT04867785|75819621|FG001|STARTED|Overall Study||46||
59700458|NCT04867785|75819622|FG002|STARTED|Overall Study||47||
59700459|NCT04867785|75819623|FG003|STARTED|Overall Study||23||
59700460|NCT04867785|75819624|FG004|STARTED|Overall Study||24||
59700461|NCT04867785|75819625|FG005|STARTED|Overall Study||26||
59700462|NCT04867785|75819626|FG006|STARTED|Overall Study||24||
59700463|NCT04867785|75819627|FG007|STARTED|Overall Study||46||
59700464|NCT04867785|75819620|FG000|Received at Least 1 Dose of Study Drug|Overall Study||45||
59700465|NCT04867785|75819621|FG001|Received at Least 1 Dose of Study Drug|Overall Study||46||
59700466|NCT04867785|75819622|FG002|Received at Least 1 Dose of Study Drug|Overall Study||47||
59700467|NCT04867785|75819623|FG003|Received at Least 1 Dose of Study Drug|Overall Study||23||
59700468|NCT04867785|75819624|FG004|Received at Least 1 Dose of Study Drug|Overall Study||24||
59700469|NCT04867785|75819625|FG005|Received at Least 1 Dose of Study Drug|Overall Study||26||
59700470|NCT04867785|75819626|FG006|Received at Least 1 Dose of Study Drug|Overall Study||24||
59700471|NCT04867785|75819627|FG007|Received at Least 1 Dose of Study Drug|Overall Study||46||
59700472|NCT04867785|75819620|FG000|COMPLETED|Overall Study||34||
59700473|NCT04867785|75819621|FG001|COMPLETED|Overall Study||40||
59700474|NCT04867785|75819622|FG002|COMPLETED|Overall Study||41||
59700475|NCT04867785|75819623|FG003|COMPLETED|Overall Study||19||
59700476|NCT04867785|75819624|FG004|COMPLETED|Overall Study||21||
59700477|NCT04867785|75819625|FG005|COMPLETED|Overall Study||25||
59700478|NCT04867785|75819626|FG006|COMPLETED|Overall Study||22||
59700479|NCT04867785|75819627|FG007|COMPLETED|Overall Study||35||
59700480|NCT04867785|75819620|FG000|NOT COMPLETED|Overall Study||11||
59700481|NCT04867785|75819621|FG001|NOT COMPLETED|Overall Study||6||
59700482|NCT04867785|75819622|FG002|NOT COMPLETED|Overall Study||6||
59700483|NCT04867785|75819623|FG003|NOT COMPLETED|Overall Study||4||
59700484|NCT04867785|75819624|FG004|NOT COMPLETED|Overall Study||3||
59700485|NCT04867785|75819625|FG005|NOT COMPLETED|Overall Study||1||
59700486|NCT04867785|75819626|FG006|NOT COMPLETED|Overall Study||2||
59700487|NCT04867785|75819627|FG007|NOT COMPLETED|Overall Study||11||
59700488|NCT04541004|75819654|FG000|STARTED|Overall Study||253||
59700489|NCT04541004|75819654|FG000|COMPLETED|Overall Study||251||
59700490|NCT04541004|75819654|FG000|NOT COMPLETED|Overall Study||2||
59700491|NCT04091646|75819661|FG000|STARTED|Overall Study||154||
59700492|NCT04091646|75819662|FG001|STARTED|Overall Study||72||
59700493|NCT04091646|75819661|FG000|COMPLETED|Overall Study||141||
59700494|NCT04091646|75819662|FG001|COMPLETED|Overall Study||67||
59700495|NCT04091646|75819661|FG000|NOT COMPLETED|Overall Study||13||
59700496|NCT04091646|75819662|FG001|NOT COMPLETED|Overall Study||5||
59700497|NCT04081298|75819668|FG000|STARTED|Overall Study||20||
59700498|NCT04081298|75819668|FG000|COMPLETED|Overall Study||19||
59700499|NCT04081298|75819668|FG000|NOT COMPLETED|Overall Study||1||
59700500|NCT04040933|75819674|FG000|STARTED|Overall Study||36||
59700501|NCT04040933|75819674|FG000|Treated|Overall Study||36||
59700502|NCT04040933|75819674|FG000|COMPLETED|Overall Study||33||
59700503|NCT04040933|75819674|FG000|NOT COMPLETED|Overall Study||3||
59700504|NCT03995355|75819687|FG000|STARTED|Overall Study||77||
59700505|NCT03995355|75819688|FG001|STARTED|Overall Study||81||
59700506|NCT03995355|75819687|FG000|COMPLETED|Overall Study||75||
59700507|NCT03995355|75819688|FG001|COMPLETED|Overall Study||80||
59700508|NCT03995355|75819687|FG000|NOT COMPLETED|Overall Study||2||
59700509|NCT03995355|75819688|FG001|NOT COMPLETED|Overall Study||1||
59700510|NCT03933397|75819696|FG000|STARTED|Overall Study||162||
59700511|NCT03933397|75819697|FG001|STARTED|Overall Study||166||
59700512|NCT03933397|75819696|FG000|COMPLETED|Overall Study||50||
59700513|NCT03933397|75819697|FG001|COMPLETED|Overall Study||46||
59700514|NCT03933397|75819696|FG000|NOT COMPLETED|Overall Study||112||
59700515|NCT03933397|75819697|FG001|NOT COMPLETED|Overall Study||120||
59700516|NCT03899753|75819706|FG000|STARTED|Overall Study||1||
59700517|NCT03899753|75819707|FG001|STARTED|Overall Study||0||
59700518|NCT03899753|75819706|FG000|COMPLETED|Overall Study||1||
59700519|NCT03899753|75819707|FG001|COMPLETED|Overall Study||0||
59700520|NCT03899753|75819706|FG000|NOT COMPLETED|Overall Study||0||
59700521|NCT03899753|75819707|FG001|NOT COMPLETED|Overall Study||0||
59700522|NCT03788434|75819716|FG000|STARTED|Overall Study||30||
59700523|NCT03788434|75819717|FG001|STARTED|Overall Study||27||
59700524|NCT03788434|75819718|FG002|STARTED|Overall Study||22||
59700525|NCT03788434|75819716|FG000|COMPLETED|Overall Study||29||
59700526|NCT03788434|75819717|FG001|COMPLETED|Overall Study||27||
59700527|NCT03788434|75819718|FG002|COMPLETED|Overall Study||22||
59700528|NCT03788434|75819716|FG000|NOT COMPLETED|Overall Study||1||
59700529|NCT03788434|75819717|FG001|NOT COMPLETED|Overall Study||0||
59700530|NCT03788434|75819718|FG002|NOT COMPLETED|Overall Study||0||
59700531|NCT03758261|75819729|FG000|STARTED|Overall Study||17||
59700532|NCT03758261|75819730|FG001|STARTED|Overall Study||16||
59700533|NCT03758261|75819729|FG000|COMPLETED|Overall Study||15||
59700534|NCT03758261|75819730|FG001|COMPLETED|Overall Study||15||
59700535|NCT03758261|75819729|FG000|NOT COMPLETED|Overall Study||2||
59700536|NCT03758261|75819730|FG001|NOT COMPLETED|Overall Study||1||
59700537|NCT03624881|75819738|FG000|STARTED|Overall Study||283||
59700538|NCT03624881|75819739|FG001|STARTED|Overall Study||50||
59700539|NCT03624881|75819738|FG000|Safety Set|Overall Study||261||
59700540|NCT03624881|75819739|FG001|Safety Set|Overall Study||49||
59700541|NCT03624881|75819738|FG000|COMPLETED|Overall Study||237||
59700542|NCT03624881|75819739|FG001|COMPLETED|Overall Study||44||
59700543|NCT03624881|75819738|FG000|NOT COMPLETED|Overall Study||46||
59700544|NCT03624881|75819739|FG001|NOT COMPLETED|Overall Study||6||
59700545|NCT03531957|75819749|FG000|STARTED|Overall Study||61|Initially 62 subjects randomized into ASN002 40 mg arm, but one subject did not received any dose, therefore the subject was excluded from all analysis sets, including mITT and safety sets. The 10 subjects who were not completed the study in ASN002 40 mg group did not include the subjects who did not received any dose.|
59700546|NCT03531957|75819750|FG001|STARTED|Overall Study||59|Initially 62 subjects randomized into ASN002 40 mg arm, but one subject did not received any dose, therefore the subject was excluded from all analysis sets, including mITT and safety sets. The 10 subjects who were not completed the study in ASN002 40 mg group did not include the subjects who did not received any dose.|
59700547|NCT03531957|75819751|FG002|STARTED|Overall Study||63|Initially 62 subjects randomized into ASN002 40 mg arm, but one subject did not received any dose, therefore the subject was excluded from all analysis sets, including mITT and safety sets. The 10 subjects who were not completed the study in ASN002 40 mg group did not include the subjects who did not received any dose.|
59700548|NCT03531957|75819752|FG003|STARTED|Overall Study||60|Initially 62 subjects randomized into ASN002 40 mg arm, but one subject did not received any dose, therefore the subject was excluded from all analysis sets, including mITT and safety sets. The 10 subjects who were not completed the study in ASN002 40 mg group did not include the subjects who did not received any dose.|
59700549|NCT03531957|75819749|FG000|COMPLETED|Overall Study||51||
59700550|NCT03531957|75819750|FG001|COMPLETED|Overall Study||54||
59700551|NCT03531957|75819751|FG002|COMPLETED|Overall Study||49||
59700552|NCT03531957|75819752|FG003|COMPLETED|Overall Study||49||
59700553|NCT03531957|75819749|FG000|NOT COMPLETED|Overall Study||10||
59700554|NCT03531957|75819750|FG001|NOT COMPLETED|Overall Study||5||
59700555|NCT03531957|75819751|FG002|NOT COMPLETED|Overall Study||14||
59700556|NCT03531957|75819752|FG003|NOT COMPLETED|Overall Study||11||
59700557|NCT03428997|75819762|FG000|STARTED|Overall Study||24||
59700558|NCT03428997|75819762|FG000|COMPLETED|Overall Study||16||
59700559|NCT03428997|75819762|FG000|NOT COMPLETED|Overall Study||8||
59700560|NCT03252431|75819770|FG000|STARTED|Overall Study||197||
59700561|NCT03252431|75819771|FG001|STARTED|Overall Study||196||
59700562|NCT03252431|75819770|FG000|COMPLETED|Overall Study||186||
59700563|NCT03252431|75819771|FG001|COMPLETED|Overall Study||187||
59700564|NCT03252431|75819770|FG000|NOT COMPLETED|Overall Study||11||
59700565|NCT03252431|75819771|FG001|NOT COMPLETED|Overall Study||9||
59700566|NCT03149757|75819779|FG000|STARTED|Overall Study||103||
59700567|NCT03149757|75819780|FG001|STARTED|Overall Study||105||
59700568|NCT03149757|75819779|FG000|COMPLETED|Overall Study||96||
59700569|NCT03149757|75819780|FG001|COMPLETED|Overall Study||100||
59700570|NCT03149757|75819779|FG000|NOT COMPLETED|Overall Study||7||
59700571|NCT03149757|75819780|FG001|NOT COMPLETED|Overall Study||5||
59700572|NCT03134703|75819788|FG000|STARTED|Overall Study||6||
59700573|NCT03134703|75819789|FG001|STARTED|Overall Study||5||
59700574|NCT03134703|75819788|FG000|COMPLETED|Overall Study||0||
59700575|NCT03134703|75819789|FG001|COMPLETED|Overall Study||3||
59700576|NCT03134703|75819788|FG000|NOT COMPLETED|Overall Study||6||
59700577|NCT03134703|75819789|FG001|NOT COMPLETED|Overall Study||2||
59700578|NCT03118674|75819795|FG000|STARTED|Overall Study||23||
59700579|NCT03118674|75819795|FG000|COMPLETED|Overall Study||8||
59700580|NCT03118674|75819795|FG000|NOT COMPLETED|Overall Study||15||
59700581|NCT03069352|75819801|FG000|STARTED|Overall Study||68||
59700582|NCT03069352|75819802|FG001|STARTED|Overall Study||143||
59700583|NCT03069352|75819801|FG000|Received Treatment|Overall Study||68||
59700584|NCT03069352|75819802|FG001|Received Treatment|Overall Study||142||
59700585|NCT03069352|75819801|FG000|COMPLETED|Overall Study||56|As of 15 August 2019|
59700586|NCT03069352|75819802|FG001|COMPLETED|Overall Study||103|As of 15 August 2019|
59700587|NCT03069352|75819801|FG000|NOT COMPLETED|Overall Study||12||
59700588|NCT03069352|75819802|FG001|NOT COMPLETED|Overall Study||40||
59700589|NCT02993523|75819813|FG000|STARTED|Overall Study||1||
59700590|NCT02993523|75819814|FG001|STARTED|Overall Study||1||
59700591|NCT02993523|75819815|FG002|STARTED|Overall Study||145||
59700592|NCT02993523|75819816|FG003|STARTED|Overall Study||286||
59700593|NCT02993523|75819817|FG004|STARTED|Overall Study||10||
59700594|NCT02993523|75819813|FG000|COMPLETED|Overall Study||0||
59700595|NCT02993523|75819814|FG001|COMPLETED|Overall Study||0||
59700596|NCT02993523|75819815|FG002|COMPLETED|Overall Study||1||
59700597|NCT02993523|75819816|FG003|COMPLETED|Overall Study||48||
59700598|NCT02993523|75819817|FG004|COMPLETED|Overall Study||4||
59700599|NCT02993523|75819813|FG000|NOT COMPLETED|Overall Study||1||
59700600|NCT02993523|75819814|FG001|NOT COMPLETED|Overall Study||1||
59700601|NCT02993523|75819815|FG002|NOT COMPLETED|Overall Study||144||
59700602|NCT02993523|75819816|FG003|NOT COMPLETED|Overall Study||238||
59700603|NCT02993523|75819817|FG004|NOT COMPLETED|Overall Study||6||
59700604|NCT02795429|75819830|FG000|STARTED|Overall Study||6||
59700605|NCT02795429|75819831|FG001|STARTED|Overall Study||10||
59700606|NCT02795429|75819832|FG002|STARTED|Overall Study||11||
59700607|NCT02795429|75819833|FG003|STARTED|Overall Study||32||
59700608|NCT02795429|75819834|FG004|STARTED|Overall Study||30||
59700609|NCT02795429|75819830|FG000|COMPLETED|Overall Study||0||
59700610|NCT02795429|75819831|FG001|COMPLETED|Overall Study||0||
59700611|NCT02795429|75819832|FG002|COMPLETED|Overall Study||0||
59700612|NCT02795429|75819833|FG003|COMPLETED|Overall Study||0||
59700613|NCT02795429|75819834|FG004|COMPLETED|Overall Study||0||
59700614|NCT02795429|75819830|FG000|NOT COMPLETED|Overall Study||6||
59700615|NCT02795429|75819831|FG001|NOT COMPLETED|Overall Study||10||
59700616|NCT02795429|75819832|FG002|NOT COMPLETED|Overall Study||11||
59700617|NCT02795429|75819833|FG003|NOT COMPLETED|Overall Study||32||
59700618|NCT02795429|75819834|FG004|NOT COMPLETED|Overall Study||30||
59700619|NCT02737163|75819853|FG000|STARTED|Overall Study|114 encounter assessments were completed on 95 participants over 15 months|95||
59700620|NCT02737163|75819853|FG000|COMPLETED|Overall Study||95||
59700621|NCT02737163|75819853|FG000|NOT COMPLETED|Overall Study||0||
59700622|NCT02652949|75819857|FG000|STARTED|30-Day Follow-up for Primary Endpoint|The 30-day primary endpoint was evaluated when 87 subjects completed 30-day follow-up.|87||
59700623|NCT02652949|75819857|FG000|COMPLETED|30-Day Follow-up for Primary Endpoint||86||
59700624|NCT02652949|75819857|FG000|NOT COMPLETED|30-Day Follow-up for Primary Endpoint||1||
59700625|NCT02652949|75819857|FG000|STARTED|30-Day Follow-up for Secondary Endpoint|The 30-day secondary endpoint was evaluated when 100 subjects completed 30-day follow-up.|100||
59700626|NCT02652949|75819857|FG000|COMPLETED|30-Day Follow-up for Secondary Endpoint||99||
59700627|NCT02652949|75819857|FG000|NOT COMPLETED|30-Day Follow-up for Secondary Endpoint||1||
59700628|NCT02652949|75819857|FG000|STARTED|6-Month Follow-up Secondary Endpoint|Note that 6-month follow up is not mandatory for OUS subjects.|99||
59700629|NCT02652949|75819857|FG000|COMPLETED|6-Month Follow-up Secondary Endpoint||91||
59700630|NCT02652949|75819857|FG000|NOT COMPLETED|6-Month Follow-up Secondary Endpoint||8||
59700631|NCT02652949|75819857|FG000|STARTED|12-Month Follow-up Secondary Endpoint||91||
59700632|NCT02652949|75819857|FG000|COMPLETED|12-Month Follow-up Secondary Endpoint||87||
59700633|NCT02652949|75819857|FG000|NOT COMPLETED|12-Month Follow-up Secondary Endpoint||4||
59700634|NCT02652949|75819857|FG000|STARTED|24-Month Follow-up Secondary Endpoint||87||
59700635|NCT02652949|75819857|FG000|COMPLETED|24-Month Follow-up Secondary Endpoint||52||
59700636|NCT02652949|75819857|FG000|NOT COMPLETED|24-Month Follow-up Secondary Endpoint||35||
59700637|NCT02652949|75819857|FG000|STARTED|36-Month Follow-up Secondary Endpoint||52||
59700638|NCT02652949|75819857|FG000|COMPLETED|36-Month Follow-up Secondary Endpoint||48||
59700639|NCT02652949|75819857|FG000|NOT COMPLETED|36-Month Follow-up Secondary Endpoint||4||
59700640|NCT02652949|75819857|FG000|STARTED|48-Month Follow-up Secondary Endpoint||48||
59700641|NCT02652949|75819857|FG000|COMPLETED|48-Month Follow-up Secondary Endpoint||42||
59700642|NCT02652949|75819857|FG000|NOT COMPLETED|48-Month Follow-up Secondary Endpoint||6||
59700643|NCT02632344|75819868|FG000|STARTED|Overall Study||21||
59700644|NCT02632344|75819868|FG000|COMPLETED|Overall Study||13||
59700645|NCT02632344|75819868|FG000|NOT COMPLETED|Overall Study||8||
59700646|NCT02625324|75819872|FG000|STARTED|30-Day Follow-up for Primary Endpoint|The 30-day primary endpoint was evaluated when 87 subjects completed 30-day follow-up.|87||
59700647|NCT02625324|75819872|FG000|COMPLETED|30-Day Follow-up for Primary Endpoint||86||
59700648|NCT02625324|75819872|FG000|NOT COMPLETED|30-Day Follow-up for Primary Endpoint||1||
59700649|NCT02625324|75819872|FG000|STARTED|30-Day Follow-up for Secondary Endpoint|The 30-day secondary endpoint was evaluated when 100 subjects completed 30-day follow-up.|100||
59700650|NCT02625324|75819872|FG000|COMPLETED|30-Day Follow-up for Secondary Endpoint||99||
59700651|NCT02625324|75819872|FG000|NOT COMPLETED|30-Day Follow-up for Secondary Endpoint||1||
59700652|NCT02625324|75819872|FG000|STARTED|6-Month Follow-up Subject Accountability|Note that 6-month follow up is not mandatory for OUS subjects|99||
59700653|NCT02625324|75819872|FG000|COMPLETED|6-Month Follow-up Subject Accountability||91||
59700654|NCT02625324|75819872|FG000|NOT COMPLETED|6-Month Follow-up Subject Accountability||8||
59700655|NCT02625324|75819872|FG000|STARTED|12-Month Follow-up Secondary Endpoint||91||
59700656|NCT02625324|75819872|FG000|COMPLETED|12-Month Follow-up Secondary Endpoint||87||
59700657|NCT02625324|75819872|FG000|NOT COMPLETED|12-Month Follow-up Secondary Endpoint||4||
59700658|NCT02625324|75819872|FG000|STARTED|24-Month Follow-up Secondary Endpoint||87||
59700659|NCT02625324|75819872|FG000|COMPLETED|24-Month Follow-up Secondary Endpoint||52||
59700660|NCT02625324|75819872|FG000|NOT COMPLETED|24-Month Follow-up Secondary Endpoint||35||
59700661|NCT02625324|75819872|FG000|STARTED|36-Month Follow-up Secondary Endpoint||52||
59700662|NCT02625324|75819872|FG000|COMPLETED|36-Month Follow-up Secondary Endpoint||48||
59700663|NCT02625324|75819872|FG000|NOT COMPLETED|36-Month Follow-up Secondary Endpoint||4||
59700664|NCT02625324|75819872|FG000|STARTED|48-Month Follow-up Secondary Endpoint||48||
59700665|NCT02625324|75819872|FG000|COMPLETED|48-Month Follow-up Secondary Endpoint||42||
59700666|NCT02625324|75819872|FG000|NOT COMPLETED|48-Month Follow-up Secondary Endpoint||6||
59700667|NCT02484287|75819887|FG000|STARTED|Overall Study||15||
59700668|NCT02484287|75819888|FG001|STARTED|Overall Study||26||
59700669|NCT02484287|75819889|FG002|STARTED|Overall Study||19||
59700670|NCT02484287|75819887|FG000|COMPLETED|Overall Study||0||
59700671|NCT02484287|75819888|FG001|COMPLETED|Overall Study||0||
59700672|NCT02484287|75819889|FG002|COMPLETED|Overall Study||0||
59700673|NCT02484287|75819887|FG000|NOT COMPLETED|Overall Study||15||
59700674|NCT02484287|75819888|FG001|NOT COMPLETED|Overall Study||26||
59700675|NCT02484287|75819889|FG002|NOT COMPLETED|Overall Study||19||
59700676|NCT02341144|75819901|FG000|STARTED|Overall Study||30||
59700677|NCT02341144|75819902|FG001|STARTED|Overall Study||31||
59700678|NCT02341144|75819901|FG000|COMPLETED|Overall Study||28||
59700679|NCT02341144|75819902|FG001|COMPLETED|Overall Study||30||
59700680|NCT02341144|75819901|FG000|NOT COMPLETED|Overall Study||2||
59700681|NCT02341144|75819902|FG001|NOT COMPLETED|Overall Study||1||
59700682|NCT02213328|75819908|FG000|STARTED|Overall Study||148||
59700683|NCT02213328|75819908|FG000|COMPLETED|Overall Study||120||
59700684|NCT02213328|75819908|FG000|NOT COMPLETED|Overall Study||28||
59700685|NCT02150967|75819917|FG000|STARTED|Overall Study||108||
59700686|NCT02150967|75819918|FG001|STARTED|Overall Study||25||
59700687|NCT02150967|75819919|FG002|STARTED|Overall Study||10||
59700688|NCT02150967|75819917|FG000|Treatment Ongoing|Overall Study||0||
59700689|NCT02150967|75819918|FG001|Treatment Ongoing|Overall Study||0||
59700690|NCT02150967|75819919|FG002|Treatment Ongoing|Overall Study||0||
59700691|NCT02150967|75819917|FG000|Treatment Ended|Overall Study||108|Per protocol, patients continue treatment until radiographical documentation of disease progression.|
59700692|NCT02150967|75819918|FG001|Treatment Ended|Overall Study||25|Per protocol, patients continue treatment until radiographical documentation of disease progression.|
59700693|NCT02150967|75819919|FG002|Treatment Ended|Overall Study||10|Per protocol, patients continue treatment until radiographical documentation of disease progression.|
59700694|NCT02150967|75819917|FG000|COMPLETED|Overall Study|Cohort 1 (FGFR2 fusions): Primary efficacy outcome measures were prespecified only for this cohort.|108|"Cohort 1: completed is defined as patients who had the opportunity to be followed for at least 10 months after their initial exposure of infigratinib. This cohort supports the primary efficacy analysis of the study~Cohort 2 and 3: completed is defined as patients who may have had the opportunity to be followed for at least 10 months after their initial exposure of infigratinib or up to the time of study termination.~These cohorts support only the exploratory endpoints of the study"|
59700695|NCT02150967|75819918|FG001|COMPLETED|Overall Study|Cohort 2 (Other FGFR Alterations): not the primary efficacy analysis population.|25|"Cohort 1: completed is defined as patients who had the opportunity to be followed for at least 10 months after their initial exposure of infigratinib. This cohort supports the primary efficacy analysis of the study~Cohort 2 and 3: completed is defined as patients who may have had the opportunity to be followed for at least 10 months after their initial exposure of infigratinib or up to the time of study termination.~These cohorts support only the exploratory endpoints of the study"|
59700696|NCT02150967|75819919|FG002|COMPLETED|Overall Study|Cohort 3 (FGFR2 fusions and prior FGFR inhibitor): not the primary efficacy analysis population.|10|"Cohort 1: completed is defined as patients who had the opportunity to be followed for at least 10 months after their initial exposure of infigratinib. This cohort supports the primary efficacy analysis of the study~Cohort 2 and 3: completed is defined as patients who may have had the opportunity to be followed for at least 10 months after their initial exposure of infigratinib or up to the time of study termination.~These cohorts support only the exploratory endpoints of the study"|
59700697|NCT02150967|75819917|FG000|NOT COMPLETED|Overall Study||0||
59700698|NCT02150967|75819918|FG001|NOT COMPLETED|Overall Study||0||
59700699|NCT02150967|75819919|FG002|NOT COMPLETED|Overall Study||0||
59700700|NCT02137603|75819928|FG000|STARTED|Overall Study||18||
59700701|NCT02137603|75819929|FG001|STARTED|Overall Study||18||
59700702|NCT02137603|75819928|FG000|COMPLETED|Overall Study||16||
59700703|NCT02137603|75819929|FG001|COMPLETED|Overall Study||18||
59700704|NCT02137603|75819928|FG000|NOT COMPLETED|Overall Study||2||
59700705|NCT02137603|75819929|FG001|NOT COMPLETED|Overall Study||0||
59700706|NCT02085408|75819937|FG000|STARTED|Step 1: Induction||363||
59700707|NCT02085408|75819938|FG001|STARTED|Step 1: Induction||364||
59700708|NCT02085408|75819937|FG000|Adverse Event Data Available|Step 1: Induction||356||
59700709|NCT02085408|75819938|FG001|Adverse Event Data Available|Step 1: Induction||360||
59700710|NCT02085408|75819937|FG000|Donor Information Available|Step 1: Induction||191||
59700711|NCT02085408|75819938|FG001|Donor Information Available|Step 1: Induction||195||
59700712|NCT02085408|75819937|FG000|COMPLETED|Step 1: Induction||227||
59700713|NCT02085408|75819938|FG001|COMPLETED|Step 1: Induction||225||
59700714|NCT02085408|75819937|FG000|NOT COMPLETED|Step 1: Induction||136||
59700715|NCT02085408|75819938|FG001|NOT COMPLETED|Step 1: Induction||139||
59700716|NCT02085408|75819937|FG000|STARTED|Step 2: Consolidation||174||
59700717|NCT02085408|75819938|FG001|STARTED|Step 2: Consolidation||154||
59700718|NCT02085408|75819937|FG000|Adverse Event Data Available|Step 2: Consolidation||170||
59700719|NCT02085408|75819938|FG001|Adverse Event Data Available|Step 2: Consolidation||148||
59700720|NCT02085408|75819937|FG000|COMPLETED|Step 2: Consolidation||129||
59700721|NCT02085408|75819938|FG001|COMPLETED|Step 2: Consolidation||104||
59700722|NCT02085408|75819937|FG000|NOT COMPLETED|Step 2: Consolidation||45||
59700723|NCT02085408|75819938|FG001|NOT COMPLETED|Step 2: Consolidation||50||
59700724|NCT02085408|75819937|FG000|STARTED|Step 3: Maintenance||103||
59700725|NCT02085408|75819938|FG001|STARTED|Step 3: Maintenance||89||
59700726|NCT02085408|75819937|FG000|Randomized to Observation|Step 3: Maintenance||35||
59700727|NCT02085408|75819938|FG001|Randomized to Observation|Step 3: Maintenance||26||
59700728|NCT02085408|75819937|FG000|Randomized to Decitabine|Step 3: Maintenance||32||
59700729|NCT02085408|75819938|FG001|Randomized to Decitabine|Step 3: Maintenance||27||
59700730|NCT02085408|75819937|FG000|Received Transplant|Step 3: Maintenance||36||
59700731|NCT02085408|75819938|FG001|Received Transplant|Step 3: Maintenance||36||
59700732|NCT02085408|75819937|FG000|COMPLETED|Step 3: Maintenance||78||
59700733|NCT02085408|75819938|FG001|COMPLETED|Step 3: Maintenance||67||
59700734|NCT02085408|75819937|FG000|NOT COMPLETED|Step 3: Maintenance||25||
59700735|NCT02085408|75819938|FG001|NOT COMPLETED|Step 3: Maintenance||22||
59700736|NCT01475786|75819956|FG000|STARTED|Overall Study||43||
59700737|NCT01475786|75819957|FG001|STARTED|Overall Study||40||
59700738|NCT01475786|75819958|FG002|STARTED|Overall Study||21||
59700739|NCT01475786|75819956|FG000|COMPLETED|Overall Study||41||
59700740|NCT01475786|75819957|FG001|COMPLETED|Overall Study||36||
59700741|NCT01475786|75819958|FG002|COMPLETED|Overall Study||19||
59700742|NCT01475786|75819956|FG000|NOT COMPLETED|Overall Study||2||
59700743|NCT01475786|75819957|FG001|NOT COMPLETED|Overall Study||4||
59700744|NCT01475786|75819958|FG002|NOT COMPLETED|Overall Study||2||
59700745|NCT01290692|75819966|FG000|STARTED|Overall Study||14||
59700746|NCT01290692|75819966|FG000|COMPLETED|Overall Study||7||
59700747|NCT01290692|75819966|FG000|NOT COMPLETED|Overall Study||7||
59700748|NCT00996866|75819972|FG000|STARTED|Overall Study||13||
59700749|NCT00996866|75819973|FG001|STARTED|Overall Study||14||
59700750|NCT00996866|75819972|FG000|COMPLETED|Overall Study||13||
59700751|NCT00996866|75819973|FG001|COMPLETED|Overall Study||14||
59700752|NCT00996866|75819972|FG000|NOT COMPLETED|Overall Study||0||
59700753|NCT00996866|75819973|FG001|NOT COMPLETED|Overall Study||0||
59700754|NCT00876993|75819984|FG000|STARTED|Overall Study||5|Began at Dose Level (DL) 1, next was DL 0 (de-escalation), followed by DL1, DL 2, finished at DL 1.|
59700755|NCT00876993|75819985|FG001|STARTED|Overall Study||6|Began at Dose Level (DL) 1, next was DL 0 (de-escalation), followed by DL1, DL 2, finished at DL 1.|
59700756|NCT00876993|75819986|FG002|STARTED|Overall Study||5|Began at Dose Level (DL) 1, next was DL 0 (de-escalation), followed by DL1, DL 2, finished at DL 1.|
59700757|NCT00876993|75819987|FG003|STARTED|Overall Study||5|Began at Dose Level (DL) 1, next was DL 0 (de-escalation), followed by DL1, DL 2, finished at DL 1.|
59700758|NCT00876993|75819988|FG004|STARTED|Overall Study||5|Began at Dose Level (DL) 1, next was DL 0 (de-escalation), followed by DL1, DL 2, finished at DL 1.|
59700759|NCT00876993|75819984|FG000|COMPLETED|Overall Study||4||
59700760|NCT00876993|75819985|FG001|COMPLETED|Overall Study||6||
59700761|NCT00876993|75819986|FG002|COMPLETED|Overall Study||3||
59700762|NCT00876993|75819987|FG003|COMPLETED|Overall Study||5||
59700763|NCT00876993|75819988|FG004|COMPLETED|Overall Study||3||
59700764|NCT00876993|75819984|FG000|NOT COMPLETED|Overall Study||1||
59700765|NCT00876993|75819985|FG001|NOT COMPLETED|Overall Study||0||
59700766|NCT00876993|75819986|FG002|NOT COMPLETED|Overall Study||2||
59700767|NCT00876993|75819987|FG003|NOT COMPLETED|Overall Study||0||
59700768|NCT00876993|75819988|FG004|NOT COMPLETED|Overall Study||2||
59700769|NCT00700882|75820002|FG000|STARTED|Overall Study||81||
59700770|NCT00700882|75820002|FG000|Received Protocol Therapy|Overall Study||75||
59700771|NCT00700882|75820002|FG000|Eligible and Treated Patients|Overall Study||73||
59700772|NCT00700882|75820002|FG000|Eligible, Treated and KIT+ Patients|Overall Study||22||
59700773|NCT00700882|75820002|FG000|Eligible and Treated Patients With Objective Response|Overall Study||7||
59700774|NCT00700882|75820002|FG000|COMPLETED|Overall Study||22||
59700775|NCT00700882|75820002|FG000|NOT COMPLETED|Overall Study||59||
59700776|NCT00673309|75820016|FG000|STARTED|Overall Study||64||
59700777|NCT00673309|75820017|FG001|STARTED|Overall Study||14||
59700778|NCT00673309|75820018|FG002|STARTED|Overall Study||14||
59700779|NCT00673309|75820019|FG003|STARTED|Overall Study||25||
59700780|NCT00673309|75820020|FG004|STARTED|Overall Study||18||
59700781|NCT00673309|75820021|FG005|STARTED|Overall Study||35||
59700782|NCT00673309|75820022|FG006|STARTED|Overall Study||14||
59700783|NCT00673309|75820023|FG007|STARTED|Overall Study||13||
59700784|NCT00673309|75820024|FG008|STARTED|Overall Study||17||
59700785|NCT00673309|75820025|FG009|STARTED|Overall Study||30||
59700786|NCT00673309|75820016|FG000|COMPLETED|Overall Study||64||
59700787|NCT00673309|75820017|FG001|COMPLETED|Overall Study||14||
59700788|NCT00673309|75820018|FG002|COMPLETED|Overall Study||14||
59700789|NCT00673309|75820019|FG003|COMPLETED|Overall Study||25||
59700790|NCT00673309|75820020|FG004|COMPLETED|Overall Study||18||
59700791|NCT00673309|75820021|FG005|COMPLETED|Overall Study||35||
59700792|NCT00673309|75820022|FG006|COMPLETED|Overall Study||14||
59700793|NCT00673309|75820023|FG007|COMPLETED|Overall Study||13||
59700794|NCT00673309|75820024|FG008|COMPLETED|Overall Study||17||
59700795|NCT00673309|75820025|FG009|COMPLETED|Overall Study||30||
59700796|NCT00673309|75820016|FG000|NOT COMPLETED|Overall Study||0||
59700797|NCT00673309|75820017|FG001|NOT COMPLETED|Overall Study||0||
59700798|NCT00673309|75820018|FG002|NOT COMPLETED|Overall Study||0||
59700799|NCT00673309|75820019|FG003|NOT COMPLETED|Overall Study||0||
59700800|NCT00673309|75820020|FG004|NOT COMPLETED|Overall Study||0||
59700801|NCT00673309|75820021|FG005|NOT COMPLETED|Overall Study||0||
59700802|NCT00673309|75820022|FG006|NOT COMPLETED|Overall Study||0||
59700803|NCT00673309|75820023|FG007|NOT COMPLETED|Overall Study||0||
59700804|NCT00673309|75820024|FG008|NOT COMPLETED|Overall Study||0||
59700805|NCT00673309|75820025|FG009|NOT COMPLETED|Overall Study||0||
59700806|NCT00666835|75820040|FG000|STARTED|Overall Study||314||
59700807|NCT00666835|75820041|FG001|STARTED|Overall Study||164||
59700808|NCT00666835|75820040|FG000|COMPLETED|Overall Study||261||
59700809|NCT00666835|75820041|FG001|COMPLETED|Overall Study||142||
59700810|NCT00666835|75820040|FG000|NOT COMPLETED|Overall Study||53||
59700811|NCT00666835|75820041|FG001|NOT COMPLETED|Overall Study||22||
59700812|NCT00551759|75820048|FG000|STARTED|Overall Study||22||
59700813|NCT00551759|75820048|FG000|Eligible and Began Treatment|Overall Study||21||
59700814|NCT00551759|75820048|FG000|Underwent Surgery|Overall Study||17||
59700815|NCT00551759|75820048|FG000|Received Adjuvant Therapy|Overall Study||12||
59700816|NCT00551759|75820048|FG000|COMPLETED|Overall Study||9||
59700817|NCT00551759|75820048|FG000|NOT COMPLETED|Overall Study||13||
59700818|NCT00335140|75820052|FG000|STARTED|Overall Study||26||
59700819|NCT00335140|75820052|FG000|Eligible|Overall Study||25||
59700820|NCT00335140|75820052|FG000|Treated|Overall Study||25||
59548171|NCT02560701|75647102|FG000|Carve Out|Overall Study||8060|Patients in employers who carved out mental health insurance coverage to a 3rd party vendor excluded|
59548172|NCT02560701|75647103|FG001|Carve Out|Overall Study||88729|Patients in employers who carved out mental health insurance coverage to a 3rd party vendor excluded|
59548173|NCT02560701|75647102|FG000|Restrict to Patients Between 12 and 64|Overall Study||7598||
59548174|NCT02560701|75647103|FG001|Restrict to Patients Between 12 and 64|Overall Study||82367||
59548175|NCT02560701|75647102|FG000|Bipolar Diagnosis Time Constraints|Overall Study||3533|Require most recent bipolar diagnosis to be between 5 years and 4 months prior to intervention date|
59700821|NCT00335140|75820052|FG000|COMPLETED|Overall Study||25||
59700822|NCT00335140|75820052|FG000|NOT COMPLETED|Overall Study||1||
59700823|NCT00304239|75820058|FG000|STARTED|Overall Study||73||
59700824|NCT00304239|75820059|FG001|STARTED|Overall Study||58||
59700825|NCT00304239|75820058|FG000|COMPLETED|Overall Study||56||
59700826|NCT00304239|75820059|FG001|COMPLETED|Overall Study||58||
59700827|NCT00304239|75820058|FG000|NOT COMPLETED|Overall Study||17||
59700828|NCT00304239|75820059|FG001|NOT COMPLETED|Overall Study||0||
59700829|NCT00101283|75820067|FG000|STARTED|Overall Study||16||
59700830|NCT00101283|75820068|FG001|STARTED|Overall Study||16||
59700831|NCT00101283|75820067|FG000|Began Treatment|Overall Study||16||
59700832|NCT00101283|75820068|FG001|Began Treatment|Overall Study||13||
59700833|NCT00101283|75820067|FG000|COMPLETED|Overall Study||16||
59700834|NCT00101283|75820068|FG001|COMPLETED|Overall Study||13||
59700835|NCT00101283|75820067|FG000|NOT COMPLETED|Overall Study||0||
59700836|NCT00101283|75820068|FG001|NOT COMPLETED|Overall Study||3||
59700837|NCT01302041|75820074|FG000|STARTED|Overall Study||67||
59700838|NCT01302041|75820074|FG000|Treatment Received|Overall Study||67||
59700839|NCT01302041|75820074|FG000|COMPLETED|Overall Study|Participants who discontinued treatment and completed the 30-day follow-up visit|27||
59700840|NCT01302041|75820074|FG000|NOT COMPLETED|Overall Study||40||
59700841|NCT01301729|75820079|FG000|STARTED|Overall Study||32||
59700842|NCT01301729|75820079|FG000|COMPLETED|Overall Study||28||
59700843|NCT01301729|75820079|FG000|NOT COMPLETED|Overall Study||4||
59700844|NCT01187043|75820089|FG000|STARTED|Overall Study||12||
59700845|NCT01187043|75820090|FG001|STARTED|Overall Study||10||
59700846|NCT01187043|75820091|FG002|STARTED|Overall Study||12||
59700847|NCT01187043|75820092|FG003|STARTED|Overall Study||12||
59700848|NCT01187043|75820093|FG004|STARTED|Overall Study||12||
59700849|NCT01187043|75820089|FG000|COMPLETED|Overall Study||11||
59700850|NCT01187043|75820090|FG001|COMPLETED|Overall Study||10||
59700851|NCT01187043|75820091|FG002|COMPLETED|Overall Study||8||
59700852|NCT01187043|75820092|FG003|COMPLETED|Overall Study||12||
59700853|NCT01187043|75820093|FG004|COMPLETED|Overall Study||10||
59700854|NCT01187043|75820089|FG000|NOT COMPLETED|Overall Study||1||
59700855|NCT01187043|75820090|FG001|NOT COMPLETED|Overall Study||0||
59700856|NCT01187043|75820091|FG002|NOT COMPLETED|Overall Study||4||
59700857|NCT01187043|75820092|FG003|NOT COMPLETED|Overall Study||0||
59700858|NCT01187043|75820093|FG004|NOT COMPLETED|Overall Study||2||
59700859|NCT01186809|75820105|FG000|STARTED|Overall Study||73||
59700860|NCT01186809|75820105|FG000|COMPLETED|Overall Study||43||
59700861|NCT01186809|75820105|FG000|NOT COMPLETED|Overall Study||30||
59700862|NCT01186419|75820111|FG000|STARTED|Overall Study||24||
59700863|NCT01186419|75820112|FG001|STARTED|Overall Study||27||
59700864|NCT01186419|75820111|FG000|COMPLETED|Overall Study||17||
59700865|NCT01186419|75820112|FG001|COMPLETED|Overall Study||18||
59700866|NCT01186419|75820111|FG000|NOT COMPLETED|Overall Study||7||
59700867|NCT01186419|75820112|FG001|NOT COMPLETED|Overall Study||9||
59700868|NCT01301027|75820119|FG000|STARTED|Overall Study||48||
59700869|NCT01301027|75820120|FG001|STARTED|Overall Study||47||
59700870|NCT01301027|75820119|FG000|COMPLETED|Overall Study||40||
59700871|NCT01301027|75820120|FG001|COMPLETED|Overall Study||37||
59700872|NCT01301027|75820119|FG000|NOT COMPLETED|Overall Study||8||
59700873|NCT01301027|75820120|FG001|NOT COMPLETED|Overall Study||10||
59700874|NCT01185639|75820126|FG000|STARTED|Overall Study||29||
59700875|NCT01185639|75820126|FG000|COMPLETED|Overall Study||27||
59700876|NCT01185639|75820126|FG000|NOT COMPLETED|Overall Study||2||
59700877|NCT01185561|75820132|FG000|STARTED|Overall Study||36||
59700878|NCT01185561|75820133|FG001|STARTED|Overall Study||38||
59700879|NCT01185561|75820132|FG000|COMPLETED|Overall Study||34||
59700880|NCT01185561|75820133|FG001|COMPLETED|Overall Study||26||
59700881|NCT01185561|75820132|FG000|NOT COMPLETED|Overall Study||2||
59700882|NCT01185561|75820133|FG001|NOT COMPLETED|Overall Study||12||
59700883|NCT01185249|75820139|FG000|STARTED|Overall Study|Total number of patients consented to participate.|66||
59700884|NCT01185249|75820139|FG000|COMPLETED|Overall Study|Data was analyzed for patients with three consecutive days of data.|24||
59700885|NCT01185249|75820139|FG000|NOT COMPLETED|Overall Study||42||
59700886|NCT01184859|75820149|FG000|STARTED|Period 1: Single Dose||23||
59700887|NCT01184859|75820150|FG001|STARTED|Period 1: Single Dose||25||
59700888|NCT01184859|75820151|FG002|STARTED|Period 1: Single Dose||22||
59700889|NCT01184859|75820152|FG003|STARTED|Period 1: Single Dose||22||
59700890|NCT01184859|75820153|FG004|STARTED|Period 1: Single Dose||24||
59700891|NCT01184859|75820149|FG000|Full Analysis Set (FAS)|Period 1: Single Dose||23||
59700892|NCT01184859|75820150|FG001|Full Analysis Set (FAS)|Period 1: Single Dose|2 participants disqualified due to no post-baseline primary efficacy data, and/or 'other'.|23||
59700893|NCT01184859|75820151|FG002|Full Analysis Set (FAS)|Period 1: Single Dose||22||
59700894|NCT01184859|75820152|FG003|Full Analysis Set (FAS)|Period 1: Single Dose|1 participant disqualified due to major entry criteria violation|21||
59700895|NCT01184859|75820153|FG004|Full Analysis Set (FAS)|Period 1: Single Dose||24||
59700896|NCT01184859|75820149|FG000|Per Protocol (PP)|Period 1: Single Dose||23||
59700897|NCT01184859|75820150|FG001|Per Protocol (PP)|Period 1: Single Dose||23||
59700898|NCT01184859|75820151|FG002|Per Protocol (PP)|Period 1: Single Dose||22||
59700899|NCT01184859|75820152|FG003|Per Protocol (PP)|Period 1: Single Dose||21||
59700900|NCT01184859|75820153|FG004|Per Protocol (PP)|Period 1: Single Dose|1 additional participant disqualified due to 'other'.|23||
59700901|NCT01184859|75820149|FG000|COMPLETED|Period 1: Single Dose||23||
59700902|NCT01184859|75820150|FG001|COMPLETED|Period 1: Single Dose||23||
59700903|NCT01184859|75820151|FG002|COMPLETED|Period 1: Single Dose||22||
59700904|NCT01184859|75820152|FG003|COMPLETED|Period 1: Single Dose||22||
59700905|NCT01184859|75820153|FG004|COMPLETED|Period 1: Single Dose||23||
59700906|NCT01184859|75820149|FG000|NOT COMPLETED|Period 1: Single Dose||0||
59700907|NCT01184859|75820150|FG001|NOT COMPLETED|Period 1: Single Dose||2||
59700908|NCT01184859|75820151|FG002|NOT COMPLETED|Period 1: Single Dose||0||
59700909|NCT01184859|75820152|FG003|NOT COMPLETED|Period 1: Single Dose||0||
59700910|NCT01184859|75820153|FG004|NOT COMPLETED|Period 1: Single Dose||1||
59700911|NCT01184859|75820149|FG000|STARTED|Washout Period||23||
59700912|NCT01184859|75820150|FG001|STARTED|Washout Period||23||
59700913|NCT01184859|75820151|FG002|STARTED|Washout Period||22||
59700914|NCT01184859|75820152|FG003|STARTED|Washout Period||22||
59700915|NCT01184859|75820153|FG004|STARTED|Washout Period||23||
59700916|NCT01184859|75820149|FG000|COMPLETED|Washout Period||23||
59700917|NCT01184859|75820150|FG001|COMPLETED|Washout Period||23||
59700918|NCT01184859|75820151|FG002|COMPLETED|Washout Period||22||
59700919|NCT01184859|75820152|FG003|COMPLETED|Washout Period||22||
59700920|NCT01184859|75820153|FG004|COMPLETED|Washout Period||23||
59700921|NCT01184859|75820149|FG000|NOT COMPLETED|Washout Period||0||
59700922|NCT01184859|75820150|FG001|NOT COMPLETED|Washout Period||0||
59700923|NCT01184859|75820151|FG002|NOT COMPLETED|Washout Period||0||
59700924|NCT01184859|75820152|FG003|NOT COMPLETED|Washout Period||0||
59700925|NCT01184859|75820153|FG004|NOT COMPLETED|Washout Period||0||
59700926|NCT01184859|75820149|FG000|STARTED|Period 2: Daily Dose for 28 Days||23||
59816219|NCT00520676|75938592|FG001|Qualified Intent-to-treat (Q-ITT)|Overall Study||105||
59816220|NCT00520676|75938591|FG000|COMPLETED|Overall Study||27||
59700927|NCT01184859|75820150|FG001|STARTED|Period 2: Daily Dose for 28 Days||23||
59700928|NCT01184859|75820151|FG002|STARTED|Period 2: Daily Dose for 28 Days||22||
59700929|NCT01184859|75820152|FG003|STARTED|Period 2: Daily Dose for 28 Days||22||
59816221|NCT00520676|75938592|FG001|COMPLETED|Overall Study||29||
59816222|NCT00520676|75938591|FG000|NOT COMPLETED|Overall Study||101||
59700930|NCT01184859|75820153|FG004|STARTED|Period 2: Daily Dose for 28 Days||23||
59700931|NCT01184859|75820149|FG000|COMPLETED|Period 2: Daily Dose for 28 Days||22||
59700932|NCT01184859|75820150|FG001|COMPLETED|Period 2: Daily Dose for 28 Days||23||
59700933|NCT01184859|75820151|FG002|COMPLETED|Period 2: Daily Dose for 28 Days||22||
59700934|NCT01184859|75820152|FG003|COMPLETED|Period 2: Daily Dose for 28 Days||22||
59700935|NCT01184859|75820153|FG004|COMPLETED|Period 2: Daily Dose for 28 Days||22||
59700936|NCT01184859|75820149|FG000|NOT COMPLETED|Period 2: Daily Dose for 28 Days||1||
59700937|NCT01184859|75820150|FG001|NOT COMPLETED|Period 2: Daily Dose for 28 Days||0||
59816223|NCT00520676|75938592|FG001|NOT COMPLETED|Overall Study||103||
59700938|NCT01184859|75820151|FG002|NOT COMPLETED|Period 2: Daily Dose for 28 Days||0||
59816224|NCT00610649|75938609|FG000|STARTED|Overall Study||4||
59700939|NCT01184859|75820152|FG003|NOT COMPLETED|Period 2: Daily Dose for 28 Days||0||
59700940|NCT01184859|75820153|FG004|NOT COMPLETED|Period 2: Daily Dose for 28 Days||1||
59700941|NCT01184079|75820172|FG000|STARTED|Overall Study||111||
59700942|NCT01184079|75820173|FG001|STARTED|Overall Study||109||
59700943|NCT01184079|75820172|FG000|Dose 2|Overall Study||110||
59700944|NCT01184079|75820173|FG001|Dose 2|Overall Study||108||
59700945|NCT01184079|75820172|FG000|Dose 3|Overall Study||101||
59700946|NCT01184079|75820173|FG001|Dose 3|Overall Study||107||
59700947|NCT01184079|75820172|FG000|Final Blood Draw|Overall Study||97||
59700948|NCT01184079|75820173|FG001|Final Blood Draw|Overall Study||107||
59700949|NCT01184079|75820172|FG000|COMPLETED|Overall Study||97||
59700950|NCT01184079|75820173|FG001|COMPLETED|Overall Study||107||
59700951|NCT01184079|75820172|FG000|NOT COMPLETED|Overall Study||14||
59700952|NCT01184079|75820173|FG001|NOT COMPLETED|Overall Study||2||
59700953|NCT01190865|75820181|FG000|STARTED|Overall Study||28||
59700954|NCT01190865|75820181|FG000|COMPLETED|Overall Study||25||
59700955|NCT01190865|75820181|FG000|NOT COMPLETED|Overall Study||3||
59700956|NCT01190475|75820188|FG000|STARTED|Overall Study||2||
59700957|NCT01190475|75820189|FG001|STARTED|Overall Study||2||
59700958|NCT01190475|75820190|FG002|STARTED|Overall Study||2||
59700959|NCT01190475|75820188|FG000|COMPLETED|Overall Study||2||
59700960|NCT01190475|75820189|FG001|COMPLETED|Overall Study||2||
59700961|NCT01190475|75820190|FG002|COMPLETED|Overall Study||1||
59700962|NCT01190475|75820188|FG000|NOT COMPLETED|Overall Study||0||
59700963|NCT01190475|75820189|FG001|NOT COMPLETED|Overall Study||0||
59700964|NCT01190475|75820190|FG002|NOT COMPLETED|Overall Study||1||
59700965|NCT01289990|75820213|FG000|STARTED|Overall Study||224||
59700966|NCT01289990|75820214|FG001|STARTED|Overall Study||224||
59700967|NCT01289990|75820215|FG002|STARTED|Overall Study||228||
59700968|NCT01289990|75820216|FG003|STARTED|Overall Study||223||
59700969|NCT01289990|75820217|FG004|STARTED|Overall Study||165||
59700970|NCT01289990|75820218|FG005|STARTED|Overall Study||168||
59700971|NCT01289990|75820219|FG006|STARTED|Overall Study||166||
59700972|NCT01289990|75820220|FG007|STARTED|Overall Study||217||
59990782|NCT02461160|76106269|FG000|NOT COMPLETED|Overall Study||0||
59990783|NCT02461160|76106270|FG001|NOT COMPLETED|Overall Study||0||
59990784|NCT02461160|76106271|FG002|NOT COMPLETED|Overall Study||0||
59990785|NCT02461160|76106272|FG003|NOT COMPLETED|Overall Study||0||
59990786|NCT02461160|76106273|FG004|NOT COMPLETED|Overall Study||0||
59990787|NCT02461160|76106274|FG005|NOT COMPLETED|Overall Study||0||
59990788|NCT02461160|76106275|FG006|NOT COMPLETED|Overall Study||0||
59990789|NCT02461160|76106276|FG007|NOT COMPLETED|Overall Study||1||
59990790|NCT02461160|76106277|FG008|NOT COMPLETED|Overall Study||0||
59990791|NCT02461160|76106278|FG009|NOT COMPLETED|Overall Study||0||
60079618|NCT03880058|76194793|FG000|Received SLI-F06|Part A: Pre-abdominoplasty Injections||22||140
60079619|NCT03880058|76194793|FG000|Received Control|Part A: Pre-abdominoplasty Injections||22||140
60079620|NCT03880058|76194793|FG000|COMPLETED|Part A: Pre-abdominoplasty Injections||22||280
60079621|NCT03880058|76194793|FG000|NOT COMPLETED|Part A: Pre-abdominoplasty Injections||0||0
60079622|NCT03880058|76194793|FG000|STARTED|Part B: Abdominoplasty Injections|One patient from Part A did not enroll in Part B|21||21
60079623|NCT03880058|76194793|FG000|Received SLI-F06|Part B: Abdominoplasty Injections||21||21
60079624|NCT03880058|76194793|FG000|Received Control|Part B: Abdominoplasty Injections||21||21
60079625|NCT03880058|76194793|FG000|COMPLETED|Part B: Abdominoplasty Injections||21||21
60079626|NCT03880058|76194793|FG000|NOT COMPLETED|Part B: Abdominoplasty Injections||0||0
60079627|NCT03790111|76194799|FG000|STARTED|Overall Study||53||
60079628|NCT03790111|76194799|FG000|COMPLETED|Overall Study|Primary endpoint was not met. Study was early terminated.|0||
60079629|NCT03790111|76194799|FG000|NOT COMPLETED|Overall Study||53||
60079630|NCT03780543|76194806|FG000|STARTED|Overall Study||26||
60079631|NCT03780543|76194807|FG001|STARTED|Overall Study||43||
60079632|NCT03780543|76194808|FG002|STARTED|Overall Study||23||
59990792|NCT02461160|76106279|FG010|NOT COMPLETED|Overall Study||0||
59990793|NCT02461160|76106280|FG011|NOT COMPLETED|Overall Study||0||
60079633|NCT03780543|76194806|FG000|COMPLETED|Overall Study||13||
59700973|NCT01289990|75820221|FG008|STARTED|Overall Study||214||
59700974|NCT01289990|75820222|FG009|STARTED|Overall Study||207||
59700975|NCT01289990|75820223|FG010|STARTED|Overall Study||226||
59700976|NCT01289990|75820224|FG011|STARTED|Overall Study||218||
59700977|NCT01289990|75820225|FG012|STARTED|Overall Study||225||
59700978|NCT01289990|75820213|FG000|COMPLETED|Overall Study||147||
59700979|NCT01289990|75820214|FG001|COMPLETED|Overall Study||143||
59700980|NCT01289990|75820215|FG002|COMPLETED|Overall Study||119||
59700981|NCT01289990|75820216|FG003|COMPLETED|Overall Study||136||
59700982|NCT01289990|75820217|FG004|COMPLETED|Overall Study||93||
59700983|NCT01289990|75820218|FG005|COMPLETED|Overall Study||94||
59700984|NCT01289990|75820219|FG006|COMPLETED|Overall Study||78||
59700985|NCT01289990|75820220|FG007|COMPLETED|Overall Study||162||
59990794|NCT02461160|76106281|FG012|NOT COMPLETED|Overall Study||0||
59990795|NCT01653704|76106332|FG000|STARTED|Overall Study||21||
59990796|NCT01653704|76106333|FG001|STARTED|Overall Study||21||
59990797|NCT01653704|76106332|FG000|COMPLETED|Overall Study||19||
59700986|NCT01289990|75820221|FG008|COMPLETED|Overall Study||139||
59700987|NCT01289990|75820222|FG009|COMPLETED|Overall Study||121||
59700988|NCT01289990|75820223|FG010|COMPLETED|Overall Study||150||
59700989|NCT01289990|75820224|FG011|COMPLETED|Overall Study||150||
59700990|NCT01289990|75820225|FG012|COMPLETED|Overall Study||127||
59700991|NCT01289990|75820213|FG000|NOT COMPLETED|Overall Study||77||
59700992|NCT01289990|75820214|FG001|NOT COMPLETED|Overall Study||81||
59700993|NCT01289990|75820215|FG002|NOT COMPLETED|Overall Study||109||
59700994|NCT01289990|75820216|FG003|NOT COMPLETED|Overall Study||87||
59700995|NCT01289990|75820217|FG004|NOT COMPLETED|Overall Study||72||
59700996|NCT01289990|75820218|FG005|NOT COMPLETED|Overall Study||74||
59700997|NCT01289990|75820219|FG006|NOT COMPLETED|Overall Study||88||
59700998|NCT01289990|75820220|FG007|NOT COMPLETED|Overall Study||55||
59700999|NCT01289990|75820221|FG008|NOT COMPLETED|Overall Study||75||
59701000|NCT01289990|75820222|FG009|NOT COMPLETED|Overall Study||86||
59701001|NCT01289990|75820223|FG010|NOT COMPLETED|Overall Study||76||
59701002|NCT01289990|75820224|FG011|NOT COMPLETED|Overall Study||68||
59701003|NCT01289990|75820225|FG012|NOT COMPLETED|Overall Study||98||
59701004|NCT01190007|75820253|FG000|STARTED|Overall Study|Treated|159||
59701005|NCT01190007|75820253|FG000|COMPLETED|Overall Study||145||
59701006|NCT01190007|75820253|FG000|NOT COMPLETED|Overall Study||14||
59701007|NCT01189461|75820257|FG000|STARTED|Overall Study||46||
59701008|NCT01189461|75820257|FG000|COMPLETED|Overall Study||12||
59701009|NCT01189461|75820257|FG000|NOT COMPLETED|Overall Study||34||
59701010|NCT01189227|75820263|FG000|STARTED|Overall Study||6||
59701011|NCT01189227|75820264|FG001|STARTED|Overall Study||3||
59701012|NCT01189227|75820263|FG000|COMPLETED|Overall Study||0||
59701013|NCT01189227|75820264|FG001|COMPLETED|Overall Study||0||
59701014|NCT01189227|75820263|FG000|NOT COMPLETED|Overall Study||6||
59701015|NCT01189227|75820264|FG001|NOT COMPLETED|Overall Study||3||
59701016|NCT01300247|75820272|FG000|STARTED|Overall Study||21||
59701017|NCT01300247|75820273|FG001|STARTED|Overall Study||20||
59701018|NCT01300247|75820272|FG000|COMPLETED|Overall Study||17||
59701019|NCT01300247|75820273|FG001|COMPLETED|Overall Study||18||
59701020|NCT01300247|75820272|FG000|NOT COMPLETED|Overall Study||4||
59701021|NCT01300247|75820273|FG001|NOT COMPLETED|Overall Study||2||
59701022|NCT01289678|75820279|FG000|STARTED|Overall Study||18||
59701023|NCT01289678|75820279|FG000|COMPLETED|Overall Study||12||
59701024|NCT01289678|75820279|FG000|NOT COMPLETED|Overall Study||6||
59701025|NCT01289210|75820283|FG000|STARTED|Overall Study||2||
59701026|NCT01289210|75820283|FG000|COMPLETED|Overall Study||1||
59701027|NCT01289210|75820283|FG000|NOT COMPLETED|Overall Study||1||
59701028|NCT01183221|75820289|FG000|STARTED|First Dose||15||
59701029|NCT01183221|75820290|FG001|STARTED|First Dose||15||
59701030|NCT01183221|75820289|FG000|COMPLETED|First Dose||15||
59701031|NCT01183221|75820290|FG001|COMPLETED|First Dose||15||
59701032|NCT01183221|75820289|FG000|NOT COMPLETED|First Dose||0||
59701033|NCT01183221|75820290|FG001|NOT COMPLETED|First Dose||0||
59701034|NCT01183221|75820289|FG000|STARTED|3 Weeks Wash Out||15||
59701035|NCT01183221|75820290|FG001|STARTED|3 Weeks Wash Out||15||
59701036|NCT01183221|75820289|FG000|COMPLETED|3 Weeks Wash Out||14||
59701037|NCT01183221|75820290|FG001|COMPLETED|3 Weeks Wash Out||14||
59701038|NCT01183221|75820289|FG000|NOT COMPLETED|3 Weeks Wash Out||1||
59701039|NCT01183221|75820290|FG001|NOT COMPLETED|3 Weeks Wash Out||1||
59701040|NCT01183221|75820289|FG000|STARTED|Second Dose||14||
59701041|NCT01183221|75820290|FG001|STARTED|Second Dose||14||
59701042|NCT01183221|75820289|FG000|COMPLETED|Second Dose||14||
59701043|NCT01183221|75820290|FG001|COMPLETED|Second Dose||14||
59701044|NCT01183221|75820289|FG000|NOT COMPLETED|Second Dose||0||
59701045|NCT01183221|75820290|FG001|NOT COMPLETED|Second Dose||0||
59701046|NCT01183143|75820296|FG000|STARTED|Overall Study||215||
59701047|NCT01183143|75820296|FG000|Intention to Treat (ITT) Population|Overall Study|ITT=Subjects who received at least 1 dose of the investigational medicinal product (IMP).|204||
59701048|NCT01183143|75820296|FG000|COMPLETED|Overall Study||65||
59701049|NCT01183143|75820296|FG000|NOT COMPLETED|Overall Study||150||
59701050|NCT01183065|75820300|FG000|STARTED|Overall Study||13||
59701051|NCT01183065|75820300|FG000|COMPLETED|Overall Study||12||
59701052|NCT01183065|75820300|FG000|NOT COMPLETED|Overall Study||1||
59701053|NCT01182441|75820306|FG000|STARTED|Overall Study||269||
59701054|NCT01182441|75820307|FG001|STARTED|Overall Study||138||
59816225|NCT00610649|75938610|FG001|STARTED|Overall Study||2||
59701055|NCT01182441|75820306|FG000|COMPLETED|Overall Study||49||
59701056|NCT01182441|75820307|FG001|COMPLETED|Overall Study||19||
59701057|NCT01182441|75820306|FG000|NOT COMPLETED|Overall Study||220||
59701058|NCT01182441|75820307|FG001|NOT COMPLETED|Overall Study||119||
59701059|NCT01182285|75820313|FG000|STARTED|First Intervention Week 1-10||13||
59701060|NCT01182285|75820314|FG001|STARTED|First Intervention Week 1-10||0||
59701061|NCT01182285|75820315|FG002|STARTED|First Intervention Week 1-10||0||
59701062|NCT01182285|75820313|FG000|COMPLETED|First Intervention Week 1-10||10||
59701063|NCT01182285|75820314|FG001|COMPLETED|First Intervention Week 1-10||0||
59701064|NCT01182285|75820315|FG002|COMPLETED|First Intervention Week 1-10||0||
59701065|NCT01182285|75820313|FG000|NOT COMPLETED|First Intervention Week 1-10||3||
59701066|NCT01182285|75820314|FG001|NOT COMPLETED|First Intervention Week 1-10||0||
59701067|NCT01182285|75820315|FG002|NOT COMPLETED|First Intervention Week 1-10||0||
59701068|NCT01182285|75820313|FG000|STARTED|Second Intervention Week 11-17||0||
59701069|NCT01182285|75820314|FG001|STARTED|Second Intervention Week 11-17||0||
59701070|NCT01182285|75820315|FG002|STARTED|Second Intervention Week 11-17||0||
59701071|NCT01182285|75820313|FG000|COMPLETED|Second Intervention Week 11-17||0||
59701072|NCT01182285|75820314|FG001|COMPLETED|Second Intervention Week 11-17||0||
59701073|NCT01182285|75820315|FG002|COMPLETED|Second Intervention Week 11-17||0||
59701074|NCT01182285|75820313|FG000|NOT COMPLETED|Second Intervention Week 11-17||0||
59701075|NCT01182285|75820314|FG001|NOT COMPLETED|Second Intervention Week 11-17||0||
59701076|NCT01182285|75820315|FG002|NOT COMPLETED|Second Intervention Week 11-17||0||
59701077|NCT01182285|75820313|FG000|STARTED|Third Intervention Week 11-52||0||
59701078|NCT01182285|75820314|FG001|STARTED|Third Intervention Week 11-52||0||
59701079|NCT01182285|75820315|FG002|STARTED|Third Intervention Week 11-52|2 subj. taken off study after completing ph 1: 1 due to a negative uptake scan & one off due to PD.|8||
59701080|NCT01182285|75820313|FG000|COMPLETED|Third Intervention Week 11-52||0||
59701081|NCT01182285|75820314|FG001|COMPLETED|Third Intervention Week 11-52||0||
59701082|NCT01182285|75820315|FG002|COMPLETED|Third Intervention Week 11-52||0||
59701083|NCT01182285|75820313|FG000|NOT COMPLETED|Third Intervention Week 11-52||0||
59701084|NCT01182285|75820314|FG001|NOT COMPLETED|Third Intervention Week 11-52||0||
59701085|NCT01182285|75820315|FG002|NOT COMPLETED|Third Intervention Week 11-52||8||
59701086|NCT01182207|75820324|FG000|STARTED|First Intervention||18||
59701087|NCT01182207|75820325|FG001|STARTED|First Intervention||15||
59701088|NCT01182207|75820324|FG000|COMPLETED|First Intervention||18||
59701089|NCT01182207|75820325|FG001|COMPLETED|First Intervention||14||
59701090|NCT01182207|75820324|FG000|NOT COMPLETED|First Intervention||0||
59701091|NCT01182207|75820325|FG001|NOT COMPLETED|First Intervention||1||
59701092|NCT01182207|75820324|FG000|STARTED|Washout of 28 Days||18||
59701093|NCT01182207|75820325|FG001|STARTED|Washout of 28 Days||14||
59701094|NCT01182207|75820324|FG000|COMPLETED|Washout of 28 Days||18||
59701095|NCT01182207|75820325|FG001|COMPLETED|Washout of 28 Days||14||
59701096|NCT01182207|75820324|FG000|NOT COMPLETED|Washout of 28 Days||0||
59701097|NCT01182207|75820325|FG001|NOT COMPLETED|Washout of 28 Days||0||
59701098|NCT01182207|75820324|FG000|STARTED|Second Intervention||18||
59701099|NCT01182207|75820325|FG001|STARTED|Second Intervention||14||
59701100|NCT01182207|75820324|FG000|COMPLETED|Second Intervention||17||
59701101|NCT01182207|75820325|FG001|COMPLETED|Second Intervention||14||
59701102|NCT01182207|75820324|FG000|NOT COMPLETED|Second Intervention||1||
59701103|NCT01182207|75820325|FG001|NOT COMPLETED|Second Intervention||0||
59701104|NCT01181895|75820334|FG000|STARTED|Overall Study||116||
59701105|NCT01181895|75820335|FG001|STARTED|Overall Study||115||
59701106|NCT01181895|75820336|FG002|STARTED|Overall Study||116||
59701107|NCT01181895|75820334|FG000|COMPLETED|Overall Study||99||
59701108|NCT01181895|75820335|FG001|COMPLETED|Overall Study||101||
59701109|NCT01181895|75820336|FG002|COMPLETED|Overall Study||98||
59701110|NCT01181895|75820334|FG000|NOT COMPLETED|Overall Study||17||
59701111|NCT01181895|75820335|FG001|NOT COMPLETED|Overall Study||14||
59701112|NCT01181895|75820336|FG002|NOT COMPLETED|Overall Study||18||
59701113|NCT01181271|75820344|FG000|STARTED|Autologous Transplant||42||
59701114|NCT01181271|75820344|FG000|COMPLETED|Autologous Transplant||42||
59701115|NCT01181271|75820344|FG000|NOT COMPLETED|Autologous Transplant||0||
59701116|NCT01181271|75820344|FG000|STARTED|Evaluation for Allogeneic Transplant||42||
59701117|NCT01181271|75820344|FG000|COMPLETED|Evaluation for Allogeneic Transplant||29||
59701118|NCT01181271|75820344|FG000|NOT COMPLETED|Evaluation for Allogeneic Transplant||13||
59701119|NCT01181271|75820344|FG000|STARTED|Allogeneic Transplant||29||
59701120|NCT01181271|75820344|FG000|COMPLETED|Allogeneic Transplant||29||
59701121|NCT01181271|75820344|FG000|NOT COMPLETED|Allogeneic Transplant||0||
59701122|NCT01180647|75820350|FG000|STARTED|Overall Study||17||
59701123|NCT01180647|75820351|FG001|STARTED|Overall Study||17||
59701124|NCT01180647|75820350|FG000|COMPLETED|Overall Study||12||
59701125|NCT01180647|75820351|FG001|COMPLETED|Overall Study||11||
59701126|NCT01180647|75820350|FG000|NOT COMPLETED|Overall Study||5||
59701127|NCT01180647|75820351|FG001|NOT COMPLETED|Overall Study||6||
59701128|NCT00969553|75820366|FG000|STARTED|Overall Study||3||
59701129|NCT00969553|75820367|FG001|STARTED|Overall Study||3||
59701130|NCT00969553|75820368|FG002|STARTED|Overall Study||6||
59701131|NCT00969553|75820369|FG003|STARTED|Overall Study||17||
59701132|NCT00969553|75820370|FG004|STARTED|Overall Study||3||
59701133|NCT00969553|75820371|FG005|STARTED|Overall Study||4||
59701134|NCT00969553|75820372|FG006|STARTED|Overall Study||4||
59701135|NCT00969553|75820373|FG007|STARTED|Overall Study||16||
59701136|NCT00969553|75820374|FG008|STARTED|Overall Study||3||
59701137|NCT00969553|75820366|FG000|COMPLETED|Overall Study||0||
59701138|NCT00969553|75820367|FG001|COMPLETED|Overall Study||0||
59701139|NCT00969553|75820368|FG002|COMPLETED|Overall Study||0||
59701140|NCT00969553|75820369|FG003|COMPLETED|Overall Study|on-treatment at analysis data base lock date (27-Oct-2011)|1||
59701141|NCT00969553|75820370|FG004|COMPLETED|Overall Study||0||
59701142|NCT00969553|75820371|FG005|COMPLETED|Overall Study||0||
59701143|NCT00969553|75820372|FG006|COMPLETED|Overall Study||0||
59701144|NCT00969553|75820373|FG007|COMPLETED|Overall Study|on-treatment at analysis data base lock date (27-Oct-2011)|2||
59701145|NCT00969553|75820374|FG008|COMPLETED|Overall Study||0||
59701146|NCT00969553|75820366|FG000|NOT COMPLETED|Overall Study||3||
59701147|NCT00969553|75820367|FG001|NOT COMPLETED|Overall Study||3||
59701148|NCT00969553|75820368|FG002|NOT COMPLETED|Overall Study||6||
59701149|NCT00969553|75820369|FG003|NOT COMPLETED|Overall Study||16||
59701150|NCT00969553|75820370|FG004|NOT COMPLETED|Overall Study||3||
59701151|NCT00969553|75820371|FG005|NOT COMPLETED|Overall Study||4||
59701152|NCT00969553|75820372|FG006|NOT COMPLETED|Overall Study||4||
59701153|NCT00969553|75820373|FG007|NOT COMPLETED|Overall Study||14||
59701154|NCT00969553|75820374|FG008|NOT COMPLETED|Overall Study||3||
59701155|NCT01179477|75820402|FG000|STARTED|Overall Study||1930||
59701156|NCT01179477|75820402|FG000|COMPLETED|Overall Study||843||
59701157|NCT01179477|75820402|FG000|NOT COMPLETED|Overall Study||1087||
59701158|NCT01179399|75820406|FG000|STARTED|Overall Study||32||
59701159|NCT01179399|75820406|FG000|COMPLETED|Overall Study||0||
59701160|NCT01179399|75820406|FG000|NOT COMPLETED|Overall Study||32||
59701161|NCT01178853|75820412|FG000|STARTED|Period 1 (Warfarin Titration)||24||
59701162|NCT01178853|75820413|FG001|STARTED|Period 1 (Warfarin Titration)||24||
59701163|NCT01178853|75820412|FG000|COMPLETED|Period 1 (Warfarin Titration)||23||
59701164|NCT01178853|75820413|FG001|COMPLETED|Period 1 (Warfarin Titration)||22||
59701165|NCT01178853|75820412|FG000|NOT COMPLETED|Period 1 (Warfarin Titration)||1||
59701166|NCT01178853|75820413|FG001|NOT COMPLETED|Period 1 (Warfarin Titration)||2||
59701167|NCT01178853|75820412|FG000|STARTED|Period 2 (Warfarin + Study Drug)||23||
59701168|NCT01178853|75820413|FG001|STARTED|Period 2 (Warfarin + Study Drug)||22||
59701169|NCT01178853|75820412|FG000|COMPLETED|Period 2 (Warfarin + Study Drug)||22||
59701170|NCT01178853|75820413|FG001|COMPLETED|Period 2 (Warfarin + Study Drug)||22||
59990798|NCT01653704|76106333|FG001|COMPLETED|Overall Study||20||
59990799|NCT01653704|76106332|FG000|NOT COMPLETED|Overall Study||2||
59990800|NCT01653704|76106333|FG001|NOT COMPLETED|Overall Study||1||
59990801|NCT02495168|76106342|FG000|STARTED|Overall Study||504||
59565869|NCT04392219|75668293|FG003|COMPLETED|Overall Study||6||
59701171|NCT01178853|75820412|FG000|NOT COMPLETED|Period 2 (Warfarin + Study Drug)||1||
59701172|NCT01178853|75820413|FG001|NOT COMPLETED|Period 2 (Warfarin + Study Drug)||0||
59701173|NCT01178853|75820412|FG000|STARTED|Period 3 (Warfarin Titration)||22||
59701174|NCT01178853|75820413|FG001|STARTED|Period 3 (Warfarin Titration)||22||
59701175|NCT01178853|75820412|FG000|COMPLETED|Period 3 (Warfarin Titration)||21||
59701176|NCT01178853|75820413|FG001|COMPLETED|Period 3 (Warfarin Titration)||22||
59701177|NCT01178853|75820412|FG000|NOT COMPLETED|Period 3 (Warfarin Titration)||1||
59701178|NCT01178853|75820413|FG001|NOT COMPLETED|Period 3 (Warfarin Titration)||0||
59701179|NCT01178853|75820412|FG000|STARTED|Period 4 (Warfarin + Study Drug)||21||
59701180|NCT01178853|75820413|FG001|STARTED|Period 4 (Warfarin + Study Drug)||22||
59701181|NCT01178853|75820412|FG000|COMPLETED|Period 4 (Warfarin + Study Drug)||21||
59701182|NCT01178853|75820413|FG001|COMPLETED|Period 4 (Warfarin + Study Drug)||19||
59701183|NCT01178853|75820412|FG000|NOT COMPLETED|Period 4 (Warfarin + Study Drug)||0||
59701184|NCT01178853|75820413|FG001|NOT COMPLETED|Period 4 (Warfarin + Study Drug)||3||
59701185|NCT01178385|75820421|FG000|STARTED|Overall Study||24||
59701186|NCT01178385|75820422|FG001|STARTED|Overall Study||21||
59701187|NCT01178385|75820421|FG000|COMPLETED|Overall Study||22||
59701188|NCT01178385|75820422|FG001|COMPLETED|Overall Study||21||
59701189|NCT01178385|75820421|FG000|NOT COMPLETED|Overall Study||2||
59701190|NCT01178385|75820422|FG001|NOT COMPLETED|Overall Study||0||
59701191|NCT01288976|75820431|FG000|STARTED|Overall Study||567||
59701192|NCT01288976|75820432|FG001|STARTED|Overall Study||49||
59701193|NCT01288976|75820433|FG002|STARTED|Overall Study||105||
59701194|NCT01288976|75820431|FG000|COMPLETED|Overall Study||389||
59701195|NCT01288976|75820432|FG001|COMPLETED|Overall Study||22||
59701196|NCT01288976|75820433|FG002|COMPLETED|Overall Study||85||
59701197|NCT01288976|75820431|FG000|NOT COMPLETED|Overall Study||178||
59701198|NCT01288976|75820432|FG001|NOT COMPLETED|Overall Study||27||
59701199|NCT01288976|75820433|FG002|NOT COMPLETED|Overall Study||20||
59701200|NCT00970489|75820441|FG000|STARTED|Overall Study||758||
59701201|NCT00970489|75820442|FG001|STARTED|Overall Study||758||
59701202|NCT00970489|75820441|FG000|COMPLETED|Overall Study||704||
59701203|NCT00970489|75820442|FG001|COMPLETED|Overall Study||717||
59701204|NCT00970489|75820441|FG000|NOT COMPLETED|Overall Study||54||
59701205|NCT00970489|75820442|FG001|NOT COMPLETED|Overall Study||41||
59701206|NCT00968617|75820448|FG000|STARTED|Overall Study||7||
59701207|NCT00968617|75820448|FG000|COMPLETED|Overall Study||1||
59701208|NCT00968617|75820448|FG000|NOT COMPLETED|Overall Study||6||
59701209|NCT00968539|75820454|FG000|STARTED|Overall Study||64||
59816226|NCT00610649|75938611|FG002|STARTED|Overall Study||4||
59701210|NCT00968539|75820455|FG001|STARTED|Overall Study||66||
59701211|NCT00968539|75820454|FG000|COMPLETED|Overall Study||63||
59701212|NCT00968539|75820455|FG001|COMPLETED|Overall Study||66||
59701213|NCT00968539|75820454|FG000|NOT COMPLETED|Overall Study||1||
59701214|NCT00968539|75820455|FG001|NOT COMPLETED|Overall Study||0||
59701215|NCT00976573|75820464|FG000|STARTED|Overall Study||75||
59701216|NCT00976573|75820465|FG001|STARTED|Overall Study||74||
59701217|NCT00976573|75820464|FG000|COMPLETED|Overall Study||71||
59816227|NCT00610649|75938612|FG003|STARTED|Overall Study||2||
59990802|NCT02495168|76106343|FG001|STARTED|Overall Study||516||
59990803|NCT02495168|76106344|FG002|STARTED|Overall Study||127||
59995080|NCT02550093|76110917|FG000|COMPLETED|Intervention 1||10||
59701218|NCT00976573|75820465|FG001|COMPLETED|Overall Study||71||
59701219|NCT00976573|75820464|FG000|NOT COMPLETED|Overall Study||4||
59701220|NCT00976573|75820465|FG001|NOT COMPLETED|Overall Study||3||
59701221|NCT00976495|75820474|FG000|STARTED|Overall Study||25||
59701222|NCT00976495|75820475|FG001|STARTED|Overall Study||24||
59701223|NCT00976495|75820476|FG002|STARTED|Overall Study||26||
59701224|NCT00976495|75820474|FG000|COMPLETED|Overall Study||25||
59701225|NCT00976495|75820475|FG001|COMPLETED|Overall Study||23||
59701226|NCT00976495|75820476|FG002|COMPLETED|Overall Study||26||
59701227|NCT00976495|75820474|FG000|NOT COMPLETED|Overall Study||0||
59701228|NCT00976495|75820475|FG001|NOT COMPLETED|Overall Study||1||
59701229|NCT00976495|75820476|FG002|NOT COMPLETED|Overall Study||0||
59701230|NCT01288430|75820494|FG000|STARTED|Part 1||2|Only participants enrolled in Pt 1 are reported in this section.|
59701231|NCT01288430|75820495|FG001|STARTED|Part 1||3|Only participants enrolled in Pt 1 are reported in this section.|
59701232|NCT01288430|75820496|FG002|STARTED|Part 1||5|Only participants enrolled in Pt 1 are reported in this section.|
59701233|NCT01288430|75820497|FG003|STARTED|Part 1||7|Only participants enrolled in Pt 1 are reported in this section.|
59701234|NCT01288430|75820498|FG004|STARTED|Part 1||3|Only participants enrolled in Pt 1 are reported in this section.|
59701235|NCT01288430|75820499|FG005|STARTED|Part 1||6|Only participants enrolled in Pt 1 are reported in this section.|
59701236|NCT01288430|75820500|FG006|STARTED|Part 1||7|Only participants enrolled in Pt 1 are reported in this section.|
59701237|NCT01288430|75820501|FG007|STARTED|Part 1||0|Only participants enrolled in Pt 1 are reported in this section.|
59701238|NCT01288430|75820502|FG008|STARTED|Part 1||0|Only participants enrolled in Pt 1 are reported in this section.|
59701239|NCT01288430|75820503|FG009|STARTED|Part 1||0|Only participants enrolled in Pt 1 are reported in this section.|
59701240|NCT01288430|75820494|FG000|COMPLETED|Part 1||0||
59701241|NCT01288430|75820495|FG001|COMPLETED|Part 1||0||
59701242|NCT01288430|75820496|FG002|COMPLETED|Part 1||0||
59701243|NCT01288430|75820497|FG003|COMPLETED|Part 1||0||
59701244|NCT01288430|75820498|FG004|COMPLETED|Part 1||0||
59701245|NCT01288430|75820499|FG005|COMPLETED|Part 1||0||
59701246|NCT01288430|75820500|FG006|COMPLETED|Part 1||0||
59701247|NCT01288430|75820501|FG007|COMPLETED|Part 1||0||
59701248|NCT01288430|75820502|FG008|COMPLETED|Part 1||0||
59701249|NCT01288430|75820503|FG009|COMPLETED|Part 1||0||
59701250|NCT01288430|75820494|FG000|NOT COMPLETED|Part 1||2||
59701251|NCT01288430|75820495|FG001|NOT COMPLETED|Part 1||3||
59701252|NCT01288430|75820496|FG002|NOT COMPLETED|Part 1||5||
59701253|NCT01288430|75820497|FG003|NOT COMPLETED|Part 1||7||
59701254|NCT01288430|75820498|FG004|NOT COMPLETED|Part 1||3||
59701255|NCT01288430|75820499|FG005|NOT COMPLETED|Part 1||6||
59701256|NCT01288430|75820500|FG006|NOT COMPLETED|Part 1||7||
59701257|NCT01288430|75820501|FG007|NOT COMPLETED|Part 1||0||
59701258|NCT01288430|75820502|FG008|NOT COMPLETED|Part 1||0||
59701259|NCT01288430|75820503|FG009|NOT COMPLETED|Part 1||0||
59701260|NCT01288430|75820494|FG000|STARTED|Part 2||0|Only participants enrolled in Pt 2 are reported in this section.|
59701261|NCT01288430|75820495|FG001|STARTED|Part 2||0|Only participants enrolled in Pt 2 are reported in this section.|
59701262|NCT01288430|75820496|FG002|STARTED|Part 2||0|Only participants enrolled in Pt 2 are reported in this section.|
59701263|NCT01288430|75820497|FG003|STARTED|Part 2||0|Only participants enrolled in Pt 2 are reported in this section.|
59701264|NCT01288430|75820498|FG004|STARTED|Part 2||0|Only participants enrolled in Pt 2 are reported in this section.|
59701265|NCT01288430|75820499|FG005|STARTED|Part 2||0|Only participants enrolled in Pt 2 are reported in this section.|
59701266|NCT01288430|75820500|FG006|STARTED|Part 2||0|Only participants enrolled in Pt 2 are reported in this section.|
59701267|NCT01288430|75820501|FG007|STARTED|Part 2||12|Only participants enrolled in Pt 2 are reported in this section.|
59701268|NCT01288430|75820502|FG008|STARTED|Part 2||12|Only participants enrolled in Pt 2 are reported in this section.|
59701269|NCT01288430|75820503|FG009|STARTED|Part 2||3|Only participants enrolled in Pt 2 are reported in this section.|
59701270|NCT01288430|75820494|FG000|COMPLETED|Part 2||0||
59701271|NCT01288430|75820495|FG001|COMPLETED|Part 2||0||
59701272|NCT01288430|75820496|FG002|COMPLETED|Part 2||0||
59701273|NCT01288430|75820497|FG003|COMPLETED|Part 2||0||
59701274|NCT01288430|75820498|FG004|COMPLETED|Part 2||0||
59701275|NCT01288430|75820499|FG005|COMPLETED|Part 2||0||
59701276|NCT01288430|75820500|FG006|COMPLETED|Part 2||0||
59701277|NCT01288430|75820501|FG007|COMPLETED|Part 2||0||
59701278|NCT01288430|75820502|FG008|COMPLETED|Part 2||0||
59701279|NCT01288430|75820503|FG009|COMPLETED|Part 2||0||
59701280|NCT01288430|75820494|FG000|NOT COMPLETED|Part 2||0||
59701281|NCT01288430|75820495|FG001|NOT COMPLETED|Part 2||0||
59701282|NCT01288430|75820496|FG002|NOT COMPLETED|Part 2||0||
59701283|NCT01288430|75820497|FG003|NOT COMPLETED|Part 2||0||
59701284|NCT01288430|75820498|FG004|NOT COMPLETED|Part 2||0||
59701285|NCT01288430|75820499|FG005|NOT COMPLETED|Part 2||0||
59701286|NCT01288430|75820500|FG006|NOT COMPLETED|Part 2||0||
59701287|NCT01288430|75820501|FG007|NOT COMPLETED|Part 2||12||
59701288|NCT01288430|75820502|FG008|NOT COMPLETED|Part 2||12||
59701289|NCT01288430|75820503|FG009|NOT COMPLETED|Part 2||3||
59701290|NCT01287416|75820532|FG000|STARTED|Pre-post Training|number of people that were invited to participate based on eligibility and consent received|48||
59701291|NCT01287416|75820533|FG001|STARTED|Pre-post Training|number of people that were invited to participate based on eligibility and consent received|48||
59701292|NCT01287416|75820532|FG000|Training Workshop|Pre-post Training|number of people that showed up for the training session|31||
59701293|NCT01287416|75820533|FG001|Training Workshop|Pre-post Training|number of people that showed up for the training session|24||
59701294|NCT01287416|75820532|FG000|Post Training Questionnaire|Pre-post Training||26||
59701295|NCT01287416|75820533|FG001|Post Training Questionnaire|Pre-post Training||23||
59701296|NCT01287416|75820532|FG000|COMPLETED|Pre-post Training||26||
59701297|NCT01287416|75820533|FG001|COMPLETED|Pre-post Training||23||
59701298|NCT01287416|75820532|FG000|NOT COMPLETED|Pre-post Training||22||
59701299|NCT01287416|75820533|FG001|NOT COMPLETED|Pre-post Training||25||
59701300|NCT01287416|75820532|FG000|STARTED|6 Month Follow-up|all participants that had completed the baseline measure were invited to do the follow-up|31||
59701301|NCT01287416|75820533|FG001|STARTED|6 Month Follow-up|all participants that had completed the baseline measure were invited to do the follow-up|24||
59701302|NCT01287416|75820532|FG000|COMPLETED|6 Month Follow-up||28||
59701303|NCT01287416|75820533|FG001|COMPLETED|6 Month Follow-up||22||
59701304|NCT01287416|75820532|FG000|NOT COMPLETED|6 Month Follow-up||3||
59701305|NCT01287416|75820533|FG001|NOT COMPLETED|6 Month Follow-up||2||
59701306|NCT00998296|75820550|FG000|STARTED|Overall Study||6||
59701307|NCT00998296|75820551|FG001|STARTED|Overall Study||3||
59701308|NCT00998296|75820552|FG002|STARTED|Overall Study||3||
59701309|NCT00998296|75820553|FG003|STARTED|Overall Study||3||
59701310|NCT00998296|75820554|FG004|STARTED|Overall Study||8||
59701311|NCT00998296|75820555|FG005|STARTED|Overall Study||3||
59701312|NCT00998296|75820556|FG006|STARTED|Overall Study||7||
59701313|NCT00998296|75820557|FG007|STARTED|Overall Study||6||
59701314|NCT00998296|75820558|FG008|STARTED|Overall Study||6||
59701315|NCT00998296|75820559|FG009|STARTED|Overall Study||18||
59701316|NCT00998296|75820560|FG010|STARTED|Overall Study||7||
59701317|NCT00998296|75820550|FG000|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|6||
59701318|NCT00998296|75820551|FG001|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|2||
59701319|NCT00998296|75820552|FG002|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|3||
59701320|NCT00998296|75820553|FG003|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|3||
59701321|NCT00998296|75820554|FG004|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|6||
59701322|NCT00998296|75820555|FG005|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|3||
59701323|NCT00998296|75820556|FG006|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|6||
59701324|NCT00998296|75820557|FG007|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|4||
59701325|NCT00998296|75820558|FG008|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|4||
59701326|NCT00998296|75820559|FG009|COMPLETED|Overall Study||0||
59701327|NCT00998296|75820560|FG010|COMPLETED|Overall Study||0||
59701328|NCT00998296|75820550|FG000|NOT COMPLETED|Overall Study||0||
59701329|NCT00998296|75820551|FG001|NOT COMPLETED|Overall Study||1||
59701330|NCT00998296|75820552|FG002|NOT COMPLETED|Overall Study||0||
59701331|NCT00998296|75820553|FG003|NOT COMPLETED|Overall Study||0||
59701332|NCT00998296|75820554|FG004|NOT COMPLETED|Overall Study||2||
59701333|NCT00998296|75820555|FG005|NOT COMPLETED|Overall Study||0||
59701334|NCT00998296|75820556|FG006|NOT COMPLETED|Overall Study||1||
59701335|NCT00998296|75820557|FG007|NOT COMPLETED|Overall Study||2||
59701336|NCT00998296|75820558|FG008|NOT COMPLETED|Overall Study||2||
59701337|NCT00998296|75820559|FG009|NOT COMPLETED|Overall Study||18||
59701338|NCT00998296|75820560|FG010|NOT COMPLETED|Overall Study||7||
59701339|NCT01178073|75820592|FG000|STARTED|Overall Study||302||
59701340|NCT01178073|75820593|FG001|STARTED|Overall Study||152||
59701341|NCT01178073|75820594|FG002|STARTED|Overall Study||151||
59701342|NCT01178073|75820592|FG000|COMPLETED|Overall Study||240||
59701343|NCT01178073|75820593|FG001|COMPLETED|Overall Study||108||
59701344|NCT01178073|75820594|FG002|COMPLETED|Overall Study||105||
59701345|NCT01178073|75820592|FG000|NOT COMPLETED|Overall Study||62||
59701346|NCT01178073|75820593|FG001|NOT COMPLETED|Overall Study||44||
59701347|NCT01178073|75820594|FG002|NOT COMPLETED|Overall Study||46||
59701348|NCT00997984|75820606|FG000|STARTED|Overall Study||113||
59701349|NCT00997984|75820607|FG001|STARTED|Overall Study||113||
59701350|NCT00997984|75820608|FG002|STARTED|Overall Study||114||
59701351|NCT00997984|75820606|FG000|COMPLETED|Overall Study||76||
59701352|NCT00997984|75820607|FG001|COMPLETED|Overall Study||79||
59701353|NCT00997984|75820608|FG002|COMPLETED|Overall Study||88||
59701354|NCT00997984|75820606|FG000|NOT COMPLETED|Overall Study||37||
59701355|NCT00997984|75820607|FG001|NOT COMPLETED|Overall Study||34||
59701356|NCT00997984|75820608|FG002|NOT COMPLETED|Overall Study||26||
59701357|NCT01177293|75820618|FG000|STARTED|First Intervention Period||7||
59701358|NCT01177293|75820619|FG001|STARTED|First Intervention Period||7||
59701359|NCT01177293|75820618|FG000|COMPLETED|First Intervention Period||7||
59701360|NCT01177293|75820619|FG001|COMPLETED|First Intervention Period||7||
59701361|NCT01177293|75820618|FG000|NOT COMPLETED|First Intervention Period||0||
59701362|NCT01177293|75820619|FG001|NOT COMPLETED|First Intervention Period||0||
59701363|NCT01177293|75820618|FG000|STARTED|Washout Period (of 14 Days)||7||
59701364|NCT01177293|75820619|FG001|STARTED|Washout Period (of 14 Days)||7||
59701365|NCT01177293|75820618|FG000|COMPLETED|Washout Period (of 14 Days)||7||
59701366|NCT01177293|75820619|FG001|COMPLETED|Washout Period (of 14 Days)||6||
59701367|NCT01177293|75820618|FG000|NOT COMPLETED|Washout Period (of 14 Days)||0||
59701368|NCT01177293|75820619|FG001|NOT COMPLETED|Washout Period (of 14 Days)||1||
59701369|NCT01177293|75820618|FG000|STARTED|Second Intervention Period||7||
59701370|NCT01177293|75820619|FG001|STARTED|Second Intervention Period||6||
59701371|NCT01177293|75820618|FG000|COMPLETED|Second Intervention Period||7||
59701372|NCT01177293|75820619|FG001|COMPLETED|Second Intervention Period||6||
59701373|NCT01177293|75820618|FG000|NOT COMPLETED|Second Intervention Period||0||
59701374|NCT01177293|75820619|FG001|NOT COMPLETED|Second Intervention Period||0||
59701375|NCT01177137|75820628|FG000|STARTED|Overall Study||51||
59701376|NCT01177137|75820629|FG001|STARTED|Overall Study||51||
59701377|NCT01177137|75820630|FG002|STARTED|Overall Study||49||
59701378|NCT01177137|75820628|FG000|COMPLETED|Overall Study||41||
59701379|NCT01177137|75820629|FG001|COMPLETED|Overall Study||41||
59701380|NCT01177137|75820630|FG002|COMPLETED|Overall Study||47||
59701381|NCT01177137|75820628|FG000|NOT COMPLETED|Overall Study||10||
59701382|NCT01177137|75820629|FG001|NOT COMPLETED|Overall Study||10||
59701383|NCT01177137|75820630|FG002|NOT COMPLETED|Overall Study||2||
59701384|NCT01177059|75820641|FG000|STARTED|Overall Study||68||
59701385|NCT01177059|75820641|FG000|COMPLETED|Overall Study||18||
59701386|NCT01177059|75820641|FG000|NOT COMPLETED|Overall Study||50||
59701387|NCT01176513|75820645|FG000|STARTED|Overall Study||25||
59701388|NCT01176513|75820645|FG000|COMPLETED|Overall Study||22||
59701389|NCT01176513|75820645|FG000|NOT COMPLETED|Overall Study||3||
59701390|NCT01299389|75820651|FG000|STARTED|Double-blind||164||
59701391|NCT01299389|75820652|FG001|STARTED|Double-blind||159||
59701392|NCT01299389|75820653|FG002|STARTED|Double-blind||0||
59701393|NCT01299389|75820654|FG003|STARTED|Double-blind||0||
59701394|NCT01299389|75820651|FG000|COMPLETED|Double-blind||55||
59701395|NCT01299389|75820652|FG001|COMPLETED|Double-blind||95||
59701396|NCT01299389|75820653|FG002|COMPLETED|Double-blind||0||
59701397|NCT01299389|75820654|FG003|COMPLETED|Double-blind||0||
59701398|NCT01299389|75820651|FG000|NOT COMPLETED|Double-blind||109||
59701399|NCT01299389|75820652|FG001|NOT COMPLETED|Double-blind||64||
59701400|NCT01299389|75820653|FG002|NOT COMPLETED|Double-blind||0||
59701401|NCT01299389|75820654|FG003|NOT COMPLETED|Double-blind||0||
59701402|NCT01299389|75820651|FG000|STARTED|Post-observational||0||
59701403|NCT01299389|75820652|FG001|STARTED|Post-observational||0||
59701404|NCT01299389|75820653|FG002|STARTED|Post-observational||156||
59701405|NCT01299389|75820654|FG003|STARTED|Post-observational||155||
59701406|NCT01299389|75820651|FG000|COMPLETED|Post-observational||0||
59701407|NCT01299389|75820652|FG001|COMPLETED|Post-observational||0||
59701408|NCT01299389|75820653|FG002|COMPLETED|Post-observational||144||
59701409|NCT01299389|75820654|FG003|COMPLETED|Post-observational||149||
59701410|NCT01299389|75820651|FG000|NOT COMPLETED|Post-observational||0||
59701411|NCT01299389|75820652|FG001|NOT COMPLETED|Post-observational||0||
59701412|NCT01299389|75820653|FG002|NOT COMPLETED|Post-observational||12||
59701413|NCT01299389|75820654|FG003|NOT COMPLETED|Post-observational||6||
59701414|NCT01298999|75820665|FG000|STARTED|Overall Study||13||
59701415|NCT01298999|75820666|FG001|STARTED|Overall Study||11||
59701416|NCT01298999|75820665|FG000|COMPLETED|Overall Study||10||
59701417|NCT01298999|75820666|FG001|COMPLETED|Overall Study||10||
59701418|NCT01298999|75820665|FG000|NOT COMPLETED|Overall Study||3||
59701419|NCT01298999|75820666|FG001|NOT COMPLETED|Overall Study||1||
59701420|NCT01007032|75820676|FG000|STARTED|Overall Study||4||
59701421|NCT01007032|75820677|FG001|STARTED|Overall Study||7||
59701422|NCT01007032|75820678|FG002|STARTED|Overall Study||3||
59701423|NCT01007032|75820679|FG003|STARTED|Overall Study||7||
59701424|NCT01007032|75820676|FG000|Received at Least 1 Dose of Study Drug|Overall Study||4||
59701425|NCT01007032|75820677|FG001|Received at Least 1 Dose of Study Drug|Overall Study||7||
59701426|NCT01007032|75820678|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3||
59701427|NCT01007032|75820679|FG003|Received at Least 1 Dose of Study Drug|Overall Study||7||
59701428|NCT01007032|75820676|FG000|COMPLETED|Overall Study||4||
59701429|NCT01007032|75820677|FG001|COMPLETED|Overall Study||6||
59701430|NCT01007032|75820678|FG002|COMPLETED|Overall Study||2||
59701431|NCT01007032|75820679|FG003|COMPLETED|Overall Study||6||
59701432|NCT01007032|75820676|FG000|NOT COMPLETED|Overall Study||0||
59701433|NCT01007032|75820677|FG001|NOT COMPLETED|Overall Study||1||
59701434|NCT01007032|75820678|FG002|NOT COMPLETED|Overall Study||1||
59701435|NCT01007032|75820679|FG003|NOT COMPLETED|Overall Study||1||
59701436|NCT00976027|75820696|FG000|STARTED|Overall Study||6108||
59701437|NCT00976027|75820697|FG001|STARTED|Overall Study||3050||
59701438|NCT00976027|75820696|FG000|COMPLETED|Overall Study||5697||
59701439|NCT00976027|75820697|FG001|COMPLETED|Overall Study||2835||
59701440|NCT00976027|75820696|FG000|NOT COMPLETED|Overall Study||411||
59701441|NCT00976027|75820697|FG001|NOT COMPLETED|Overall Study||215||
59701442|NCT01298765|75820703|FG000|STARTED|Titration Period||302||
59701443|NCT01298765|75820703|FG000|COMPLETED|Titration Period||226||
59701444|NCT01298765|75820703|FG000|NOT COMPLETED|Titration Period||76||
59701445|NCT01298765|75820703|FG000|STARTED|Long-Term Treatment Period||226||
59701446|NCT01298765|75820703|FG000|COMPLETED|Long-Term Treatment Period||127||
59701447|NCT01298765|75820703|FG000|NOT COMPLETED|Long-Term Treatment Period||99||
59701448|NCT00997438|75820710|FG000|STARTED|Overall Study||21||
59701449|NCT00997438|75820711|FG001|STARTED|Overall Study||24||
59701450|NCT00997438|75820712|FG002|STARTED|Overall Study||24||
59701451|NCT00997438|75820710|FG000|COMPLETED|Overall Study||16||
59701452|NCT00997438|75820711|FG001|COMPLETED|Overall Study||21||
59701453|NCT00997438|75820712|FG002|COMPLETED|Overall Study||20||
59701454|NCT00997438|75820710|FG000|NOT COMPLETED|Overall Study||5||
59701455|NCT00997438|75820711|FG001|NOT COMPLETED|Overall Study||3||
59701456|NCT00997438|75820712|FG002|NOT COMPLETED|Overall Study||4||
59701457|NCT00997126|75820723|FG000|STARTED|Overall Study||63||
59701458|NCT00997126|75820724|FG001|STARTED|Overall Study||63||
59701459|NCT00997126|75820723|FG000|COMPLETED|Overall Study||56||
59701460|NCT00997126|75820724|FG001|COMPLETED|Overall Study||52||
59701461|NCT00997126|75820723|FG000|NOT COMPLETED|Overall Study||7||
59701462|NCT00997126|75820724|FG001|NOT COMPLETED|Overall Study||11||
59701463|NCT01000636|75820730|FG000|STARTED|Overall Study||9||
59701464|NCT01000636|75820730|FG000|COMPLETED|Overall Study||7||
59701465|NCT01000636|75820730|FG000|NOT COMPLETED|Overall Study||2||
59701466|NCT00965419|75820734|FG000|STARTED|Open Label Treatment for Responders||267||
59701467|NCT00965419|75820734|FG000|Not Lost to f/u at First Post-baseline|Open Label Treatment for Responders||264||
59701468|NCT00965419|75820734|FG000|COMPLETED|Open Label Treatment for Responders||20||
59701469|NCT00965419|75820734|FG000|NOT COMPLETED|Open Label Treatment for Responders||247||
59701470|NCT00965419|75820734|FG000|STARTED|Follow-up Phase||80|Participants who dropped out of treatment period early had the option to enter follow-up period.|
59701471|NCT00965419|75820734|FG000|COMPLETED|Follow-up Phase||18||
59701472|NCT00965419|75820734|FG000|NOT COMPLETED|Follow-up Phase||62||
59701473|NCT01000480|75820739|FG000|STARTED|Induction Phase||90||
59701474|NCT01000480|75820739|FG000|Received at Least 1 Dose of Either Drug|Induction Phase||90||
59701475|NCT01000480|75820739|FG000|Death (Any Cause) or Disease Progression|Induction Phase|Participants who died (any cause) or had disease progression considered to have completed phase.|8||
59701476|NCT01000480|75820739|FG000|COMPLETED|Induction Phase||83||
59701477|NCT01000480|75820739|FG000|NOT COMPLETED|Induction Phase||7||
59701478|NCT01000480|75820739|FG000|STARTED|Concurrent Therapy Phase|Eight participants (pts) who completed Induction Phase, not eligible for Concurrent Therapy Phase.|75||
59701479|NCT01000480|75820739|FG000|Death (Any Cause) or Disease Progression|Concurrent Therapy Phase|Pts who died (any cause) or had disease progression considered to have completed the phase.|1||
59701480|NCT01000480|75820739|FG000|COMPLETED|Concurrent Therapy Phase||65||
59701481|NCT01000480|75820739|FG000|NOT COMPLETED|Concurrent Therapy Phase||10||
59701482|NCT01000480|75820739|FG000|STARTED|Follow-Up Period|One pt lost to follow-up during induction, 1 pt died in concurrent therapy, both not enter follow-up|88||
59701483|NCT01000480|75820739|FG000|COMPLETED|Follow-Up Period||88||
59701484|NCT01000480|75820739|FG000|NOT COMPLETED|Follow-Up Period||0||
59701485|NCT00965341|75820745|FG000|STARTED|Overall Study||19||
59701486|NCT00965341|75820746|FG001|STARTED|Overall Study||24||
59701487|NCT00965341|75820745|FG000|COMPLETED|Overall Study||13||
59701488|NCT00965341|75820746|FG001|COMPLETED|Overall Study||16||
59701489|NCT00965341|75820745|FG000|NOT COMPLETED|Overall Study||6||
59701490|NCT00965341|75820746|FG001|NOT COMPLETED|Overall Study||8||
59701491|NCT01175811|75820754|FG000|STARTED|Overall Study||199||
59701492|NCT01175811|75820755|FG001|STARTED|Overall Study||203||
59701493|NCT01175811|75820754|FG000|Received at Least 1 Dose of Study Drug|Overall Study||197||
59701494|NCT01175811|75820755|FG001|Received at Least 1 Dose of Study Drug|Overall Study||202||
59701495|NCT01175811|75820754|FG000|COMPLETED|Overall Study||183||
59701496|NCT01175811|75820755|FG001|COMPLETED|Overall Study||189||
59701497|NCT01175811|75820754|FG000|NOT COMPLETED|Overall Study||16||
59701498|NCT01175811|75820755|FG001|NOT COMPLETED|Overall Study||14||
59701499|NCT00965263|75820763|FG000|STARTED|Overall Study||6||
59701500|NCT00965263|75820764|FG001|STARTED|Overall Study||9||
59701501|NCT00965263|75820763|FG000|COMPLETED|Overall Study||4||
59701502|NCT00965263|75820764|FG001|COMPLETED|Overall Study||6||
59701503|NCT00965263|75820763|FG000|NOT COMPLETED|Overall Study||2||
59701504|NCT00965263|75820764|FG001|NOT COMPLETED|Overall Study||3||
59701505|NCT00965185|75820790|FG000|STARTED|Overall Study||19||
59701506|NCT00965185|75820791|FG001|STARTED|Overall Study||21||
59701507|NCT00965185|75820790|FG000|1 Month Visit|Overall Study||18||
59701508|NCT00965185|75820791|FG001|1 Month Visit|Overall Study||21||
59701509|NCT00965185|75820790|FG000|3 Month Visit|Overall Study||18||
59701510|NCT00965185|75820791|FG001|3 Month Visit|Overall Study||21||
59701511|NCT00965185|75820790|FG000|6 Month Visit|Overall Study||18||
59701512|NCT00965185|75820791|FG001|6 Month Visit|Overall Study||21||
59701513|NCT00965185|75820790|FG000|9 Month Visit|Overall Study||18||
59701514|NCT00965185|75820791|FG001|9 Month Visit|Overall Study||21||
59701515|NCT00965185|75820790|FG000|COMPLETED|Overall Study||17||
59701516|NCT00965185|75820791|FG001|COMPLETED|Overall Study||20||
59701517|NCT00965185|75820790|FG000|NOT COMPLETED|Overall Study||2||
59701518|NCT00965185|75820791|FG001|NOT COMPLETED|Overall Study||1||
59701519|NCT01174563|75820799|FG000|STARTED|Overall Study||60||
59701520|NCT01174563|75820799|FG000|Efficacy Set|Overall Study||59|Efficacy set included all participants who received at least one dose of study medication.|
59701521|NCT01174563|75820799|FG000|Safety Set|Overall Study||59|Safety set included all participants who received at least one dose of study medication.|
59701522|NCT01174563|75820799|FG000|COMPLETED|Overall Study||0||
59701523|NCT01174563|75820799|FG000|NOT COMPLETED|Overall Study||60||
59701524|NCT01298531|75820805|FG000|STARTED|Overall Study||42||
59701525|NCT01298531|75820806|FG001|STARTED|Overall Study||48||
59701526|NCT01298531|75820805|FG000|COMPLETED|Overall Study||33||
59701527|NCT01298531|75820806|FG001|COMPLETED|Overall Study||41||
59701528|NCT01298531|75820805|FG000|NOT COMPLETED|Overall Study||9||
59701529|NCT01298531|75820806|FG001|NOT COMPLETED|Overall Study||7||
59701530|NCT01174173|75820813|FG000|STARTED|Overall Study||11||
59701531|NCT01174173|75820813|FG000|COMPLETED|Overall Study||10||
59701532|NCT01174173|75820813|FG000|NOT COMPLETED|Overall Study||1||
59701533|NCT00964795|75820818|FG000|STARTED|Overall Study|randomized|323||
59701534|NCT00964795|75820818|FG000|Number of Participants Treated|Overall Study||320||
59701535|NCT00964795|75820818|FG000|COMPLETED|Overall Study|Prior to amendment 4, 16 participants completed up to Week 120. No participants completed Week 180.|16||
59701536|NCT00964795|75820818|FG000|NOT COMPLETED|Overall Study||307||
59701537|NCT01173471|75820827|FG000|STARTED|Overall Study|Randomized|6||
59701538|NCT01173471|75820828|FG001|STARTED|Overall Study|Randomized|7||
59701539|NCT01173471|75820829|FG002|STARTED|Overall Study|Randomized|18||
59701540|NCT01173471|75820830|FG003|STARTED|Overall Study|Randomized|19||
59701541|NCT01173471|75820827|FG000|Received Treatment|Overall Study||6||
59701542|NCT01173471|75820828|FG001|Received Treatment|Overall Study||7||
59701543|NCT01173471|75820829|FG002|Received Treatment|Overall Study||18||
59701544|NCT01173471|75820830|FG003|Received Treatment|Overall Study||19||
59701545|NCT01173471|75820827|FG000|Completed Treatment|Overall Study||4||
59701546|NCT01173471|75820828|FG001|Completed Treatment|Overall Study||7||
59701547|NCT01173471|75820829|FG002|Completed Treatment|Overall Study||15||
59701548|NCT01173471|75820830|FG003|Completed Treatment|Overall Study||18||
59701549|NCT01173471|75820827|FG000|COMPLETED|Overall Study|Completed study|4||
59701550|NCT01173471|75820828|FG001|COMPLETED|Overall Study|Completed study|7||
59701551|NCT01173471|75820829|FG002|COMPLETED|Overall Study|Completed study|15||
59701552|NCT01173471|75820830|FG003|COMPLETED|Overall Study|Completed study|18||
59701553|NCT01173471|75820827|FG000|NOT COMPLETED|Overall Study||2||
59701554|NCT01173471|75820828|FG001|NOT COMPLETED|Overall Study||0||
59701555|NCT01173471|75820829|FG002|NOT COMPLETED|Overall Study||3||
59701556|NCT01173471|75820830|FG003|NOT COMPLETED|Overall Study||1||
59701557|NCT01172847|75820840|FG000|STARTED|Overall Study||24||
59701558|NCT01172847|75820840|FG000|Oseltamivir|Overall Study||24||
59701559|NCT01172847|75820840|FG000|Rimantadine|Overall Study||22||
59701560|NCT01172847|75820840|FG000|Oseltamivir + Rimantadine|Overall Study||21||
59701561|NCT01172847|75820840|FG000|COMPLETED|Overall Study||21||
59701562|NCT01172847|75820840|FG000|NOT COMPLETED|Overall Study||3||
59701563|NCT00966355|75820853|FG000|STARTED|Overall Study||344||
59701564|NCT00966355|75820854|FG001|STARTED|Overall Study||345||
59701565|NCT00966355|75820855|FG002|STARTED|Overall Study||345||
59701566|NCT00966355|75820853|FG000|COMPLETED|Overall Study||260||
59701567|NCT00966355|75820854|FG001|COMPLETED|Overall Study||259||
59701568|NCT00966355|75820855|FG002|COMPLETED|Overall Study||261||
59701569|NCT00966355|75820853|FG000|NOT COMPLETED|Overall Study||84||
59701570|NCT00966355|75820854|FG001|NOT COMPLETED|Overall Study||86||
59701571|NCT00966355|75820855|FG002|NOT COMPLETED|Overall Study||84||
59701572|NCT01172535|75820863|FG000|STARTED|Overall Study||97||
59701573|NCT01172535|75820863|FG000|COMPLETED|Overall Study||89||
59701574|NCT01172535|75820863|FG000|NOT COMPLETED|Overall Study||8||
59701575|NCT00966277|75820872|FG000|STARTED|Overall Study||38||
59701576|NCT00966277|75820873|FG001|STARTED|Overall Study||37||
59701577|NCT00966277|75820872|FG000|COMPLETED|Overall Study|Four participants did not receive study treatment, see 'Reasons Not Completed.'|34||
59701578|NCT00966277|75820873|FG001|COMPLETED|Overall Study|Four participants did not receive study treatment, see 'Reasons Not Completed.'|33||
59701579|NCT00966277|75820872|FG000|NOT COMPLETED|Overall Study||4||
59701580|NCT00966277|75820873|FG001|NOT COMPLETED|Overall Study||4||
59701581|NCT01298141|75820879|FG000|STARTED|Overall Study||171||
59816228|NCT00610649|75938613|FG004|STARTED|Overall Study||4||
59816229|NCT00610649|75938614|FG005|STARTED|Overall Study||2||
59701582|NCT01298141|75820879|FG000|Treated|Overall Study||167||
59701583|NCT01298141|75820879|FG000|COMPLETED|Overall Study||140||
59701584|NCT01298141|75820879|FG000|NOT COMPLETED|Overall Study||31||
59701585|NCT01171989|75820886|FG000|STARTED|Overall Study||137||
59701586|NCT01171989|75820887|FG001|STARTED|Overall Study||133||
59701587|NCT01171989|75820888|FG002|STARTED|Overall Study||121||
59701588|NCT01171989|75820886|FG000|COMPLETED|Overall Study||137||
59701589|NCT01171989|75820887|FG001|COMPLETED|Overall Study||133||
59701590|NCT01171989|75820888|FG002|COMPLETED|Overall Study||120||
59701591|NCT01171989|75820886|FG000|NOT COMPLETED|Overall Study||0||
59701592|NCT01171989|75820887|FG001|NOT COMPLETED|Overall Study||0||
59701593|NCT01171989|75820888|FG002|NOT COMPLETED|Overall Study||1||
59701594|NCT01297517|75820899|FG000|STARTED|Overall Study||214||
59701595|NCT01297517|75820900|FG001|STARTED|Overall Study||226||
59701596|NCT01297517|75820901|FG002|STARTED|Overall Study||220||
59701597|NCT01297517|75820899|FG000|COMPLETED|Overall Study||187||
59701598|NCT01297517|75820900|FG001|COMPLETED|Overall Study||214||
59701599|NCT01297517|75820901|FG002|COMPLETED|Overall Study||193||
59701600|NCT01297517|75820899|FG000|NOT COMPLETED|Overall Study||27||
59701601|NCT01297517|75820900|FG001|NOT COMPLETED|Overall Study||12||
59701602|NCT01297517|75820901|FG002|NOT COMPLETED|Overall Study||27||
59701603|NCT01171677|75820911|FG000|STARTED|Overall Study||17||
59701604|NCT01171677|75820912|FG001|STARTED|Overall Study||15||
59701605|NCT01171677|75820911|FG000|COMPLETED|Overall Study||11||
59701606|NCT01171677|75820912|FG001|COMPLETED|Overall Study||12||
59701607|NCT01171677|75820911|FG000|NOT COMPLETED|Overall Study||6||
59701608|NCT01171677|75820912|FG001|NOT COMPLETED|Overall Study||3||
59701609|NCT01171521|75820918|FG000|STARTED|Overall Study||6||
59701610|NCT01171521|75820918|FG000|COMPLETED|Overall Study||0||
59701611|NCT01171521|75820918|FG000|NOT COMPLETED|Overall Study||6||
59701612|NCT01296347|75820924|FG000|STARTED|Allocation||38||
59701613|NCT01296347|75820925|FG001|STARTED|Allocation||39||
59701614|NCT01296347|75820924|FG000|COMPLETED|Allocation||35||
59701615|NCT01296347|75820925|FG001|COMPLETED|Allocation||35||
59701616|NCT01296347|75820924|FG000|NOT COMPLETED|Allocation||3||
59701617|NCT01296347|75820925|FG001|NOT COMPLETED|Allocation||4||
59701618|NCT01296347|75820924|FG000|STARTED|6 Week Follow up||35||
59701619|NCT01296347|75820925|FG001|STARTED|6 Week Follow up||35||
59701620|NCT01296347|75820924|FG000|COMPLETED|6 Week Follow up||35||
59701621|NCT01296347|75820925|FG001|COMPLETED|6 Week Follow up||34||
59701622|NCT01296347|75820924|FG000|NOT COMPLETED|6 Week Follow up||0||
59701623|NCT01296347|75820925|FG001|NOT COMPLETED|6 Week Follow up||1||
59701624|NCT01296347|75820924|FG000|STARTED|3 Month Follow up||35||
59701625|NCT01296347|75820925|FG001|STARTED|3 Month Follow up||34||
59701626|NCT01296347|75820924|FG000|COMPLETED|3 Month Follow up||34||
59701627|NCT01296347|75820925|FG001|COMPLETED|3 Month Follow up||33||
59701628|NCT01296347|75820924|FG000|NOT COMPLETED|3 Month Follow up||1||
59701629|NCT01296347|75820925|FG001|NOT COMPLETED|3 Month Follow up||1||
59701630|NCT01296347|75820924|FG000|STARTED|6 Month Follow up||34||
59701631|NCT01296347|75820925|FG001|STARTED|6 Month Follow up||33||
59701632|NCT01296347|75820924|FG000|COMPLETED|6 Month Follow up||32||
59701633|NCT01296347|75820925|FG001|COMPLETED|6 Month Follow up||31||
59701634|NCT01296347|75820924|FG000|NOT COMPLETED|6 Month Follow up||2||
59701635|NCT01296347|75820925|FG001|NOT COMPLETED|6 Month Follow up||2||
59701636|NCT01296347|75820924|FG000|STARTED|12 Month Follow up||32||
59701637|NCT01296347|75820925|FG001|STARTED|12 Month Follow up||31||
59701638|NCT01296347|75820924|FG000|COMPLETED|12 Month Follow up||28||
59701639|NCT01296347|75820925|FG001|COMPLETED|12 Month Follow up||28||
59701640|NCT01296347|75820924|FG000|NOT COMPLETED|12 Month Follow up||4||
59701641|NCT01296347|75820925|FG001|NOT COMPLETED|12 Month Follow up||3||
59701642|NCT01296035|75820934|FG000|STARTED|Overall Study||8||
59701643|NCT01296035|75820934|FG000|COMPLETED|Overall Study||7||
59701644|NCT01296035|75820934|FG000|NOT COMPLETED|Overall Study||1||
59701645|NCT01294787|75820938|FG000|STARTED|Period 1||12||
59701646|NCT01294787|75820939|FG001|STARTED|Period 1||16||
59701647|NCT01294787|75820940|FG002|STARTED|Period 1||14||
59701648|NCT01294787|75820941|FG003|STARTED|Period 1||12||
59701649|NCT01294787|75820942|FG004|STARTED|Period 1||16||
59701650|NCT01294787|75820943|FG005|STARTED|Period 1|One randomized participant did not receive study drug|15||
59701651|NCT01294787|75820938|FG000|COMPLETED|Period 1||12||
59701652|NCT01294787|75820939|FG001|COMPLETED|Period 1||16||
59701653|NCT01294787|75820940|FG002|COMPLETED|Period 1||13||
59701654|NCT01294787|75820941|FG003|COMPLETED|Period 1||11||
59701655|NCT01294787|75820942|FG004|COMPLETED|Period 1||14||
59701656|NCT01294787|75820943|FG005|COMPLETED|Period 1||13||
59701657|NCT01294787|75820938|FG000|NOT COMPLETED|Period 1||0||
59701658|NCT01294787|75820939|FG001|NOT COMPLETED|Period 1||0||
59701659|NCT01294787|75820940|FG002|NOT COMPLETED|Period 1||1||
59701660|NCT01294787|75820941|FG003|NOT COMPLETED|Period 1||1||
59701661|NCT01294787|75820942|FG004|NOT COMPLETED|Period 1||2||
59701662|NCT01294787|75820943|FG005|NOT COMPLETED|Period 1||2||
59701663|NCT01294787|75820938|FG000|STARTED|Period 2||12||
59701664|NCT01294787|75820939|FG001|STARTED|Period 2||16||
59701665|NCT01294787|75820940|FG002|STARTED|Period 2||13||
59701666|NCT01294787|75820941|FG003|STARTED|Period 2||11||
59701667|NCT01294787|75820942|FG004|STARTED|Period 2||14||
59701668|NCT01294787|75820943|FG005|STARTED|Period 2||13||
59701669|NCT01294787|75820938|FG000|COMPLETED|Period 2||12||
59701670|NCT01294787|75820939|FG001|COMPLETED|Period 2||13||
59701671|NCT01294787|75820940|FG002|COMPLETED|Period 2||13||
59701672|NCT01294787|75820941|FG003|COMPLETED|Period 2||9||
59701673|NCT01294787|75820942|FG004|COMPLETED|Period 2||14||
59701674|NCT01294787|75820943|FG005|COMPLETED|Period 2||13||
59701675|NCT01294787|75820938|FG000|NOT COMPLETED|Period 2||0||
59701676|NCT01294787|75820939|FG001|NOT COMPLETED|Period 2||3||
59701677|NCT01294787|75820940|FG002|NOT COMPLETED|Period 2||0||
59701678|NCT01294787|75820941|FG003|NOT COMPLETED|Period 2||2||
59701679|NCT01294787|75820942|FG004|NOT COMPLETED|Period 2||0||
59701680|NCT01294787|75820943|FG005|NOT COMPLETED|Period 2||0||
59701681|NCT01294787|75820938|FG000|STARTED|Period 3||12||
59701682|NCT01294787|75820939|FG001|STARTED|Period 3||13||
59701683|NCT01294787|75820940|FG002|STARTED|Period 3||13||
59701684|NCT01294787|75820941|FG003|STARTED|Period 3||9||
59701685|NCT01294787|75820942|FG004|STARTED|Period 3||14||
59701686|NCT01294787|75820943|FG005|STARTED|Period 3||13||
59701687|NCT01294787|75820938|FG000|COMPLETED|Period 3||12||
59701688|NCT01294787|75820939|FG001|COMPLETED|Period 3||13||
59701689|NCT01294787|75820940|FG002|COMPLETED|Period 3||13||
59701690|NCT01294787|75820941|FG003|COMPLETED|Period 3||9||
59701691|NCT01294787|75820942|FG004|COMPLETED|Period 3||13||
59701692|NCT01294787|75820943|FG005|COMPLETED|Period 3||13||
59701693|NCT01294787|75820938|FG000|NOT COMPLETED|Period 3||0||
59701694|NCT01294787|75820939|FG001|NOT COMPLETED|Period 3||0||
59701695|NCT01294787|75820940|FG002|NOT COMPLETED|Period 3||0||
59701696|NCT01294787|75820941|FG003|NOT COMPLETED|Period 3||0||
59701697|NCT01294787|75820942|FG004|NOT COMPLETED|Period 3||1||
59701698|NCT01294787|75820943|FG005|NOT COMPLETED|Period 3||0||
59701699|NCT01294553|75820954|FG000|STARTED|Overall Study||982||
59701700|NCT01294553|75820954|FG000|COMPLETED|Overall Study||713||
59701701|NCT01294553|75820954|FG000|NOT COMPLETED|Overall Study||269||
59701702|NCT01294397|75820959|FG000|STARTED|Overall Study||19||
59701703|NCT01294397|75820959|FG000|COMPLETED|Overall Study||17||
59701704|NCT01294397|75820959|FG000|NOT COMPLETED|Overall Study||2||
59701705|NCT01293695|75820967|FG000|STARTED|Overall Study||93||
59701706|NCT01293695|75820968|FG001|STARTED|Overall Study||94||
59701707|NCT01293695|75820967|FG000|COMPLETED|Overall Study||78||
59701708|NCT01293695|75820968|FG001|COMPLETED|Overall Study||87||
59701709|NCT01293695|75820967|FG000|NOT COMPLETED|Overall Study||15||
59701710|NCT01293695|75820968|FG001|NOT COMPLETED|Overall Study||7||
59701711|NCT01293539|75820977|FG000|STARTED|Overall Study||10||
59701712|NCT01293539|75820977|FG000|COMPLETED|Overall Study||9||
59701713|NCT01293539|75820977|FG000|NOT COMPLETED|Overall Study||1||
59701714|NCT01292837|75820981|FG000|STARTED|Overall Study||13||
59701715|NCT01292837|75820981|FG000|COMPLETED|Overall Study||11||
59701716|NCT01292837|75820981|FG000|NOT COMPLETED|Overall Study||2||
59701717|NCT00965731|75820987|FG000|STARTED|Overall Study||7||
59701718|NCT00965731|75820988|FG001|STARTED|Overall Study|Dose level given only after lower dose was successfully administered|20||
59701719|NCT00965731|75820987|FG000|COMPLETED|Overall Study||0||
59701720|NCT00965731|75820988|FG001|COMPLETED|Overall Study||0||
59701721|NCT00965731|75820987|FG000|NOT COMPLETED|Overall Study||7||
59701722|NCT00965731|75820988|FG001|NOT COMPLETED|Overall Study||20||
59701723|NCT00965575|75821001|FG000|STARTED|Overall Study|cross over, total enrolled 11|6||
59701724|NCT00965575|75821002|FG001|STARTED|Overall Study|cross over, total enrolled 11|5||
59701725|NCT00965575|75821001|FG000|COMPLETED|Overall Study||5||
59701726|NCT00965575|75821002|FG001|COMPLETED|Overall Study||5||
59701727|NCT00965575|75821001|FG000|NOT COMPLETED|Overall Study||1||
59701728|NCT00965575|75821002|FG001|NOT COMPLETED|Overall Study||0||
59701729|NCT00965497|75821010|FG000|STARTED|Overall Study||14||
59701730|NCT00965497|75821010|FG000|COMPLETED|Overall Study||13||
59701731|NCT00965497|75821010|FG000|NOT COMPLETED|Overall Study||1||
59701732|NCT00963937|75821017|FG000|STARTED|Overall Study||89||
59701733|NCT00963937|75821018|FG001|STARTED|Overall Study||44||
59701734|NCT00963937|75821019|FG002|STARTED|Overall Study||45||
59701735|NCT00963937|75821017|FG000|COMPLETED|Overall Study||70||
59701736|NCT00963937|75821018|FG001|COMPLETED|Overall Study||33||
59701737|NCT00963937|75821019|FG002|COMPLETED|Overall Study||41||
59701738|NCT00963937|75821017|FG000|NOT COMPLETED|Overall Study||19||
59701739|NCT00963937|75821018|FG001|NOT COMPLETED|Overall Study||11||
59701740|NCT00963937|75821019|FG002|NOT COMPLETED|Overall Study||4||
59701741|NCT01170663|75821032|FG000|STARTED|Overall Study|Participant was included in ramucirumab (IMC-1121B)/paclitaxel treatment arm (safety population).|330|One participant randomized to placebo/paclitaxel arm but received ramucirumab (IMC-1121B) in error.|
59701742|NCT01170663|75821033|FG001|STARTED|Overall Study|Participant was included in the placebo/paclitaxel treatment arm (intent-to-treat (ITT) population).|335|One participant randomized to placebo/paclitaxel arm but received ramucirumab (IMC-1121B) in error.|
59701743|NCT01170663|75821032|FG000|Received Any Treatment (Safety Pop)|Overall Study||327||
59701744|NCT01170663|75821033|FG001|Received Any Treatment (Safety Pop)|Overall Study||329||
59701745|NCT01170663|75821032|FG000|COMPLETED|Overall Study||316||
59701746|NCT01170663|75821033|FG001|COMPLETED|Overall Study||315||
59701747|NCT01170663|75821032|FG000|NOT COMPLETED|Overall Study||14||
59701748|NCT01170663|75821033|FG001|NOT COMPLETED|Overall Study||20||
59701749|NCT01170273|75821041|FG000|STARTED|Overall Study||64||
59701750|NCT01170273|75821042|FG001|STARTED|Overall Study||66||
59701751|NCT01170273|75821041|FG000|COMPLETED|Overall Study||56||
59701752|NCT01170273|75821042|FG001|COMPLETED|Overall Study||57||
59701753|NCT01170273|75821041|FG000|NOT COMPLETED|Overall Study||8||
59701754|NCT01170273|75821042|FG001|NOT COMPLETED|Overall Study||9||
59701755|NCT01170039|75821050|FG000|STARTED|Overall Study||37||
59701756|NCT01170039|75821051|FG001|STARTED|Overall Study||39||
59701757|NCT01170039|75821050|FG000|COMPLETED|Overall Study||29||
59701758|NCT01170039|75821051|FG001|COMPLETED|Overall Study||33||
59701759|NCT01170039|75821050|FG000|NOT COMPLETED|Overall Study||8||
59701760|NCT01170039|75821051|FG001|NOT COMPLETED|Overall Study||6||
59701761|NCT01169649|75821057|FG000|STARTED|Overall Study||11||
59701762|NCT01169649|75821057|FG000|COMPLETED|Overall Study||8||
59701763|NCT01169649|75821057|FG000|NOT COMPLETED|Overall Study||3||
59701764|NCT01169493|75821067|FG000|STARTED|Period 1 (6 Months)||2||
59701765|NCT01169493|75821068|FG001|STARTED|Period 1 (6 Months)||4||
59701766|NCT01169493|75821069|FG002|STARTED|Period 1 (6 Months)||5||
59701767|NCT01169493|75821070|FG003|STARTED|Period 1 (6 Months)||0||
59701768|NCT01169493|75821071|FG004|STARTED|Period 1 (6 Months)||0||
59701769|NCT01169493|75821072|FG005|STARTED|Period 1 (6 Months)||5||
59701770|NCT01169493|75821067|FG000|COMPLETED|Period 1 (6 Months)||2||
59701771|NCT01169493|75821068|FG001|COMPLETED|Period 1 (6 Months)||3||
59701772|NCT01169493|75821069|FG002|COMPLETED|Period 1 (6 Months)||3||
59701773|NCT01169493|75821070|FG003|COMPLETED|Period 1 (6 Months)||0||
59701774|NCT01169493|75821071|FG004|COMPLETED|Period 1 (6 Months)||0||
59701775|NCT01169493|75821072|FG005|COMPLETED|Period 1 (6 Months)||2||
59701776|NCT01169493|75821067|FG000|NOT COMPLETED|Period 1 (6 Months)||0||
59701777|NCT01169493|75821068|FG001|NOT COMPLETED|Period 1 (6 Months)||1||
59701778|NCT01169493|75821069|FG002|NOT COMPLETED|Period 1 (6 Months)||2||
59701779|NCT01169493|75821070|FG003|NOT COMPLETED|Period 1 (6 Months)||0||
59701780|NCT01169493|75821071|FG004|NOT COMPLETED|Period 1 (6 Months)||0||
59701781|NCT01169493|75821072|FG005|NOT COMPLETED|Period 1 (6 Months)||3||
59701782|NCT01169493|75821067|FG000|STARTED|Period 2 (6 Months)||2||
59701783|NCT01169493|75821068|FG001|STARTED|Period 2 (6 Months)||3||
59701784|NCT01169493|75821069|FG002|STARTED|Period 2 (6 Months)||3||
59701785|NCT01169493|75821070|FG003|STARTED|Period 2 (6 Months)||0||
59701786|NCT01169493|75821071|FG004|STARTED|Period 2 (6 Months)||0||
59701787|NCT01169493|75821072|FG005|STARTED|Period 2 (6 Months)||2||
59701788|NCT01169493|75821067|FG000|COMPLETED|Period 2 (6 Months)||2||
59701789|NCT01169493|75821068|FG001|COMPLETED|Period 2 (6 Months)||3||
59701790|NCT01169493|75821069|FG002|COMPLETED|Period 2 (6 Months)||3||
59701791|NCT01169493|75821070|FG003|COMPLETED|Period 2 (6 Months)||0||
59701792|NCT01169493|75821071|FG004|COMPLETED|Period 2 (6 Months)||0||
59701793|NCT01169493|75821072|FG005|COMPLETED|Period 2 (6 Months)||2||
59701794|NCT01169493|75821067|FG000|NOT COMPLETED|Period 2 (6 Months)||0||
59701795|NCT01169493|75821068|FG001|NOT COMPLETED|Period 2 (6 Months)||0||
59701796|NCT01169493|75821069|FG002|NOT COMPLETED|Period 2 (6 Months)||0||
59701797|NCT01169493|75821070|FG003|NOT COMPLETED|Period 2 (6 Months)||0||
59701798|NCT01169493|75821071|FG004|NOT COMPLETED|Period 2 (6 Months)||0||
59701799|NCT01169493|75821072|FG005|NOT COMPLETED|Period 2 (6 Months)||0||
59701800|NCT01169493|75821067|FG000|STARTED|Period 3 (6 Months)||2||
59701801|NCT01169493|75821068|FG001|STARTED|Period 3 (6 Months)||3||
59701802|NCT01169493|75821069|FG002|STARTED|Period 3 (6 Months)||3||
59701803|NCT01169493|75821070|FG003|STARTED|Period 3 (6 Months)||0||
59701804|NCT01169493|75821071|FG004|STARTED|Period 3 (6 Months)||0||
59701805|NCT01169493|75821072|FG005|STARTED|Period 3 (6 Months)||2||
59701806|NCT01169493|75821067|FG000|COMPLETED|Period 3 (6 Months)||2||
59701807|NCT01169493|75821068|FG001|COMPLETED|Period 3 (6 Months)||1||
59701808|NCT01169493|75821069|FG002|COMPLETED|Period 3 (6 Months)||2||
59701809|NCT01169493|75821070|FG003|COMPLETED|Period 3 (6 Months)||0||
59701810|NCT01169493|75821071|FG004|COMPLETED|Period 3 (6 Months)||0||
59701811|NCT01169493|75821072|FG005|COMPLETED|Period 3 (6 Months)||2||
59701812|NCT01169493|75821067|FG000|NOT COMPLETED|Period 3 (6 Months)||0||
59701813|NCT01169493|75821068|FG001|NOT COMPLETED|Period 3 (6 Months)||2||
59701814|NCT01169493|75821069|FG002|NOT COMPLETED|Period 3 (6 Months)||1||
59701815|NCT01169493|75821070|FG003|NOT COMPLETED|Period 3 (6 Months)||0||
59701816|NCT01169493|75821071|FG004|NOT COMPLETED|Period 3 (6 Months)||0||
59701817|NCT01169493|75821072|FG005|NOT COMPLETED|Period 3 (6 Months)||0||
59701818|NCT01287104|75821084|FG000|STARTED|Overall Study||4||
59701819|NCT01287104|75821085|FG001|STARTED|Overall Study||7||
59701820|NCT01287104|75821086|FG002|STARTED|Overall Study||12||
59701821|NCT01287104|75821087|FG003|STARTED|Overall Study||11||
59701822|NCT01287104|75821084|FG000|COMPLETED|Overall Study||3||
59701823|NCT01287104|75821085|FG001|COMPLETED|Overall Study||2||
59701824|NCT01287104|75821086|FG002|COMPLETED|Overall Study||5||
59701825|NCT01287104|75821087|FG003|COMPLETED|Overall Study||8||
59701826|NCT01287104|75821084|FG000|NOT COMPLETED|Overall Study||1||
59701827|NCT01287104|75821085|FG001|NOT COMPLETED|Overall Study||5||
59701828|NCT01287104|75821086|FG002|NOT COMPLETED|Overall Study||7||
59701829|NCT01287104|75821087|FG003|NOT COMPLETED|Overall Study||3||
59701830|NCT01286558|75821106|FG000|STARTED|Overall Study||112||
59701831|NCT01286558|75821107|FG001|STARTED|Overall Study||113||
59701832|NCT01286558|75821106|FG000|COMPLETED|Overall Study||111||
59701833|NCT01286558|75821107|FG001|COMPLETED|Overall Study||111||
59701834|NCT01286558|75821106|FG000|NOT COMPLETED|Overall Study||1||
59701835|NCT01286558|75821107|FG001|NOT COMPLETED|Overall Study||2||
59701836|NCT01169103|75821115|FG000|STARTED|Overall Study||11||
59701837|NCT01169103|75821116|FG001|STARTED|Overall Study||11||
59701838|NCT01169103|75821115|FG000|COMPLETED|Overall Study||5||
59701839|NCT01169103|75821116|FG001|COMPLETED|Overall Study||7||
59701840|NCT01169103|75821115|FG000|NOT COMPLETED|Overall Study||6||
59701841|NCT01169103|75821116|FG001|NOT COMPLETED|Overall Study||4||
59701842|NCT01286480|75821124|FG000|STARTED|Overall Study||32||
59701843|NCT01286480|75821125|FG001|STARTED|Overall Study||34||
59701844|NCT01286480|75821124|FG000|COMPLETED|Overall Study||27||
59701845|NCT01286480|75821125|FG001|COMPLETED|Overall Study||31||
59701846|NCT01286480|75821124|FG000|NOT COMPLETED|Overall Study||5||
59701847|NCT01286480|75821125|FG001|NOT COMPLETED|Overall Study||3||
59701848|NCT01286168|75821131|FG000|STARTED|Overall Study||104||
59701849|NCT01286168|75821131|FG000|COMPLETED|Overall Study||101||
59701850|NCT01286168|75821131|FG000|NOT COMPLETED|Overall Study||3||
59701851|NCT01286012|75821138|FG000|STARTED|Overall Study|2 patients randomized to SFP did not receive study drug.|54||
59701852|NCT01286012|75821139|FG001|STARTED|Overall Study|3 patients randomized to placebo did not receive study drug.|54||
59701853|NCT01286012|75821138|FG000|COMPLETED|Overall Study||41||
59701854|NCT01286012|75821139|FG001|COMPLETED|Overall Study||40||
59701855|NCT01286012|75821138|FG000|NOT COMPLETED|Overall Study||13||
59701856|NCT01286012|75821139|FG001|NOT COMPLETED|Overall Study||14||
59701857|NCT00963547|75821150|FG000|STARTED|Overall Study||4||
59701858|NCT00963547|75821151|FG001|STARTED|Overall Study||11||
59701859|NCT00963547|75821152|FG002|STARTED|Overall Study||12||
59701860|NCT00963547|75821153|FG003|STARTED|Overall Study||6||
59701861|NCT00963547|75821154|FG004|STARTED|Overall Study|Study terminated before Part 2 enrollment.|0||
59701862|NCT00963547|75821155|FG005|STARTED|Overall Study|Study terminated before Part 2 enrollment.|0||
59701863|NCT00963547|75821156|FG006|STARTED|Overall Study|Study terminated before Part 2 enrollment.|0||
59701864|NCT00963547|75821150|FG000|Treated|Overall Study||3||
59701865|NCT00963547|75821151|FG001|Treated|Overall Study||11||
59701866|NCT00963547|75821152|FG002|Treated|Overall Study||11||
59701867|NCT00963547|75821153|FG003|Treated|Overall Study||6||
59701868|NCT00963547|75821154|FG004|Treated|Overall Study|Study terminated before Part 2 enrollment.|0||
59701869|NCT00963547|75821155|FG005|Treated|Overall Study|Study terminated before Part 2 enrollment.|0||
59701870|NCT00963547|75821156|FG006|Treated|Overall Study|Study terminated before Part 2 enrollment.|0||
59701871|NCT00963547|75821150|FG000|COMPLETED|Overall Study||0||
59701872|NCT00963547|75821151|FG001|COMPLETED|Overall Study||0||
59701873|NCT00963547|75821152|FG002|COMPLETED|Overall Study||0||
59701874|NCT00963547|75821153|FG003|COMPLETED|Overall Study||0||
59701875|NCT00963547|75821154|FG004|COMPLETED|Overall Study|Study terminated before Part 2 enrollment.|0||
59701876|NCT00963547|75821155|FG005|COMPLETED|Overall Study|Study terminated before Part 2 enrollment.|0||
59701877|NCT00963547|75821156|FG006|COMPLETED|Overall Study|Study terminated before Part 2 enrollment.|0||
59701878|NCT00963547|75821150|FG000|NOT COMPLETED|Overall Study||4||
59701879|NCT00963547|75821151|FG001|NOT COMPLETED|Overall Study||11||
59701880|NCT00963547|75821152|FG002|NOT COMPLETED|Overall Study||12||
59701881|NCT00963547|75821153|FG003|NOT COMPLETED|Overall Study||6||
59701882|NCT00963547|75821154|FG004|NOT COMPLETED|Overall Study||0||
59701883|NCT00963547|75821155|FG005|NOT COMPLETED|Overall Study||0||
59701884|NCT00963547|75821156|FG006|NOT COMPLETED|Overall Study||0||
59701885|NCT01285310|75821172|FG000|STARTED|Placebo Controlled Phase: Weeks 0-24||79||
59701886|NCT01285310|75821173|FG001|STARTED|Placebo Controlled Phase: Weeks 0-24||82||
59701887|NCT01285310|75821174|FG002|STARTED|Placebo Controlled Phase: Weeks 0-24||76||
59701888|NCT01285310|75821175|FG003|STARTED|Placebo Controlled Phase: Weeks 0-24||0||
59701889|NCT01285310|75821176|FG004|STARTED|Placebo Controlled Phase: Weeks 0-24||0||
59701890|NCT01285310|75821172|FG000|COMPLETED|Placebo Controlled Phase: Weeks 0-24|1 participant chose not to enter the active treatment phase|70||
59701891|NCT01285310|75821173|FG001|COMPLETED|Placebo Controlled Phase: Weeks 0-24|Four participants chose not to enter the active treatment phase|67||
59701892|NCT01285310|75821174|FG002|COMPLETED|Placebo Controlled Phase: Weeks 0-24|1 participant chose not to enter active treatment phase|61||
59701893|NCT01285310|75821175|FG003|COMPLETED|Placebo Controlled Phase: Weeks 0-24||0||
59701894|NCT01285310|75821176|FG004|COMPLETED|Placebo Controlled Phase: Weeks 0-24||0||
59701895|NCT01285310|75821172|FG000|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||9||
59701896|NCT01285310|75821173|FG001|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||15||
59701897|NCT01285310|75821174|FG002|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||15||
59701898|NCT01285310|75821175|FG003|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||0||
59701899|NCT01285310|75821176|FG004|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||0||
59701900|NCT01285310|75821172|FG000|STARTED|Active Treatment Phase: Weeks 25-52||0||
59701901|NCT01285310|75821173|FG001|STARTED|Active Treatment Phase: Weeks 25-52||63||
59701902|NCT01285310|75821174|FG002|STARTED|Active Treatment Phase: Weeks 25-52||60||
59701903|NCT01285310|75821175|FG003|STARTED|Active Treatment Phase: Weeks 25-52||27||
59701904|NCT01285310|75821176|FG004|STARTED|Active Treatment Phase: Weeks 25-52||42||
59701905|NCT01285310|75821172|FG000|COMPLETED|Active Treatment Phase: Weeks 25-52||0||
59701906|NCT01285310|75821173|FG001|COMPLETED|Active Treatment Phase: Weeks 25-52||31||
59701907|NCT01285310|75821174|FG002|COMPLETED|Active Treatment Phase: Weeks 25-52||34||
59701908|NCT01285310|75821175|FG003|COMPLETED|Active Treatment Phase: Weeks 25-52||17||
59701909|NCT01285310|75821176|FG004|COMPLETED|Active Treatment Phase: Weeks 25-52||23||
59701910|NCT01285310|75821172|FG000|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||0||
59701911|NCT01285310|75821173|FG001|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||32||
59701912|NCT01285310|75821174|FG002|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||26||
59701913|NCT01285310|75821175|FG003|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||10||
59701914|NCT01285310|75821176|FG004|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||19||
59701915|NCT01254630|75821218|FG000|STARTED|Overall Study||1348||
59701916|NCT01254630|75821219|FG001|STARTED|Overall Study||1288||
59701917|NCT01254630|75821220|FG002|STARTED|Overall Study||1364||
59701918|NCT01254630|75821221|FG003|STARTED|Overall Study||1285||
59701919|NCT01254630|75821218|FG000|Received Vaccination 1|Overall Study||1328||
59701920|NCT01254630|75821219|FG001|Received Vaccination 1|Overall Study||1277||
59701921|NCT01254630|75821220|FG002|Received Vaccination 1|Overall Study||1350||
59701922|NCT01254630|75821221|FG003|Received Vaccination 1|Overall Study||1275||
59701923|NCT01254630|75821218|FG000|Received Vaccination 2|Overall Study||1255||
59701924|NCT01254630|75821219|FG001|Received Vaccination 2|Overall Study||1217||
59701925|NCT01254630|75821220|FG002|Received Vaccination 2|Overall Study||1286||
59701926|NCT01254630|75821221|FG003|Received Vaccination 2|Overall Study||1226||
59701927|NCT01254630|75821218|FG000|Received Vaccination 3|Overall Study||1198||
59701928|NCT01254630|75821219|FG001|Received Vaccination 3|Overall Study||1178||
59701929|NCT01254630|75821220|FG002|Received Vaccination 3|Overall Study||1247||
59701930|NCT01254630|75821221|FG003|Received Vaccination 3|Overall Study||1194||
59701931|NCT01254630|75821218|FG000|Received Vaccination 4|Overall Study||1155||
59701932|NCT01254630|75821219|FG001|Received Vaccination 4|Overall Study||1145||
59701933|NCT01254630|75821220|FG002|Received Vaccination 4|Overall Study||1212||
59701934|NCT01254630|75821221|FG003|Received Vaccination 4|Overall Study||1160||
59701935|NCT01254630|75821218|FG000|COMPLETED|Overall Study||546||
59701936|NCT01254630|75821219|FG001|COMPLETED|Overall Study||0||
59701937|NCT01254630|75821220|FG002|COMPLETED|Overall Study||552||
59701938|NCT01254630|75821221|FG003|COMPLETED|Overall Study||0||
59701939|NCT01254630|75821218|FG000|NOT COMPLETED|Overall Study||802||
59701940|NCT01254630|75821219|FG001|NOT COMPLETED|Overall Study||1288||
59701941|NCT01254630|75821220|FG002|NOT COMPLETED|Overall Study||812||
59701942|NCT01254630|75821221|FG003|NOT COMPLETED|Overall Study||1285||
59701943|NCT01284140|75821231|FG000|STARTED|Randomization and Intervention||11||
59701944|NCT01284140|75821232|FG001|STARTED|Randomization and Intervention||11||
59701945|NCT01284140|75821231|FG000|COMPLETED|Randomization and Intervention||11||
59701946|NCT01284140|75821232|FG001|COMPLETED|Randomization and Intervention||11||
59701947|NCT01284140|75821231|FG000|NOT COMPLETED|Randomization and Intervention||0||
59701948|NCT01284140|75821232|FG001|NOT COMPLETED|Randomization and Intervention||0||
59701949|NCT01284140|75821231|FG000|STARTED|Subjects With Paired 24hr Collections||11||
59701950|NCT01284140|75821232|FG001|STARTED|Subjects With Paired 24hr Collections||11||
59701951|NCT01284140|75821231|FG000|COMPLETED|Subjects With Paired 24hr Collections||6||
59701952|NCT01284140|75821232|FG001|COMPLETED|Subjects With Paired 24hr Collections||5||
59701953|NCT01284140|75821231|FG000|NOT COMPLETED|Subjects With Paired 24hr Collections||5||
59701954|NCT01284140|75821232|FG001|NOT COMPLETED|Subjects With Paired 24hr Collections||6||
59701955|NCT01254318|75821238|FG000|STARTED|Overall Study|Alive at start of study|130||
59701956|NCT01254318|75821238|FG000|COMPLETED|Overall Study|Alive at end of study|78||
59701957|NCT01254318|75821238|FG000|NOT COMPLETED|Overall Study||52||
59701958|NCT01284062|75821246|FG000|STARTED|Overall Study||21||
59701959|NCT01284062|75821247|FG001|STARTED|Overall Study||21||
59701960|NCT01284062|75821248|FG002|STARTED|Overall Study||21||
59701961|NCT01284062|75821249|FG003|STARTED|Overall Study||21||
59701962|NCT01284062|75821246|FG000|COMPLETED|Overall Study||10||
59701963|NCT01284062|75821247|FG001|COMPLETED|Overall Study||13||
59701964|NCT01284062|75821248|FG002|COMPLETED|Overall Study||15||
59701965|NCT01284062|75821249|FG003|COMPLETED|Overall Study||7||
59701966|NCT01284062|75821246|FG000|NOT COMPLETED|Overall Study||11||
59701967|NCT01284062|75821247|FG001|NOT COMPLETED|Overall Study||8||
59701968|NCT01284062|75821248|FG002|NOT COMPLETED|Overall Study||6||
59701969|NCT01284062|75821249|FG003|NOT COMPLETED|Overall Study||14||
59701970|NCT01253304|75821266|FG000|STARTED|Overall Study||11||
59701971|NCT01253304|75821267|FG001|STARTED|Overall Study||6||
59701972|NCT01253304|75821268|FG002|STARTED|Overall Study||6||
59701973|NCT01253304|75821269|FG003|STARTED|Overall Study||3||
59701974|NCT01253304|75821266|FG000|Received at Least 1 Dose of Study Drug|Overall Study||11||
59701975|NCT01253304|75821267|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6||
59701976|NCT01253304|75821268|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6||
59701977|NCT01253304|75821269|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3||
59701978|NCT01253304|75821266|FG000|COMPLETED|Overall Study||11||
59701979|NCT01253304|75821267|FG001|COMPLETED|Overall Study||6||
59701980|NCT01253304|75821268|FG002|COMPLETED|Overall Study||6||
59701981|NCT01253304|75821269|FG003|COMPLETED|Overall Study||2||
59990804|NCT02495168|76106342|FG000|Safety Population|Overall Study||501|Randomized participants who received at least 1 dose of study drug during Treatment Period|
59701982|NCT01253304|75821266|FG000|NOT COMPLETED|Overall Study||0||
59701983|NCT01253304|75821267|FG001|NOT COMPLETED|Overall Study||0||
59701984|NCT01253304|75821268|FG002|NOT COMPLETED|Overall Study||0||
59701985|NCT01253304|75821269|FG003|NOT COMPLETED|Overall Study||1||
59701986|NCT01253226|75821284|FG000|STARTED|Overall Study||6||
59701987|NCT01253226|75821285|FG001|STARTED|Overall Study||6||
59701988|NCT01253226|75821286|FG002|STARTED|Overall Study||6||
59701989|NCT01253226|75821287|FG003|STARTED|Overall Study||6||
59701990|NCT01253226|75821288|FG004|STARTED|Overall Study||8||
59701991|NCT01253226|75821284|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6||
59701992|NCT01253226|75821285|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6||
59701993|NCT01253226|75821286|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6||
59701994|NCT01253226|75821287|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6||
59701995|NCT01253226|75821288|FG004|Received at Least 1 Dose of Study Drug|Overall Study||8||
59701996|NCT01253226|75821284|FG000|COMPLETED|Overall Study||6||
59701997|NCT01253226|75821285|FG001|COMPLETED|Overall Study||5||
59701998|NCT01253226|75821286|FG002|COMPLETED|Overall Study||5||
59701999|NCT01253226|75821287|FG003|COMPLETED|Overall Study||5||
59702000|NCT01253226|75821288|FG004|COMPLETED|Overall Study||6||
59702001|NCT01253226|75821284|FG000|NOT COMPLETED|Overall Study||0||
59702002|NCT01253226|75821285|FG001|NOT COMPLETED|Overall Study||1||
59702003|NCT01253226|75821286|FG002|NOT COMPLETED|Overall Study||1||
59702004|NCT01253226|75821287|FG003|NOT COMPLETED|Overall Study||1||
59702005|NCT01253226|75821288|FG004|NOT COMPLETED|Overall Study||2||
59702006|NCT01252290|75821300|FG000|STARTED|Overall Study||35||
59702007|NCT01252290|75821300|FG000|COMPLETED|Overall Study||34||
59702008|NCT01252290|75821300|FG000|NOT COMPLETED|Overall Study||1||
59702009|NCT01252134|75821304|FG000|STARTED|Period 1, 8 Hours||3||
60079634|NCT03780543|76194807|FG001|COMPLETED|Overall Study||28||
60079635|NCT03780543|76194808|FG002|COMPLETED|Overall Study||6||
60079636|NCT03780543|76194806|FG000|NOT COMPLETED|Overall Study||13||
60079637|NCT03780543|76194807|FG001|NOT COMPLETED|Overall Study||15||
60079638|NCT03780543|76194808|FG002|NOT COMPLETED|Overall Study||17||
60079639|NCT03745820|76194821|FG000|STARTED|Overall Study||64||
60079640|NCT03745820|76194822|FG001|STARTED|Overall Study||66||
60079641|NCT03745820|76194823|FG002|STARTED|Overall Study||65||
60079642|NCT03745820|76194821|FG000|Safety Analysis Set|Overall Study||63|The safety population included all randomized participants who received at least 1 dose of study treatment(BIIB104 or placebo). One participant randomized to placebo, inadvertently received one or more doses of active treatment.|
60079643|NCT03745820|76194822|FG001|Safety Analysis Set|Overall Study||66|The safety population included all randomized participants who received at least 1 dose of study treatment(BIIB104 or placebo). One participant randomized to placebo, inadvertently received one or more doses of active treatment.|
60079644|NCT03745820|76194823|FG002|Safety Analysis Set|Overall Study||66|The safety population included all randomized participants who received at least 1 dose of study treatment(BIIB104 or placebo). One participant randomized to placebo, inadvertently received one or more doses of active treatment.|
60079645|NCT03745820|76194821|FG000|COMPLETED|Overall Study||52||
60079646|NCT03745820|76194822|FG001|COMPLETED|Overall Study||52||
60079647|NCT03745820|76194823|FG002|COMPLETED|Overall Study||51||
60079648|NCT03745820|76194821|FG000|NOT COMPLETED|Overall Study||12||
60079649|NCT03745820|76194822|FG001|NOT COMPLETED|Overall Study||14||
60079650|NCT03745820|76194823|FG002|NOT COMPLETED|Overall Study||14||
60079651|NCT03699631|76194831|FG000|STARTED|Overall Study||29||
60079652|NCT03699631|76194831|FG000|COMPLETED|Overall Study||26||
60079653|NCT03699631|76194831|FG000|NOT COMPLETED|Overall Study||3||
60079654|NCT03686150|76194841|FG000|STARTED|Overall Study||13||
59702010|NCT01252134|75821305|FG001|STARTED|Period 1, 8 Hours||4||
59702011|NCT01252134|75821306|FG002|STARTED|Period 1, 8 Hours||3||
59702012|NCT01252134|75821307|FG003|STARTED|Period 1, 8 Hours||5||
59702013|NCT01252134|75821308|FG004|STARTED|Period 1, 8 Hours||3||
59702014|NCT01252134|75821309|FG005|STARTED|Period 1, 8 Hours||4||
59702015|NCT01252134|75821304|FG000|COMPLETED|Period 1, 8 Hours||3||
59702016|NCT01252134|75821305|FG001|COMPLETED|Period 1, 8 Hours||3||
59702017|NCT01252134|75821306|FG002|COMPLETED|Period 1, 8 Hours||2||
59702018|NCT01252134|75821307|FG003|COMPLETED|Period 1, 8 Hours||5||
59702019|NCT01252134|75821308|FG004|COMPLETED|Period 1, 8 Hours||3||
59702020|NCT01252134|75821309|FG005|COMPLETED|Period 1, 8 Hours||4||
59702021|NCT01252134|75821304|FG000|NOT COMPLETED|Period 1, 8 Hours||0||
59702022|NCT01252134|75821305|FG001|NOT COMPLETED|Period 1, 8 Hours||1||
59702023|NCT01252134|75821306|FG002|NOT COMPLETED|Period 1, 8 Hours||1||
59702024|NCT01252134|75821307|FG003|NOT COMPLETED|Period 1, 8 Hours||0||
59702025|NCT01252134|75821308|FG004|NOT COMPLETED|Period 1, 8 Hours||0||
59702026|NCT01252134|75821309|FG005|NOT COMPLETED|Period 1, 8 Hours||0||
59702027|NCT01252134|75821304|FG000|STARTED|Period 2, 8 Hours||3||
59702028|NCT01252134|75821305|FG001|STARTED|Period 2, 8 Hours||3||
59702029|NCT01252134|75821306|FG002|STARTED|Period 2, 8 Hours||2||
59702030|NCT01252134|75821307|FG003|STARTED|Period 2, 8 Hours||5||
59702031|NCT01252134|75821308|FG004|STARTED|Period 2, 8 Hours||3||
59816230|NCT00610649|75938615|FG006|STARTED|Overall Study||4||
59816231|NCT00610649|75938616|FG007|STARTED|Overall Study||2||
59702032|NCT01252134|75821309|FG005|STARTED|Period 2, 8 Hours||4||
59702033|NCT01252134|75821304|FG000|COMPLETED|Period 2, 8 Hours||3||
59702034|NCT01252134|75821305|FG001|COMPLETED|Period 2, 8 Hours||3||
59702035|NCT01252134|75821306|FG002|COMPLETED|Period 2, 8 Hours||2||
59816232|NCT00610649|75938617|FG008|STARTED|Overall Study||10||
60079655|NCT03686150|76194842|FG001|STARTED|Overall Study||12||
60079656|NCT03686150|76194843|FG002|STARTED|Overall Study||11||
60079657|NCT03686150|76194844|FG003|STARTED|Overall Study||12||
60079658|NCT03686150|76194845|FG004|STARTED|Overall Study||43||
60079659|NCT03686150|76194846|FG005|STARTED|Overall Study||21||
60079660|NCT03686150|76194841|FG000|COMPLETED|Overall Study||11||
60079661|NCT03686150|76194842|FG001|COMPLETED|Overall Study||10||
60079662|NCT03686150|76194843|FG002|COMPLETED|Overall Study||10||
60079663|NCT03686150|76194844|FG003|COMPLETED|Overall Study||12||
60079664|NCT03686150|76194845|FG004|COMPLETED|Overall Study||42||
60079665|NCT03686150|76194846|FG005|COMPLETED|Overall Study||18||
60079666|NCT03686150|76194841|FG000|NOT COMPLETED|Overall Study||2||
60079667|NCT03686150|76194842|FG001|NOT COMPLETED|Overall Study||2||
59702036|NCT01252134|75821307|FG003|COMPLETED|Period 2, 8 Hours||5||
59702037|NCT01252134|75821308|FG004|COMPLETED|Period 2, 8 Hours||3||
59702038|NCT01252134|75821309|FG005|COMPLETED|Period 2, 8 Hours||4||
59702039|NCT01252134|75821304|FG000|NOT COMPLETED|Period 2, 8 Hours||0||
59702040|NCT01252134|75821305|FG001|NOT COMPLETED|Period 2, 8 Hours||0||
59702041|NCT01252134|75821306|FG002|NOT COMPLETED|Period 2, 8 Hours||0||
59702042|NCT01252134|75821307|FG003|NOT COMPLETED|Period 2, 8 Hours||0||
59702043|NCT01252134|75821308|FG004|NOT COMPLETED|Period 2, 8 Hours||0||
59702044|NCT01252134|75821309|FG005|NOT COMPLETED|Period 2, 8 Hours||0||
59702045|NCT01252134|75821304|FG000|STARTED|Period 3, 8 Hours||3||
59702046|NCT01252134|75821305|FG001|STARTED|Period 3, 8 Hours||3||
59702047|NCT01252134|75821306|FG002|STARTED|Period 3, 8 Hours||2||
59702048|NCT01252134|75821307|FG003|STARTED|Period 3, 8 Hours||5||
59702049|NCT01252134|75821308|FG004|STARTED|Period 3, 8 Hours||3||
59702050|NCT01252134|75821309|FG005|STARTED|Period 3, 8 Hours||4||
59702051|NCT01252134|75821304|FG000|COMPLETED|Period 3, 8 Hours||3||
59702052|NCT01252134|75821305|FG001|COMPLETED|Period 3, 8 Hours||3||
59702053|NCT01252134|75821306|FG002|COMPLETED|Period 3, 8 Hours||2||
59702054|NCT01252134|75821307|FG003|COMPLETED|Period 3, 8 Hours||5||
59702055|NCT01252134|75821308|FG004|COMPLETED|Period 3, 8 Hours||3||
59702056|NCT01252134|75821309|FG005|COMPLETED|Period 3, 8 Hours||4||
59702057|NCT01252134|75821304|FG000|NOT COMPLETED|Period 3, 8 Hours||0||
59702058|NCT01252134|75821305|FG001|NOT COMPLETED|Period 3, 8 Hours||0||
59702059|NCT01252134|75821306|FG002|NOT COMPLETED|Period 3, 8 Hours||0||
59702060|NCT01252134|75821307|FG003|NOT COMPLETED|Period 3, 8 Hours||0||
59702061|NCT01252134|75821308|FG004|NOT COMPLETED|Period 3, 8 Hours||0||
59702062|NCT01252134|75821309|FG005|NOT COMPLETED|Period 3, 8 Hours||0||
59702063|NCT01251744|75821319|FG000|STARTED|Overall Study||77||
59702064|NCT01251744|75821320|FG001|STARTED|Overall Study||78||
59702065|NCT01251744|75821319|FG000|COMPLETED|Overall Study||76||
59702066|NCT01251744|75821320|FG001|COMPLETED|Overall Study||78||
59702067|NCT01251744|75821319|FG000|NOT COMPLETED|Overall Study||1||
59702068|NCT01251744|75821320|FG001|NOT COMPLETED|Overall Study||0||
59702069|NCT01251354|75821333|FG000|STARTED|Overall Study||6||
59702070|NCT01251354|75821333|FG000|COMPLETED|Overall Study||0||
59702071|NCT01251354|75821333|FG000|NOT COMPLETED|Overall Study||6||
59702072|NCT01251276|75821339|FG000|STARTED|Overall Study|Not all Base Study completers enrolled in the Challenge Dose Study|96||
59702073|NCT01251276|75821340|FG001|STARTED|Overall Study|Not all Base Study completers enrolled in the Challenge Dose Study|108||
59702074|NCT01251276|75821339|FG000|Vaccinated|Overall Study||96||
59702075|NCT01251276|75821340|FG001|Vaccinated|Overall Study||108||
59702076|NCT01251276|75821339|FG000|COMPLETED|Overall Study||95||
59702077|NCT01251276|75821340|FG001|COMPLETED|Overall Study||107||
59702078|NCT01251276|75821339|FG000|NOT COMPLETED|Overall Study||1||
59702079|NCT01251276|75821340|FG001|NOT COMPLETED|Overall Study||1||
59702080|NCT01251120|75821348|FG000|STARTED|Overall Study||1||
59702081|NCT01251120|75821349|FG001|STARTED|Overall Study||1||
60079668|NCT03686150|76194843|FG002|NOT COMPLETED|Overall Study||1||
59702082|NCT01251120|75821348|FG000|COMPLETED|Overall Study||1||
59702083|NCT01251120|75821349|FG001|COMPLETED|Overall Study||0||
59702084|NCT01251120|75821348|FG000|NOT COMPLETED|Overall Study||0||
59702085|NCT01251120|75821349|FG001|NOT COMPLETED|Overall Study||1||
59702086|NCT01250418|75821357|FG000|STARTED|Overall Study||9||
59702087|NCT01250418|75821358|FG001|STARTED|Overall Study||16||
59702088|NCT01250418|75821357|FG000|COMPLETED|Overall Study||8||
59702089|NCT01250418|75821358|FG001|COMPLETED|Overall Study||15||
59702090|NCT01250418|75821357|FG000|NOT COMPLETED|Overall Study||1||
59702091|NCT01250418|75821358|FG001|NOT COMPLETED|Overall Study||1||
59702092|NCT01292603|75821369|FG000|STARTED|Part 1: Pilot Dose Selection Period||16||
59702093|NCT01292603|75821370|FG001|STARTED|Part 1: Pilot Dose Selection Period||17||
59702094|NCT01292603|75821371|FG002|STARTED|Part 1: Pilot Dose Selection Period|1 participant received a dose of 1000mg of rituximab by oversight.|23||
59702095|NCT01292603|75821372|FG003|STARTED|Part 1: Pilot Dose Selection Period|These participants were withdrawn prior to SC treatment.|8||
59702096|NCT01292603|75821373|FG004|STARTED|Part 1: Pilot Dose Selection Period||0||
59702097|NCT01292603|75821374|FG005|STARTED|Part 1: Pilot Dose Selection Period||0||
59990805|NCT02495168|76106343|FG001|Safety Population|Overall Study||514|Randomized participants who received at least 1 dose of study drug during Treatment Period|
59990806|NCT02495168|76106344|FG002|Safety Population|Overall Study||126|Randomized participants who received at least 1 dose of study drug during Treatment Period|
59990807|NCT02495168|76106342|FG000|Modified Intent-to-Treat Population|Overall Study||468|Participants in Safety Population with no major inclusion/exclusion deviations, enrolled only once|
59995081|NCT02550093|76110918|FG001|COMPLETED|Intervention 1||10||
59995082|NCT02550093|76110917|FG000|NOT COMPLETED|Intervention 1||0||
60079669|NCT03686150|76194844|FG003|NOT COMPLETED|Overall Study||0||
59702098|NCT01292603|75821369|FG000|COMPLETED|Part 1: Pilot Dose Selection Period||16||
59702099|NCT01292603|75821370|FG001|COMPLETED|Part 1: Pilot Dose Selection Period||17||
59702100|NCT01292603|75821371|FG002|COMPLETED|Part 1: Pilot Dose Selection Period||23||
59702101|NCT01292603|75821372|FG003|COMPLETED|Part 1: Pilot Dose Selection Period||0||
59816233|NCT00610649|75938618|FG009|STARTED|Overall Study||10||
59816234|NCT00610649|75938619|FG010|STARTED|Overall Study||10||
60079670|NCT03686150|76194845|FG004|NOT COMPLETED|Overall Study||1||
59702102|NCT01292603|75821373|FG004|COMPLETED|Part 1: Pilot Dose Selection Period||0||
59702103|NCT01292603|75821374|FG005|COMPLETED|Part 1: Pilot Dose Selection Period||0||
59702104|NCT01292603|75821369|FG000|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0||
59702105|NCT01292603|75821370|FG001|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0||
59702106|NCT01292603|75821371|FG002|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0||
59702107|NCT01292603|75821372|FG003|NOT COMPLETED|Part 1: Pilot Dose Selection Period||8||
59702108|NCT01292603|75821373|FG004|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0||
59702109|NCT01292603|75821374|FG005|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0||
59702110|NCT01292603|75821369|FG000|STARTED|Part 1: Regular Follow-Up Period||16||
59702111|NCT01292603|75821370|FG001|STARTED|Part 1: Regular Follow-Up Period||17||
59702112|NCT01292603|75821371|FG002|STARTED|Part 1: Regular Follow-Up Period||23||
59702113|NCT01292603|75821372|FG003|STARTED|Part 1: Regular Follow-Up Period||8||
59702114|NCT01292603|75821373|FG004|STARTED|Part 1: Regular Follow-Up Period||0||
59702115|NCT01292603|75821374|FG005|STARTED|Part 1: Regular Follow-Up Period||0||
59702116|NCT01292603|75821369|FG000|COMPLETED|Part 1: Regular Follow-Up Period|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|10||
59702117|NCT01292603|75821370|FG001|COMPLETED|Part 1: Regular Follow-Up Period|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|10||
59702118|NCT01292603|75821371|FG002|COMPLETED|Part 1: Regular Follow-Up Period|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|17||
59702119|NCT01292603|75821372|FG003|COMPLETED|Part 1: Regular Follow-Up Period||7||
59702120|NCT01292603|75821373|FG004|COMPLETED|Part 1: Regular Follow-Up Period||0||
59702121|NCT01292603|75821374|FG005|COMPLETED|Part 1: Regular Follow-Up Period||0||
59702122|NCT01292603|75821369|FG000|NOT COMPLETED|Part 1: Regular Follow-Up Period||6||
59702123|NCT01292603|75821370|FG001|NOT COMPLETED|Part 1: Regular Follow-Up Period||7||
59702124|NCT01292603|75821371|FG002|NOT COMPLETED|Part 1: Regular Follow-Up Period||6||
59702125|NCT01292603|75821372|FG003|NOT COMPLETED|Part 1: Regular Follow-Up Period||1||
60079671|NCT03686150|76194846|FG005|NOT COMPLETED|Overall Study||3||
60079672|NCT03604172|76194859|FG000|STARTED|Overall Study||20||
60079673|NCT03604172|76194860|FG001|STARTED|Overall Study||20||
60079674|NCT03604172|76194859|FG000|COMPLETED|Overall Study||19||
60079675|NCT03604172|76194860|FG001|COMPLETED|Overall Study||18||
60079676|NCT03604172|76194859|FG000|NOT COMPLETED|Overall Study||1||
60079677|NCT03604172|76194860|FG001|NOT COMPLETED|Overall Study||2||
60079678|NCT03496207|76194869|FG000|STARTED|Base Study||0||
60079679|NCT03496207|76194870|FG001|STARTED|Base Study||0||
60079680|NCT03496207|76194871|FG002|STARTED|Base Study||32||
60079681|NCT03496207|76194872|FG003|STARTED|Base Study||32||
60079682|NCT03496207|76194873|FG004|STARTED|Base Study||42||
60079683|NCT03496207|76194869|FG000|COMPLETED|Base Study||0||
60079684|NCT03496207|76194870|FG001|COMPLETED|Base Study||0||
60079685|NCT03496207|76194871|FG002|COMPLETED|Base Study||30||
60079686|NCT03496207|76194872|FG003|COMPLETED|Base Study||31||
60079687|NCT03496207|76194873|FG004|COMPLETED|Base Study||36||
60079688|NCT03496207|76194869|FG000|NOT COMPLETED|Base Study||0||
60079689|NCT03496207|76194870|FG001|NOT COMPLETED|Base Study||0||
60079690|NCT03496207|76194871|FG002|NOT COMPLETED|Base Study||2||
60079691|NCT03496207|76194872|FG003|NOT COMPLETED|Base Study||1||
60079692|NCT03496207|76194873|FG004|NOT COMPLETED|Base Study||6||
60079693|NCT03496207|76194869|FG000|STARTED|Extension Period||15||
60079694|NCT03496207|76194870|FG001|STARTED|Extension Period||15||
60079695|NCT03496207|76194871|FG002|STARTED|Extension Period||0||
60079696|NCT03496207|76194872|FG003|STARTED|Extension Period||31||
60079697|NCT03496207|76194873|FG004|STARTED|Extension Period||36||
60079698|NCT03496207|76194869|FG000|COMPLETED|Extension Period||13||
60079699|NCT03496207|76194870|FG001|COMPLETED|Extension Period||15||
60079700|NCT03496207|76194871|FG002|COMPLETED|Extension Period||0||
60079701|NCT03496207|76194872|FG003|COMPLETED|Extension Period||28||
60079702|NCT03496207|76194873|FG004|COMPLETED|Extension Period||31||
59702126|NCT01292603|75821373|FG004|NOT COMPLETED|Part 1: Regular Follow-Up Period||0||
59702127|NCT01292603|75821374|FG005|NOT COMPLETED|Part 1: Regular Follow-Up Period||0||
59702128|NCT01292603|75821369|FG000|STARTED|Part 2: Dose Confirmation Period||0||
59702129|NCT01292603|75821370|FG001|STARTED|Part 2: Dose Confirmation Period||0||
59702130|NCT01292603|75821371|FG002|STARTED|Part 2: Dose Confirmation Period||0||
59702131|NCT01292603|75821372|FG003|STARTED|Part 2: Dose Confirmation Period||0||
59702132|NCT01292603|75821373|FG004|STARTED|Part 2: Dose Confirmation Period||88||
59702133|NCT01292603|75821374|FG005|STARTED|Part 2: Dose Confirmation Period||88||
59702134|NCT01292603|75821369|FG000|COMPLETED|Part 2: Dose Confirmation Period||0||
59702135|NCT01292603|75821370|FG001|COMPLETED|Part 2: Dose Confirmation Period||0||
60079703|NCT03496207|76194869|FG000|NOT COMPLETED|Extension Period||2||
60079704|NCT03496207|76194870|FG001|NOT COMPLETED|Extension Period||0||
60079705|NCT03496207|76194871|FG002|NOT COMPLETED|Extension Period||0||
60079706|NCT03496207|76194872|FG003|NOT COMPLETED|Extension Period||3||
60079707|NCT03496207|76194873|FG004|NOT COMPLETED|Extension Period||5||
60079708|NCT03444870|76194898|FG000|STARTED|Double-Blind Treatment (DBT) Period||486||
60079709|NCT03444870|76194899|FG001|STARTED|Double-Blind Treatment (DBT) Period||499||
60079710|NCT03444870|76194900|FG002|STARTED|Double-Blind Treatment (DBT) Period||33||
60079711|NCT03444870|76194901|FG003|STARTED|Double-Blind Treatment (DBT) Period||35||
59702136|NCT01292603|75821371|FG002|COMPLETED|Part 2: Dose Confirmation Period||0||
59702137|NCT01292603|75821372|FG003|COMPLETED|Part 2: Dose Confirmation Period||0||
59702138|NCT01292603|75821373|FG004|COMPLETED|Part 2: Dose Confirmation Period||72||
59702139|NCT01292603|75821374|FG005|COMPLETED|Part 2: Dose Confirmation Period||73||
59702140|NCT01292603|75821369|FG000|NOT COMPLETED|Part 2: Dose Confirmation Period||0||
59702141|NCT01292603|75821370|FG001|NOT COMPLETED|Part 2: Dose Confirmation Period||0||
59702142|NCT01292603|75821371|FG002|NOT COMPLETED|Part 2: Dose Confirmation Period||0||
59702143|NCT01292603|75821372|FG003|NOT COMPLETED|Part 2: Dose Confirmation Period||0||
59702144|NCT01292603|75821373|FG004|NOT COMPLETED|Part 2: Dose Confirmation Period||16||
59702145|NCT01292603|75821374|FG005|NOT COMPLETED|Part 2: Dose Confirmation Period||15||
59702146|NCT01292603|75821369|FG000|STARTED|Part 2: Regular Follow-Up||0||
59702147|NCT01292603|75821370|FG001|STARTED|Part 2: Regular Follow-Up||0||
59702148|NCT01292603|75821371|FG002|STARTED|Part 2: Regular Follow-Up||0||
59702149|NCT01292603|75821372|FG003|STARTED|Part 2: Regular Follow-Up||0||
59702150|NCT01292603|75821373|FG004|STARTED|Part 2: Regular Follow-Up|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|87||
59702151|NCT01292603|75821374|FG005|STARTED|Part 2: Regular Follow-Up|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|87||
59702152|NCT01292603|75821369|FG000|COMPLETED|Part 2: Regular Follow-Up||0||
59702153|NCT01292603|75821370|FG001|COMPLETED|Part 2: Regular Follow-Up||0||
59702154|NCT01292603|75821371|FG002|COMPLETED|Part 2: Regular Follow-Up||0||
59702155|NCT01292603|75821372|FG003|COMPLETED|Part 2: Regular Follow-Up||0||
59702156|NCT01292603|75821373|FG004|COMPLETED|Part 2: Regular Follow-Up||68||
59702157|NCT01292603|75821374|FG005|COMPLETED|Part 2: Regular Follow-Up||75||
59702158|NCT01292603|75821369|FG000|NOT COMPLETED|Part 2: Regular Follow-Up||0||
59702159|NCT01292603|75821370|FG001|NOT COMPLETED|Part 2: Regular Follow-Up||0||
59702160|NCT01292603|75821371|FG002|NOT COMPLETED|Part 2: Regular Follow-Up||0||
59702161|NCT01292603|75821372|FG003|NOT COMPLETED|Part 2: Regular Follow-Up||0||
59702162|NCT01292603|75821373|FG004|NOT COMPLETED|Part 2: Regular Follow-Up||19||
59702163|NCT01292603|75821374|FG005|NOT COMPLETED|Part 2: Regular Follow-Up||12||
59702164|NCT01292603|75821369|FG000|STARTED|Overall Survival Status||16|Patients could enter survival follow-up directly after premature treatment withdrawal,|
59702165|NCT01292603|75821370|FG001|STARTED|Overall Survival Status||17|Patients could enter survival follow-up directly after premature treatment withdrawal,|
59702166|NCT01292603|75821371|FG002|STARTED|Overall Survival Status||23|Patients could enter survival follow-up directly after premature treatment withdrawal,|
59702167|NCT01292603|75821372|FG003|STARTED|Overall Survival Status||8|Patients could enter survival follow-up directly after premature treatment withdrawal,|
59702168|NCT01292603|75821373|FG004|STARTED|Overall Survival Status||88|Patients could enter survival follow-up directly after premature treatment withdrawal,|
59702169|NCT01292603|75821374|FG005|STARTED|Overall Survival Status||88|Patients could enter survival follow-up directly after premature treatment withdrawal,|
59702170|NCT01292603|75821369|FG000|COMPLETED|Overall Survival Status||13|Overall survival.|
59702171|NCT01292603|75821370|FG001|COMPLETED|Overall Survival Status||16|Overall survival.|
59702172|NCT01292603|75821371|FG002|COMPLETED|Overall Survival Status||20|Overall survival.|
59702173|NCT01292603|75821372|FG003|COMPLETED|Overall Survival Status||7|Overall survival.|
59702174|NCT01292603|75821373|FG004|COMPLETED|Overall Survival Status||72|Overall survival.|
59702175|NCT01292603|75821374|FG005|COMPLETED|Overall Survival Status||78|Overall survival.|
59702176|NCT01292603|75821369|FG000|NOT COMPLETED|Overall Survival Status||3||
59702177|NCT01292603|75821370|FG001|NOT COMPLETED|Overall Survival Status||1||
59702178|NCT01292603|75821371|FG002|NOT COMPLETED|Overall Survival Status||3||
59702179|NCT01292603|75821372|FG003|NOT COMPLETED|Overall Survival Status||1||
59702180|NCT01292603|75821373|FG004|NOT COMPLETED|Overall Survival Status||16||
59702181|NCT01292603|75821374|FG005|NOT COMPLETED|Overall Survival Status||10||
59702182|NCT01292057|75821397|FG000|STARTED|Overall Study||49||
59702183|NCT01292057|75821398|FG001|STARTED|Overall Study||50||
59702184|NCT01292057|75821397|FG000|COMPLETED|Overall Study||47||
59702185|NCT01292057|75821398|FG001|COMPLETED|Overall Study||48||
59702186|NCT01292057|75821397|FG000|NOT COMPLETED|Overall Study||2||
59702187|NCT01292057|75821398|FG001|NOT COMPLETED|Overall Study||2||
59702188|NCT01291277|75821406|FG000|STARTED|Overall Study||45||
59702189|NCT01291277|75821407|FG001|STARTED|Overall Study||45||
59702190|NCT01291277|75821406|FG000|COMPLETED|Overall Study||40||
59702191|NCT01291277|75821407|FG001|COMPLETED|Overall Study||42||
59702192|NCT01291277|75821406|FG000|NOT COMPLETED|Overall Study||5||
59702193|NCT01291277|75821407|FG001|NOT COMPLETED|Overall Study||3||
59702194|NCT01290887|75821415|FG000|STARTED|Overall Study||481||
59702195|NCT01290887|75821416|FG001|STARTED|Overall Study||571||
60079712|NCT03444870|76194902|FG004|STARTED|Double-Blind Treatment (DBT) Period||0||
60079713|NCT03444870|76194903|FG005|STARTED|Double-Blind Treatment (DBT) Period||0||
59702196|NCT01290887|75821415|FG000|Safety Analysis Set|Overall Study|One patient was enrolled but not treated.|480||
59702197|NCT01290887|75821416|FG001|Safety Analysis Set|Overall Study||571||
59702198|NCT01290887|75821415|FG000|COMPLETED|Overall Study|Completed study includes completion of the 104 week treatment phase and the 90-day follow-up.|15||
59702199|NCT01290887|75821416|FG001|COMPLETED|Overall Study|Completed study includes completion of the 104 week treatment phase and the 90-day follow-up.|35||
59702200|NCT01290887|75821415|FG000|NOT COMPLETED|Overall Study||466||
59702201|NCT01290887|75821416|FG001|NOT COMPLETED|Overall Study||536||
59702202|NCT01290731|75821422|FG000|STARTED|Overall Study||49||
59702203|NCT01290731|75821422|FG000|COMPLETED|Overall Study||48||
59702204|NCT01290731|75821422|FG000|NOT COMPLETED|Overall Study||1||
59702205|NCT01290341|75821428|FG000|STARTED|Overall Study||573||
59702206|NCT01290341|75821429|FG001|STARTED|Overall Study||287||
59702207|NCT01290341|75821428|FG000|COMPLETED|Overall Study||481||
59702208|NCT01290341|75821429|FG001|COMPLETED|Overall Study||258||
59702209|NCT01290341|75821428|FG000|NOT COMPLETED|Overall Study||92||
59702210|NCT01290341|75821429|FG001|NOT COMPLETED|Overall Study||29||
59702211|NCT01290263|75821437|FG000|STARTED|Overall Study||11||
59702212|NCT01290263|75821438|FG001|STARTED|Overall Study||3||
59702213|NCT01290263|75821439|FG002|STARTED|Overall Study||7||
59702214|NCT01290263|75821440|FG003|STARTED|Overall Study||27||
59702215|NCT01290263|75821441|FG004|STARTED|Overall Study||37||
59702216|NCT01290263|75821437|FG000|COMPLETED|Overall Study||0||
59702217|NCT01290263|75821438|FG001|COMPLETED|Overall Study||0||
59702218|NCT01290263|75821439|FG002|COMPLETED|Overall Study||0||
59702219|NCT01290263|75821440|FG003|COMPLETED|Overall Study||0||
59702220|NCT01290263|75821441|FG004|COMPLETED|Overall Study||0||
59702221|NCT01290263|75821437|FG000|NOT COMPLETED|Overall Study||11||
59702222|NCT01290263|75821438|FG001|NOT COMPLETED|Overall Study||3||
59702223|NCT01290263|75821439|FG002|NOT COMPLETED|Overall Study||7||
59702224|NCT01290263|75821440|FG003|NOT COMPLETED|Overall Study||27||
59702225|NCT01290263|75821441|FG004|NOT COMPLETED|Overall Study||37||
59702226|NCT01290029|75821449|FG000|STARTED|Overall Study||14||
59702227|NCT01290029|75821449|FG000|Received Study Treatment|Overall Study||12||
59702228|NCT01290029|75821449|FG000|COMPLETED|Overall Study||12||
59702229|NCT01290029|75821449|FG000|NOT COMPLETED|Overall Study||2||
59702230|NCT01289639|75821456|FG000|STARTED|Overall Study||5||
59702231|NCT01289639|75821457|FG001|STARTED|Overall Study||6||
59702232|NCT01289639|75821458|FG002|STARTED|Overall Study||0||
59702233|NCT01289639|75821456|FG000|COMPLETED|Overall Study||4||
59702234|NCT01289639|75821457|FG001|COMPLETED|Overall Study||6||
59702235|NCT01289639|75821458|FG002|COMPLETED|Overall Study||0||
59702236|NCT01289639|75821456|FG000|NOT COMPLETED|Overall Study||1||
59702237|NCT01289639|75821457|FG001|NOT COMPLETED|Overall Study||0||
59702238|NCT01289639|75821458|FG002|NOT COMPLETED|Overall Study||0||
59702239|NCT01289015|75821468|FG000|STARTED|Overall Study||571||
59702240|NCT01289015|75821469|FG001|STARTED|Overall Study||284||
59702241|NCT01289015|75821468|FG000|COMPLETED|Overall Study||472||
59702242|NCT01289015|75821469|FG001|COMPLETED|Overall Study||230||
59702243|NCT01289015|75821468|FG000|NOT COMPLETED|Overall Study||99||
59702244|NCT01289015|75821469|FG001|NOT COMPLETED|Overall Study||54||
59702245|NCT01288937|75821477|FG000|STARTED|Overall Study||4||
59702246|NCT01288937|75821478|FG001|STARTED|Overall Study||2||
59702247|NCT01288937|75821477|FG000|COMPLETED|Overall Study||3||
59702248|NCT01288937|75821478|FG001|COMPLETED|Overall Study||2||
59702249|NCT01288937|75821477|FG000|NOT COMPLETED|Overall Study||1||
59702250|NCT01288937|75821478|FG001|NOT COMPLETED|Overall Study||0||
59702251|NCT01288469|75821487|FG000|STARTED|Overall Study|Randomized|31||
59702252|NCT01288469|75821488|FG001|STARTED|Overall Study|Randomized|31||
59702253|NCT01288469|75821489|FG002|STARTED|Overall Study|Randomized|30||
59702254|NCT01288469|75821487|FG000|Treated|Overall Study||31||
59702255|NCT01288469|75821488|FG001|Treated|Overall Study||31||
59702256|NCT01288469|75821489|FG002|Treated|Overall Study||30||
59702257|NCT01288469|75821487|FG000|COMPLETED|Overall Study||24||
59702258|NCT01288469|75821488|FG001|COMPLETED|Overall Study||28||
59702259|NCT01288469|75821489|FG002|COMPLETED|Overall Study||28||
59702260|NCT01288469|75821487|FG000|NOT COMPLETED|Overall Study||7||
59702261|NCT01288469|75821488|FG001|NOT COMPLETED|Overall Study||3||
59702262|NCT01288469|75821489|FG002|NOT COMPLETED|Overall Study||2||
59702263|NCT01288079|75821501|FG000|STARTED|Overall Study||37||
59702264|NCT01288079|75821502|FG001|STARTED|Overall Study||36||
59702265|NCT01288079|75821503|FG002|STARTED|Overall Study||37||
59702266|NCT01288079|75821504|FG003|STARTED|Overall Study||35||
59702267|NCT01288079|75821501|FG000|COMPLETED|Overall Study||17||
59702268|NCT01288079|75821502|FG001|COMPLETED|Overall Study||9||
59702269|NCT01288079|75821503|FG002|COMPLETED|Overall Study||18||
59702270|NCT01288079|75821504|FG003|COMPLETED|Overall Study||18||
59702271|NCT01288079|75821501|FG000|NOT COMPLETED|Overall Study||20||
59702272|NCT01288079|75821502|FG001|NOT COMPLETED|Overall Study||27||
59702273|NCT01288079|75821503|FG002|NOT COMPLETED|Overall Study||19||
59702274|NCT01288079|75821504|FG003|NOT COMPLETED|Overall Study||17||
59702275|NCT01287221|75821516|FG000|STARTED|Overall Study||50||
59702276|NCT01287221|75821517|FG001|STARTED|Overall Study||50||
59702277|NCT01287221|75821516|FG000|Completed 3 Months Follow-up|Overall Study||49||
59702278|NCT01287221|75821517|FG001|Completed 3 Months Follow-up|Overall Study||50||
59702279|NCT01287221|75821516|FG000|Completed 6 Months Follow-up|Overall Study||47||
59702280|NCT01287221|75821517|FG001|Completed 6 Months Follow-up|Overall Study||43||
59702281|NCT01287221|75821516|FG000|Completed 9 Months Follow-up|Overall Study||42||
59702282|NCT01287221|75821517|FG001|Completed 9 Months Follow-up|Overall Study||40||
59702283|NCT01287221|75821516|FG000|Completed 12 Months Follow-up|Overall Study||40||
59702284|NCT01287221|75821517|FG001|Completed 12 Months Follow-up|Overall Study||39||
59702285|NCT01287221|75821516|FG000|COMPLETED|Overall Study||46||
59702286|NCT01287221|75821517|FG001|COMPLETED|Overall Study||45||
59702287|NCT01287221|75821516|FG000|NOT COMPLETED|Overall Study||4||
59702288|NCT01287221|75821517|FG001|NOT COMPLETED|Overall Study||5||
59702289|NCT01168401|75821534|FG000|STARTED|Overall Study||10||
59702290|NCT01168401|75821535|FG001|STARTED|Overall Study||10||
59702291|NCT01168401|75821536|FG002|STARTED|Overall Study||10||
59702292|NCT01168401|75821537|FG003|STARTED|Overall Study||9||
59702293|NCT01168401|75821538|FG004|STARTED|Overall Study||9||
59702294|NCT01168401|75821539|FG005|STARTED|Overall Study||9||
59702295|NCT01168401|75821540|FG006|STARTED|Overall Study||10||
59702296|NCT01168401|75821541|FG007|STARTED|Overall Study||10||
59702297|NCT01168401|75821542|FG008|STARTED|Overall Study||9||
59702298|NCT01168401|75821543|FG009|STARTED|Overall Study||8||
59702299|NCT01168401|75821544|FG010|STARTED|Overall Study||8||
59702300|NCT01168401|75821534|FG000|COMPLETED|Overall Study||9||
60079714|NCT03444870|76194898|FG000|Intent-to-treat (ITT) Analysis Set|Double-Blind Treatment (DBT) Period||485|ITT analysis set included all participants randomized during the global phase, who received at least one dose of study drug.|
59702301|NCT01168401|75821535|FG001|COMPLETED|Overall Study||9||
59702302|NCT01168401|75821536|FG002|COMPLETED|Overall Study||8||
59702303|NCT01168401|75821537|FG003|COMPLETED|Overall Study||7||
59702304|NCT01168401|75821538|FG004|COMPLETED|Overall Study||9||
59702305|NCT01168401|75821539|FG005|COMPLETED|Overall Study||9||
59702306|NCT01168401|75821540|FG006|COMPLETED|Overall Study||10||
59702307|NCT01168401|75821541|FG007|COMPLETED|Overall Study||10||
59702308|NCT01168401|75821542|FG008|COMPLETED|Overall Study||9||
59702309|NCT01168401|75821543|FG009|COMPLETED|Overall Study||8||
59702310|NCT01168401|75821544|FG010|COMPLETED|Overall Study||8||
59702311|NCT01168401|75821534|FG000|NOT COMPLETED|Overall Study||1||
59702312|NCT01168401|75821535|FG001|NOT COMPLETED|Overall Study||1||
59702313|NCT01168401|75821536|FG002|NOT COMPLETED|Overall Study||2||
59702314|NCT01168401|75821537|FG003|NOT COMPLETED|Overall Study||2||
59702315|NCT01168401|75821538|FG004|NOT COMPLETED|Overall Study||0||
59702316|NCT01168401|75821539|FG005|NOT COMPLETED|Overall Study||0||
59702317|NCT01168401|75821540|FG006|NOT COMPLETED|Overall Study||0||
59702318|NCT01168401|75821541|FG007|NOT COMPLETED|Overall Study||0||
59702319|NCT01168401|75821542|FG008|NOT COMPLETED|Overall Study||0||
59702320|NCT01168401|75821543|FG009|NOT COMPLETED|Overall Study||0||
59702321|NCT01168401|75821544|FG010|NOT COMPLETED|Overall Study||0||
59702322|NCT01287065|75821568|FG000|STARTED|Treatment Period 1||4||
59702323|NCT01287065|75821569|FG001|STARTED|Treatment Period 1||4||
59702324|NCT01287065|75821570|FG002|STARTED|Treatment Period 1||4||
59702325|NCT01287065|75821571|FG003|STARTED|Treatment Period 1||4||
59702326|NCT01287065|75821572|FG004|STARTED|Treatment Period 1||5||
59702327|NCT01287065|75821573|FG005|STARTED|Treatment Period 1||5||
59702328|NCT01287065|75821568|FG000|COMPLETED|Treatment Period 1||4||
59702329|NCT01287065|75821569|FG001|COMPLETED|Treatment Period 1||4||
59702330|NCT01287065|75821570|FG002|COMPLETED|Treatment Period 1||4||
59702331|NCT01287065|75821571|FG003|COMPLETED|Treatment Period 1||4||
59702332|NCT01287065|75821572|FG004|COMPLETED|Treatment Period 1||4||
59702333|NCT01287065|75821573|FG005|COMPLETED|Treatment Period 1||4||
59702334|NCT01287065|75821568|FG000|NOT COMPLETED|Treatment Period 1||0||
59702335|NCT01287065|75821569|FG001|NOT COMPLETED|Treatment Period 1||0||
59702336|NCT01287065|75821570|FG002|NOT COMPLETED|Treatment Period 1||0||
59702337|NCT01287065|75821571|FG003|NOT COMPLETED|Treatment Period 1||0||
59702338|NCT01287065|75821572|FG004|NOT COMPLETED|Treatment Period 1||1||
59702339|NCT01287065|75821573|FG005|NOT COMPLETED|Treatment Period 1||1||
59702340|NCT01287065|75821568|FG000|STARTED|Washout Period 1||4||
59702341|NCT01287065|75821569|FG001|STARTED|Washout Period 1||4||
59702342|NCT01287065|75821570|FG002|STARTED|Washout Period 1||4||
59702343|NCT01287065|75821571|FG003|STARTED|Washout Period 1||4||
59702344|NCT01287065|75821572|FG004|STARTED|Washout Period 1||4||
59702345|NCT01287065|75821573|FG005|STARTED|Washout Period 1||4||
59702346|NCT01287065|75821568|FG000|COMPLETED|Washout Period 1||4||
59702347|NCT01287065|75821569|FG001|COMPLETED|Washout Period 1||4||
59702348|NCT01287065|75821570|FG002|COMPLETED|Washout Period 1||4||
59702349|NCT01287065|75821571|FG003|COMPLETED|Washout Period 1||4||
59702350|NCT01287065|75821572|FG004|COMPLETED|Washout Period 1||4||
60079715|NCT03444870|76194899|FG001|Intent-to-treat (ITT) Analysis Set|Double-Blind Treatment (DBT) Period||499|ITT analysis set included all participants randomized during the global phase, who received at least one dose of study drug.|
60103832|NCT03746522|76222152|FG000|STARTED|Period 2: Open-Label (38 Weeks)||0||
59702351|NCT01287065|75821573|FG005|COMPLETED|Washout Period 1||4||
59702352|NCT01287065|75821568|FG000|NOT COMPLETED|Washout Period 1||0||
59702353|NCT01287065|75821569|FG001|NOT COMPLETED|Washout Period 1||0||
59702354|NCT01287065|75821570|FG002|NOT COMPLETED|Washout Period 1||0||
59702355|NCT01287065|75821571|FG003|NOT COMPLETED|Washout Period 1||0||
59702356|NCT01287065|75821572|FG004|NOT COMPLETED|Washout Period 1||0||
59702357|NCT01287065|75821573|FG005|NOT COMPLETED|Washout Period 1||0||
59702358|NCT01287065|75821568|FG000|STARTED|Treatment Period 2||4||
59702359|NCT01287065|75821569|FG001|STARTED|Treatment Period 2||4||
59702360|NCT01287065|75821570|FG002|STARTED|Treatment Period 2||4||
59702361|NCT01287065|75821571|FG003|STARTED|Treatment Period 2||4||
59702362|NCT01287065|75821572|FG004|STARTED|Treatment Period 2||4||
59702363|NCT01287065|75821573|FG005|STARTED|Treatment Period 2||4||
59702364|NCT01287065|75821568|FG000|COMPLETED|Treatment Period 2||4||
59702365|NCT01287065|75821569|FG001|COMPLETED|Treatment Period 2||4||
59702366|NCT01287065|75821570|FG002|COMPLETED|Treatment Period 2||4||
59702367|NCT01287065|75821571|FG003|COMPLETED|Treatment Period 2||4||
59702368|NCT01287065|75821572|FG004|COMPLETED|Treatment Period 2||4||
59702369|NCT01287065|75821573|FG005|COMPLETED|Treatment Period 2||4||
59702370|NCT01287065|75821568|FG000|NOT COMPLETED|Treatment Period 2||0||
59702371|NCT01287065|75821569|FG001|NOT COMPLETED|Treatment Period 2||0||
59702372|NCT01287065|75821570|FG002|NOT COMPLETED|Treatment Period 2||0||
59702373|NCT01287065|75821571|FG003|NOT COMPLETED|Treatment Period 2||0||
59702374|NCT01287065|75821572|FG004|NOT COMPLETED|Treatment Period 2||0||
59702375|NCT01287065|75821573|FG005|NOT COMPLETED|Treatment Period 2||0||
59702376|NCT01287065|75821568|FG000|STARTED|Washout Period 2||4||
59702377|NCT01287065|75821569|FG001|STARTED|Washout Period 2||4||
59702378|NCT01287065|75821570|FG002|STARTED|Washout Period 2||4||
59702379|NCT01287065|75821571|FG003|STARTED|Washout Period 2||4||
59702380|NCT01287065|75821572|FG004|STARTED|Washout Period 2||4||
59702381|NCT01287065|75821573|FG005|STARTED|Washout Period 2||4||
59702382|NCT01287065|75821568|FG000|COMPLETED|Washout Period 2||4||
59702383|NCT01287065|75821569|FG001|COMPLETED|Washout Period 2||4||
59702384|NCT01287065|75821570|FG002|COMPLETED|Washout Period 2||4||
59702385|NCT01287065|75821571|FG003|COMPLETED|Washout Period 2||4||
59702386|NCT01287065|75821572|FG004|COMPLETED|Washout Period 2||4||
59702387|NCT01287065|75821573|FG005|COMPLETED|Washout Period 2||4||
59702388|NCT01287065|75821568|FG000|NOT COMPLETED|Washout Period 2||0||
59702389|NCT01287065|75821569|FG001|NOT COMPLETED|Washout Period 2||0||
59702390|NCT01287065|75821570|FG002|NOT COMPLETED|Washout Period 2||0||
59702391|NCT01287065|75821571|FG003|NOT COMPLETED|Washout Period 2||0||
59702392|NCT01287065|75821572|FG004|NOT COMPLETED|Washout Period 2||0||
59702393|NCT01287065|75821573|FG005|NOT COMPLETED|Washout Period 2||0||
59702394|NCT01287065|75821568|FG000|STARTED|Treatment Period 3||4||
59702395|NCT01287065|75821569|FG001|STARTED|Treatment Period 3||4||
59702396|NCT01287065|75821570|FG002|STARTED|Treatment Period 3||4||
59702397|NCT01287065|75821571|FG003|STARTED|Treatment Period 3||4||
59702398|NCT01287065|75821572|FG004|STARTED|Treatment Period 3||4||
59702399|NCT01287065|75821573|FG005|STARTED|Treatment Period 3||4||
59702400|NCT01287065|75821568|FG000|COMPLETED|Treatment Period 3||4||
59702401|NCT01287065|75821569|FG001|COMPLETED|Treatment Period 3||4||
59702402|NCT01287065|75821570|FG002|COMPLETED|Treatment Period 3||4||
59702403|NCT01287065|75821571|FG003|COMPLETED|Treatment Period 3||4||
59702404|NCT01287065|75821572|FG004|COMPLETED|Treatment Period 3||4||
59702405|NCT01287065|75821573|FG005|COMPLETED|Treatment Period 3||4||
59702406|NCT01287065|75821568|FG000|NOT COMPLETED|Treatment Period 3||0||
59702407|NCT01287065|75821569|FG001|NOT COMPLETED|Treatment Period 3||0||
59702408|NCT01287065|75821570|FG002|NOT COMPLETED|Treatment Period 3||0||
59702409|NCT01287065|75821571|FG003|NOT COMPLETED|Treatment Period 3||0||
59702410|NCT01287065|75821572|FG004|NOT COMPLETED|Treatment Period 3||0||
59702411|NCT01287065|75821573|FG005|NOT COMPLETED|Treatment Period 3||0||
59702412|NCT01167153|75821583|FG000|STARTED|Overall Study||282||
59702413|NCT01167153|75821584|FG001|STARTED|Overall Study||282||
59702414|NCT01167153|75821583|FG000|Intention to Treat (ITT)|Overall Study||272||
59702415|NCT01167153|75821584|FG001|Intention to Treat (ITT)|Overall Study||268||
59702416|NCT01167153|75821583|FG000|COMPLETED|Overall Study||264||
59702417|NCT01167153|75821584|FG001|COMPLETED|Overall Study||249||
59702418|NCT01167153|75821583|FG000|NOT COMPLETED|Overall Study||18||
59702419|NCT01167153|75821584|FG001|NOT COMPLETED|Overall Study||33||
59702420|NCT01166763|75821590|FG000|STARTED|Overall Study||30||
59702421|NCT01166763|75821590|FG000|COMPLETED|Overall Study||27||
59702422|NCT01166763|75821590|FG000|NOT COMPLETED|Overall Study||3||
59702423|NCT01166373|75821598|FG000|STARTED|Overall Study||95|Randomized in Primary OPTIMAL Trial|
59702424|NCT01166373|75821599|FG001|STARTED|Overall Study||91|Randomized in Primary OPTIMAL Trial|
59702425|NCT01166373|75821600|FG002|STARTED|Overall Study||91|Randomized in Primary OPTIMAL Trial|
59702426|NCT01166373|75821601|FG003|STARTED|Overall Study||97|Randomized in Primary OPTIMAL Trial|
59702427|NCT01166373|75821598|FG000|Completed OPTIMAL Year 2 Visit|Overall Study||81||
59702428|NCT01166373|75821599|FG001|Completed OPTIMAL Year 2 Visit|Overall Study||80||
59702429|NCT01166373|75821600|FG002|Completed OPTIMAL Year 2 Visit|Overall Study||79||
59702430|NCT01166373|75821601|FG003|Completed OPTIMAL Year 2 Visit|Overall Study||87||
59702431|NCT01166373|75821598|FG000|Randomized to Video|Overall Study||32|Prior to E-OPTIMAL consent. Used only to assess recruitment and retention regardless of treatment|
59702432|NCT01166373|75821599|FG001|Randomized to Video|Overall Study||43|Prior to E-OPTIMAL consent. Used only to assess recruitment and retention regardless of treatment|
59702433|NCT01166373|75821600|FG002|Randomized to Video|Overall Study||38|Prior to E-OPTIMAL consent. Used only to assess recruitment and retention regardless of treatment|
59702434|NCT01166373|75821601|FG003|Randomized to Video|Overall Study||40|Prior to E-OPTIMAL consent. Used only to assess recruitment and retention regardless of treatment|
59702435|NCT01166373|75821598|FG000|Randomized to No Video|Overall Study||45|Prior to E-OPTIMAL consent. Used only to assess recruitment and retention regardless of treatment|
59702436|NCT01166373|75821599|FG001|Randomized to No Video|Overall Study||30|Prior to E-OPTIMAL consent. Used only to assess recruitment and retention regardless of treatment|
59702437|NCT01166373|75821600|FG002|Randomized to No Video|Overall Study||34|Prior to E-OPTIMAL consent. Used only to assess recruitment and retention regardless of treatment|
59702438|NCT01166373|75821601|FG003|Randomized to No Video|Overall Study||42|Prior to E-OPTIMAL consent. Used only to assess recruitment and retention regardless of treatment|
59702439|NCT01166373|75821598|FG000|Consented to Participate E-OPTIMAL|Overall Study||72||
59702440|NCT01166373|75821599|FG001|Consented to Participate E-OPTIMAL|Overall Study||66||
59702441|NCT01166373|75821600|FG002|Consented to Participate E-OPTIMAL|Overall Study||69||
59702442|NCT01166373|75821601|FG003|Consented to Participate E-OPTIMAL|Overall Study||78||
59702443|NCT01166373|75821598|FG000|Completed E-OPTIMAL Year 3 Visit|Overall Study||70||
59702444|NCT01166373|75821599|FG001|Completed E-OPTIMAL Year 3 Visit|Overall Study||66||
59702445|NCT01166373|75821600|FG002|Completed E-OPTIMAL Year 3 Visit|Overall Study||66||
59702446|NCT01166373|75821601|FG003|Completed E-OPTIMAL Year 3 Visit|Overall Study||77||
59702447|NCT01166373|75821598|FG000|Completed E-OPTIMAL Year 4 Visit|Overall Study||67||
59702448|NCT01166373|75821599|FG001|Completed E-OPTIMAL Year 4 Visit|Overall Study||61||
59702449|NCT01166373|75821600|FG002|Completed E-OPTIMAL Year 4 Visit|Overall Study||63||
59702450|NCT01166373|75821601|FG003|Completed E-OPTIMAL Year 4 Visit|Overall Study||68||
59702451|NCT01166373|75821598|FG000|Completed E-OPTIMAL Year 5 Visit|Overall Study||62||
59702452|NCT01166373|75821599|FG001|Completed E-OPTIMAL Year 5 Visit|Overall Study||56||
59702453|NCT01166373|75821600|FG002|Completed E-OPTIMAL Year 5 Visit|Overall Study||62||
59702454|NCT01166373|75821601|FG003|Completed E-OPTIMAL Year 5 Visit|Overall Study||64||
59702455|NCT01166373|75821598|FG000|COMPLETED|Overall Study||90|Included in Primary Analysis|
59702456|NCT01166373|75821599|FG001|COMPLETED|Overall Study||87|Included in Primary Analysis|
59702457|NCT01166373|75821600|FG002|COMPLETED|Overall Study||87|Included in Primary Analysis|
59702458|NCT01166373|75821601|FG003|COMPLETED|Overall Study||92|Included in Primary Analysis|
59702459|NCT01166373|75821598|FG000|NOT COMPLETED|Overall Study||5||
59702460|NCT01166373|75821599|FG001|NOT COMPLETED|Overall Study||4||
59702461|NCT01166373|75821600|FG002|NOT COMPLETED|Overall Study||4||
59702462|NCT01166373|75821601|FG003|NOT COMPLETED|Overall Study||5||
59702463|NCT00963235|75821613|FG000|STARTED|Overall Study||331||
59702464|NCT00963235|75821613|FG000|Vaccinated Dose 1|Overall Study||329||
59702465|NCT00963235|75821613|FG000|Vaccinated Dose 2|Overall Study||300||
59702466|NCT00963235|75821613|FG000|Vaccinated Dose 3|Overall Study||279||
59702467|NCT00963235|75821613|FG000|Completed Dose 3 1-month Blood Draw|Overall Study||277||
59702468|NCT00963235|75821613|FG000|COMPLETED|Overall Study||271||
59702469|NCT00963235|75821613|FG000|NOT COMPLETED|Overall Study||60||
59702470|NCT01165281|75821622|FG000|STARTED|Overall Study||168||
59702471|NCT01165281|75821623|FG001|STARTED|Overall Study||172||
59702472|NCT01165281|75821622|FG000|COMPLETED|Overall Study||110||
59702473|NCT01165281|75821623|FG001|COMPLETED|Overall Study||121||
59702474|NCT01165281|75821622|FG000|NOT COMPLETED|Overall Study||58||
59702475|NCT01165281|75821623|FG001|NOT COMPLETED|Overall Study||51||
59702476|NCT01165203|75821631|FG000|STARTED|Active Phase||74||
59702477|NCT01165203|75821632|FG001|STARTED|Active Phase||49||
59702478|NCT01165203|75821631|FG000|COMPLETED|Active Phase||69||
59702479|NCT01165203|75821632|FG001|COMPLETED|Active Phase||47||
59702480|NCT01165203|75821631|FG000|NOT COMPLETED|Active Phase||5||
59702481|NCT01165203|75821632|FG001|NOT COMPLETED|Active Phase||2||
59702482|NCT01165203|75821631|FG000|STARTED|Extended Safety Follow-up Phase||74||
59702483|NCT01165203|75821632|FG001|STARTED|Extended Safety Follow-up Phase||49||
59702484|NCT01165203|75821631|FG000|COMPLETED|Extended Safety Follow-up Phase||67||
59702485|NCT01165203|75821632|FG001|COMPLETED|Extended Safety Follow-up Phase||45||
59702486|NCT01165203|75821631|FG000|NOT COMPLETED|Extended Safety Follow-up Phase||7||
59702487|NCT01165203|75821632|FG001|NOT COMPLETED|Extended Safety Follow-up Phase||4||
59702488|NCT00960661|75821647|FG000|STARTED|Basal Insulin Optimization Phase (BIO)||1036||
59702489|NCT00960661|75821648|FG001|STARTED|Basal Insulin Optimization Phase (BIO)||0||
59702490|NCT00960661|75821649|FG002|STARTED|Basal Insulin Optimization Phase (BIO)||0||
59702491|NCT00960661|75821647|FG000|COMPLETED|Basal Insulin Optimization Phase (BIO)||637||
59702492|NCT00960661|75821648|FG001|COMPLETED|Basal Insulin Optimization Phase (BIO)||0||
59702493|NCT00960661|75821649|FG002|COMPLETED|Basal Insulin Optimization Phase (BIO)||0||
59702494|NCT00960661|75821647|FG000|NOT COMPLETED|Basal Insulin Optimization Phase (BIO)||399||
59702495|NCT00960661|75821648|FG001|NOT COMPLETED|Basal Insulin Optimization Phase (BIO)||0||
59702496|NCT00960661|75821649|FG002|NOT COMPLETED|Basal Insulin Optimization Phase (BIO)||0||
59702497|NCT00960661|75821647|FG000|STARTED|Interventional Phase||0||
59990808|NCT02495168|76106343|FG001|Modified Intent-to-Treat Population|Overall Study||478|Participants in Safety Population with no major inclusion/exclusion deviations, enrolled only once|
59995083|NCT02550093|76110918|FG001|NOT COMPLETED|Intervention 1||0||
59702498|NCT00960661|75821648|FG001|STARTED|Interventional Phase||316||
59702499|NCT00960661|75821649|FG002|STARTED|Interventional Phase||321||
59702500|NCT00960661|75821647|FG000|Intent to Treat Population|Interventional Phase||0||
59702501|NCT00960661|75821648|FG001|Intent to Treat Population|Interventional Phase|all randomized participants who took at least one dose of study drug|315||
59702502|NCT00960661|75821649|FG002|Intent to Treat Population|Interventional Phase|all randomized participants who took at least one dose of study drug|312||
59702503|NCT00960661|75821647|FG000|Per Protocol Population|Interventional Phase||0||
59702504|NCT00960661|75821648|FG001|Per Protocol Population|Interventional Phase|all randomized participants who completed study and had no violations|247||
59702505|NCT00960661|75821649|FG002|Per Protocol Population|Interventional Phase|all randomized participants who completed study and had no violations|263||
59702506|NCT00960661|75821647|FG000|COMPLETED|Interventional Phase||0||
59702507|NCT00960661|75821648|FG001|COMPLETED|Interventional Phase||264||
59702508|NCT00960661|75821649|FG002|COMPLETED|Interventional Phase||275||
59702509|NCT00960661|75821647|FG000|NOT COMPLETED|Interventional Phase||0||
59702510|NCT00960661|75821648|FG001|NOT COMPLETED|Interventional Phase||52||
59702511|NCT00960661|75821649|FG002|NOT COMPLETED|Interventional Phase||46||
59702512|NCT00960193|75821655|FG000|STARTED|Colchicine Alone||24||
59702513|NCT00960193|75821655|FG000|COMPLETED|Colchicine Alone||24||
59702514|NCT00960193|75821655|FG000|NOT COMPLETED|Colchicine Alone||0||
59702515|NCT00960193|75821655|FG000|STARTED|14 Day Washout Period||24||
59702516|NCT00960193|75821655|FG000|COMPLETED|14 Day Washout Period||23||
59702517|NCT00960193|75821655|FG000|NOT COMPLETED|14 Day Washout Period||1||
59702518|NCT00960193|75821655|FG000|STARTED|Seville Orange Juice Alone||23||
59702519|NCT00960193|75821655|FG000|COMPLETED|Seville Orange Juice Alone||23||
59702520|NCT00960193|75821655|FG000|NOT COMPLETED|Seville Orange Juice Alone||0||
59702521|NCT00960193|75821655|FG000|STARTED|Colchicine With Seville Orange Juice||23||
59702522|NCT00960193|75821655|FG000|COMPLETED|Colchicine With Seville Orange Juice||23||
59702523|NCT00960193|75821655|FG000|NOT COMPLETED|Colchicine With Seville Orange Juice||0||
59702524|NCT00960115|75821664|FG000|STARTED|Overall Study||114||
59702525|NCT00960115|75821665|FG001|STARTED|Overall Study||58||
59702526|NCT00960115|75821664|FG000|COMPLETED|Overall Study||95||
59702527|NCT00960115|75821665|FG001|COMPLETED|Overall Study||43||
59702528|NCT00960115|75821664|FG000|NOT COMPLETED|Overall Study||19||
59702529|NCT00960115|75821665|FG001|NOT COMPLETED|Overall Study||15||
59702530|NCT00959647|75821671|FG000|STARTED|Overall Study||19||
59702531|NCT00959647|75821671|FG000|COMPLETED|Overall Study||0||
59702532|NCT00959647|75821671|FG000|NOT COMPLETED|Overall Study||19||
59702533|NCT00957931|75821675|FG000|STARTED|Overall Study||6||
59702534|NCT00957931|75821675|FG000|COMPLETED|Overall Study||2||
59702535|NCT00957931|75821675|FG000|NOT COMPLETED|Overall Study||4||
59702536|NCT00957853|75821682|FG000|STARTED|Overall Study||4||
59702537|NCT00957853|75821683|FG001|STARTED|Overall Study||6||
59702538|NCT00957853|75821684|FG002|STARTED|Overall Study||5||
59702539|NCT00957853|75821682|FG000|Randomization|Overall Study||4||
59702540|NCT00957853|75821683|FG001|Randomization|Overall Study||6||
59702541|NCT00957853|75821684|FG002|Randomization|Overall Study||5||
59702542|NCT00957853|75821682|FG000|Neoadjuvant Tx Completion|Overall Study||3||
59702543|NCT00957853|75821683|FG001|Neoadjuvant Tx Completion|Overall Study||6||
59702544|NCT00957853|75821684|FG002|Neoadjuvant Tx Completion|Overall Study||5||
59702545|NCT00957853|75821682|FG000|COMPLETED|Overall Study||3||
59702546|NCT00957853|75821683|FG001|COMPLETED|Overall Study||6||
59702547|NCT00957853|75821684|FG002|COMPLETED|Overall Study||5||
59702548|NCT00957853|75821682|FG000|NOT COMPLETED|Overall Study||1||
59702549|NCT00957853|75821683|FG001|NOT COMPLETED|Overall Study||0||
59702550|NCT00957853|75821684|FG002|NOT COMPLETED|Overall Study||0||
59702551|NCT00957229|75821694|FG000|STARTED|Study Start||15||
59702552|NCT00957229|75821695|FG001|STARTED|Study Start||26||
59702553|NCT00957229|75821694|FG000|COMPLETED|Study Start||14||
59702554|NCT00957229|75821695|FG001|COMPLETED|Study Start||23||
59702555|NCT00957229|75821694|FG000|NOT COMPLETED|Study Start||1||
59702556|NCT00957229|75821695|FG001|NOT COMPLETED|Study Start||3||
59702557|NCT00957229|75821694|FG000|STARTED|Reallocated to or Continued Vismodegib||14||
60079716|NCT03444870|76194900|FG002|Intent-to-treat (ITT) Analysis Set|Double-Blind Treatment (DBT) Period||0|ITT analysis set included all participants randomized during the global phase, who received at least one dose of study drug.|
59702558|NCT00957229|75821695|FG001|STARTED|Reallocated to or Continued Vismodegib||23||
59702559|NCT00957229|75821694|FG000|COMPLETED|Reallocated to or Continued Vismodegib||11||
59702560|NCT00957229|75821695|FG001|COMPLETED|Reallocated to or Continued Vismodegib||21||
59702561|NCT00957229|75821694|FG000|NOT COMPLETED|Reallocated to or Continued Vismodegib||3||
60079717|NCT03444870|76194901|FG003|Intent-to-treat (ITT) Analysis Set|Double-Blind Treatment (DBT) Period||0|ITT analysis set included all participants randomized during the global phase, who received at least one dose of study drug.|
59702562|NCT00957229|75821695|FG001|NOT COMPLETED|Reallocated to or Continued Vismodegib||2||
59702563|NCT02604511|75821701|FG000|STARTED|Overall Study||31||
59702564|NCT02604511|75821701|FG000|COMPLETED|Overall Study||19||
59702565|NCT02604511|75821701|FG000|NOT COMPLETED|Overall Study||12||
59702566|NCT00956839|75821709|FG000|STARTED|Overall Study||14||
60103784|NCT03915574|76222056|FG001|COMPLETED|Overall Study|66 mother-infant dyads completed the study (participants = 132)|66||
59702567|NCT00956839|75821710|FG001|STARTED|Overall Study||13||
59702568|NCT00956839|75821711|FG002|STARTED|Overall Study||13||
59702569|NCT00956839|75821709|FG000|COMPLETED|Overall Study||11||
59702570|NCT00956839|75821710|FG001|COMPLETED|Overall Study||13||
59702571|NCT00956839|75821711|FG002|COMPLETED|Overall Study||10||
59702572|NCT00956839|75821709|FG000|NOT COMPLETED|Overall Study||3||
59702573|NCT00956839|75821710|FG001|NOT COMPLETED|Overall Study||0||
59702574|NCT00956839|75821711|FG002|NOT COMPLETED|Overall Study||3||
59702575|NCT00956293|75821721|FG000|STARTED|Main Period (Pre-randomization)||0||
59702576|NCT00956293|75821722|FG001|STARTED|Main Period (Pre-randomization)||0||
59702577|NCT00956293|75821723|FG002|STARTED|Main Period (Pre-randomization)||207||
59702578|NCT00956293|75821721|FG000|Enrolled Safety Set|Main Period (Pre-randomization)||0||
59702579|NCT00956293|75821722|FG001|Enrolled Safety Set|Main Period (Pre-randomization)||0||
59702580|NCT00956293|75821723|FG002|Enrolled Safety Set|Main Period (Pre-randomization)||203||
59702581|NCT00956293|75821721|FG000|COMPLETED|Main Period (Pre-randomization)||0||
59702582|NCT00956293|75821722|FG001|COMPLETED|Main Period (Pre-randomization)||0||
59702583|NCT00956293|75821723|FG002|COMPLETED|Main Period (Pre-randomization)||77||
59702584|NCT00956293|75821721|FG000|NOT COMPLETED|Main Period (Pre-randomization)||0||
59702585|NCT00956293|75821722|FG001|NOT COMPLETED|Main Period (Pre-randomization)||0||
59702586|NCT00956293|75821723|FG002|NOT COMPLETED|Main Period (Pre-randomization)||130||
59702587|NCT00956293|75821721|FG000|STARTED|Main Period (Randomization)||24||
59702588|NCT00956293|75821722|FG001|STARTED|Main Period (Randomization)||53||
59702589|NCT00956293|75821723|FG002|STARTED|Main Period (Randomization)||0||
59548176|NCT02560701|75647103|FG001|Bipolar Diagnosis Time Constraints|Overall Study||39427|Require most recent bipolar diagnosis to be between 5 years and 4 months prior to intervention date|
59548177|NCT02560701|75647102|FG000|Matched Cohort|Overall Study||3517||
59548178|NCT02560701|75647103|FG001|Matched Cohort|Overall Study||37776||
59548179|NCT02560701|75647102|FG000|COMPLETED|Overall Study||3517||
59548180|NCT02560701|75647103|FG001|COMPLETED|Overall Study||37776||
59548181|NCT02560701|75647102|FG000|NOT COMPLETED|Overall Study||4543||
59702590|NCT00956293|75821721|FG000|Full Analysis Set|Main Period (Randomization)||24||
59702591|NCT00956293|75821722|FG001|Full Analysis Set|Main Period (Randomization)|Two participants, randomized to this arm, did not receive everolimus.|51||
59702592|NCT00956293|75821723|FG002|Full Analysis Set|Main Period (Randomization)||0||
59702593|NCT00956293|75821721|FG000|Randomized Safety Set|Main Period (Randomization)||24||
59702594|NCT00956293|75821722|FG001|Randomized Safety Set|Main Period (Randomization)||51||
59702595|NCT00956293|75821723|FG002|Randomized Safety Set|Main Period (Randomization)||0||
59702596|NCT00956293|75821721|FG000|COMPLETED|Main Period (Randomization)||23||
59702597|NCT00956293|75821722|FG001|COMPLETED|Main Period (Randomization)||26||
59702598|NCT00956293|75821723|FG002|COMPLETED|Main Period (Randomization)||0||
59702599|NCT00956293|75821721|FG000|NOT COMPLETED|Main Period (Randomization)||1||
59702600|NCT00956293|75821722|FG001|NOT COMPLETED|Main Period (Randomization)||27||
59702601|NCT00956293|75821723|FG002|NOT COMPLETED|Main Period (Randomization)||0||
59702602|NCT00956293|75821721|FG000|STARTED|Follow-up Period||20||
59702603|NCT00956293|75821722|FG001|STARTED|Follow-up Period||32||
59702604|NCT00956293|75821723|FG002|STARTED|Follow-up Period||0||
59702605|NCT00956293|75821721|FG000|COMPLETED|Follow-up Period||0||
59702606|NCT00956293|75821722|FG001|COMPLETED|Follow-up Period||0||
59702607|NCT00956293|75821723|FG002|COMPLETED|Follow-up Period||0||
59702608|NCT00956293|75821721|FG000|NOT COMPLETED|Follow-up Period||20||
59702609|NCT00956293|75821722|FG001|NOT COMPLETED|Follow-up Period||32||
59702610|NCT00956293|75821723|FG002|NOT COMPLETED|Follow-up Period||0||
59702611|NCT00955825|75821731|FG000|STARTED|Overall Study||233||
59702612|NCT00955825|75821732|FG001|STARTED|Overall Study||240||
59702613|NCT00955825|75821731|FG000|COMPLETED|Overall Study||207||
59990809|NCT02495168|76106344|FG002|Modified Intent-to-Treat Population|Overall Study||111|Participants in Safety Population with no major inclusion/exclusion deviations, enrolled only once|
59702614|NCT00955825|75821732|FG001|COMPLETED|Overall Study||223||
59702615|NCT00955825|75821731|FG000|NOT COMPLETED|Overall Study||26||
59702616|NCT00955825|75821732|FG001|NOT COMPLETED|Overall Study||17||
59702617|NCT01164579|75821741|FG000|STARTED|Overall Study||36||
59702618|NCT01164579|75821742|FG001|STARTED|Overall Study||36||
59702619|NCT01164579|75821743|FG002|STARTED|Overall Study||37||
59702620|NCT01164579|75821741|FG000|COMPLETED|Overall Study||28||
59702621|NCT01164579|75821742|FG001|COMPLETED|Overall Study||27||
59702622|NCT01164579|75821743|FG002|COMPLETED|Overall Study||21||
59990810|NCT02495168|76106342|FG000|Day1 Per-protocol Set (D1PPS) Population|Overall Study||437|mITT Population, no major protocol violations that impacted analysis of the Day 1 primary endpoint|
59990811|NCT02495168|76106343|FG001|Day1 Per-protocol Set (D1PPS) Population|Overall Study||437|mITT Population, no major protocol violations that impacted analysis of the Day 1 primary endpoint|
59990812|NCT02495168|76106344|FG002|Day1 Per-protocol Set (D1PPS) Population|Overall Study||99|mITT Population, no major protocol violations that impacted analysis of the Day 1 primary endpoint|
59990813|NCT02495168|76106342|FG000|Day 42 (D42PPS) Population|Overall Study||382|mITT Population, no major protocol violations that impacted analysis of the Day 42 primary endpoint|
59990814|NCT02495168|76106343|FG001|Day 42 (D42PPS) Population|Overall Study||383|mITT Population, no major protocol violations that impacted analysis of the Day 42 primary endpoint|
59990815|NCT02495168|76106344|FG002|Day 42 (D42PPS) Population|Overall Study||88|mITT Population, no major protocol violations that impacted analysis of the Day 42 primary endpoint|
59990816|NCT02495168|76106342|FG000|COMPLETED|Overall Study||466||
59990817|NCT02495168|76106343|FG001|COMPLETED|Overall Study||462||
59548182|NCT02560701|75647103|FG001|NOT COMPLETED|Overall Study||51466||
59548183|NCT02488317|75647111|FG000|STARTED|Overall Study||117||
59702623|NCT01164579|75821741|FG000|NOT COMPLETED|Overall Study||8||
59702624|NCT01164579|75821742|FG001|NOT COMPLETED|Overall Study||9||
59702625|NCT01164579|75821743|FG002|NOT COMPLETED|Overall Study||16||
59702626|NCT00958789|75821752|FG000|STARTED|Overall Study||180||
59702627|NCT00958789|75821752|FG000|COMPLETED|Overall Study|Participant status at the 2 year primary outcome interval determined Completed/Not Completed counts.|130|1 bilateral participant had a knee complete primary endpoint; other knee was revised|
59702628|NCT00958789|75821752|FG000|NOT COMPLETED|Overall Study||50||
59702629|NCT02445391|75821763|FG000|STARTED|Overall Study|Patients on arm A were under observation, and there was no specified active protocol therapy.|3|All patients who were randomized to one of the three arms in the trial throughout the accrual period between April 2015 and March 2021.|
59702630|NCT02445391|75821764|FG001|STARTED|Overall Study|2 patients were assigned to arm B before 6/22/2106 (activation date of amendment #3), 197 patients were assigned to arm B after 6/22/2016. Arm A was permanently closed to accrual by 6/22/2016 and arm C was open to accrual after 6/22/2016.|199|All patients who were randomized to one of the three arms in the trial throughout the accrual period between April 2015 and March 2021.|
59702631|NCT02445391|75821765|FG002|STARTED|Overall Study||213|All patients who were randomized to one of the three arms in the trial throughout the accrual period between April 2015 and March 2021.|
59702632|NCT02445391|75821763|FG000|Concurrently Randomized to Arms B and C|Overall Study||0||
59702633|NCT02445391|75821764|FG001|Concurrently Randomized to Arms B and C|Overall Study||197||
59702634|NCT02445391|75821765|FG002|Concurrently Randomized to Arms B and C|Overall Study||213||
59702635|NCT02445391|75821763|FG000|Concurrently Randomized to Arms A and B|Overall Study||3||
59702636|NCT02445391|75821764|FG001|Concurrently Randomized to Arms A and B|Overall Study||2||
59702637|NCT02445391|75821765|FG002|Concurrently Randomized to Arms A and B|Overall Study||0||
59702638|NCT02445391|75821763|FG000|Started Protocol Therapy|Overall Study||0||
59702639|NCT02445391|75821764|FG001|Started Protocol Therapy|Overall Study||187||
59702640|NCT02445391|75821765|FG002|Started Protocol Therapy|Overall Study||204||
59702641|NCT02445391|75821763|FG000|Reported Treatment Data|Overall Study||0||
59702642|NCT02445391|75821764|FG001|Reported Treatment Data|Overall Study||185||
59702643|NCT02445391|75821765|FG002|Reported Treatment Data|Overall Study||199||
59702644|NCT02445391|75821763|FG000|Reported Adverse Event Data|Overall Study||0|This is the analysis population for adverse event outcomes|
59702645|NCT02445391|75821764|FG001|Reported Adverse Event Data|Overall Study||186|This is the analysis population for adverse event outcomes|
59702646|NCT02445391|75821765|FG002|Reported Adverse Event Data|Overall Study||201|This is the analysis population for adverse event outcomes|
59702647|NCT02445391|75821763|FG000|Reported Mortality Data|Overall Study||3||
59702648|NCT02445391|75821764|FG001|Reported Mortality Data|Overall Study||199||
59702649|NCT02445391|75821765|FG002|Reported Mortality Data|Overall Study||213||
59702650|NCT02445391|75821763|FG000|Basal-subtype Disease|Overall Study||3||
59702651|NCT02445391|75821764|FG001|Basal-subtype Disease|Overall Study|2 patients with basal-subtype disease were assigned to arm B before 6/22/2016; 148 patients with basal-subtype disease were assigned to arm B after 6/22/2016.|150||
59702652|NCT02445391|75821765|FG002|Basal-subtype Disease|Overall Study||160||
59702653|NCT02445391|75821763|FG000|Basal-subtype Disease Randomized After 6/22/2016|Overall Study||0|This is the primary analysis population for IDFS (primary endpoint) and OS and RFS (secondary endpoints).|
59702654|NCT02445391|75821764|FG001|Basal-subtype Disease Randomized After 6/22/2016|Overall Study||148|This is the primary analysis population for IDFS (primary endpoint) and OS and RFS (secondary endpoints).|
59702655|NCT02445391|75821765|FG002|Basal-subtype Disease Randomized After 6/22/2016|Overall Study||160|This is the primary analysis population for IDFS (primary endpoint) and OS and RFS (secondary endpoints).|
59702656|NCT02445391|75821763|FG000|Non Basal-subtype Disease|Overall Study||0|Intrinsic subtype was added as a stratification factor in amendment #3 (activated on 6/22/2016), all eligible patients regardless of intrinsic subtype were randomized to arms B and C|
59702657|NCT02445391|75821764|FG001|Non Basal-subtype Disease|Overall Study||42|Intrinsic subtype was added as a stratification factor in amendment #3 (activated on 6/22/2016), all eligible patients regardless of intrinsic subtype were randomized to arms B and C|
59702658|NCT02445391|75821765|FG002|Non Basal-subtype Disease|Overall Study||46|Intrinsic subtype was added as a stratification factor in amendment #3 (activated on 6/22/2016), all eligible patients regardless of intrinsic subtype were randomized to arms B and C|
59702659|NCT02445391|75821763|FG000|Intrinsic Subtype Unknown|Overall Study||0|In amendment #7 (activated in Nov 2020), intrinsic subtype was removed as a stratification factor, all patients were randomized to arms B and C as long as they submitted tumor specimen for PAM50 test. Intrinsic subtype was not known at randomization. At the time of the final analysis, intrinsic subtype was still pending for these patients.|
59702660|NCT02445391|75821764|FG001|Intrinsic Subtype Unknown|Overall Study||7|In amendment #7 (activated in Nov 2020), intrinsic subtype was removed as a stratification factor, all patients were randomized to arms B and C as long as they submitted tumor specimen for PAM50 test. Intrinsic subtype was not known at randomization. At the time of the final analysis, intrinsic subtype was still pending for these patients.|
59702661|NCT02445391|75821765|FG002|Intrinsic Subtype Unknown|Overall Study||7|In amendment #7 (activated in Nov 2020), intrinsic subtype was removed as a stratification factor, all patients were randomized to arms B and C as long as they submitted tumor specimen for PAM50 test. Intrinsic subtype was not known at randomization. At the time of the final analysis, intrinsic subtype was still pending for these patients.|
59702662|NCT02445391|75821763|FG000|Reported Health-related Quality of Life Data at 6 Months Assessment|Overall Study||0||
59702663|NCT02445391|75821764|FG001|Reported Health-related Quality of Life Data at 6 Months Assessment|Overall Study||69||
59702664|NCT02445391|75821765|FG002|Reported Health-related Quality of Life Data at 6 Months Assessment|Overall Study||84||
59702665|NCT02445391|75821763|FG000|Reported Health-related Quality of Life Data at 15 Months Assessment|Overall Study||0||
59702666|NCT02445391|75821764|FG001|Reported Health-related Quality of Life Data at 15 Months Assessment|Overall Study||37||
59702667|NCT02445391|75821765|FG002|Reported Health-related Quality of Life Data at 15 Months Assessment|Overall Study||54||
59702668|NCT02445391|75821763|FG000|COMPLETED|Overall Study||0||
59702669|NCT02445391|75821764|FG001|COMPLETED|Overall Study||146||
59702670|NCT02445391|75821765|FG002|COMPLETED|Overall Study||141||
59702671|NCT02445391|75821763|FG000|NOT COMPLETED|Overall Study||3||
59702672|NCT02445391|75821764|FG001|NOT COMPLETED|Overall Study||53||
59702673|NCT02445391|75821765|FG002|NOT COMPLETED|Overall Study||72||
59702674|NCT01246986|75821781|FG000|STARTED|Overall Study||37||
59702675|NCT01246986|75821782|FG001|STARTED|Overall Study||72||
59702676|NCT01246986|75821783|FG002|STARTED|Overall Study||40||
59702677|NCT01246986|75821784|FG003|STARTED|Overall Study||3||
59702678|NCT01246986|75821785|FG004|STARTED|Overall Study||44||
59702679|NCT01246986|75821786|FG005|STARTED|Overall Study||3||
59702680|NCT01246986|75821787|FG006|STARTED|Overall Study||5||
59702681|NCT01246986|75821781|FG000|Received at Least 1 Dose of Study Drug|Overall Study||37||
59702682|NCT01246986|75821782|FG001|Received at Least 1 Dose of Study Drug|Overall Study||72||
59702683|NCT01246986|75821783|FG002|Received at Least 1 Dose of Study Drug|Overall Study||40||
59702684|NCT01246986|75821784|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3||
59702685|NCT01246986|75821785|FG004|Received at Least 1 Dose of Study Drug|Overall Study||44||
59702686|NCT01246986|75821786|FG005|Received at Least 1 Dose of Study Drug|Overall Study||3||
59702687|NCT01246986|75821787|FG006|Received at Least 1 Dose of Study Drug|Overall Study||5||
59702688|NCT01246986|75821781|FG000|COMPLETED|Overall Study||34||
59702689|NCT01246986|75821782|FG001|COMPLETED|Overall Study||67||
59702690|NCT01246986|75821783|FG002|COMPLETED|Overall Study||34||
59702691|NCT01246986|75821784|FG003|COMPLETED|Overall Study||3||
59702692|NCT01246986|75821785|FG004|COMPLETED|Overall Study||40||
59702693|NCT01246986|75821786|FG005|COMPLETED|Overall Study||2||
59702694|NCT01246986|75821787|FG006|COMPLETED|Overall Study||5||
59702695|NCT01246986|75821781|FG000|NOT COMPLETED|Overall Study||3||
59702696|NCT01246986|75821782|FG001|NOT COMPLETED|Overall Study||5||
59702697|NCT01246986|75821783|FG002|NOT COMPLETED|Overall Study||6||
59702698|NCT01246986|75821784|FG003|NOT COMPLETED|Overall Study||0||
59702699|NCT01246986|75821785|FG004|NOT COMPLETED|Overall Study||4||
59702700|NCT01246986|75821786|FG005|NOT COMPLETED|Overall Study||1||
59702701|NCT01246986|75821787|FG006|NOT COMPLETED|Overall Study||0||
59702702|NCT01164501|75821821|FG000|STARTED|Overall Study||321||
59702703|NCT01164501|75821822|FG001|STARTED|Overall Study||98||
59702704|NCT01164501|75821823|FG002|STARTED|Overall Study||322||
59702705|NCT01164501|75821821|FG000|COMPLETED|Overall Study||278||
59702706|NCT01164501|75821822|FG001|COMPLETED|Overall Study||88||
59702707|NCT01164501|75821823|FG002|COMPLETED|Overall Study||280||
59702708|NCT01164501|75821821|FG000|NOT COMPLETED|Overall Study||43||
59702709|NCT01164501|75821822|FG001|NOT COMPLETED|Overall Study||10||
59702710|NCT01164501|75821823|FG002|NOT COMPLETED|Overall Study||42||
59702711|NCT00958711|75821835|FG000|STARTED|Overall Study||42||
59702712|NCT00958711|75821836|FG001|STARTED|Overall Study||48||
59702713|NCT00958711|75821835|FG000|COMPLETED|Overall Study||29||
59702714|NCT00958711|75821836|FG001|COMPLETED|Overall Study||27||
59702715|NCT00958711|75821835|FG000|NOT COMPLETED|Overall Study||13||
59702716|NCT00958711|75821836|FG001|NOT COMPLETED|Overall Study||21||
59702717|NCT01163721|75821844|FG000|STARTED|Overall Study||39||
59702718|NCT01163721|75821845|FG001|STARTED|Overall Study||41||
59702719|NCT01163721|75821844|FG000|COMPLETED|Overall Study||31||
59702720|NCT01163721|75821845|FG001|COMPLETED|Overall Study||29||
59702721|NCT01163721|75821844|FG000|NOT COMPLETED|Overall Study||8||
59702722|NCT01163721|75821845|FG001|NOT COMPLETED|Overall Study||12||
59702723|NCT00958243|75821857|FG000|STARTED|Overall Study||26||
59702724|NCT00958243|75821858|FG001|STARTED|Overall Study||105||
59702725|NCT00958243|75821859|FG002|STARTED|Overall Study||96||
59702726|NCT00958243|75821860|FG003|STARTED|Overall Study||28||
59702727|NCT00958243|75821861|FG004|STARTED|Overall Study||109||
59702728|NCT00958243|75821862|FG005|STARTED|Overall Study||109||
59702729|NCT00958243|75821857|FG000|COMPLETED|Overall Study||24||
59702730|NCT00958243|75821858|FG001|COMPLETED|Overall Study||99||
59702731|NCT00958243|75821859|FG002|COMPLETED|Overall Study||82||
59702732|NCT00958243|75821860|FG003|COMPLETED|Overall Study||25||
59702733|NCT00958243|75821861|FG004|COMPLETED|Overall Study||100||
59702734|NCT00958243|75821862|FG005|COMPLETED|Overall Study||99||
59816235|NCT00610649|75938609|FG000|COMPLETED|Overall Study||3||
59816236|NCT00610649|75938610|FG001|COMPLETED|Overall Study||1||
59816237|NCT00610649|75938611|FG002|COMPLETED|Overall Study||4||
59816238|NCT00610649|75938612|FG003|COMPLETED|Overall Study||2||
59816239|NCT00610649|75938613|FG004|COMPLETED|Overall Study||4||
59816240|NCT00610649|75938614|FG005|COMPLETED|Overall Study||2||
59702735|NCT00958243|75821857|FG000|NOT COMPLETED|Overall Study||2||
59702736|NCT00958243|75821858|FG001|NOT COMPLETED|Overall Study||6||
59702737|NCT00958243|75821859|FG002|NOT COMPLETED|Overall Study||14||
59702738|NCT00958243|75821860|FG003|NOT COMPLETED|Overall Study||3||
59702739|NCT00958243|75821861|FG004|NOT COMPLETED|Overall Study||9||
59702740|NCT00958243|75821862|FG005|NOT COMPLETED|Overall Study||10||
59702741|NCT01241760|75821884|FG000|STARTED|Overall Study||371||
59702742|NCT01241760|75821885|FG001|STARTED|Overall Study||369||
59702743|NCT01241760|75821884|FG000|COMPLETED|Overall Study||337||
59702744|NCT01241760|75821885|FG001|COMPLETED|Overall Study||329||
59702745|NCT01241760|75821884|FG000|NOT COMPLETED|Overall Study||34||
59702746|NCT01241760|75821885|FG001|NOT COMPLETED|Overall Study||40||
59702747|NCT00958165|75821892|FG000|STARTED|Overall Study|81 enrolled participants resulted in 72 eligible participants that were treated.|81||
59816241|NCT00610649|75938615|FG006|COMPLETED|Overall Study||4||
59702748|NCT00958165|75821892|FG000|Treated|Overall Study||72||
59702749|NCT00958165|75821892|FG000|COMPLETED|Overall Study|Of the 72 treated participants, 67 completed follow-up and were evaluable for effectiveness.|67||
59702750|NCT00958165|75821892|FG000|NOT COMPLETED|Overall Study||14||
59702751|NCT00958009|75821896|FG000|STARTED|Overall Study||109||
59702752|NCT00958009|75821896|FG000|COMPLETED|Overall Study||107||
59702753|NCT00958009|75821896|FG000|NOT COMPLETED|Overall Study||2||
59702754|NCT00953407|75821905|FG000|STARTED|Overall Study||26||
59702755|NCT00953407|75821906|FG001|STARTED|Overall Study||25||
59702756|NCT00953407|75821907|FG002|STARTED|Overall Study||26||
59702757|NCT00953407|75821908|FG003|STARTED|Overall Study||25||
59702758|NCT00953407|75821909|FG004|STARTED|Overall Study||24||
59702759|NCT00953407|75821905|FG000|COMPLETED|Overall Study||25||
59702760|NCT00953407|75821906|FG001|COMPLETED|Overall Study||24||
59702761|NCT00953407|75821907|FG002|COMPLETED|Overall Study||25||
59702762|NCT00953407|75821908|FG003|COMPLETED|Overall Study||23||
59702763|NCT00953407|75821909|FG004|COMPLETED|Overall Study||23||
59702764|NCT00953407|75821905|FG000|NOT COMPLETED|Overall Study||1||
59702765|NCT00953407|75821906|FG001|NOT COMPLETED|Overall Study||1||
59702766|NCT00953407|75821907|FG002|NOT COMPLETED|Overall Study||1||
59702767|NCT00953407|75821908|FG003|NOT COMPLETED|Overall Study||2||
59702768|NCT00953407|75821909|FG004|NOT COMPLETED|Overall Study||1||
59702769|NCT00953329|75821921|FG000|STARTED|Overall Study||1||
59702770|NCT00953329|75821921|FG000|COMPLETED|Overall Study||0||
59702771|NCT00953329|75821921|FG000|NOT COMPLETED|Overall Study||1||
59702772|NCT00953017|75821929|FG000|STARTED|Overall Study||106||
59702773|NCT00953017|75821930|FG001|STARTED|Overall Study||107||
59702774|NCT00953017|75821931|FG002|STARTED|Overall Study||106||
59702775|NCT00953017|75821932|FG003|STARTED|Overall Study||106||
59702776|NCT00953017|75821929|FG000|COMPLETED|Overall Study||101||
59702777|NCT00953017|75821930|FG001|COMPLETED|Overall Study||101||
59702778|NCT00953017|75821931|FG002|COMPLETED|Overall Study||100||
59702779|NCT00953017|75821932|FG003|COMPLETED|Overall Study||101||
59702780|NCT00953017|75821929|FG000|NOT COMPLETED|Overall Study||5||
59702781|NCT00953017|75821930|FG001|NOT COMPLETED|Overall Study||6||
59702782|NCT00953017|75821931|FG002|NOT COMPLETED|Overall Study||6||
59702783|NCT00953017|75821932|FG003|NOT COMPLETED|Overall Study||5||
59702784|NCT00952705|75821945|FG000|STARTED|Overall Study|Three not treated with Q/LAIV-BFS (1 treated with FluMist/B/Yamagata; 2 withdrew prior to dosing).|1202||
59702785|NCT00952705|75821946|FG001|STARTED|Overall Study||300||
59702786|NCT00952705|75821947|FG002|STARTED|Overall Study||298||
59702787|NCT00952705|75821945|FG000|COMPLETED|Overall Study||1169||
59702788|NCT00952705|75821946|FG001|COMPLETED|Overall Study||290||
59702789|NCT00952705|75821947|FG002|COMPLETED|Overall Study||288||
59702790|NCT00952705|75821945|FG000|NOT COMPLETED|Overall Study||33||
59702791|NCT00952705|75821946|FG001|NOT COMPLETED|Overall Study||10||
59702792|NCT00952705|75821947|FG002|NOT COMPLETED|Overall Study||10||
59702793|NCT00955357|75821961|FG000|STARTED|Titration Phase||96||
59702794|NCT00955357|75821962|FG001|STARTED|Titration Phase||360||
59702795|NCT00955357|75821961|FG000|COMPLETED|Titration Phase||80||
59702796|NCT00955357|75821962|FG001|COMPLETED|Titration Phase||294||
59702797|NCT00955357|75821961|FG000|NOT COMPLETED|Titration Phase||16||
59702798|NCT00955357|75821962|FG001|NOT COMPLETED|Titration Phase||66||
59702799|NCT00955357|75821961|FG000|STARTED|Maintenance Phase||80||
59702800|NCT00955357|75821962|FG001|STARTED|Maintenance Phase||294||
59702801|NCT00955357|75821961|FG000|COMPLETED|Maintenance Phase||68||
59702802|NCT00955357|75821962|FG001|COMPLETED|Maintenance Phase||249||
59702803|NCT00955357|75821961|FG000|NOT COMPLETED|Maintenance Phase||12||
59702804|NCT00955357|75821962|FG001|NOT COMPLETED|Maintenance Phase||45||
59702805|NCT00955279|75821971|FG000|STARTED|Overall Study||58||
59702806|NCT00955279|75821972|FG001|STARTED|Overall Study||55||
59702807|NCT00955279|75821973|FG002|STARTED|Overall Study||60||
59702808|NCT00955279|75821971|FG000|COMPLETED|Overall Study||55||
59702809|NCT00955279|75821972|FG001|COMPLETED|Overall Study||51||
59702810|NCT00955279|75821973|FG002|COMPLETED|Overall Study||52||
59702811|NCT00955279|75821971|FG000|NOT COMPLETED|Overall Study||3||
59702812|NCT00955279|75821972|FG001|NOT COMPLETED|Overall Study||4||
59702813|NCT00955279|75821973|FG002|NOT COMPLETED|Overall Study||8||
59702814|NCT00954733|75821981|FG000|STARTED|Overall Study||40||
59702815|NCT00954733|75821981|FG000|COMPLETED|Overall Study||39||
59702816|NCT00954733|75821981|FG000|NOT COMPLETED|Overall Study||1||
59702817|NCT00954421|75821985|FG000|STARTED|Screening||16||
59702818|NCT00954421|75821985|FG000|COMPLETED|Screening||13||
59702819|NCT00954421|75821985|FG000|NOT COMPLETED|Screening||3||
59702820|NCT00954421|75821985|FG000|STARTED|Baseline||13||
59702821|NCT00954421|75821985|FG000|COMPLETED|Baseline||13||
59702822|NCT00954421|75821985|FG000|NOT COMPLETED|Baseline||0||
59702823|NCT00954421|75821985|FG000|STARTED|6 Months of DBS||13||
59702824|NCT00954421|75821985|FG000|COMPLETED|6 Months of DBS||12||
59702825|NCT00954421|75821985|FG000|NOT COMPLETED|6 Months of DBS||1||
59702826|NCT00954421|75821985|FG000|STARTED|VIM=ON VO=ON at 6 Months|This is the point of evaluation: Order of assessment was random for periods 4-7|12||
59702827|NCT00954421|75821985|FG000|COMPLETED|VIM=ON VO=ON at 6 Months||12||
59702828|NCT00954421|75821985|FG000|NOT COMPLETED|VIM=ON VO=ON at 6 Months||0||
59702829|NCT00954421|75821985|FG000|STARTED|VIM=OFF VO=OFF at 6 Months||12||
59816242|NCT00610649|75938616|FG007|COMPLETED|Overall Study||2||
59702830|NCT00954421|75821985|FG000|COMPLETED|VIM=OFF VO=OFF at 6 Months||12||
59702831|NCT00954421|75821985|FG000|NOT COMPLETED|VIM=OFF VO=OFF at 6 Months||0||
59702832|NCT00954421|75821985|FG000|STARTED|VIM=OFF VO=ON at 6 Months||12||
59702833|NCT00954421|75821985|FG000|COMPLETED|VIM=OFF VO=ON at 6 Months||12||
59702834|NCT00954421|75821985|FG000|NOT COMPLETED|VIM=OFF VO=ON at 6 Months||0||
59702835|NCT00954421|75821985|FG000|STARTED|VIM=ON VO=OFF at 6 Months||12||
59702836|NCT00954421|75821985|FG000|COMPLETED|VIM=ON VO=OFF at 6 Months||11||
59702837|NCT00954421|75821985|FG000|NOT COMPLETED|VIM=ON VO=OFF at 6 Months||1||
59702838|NCT01241448|75821995|FG000|STARTED|Overall Study||66||
59702839|NCT01241448|75821996|FG001|STARTED|Overall Study||65||
59702840|NCT01241448|75821997|FG002|STARTED|Overall Study||66||
59702841|NCT01241448|75821998|FG003|STARTED|Overall Study||66||
59702842|NCT01241448|75821995|FG000|Intent-to-Treat Population (ITT)|Overall Study||63||
59702843|NCT01241448|75821996|FG001|Intent-to-Treat Population (ITT)|Overall Study||63||
59702844|NCT01241448|75821997|FG002|Intent-to-Treat Population (ITT)|Overall Study||64||
59702845|NCT01241448|75821998|FG003|Intent-to-Treat Population (ITT)|Overall Study||64||
59702846|NCT01241448|75821995|FG000|ITT With ≥1 Post-Baseline Measure|Overall Study||61||
59702847|NCT01241448|75821996|FG001|ITT With ≥1 Post-Baseline Measure|Overall Study||61||
59702848|NCT01241448|75821997|FG002|ITT With ≥1 Post-Baseline Measure|Overall Study||64||
59702849|NCT01241448|75821998|FG003|ITT With ≥1 Post-Baseline Measure|Overall Study||62||
59702850|NCT01241448|75821995|FG000|COMPLETED|Overall Study||29||
59702851|NCT01241448|75821996|FG001|COMPLETED|Overall Study||36||
59702852|NCT01241448|75821997|FG002|COMPLETED|Overall Study||43||
59702853|NCT01241448|75821998|FG003|COMPLETED|Overall Study||43||
60079718|NCT03444870|76194902|FG004|Intent-to-treat (ITT) Analysis Set|Double-Blind Treatment (DBT) Period||0|ITT analysis set included all participants randomized during the global phase, who received at least one dose of study drug.|
60079719|NCT03444870|76194903|FG005|Intent-to-treat (ITT) Analysis Set|Double-Blind Treatment (DBT) Period||0|ITT analysis set included all participants randomized during the global phase, who received at least one dose of study drug.|
60079720|NCT03444870|76194898|FG000|Safety-evaluable (SE) Analysis Set|Double-Blind Treatment (DBT) Period||481|SE analysis set included all participants randomized during the global phase who received at least one dose of study drug. In the DBT period, 4 participants randomized to placebo arm received at least one dose of gantenerumab and were considered in the gantenerumab arm for safety evaluable set, of which 1 participant entered OLE period.|
60079721|NCT03444870|76194899|FG001|Safety-evaluable (SE) Analysis Set|Double-Blind Treatment (DBT) Period||503|SE analysis set included all participants randomized during the global phase who received at least one dose of study drug. In the DBT period, 4 participants randomized to placebo arm received at least one dose of gantenerumab and were considered in the gantenerumab arm for safety evaluable set, of which 1 participant entered OLE period.|
60079722|NCT03444870|76194900|FG002|Safety-evaluable (SE) Analysis Set|Double-Blind Treatment (DBT) Period||0|SE analysis set included all participants randomized during the global phase who received at least one dose of study drug. In the DBT period, 4 participants randomized to placebo arm received at least one dose of gantenerumab and were considered in the gantenerumab arm for safety evaluable set, of which 1 participant entered OLE period.|
60079723|NCT03444870|76194901|FG003|Safety-evaluable (SE) Analysis Set|Double-Blind Treatment (DBT) Period||0|SE analysis set included all participants randomized during the global phase who received at least one dose of study drug. In the DBT period, 4 participants randomized to placebo arm received at least one dose of gantenerumab and were considered in the gantenerumab arm for safety evaluable set, of which 1 participant entered OLE period.|
60079724|NCT03444870|76194902|FG004|Safety-evaluable (SE) Analysis Set|Double-Blind Treatment (DBT) Period||0|SE analysis set included all participants randomized during the global phase who received at least one dose of study drug. In the DBT period, 4 participants randomized to placebo arm received at least one dose of gantenerumab and were considered in the gantenerumab arm for safety evaluable set, of which 1 participant entered OLE period.|
60079725|NCT03444870|76194903|FG005|Safety-evaluable (SE) Analysis Set|Double-Blind Treatment (DBT) Period||0|SE analysis set included all participants randomized during the global phase who received at least one dose of study drug. In the DBT period, 4 participants randomized to placebo arm received at least one dose of gantenerumab and were considered in the gantenerumab arm for safety evaluable set, of which 1 participant entered OLE period.|
60079726|NCT03444870|76194898|FG000|ITT Analysis Set (China)|Double-Blind Treatment (DBT) Period||0|ITT analysis set (China) included all participants enrolled in China in the China extension phase who received at least one dose of study drug.|
60079727|NCT03444870|76194899|FG001|ITT Analysis Set (China)|Double-Blind Treatment (DBT) Period||0|ITT analysis set (China) included all participants enrolled in China in the China extension phase who received at least one dose of study drug.|
60079728|NCT03444870|76194900|FG002|ITT Analysis Set (China)|Double-Blind Treatment (DBT) Period||33|ITT analysis set (China) included all participants enrolled in China in the China extension phase who received at least one dose of study drug.|
60103785|NCT03915574|76222055|FG000|NOT COMPLETED|Overall Study||0||
59702854|NCT01241448|75821995|FG000|NOT COMPLETED|Overall Study||37||
59702855|NCT01241448|75821996|FG001|NOT COMPLETED|Overall Study||29||
59702856|NCT01241448|75821997|FG002|NOT COMPLETED|Overall Study||23||
59702857|NCT01241448|75821998|FG003|NOT COMPLETED|Overall Study||23||
59816243|NCT00610649|75938617|FG008|COMPLETED|Overall Study||10||
59816244|NCT00610649|75938618|FG009|COMPLETED|Overall Study||9||
59702858|NCT01240356|75822011|FG000|STARTED|Overall Study||18||
59702859|NCT01240356|75822012|FG001|STARTED|Overall Study||20||
59702860|NCT01240356|75822011|FG000|COMPLETED|Overall Study||15||
59702861|NCT01240356|75822012|FG001|COMPLETED|Overall Study||20||
59702862|NCT01240356|75822011|FG000|NOT COMPLETED|Overall Study||3||
59702863|NCT01240356|75822012|FG001|NOT COMPLETED|Overall Study||0||
59702864|NCT01239732|75822021|FG000|STARTED|Overall Study||1021||
59702865|NCT01239732|75822021|FG000|COMPLETED|Overall Study||0||
59702866|NCT01239732|75822021|FG000|NOT COMPLETED|Overall Study||1021||
59702867|NCT02227147|75822027|FG000|STARTED|Controlled Treatment Period||24||
59702868|NCT02227147|75822028|FG001|STARTED|Controlled Treatment Period||24||
59702869|NCT02227147|75822027|FG000|COMPLETED|Controlled Treatment Period||18||
59702870|NCT02227147|75822028|FG001|COMPLETED|Controlled Treatment Period||21||
59702871|NCT02227147|75822027|FG000|NOT COMPLETED|Controlled Treatment Period||6||
59702872|NCT02227147|75822028|FG001|NOT COMPLETED|Controlled Treatment Period||3||
59702873|NCT02227147|75822027|FG000|STARTED|Follow-up Period||18||
59702874|NCT02227147|75822028|FG001|STARTED|Follow-up Period||21||
59702875|NCT02227147|75822027|FG000|COMPLETED|Follow-up Period||15||
59702876|NCT02227147|75822028|FG001|COMPLETED|Follow-up Period||16||
59702877|NCT02227147|75822027|FG000|NOT COMPLETED|Follow-up Period||3||
59702878|NCT02227147|75822028|FG001|NOT COMPLETED|Follow-up Period||5||
59702879|NCT00948025|75822040|FG000|STARTED|Phase 1 (Pilot Phase)||14||
59702880|NCT00948025|75822041|FG001|STARTED|Phase 1 (Pilot Phase)||9||
59702881|NCT00948025|75822040|FG000|COMPLETED|Phase 1 (Pilot Phase)||5||
59702882|NCT00948025|75822041|FG001|COMPLETED|Phase 1 (Pilot Phase)||6||
59702883|NCT00948025|75822040|FG000|NOT COMPLETED|Phase 1 (Pilot Phase)||9||
59702884|NCT00948025|75822041|FG001|NOT COMPLETED|Phase 1 (Pilot Phase)||3||
59702885|NCT00948025|75822040|FG000|STARTED|Phase 2 (Comparative Phase)||0||
59702886|NCT00948025|75822041|FG001|STARTED|Phase 2 (Comparative Phase)||0||
59702887|NCT00948025|75822040|FG000|COMPLETED|Phase 2 (Comparative Phase)||0||
59702888|NCT00948025|75822041|FG001|COMPLETED|Phase 2 (Comparative Phase)||0||
59702889|NCT00948025|75822040|FG000|NOT COMPLETED|Phase 2 (Comparative Phase)||0||
59702890|NCT00948025|75822041|FG001|NOT COMPLETED|Phase 2 (Comparative Phase)||0||
59702891|NCT00947011|75822048|FG000|STARTED|Overall Study||12||
59702892|NCT00947011|75822048|FG000|COMPLETED|Overall Study||0||
59702893|NCT00947011|75822048|FG000|NOT COMPLETED|Overall Study||12||
59702894|NCT01239342|75822056|FG000|STARTED|Overall Study||29||
59702895|NCT01239342|75822057|FG001|STARTED|Overall Study||14||
59702896|NCT01239342|75822056|FG000|COMPLETED|Overall Study||26||
59702897|NCT01239342|75822057|FG001|COMPLETED|Overall Study||8||
59702898|NCT01239342|75822056|FG000|NOT COMPLETED|Overall Study||3||
59702899|NCT01239342|75822057|FG001|NOT COMPLETED|Overall Study||6||
59702900|NCT00946309|75822065|FG000|STARTED|Overall Study||22||
59702901|NCT00946309|75822066|FG001|STARTED|Overall Study||23||
59702902|NCT00946309|75822065|FG000|COMPLETED|Overall Study||21||
59702903|NCT00946309|75822066|FG001|COMPLETED|Overall Study||19||
59702904|NCT00946309|75822065|FG000|NOT COMPLETED|Overall Study||1||
59702905|NCT00946309|75822066|FG001|NOT COMPLETED|Overall Study||4||
59702906|NCT01236534|75822075|FG000|STARTED|Overall Study||11||
59702907|NCT01236534|75822076|FG001|STARTED|Overall Study||10||
59702908|NCT01236534|75822075|FG000|COMPLETED|Overall Study|2 subjects stopped treatment due to diarrhea, and 1 stopped treatment due to constipation.|8||
59702909|NCT01236534|75822076|FG001|COMPLETED|Overall Study||10||
59702910|NCT01236534|75822075|FG000|NOT COMPLETED|Overall Study||3||
59702911|NCT01236534|75822076|FG001|NOT COMPLETED|Overall Study||0||
59702912|NCT01235598|75822084|FG000|STARTED|Overall Study||13||
59702913|NCT01235598|75822085|FG001|STARTED|Overall Study|One subject was randomized to the CZP Arm but never received an injection (due to pre-treatment AE)|28||
59702914|NCT01235598|75822084|FG000|COMPLETED|Overall Study||12||
59702915|NCT01235598|75822085|FG001|COMPLETED|Overall Study||24||
59702916|NCT01235598|75822084|FG000|NOT COMPLETED|Overall Study||1||
59702917|NCT01235598|75822085|FG001|NOT COMPLETED|Overall Study||4||
59702918|NCT01235442|75822094|FG000|STARTED|Overall Study||297||
59702919|NCT01235442|75822095|FG001|STARTED|Overall Study||295||
59702920|NCT01235442|75822094|FG000|COMPLETED|Overall Study||253||
59702921|NCT01235442|75822095|FG001|COMPLETED|Overall Study||251||
59702922|NCT01235442|75822094|FG000|NOT COMPLETED|Overall Study||44||
59702923|NCT01235442|75822095|FG001|NOT COMPLETED|Overall Study||44||
59702924|NCT01163253|75822103|FG000|STARTED|Overall Study||2281||
59702925|NCT01163253|75822104|FG001|STARTED|Overall Study||586||
59702926|NCT01163253|75822103|FG000|COMPLETED|Overall Study||0||
59702927|NCT01163253|75822104|FG001|COMPLETED|Overall Study||0||
59702928|NCT01163253|75822103|FG000|NOT COMPLETED|Overall Study||2281||
59816245|NCT00610649|75938619|FG010|COMPLETED|Overall Study||9||
59702929|NCT01163253|75822104|FG001|NOT COMPLETED|Overall Study||586||
59702930|NCT01162863|75822113|FG000|STARTED|Overall Study||18||
59702931|NCT01162863|75822114|FG001|STARTED|Overall Study||17||
59702932|NCT01162863|75822115|FG002|STARTED|Overall Study||17||
59702933|NCT01162863|75822113|FG000|COMPLETED|Overall Study||17||
59702934|NCT01162863|75822114|FG001|COMPLETED|Overall Study||16||
59702935|NCT01162863|75822115|FG002|COMPLETED|Overall Study||17||
59702936|NCT01162863|75822113|FG000|NOT COMPLETED|Overall Study||1||
59702937|NCT01162863|75822114|FG001|NOT COMPLETED|Overall Study||1||
59702938|NCT01162863|75822115|FG002|NOT COMPLETED|Overall Study||0||
59702939|NCT01162473|75822125|FG000|STARTED|Overall Study||8||
59702940|NCT01162473|75822126|FG001|STARTED|Overall Study||17||
59702941|NCT01162473|75822125|FG000|COMPLETED|Overall Study||6||
59702942|NCT01162473|75822126|FG001|COMPLETED|Overall Study||12||
59702943|NCT01162473|75822125|FG000|NOT COMPLETED|Overall Study||2||
59702944|NCT01162473|75822126|FG001|NOT COMPLETED|Overall Study||5||
59702945|NCT01162239|75822136|FG000|STARTED|Treatment Phase||55||
59702946|NCT01162239|75822137|FG001|STARTED|Treatment Phase||54||
59702947|NCT01162239|75822138|FG002|STARTED|Treatment Phase||52||
59702948|NCT01162239|75822139|FG003|STARTED|Treatment Phase||55||
59702949|NCT01162239|75822136|FG000|Week 12|Treatment Phase||50||
59702950|NCT01162239|75822137|FG001|Week 12|Treatment Phase||51||
59702951|NCT01162239|75822138|FG002|Week 12|Treatment Phase||49||
59702952|NCT01162239|75822139|FG003|Week 12|Treatment Phase||53||
59702953|NCT01162239|75822136|FG000|Week 24|Treatment Phase||51||
59702954|NCT01162239|75822137|FG001|Week 24|Treatment Phase||48||
59702955|NCT01162239|75822138|FG002|Week 24|Treatment Phase||48||
59702956|NCT01162239|75822139|FG003|Week 24|Treatment Phase||50||
59702957|NCT01162239|75822136|FG000|Week 52|Treatment Phase||49||
59702958|NCT01162239|75822137|FG001|Week 52|Treatment Phase||47||
59702959|NCT01162239|75822138|FG002|Week 52|Treatment Phase||48||
59702960|NCT01162239|75822139|FG003|Week 52|Treatment Phase||50||
59548184|NCT02488317|75647112|FG001|STARTED|Overall Study||117||
59548185|NCT02488317|75647111|FG000|COMPLETED|Overall Study||63||
59548186|NCT02488317|75647112|FG001|COMPLETED|Overall Study||70||
59548187|NCT02488317|75647111|FG000|NOT COMPLETED|Overall Study||54||
59548188|NCT02488317|75647112|FG001|NOT COMPLETED|Overall Study||47||
59548189|NCT01168934|75647122|FG000|STARTED|First Intervention Period||7||
59702961|NCT01162239|75822136|FG000|COMPLETED|Treatment Phase||49|Treatment regimens were completed at 52 weeks|
59702962|NCT01162239|75822137|FG001|COMPLETED|Treatment Phase||47|Treatment regimens were completed at 52 weeks|
59702963|NCT01162239|75822138|FG002|COMPLETED|Treatment Phase||48|Treatment regimens were completed at 52 weeks|
59702964|NCT01162239|75822139|FG003|COMPLETED|Treatment Phase||50|Treatment regimens were completed at 52 weeks|
59702965|NCT01162239|75822136|FG000|NOT COMPLETED|Treatment Phase||6||
59548190|NCT01168934|75647123|FG001|STARTED|First Intervention Period||7||
59548191|NCT01168934|75647122|FG000|COMPLETED|First Intervention Period||7||
59548192|NCT01168934|75647123|FG001|COMPLETED|First Intervention Period||7||
59548193|NCT01168934|75647122|FG000|NOT COMPLETED|First Intervention Period||0||
59548194|NCT01168934|75647123|FG001|NOT COMPLETED|First Intervention Period||0||
59548195|NCT01168934|75647122|FG000|STARTED|Washout Period (at Least 14 Days)||7||
59548196|NCT01168934|75647123|FG001|STARTED|Washout Period (at Least 14 Days)||7||
59548197|NCT01168934|75647122|FG000|COMPLETED|Washout Period (at Least 14 Days)||7||
59548198|NCT01168934|75647123|FG001|COMPLETED|Washout Period (at Least 14 Days)||7||
59548199|NCT01168934|75647122|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0||
59548200|NCT01168934|75647123|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0||
59548201|NCT01168934|75647122|FG000|STARTED|Second Intervention Period||7||
59548202|NCT01168934|75647123|FG001|STARTED|Second Intervention Period||7||
59548203|NCT01168934|75647122|FG000|COMPLETED|Second Intervention Period||7||
59548204|NCT01168934|75647123|FG001|COMPLETED|Second Intervention Period||7||
59548205|NCT01168934|75647122|FG000|NOT COMPLETED|Second Intervention Period||0||
59548206|NCT01168934|75647123|FG001|NOT COMPLETED|Second Intervention Period||0||
59548207|NCT01170884|75647132|FG000|STARTED|Overall Study||59||
59548208|NCT01170884|75647133|FG001|STARTED|Overall Study||62||
59548209|NCT01170884|75647132|FG000|COMPLETED|Overall Study||54||
59548210|NCT01170884|75647133|FG001|COMPLETED|Overall Study||60||
59548211|NCT01170884|75647132|FG000|NOT COMPLETED|Overall Study||5||
59702966|NCT01162239|75822137|FG001|NOT COMPLETED|Treatment Phase||7||
59702967|NCT01162239|75822138|FG002|NOT COMPLETED|Treatment Phase||4||
59702968|NCT01162239|75822139|FG003|NOT COMPLETED|Treatment Phase||5||
59702969|NCT01162239|75822136|FG000|STARTED|Extended Follow-up||47|Week 64|
59702970|NCT01162239|75822137|FG001|STARTED|Extended Follow-up||45|Week 64|
59702971|NCT01162239|75822138|FG002|STARTED|Extended Follow-up||45|Week 64|
59702972|NCT01162239|75822139|FG003|STARTED|Extended Follow-up||47|Week 64|
59548212|NCT01170884|75647133|FG001|NOT COMPLETED|Overall Study||2||
59548213|NCT01171118|75647139|FG000|STARTED|Overall Study||10||
59548214|NCT01171118|75647139|FG000|COMPLETED|Overall Study||10||
59548215|NCT01171118|75647139|FG000|NOT COMPLETED|Overall Study||0||
59548216|NCT01136486|75647149|FG000|STARTED|Overall Study||56||
59548217|NCT01136486|75647149|FG000|COMPLETED|Overall Study||56||
59702973|NCT01162239|75822136|FG000|COMPLETED|Extended Follow-up||39|Week 104|
59702974|NCT01162239|75822137|FG001|COMPLETED|Extended Follow-up||32|Week 104|
59702975|NCT01162239|75822138|FG002|COMPLETED|Extended Follow-up||37|Week 104|
59702976|NCT01162239|75822139|FG003|COMPLETED|Extended Follow-up||41|Week 104|
59702977|NCT01162239|75822136|FG000|NOT COMPLETED|Extended Follow-up||8||
59702978|NCT01162239|75822137|FG001|NOT COMPLETED|Extended Follow-up||13||
59702979|NCT01162239|75822138|FG002|NOT COMPLETED|Extended Follow-up||8||
59548218|NCT01136486|75647149|FG000|NOT COMPLETED|Overall Study||0||
59548219|NCT01136798|75647155|FG000|STARTED|Overall Study||10||
59548220|NCT01136798|75647156|FG001|STARTED|Overall Study||8||
59548221|NCT01136798|75647155|FG000|COMPLETED|Overall Study||10||
59548222|NCT01136798|75647156|FG001|COMPLETED|Overall Study||8||
59548223|NCT01136798|75647155|FG000|NOT COMPLETED|Overall Study||0||
59702980|NCT01162239|75822139|FG003|NOT COMPLETED|Extended Follow-up||6||
59702981|NCT01161537|75822150|FG000|STARTED|Part A||8||
59702982|NCT01161537|75822150|FG000|COMPLETED|Part A||8||
59702983|NCT01161537|75822150|FG000|NOT COMPLETED|Part A||0||
59702984|NCT01161537|75822150|FG000|STARTED|Part B|4 subjects from Part A continued in Part B of the study.|9||
59702985|NCT01161537|75822150|FG000|COMPLETED|Part B||7||
59702986|NCT01161537|75822150|FG000|NOT COMPLETED|Part B||2||
59702987|NCT01234350|75822161|FG000|STARTED|Overall Study||1000||
59702988|NCT01234350|75822162|FG001|STARTED|Overall Study||493||
59702989|NCT01234350|75822161|FG000|COMPLETED|Overall Study||313||
59702990|NCT01234350|75822162|FG001|COMPLETED|Overall Study||226||
59702991|NCT01234350|75822161|FG000|NOT COMPLETED|Overall Study||687||
59702992|NCT01234350|75822162|FG001|NOT COMPLETED|Overall Study||267||
59702993|NCT01233258|75822173|FG000|STARTED|First Intervention (6 Months)||11||
59702994|NCT01233258|75822174|FG001|STARTED|First Intervention (6 Months)||10||
59702995|NCT01233258|75822175|FG002|STARTED|First Intervention (6 Months)||14||
59702996|NCT01233258|75822176|FG003|STARTED|First Intervention (6 Months)||16||
59702997|NCT01233258|75822177|FG004|STARTED|First Intervention (6 Months)||16||
59702998|NCT01233258|75822178|FG005|STARTED|First Intervention (6 Months)||16||
59702999|NCT01233258|75822173|FG000|Participants Received Treatment|First Intervention (6 Months)||11||
59703000|NCT01233258|75822174|FG001|Participants Received Treatment|First Intervention (6 Months)||10||
59703001|NCT01233258|75822175|FG002|Participants Received Treatment|First Intervention (6 Months)||13||
59703002|NCT01233258|75822176|FG003|Participants Received Treatment|First Intervention (6 Months)||15||
59703003|NCT01233258|75822177|FG004|Participants Received Treatment|First Intervention (6 Months)||16||
59703004|NCT01233258|75822178|FG005|Participants Received Treatment|First Intervention (6 Months)||15||
59703005|NCT01233258|75822173|FG000|COMPLETED|First Intervention (6 Months)||10||
59703006|NCT01233258|75822174|FG001|COMPLETED|First Intervention (6 Months)||10||
59703007|NCT01233258|75822175|FG002|COMPLETED|First Intervention (6 Months)||13||
59703008|NCT01233258|75822176|FG003|COMPLETED|First Intervention (6 Months)||15||
59703009|NCT01233258|75822177|FG004|COMPLETED|First Intervention (6 Months)||16||
59703010|NCT01233258|75822178|FG005|COMPLETED|First Intervention (6 Months)||15||
59703011|NCT01233258|75822173|FG000|NOT COMPLETED|First Intervention (6 Months)||1||
59703012|NCT01233258|75822174|FG001|NOT COMPLETED|First Intervention (6 Months)||0||
59703013|NCT01233258|75822175|FG002|NOT COMPLETED|First Intervention (6 Months)||1||
59703014|NCT01233258|75822176|FG003|NOT COMPLETED|First Intervention (6 Months)||1||
59703015|NCT01233258|75822177|FG004|NOT COMPLETED|First Intervention (6 Months)||0||
59703016|NCT01233258|75822178|FG005|NOT COMPLETED|First Intervention (6 Months)||1||
59703017|NCT01233258|75822173|FG000|STARTED|Washout (2-3 Days)||10||
59703018|NCT01233258|75822174|FG001|STARTED|Washout (2-3 Days)||10||
59703019|NCT01233258|75822175|FG002|STARTED|Washout (2-3 Days)||13||
59703020|NCT01233258|75822176|FG003|STARTED|Washout (2-3 Days)||15||
59703021|NCT01233258|75822177|FG004|STARTED|Washout (2-3 Days)||16||
59703022|NCT01233258|75822178|FG005|STARTED|Washout (2-3 Days)||15||
59703023|NCT01233258|75822173|FG000|COMPLETED|Washout (2-3 Days)||10||
59703024|NCT01233258|75822174|FG001|COMPLETED|Washout (2-3 Days)||10||
59703025|NCT01233258|75822175|FG002|COMPLETED|Washout (2-3 Days)||13||
59703026|NCT01233258|75822176|FG003|COMPLETED|Washout (2-3 Days)||15||
59703027|NCT01233258|75822177|FG004|COMPLETED|Washout (2-3 Days)||16||
59703028|NCT01233258|75822178|FG005|COMPLETED|Washout (2-3 Days)||15||
59703029|NCT01233258|75822173|FG000|NOT COMPLETED|Washout (2-3 Days)||0||
59703030|NCT01233258|75822174|FG001|NOT COMPLETED|Washout (2-3 Days)||0||
59703031|NCT01233258|75822175|FG002|NOT COMPLETED|Washout (2-3 Days)||0||
59703032|NCT01233258|75822176|FG003|NOT COMPLETED|Washout (2-3 Days)||0||
59703033|NCT01233258|75822177|FG004|NOT COMPLETED|Washout (2-3 Days)||0||
59703034|NCT01233258|75822178|FG005|NOT COMPLETED|Washout (2-3 Days)||0||
59703035|NCT01233258|75822173|FG000|STARTED|Second Intervention (6 Months)||10||
59703036|NCT01233258|75822174|FG001|STARTED|Second Intervention (6 Months)||10||
59703037|NCT01233258|75822175|FG002|STARTED|Second Intervention (6 Months)||13||
59703038|NCT01233258|75822176|FG003|STARTED|Second Intervention (6 Months)||15||
59703039|NCT01233258|75822177|FG004|STARTED|Second Intervention (6 Months)||16||
59703040|NCT01233258|75822178|FG005|STARTED|Second Intervention (6 Months)||15||
59703041|NCT01233258|75822173|FG000|COMPLETED|Second Intervention (6 Months)||10||
59703042|NCT01233258|75822174|FG001|COMPLETED|Second Intervention (6 Months)||10||
59703043|NCT01233258|75822175|FG002|COMPLETED|Second Intervention (6 Months)||13||
59703044|NCT01233258|75822176|FG003|COMPLETED|Second Intervention (6 Months)||15||
59703045|NCT01233258|75822177|FG004|COMPLETED|Second Intervention (6 Months)||16||
59703046|NCT01233258|75822178|FG005|COMPLETED|Second Intervention (6 Months)||15||
59703047|NCT01233258|75822173|FG000|NOT COMPLETED|Second Intervention (6 Months)||0||
59703048|NCT01233258|75822174|FG001|NOT COMPLETED|Second Intervention (6 Months)||0||
59703049|NCT01233258|75822175|FG002|NOT COMPLETED|Second Intervention (6 Months)||0||
59703050|NCT01233258|75822176|FG003|NOT COMPLETED|Second Intervention (6 Months)||0||
59703051|NCT01233258|75822177|FG004|NOT COMPLETED|Second Intervention (6 Months)||0||
59703052|NCT01233258|75822178|FG005|NOT COMPLETED|Second Intervention (6 Months)||0||
59703053|NCT01232868|75822195|FG000|STARTED|Overall Study||22||
59703054|NCT01232868|75822196|FG001|STARTED|Overall Study||44||
59703055|NCT01232868|75822195|FG000|COMPLETED|Overall Study||20||
59703056|NCT01232868|75822196|FG001|COMPLETED|Overall Study||40||
59703057|NCT01232868|75822195|FG000|NOT COMPLETED|Overall Study||2||
59703058|NCT01232868|75822196|FG001|NOT COMPLETED|Overall Study||4||
59703059|NCT01232790|75822202|FG000|STARTED|Randomization||14||
59703060|NCT01232790|75822203|FG001|STARTED|Randomization||14||
59703061|NCT01232790|75822202|FG000|COMPLETED|Randomization||12||
59703062|NCT01232790|75822203|FG001|COMPLETED|Randomization||12||
59703063|NCT01232790|75822202|FG000|NOT COMPLETED|Randomization||2||
59703064|NCT01232790|75822203|FG001|NOT COMPLETED|Randomization||2||
59703065|NCT01232790|75822202|FG000|STARTED|Initial Assessment||12||
59703066|NCT01232790|75822203|FG001|STARTED|Initial Assessment||12||
59703067|NCT01232790|75822202|FG000|COMPLETED|Initial Assessment||12||
59703068|NCT01232790|75822203|FG001|COMPLETED|Initial Assessment||11||
59703069|NCT01232790|75822202|FG000|NOT COMPLETED|Initial Assessment||0||
59703070|NCT01232790|75822203|FG001|NOT COMPLETED|Initial Assessment||1||
59703071|NCT01232790|75822202|FG000|STARTED|First Crossover||12||
59703072|NCT01232790|75822203|FG001|STARTED|First Crossover||11||
59703073|NCT01232790|75822202|FG000|COMPLETED|First Crossover||11||
59703074|NCT01232790|75822203|FG001|COMPLETED|First Crossover||11||
59703075|NCT01232790|75822202|FG000|NOT COMPLETED|First Crossover||1||
59703076|NCT01232790|75822203|FG001|NOT COMPLETED|First Crossover||0||
59703077|NCT01232790|75822202|FG000|STARTED|Second Crossover||11||
59703078|NCT01232790|75822203|FG001|STARTED|Second Crossover||11||
59703079|NCT01232790|75822202|FG000|COMPLETED|Second Crossover||10||
59703080|NCT01232790|75822203|FG001|COMPLETED|Second Crossover||9||
59703081|NCT01232790|75822202|FG000|NOT COMPLETED|Second Crossover||1||
59703082|NCT01232790|75822203|FG001|NOT COMPLETED|Second Crossover||2||
59703083|NCT01232556|75822221|FG000|STARTED|Overall Study||166||
59703084|NCT01232556|75822222|FG001|STARTED|Overall Study||172||
59703085|NCT01232556|75822221|FG000|Treated|Overall Study|One subject in this arm received rituximab only and was excluded from the safety population.|165||
59703086|NCT01232556|75822222|FG001|Treated|Overall Study||167||
59703087|NCT01232556|75822221|FG000|COMPLETED|Overall Study||7||
59703088|NCT01232556|75822222|FG001|COMPLETED|Overall Study||1||
59703089|NCT01232556|75822221|FG000|NOT COMPLETED|Overall Study||159||
59703090|NCT01232556|75822222|FG001|NOT COMPLETED|Overall Study||171||
59703091|NCT00946153|75822233|FG000|STARTED|Phase 1||6||
59703092|NCT00946153|75822234|FG001|STARTED|Phase 1||3||
59703093|NCT00946153|75822235|FG002|STARTED|Phase 1||6||
59703094|NCT00946153|75822236|FG003|STARTED|Phase 1||5||
59703095|NCT00946153|75822237|FG004|STARTED|Phase 1||0||
59703096|NCT00946153|75822233|FG000|COMPLETED|Phase 1||6||
59703097|NCT00946153|75822234|FG001|COMPLETED|Phase 1||3||
59703098|NCT00946153|75822235|FG002|COMPLETED|Phase 1||6||
59703099|NCT00946153|75822236|FG003|COMPLETED|Phase 1||5||
59703100|NCT00946153|75822237|FG004|COMPLETED|Phase 1||0||
59703101|NCT00946153|75822233|FG000|NOT COMPLETED|Phase 1||0||
59703102|NCT00946153|75822234|FG001|NOT COMPLETED|Phase 1||0||
59703103|NCT00946153|75822235|FG002|NOT COMPLETED|Phase 1||0||
59703104|NCT00946153|75822236|FG003|NOT COMPLETED|Phase 1||0||
59703105|NCT00946153|75822237|FG004|NOT COMPLETED|Phase 1||0||
59703106|NCT00946153|75822233|FG000|STARTED|Phase 2||0||
59703107|NCT00946153|75822234|FG001|STARTED|Phase 2||0||
59703108|NCT00946153|75822235|FG002|STARTED|Phase 2||0||
59703109|NCT00946153|75822236|FG003|STARTED|Phase 2||0||
59703110|NCT00946153|75822237|FG004|STARTED|Phase 2||46||
59703111|NCT00946153|75822233|FG000|COMPLETED|Phase 2||0||
59990818|NCT02495168|76106344|FG002|COMPLETED|Overall Study||110||
59990819|NCT02495168|76106342|FG000|NOT COMPLETED|Overall Study||38||
59990820|NCT02495168|76106343|FG001|NOT COMPLETED|Overall Study||54||
59703112|NCT00946153|75822234|FG001|COMPLETED|Phase 2||0||
59703113|NCT00946153|75822235|FG002|COMPLETED|Phase 2||0||
59703114|NCT00946153|75822236|FG003|COMPLETED|Phase 2||0||
59703115|NCT00946153|75822237|FG004|COMPLETED|Phase 2||33||
59703116|NCT00946153|75822233|FG000|NOT COMPLETED|Phase 2||0||
59703117|NCT00946153|75822234|FG001|NOT COMPLETED|Phase 2||0||
59703118|NCT00946153|75822235|FG002|NOT COMPLETED|Phase 2||0||
59703119|NCT00946153|75822236|FG003|NOT COMPLETED|Phase 2||0||
59703120|NCT00946153|75822237|FG004|NOT COMPLETED|Phase 2||13||
59703121|NCT01160289|75822259|FG000|STARTED|Screening, Washout, and Lead-In Period||894||
59703122|NCT01160289|75822260|FG001|STARTED|Screening, Washout, and Lead-In Period||0||
59703123|NCT01160289|75822261|FG002|STARTED|Screening, Washout, and Lead-In Period||0||
59703124|NCT01160289|75822262|FG003|STARTED|Screening, Washout, and Lead-In Period||0||
59703125|NCT01160289|75822263|FG004|STARTED|Screening, Washout, and Lead-In Period||0||
59703126|NCT01160289|75822264|FG005|STARTED|Screening, Washout, and Lead-In Period||0||
59990821|NCT02495168|76106344|FG002|NOT COMPLETED|Overall Study||17||
59990822|NCT02494778|76106352|FG000|STARTED|Overall Study||248||
59990823|NCT02494778|76106352|FG000|COMPLETED|Overall Study||27||
59703127|NCT01160289|75822259|FG000|COMPLETED|Screening, Washout, and Lead-In Period||410||
59703128|NCT01160289|75822260|FG001|COMPLETED|Screening, Washout, and Lead-In Period||0||
59703129|NCT01160289|75822261|FG002|COMPLETED|Screening, Washout, and Lead-In Period||0||
59703130|NCT01160289|75822262|FG003|COMPLETED|Screening, Washout, and Lead-In Period||0||
59703131|NCT01160289|75822263|FG004|COMPLETED|Screening, Washout, and Lead-In Period||0||
59703132|NCT01160289|75822264|FG005|COMPLETED|Screening, Washout, and Lead-In Period||0||
59703133|NCT01160289|75822259|FG000|NOT COMPLETED|Screening, Washout, and Lead-In Period||484||
59703134|NCT01160289|75822260|FG001|NOT COMPLETED|Screening, Washout, and Lead-In Period||0||
59703135|NCT01160289|75822261|FG002|NOT COMPLETED|Screening, Washout, and Lead-In Period||0||
59703136|NCT01160289|75822262|FG003|NOT COMPLETED|Screening, Washout, and Lead-In Period||0||
59703137|NCT01160289|75822263|FG004|NOT COMPLETED|Screening, Washout, and Lead-In Period||0||
59703138|NCT01160289|75822264|FG005|NOT COMPLETED|Screening, Washout, and Lead-In Period||0||
59703139|NCT01160289|75822259|FG000|STARTED|Post-Randomization Period||0||
59703140|NCT01160289|75822260|FG001|STARTED|Post-Randomization Period||85||
59703141|NCT01160289|75822261|FG002|STARTED|Post-Randomization Period||97||
59703142|NCT01160289|75822262|FG003|STARTED|Post-Randomization Period||52||
59703143|NCT01160289|75822263|FG004|STARTED|Post-Randomization Period||89||
59703144|NCT01160289|75822264|FG005|STARTED|Post-Randomization Period||87||
59703145|NCT01160289|75822259|FG000|Received at Least 1 Dose of Study Drug|Post-Randomization Period||0||
59703146|NCT01160289|75822260|FG001|Received at Least 1 Dose of Study Drug|Post-Randomization Period||85||
59703147|NCT01160289|75822261|FG002|Received at Least 1 Dose of Study Drug|Post-Randomization Period||97||
59703148|NCT01160289|75822262|FG003|Received at Least 1 Dose of Study Drug|Post-Randomization Period||52||
59703149|NCT01160289|75822263|FG004|Received at Least 1 Dose of Study Drug|Post-Randomization Period||89||
59703150|NCT01160289|75822264|FG005|Received at Least 1 Dose of Study Drug|Post-Randomization Period||87||
59703151|NCT01160289|75822259|FG000|COMPLETED|Post-Randomization Period||0||
59703152|NCT01160289|75822260|FG001|COMPLETED|Post-Randomization Period||65||
59703153|NCT01160289|75822261|FG002|COMPLETED|Post-Randomization Period||73||
59703154|NCT01160289|75822262|FG003|COMPLETED|Post-Randomization Period||31||
59703155|NCT01160289|75822263|FG004|COMPLETED|Post-Randomization Period||80||
59703156|NCT01160289|75822264|FG005|COMPLETED|Post-Randomization Period||73||
59703157|NCT01160289|75822259|FG000|NOT COMPLETED|Post-Randomization Period||0||
59703158|NCT01160289|75822260|FG001|NOT COMPLETED|Post-Randomization Period||20||
59703159|NCT01160289|75822261|FG002|NOT COMPLETED|Post-Randomization Period||24||
59703160|NCT01160289|75822262|FG003|NOT COMPLETED|Post-Randomization Period||21||
59703161|NCT01160289|75822263|FG004|NOT COMPLETED|Post-Randomization Period||9||
59703162|NCT01160289|75822264|FG005|NOT COMPLETED|Post-Randomization Period||14||
59703163|NCT01159665|75822283|FG000|STARTED|Overall Study||9||
59703164|NCT01159665|75822284|FG001|STARTED|Overall Study||9||
59703165|NCT01159665|75822285|FG002|STARTED|Overall Study||8||
59703166|NCT01159665|75822286|FG003|STARTED|Overall Study||4||
59703167|NCT01159665|75822287|FG004|STARTED|Overall Study||4||
59703168|NCT01159665|75822288|FG005|STARTED|Overall Study||4||
59703169|NCT01159665|75822283|FG000|COMPLETED|Overall Study||9||
59703170|NCT01159665|75822284|FG001|COMPLETED|Overall Study||8||
59703171|NCT01159665|75822285|FG002|COMPLETED|Overall Study||8||
59703172|NCT01159665|75822286|FG003|COMPLETED|Overall Study||4||
59703173|NCT01159665|75822287|FG004|COMPLETED|Overall Study||4||
59703174|NCT01159665|75822288|FG005|COMPLETED|Overall Study||4||
59703175|NCT01159665|75822283|FG000|NOT COMPLETED|Overall Study||0||
59703176|NCT01159665|75822284|FG001|NOT COMPLETED|Overall Study||1||
59703177|NCT01159665|75822285|FG002|NOT COMPLETED|Overall Study||0||
59703178|NCT01159665|75822286|FG003|NOT COMPLETED|Overall Study||0||
59703179|NCT01159665|75822287|FG004|NOT COMPLETED|Overall Study||0||
59703180|NCT01159665|75822288|FG005|NOT COMPLETED|Overall Study||0||
59703181|NCT01159431|75822304|FG000|STARTED|Overall Study||25||
59703182|NCT01159431|75822305|FG001|STARTED|Overall Study||25||
59703183|NCT01159431|75822304|FG000|COMPLETED|Overall Study||23||
59703184|NCT01159431|75822305|FG001|COMPLETED|Overall Study||19||
59703185|NCT01159431|75822304|FG000|NOT COMPLETED|Overall Study||2||
59703186|NCT01159431|75822305|FG001|NOT COMPLETED|Overall Study||6||
59703187|NCT01158261|75822318|FG000|STARTED|Overall Study||300||
59703188|NCT01158261|75822318|FG000|COMPLETED|Overall Study||283||
59703189|NCT01158261|75822318|FG000|NOT COMPLETED|Overall Study||17||
59703190|NCT01157169|75822324|FG000|STARTED|First Intervention||20||
59703191|NCT01157169|75822325|FG001|STARTED|First Intervention||20||
59703192|NCT01157169|75822324|FG000|COMPLETED|First Intervention||16||
59703193|NCT01157169|75822325|FG001|COMPLETED|First Intervention||18||
59703194|NCT01157169|75822324|FG000|NOT COMPLETED|First Intervention||4||
59703195|NCT01157169|75822325|FG001|NOT COMPLETED|First Intervention||2||
59703196|NCT01157169|75822324|FG000|STARTED|Washout of 10 Days||16||
59703197|NCT01157169|75822325|FG001|STARTED|Washout of 10 Days||18||
59703198|NCT01157169|75822324|FG000|COMPLETED|Washout of 10 Days||16||
59703199|NCT01157169|75822325|FG001|COMPLETED|Washout of 10 Days||18||
59703200|NCT01157169|75822324|FG000|NOT COMPLETED|Washout of 10 Days||0||
59703201|NCT01157169|75822325|FG001|NOT COMPLETED|Washout of 10 Days||0||
59703202|NCT01157169|75822324|FG000|STARTED|Second Intervention||16||
59703203|NCT01157169|75822325|FG001|STARTED|Second Intervention||18||
59703204|NCT01157169|75822324|FG000|COMPLETED|Second Intervention||16||
59703205|NCT01157169|75822325|FG001|COMPLETED|Second Intervention||17||
59703206|NCT01157169|75822324|FG000|NOT COMPLETED|Second Intervention||0||
59703207|NCT01157169|75822325|FG001|NOT COMPLETED|Second Intervention||1||
59703208|NCT01231620|75822334|FG000|STARTED|Overall Study||201||
59703209|NCT01231620|75822335|FG001|STARTED|Overall Study||209||
59703210|NCT01231620|75822336|FG002|STARTED|Overall Study||205||
59703211|NCT01231620|75822334|FG000|COMPLETED|Overall Study||175||
59703212|NCT01231620|75822335|FG001|COMPLETED|Overall Study||178||
59703213|NCT01231620|75822336|FG002|COMPLETED|Overall Study||166||
59703214|NCT01231620|75822334|FG000|NOT COMPLETED|Overall Study||26||
59703215|NCT01231620|75822335|FG001|NOT COMPLETED|Overall Study||31||
59703216|NCT01231620|75822336|FG002|NOT COMPLETED|Overall Study||39||
59703217|NCT01231464|75822346|FG000|STARTED|Overall Study||182||
59703218|NCT01231464|75822347|FG001|STARTED|Overall Study||183||
59703219|NCT01231464|75822346|FG000|COMPLETED|Overall Study||177||
59703220|NCT01231464|75822347|FG001|COMPLETED|Overall Study||176||
59703221|NCT01231464|75822346|FG000|NOT COMPLETED|Overall Study||5||
59703222|NCT01231464|75822347|FG001|NOT COMPLETED|Overall Study||7||
59703223|NCT01156311|75822357|FG000|STARTED|2-Month Monotherapy Period||59||
59703224|NCT01156311|75822358|FG001|STARTED|2-Month Monotherapy Period||49||
59703225|NCT01156311|75822359|FG002|STARTED|2-Month Monotherapy Period||0||
59703226|NCT01156311|75822360|FG003|STARTED|2-Month Monotherapy Period||0||
59703227|NCT01156311|75822357|FG000|COMPLETED|2-Month Monotherapy Period||57||
59703228|NCT01156311|75822358|FG001|COMPLETED|2-Month Monotherapy Period||47||
59990824|NCT02494778|76106352|FG000|NOT COMPLETED|Overall Study||221||
59990825|NCT02493764|76106358|FG000|STARTED|Overall Study||268||
59990826|NCT02493764|76106359|FG001|STARTED|Overall Study||269||
59990827|NCT02493764|76106358|FG000|COMPLETED|Overall Study||185||
59990828|NCT02493764|76106359|FG001|COMPLETED|Overall Study||187||
59990829|NCT02493764|76106358|FG000|NOT COMPLETED|Overall Study||83||
59990830|NCT02493764|76106359|FG001|NOT COMPLETED|Overall Study||82||
59990831|NCT02460380|76106367|FG000|STARTED|Overall Study||45||
59990832|NCT02460380|76106368|FG001|STARTED|Overall Study||23||
59990833|NCT02460380|76106367|FG000|COMPLETED|Overall Study||35||
59990834|NCT02460380|76106368|FG001|COMPLETED|Overall Study||18||
60079729|NCT03444870|76194901|FG003|ITT Analysis Set (China)|Double-Blind Treatment (DBT) Period||35|ITT analysis set (China) included all participants enrolled in China in the China extension phase who received at least one dose of study drug.|
60079730|NCT03444870|76194902|FG004|ITT Analysis Set (China)|Double-Blind Treatment (DBT) Period||0|ITT analysis set (China) included all participants enrolled in China in the China extension phase who received at least one dose of study drug.|
60079731|NCT03444870|76194903|FG005|ITT Analysis Set (China)|Double-Blind Treatment (DBT) Period||0|ITT analysis set (China) included all participants enrolled in China in the China extension phase who received at least one dose of study drug.|
60079732|NCT03444870|76194898|FG000|SE Analysis Set (China)|Double-Blind Treatment (DBT) Period||0|SE analysis set (China) included all participants enrolled in China in the China extension phase who received at least one dose of study drug.|
60079733|NCT03444870|76194899|FG001|SE Analysis Set (China)|Double-Blind Treatment (DBT) Period||0|SE analysis set (China) included all participants enrolled in China in the China extension phase who received at least one dose of study drug.|
60079734|NCT03444870|76194900|FG002|SE Analysis Set (China)|Double-Blind Treatment (DBT) Period||33|SE analysis set (China) included all participants enrolled in China in the China extension phase who received at least one dose of study drug.|
60079735|NCT03444870|76194901|FG003|SE Analysis Set (China)|Double-Blind Treatment (DBT) Period||35|SE analysis set (China) included all participants enrolled in China in the China extension phase who received at least one dose of study drug.|
60079736|NCT03444870|76194902|FG004|SE Analysis Set (China)|Double-Blind Treatment (DBT) Period||0|SE analysis set (China) included all participants enrolled in China in the China extension phase who received at least one dose of study drug.|
60079737|NCT03444870|76194903|FG005|SE Analysis Set (China)|Double-Blind Treatment (DBT) Period||0|SE analysis set (China) included all participants enrolled in China in the China extension phase who received at least one dose of study drug.|
60079738|NCT03444870|76194898|FG000|Safety Magnetic Resonance Imaging (MRI)-Evaluable (SEMRI) Analysis Set|Double-Blind Treatment (DBT) Period||476|SEMRI analysis set included all participants in the SE analysis set who had at least one post-baseline safety MRI scan.|
60079739|NCT03444870|76194899|FG001|Safety Magnetic Resonance Imaging (MRI)-Evaluable (SEMRI) Analysis Set|Double-Blind Treatment (DBT) Period||497|SEMRI analysis set included all participants in the SE analysis set who had at least one post-baseline safety MRI scan.|
59990835|NCT02460380|76106367|FG000|NOT COMPLETED|Overall Study||10||
59990836|NCT02460380|76106368|FG001|NOT COMPLETED|Overall Study||5||
59990837|NCT02493062|76106375|FG000|STARTED|Overall Study||35||
59990838|NCT02493062|76106375|FG000|COMPLETED|Overall Study||23||
59990839|NCT02493062|76106375|FG000|NOT COMPLETED|Overall Study||12||
60103786|NCT03915574|76222056|FG001|NOT COMPLETED|Overall Study||4||
59548224|NCT01136798|75647156|FG001|NOT COMPLETED|Overall Study||0||
59548225|NCT01172522|75647164|FG000|STARTED|Overall Study||15||
59703229|NCT01156311|75822359|FG002|COMPLETED|2-Month Monotherapy Period||0||
59703230|NCT01156311|75822360|FG003|COMPLETED|2-Month Monotherapy Period||0||
59703231|NCT01156311|75822357|FG000|NOT COMPLETED|2-Month Monotherapy Period||2||
59703232|NCT01156311|75822358|FG001|NOT COMPLETED|2-Month Monotherapy Period||2||
59703233|NCT01156311|75822359|FG002|NOT COMPLETED|2-Month Monotherapy Period||0||
59703234|NCT01156311|75822360|FG003|NOT COMPLETED|2-Month Monotherapy Period||0||
59703235|NCT01156311|75822357|FG000|STARTED|6-month Add-on Therapy Period||0||
59703236|NCT01156311|75822358|FG001|STARTED|6-month Add-on Therapy Period||0||
59703237|NCT01156311|75822359|FG002|STARTED|6-month Add-on Therapy Period||57||
59703238|NCT01156311|75822360|FG003|STARTED|6-month Add-on Therapy Period||47||
59703239|NCT01156311|75822357|FG000|Completed BG00012 Combination Therapy|6-month Add-on Therapy Period||0||
59990840|NCT02492984|76106381|FG000|STARTED|Overall Study||73||
59990841|NCT02492984|76106382|FG001|STARTED|Overall Study||14||
59990842|NCT02492984|76106381|FG000|COMPLETED|Overall Study||70||
59990843|NCT02492984|76106382|FG001|COMPLETED|Overall Study||14||
59703240|NCT01156311|75822358|FG001|Completed BG00012 Combination Therapy|6-month Add-on Therapy Period||0||
59709831|NCT01072149|75828525|FG005|STARTED|Treatment Period 2 (28 Days)||3||
59703241|NCT01156311|75822359|FG002|Completed BG00012 Combination Therapy|6-month Add-on Therapy Period||45||
59703242|NCT01156311|75822360|FG003|Completed BG00012 Combination Therapy|6-month Add-on Therapy Period||38||
59703243|NCT01156311|75822357|FG000|COMPLETED|6-month Add-on Therapy Period||0||
59703244|NCT01156311|75822358|FG001|COMPLETED|6-month Add-on Therapy Period||0||
59703245|NCT01156311|75822359|FG002|COMPLETED|6-month Add-on Therapy Period||45||
59703246|NCT01156311|75822360|FG003|COMPLETED|6-month Add-on Therapy Period||37||
59703247|NCT01156311|75822357|FG000|NOT COMPLETED|6-month Add-on Therapy Period||0||
59703248|NCT01156311|75822358|FG001|NOT COMPLETED|6-month Add-on Therapy Period||0||
59703249|NCT01156311|75822359|FG002|NOT COMPLETED|6-month Add-on Therapy Period||12||
59703250|NCT01156311|75822360|FG003|NOT COMPLETED|6-month Add-on Therapy Period||10||
59703251|NCT01230060|75822371|FG000|STARTED|Overall Study||122||
59703252|NCT01230060|75822371|FG000|COMPLETED|Overall Study||121||
59703253|NCT01230060|75822371|FG000|NOT COMPLETED|Overall Study||1||
59703254|NCT01155531|75822379|FG000|STARTED|Overall Study||10||
59703255|NCT01155531|75822380|FG001|STARTED|Overall Study||10||
59703256|NCT01155531|75822381|FG002|STARTED|Overall Study||10||
59703257|NCT01155531|75822382|FG003|STARTED|Overall Study||10||
59703258|NCT01155531|75822379|FG000|COMPLETED|Overall Study||9||
59703259|NCT01155531|75822380|FG001|COMPLETED|Overall Study||10||
59703260|NCT01155531|75822381|FG002|COMPLETED|Overall Study||8||
59703261|NCT01155531|75822382|FG003|COMPLETED|Overall Study||9||
59703262|NCT01155531|75822379|FG000|NOT COMPLETED|Overall Study||1||
59703263|NCT01155531|75822380|FG001|NOT COMPLETED|Overall Study||0||
59703264|NCT01155531|75822381|FG002|NOT COMPLETED|Overall Study||2||
59703265|NCT01155531|75822382|FG003|NOT COMPLETED|Overall Study||1||
59703266|NCT01155219|75822394|FG000|STARTED|Overall Study||77||
59703267|NCT01155219|75822395|FG001|STARTED|Overall Study||73||
59703268|NCT01155219|75822394|FG000|COMPLETED|Overall Study||73||
59703269|NCT01155219|75822395|FG001|COMPLETED|Overall Study||70||
59703270|NCT01155219|75822394|FG000|NOT COMPLETED|Overall Study||4||
59703271|NCT01155219|75822395|FG001|NOT COMPLETED|Overall Study||3||
59703272|NCT01229436|75822401|FG000|STARTED|Overall Study||254||
59703273|NCT01229436|75822401|FG000|COMPLETED|Overall Study||249||
59703274|NCT01229436|75822401|FG000|NOT COMPLETED|Overall Study||5||
59703275|NCT01155141|75822405|FG000|STARTED|Overall Study||16||
59703276|NCT01155141|75822405|FG000|COMPLETED|Overall Study||14||
59703277|NCT01155141|75822405|FG000|NOT COMPLETED|Overall Study||2||
59703278|NCT01155063|75822409|FG000|STARTED|Overall Study||89||
59703279|NCT01155063|75822409|FG000|COMPLETED|Overall Study||0||
59703280|NCT01155063|75822409|FG000|NOT COMPLETED|Overall Study||89||
59703281|NCT01154673|75822415|FG000|STARTED|Overall Study||16||
59703282|NCT01154673|75822416|FG001|STARTED|Overall Study||16||
59703283|NCT01154673|75822415|FG000|COMPLETED|Overall Study||14||
59703284|NCT01154673|75822416|FG001|COMPLETED|Overall Study||16||
59703285|NCT01154673|75822415|FG000|NOT COMPLETED|Overall Study||2||
59703286|NCT01154673|75822416|FG001|NOT COMPLETED|Overall Study||0||
59703287|NCT01154283|75822424|FG000|STARTED|0-6 Weeks||14||
59703288|NCT01154283|75822425|FG001|STARTED|0-6 Weeks||14||
59703289|NCT01154283|75822424|FG000|COMPLETED|0-6 Weeks||7||
59703290|NCT01154283|75822425|FG001|COMPLETED|0-6 Weeks||11||
59703291|NCT01154283|75822424|FG000|NOT COMPLETED|0-6 Weeks||7||
59703292|NCT01154283|75822425|FG001|NOT COMPLETED|0-6 Weeks||3||
59703293|NCT01154283|75822424|FG000|STARTED|7-12 Weeks||7||
59703294|NCT01154283|75822425|FG001|STARTED|7-12 Weeks||11||
59703295|NCT01154283|75822424|FG000|COMPLETED|7-12 Weeks||6||
59703296|NCT01154283|75822425|FG001|COMPLETED|7-12 Weeks||10||
59703297|NCT01154283|75822424|FG000|NOT COMPLETED|7-12 Weeks||1||
59990844|NCT02492984|76106381|FG000|NOT COMPLETED|Overall Study||3||
59990845|NCT02492984|76106382|FG001|NOT COMPLETED|Overall Study||0||
59703298|NCT01154283|75822425|FG001|NOT COMPLETED|7-12 Weeks||1||
59703299|NCT00944125|75822431|FG000|STARTED|Baseline to 3 Months||19||
59703300|NCT00944125|75822432|FG001|STARTED|Baseline to 3 Months||22||
59703301|NCT00944125|75822431|FG000|COMPLETED|Baseline to 3 Months||19||
59703302|NCT00944125|75822432|FG001|COMPLETED|Baseline to 3 Months||22||
59703303|NCT00944125|75822431|FG000|NOT COMPLETED|Baseline to 3 Months||0||
59703304|NCT00944125|75822432|FG001|NOT COMPLETED|Baseline to 3 Months||0||
59703305|NCT00944125|75822431|FG000|STARTED|3 to 6 Months||19||
59990846|NCT01680159|76106395|FG000|STARTED|Screening Period||46||
59990847|NCT01680159|76106395|FG000|COMPLETED|Screening Period||39||
59703306|NCT00944125|75822432|FG001|STARTED|3 to 6 Months||22||
59990848|NCT01680159|76106395|FG000|NOT COMPLETED|Screening Period||7||
59990849|NCT01680159|76106395|FG000|STARTED|Increased Dose Period||51||
59990850|NCT01680159|76106395|FG000|COMPLETED|Increased Dose Period||43||
59703307|NCT00944125|75822431|FG000|COMPLETED|3 to 6 Months||19||
59703308|NCT00944125|75822432|FG001|COMPLETED|3 to 6 Months||20||
59703309|NCT00944125|75822431|FG000|NOT COMPLETED|3 to 6 Months||0||
59703310|NCT00944125|75822432|FG001|NOT COMPLETED|3 to 6 Months||2||
59703311|NCT00944125|75822431|FG000|STARTED|6 Months to Study Completion||19||
59703312|NCT00944125|75822432|FG001|STARTED|6 Months to Study Completion||20||
59703313|NCT00944125|75822431|FG000|COMPLETED|6 Months to Study Completion||19||
59703314|NCT00944125|75822432|FG001|COMPLETED|6 Months to Study Completion||18||
59703315|NCT00944125|75822431|FG000|NOT COMPLETED|6 Months to Study Completion||0||
59703316|NCT00944125|75822432|FG001|NOT COMPLETED|6 Months to Study Completion||2||
59703317|NCT00912223|75822438|FG000|STARTED|Overall Study||65||
59703318|NCT00912223|75822438|FG000|COMPLETED|Overall Study||62||
59703319|NCT00912223|75822438|FG000|NOT COMPLETED|Overall Study||3||
59703320|NCT01154127|75822444|FG000|STARTED|Period 1 (21 Days)||55||
59703321|NCT01154127|75822445|FG001|STARTED|Period 1 (21 Days)||53||
59703322|NCT01154127|75822444|FG000|COMPLETED|Period 1 (21 Days)||52||
59703323|NCT01154127|75822445|FG001|COMPLETED|Period 1 (21 Days)||47||
59703324|NCT01154127|75822444|FG000|NOT COMPLETED|Period 1 (21 Days)||3||
59703325|NCT01154127|75822445|FG001|NOT COMPLETED|Period 1 (21 Days)||6||
59703326|NCT01154127|75822444|FG000|STARTED|Washout (14 - 28 Days)||52||
59703327|NCT01154127|75822445|FG001|STARTED|Washout (14 - 28 Days)||47||
59703328|NCT01154127|75822444|FG000|COMPLETED|Washout (14 - 28 Days)||49||
59703329|NCT01154127|75822445|FG001|COMPLETED|Washout (14 - 28 Days)||47||
59703330|NCT01154127|75822444|FG000|NOT COMPLETED|Washout (14 - 28 Days)||3||
59703331|NCT01154127|75822445|FG001|NOT COMPLETED|Washout (14 - 28 Days)||0||
59703332|NCT01154127|75822444|FG000|STARTED|Period 2 (21 Days)||49||
59703333|NCT01154127|75822445|FG001|STARTED|Period 2 (21 Days)||47||
59703334|NCT01154127|75822444|FG000|COMPLETED|Period 2 (21 Days)||49||
59703335|NCT01154127|75822445|FG001|COMPLETED|Period 2 (21 Days)||46||
59703336|NCT01154127|75822444|FG000|NOT COMPLETED|Period 2 (21 Days)||0||
59703337|NCT01154127|75822445|FG001|NOT COMPLETED|Period 2 (21 Days)||1||
59703338|NCT01228734|75822453|FG000|STARTED|Overall Study||193||
59703339|NCT01228734|75822454|FG001|STARTED|Overall Study||204||
59703340|NCT01228734|75822453|FG000|Modified Intent-to-treat Population|Overall Study||193||
59703341|NCT01228734|75822454|FG001|Modified Intent-to-treat Population|Overall Study||200||
59703342|NCT01228734|75822453|FG000|Modified Safety Population|Overall Study|One subject was randomized to FOLFOX-4 group but received cetuximab + FOLFOX-4 treatment instead|194||
59703343|NCT01228734|75822454|FG001|Modified Safety Population|Overall Study||199||
59703344|NCT01228734|75822453|FG000|COMPLETED|Overall Study||193||
59703345|NCT01228734|75822454|FG001|COMPLETED|Overall Study||200||
59703346|NCT01228734|75822453|FG000|NOT COMPLETED|Overall Study||0||
59703347|NCT01228734|75822454|FG001|NOT COMPLETED|Overall Study||4||
59703348|NCT01227954|75822460|FG000|STARTED|Overall Study||113||
59703349|NCT01227954|75822460|FG000|COMPLETED|Overall Study|Eligible subjects available for analysis|100||
59703350|NCT01227954|75822460|FG000|NOT COMPLETED|Overall Study||13||
59703351|NCT01153971|75822464|FG000|STARTED|Induction Phase (Months 1 to 7 of Study)||47||
59703352|NCT01153971|75822464|FG000|COMPLETED|Induction Phase (Months 1 to 7 of Study)||44||
59703353|NCT01153971|75822464|FG000|NOT COMPLETED|Induction Phase (Months 1 to 7 of Study)||3||
59703354|NCT01153971|75822464|FG000|STARTED|Maintenance Phase (Months 8-16 of Study)||44||
59703355|NCT01153971|75822464|FG000|COMPLETED|Maintenance Phase (Months 8-16 of Study)||41||
59703356|NCT01153971|75822464|FG000|NOT COMPLETED|Maintenance Phase (Months 8-16 of Study)||3||
59703357|NCT01153971|75822464|FG000|STARTED|Follow-up (Months 17-40 of Study)||41||
59703358|NCT01153971|75822464|FG000|COMPLETED|Follow-up (Months 17-40 of Study)||37||
59703359|NCT01153971|75822464|FG000|NOT COMPLETED|Follow-up (Months 17-40 of Study)||4||
59703360|NCT01153893|75822470|FG000|STARTED|Overall Study|Issues with the informed consent obtained from one child led to related data not used in this report|68||
59703361|NCT01153893|75822471|FG001|STARTED|Overall Study||36||
59703362|NCT01153893|75822470|FG000|COMPLETED|Overall Study|Number of subjects who completed the follow-up visit at Month 1.|67||
59703363|NCT01153893|75822471|FG001|COMPLETED|Overall Study|Number of subjects who completed the follow-up visit at Month 3.|36||
59703364|NCT01153893|75822470|FG000|NOT COMPLETED|Overall Study||1||
59703365|NCT01153893|75822471|FG001|NOT COMPLETED|Overall Study||0||
59703366|NCT00951379|75822479|FG000|STARTED|Overall Study||27||
59703367|NCT00951379|75822480|FG001|STARTED|Overall Study||25||
59703368|NCT00951379|75822479|FG000|COMPLETED|Overall Study||21||
59703369|NCT00951379|75822480|FG001|COMPLETED|Overall Study||23||
59703370|NCT00951379|75822479|FG000|NOT COMPLETED|Overall Study||6||
59703371|NCT00951379|75822480|FG001|NOT COMPLETED|Overall Study||2||
59703372|NCT01153815|75822496|FG000|STARTED|Overall Study||83||
59703373|NCT01153815|75822497|FG001|STARTED|Overall Study||87||
59703374|NCT01153815|75822496|FG000|COMPLETED|Overall Study||74||
59703375|NCT01153815|75822497|FG001|COMPLETED|Overall Study||82||
59703376|NCT01153815|75822496|FG000|NOT COMPLETED|Overall Study||9||
59816246|NCT00610649|75938609|FG000|NOT COMPLETED|Overall Study||1||
59816247|NCT00610649|75938610|FG001|NOT COMPLETED|Overall Study||1||
59816248|NCT00610649|75938611|FG002|NOT COMPLETED|Overall Study||0||
59703377|NCT01153815|75822497|FG001|NOT COMPLETED|Overall Study||5||
59703378|NCT01153425|75822505|FG000|STARTED|Overall Study||16||
59703379|NCT01153425|75822506|FG001|STARTED|Overall Study||17||
59816249|NCT00610649|75938612|FG003|NOT COMPLETED|Overall Study||0||
59703380|NCT01153425|75822505|FG000|COMPLETED|Overall Study||13||
59703381|NCT01153425|75822506|FG001|COMPLETED|Overall Study||14||
59703382|NCT01153425|75822505|FG000|NOT COMPLETED|Overall Study||3||
59703383|NCT01153425|75822506|FG001|NOT COMPLETED|Overall Study||3||
59703384|NCT01153347|75822517|FG000|STARTED|Overall Study||160||
59703385|NCT01153347|75822518|FG001|STARTED|Overall Study||160||
59703386|NCT01153347|75822519|FG002|STARTED|Overall Study||160||
59703387|NCT01153347|75822520|FG003|STARTED|Overall Study||161||
59816250|NCT00610649|75938613|FG004|NOT COMPLETED|Overall Study||0||
59703388|NCT01153347|75822517|FG000|Received Treatment|Overall Study||160||
59703389|NCT01153347|75822518|FG001|Received Treatment|Overall Study||158||
59703390|NCT01153347|75822519|FG002|Received Treatment|Overall Study||158||
59703391|NCT01153347|75822520|FG003|Received Treatment|Overall Study||160||
59703392|NCT01153347|75822517|FG000|COMPLETED|Overall Study||127||
59703393|NCT01153347|75822518|FG001|COMPLETED|Overall Study||116||
59703394|NCT01153347|75822519|FG002|COMPLETED|Overall Study||110||
59703395|NCT01153347|75822520|FG003|COMPLETED|Overall Study||129||
59703396|NCT01153347|75822517|FG000|NOT COMPLETED|Overall Study||33||
59703397|NCT01153347|75822518|FG001|NOT COMPLETED|Overall Study||44||
59703398|NCT01153347|75822519|FG002|NOT COMPLETED|Overall Study||50||
59703399|NCT01153347|75822520|FG003|NOT COMPLETED|Overall Study||32||
59703400|NCT01153269|75822530|FG000|STARTED|Overall Study||33||
59703401|NCT01153269|75822530|FG000|Participants Analyzed|Overall Study||33||
59703402|NCT01153269|75822530|FG000|COMPLETED|Overall Study||31||
59703403|NCT01153269|75822530|FG000|NOT COMPLETED|Overall Study||2||
59703404|NCT01152021|75822539|FG000|STARTED|Overall Study||8||
59703405|NCT01152021|75822540|FG001|STARTED|Overall Study||7||
59703406|NCT01152021|75822539|FG000|COMPLETED|Overall Study||2||
59703407|NCT01152021|75822540|FG001|COMPLETED|Overall Study||1||
59703408|NCT01152021|75822539|FG000|NOT COMPLETED|Overall Study||6||
59703409|NCT01152021|75822540|FG001|NOT COMPLETED|Overall Study||6||
59703410|NCT01151085|75822548|FG000|STARTED|Overall Study||1002||
59703411|NCT01151085|75822548|FG000|COMPLETED|Overall Study||946||
59703412|NCT01151085|75822548|FG000|NOT COMPLETED|Overall Study||56||
59703413|NCT01149681|75822559|FG000|STARTED|Overall Study||12||
59703414|NCT01149681|75822559|FG000|COMPLETED|Overall Study||0||
59703415|NCT01149681|75822559|FG000|NOT COMPLETED|Overall Study||12||
59703416|NCT01149369|75822566|FG000|STARTED|Overall Study||63||
59703417|NCT01149369|75822567|FG001|STARTED|Overall Study||63||
59703418|NCT01149369|75822566|FG000|COMPLETED|Overall Study||57||
59703419|NCT01149369|75822567|FG001|COMPLETED|Overall Study||60||
59703420|NCT01149369|75822566|FG000|NOT COMPLETED|Overall Study||6||
59703421|NCT01149369|75822567|FG001|NOT COMPLETED|Overall Study||3||
59703422|NCT01149057|75822573|FG000|STARTED|Overall Study||145||
59703423|NCT01149057|75822573|FG000|COMPLETED|Overall Study||88||
59703424|NCT01149057|75822573|FG000|NOT COMPLETED|Overall Study||57||
59703425|NCT01227564|75822580|FG000|STARTED|Overall Study||22||
59703426|NCT01227564|75822581|FG001|STARTED|Overall Study||20||
59703427|NCT01227564|75822582|FG002|STARTED|Overall Study||21||
59703428|NCT01227564|75822580|FG000|Treated|Overall Study||22||
59703429|NCT01227564|75822581|FG001|Treated|Overall Study||20||
59703430|NCT01227564|75822582|FG002|Treated|Overall Study||21||
59703431|NCT01227564|75822580|FG000|Completed Treatment|Overall Study|1 participant discontinued treatment due to an adverse event (AE).|21||
59703432|NCT01227564|75822581|FG001|Completed Treatment|Overall Study|2 participants discontinued treatment due to no longer willing to participate in study.|18||
59703433|NCT01227564|75822582|FG002|Completed Treatment|Overall Study|1 participant stopped treatment due to lack of efficacy, 3 due to no longer willing to participate.|17||
59703434|NCT01227564|75822580|FG000|COMPLETED|Overall Study|Completed study|18||
59703435|NCT01227564|75822581|FG001|COMPLETED|Overall Study|Completed study|18||
59703436|NCT01227564|75822582|FG002|COMPLETED|Overall Study|Completed study|15||
59703437|NCT01227564|75822580|FG000|NOT COMPLETED|Overall Study||4||
59703438|NCT01227564|75822581|FG001|NOT COMPLETED|Overall Study||2||
59703439|NCT01227564|75822582|FG002|NOT COMPLETED|Overall Study||6||
59703440|NCT00739141|75822592|FG000|STARTED|Overall Study||86||
59703441|NCT00739141|75822592|FG000|COMPLETED|Overall Study||81||
59703442|NCT00739141|75822592|FG000|NOT COMPLETED|Overall Study||5||
59703443|NCT01148979|75822598|FG000|STARTED|Overall Study||13||
59703444|NCT01148979|75822599|FG001|STARTED|Overall Study||16||
59703445|NCT01148979|75822598|FG000|COMPLETED|Overall Study||13||
59703446|NCT01148979|75822599|FG001|COMPLETED|Overall Study||15||
59703447|NCT01148979|75822598|FG000|NOT COMPLETED|Overall Study||0||
59703448|NCT01148979|75822599|FG001|NOT COMPLETED|Overall Study||1||
59703449|NCT01148511|75822607|FG000|STARTED|Exposed to Study Drug||99||
59703450|NCT01148511|75822608|FG001|STARTED|Exposed to Study Drug|Patients were not randomized to this group until the Randomized Period.|0||
59703451|NCT01148511|75822609|FG002|STARTED|Exposed to Study Drug|Patients were not randomized to this group until the Randomized Period.|0||
59703452|NCT01148511|75822607|FG000|COMPLETED|Exposed to Study Drug||93||
59703453|NCT01148511|75822608|FG001|COMPLETED|Exposed to Study Drug||0||
59703454|NCT01148511|75822609|FG002|COMPLETED|Exposed to Study Drug||0||
59703455|NCT01148511|75822607|FG000|NOT COMPLETED|Exposed to Study Drug||6||
59703456|NCT01148511|75822608|FG001|NOT COMPLETED|Exposed to Study Drug||0||
59703457|NCT01148511|75822609|FG002|NOT COMPLETED|Exposed to Study Drug||0||
59703458|NCT01148511|75822607|FG000|STARTED|Randomized|All patients were randomized into the Treat and Extend and the Treat and Observe treatment groups.|0||
59703459|NCT01148511|75822608|FG001|STARTED|Randomized||48||
59703460|NCT01148511|75822609|FG002|STARTED|Randomized||45||
59703461|NCT01148511|75822607|FG000|COMPLETED|Randomized||0||
59703462|NCT01148511|75822608|FG001|COMPLETED|Randomized||38||
59703463|NCT01148511|75822609|FG002|COMPLETED|Randomized||39||
59703464|NCT01148511|75822607|FG000|NOT COMPLETED|Randomized||0||
59703465|NCT01148511|75822608|FG001|NOT COMPLETED|Randomized||10||
59703466|NCT01148511|75822609|FG002|NOT COMPLETED|Randomized||6||
59703467|NCT00547339|75822620|FG000|STARTED|Overall Study||15||
59703468|NCT00547339|75822621|FG001|STARTED|Overall Study||15||
59703469|NCT00547339|75822622|FG002|STARTED|Overall Study||15||
59703470|NCT00547339|75822623|FG003|STARTED|Overall Study||47||
59703471|NCT00547339|75822620|FG000|COMPLETED|Overall Study||15||
59703472|NCT00547339|75822621|FG001|COMPLETED|Overall Study||15||
59703473|NCT00547339|75822622|FG002|COMPLETED|Overall Study||14||
59703474|NCT00547339|75822623|FG003|COMPLETED|Overall Study||47||
59703475|NCT00547339|75822620|FG000|NOT COMPLETED|Overall Study||0||
59703476|NCT00547339|75822621|FG001|NOT COMPLETED|Overall Study||0||
59703477|NCT00547339|75822622|FG002|NOT COMPLETED|Overall Study||1||
59703478|NCT00547339|75822623|FG003|NOT COMPLETED|Overall Study||0||
59703479|NCT01227252|75822646|FG000|STARTED|Overall Study||12||
59703480|NCT01227252|75822647|FG001|STARTED|Overall Study||10||
59703481|NCT01227252|75822648|FG002|STARTED|Overall Study||10||
59703482|NCT01227252|75822649|FG003|STARTED|Overall Study||10||
60079740|NCT03444870|76194900|FG002|Safety Magnetic Resonance Imaging (MRI)-Evaluable (SEMRI) Analysis Set|Double-Blind Treatment (DBT) Period||0|SEMRI analysis set included all participants in the SE analysis set who had at least one post-baseline safety MRI scan.|
60079741|NCT03444870|76194901|FG003|Safety Magnetic Resonance Imaging (MRI)-Evaluable (SEMRI) Analysis Set|Double-Blind Treatment (DBT) Period||0|SEMRI analysis set included all participants in the SE analysis set who had at least one post-baseline safety MRI scan.|
60079742|NCT03444870|76194902|FG004|Safety Magnetic Resonance Imaging (MRI)-Evaluable (SEMRI) Analysis Set|Double-Blind Treatment (DBT) Period||0|SEMRI analysis set included all participants in the SE analysis set who had at least one post-baseline safety MRI scan.|
59990851|NCT01680159|76106395|FG000|NOT COMPLETED|Increased Dose Period||8||
59990852|NCT02491892|76106417|FG000|STARTED|Overall Study||41||
59990853|NCT02491892|76106418|FG001|STARTED|Overall Study||38||
59990854|NCT02491892|76106417|FG000|Treated|Overall Study||41||
59990855|NCT02491892|76106418|FG001|Treated|Overall Study|One participant was randomized but died before receiving study medication.|37||
59990856|NCT02491892|76106417|FG000|COMPLETED|Overall Study||0||
60079743|NCT03444870|76194903|FG005|Safety Magnetic Resonance Imaging (MRI)-Evaluable (SEMRI) Analysis Set|Double-Blind Treatment (DBT) Period||0|SEMRI analysis set included all participants in the SE analysis set who had at least one post-baseline safety MRI scan.|
60079744|NCT03444870|76194898|FG000|COMPLETED|Double-Blind Treatment (DBT) Period||387||
60079745|NCT03444870|76194899|FG001|COMPLETED|Double-Blind Treatment (DBT) Period||375||
60079746|NCT03444870|76194900|FG002|COMPLETED|Double-Blind Treatment (DBT) Period||0||
60079747|NCT03444870|76194901|FG003|COMPLETED|Double-Blind Treatment (DBT) Period||0||
60079748|NCT03444870|76194902|FG004|COMPLETED|Double-Blind Treatment (DBT) Period||0||
60079749|NCT03444870|76194903|FG005|COMPLETED|Double-Blind Treatment (DBT) Period||0||
60079750|NCT03444870|76194898|FG000|NOT COMPLETED|Double-Blind Treatment (DBT) Period||99||
60079751|NCT03444870|76194899|FG001|NOT COMPLETED|Double-Blind Treatment (DBT) Period||124||
60079752|NCT03444870|76194900|FG002|NOT COMPLETED|Double-Blind Treatment (DBT) Period||33||
60079753|NCT03444870|76194901|FG003|NOT COMPLETED|Double-Blind Treatment (DBT) Period||35||
60079754|NCT03444870|76194902|FG004|NOT COMPLETED|Double-Blind Treatment (DBT) Period||0||
60079755|NCT03444870|76194903|FG005|NOT COMPLETED|Double-Blind Treatment (DBT) Period||0||
60079756|NCT03444870|76194898|FG000|STARTED|Open-Label Extension (OLE) Period|Participants who completed the DBT Period were given the option to enroll in the OLE Period to receive gantenerumab.|0||
60079757|NCT03444870|76194899|FG001|STARTED|Open-Label Extension (OLE) Period|Participants who completed the DBT Period were given the option to enroll in the OLE Period to receive gantenerumab.|0||
59703483|NCT01227252|75822646|FG000|Received at Least 1 Dose of Study Drug|Overall Study||12||
59703484|NCT01227252|75822647|FG001|Received at Least 1 Dose of Study Drug|Overall Study||10||
59703485|NCT01227252|75822648|FG002|Received at Least 1 Dose of Study Drug|Overall Study||10||
59990857|NCT02491892|76106418|FG001|COMPLETED|Overall Study||0||
59703486|NCT01227252|75822649|FG003|Received at Least 1 Dose of Study Drug|Overall Study||10||
59703487|NCT01227252|75822646|FG000|COMPLETED|Overall Study||12||
59703488|NCT01227252|75822647|FG001|COMPLETED|Overall Study||7||
59703489|NCT01227252|75822648|FG002|COMPLETED|Overall Study||10||
59703490|NCT01227252|75822649|FG003|COMPLETED|Overall Study||10||
59703491|NCT01227252|75822646|FG000|NOT COMPLETED|Overall Study||0||
59990858|NCT02491892|76106417|FG000|NOT COMPLETED|Overall Study||41||
59990859|NCT02491892|76106418|FG001|NOT COMPLETED|Overall Study||38||
59990860|NCT04931888|76106428|FG000|STARTED|Overall Study||17|"Unit applied to children for consistency across columns. Although written as 0 units for parents to ensure the total column is correct, each parent is also from one family unit as well, corresponding to their child's family unit."|5
59990861|NCT04931888|76106429|FG001|STARTED|Overall Study|The family unit is only applicable to the child arms of the study.|5|"Unit applied to children for consistency across columns. Although written as 0 units for parents to ensure the total column is correct, each parent is also from one family unit as well, corresponding to their child's family unit."|0
59703492|NCT01227252|75822647|FG001|NOT COMPLETED|Overall Study||3||
59703493|NCT01227252|75822648|FG002|NOT COMPLETED|Overall Study||0||
59703494|NCT01227252|75822649|FG003|NOT COMPLETED|Overall Study||0||
59703495|NCT01227018|75822662|FG000|STARTED|Overall Study||15||
59703496|NCT01227018|75822662|FG000|COMPLETED|Overall Study||0||
59703497|NCT01227018|75822662|FG000|NOT COMPLETED|Overall Study||15||
59703498|NCT01659541|75822666|FG000|STARTED|Overall Study||12||
59703499|NCT01659541|75822666|FG000|COMPLETED|Overall Study||11||
59703500|NCT01659541|75822666|FG000|NOT COMPLETED|Overall Study||1||
59703501|NCT01226472|75822676|FG000|STARTED|Overall Study||1||
59703502|NCT01226472|75822676|FG000|COMPLETED|Overall Study||0||
59703503|NCT01226472|75822676|FG000|NOT COMPLETED|Overall Study||1||
59703504|NCT01225146|75822682|FG000|STARTED|Overall Study||6||
59703505|NCT01225146|75822683|FG001|STARTED|Overall Study||2||
59703506|NCT01225146|75822682|FG000|COMPLETED|Overall Study||6||
59703507|NCT01225146|75822683|FG001|COMPLETED|Overall Study||0||
59703508|NCT01225146|75822682|FG000|NOT COMPLETED|Overall Study||0||
59703509|NCT01225146|75822683|FG001|NOT COMPLETED|Overall Study||2||
59703510|NCT01223196|75822693|FG000|STARTED|Overall Study||13||
59703511|NCT01223196|75822694|FG001|STARTED|Overall Study||11||
59703512|NCT01223196|75822693|FG000|COMPLETED|Overall Study||9||
59703513|NCT01223196|75822694|FG001|COMPLETED|Overall Study||11||
59703514|NCT01223196|75822693|FG000|NOT COMPLETED|Overall Study||4||
59703515|NCT01223196|75822694|FG001|NOT COMPLETED|Overall Study||0||
59703516|NCT01222416|75822704|FG000|STARTED|Overall Study||50||
59703517|NCT01222416|75822705|FG001|STARTED|Overall Study||0||
59703518|NCT01222416|75822704|FG000|COMPLETED|Overall Study||30||
59703519|NCT01222416|75822705|FG001|COMPLETED|Overall Study||0||
59703520|NCT01222416|75822704|FG000|NOT COMPLETED|Overall Study||20||
59703521|NCT01222416|75822705|FG001|NOT COMPLETED|Overall Study||0||
59703522|NCT01222104|75822711|FG000|STARTED|Overall Study||634||
59703523|NCT01222104|75822711|FG000|Angio-Seal Deployment Attempted|Overall Study||534||
59703524|NCT01222104|75822711|FG000|Successful Deployment|Overall Study||529||
59703525|NCT01222104|75822711|FG000|Successful Deployment and Hemostasis|Overall Study||524||
59703526|NCT01222104|75822711|FG000|Completed 30-day Visit-Angio-Seal|Overall Study||497||
59703527|NCT01222104|75822711|FG000|Completed 30-day Visit-No Angio-Seal|Overall Study||90||
59703528|NCT01222104|75822711|FG000|COMPLETED|Overall Study||587||
59703529|NCT01222104|75822711|FG000|NOT COMPLETED|Overall Study||47||
59703530|NCT01221948|75822721|FG000|STARTED|Overall Study||53||
59703531|NCT01221948|75822721|FG000|COMPLETED|Overall Study||39||
59703532|NCT01221948|75822721|FG000|NOT COMPLETED|Overall Study||14||
59703533|NCT01221090|75822729|FG000|STARTED|Overall Study||101||
59703534|NCT01221090|75822730|FG001|STARTED|Overall Study||81||
59703535|NCT01221090|75822731|FG002|STARTED|Overall Study||99||
59703536|NCT01221090|75822732|FG003|STARTED|Overall Study||95||
59703537|NCT01221090|75822729|FG000|COMPLETED|Overall Study||86||
59703538|NCT01221090|75822730|FG001|COMPLETED|Overall Study||47||
59703539|NCT01221090|75822731|FG002|COMPLETED|Overall Study||57||
59703540|NCT01221090|75822732|FG003|COMPLETED|Overall Study||73||
59703541|NCT01221090|75822729|FG000|NOT COMPLETED|Overall Study||15||
59703542|NCT01221090|75822730|FG001|NOT COMPLETED|Overall Study||34||
59703543|NCT01221090|75822731|FG002|NOT COMPLETED|Overall Study||42||
59703544|NCT01221090|75822732|FG003|NOT COMPLETED|Overall Study||22||
59703545|NCT00950911|75822744|FG000|STARTED|Overall Study||17||
59703546|NCT00950911|75822745|FG001|STARTED|Overall Study||18||
59703547|NCT00950911|75822744|FG000|COMPLETED|Overall Study||5||
59703548|NCT00950911|75822745|FG001|COMPLETED|Overall Study||3||
59703549|NCT00950911|75822744|FG000|NOT COMPLETED|Overall Study||12||
59703550|NCT00950911|75822745|FG001|NOT COMPLETED|Overall Study||15||
59703551|NCT01220856|75822753|FG000|STARTED|Overall Study||6||
59703552|NCT01220856|75822754|FG001|STARTED|Overall Study||3||
59703553|NCT01220856|75822753|FG000|COMPLETED|Overall Study||2||
59703554|NCT01220856|75822754|FG001|COMPLETED|Overall Study||0||
59703555|NCT01220856|75822753|FG000|NOT COMPLETED|Overall Study||4||
59703556|NCT01220856|75822754|FG001|NOT COMPLETED|Overall Study||3||
59703557|NCT01218594|75822763|FG000|STARTED|Overall Study||48||
59703558|NCT01218594|75822763|FG000|COMPLETED|Overall Study||36||
59703559|NCT01218594|75822763|FG000|NOT COMPLETED|Overall Study||12||
59703560|NCT01610557|75822771|FG000|STARTED|36-Week Randomized Crossover Phase|Participants randomly assigned to Grp 1: 14 unilateral and 2 bilateral (left eye assigned to Grp 3)|16||
59703561|NCT01610557|75822772|FG001|STARTED|36-Week Randomized Crossover Phase|Participants randomly assigned to Grp 2: 12 unilateral and 1 bilateral (left eye assigned to Grp 4)|13||
59703562|NCT01610557|75822773|FG002|STARTED|36-Week Randomized Crossover Phase|Participants randomly assigned to Grp 3: 13 unilateral and 1 bilateral (left eye assigned to Grp 1)|14||
59703563|NCT01610557|75822774|FG003|STARTED|36-Week Randomized Crossover Phase|Participants randomly assigned to Grp 4: 11 unilateral and 2 bilateral (left eye assigned to Grp 2)|13||
59703564|NCT01610557|75822775|FG004|STARTED|36-Week Randomized Crossover Phase|Not applicable for 36-week double-masked randomized crossover phase|0||
59548226|NCT01172522|75647165|FG001|STARTED|Overall Study||15||
59548227|NCT01172522|75647164|FG000|COMPLETED|Overall Study||15||
59703565|NCT01610557|75822771|FG000|COMPLETED|36-Week Randomized Crossover Phase||16||
59703566|NCT01610557|75822772|FG001|COMPLETED|36-Week Randomized Crossover Phase|Unilateral participant unable to return for visits after Wk 4 due to recovery from an adverse event|12||
59703567|NCT01610557|75822773|FG002|COMPLETED|36-Week Randomized Crossover Phase||14||
59703568|NCT01610557|75822774|FG003|COMPLETED|36-Week Randomized Crossover Phase||13||
59703569|NCT01610557|75822775|FG004|COMPLETED|36-Week Randomized Crossover Phase|Not applicable for 36-week double-masked randomized crossover phase|0||
59703570|NCT01610557|75822771|FG000|NOT COMPLETED|36-Week Randomized Crossover Phase||0||
59703571|NCT01610557|75822772|FG001|NOT COMPLETED|36-Week Randomized Crossover Phase||1||
59703572|NCT01610557|75822773|FG002|NOT COMPLETED|36-Week Randomized Crossover Phase||0||
59816251|NCT00610649|75938614|FG005|NOT COMPLETED|Overall Study||0||
59548228|NCT01172522|75647165|FG001|COMPLETED|Overall Study||15||
59703573|NCT01610557|75822774|FG003|NOT COMPLETED|36-Week Randomized Crossover Phase||0||
59703574|NCT01610557|75822775|FG004|NOT COMPLETED|36-Week Randomized Crossover Phase||0||
59703575|NCT01610557|75822771|FG000|STARTED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0||
59703576|NCT01610557|75822772|FG001|STARTED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0||
59703577|NCT01610557|75822773|FG002|STARTED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0||
59703578|NCT01610557|75822774|FG003|STARTED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0||
59703579|NCT01610557|75822775|FG004|STARTED|Post-36-Week Extension Phase||55||
59703580|NCT01610557|75822771|FG000|COMPLETED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0||
59703581|NCT01610557|75822772|FG001|COMPLETED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0||
59703582|NCT01610557|75822773|FG002|COMPLETED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0||
59703583|NCT01610557|75822774|FG003|COMPLETED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0||
59703584|NCT01610557|75822775|FG004|COMPLETED|Post-36-Week Extension Phase|2 bilateral participants withdrew before their first post-36-week extension visit|52||
59703585|NCT01610557|75822771|FG000|NOT COMPLETED|Post-36-Week Extension Phase||0||
59703586|NCT01610557|75822772|FG001|NOT COMPLETED|Post-36-Week Extension Phase||0||
59703587|NCT01610557|75822773|FG002|NOT COMPLETED|Post-36-Week Extension Phase||0||
59703588|NCT01610557|75822774|FG003|NOT COMPLETED|Post-36-Week Extension Phase||0||
59703589|NCT01610557|75822775|FG004|NOT COMPLETED|Post-36-Week Extension Phase||3||
59703590|NCT00943735|75822786|FG000|STARTED|Overall Study||774||
59703591|NCT00943735|75822786|FG000|Per Protocol Population|Overall Study||500||
59703592|NCT00943735|75822786|FG000|COMPLETED|Overall Study||742||
59703593|NCT00943735|75822786|FG000|NOT COMPLETED|Overall Study||32||
59703594|NCT00943579|75822792|FG000|STARTED|Overall Study||21||
59703595|NCT00943579|75822793|FG001|STARTED|Overall Study||20||
59703596|NCT00943579|75822792|FG000|COMPLETED|Overall Study||15||
59703597|NCT00943579|75822793|FG001|COMPLETED|Overall Study||15||
59703598|NCT00943579|75822792|FG000|NOT COMPLETED|Overall Study||6||
59703599|NCT00943579|75822793|FG001|NOT COMPLETED|Overall Study||5||
59703600|NCT01147809|75822808|FG000|STARTED|Phase I (168 Days)||3||
59703601|NCT01147809|75822809|FG001|STARTED|Phase I (168 Days)||9||
59703602|NCT01147809|75822810|FG002|STARTED|Phase I (168 Days)||4||
59703603|NCT01147809|75822811|FG003|STARTED|Phase I (168 Days)||10||
59703604|NCT01147809|75822812|FG004|STARTED|Phase I (168 Days)||0||
59703605|NCT01147809|75822813|FG005|STARTED|Phase I (168 Days)||0||
59703606|NCT01147809|75822808|FG000|COMPLETED|Phase I (168 Days)||2||
59703607|NCT01147809|75822809|FG001|COMPLETED|Phase I (168 Days)||8||
59703608|NCT01147809|75822810|FG002|COMPLETED|Phase I (168 Days)||2||
59703609|NCT01147809|75822811|FG003|COMPLETED|Phase I (168 Days)||5||
59703610|NCT01147809|75822812|FG004|COMPLETED|Phase I (168 Days)||0||
59703611|NCT01147809|75822813|FG005|COMPLETED|Phase I (168 Days)||0||
59703612|NCT01147809|75822808|FG000|NOT COMPLETED|Phase I (168 Days)||1||
59703613|NCT01147809|75822809|FG001|NOT COMPLETED|Phase I (168 Days)||1||
59703614|NCT01147809|75822810|FG002|NOT COMPLETED|Phase I (168 Days)||2||
59703615|NCT01147809|75822811|FG003|NOT COMPLETED|Phase I (168 Days)||5||
59703616|NCT01147809|75822812|FG004|NOT COMPLETED|Phase I (168 Days)||0||
59703617|NCT01147809|75822813|FG005|NOT COMPLETED|Phase I (168 Days)||0||
59703618|NCT01147809|75822808|FG000|STARTED|Phase II (168 Days)||0||
59703619|NCT01147809|75822809|FG001|STARTED|Phase II (168 Days)||0||
59703620|NCT01147809|75822810|FG002|STARTED|Phase II (168 Days)||0||
59703621|NCT01147809|75822811|FG003|STARTED|Phase II (168 Days)||0||
59703622|NCT01147809|75822812|FG004|STARTED|Phase II (168 Days)||23||
59703623|NCT01147809|75822813|FG005|STARTED|Phase II (168 Days)||52||
59703624|NCT01147809|75822808|FG000|Ongoing|Phase II (168 Days)||0||
59703625|NCT01147809|75822809|FG001|Ongoing|Phase II (168 Days)||0||
59703626|NCT01147809|75822810|FG002|Ongoing|Phase II (168 Days)||0||
59703627|NCT01147809|75822811|FG003|Ongoing|Phase II (168 Days)||0||
59703628|NCT01147809|75822812|FG004|Ongoing|Phase II (168 Days)||1||
59703629|NCT01147809|75822813|FG005|Ongoing|Phase II (168 Days)||0||
59703630|NCT01147809|75822808|FG000|COMPLETED|Phase II (168 Days)||0||
59703631|NCT01147809|75822809|FG001|COMPLETED|Phase II (168 Days)||0||
59703632|NCT01147809|75822810|FG002|COMPLETED|Phase II (168 Days)||0||
59703633|NCT01147809|75822811|FG003|COMPLETED|Phase II (168 Days)||0||
59703634|NCT01147809|75822812|FG004|COMPLETED|Phase II (168 Days)||7||
59703635|NCT01147809|75822813|FG005|COMPLETED|Phase II (168 Days)||19||
59703636|NCT01147809|75822808|FG000|NOT COMPLETED|Phase II (168 Days)||0||
59703637|NCT01147809|75822809|FG001|NOT COMPLETED|Phase II (168 Days)||0||
59703638|NCT01147809|75822810|FG002|NOT COMPLETED|Phase II (168 Days)||0||
59703639|NCT01147809|75822811|FG003|NOT COMPLETED|Phase II (168 Days)||0||
59703640|NCT01147809|75822812|FG004|NOT COMPLETED|Phase II (168 Days)||16||
59703641|NCT01147809|75822813|FG005|NOT COMPLETED|Phase II (168 Days)||33||
59703642|NCT00943111|75822830|FG000|STARTED|52-Weeks Primary Analysis Period||106||
59703643|NCT00943111|75822831|FG001|STARTED|52-Weeks Primary Analysis Period||54||
59703644|NCT00943111|75822832|FG002|STARTED|52-Weeks Primary Analysis Period||0||
59703645|NCT00943111|75822830|FG000|Treated|52-Weeks Primary Analysis Period||106||
59703646|NCT00943111|75822831|FG001|Treated|52-Weeks Primary Analysis Period||53||
59703647|NCT00943111|75822832|FG002|Treated|52-Weeks Primary Analysis Period||0||
59703648|NCT00943111|75822830|FG000|COMPLETED|52-Weeks Primary Analysis Period||104||
59703649|NCT00943111|75822831|FG001|COMPLETED|52-Weeks Primary Analysis Period||52||
59703650|NCT00943111|75822832|FG002|COMPLETED|52-Weeks Primary Analysis Period||0||
59703651|NCT00943111|75822830|FG000|NOT COMPLETED|52-Weeks Primary Analysis Period||2||
59703652|NCT00943111|75822831|FG001|NOT COMPLETED|52-Weeks Primary Analysis Period||2||
59703653|NCT00943111|75822832|FG002|NOT COMPLETED|52-Weeks Primary Analysis Period||0||
59703654|NCT00943111|75822830|FG000|STARTED|5 Years Long-term Treatment Period||0||
59703655|NCT00943111|75822831|FG001|STARTED|5 Years Long-term Treatment Period||0||
59703656|NCT00943111|75822832|FG002|STARTED|5 Years Long-term Treatment Period|Participants from both the arms of PAP who completed PAP and remained on-study|152||
59703657|NCT00943111|75822830|FG000|COMPLETED|5 Years Long-term Treatment Period||0||
59703658|NCT00943111|75822831|FG001|COMPLETED|5 Years Long-term Treatment Period||0||
59703659|NCT00943111|75822832|FG002|COMPLETED|5 Years Long-term Treatment Period||77||
59703660|NCT00943111|75822830|FG000|NOT COMPLETED|5 Years Long-term Treatment Period||0||
59703661|NCT00943111|75822831|FG001|NOT COMPLETED|5 Years Long-term Treatment Period||0||
59703662|NCT00943111|75822832|FG002|NOT COMPLETED|5 Years Long-term Treatment Period||75||
59703663|NCT01147497|75822841|FG000|STARTED|Overall Study||37||
59703664|NCT01147497|75822842|FG001|STARTED|Overall Study||36||
59703665|NCT01147497|75822841|FG000|COMPLETED|Overall Study||35||
59703666|NCT01147497|75822842|FG001|COMPLETED|Overall Study||36||
59703667|NCT01147497|75822841|FG000|NOT COMPLETED|Overall Study||2||
59703668|NCT01147497|75822842|FG001|NOT COMPLETED|Overall Study||0||
59703669|NCT01147341|75822850|FG000|STARTED|Double Blind Period||27||
59703670|NCT01147341|75822851|FG001|STARTED|Double Blind Period||10||
59703671|NCT01147341|75822850|FG000|COMPLETED|Double Blind Period||26||
59703672|NCT01147341|75822851|FG001|COMPLETED|Double Blind Period||8||
59703673|NCT01147341|75822850|FG000|NOT COMPLETED|Double Blind Period||1||
59703674|NCT01147341|75822851|FG001|NOT COMPLETED|Double Blind Period||2||
59703675|NCT01147341|75822850|FG000|STARTED|Open Label Period||26||
59703676|NCT01147341|75822851|FG001|STARTED|Open Label Period||8||
59703677|NCT01147341|75822850|FG000|COMPLETED|Open Label Period||22||
59703678|NCT01147341|75822851|FG001|COMPLETED|Open Label Period||8||
59703679|NCT01147341|75822850|FG000|NOT COMPLETED|Open Label Period||4||
59703680|NCT01147341|75822851|FG001|NOT COMPLETED|Open Label Period||0||
59703681|NCT00950755|75822857|FG000|STARTED|Dosimetric and Therapeutic Treatment||41||
59703682|NCT00950755|75822857|FG000|COMPLETED|Dosimetric and Therapeutic Treatment||0||
59703683|NCT00950755|75822857|FG000|NOT COMPLETED|Dosimetric and Therapeutic Treatment||41||
59703684|NCT00950755|75822857|FG000|STARTED|Long-Term Follow-Up|18 of the 41 participants withdrawing from Study BEX104505 enrolled in the LTFU study.|18||
59703685|NCT00950755|75822857|FG000|COMPLETED|Long-Term Follow-Up||9||
59703686|NCT00950755|75822857|FG000|NOT COMPLETED|Long-Term Follow-Up||9||
59703687|NCT01147107|75822863|FG000|STARTED|Overall Study||39||
59703688|NCT01147107|75822864|FG001|STARTED|Overall Study||41||
59703689|NCT01147107|75822863|FG000|COMPLETED|Overall Study||33||
59703690|NCT01147107|75822864|FG001|COMPLETED|Overall Study||40||
59703691|NCT01147107|75822863|FG000|NOT COMPLETED|Overall Study||6||
59703692|NCT01147107|75822864|FG001|NOT COMPLETED|Overall Study||1||
59703693|NCT00942409|75822870|FG000|STARTED|Overall Study||5||
59703694|NCT00942409|75822870|FG000|COMPLETED|Overall Study||2||
59703695|NCT00942409|75822870|FG000|NOT COMPLETED|Overall Study||3||
59703696|NCT01146951|75822876|FG000|STARTED|Overall Study||29||
59703697|NCT01146951|75822877|FG001|STARTED|Overall Study||30||
59703698|NCT01146951|75822876|FG000|COMPLETED|Overall Study||25||
59703699|NCT01146951|75822877|FG001|COMPLETED|Overall Study||29||
59703700|NCT01146951|75822876|FG000|NOT COMPLETED|Overall Study||4||
59703701|NCT01146951|75822877|FG001|NOT COMPLETED|Overall Study||1||
59703702|NCT01146873|75822885|FG000|STARTED|Overall Study||148||
59703703|NCT01146873|75822886|FG001|STARTED|Overall Study||150||
59703704|NCT01146873|75822885|FG000|COMPLETED|Overall Study||148||
59703705|NCT01146873|75822886|FG001|COMPLETED|Overall Study||144||
59703706|NCT01146873|75822885|FG000|NOT COMPLETED|Overall Study||0||
59703707|NCT01146873|75822886|FG001|NOT COMPLETED|Overall Study||6||
59703708|NCT01146795|75822892|FG000|STARTED|Overall Study||32||
59703709|NCT01146795|75822892|FG000|COMPLETED|Overall Study||12||
59703710|NCT01146795|75822892|FG000|NOT COMPLETED|Overall Study||20||
59703711|NCT01146561|75822896|FG000|STARTED|Overall Study||2||
59703712|NCT01146561|75822896|FG000|COMPLETED|Overall Study||0||
59703713|NCT01146561|75822896|FG000|NOT COMPLETED|Overall Study||2||
59703714|NCT00942175|75822904|FG000|STARTED|Overall Study||40||
59703715|NCT00942175|75822905|FG001|STARTED|Overall Study||40||
59703716|NCT00942175|75822906|FG002|STARTED|Overall Study||40||
59703717|NCT00942175|75822907|FG003|STARTED|Overall Study||40||
59703718|NCT00942175|75822904|FG000|COMPLETED|Overall Study||38||
59703719|NCT00942175|75822905|FG001|COMPLETED|Overall Study||36||
59703720|NCT00942175|75822906|FG002|COMPLETED|Overall Study||38||
59703721|NCT00942175|75822907|FG003|COMPLETED|Overall Study||38||
59703722|NCT00942175|75822904|FG000|NOT COMPLETED|Overall Study||2||
59703723|NCT00942175|75822905|FG001|NOT COMPLETED|Overall Study||4||
59703724|NCT00942175|75822906|FG002|NOT COMPLETED|Overall Study||2||
59703725|NCT00942175|75822907|FG003|NOT COMPLETED|Overall Study||2||
59703726|NCT01145625|75822927|FG000|STARTED|Overall Study||161||
59703727|NCT01145625|75822928|FG001|STARTED|Overall Study||161||
59990862|NCT04931888|76106430|FG002|STARTED|Overall Study||6|"Unit applied to children for consistency across columns. Although written as 0 units for parents to ensure the total column is correct, each parent is also from one family unit as well, corresponding to their child's family unit."|3
59990863|NCT04931888|76106431|FG003|STARTED|Overall Study|The family unit is only applicable to the child arms of the study.|3|"Unit applied to children for consistency across columns. Although written as 0 units for parents to ensure the total column is correct, each parent is also from one family unit as well, corresponding to their child's family unit."|0
59990864|NCT04931888|76106428|FG000|COMPLETED|Overall Study||13||3
59990865|NCT04931888|76106429|FG001|COMPLETED|Overall Study|The family unit is only applicable to the child arms of the study.|3||0
59990866|NCT04931888|76106430|FG002|COMPLETED|Overall Study||6||3
59990867|NCT04931888|76106431|FG003|COMPLETED|Overall Study|The family unit is only applicable to the child arms of the study.|3||0
59703728|NCT01145625|75822927|FG000|COMPLETED|Overall Study||137||
59703729|NCT01145625|75822928|FG001|COMPLETED|Overall Study||130||
59703730|NCT01145625|75822927|FG000|NOT COMPLETED|Overall Study||24||
59703731|NCT01145625|75822928|FG001|NOT COMPLETED|Overall Study||31||
59703732|NCT01144377|75822939|FG000|STARTED|52 Week Treatment Period||31||
59703733|NCT01144377|75822940|FG001|STARTED|52 Week Treatment Period||30||
59703734|NCT01144377|75822941|FG002|STARTED|52 Week Treatment Period||30||
59703735|NCT01144377|75822942|FG003|STARTED|52 Week Treatment Period||26||
59703736|NCT01144377|75822943|FG004|STARTED|52 Week Treatment Period||37||
59703737|NCT01144377|75822939|FG000|Received at Least One Dose of Study Drug|52 Week Treatment Period||31||
59703738|NCT01144377|75822940|FG001|Received at Least One Dose of Study Drug|52 Week Treatment Period||30||
59703739|NCT01144377|75822941|FG002|Received at Least One Dose of Study Drug|52 Week Treatment Period||30||
59703740|NCT01144377|75822942|FG003|Received at Least One Dose of Study Drug|52 Week Treatment Period||25||
59703741|NCT01144377|75822943|FG004|Received at Least One Dose of Study Drug|52 Week Treatment Period||37||
59703742|NCT01144377|75822939|FG000|COMPLETED|52 Week Treatment Period||26||
59703743|NCT01144377|75822940|FG001|COMPLETED|52 Week Treatment Period||29||
59703744|NCT01144377|75822941|FG002|COMPLETED|52 Week Treatment Period||25||
59703745|NCT01144377|75822942|FG003|COMPLETED|52 Week Treatment Period||22||
59703746|NCT01144377|75822943|FG004|COMPLETED|52 Week Treatment Period||34||
59703747|NCT01144377|75822939|FG000|NOT COMPLETED|52 Week Treatment Period||5||
59703748|NCT01144377|75822940|FG001|NOT COMPLETED|52 Week Treatment Period||1||
59703749|NCT01144377|75822941|FG002|NOT COMPLETED|52 Week Treatment Period||5||
59703750|NCT01144377|75822942|FG003|NOT COMPLETED|52 Week Treatment Period||4||
59703751|NCT01144377|75822943|FG004|NOT COMPLETED|52 Week Treatment Period||3||
59703752|NCT01144377|75822939|FG000|STARTED|12 Week Safety Follow-up Period||26||
59703753|NCT01144377|75822940|FG001|STARTED|12 Week Safety Follow-up Period||29||
59703754|NCT01144377|75822941|FG002|STARTED|12 Week Safety Follow-up Period||25||
59703755|NCT01144377|75822942|FG003|STARTED|12 Week Safety Follow-up Period||22||
59703756|NCT01144377|75822943|FG004|STARTED|12 Week Safety Follow-up Period||34||
59703757|NCT01144377|75822939|FG000|COMPLETED|12 Week Safety Follow-up Period|Of the 26 participants who completed this Period, 22 continued to the Optional 40 Week follow-up.|26||
60079758|NCT03444870|76194900|FG002|STARTED|Open-Label Extension (OLE) Period|Participants who completed the China Extension -DBT Period were given the option to enroll in the OLE Period to receive gantenerumab.|0||
60079759|NCT03444870|76194901|FG003|STARTED|Open-Label Extension (OLE) Period|Participants who completed the China Extension -DBT Period were given the option to enroll in the OLE Period to receive gantenerumab.|0||
60079760|NCT03444870|76194902|FG004|STARTED|Open-Label Extension (OLE) Period|10 participants who completed the DBT Period enrolled into the OLE Period.|10||
60079761|NCT03444870|76194903|FG005|STARTED|Open-Label Extension (OLE) Period|19 Participants who completed the DBT Period enrolled into the OLE Period.|19||
60079762|NCT03444870|76194898|FG000|SE Analysis Set|Open-Label Extension (OLE) Period||0|SE analysis set included all participants randomized during the global phase who received at least one dose of study drug. In the DBT period, 4 participants randomized to placebo arm received at least one dose of gantenerumab and were considered in the gantenerumab arm for safety evaluable set, of which 1 participant entered OLE period.|
60103618|NCT01291108|76221863|FG000|STARTED|Month 2 (Adjunctive Therapy)|All patients who completed Month 1 were randomized to adjunctive therapy for Month 2.|0||
59703758|NCT01144377|75822940|FG001|COMPLETED|12 Week Safety Follow-up Period|Of the 29 participants who completed this Period, 25 continued to the Optional 40 Week follow-up.|29||
59703759|NCT01144377|75822941|FG002|COMPLETED|12 Week Safety Follow-up Period|Of the 25 participants who completed this Period, 23 continued to the Optional 40 Week follow-up.|25||
59703760|NCT01144377|75822942|FG003|COMPLETED|12 Week Safety Follow-up Period|Of the 22 participants who completed this Period, 3 continued to the Optional 40 Week follow-up.|22||
59703761|NCT01144377|75822943|FG004|COMPLETED|12 Week Safety Follow-up Period|Of the 34 participants who completed this Period, 23 continued to the Optional 40 Week follow-up.|34||
59703762|NCT01144377|75822939|FG000|NOT COMPLETED|12 Week Safety Follow-up Period||0||
59703763|NCT01144377|75822940|FG001|NOT COMPLETED|12 Week Safety Follow-up Period||0||
59703764|NCT01144377|75822941|FG002|NOT COMPLETED|12 Week Safety Follow-up Period||0||
59703765|NCT01144377|75822942|FG003|NOT COMPLETED|12 Week Safety Follow-up Period||0||
59703766|NCT01144377|75822943|FG004|NOT COMPLETED|12 Week Safety Follow-up Period||0||
59703767|NCT01144377|75822939|FG000|STARTED|Optional 40 Week Safety Follow-up Period||22||
59703768|NCT01144377|75822940|FG001|STARTED|Optional 40 Week Safety Follow-up Period||25||
59816252|NCT00610649|75938615|FG006|NOT COMPLETED|Overall Study||0||
59703769|NCT01144377|75822941|FG002|STARTED|Optional 40 Week Safety Follow-up Period||23||
59703770|NCT01144377|75822942|FG003|STARTED|Optional 40 Week Safety Follow-up Period||3||
59703771|NCT01144377|75822943|FG004|STARTED|Optional 40 Week Safety Follow-up Period||23||
59703772|NCT01144377|75822939|FG000|COMPLETED|Optional 40 Week Safety Follow-up Period||21||
59703773|NCT01144377|75822940|FG001|COMPLETED|Optional 40 Week Safety Follow-up Period||24||
59703774|NCT01144377|75822941|FG002|COMPLETED|Optional 40 Week Safety Follow-up Period||23||
59703775|NCT01144377|75822942|FG003|COMPLETED|Optional 40 Week Safety Follow-up Period||3||
59703776|NCT01144377|75822943|FG004|COMPLETED|Optional 40 Week Safety Follow-up Period||21||
59703777|NCT01144377|75822939|FG000|NOT COMPLETED|Optional 40 Week Safety Follow-up Period||1||
59703778|NCT01144377|75822940|FG001|NOT COMPLETED|Optional 40 Week Safety Follow-up Period||1||
59703779|NCT01144377|75822941|FG002|NOT COMPLETED|Optional 40 Week Safety Follow-up Period||0||
59703780|NCT01144377|75822942|FG003|NOT COMPLETED|Optional 40 Week Safety Follow-up Period||0||
59703781|NCT01144377|75822943|FG004|NOT COMPLETED|Optional 40 Week Safety Follow-up Period||2||
59703782|NCT00950599|75822965|FG000|STARTED|Double-Blind Treatment Period||55||
59703783|NCT00950599|75822966|FG001|STARTED|Double-Blind Treatment Period||47||
59703784|NCT00950599|75822967|FG002|STARTED|Double-Blind Treatment Period||63||
59703785|NCT00950599|75822968|FG003|STARTED|Double-Blind Treatment Period||54||
59703786|NCT00950599|75822969|FG004|STARTED|Double-Blind Treatment Period||52||
59703787|NCT00950599|75822970|FG005|STARTED|Double-Blind Treatment Period||67||
59703788|NCT00950599|75822971|FG006|STARTED|Double-Blind Treatment Period||44||
59703789|NCT00950599|75822972|FG007|STARTED|Double-Blind Treatment Period||41||
59703790|NCT00950599|75822973|FG008|STARTED|Double-Blind Treatment Period||0||
59703791|NCT00950599|75822974|FG009|STARTED|Double-Blind Treatment Period||0||
59703792|NCT00950599|75822965|FG000|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|48||
59703793|NCT00950599|75822966|FG001|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|37||
59703794|NCT00950599|75822967|FG002|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|54||
59703795|NCT00950599|75822968|FG003|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|43||
59703796|NCT00950599|75822969|FG004|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|45||
59703797|NCT00950599|75822970|FG005|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|55||
59703798|NCT00950599|75822971|FG006|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|44||
59703799|NCT00950599|75822972|FG007|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|35||
59703800|NCT00950599|75822973|FG008|COMPLETED|Double-Blind Treatment Period||0||
59703801|NCT00950599|75822974|FG009|COMPLETED|Double-Blind Treatment Period||0||
59703802|NCT00950599|75822965|FG000|NOT COMPLETED|Double-Blind Treatment Period||7||
59703803|NCT00950599|75822966|FG001|NOT COMPLETED|Double-Blind Treatment Period||10||
59703804|NCT00950599|75822967|FG002|NOT COMPLETED|Double-Blind Treatment Period||9||
59703805|NCT00950599|75822968|FG003|NOT COMPLETED|Double-Blind Treatment Period||11||
59703806|NCT00950599|75822969|FG004|NOT COMPLETED|Double-Blind Treatment Period||7||
59703807|NCT00950599|75822970|FG005|NOT COMPLETED|Double-Blind Treatment Period||12||
59703808|NCT00950599|75822971|FG006|NOT COMPLETED|Double-Blind Treatment Period||0||
59816253|NCT00610649|75938616|FG007|NOT COMPLETED|Overall Study||0||
59816254|NCT00610649|75938617|FG008|NOT COMPLETED|Overall Study||0||
59703809|NCT00950599|75822972|FG007|NOT COMPLETED|Double-Blind Treatment Period||6||
59703810|NCT00950599|75822973|FG008|NOT COMPLETED|Double-Blind Treatment Period||0||
59703811|NCT00950599|75822974|FG009|NOT COMPLETED|Double-Blind Treatment Period||0||
59703812|NCT00950599|75822965|FG000|STARTED|Follow-Up Period||0||
59703813|NCT00950599|75822966|FG001|STARTED|Follow-Up Period||0||
59703814|NCT00950599|75822967|FG002|STARTED|Follow-Up Period||0||
59703815|NCT00950599|75822968|FG003|STARTED|Follow-Up Period||0||
59703816|NCT00950599|75822969|FG004|STARTED|Follow-Up Period||0||
59703817|NCT00950599|75822970|FG005|STARTED|Follow-Up Period||0||
59703818|NCT00950599|75822971|FG006|STARTED|Follow-Up Period||0||
59703819|NCT00950599|75822972|FG007|STARTED|Follow-Up Period||0||
59703820|NCT00950599|75822973|FG008|STARTED|Follow-Up Period|those completing double blind period (DB) + those rescued/discontinued from DB due to hyperglycemia|309||
59703821|NCT00950599|75822974|FG009|STARTED|Follow-Up Period|those completing double blind period (DB) + those rescued/discontinued from DB due to hyperglycemia|80||
59703822|NCT00950599|75822965|FG000|COMPLETED|Follow-Up Period||0||
59703823|NCT00950599|75822966|FG001|COMPLETED|Follow-Up Period||0||
59703824|NCT00950599|75822967|FG002|COMPLETED|Follow-Up Period||0||
59703825|NCT00950599|75822968|FG003|COMPLETED|Follow-Up Period||0||
59703826|NCT00950599|75822969|FG004|COMPLETED|Follow-Up Period||0||
59703827|NCT00950599|75822970|FG005|COMPLETED|Follow-Up Period||0||
59703828|NCT00950599|75822971|FG006|COMPLETED|Follow-Up Period||0||
59703829|NCT00950599|75822972|FG007|COMPLETED|Follow-Up Period||0||
59703830|NCT00950599|75822973|FG008|COMPLETED|Follow-Up Period||296||
59703831|NCT00950599|75822974|FG009|COMPLETED|Follow-Up Period||78||
59703832|NCT00950599|75822965|FG000|NOT COMPLETED|Follow-Up Period||0||
59703833|NCT00950599|75822966|FG001|NOT COMPLETED|Follow-Up Period||0||
59703834|NCT00950599|75822967|FG002|NOT COMPLETED|Follow-Up Period||0||
59816255|NCT00610649|75938618|FG009|NOT COMPLETED|Overall Study||1||
59816256|NCT00610649|75938619|FG010|NOT COMPLETED|Overall Study||1||
59816257|NCT00608543|75938643|FG000|STARTED|Overall Study||17||
59703835|NCT00950599|75822968|FG003|NOT COMPLETED|Follow-Up Period||0||
59703836|NCT00950599|75822969|FG004|NOT COMPLETED|Follow-Up Period||0||
59703837|NCT00950599|75822970|FG005|NOT COMPLETED|Follow-Up Period||0||
59703838|NCT00950599|75822971|FG006|NOT COMPLETED|Follow-Up Period||0||
59703839|NCT00950599|75822972|FG007|NOT COMPLETED|Follow-Up Period||0||
59703840|NCT00950599|75822973|FG008|NOT COMPLETED|Follow-Up Period||13||
59703841|NCT00950599|75822974|FG009|NOT COMPLETED|Follow-Up Period||2||
59703842|NCT01144299|75822999|FG000|STARTED|Overall Study||60||
59703843|NCT01144299|75823000|FG001|STARTED|Overall Study||54||
59703844|NCT01144299|75822999|FG000|COMPLETED|Overall Study||58||
59703845|NCT01144299|75823000|FG001|COMPLETED|Overall Study||54||
59703846|NCT01144299|75822999|FG000|NOT COMPLETED|Overall Study||2||
59703847|NCT01144299|75823000|FG001|NOT COMPLETED|Overall Study||0||
59703848|NCT01143207|75823006|FG000|STARTED|Overall Study||26||
59703849|NCT01143207|75823006|FG000|COMPLETED|Overall Study||24||
59703850|NCT01143207|75823006|FG000|NOT COMPLETED|Overall Study||2||
59703851|NCT01143051|75823016|FG000|STARTED|Visit 1||4||
59703852|NCT01143051|75823017|FG001|STARTED|Visit 1||4||
59703853|NCT01143051|75823018|FG002|STARTED|Visit 1||4||
59703854|NCT01143051|75823019|FG003|STARTED|Visit 1||4||
59703855|NCT01143051|75823020|FG004|STARTED|Visit 1||4||
59703856|NCT01143051|75823021|FG005|STARTED|Visit 1||4||
59703857|NCT01143051|75823016|FG000|COMPLETED|Visit 1||4||
59703858|NCT01143051|75823017|FG001|COMPLETED|Visit 1||4||
59703859|NCT01143051|75823018|FG002|COMPLETED|Visit 1||4||
59703860|NCT01143051|75823019|FG003|COMPLETED|Visit 1||4||
59703861|NCT01143051|75823020|FG004|COMPLETED|Visit 1||4||
59703862|NCT01143051|75823021|FG005|COMPLETED|Visit 1||4||
59703863|NCT01143051|75823016|FG000|NOT COMPLETED|Visit 1||0||
59703864|NCT01143051|75823017|FG001|NOT COMPLETED|Visit 1||0||
59703865|NCT01143051|75823018|FG002|NOT COMPLETED|Visit 1||0||
59703866|NCT01143051|75823019|FG003|NOT COMPLETED|Visit 1||0||
59703867|NCT01143051|75823020|FG004|NOT COMPLETED|Visit 1||0||
59703868|NCT01143051|75823021|FG005|NOT COMPLETED|Visit 1||0||
59703869|NCT01143051|75823016|FG000|STARTED|3-14 Day Washout||4||
59703870|NCT01143051|75823017|FG001|STARTED|3-14 Day Washout||4||
59703871|NCT01143051|75823018|FG002|STARTED|3-14 Day Washout||4||
59703872|NCT01143051|75823019|FG003|STARTED|3-14 Day Washout||4||
59703873|NCT01143051|75823020|FG004|STARTED|3-14 Day Washout||4||
59703874|NCT01143051|75823021|FG005|STARTED|3-14 Day Washout||4||
59703875|NCT01143051|75823016|FG000|COMPLETED|3-14 Day Washout||4||
59703876|NCT01143051|75823017|FG001|COMPLETED|3-14 Day Washout||4||
59703877|NCT01143051|75823018|FG002|COMPLETED|3-14 Day Washout||3||
59703878|NCT01143051|75823019|FG003|COMPLETED|3-14 Day Washout||4||
59703879|NCT01143051|75823020|FG004|COMPLETED|3-14 Day Washout||4||
59703880|NCT01143051|75823021|FG005|COMPLETED|3-14 Day Washout||4||
59703881|NCT01143051|75823016|FG000|NOT COMPLETED|3-14 Day Washout||0||
59703882|NCT01143051|75823017|FG001|NOT COMPLETED|3-14 Day Washout||0||
59703883|NCT01143051|75823018|FG002|NOT COMPLETED|3-14 Day Washout||1||
59703884|NCT01143051|75823019|FG003|NOT COMPLETED|3-14 Day Washout||0||
59703885|NCT01143051|75823020|FG004|NOT COMPLETED|3-14 Day Washout||0||
59703886|NCT01143051|75823021|FG005|NOT COMPLETED|3-14 Day Washout||0||
59703887|NCT01143051|75823016|FG000|STARTED|Visit 2||4||
59703888|NCT01143051|75823017|FG001|STARTED|Visit 2||4||
60103619|NCT01291108|76221864|FG001|STARTED|Month 2 (Adjunctive Therapy)||40||
60103620|NCT01291108|76221865|FG002|STARTED|Month 2 (Adjunctive Therapy)||24||
59703889|NCT01143051|75823018|FG002|STARTED|Visit 2||3||
59703890|NCT01143051|75823019|FG003|STARTED|Visit 2||4||
59703891|NCT01143051|75823020|FG004|STARTED|Visit 2||4||
59703892|NCT01143051|75823021|FG005|STARTED|Visit 2||4||
59703893|NCT01143051|75823016|FG000|COMPLETED|Visit 2||4||
59703894|NCT01143051|75823017|FG001|COMPLETED|Visit 2||4||
59703895|NCT01143051|75823018|FG002|COMPLETED|Visit 2||3||
59703896|NCT01143051|75823019|FG003|COMPLETED|Visit 2||4||
59703897|NCT01143051|75823020|FG004|COMPLETED|Visit 2||4||
59703898|NCT01143051|75823021|FG005|COMPLETED|Visit 2||4||
59703899|NCT01143051|75823016|FG000|NOT COMPLETED|Visit 2||0||
60103621|NCT01291108|76221866|FG003|STARTED|Month 2 (Adjunctive Therapy)|All patients who completed Month 1 were randomized to adjunctive therapy for Month 2.|0||
59703900|NCT01143051|75823017|FG001|NOT COMPLETED|Visit 2||0||
59703901|NCT01143051|75823018|FG002|NOT COMPLETED|Visit 2||0||
59703902|NCT01143051|75823019|FG003|NOT COMPLETED|Visit 2||0||
59703903|NCT01143051|75823020|FG004|NOT COMPLETED|Visit 2||0||
59703904|NCT01143051|75823021|FG005|NOT COMPLETED|Visit 2||0||
59703905|NCT01143051|75823016|FG000|STARTED|3-14 Day Washout||4||
59703906|NCT01143051|75823017|FG001|STARTED|3-14 Day Washout||4||
59703907|NCT01143051|75823018|FG002|STARTED|3-14 Day Washout||3||
59703908|NCT01143051|75823019|FG003|STARTED|3-14 Day Washout||4||
59703909|NCT01143051|75823020|FG004|STARTED|3-14 Day Washout||4||
59703910|NCT01143051|75823021|FG005|STARTED|3-14 Day Washout||4||
59703911|NCT01143051|75823016|FG000|COMPLETED|3-14 Day Washout||4||
59703912|NCT01143051|75823017|FG001|COMPLETED|3-14 Day Washout||4||
59703913|NCT01143051|75823018|FG002|COMPLETED|3-14 Day Washout||3||
59703914|NCT01143051|75823019|FG003|COMPLETED|3-14 Day Washout||4||
59703915|NCT01143051|75823020|FG004|COMPLETED|3-14 Day Washout||4||
59703916|NCT01143051|75823021|FG005|COMPLETED|3-14 Day Washout||3||
59703917|NCT01143051|75823016|FG000|NOT COMPLETED|3-14 Day Washout||0||
59703918|NCT01143051|75823017|FG001|NOT COMPLETED|3-14 Day Washout||0||
59703919|NCT01143051|75823018|FG002|NOT COMPLETED|3-14 Day Washout||0||
59703920|NCT01143051|75823019|FG003|NOT COMPLETED|3-14 Day Washout||0||
59703921|NCT01143051|75823020|FG004|NOT COMPLETED|3-14 Day Washout||0||
59703922|NCT01143051|75823021|FG005|NOT COMPLETED|3-14 Day Washout||1||
59703923|NCT01143051|75823016|FG000|STARTED|Visit 3||4||
59703924|NCT01143051|75823017|FG001|STARTED|Visit 3||4||
59703925|NCT01143051|75823018|FG002|STARTED|Visit 3||3||
59703926|NCT01143051|75823019|FG003|STARTED|Visit 3||4||
59703927|NCT01143051|75823020|FG004|STARTED|Visit 3||4||
59703928|NCT01143051|75823021|FG005|STARTED|Visit 3||3||
59703929|NCT01143051|75823016|FG000|COMPLETED|Visit 3||4||
59703930|NCT01143051|75823017|FG001|COMPLETED|Visit 3||4||
59703931|NCT01143051|75823018|FG002|COMPLETED|Visit 3||3||
59703932|NCT01143051|75823019|FG003|COMPLETED|Visit 3||4||
59703933|NCT01143051|75823020|FG004|COMPLETED|Visit 3||4||
59703934|NCT01143051|75823021|FG005|COMPLETED|Visit 3||3||
59703935|NCT01143051|75823016|FG000|NOT COMPLETED|Visit 3||0||
59703936|NCT01143051|75823017|FG001|NOT COMPLETED|Visit 3||0||
59703937|NCT01143051|75823018|FG002|NOT COMPLETED|Visit 3||0||
59703938|NCT01143051|75823019|FG003|NOT COMPLETED|Visit 3||0||
59703939|NCT01143051|75823020|FG004|NOT COMPLETED|Visit 3||0||
59703940|NCT01143051|75823021|FG005|NOT COMPLETED|Visit 3||0||
59703941|NCT01142661|75823031|FG000|STARTED|Overall Study||9||
59703942|NCT01142661|75823031|FG000|COMPLETED|Overall Study||5||
59703943|NCT01142661|75823031|FG000|NOT COMPLETED|Overall Study||4||
59703944|NCT01142193|75823037|FG000|STARTED|Overall Study||124||
59703945|NCT01142193|75823038|FG001|STARTED|Overall Study||125||
59703946|NCT01142193|75823037|FG000|COMPLETED|Overall Study||103||
59703947|NCT01142193|75823038|FG001|COMPLETED|Overall Study||114||
59703948|NCT01142193|75823037|FG000|NOT COMPLETED|Overall Study||21||
59703949|NCT01142193|75823038|FG001|NOT COMPLETED|Overall Study||11||
59703950|NCT01142115|75823044|FG000|STARTED|First Intervention||21||
59703951|NCT01142115|75823045|FG001|STARTED|First Intervention||20||
59703952|NCT01142115|75823044|FG000|COMPLETED|First Intervention||19||
59703953|NCT01142115|75823045|FG001|COMPLETED|First Intervention||19||
59703954|NCT01142115|75823044|FG000|NOT COMPLETED|First Intervention||2||
59703955|NCT01142115|75823045|FG001|NOT COMPLETED|First Intervention||1||
59703956|NCT01142115|75823044|FG000|STARTED|Second Intervention||19||
59703957|NCT01142115|75823045|FG001|STARTED|Second Intervention||19||
59703958|NCT01142115|75823044|FG000|COMPLETED|Second Intervention||19||
59703959|NCT01142115|75823045|FG001|COMPLETED|Second Intervention||19||
59703960|NCT01142115|75823044|FG000|NOT COMPLETED|Second Intervention||0||
59703961|NCT01142115|75823045|FG001|NOT COMPLETED|Second Intervention||0||
59703962|NCT01140477|75823052|FG000|STARTED|Overall Study||153||
59703963|NCT01140477|75823053|FG001|STARTED|Overall Study||76||
59703964|NCT01140477|75823052|FG000|COMPLETED|Overall Study||145||
59703965|NCT01140477|75823053|FG001|COMPLETED|Overall Study||70||
59703966|NCT01140477|75823052|FG000|NOT COMPLETED|Overall Study||8||
59703967|NCT01140477|75823053|FG001|NOT COMPLETED|Overall Study||6||
59703968|NCT01139775|75823062|FG000|STARTED|Overall Study||14||
59703969|NCT01139775|75823063|FG001|STARTED|Overall Study||39||
59703970|NCT01139775|75823064|FG002|STARTED|Overall Study||23||
59703971|NCT01139775|75823062|FG000|Received at Least 1 Dose of Study Drug|Overall Study||14||
59703972|NCT01139775|75823063|FG001|Received at Least 1 Dose of Study Drug|Overall Study||39||
59703973|NCT01139775|75823064|FG002|Received at Least 1 Dose of Study Drug|Overall Study||22||
59703974|NCT01139775|75823062|FG000|COMPLETED|Overall Study||13||
59703975|NCT01139775|75823063|FG001|COMPLETED|Overall Study||26||
59703976|NCT01139775|75823064|FG002|COMPLETED|Overall Study||17||
59703977|NCT01139775|75823062|FG000|NOT COMPLETED|Overall Study||1||
59703978|NCT01139775|75823063|FG001|NOT COMPLETED|Overall Study||13||
59703979|NCT01139775|75823064|FG002|NOT COMPLETED|Overall Study||6||
59703980|NCT01283516|75823083|FG000|STARTED|Overall Study|Started = Full Analysis Set and Safety Set|2||
59703981|NCT01283516|75823084|FG001|STARTED|Overall Study||2||
59703982|NCT01283516|75823085|FG002|STARTED|Overall Study||3||
59703983|NCT01283516|75823086|FG003|STARTED|Overall Study||3||
59703984|NCT01283516|75823087|FG004|STARTED|Overall Study||14||
59703985|NCT01283516|75823088|FG005|STARTED|Overall Study||10||
59703986|NCT01283516|75823089|FG006|STARTED|Overall Study||10||
59703987|NCT01283516|75823090|FG007|STARTED|Overall Study||5||
59703988|NCT01283516|75823091|FG008|STARTED|Overall Study||255||
59703989|NCT01283516|75823083|FG000|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||2||
59703990|NCT01283516|75823084|FG001|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||1||
59703991|NCT01283516|75823085|FG002|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||2||
59703992|NCT01283516|75823086|FG003|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||3||
59703993|NCT01283516|75823087|FG004|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||12||
59703994|NCT01283516|75823088|FG005|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||10||
59703995|NCT01283516|75823089|FG006|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||9||
59703996|NCT01283516|75823090|FG007|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||5||
59703997|NCT01283516|75823091|FG008|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||246||
59703998|NCT01283516|75823083|FG000|Dose-Determining Set (DDS)|Overall Study||2||
59703999|NCT01283516|75823084|FG001|Dose-Determining Set (DDS)|Overall Study||1||
59704000|NCT01283516|75823085|FG002|Dose-Determining Set (DDS)|Overall Study||3||
59704001|NCT01283516|75823086|FG003|Dose-Determining Set (DDS)|Overall Study||3||
59704002|NCT01283516|75823087|FG004|Dose-Determining Set (DDS)|Overall Study||14||
59704003|NCT01283516|75823088|FG005|Dose-Determining Set (DDS)|Overall Study||8||
59704004|NCT01283516|75823089|FG006|Dose-Determining Set (DDS)|Overall Study||10||
59704005|NCT01283516|75823090|FG007|Dose-Determining Set (DDS)|Overall Study||5||
59704006|NCT01283516|75823091|FG008|Dose-Determining Set (DDS)|Overall Study||8||
59704007|NCT01283516|75823083|FG000|Non-NSCLC|Overall Study||0||
59704008|NCT01283516|75823084|FG001|Non-NSCLC|Overall Study||1||
59704009|NCT01283516|75823085|FG002|Non-NSCLC|Overall Study||1||
59704010|NCT01283516|75823086|FG003|Non-NSCLC|Overall Study||0||
59704011|NCT01283516|75823087|FG004|Non-NSCLC|Overall Study||2||
59704012|NCT01283516|75823088|FG005|Non-NSCLC|Overall Study||0||
59704013|NCT01283516|75823089|FG006|Non-NSCLC|Overall Study||1||
59704014|NCT01283516|75823090|FG007|Non-NSCLC|Overall Study||0||
59704015|NCT01283516|75823091|FG008|Non-NSCLC|Overall Study|Small number of patients at 750 mg - non-NSCLC, assessment limited, not included in efficacy tables|9||
59704016|NCT01283516|75823083|FG000|COMPLETED|Overall Study|Completed - see explanation in Recruitment Details.|0||
59704017|NCT01283516|75823084|FG001|COMPLETED|Overall Study||0||
59704018|NCT01283516|75823085|FG002|COMPLETED|Overall Study||0||
59704019|NCT01283516|75823086|FG003|COMPLETED|Overall Study||0||
59704020|NCT01283516|75823087|FG004|COMPLETED|Overall Study||0||
59704021|NCT01283516|75823088|FG005|COMPLETED|Overall Study||0||
59704022|NCT01283516|75823089|FG006|COMPLETED|Overall Study||0||
59704023|NCT01283516|75823090|FG007|COMPLETED|Overall Study||0||
59704024|NCT01283516|75823091|FG008|COMPLETED|Overall Study||0||
59704025|NCT01283516|75823083|FG000|NOT COMPLETED|Overall Study||2||
59704026|NCT01283516|75823084|FG001|NOT COMPLETED|Overall Study||2||
59704027|NCT01283516|75823085|FG002|NOT COMPLETED|Overall Study||3||
59704028|NCT01283516|75823086|FG003|NOT COMPLETED|Overall Study||3||
59704029|NCT01283516|75823087|FG004|NOT COMPLETED|Overall Study||14||
59704030|NCT01283516|75823088|FG005|NOT COMPLETED|Overall Study||10||
59704031|NCT01283516|75823089|FG006|NOT COMPLETED|Overall Study||10||
59704032|NCT01283516|75823090|FG007|NOT COMPLETED|Overall Study||5||
59704033|NCT01283516|75823091|FG008|NOT COMPLETED|Overall Study||255||
59704034|NCT01137435|75823119|FG000|STARTED|Overall Study||687||
59704035|NCT01137435|75823119|FG000|COMPLETED|Overall Study||659||
59704036|NCT01137435|75823119|FG000|NOT COMPLETED|Overall Study||28||
59704037|NCT01283282|75823123|FG000|STARTED|First Intervention (6 Weeks)||25||
59704038|NCT01283282|75823124|FG001|STARTED|First Intervention (6 Weeks)||23||
59704039|NCT01283282|75823123|FG000|COMPLETED|First Intervention (6 Weeks)||22||
59704040|NCT01283282|75823124|FG001|COMPLETED|First Intervention (6 Weeks)||19||
59704041|NCT01283282|75823123|FG000|NOT COMPLETED|First Intervention (6 Weeks)||3||
59704042|NCT01283282|75823124|FG001|NOT COMPLETED|First Intervention (6 Weeks)||4||
59704043|NCT01283282|75823123|FG000|STARTED|Second Intervention (6 Weeks)||22||
59704044|NCT01283282|75823124|FG001|STARTED|Second Intervention (6 Weeks)||19||
59704045|NCT01283282|75823123|FG000|COMPLETED|Second Intervention (6 Weeks)||22||
59704046|NCT01283282|75823124|FG001|COMPLETED|Second Intervention (6 Weeks)||19||
59704047|NCT01283282|75823123|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0||
59704048|NCT01283282|75823124|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||0||
59704049|NCT01282814|75823133|FG000|STARTED|First Intervention||12||
59704050|NCT01282814|75823134|FG001|STARTED|First Intervention||12||
59704051|NCT01282814|75823133|FG000|COMPLETED|First Intervention||12||
59704052|NCT01282814|75823134|FG001|COMPLETED|First Intervention||9||
59704053|NCT01282814|75823133|FG000|NOT COMPLETED|First Intervention||0||
59704054|NCT01282814|75823134|FG001|NOT COMPLETED|First Intervention||3||
59704055|NCT01282814|75823133|FG000|STARTED|Washout of 7 Days||12||
59704056|NCT01282814|75823134|FG001|STARTED|Washout of 7 Days||9||
59704057|NCT01282814|75823133|FG000|COMPLETED|Washout of 7 Days||10||
59704058|NCT01282814|75823134|FG001|COMPLETED|Washout of 7 Days||9||
59704059|NCT01282814|75823133|FG000|NOT COMPLETED|Washout of 7 Days||2||
59704060|NCT01282814|75823134|FG001|NOT COMPLETED|Washout of 7 Days||0||
59704061|NCT01282814|75823133|FG000|STARTED|Second Intervention||10||
59704062|NCT01282814|75823134|FG001|STARTED|Second Intervention||9||
59704063|NCT01282814|75823133|FG000|COMPLETED|Second Intervention||10||
59704064|NCT01282814|75823134|FG001|COMPLETED|Second Intervention||9||
59704065|NCT01282814|75823133|FG000|NOT COMPLETED|Second Intervention||0||
59704066|NCT01282814|75823134|FG001|NOT COMPLETED|Second Intervention||0||
59704067|NCT00941863|75823145|FG000|STARTED|Until Primary Completion Date (PCD)||7||
59704068|NCT00941863|75823146|FG001|STARTED|Until Primary Completion Date (PCD)||3||
59704069|NCT00941863|75823147|FG002|STARTED|Until Primary Completion Date (PCD)||12||
59704070|NCT00941863|75823148|FG003|STARTED|Until Primary Completion Date (PCD)||17||
59704071|NCT00941863|75823149|FG004|STARTED|Until Primary Completion Date (PCD)||119||
59704072|NCT00941863|75823145|FG000|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||7||
59704073|NCT00941863|75823146|FG001|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||3||
59704074|NCT00941863|75823147|FG002|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||12||
59704075|NCT00941863|75823148|FG003|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||17||
59704076|NCT00941863|75823149|FG004|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||94||
59704077|NCT00941863|75823145|FG000|COMPLETED|Until Primary Completion Date (PCD)||0||
59704078|NCT00941863|75823146|FG001|COMPLETED|Until Primary Completion Date (PCD)||0||
59704079|NCT00941863|75823147|FG002|COMPLETED|Until Primary Completion Date (PCD)||0||
59704080|NCT00941863|75823148|FG003|COMPLETED|Until Primary Completion Date (PCD)||0||
59704081|NCT00941863|75823149|FG004|COMPLETED|Until Primary Completion Date (PCD)||25||
59704082|NCT00941863|75823145|FG000|NOT COMPLETED|Until Primary Completion Date (PCD)||7||
59704083|NCT00941863|75823146|FG001|NOT COMPLETED|Until Primary Completion Date (PCD)||3||
59704084|NCT00941863|75823147|FG002|NOT COMPLETED|Until Primary Completion Date (PCD)||12||
59704085|NCT00941863|75823148|FG003|NOT COMPLETED|Until Primary Completion Date (PCD)||17||
59704086|NCT00941863|75823149|FG004|NOT COMPLETED|Until Primary Completion Date (PCD)||94||
59704087|NCT00941863|75823145|FG000|STARTED|Continued After PCD||0||
59704088|NCT00941863|75823146|FG001|STARTED|Continued After PCD||0||
59704089|NCT00941863|75823147|FG002|STARTED|Continued After PCD||0||
59704090|NCT00941863|75823148|FG003|STARTED|Continued After PCD||0||
59704091|NCT00941863|75823149|FG004|STARTED|Continued After PCD|25 of 119 participants from the Expansion Phase, were still on the treatment as of 31 May 2005.|25||
59704092|NCT00941863|75823145|FG000|COMPLETED|Continued After PCD||0||
59704093|NCT00941863|75823146|FG001|COMPLETED|Continued After PCD||0||
59704094|NCT00941863|75823147|FG002|COMPLETED|Continued After PCD||0||
59704095|NCT00941863|75823148|FG003|COMPLETED|Continued After PCD||0||
59704096|NCT00941863|75823149|FG004|COMPLETED|Continued After PCD||6||
59704097|NCT00941863|75823145|FG000|NOT COMPLETED|Continued After PCD||0||
59704098|NCT00941863|75823146|FG001|NOT COMPLETED|Continued After PCD||0||
59704099|NCT00941863|75823147|FG002|NOT COMPLETED|Continued After PCD||0||
59704100|NCT00941863|75823148|FG003|NOT COMPLETED|Continued After PCD||0||
59704101|NCT00941863|75823149|FG004|NOT COMPLETED|Continued After PCD||19||
59704102|NCT01282424|75823165|FG000|STARTED|Treatment Period (TP) (81 Months)||125||
59704103|NCT01282424|75823165|FG000|Completed: Disease Progression|Treatment Period (TP) (81 Months)||70||
59704104|NCT01282424|75823165|FG000|Completed: Death|Treatment Period (TP) (81 Months)||9||
59704105|NCT01282424|75823165|FG000|COMPLETED|Treatment Period (TP) (81 Months)||79||
59704106|NCT01282424|75823165|FG000|NOT COMPLETED|Treatment Period (TP) (81 Months)||46||
59704107|NCT01282424|75823165|FG000|STARTED|Long-term Follow-up Period (5 Years)|Participants did not have to complete the TP in order to enter the Long-term Follow-up Period.|84||
59704108|NCT01282424|75823165|FG000|COMPLETED|Long-term Follow-up Period (5 Years)||20||
59704109|NCT01282424|75823165|FG000|NOT COMPLETED|Long-term Follow-up Period (5 Years)||64||
59704110|NCT01281956|75823169|FG000|STARTED|1st Intervention (3 Months)||5||
59704111|NCT01281956|75823170|FG001|STARTED|1st Intervention (3 Months)||5||
59704112|NCT01281956|75823169|FG000|COMPLETED|1st Intervention (3 Months)||5||
59704113|NCT01281956|75823170|FG001|COMPLETED|1st Intervention (3 Months)||5||
59704114|NCT01281956|75823169|FG000|NOT COMPLETED|1st Intervention (3 Months)||0||
59704115|NCT01281956|75823170|FG001|NOT COMPLETED|1st Intervention (3 Months)||0||
59704116|NCT01281956|75823169|FG000|STARTED|2nd Intervention (3 Months)||5||
59704117|NCT01281956|75823170|FG001|STARTED|2nd Intervention (3 Months)||5||
59704118|NCT01281956|75823169|FG000|COMPLETED|2nd Intervention (3 Months)||4||
59704119|NCT01281956|75823170|FG001|COMPLETED|2nd Intervention (3 Months)||5||
59704120|NCT01281956|75823169|FG000|NOT COMPLETED|2nd Intervention (3 Months)||1||
59704121|NCT01281956|75823170|FG001|NOT COMPLETED|2nd Intervention (3 Months)||0||
59704122|NCT00949975|75823183|FG000|STARTED|Overall Study||212||
59704123|NCT00949975|75823184|FG001|STARTED|Overall Study||206||
59704124|NCT00949975|75823185|FG002|STARTED|Overall Study||202||
59704125|NCT00949975|75823186|FG003|STARTED|Overall Study||218||
59704126|NCT00949975|75823183|FG000|COMPLETED|Overall Study||185||
59704127|NCT00949975|75823184|FG001|COMPLETED|Overall Study||177||
59704128|NCT00949975|75823185|FG002|COMPLETED|Overall Study||183||
59704129|NCT00949975|75823186|FG003|COMPLETED|Overall Study||190||
59704130|NCT00949975|75823183|FG000|NOT COMPLETED|Overall Study||27||
59704131|NCT00949975|75823184|FG001|NOT COMPLETED|Overall Study||29||
59704132|NCT00949975|75823185|FG002|NOT COMPLETED|Overall Study||19||
59704133|NCT00949975|75823186|FG003|NOT COMPLETED|Overall Study||28||
59704134|NCT00939055|75823198|FG000|STARTED|Overall Study||73||
59704135|NCT00939055|75823199|FG001|STARTED|Overall Study||39||
59704136|NCT00939055|75823198|FG000|COMPLETED|Overall Study||69||
59704137|NCT00939055|75823199|FG001|COMPLETED|Overall Study||39||
59704138|NCT00939055|75823198|FG000|NOT COMPLETED|Overall Study||4||
59704139|NCT00939055|75823199|FG001|NOT COMPLETED|Overall Study||0||
59704140|NCT01136967|75823208|FG000|STARTED|Overall Study||93||
59704141|NCT01136967|75823209|FG001|STARTED|Overall Study||89||
59704142|NCT01136967|75823208|FG000|Disease Progression|Overall Study||55||
59704143|NCT01136967|75823209|FG001|Disease Progression|Overall Study||56||
59704144|NCT01136967|75823208|FG000|Treatment Ongoing at Data Cutoff|Overall Study|Entered Extension Phase on treatment at data cut-off (18 January 2012)|14||
59816258|NCT00608543|75938643|FG000|COMPLETED|Overall Study||13||
59816259|NCT00608543|75938643|FG000|NOT COMPLETED|Overall Study||4||
59816260|NCT00520130|75938650|FG000|STARTED|Overall Study||44||
59816261|NCT00520130|75938651|FG001|STARTED|Overall Study||45||
59816262|NCT00520130|75938650|FG000|COMPLETED|Overall Study||39||
59704145|NCT01136967|75823209|FG001|Treatment Ongoing at Data Cutoff|Overall Study|Entered Extension Phase on treatment at data cut-off (15 April 2013)|6||
59704146|NCT01136967|75823208|FG000|COMPLETED|Overall Study|Disease Progression and treatment ongoing at data cutoff (18 January 2012)|69||
59704147|NCT01136967|75823209|FG001|COMPLETED|Overall Study|Disease Progression and treatment ongoing at data cutoff (15 April 2013)|62||
59704148|NCT01136967|75823208|FG000|NOT COMPLETED|Overall Study||24||
59704149|NCT01136967|75823209|FG001|NOT COMPLETED|Overall Study||27||
59704150|NCT01218516|75823217|FG000|STARTED|Combination Therapy (up to 4.5 Months)||67||
59704151|NCT01218516|75823218|FG001|STARTED|Combination Therapy (up to 4.5 Months)||63||
59704152|NCT01218516|75823219|FG002|STARTED|Combination Therapy (up to 4.5 Months)||0||
59704153|NCT01218516|75823220|FG003|STARTED|Combination Therapy (up to 4.5 Months)||0||
59704154|NCT01218516|75823217|FG000|COMPLETED|Combination Therapy (up to 4.5 Months)||38||
59704155|NCT01218516|75823218|FG001|COMPLETED|Combination Therapy (up to 4.5 Months)||28||
59704156|NCT01218516|75823219|FG002|COMPLETED|Combination Therapy (up to 4.5 Months)||0||
59704157|NCT01218516|75823220|FG003|COMPLETED|Combination Therapy (up to 4.5 Months)||0||
59704158|NCT01218516|75823217|FG000|NOT COMPLETED|Combination Therapy (up to 4.5 Months)||29||
59704159|NCT01218516|75823218|FG001|NOT COMPLETED|Combination Therapy (up to 4.5 Months)||35||
59704160|NCT01218516|75823219|FG002|NOT COMPLETED|Combination Therapy (up to 4.5 Months)||0||
59704161|NCT01218516|75823220|FG003|NOT COMPLETED|Combination Therapy (up to 4.5 Months)||0||
59704162|NCT01218516|75823217|FG000|STARTED|Monotherapy (up to 23.5 Months)|This phase ended once all participants finished.|0||
59704163|NCT01218516|75823218|FG001|STARTED|Monotherapy (up to 23.5 Months)|This phase ended once all participants finished.|0||
59704164|NCT01218516|75823219|FG002|STARTED|Monotherapy (up to 23.5 Months)|Only eligible participants entered this phase of the study.|38||
59704165|NCT01218516|75823220|FG003|STARTED|Monotherapy (up to 23.5 Months)|Only eligible participants entered this phase of the study.|28||
59704166|NCT01218516|75823217|FG000|Safety Analysis Set|Monotherapy (up to 23.5 Months)||0||
59704167|NCT01218516|75823218|FG001|Safety Analysis Set|Monotherapy (up to 23.5 Months)||0||
59704168|NCT01218516|75823219|FG002|Safety Analysis Set|Monotherapy (up to 23.5 Months)||35||
59704169|NCT01218516|75823220|FG003|Safety Analysis Set|Monotherapy (up to 23.5 Months)|Three participants were randomized to placebo but actually received Farletuzumab.|31||
59704170|NCT01218516|75823217|FG000|COMPLETED|Monotherapy (up to 23.5 Months)||0||
59704171|NCT01218516|75823218|FG001|COMPLETED|Monotherapy (up to 23.5 Months)||0||
59704172|NCT01218516|75823219|FG002|COMPLETED|Monotherapy (up to 23.5 Months)||38||
59704173|NCT01218516|75823220|FG003|COMPLETED|Monotherapy (up to 23.5 Months)||28||
59704174|NCT01218516|75823217|FG000|NOT COMPLETED|Monotherapy (up to 23.5 Months)||0||
59704175|NCT01218516|75823218|FG001|NOT COMPLETED|Monotherapy (up to 23.5 Months)||0||
59704176|NCT01218516|75823219|FG002|NOT COMPLETED|Monotherapy (up to 23.5 Months)||0||
59704177|NCT01218516|75823220|FG003|NOT COMPLETED|Monotherapy (up to 23.5 Months)||0||
59704178|NCT00938431|75823233|FG000|STARTED|Overall Study||15||
59704179|NCT00938431|75823234|FG001|STARTED|Overall Study||23||
59704180|NCT00938431|75823235|FG002|STARTED|Overall Study||9||
59704181|NCT00938431|75823233|FG000|COMPLETED|Overall Study||9||
59704182|NCT00938431|75823234|FG001|COMPLETED|Overall Study||14||
59704183|NCT00938431|75823235|FG002|COMPLETED|Overall Study||1||
59704184|NCT00938431|75823233|FG000|NOT COMPLETED|Overall Study||6||
59704185|NCT00938431|75823234|FG001|NOT COMPLETED|Overall Study||9||
59704186|NCT00938431|75823235|FG002|NOT COMPLETED|Overall Study||8||
59704187|NCT01136811|75823247|FG000|STARTED|Overall Study||11||
59704188|NCT01136811|75823247|FG000|COMPLETED|Overall Study||0||
59704189|NCT01136811|75823247|FG000|NOT COMPLETED|Overall Study||11||
59704190|NCT00949117|75823253|FG000|STARTED|Overall Study||4||
59704191|NCT00949117|75823254|FG001|STARTED|Overall Study||5||
59704192|NCT00949117|75823253|FG000|COMPLETED|Overall Study||1||
59704193|NCT00949117|75823254|FG001|COMPLETED|Overall Study||0||
59704194|NCT00949117|75823253|FG000|NOT COMPLETED|Overall Study||3||
59704195|NCT00949117|75823254|FG001|NOT COMPLETED|Overall Study||5||
59704196|NCT00938041|75823262|FG000|STARTED|Overall Study||32||
59704197|NCT00938041|75823262|FG000|COMPLETED|Overall Study||5||
59704198|NCT00938041|75823262|FG000|NOT COMPLETED|Overall Study||27||
59704199|NCT01218438|75823266|FG000|STARTED|Epoch 1||77||
59704200|NCT01218438|75823266|FG000|COMPLETED|Epoch 1||74||
59704201|NCT01218438|75823266|FG000|NOT COMPLETED|Epoch 1||3||
59704202|NCT01218438|75823266|FG000|STARTED|Epoch 2||45||
59704203|NCT01218438|75823266|FG000|COMPLETED|Epoch 2||45||
59704204|NCT01218438|75823266|FG000|NOT COMPLETED|Epoch 2||0||
59704205|NCT01218438|75823266|FG000|STARTED|Epoch 3||74||
59704206|NCT01218438|75823266|FG000|COMPLETED|Epoch 3||70||
59704207|NCT01218438|75823266|FG000|NOT COMPLETED|Epoch 3||4||
59704208|NCT01218438|75823266|FG000|STARTED|Epoch 4||70||
59704209|NCT01218438|75823266|FG000|COMPLETED|Epoch 4||67||
59704210|NCT01218438|75823266|FG000|NOT COMPLETED|Epoch 4||3||
59704211|NCT00935701|75823340|FG000|STARTED|Overall Study||10||
59704212|NCT00935701|75823340|FG000|Transition Acupressure to Acupuncture|Overall Study||9||
59704213|NCT00935701|75823340|FG000|COMPLETED|Overall Study||9||
59704214|NCT00935701|75823340|FG000|NOT COMPLETED|Overall Study||1||
59704215|NCT01277510|75823347|FG000|STARTED|Double-blind Phase||21||
59704216|NCT01277510|75823348|FG001|STARTED|Double-blind Phase||22||
59704217|NCT01277510|75823347|FG000|Received Investigational Product|Double-blind Phase||21||
59704218|NCT01277510|75823348|FG001|Received Investigational Product|Double-blind Phase||22||
59704219|NCT01277510|75823347|FG000|COMPLETED|Double-blind Phase|Completed investigational product|8||
59704220|NCT01277510|75823348|FG001|COMPLETED|Double-blind Phase|Completed investigational product|4||
59704221|NCT01277510|75823347|FG000|NOT COMPLETED|Double-blind Phase||13||
59704222|NCT01277510|75823348|FG001|NOT COMPLETED|Double-blind Phase||18||
59704223|NCT01277510|75823347|FG000|STARTED|Open-label Phase||8||
59704224|NCT01277510|75823348|FG001|STARTED|Open-label Phase||4||
59704225|NCT01277510|75823347|FG000|Received Investigational Product|Open-label Phase||6||
59704226|NCT01277510|75823348|FG001|Received Investigational Product|Open-label Phase||4||
59704227|NCT01277510|75823347|FG000|COMPLETED|Open-label Phase|Completed investigational product|1||
59704228|NCT01277510|75823348|FG001|COMPLETED|Open-label Phase|Completed investigational product|1||
59704229|NCT01277510|75823347|FG000|NOT COMPLETED|Open-label Phase||7||
59704230|NCT01277510|75823348|FG001|NOT COMPLETED|Open-label Phase||3||
59704231|NCT00937495|75823356|FG000|STARTED|Overall Study||16||
59704232|NCT00937495|75823356|FG000|COMPLETED|Overall Study||14||
59704233|NCT00937495|75823356|FG000|NOT COMPLETED|Overall Study||2||
59704234|NCT01268306|75823360|FG000|STARTED|Overall Study||8||
59704235|NCT01268306|75823360|FG000|COMPLETED|Overall Study||7||
59704236|NCT01268306|75823360|FG000|NOT COMPLETED|Overall Study||1||
59704237|NCT00936715|75823364|FG000|STARTED|Overall Study||24||
59704238|NCT00936715|75823364|FG000|COMPLETED|Overall Study||18||
59704239|NCT00936715|75823364|FG000|NOT COMPLETED|Overall Study||6||
59704240|NCT01267994|75823368|FG000|STARTED|Overall Study|Declined to participate. n=1 Did not receive intervention due to infeciton, n=1|12||
59704241|NCT01267994|75823368|FG000|COMPLETED|Overall Study|Excluded from analysis, could not reach first milestone (day 28) for efficacy assessment, n=2|10||
59704242|NCT01267994|75823368|FG000|NOT COMPLETED|Overall Study||2||
59704243|NCT00934843|75823375|FG000|STARTED|Overall Study||37||
59704244|NCT00934843|75823376|FG001|STARTED|Overall Study||40||
59704245|NCT00934843|75823375|FG000|COMPLETED|Overall Study||37||
59704246|NCT00934843|75823376|FG001|COMPLETED|Overall Study|1 subject discontinued intervention, surgery plan changed and did not require CPB|39||
59704247|NCT00934843|75823375|FG000|NOT COMPLETED|Overall Study||0||
59704248|NCT00934843|75823376|FG001|NOT COMPLETED|Overall Study||1||
59704249|NCT01266902|75823384|FG000|STARTED|Period 1 (Main Study)||119||
59704250|NCT01266902|75823385|FG001|STARTED|Period 1 (Main Study)||363||
59704251|NCT01266902|75823386|FG002|STARTED|Period 1 (Main Study)||0||
59704252|NCT01266902|75823384|FG000|COMPLETED|Period 1 (Main Study)||89||
59704253|NCT01266902|75823385|FG001|COMPLETED|Period 1 (Main Study)||282||
59704254|NCT01266902|75823386|FG002|COMPLETED|Period 1 (Main Study)||0||
59704255|NCT01266902|75823384|FG000|NOT COMPLETED|Period 1 (Main Study)||30||
59704256|NCT01266902|75823385|FG001|NOT COMPLETED|Period 1 (Main Study)||81||
59704257|NCT01266902|75823386|FG002|NOT COMPLETED|Period 1 (Main Study)||0||
59704258|NCT01266902|75823384|FG000|STARTED|Period 2 (After Protocol Amendment 3)||0||
59704259|NCT01266902|75823385|FG001|STARTED|Period 2 (After Protocol Amendment 3)||0||
59704260|NCT01266902|75823386|FG002|STARTED|Period 2 (After Protocol Amendment 3)||45||
59704261|NCT01266902|75823384|FG000|COMPLETED|Period 2 (After Protocol Amendment 3)||0||
59704262|NCT01266902|75823385|FG001|COMPLETED|Period 2 (After Protocol Amendment 3)||0||
59704263|NCT01266902|75823386|FG002|COMPLETED|Period 2 (After Protocol Amendment 3)||37||
59704264|NCT01266902|75823384|FG000|NOT COMPLETED|Period 2 (After Protocol Amendment 3)||0||
59704265|NCT01266902|75823385|FG001|NOT COMPLETED|Period 2 (After Protocol Amendment 3)||0||
59704266|NCT01266902|75823386|FG002|NOT COMPLETED|Period 2 (After Protocol Amendment 3)||8||
59704267|NCT01266824|75823396|FG000|STARTED|Overall Study||2||
59704268|NCT01266824|75823397|FG001|STARTED|Overall Study||3||
59704269|NCT01266824|75823396|FG000|COMPLETED|Overall Study||0||
59704270|NCT01266824|75823397|FG001|COMPLETED|Overall Study||0||
59704271|NCT01266824|75823396|FG000|NOT COMPLETED|Overall Study||2||
59704272|NCT01266824|75823397|FG001|NOT COMPLETED|Overall Study||3||
59704273|NCT01266590|75823403|FG000|STARTED|Overall Study||30||
59704274|NCT01266590|75823403|FG000|COMPLETED|Overall Study||24||
59704275|NCT01266590|75823403|FG000|NOT COMPLETED|Overall Study||6||
59704276|NCT01266122|75823412|FG000|STARTED|Overall Study||48||
59704277|NCT01266122|75823413|FG001|STARTED|Overall Study||48||
59704278|NCT01266122|75823412|FG000|COMPLETED|Overall Study||42||
59704279|NCT01266122|75823413|FG001|COMPLETED|Overall Study||42||
59704280|NCT01266122|75823412|FG000|NOT COMPLETED|Overall Study||6||
59704281|NCT01266122|75823413|FG001|NOT COMPLETED|Overall Study||6||
59704282|NCT01265498|75823421|FG000|STARTED|Overall Study||141||
59704283|NCT01265498|75823422|FG001|STARTED|Overall Study||142||
59704284|NCT01265498|75823421|FG000|Both Baseline and Week 72 Biopsy|Overall Study||102||
59704285|NCT01265498|75823422|FG001|Both Baseline and Week 72 Biopsy|Overall Study||98||
59704286|NCT01265498|75823421|FG000|COMPLETED|Overall Study||110||
59704287|NCT01265498|75823422|FG001|COMPLETED|Overall Study||109||
59704288|NCT01265498|75823421|FG000|NOT COMPLETED|Overall Study||31||
59704289|NCT01265498|75823422|FG001|NOT COMPLETED|Overall Study||33||
59704290|NCT01265420|75823428|FG000|STARTED|Overall Study||7||
59704291|NCT01265420|75823428|FG000|COMPLETED|Overall Study|One patient was seen at Day 10 but did not return for Day 30 evaluation|6||
59704292|NCT01265420|75823428|FG000|NOT COMPLETED|Overall Study||1||
59704293|NCT01264718|75823434|FG000|STARTED|Overall Study||172||
59704294|NCT01264718|75823435|FG001|STARTED|Overall Study||157||
59704295|NCT01264718|75823434|FG000|COMPLETED|Overall Study||123||
59704296|NCT01264718|75823435|FG001|COMPLETED|Overall Study||114||
59704297|NCT01264718|75823434|FG000|NOT COMPLETED|Overall Study||49||
59704298|NCT01264718|75823435|FG001|NOT COMPLETED|Overall Study||43||
59704299|NCT01264016|75823441|FG000|STARTED|Overall Study||96||
59704300|NCT01264016|75823441|FG000|COMPLETED|Overall Study||94||
59704301|NCT01264016|75823441|FG000|NOT COMPLETED|Overall Study||2||
59704302|NCT01263782|75823450|FG000|STARTED|Overall Study||6||
59704303|NCT01263782|75823451|FG001|STARTED|Overall Study||6||
59704304|NCT01263782|75823452|FG002|STARTED|Overall Study||6||
59704305|NCT01263782|75823453|FG003|STARTED|Overall Study||6||
59704306|NCT01263782|75823450|FG000|COMPLETED|Overall Study||6||
59704307|NCT01263782|75823451|FG001|COMPLETED|Overall Study||6||
59704308|NCT01263782|75823452|FG002|COMPLETED|Overall Study||3||
59704309|NCT01263782|75823453|FG003|COMPLETED|Overall Study||5||
59704310|NCT01263782|75823450|FG000|NOT COMPLETED|Overall Study||0||
59704311|NCT01263782|75823451|FG001|NOT COMPLETED|Overall Study||0||
59704312|NCT01263782|75823452|FG002|NOT COMPLETED|Overall Study||3||
59704313|NCT01263782|75823453|FG003|NOT COMPLETED|Overall Study||1||
59704314|NCT01263704|75823463|FG000|STARTED|Overall Study||42||
59704315|NCT01263704|75823463|FG000|COMPLETED|Overall Study||13||
59704316|NCT01263704|75823463|FG000|NOT COMPLETED|Overall Study||29||
59704317|NCT01263470|75823473|FG000|STARTED|Overall Study||75||
59704318|NCT01263470|75823474|FG001|STARTED|Overall Study||79||
59704319|NCT01263470|75823475|FG002|STARTED|Overall Study||84||
59704320|NCT01263470|75823476|FG003|STARTED|Overall Study||80||
59704321|NCT01263470|75823477|FG004|STARTED|Overall Study||79||
59704322|NCT01263470|75823478|FG005|STARTED|Overall Study||83||
59704323|NCT01263470|75823473|FG000|COMPLETED|Overall Study||73||
59704324|NCT01263470|75823474|FG001|COMPLETED|Overall Study||74||
59704325|NCT01263470|75823475|FG002|COMPLETED|Overall Study||80||
59704326|NCT01263470|75823476|FG003|COMPLETED|Overall Study||77||
59704327|NCT01263470|75823477|FG004|COMPLETED|Overall Study||76||
59704328|NCT01263470|75823478|FG005|COMPLETED|Overall Study||78||
59704329|NCT01263470|75823473|FG000|NOT COMPLETED|Overall Study||2||
59704330|NCT01263470|75823474|FG001|NOT COMPLETED|Overall Study||5||
59704331|NCT01263470|75823475|FG002|NOT COMPLETED|Overall Study||4||
59704332|NCT01263470|75823476|FG003|NOT COMPLETED|Overall Study||3||
59704333|NCT01263470|75823477|FG004|NOT COMPLETED|Overall Study||3||
59704334|NCT01263470|75823478|FG005|NOT COMPLETED|Overall Study||5||
59704335|NCT01262456|75823495|FG000|STARTED|3-Month Double-Blind Period|Intent-to-Treat (ITT) population: randomized participants regardless of exposure to treatment|143||
59704336|NCT01262456|75823496|FG001|STARTED|3-Month Double-Blind Period|ITT population: randomized participants regardless of exposure to treatment|123||
59704337|NCT01262456|75823497|FG002|STARTED|3-Month Double-Blind Period|ITT population: randomized participants regardless of exposure to treatment|129||
59704338|NCT01262456|75823495|FG000|Full Analysis Set (FAS)|3-Month Double-Blind Period|FAS: ITT with at least 1 post-treatment efficacy assessment. Analysis as randomized.|142||
59704339|NCT01262456|75823496|FG001|Full Analysis Set (FAS)|3-Month Double-Blind Period|FAS: ITT with at least 1 post-treatment efficacy assessment. Analysis as randomized.|119||
59704340|NCT01262456|75823497|FG002|Full Analysis Set (FAS)|3-Month Double-Blind Period|FAS: ITT with at least 1 post-treatment efficacy assessment. Analysis as randomized.|124||
59704341|NCT01262456|75823495|FG000|Safety Analysis Set (SAS)|3-Month Double-Blind Period|SAS: received at least 1 dose and had at least 1 safety assessment. Analysis on actual treatment.|143||
59704342|NCT01262456|75823496|FG001|Safety Analysis Set (SAS)|3-Month Double-Blind Period|SAS: received at least 1 dose and had at least 1 safety assessment. Analysis on actual treatment.|119||
59704343|NCT01262456|75823497|FG002|Safety Analysis Set (SAS)|3-Month Double-Blind Period|SAS: received at least 1 dose and had at least 1 safety assessment. Analysis on actual treatment.|122||
59704344|NCT01262456|75823495|FG000|COMPLETED|3-Month Double-Blind Period||124||
59704345|NCT01262456|75823496|FG001|COMPLETED|3-Month Double-Blind Period||100||
59704346|NCT01262456|75823497|FG002|COMPLETED|3-Month Double-Blind Period||103||
59704347|NCT01262456|75823495|FG000|NOT COMPLETED|3-Month Double-Blind Period||19||
59704348|NCT01262456|75823496|FG001|NOT COMPLETED|3-Month Double-Blind Period||23||
59704349|NCT01262456|75823497|FG002|NOT COMPLETED|3-Month Double-Blind Period||26||
59704350|NCT01262456|75823495|FG000|STARTED|1-Month Open-Label Extension Period||124||
59704351|NCT01262456|75823496|FG001|STARTED|1-Month Open-Label Extension Period||100||
59704352|NCT01262456|75823497|FG002|STARTED|1-Month Open-Label Extension Period||103||
59704353|NCT01262456|75823495|FG000|Safety Analysis Set (SAS)|1-Month Open-Label Extension Period||124||
59704354|NCT01262456|75823496|FG001|Safety Analysis Set (SAS)|1-Month Open-Label Extension Period||101||
59704355|NCT01262456|75823497|FG002|Safety Analysis Set (SAS)|1-Month Open-Label Extension Period|1 subject was randomized to Desmopressin 75 μg but received 50 μg. Also true in Double-Blind Period|102||
59704356|NCT01262456|75823495|FG000|COMPLETED|1-Month Open-Label Extension Period||120||
59704357|NCT01262456|75823496|FG001|COMPLETED|1-Month Open-Label Extension Period||97||
59704358|NCT01262456|75823497|FG002|COMPLETED|1-Month Open-Label Extension Period||98||
59704359|NCT01262456|75823495|FG000|NOT COMPLETED|1-Month Open-Label Extension Period||4||
59704360|NCT01262456|75823496|FG001|NOT COMPLETED|1-Month Open-Label Extension Period||3||
59704361|NCT01262456|75823497|FG002|NOT COMPLETED|1-Month Open-Label Extension Period||5||
59704362|NCT00932893|75823515|FG000|STARTED|Overall Study||173||
59704363|NCT00932893|75823516|FG001|STARTED|Overall Study||174||
59704364|NCT00932893|75823515|FG000|Treated|Overall Study||172||
59704365|NCT00932893|75823516|FG001|Treated|Overall Study||171||
59704366|NCT00932893|75823515|FG000|COMPLETED|Overall Study||40||
59704367|NCT00932893|75823516|FG001|COMPLETED|Overall Study||4||
59704368|NCT00932893|75823515|FG000|NOT COMPLETED|Overall Study||133||
59704369|NCT00932893|75823516|FG001|NOT COMPLETED|Overall Study||170||
59704370|NCT01260896|75823525|FG000|STARTED|First Intervention||12||
59704371|NCT01260896|75823526|FG001|STARTED|First Intervention||12||
59704372|NCT01260896|75823525|FG000|COMPLETED|First Intervention||10||
59704373|NCT01260896|75823526|FG001|COMPLETED|First Intervention||12||
59704374|NCT01260896|75823525|FG000|NOT COMPLETED|First Intervention||2||
59704375|NCT01260896|75823526|FG001|NOT COMPLETED|First Intervention||0||
59704376|NCT01260896|75823525|FG000|STARTED|Washout of 7 Days||10||
59704377|NCT01260896|75823526|FG001|STARTED|Washout of 7 Days||12||
59704378|NCT01260896|75823525|FG000|COMPLETED|Washout of 7 Days||10||
59704379|NCT01260896|75823526|FG001|COMPLETED|Washout of 7 Days||12||
59704380|NCT01260896|75823525|FG000|NOT COMPLETED|Washout of 7 Days||0||
59704381|NCT01260896|75823526|FG001|NOT COMPLETED|Washout of 7 Days||0||
59704382|NCT01260896|75823525|FG000|STARTED|Second Intervention||10||
59704383|NCT01260896|75823526|FG001|STARTED|Second Intervention||12||
59704384|NCT01260896|75823525|FG000|COMPLETED|Second Intervention||10||
59704385|NCT01260896|75823526|FG001|COMPLETED|Second Intervention||12||
59704386|NCT01260896|75823525|FG000|NOT COMPLETED|Second Intervention||0||
59704387|NCT01260896|75823526|FG001|NOT COMPLETED|Second Intervention||0||
59704388|NCT00932737|75823534|FG000|STARTED|Overall Study||87||
59704389|NCT00932737|75823535|FG001|STARTED|Overall Study||88||
59704390|NCT00932737|75823534|FG000|COMPLETED|Overall Study||86||
59704391|NCT00932737|75823535|FG001|COMPLETED|Overall Study||87||
59704392|NCT00932737|75823534|FG000|NOT COMPLETED|Overall Study||1||
59704393|NCT00932737|75823535|FG001|NOT COMPLETED|Overall Study||1||
59704394|NCT00939523|75823541|FG000|STARTED|Overall Study||9||
59704395|NCT00939523|75823541|FG000|COMPLETED|Overall Study||6||
59704396|NCT00939523|75823541|FG000|NOT COMPLETED|Overall Study||3||
59704397|NCT01260584|75823549|FG000|STARTED|Period 1||27||
59704398|NCT01260584|75823550|FG001|STARTED|Period 1||28||
59704399|NCT01260584|75823551|FG002|STARTED|Period 1||27||
59704400|NCT01260584|75823552|FG003|STARTED|Period 1||28||
59704401|NCT01260584|75823549|FG000|COMPLETED|Period 1||27||
59704402|NCT01260584|75823550|FG001|COMPLETED|Period 1||28||
59704403|NCT01260584|75823551|FG002|COMPLETED|Period 1||25||
59704404|NCT01260584|75823552|FG003|COMPLETED|Period 1||27||
59704405|NCT01260584|75823549|FG000|NOT COMPLETED|Period 1||0||
59704406|NCT01260584|75823550|FG001|NOT COMPLETED|Period 1||0||
59704407|NCT01260584|75823551|FG002|NOT COMPLETED|Period 1||2||
59704408|NCT01260584|75823552|FG003|NOT COMPLETED|Period 1||1||
59704409|NCT01260584|75823549|FG000|STARTED|Period 2||27||
59704410|NCT01260584|75823550|FG001|STARTED|Period 2||28||
59704411|NCT01260584|75823551|FG002|STARTED|Period 2||25||
59704412|NCT01260584|75823552|FG003|STARTED|Period 2||27||
59704413|NCT01260584|75823549|FG000|COMPLETED|Period 2||26||
59704414|NCT01260584|75823550|FG001|COMPLETED|Period 2||25||
59704415|NCT01260584|75823551|FG002|COMPLETED|Period 2||20||
59704416|NCT01260584|75823552|FG003|COMPLETED|Period 2||26||
59704417|NCT01260584|75823549|FG000|NOT COMPLETED|Period 2||1||
59704418|NCT01260584|75823550|FG001|NOT COMPLETED|Period 2||3||
59704419|NCT01260584|75823551|FG002|NOT COMPLETED|Period 2||5||
59704420|NCT01260584|75823552|FG003|NOT COMPLETED|Period 2||1||
59704421|NCT00927589|75823562|FG000|STARTED|Overall Study||59||
59704422|NCT00927589|75823562|FG000|COMPLETED|Overall Study|Participants were considered to have completed the study after receiving 3 cycles of treatment.|43||
59704423|NCT00927589|75823562|FG000|NOT COMPLETED|Overall Study||16||
59704424|NCT00932425|75823568|FG000|STARTED|Overall Study||20||
59704425|NCT00932425|75823569|FG001|STARTED|Overall Study||20||
59704426|NCT00932425|75823568|FG000|COMPLETED|Overall Study||20||
59704427|NCT00932425|75823569|FG001|COMPLETED|Overall Study||18||
59704428|NCT00932425|75823568|FG000|NOT COMPLETED|Overall Study||0||
59704429|NCT00932425|75823569|FG001|NOT COMPLETED|Overall Study||2||
59704430|NCT05867342|75823575|FG000|STARTED|Overall Study||40||40
59990868|NCT04931888|76106428|FG000|NOT COMPLETED|Overall Study||4||2
59704431|NCT05867342|75823576|FG001|STARTED|Overall Study||40||40
59816263|NCT00520130|75938651|FG001|COMPLETED|Overall Study||44||
59816264|NCT00520130|75938650|FG000|NOT COMPLETED|Overall Study||5||
59990869|NCT04931888|76106429|FG001|NOT COMPLETED|Overall Study||2||0
59990870|NCT04931888|76106430|FG002|NOT COMPLETED|Overall Study||0||0
59990871|NCT04931888|76106431|FG003|NOT COMPLETED|Overall Study||0||0
59704432|NCT05867342|75823575|FG000|COMPLETED|Overall Study||37||37
59704433|NCT05867342|75823576|FG001|COMPLETED|Overall Study||37||37
59704434|NCT05867342|75823575|FG000|NOT COMPLETED|Overall Study||3||3
59704435|NCT05867342|75823576|FG001|NOT COMPLETED|Overall Study||3||3
59704436|NCT05787782|75823582|FG000|STARTED|Overall Study||60||
59704437|NCT05787782|75823582|FG000|COMPLETED|Overall Study||60||
59704438|NCT05787782|75823582|FG000|NOT COMPLETED|Overall Study||0||
59704439|NCT05274178|75823588|FG000|STARTED|Overall Study||10||
59704440|NCT05274178|75823589|FG001|STARTED|Overall Study||10||
59704441|NCT05274178|75823588|FG000|"Tested With OTC Labeled Devices"|Overall Study||10||
59704442|NCT05274178|75823589|FG001|"Tested With OTC Labeled Devices"|Overall Study||10||
59704443|NCT05274178|75823588|FG000|"Tested With Prescriptive Laeled Devices"|Overall Study||10||
59704444|NCT05274178|75823589|FG001|"Tested With Prescriptive Laeled Devices"|Overall Study||10||
59816265|NCT00520130|75938651|FG001|NOT COMPLETED|Overall Study||1||
59816266|NCT00519896|75938661|FG000|STARTED|Overall Study||35||
59990872|NCT04542525|76106450|FG000|STARTED|Overall Study||32||41
59704445|NCT05274178|75823588|FG000|COMPLETED|Overall Study||10||
59704446|NCT05274178|75823589|FG001|COMPLETED|Overall Study||10||
59704447|NCT05274178|75823588|FG000|NOT COMPLETED|Overall Study||0||
59704448|NCT05274178|75823589|FG001|NOT COMPLETED|Overall Study||0||
59704449|NCT05207436|75823595|FG000|STARTED|Overall Study||20||
59704450|NCT05207436|75823595|FG000|COMPLETED|Overall Study||18||
59704451|NCT05207436|75823595|FG000|NOT COMPLETED|Overall Study||2||
59704452|NCT05057221|75823603|FG000|STARTED|Overall Study||6||
59704453|NCT05057221|75823603|FG000|COMPLETED|Overall Study||6||
59704454|NCT05057221|75823603|FG000|NOT COMPLETED|Overall Study||0||
59704455|NCT04957745|75823607|FG000|STARTED|Overall Study||13||
59704456|NCT04957745|75823607|FG000|COMPLETED|Overall Study||13||
59704457|NCT04957745|75823607|FG000|NOT COMPLETED|Overall Study||0||
59704458|NCT04340362|75823611|FG000|STARTED|Overall Study||16||
59704459|NCT04340362|75823611|FG000|Cohort 1|Overall Study||3|The milestone represents the number of participants in Cohort 1.|
59704460|NCT04340362|75823611|FG000|Cohort 2|Overall Study||13|The milestone represents the number of participants in Cohort 2.|
59704461|NCT04340362|75823611|FG000|COMPLETED|Overall Study||15||
59704462|NCT04340362|75823611|FG000|NOT COMPLETED|Overall Study||1||
59704463|NCT04069702|75823618|FG000|STARTED|Overall Study||20||
59704464|NCT04069702|75823618|FG000|COMPLETED|Overall Study||20||
59704465|NCT04069702|75823618|FG000|NOT COMPLETED|Overall Study||0||
59704466|NCT04048356|75823624|FG000|STARTED|Overall Study||72||
59704467|NCT04048356|75823625|FG001|STARTED|Overall Study||65||
59704468|NCT04048356|75823624|FG000|COMPLETED|Overall Study||61||
59704469|NCT04048356|75823625|FG001|COMPLETED|Overall Study||58||
59704470|NCT04048356|75823624|FG000|NOT COMPLETED|Overall Study||11||
59704471|NCT04048356|75823625|FG001|NOT COMPLETED|Overall Study||7||
59704472|NCT03980808|75823633|FG000|STARTED|Overall Study||24||
59704473|NCT03980808|75823634|FG001|STARTED|Overall Study||17||
59704474|NCT03980808|75823633|FG000|Phase 2 - 30-day Follow-up|Overall Study||24||
59704475|NCT03980808|75823634|FG001|Phase 2 - 30-day Follow-up|Overall Study||17||
59704476|NCT03980808|75823633|FG000|COMPLETED|Overall Study||22||
59704477|NCT03980808|75823634|FG001|COMPLETED|Overall Study||15||
59704478|NCT03980808|75823633|FG000|NOT COMPLETED|Overall Study||2||
59704479|NCT03980808|75823634|FG001|NOT COMPLETED|Overall Study||2||
59704480|NCT03955055|75823642|FG000|STARTED|Overall Study||15||
59704481|NCT03955055|75823643|FG001|STARTED|Overall Study||20||
59704482|NCT03955055|75823642|FG000|COMPLETED|Overall Study||14||
59704483|NCT03955055|75823643|FG001|COMPLETED|Overall Study||18||
59704484|NCT03955055|75823642|FG000|NOT COMPLETED|Overall Study||1||
59704485|NCT03955055|75823643|FG001|NOT COMPLETED|Overall Study||2||
59704486|NCT03943953|75823651|FG000|STARTED|Trial of ITG 1|"88 unique participants were enrolled at the outset. 44 of these were re-enrolled to trial a second guide. 18 of these re-enrolled to trial a third guide. 10 of these re-enrolled to trial a fourth guide. Three of these re-enrolled to trial a fifth guide.~These 88 participants provided a total of 132 Time 1 data points"|88||
59704487|NCT03943953|75823652|FG001|STARTED|Trial of ITG 1||9||
59704488|NCT03943953|75823651|FG000|COMPLETED|Trial of ITG 1|57 unique participants completed the study (e.g. completed all guides they had been enrolled to trial).|69||
59704489|NCT03943953|75823652|FG001|COMPLETED|Trial of ITG 1||8||
59704490|NCT03943953|75823651|FG000|NOT COMPLETED|Trial of ITG 1||19||
59704491|NCT03943953|75823652|FG001|NOT COMPLETED|Trial of ITG 1||1||
59704492|NCT03943953|75823651|FG000|STARTED|Trial of ITG 2|The number of participants trialling a second guide was lower than the number trailling the first guide, as not all were eligible to trial a second guide|44||
59704493|NCT03943953|75823652|FG001|STARTED|Trial of ITG 2|There was only one ITG available to friends and family|0||
59704494|NCT03943953|75823651|FG000|COMPLETED|Trial of ITG 2||36||
59704495|NCT03943953|75823652|FG001|COMPLETED|Trial of ITG 2|There was only one ITG available to friends and family|0||
59704496|NCT03943953|75823651|FG000|NOT COMPLETED|Trial of ITG 2||8||
59704497|NCT03943953|75823652|FG001|NOT COMPLETED|Trial of ITG 2||0||
60079763|NCT03444870|76194899|FG001|SE Analysis Set|Open-Label Extension (OLE) Period||0|SE analysis set included all participants randomized during the global phase who received at least one dose of study drug. In the DBT period, 4 participants randomized to placebo arm received at least one dose of gantenerumab and were considered in the gantenerumab arm for safety evaluable set, of which 1 participant entered OLE period.|
60079764|NCT03444870|76194900|FG002|SE Analysis Set|Open-Label Extension (OLE) Period||0|SE analysis set included all participants randomized during the global phase who received at least one dose of study drug. In the DBT period, 4 participants randomized to placebo arm received at least one dose of gantenerumab and were considered in the gantenerumab arm for safety evaluable set, of which 1 participant entered OLE period.|
60103622|NCT01291108|76221867|FG004|STARTED|Month 2 (Adjunctive Therapy)||34||
59704498|NCT03943953|75823651|FG000|STARTED|Trial of ITG 3|The number of participants trialling a third guide was lower than the number trailling the second guide, as not all were eligible to trial a further third guide|18||
59704499|NCT03943953|75823652|FG001|STARTED|Trial of ITG 3||0||
59704500|NCT03943953|75823651|FG000|COMPLETED|Trial of ITG 3||16||
59704501|NCT03943953|75823652|FG001|COMPLETED|Trial of ITG 3||0||
59704502|NCT03943953|75823651|FG000|NOT COMPLETED|Trial of ITG 3||2||
59704503|NCT03943953|75823652|FG001|NOT COMPLETED|Trial of ITG 3||0||
59704504|NCT03943953|75823651|FG000|STARTED|Trial of ITG 4|The number of participants trialling a fourth guide was lower than the number trailling the third guide, as not all were eligible to trial a further fourth guide|10||
59704505|NCT03943953|75823652|FG001|STARTED|Trial of ITG 4||0||
60079765|NCT03444870|76194901|FG003|SE Analysis Set|Open-Label Extension (OLE) Period||0|SE analysis set included all participants randomized during the global phase who received at least one dose of study drug. In the DBT period, 4 participants randomized to placebo arm received at least one dose of gantenerumab and were considered in the gantenerumab arm for safety evaluable set, of which 1 participant entered OLE period.|
60079766|NCT03444870|76194902|FG004|SE Analysis Set|Open-Label Extension (OLE) Period||9|SE analysis set included all participants randomized during the global phase who received at least one dose of study drug. In the DBT period, 4 participants randomized to placebo arm received at least one dose of gantenerumab and were considered in the gantenerumab arm for safety evaluable set, of which 1 participant entered OLE period.|
60079767|NCT03444870|76194903|FG005|SE Analysis Set|Open-Label Extension (OLE) Period||20|SE analysis set included all participants randomized during the global phase who received at least one dose of study drug. In the DBT period, 4 participants randomized to placebo arm received at least one dose of gantenerumab and were considered in the gantenerumab arm for safety evaluable set, of which 1 participant entered OLE period.|
60079768|NCT03444870|76194898|FG000|COMPLETED|Open-Label Extension (OLE) Period||0||
60079769|NCT03444870|76194899|FG001|COMPLETED|Open-Label Extension (OLE) Period||0||
60079770|NCT03444870|76194900|FG002|COMPLETED|Open-Label Extension (OLE) Period||0||
60079771|NCT03444870|76194901|FG003|COMPLETED|Open-Label Extension (OLE) Period||0||
60079772|NCT03444870|76194902|FG004|COMPLETED|Open-Label Extension (OLE) Period||7||
60079773|NCT03444870|76194903|FG005|COMPLETED|Open-Label Extension (OLE) Period||17||
60079774|NCT03444870|76194898|FG000|NOT COMPLETED|Open-Label Extension (OLE) Period||0||
60079775|NCT03444870|76194899|FG001|NOT COMPLETED|Open-Label Extension (OLE) Period||0||
60079776|NCT03444870|76194900|FG002|NOT COMPLETED|Open-Label Extension (OLE) Period||0||
60079777|NCT03444870|76194901|FG003|NOT COMPLETED|Open-Label Extension (OLE) Period||0||
60079778|NCT03444870|76194902|FG004|NOT COMPLETED|Open-Label Extension (OLE) Period||3||
60079779|NCT03444870|76194903|FG005|NOT COMPLETED|Open-Label Extension (OLE) Period||2||
60079780|NCT03290391|76194921|FG000|STARTED|Allocation||111||
60079781|NCT03290391|76194922|FG001|STARTED|Allocation||114||
60079782|NCT03290391|76194921|FG000|COMPLETED|Allocation||111||
60079783|NCT03290391|76194922|FG001|COMPLETED|Allocation||114||
60079784|NCT03290391|76194921|FG000|NOT COMPLETED|Allocation||0||
60079785|NCT03290391|76194922|FG001|NOT COMPLETED|Allocation||0||
60079786|NCT03290391|76194921|FG000|STARTED|Completed 6 Month Assessment||111||
60079787|NCT03290391|76194922|FG001|STARTED|Completed 6 Month Assessment||114||
60079788|NCT03290391|76194921|FG000|COMPLETED|Completed 6 Month Assessment||79||
60079789|NCT03290391|76194922|FG001|COMPLETED|Completed 6 Month Assessment||85||
60079790|NCT03290391|76194921|FG000|NOT COMPLETED|Completed 6 Month Assessment||32||
60079791|NCT03290391|76194922|FG001|NOT COMPLETED|Completed 6 Month Assessment||29||
60079792|NCT03290391|76194921|FG000|STARTED|Completed 12 Month Assessment||111||
60079793|NCT03290391|76194922|FG001|STARTED|Completed 12 Month Assessment||114||
60079794|NCT03290391|76194921|FG000|COMPLETED|Completed 12 Month Assessment||82||
60079795|NCT03290391|76194922|FG001|COMPLETED|Completed 12 Month Assessment||83||
60079796|NCT03290391|76194921|FG000|NOT COMPLETED|Completed 12 Month Assessment||29||
60079797|NCT03290391|76194922|FG001|NOT COMPLETED|Completed 12 Month Assessment||31||
60079798|NCT03112590|76194931|FG000|STARTED|Overall Study||3||
60079799|NCT03112590|76194932|FG001|STARTED|Overall Study||6||
60079800|NCT03112590|76194933|FG002|STARTED|Overall Study||42||
60079801|NCT03112590|76194931|FG000|COMPLETED|Overall Study||3||
60079802|NCT03112590|76194932|FG001|COMPLETED|Overall Study||5||
60079803|NCT03112590|76194933|FG002|COMPLETED|Overall Study||42||
60079804|NCT03112590|76194931|FG000|NOT COMPLETED|Overall Study||0||
60079805|NCT03112590|76194932|FG001|NOT COMPLETED|Overall Study||1||
60079806|NCT03112590|76194933|FG002|NOT COMPLETED|Overall Study||0||
60079807|NCT03060629|76194943|FG000|STARTED|Overall Study||1313||
60079808|NCT03060629|76194944|FG001|STARTED|Overall Study||1323||
60079809|NCT03060629|76194943|FG000|COMPLETED|Overall Study||78||
60079810|NCT03060629|76194944|FG001|COMPLETED|Overall Study||88||
60079811|NCT03060629|76194943|FG000|NOT COMPLETED|Overall Study||1235||
60079812|NCT03060629|76194944|FG001|NOT COMPLETED|Overall Study||1235||
60079813|NCT03021486|76194953|FG000|STARTED|Overall Study||23||
60079814|NCT03021486|76194954|FG001|STARTED|Overall Study||22||
60079815|NCT03021486|76194955|FG002|STARTED|Overall Study||23||
60079816|NCT03021486|76194953|FG000|COMPLETED|Overall Study||15||
60079817|NCT03021486|76194954|FG001|COMPLETED|Overall Study||16||
60079818|NCT03021486|76194955|FG002|COMPLETED|Overall Study||14||
60079819|NCT03021486|76194953|FG000|NOT COMPLETED|Overall Study||8||
60079820|NCT03021486|76194954|FG001|NOT COMPLETED|Overall Study||6||
60079821|NCT03021486|76194955|FG002|NOT COMPLETED|Overall Study||9||
60079822|NCT02999789|76194967|FG000|STARTED|Overall Study||4||
60079823|NCT02999789|76194968|FG001|STARTED|Overall Study||3||
60079824|NCT02999789|76194967|FG000|COMPLETED|Overall Study||3||
60079825|NCT02999789|76194968|FG001|COMPLETED|Overall Study||0||
60079826|NCT02999789|76194967|FG000|NOT COMPLETED|Overall Study||1||
60079827|NCT02999789|76194968|FG001|NOT COMPLETED|Overall Study||3||
60079828|NCT02949128|76194975|FG000|STARTED|Initial Evaluation Period||58||
60079829|NCT02949128|76194975|FG000|Received At Least 1 Dose of Study Drug|Initial Evaluation Period||58||
60079830|NCT02949128|76194975|FG000|COMPLETED|Initial Evaluation Period||49|Completed the Initial Evaluation Period|
60079831|NCT02949128|76194975|FG000|NOT COMPLETED|Initial Evaluation Period||9||
60079832|NCT02949128|76194975|FG000|STARTED|Extension Period||49||
60079833|NCT02949128|76194975|FG000|Received At Least 1 Dose of Study Drug|Extension Period||47||
60079834|NCT02949128|76194975|FG000|COMPLETED|Extension Period||0||
60079835|NCT02949128|76194975|FG000|NOT COMPLETED|Extension Period||49||
60079836|NCT02944617|76194981|FG000|STARTED|Overall Study||11||
60079837|NCT02944617|76194982|FG001|STARTED|Overall Study||10||
60079838|NCT02944617|76194981|FG000|COMPLETED|Overall Study||10||
60079839|NCT02944617|76194982|FG001|COMPLETED|Overall Study||10||
60079840|NCT02944617|76194981|FG000|NOT COMPLETED|Overall Study||1||
60079841|NCT02944617|76194982|FG001|NOT COMPLETED|Overall Study||0||
60079842|NCT02923115|76194994|FG000|STARTED|Overall Study||12|Randomized|
60079843|NCT02923115|76194995|FG001|STARTED|Overall Study||16|Randomized|
60079844|NCT02923115|76194996|FG002|STARTED|Overall Study||23|Randomized|
60079845|NCT02923115|76194997|FG003|STARTED|Overall Study||23|Randomized|
60079846|NCT02923115|76194998|FG004|STARTED|Overall Study||22|Randomized|
60079847|NCT02923115|76194999|FG005|STARTED|Overall Study||38|Randomized|
60079848|NCT02923115|76194994|FG000|Treated|Overall Study||12||
60079849|NCT02923115|76194995|FG001|Treated|Overall Study||16||
60079850|NCT02923115|76194996|FG002|Treated|Overall Study||20||
60079851|NCT02923115|76194997|FG003|Treated|Overall Study||22||
60079852|NCT02923115|76194998|FG004|Treated|Overall Study||17||
60079853|NCT02923115|76194999|FG005|Treated|Overall Study||38||
60079854|NCT02923115|76194994|FG000|COMPLETED|Overall Study||12||
60079855|NCT02923115|76194995|FG001|COMPLETED|Overall Study||15||
60079856|NCT02923115|76194996|FG002|COMPLETED|Overall Study||20||
60079857|NCT02923115|76194997|FG003|COMPLETED|Overall Study||21||
60079858|NCT02923115|76194998|FG004|COMPLETED|Overall Study||17||
59990873|NCT04542525|76106450|FG000|Attempted Implantation|Overall Study||32||41
59990874|NCT04542525|76106450|FG000|Successful Implantation|Overall Study||32||41
59704506|NCT03943953|75823651|FG000|COMPLETED|Trial of ITG 4||8||
59990875|NCT04542525|76106450|FG000|COMPLETED|Overall Study||32||41
59990876|NCT04542525|76106450|FG000|NOT COMPLETED|Overall Study||0||0
59990877|NCT02436356|76106460|FG000|STARTED|Overall Study||33||
59990878|NCT02436356|76106461|FG001|STARTED|Overall Study||11||
59990879|NCT02436356|76106462|FG002|STARTED|Overall Study||4||
60079859|NCT02923115|76194999|FG005|COMPLETED|Overall Study||38||
60079860|NCT02923115|76194994|FG000|NOT COMPLETED|Overall Study||0||
60079861|NCT02923115|76194995|FG001|NOT COMPLETED|Overall Study||1||
60079862|NCT02923115|76194996|FG002|NOT COMPLETED|Overall Study||3||
60079863|NCT02923115|76194997|FG003|NOT COMPLETED|Overall Study||2||
60079864|NCT02923115|76194998|FG004|NOT COMPLETED|Overall Study||5||
60079865|NCT02923115|76194999|FG005|NOT COMPLETED|Overall Study||0||
60079866|NCT02910583|76195015|FG000|STARTED|Overall Study||159||
60079867|NCT02910583|76195016|FG001|STARTED|Overall Study||164||
60079868|NCT02910583|76195015|FG000|MRD Cohort/ Not Randomized|Overall Study|Not applicable to this cohort.|0||
60079869|NCT02910583|76195016|FG001|MRD Cohort/ Not Randomized|Overall Study||15||
60079870|NCT02910583|76195015|FG000|MRD Cohort/ Confirmed uMRD: Randomized to Ibrutinib (Blinded)|Overall Study|Not applicable to this cohort.|0||
60079871|NCT02910583|76195016|FG001|MRD Cohort/ Confirmed uMRD: Randomized to Ibrutinib (Blinded)|Overall Study||43||
60079872|NCT02910583|76195015|FG000|MRD Cohort/ Confirmed uMRD: Randomized Placebo (Blinded)|Overall Study|Not applicable to this cohort.|0||
60079873|NCT02910583|76195016|FG001|MRD Cohort/ Confirmed uMRD: Randomized Placebo (Blinded)|Overall Study||43||
60079874|NCT02910583|76195015|FG000|MRD Cohort/uMRD Not Confirmed: Randomized to Ibrutinib (Open-Label)|Overall Study|Not applicable to this cohort.|0||
60079875|NCT02910583|76195016|FG001|MRD Cohort/uMRD Not Confirmed: Randomized to Ibrutinib (Open-Label)|Overall Study||31||
60079876|NCT02910583|76195015|FG000|MRD Cohort/uMRD Not Confirmed: Randomized Ibrutinib + Venetoclax (Open-Label)|Overall Study|Not applicable to this cohort.|0||
60079877|NCT02910583|76195016|FG001|MRD Cohort/uMRD Not Confirmed: Randomized Ibrutinib + Venetoclax (Open-Label)|Overall Study||32||
60079878|NCT02910583|76195015|FG000|COMPLETED|Overall Study||152|Participants who were still on study or died as of the data extraction.|
59704507|NCT03943953|75823652|FG001|COMPLETED|Trial of ITG 4||0||
59990880|NCT02436356|76106460|FG000|High Energy Fracture|Overall Study||14||
59990881|NCT02436356|76106461|FG001|High Energy Fracture|Overall Study||0||
59990882|NCT02436356|76106462|FG002|High Energy Fracture|Overall Study||4||
59990883|NCT02436356|76106460|FG000|Low Energy Fracture|Overall Study||19||
59990884|NCT02436356|76106461|FG001|Low Energy Fracture|Overall Study||0||
59990885|NCT02436356|76106462|FG002|Low Energy Fracture|Overall Study||0||
60079879|NCT02910583|76195016|FG001|COMPLETED|Overall Study||157|Participants who were still on study or died as of the data extraction.|
60079880|NCT02910583|76195015|FG000|NOT COMPLETED|Overall Study||7||
60079881|NCT02910583|76195016|FG001|NOT COMPLETED|Overall Study||7||
60079882|NCT02648477|76195052|FG000|STARTED|Overall Study||10||
60079883|NCT02648477|76195053|FG001|STARTED|Overall Study||20||
60079884|NCT02648477|76195052|FG000|COMPLETED|Overall Study||10||
60079885|NCT02648477|76195053|FG001|COMPLETED|Overall Study||20||
60079886|NCT02648477|76195052|FG000|NOT COMPLETED|Overall Study||0||
60079887|NCT02648477|76195053|FG001|NOT COMPLETED|Overall Study||0||
60079888|NCT02487394|76195061|FG000|STARTED|Phase 1||8||
60079889|NCT02487394|76195062|FG001|STARTED|Phase 1||1||
59704508|NCT03943953|75823651|FG000|NOT COMPLETED|Trial of ITG 4||2||
59704509|NCT03943953|75823652|FG001|NOT COMPLETED|Trial of ITG 4||0||
59990886|NCT02436356|76106460|FG000|COMPLETED|Overall Study||28||
59990887|NCT02436356|76106461|FG001|COMPLETED|Overall Study||10||
60079890|NCT02487394|76195061|FG000|COMPLETED|Phase 1||8|One subject was withdrawn|
60079891|NCT02487394|76195062|FG001|COMPLETED|Phase 1||0|One subject was withdrawn|
60079892|NCT02487394|76195061|FG000|NOT COMPLETED|Phase 1||0||
60079893|NCT02487394|76195062|FG001|NOT COMPLETED|Phase 1||1||
60079894|NCT02487394|76195061|FG000|STARTED|Phase 2||4|Only 4 subjects who completed phase I enrolled in phase II of asthmatics. None of the COPD subjects who completed phase 1 enrolled in phase II.|
60079895|NCT02487394|76195062|FG001|STARTED|Phase 2||0|Only 4 subjects who completed phase I enrolled in phase II of asthmatics. None of the COPD subjects who completed phase 1 enrolled in phase II.|
60079896|NCT02487394|76195061|FG000|COMPLETED|Phase 2||4||
60079897|NCT02487394|76195062|FG001|COMPLETED|Phase 2||0||
60079898|NCT02487394|76195061|FG000|NOT COMPLETED|Phase 2||0||
60079899|NCT02487394|76195062|FG001|NOT COMPLETED|Phase 2||0||
60079900|NCT02134184|76195071|FG000|STARTED|Overall Study||33||
60079901|NCT02134184|76195072|FG001|STARTED|Overall Study||37||
60079902|NCT02134184|76195073|FG002|STARTED|Overall Study||8||
60079903|NCT02134184|76195071|FG000|COMPLETED|Overall Study||33||
60079904|NCT02134184|76195072|FG001|COMPLETED|Overall Study||37||
59548229|NCT01172522|75647164|FG000|NOT COMPLETED|Overall Study||0||
59548230|NCT01172522|75647165|FG001|NOT COMPLETED|Overall Study||0||
59548231|NCT01172600|75647172|FG000|STARTED|Overall Study||39||
59704510|NCT03943953|75823651|FG000|STARTED|Trial of ITG 5|The number of participants trialling a fifth guide was lower than the number trailling the fourth guide, as not all were eligible to trial a further fifth guide|3||
59704511|NCT03943953|75823652|FG001|STARTED|Trial of ITG 5||0||
59704512|NCT03943953|75823651|FG000|COMPLETED|Trial of ITG 5||3||
60079905|NCT02134184|76195073|FG002|COMPLETED|Overall Study||8||
60079906|NCT02134184|76195071|FG000|NOT COMPLETED|Overall Study||0||
60079907|NCT02134184|76195072|FG001|NOT COMPLETED|Overall Study||0||
60079908|NCT02134184|76195073|FG002|NOT COMPLETED|Overall Study||0||
60079909|NCT02029846|76195083|FG000|STARTED|Overall Study||1||
60079910|NCT02029846|76195084|FG001|STARTED|Overall Study||1||
60079911|NCT02029846|76195083|FG000|COMPLETED|Overall Study||0||
60079912|NCT02029846|76195084|FG001|COMPLETED|Overall Study||0||
60079913|NCT02029846|76195083|FG000|NOT COMPLETED|Overall Study||1||
60079914|NCT02029846|76195084|FG001|NOT COMPLETED|Overall Study||1||
60079915|NCT05889039|76195094|FG000|STARTED|Overall Study||12||
60079916|NCT05889039|76195095|FG001|STARTED|Overall Study||12||
59548232|NCT01172600|75647173|FG001|STARTED|Overall Study||39||
60079917|NCT05889039|76195096|FG002|STARTED|Overall Study||10||
60079918|NCT05889039|76195097|FG003|STARTED|Overall Study||10||
60079919|NCT05889039|76195094|FG000|COMPLETED|Overall Study||8||
60079920|NCT05889039|76195095|FG001|COMPLETED|Overall Study||10||
60079921|NCT05889039|76195096|FG002|COMPLETED|Overall Study||10||
60079922|NCT05889039|76195097|FG003|COMPLETED|Overall Study||10||
60079923|NCT05889039|76195094|FG000|NOT COMPLETED|Overall Study||4||
60079924|NCT05889039|76195095|FG001|NOT COMPLETED|Overall Study||2||
60079925|NCT05889039|76195096|FG002|NOT COMPLETED|Overall Study||0||
60079926|NCT05889039|76195097|FG003|NOT COMPLETED|Overall Study||0||
60079927|NCT05790408|76195107|FG000|STARTED|Overall Study||10||10
59548233|NCT01172600|75647172|FG000|COMPLETED|Overall Study||39||
59548234|NCT01172600|75647173|FG001|COMPLETED|Overall Study||39||
59548235|NCT01172600|75647172|FG000|NOT COMPLETED|Overall Study||0||
59548236|NCT01172600|75647173|FG001|NOT COMPLETED|Overall Study||0||
59548237|NCT01137032|75647179|FG000|STARTED|Overall Study||19||
59548238|NCT01137032|75647179|FG000|COMPLETED|Overall Study||19||
59548239|NCT01137032|75647179|FG000|NOT COMPLETED|Overall Study||0||
59548240|NCT01137890|75647185|FG000|STARTED|Overall Study||14||
59548241|NCT01137890|75647186|FG001|STARTED|Overall Study||5||
59548242|NCT01137890|75647185|FG000|COMPLETED|Overall Study||8||
59704513|NCT03943953|75823652|FG001|COMPLETED|Trial of ITG 5||0||
59548243|NCT01137890|75647186|FG001|COMPLETED|Overall Study||2||
59548244|NCT01137890|75647185|FG000|NOT COMPLETED|Overall Study||6||
59548245|NCT01137890|75647186|FG001|NOT COMPLETED|Overall Study||3||
59548246|NCT01138124|75647242|FG000|STARTED|Overall Study||3149||
59548247|NCT01138124|75647243|FG001|STARTED|Overall Study||30026||
59548248|NCT01138124|75647244|FG002|STARTED|Overall Study||1981||
59704514|NCT03943953|75823651|FG000|NOT COMPLETED|Trial of ITG 5||0||
60079928|NCT05790408|76195107|FG000|COMPLETED|Overall Study||7||7
60079929|NCT05790408|76195107|FG000|NOT COMPLETED|Overall Study||3||3
60079930|NCT05439421|76195113|FG000|STARTED|Zero Percent Tar||742||
60079931|NCT05439421|76195114|FG001|STARTED|Zero Percent Tar||765||
60079932|NCT05439421|76195113|FG000|COMPLETED|Zero Percent Tar||742||
60079933|NCT05439421|76195114|FG001|COMPLETED|Zero Percent Tar||765||
60079934|NCT05439421|76195113|FG000|NOT COMPLETED|Zero Percent Tar||0||
60079935|NCT05439421|76195114|FG001|NOT COMPLETED|Zero Percent Tar||0||
60079936|NCT05439421|76195113|FG000|STARTED|No Chemicals||764||
60079937|NCT05439421|76195114|FG001|STARTED|No Chemicals||743||
60079938|NCT05439421|76195113|FG000|COMPLETED|No Chemicals||764||
60079939|NCT05439421|76195114|FG001|COMPLETED|No Chemicals||743||
60079940|NCT05439421|76195113|FG000|NOT COMPLETED|No Chemicals||0||
60079941|NCT05439421|76195114|FG001|NOT COMPLETED|No Chemicals||0||
60079942|NCT05439421|76195113|FG000|STARTED|Apple Image||743||
60079943|NCT05439421|76195114|FG001|STARTED|Apple Image||764||
60079944|NCT05439421|76195113|FG000|COMPLETED|Apple Image||743||
60079945|NCT05439421|76195114|FG001|COMPLETED|Apple Image||764||
59704515|NCT03943953|75823652|FG001|NOT COMPLETED|Trial of ITG 5||0||
59704516|NCT03670628|75823662|FG000|STARTED|Baseline Visit||13||
59704517|NCT03670628|75823663|FG001|STARTED|Baseline Visit||10||
59704518|NCT03670628|75823662|FG000|COMPLETED|Baseline Visit||13||
59704519|NCT03670628|75823663|FG001|COMPLETED|Baseline Visit||10||
59704520|NCT03670628|75823662|FG000|NOT COMPLETED|Baseline Visit||0||
59704521|NCT03670628|75823663|FG001|NOT COMPLETED|Baseline Visit||0||
59990888|NCT02436356|76106462|FG002|COMPLETED|Overall Study||2||
59990889|NCT02436356|76106460|FG000|NOT COMPLETED|Overall Study||5||
59990890|NCT02436356|76106461|FG001|NOT COMPLETED|Overall Study||1||
59990891|NCT02436356|76106462|FG002|NOT COMPLETED|Overall Study||2||
59990892|NCT02436200|76106475|FG000|STARTED|Overall Study||21||
59990893|NCT02436200|76106475|FG000|COMPLETED|Overall Study||20||
59990894|NCT02436200|76106475|FG000|NOT COMPLETED|Overall Study||1||
59990895|NCT01679613|76106479|FG000|STARTED|Overall Study||4||
59990896|NCT01679613|76106480|FG001|STARTED|Overall Study||4||
59990897|NCT01679613|76106481|FG002|STARTED|Overall Study||13||
59990898|NCT01679613|76106482|FG003|STARTED|Overall Study||13||
59990899|NCT01679613|76106479|FG000|Received Nintedanib (Pilot)|Overall Study||4||
59990900|NCT01679613|76106480|FG001|Received Nintedanib (Pilot)|Overall Study||3||
59990901|NCT01679613|76106481|FG002|Received Nintedanib (Pilot)|Overall Study||0||
59990902|NCT01679613|76106482|FG003|Received Nintedanib (Pilot)|Overall Study||0||
59990903|NCT01679613|76106479|FG000|Received Nintedanib+Ketoconazole (Pilot)|Overall Study||4||
59990904|NCT01679613|76106480|FG001|Received Nintedanib+Ketoconazole (Pilot)|Overall Study|One subject received only ketoconazole not nintedanib|4||
59990905|NCT01679613|76106481|FG002|Received Nintedanib+Ketoconazole (Pilot)|Overall Study||0||
59990906|NCT01679613|76106482|FG003|Received Nintedanib+Ketoconazole (Pilot)|Overall Study||0||
59990907|NCT01679613|76106479|FG000|Received Nintedanib (Main)|Overall Study||0||
59990908|NCT01679613|76106480|FG001|Received Nintedanib (Main)|Overall Study||0||
59990909|NCT01679613|76106481|FG002|Received Nintedanib (Main)|Overall Study||13||
59990910|NCT01679613|76106482|FG003|Received Nintedanib (Main)|Overall Study||11||
59990911|NCT01679613|76106479|FG000|Received Nintedanib+Ketoconazole (Main)|Overall Study||0||
59990912|NCT01679613|76106480|FG001|Received Nintedanib+Ketoconazole (Main)|Overall Study||0||
59990913|NCT01679613|76106481|FG002|Received Nintedanib+Ketoconazole (Main)|Overall Study|Two subjects received only ketoconazole not nintedanib|13||
59990914|NCT01679613|76106482|FG003|Received Nintedanib+Ketoconazole (Main)|Overall Study|Two subjects received only ketoconazole not nintedanib|13||
59990915|NCT01679613|76106479|FG000|COMPLETED|Overall Study||4||
59990916|NCT01679613|76106480|FG001|COMPLETED|Overall Study||3||
59990917|NCT01679613|76106481|FG002|COMPLETED|Overall Study||11||
59990918|NCT01679613|76106482|FG003|COMPLETED|Overall Study||11||
59990919|NCT01679613|76106479|FG000|NOT COMPLETED|Overall Study||0||
59704522|NCT03670628|75823662|FG000|STARTED|Weekly Therapy Sessions||13||
59704523|NCT03670628|75823663|FG001|STARTED|Weekly Therapy Sessions||10||
59704524|NCT03670628|75823662|FG000|COMPLETED|Weekly Therapy Sessions||5||
59704525|NCT03670628|75823663|FG001|COMPLETED|Weekly Therapy Sessions||7||
59704526|NCT03670628|75823662|FG000|NOT COMPLETED|Weekly Therapy Sessions||8||
59704527|NCT03670628|75823663|FG001|NOT COMPLETED|Weekly Therapy Sessions||3||
59704528|NCT03670628|75823662|FG000|STARTED|Month 1 Visit||5||
59704529|NCT03670628|75823663|FG001|STARTED|Month 1 Visit||7||
59704530|NCT03670628|75823662|FG000|COMPLETED|Month 1 Visit||5||
59704531|NCT03670628|75823663|FG001|COMPLETED|Month 1 Visit||7||
59704532|NCT03670628|75823662|FG000|NOT COMPLETED|Month 1 Visit||0||
59704533|NCT03670628|75823663|FG001|NOT COMPLETED|Month 1 Visit||0||
59704534|NCT03670628|75823662|FG000|STARTED|Waiting Period||5||
59704535|NCT03670628|75823663|FG001|STARTED|Waiting Period||7||
59704536|NCT03670628|75823662|FG000|COMPLETED|Waiting Period||1||
59704537|NCT03670628|75823663|FG001|COMPLETED|Waiting Period||1||
59704538|NCT03670628|75823662|FG000|NOT COMPLETED|Waiting Period||4||
59704539|NCT03670628|75823663|FG001|NOT COMPLETED|Waiting Period||6||
59704540|NCT03670628|75823662|FG000|STARTED|Month 3 Visit||1||
59704541|NCT03670628|75823663|FG001|STARTED|Month 3 Visit||1||
59704542|NCT03670628|75823662|FG000|COMPLETED|Month 3 Visit||1||
59704543|NCT03670628|75823663|FG001|COMPLETED|Month 3 Visit||1||
59704544|NCT03670628|75823662|FG000|NOT COMPLETED|Month 3 Visit||0||
59704545|NCT03670628|75823663|FG001|NOT COMPLETED|Month 3 Visit||0||
59704546|NCT03637764|75823673|FG000|STARTED|Overall Study||27||
59990920|NCT01679613|76106480|FG001|NOT COMPLETED|Overall Study||1||
59990921|NCT01679613|76106481|FG002|NOT COMPLETED|Overall Study||2||
59990922|NCT01679613|76106482|FG003|NOT COMPLETED|Overall Study||2||
59990923|NCT02489630|76106491|FG000|STARTED|Overall Study||53||
59704547|NCT03637764|75823674|FG001|STARTED|Overall Study||29||
59704548|NCT03637764|75823675|FG002|STARTED|Overall Study||18||
59704549|NCT03637764|75823676|FG003|STARTED|Overall Study||33||
59704550|NCT03637764|75823673|FG000|COMPLETED|Overall Study||1|Participants who completed the study treatment duration.|
59704551|NCT03637764|75823674|FG001|COMPLETED|Overall Study||3|Participants who completed the study treatment duration.|
59704552|NCT03637764|75823675|FG002|COMPLETED|Overall Study||0|Participants who completed the study treatment duration.|
59990924|NCT02489630|76106492|FG001|STARTED|Overall Study||63||
59990925|NCT02489630|76106491|FG000|COMPLETED|Overall Study||51||
59990926|NCT02489630|76106492|FG001|COMPLETED|Overall Study||61||
59704553|NCT03637764|75823676|FG003|COMPLETED|Overall Study||0|Participants who completed the study treatment duration.|
59704554|NCT03637764|75823673|FG000|NOT COMPLETED|Overall Study||26||
59704555|NCT03637764|75823674|FG001|NOT COMPLETED|Overall Study||26||
59704556|NCT03637764|75823675|FG002|NOT COMPLETED|Overall Study||18||
59704557|NCT03637764|75823676|FG003|NOT COMPLETED|Overall Study||33||
59704558|NCT03594266|75823693|FG000|STARTED|Overall Study||38||
59704559|NCT03594266|75823694|FG001|STARTED|Overall Study||39||
59704560|NCT03594266|75823693|FG000|COMPLETED|Overall Study||31||
59704561|NCT03594266|75823694|FG001|COMPLETED|Overall Study||34||
59704562|NCT03594266|75823693|FG000|NOT COMPLETED|Overall Study||7||
59704563|NCT03594266|75823694|FG001|NOT COMPLETED|Overall Study||5||
59704564|NCT03483116|75823706|FG000|STARTED|Overall Study||178||
59704565|NCT03483116|75823707|FG001|STARTED|Overall Study||179||
59704566|NCT03483116|75823708|FG002|STARTED|Overall Study||175||
59704567|NCT03483116|75823709|FG003|STARTED|Overall Study||179||
59704568|NCT03483116|75823706|FG000|COMPLETED|Overall Study||150||
59704569|NCT03483116|75823707|FG001|COMPLETED|Overall Study||156||
59990927|NCT02489630|76106491|FG000|NOT COMPLETED|Overall Study||2||
59990928|NCT02489630|76106492|FG001|NOT COMPLETED|Overall Study||2||
59990929|NCT02739347|76106500|FG000|STARTED|Overall Study||5||
59704570|NCT03483116|75823708|FG002|COMPLETED|Overall Study||149||
59704571|NCT03483116|75823709|FG003|COMPLETED|Overall Study||148||
59704572|NCT03483116|75823706|FG000|NOT COMPLETED|Overall Study||28||
59704573|NCT03483116|75823707|FG001|NOT COMPLETED|Overall Study||23||
59704574|NCT03483116|75823708|FG002|NOT COMPLETED|Overall Study||26||
59704575|NCT03483116|75823709|FG003|NOT COMPLETED|Overall Study||31||
59704576|NCT03222076|75823725|FG000|STARTED|Overall Study||13||
59704577|NCT03222076|75823726|FG001|STARTED|Overall Study||14||
59704578|NCT03222076|75823727|FG002|STARTED|Overall Study||0||
59704579|NCT03222076|75823725|FG000|COMPLETED|Overall Study||13||
59704580|NCT03222076|75823726|FG001|COMPLETED|Overall Study||14||
59704581|NCT03222076|75823727|FG002|COMPLETED|Overall Study||0||
59704582|NCT03222076|75823725|FG000|NOT COMPLETED|Overall Study||0||
59704583|NCT03222076|75823726|FG001|NOT COMPLETED|Overall Study||0||
59704584|NCT03222076|75823727|FG002|NOT COMPLETED|Overall Study||0||
59704585|NCT02811861|75823740|FG000|STARTED|Overall Study||357||
59704586|NCT02811861|75823741|FG001|STARTED|Overall Study||355||
59704587|NCT02811861|75823742|FG002|STARTED|Overall Study||357||
59704588|NCT02811861|75823740|FG000|Treated|Overall Study||355||
59704589|NCT02811861|75823741|FG001|Treated|Overall Study||352||
59704590|NCT02811861|75823742|FG002|Treated|Overall Study||340||
59704591|NCT02811861|75823740|FG000|COMPLETED|Overall Study||0||
59704592|NCT02811861|75823741|FG001|COMPLETED|Overall Study||0||
59704593|NCT02811861|75823742|FG002|COMPLETED|Overall Study||0||
59704594|NCT02811861|75823740|FG000|NOT COMPLETED|Overall Study||357||
59704595|NCT02811861|75823741|FG001|NOT COMPLETED|Overall Study||355||
59704596|NCT02811861|75823742|FG002|NOT COMPLETED|Overall Study||357||
59704597|NCT02700451|75823753|FG000|STARTED|Overall Study||60||
59704598|NCT02700451|75823754|FG001|STARTED|Overall Study||60||
59704599|NCT02700451|75823755|FG002|STARTED|Overall Study||58||
59704600|NCT02700451|75823753|FG000|COMPLETED|Overall Study||44||
59704601|NCT02700451|75823754|FG001|COMPLETED|Overall Study||43||
59704602|NCT02700451|75823755|FG002|COMPLETED|Overall Study||41||
59704603|NCT02700451|75823753|FG000|NOT COMPLETED|Overall Study||16||
59704604|NCT02700451|75823754|FG001|NOT COMPLETED|Overall Study||17||
59704605|NCT02700451|75823755|FG002|NOT COMPLETED|Overall Study||17||
59704606|NCT02623426|75823766|FG000|STARTED|Overall Study||65||77
59704607|NCT02623426|75823767|FG001|STARTED|Overall Study||65||79
59704608|NCT02623426|75823768|FG002|STARTED|Overall Study||64||69
59704609|NCT02623426|75823766|FG000|4 Week Visit|Overall Study||65||77
59704610|NCT02623426|75823767|FG001|4 Week Visit|Overall Study||64||78
59704611|NCT02623426|75823768|FG002|4 Week Visit|Overall Study||63||68
59704612|NCT02623426|75823766|FG000|8 Week Visit|Overall Study||65||77
59704613|NCT02623426|75823767|FG001|8 Week Visit|Overall Study||64||78
59704614|NCT02623426|75823768|FG002|8 Week Visit|Overall Study||61||66
59704615|NCT02623426|75823766|FG000|COMPLETED|Overall Study||64|12 week visit|76
59704616|NCT02623426|75823767|FG001|COMPLETED|Overall Study||63|12 week visit|77
59704617|NCT02623426|75823768|FG002|COMPLETED|Overall Study||61|12 week visit|66
59704618|NCT02623426|75823766|FG000|NOT COMPLETED|Overall Study||1||1
59704619|NCT02623426|75823767|FG001|NOT COMPLETED|Overall Study||2||2
59704620|NCT02623426|75823768|FG002|NOT COMPLETED|Overall Study||3||3
59816267|NCT00519896|75938661|FG000|COMPLETED|Overall Study||33||
59990930|NCT02739347|76106501|FG001|STARTED|Overall Study||7||
59990931|NCT02739347|76106500|FG000|COMPLETED|Overall Study||2||
59990932|NCT02739347|76106501|FG001|COMPLETED|Overall Study||4||
59990933|NCT02739347|76106500|FG000|NOT COMPLETED|Overall Study||3||
59990934|NCT02739347|76106501|FG001|NOT COMPLETED|Overall Study||3||
59704621|NCT02580058|75823779|FG000|STARTED|Overall Study||188|This table included all randomized participants.|
59704622|NCT02580058|75823780|FG001|STARTED|Overall Study||188|This table included all randomized participants.|
59704623|NCT02580058|75823781|FG002|STARTED|Overall Study||190|This table included all randomized participants.|
59816268|NCT00519896|75938661|FG000|NOT COMPLETED|Overall Study||2||
59990935|NCT02435966|76106510|FG000|STARTED|Overall Study||47||
59704624|NCT02580058|75823779|FG000|Treated|Overall Study||187|Participants received at least 1 dose of study drug.|
59704625|NCT02580058|75823780|FG001|Treated|Overall Study||182|Participants received at least 1 dose of study drug.|
59704626|NCT02580058|75823781|FG002|Treated|Overall Study||177|Participants received at least 1 dose of study drug.|
59704627|NCT02580058|75823779|FG000|COMPLETED|Overall Study||0|Participants were considered completed when at least one drug of the combination is completed.|
59704628|NCT02580058|75823780|FG001|COMPLETED|Overall Study||0|Participants were considered completed when at least one drug of the combination is completed.|
59704629|NCT02580058|75823781|FG002|COMPLETED|Overall Study||0|Participants were considered completed when at least one drug of the combination is completed.|
59704630|NCT02580058|75823779|FG000|NOT COMPLETED|Overall Study||188||
59704631|NCT02580058|75823780|FG001|NOT COMPLETED|Overall Study||188||
59704632|NCT02580058|75823781|FG002|NOT COMPLETED|Overall Study||190||
59704633|NCT02539394|75823793|FG000|STARTED|Overall Study||64||
59704634|NCT02539394|75823794|FG001|STARTED|Overall Study||64||
59704635|NCT02539394|75823793|FG000|COMPLETED|Overall Study||56||
59704636|NCT02539394|75823794|FG001|COMPLETED|Overall Study||53||
59704637|NCT02539394|75823793|FG000|NOT COMPLETED|Overall Study||8||
59704638|NCT02539394|75823794|FG001|NOT COMPLETED|Overall Study||11||
59704639|NCT02530437|75823802|FG000|STARTED|Overall Study||7||
59704640|NCT02530437|75823802|FG000|COMPLETED|Overall Study||7||
59704641|NCT02530437|75823802|FG000|NOT COMPLETED|Overall Study||0||
59704642|NCT02412670|75823808|FG000|STARTED|Overall Study||30||
59704643|NCT02412670|75823809|FG001|STARTED|Overall Study||6||
59704644|NCT02412670|75823808|FG000|Eligible and Treated|Overall Study||29||
59704645|NCT02412670|75823809|FG001|Eligible and Treated|Overall Study||6||
59704646|NCT02412670|75823808|FG000|COMPLETED|Overall Study||23||
59704647|NCT02412670|75823809|FG001|COMPLETED|Overall Study||5||
59704648|NCT02412670|75823808|FG000|NOT COMPLETED|Overall Study||7||
59704649|NCT02412670|75823809|FG001|NOT COMPLETED|Overall Study||1||
59704650|NCT01263379|75823815|FG000|STARTED|Overall Study||7||
59704651|NCT01263379|75823815|FG000|COMPLETED|Overall Study||7||
59704652|NCT01263379|75823815|FG000|NOT COMPLETED|Overall Study||0||
59704653|NCT00858897|75823822|FG000|STARTED|First Intervention (1 Day)||4||
59704654|NCT00858897|75823823|FG001|STARTED|First Intervention (1 Day)||6||
59704655|NCT00858897|75823822|FG000|COMPLETED|First Intervention (1 Day)||4||
59704656|NCT00858897|75823823|FG001|COMPLETED|First Intervention (1 Day)||6||
59704657|NCT00858897|75823822|FG000|NOT COMPLETED|First Intervention (1 Day)||0||
59704658|NCT00858897|75823823|FG001|NOT COMPLETED|First Intervention (1 Day)||0||
59704659|NCT00858897|75823822|FG000|STARTED|Washout (~9 Days)||4||
59704660|NCT00858897|75823823|FG001|STARTED|Washout (~9 Days)||6||
59704661|NCT00858897|75823822|FG000|COMPLETED|Washout (~9 Days)||4||
59704662|NCT00858897|75823823|FG001|COMPLETED|Washout (~9 Days)||6||
59704663|NCT00858897|75823822|FG000|NOT COMPLETED|Washout (~9 Days)||0||
59704664|NCT00858897|75823823|FG001|NOT COMPLETED|Washout (~9 Days)||0||
59704665|NCT00858897|75823822|FG000|STARTED|2nd Intervention (1 Day)||4||
59704666|NCT00858897|75823823|FG001|STARTED|2nd Intervention (1 Day)||6||
59704667|NCT00858897|75823822|FG000|COMPLETED|2nd Intervention (1 Day)||4||
59704668|NCT00858897|75823823|FG001|COMPLETED|2nd Intervention (1 Day)||6||
59704669|NCT00858897|75823822|FG000|NOT COMPLETED|2nd Intervention (1 Day)||0||
59704670|NCT00858897|75823823|FG001|NOT COMPLETED|2nd Intervention (1 Day)||0||
59704671|NCT05111145|75823829|FG000|STARTED|Overall Study||86||
59816269|NCT03941600|75938667|FG000|STARTED|Overall Study||27||
59990936|NCT02435966|76106511|FG001|STARTED|Overall Study||54||
59990937|NCT02435966|76106512|FG002|STARTED|Overall Study||30||
59990938|NCT02435966|76106510|FG000|First Intervention|Overall Study||47||
59990939|NCT02435966|76106511|FG001|First Intervention|Overall Study||54||
59704672|NCT05111145|75823829|FG000|COMPLETED|Overall Study||0||
59704673|NCT05111145|75823829|FG000|NOT COMPLETED|Overall Study||86||
59704674|NCT05095272|75823833|FG000|STARTED|Overall Study||2||
59704675|NCT05095272|75823833|FG000|COMPLETED|Overall Study||2||
59704676|NCT05095272|75823833|FG000|NOT COMPLETED|Overall Study||0||
59704677|NCT04870099|75823837|FG000|STARTED|Overall Study|Of these 141 people, 119 actually started the guided self-help (GSH) cognitive-behavioral therapy (CBT)|141||
59704678|NCT04870099|75823837|FG000|COMPLETED|Overall Study||97||
59704679|NCT04870099|75823837|FG000|NOT COMPLETED|Overall Study||44||
59704680|NCT04828551|75823841|FG000|STARTED|Overall Study||40||
59704681|NCT04828551|75823841|FG000|COMPLETED|Overall Study||40||
59704682|NCT04828551|75823841|FG000|NOT COMPLETED|Overall Study||0||
59704683|NCT04823130|75823848|FG000|STARTED|Overall Study||19||
59704684|NCT04823130|75823849|FG001|STARTED|Overall Study||35||
59704685|NCT04823130|75823848|FG000|Safety Population|Overall Study||13|Safety population included all participants, who actually received at least 1 dose of investigational medicinal product (IMP) or had at least 1 skin biopsy and all healthy participants who had a skin biopsy or another safety assessment performed.|
59704686|NCT04823130|75823849|FG001|Safety Population|Overall Study||31|Safety population included all participants, who actually received at least 1 dose of investigational medicinal product (IMP) or had at least 1 skin biopsy and all healthy participants who had a skin biopsy or another safety assessment performed.|
59816270|NCT03941600|75938668|FG001|STARTED|Overall Study||22||
59990940|NCT02435966|76106512|FG002|First Intervention|Overall Study||30||
59990941|NCT02435966|76106510|FG000|Second Intervention|Overall Study||47||
59990942|NCT02435966|76106511|FG001|Second Intervention|Overall Study||53||
59704687|NCT04823130|75823848|FG000|COMPLETED|Overall Study||10||
59704688|NCT04823130|75823849|FG001|COMPLETED|Overall Study||28||
59704689|NCT04823130|75823848|FG000|NOT COMPLETED|Overall Study||9||
59704690|NCT04823130|75823849|FG001|NOT COMPLETED|Overall Study||7||
59704691|NCT04808622|75823860|FG000|STARTED|Overall Study||5||
59704692|NCT04808622|75823861|FG001|STARTED|Overall Study||5||
59704693|NCT04808622|75823862|FG002|STARTED|Overall Study||5||
59704694|NCT04808622|75823863|FG003|STARTED|Overall Study||5||
59704695|NCT04808622|75823864|FG004|STARTED|Overall Study||5||
59704696|NCT04808622|75823865|FG005|STARTED|Overall Study||5||
59704697|NCT04808622|75823860|FG000|COMPLETED|Overall Study||5||
59704698|NCT04808622|75823861|FG001|COMPLETED|Overall Study||5||
59704699|NCT04808622|75823862|FG002|COMPLETED|Overall Study||5||
59704700|NCT04808622|75823863|FG003|COMPLETED|Overall Study||5||
59704701|NCT04808622|75823864|FG004|COMPLETED|Overall Study||5||
59704702|NCT04808622|75823865|FG005|COMPLETED|Overall Study||5||
59704703|NCT04808622|75823860|FG000|NOT COMPLETED|Overall Study||0||
59704704|NCT04808622|75823861|FG001|NOT COMPLETED|Overall Study||0||
59704705|NCT04808622|75823862|FG002|NOT COMPLETED|Overall Study||0||
59704706|NCT04808622|75823863|FG003|NOT COMPLETED|Overall Study||0||
59704707|NCT04808622|75823864|FG004|NOT COMPLETED|Overall Study||0||
59704708|NCT04808622|75823865|FG005|NOT COMPLETED|Overall Study||0||
59704709|NCT04736316|75823881|FG000|STARTED|Overall Study||31||
59704710|NCT04736316|75823882|FG001|STARTED|Overall Study||61||
59704711|NCT04736316|75823881|FG000|COMPLETED|Overall Study||31||
59704712|NCT04736316|75823882|FG001|COMPLETED|Overall Study||61||
59704713|NCT04736316|75823881|FG000|NOT COMPLETED|Overall Study||0||
59704714|NCT04736316|75823882|FG001|NOT COMPLETED|Overall Study||0||
59704715|NCT04624932|75823890|FG000|STARTED|Overall Study||282||
59704716|NCT04624932|75823891|FG001|STARTED|Overall Study||281||
59704717|NCT04624932|75823890|FG000|1-week Post-intervention|Overall Study||209||
59704718|NCT04624932|75823891|FG001|1-week Post-intervention|Overall Study||126||
59704719|NCT04624932|75823890|FG000|COMPLETED|Overall Study||195||
59704720|NCT04624932|75823891|FG001|COMPLETED|Overall Study||119||
59704721|NCT04624932|75823890|FG000|NOT COMPLETED|Overall Study||87||
59704722|NCT04624932|75823891|FG001|NOT COMPLETED|Overall Study||162||
59704723|NCT04591353|75823899|FG000|STARTED|Overall Study||61||
59704724|NCT04591353|75823900|FG001|STARTED|Overall Study||61||
59704725|NCT04591353|75823899|FG000|COMPLETED|Overall Study||56||
59704726|NCT04591353|75823900|FG001|COMPLETED|Overall Study||56||
59704727|NCT04591353|75823899|FG000|NOT COMPLETED|Overall Study||5||
59704728|NCT04591353|75823900|FG001|NOT COMPLETED|Overall Study||5||
59704729|NCT04402385|75823908|FG000|STARTED|Overall Study||25||
59704730|NCT04402385|75823909|FG001|STARTED|Overall Study||25||
59704731|NCT04402385|75823908|FG000|COMPLETED|Overall Study||20||
59704732|NCT04402385|75823909|FG001|COMPLETED|Overall Study||19||
59704733|NCT04402385|75823908|FG000|NOT COMPLETED|Overall Study||5||
59704734|NCT04402385|75823909|FG001|NOT COMPLETED|Overall Study||6||
59704735|NCT03785210|75823919|FG000|STARTED|Overall Study||6||
59704736|NCT03785210|75823920|FG001|STARTED|Overall Study||16||
59704737|NCT03785210|75823919|FG000|COMPLETED|Overall Study||5||
59704738|NCT03785210|75823920|FG001|COMPLETED|Overall Study||10||
59704739|NCT03785210|75823919|FG000|NOT COMPLETED|Overall Study||1||
59704740|NCT03785210|75823920|FG001|NOT COMPLETED|Overall Study||6||
59704741|NCT03750968|75823928|FG000|STARTED|Overall Study|By definition, only mothers carrying one infant were included in the study. 24 mothers enrolled in the study were assigned to the carotenoid group and out of that, only 21 completed the study. The mother and infant were considered one unit. The 21 mothers and their infants were used for statistical analysis.|24||
59704742|NCT03750968|75823929|FG001|STARTED|Overall Study|By definition, only mothers carrying one infant were included in the study. 23 mothers enrolled in the study were assigned to the control group and out of that, only 20 completed the study. The mother and infant were considered one unit. The 20 mothers and their infants were used for statistical analysis.|23||
59704743|NCT03750968|75823928|FG000|COMPLETED|Overall Study||21||
59704744|NCT03750968|75823929|FG001|COMPLETED|Overall Study||20||
59704745|NCT03750968|75823928|FG000|NOT COMPLETED|Overall Study||3||
59704746|NCT03750968|75823929|FG001|NOT COMPLETED|Overall Study||3||
59816271|NCT03941600|75938667|FG000|COMPLETED|Overall Study||15||
59704747|NCT03699826|75823935|FG000|STARTED|Overall Study||1||
59704748|NCT03699826|75823935|FG000|COMPLETED|Overall Study||1||
59816272|NCT03941600|75938668|FG001|COMPLETED|Overall Study||17||
59816273|NCT03941600|75938667|FG000|NOT COMPLETED|Overall Study||12||
59816274|NCT03941600|75938668|FG001|NOT COMPLETED|Overall Study||5||
59816275|NCT00527618|75938674|FG000|STARTED|Week 1-12 (First Intervention)|Acyclovir|16||
59704749|NCT03699826|75823935|FG000|NOT COMPLETED|Overall Study||0||
59704750|NCT03690388|75823941|FG000|STARTED|Overall Study||125||
59704751|NCT03690388|75823942|FG001|STARTED|Overall Study||62||
59704752|NCT03690388|75823941|FG000|COMPLETED|Overall Study||89||
59704753|NCT03690388|75823942|FG001|COMPLETED|Overall Study||26||
59704754|NCT03690388|75823941|FG000|NOT COMPLETED|Overall Study||36||
59816276|NCT00527618|75938675|FG001|STARTED|Week 1-12 (First Intervention)|Valacyclovir; one participant was removed from the study due to urticaria after 2.5 weeks|18||
59704755|NCT03690388|75823942|FG001|NOT COMPLETED|Overall Study||36||
59704756|NCT03648892|75823948|FG000|STARTED|Overall Study||61||
59704757|NCT03648892|75823948|FG000|COMPLETED|Overall Study||61||
59704758|NCT03648892|75823948|FG000|NOT COMPLETED|Overall Study||0||
59704759|NCT03619213|75823954|FG000|STARTED|Overall Study||3131||
59704760|NCT03619213|75823955|FG001|STARTED|Overall Study||3132||
59704761|NCT03619213|75823954|FG000|COMPLETED|Overall Study||3121||
59704762|NCT03619213|75823955|FG001|COMPLETED|Overall Study||3121||
59704763|NCT03619213|75823954|FG000|NOT COMPLETED|Overall Study||10||
59704764|NCT03619213|75823955|FG001|NOT COMPLETED|Overall Study||11||
59704765|NCT03342690|75823961|FG000|STARTED|Overall Study||1164||
59704766|NCT03342690|75823961|FG000|COMPLETED|Overall Study||1139||
59704767|NCT03342690|75823961|FG000|NOT COMPLETED|Overall Study||25||
59704768|NCT03262662|75823967|FG000|STARTED|Overall Study||163||
59704769|NCT03262662|75823968|FG001|STARTED|Overall Study||157||
59704770|NCT03262662|75823967|FG000|Retained at Wk 15 (EOT)|Overall Study||127||
59704771|NCT03262662|75823968|FG001|Retained at Wk 15 (EOT)|Overall Study||126||
59704772|NCT03262662|75823967|FG000|Retained at Wk 28 (6-month Follow-up)|Overall Study||124||
59704773|NCT03262662|75823968|FG001|Retained at Wk 28 (6-month Follow-up)|Overall Study||121||
59704774|NCT03262662|75823967|FG000|COMPLETED|Overall Study|Intent-to-treat|163||
59704775|NCT03262662|75823968|FG001|COMPLETED|Overall Study|Intent-to-treat|157||
59704776|NCT03262662|75823967|FG000|NOT COMPLETED|Overall Study||0||
59704777|NCT03262662|75823968|FG001|NOT COMPLETED|Overall Study||0||
59704778|NCT03257267|75823980|FG000|STARTED|Overall Study||304||
59704779|NCT03257267|75823981|FG001|STARTED|Overall Study||304||
59704780|NCT03257267|75823980|FG000|Full Analysis Set (FAS)|Overall Study||304|The FAS included all randomized participants.|
59704781|NCT03257267|75823981|FG001|Full Analysis Set (FAS)|Overall Study||304|The FAS included all randomized participants.|
59704782|NCT03257267|75823980|FG000|Safety Analysis Set (SAF)|Overall Study||300|The SAF included all randomized participants who received any study drug.|
59704783|NCT03257267|75823981|FG001|Safety Analysis Set (SAF)|Overall Study||290|The SAF included all randomized participants who received any study drug.|
59704784|NCT03257267|75823980|FG000|Completed Treatment|Overall Study||13||
59704785|NCT03257267|75823981|FG001|Completed Treatment|Overall Study||0||
59704786|NCT03257267|75823980|FG000|COMPLETED|Overall Study||7|Completed Study|
59704787|NCT03257267|75823981|FG001|COMPLETED|Overall Study||0|Completed Study|
59704788|NCT03257267|75823980|FG000|NOT COMPLETED|Overall Study||297||
59704789|NCT03257267|75823981|FG001|NOT COMPLETED|Overall Study||304||
59704790|NCT03190668|75823989|FG000|STARTED|Overall Study||6||
59704791|NCT03190668|75823990|FG001|STARTED|Overall Study||6||
59704792|NCT03190668|75823989|FG000|COMPLETED|Overall Study||6||
59704793|NCT03190668|75823990|FG001|COMPLETED|Overall Study||6||
59704794|NCT03190668|75823989|FG000|NOT COMPLETED|Overall Study||0||
59704795|NCT03190668|75823990|FG001|NOT COMPLETED|Overall Study||0||
59704796|NCT02991456|75823998|FG000|STARTED|Overall Study||25||
59704797|NCT02991456|75823999|FG001|STARTED|Overall Study||23||
59704798|NCT02991456|75823998|FG000|COMPLETED|Overall Study||22||
59704799|NCT02991456|75823999|FG001|COMPLETED|Overall Study||21||
59704800|NCT02991456|75823998|FG000|NOT COMPLETED|Overall Study||3||
59704801|NCT02991456|75823999|FG001|NOT COMPLETED|Overall Study||2||
59704802|NCT02842827|75824016|FG000|STARTED|Overall Study||3||
59704803|NCT02842827|75824017|FG001|STARTED|Overall Study||6||
59704804|NCT02842827|75824018|FG002|STARTED|Overall Study||4||
59704805|NCT02842827|75824019|FG003|STARTED|Overall Study||6||
59704806|NCT02842827|75824020|FG004|STARTED|Overall Study||5||
59704807|NCT02842827|75824021|FG005|STARTED|Overall Study||9||
59704808|NCT02842827|75824022|FG006|STARTED|Overall Study||4||
59704809|NCT02842827|75824023|FG007|STARTED|Overall Study||8||
59704810|NCT02842827|75824016|FG000|Treated|Overall Study||3||
59704811|NCT02842827|75824017|FG001|Treated|Overall Study||6||
59704812|NCT02842827|75824018|FG002|Treated|Overall Study||4||
59704813|NCT02842827|75824019|FG003|Treated|Overall Study||6||
59704814|NCT02842827|75824020|FG004|Treated|Overall Study||5||
59704815|NCT02842827|75824021|FG005|Treated|Overall Study||9||
59704816|NCT02842827|75824022|FG006|Treated|Overall Study||4||
59704817|NCT02842827|75824023|FG007|Treated|Overall Study||8||
59704818|NCT02842827|75824016|FG000|COMPLETED|Overall Study||0||
59704819|NCT02842827|75824017|FG001|COMPLETED|Overall Study||0||
59704820|NCT02842827|75824018|FG002|COMPLETED|Overall Study||0||
59704821|NCT02842827|75824019|FG003|COMPLETED|Overall Study||0||
59704822|NCT02842827|75824020|FG004|COMPLETED|Overall Study||0||
59704823|NCT02842827|75824021|FG005|COMPLETED|Overall Study||1||
59704824|NCT02842827|75824022|FG006|COMPLETED|Overall Study||0||
59704825|NCT02842827|75824023|FG007|COMPLETED|Overall Study||2||
59704826|NCT02842827|75824016|FG000|NOT COMPLETED|Overall Study||3||
59704827|NCT02842827|75824017|FG001|NOT COMPLETED|Overall Study||6||
59704828|NCT02842827|75824018|FG002|NOT COMPLETED|Overall Study||4||
59704829|NCT02842827|75824019|FG003|NOT COMPLETED|Overall Study||6||
59704830|NCT02842827|75824020|FG004|NOT COMPLETED|Overall Study||5||
59704831|NCT02842827|75824021|FG005|NOT COMPLETED|Overall Study||8||
59704832|NCT02842827|75824022|FG006|NOT COMPLETED|Overall Study||4||
59704833|NCT02842827|75824023|FG007|NOT COMPLETED|Overall Study||6||
59704834|NCT02432274|75824049|FG000|STARTED|Overall Study||3|The Participants Flow module (including deaths in reasons for not completed) presentation is based on full analysis set. (Full analysis set included all enrolled participants who did not fail study screening).|
59709832|NCT01072149|75828526|FG006|STARTED|Treatment Period 2 (28 Days)||3||
59990943|NCT02435966|76106512|FG002|Second Intervention|Overall Study||30||
59704835|NCT02432274|75824050|FG001|STARTED|Overall Study||9|The Participants Flow module (including deaths in reasons for not completed) presentation is based on full analysis set. (Full analysis set included all enrolled participants who did not fail study screening).|
59704836|NCT02432274|75824051|FG002|STARTED|Overall Study||11|The Participants Flow module (including deaths in reasons for not completed) presentation is based on full analysis set. (Full analysis set included all enrolled participants who did not fail study screening).|
59704837|NCT02432274|75824052|FG003|STARTED|Overall Study||1|The Participants Flow module (including deaths in reasons for not completed) presentation is based on full analysis set. (Full analysis set included all enrolled participants who did not fail study screening).|
59704838|NCT02432274|75824053|FG004|STARTED|Overall Study||31|The Participants Flow module (including deaths in reasons for not completed) presentation is based on full analysis set. (Full analysis set included all enrolled participants who did not fail study screening).|
59704839|NCT02432274|75824054|FG005|STARTED|Overall Study||7|The Participants Flow module (including deaths in reasons for not completed) presentation is based on full analysis set. (Full analysis set included all enrolled participants who did not fail study screening).|
59704840|NCT02432274|75824055|FG006|STARTED|Overall Study||15|The Participants Flow module (including deaths in reasons for not completed) presentation is based on full analysis set. (Full analysis set included all enrolled participants who did not fail study screening).|
59704841|NCT02432274|75824056|FG007|STARTED|Overall Study||20|The Participants Flow module (including deaths in reasons for not completed) presentation is based on full analysis set. (Full analysis set included all enrolled participants who did not fail study screening).|
59704842|NCT02432274|75824049|FG000|Underwent Run-in Period|Overall Study||1||
59704843|NCT02432274|75824050|FG001|Underwent Run-in Period|Overall Study||1||
59704844|NCT02432274|75824051|FG002|Underwent Run-in Period|Overall Study||0||
59704845|NCT02432274|75824052|FG003|Underwent Run-in Period|Overall Study||0||
59704846|NCT02432274|75824053|FG004|Underwent Run-in Period|Overall Study||0||
59704847|NCT02432274|75824054|FG005|Underwent Run-in Period|Overall Study||0||
59704848|NCT02432274|75824055|FG006|Underwent Run-in Period|Overall Study||0||
59704849|NCT02432274|75824056|FG007|Underwent Run-in Period|Overall Study||0||
59704850|NCT02432274|75824049|FG000|Treated (Safety Population)|Overall Study|2 participants assigned to lenvatinib17mg/m^2 actually received 11mg/m^2 (dose capped at 24 mg/day).|5||
59704851|NCT02432274|75824050|FG001|Treated (Safety Population)|Overall Study|2 participants assigned to lenvatinib17mg/m^2 actually received 14mg/m^2 (dose capped at 24 mg/day).|11||
59704852|NCT02432274|75824051|FG002|Treated (Safety Population)|Overall Study||7||
59704853|NCT02432274|75824052|FG003|Treated (Safety Population)|Overall Study||1||
59704854|NCT02432274|75824053|FG004|Treated (Safety Population)|Overall Study||31||
59704855|NCT02432274|75824054|FG005|Treated (Safety Population)|Overall Study|4 participants assigned to lenvatinib14mg/m^2 actually received 11mg/m^2 (dose capped at 24 mg/day).|11||
59704856|NCT02432274|75824055|FG006|Treated (Safety Population)|Overall Study||11||
59704857|NCT02432274|75824056|FG007|Treated (Safety Population)|Overall Study||20||
59704858|NCT02432274|75824049|FG000|COMPLETED|Overall Study||1||
59704859|NCT02432274|75824050|FG001|COMPLETED|Overall Study||3||
59704860|NCT02432274|75824051|FG002|COMPLETED|Overall Study||4||
59704861|NCT02432274|75824052|FG003|COMPLETED|Overall Study||1||
59704862|NCT02432274|75824053|FG004|COMPLETED|Overall Study||2||
59704863|NCT02432274|75824054|FG005|COMPLETED|Overall Study||0||
59704864|NCT02432274|75824055|FG006|COMPLETED|Overall Study||5||
59704865|NCT02432274|75824056|FG007|COMPLETED|Overall Study||4||
59704866|NCT02432274|75824049|FG000|NOT COMPLETED|Overall Study||2||
59704867|NCT02432274|75824050|FG001|NOT COMPLETED|Overall Study||6||
59704868|NCT02432274|75824051|FG002|NOT COMPLETED|Overall Study||7||
59704869|NCT02432274|75824052|FG003|NOT COMPLETED|Overall Study||0||
59704870|NCT02432274|75824053|FG004|NOT COMPLETED|Overall Study||29||
59704871|NCT02432274|75824054|FG005|NOT COMPLETED|Overall Study||7||
59704872|NCT02432274|75824055|FG006|NOT COMPLETED|Overall Study||10||
59704873|NCT02432274|75824056|FG007|NOT COMPLETED|Overall Study||16||
59704874|NCT02424955|75824086|FG000|STARTED|Overall Study||11||
59704875|NCT02424955|75824086|FG000|COMPLETED|Overall Study||11||
59704876|NCT02424955|75824086|FG000|NOT COMPLETED|Overall Study||0||
59704877|NCT02393859|75824092|FG000|STARTED|Overall Study||57||
59704878|NCT02393859|75824093|FG001|STARTED|Overall Study||54||
59704879|NCT02393859|75824092|FG000|Participants Treated|Overall Study||52||
59704880|NCT02393859|75824093|FG001|Participants Treated|Overall Study||54||
59704881|NCT02393859|75824092|FG000|Participants in the Primary Analysis Population|Overall Study||54|Included all randomized participants analyzed according to their randomized treatment assignment, regardless of treatment received (the full analysis set; FAS) at the primary completion date (17 July 2019)|
59704882|NCT02393859|75824093|FG001|Participants in the Primary Analysis Population|Overall Study||54|Included all randomized participants analyzed according to their randomized treatment assignment, regardless of treatment received (the full analysis set; FAS) at the primary completion date (17 July 2019)|
59704883|NCT02393859|75824092|FG000|Participants in the Final Analysis Population|Overall Study||57|Included all randomized participants analyzed according to their randomized treatment assignment, regardless of treatment received (FAS) at study completion (21 November 2022)|
59990944|NCT02435966|76106510|FG000|Follow-up|Overall Study||47||
59990945|NCT02435966|76106511|FG001|Follow-up|Overall Study||53||
59990946|NCT02435966|76106512|FG002|Follow-up|Overall Study||30||
59990947|NCT02435966|76106510|FG000|COMPLETED|Overall Study||47||
59990948|NCT02435966|76106511|FG001|COMPLETED|Overall Study||53||
59990949|NCT02435966|76106512|FG002|COMPLETED|Overall Study||30||
59990950|NCT02435966|76106510|FG000|NOT COMPLETED|Overall Study||0||
59990951|NCT02435966|76106511|FG001|NOT COMPLETED|Overall Study||1||
59704884|NCT02393859|75824093|FG001|Participants in the Final Analysis Population|Overall Study||54|Included all randomized participants analyzed according to their randomized treatment assignment, regardless of treatment received (FAS) at study completion (21 November 2022)|
59704885|NCT02393859|75824092|FG000|COMPLETED|Overall Study||16||
59704886|NCT02393859|75824093|FG001|COMPLETED|Overall Study||33||
59704887|NCT02393859|75824092|FG000|NOT COMPLETED|Overall Study||41||
59704888|NCT02393859|75824093|FG001|NOT COMPLETED|Overall Study||21||
59704889|NCT02096588|75824102|FG000|STARTED|Overall Study||15||
59704890|NCT02096588|75824103|FG001|STARTED|Overall Study||16||
59704891|NCT02096588|75824102|FG000|COMPLETED|Overall Study||13||
59704892|NCT02096588|75824103|FG001|COMPLETED|Overall Study||15||
59704893|NCT02096588|75824102|FG000|NOT COMPLETED|Overall Study||2||
59704894|NCT02096588|75824103|FG001|NOT COMPLETED|Overall Study||1||
59704895|NCT01359592|75824109|FG000|STARTED|Initial Registration||158||
59704896|NCT01359592|75824110|FG001|STARTED|Initial Registration||1||
59704897|NCT01359592|75824111|FG002|STARTED|Initial Registration||0||
59704898|NCT01359592|75824112|FG003|STARTED|Initial Registration||0||
59704899|NCT01359592|75824109|FG000|Eligible and Evaluable|Initial Registration||132||
59704900|NCT01359592|75824110|FG001|Eligible and Evaluable|Initial Registration||1||
59704901|NCT01359592|75824111|FG002|Eligible and Evaluable|Initial Registration||0||
59704902|NCT01359592|75824112|FG003|Eligible and Evaluable|Initial Registration||0||
59548249|NCT01138124|75647245|FG003|STARTED|Overall Study||19046||
59548250|NCT01138124|75647242|FG000|COMPLETED|Overall Study||3149||
59704903|NCT01359592|75824109|FG000|COMPLETED|Initial Registration||129||
59704904|NCT01359592|75824110|FG001|COMPLETED|Initial Registration||1||
59704905|NCT01359592|75824111|FG002|COMPLETED|Initial Registration||0||
59704906|NCT01359592|75824112|FG003|COMPLETED|Initial Registration||0||
59704907|NCT01359592|75824109|FG000|NOT COMPLETED|Initial Registration||29||
59704908|NCT01359592|75824110|FG001|NOT COMPLETED|Initial Registration||0||
59704909|NCT01359592|75824111|FG002|NOT COMPLETED|Initial Registration||0||
59704910|NCT01359592|75824112|FG003|NOT COMPLETED|Initial Registration||0||
60079946|NCT05439421|76195113|FG000|NOT COMPLETED|Apple Image||0||
60079947|NCT05439421|76195114|FG001|NOT COMPLETED|Apple Image||0||
60079948|NCT05439421|76195113|FG000|STARTED|Hundred Percent Food Grade Glycerin||746||
60079949|NCT05439421|76195114|FG001|STARTED|Hundred Percent Food Grade Glycerin||761||
60079950|NCT05439421|76195113|FG000|COMPLETED|Hundred Percent Food Grade Glycerin||746||
60079951|NCT05439421|76195114|FG001|COMPLETED|Hundred Percent Food Grade Glycerin||761||
60079952|NCT05439421|76195113|FG000|NOT COMPLETED|Hundred Percent Food Grade Glycerin||0||
60079953|NCT05439421|76195114|FG001|NOT COMPLETED|Hundred Percent Food Grade Glycerin||0||
60079954|NCT05439421|76195113|FG000|STARTED|Ultra Light||731||
60079955|NCT05439421|76195114|FG001|STARTED|Ultra Light||776||
60079956|NCT05439421|76195113|FG000|COMPLETED|Ultra Light||731||
60079957|NCT05439421|76195114|FG001|COMPLETED|Ultra Light||776||
59704911|NCT01359592|75824109|FG000|STARTED|PET-Directed Therapy||0||
59704912|NCT01359592|75824110|FG001|STARTED|PET-Directed Therapy||0||
59704913|NCT01359592|75824111|FG002|STARTED|PET-Directed Therapy||137||
59704914|NCT01359592|75824112|FG003|STARTED|PET-Directed Therapy||12||
59704915|NCT01359592|75824109|FG000|Eligible and Evaluable|PET-Directed Therapy||0||
59548251|NCT01138124|75647243|FG001|COMPLETED|Overall Study||30026||
59548252|NCT01138124|75647244|FG002|COMPLETED|Overall Study||1981||
59704916|NCT01359592|75824110|FG001|Eligible and Evaluable|PET-Directed Therapy||0||
59990952|NCT02435966|76106512|FG002|NOT COMPLETED|Overall Study||0||
59990953|NCT01679301|76106520|FG000|STARTED|Screening Period||11||
59990954|NCT01679301|76106521|FG001|STARTED|Screening Period||0||
59990955|NCT01679301|76106522|FG002|STARTED|Screening Period||0||
59990956|NCT01679301|76106520|FG000|COMPLETED|Screening Period||8||
59990957|NCT01679301|76106521|FG001|COMPLETED|Screening Period||0||
59990958|NCT01679301|76106522|FG002|COMPLETED|Screening Period||0||
59990959|NCT01679301|76106520|FG000|NOT COMPLETED|Screening Period||3||
59990960|NCT01679301|76106521|FG001|NOT COMPLETED|Screening Period||0||
59990961|NCT01679301|76106522|FG002|NOT COMPLETED|Screening Period||0||
59990962|NCT01679301|76106520|FG000|STARTED|Study Period||0||
59990963|NCT01679301|76106521|FG001|STARTED|Study Period||4||
59990964|NCT01679301|76106522|FG002|STARTED|Study Period||4||
59990965|NCT01679301|76106520|FG000|COMPLETED|Study Period||0||
59990966|NCT01679301|76106521|FG001|COMPLETED|Study Period||4||
59990967|NCT01679301|76106522|FG002|COMPLETED|Study Period||4||
59990968|NCT01679301|76106520|FG000|NOT COMPLETED|Study Period||0||
59990969|NCT01679301|76106521|FG001|NOT COMPLETED|Study Period||0||
59990970|NCT01679301|76106522|FG002|NOT COMPLETED|Study Period||0||
59990971|NCT01678911|76106528|FG000|STARTED|First Intervention||4||
59990972|NCT01678911|76106529|FG001|STARTED|First Intervention||1||
59990973|NCT01678911|76106528|FG000|Cross Over|First Intervention||4||
59990974|NCT01678911|76106529|FG001|Cross Over|First Intervention||1||
59990975|NCT01678911|76106528|FG000|COMPLETED|First Intervention||4||
59990976|NCT01678911|76106529|FG001|COMPLETED|First Intervention||1||
59990977|NCT01678911|76106528|FG000|NOT COMPLETED|First Intervention||0||
59990978|NCT01678911|76106529|FG001|NOT COMPLETED|First Intervention||0||
59990979|NCT01678911|76106528|FG000|STARTED|Second Intervention||4||
59990980|NCT01678911|76106529|FG001|STARTED|Second Intervention||1||
59704917|NCT01359592|75824111|FG002|Eligible and Evaluable|PET-Directed Therapy||113||
59704918|NCT01359592|75824112|FG003|Eligible and Evaluable|PET-Directed Therapy||12||
59704919|NCT01359592|75824109|FG000|COMPLETED|PET-Directed Therapy||0||
59704920|NCT01359592|75824110|FG001|COMPLETED|PET-Directed Therapy||0||
59704921|NCT01359592|75824111|FG002|COMPLETED|PET-Directed Therapy||111||
59704922|NCT01359592|75824112|FG003|COMPLETED|PET-Directed Therapy||12||
59704923|NCT01359592|75824109|FG000|NOT COMPLETED|PET-Directed Therapy||0||
59704924|NCT01359592|75824110|FG001|NOT COMPLETED|PET-Directed Therapy||0||
59704925|NCT01359592|75824111|FG002|NOT COMPLETED|PET-Directed Therapy||26||
59704926|NCT01359592|75824112|FG003|NOT COMPLETED|PET-Directed Therapy||0||
59704927|NCT00699816|75824129|FG000|STARTED|Overall Study||115||
59704928|NCT00699816|75824130|FG001|STARTED|Overall Study||115||
59704929|NCT00699816|75824129|FG000|COMPLETED|Overall Study||114||
59704930|NCT00699816|75824130|FG001|COMPLETED|Overall Study||112||
59704931|NCT00699816|75824129|FG000|NOT COMPLETED|Overall Study||1||
59704932|NCT00699816|75824130|FG001|NOT COMPLETED|Overall Study||3||
59704933|NCT00697073|75824136|FG000|STARTED|Overall Study||68||
59704934|NCT00697073|75824136|FG000|COMPLETED|Overall Study||59||
59704935|NCT00697073|75824136|FG000|NOT COMPLETED|Overall Study||9||
59704936|NCT00653432|75824142|FG000|STARTED|Overall Study||184|Safety Population|
59704937|NCT00653432|75824143|FG001|STARTED|Overall Study||185|Safety Population|
59704938|NCT00653432|75824142|FG000|Intend-to-treat ITT|Overall Study|3 of 184 excluded from ITT group for not having at least 1 post-injection visit. ITT=181 subjects|181||
59704939|NCT00653432|75824143|FG001|Intend-to-treat ITT|Overall Study|1 of 185 excluded from ITT group for not having at least 1 post-injection visit. ITT=184 subjects|184||
59704940|NCT00653432|75824142|FG000|COMPLETED|Overall Study||162|Completed through 26 weeks follow-up|
59704941|NCT00653432|75824143|FG001|COMPLETED|Overall Study||169|Completed through 26 weeks follow-up|
59704942|NCT00653432|75824142|FG000|NOT COMPLETED|Overall Study||22||
59704943|NCT00653432|75824143|FG001|NOT COMPLETED|Overall Study||16||
59704944|NCT00537680|75824152|FG000|STARTED|Overall Study||22||
59704945|NCT00537680|75824153|FG001|STARTED|Overall Study||24||
59704946|NCT00537680|75824154|FG002|STARTED|Overall Study||24||
59704947|NCT00537680|75824152|FG000|COMPLETED|Overall Study||22||
59704948|NCT00537680|75824153|FG001|COMPLETED|Overall Study||22||
59704949|NCT00537680|75824154|FG002|COMPLETED|Overall Study||24||
59704950|NCT00537680|75824152|FG000|NOT COMPLETED|Overall Study||0||
59704951|NCT00537680|75824153|FG001|NOT COMPLETED|Overall Study||2||
59704952|NCT00537680|75824154|FG002|NOT COMPLETED|Overall Study||0||
59704953|NCT00446043|75824162|FG000|STARTED|Overall Study||452||
59704954|NCT00446043|75824162|FG000|COMPLETED|Overall Study||327||
59704955|NCT00446043|75824162|FG000|NOT COMPLETED|Overall Study||125||
59704956|NCT00400725|75824169|FG000|STARTED|Initial Phase (up to 4 Weeks)||288||
59704957|NCT00400725|75824170|FG001|STARTED|Initial Phase (up to 4 Weeks)||0||
59704958|NCT00400725|75824171|FG002|STARTED|Initial Phase (up to 4 Weeks)||0||
59704959|NCT00400725|75824169|FG000|COMPLETED|Initial Phase (up to 4 Weeks)||271||
59704960|NCT00400725|75824170|FG001|COMPLETED|Initial Phase (up to 4 Weeks)||0||
59704961|NCT00400725|75824171|FG002|COMPLETED|Initial Phase (up to 4 Weeks)||0||
59704962|NCT00400725|75824169|FG000|NOT COMPLETED|Initial Phase (up to 4 Weeks)||17||
59704963|NCT00400725|75824170|FG001|NOT COMPLETED|Initial Phase (up to 4 Weeks)||0||
59704964|NCT00400725|75824171|FG002|NOT COMPLETED|Initial Phase (up to 4 Weeks)||0||
59704965|NCT00400725|75824169|FG000|STARTED|Maintenance Phase (up to 6 Months)||0||
59704966|NCT00400725|75824170|FG001|STARTED|Maintenance Phase (up to 6 Months)|271 participants completed initial phase, of which 217 participants were randomized to the maintenance phase.|106||
59704967|NCT00400725|75824171|FG002|STARTED|Maintenance Phase (up to 6 Months)|271 participants completed initial phase, of which 217 participants were randomized to the maintenance phase|111||
59704968|NCT00400725|75824169|FG000|COMPLETED|Maintenance Phase (up to 6 Months)||0||
59704969|NCT00400725|75824170|FG001|COMPLETED|Maintenance Phase (up to 6 Months)||90||
59704970|NCT00400725|75824171|FG002|COMPLETED|Maintenance Phase (up to 6 Months)||82||
59704971|NCT00400725|75824169|FG000|NOT COMPLETED|Maintenance Phase (up to 6 Months)||0||
59704972|NCT00400725|75824170|FG001|NOT COMPLETED|Maintenance Phase (up to 6 Months)||16||
59704973|NCT00400725|75824171|FG002|NOT COMPLETED|Maintenance Phase (up to 6 Months)||29||
59704974|NCT00932113|75824187|FG000|STARTED|Overall Study||15||
59704975|NCT00932113|75824188|FG001|STARTED|Overall Study||15||
59704976|NCT00932113|75824187|FG000|COMPLETED|Overall Study||14||
59704977|NCT00932113|75824188|FG001|COMPLETED|Overall Study||15||
59704978|NCT00932113|75824187|FG000|NOT COMPLETED|Overall Study||1||
59704979|NCT00932113|75824188|FG001|NOT COMPLETED|Overall Study||0||
59704980|NCT00931801|75824197|FG000|STARTED|Overall Study||14||
59704981|NCT00931801|75824198|FG001|STARTED|Overall Study||15||
60079958|NCT05439421|76195113|FG000|NOT COMPLETED|Ultra Light||0||
60079959|NCT05439421|76195114|FG001|NOT COMPLETED|Ultra Light||0||
60079960|NCT05439421|76195113|FG000|STARTED|Fresh Hookah Tobacco||706||
60079961|NCT05439421|76195114|FG001|STARTED|Fresh Hookah Tobacco||801||
59704982|NCT00931801|75824199|FG002|STARTED|Overall Study||14||
59704983|NCT00931801|75824197|FG000|COMPLETED|Overall Study||13||
59704984|NCT00931801|75824198|FG001|COMPLETED|Overall Study||14||
59704985|NCT00931801|75824199|FG002|COMPLETED|Overall Study||10||
59704986|NCT00931801|75824197|FG000|NOT COMPLETED|Overall Study||1||
59704987|NCT00931801|75824198|FG001|NOT COMPLETED|Overall Study||1||
60079962|NCT05439421|76195113|FG000|COMPLETED|Fresh Hookah Tobacco||706||
59704988|NCT00931801|75824199|FG002|NOT COMPLETED|Overall Study||4||
59704989|NCT00931723|75824213|FG000|STARTED|Overall Study||173||
59704990|NCT00931723|75824214|FG001|STARTED|Overall Study||183||
59704991|NCT00931723|75824213|FG000|COMPLETED|Overall Study||147||
59704992|NCT00931723|75824214|FG001|COMPLETED|Overall Study||144||
59704993|NCT00931723|75824213|FG000|NOT COMPLETED|Overall Study||26||
59704994|NCT00931723|75824214|FG001|NOT COMPLETED|Overall Study||39||
59704995|NCT00931411|75824222|FG000|STARTED|First Intervention - 42 Days||35||
59704996|NCT00931411|75824223|FG001|STARTED|First Intervention - 42 Days||38||
59704997|NCT00931411|75824222|FG000|COMPLETED|First Intervention - 42 Days||31||
59704998|NCT00931411|75824223|FG001|COMPLETED|First Intervention - 42 Days||35||
59704999|NCT00931411|75824222|FG000|NOT COMPLETED|First Intervention - 42 Days||4||
59705000|NCT00931411|75824223|FG001|NOT COMPLETED|First Intervention - 42 Days||3||
59705001|NCT00931411|75824222|FG000|STARTED|After Crossover - 14 Days (up to Day 56)||31||
59705002|NCT00931411|75824223|FG001|STARTED|After Crossover - 14 Days (up to Day 56)||35||
59705003|NCT00931411|75824222|FG000|COMPLETED|After Crossover - 14 Days (up to Day 56)||31||
59705004|NCT00931411|75824223|FG001|COMPLETED|After Crossover - 14 Days (up to Day 56)||34||
59705005|NCT00931411|75824222|FG000|NOT COMPLETED|After Crossover - 14 Days (up to Day 56)||0||
59705006|NCT00931411|75824223|FG001|NOT COMPLETED|After Crossover - 14 Days (up to Day 56)||1||
59705007|NCT00931255|75824235|FG000|STARTED|Overall Study||17||
59705008|NCT00931255|75824236|FG001|STARTED|Overall Study||15||
59705009|NCT00931255|75824235|FG000|COMPLETED|Overall Study||15||
59705010|NCT00931255|75824236|FG001|COMPLETED|Overall Study||12||
59705011|NCT00931255|75824235|FG000|NOT COMPLETED|Overall Study||2||
59705012|NCT00931255|75824236|FG001|NOT COMPLETED|Overall Study||3||
59705013|NCT00930553|75824242|FG000|STARTED|Overall Study||1314||
59705014|NCT00930553|75824242|FG000|Participants Entered From CAMMS223|Overall Study||141||
59705015|NCT00930553|75824242|FG000|Participants Entered From CAMMS323|Overall Study||488||
59705016|NCT00930553|75824242|FG000|Participants Entered From CAMMS324|Overall Study||685||
59705017|NCT00930553|75824242|FG000|COMPLETED|Overall Study||1091||
59705018|NCT00930553|75824242|FG000|NOT COMPLETED|Overall Study||223||
59705019|NCT00929695|75824266|FG000|STARTED|Overall Study||81||
59705020|NCT00929695|75824267|FG001|STARTED|Overall Study||83||
59705021|NCT00929695|75824266|FG000|COMPLETED|Overall Study||73||
59705022|NCT00929695|75824267|FG001|COMPLETED|Overall Study||77||
59705023|NCT00929695|75824266|FG000|NOT COMPLETED|Overall Study||8||
59705024|NCT00929695|75824267|FG001|NOT COMPLETED|Overall Study||6||
59705025|NCT00927355|75824280|FG000|STARTED|Overall Study||5||
59705026|NCT00927355|75824281|FG001|STARTED|Overall Study||5||
59705027|NCT00927355|75824280|FG000|COMPLETED|Overall Study||4||
59705028|NCT00927355|75824281|FG001|COMPLETED|Overall Study||4||
59705029|NCT00927355|75824280|FG000|NOT COMPLETED|Overall Study||1||
59705030|NCT00927355|75824281|FG001|NOT COMPLETED|Overall Study||1||
59705031|NCT00923845|75824301|FG000|STARTED|Donor Lymphocyte Harvest||13||
59705032|NCT00923845|75824302|FG001|STARTED|Donor Lymphocyte Harvest||0||
59705033|NCT00923845|75824301|FG000|COMPLETED|Donor Lymphocyte Harvest||13||
59705034|NCT00923845|75824302|FG001|COMPLETED|Donor Lymphocyte Harvest||0||
59705035|NCT00923845|75824301|FG000|NOT COMPLETED|Donor Lymphocyte Harvest||0||
59705036|NCT00923845|75824302|FG001|NOT COMPLETED|Donor Lymphocyte Harvest||0||
59705037|NCT00923845|75824301|FG000|STARTED|Donor Hematopoietic Stem Cell Harvest||13||
59705038|NCT00923845|75824302|FG001|STARTED|Donor Hematopoietic Stem Cell Harvest||0||
59705039|NCT00923845|75824301|FG000|COMPLETED|Donor Hematopoietic Stem Cell Harvest||13||
59705040|NCT00923845|75824302|FG001|COMPLETED|Donor Hematopoietic Stem Cell Harvest||0||
59705041|NCT00923845|75824301|FG000|NOT COMPLETED|Donor Hematopoietic Stem Cell Harvest||0||
59816277|NCT00527618|75938674|FG000|COMPLETED|Week 1-12 (First Intervention)|Acyclovir|13||
59705042|NCT00923845|75824302|FG001|NOT COMPLETED|Donor Hematopoietic Stem Cell Harvest||0||
59816278|NCT00527618|75938675|FG001|COMPLETED|Week 1-12 (First Intervention)|Valacyclovir|16||
59705043|NCT00923845|75824301|FG000|STARTED|Induction Therapy||0||
59705044|NCT00923845|75824302|FG001|STARTED|Induction Therapy||12||
59705045|NCT00923845|75824301|FG000|COMPLETED|Induction Therapy||0||
59705046|NCT00923845|75824302|FG001|COMPLETED|Induction Therapy||10||
59705047|NCT00923845|75824301|FG000|NOT COMPLETED|Induction Therapy||0||
59705048|NCT00923845|75824302|FG001|NOT COMPLETED|Induction Therapy||2||
59705049|NCT00923845|75824301|FG000|STARTED|Allogeneic Stem Cell Therapy||0||
59705050|NCT00923845|75824302|FG001|STARTED|Allogeneic Stem Cell Therapy||10||
59705051|NCT00923845|75824301|FG000|Received Each of 3 Planned T-Rapa DLI|Allogeneic Stem Cell Therapy||0||
59705052|NCT00923845|75824302|FG001|Received Each of 3 Planned T-Rapa DLI|Allogeneic Stem Cell Therapy||8||
59705053|NCT00923845|75824301|FG000|Received More Unmanipulated DLI for PD|Allogeneic Stem Cell Therapy||0||
59705054|NCT00923845|75824302|FG001|Received More Unmanipulated DLI for PD|Allogeneic Stem Cell Therapy||6||
59705055|NCT00923845|75824301|FG000|COMPLETED|Allogeneic Stem Cell Therapy||0||
59705056|NCT00923845|75824302|FG001|COMPLETED|Allogeneic Stem Cell Therapy||10||
59705057|NCT00923845|75824301|FG000|NOT COMPLETED|Allogeneic Stem Cell Therapy||0||
59990981|NCT01678911|76106528|FG000|COMPLETED|Second Intervention||2||
59990982|NCT01678911|76106529|FG001|COMPLETED|Second Intervention||1||
59990983|NCT01678911|76106528|FG000|NOT COMPLETED|Second Intervention||2||
59705058|NCT00923845|75824302|FG001|NOT COMPLETED|Allogeneic Stem Cell Therapy||0||
59705059|NCT00922987|75824309|FG000|STARTED|Overall Study||281||
59705060|NCT00922987|75824309|FG000|COMPLETED|Overall Study||277||
59705061|NCT00922987|75824309|FG000|NOT COMPLETED|Overall Study||4||
59705062|NCT00928135|75824315|FG000|STARTED|Overall Study||30||
59705063|NCT00928135|75824316|FG001|STARTED|Overall Study||30||
59705064|NCT00928135|75824315|FG000|COMPLETED|Overall Study||29||
59705065|NCT00928135|75824316|FG001|COMPLETED|Overall Study||30||
59705066|NCT00928135|75824315|FG000|NOT COMPLETED|Overall Study||1||
60079963|NCT05439421|76195114|FG001|COMPLETED|Fresh Hookah Tobacco||801||
60079964|NCT05439421|76195113|FG000|NOT COMPLETED|Fresh Hookah Tobacco||0||
59705067|NCT00928135|75824316|FG001|NOT COMPLETED|Overall Study||0||
59705068|NCT00928057|75824324|FG000|STARTED|Overall Study||84||
59705069|NCT00928057|75824325|FG001|STARTED|Overall Study||89||
59705070|NCT00928057|75824324|FG000|COMPLETED|Overall Study||82||
59705071|NCT00928057|75824325|FG001|COMPLETED|Overall Study||85||
59705072|NCT00928057|75824324|FG000|NOT COMPLETED|Overall Study||2||
59705073|NCT00928057|75824325|FG001|NOT COMPLETED|Overall Study||4||
59705074|NCT00927901|75824341|FG000|STARTED|Treatment Period 1||7||
59705075|NCT00927901|75824342|FG001|STARTED|Treatment Period 1||7||
59705076|NCT00927901|75824343|FG002|STARTED|Treatment Period 1||7||
59705077|NCT00927901|75824344|FG003|STARTED|Treatment Period 1||9||
59705078|NCT00927901|75824341|FG000|COMPLETED|Treatment Period 1||7||
59705079|NCT00927901|75824342|FG001|COMPLETED|Treatment Period 1||7||
59705080|NCT00927901|75824343|FG002|COMPLETED|Treatment Period 1||6||
59705081|NCT00927901|75824344|FG003|COMPLETED|Treatment Period 1||9||
59705082|NCT00927901|75824341|FG000|NOT COMPLETED|Treatment Period 1||0||
59705083|NCT00927901|75824342|FG001|NOT COMPLETED|Treatment Period 1||0||
59705084|NCT00927901|75824343|FG002|NOT COMPLETED|Treatment Period 1||1||
59705085|NCT00927901|75824344|FG003|NOT COMPLETED|Treatment Period 1||0||
59705086|NCT00927901|75824341|FG000|STARTED|Treatment Period 2||7||
59705087|NCT00927901|75824342|FG001|STARTED|Treatment Period 2||7||
59705088|NCT00927901|75824343|FG002|STARTED|Treatment Period 2||6||
59705089|NCT00927901|75824344|FG003|STARTED|Treatment Period 2||9||
59705090|NCT00927901|75824341|FG000|COMPLETED|Treatment Period 2||7||
59705091|NCT00927901|75824342|FG001|COMPLETED|Treatment Period 2||7||
59705092|NCT00927901|75824343|FG002|COMPLETED|Treatment Period 2||6||
59705093|NCT00927901|75824344|FG003|COMPLETED|Treatment Period 2||9||
60079965|NCT05439421|76195114|FG001|NOT COMPLETED|Fresh Hookah Tobacco||0||
60079966|NCT05439421|76195113|FG000|STARTED|Lower Nicotine Tobacco||742||
60079967|NCT05439421|76195114|FG001|STARTED|Lower Nicotine Tobacco||765||
60079968|NCT05439421|76195113|FG000|COMPLETED|Lower Nicotine Tobacco||742||
60079969|NCT05439421|76195114|FG001|COMPLETED|Lower Nicotine Tobacco||765||
60079970|NCT05439421|76195113|FG000|NOT COMPLETED|Lower Nicotine Tobacco||0||
59705094|NCT00927901|75824341|FG000|NOT COMPLETED|Treatment Period 2||0||
59705095|NCT00927901|75824342|FG001|NOT COMPLETED|Treatment Period 2||0||
59705096|NCT00927901|75824343|FG002|NOT COMPLETED|Treatment Period 2||0||
59705097|NCT00927901|75824344|FG003|NOT COMPLETED|Treatment Period 2||0||
59705098|NCT00927901|75824341|FG000|STARTED|Treatment Period 3||7||
59705099|NCT00927901|75824342|FG001|STARTED|Treatment Period 3||7||
59705100|NCT00927901|75824343|FG002|STARTED|Treatment Period 3||6||
59705101|NCT00927901|75824344|FG003|STARTED|Treatment Period 3||9||
59705102|NCT00927901|75824341|FG000|COMPLETED|Treatment Period 3||7||
59705103|NCT00927901|75824342|FG001|COMPLETED|Treatment Period 3||7||
59705104|NCT00927901|75824343|FG002|COMPLETED|Treatment Period 3||6||
59705105|NCT00927901|75824344|FG003|COMPLETED|Treatment Period 3||9||
59705106|NCT00927901|75824341|FG000|NOT COMPLETED|Treatment Period 3||0||
59705107|NCT00927901|75824342|FG001|NOT COMPLETED|Treatment Period 3||0||
59705108|NCT00927901|75824343|FG002|NOT COMPLETED|Treatment Period 3||0||
60079971|NCT05439421|76195114|FG001|NOT COMPLETED|Lower Nicotine Tobacco||0||
60079972|NCT05439421|76195113|FG000|STARTED|Premium Shisha Tobacco||764||
59705109|NCT00927901|75824344|FG003|NOT COMPLETED|Treatment Period 3||0||
59705110|NCT00927901|75824341|FG000|STARTED|Treatment Period 4||7||
59705111|NCT00927901|75824342|FG001|STARTED|Treatment Period 4||7||
59705112|NCT00927901|75824343|FG002|STARTED|Treatment Period 4||6||
59705113|NCT00927901|75824344|FG003|STARTED|Treatment Period 4||9||
59705114|NCT00927901|75824341|FG000|COMPLETED|Treatment Period 4||7||
59705115|NCT00927901|75824342|FG001|COMPLETED|Treatment Period 4||7||
59705116|NCT00927901|75824343|FG002|COMPLETED|Treatment Period 4||5||
59705117|NCT00927901|75824344|FG003|COMPLETED|Treatment Period 4||8||
59705118|NCT00927901|75824341|FG000|NOT COMPLETED|Treatment Period 4||0||
59705119|NCT00927901|75824342|FG001|NOT COMPLETED|Treatment Period 4||0||
59705120|NCT00927901|75824343|FG002|NOT COMPLETED|Treatment Period 4||1||
59705121|NCT00927901|75824344|FG003|NOT COMPLETED|Treatment Period 4||1||
59705122|NCT01218204|75824359|FG000|STARTED|Part A||6||
59705123|NCT01218204|75824360|FG001|STARTED|Part A||0||
59705124|NCT01218204|75824361|FG002|STARTED|Part A||0||
59705125|NCT01218204|75824362|FG003|STARTED|Part A||0||
59705126|NCT01218204|75824359|FG000|COMPLETED|Part A||6||
59705127|NCT01218204|75824360|FG001|COMPLETED|Part A||0||
59705128|NCT01218204|75824361|FG002|COMPLETED|Part A||0||
59705129|NCT01218204|75824362|FG003|COMPLETED|Part A||0||
59705130|NCT01218204|75824359|FG000|NOT COMPLETED|Part A||0||
59705131|NCT01218204|75824360|FG001|NOT COMPLETED|Part A||0||
59705132|NCT01218204|75824361|FG002|NOT COMPLETED|Part A||0||
59705133|NCT01218204|75824362|FG003|NOT COMPLETED|Part A||0||
59705134|NCT01218204|75824359|FG000|STARTED|Part B Washout||0||
59705135|NCT01218204|75824360|FG001|STARTED|Part B Washout||281||
59705136|NCT01218204|75824361|FG002|STARTED|Part B Washout||0||
59705137|NCT01218204|75824362|FG003|STARTED|Part B Washout||0||
59705138|NCT01218204|75824359|FG000|COMPLETED|Part B Washout||0||
59705139|NCT01218204|75824360|FG001|COMPLETED|Part B Washout||136||
59705140|NCT01218204|75824361|FG002|COMPLETED|Part B Washout||0||
59705141|NCT01218204|75824362|FG003|COMPLETED|Part B Washout||0||
59705142|NCT01218204|75824359|FG000|NOT COMPLETED|Part B Washout||0||
59705143|NCT01218204|75824360|FG001|NOT COMPLETED|Part B Washout||145||
59705144|NCT01218204|75824361|FG002|NOT COMPLETED|Part B Washout||0||
59705145|NCT01218204|75824362|FG003|NOT COMPLETED|Part B Washout||0||
59705146|NCT01218204|75824359|FG000|STARTED|Part B Run-in||0||
59705147|NCT01218204|75824360|FG001|STARTED|Part B Run-in||0||
59705148|NCT01218204|75824361|FG002|STARTED|Part B Run-in||89||
59705149|NCT01218204|75824362|FG003|STARTED|Part B Run-in||0||
59705150|NCT01218204|75824359|FG000|COMPLETED|Part B Run-in||0||
59705151|NCT01218204|75824360|FG001|COMPLETED|Part B Run-in||0||
59705152|NCT01218204|75824361|FG002|COMPLETED|Part B Run-in||83||
59705153|NCT01218204|75824362|FG003|COMPLETED|Part B Run-in||0||
59705154|NCT01218204|75824359|FG000|NOT COMPLETED|Part B Run-in||0||
59705155|NCT01218204|75824360|FG001|NOT COMPLETED|Part B Run-in||0||
59705156|NCT01218204|75824361|FG002|NOT COMPLETED|Part B Run-in||6||
59705157|NCT01218204|75824362|FG003|NOT COMPLETED|Part B Run-in||0||
59705158|NCT01218204|75824359|FG000|STARTED|Part B Pooled Treatment Arm||0||
59705159|NCT01218204|75824360|FG001|STARTED|Part B Pooled Treatment Arm||0||
59705160|NCT01218204|75824361|FG002|STARTED|Part B Pooled Treatment Arm||0||
59705161|NCT01218204|75824362|FG003|STARTED|Part B Pooled Treatment Arm||130||
59705162|NCT01218204|75824359|FG000|COMPLETED|Part B Pooled Treatment Arm||0||
59705163|NCT01218204|75824360|FG001|COMPLETED|Part B Pooled Treatment Arm||0||
59705164|NCT01218204|75824361|FG002|COMPLETED|Part B Pooled Treatment Arm||0||
59705165|NCT01218204|75824362|FG003|COMPLETED|Part B Pooled Treatment Arm||127||
59705166|NCT01218204|75824359|FG000|NOT COMPLETED|Part B Pooled Treatment Arm||0||
59705167|NCT01218204|75824360|FG001|NOT COMPLETED|Part B Pooled Treatment Arm||0||
59705168|NCT01218204|75824361|FG002|NOT COMPLETED|Part B Pooled Treatment Arm||0||
59705169|NCT01218204|75824362|FG003|NOT COMPLETED|Part B Pooled Treatment Arm||3||
59705170|NCT00926575|75824411|FG000|STARTED|Overall Study||70||
59705171|NCT00926575|75824412|FG001|STARTED|Overall Study||70||
59705172|NCT00926575|75824411|FG000|COMPLETED|Overall Study||54||
59705173|NCT00926575|75824412|FG001|COMPLETED|Overall Study||53||
59705174|NCT00926575|75824411|FG000|NOT COMPLETED|Overall Study||16||
59705175|NCT00926575|75824412|FG001|NOT COMPLETED|Overall Study||17||
59705176|NCT01218126|75824422|FG000|STARTED|Overall Study||153||
59705177|NCT01218126|75824423|FG001|STARTED|Overall Study||149||
59705178|NCT01218126|75824424|FG002|STARTED|Overall Study||151||
59705179|NCT01218126|75824425|FG003|STARTED|Overall Study||149||
59705180|NCT01218126|75824422|FG000|COMPLETED|Overall Study||129||
59705181|NCT01218126|75824423|FG001|COMPLETED|Overall Study||127||
59705182|NCT01218126|75824424|FG002|COMPLETED|Overall Study||127||
59705183|NCT01218126|75824425|FG003|COMPLETED|Overall Study||114||
59705184|NCT01218126|75824422|FG000|NOT COMPLETED|Overall Study||24||
59705185|NCT01218126|75824423|FG001|NOT COMPLETED|Overall Study||22||
59705186|NCT01218126|75824424|FG002|NOT COMPLETED|Overall Study||24||
59705187|NCT01218126|75824425|FG003|NOT COMPLETED|Overall Study||35||
59705188|NCT01217892|75824439|FG000|STARTED|Overall Study||100||
59705189|NCT01217892|75824440|FG001|STARTED|Overall Study||100||
59705190|NCT01217892|75824441|FG002|STARTED|Overall Study||99||
59705191|NCT01217892|75824442|FG003|STARTED|Overall Study||101||
59705192|NCT01217892|75824439|FG000|COMPLETED|Overall Study||93||
59705193|NCT01217892|75824440|FG001|COMPLETED|Overall Study||94||
59705194|NCT01217892|75824441|FG002|COMPLETED|Overall Study||90||
59705195|NCT01217892|75824442|FG003|COMPLETED|Overall Study||93||
59705196|NCT01217892|75824439|FG000|NOT COMPLETED|Overall Study||7||
59705197|NCT01217892|75824440|FG001|NOT COMPLETED|Overall Study||6||
59705198|NCT01217892|75824441|FG002|NOT COMPLETED|Overall Study||9||
59705199|NCT01217892|75824442|FG003|NOT COMPLETED|Overall Study||8||
59705200|NCT01217814|75824455|FG000|STARTED|Overall Study||4||
59705201|NCT01217814|75824456|FG001|STARTED|Overall Study||5||
59705202|NCT01217814|75824457|FG002|STARTED|Overall Study||7||
59705203|NCT01217814|75824455|FG000|COMPLETED|Overall Study||3||
59705204|NCT01217814|75824456|FG001|COMPLETED|Overall Study||4||
59705205|NCT01217814|75824457|FG002|COMPLETED|Overall Study||6||
59705206|NCT01217814|75824455|FG000|NOT COMPLETED|Overall Study||1||
59705207|NCT01217814|75824456|FG001|NOT COMPLETED|Overall Study||1||
59705208|NCT01217814|75824457|FG002|NOT COMPLETED|Overall Study||1||
59705209|NCT01217190|75824468|FG000|STARTED|First Dosing||24||
59705210|NCT01217190|75824469|FG001|STARTED|First Dosing||24||
59705211|NCT01217190|75824468|FG000|COMPLETED|First Dosing||24||
59705212|NCT01217190|75824469|FG001|COMPLETED|First Dosing||24||
59705213|NCT01217190|75824468|FG000|NOT COMPLETED|First Dosing||0||
59705214|NCT01217190|75824469|FG001|NOT COMPLETED|First Dosing||0||
59705215|NCT01217190|75824468|FG000|STARTED|Second Dosing||24||
59705216|NCT01217190|75824469|FG001|STARTED|Second Dosing||24||
59705217|NCT01217190|75824468|FG000|COMPLETED|Second Dosing||24||
59705218|NCT01217190|75824469|FG001|COMPLETED|Second Dosing|Two subjects withdrew for personal reasons (other than adverse event).|22||
59705219|NCT01217190|75824468|FG000|NOT COMPLETED|Second Dosing||0||
59705220|NCT01217190|75824469|FG001|NOT COMPLETED|Second Dosing||2||
59705221|NCT01136733|75824485|FG000|STARTED|Phase 1b|Participants in Phase 1b did not advance to Phase 2.|7||
59705222|NCT01136733|75824486|FG001|STARTED|Phase 1b|Participants in Phase 1b did not advance to Phase 2.|11||
59705223|NCT01136733|75824487|FG002|STARTED|Phase 1b|Participants in Phase 1b did not advance to Phase 2.|2||
59705224|NCT01136733|75824488|FG003|STARTED|Phase 1b|Participants in Phase 1b did not advance to Phase 2.|0||
59705225|NCT01136733|75824489|FG004|STARTED|Phase 1b||0||
59705226|NCT01136733|75824490|FG005|STARTED|Phase 1b||0||
59705227|NCT01136733|75824491|FG006|STARTED|Phase 1b||0||
59705228|NCT01136733|75824485|FG000|COMPLETED|Phase 1b||6||
59705229|NCT01136733|75824486|FG001|COMPLETED|Phase 1b||6||
59705230|NCT01136733|75824487|FG002|COMPLETED|Phase 1b||0||
59705231|NCT01136733|75824488|FG003|COMPLETED|Phase 1b||0||
59705232|NCT01136733|75824489|FG004|COMPLETED|Phase 1b||0||
59705233|NCT01136733|75824490|FG005|COMPLETED|Phase 1b||0||
59705234|NCT01136733|75824491|FG006|COMPLETED|Phase 1b||0||
59705235|NCT01136733|75824485|FG000|NOT COMPLETED|Phase 1b||1||
59705236|NCT01136733|75824486|FG001|NOT COMPLETED|Phase 1b||5||
59705237|NCT01136733|75824487|FG002|NOT COMPLETED|Phase 1b||2||
59705238|NCT01136733|75824488|FG003|NOT COMPLETED|Phase 1b||0||
59705239|NCT01136733|75824489|FG004|NOT COMPLETED|Phase 1b||0||
59705240|NCT01136733|75824490|FG005|NOT COMPLETED|Phase 1b||0||
59705241|NCT01136733|75824491|FG006|NOT COMPLETED|Phase 1b||0||
59705242|NCT01136733|75824485|FG000|STARTED|Phase 2||0||
59705243|NCT01136733|75824486|FG001|STARTED|Phase 2||0||
59705244|NCT01136733|75824487|FG002|STARTED|Phase 2||0||
59705245|NCT01136733|75824488|FG003|STARTED|Phase 2||0||
59705246|NCT01136733|75824489|FG004|STARTED|Phase 2|Participants in Phase 2 did not participate in Phase 1b.|51||
59705247|NCT01136733|75824490|FG005|STARTED|Phase 2|Participants in Phase 2 did not participate in Phase 1b.|52||
59705248|NCT01136733|75824491|FG006|STARTED|Phase 2|Participants in Phase 2 did not participate in Phase 1b.|50||
59705249|NCT01136733|75824485|FG000|COMPLETED|Phase 2||0||
59705250|NCT01136733|75824486|FG001|COMPLETED|Phase 2||0||
59705251|NCT01136733|75824487|FG002|COMPLETED|Phase 2||0||
59705252|NCT01136733|75824488|FG003|COMPLETED|Phase 2||0||
59705253|NCT01136733|75824489|FG004|COMPLETED|Phase 2||0||
59705254|NCT01136733|75824490|FG005|COMPLETED|Phase 2||0||
59705255|NCT01136733|75824491|FG006|COMPLETED|Phase 2||0||
59705256|NCT01136733|75824485|FG000|NOT COMPLETED|Phase 2||0||
59705257|NCT01136733|75824486|FG001|NOT COMPLETED|Phase 2||0||
59705258|NCT01136733|75824487|FG002|NOT COMPLETED|Phase 2||0||
59705259|NCT01136733|75824488|FG003|NOT COMPLETED|Phase 2||0||
59705260|NCT01136733|75824489|FG004|NOT COMPLETED|Phase 2||51||
59705261|NCT01136733|75824490|FG005|NOT COMPLETED|Phase 2||52||
59705262|NCT01136733|75824491|FG006|NOT COMPLETED|Phase 2||50||
59705263|NCT01136655|75824521|FG000|STARTED|BUD 160/FM 2.25 (1 Dose)||54||
59705264|NCT01136655|75824521|FG000|COMPLETED|BUD 160/FM 2.25 (1 Dose)||54||
59705265|NCT01136655|75824521|FG000|NOT COMPLETED|BUD 160/FM 2.25 (1 Dose)||0||
59705266|NCT01136655|75824521|FG000|STARTED|Washout After BUD 160/FM 2.25 (7 Days)||54||
59705267|NCT01136655|75824521|FG000|COMPLETED|Washout After BUD 160/FM 2.25 (7 Days)||53||
59705268|NCT01136655|75824521|FG000|NOT COMPLETED|Washout After BUD 160/FM 2.25 (7 Days)||1||
59705269|NCT01136655|75824521|FG000|STARTED|BUD 160/FM 4.5 (1 Dose)||53||
59705270|NCT01136655|75824521|FG000|COMPLETED|BUD 160/FM 4.5 (1 Dose)||53||
59705271|NCT01136655|75824521|FG000|NOT COMPLETED|BUD 160/FM 4.5 (1 Dose)||0||
59705272|NCT01136655|75824521|FG000|STARTED|Washout After BUD 160/FM 4.5 (7 Days)||53||
59705273|NCT01136655|75824521|FG000|COMPLETED|Washout After BUD 160/FM 4.5 (7 Days)||52||
59705274|NCT01136655|75824521|FG000|NOT COMPLETED|Washout After BUD 160/FM 4.5 (7 Days)||1||
59705275|NCT01136655|75824521|FG000|STARTED|BUD 160/FM 9.0 (1 Dose)||53||
59705276|NCT01136655|75824521|FG000|COMPLETED|BUD 160/FM 9.0 (1 Dose)||53||
59705277|NCT01136655|75824521|FG000|NOT COMPLETED|BUD 160/FM 9.0 (1 Dose)||0||
59705278|NCT01136655|75824521|FG000|STARTED|Washout After BUD 160/FM 9.0 (7 Days)||53||
59705279|NCT01136655|75824521|FG000|COMPLETED|Washout After BUD 160/FM 9.0 (7 Days)||51||
59705280|NCT01136655|75824521|FG000|NOT COMPLETED|Washout After BUD 160/FM 9.0 (7 Days)||2||
59705281|NCT01136655|75824521|FG000|STARTED|BUD 160 (1 Dose)||51||
59705282|NCT01136655|75824521|FG000|COMPLETED|BUD 160 (1 Dose)||51||
59705283|NCT01136655|75824521|FG000|NOT COMPLETED|BUD 160 (1 Dose)||0||
59705284|NCT01136655|75824521|FG000|STARTED|Washout After BUD 160 (7 Days)||51||
59705285|NCT01136655|75824521|FG000|COMPLETED|Washout After BUD 160 (7 Days)||51||
59705286|NCT01136655|75824521|FG000|NOT COMPLETED|Washout After BUD 160 (7 Days)||0||
59705287|NCT01136655|75824521|FG000|STARTED|BUD 160/ Foradil 12.0 (1 Dose)||50||
59705288|NCT01136655|75824521|FG000|COMPLETED|BUD 160/ Foradil 12.0 (1 Dose)||50||
59705289|NCT01136655|75824521|FG000|NOT COMPLETED|BUD 160/ Foradil 12.0 (1 Dose)||0||
59705290|NCT01136655|75824521|FG000|STARTED|Washout After BUD 160/ Foradil (7 Days)||50||
59705291|NCT01136655|75824521|FG000|COMPLETED|Washout After BUD 160/ Foradil (7 Days)||50||
59705292|NCT01136655|75824521|FG000|NOT COMPLETED|Washout After BUD 160/ Foradil (7 Days)||0||
59705293|NCT01135017|75824536|FG000|STARTED|Overall Study||55||
59705294|NCT01135017|75824537|FG001|STARTED|Overall Study||57||
59705295|NCT01135017|75824536|FG000|Treated|Overall Study||55||
59705296|NCT01135017|75824537|FG001|Treated|Overall Study||57||
59705297|NCT01135017|75824536|FG000|Evaluable for Efficacy|Overall Study||55||
59705298|NCT01135017|75824537|FG001|Evaluable for Efficacy|Overall Study|Two participants did not have interrogation of the pacemaker after randomization|55||
59705299|NCT01135017|75824536|FG000|COMPLETED|Overall Study|The study was terminated after enrolled participants completed the study period as per protocol|49||
59705300|NCT01135017|75824537|FG001|COMPLETED|Overall Study|The study was terminated after enrolled participants completed the study period as per protocol|45||
59705301|NCT01135017|75824536|FG000|NOT COMPLETED|Overall Study||6||
59705302|NCT01135017|75824537|FG001|NOT COMPLETED|Overall Study||12||
59705303|NCT01134939|75824551|FG000|STARTED|Overall Study||59||
59705304|NCT01134939|75824552|FG001|STARTED|Overall Study||42||
59705305|NCT01134939|75824553|FG002|STARTED|Overall Study||51||
59705306|NCT01134939|75824554|FG003|STARTED|Overall Study||46||
59705307|NCT01134939|75824555|FG004|STARTED|Overall Study||33||
59705308|NCT01134939|75824556|FG005|STARTED|Overall Study||14||
59705309|NCT01134939|75824557|FG006|STARTED|Overall Study||19||
59705310|NCT01134939|75824558|FG007|STARTED|Overall Study||1||
59705311|NCT01134939|75824551|FG000|COMPLETED|Overall Study||42||
59705312|NCT01134939|75824552|FG001|COMPLETED|Overall Study||24||
59705313|NCT01134939|75824553|FG002|COMPLETED|Overall Study||41||
59705314|NCT01134939|75824554|FG003|COMPLETED|Overall Study||32||
59705315|NCT01134939|75824555|FG004|COMPLETED|Overall Study||23||
59705316|NCT01134939|75824556|FG005|COMPLETED|Overall Study||5||
59705317|NCT01134939|75824557|FG006|COMPLETED|Overall Study||10||
59705318|NCT01134939|75824558|FG007|COMPLETED|Overall Study||1||
59705319|NCT01134939|75824551|FG000|NOT COMPLETED|Overall Study||17||
59705320|NCT01134939|75824552|FG001|NOT COMPLETED|Overall Study||18||
59705321|NCT01134939|75824553|FG002|NOT COMPLETED|Overall Study||10||
59705322|NCT01134939|75824554|FG003|NOT COMPLETED|Overall Study||14||
59705323|NCT01134939|75824555|FG004|NOT COMPLETED|Overall Study||10||
59705324|NCT01134939|75824556|FG005|NOT COMPLETED|Overall Study||9||
59705325|NCT01134939|75824557|FG006|NOT COMPLETED|Overall Study||9||
59705326|NCT01134939|75824558|FG007|NOT COMPLETED|Overall Study||0||
59705327|NCT01134783|75824574|FG000|STARTED|Overall Study||224||
59705328|NCT01134783|75824575|FG001|STARTED|Overall Study||217||
59705329|NCT01134783|75824574|FG000|COMPLETED|Overall Study||188||
59705330|NCT01134783|75824575|FG001|COMPLETED|Overall Study||180||
59705331|NCT01134783|75824574|FG000|NOT COMPLETED|Overall Study||36||
59705332|NCT01134783|75824575|FG001|NOT COMPLETED|Overall Study||37||
59705333|NCT01134705|75824587|FG000|STARTED|Overall Study||236||
59705334|NCT01134705|75824588|FG001|STARTED|Overall Study||238||
59705335|NCT01134705|75824587|FG000|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment.|232||
59705336|NCT01134705|75824588|FG001|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment.|234||
59705337|NCT01134705|75824587|FG000|COMPLETED|Overall Study||221||
59705338|NCT01134705|75824588|FG001|COMPLETED|Overall Study||216||
59705339|NCT01134705|75824587|FG000|NOT COMPLETED|Overall Study||15||
59705340|NCT01134705|75824588|FG001|NOT COMPLETED|Overall Study||22||
59705341|NCT00927823|75824594|FG000|STARTED|Lead-In Period||3||
59705342|NCT00927823|75824595|FG001|STARTED|Lead-In Period||3||
59705343|NCT00927823|75824596|FG002|STARTED|Lead-In Period||26||
59705344|NCT00927823|75824597|FG003|STARTED|Lead-In Period||5||
59705345|NCT00927823|75824594|FG000|COMPLETED|Lead-In Period||3||
59705346|NCT00927823|75824595|FG001|COMPLETED|Lead-In Period||3||
59705347|NCT00927823|75824596|FG002|COMPLETED|Lead-In Period||26||
59705348|NCT00927823|75824597|FG003|COMPLETED|Lead-In Period||5||
59705349|NCT00927823|75824594|FG000|NOT COMPLETED|Lead-In Period||0||
59705350|NCT00927823|75824595|FG001|NOT COMPLETED|Lead-In Period||0||
59705351|NCT00927823|75824596|FG002|NOT COMPLETED|Lead-In Period||0||
59705352|NCT00927823|75824597|FG003|NOT COMPLETED|Lead-In Period||0||
59705353|NCT00927823|75824594|FG000|STARTED|Continuous Dosing Period||3||
59705354|NCT00927823|75824595|FG001|STARTED|Continuous Dosing Period||3||
59705355|NCT00927823|75824596|FG002|STARTED|Continuous Dosing Period||26||
59705356|NCT00927823|75824597|FG003|STARTED|Continuous Dosing Period||5||
59705357|NCT00927823|75824594|FG000|Treated|Continuous Dosing Period||3||
59705358|NCT00927823|75824595|FG001|Treated|Continuous Dosing Period||3||
59705359|NCT00927823|75824596|FG002|Treated|Continuous Dosing Period||23||
59705360|NCT00927823|75824597|FG003|Treated|Continuous Dosing Period||5||
59705361|NCT00927823|75824594|FG000|COMPLETED|Continuous Dosing Period||0||
59705362|NCT00927823|75824595|FG001|COMPLETED|Continuous Dosing Period||0||
59705363|NCT00927823|75824596|FG002|COMPLETED|Continuous Dosing Period||0||
59705364|NCT00927823|75824597|FG003|COMPLETED|Continuous Dosing Period||0||
59705365|NCT00927823|75824594|FG000|NOT COMPLETED|Continuous Dosing Period||3||
59705366|NCT00927823|75824595|FG001|NOT COMPLETED|Continuous Dosing Period||3||
59705367|NCT00927823|75824596|FG002|NOT COMPLETED|Continuous Dosing Period||26||
59705368|NCT00927823|75824597|FG003|NOT COMPLETED|Continuous Dosing Period||5||
59705369|NCT01134627|75824616|FG000|STARTED|Overall Study|Number of participants treated.|149||
59705370|NCT01134627|75824617|FG001|STARTED|Overall Study|Number of participants treated.|155||
59705371|NCT01134627|75824616|FG000|COMPLETED|Overall Study||80||
59705372|NCT01134627|75824617|FG001|COMPLETED|Overall Study||88||
59705373|NCT01134627|75824616|FG000|NOT COMPLETED|Overall Study||69||
59705374|NCT01134627|75824617|FG001|NOT COMPLETED|Overall Study||67||
59705375|NCT01134393|75824623|FG000|STARTED|Overall Study|Entered and treated.|501||
59705376|NCT01134393|75824623|FG000|COMPLETED|Overall Study|Completed trial medication.|449||
59705377|NCT01134393|75824623|FG000|NOT COMPLETED|Overall Study||52||
59705378|NCT00922441|75824631|FG000|STARTED|Overall Study||30||
59705379|NCT00922441|75824632|FG001|STARTED|Overall Study||30||
59705380|NCT00922441|75824633|FG002|STARTED|Overall Study||32||
59705381|NCT00922441|75824631|FG000|COMPLETED|Overall Study||30||
59705382|NCT00922441|75824632|FG001|COMPLETED|Overall Study||30||
59705383|NCT00922441|75824633|FG002|COMPLETED|Overall Study||29||
59705384|NCT00922441|75824631|FG000|NOT COMPLETED|Overall Study||0||
59705385|NCT00922441|75824632|FG001|NOT COMPLETED|Overall Study||0||
59705386|NCT00922441|75824633|FG002|NOT COMPLETED|Overall Study||3||
59705387|NCT01217112|75824646|FG000|STARTED|Overall Study||11||
59705388|NCT01217112|75824647|FG001|STARTED|Overall Study||12||
59705389|NCT01217112|75824648|FG002|STARTED|Overall Study||13||
59705390|NCT01217112|75824649|FG003|STARTED|Overall Study||12||
59705391|NCT01217112|75824650|FG004|STARTED|Overall Study||14||
59705392|NCT01217112|75824646|FG000|COMPLETED|Overall Study||11||
59705393|NCT01217112|75824647|FG001|COMPLETED|Overall Study||10||
59705394|NCT01217112|75824648|FG002|COMPLETED|Overall Study||12||
59705395|NCT01217112|75824649|FG003|COMPLETED|Overall Study||10||
59705396|NCT01217112|75824650|FG004|COMPLETED|Overall Study||13||
59705397|NCT01217112|75824646|FG000|NOT COMPLETED|Overall Study||0||
59705398|NCT01217112|75824647|FG001|NOT COMPLETED|Overall Study||2||
59705399|NCT01217112|75824648|FG002|NOT COMPLETED|Overall Study||1||
59705400|NCT01217112|75824649|FG003|NOT COMPLETED|Overall Study||2||
59705401|NCT01217112|75824650|FG004|NOT COMPLETED|Overall Study||1||
59705402|NCT01216332|75824664|FG000|STARTED|Overall Study||34||
59705403|NCT01216332|75824665|FG001|STARTED|Overall Study||16||
59705404|NCT01216332|75824664|FG000|COMPLETED|Overall Study||30||
59705405|NCT01216332|75824665|FG001|COMPLETED|Overall Study||16||
59705406|NCT01216332|75824664|FG000|NOT COMPLETED|Overall Study||4||
59705407|NCT01216332|75824665|FG001|NOT COMPLETED|Overall Study||0||
59705408|NCT00922207|75824674|FG000|STARTED|Overall Study||91||
59705409|NCT00922207|75824675|FG001|STARTED|Overall Study||95||
59705410|NCT00922207|75824676|FG002|STARTED|Overall Study||94||
59705411|NCT00922207|75824674|FG000|COMPLETED|Overall Study||85||
59705412|NCT00922207|75824675|FG001|COMPLETED|Overall Study||88||
59705413|NCT00922207|75824676|FG002|COMPLETED|Overall Study||90||
59705414|NCT00922207|75824674|FG000|NOT COMPLETED|Overall Study||6||
59705415|NCT00922207|75824675|FG001|NOT COMPLETED|Overall Study||7||
59705416|NCT00922207|75824676|FG002|NOT COMPLETED|Overall Study||4||
59705417|NCT01134315|75824686|FG000|STARTED|Overall Study||21||
59705418|NCT01134315|75824687|FG001|STARTED|Overall Study||40||
59705419|NCT01134315|75824686|FG000|COMPLETED|Overall Study|Completed study drug treatment during the observational study (ie, prior to study termination).|12||
59705420|NCT01134315|75824687|FG001|COMPLETED|Overall Study|Completed study drug treatment during the observational study (ie, prior to study termination).|21||
59705421|NCT01134315|75824686|FG000|NOT COMPLETED|Overall Study||9||
59705422|NCT01134315|75824687|FG001|NOT COMPLETED|Overall Study||19||
59705423|NCT01216176|75824696|FG000|STARTED|Overall Study||12||
59705424|NCT01216176|75824697|FG001|STARTED|Overall Study||39||
59705425|NCT01216176|75824698|FG002|STARTED|Overall Study||20||
59705426|NCT01216176|75824696|FG000|COMPLETED|Overall Study||12||
59705427|NCT01216176|75824697|FG001|COMPLETED|Overall Study||31||
59705428|NCT01216176|75824698|FG002|COMPLETED|Overall Study||19||
59705429|NCT01216176|75824696|FG000|NOT COMPLETED|Overall Study||0||
59705430|NCT01216176|75824697|FG001|NOT COMPLETED|Overall Study||8||
59705431|NCT01216176|75824698|FG002|NOT COMPLETED|Overall Study||1||
59705432|NCT01133847|75824710|FG000|STARTED|Active Treatment Phase (Weeks 1-16)||78||
59705433|NCT01133847|75824711|FG001|STARTED|Active Treatment Phase (Weeks 1-16)||74||
59705434|NCT01133847|75824712|FG002|STARTED|Active Treatment Phase (Weeks 1-16)||70||
59705435|NCT01133847|75824710|FG000|COMPLETED|Active Treatment Phase (Weeks 1-16)||73||
59705436|NCT01133847|75824711|FG001|COMPLETED|Active Treatment Phase (Weeks 1-16)||73||
59705437|NCT01133847|75824712|FG002|COMPLETED|Active Treatment Phase (Weeks 1-16)||67||
59705438|NCT01133847|75824710|FG000|NOT COMPLETED|Active Treatment Phase (Weeks 1-16)||5||
59705439|NCT01133847|75824711|FG001|NOT COMPLETED|Active Treatment Phase (Weeks 1-16)||1||
59705440|NCT01133847|75824712|FG002|NOT COMPLETED|Active Treatment Phase (Weeks 1-16)||3||
59705441|NCT01133847|75824710|FG000|STARTED|Follow-Up Phase||73||
59705442|NCT01133847|75824711|FG001|STARTED|Follow-Up Phase||73||
59705443|NCT01133847|75824712|FG002|STARTED|Follow-Up Phase||67||
59705444|NCT01133847|75824710|FG000|COMPLETED|Follow-Up Phase||72||
59705445|NCT01133847|75824711|FG001|COMPLETED|Follow-Up Phase||70||
59705446|NCT01133847|75824712|FG002|COMPLETED|Follow-Up Phase||60||
59705447|NCT01133847|75824710|FG000|NOT COMPLETED|Follow-Up Phase||1||
59705448|NCT01133847|75824711|FG001|NOT COMPLETED|Follow-Up Phase||3||
59705449|NCT01133847|75824712|FG002|NOT COMPLETED|Follow-Up Phase||7||
59705450|NCT01133379|75824724|FG000|STARTED|Overall Study||58||
59705451|NCT01133379|75824725|FG001|STARTED|Overall Study||58||
59705452|NCT01133379|75824726|FG002|STARTED|Overall Study||58||
59705453|NCT01133379|75824724|FG000|COMPLETED|Overall Study||57||
59705454|NCT01133379|75824725|FG001|COMPLETED|Overall Study||56||
59705455|NCT01133379|75824726|FG002|COMPLETED|Overall Study||56||
59705456|NCT01133379|75824724|FG000|NOT COMPLETED|Overall Study||1||
59705457|NCT01133379|75824725|FG001|NOT COMPLETED|Overall Study||2||
59705458|NCT01133379|75824726|FG002|NOT COMPLETED|Overall Study||2||
59705459|NCT01133067|75824734|FG000|STARTED|Overall Study||200||
59705460|NCT01133067|75824734|FG000|COMPLETED|Overall Study||61||
59705461|NCT01133067|75824734|FG000|NOT COMPLETED|Overall Study||139||
59705462|NCT01132755|75824738|FG000|STARTED|Overall Study||112||
59705463|NCT01132755|75824738|FG000|COMPLETED|Overall Study||70||
59705464|NCT01132755|75824738|FG000|NOT COMPLETED|Overall Study||42||
59705465|NCT00919711|75824744|FG000|STARTED|Overall Study||435||
59705466|NCT00919711|75824745|FG001|STARTED|Overall Study||435||
59705467|NCT00919711|75824744|FG000|COMPLETED|Overall Study||402||
59705468|NCT00919711|75824745|FG001|COMPLETED|Overall Study||422||
59705469|NCT00919711|75824744|FG000|NOT COMPLETED|Overall Study||33||
59705470|NCT00919711|75824745|FG001|NOT COMPLETED|Overall Study||13||
59705471|NCT01131585|75824753|FG000|STARTED|Overall Study||85||
59705472|NCT01131585|75824754|FG001|STARTED|Overall Study||43||
59705473|NCT01131585|75824753|FG000|COMPLETED|Overall Study||0||
59705474|NCT01131585|75824754|FG001|COMPLETED|Overall Study||0||
59705475|NCT01131585|75824753|FG000|NOT COMPLETED|Overall Study||85||
59705476|NCT01131585|75824754|FG001|NOT COMPLETED|Overall Study||43||
59705477|NCT01131507|75824760|FG000|STARTED|Overall Study||15||
59705478|NCT01131507|75824760|FG000|COMPLETED|Overall Study||12||
59705479|NCT01131507|75824760|FG000|NOT COMPLETED|Overall Study||3||
59705480|NCT01131351|75824766|FG000|STARTED|Overall Study||5||
59705481|NCT01131351|75824767|FG001|STARTED|Overall Study||5||
59705482|NCT01131351|75824766|FG000|COMPLETED|Overall Study||5||
59705483|NCT01131351|75824767|FG001|COMPLETED|Overall Study||2||
59705484|NCT01131351|75824766|FG000|NOT COMPLETED|Overall Study||0||
59705485|NCT01131351|75824767|FG001|NOT COMPLETED|Overall Study||3||
59705486|NCT00919633|75824777|FG000|STARTED|Overall Study||28||
59705487|NCT00919633|75824778|FG001|STARTED|Overall Study||25||
59705488|NCT00919633|75824779|FG002|STARTED|Overall Study||27||
59705489|NCT00919633|75824780|FG003|STARTED|Overall Study||26||
59705490|NCT00919633|75824777|FG000|COMPLETED|Overall Study||6||
59705491|NCT00919633|75824778|FG001|COMPLETED|Overall Study||10||
59705492|NCT00919633|75824779|FG002|COMPLETED|Overall Study||4||
59705493|NCT00919633|75824780|FG003|COMPLETED|Overall Study||5||
59705494|NCT00919633|75824777|FG000|NOT COMPLETED|Overall Study||22||
59705495|NCT00919633|75824778|FG001|NOT COMPLETED|Overall Study||15||
59705496|NCT00919633|75824779|FG002|NOT COMPLETED|Overall Study||23||
59705497|NCT00919633|75824780|FG003|NOT COMPLETED|Overall Study||21||
59705498|NCT01130883|75824790|FG000|STARTED|Overall Study||3130||
59705499|NCT01130883|75824790|FG000|Participants Analyzed|Overall Study||3128||
59705500|NCT01130883|75824790|FG000|COMPLETED|Overall Study||3120||
59705501|NCT01130883|75824790|FG000|NOT COMPLETED|Overall Study||10||
59705502|NCT00926029|75824797|FG000|STARTED|Overall Study||34||
59705503|NCT00926029|75824798|FG001|STARTED|Overall Study||34||
59705504|NCT00926029|75824799|FG002|STARTED|Overall Study||34||
59705505|NCT00926029|75824797|FG000|COMPLETED|Overall Study||32||
59705506|NCT00926029|75824798|FG001|COMPLETED|Overall Study||33||
59705507|NCT00926029|75824799|FG002|COMPLETED|Overall Study||33||
59705508|NCT00926029|75824797|FG000|NOT COMPLETED|Overall Study||2||
59705509|NCT00926029|75824798|FG001|NOT COMPLETED|Overall Study||1||
59705510|NCT00926029|75824799|FG002|NOT COMPLETED|Overall Study||1||
59705511|NCT01130493|75824809|FG000|STARTED|Open-label Dose Conversion to IPX066|During the open-label dose conversion to IPX066, all subjects received IPX066|110||
59705512|NCT01130493|75824810|FG001|STARTED|Open-label Dose Conversion to IPX066||0||
59705513|NCT01130493|75824811|FG002|STARTED|Open-label Dose Conversion to IPX066||0||
59705514|NCT01130493|75824809|FG000|COMPLETED|Open-label Dose Conversion to IPX066||91||
59705515|NCT01130493|75824810|FG001|COMPLETED|Open-label Dose Conversion to IPX066||0||
59990984|NCT01678911|76106529|FG001|NOT COMPLETED|Second Intervention||0||
59705516|NCT01130493|75824811|FG002|COMPLETED|Open-label Dose Conversion to IPX066||0||
59705517|NCT01130493|75824809|FG000|NOT COMPLETED|Open-label Dose Conversion to IPX066||19||
59705518|NCT01130493|75824810|FG001|NOT COMPLETED|Open-label Dose Conversion to IPX066||0||
59705519|NCT01130493|75824811|FG002|NOT COMPLETED|Open-label Dose Conversion to IPX066||0||
59705520|NCT01130493|75824809|FG000|STARTED|Part 1: Double-blind Treatment Period 1|91 subjects completed IPX066 dose conversion and were then randomized to the two treatment sequences|0||
59705521|NCT01130493|75824810|FG001|STARTED|Part 1: Double-blind Treatment Period 1|48 were randomized to IPX066-CLE double-blind treatment sequence|48||
59705522|NCT01130493|75824811|FG002|STARTED|Part 1: Double-blind Treatment Period 1|43 were randomized to CLE-IPX066 double-blind treatment sequence|43||
59705523|NCT01130493|75824809|FG000|COMPLETED|Part 1: Double-blind Treatment Period 1||0||
59705524|NCT01130493|75824810|FG001|COMPLETED|Part 1: Double-blind Treatment Period 1||46||
59990985|NCT02487446|76106535|FG000|STARTED|Period 1||178||
59705525|NCT01130493|75824811|FG002|COMPLETED|Part 1: Double-blind Treatment Period 1||43||
59705526|NCT01130493|75824809|FG000|NOT COMPLETED|Part 1: Double-blind Treatment Period 1||0||
59548253|NCT01138124|75647245|FG003|COMPLETED|Overall Study||19046||
59548254|NCT01138124|75647242|FG000|NOT COMPLETED|Overall Study||0||
59548255|NCT01138124|75647243|FG001|NOT COMPLETED|Overall Study||0||
59548256|NCT01138124|75647244|FG002|NOT COMPLETED|Overall Study||0||
59705527|NCT01130493|75824810|FG001|NOT COMPLETED|Part 1: Double-blind Treatment Period 1||2||
59705528|NCT01130493|75824811|FG002|NOT COMPLETED|Part 1: Double-blind Treatment Period 1||0||
59705529|NCT01130493|75824809|FG000|STARTED|Part 1: Open-Label IPX066 Washout||0||
59705530|NCT01130493|75824810|FG001|STARTED|Part 1: Open-Label IPX066 Washout||46||
59705531|NCT01130493|75824811|FG002|STARTED|Part 1: Open-Label IPX066 Washout||43||
59705532|NCT01130493|75824809|FG000|COMPLETED|Part 1: Open-Label IPX066 Washout||0||
59705533|NCT01130493|75824810|FG001|COMPLETED|Part 1: Open-Label IPX066 Washout||45||
59705534|NCT01130493|75824811|FG002|COMPLETED|Part 1: Open-Label IPX066 Washout||41||
59705535|NCT01130493|75824809|FG000|NOT COMPLETED|Part 1: Open-Label IPX066 Washout||0||
59705536|NCT01130493|75824810|FG001|NOT COMPLETED|Part 1: Open-Label IPX066 Washout||1||
59705537|NCT01130493|75824811|FG002|NOT COMPLETED|Part 1: Open-Label IPX066 Washout||2||
59705538|NCT01130493|75824809|FG000|STARTED|Part 1: Double-blind Treatment Period 2||0||
59705539|NCT01130493|75824810|FG001|STARTED|Part 1: Double-blind Treatment Period 2||45||
59705540|NCT01130493|75824811|FG002|STARTED|Part 1: Double-blind Treatment Period 2||41||
59705541|NCT01130493|75824809|FG000|COMPLETED|Part 1: Double-blind Treatment Period 2||0||
59705542|NCT01130493|75824810|FG001|COMPLETED|Part 1: Double-blind Treatment Period 2||45||
59705543|NCT01130493|75824811|FG002|COMPLETED|Part 1: Double-blind Treatment Period 2||39||
59705544|NCT01130493|75824809|FG000|NOT COMPLETED|Part 1: Double-blind Treatment Period 2||0||
59705545|NCT01130493|75824810|FG001|NOT COMPLETED|Part 1: Double-blind Treatment Period 2||0||
59705546|NCT01130493|75824811|FG002|NOT COMPLETED|Part 1: Double-blind Treatment Period 2||2||
59705547|NCT01130493|75824809|FG000|STARTED|Part 2: OLE||0|10 subjects did not roll over to Part 2 (OLE) as it was optional. Reasons were not collected.|
59705548|NCT01130493|75824810|FG001|STARTED|Part 2: OLE|All subjects received IPX066 during OLE|39|10 subjects did not roll over to Part 2 (OLE) as it was optional. Reasons were not collected.|
59705549|NCT01130493|75824811|FG002|STARTED|Part 2: OLE|No subjects received CLE during OLE|35|10 subjects did not roll over to Part 2 (OLE) as it was optional. Reasons were not collected.|
59705550|NCT01130493|75824809|FG000|COMPLETED|Part 2: OLE||0||
59705551|NCT01130493|75824810|FG001|COMPLETED|Part 2: OLE||36||
59705552|NCT01130493|75824811|FG002|COMPLETED|Part 2: OLE||30||
59705553|NCT01130493|75824809|FG000|NOT COMPLETED|Part 2: OLE||0||
59705554|NCT01130493|75824810|FG001|NOT COMPLETED|Part 2: OLE||3||
59705555|NCT01130493|75824811|FG002|NOT COMPLETED|Part 2: OLE||5||
59705556|NCT01130337|75824822|FG000|STARTED|Overall Study||36||
59705557|NCT01130337|75824822|FG000|COMPLETED|Overall Study||22||
59705558|NCT01130337|75824822|FG000|NOT COMPLETED|Overall Study||14||
59705559|NCT01130103|75824828|FG000|STARTED|Randomized Treatment||19||
59705560|NCT01130103|75824829|FG001|STARTED|Randomized Treatment||18||
59705561|NCT01130103|75824828|FG000|COMPLETED|Randomized Treatment||13||
59705562|NCT01130103|75824829|FG001|COMPLETED|Randomized Treatment||13||
59705563|NCT01130103|75824828|FG000|NOT COMPLETED|Randomized Treatment||6||
59705564|NCT01130103|75824829|FG001|NOT COMPLETED|Randomized Treatment||5||
59705565|NCT01130103|75824828|FG000|STARTED|Maintenance Treatment||13||
59705566|NCT01130103|75824829|FG001|STARTED|Maintenance Treatment||13||
59705567|NCT01130103|75824828|FG000|COMPLETED|Maintenance Treatment||11||
59705568|NCT01130103|75824829|FG001|COMPLETED|Maintenance Treatment||11||
59705569|NCT01130103|75824828|FG000|NOT COMPLETED|Maintenance Treatment||2||
59705570|NCT01130103|75824829|FG001|NOT COMPLETED|Maintenance Treatment||2||
59705571|NCT01129557|75824838|FG000|STARTED|Overall Study||15||
59705572|NCT01129557|75824839|FG001|STARTED|Overall Study||17||
59705573|NCT01129557|75824840|FG002|STARTED|Overall Study||14||
59705574|NCT01129557|75824838|FG000|COMPLETED|Overall Study||11||
59705575|NCT01129557|75824839|FG001|COMPLETED|Overall Study||12||
59705576|NCT01129557|75824840|FG002|COMPLETED|Overall Study||10||
59705577|NCT01129557|75824838|FG000|NOT COMPLETED|Overall Study||4||
59705578|NCT01129557|75824839|FG001|NOT COMPLETED|Overall Study||5||
59705579|NCT01129557|75824840|FG002|NOT COMPLETED|Overall Study||4||
59705580|NCT01129011|75824861|FG000|STARTED|Overall Study|Safety, Intent-to-Treat population|210||
59705581|NCT01129011|75824862|FG001|STARTED|Overall Study|Safety, Intent-to-Treat population|210||
59705582|NCT01129011|75824861|FG000|COMPLETED|Overall Study||151||
59705583|NCT01129011|75824862|FG001|COMPLETED|Overall Study||153||
59705584|NCT01129011|75824861|FG000|NOT COMPLETED|Overall Study||59||
59705585|NCT01129011|75824862|FG001|NOT COMPLETED|Overall Study||57||
59705586|NCT00919867|75824874|FG000|STARTED|First Intervention||7||
59705587|NCT00919867|75824875|FG001|STARTED|First Intervention||7||
59705588|NCT00919867|75824876|FG002|STARTED|First Intervention||7||
59705589|NCT00919867|75824877|FG003|STARTED|First Intervention||7||
59705590|NCT00919867|75824878|FG004|STARTED|First Intervention||7||
59705591|NCT00919867|75824879|FG005|STARTED|First Intervention||7||
59705592|NCT00919867|75824874|FG000|COMPLETED|First Intervention||7||
59816279|NCT00527618|75938674|FG000|NOT COMPLETED|Week 1-12 (First Intervention)||3||
59816280|NCT00527618|75938675|FG001|NOT COMPLETED|Week 1-12 (First Intervention)||2||
59705593|NCT00919867|75824875|FG001|COMPLETED|First Intervention||7||
59705594|NCT00919867|75824876|FG002|COMPLETED|First Intervention||6||
59705595|NCT00919867|75824877|FG003|COMPLETED|First Intervention||7||
59705596|NCT00919867|75824878|FG004|COMPLETED|First Intervention||7||
59705597|NCT00919867|75824879|FG005|COMPLETED|First Intervention||6||
59705598|NCT00919867|75824874|FG000|NOT COMPLETED|First Intervention||0||
59705599|NCT00919867|75824875|FG001|NOT COMPLETED|First Intervention||0||
59990986|NCT02487446|76106536|FG001|STARTED|Period 1||179||
59990987|NCT02487446|76106535|FG000|COMPLETED|Period 1||165||
59990988|NCT02487446|76106536|FG001|COMPLETED|Period 1||171||
59990989|NCT02487446|76106535|FG000|NOT COMPLETED|Period 1||13||
60079973|NCT05439421|76195114|FG001|STARTED|Premium Shisha Tobacco||743||
60079974|NCT05439421|76195113|FG000|COMPLETED|Premium Shisha Tobacco||764||
60079975|NCT05439421|76195114|FG001|COMPLETED|Premium Shisha Tobacco||743||
60079976|NCT05439421|76195113|FG000|NOT COMPLETED|Premium Shisha Tobacco||0||
60079977|NCT05439421|76195114|FG001|NOT COMPLETED|Premium Shisha Tobacco||0||
60079978|NCT05439421|76195113|FG000|STARTED|High Quality Shisha Tobacco||743||
60079979|NCT05439421|76195114|FG001|STARTED|High Quality Shisha Tobacco||764||
60079980|NCT05439421|76195113|FG000|COMPLETED|High Quality Shisha Tobacco||743||
60079981|NCT05439421|76195114|FG001|COMPLETED|High Quality Shisha Tobacco||764||
60079982|NCT05439421|76195113|FG000|NOT COMPLETED|High Quality Shisha Tobacco||0||
60079983|NCT05439421|76195114|FG001|NOT COMPLETED|High Quality Shisha Tobacco||0||
60079984|NCT05439421|76195113|FG000|STARTED|Don't Blow Smoke - Blow Clouds||746||
60079985|NCT05439421|76195114|FG001|STARTED|Don't Blow Smoke - Blow Clouds||761||
60079986|NCT05439421|76195113|FG000|COMPLETED|Don't Blow Smoke - Blow Clouds||746||
60079987|NCT05439421|76195114|FG001|COMPLETED|Don't Blow Smoke - Blow Clouds||761||
60079988|NCT05439421|76195113|FG000|NOT COMPLETED|Don't Blow Smoke - Blow Clouds||0||
60079989|NCT05439421|76195114|FG001|NOT COMPLETED|Don't Blow Smoke - Blow Clouds||0||
60079990|NCT05439421|76195113|FG000|STARTED|Contains Natural, Unwashed Tobacco Leaf||731||
60079991|NCT05439421|76195114|FG001|STARTED|Contains Natural, Unwashed Tobacco Leaf||776||
59705600|NCT00919867|75824876|FG002|NOT COMPLETED|First Intervention||1||
59705601|NCT00919867|75824877|FG003|NOT COMPLETED|First Intervention||0||
59990990|NCT02487446|76106536|FG001|NOT COMPLETED|Period 1||8||
59990991|NCT02487446|76106535|FG000|STARTED|Washout||165||
59990992|NCT02487446|76106536|FG001|STARTED|Washout||171||
59990993|NCT02487446|76106535|FG000|COMPLETED|Washout||162||
59990994|NCT02487446|76106536|FG001|COMPLETED|Washout||163||
60079992|NCT05439421|76195113|FG000|COMPLETED|Contains Natural, Unwashed Tobacco Leaf||731||
60079993|NCT05439421|76195114|FG001|COMPLETED|Contains Natural, Unwashed Tobacco Leaf||776||
60079994|NCT05439421|76195113|FG000|NOT COMPLETED|Contains Natural, Unwashed Tobacco Leaf||0||
60079995|NCT05439421|76195114|FG001|NOT COMPLETED|Contains Natural, Unwashed Tobacco Leaf||0||
59705602|NCT00919867|75824878|FG004|NOT COMPLETED|First Intervention||0||
59705603|NCT00919867|75824879|FG005|NOT COMPLETED|First Intervention||1||
59705604|NCT00919867|75824874|FG000|STARTED|Washout||7||
59990995|NCT02487446|76106535|FG000|NOT COMPLETED|Washout||3||
59990996|NCT02487446|76106536|FG001|NOT COMPLETED|Washout||8||
60079996|NCT05439421|76195113|FG000|STARTED|We Only Use FDA Approved Ingredients||706||
59705605|NCT00919867|75824875|FG001|STARTED|Washout||7||
59705606|NCT00919867|75824876|FG002|STARTED|Washout||6||
59705607|NCT00919867|75824877|FG003|STARTED|Washout||7||
59705608|NCT00919867|75824878|FG004|STARTED|Washout||7||
59990997|NCT02487446|76106535|FG000|STARTED|Period 2||162||
59990998|NCT02487446|76106536|FG001|STARTED|Period 2||163||
59990999|NCT02487446|76106535|FG000|COMPLETED|Period 2||154||
59991000|NCT02487446|76106536|FG001|COMPLETED|Period 2||158||
59991001|NCT02487446|76106535|FG000|NOT COMPLETED|Period 2||8||
59705609|NCT00919867|75824879|FG005|STARTED|Washout||6||
59705610|NCT00919867|75824874|FG000|COMPLETED|Washout||7||
59705611|NCT00919867|75824875|FG001|COMPLETED|Washout||7||
59705612|NCT00919867|75824876|FG002|COMPLETED|Washout||6||
59705613|NCT00919867|75824877|FG003|COMPLETED|Washout||7||
59705614|NCT00919867|75824878|FG004|COMPLETED|Washout||7||
59705615|NCT00919867|75824879|FG005|COMPLETED|Washout||6||
59705616|NCT00919867|75824874|FG000|NOT COMPLETED|Washout||0||
59705617|NCT00919867|75824875|FG001|NOT COMPLETED|Washout||0||
59705618|NCT00919867|75824876|FG002|NOT COMPLETED|Washout||0||
59705619|NCT00919867|75824877|FG003|NOT COMPLETED|Washout||0||
59705620|NCT00919867|75824878|FG004|NOT COMPLETED|Washout||0||
59705621|NCT00919867|75824879|FG005|NOT COMPLETED|Washout||0||
59705622|NCT00919867|75824874|FG000|STARTED|Second Intervention||7||
59705623|NCT00919867|75824875|FG001|STARTED|Second Intervention||7||
59705624|NCT00919867|75824876|FG002|STARTED|Second Intervention||6||
59705625|NCT00919867|75824877|FG003|STARTED|Second Intervention||7||
59705626|NCT00919867|75824878|FG004|STARTED|Second Intervention||7||
59705627|NCT00919867|75824879|FG005|STARTED|Second Intervention||6||
59705628|NCT00919867|75824874|FG000|COMPLETED|Second Intervention||7||
59705629|NCT00919867|75824875|FG001|COMPLETED|Second Intervention||7||
59705630|NCT00919867|75824876|FG002|COMPLETED|Second Intervention||6||
59705631|NCT00919867|75824877|FG003|COMPLETED|Second Intervention||7||
59705632|NCT00919867|75824878|FG004|COMPLETED|Second Intervention||7||
59705633|NCT00919867|75824879|FG005|COMPLETED|Second Intervention||6||
59705634|NCT00919867|75824874|FG000|NOT COMPLETED|Second Intervention||0||
59705635|NCT00919867|75824875|FG001|NOT COMPLETED|Second Intervention||0||
59705636|NCT00919867|75824876|FG002|NOT COMPLETED|Second Intervention||0||
59705637|NCT00919867|75824877|FG003|NOT COMPLETED|Second Intervention||0||
59705638|NCT00919867|75824878|FG004|NOT COMPLETED|Second Intervention||0||
59705639|NCT00919867|75824879|FG005|NOT COMPLETED|Second Intervention||0||
59705640|NCT00919867|75824874|FG000|STARTED|Washout||7||
59705641|NCT00919867|75824875|FG001|STARTED|Washout||7||
59705642|NCT00919867|75824876|FG002|STARTED|Washout||6||
59705643|NCT00919867|75824877|FG003|STARTED|Washout||7||
59705644|NCT00919867|75824878|FG004|STARTED|Washout||7||
59705645|NCT00919867|75824879|FG005|STARTED|Washout||6||
59705646|NCT00919867|75824874|FG000|COMPLETED|Washout||7||
59705647|NCT00919867|75824875|FG001|COMPLETED|Washout||7||
59705648|NCT00919867|75824876|FG002|COMPLETED|Washout||6||
59705649|NCT00919867|75824877|FG003|COMPLETED|Washout||7||
59705650|NCT00919867|75824878|FG004|COMPLETED|Washout||7||
59705651|NCT00919867|75824879|FG005|COMPLETED|Washout||6||
59705652|NCT00919867|75824874|FG000|NOT COMPLETED|Washout||0||
59705653|NCT00919867|75824875|FG001|NOT COMPLETED|Washout||0||
59705654|NCT00919867|75824876|FG002|NOT COMPLETED|Washout||0||
59705655|NCT00919867|75824877|FG003|NOT COMPLETED|Washout||0||
59705656|NCT00919867|75824878|FG004|NOT COMPLETED|Washout||0||
59705657|NCT00919867|75824879|FG005|NOT COMPLETED|Washout||0||
59705658|NCT00919867|75824874|FG000|STARTED|Third Intervention||7||
59705659|NCT00919867|75824875|FG001|STARTED|Third Intervention||7||
59705660|NCT00919867|75824876|FG002|STARTED|Third Intervention||6||
59705661|NCT00919867|75824877|FG003|STARTED|Third Intervention||7||
59705662|NCT00919867|75824878|FG004|STARTED|Third Intervention||7||
59705663|NCT00919867|75824879|FG005|STARTED|Third Intervention||6||
59705664|NCT00919867|75824874|FG000|COMPLETED|Third Intervention||7||
59705665|NCT00919867|75824875|FG001|COMPLETED|Third Intervention||7||
59705666|NCT00919867|75824876|FG002|COMPLETED|Third Intervention||6||
59705667|NCT00919867|75824877|FG003|COMPLETED|Third Intervention||7||
59705668|NCT00919867|75824878|FG004|COMPLETED|Third Intervention||7||
59705669|NCT00919867|75824879|FG005|COMPLETED|Third Intervention||6||
59705670|NCT00919867|75824874|FG000|NOT COMPLETED|Third Intervention||0||
59816281|NCT00527618|75938674|FG000|STARTED|Week 13-14 (Washout)||13||
59816282|NCT00527618|75938675|FG001|STARTED|Week 13-14 (Washout)||16||
59816283|NCT00527618|75938674|FG000|COMPLETED|Week 13-14 (Washout)||12||
59705671|NCT00919867|75824875|FG001|NOT COMPLETED|Third Intervention||0||
59705672|NCT00919867|75824876|FG002|NOT COMPLETED|Third Intervention||0||
59705673|NCT00919867|75824877|FG003|NOT COMPLETED|Third Intervention||0||
59705674|NCT00919867|75824878|FG004|NOT COMPLETED|Third Intervention||0||
59705675|NCT00919867|75824879|FG005|NOT COMPLETED|Third Intervention||0||
59705676|NCT01215942|75824889|FG000|STARTED|Treatment Period|Participants who discontinued treatment were followed in post-treatment follow-up.|414||
59705677|NCT01215942|75824890|FG001|STARTED|Treatment Period|Participants who discontinued treatment were followed in post-treatment follow-up.|672||
59705678|NCT01215942|75824889|FG000|COMPLETED|Treatment Period||0||
59705679|NCT01215942|75824890|FG001|COMPLETED|Treatment Period||0||
59705680|NCT01215942|75824889|FG000|NOT COMPLETED|Treatment Period||414||
59705681|NCT01215942|75824890|FG001|NOT COMPLETED|Treatment Period||672||
59705682|NCT01215942|75824889|FG000|STARTED|Post-Treatment Follow-Up Period|Not all participants who discontinued treatment entered post-treatment follow-up period.|368||
59816284|NCT00527618|75938675|FG001|COMPLETED|Week 13-14 (Washout)||16||
59816285|NCT00527618|75938674|FG000|NOT COMPLETED|Week 13-14 (Washout)||1||
59705683|NCT01215942|75824890|FG001|STARTED|Post-Treatment Follow-Up Period|Not all participants who discontinued treatment entered post-treatment follow-up period.|591||
59705684|NCT01215942|75824889|FG000|COMPLETED|Post-Treatment Follow-Up Period||283||
59991002|NCT02487446|76106536|FG001|NOT COMPLETED|Period 2||5||
59705685|NCT01215942|75824890|FG001|COMPLETED|Post-Treatment Follow-Up Period||445||
59705686|NCT01215942|75824889|FG000|NOT COMPLETED|Post-Treatment Follow-Up Period||85||
59705687|NCT01215942|75824890|FG001|NOT COMPLETED|Post-Treatment Follow-Up Period||146||
59705688|NCT01128621|75824909|FG000|STARTED|Part A: GSK1292263 300 mg||6||
59705689|NCT01128621|75824910|FG001|STARTED|Part A: GSK1292263 300 mg||0||
59705690|NCT01128621|75824909|FG000|COMPLETED|Part A: GSK1292263 300 mg||6||
59705691|NCT01128621|75824910|FG001|COMPLETED|Part A: GSK1292263 300 mg||0||
59705692|NCT01128621|75824909|FG000|NOT COMPLETED|Part A: GSK1292263 300 mg||0||
59705693|NCT01128621|75824910|FG001|NOT COMPLETED|Part A: GSK1292263 300 mg||0||
59705694|NCT01128621|75824909|FG000|STARTED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||0||
59705695|NCT01128621|75824910|FG001|STARTED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||67||
59705696|NCT01128621|75824909|FG000|COMPLETED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||0||
59705697|NCT01128621|75824910|FG001|COMPLETED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||65||
59705698|NCT01128621|75824909|FG000|NOT COMPLETED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||0||
59705699|NCT01128621|75824910|FG001|NOT COMPLETED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||2||
59705700|NCT00918463|75824932|FG000|STARTED|Overall Study||2||
59705701|NCT00918463|75824932|FG000|COMPLETED|Overall Study||0||
59705702|NCT00918463|75824932|FG000|NOT COMPLETED|Overall Study||2||
59705703|NCT01128543|75824936|FG000|STARTED|Overall Study||29||
59705704|NCT01128543|75824936|FG000|COMPLETED|Overall Study||25||
59705705|NCT01128543|75824936|FG000|NOT COMPLETED|Overall Study||4||
59705706|NCT01128387|75824942|FG000|STARTED|Overall Study||5||
59705707|NCT01128387|75824943|FG001|STARTED|Overall Study||6||
59705708|NCT01128387|75824942|FG000|COMPLETED|Overall Study||5||
59705709|NCT01128387|75824943|FG001|COMPLETED|Overall Study||5||
59705710|NCT01128387|75824942|FG000|NOT COMPLETED|Overall Study||0||
59705711|NCT01128387|75824943|FG001|NOT COMPLETED|Overall Study||1||
59705712|NCT01214850|75824952|FG000|STARTED|Overall Study||979||
59705713|NCT01214850|75824953|FG001|STARTED|Overall Study||988||
59705714|NCT01214850|75824954|FG002|STARTED|Overall Study||987||
59705715|NCT01214850|75824952|FG000|COMPLETED|Overall Study||796||
59705716|NCT01214850|75824953|FG001|COMPLETED|Overall Study||844||
59705717|NCT01214850|75824954|FG002|COMPLETED|Overall Study||826||
59705718|NCT01214850|75824952|FG000|NOT COMPLETED|Overall Study||183||
59705719|NCT01214850|75824953|FG001|NOT COMPLETED|Overall Study||144||
59705720|NCT01214850|75824954|FG002|NOT COMPLETED|Overall Study||161||
59705721|NCT01128153|75824967|FG000|STARTED|Overall Study|Randomised|129||
59705722|NCT01128153|75824968|FG001|STARTED|Overall Study|Randomised|128||
59705723|NCT01128153|75824967|FG000|Full Analysis Set|Overall Study|Received at least 1 dose of investigational product during 24 week blinded period|127||
59705724|NCT01128153|75824968|FG001|Full Analysis Set|Overall Study|Received at least 1 dose of investigational product during 24 week blinded period|128||
59705725|NCT01128153|75824967|FG000|COMPLETED|Overall Study|Completed 24 weeks|113||
59705726|NCT01128153|75824968|FG001|COMPLETED|Overall Study|Completed 24 weeks|113||
59705727|NCT01128153|75824967|FG000|NOT COMPLETED|Overall Study||16||
59705728|NCT01128153|75824968|FG001|NOT COMPLETED|Overall Study||15||
59705729|NCT00925015|75824977|FG000|STARTED|Overall Study||8||
59705730|NCT00925015|75824978|FG001|STARTED|Overall Study||6||
59705731|NCT00925015|75824979|FG002|STARTED|Overall Study||6||
59705732|NCT00925015|75824977|FG000|COMPLETED|Overall Study||0||
59705733|NCT00925015|75824978|FG001|COMPLETED|Overall Study||0||
59705734|NCT00925015|75824979|FG002|COMPLETED|Overall Study||0||
59705735|NCT00925015|75824977|FG000|NOT COMPLETED|Overall Study||8||
59705736|NCT00925015|75824978|FG001|NOT COMPLETED|Overall Study||6||
59705737|NCT00925015|75824979|FG002|NOT COMPLETED|Overall Study||6||
59705738|NCT01127763|75824991|FG000|STARTED|Overall Study||25||
59705739|NCT01127763|75824991|FG000|COMPLETED|Overall Study|Patients off study due to disease progression were considered to have completed the study.|20||
59705740|NCT01127763|75824991|FG000|NOT COMPLETED|Overall Study||5||
59705741|NCT01127607|75825001|FG000|STARTED|Phase I (Within Subjects)||14||
59705742|NCT01127607|75825002|FG001|STARTED|Phase I (Within Subjects)||13||
59705743|NCT01127607|75825001|FG000|COMPLETED|Phase I (Within Subjects)||14||
59705744|NCT01127607|75825002|FG001|COMPLETED|Phase I (Within Subjects)||13||
59705745|NCT01127607|75825001|FG000|NOT COMPLETED|Phase I (Within Subjects)||0||
59705746|NCT01127607|75825002|FG001|NOT COMPLETED|Phase I (Within Subjects)||0||
59705747|NCT01127607|75825001|FG000|STARTED|Phase II (Between Subjects)||14||
59705748|NCT01127607|75825002|FG001|STARTED|Phase II (Between Subjects)||13||
59705749|NCT01127607|75825001|FG000|COMPLETED|Phase II (Between Subjects)||13||
59705750|NCT01127607|75825002|FG001|COMPLETED|Phase II (Between Subjects)||11||
59705751|NCT01127607|75825001|FG000|NOT COMPLETED|Phase II (Between Subjects)||1||
59705752|NCT01127607|75825002|FG001|NOT COMPLETED|Phase II (Between Subjects)||2||
59705753|NCT00924781|75825029|FG000|STARTED|Overall Study||20||
59705754|NCT00924781|75825030|FG001|STARTED|Overall Study||19||
59705755|NCT00924781|75825029|FG000|COMPLETED|Overall Study||8||
59705756|NCT00924781|75825030|FG001|COMPLETED|Overall Study||9||
59705757|NCT00924781|75825029|FG000|NOT COMPLETED|Overall Study||12||
59705758|NCT00924781|75825030|FG001|NOT COMPLETED|Overall Study||10||
59705759|NCT01127451|75825048|FG000|STARTED|Overall Study||43||
59705760|NCT01127451|75825049|FG001|STARTED|Overall Study||32||
59705761|NCT01127451|75825048|FG000|Safety Analysis Set|Overall Study||43||
59705762|NCT01127451|75825049|FG001|Safety Analysis Set|Overall Study||32||
59705763|NCT01127451|75825048|FG000|Modified Intent-to-Treat (MITT)|Overall Study||42||
59705764|NCT01127451|75825049|FG001|Modified Intent-to-Treat (MITT)|Overall Study||32||
59705765|NCT01127451|75825048|FG000|COMPLETED|Overall Study||0||
59705766|NCT01127451|75825049|FG001|COMPLETED|Overall Study||0||
59705767|NCT01127451|75825048|FG000|NOT COMPLETED|Overall Study||43||
59705768|NCT01127451|75825049|FG001|NOT COMPLETED|Overall Study||32||
59705769|NCT01127373|75825055|FG000|STARTED|Overall Study||116||
59705770|NCT01127373|75825055|FG000|COMPLETED|Overall Study||104||
59705771|NCT01127373|75825055|FG000|NOT COMPLETED|Overall Study||12||
59705772|NCT01127139|75825059|FG000|STARTED|Overall Study||3828||
59705773|NCT01127139|75825059|FG000|Number of Participants Analyzed|Overall Study||3828||
59705774|NCT01127139|75825059|FG000|COMPLETED|Overall Study||3771||
59705775|NCT01127139|75825059|FG000|NOT COMPLETED|Overall Study||57||
59705776|NCT01214616|75825070|FG000|STARTED|Overall Study||3||
59705777|NCT01214616|75825071|FG001|STARTED|Overall Study||5||
59705778|NCT01214616|75825072|FG002|STARTED|Overall Study||3||
59705779|NCT01214616|75825073|FG003|STARTED|Overall Study|Cohort 3 with afatinib/vinorelbine modification. Skipping vinorelbine allowed and not considered DLT|6||
59705780|NCT01214616|75825070|FG000|COMPLETED|Overall Study||0||
59705781|NCT01214616|75825071|FG001|COMPLETED|Overall Study||0||
59705782|NCT01214616|75825072|FG002|COMPLETED|Overall Study||0||
59705783|NCT01214616|75825073|FG003|COMPLETED|Overall Study||0||
59705784|NCT01214616|75825070|FG000|NOT COMPLETED|Overall Study||3||
59705785|NCT01214616|75825071|FG001|NOT COMPLETED|Overall Study||5||
59705786|NCT01214616|75825072|FG002|NOT COMPLETED|Overall Study||3||
59705787|NCT01214616|75825073|FG003|NOT COMPLETED|Overall Study||6||
59705788|NCT01213836|75825093|FG000|STARTED|Period 1, First Intervention||34||
59705789|NCT01213836|75825094|FG001|STARTED|Period 1, First Intervention||32||
59705790|NCT01213836|75825093|FG000|COMPLETED|Period 1, First Intervention||31||
59705791|NCT01213836|75825094|FG001|COMPLETED|Period 1, First Intervention||29||
59705792|NCT01213836|75825093|FG000|NOT COMPLETED|Period 1, First Intervention||3||
59705793|NCT01213836|75825094|FG001|NOT COMPLETED|Period 1, First Intervention||3||
59705794|NCT01213836|75825093|FG000|STARTED|Period 2, Second Intervention||31||
59705795|NCT01213836|75825094|FG001|STARTED|Period 2, Second Intervention||29||
59705796|NCT01213836|75825093|FG000|COMPLETED|Period 2, Second Intervention||31||
59705797|NCT01213836|75825094|FG001|COMPLETED|Period 2, Second Intervention||29||
59705798|NCT01213836|75825093|FG000|NOT COMPLETED|Period 2, Second Intervention||0||
59705799|NCT01213836|75825094|FG001|NOT COMPLETED|Period 2, Second Intervention||0||
59705800|NCT01127061|75825105|FG000|STARTED|Overall Study||67||
59705801|NCT01127061|75825106|FG001|STARTED|Overall Study||69||
59705802|NCT01127061|75825105|FG000|COMPLETED|Overall Study||57||
59705803|NCT01127061|75825106|FG001|COMPLETED|Overall Study||56||
59705804|NCT01127061|75825105|FG000|NOT COMPLETED|Overall Study||10||
59705805|NCT01127061|75825106|FG001|NOT COMPLETED|Overall Study||13||
59705806|NCT00924703|75825112|FG000|STARTED|Overall Study||68||
59705807|NCT00924703|75825112|FG000|COMPLETED|Overall Study||46||
59705808|NCT00924703|75825112|FG000|NOT COMPLETED|Overall Study||22||
59705809|NCT01213524|75825118|FG000|STARTED|Baseline|Total number who signed informed consent.|75||
59705810|NCT01213524|75825118|FG000|COMPLETED|Baseline|Number of participants who continued in the study past baseline|68||
59705811|NCT01213524|75825118|FG000|NOT COMPLETED|Baseline||7||
59705812|NCT01213524|75825118|FG000|STARTED|Session 2||68||
59705813|NCT01213524|75825118|FG000|COMPLETED|Session 2|Number who continued in the study to the next session|63||
59705814|NCT01213524|75825118|FG000|NOT COMPLETED|Session 2||5||
59705815|NCT01213524|75825118|FG000|STARTED|Session 3||63||
59705816|NCT01213524|75825118|FG000|COMPLETED|Session 3|Number who continued in study to next session|59||
59705817|NCT01213524|75825118|FG000|NOT COMPLETED|Session 3||4||
59705818|NCT01213524|75825118|FG000|STARTED|Session 4||59||
59705819|NCT01213524|75825118|FG000|COMPLETED|Session 4|Number who continued in the study to the next session|56||
59705820|NCT01213524|75825118|FG000|NOT COMPLETED|Session 4||3||
59705821|NCT01213524|75825118|FG000|STARTED|Session 5||56||
59705822|NCT01213524|75825118|FG000|COMPLETED|Session 5|Number who continued in the study to the next session|56||
59705823|NCT01213524|75825118|FG000|NOT COMPLETED|Session 5||0||
59705824|NCT01213524|75825118|FG000|STARTED|Session 6||56||
59705825|NCT01213524|75825118|FG000|COMPLETED|Session 6|Number who continued in the study to the next session|56||
59705826|NCT01213524|75825118|FG000|NOT COMPLETED|Session 6||0||
59705827|NCT01213524|75825118|FG000|STARTED|Session 7||56||
59705828|NCT01213524|75825118|FG000|COMPLETED|Session 7||56||
59705829|NCT01213524|75825118|FG000|NOT COMPLETED|Session 7||0||
59705830|NCT01212744|75825129|FG000|STARTED|Overall Study||16||
59705831|NCT01212744|75825129|FG000|COMPLETED|Overall Study||15||
59705832|NCT01212744|75825129|FG000|NOT COMPLETED|Overall Study||1||
59705833|NCT01212588|75825137|FG000|STARTED|Overall Study||10||
59705834|NCT01212588|75825138|FG001|STARTED|Overall Study||12||
59705835|NCT01212588|75825137|FG000|COMPLETED|Overall Study||9||
59705836|NCT01212588|75825138|FG001|COMPLETED|Overall Study||10||
59705837|NCT01212588|75825137|FG000|NOT COMPLETED|Overall Study||1||
59705838|NCT01212588|75825138|FG001|NOT COMPLETED|Overall Study||2||
59705839|NCT00918385|75825146|FG000|STARTED|Monotherapy||14||
59705840|NCT00918385|75825147|FG001|STARTED|Monotherapy||17||
59705841|NCT00918385|75825146|FG000|COMPLETED|Monotherapy|Completed = received treatment until first disease progression on single agent.|12||
59705842|NCT00918385|75825147|FG001|COMPLETED|Monotherapy|Completed = received treatment until first disease progression on single agent.|11||
59705843|NCT00918385|75825146|FG000|NOT COMPLETED|Monotherapy||2||
59705844|NCT00918385|75825147|FG001|NOT COMPLETED|Monotherapy||6||
59705845|NCT00918385|75825146|FG000|STARTED|Combination Nilutamide and Dasatinib||12||
59705846|NCT00918385|75825147|FG001|STARTED|Combination Nilutamide and Dasatinib||11||
59548257|NCT01138124|75647245|FG003|NOT COMPLETED|Overall Study||0||
59548258|NCT02437890|75647258|FG000|STARTED|Overall Study||62||
59548259|NCT02437890|75647259|FG001|STARTED|Overall Study||64||
59548260|NCT02437890|75647260|FG002|STARTED|Overall Study||62||
59548261|NCT02437890|75647261|FG003|STARTED|Overall Study||62||
59548262|NCT02437890|75647262|FG004|STARTED|Overall Study||62||
59705847|NCT00918385|75825146|FG000|COMPLETED|Combination Nilutamide and Dasatinib||6||
59705848|NCT00918385|75825147|FG001|COMPLETED|Combination Nilutamide and Dasatinib||3||
59705849|NCT00918385|75825146|FG000|NOT COMPLETED|Combination Nilutamide and Dasatinib||6||
59705850|NCT00918385|75825147|FG001|NOT COMPLETED|Combination Nilutamide and Dasatinib||8||
59705851|NCT01211262|75825157|FG000|STARTED|Overall Study||66||
59705852|NCT01211262|75825158|FG001|STARTED|Overall Study||18||
59705853|NCT01211262|75825157|FG000|COMPLETED|Overall Study||43||
59705854|NCT01211262|75825158|FG001|COMPLETED|Overall Study||8||
59705855|NCT01211262|75825157|FG000|NOT COMPLETED|Overall Study||23||
59705856|NCT01211262|75825158|FG001|NOT COMPLETED|Overall Study||10||
59705857|NCT01211184|75825170|FG000|STARTED|Overall Study||20||
59705858|NCT01211184|75825171|FG001|STARTED|Overall Study||20||
59705859|NCT01211184|75825172|FG002|STARTED|Overall Study||20||
59705860|NCT01211184|75825170|FG000|COMPLETED|Overall Study||20||
59705861|NCT01211184|75825171|FG001|COMPLETED|Overall Study||18||
59705862|NCT01211184|75825172|FG002|COMPLETED|Overall Study||19||
59705863|NCT01211184|75825170|FG000|NOT COMPLETED|Overall Study||0||
59705864|NCT01211184|75825171|FG001|NOT COMPLETED|Overall Study||2||
59705865|NCT01211184|75825172|FG002|NOT COMPLETED|Overall Study||1||
59705866|NCT00924469|75825185|FG000|STARTED|Overall Study||30||
59705867|NCT00924469|75825186|FG001|STARTED|Overall Study||28||
59705868|NCT00924469|75825185|FG000|COMPLETED|Overall Study||28||
59705869|NCT00924469|75825186|FG001|COMPLETED|Overall Study||26||
59705870|NCT00924469|75825185|FG000|NOT COMPLETED|Overall Study||2||
59705871|NCT00924469|75825186|FG001|NOT COMPLETED|Overall Study||2||
59705872|NCT00924313|75825192|FG000|STARTED|Overall Study||40||
59705873|NCT00924313|75825192|FG000|COMPLETED|Overall Study||39||
59705874|NCT00924313|75825192|FG000|NOT COMPLETED|Overall Study||1||
59705875|NCT01209780|75825200|FG000|STARTED|Overall Study||1042||
59705876|NCT01209780|75825201|FG001|STARTED|Overall Study||485||
59705877|NCT01209780|75825202|FG002|STARTED|Overall Study||48||
59705878|NCT01209780|75825203|FG003|STARTED|Overall Study||817||
59816286|NCT00527618|75938675|FG001|NOT COMPLETED|Week 13-14 (Washout)||0||
59816287|NCT00527618|75938674|FG000|STARTED|Week 15-18 (Second Intervention)|Valacyclovir|12||
59816288|NCT00527618|75938675|FG001|STARTED|Week 15-18 (Second Intervention)|Acyclovir|16||
59816289|NCT00527618|75938674|FG000|COMPLETED|Week 15-18 (Second Intervention)|Valacyclovir|12||
59705879|NCT01209780|75825204|FG004|STARTED|Overall Study||412||
59705880|NCT01209780|75825200|FG000|COMPLETED|Overall Study||1016||
59705881|NCT01209780|75825201|FG001|COMPLETED|Overall Study||467||
59705882|NCT01209780|75825202|FG002|COMPLETED|Overall Study||44||
59705883|NCT01209780|75825203|FG003|COMPLETED|Overall Study||807||
59705884|NCT01209780|75825204|FG004|COMPLETED|Overall Study||407||
59816290|NCT00527618|75938675|FG001|COMPLETED|Week 15-18 (Second Intervention)|Acyclovir|13||
59816291|NCT00527618|75938674|FG000|NOT COMPLETED|Week 15-18 (Second Intervention)||0||
59816292|NCT00527618|75938675|FG001|NOT COMPLETED|Week 15-18 (Second Intervention)||3||
59816293|NCT00527072|75938682|FG000|STARTED|Overall Study||215||
59816294|NCT00527072|75938682|FG000|COMPLETED|Overall Study||179||
59548263|NCT02437890|75647258|FG000|COMPLETED|Overall Study||54||
59548264|NCT02437890|75647259|FG001|COMPLETED|Overall Study||48||
59705885|NCT01209780|75825200|FG000|NOT COMPLETED|Overall Study||26||
59705886|NCT01209780|75825201|FG001|NOT COMPLETED|Overall Study||18||
59705887|NCT01209780|75825202|FG002|NOT COMPLETED|Overall Study||4||
59705888|NCT01209780|75825203|FG003|NOT COMPLETED|Overall Study||10||
59705889|NCT01209780|75825204|FG004|NOT COMPLETED|Overall Study||5||
59705890|NCT00916357|75825217|FG000|STARTED|Period 1||4||
59705891|NCT00916357|75825218|FG001|STARTED|Period 1||4||
59705892|NCT00916357|75825219|FG002|STARTED|Period 1||4||
59705893|NCT00916357|75825220|FG003|STARTED|Period 1||4||
59705894|NCT00916357|75825221|FG004|STARTED|Period 1||3||
59548265|NCT02437890|75647260|FG002|COMPLETED|Overall Study||47||
59548266|NCT02437890|75647261|FG003|COMPLETED|Overall Study||40||
59548267|NCT02437890|75647262|FG004|COMPLETED|Overall Study||46||
59548268|NCT02437890|75647258|FG000|NOT COMPLETED|Overall Study||8||
59548269|NCT02437890|75647259|FG001|NOT COMPLETED|Overall Study||16||
59548270|NCT02437890|75647260|FG002|NOT COMPLETED|Overall Study||15||
59548271|NCT02437890|75647261|FG003|NOT COMPLETED|Overall Study||22||
59548272|NCT02437890|75647262|FG004|NOT COMPLETED|Overall Study||16||
59548273|NCT02560779|75647280|FG000|STARTED|Overall Study||14||
59548274|NCT02560779|75647281|FG001|STARTED|Overall Study||13||
59548275|NCT02560779|75647280|FG000|COMPLETED|Overall Study||14||
59548276|NCT02560779|75647281|FG001|COMPLETED|Overall Study||13||
59548277|NCT02560779|75647280|FG000|NOT COMPLETED|Overall Study||0||
59548278|NCT02560779|75647281|FG001|NOT COMPLETED|Overall Study||0||
59548279|NCT01138514|75647290|FG000|STARTED|Overall Study||522||
59548280|NCT01138514|75647291|FG001|STARTED|Overall Study||516||
59548281|NCT01138514|75647292|FG002|STARTED|Overall Study||517||
59548282|NCT01138514|75647290|FG000|COMPLETED|Overall Study||474||
59548283|NCT01138514|75647291|FG001|COMPLETED|Overall Study||463||
59548284|NCT01138514|75647292|FG002|COMPLETED|Overall Study||424||
59548285|NCT01138514|75647290|FG000|NOT COMPLETED|Overall Study||48||
59548286|NCT01138514|75647291|FG001|NOT COMPLETED|Overall Study||53||
59548287|NCT01138514|75647292|FG002|NOT COMPLETED|Overall Study||93||
59548288|NCT02561481|75647303|FG000|STARTED|Pilot Trial||10|Pilot study|
59548289|NCT02561481|75647304|FG001|STARTED|Pilot Trial||0|Pilot study|
59548290|NCT02561481|75647303|FG000|COMPLETED|Pilot Trial||10||
59548291|NCT02561481|75647304|FG001|COMPLETED|Pilot Trial||0||
59548292|NCT02561481|75647303|FG000|NOT COMPLETED|Pilot Trial||0||
59548293|NCT02561481|75647304|FG001|NOT COMPLETED|Pilot Trial||0||
59548294|NCT02561481|75647303|FG000|STARTED|Main Trial - Double Blind Phase||25||
59548295|NCT02561481|75647304|FG001|STARTED|Main Trial - Double Blind Phase||25||
59548296|NCT02561481|75647303|FG000|COMPLETED|Main Trial - Double Blind Phase||22||
59548297|NCT02561481|75647304|FG001|COMPLETED|Main Trial - Double Blind Phase||23||
59548298|NCT02561481|75647303|FG000|NOT COMPLETED|Main Trial - Double Blind Phase||3||
59548299|NCT02561481|75647304|FG001|NOT COMPLETED|Main Trial - Double Blind Phase||2||
59548300|NCT02561481|75647303|FG000|STARTED|Main Trial - Open Label Phase||45||
59548301|NCT02561481|75647304|FG001|STARTED|Main Trial - Open Label Phase||0||
59548302|NCT02561481|75647303|FG000|COMPLETED|Main Trial - Open Label Phase||32||
59548303|NCT02561481|75647304|FG001|COMPLETED|Main Trial - Open Label Phase||0||
59548304|NCT02561481|75647303|FG000|NOT COMPLETED|Main Trial - Open Label Phase||13||
59548305|NCT02561481|75647304|FG001|NOT COMPLETED|Main Trial - Open Label Phase||0||
59548306|NCT01173848|75647315|FG000|STARTED|Overall Study||8||
59548307|NCT01173848|75647316|FG001|STARTED|Overall Study||11||
59548308|NCT01173848|75647315|FG000|COMPLETED|Overall Study||4||
59548309|NCT01173848|75647316|FG001|COMPLETED|Overall Study||3||
59548310|NCT01173848|75647315|FG000|NOT COMPLETED|Overall Study||4||
59548311|NCT01173848|75647316|FG001|NOT COMPLETED|Overall Study||8||
59548312|NCT02384538|75647323|FG000|STARTED|Overall Study||67||
59548313|NCT02384538|75647324|FG001|STARTED|Overall Study||64||
59548314|NCT02384538|75647323|FG000|COMPLETED|Overall Study||61||
59548315|NCT02384538|75647324|FG001|COMPLETED|Overall Study||49||
59548316|NCT02384538|75647323|FG000|NOT COMPLETED|Overall Study||6||
59548317|NCT02384538|75647324|FG001|NOT COMPLETED|Overall Study||15||
59548318|NCT01174082|75647332|FG000|STARTED|Overall Study||1||
59548319|NCT01174082|75647333|FG001|STARTED|Overall Study||1||
59548320|NCT01174082|75647332|FG000|COMPLETED|Overall Study||1||
59548321|NCT01174082|75647333|FG001|COMPLETED|Overall Study||1||
59548322|NCT01174082|75647332|FG000|NOT COMPLETED|Overall Study||0||
59548323|NCT01174082|75647333|FG001|NOT COMPLETED|Overall Study||0||
59548324|NCT02566083|75647341|FG000|STARTED|Overall Study||214||
59548325|NCT02566083|75647342|FG001|STARTED|Overall Study||151||
59548326|NCT02566083|75647341|FG000|COMPLETED|Overall Study||198||
59548327|NCT02566083|75647342|FG001|COMPLETED|Overall Study||141||
59548328|NCT02566083|75647341|FG000|NOT COMPLETED|Overall Study||16||
59548329|NCT02566083|75647342|FG001|NOT COMPLETED|Overall Study||10||
59548330|NCT02410824|75647348|FG000|STARTED|First Intervention (One Week)||22||
59548331|NCT02410824|75647349|FG001|STARTED|First Intervention (One Week)||23||
59548332|NCT02410824|75647348|FG000|COMPLETED|First Intervention (One Week)||22||
59548333|NCT02410824|75647349|FG001|COMPLETED|First Intervention (One Week)||22||
59548334|NCT02410824|75647348|FG000|NOT COMPLETED|First Intervention (One Week)||0||
59548335|NCT02410824|75647349|FG001|NOT COMPLETED|First Intervention (One Week)||1||
59548336|NCT02410824|75647348|FG000|STARTED|Second Intervention (One Week)||22||
59548337|NCT02410824|75647349|FG001|STARTED|Second Intervention (One Week)||22||
59548338|NCT02410824|75647348|FG000|COMPLETED|Second Intervention (One Week)||22||
59548339|NCT02410824|75647349|FG001|COMPLETED|Second Intervention (One Week)||22||
59548340|NCT02410824|75647348|FG000|NOT COMPLETED|Second Intervention (One Week)||0||
59548341|NCT02410824|75647349|FG001|NOT COMPLETED|Second Intervention (One Week)||0||
59548342|NCT02491359|75647356|FG000|STARTED|Overall Study||20||
59548343|NCT02491359|75647356|FG000|COMPLETED|Overall Study||4||
59548344|NCT02491359|75647356|FG000|NOT COMPLETED|Overall Study||16||
59548345|NCT01175798|75647364|FG000|STARTED|Overall Study||34||
59548346|NCT01175798|75647365|FG001|STARTED|Overall Study||62||
59548347|NCT01175798|75647364|FG000|COMPLETED|Overall Study||27||
59548348|NCT01175798|75647365|FG001|COMPLETED|Overall Study||41||
59705895|NCT00916357|75825222|FG005|STARTED|Period 1||4||
59705896|NCT00916357|75825217|FG000|Received at Least 1 Dose of Study Drug|Period 1||4||
59705897|NCT00916357|75825218|FG001|Received at Least 1 Dose of Study Drug|Period 1||4||
59705898|NCT00916357|75825219|FG002|Received at Least 1 Dose of Study Drug|Period 1||4||
59705899|NCT00916357|75825220|FG003|Received at Least 1 Dose of Study Drug|Period 1||4||
59705900|NCT00916357|75825221|FG004|Received at Least 1 Dose of Study Drug|Period 1||3||
59705901|NCT00916357|75825222|FG005|Received at Least 1 Dose of Study Drug|Period 1||4||
59705902|NCT00916357|75825217|FG000|COMPLETED|Period 1||3||
59705903|NCT00916357|75825218|FG001|COMPLETED|Period 1||4||
59705904|NCT00916357|75825219|FG002|COMPLETED|Period 1||4||
59705905|NCT00916357|75825220|FG003|COMPLETED|Period 1||4||
59705906|NCT00916357|75825221|FG004|COMPLETED|Period 1||3||
59705907|NCT00916357|75825222|FG005|COMPLETED|Period 1||4||
59705908|NCT00916357|75825217|FG000|NOT COMPLETED|Period 1||1||
59705909|NCT00916357|75825218|FG001|NOT COMPLETED|Period 1||0||
59705910|NCT00916357|75825219|FG002|NOT COMPLETED|Period 1||0||
59705911|NCT00916357|75825220|FG003|NOT COMPLETED|Period 1||0||
59705912|NCT00916357|75825221|FG004|NOT COMPLETED|Period 1||0||
59705913|NCT00916357|75825222|FG005|NOT COMPLETED|Period 1||0||
59705914|NCT00916357|75825217|FG000|STARTED|Washout (3 to 14 Days)||3||
59705915|NCT00916357|75825218|FG001|STARTED|Washout (3 to 14 Days)||4||
59705916|NCT00916357|75825219|FG002|STARTED|Washout (3 to 14 Days)||4||
59705917|NCT00916357|75825220|FG003|STARTED|Washout (3 to 14 Days)||4||
59705918|NCT00916357|75825221|FG004|STARTED|Washout (3 to 14 Days)||3||
59705919|NCT00916357|75825222|FG005|STARTED|Washout (3 to 14 Days)||4||
59548349|NCT01175798|75647364|FG000|NOT COMPLETED|Overall Study||7||
59548350|NCT01175798|75647365|FG001|NOT COMPLETED|Overall Study||21||
59548351|NCT02181140|75647371|FG000|STARTED|Overall Study||56||
59548352|NCT02181140|75647371|FG000|COMPLETED|Overall Study||56||
59548353|NCT02181140|75647371|FG000|NOT COMPLETED|Overall Study||0||
59548354|NCT02384460|75647379|FG000|STARTED|Overall Study||82||
59548355|NCT02384460|75647380|FG001|STARTED|Overall Study||87||
59548356|NCT02384460|75647379|FG000|Received at Least 1 Dose of Study Drug|Overall Study||82||
59548357|NCT02384460|75647380|FG001|Received at Least 1 Dose of Study Drug|Overall Study||87||
59548358|NCT02384460|75647379|FG000|COMPLETED|Overall Study||75||
59548359|NCT02384460|75647380|FG001|COMPLETED|Overall Study||80||
59548360|NCT02384460|75647379|FG000|NOT COMPLETED|Overall Study||7||
59548361|NCT02384460|75647380|FG001|NOT COMPLETED|Overall Study||7||
59548362|NCT02184494|75647389|FG000|STARTED|Overall Study||13||
59548363|NCT02184494|75647390|FG001|STARTED|Overall Study||13||
59548364|NCT02184494|75647391|FG002|STARTED|Overall Study||8||
59548365|NCT02184494|75647389|FG000|COMPLETED|Overall Study||12||
59548366|NCT02184494|75647390|FG001|COMPLETED|Overall Study||11||
59548367|NCT02184494|75647391|FG002|COMPLETED|Overall Study||8||
59548368|NCT02184494|75647389|FG000|NOT COMPLETED|Overall Study||1||
59548369|NCT02184494|75647390|FG001|NOT COMPLETED|Overall Study||2||
59548370|NCT02184494|75647391|FG002|NOT COMPLETED|Overall Study||0||
59548371|NCT01178216|75647399|FG000|STARTED|Overall Study||41||
59548372|NCT01178216|75647399|FG000|COMPLETED|Overall Study||39||
59548373|NCT01178216|75647399|FG000|NOT COMPLETED|Overall Study||2||
59548374|NCT02384382|75647403|FG000|STARTED|Overall Study||23||
59548375|NCT02384382|75647403|FG000|COMPLETED|Overall Study||0||
59548376|NCT02384382|75647403|FG000|NOT COMPLETED|Overall Study||23||
59548377|NCT01178528|75647410|FG000|STARTED|Overall Study||41||
59548378|NCT01178528|75647411|FG001|STARTED|Overall Study||38||
59548379|NCT01178528|75647412|FG002|STARTED|Overall Study||42||
59548380|NCT01178528|75647410|FG000|COMPLETED|Overall Study||41||
59548381|NCT01178528|75647411|FG001|COMPLETED|Overall Study||38||
59548382|NCT01178528|75647412|FG002|COMPLETED|Overall Study||42||
59548383|NCT01178528|75647410|FG000|NOT COMPLETED|Overall Study||0||
59548384|NCT01178528|75647411|FG001|NOT COMPLETED|Overall Study||0||
59548385|NCT01178528|75647412|FG002|NOT COMPLETED|Overall Study||0||
59548386|NCT02437188|75647423|FG000|STARTED|Overall Study||44||
59548387|NCT02437188|75647424|FG001|STARTED|Overall Study||44||
59548388|NCT02437188|75647423|FG000|COMPLETED|Overall Study||40||
59548389|NCT02437188|75647424|FG001|COMPLETED|Overall Study||35||
59548390|NCT02437188|75647423|FG000|NOT COMPLETED|Overall Study||4||
59548391|NCT02437188|75647424|FG001|NOT COMPLETED|Overall Study||9||
59548392|NCT02491437|75647435|FG000|STARTED|Overall Study||520||
59548393|NCT02491437|75647436|FG001|STARTED|Overall Study||514||
59548394|NCT02491437|75647435|FG000|Safety Sample|Overall Study||518||
59548395|NCT02491437|75647436|FG001|Safety Sample|Overall Study||512||
59548396|NCT02491437|75647435|FG000|Full Analysis Sample|Overall Study||494||
59548397|NCT02491437|75647436|FG001|Full Analysis Sample|Overall Study||489||
59548398|NCT02491437|75647435|FG000|COMPLETED|Overall Study||168||
59548399|NCT02491437|75647436|FG001|COMPLETED|Overall Study||157||
59548400|NCT02491437|75647435|FG000|NOT COMPLETED|Overall Study||352||
59705920|NCT00916357|75825217|FG000|COMPLETED|Washout (3 to 14 Days)||3||
59705921|NCT00916357|75825218|FG001|COMPLETED|Washout (3 to 14 Days)||4||
59705922|NCT00916357|75825219|FG002|COMPLETED|Washout (3 to 14 Days)||4||
59705923|NCT00916357|75825220|FG003|COMPLETED|Washout (3 to 14 Days)||4||
59705924|NCT00916357|75825221|FG004|COMPLETED|Washout (3 to 14 Days)||3||
59705925|NCT00916357|75825222|FG005|COMPLETED|Washout (3 to 14 Days)||4||
59705926|NCT00916357|75825217|FG000|NOT COMPLETED|Washout (3 to 14 Days)||0||
59705927|NCT00916357|75825218|FG001|NOT COMPLETED|Washout (3 to 14 Days)||0||
59705928|NCT00916357|75825219|FG002|NOT COMPLETED|Washout (3 to 14 Days)||0||
59705929|NCT00916357|75825220|FG003|NOT COMPLETED|Washout (3 to 14 Days)||0||
60079997|NCT05439421|76195114|FG001|STARTED|We Only Use FDA Approved Ingredients||801||
60079998|NCT05439421|76195113|FG000|COMPLETED|We Only Use FDA Approved Ingredients||706||
60079999|NCT05439421|76195114|FG001|COMPLETED|We Only Use FDA Approved Ingredients||801||
60080000|NCT05439421|76195113|FG000|NOT COMPLETED|We Only Use FDA Approved Ingredients||0||
60080001|NCT05439421|76195114|FG001|NOT COMPLETED|We Only Use FDA Approved Ingredients||0||
59705930|NCT00916357|75825221|FG004|NOT COMPLETED|Washout (3 to 14 Days)||0||
59705931|NCT00916357|75825222|FG005|NOT COMPLETED|Washout (3 to 14 Days)||0||
59705932|NCT00916357|75825217|FG000|STARTED|Period 2||3||
59705933|NCT00916357|75825218|FG001|STARTED|Period 2||4||
59705934|NCT00916357|75825219|FG002|STARTED|Period 2||4||
59705935|NCT00916357|75825220|FG003|STARTED|Period 2||4||
59705936|NCT00916357|75825221|FG004|STARTED|Period 2||3||
59705937|NCT00916357|75825222|FG005|STARTED|Period 2||4||
59705938|NCT00916357|75825217|FG000|COMPLETED|Period 2||3||
59705939|NCT00916357|75825218|FG001|COMPLETED|Period 2||4||
59705940|NCT00916357|75825219|FG002|COMPLETED|Period 2||4||
59705941|NCT00916357|75825220|FG003|COMPLETED|Period 2||3||
59705942|NCT00916357|75825221|FG004|COMPLETED|Period 2||3||
59705943|NCT00916357|75825222|FG005|COMPLETED|Period 2||4||
59705944|NCT00916357|75825217|FG000|NOT COMPLETED|Period 2||0||
59705945|NCT00916357|75825218|FG001|NOT COMPLETED|Period 2||0||
59705946|NCT00916357|75825219|FG002|NOT COMPLETED|Period 2||0||
59705947|NCT00916357|75825220|FG003|NOT COMPLETED|Period 2||1||
59705948|NCT00916357|75825221|FG004|NOT COMPLETED|Period 2||0||
59705949|NCT00916357|75825222|FG005|NOT COMPLETED|Period 2||0||
59705950|NCT00916357|75825217|FG000|STARTED|Washout (3 to 14 Days)||3||
59705951|NCT00916357|75825218|FG001|STARTED|Washout (3 to 14 Days)||4||
59705952|NCT00916357|75825219|FG002|STARTED|Washout (3 to 14 Days)||4||
59705953|NCT00916357|75825220|FG003|STARTED|Washout (3 to 14 Days)||3||
59705954|NCT00916357|75825221|FG004|STARTED|Washout (3 to 14 Days)||3||
59705955|NCT00916357|75825222|FG005|STARTED|Washout (3 to 14 Days)||4||
59705956|NCT00916357|75825217|FG000|COMPLETED|Washout (3 to 14 Days)||3||
59705957|NCT00916357|75825218|FG001|COMPLETED|Washout (3 to 14 Days)||4||
59705958|NCT00916357|75825219|FG002|COMPLETED|Washout (3 to 14 Days)||4||
59705959|NCT00916357|75825220|FG003|COMPLETED|Washout (3 to 14 Days)||3||
59705960|NCT00916357|75825221|FG004|COMPLETED|Washout (3 to 14 Days)||3||
59705961|NCT00916357|75825222|FG005|COMPLETED|Washout (3 to 14 Days)||4||
59705962|NCT00916357|75825217|FG000|NOT COMPLETED|Washout (3 to 14 Days)||0||
59705963|NCT00916357|75825218|FG001|NOT COMPLETED|Washout (3 to 14 Days)||0||
59705964|NCT00916357|75825219|FG002|NOT COMPLETED|Washout (3 to 14 Days)||0||
59705965|NCT00916357|75825220|FG003|NOT COMPLETED|Washout (3 to 14 Days)||0||
59705966|NCT00916357|75825221|FG004|NOT COMPLETED|Washout (3 to 14 Days)||0||
59705967|NCT00916357|75825222|FG005|NOT COMPLETED|Washout (3 to 14 Days)||0||
59705968|NCT00916357|75825217|FG000|STARTED|Period 3||3||
59705969|NCT00916357|75825218|FG001|STARTED|Period 3||4||
59705970|NCT00916357|75825219|FG002|STARTED|Period 3||4||
59705971|NCT00916357|75825220|FG003|STARTED|Period 3||3||
59705972|NCT00916357|75825221|FG004|STARTED|Period 3||3||
59705973|NCT00916357|75825222|FG005|STARTED|Period 3||4||
59705974|NCT00916357|75825217|FG000|COMPLETED|Period 3||3||
60080002|NCT05439421|76195113|FG000|STARTED|H2O Cools Puirfies Tobacco Smoke||753||
59705975|NCT00916357|75825218|FG001|COMPLETED|Period 3||4||
59705976|NCT00916357|75825219|FG002|COMPLETED|Period 3||4||
59705977|NCT00916357|75825220|FG003|COMPLETED|Period 3||3||
59705978|NCT00916357|75825221|FG004|COMPLETED|Period 3||3||
59705979|NCT00916357|75825222|FG005|COMPLETED|Period 3||4||
59705980|NCT00916357|75825217|FG000|NOT COMPLETED|Period 3||0||
59705981|NCT00916357|75825218|FG001|NOT COMPLETED|Period 3||0||
59705982|NCT00916357|75825219|FG002|NOT COMPLETED|Period 3||0||
59705983|NCT00916357|75825220|FG003|NOT COMPLETED|Period 3||0||
59705984|NCT00916357|75825221|FG004|NOT COMPLETED|Period 3||0||
59705985|NCT00916357|75825222|FG005|NOT COMPLETED|Period 3||0||
59705986|NCT01209624|75825231|FG000|STARTED|Overall Study||902||
59705987|NCT01209624|75825231|FG000|Per Protocol Population|Overall Study||469||
59705988|NCT01209624|75825231|FG000|COMPLETED|Overall Study||576||
59705989|NCT01209624|75825231|FG000|NOT COMPLETED|Overall Study||326||
59705990|NCT00916279|75825235|FG000|STARTED|Overall Study||41||
59705991|NCT00916279|75825235|FG000|30 Days|Overall Study||41||
59705992|NCT00916279|75825235|FG000|6 Months|Overall Study||41||
59705993|NCT00916279|75825235|FG000|24 Months|Overall Study||37||
59705994|NCT00916279|75825235|FG000|COMPLETED|Overall Study||37||
60080003|NCT05439421|76195114|FG001|STARTED|H2O Cools Puirfies Tobacco Smoke||754||
59705995|NCT00916279|75825235|FG000|NOT COMPLETED|Overall Study||4||
59705996|NCT01209078|75825244|FG000|STARTED|Overall Study||57||
59705997|NCT01209078|75825245|FG001|STARTED|Overall Study||27||
59705998|NCT01209078|75825244|FG000|COMPLETED|Overall Study||41||
59705999|NCT01209078|75825245|FG001|COMPLETED|Overall Study||24||
59706000|NCT01209078|75825244|FG000|NOT COMPLETED|Overall Study||16||
59706001|NCT01209078|75825245|FG001|NOT COMPLETED|Overall Study||3||
59706002|NCT01207596|75825253|FG000|STARTED|Overall Study||30||
59706003|NCT01207596|75825253|FG000|COMPLETED|Overall Study||21||
59706004|NCT01207596|75825253|FG000|NOT COMPLETED|Overall Study||9||
59706005|NCT00915343|75825257|FG000|STARTED|Part A - First Intervention Period||32||
59706006|NCT00915343|75825258|FG001|STARTED|Part A - First Intervention Period||32||
59706007|NCT00915343|75825259|FG002|STARTED|Part A - First Intervention Period||0||
59706008|NCT00915343|75825257|FG000|COMPLETED|Part A - First Intervention Period||32||
59706009|NCT00915343|75825258|FG001|COMPLETED|Part A - First Intervention Period||32||
59706010|NCT00915343|75825259|FG002|COMPLETED|Part A - First Intervention Period||0||
59706011|NCT00915343|75825257|FG000|NOT COMPLETED|Part A - First Intervention Period||0||
59706012|NCT00915343|75825258|FG001|NOT COMPLETED|Part A - First Intervention Period||0||
59706013|NCT00915343|75825259|FG002|NOT COMPLETED|Part A - First Intervention Period||0||
59706014|NCT00915343|75825257|FG000|STARTED|Part A - Second Intervention Period||32||
59706015|NCT00915343|75825258|FG001|STARTED|Part A - Second Intervention Period||32||
59706016|NCT00915343|75825259|FG002|STARTED|Part A - Second Intervention Period||0||
59706017|NCT00915343|75825257|FG000|COMPLETED|Part A - Second Intervention Period||32||
59706018|NCT00915343|75825258|FG001|COMPLETED|Part A - Second Intervention Period||32||
59706019|NCT00915343|75825259|FG002|COMPLETED|Part A - Second Intervention Period||0||
59706020|NCT00915343|75825257|FG000|NOT COMPLETED|Part A - Second Intervention Period||0||
59706021|NCT00915343|75825258|FG001|NOT COMPLETED|Part A - Second Intervention Period||0||
59706022|NCT00915343|75825259|FG002|NOT COMPLETED|Part A - Second Intervention Period||0||
59706023|NCT00915343|75825257|FG000|STARTED|Part B - Open Label Period||0||
59706024|NCT00915343|75825258|FG001|STARTED|Part B - Open Label Period||0||
59706025|NCT00915343|75825259|FG002|STARTED|Part B - Open Label Period||59||
59706026|NCT00915343|75825257|FG000|COMPLETED|Part B - Open Label Period||0||
59706027|NCT00915343|75825258|FG001|COMPLETED|Part B - Open Label Period||0||
59706028|NCT00915343|75825259|FG002|COMPLETED|Part B - Open Label Period||57||
59706029|NCT00915343|75825257|FG000|NOT COMPLETED|Part B - Open Label Period||0||
59706030|NCT00915343|75825258|FG001|NOT COMPLETED|Part B - Open Label Period||0||
59706031|NCT00915343|75825259|FG002|NOT COMPLETED|Part B - Open Label Period||2||
59706032|NCT00911989|75825271|FG000|STARTED|Overall Study||4||
59706033|NCT00911989|75825271|FG000|COMPLETED|Overall Study||3||
59706034|NCT00911989|75825271|FG000|NOT COMPLETED|Overall Study||1||
59706035|NCT00910273|75825277|FG000|STARTED|Overall Study||18||
59991003|NCT02739269|76106545|FG000|STARTED|Overall Study||100||
59991004|NCT02739269|76106546|FG001|STARTED|Overall Study||100||
59991005|NCT02739269|76106545|FG000|COMPLETED|Overall Study||93||
59991006|NCT02739269|76106546|FG001|COMPLETED|Overall Study||96||
59706036|NCT00910273|75825278|FG001|STARTED|Overall Study||16||
59706037|NCT00910273|75825277|FG000|COMPLETED|Overall Study||0||
59706038|NCT00910273|75825278|FG001|COMPLETED|Overall Study||3||
59706039|NCT00910273|75825277|FG000|NOT COMPLETED|Overall Study||18||
59706040|NCT00910273|75825278|FG001|NOT COMPLETED|Overall Study||13||
59706041|NCT00910039|75825284|FG000|STARTED|Overall Study||14||
59706042|NCT00910039|75825284|FG000|COMPLETED|Overall Study||13||
59706043|NCT00910039|75825284|FG000|NOT COMPLETED|Overall Study||1||
59706044|NCT00909181|75825292|FG000|STARTED|Overall Study||210||
59706045|NCT00909181|75825293|FG001|STARTED|Overall Study||214||
59706046|NCT00909181|75825294|FG002|STARTED|Overall Study||202||
59706047|NCT00909181|75825292|FG000|COMPLETED|Overall Study||171||
59706048|NCT00909181|75825293|FG001|COMPLETED|Overall Study||196||
59706049|NCT00909181|75825294|FG002|COMPLETED|Overall Study||169||
59706050|NCT00909181|75825292|FG000|NOT COMPLETED|Overall Study||39||
59706051|NCT00909181|75825293|FG001|NOT COMPLETED|Overall Study||18||
59706052|NCT00909181|75825294|FG002|NOT COMPLETED|Overall Study||33||
59706053|NCT01286987|75825317|FG000|STARTED|Part 1: Dose Escalation||3||
59706054|NCT01286987|75825318|FG001|STARTED|Part 1: Dose Escalation||3||
59706055|NCT01286987|75825319|FG002|STARTED|Part 1: Dose Escalation||3||
59706056|NCT01286987|75825320|FG003|STARTED|Part 1: Dose Escalation||3||
59706057|NCT01286987|75825321|FG004|STARTED|Part 1: Dose Escalation||3||
59706058|NCT01286987|75825322|FG005|STARTED|Part 1: Dose Escalation||6||
59706059|NCT01286987|75825323|FG006|STARTED|Part 1: Dose Escalation||6||
59706060|NCT01286987|75825324|FG007|STARTED|Part 1: Dose Escalation||6||
59706061|NCT01286987|75825325|FG008|STARTED|Part 1: Dose Escalation||6||
59706062|NCT01286987|75825326|FG009|STARTED|Part 1: Dose Escalation||0||
59706063|NCT01286987|75825327|FG010|STARTED|Part 1: Dose Escalation||0||
59706064|NCT01286987|75825328|FG011|STARTED|Part 1: Dose Escalation||0||
59706065|NCT01286987|75825329|FG012|STARTED|Part 1: Dose Escalation||0||
59706066|NCT01286987|75825330|FG013|STARTED|Part 1: Dose Escalation||0||
59706067|NCT01286987|75825331|FG014|STARTED|Part 1: Dose Escalation||0||
59991007|NCT02739269|76106545|FG000|NOT COMPLETED|Overall Study||7||
59706068|NCT01286987|75825317|FG000|Colorectal Cancer|Part 1: Dose Escalation||1||
59706069|NCT01286987|75825318|FG001|Colorectal Cancer|Part 1: Dose Escalation||0||
59706070|NCT01286987|75825319|FG002|Colorectal Cancer|Part 1: Dose Escalation||1||
59991008|NCT02739269|76106546|FG001|NOT COMPLETED|Overall Study||4||
59706071|NCT01286987|75825320|FG003|Colorectal Cancer|Part 1: Dose Escalation||0||
59991009|NCT03318523|76106556|FG000|STARTED|PC Period: Up to Year 1||100||
59991010|NCT03318523|76106557|FG001|STARTED|PC Period: Up to Year 1||55||
59706072|NCT01286987|75825321|FG004|Colorectal Cancer|Part 1: Dose Escalation||0||
59706073|NCT01286987|75825322|FG005|Colorectal Cancer|Part 1: Dose Escalation||0||
59706074|NCT01286987|75825323|FG006|Colorectal Cancer|Part 1: Dose Escalation||0||
59706075|NCT01286987|75825324|FG007|Colorectal Cancer|Part 1: Dose Escalation||0||
59706076|NCT01286987|75825325|FG008|Colorectal Cancer|Part 1: Dose Escalation||0||
59706077|NCT01286987|75825326|FG009|Colorectal Cancer|Part 1: Dose Escalation||0||
59706078|NCT01286987|75825327|FG010|Colorectal Cancer|Part 1: Dose Escalation||0||
59706079|NCT01286987|75825328|FG011|Colorectal Cancer|Part 1: Dose Escalation||0||
59706080|NCT01286987|75825329|FG012|Colorectal Cancer|Part 1: Dose Escalation||0||
59706081|NCT01286987|75825330|FG013|Colorectal Cancer|Part 1: Dose Escalation||0||
59706082|NCT01286987|75825331|FG014|Colorectal Cancer|Part 1: Dose Escalation||0||
59706083|NCT01286987|75825317|FG000|Prostate Cancer|Part 1: Dose Escalation||0||
59706084|NCT01286987|75825318|FG001|Prostate Cancer|Part 1: Dose Escalation||0||
59706085|NCT01286987|75825319|FG002|Prostate Cancer|Part 1: Dose Escalation||0||
59706086|NCT01286987|75825320|FG003|Prostate Cancer|Part 1: Dose Escalation||0||
59706087|NCT01286987|75825321|FG004|Prostate Cancer|Part 1: Dose Escalation||0||
59706088|NCT01286987|75825322|FG005|Prostate Cancer|Part 1: Dose Escalation||1||
59706089|NCT01286987|75825323|FG006|Prostate Cancer|Part 1: Dose Escalation||0||
59706090|NCT01286987|75825324|FG007|Prostate Cancer|Part 1: Dose Escalation||0||
59706091|NCT01286987|75825325|FG008|Prostate Cancer|Part 1: Dose Escalation||0||
59706092|NCT01286987|75825326|FG009|Prostate Cancer|Part 1: Dose Escalation||0||
59706093|NCT01286987|75825327|FG010|Prostate Cancer|Part 1: Dose Escalation||0||
59706094|NCT01286987|75825328|FG011|Prostate Cancer|Part 1: Dose Escalation||0||
59706095|NCT01286987|75825329|FG012|Prostate Cancer|Part 1: Dose Escalation||0||
59706096|NCT01286987|75825330|FG013|Prostate Cancer|Part 1: Dose Escalation||0||
59706097|NCT01286987|75825331|FG014|Prostate Cancer|Part 1: Dose Escalation||0||
59706098|NCT01286987|75825317|FG000|Ewing Cancer|Part 1: Dose Escalation||0||
59706099|NCT01286987|75825318|FG001|Ewing Cancer|Part 1: Dose Escalation||0||
59706100|NCT01286987|75825319|FG002|Ewing Cancer|Part 1: Dose Escalation||0||
59706101|NCT01286987|75825320|FG003|Ewing Cancer|Part 1: Dose Escalation||0||
59706102|NCT01286987|75825321|FG004|Ewing Cancer|Part 1: Dose Escalation||0||
59706103|NCT01286987|75825322|FG005|Ewing Cancer|Part 1: Dose Escalation||0||
59706104|NCT01286987|75825323|FG006|Ewing Cancer|Part 1: Dose Escalation||0||
59706105|NCT01286987|75825324|FG007|Ewing Cancer|Part 1: Dose Escalation||1||
59706106|NCT01286987|75825325|FG008|Ewing Cancer|Part 1: Dose Escalation||1||
59706107|NCT01286987|75825326|FG009|Ewing Cancer|Part 1: Dose Escalation||0||
59706108|NCT01286987|75825327|FG010|Ewing Cancer|Part 1: Dose Escalation||0||
59706109|NCT01286987|75825328|FG011|Ewing Cancer|Part 1: Dose Escalation||0||
59706110|NCT01286987|75825329|FG012|Ewing Cancer|Part 1: Dose Escalation||0||
59706111|NCT01286987|75825330|FG013|Ewing Cancer|Part 1: Dose Escalation||0||
59706112|NCT01286987|75825331|FG014|Ewing Cancer|Part 1: Dose Escalation||0||
59706113|NCT01286987|75825317|FG000|Pancreatic Cancer|Part 1: Dose Escalation||1||
59706114|NCT01286987|75825318|FG001|Pancreatic Cancer|Part 1: Dose Escalation||2||
59706115|NCT01286987|75825319|FG002|Pancreatic Cancer|Part 1: Dose Escalation||0||
59706116|NCT01286987|75825320|FG003|Pancreatic Cancer|Part 1: Dose Escalation||0||
59706117|NCT01286987|75825321|FG004|Pancreatic Cancer|Part 1: Dose Escalation||0||
59706118|NCT01286987|75825322|FG005|Pancreatic Cancer|Part 1: Dose Escalation||0||
59706119|NCT01286987|75825323|FG006|Pancreatic Cancer|Part 1: Dose Escalation||0||
59706120|NCT01286987|75825324|FG007|Pancreatic Cancer|Part 1: Dose Escalation||0||
59706121|NCT01286987|75825325|FG008|Pancreatic Cancer|Part 1: Dose Escalation||0||
59706122|NCT01286987|75825326|FG009|Pancreatic Cancer|Part 1: Dose Escalation||0||
59706123|NCT01286987|75825327|FG010|Pancreatic Cancer|Part 1: Dose Escalation||0||
59706124|NCT01286987|75825328|FG011|Pancreatic Cancer|Part 1: Dose Escalation||0||
59706125|NCT01286987|75825329|FG012|Pancreatic Cancer|Part 1: Dose Escalation||0||
59706126|NCT01286987|75825330|FG013|Pancreatic Cancer|Part 1: Dose Escalation||0||
59706127|NCT01286987|75825331|FG014|Pancreatic Cancer|Part 1: Dose Escalation||0||
59816295|NCT00527072|75938682|FG000|NOT COMPLETED|Overall Study||36||
59816296|NCT00526994|75938690|FG000|STARTED|Overall Study||909||
59706128|NCT01286987|75825317|FG000|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||1||
59706129|NCT01286987|75825318|FG001|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||1||
59706130|NCT01286987|75825319|FG002|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||2||
59706131|NCT01286987|75825320|FG003|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||3||
59706132|NCT01286987|75825321|FG004|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||3||
59706133|NCT01286987|75825322|FG005|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||4||
59706134|NCT01286987|75825323|FG006|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||4||
59706135|NCT01286987|75825324|FG007|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||3||
59706136|NCT01286987|75825325|FG008|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||2||
59706137|NCT01286987|75825326|FG009|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||0||
59706138|NCT01286987|75825327|FG010|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||0||
59706139|NCT01286987|75825328|FG011|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||0||
59706140|NCT01286987|75825329|FG012|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||0||
59816297|NCT00526994|75938691|FG001|STARTED|Overall Study||893||
59816298|NCT00526994|75938692|FG002|STARTED|Overall Study||898||
59816299|NCT00526994|75938690|FG000|COMPLETED|Overall Study||801||
59706141|NCT01286987|75825330|FG013|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||0||
59706142|NCT01286987|75825331|FG014|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||0||
59706143|NCT01286987|75825317|FG000|Breast Cancer|Part 1: Dose Escalation||0||
59706144|NCT01286987|75825318|FG001|Breast Cancer|Part 1: Dose Escalation||0||
59706145|NCT01286987|75825319|FG002|Breast Cancer|Part 1: Dose Escalation||0||
59706146|NCT01286987|75825320|FG003|Breast Cancer|Part 1: Dose Escalation||0||
59706147|NCT01286987|75825321|FG004|Breast Cancer|Part 1: Dose Escalation||0||
59706148|NCT01286987|75825322|FG005|Breast Cancer|Part 1: Dose Escalation||1||
59706149|NCT01286987|75825323|FG006|Breast Cancer|Part 1: Dose Escalation||2||
59706150|NCT01286987|75825324|FG007|Breast Cancer|Part 1: Dose Escalation||2||
59706151|NCT01286987|75825325|FG008|Breast Cancer|Part 1: Dose Escalation||3||
59706152|NCT01286987|75825326|FG009|Breast Cancer|Part 1: Dose Escalation||0||
59706153|NCT01286987|75825327|FG010|Breast Cancer|Part 1: Dose Escalation||0||
59706154|NCT01286987|75825328|FG011|Breast Cancer|Part 1: Dose Escalation||0||
59706155|NCT01286987|75825329|FG012|Breast Cancer|Part 1: Dose Escalation||0||
59706156|NCT01286987|75825330|FG013|Breast Cancer|Part 1: Dose Escalation||0||
59706157|NCT01286987|75825331|FG014|Breast Cancer|Part 1: Dose Escalation||0||
59706158|NCT01286987|75825317|FG000|COMPLETED|Part 1: Dose Escalation||0||
59706159|NCT01286987|75825318|FG001|COMPLETED|Part 1: Dose Escalation||0||
59706160|NCT01286987|75825319|FG002|COMPLETED|Part 1: Dose Escalation||0||
59706161|NCT01286987|75825320|FG003|COMPLETED|Part 1: Dose Escalation||0||
59706162|NCT01286987|75825321|FG004|COMPLETED|Part 1: Dose Escalation||0||
59706163|NCT01286987|75825322|FG005|COMPLETED|Part 1: Dose Escalation||0||
59706164|NCT01286987|75825323|FG006|COMPLETED|Part 1: Dose Escalation||1||
59706165|NCT01286987|75825324|FG007|COMPLETED|Part 1: Dose Escalation||1||
59706166|NCT01286987|75825325|FG008|COMPLETED|Part 1: Dose Escalation||0||
59706167|NCT01286987|75825326|FG009|COMPLETED|Part 1: Dose Escalation||0||
59706168|NCT01286987|75825327|FG010|COMPLETED|Part 1: Dose Escalation||0||
59706169|NCT01286987|75825328|FG011|COMPLETED|Part 1: Dose Escalation||0||
59706170|NCT01286987|75825329|FG012|COMPLETED|Part 1: Dose Escalation||0||
59706171|NCT01286987|75825330|FG013|COMPLETED|Part 1: Dose Escalation||0||
59706172|NCT01286987|75825331|FG014|COMPLETED|Part 1: Dose Escalation||0||
59706173|NCT01286987|75825317|FG000|NOT COMPLETED|Part 1: Dose Escalation||3||
59706174|NCT01286987|75825318|FG001|NOT COMPLETED|Part 1: Dose Escalation||3||
59706175|NCT01286987|75825319|FG002|NOT COMPLETED|Part 1: Dose Escalation||3||
59706176|NCT01286987|75825320|FG003|NOT COMPLETED|Part 1: Dose Escalation||3||
59706177|NCT01286987|75825321|FG004|NOT COMPLETED|Part 1: Dose Escalation||3||
59706178|NCT01286987|75825322|FG005|NOT COMPLETED|Part 1: Dose Escalation||6||
59706179|NCT01286987|75825323|FG006|NOT COMPLETED|Part 1: Dose Escalation||5||
59706180|NCT01286987|75825324|FG007|NOT COMPLETED|Part 1: Dose Escalation||5||
59706181|NCT01286987|75825325|FG008|NOT COMPLETED|Part 1: Dose Escalation||6||
59706182|NCT01286987|75825326|FG009|NOT COMPLETED|Part 1: Dose Escalation||0||
59706183|NCT01286987|75825327|FG010|NOT COMPLETED|Part 1: Dose Escalation||0||
59706184|NCT01286987|75825328|FG011|NOT COMPLETED|Part 1: Dose Escalation||0||
59706185|NCT01286987|75825329|FG012|NOT COMPLETED|Part 1: Dose Escalation||0||
59706186|NCT01286987|75825330|FG013|NOT COMPLETED|Part 1: Dose Escalation||0||
59706187|NCT01286987|75825331|FG014|NOT COMPLETED|Part 1: Dose Escalation||0||
59706188|NCT01286987|75825317|FG000|STARTED|Part 2: Dose Expansion||0||
59706189|NCT01286987|75825318|FG001|STARTED|Part 2: Dose Expansion||0||
59706190|NCT01286987|75825319|FG002|STARTED|Part 2: Dose Expansion||0||
59706191|NCT01286987|75825320|FG003|STARTED|Part 2: Dose Expansion||0||
59706192|NCT01286987|75825321|FG004|STARTED|Part 2: Dose Expansion||0||
59706193|NCT01286987|75825322|FG005|STARTED|Part 2: Dose Expansion||0||
59706194|NCT01286987|75825323|FG006|STARTED|Part 2: Dose Expansion||0||
59706195|NCT01286987|75825324|FG007|STARTED|Part 2: Dose Expansion||0||
59706196|NCT01286987|75825325|FG008|STARTED|Part 2: Dose Expansion||0||
59706197|NCT01286987|75825326|FG009|STARTED|Part 2: Dose Expansion||12||
59706198|NCT01286987|75825327|FG010|STARTED|Part 2: Dose Expansion||12||
59706199|NCT01286987|75825328|FG011|STARTED|Part 2: Dose Expansion||11||
59706200|NCT01286987|75825329|FG012|STARTED|Part 2: Dose Expansion||12||
59706201|NCT01286987|75825330|FG013|STARTED|Part 2: Dose Expansion||24||
59706202|NCT01286987|75825331|FG014|STARTED|Part 2: Dose Expansion||3||
59706203|NCT01286987|75825317|FG000|Treated|Part 2: Dose Expansion||0||
59706204|NCT01286987|75825318|FG001|Treated|Part 2: Dose Expansion||0||
59706205|NCT01286987|75825319|FG002|Treated|Part 2: Dose Expansion||0||
59706206|NCT01286987|75825320|FG003|Treated|Part 2: Dose Expansion||0||
59706207|NCT01286987|75825321|FG004|Treated|Part 2: Dose Expansion||0||
59816300|NCT00526994|75938691|FG001|COMPLETED|Overall Study||772||
59816301|NCT00526994|75938692|FG002|COMPLETED|Overall Study||791||
59706208|NCT01286987|75825322|FG005|Treated|Part 2: Dose Expansion||0||
59706209|NCT01286987|75825323|FG006|Treated|Part 2: Dose Expansion||0||
59706210|NCT01286987|75825324|FG007|Treated|Part 2: Dose Expansion||0||
59706211|NCT01286987|75825325|FG008|Treated|Part 2: Dose Expansion||0||
59706212|NCT01286987|75825326|FG009|Treated|Part 2: Dose Expansion||12||
59706213|NCT01286987|75825327|FG010|Treated|Part 2: Dose Expansion||11||
59706214|NCT01286987|75825328|FG011|Treated|Part 2: Dose Expansion||10||
59706215|NCT01286987|75825329|FG012|Treated|Part 2: Dose Expansion||12||
59706216|NCT01286987|75825330|FG013|Treated|Part 2: Dose Expansion||23||
59706217|NCT01286987|75825331|FG014|Treated|Part 2: Dose Expansion||3||
59706218|NCT01286987|75825317|FG000|COMPLETED|Part 2: Dose Expansion||0||
59706219|NCT01286987|75825318|FG001|COMPLETED|Part 2: Dose Expansion||0||
59706220|NCT01286987|75825319|FG002|COMPLETED|Part 2: Dose Expansion||0||
59706221|NCT01286987|75825320|FG003|COMPLETED|Part 2: Dose Expansion||0||
59706222|NCT01286987|75825321|FG004|COMPLETED|Part 2: Dose Expansion||0||
59706223|NCT01286987|75825322|FG005|COMPLETED|Part 2: Dose Expansion||0||
59706224|NCT01286987|75825323|FG006|COMPLETED|Part 2: Dose Expansion||0||
59706225|NCT01286987|75825324|FG007|COMPLETED|Part 2: Dose Expansion||0||
59706226|NCT01286987|75825325|FG008|COMPLETED|Part 2: Dose Expansion||0||
59706227|NCT01286987|75825326|FG009|COMPLETED|Part 2: Dose Expansion||1||
59706228|NCT01286987|75825327|FG010|COMPLETED|Part 2: Dose Expansion||2||
59706229|NCT01286987|75825328|FG011|COMPLETED|Part 2: Dose Expansion||1||
59706230|NCT01286987|75825329|FG012|COMPLETED|Part 2: Dose Expansion||0||
59706231|NCT01286987|75825330|FG013|COMPLETED|Part 2: Dose Expansion||0||
59706232|NCT01286987|75825331|FG014|COMPLETED|Part 2: Dose Expansion||1||
59706233|NCT01286987|75825317|FG000|NOT COMPLETED|Part 2: Dose Expansion||0||
59706234|NCT01286987|75825318|FG001|NOT COMPLETED|Part 2: Dose Expansion||0||
59706235|NCT01286987|75825319|FG002|NOT COMPLETED|Part 2: Dose Expansion||0||
59706236|NCT01286987|75825320|FG003|NOT COMPLETED|Part 2: Dose Expansion||0||
59706237|NCT01286987|75825321|FG004|NOT COMPLETED|Part 2: Dose Expansion||0||
59706238|NCT01286987|75825322|FG005|NOT COMPLETED|Part 2: Dose Expansion||0||
59706239|NCT01286987|75825323|FG006|NOT COMPLETED|Part 2: Dose Expansion||0||
59706240|NCT01286987|75825324|FG007|NOT COMPLETED|Part 2: Dose Expansion||0||
59706241|NCT01286987|75825325|FG008|NOT COMPLETED|Part 2: Dose Expansion||0||
59706242|NCT01286987|75825326|FG009|NOT COMPLETED|Part 2: Dose Expansion||11||
59706243|NCT01286987|75825327|FG010|NOT COMPLETED|Part 2: Dose Expansion||10||
59706244|NCT01286987|75825328|FG011|NOT COMPLETED|Part 2: Dose Expansion||10||
59706245|NCT01286987|75825329|FG012|NOT COMPLETED|Part 2: Dose Expansion||12||
59706246|NCT01286987|75825330|FG013|NOT COMPLETED|Part 2: Dose Expansion||24||
59706247|NCT01286987|75825331|FG014|NOT COMPLETED|Part 2: Dose Expansion||2||
59706248|NCT01286753|75825374|FG000|STARTED|Overall Study||26||
59706249|NCT01286753|75825375|FG001|STARTED|Overall Study||25||
59706250|NCT01286753|75825374|FG000|COMPLETED|Overall Study||0||
59706251|NCT01286753|75825375|FG001|COMPLETED|Overall Study||0||
59706252|NCT01286753|75825374|FG000|NOT COMPLETED|Overall Study||26||
59706253|NCT01286753|75825375|FG001|NOT COMPLETED|Overall Study||25||
59706254|NCT01286129|75825384|FG000|STARTED|Overall Study||27||
59706255|NCT01286129|75825385|FG001|STARTED|Overall Study||18||
59706256|NCT01286129|75825384|FG000|COMPLETED|Overall Study||19||
59706257|NCT01286129|75825385|FG001|COMPLETED|Overall Study||13||
59706258|NCT01286129|75825384|FG000|NOT COMPLETED|Overall Study||8||
59706259|NCT01286129|75825385|FG001|NOT COMPLETED|Overall Study||5||
59706260|NCT01285349|75825396|FG000|STARTED|Overall Study||190||
59706261|NCT01285349|75825397|FG001|STARTED|Overall Study||190||
59706262|NCT01285349|75825398|FG002|STARTED|Overall Study||184||
59706263|NCT01285349|75825396|FG000|COMPLETED|Overall Study||163||
59706264|NCT01285349|75825397|FG001|COMPLETED|Overall Study||170||
59706265|NCT01285349|75825398|FG002|COMPLETED|Overall Study||157||
59706266|NCT01285349|75825396|FG000|NOT COMPLETED|Overall Study||27||
59706267|NCT01285349|75825397|FG001|NOT COMPLETED|Overall Study||20||
59706268|NCT01285349|75825398|FG002|NOT COMPLETED|Overall Study||27||
59706269|NCT01284959|75825410|FG000|STARTED|Overall Study||11||
59706270|NCT01284959|75825411|FG001|STARTED|Overall Study||12||
59706271|NCT01284959|75825412|FG002|STARTED|Overall Study||11||
59706272|NCT01284959|75825410|FG000|COMPLETED|Overall Study||10||
59706273|NCT01284959|75825411|FG001|COMPLETED|Overall Study||12||
59706274|NCT01284959|75825412|FG002|COMPLETED|Overall Study||10||
59706275|NCT01284959|75825410|FG000|NOT COMPLETED|Overall Study||1||
59706276|NCT01284959|75825411|FG001|NOT COMPLETED|Overall Study||0||
59706277|NCT01284959|75825412|FG002|NOT COMPLETED|Overall Study||1||
59706278|NCT01284491|75825420|FG000|STARTED|Overall Study||13||
59706279|NCT01284491|75825420|FG000|COMPLETED|Overall Study||0||
59706280|NCT01284491|75825420|FG000|NOT COMPLETED|Overall Study||13||
59706281|NCT01283009|75825428|FG000|STARTED|Overall Study||287||
59706282|NCT01283009|75825429|FG001|STARTED|Overall Study||297||
59706283|NCT01283009|75825428|FG000|COMPLETED|Overall Study||169||
59706284|NCT01283009|75825429|FG001|COMPLETED|Overall Study||180||
59706285|NCT01283009|75825428|FG000|NOT COMPLETED|Overall Study||118||
59706286|NCT01283009|75825429|FG001|NOT COMPLETED|Overall Study||117||
59706287|NCT01282463|75825438|FG000|STARTED|Overall Study||49||
59706288|NCT01282463|75825439|FG001|STARTED|Overall Study||49||
59706289|NCT01282463|75825440|FG002|STARTED|Overall Study||50||
59706290|NCT01282463|75825438|FG000|Received at Least 1 Dose of Study Drug|Overall Study||45||
59706291|NCT01282463|75825439|FG001|Received at Least 1 Dose of Study Drug|Overall Study||46||
59706292|NCT01282463|75825440|FG002|Received at Least 1 Dose of Study Drug|Overall Study||49||
59706293|NCT01282463|75825438|FG000|COMPLETED|Overall Study||41||
59706294|NCT01282463|75825439|FG001|COMPLETED|Overall Study||45||
59706295|NCT01282463|75825440|FG002|COMPLETED|Overall Study||46||
59706296|NCT01282463|75825438|FG000|NOT COMPLETED|Overall Study||8||
59706297|NCT01282463|75825439|FG001|NOT COMPLETED|Overall Study||4||
59706298|NCT01282463|75825440|FG002|NOT COMPLETED|Overall Study||4||
59706299|NCT01282229|75825456|FG000|STARTED|Overall Study|59 Participants contributed 236 quadrants (59*4)|59||
59706300|NCT01282229|75825456|FG000|COMPLETED|Overall Study|57 Participants contributed 228 quadrants (57*4)|57||
59706301|NCT01282229|75825456|FG000|NOT COMPLETED|Overall Study||2||
59706302|NCT01281917|75825474|FG000|STARTED|Overall Study||40||
59706303|NCT01281917|75825474|FG000|COMPLETED|Overall Study||39||
59706304|NCT01281917|75825474|FG000|NOT COMPLETED|Overall Study||1||
59706305|NCT01281839|75825480|FG000|STARTED|Overall Study|Not including 1 participant was randomized to this group, but never received treatment.|260||
59706306|NCT01281839|75825481|FG001|STARTED|Overall Study||133||
59991011|NCT03318523|76106558|FG002|STARTED|PC Period: Up to Year 1||102||
59991012|NCT03318523|76106559|FG003|STARTED|PC Period: Up to Year 1||100||
59991013|NCT03318523|76106560|FG004|STARTED|PC Period: Up to Year 1||0||
59991014|NCT03318523|76106561|FG005|STARTED|PC Period: Up to Year 1||0||
59991015|NCT03318523|76106562|FG006|STARTED|PC Period: Up to Year 1||0||
59991016|NCT03318523|76106563|FG007|STARTED|PC Period: Up to Year 1||0||
59991017|NCT03318523|76106564|FG008|STARTED|PC Period: Up to Year 1||0||
59991018|NCT03318523|76106565|FG009|STARTED|PC Period: Up to Year 1||0||
59991019|NCT03318523|76106556|FG000|COMPLETED|PC Period: Up to Year 1||96||
60080004|NCT05439421|76195113|FG000|COMPLETED|H2O Cools Puirfies Tobacco Smoke||753||
60080005|NCT05439421|76195114|FG001|COMPLETED|H2O Cools Puirfies Tobacco Smoke||754||
60080006|NCT05439421|76195113|FG000|NOT COMPLETED|H2O Cools Puirfies Tobacco Smoke||0||
60080007|NCT05439421|76195114|FG001|NOT COMPLETED|H2O Cools Puirfies Tobacco Smoke||0||
60080008|NCT05439421|76195113|FG000|STARTED|Natural Flavor||783||
60080009|NCT05439421|76195114|FG001|STARTED|Natural Flavor||724||
60080010|NCT05439421|76195113|FG000|COMPLETED|Natural Flavor||783||
60080011|NCT05439421|76195114|FG001|COMPLETED|Natural Flavor||724||
60080012|NCT05439421|76195113|FG000|NOT COMPLETED|Natural Flavor||0||
60080013|NCT05439421|76195114|FG001|NOT COMPLETED|Natural Flavor||0||
60080014|NCT05439421|76195113|FG000|STARTED|Shisha/Hookah Tobacco is Unique||749||
60080015|NCT05439421|76195114|FG001|STARTED|Shisha/Hookah Tobacco is Unique||758||
60080016|NCT05439421|76195113|FG000|COMPLETED|Shisha/Hookah Tobacco is Unique||749||
60080017|NCT05439421|76195114|FG001|COMPLETED|Shisha/Hookah Tobacco is Unique||758||
60080018|NCT05439421|76195113|FG000|NOT COMPLETED|Shisha/Hookah Tobacco is Unique||0||
60080019|NCT05439421|76195114|FG001|NOT COMPLETED|Shisha/Hookah Tobacco is Unique||0||
60080020|NCT05439421|76195113|FG000|STARTED|Shisha H2O Cools and Filters Smoke||722||
60080021|NCT05439421|76195114|FG001|STARTED|Shisha H2O Cools and Filters Smoke||785||
60080022|NCT05439421|76195113|FG000|COMPLETED|Shisha H2O Cools and Filters Smoke||722||
60080023|NCT05439421|76195114|FG001|COMPLETED|Shisha H2O Cools and Filters Smoke||785||
60080024|NCT05439421|76195113|FG000|NOT COMPLETED|Shisha H2O Cools and Filters Smoke||0||
60080025|NCT05439421|76195114|FG001|NOT COMPLETED|Shisha H2O Cools and Filters Smoke||0||
60080026|NCT05011279|76195150|FG000|STARTED|Overall Study|5 survivors and 5 relatives|10||
60080027|NCT05011279|76195150|FG000|COMPLETED|Overall Study|5 survivors and 5 relatives|10||
60080028|NCT05011279|76195150|FG000|NOT COMPLETED|Overall Study||0||
60080029|NCT04944992|76195156|FG000|STARTED|Overall Study||72||
60080030|NCT04944992|76195157|FG001|STARTED|Overall Study||73||
60080031|NCT04944992|76195156|FG000|COMPLETED|Overall Study||64||
60080032|NCT04944992|76195157|FG001|COMPLETED|Overall Study||71||
59706307|NCT01281839|75825480|FG000|COMPLETED|Overall Study||250||
59706308|NCT01281839|75825481|FG001|COMPLETED|Overall Study||119||
59706309|NCT01281839|75825480|FG000|NOT COMPLETED|Overall Study||10||
59706310|NCT01281839|75825481|FG001|NOT COMPLETED|Overall Study||14||
59706311|NCT01281137|75825489|FG000|STARTED|Baseline Population||25||
59706312|NCT01281137|75825490|FG001|STARTED|Baseline Population||79||
59706313|NCT01281137|75825489|FG000|COMPLETED|Baseline Population||25||
59706314|NCT01281137|75825490|FG001|COMPLETED|Baseline Population||78||
59706315|NCT01281137|75825489|FG000|NOT COMPLETED|Baseline Population||0||
59706316|NCT01281137|75825490|FG001|NOT COMPLETED|Baseline Population||1||
59991020|NCT03318523|76106557|FG001|COMPLETED|PC Period: Up to Year 1||53||
59991021|NCT03318523|76106558|FG002|COMPLETED|PC Period: Up to Year 1||100||
59991022|NCT03318523|76106559|FG003|COMPLETED|PC Period: Up to Year 1||96||
59991023|NCT03318523|76106560|FG004|COMPLETED|PC Period: Up to Year 1||0||
59991024|NCT03318523|76106561|FG005|COMPLETED|PC Period: Up to Year 1||0||
59991025|NCT03318523|76106562|FG006|COMPLETED|PC Period: Up to Year 1||0||
59991026|NCT03318523|76106563|FG007|COMPLETED|PC Period: Up to Year 1||0||
60080033|NCT04944992|76195156|FG000|NOT COMPLETED|Overall Study||8||
60080034|NCT04944992|76195157|FG001|NOT COMPLETED|Overall Study||2||
60080035|NCT04820530|76195163|FG000|STARTED|Core Treatment Period||40||
60080036|NCT04820530|76195163|FG000|COMPLETED|Core Treatment Period||40||
60080037|NCT04820530|76195163|FG000|NOT COMPLETED|Core Treatment Period||0||
60080038|NCT04820530|76195163|FG000|STARTED|Extension Treatment Period||39||
60080039|NCT04820530|76195163|FG000|COMPLETED|Extension Treatment Period||7|Completed the extension treatment period on LNP023, as of the data cut-off (02-Nov-2022).|
60080040|NCT04820530|76195163|FG000|NOT COMPLETED|Extension Treatment Period||32||
60080041|NCT04812795|76195171|FG000|STARTED|Overall Study||501||
60080042|NCT04812795|76195172|FG001|STARTED|Overall Study||501||
60080043|NCT04812795|76195173|FG002|STARTED|Overall Study||613||
59991027|NCT03318523|76106564|FG008|COMPLETED|PC Period: Up to Year 1||0||
59991028|NCT03318523|76106565|FG009|COMPLETED|PC Period: Up to Year 1||0||
59991029|NCT03318523|76106556|FG000|NOT COMPLETED|PC Period: Up to Year 1||4||
59706317|NCT01281137|75825489|FG000|STARTED|Analysis Population (Baseline)||25|13 patients excluded from the longitudinal analyses, baseline sample only|
59706318|NCT01281137|75825490|FG001|STARTED|Analysis Population (Baseline)||78|13 patients excluded from the longitudinal analyses, baseline sample only|
59706319|NCT01281137|75825489|FG000|COMPLETED|Analysis Population (Baseline)||21||
59706320|NCT01281137|75825490|FG001|COMPLETED|Analysis Population (Baseline)||69||
59706321|NCT01281137|75825489|FG000|NOT COMPLETED|Analysis Population (Baseline)||4||
59706322|NCT01281137|75825490|FG001|NOT COMPLETED|Analysis Population (Baseline)||9||
59706323|NCT01281137|75825489|FG000|STARTED|Analysis Population (9 Months)||21||
59706324|NCT01281137|75825490|FG001|STARTED|Analysis Population (9 Months)||69||
59706325|NCT01281137|75825489|FG000|COMPLETED|Analysis Population (9 Months)||21||
59706326|NCT01281137|75825490|FG001|COMPLETED|Analysis Population (9 Months)||64||
59706327|NCT01281137|75825489|FG000|NOT COMPLETED|Analysis Population (9 Months)||0||
59706328|NCT01281137|75825490|FG001|NOT COMPLETED|Analysis Population (9 Months)||5||
59706329|NCT01281137|75825489|FG000|STARTED|Analysis Population (10.5 Months)||21||
59706330|NCT01281137|75825490|FG001|STARTED|Analysis Population (10.5 Months)||64||
59706331|NCT01281137|75825489|FG000|COMPLETED|Analysis Population (10.5 Months)||20||
59706332|NCT01281137|75825490|FG001|COMPLETED|Analysis Population (10.5 Months)||64||
59706333|NCT01281137|75825489|FG000|NOT COMPLETED|Analysis Population (10.5 Months)||1||
59706334|NCT01281137|75825490|FG001|NOT COMPLETED|Analysis Population (10.5 Months)||0||
59706335|NCT01281137|75825489|FG000|STARTED|Analysis Population (12 Months)||20||
59706336|NCT01281137|75825490|FG001|STARTED|Analysis Population (12 Months)||64||
59706337|NCT01281137|75825489|FG000|COMPLETED|Analysis Population (12 Months)||19||
59706338|NCT01281137|75825490|FG001|COMPLETED|Analysis Population (12 Months)||62||
59706339|NCT01281137|75825489|FG000|NOT COMPLETED|Analysis Population (12 Months)||1||
59706340|NCT01281137|75825490|FG001|NOT COMPLETED|Analysis Population (12 Months)||2||
59706341|NCT01280981|75825514|FG000|STARTED|Overall Study||288||
59706342|NCT01280981|75825514|FG000|Intent to Treat (ITT) Population|Overall Study|Participants who took drug during at least one menstrual cycle|260||
59706343|NCT01280981|75825514|FG000|COMPLETED|Overall Study||196||
59706344|NCT01280981|75825514|FG000|NOT COMPLETED|Overall Study||92||
59706345|NCT01280903|75825520|FG000|STARTED|Overall Study||91||
59706346|NCT01280903|75825521|FG001|STARTED|Overall Study||91||
59706347|NCT01280903|75825520|FG000|COMPLETED|Overall Study|91 participants analyzed per intention-to-treat|68||
59706348|NCT01280903|75825521|FG001|COMPLETED|Overall Study|91 participants analyzed per intention-to-treat|75||
59706349|NCT01280903|75825520|FG000|NOT COMPLETED|Overall Study||23||
59706350|NCT01280903|75825521|FG001|NOT COMPLETED|Overall Study||16||
59706351|NCT01280591|75825531|FG000|STARTED|Overall Study||203||
59706352|NCT01280591|75825532|FG001|STARTED|Overall Study||204||
59706353|NCT01280591|75825533|FG002|STARTED|Overall Study||203||
59706354|NCT01280591|75825534|FG003|STARTED|Overall Study||102||
59706355|NCT01280591|75825531|FG000|COMPLETED|Overall Study||203||
59706356|NCT01280591|75825532|FG001|COMPLETED|Overall Study||204||
59706357|NCT01280591|75825533|FG002|COMPLETED|Overall Study||203||
59706358|NCT01280591|75825534|FG003|COMPLETED|Overall Study||99||
59706359|NCT01280591|75825531|FG000|NOT COMPLETED|Overall Study||0||
59706360|NCT01280591|75825532|FG001|NOT COMPLETED|Overall Study||0||
59706361|NCT01280591|75825533|FG002|NOT COMPLETED|Overall Study||0||
59706362|NCT01280591|75825534|FG003|NOT COMPLETED|Overall Study||3||
59706363|NCT01280357|75825544|FG000|STARTED|Overall Study||60||
59706364|NCT01280357|75825544|FG000|COMPLETED|Overall Study||34||
59706365|NCT01280357|75825544|FG000|NOT COMPLETED|Overall Study||26||
59706366|NCT01274351|75825551|FG000|STARTED|Overall Study||112|participants enrolled|
59706367|NCT01274351|75825551|FG000|COMPLETED|Overall Study||92||
59706368|NCT01274351|75825551|FG000|NOT COMPLETED|Overall Study||20||
59706369|NCT01271933|75825555|FG000|STARTED|Single-Blind Phase||441||
59706370|NCT01271933|75825556|FG001|STARTED|Single-Blind Phase||0||
59706371|NCT01271933|75825557|FG002|STARTED|Single-Blind Phase||0||
59706372|NCT01271933|75825555|FG000|COMPLETED|Single-Blind Phase||320||
59706373|NCT01271933|75825556|FG001|COMPLETED|Single-Blind Phase||0||
59706374|NCT01271933|75825557|FG002|COMPLETED|Single-Blind Phase||0||
59706375|NCT01271933|75825555|FG000|NOT COMPLETED|Single-Blind Phase||121||
59706376|NCT01271933|75825556|FG001|NOT COMPLETED|Single-Blind Phase||0||
59706377|NCT01271933|75825557|FG002|NOT COMPLETED|Single-Blind Phase||0||
59706378|NCT01271933|75825555|FG000|STARTED|Double-Blind Phase||0|198 participants completed SB phase but not randomized in DB phase|
59706379|NCT01271933|75825556|FG001|STARTED|Double-Blind Phase||63|198 participants completed SB phase but not randomized in DB phase|
59706380|NCT01271933|75825557|FG002|STARTED|Double-Blind Phase||59|198 participants completed SB phase but not randomized in DB phase|
59816302|NCT00526994|75938690|FG000|NOT COMPLETED|Overall Study||108||
59706381|NCT01271933|75825555|FG000|Treated|Double-Blind Phase||0||
59706382|NCT01271933|75825556|FG001|Treated|Double-Blind Phase||63||
59706383|NCT01271933|75825557|FG002|Treated|Double-Blind Phase||58||
59706384|NCT01271933|75825555|FG000|COMPLETED|Double-Blind Phase||0||
59706385|NCT01271933|75825556|FG001|COMPLETED|Double-Blind Phase||46||
59706386|NCT01271933|75825557|FG002|COMPLETED|Double-Blind Phase||47||
59706387|NCT01271933|75825555|FG000|NOT COMPLETED|Double-Blind Phase||0||
59706388|NCT01271933|75825556|FG001|NOT COMPLETED|Double-Blind Phase||17||
59706389|NCT01271933|75825557|FG002|NOT COMPLETED|Double-Blind Phase||12||
59706390|NCT01269125|75825570|FG000|STARTED|Overall Study||60||
59706391|NCT01269125|75825571|FG001|STARTED|Overall Study||60||
59706392|NCT01269125|75825572|FG002|STARTED|Overall Study||60||
59706393|NCT01269125|75825570|FG000|COMPLETED|Overall Study|lost to follow up:4; OHSS: 2; premature luteinization: 1|53||
59706394|NCT01269125|75825571|FG001|COMPLETED|Overall Study|OHSS:4; premature luteinization: 1|55||
59706395|NCT01269125|75825572|FG002|COMPLETED|Overall Study||60||
59706396|NCT01269125|75825570|FG000|NOT COMPLETED|Overall Study||7||
59706397|NCT01269125|75825571|FG001|NOT COMPLETED|Overall Study||5||
59706398|NCT01269125|75825572|FG002|NOT COMPLETED|Overall Study||0||
59706399|NCT01268891|75825582|FG000|STARTED|Overall Study||66||
59706400|NCT01268891|75825583|FG001|STARTED|Overall Study||66||
59706401|NCT01268891|75825582|FG000|COMPLETED|Overall Study||58||
59706402|NCT01268891|75825583|FG001|COMPLETED|Overall Study||58||
59706403|NCT01268891|75825582|FG000|NOT COMPLETED|Overall Study||8||
59991030|NCT03318523|76106557|FG001|NOT COMPLETED|PC Period: Up to Year 1||2||
59991031|NCT03318523|76106558|FG002|NOT COMPLETED|PC Period: Up to Year 1||2||
59991032|NCT03318523|76106559|FG003|NOT COMPLETED|PC Period: Up to Year 1||4||
59991033|NCT03318523|76106560|FG004|NOT COMPLETED|PC Period: Up to Year 1||0||
59991034|NCT03318523|76106561|FG005|NOT COMPLETED|PC Period: Up to Year 1||0||
60080044|NCT04812795|76195174|FG003|STARTED|Overall Study||599||
60080045|NCT04812795|76195171|FG000|COMPLETED|Overall Study||407||
60080046|NCT04812795|76195172|FG001|COMPLETED|Overall Study||401||
59991035|NCT03318523|76106562|FG006|NOT COMPLETED|PC Period: Up to Year 1||0||
59991036|NCT03318523|76106563|FG007|NOT COMPLETED|PC Period: Up to Year 1||0||
59991037|NCT03318523|76106564|FG008|NOT COMPLETED|PC Period: Up to Year 1||0||
59991038|NCT03318523|76106565|FG009|NOT COMPLETED|PC Period: Up to Year 1||0||
59991039|NCT03318523|76106556|FG000|STARTED|DBE Period:Year 2 to EOS (Up to 3 Years)||0|Out of 345 participants who completed the PC Period, only 344 entered the DBE Period.|
59991040|NCT03318523|76106557|FG001|STARTED|DBE Period:Year 2 to EOS (Up to 3 Years)||0|Out of 345 participants who completed the PC Period, only 344 entered the DBE Period.|
60080047|NCT04812795|76195173|FG002|COMPLETED|Overall Study||492||
60080048|NCT04812795|76195174|FG003|COMPLETED|Overall Study||476||
60080049|NCT04812795|76195171|FG000|NOT COMPLETED|Overall Study||94||
60080050|NCT04812795|76195172|FG001|NOT COMPLETED|Overall Study||100||
60080051|NCT04812795|76195173|FG002|NOT COMPLETED|Overall Study||121||
60080052|NCT04812795|76195174|FG003|NOT COMPLETED|Overall Study||123||
59706404|NCT01268891|75825583|FG001|NOT COMPLETED|Overall Study||8||
59706405|NCT01268501|75825589|FG000|STARTED|Overall Study||96||
59706406|NCT01268501|75825589|FG000|COMPLETED|Overall Study||87||
60080053|NCT04535583|76195184|FG000|STARTED|Overall Study||65||
60080054|NCT04535583|76195184|FG000|COMPLETED|Overall Study||62||
60080055|NCT04535583|76195184|FG000|NOT COMPLETED|Overall Study||3||
60080056|NCT04523324|76195190|FG000|STARTED|Overall Study||211||
60080057|NCT04523324|76195191|FG001|STARTED|Overall Study||366||
60080058|NCT04523324|76195190|FG000|COMPLETED|Overall Study||203||
60080059|NCT04523324|76195191|FG001|COMPLETED|Overall Study||334||
59548401|NCT02491437|75647436|FG001|NOT COMPLETED|Overall Study||357||
59548402|NCT02383758|75647446|FG000|STARTED|Overall Study||10||
59548403|NCT02383758|75647447|FG001|STARTED|Overall Study||10||
59548404|NCT02383758|75647446|FG000|COMPLETED|Overall Study||10||
59548405|NCT02383758|75647447|FG001|COMPLETED|Overall Study||8||
59548406|NCT02383758|75647446|FG000|NOT COMPLETED|Overall Study||0||
59548407|NCT02383758|75647447|FG001|NOT COMPLETED|Overall Study||2||
59548408|NCT02492451|75647456|FG000|STARTED|Overall Study||40||
59548409|NCT02492451|75647457|FG001|STARTED|Overall Study||39||
59548410|NCT02492451|75647458|FG002|STARTED|Overall Study||39||
59548411|NCT02492451|75647456|FG000|COMPLETED|Overall Study||40||
59548412|NCT02492451|75647457|FG001|COMPLETED|Overall Study||39||
59548413|NCT02492451|75647458|FG002|COMPLETED|Overall Study||39||
59548414|NCT02492451|75647456|FG000|NOT COMPLETED|Overall Study||0||
59548415|NCT02492451|75647457|FG001|NOT COMPLETED|Overall Study||0||
59548416|NCT02492451|75647458|FG002|NOT COMPLETED|Overall Study||0||
59548417|NCT02493621|75647468|FG000|STARTED|Overall Study||58||
59548418|NCT02493621|75647469|FG001|STARTED|Overall Study||58||
59548419|NCT02493621|75647468|FG000|COMPLETED|Overall Study||58||
59548420|NCT02493621|75647469|FG001|COMPLETED|Overall Study||58||
59548421|NCT02493621|75647468|FG000|NOT COMPLETED|Overall Study||0||
59548422|NCT02493621|75647469|FG001|NOT COMPLETED|Overall Study||0||
59548423|NCT01180478|75647477|FG000|STARTED|Overall Study||484||
59548424|NCT01180478|75647478|FG001|STARTED|Overall Study||481||
59548425|NCT01180478|75647477|FG000|COMPLETED|Overall Study||303||
59548426|NCT01180478|75647478|FG001|COMPLETED|Overall Study||293||
59548427|NCT01180478|75647477|FG000|NOT COMPLETED|Overall Study||181||
59548428|NCT01180478|75647478|FG001|NOT COMPLETED|Overall Study||188||
59548429|NCT02566239|75647488|FG000|STARTED|Overall Study||43||
59548430|NCT02566239|75647489|FG001|STARTED|Overall Study||48||
59548431|NCT02566239|75647488|FG000|COMPLETED|Overall Study||39||
59548432|NCT02566239|75647489|FG001|COMPLETED|Overall Study||44||
59548433|NCT02566239|75647488|FG000|NOT COMPLETED|Overall Study||4||
59548434|NCT02566239|75647489|FG001|NOT COMPLETED|Overall Study||4||
59548435|NCT02410278|75647497|FG000|STARTED|Run-in Period||102||
59548436|NCT02410278|75647498|FG001|STARTED|Run-in Period||0||
59548437|NCT02410278|75647499|FG002|STARTED|Run-in Period||0||
59548438|NCT02410278|75647497|FG000|Received at Least 1 Dose of DMF|Run-in Period||98||
59548439|NCT02410278|75647498|FG001|Received at Least 1 Dose of DMF|Run-in Period||0||
59548440|NCT02410278|75647499|FG002|Received at Least 1 Dose of DMF|Run-in Period||0||
59548441|NCT02410278|75647497|FG000|COMPLETED|Run-in Period||64||
59548442|NCT02410278|75647498|FG001|COMPLETED|Run-in Period||0||
59548443|NCT02410278|75647499|FG002|COMPLETED|Run-in Period||0||
59548444|NCT02410278|75647497|FG000|NOT COMPLETED|Run-in Period||38||
59548445|NCT02410278|75647498|FG001|NOT COMPLETED|Run-in Period||0||
59548446|NCT02410278|75647499|FG002|NOT COMPLETED|Run-in Period||0||
59548447|NCT02410278|75647497|FG000|STARTED|Study Treatment Period||0||
59548448|NCT02410278|75647498|FG001|STARTED|Study Treatment Period||31||
59548449|NCT02410278|75647499|FG002|STARTED|Study Treatment Period||33||
59548450|NCT02410278|75647497|FG000|Modified Intent-to Treat(mITT)Population|Study Treatment Period||0||
59548451|NCT02410278|75647498|FG001|Modified Intent-to Treat(mITT)Population|Study Treatment Period||30||
59548452|NCT02410278|75647499|FG002|Modified Intent-to Treat(mITT)Population|Study Treatment Period||33||
59548453|NCT02410278|75647497|FG000|Completed Randomized Study Treatment|Study Treatment Period||0||
59548454|NCT02410278|75647498|FG001|Completed Randomized Study Treatment|Study Treatment Period||20||
59548455|NCT02410278|75647499|FG002|Completed Randomized Study Treatment|Study Treatment Period||29||
59548456|NCT02410278|75647497|FG000|COMPLETED|Study Treatment Period||0||
59548457|NCT02410278|75647498|FG001|COMPLETED|Study Treatment Period||20||
59548458|NCT02410278|75647499|FG002|COMPLETED|Study Treatment Period||29||
59548459|NCT02410278|75647497|FG000|NOT COMPLETED|Study Treatment Period||0||
59548460|NCT02410278|75647498|FG001|NOT COMPLETED|Study Treatment Period||11||
59548461|NCT02410278|75647499|FG002|NOT COMPLETED|Study Treatment Period||4||
59548462|NCT02566317|75647508|FG000|STARTED|Overall Study||276||12
59548463|NCT02566317|75647509|FG001|STARTED|Overall Study||354||12
60080060|NCT04523324|76195190|FG000|NOT COMPLETED|Overall Study||8||
60080061|NCT04523324|76195191|FG001|NOT COMPLETED|Overall Study||32||
60080062|NCT04484935|76195199|FG000|STARTED|Overall Study||48||
60080063|NCT04484935|76195200|FG001|STARTED|Overall Study||52||
60080064|NCT04484935|76195199|FG000|COMPLETED|Overall Study||45||
60080065|NCT04484935|76195200|FG001|COMPLETED|Overall Study||49||
60080066|NCT04484935|76195199|FG000|NOT COMPLETED|Overall Study||3||
60080067|NCT04484935|76195200|FG001|NOT COMPLETED|Overall Study||3||
60080068|NCT04262882|76195209|FG000|STARTED|Overall Study||84||42
60080069|NCT04262882|76195210|FG001|STARTED|Overall Study||76||38
60080070|NCT04262882|76195209|FG000|COMPLETED|Overall Study||69||35
60080071|NCT04262882|76195210|FG001|COMPLETED|Overall Study||70||35
60080072|NCT04262882|76195209|FG000|NOT COMPLETED|Overall Study||15||7
60080073|NCT04262882|76195210|FG001|NOT COMPLETED|Overall Study||6||3
60080074|NCT04135859|76195218|FG000|STARTED|Overall Study||19||
60080075|NCT04135859|76195219|FG001|STARTED|Overall Study||17||
60080076|NCT04135859|76195218|FG000|COMPLETED|Overall Study||14||
60080077|NCT04135859|76195219|FG001|COMPLETED|Overall Study||10||
60080078|NCT04135859|76195218|FG000|NOT COMPLETED|Overall Study||5||
60080079|NCT04135859|76195219|FG001|NOT COMPLETED|Overall Study||7||
60080080|NCT04071756|76195227|FG000|STARTED|Overall Study||5||
60080081|NCT04071756|76195228|FG001|STARTED|Overall Study||3||
60080082|NCT04071756|76195227|FG000|Patient Reported Outcomes (PRO) Evaluable|Overall Study||2||
60080083|NCT04071756|76195228|FG001|Patient Reported Outcomes (PRO) Evaluable|Overall Study||1||
60080084|NCT04071756|76195227|FG000|COMPLETED|Overall Study||5||
60080085|NCT04071756|76195228|FG001|COMPLETED|Overall Study||3||
60080086|NCT04071756|76195227|FG000|NOT COMPLETED|Overall Study||0||
60080087|NCT04071756|76195228|FG001|NOT COMPLETED|Overall Study||0||
60080088|NCT04068610|76195237|FG000|STARTED|Overall Study||7||
60080089|NCT04068610|76195238|FG001|STARTED|Overall Study||26||
60080090|NCT04068610|76195239|FG002|STARTED|Overall Study||26||
60080091|NCT04068610|76195237|FG000|COMPLETED|Overall Study||0||
60080092|NCT04068610|76195238|FG001|COMPLETED|Overall Study||0||
60080093|NCT04068610|76195239|FG002|COMPLETED|Overall Study||0||
60080094|NCT04068610|76195237|FG000|NOT COMPLETED|Overall Study||7||
60080095|NCT04068610|76195238|FG001|NOT COMPLETED|Overall Study||26||
60080096|NCT04068610|76195239|FG002|NOT COMPLETED|Overall Study||26||
60080097|NCT03860844|76195250|FG000|STARTED|Overall Study||27||
60080098|NCT03860844|76195251|FG001|STARTED|Overall Study||13||
60080099|NCT03860844|76195252|FG002|STARTED|Overall Study||27||
60080100|NCT03860844|76195250|FG000|COMPLETED|Overall Study||19||
60080101|NCT03860844|76195251|FG001|COMPLETED|Overall Study||7||
60080102|NCT03860844|76195252|FG002|COMPLETED|Overall Study||20||
60080103|NCT03860844|76195250|FG000|NOT COMPLETED|Overall Study||8||
60080104|NCT03860844|76195251|FG001|NOT COMPLETED|Overall Study||6||
60080105|NCT03860844|76195252|FG002|NOT COMPLETED|Overall Study||7||
60080106|NCT03459846|76195264|FG000|STARTED|Overall Study||78||
60080107|NCT03459846|76195265|FG001|STARTED|Overall Study||76||
60080108|NCT03459846|76195264|FG000|COMPLETED|Overall Study||0||
60080109|NCT03459846|76195265|FG001|COMPLETED|Overall Study||0||
60080110|NCT03459846|76195264|FG000|NOT COMPLETED|Overall Study||78||
60080111|NCT03459846|76195265|FG001|NOT COMPLETED|Overall Study||76||
59548464|NCT02566317|75647508|FG000|COMPLETED|Overall Study||247||12
59548465|NCT02566317|75647509|FG001|COMPLETED|Overall Study||292||12
59548466|NCT02566317|75647508|FG000|NOT COMPLETED|Overall Study||29||0
59548467|NCT02566317|75647509|FG001|NOT COMPLETED|Overall Study||62||0
59548468|NCT01181258|75647515|FG000|STARTED|Overall Study||16||
59548469|NCT01181258|75647515|FG000|COMPLETED|Overall Study||16||
59548470|NCT01181258|75647515|FG000|NOT COMPLETED|Overall Study||0||
59548471|NCT02568345|75647519|FG000|STARTED|Overall Study||31||
59548472|NCT02568345|75647519|FG000|Treated at 2.2 mg/kg|Overall Study|patients: 6th, 20th, 26th|3||
59548473|NCT02568345|75647519|FG000|Treated at 2.4 mg/kg|Overall Study|Patients: 1st-5th; 7th; 11th-15th; 21st-25th; 27th-31st|25||
59548474|NCT02568345|75647519|FG000|Treated at 2.6 mg/kg|Overall Study|Patients: 8th-10th|3||
59548475|NCT02568345|75647519|FG000|COMPLETED|Overall Study||31||
59548476|NCT02568345|75647519|FG000|NOT COMPLETED|Overall Study||0||
59548477|NCT02570139|75647525|FG000|STARTED|Overall Study|24 subjects were treated w/ Cavilon Advanced Skin Protectant. Study terminated due to low enrollment|24||
59548478|NCT02570139|75647526|FG001|STARTED|Overall Study|21 subjects treated with SensiCare Protective Barrier|21||
59548479|NCT02570139|75647525|FG000|COMPLETED|Overall Study||24||
59548480|NCT02570139|75647526|FG001|COMPLETED|Overall Study||21||
59548481|NCT02570139|75647525|FG000|NOT COMPLETED|Overall Study||0||
59548482|NCT02570139|75647526|FG001|NOT COMPLETED|Overall Study||0||
59548483|NCT02410200|75647532|FG000|STARTED|Overall Study||22||
59548484|NCT02410200|75647532|FG000|COMPLETED|Overall Study||20||
59548485|NCT02410200|75647532|FG000|NOT COMPLETED|Overall Study||2||
60080112|NCT03298984|76195275|FG000|STARTED|Overall Study||3||
60080113|NCT03298984|76195276|FG001|STARTED|Overall Study||3||
60080114|NCT03298984|76195277|FG002|STARTED|Overall Study||3||
60080115|NCT03298984|76195278|FG003|STARTED|Overall Study||23||
60080116|NCT03298984|76195275|FG000|COMPLETED|Overall Study||2||
60080117|NCT03298984|76195276|FG001|COMPLETED|Overall Study||2||
59548486|NCT02494323|75647536|FG000|STARTED|Overall Study||70||
59548487|NCT02494323|75647536|FG000|COMPLETED|Overall Study||70||
59548488|NCT02494323|75647536|FG000|NOT COMPLETED|Overall Study||0||
59548489|NCT01143272|75647542|FG000|STARTED|Overall Study||246||
59548490|NCT01143272|75647543|FG001|STARTED|Overall Study||231||
59548491|NCT01143272|75647542|FG000|COMPLETED|Overall Study||246||
59548492|NCT01143272|75647543|FG001|COMPLETED|Overall Study||231||
59548493|NCT01143272|75647542|FG000|NOT COMPLETED|Overall Study||0||
59548494|NCT01143272|75647543|FG001|NOT COMPLETED|Overall Study||0||
59816303|NCT00526994|75938691|FG001|NOT COMPLETED|Overall Study||121||
59548495|NCT02383056|75647551|FG000|STARTED|Overall Study||7||
59548496|NCT02383056|75647552|FG001|STARTED|Overall Study||7||
59548497|NCT02383056|75647551|FG000|COMPLETED|Overall Study||6||
59548498|NCT02383056|75647552|FG001|COMPLETED|Overall Study||5||
59548499|NCT02383056|75647551|FG000|NOT COMPLETED|Overall Study||1||
59548500|NCT02383056|75647552|FG001|NOT COMPLETED|Overall Study||2||
59548501|NCT02409732|75647558|FG000|STARTED|Overall Study|First patient consented on 4/23/15|20||
59548502|NCT02409732|75647558|FG000|COMPLETED|Overall Study||14||
59548503|NCT02409732|75647558|FG000|NOT COMPLETED|Overall Study||6||
59548504|NCT02494713|75647563|FG000|STARTED|Overall Study||4||
59548505|NCT02494713|75647563|FG000|COMPLETED|Overall Study||4||
59548506|NCT02494713|75647563|FG000|NOT COMPLETED|Overall Study||0||
59548507|NCT01650636|75647569|FG000|STARTED|Intervention Phase||150||
60080118|NCT03298984|76195277|FG002|COMPLETED|Overall Study||1||
60080119|NCT03298984|76195278|FG003|COMPLETED|Overall Study||8||
60080120|NCT03298984|76195275|FG000|NOT COMPLETED|Overall Study||1||
60080121|NCT03298984|76195276|FG001|NOT COMPLETED|Overall Study||1||
60080122|NCT03298984|76195277|FG002|NOT COMPLETED|Overall Study||2||
60080123|NCT03298984|76195278|FG003|NOT COMPLETED|Overall Study||15||
60080124|NCT03248492|76195294|FG000|STARTED|Overall Study||50||
60080125|NCT03248492|76195295|FG001|STARTED|Overall Study||48||
60080126|NCT03248492|76195296|FG002|STARTED|Overall Study||21||
60080127|NCT03248492|76195297|FG003|STARTED|Overall Study||130||
59548508|NCT01650636|75647570|FG001|STARTED|Intervention Phase||150||
59548509|NCT01650636|75647569|FG000|COMPLETED|Intervention Phase||150||
59548510|NCT01650636|75647570|FG001|COMPLETED|Intervention Phase||150||
59548511|NCT01650636|75647569|FG000|NOT COMPLETED|Intervention Phase||0||
59548512|NCT01650636|75647570|FG001|NOT COMPLETED|Intervention Phase||0||
59548513|NCT01650636|75647569|FG000|STARTED|Washout up to 5 Months||150||
59548514|NCT01650636|75647570|FG001|STARTED|Washout up to 5 Months||150||
59548515|NCT01650636|75647569|FG000|COMPLETED|Washout up to 5 Months||141||
59548516|NCT01650636|75647570|FG001|COMPLETED|Washout up to 5 Months||132||
59548517|NCT01650636|75647569|FG000|NOT COMPLETED|Washout up to 5 Months||9||
59548518|NCT01650636|75647570|FG001|NOT COMPLETED|Washout up to 5 Months||18||
59548519|NCT01650636|75647569|FG000|STARTED|5 Month Visit||141||
59548520|NCT01650636|75647570|FG001|STARTED|5 Month Visit||132||
59706407|NCT01268501|75825589|FG000|NOT COMPLETED|Overall Study||9||
59548521|NCT01650636|75647569|FG000|COMPLETED|5 Month Visit||141||
59706408|NCT01268267|75825593|FG000|STARTED|Overall Study||94||
59548522|NCT01650636|75647570|FG001|COMPLETED|5 Month Visit||132||
59548523|NCT01650636|75647569|FG000|NOT COMPLETED|5 Month Visit||0||
59548524|NCT01650636|75647570|FG001|NOT COMPLETED|5 Month Visit||0||
59548525|NCT01650636|75647569|FG000|STARTED|Washout up to 9 Months||141||
59706409|NCT01268267|75825593|FG000|COMPLETED|Overall Study||93||
59548526|NCT01650636|75647570|FG001|STARTED|Washout up to 9 Months||132||
59548527|NCT01650636|75647569|FG000|COMPLETED|Washout up to 9 Months||135||
59548528|NCT01650636|75647570|FG001|COMPLETED|Washout up to 9 Months||129||
59548529|NCT01650636|75647569|FG000|NOT COMPLETED|Washout up to 9 Months||6||
59548530|NCT01650636|75647570|FG001|NOT COMPLETED|Washout up to 9 Months||3||
59548531|NCT01650636|75647569|FG000|STARTED|9 Month Visit||135||
59548532|NCT01650636|75647570|FG001|STARTED|9 Month Visit||129||
59548533|NCT01650636|75647569|FG000|COMPLETED|9 Month Visit||135||
59548534|NCT01650636|75647570|FG001|COMPLETED|9 Month Visit||129||
59706410|NCT01268267|75825593|FG000|NOT COMPLETED|Overall Study||1||
59706411|NCT01267253|75825598|FG000|STARTED|Overall Study||31||
60080128|NCT03248492|76195298|FG004|STARTED|Overall Study||4||
60080129|NCT03248492|76195294|FG000|COMPLETED|Overall Study||0|Data from the Ongoing and Discontinued participants are presented as of data cutoff on 21 March 2019|
60080130|NCT03248492|76195295|FG001|COMPLETED|Overall Study||0|Data from the Ongoing and Discontinued participants are presented as of data cutoff on 21 March 2019|
60080131|NCT03248492|76195296|FG002|COMPLETED|Overall Study||0|Data from the Ongoing and Discontinued participants are presented as of data cutoff on 21 March 2019|
60080132|NCT03248492|76195297|FG003|COMPLETED|Overall Study||0|Data from the Ongoing and Discontinued participants are presented as of data cutoff on 21 March 2019|
60080133|NCT03248492|76195298|FG004|COMPLETED|Overall Study||0|Data from the Ongoing and Discontinued participants are presented as of data cutoff on 21 March 2019|
60080134|NCT03248492|76195294|FG000|NOT COMPLETED|Overall Study||50||
60080135|NCT03248492|76195295|FG001|NOT COMPLETED|Overall Study||48||
60080136|NCT03248492|76195296|FG002|NOT COMPLETED|Overall Study||21||
60080137|NCT03248492|76195297|FG003|NOT COMPLETED|Overall Study||130||
60080138|NCT03248492|76195298|FG004|NOT COMPLETED|Overall Study||4||
60080139|NCT03224468|76195320|FG000|STARTED|Overall Study||173||
60080140|NCT03224468|76195321|FG001|STARTED|Overall Study||96||
60080141|NCT03224468|76195320|FG000|COMPLETED|Overall Study||105||
60080142|NCT03224468|76195321|FG001|COMPLETED|Overall Study||81||
60080143|NCT03224468|76195320|FG000|NOT COMPLETED|Overall Study||68||
60080144|NCT03224468|76195321|FG001|NOT COMPLETED|Overall Study||15||
60080145|NCT03149003|76195330|FG000|STARTED|Overall Study||4||
60080146|NCT03149003|76195331|FG001|STARTED|Overall Study||109||
60080147|NCT03149003|76195332|FG002|STARTED|Overall Study||108||
60080148|NCT03149003|76195330|FG000|COMPLETED|Overall Study||4||
60080149|NCT03149003|76195331|FG001|COMPLETED|Overall Study||108||
60080150|NCT03149003|76195332|FG002|COMPLETED|Overall Study||90||
60080151|NCT03149003|76195330|FG000|NOT COMPLETED|Overall Study||0||
60080152|NCT03149003|76195331|FG001|NOT COMPLETED|Overall Study||1||
60080153|NCT03149003|76195332|FG002|NOT COMPLETED|Overall Study||18||
60080154|NCT03103581|76195340|FG000|STARTED|Overall Study||17||
60080155|NCT03103581|76195340|FG000|COMPLETED|Overall Study||15||
60080156|NCT03103581|76195340|FG000|NOT COMPLETED|Overall Study||2||
60080157|NCT03093974|76195346|FG000|STARTED|Overall Study||177||
60080158|NCT03093974|76195347|FG001|STARTED|Overall Study||200||
60080159|NCT03093974|76195346|FG000|Modified Intention to Treat Population - (mITT)|Overall Study||176||
60080160|NCT03093974|76195347|FG001|Modified Intention to Treat Population - (mITT)|Overall Study||197||
60080161|NCT03093974|76195346|FG000|Safety Population (SAF)|Overall Study||176||
60080162|NCT03093974|76195347|FG001|Safety Population (SAF)|Overall Study||197||
60080163|NCT03093974|76195346|FG000|Per -Protocol Population (PP)|Overall Study||117||
60080164|NCT03093974|76195347|FG001|Per -Protocol Population (PP)|Overall Study||122||
60080165|NCT03093974|76195346|FG000|COMPLETED|Overall Study||123||
60080166|NCT03093974|76195347|FG001|COMPLETED|Overall Study||129||
60080167|NCT03093974|76195346|FG000|NOT COMPLETED|Overall Study||54||
60080168|NCT03093974|76195347|FG001|NOT COMPLETED|Overall Study||71||
60080169|NCT03089606|76195353|FG000|STARTED|Overall Study||27||
59548535|NCT01650636|75647569|FG000|NOT COMPLETED|9 Month Visit||0||
59548536|NCT01650636|75647570|FG001|NOT COMPLETED|9 Month Visit||0||
59706412|NCT01267253|75825598|FG000|COMPLETED|Overall Study|Eligible and treated patients|28||
59706413|NCT01267253|75825598|FG000|NOT COMPLETED|Overall Study||3||
59706414|NCT01266317|75825602|FG000|STARTED|Overall Study|One additional patient was a protocol violation post consent when autoantibodies returned positive|9||
60080170|NCT03089606|76195353|FG000|COMPLETED|Overall Study||26||
60080171|NCT03089606|76195353|FG000|NOT COMPLETED|Overall Study||1||
60080172|NCT03023332|76195369|FG000|STARTED|Overall Study||86||
60080173|NCT03023332|76195370|FG001|STARTED|Overall Study||86||
60080174|NCT03023332|76195371|FG002|STARTED|Overall Study||70||
60080175|NCT03023332|76195372|FG003|STARTED|Overall Study||68||
60080176|NCT03023332|76195369|FG000|COMPLETED|Overall Study||62||
60080177|NCT03023332|76195370|FG001|COMPLETED|Overall Study||65||
60080178|NCT03023332|76195371|FG002|COMPLETED|Overall Study||58||
60080179|NCT03023332|76195372|FG003|COMPLETED|Overall Study||48||
60080180|NCT03023332|76195369|FG000|NOT COMPLETED|Overall Study||24||
60080181|NCT03023332|76195370|FG001|NOT COMPLETED|Overall Study||21||
60080182|NCT03023332|76195371|FG002|NOT COMPLETED|Overall Study||12||
60080183|NCT03023332|76195372|FG003|NOT COMPLETED|Overall Study||20||
60080184|NCT03023085|76195386|FG000|STARTED|Overall Study||40||
59548537|NCT02436876|75647580|FG000|STARTED|Overall Study||6||
59548538|NCT02436876|75647581|FG001|STARTED|Overall Study||9||
59548539|NCT02436876|75647582|FG002|STARTED|Overall Study||7||
60080185|NCT03023085|76195387|FG001|STARTED|Overall Study||37||
60080186|NCT03023085|76195388|FG002|STARTED|Overall Study||17||
60080187|NCT03023085|76195389|FG003|STARTED|Overall Study||20||
60080188|NCT03023085|76195386|FG000|COMPLETED|Overall Study||38||
59548540|NCT02436876|75647583|FG003|STARTED|Overall Study||7||
59706415|NCT01266317|75825602|FG000|COMPLETED|Overall Study||7||
59706416|NCT01266317|75825602|FG000|NOT COMPLETED|Overall Study||2||
59706417|NCT01266161|75825608|FG000|STARTED|Overall Study||52||
59706418|NCT01266161|75825609|FG001|STARTED|Overall Study||54||
59706419|NCT01266161|75825608|FG000|COMPLETED|Overall Study||48||
59706420|NCT01266161|75825609|FG001|COMPLETED|Overall Study||53||
60080189|NCT03023085|76195387|FG001|COMPLETED|Overall Study||26||
60080190|NCT03023085|76195388|FG002|COMPLETED|Overall Study||17||
60080191|NCT03023085|76195389|FG003|COMPLETED|Overall Study||19||
60080192|NCT03023085|76195386|FG000|NOT COMPLETED|Overall Study||2||
59706421|NCT01266161|75825608|FG000|NOT COMPLETED|Overall Study||4||
60080193|NCT03023085|76195387|FG001|NOT COMPLETED|Overall Study||11||
60080194|NCT03023085|76195388|FG002|NOT COMPLETED|Overall Study||0||
60080195|NCT03023085|76195389|FG003|NOT COMPLETED|Overall Study||1||
60080196|NCT02993731|76195401|FG000|STARTED|Overall Study||565||
60080197|NCT02993731|76195402|FG001|STARTED|Overall Study||569||
60080198|NCT02993731|76195401|FG000|COMPLETED|Overall Study||464||
60080199|NCT02993731|76195402|FG001|COMPLETED|Overall Study||464||
60080200|NCT02993731|76195401|FG000|NOT COMPLETED|Overall Study||101||
60080201|NCT02993731|76195402|FG001|NOT COMPLETED|Overall Study||105||
60080202|NCT02903368|76195420|FG000|STARTED|Part 1||59||
60080203|NCT02903368|76195421|FG001|STARTED|Part 1||59||
60080204|NCT02903368|76195422|FG002|STARTED|Part 1||0||
60080205|NCT02903368|76195423|FG003|STARTED|Part 1||0||
60080206|NCT02903368|76195420|FG000|COMPLETED|Part 1||55||
60080207|NCT02903368|76195421|FG001|COMPLETED|Part 1||59||
60080208|NCT02903368|76195422|FG002|COMPLETED|Part 1||0||
60080209|NCT02903368|76195423|FG003|COMPLETED|Part 1||0||
60080210|NCT02903368|76195420|FG000|NOT COMPLETED|Part 1||4||
60080211|NCT02903368|76195421|FG001|NOT COMPLETED|Part 1||0||
60080212|NCT02903368|76195422|FG002|NOT COMPLETED|Part 1||0||
60080213|NCT02903368|76195423|FG003|NOT COMPLETED|Part 1||0||
60080214|NCT02903368|76195420|FG000|STARTED|Part 2||0|Only 82 patients underwent part 2 randomization; the remaining 36 patients did not participate in part 2 randomization.|
60080215|NCT02903368|76195421|FG001|STARTED|Part 2||0|Only 82 patients underwent part 2 randomization; the remaining 36 patients did not participate in part 2 randomization.|
60080216|NCT02903368|76195422|FG002|STARTED|Part 2||42|Only 82 patients underwent part 2 randomization; the remaining 36 patients did not participate in part 2 randomization.|
60080217|NCT02903368|76195423|FG003|STARTED|Part 2||40|Only 82 patients underwent part 2 randomization; the remaining 36 patients did not participate in part 2 randomization.|
60080218|NCT02903368|76195420|FG000|COMPLETED|Part 2||0||
60080219|NCT02903368|76195421|FG001|COMPLETED|Part 2||0||
60080220|NCT02903368|76195422|FG002|COMPLETED|Part 2||31||
60080221|NCT02903368|76195423|FG003|COMPLETED|Part 2||38||
60080222|NCT02903368|76195420|FG000|NOT COMPLETED|Part 2||0||
60080223|NCT02903368|76195421|FG001|NOT COMPLETED|Part 2||0||
60080224|NCT02903368|76195422|FG002|NOT COMPLETED|Part 2||11||
60080225|NCT02903368|76195423|FG003|NOT COMPLETED|Part 2||2||
60080226|NCT02826161|76195435|FG000|STARTED|Overall Study||1||
60080227|NCT02826161|76195436|FG001|STARTED|Overall Study||3||
60080228|NCT02826161|76195435|FG000|Discontinued Due to Treatment Related AE|Overall Study||1||
60080229|NCT02826161|76195436|FG001|Discontinued Due to Treatment Related AE|Overall Study||0||
60080230|NCT02826161|76195435|FG000|Discontinued Due to Death|Overall Study||0||
60080231|NCT02826161|76195436|FG001|Discontinued Due to Death|Overall Study||1||
60080232|NCT02826161|76195435|FG000|Discontinued Due to Patient Withdrawal|Overall Study||0||
60080233|NCT02826161|76195436|FG001|Discontinued Due to Patient Withdrawal|Overall Study||1||
60080234|NCT02826161|76195435|FG000|Discontinued Due to Withdrawal of ICF From Further FU|Overall Study||1||
60080235|NCT02826161|76195436|FG001|Discontinued Due to Withdrawal of ICF From Further FU|Overall Study||1||
60080236|NCT02826161|76195435|FG000|COMPLETED|Overall Study||1||
60080237|NCT02826161|76195436|FG001|COMPLETED|Overall Study||3||
60080238|NCT02826161|76195435|FG000|NOT COMPLETED|Overall Study||0||
60080239|NCT02826161|76195436|FG001|NOT COMPLETED|Overall Study||0||
60080240|NCT02753127|76195443|FG000|STARTED|Overall Study||624||
60080241|NCT02753127|76195444|FG001|STARTED|Overall Study||629||
60080242|NCT02753127|76195443|FG000|Discontinued Due to Death|Overall Study||507||
60080243|NCT02753127|76195444|FG001|Discontinued Due to Death|Overall Study||499||
60080244|NCT02753127|76195443|FG000|Completion of Survival Follow-Up Due to Study Completion|Overall Study||64||
60080245|NCT02753127|76195444|FG001|Completion of Survival Follow-Up Due to Study Completion|Overall Study||62||
60080246|NCT02753127|76195443|FG000|COMPLETED|Overall Study||571||
60080247|NCT02753127|76195444|FG001|COMPLETED|Overall Study||561||
60080248|NCT02753127|76195443|FG000|NOT COMPLETED|Overall Study||53||
60080249|NCT02753127|76195444|FG001|NOT COMPLETED|Overall Study||68||
60080250|NCT02657551|76195458|FG000|STARTED|Overall Study||8||
60080251|NCT02657551|76195458|FG000|COMPLETED|Overall Study||0||
60080252|NCT02657551|76195458|FG000|NOT COMPLETED|Overall Study||8||
60080253|NCT02577406|76195464|FG000|STARTED|Randomized Period||158||
60080254|NCT02577406|76195465|FG001|STARTED|Randomized Period||161||
60080255|NCT02577406|76195464|FG000|COMPLETED|Randomized Period||157|Continuing to treatment period|
59706422|NCT01266161|75825609|FG001|NOT COMPLETED|Overall Study||1||
59706423|NCT01265849|75825618|FG000|STARTED|Overall Study||396||
59706424|NCT01265849|75825619|FG001|STARTED|Overall Study||398||
59706425|NCT01265849|75825620|FG002|STARTED|Overall Study||134||
60080256|NCT02577406|76195465|FG001|COMPLETED|Randomized Period||141|Continuing to treatment period|
60080257|NCT02577406|76195464|FG000|NOT COMPLETED|Randomized Period||1||
60080258|NCT02577406|76195465|FG001|NOT COMPLETED|Randomized Period||20||
60080259|NCT02577406|76195464|FG000|STARTED|Treatment Period||157||
59706426|NCT01265849|75825618|FG000|COMPLETED|Overall Study||350||
59706427|NCT01265849|75825619|FG001|COMPLETED|Overall Study||337||
59706428|NCT01265849|75825620|FG002|COMPLETED|Overall Study||115||
59706429|NCT01265849|75825618|FG000|NOT COMPLETED|Overall Study||46||
59706430|NCT01265849|75825619|FG001|NOT COMPLETED|Overall Study||61||
59706431|NCT01265849|75825620|FG002|NOT COMPLETED|Overall Study||19||
59706432|NCT01265615|75825636|FG000|STARTED|Overall Study||30||
59706433|NCT01265615|75825637|FG001|STARTED|Overall Study||30||
59706434|NCT01265615|75825638|FG002|STARTED|Overall Study||30||
59706435|NCT01265615|75825639|FG003|STARTED|Overall Study||30||
59706436|NCT01265615|75825636|FG000|COMPLETED|Overall Study||28||
59548541|NCT02436876|75647580|FG000|Treated|Overall Study||6||
59548542|NCT02436876|75647581|FG001|Treated|Overall Study||6||
59548543|NCT02436876|75647582|FG002|Treated|Overall Study||6||
59548544|NCT02436876|75647583|FG003|Treated|Overall Study||7||
59548545|NCT02436876|75647580|FG000|COMPLETED|Overall Study||5||
59548546|NCT02436876|75647581|FG001|COMPLETED|Overall Study||5||
59548547|NCT02436876|75647582|FG002|COMPLETED|Overall Study||5||
59548548|NCT02436876|75647583|FG003|COMPLETED|Overall Study||5||
59548549|NCT02436876|75647580|FG000|NOT COMPLETED|Overall Study||1||
59548550|NCT02436876|75647581|FG001|NOT COMPLETED|Overall Study||4||
59548551|NCT02436876|75647582|FG002|NOT COMPLETED|Overall Study||2||
59548552|NCT02436876|75647583|FG003|NOT COMPLETED|Overall Study||2||
59548553|NCT02495103|75647600|FG000|STARTED|Overall Study||3||
59548554|NCT02495103|75647601|FG001|STARTED|Overall Study||4||
59548555|NCT02495103|75647600|FG000|COMPLETED|Overall Study||3||
59548556|NCT02495103|75647601|FG001|COMPLETED|Overall Study||4||
59548557|NCT02495103|75647600|FG000|NOT COMPLETED|Overall Study||0||
59548558|NCT02495103|75647601|FG001|NOT COMPLETED|Overall Study||0||
59548559|NCT02382276|75647612|FG000|STARTED|Overall Study||137||
59548560|NCT02382276|75647613|FG001|STARTED|Overall Study||94||
59548561|NCT02382276|75647614|FG002|STARTED|Overall Study||172||
59548562|NCT02382276|75647612|FG000|COMPLETED|Overall Study||126||
59548563|NCT02382276|75647613|FG001|COMPLETED|Overall Study||84||
59548564|NCT02382276|75647614|FG002|COMPLETED|Overall Study||133||
59548565|NCT02382276|75647612|FG000|NOT COMPLETED|Overall Study||11||
59548566|NCT02382276|75647613|FG001|NOT COMPLETED|Overall Study||10||
59548567|NCT02382276|75647614|FG002|NOT COMPLETED|Overall Study||39||
59548568|NCT02495259|75647623|FG000|STARTED|Overall Study||7||
59548569|NCT02495259|75647624|FG001|STARTED|Overall Study||4||
59548570|NCT02495259|75647625|FG002|STARTED|Overall Study||8||
59548571|NCT02495259|75647623|FG000|COMPLETED|Overall Study||7||
59548572|NCT02495259|75647624|FG001|COMPLETED|Overall Study||3||
59548573|NCT02495259|75647625|FG002|COMPLETED|Overall Study||8||
59548574|NCT02495259|75647623|FG000|NOT COMPLETED|Overall Study||0||
59548575|NCT02495259|75647624|FG001|NOT COMPLETED|Overall Study||1||
59548576|NCT02495259|75647625|FG002|NOT COMPLETED|Overall Study||0||
59548577|NCT02570295|75647635|FG000|STARTED|Overall Study||375||
59548578|NCT02570295|75647636|FG001|STARTED|Overall Study||347||
59548579|NCT02570295|75647635|FG000|COMPLETED|Overall Study||364||
59548580|NCT02570295|75647636|FG001|COMPLETED|Overall Study||289||
59548581|NCT02570295|75647635|FG000|NOT COMPLETED|Overall Study||11||
59548582|NCT02570295|75647636|FG001|NOT COMPLETED|Overall Study||58||
59548583|NCT02571153|75647645|FG000|STARTED|Overall Study||45||
59548584|NCT02571153|75647646|FG001|STARTED|Overall Study||45||
59548585|NCT02571153|75647647|FG002|STARTED|Overall Study||45||
59548586|NCT02571153|75647645|FG000|COMPLETED|Overall Study||39||
59548587|NCT02571153|75647646|FG001|COMPLETED|Overall Study||37||
59548588|NCT02571153|75647647|FG002|COMPLETED|Overall Study||43||
59548589|NCT02571153|75647645|FG000|NOT COMPLETED|Overall Study||6||
59548590|NCT02571153|75647646|FG001|NOT COMPLETED|Overall Study||8||
59548591|NCT02571153|75647647|FG002|NOT COMPLETED|Overall Study||2||
59548592|NCT02436408|75647655|FG000|STARTED|Overall Study||35||
59548593|NCT02436408|75647655|FG000|COMPLETED|Overall Study||34||
59548594|NCT02436408|75647655|FG000|NOT COMPLETED|Overall Study||1||
59548595|NCT04573322|75647663|FG000|STARTED|Overall Study||6||
59548596|NCT04573322|75647664|FG001|STARTED|Overall Study||6||
59548597|NCT04573322|75647665|FG002|STARTED|Overall Study||7||
59548598|NCT04573322|75647666|FG003|STARTED|Overall Study||6||
59706437|NCT01265615|75825637|FG001|COMPLETED|Overall Study||28||
59548599|NCT04573322|75647663|FG000|COMPLETED|Overall Study||5||
59548600|NCT04573322|75647664|FG001|COMPLETED|Overall Study||4||
59548601|NCT04573322|75647665|FG002|COMPLETED|Overall Study||5||
59706438|NCT01265615|75825638|FG002|COMPLETED|Overall Study||26||
59706439|NCT01265615|75825639|FG003|COMPLETED|Overall Study||27||
59548602|NCT04573322|75647666|FG003|COMPLETED|Overall Study||3||
59706440|NCT01265615|75825636|FG000|NOT COMPLETED|Overall Study||2||
59706441|NCT01265615|75825637|FG001|NOT COMPLETED|Overall Study||2||
59548603|NCT04573322|75647663|FG000|NOT COMPLETED|Overall Study||1||
59548604|NCT04573322|75647664|FG001|NOT COMPLETED|Overall Study||2||
59548605|NCT04573322|75647665|FG002|NOT COMPLETED|Overall Study||2||
59548606|NCT04573322|75647666|FG003|NOT COMPLETED|Overall Study||3||
59548607|NCT02436330|75647678|FG000|STARTED|Cohort 1||14||
59548608|NCT02436330|75647679|FG001|STARTED|Cohort 1||4||
59548609|NCT02436330|75647678|FG000|COMPLETED|Cohort 1||9||
59548610|NCT02436330|75647679|FG001|COMPLETED|Cohort 1||1||
59548611|NCT02436330|75647678|FG000|NOT COMPLETED|Cohort 1||5||
59548612|NCT02436330|75647679|FG001|NOT COMPLETED|Cohort 1||3||
59548613|NCT02436330|75647678|FG000|STARTED|Cohort 2||14||
59548614|NCT02436330|75647679|FG001|STARTED|Cohort 2||10||
59548615|NCT02436330|75647678|FG000|COMPLETED|Cohort 2||10||
59548616|NCT02436330|75647679|FG001|COMPLETED|Cohort 2||7||
59548617|NCT02436330|75647678|FG000|NOT COMPLETED|Cohort 2||4||
59548618|NCT02436330|75647679|FG001|NOT COMPLETED|Cohort 2||3||
59548619|NCT02436330|75647678|FG000|STARTED|Cohort 3||12||
59548620|NCT02436330|75647679|FG001|STARTED|Cohort 3|Enrollment too low to have control group. All subjects in this cohort received intervention.|0||
59548621|NCT02436330|75647678|FG000|COMPLETED|Cohort 3||7||
59548622|NCT02436330|75647679|FG001|COMPLETED|Cohort 3||0||
59548623|NCT02436330|75647678|FG000|NOT COMPLETED|Cohort 3||5||
59548624|NCT02436330|75647679|FG001|NOT COMPLETED|Cohort 3||0||
59548625|NCT02436330|75647678|FG000|STARTED|Cohort 4||6||
59548626|NCT02436330|75647679|FG001|STARTED|Cohort 4|Enrollment too low to have control group. All subjects in this cohort received intervention.|0||
59548627|NCT02436330|75647678|FG000|COMPLETED|Cohort 4||4||
59548628|NCT02436330|75647679|FG001|COMPLETED|Cohort 4||0||
59548629|NCT02436330|75647678|FG000|NOT COMPLETED|Cohort 4||2||
59548630|NCT02436330|75647679|FG001|NOT COMPLETED|Cohort 4||0||
59548631|NCT02436330|75647678|FG000|STARTED|Cohort 5||10||
59548632|NCT02436330|75647679|FG001|STARTED|Cohort 5||5||
59548633|NCT02436330|75647678|FG000|COMPLETED|Cohort 5||4||
59548634|NCT02436330|75647679|FG001|COMPLETED|Cohort 5||1||
59548635|NCT02436330|75647678|FG000|NOT COMPLETED|Cohort 5||6||
59548636|NCT02436330|75647679|FG001|NOT COMPLETED|Cohort 5||4||
59548637|NCT02436330|75647678|FG000|STARTED|Cohort 6||4||
59548638|NCT02436330|75647679|FG001|STARTED|Cohort 6||5||
59548639|NCT02436330|75647678|FG000|COMPLETED|Cohort 6||1||
59548640|NCT02436330|75647679|FG001|COMPLETED|Cohort 6||4||
59548641|NCT02436330|75647678|FG000|NOT COMPLETED|Cohort 6||3||
59548642|NCT02436330|75647679|FG001|NOT COMPLETED|Cohort 6||1||
59548643|NCT01143818|75647691|FG000|STARTED|Overall Study|A total of 1053 participants were enrolled but only 1049 received study drug.|1049||
59548644|NCT01143818|75647691|FG000|COMPLETED|Overall Study||799||
59548645|NCT01143818|75647691|FG000|NOT COMPLETED|Overall Study||250||
59548646|NCT02573181|75647697|FG000|STARTED|Overall Study||127||
59548647|NCT02573181|75647698|FG001|STARTED|Overall Study||126||
59548648|NCT02573181|75647697|FG000|Vaccinated|Overall Study||127||
59548649|NCT02573181|75647698|FG001|Vaccinated|Overall Study||126||
59548650|NCT02573181|75647697|FG000|COMPLETED|Overall Study||127||
59548651|NCT02573181|75647698|FG001|COMPLETED|Overall Study||126||
59548652|NCT02573181|75647697|FG000|NOT COMPLETED|Overall Study||0||
59548653|NCT02573181|75647698|FG001|NOT COMPLETED|Overall Study||0||
59548654|NCT02498769|75647706|FG000|STARTED|Overall Study||63||
59548655|NCT02498769|75647707|FG001|STARTED|Overall Study||67||
59548656|NCT02498769|75647706|FG000|COMPLETED|Overall Study||63||
59548657|NCT02498769|75647707|FG001|COMPLETED|Overall Study||67||
59548658|NCT02498769|75647706|FG000|NOT COMPLETED|Overall Study||0||
59548659|NCT02498769|75647707|FG001|NOT COMPLETED|Overall Study||0||
59548660|NCT01650558|75647716|FG000|STARTED|Overall Study||500||
59548661|NCT01650558|75647717|FG001|STARTED|Overall Study||500||
59548662|NCT01650558|75647718|FG002|STARTED|Overall Study||499||
59548663|NCT01650558|75647716|FG000|COMPLETED|Overall Study||417||
59548664|NCT01650558|75647717|FG001|COMPLETED|Overall Study||408||
59548665|NCT01650558|75647718|FG002|COMPLETED|Overall Study||424||
59548666|NCT01650558|75647716|FG000|NOT COMPLETED|Overall Study||83||
59548667|NCT01650558|75647717|FG001|NOT COMPLETED|Overall Study||92||
59548668|NCT01650558|75647718|FG002|NOT COMPLETED|Overall Study||75||
59548669|NCT02579343|75647729|FG000|STARTED|Overall Study||7||
59548670|NCT02579343|75647730|FG001|STARTED|Overall Study||6||
59548671|NCT02579343|75647729|FG000|COMPLETED|Overall Study||7||
59548672|NCT02579343|75647730|FG001|COMPLETED|Overall Study||6||
59548673|NCT02579343|75647729|FG000|NOT COMPLETED|Overall Study||0||
59548674|NCT02579343|75647730|FG001|NOT COMPLETED|Overall Study||0||
59548675|NCT01144286|75647740|FG000|STARTED|Overall Study||57||
59548676|NCT01144286|75647741|FG001|STARTED|Overall Study||58||
59548677|NCT01144286|75647742|FG002|STARTED|Overall Study||58||
59548678|NCT01144286|75647743|FG003|STARTED|Overall Study||56||
59548679|NCT01144286|75647740|FG000|COMPLETED|Overall Study||57||
59548680|NCT01144286|75647741|FG001|COMPLETED|Overall Study||58||
59548681|NCT01144286|75647742|FG002|COMPLETED|Overall Study||58||
59548682|NCT01144286|75647743|FG003|COMPLETED|Overall Study||56||
59548683|NCT01144286|75647740|FG000|NOT COMPLETED|Overall Study||0||
59548684|NCT01144286|75647741|FG001|NOT COMPLETED|Overall Study||0||
59548685|NCT01144286|75647742|FG002|NOT COMPLETED|Overall Study||0||
59548686|NCT01144286|75647743|FG003|NOT COMPLETED|Overall Study||0||
59548687|NCT01144442|75647753|FG000|STARTED|Overall Study||10||
59548688|NCT01144442|75647753|FG000|COMPLETED|Overall Study||10||
59548689|NCT01144442|75647753|FG000|NOT COMPLETED|Overall Study||0||
59548690|NCT02408484|75647757|FG000|STARTED|Overall Study||15||
59548691|NCT02408484|75647757|FG000|SAF Population|Overall Study||14|SAF = safety analysis population|
59548692|NCT02408484|75647757|FG000|FAS Population|Overall Study||14|FAS = full analysis population|
59548693|NCT02408484|75647757|FG000|PK Population|Overall Study||13|PK = pharmacokinetic population|
59548694|NCT02408484|75647757|FG000|firstBLEED Population|Overall Study||8|firstBLEED population = patients that have had at least one bleeding event treated with Octafibrin|
59548695|NCT02408484|75647757|FG000|BLEED Population|Overall Study||8|BLEED population = patients with all documented BEs treated with Octafibrin|
59548696|NCT02408484|75647757|FG000|SURG Population|Overall Study||3|SURG population = patients with surgical interventions with a least one infusion of Octafibrin|
59548697|NCT02408484|75647757|FG000|COMPLETED|Overall Study||11||
59548698|NCT02408484|75647757|FG000|NOT COMPLETED|Overall Study||4||
59548699|NCT01144598|75647777|FG000|STARTED|Overall Study||356||
59548700|NCT01144598|75647777|FG000|Analysis Population|Overall Study||356||
59548701|NCT01144598|75647777|FG000|COMPLETED|Overall Study||356||
59548702|NCT01144598|75647777|FG000|NOT COMPLETED|Overall Study||0||
59548703|NCT02499081|75647781|FG000|STARTED|Overall Study||20||
59548704|NCT02499081|75647781|FG000|COMPLETED|Overall Study||1||
59548705|NCT02499081|75647781|FG000|NOT COMPLETED|Overall Study||19||
59548706|NCT02380248|75647785|FG000|STARTED|Overall Study||200||
59548707|NCT02380248|75647785|FG000|COMPLETED|Overall Study||186||
59548708|NCT02380248|75647785|FG000|NOT COMPLETED|Overall Study||14||
59548709|NCT01146704|75647792|FG000|STARTED|Overall Study||16||
59548710|NCT01146704|75647793|FG001|STARTED|Overall Study||15||
59548711|NCT01146704|75647792|FG000|COMPLETED|Overall Study||16||
59548712|NCT01146704|75647793|FG001|COMPLETED|Overall Study||15||
59548713|NCT01146704|75647792|FG000|NOT COMPLETED|Overall Study||0||
59548714|NCT01146704|75647793|FG001|NOT COMPLETED|Overall Study||0||
59548715|NCT02501265|75647803|FG000|STARTED|Overall Study||63||
59548716|NCT02501265|75647804|FG001|STARTED|Overall Study||30||
59548717|NCT02501265|75647805|FG002|STARTED|Overall Study||64||
59548718|NCT02501265|75647806|FG003|STARTED|Overall Study||31||
59548719|NCT02501265|75647803|FG000|COMPLETED|Overall Study||46||
59548720|NCT02501265|75647804|FG001|COMPLETED|Overall Study||21||
59548721|NCT02501265|75647805|FG002|COMPLETED|Overall Study||46||
59548722|NCT02501265|75647806|FG003|COMPLETED|Overall Study||23||
59548723|NCT02501265|75647803|FG000|NOT COMPLETED|Overall Study||17||
59548724|NCT02501265|75647804|FG001|NOT COMPLETED|Overall Study||9||
59548725|NCT02501265|75647805|FG002|NOT COMPLETED|Overall Study||18||
59548726|NCT02501265|75647806|FG003|NOT COMPLETED|Overall Study||8||
59548727|NCT01181492|75647819|FG000|STARTED|Overall Study||103||
59548728|NCT01181492|75647820|FG001|STARTED|Overall Study||66||
59548729|NCT01181492|75647821|FG002|STARTED|Overall Study||7||
59548730|NCT01181492|75647819|FG000|COMPLETED|Overall Study||103||
59548731|NCT01181492|75647820|FG001|COMPLETED|Overall Study||66||
59548732|NCT01181492|75647821|FG002|COMPLETED|Overall Study||7||
59548733|NCT01181492|75647819|FG000|NOT COMPLETED|Overall Study||0||
59548734|NCT01181492|75647820|FG001|NOT COMPLETED|Overall Study||0||
59548735|NCT01181492|75647821|FG002|NOT COMPLETED|Overall Study||0||
59548736|NCT02408016|75647832|FG000|STARTED|Overall Study||6||
59548737|NCT02408016|75647833|FG001|STARTED|Overall Study||4||
59548738|NCT02408016|75647834|FG002|STARTED|Overall Study||0||
59548739|NCT02408016|75647832|FG000|COMPLETED|Overall Study||0||
59548740|NCT02408016|75647833|FG001|COMPLETED|Overall Study||1||
59548741|NCT02408016|75647834|FG002|COMPLETED|Overall Study||0||
59548742|NCT02408016|75647832|FG000|NOT COMPLETED|Overall Study||6||
59548743|NCT02408016|75647833|FG001|NOT COMPLETED|Overall Study||3||
59548744|NCT02408016|75647834|FG002|NOT COMPLETED|Overall Study||0||
59548745|NCT02579421|75647846|FG000|STARTED|Overall Study||23||
59548746|NCT02579421|75647847|FG001|STARTED|Overall Study||23||
59548747|NCT02579421|75647848|FG002|STARTED|Overall Study||6||
59548748|NCT02579421|75647849|FG003|STARTED|Overall Study||6||
59548749|NCT02579421|75647846|FG000|COMPLETED|Overall Study||17||
59548750|NCT02579421|75647847|FG001|COMPLETED|Overall Study||18||
59548751|NCT02579421|75647848|FG002|COMPLETED|Overall Study||5||
59548752|NCT02579421|75647849|FG003|COMPLETED|Overall Study||3||
59548753|NCT02579421|75647846|FG000|NOT COMPLETED|Overall Study||6||
59548754|NCT02579421|75647847|FG001|NOT COMPLETED|Overall Study||5||
59548755|NCT02579421|75647848|FG002|NOT COMPLETED|Overall Study||1||
59548756|NCT02579421|75647849|FG003|NOT COMPLETED|Overall Study||3||
59548757|NCT01181804|75647863|FG000|STARTED|Period 1, Fed (Part 1)||30||
59548758|NCT01181804|75647864|FG001|STARTED|Period 1, Fed (Part 1)||30||
59548759|NCT01181804|75647865|FG002|STARTED|Period 1, Fed (Part 1)||0||
59548760|NCT01181804|75647866|FG003|STARTED|Period 1, Fed (Part 1)||0||
59548761|NCT01181804|75647863|FG000|COMPLETED|Period 1, Fed (Part 1)||30||
59548762|NCT01181804|75647864|FG001|COMPLETED|Period 1, Fed (Part 1)||30||
59548763|NCT01181804|75647865|FG002|COMPLETED|Period 1, Fed (Part 1)||0||
59548764|NCT01181804|75647866|FG003|COMPLETED|Period 1, Fed (Part 1)||0||
59548765|NCT01181804|75647863|FG000|NOT COMPLETED|Period 1, Fed (Part 1)||0||
59548766|NCT01181804|75647864|FG001|NOT COMPLETED|Period 1, Fed (Part 1)||0||
59548767|NCT01181804|75647865|FG002|NOT COMPLETED|Period 1, Fed (Part 1)||0||
59548768|NCT01181804|75647866|FG003|NOT COMPLETED|Period 1, Fed (Part 1)||0||
59548769|NCT01181804|75647863|FG000|STARTED|Period 2, Fed (Part 1)||30||
59548770|NCT01181804|75647864|FG001|STARTED|Period 2, Fed (Part 1)||30||
59548771|NCT01181804|75647865|FG002|STARTED|Period 2, Fed (Part 1)||0||
59548772|NCT01181804|75647866|FG003|STARTED|Period 2, Fed (Part 1)||0||
59548773|NCT01181804|75647863|FG000|COMPLETED|Period 2, Fed (Part 1)||30||
59548774|NCT01181804|75647864|FG001|COMPLETED|Period 2, Fed (Part 1)||30||
59548775|NCT01181804|75647865|FG002|COMPLETED|Period 2, Fed (Part 1)||0||
59548776|NCT01181804|75647866|FG003|COMPLETED|Period 2, Fed (Part 1)||0||
59548777|NCT01181804|75647863|FG000|NOT COMPLETED|Period 2, Fed (Part 1)||0||
59548778|NCT01181804|75647864|FG001|NOT COMPLETED|Period 2, Fed (Part 1)||0||
59548779|NCT01181804|75647865|FG002|NOT COMPLETED|Period 2, Fed (Part 1)||0||
59548780|NCT01181804|75647866|FG003|NOT COMPLETED|Period 2, Fed (Part 1)||0||
59548781|NCT01181804|75647863|FG000|STARTED|Period 3, Fasted (Part 2)||0||
59548782|NCT01181804|75647864|FG001|STARTED|Period 3, Fasted (Part 2)||0||
59548783|NCT01181804|75647865|FG002|STARTED|Period 3, Fasted (Part 2)||59||
59548784|NCT01181804|75647866|FG003|STARTED|Period 3, Fasted (Part 2)||58||
59548785|NCT01181804|75647863|FG000|COMPLETED|Period 3, Fasted (Part 2)||0||
59548786|NCT01181804|75647864|FG001|COMPLETED|Period 3, Fasted (Part 2)||0||
59548787|NCT01181804|75647865|FG002|COMPLETED|Period 3, Fasted (Part 2)||59||
59548788|NCT01181804|75647866|FG003|COMPLETED|Period 3, Fasted (Part 2)||58||
59548789|NCT01181804|75647863|FG000|NOT COMPLETED|Period 3, Fasted (Part 2)||0||
59548790|NCT01181804|75647864|FG001|NOT COMPLETED|Period 3, Fasted (Part 2)||0||
59548791|NCT01181804|75647865|FG002|NOT COMPLETED|Period 3, Fasted (Part 2)||0||
59548792|NCT01181804|75647866|FG003|NOT COMPLETED|Period 3, Fasted (Part 2)||0||
59548793|NCT01181804|75647863|FG000|STARTED|Period 4, Fasted (Part 2)||0||
59991041|NCT03318523|76106558|FG002|STARTED|DBE Period:Year 2 to EOS (Up to 3 Years)||0|Out of 345 participants who completed the PC Period, only 344 entered the DBE Period.|
59991042|NCT03318523|76106559|FG003|STARTED|DBE Period:Year 2 to EOS (Up to 3 Years)||0|Out of 345 participants who completed the PC Period, only 344 entered the DBE Period.|
59991043|NCT03318523|76106560|FG004|STARTED|DBE Period:Year 2 to EOS (Up to 3 Years)||20|Out of 345 participants who completed the PC Period, only 344 entered the DBE Period.|
59991044|NCT03318523|76106561|FG005|STARTED|DBE Period:Year 2 to EOS (Up to 3 Years)||37|Out of 345 participants who completed the PC Period, only 344 entered the DBE Period.|
59995084|NCT02550093|76110917|FG000|STARTED|Wash-out Period||10||
59995085|NCT02550093|76110918|FG001|STARTED|Wash-out Period||10||
59548794|NCT01181804|75647864|FG001|STARTED|Period 4, Fasted (Part 2)||0||
59548795|NCT01181804|75647865|FG002|STARTED|Period 4, Fasted (Part 2)||59||
59548796|NCT01181804|75647866|FG003|STARTED|Period 4, Fasted (Part 2)||58||
59548797|NCT01181804|75647863|FG000|COMPLETED|Period 4, Fasted (Part 2)||0||
59548798|NCT01181804|75647864|FG001|COMPLETED|Period 4, Fasted (Part 2)||0||
59548799|NCT01181804|75647865|FG002|COMPLETED|Period 4, Fasted (Part 2)||58||
59548800|NCT01181804|75647866|FG003|COMPLETED|Period 4, Fasted (Part 2)||58||
59548801|NCT01181804|75647863|FG000|NOT COMPLETED|Period 4, Fasted (Part 2)||0||
59548802|NCT01181804|75647864|FG001|NOT COMPLETED|Period 4, Fasted (Part 2)||0||
59548803|NCT01181804|75647865|FG002|NOT COMPLETED|Period 4, Fasted (Part 2)||1||
59548804|NCT01181804|75647866|FG003|NOT COMPLETED|Period 4, Fasted (Part 2)||0||
59548805|NCT01186250|75647878|FG000|STARTED|Overall Study||9||
59548806|NCT01186250|75647879|FG001|STARTED|Overall Study||9||
59548807|NCT01186250|75647878|FG000|COMPLETED|Overall Study||8||
59548808|NCT01186250|75647879|FG001|COMPLETED|Overall Study||9||
59548809|NCT01186250|75647878|FG000|NOT COMPLETED|Overall Study||1||
59548810|NCT01186250|75647879|FG001|NOT COMPLETED|Overall Study||0||
59548811|NCT01186406|75647885|FG000|STARTED|Overall Study||41||
59548812|NCT01186406|75647885|FG000|COMPLETED|Overall Study||41||
59548813|NCT01186406|75647885|FG000|NOT COMPLETED|Overall Study||0||
59548814|NCT02504073|75647889|FG000|STARTED|Overall Study||54||
59548815|NCT02504073|75647889|FG000|COMPLETED|Overall Study||54||
59548816|NCT02504073|75647889|FG000|NOT COMPLETED|Overall Study||0||
59548817|NCT02407704|75647898|FG000|STARTED|Overall Study||2||
59548818|NCT02407704|75647899|FG001|STARTED|Overall Study||3||
59548819|NCT02407704|75647900|FG002|STARTED|Overall Study||5||
59548820|NCT02407704|75647901|FG003|STARTED|Overall Study||5||
59706442|NCT01265615|75825638|FG002|NOT COMPLETED|Overall Study||4||
59995086|NCT02550093|76110917|FG000|COMPLETED|Wash-out Period||10||
59995087|NCT02550093|76110918|FG001|COMPLETED|Wash-out Period||10||
59995088|NCT02550093|76110917|FG000|NOT COMPLETED|Wash-out Period||0||
59995089|NCT02550093|76110918|FG001|NOT COMPLETED|Wash-out Period||0||
59995090|NCT02550093|76110917|FG000|STARTED|Intervention 2||10||
59995091|NCT02550093|76110918|FG001|STARTED|Intervention 2||10||
59995092|NCT02550093|76110917|FG000|COMPLETED|Intervention 2||10||
59995093|NCT02550093|76110918|FG001|COMPLETED|Intervention 2||10||
59995094|NCT02550093|76110917|FG000|NOT COMPLETED|Intervention 2||0||
59995095|NCT02550093|76110918|FG001|NOT COMPLETED|Intervention 2||0||
59995096|NCT04109547|76110930|FG000|STARTED|Overall Study||130||
59995097|NCT04109547|76110931|FG001|STARTED|Overall Study||130||
59995098|NCT04109547|76110932|FG002|STARTED|Overall Study||130||
59995099|NCT04109547|76110933|FG003|STARTED|Overall Study||131||
59995100|NCT04109547|76110930|FG000|Treated|Overall Study||130||
59995101|NCT04109547|76110931|FG001|Treated|Overall Study||130||
59995102|NCT04109547|76110932|FG002|Treated|Overall Study||129||
59995103|NCT04109547|76110933|FG003|Treated|Overall Study||131||
59995104|NCT04109547|76110930|FG000|Full Analysis Set|Overall Study||130||
59995105|NCT04109547|76110931|FG001|Full Analysis Set|Overall Study||130||
59995106|NCT04109547|76110932|FG002|Full Analysis Set|Overall Study||130||
59995107|NCT04109547|76110933|FG003|Full Analysis Set|Overall Study||131||
59995108|NCT04109547|76110930|FG000|Safety Analysis Set|Overall Study||130||
59995109|NCT04109547|76110931|FG001|Safety Analysis Set|Overall Study||130||
59995110|NCT04109547|76110932|FG002|Safety Analysis Set|Overall Study||129||
59995111|NCT04109547|76110933|FG003|Safety Analysis Set|Overall Study||131||
59995112|NCT04109547|76110930|FG000|COMPLETED|Overall Study||126||
59995113|NCT04109547|76110931|FG001|COMPLETED|Overall Study||126||
59995114|NCT04109547|76110932|FG002|COMPLETED|Overall Study||124||
59995115|NCT04109547|76110933|FG003|COMPLETED|Overall Study||124||
59995116|NCT04109547|76110930|FG000|NOT COMPLETED|Overall Study||4||
59995117|NCT04109547|76110931|FG001|NOT COMPLETED|Overall Study||4||
59995118|NCT04109547|76110932|FG002|NOT COMPLETED|Overall Study||6||
59995119|NCT04109547|76110933|FG003|NOT COMPLETED|Overall Study||7||
59995120|NCT04925271|76110945|FG000|STARTED|Overall Study||20||
60080260|NCT02577406|76195465|FG001|STARTED|Treatment Period||141||
60080261|NCT02577406|76195464|FG000|COMPLETED|Treatment Period||10|Ongoing treatment|
60080262|NCT02577406|76195465|FG001|COMPLETED|Treatment Period||4|Ongoing treatment|
60080263|NCT02577406|76195464|FG000|NOT COMPLETED|Treatment Period||147||
60080264|NCT02577406|76195465|FG001|NOT COMPLETED|Treatment Period||137||
60080265|NCT02527434|76195478|FG000|STARTED|Overall Study||32|Full Analysis Set (FAS)|
60080266|NCT02527434|76195479|FG001|STARTED|Overall Study||12|Full Analysis Set (FAS)|
60080267|NCT02527434|76195480|FG002|STARTED|Overall Study||20|Full Analysis Set (FAS)|
60080268|NCT02527434|76195478|FG000|Started Retreatment Phase (COMBO)|Overall Study||7|COMBO Analysis Set|
60080269|NCT02527434|76195479|FG001|Started Retreatment Phase (COMBO)|Overall Study||5|COMBO Analysis Set|
60080270|NCT02527434|76195480|FG002|Started Retreatment Phase (COMBO)|Overall Study||4|COMBO Analysis Set|
60080271|NCT02527434|76195478|FG000|Started Retreatment Phase (MEDI)|Overall Study||4|MEDI Analysis Set|
60080272|NCT02527434|76195479|FG001|Started Retreatment Phase (MEDI)|Overall Study||0|MEDI Analysis Set|
60080273|NCT02527434|76195480|FG002|Started Retreatment Phase (MEDI)|Overall Study||1|MEDI Analysis Set|
60080274|NCT02527434|76195478|FG000|COMPLETED|Overall Study||4||
60080275|NCT02527434|76195479|FG001|COMPLETED|Overall Study||1||
60080276|NCT02527434|76195480|FG002|COMPLETED|Overall Study||0||
60080277|NCT02527434|76195478|FG000|NOT COMPLETED|Overall Study||28||
60080278|NCT02527434|76195479|FG001|NOT COMPLETED|Overall Study||11||
60080279|NCT02527434|76195480|FG002|NOT COMPLETED|Overall Study||20||
60080280|NCT02460835|76195498|FG000|STARTED|Overall Study||77||
60080281|NCT02460835|76195498|FG000|COMPLETED|Overall Study||56||
60080282|NCT02460835|76195498|FG000|NOT COMPLETED|Overall Study||21||
60080283|NCT02432690|76195502|FG000|STARTED|Overall Study||13||
60080284|NCT02432690|76195502|FG000|COMPLETED|Overall Study||13||
60080285|NCT02432690|76195502|FG000|NOT COMPLETED|Overall Study||0||
60080286|NCT02320292|76195508|FG000|STARTED|Overall Study||10||
60080287|NCT02320292|76195509|FG001|STARTED|Overall Study||10||
60080288|NCT02320292|76195508|FG000|COMPLETED|Overall Study||10||
60080289|NCT02320292|76195509|FG001|COMPLETED|Overall Study||10||
60080290|NCT02320292|76195508|FG000|NOT COMPLETED|Overall Study||0||
60080291|NCT02320292|76195509|FG001|NOT COMPLETED|Overall Study||0||
60080292|NCT02315534|76195517|FG000|STARTED|Overall Study||4||
60080293|NCT02315534|76195518|FG001|STARTED|Overall Study||30||
60080294|NCT02315534|76195517|FG000|Assessment of Dose-limiting Toxicity (DLT)|Overall Study||0||
60080295|NCT02315534|76195518|FG001|Assessment of Dose-limiting Toxicity (DLT)|Overall Study||0||
60080296|NCT02315534|76195517|FG000|Off Treatment Due to Radiologic Disease Progression (PD)|Overall Study||2||
60080297|NCT02315534|76195518|FG001|Off Treatment Due to Radiologic Disease Progression (PD)|Overall Study||20||
60080298|NCT02315534|76195517|FG000|Off Treatment Due to Clinically Unacceptable Toxicities|Overall Study||1||
60080299|NCT02315534|76195518|FG001|Off Treatment Due to Clinically Unacceptable Toxicities|Overall Study||7||
60080300|NCT02315534|76195517|FG000|Off Treatment Due to Patient Request|Overall Study||1||
60080301|NCT02315534|76195518|FG001|Off Treatment Due to Patient Request|Overall Study||2||
60080302|NCT02315534|76195517|FG000|Off Treatment Due to Clinical PD|Overall Study||0||
60080303|NCT02315534|76195518|FG001|Off Treatment Due to Clinical PD|Overall Study||1||
60080304|NCT02315534|76195517|FG000|COMPLETED|Overall Study||4||
60080305|NCT02315534|76195518|FG001|COMPLETED|Overall Study||30||
60080306|NCT02315534|76195517|FG000|NOT COMPLETED|Overall Study||0||
60080307|NCT02315534|76195518|FG001|NOT COMPLETED|Overall Study||0||
60080308|NCT02231749|76195534|FG000|STARTED|Overall Study||550|Started = Randomized|
60080309|NCT02231749|76195535|FG001|STARTED|Overall Study||546|Started = Randomized|
59816304|NCT00526994|75938692|FG002|NOT COMPLETED|Overall Study||107||
59816305|NCT00519428|75938703|FG000|STARTED|Overall Study||78||
59816306|NCT00519428|75938704|FG001|STARTED|Overall Study||84||
59548821|NCT02407704|75647898|FG000|COMPLETED|Overall Study||2||
59816307|NCT00519428|75938705|FG002|STARTED|Overall Study||83||
59816308|NCT00519428|75938703|FG000|COMPLETED|Overall Study||57||
60080310|NCT02231749|76195534|FG000|Received Treatment|Overall Study||547||
60080311|NCT02231749|76195535|FG001|Received Treatment|Overall Study||535||
60080312|NCT02231749|76195534|FG000|COMPLETED|Overall Study||128|Completed = Continuing in the Treatment Period|
60080313|NCT02231749|76195535|FG001|COMPLETED|Overall Study||97|Completed = Continuing in the Treatment Period|
60080314|NCT02231749|76195534|FG000|NOT COMPLETED|Overall Study||422||
60080315|NCT02231749|76195535|FG001|NOT COMPLETED|Overall Study||449||
60080316|NCT02024607|76195548|FG000|STARTED|Overall Study||115||
60080317|NCT02024607|76195549|FG001|STARTED|Overall Study||41||
60080318|NCT02024607|76195550|FG002|STARTED|Overall Study||87||
60080319|NCT02024607|76195551|FG003|STARTED|Overall Study||156||
60080320|NCT02024607|76195552|FG004|STARTED|Overall Study||40||
60080321|NCT02024607|76195553|FG005|STARTED|Overall Study||54||
60080322|NCT02024607|76195554|FG006|STARTED|Overall Study||2||
60080323|NCT02024607|76195548|FG000|COMPLETED|Overall Study||115||
60080324|NCT02024607|76195549|FG001|COMPLETED|Overall Study||41||
60080325|NCT02024607|76195550|FG002|COMPLETED|Overall Study||87||
60080326|NCT02024607|76195551|FG003|COMPLETED|Overall Study||156||
60080327|NCT02024607|76195552|FG004|COMPLETED|Overall Study||40||
60080328|NCT02024607|76195553|FG005|COMPLETED|Overall Study||54||
60080329|NCT02024607|76195554|FG006|COMPLETED|Overall Study||2||
60080330|NCT02024607|76195548|FG000|NOT COMPLETED|Overall Study||0||
60080331|NCT02024607|76195549|FG001|NOT COMPLETED|Overall Study||0||
60080332|NCT02024607|76195550|FG002|NOT COMPLETED|Overall Study||0||
60080333|NCT02024607|76195551|FG003|NOT COMPLETED|Overall Study||0||
60080334|NCT02024607|76195552|FG004|NOT COMPLETED|Overall Study||0||
60080335|NCT02024607|76195553|FG005|NOT COMPLETED|Overall Study||0||
60080336|NCT02024607|76195554|FG006|NOT COMPLETED|Overall Study||0||
60080337|NCT01966159|76195590|FG000|STARTED|Overall Study||205||
60080338|NCT01966159|76195591|FG001|STARTED|Overall Study||207||
60080339|NCT01966159|76195590|FG000|COMPLETED|Overall Study||205||
60080340|NCT01966159|76195591|FG001|COMPLETED|Overall Study||207||
60080341|NCT01966159|76195590|FG000|NOT COMPLETED|Overall Study||0||
60080342|NCT01966159|76195591|FG001|NOT COMPLETED|Overall Study||0||
60080343|NCT01776307|76195600|FG000|STARTED|Overall Study||49||
60080344|NCT01776307|76195601|FG001|STARTED|Overall Study||75||
60080345|NCT01776307|76195602|FG002|STARTED|Overall Study||76||
60080346|NCT01776307|76195600|FG000|COMPLETED|Overall Study||49||
60080347|NCT01776307|76195601|FG001|COMPLETED|Overall Study||75||
60080348|NCT01776307|76195602|FG002|COMPLETED|Overall Study||75||
60080349|NCT01776307|76195600|FG000|NOT COMPLETED|Overall Study||0||
60080350|NCT01776307|76195601|FG001|NOT COMPLETED|Overall Study||0||
60080351|NCT01776307|76195602|FG002|NOT COMPLETED|Overall Study||1||
60080352|NCT01531803|76195633|FG000|STARTED|Overall Study||1||
60080353|NCT01531803|76195634|FG001|STARTED|Overall Study||2||
60080354|NCT01531803|76195633|FG000|COMPLETED|Overall Study||1||
60080355|NCT01531803|76195634|FG001|COMPLETED|Overall Study||2||
60080356|NCT01531803|76195633|FG000|NOT COMPLETED|Overall Study||0||
60080357|NCT01531803|76195634|FG001|NOT COMPLETED|Overall Study||0||
60080358|NCT01325441|76195645|FG000|STARTED|Overall Study||2||
60080359|NCT01325441|76195646|FG001|STARTED|Overall Study||185||
60080360|NCT01325441|76195647|FG002|STARTED|Overall Study||4||
60080361|NCT01325441|76195648|FG003|STARTED|Overall Study||317||
60080362|NCT01325441|76195649|FG004|STARTED|Overall Study||57||
60080363|NCT01325441|76195645|FG000|COMPLETED|Overall Study||2||
60080364|NCT01325441|76195646|FG001|COMPLETED|Overall Study||185||
60080365|NCT01325441|76195647|FG002|COMPLETED|Overall Study||4||
60080366|NCT01325441|76195648|FG003|COMPLETED|Overall Study||317||
60080367|NCT01325441|76195649|FG004|COMPLETED|Overall Study||57||
60080368|NCT01325441|76195645|FG000|NOT COMPLETED|Overall Study||0||
60080369|NCT01325441|76195646|FG001|NOT COMPLETED|Overall Study||0||
60080370|NCT01325441|76195647|FG002|NOT COMPLETED|Overall Study||0||
60080371|NCT01325441|76195648|FG003|NOT COMPLETED|Overall Study||0||
60080372|NCT01325441|76195649|FG004|NOT COMPLETED|Overall Study||0||
60080373|NCT05419908|76195664|FG000|STARTED|Overall Study||44||
60080374|NCT05419908|76195665|FG001|STARTED|Overall Study||43||
60080375|NCT05419908|76195664|FG000|COMPLETED|Overall Study||40||
60080376|NCT05419908|76195665|FG001|COMPLETED|Overall Study||40||
60080377|NCT05419908|76195664|FG000|NOT COMPLETED|Overall Study||4||
60080378|NCT05419908|76195665|FG001|NOT COMPLETED|Overall Study||3||
60080379|NCT05091060|76195671|FG000|STARTED|Overall Study||5||
60080380|NCT05091060|76195671|FG000|COMPLETED|Overall Study||4||
60080381|NCT05091060|76195671|FG000|NOT COMPLETED|Overall Study||1||
60080382|NCT05056311|76195675|FG000|STARTED|Overall Study||65||
60080383|NCT05056311|76195675|FG000|Received Intervention|Overall Study||64||
60080384|NCT05056311|76195675|FG000|COMPLETED|Overall Study||27||
60080385|NCT05056311|76195675|FG000|NOT COMPLETED|Overall Study||38||
60080386|NCT05020899|76195682|FG000|STARTED|8 Week Follow-up||54||
60080387|NCT05020899|76195683|FG001|STARTED|8 Week Follow-up||55||
60080388|NCT05020899|76195682|FG000|COMPLETED|8 Week Follow-up||51||
60080389|NCT05020899|76195683|FG001|COMPLETED|8 Week Follow-up||49||
59548822|NCT02407704|75647899|FG001|COMPLETED|Overall Study||3||
60080390|NCT05020899|76195682|FG000|NOT COMPLETED|8 Week Follow-up||3||
59991045|NCT03318523|76106562|FG006|STARTED|DBE Period:Year 2 to EOS (Up to 3 Years)||39|Out of 345 participants who completed the PC Period, only 344 entered the DBE Period.|
59991046|NCT03318523|76106563|FG007|STARTED|DBE Period:Year 2 to EOS (Up to 3 Years)||52|Out of 345 participants who completed the PC Period, only 344 entered the DBE Period.|
59991047|NCT03318523|76106564|FG008|STARTED|DBE Period:Year 2 to EOS (Up to 3 Years)||100|Out of 345 participants who completed the PC Period, only 344 entered the DBE Period.|
59706443|NCT01265615|75825639|FG003|NOT COMPLETED|Overall Study||3||
59706444|NCT01264835|75825649|FG000|STARTED|Overall Study||2||
59706445|NCT01264835|75825649|FG000|COMPLETED|Overall Study||1||
59706446|NCT01264835|75825649|FG000|NOT COMPLETED|Overall Study||1||
59706447|NCT01264679|75825653|FG000|STARTED|Overall Study||8||
59706448|NCT01264679|75825653|FG000|Received at Least 1 Dose of Study Drug|Overall Study||7|Participants included in Safety and Intent-to-Treat (ITT) populations.|
59706449|NCT01264679|75825653|FG000|COMPLETED|Overall Study||3||
59706450|NCT01264679|75825653|FG000|NOT COMPLETED|Overall Study||5||
59706451|NCT01263665|75825658|FG000|STARTED|Overall Study||71||
59706452|NCT01263665|75825658|FG000|COMPLETED|Overall Study||62||
59706453|NCT01263665|75825658|FG000|NOT COMPLETED|Overall Study||9||
59706454|NCT01263509|75825664|FG000|STARTED|Enrolled - Long-Term Extension Study||61||
59706455|NCT01263509|75825665|FG001|STARTED|Enrolled - Long-Term Extension Study||60||
59706456|NCT01263509|75825666|FG002|STARTED|Enrolled - Long-Term Extension Study||32||
59706457|NCT01263509|75825667|FG003|STARTED|Enrolled - Long-Term Extension Study||26||
59706458|NCT01263509|75825664|FG000|COMPLETED|Enrolled - Long-Term Extension Study||61||
59706459|NCT01263509|75825665|FG001|COMPLETED|Enrolled - Long-Term Extension Study||60||
59706460|NCT01263509|75825666|FG002|COMPLETED|Enrolled - Long-Term Extension Study||32||
59706461|NCT01263509|75825667|FG003|COMPLETED|Enrolled - Long-Term Extension Study||26||
59706462|NCT01263509|75825664|FG000|NOT COMPLETED|Enrolled - Long-Term Extension Study||0||
59706463|NCT01263509|75825665|FG001|NOT COMPLETED|Enrolled - Long-Term Extension Study||0||
59991048|NCT03318523|76106565|FG009|STARTED|DBE Period:Year 2 to EOS (Up to 3 Years)||96|Out of 345 participants who completed the PC Period, only 344 entered the DBE Period.|
60080391|NCT05020899|76195683|FG001|NOT COMPLETED|8 Week Follow-up||6||
60080392|NCT05020899|76195682|FG000|STARTED|12 Week Follow-up||51||
60080393|NCT05020899|76195683|FG001|STARTED|12 Week Follow-up||49||
60080394|NCT05020899|76195682|FG000|COMPLETED|12 Week Follow-up||50||
60080395|NCT05020899|76195683|FG001|COMPLETED|12 Week Follow-up||48||
60080396|NCT05020899|76195682|FG000|NOT COMPLETED|12 Week Follow-up||1||
60080397|NCT05020899|76195683|FG001|NOT COMPLETED|12 Week Follow-up||1||
60080398|NCT04942665|76195691|FG000|STARTED|Overall Study||32||
60080399|NCT04942665|76195692|FG001|STARTED|Overall Study||28||
60080400|NCT04942665|76195691|FG000|COMPLETED|Overall Study||32||
60080401|NCT04942665|76195692|FG001|COMPLETED|Overall Study||28||
60080402|NCT04942665|76195691|FG000|NOT COMPLETED|Overall Study||0||
60080403|NCT04942665|76195692|FG001|NOT COMPLETED|Overall Study||0||
60080404|NCT04895605|76195701|FG000|STARTED|Overall Study||19||
60080405|NCT04895605|76195702|FG001|STARTED|Overall Study||21||
60080406|NCT04895605|76195701|FG000|COMPLETED|Overall Study||19||
60080407|NCT04895605|76195702|FG001|COMPLETED|Overall Study||21||
60080408|NCT04895605|76195701|FG000|NOT COMPLETED|Overall Study||0||
60080409|NCT04895605|76195702|FG001|NOT COMPLETED|Overall Study||0||
60080410|NCT04806503|76195713|FG000|STARTED|Overall Study||48||
60080411|NCT04806503|76195714|FG001|STARTED|Overall Study||48||
60080412|NCT04806503|76195715|FG002|STARTED|Overall Study||44||
60080413|NCT04806503|76195716|FG003|STARTED|Overall Study||48||
60080414|NCT04806503|76195717|FG004|STARTED|Overall Study||46||
60080415|NCT04806503|76195713|FG000|COMPLETED|Overall Study||46||
60080416|NCT04806503|76195714|FG001|COMPLETED|Overall Study||47||
60080417|NCT04806503|76195715|FG002|COMPLETED|Overall Study||42||
60080418|NCT04806503|76195716|FG003|COMPLETED|Overall Study||46||
60080419|NCT04806503|76195717|FG004|COMPLETED|Overall Study||45||
60080420|NCT04806503|76195713|FG000|NOT COMPLETED|Overall Study||2||
60080421|NCT04806503|76195714|FG001|NOT COMPLETED|Overall Study||1||
59548823|NCT02407704|75647900|FG002|COMPLETED|Overall Study||4||
59548824|NCT02407704|75647901|FG003|COMPLETED|Overall Study||2||
59706464|NCT01263509|75825666|FG002|NOT COMPLETED|Enrolled - Long-Term Extension Study||0||
60080422|NCT04806503|76195715|FG002|NOT COMPLETED|Overall Study||2||
60080423|NCT04806503|76195716|FG003|NOT COMPLETED|Overall Study||2||
60080424|NCT04806503|76195717|FG004|NOT COMPLETED|Overall Study||1||
60080425|NCT04508751|76195733|FG000|STARTED|Overall Study||10||
60080426|NCT04508751|76195734|FG001|STARTED|Overall Study||5||
60080427|NCT04508751|76195735|FG002|STARTED|Overall Study||7||
60080428|NCT04508751|76195733|FG000|COMPLETED|Overall Study||10||
60080429|NCT04508751|76195734|FG001|COMPLETED|Overall Study||5||
60080430|NCT04508751|76195735|FG002|COMPLETED|Overall Study||5||
60080431|NCT04508751|76195733|FG000|NOT COMPLETED|Overall Study||0||
60080432|NCT04508751|76195734|FG001|NOT COMPLETED|Overall Study||0||
60080433|NCT04508751|76195735|FG002|NOT COMPLETED|Overall Study||2||
60080434|NCT04473482|76195745|FG000|STARTED|Overall Study||30||
60080435|NCT04473482|76195746|FG001|STARTED|Overall Study||30||
60080436|NCT04473482|76195745|FG000|3-month Post Intervention Phone Call|Overall Study||22||
60080437|NCT04473482|76195746|FG001|3-month Post Intervention Phone Call|Overall Study||27||
60080438|NCT04473482|76195745|FG000|6-month Post Intervention Phone Call|Overall Study||19||
60080439|NCT04473482|76195746|FG001|6-month Post Intervention Phone Call|Overall Study||19||
60080440|NCT04473482|76195745|FG000|COMPLETED|Overall Study||19||
60080441|NCT04473482|76195746|FG001|COMPLETED|Overall Study||19||
60080442|NCT04473482|76195745|FG000|NOT COMPLETED|Overall Study||11||
60080443|NCT04473482|76195746|FG001|NOT COMPLETED|Overall Study||11||
60080444|NCT03919799|76195756|FG000|STARTED|DB Period (28 Weeks)||12||
60080445|NCT03919799|76195757|FG001|STARTED|DB Period (28 Weeks)||12||
60080446|NCT03919799|76195758|FG002|STARTED|DB Period (28 Weeks)||12||
60080447|NCT03919799|76195759|FG003|STARTED|DB Period (28 Weeks)||0||
60080448|NCT03919799|76195760|FG004|STARTED|DB Period (28 Weeks)||0||
60080449|NCT03919799|76195756|FG000|Treated|DB Period (28 Weeks)||11||
60080450|NCT03919799|76195757|FG001|Treated|DB Period (28 Weeks)||12||
60080451|NCT03919799|76195758|FG002|Treated|DB Period (28 Weeks)||12||
60080452|NCT03919799|76195759|FG003|Treated|DB Period (28 Weeks)||0||
60080453|NCT03919799|76195760|FG004|Treated|DB Period (28 Weeks)||0||
60080454|NCT03919799|76195756|FG000|COMPLETED|DB Period (28 Weeks)||10||
60080455|NCT03919799|76195757|FG001|COMPLETED|DB Period (28 Weeks)||10||
60080456|NCT03919799|76195758|FG002|COMPLETED|DB Period (28 Weeks)||11||
60080457|NCT03919799|76195759|FG003|COMPLETED|DB Period (28 Weeks)||0||
60080458|NCT03919799|76195760|FG004|COMPLETED|DB Period (28 Weeks)||0||
60080459|NCT03919799|76195756|FG000|NOT COMPLETED|DB Period (28 Weeks)||2||
60080460|NCT03919799|76195757|FG001|NOT COMPLETED|DB Period (28 Weeks)||2||
60080461|NCT03919799|76195758|FG002|NOT COMPLETED|DB Period (28 Weeks)||1||
60080462|NCT03919799|76195759|FG003|NOT COMPLETED|DB Period (28 Weeks)||0||
60080463|NCT03919799|76195760|FG004|NOT COMPLETED|DB Period (28 Weeks)||0||
60080464|NCT03919799|76195756|FG000|STARTED|OLE Period (24 Weeks)||10||
60080465|NCT03919799|76195757|FG001|STARTED|OLE Period (24 Weeks)||10||
60080466|NCT03919799|76195758|FG002|STARTED|OLE Period (24 Weeks)|Participants who completed DB period in this arm were re-randomized to 2 different arms Belumosudil (QD or BID) in OLE period.|0||
60080467|NCT03919799|76195759|FG003|STARTED|OLE Period (24 Weeks)|Participants who received placebo and completed DB period and were re-randomized to QD arm in the OLE period.|5||
60080468|NCT03919799|76195760|FG004|STARTED|OLE Period (24 Weeks)|Participants who received placebo and completed DB period and were re-randomized to BID arm in the OLE period.|6||
60080469|NCT03919799|76195756|FG000|COMPLETED|OLE Period (24 Weeks)||10||
60080470|NCT03919799|76195757|FG001|COMPLETED|OLE Period (24 Weeks)||7||
60080471|NCT03919799|76195758|FG002|COMPLETED|OLE Period (24 Weeks)||0||
60080472|NCT03919799|76195759|FG003|COMPLETED|OLE Period (24 Weeks)||5||
60080473|NCT03919799|76195760|FG004|COMPLETED|OLE Period (24 Weeks)||6||
60080474|NCT03919799|76195756|FG000|NOT COMPLETED|OLE Period (24 Weeks)||0||
60080475|NCT03919799|76195757|FG001|NOT COMPLETED|OLE Period (24 Weeks)||3||
60080476|NCT03919799|76195758|FG002|NOT COMPLETED|OLE Period (24 Weeks)||0||
60080477|NCT03919799|76195759|FG003|NOT COMPLETED|OLE Period (24 Weeks)||0||
59548825|NCT02407704|75647898|FG000|NOT COMPLETED|Overall Study||0||
59706465|NCT01263509|75825667|FG003|NOT COMPLETED|Enrolled - Long-Term Extension Study||0||
59706466|NCT01263509|75825664|FG000|STARTED|Entered - Long-Term Extension Study||61||
59706467|NCT01263509|75825665|FG001|STARTED|Entered - Long-Term Extension Study||60||
60080478|NCT03919799|76195760|FG004|NOT COMPLETED|OLE Period (24 Weeks)||0||
60080479|NCT03697811|76195780|FG000|STARTED|Overall Study||107||
60080480|NCT03697811|76195780|FG000|COMPLETED|Overall Study||104||
60080481|NCT03697811|76195780|FG000|NOT COMPLETED|Overall Study||3||
60080482|NCT03691649|76195786|FG000|STARTED|Double Masked Treatment Period (DMTP)|Includes 6 pediatric participants.|212||
60080483|NCT03691649|76195787|FG001|STARTED|Double Masked Treatment Period (DMTP)|Includes 7 pediatric participants.|214||
60080484|NCT03691649|76195786|FG000|Full Analysis Set Participants|Double Masked Treatment Period (DMTP)||212||
60080485|NCT03691649|76195787|FG001|Full Analysis Set Participants|Double Masked Treatment Period (DMTP)||213||
60080486|NCT03691649|76195786|FG000|Safety Analysis Set Participants|Double Masked Treatment Period (DMTP)|One participant that was randomized to DE-117 arm inadvertently received Timolol during Double Masked Treatment Period hence 211 participants were dosed with study drug and assessed for safety.|211||
59548826|NCT02407704|75647899|FG001|NOT COMPLETED|Overall Study||0||
59548827|NCT02407704|75647900|FG002|NOT COMPLETED|Overall Study||1||
59548828|NCT02407704|75647901|FG003|NOT COMPLETED|Overall Study||3||
59548829|NCT02504619|75647915|FG000|STARTED|Overall Study||1||
59548830|NCT02504619|75647915|FG000|COMPLETED|Overall Study||1||
59548831|NCT02504619|75647915|FG000|NOT COMPLETED|Overall Study||0||
59548832|NCT02406612|75647922|FG000|STARTED|Overall Study||26||
59548833|NCT02406612|75647923|FG001|STARTED|Overall Study||21||
59548834|NCT02406612|75647922|FG000|COMPLETED|Overall Study||22||
59548835|NCT02406612|75647923|FG001|COMPLETED|Overall Study||17||
59548836|NCT02406612|75647922|FG000|NOT COMPLETED|Overall Study||4||
59548837|NCT02406612|75647923|FG001|NOT COMPLETED|Overall Study||4||
59548838|NCT02581839|75647929|FG000|STARTED|Overall Study||9||
59548839|NCT02581839|75647929|FG000|COMPLETED|Overall Study||9||
59548840|NCT02581839|75647929|FG000|NOT COMPLETED|Overall Study||0||
59548841|NCT02504775|75647933|FG000|STARTED|Period 1||14||
59548842|NCT02504775|75647934|FG001|STARTED|Period 1||14||
59548843|NCT02504775|75647933|FG000|COMPLETED|Period 1||14||
59548844|NCT02504775|75647934|FG001|COMPLETED|Period 1||14||
59548845|NCT02504775|75647933|FG000|NOT COMPLETED|Period 1||0||
59548846|NCT02504775|75647934|FG001|NOT COMPLETED|Period 1||0||
59548847|NCT02504775|75647933|FG000|STARTED|Washout||14||
59548848|NCT02504775|75647934|FG001|STARTED|Washout||14||
59548849|NCT02504775|75647933|FG000|COMPLETED|Washout||14||
59548850|NCT02504775|75647934|FG001|COMPLETED|Washout||14||
59548851|NCT02504775|75647933|FG000|NOT COMPLETED|Washout||0||
59548852|NCT02504775|75647934|FG001|NOT COMPLETED|Washout||0||
59548853|NCT02504775|75647933|FG000|STARTED|Period 2||14||
59548854|NCT02504775|75647934|FG001|STARTED|Period 2||14||
59548855|NCT02504775|75647933|FG000|COMPLETED|Period 2||14||
59548856|NCT02504775|75647934|FG001|COMPLETED|Period 2||14||
59548857|NCT02504775|75647933|FG000|NOT COMPLETED|Period 2||0||
59548858|NCT02504775|75647934|FG001|NOT COMPLETED|Period 2||0||
59548859|NCT02504931|75647944|FG000|STARTED|Overall Study||26||
59548860|NCT02504931|75647945|FG001|STARTED|Overall Study||23||
59548861|NCT02504931|75647944|FG000|COMPLETED|Overall Study||14||
60080487|NCT03691649|76195787|FG001|Safety Analysis Set Participants|Double Masked Treatment Period (DMTP)||215||
60080488|NCT03691649|76195786|FG000|COMPLETED|Double Masked Treatment Period (DMTP)||189||
60080489|NCT03691649|76195787|FG001|COMPLETED|Double Masked Treatment Period (DMTP)||204||
60080490|NCT03691649|76195786|FG000|NOT COMPLETED|Double Masked Treatment Period (DMTP)||23||
60080491|NCT03691649|76195787|FG001|NOT COMPLETED|Double Masked Treatment Period (DMTP)||10||
60080492|NCT03691649|76195786|FG000|STARTED|Open Label Treatment Period (OLTP)|Some participants exited the study after Double Masked Treatment Period at Month 3, hence, 377 participants entered the Open Label Treatment Period.|377||
60080493|NCT03691649|76195787|FG001|STARTED|Open Label Treatment Period (OLTP)|After completion of the Double Masked Treatment Period (DMTP), the adult participants converted to the single DE-117 QD arm at Month 3 to Open Label Treatment Period (OLPT) for additional 9 months.|0||
60080494|NCT03691649|76195786|FG000|COMPLETED|Open Label Treatment Period (OLTP)|304 completed the study|304||
60080495|NCT03691649|76195787|FG001|COMPLETED|Open Label Treatment Period (OLTP)||0||
60080496|NCT03691649|76195786|FG000|NOT COMPLETED|Open Label Treatment Period (OLTP)||73||
60080497|NCT03691649|76195787|FG001|NOT COMPLETED|Open Label Treatment Period (OLTP)||0||
60080498|NCT03687190|76195796|FG000|STARTED|Overall Study||12||
60080499|NCT03687190|76195797|FG001|STARTED|Overall Study||9||
60080500|NCT03687190|76195796|FG000|COMPLETED|Overall Study||12||
60080501|NCT03687190|76195797|FG001|COMPLETED|Overall Study||9||
60080502|NCT03687190|76195796|FG000|NOT COMPLETED|Overall Study||0||
60080503|NCT03687190|76195797|FG001|NOT COMPLETED|Overall Study||0||
60080504|NCT03621735|76195805|FG000|STARTED|Overall Study||50||
60080505|NCT03621735|76195806|FG001|STARTED|Overall Study||50||
60080506|NCT03621735|76195805|FG000|Received Device or Sham Device to Use|Overall Study||49||
60080507|NCT03621735|76195806|FG001|Received Device or Sham Device to Use|Overall Study||50||
60080508|NCT03621735|76195805|FG000|Began First Washout Period|Overall Study||41||
60080509|NCT03621735|76195806|FG001|Began First Washout Period|Overall Study||44||
60080510|NCT03621735|76195805|FG000|Began Crossover Assignment|Overall Study||39||
59548862|NCT02504931|75647945|FG001|COMPLETED|Overall Study||13||
59548863|NCT02504931|75647944|FG000|NOT COMPLETED|Overall Study||12||
59548864|NCT02504931|75647945|FG001|NOT COMPLETED|Overall Study||10||
59548865|NCT02582151|75647953|FG000|STARTED|Overall Study||14||
59548866|NCT02582151|75647954|FG001|STARTED|Overall Study||16||
59706468|NCT01263509|75825666|FG002|STARTED|Entered - Long-Term Extension Study||32||
59706469|NCT01263509|75825667|FG003|STARTED|Entered - Long-Term Extension Study||26||
59706470|NCT01263509|75825664|FG000|COMPLETED|Entered - Long-Term Extension Study||53||
59706471|NCT01263509|75825665|FG001|COMPLETED|Entered - Long-Term Extension Study||48||
59706472|NCT01263509|75825666|FG002|COMPLETED|Entered - Long-Term Extension Study||27||
59991049|NCT03318523|76106556|FG000|Number of Participants Dosed|DBE Period:Year 2 to EOS (Up to 3 Years)||0||
59991050|NCT03318523|76106557|FG001|Number of Participants Dosed|DBE Period:Year 2 to EOS (Up to 3 Years)||0||
59991051|NCT03318523|76106558|FG002|Number of Participants Dosed|DBE Period:Year 2 to EOS (Up to 3 Years)||0||
59991052|NCT03318523|76106559|FG003|Number of Participants Dosed|DBE Period:Year 2 to EOS (Up to 3 Years)||0||
59991053|NCT03318523|76106560|FG004|Number of Participants Dosed|DBE Period:Year 2 to EOS (Up to 3 Years)||20||
59991054|NCT03318523|76106561|FG005|Number of Participants Dosed|DBE Period:Year 2 to EOS (Up to 3 Years)||37||
59991055|NCT03318523|76106562|FG006|Number of Participants Dosed|DBE Period:Year 2 to EOS (Up to 3 Years)||39||
60080511|NCT03621735|76195806|FG001|Began Crossover Assignment|Overall Study||40||
60080512|NCT03621735|76195805|FG000|Began Second Washout Period|Overall Study||39||
60080513|NCT03621735|76195806|FG001|Began Second Washout Period|Overall Study||39||
60080514|NCT03621735|76195805|FG000|Began 12-Week Follow Up|Overall Study||38||
60080515|NCT03621735|76195806|FG001|Began 12-Week Follow Up|Overall Study||39||
60080516|NCT03621735|76195805|FG000|COMPLETED|Overall Study||37||
60080517|NCT03621735|76195806|FG001|COMPLETED|Overall Study||37||
60080518|NCT03621735|76195805|FG000|NOT COMPLETED|Overall Study||13||
60080519|NCT03621735|76195806|FG001|NOT COMPLETED|Overall Study||13||
60080520|NCT03531918|76195830|FG000|STARTED|Overall Study||6||
60080521|NCT03531918|76195831|FG001|STARTED|Overall Study||60||
60080522|NCT03531918|76195830|FG000|COMPLETED|Overall Study||6||
60080523|NCT03531918|76195831|FG001|COMPLETED|Overall Study||56||
60080524|NCT03531918|76195830|FG000|NOT COMPLETED|Overall Study||0||
60080525|NCT03531918|76195831|FG001|NOT COMPLETED|Overall Study||4||
60080526|NCT03498612|76195839|FG000|STARTED|Overall Study||9||
60080527|NCT03498612|76195839|FG000|COMPLETED|Overall Study||9||
60080528|NCT03498612|76195839|FG000|NOT COMPLETED|Overall Study||0||
60080529|NCT03362515|76195845|FG000|STARTED|Overall Study||9||
60080530|NCT03362515|76195846|FG001|STARTED|Overall Study||9||
60080531|NCT03362515|76195845|FG000|COMPLETED|Overall Study||6||
60080532|NCT03362515|76195846|FG001|COMPLETED|Overall Study||6||
60080533|NCT03362515|76195845|FG000|NOT COMPLETED|Overall Study||3||
60080534|NCT03362515|76195846|FG001|NOT COMPLETED|Overall Study||3||
60080535|NCT03292926|76195854|FG000|STARTED|Overall Study||39||
60080536|NCT03292926|76195855|FG001|STARTED|Overall Study||39||
60080537|NCT03292926|76195854|FG000|COMPLETED|Overall Study||39||
60080538|NCT03292926|76195855|FG001|COMPLETED|Overall Study||39||
60080539|NCT03292926|76195854|FG000|NOT COMPLETED|Overall Study||0||
60080540|NCT03292926|76195855|FG001|NOT COMPLETED|Overall Study||0||
60080541|NCT03245151|76195866|FG000|STARTED|Overall Study||5||
60080542|NCT03245151|76195867|FG001|STARTED|Overall Study||18||
60080543|NCT03245151|76195868|FG002|STARTED|Overall Study||10||
60080544|NCT03245151|76195869|FG003|STARTED|Overall Study||20||
60080545|NCT03245151|76195870|FG004|STARTED|Overall Study||11||
60080546|NCT03245151|76195866|FG000|COMPLETED|Overall Study||0||
60080547|NCT03245151|76195867|FG001|COMPLETED|Overall Study||3||
59548867|NCT02582151|75647953|FG000|COMPLETED|Overall Study||12||
59548868|NCT02582151|75647954|FG001|COMPLETED|Overall Study||16||
59548869|NCT02582151|75647953|FG000|NOT COMPLETED|Overall Study||2||
59548870|NCT02582151|75647954|FG001|NOT COMPLETED|Overall Study||0||
59548871|NCT02584725|75647963|FG000|STARTED|Overall Study||28||
59548872|NCT02584725|75647964|FG001|STARTED|Overall Study||28||
59548873|NCT02584725|75647965|FG002|STARTED|Overall Study||28||
59548874|NCT02584725|75647963|FG000|COMPLETED|Overall Study||28||
59548875|NCT02584725|75647964|FG001|COMPLETED|Overall Study||28||
59548876|NCT02584725|75647965|FG002|COMPLETED|Overall Study||28||
59548877|NCT02584725|75647963|FG000|NOT COMPLETED|Overall Study||0||
59548878|NCT02584725|75647964|FG001|NOT COMPLETED|Overall Study||0||
59548879|NCT02584725|75647965|FG002|NOT COMPLETED|Overall Study||0||
59548880|NCT01186562|75647975|FG000|STARTED|Overall Study||54||
59548881|NCT01186562|75647976|FG001|STARTED|Overall Study||29||
59548882|NCT01186562|75647975|FG000|COMPLETED|Overall Study||50||
59548883|NCT01186562|75647976|FG001|COMPLETED|Overall Study||27||
59548884|NCT01186562|75647975|FG000|NOT COMPLETED|Overall Study||4||
59548885|NCT01186562|75647976|FG001|NOT COMPLETED|Overall Study||2||
59548886|NCT01187498|75647984|FG000|STARTED|Overall Study||73||
59548887|NCT01187498|75647985|FG001|STARTED|Overall Study||70||
59548888|NCT01187498|75647984|FG000|COMPLETED|Overall Study||64||
59548889|NCT01187498|75647985|FG001|COMPLETED|Overall Study||60||
59548890|NCT01187498|75647984|FG000|NOT COMPLETED|Overall Study||9||
59548891|NCT01187498|75647985|FG001|NOT COMPLETED|Overall Study||10||
59548892|NCT01147406|75647997|FG000|STARTED|Overall Study||6||
59548893|NCT01147406|75647998|FG001|STARTED|Overall Study||12||
59548894|NCT01147406|75647999|FG002|STARTED|Overall Study||1||
59548895|NCT01147406|75648000|FG003|STARTED|Overall Study||6||
59548896|NCT01147406|75648001|FG004|STARTED|Overall Study||6||
59548897|NCT01147406|75648002|FG005|STARTED|Overall Study||10||
60080548|NCT03245151|76195868|FG002|COMPLETED|Overall Study||1||
60080549|NCT03245151|76195869|FG003|COMPLETED|Overall Study||2||
60080550|NCT03245151|76195870|FG004|COMPLETED|Overall Study||3||
60080551|NCT03245151|76195866|FG000|NOT COMPLETED|Overall Study||5||
60080552|NCT03245151|76195867|FG001|NOT COMPLETED|Overall Study||15||
59548898|NCT01147406|75647997|FG000|COMPLETED|Overall Study||6||
59548899|NCT01147406|75647998|FG001|COMPLETED|Overall Study||12||
59548900|NCT01147406|75647999|FG002|COMPLETED|Overall Study||1||
59548901|NCT01147406|75648000|FG003|COMPLETED|Overall Study||6||
59548902|NCT01147406|75648001|FG004|COMPLETED|Overall Study||6||
59548903|NCT01147406|75648002|FG005|COMPLETED|Overall Study||10||
59548904|NCT01147406|75647997|FG000|NOT COMPLETED|Overall Study||0||
59548905|NCT01147406|75647998|FG001|NOT COMPLETED|Overall Study||0||
59548906|NCT01147406|75647999|FG002|NOT COMPLETED|Overall Study||0||
59548907|NCT01147406|75648000|FG003|NOT COMPLETED|Overall Study||0||
59548908|NCT01147406|75648001|FG004|NOT COMPLETED|Overall Study||0||
59548909|NCT01147406|75648002|FG005|NOT COMPLETED|Overall Study||0||
59548910|NCT01148420|75648017|FG000|STARTED|Overall Study||48||
59548911|NCT01148420|75648017|FG000|COMPLETED|Overall Study||48||
59548912|NCT01148420|75648017|FG000|NOT COMPLETED|Overall Study||0||
59548913|NCT01149434|75648024|FG000|STARTED|Overall Study||4||
59548914|NCT01149434|75648025|FG001|STARTED|Overall Study||15||
59548915|NCT01149434|75648024|FG000|COMPLETED|Overall Study||4||
59548916|NCT01149434|75648025|FG001|COMPLETED|Overall Study||10||
59548917|NCT01149434|75648024|FG000|NOT COMPLETED|Overall Study||0||
59548918|NCT01149434|75648025|FG001|NOT COMPLETED|Overall Study||5||
59706473|NCT01263509|75825667|FG003|COMPLETED|Entered - Long-Term Extension Study||24||
59706474|NCT01263509|75825664|FG000|NOT COMPLETED|Entered - Long-Term Extension Study||8||
59706475|NCT01263509|75825665|FG001|NOT COMPLETED|Entered - Long-Term Extension Study||12||
59548919|NCT01149512|75648032|FG000|STARTED|Overall Study||178||
59548920|NCT01149512|75648032|FG000|COMPLETED|Overall Study||178||
59548921|NCT01149512|75648032|FG000|NOT COMPLETED|Overall Study||0||
59548922|NCT01150760|75648038|FG000|STARTED|Overall Study||3525||
59548923|NCT01150760|75648039|FG001|STARTED|Overall Study||3525||
59548924|NCT01150760|75648038|FG000|COMPLETED|Overall Study||3525||
59548925|NCT01150760|75648039|FG001|COMPLETED|Overall Study||3525||
59548926|NCT01150760|75648038|FG000|NOT COMPLETED|Overall Study||0||
59548927|NCT01150760|75648039|FG001|NOT COMPLETED|Overall Study||0||
59548928|NCT01150838|75648050|FG000|STARTED|Overall Study||19||
59548929|NCT01150838|75648051|FG001|STARTED|Overall Study||26||
59548930|NCT01150838|75648052|FG002|STARTED|Overall Study||24||
59548931|NCT01150838|75648053|FG003|STARTED|Overall Study||15||
59548932|NCT01150838|75648054|FG004|STARTED|Overall Study||16||
59548933|NCT01150838|75648055|FG005|STARTED|Overall Study||2||
59548934|NCT01150838|75648050|FG000|COMPLETED|Overall Study||19||
59548935|NCT01150838|75648051|FG001|COMPLETED|Overall Study||26||
59548936|NCT01150838|75648052|FG002|COMPLETED|Overall Study||24||
59548937|NCT01150838|75648053|FG003|COMPLETED|Overall Study||15||
59548938|NCT01150838|75648054|FG004|COMPLETED|Overall Study||16||
59548939|NCT01150838|75648055|FG005|COMPLETED|Overall Study||2||
59548940|NCT01150838|75648050|FG000|NOT COMPLETED|Overall Study||0||
59548941|NCT01150838|75648051|FG001|NOT COMPLETED|Overall Study||0||
59706476|NCT01263509|75825666|FG002|NOT COMPLETED|Entered - Long-Term Extension Study||5||
60080553|NCT03245151|76195868|FG002|NOT COMPLETED|Overall Study||9||
59706477|NCT01263509|75825667|FG003|NOT COMPLETED|Entered - Long-Term Extension Study||2||
59706478|NCT01263197|75825675|FG000|STARTED|First Intervention (Period 1)||8||
59706479|NCT01263197|75825676|FG001|STARTED|First Intervention (Period 1)||8||
59706480|NCT01263197|75825677|FG002|STARTED|First Intervention (Period 1)||8||
59706481|NCT01263197|75825678|FG003|STARTED|First Intervention (Period 1)||8||
59991056|NCT03318523|76106563|FG007|Number of Participants Dosed|DBE Period:Year 2 to EOS (Up to 3 Years)||52||
59991057|NCT03318523|76106564|FG008|Number of Participants Dosed|DBE Period:Year 2 to EOS (Up to 3 Years)||100||
59706482|NCT01263197|75825679|FG004|STARTED|First Intervention (Period 1)||8||
59706483|NCT01263197|75825680|FG005|STARTED|First Intervention (Period 1)||8||
59706484|NCT01263197|75825675|FG000|COMPLETED|First Intervention (Period 1)||8||
59706485|NCT01263197|75825676|FG001|COMPLETED|First Intervention (Period 1)||8||
59706486|NCT01263197|75825677|FG002|COMPLETED|First Intervention (Period 1)||8||
59706487|NCT01263197|75825678|FG003|COMPLETED|First Intervention (Period 1)||8||
59706488|NCT01263197|75825679|FG004|COMPLETED|First Intervention (Period 1)||8||
59706489|NCT01263197|75825680|FG005|COMPLETED|First Intervention (Period 1)||7||
59706490|NCT01263197|75825675|FG000|NOT COMPLETED|First Intervention (Period 1)||0||
59706491|NCT01263197|75825676|FG001|NOT COMPLETED|First Intervention (Period 1)||0||
59706492|NCT01263197|75825677|FG002|NOT COMPLETED|First Intervention (Period 1)||0||
59706493|NCT01263197|75825678|FG003|NOT COMPLETED|First Intervention (Period 1)||0||
59991058|NCT03318523|76106565|FG009|Number of Participants Dosed|DBE Period:Year 2 to EOS (Up to 3 Years)||94||
59991059|NCT03318523|76106556|FG000|COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0||
59991060|NCT03318523|76106557|FG001|COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0||
59991061|NCT03318523|76106558|FG002|COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0||
59991062|NCT03318523|76106559|FG003|COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0||
59991063|NCT03318523|76106560|FG004|COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0||
59991064|NCT03318523|76106561|FG005|COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0||
59991065|NCT03318523|76106562|FG006|COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0||
60080554|NCT03245151|76195869|FG003|NOT COMPLETED|Overall Study||18||
60080555|NCT03245151|76195870|FG004|NOT COMPLETED|Overall Study||8||
60080556|NCT02667951|76195885|FG000|STARTED|Overall Study||66||
60080557|NCT02667951|76195886|FG001|STARTED|Overall Study||63||
60080558|NCT02667951|76195885|FG000|COMPLETED|Overall Study||45||
60080559|NCT02667951|76195886|FG001|COMPLETED|Overall Study||40||
60080560|NCT02667951|76195885|FG000|NOT COMPLETED|Overall Study||21||
60080561|NCT02667951|76195886|FG001|NOT COMPLETED|Overall Study||23||
60080562|NCT02600429|76195894|FG000|STARTED|Overall Study||10||
60080563|NCT02600429|76195895|FG001|STARTED|Overall Study||8||
60080564|NCT02600429|76195894|FG000|COMPLETED|Overall Study||10||
60080565|NCT02600429|76195895|FG001|COMPLETED|Overall Study||8||
60080566|NCT02600429|76195894|FG000|NOT COMPLETED|Overall Study||0||
60080567|NCT02600429|76195895|FG001|NOT COMPLETED|Overall Study||0||
60080568|NCT02227199|76195904|FG000|STARTED|Overall Study||3||
60080569|NCT02227199|76195905|FG001|STARTED|Overall Study||3||
60080570|NCT02227199|76195906|FG002|STARTED|Overall Study||39||
60080571|NCT02227199|76195904|FG000|COMPLETED|Overall Study||3||
60080572|NCT02227199|76195905|FG001|COMPLETED|Overall Study||3||
60080573|NCT02227199|76195906|FG002|COMPLETED|Overall Study||35||
59548942|NCT01150838|75648052|FG002|NOT COMPLETED|Overall Study||0||
59548943|NCT01150838|75648053|FG003|NOT COMPLETED|Overall Study||0||
59548944|NCT01150838|75648054|FG004|NOT COMPLETED|Overall Study||0||
59548945|NCT01150838|75648055|FG005|NOT COMPLETED|Overall Study||0||
59548946|NCT02405442|75648067|FG000|STARTED|Double-Blind Phase (up to Week 8)||53||
59548947|NCT02405442|75648068|FG001|STARTED|Double-Blind Phase (up to Week 8)||53||
59548948|NCT02405442|75648069|FG002|STARTED|Double-Blind Phase (up to Week 8)||53||
59548949|NCT02405442|75648070|FG003|STARTED|Double-Blind Phase (up to Week 8)||28||
59548950|NCT02405442|75648067|FG000|COMPLETED|Double-Blind Phase (up to Week 8)||52||
59548951|NCT02405442|75648068|FG001|COMPLETED|Double-Blind Phase (up to Week 8)||48||
59548952|NCT02405442|75648069|FG002|COMPLETED|Double-Blind Phase (up to Week 8)||47||
59548953|NCT02405442|75648070|FG003|COMPLETED|Double-Blind Phase (up to Week 8)||27||
59548954|NCT02405442|75648067|FG000|NOT COMPLETED|Double-Blind Phase (up to Week 8)||1||
59548955|NCT02405442|75648068|FG001|NOT COMPLETED|Double-Blind Phase (up to Week 8)||5||
59548956|NCT02405442|75648069|FG002|NOT COMPLETED|Double-Blind Phase (up to Week 8)||6||
59548957|NCT02405442|75648070|FG003|NOT COMPLETED|Double-Blind Phase (up to Week 8)||1||
59548958|NCT02405442|75648067|FG000|STARTED|Open-Label Phase (up to Week 52)||52||
59548959|NCT02405442|75648068|FG001|STARTED|Open-Label Phase (up to Week 52)||48||
59548960|NCT02405442|75648069|FG002|STARTED|Open-Label Phase (up to Week 52)||47||
59548961|NCT02405442|75648070|FG003|STARTED|Open-Label Phase (up to Week 52)|1 participant completed Double-Blind Phase, but did not continue in Open-Label Phase.|26||
59548962|NCT02405442|75648067|FG000|COMPLETED|Open-Label Phase (up to Week 52)||4||
59548963|NCT02405442|75648068|FG001|COMPLETED|Open-Label Phase (up to Week 52)||3||
59548964|NCT02405442|75648069|FG002|COMPLETED|Open-Label Phase (up to Week 52)||2||
59548965|NCT02405442|75648070|FG003|COMPLETED|Open-Label Phase (up to Week 52)||2||
59548966|NCT02405442|75648067|FG000|NOT COMPLETED|Open-Label Phase (up to Week 52)||48||
59548967|NCT02405442|75648068|FG001|NOT COMPLETED|Open-Label Phase (up to Week 52)||45||
59548968|NCT02405442|75648069|FG002|NOT COMPLETED|Open-Label Phase (up to Week 52)||45||
59548969|NCT02405442|75648070|FG003|NOT COMPLETED|Open-Label Phase (up to Week 52)||24||
59548970|NCT02405442|75648067|FG000|STARTED|Extended Treatment Phase(up to Week 208)|1 participant completed Open-Label Phase, but did not continue in Extended Treatment Phase.|3||
59816309|NCT00519428|75938704|FG001|COMPLETED|Overall Study||69||
59816310|NCT00519428|75938705|FG002|COMPLETED|Overall Study||58||
59816311|NCT00519428|75938703|FG000|NOT COMPLETED|Overall Study||21||
59816312|NCT00519428|75938704|FG001|NOT COMPLETED|Overall Study||15||
59816313|NCT00519428|75938705|FG002|NOT COMPLETED|Overall Study||25||
59816314|NCT00432159|75938721|FG000|STARTED|Overall Study||185||
59816315|NCT00432159|75938722|FG001|STARTED|Overall Study||167||
59816316|NCT00432159|75938723|FG002|STARTED|Overall Study||39||
59706494|NCT01263197|75825679|FG004|NOT COMPLETED|First Intervention (Period 1)||0||
59706495|NCT01263197|75825680|FG005|NOT COMPLETED|First Intervention (Period 1)||1||
59706496|NCT01263197|75825675|FG000|STARTED|Washout Period 1||8||
59706497|NCT01263197|75825676|FG001|STARTED|Washout Period 1||8||
59706498|NCT01263197|75825677|FG002|STARTED|Washout Period 1||8||
59706499|NCT01263197|75825678|FG003|STARTED|Washout Period 1||8||
59706500|NCT01263197|75825679|FG004|STARTED|Washout Period 1||8||
59706501|NCT01263197|75825680|FG005|STARTED|Washout Period 1||7||
59706502|NCT01263197|75825675|FG000|COMPLETED|Washout Period 1||8||
59706503|NCT01263197|75825676|FG001|COMPLETED|Washout Period 1||8||
59706504|NCT01263197|75825677|FG002|COMPLETED|Washout Period 1||8||
59706505|NCT01263197|75825678|FG003|COMPLETED|Washout Period 1||8||
59991066|NCT03318523|76106563|FG007|COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0||
59991067|NCT03318523|76106564|FG008|COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0||
59991068|NCT03318523|76106565|FG009|COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0||
60080574|NCT02227199|76195904|FG000|NOT COMPLETED|Overall Study||0||
59991069|NCT03318523|76106556|FG000|NOT COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0||
59991070|NCT03318523|76106557|FG001|NOT COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0||
59991071|NCT03318523|76106558|FG002|NOT COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0||
59991072|NCT03318523|76106559|FG003|NOT COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0||
59991073|NCT03318523|76106560|FG004|NOT COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||20||
59991074|NCT03318523|76106561|FG005|NOT COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||37||
59991075|NCT03318523|76106562|FG006|NOT COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||39||
59991076|NCT03318523|76106563|FG007|NOT COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||52||
59991077|NCT03318523|76106564|FG008|NOT COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||100||
59991078|NCT03318523|76106565|FG009|NOT COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||96||
60080575|NCT02227199|76195905|FG001|NOT COMPLETED|Overall Study||0||
60080576|NCT02227199|76195906|FG002|NOT COMPLETED|Overall Study||4||
60080577|NCT02087865|76195921|FG000|STARTED|Overall Study||28||
60080578|NCT02087865|76195922|FG001|STARTED|Overall Study||29||
60080579|NCT02087865|76195923|FG002|STARTED|Overall Study||32||
60080580|NCT02087865|76195921|FG000|COMPLETED|Overall Study||22||
60080581|NCT02087865|76195922|FG001|COMPLETED|Overall Study||26||
60080582|NCT02087865|76195923|FG002|COMPLETED|Overall Study||29||
60080583|NCT02087865|76195921|FG000|NOT COMPLETED|Overall Study||6||
60080584|NCT02087865|76195922|FG001|NOT COMPLETED|Overall Study||3||
60080585|NCT02087865|76195923|FG002|NOT COMPLETED|Overall Study||3||
60080586|NCT01839734|76195934|FG000|STARTED|Overall Study||16||
60080587|NCT01839734|76195935|FG001|STARTED|Overall Study||4||
60080588|NCT01839734|76195934|FG000|COMPLETED|Overall Study||16||
60080589|NCT01839734|76195935|FG001|COMPLETED|Overall Study||4||
60080590|NCT01839734|76195934|FG000|NOT COMPLETED|Overall Study||0||
60080591|NCT01839734|76195935|FG001|NOT COMPLETED|Overall Study||0||
60080592|NCT01682083|76195943|FG000|STARTED|Overall Study||438||
60080593|NCT01682083|76195944|FG001|STARTED|Overall Study||432||
60080594|NCT01682083|76195943|FG000|COMPLETED|Overall Study|Ongoing patients at the time of data cut-off. 3 patients were untreated|331||
60080595|NCT01682083|76195944|FG001|COMPLETED|Overall Study|Ongoing patients at the time of data cut-off.|277||
60080596|NCT01682083|76195943|FG000|NOT COMPLETED|Overall Study||107||
60080597|NCT01682083|76195944|FG001|NOT COMPLETED|Overall Study||155||
60080598|NCT01511068|76195950|FG000|STARTED|Overall Study||2||
60080599|NCT01511068|76195950|FG000|COMPLETED|Overall Study||2||
60080600|NCT01511068|76195950|FG000|NOT COMPLETED|Overall Study||0||
60080601|NCT01180790|76195961|FG000|STARTED|Overall Study||16||
60080602|NCT01180790|76195962|FG001|STARTED|Overall Study||16||
60080603|NCT01180790|76195963|FG002|STARTED|Overall Study||17||
60080604|NCT01180790|76195964|FG003|STARTED|Overall Study||15||
60080605|NCT01180790|76195965|FG004|STARTED|Overall Study||19||
60080606|NCT01180790|76195966|FG005|STARTED|Overall Study||20||
60080607|NCT01180790|76195967|FG006|STARTED|Overall Study||19||
60080608|NCT01180790|76195961|FG000|COMPLETED|Overall Study||7||
60080609|NCT01180790|76195962|FG001|COMPLETED|Overall Study||11||
60080610|NCT01180790|76195963|FG002|COMPLETED|Overall Study||4||
60080611|NCT01180790|76195964|FG003|COMPLETED|Overall Study||6||
60080612|NCT01180790|76195965|FG004|COMPLETED|Overall Study||14||
60080613|NCT01180790|76195966|FG005|COMPLETED|Overall Study||13||
60080614|NCT01180790|76195967|FG006|COMPLETED|Overall Study||18||
60080615|NCT01180790|76195961|FG000|NOT COMPLETED|Overall Study||9||
60080616|NCT01180790|76195962|FG001|NOT COMPLETED|Overall Study||5||
60080617|NCT01180790|76195963|FG002|NOT COMPLETED|Overall Study||13||
59706506|NCT01263197|75825679|FG004|COMPLETED|Washout Period 1||7||
59706507|NCT01263197|75825680|FG005|COMPLETED|Washout Period 1||7||
60080618|NCT01180790|76195964|FG003|NOT COMPLETED|Overall Study||9||
60080619|NCT01180790|76195965|FG004|NOT COMPLETED|Overall Study||5||
60080620|NCT01180790|76195966|FG005|NOT COMPLETED|Overall Study||7||
60080621|NCT01180790|76195967|FG006|NOT COMPLETED|Overall Study||1||
60080622|NCT00721526|76196012|FG000|STARTED|Overall Study||41|Intent-to-treat sample|
60080623|NCT00721526|76196012|FG000|Received Study Medication|Overall Study||40||
60080624|NCT00721526|76196012|FG000|Completed Week 1 Follow-up|Overall Study||38||
60080625|NCT00721526|76196012|FG000|Completed Week 2 Follow-up|Overall Study||37||
60080626|NCT00721526|76196012|FG000|Completed Week 4 Follow-up|Overall Study||36||
60080627|NCT00721526|76196012|FG000|Completed Week 6 Follow-up|Overall Study||35||
60080628|NCT00721526|76196012|FG000|Completed Week 8 Follow-up|Overall Study||32||
60080629|NCT00721526|76196012|FG000|Completed Week 10 Follow-up|Overall Study||29||
60080630|NCT00721526|76196012|FG000|Completed Week 12 Follow-up|Overall Study||27||
60080631|NCT00721526|76196012|FG000|Completed Week 16 Follow-up|Overall Study||26|End of treatment|
60080632|NCT00721526|76196012|FG000|COMPLETED|Overall Study||20|28 week followup|
59548971|NCT02405442|75648068|FG001|STARTED|Extended Treatment Phase(up to Week 208)|1 participant completed Open-Label Phase, but did not continue in Extended Treatment Phase.|2||
59548972|NCT02405442|75648069|FG002|STARTED|Extended Treatment Phase(up to Week 208)||2||
59548973|NCT02405442|75648070|FG003|STARTED|Extended Treatment Phase(up to Week 208)||2||
59548974|NCT02405442|75648067|FG000|COMPLETED|Extended Treatment Phase(up to Week 208)||0||
59548975|NCT02405442|75648068|FG001|COMPLETED|Extended Treatment Phase(up to Week 208)||0||
59548976|NCT02405442|75648069|FG002|COMPLETED|Extended Treatment Phase(up to Week 208)||0||
59548977|NCT02405442|75648070|FG003|COMPLETED|Extended Treatment Phase(up to Week 208)||0||
59548978|NCT02405442|75648067|FG000|NOT COMPLETED|Extended Treatment Phase(up to Week 208)||3||
59548979|NCT02405442|75648068|FG001|NOT COMPLETED|Extended Treatment Phase(up to Week 208)||2||
59548980|NCT02405442|75648069|FG002|NOT COMPLETED|Extended Treatment Phase(up to Week 208)||2||
59548981|NCT02405442|75648070|FG003|NOT COMPLETED|Extended Treatment Phase(up to Week 208)||2||
59548982|NCT01189136|75648086|FG000|STARTED|Overall Study||42||
59548983|NCT01189136|75648087|FG001|STARTED|Overall Study||42||
59548984|NCT01189136|75648086|FG000|COMPLETED|Overall Study||42||
59548985|NCT01189136|75648087|FG001|COMPLETED|Overall Study||42||
59548986|NCT01189136|75648086|FG000|NOT COMPLETED|Overall Study||0||
59548987|NCT01189136|75648087|FG001|NOT COMPLETED|Overall Study||0||
59816317|NCT00432159|75938724|FG003|STARTED|Overall Study||20||
59816318|NCT00432159|75938725|FG004|STARTED|Overall Study||89||
59816319|NCT00432159|75938721|FG000|COMPLETED|Overall Study|Actual (Complete efficacy)|163||
59816320|NCT00432159|75938722|FG001|COMPLETED|Overall Study|Actual (Complete efficacy)|137||
59816321|NCT00432159|75938723|FG002|COMPLETED|Overall Study|Actual (Complete efficacy)|35||
60080633|NCT00721526|76196012|FG000|NOT COMPLETED|Overall Study||21||
60080634|NCT00679042|76196016|FG000|STARTED|Transplant + 1 Year Follow Up||21||
60080635|NCT00679042|76196016|FG000|COMPLETED|Transplant + 1 Year Follow Up||19||
60080636|NCT00679042|76196016|FG000|NOT COMPLETED|Transplant + 1 Year Follow Up||2||
60080637|NCT00679042|76196016|FG000|STARTED|5-Year Follow Up||19||
59548988|NCT01189292|75648095|FG000|STARTED|Intention to Treat Analysis||76||
59548989|NCT01189292|75648096|FG001|STARTED|Intention to Treat Analysis||76||
59548990|NCT01189292|75648095|FG000|COMPLETED|Intention to Treat Analysis||76||
59548991|NCT01189292|75648096|FG001|COMPLETED|Intention to Treat Analysis||76||
60080638|NCT00679042|76196016|FG000|COMPLETED|5-Year Follow Up||5||
60080639|NCT00679042|76196016|FG000|NOT COMPLETED|5-Year Follow Up||14||
60080640|NCT00679042|76196016|FG000|STARTED|10-Year Follow Up||5||
59548992|NCT01189292|75648095|FG000|NOT COMPLETED|Intention to Treat Analysis||0||
59816322|NCT00432159|75938724|FG003|COMPLETED|Overall Study|Actual (Complete efficacy)|15||
59816323|NCT00432159|75938725|FG004|COMPLETED|Overall Study|Actual (Complete efficacy)|79||
59816324|NCT00432159|75938721|FG000|NOT COMPLETED|Overall Study||22||
59816325|NCT00432159|75938722|FG001|NOT COMPLETED|Overall Study||30||
59548993|NCT01189292|75648096|FG001|NOT COMPLETED|Intention to Treat Analysis||0||
60080641|NCT00679042|76196016|FG000|COMPLETED|10-Year Follow Up||0||
60080642|NCT00679042|76196016|FG000|NOT COMPLETED|10-Year Follow Up||5||
59548994|NCT01189292|75648095|FG000|STARTED|Per Protocol Analysis||76||
59548995|NCT01189292|75648096|FG001|STARTED|Per Protocol Analysis||76||
59548996|NCT01189292|75648095|FG000|COMPLETED|Per Protocol Analysis||65||
59548997|NCT01189292|75648096|FG001|COMPLETED|Per Protocol Analysis||60||
59816326|NCT00432159|75938723|FG002|NOT COMPLETED|Overall Study||4||
59816327|NCT00432159|75938724|FG003|NOT COMPLETED|Overall Study||5||
60080643|NCT00350272|76196022|FG000|STARTED|Blinded 12-Week Treatment||39||
59548998|NCT01189292|75648095|FG000|NOT COMPLETED|Per Protocol Analysis||11||
59548999|NCT01189292|75648096|FG001|NOT COMPLETED|Per Protocol Analysis||16||
59549000|NCT01189370|75648102|FG000|STARTED|Dose Level 1||25||
59549001|NCT01189370|75648103|FG001|STARTED|Dose Level 1||0||
59549002|NCT01189370|75648104|FG002|STARTED|Dose Level 1||0||
59549003|NCT01189370|75648102|FG000|COMPLETED|Dose Level 1||16||
59549004|NCT01189370|75648103|FG001|COMPLETED|Dose Level 1||0||
59549005|NCT01189370|75648104|FG002|COMPLETED|Dose Level 1||0||
59549006|NCT01189370|75648102|FG000|NOT COMPLETED|Dose Level 1||9||
59549007|NCT01189370|75648103|FG001|NOT COMPLETED|Dose Level 1||0||
59549008|NCT01189370|75648104|FG002|NOT COMPLETED|Dose Level 1||0||
59549009|NCT01189370|75648102|FG000|STARTED|Dose Level 2||0||
59549010|NCT01189370|75648103|FG001|STARTED|Dose Level 2||16||
59549011|NCT01189370|75648104|FG002|STARTED|Dose Level 2||0||
59549012|NCT01189370|75648102|FG000|COMPLETED|Dose Level 2||0||
59549013|NCT01189370|75648103|FG001|COMPLETED|Dose Level 2||12||
59549014|NCT01189370|75648104|FG002|COMPLETED|Dose Level 2||0||
59549015|NCT01189370|75648102|FG000|NOT COMPLETED|Dose Level 2||0||
59549016|NCT01189370|75648103|FG001|NOT COMPLETED|Dose Level 2||4||
59549017|NCT01189370|75648104|FG002|NOT COMPLETED|Dose Level 2||0||
59549018|NCT01189370|75648102|FG000|STARTED|Dose Level 3||0||
59549019|NCT01189370|75648103|FG001|STARTED|Dose Level 3||0||
59549020|NCT01189370|75648104|FG002|STARTED|Dose Level 3||12||
59549021|NCT01189370|75648102|FG000|COMPLETED|Dose Level 3||0||
59549022|NCT01189370|75648103|FG001|COMPLETED|Dose Level 3||0||
59549023|NCT01189370|75648104|FG002|COMPLETED|Dose Level 3||6||
59549024|NCT01189370|75648102|FG000|NOT COMPLETED|Dose Level 3||0||
59549025|NCT01189370|75648103|FG001|NOT COMPLETED|Dose Level 3||0||
59549026|NCT01189370|75648104|FG002|NOT COMPLETED|Dose Level 3||6||
59549027|NCT01189760|75648114|FG000|STARTED|Overall Study||305||
59549028|NCT01189760|75648115|FG001|STARTED|Overall Study||306||
59549029|NCT01189760|75648116|FG002|STARTED|Overall Study||306||
59549030|NCT01189760|75648114|FG000|COMPLETED|Overall Study||291||
59549031|NCT01189760|75648115|FG001|COMPLETED|Overall Study||283||
59549032|NCT01189760|75648116|FG002|COMPLETED|Overall Study||255||
59549033|NCT01189760|75648114|FG000|NOT COMPLETED|Overall Study||14||
59549034|NCT01189760|75648115|FG001|NOT COMPLETED|Overall Study||23||
59549035|NCT01189760|75648116|FG002|NOT COMPLETED|Overall Study||51||
59549036|NCT01191242|75648124|FG000|STARTED|Overall Study||31||
59549037|NCT01191242|75648124|FG000|COMPLETED|Overall Study||31||
59549038|NCT01191242|75648124|FG000|NOT COMPLETED|Overall Study||0||
59549039|NCT01191320|75648131|FG000|STARTED|Overall Study||43||
59549040|NCT01191320|75648132|FG001|STARTED|Overall Study||38||
59549041|NCT01191320|75648133|FG002|STARTED|Overall Study||38||
59549042|NCT01191320|75648131|FG000|COMPLETED|Overall Study||36||
59549043|NCT01191320|75648132|FG001|COMPLETED|Overall Study||32||
59549044|NCT01191320|75648133|FG002|COMPLETED|Overall Study||31||
59549045|NCT01191320|75648131|FG000|NOT COMPLETED|Overall Study||7||
59549046|NCT01191320|75648132|FG001|NOT COMPLETED|Overall Study||6||
59549047|NCT01191320|75648133|FG002|NOT COMPLETED|Overall Study||7||
59549048|NCT01151852|75648143|FG000|STARTED|Overall Study||41||
60080644|NCT00350272|76196023|FG001|STARTED|Blinded 12-Week Treatment||37||
60080645|NCT00350272|76196022|FG000|COMPLETED|Blinded 12-Week Treatment||30||
60080646|NCT00350272|76196023|FG001|COMPLETED|Blinded 12-Week Treatment||35||
60080647|NCT00350272|76196022|FG000|NOT COMPLETED|Blinded 12-Week Treatment||9||
60080648|NCT00350272|76196023|FG001|NOT COMPLETED|Blinded 12-Week Treatment||2||
60080649|NCT00350272|76196022|FG000|STARTED|Open-Label 84 Week Treatment||30||
60080650|NCT00350272|76196023|FG001|STARTED|Open-Label 84 Week Treatment||35||
60080651|NCT00350272|76196022|FG000|COMPLETED|Open-Label 84 Week Treatment||21||
60080652|NCT00350272|76196023|FG001|COMPLETED|Open-Label 84 Week Treatment||27||
60080653|NCT00350272|76196022|FG000|NOT COMPLETED|Open-Label 84 Week Treatment||9||
60080654|NCT00350272|76196023|FG001|NOT COMPLETED|Open-Label 84 Week Treatment||8||
60080655|NCT02028884|76196034|FG000|STARTED|Double-blind Period||42||
60080656|NCT02028884|76196035|FG001|STARTED|Double-blind Period||42||
60080657|NCT02028884|76196036|FG002|STARTED|Double-blind Period||0||
60080658|NCT02028884|76196034|FG000|COMPLETED|Double-blind Period||32|Double-blind period|
60080659|NCT02028884|76196035|FG001|COMPLETED|Double-blind Period||39|Double-blind period|
60080660|NCT02028884|76196036|FG002|COMPLETED|Double-blind Period||0|Double-blind period|
60080661|NCT02028884|76196034|FG000|NOT COMPLETED|Double-blind Period||10||
59549049|NCT01151852|75648144|FG001|STARTED|Overall Study||40||
59549050|NCT01151852|75648143|FG000|COMPLETED|Overall Study||41||
59549051|NCT01151852|75648144|FG001|COMPLETED|Overall Study||40||
59549052|NCT01151852|75648143|FG000|NOT COMPLETED|Overall Study||0||
59549053|NCT01151852|75648144|FG001|NOT COMPLETED|Overall Study||0||
59549054|NCT02586909|75648150|FG000|STARTED|Overall Study||1099||
59549055|NCT02586909|75648150|FG000|COMPLETED|Overall Study||151||
59549056|NCT02586909|75648150|FG000|NOT COMPLETED|Overall Study||948||
59549057|NCT01191398|75648157|FG000|STARTED|Overall Study||17||
60080662|NCT02028884|76196035|FG001|NOT COMPLETED|Double-blind Period||3||
60080663|NCT02028884|76196036|FG002|NOT COMPLETED|Double-blind Period||0||
60080664|NCT02028884|76196034|FG000|STARTED|Open-label Extension Period||32||
60080665|NCT02028884|76196035|FG001|STARTED|Open-label Extension Period||39||
59549058|NCT01191398|75648158|FG001|STARTED|Overall Study||17||
59549059|NCT01191398|75648159|FG002|STARTED|Overall Study||18||
59549060|NCT01191398|75648157|FG000|COMPLETED|Overall Study||17||
59549061|NCT01191398|75648158|FG001|COMPLETED|Overall Study||17||
59549062|NCT01191398|75648159|FG002|COMPLETED|Overall Study||18||
59549063|NCT01191398|75648157|FG000|NOT COMPLETED|Overall Study||0||
59549064|NCT01191398|75648158|FG001|NOT COMPLETED|Overall Study||0||
59549065|NCT01191398|75648159|FG002|NOT COMPLETED|Overall Study||0||
59549066|NCT01191476|75648170|FG000|STARTED|Overall Study||112||
59549067|NCT01191476|75648171|FG001|STARTED|Overall Study|Data was not collected for 1 subject for baseline characteristics or the full analysis set.|111||
59549068|NCT01191476|75648172|FG002|STARTED|Overall Study|Data was not collected for 1 subject for baseline characteristics or the full analysis set.|111||
59549069|NCT01191476|75648170|FG000|COMPLETED|Overall Study||109||
59549070|NCT01191476|75648171|FG001|COMPLETED|Overall Study||107||
59549071|NCT01191476|75648172|FG002|COMPLETED|Overall Study||111||
59549072|NCT01191476|75648170|FG000|NOT COMPLETED|Overall Study||3||
59549073|NCT01191476|75648171|FG001|NOT COMPLETED|Overall Study||4||
59549074|NCT01191476|75648172|FG002|NOT COMPLETED|Overall Study||0||
59549075|NCT02404350|75648186|FG000|STARTED|Overall Study||222||
59549076|NCT02404350|75648187|FG001|STARTED|Overall Study||220||
59549077|NCT02404350|75648188|FG002|STARTED|Overall Study||222||
59549078|NCT02404350|75648189|FG003|STARTED|Overall Study||332||
59549079|NCT02404350|75648186|FG000|COMPLETED|Overall Study||207|Completed Randomisation phase (up to week 24).|
59549080|NCT02404350|75648187|FG001|COMPLETED|Overall Study||214|Completed Randomisation phase (up to week 24).|
59549081|NCT02404350|75648188|FG002|COMPLETED|Overall Study||216|Completed Randomisation phase (up to week 24).|
59549082|NCT02404350|75648189|FG003|COMPLETED|Overall Study||295|Completed Randomisation phase (up to week 24).|
59549083|NCT02404350|75648186|FG000|NOT COMPLETED|Overall Study||15||
59549084|NCT02404350|75648187|FG001|NOT COMPLETED|Overall Study||6||
59549085|NCT02404350|75648188|FG002|NOT COMPLETED|Overall Study||6||
59549086|NCT02404350|75648189|FG003|NOT COMPLETED|Overall Study||37||
59549087|NCT02508207|75648202|FG000|STARTED|Overall Study||7||
59549088|NCT02508207|75648203|FG001|STARTED|Overall Study||27||
59549089|NCT02508207|75648202|FG000|COMPLETED|Overall Study||7||
59549090|NCT02508207|75648203|FG001|COMPLETED|Overall Study||27||
59549091|NCT02508207|75648202|FG000|NOT COMPLETED|Overall Study||0||
59549092|NCT02508207|75648203|FG001|NOT COMPLETED|Overall Study||0||
59549093|NCT02181530|75648209|FG000|STARTED|Overall Study||43||
59549094|NCT02181530|75648209|FG000|COMPLETED|Overall Study||43||
59549095|NCT02181530|75648209|FG000|NOT COMPLETED|Overall Study||0||
59549096|NCT01193114|75648215|FG000|STARTED|Overall Study||30||
59549097|NCT01193114|75648216|FG001|STARTED|Overall Study||30||
59549098|NCT01193114|75648215|FG000|COMPLETED|Overall Study||30||
59549099|NCT01193114|75648216|FG001|COMPLETED|Overall Study||30||
59549100|NCT01193114|75648215|FG000|NOT COMPLETED|Overall Study||0||
59549101|NCT01193114|75648216|FG001|NOT COMPLETED|Overall Study||0||
59549102|NCT02509065|75648222|FG000|STARTED|Overall Study||1||
59549103|NCT02509065|75648223|FG001|STARTED|Overall Study||1||
59549104|NCT02509065|75648224|FG002|STARTED|Overall Study||2||
59549105|NCT02509065|75648225|FG003|STARTED|Overall Study||1||
59549106|NCT02509065|75648226|FG004|STARTED|Overall Study||1||
59549107|NCT02509065|75648227|FG005|STARTED|Overall Study||1||
59549108|NCT02509065|75648228|FG006|STARTED|Overall Study||1||
59549109|NCT02509065|75648229|FG007|STARTED|Overall Study||1||
59549110|NCT02509065|75648230|FG008|STARTED|Overall Study||1||
59549111|NCT02509065|75648231|FG009|STARTED|Overall Study||1||
60080666|NCT02028884|76196036|FG002|STARTED|Open-label Extension Period||1||
60080667|NCT02028884|76196034|FG000|COMPLETED|Open-label Extension Period||23|Open-label extension period|
60080668|NCT02028884|76196035|FG001|COMPLETED|Open-label Extension Period||31|Open-label extension period|
60080669|NCT02028884|76196036|FG002|COMPLETED|Open-label Extension Period||1|Open-label extension period|
60080670|NCT02028884|76196034|FG000|NOT COMPLETED|Open-label Extension Period||9||
60080671|NCT02028884|76196035|FG001|NOT COMPLETED|Open-label Extension Period||8||
60080672|NCT02028884|76196036|FG002|NOT COMPLETED|Open-label Extension Period||0||
60080673|NCT02019875|76196052|FG000|STARTED|Overall Study||16||
60080674|NCT02019875|76196053|FG001|STARTED|Overall Study||18||
59549112|NCT02509065|75648232|FG010|STARTED|Overall Study||1||
59549113|NCT02509065|75648233|FG011|STARTED|Overall Study||1||
59549114|NCT02509065|75648234|FG012|STARTED|Overall Study||1||
59549115|NCT02509065|75648235|FG013|STARTED|Overall Study||1||
59549116|NCT02509065|75648236|FG014|STARTED|Overall Study||1||
59549117|NCT02509065|75648237|FG015|STARTED|Overall Study||1||
59549118|NCT02509065|75648238|FG016|STARTED|Overall Study||1||
59549119|NCT02509065|75648239|FG017|STARTED|Overall Study||1||
59549120|NCT02509065|75648240|FG018|STARTED|Overall Study||1||
59549121|NCT02509065|75648241|FG019|STARTED|Overall Study||1||
59549122|NCT02509065|75648242|FG020|STARTED|Overall Study||1||
59549123|NCT02509065|75648243|FG021|STARTED|Overall Study||1||
59549124|NCT02509065|75648244|FG022|STARTED|Overall Study||1||
59549125|NCT02509065|75648222|FG000|COMPLETED|Overall Study||1||
59549126|NCT02509065|75648223|FG001|COMPLETED|Overall Study||1||
59549127|NCT02509065|75648224|FG002|COMPLETED|Overall Study||2||
59549128|NCT02509065|75648225|FG003|COMPLETED|Overall Study||1||
59549129|NCT02509065|75648226|FG004|COMPLETED|Overall Study||1||
59549130|NCT02509065|75648227|FG005|COMPLETED|Overall Study||1||
59549131|NCT02509065|75648228|FG006|COMPLETED|Overall Study||1||
59549132|NCT02509065|75648229|FG007|COMPLETED|Overall Study||1||
59549133|NCT02509065|75648230|FG008|COMPLETED|Overall Study||1||
59549134|NCT02509065|75648231|FG009|COMPLETED|Overall Study||1||
59549135|NCT02509065|75648232|FG010|COMPLETED|Overall Study||1||
59549136|NCT02509065|75648233|FG011|COMPLETED|Overall Study||1||
59549137|NCT02509065|75648234|FG012|COMPLETED|Overall Study||1||
59549138|NCT02509065|75648235|FG013|COMPLETED|Overall Study||1||
59549139|NCT02509065|75648236|FG014|COMPLETED|Overall Study||1||
59816328|NCT00432159|75938725|FG004|NOT COMPLETED|Overall Study||10||
60080675|NCT02019875|76196054|FG002|STARTED|Overall Study||15||
60080676|NCT02019875|76196055|FG003|STARTED|Overall Study||15||
60080677|NCT02019875|76196056|FG004|STARTED|Overall Study||16||
60080678|NCT02019875|76196057|FG005|STARTED|Overall Study||12||
60080679|NCT02019875|76196052|FG000|COMPLETED|Overall Study||14||
60080680|NCT02019875|76196053|FG001|COMPLETED|Overall Study||16||
60080681|NCT02019875|76196054|FG002|COMPLETED|Overall Study||15||
60080682|NCT02019875|76196055|FG003|COMPLETED|Overall Study||14||
60080683|NCT02019875|76196056|FG004|COMPLETED|Overall Study||15||
60080684|NCT02019875|76196057|FG005|COMPLETED|Overall Study||11||
60080685|NCT02019875|76196052|FG000|NOT COMPLETED|Overall Study||2||
60080686|NCT02019875|76196053|FG001|NOT COMPLETED|Overall Study||2||
60080687|NCT02019875|76196054|FG002|NOT COMPLETED|Overall Study||0||
60080688|NCT02019875|76196055|FG003|NOT COMPLETED|Overall Study||1||
60080689|NCT02019875|76196056|FG004|NOT COMPLETED|Overall Study||1||
60080690|NCT02019875|76196057|FG005|NOT COMPLETED|Overall Study||1||
59549140|NCT02509065|75648237|FG015|COMPLETED|Overall Study||1||
59549141|NCT02509065|75648238|FG016|COMPLETED|Overall Study||1||
59549142|NCT02509065|75648239|FG017|COMPLETED|Overall Study||1||
59549143|NCT02509065|75648240|FG018|COMPLETED|Overall Study||1||
59549144|NCT02509065|75648241|FG019|COMPLETED|Overall Study||1||
59549145|NCT02509065|75648242|FG020|COMPLETED|Overall Study||1||
59549146|NCT02509065|75648243|FG021|COMPLETED|Overall Study||1||
60080691|NCT01531582|76196071|FG000|STARTED|Overall Study||25||
60080692|NCT01531582|76196071|FG000|COMPLETED|Overall Study||24||
60080693|NCT01531582|76196071|FG000|NOT COMPLETED|Overall Study||1||
59549147|NCT02509065|75648244|FG022|COMPLETED|Overall Study||1||
59549148|NCT02509065|75648222|FG000|NOT COMPLETED|Overall Study||0||
59549149|NCT02509065|75648223|FG001|NOT COMPLETED|Overall Study||0||
59549150|NCT02509065|75648224|FG002|NOT COMPLETED|Overall Study||0||
59549151|NCT02509065|75648225|FG003|NOT COMPLETED|Overall Study||0||
59549152|NCT02509065|75648226|FG004|NOT COMPLETED|Overall Study||0||
59549153|NCT02509065|75648227|FG005|NOT COMPLETED|Overall Study||0||
59549154|NCT02509065|75648228|FG006|NOT COMPLETED|Overall Study||0||
60080694|NCT01500733|76196079|FG000|STARTED|Overall Study||35||
60080695|NCT01500733|76196080|FG001|STARTED|Overall Study||51||
60080696|NCT01500733|76196079|FG000|COMPLETED|Overall Study||33||
60080697|NCT01500733|76196080|FG001|COMPLETED|Overall Study||48||
60080698|NCT01500733|76196079|FG000|NOT COMPLETED|Overall Study||2||
59991079|NCT01678209|76106592|FG000|STARTED|Overall Study||47||
59991080|NCT01678209|76106593|FG001|STARTED|Overall Study||40||
59991081|NCT01678209|76106594|FG002|STARTED|Overall Study||40||
59549155|NCT02509065|75648229|FG007|NOT COMPLETED|Overall Study||0||
59549156|NCT02509065|75648230|FG008|NOT COMPLETED|Overall Study||0||
59549157|NCT02509065|75648231|FG009|NOT COMPLETED|Overall Study||0||
59549158|NCT02509065|75648232|FG010|NOT COMPLETED|Overall Study||0||
59549159|NCT02509065|75648233|FG011|NOT COMPLETED|Overall Study||0||
59549160|NCT02509065|75648234|FG012|NOT COMPLETED|Overall Study||0||
59549161|NCT02509065|75648235|FG013|NOT COMPLETED|Overall Study||0||
59549162|NCT02509065|75648236|FG014|NOT COMPLETED|Overall Study||0||
59549163|NCT02509065|75648237|FG015|NOT COMPLETED|Overall Study||0||
59549164|NCT02509065|75648238|FG016|NOT COMPLETED|Overall Study||0||
59549165|NCT02509065|75648239|FG017|NOT COMPLETED|Overall Study||0||
59549166|NCT02509065|75648240|FG018|NOT COMPLETED|Overall Study||0||
59549167|NCT02509065|75648241|FG019|NOT COMPLETED|Overall Study||0||
59549168|NCT02509065|75648242|FG020|NOT COMPLETED|Overall Study||0||
59549169|NCT02509065|75648243|FG021|NOT COMPLETED|Overall Study||0||
59549170|NCT02509065|75648244|FG022|NOT COMPLETED|Overall Study||0||
59549171|NCT01194674|75648260|FG000|STARTED|Overall Study||2||
59549172|NCT01194674|75648260|FG000|COMPLETED|Overall Study||2||
59549173|NCT01194674|75648260|FG000|NOT COMPLETED|Overall Study||0||
59549174|NCT02509767|75648267|FG000|STARTED|Overall Study||201||
59549175|NCT02509767|75648268|FG001|STARTED|Overall Study||200||
59549176|NCT02509767|75648267|FG000|COMPLETED|Overall Study||157||
59549177|NCT02509767|75648268|FG001|COMPLETED|Overall Study||159||
59549178|NCT02509767|75648267|FG000|NOT COMPLETED|Overall Study||44||
59549179|NCT02509767|75648268|FG001|NOT COMPLETED|Overall Study||41||
59549180|NCT01154192|75648280|FG000|STARTED|Overall Study||14||
59549181|NCT01154192|75648281|FG001|STARTED|Overall Study||10||
59549182|NCT01154192|75648282|FG002|STARTED|Overall Study||0||
59549183|NCT01154192|75648280|FG000|COMPLETED|Overall Study||14||
59549184|NCT01154192|75648281|FG001|COMPLETED|Overall Study||10||
59549185|NCT01154192|75648282|FG002|COMPLETED|Overall Study||0||
59549186|NCT01154192|75648280|FG000|NOT COMPLETED|Overall Study||0||
59549187|NCT01154192|75648281|FG001|NOT COMPLETED|Overall Study||0||
59549188|NCT01154192|75648282|FG002|NOT COMPLETED|Overall Study||0||
59549189|NCT02511561|75648294|FG000|STARTED|Overall Study||25||
59549190|NCT02511561|75648295|FG001|STARTED|Overall Study||25||
59549191|NCT02511561|75648296|FG002|STARTED|Overall Study||25||
59549192|NCT02511561|75648294|FG000|COMPLETED|Overall Study||25||
59549193|NCT02511561|75648295|FG001|COMPLETED|Overall Study||25||
59549194|NCT02511561|75648296|FG002|COMPLETED|Overall Study||25||
59549195|NCT02511561|75648294|FG000|NOT COMPLETED|Overall Study||0||
59549196|NCT02511561|75648295|FG001|NOT COMPLETED|Overall Study||0||
59549197|NCT02511561|75648296|FG002|NOT COMPLETED|Overall Study||0||
59549198|NCT03884270|75648305|FG000|STARTED|Overall Study||23||
59549199|NCT03884270|75648305|FG000|COMPLETED|Overall Study||22||
59549200|NCT03884270|75648305|FG000|NOT COMPLETED|Overall Study||1||
59549201|NCT02511717|75648311|FG000|STARTED|Overall Study||10||
59549202|NCT02511717|75648312|FG001|STARTED|Overall Study||10||
59549203|NCT02511717|75648311|FG000|COMPLETED|Overall Study||8||
59549204|NCT02511717|75648312|FG001|COMPLETED|Overall Study||10||
59549205|NCT02511717|75648311|FG000|NOT COMPLETED|Overall Study||2||
59549206|NCT02511717|75648312|FG001|NOT COMPLETED|Overall Study||0||
59549207|NCT02512419|75648320|FG000|STARTED|Overall Study||24||
59549208|NCT02512419|75648321|FG001|STARTED|Overall Study||24||
59549209|NCT02512419|75648320|FG000|COMPLETED|Overall Study|2 participants became ineligible after enrolling therefore were not included in analysis.|22||
59549210|NCT02512419|75648321|FG001|COMPLETED|Overall Study||24||
59549211|NCT02512419|75648320|FG000|NOT COMPLETED|Overall Study||2||
59549212|NCT02512419|75648321|FG001|NOT COMPLETED|Overall Study||0||
59549213|NCT01155830|75648330|FG000|STARTED|Overall Study||0||
59549214|NCT01155830|75648331|FG001|STARTED|Overall Study||0||
59549215|NCT01155830|75648332|FG002|STARTED|Overall Study||21||
59549216|NCT01155830|75648330|FG000|COMPLETED|Overall Study||0||
59549217|NCT01155830|75648331|FG001|COMPLETED|Overall Study||0||
59549218|NCT01155830|75648332|FG002|COMPLETED|Overall Study||21||
59549219|NCT01155830|75648330|FG000|NOT COMPLETED|Overall Study||0||
59549220|NCT01155830|75648331|FG001|NOT COMPLETED|Overall Study||0||
59549221|NCT01155830|75648332|FG002|NOT COMPLETED|Overall Study||0||
59549222|NCT02186210|75648342|FG000|STARTED|Overall Study||20||
59549223|NCT02186210|75648343|FG001|STARTED|Overall Study||20||
59549224|NCT02186210|75648342|FG000|COMPLETED|Overall Study||20||
59549225|NCT02186210|75648343|FG001|COMPLETED|Overall Study||20||
59549226|NCT02186210|75648342|FG000|NOT COMPLETED|Overall Study||0||
59549227|NCT02186210|75648343|FG001|NOT COMPLETED|Overall Study||0||
59549228|NCT01195922|75648351|FG000|STARTED|Overall Study||16||
59549229|NCT01195922|75648351|FG000|COMPLETED|Overall Study||16||
59549230|NCT01195922|75648351|FG000|NOT COMPLETED|Overall Study||0||
59549231|NCT01197326|75648357|FG000|STARTED|Overall Study||205||
59549232|NCT01197326|75648358|FG001|STARTED|Overall Study||209||
59549233|NCT01197326|75648357|FG000|COMPLETED|Overall Study||205||
59549234|NCT01197326|75648358|FG001|COMPLETED|Overall Study||209||
59549235|NCT01197326|75648357|FG000|NOT COMPLETED|Overall Study||0||
59549236|NCT01197326|75648358|FG001|NOT COMPLETED|Overall Study||0||
59549237|NCT02512575|75648376|FG000|STARTED|Overall Study||6||
59549238|NCT02512575|75648377|FG001|STARTED|Overall Study||6||
59549239|NCT02512575|75648378|FG002|STARTED|Overall Study||6||
59549240|NCT02512575|75648379|FG003|STARTED|Overall Study||6||
59706508|NCT01263197|75825675|FG000|NOT COMPLETED|Washout Period 1||0||
59706509|NCT01263197|75825676|FG001|NOT COMPLETED|Washout Period 1||0||
59706510|NCT01263197|75825677|FG002|NOT COMPLETED|Washout Period 1||0||
59706511|NCT01263197|75825678|FG003|NOT COMPLETED|Washout Period 1||0||
59706512|NCT01263197|75825679|FG004|NOT COMPLETED|Washout Period 1||1||
59706513|NCT01263197|75825680|FG005|NOT COMPLETED|Washout Period 1||0||
59706514|NCT01263197|75825675|FG000|STARTED|Second Intervention (Period 2)||8||
59706515|NCT01263197|75825676|FG001|STARTED|Second Intervention (Period 2)||8||
60080699|NCT01500733|76196080|FG001|NOT COMPLETED|Overall Study||3||
60080700|NCT01422187|76196089|FG000|STARTED|Overall Study||8||
60080701|NCT01422187|76196090|FG001|STARTED|Overall Study||9||
59706516|NCT01263197|75825677|FG002|STARTED|Second Intervention (Period 2)||8||
59706517|NCT01263197|75825678|FG003|STARTED|Second Intervention (Period 2)||8||
59706518|NCT01263197|75825679|FG004|STARTED|Second Intervention (Period 2)||7||
59706519|NCT01263197|75825680|FG005|STARTED|Second Intervention (Period 2)||7||
59706520|NCT01263197|75825675|FG000|COMPLETED|Second Intervention (Period 2)||8||
59706521|NCT01263197|75825676|FG001|COMPLETED|Second Intervention (Period 2)||8||
59991082|NCT01678209|76106592|FG000|COMPLETED|Overall Study||30||
59991083|NCT01678209|76106593|FG001|COMPLETED|Overall Study||22||
59991084|NCT01678209|76106594|FG002|COMPLETED|Overall Study||22||
59991085|NCT01678209|76106592|FG000|NOT COMPLETED|Overall Study||17||
59991086|NCT01678209|76106593|FG001|NOT COMPLETED|Overall Study||18||
59991087|NCT01678209|76106594|FG002|NOT COMPLETED|Overall Study||18||
59991088|NCT02239120|76106604|FG000|STARTED|Overall Study||2695|Randomised|
59991089|NCT02239120|76106605|FG001|STARTED|Overall Study||2695|Randomised|
59991090|NCT02239120|76106604|FG000|COMPLETED|Overall Study||2620||
59991091|NCT02239120|76106605|FG001|COMPLETED|Overall Study||2623||
60080702|NCT01422187|76196091|FG002|STARTED|Overall Study||2||
60080703|NCT01422187|76196089|FG000|COMPLETED|Overall Study||7||
60080704|NCT01422187|76196090|FG001|COMPLETED|Overall Study||8||
60080705|NCT01422187|76196091|FG002|COMPLETED|Overall Study||2||
60080706|NCT01422187|76196089|FG000|NOT COMPLETED|Overall Study||1||
60080707|NCT01422187|76196090|FG001|NOT COMPLETED|Overall Study||1||
60080708|NCT01422187|76196091|FG002|NOT COMPLETED|Overall Study||0||
59991092|NCT02239120|76106604|FG000|NOT COMPLETED|Overall Study||75||
60080709|NCT00472212|76196101|FG000|STARTED|Overall Study||31||
60080710|NCT00472212|76196102|FG001|STARTED|Overall Study||27||
59549241|NCT02512575|75648380|FG004|STARTED|Overall Study||6||
59549242|NCT02512575|75648381|FG005|STARTED|Overall Study||6||
59549243|NCT02512575|75648382|FG006|STARTED|Overall Study||6||
59549244|NCT02512575|75648383|FG007|STARTED|Overall Study||6||
59549245|NCT02512575|75648384|FG008|STARTED|Overall Study||6||
59549246|NCT02512575|75648385|FG009|STARTED|Overall Study||18||
59549247|NCT02512575|75648376|FG000|COMPLETED|Overall Study||6||
59549248|NCT02512575|75648377|FG001|COMPLETED|Overall Study||6||
59549249|NCT02512575|75648378|FG002|COMPLETED|Overall Study||6||
59549250|NCT02512575|75648379|FG003|COMPLETED|Overall Study||6||
59549251|NCT02512575|75648380|FG004|COMPLETED|Overall Study||6||
59549252|NCT02512575|75648381|FG005|COMPLETED|Overall Study||6||
59549253|NCT02512575|75648382|FG006|COMPLETED|Overall Study||6||
59706522|NCT01263197|75825677|FG002|COMPLETED|Second Intervention (Period 2)||8||
59706523|NCT01263197|75825678|FG003|COMPLETED|Second Intervention (Period 2)||8||
59706524|NCT01263197|75825679|FG004|COMPLETED|Second Intervention (Period 2)||7||
60080711|NCT00472212|76196101|FG000|COMPLETED|Overall Study||25||
60080712|NCT00472212|76196102|FG001|COMPLETED|Overall Study||23||
60080713|NCT00472212|76196101|FG000|NOT COMPLETED|Overall Study||6||
60080714|NCT00472212|76196102|FG001|NOT COMPLETED|Overall Study||4||
60080715|NCT00378105|76196110|FG000|STARTED|Overall Study|Out of 33 enrolled, two patients went off study before start of therapy.|31||
60080716|NCT00378105|76196111|FG001|STARTED|Overall Study||35||
60080717|NCT00378105|76196110|FG000|COMPLETED|Overall Study||11||
60080718|NCT00378105|76196111|FG001|COMPLETED|Overall Study||5||
60080719|NCT00378105|76196110|FG000|NOT COMPLETED|Overall Study||20||
60080720|NCT00378105|76196111|FG001|NOT COMPLETED|Overall Study||30||
59706525|NCT01263197|75825680|FG005|COMPLETED|Second Intervention (Period 2)||7||
59706526|NCT01263197|75825675|FG000|NOT COMPLETED|Second Intervention (Period 2)||0||
59706527|NCT01263197|75825676|FG001|NOT COMPLETED|Second Intervention (Period 2)||0||
60080721|NCT00139477|76196120|FG000|STARTED|First Intervention -Baseline to 6Months||31||
60080722|NCT00139477|76196121|FG001|STARTED|First Intervention -Baseline to 6Months||35||
60080723|NCT00139477|76196120|FG000|COMPLETED|First Intervention -Baseline to 6Months||19||
59549254|NCT02512575|75648383|FG007|COMPLETED|Overall Study||6||
59549255|NCT02512575|75648384|FG008|COMPLETED|Overall Study||6||
59549256|NCT02512575|75648385|FG009|COMPLETED|Overall Study||18||
59549257|NCT02512575|75648376|FG000|NOT COMPLETED|Overall Study||0||
59549258|NCT02512575|75648377|FG001|NOT COMPLETED|Overall Study||0||
59549259|NCT02512575|75648378|FG002|NOT COMPLETED|Overall Study||0||
59549260|NCT02512575|75648379|FG003|NOT COMPLETED|Overall Study||0||
59549261|NCT02512575|75648380|FG004|NOT COMPLETED|Overall Study||0||
59549262|NCT02512575|75648381|FG005|NOT COMPLETED|Overall Study||0||
59706528|NCT01263197|75825677|FG002|NOT COMPLETED|Second Intervention (Period 2)||0||
59706529|NCT01263197|75825678|FG003|NOT COMPLETED|Second Intervention (Period 2)||0||
60080724|NCT00139477|76196121|FG001|COMPLETED|First Intervention -Baseline to 6Months||23||
59549263|NCT02512575|75648382|FG006|NOT COMPLETED|Overall Study||0||
59549264|NCT02512575|75648383|FG007|NOT COMPLETED|Overall Study||0||
59549265|NCT02512575|75648384|FG008|NOT COMPLETED|Overall Study||0||
60103787|NCT03864406|76222062|FG000|STARTED|Overall Study||12||
59549266|NCT02512575|75648385|FG009|NOT COMPLETED|Overall Study||0||
59549267|NCT01199744|75648407|FG000|STARTED|Overall Study||1575||
59549268|NCT01199744|75648407|FG000|COMPLETED|Overall Study||1575||
59549269|NCT01199744|75648407|FG000|NOT COMPLETED|Overall Study||0||
59549270|NCT02512809|75648414|FG000|STARTED|Overall Study||25||
59549271|NCT02512809|75648414|FG000|COMPLETED|Overall Study||25||
59549272|NCT02512809|75648414|FG000|NOT COMPLETED|Overall Study||0||
59549273|NCT01201772|75648421|FG000|STARTED|Overall Study||23||
59549274|NCT01201772|75648422|FG001|STARTED|Overall Study||21||
59549275|NCT01201772|75648423|FG002|STARTED|Overall Study||21||
59549276|NCT01201772|75648421|FG000|COMPLETED|Overall Study||22||
59549277|NCT01201772|75648422|FG001|COMPLETED|Overall Study||21||
59549278|NCT01201772|75648423|FG002|COMPLETED|Overall Study||21||
59549279|NCT01201772|75648421|FG000|NOT COMPLETED|Overall Study||1||
59549280|NCT01201772|75648422|FG001|NOT COMPLETED|Overall Study||0||
59549281|NCT01201772|75648423|FG002|NOT COMPLETED|Overall Study||0||
59549282|NCT02513121|75648431|FG000|STARTED|Overall Study||20||
59549283|NCT02513121|75648432|FG001|STARTED|Overall Study||20||
59549284|NCT02513121|75648431|FG000|COMPLETED|Overall Study||20||
59549285|NCT02513121|75648432|FG001|COMPLETED|Overall Study||20||
59549286|NCT02513121|75648431|FG000|NOT COMPLETED|Overall Study||0||
59549287|NCT02513121|75648432|FG001|NOT COMPLETED|Overall Study||0||
59549288|NCT01202162|75648442|FG000|STARTED|Overall Study||43||
59549289|NCT01202162|75648443|FG001|STARTED|Overall Study||42||
59549290|NCT01202162|75648442|FG000|COMPLETED|Overall Study|40 completed the intraoperative through discharge phase of the study.|40||
59549291|NCT01202162|75648443|FG001|COMPLETED|Overall Study|40 completed the intraoperative through discharge phase of the study.|40||
59549292|NCT01202162|75648442|FG000|NOT COMPLETED|Overall Study||3||
59549293|NCT01202162|75648443|FG001|NOT COMPLETED|Overall Study||2||
59549294|NCT01158716|75648451|FG000|STARTED|Overall Study||48||
59549295|NCT01158716|75648452|FG001|STARTED|Overall Study||48||
59549296|NCT01158716|75648451|FG000|COMPLETED|Overall Study||47||
59549297|NCT01158716|75648452|FG001|COMPLETED|Overall Study||47||
59549298|NCT01158716|75648451|FG000|NOT COMPLETED|Overall Study||1||
59549299|NCT01158716|75648452|FG001|NOT COMPLETED|Overall Study||1||
59549300|NCT01159262|75648461|FG000|STARTED|Overall Study||14||
59549301|NCT01159262|75648462|FG001|STARTED|Overall Study||14||
59549302|NCT01159262|75648463|FG002|STARTED|Overall Study||8||
59549303|NCT01159262|75648461|FG000|COMPLETED|Overall Study||14||
59549304|NCT01159262|75648462|FG001|COMPLETED|Overall Study||14||
59549305|NCT01159262|75648463|FG002|COMPLETED|Overall Study||8||
59549306|NCT01159262|75648461|FG000|NOT COMPLETED|Overall Study||0||
59549307|NCT01159262|75648462|FG001|NOT COMPLETED|Overall Study||0||
59549308|NCT01159262|75648463|FG002|NOT COMPLETED|Overall Study||0||
59549309|NCT04377711|75648473|FG000|STARTED|Overall Study||197||
59549310|NCT04377711|75648474|FG001|STARTED|Overall Study||203||
59549311|NCT04377711|75648473|FG000|COMPLETED|Overall Study||178||
59549312|NCT04377711|75648474|FG001|COMPLETED|Overall Study||181||
59549313|NCT04377711|75648473|FG000|NOT COMPLETED|Overall Study||19||
59549314|NCT04377711|75648474|FG001|NOT COMPLETED|Overall Study||22||
59549315|NCT04366713|75648480|FG000|STARTED|Overall Study||6||
59816329|NCT00519194|75938737|FG000|STARTED|Overall Study||112||
60080725|NCT00139477|76196120|FG000|NOT COMPLETED|First Intervention -Baseline to 6Months||12||
60080726|NCT00139477|76196121|FG001|NOT COMPLETED|First Intervention -Baseline to 6Months||12||
60080727|NCT00139477|76196120|FG000|STARTED|Second Intervention -6Months to 12Months||19||
60080728|NCT00139477|76196121|FG001|STARTED|Second Intervention -6Months to 12Months||23||
60080729|NCT00139477|76196120|FG000|COMPLETED|Second Intervention -6Months to 12Months||14||
60080730|NCT00139477|76196121|FG001|COMPLETED|Second Intervention -6Months to 12Months||18||
60080731|NCT00139477|76196120|FG000|NOT COMPLETED|Second Intervention -6Months to 12Months||5||
60080732|NCT00139477|76196121|FG001|NOT COMPLETED|Second Intervention -6Months to 12Months||5||
60080733|NCT00119158|76196131|FG000|STARTED|Active Treatment|patients are self controls|45||
60080734|NCT00119158|76196132|FG001|STARTED|Active Treatment||45||
60080735|NCT00119158|76196131|FG000|COMPLETED|Active Treatment||45||
59549316|NCT04366713|75648480|FG000|Treated|Overall Study||5||
59549317|NCT04366713|75648480|FG000|COMPLETED|Overall Study||4||
59549318|NCT04366713|75648480|FG000|NOT COMPLETED|Overall Study||2||
59549319|NCT02434770|75648488|FG000|STARTED|Week 1 to Week 18||250||
59549320|NCT02434770|75648489|FG001|STARTED|Week 1 to Week 18||250||
59549321|NCT02434770|75648490|FG002|STARTED|Week 1 to Week 18||250||
59549322|NCT02434770|75648488|FG000|Received at Least One Vaccination|Week 1 to Week 18||249||
59706530|NCT01263197|75825679|FG004|NOT COMPLETED|Second Intervention (Period 2)||0||
59816330|NCT00519194|75938737|FG000|COMPLETED|Overall Study||91||
60080736|NCT00119158|76196132|FG001|COMPLETED|Active Treatment||45||
60080737|NCT00119158|76196131|FG000|NOT COMPLETED|Active Treatment||0||
60080738|NCT00119158|76196132|FG001|NOT COMPLETED|Active Treatment||0||
60080739|NCT00119158|76196131|FG000|STARTED|Placebo Treatment||45||
60080740|NCT00119158|76196132|FG001|STARTED|Placebo Treatment||45||
60080741|NCT00119158|76196131|FG000|COMPLETED|Placebo Treatment||45||
60080742|NCT00119158|76196132|FG001|COMPLETED|Placebo Treatment||45||
60080743|NCT00119158|76196131|FG000|NOT COMPLETED|Placebo Treatment||0||
60080744|NCT00119158|76196132|FG001|NOT COMPLETED|Placebo Treatment||0||
60080745|NCT00119392|76196138|FG000|STARTED|Overall Study||45||
60080746|NCT00119392|76196138|FG000|COMPLETED|Overall Study||40||
60080747|NCT00119392|76196138|FG000|NOT COMPLETED|Overall Study||5||
60080748|NCT00218062|76196146|FG000|STARTED|Overall Study||22||
60080749|NCT00218062|76196147|FG001|STARTED|Overall Study||20||
60080750|NCT00218062|76196148|FG002|STARTED|Overall Study||15||
60080751|NCT00218062|76196149|FG003|STARTED|Overall Study||16||
60080752|NCT00218062|76196146|FG000|Received First Dose of Study Medication|Overall Study||16||
60080753|NCT00218062|76196147|FG001|Received First Dose of Study Medication|Overall Study||11||
60080754|NCT00218062|76196148|FG002|Received First Dose of Study Medication|Overall Study||10||
59706531|NCT01263197|75825680|FG005|NOT COMPLETED|Second Intervention (Period 2)||0||
60080755|NCT00218062|76196149|FG003|Received First Dose of Study Medication|Overall Study||12||
60080756|NCT00218062|76196146|FG000|COMPLETED|Overall Study||7||
59549323|NCT02434770|75648489|FG001|Received at Least One Vaccination|Week 1 to Week 18||250||
59549324|NCT02434770|75648490|FG002|Received at Least One Vaccination|Week 1 to Week 18||250||
59549325|NCT02434770|75648488|FG000|COMPLETED|Week 1 to Week 18||235||
59549326|NCT02434770|75648489|FG001|COMPLETED|Week 1 to Week 18||228||
59549327|NCT02434770|75648490|FG002|COMPLETED|Week 1 to Week 18||233||
59549328|NCT02434770|75648488|FG000|NOT COMPLETED|Week 1 to Week 18||15||
59549329|NCT02434770|75648489|FG001|NOT COMPLETED|Week 1 to Week 18||22||
59706532|NCT01263197|75825675|FG000|STARTED|Washout Period 2||8||
59706533|NCT01263197|75825676|FG001|STARTED|Washout Period 2||8||
59549330|NCT02434770|75648490|FG002|NOT COMPLETED|Week 1 to Week 18||17||
59549331|NCT02434770|75648488|FG000|STARTED|Week 18 to Week||235||
59706534|NCT01263197|75825677|FG002|STARTED|Washout Period 2||8||
59549332|NCT02434770|75648489|FG001|STARTED|Week 18 to Week||228||
59549333|NCT02434770|75648490|FG002|STARTED|Week 18 to Week||233||
59549334|NCT02434770|75648488|FG000|COMPLETED|Week 18 to Week||227||
59549335|NCT02434770|75648489|FG001|COMPLETED|Week 18 to Week||220||
59549336|NCT02434770|75648490|FG002|COMPLETED|Week 18 to Week||227||
59549337|NCT02434770|75648488|FG000|NOT COMPLETED|Week 18 to Week||8||
59549338|NCT02434770|75648489|FG001|NOT COMPLETED|Week 18 to Week||8||
59549339|NCT02434770|75648490|FG002|NOT COMPLETED|Week 18 to Week||6||
59549340|NCT01203644|75648502|FG000|STARTED|Overall Study||26||
59549341|NCT01203644|75648503|FG001|STARTED|Overall Study||50||
59549342|NCT01203644|75648502|FG000|COMPLETED|Overall Study||26||
59549343|NCT01203644|75648503|FG001|COMPLETED|Overall Study||50||
59549344|NCT01203644|75648502|FG000|NOT COMPLETED|Overall Study||0||
59549345|NCT01203644|75648503|FG001|NOT COMPLETED|Overall Study||0||
59549346|NCT01220726|75648514|FG000|STARTED|Overall Study||15||
59549347|NCT01220726|75648515|FG001|STARTED|Overall Study||15||
59549348|NCT01220726|75648514|FG000|COMPLETED|Overall Study||15||
59549349|NCT01220726|75648515|FG001|COMPLETED|Overall Study||13||
59549350|NCT01220726|75648514|FG000|NOT COMPLETED|Overall Study||0||
59549351|NCT01220726|75648515|FG001|NOT COMPLETED|Overall Study||2||
59549352|NCT02433834|75648521|FG000|STARTED|Overall Study||248||
59549353|NCT02433834|75648521|FG000|GP MDI 28.8 µg|Overall Study||112||
59549354|NCT02433834|75648521|FG000|GP MDI 14.4 µg|Overall Study||230||
59549355|NCT02433834|75648521|FG000|GP MDI 7.2 µg|Overall Study||228||
59549356|NCT02433834|75648521|FG000|GP MDI 3.6 µg|Overall Study||118||
59816331|NCT00519194|75938737|FG000|NOT COMPLETED|Overall Study||21||
59816332|NCT00431847|75938745|FG000|STARTED|Overall Study||132||
59816333|NCT00431847|75938746|FG001|STARTED|Overall Study||45||
59816334|NCT00431847|75938747|FG002|STARTED|Overall Study||24||
59816335|NCT00431847|75938748|FG003|STARTED|Overall Study||184||
59816336|NCT00431847|75938749|FG004|STARTED|Overall Study||1||
59549357|NCT02433834|75648521|FG000|GP MDI 1.9 µg|Overall Study||107||
59549358|NCT02433834|75648521|FG000|Placebo MDI|Overall Study||174||
59549359|NCT02433834|75648521|FG000|SAL 50 µg|Overall Study||167||
59549360|NCT02433834|75648521|FG000|COMPLETED|Overall Study|Subject PT001101-040014 did not complete Period 4 but completed the study. CSR states 210 completed.|211||
59549361|NCT02433834|75648521|FG000|NOT COMPLETED|Overall Study||37||
59549362|NCT01204736|75648541|FG000|STARTED|Overall Study||4||
59549363|NCT01204736|75648542|FG001|STARTED|Overall Study||5||
59549364|NCT01204736|75648543|FG002|STARTED|Overall Study||3||
59549365|NCT01204736|75648544|FG003|STARTED|Overall Study||2||
59549366|NCT01204736|75648541|FG000|COMPLETED|Overall Study||4||
59549367|NCT01204736|75648542|FG001|COMPLETED|Overall Study||5||
59549368|NCT01204736|75648543|FG002|COMPLETED|Overall Study||3||
59549369|NCT01204736|75648544|FG003|COMPLETED|Overall Study||2||
59549370|NCT01204736|75648541|FG000|NOT COMPLETED|Overall Study||0||
59549371|NCT01204736|75648542|FG001|NOT COMPLETED|Overall Study||0||
59549372|NCT01204736|75648543|FG002|NOT COMPLETED|Overall Study||0||
59549373|NCT01204736|75648544|FG003|NOT COMPLETED|Overall Study||0||
59549374|NCT01221194|75648556|FG000|STARTED|Overall Study||195||
59549375|NCT01221194|75648557|FG001|STARTED|Overall Study||186||
59549376|NCT01221194|75648556|FG000|COMPLETED|Overall Study||195||
59549377|NCT01221194|75648557|FG001|COMPLETED|Overall Study||186||
59549378|NCT01221194|75648556|FG000|NOT COMPLETED|Overall Study||0||
59549379|NCT01221194|75648557|FG001|NOT COMPLETED|Overall Study||0||
59549380|NCT02433678|75648565|FG000|STARTED|Overall Study||26||
59549381|NCT02433678|75648566|FG001|STARTED|Overall Study||26||
59549382|NCT02433678|75648565|FG000|COMPLETED|Overall Study||25||
59549383|NCT02433678|75648566|FG001|COMPLETED|Overall Study||24||
59549384|NCT02433678|75648565|FG000|NOT COMPLETED|Overall Study||1||
59549385|NCT02433678|75648566|FG001|NOT COMPLETED|Overall Study||2||
59549386|NCT01205828|75648572|FG000|STARTED|Overall Study||16||
59549387|NCT01205828|75648572|FG000|COMPLETED|Overall Study|Completed the first stage of the study, terminated as pre-planned due to lack of efficacy|16||
59549388|NCT01205828|75648572|FG000|NOT COMPLETED|Overall Study||0||
59549389|NCT02433288|75648579|FG000|STARTED|Overall Study||443||
59549390|NCT02433288|75648580|FG001|STARTED|Overall Study||442||
59549391|NCT02433288|75648579|FG000|COMPLETED|Overall Study||320||
59549392|NCT02433288|75648580|FG001|COMPLETED|Overall Study||316||
59549393|NCT02433288|75648579|FG000|NOT COMPLETED|Overall Study||123||
59549394|NCT02433288|75648580|FG001|NOT COMPLETED|Overall Study||126||
59549395|NCT01206062|75648588|FG000|STARTED|Overall Study||4678||
59549396|NCT01206062|75648589|FG001|STARTED|Overall Study||4683||
59549397|NCT01206062|75648588|FG000|COMPLETED|Overall Study||4678||
59549398|NCT01206062|75648589|FG001|COMPLETED|Overall Study||4683||
59549399|NCT01206062|75648588|FG000|NOT COMPLETED|Overall Study||0||
59549400|NCT01206062|75648589|FG001|NOT COMPLETED|Overall Study||0||
59549401|NCT02433210|75648600|FG000|STARTED|Overall Study||5||
59549402|NCT02433210|75648601|FG001|STARTED|Overall Study||3||
59549403|NCT02433210|75648602|FG002|STARTED|Overall Study||3||
59549404|NCT02433210|75648600|FG000|COMPLETED|Overall Study||4||
59549405|NCT02433210|75648601|FG001|COMPLETED|Overall Study||3||
59549406|NCT02433210|75648602|FG002|COMPLETED|Overall Study||3||
59549407|NCT02433210|75648600|FG000|NOT COMPLETED|Overall Study||1||
59549408|NCT02433210|75648601|FG001|NOT COMPLETED|Overall Study||0||
59549409|NCT02433210|75648602|FG002|NOT COMPLETED|Overall Study||0||
59549410|NCT02515305|75648691|FG000|STARTED|Overall Study||385||
59549411|NCT02515305|75648692|FG001|STARTED|Overall Study||378||
59549412|NCT02515305|75648693|FG002|STARTED|Overall Study||127||
59549413|NCT02515305|75648691|FG000|COMPLETED|Overall Study||356||
59549414|NCT02515305|75648692|FG001|COMPLETED|Overall Study||343||
59549415|NCT02515305|75648693|FG002|COMPLETED|Overall Study||113||
59549416|NCT02515305|75648691|FG000|NOT COMPLETED|Overall Study||29||
59549417|NCT02515305|75648692|FG001|NOT COMPLETED|Overall Study||35||
59549418|NCT02515305|75648693|FG002|NOT COMPLETED|Overall Study||14||
59549419|NCT01222286|75648703|FG000|STARTED|Overall Study||16||
59549420|NCT01222286|75648704|FG001|STARTED|Overall Study||14||
59549421|NCT01222286|75648703|FG000|COMPLETED|Overall Study||16||
59549422|NCT01222286|75648704|FG001|COMPLETED|Overall Study||14||
59549423|NCT01222286|75648703|FG000|NOT COMPLETED|Overall Study||0||
59549424|NCT01222286|75648704|FG001|NOT COMPLETED|Overall Study||0||
59549425|NCT01206452|75648712|FG000|STARTED|Overall Study||30||
59549426|NCT01206452|75648713|FG001|STARTED|Overall Study||30||
59549427|NCT01206452|75648712|FG000|COMPLETED|Overall Study||30||
59549428|NCT01206452|75648713|FG001|COMPLETED|Overall Study||30||
59549429|NCT01206452|75648712|FG000|NOT COMPLETED|Overall Study||0||
59816337|NCT00431847|75938745|FG000|COMPLETED|Overall Study|All participants with at least two study visits were included in analysis.|126||
59549430|NCT01206452|75648713|FG001|NOT COMPLETED|Overall Study||0||
59549431|NCT01206608|75648721|FG000|STARTED|Overall Study||20||
59549432|NCT01206608|75648722|FG001|STARTED|Overall Study||20||
59549433|NCT01206608|75648721|FG000|COMPLETED|Overall Study||20||
59549434|NCT01206608|75648722|FG001|COMPLETED|Overall Study||20||
59549435|NCT01206608|75648721|FG000|NOT COMPLETED|Overall Study||0||
59549436|NCT01206608|75648722|FG001|NOT COMPLETED|Overall Study||0||
59549437|NCT01207466|75648728|FG000|STARTED|Period 1, One Week of Wear||46||
59549438|NCT01207466|75648729|FG001|STARTED|Period 1, One Week of Wear||48||
59549439|NCT01207466|75648728|FG000|COMPLETED|Period 1, One Week of Wear|One participant discontinued between Period 1 and Period 2 due to inclusion/exclusion criteria.|46||
59549440|NCT01207466|75648729|FG001|COMPLETED|Period 1, One Week of Wear||48||
59549441|NCT01207466|75648728|FG000|NOT COMPLETED|Period 1, One Week of Wear||0||
59549442|NCT01207466|75648729|FG001|NOT COMPLETED|Period 1, One Week of Wear||0||
59549443|NCT01207466|75648728|FG000|STARTED|Period 2, One Week of Wear||45||
59549444|NCT01207466|75648729|FG001|STARTED|Period 2, One Week of Wear||48||
59549445|NCT01207466|75648728|FG000|COMPLETED|Period 2, One Week of Wear||45||
59549446|NCT01207466|75648729|FG001|COMPLETED|Period 2, One Week of Wear||48||
59549447|NCT01207466|75648728|FG000|NOT COMPLETED|Period 2, One Week of Wear||0||
59549448|NCT01207466|75648729|FG001|NOT COMPLETED|Period 2, One Week of Wear||0||
59549449|NCT02432040|75648737|FG000|STARTED|Overall Study||14||
59549450|NCT02432040|75648738|FG001|STARTED|Overall Study||14||
59549451|NCT02432040|75648737|FG000|COMPLETED|Overall Study||6||
59549452|NCT02432040|75648738|FG001|COMPLETED|Overall Study||8||
59549453|NCT02432040|75648737|FG000|NOT COMPLETED|Overall Study||8||
59549454|NCT02432040|75648738|FG001|NOT COMPLETED|Overall Study||6||
59549455|NCT02517021|75648746|FG000|STARTED|Overall Study||203||
59549456|NCT02517021|75648747|FG001|STARTED|Overall Study||202||
59549457|NCT02517021|75648746|FG000|COMPLETED|Overall Study||120||
59549458|NCT02517021|75648747|FG001|COMPLETED|Overall Study||117||
59549459|NCT02517021|75648746|FG000|NOT COMPLETED|Overall Study||83||
59549460|NCT02517021|75648747|FG001|NOT COMPLETED|Overall Study||85||
59549461|NCT01207934|75648756|FG000|STARTED|Overall Study||6||
59549462|NCT01207934|75648757|FG001|STARTED|Overall Study||6||
59549463|NCT01207934|75648758|FG002|STARTED|Overall Study||6||
59549464|NCT01207934|75648756|FG000|COMPLETED|Overall Study||6||
59549465|NCT01207934|75648757|FG001|COMPLETED|Overall Study||6||
59549466|NCT01207934|75648758|FG002|COMPLETED|Overall Study||6||
59549467|NCT01207934|75648756|FG000|NOT COMPLETED|Overall Study||0||
59549468|NCT01207934|75648757|FG001|NOT COMPLETED|Overall Study||0||
59549469|NCT01207934|75648758|FG002|NOT COMPLETED|Overall Study||0||
59549470|NCT04813354|75648770|FG000|STARTED|Overall Study||29||
59549471|NCT04813354|75648771|FG001|STARTED|Overall Study||29||
59549472|NCT04813354|75648772|FG002|STARTED|Overall Study||28||
59549473|NCT04813354|75648773|FG003|STARTED|Overall Study||28||
59549474|NCT04813354|75648770|FG000|COMPLETED|Overall Study||29||
59549475|NCT04813354|75648771|FG001|COMPLETED|Overall Study||29||
59549476|NCT04813354|75648772|FG002|COMPLETED|Overall Study||28||
59549477|NCT04813354|75648773|FG003|COMPLETED|Overall Study||28||
59549478|NCT04813354|75648770|FG000|NOT COMPLETED|Overall Study||0||
59549479|NCT04813354|75648771|FG001|NOT COMPLETED|Overall Study||0||
59549480|NCT04813354|75648772|FG002|NOT COMPLETED|Overall Study||0||
59549481|NCT04813354|75648773|FG003|NOT COMPLETED|Overall Study||0||
59549482|NCT04418076|75648784|FG000|STARTED|Overall Study||19||
59549483|NCT04418076|75648785|FG001|STARTED|Overall Study||20||
59549484|NCT04418076|75648786|FG002|STARTED|Overall Study||16||
59549485|NCT04418076|75648787|FG003|STARTED|Overall Study||23||
59549486|NCT04418076|75648784|FG000|9 Participants Had Complete Lab Results at 16 Weeks|Overall Study||1||
59549487|NCT04418076|75648785|FG001|9 Participants Had Complete Lab Results at 16 Weeks|Overall Study||3||
59549488|NCT04418076|75648786|FG002|9 Participants Had Complete Lab Results at 16 Weeks|Overall Study||4||
59549489|NCT04418076|75648787|FG003|9 Participants Had Complete Lab Results at 16 Weeks|Overall Study||1||
59549490|NCT04418076|75648784|FG000|57 Participants Completed 12 Weeks|Overall Study||15||
59549491|NCT04418076|75648785|FG001|57 Participants Completed 12 Weeks|Overall Study||15||
59549492|NCT04418076|75648786|FG002|57 Participants Completed 12 Weeks|Overall Study||11||
59549493|NCT04418076|75648787|FG003|57 Participants Completed 12 Weeks|Overall Study||16||
59549494|NCT04418076|75648784|FG000|COMPLETED|Overall Study||13||
59549495|NCT04418076|75648785|FG001|COMPLETED|Overall Study||15||
59549496|NCT04418076|75648786|FG002|COMPLETED|Overall Study||12||
59549497|NCT04418076|75648787|FG003|COMPLETED|Overall Study||17||
59549498|NCT04418076|75648784|FG000|NOT COMPLETED|Overall Study||6||
59549499|NCT04418076|75648785|FG001|NOT COMPLETED|Overall Study||5||
59549500|NCT04418076|75648786|FG002|NOT COMPLETED|Overall Study||4||
59549501|NCT04418076|75648787|FG003|NOT COMPLETED|Overall Study||6||
59817937|NCT04488770|75940337|FG011|COMPLETED|Part 1-Cohort 2: Period 2 (Up to 5 Days)||0||
59549502|NCT04165824|75648797|FG000|STARTED|Overall Study||185||
59549503|NCT04165824|75648797|FG000|COMPLETED|Overall Study||139||
59549504|NCT04165824|75648797|FG000|NOT COMPLETED|Overall Study||46||
59565870|NCT04392219|75668294|FG004|COMPLETED|Overall Study||6||
59549505|NCT03809039|75648810|FG000|STARTED|Part 1|11 subjects (2 subjects in each of Part 1 MT-6345 1 mg, 5 mg, 20 mg, 60 mg, 240 mg, and 1 subject in Part 1 MT-6345 120 mg) received a matching placebo per their respective dose. The subjects are unique subjects, and were not counted more than once across any arms except for Part 2 Placebo.|11||
59549506|NCT03809039|75648811|FG001|STARTED|Part 1|The subjects are unique subjects, and were not counted more than once across any arms.|6||
59549507|NCT03809039|75648812|FG002|STARTED|Part 1|The subjects are unique subjects, and were not counted more than once across any arms.|6||
59549508|NCT03809039|75648813|FG003|STARTED|Part 1|The subjects are unique subjects, and were not counted more than once across any arms except for Part 2 MT-6345 20mg.|6||
59549509|NCT03809039|75648814|FG004|STARTED|Part 1|The subjects are unique subjects, and were not counted more than once across any arms.|6||
59549510|NCT03809039|75648815|FG005|STARTED|Part 1|The subjects are unique subjects, and were not counted more than once across any arms.|4||
59549511|NCT03809039|75648816|FG006|STARTED|Part 1|The subjects are unique subjects, and were not counted more than once across any arms.|5||
59549512|NCT03809039|75648817|FG007|STARTED|Part 1||0||
59549513|NCT03809039|75648818|FG008|STARTED|Part 1||0||
59549514|NCT03809039|75648810|FG000|COMPLETED|Part 1||10||
59549515|NCT03809039|75648811|FG001|COMPLETED|Part 1||6||
59549516|NCT03809039|75648812|FG002|COMPLETED|Part 1||6||
59549517|NCT03809039|75648813|FG003|COMPLETED|Part 1||5||
59549518|NCT03809039|75648814|FG004|COMPLETED|Part 1||6||
59549519|NCT03809039|75648815|FG005|COMPLETED|Part 1||4||
59549520|NCT03809039|75648816|FG006|COMPLETED|Part 1||5||
59549521|NCT03809039|75648817|FG007|COMPLETED|Part 1||0||
59549522|NCT03809039|75648818|FG008|COMPLETED|Part 1||0||
59549523|NCT03809039|75648810|FG000|NOT COMPLETED|Part 1||1||
59549524|NCT03809039|75648811|FG001|NOT COMPLETED|Part 1||0||
59549525|NCT03809039|75648812|FG002|NOT COMPLETED|Part 1||0||
59706535|NCT01263197|75825678|FG003|STARTED|Washout Period 2||8||
59706536|NCT01263197|75825679|FG004|STARTED|Washout Period 2||7||
59706537|NCT01263197|75825680|FG005|STARTED|Washout Period 2||7||
59549526|NCT03809039|75648813|FG003|NOT COMPLETED|Part 1||1||
59549527|NCT03809039|75648814|FG004|NOT COMPLETED|Part 1||0||
59549528|NCT03809039|75648815|FG005|NOT COMPLETED|Part 1||0||
59549529|NCT03809039|75648816|FG006|NOT COMPLETED|Part 1||0||
59549530|NCT03809039|75648817|FG007|NOT COMPLETED|Part 1||0||
59549531|NCT03809039|75648818|FG008|NOT COMPLETED|Part 1||0||
59565871|NCT04392219|75668295|FG005|COMPLETED|Overall Study||6||
59706538|NCT01263197|75825675|FG000|COMPLETED|Washout Period 2||8||
59706539|NCT01263197|75825676|FG001|COMPLETED|Washout Period 2||8||
59706540|NCT01263197|75825677|FG002|COMPLETED|Washout Period 2||8||
59706541|NCT01263197|75825678|FG003|COMPLETED|Washout Period 2||7||
59991093|NCT02239120|76106605|FG001|NOT COMPLETED|Overall Study||72||
59706542|NCT01263197|75825679|FG004|COMPLETED|Washout Period 2||7||
59549532|NCT03809039|75648810|FG000|STARTED|Part 2|2 subjects who received a matching placebo per Part 1 MT-6345 20mg were selected to return for Part 2. Out of 2 subjects, only 1 subject received the placebo, and another subject withdrew the consent after Part 1. Therefore, this 1 subject is not a unique subject and was not counted again in the total number of exposed subjects.|1||
59549533|NCT03809039|75648811|FG001|STARTED|Part 2||0||
59549534|NCT03809039|75648812|FG002|STARTED|Part 2||0||
59549535|NCT03809039|75648813|FG003|STARTED|Part 2|6 subjects in Part 1 MT-6345 20mg were selected to return for Part 2. Out of 6 subjects, only 5 subjects received MT-6345, and 1 subject withdrew the consent after Part 1. Therefore, these 5 subjects are not a unique subject and were not counted again in the total number of exposed subjects.|5||
59549536|NCT03809039|75648814|FG004|STARTED|Part 2||0||
59706543|NCT01263197|75825680|FG005|COMPLETED|Washout Period 2||6||
59549537|NCT03809039|75648815|FG005|STARTED|Part 2||0||
60080757|NCT00218062|76196147|FG001|COMPLETED|Overall Study||4||
60080758|NCT00218062|76196148|FG002|COMPLETED|Overall Study||3||
60080759|NCT00218062|76196149|FG003|COMPLETED|Overall Study||3||
60080760|NCT00218062|76196146|FG000|NOT COMPLETED|Overall Study||15||
60080761|NCT00218062|76196147|FG001|NOT COMPLETED|Overall Study||16||
60080762|NCT00218062|76196148|FG002|NOT COMPLETED|Overall Study||12||
60080763|NCT00218062|76196149|FG003|NOT COMPLETED|Overall Study||13||
60080764|NCT00121186|76196159|FG000|STARTED|Overall Study||1||
60080765|NCT00121186|76196159|FG000|COMPLETED|Overall Study||1||
60080766|NCT00121186|76196159|FG000|NOT COMPLETED|Overall Study||0||
60080767|NCT00121810|76196165|FG000|STARTED|Overall Study||151||
60080768|NCT00121810|76196166|FG001|STARTED|Overall Study||154||
60080769|NCT00121810|76196165|FG000|Safety Population|Overall Study||148||
60080770|NCT00121810|76196166|FG001|Safety Population|Overall Study||153||
60080771|NCT00121810|76196165|FG000|Intent-to-Treat (ITT) Population|Overall Study||148||
60080772|NCT00121810|76196166|FG001|Intent-to-Treat (ITT) Population|Overall Study||151||
60080773|NCT00121810|76196165|FG000|COMPLETED|Overall Study||121||
60080774|NCT00121810|76196166|FG001|COMPLETED|Overall Study||115||
60080775|NCT00121810|76196165|FG000|NOT COMPLETED|Overall Study||30||
60080776|NCT00121810|76196166|FG001|NOT COMPLETED|Overall Study||39||
60080777|NCT00053014|76196172|FG000|STARTED|Overall Study||5||
60080778|NCT00053014|76196172|FG000|COMPLETED|Overall Study||5||
60080779|NCT00053014|76196172|FG000|NOT COMPLETED|Overall Study||0||
60080780|NCT00123604|76196178|FG000|STARTED|Overall Study||19||
60080781|NCT00123604|76196179|FG001|STARTED|Overall Study||17||
59549538|NCT03809039|75648816|FG006|STARTED|Part 2||0||
59706544|NCT01263197|75825675|FG000|NOT COMPLETED|Washout Period 2||0||
60080782|NCT00123604|76196178|FG000|COMPLETED|Overall Study||18||
60080783|NCT00123604|76196179|FG001|COMPLETED|Overall Study||16||
60080784|NCT00123604|76196178|FG000|NOT COMPLETED|Overall Study||1||
60080785|NCT00123604|76196179|FG001|NOT COMPLETED|Overall Study||1||
60080786|NCT00123682|76196189|FG000|STARTED|Overall Study||1069||
60080787|NCT00123682|76196190|FG001|STARTED|Overall Study||934||
60080788|NCT00123682|76196191|FG002|STARTED|Overall Study||592||
60080789|NCT00123682|76196192|FG003|STARTED|Overall Study||525||
60080790|NCT00123682|76196189|FG000|COMPLETED|Overall Study||749||
60080791|NCT00123682|76196190|FG001|COMPLETED|Overall Study||731||
60080792|NCT00123682|76196191|FG002|COMPLETED|Overall Study||438||
59549539|NCT03809039|75648817|FG007|STARTED|Part 2||0||
59549540|NCT03809039|75648818|FG008|STARTED|Part 2||0||
59549541|NCT03809039|75648810|FG000|COMPLETED|Part 2||1||
59549542|NCT03809039|75648811|FG001|COMPLETED|Part 2||0||
59549543|NCT03809039|75648812|FG002|COMPLETED|Part 2||0||
59549544|NCT03809039|75648813|FG003|COMPLETED|Part 2||5||
59549545|NCT03809039|75648814|FG004|COMPLETED|Part 2||0||
59549546|NCT03809039|75648815|FG005|COMPLETED|Part 2||0||
59549547|NCT03809039|75648816|FG006|COMPLETED|Part 2||0||
59549548|NCT03809039|75648817|FG007|COMPLETED|Part 2||0||
59549549|NCT03809039|75648818|FG008|COMPLETED|Part 2||0||
59549550|NCT03809039|75648810|FG000|NOT COMPLETED|Part 2||0||
59549551|NCT03809039|75648811|FG001|NOT COMPLETED|Part 2||0||
59549552|NCT03809039|75648812|FG002|NOT COMPLETED|Part 2||0||
59549553|NCT03809039|75648813|FG003|NOT COMPLETED|Part 2||0||
59549554|NCT03809039|75648814|FG004|NOT COMPLETED|Part 2||0||
59549555|NCT03809039|75648815|FG005|NOT COMPLETED|Part 2||0||
59549556|NCT03809039|75648816|FG006|NOT COMPLETED|Part 2||0||
59549557|NCT03809039|75648817|FG007|NOT COMPLETED|Part 2||0||
59549558|NCT03809039|75648818|FG008|NOT COMPLETED|Part 2||0||
59549559|NCT03809039|75648810|FG000|STARTED|Part 3||0||
59549560|NCT03809039|75648811|FG001|STARTED|Part 3||0||
59549561|NCT03809039|75648812|FG002|STARTED|Part 3||0||
59549562|NCT03809039|75648813|FG003|STARTED|Part 3||0||
59549563|NCT03809039|75648814|FG004|STARTED|Part 3||0||
59549564|NCT03809039|75648815|FG005|STARTED|Part 3||0||
59549565|NCT03809039|75648816|FG006|STARTED|Part 3||0||
59549566|NCT03809039|75648817|FG007|STARTED|Part 3|The subjects are unique subjects, and were not counted more than once across any arms.|2||
59549567|NCT03809039|75648818|FG008|STARTED|Part 3|The subjects are unique subjects, and were not counted more than once across any arms.|6||
59549568|NCT03809039|75648810|FG000|COMPLETED|Part 3||0||
59549569|NCT03809039|75648811|FG001|COMPLETED|Part 3||0||
59549570|NCT03809039|75648812|FG002|COMPLETED|Part 3||0||
59549571|NCT03809039|75648813|FG003|COMPLETED|Part 3||0||
59549572|NCT03809039|75648814|FG004|COMPLETED|Part 3||0||
59549573|NCT03809039|75648815|FG005|COMPLETED|Part 3||0||
59549574|NCT03809039|75648816|FG006|COMPLETED|Part 3||0||
59549575|NCT03809039|75648817|FG007|COMPLETED|Part 3||0||
59549576|NCT03809039|75648818|FG008|COMPLETED|Part 3||0||
59549577|NCT03809039|75648810|FG000|NOT COMPLETED|Part 3||0||
59549578|NCT03809039|75648811|FG001|NOT COMPLETED|Part 3||0||
59549579|NCT03809039|75648812|FG002|NOT COMPLETED|Part 3||0||
59549580|NCT03809039|75648813|FG003|NOT COMPLETED|Part 3||0||
59549581|NCT03809039|75648814|FG004|NOT COMPLETED|Part 3||0||
59549582|NCT03809039|75648815|FG005|NOT COMPLETED|Part 3||0||
59549583|NCT03809039|75648816|FG006|NOT COMPLETED|Part 3||0||
59549584|NCT03809039|75648817|FG007|NOT COMPLETED|Part 3||2||
59549585|NCT03809039|75648818|FG008|NOT COMPLETED|Part 3||6||
59549586|NCT03541200|75648851|FG000|STARTED|Overall Study||190||
59549587|NCT03541200|75648851|FG000|COMPLETED|Overall Study||77||
59549588|NCT03541200|75648851|FG000|NOT COMPLETED|Overall Study||113||
59549589|NCT03520036|75648858|FG000|STARTED|Overall Study||33||
59549590|NCT03520036|75648859|FG001|STARTED|Overall Study||34||
59549591|NCT03520036|75648860|FG002|STARTED|Overall Study||35||
59549592|NCT03520036|75648858|FG000|COMPLETED|Overall Study||31||
59549593|NCT03520036|75648859|FG001|COMPLETED|Overall Study||30||
59549594|NCT03520036|75648860|FG002|COMPLETED|Overall Study||31||
59549595|NCT03520036|75648858|FG000|NOT COMPLETED|Overall Study||2||
59549596|NCT03520036|75648859|FG001|NOT COMPLETED|Overall Study||4||
59549597|NCT03520036|75648860|FG002|NOT COMPLETED|Overall Study||4||
59549598|NCT03505710|75648871|FG000|STARTED|Overall Study||49||
59549599|NCT03505710|75648872|FG001|STARTED|Overall Study||41||
59549600|NCT03505710|75648873|FG002|STARTED|Overall Study||91||
59549601|NCT03505710|75648871|FG000|COMPLETED|Overall Study||2|Completed = Participants ongoing treatment as of 03 May 2021, Not Completed = Participants who discontinued treatment|
59549602|NCT03505710|75648872|FG001|COMPLETED|Overall Study||14|Completed = Participants ongoing treatment as of 03 May 2021, Not Completed = Participants who discontinued treatment|
59549603|NCT03505710|75648873|FG002|COMPLETED|Overall Study||15|Completed = Participants ongoing treatment as of 03 May 2021, Not Completed = Participants who discontinued treatment|
59549604|NCT03505710|75648871|FG000|NOT COMPLETED|Overall Study||47||
59549605|NCT03505710|75648872|FG001|NOT COMPLETED|Overall Study||27||
59549606|NCT03505710|75648873|FG002|NOT COMPLETED|Overall Study||76||
59549607|NCT03459729|75648881|FG000|STARTED|Overall Study||6||
59549608|NCT03459729|75648881|FG000|Received Therapy|Overall Study||4||
59549609|NCT03459729|75648881|FG000|COMPLETED|Overall Study||4||
59549610|NCT03459729|75648881|FG000|NOT COMPLETED|Overall Study||2||
59549611|NCT03291067|75648889|FG000|STARTED|Overall Study||94||
59549612|NCT03291067|75648890|FG001|STARTED|Overall Study||92||
59549613|NCT03291067|75648891|FG002|STARTED|Overall Study||94||
59549614|NCT03291067|75648892|FG003|STARTED|Overall Study||94||
59549615|NCT03291067|75648889|FG000|Treated|Overall Study||95||
59549616|NCT03291067|75648890|FG001|Treated|Overall Study||90||
59549617|NCT03291067|75648891|FG002|Treated|Overall Study||93||
59549618|NCT03291067|75648892|FG003|Treated|Overall Study||90||
59549619|NCT03291067|75648889|FG000|COMPLETED|Overall Study||84||
59549620|NCT03291067|75648890|FG001|COMPLETED|Overall Study||78||
59549621|NCT03291067|75648891|FG002|COMPLETED|Overall Study||61||
59549622|NCT03291067|75648892|FG003|COMPLETED|Overall Study||77||
59706545|NCT01263197|75825676|FG001|NOT COMPLETED|Washout Period 2||0||
59706546|NCT01263197|75825677|FG002|NOT COMPLETED|Washout Period 2||0||
59706547|NCT01263197|75825678|FG003|NOT COMPLETED|Washout Period 2||1||
59549623|NCT03291067|75648889|FG000|NOT COMPLETED|Overall Study||10||
59549624|NCT03291067|75648890|FG001|NOT COMPLETED|Overall Study||14||
59549625|NCT03291067|75648891|FG002|NOT COMPLETED|Overall Study||33||
59549626|NCT03291067|75648892|FG003|NOT COMPLETED|Overall Study||17||
59549627|NCT02841280|75648904|FG000|STARTED|Overall Study||81||
59549628|NCT02841280|75648905|FG001|STARTED|Overall Study||79||
59549629|NCT02841280|75648904|FG000|COMPLETED|Overall Study||67||
59549630|NCT02841280|75648905|FG001|COMPLETED|Overall Study||73||
59549631|NCT02841280|75648904|FG000|NOT COMPLETED|Overall Study||14||
59549632|NCT02841280|75648905|FG001|NOT COMPLETED|Overall Study||6||
59549633|NCT02620865|75648911|FG000|STARTED|Overall Study||2||
59549634|NCT02620865|75648911|FG000|COMPLETED|Overall Study||2||
59549635|NCT02620865|75648911|FG000|NOT COMPLETED|Overall Study||0||
59549636|NCT02526498|75648915|FG000|STARTED|Overall Study||200||
59549637|NCT02526498|75648915|FG000|COMPLETED|Overall Study||200||
59549638|NCT02526498|75648915|FG000|NOT COMPLETED|Overall Study||0||
59549639|NCT02345330|75648919|FG000|STARTED|Overall Study||4||
59706548|NCT01263197|75825679|FG004|NOT COMPLETED|Washout Period 2||0||
59706549|NCT01263197|75825680|FG005|NOT COMPLETED|Washout Period 2||1||
60080793|NCT00123682|76196192|FG003|COMPLETED|Overall Study||430||
60080794|NCT00123682|76196189|FG000|NOT COMPLETED|Overall Study||320||
60080795|NCT00123682|76196190|FG001|NOT COMPLETED|Overall Study||203||
60080796|NCT00123682|76196191|FG002|NOT COMPLETED|Overall Study||154||
60080797|NCT00123682|76196192|FG003|NOT COMPLETED|Overall Study||95||
60080798|NCT00125788|76196208|FG000|STARTED|Overall Study||37||
60080799|NCT00125788|76196209|FG001|STARTED|Overall Study||33||
60080800|NCT00125788|76196208|FG000|COMPLETED|Overall Study||33||
60080801|NCT00125788|76196209|FG001|COMPLETED|Overall Study||29||
60080802|NCT00125788|76196208|FG000|NOT COMPLETED|Overall Study||4||
60080803|NCT00125788|76196209|FG001|NOT COMPLETED|Overall Study||4||
60080804|NCT00221338|76196217|FG000|STARTED|Overall Study||374||
60080805|NCT00221338|76196218|FG001|STARTED|Overall Study||376||
60080806|NCT00221338|76196217|FG000|COMPLETED|Overall Study||350||
60080807|NCT00221338|76196218|FG001|COMPLETED|Overall Study||347||
60080808|NCT00221338|76196217|FG000|NOT COMPLETED|Overall Study||24||
60080809|NCT00221338|76196218|FG001|NOT COMPLETED|Overall Study||29||
60080810|NCT00223678|76196226|FG000|STARTED|Overall Study||13||
60080811|NCT00223678|76196227|FG001|STARTED|Overall Study||7||
60080812|NCT00223678|76196226|FG000|COMPLETED|Overall Study||13||
60080813|NCT00223678|76196227|FG001|COMPLETED|Overall Study||7||
60080814|NCT00223678|76196226|FG000|NOT COMPLETED|Overall Study||0||
60080815|NCT00223678|76196227|FG001|NOT COMPLETED|Overall Study||0||
60080816|NCT00053482|76196238|FG000|STARTED|Overall Study||51||
60080817|NCT00053482|76196239|FG001|STARTED|Overall Study||102||
60080818|NCT00053482|76196240|FG002|STARTED|Overall Study||102||
60080819|NCT00053482|76196241|FG003|STARTED|Overall Study||50||
60080820|NCT00053482|76196242|FG004|STARTED|Overall Study||52||
60080821|NCT00053482|76196238|FG000|COMPLETED|Overall Study||51||
60080822|NCT00053482|76196239|FG001|COMPLETED|Overall Study||102||
60080823|NCT00053482|76196240|FG002|COMPLETED|Overall Study||102||
60080824|NCT00053482|76196241|FG003|COMPLETED|Overall Study||50||
60080825|NCT00053482|76196242|FG004|COMPLETED|Overall Study||52||
60080826|NCT00053482|76196238|FG000|NOT COMPLETED|Overall Study||0||
60080827|NCT00053482|76196239|FG001|NOT COMPLETED|Overall Study||0||
60080828|NCT00053482|76196240|FG002|NOT COMPLETED|Overall Study||0||
60080829|NCT00053482|76196241|FG003|NOT COMPLETED|Overall Study||0||
60080830|NCT00053482|76196242|FG004|NOT COMPLETED|Overall Study||0||
60080831|NCT00130780|76196256|FG000|STARTED|Overall Study||51||
60080832|NCT00130780|76196257|FG001|STARTED|Overall Study||20||
60080833|NCT00130780|76196256|FG000|COMPLETED|Overall Study||51||
60080834|NCT00130780|76196257|FG001|COMPLETED|Overall Study||20||
60080835|NCT00130780|76196256|FG000|NOT COMPLETED|Overall Study||0||
60080836|NCT00130780|76196257|FG001|NOT COMPLETED|Overall Study||0||
60080837|NCT00041392|76196265|FG000|STARTED|Overall Study||198||
60080838|NCT00041392|76196266|FG001|STARTED|Overall Study||191||
60080839|NCT00041392|76196265|FG000|COMPLETED|Overall Study||198||
60080840|NCT00041392|76196266|FG001|COMPLETED|Overall Study||191||
60080841|NCT00041392|76196265|FG000|NOT COMPLETED|Overall Study||0||
60080842|NCT00041392|76196266|FG001|NOT COMPLETED|Overall Study||0||
60080843|NCT02091778|76196272|FG000|STARTED|Overall Study||21||
60080844|NCT02091778|76196272|FG000|COMPLETED|Overall Study||20||
60080845|NCT02091778|76196272|FG000|NOT COMPLETED|Overall Study||1||
59549640|NCT02345330|75648919|FG000|COMPLETED|Overall Study||1||
60080846|NCT02091856|76196279|FG000|STARTED|Active Intervention Interval||34||
60080847|NCT02091856|76196280|FG001|STARTED|Active Intervention Interval||19||
60103788|NCT03864406|76222062|FG000|COMPLETED|Overall Study||12||
59549641|NCT02345330|75648919|FG000|NOT COMPLETED|Overall Study||3||
59549642|NCT01665677|75648925|FG000|STARTED|Overall Study||30||
59549643|NCT01665677|75648926|FG001|STARTED|Overall Study||39||
59549644|NCT01665677|75648925|FG000|COMPLETED|Overall Study||30||
59549645|NCT01665677|75648926|FG001|COMPLETED|Overall Study||39||
59549646|NCT01665677|75648925|FG000|NOT COMPLETED|Overall Study||0||
59549647|NCT01665677|75648926|FG001|NOT COMPLETED|Overall Study||0||
59549648|NCT01513343|75648934|FG000|STARTED|Group Allocation||136|Numbers reported reflect parent/child dyads; there are 2 unique participants within each dyad.|
59549649|NCT01513343|75648935|FG001|STARTED|Group Allocation||119|Numbers reported reflect parent/child dyads; there are 2 unique participants within each dyad.|
59549650|NCT01513343|75648934|FG000|COMPLETED|Group Allocation||128|Numbers reported reflect parent/child dyads; there are 2 unique participants within each dyad.|
59549651|NCT01513343|75648935|FG001|COMPLETED|Group Allocation||119|Numbers reported reflect parent/child dyads; there are 2 unique participants within each dyad.|
59549652|NCT01513343|75648934|FG000|NOT COMPLETED|Group Allocation||8||
59549653|NCT01513343|75648935|FG001|NOT COMPLETED|Group Allocation||0||
59549654|NCT01513343|75648934|FG000|STARTED|Post Data Collection||136|Numbers reported reflect parent/child dyads; there are 2 unique participants within each dyad.|
59549655|NCT01513343|75648935|FG001|STARTED|Post Data Collection||119|Numbers reported reflect parent/child dyads; there are 2 unique participants within each dyad.|
59549656|NCT01513343|75648934|FG000|COMPLETED|Post Data Collection||119|Numbers reported reflect parent/child dyads; there are 2 unique participants within each dyad.|
59549657|NCT01513343|75648935|FG001|COMPLETED|Post Data Collection||95|Numbers reported reflect parent/child dyads; there are 2 unique participants within each dyad.|
59549658|NCT01513343|75648934|FG000|NOT COMPLETED|Post Data Collection||17||
59549659|NCT01513343|75648935|FG001|NOT COMPLETED|Post Data Collection||24||
59549660|NCT01513343|75648934|FG000|STARTED|6-month Follow-up||119|Numbers reported reflect parent/child dyads; there are 2 unique participants within each dyad.|
59549661|NCT01513343|75648935|FG001|STARTED|6-month Follow-up||95|Numbers reported reflect parent/child dyads; there are 2 unique participants within each dyad.|
59549662|NCT01513343|75648934|FG000|COMPLETED|6-month Follow-up||91|Numbers reported reflect parent/child dyads; there are 2 unique participants within each dyad.|
59549663|NCT01513343|75648935|FG001|COMPLETED|6-month Follow-up||78|Numbers reported reflect parent/child dyads; there are 2 unique participants within each dyad.|
59549664|NCT01513343|75648934|FG000|NOT COMPLETED|6-month Follow-up||28||
59549665|NCT01513343|75648935|FG001|NOT COMPLETED|6-month Follow-up||17||
59549666|NCT01513343|75648934|FG000|STARTED|12-month Follow-up||91|Numbers reported reflect parent/child dyads; there are 2 unique participants within each dyad.|
59549667|NCT01513343|75648935|FG001|STARTED|12-month Follow-up||78|Numbers reported reflect parent/child dyads; there are 2 unique participants within each dyad.|
59549668|NCT01513343|75648934|FG000|COMPLETED|12-month Follow-up||81|Numbers reported reflect parent/child dyads; there are 2 unique participants within each dyad.|
59549669|NCT01513343|75648935|FG001|COMPLETED|12-month Follow-up||75|Numbers reported reflect parent/child dyads; there are 2 unique participants within each dyad.|
59549670|NCT01513343|75648934|FG000|NOT COMPLETED|12-month Follow-up||10||
59549671|NCT01513343|75648935|FG001|NOT COMPLETED|12-month Follow-up||3||
59549672|NCT01499953|75648944|FG000|STARTED|Overall Study||236||
59549673|NCT01499953|75648945|FG001|STARTED|Overall Study||236||
59549674|NCT01499953|75648944|FG000|Participants Who Received at Least One Dose of Study Medication|Overall Study||235||
59549675|NCT01499953|75648945|FG001|Participants Who Received at Least One Dose of Study Medication|Overall Study||236||
59549676|NCT01499953|75648944|FG000|COMPLETED|Overall Study||226||
59549677|NCT01499953|75648945|FG001|COMPLETED|Overall Study||222||
59549678|NCT01499953|75648944|FG000|NOT COMPLETED|Overall Study||10||
59549679|NCT01499953|75648945|FG001|NOT COMPLETED|Overall Study||14||
59549680|NCT01461226|75648953|FG000|STARTED|Overall Study||33||
59549681|NCT01461226|75648954|FG001|STARTED|Overall Study||28||
59549682|NCT01461226|75648953|FG000|COMPLETED|Overall Study||27||
59549683|NCT01461226|75648954|FG001|COMPLETED|Overall Study||21||
59549684|NCT01461226|75648953|FG000|NOT COMPLETED|Overall Study||6||
59549685|NCT01461226|75648954|FG001|NOT COMPLETED|Overall Study||7||
59549686|NCT01440816|75648962|FG000|STARTED|Overall Study||3||
59549687|NCT01440816|75648963|FG001|STARTED|Overall Study||12||
59549688|NCT01440816|75648962|FG000|COMPLETED|Overall Study||2||
59549689|NCT01440816|75648963|FG001|COMPLETED|Overall Study||1||
59549690|NCT01440816|75648962|FG000|NOT COMPLETED|Overall Study||1||
59549691|NCT01440816|75648963|FG001|NOT COMPLETED|Overall Study||11||
59549692|NCT01348919|75648974|FG000|STARTED|Overall Study||3||
59549693|NCT01348919|75648975|FG001|STARTED|Overall Study||5||
59549694|NCT01348919|75648976|FG002|STARTED|Overall Study||3||
59549695|NCT01348919|75648974|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3||
59549696|NCT01348919|75648975|FG001|Received at Least 1 Dose of Study Drug|Overall Study||5||
59549697|NCT01348919|75648976|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3||
59549698|NCT01348919|75648974|FG000|COMPLETED|Overall Study||0||
59549699|NCT01348919|75648975|FG001|COMPLETED|Overall Study||2||
59549700|NCT01348919|75648976|FG002|COMPLETED|Overall Study||2||
59549701|NCT01348919|75648974|FG000|NOT COMPLETED|Overall Study||3||
59549702|NCT01348919|75648975|FG001|NOT COMPLETED|Overall Study||3||
59549703|NCT01348919|75648976|FG002|NOT COMPLETED|Overall Study||1||
59549704|NCT00966381|75648988|FG000|STARTED|Overall Study||15||
59549705|NCT00966381|75648989|FG001|STARTED|Overall Study||16||
59549706|NCT00966381|75648988|FG000|COMPLETED|Overall Study||13||
59549707|NCT00966381|75648989|FG001|COMPLETED|Overall Study||14||
59549708|NCT00966381|75648988|FG000|NOT COMPLETED|Overall Study||2||
59549709|NCT00966381|75648989|FG001|NOT COMPLETED|Overall Study||2||
59549710|NCT02431806|75649001|FG000|STARTED|Double-blind Treatment Period||142||
59549711|NCT02431806|75649002|FG001|STARTED|Double-blind Treatment Period||136||
59549712|NCT02431806|75649003|FG002|STARTED|Double-blind Treatment Period||139||
59549713|NCT02431806|75649004|FG003|STARTED|Double-blind Treatment Period||135||
59549714|NCT02431806|75649001|FG000|Safety Population|Double-blind Treatment Period||141||
59549715|NCT02431806|75649002|FG001|Safety Population|Double-blind Treatment Period||134||
59549716|NCT02431806|75649003|FG002|Safety Population|Double-blind Treatment Period||138||
59549717|NCT02431806|75649004|FG003|Safety Population|Double-blind Treatment Period||134||
59549718|NCT02431806|75649001|FG000|COMPLETED|Double-blind Treatment Period||117||
59549719|NCT02431806|75649002|FG001|COMPLETED|Double-blind Treatment Period||115||
59549720|NCT02431806|75649003|FG002|COMPLETED|Double-blind Treatment Period||107||
59549721|NCT02431806|75649004|FG003|COMPLETED|Double-blind Treatment Period||109||
59549722|NCT02431806|75649001|FG000|NOT COMPLETED|Double-blind Treatment Period||25||
59549723|NCT02431806|75649002|FG001|NOT COMPLETED|Double-blind Treatment Period||21||
59549724|NCT02431806|75649003|FG002|NOT COMPLETED|Double-blind Treatment Period||32||
59549725|NCT02431806|75649004|FG003|NOT COMPLETED|Double-blind Treatment Period||26||
59549726|NCT02431806|75649001|FG000|STARTED|Double-blind Down-taper Period||111||
59549727|NCT02431806|75649002|FG001|STARTED|Double-blind Down-taper Period||109||
59549728|NCT02431806|75649003|FG002|STARTED|Double-blind Down-taper Period||104||
59549729|NCT02431806|75649004|FG003|STARTED|Double-blind Down-taper Period||107||
59549730|NCT02431806|75649001|FG000|COMPLETED|Double-blind Down-taper Period||111||
59549731|NCT02431806|75649002|FG001|COMPLETED|Double-blind Down-taper Period||109||
59549732|NCT02431806|75649003|FG002|COMPLETED|Double-blind Down-taper Period||104||
59549733|NCT02431806|75649004|FG003|COMPLETED|Double-blind Down-taper Period||107||
59549734|NCT02431806|75649001|FG000|NOT COMPLETED|Double-blind Down-taper Period||0||
59706550|NCT01263197|75825675|FG000|STARTED|Third Intervention (Period 3)||8||
59706551|NCT01263197|75825676|FG001|STARTED|Third Intervention (Period 3)||8||
59706552|NCT01263197|75825677|FG002|STARTED|Third Intervention (Period 3)||8||
59706553|NCT01263197|75825678|FG003|STARTED|Third Intervention (Period 3)||7||
59706554|NCT01263197|75825679|FG004|STARTED|Third Intervention (Period 3)||7||
59706555|NCT01263197|75825680|FG005|STARTED|Third Intervention (Period 3)||6||
59706556|NCT01263197|75825675|FG000|COMPLETED|Third Intervention (Period 3)||8||
59706557|NCT01263197|75825676|FG001|COMPLETED|Third Intervention (Period 3)||7||
59816338|NCT00431847|75938746|FG001|COMPLETED|Overall Study|All participants with at least two study visits were included in analysis.|42||
59816339|NCT00431847|75938747|FG002|COMPLETED|Overall Study|All participants with at least two study visits were included in analysis.|20||
59816340|NCT00431847|75938748|FG003|COMPLETED|Overall Study|All participants with at least two study visits were included in analysis.|170||
59549735|NCT02431806|75649002|FG001|NOT COMPLETED|Double-blind Down-taper Period||0||
59549736|NCT02431806|75649003|FG002|NOT COMPLETED|Double-blind Down-taper Period||0||
59549737|NCT02431806|75649004|FG003|NOT COMPLETED|Double-blind Down-taper Period||0||
59549738|NCT01209260|75649016|FG000|STARTED|Overall Study||36||
59549739|NCT01209260|75649017|FG001|STARTED|Overall Study||36||
59549740|NCT01209260|75649016|FG000|COMPLETED|Overall Study||36||
59549741|NCT01209260|75649017|FG001|COMPLETED|Overall Study||36||
59549742|NCT01209260|75649016|FG000|NOT COMPLETED|Overall Study||0||
59549743|NCT01209260|75649017|FG001|NOT COMPLETED|Overall Study||0||
59549744|NCT01210820|75649027|FG000|STARTED|Overall Study||17||
59549745|NCT01210820|75649028|FG001|STARTED|Overall Study||4||
59549746|NCT01210820|75649027|FG000|COMPLETED|Overall Study||17||
59549747|NCT01210820|75649028|FG001|COMPLETED|Overall Study||4||
59549748|NCT01210820|75649027|FG000|NOT COMPLETED|Overall Study||0||
59549749|NCT01210820|75649028|FG001|NOT COMPLETED|Overall Study||0||
59549750|NCT01211600|75649036|FG000|STARTED|Overall Study||370||
59549751|NCT01211600|75649037|FG001|STARTED|Overall Study||376||
59549752|NCT01211600|75649036|FG000|COMPLETED|Overall Study||370||
59549753|NCT01211600|75649037|FG001|COMPLETED|Overall Study||376||
59549754|NCT01211600|75649036|FG000|NOT COMPLETED|Overall Study||0||
59549755|NCT01211600|75649037|FG001|NOT COMPLETED|Overall Study||0||
59549756|NCT01650246|75649045|FG000|STARTED|Overall Study||143||
59549757|NCT01650246|75649045|FG000|COMPLETED|Overall Study||0||
59549758|NCT01650246|75649045|FG000|NOT COMPLETED|Overall Study||143||
59549759|NCT01212302|75649049|FG000|STARTED|Overall Study||504||
59549760|NCT01212302|75649049|FG000|COMPLETED|Overall Study||504||
59549761|NCT01212302|75649049|FG000|NOT COMPLETED|Overall Study||0||
59549762|NCT01284296|75649053|FG000|STARTED|Overall Study||20||
59549763|NCT01284296|75649053|FG000|COMPLETED|Overall Study||20||
59549764|NCT01284296|75649053|FG000|NOT COMPLETED|Overall Study||0||
59549765|NCT01285076|75649058|FG000|STARTED|Overall Study||834||
59549766|NCT01285076|75649058|FG000|COMPLETED|Overall Study||834||
59549767|NCT01285076|75649058|FG000|NOT COMPLETED|Overall Study||0||
59549768|NCT01652664|75649064|FG000|STARTED|Overall Study||77||
59549769|NCT01652664|75649065|FG001|STARTED|Overall Study||75||
59549770|NCT01652664|75649064|FG000|COMPLETED|Overall Study||71||
59549771|NCT01652664|75649065|FG001|COMPLETED|Overall Study||74||
59549772|NCT01652664|75649064|FG000|NOT COMPLETED|Overall Study||6||
59549773|NCT01652664|75649065|FG001|NOT COMPLETED|Overall Study||1||
59549774|NCT01286324|75649074|FG000|STARTED|Overall Study||17||
59549775|NCT01286324|75649075|FG001|STARTED|Overall Study||17||
59549776|NCT01286324|75649074|FG000|COMPLETED|Overall Study||17||
59549777|NCT01286324|75649075|FG001|COMPLETED|Overall Study||17||
59549778|NCT01286324|75649074|FG000|NOT COMPLETED|Overall Study||0||
59549779|NCT01286324|75649075|FG001|NOT COMPLETED|Overall Study||0||
59549780|NCT01286402|75649083|FG000|STARTED|Overall Study||5||
59549781|NCT01286402|75649084|FG001|STARTED|Overall Study||6||
59549782|NCT01286402|75649083|FG000|COMPLETED|Overall Study||5||
59549783|NCT01286402|75649084|FG001|COMPLETED|Overall Study||6||
59549784|NCT01286402|75649083|FG000|NOT COMPLETED|Overall Study||0||
59549785|NCT01286402|75649084|FG001|NOT COMPLETED|Overall Study||0||
59549786|NCT01222832|75649092|FG000|STARTED|Overall Study||113||
59549787|NCT01222832|75649093|FG001|STARTED|Overall Study||113||
59549788|NCT01222832|75649092|FG000|COMPLETED|Overall Study||113||
59549789|NCT01222832|75649093|FG001|COMPLETED|Overall Study||112||
59549790|NCT01222832|75649092|FG000|NOT COMPLETED|Overall Study||0||
59549791|NCT01222832|75649093|FG001|NOT COMPLETED|Overall Study||1||
59549792|NCT01286870|75649099|FG000|STARTED|Overall Study||11|September 22, 2008|
59549793|NCT01286870|75649099|FG000|COMPLETED|Overall Study||11|February 28, 2014|
59549794|NCT01286870|75649099|FG000|NOT COMPLETED|Overall Study||0||
59549795|NCT02379390|75649105|FG000|STARTED|Overall Study||4||
59549796|NCT02379390|75649106|FG001|STARTED|Overall Study||4||
59549797|NCT02379390|75649105|FG000|COMPLETED|Overall Study||2|Participant with Disease Progression were counted as completed.|
59549798|NCT02379390|75649106|FG001|COMPLETED|Overall Study||2|Participant with Disease Progression were counted as completed.|
59549799|NCT02379390|75649105|FG000|NOT COMPLETED|Overall Study||2||
59549800|NCT02379390|75649106|FG001|NOT COMPLETED|Overall Study||2||
59549801|NCT02379078|75649117|FG000|STARTED|Overall Study||111||
59549802|NCT02379078|75649118|FG001|STARTED|Overall Study||114||
59549803|NCT02379078|75649117|FG000|COMPLETED|Overall Study||72||
59549804|NCT02379078|75649118|FG001|COMPLETED|Overall Study||79||
59549805|NCT02379078|75649117|FG000|NOT COMPLETED|Overall Study||39||
59549806|NCT02379078|75649118|FG001|NOT COMPLETED|Overall Study||35||
59549807|NCT01223378|75649129|FG000|STARTED|Overall Study||82||
59549808|NCT01223378|75649130|FG001|STARTED|Overall Study||85||
59549809|NCT01223378|75649131|FG002|STARTED|Overall Study||83||
59549810|NCT01223378|75649132|FG003|STARTED|Overall Study||81||
59549811|NCT01223378|75649133|FG004|STARTED|Overall Study||82||
59549812|NCT01223378|75649129|FG000|COMPLETED|Overall Study||76||
59549813|NCT01223378|75649130|FG001|COMPLETED|Overall Study||81||
59549814|NCT01223378|75649131|FG002|COMPLETED|Overall Study||80||
59549815|NCT01223378|75649132|FG003|COMPLETED|Overall Study||80||
59549816|NCT01223378|75649133|FG004|COMPLETED|Overall Study||79||
59549817|NCT01223378|75649129|FG000|NOT COMPLETED|Overall Study||6||
59549818|NCT01223378|75649130|FG001|NOT COMPLETED|Overall Study||4||
59549819|NCT01223378|75649131|FG002|NOT COMPLETED|Overall Study||3||
59549820|NCT01223378|75649132|FG003|NOT COMPLETED|Overall Study||1||
59549821|NCT01223378|75649133|FG004|NOT COMPLETED|Overall Study||3||
59549822|NCT01224236|75649147|FG000|STARTED|Overall Study||76||
59549823|NCT01224236|75649148|FG001|STARTED|Overall Study||74||
59816341|NCT00431847|75938749|FG004|COMPLETED|Overall Study||0||
59816342|NCT00431847|75938745|FG000|NOT COMPLETED|Overall Study||6||
59549824|NCT01224236|75649147|FG000|COMPLETED|Overall Study||75||
59549825|NCT01224236|75649148|FG001|COMPLETED|Overall Study||73||
59549826|NCT01224236|75649147|FG000|NOT COMPLETED|Overall Study||1||
59549827|NCT01224236|75649148|FG001|NOT COMPLETED|Overall Study||1||
59549828|NCT01224626|75649154|FG000|STARTED|Overall Study||42||
59549829|NCT01224626|75649154|FG000|COMPLETED|Overall Study||41||
59549830|NCT01224626|75649154|FG000|NOT COMPLETED|Overall Study||1||
59549831|NCT01225250|75649160|FG000|STARTED|Overall Study||15||
59549832|NCT01225250|75649161|FG001|STARTED|Overall Study||15||
59549833|NCT01225250|75649160|FG000|COMPLETED|Overall Study||10||
59549834|NCT01225250|75649161|FG001|COMPLETED|Overall Study||10||
59549835|NCT01225250|75649160|FG000|NOT COMPLETED|Overall Study||5||
59549836|NCT01225250|75649161|FG001|NOT COMPLETED|Overall Study||5||
59549837|NCT01289522|75649167|FG000|STARTED|Overall Study||54||
59549838|NCT01289522|75649167|FG000|COMPLETED|Overall Study||43||
59549839|NCT01289522|75649167|FG000|NOT COMPLETED|Overall Study||11||
59816343|NCT00431847|75938746|FG001|NOT COMPLETED|Overall Study||3||
59549840|NCT01226420|75649171|FG000|STARTED|Overall Study||6||
59549841|NCT01226420|75649171|FG000|COMPLETED|Overall Study||6||
59549842|NCT01226420|75649171|FG000|NOT COMPLETED|Overall Study||0||
59549843|NCT01289912|75649177|FG000|STARTED|Overall Study||32||
59549844|NCT01289912|75649178|FG001|STARTED|Overall Study||15||
59549845|NCT01289912|75649177|FG000|COMPLETED|Overall Study||29||
59549846|NCT01289912|75649178|FG001|COMPLETED|Overall Study||13||
59816344|NCT00431847|75938747|FG002|NOT COMPLETED|Overall Study||4||
59549847|NCT01289912|75649177|FG000|NOT COMPLETED|Overall Study||3||
59549848|NCT01289912|75649178|FG001|NOT COMPLETED|Overall Study||2||
59549849|NCT01227434|75649196|FG000|STARTED|Overall Study||6||
59549850|NCT01227434|75649197|FG001|STARTED|Overall Study||16||
59549851|NCT01227434|75649196|FG000|COMPLETED|Overall Study||6||
59549852|NCT01227434|75649197|FG001|COMPLETED|Overall Study||16||
59549853|NCT01227434|75649196|FG000|NOT COMPLETED|Overall Study||0||
59549854|NCT01227434|75649197|FG001|NOT COMPLETED|Overall Study||0||
59549855|NCT01714739|75649211|FG000|STARTED|Overall Study||4||
59549856|NCT01714739|75649212|FG001|STARTED|Overall Study||16||
59549857|NCT01714739|75649213|FG002|STARTED|Overall Study||15||
59549858|NCT01714739|75649214|FG003|STARTED|Overall Study||287||
59549859|NCT01714739|75649215|FG004|STARTED|Overall Study||2||
59549860|NCT01714739|75649216|FG005|STARTED|Overall Study||3||
59549861|NCT01714739|75649217|FG006|STARTED|Overall Study||10||
59549862|NCT01714739|75649211|FG000|COMPLETED|Overall Study||0||
59549863|NCT01714739|75649212|FG001|COMPLETED|Overall Study||6||
59549864|NCT01714739|75649213|FG002|COMPLETED|Overall Study||5||
59549865|NCT01714739|75649214|FG003|COMPLETED|Overall Study||23||
59549866|NCT01714739|75649215|FG004|COMPLETED|Overall Study||0||
59549867|NCT01714739|75649216|FG005|COMPLETED|Overall Study||0||
59549868|NCT01714739|75649217|FG006|COMPLETED|Overall Study||0||
59549869|NCT01714739|75649211|FG000|NOT COMPLETED|Overall Study||4||
59549870|NCT01714739|75649212|FG001|NOT COMPLETED|Overall Study||10||
59549871|NCT01714739|75649213|FG002|NOT COMPLETED|Overall Study||10||
59549872|NCT01714739|75649214|FG003|NOT COMPLETED|Overall Study||264||
59549873|NCT01714739|75649215|FG004|NOT COMPLETED|Overall Study||2||
59549874|NCT01714739|75649216|FG005|NOT COMPLETED|Overall Study||3||
59549875|NCT01714739|75649217|FG006|NOT COMPLETED|Overall Study||10||
59549876|NCT01290536|75649237|FG000|STARTED|Overall Study||42||
59549877|NCT01290536|75649237|FG000|COMPLETED|Overall Study||42||
59549878|NCT01290536|75649237|FG000|NOT COMPLETED|Overall Study||0||
59549879|NCT01290614|75649246|FG000|STARTED|Overall Study||1070||
59549880|NCT01290614|75649247|FG001|STARTED|Overall Study||1129||
59549881|NCT01290614|75649246|FG000|COMPLETED|Overall Study||518||
59549882|NCT01290614|75649247|FG001|COMPLETED|Overall Study||1129||
59549883|NCT01290614|75649246|FG000|NOT COMPLETED|Overall Study||552||
59549884|NCT01290614|75649247|FG001|NOT COMPLETED|Overall Study||0||
59549885|NCT01227980|75649255|FG000|STARTED|Overall Study||40||
59549886|NCT01227980|75649256|FG001|STARTED|Overall Study||30||
59549887|NCT01227980|75649255|FG000|Scripts Challenge Sessions|Overall Study||26||
59549888|NCT01227980|75649256|FG001|Scripts Challenge Sessions|Overall Study||25||
59549889|NCT01227980|75649255|FG000|Measure Drug Level Concentration|Overall Study||10||
59549890|NCT01227980|75649256|FG001|Measure Drug Level Concentration|Overall Study|No placebo subjects completed this milestone which measured active drug levels|0||
59706558|NCT01263197|75825677|FG002|COMPLETED|Third Intervention (Period 3)||8||
59706559|NCT01263197|75825678|FG003|COMPLETED|Third Intervention (Period 3)||7||
59706560|NCT01263197|75825679|FG004|COMPLETED|Third Intervention (Period 3)||7||
59706561|NCT01263197|75825680|FG005|COMPLETED|Third Intervention (Period 3)||6||
59549891|NCT01227980|75649255|FG000|COMPLETED|Overall Study|Two subjects did not complete the scripts sessions but completed the remainder of the protocol|38||
59549892|NCT01227980|75649256|FG001|COMPLETED|Overall Study||25||
59549893|NCT01227980|75649255|FG000|NOT COMPLETED|Overall Study||2||
59549894|NCT01227980|75649256|FG001|NOT COMPLETED|Overall Study||5||
59549895|NCT01291160|75649264|FG000|STARTED|Overall Study||66||
59549896|NCT01291160|75649265|FG001|STARTED|Overall Study||64||
59549897|NCT01291160|75649264|FG000|COMPLETED|Overall Study||48||
59549898|NCT01291160|75649265|FG001|COMPLETED|Overall Study||48||
59706562|NCT01263197|75825675|FG000|NOT COMPLETED|Third Intervention (Period 3)||0||
59549899|NCT01291160|75649264|FG000|NOT COMPLETED|Overall Study||18||
59549900|NCT01291160|75649265|FG001|NOT COMPLETED|Overall Study||16||
59549901|NCT02595567|75649271|FG000|STARTED|Overall Study||25||
59549902|NCT02595567|75649271|FG000|COMPLETED|Overall Study||25||
59706563|NCT01263197|75825676|FG001|NOT COMPLETED|Third Intervention (Period 3)||1||
59706564|NCT01263197|75825677|FG002|NOT COMPLETED|Third Intervention (Period 3)||0||
59549903|NCT02595567|75649271|FG000|NOT COMPLETED|Overall Study||0||
59549904|NCT01291784|75649275|FG000|STARTED|Overall Study||1||
59549905|NCT01291784|75649276|FG001|STARTED|Overall Study||1||
59549906|NCT01291784|75649277|FG002|STARTED|Overall Study||1||
59549907|NCT01291784|75649275|FG000|COMPLETED|Overall Study||1||
59549908|NCT01291784|75649276|FG001|COMPLETED|Overall Study||0||
59549909|NCT01291784|75649277|FG002|COMPLETED|Overall Study||1||
59549910|NCT01291784|75649275|FG000|NOT COMPLETED|Overall Study||0||
59549911|NCT01291784|75649276|FG001|NOT COMPLETED|Overall Study||1||
59549912|NCT01291784|75649277|FG002|NOT COMPLETED|Overall Study||0||
59549913|NCT01213316|75649285|FG000|STARTED|Overall Study|Participants in the initial and amendment cohorts|451||
59549914|NCT01213316|75649285|FG000|Amendment Cohort: Prolonged Participants|Overall Study|Participants >=50 years of age in the initial cohort who accept an additional 48-week observation|48||
59549915|NCT01213316|75649285|FG000|Amendment Cohort: Newly Enrolled|Overall Study|Participants >=50 years of age newly enrolled|179||
59549916|NCT01213316|75649285|FG000|Discontinued Treatment Before 48 Weeks|Overall Study||67||
59549917|NCT01213316|75649285|FG000|Initial Cohort|Overall Study|Participants >=18 years of age in the initial cohort|272||
59549918|NCT01213316|75649285|FG000|COMPLETED|Overall Study||451||
59549919|NCT01213316|75649285|FG000|NOT COMPLETED|Overall Study||0||
59549920|NCT01229228|75649298|FG000|STARTED|Overall Study||51||
59549921|NCT01229228|75649299|FG001|STARTED|Overall Study||51||
59549922|NCT01229228|75649300|FG002|STARTED|Overall Study||50||
59549923|NCT01229228|75649301|FG003|STARTED|Overall Study||51||
59549924|NCT01229228|75649302|FG004|STARTED|Overall Study||51||
59549925|NCT01229228|75649298|FG000|COMPLETED|Overall Study||50||
59549926|NCT01229228|75649299|FG001|COMPLETED|Overall Study||51||
59549927|NCT01229228|75649300|FG002|COMPLETED|Overall Study||49||
59549928|NCT01229228|75649301|FG003|COMPLETED|Overall Study||51||
59549929|NCT01229228|75649302|FG004|COMPLETED|Overall Study||50||
59549930|NCT01229228|75649298|FG000|NOT COMPLETED|Overall Study||1||
59549931|NCT01229228|75649299|FG001|NOT COMPLETED|Overall Study||0||
59549932|NCT01229228|75649300|FG002|NOT COMPLETED|Overall Study||1||
59549933|NCT01229228|75649301|FG003|NOT COMPLETED|Overall Study||0||
59549934|NCT01229228|75649302|FG004|NOT COMPLETED|Overall Study||1||
59706565|NCT01263197|75825678|FG003|NOT COMPLETED|Third Intervention (Period 3)||0||
59549935|NCT01213706|75649314|FG000|STARTED|Sham WBPA||45||
59549936|NCT01213706|75649314|FG000|COMPLETED|Sham WBPA||45||
59549937|NCT01213706|75649314|FG000|NOT COMPLETED|Sham WBPA||0||
59549938|NCT01213706|75649314|FG000|STARTED|Washout (1 Hour)||45||
59549939|NCT01213706|75649314|FG000|COMPLETED|Washout (1 Hour)||45||
59706566|NCT01263197|75825679|FG004|NOT COMPLETED|Third Intervention (Period 3)||0||
59549940|NCT01213706|75649314|FG000|NOT COMPLETED|Washout (1 Hour)||0||
59706567|NCT01263197|75825680|FG005|NOT COMPLETED|Third Intervention (Period 3)||0||
59706568|NCT01263119|75825694|FG000|STARTED|Period 1||18||
59549941|NCT01213706|75649314|FG000|STARTED|WBPA||45||
59549942|NCT01213706|75649314|FG000|COMPLETED|WBPA||45||
59706569|NCT01263119|75825694|FG000|COMPLETED|Period 1||16||
59549943|NCT01213706|75649314|FG000|NOT COMPLETED|WBPA||0||
59549944|NCT01213940|75649322|FG000|STARTED|Overall Study||14||
59706570|NCT01263119|75825694|FG000|NOT COMPLETED|Period 1||2||
59549945|NCT01213940|75649323|FG001|STARTED|Overall Study||6||
59549946|NCT01213940|75649322|FG000|COMPLETED|Overall Study||14||
59549947|NCT01213940|75649323|FG001|COMPLETED|Overall Study||6||
59549948|NCT01213940|75649322|FG000|NOT COMPLETED|Overall Study||0||
59549949|NCT01213940|75649323|FG001|NOT COMPLETED|Overall Study||0||
59549950|NCT01292252|75649331|FG000|STARTED|Overall Study||21||
60080848|NCT02091856|76196281|FG002|STARTED|Active Intervention Interval||26||
60080849|NCT02091856|76196279|FG000|COMPLETED|Active Intervention Interval||15||
60080850|NCT02091856|76196280|FG001|COMPLETED|Active Intervention Interval||12||
59549951|NCT01292252|75649332|FG001|STARTED|Overall Study||15||
59549952|NCT01292252|75649331|FG000|COMPLETED|Overall Study||21||
59549953|NCT01292252|75649332|FG001|COMPLETED|Overall Study||14||
59549954|NCT01292252|75649331|FG000|NOT COMPLETED|Overall Study||0||
59549955|NCT01292252|75649332|FG001|NOT COMPLETED|Overall Study||1||
60080851|NCT02091856|76196281|FG002|COMPLETED|Active Intervention Interval||19||
60080852|NCT02091856|76196279|FG000|NOT COMPLETED|Active Intervention Interval||19||
60080853|NCT02091856|76196280|FG001|NOT COMPLETED|Active Intervention Interval||7||
60080854|NCT02091856|76196281|FG002|NOT COMPLETED|Active Intervention Interval||7||
60080855|NCT02091856|76196279|FG000|STARTED|Follow-up Assessment|Only a subset of C-CBT participants responded to our request to complete the follow-up assessment.|15||
60080856|NCT02091856|76196280|FG001|STARTED|Follow-up Assessment|Only a subset of R-CBT participants responded to our request to complete the follow-up assessment.|12||
59549956|NCT02192684|75649340|FG000|STARTED|Overall Study||30||
59549957|NCT02192684|75649341|FG001|STARTED|Overall Study||15||
59549958|NCT02192684|75649340|FG000|COMPLETED|Overall Study||30||
59549959|NCT02192684|75649341|FG001|COMPLETED|Overall Study||15||
59549960|NCT02192684|75649340|FG000|NOT COMPLETED|Overall Study||0||
59549961|NCT02192684|75649341|FG001|NOT COMPLETED|Overall Study||0||
60080857|NCT02091856|76196281|FG002|STARTED|Follow-up Assessment|WLCG participants were lost at follow-up.|0||
60080858|NCT02091856|76196279|FG000|COMPLETED|Follow-up Assessment||10||
60080859|NCT02091856|76196280|FG001|COMPLETED|Follow-up Assessment||9||
59549962|NCT02243579|75649347|FG000|STARTED|Overall Study||24||
59549963|NCT02243579|75649347|FG000|COMPLETED|Overall Study||4||
59549964|NCT02243579|75649347|FG000|NOT COMPLETED|Overall Study||20||
59549965|NCT02195414|75649351|FG000|STARTED|Overall Study||31||
59549966|NCT02195414|75649351|FG000|Primary Endpoint|Overall Study||31||
59549967|NCT02195414|75649351|FG000|COMPLETED|Overall Study||31||
59549968|NCT02195414|75649351|FG000|NOT COMPLETED|Overall Study||0||
59706571|NCT01263119|75825694|FG000|STARTED|Period 2||16||
59549969|NCT01214330|75649355|FG000|STARTED|Overall Study||150||
59549970|NCT01214330|75649355|FG000|COMPLETED|Overall Study||102||
59549971|NCT01214330|75649355|FG000|NOT COMPLETED|Overall Study||48||
59549972|NCT01710137|75649361|FG000|STARTED|Overall Study||89||
59549973|NCT01710137|75649362|FG001|STARTED|Overall Study||90||
59549974|NCT01710137|75649361|FG000|COMPLETED|Overall Study||65||
59549975|NCT01710137|75649362|FG001|COMPLETED|Overall Study||76||
59549976|NCT01710137|75649361|FG000|NOT COMPLETED|Overall Study||24||
59549977|NCT01710137|75649362|FG001|NOT COMPLETED|Overall Study||14||
59549978|NCT02248727|75649368|FG000|STARTED|Overall Study||30||
59549979|NCT02248727|75649368|FG000|COMPLETED|Overall Study||30||
59549980|NCT02248727|75649368|FG000|NOT COMPLETED|Overall Study||0||
59549981|NCT01710839|75649377|FG000|STARTED|Overall Study||24||
60080860|NCT02091856|76196281|FG002|COMPLETED|Follow-up Assessment||0||
60080861|NCT02091856|76196279|FG000|NOT COMPLETED|Follow-up Assessment||5||
60080862|NCT02091856|76196280|FG001|NOT COMPLETED|Follow-up Assessment||3||
60080863|NCT02091856|76196281|FG002|NOT COMPLETED|Follow-up Assessment||0||
60080864|NCT00225784|76196289|FG000|STARTED|Overall Study||37||
60080865|NCT00225784|76196289|FG000|COMPLETED|Overall Study||33||
60080866|NCT00225784|76196289|FG000|NOT COMPLETED|Overall Study||4||
60080867|NCT02092168|76196298|FG000|STARTED|Overall Study||12||
60080868|NCT02092168|76196299|FG001|STARTED|Overall Study||12||
60080869|NCT02092168|76196298|FG000|COMPLETED|Overall Study||12||
60080870|NCT02092168|76196299|FG001|COMPLETED|Overall Study||12||
60080871|NCT02092168|76196298|FG000|NOT COMPLETED|Overall Study||0||
59549982|NCT01710839|75649378|FG001|STARTED|Overall Study||6||
59549983|NCT01710839|75649377|FG000|COMPLETED|Overall Study||23||
59549984|NCT01710839|75649378|FG001|COMPLETED|Overall Study||0||
59549985|NCT01710839|75649377|FG000|NOT COMPLETED|Overall Study||1||
59549986|NCT01710839|75649378|FG001|NOT COMPLETED|Overall Study||6||
59549987|NCT01215110|75649389|FG000|STARTED|Overall Study||15||
59549988|NCT01215110|75649390|FG001|STARTED|Overall Study||15||
59549989|NCT01215110|75649391|FG002|STARTED|Overall Study||15||
59549990|NCT01215110|75649392|FG003|STARTED|Overall Study||15||
59549991|NCT01215110|75649393|FG004|STARTED|Overall Study||8||
59549992|NCT01215110|75649389|FG000|COMPLETED|Overall Study||15||
59549993|NCT01215110|75649390|FG001|COMPLETED|Overall Study||15||
59549994|NCT01215110|75649391|FG002|COMPLETED|Overall Study||13||
59549995|NCT01215110|75649392|FG003|COMPLETED|Overall Study||14||
59549996|NCT01215110|75649393|FG004|COMPLETED|Overall Study||8||
59549997|NCT01215110|75649389|FG000|NOT COMPLETED|Overall Study||0||
59549998|NCT01215110|75649390|FG001|NOT COMPLETED|Overall Study||0||
59549999|NCT01215110|75649391|FG002|NOT COMPLETED|Overall Study||2||
59550000|NCT01215110|75649392|FG003|NOT COMPLETED|Overall Study||1||
59550001|NCT01215110|75649393|FG004|NOT COMPLETED|Overall Study||0||
59550002|NCT01229462|75649411|FG000|STARTED|Overall Study||120||
59550003|NCT01229462|75649412|FG001|STARTED|Overall Study||118||
59550004|NCT01229462|75649411|FG000|COMPLETED|Overall Study||115||
59550005|NCT01229462|75649412|FG001|COMPLETED|Overall Study||109||
59550006|NCT01229462|75649411|FG000|NOT COMPLETED|Overall Study||5||
59550007|NCT01229462|75649412|FG001|NOT COMPLETED|Overall Study||9||
59550008|NCT01712711|75649420|FG000|STARTED|Overall Study||20||
59550009|NCT01712711|75649421|FG001|STARTED|Overall Study||20||
59550010|NCT01712711|75649420|FG000|COMPLETED|Overall Study||20||
59550011|NCT01712711|75649421|FG001|COMPLETED|Overall Study||20||
59550012|NCT01712711|75649420|FG000|NOT COMPLETED|Overall Study||0||
59550013|NCT01712711|75649421|FG001|NOT COMPLETED|Overall Study||0||
59550014|NCT01292642|75649427|FG000|STARTED|Overall Study||12||
59550015|NCT01292642|75649427|FG000|COMPLETED|Overall Study||7||
59550016|NCT01292642|75649427|FG000|NOT COMPLETED|Overall Study||5||
59550017|NCT01231334|75649437|FG000|STARTED|Overall Study||145||
59550018|NCT01231334|75649438|FG001|STARTED|Overall Study||141||
59550019|NCT01231334|75649437|FG000|COMPLETED|Overall Study||126||
59550020|NCT01231334|75649438|FG001|COMPLETED|Overall Study||120||
59550021|NCT01231334|75649437|FG000|NOT COMPLETED|Overall Study||19||
59550022|NCT01231334|75649438|FG001|NOT COMPLETED|Overall Study||21||
59550023|NCT01292798|75649444|FG000|STARTED|Overall Study||43||
59550024|NCT01292798|75649444|FG000|Persistent DME After 3 Months|Overall Study|Subjects with persistent DME after 3 monthly injections of 0.5 mg of ranibizumab|29||
59550025|NCT01292798|75649444|FG000|COMPLETED|Overall Study||43||
59550026|NCT01292798|75649444|FG000|NOT COMPLETED|Overall Study||0||
59550027|NCT02189954|75649450|FG000|STARTED|Overall Study||45||
59550028|NCT02189954|75649451|FG001|STARTED|Overall Study||45||
59550029|NCT02189954|75649450|FG000|COMPLETED|Overall Study||45||
59550030|NCT02189954|75649451|FG001|COMPLETED|Overall Study||45||
59550031|NCT02189954|75649450|FG000|NOT COMPLETED|Overall Study||0||
59550032|NCT02189954|75649451|FG001|NOT COMPLETED|Overall Study||0||
59550033|NCT01714505|75649457|FG000|STARTED|Admission 1 (40 Hours)||10||
59550034|NCT01714505|75649458|FG001|STARTED|Admission 1 (40 Hours)||10||
59550035|NCT01714505|75649457|FG000|COMPLETED|Admission 1 (40 Hours)||9||
59550036|NCT01714505|75649458|FG001|COMPLETED|Admission 1 (40 Hours)||9||
60080872|NCT02092168|76196299|FG001|NOT COMPLETED|Overall Study||0||
60080873|NCT00132964|76196307|FG000|STARTED|Overall Study||54||
60080874|NCT00132964|76196308|FG001|STARTED|Overall Study||57||
60080875|NCT00132964|76196307|FG000|COMPLETED|Overall Study||50||
60080876|NCT00132964|76196308|FG001|COMPLETED|Overall Study||54||
60080877|NCT00132964|76196307|FG000|NOT COMPLETED|Overall Study||4||
60080878|NCT00132964|76196308|FG001|NOT COMPLETED|Overall Study||3||
60080879|NCT00133978|76196318|FG000|STARTED|Overall Study||303||
59816345|NCT00431847|75938748|FG003|NOT COMPLETED|Overall Study||14||
59816346|NCT00431847|75938749|FG004|NOT COMPLETED|Overall Study||1||
59550037|NCT01714505|75649457|FG000|NOT COMPLETED|Admission 1 (40 Hours)||1||
59550038|NCT01714505|75649458|FG001|NOT COMPLETED|Admission 1 (40 Hours)||1||
59550039|NCT01714505|75649457|FG000|STARTED|Admission 2 (40 Hours)||9||
59550040|NCT01714505|75649458|FG001|STARTED|Admission 2 (40 Hours)||9||
59550041|NCT01714505|75649457|FG000|COMPLETED|Admission 2 (40 Hours)||9||
59550042|NCT01714505|75649458|FG001|COMPLETED|Admission 2 (40 Hours)||9||
59550043|NCT01714505|75649457|FG000|NOT COMPLETED|Admission 2 (40 Hours)||0||
59550044|NCT01714505|75649458|FG001|NOT COMPLETED|Admission 2 (40 Hours)||0||
59550045|NCT01715207|75649466|FG000|STARTED|Overall Study||15||
59550046|NCT01715207|75649467|FG001|STARTED|Overall Study||15||
59550047|NCT01715207|75649466|FG000|COMPLETED|Overall Study||14||
59550048|NCT01715207|75649467|FG001|COMPLETED|Overall Study||14||
59550049|NCT01715207|75649466|FG000|NOT COMPLETED|Overall Study||1||
59550050|NCT01715207|75649467|FG001|NOT COMPLETED|Overall Study||1||
59550051|NCT01716221|75649475|FG000|STARTED|Overall Study||1||
59550052|NCT01716221|75649475|FG000|COMPLETED|Overall Study||1||
59550053|NCT01716221|75649475|FG000|NOT COMPLETED|Overall Study||0||
59550054|NCT01215344|75649493|FG000|STARTED|Overall Study||33||
59816347|NCT00431067|75938759|FG000|STARTED|Overall Study|52 patients screened, 41 treated|41||
59816348|NCT00431067|75938759|FG000|COMPLETED|Overall Study|On treatment at analysis cut-off date (22-Sep-2009)|0||
60080880|NCT00133978|76196319|FG001|STARTED|Overall Study||308||
60080881|NCT00133978|76196320|FG002|STARTED|Overall Study||310||
60080882|NCT00133978|76196321|FG003|STARTED|Overall Study||302||
60080883|NCT00133978|76196318|FG000|COMPLETED|Overall Study||301||
60080884|NCT00133978|76196319|FG001|COMPLETED|Overall Study||307||
60080885|NCT00133978|76196320|FG002|COMPLETED|Overall Study||310||
60080886|NCT00133978|76196321|FG003|COMPLETED|Overall Study||300||
60080887|NCT00133978|76196318|FG000|NOT COMPLETED|Overall Study||2||
60080888|NCT00133978|76196319|FG001|NOT COMPLETED|Overall Study||1||
59550055|NCT01215344|75649494|FG001|STARTED|Overall Study||3||
59550056|NCT01215344|75649493|FG000|COMPLETED|Overall Study||23||
59550057|NCT01215344|75649494|FG001|COMPLETED|Overall Study||3||
60080889|NCT00133978|76196320|FG002|NOT COMPLETED|Overall Study||0||
60080890|NCT00133978|76196321|FG003|NOT COMPLETED|Overall Study||2||
60080891|NCT00253708|76196338|FG000|STARTED|Overall Study||20||
59550058|NCT01215344|75649493|FG000|NOT COMPLETED|Overall Study||10||
59550059|NCT01215344|75649494|FG001|NOT COMPLETED|Overall Study||0||
59550060|NCT01231412|75649505|FG000|STARTED|Overall Study||77||
59550061|NCT01231412|75649506|FG001|STARTED|Overall Study||91||
59550062|NCT01231412|75649507|FG002|STARTED|Overall Study||6||
59550063|NCT01231412|75649505|FG000|COMPLETED|Overall Study||77||
59550064|NCT01231412|75649506|FG001|COMPLETED|Overall Study||90||
59550065|NCT01231412|75649507|FG002|COMPLETED|Overall Study||6||
59550066|NCT01231412|75649505|FG000|NOT COMPLETED|Overall Study||0||
59550067|NCT01231412|75649506|FG001|NOT COMPLETED|Overall Study||1||
59550068|NCT01231412|75649507|FG002|NOT COMPLETED|Overall Study||0||
59550069|NCT01719653|75649520|FG000|STARTED|Overall Study||209||
59550070|NCT01719653|75649521|FG001|STARTED|Overall Study||213||
59550071|NCT01719653|75649522|FG002|STARTED|Overall Study||218||
59550072|NCT01719653|75649523|FG003|STARTED|Overall Study||218||
59550073|NCT01719653|75649524|FG004|STARTED|Overall Study||221||
59550074|NCT01719653|75649520|FG000|COMPLETED|Overall Study||200||
59550075|NCT01719653|75649521|FG001|COMPLETED|Overall Study||200||
59816349|NCT00431067|75938759|FG000|NOT COMPLETED|Overall Study||41||
59816350|NCT00430989|75938765|FG000|STARTED|Overall Study||3543||
59816351|NCT00430989|75938766|FG001|STARTED|Overall Study||3569||
60080892|NCT00253708|76196339|FG001|STARTED|Overall Study||10||
60080893|NCT00253708|76196340|FG002|STARTED|Overall Study||9||
60080894|NCT00253708|76196338|FG000|COMPLETED|Overall Study||20||
60080895|NCT00253708|76196339|FG001|COMPLETED|Overall Study||10||
60080896|NCT00253708|76196340|FG002|COMPLETED|Overall Study||8||
60080897|NCT00253708|76196338|FG000|NOT COMPLETED|Overall Study||0||
60080898|NCT00253708|76196339|FG001|NOT COMPLETED|Overall Study||0||
60080899|NCT00253708|76196340|FG002|NOT COMPLETED|Overall Study||1||
60080900|NCT00254410|76196348|FG000|STARTED|Overall Study||30||
60080901|NCT00254410|76196348|FG000|COMPLETED|Overall Study||30||
60080902|NCT00254410|76196348|FG000|NOT COMPLETED|Overall Study||0||
60080903|NCT00254488|76196354|FG000|STARTED|Overall Study||112||
60080904|NCT00254488|76196355|FG001|STARTED|Overall Study||112||
60080905|NCT00254488|76196354|FG000|COMPLETED|Overall Study||55||
60080906|NCT00254488|76196355|FG001|COMPLETED|Overall Study||63||
60080907|NCT00254488|76196354|FG000|NOT COMPLETED|Overall Study||57||
60080908|NCT00254488|76196355|FG001|NOT COMPLETED|Overall Study||49||
60080909|NCT00255970|76196363|FG000|STARTED|Overall Study||21||
60080910|NCT00255970|76196364|FG001|STARTED|Overall Study||19||
60080911|NCT00255970|76196363|FG000|Screening Visit|Overall Study||21||
60080912|NCT00255970|76196364|FG001|Screening Visit|Overall Study||19||
60080913|NCT00255970|76196363|FG000|Final Visit Week 24|Overall Study||21||
60080914|NCT00255970|76196364|FG001|Final Visit Week 24|Overall Study||19||
60080915|NCT00255970|76196363|FG000|COMPLETED|Overall Study||21||
60080916|NCT00255970|76196364|FG001|COMPLETED|Overall Study||19||
60080917|NCT00255970|76196363|FG000|NOT COMPLETED|Overall Study||0||
60080918|NCT00255970|76196364|FG001|NOT COMPLETED|Overall Study||0||
60080919|NCT00256984|76196370|FG000|STARTED|Overall Study||75||
60080920|NCT00256984|76196370|FG000|COMPLETED|Overall Study||59||
60080921|NCT00256984|76196370|FG000|NOT COMPLETED|Overall Study||16||
60080922|NCT00231868|76196374|FG000|STARTED|Overall Study||81||
60080923|NCT00231868|76196374|FG000|COMPLETED|Overall Study||65||
60080924|NCT00231868|76196374|FG000|NOT COMPLETED|Overall Study||16||
60080925|NCT00257686|76196384|FG000|STARTED|Overall Study||209||
60080926|NCT00257686|76196385|FG001|STARTED|Overall Study||108||
60080927|NCT00257686|76196386|FG002|STARTED|Overall Study||226||
60080928|NCT00257686|76196387|FG003|STARTED|Overall Study||99||
60080929|NCT00257686|76196388|FG004|STARTED|Overall Study||216||
60080930|NCT00257686|76196389|FG005|STARTED|Overall Study||104||
60080931|NCT00257686|76196384|FG000|Safety Population|Overall Study|Subjects who received at least one dose of study medication|207||
60080932|NCT00257686|76196385|FG001|Safety Population|Overall Study|Subjects who received at least one dose of study medication|103||
60080933|NCT00257686|76196386|FG002|Safety Population|Overall Study|Subjects who received at least one dose of study medication|224||
60080934|NCT00257686|76196387|FG003|Safety Population|Overall Study|Subjects who received at least one dose of study medication|96||
60080935|NCT00257686|76196388|FG004|Safety Population|Overall Study|Subjects who received at least one dose of study medication|210||
59816352|NCT00430989|75938765|FG000|COMPLETED|Overall Study||3483||
60080936|NCT00257686|76196389|FG005|Safety Population|Overall Study|Subjects who received at least one dose of study medication|102||
60080937|NCT00257686|76196384|FG000|COMPLETED|Overall Study||188||
60080938|NCT00257686|76196385|FG001|COMPLETED|Overall Study||89||
59550076|NCT01719653|75649522|FG002|COMPLETED|Overall Study||200||
59550077|NCT01719653|75649523|FG003|COMPLETED|Overall Study||200||
60080939|NCT00257686|76196386|FG002|COMPLETED|Overall Study||208||
60080940|NCT00257686|76196387|FG003|COMPLETED|Overall Study||88||
59816353|NCT00430989|75938766|FG001|COMPLETED|Overall Study||3509||
59550078|NCT01719653|75649524|FG004|COMPLETED|Overall Study||200||
59550079|NCT01719653|75649520|FG000|NOT COMPLETED|Overall Study||9||
59550080|NCT01719653|75649521|FG001|NOT COMPLETED|Overall Study||13||
59550081|NCT01719653|75649522|FG002|NOT COMPLETED|Overall Study||18||
59550082|NCT01719653|75649523|FG003|NOT COMPLETED|Overall Study||18||
59550083|NCT01719653|75649524|FG004|NOT COMPLETED|Overall Study||21||
60080941|NCT00257686|76196388|FG004|COMPLETED|Overall Study||194||
60080942|NCT00257686|76196389|FG005|COMPLETED|Overall Study||95||
60080943|NCT00257686|76196384|FG000|NOT COMPLETED|Overall Study||21||
59550084|NCT01716455|75649542|FG000|STARTED|Overall Study||8||
59550085|NCT01716455|75649543|FG001|STARTED|Overall Study||8||
59550086|NCT01716455|75649544|FG002|STARTED|Overall Study||8||
59550087|NCT01716455|75649545|FG003|STARTED|Overall Study||8||
59550088|NCT01716455|75649546|FG004|STARTED|Overall Study||26||
59550089|NCT01716455|75649547|FG005|STARTED|Overall Study||8||
59550090|NCT01716455|75649542|FG000|COMPLETED|Overall Study||8||
59550091|NCT01716455|75649543|FG001|COMPLETED|Overall Study||8||
59550092|NCT01716455|75649544|FG002|COMPLETED|Overall Study||8||
59550093|NCT01716455|75649545|FG003|COMPLETED|Overall Study||8||
59550094|NCT01716455|75649546|FG004|COMPLETED|Overall Study||26||
60080944|NCT00257686|76196385|FG001|NOT COMPLETED|Overall Study||19||
60080945|NCT00257686|76196386|FG002|NOT COMPLETED|Overall Study||18||
60080946|NCT00257686|76196387|FG003|NOT COMPLETED|Overall Study||11||
60080947|NCT00257686|76196388|FG004|NOT COMPLETED|Overall Study||22||
60080948|NCT00257686|76196389|FG005|NOT COMPLETED|Overall Study||9||
60080949|NCT00234286|76196403|FG000|STARTED|Overall Study|We reviewed eletronic health records for 6066 deceased individuals within 6 VA Hospitals|6066||
60080950|NCT00234286|76196403|FG000|COMPLETED|Overall Study|We reviewed eletronic health records for 6066 deceased individuals within 6 VA Hospitals|6066||
60080951|NCT00234286|76196403|FG000|NOT COMPLETED|Overall Study||0||
60080952|NCT01469013|76196441|FG000|STARTED|Part A (Treatment Period)||24||
60080953|NCT01469013|76196442|FG001|STARTED|Part A (Treatment Period)||24||
60080954|NCT01469013|76196443|FG002|STARTED|Part A (Treatment Period)||24||
60080955|NCT01469013|76196444|FG003|STARTED|Part A (Treatment Period)||24||
60080956|NCT01469013|76196445|FG004|STARTED|Part A (Treatment Period)||49||
60080957|NCT01469013|76196446|FG005|STARTED|Part A (Treatment Period)||0||
60080958|NCT01469013|76196447|FG006|STARTED|Part A (Treatment Period)||0||
60080959|NCT01469013|76196448|FG007|STARTED|Part A (Treatment Period)||0||
60080960|NCT01469013|76196449|FG008|STARTED|Part A (Treatment Period)||0||
60080961|NCT01469013|76196450|FG009|STARTED|Part A (Treatment Period)||0||
60080962|NCT01469013|76196451|FG010|STARTED|Part A (Treatment Period)||0||
60080963|NCT01469013|76196452|FG011|STARTED|Part A (Treatment Period)||0||
60080964|NCT01469013|76196453|FG012|STARTED|Part A (Treatment Period)||0||
60080965|NCT01469013|76196441|FG000|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||24||
60080966|NCT01469013|76196442|FG001|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||24||
60080967|NCT01469013|76196443|FG002|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||24||
60080968|NCT01469013|76196444|FG003|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||24||
60080969|NCT01469013|76196445|FG004|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||49||
60080970|NCT01469013|76196446|FG005|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0||
60080971|NCT01469013|76196447|FG006|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0||
60080972|NCT01469013|76196448|FG007|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0||
60080973|NCT01469013|76196449|FG008|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0||
60080974|NCT01469013|76196450|FG009|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0||
59550095|NCT01716455|75649547|FG005|COMPLETED|Overall Study||8||
59550096|NCT01716455|75649542|FG000|NOT COMPLETED|Overall Study||0||
59550097|NCT01716455|75649543|FG001|NOT COMPLETED|Overall Study||0||
59550098|NCT01716455|75649544|FG002|NOT COMPLETED|Overall Study||0||
59550099|NCT01716455|75649545|FG003|NOT COMPLETED|Overall Study||0||
59550100|NCT01716455|75649546|FG004|NOT COMPLETED|Overall Study||0||
59550101|NCT01716455|75649547|FG005|NOT COMPLETED|Overall Study||0||
59550102|NCT01294748|75649560|FG000|STARTED|Overall Study||123||
59550103|NCT01294748|75649561|FG001|STARTED|Overall Study||61||
59550104|NCT01294748|75649560|FG000|COMPLETED|Overall Study|At 270 days|118||
59550105|NCT01294748|75649561|FG001|COMPLETED|Overall Study|At 270 days|59||
59550106|NCT01294748|75649560|FG000|NOT COMPLETED|Overall Study||5||
59550107|NCT01294748|75649561|FG001|NOT COMPLETED|Overall Study||2||
59550108|NCT01720277|75649569|FG000|STARTED|Overall Study||1461||20
59550109|NCT01720277|75649570|FG001|STARTED|Overall Study||1496||19
59550110|NCT01720277|75649569|FG000|COMPLETED|Overall Study|intent-to-treat approach|958||20
59550111|NCT01720277|75649570|FG001|COMPLETED|Overall Study|intent-to-treat approach|938||19
59550112|NCT01720277|75649569|FG000|NOT COMPLETED|Overall Study||503||0
59550113|NCT01720277|75649570|FG001|NOT COMPLETED|Overall Study||558||0
59550114|NCT01231646|75649580|FG000|STARTED|Overall Study||28||
59550115|NCT01231646|75649581|FG001|STARTED|Overall Study||10||
59550116|NCT01231646|75649580|FG000|COMPLETED|Overall Study||28||
59550117|NCT01231646|75649581|FG001|COMPLETED|Overall Study||10||
59706572|NCT01263119|75825694|FG000|COMPLETED|Period 2||14||
59991094|NCT01603407|76106614|FG000|STARTED|Overall Study||65||
59991095|NCT01603407|76106615|FG001|STARTED|Overall Study||65||
59991096|NCT01603407|76106616|FG002|STARTED|Overall Study||66||
59991097|NCT01603407|76106614|FG000|COMPLETED|Overall Study||54||
59991098|NCT01603407|76106615|FG001|COMPLETED|Overall Study||54||
60080975|NCT01469013|76196451|FG010|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0||
59991099|NCT01603407|76106616|FG002|COMPLETED|Overall Study||56||
59991100|NCT01603407|76106614|FG000|NOT COMPLETED|Overall Study||11||
59991101|NCT01603407|76106615|FG001|NOT COMPLETED|Overall Study||11||
59991102|NCT01603407|76106616|FG002|NOT COMPLETED|Overall Study||10||
59991103|NCT03122431|76106627|FG000|STARTED|Overall Study||41||
59991104|NCT03122431|76106628|FG001|STARTED|Overall Study||32||
59991105|NCT03122431|76106629|FG002|STARTED|Overall Study||20||
59991106|NCT03122431|76106627|FG000|COMPLETED|Overall Study||41||
59991107|NCT03122431|76106628|FG001|COMPLETED|Overall Study||32||
59991108|NCT03122431|76106629|FG002|COMPLETED|Overall Study||9||
59991109|NCT03122431|76106627|FG000|NOT COMPLETED|Overall Study||0||
59991110|NCT03122431|76106628|FG001|NOT COMPLETED|Overall Study||0||
59991111|NCT03122431|76106629|FG002|NOT COMPLETED|Overall Study||11||
59991112|NCT02506465|76106639|FG000|STARTED|Overall Study||128||
59991113|NCT02506465|76106640|FG001|STARTED|Overall Study||57||
59991114|NCT02506465|76106639|FG000|COMPLETED|Overall Study|78 patients reached 12 months FU visit.|78||
59991115|NCT02506465|76106640|FG001|COMPLETED|Overall Study|The Sham arm was analyzed up to 3 months FU visit as primary endpoint timeframe in accordance with the FDA guideline for BPH treatments, published in 2010, the most recent guidance available at the time of the study.|57||
59991116|NCT02506465|76106639|FG000|NOT COMPLETED|Overall Study||50||
59991117|NCT02506465|76106640|FG001|NOT COMPLETED|Overall Study||0||
59991118|NCT02235454|76106646|FG000|STARTED|Overall Study||57||
59991119|NCT02235454|76106646|FG000|COMPLETED|Overall Study||55||
59991120|NCT02235454|76106646|FG000|NOT COMPLETED|Overall Study||2||
59991121|NCT02235298|76106652|FG000|STARTED|Overall Study||50||
59991122|NCT02235298|76106653|FG001|STARTED|Overall Study||50||
59991123|NCT02235298|76106652|FG000|COMPLETED|Overall Study||42||
59991124|NCT02235298|76106653|FG001|COMPLETED|Overall Study||42||
59991125|NCT02235298|76106652|FG000|NOT COMPLETED|Overall Study||8||
59991126|NCT02235298|76106653|FG001|NOT COMPLETED|Overall Study||8||
59991127|NCT02234596|76106659|FG000|STARTED|Overall Study||34||
59991128|NCT02234596|76106659|FG000|COMPLETED|Overall Study||32||
59991129|NCT02234596|76106659|FG000|NOT COMPLETED|Overall Study||2||
59991130|NCT02234362|76106663|FG000|STARTED|Overall Study||47||
59991131|NCT02234362|76106663|FG000|Received at Least One Dose of Medication|Overall Study||27||
59991132|NCT02234362|76106663|FG000|COMPLETED|Overall Study||21||
59991133|NCT02234362|76106663|FG000|NOT COMPLETED|Overall Study||26||
59991134|NCT02234284|76106669|FG000|STARTED|Overall Study||100||
59991135|NCT02234284|76106670|FG001|STARTED|Overall Study||92||
59991136|NCT02234284|76106669|FG000|COMPLETED|Overall Study||75||
59991137|NCT02234284|76106670|FG001|COMPLETED|Overall Study||83||
59991138|NCT02234284|76106669|FG000|NOT COMPLETED|Overall Study||25||
59991139|NCT02234284|76106670|FG001|NOT COMPLETED|Overall Study||9||
59991140|NCT02232880|76106680|FG000|STARTED|Overall Study||1||
59991141|NCT02232880|76106680|FG000|COMPLETED|Overall Study||0||
59991142|NCT02232880|76106680|FG000|NOT COMPLETED|Overall Study||1||
59991143|NCT02896855|76106686|FG000|STARTED|Overall Study||121|Intent-to-Treat (ITT) Population|
59991144|NCT02896855|76106687|FG001|STARTED|Overall Study||122|Intent-to-Treat (ITT) Population|
59991145|NCT02896855|76106686|FG000|Received Any Study Treatment|Overall Study||120|Safety Population|
59991146|NCT02896855|76106687|FG001|Received Any Study Treatment|Overall Study||122|Safety Population|
59991147|NCT02896855|76106686|FG000|Crossed Over From Placebo to Receive Pertuzumab|Overall Study|From 07-March-2020, 12 participants randomized to the Placebo arm crossed over to open-label pertuzumab.|12||
59550118|NCT01231646|75649580|FG000|NOT COMPLETED|Overall Study||0||
59550119|NCT01231646|75649581|FG001|NOT COMPLETED|Overall Study||0||
60080976|NCT01469013|76196452|FG011|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0||
59550120|NCT01295216|75649589|FG000|STARTED|Overall Study||316||
59550121|NCT01295216|75649590|FG001|STARTED|Overall Study||321||
59706573|NCT01263119|75825694|FG000|NOT COMPLETED|Period 2||2||
59991148|NCT02896855|76106687|FG001|Crossed Over From Placebo to Receive Pertuzumab|Overall Study||0||
59991149|NCT02896855|76106686|FG000|COMPLETED|Overall Study||49||
59991150|NCT02896855|76106687|FG001|COMPLETED|Overall Study||69||
60080977|NCT01469013|76196453|FG012|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0||
59991151|NCT02896855|76106686|FG000|NOT COMPLETED|Overall Study||72||
59991152|NCT02896855|76106687|FG001|NOT COMPLETED|Overall Study||53||
59550122|NCT01295216|75649589|FG000|COMPLETED|Overall Study||266||
59550123|NCT01295216|75649590|FG001|COMPLETED|Overall Study||287||
59550124|NCT01295216|75649589|FG000|NOT COMPLETED|Overall Study||50||
59550125|NCT01295216|75649590|FG001|NOT COMPLETED|Overall Study||34||
59550126|NCT01232504|75649599|FG000|STARTED|Overall Study||68||
59550127|NCT01232504|75649600|FG001|STARTED|Overall Study||69||
59550128|NCT01232504|75649601|FG002|STARTED|Overall Study||69||
59550129|NCT01232504|75649599|FG000|COMPLETED|Overall Study||59||
59550130|NCT01232504|75649600|FG001|COMPLETED|Overall Study||67||
59550131|NCT01232504|75649601|FG002|COMPLETED|Overall Study||61||
59550132|NCT01232504|75649599|FG000|NOT COMPLETED|Overall Study||9||
59550133|NCT01232504|75649600|FG001|NOT COMPLETED|Overall Study||2||
59550134|NCT01232504|75649601|FG002|NOT COMPLETED|Overall Study||8||
59550135|NCT01721447|75649617|FG000|STARTED|Overall Study||100||
59550136|NCT01721447|75649617|FG000|COMPLETED|Overall Study||100||
59550137|NCT01721447|75649617|FG000|NOT COMPLETED|Overall Study||0||
59550138|NCT02249819|75649622|FG000|STARTED|Overall Study||8||
59550139|NCT02249819|75649623|FG001|STARTED|Overall Study||7||
59550140|NCT02249819|75649622|FG000|COMPLETED|Overall Study||8||
59550141|NCT02249819|75649623|FG001|COMPLETED|Overall Study||7||
59550142|NCT02249819|75649622|FG000|NOT COMPLETED|Overall Study||0||
59550143|NCT02249819|75649623|FG001|NOT COMPLETED|Overall Study||0||
59550144|NCT01295840|75649629|FG000|STARTED|Overall Study||51||
59550145|NCT01295840|75649629|FG000|COMPLETED|Overall Study||50||
59550146|NCT01295840|75649629|FG000|NOT COMPLETED|Overall Study||1||
59550147|NCT01737281|75649637|FG000|STARTED|Overall Study||969||
59550148|NCT01737281|75649638|FG001|STARTED|Overall Study||969||
60080978|NCT01469013|76196441|FG000|COMPLETED|Part A (Treatment Period)||23||
60080979|NCT01469013|76196442|FG001|COMPLETED|Part A (Treatment Period)||24||
60080980|NCT01469013|76196443|FG002|COMPLETED|Part A (Treatment Period)||23||
60080981|NCT01469013|76196444|FG003|COMPLETED|Part A (Treatment Period)||24||
60080982|NCT01469013|76196445|FG004|COMPLETED|Part A (Treatment Period)||48||
60080983|NCT01469013|76196446|FG005|COMPLETED|Part A (Treatment Period)||0||
60080984|NCT01469013|76196447|FG006|COMPLETED|Part A (Treatment Period)||0||
60080985|NCT01469013|76196448|FG007|COMPLETED|Part A (Treatment Period)||0||
60080986|NCT01469013|76196449|FG008|COMPLETED|Part A (Treatment Period)||0||
59550149|NCT01737281|75649637|FG000|COMPLETED|Overall Study||603||
59550150|NCT01737281|75649638|FG001|COMPLETED|Overall Study||689||
59550151|NCT01737281|75649637|FG000|NOT COMPLETED|Overall Study||366||
59550152|NCT01737281|75649638|FG001|NOT COMPLETED|Overall Study||280||
59550153|NCT01216748|75649644|FG000|STARTED|Overall Study||10||
59550154|NCT01216748|75649644|FG000|Quiet Breathing|Overall Study||10||
59550155|NCT01216748|75649644|FG000|Hypocapnic Hyperventilation|Overall Study||10||
59550156|NCT01216748|75649644|FG000|Hypercapnic Hyperventilation|Overall Study||10||
59550157|NCT01216748|75649644|FG000|Eucapnic Hyperventilation|Overall Study||10||
59550158|NCT01216748|75649644|FG000|COMPLETED|Overall Study||10||
59550159|NCT01216748|75649644|FG000|NOT COMPLETED|Overall Study||0||
59550160|NCT01233518|75649648|FG000|STARTED|Overall Study||285||
59550161|NCT01233518|75649648|FG000|COMPLETED|Overall Study||252||
59550162|NCT01233518|75649648|FG000|NOT COMPLETED|Overall Study||33||
59550163|NCT01737593|75649656|FG000|STARTED|Overall Study||37||
59550164|NCT01737593|75649657|FG001|STARTED|Overall Study||32||
59550165|NCT01737593|75649658|FG002|STARTED|Overall Study||39||
59550166|NCT01737593|75649656|FG000|COMPLETED|Overall Study||37||
60080987|NCT01469013|76196450|FG009|COMPLETED|Part A (Treatment Period)||0||
60080988|NCT01469013|76196451|FG010|COMPLETED|Part A (Treatment Period)||0||
59550167|NCT01737593|75649657|FG001|COMPLETED|Overall Study||32||
59550168|NCT01737593|75649658|FG002|COMPLETED|Overall Study||39||
59550169|NCT01737593|75649656|FG000|NOT COMPLETED|Overall Study||0||
59550170|NCT01737593|75649657|FG001|NOT COMPLETED|Overall Study||0||
59550171|NCT01737593|75649658|FG002|NOT COMPLETED|Overall Study||0||
59550172|NCT01217840|75649671|FG000|STARTED|Overall Study||20||
59550173|NCT01217840|75649672|FG001|STARTED|Overall Study||20||
60103789|NCT03864406|76222062|FG000|NOT COMPLETED|Overall Study||0||
60103790|NCT03846804|76222066|FG000|STARTED|Overall Study||38||
60103791|NCT03846804|76222066|FG000|COMPLETED|Overall Study||36||
60103792|NCT03846804|76222066|FG000|NOT COMPLETED|Overall Study||2||
60103793|NCT03826199|76222071|FG000|STARTED|Overall Study||200||
60103794|NCT03826199|76222071|FG000|COMPLETED|Overall Study||200||
60103795|NCT03826199|76222071|FG000|NOT COMPLETED|Overall Study||0||
60103796|NCT03807440|76222075|FG000|STARTED|Overall Study|Study index date 1|4055|Patients included in the prescribed patient set (PPS)|
60103797|NCT03807440|76222075|FG000|COMPLETED|Overall Study|study index date 2|3618|Patients included in the full analysis set (FAS)|
60103798|NCT03807440|76222075|FG000|NOT COMPLETED|Overall Study||437||
59706574|NCT01262651|75825704|FG000|STARTED|Overall Study||199||
59706575|NCT01262651|75825705|FG001|STARTED|Overall Study||198||
59706576|NCT01262651|75825704|FG000|Received at Least 1 Dose of Study Drug|Overall Study||199||
59706577|NCT01262651|75825705|FG001|Received at Least 1 Dose of Study Drug|Overall Study||198||
59706578|NCT01262651|75825704|FG000|Safety Population|Overall Study||199||
59706579|NCT01262651|75825705|FG001|Safety Population|Overall Study||198||
59816354|NCT00430989|75938765|FG000|NOT COMPLETED|Overall Study||60||
59550174|NCT01217840|75649671|FG000|COMPLETED|Overall Study||14||
59550175|NCT01217840|75649672|FG001|COMPLETED|Overall Study||17||
59550176|NCT01217840|75649671|FG000|NOT COMPLETED|Overall Study||6||
59550177|NCT01217840|75649672|FG001|NOT COMPLETED|Overall Study||3||
59550178|NCT02250521|75649679|FG000|STARTED|Overall Study||100||
59550179|NCT02250521|75649679|FG000|COMPLETED|Overall Study||99||
59550180|NCT02250521|75649679|FG000|NOT COMPLETED|Overall Study||1||
59550181|NCT01218542|75649683|FG000|STARTED|Overall Study||22||
60080989|NCT01469013|76196452|FG011|COMPLETED|Part A (Treatment Period)||0||
60080990|NCT01469013|76196453|FG012|COMPLETED|Part A (Treatment Period)||0||
60080991|NCT01469013|76196441|FG000|NOT COMPLETED|Part A (Treatment Period)||1||
60080992|NCT01469013|76196442|FG001|NOT COMPLETED|Part A (Treatment Period)||0||
60080993|NCT01469013|76196443|FG002|NOT COMPLETED|Part A (Treatment Period)||1||
60080994|NCT01469013|76196444|FG003|NOT COMPLETED|Part A (Treatment Period)||0||
60080995|NCT01469013|76196445|FG004|NOT COMPLETED|Part A (Treatment Period)||1||
60080996|NCT01469013|76196446|FG005|NOT COMPLETED|Part A (Treatment Period)||0||
60080997|NCT01469013|76196447|FG006|NOT COMPLETED|Part A (Treatment Period)||0||
60080998|NCT01469013|76196448|FG007|NOT COMPLETED|Part A (Treatment Period)||0||
60080999|NCT01469013|76196449|FG008|NOT COMPLETED|Part A (Treatment Period)||0||
60081000|NCT01469013|76196450|FG009|NOT COMPLETED|Part A (Treatment Period)||0||
60081001|NCT01469013|76196451|FG010|NOT COMPLETED|Part A (Treatment Period)||0||
60081002|NCT01469013|76196452|FG011|NOT COMPLETED|Part A (Treatment Period)||0||
60081003|NCT01469013|76196453|FG012|NOT COMPLETED|Part A (Treatment Period)||0||
60081004|NCT01469013|76196441|FG000|STARTED|Part B (Extension Period)||0||
60081005|NCT01469013|76196442|FG001|STARTED|Part B (Extension Period)||0||
60081006|NCT01469013|76196443|FG002|STARTED|Part B (Extension Period)||0||
60081007|NCT01469013|76196444|FG003|STARTED|Part B (Extension Period)||0||
60081008|NCT01469013|76196445|FG004|STARTED|Part B (Extension Period)||0||
60081009|NCT01469013|76196446|FG005|STARTED|Part B (Extension Period)||12||
60081010|NCT01469013|76196447|FG006|STARTED|Part B (Extension Period)||12||
60081011|NCT01469013|76196448|FG007|STARTED|Part B (Extension Period)||23||
60081012|NCT01469013|76196449|FG008|STARTED|Part B (Extension Period)||24||
60081013|NCT01469013|76196450|FG009|STARTED|Part B (Extension Period)||11||
60081014|NCT01469013|76196451|FG010|STARTED|Part B (Extension Period)||12||
60081015|NCT01469013|76196452|FG011|STARTED|Part B (Extension Period)||24||
60081016|NCT01469013|76196453|FG012|STARTED|Part B (Extension Period)||24||
60081017|NCT01469013|76196441|FG000|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||0||
60081018|NCT01469013|76196442|FG001|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||0||
60081019|NCT01469013|76196443|FG002|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||0||
60081020|NCT01469013|76196444|FG003|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||0||
60081021|NCT01469013|76196445|FG004|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||0||
60081022|NCT01469013|76196446|FG005|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||12||
60081023|NCT01469013|76196447|FG006|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||12||
60081024|NCT01469013|76196448|FG007|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||23||
60081025|NCT01469013|76196449|FG008|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||24||
60081026|NCT01469013|76196450|FG009|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||11||
60081027|NCT01469013|76196451|FG010|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||12||
60081028|NCT01469013|76196452|FG011|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||24||
60081029|NCT01469013|76196453|FG012|Received at Least 1 Dose of Study Drug|Part B (Extension Period)|1 participant discontinued prior to receiving study drug|23||
60081030|NCT01469013|76196441|FG000|COMPLETED|Part B (Extension Period)||0||
60081031|NCT01469013|76196442|FG001|COMPLETED|Part B (Extension Period)||0||
60081032|NCT01469013|76196443|FG002|COMPLETED|Part B (Extension Period)||0||
60081033|NCT01469013|76196444|FG003|COMPLETED|Part B (Extension Period)||0||
60081034|NCT01469013|76196445|FG004|COMPLETED|Part B (Extension Period)||0||
60081035|NCT01469013|76196446|FG005|COMPLETED|Part B (Extension Period)||10||
60081036|NCT01469013|76196447|FG006|COMPLETED|Part B (Extension Period)||7||
60081037|NCT01469013|76196448|FG007|COMPLETED|Part B (Extension Period)||18||
60081038|NCT01469013|76196449|FG008|COMPLETED|Part B (Extension Period)||20||
59706580|NCT01262651|75825704|FG000|ITT Population|Overall Study||199||
59706581|NCT01262651|75825705|FG001|ITT Population|Overall Study||198||
59706582|NCT01262651|75825704|FG000|COMPLETED|Overall Study||141||
59706583|NCT01262651|75825705|FG001|COMPLETED|Overall Study||150||
59706584|NCT01262651|75825704|FG000|NOT COMPLETED|Overall Study||58||
59706585|NCT01262651|75825705|FG001|NOT COMPLETED|Overall Study||48||
60081039|NCT01469013|76196450|FG009|COMPLETED|Part B (Extension Period)||8||
60081040|NCT01469013|76196451|FG010|COMPLETED|Part B (Extension Period)||10||
60081041|NCT01469013|76196452|FG011|COMPLETED|Part B (Extension Period)||18||
60081042|NCT01469013|76196453|FG012|COMPLETED|Part B (Extension Period)||18||
60081043|NCT01469013|76196441|FG000|NOT COMPLETED|Part B (Extension Period)||0||
60081044|NCT01469013|76196442|FG001|NOT COMPLETED|Part B (Extension Period)||0||
60081045|NCT01469013|76196443|FG002|NOT COMPLETED|Part B (Extension Period)||0||
60081046|NCT01469013|76196444|FG003|NOT COMPLETED|Part B (Extension Period)||0||
59550182|NCT01218542|75649683|FG000|COMPLETED|Overall Study||13||
59550183|NCT01218542|75649683|FG000|NOT COMPLETED|Overall Study||9||
60081047|NCT01469013|76196445|FG004|NOT COMPLETED|Part B (Extension Period)||0||
60081048|NCT01469013|76196446|FG005|NOT COMPLETED|Part B (Extension Period)||2||
60081049|NCT01469013|76196447|FG006|NOT COMPLETED|Part B (Extension Period)||5||
60081050|NCT01469013|76196448|FG007|NOT COMPLETED|Part B (Extension Period)||5||
60081051|NCT01469013|76196449|FG008|NOT COMPLETED|Part B (Extension Period)||4||
60081052|NCT01469013|76196450|FG009|NOT COMPLETED|Part B (Extension Period)||3||
60081053|NCT01469013|76196451|FG010|NOT COMPLETED|Part B (Extension Period)||2||
60081054|NCT01469013|76196452|FG011|NOT COMPLETED|Part B (Extension Period)||6||
59550184|NCT01721603|75649688|FG000|STARTED|Overall Study||2||
59550185|NCT01721603|75649688|FG000|COMPLETED|Overall Study||2||
59550186|NCT01721603|75649688|FG000|NOT COMPLETED|Overall Study||0||
59550187|NCT01296542|75649694|FG000|STARTED|Overall Study||30||
59550188|NCT01296542|75649695|FG001|STARTED|Overall Study||30||
59550189|NCT01296542|75649694|FG000|COMPLETED|Overall Study||30||
59550190|NCT01296542|75649695|FG001|COMPLETED|Overall Study||28||
59550191|NCT01296542|75649694|FG000|NOT COMPLETED|Overall Study||0||
59550192|NCT01296542|75649695|FG001|NOT COMPLETED|Overall Study||2||
59550193|NCT01234766|75649701|FG000|STARTED|Overall Study||39||
59550194|NCT01234766|75649701|FG000|COMPLETED|Overall Study||35||
59550195|NCT01234766|75649701|FG000|NOT COMPLETED|Overall Study||4||
59550196|NCT01234922|75649709|FG000|STARTED|Overall Study||1||
59550197|NCT01234922|75649710|FG001|STARTED|Overall Study||1||
59550198|NCT01234922|75649711|FG002|STARTED|Overall Study||2||
59550199|NCT01234922|75649712|FG003|STARTED|Overall Study||2||
59550200|NCT01234922|75649709|FG000|COMPLETED|Overall Study||1||
59550201|NCT01234922|75649710|FG001|COMPLETED|Overall Study||1||
59550202|NCT01234922|75649711|FG002|COMPLETED|Overall Study||2||
59550203|NCT01234922|75649712|FG003|COMPLETED|Overall Study||2||
59550204|NCT01234922|75649709|FG000|NOT COMPLETED|Overall Study||0||
59550205|NCT01234922|75649710|FG001|NOT COMPLETED|Overall Study||0||
59550206|NCT01234922|75649711|FG002|NOT COMPLETED|Overall Study||0||
59550207|NCT01234922|75649712|FG003|NOT COMPLETED|Overall Study||0||
59550208|NCT01337336|75649724|FG000|STARTED|Overall Study||1078||
59550209|NCT01337336|75649725|FG001|STARTED|Overall Study||2923||
59550210|NCT01337336|75649724|FG000|COMPLETED|Overall Study||1078||
59550211|NCT01337336|75649725|FG001|COMPLETED|Overall Study||2923||
59550212|NCT01337336|75649724|FG000|NOT COMPLETED|Overall Study||0||
59706586|NCT01262573|75825713|FG000|STARTED|Overall Study||32||
59706587|NCT01262573|75825714|FG001|STARTED|Overall Study||32||
59706588|NCT01262573|75825713|FG000|COMPLETED|Overall Study||32||
59706589|NCT01262573|75825714|FG001|COMPLETED|Overall Study||31||
59706590|NCT01262573|75825713|FG000|NOT COMPLETED|Overall Study||0||
59706591|NCT01262573|75825714|FG001|NOT COMPLETED|Overall Study||1||
59706592|NCT01262027|75825720|FG000|STARTED|Overall Study||22||
60081055|NCT01469013|76196453|FG012|NOT COMPLETED|Part B (Extension Period)||6||
60081056|NCT01493427|76196480|FG000|STARTED|Overall Study||199||
60081057|NCT01493427|76196480|FG000|COMPLETED|Overall Study||179||
60081058|NCT01493427|76196480|FG000|NOT COMPLETED|Overall Study||20||
60081059|NCT01523457|76196486|FG000|STARTED|Overall Study||44||
60081060|NCT01523457|76196487|FG001|STARTED|Overall Study||31||
60081061|NCT01523457|76196486|FG000|COMPLETED|Overall Study||37||
59550213|NCT01337336|75649725|FG001|NOT COMPLETED|Overall Study||0||
59550214|NCT01338506|75649733|FG000|STARTED|Overall Study||54||
59706593|NCT01262027|75825720|FG000|COMPLETED|Overall Study||17||
60081062|NCT01523457|76196487|FG001|COMPLETED|Overall Study||29||
59550215|NCT01338506|75649734|FG001|STARTED|Overall Study||27||
59550216|NCT01338506|75649733|FG000|COMPLETED|Overall Study||29||
59706594|NCT01262027|75825720|FG000|NOT COMPLETED|Overall Study||5||
59706595|NCT01261793|75825727|FG000|STARTED|Overall Study||263||
59550217|NCT01338506|75649734|FG001|COMPLETED|Overall Study||13||
59550218|NCT01338506|75649733|FG000|NOT COMPLETED|Overall Study||25||
59550219|NCT01338506|75649734|FG001|NOT COMPLETED|Overall Study||14||
59706596|NCT01261793|75825728|FG001|STARTED|Overall Study||262||
59550220|NCT01236170|75649744|FG000|STARTED|Overall Study||497||
59550221|NCT01236170|75649744|FG000|COMPLETED|Overall Study||482||
59550222|NCT01236170|75649744|FG000|NOT COMPLETED|Overall Study||15||
59550223|NCT01236326|75649750|FG000|STARTED|Overall Study||50||
59550224|NCT01236326|75649751|FG001|STARTED|Overall Study||55||
59550225|NCT01236326|75649750|FG000|COMPLETED|Overall Study||49||
59550226|NCT01236326|75649751|FG001|COMPLETED|Overall Study||51||
59550227|NCT01236326|75649750|FG000|NOT COMPLETED|Overall Study||1||
59550228|NCT01236326|75649751|FG001|NOT COMPLETED|Overall Study||4||
59550229|NCT01239056|75649757|FG000|STARTED|Overall Study||20||
59550230|NCT01239056|75649757|FG000|COMPLETED|Overall Study||20||
59550231|NCT01239056|75649757|FG000|NOT COMPLETED|Overall Study||0||
59550232|NCT01302860|75649762|FG000|STARTED|Overall Study||17||
59706597|NCT01261793|75825729|FG002|STARTED|Overall Study||266||
59550233|NCT01302860|75649762|FG000|COMPLETED|Overall Study||17||
59550234|NCT01302860|75649762|FG000|NOT COMPLETED|Overall Study||0||
59550235|NCT01239212|75649766|FG000|STARTED|Overall Study||7||
59550236|NCT01239212|75649766|FG000|COMPLETED|Overall Study||7||
59550237|NCT01239212|75649766|FG000|NOT COMPLETED|Overall Study||0||
59706598|NCT01261793|75825727|FG000|COMPLETED|Overall Study||178||
59550238|NCT01242644|75649773|FG000|STARTED|Overall Study||16||
59550239|NCT01242644|75649774|FG001|STARTED|Overall Study||17||
59550240|NCT01242644|75649775|FG002|STARTED|Overall Study||15||
59550241|NCT01242644|75649773|FG000|COMPLETED|Overall Study||16||
59550242|NCT01242644|75649774|FG001|COMPLETED|Overall Study||17||
59550243|NCT01242644|75649775|FG002|COMPLETED|Overall Study||15||
59550244|NCT01242644|75649773|FG000|NOT COMPLETED|Overall Study||0||
59550245|NCT01242644|75649774|FG001|NOT COMPLETED|Overall Study||0||
59550246|NCT01242644|75649775|FG002|NOT COMPLETED|Overall Study||0||
59550247|NCT01303406|75649785|FG000|STARTED|Overall Study||13||
59550248|NCT01303406|75649786|FG001|STARTED|Overall Study||16||
59550249|NCT01303406|75649785|FG000|COMPLETED|Overall Study||13||
59550250|NCT01303406|75649786|FG001|COMPLETED|Overall Study||15||
59550251|NCT01303406|75649785|FG000|NOT COMPLETED|Overall Study||0||
59550252|NCT01303406|75649786|FG001|NOT COMPLETED|Overall Study||1||
59550253|NCT01304966|75649792|FG000|STARTED|Overall Study||15||
59550254|NCT01304966|75649792|FG000|COMPLETED|Overall Study||15||
59550255|NCT01304966|75649792|FG000|NOT COMPLETED|Overall Study||0||
59550256|NCT02597127|75649806|FG000|STARTED|Overall Study||60||
59550257|NCT02597127|75649807|FG001|STARTED|Overall Study||62||
59550258|NCT02597127|75649808|FG002|STARTED|Overall Study||66||
59550259|NCT02597127|75649809|FG003|STARTED|Overall Study||65||
59550260|NCT02597127|75649810|FG004|STARTED|Overall Study||62||
59550261|NCT02597127|75649811|FG005|STARTED|Overall Study||63||
60081063|NCT01523457|76196486|FG000|NOT COMPLETED|Overall Study||7||
60081064|NCT01523457|76196487|FG001|NOT COMPLETED|Overall Study||2||
60081065|NCT01523301|76196495|FG000|STARTED|Overall Study||184||
59550262|NCT02597127|75649812|FG006|STARTED|Overall Study||61||
59550263|NCT02597127|75649813|FG007|STARTED|Overall Study||62||
59550264|NCT02597127|75649806|FG000|Treated|Overall Study||60||
59816355|NCT00430989|75938766|FG001|NOT COMPLETED|Overall Study||60||
60081066|NCT01523301|76196496|FG001|STARTED|Overall Study||196||
60081067|NCT01523301|76196495|FG000|COMPLETED|Overall Study||149||
60081068|NCT01523301|76196496|FG001|COMPLETED|Overall Study||164||
60081069|NCT01523301|76196495|FG000|NOT COMPLETED|Overall Study||35||
60081070|NCT01523301|76196496|FG001|NOT COMPLETED|Overall Study||32||
60081071|NCT01806506|76196504|FG000|STARTED|Overall Study||36||
60081072|NCT01806506|76196505|FG001|STARTED|Overall Study||36||
60081073|NCT01806506|76196504|FG000|1 Month|Overall Study||36||
60081074|NCT01806506|76196505|FG001|1 Month|Overall Study||36||
60081075|NCT01806506|76196504|FG000|3 Months|Overall Study|1 patient (reason - lost contact)|35||
60081076|NCT01806506|76196505|FG001|3 Months|Overall Study||36||
60081077|NCT01806506|76196504|FG000|6 Months|Overall Study|1 patient (reason - lost contact)|34||
60081078|NCT01806506|76196505|FG001|6 Months|Overall Study||36||
60081079|NCT01806506|76196504|FG000|9 Months|Overall Study||34||
60081080|NCT01806506|76196505|FG001|9 Months|Overall Study|1 patient (reason - lost contact)|35||
60081081|NCT01806506|76196504|FG000|COMPLETED|Overall Study||34||
60081082|NCT01806506|76196505|FG001|COMPLETED|Overall Study||35||
60081083|NCT01806506|76196504|FG000|NOT COMPLETED|Overall Study||2||
60081084|NCT01806506|76196505|FG001|NOT COMPLETED|Overall Study||1||
60081085|NCT01766336|76196513|FG000|STARTED|Overall Study||150||
60081086|NCT01766336|76196514|FG001|STARTED|Overall Study||146||
60081087|NCT01766336|76196513|FG000|COMPLETED|Overall Study||60||
60081088|NCT01766336|76196514|FG001|COMPLETED|Overall Study||71||
60081089|NCT01766336|76196513|FG000|NOT COMPLETED|Overall Study||90||
60081090|NCT01766336|76196514|FG001|NOT COMPLETED|Overall Study||75||
60081091|NCT01797536|76196524|FG000|STARTED|Overall Study||8||
60081092|NCT01797536|76196525|FG001|STARTED|Overall Study|Includes 3 participants from mild arm who were mistakenly re-enrolled and also dosed in moderate arm|11||
60081093|NCT01797536|76196526|FG002|STARTED|Overall Study||7||
60081094|NCT01797536|76196527|FG003|STARTED|Overall Study||8||
60081095|NCT01797536|76196524|FG000|COMPLETED|Overall Study||8||
60081096|NCT01797536|76196525|FG001|COMPLETED|Overall Study||10||
60081097|NCT01797536|76196526|FG002|COMPLETED|Overall Study||7||
60081098|NCT01797536|76196527|FG003|COMPLETED|Overall Study||8||
60081099|NCT01797536|76196524|FG000|NOT COMPLETED|Overall Study||0||
60081100|NCT01797536|76196525|FG001|NOT COMPLETED|Overall Study||1||
60081101|NCT01797536|76196526|FG002|NOT COMPLETED|Overall Study||0||
60081102|NCT01797536|76196527|FG003|NOT COMPLETED|Overall Study||0||
60081103|NCT01797302|76196540|FG000|STARTED|Overall Study||75||
60081104|NCT01797302|76196541|FG001|STARTED|Overall Study||74||
59550265|NCT02597127|75649807|FG001|Treated|Overall Study||61||
59550266|NCT02597127|75649808|FG002|Treated|Overall Study||65||
59550267|NCT02597127|75649809|FG003|Treated|Overall Study||65||
60081105|NCT01797302|76196542|FG002|STARTED|Overall Study||76||
60081106|NCT01797302|76196540|FG000|3 Month Visit|Overall Study||60||
60081107|NCT01797302|76196541|FG001|3 Month Visit|Overall Study||57||
60081108|NCT01797302|76196542|FG002|3 Month Visit|Overall Study||57||
60081109|NCT01797302|76196540|FG000|COMPLETED|Overall Study||58||
60081110|NCT01797302|76196541|FG001|COMPLETED|Overall Study||48||
60081111|NCT01797302|76196542|FG002|COMPLETED|Overall Study||50||
60081112|NCT01797302|76196540|FG000|NOT COMPLETED|Overall Study||17||
60081113|NCT01797302|76196541|FG001|NOT COMPLETED|Overall Study||26||
60081114|NCT01797302|76196542|FG002|NOT COMPLETED|Overall Study||26||
60081115|NCT01805180|76196552|FG000|STARTED|Lead-in Donor Phase||7||
60081116|NCT01805180|76196553|FG001|STARTED|Lead-in Donor Phase|pivotal trial subjects were not screened or enrolled in this period.|0||
60081117|NCT01805180|76196554|FG002|STARTED|Lead-in Donor Phase|pivotal trial subjects were not screened or enrolled in this period.|0||
60081118|NCT01805180|76196552|FG000|COMPLETED|Lead-in Donor Phase||6||
60081119|NCT01805180|76196553|FG001|COMPLETED|Lead-in Donor Phase||0||
60081120|NCT01805180|76196554|FG002|COMPLETED|Lead-in Donor Phase||0||
60081121|NCT01805180|76196552|FG000|NOT COMPLETED|Lead-in Donor Phase||1||
60081122|NCT01805180|76196553|FG001|NOT COMPLETED|Lead-in Donor Phase||0||
60081123|NCT01805180|76196554|FG002|NOT COMPLETED|Lead-in Donor Phase||0||
60081124|NCT01805180|76196552|FG000|STARTED|Pivotal Randomization Through Study Exit|lead-in donors were not randomized and did not participate in this period.|0||
60081125|NCT01805180|76196553|FG001|STARTED|Pivotal Randomization Through Study Exit||22||
60081126|NCT01805180|76196554|FG002|STARTED|Pivotal Randomization Through Study Exit||20||
60081127|NCT01805180|76196552|FG000|COMPLETED|Pivotal Randomization Through Study Exit||0||
60081128|NCT01805180|76196553|FG001|COMPLETED|Pivotal Randomization Through Study Exit||17||
60081129|NCT01805180|76196554|FG002|COMPLETED|Pivotal Randomization Through Study Exit||15||
60081130|NCT01805180|76196552|FG000|NOT COMPLETED|Pivotal Randomization Through Study Exit||0||
60081131|NCT01805180|76196553|FG001|NOT COMPLETED|Pivotal Randomization Through Study Exit||5||
60081132|NCT01805180|76196554|FG002|NOT COMPLETED|Pivotal Randomization Through Study Exit||5||
60081133|NCT01804946|76196564|FG000|STARTED|Overall Study||81||
60081134|NCT01804946|76196565|FG001|STARTED|Overall Study||80||
60081135|NCT01804946|76196564|FG000|COMPLETED|Overall Study||79||
59706599|NCT01261793|75825728|FG001|COMPLETED|Overall Study||171||
60081136|NCT01804946|76196565|FG001|COMPLETED|Overall Study||76||
60081137|NCT01804946|76196564|FG000|NOT COMPLETED|Overall Study||2||
60081138|NCT01804946|76196565|FG001|NOT COMPLETED|Overall Study||4||
60081139|NCT01737398|76196575|FG000|STARTED|Overall Study||113||
60081140|NCT01737398|76196576|FG001|STARTED|Overall Study||60||
60081141|NCT01737398|76196575|FG000|Received at Least 1 Dose of Study Drug|Overall Study||112|One participant in the inotersen group was ineligible, but was randomized in error.|
60081142|NCT01737398|76196576|FG001|Received at Least 1 Dose of Study Drug|Overall Study||60|One participant in the inotersen group was ineligible, but was randomized in error.|
60081143|NCT01737398|76196575|FG000|Safety Set|Overall Study||112||
60081144|NCT01737398|76196576|FG001|Safety Set|Overall Study||60||
60081145|NCT01737398|76196575|FG000|COMPLETED|Overall Study||87||
60081146|NCT01737398|76196576|FG001|COMPLETED|Overall Study||52||
60081147|NCT01737398|76196575|FG000|NOT COMPLETED|Overall Study||26||
60081148|NCT01737398|76196576|FG001|NOT COMPLETED|Overall Study||8||
60081149|NCT01795898|76196585|FG000|STARTED|Overall Study||237||
60081150|NCT01795898|76196585|FG000|COMPLETED|Overall Study||177||
60081151|NCT01795898|76196585|FG000|NOT COMPLETED|Overall Study||60||
60081152|NCT01736696|76196596|FG000|STARTED|Overall Study||5||
60081153|NCT01736696|76196597|FG001|STARTED|Overall Study||5||
60081154|NCT01736696|76196598|FG002|STARTED|Overall Study||10||
60081155|NCT01736696|76196599|FG003|STARTED|Overall Study||9||
59706600|NCT01261793|75825729|FG002|COMPLETED|Overall Study||184||
60081156|NCT01736696|76196600|FG004|STARTED|Overall Study||9||
60081157|NCT01736696|76196601|FG005|STARTED|Overall Study||8||
60081158|NCT01736696|76196602|FG006|STARTED|Overall Study||13||
60081159|NCT01736696|76196596|FG000|COMPLETED|Overall Study||5||
59706601|NCT01261793|75825727|FG000|NOT COMPLETED|Overall Study||85||
60081160|NCT01736696|76196597|FG001|COMPLETED|Overall Study||5||
60081161|NCT01736696|76196598|FG002|COMPLETED|Overall Study||9||
60081162|NCT01736696|76196599|FG003|COMPLETED|Overall Study||9||
60081163|NCT01736696|76196600|FG004|COMPLETED|Overall Study||9||
60081164|NCT01736696|76196601|FG005|COMPLETED|Overall Study||8||
60081165|NCT01736696|76196602|FG006|COMPLETED|Overall Study||13||
60081166|NCT01736696|76196596|FG000|NOT COMPLETED|Overall Study||0||
60081167|NCT01736696|76196597|FG001|NOT COMPLETED|Overall Study||0||
60081168|NCT01736696|76196598|FG002|NOT COMPLETED|Overall Study||1||
60081169|NCT01736696|76196599|FG003|NOT COMPLETED|Overall Study||0||
60081170|NCT01736696|76196600|FG004|NOT COMPLETED|Overall Study||0||
60081171|NCT01736696|76196601|FG005|NOT COMPLETED|Overall Study||0||
60081172|NCT01736696|76196602|FG006|NOT COMPLETED|Overall Study||0||
60081173|NCT01736540|76196626|FG000|STARTED|Overall Study||243||
60081174|NCT01736540|76196626|FG000|COMPLETED|Overall Study||228||
60081175|NCT01736540|76196626|FG000|NOT COMPLETED|Overall Study||15||
60081176|NCT01794338|76196639|FG000|STARTED|Overall Study||8||
60081177|NCT01794338|76196640|FG001|STARTED|Overall Study||9||
60081178|NCT01794338|76196639|FG000|Screen Failure|Overall Study||3||
60081179|NCT01794338|76196640|FG001|Screen Failure|Overall Study||3||
60081180|NCT01794338|76196639|FG000|1 Month Follow Up|Overall Study||6||
60081181|NCT01794338|76196640|FG001|1 Month Follow Up|Overall Study||9||
60081182|NCT01794338|76196639|FG000|6 Month Follow Up|Overall Study||0||
60081183|NCT01794338|76196640|FG001|6 Month Follow Up|Overall Study||0||
60081184|NCT01794338|76196639|FG000|12 Month Follow Up|Overall Study||0||
60081185|NCT01794338|76196640|FG001|12 Month Follow Up|Overall Study||0||
60081186|NCT01794338|76196639|FG000|24 Month Follow Up|Overall Study||0||
60081187|NCT01794338|76196640|FG001|24 Month Follow Up|Overall Study||0||
60081188|NCT01794338|76196639|FG000|36 Month Follow Up|Overall Study||0||
60081189|NCT01794338|76196640|FG001|36 Month Follow Up|Overall Study||0||
60081190|NCT01794338|76196639|FG000|COMPLETED|Overall Study||0||
60081191|NCT01794338|76196640|FG001|COMPLETED|Overall Study||0||
60081192|NCT01794338|76196639|FG000|NOT COMPLETED|Overall Study||8||
60081193|NCT01794338|76196640|FG001|NOT COMPLETED|Overall Study||9||
60081194|NCT01609478|76196649|FG000|STARTED|Overall Study||111||
60081195|NCT01609478|76196650|FG001|STARTED|Overall Study||108||
60081196|NCT01609478|76196651|FG002|STARTED|Overall Study||116||
60081197|NCT01609478|76196649|FG000|Full Analysis Set (FAS)|Overall Study||110||
60081198|NCT01609478|76196650|FG001|Full Analysis Set (FAS)|Overall Study||108||
60081199|NCT01609478|76196651|FG002|Full Analysis Set (FAS)|Overall Study||115||
60081200|NCT01609478|76196649|FG000|COMPLETED|Overall Study||104||
60081201|NCT01609478|76196650|FG001|COMPLETED|Overall Study||106||
60081202|NCT01609478|76196651|FG002|COMPLETED|Overall Study||107||
60081203|NCT01609478|76196649|FG000|NOT COMPLETED|Overall Study||7||
60081204|NCT01609478|76196650|FG001|NOT COMPLETED|Overall Study||2||
60081205|NCT01609478|76196651|FG002|NOT COMPLETED|Overall Study||9||
60081206|NCT01764854|76196663|FG000|STARTED|Overall Study||8||
60081207|NCT01764854|76196664|FG001|STARTED|Overall Study||8||
60081208|NCT01764854|76196665|FG002|STARTED|Overall Study||37||
60081209|NCT01764854|76196666|FG003|STARTED|Overall Study||35||
60081210|NCT01764854|76196663|FG000|COMPLETED|Overall Study||8||
60081211|NCT01764854|76196664|FG001|COMPLETED|Overall Study||8||
60081212|NCT01764854|76196665|FG002|COMPLETED|Overall Study||31||
60081213|NCT01764854|76196666|FG003|COMPLETED|Overall Study||33||
60081214|NCT01764854|76196663|FG000|NOT COMPLETED|Overall Study||0||
60081215|NCT01764854|76196664|FG001|NOT COMPLETED|Overall Study||0||
60081216|NCT01764854|76196665|FG002|NOT COMPLETED|Overall Study||6||
60081217|NCT01764854|76196666|FG003|NOT COMPLETED|Overall Study||2||
60081218|NCT01764464|76196678|FG000|STARTED|First Intervention|Started Gralise|16||
60081219|NCT01764464|76196679|FG001|STARTED|First Intervention|Started Placebo|16||
60081220|NCT01764464|76196678|FG000|COMPLETED|First Intervention|Completed Gralise|14||
60081221|NCT01764464|76196679|FG001|COMPLETED|First Intervention|Completed Placebo|13||
60081222|NCT01764464|76196678|FG000|NOT COMPLETED|First Intervention||2||
60081223|NCT01764464|76196679|FG001|NOT COMPLETED|First Intervention||3||
60081224|NCT01764464|76196678|FG000|STARTED|Second Intervention (Cross-over)|Started Placebo|14||
60081225|NCT01764464|76196679|FG001|STARTED|Second Intervention (Cross-over)|Started Gralise|13||
60081226|NCT01764464|76196678|FG000|COMPLETED|Second Intervention (Cross-over)|Completed Placebo|12||
60081227|NCT01764464|76196679|FG001|COMPLETED|Second Intervention (Cross-over)|Completed Gralise|13||
60081228|NCT01764464|76196678|FG000|NOT COMPLETED|Second Intervention (Cross-over)||2||
60081229|NCT01764464|76196679|FG001|NOT COMPLETED|Second Intervention (Cross-over)||0||
60081230|NCT01764386|76196687|FG000|STARTED|Controlled Treatment Period (CTP)||153||
60081231|NCT01764386|76196688|FG001|STARTED|Controlled Treatment Period (CTP)||89||
60081232|NCT01764386|76196687|FG000|COMPLETED|Controlled Treatment Period (CTP)|Completed the 26-week Controlled Treatment Period.|71||
60081233|NCT01764386|76196688|FG001|COMPLETED|Controlled Treatment Period (CTP)|Completed the 26-week Controlled Treatment Period.|82||
60081234|NCT01764386|76196687|FG000|NOT COMPLETED|Controlled Treatment Period (CTP)||82||
60081235|NCT01764386|76196688|FG001|NOT COMPLETED|Controlled Treatment Period (CTP)||7||
60081236|NCT01764386|76196687|FG000|STARTED|Uncontrolled Treatment Period (UTP)||71||
60081237|NCT01764386|76196688|FG001|STARTED|Uncontrolled Treatment Period (UTP)|One subject completed the 26-week CTP, but did not continue in the UTP.|81||
60081238|NCT01764386|76196687|FG000|Completed 52 Weeks|Uncontrolled Treatment Period (UTP)||61||
59550268|NCT02597127|75649810|FG004|Treated|Overall Study||61||
59550269|NCT02597127|75649811|FG005|Treated|Overall Study||62||
59550270|NCT02597127|75649812|FG006|Treated|Overall Study||61||
59550271|NCT02597127|75649813|FG007|Treated|Overall Study||62||
59550272|NCT02597127|75649806|FG000|COMPLETED|Overall Study||59|LDL-C returned to >80% of baseline from Day 210-360 or completed Day 360 with LDL-C<=80% of baseline|
59550273|NCT02597127|75649807|FG001|COMPLETED|Overall Study||59|LDL-C returned to >80% of baseline from Day 210-360 or completed Day 360 with LDL-C<=80% of baseline|
59706602|NCT01261793|75825728|FG001|NOT COMPLETED|Overall Study||91||
59706603|NCT01261793|75825729|FG002|NOT COMPLETED|Overall Study||82||
59706604|NCT01261325|75825740|FG000|STARTED|Overall Study||263||
59706605|NCT01261325|75825741|FG001|STARTED|Overall Study||254||
59706606|NCT01261325|75825742|FG002|STARTED|Overall Study||251||
59706607|NCT01261325|75825740|FG000|COMPLETED|Overall Study||246||
59706608|NCT01261325|75825741|FG001|COMPLETED|Overall Study||225||
59706609|NCT01261325|75825742|FG002|COMPLETED|Overall Study||225||
59706610|NCT01261325|75825740|FG000|NOT COMPLETED|Overall Study||17||
59706611|NCT01261325|75825741|FG001|NOT COMPLETED|Overall Study||29||
59706612|NCT01261325|75825742|FG002|NOT COMPLETED|Overall Study||26||
59706613|NCT01260701|75825753|FG000|STARTED|Overall Study||75||
59706614|NCT01260701|75825753|FG000|Eligible|Overall Study||71||
60081239|NCT01764386|76196688|FG001|Completed 52 Weeks|Uncontrolled Treatment Period (UTP)||35||
60081240|NCT01764386|76196687|FG000|COMPLETED|Uncontrolled Treatment Period (UTP)|Completed the 78-week study.|55||
60081241|NCT01764386|76196688|FG001|COMPLETED|Uncontrolled Treatment Period (UTP)|Completed the 78-week study.|28||
60081242|NCT01764386|76196687|FG000|NOT COMPLETED|Uncontrolled Treatment Period (UTP)||16||
59565872|NCT04392219|75668296|FG006|COMPLETED|Overall Study||6||
60081243|NCT01764386|76196688|FG001|NOT COMPLETED|Uncontrolled Treatment Period (UTP)||53||
59991153|NCT02232802|76106698|FG000|STARTED|Period 1||24||
59991154|NCT02232802|76106699|FG001|STARTED|Period 1||23||
59991155|NCT02232802|76106698|FG000|COMPLETED|Period 1||22||
59991156|NCT02232802|76106699|FG001|COMPLETED|Period 1||22||
59991157|NCT02232802|76106698|FG000|NOT COMPLETED|Period 1||2||
59991158|NCT02232802|76106699|FG001|NOT COMPLETED|Period 1||1||
60081244|NCT01763918|76196699|FG000|STARTED|Overall Study||55||
60081245|NCT01763918|76196700|FG001|STARTED|Overall Study||55||
60081246|NCT01763918|76196701|FG002|STARTED|Overall Study||111||
60081247|NCT01763918|76196702|FG003|STARTED|Overall Study||110||
60081248|NCT01763918|76196699|FG000|Received Treatment|Overall Study||54||
60081249|NCT01763918|76196700|FG001|Received Treatment|Overall Study||55||
60081250|NCT01763918|76196701|FG002|Received Treatment|Overall Study||110||
60081251|NCT01763918|76196702|FG003|Received Treatment|Overall Study||110||
60081252|NCT01763918|76196699|FG000|COMPLETED|Overall Study||49||
60081253|NCT01763918|76196700|FG001|COMPLETED|Overall Study||54||
60081254|NCT01763918|76196701|FG002|COMPLETED|Overall Study||101||
60081255|NCT01763918|76196702|FG003|COMPLETED|Overall Study||108||
60081256|NCT01763918|76196699|FG000|NOT COMPLETED|Overall Study||6||
60081257|NCT01763918|76196700|FG001|NOT COMPLETED|Overall Study||1||
60081258|NCT01763918|76196701|FG002|NOT COMPLETED|Overall Study||10||
60081259|NCT01763918|76196702|FG003|NOT COMPLETED|Overall Study||2||
60081260|NCT01763684|76196714|FG000|STARTED|Overall Study||133||
60081261|NCT01763684|76196715|FG001|STARTED|Overall Study||133||
60081262|NCT01763684|76196714|FG000|Completed Surgery|Overall Study||126||
60081263|NCT01763684|76196715|FG001|Completed Surgery|Overall Study||127||
60081264|NCT01763684|76196714|FG000|COMPLETED|Overall Study||0||
60081265|NCT01763684|76196715|FG001|COMPLETED|Overall Study||0||
60081266|NCT01763684|76196714|FG000|NOT COMPLETED|Overall Study||133||
60081267|NCT01763684|76196715|FG001|NOT COMPLETED|Overall Study||133||
60081268|NCT01606748|76196723|FG000|STARTED|Overall Study||18||
60081269|NCT01606748|76196724|FG001|STARTED|Overall Study||17||
60081270|NCT01606748|76196723|FG000|Received at Least 1 Dose of Study Drug|Overall Study||18||
60081271|NCT01606748|76196724|FG001|Received at Least 1 Dose of Study Drug|Overall Study||17||
60081272|NCT01606748|76196723|FG000|COMPLETED|Overall Study||15||
60081273|NCT01606748|76196724|FG001|COMPLETED|Overall Study||17||
60081274|NCT01606748|76196723|FG000|NOT COMPLETED|Overall Study||3||
60081275|NCT01606748|76196724|FG001|NOT COMPLETED|Overall Study||0||
60081276|NCT01597622|76196742|FG000|STARTED|Overall Study||142||
60081277|NCT01597622|76196742|FG000|COMPLETED|Overall Study||104||
60081278|NCT01597622|76196742|FG000|NOT COMPLETED|Overall Study||38||
60081279|NCT01761266|76196748|FG000|STARTED|Overall Study||478||
60081280|NCT01761266|76196749|FG001|STARTED|Overall Study||476||
60081281|NCT01761266|76196748|FG000|Treated|Overall Study||476||
60081282|NCT01761266|76196749|FG001|Treated|Overall Study||475||
60081283|NCT01761266|76196748|FG000|COMPLETED|Overall Study||0||
60081284|NCT01761266|76196749|FG001|COMPLETED|Overall Study||0||
60081285|NCT01761266|76196748|FG000|NOT COMPLETED|Overall Study||478||
60081286|NCT01761266|76196749|FG001|NOT COMPLETED|Overall Study||476||
60081287|NCT01760954|76196762|FG000|STARTED|Treatment Period (6 Months)||149||
60081288|NCT01760954|76196763|FG001|STARTED|Treatment Period (6 Months)||138||
60081289|NCT01760954|76196764|FG002|STARTED|Treatment Period (6 Months)||108||
60081290|NCT01760954|76196765|FG003|STARTED|Treatment Period (6 Months)||109||
60081291|NCT01760954|76196762|FG000|COMPLETED|Treatment Period (6 Months)||116||
60081292|NCT01760954|76196763|FG001|COMPLETED|Treatment Period (6 Months)||110||
59991159|NCT02232802|76106698|FG000|STARTED|Washout||22||
59991160|NCT02232802|76106699|FG001|STARTED|Washout||22||
59991161|NCT02232802|76106698|FG000|COMPLETED|Washout||22||
59991162|NCT02232802|76106699|FG001|COMPLETED|Washout||22||
59991163|NCT02232802|76106698|FG000|NOT COMPLETED|Washout||0||
59991164|NCT02232802|76106699|FG001|NOT COMPLETED|Washout||0||
59991165|NCT02232802|76106698|FG000|STARTED|Period 2||22||
59991166|NCT02232802|76106699|FG001|STARTED|Period 2||22||
60081293|NCT01760954|76196764|FG002|COMPLETED|Treatment Period (6 Months)||87||
60081294|NCT01760954|76196765|FG003|COMPLETED|Treatment Period (6 Months)||83||
60081295|NCT01760954|76196762|FG000|NOT COMPLETED|Treatment Period (6 Months)||33||
60081296|NCT01760954|76196763|FG001|NOT COMPLETED|Treatment Period (6 Months)||28||
60081297|NCT01760954|76196764|FG002|NOT COMPLETED|Treatment Period (6 Months)||21||
60081298|NCT01760954|76196765|FG003|NOT COMPLETED|Treatment Period (6 Months)||26||
59565873|NCT04392219|75668297|FG007|COMPLETED|Overall Study||6||
60081299|NCT01760954|76196762|FG000|STARTED|Post-treatment Follow-up (12 Months)||126|Participants who completed the 6-month Treatment Period or prematurely discontinued could enter PTFU|
59991167|NCT02232802|76106698|FG000|COMPLETED|Period 2||22||
59991168|NCT02232802|76106699|FG001|COMPLETED|Period 2||22||
59991169|NCT02232802|76106698|FG000|NOT COMPLETED|Period 2||0||
59991170|NCT02232802|76106699|FG001|NOT COMPLETED|Period 2||0||
59991171|NCT02232802|76106698|FG000|STARTED|Washout||22||
59991172|NCT02232802|76106699|FG001|STARTED|Washout||22||
59991173|NCT02232802|76106698|FG000|COMPLETED|Washout||22||
59706615|NCT01260701|75825753|FG000|Eligible and Began Protocol Therapy|Overall Study||70||
59706616|NCT01260701|75825753|FG000|COMPLETED|Overall Study||0||
59706617|NCT01260701|75825753|FG000|NOT COMPLETED|Overall Study||75||
59706618|NCT01260467|75825757|FG000|STARTED|Overall Study||4||
59706619|NCT01260467|75825757|FG000|COMPLETED|Overall Study||2||
59706620|NCT01260467|75825757|FG000|NOT COMPLETED|Overall Study||2||
59706621|NCT01260311|75825763|FG000|STARTED|Overall Study||508||
59706622|NCT01260311|75825763|FG000|COMPLETED|Overall Study||381||
59706623|NCT01260311|75825763|FG000|NOT COMPLETED|Overall Study||127||
59706624|NCT01259375|75825767|FG000|STARTED|Overall Study||24||
59706625|NCT01259375|75825767|FG000|COMPLETED|Overall Study||23||
60081300|NCT01760954|76196763|FG001|STARTED|Post-treatment Follow-up (12 Months)||118|Participants who completed the 6-month Treatment Period or prematurely discontinued could enter PTFU|
60081301|NCT01760954|76196764|FG002|STARTED|Post-treatment Follow-up (12 Months)||86|Participants who completed the 6-month Treatment Period or prematurely discontinued could enter PTFU|
60081302|NCT01760954|76196765|FG003|STARTED|Post-treatment Follow-up (12 Months)||87|Participants who completed the 6-month Treatment Period or prematurely discontinued could enter PTFU|
60081303|NCT01760954|76196762|FG000|COMPLETED|Post-treatment Follow-up (12 Months)||96||
60081304|NCT01760954|76196763|FG001|COMPLETED|Post-treatment Follow-up (12 Months)||83||
60081305|NCT01760954|76196764|FG002|COMPLETED|Post-treatment Follow-up (12 Months)||65||
60081306|NCT01760954|76196765|FG003|COMPLETED|Post-treatment Follow-up (12 Months)||67||
60081307|NCT01760954|76196762|FG000|NOT COMPLETED|Post-treatment Follow-up (12 Months)||30||
60081308|NCT01760954|76196763|FG001|NOT COMPLETED|Post-treatment Follow-up (12 Months)||35||
60081309|NCT01760954|76196764|FG002|NOT COMPLETED|Post-treatment Follow-up (12 Months)||21||
60081310|NCT01760954|76196765|FG003|NOT COMPLETED|Post-treatment Follow-up (12 Months)||20||
60081311|NCT01760876|76196775|FG000|STARTED|Overall Study||106||
60081312|NCT01760876|76196775|FG000|COMPLETED|Overall Study|12 months clinical FU of last patient in July 2015.|100||
60081313|NCT01760876|76196775|FG000|NOT COMPLETED|Overall Study||6||
60081314|NCT01759862|76196781|FG000|STARTED|Overall Study||23||
60081315|NCT01759862|76196782|FG001|STARTED|Overall Study||27||
60081316|NCT01759862|76196781|FG000|COMPLETED|Overall Study||20||
60081317|NCT01759862|76196782|FG001|COMPLETED|Overall Study||25||
60081318|NCT01759862|76196781|FG000|NOT COMPLETED|Overall Study||3||
60081319|NCT01759862|76196782|FG001|NOT COMPLETED|Overall Study||2||
60081320|NCT01606670|76196788|FG000|STARTED|Overall Study||93||
60081321|NCT01606670|76196788|FG000|Safety Set|Overall Study||93||
60081322|NCT01606670|76196788|FG000|Full Analysis Set|Overall Study||70||
60081323|NCT01606670|76196788|FG000|COMPLETED|Overall Study||77||
60081324|NCT01606670|76196788|FG000|NOT COMPLETED|Overall Study||16||
60081325|NCT01793792|76196792|FG000|STARTED|Overall Study|153 treated: 1 attempted no device implanted, 152 device implanted.|153||
60081326|NCT01793792|76196792|FG000|Treated|Overall Study|153 Treated, 152 implanted with device, 1 attempted no device implanted|153||
60081327|NCT01793792|76196792|FG000|COMPLETED|Overall Study||141||
60081328|NCT01793792|76196792|FG000|NOT COMPLETED|Overall Study||12||
60081329|NCT01790984|76196798|FG000|STARTED|First Dietary Intervention (12 Weeks)||6||
60081330|NCT01790984|76196799|FG001|STARTED|First Dietary Intervention (12 Weeks)||8||
60081331|NCT01790984|76196800|FG002|STARTED|First Dietary Intervention (12 Weeks)||6||
60081332|NCT01790984|76196801|FG003|STARTED|First Dietary Intervention (12 Weeks)||7||
60081333|NCT01790984|76196798|FG000|COMPLETED|First Dietary Intervention (12 Weeks)||5||
59706626|NCT01259375|75825767|FG000|NOT COMPLETED|Overall Study||1||
59706627|NCT02914301|75825775|FG000|STARTED|Overall Study||60||
59706628|NCT02914301|75825776|FG001|STARTED|Overall Study||58||
59706629|NCT02914301|75825775|FG000|COMPLETED|Overall Study||47||
59706630|NCT02914301|75825776|FG001|COMPLETED|Overall Study||41||
59706631|NCT02914301|75825775|FG000|NOT COMPLETED|Overall Study||13||
59706632|NCT02914301|75825776|FG001|NOT COMPLETED|Overall Study||17||
59706633|NCT01259297|75825790|FG000|STARTED|Run-in Open Label Period (4-5 Weeks)||1335||
59706634|NCT01259297|75825791|FG001|STARTED|Run-in Open Label Period (4-5 Weeks)||0||
59706635|NCT01259297|75825792|FG002|STARTED|Run-in Open Label Period (4-5 Weeks)||1001||
59706636|NCT01259297|75825793|FG003|STARTED|Run-in Open Label Period (4-5 Weeks)||0||
59706637|NCT01259297|75825794|FG004|STARTED|Run-in Open Label Period (4-5 Weeks)||0||
59991174|NCT02232802|76106699|FG001|COMPLETED|Washout||22||
59991175|NCT02232802|76106698|FG000|NOT COMPLETED|Washout||0||
59991176|NCT02232802|76106699|FG001|NOT COMPLETED|Washout||0||
59991177|NCT02434328|76106707|FG000|STARTED|Overall Study||372|All randomized subjects|
59991178|NCT02434328|76106708|FG001|STARTED|Overall Study||371|All randomized subjects|
59991179|NCT02434328|76106707|FG000|Randomized and Treated|Overall Study||370||
59991180|NCT02434328|76106708|FG001|Randomized and Treated|Overall Study||369||
59991181|NCT02434328|76106707|FG000|COMPLETED|Overall Study||342||
59991182|NCT02434328|76106708|FG001|COMPLETED|Overall Study||329||
60081334|NCT01790984|76196799|FG001|COMPLETED|First Dietary Intervention (12 Weeks)||7||
60081335|NCT01790984|76196800|FG002|COMPLETED|First Dietary Intervention (12 Weeks)||6||
60081336|NCT01790984|76196801|FG003|COMPLETED|First Dietary Intervention (12 Weeks)||7||
60081337|NCT01790984|76196798|FG000|NOT COMPLETED|First Dietary Intervention (12 Weeks)||1||
60081338|NCT01790984|76196799|FG001|NOT COMPLETED|First Dietary Intervention (12 Weeks)||1||
60081339|NCT01790984|76196800|FG002|NOT COMPLETED|First Dietary Intervention (12 Weeks)||0||
60081340|NCT01790984|76196801|FG003|NOT COMPLETED|First Dietary Intervention (12 Weeks)||0||
59816356|NCT00430755|75938774|FG000|STARTED|Overall Study||98||
59816357|NCT00430755|75938774|FG000|COMPLETED|Overall Study||45||
59816358|NCT00430755|75938774|FG000|NOT COMPLETED|Overall Study||53||
59816359|NCT00518882|75938780|FG000|STARTED|Double-Blind, Week 0-26|2 subjects exposed to study drug before randomisation. Subjects only included in safety analysis set|235||
59816360|NCT00518882|75938781|FG001|STARTED|Double-Blind, Week 0-26|1 subject exposed to study drug before randomisation. Subject only included in safety analysis set|232||
59816361|NCT00518882|75938780|FG000|Randomised|Double-Blind, Week 0-26||233||
59991183|NCT02434328|76106707|FG000|NOT COMPLETED|Overall Study||30||
59991184|NCT02434328|76106708|FG001|NOT COMPLETED|Overall Study||42||
59991185|NCT02660229|76106717|FG000|STARTED|Overall Study|Randomization|34||
59991186|NCT02660229|76106718|FG001|STARTED|Overall Study|Randomization|32||
59991187|NCT02660229|76106717|FG000|Safety Analysis Set|Overall Study||34||
59991188|NCT02660229|76106718|FG001|Safety Analysis Set|Overall Study||32||
59991189|NCT02660229|76106717|FG000|FAS Set|Overall Study|Oxycodone group: 1 patient was missed any efficacy assessment.|33||
59991190|NCT02660229|76106718|FG001|FAS Set|Overall Study||32||
59991191|NCT02660229|76106717|FG000|Per Protocol Set|Overall Study|Adverse events N=1, Prohibited medication N=4|28||
59991192|NCT02660229|76106718|FG001|Per Protocol Set|Overall Study|Withdrawal of ICF N=1, IC/EC deviation N=1, Prohibited medication N=1|29||
59991193|NCT02660229|76106717|FG000|COMPLETED|Overall Study||32||
59991194|NCT02660229|76106718|FG001|COMPLETED|Overall Study||31||
59991195|NCT02660229|76106717|FG000|NOT COMPLETED|Overall Study||2||
59991196|NCT02660229|76106718|FG001|NOT COMPLETED|Overall Study||1||
59991197|NCT02232178|76106727|FG000|STARTED|Overall Study||26||
59991198|NCT02232178|76106728|FG001|STARTED|Overall Study||25||
59991199|NCT02232178|76106729|FG002|STARTED|Overall Study||13||
59991200|NCT02232178|76106727|FG000|Per Protocol PK Population|Overall Study||26||
59991201|NCT02232178|76106728|FG001|Per Protocol PK Population|Overall Study||24||
59550274|NCT02597127|75649808|FG002|COMPLETED|Overall Study||58|LDL-C returned to >80% of baseline from Day 210-360 or completed Day 360 with LDL-C<=80% of baseline|
59991202|NCT02232178|76106729|FG002|Per Protocol PK Population|Overall Study||11||
59991203|NCT02232178|76106727|FG000|Safety Population|Overall Study||26||
59991204|NCT02232178|76106728|FG001|Safety Population|Overall Study||24||
59991205|NCT02232178|76106729|FG002|Safety Population|Overall Study||12||
59991206|NCT02232178|76106727|FG000|COMPLETED|Overall Study||25||
59991207|NCT02232178|76106728|FG001|COMPLETED|Overall Study||24||
59991208|NCT02232178|76106729|FG002|COMPLETED|Overall Study||12||
59991209|NCT02232178|76106727|FG000|NOT COMPLETED|Overall Study||1||
59991210|NCT02232178|76106728|FG001|NOT COMPLETED|Overall Study||1||
59991211|NCT02232178|76106729|FG002|NOT COMPLETED|Overall Study||1||
59991212|NCT01678131|76106740|FG000|STARTED|Overall Study||10||
59565874|NCT04392219|75668298|FG008|COMPLETED|Overall Study||6||
59816362|NCT00518882|75938781|FG001|Randomised|Double-Blind, Week 0-26||231||
59816363|NCT00518882|75938780|FG000|COMPLETED|Double-Blind, Week 0-26||202||
59991213|NCT01678131|76106741|FG001|STARTED|Overall Study||10||
59991214|NCT01678131|76106742|FG002|STARTED|Overall Study||11||
60081341|NCT01790984|76196798|FG000|STARTED|Wash-out (4 Weeks)||5||
60081342|NCT01790984|76196799|FG001|STARTED|Wash-out (4 Weeks)||7||
60081343|NCT01790984|76196800|FG002|STARTED|Wash-out (4 Weeks)||6||
59550275|NCT02597127|75649809|FG003|COMPLETED|Overall Study||60|LDL-C returned to >80% of baseline from Day 210-360 or completed Day 360 with LDL-C<=80% of baseline|
59550276|NCT02597127|75649810|FG004|COMPLETED|Overall Study||57|LDL-C returned to >80% of baseline from Day 210-360 or completed Day 360 with LDL-C<=80% of baseline|
59550277|NCT02597127|75649811|FG005|COMPLETED|Overall Study||59|LDL-C returned to >80% of baseline from Day 210-360 or completed Day 360 with LDL-C<=80% of baseline|
59550278|NCT02597127|75649812|FG006|COMPLETED|Overall Study||57|LDL-C returned to >80% of baseline from Day 210-360 or completed Day 360 with LDL-C<=80% of baseline|
59550279|NCT02597127|75649813|FG007|COMPLETED|Overall Study||60|LDL-C returned to >80% of baseline from Day 210-360 or completed Day 360 with LDL-C<=80% of baseline|
59550280|NCT02597127|75649806|FG000|NOT COMPLETED|Overall Study||1||
59550281|NCT02597127|75649807|FG001|NOT COMPLETED|Overall Study||3||
59550282|NCT02597127|75649808|FG002|NOT COMPLETED|Overall Study||8||
59550283|NCT02597127|75649809|FG003|NOT COMPLETED|Overall Study||5||
59550284|NCT02597127|75649810|FG004|NOT COMPLETED|Overall Study||5||
59550285|NCT02597127|75649811|FG005|NOT COMPLETED|Overall Study||4||
59550286|NCT02597127|75649812|FG006|NOT COMPLETED|Overall Study||4||
59550287|NCT02597127|75649813|FG007|NOT COMPLETED|Overall Study||2||
59550288|NCT02597673|75649856|FG000|STARTED|Overall Study||34||
59550289|NCT02597673|75649857|FG001|STARTED|Overall Study||33||
59550290|NCT02597673|75649858|FG002|STARTED|Overall Study||33||
59550291|NCT02597673|75649859|FG003|STARTED|Overall Study||30||
59550292|NCT02597673|75649856|FG000|COMPLETED|Overall Study||31||
59550293|NCT02597673|75649857|FG001|COMPLETED|Overall Study||27||
59550294|NCT02597673|75649858|FG002|COMPLETED|Overall Study||28||
59550295|NCT02597673|75649859|FG003|COMPLETED|Overall Study||25||
60081344|NCT01790984|76196801|FG003|STARTED|Wash-out (4 Weeks)||7||
60081345|NCT01790984|76196798|FG000|COMPLETED|Wash-out (4 Weeks)||5||
60081346|NCT01790984|76196799|FG001|COMPLETED|Wash-out (4 Weeks)||7||
60081347|NCT01790984|76196800|FG002|COMPLETED|Wash-out (4 Weeks)||6||
59550296|NCT02597673|75649856|FG000|NOT COMPLETED|Overall Study||3||
59550297|NCT02597673|75649857|FG001|NOT COMPLETED|Overall Study||6||
59550298|NCT02597673|75649858|FG002|NOT COMPLETED|Overall Study||5||
60081348|NCT01790984|76196801|FG003|COMPLETED|Wash-out (4 Weeks)||7||
60081349|NCT01790984|76196798|FG000|NOT COMPLETED|Wash-out (4 Weeks)||0||
60081350|NCT01790984|76196799|FG001|NOT COMPLETED|Wash-out (4 Weeks)||0||
60081351|NCT01790984|76196800|FG002|NOT COMPLETED|Wash-out (4 Weeks)||0||
60081352|NCT01790984|76196801|FG003|NOT COMPLETED|Wash-out (4 Weeks)||0||
60081353|NCT01790984|76196798|FG000|STARTED|Second Dietary Intervention (12 Weeks)||5||
60081354|NCT01790984|76196799|FG001|STARTED|Second Dietary Intervention (12 Weeks)||7||
60081355|NCT01790984|76196800|FG002|STARTED|Second Dietary Intervention (12 Weeks)||6||
60081356|NCT01790984|76196801|FG003|STARTED|Second Dietary Intervention (12 Weeks)||7||
60081357|NCT01790984|76196798|FG000|COMPLETED|Second Dietary Intervention (12 Weeks)||5||
60081358|NCT01790984|76196799|FG001|COMPLETED|Second Dietary Intervention (12 Weeks)||7||
60081359|NCT01790984|76196800|FG002|COMPLETED|Second Dietary Intervention (12 Weeks)||6||
60081360|NCT01790984|76196801|FG003|COMPLETED|Second Dietary Intervention (12 Weeks)||7||
60081361|NCT01790984|76196798|FG000|NOT COMPLETED|Second Dietary Intervention (12 Weeks)||0||
60081362|NCT01790984|76196799|FG001|NOT COMPLETED|Second Dietary Intervention (12 Weeks)||0||
60081363|NCT01790984|76196800|FG002|NOT COMPLETED|Second Dietary Intervention (12 Weeks)||0||
59550299|NCT02597673|75649859|FG003|NOT COMPLETED|Overall Study||5||
59550300|NCT02597907|75649872|FG000|STARTED|Overall Study||44||
59550301|NCT02597907|75649873|FG001|STARTED|Overall Study||44||
59550302|NCT02597907|75649872|FG000|COMPLETED|Overall Study||44||
59550303|NCT02597907|75649873|FG001|COMPLETED|Overall Study||44||
59550304|NCT02597907|75649872|FG000|NOT COMPLETED|Overall Study||0||
59550305|NCT02597907|75649873|FG001|NOT COMPLETED|Overall Study||0||
59550306|NCT02600325|75649879|FG000|STARTED|Overall Study||80||
59550307|NCT02600325|75649879|FG000|COMPLETED|Overall Study||80||
59550308|NCT02600325|75649879|FG000|NOT COMPLETED|Overall Study||0||
59550309|NCT02600403|75649886|FG000|STARTED|Overall Study||44||
59550310|NCT02600403|75649887|FG001|STARTED|Overall Study||6||
59550311|NCT02600403|75649888|FG002|STARTED|Overall Study||11||
59550312|NCT02600403|75649886|FG000|COMPLETED|Overall Study||44||
59550313|NCT02600403|75649887|FG001|COMPLETED|Overall Study||6||
59550314|NCT02600403|75649888|FG002|COMPLETED|Overall Study||11||
59550315|NCT02600403|75649886|FG000|NOT COMPLETED|Overall Study||0||
59550316|NCT02600403|75649887|FG001|NOT COMPLETED|Overall Study||0||
59550317|NCT02600403|75649888|FG002|NOT COMPLETED|Overall Study||0||
59550318|NCT02600637|75649901|FG000|STARTED|Overall Study||19||
59550319|NCT02600637|75649902|FG001|STARTED|Overall Study||18||
59550320|NCT02600637|75649901|FG000|COMPLETED|Overall Study||14||
59550321|NCT02600637|75649902|FG001|COMPLETED|Overall Study||13||
59550322|NCT02600637|75649901|FG000|NOT COMPLETED|Overall Study||5||
59550323|NCT02600637|75649902|FG001|NOT COMPLETED|Overall Study||5||
59550324|NCT02600715|75649910|FG000|STARTED|Overall Study||13||
59550325|NCT02600715|75649911|FG001|STARTED|Overall Study||13||
59550326|NCT02600715|75649910|FG000|Allocated to Randomization|Overall Study||13||
59550327|NCT02600715|75649911|FG001|Allocated to Randomization|Overall Study||13||
59550328|NCT02600715|75649910|FG000|Received Treatment and Suppository|Overall Study||13||
59550329|NCT02600715|75649911|FG001|Received Treatment and Suppository|Overall Study||13||
59550330|NCT02600715|75649910|FG000|Completed 2-week Follow-up Appointment|Overall Study||13||
59550331|NCT02600715|75649911|FG001|Completed 2-week Follow-up Appointment|Overall Study||12||
59550332|NCT02600715|75649910|FG000|COMPLETED|Overall Study||13|Included in final analysis|
59550333|NCT02600715|75649911|FG001|COMPLETED|Overall Study||13|Included in final analysis|
59550334|NCT02600715|75649910|FG000|NOT COMPLETED|Overall Study||0||
59550335|NCT02600715|75649911|FG001|NOT COMPLETED|Overall Study||0||
59706638|NCT01259297|75825795|FG005|STARTED|Run-in Open Label Period (4-5 Weeks)||0||
59706639|NCT01259297|75825796|FG006|STARTED|Run-in Open Label Period (4-5 Weeks)||0||
59706640|NCT01259297|75825797|FG007|STARTED|Run-in Open Label Period (4-5 Weeks)||0||
59706641|NCT01259297|75825790|FG000|COMPLETED|Run-in Open Label Period (4-5 Weeks)||980||
59706642|NCT01259297|75825791|FG001|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0||
59706643|NCT01259297|75825792|FG002|COMPLETED|Run-in Open Label Period (4-5 Weeks)||779||
59706644|NCT01259297|75825793|FG003|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0||
59706645|NCT01259297|75825794|FG004|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0||
59550336|NCT02601105|75649920|FG000|STARTED|Placebo Cream; Centella Asiatica Bsln.||15||
59550337|NCT02601105|75649920|FG000|COMPLETED|Placebo Cream; Centella Asiatica Bsln.||15||
59550338|NCT02601105|75649920|FG000|NOT COMPLETED|Placebo Cream; Centella Asiatica Bsln.||0||
59550339|NCT02601105|75649920|FG000|STARTED|Placebo Cream; Centella Asiatica Week 6||15||
59550340|NCT02601105|75649920|FG000|COMPLETED|Placebo Cream; Centella Asiatica Week 6||15||
59550341|NCT02601105|75649920|FG000|NOT COMPLETED|Placebo Cream; Centella Asiatica Week 6||0||
59550342|NCT02601105|75649920|FG000|STARTED|Placebo Cream; Centella Asiatica Week 12||15||
59550343|NCT02601105|75649920|FG000|COMPLETED|Placebo Cream; Centella Asiatica Week 12||13||
59550344|NCT02601105|75649920|FG000|NOT COMPLETED|Placebo Cream; Centella Asiatica Week 12||2||
59550345|NCT02603211|75649926|FG000|STARTED|Overall Study||20||
59550346|NCT02603211|75649926|FG000|COMPLETED|Overall Study||20||
59550347|NCT02603211|75649926|FG000|NOT COMPLETED|Overall Study||0||
59550348|NCT02605395|75649931|FG000|STARTED|Period 1, Day 1||35||
59706646|NCT01259297|75825795|FG005|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0||
59550349|NCT02605395|75649932|FG001|STARTED|Period 1, Day 1||35||
59550350|NCT02605395|75649931|FG000|COMPLETED|Period 1, Day 1||35||
59550351|NCT02605395|75649932|FG001|COMPLETED|Period 1, Day 1||35||
59550352|NCT02605395|75649931|FG000|NOT COMPLETED|Period 1, Day 1||0||
59706647|NCT01259297|75825796|FG006|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0||
59550353|NCT02605395|75649932|FG001|NOT COMPLETED|Period 1, Day 1||0||
59706648|NCT01259297|75825797|FG007|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0||
59706649|NCT01259297|75825790|FG000|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||355||
59706650|NCT01259297|75825791|FG001|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0||
59706651|NCT01259297|75825792|FG002|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||222||
59706652|NCT01259297|75825793|FG003|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0||
59706653|NCT01259297|75825794|FG004|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0||
59816364|NCT00518882|75938781|FG001|COMPLETED|Double-Blind, Week 0-26||187||
59816365|NCT00518882|75938780|FG000|NOT COMPLETED|Double-Blind, Week 0-26||33||
59706654|NCT01259297|75825795|FG005|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0||
59991215|NCT01678131|76106740|FG000|COMPLETED|Overall Study||10||
59550354|NCT02605395|75649931|FG000|STARTED|Washout Period, Day 2 to Day 7||35||
59550355|NCT02605395|75649932|FG001|STARTED|Washout Period, Day 2 to Day 7||35||
59550356|NCT02605395|75649931|FG000|COMPLETED|Washout Period, Day 2 to Day 7||35||
59550357|NCT02605395|75649932|FG001|COMPLETED|Washout Period, Day 2 to Day 7||35||
59550358|NCT02605395|75649931|FG000|NOT COMPLETED|Washout Period, Day 2 to Day 7||0||
59550359|NCT02605395|75649932|FG001|NOT COMPLETED|Washout Period, Day 2 to Day 7||0||
59550360|NCT02605395|75649931|FG000|STARTED|Period 2, Day 8||35||
59550361|NCT02605395|75649932|FG001|STARTED|Period 2, Day 8||35||
59550362|NCT02605395|75649931|FG000|COMPLETED|Period 2, Day 8||35||
59550363|NCT02605395|75649932|FG001|COMPLETED|Period 2, Day 8||35||
59550364|NCT02605395|75649931|FG000|NOT COMPLETED|Period 2, Day 8||0||
59550365|NCT02605395|75649932|FG001|NOT COMPLETED|Period 2, Day 8||0||
59550366|NCT01739231|75649944|FG000|STARTED|Part A||24||
59550367|NCT01739231|75649945|FG001|STARTED|Part A||24||
59550368|NCT01739231|75649946|FG002|STARTED|Part A||12||
59550369|NCT01739231|75649947|FG003|STARTED|Part A||0||
59550370|NCT01739231|75649944|FG000|Received All 3 Vaccinations|Part A||21||
59550371|NCT01739231|75649945|FG001|Received All 3 Vaccinations|Part A||20||
59550372|NCT01739231|75649946|FG002|Received All 3 Vaccinations|Part A||12||
59550373|NCT01739231|75649947|FG003|Received All 3 Vaccinations|Part A||0||
59550374|NCT01739231|75649944|FG000|COMPLETED|Part A||20||
59550375|NCT01739231|75649945|FG001|COMPLETED|Part A||17||
59706655|NCT01259297|75825796|FG006|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0||
59706656|NCT01259297|75825797|FG007|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0||
59550376|NCT01739231|75649946|FG002|COMPLETED|Part A||12||
59550377|NCT01739231|75649947|FG003|COMPLETED|Part A||0||
59550378|NCT01739231|75649944|FG000|NOT COMPLETED|Part A||4||
59550379|NCT01739231|75649945|FG001|NOT COMPLETED|Part A||7||
59550380|NCT01739231|75649946|FG002|NOT COMPLETED|Part A||0||
59550381|NCT01739231|75649947|FG003|NOT COMPLETED|Part A||0||
59550382|NCT01739231|75649944|FG000|STARTED|Part B||20||
59550383|NCT01739231|75649945|FG001|STARTED|Part B||17||
59550384|NCT01739231|75649946|FG002|STARTED|Part B||12||
59550385|NCT01739231|75649947|FG003|STARTED|Part B||21||
59550386|NCT01739231|75649944|FG000|Challenged|Part B||13||
59706657|NCT01259297|75825790|FG000|STARTED|Double Blind Randomized Period||244||
59706658|NCT01259297|75825791|FG001|STARTED|Double Blind Randomized Period||232||
59706659|NCT01259297|75825792|FG002|STARTED|Double Blind Randomized Period||189||
59706660|NCT01259297|75825793|FG003|STARTED|Double Blind Randomized Period||195||
59550387|NCT01739231|75649945|FG001|Challenged|Part B||13||
59550388|NCT01739231|75649946|FG002|Challenged|Part B||10||
59550389|NCT01739231|75649947|FG003|Challenged|Part B||21||
59550390|NCT01739231|75649944|FG000|COMPLETED|Part B||13||
59550391|NCT01739231|75649945|FG001|COMPLETED|Part B||12||
59550392|NCT01739231|75649946|FG002|COMPLETED|Part B||10||
59550393|NCT01739231|75649947|FG003|COMPLETED|Part B||19||
59550394|NCT01739231|75649944|FG000|NOT COMPLETED|Part B||7||
59550395|NCT01739231|75649945|FG001|NOT COMPLETED|Part B||5||
59550396|NCT01739231|75649946|FG002|NOT COMPLETED|Part B||2||
59550397|NCT01739231|75649947|FG003|NOT COMPLETED|Part B||2||
59550398|NCT02605863|75649967|FG000|STARTED|Overall Study||1||
59550399|NCT02605863|75649968|FG001|STARTED|Overall Study||0||
59550400|NCT02605863|75649967|FG000|COMPLETED|Overall Study||1||
59550401|NCT02605863|75649968|FG001|COMPLETED|Overall Study||0||
59550402|NCT02605863|75649967|FG000|NOT COMPLETED|Overall Study||0||
59550403|NCT02605863|75649968|FG001|NOT COMPLETED|Overall Study||0||
59550404|NCT01739699|75649976|FG000|STARTED|Overall Study||70||
59550405|NCT01739699|75649977|FG001|STARTED|Overall Study||70||
59550406|NCT01739699|75649976|FG000|COMPLETED|Overall Study||66||
59550407|NCT01739699|75649977|FG001|COMPLETED|Overall Study||65||
59706661|NCT01259297|75825794|FG004|STARTED|Double Blind Randomized Period||251||
59706662|NCT01259297|75825795|FG005|STARTED|Double Blind Randomized Period||253||
59550408|NCT01739699|75649976|FG000|NOT COMPLETED|Overall Study||4||
59550409|NCT01739699|75649977|FG001|NOT COMPLETED|Overall Study||5||
59550410|NCT01721681|75649983|FG000|STARTED|Overall Study||9||
59550411|NCT01721681|75649983|FG000|COMPLETED|Overall Study||9||
59706663|NCT01259297|75825796|FG006|STARTED|Double Blind Randomized Period||196||
59550412|NCT01721681|75649983|FG000|NOT COMPLETED|Overall Study||0||
59550413|NCT01740713|75649990|FG000|STARTED|Overall Study||6||
59550414|NCT01740713|75649991|FG001|STARTED|Overall Study||8||
59550415|NCT01740713|75649992|FG002|STARTED|Overall Study||7||
59550416|NCT01740713|75649990|FG000|COMPLETED|Overall Study||6||
59550417|NCT01740713|75649991|FG001|COMPLETED|Overall Study||6||
59550418|NCT01740713|75649992|FG002|COMPLETED|Overall Study||6||
59550419|NCT01740713|75649990|FG000|NOT COMPLETED|Overall Study||0||
59550420|NCT01740713|75649991|FG001|NOT COMPLETED|Overall Study||2||
59550421|NCT01740713|75649992|FG002|NOT COMPLETED|Overall Study||1||
59550422|NCT02609841|75650004|FG000|STARTED|Overall Study||240||
59550423|NCT02609841|75650004|FG000|COMPLETED|Overall Study||212||
59550424|NCT02609841|75650004|FG000|NOT COMPLETED|Overall Study||28||
59550425|NCT02613117|75650012|FG000|STARTED|Overall Study||57||
59550426|NCT02613117|75650013|FG001|STARTED|Overall Study||47||
59550427|NCT02613117|75650012|FG000|COMPLETED|Overall Study||57||
59550428|NCT02613117|75650013|FG001|COMPLETED|Overall Study||47||
59550429|NCT02613117|75650012|FG000|NOT COMPLETED|Overall Study||0||
59550430|NCT02613117|75650013|FG001|NOT COMPLETED|Overall Study||0||
59550431|NCT01742117|75650021|FG000|STARTED|Overall Study||2641||
59550432|NCT01742117|75650022|FG001|STARTED|Overall Study||2635||
59550433|NCT01742117|75650021|FG000|COMPLETED|Overall Study||2641||
59550434|NCT01742117|75650022|FG001|COMPLETED|Overall Study||2635||
59550435|NCT01742117|75650021|FG000|NOT COMPLETED|Overall Study||0||
59550436|NCT01742117|75650022|FG001|NOT COMPLETED|Overall Study||0||
59550437|NCT02613897|75650031|FG000|STARTED|Overall Study||22||
59550438|NCT02613897|75650032|FG001|STARTED|Overall Study||22||
59550439|NCT02613897|75650033|FG002|STARTED|Overall Study||12||
59550440|NCT02613897|75650031|FG000|COMPLETED|Overall Study||22||
59550441|NCT02613897|75650032|FG001|COMPLETED|Overall Study||22||
59550442|NCT02613897|75650033|FG002|COMPLETED|Overall Study||12||
59550443|NCT02613897|75650031|FG000|NOT COMPLETED|Overall Study||0||
59550444|NCT02613897|75650032|FG001|NOT COMPLETED|Overall Study||0||
59550445|NCT02613897|75650033|FG002|NOT COMPLETED|Overall Study||0||
59550446|NCT01305356|75650044|FG000|STARTED|Overall Study||132||
59550447|NCT01305356|75650045|FG001|STARTED|Overall Study||167||
59550448|NCT01305356|75650044|FG000|COMPLETED|Overall Study||132||
59550449|NCT01305356|75650045|FG001|COMPLETED|Overall Study||167||
59550450|NCT01305356|75650044|FG000|NOT COMPLETED|Overall Study||0||
59550451|NCT01305356|75650045|FG001|NOT COMPLETED|Overall Study||0||
59550452|NCT02615535|75650053|FG000|STARTED|Overall Study||14||
59706664|NCT01259297|75825797|FG007|STARTED|Double Blind Randomized Period||199||
59706665|NCT01259297|75825790|FG000|COMPLETED|Double Blind Randomized Period||242||
59706666|NCT01259297|75825791|FG001|COMPLETED|Double Blind Randomized Period||229||
59706667|NCT01259297|75825792|FG002|COMPLETED|Double Blind Randomized Period||188||
59706668|NCT01259297|75825793|FG003|COMPLETED|Double Blind Randomized Period||191||
59706669|NCT01259297|75825794|FG004|COMPLETED|Double Blind Randomized Period||247||
59550453|NCT02615535|75650054|FG001|STARTED|Overall Study||11||
60081364|NCT01790984|76196801|FG003|NOT COMPLETED|Second Dietary Intervention (12 Weeks)||0||
60081365|NCT01735994|76196826|FG000|STARTED|Overall Study||263||13
60081366|NCT01735994|76196827|FG001|STARTED|Overall Study||218||15
60081367|NCT01735994|76196826|FG000|Post Intervention (3 Weeks)|Overall Study||239||13
60081368|NCT01735994|76196827|FG001|Post Intervention (3 Weeks)|Overall Study||198||15
60081369|NCT01735994|76196826|FG000|Follow-Up #1 (6 Months)|Overall Study||213||13
60081370|NCT01735994|76196827|FG001|Follow-Up #1 (6 Months)|Overall Study||163||15
60081371|NCT01735994|76196826|FG000|Follow-Up #2 (12 Months)|Overall Study||212||13
60081372|NCT01735994|76196827|FG001|Follow-Up #2 (12 Months)|Overall Study||174||15
60081373|NCT01735994|76196826|FG000|COMPLETED|Overall Study||200||13
60081374|NCT01735994|76196827|FG001|COMPLETED|Overall Study||152||15
60081375|NCT01735994|76196826|FG000|NOT COMPLETED|Overall Study||63||0
60081376|NCT01735994|76196827|FG001|NOT COMPLETED|Overall Study||66||0
60081377|NCT01790828|76196833|FG000|STARTED|Overall Study||42||
60081378|NCT01790828|76196833|FG000|COMPLETED|Overall Study||8||
60081379|NCT01790828|76196833|FG000|NOT COMPLETED|Overall Study||34||
60081380|NCT01790594|76196839|FG000|STARTED|Overall Study||22||
60081381|NCT01790594|76196840|FG001|STARTED|Overall Study||21||
60081382|NCT01790594|76196841|FG002|STARTED|Overall Study||3||
60081383|NCT01790594|76196839|FG000|COMPLETED|Overall Study||17||
60081384|NCT01790594|76196840|FG001|COMPLETED|Overall Study||18||
60081385|NCT01790594|76196841|FG002|COMPLETED|Overall Study||0||
60081386|NCT01790594|76196839|FG000|NOT COMPLETED|Overall Study||5||
60081387|NCT01790594|76196840|FG001|NOT COMPLETED|Overall Study||3||
60081388|NCT01790594|76196841|FG002|NOT COMPLETED|Overall Study||3||
60081389|NCT01790516|76196850|FG000|STARTED|Overall Study||1||
60081390|NCT01790516|76196851|FG001|STARTED|Overall Study||1||
60081391|NCT01790516|76196850|FG000|COMPLETED|Overall Study||0||
60081392|NCT01790516|76196851|FG001|COMPLETED|Overall Study||1||
60081393|NCT01790516|76196850|FG000|NOT COMPLETED|Overall Study||1||
60081394|NCT01790516|76196851|FG001|NOT COMPLETED|Overall Study||0||
60081395|NCT01790438|76196859|FG000|STARTED|Overall Study||428||
60081396|NCT01790438|76196860|FG001|STARTED|Overall Study||213||
60081397|NCT01790438|76196859|FG000|Received at Least One Dose of Study Drug|Overall Study||427||
60081398|NCT01790438|76196860|FG001|Received at Least One Dose of Study Drug|Overall Study||212||
60081399|NCT01790438|76196859|FG000|COMPLETED|Overall Study||393||
60081400|NCT01790438|76196860|FG001|COMPLETED|Overall Study||202||
60081401|NCT01790438|76196859|FG000|NOT COMPLETED|Overall Study||35||
60081402|NCT01790438|76196860|FG001|NOT COMPLETED|Overall Study||11||
60081403|NCT01735916|76196871|FG000|STARTED|Overall Study||18||
60081404|NCT01735916|76196872|FG001|STARTED|Overall Study||19||
60081405|NCT01735916|76196873|FG002|STARTED|Overall Study||7||
60081406|NCT01735916|76196871|FG000|COMPLETED|Overall Study||0||
60081407|NCT01735916|76196872|FG001|COMPLETED|Overall Study|Study was cancelled before any subjects completed 24 months of follow-up or met any study endpoints.|0||
60081408|NCT01735916|76196873|FG002|COMPLETED|Overall Study|Study was cancelled before any subjects completed 24 months of follow-up or met any study endpoints.|0||
60081409|NCT01735916|76196871|FG000|NOT COMPLETED|Overall Study||18||
60081410|NCT01735916|76196872|FG001|NOT COMPLETED|Overall Study||19||
60081411|NCT01735916|76196873|FG002|NOT COMPLETED|Overall Study||7||
60081412|NCT01790126|76196883|FG000|STARTED|Overall Study||30||
60081413|NCT01790126|76196884|FG001|STARTED|Overall Study||29||
60081414|NCT01790126|76196885|FG002|STARTED|Overall Study||31||
60081415|NCT01790126|76196883|FG000|Treated|Overall Study||29||
60081416|NCT01790126|76196884|FG001|Treated|Overall Study||29||
60081417|NCT01790126|76196885|FG002|Treated|Overall Study||31||
60081418|NCT01790126|76196883|FG000|COMPLETED|Overall Study||0||
60081419|NCT01790126|76196884|FG001|COMPLETED|Overall Study||0||
60081420|NCT01790126|76196885|FG002|COMPLETED|Overall Study||0||
60081421|NCT01790126|76196883|FG000|NOT COMPLETED|Overall Study||30||
60081422|NCT01790126|76196884|FG001|NOT COMPLETED|Overall Study||29||
60081423|NCT01790126|76196885|FG002|NOT COMPLETED|Overall Study||31||
60081424|NCT01734902|76196896|FG000|STARTED|Overall Study||14||
60081425|NCT01734902|76196897|FG001|STARTED|Overall Study||16||
60081426|NCT01734902|76196896|FG000|COMPLETED|Overall Study||14||
60081427|NCT01734902|76196897|FG001|COMPLETED|Overall Study||14||
60081428|NCT01734902|76196896|FG000|NOT COMPLETED|Overall Study||0||
60081429|NCT01734902|76196897|FG001|NOT COMPLETED|Overall Study||2||
60081430|NCT01790048|76196905|FG000|STARTED|Overall Study||1156||
60081431|NCT01790048|76196906|FG001|STARTED|Overall Study||1103||
60081432|NCT01790048|76196905|FG000|COMPLETED|Overall Study||1144||
60081433|NCT01790048|76196906|FG001|COMPLETED|Overall Study||1086||
60081434|NCT01790048|76196905|FG000|NOT COMPLETED|Overall Study||12||
60081435|NCT01790048|76196906|FG001|NOT COMPLETED|Overall Study||17||
60081436|NCT01789970|76196916|FG000|STARTED|Open-label Titration Period||625||
60081437|NCT01789970|76196917|FG001|STARTED|Open-label Titration Period||0||
60081438|NCT01789970|76196918|FG002|STARTED|Open-label Titration Period||0||
60081439|NCT01789970|76196916|FG000|Safety Analysis Set|Open-label Titration Period|Two enrolled patients were not treated|623||
60081440|NCT01789970|76196917|FG001|Safety Analysis Set|Open-label Titration Period||0||
60081441|NCT01789970|76196918|FG002|Safety Analysis Set|Open-label Titration Period||0||
60081442|NCT01789970|76196916|FG000|COMPLETED|Open-label Titration Period||371||
60081443|NCT01789970|76196917|FG001|COMPLETED|Open-label Titration Period||0||
59550454|NCT02615535|75650053|FG000|COMPLETED|Overall Study||10||
59550455|NCT02615535|75650054|FG001|COMPLETED|Overall Study||10||
59550456|NCT02615535|75650053|FG000|NOT COMPLETED|Overall Study||4||
59550457|NCT02615535|75650054|FG001|NOT COMPLETED|Overall Study||1||
59550458|NCT01340144|75650062|FG000|STARTED|Overall Study||625||
59550459|NCT01340144|75650063|FG001|STARTED|Overall Study||625||
59550460|NCT01340144|75650062|FG000|COMPLETED|Overall Study||553||
59550461|NCT01340144|75650063|FG001|COMPLETED|Overall Study||567||
59550462|NCT01340144|75650062|FG000|NOT COMPLETED|Overall Study||72||
59550463|NCT01340144|75650063|FG001|NOT COMPLETED|Overall Study||58||
59550464|NCT02589171|75650071|FG000|STARTED|Overall Study||35||
59550465|NCT02589171|75650072|FG001|STARTED|Overall Study||35||
59550466|NCT02589171|75650071|FG000|Day 1 Follow up|Overall Study||35||
59550467|NCT02589171|75650072|FG001|Day 1 Follow up|Overall Study||35||
59550468|NCT02589171|75650071|FG000|Week 1 Follow up|Overall Study||35||
59550469|NCT02589171|75650072|FG001|Week 1 Follow up|Overall Study||34||
59550470|NCT02589171|75650071|FG000|Week 6 Follow up|Overall Study||28||
59550471|NCT02589171|75650072|FG001|Week 6 Follow up|Overall Study||30||
59550472|NCT02589171|75650071|FG000|COMPLETED|Overall Study||28||
59550473|NCT02589171|75650072|FG001|COMPLETED|Overall Study||30||
59550474|NCT02589171|75650071|FG000|NOT COMPLETED|Overall Study||7||
59550475|NCT02589171|75650072|FG001|NOT COMPLETED|Overall Study||5||
60081444|NCT01789970|76196918|FG002|COMPLETED|Open-label Titration Period||0||
60081445|NCT01789970|76196916|FG000|NOT COMPLETED|Open-label Titration Period||254||
60081446|NCT01789970|76196917|FG001|NOT COMPLETED|Open-label Titration Period||0||
60081447|NCT01789970|76196918|FG002|NOT COMPLETED|Open-label Titration Period||0||
60081448|NCT01789970|76196916|FG000|STARTED|Double-blind Treatment Period (12 Weeks)||0||
60081449|NCT01789970|76196917|FG001|STARTED|Double-blind Treatment Period (12 Weeks)||180||
60081450|NCT01789970|76196918|FG002|STARTED|Double-blind Treatment Period (12 Weeks)||191||
60081451|NCT01789970|76196916|FG000|Full Analysis Set and Safety Set|Double-blind Treatment Period (12 Weeks)||0||
60081452|NCT01789970|76196917|FG001|Full Analysis Set and Safety Set|Double-blind Treatment Period (12 Weeks)|One participant was randomized but not treated.|179||
60081453|NCT01789970|76196918|FG002|Full Analysis Set and Safety Set|Double-blind Treatment Period (12 Weeks)||191||
60081454|NCT01789970|76196916|FG000|COMPLETED|Double-blind Treatment Period (12 Weeks)||0||
60081455|NCT01789970|76196917|FG001|COMPLETED|Double-blind Treatment Period (12 Weeks)||130||
60081456|NCT01789970|76196918|FG002|COMPLETED|Double-blind Treatment Period (12 Weeks)||147||
60081457|NCT01789970|76196916|FG000|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||0||
60081458|NCT01789970|76196917|FG001|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||50||
60081459|NCT01789970|76196918|FG002|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||44||
60081460|NCT01734434|76196936|FG000|STARTED|Overall Study||500||
60081461|NCT01734434|76196937|FG001|STARTED|Overall Study||500||
60081462|NCT01734434|76196938|FG002|STARTED|Overall Study||1992||
60081463|NCT01734434|76196939|FG003|STARTED|Overall Study||251||
60081464|NCT01734434|76196936|FG000|COMPLETED|Overall Study||490||
60081465|NCT01734434|76196937|FG001|COMPLETED|Overall Study||488||
60081466|NCT01734434|76196938|FG002|COMPLETED|Overall Study||1863||
60081467|NCT01734434|76196939|FG003|COMPLETED|Overall Study||228||
59550476|NCT02591511|75650080|FG000|STARTED|Overall Study||30||
59550477|NCT02591511|75650081|FG001|STARTED|Overall Study||33||
59550478|NCT02591511|75650080|FG000|COMPLETED|Overall Study||30||
59550479|NCT02591511|75650081|FG001|COMPLETED|Overall Study||33||
59550480|NCT02591511|75650080|FG000|NOT COMPLETED|Overall Study||0||
59550481|NCT02591511|75650081|FG001|NOT COMPLETED|Overall Study||0||
59550482|NCT01342172|75650087|FG000|STARTED|Overall Study||9||
59550483|NCT01342172|75650087|FG000|COMPLETED|Overall Study||9||
59550484|NCT01342172|75650087|FG000|NOT COMPLETED|Overall Study||0||
59550485|NCT01243112|75650092|FG000|STARTED|Overall Study||25||
59550486|NCT01243112|75650092|FG000|COMPLETED|Overall Study||25||
59550487|NCT01243112|75650092|FG000|NOT COMPLETED|Overall Study||0||
59550488|NCT01243580|75650098|FG000|STARTED|Overall Study||18||
59550489|NCT01243580|75650099|FG001|STARTED|Overall Study||18||
60081468|NCT01734434|76196936|FG000|NOT COMPLETED|Overall Study||10||
60081469|NCT01734434|76196937|FG001|NOT COMPLETED|Overall Study||12||
60081470|NCT01734434|76196938|FG002|NOT COMPLETED|Overall Study||129||
60081471|NCT01734434|76196939|FG003|NOT COMPLETED|Overall Study||23||
60081472|NCT01788566|76196957|FG000|STARTED|Overall Study||61||
60081473|NCT01788566|76196957|FG000|COMPLETED|Overall Study||53||
60081474|NCT01788566|76196957|FG000|NOT COMPLETED|Overall Study||8||
60081475|NCT01733732|76196963|FG000|STARTED|Overall Study||27||
60081476|NCT01733732|76196964|FG001|STARTED|Overall Study||27||
60081477|NCT01733732|76196963|FG000|COMPLETED|Overall Study||25||
60081478|NCT01733732|76196964|FG001|COMPLETED|Overall Study||27||
60081479|NCT01733732|76196963|FG000|NOT COMPLETED|Overall Study||2||
60081480|NCT01733732|76196964|FG001|NOT COMPLETED|Overall Study||0||
60081481|NCT01732874|76196982|FG000|STARTED|Overall Study||16||
60081482|NCT01732874|76196983|FG001|STARTED|Overall Study||11||
60081483|NCT01732874|76196982|FG000|COMPLETED|Overall Study||8||
60081484|NCT01732874|76196983|FG001|COMPLETED|Overall Study||8||
60081485|NCT01732874|76196982|FG000|NOT COMPLETED|Overall Study||8||
60081486|NCT01732874|76196983|FG001|NOT COMPLETED|Overall Study||3||
60081487|NCT01732796|76196992|FG000|STARTED|Overall Study||208||
59550490|NCT01243580|75650098|FG000|COMPLETED|Overall Study||18||
59550491|NCT01243580|75650099|FG001|COMPLETED|Overall Study||16||
59550492|NCT01243580|75650098|FG000|NOT COMPLETED|Overall Study||0||
59550493|NCT01243580|75650099|FG001|NOT COMPLETED|Overall Study||2||
59550494|NCT01306292|75650109|FG000|STARTED|First Injection||10||
59550495|NCT01306292|75650110|FG001|STARTED|First Injection||8||
59550496|NCT01306292|75650111|FG002|STARTED|First Injection||8||
59550497|NCT01306292|75650112|FG003|STARTED|First Injection||10||
59550498|NCT01306292|75650109|FG000|COMPLETED|First Injection||10||
59550499|NCT01306292|75650110|FG001|COMPLETED|First Injection||8||
59550500|NCT01306292|75650111|FG002|COMPLETED|First Injection||8||
59550501|NCT01306292|75650112|FG003|COMPLETED|First Injection||10||
59816366|NCT00518882|75938781|FG001|NOT COMPLETED|Double-Blind, Week 0-26||45||
59550502|NCT01306292|75650109|FG000|NOT COMPLETED|First Injection||0||
59550503|NCT01306292|75650110|FG001|NOT COMPLETED|First Injection||0||
59550504|NCT01306292|75650111|FG002|NOT COMPLETED|First Injection||0||
59550505|NCT01306292|75650112|FG003|NOT COMPLETED|First Injection||0||
59550506|NCT01306292|75650109|FG000|STARTED|Washout (at Least 10 Minutes)||10||
59550507|NCT01306292|75650110|FG001|STARTED|Washout (at Least 10 Minutes)||8||
59816367|NCT00518882|75938780|FG000|STARTED|Open-Label Extension, Week 26-78||202||
59816368|NCT00518882|75938781|FG001|STARTED|Open-Label Extension, Week 26-78||187||
59816369|NCT00518882|75938780|FG000|COMPLETED|Open-Label Extension, Week 26-78||161||
59816370|NCT00518882|75938781|FG001|COMPLETED|Open-Label Extension, Week 26-78||138||
59816371|NCT00518882|75938780|FG000|NOT COMPLETED|Open-Label Extension, Week 26-78||41||
59991216|NCT01678131|76106741|FG001|COMPLETED|Overall Study||9||
59991217|NCT01678131|76106742|FG002|COMPLETED|Overall Study||9||
59991218|NCT01678131|76106740|FG000|NOT COMPLETED|Overall Study||0||
59991219|NCT01678131|76106741|FG001|NOT COMPLETED|Overall Study||1||
59991220|NCT01678131|76106742|FG002|NOT COMPLETED|Overall Study||2||
59991221|NCT02231164|76106752|FG000|STARTED|Overall Study||6||
59991222|NCT02231164|76106753|FG001|STARTED|Overall Study||6||
59991223|NCT02231164|76106752|FG000|COMPLETED|Overall Study||0||
59991224|NCT02231164|76106753|FG001|COMPLETED|Overall Study||0||
59991225|NCT02231164|76106752|FG000|NOT COMPLETED|Overall Study||6||
59991226|NCT02231164|76106753|FG001|NOT COMPLETED|Overall Study||6||
59991227|NCT02457182|76106761|FG000|STARTED|Overall Study||9||
59991228|NCT02457182|76106762|FG001|STARTED|Overall Study||11||
59991229|NCT02457182|76106761|FG000|COMPLETED|Overall Study||8||
59991230|NCT02457182|76106762|FG001|COMPLETED|Overall Study||11||
59550508|NCT01306292|75650111|FG002|STARTED|Washout (at Least 10 Minutes)||8||
59550509|NCT01306292|75650112|FG003|STARTED|Washout (at Least 10 Minutes)||10||
59550510|NCT01306292|75650109|FG000|COMPLETED|Washout (at Least 10 Minutes)||10||
59550511|NCT01306292|75650110|FG001|COMPLETED|Washout (at Least 10 Minutes)||8||
59991231|NCT02457182|76106761|FG000|NOT COMPLETED|Overall Study||1||
59816372|NCT00518882|75938781|FG001|NOT COMPLETED|Open-Label Extension, Week 26-78||49||
59816373|NCT00518336|75938789|FG000|STARTED|Year 7||222||
59816374|NCT00518336|75938790|FG001|STARTED|Year 7||211||
59816375|NCT00518336|75938789|FG000|COMPLETED|Year 7||220||
59706670|NCT01259297|75825795|FG005|COMPLETED|Double Blind Randomized Period||245||
59706671|NCT01259297|75825796|FG006|COMPLETED|Double Blind Randomized Period||190||
59706672|NCT01259297|75825797|FG007|COMPLETED|Double Blind Randomized Period||196||
59706673|NCT01259297|75825790|FG000|NOT COMPLETED|Double Blind Randomized Period||2||
59706674|NCT01259297|75825791|FG001|NOT COMPLETED|Double Blind Randomized Period||3||
59706675|NCT01259297|75825792|FG002|NOT COMPLETED|Double Blind Randomized Period||1||
59706676|NCT01259297|75825793|FG003|NOT COMPLETED|Double Blind Randomized Period||4||
59550512|NCT01306292|75650111|FG002|COMPLETED|Washout (at Least 10 Minutes)||8||
59550513|NCT01306292|75650112|FG003|COMPLETED|Washout (at Least 10 Minutes)||10||
59550514|NCT01306292|75650109|FG000|NOT COMPLETED|Washout (at Least 10 Minutes)||0||
59706677|NCT01259297|75825794|FG004|NOT COMPLETED|Double Blind Randomized Period||4||
59550515|NCT01306292|75650110|FG001|NOT COMPLETED|Washout (at Least 10 Minutes)||0||
59706678|NCT01259297|75825795|FG005|NOT COMPLETED|Double Blind Randomized Period||8||
59706679|NCT01259297|75825796|FG006|NOT COMPLETED|Double Blind Randomized Period||6||
59706680|NCT01259297|75825797|FG007|NOT COMPLETED|Double Blind Randomized Period||3||
59706681|NCT01126437|75825817|FG000|STARTED|Overall Study||5741||
59706682|NCT01126437|75825818|FG001|STARTED|Overall Study||5729||
59706683|NCT01126437|75825819|FG002|STARTED|Overall Study||5713||
59550516|NCT01306292|75650111|FG002|NOT COMPLETED|Washout (at Least 10 Minutes)||0||
59550517|NCT01306292|75650112|FG003|NOT COMPLETED|Washout (at Least 10 Minutes)||0||
60081488|NCT01732796|76196993|FG001|STARTED|Overall Study||211||
60081489|NCT01732796|76196994|FG002|STARTED|Overall Study||51||
60081490|NCT01732796|76196992|FG000|COMPLETED|Overall Study||162||
60081491|NCT01732796|76196993|FG001|COMPLETED|Overall Study||169||
60081492|NCT01732796|76196994|FG002|COMPLETED|Overall Study||38||
60081493|NCT01732796|76196992|FG000|NOT COMPLETED|Overall Study||46||
60081494|NCT01732796|76196993|FG001|NOT COMPLETED|Overall Study||42||
60081495|NCT01732796|76196994|FG002|NOT COMPLETED|Overall Study||13||
60081496|NCT01732640|76197004|FG000|STARTED|Overall Study||6||
60081497|NCT01732640|76197005|FG001|STARTED|Overall Study||3||
60081498|NCT01732640|76197004|FG000|COMPLETED|Overall Study||6||
60081499|NCT01732640|76197005|FG001|COMPLETED|Overall Study||1||
60081500|NCT01732640|76197004|FG000|NOT COMPLETED|Overall Study||0||
60081501|NCT01732640|76197005|FG001|NOT COMPLETED|Overall Study||2||
60081502|NCT01732484|76197015|FG000|STARTED|Overall Study||100||
60081503|NCT01732484|76197015|FG000|Randomized|Overall Study|Randomized implantation SN60WF IOL in on eye and iMics NY-60 in the other eye.|100||
60081504|NCT01732484|76197015|FG000|Allocation|Overall Study||100||
60081505|NCT01732484|76197015|FG000|COMPLETED|Overall Study||74||
60081506|NCT01732484|76197015|FG000|NOT COMPLETED|Overall Study||26||
60081507|NCT01786148|76197023|FG000|STARTED|Overall Study||77||
60081508|NCT01786148|76197024|FG001|STARTED|Overall Study||72||
60081509|NCT01786148|76197023|FG000|COMPLETED|Overall Study||55||
60081510|NCT01786148|76197024|FG001|COMPLETED|Overall Study||50||
60081511|NCT01786148|76197023|FG000|NOT COMPLETED|Overall Study||22||
60081512|NCT01786148|76197024|FG001|NOT COMPLETED|Overall Study||22||
60081513|NCT04560686|76197030|FG000|STARTED|Overall Study||1||
60081514|NCT04560686|76197030|FG000|COMPLETED|Overall Study||1||
60081515|NCT04560686|76197030|FG000|NOT COMPLETED|Overall Study||0||
60081516|NCT01785602|76197036|FG000|STARTED|Overall Study||76||
60081517|NCT01785602|76197037|FG001|STARTED|Overall Study||27||
60081518|NCT01785602|76197036|FG000|COMPLETED|Overall Study||63||
60081519|NCT01785602|76197037|FG001|COMPLETED|Overall Study||18||
59550518|NCT01306292|75650109|FG000|STARTED|Second Injection||10||
59550519|NCT01306292|75650110|FG001|STARTED|Second Injection||8||
59550520|NCT01306292|75650111|FG002|STARTED|Second Injection||8||
59550521|NCT01306292|75650112|FG003|STARTED|Second Injection||10||
60081520|NCT01785602|76197036|FG000|NOT COMPLETED|Overall Study||13||
60081521|NCT01785602|76197037|FG001|NOT COMPLETED|Overall Study||9||
60081522|NCT01785524|76197045|FG000|STARTED|Overall Study||7||
60081523|NCT01785524|76197046|FG001|STARTED|Overall Study||4||
60081524|NCT01785524|76197045|FG000|COMPLETED|Overall Study||5||
60081525|NCT01785524|76197046|FG001|COMPLETED|Overall Study||2||
60081526|NCT01785524|76197045|FG000|NOT COMPLETED|Overall Study||2||
60081527|NCT01785524|76197046|FG001|NOT COMPLETED|Overall Study||2||
60081528|NCT01757288|76197055|FG000|STARTED|Overall Study||6||
60081529|NCT01757288|76197056|FG001|STARTED|Overall Study||46||
60081530|NCT01757288|76197057|FG002|STARTED|Overall Study||46||
60081531|NCT01757288|76197055|FG000|COMPLETED|Overall Study||6||
60081532|NCT01757288|76197056|FG001|COMPLETED|Overall Study||38||
60081533|NCT01757288|76197057|FG002|COMPLETED|Overall Study||37||
60081534|NCT01757288|76197055|FG000|NOT COMPLETED|Overall Study||0||
60081535|NCT01757288|76197056|FG001|NOT COMPLETED|Overall Study||8||
60081536|NCT01757288|76197057|FG002|NOT COMPLETED|Overall Study||9||
60081537|NCT01756898|76197070|FG000|STARTED|Overall Study||92||
60081538|NCT01756898|76197071|FG001|STARTED|Overall Study||92||
60081539|NCT01756898|76197072|FG002|STARTED|Overall Study||93||
60081540|NCT01756898|76197073|FG003|STARTED|Overall Study||93||
60081541|NCT01756898|76197070|FG000|COMPLETED|Overall Study||73||
60081542|NCT01756898|76197071|FG001|COMPLETED|Overall Study||73||
60081543|NCT01756898|76197072|FG002|COMPLETED|Overall Study||76||
60081544|NCT01756898|76197073|FG003|COMPLETED|Overall Study||77||
60081545|NCT01756898|76197070|FG000|NOT COMPLETED|Overall Study||19||
60081546|NCT01756898|76197071|FG001|NOT COMPLETED|Overall Study||19||
60081547|NCT01756898|76197072|FG002|NOT COMPLETED|Overall Study||17||
60081548|NCT01756898|76197073|FG003|NOT COMPLETED|Overall Study||16||
60081549|NCT01731938|76197090|FG000|STARTED|Preliminary Part I||51||
60081550|NCT01731938|76197091|FG001|STARTED|Preliminary Part I||52||
60081551|NCT01731938|76197090|FG000|COMPLETED|Preliminary Part I||48||
60081552|NCT01731938|76197091|FG001|COMPLETED|Preliminary Part I||44||
60081553|NCT01731938|76197090|FG000|NOT COMPLETED|Preliminary Part I||3||
60081554|NCT01731938|76197091|FG001|NOT COMPLETED|Preliminary Part I||8||
60081555|NCT01731938|76197090|FG000|STARTED|Primary Part II|Preliminary Part I was for study team familiarization with FS Grifols application.|116||
60081556|NCT01731938|76197091|FG001|STARTED|Primary Part II|Subjects from Preliminary Part I were not carried over to Primary Part II to assess safety/efficacy.|108||
60081557|NCT01731938|76197090|FG000|COMPLETED|Primary Part II||103||
60081558|NCT01731938|76197091|FG001|COMPLETED|Primary Part II||95||
60081559|NCT01731938|76197090|FG000|NOT COMPLETED|Primary Part II||13||
60081560|NCT01731938|76197091|FG001|NOT COMPLETED|Primary Part II||13||
60081561|NCT01731470|76197098|FG000|STARTED|Overall Study|Number of patients consented to participate in the study|16||
60081562|NCT01731470|76197098|FG000|COMPLETED|Overall Study|Number of patients enrolled in the study|14||
60081563|NCT01731470|76197098|FG000|NOT COMPLETED|Overall Study||2||
60081564|NCT01756352|76197102|FG000|STARTED|Overall Study||13||
60081565|NCT01756352|76197102|FG000|COMPLETED|Overall Study||12||
60081566|NCT01756352|76197102|FG000|NOT COMPLETED|Overall Study||1||
59550522|NCT01306292|75650109|FG000|COMPLETED|Second Injection||10||
59550523|NCT01306292|75650110|FG001|COMPLETED|Second Injection||8||
59550524|NCT01306292|75650111|FG002|COMPLETED|Second Injection|1 subject completed both injections but not 24-hour follow-up; all other values were recorded.|7||
59550525|NCT01306292|75650112|FG003|COMPLETED|Second Injection||10||
59550526|NCT01306292|75650109|FG000|NOT COMPLETED|Second Injection||0||
59550527|NCT01306292|75650110|FG001|NOT COMPLETED|Second Injection||0||
59550528|NCT01306292|75650111|FG002|NOT COMPLETED|Second Injection||1||
59550529|NCT01306292|75650112|FG003|NOT COMPLETED|Second Injection||0||
59550530|NCT01743521|75650124|FG000|STARTED|Overall Study||7||
59550531|NCT01743521|75650125|FG001|STARTED|Overall Study||3||
60081567|NCT01756274|76197106|FG000|STARTED|Overall Study||162||
60081568|NCT01756274|76197106|FG000|COMPLETED|Overall Study||159||
60081569|NCT01756274|76197106|FG000|NOT COMPLETED|Overall Study||3||
60081570|NCT01731002|76197114|FG000|STARTED|Overall Study||75||
60081571|NCT01731002|76197115|FG001|STARTED|Overall Study||72||
60081572|NCT01731002|76197116|FG002|STARTED|Overall Study||77||
60081573|NCT01731002|76197114|FG000|COMPLETED|Overall Study||71||
60081574|NCT01731002|76197115|FG001|COMPLETED|Overall Study||68||
59550532|NCT01743521|75650126|FG002|STARTED|Overall Study||2||
59550533|NCT01743521|75650127|FG003|STARTED|Overall Study||2||
59550534|NCT01743521|75650124|FG000|COMPLETED|Overall Study||7||
59550535|NCT01743521|75650125|FG001|COMPLETED|Overall Study||3||
60081575|NCT01731002|76197116|FG002|COMPLETED|Overall Study||74||
60081576|NCT01731002|76197114|FG000|NOT COMPLETED|Overall Study||4||
60081577|NCT01731002|76197115|FG001|NOT COMPLETED|Overall Study||4||
60081578|NCT01731002|76197116|FG002|NOT COMPLETED|Overall Study||3||
60081579|NCT01783886|76197127|FG000|STARTED|Overall Study||127||
60081580|NCT01783886|76197128|FG001|STARTED|Overall Study||127||
60081581|NCT01783886|76197129|FG002|STARTED|Overall Study||127||
60081582|NCT01783886|76197127|FG000|Participants Received Treatment|Overall Study||127||
60081583|NCT01783886|76197128|FG001|Participants Received Treatment|Overall Study||127||
60081584|NCT01783886|76197129|FG002|Participants Received Treatment|Overall Study||124||
60081585|NCT01783886|76197127|FG000|COMPLETED|Overall Study||122||
60081586|NCT01783886|76197128|FG001|COMPLETED|Overall Study||116||
60081587|NCT01783886|76197129|FG002|COMPLETED|Overall Study||117||
59550536|NCT01743521|75650126|FG002|COMPLETED|Overall Study||2||
59550537|NCT01743521|75650127|FG003|COMPLETED|Overall Study||2||
59550538|NCT01743521|75650124|FG000|NOT COMPLETED|Overall Study||0||
59550539|NCT01743521|75650125|FG001|NOT COMPLETED|Overall Study||0||
59550540|NCT01743521|75650126|FG002|NOT COMPLETED|Overall Study||0||
59550541|NCT01743521|75650127|FG003|NOT COMPLETED|Overall Study||0||
59550542|NCT01743677|75650135|FG000|STARTED|First Intervention Period||10||
59550543|NCT01743677|75650136|FG001|STARTED|First Intervention Period||10||
59550544|NCT01743677|75650137|FG002|STARTED|First Intervention Period||10||
59550545|NCT01743677|75650138|FG003|STARTED|First Intervention Period||10||
59550546|NCT01743677|75650139|FG004|STARTED|First Intervention Period||10||
59550547|NCT01743677|75650140|FG005|STARTED|First Intervention Period||10||
59550548|NCT01743677|75650135|FG000|COMPLETED|First Intervention Period||10||
59550549|NCT01743677|75650136|FG001|COMPLETED|First Intervention Period||10||
59550550|NCT01743677|75650137|FG002|COMPLETED|First Intervention Period||10||
59550551|NCT01743677|75650138|FG003|COMPLETED|First Intervention Period||10||
59550552|NCT01743677|75650139|FG004|COMPLETED|First Intervention Period||10||
59550553|NCT01743677|75650140|FG005|COMPLETED|First Intervention Period||10||
59550554|NCT01743677|75650135|FG000|NOT COMPLETED|First Intervention Period||0||
59550555|NCT01743677|75650136|FG001|NOT COMPLETED|First Intervention Period||0||
59550556|NCT01743677|75650137|FG002|NOT COMPLETED|First Intervention Period||0||
59550557|NCT01743677|75650138|FG003|NOT COMPLETED|First Intervention Period||0||
59550558|NCT01743677|75650139|FG004|NOT COMPLETED|First Intervention Period||0||
59550559|NCT01743677|75650140|FG005|NOT COMPLETED|First Intervention Period||0||
59550560|NCT01743677|75650135|FG000|STARTED|Washout Period 1 (at Least 7 Days)||10||
59550561|NCT01743677|75650136|FG001|STARTED|Washout Period 1 (at Least 7 Days)||10||
59550562|NCT01743677|75650137|FG002|STARTED|Washout Period 1 (at Least 7 Days)||10||
59550563|NCT01743677|75650138|FG003|STARTED|Washout Period 1 (at Least 7 Days)||10||
59550564|NCT01743677|75650139|FG004|STARTED|Washout Period 1 (at Least 7 Days)||10||
59550565|NCT01743677|75650140|FG005|STARTED|Washout Period 1 (at Least 7 Days)||10||
59550566|NCT01743677|75650135|FG000|COMPLETED|Washout Period 1 (at Least 7 Days)||10||
59550567|NCT01743677|75650136|FG001|COMPLETED|Washout Period 1 (at Least 7 Days)||10||
59550568|NCT01743677|75650137|FG002|COMPLETED|Washout Period 1 (at Least 7 Days)||10||
59550569|NCT01743677|75650138|FG003|COMPLETED|Washout Period 1 (at Least 7 Days)||10||
59550570|NCT01743677|75650139|FG004|COMPLETED|Washout Period 1 (at Least 7 Days)||10||
59550571|NCT01743677|75650140|FG005|COMPLETED|Washout Period 1 (at Least 7 Days)||10||
59550572|NCT01743677|75650135|FG000|NOT COMPLETED|Washout Period 1 (at Least 7 Days)||0||
59550573|NCT01743677|75650136|FG001|NOT COMPLETED|Washout Period 1 (at Least 7 Days)||0||
59550574|NCT01743677|75650137|FG002|NOT COMPLETED|Washout Period 1 (at Least 7 Days)||0||
59550575|NCT01743677|75650138|FG003|NOT COMPLETED|Washout Period 1 (at Least 7 Days)||0||
59550576|NCT01743677|75650139|FG004|NOT COMPLETED|Washout Period 1 (at Least 7 Days)||0||
59550577|NCT01743677|75650140|FG005|NOT COMPLETED|Washout Period 1 (at Least 7 Days)||0||
59550578|NCT01743677|75650135|FG000|STARTED|Second Intervention Period||10||
59550579|NCT01743677|75650136|FG001|STARTED|Second Intervention Period||10||
60081588|NCT01783886|76197127|FG000|NOT COMPLETED|Overall Study||5||
60081589|NCT01783886|76197128|FG001|NOT COMPLETED|Overall Study||11||
60081590|NCT01783886|76197129|FG002|NOT COMPLETED|Overall Study||10||
60081591|NCT01609556|76197153|FG000|STARTED|Dose Escalation: Maximum 101.3 Weeks||2||
60081592|NCT01609556|76197154|FG001|STARTED|Dose Escalation: Maximum 101.3 Weeks||1||
60081593|NCT01609556|76197155|FG002|STARTED|Dose Escalation: Maximum 101.3 Weeks||1||
60081594|NCT01609556|76197156|FG003|STARTED|Dose Escalation: Maximum 101.3 Weeks||1||
60081595|NCT01609556|76197157|FG004|STARTED|Dose Escalation: Maximum 101.3 Weeks||9||
60081596|NCT01609556|76197158|FG005|STARTED|Dose Escalation: Maximum 101.3 Weeks||18||
60081597|NCT01609556|76197159|FG006|STARTED|Dose Escalation: Maximum 101.3 Weeks||7||
60081598|NCT01609556|76197160|FG007|STARTED|Dose Escalation: Maximum 101.3 Weeks||5||
60081599|NCT01609556|76197161|FG008|STARTED|Dose Escalation: Maximum 101.3 Weeks||5||
60081600|NCT01609556|76197162|FG009|STARTED|Dose Escalation: Maximum 101.3 Weeks||4||
60081601|NCT01609556|76197163|FG010|STARTED|Dose Escalation: Maximum 101.3 Weeks||9||
60081602|NCT01609556|76197164|FG011|STARTED|Dose Escalation: Maximum 101.3 Weeks||7||
60081603|NCT01609556|76197165|FG012|STARTED|Dose Escalation: Maximum 101.3 Weeks||0||
60081604|NCT01609556|76197166|FG013|STARTED|Dose Escalation: Maximum 101.3 Weeks||0||
60081605|NCT01609556|76197167|FG014|STARTED|Dose Escalation: Maximum 101.3 Weeks||0||
60081606|NCT01609556|76197168|FG015|STARTED|Dose Escalation: Maximum 101.3 Weeks||0||
60081607|NCT01609556|76197153|FG000|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||2||
60081608|NCT01609556|76197154|FG001|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||1||
59550580|NCT01743677|75650137|FG002|STARTED|Second Intervention Period||10||
59550581|NCT01743677|75650138|FG003|STARTED|Second Intervention Period||10||
59550582|NCT01743677|75650139|FG004|STARTED|Second Intervention Period||10||
59550583|NCT01743677|75650140|FG005|STARTED|Second Intervention Period||10||
59550584|NCT01743677|75650135|FG000|COMPLETED|Second Intervention Period||10||
59550585|NCT01743677|75650136|FG001|COMPLETED|Second Intervention Period||10||
59550586|NCT01743677|75650137|FG002|COMPLETED|Second Intervention Period||10||
59550587|NCT01743677|75650138|FG003|COMPLETED|Second Intervention Period||10||
59706684|NCT01126437|75825817|FG000|COMPLETED|Overall Study|See Pre-Assignment Details above for comments.|4400||
59706685|NCT01126437|75825818|FG001|COMPLETED|Overall Study|See Pre-Assignment Details above for comments.|4399||
60081609|NCT01609556|76197155|FG002|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||1||
60081610|NCT01609556|76197156|FG003|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||1||
60081611|NCT01609556|76197157|FG004|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||9||
60081612|NCT01609556|76197158|FG005|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||18||
60081613|NCT01609556|76197159|FG006|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||7||
60081614|NCT01609556|76197160|FG007|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||5||
60081615|NCT01609556|76197161|FG008|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||5||
60081616|NCT01609556|76197162|FG009|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||4||
60081617|NCT01609556|76197163|FG010|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||9||
60081618|NCT01609556|76197164|FG011|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||7||
60081619|NCT01609556|76197165|FG012|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||0||
60081620|NCT01609556|76197166|FG013|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||0||
60081621|NCT01609556|76197167|FG014|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||0||
60081622|NCT01609556|76197168|FG015|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||0||
60081623|NCT01609556|76197153|FG000|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0||
60081624|NCT01609556|76197154|FG001|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0||
60081625|NCT01609556|76197155|FG002|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0||
60081626|NCT01609556|76197156|FG003|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0||
60081627|NCT01609556|76197157|FG004|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0||
60081628|NCT01609556|76197158|FG005|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0||
60081629|NCT01609556|76197159|FG006|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0||
60081630|NCT01609556|76197160|FG007|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0||
60081631|NCT01609556|76197161|FG008|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0||
60081632|NCT01609556|76197162|FG009|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0||
60081633|NCT01609556|76197163|FG010|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0||
60081634|NCT01609556|76197164|FG011|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0||
60081635|NCT01609556|76197165|FG012|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0||
60081636|NCT01609556|76197166|FG013|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0||
60103799|NCT03774849|76222135|FG000|STARTED|Overall Study||80||
60103800|NCT03774849|76222136|FG001|STARTED|Overall Study||31||
60103801|NCT03774849|76222137|FG002|STARTED|Overall Study||4||
60103802|NCT03774849|76222135|FG000|PicoWay 532nm|Overall Study||43||
60103803|NCT03774849|76222136|FG001|PicoWay 532nm|Overall Study||0||
60103804|NCT03774849|76222137|FG002|PicoWay 532nm|Overall Study||0||
60103805|NCT03774849|76222135|FG000|PicoWay 1064nm|Overall Study||1||
60103806|NCT03774849|76222136|FG001|PicoWay 1064nm|Overall Study||31||
60103807|NCT03774849|76222137|FG002|PicoWay 1064nm|Overall Study||0||
60103808|NCT03774849|76222135|FG000|PicoWay 730nm|Overall Study||22||
60103809|NCT03774849|76222136|FG001|PicoWay 730nm|Overall Study||0||
60103810|NCT03774849|76222137|FG002|PicoWay 730nm|Overall Study||0||
60103811|NCT03774849|76222135|FG000|PicoWay 532nm and 730nm|Overall Study||4||
60103812|NCT03774849|76222136|FG001|PicoWay 532nm and 730nm|Overall Study||0||
60103813|NCT03774849|76222137|FG002|PicoWay 532nm and 730nm|Overall Study||0||
60103814|NCT03774849|76222135|FG000|PicoWay 730nm and 1064nm|Overall Study||0||
60103815|NCT03774849|76222136|FG001|PicoWay 730nm and 1064nm|Overall Study||0||
60103816|NCT03774849|76222137|FG002|PicoWay 730nm and 1064nm|Overall Study||4||
60103817|NCT03774849|76222135|FG000|COMPLETED|Overall Study||70||
60103818|NCT03774849|76222136|FG001|COMPLETED|Overall Study||31||
60103819|NCT03774849|76222137|FG002|COMPLETED|Overall Study||4||
59550588|NCT01743677|75650139|FG004|COMPLETED|Second Intervention Period||10||
59550589|NCT01743677|75650140|FG005|COMPLETED|Second Intervention Period||10||
59550590|NCT01743677|75650135|FG000|NOT COMPLETED|Second Intervention Period||0||
59550591|NCT01743677|75650136|FG001|NOT COMPLETED|Second Intervention Period||0||
59550592|NCT01743677|75650137|FG002|NOT COMPLETED|Second Intervention Period||0||
59550593|NCT01743677|75650138|FG003|NOT COMPLETED|Second Intervention Period||0||
59550594|NCT01743677|75650139|FG004|NOT COMPLETED|Second Intervention Period||0||
59550595|NCT01743677|75650140|FG005|NOT COMPLETED|Second Intervention Period||0||
59550596|NCT01743677|75650135|FG000|STARTED|Washout Period 2 (at Least 7 Days)||10||
59550597|NCT01743677|75650136|FG001|STARTED|Washout Period 2 (at Least 7 Days)||10||
59550598|NCT01743677|75650137|FG002|STARTED|Washout Period 2 (at Least 7 Days)||10||
59550599|NCT01743677|75650138|FG003|STARTED|Washout Period 2 (at Least 7 Days)||10||
59550600|NCT01743677|75650139|FG004|STARTED|Washout Period 2 (at Least 7 Days)||10||
59550601|NCT01743677|75650140|FG005|STARTED|Washout Period 2 (at Least 7 Days)||10||
59550602|NCT01743677|75650135|FG000|COMPLETED|Washout Period 2 (at Least 7 Days)||10||
59550603|NCT01743677|75650136|FG001|COMPLETED|Washout Period 2 (at Least 7 Days)||10||
59550604|NCT01743677|75650137|FG002|COMPLETED|Washout Period 2 (at Least 7 Days)||10||
59706686|NCT01126437|75825819|FG002|COMPLETED|Overall Study|See Pre-Assignment Details above for comments.|4400||
59550605|NCT01743677|75650138|FG003|COMPLETED|Washout Period 2 (at Least 7 Days)||10||
59550606|NCT01743677|75650139|FG004|COMPLETED|Washout Period 2 (at Least 7 Days)||10||
59550607|NCT01743677|75650140|FG005|COMPLETED|Washout Period 2 (at Least 7 Days)||10||
59550608|NCT01743677|75650135|FG000|NOT COMPLETED|Washout Period 2 (at Least 7 Days)||0||
59550609|NCT01743677|75650136|FG001|NOT COMPLETED|Washout Period 2 (at Least 7 Days)||0||
59550610|NCT01743677|75650137|FG002|NOT COMPLETED|Washout Period 2 (at Least 7 Days)||0||
59550611|NCT01743677|75650138|FG003|NOT COMPLETED|Washout Period 2 (at Least 7 Days)||0||
59706687|NCT01126437|75825817|FG000|NOT COMPLETED|Overall Study||1341||
59706688|NCT01126437|75825818|FG001|NOT COMPLETED|Overall Study||1330||
59550612|NCT01743677|75650139|FG004|NOT COMPLETED|Washout Period 2 (at Least 7 Days)||0||
59550613|NCT01743677|75650140|FG005|NOT COMPLETED|Washout Period 2 (at Least 7 Days)||0||
59706689|NCT01126437|75825819|FG002|NOT COMPLETED|Overall Study||1313||
59706690|NCT01258595|75825829|FG000|STARTED|Overall Study||148||
59550614|NCT01743677|75650135|FG000|STARTED|Third Intervention Period||10||
59550615|NCT01743677|75650136|FG001|STARTED|Third Intervention Period||10||
59550616|NCT01743677|75650137|FG002|STARTED|Third Intervention Period||10||
59550617|NCT01743677|75650138|FG003|STARTED|Third Intervention Period||10||
59550618|NCT01743677|75650139|FG004|STARTED|Third Intervention Period||10||
59550619|NCT01743677|75650140|FG005|STARTED|Third Intervention Period||10||
59550620|NCT01743677|75650135|FG000|COMPLETED|Third Intervention Period||10||
59550621|NCT01743677|75650136|FG001|COMPLETED|Third Intervention Period||10||
59550622|NCT01743677|75650137|FG002|COMPLETED|Third Intervention Period||10||
59550623|NCT01743677|75650138|FG003|COMPLETED|Third Intervention Period||10||
59550624|NCT01743677|75650139|FG004|COMPLETED|Third Intervention Period||10||
59550625|NCT01743677|75650140|FG005|COMPLETED|Third Intervention Period||10||
59550626|NCT01743677|75650135|FG000|NOT COMPLETED|Third Intervention Period||0||
59550627|NCT01743677|75650136|FG001|NOT COMPLETED|Third Intervention Period||0||
59550628|NCT01743677|75650137|FG002|NOT COMPLETED|Third Intervention Period||0||
59550629|NCT01743677|75650138|FG003|NOT COMPLETED|Third Intervention Period||0||
59550630|NCT01743677|75650139|FG004|NOT COMPLETED|Third Intervention Period||0||
59550631|NCT01743677|75650140|FG005|NOT COMPLETED|Third Intervention Period||0||
59550632|NCT01246076|75650150|FG000|STARTED|Overall Study||24||
59550633|NCT01246076|75650150|FG000|COMPLETED|Overall Study||24||
59550634|NCT01246076|75650150|FG000|NOT COMPLETED|Overall Study||0||
59550635|NCT01745627|75650154|FG000|STARTED|Overall Study||42||
59550636|NCT01745627|75650154|FG000|COMPLETED|Overall Study||20||
59550637|NCT01745627|75650154|FG000|NOT COMPLETED|Overall Study||22||
59550638|NCT01307462|75650158|FG000|STARTED|Overall Study||36||
59550639|NCT01307462|75650158|FG000|COMPLETED|Overall Study||35||
59550640|NCT01307462|75650158|FG000|NOT COMPLETED|Overall Study||1||
59550641|NCT01307618|75650164|FG000|STARTED|Overall Study||5||
59550642|NCT01307618|75650165|FG001|STARTED|Overall Study||5||
59706691|NCT01258595|75825830|FG001|STARTED|Overall Study||152||
59706692|NCT01258595|75825829|FG000|COMPLETED|Overall Study||147||
59706693|NCT01258595|75825830|FG001|COMPLETED|Overall Study||151||
60081637|NCT01609556|76197167|FG014|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0||
60081638|NCT01609556|76197168|FG015|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0||
60081639|NCT01609556|76197153|FG000|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||2||
60081640|NCT01609556|76197154|FG001|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||1||
60081641|NCT01609556|76197155|FG002|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||1||
60081642|NCT01609556|76197156|FG003|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||1||
60081643|NCT01609556|76197157|FG004|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||9||
60081644|NCT01609556|76197158|FG005|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||18||
60081645|NCT01609556|76197159|FG006|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||7||
60081646|NCT01609556|76197160|FG007|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||5||
60081647|NCT01609556|76197161|FG008|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||5||
60081648|NCT01609556|76197162|FG009|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||4||
60081649|NCT01609556|76197163|FG010|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||9||
60081650|NCT01609556|76197164|FG011|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||7||
60081651|NCT01609556|76197165|FG012|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0||
60081652|NCT01609556|76197166|FG013|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0||
60081653|NCT01609556|76197167|FG014|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0||
60081654|NCT01609556|76197168|FG015|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0||
60081655|NCT01609556|76197153|FG000|STARTED|Dose Expansion: Maximum 124 Weeks||0||
60081656|NCT01609556|76197154|FG001|STARTED|Dose Expansion: Maximum 124 Weeks||0||
60081657|NCT01609556|76197155|FG002|STARTED|Dose Expansion: Maximum 124 Weeks||0||
60081658|NCT01609556|76197156|FG003|STARTED|Dose Expansion: Maximum 124 Weeks||0||
60081659|NCT01609556|76197157|FG004|STARTED|Dose Expansion: Maximum 124 Weeks||0||
59550643|NCT01307618|75650164|FG000|COMPLETED|Overall Study||5||
59550644|NCT01307618|75650165|FG001|COMPLETED|Overall Study||5||
59550645|NCT01307618|75650164|FG000|NOT COMPLETED|Overall Study||0||
59550646|NCT01307618|75650165|FG001|NOT COMPLETED|Overall Study||0||
59550647|NCT01307930|75650171|FG000|STARTED|Overall Study||20||
59550648|NCT01307930|75650171|FG000|COMPLETED|Overall Study||18||
59550649|NCT01307930|75650171|FG000|NOT COMPLETED|Overall Study||2||
59550650|NCT01309646|75650177|FG000|STARTED|Overall Study||224||
59550651|NCT01309646|75650178|FG001|STARTED|Overall Study||227||
59550652|NCT01309646|75650177|FG000|COMPLETED|Overall Study||224||
59550653|NCT01309646|75650178|FG001|COMPLETED|Overall Study||227||
59550654|NCT01309646|75650177|FG000|NOT COMPLETED|Overall Study||0||
59550655|NCT01309646|75650178|FG001|NOT COMPLETED|Overall Study||0||
59550656|NCT01746095|75650188|FG000|STARTED|Overall Study||20||
59550657|NCT01746095|75650189|FG001|STARTED|Overall Study||20||
59706694|NCT01258595|75825829|FG000|NOT COMPLETED|Overall Study||1||
60081660|NCT01609556|76197158|FG005|STARTED|Dose Expansion: Maximum 124 Weeks||0||
59550658|NCT01746095|75650190|FG002|STARTED|Overall Study||24||
59550659|NCT01746095|75650191|FG003|STARTED|Overall Study||23||
60081661|NCT01609556|76197159|FG006|STARTED|Dose Expansion: Maximum 124 Weeks||0||
60081662|NCT01609556|76197160|FG007|STARTED|Dose Expansion: Maximum 124 Weeks||0||
60081663|NCT01609556|76197161|FG008|STARTED|Dose Expansion: Maximum 124 Weeks||0||
59550660|NCT01746095|75650188|FG000|COMPLETED|Overall Study||16||
59550661|NCT01746095|75650189|FG001|COMPLETED|Overall Study||16||
59550662|NCT01746095|75650190|FG002|COMPLETED|Overall Study||11||
59550663|NCT01746095|75650191|FG003|COMPLETED|Overall Study||15||
59550664|NCT01746095|75650188|FG000|NOT COMPLETED|Overall Study||4||
59550665|NCT01746095|75650189|FG001|NOT COMPLETED|Overall Study||4||
59550666|NCT01746095|75650190|FG002|NOT COMPLETED|Overall Study||13||
59550667|NCT01746095|75650191|FG003|NOT COMPLETED|Overall Study||8||
59550668|NCT01309802|75650203|FG000|STARTED|Overall Study||25||
59550669|NCT01309802|75650204|FG001|STARTED|Overall Study||23||
59550670|NCT01309802|75650203|FG000|COMPLETED|Overall Study||13||
59550671|NCT01309802|75650204|FG001|COMPLETED|Overall Study||14||
59550672|NCT01309802|75650203|FG000|NOT COMPLETED|Overall Study||12||
59550673|NCT01309802|75650204|FG001|NOT COMPLETED|Overall Study||9||
59550674|NCT01309880|75650210|FG000|STARTED|Overall Study||33||
59550675|NCT01309880|75650211|FG001|STARTED|Overall Study||33||
59550676|NCT01309880|75650210|FG000|COMPLETED|Overall Study||33||
59550677|NCT01309880|75650211|FG001|COMPLETED|Overall Study||33||
59550678|NCT01309880|75650210|FG000|NOT COMPLETED|Overall Study||0||
59550679|NCT01309880|75650211|FG001|NOT COMPLETED|Overall Study||0||
59550680|NCT01346072|75650219|FG000|STARTED|Overall Study||11||
59550681|NCT01346072|75650220|FG001|STARTED|Overall Study||10||
59550682|NCT01346072|75650219|FG000|COMPLETED|Overall Study||11||
59550683|NCT01346072|75650220|FG001|COMPLETED|Overall Study||10||
59550684|NCT01346072|75650219|FG000|NOT COMPLETED|Overall Study||0||
59550685|NCT01346072|75650220|FG001|NOT COMPLETED|Overall Study||0||
59550686|NCT01346852|75650228|FG000|STARTED|Overall Study||41753||
59550687|NCT01346852|75650229|FG001|STARTED|Overall Study||59684||
59550688|NCT01346852|75650228|FG000|COMPLETED|Overall Study||41753||
59550689|NCT01346852|75650229|FG001|COMPLETED|Overall Study||59684||
59550690|NCT01346852|75650228|FG000|NOT COMPLETED|Overall Study||0||
59550691|NCT01346852|75650229|FG001|NOT COMPLETED|Overall Study||0||
59550692|NCT01721837|75650235|FG000|STARTED|Overall Study||2120||
59550693|NCT01721837|75650235|FG000|COMPLETED|Overall Study||2120||
59550694|NCT01721837|75650235|FG000|NOT COMPLETED|Overall Study||0||
59550695|NCT01347008|75650241|FG000|STARTED|Overall Study||21||
59550696|NCT01347008|75650242|FG001|STARTED|Overall Study||20||
59550697|NCT01347008|75650241|FG000|COMPLETED|Overall Study||21||
59550698|NCT01347008|75650242|FG001|COMPLETED|Overall Study||20||
59550699|NCT01347008|75650241|FG000|NOT COMPLETED|Overall Study||0||
59550700|NCT01347008|75650242|FG001|NOT COMPLETED|Overall Study||0||
59550701|NCT01347788|75650248|FG000|STARTED|Overall Study||11||
59550702|NCT01347788|75650249|FG001|STARTED|Overall Study||10||
59550703|NCT01347788|75650250|FG002|STARTED|Overall Study||13||
59550704|NCT01347788|75650248|FG000|COMPLETED|Overall Study||11||
59550705|NCT01347788|75650249|FG001|COMPLETED|Overall Study||10||
59550706|NCT01347788|75650250|FG002|COMPLETED|Overall Study||13||
59550707|NCT01347788|75650248|FG000|NOT COMPLETED|Overall Study||0||
59550708|NCT01347788|75650249|FG001|NOT COMPLETED|Overall Study||0||
59550709|NCT01347788|75650250|FG002|NOT COMPLETED|Overall Study||0||
59550710|NCT01349114|75650260|FG000|STARTED|Overall Study||10||
59550711|NCT01349114|75650261|FG001|STARTED|Overall Study||11||
59550712|NCT01349114|75650260|FG000|COMPLETED|Overall Study||10||
59550713|NCT01349114|75650261|FG001|COMPLETED|Overall Study||11||
59550714|NCT01349114|75650260|FG000|NOT COMPLETED|Overall Study||0||
59550715|NCT01349114|75650261|FG001|NOT COMPLETED|Overall Study||0||
59550716|NCT01310582|75650271|FG000|STARTED|Overall Study||31||
59550717|NCT01310582|75650272|FG001|STARTED|Overall Study||26||
59550718|NCT01310582|75650271|FG000|COMPLETED|Overall Study||31||
59550719|NCT01310582|75650272|FG001|COMPLETED|Overall Study||26||
59550720|NCT01310582|75650271|FG000|NOT COMPLETED|Overall Study||0||
59550721|NCT01310582|75650272|FG001|NOT COMPLETED|Overall Study||0||
59550722|NCT01311362|75650278|FG000|STARTED|Ambrisentan Single Dose|All 20 study participants completed each study period. Total number of study participants: 20|20||
59550723|NCT01311362|75650278|FG000|COMPLETED|Ambrisentan Single Dose||20||
59550724|NCT01311362|75650278|FG000|NOT COMPLETED|Ambrisentan Single Dose||0||
59550725|NCT01311362|75650278|FG000|STARTED|Ambrisentan Steady-state||20||
59550726|NCT01311362|75650278|FG000|COMPLETED|Ambrisentan Steady-state||20||
59550727|NCT01311362|75650278|FG000|NOT COMPLETED|Ambrisentan Steady-state||0||
59706695|NCT01258595|75825830|FG001|NOT COMPLETED|Overall Study||1||
59706696|NCT01257737|75825838|FG000|STARTED|Overall Study||45||
59706697|NCT01257737|75825839|FG001|STARTED|Overall Study||43||
59706698|NCT01257737|75825838|FG000|COMPLETED|Overall Study||43||
59706699|NCT01257737|75825839|FG001|COMPLETED|Overall Study||39||
59706700|NCT01257737|75825838|FG000|NOT COMPLETED|Overall Study||2||
59816376|NCT00518336|75938790|FG001|COMPLETED|Year 7||208||
59816377|NCT00518336|75938789|FG000|NOT COMPLETED|Year 7||2||
59550728|NCT01311362|75650278|FG000|STARTED|Ambrisentan and SJW||20||
59550729|NCT01311362|75650278|FG000|COMPLETED|Ambrisentan and SJW||20||
59550730|NCT01311362|75650278|FG000|NOT COMPLETED|Ambrisentan and SJW||0||
59550731|NCT01311674|75650289|FG000|STARTED|Overall Study||72||
59550732|NCT01311674|75650290|FG001|STARTED|Overall Study||69||
59550733|NCT01311674|75650289|FG000|COMPLETED|Overall Study||28||
59550734|NCT01311674|75650290|FG001|COMPLETED|Overall Study||29||
59706701|NCT01257737|75825839|FG001|NOT COMPLETED|Overall Study||4||
59706702|NCT01126359|75825846|FG000|STARTED|First Intervention (20-minutes)||5||
59706703|NCT01126359|75825847|FG001|STARTED|First Intervention (20-minutes)||6||
59706704|NCT01126359|75825846|FG000|COMPLETED|First Intervention (20-minutes)||5||
59706705|NCT01126359|75825847|FG001|COMPLETED|First Intervention (20-minutes)||5||
59816378|NCT00518336|75938790|FG001|NOT COMPLETED|Year 7||3||
59816379|NCT00518336|75938789|FG000|STARTED|Year 8|1 subject withdrawn at Year 7 came back and was therefore no longer considered as withdrawn.|223||
59550735|NCT01311674|75650289|FG000|NOT COMPLETED|Overall Study||44||
59550736|NCT01311674|75650290|FG001|NOT COMPLETED|Overall Study||40||
59550737|NCT01349972|75650299|FG000|STARTED|Overall Study||114||
59550738|NCT01349972|75650300|FG001|STARTED|Overall Study||58||
59550739|NCT01349972|75650299|FG000|COMPLETED|Overall Study||109||
59550740|NCT01349972|75650300|FG001|COMPLETED|Overall Study||56||
59550741|NCT01349972|75650299|FG000|NOT COMPLETED|Overall Study||5||
59550742|NCT01349972|75650300|FG001|NOT COMPLETED|Overall Study||2||
59550743|NCT01248104|75650308|FG000|STARTED|Overall Study||50||
59550744|NCT01248104|75650309|FG001|STARTED|Overall Study||50||
59550745|NCT01248104|75650308|FG000|COMPLETED|Overall Study||40||
59550746|NCT01248104|75650309|FG001|COMPLETED|Overall Study||42||
59550747|NCT01248104|75650308|FG000|NOT COMPLETED|Overall Study||10||
59550748|NCT01248104|75650309|FG001|NOT COMPLETED|Overall Study||8||
59550749|NCT01725815|75650317|FG000|STARTED|Overall Study||198||
59550750|NCT01725815|75650318|FG001|STARTED|Overall Study||202||
59550751|NCT01725815|75650317|FG000|COMPLETED|Overall Study||198||
59550752|NCT01725815|75650318|FG001|COMPLETED|Overall Study||202||
59550753|NCT01725815|75650317|FG000|NOT COMPLETED|Overall Study||0||
59550754|NCT01725815|75650318|FG001|NOT COMPLETED|Overall Study||0||
59550755|NCT01351064|75650326|FG000|STARTED|Overall Study||42||
59550756|NCT01351064|75650327|FG001|STARTED|Overall Study||42||
59550757|NCT01351064|75650326|FG000|COMPLETED|Overall Study||42||
59550758|NCT01351064|75650327|FG001|COMPLETED|Overall Study||42||
59550759|NCT01351064|75650326|FG000|NOT COMPLETED|Overall Study||0||
59550760|NCT01351064|75650327|FG001|NOT COMPLETED|Overall Study||0||
59550761|NCT01747343|75650333|FG000|STARTED|Baseline||4||
59550762|NCT01747343|75650333|FG000|COMPLETED|Baseline||4||
59550763|NCT01747343|75650333|FG000|NOT COMPLETED|Baseline||0||
59550764|NCT01747343|75650333|FG000|STARTED|Underwear||4||
59550765|NCT01747343|75650333|FG000|COMPLETED|Underwear||4||
59550766|NCT01747343|75650333|FG000|NOT COMPLETED|Underwear||0||
59550767|NCT01747343|75650333|FG000|STARTED|Underwear/Differential Reinforcement||4||
59550768|NCT01747343|75650333|FG000|COMPLETED|Underwear/Differential Reinforcement||4||
59550769|NCT01747343|75650333|FG000|NOT COMPLETED|Underwear/Differential Reinforcement||0||
59550770|NCT01351376|75650339|FG000|STARTED|Overall Study||10||
59550771|NCT01351376|75650340|FG001|STARTED|Overall Study||11||
59550772|NCT01351376|75650339|FG000|COMPLETED|Overall Study||10||
59550773|NCT01351376|75650340|FG001|COMPLETED|Overall Study||11||
59550774|NCT01351376|75650339|FG000|NOT COMPLETED|Overall Study||0||
59550775|NCT01351376|75650340|FG001|NOT COMPLETED|Overall Study||0||
59550776|NCT01748045|75650348|FG000|STARTED|Overall Study||2||
59550777|NCT01748045|75650349|FG001|STARTED|Overall Study||1||
60081664|NCT01609556|76197162|FG009|STARTED|Dose Expansion: Maximum 124 Weeks||0||
60081665|NCT01609556|76197163|FG010|STARTED|Dose Expansion: Maximum 124 Weeks||0||
60081666|NCT01609556|76197164|FG011|STARTED|Dose Expansion: Maximum 124 Weeks||0||
60081667|NCT01609556|76197165|FG012|STARTED|Dose Expansion: Maximum 124 Weeks||46||
60081668|NCT01609556|76197166|FG013|STARTED|Dose Expansion: Maximum 124 Weeks||24||
60081669|NCT01609556|76197167|FG014|STARTED|Dose Expansion: Maximum 124 Weeks||27||
60081670|NCT01609556|76197168|FG015|STARTED|Dose Expansion: Maximum 124 Weeks||40||
60081671|NCT01609556|76197153|FG000|COMPLETED|Dose Expansion: Maximum 124 Weeks||0||
60081672|NCT01609556|76197154|FG001|COMPLETED|Dose Expansion: Maximum 124 Weeks||0||
60081673|NCT01609556|76197155|FG002|COMPLETED|Dose Expansion: Maximum 124 Weeks||0||
60081674|NCT01609556|76197156|FG003|COMPLETED|Dose Expansion: Maximum 124 Weeks||0||
60081675|NCT01609556|76197157|FG004|COMPLETED|Dose Expansion: Maximum 124 Weeks||0||
60081676|NCT01609556|76197158|FG005|COMPLETED|Dose Expansion: Maximum 124 Weeks||0||
60081677|NCT01609556|76197159|FG006|COMPLETED|Dose Expansion: Maximum 124 Weeks||0||
60081678|NCT01609556|76197160|FG007|COMPLETED|Dose Expansion: Maximum 124 Weeks||0||
60081679|NCT01609556|76197161|FG008|COMPLETED|Dose Expansion: Maximum 124 Weeks||0||
60081680|NCT01609556|76197162|FG009|COMPLETED|Dose Expansion: Maximum 124 Weeks||0||
60081681|NCT01609556|76197163|FG010|COMPLETED|Dose Expansion: Maximum 124 Weeks||0||
60081682|NCT01609556|76197164|FG011|COMPLETED|Dose Expansion: Maximum 124 Weeks||0||
60081683|NCT01609556|76197165|FG012|COMPLETED|Dose Expansion: Maximum 124 Weeks||0||
60081684|NCT01609556|76197166|FG013|COMPLETED|Dose Expansion: Maximum 124 Weeks||0||
60081685|NCT01609556|76197167|FG014|COMPLETED|Dose Expansion: Maximum 124 Weeks||0||
60081686|NCT01609556|76197168|FG015|COMPLETED|Dose Expansion: Maximum 124 Weeks||0||
60081687|NCT01609556|76197153|FG000|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0||
60081688|NCT01609556|76197154|FG001|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0||
60081689|NCT01609556|76197155|FG002|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0||
60081690|NCT01609556|76197156|FG003|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0||
60081691|NCT01609556|76197157|FG004|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0||
60081692|NCT01609556|76197158|FG005|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0||
60081693|NCT01609556|76197159|FG006|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0||
60081694|NCT01609556|76197160|FG007|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0||
60081695|NCT01609556|76197161|FG008|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0||
60081696|NCT01609556|76197162|FG009|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0||
60081697|NCT01609556|76197163|FG010|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0||
60081698|NCT01609556|76197164|FG011|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0||
59550778|NCT01748045|75650348|FG000|COMPLETED|Overall Study||2||
59550779|NCT01748045|75650349|FG001|COMPLETED|Overall Study||1||
59550780|NCT01748045|75650348|FG000|NOT COMPLETED|Overall Study||0||
59550781|NCT01748045|75650349|FG001|NOT COMPLETED|Overall Study||0||
59550782|NCT01312766|75650363|FG000|STARTED|Overall Study||135||
59550783|NCT01312766|75650364|FG001|STARTED|Overall Study||135||
59550784|NCT01312766|75650363|FG000|COMPLETED|Overall Study||129||
59550785|NCT01312766|75650364|FG001|COMPLETED|Overall Study||130||
59550786|NCT01312766|75650363|FG000|NOT COMPLETED|Overall Study||6||
59550787|NCT01312766|75650364|FG001|NOT COMPLETED|Overall Study||5||
59550788|NCT01749215|75650372|FG000|STARTED|Overall Study||72||
59550789|NCT01749215|75650373|FG001|STARTED|Overall Study||79||
59550790|NCT01749215|75650372|FG000|COMPLETED|Overall Study||47||
59991232|NCT02457182|76106762|FG001|NOT COMPLETED|Overall Study||0||
59991233|NCT02230384|76106770|FG000|STARTED|Phase 1||30||
59991234|NCT02230384|76106771|FG001|STARTED|Phase 1||32||
59991235|NCT02230384|76106770|FG000|COMPLETED|Phase 1||29||
59991236|NCT02230384|76106771|FG001|COMPLETED|Phase 1||31||
59991237|NCT02230384|76106770|FG000|NOT COMPLETED|Phase 1||1||
59991238|NCT02230384|76106771|FG001|NOT COMPLETED|Phase 1||1||
59991239|NCT02230384|76106770|FG000|STARTED|Phase 1 Wash Out||29||
59991240|NCT02230384|76106771|FG001|STARTED|Phase 1 Wash Out||31||
59991241|NCT02230384|76106770|FG000|COMPLETED|Phase 1 Wash Out||29||
60081699|NCT01609556|76197165|FG012|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||46||
60081700|NCT01609556|76197166|FG013|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||24||
59991242|NCT02230384|76106771|FG001|COMPLETED|Phase 1 Wash Out||31||
59991243|NCT02230384|76106770|FG000|NOT COMPLETED|Phase 1 Wash Out||0||
59991244|NCT02230384|76106771|FG001|NOT COMPLETED|Phase 1 Wash Out||0||
59991245|NCT02230384|76106770|FG000|STARTED|Phase 2 - Switch||29||
59991246|NCT02230384|76106771|FG001|STARTED|Phase 2 - Switch||31||
60081701|NCT01609556|76197167|FG014|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||27||
60081702|NCT01609556|76197168|FG015|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||40||
60081703|NCT00234832|76197211|FG000|STARTED|Overall Study|Subjects completed the 6-week Lead-in Period and were dispensed randomized study drug.|4906||
60081704|NCT00234832|76197212|FG001|STARTED|Overall Study|Subjects completed the 6-week Lead-in Period and were dispensed randomized study drug.|4898||
60081705|NCT00234832|76197211|FG000|COMPLETED|Overall Study|Subjects completed the Randomization Phase.|3890||
60081706|NCT00234832|76197212|FG001|COMPLETED|Overall Study|Subjects completed the Randomization Phase.|3902||
60081707|NCT00234832|76197211|FG000|NOT COMPLETED|Overall Study||1016||
60081708|NCT00234832|76197212|FG001|NOT COMPLETED|Overall Study||996||
60081709|NCT00259090|76197228|FG000|STARTED|Overall Study|Doesn't include protocol deviators, those who didn't complete the study or had missing tumor samples|35||
60081710|NCT00259090|76197229|FG001|STARTED|Overall Study|Doesn't include protocol deviators, those who didn't complete the study or had missing tumor samples|31||
60081711|NCT00259090|76197230|FG002|STARTED|Overall Study|Doesn't include protocol deviators, those who didn't complete the study or had missing tumor samples|37||
60081712|NCT00259090|76197228|FG000|COMPLETED|Overall Study||35||
60081713|NCT00259090|76197229|FG001|COMPLETED|Overall Study||31||
60081714|NCT00259090|76197230|FG002|COMPLETED|Overall Study||37||
60081715|NCT00259090|76197228|FG000|NOT COMPLETED|Overall Study||0||
60081716|NCT00259090|76197229|FG001|NOT COMPLETED|Overall Study||0||
60081717|NCT00259090|76197230|FG002|NOT COMPLETED|Overall Study||0||
60081718|NCT00235456|76197240|FG000|STARTED|Overall Study||150||
60081719|NCT00235456|76197241|FG001|STARTED|Overall Study||150||
60081720|NCT00235456|76197240|FG000|COMPLETED|Overall Study||148||
60081721|NCT00235456|76197241|FG001|COMPLETED|Overall Study||143||
60081722|NCT00235456|76197240|FG000|NOT COMPLETED|Overall Study||2||
60081723|NCT00235456|76197241|FG001|NOT COMPLETED|Overall Study||7||
60081724|NCT00236938|76197249|FG000|STARTED|Overall Study||75||
60081725|NCT00236938|76197250|FG001|STARTED|Overall Study||46||
60081726|NCT00236938|76197249|FG000|COMPLETED|Overall Study||62||
60081727|NCT00236938|76197250|FG001|COMPLETED|Overall Study||26||
60081728|NCT00236938|76197249|FG000|NOT COMPLETED|Overall Study||13||
60081729|NCT00236938|76197250|FG001|NOT COMPLETED|Overall Study||20||
59550791|NCT01749215|75650373|FG001|COMPLETED|Overall Study||53||
59550792|NCT01749215|75650372|FG000|NOT COMPLETED|Overall Study||25||
60081730|NCT00260962|76197258|FG000|STARTED|Overall Study||18||
60081731|NCT00260962|76197259|FG001|STARTED|Overall Study||16||
60081732|NCT00260962|76197258|FG000|COMPLETED|Overall Study||14||
59550793|NCT01749215|75650373|FG001|NOT COMPLETED|Overall Study||26||
59991247|NCT02230384|76106770|FG000|COMPLETED|Phase 2 - Switch||26||
59991248|NCT02230384|76106771|FG001|COMPLETED|Phase 2 - Switch||30||
59991249|NCT02230384|76106770|FG000|NOT COMPLETED|Phase 2 - Switch||3||
59706706|NCT01126359|75825846|FG000|NOT COMPLETED|First Intervention (20-minutes)||0||
59706707|NCT01126359|75825847|FG001|NOT COMPLETED|First Intervention (20-minutes)||1||
59706708|NCT01126359|75825846|FG000|STARTED|Dressing Replacement/Healing (48-hours)||5||
59991250|NCT02230384|76106771|FG001|NOT COMPLETED|Phase 2 - Switch||1||
59991251|NCT02230384|76106770|FG000|STARTED|Phase 2 Wash Out||26||
59706709|NCT01126359|75825847|FG001|STARTED|Dressing Replacement/Healing (48-hours)||5||
59550794|NCT01726673|75650381|FG000|STARTED|Overall Study||30||
59550795|NCT01726673|75650382|FG001|STARTED|Overall Study||24||
59550796|NCT01726673|75650381|FG000|COMPLETED|Overall Study||24||
59550797|NCT01726673|75650382|FG001|COMPLETED|Overall Study||21||
59550798|NCT01726673|75650381|FG000|NOT COMPLETED|Overall Study||6||
59550799|NCT01726673|75650382|FG001|NOT COMPLETED|Overall Study||3||
59550800|NCT01248416|75650391|FG000|STARTED|Overall Study||25||
59550801|NCT01248416|75650392|FG001|STARTED|Overall Study||25||
59550802|NCT01248416|75650393|FG002|STARTED|Overall Study||26||
59550803|NCT01248416|75650391|FG000|COMPLETED|Overall Study||21||
59550804|NCT01248416|75650392|FG001|COMPLETED|Overall Study||25||
59550805|NCT01248416|75650393|FG002|COMPLETED|Overall Study||25||
59550806|NCT01248416|75650391|FG000|NOT COMPLETED|Overall Study||4||
59550807|NCT01248416|75650392|FG001|NOT COMPLETED|Overall Study||0||
59550808|NCT01248416|75650393|FG002|NOT COMPLETED|Overall Study||1||
59550809|NCT01749293|75650403|FG000|STARTED|Overall Study||3||
59550810|NCT01749293|75650403|FG000|COMPLETED|Overall Study||3||
59550811|NCT01749293|75650403|FG000|NOT COMPLETED|Overall Study||0||
59706710|NCT01126359|75825846|FG000|COMPLETED|Dressing Replacement/Healing (48-hours)||5||
59706711|NCT01126359|75825847|FG001|COMPLETED|Dressing Replacement/Healing (48-hours)||5||
59706712|NCT01126359|75825846|FG000|NOT COMPLETED|Dressing Replacement/Healing (48-hours)||0||
59706713|NCT01126359|75825847|FG001|NOT COMPLETED|Dressing Replacement/Healing (48-hours)||0||
59706714|NCT01126359|75825846|FG000|STARTED|Second Intervention (20-minutes)||5||
59706715|NCT01126359|75825847|FG001|STARTED|Second Intervention (20-minutes)||5||
59706716|NCT01126359|75825846|FG000|COMPLETED|Second Intervention (20-minutes)||5||
59706717|NCT01126359|75825847|FG001|COMPLETED|Second Intervention (20-minutes)||5||
59706718|NCT01126359|75825846|FG000|NOT COMPLETED|Second Intervention (20-minutes)||0||
59706719|NCT01126359|75825847|FG001|NOT COMPLETED|Second Intervention (20-minutes)||0||
59706720|NCT01125813|75825857|FG000|STARTED|Overall Study||36||
59706721|NCT01125813|75825857|FG000|COMPLETED|Overall Study||30||
59706722|NCT01125813|75825857|FG000|NOT COMPLETED|Overall Study||6||
59706723|NCT00996892|75825861|FG000|STARTED|Dose-Escalation Stage 1||4||
59706724|NCT00996892|75825862|FG001|STARTED|Dose-Escalation Stage 1||3||
59706725|NCT00996892|75825863|FG002|STARTED|Dose-Escalation Stage 1||3||
59706726|NCT00996892|75825864|FG003|STARTED|Dose-Escalation Stage 1||9||
59706727|NCT00996892|75825865|FG004|STARTED|Dose-Escalation Stage 1||11||
59706728|NCT00996892|75825866|FG005|STARTED|Dose-Escalation Stage 1||10||
59706729|NCT00996892|75825867|FG006|STARTED|Dose-Escalation Stage 1||4||
59706730|NCT00996892|75825868|FG007|STARTED|Dose-Escalation Stage 1||0||
59706731|NCT00996892|75825869|FG008|STARTED|Dose-Escalation Stage 1||0||
59706732|NCT00996892|75825870|FG009|STARTED|Dose-Escalation Stage 1||0||
59706733|NCT00996892|75825871|FG010|STARTED|Dose-Escalation Stage 1||0||
59706734|NCT00996892|75825872|FG011|STARTED|Dose-Escalation Stage 1||0||
59706735|NCT00996892|75825873|FG012|STARTED|Dose-Escalation Stage 1||0||
59706736|NCT00996892|75825874|FG013|STARTED|Dose-Escalation Stage 1||0||
59550812|NCT01727765|75650410|FG000|STARTED|Overall Study||8||
59550813|NCT01727765|75650411|FG001|STARTED|Overall Study||8||
59550814|NCT01727765|75650410|FG000|COMPLETED|Overall Study||8||
59550815|NCT01727765|75650411|FG001|COMPLETED|Overall Study||8||
59550816|NCT01727765|75650410|FG000|NOT COMPLETED|Overall Study||0||
59706737|NCT00996892|75825875|FG014|STARTED|Dose-Escalation Stage 1||0||
59706738|NCT00996892|75825876|FG015|STARTED|Dose-Escalation Stage 1||0||
59706739|NCT00996892|75825877|FG016|STARTED|Dose-Escalation Stage 1||0||
59550817|NCT01727765|75650411|FG001|NOT COMPLETED|Overall Study||0||
59706740|NCT00996892|75825878|FG017|STARTED|Dose-Escalation Stage 1||0||
59706741|NCT00996892|75825879|FG018|STARTED|Dose-Escalation Stage 1||0||
59706742|NCT00996892|75825880|FG019|STARTED|Dose-Escalation Stage 1||0||
59706743|NCT00996892|75825861|FG000|COMPLETED|Dose-Escalation Stage 1||0||
59550818|NCT01250210|75650420|FG000|STARTED|Overall Study||45|Number of participants enrolled.|
59550819|NCT01250210|75650421|FG001|STARTED|Overall Study||45|Number of participants enrolled.|
59550820|NCT01250210|75650422|FG002|STARTED|Overall Study||33|Number of participants enrolled.|
59550821|NCT01250210|75650420|FG000|COMPLETED|Overall Study||41||
59550822|NCT01250210|75650421|FG001|COMPLETED|Overall Study||41||
59550823|NCT01250210|75650422|FG002|COMPLETED|Overall Study||25||
59550824|NCT01250210|75650420|FG000|NOT COMPLETED|Overall Study||4||
59550825|NCT01250210|75650421|FG001|NOT COMPLETED|Overall Study||4||
59550826|NCT01250210|75650422|FG002|NOT COMPLETED|Overall Study||8||
59550827|NCT01749605|75650432|FG000|STARTED|Overall Study||18||
59550828|NCT01749605|75650433|FG001|STARTED|Overall Study||17||
59550829|NCT01749605|75650432|FG000|COMPLETED|Overall Study||14||
59550830|NCT01749605|75650433|FG001|COMPLETED|Overall Study||14||
59550831|NCT01749605|75650432|FG000|NOT COMPLETED|Overall Study||4||
59550832|NCT01749605|75650433|FG001|NOT COMPLETED|Overall Study||3||
59550833|NCT01749995|75650439|FG000|STARTED|Overall Study||200||
59550834|NCT01749995|75650439|FG000|COMPLETED|Overall Study||196||
59550835|NCT01749995|75650439|FG000|NOT COMPLETED|Overall Study||4||
59550836|NCT01312844|75650445|FG000|STARTED|Overall Study||4||
59550837|NCT01312844|75650446|FG001|STARTED|Overall Study||3||
59550838|NCT01312844|75650445|FG000|COMPLETED|Overall Study||4||
59550839|NCT01312844|75650446|FG001|COMPLETED|Overall Study||3||
59550840|NCT01312844|75650445|FG000|NOT COMPLETED|Overall Study||0||
59550841|NCT01312844|75650446|FG001|NOT COMPLETED|Overall Study||0||
59550842|NCT01729247|75650452|FG000|STARTED|Overall Study||50||
59550843|NCT01729247|75650452|FG000|COMPLETED|Overall Study||50||
59550844|NCT01729247|75650452|FG000|NOT COMPLETED|Overall Study||0||
59550845|NCT01750931|75650463|FG000|STARTED|Period 1||14||
59550846|NCT01750931|75650464|FG001|STARTED|Period 1||14||
59550847|NCT01750931|75650463|FG000|COMPLETED|Period 1||14||
59706744|NCT00996892|75825862|FG001|COMPLETED|Dose-Escalation Stage 1||0||
59706745|NCT00996892|75825863|FG002|COMPLETED|Dose-Escalation Stage 1||0||
59706746|NCT00996892|75825864|FG003|COMPLETED|Dose-Escalation Stage 1||0||
59550848|NCT01750931|75650464|FG001|COMPLETED|Period 1||14||
59550849|NCT01750931|75650463|FG000|NOT COMPLETED|Period 1||0||
59550850|NCT01750931|75650464|FG001|NOT COMPLETED|Period 1||0||
59550851|NCT01750931|75650463|FG000|STARTED|Wash Out||14||
59550852|NCT01750931|75650464|FG001|STARTED|Wash Out||14||
59550853|NCT01750931|75650463|FG000|COMPLETED|Wash Out||14||
59550854|NCT01750931|75650464|FG001|COMPLETED|Wash Out||14||
59550855|NCT01750931|75650463|FG000|NOT COMPLETED|Wash Out||0||
59550856|NCT01750931|75650464|FG001|NOT COMPLETED|Wash Out||0||
59550857|NCT01750931|75650463|FG000|STARTED|Period 2||14||
59550858|NCT01750931|75650464|FG001|STARTED|Period 2||14||
59550859|NCT01750931|75650463|FG000|COMPLETED|Period 2||14||
59550860|NCT01750931|75650464|FG001|COMPLETED|Period 2||14||
59550861|NCT01750931|75650463|FG000|NOT COMPLETED|Period 2||0||
59550862|NCT01750931|75650464|FG001|NOT COMPLETED|Period 2||0||
59550863|NCT01352468|75650472|FG000|STARTED|Overall Study||22||
59550864|NCT01352468|75650473|FG001|STARTED|Overall Study||22||
59550865|NCT01352468|75650472|FG000|COMPLETED|Overall Study||17||
59550866|NCT01352468|75650473|FG001|COMPLETED|Overall Study||18||
59706747|NCT00996892|75825865|FG004|COMPLETED|Dose-Escalation Stage 1||0||
59706748|NCT00996892|75825866|FG005|COMPLETED|Dose-Escalation Stage 1||0||
59706749|NCT00996892|75825867|FG006|COMPLETED|Dose-Escalation Stage 1||0||
59706750|NCT00996892|75825868|FG007|COMPLETED|Dose-Escalation Stage 1||0||
59706751|NCT00996892|75825869|FG008|COMPLETED|Dose-Escalation Stage 1||0||
59706752|NCT00996892|75825870|FG009|COMPLETED|Dose-Escalation Stage 1||0||
59706753|NCT00996892|75825871|FG010|COMPLETED|Dose-Escalation Stage 1||0||
59706754|NCT00996892|75825872|FG011|COMPLETED|Dose-Escalation Stage 1||0||
59706755|NCT00996892|75825873|FG012|COMPLETED|Dose-Escalation Stage 1||0||
59550867|NCT01352468|75650472|FG000|NOT COMPLETED|Overall Study||5||
59550868|NCT01352468|75650473|FG001|NOT COMPLETED|Overall Study||4||
59550869|NCT01731041|75650481|FG000|STARTED|Overall Study||30||
59550870|NCT01731041|75650482|FG001|STARTED|Overall Study||30||
59550871|NCT01731041|75650481|FG000|COMPLETED|Overall Study||30||
59550872|NCT01731041|75650482|FG001|COMPLETED|Overall Study||30||
59550873|NCT01731041|75650481|FG000|NOT COMPLETED|Overall Study||0||
59550874|NCT01731041|75650482|FG001|NOT COMPLETED|Overall Study||0||
59550875|NCT01352546|75650488|FG000|STARTED|Overall Study||31||
59550876|NCT01352546|75650488|FG000|COMPLETED|Overall Study||31||
59550877|NCT01352546|75650488|FG000|NOT COMPLETED|Overall Study||0||
59550878|NCT01313936|75650494|FG000|STARTED|Overall Study||6||
59550879|NCT01313936|75650495|FG001|STARTED|Overall Study||26||
59550880|NCT01313936|75650494|FG000|COMPLETED|Overall Study||6||
59550881|NCT01313936|75650495|FG001|COMPLETED|Overall Study||26||
59550882|NCT01313936|75650494|FG000|NOT COMPLETED|Overall Study||0||
59550883|NCT01313936|75650495|FG001|NOT COMPLETED|Overall Study||0||
59550884|NCT01751399|75650508|FG000|STARTED|Overall Study||12||
59550885|NCT01751399|75650509|FG001|STARTED|Overall Study||8||
59550886|NCT01751399|75650510|FG002|STARTED|Overall Study||8||
59550887|NCT01751399|75650511|FG003|STARTED|Overall Study||7||
59550888|NCT01751399|75650508|FG000|Received 1 Dose of Study Drug|Overall Study||12||
59550889|NCT01751399|75650509|FG001|Received 1 Dose of Study Drug|Overall Study||8||
59550890|NCT01751399|75650510|FG002|Received 1 Dose of Study Drug|Overall Study||8||
59550891|NCT01751399|75650511|FG003|Received 1 Dose of Study Drug|Overall Study||7||
59550892|NCT01751399|75650508|FG000|COMPLETED|Overall Study||12||
59550893|NCT01751399|75650509|FG001|COMPLETED|Overall Study||8||
60081733|NCT00260962|76197259|FG001|COMPLETED|Overall Study||14||
60081734|NCT00260962|76197258|FG000|NOT COMPLETED|Overall Study||4||
60081735|NCT00260962|76197259|FG001|NOT COMPLETED|Overall Study||2||
60081736|NCT00261040|76197267|FG000|STARTED|Overall Study||20||
60081737|NCT00261040|76197268|FG001|STARTED|Overall Study||20||
60081738|NCT00261040|76197267|FG000|COMPLETED|Overall Study||19||
60081739|NCT00261040|76197268|FG001|COMPLETED|Overall Study||20||
60081740|NCT00261040|76197267|FG000|NOT COMPLETED|Overall Study||1||
60081741|NCT00261040|76197268|FG001|NOT COMPLETED|Overall Study||0||
60081742|NCT00237718|76197276|FG000|STARTED|Overall Study||160||
60081743|NCT00237718|76197277|FG001|STARTED|Overall Study||165||
60081744|NCT00237718|76197276|FG000|COMPLETED|Overall Study||114||
60081745|NCT00237718|76197277|FG001|COMPLETED|Overall Study||124||
60081746|NCT00237718|76197276|FG000|NOT COMPLETED|Overall Study||46||
60081747|NCT00237718|76197277|FG001|NOT COMPLETED|Overall Study||41||
60081748|NCT00238108|76197285|FG000|STARTED|Overall Study||8||
60081749|NCT00238108|76197286|FG001|STARTED|Overall Study||8||
60081750|NCT00238108|76197285|FG000|COMPLETED|Overall Study||8||
60081751|NCT00238108|76197286|FG001|COMPLETED|Overall Study||8||
60081752|NCT00238108|76197285|FG000|NOT COMPLETED|Overall Study||0||
60081753|NCT00238108|76197286|FG001|NOT COMPLETED|Overall Study||0||
60081754|NCT00266110|76197292|FG000|STARTED|Overall Study||17||
60081755|NCT00266110|76197292|FG000|COMPLETED|Overall Study||10||
60081756|NCT00266110|76197292|FG000|NOT COMPLETED|Overall Study||7||
60081757|NCT00240526|76197301|FG000|STARTED|Year 15|Number of subjects who come back at Year 15 (Month 180) time-point|19||
60081758|NCT00240526|76197302|FG001|STARTED|Year 15|Number of subjects who come back at Year 15 (Month 180) time-point|19||
60081759|NCT00240526|76197303|FG002|STARTED|Year 15|Number of subjects who come back at Year 15 (Month 180) time-point|14||
60081760|NCT00240526|76197304|FG003|STARTED|Year 15|Number of subjects who come back at Year 15 (Month 180) time-point|21||
60081761|NCT00240526|76197301|FG000|COMPLETED|Year 15||19||
60081762|NCT00240526|76197302|FG001|COMPLETED|Year 15||19||
60081763|NCT00240526|76197303|FG002|COMPLETED|Year 15||14||
60081764|NCT00240526|76197304|FG003|COMPLETED|Year 15||21||
59550894|NCT01751399|75650510|FG002|COMPLETED|Overall Study||8||
59550895|NCT01751399|75650511|FG003|COMPLETED|Overall Study||7||
59550896|NCT01751399|75650508|FG000|NOT COMPLETED|Overall Study||0||
59550897|NCT01751399|75650509|FG001|NOT COMPLETED|Overall Study||0||
59550898|NCT01751399|75650510|FG002|NOT COMPLETED|Overall Study||0||
59550899|NCT01751399|75650511|FG003|NOT COMPLETED|Overall Study||0||
60081765|NCT00240526|76197301|FG000|NOT COMPLETED|Year 15||0||
60081766|NCT00240526|76197302|FG001|NOT COMPLETED|Year 15||0||
60081767|NCT00240526|76197303|FG002|NOT COMPLETED|Year 15||0||
60081768|NCT00240526|76197304|FG003|NOT COMPLETED|Year 15||0||
60081769|NCT00240526|76197301|FG000|STARTED|Year 16|Number of subjects who come back at Year 16 (Month 192) time-point|17||
60081770|NCT00240526|76197302|FG001|STARTED|Year 16|Number of subjects who come back at Year 16 (Month 192) time-point|19||
59550900|NCT01752413|75650523|FG000|STARTED|Overall Study||170||
59550901|NCT01752413|75650524|FG001|STARTED|Overall Study||27||
60081771|NCT00240526|76197303|FG002|STARTED|Year 16|Number of subjects who come back at Year 16 (Month 192) time-point|16||
59816380|NCT00518336|75938790|FG001|STARTED|Year 8|2 subjects withdrawn at Year 7 came back and were therefore no longer considered as withdrawn.|213||
59816381|NCT00518336|75938789|FG000|COMPLETED|Year 8||222||
59816382|NCT00518336|75938790|FG001|COMPLETED|Year 8||211||
59816383|NCT00518336|75938789|FG000|NOT COMPLETED|Year 8||1||
59816384|NCT00518336|75938790|FG001|NOT COMPLETED|Year 8||2||
59816385|NCT00518336|75938789|FG000|STARTED|Year 9|1 subject did not particpate at the previous timepoint, came back and was added in the Total cohort|224||
59816386|NCT00518336|75938790|FG001|STARTED|Year 9||213||
59816387|NCT00518336|75938789|FG000|COMPLETED|Year 9||219||
59816388|NCT00518336|75938790|FG001|COMPLETED|Year 9||212||
59816389|NCT00518336|75938789|FG000|NOT COMPLETED|Year 9||5||
59816390|NCT00518336|75938790|FG001|NOT COMPLETED|Year 9||1||
59816391|NCT00518180|75938799|FG000|STARTED|Overall Study||540||
59816392|NCT00518180|75938800|FG001|STARTED|Overall Study||541||
59816393|NCT00518180|75938801|FG002|STARTED|Overall Study||539||
59816394|NCT00518180|75938799|FG000|COMPLETED|Overall Study||475||
59816395|NCT00518180|75938800|FG001|COMPLETED|Overall Study||472||
59706756|NCT00996892|75825874|FG013|COMPLETED|Dose-Escalation Stage 1||0||
59991252|NCT02230384|76106771|FG001|STARTED|Phase 2 Wash Out||30||
59550902|NCT01752413|75650523|FG000|COMPLETED|Overall Study||58||
59550903|NCT01752413|75650524|FG001|COMPLETED|Overall Study||6||
59550904|NCT01752413|75650523|FG000|NOT COMPLETED|Overall Study||112||
59550905|NCT01752413|75650524|FG001|NOT COMPLETED|Overall Study||21||
59550906|NCT01314014|75650530|FG000|STARTED|Overall Study||22||
59550907|NCT01314014|75650530|FG000|COMPLETED|Overall Study|Treatment continued for as long as the subject derived benefit.|22||
59550908|NCT01314014|75650530|FG000|NOT COMPLETED|Overall Study||0||
59550909|NCT01731119|75650534|FG000|STARTED|Overall Study||9||
59550910|NCT01731119|75650534|FG000|COMPLETED|Overall Study||7||
59550911|NCT01731119|75650534|FG000|NOT COMPLETED|Overall Study||2||
59550912|NCT02326649|75650538|FG000|STARTED|Overall Study||33||
59550913|NCT02326649|75650538|FG000|COMPLETED|Overall Study||21||
59550914|NCT02326649|75650538|FG000|NOT COMPLETED|Overall Study||12||
59550915|NCT01732445|75650542|FG000|STARTED|Overall Study||14||
59550916|NCT01732445|75650542|FG000|COMPLETED|Overall Study||14||
59550917|NCT01732445|75650542|FG000|NOT COMPLETED|Overall Study||0||
59550918|NCT01250834|75650546|FG000|STARTED|Overall Study||27||
59550919|NCT01250834|75650546|FG000|COMPLETED|Overall Study||27||
59550920|NCT01250834|75650546|FG000|NOT COMPLETED|Overall Study||0||
59550921|NCT01354652|75650556|FG000|STARTED|Overall Study||3||
59550922|NCT01354652|75650557|FG001|STARTED|Overall Study||2||
59550923|NCT01354652|75650558|FG002|STARTED|Overall Study||0||
59550924|NCT01354652|75650556|FG000|COMPLETED|Overall Study||0||
59550925|NCT01354652|75650557|FG001|COMPLETED|Overall Study||0||
59550926|NCT01354652|75650558|FG002|COMPLETED|Overall Study||0||
59550927|NCT01354652|75650556|FG000|NOT COMPLETED|Overall Study||3||
59550928|NCT01354652|75650557|FG001|NOT COMPLETED|Overall Study||2||
59550929|NCT01354652|75650558|FG002|NOT COMPLETED|Overall Study||0||
59550930|NCT01753739|75650572|FG000|STARTED|Overall Study||124||
59550931|NCT01753739|75650573|FG001|STARTED|Overall Study||123||
59550932|NCT01753739|75650574|FG002|STARTED|Overall Study||123||
59550933|NCT01753739|75650575|FG003|STARTED|Overall Study||124||
59550934|NCT01753739|75650576|FG004|STARTED|Overall Study||123||
59550935|NCT01753739|75650572|FG000|COMPLETED|Overall Study||120||
59550936|NCT01753739|75650573|FG001|COMPLETED|Overall Study||118||
59550937|NCT01753739|75650574|FG002|COMPLETED|Overall Study||118||
59550938|NCT01753739|75650575|FG003|COMPLETED|Overall Study||117||
59550939|NCT01753739|75650576|FG004|COMPLETED|Overall Study||120||
59550940|NCT01753739|75650572|FG000|NOT COMPLETED|Overall Study||4||
59550941|NCT01753739|75650573|FG001|NOT COMPLETED|Overall Study||5||
60081772|NCT00240526|76197304|FG003|STARTED|Year 16|Number of subjects who come back at Year 16 (Month 192) time-point|22||
60081773|NCT00240526|76197301|FG000|COMPLETED|Year 16||17||
60081774|NCT00240526|76197302|FG001|COMPLETED|Year 16||19||
60081775|NCT00240526|76197303|FG002|COMPLETED|Year 16||16||
60081776|NCT00240526|76197304|FG003|COMPLETED|Year 16||22||
60081777|NCT00240526|76197301|FG000|NOT COMPLETED|Year 16||0||
60081778|NCT00240526|76197302|FG001|NOT COMPLETED|Year 16||0||
60081779|NCT00240526|76197303|FG002|NOT COMPLETED|Year 16||0||
60081780|NCT00240526|76197304|FG003|NOT COMPLETED|Year 16||0||
59550942|NCT01753739|75650574|FG002|NOT COMPLETED|Overall Study||5||
59550943|NCT01753739|75650575|FG003|NOT COMPLETED|Overall Study||7||
59550944|NCT01753739|75650576|FG004|NOT COMPLETED|Overall Study||3||
59550945|NCT01250990|75650590|FG000|STARTED|Overall Study||11||
59706757|NCT00996892|75825875|FG014|COMPLETED|Dose-Escalation Stage 1||0||
59550946|NCT01250990|75650591|FG001|STARTED|Overall Study||11||
59706758|NCT00996892|75825876|FG015|COMPLETED|Dose-Escalation Stage 1||0||
59706759|NCT00996892|75825877|FG016|COMPLETED|Dose-Escalation Stage 1||0||
60081781|NCT00240526|76197301|FG000|STARTED|Year 17|Number of subjects who come back at Year 17 (Month 204) time-point|19||
60081782|NCT00240526|76197302|FG001|STARTED|Year 17|Number of subjects who come back at Year 17 (Month 204) time-point|17||
60081783|NCT00240526|76197303|FG002|STARTED|Year 17|Number of subjects who come back at Year 17 (Month 204) time-point|13||
59550947|NCT01250990|75650590|FG000|COMPLETED|Overall Study||7||
59550948|NCT01250990|75650591|FG001|COMPLETED|Overall Study||9||
59550949|NCT01250990|75650590|FG000|NOT COMPLETED|Overall Study||4||
59550950|NCT01250990|75650591|FG001|NOT COMPLETED|Overall Study||2||
59550951|NCT01754207|75650597|FG000|STARTED|Overall Study||20||
59550952|NCT01754207|75650597|FG000|COMPLETED|Overall Study||17||
59550953|NCT01754207|75650597|FG000|NOT COMPLETED|Overall Study||3||
59550954|NCT01315574|75650603|FG000|STARTED|Overall Study||7||
60081784|NCT00240526|76197304|FG003|STARTED|Year 17|Number of subjects who come back at Year 17 (Month 204) time-point|20||
60081785|NCT00240526|76197301|FG000|COMPLETED|Year 17||19||
59550955|NCT01315574|75650604|FG001|STARTED|Overall Study||7||
59550956|NCT01315574|75650603|FG000|COMPLETED|Overall Study||7||
59550957|NCT01315574|75650604|FG001|COMPLETED|Overall Study||7||
59706760|NCT00996892|75825878|FG017|COMPLETED|Dose-Escalation Stage 1||0||
59706761|NCT00996892|75825879|FG018|COMPLETED|Dose-Escalation Stage 1||0||
59816396|NCT00518180|75938801|FG002|COMPLETED|Overall Study||457||
59550958|NCT01315574|75650603|FG000|NOT COMPLETED|Overall Study||0||
59550959|NCT01315574|75650604|FG001|NOT COMPLETED|Overall Study||0||
59550960|NCT01754519|75650610|FG000|STARTED|Overall Study||1||
59706762|NCT00996892|75825880|FG019|COMPLETED|Dose-Escalation Stage 1||0||
59706763|NCT00996892|75825861|FG000|NOT COMPLETED|Dose-Escalation Stage 1||4||
59550961|NCT01754519|75650610|FG000|COMPLETED|Overall Study||1||
59706764|NCT00996892|75825862|FG001|NOT COMPLETED|Dose-Escalation Stage 1||3||
59550962|NCT01754519|75650610|FG000|NOT COMPLETED|Overall Study||0||
59550963|NCT01316042|75650616|FG000|STARTED|Overall Study||2||
59550964|NCT01316042|75650617|FG001|STARTED|Overall Study||2||
59550965|NCT01316042|75650616|FG000|COMPLETED|Overall Study||2||
59550966|NCT01316042|75650617|FG001|COMPLETED|Overall Study||1||
59550967|NCT01316042|75650616|FG000|NOT COMPLETED|Overall Study||0||
59706765|NCT00996892|75825863|FG002|NOT COMPLETED|Dose-Escalation Stage 1||3||
59550968|NCT01316042|75650617|FG001|NOT COMPLETED|Overall Study||1||
59550969|NCT01754909|75650625|FG000|STARTED|Overall Study||20||
59550970|NCT01754909|75650626|FG001|STARTED|Overall Study||23||
59550971|NCT01754909|75650625|FG000|COMPLETED|Overall Study||20||
59550972|NCT01754909|75650626|FG001|COMPLETED|Overall Study||23||
59550973|NCT01754909|75650625|FG000|NOT COMPLETED|Overall Study||0||
59550974|NCT01754909|75650626|FG001|NOT COMPLETED|Overall Study||0||
59550975|NCT01755143|75650634|FG000|STARTED|Overall Study||177||
59550976|NCT01755143|75650635|FG001|STARTED|Overall Study||89||
59550977|NCT01755143|75650634|FG000|COMPLETED|Overall Study||166||
59550978|NCT01755143|75650635|FG001|COMPLETED|Overall Study||86||
59550979|NCT01755143|75650634|FG000|NOT COMPLETED|Overall Study||11||
59550980|NCT01755143|75650635|FG001|NOT COMPLETED|Overall Study||3||
59550981|NCT01755455|75650641|FG000|STARTED|First Intervention (6 Weeks)||11||
59550982|NCT01755455|75650642|FG001|STARTED|First Intervention (6 Weeks)||11||
59550983|NCT01755455|75650641|FG000|COMPLETED|First Intervention (6 Weeks)||11||
59550984|NCT01755455|75650642|FG001|COMPLETED|First Intervention (6 Weeks)||11||
59550985|NCT01755455|75650641|FG000|NOT COMPLETED|First Intervention (6 Weeks)||0||
59550986|NCT01755455|75650642|FG001|NOT COMPLETED|First Intervention (6 Weeks)||0||
59550987|NCT01755455|75650641|FG000|STARTED|Washout (4 Weeks)||11||
59550988|NCT01755455|75650642|FG001|STARTED|Washout (4 Weeks)||11||
59550989|NCT01755455|75650641|FG000|COMPLETED|Washout (4 Weeks)||11||
59550990|NCT01755455|75650642|FG001|COMPLETED|Washout (4 Weeks)||11||
59550991|NCT01755455|75650641|FG000|NOT COMPLETED|Washout (4 Weeks)||0||
59550992|NCT01755455|75650642|FG001|NOT COMPLETED|Washout (4 Weeks)||0||
59550993|NCT01755455|75650641|FG000|STARTED|Second Intervention (6 Weeks)||11||
59550994|NCT01755455|75650642|FG001|STARTED|Second Intervention (6 Weeks)||11||
59550995|NCT01755455|75650641|FG000|COMPLETED|Second Intervention (6 Weeks)||11||
59550996|NCT01755455|75650642|FG001|COMPLETED|Second Intervention (6 Weeks)||11||
59550997|NCT01755455|75650641|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0||
59550998|NCT01755455|75650642|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||0||
59550999|NCT01756391|75650648|FG000|STARTED|Overall Study||351||
59551000|NCT01756391|75650648|FG000|COMPLETED|Overall Study||319||
59551001|NCT01756391|75650648|FG000|NOT COMPLETED|Overall Study||32||
59551002|NCT02618031|75650654|FG000|STARTED|Overall Study||46||
59551003|NCT02618031|75650655|FG001|STARTED|Overall Study||11||
59551004|NCT02618031|75650654|FG000|COMPLETED|Overall Study||45||
59551005|NCT02618031|75650655|FG001|COMPLETED|Overall Study||11||
59551006|NCT02618031|75650654|FG000|NOT COMPLETED|Overall Study||1||
59551007|NCT02618031|75650655|FG001|NOT COMPLETED|Overall Study||0||
59551008|NCT01757561|75650669|FG000|STARTED|Overall Study||38||
59706766|NCT00996892|75825864|FG003|NOT COMPLETED|Dose-Escalation Stage 1||9||
59706767|NCT00996892|75825865|FG004|NOT COMPLETED|Dose-Escalation Stage 1||11||
59551009|NCT01757561|75650670|FG001|STARTED|Overall Study||34||
59551010|NCT01757561|75650671|FG002|STARTED|Overall Study||38||
59551011|NCT01757561|75650672|FG003|STARTED|Overall Study||34||
59551012|NCT01757561|75650669|FG000|COMPLETED|Overall Study||32||
59551013|NCT01757561|75650670|FG001|COMPLETED|Overall Study||28||
59551014|NCT01757561|75650671|FG002|COMPLETED|Overall Study||31||
59551015|NCT01757561|75650672|FG003|COMPLETED|Overall Study||25||
59551016|NCT01757561|75650669|FG000|NOT COMPLETED|Overall Study||6||
59551017|NCT01757561|75650670|FG001|NOT COMPLETED|Overall Study||6||
59551018|NCT01757561|75650671|FG002|NOT COMPLETED|Overall Study||7||
59551019|NCT01757561|75650672|FG003|NOT COMPLETED|Overall Study||9||
59551020|NCT01757717|75650682|FG000|STARTED|Overall Study||3||
59551021|NCT01757717|75650682|FG000|COMPLETED|Overall Study||3||
59551022|NCT01757717|75650682|FG000|NOT COMPLETED|Overall Study||0||
59551023|NCT02618187|75650690|FG000|STARTED|Overall Study||15||
59551024|NCT02618187|75650691|FG001|STARTED|Overall Study||11||
59551025|NCT02618187|75650692|FG002|STARTED|Overall Study||15||
59551026|NCT02618187|75650693|FG003|STARTED|Overall Study||17||
59551027|NCT02618187|75650690|FG000|Completed|Overall Study||13|Subjects Completed Visit 12 Endoscopy (8-week treatment)|
59706768|NCT00996892|75825866|FG005|NOT COMPLETED|Dose-Escalation Stage 1||10||
59551028|NCT02618187|75650691|FG001|Completed|Overall Study||10|Subjects Completed Visit 12 Endoscopy (8-week treatment)|
59551029|NCT02618187|75650692|FG002|Completed|Overall Study||13|Subjects Completed Visit 12 Endoscopy (8-week treatment)|
59551030|NCT02618187|75650693|FG003|Completed|Overall Study||13|Subjects Completed Visit 12 Endoscopy (8-week treatment)|
59706769|NCT00996892|75825867|FG006|NOT COMPLETED|Dose-Escalation Stage 1||4||
60081786|NCT00240526|76197302|FG001|COMPLETED|Year 17||17||
60081787|NCT00240526|76197303|FG002|COMPLETED|Year 17||13||
60081788|NCT00240526|76197304|FG003|COMPLETED|Year 17||20||
60081789|NCT00240526|76197301|FG000|NOT COMPLETED|Year 17||0||
60081790|NCT00240526|76197302|FG001|NOT COMPLETED|Year 17||0||
60081791|NCT00240526|76197303|FG002|NOT COMPLETED|Year 17||0||
60081792|NCT00240526|76197304|FG003|NOT COMPLETED|Year 17||0||
60081793|NCT00240526|76197301|FG000|STARTED|Year 18|Number of subjects who come back at Year 18 (Month 216) time-point|16||
60081794|NCT00240526|76197302|FG001|STARTED|Year 18|Number of subjects who come back at Year 18 (Month 216) time-point|17||
60081795|NCT00240526|76197303|FG002|STARTED|Year 18|Number of subjects who come back at Year 18 (Month 216) time-point|14||
60081796|NCT00240526|76197304|FG003|STARTED|Year 18|Number of subjects who come back at Year 18 (Month 216) time-point|20||
60081797|NCT00240526|76197301|FG000|COMPLETED|Year 18||16||
60081798|NCT00240526|76197302|FG001|COMPLETED|Year 18||17||
60081799|NCT00240526|76197303|FG002|COMPLETED|Year 18||14||
60081800|NCT00240526|76197304|FG003|COMPLETED|Year 18||20||
60081801|NCT00240526|76197301|FG000|NOT COMPLETED|Year 18||0||
60081802|NCT00240526|76197302|FG001|NOT COMPLETED|Year 18||0||
60081803|NCT00240526|76197303|FG002|NOT COMPLETED|Year 18||0||
60081804|NCT00240526|76197304|FG003|NOT COMPLETED|Year 18||0||
60081805|NCT00240526|76197301|FG000|STARTED|Year 19|Number of subjects who come back at Year 19 (Month 228) time-point|17||
60081806|NCT00240526|76197302|FG001|STARTED|Year 19|Number of subjects who come back at Year 19 (Month 228) time-point|16||
60081807|NCT00240526|76197303|FG002|STARTED|Year 19|Number of subjects who come back at Year 19 (Month 228) time-point|12||
60081808|NCT00240526|76197304|FG003|STARTED|Year 19|Number of subjects who come back at Year 19 (Month 228) time-point|18||
60081809|NCT00240526|76197301|FG000|COMPLETED|Year 19||17||
60081810|NCT00240526|76197302|FG001|COMPLETED|Year 19||16||
60081811|NCT00240526|76197303|FG002|COMPLETED|Year 19||12||
60081812|NCT00240526|76197304|FG003|COMPLETED|Year 19||18||
60081813|NCT00240526|76197301|FG000|NOT COMPLETED|Year 19||0||
60081814|NCT00240526|76197302|FG001|NOT COMPLETED|Year 19||0||
60081815|NCT00240526|76197303|FG002|NOT COMPLETED|Year 19||0||
60081816|NCT00240526|76197304|FG003|NOT COMPLETED|Year 19||0||
60081817|NCT00240526|76197301|FG000|STARTED|Year 20|Number of subjects who come back at Year 20 (Month 240) time-point|19||
60081818|NCT00240526|76197302|FG001|STARTED|Year 20|Number of subjects who come back at Year 20 (Month 240) time-point|17||
60081819|NCT00240526|76197303|FG002|STARTED|Year 20|Number of subjects who come back at Year 20 (Month 240) time-point|13||
60081820|NCT00240526|76197304|FG003|STARTED|Year 20|Number of subjects who come back at Year 20 (Month 240) time-point|20||
60081821|NCT00240526|76197301|FG000|COMPLETED|Year 20||19||
60081822|NCT00240526|76197302|FG001|COMPLETED|Year 20||17||
60081823|NCT00240526|76197303|FG002|COMPLETED|Year 20||13||
60081824|NCT00240526|76197304|FG003|COMPLETED|Year 20||20||
60081825|NCT00240526|76197301|FG000|NOT COMPLETED|Year 20||0||
60081826|NCT00240526|76197302|FG001|NOT COMPLETED|Year 20||0||
60081827|NCT00240526|76197303|FG002|NOT COMPLETED|Year 20||0||
60081828|NCT00240526|76197304|FG003|NOT COMPLETED|Year 20||0||
60081829|NCT00242632|76197320|FG000|STARTED|Overall Study||11||
60081830|NCT00242632|76197321|FG001|STARTED|Overall Study||11||
60081831|NCT00242632|76197320|FG000|COMPLETED|Overall Study||11||
60081832|NCT00242632|76197321|FG001|COMPLETED|Overall Study||11||
60081833|NCT00242632|76197320|FG000|NOT COMPLETED|Overall Study||0||
60081834|NCT00242632|76197321|FG001|NOT COMPLETED|Overall Study||0||
60081835|NCT00245518|76197328|FG000|STARTED|Overall Study||17||
60081836|NCT00245518|76197329|FG001|STARTED|Overall Study||16||
60081837|NCT00245518|76197328|FG000|COMPLETED|Overall Study||17||
60081838|NCT00245518|76197329|FG001|COMPLETED|Overall Study||16||
60081839|NCT00245518|76197328|FG000|NOT COMPLETED|Overall Study||0||
60081840|NCT00245518|76197329|FG001|NOT COMPLETED|Overall Study||0||
60081841|NCT00267670|76197337|FG000|STARTED|Overall Study||19||
60081842|NCT00267670|76197338|FG001|STARTED|Overall Study||7||
60081843|NCT00267670|76197337|FG000|COMPLETED|Overall Study||15||
60081844|NCT00267670|76197338|FG001|COMPLETED|Overall Study||7||
60081845|NCT00267670|76197337|FG000|NOT COMPLETED|Overall Study||4||
60081846|NCT00267670|76197338|FG001|NOT COMPLETED|Overall Study||0||
60081847|NCT00247624|76197347|FG000|STARTED|Overall Study||30||
60081848|NCT00247624|76197348|FG001|STARTED|Overall Study||30||
60081849|NCT00247624|76197347|FG000|COMPLETED|Overall Study||25||
60081850|NCT00247624|76197348|FG001|COMPLETED|Overall Study||26||
60081851|NCT00247624|76197347|FG000|NOT COMPLETED|Overall Study||5||
60081852|NCT00247624|76197348|FG001|NOT COMPLETED|Overall Study||4||
60081853|NCT00248560|76197354|FG000|STARTED|Overall Study||36||
60081854|NCT00248560|76197354|FG000|COMPLETED|Overall Study||36||
60081855|NCT00248560|76197354|FG000|NOT COMPLETED|Overall Study||0||
60081856|NCT00248638|76197361|FG000|STARTED|Overall Study||75||
60081857|NCT00248638|76197362|FG001|STARTED|Overall Study||75||
60081858|NCT00248638|76197361|FG000|COMPLETED|Overall Study||75||
60081859|NCT00248638|76197362|FG001|COMPLETED|Overall Study||75||
60081860|NCT00248638|76197361|FG000|NOT COMPLETED|Overall Study||0||
60081861|NCT00248638|76197362|FG001|NOT COMPLETED|Overall Study||0||
60081862|NCT00249496|76197372|FG000|STARTED|Overall Study||24||
60081863|NCT00249496|76197373|FG001|STARTED|Overall Study||27||
60081864|NCT00249496|76197372|FG000|COMPLETED|Overall Study||24||
60081865|NCT00249496|76197373|FG001|COMPLETED|Overall Study||26||
59706770|NCT00996892|75825868|FG007|NOT COMPLETED|Dose-Escalation Stage 1||0||
59706771|NCT00996892|75825869|FG008|NOT COMPLETED|Dose-Escalation Stage 1||0||
59706772|NCT00996892|75825870|FG009|NOT COMPLETED|Dose-Escalation Stage 1||0||
59706773|NCT00996892|75825871|FG010|NOT COMPLETED|Dose-Escalation Stage 1||0||
59706774|NCT00996892|75825872|FG011|NOT COMPLETED|Dose-Escalation Stage 1||0||
59706775|NCT00996892|75825873|FG012|NOT COMPLETED|Dose-Escalation Stage 1||0||
59551031|NCT02618187|75650690|FG000|COMPLETED|Overall Study||13|Subjects Completed Visit 13 (short-term safety follow-up)|
59551032|NCT02618187|75650691|FG001|COMPLETED|Overall Study||9|Subjects Completed Visit 13 (short-term safety follow-up)|
59551033|NCT02618187|75650692|FG002|COMPLETED|Overall Study||11|Subjects Completed Visit 13 (short-term safety follow-up)|
60081866|NCT00249496|76197372|FG000|NOT COMPLETED|Overall Study||0||
60081867|NCT00249496|76197373|FG001|NOT COMPLETED|Overall Study||1||
60081868|NCT00268762|76197381|FG000|STARTED|Overall Study||65||
60081869|NCT00268762|76197381|FG000|COMPLETED|Overall Study||65||
60081870|NCT00268762|76197381|FG000|NOT COMPLETED|Overall Study||0||
60081871|NCT00252382|76197385|FG000|STARTED|Overall Study||31||
60081872|NCT00252382|76197385|FG000|COMPLETED|Overall Study||5||
60081873|NCT00252382|76197385|FG000|NOT COMPLETED|Overall Study||26||
60081874|NCT00270634|76197393|FG000|STARTED|Overall Study||87||
60081875|NCT00270634|76197394|FG001|STARTED|Overall Study||77||
60081876|NCT00270634|76197395|FG002|STARTED|Overall Study||84||
60081877|NCT00270634|76197396|FG003|STARTED|Overall Study||86||
60081878|NCT00270634|76197393|FG000|COMPLETED|Overall Study||70||
59565875|NCT04392219|75668299|FG009|COMPLETED|Overall Study||10||
60081879|NCT00270634|76197394|FG001|COMPLETED|Overall Study||64||
60081880|NCT00270634|76197395|FG002|COMPLETED|Overall Study||62||
60081881|NCT00270634|76197396|FG003|COMPLETED|Overall Study||81||
60081882|NCT00270634|76197393|FG000|NOT COMPLETED|Overall Study||17||
60081883|NCT00270634|76197394|FG001|NOT COMPLETED|Overall Study||13||
60081884|NCT00270634|76197395|FG002|NOT COMPLETED|Overall Study||22||
60081885|NCT00270634|76197396|FG003|NOT COMPLETED|Overall Study||5||
60081886|NCT00252538|76197410|FG000|STARTED|Overall Study||19||
60081887|NCT00252538|76197411|FG001|STARTED|Overall Study||114||
60081888|NCT00252538|76197410|FG000|COMPLETED|Overall Study||19||
60081889|NCT00252538|76197411|FG001|COMPLETED|Overall Study||114||
60081890|NCT00252538|76197410|FG000|NOT COMPLETED|Overall Study||0||
60081891|NCT00252538|76197411|FG001|NOT COMPLETED|Overall Study||0||
60081892|NCT00270790|76197416|FG000|STARTED|Overall Study||21||
60081893|NCT00270790|76197416|FG000|COMPLETED|Overall Study||16||
60081894|NCT00270790|76197416|FG000|NOT COMPLETED|Overall Study||5||
60081895|NCT00271570|76197422|FG000|STARTED|Overall Study||12||
60081896|NCT00271570|76197423|FG001|STARTED|Overall Study||12||
60081897|NCT00271570|76197422|FG000|COMPLETED|Overall Study||12||
60081898|NCT00271570|76197423|FG001|COMPLETED|Overall Study||12||
60081899|NCT00271570|76197422|FG000|NOT COMPLETED|Overall Study||0||
59706776|NCT00996892|75825874|FG013|NOT COMPLETED|Dose-Escalation Stage 1||0||
59706777|NCT00996892|75825875|FG014|NOT COMPLETED|Dose-Escalation Stage 1||0||
59706778|NCT00996892|75825876|FG015|NOT COMPLETED|Dose-Escalation Stage 1||0||
59706779|NCT00996892|75825877|FG016|NOT COMPLETED|Dose-Escalation Stage 1||0||
59706780|NCT00996892|75825878|FG017|NOT COMPLETED|Dose-Escalation Stage 1||0||
59706781|NCT00996892|75825879|FG018|NOT COMPLETED|Dose-Escalation Stage 1||0||
59706782|NCT00996892|75825880|FG019|NOT COMPLETED|Dose-Escalation Stage 1||0||
59706783|NCT00996892|75825861|FG000|STARTED|Dose-Escalation Stage 1A||0||
59706784|NCT00996892|75825862|FG001|STARTED|Dose-Escalation Stage 1A||0||
59706785|NCT00996892|75825863|FG002|STARTED|Dose-Escalation Stage 1A||0||
59706786|NCT00996892|75825864|FG003|STARTED|Dose-Escalation Stage 1A||0||
59551034|NCT02618187|75650693|FG003|COMPLETED|Overall Study||12|Subjects Completed Visit 13 (short-term safety follow-up)|
59551035|NCT02618187|75650690|FG000|NOT COMPLETED|Overall Study||2||
59706787|NCT00996892|75825865|FG004|STARTED|Dose-Escalation Stage 1A||0||
59706788|NCT00996892|75825866|FG005|STARTED|Dose-Escalation Stage 1A||0||
59706789|NCT00996892|75825867|FG006|STARTED|Dose-Escalation Stage 1A||0||
59551036|NCT02618187|75650691|FG001|NOT COMPLETED|Overall Study||2||
59551037|NCT02618187|75650692|FG002|NOT COMPLETED|Overall Study||4||
59551038|NCT02618187|75650693|FG003|NOT COMPLETED|Overall Study||5||
59551039|NCT01759277|75650705|FG000|STARTED|Overall Study||41||
59551040|NCT01759277|75650706|FG001|STARTED|Overall Study||39||
59551041|NCT01759277|75650705|FG000|COMPLETED|Overall Study||41||
59551042|NCT01759277|75650706|FG001|COMPLETED|Overall Study||39||
59551043|NCT01759277|75650705|FG000|NOT COMPLETED|Overall Study||0||
59551044|NCT01759277|75650706|FG001|NOT COMPLETED|Overall Study||0||
59551045|NCT02618343|75650716|FG000|STARTED|Overall Study||28||
59551046|NCT02618343|75650717|FG001|STARTED|Overall Study||23||
59551047|NCT02618343|75650716|FG000|COMPLETED|Overall Study||28||
59551048|NCT02618343|75650717|FG001|COMPLETED|Overall Study||23||
59551049|NCT02618343|75650716|FG000|NOT COMPLETED|Overall Study||0||
59551050|NCT02618343|75650717|FG001|NOT COMPLETED|Overall Study||0||
59551051|NCT01762631|75650725|FG000|STARTED|Overall Study||53||
59551052|NCT01762631|75650726|FG001|STARTED|Overall Study||22||
59551053|NCT01762631|75650725|FG000|COMPLETED|Overall Study||53||
60081900|NCT00271570|76197423|FG001|NOT COMPLETED|Overall Study||0||
60081901|NCT00273364|76197431|FG000|STARTED|Overall Study||55||
60081902|NCT00273364|76197432|FG001|STARTED|Overall Study||55||
60081903|NCT00273364|76197431|FG000|COMPLETED|Overall Study||55||
60081904|NCT00273364|76197432|FG001|COMPLETED|Overall Study||55||
60081905|NCT00273364|76197431|FG000|NOT COMPLETED|Overall Study||0||
59551054|NCT01762631|75650726|FG001|COMPLETED|Overall Study||22||
59551055|NCT01762631|75650725|FG000|NOT COMPLETED|Overall Study||0||
59551056|NCT01762631|75650726|FG001|NOT COMPLETED|Overall Study||0||
59551057|NCT01251536|75650735|FG000|STARTED|Overall Study||8||
59551058|NCT01251536|75650736|FG001|STARTED|Overall Study||93||
59551059|NCT01251536|75650737|FG002|STARTED|Overall Study||7||
59551060|NCT01251536|75650735|FG000|COMPLETED|Overall Study||8||
59551061|NCT01251536|75650736|FG001|COMPLETED|Overall Study||93||
59551062|NCT01251536|75650737|FG002|COMPLETED|Overall Study||7||
59551063|NCT01251536|75650735|FG000|NOT COMPLETED|Overall Study||0||
59551064|NCT01251536|75650736|FG001|NOT COMPLETED|Overall Study||0||
59551065|NCT01251536|75650737|FG002|NOT COMPLETED|Overall Study||0||
60081906|NCT00273364|76197432|FG001|NOT COMPLETED|Overall Study||0||
60081907|NCT02102932|76197446|FG000|STARTED|Overall Study||12||
60081908|NCT02102932|76197447|FG001|STARTED|Overall Study||12||
60081909|NCT02102932|76197448|FG002|STARTED|Overall Study||12||
60081910|NCT02102932|76197449|FG003|STARTED|Overall Study||12||
60081911|NCT02102932|76197450|FG004|STARTED|Overall Study||12||
60081912|NCT02102932|76197451|FG005|STARTED|Overall Study||12||
60081913|NCT02102932|76197452|FG006|STARTED|Overall Study||12||
60081914|NCT02102932|76197453|FG007|STARTED|Overall Study||12||
60081915|NCT02102932|76197446|FG000|COMPLETED|Overall Study||12||
60081916|NCT02102932|76197447|FG001|COMPLETED|Overall Study||12||
60081917|NCT02102932|76197448|FG002|COMPLETED|Overall Study||12||
59551066|NCT02619591|75650749|FG000|STARTED|Overall Study||139||
59551067|NCT02619591|75650750|FG001|STARTED|Overall Study||121||
59551068|NCT02619591|75650749|FG000|COMPLETED|Overall Study||0||
59551069|NCT02619591|75650750|FG001|COMPLETED|Overall Study||0||
59551070|NCT02619591|75650749|FG000|NOT COMPLETED|Overall Study||139||
60081918|NCT02102932|76197449|FG003|COMPLETED|Overall Study||12||
60081919|NCT02102932|76197450|FG004|COMPLETED|Overall Study||12||
60081920|NCT02102932|76197451|FG005|COMPLETED|Overall Study||12||
59551071|NCT02619591|75650750|FG001|NOT COMPLETED|Overall Study||121||
59551072|NCT02620683|75650756|FG000|STARTED|First Intervention (Visit 1)||12||
59551073|NCT02620683|75650757|FG001|STARTED|First Intervention (Visit 1)||11||
59551074|NCT02620683|75650756|FG000|COMPLETED|First Intervention (Visit 1)||12||
59551075|NCT02620683|75650757|FG001|COMPLETED|First Intervention (Visit 1)||11||
59551076|NCT02620683|75650756|FG000|NOT COMPLETED|First Intervention (Visit 1)||0||
59551077|NCT02620683|75650757|FG001|NOT COMPLETED|First Intervention (Visit 1)||0||
59551078|NCT02620683|75650756|FG000|STARTED|Washout (2 Weeks)||12||
59551079|NCT02620683|75650757|FG001|STARTED|Washout (2 Weeks)||11||
59551080|NCT02620683|75650756|FG000|COMPLETED|Washout (2 Weeks)||12||
59551081|NCT02620683|75650757|FG001|COMPLETED|Washout (2 Weeks)||11||
59551082|NCT02620683|75650756|FG000|NOT COMPLETED|Washout (2 Weeks)||0||
59551083|NCT02620683|75650757|FG001|NOT COMPLETED|Washout (2 Weeks)||0||
59551084|NCT02620683|75650756|FG000|STARTED|Second Intervention (Visit 2)||12||
59551085|NCT02620683|75650757|FG001|STARTED|Second Intervention (Visit 2)||11||
59551086|NCT02620683|75650756|FG000|COMPLETED|Second Intervention (Visit 2)||12||
59551087|NCT02620683|75650757|FG001|COMPLETED|Second Intervention (Visit 2)||11||
59551088|NCT02620683|75650756|FG000|NOT COMPLETED|Second Intervention (Visit 2)||0||
59565876|NCT04392219|75668300|FG010|COMPLETED|Overall Study||14||
59551089|NCT02620683|75650757|FG001|NOT COMPLETED|Second Intervention (Visit 2)||0||
59551090|NCT02620917|75650762|FG000|STARTED|Overall Study||6623||
59551091|NCT02620917|75650762|FG000|COMPLETED|Overall Study||6623||
59551092|NCT02620917|75650762|FG000|NOT COMPLETED|Overall Study||0||
59551093|NCT02621463|75650768|FG000|STARTED|Overall Study||29||
59551094|NCT02621463|75650768|FG000|COMPLETED|Overall Study||29||
59551095|NCT02621463|75650768|FG000|NOT COMPLETED|Overall Study||0||
59551096|NCT01355588|75650776|FG000|STARTED|First Intervention (Day 1)||4||
59551097|NCT01355588|75650777|FG001|STARTED|First Intervention (Day 1)||4||
59551098|NCT01355588|75650778|FG002|STARTED|First Intervention (Day 1)||4||
59551099|NCT01355588|75650779|FG003|STARTED|First Intervention (Day 1)||4||
59551100|NCT01355588|75650776|FG000|COMPLETED|First Intervention (Day 1)||4||
59551101|NCT01355588|75650777|FG001|COMPLETED|First Intervention (Day 1)||4||
59551102|NCT01355588|75650778|FG002|COMPLETED|First Intervention (Day 1)||4||
59551103|NCT01355588|75650779|FG003|COMPLETED|First Intervention (Day 1)||4||
59551104|NCT01355588|75650776|FG000|NOT COMPLETED|First Intervention (Day 1)||0||
59551105|NCT01355588|75650777|FG001|NOT COMPLETED|First Intervention (Day 1)||0||
59551106|NCT01355588|75650778|FG002|NOT COMPLETED|First Intervention (Day 1)||0||
59551107|NCT01355588|75650779|FG003|NOT COMPLETED|First Intervention (Day 1)||0||
59551108|NCT01355588|75650776|FG000|STARTED|Washout (3-7 Days)||4||
59551109|NCT01355588|75650777|FG001|STARTED|Washout (3-7 Days)||4||
59551110|NCT01355588|75650778|FG002|STARTED|Washout (3-7 Days)||4||
59706790|NCT00996892|75825868|FG007|STARTED|Dose-Escalation Stage 1A||3||
59706791|NCT00996892|75825869|FG008|STARTED|Dose-Escalation Stage 1A||3||
59551111|NCT01355588|75650779|FG003|STARTED|Washout (3-7 Days)||4||
59551112|NCT01355588|75650776|FG000|COMPLETED|Washout (3-7 Days)||4||
59551113|NCT01355588|75650777|FG001|COMPLETED|Washout (3-7 Days)||4||
59551114|NCT01355588|75650778|FG002|COMPLETED|Washout (3-7 Days)||4||
59551115|NCT01355588|75650779|FG003|COMPLETED|Washout (3-7 Days)||4||
59551116|NCT01355588|75650776|FG000|NOT COMPLETED|Washout (3-7 Days)||0||
59551117|NCT01355588|75650777|FG001|NOT COMPLETED|Washout (3-7 Days)||0||
59551118|NCT01355588|75650778|FG002|NOT COMPLETED|Washout (3-7 Days)||0||
59551119|NCT01355588|75650779|FG003|NOT COMPLETED|Washout (3-7 Days)||0||
59551120|NCT01355588|75650776|FG000|STARTED|Second Intervention (After Washout)||4||
59551121|NCT01355588|75650777|FG001|STARTED|Second Intervention (After Washout)||4||
59551122|NCT01355588|75650778|FG002|STARTED|Second Intervention (After Washout)||4||
59551123|NCT01355588|75650779|FG003|STARTED|Second Intervention (After Washout)||4||
59551124|NCT01355588|75650776|FG000|COMPLETED|Second Intervention (After Washout)||4||
59551125|NCT01355588|75650777|FG001|COMPLETED|Second Intervention (After Washout)||4||
59551126|NCT01355588|75650778|FG002|COMPLETED|Second Intervention (After Washout)||4||
59551127|NCT01355588|75650779|FG003|COMPLETED|Second Intervention (After Washout)||4||
60081921|NCT02102932|76197452|FG006|COMPLETED|Overall Study||12||
60081922|NCT02102932|76197453|FG007|COMPLETED|Overall Study||12||
60081923|NCT02102932|76197446|FG000|NOT COMPLETED|Overall Study||0||
60081924|NCT02102932|76197447|FG001|NOT COMPLETED|Overall Study||0||
60081925|NCT02102932|76197448|FG002|NOT COMPLETED|Overall Study||0||
60081926|NCT02102932|76197449|FG003|NOT COMPLETED|Overall Study||0||
60081927|NCT02102932|76197450|FG004|NOT COMPLETED|Overall Study||0||
60081928|NCT02102932|76197451|FG005|NOT COMPLETED|Overall Study||0||
60081929|NCT02102932|76197452|FG006|NOT COMPLETED|Overall Study||0||
60081930|NCT02102932|76197453|FG007|NOT COMPLETED|Overall Study||0||
60081931|NCT00273754|76197473|FG000|STARTED|Overall Study||36||
60081932|NCT00273754|76197474|FG001|STARTED|Overall Study||36||
60081933|NCT00273754|76197473|FG000|COMPLETED|Overall Study||36||
60081934|NCT00273754|76197474|FG001|COMPLETED|Overall Study||36||
60081935|NCT00273754|76197473|FG000|NOT COMPLETED|Overall Study||0||
60081936|NCT00273754|76197474|FG001|NOT COMPLETED|Overall Study||0||
60081937|NCT00273910|76197486|FG000|STARTED|Overall Study||19||
60081938|NCT00273910|76197487|FG001|STARTED|Overall Study||19||
60081939|NCT00273910|76197488|FG002|STARTED|Overall Study||18||
60081940|NCT00273910|76197489|FG003|STARTED|Overall Study||19||
60081941|NCT00273910|76197490|FG004|STARTED|Overall Study||15||
60081942|NCT00273910|76197491|FG005|STARTED|Overall Study||14||
60081943|NCT00273910|76197486|FG000|COMPLETED|Overall Study||19||
60081944|NCT00273910|76197487|FG001|COMPLETED|Overall Study||19||
60081945|NCT00273910|76197488|FG002|COMPLETED|Overall Study||18||
60081946|NCT00273910|76197489|FG003|COMPLETED|Overall Study||19||
60081947|NCT00273910|76197490|FG004|COMPLETED|Overall Study||15||
60081948|NCT00273910|76197491|FG005|COMPLETED|Overall Study||14||
60081949|NCT00273910|76197486|FG000|NOT COMPLETED|Overall Study||0||
60081950|NCT00273910|76197487|FG001|NOT COMPLETED|Overall Study||0||
60081951|NCT00273910|76197488|FG002|NOT COMPLETED|Overall Study||0||
60081952|NCT00273910|76197489|FG003|NOT COMPLETED|Overall Study||0||
60081953|NCT00273910|76197490|FG004|NOT COMPLETED|Overall Study||0||
60081954|NCT00273910|76197491|FG005|NOT COMPLETED|Overall Study||0||
60081955|NCT00274768|76197505|FG000|STARTED|Overall Study||26||
60081956|NCT00274768|76197505|FG000|COMPLETED|Overall Study||26||
60081957|NCT00274768|76197505|FG000|NOT COMPLETED|Overall Study||0||
60081958|NCT00280384|76197517|FG000|STARTED|Overall Study||6||
60081959|NCT00280384|76197518|FG001|STARTED|Overall Study||6||
60081960|NCT00280384|76197519|FG002|STARTED|Overall Study||6||
60081961|NCT00280384|76197520|FG003|STARTED|Overall Study||6||
60081962|NCT00280384|76197521|FG004|STARTED|Overall Study||6||
60081963|NCT00280384|76197522|FG005|STARTED|Overall Study||6||
60081964|NCT00280384|76197523|FG006|STARTED|Overall Study||6||
60081965|NCT00280384|76197524|FG007|STARTED|Overall Study||6||
60081966|NCT00280384|76197517|FG000|COMPLETED|Overall Study||6||
60081967|NCT00280384|76197518|FG001|COMPLETED|Overall Study||6||
60081968|NCT00280384|76197519|FG002|COMPLETED|Overall Study||6||
60081969|NCT00280384|76197520|FG003|COMPLETED|Overall Study||6||
60081970|NCT00280384|76197521|FG004|COMPLETED|Overall Study||6||
59551128|NCT01355588|75650776|FG000|NOT COMPLETED|Second Intervention (After Washout)||0||
59551129|NCT01355588|75650777|FG001|NOT COMPLETED|Second Intervention (After Washout)||0||
59551130|NCT01355588|75650778|FG002|NOT COMPLETED|Second Intervention (After Washout)||0||
59551131|NCT01355588|75650779|FG003|NOT COMPLETED|Second Intervention (After Washout)||0||
59551132|NCT01355588|75650776|FG000|STARTED|Washout (3-7 Days)||4||
60081971|NCT00280384|76197522|FG005|COMPLETED|Overall Study||6||
60081972|NCT00280384|76197523|FG006|COMPLETED|Overall Study||6||
60081973|NCT00280384|76197524|FG007|COMPLETED|Overall Study||6||
60081974|NCT00280384|76197517|FG000|NOT COMPLETED|Overall Study||0||
60081975|NCT00280384|76197518|FG001|NOT COMPLETED|Overall Study||0||
60081976|NCT00280384|76197519|FG002|NOT COMPLETED|Overall Study||0||
59551133|NCT01355588|75650777|FG001|STARTED|Washout (3-7 Days)||4||
60081977|NCT00280384|76197520|FG003|NOT COMPLETED|Overall Study||0||
60081978|NCT00280384|76197521|FG004|NOT COMPLETED|Overall Study||0||
60081979|NCT00280384|76197522|FG005|NOT COMPLETED|Overall Study||0||
60081980|NCT00280384|76197523|FG006|NOT COMPLETED|Overall Study||0||
60081981|NCT00280384|76197524|FG007|NOT COMPLETED|Overall Study||0||
60081982|NCT01763996|76197542|FG000|STARTED|Treatment Period 1||15||
59551134|NCT01355588|75650778|FG002|STARTED|Washout (3-7 Days)||4||
59551135|NCT01355588|75650779|FG003|STARTED|Washout (3-7 Days)||4||
59551136|NCT01355588|75650776|FG000|COMPLETED|Washout (3-7 Days)||4||
59551137|NCT01355588|75650777|FG001|COMPLETED|Washout (3-7 Days)||4||
59551138|NCT01355588|75650778|FG002|COMPLETED|Washout (3-7 Days)||4||
59551139|NCT01355588|75650779|FG003|COMPLETED|Washout (3-7 Days)||4||
59551140|NCT01355588|75650776|FG000|NOT COMPLETED|Washout (3-7 Days)||0||
59551141|NCT01355588|75650777|FG001|NOT COMPLETED|Washout (3-7 Days)||0||
59551142|NCT01355588|75650778|FG002|NOT COMPLETED|Washout (3-7 Days)||0||
60081983|NCT01763996|76197543|FG001|STARTED|Treatment Period 1||15||
60081984|NCT01763996|76197542|FG000|COMPLETED|Treatment Period 1||15||
60081985|NCT01763996|76197543|FG001|COMPLETED|Treatment Period 1||15||
60081986|NCT01763996|76197542|FG000|NOT COMPLETED|Treatment Period 1||0||
60081987|NCT01763996|76197543|FG001|NOT COMPLETED|Treatment Period 1||0||
60081988|NCT01763996|76197542|FG000|STARTED|Treatment Period 2||15||
60081989|NCT01763996|76197543|FG001|STARTED|Treatment Period 2||15||
60081990|NCT01763996|76197542|FG000|COMPLETED|Treatment Period 2||15||
60081991|NCT01763996|76197543|FG001|COMPLETED|Treatment Period 2||14||
60081992|NCT01763996|76197542|FG000|NOT COMPLETED|Treatment Period 2||0||
60081993|NCT01763996|76197543|FG001|NOT COMPLETED|Treatment Period 2||1||
60081994|NCT02099266|76197549|FG000|STARTED|Overall Study||15||
60081995|NCT02099266|76197549|FG000|COMPLETED|Overall Study||15||
60081996|NCT02099266|76197549|FG000|NOT COMPLETED|Overall Study||0||
60081997|NCT04511338|76197558|FG000|STARTED|Period 1||8||
60081998|NCT04511338|76197559|FG001|STARTED|Period 1||8||
60081999|NCT04511338|76197558|FG000|COMPLETED|Period 1||7||
59551143|NCT01355588|75650779|FG003|NOT COMPLETED|Washout (3-7 Days)||0||
59551144|NCT01355588|75650776|FG000|STARTED|Third Intervention (After Washout)||4||
60082000|NCT04511338|76197559|FG001|COMPLETED|Period 1||8||
59551145|NCT01355588|75650777|FG001|STARTED|Third Intervention (After Washout)||4||
60082001|NCT04511338|76197558|FG000|NOT COMPLETED|Period 1||1||
60082002|NCT04511338|76197559|FG001|NOT COMPLETED|Period 1||0||
60103623|NCT01291108|76221868|FG005|STARTED|Month 2 (Adjunctive Therapy)||26||
60103624|NCT01291108|76221863|FG000|COMPLETED|Month 2 (Adjunctive Therapy)||0||
60103625|NCT01291108|76221864|FG001|COMPLETED|Month 2 (Adjunctive Therapy)||38||
60103626|NCT01291108|76221865|FG002|COMPLETED|Month 2 (Adjunctive Therapy)||24||
60103627|NCT01291108|76221866|FG003|COMPLETED|Month 2 (Adjunctive Therapy)||0||
60103628|NCT01291108|76221867|FG004|COMPLETED|Month 2 (Adjunctive Therapy)||34||
60103629|NCT01291108|76221868|FG005|COMPLETED|Month 2 (Adjunctive Therapy)||25||
60103630|NCT01291108|76221863|FG000|NOT COMPLETED|Month 2 (Adjunctive Therapy)||0||
60103631|NCT01291108|76221864|FG001|NOT COMPLETED|Month 2 (Adjunctive Therapy)||2||
60103632|NCT01291108|76221865|FG002|NOT COMPLETED|Month 2 (Adjunctive Therapy)||0||
60103633|NCT01291108|76221866|FG003|NOT COMPLETED|Month 2 (Adjunctive Therapy)||0||
60103634|NCT01291108|76221867|FG004|NOT COMPLETED|Month 2 (Adjunctive Therapy)||0||
60103635|NCT01291108|76221868|FG005|NOT COMPLETED|Month 2 (Adjunctive Therapy)||1||
60103636|NCT01291264|76221879|FG000|STARTED|Overall Study||260||
60103637|NCT01291264|76221879|FG000|COMPLETED|Overall Study||260||
60103638|NCT01291264|76221879|FG000|NOT COMPLETED|Overall Study||0||
60103639|NCT01291498|76221883|FG000|STARTED|Overall Study||1||
60103640|NCT01291498|76221883|FG000|COMPLETED|Overall Study||0||
60103641|NCT01291498|76221883|FG000|NOT COMPLETED|Overall Study||1||
60103642|NCT01346488|76221889|FG000|STARTED|Overall Study||1968||
60103643|NCT01346488|76221889|FG000|COMPLETED|Overall Study||1262||
60103644|NCT01346488|76221889|FG000|NOT COMPLETED|Overall Study||706||
60103645|NCT00989781|76221895|FG000|STARTED|Ovarian Response to hCG||21||
60103646|NCT00989781|76221896|FG001|STARTED|Ovarian Response to hCG||20||
60103647|NCT00989781|76221895|FG000|COMPLETED|Ovarian Response to hCG||18||
60103648|NCT00989781|76221896|FG001|COMPLETED|Ovarian Response to hCG||18||
60103649|NCT00989781|76221895|FG000|NOT COMPLETED|Ovarian Response to hCG||3||
60103650|NCT00989781|76221896|FG001|NOT COMPLETED|Ovarian Response to hCG||2||
60103651|NCT00989781|76221895|FG000|STARTED|Adrenal Response ot ACTH|15 subjects that completed part 1 elected to participate in Part 2|18||
60103820|NCT03774849|76222135|FG000|NOT COMPLETED|Overall Study||10||
60082003|NCT04511338|76197558|FG000|STARTED|Washout|"We followed the rules in protocol (brief version in SARP sec. 3.1) to withdraw or move subjects to the next period.~Period 1:~Dialyzer with Endexo has grade 4 clotting, subjects is withdrawn from the study~CombiSet with grade 4 clotting only (not the dialyzer): subjects end Period 1, move to Washout, and then Period 2~There was a subject with CombiSet bloodline grade 4 clotting in the 50% heparin reduction HD. The subject was moved to washout period without any heparin free sessions."|8||
60082004|NCT04511338|76197559|FG001|STARTED|Washout||8||
60082005|NCT04511338|76197558|FG000|COMPLETED|Washout||8||
60082006|NCT04511338|76197559|FG001|COMPLETED|Washout||8||
60082007|NCT04511338|76197558|FG000|NOT COMPLETED|Washout||0||
60082008|NCT04511338|76197559|FG001|NOT COMPLETED|Washout||0||
60082009|NCT04511338|76197558|FG000|STARTED|Period 2||8||
60082010|NCT04511338|76197559|FG001|STARTED|Period 2||8||
60082011|NCT04511338|76197558|FG000|COMPLETED|Period 2||8||
60082012|NCT04511338|76197559|FG001|COMPLETED|Period 2||5||
60082013|NCT04511338|76197558|FG000|NOT COMPLETED|Period 2||0||
60082014|NCT04511338|76197559|FG001|NOT COMPLETED|Period 2||3||
60082015|NCT02100748|76197577|FG000|STARTED|Overall Study||25||
60082016|NCT02100748|76197578|FG001|STARTED|Overall Study||24||
60082017|NCT02100748|76197579|FG002|STARTED|Overall Study||22||
60082018|NCT02100748|76197580|FG003|STARTED|Overall Study||22||
60082019|NCT02100748|76197581|FG004|STARTED|Overall Study||25||
60082020|NCT02100748|76197582|FG005|STARTED|Overall Study||23||
60082021|NCT02100748|76197583|FG006|STARTED|Overall Study||20||
60082022|NCT02100748|76197584|FG007|STARTED|Overall Study||38||
60082023|NCT02100748|76197585|FG008|STARTED|Overall Study||36||
60082024|NCT02100748|76197586|FG009|STARTED|Overall Study||31||
60082025|NCT02100748|76197587|FG010|STARTED|Overall Study||28||
60082026|NCT02100748|76197588|FG011|STARTED|Overall Study||39||
60082027|NCT02100748|76197577|FG000|COMPLETED|Overall Study||23||
60082028|NCT02100748|76197578|FG001|COMPLETED|Overall Study||23||
60082029|NCT02100748|76197579|FG002|COMPLETED|Overall Study||21||
60082030|NCT02100748|76197580|FG003|COMPLETED|Overall Study||21||
60082031|NCT02100748|76197581|FG004|COMPLETED|Overall Study||23||
60082032|NCT02100748|76197582|FG005|COMPLETED|Overall Study||23||
60082033|NCT02100748|76197583|FG006|COMPLETED|Overall Study||18||
60082034|NCT02100748|76197584|FG007|COMPLETED|Overall Study||34||
60082035|NCT02100748|76197585|FG008|COMPLETED|Overall Study||33||
60082036|NCT02100748|76197586|FG009|COMPLETED|Overall Study||29||
60082037|NCT02100748|76197587|FG010|COMPLETED|Overall Study||26||
60082038|NCT02100748|76197588|FG011|COMPLETED|Overall Study||39||
60082039|NCT02100748|76197577|FG000|NOT COMPLETED|Overall Study||2||
60082040|NCT02100748|76197578|FG001|NOT COMPLETED|Overall Study||1||
60082041|NCT02100748|76197579|FG002|NOT COMPLETED|Overall Study||1||
60082042|NCT02100748|76197580|FG003|NOT COMPLETED|Overall Study||1||
60082043|NCT02100748|76197581|FG004|NOT COMPLETED|Overall Study||2||
60082044|NCT02100748|76197582|FG005|NOT COMPLETED|Overall Study||0||
60082045|NCT02100748|76197583|FG006|NOT COMPLETED|Overall Study||2||
60082046|NCT02100748|76197584|FG007|NOT COMPLETED|Overall Study||4||
60082047|NCT02100748|76197585|FG008|NOT COMPLETED|Overall Study||3||
60082048|NCT02100748|76197586|FG009|NOT COMPLETED|Overall Study||2||
60082049|NCT02100748|76197587|FG010|NOT COMPLETED|Overall Study||2||
60082050|NCT02100748|76197588|FG011|NOT COMPLETED|Overall Study||0||
60082051|NCT00283504|76197616|FG000|STARTED|Overall Study||7||
60082052|NCT00283504|76197617|FG001|STARTED|Overall Study||6||
60082053|NCT00283504|76197616|FG000|COMPLETED|Overall Study||7||
60082054|NCT00283504|76197617|FG001|COMPLETED|Overall Study||6||
60082055|NCT00283504|76197616|FG000|NOT COMPLETED|Overall Study||0||
60082056|NCT00283504|76197617|FG001|NOT COMPLETED|Overall Study||0||
60082057|NCT00283816|76197627|FG000|STARTED|Overall Study||18||
60082058|NCT00283816|76197628|FG001|STARTED|Overall Study||18||
60082059|NCT00283816|76197627|FG000|COMPLETED|Overall Study||16||
60082060|NCT00283816|76197628|FG001|COMPLETED|Overall Study||16||
60082061|NCT00283816|76197627|FG000|NOT COMPLETED|Overall Study||2||
60082062|NCT00283816|76197628|FG001|NOT COMPLETED|Overall Study||2||
60082063|NCT00284518|76197640|FG000|STARTED|Overall Study||97||
60082064|NCT00284518|76197641|FG001|STARTED|Overall Study||94||
60082065|NCT00284518|76197642|FG002|STARTED|Overall Study||95||
60082066|NCT00284518|76197643|FG003|STARTED|Overall Study||94||
60082067|NCT00284518|76197640|FG000|COMPLETED|Overall Study||71||
60082068|NCT00284518|76197641|FG001|COMPLETED|Overall Study||66||
60082069|NCT00284518|76197642|FG002|COMPLETED|Overall Study||67||
60082070|NCT00284518|76197643|FG003|COMPLETED|Overall Study||61||
60082071|NCT00284518|76197640|FG000|NOT COMPLETED|Overall Study||26||
60082072|NCT00284518|76197641|FG001|NOT COMPLETED|Overall Study||28||
60082073|NCT00284518|76197642|FG002|NOT COMPLETED|Overall Study||28||
60082074|NCT00284518|76197643|FG003|NOT COMPLETED|Overall Study||33||
60082075|NCT00286078|76197655|FG000|STARTED|Overall Study||72||
60082076|NCT00286078|76197656|FG001|STARTED|Overall Study||68||
60082077|NCT00286078|76197655|FG000|12 Weeks|Overall Study||63||
60082078|NCT00286078|76197656|FG001|12 Weeks|Overall Study||62||
60082079|NCT00286078|76197655|FG000|COMPLETED|Overall Study||40||
60082080|NCT00286078|76197656|FG001|COMPLETED|Overall Study||34||
60082081|NCT00286078|76197655|FG000|NOT COMPLETED|Overall Study||32||
60082082|NCT00286078|76197656|FG001|NOT COMPLETED|Overall Study||34||
60082083|NCT00287716|76197665|FG000|STARTED|Overall Study||174||
60082084|NCT00287716|76197666|FG001|STARTED|Overall Study||87||
59706792|NCT00996892|75825870|FG009|STARTED|Dose-Escalation Stage 1A||4||
59706793|NCT00996892|75825871|FG010|STARTED|Dose-Escalation Stage 1A||7||
59706794|NCT00996892|75825872|FG011|STARTED|Dose-Escalation Stage 1A||9||
59706795|NCT00996892|75825873|FG012|STARTED|Dose-Escalation Stage 1A||8||
60082085|NCT00287716|76197667|FG002|STARTED|Overall Study||174||
60082086|NCT00287716|76197665|FG000|COMPLETED|Overall Study||136||
60082087|NCT00287716|76197666|FG001|COMPLETED|Overall Study||70||
60082088|NCT00287716|76197667|FG002|COMPLETED|Overall Study||143||
60082089|NCT00287716|76197665|FG000|NOT COMPLETED|Overall Study||38||
59706796|NCT00996892|75825874|FG013|STARTED|Dose-Escalation Stage 1A||5||
59706797|NCT00996892|75825875|FG014|STARTED|Dose-Escalation Stage 1A||0||
59706798|NCT00996892|75825876|FG015|STARTED|Dose-Escalation Stage 1A||0||
59706799|NCT00996892|75825877|FG016|STARTED|Dose-Escalation Stage 1A||0||
59706800|NCT00996892|75825878|FG017|STARTED|Dose-Escalation Stage 1A||0||
60082090|NCT00287716|76197666|FG001|NOT COMPLETED|Overall Study||17||
60082091|NCT00287716|76197667|FG002|NOT COMPLETED|Overall Study||31||
60082092|NCT00287872|76197675|FG000|STARTED|Overall Study||30||
60082093|NCT00287872|76197675|FG000|COMPLETED|Overall Study||30||
60082094|NCT00287872|76197675|FG000|NOT COMPLETED|Overall Study||0||
60082095|NCT00288574|76197682|FG000|STARTED|Overall Study||49||
60082096|NCT00288574|76197683|FG001|STARTED|Overall Study||44||
60082097|NCT00288574|76197682|FG000|COMPLETED|Overall Study||49||
60082098|NCT00288574|76197683|FG001|COMPLETED|Overall Study||44||
60082099|NCT00288574|76197682|FG000|NOT COMPLETED|Overall Study||0||
60082100|NCT00288574|76197683|FG001|NOT COMPLETED|Overall Study||0||
60082101|NCT00288886|76197694|FG000|STARTED|Overall Study||91||
60082102|NCT00288886|76197695|FG001|STARTED|Overall Study||92||
60082103|NCT00288886|76197694|FG000|3-month Follow Up|Overall Study||82||
60082104|NCT00288886|76197695|FG001|3-month Follow Up|Overall Study||85||
60082105|NCT00288886|76197694|FG000|6-month Follow Up|Overall Study||85||
59706801|NCT00996892|75825879|FG018|STARTED|Dose-Escalation Stage 1A||0||
59706802|NCT00996892|75825880|FG019|STARTED|Dose-Escalation Stage 1A||0||
59706803|NCT00996892|75825861|FG000|COMPLETED|Dose-Escalation Stage 1A||0||
59706804|NCT00996892|75825862|FG001|COMPLETED|Dose-Escalation Stage 1A||0||
59706805|NCT00996892|75825863|FG002|COMPLETED|Dose-Escalation Stage 1A||0||
59706806|NCT00996892|75825864|FG003|COMPLETED|Dose-Escalation Stage 1A||0||
59706807|NCT00996892|75825865|FG004|COMPLETED|Dose-Escalation Stage 1A||0||
59706808|NCT00996892|75825866|FG005|COMPLETED|Dose-Escalation Stage 1A||0||
59706809|NCT00996892|75825867|FG006|COMPLETED|Dose-Escalation Stage 1A||0||
59706810|NCT00996892|75825868|FG007|COMPLETED|Dose-Escalation Stage 1A||0||
60082106|NCT00288886|76197695|FG001|6-month Follow Up|Overall Study||84||
60082107|NCT00288886|76197694|FG000|12-month Follow Up|Overall Study||80||
60082108|NCT00288886|76197695|FG001|12-month Follow Up|Overall Study||81||
60082109|NCT00288886|76197694|FG000|COMPLETED|Overall Study||80||
60082110|NCT00288886|76197695|FG001|COMPLETED|Overall Study||81||
60082111|NCT00288886|76197694|FG000|NOT COMPLETED|Overall Study||11||
60082112|NCT00288886|76197695|FG001|NOT COMPLETED|Overall Study||11||
60082113|NCT00289120|76197701|FG000|STARTED|Overall Study||13||
60082114|NCT00289120|76197701|FG000|COMPLETED|Overall Study||13||
60082115|NCT00289120|76197701|FG000|NOT COMPLETED|Overall Study||0||
60082116|NCT00289744|76197709|FG000|STARTED|Year 6 Long-term Follow-up|Number of subjects who come back at Year 6 blood sampling time-point|178||
60082117|NCT00289744|76197710|FG001|STARTED|Year 6 Long-term Follow-up||0||
59991253|NCT02230384|76106770|FG000|COMPLETED|Phase 2 Wash Out||26||
59991254|NCT02230384|76106771|FG001|COMPLETED|Phase 2 Wash Out||30||
59991255|NCT02230384|76106770|FG000|NOT COMPLETED|Phase 2 Wash Out||0||
59991256|NCT02230384|76106771|FG001|NOT COMPLETED|Phase 2 Wash Out||0||
59991257|NCT02738801|76106787|FG000|STARTED|Overall Study||6||
59991258|NCT02738801|76106788|FG001|STARTED|Overall Study||17||
59991259|NCT02738801|76106787|FG000|COMPLETED|Overall Study||5||
60082118|NCT00289744|76197711|FG002|STARTED|Year 6 Long-term Follow-up||0||
60082119|NCT00289744|76197709|FG000|COMPLETED|Year 6 Long-term Follow-up||178||
60082120|NCT00289744|76197710|FG001|COMPLETED|Year 6 Long-term Follow-up||0||
60082121|NCT00289744|76197711|FG002|COMPLETED|Year 6 Long-term Follow-up||0||
60082122|NCT00289744|76197709|FG000|NOT COMPLETED|Year 6 Long-term Follow-up||0||
60082123|NCT00289744|76197710|FG001|NOT COMPLETED|Year 6 Long-term Follow-up||0||
60082124|NCT00289744|76197711|FG002|NOT COMPLETED|Year 6 Long-term Follow-up||0||
60082125|NCT00289744|76197709|FG000|STARTED|Year 7 Long-term Follow-up|Subjects who came back at Year 7 blood sampling time-point|175||
60082126|NCT00289744|76197710|FG001|STARTED|Year 7 Long-term Follow-up||0||
60082127|NCT00289744|76197711|FG002|STARTED|Year 7 Long-term Follow-up||0||
60082128|NCT00289744|76197709|FG000|COMPLETED|Year 7 Long-term Follow-up||175||
60082129|NCT00289744|76197710|FG001|COMPLETED|Year 7 Long-term Follow-up||0||
60082130|NCT00289744|76197711|FG002|COMPLETED|Year 7 Long-term Follow-up||0||
59991260|NCT02738801|76106788|FG001|COMPLETED|Overall Study||15||
59991261|NCT02738801|76106787|FG000|NOT COMPLETED|Overall Study||1||
59991262|NCT02738801|76106788|FG001|NOT COMPLETED|Overall Study||2||
60082131|NCT00289744|76197709|FG000|NOT COMPLETED|Year 7 Long-term Follow-up||0||
60082132|NCT00289744|76197710|FG001|NOT COMPLETED|Year 7 Long-term Follow-up||0||
59551146|NCT01355588|75650778|FG002|STARTED|Third Intervention (After Washout)||4||
59551147|NCT01355588|75650779|FG003|STARTED|Third Intervention (After Washout)||4||
59551148|NCT01355588|75650776|FG000|COMPLETED|Third Intervention (After Washout)||4||
59551149|NCT01355588|75650777|FG001|COMPLETED|Third Intervention (After Washout)||4||
59551150|NCT01355588|75650778|FG002|COMPLETED|Third Intervention (After Washout)||4||
59551151|NCT01355588|75650779|FG003|COMPLETED|Third Intervention (After Washout)||4||
59551152|NCT01355588|75650776|FG000|NOT COMPLETED|Third Intervention (After Washout)||0||
59551153|NCT01355588|75650777|FG001|NOT COMPLETED|Third Intervention (After Washout)||0||
59551154|NCT01355588|75650778|FG002|NOT COMPLETED|Third Intervention (After Washout)||0||
59551155|NCT01355588|75650779|FG003|NOT COMPLETED|Third Intervention (After Washout)||0||
59551156|NCT01355588|75650776|FG000|STARTED|Washout (3-7 Days)||4||
59551157|NCT01355588|75650777|FG001|STARTED|Washout (3-7 Days)||4||
59551158|NCT01355588|75650778|FG002|STARTED|Washout (3-7 Days)||4||
59551159|NCT01355588|75650779|FG003|STARTED|Washout (3-7 Days)||4||
59551160|NCT01355588|75650776|FG000|COMPLETED|Washout (3-7 Days)||4||
59551161|NCT01355588|75650777|FG001|COMPLETED|Washout (3-7 Days)||4||
59551162|NCT01355588|75650778|FG002|COMPLETED|Washout (3-7 Days)||4||
59551163|NCT01355588|75650779|FG003|COMPLETED|Washout (3-7 Days)||4||
59551164|NCT01355588|75650776|FG000|NOT COMPLETED|Washout (3-7 Days)||0||
59551165|NCT01355588|75650777|FG001|NOT COMPLETED|Washout (3-7 Days)||0||
59551166|NCT01355588|75650778|FG002|NOT COMPLETED|Washout (3-7 Days)||0||
59551167|NCT01355588|75650779|FG003|NOT COMPLETED|Washout (3-7 Days)||0||
59551168|NCT01355588|75650776|FG000|STARTED|Fourth Intervention (After Washout)||4||
59551169|NCT01355588|75650777|FG001|STARTED|Fourth Intervention (After Washout)||4||
59551170|NCT01355588|75650778|FG002|STARTED|Fourth Intervention (After Washout)||4||
59551171|NCT01355588|75650779|FG003|STARTED|Fourth Intervention (After Washout)||4||
59551172|NCT01355588|75650776|FG000|COMPLETED|Fourth Intervention (After Washout)||4||
59551173|NCT01355588|75650777|FG001|COMPLETED|Fourth Intervention (After Washout)||4||
59816397|NCT00518180|75938799|FG000|NOT COMPLETED|Overall Study||65||
59816398|NCT00518180|75938800|FG001|NOT COMPLETED|Overall Study||69||
59816399|NCT00518180|75938801|FG002|NOT COMPLETED|Overall Study||82||
59816400|NCT00525902|75938818|FG000|STARTED|Overall Study||31||
59816401|NCT00525902|75938818|FG000|10 Weeks|Overall Study||30||
59816402|NCT00525902|75938818|FG000|50 Weeks|Overall Study||12||
59816403|NCT00525902|75938818|FG000|COMPLETED|Overall Study||30||
59816404|NCT00525902|75938818|FG000|NOT COMPLETED|Overall Study||1||
59816405|NCT00525824|75938826|FG000|STARTED|Overall Study|Randomized population|214||
59816406|NCT00525824|75938827|FG001|STARTED|Overall Study|Randomized population|214||
59816407|NCT00525824|75938828|FG002|STARTED|Overall Study|Randomized population|202||
59816408|NCT00525824|75938829|FG003|STARTED|Overall Study|Randomized population|203||
59816409|NCT00525824|75938826|FG000|COMPLETED|Overall Study||195||
60082133|NCT00289744|76197711|FG002|NOT COMPLETED|Year 7 Long-term Follow-up||0||
60082134|NCT00289744|76197709|FG000|STARTED|Year 8 Long-term Follow-up|Subjects who came back at Year 8 blood sampling time-point|174||
60082135|NCT00289744|76197710|FG001|STARTED|Year 8 Long-term Follow-up||0||
60082136|NCT00289744|76197711|FG002|STARTED|Year 8 Long-term Follow-up||0||
60082137|NCT00289744|76197709|FG000|COMPLETED|Year 8 Long-term Follow-up||174||
60082138|NCT00289744|76197710|FG001|COMPLETED|Year 8 Long-term Follow-up||0||
60082139|NCT00289744|76197711|FG002|COMPLETED|Year 8 Long-term Follow-up||0||
59551174|NCT01355588|75650778|FG002|COMPLETED|Fourth Intervention (After Washout)||4||
59551175|NCT01355588|75650779|FG003|COMPLETED|Fourth Intervention (After Washout)||4||
59551176|NCT01355588|75650776|FG000|NOT COMPLETED|Fourth Intervention (After Washout)||0||
59551177|NCT01355588|75650777|FG001|NOT COMPLETED|Fourth Intervention (After Washout)||0||
59551178|NCT01355588|75650778|FG002|NOT COMPLETED|Fourth Intervention (After Washout)||0||
59816410|NCT00525824|75938827|FG001|COMPLETED|Overall Study||186||
59816411|NCT00525824|75938828|FG002|COMPLETED|Overall Study||183||
59816412|NCT00525824|75938829|FG003|COMPLETED|Overall Study||188||
60082140|NCT00289744|76197709|FG000|NOT COMPLETED|Year 8 Long-term Follow-up||0||
60082141|NCT00289744|76197710|FG001|NOT COMPLETED|Year 8 Long-term Follow-up||0||
60082142|NCT00289744|76197711|FG002|NOT COMPLETED|Year 8 Long-term Follow-up||0||
59816413|NCT00525824|75938826|FG000|NOT COMPLETED|Overall Study||19||
59816414|NCT00525824|75938827|FG001|NOT COMPLETED|Overall Study||28||
59816415|NCT00525824|75938828|FG002|NOT COMPLETED|Overall Study||19||
59816416|NCT00525824|75938829|FG003|NOT COMPLETED|Overall Study||15||
59816417|NCT00525590|75938843|FG000|STARTED|Overall Study||59||
59816418|NCT00525590|75938843|FG000|COMPLETED|Overall Study||14||
59816419|NCT00525590|75938843|FG000|NOT COMPLETED|Overall Study||45||
59816420|NCT00430677|75938850|FG000|STARTED|Short-term Period|1 participant died before receiving the first dose of study medication|99||
59816421|NCT00430677|75938851|FG001|STARTED|Short-term Period|1 participant took infliximab on day 1 and was discontinued before receiving study medication.|99||
59816422|NCT00430677|75938852|FG002|STARTED|Short-term Period||100||
59816423|NCT00430677|75938850|FG000|COMPLETED|Short-term Period|Completed the short-term period|76||
59816424|NCT00430677|75938851|FG001|COMPLETED|Short-term Period|Completed the short-term period|74||
59816425|NCT00430677|75938852|FG002|COMPLETED|Short-term Period|Completed the short-term period|78||
59816426|NCT00430677|75938850|FG000|NOT COMPLETED|Short-term Period||23||
59816427|NCT00430677|75938851|FG001|NOT COMPLETED|Short-term Period||25||
59816428|NCT00430677|75938852|FG002|NOT COMPLETED|Short-term Period||22||
59816429|NCT00430677|75938850|FG000|STARTED|Long-term Extension Period||70||
59816430|NCT00430677|75938851|FG001|STARTED|Long-term Extension Period||67||
59816431|NCT00430677|75938852|FG002|STARTED|Long-term Extension Period||74||
59816432|NCT00430677|75938850|FG000|COMPLETED|Long-term Extension Period|Completed the long-term extension period|10||
59816433|NCT00430677|75938851|FG001|COMPLETED|Long-term Extension Period|Completed the long-term extension period|9||
59991263|NCT02067819|76106797|FG000|STARTED|Overall Study||11||
59991264|NCT02067819|76106798|FG001|STARTED|Overall Study||10||
59551179|NCT01355588|75650779|FG003|NOT COMPLETED|Fourth Intervention (After Washout)||0||
59551180|NCT02621619|75650791|FG000|STARTED|Overall Study||80||
59551181|NCT02621619|75650792|FG001|STARTED|Overall Study||79||
59551182|NCT02621619|75650791|FG000|COMPLETED|Overall Study||80||
59551183|NCT02621619|75650792|FG001|COMPLETED|Overall Study||79||
59551184|NCT02621619|75650791|FG000|NOT COMPLETED|Overall Study||0||
59551185|NCT02621619|75650792|FG001|NOT COMPLETED|Overall Study||0||
59551186|NCT01253642|75650798|FG000|STARTED|Overall Study||11||
59551187|NCT01253642|75650798|FG000|COMPLETED|Overall Study||6||
59706811|NCT00996892|75825869|FG008|COMPLETED|Dose-Escalation Stage 1A||0||
59991265|NCT02067819|76106797|FG000|COMPLETED|Overall Study||6||
59991266|NCT02067819|76106798|FG001|COMPLETED|Overall Study||7||
59991267|NCT02067819|76106797|FG000|NOT COMPLETED|Overall Study||5||
59991268|NCT02067819|76106798|FG001|NOT COMPLETED|Overall Study||3||
59991269|NCT02230306|76106804|FG000|STARTED|Overall Study||5||
59991270|NCT02230306|76106804|FG000|COMPLETED|Overall Study||4||
59991271|NCT02230306|76106804|FG000|NOT COMPLETED|Overall Study||1||
59991272|NCT01680861|76106810|FG000|STARTED|Early Post-transplant Period|One patient didn't produce sufficient urine during first 24hr post-transplant (ineligible).|16||
59551188|NCT01253642|75650798|FG000|NOT COMPLETED|Overall Study||5||
59995121|NCT04925271|76110946|FG001|STARTED|Overall Study||20||
59551189|NCT01355978|75650803|FG000|STARTED|Overall Study||22||
59551190|NCT01355978|75650803|FG000|COMPLETED|Overall Study||18||
59551191|NCT01355978|75650803|FG000|NOT COMPLETED|Overall Study||4||
59551192|NCT01357148|75650807|FG000|STARTED|Overall Study||143||
59551193|NCT01357148|75650807|FG000|COMPLETED|Overall Study||143||
59551194|NCT01357148|75650807|FG000|NOT COMPLETED|Overall Study||0||
59551195|NCT02623803|75650814|FG000|STARTED|Overall Study||25||
59551196|NCT02623803|75650815|FG001|STARTED|Overall Study||23||
59551197|NCT02623803|75650814|FG000|COMPLETED|Overall Study||25||
59551198|NCT02623803|75650815|FG001|COMPLETED|Overall Study||23||
59551199|NCT02623803|75650814|FG000|NOT COMPLETED|Overall Study||0||
59551200|NCT02623803|75650815|FG001|NOT COMPLETED|Overall Study||0||
59551201|NCT02322788|75650821|FG000|STARTED|Visit 3||15||
59551202|NCT02322788|75650822|FG001|STARTED|Visit 3||15||
59706812|NCT00996892|75825870|FG009|COMPLETED|Dose-Escalation Stage 1A||0||
59706813|NCT00996892|75825871|FG010|COMPLETED|Dose-Escalation Stage 1A||0||
59706814|NCT00996892|75825872|FG011|COMPLETED|Dose-Escalation Stage 1A||0||
59706815|NCT00996892|75825873|FG012|COMPLETED|Dose-Escalation Stage 1A||0||
59991273|NCT01680861|76106811|FG001|STARTED|Early Post-transplant Period|One patient developed immediate DGF (delayed graft function) and was therefore ineligible.|16||
59991274|NCT01680861|76106810|FG000|COMPLETED|Early Post-transplant Period||15||
59706816|NCT00996892|75825874|FG013|COMPLETED|Dose-Escalation Stage 1A||0||
59706817|NCT00996892|75825875|FG014|COMPLETED|Dose-Escalation Stage 1A||0||
59706818|NCT00996892|75825876|FG015|COMPLETED|Dose-Escalation Stage 1A||0||
59706819|NCT00996892|75825877|FG016|COMPLETED|Dose-Escalation Stage 1A||0||
59991275|NCT01680861|76106811|FG001|COMPLETED|Early Post-transplant Period||15||
59551203|NCT02322788|75650823|FG002|STARTED|Visit 3||14||
59551204|NCT02322788|75650824|FG003|STARTED|Visit 3||16||
59551205|NCT02322788|75650821|FG000|COMPLETED|Visit 3||15||
59551206|NCT02322788|75650822|FG001|COMPLETED|Visit 3||15||
59551207|NCT02322788|75650823|FG002|COMPLETED|Visit 3||14||
59551208|NCT02322788|75650824|FG003|COMPLETED|Visit 3||16||
59551209|NCT02322788|75650821|FG000|NOT COMPLETED|Visit 3||0||
59551210|NCT02322788|75650822|FG001|NOT COMPLETED|Visit 3||0||
59551211|NCT02322788|75650823|FG002|NOT COMPLETED|Visit 3||0||
59551212|NCT02322788|75650824|FG003|NOT COMPLETED|Visit 3||0||
59551213|NCT02322788|75650821|FG000|STARTED|Visit 4||15||
59551214|NCT02322788|75650822|FG001|STARTED|Visit 4||14||
59551215|NCT02322788|75650823|FG002|STARTED|Visit 4||16||
59551216|NCT02322788|75650824|FG003|STARTED|Visit 4||15||
59551217|NCT02322788|75650821|FG000|COMPLETED|Visit 4||15||
59551218|NCT02322788|75650822|FG001|COMPLETED|Visit 4||14||
59551219|NCT02322788|75650823|FG002|COMPLETED|Visit 4||16||
59551220|NCT02322788|75650824|FG003|COMPLETED|Visit 4||15||
59551221|NCT02322788|75650821|FG000|NOT COMPLETED|Visit 4||0||
59551222|NCT02322788|75650822|FG001|NOT COMPLETED|Visit 4||0||
59551223|NCT02322788|75650823|FG002|NOT COMPLETED|Visit 4||0||
59551224|NCT02322788|75650824|FG003|NOT COMPLETED|Visit 4||0||
59551225|NCT02322788|75650821|FG000|STARTED|Visit 5||16||
59551226|NCT02322788|75650822|FG001|STARTED|Visit 5||15||
59551227|NCT02322788|75650823|FG002|STARTED|Visit 5||15||
59551228|NCT02322788|75650824|FG003|STARTED|Visit 5||14||
59551229|NCT02322788|75650821|FG000|COMPLETED|Visit 5||16||
59551230|NCT02322788|75650822|FG001|COMPLETED|Visit 5||15||
59551231|NCT02322788|75650823|FG002|COMPLETED|Visit 5||15||
59551232|NCT02322788|75650824|FG003|COMPLETED|Visit 5||14||
59551233|NCT02322788|75650821|FG000|NOT COMPLETED|Visit 5||0||
59551234|NCT02322788|75650822|FG001|NOT COMPLETED|Visit 5||0||
59551235|NCT02322788|75650823|FG002|NOT COMPLETED|Visit 5||0||
59551236|NCT02322788|75650824|FG003|NOT COMPLETED|Visit 5||0||
59551237|NCT02322788|75650821|FG000|STARTED|Visit 6||14||
59551238|NCT02322788|75650822|FG001|STARTED|Visit 6||16||
59551239|NCT02322788|75650823|FG002|STARTED|Visit 6||15||
59551240|NCT02322788|75650824|FG003|STARTED|Visit 6||15||
59551241|NCT02322788|75650821|FG000|COMPLETED|Visit 6||14||
59551242|NCT02322788|75650822|FG001|COMPLETED|Visit 6||16||
59551243|NCT02322788|75650823|FG002|COMPLETED|Visit 6||15||
59551244|NCT02322788|75650824|FG003|COMPLETED|Visit 6||15||
59551245|NCT02322788|75650821|FG000|NOT COMPLETED|Visit 6||0||
59551246|NCT02322788|75650822|FG001|NOT COMPLETED|Visit 6||0||
59551247|NCT02322788|75650823|FG002|NOT COMPLETED|Visit 6||0||
59551248|NCT02322788|75650824|FG003|NOT COMPLETED|Visit 6||0||
59551249|NCT01316510|75650836|FG000|STARTED|Overall Study||12||
59551250|NCT01316510|75650837|FG001|STARTED|Overall Study||12||
59551251|NCT01316510|75650836|FG000|COMPLETED|Overall Study||12||
59551252|NCT01316510|75650837|FG001|COMPLETED|Overall Study||12||
59551253|NCT01316510|75650836|FG000|NOT COMPLETED|Overall Study||0||
59551254|NCT01316510|75650837|FG001|NOT COMPLETED|Overall Study||0||
59551255|NCT01318538|75650845|FG000|STARTED|Overall Study||52||
59551256|NCT01318538|75650846|FG001|STARTED|Overall Study||106||
59551257|NCT01318538|75650847|FG002|STARTED|Overall Study||8||
59551258|NCT01318538|75650845|FG000|COMPLETED|Overall Study||52||
59551259|NCT01318538|75650846|FG001|COMPLETED|Overall Study||106||
59551260|NCT01318538|75650847|FG002|COMPLETED|Overall Study||8||
59706820|NCT00996892|75825878|FG017|COMPLETED|Dose-Escalation Stage 1A||0||
59706821|NCT00996892|75825879|FG018|COMPLETED|Dose-Escalation Stage 1A||0||
59706822|NCT00996892|75825880|FG019|COMPLETED|Dose-Escalation Stage 1A||0||
59706823|NCT00996892|75825861|FG000|NOT COMPLETED|Dose-Escalation Stage 1A||0||
59706824|NCT00996892|75825862|FG001|NOT COMPLETED|Dose-Escalation Stage 1A||0||
59706825|NCT00996892|75825863|FG002|NOT COMPLETED|Dose-Escalation Stage 1A||0||
59706826|NCT00996892|75825864|FG003|NOT COMPLETED|Dose-Escalation Stage 1A||0||
59706827|NCT00996892|75825865|FG004|NOT COMPLETED|Dose-Escalation Stage 1A||0||
59816434|NCT00430677|75938852|FG002|COMPLETED|Long-term Extension Period|Completed the long-term extension period|11||
59991276|NCT01680861|76106810|FG000|NOT COMPLETED|Early Post-transplant Period||1||
59991277|NCT01680861|76106811|FG001|NOT COMPLETED|Early Post-transplant Period||1||
59991278|NCT01680861|76106810|FG000|STARTED|First 12 Months Post-transplant||15||
59991279|NCT01680861|76106811|FG001|STARTED|First 12 Months Post-transplant||15||
59991280|NCT01680861|76106810|FG000|COMPLETED|First 12 Months Post-transplant||15||
59991281|NCT01680861|76106811|FG001|COMPLETED|First 12 Months Post-transplant||15||
59991282|NCT01680861|76106810|FG000|NOT COMPLETED|First 12 Months Post-transplant||0||
59991283|NCT01680861|76106811|FG001|NOT COMPLETED|First 12 Months Post-transplant||0||
59991284|NCT02229214|76106821|FG000|STARTED|Overall Study||41||
59991285|NCT02229214|76106822|FG001|STARTED|Overall Study||10||
59991286|NCT02229214|76106821|FG000|COMPLETED|Overall Study||35||
60082143|NCT00289744|76197709|FG000|STARTED|Year 9 Long-term Follow-up|Subjects who came back at Year 9 blood sampling time-point|173||
60082144|NCT00289744|76197710|FG001|STARTED|Year 9 Long-term Follow-up||0||
60082145|NCT00289744|76197711|FG002|STARTED|Year 9 Long-term Follow-up||0||
60082146|NCT00289744|76197709|FG000|COMPLETED|Year 9 Long-term Follow-up||173||
60082147|NCT00289744|76197710|FG001|COMPLETED|Year 9 Long-term Follow-up||0||
60082148|NCT00289744|76197711|FG002|COMPLETED|Year 9 Long-term Follow-up||0||
60082149|NCT00289744|76197709|FG000|NOT COMPLETED|Year 9 Long-term Follow-up||0||
60082150|NCT00289744|76197710|FG001|NOT COMPLETED|Year 9 Long-term Follow-up||0||
59991287|NCT02229214|76106822|FG001|COMPLETED|Overall Study||10||
60082151|NCT00289744|76197711|FG002|NOT COMPLETED|Year 9 Long-term Follow-up||0||
60082152|NCT00289744|76197709|FG000|STARTED|Year 10 Long-term Follow-up|Subjects who came back at Year 10 blood sampling time-point|171||
60082153|NCT00289744|76197710|FG001|STARTED|Year 10 Long-term Follow-up||0||
60082154|NCT00289744|76197711|FG002|STARTED|Year 10 Long-term Follow-up||0||
60082155|NCT00289744|76197709|FG000|COMPLETED|Year 10 Long-term Follow-up||171||
60082156|NCT00289744|76197710|FG001|COMPLETED|Year 10 Long-term Follow-up||0||
60082157|NCT00289744|76197711|FG002|COMPLETED|Year 10 Long-term Follow-up||0||
60082158|NCT00289744|76197709|FG000|NOT COMPLETED|Year 10 Long-term Follow-up||0||
60082159|NCT00289744|76197710|FG001|NOT COMPLETED|Year 10 Long-term Follow-up||0||
60082160|NCT00289744|76197711|FG002|NOT COMPLETED|Year 10 Long-term Follow-up||0||
60082161|NCT00289744|76197709|FG000|STARTED|Additional Dose Phase||0||
60082162|NCT00289744|76197710|FG001|STARTED|Additional Dose Phase||19||
60082163|NCT00289744|76197711|FG002|STARTED|Additional Dose Phase||6||
60082164|NCT00289744|76197709|FG000|COMPLETED|Additional Dose Phase||0||
60082165|NCT00289744|76197710|FG001|COMPLETED|Additional Dose Phase||19||
60082166|NCT00289744|76197711|FG002|COMPLETED|Additional Dose Phase||6||
60082167|NCT00289744|76197709|FG000|NOT COMPLETED|Additional Dose Phase||0||
59706828|NCT00996892|75825866|FG005|NOT COMPLETED|Dose-Escalation Stage 1A||0||
59706829|NCT00996892|75825867|FG006|NOT COMPLETED|Dose-Escalation Stage 1A||0||
59706830|NCT00996892|75825868|FG007|NOT COMPLETED|Dose-Escalation Stage 1A||3||
59991288|NCT02229214|76106821|FG000|NOT COMPLETED|Overall Study||6||
59991289|NCT02229214|76106822|FG001|NOT COMPLETED|Overall Study||0||
60082168|NCT00289744|76197710|FG001|NOT COMPLETED|Additional Dose Phase||0||
60082169|NCT00289744|76197711|FG002|NOT COMPLETED|Additional Dose Phase||0||
60082170|NCT00291226|76197721|FG000|STARTED|Overall Study||4||
60082171|NCT00291226|76197722|FG001|STARTED|Overall Study||4||
60082172|NCT00291226|76197721|FG000|COMPLETED|Overall Study||3||
60082173|NCT00291226|76197722|FG001|COMPLETED|Overall Study||3||
60082174|NCT00291226|76197721|FG000|NOT COMPLETED|Overall Study||1||
59991290|NCT02228980|76106834|FG000|STARTED|Overall Study||150||
59991291|NCT02228980|76106835|FG001|STARTED|Overall Study||150||
59991292|NCT02228980|76106836|FG002|STARTED|Overall Study||151||
59551261|NCT01318538|75650845|FG000|NOT COMPLETED|Overall Study||0||
59551262|NCT01318538|75650846|FG001|NOT COMPLETED|Overall Study||0||
59551263|NCT01318538|75650847|FG002|NOT COMPLETED|Overall Study||0||
59551264|NCT02625207|75650859|FG000|STARTED|Part 1 (6 Days)||11||
59551265|NCT02625207|75650860|FG001|STARTED|Part 1 (6 Days)||12||
59551266|NCT02625207|75650861|FG002|STARTED|Part 1 (6 Days)||12||
59551267|NCT02625207|75650862|FG003|STARTED|Part 1 (6 Days)||12||
59551268|NCT02625207|75650859|FG000|COMPLETED|Part 1 (6 Days)||11||
59551269|NCT02625207|75650860|FG001|COMPLETED|Part 1 (6 Days)||12||
59551270|NCT02625207|75650861|FG002|COMPLETED|Part 1 (6 Days)||12||
59551271|NCT02625207|75650862|FG003|COMPLETED|Part 1 (6 Days)||12||
59551272|NCT02625207|75650859|FG000|NOT COMPLETED|Part 1 (6 Days)||0||
59551273|NCT02625207|75650860|FG001|NOT COMPLETED|Part 1 (6 Days)||0||
59551274|NCT02625207|75650861|FG002|NOT COMPLETED|Part 1 (6 Days)||0||
59551275|NCT02625207|75650862|FG003|NOT COMPLETED|Part 1 (6 Days)||0||
59551276|NCT02625207|75650859|FG000|STARTED|Part 2 (11 Days)||11||
59551277|NCT02625207|75650860|FG001|STARTED|Part 2 (11 Days)|Part 2 was conducted only in Cohorts 1 and 3, as pre-specified in protocol.|0||
59551278|NCT02625207|75650861|FG002|STARTED|Part 2 (11 Days)||12||
59551279|NCT02625207|75650862|FG003|STARTED|Part 2 (11 Days)|Part 2 was conducted only in Cohorts 1 and 3, as pre-specified in protocol.|0||
59551280|NCT02625207|75650859|FG000|COMPLETED|Part 2 (11 Days)||11||
59551281|NCT02625207|75650860|FG001|COMPLETED|Part 2 (11 Days)||0||
59551282|NCT02625207|75650861|FG002|COMPLETED|Part 2 (11 Days)||12||
59551283|NCT02625207|75650862|FG003|COMPLETED|Part 2 (11 Days)||0||
59551284|NCT02625207|75650859|FG000|NOT COMPLETED|Part 2 (11 Days)||0||
59551285|NCT02625207|75650860|FG001|NOT COMPLETED|Part 2 (11 Days)||0||
59551286|NCT02625207|75650861|FG002|NOT COMPLETED|Part 2 (11 Days)||0||
59551287|NCT02625207|75650862|FG003|NOT COMPLETED|Part 2 (11 Days)||0||
59551288|NCT01256840|75650881|FG000|STARTED|Overall Study||30||
59551289|NCT01256840|75650882|FG001|STARTED|Overall Study||16||
59551290|NCT01256840|75650883|FG002|STARTED|Overall Study||25||
59551291|NCT01256840|75650881|FG000|COMPLETED|Overall Study||30||
59551292|NCT01256840|75650882|FG001|COMPLETED|Overall Study||16||
59551293|NCT01256840|75650883|FG002|COMPLETED|Overall Study||25||
59551294|NCT01256840|75650881|FG000|NOT COMPLETED|Overall Study||0||
59551295|NCT01256840|75650882|FG001|NOT COMPLETED|Overall Study||0||
59551296|NCT01256840|75650883|FG002|NOT COMPLETED|Overall Study||0||
59551297|NCT01763333|75650905|FG000|STARTED|Overall Study||6||
59551298|NCT01763333|75650906|FG001|STARTED|Overall Study||6||
59551299|NCT01763333|75650907|FG002|STARTED|Overall Study||6||
59551300|NCT01763333|75650908|FG003|STARTED|Overall Study||6||
59551301|NCT01763333|75650909|FG004|STARTED|Overall Study||4||
59551302|NCT01763333|75650910|FG005|STARTED|Overall Study||6||
59551303|NCT01763333|75650911|FG006|STARTED|Overall Study||5||
59551304|NCT01763333|75650912|FG007|STARTED|Overall Study||6||
59551305|NCT01763333|75650913|FG008|STARTED|Overall Study||5||
59551306|NCT01763333|75650914|FG009|STARTED|Overall Study||18||
59551307|NCT01763333|75650915|FG010|STARTED|Overall Study||3||
59551308|NCT01763333|75650916|FG011|STARTED|Overall Study||3||
59551309|NCT01763333|75650917|FG012|STARTED|Overall Study||3||
59551310|NCT01763333|75650918|FG013|STARTED|Overall Study||3||
59551311|NCT01763333|75650905|FG000|COMPLETED|Overall Study||6||
60082175|NCT00291226|76197722|FG001|NOT COMPLETED|Overall Study||1||
60082176|NCT00291694|76197730|FG000|STARTED|Overall Study||24||
60082177|NCT00291694|76197731|FG001|STARTED|Overall Study||48||
60082178|NCT00291694|76197730|FG000|COMPLETED|Overall Study||21||
60082179|NCT00291694|76197731|FG001|COMPLETED|Overall Study||43||
60082180|NCT00291694|76197730|FG000|NOT COMPLETED|Overall Study||3||
60082181|NCT00291694|76197731|FG001|NOT COMPLETED|Overall Study||5||
60082182|NCT00292162|76197741|FG000|STARTED|Overall Study||19||
60082183|NCT00292162|76197742|FG001|STARTED|Overall Study||22||
60082184|NCT00292162|76197741|FG000|COMPLETED|Overall Study||18||
60082185|NCT00292162|76197742|FG001|COMPLETED|Overall Study||20||
60082186|NCT00292162|76197741|FG000|NOT COMPLETED|Overall Study||1||
60082187|NCT00292162|76197742|FG001|NOT COMPLETED|Overall Study||2||
60082188|NCT00296296|76197750|FG000|STARTED|Overall Study||11||
60082189|NCT00296296|76197751|FG001|STARTED|Overall Study||18||
60082190|NCT00296296|76197750|FG000|COMPLETED|Overall Study||9||
60082191|NCT00296296|76197751|FG001|COMPLETED|Overall Study||5||
60082192|NCT00296296|76197750|FG000|NOT COMPLETED|Overall Study||2||
60082193|NCT00296296|76197751|FG001|NOT COMPLETED|Overall Study||13||
60082194|NCT00298090|76197757|FG000|STARTED|Overall Study||47||
60082195|NCT00298090|76197757|FG000|COMPLETED|Overall Study|Eighteen subjects were not included in final analysis due to incomplete data sets|29||
60082196|NCT00298090|76197757|FG000|NOT COMPLETED|Overall Study||18||
60082197|NCT00298558|76197765|FG000|STARTED|Baseline||711||
60082198|NCT00298558|76197766|FG001|STARTED|Baseline||705||
60082199|NCT00298558|76197767|FG002|STARTED|Baseline||712||
60082200|NCT00298558|76197768|FG003|STARTED|Baseline||704||
60082201|NCT00298558|76197765|FG000|COMPLETED|Baseline||711||
60082202|NCT00298558|76197766|FG001|COMPLETED|Baseline||705||
60082203|NCT00298558|76197767|FG002|COMPLETED|Baseline||712||
60082204|NCT00298558|76197768|FG003|COMPLETED|Baseline||704||
60082205|NCT00298558|76197765|FG000|NOT COMPLETED|Baseline||0||
60082206|NCT00298558|76197766|FG001|NOT COMPLETED|Baseline||0||
60082207|NCT00298558|76197767|FG002|NOT COMPLETED|Baseline||0||
60082208|NCT00298558|76197768|FG003|NOT COMPLETED|Baseline||0||
60082209|NCT00298558|76197765|FG000|STARTED|Intervention||711||
60082210|NCT00298558|76197766|FG001|STARTED|Intervention||705||
60082211|NCT00298558|76197767|FG002|STARTED|Intervention||712||
60082212|NCT00298558|76197768|FG003|STARTED|Intervention||704||
60082213|NCT00298558|76197765|FG000|COMPLETED|Intervention||620||
60082214|NCT00298558|76197766|FG001|COMPLETED|Intervention||627||
60082215|NCT00298558|76197767|FG002|COMPLETED|Intervention||637||
60082216|NCT00298558|76197768|FG003|COMPLETED|Intervention||285||
60082217|NCT00298558|76197765|FG000|NOT COMPLETED|Intervention||91||
60082218|NCT00298558|76197766|FG001|NOT COMPLETED|Intervention||78||
60082219|NCT00298558|76197767|FG002|NOT COMPLETED|Intervention||75||
60082220|NCT00298558|76197768|FG003|NOT COMPLETED|Intervention||419||
60082221|NCT00298558|76197765|FG000|STARTED|Immediate Post Test||711||
60082222|NCT00298558|76197766|FG001|STARTED|Immediate Post Test||705||
60082223|NCT00298558|76197767|FG002|STARTED|Immediate Post Test||712||
59706831|NCT00996892|75825869|FG008|NOT COMPLETED|Dose-Escalation Stage 1A||3||
59706832|NCT00996892|75825870|FG009|NOT COMPLETED|Dose-Escalation Stage 1A||4||
60082224|NCT00298558|76197768|FG003|STARTED|Immediate Post Test||704||
60082225|NCT00298558|76197765|FG000|COMPLETED|Immediate Post Test||640||
60082226|NCT00298558|76197766|FG001|COMPLETED|Immediate Post Test||629||
60082227|NCT00298558|76197767|FG002|COMPLETED|Immediate Post Test||653||
60082228|NCT00298558|76197768|FG003|COMPLETED|Immediate Post Test||639||
60082229|NCT00298558|76197765|FG000|NOT COMPLETED|Immediate Post Test||71||
60082230|NCT00298558|76197766|FG001|NOT COMPLETED|Immediate Post Test||76||
60082231|NCT00298558|76197767|FG002|NOT COMPLETED|Immediate Post Test||59||
60082232|NCT00298558|76197768|FG003|NOT COMPLETED|Immediate Post Test||65||
60082233|NCT00298558|76197765|FG000|STARTED|Booster||372||
60082234|NCT00298558|76197766|FG001|STARTED|Booster||371||
59551312|NCT01763333|75650906|FG001|COMPLETED|Overall Study||6||
59551313|NCT01763333|75650907|FG002|COMPLETED|Overall Study||6||
59551314|NCT01763333|75650908|FG003|COMPLETED|Overall Study||6||
60082235|NCT00298558|76197767|FG002|STARTED|Booster||370||
60082236|NCT00298558|76197768|FG003|STARTED|Booster||0||
59551315|NCT01763333|75650909|FG004|COMPLETED|Overall Study||4||
59551316|NCT01763333|75650910|FG005|COMPLETED|Overall Study||6||
59551317|NCT01763333|75650911|FG006|COMPLETED|Overall Study||5||
60082237|NCT00298558|76197765|FG000|COMPLETED|Booster||283||
60082238|NCT00298558|76197766|FG001|COMPLETED|Booster||301||
60082239|NCT00298558|76197767|FG002|COMPLETED|Booster||295||
60082240|NCT00298558|76197768|FG003|COMPLETED|Booster||0||
60082241|NCT00298558|76197765|FG000|NOT COMPLETED|Booster||89||
60082242|NCT00298558|76197766|FG001|NOT COMPLETED|Booster||70||
60082243|NCT00298558|76197767|FG002|NOT COMPLETED|Booster||75||
60082244|NCT00298558|76197768|FG003|NOT COMPLETED|Booster||0||
59706833|NCT00996892|75825871|FG010|NOT COMPLETED|Dose-Escalation Stage 1A||7||
59706834|NCT00996892|75825872|FG011|NOT COMPLETED|Dose-Escalation Stage 1A||9||
59706835|NCT00996892|75825873|FG012|NOT COMPLETED|Dose-Escalation Stage 1A||8||
59706836|NCT00996892|75825874|FG013|NOT COMPLETED|Dose-Escalation Stage 1A||5||
59816435|NCT00430677|75938850|FG000|NOT COMPLETED|Long-term Extension Period||60||
59551318|NCT01763333|75650912|FG007|COMPLETED|Overall Study||6||
59551319|NCT01763333|75650913|FG008|COMPLETED|Overall Study||5||
59551320|NCT01763333|75650914|FG009|COMPLETED|Overall Study||18||
59551321|NCT01763333|75650915|FG010|COMPLETED|Overall Study||3||
59551322|NCT01763333|75650916|FG011|COMPLETED|Overall Study||3||
59551323|NCT01763333|75650917|FG012|COMPLETED|Overall Study||3||
59551324|NCT01763333|75650918|FG013|COMPLETED|Overall Study||3||
59551325|NCT01763333|75650905|FG000|NOT COMPLETED|Overall Study||0||
59551326|NCT01763333|75650906|FG001|NOT COMPLETED|Overall Study||0||
59551327|NCT01763333|75650907|FG002|NOT COMPLETED|Overall Study||0||
59551328|NCT01763333|75650908|FG003|NOT COMPLETED|Overall Study||0||
59551329|NCT01763333|75650909|FG004|NOT COMPLETED|Overall Study||0||
59551330|NCT01763333|75650910|FG005|NOT COMPLETED|Overall Study||0||
59551331|NCT01763333|75650911|FG006|NOT COMPLETED|Overall Study||0||
59551332|NCT01763333|75650912|FG007|NOT COMPLETED|Overall Study||0||
59551333|NCT01763333|75650913|FG008|NOT COMPLETED|Overall Study||0||
59551334|NCT01763333|75650914|FG009|NOT COMPLETED|Overall Study||0||
59551335|NCT01763333|75650915|FG010|NOT COMPLETED|Overall Study||0||
59551336|NCT01763333|75650916|FG011|NOT COMPLETED|Overall Study||0||
59551337|NCT01763333|75650917|FG012|NOT COMPLETED|Overall Study||0||
59551338|NCT01763333|75650918|FG013|NOT COMPLETED|Overall Study||0||
59551339|NCT01763567|75650952|FG000|STARTED|Overall Study||19||
59551340|NCT01763567|75650952|FG000|COMPLETED|Overall Study||19||
59551341|NCT01763567|75650952|FG000|NOT COMPLETED|Overall Study||0||
59551342|NCT02253173|75650960|FG000|STARTED|Overall Study||191||
59551343|NCT02253173|75650961|FG001|STARTED|Overall Study||191||
59551344|NCT02253173|75650962|FG002|STARTED|Overall Study||190||
59551345|NCT02253173|75650963|FG003|STARTED|Overall Study||192||
59551346|NCT02253173|75650960|FG000|COMPLETED|Overall Study||175||
59551347|NCT02253173|75650961|FG001|COMPLETED|Overall Study||174||
59551348|NCT02253173|75650962|FG002|COMPLETED|Overall Study||177||
60082245|NCT00298558|76197765|FG000|STARTED|1st Annual (A1)||640||
59551349|NCT02253173|75650963|FG003|COMPLETED|Overall Study||178||
59551350|NCT02253173|75650960|FG000|NOT COMPLETED|Overall Study||16||
59551351|NCT02253173|75650961|FG001|NOT COMPLETED|Overall Study||17||
59551352|NCT02253173|75650962|FG002|NOT COMPLETED|Overall Study||13||
59551353|NCT02253173|75650963|FG003|NOT COMPLETED|Overall Study||14||
59551354|NCT01318694|75650981|FG000|STARTED|Overall Study||275||
59551355|NCT01318694|75650982|FG001|STARTED|Overall Study||270||
59551356|NCT01318694|75650983|FG002|STARTED|Overall Study||268||
59551357|NCT01318694|75650984|FG003|STARTED|Overall Study||268||
59551358|NCT01318694|75650981|FG000|Full Analysis Set|Overall Study||274||
59551359|NCT01318694|75650982|FG001|Full Analysis Set|Overall Study||270||
59551360|NCT01318694|75650983|FG002|Full Analysis Set|Overall Study||265||
59991293|NCT02228980|76106837|FG003|STARTED|Overall Study||151||
59551361|NCT01318694|75650984|FG003|Full Analysis Set|Overall Study||268||
59551362|NCT01318694|75650981|FG000|Safety Set|Overall Study||273||
59551363|NCT01318694|75650982|FG001|Safety Set|Overall Study||268||
59551364|NCT01318694|75650983|FG002|Safety Set|Overall Study||265||
59551365|NCT01318694|75650984|FG003|Safety Set|Overall Study||265||
59551366|NCT01318694|75650981|FG000|COMPLETED|Overall Study||223||
59551367|NCT01318694|75650982|FG001|COMPLETED|Overall Study||212||
59551368|NCT01318694|75650983|FG002|COMPLETED|Overall Study||225||
59551369|NCT01318694|75650984|FG003|COMPLETED|Overall Study||200||
59551370|NCT01318694|75650981|FG000|NOT COMPLETED|Overall Study||52||
59551371|NCT01318694|75650982|FG001|NOT COMPLETED|Overall Study||58||
59706837|NCT00996892|75825875|FG014|NOT COMPLETED|Dose-Escalation Stage 1A||0||
59551372|NCT01318694|75650983|FG002|NOT COMPLETED|Overall Study||43||
59551373|NCT01318694|75650984|FG003|NOT COMPLETED|Overall Study||68||
59991294|NCT02228980|76106834|FG000|COMPLETED|Overall Study||126||
59551374|NCT01319318|75650994|FG000|STARTED|Overall Study||25||
59706838|NCT00996892|75825876|FG015|NOT COMPLETED|Dose-Escalation Stage 1A||0||
59551375|NCT01319318|75650994|FG000|COMPLETED|Overall Study||25||
59551376|NCT01319318|75650994|FG000|NOT COMPLETED|Overall Study||0||
59551377|NCT01319396|75650998|FG000|STARTED|Overall Study||24||
59551378|NCT01319396|75650998|FG000|COMPLETED|Overall Study||24||
59551379|NCT01319396|75650998|FG000|NOT COMPLETED|Overall Study||0||
59551380|NCT01319552|75651002|FG000|STARTED|Overall Study||14||
59551381|NCT01319552|75651002|FG000|COMPLETED|Overall Study||14||
59551382|NCT01319552|75651002|FG000|NOT COMPLETED|Overall Study||0||
59551383|NCT02324660|75651007|FG000|STARTED|Overall Study||169||
59551384|NCT02324660|75651007|FG000|COMPLETED|Overall Study||137||
59551385|NCT02324660|75651007|FG000|NOT COMPLETED|Overall Study||32||
59551386|NCT01359410|75651014|FG000|STARTED|Overall Study||54||
59551387|NCT01359410|75651015|FG001|STARTED|Overall Study||46||
59551388|NCT01359410|75651014|FG000|COMPLETED|Overall Study||54||
59551389|NCT01359410|75651015|FG001|COMPLETED|Overall Study||46||
59551390|NCT01359410|75651014|FG000|NOT COMPLETED|Overall Study||0||
59551391|NCT01359410|75651015|FG001|NOT COMPLETED|Overall Study||0||
59551392|NCT01256918|75651021|FG000|STARTED|Overall Study||200||
59551393|NCT01256918|75651021|FG000|Full Thickness Nuclear Crack Achieved|Overall Study||200||
59551394|NCT01256918|75651021|FG000|COMPLETED|Overall Study||200||
59551395|NCT01256918|75651021|FG000|NOT COMPLETED|Overall Study||0||
59551396|NCT01361048|75651035|FG000|STARTED|Overall Study||20||
59551397|NCT01361048|75651036|FG001|STARTED|Overall Study||10||
59551398|NCT01361048|75651037|FG002|STARTED|Overall Study||10||
59551399|NCT01361048|75651035|FG000|COMPLETED|Overall Study||20||
59551400|NCT01361048|75651036|FG001|COMPLETED|Overall Study||10||
59551401|NCT01361048|75651037|FG002|COMPLETED|Overall Study||9||
59551402|NCT01361048|75651035|FG000|NOT COMPLETED|Overall Study||0||
59551403|NCT01361048|75651036|FG001|NOT COMPLETED|Overall Study||0||
59551404|NCT01361048|75651037|FG002|NOT COMPLETED|Overall Study||1||
59551405|NCT01258790|75651050|FG000|STARTED|Overall Study||6||
59551406|NCT01258790|75651051|FG001|STARTED|Overall Study||6||
59551407|NCT01258790|75651050|FG000|COMPLETED|Overall Study||6||
59551408|NCT01258790|75651051|FG001|COMPLETED|Overall Study||6||
59551409|NCT01258790|75651050|FG000|NOT COMPLETED|Overall Study||0||
59551410|NCT01258790|75651051|FG001|NOT COMPLETED|Overall Study||0||
59551411|NCT01766219|75651060|FG000|STARTED|Overall Study||4||
59551412|NCT01766219|75651061|FG001|STARTED|Overall Study||2||
59551413|NCT01766219|75651062|FG002|STARTED|Overall Study||11||
59551414|NCT01766219|75651060|FG000|COMPLETED|Overall Study||4||
59551415|NCT01766219|75651061|FG001|COMPLETED|Overall Study||2||
59551416|NCT01766219|75651062|FG002|COMPLETED|Overall Study||11||
59551417|NCT01766219|75651060|FG000|NOT COMPLETED|Overall Study||0||
59551418|NCT01766219|75651061|FG001|NOT COMPLETED|Overall Study||0||
59551419|NCT01766219|75651062|FG002|NOT COMPLETED|Overall Study||0||
59551420|NCT01767155|75651073|FG000|STARTED|Overall Study|Patients allocated to AEZS-108|256|Intent-to-treat population (ITT)|
59551421|NCT01767155|75651074|FG001|STARTED|Overall Study|Patients allocated to doxorubicin|255|Intent-to-treat population (ITT)|
59551422|NCT01767155|75651073|FG000|Modified ITT (mITT)|Overall Study||252|Excluding patients allocated to a treatment but never treated|
59551423|NCT01767155|75651074|FG001|Modified ITT (mITT)|Overall Study||249|Excluding patients allocated to a treatment but never treated|
59551424|NCT01767155|75651073|FG000|Safety Population (SAF)|Overall Study||252||
59551425|NCT01767155|75651074|FG001|Safety Population (SAF)|Overall Study||249||
59551426|NCT01767155|75651073|FG000|COMPLETED|Overall Study||243|Per protocol (PP) population|
59551427|NCT01767155|75651074|FG001|COMPLETED|Overall Study||240|Per protocol (PP) population|
59551428|NCT01767155|75651073|FG000|NOT COMPLETED|Overall Study||13||
59551429|NCT01767155|75651074|FG001|NOT COMPLETED|Overall Study||15||
59551430|NCT01362686|75651083|FG000|STARTED|Overall Study||67||
59551431|NCT01362686|75651084|FG001|STARTED|Overall Study||66||
59551432|NCT01362686|75651085|FG002|STARTED|Overall Study||63||
59551433|NCT01362686|75651083|FG000|COMPLETED|Overall Study||59||
59551434|NCT01362686|75651084|FG001|COMPLETED|Overall Study||54||
59551435|NCT01362686|75651085|FG002|COMPLETED|Overall Study||53||
59551436|NCT01362686|75651083|FG000|NOT COMPLETED|Overall Study||8||
59551437|NCT01362686|75651084|FG001|NOT COMPLETED|Overall Study||12||
59551438|NCT01362686|75651085|FG002|NOT COMPLETED|Overall Study||10||
59551439|NCT01322048|75651095|FG000|STARTED|Overall Study||21||
59551440|NCT01322048|75651096|FG001|STARTED|Overall Study||26||
59551441|NCT01322048|75651095|FG000|COMPLETED|Overall Study||21||
59551442|NCT01322048|75651096|FG001|COMPLETED|Overall Study||26||
59551443|NCT01322048|75651095|FG000|NOT COMPLETED|Overall Study||0||
59551444|NCT01322048|75651096|FG001|NOT COMPLETED|Overall Study||0||
59551445|NCT01322360|75651102|FG000|STARTED|Overall Study||50||
59551446|NCT01322360|75651102|FG000|COMPLETED|Overall Study||50||
59551447|NCT01322360|75651102|FG000|NOT COMPLETED|Overall Study||0||
59551448|NCT01767701|75651107|FG000|STARTED|Overall Study|All 20 patients who entered the treatment phase completed the six months trial period.|20||
59551449|NCT01767701|75651107|FG000|COMPLETED|Overall Study||20||
59551450|NCT01767701|75651107|FG000|NOT COMPLETED|Overall Study||0||
59551451|NCT01322594|75651118|FG000|STARTED|Overall Study|RANDOMIZED SUBJECTS THROUGH STUDY DAY 240-300|6||
59551452|NCT01322594|75651119|FG001|STARTED|Overall Study||3||
59551453|NCT01322594|75651120|FG002|STARTED|Overall Study||3||
59551454|NCT01322594|75651121|FG003|STARTED|Overall Study||6||
59551455|NCT01322594|75651122|FG004|STARTED|Overall Study||7||
59551456|NCT01322594|75651123|FG005|STARTED|Overall Study||6||
59551457|NCT01322594|75651118|FG000|COMPLETED|Overall Study||6||
59551458|NCT01322594|75651119|FG001|COMPLETED|Overall Study||3||
59551459|NCT01322594|75651120|FG002|COMPLETED|Overall Study||3||
59551460|NCT01322594|75651121|FG003|COMPLETED|Overall Study||6||
59551461|NCT01322594|75651122|FG004|COMPLETED|Overall Study||7||
59551462|NCT01322594|75651123|FG005|COMPLETED|Overall Study||6||
59551463|NCT01322594|75651118|FG000|NOT COMPLETED|Overall Study||0||
59551464|NCT01322594|75651119|FG001|NOT COMPLETED|Overall Study||0||
59706839|NCT00996892|75825877|FG016|NOT COMPLETED|Dose-Escalation Stage 1A||0||
59706840|NCT00996892|75825878|FG017|NOT COMPLETED|Dose-Escalation Stage 1A||0||
59551465|NCT01322594|75651120|FG002|NOT COMPLETED|Overall Study||0||
59551466|NCT01322594|75651121|FG003|NOT COMPLETED|Overall Study||0||
59551467|NCT01322594|75651122|FG004|NOT COMPLETED|Overall Study||0||
59551468|NCT01322594|75651123|FG005|NOT COMPLETED|Overall Study||0||
59551469|NCT01767935|75651137|FG000|STARTED|Overall Study||1||
59551470|NCT01767935|75651137|FG000|COMPLETED|Overall Study||1||
59551471|NCT01767935|75651137|FG000|NOT COMPLETED|Overall Study||0||
59551472|NCT01363388|75651144|FG000|STARTED|Overall Study||23||
59551473|NCT01363388|75651145|FG001|STARTED|Overall Study||22||
59551474|NCT01363388|75651146|FG002|STARTED|Overall Study||22||
59551475|NCT01363388|75651144|FG000|COMPLETED|Overall Study||18||
59551476|NCT01363388|75651145|FG001|COMPLETED|Overall Study||19||
59551477|NCT01363388|75651146|FG002|COMPLETED|Overall Study||18||
59551478|NCT01363388|75651144|FG000|NOT COMPLETED|Overall Study||5||
59551479|NCT01363388|75651145|FG001|NOT COMPLETED|Overall Study||3||
59551480|NCT01363388|75651146|FG002|NOT COMPLETED|Overall Study||4||
59551481|NCT01768013|75651154|FG000|STARTED|Overall Study||13||
59551482|NCT01768013|75651154|FG000|COMPLETED|Overall Study||13||
59551483|NCT01768013|75651154|FG000|NOT COMPLETED|Overall Study||0||
59551484|NCT01768325|75651160|FG000|STARTED|Overall Study||37||
59551485|NCT01768325|75651161|FG001|STARTED|Overall Study||41||
59551486|NCT01768325|75651160|FG000|COMPLETED|Overall Study||37||
59551487|NCT01768325|75651161|FG001|COMPLETED|Overall Study||41||
59551488|NCT01768325|75651160|FG000|NOT COMPLETED|Overall Study||0||
59706841|NCT00996892|75825879|FG018|NOT COMPLETED|Dose-Escalation Stage 1A||0||
59706842|NCT00996892|75825880|FG019|NOT COMPLETED|Dose-Escalation Stage 1A||0||
60082246|NCT00298558|76197766|FG001|STARTED|1st Annual (A1)||629||
60082247|NCT00298558|76197767|FG002|STARTED|1st Annual (A1)||653||
60082248|NCT00298558|76197768|FG003|STARTED|1st Annual (A1)||639||
60082249|NCT00298558|76197765|FG000|COMPLETED|1st Annual (A1)||585||
60082250|NCT00298558|76197766|FG001|COMPLETED|1st Annual (A1)||566||
60082251|NCT00298558|76197767|FG002|COMPLETED|1st Annual (A1)||601||
60082252|NCT00298558|76197768|FG003|COMPLETED|1st Annual (A1)||584||
60082253|NCT00298558|76197765|FG000|NOT COMPLETED|1st Annual (A1)||55||
59551489|NCT01768325|75651161|FG001|NOT COMPLETED|Overall Study||0||
59551490|NCT01364090|75651172|FG000|STARTED|Overall Study||61||
59551491|NCT01364090|75651173|FG001|STARTED|Overall Study||26||
59551492|NCT01364090|75651174|FG002|STARTED|Overall Study||6||
59551493|NCT01364090|75651172|FG000|COMPLETED|Overall Study||58||
59551494|NCT01364090|75651173|FG001|COMPLETED|Overall Study||12||
59551495|NCT01364090|75651174|FG002|COMPLETED|Overall Study||0||
59551496|NCT01364090|75651172|FG000|NOT COMPLETED|Overall Study||3||
59551497|NCT01364090|75651173|FG001|NOT COMPLETED|Overall Study||14||
59551498|NCT01364090|75651174|FG002|NOT COMPLETED|Overall Study||6||
59551499|NCT01364558|75651182|FG000|STARTED|Dose One||8||
59551500|NCT01364558|75651183|FG001|STARTED|Dose One||8||
59551501|NCT01364558|75651184|FG002|STARTED|Dose One||8||
59551502|NCT01364558|75651182|FG000|COMPLETED|Dose One||8||
59551503|NCT01364558|75651183|FG001|COMPLETED|Dose One||8||
59551504|NCT01364558|75651184|FG002|COMPLETED|Dose One||8||
59551505|NCT01364558|75651182|FG000|NOT COMPLETED|Dose One||0||
59706843|NCT00996892|75825861|FG000|STARTED|Dose-Escalation Stage 1B||0||
59706844|NCT00996892|75825862|FG001|STARTED|Dose-Escalation Stage 1B||0||
59706845|NCT00996892|75825863|FG002|STARTED|Dose-Escalation Stage 1B||0||
59706846|NCT00996892|75825864|FG003|STARTED|Dose-Escalation Stage 1B||0||
59991295|NCT02228980|76106835|FG001|COMPLETED|Overall Study||147||
59991296|NCT02228980|76106836|FG002|COMPLETED|Overall Study||149||
59991297|NCT02228980|76106837|FG003|COMPLETED|Overall Study||148||
59991298|NCT02228980|76106834|FG000|NOT COMPLETED|Overall Study||24||
59991299|NCT02228980|76106835|FG001|NOT COMPLETED|Overall Study||3||
59991300|NCT02228980|76106836|FG002|NOT COMPLETED|Overall Study||2||
59991301|NCT02228980|76106837|FG003|NOT COMPLETED|Overall Study||3||
59991302|NCT02228590|76106851|FG000|STARTED|Overall Study||20||
60082254|NCT00298558|76197766|FG001|NOT COMPLETED|1st Annual (A1)||63||
60082255|NCT00298558|76197767|FG002|NOT COMPLETED|1st Annual (A1)||52||
59991303|NCT02228590|76106851|FG000|COMPLETED|Overall Study||19||
59991304|NCT02228590|76106851|FG000|NOT COMPLETED|Overall Study||1||
60082256|NCT00298558|76197768|FG003|NOT COMPLETED|1st Annual (A1)||55||
60082257|NCT00298558|76197765|FG000|STARTED|2nd Annual (A2)||585||
60082258|NCT00298558|76197766|FG001|STARTED|2nd Annual (A2)||566||
60082259|NCT00298558|76197767|FG002|STARTED|2nd Annual (A2)||601||
60082260|NCT00298558|76197768|FG003|STARTED|2nd Annual (A2)||584||
60082261|NCT00298558|76197765|FG000|COMPLETED|2nd Annual (A2)||563||
60082262|NCT00298558|76197766|FG001|COMPLETED|2nd Annual (A2)||555||
60082263|NCT00298558|76197767|FG002|COMPLETED|2nd Annual (A2)||574||
60082264|NCT00298558|76197768|FG003|COMPLETED|2nd Annual (A2)||552||
60082265|NCT00298558|76197765|FG000|NOT COMPLETED|2nd Annual (A2)||22||
60082266|NCT00298558|76197766|FG001|NOT COMPLETED|2nd Annual (A2)||11||
60082267|NCT00298558|76197767|FG002|NOT COMPLETED|2nd Annual (A2)||27||
60082268|NCT00298558|76197768|FG003|NOT COMPLETED|2nd Annual (A2)||32||
60082269|NCT00298558|76197765|FG000|STARTED|3rd Annual Booster||372||
60082270|NCT00298558|76197766|FG001|STARTED|3rd Annual Booster||371||
60082271|NCT00298558|76197767|FG002|STARTED|3rd Annual Booster||370||
60082272|NCT00298558|76197768|FG003|STARTED|3rd Annual Booster||0||
60082273|NCT00298558|76197765|FG000|COMPLETED|3rd Annual Booster||250||
60082274|NCT00298558|76197766|FG001|COMPLETED|3rd Annual Booster||243||
60082275|NCT00298558|76197767|FG002|COMPLETED|3rd Annual Booster||230||
60082276|NCT00298558|76197768|FG003|COMPLETED|3rd Annual Booster||0||
60082277|NCT00298558|76197765|FG000|NOT COMPLETED|3rd Annual Booster||122||
60082278|NCT00298558|76197766|FG001|NOT COMPLETED|3rd Annual Booster||128||
60082279|NCT00298558|76197767|FG002|NOT COMPLETED|3rd Annual Booster||140||
60082280|NCT00298558|76197768|FG003|NOT COMPLETED|3rd Annual Booster||0||
60082281|NCT00298558|76197765|FG000|STARTED|3rd Annual (A3) and 5th Annual (A5)||563||
60082282|NCT00298558|76197766|FG001|STARTED|3rd Annual (A3) and 5th Annual (A5)||555||
60082283|NCT00298558|76197767|FG002|STARTED|3rd Annual (A3) and 5th Annual (A5)||574||
60082284|NCT00298558|76197768|FG003|STARTED|3rd Annual (A3) and 5th Annual (A5)||552||
60082285|NCT00298558|76197765|FG000|COMPLETED|3rd Annual (A3) and 5th Annual (A5)||472||
60082286|NCT00298558|76197766|FG001|COMPLETED|3rd Annual (A3) and 5th Annual (A5)||469||
60082287|NCT00298558|76197767|FG002|COMPLETED|3rd Annual (A3) and 5th Annual (A5)||490||
60082288|NCT00298558|76197768|FG003|COMPLETED|3rd Annual (A3) and 5th Annual (A5)||448||
60082289|NCT00298558|76197765|FG000|NOT COMPLETED|3rd Annual (A3) and 5th Annual (A5)||91||
60082290|NCT00298558|76197766|FG001|NOT COMPLETED|3rd Annual (A3) and 5th Annual (A5)||86||
59551506|NCT01364558|75651183|FG001|NOT COMPLETED|Dose One||0||
59551507|NCT01364558|75651184|FG002|NOT COMPLETED|Dose One||0||
59551508|NCT01364558|75651182|FG000|STARTED|Dose Two||8||
59551509|NCT01364558|75651183|FG001|STARTED|Dose Two||8||
59551510|NCT01364558|75651184|FG002|STARTED|Dose Two||8||
59551511|NCT01364558|75651182|FG000|COMPLETED|Dose Two||8||
59551512|NCT01364558|75651183|FG001|COMPLETED|Dose Two||8||
59551513|NCT01364558|75651184|FG002|COMPLETED|Dose Two||8||
59551514|NCT01364558|75651182|FG000|NOT COMPLETED|Dose Two||0||
59551515|NCT01364558|75651183|FG001|NOT COMPLETED|Dose Two||0||
59551516|NCT01364558|75651184|FG002|NOT COMPLETED|Dose Two||0||
59551517|NCT01364558|75651182|FG000|STARTED|Dose Three||8||
59551518|NCT01364558|75651183|FG001|STARTED|Dose Three||8||
59551519|NCT01364558|75651184|FG002|STARTED|Dose Three||8||
59551520|NCT01364558|75651182|FG000|COMPLETED|Dose Three||8||
59551521|NCT01364558|75651183|FG001|COMPLETED|Dose Three||8||
59551522|NCT01364558|75651184|FG002|COMPLETED|Dose Three||8||
59551523|NCT01364558|75651182|FG000|NOT COMPLETED|Dose Three||0||
59551524|NCT01364558|75651183|FG001|NOT COMPLETED|Dose Three||0||
59551525|NCT01364558|75651184|FG002|NOT COMPLETED|Dose Three||0||
59551526|NCT01323140|75651192|FG000|STARTED|Overall Study||40||
60082291|NCT00298558|76197767|FG002|NOT COMPLETED|3rd Annual (A3) and 5th Annual (A5)||84||
60082292|NCT00298558|76197768|FG003|NOT COMPLETED|3rd Annual (A3) and 5th Annual (A5)||104||
60082293|NCT00298558|76197765|FG000|STARTED|10th Annual (A10)||472||
60082294|NCT00298558|76197766|FG001|STARTED|10th Annual (A10)||469||
59706847|NCT00996892|75825865|FG004|STARTED|Dose-Escalation Stage 1B||0||
59706848|NCT00996892|75825866|FG005|STARTED|Dose-Escalation Stage 1B||0||
59706849|NCT00996892|75825867|FG006|STARTED|Dose-Escalation Stage 1B||0||
59706850|NCT00996892|75825868|FG007|STARTED|Dose-Escalation Stage 1B||0||
59706851|NCT00996892|75825869|FG008|STARTED|Dose-Escalation Stage 1B||0||
59706852|NCT00996892|75825870|FG009|STARTED|Dose-Escalation Stage 1B||0||
59706853|NCT00996892|75825871|FG010|STARTED|Dose-Escalation Stage 1B||0||
60082295|NCT00298558|76197767|FG002|STARTED|10th Annual (A10)||490||
59551527|NCT01323140|75651192|FG000|COMPLETED|Overall Study||38||
59551528|NCT01323140|75651192|FG000|NOT COMPLETED|Overall Study||2||
59551529|NCT03823287|75651198|FG000|STARTED|Overall Study||334|Intent-to-Treat (ITT) Population|
59551530|NCT03823287|75651199|FG001|STARTED|Overall Study||337|Intent-to-Treat (ITT) Population|
59551531|NCT03823287|75651198|FG000|Received at Least One Dose of Study Drug|Overall Study||333|Safety Population|
59706854|NCT00996892|75825872|FG011|STARTED|Dose-Escalation Stage 1B||0||
60082296|NCT00298558|76197768|FG003|STARTED|10th Annual (A10)||448||
60082297|NCT00298558|76197765|FG000|COMPLETED|10th Annual (A10)||300||
60082298|NCT00298558|76197766|FG001|COMPLETED|10th Annual (A10)||316||
60082299|NCT00298558|76197767|FG002|COMPLETED|10th Annual (A10)||319||
60082300|NCT00298558|76197768|FG003|COMPLETED|10th Annual (A10)||285||
60082301|NCT00298558|76197765|FG000|NOT COMPLETED|10th Annual (A10)||172||
60082302|NCT00298558|76197766|FG001|NOT COMPLETED|10th Annual (A10)||153||
60082303|NCT00298558|76197767|FG002|NOT COMPLETED|10th Annual (A10)||171||
60082304|NCT00298558|76197768|FG003|NOT COMPLETED|10th Annual (A10)||163||
60082305|NCT00299416|76197778|FG000|STARTED|Overall Study||30||
60082306|NCT00299416|76197778|FG000|COMPLETED|Overall Study||30||
59706855|NCT00996892|75825873|FG012|STARTED|Dose-Escalation Stage 1B||0||
60082307|NCT00299416|76197778|FG000|NOT COMPLETED|Overall Study||0||
60082308|NCT00300430|76197785|FG000|STARTED|Overall Study|"Started = received combo therapy in double-blind and/or open-label study."|1186||
60082309|NCT00300430|76197786|FG001|STARTED|Overall Study|"Started = received combo therapy in double-blind and/or open-label study."|514||
60082310|NCT00300430|76197787|FG002|STARTED|Overall Study|"Started = received combo therapy in double-blind and/or open-label study."|501||
60082311|NCT00300430|76197785|FG000|COMPLETED|Overall Study|"Completed = completed both the double-blind and open-label studies."|819||
60082312|NCT00300430|76197786|FG001|COMPLETED|Overall Study|"Completed = completed both the double-blind and open-label studies."|345||
60082313|NCT00300430|76197787|FG002|COMPLETED|Overall Study|"Completed = completed both the double-blind and open-label studies."|350||
60082314|NCT00300430|76197785|FG000|NOT COMPLETED|Overall Study||367||
59551532|NCT03823287|75651199|FG001|Received at Least One Dose of Study Drug|Overall Study||336|Safety Population|
59551533|NCT03823287|75651198|FG000|Completed up to Week 48|Overall Study||319|Primary Completion Date Cutoff|
59551534|NCT03823287|75651199|FG001|Completed up to Week 48|Overall Study||323|Primary Completion Date Cutoff|
59551535|NCT03823287|75651198|FG000|COMPLETED|Overall Study||274||
59551536|NCT03823287|75651199|FG001|COMPLETED|Overall Study||291||
59551537|NCT03823287|75651198|FG000|NOT COMPLETED|Overall Study||60||
59551538|NCT03823287|75651199|FG001|NOT COMPLETED|Overall Study||46||
59551539|NCT01260272|75651207|FG000|STARTED|Overall Study||17||
59551540|NCT01260272|75651208|FG001|STARTED|Overall Study||32||
59551541|NCT01260272|75651207|FG000|COMPLETED|Overall Study||15||
59551542|NCT01260272|75651208|FG001|COMPLETED|Overall Study||30||
59551543|NCT01260272|75651207|FG000|NOT COMPLETED|Overall Study||2||
59551544|NCT01260272|75651208|FG001|NOT COMPLETED|Overall Study||2||
59551545|NCT01769573|75651221|FG000|STARTED|Overall Study||10||
59551546|NCT01769573|75651222|FG001|STARTED|Overall Study||6||
59551547|NCT01769573|75651223|FG002|STARTED|Overall Study||10||
59551548|NCT01769573|75651224|FG003|STARTED|Overall Study||0||
59551549|NCT01769573|75651225|FG004|STARTED|Overall Study||10||
59551550|NCT01769573|75651221|FG000|COMPLETED|Overall Study||10||
59991305|NCT02227108|76106856|FG000|STARTED|Overall Study||32||
59991306|NCT02227108|76106856|FG000|Treated|Overall Study||30||
59991307|NCT02227108|76106856|FG000|COMPLETED|Overall Study||1||
59991308|NCT02227108|76106856|FG000|NOT COMPLETED|Overall Study||31||
59991309|NCT03564145|76106860|FG000|STARTED|Overall Study||547||
59991310|NCT03564145|76106860|FG000|Received at Least 1 Dose of Study Drug|Overall Study||535||
59991311|NCT03564145|76106860|FG000|COMPLETED|Overall Study||323||
59991312|NCT03564145|76106860|FG000|NOT COMPLETED|Overall Study||224||
59991313|NCT02226562|76106866|FG000|STARTED|Overall Study||95||
59991314|NCT02226562|76106867|FG001|STARTED|Overall Study||96||
59991315|NCT02226562|76106866|FG000|COMPLETED|Overall Study||95||
59991316|NCT02226562|76106867|FG001|COMPLETED|Overall Study|Lost to follow up|95||
59991317|NCT02226562|76106866|FG000|NOT COMPLETED|Overall Study||0||
59991318|NCT02226562|76106867|FG001|NOT COMPLETED|Overall Study||1||
59991319|NCT03365635|76106879|FG000|STARTED|Overall Study||3||
60082315|NCT00300430|76197786|FG001|NOT COMPLETED|Overall Study||169||
60082316|NCT00300430|76197787|FG002|NOT COMPLETED|Overall Study||151||
60082317|NCT02104414|76197798|FG000|STARTED|Overall Study||5||
60082318|NCT02104414|76197799|FG001|STARTED|Overall Study||4||
60082319|NCT02104414|76197800|FG002|STARTED|Overall Study||2||
60082320|NCT02104414|76197798|FG000|COMPLETED|Overall Study||5||
60082321|NCT02104414|76197799|FG001|COMPLETED|Overall Study||4||
60082322|NCT02104414|76197800|FG002|COMPLETED|Overall Study||2||
60082323|NCT02104414|76197798|FG000|NOT COMPLETED|Overall Study||0||
60082324|NCT02104414|76197799|FG001|NOT COMPLETED|Overall Study||0||
60082325|NCT02104414|76197800|FG002|NOT COMPLETED|Overall Study||0||
60082326|NCT02100826|76197808|FG000|STARTED|Period 1 (7 Days)||14||
60082327|NCT02100826|76197809|FG001|STARTED|Period 1 (7 Days)||14||
60082328|NCT02100826|76197808|FG000|COMPLETED|Period 1 (7 Days)||14||
60082329|NCT02100826|76197809|FG001|COMPLETED|Period 1 (7 Days)||14||
60082330|NCT02100826|76197808|FG000|NOT COMPLETED|Period 1 (7 Days)||0||
60082331|NCT02100826|76197809|FG001|NOT COMPLETED|Period 1 (7 Days)||0||
60082332|NCT02100826|76197808|FG000|STARTED|Washout Period (1 Day)||14||
60082333|NCT02100826|76197809|FG001|STARTED|Washout Period (1 Day)||14||
60082334|NCT02100826|76197808|FG000|COMPLETED|Washout Period (1 Day)||14||
60082335|NCT02100826|76197809|FG001|COMPLETED|Washout Period (1 Day)||14||
60082336|NCT02100826|76197808|FG000|NOT COMPLETED|Washout Period (1 Day)||0||
60082337|NCT02100826|76197809|FG001|NOT COMPLETED|Washout Period (1 Day)||0||
59551551|NCT01769573|75651222|FG001|COMPLETED|Overall Study||6||
59551552|NCT01769573|75651223|FG002|COMPLETED|Overall Study||10||
59551553|NCT01769573|75651224|FG003|COMPLETED|Overall Study||0||
59551554|NCT01769573|75651225|FG004|COMPLETED|Overall Study||10||
59551555|NCT01769573|75651221|FG000|NOT COMPLETED|Overall Study||0||
59551556|NCT01769573|75651222|FG001|NOT COMPLETED|Overall Study||0||
59551557|NCT01769573|75651223|FG002|NOT COMPLETED|Overall Study||0||
59551558|NCT01769573|75651224|FG003|NOT COMPLETED|Overall Study||0||
59991320|NCT03365635|76106880|FG001|STARTED|Overall Study||0||
59991321|NCT03365635|76106881|FG002|STARTED|Overall Study||1||
59991322|NCT03365635|76106882|FG003|STARTED|Overall Study||0||
59991323|NCT03365635|76106883|FG004|STARTED|Overall Study||0||
59991324|NCT03365635|76106884|FG005|STARTED|Overall Study||0||
60082338|NCT02100826|76197808|FG000|STARTED|Period 2 (7 Days)||14||
60082339|NCT02100826|76197809|FG001|STARTED|Period 2 (7 Days)||14||
60082340|NCT02100826|76197808|FG000|COMPLETED|Period 2 (7 Days)||14||
60082341|NCT02100826|76197809|FG001|COMPLETED|Period 2 (7 Days)||14||
60082342|NCT02100826|76197808|FG000|NOT COMPLETED|Period 2 (7 Days)||0||
60082343|NCT02100826|76197809|FG001|NOT COMPLETED|Period 2 (7 Days)||0||
60082344|NCT02101918|76197815|FG000|STARTED|Overall Study||22||
60082345|NCT02101918|76197815|FG000|COMPLETED|Overall Study||22||
60082346|NCT02101918|76197815|FG000|NOT COMPLETED|Overall Study||0||
60082347|NCT02102230|76197822|FG000|STARTED|Overall Study||42||
60082348|NCT02102230|76197823|FG001|STARTED|Overall Study||28||
60082349|NCT02102230|76197824|FG002|STARTED|Overall Study||41||
60082350|NCT02102230|76197822|FG000|COMPLETED|Overall Study||25||
59706856|NCT00996892|75825874|FG013|STARTED|Dose-Escalation Stage 1B||0||
59991325|NCT03365635|76106879|FG000|COMPLETED|Overall Study||3||
59991326|NCT03365635|76106880|FG001|COMPLETED|Overall Study||0||
59991327|NCT03365635|76106881|FG002|COMPLETED|Overall Study||1||
59991328|NCT03365635|76106882|FG003|COMPLETED|Overall Study||0||
59991329|NCT03365635|76106883|FG004|COMPLETED|Overall Study||0||
60082351|NCT02102230|76197823|FG001|COMPLETED|Overall Study||11||
60082352|NCT02102230|76197824|FG002|COMPLETED|Overall Study||24||
60082353|NCT02102230|76197822|FG000|NOT COMPLETED|Overall Study||17||
60082354|NCT02102230|76197823|FG001|NOT COMPLETED|Overall Study||17||
60082355|NCT02102230|76197824|FG002|NOT COMPLETED|Overall Study||17||
60082356|NCT00300742|76197833|FG000|STARTED|Overall Study||5||
60082357|NCT00300742|76197833|FG000|COMPLETED|Overall Study||3||
60082358|NCT00300742|76197833|FG000|NOT COMPLETED|Overall Study||2||
60082359|NCT00301756|76197838|FG000|STARTED|Overall Study||32||
60082360|NCT00301756|76197838|FG000|COMPLETED|Overall Study||32||
60082361|NCT00301756|76197838|FG000|NOT COMPLETED|Overall Study||0||
60082362|NCT00302068|76197847|FG000|STARTED|Overall Study||37||
60082363|NCT00302068|76197848|FG001|STARTED|Overall Study||40||
60082364|NCT00302068|76197849|FG002|STARTED|Overall Study||24||
60082365|NCT00302068|76197847|FG000|COMPLETED|Overall Study||36||
60082366|NCT00302068|76197848|FG001|COMPLETED|Overall Study||36||
60082367|NCT00302068|76197849|FG002|COMPLETED|Overall Study||23||
60082368|NCT00302068|76197847|FG000|NOT COMPLETED|Overall Study||1||
60082369|NCT00302068|76197848|FG001|NOT COMPLETED|Overall Study||4||
60082370|NCT00302068|76197849|FG002|NOT COMPLETED|Overall Study||1||
60082371|NCT00302848|76197861|FG000|STARTED|Overall Study||16534||
60082372|NCT00302848|76197862|FG001|STARTED|Overall Study||15428||
60082373|NCT00302848|76197863|FG002|STARTED|Overall Study||26341||
60082374|NCT00302848|76197861|FG000|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 1.5 and 5.0 years.|16133||
60082375|NCT00302848|76197862|FG001|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 1.5 and 5.0 years.|15009||
60082376|NCT00302848|76197863|FG002|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 1.5 and 5.0 years.|25762||
60082377|NCT00302848|76197861|FG000|NOT COMPLETED|Overall Study||401||
60082378|NCT00302848|76197862|FG001|NOT COMPLETED|Overall Study||419||
60082379|NCT00302848|76197863|FG002|NOT COMPLETED|Overall Study||579||
60082380|NCT00138034|76197872|FG000|STARTED|Overall Study||26||
60082381|NCT00138034|76197873|FG001|STARTED|Overall Study||23||
60082382|NCT00138034|76197872|FG000|COMPLETED|Overall Study||23||
60082383|NCT00138034|76197873|FG001|COMPLETED|Overall Study||20||
60082384|NCT00138034|76197872|FG000|NOT COMPLETED|Overall Study||3||
60082385|NCT00138034|76197873|FG001|NOT COMPLETED|Overall Study||3||
60082386|NCT00303862|76197879|FG000|STARTED|Overall Study||10||
59706857|NCT00996892|75825875|FG014|STARTED|Dose-Escalation Stage 1B||4||
59706858|NCT00996892|75825876|FG015|STARTED|Dose-Escalation Stage 1B||3||
60082387|NCT00303862|76197879|FG000|COMPLETED|Overall Study||10||
59991330|NCT03365635|76106884|FG005|COMPLETED|Overall Study||0||
59991331|NCT03365635|76106879|FG000|NOT COMPLETED|Overall Study||0||
59991332|NCT03365635|76106880|FG001|NOT COMPLETED|Overall Study||0||
59991333|NCT03365635|76106881|FG002|NOT COMPLETED|Overall Study||0||
60082388|NCT00303862|76197879|FG000|NOT COMPLETED|Overall Study||0||
60082389|NCT00304096|76197885|FG000|STARTED|Overall Study||6||
60082390|NCT00304096|76197886|FG001|STARTED|Overall Study||5||
60082391|NCT00304096|76197885|FG000|COMPLETED|Overall Study||6||
60082392|NCT00304096|76197886|FG001|COMPLETED|Overall Study|6 patients enrolled, 1 not treated|5||
59991334|NCT03365635|76106882|FG003|NOT COMPLETED|Overall Study||0||
59991335|NCT03365635|76106883|FG004|NOT COMPLETED|Overall Study||0||
59991336|NCT03365635|76106884|FG005|NOT COMPLETED|Overall Study||0||
59991337|NCT02456636|76106901|FG000|STARTED|Overall Study||478||
59991338|NCT02456636|76106902|FG001|STARTED|Overall Study||479||
59551559|NCT01769573|75651225|FG004|NOT COMPLETED|Overall Study||0||
59991339|NCT02456636|76106903|FG002|STARTED|Overall Study||475||
59991340|NCT02456636|76106901|FG000|6 Month|Overall Study||474||
59991341|NCT02456636|76106902|FG001|6 Month|Overall Study||474||
60082393|NCT00304096|76197885|FG000|NOT COMPLETED|Overall Study||0||
59551560|NCT02193152|75651237|FG000|STARTED|Overall Study||16||
59551561|NCT02193152|75651237|FG000|COMPLETED|Overall Study||16||
59991342|NCT02456636|76106903|FG002|6 Month|Overall Study||468||
59991343|NCT02456636|76106901|FG000|18 Month|Overall Study||467||
59551562|NCT02193152|75651237|FG000|NOT COMPLETED|Overall Study||0||
60082394|NCT00304096|76197886|FG001|NOT COMPLETED|Overall Study||0||
60082395|NCT00140842|76197894|FG000|STARTED|Overall Study||15||
60082396|NCT00140842|76197895|FG001|STARTED|Overall Study||15||
60082397|NCT00140842|76197894|FG000|COMPLETED|Overall Study||15||
60082398|NCT00140842|76197895|FG001|COMPLETED|Overall Study||15||
60082399|NCT00140842|76197894|FG000|NOT COMPLETED|Overall Study||0||
60082400|NCT00140842|76197895|FG001|NOT COMPLETED|Overall Study||0||
60082401|NCT00142168|76197901|FG000|STARTED|Overall Study||16||
60082402|NCT00142168|76197901|FG000|COMPLETED|Overall Study||16||
60082403|NCT00142168|76197901|FG000|NOT COMPLETED|Overall Study||0||
60082404|NCT00147082|76197908|FG000|STARTED|Overall Study||37||
60082405|NCT00147082|76197909|FG001|STARTED|Overall Study||33||
60082406|NCT00147082|76197910|FG002|STARTED|Overall Study||30||
60082407|NCT00147082|76197908|FG000|COMPLETED|Overall Study||37||
60082408|NCT00147082|76197909|FG001|COMPLETED|Overall Study||33||
60082409|NCT00147082|76197910|FG002|COMPLETED|Overall Study||30||
60082410|NCT00147082|76197908|FG000|NOT COMPLETED|Overall Study||0||
60082411|NCT00147082|76197909|FG001|NOT COMPLETED|Overall Study||0||
60082412|NCT00147082|76197910|FG002|NOT COMPLETED|Overall Study||0||
60082413|NCT00147316|76197918|FG000|STARTED|Overall Study||103||
60082414|NCT00147316|76197918|FG000|COMPLETED|Overall Study||103||
60082415|NCT00147316|76197918|FG000|NOT COMPLETED|Overall Study||0||
60082416|NCT00148798|76197924|FG000|STARTED|Overall Study|Intent To Treat (ITT) Population|557||
60082417|NCT00148798|76197925|FG001|STARTED|Overall Study|ITT Population|568||
60082418|NCT00148798|76197924|FG000|COMPLETED|Overall Study||557||
60082419|NCT00148798|76197925|FG001|COMPLETED|Overall Study||568||
60082420|NCT00148798|76197924|FG000|NOT COMPLETED|Overall Study||0||
60082421|NCT00148798|76197925|FG001|NOT COMPLETED|Overall Study||0||
60082422|NCT00148954|76197935|FG000|STARTED|Overall Study||985||
60082423|NCT00148954|76197936|FG001|STARTED|Overall Study||977||
60082424|NCT00148954|76197935|FG000|COMPLETED|Overall Study||678||
60082425|NCT00148954|76197936|FG001|COMPLETED|Overall Study||677||
60082426|NCT00148954|76197935|FG000|NOT COMPLETED|Overall Study||307||
60082427|NCT00148954|76197936|FG001|NOT COMPLETED|Overall Study||300||
60082428|NCT00149734|76197942|FG000|STARTED|Overall Study||4||
60082429|NCT00149734|76197943|FG001|STARTED|Overall Study||4||
60082430|NCT00149734|76197942|FG000|Started Intervention 2|Overall Study||4||
60082431|NCT00149734|76197943|FG001|Started Intervention 2|Overall Study||4||
60082432|NCT00149734|76197942|FG000|COMPLETED|Overall Study||4||
60082433|NCT00149734|76197943|FG001|COMPLETED|Overall Study||4||
60082434|NCT00149734|76197942|FG000|NOT COMPLETED|Overall Study||0||
60082435|NCT00149734|76197943|FG001|NOT COMPLETED|Overall Study||0||
60082436|NCT00305578|76197951|FG000|STARTED|Overall Study||15||
60082437|NCT00305578|76197952|FG001|STARTED|Overall Study||14||
60082438|NCT00305578|76197951|FG000|COMPLETED|Overall Study||12||
60082439|NCT00305578|76197952|FG001|COMPLETED|Overall Study||12||
60082440|NCT00305578|76197951|FG000|NOT COMPLETED|Overall Study||3||
60082441|NCT00305578|76197952|FG001|NOT COMPLETED|Overall Study||2||
60082442|NCT01468701|76197975|FG000|STARTED|Overall Study||4964||
60082443|NCT01468701|76197976|FG001|STARTED|Overall Study||5103||
60082444|NCT01468701|76197977|FG002|STARTED|Overall Study||1784||
60082445|NCT01468701|76197978|FG003|STARTED|Overall Study||715||
60082446|NCT01468701|76197979|FG004|STARTED|Overall Study||1736||
60082447|NCT01468701|76197980|FG005|STARTED|Overall Study||128||
60082448|NCT01468701|76197981|FG006|STARTED|Overall Study||1209||
60082449|NCT01468701|76197982|FG007|STARTED|Overall Study||5||
60082450|NCT01468701|76197983|FG008|STARTED|Overall Study||3879||
60082451|NCT01468701|76197984|FG009|STARTED|Overall Study||4962||
60082452|NCT01468701|76197985|FG010|STARTED|Overall Study||4054||
60082453|NCT01468701|76197986|FG011|STARTED|Overall Study||4538||
60082454|NCT01468701|76197987|FG012|STARTED|Overall Study||333||
60082455|NCT01468701|76197988|FG013|STARTED|Overall Study||2182||
60082456|NCT01468701|76197989|FG014|STARTED|Overall Study||214||
60082457|NCT01468701|76197990|FG015|STARTED|Overall Study||1418||
60082458|NCT01468701|76197991|FG016|STARTED|Overall Study||11||
60082459|NCT01468701|76197975|FG000|All Eligible Patient|Overall Study||4873||
60082460|NCT01468701|76197976|FG001|All Eligible Patient|Overall Study||4963||
60082461|NCT01468701|76197977|FG002|All Eligible Patient|Overall Study||1755||
60082462|NCT01468701|76197978|FG003|All Eligible Patient|Overall Study||703||
59551563|NCT01323998|75651246|FG000|STARTED|Overall Study||200631||
60082463|NCT01468701|76197979|FG004|All Eligible Patient|Overall Study||1714||
60082464|NCT01468701|76197980|FG005|All Eligible Patient|Overall Study||126||
60082465|NCT01468701|76197981|FG006|All Eligible Patient|Overall Study||1170||
60082466|NCT01468701|76197982|FG007|All Eligible Patient|Overall Study||4||
60082467|NCT01468701|76197983|FG008|All Eligible Patient|Overall Study||3839||
60082468|NCT01468701|76197984|FG009|All Eligible Patient|Overall Study||4836||
60082469|NCT01468701|76197985|FG010|All Eligible Patient|Overall Study||4015||
60082470|NCT01468701|76197986|FG011|All Eligible Patient|Overall Study||4505||
60082471|NCT01468701|76197987|FG012|All Eligible Patient|Overall Study||332||
60082472|NCT01468701|76197988|FG013|All Eligible Patient|Overall Study||2163||
60082473|NCT01468701|76197989|FG014|All Eligible Patient|Overall Study||213||
60082474|NCT01468701|76197990|FG015|All Eligible Patient|Overall Study||1386||
59551564|NCT01323998|75651247|FG001|STARTED|Overall Study||18681||
59706859|NCT00996892|75825877|FG016|STARTED|Dose-Escalation Stage 1B||3||
59706860|NCT00996892|75825878|FG017|STARTED|Dose-Escalation Stage 1B||5||
59551565|NCT01323998|75651248|FG002|STARTED|Overall Study||10294||
59551566|NCT01323998|75651249|FG003|STARTED|Overall Study||12052||
59551567|NCT01323998|75651250|FG004|STARTED|Overall Study||6735||
59551568|NCT01323998|75651246|FG000|COMPLETED|Overall Study||200631||
59551569|NCT01323998|75651247|FG001|COMPLETED|Overall Study||18681||
59551570|NCT01323998|75651248|FG002|COMPLETED|Overall Study||10294||
59551571|NCT01323998|75651249|FG003|COMPLETED|Overall Study||12052||
59551572|NCT01323998|75651250|FG004|COMPLETED|Overall Study||6735||
59551573|NCT01323998|75651246|FG000|NOT COMPLETED|Overall Study||0||
59551574|NCT01323998|75651247|FG001|NOT COMPLETED|Overall Study||0||
59551575|NCT01323998|75651248|FG002|NOT COMPLETED|Overall Study||0||
59551576|NCT01323998|75651249|FG003|NOT COMPLETED|Overall Study||0||
59551577|NCT01323998|75651250|FG004|NOT COMPLETED|Overall Study||0||
59551578|NCT02258477|75651262|FG000|STARTED|First Intervention (1 Week)||10||
59551579|NCT02258477|75651263|FG001|STARTED|First Intervention (1 Week)||9||
59551580|NCT02258477|75651264|FG002|STARTED|First Intervention (1 Week)||9||
59551581|NCT02258477|75651265|FG003|STARTED|First Intervention (1 Week)||9||
59551582|NCT02258477|75651262|FG000|COMPLETED|First Intervention (1 Week)||9||
59551583|NCT02258477|75651263|FG001|COMPLETED|First Intervention (1 Week)||8||
59551584|NCT02258477|75651264|FG002|COMPLETED|First Intervention (1 Week)||9||
59551585|NCT02258477|75651265|FG003|COMPLETED|First Intervention (1 Week)||9||
59551586|NCT02258477|75651262|FG000|NOT COMPLETED|First Intervention (1 Week)||1||
59551587|NCT02258477|75651263|FG001|NOT COMPLETED|First Intervention (1 Week)||1||
59551588|NCT02258477|75651264|FG002|NOT COMPLETED|First Intervention (1 Week)||0||
59551589|NCT02258477|75651265|FG003|NOT COMPLETED|First Intervention (1 Week)||0||
59551590|NCT02258477|75651262|FG000|STARTED|Second Intervention (1 Week)||9||
59551591|NCT02258477|75651263|FG001|STARTED|Second Intervention (1 Week)||8||
59706861|NCT00996892|75825879|FG018|STARTED|Dose-Escalation Stage 1B||0||
59551592|NCT02258477|75651264|FG002|STARTED|Second Intervention (1 Week)||9||
59551593|NCT02258477|75651265|FG003|STARTED|Second Intervention (1 Week)||9||
59551594|NCT02258477|75651262|FG000|COMPLETED|Second Intervention (1 Week)||9||
59551595|NCT02258477|75651263|FG001|COMPLETED|Second Intervention (1 Week)||8||
59551596|NCT02258477|75651264|FG002|COMPLETED|Second Intervention (1 Week)||8||
59551597|NCT02258477|75651265|FG003|COMPLETED|Second Intervention (1 Week)||8||
59551598|NCT02258477|75651262|FG000|NOT COMPLETED|Second Intervention (1 Week)||0||
59551599|NCT02258477|75651263|FG001|NOT COMPLETED|Second Intervention (1 Week)||0||
59551600|NCT02258477|75651264|FG002|NOT COMPLETED|Second Intervention (1 Week)||1||
59551601|NCT02258477|75651265|FG003|NOT COMPLETED|Second Intervention (1 Week)||1||
59551602|NCT02258477|75651262|FG000|STARTED|Third Intervention (1 Week)||9||
59551603|NCT02258477|75651263|FG001|STARTED|Third Intervention (1 Week)||8||
59551604|NCT02258477|75651264|FG002|STARTED|Third Intervention (1 Week)||8||
59551605|NCT02258477|75651265|FG003|STARTED|Third Intervention (1 Week)||8||
59706862|NCT00996892|75825880|FG019|STARTED|Dose-Escalation Stage 1B||0||
59816436|NCT00430677|75938851|FG001|NOT COMPLETED|Long-term Extension Period||58||
59551606|NCT02258477|75651262|FG000|COMPLETED|Third Intervention (1 Week)||9||
59551607|NCT02258477|75651263|FG001|COMPLETED|Third Intervention (1 Week)||8||
59551608|NCT02258477|75651264|FG002|COMPLETED|Third Intervention (1 Week)||8||
59551609|NCT02258477|75651265|FG003|COMPLETED|Third Intervention (1 Week)||8||
59551610|NCT02258477|75651262|FG000|NOT COMPLETED|Third Intervention (1 Week)||0||
59551611|NCT02258477|75651263|FG001|NOT COMPLETED|Third Intervention (1 Week)||0||
59551612|NCT02258477|75651264|FG002|NOT COMPLETED|Third Intervention (1 Week)||0||
59551613|NCT02258477|75651265|FG003|NOT COMPLETED|Third Intervention (1 Week)||0||
59551614|NCT02258477|75651262|FG000|STARTED|Fourth Intervention (1 Week)||9||
59551615|NCT02258477|75651263|FG001|STARTED|Fourth Intervention (1 Week)||8||
59551616|NCT02258477|75651264|FG002|STARTED|Fourth Intervention (1 Week)||8||
59551617|NCT02258477|75651265|FG003|STARTED|Fourth Intervention (1 Week)||8||
59551618|NCT02258477|75651262|FG000|COMPLETED|Fourth Intervention (1 Week)||9||
59551619|NCT02258477|75651263|FG001|COMPLETED|Fourth Intervention (1 Week)||8||
59551620|NCT02258477|75651264|FG002|COMPLETED|Fourth Intervention (1 Week)||8||
59551621|NCT02258477|75651265|FG003|COMPLETED|Fourth Intervention (1 Week)||8||
59551622|NCT02258477|75651262|FG000|NOT COMPLETED|Fourth Intervention (1 Week)||0||
59551623|NCT02258477|75651263|FG001|NOT COMPLETED|Fourth Intervention (1 Week)||0||
60082475|NCT01468701|76197991|FG016|All Eligible Patient|Overall Study||11||
60082476|NCT01468701|76197975|FG000|COMPLETED|Overall Study||3965||
60082477|NCT01468701|76197976|FG001|COMPLETED|Overall Study||0||
60082478|NCT01468701|76197977|FG002|COMPLETED|Overall Study||0||
60082479|NCT01468701|76197978|FG003|COMPLETED|Overall Study||0||
60082480|NCT01468701|76197979|FG004|COMPLETED|Overall Study||0||
60082481|NCT01468701|76197980|FG005|COMPLETED|Overall Study||0||
60082482|NCT01468701|76197981|FG006|COMPLETED|Overall Study||0||
60082483|NCT01468701|76197982|FG007|COMPLETED|Overall Study||0||
60082484|NCT01468701|76197983|FG008|COMPLETED|Overall Study||3219||
60082485|NCT01468701|76197984|FG009|COMPLETED|Overall Study||3780||
60082486|NCT01468701|76197985|FG010|COMPLETED|Overall Study||3256||
60082487|NCT01468701|76197986|FG011|COMPLETED|Overall Study||3672||
60082488|NCT01468701|76197987|FG012|COMPLETED|Overall Study||284||
60082489|NCT01468701|76197988|FG013|COMPLETED|Overall Study||1712||
60082490|NCT01468701|76197989|FG014|COMPLETED|Overall Study||151||
60082491|NCT01468701|76197990|FG015|COMPLETED|Overall Study||1056||
60082492|NCT01468701|76197991|FG016|COMPLETED|Overall Study||10||
60082493|NCT01468701|76197975|FG000|NOT COMPLETED|Overall Study||999||
60082494|NCT01468701|76197976|FG001|NOT COMPLETED|Overall Study||5103||
60082495|NCT01468701|76197977|FG002|NOT COMPLETED|Overall Study||1784||
60082496|NCT01468701|76197978|FG003|NOT COMPLETED|Overall Study||715||
60082497|NCT01468701|76197979|FG004|NOT COMPLETED|Overall Study||1736||
60082498|NCT01468701|76197980|FG005|NOT COMPLETED|Overall Study||128||
60082499|NCT01468701|76197981|FG006|NOT COMPLETED|Overall Study||1209||
60082500|NCT01468701|76197982|FG007|NOT COMPLETED|Overall Study||5||
60082501|NCT01468701|76197983|FG008|NOT COMPLETED|Overall Study||660||
60082502|NCT01468701|76197984|FG009|NOT COMPLETED|Overall Study||1182||
60082503|NCT01468701|76197985|FG010|NOT COMPLETED|Overall Study||798||
60082504|NCT01468701|76197986|FG011|NOT COMPLETED|Overall Study||866||
60082505|NCT01468701|76197987|FG012|NOT COMPLETED|Overall Study||49||
60082506|NCT01468701|76197988|FG013|NOT COMPLETED|Overall Study||470||
60082507|NCT01468701|76197989|FG014|NOT COMPLETED|Overall Study||63||
60082508|NCT01468701|76197990|FG015|NOT COMPLETED|Overall Study||362||
60082509|NCT01468701|76197991|FG016|NOT COMPLETED|Overall Study||1||
60082510|NCT01492101|76198006|FG000|STARTED|Overall Study||429||
60082511|NCT01492101|76198007|FG001|STARTED|Overall Study||423||
60082512|NCT01492101|76198006|FG000|COMPLETED|Overall Study||92||
60082513|NCT01492101|76198007|FG001|COMPLETED|Overall Study||81||
60082514|NCT01492101|76198006|FG000|NOT COMPLETED|Overall Study||337||
60082515|NCT01492101|76198007|FG001|NOT COMPLETED|Overall Study||342||
60082516|NCT01468311|76198013|FG000|STARTED|Overall Study||6||
60082517|NCT01468311|76198013|FG000|COMPLETED|Overall Study||4||
60082518|NCT01468311|76198013|FG000|NOT COMPLETED|Overall Study||2||
60082519|NCT00306202|76198020|FG000|STARTED|Overall Study|Started = Treated. 18 were enrolled; 1 no longer met study criteria and was never treated|17||
60082520|NCT00306202|76198021|FG001|STARTED|Overall Study|Started=Treated. 20 were enrolled;3 never treated(2 no longer met study criteria;1 withdrew consent)|17||
60082521|NCT00306202|76198022|FG002|STARTED|Overall Study|Started = Treated. 25 were enrolled; 1 no longer met study criteria and was never treated|24||
60082522|NCT00306202|76198020|FG000|COMPLETED|Overall Study|Completed = Off-treatment|17||
60082523|NCT00306202|76198021|FG001|COMPLETED|Overall Study|Completed = Off-treatment|17||
60082524|NCT00306202|76198022|FG002|COMPLETED|Overall Study|Completed = Off-treatment|24||
60082525|NCT00306202|76198020|FG000|NOT COMPLETED|Overall Study||0||
60082526|NCT00306202|76198021|FG001|NOT COMPLETED|Overall Study||0||
60082527|NCT00306202|76198022|FG002|NOT COMPLETED|Overall Study||0||
60082528|NCT00308230|76198071|FG000|STARTED|Overall Study||6||
60082529|NCT00308230|76198072|FG001|STARTED|Overall Study||8||
60082530|NCT00308230|76198073|FG002|STARTED|Overall Study||20||
60082531|NCT00308230|76198071|FG000|COMPLETED|Overall Study||6||
59551624|NCT02258477|75651264|FG002|NOT COMPLETED|Fourth Intervention (1 Week)||0||
59551625|NCT02258477|75651265|FG003|NOT COMPLETED|Fourth Intervention (1 Week)||0||
59551626|NCT02626611|75651277|FG000|STARTED|Overall Study||20||
59551627|NCT02626611|75651278|FG001|STARTED|Overall Study||21||
59551628|NCT02626611|75651279|FG002|STARTED|Overall Study||19||
60082532|NCT00308230|76198072|FG001|COMPLETED|Overall Study||8||
60082533|NCT00308230|76198073|FG002|COMPLETED|Overall Study||20||
60082534|NCT00308230|76198071|FG000|NOT COMPLETED|Overall Study||0||
60082535|NCT00308230|76198072|FG001|NOT COMPLETED|Overall Study||0||
60082536|NCT00308230|76198073|FG002|NOT COMPLETED|Overall Study||0||
60082537|NCT00325078|76198084|FG000|STARTED|Overall Study||8||
60082538|NCT00325078|76198085|FG001|STARTED|Overall Study||7||
60082539|NCT00325078|76198086|FG002|STARTED|Overall Study||25||
60082540|NCT00325078|76198084|FG000|COMPLETED|Overall Study||3||
60082541|NCT00325078|76198085|FG001|COMPLETED|Overall Study||2||
60082542|NCT00325078|76198086|FG002|COMPLETED|Overall Study||23||
59551629|NCT02626611|75651277|FG000|COMPLETED|Overall Study||16||
59551630|NCT02626611|75651278|FG001|COMPLETED|Overall Study||20||
59551631|NCT02626611|75651279|FG002|COMPLETED|Overall Study||16||
59551632|NCT02626611|75651277|FG000|NOT COMPLETED|Overall Study||4||
59551633|NCT02626611|75651278|FG001|NOT COMPLETED|Overall Study||1||
59551634|NCT02626611|75651279|FG002|NOT COMPLETED|Overall Study||3||
59551635|NCT01260662|75651297|FG000|STARTED|Overall Study||90||
59551636|NCT01260662|75651298|FG001|STARTED|Overall Study||85||
59551637|NCT01260662|75651299|FG002|STARTED|Overall Study||96||
59551638|NCT01260662|75651297|FG000|COMPLETED|Overall Study||90||
60082543|NCT00325078|76198084|FG000|NOT COMPLETED|Overall Study||5||
60082544|NCT00325078|76198085|FG001|NOT COMPLETED|Overall Study||5||
60082545|NCT00325078|76198086|FG002|NOT COMPLETED|Overall Study||2||
60082546|NCT00325780|76198095|FG000|STARTED|Overall Study||1355||
60082547|NCT00325780|76198095|FG000|Safety Population|Overall Study|Patients who received at least one dose of study treatment in this extension study.|1353||
60082548|NCT00325780|76198095|FG000|COMPLETED|Overall Study||1200||
60082549|NCT00325780|76198095|FG000|NOT COMPLETED|Overall Study||155||
60082550|NCT00326170|76198099|FG000|STARTED|Overall Study||34||
60082551|NCT00326170|76198099|FG000|COMPLETED|Overall Study||34||
60082552|NCT00326170|76198099|FG000|NOT COMPLETED|Overall Study||0||
60082553|NCT00326872|76198103|FG000|STARTED|Overall Study||26||
59551639|NCT01260662|75651298|FG001|COMPLETED|Overall Study||85||
59551640|NCT01260662|75651299|FG002|COMPLETED|Overall Study||96||
59551641|NCT01260662|75651297|FG000|NOT COMPLETED|Overall Study||0||
59551642|NCT01260662|75651298|FG001|NOT COMPLETED|Overall Study||0||
59551643|NCT01260662|75651299|FG002|NOT COMPLETED|Overall Study||0||
59551644|NCT02327117|75651309|FG000|STARTED|Overall Study||45||
59551645|NCT02327117|75651310|FG001|STARTED|Overall Study||45||
59551646|NCT02327117|75651309|FG000|COMPLETED|Overall Study||45||
59551647|NCT02327117|75651310|FG001|COMPLETED|Overall Study||45||
60082554|NCT00326872|76198103|FG000|COMPLETED|Overall Study||26||
59551648|NCT02327117|75651309|FG000|NOT COMPLETED|Overall Study||0||
59551649|NCT02327117|75651310|FG001|NOT COMPLETED|Overall Study||0||
59551650|NCT03819543|75651316|FG000|STARTED|Overall Study||10||
59551651|NCT03819543|75651316|FG000|COMPLETED|Overall Study||10||
59551652|NCT03819543|75651316|FG000|NOT COMPLETED|Overall Study||0||
59551653|NCT01365650|75651320|FG000|STARTED|Treatment A||24||
59551654|NCT01365650|75651320|FG000|COMPLETED|Treatment A||24||
59551655|NCT01365650|75651320|FG000|NOT COMPLETED|Treatment A||0||
59551656|NCT01365650|75651320|FG000|STARTED|Treatment B||24||
59551657|NCT01365650|75651320|FG000|COMPLETED|Treatment B||24||
59551658|NCT01365650|75651320|FG000|NOT COMPLETED|Treatment B||0||
59551659|NCT01365650|75651320|FG000|STARTED|Treatment C||24||
60082555|NCT00326872|76198103|FG000|NOT COMPLETED|Overall Study||0||
59551660|NCT01365650|75651320|FG000|COMPLETED|Treatment C||24||
59551661|NCT01365650|75651320|FG000|NOT COMPLETED|Treatment C||0||
59551662|NCT02327351|75651328|FG000|STARTED|Overall Study||98||
60082556|NCT00328042|76198109|FG000|STARTED|Overall Study||69||
60082557|NCT00328042|76198110|FG001|STARTED|Overall Study||65||
60082558|NCT00328042|76198109|FG000|COMPLETED|Overall Study||69||
60082559|NCT00328042|76198110|FG001|COMPLETED|Overall Study||63||
60082560|NCT00328042|76198109|FG000|NOT COMPLETED|Overall Study||0||
59551663|NCT02327351|75651328|FG000|COMPLETED|Overall Study||98||
59551664|NCT02327351|75651328|FG000|NOT COMPLETED|Overall Study||0||
59551665|NCT02627001|75651338|FG000|STARTED|Overall Study||13||
59551666|NCT02627001|75651339|FG001|STARTED|Overall Study||14||
59551667|NCT02627001|75651338|FG000|COMPLETED|Overall Study||13||
59551668|NCT02627001|75651339|FG001|COMPLETED|Overall Study||14||
59551669|NCT02627001|75651338|FG000|NOT COMPLETED|Overall Study||0||
59551670|NCT02627001|75651339|FG001|NOT COMPLETED|Overall Study||0||
59551671|NCT01261052|75651345|FG000|STARTED|FMPD/APD Intervention (33 Hours)||14||
59551672|NCT01261052|75651345|FG000|COMPLETED|FMPD/APD Intervention (33 Hours)||14||
59551673|NCT01261052|75651345|FG000|NOT COMPLETED|FMPD/APD Intervention (33 Hours)||0||
59551674|NCT01261052|75651345|FG000|STARTED|APD Only Intervention (33 Hours)||14||
59551675|NCT01261052|75651345|FG000|COMPLETED|APD Only Intervention (33 Hours)||14||
59551676|NCT01261052|75651345|FG000|NOT COMPLETED|APD Only Intervention (33 Hours)||0||
59551677|NCT01770431|75651352|FG000|STARTED|Overall Study||696||
59551678|NCT01770431|75651353|FG001|STARTED|Overall Study||348||
59551679|NCT01770431|75651352|FG000|COMPLETED|Overall Study||686||
59551680|NCT01770431|75651353|FG001|COMPLETED|Overall Study||316||
59551681|NCT01770431|75651352|FG000|NOT COMPLETED|Overall Study||10||
59551682|NCT01770431|75651353|FG001|NOT COMPLETED|Overall Study||32||
59551683|NCT03707925|75651360|FG000|STARTED|Overall Study||4||
59551684|NCT03707925|75651360|FG000|COMPLETED|Overall Study||3||
59551685|NCT03707925|75651360|FG000|NOT COMPLETED|Overall Study||1||
59551686|NCT01771055|75651366|FG000|STARTED|Overall Study||4||
59551687|NCT01771055|75651367|FG001|STARTED|Overall Study||3||
59551688|NCT01771055|75651366|FG000|COMPLETED|Overall Study||4||
59706863|NCT00996892|75825861|FG000|COMPLETED|Dose-Escalation Stage 1B||0||
59551689|NCT01771055|75651367|FG001|COMPLETED|Overall Study||3||
59551690|NCT01771055|75651366|FG000|NOT COMPLETED|Overall Study||0||
59551691|NCT01771055|75651367|FG001|NOT COMPLETED|Overall Study||0||
59551692|NCT02628093|75651375|FG000|STARTED|Overall Study||31||
59551693|NCT02628093|75651376|FG001|STARTED|Overall Study||29||
59551694|NCT02628093|75651375|FG000|COMPLETED|Overall Study||31||
59551695|NCT02628093|75651376|FG001|COMPLETED|Overall Study||29||
59551696|NCT02628093|75651375|FG000|NOT COMPLETED|Overall Study||0||
59551697|NCT02628093|75651376|FG001|NOT COMPLETED|Overall Study||0||
59551698|NCT01771991|75651384|FG000|STARTED|Overall Study||38||
59551699|NCT01771991|75651385|FG001|STARTED|Overall Study||36||
59551700|NCT01771991|75651384|FG000|Started Treatment|Overall Study||37||
59551701|NCT01771991|75651385|FG001|Started Treatment|Overall Study||34||
59551702|NCT01771991|75651384|FG000|COMPLETED|Overall Study||30||
59551703|NCT01771991|75651385|FG001|COMPLETED|Overall Study||30||
59551704|NCT01771991|75651384|FG000|NOT COMPLETED|Overall Study||8||
59551705|NCT01771991|75651385|FG001|NOT COMPLETED|Overall Study||6||
59551706|NCT01324700|75651396|FG000|STARTED|Overall Study||22||
59551707|NCT01324700|75651397|FG001|STARTED|Overall Study||20||
59551708|NCT01324700|75651398|FG002|STARTED|Overall Study||49||
59551709|NCT01324700|75651399|FG003|STARTED|Overall Study||48||
59551710|NCT01324700|75651396|FG000|COMPLETED|Overall Study||13||
59551711|NCT01324700|75651397|FG001|COMPLETED|Overall Study||16||
59551712|NCT01324700|75651398|FG002|COMPLETED|Overall Study||33||
59551713|NCT01324700|75651399|FG003|COMPLETED|Overall Study||37||
59551714|NCT01324700|75651396|FG000|NOT COMPLETED|Overall Study||9||
59551715|NCT01324700|75651397|FG001|NOT COMPLETED|Overall Study||4||
59551716|NCT01324700|75651398|FG002|NOT COMPLETED|Overall Study||16||
59551717|NCT01324700|75651399|FG003|NOT COMPLETED|Overall Study||11||
59551718|NCT01262846|75651411|FG000|STARTED|Overall Study||95||
59551719|NCT01262846|75651412|FG001|STARTED|Overall Study||100||
59551720|NCT01262846|75651411|FG000|COMPLETED|Overall Study||93||
59551721|NCT01262846|75651412|FG001|COMPLETED|Overall Study||97||
59551722|NCT01262846|75651411|FG000|NOT COMPLETED|Overall Study||2||
59551723|NCT01262846|75651412|FG001|NOT COMPLETED|Overall Study||3||
59551724|NCT03461757|75651420|FG000|STARTED|Overall Study||732||
59551725|NCT03461757|75651421|FG001|STARTED|Overall Study||734||
59551726|NCT03461757|75651420|FG000|Treated|Overall Study||682||
59551727|NCT03461757|75651421|FG001|Treated|Overall Study||693||
59551728|NCT03461757|75651420|FG000|COMPLETED|Overall Study||679||
59551729|NCT03461757|75651421|FG001|COMPLETED|Overall Study||689||
59551730|NCT03461757|75651420|FG000|NOT COMPLETED|Overall Study||53||
59551731|NCT03461757|75651421|FG001|NOT COMPLETED|Overall Study||45||
59551732|NCT01325714|75651429|FG000|STARTED|Overall Study||101||
59551733|NCT01325714|75651430|FG001|STARTED|Overall Study||102||
59551734|NCT01325714|75651429|FG000|3 Month Assessment|Overall Study||82||
59551735|NCT01325714|75651430|FG001|3 Month Assessment|Overall Study||86||
59551736|NCT01325714|75651429|FG000|6 Month Asessment|Overall Study||75||
59551737|NCT01325714|75651430|FG001|6 Month Asessment|Overall Study||82||
59551738|NCT01325714|75651429|FG000|12 Month Assessment|Overall Study||67||
59551739|NCT01325714|75651430|FG001|12 Month Assessment|Overall Study||71||
59551740|NCT01325714|75651429|FG000|COMPLETED|Overall Study||67||
59551741|NCT01325714|75651430|FG001|COMPLETED|Overall Study||71||
59551742|NCT01325714|75651429|FG000|NOT COMPLETED|Overall Study||34||
59551743|NCT01325714|75651430|FG001|NOT COMPLETED|Overall Study||31||
59551744|NCT01325792|75651438|FG000|STARTED|Overall Study||104||
59551745|NCT01325792|75651438|FG000|COMPLETED|Overall Study||87||
59551746|NCT01325792|75651438|FG000|NOT COMPLETED|Overall Study||17||
59551747|NCT02631057|75651444|FG000|STARTED|Overall Study||899||
59551748|NCT02631057|75651445|FG001|STARTED|Overall Study||3414||
59551749|NCT02631057|75651444|FG000|COMPLETED|Overall Study||899||
59991344|NCT02456636|76106902|FG001|18 Month|Overall Study||463||
59551750|NCT02631057|75651445|FG001|COMPLETED|Overall Study||3414||
59551751|NCT02631057|75651444|FG000|NOT COMPLETED|Overall Study||0||
59551752|NCT02631057|75651445|FG001|NOT COMPLETED|Overall Study||0||
59551753|NCT01325870|75651454|FG000|STARTED|Overall Study||18||
59551754|NCT01325870|75651455|FG001|STARTED|Overall Study||16||
59551755|NCT01325870|75651456|FG002|STARTED|Overall Study||14||
59551756|NCT01325870|75651454|FG000|COMPLETED|Overall Study||7||
59551757|NCT01325870|75651455|FG001|COMPLETED|Overall Study||3||
59551758|NCT01325870|75651456|FG002|COMPLETED|Overall Study||6||
59551759|NCT01325870|75651454|FG000|NOT COMPLETED|Overall Study||11||
59551760|NCT01325870|75651455|FG001|NOT COMPLETED|Overall Study||13||
59551761|NCT01325870|75651456|FG002|NOT COMPLETED|Overall Study||8||
59551762|NCT01775735|75651466|FG000|STARTED|Intervention (6 Months)||8||
59551763|NCT01775735|75651467|FG001|STARTED|Intervention (6 Months)||7||
59551764|NCT01775735|75651466|FG000|COMPLETED|Intervention (6 Months)||8||
59991345|NCT02456636|76106903|FG002|18 Month|Overall Study||461||
59991346|NCT02456636|76106901|FG000|COMPLETED|Overall Study||410||
59551765|NCT01775735|75651467|FG001|COMPLETED|Intervention (6 Months)||7||
59551766|NCT01775735|75651466|FG000|NOT COMPLETED|Intervention (6 Months)||0||
59551767|NCT01775735|75651467|FG001|NOT COMPLETED|Intervention (6 Months)||0||
59551768|NCT01775735|75651466|FG000|STARTED|Open Label (24 Months)||8||
59551769|NCT01775735|75651467|FG001|STARTED|Open Label (24 Months)||7||
59551770|NCT01775735|75651466|FG000|COMPLETED|Open Label (24 Months)||7||
59551771|NCT01775735|75651467|FG001|COMPLETED|Open Label (24 Months)||3||
59551772|NCT01775735|75651466|FG000|NOT COMPLETED|Open Label (24 Months)||1||
59551773|NCT01775735|75651467|FG001|NOT COMPLETED|Open Label (24 Months)||4||
59551774|NCT02631525|75651475|FG000|STARTED|Overall Study||20||
59551775|NCT02631525|75651476|FG001|STARTED|Overall Study||20||
59551776|NCT02631525|75651475|FG000|COMPLETED|Overall Study||20||
59551777|NCT02631525|75651476|FG001|COMPLETED|Overall Study||20||
60082561|NCT00328042|76198110|FG001|NOT COMPLETED|Overall Study||2||
60082562|NCT00329524|76198118|FG000|STARTED|Overall Study||5||
60082563|NCT00329524|76198118|FG000|COMPLETED|Overall Study||5||
60082564|NCT00329524|76198118|FG000|NOT COMPLETED|Overall Study||0||
60082565|NCT01730534|76198124|FG000|STARTED|Overall Study||8582||
60082566|NCT01730534|76198125|FG001|STARTED|Overall Study||8578||
60082567|NCT01730534|76198124|FG000|COMPLETED|Overall Study||8473||
60082568|NCT01730534|76198125|FG001|COMPLETED|Overall Study||8433||
60082569|NCT01730534|76198124|FG000|NOT COMPLETED|Overall Study||109||
60082570|NCT01730534|76198125|FG001|NOT COMPLETED|Overall Study||145||
60082571|NCT00329836|76198131|FG000|STARTED|Overall Study||41||
60082572|NCT00329836|76198131|FG000|COMPLETED|Overall Study||41||
60082573|NCT00329836|76198131|FG000|NOT COMPLETED|Overall Study||0||
60082574|NCT00330382|76198137|FG000|STARTED|Overall Study||67||
60082575|NCT00330382|76198138|FG001|STARTED|Overall Study||65||
60082576|NCT00330382|76198137|FG000|COMPLETED|Overall Study||43||
59551778|NCT02631525|75651475|FG000|NOT COMPLETED|Overall Study||0||
59551779|NCT02631525|75651476|FG001|NOT COMPLETED|Overall Study||0||
60082577|NCT00330382|76198138|FG001|COMPLETED|Overall Study||48||
60082578|NCT00330382|76198137|FG000|NOT COMPLETED|Overall Study||24||
60082579|NCT00330382|76198138|FG001|NOT COMPLETED|Overall Study||17||
60082580|NCT01783730|76198145|FG000|STARTED|Overall Study||163||
60082581|NCT01783730|76198145|FG000|COMPLETED|Overall Study||157||
60082582|NCT01783730|76198145|FG000|NOT COMPLETED|Overall Study||6||
59551780|NCT01327274|75651482|FG000|STARTED|Overall Study||15||
59551781|NCT01327274|75651482|FG000|COMPLETED|Overall Study||15||
59551782|NCT01327274|75651482|FG000|NOT COMPLETED|Overall Study||0||
59551783|NCT01366196|75651489|FG000|STARTED|Overall Study||43||
59551784|NCT01366196|75651490|FG001|STARTED|Overall Study||43||
59551785|NCT01366196|75651489|FG000|COMPLETED|Overall Study||43||
59551786|NCT01366196|75651490|FG001|COMPLETED|Overall Study||43||
59551787|NCT01366196|75651489|FG000|NOT COMPLETED|Overall Study||0||
59551788|NCT01366196|75651490|FG001|NOT COMPLETED|Overall Study||0||
59551789|NCT01366976|75651498|FG000|STARTED|Overall Study||30||
59551790|NCT01366976|75651499|FG001|STARTED|Overall Study||30||
59551791|NCT01366976|75651498|FG000|COMPLETED|Overall Study||30||
59551792|NCT01366976|75651499|FG001|COMPLETED|Overall Study||30||
59551793|NCT01366976|75651498|FG000|NOT COMPLETED|Overall Study||0||
59551794|NCT01366976|75651499|FG001|NOT COMPLETED|Overall Study||0||
59551795|NCT01777217|75651507|FG000|STARTED|Overall Study||4||
59551796|NCT01777217|75651508|FG001|STARTED|Overall Study||4||
59551797|NCT01777217|75651507|FG000|COMPLETED|Overall Study||4||
59551798|NCT01777217|75651508|FG001|COMPLETED|Overall Study||4||
59551799|NCT01777217|75651507|FG000|NOT COMPLETED|Overall Study||0||
59551800|NCT01777217|75651508|FG001|NOT COMPLETED|Overall Study||0||
59551801|NCT02251379|75651516|FG000|STARTED|Overall Study||77||
59551802|NCT02251379|75651517|FG001|STARTED|Overall Study||78||
59551803|NCT02251379|75651516|FG000|COMPLETED|Overall Study||57||
59551804|NCT02251379|75651517|FG001|COMPLETED|Overall Study||58||
59551805|NCT02251379|75651516|FG000|NOT COMPLETED|Overall Study||20||
59551806|NCT02251379|75651517|FG001|NOT COMPLETED|Overall Study||20||
59551807|NCT02255513|75651525|FG000|STARTED|Open-label, Treatment Optimization||43||
59551808|NCT02255513|75651526|FG001|STARTED|Open-label, Treatment Optimization||0||
59551809|NCT02255513|75651525|FG000|COMPLETED|Open-label, Treatment Optimization||43||
59551810|NCT02255513|75651526|FG001|COMPLETED|Open-label, Treatment Optimization||0||
59551811|NCT02255513|75651525|FG000|NOT COMPLETED|Open-label, Treatment Optimization||0||
59551812|NCT02255513|75651526|FG001|NOT COMPLETED|Open-label, Treatment Optimization||0||
59551813|NCT02255513|75651525|FG000|STARTED|Double Blind, Placebo-controlled||22||
59551814|NCT02255513|75651526|FG001|STARTED|Double Blind, Placebo-controlled||21||
59551815|NCT02255513|75651525|FG000|COMPLETED|Double Blind, Placebo-controlled||22||
59551816|NCT02255513|75651526|FG001|COMPLETED|Double Blind, Placebo-controlled||21||
59551817|NCT02255513|75651525|FG000|NOT COMPLETED|Double Blind, Placebo-controlled||0||
59551818|NCT02255513|75651526|FG001|NOT COMPLETED|Double Blind, Placebo-controlled||0||
59551819|NCT01778465|75651532|FG000|STARTED|First Intervention (7 Days)||3||
59551820|NCT01778465|75651533|FG001|STARTED|First Intervention (7 Days)||4||
59551821|NCT01778465|75651532|FG000|COMPLETED|First Intervention (7 Days)||3||
59551822|NCT01778465|75651533|FG001|COMPLETED|First Intervention (7 Days)||4||
59551823|NCT01778465|75651532|FG000|NOT COMPLETED|First Intervention (7 Days)||0||
59551824|NCT01778465|75651533|FG001|NOT COMPLETED|First Intervention (7 Days)||0||
59991347|NCT02456636|76106902|FG001|COMPLETED|Overall Study||410||
59551825|NCT01778465|75651532|FG000|STARTED|Second Intervention (7 Days)||3||
59551826|NCT01778465|75651533|FG001|STARTED|Second Intervention (7 Days)||4||
59551827|NCT01778465|75651532|FG000|COMPLETED|Second Intervention (7 Days)||3||
59551828|NCT01778465|75651533|FG001|COMPLETED|Second Intervention (7 Days)||4||
59551829|NCT01778465|75651532|FG000|NOT COMPLETED|Second Intervention (7 Days)||0||
59551830|NCT01778465|75651533|FG001|NOT COMPLETED|Second Intervention (7 Days)||0||
59551831|NCT01779167|75651542|FG000|STARTED|Overall Study||4||
59551832|NCT01779167|75651542|FG000|COMPLETED|Overall Study||3||
59551833|NCT01779167|75651542|FG000|NOT COMPLETED|Overall Study||1||
59551834|NCT01780337|75651548|FG000|STARTED|Overall Study||6||
59551835|NCT01780337|75651549|FG001|STARTED|Overall Study||6||
59551836|NCT01780337|75651548|FG000|COMPLETED|Overall Study||6||
59551837|NCT01780337|75651549|FG001|COMPLETED|Overall Study||6||
59551838|NCT01780337|75651548|FG000|NOT COMPLETED|Overall Study||0||
59551839|NCT01780337|75651549|FG001|NOT COMPLETED|Overall Study||0||
59551840|NCT02251613|75651555|FG000|STARTED|Overall Study||50||
59551841|NCT02251613|75651555|FG000|COMPLETED|Overall Study||50||
59551842|NCT02251613|75651555|FG000|NOT COMPLETED|Overall Study||0||
59551843|NCT01782209|75651561|FG000|STARTED|Overall Study||335||
59551844|NCT01782209|75651561|FG000|COMPLETED|Overall Study||225||
59551845|NCT01782209|75651561|FG000|NOT COMPLETED|Overall Study||110||
59551846|NCT01782833|75651565|FG000|STARTED|Overall Study||3635||
59551847|NCT01782833|75651565|FG000|COMPLETED|Overall Study||3365||
59551848|NCT01782833|75651565|FG000|NOT COMPLETED|Overall Study||270||
59551849|NCT01783847|75651572|FG000|STARTED|Overall Study||85||
59551850|NCT01783847|75651573|FG001|STARTED|Overall Study||16||
59551851|NCT01783847|75651574|FG002|STARTED|Overall Study||16||
59551852|NCT01783847|75651572|FG000|COMPLETED|Overall Study||69||
59551853|NCT01783847|75651573|FG001|COMPLETED|Overall Study||15||
59551854|NCT01783847|75651574|FG002|COMPLETED|Overall Study||16||
59551855|NCT01783847|75651572|FG000|NOT COMPLETED|Overall Study||16||
59551856|NCT01783847|75651573|FG001|NOT COMPLETED|Overall Study||1||
59551857|NCT01783847|75651574|FG002|NOT COMPLETED|Overall Study||0||
59551858|NCT01785095|75651585|FG000|STARTED|Overall Study||27||
59551859|NCT01785095|75651585|FG000|COMPLETED|Overall Study||24||
59551860|NCT01785095|75651585|FG000|NOT COMPLETED|Overall Study||3||
59551861|NCT01786187|75651594|FG000|STARTED|Overall Study||40||
59551862|NCT01786187|75651595|FG001|STARTED|Overall Study||47||
59551863|NCT01786187|75651594|FG000|COMPLETED|Overall Study||35||
59551864|NCT01786187|75651595|FG001|COMPLETED|Overall Study||37||
59551865|NCT01786187|75651594|FG000|NOT COMPLETED|Overall Study||5||
59551866|NCT01786187|75651595|FG001|NOT COMPLETED|Overall Study||10||
59551867|NCT01367444|75651611|FG000|STARTED|Overall Study||4||
59551868|NCT01367444|75651612|FG001|STARTED|Overall Study||4||
59551869|NCT01367444|75651613|FG002|STARTED|Overall Study||4||
59551870|NCT01367444|75651614|FG003|STARTED|Overall Study||4||
59551871|NCT01367444|75651615|FG004|STARTED|Overall Study||6||
59551872|NCT01367444|75651616|FG005|STARTED|Overall Study||4||
59551873|NCT01367444|75651617|FG006|STARTED|Overall Study||1||
59551874|NCT01367444|75651611|FG000|COMPLETED|Overall Study||4||
59551875|NCT01367444|75651612|FG001|COMPLETED|Overall Study||4||
59551876|NCT01367444|75651613|FG002|COMPLETED|Overall Study||4||
59551877|NCT01367444|75651614|FG003|COMPLETED|Overall Study||4||
59551878|NCT01367444|75651615|FG004|COMPLETED|Overall Study||6||
59551879|NCT01367444|75651616|FG005|COMPLETED|Overall Study||4||
59551880|NCT01367444|75651617|FG006|COMPLETED|Overall Study||1||
59551881|NCT01367444|75651611|FG000|NOT COMPLETED|Overall Study||0||
59551882|NCT01367444|75651612|FG001|NOT COMPLETED|Overall Study||0||
59551883|NCT01367444|75651613|FG002|NOT COMPLETED|Overall Study||0||
59551884|NCT01367444|75651614|FG003|NOT COMPLETED|Overall Study||0||
59551885|NCT01367444|75651615|FG004|NOT COMPLETED|Overall Study||0||
59551886|NCT01367444|75651616|FG005|NOT COMPLETED|Overall Study||0||
59551887|NCT01367444|75651617|FG006|NOT COMPLETED|Overall Study||0||
59551888|NCT01786343|75651635|FG000|STARTED|Overall Study||28||
59551889|NCT01786343|75651636|FG001|STARTED|Overall Study||46||
59551890|NCT01786343|75651635|FG000|COMPLETED|Overall Study||28||
59706864|NCT00996892|75825862|FG001|COMPLETED|Dose-Escalation Stage 1B||0||
59816437|NCT00430677|75938852|FG002|NOT COMPLETED|Long-term Extension Period||63||
59816438|NCT00525512|75938880|FG000|STARTED|Double-Blind Phase||259||
59816439|NCT00525512|75938881|FG001|STARTED|Double-Blind Phase||260||
59816440|NCT00525512|75938882|FG002|STARTED|Double-Blind Phase||0||
59816441|NCT00525512|75938883|FG003|STARTED|Double-Blind Phase||0||
59816442|NCT00525512|75938880|FG000|COMPLETED|Double-Blind Phase||163||
59816443|NCT00525512|75938881|FG001|COMPLETED|Double-Blind Phase||194||
59816444|NCT00525512|75938882|FG002|COMPLETED|Double-Blind Phase||0||
59816445|NCT00525512|75938883|FG003|COMPLETED|Double-Blind Phase||0||
59816446|NCT00525512|75938880|FG000|NOT COMPLETED|Double-Blind Phase||96||
59816447|NCT00525512|75938881|FG001|NOT COMPLETED|Double-Blind Phase||66||
59816448|NCT00525512|75938882|FG002|NOT COMPLETED|Double-Blind Phase||0||
59816449|NCT00525512|75938883|FG003|NOT COMPLETED|Double-Blind Phase||0||
59816450|NCT00525512|75938880|FG000|STARTED|Open-Label Phase||0||
59816451|NCT00525512|75938881|FG001|STARTED|Open-Label Phase||0||
59816452|NCT00525512|75938882|FG002|STARTED|Open-Label Phase||164||
59816453|NCT00525512|75938883|FG003|STARTED|Open-Label Phase||194||
59551891|NCT01786343|75651636|FG001|COMPLETED|Overall Study||46||
59551892|NCT01786343|75651635|FG000|NOT COMPLETED|Overall Study||0||
59706865|NCT00996892|75825863|FG002|COMPLETED|Dose-Escalation Stage 1B||0||
59706866|NCT00996892|75825864|FG003|COMPLETED|Dose-Escalation Stage 1B||0||
59706867|NCT00996892|75825865|FG004|COMPLETED|Dose-Escalation Stage 1B||0||
59706868|NCT00996892|75825866|FG005|COMPLETED|Dose-Escalation Stage 1B||0||
59706869|NCT00996892|75825867|FG006|COMPLETED|Dose-Escalation Stage 1B||0||
59706870|NCT00996892|75825868|FG007|COMPLETED|Dose-Escalation Stage 1B||0||
59706871|NCT00996892|75825869|FG008|COMPLETED|Dose-Escalation Stage 1B||0||
59706872|NCT00996892|75825870|FG009|COMPLETED|Dose-Escalation Stage 1B||0||
59816454|NCT00525512|75938880|FG000|COMPLETED|Open-Label Phase||0||
59816455|NCT00525512|75938881|FG001|COMPLETED|Open-Label Phase||0||
59816456|NCT00525512|75938882|FG002|COMPLETED|Open-Label Phase||158||
59816457|NCT00525512|75938883|FG003|COMPLETED|Open-Label Phase||189||
59991348|NCT02456636|76106903|FG002|COMPLETED|Overall Study||400||
59991349|NCT02456636|76106901|FG000|NOT COMPLETED|Overall Study||68||
59991350|NCT02456636|76106902|FG001|NOT COMPLETED|Overall Study||69||
59991351|NCT02456636|76106903|FG002|NOT COMPLETED|Overall Study||75||
60082583|NCT01730378|76198151|FG000|STARTED|Overall Study||84||
59551893|NCT01786343|75651636|FG001|NOT COMPLETED|Overall Study||0||
59551894|NCT02327429|75651642|FG000|STARTED|Overall Study||19||
59551895|NCT02327429|75651642|FG000|COMPLETED|Overall Study||17||
59551896|NCT02327429|75651642|FG000|NOT COMPLETED|Overall Study||2||
59551897|NCT01786967|75651646|FG000|STARTED|Overall Study||61||
59551898|NCT01786967|75651646|FG000|Extensive Metabolizers|Overall Study||54||
59551899|NCT01786967|75651646|FG000|Poor Metabolizers|Overall Study||4||
59551900|NCT01786967|75651646|FG000|Metabolizer Status Undetermined|Overall Study||3||
59551901|NCT01786967|75651646|FG000|COMPLETED|Overall Study||61||
59551902|NCT01786967|75651646|FG000|NOT COMPLETED|Overall Study||0||
59706873|NCT00996892|75825871|FG010|COMPLETED|Dose-Escalation Stage 1B||0||
59706874|NCT00996892|75825872|FG011|COMPLETED|Dose-Escalation Stage 1B||0||
59706875|NCT00996892|75825873|FG012|COMPLETED|Dose-Escalation Stage 1B||0||
59706876|NCT00996892|75825874|FG013|COMPLETED|Dose-Escalation Stage 1B||0||
59706877|NCT00996892|75825875|FG014|COMPLETED|Dose-Escalation Stage 1B||0||
59706878|NCT00996892|75825876|FG015|COMPLETED|Dose-Escalation Stage 1B||0||
59706879|NCT00996892|75825877|FG016|COMPLETED|Dose-Escalation Stage 1B||0||
59991352|NCT02226172|76106911|FG000|STARTED|Overall Study||21||
59991353|NCT02226172|76106911|FG000|COMPLETED|Overall Study||4||
59991354|NCT02226172|76106911|FG000|NOT COMPLETED|Overall Study||17||
59991355|NCT01676961|76106915|FG000|STARTED|Overall Study||5||
59991356|NCT01676961|76106915|FG000|COMPLETED|Overall Study||0||
60082584|NCT01730378|76198152|FG001|STARTED|Overall Study||47||
60082585|NCT01730378|76198151|FG000|COMPLETED|Overall Study||83||
60082586|NCT01730378|76198152|FG001|COMPLETED|Overall Study||47||
60082587|NCT01730378|76198151|FG000|NOT COMPLETED|Overall Study||1||
60082588|NCT01730378|76198152|FG001|NOT COMPLETED|Overall Study||0||
60082589|NCT01783496|76198165|FG000|STARTED|Overall Study||10||
60082590|NCT01783496|76198166|FG001|STARTED|Overall Study||10||
59991357|NCT01676961|76106915|FG000|NOT COMPLETED|Overall Study||5||
59991358|NCT03874351|76106921|FG000|STARTED|Overall Study||11||
59991359|NCT03874351|76106922|FG001|STARTED|Overall Study||11||
59991360|NCT03874351|76106921|FG000|COMPLETED|Overall Study||7||
59991361|NCT03874351|76106922|FG001|COMPLETED|Overall Study||9||
59991362|NCT03874351|76106921|FG000|NOT COMPLETED|Overall Study||4||
59991363|NCT03874351|76106922|FG001|NOT COMPLETED|Overall Study||2||
59991364|NCT03769519|76106930|FG000|STARTED|Overall Study||14||
59991365|NCT03769519|76106931|FG001|STARTED|Overall Study||15||
59991366|NCT03769519|76106930|FG000|COMPLETED|Overall Study||14||
59991367|NCT03769519|76106931|FG001|COMPLETED|Overall Study||14||
59991368|NCT03769519|76106930|FG000|NOT COMPLETED|Overall Study||0||
59991369|NCT03769519|76106931|FG001|NOT COMPLETED|Overall Study||1||
59991370|NCT01676727|76106937|FG000|STARTED|Overall Study||100||
59991371|NCT01676727|76106937|FG000|Implanted|Overall Study||92||
59991372|NCT01676727|76106937|FG000|COMPLETED|Overall Study||68||
60082591|NCT01783496|76198167|FG002|STARTED|Overall Study||10||
60082592|NCT01783496|76198168|FG003|STARTED|Overall Study||10||
60082593|NCT01783496|76198169|FG004|STARTED|Overall Study||5||
60082594|NCT01783496|76198170|FG005|STARTED|Overall Study||5||
60082595|NCT01783496|76198165|FG000|COMPLETED|Overall Study||9||
59551903|NCT01807637|75651657|FG000|STARTED|Baseline||4||
59551904|NCT01807637|75651658|FG001|STARTED|Baseline||2||
59551905|NCT01807637|75651657|FG000|COMPLETED|Baseline||4||
59551906|NCT01807637|75651658|FG001|COMPLETED|Baseline||2||
59551907|NCT01807637|75651657|FG000|NOT COMPLETED|Baseline||0||
59991373|NCT01676727|76106937|FG000|NOT COMPLETED|Overall Study||32||
60082596|NCT01783496|76198166|FG001|COMPLETED|Overall Study||10||
59991374|NCT02738879|76106944|FG000|STARTED|Overall Study||374||
59991375|NCT02738879|76106945|FG001|STARTED|Overall Study||372||
59991376|NCT02738879|76106944|FG000|Treated|Overall Study||373||
59991377|NCT02738879|76106945|FG001|Treated|Overall Study||370||
59991378|NCT02738879|76106944|FG000|COMPLETED|Overall Study||361||
60082597|NCT01783496|76198167|FG002|COMPLETED|Overall Study||10||
60082598|NCT01783496|76198168|FG003|COMPLETED|Overall Study||8||
60082599|NCT01783496|76198169|FG004|COMPLETED|Overall Study||5||
59991379|NCT02738879|76106945|FG001|COMPLETED|Overall Study||347||
59991380|NCT02738879|76106944|FG000|NOT COMPLETED|Overall Study||13||
59991381|NCT02738879|76106945|FG001|NOT COMPLETED|Overall Study||25||
59991382|NCT03502811|76106951|FG000|STARTED|Overall Study||1041||
60082600|NCT01783496|76198170|FG005|COMPLETED|Overall Study||4||
60082601|NCT01783496|76198165|FG000|NOT COMPLETED|Overall Study||1||
60082602|NCT01783496|76198166|FG001|NOT COMPLETED|Overall Study||0||
60082603|NCT01783496|76198167|FG002|NOT COMPLETED|Overall Study||0||
60082604|NCT01783496|76198168|FG003|NOT COMPLETED|Overall Study||2||
59991383|NCT03502811|76106951|FG000|COMPLETED|Overall Study||722||
59991384|NCT03502811|76106951|FG000|NOT COMPLETED|Overall Study||319||
60082605|NCT01783496|76198169|FG004|NOT COMPLETED|Overall Study||0||
60082606|NCT01783496|76198170|FG005|NOT COMPLETED|Overall Study||1||
60082607|NCT00314236|76198186|FG000|STARTED|Overall Study||41||
60082608|NCT00314236|76198187|FG001|STARTED|Overall Study||39||
59551908|NCT01807637|75651658|FG001|NOT COMPLETED|Baseline||0||
59551909|NCT01807637|75651657|FG000|STARTED|One Week||4||
59551910|NCT01807637|75651658|FG001|STARTED|One Week||2||
59551911|NCT01807637|75651657|FG000|COMPLETED|One Week||4||
59551912|NCT01807637|75651658|FG001|COMPLETED|One Week||2||
59551913|NCT01807637|75651657|FG000|NOT COMPLETED|One Week||0||
59551914|NCT01807637|75651658|FG001|NOT COMPLETED|One Week||0||
59551915|NCT01807637|75651657|FG000|STARTED|One Month||4||
59551916|NCT01807637|75651658|FG001|STARTED|One Month||2||
59551917|NCT01807637|75651657|FG000|COMPLETED|One Month||4||
60082609|NCT00314236|76198186|FG000|COMPLETED|Overall Study||41||
60082610|NCT00314236|76198187|FG001|COMPLETED|Overall Study||37||
60082611|NCT00314236|76198186|FG000|NOT COMPLETED|Overall Study||0||
60082612|NCT00314236|76198187|FG001|NOT COMPLETED|Overall Study||2||
59551918|NCT01807637|75651658|FG001|COMPLETED|One Month||2||
59551919|NCT01807637|75651657|FG000|NOT COMPLETED|One Month||0||
59551920|NCT01807637|75651658|FG001|NOT COMPLETED|One Month||0||
59551921|NCT01263314|75651668|FG000|STARTED|Period 1||2||
59551922|NCT01263314|75651669|FG001|STARTED|Period 1||2||
59551923|NCT01263314|75651670|FG002|STARTED|Period 1||2||
59551924|NCT01263314|75651671|FG003|STARTED|Period 1||2||
60082613|NCT01729208|76198195|FG000|STARTED|Baseline||70||
60082614|NCT01729208|76198196|FG001|STARTED|Baseline||74||
60082615|NCT01729208|76198195|FG000|COMPLETED|Baseline||65||
60082616|NCT01729208|76198196|FG001|COMPLETED|Baseline||70||
60082617|NCT01729208|76198195|FG000|NOT COMPLETED|Baseline||5||
60082618|NCT01729208|76198196|FG001|NOT COMPLETED|Baseline||4||
60082619|NCT01729208|76198195|FG000|STARTED|12 Months Follow-up||65||
60082620|NCT01729208|76198196|FG001|STARTED|12 Months Follow-up||70||
60082621|NCT01729208|76198195|FG000|COMPLETED|12 Months Follow-up||58||
60082622|NCT01729208|76198196|FG001|COMPLETED|12 Months Follow-up||60||
60082623|NCT01729208|76198195|FG000|NOT COMPLETED|12 Months Follow-up||7||
60082624|NCT01729208|76198196|FG001|NOT COMPLETED|12 Months Follow-up||10||
60082625|NCT01729208|76198195|FG000|STARTED|24 Months Follow-up||58||
60082626|NCT01729208|76198196|FG001|STARTED|24 Months Follow-up||60||
60082627|NCT01729208|76198195|FG000|COMPLETED|24 Months Follow-up||55||
60082628|NCT01729208|76198196|FG001|COMPLETED|24 Months Follow-up||60||
60082629|NCT01729208|76198195|FG000|NOT COMPLETED|24 Months Follow-up||3||
60082630|NCT01729208|76198196|FG001|NOT COMPLETED|24 Months Follow-up||0||
60082631|NCT01729208|76198195|FG000|STARTED|36 Months Follow-up||55||
60082632|NCT01729208|76198196|FG001|STARTED|36 Months Follow-up||60||
60082633|NCT01729208|76198195|FG000|COMPLETED|36 Months Follow-up||52||
60082634|NCT01729208|76198196|FG001|COMPLETED|36 Months Follow-up||56||
60082635|NCT01729208|76198195|FG000|NOT COMPLETED|36 Months Follow-up||3||
60082636|NCT01729208|76198196|FG001|NOT COMPLETED|36 Months Follow-up||4||
60082637|NCT00331162|76198204|FG000|STARTED|Overall Study||113||
60082638|NCT00331162|76198205|FG001|STARTED|Overall Study||109||
60082639|NCT00331162|76198204|FG000|COMPLETED|Overall Study||113||
60082640|NCT00331162|76198205|FG001|COMPLETED|Overall Study||109||
60082641|NCT00331162|76198204|FG000|NOT COMPLETED|Overall Study||0||
60082642|NCT00331162|76198205|FG001|NOT COMPLETED|Overall Study||0||
60082643|NCT01609010|76198213|FG000|STARTED|Overall Study||156||
60082644|NCT01609010|76198214|FG001|STARTED|Overall Study||157||
60082645|NCT01609010|76198213|FG000|Entering Cycle 2|Overall Study||120||
60082646|NCT01609010|76198214|FG001|Entering Cycle 2|Overall Study||124||
60082647|NCT01609010|76198213|FG000|COMPLETED|Overall Study||113||
60082648|NCT01609010|76198214|FG001|COMPLETED|Overall Study||120||
60082649|NCT01609010|76198213|FG000|NOT COMPLETED|Overall Study||43||
60082650|NCT01609010|76198214|FG001|NOT COMPLETED|Overall Study||37||
60082651|NCT01608308|76198222|FG000|STARTED|Overall Study||31||
60082652|NCT01608308|76198223|FG001|STARTED|Overall Study||31||
60082653|NCT01608308|76198222|FG000|COMPLETED|Overall Study||31||
60082654|NCT01608308|76198223|FG001|COMPLETED|Overall Study||29||
60082655|NCT01608308|76198222|FG000|NOT COMPLETED|Overall Study||0||
60082656|NCT01608308|76198223|FG001|NOT COMPLETED|Overall Study||2||
59551925|NCT01263314|75651672|FG004|STARTED|Period 1||2||
59551926|NCT01263314|75651673|FG005|STARTED|Period 1||2||
59551927|NCT01263314|75651674|FG006|STARTED|Period 1||2||
59551928|NCT01263314|75651675|FG007|STARTED|Period 1||2||
60082657|NCT00332644|76198235|FG000|STARTED|Overall Study||262||
60082658|NCT00332644|76198236|FG001|STARTED|Overall Study||260||
60082659|NCT00332644|76198237|FG002|STARTED|Overall Study||267||
60082660|NCT00332644|76198238|FG003|STARTED|Overall Study||264||
59551929|NCT01263314|75651668|FG000|COMPLETED|Period 1||2||
59551930|NCT01263314|75651669|FG001|COMPLETED|Period 1||2||
59551931|NCT01263314|75651670|FG002|COMPLETED|Period 1||2||
59551932|NCT01263314|75651671|FG003|COMPLETED|Period 1||2||
59551933|NCT01263314|75651672|FG004|COMPLETED|Period 1||2||
59551934|NCT01263314|75651673|FG005|COMPLETED|Period 1||2||
59551935|NCT01263314|75651674|FG006|COMPLETED|Period 1||2||
59551936|NCT01263314|75651675|FG007|COMPLETED|Period 1||2||
59551937|NCT01263314|75651668|FG000|NOT COMPLETED|Period 1||0||
59551938|NCT01263314|75651669|FG001|NOT COMPLETED|Period 1||0||
59551939|NCT01263314|75651670|FG002|NOT COMPLETED|Period 1||0||
59551940|NCT01263314|75651671|FG003|NOT COMPLETED|Period 1||0||
59551941|NCT01263314|75651672|FG004|NOT COMPLETED|Period 1||0||
59551942|NCT01263314|75651673|FG005|NOT COMPLETED|Period 1||0||
59551943|NCT01263314|75651674|FG006|NOT COMPLETED|Period 1||0||
59551944|NCT01263314|75651675|FG007|NOT COMPLETED|Period 1||0||
59551945|NCT01263314|75651668|FG000|STARTED|Period 2||2||
59551946|NCT01263314|75651669|FG001|STARTED|Period 2||2||
59551947|NCT01263314|75651670|FG002|STARTED|Period 2||2||
59551948|NCT01263314|75651671|FG003|STARTED|Period 2||2||
59551949|NCT01263314|75651672|FG004|STARTED|Period 2||2||
59551950|NCT01263314|75651673|FG005|STARTED|Period 2||2||
59551951|NCT01263314|75651674|FG006|STARTED|Period 2||2||
59551952|NCT01263314|75651675|FG007|STARTED|Period 2||2||
59551953|NCT01263314|75651668|FG000|COMPLETED|Period 2||2||
59551954|NCT01263314|75651669|FG001|COMPLETED|Period 2||2||
59551955|NCT01263314|75651670|FG002|COMPLETED|Period 2||2||
59551956|NCT01263314|75651671|FG003|COMPLETED|Period 2||2||
59551957|NCT01263314|75651672|FG004|COMPLETED|Period 2||2||
59551958|NCT01263314|75651673|FG005|COMPLETED|Period 2||2||
59551959|NCT01263314|75651674|FG006|COMPLETED|Period 2||2||
59551960|NCT01263314|75651675|FG007|COMPLETED|Period 2||2||
59551961|NCT01263314|75651668|FG000|NOT COMPLETED|Period 2||0||
59551962|NCT01263314|75651669|FG001|NOT COMPLETED|Period 2||0||
59551963|NCT01263314|75651670|FG002|NOT COMPLETED|Period 2||0||
59551964|NCT01263314|75651671|FG003|NOT COMPLETED|Period 2||0||
59551965|NCT01263314|75651672|FG004|NOT COMPLETED|Period 2||0||
59551966|NCT01263314|75651673|FG005|NOT COMPLETED|Period 2||0||
59551967|NCT01263314|75651674|FG006|NOT COMPLETED|Period 2||0||
59551968|NCT01263314|75651675|FG007|NOT COMPLETED|Period 2||0||
59551969|NCT01263314|75651668|FG000|STARTED|Period 3||2||
59551970|NCT01263314|75651669|FG001|STARTED|Period 3||2||
59551971|NCT01263314|75651670|FG002|STARTED|Period 3||2||
59551972|NCT01263314|75651671|FG003|STARTED|Period 3||2||
59991385|NCT03253913|76106955|FG000|STARTED|First 8 Weeks (250mg Daily Resveratrol)||25||
59991386|NCT03253913|76106955|FG000|COMPLETED|First 8 Weeks (250mg Daily Resveratrol)||25||
59991387|NCT03253913|76106955|FG000|NOT COMPLETED|First 8 Weeks (250mg Daily Resveratrol)||0||
59991388|NCT03253913|76106955|FG000|STARTED|Weeks 8 - 16 (Resveratrol 500mg Daily)||25||
59991389|NCT03253913|76106955|FG000|COMPLETED|Weeks 8 - 16 (Resveratrol 500mg Daily)||25||
59991390|NCT03253913|76106955|FG000|NOT COMPLETED|Weeks 8 - 16 (Resveratrol 500mg Daily)||0||
59991391|NCT03253913|76106955|FG000|STARTED|Weeks 16-24 (Resveratrol 1,000mg Daily)||25||
59991392|NCT03253913|76106955|FG000|COMPLETED|Weeks 16-24 (Resveratrol 1,000mg Daily)||25||
59991393|NCT03253913|76106955|FG000|NOT COMPLETED|Weeks 16-24 (Resveratrol 1,000mg Daily)||0||
59551973|NCT01263314|75651672|FG004|STARTED|Period 3||2||
59551974|NCT01263314|75651673|FG005|STARTED|Period 3||2||
59991394|NCT00515671|76106963|FG000|STARTED|Overall Study||60||
59991395|NCT00515671|76106964|FG001|STARTED|Overall Study||58||
59991396|NCT00515671|76106963|FG000|COMPLETED|Overall Study||43||
59991397|NCT00515671|76106964|FG001|COMPLETED|Overall Study||41||
59991398|NCT00515671|76106963|FG000|NOT COMPLETED|Overall Study||17||
59991399|NCT00515671|76106964|FG001|NOT COMPLETED|Overall Study||17||
59991400|NCT01677195|76106973|FG000|STARTED|Overall Study||71||
59991401|NCT01677195|76106974|FG001|STARTED|Overall Study||83||
59991402|NCT01677195|76106975|FG002|STARTED|Overall Study||80||
59991403|NCT01677195|76106973|FG000|COMPLETED|Overall Study||42||
59991404|NCT01677195|76106974|FG001|COMPLETED|Overall Study||51||
59991405|NCT01677195|76106975|FG002|COMPLETED|Overall Study||50||
59991406|NCT01677195|76106973|FG000|NOT COMPLETED|Overall Study||29||
59991407|NCT01677195|76106974|FG001|NOT COMPLETED|Overall Study||32||
59991408|NCT01677195|76106975|FG002|NOT COMPLETED|Overall Study||30||
59991409|NCT01727011|76106983|FG000|STARTED|Overall Study||31||
60082661|NCT00332644|76198239|FG004|STARTED|Overall Study||262||
60082662|NCT00332644|76198240|FG005|STARTED|Overall Study||189||
60082663|NCT00332644|76198235|FG000|COMPLETED|Overall Study||250||
60082664|NCT00332644|76198236|FG001|COMPLETED|Overall Study||238||
60082665|NCT00332644|76198237|FG002|COMPLETED|Overall Study||258||
60082666|NCT00332644|76198238|FG003|COMPLETED|Overall Study||244||
60082667|NCT00332644|76198239|FG004|COMPLETED|Overall Study||250||
60082668|NCT00332644|76198240|FG005|COMPLETED|Overall Study||174||
60082669|NCT00332644|76198235|FG000|NOT COMPLETED|Overall Study||12||
60082670|NCT00332644|76198236|FG001|NOT COMPLETED|Overall Study||22||
60082671|NCT00332644|76198237|FG002|NOT COMPLETED|Overall Study||9||
60082672|NCT00332644|76198238|FG003|NOT COMPLETED|Overall Study||20||
59991410|NCT01727011|76106983|FG000|COMPLETED|Overall Study||26||
59991411|NCT01727011|76106983|FG000|NOT COMPLETED|Overall Study||5||
60082673|NCT00332644|76198239|FG004|NOT COMPLETED|Overall Study||12||
60082674|NCT00332644|76198240|FG005|NOT COMPLETED|Overall Study||15||
60082675|NCT01755416|76198254|FG000|STARTED|First Intervention ( Upto 2 Days)||9||
60082676|NCT01755416|76198255|FG001|STARTED|First Intervention ( Upto 2 Days)||9||
60082677|NCT01755416|76198254|FG000|COMPLETED|First Intervention ( Upto 2 Days)||8||
60082678|NCT01755416|76198255|FG001|COMPLETED|First Intervention ( Upto 2 Days)||7||
60082679|NCT01755416|76198254|FG000|NOT COMPLETED|First Intervention ( Upto 2 Days)||1||
60082680|NCT01755416|76198255|FG001|NOT COMPLETED|First Intervention ( Upto 2 Days)||2||
60082681|NCT01755416|76198254|FG000|STARTED|Second Intervention (Upto 2 Days)||8||
60082682|NCT01755416|76198255|FG001|STARTED|Second Intervention (Upto 2 Days)||7||
60082683|NCT01755416|76198254|FG000|COMPLETED|Second Intervention (Upto 2 Days)||8||
60082684|NCT01755416|76198255|FG001|COMPLETED|Second Intervention (Upto 2 Days)||7||
60082685|NCT01755416|76198254|FG000|NOT COMPLETED|Second Intervention (Upto 2 Days)||0||
60082686|NCT01755416|76198255|FG001|NOT COMPLETED|Second Intervention (Upto 2 Days)||0||
60082687|NCT01755026|76198263|FG000|STARTED|Overall Study||11||
60082688|NCT01755026|76198264|FG001|STARTED|Overall Study||12||
60082689|NCT01755026|76198263|FG000|COMPLETED|Overall Study||9||
60082690|NCT01755026|76198264|FG001|COMPLETED|Overall Study||11||
60082691|NCT01755026|76198263|FG000|NOT COMPLETED|Overall Study||2||
60082692|NCT01755026|76198264|FG001|NOT COMPLETED|Overall Study||1||
60082693|NCT00332722|76198272|FG000|STARTED|Overall Study||60||
60082694|NCT00332722|76198273|FG001|STARTED|Overall Study||60||
60082695|NCT00332722|76198272|FG000|COMPLETED|Overall Study||60||
60082696|NCT00332722|76198273|FG001|COMPLETED|Overall Study||60||
60082697|NCT00332722|76198272|FG000|NOT COMPLETED|Overall Study||0||
60082698|NCT00332722|76198273|FG001|NOT COMPLETED|Overall Study||0||
60082699|NCT01491945|76198279|FG000|STARTED|Overall Study||76||
60082700|NCT01491945|76198279|FG000|COMPLETED|Overall Study||25||
60082701|NCT01491945|76198279|FG000|NOT COMPLETED|Overall Study||51||
60082702|NCT00333814|76198287|FG000|STARTED|Overall Study||76||
60082703|NCT00333814|76198288|FG001|STARTED|Overall Study||77||
60082704|NCT00333814|76198289|FG002|STARTED|Overall Study||76||
60082705|NCT00333814|76198287|FG000|COMPLETED|Overall Study||73||
60082706|NCT00333814|76198288|FG001|COMPLETED|Overall Study||73||
60082707|NCT00333814|76198289|FG002|COMPLETED|Overall Study||71||
59551975|NCT01263314|75651674|FG006|STARTED|Period 3||2||
59551976|NCT01263314|75651675|FG007|STARTED|Period 3||2||
59551977|NCT01263314|75651668|FG000|COMPLETED|Period 3||2||
59551978|NCT01263314|75651669|FG001|COMPLETED|Period 3||2||
59551979|NCT01263314|75651670|FG002|COMPLETED|Period 3||2||
59551980|NCT01263314|75651671|FG003|COMPLETED|Period 3||2||
59551981|NCT01263314|75651672|FG004|COMPLETED|Period 3||2||
59551982|NCT01263314|75651673|FG005|COMPLETED|Period 3||2||
59551983|NCT01263314|75651674|FG006|COMPLETED|Period 3||2||
59551984|NCT01263314|75651675|FG007|COMPLETED|Period 3||2||
59551985|NCT01263314|75651668|FG000|NOT COMPLETED|Period 3||0||
59551986|NCT01263314|75651669|FG001|NOT COMPLETED|Period 3||0||
59551987|NCT01263314|75651670|FG002|NOT COMPLETED|Period 3||0||
59551988|NCT01263314|75651671|FG003|NOT COMPLETED|Period 3||0||
59551989|NCT01263314|75651672|FG004|NOT COMPLETED|Period 3||0||
59551990|NCT01263314|75651673|FG005|NOT COMPLETED|Period 3||0||
59551991|NCT01263314|75651674|FG006|NOT COMPLETED|Period 3||0||
59551992|NCT01263314|75651675|FG007|NOT COMPLETED|Period 3||0||
59551993|NCT02261597|75651701|FG000|STARTED|Overall Study||22||
59551994|NCT02261597|75651702|FG001|STARTED|Overall Study||22||
59551995|NCT02261597|75651701|FG000|COMPLETED|Overall Study||22||
59551996|NCT02261597|75651702|FG001|COMPLETED|Overall Study||22||
59551997|NCT02261597|75651701|FG000|NOT COMPLETED|Overall Study||0||
59551998|NCT02261597|75651702|FG001|NOT COMPLETED|Overall Study||0||
59551999|NCT01327508|75651710|FG000|STARTED|Overall Study||30||
59552000|NCT01327508|75651711|FG001|STARTED|Overall Study||30||
59552001|NCT01327508|75651710|FG000|COMPLETED|Overall Study||30||
59552002|NCT01327508|75651711|FG001|COMPLETED|Overall Study||30||
59552003|NCT01327508|75651710|FG000|NOT COMPLETED|Overall Study||0||
59552004|NCT01327508|75651711|FG001|NOT COMPLETED|Overall Study||0||
59552005|NCT01807871|75651719|FG000|STARTED|Overall Study||356||
59552006|NCT01807871|75651720|FG001|STARTED|Overall Study||345||
59552007|NCT01807871|75651719|FG000|COMPLETED|Overall Study||178||
59552008|NCT01807871|75651720|FG001|COMPLETED|Overall Study||127||
59552009|NCT01807871|75651719|FG000|NOT COMPLETED|Overall Study||178||
59552010|NCT01807871|75651720|FG001|NOT COMPLETED|Overall Study||218||
59552011|NCT01808963|75651726|FG000|STARTED|Overall Study||13||
59552012|NCT01808963|75651726|FG000|COMPLETED|Overall Study||13||
59552013|NCT01808963|75651726|FG000|NOT COMPLETED|Overall Study||0||
59552014|NCT01327976|75651732|FG000|STARTED|Overall Study||162||
59552015|NCT01327976|75651733|FG001|STARTED|Overall Study||77||
59552016|NCT01327976|75651732|FG000|COMPLETED|Overall Study||154||
60082708|NCT00333814|76198287|FG000|NOT COMPLETED|Overall Study||3||
60082709|NCT00333814|76198288|FG001|NOT COMPLETED|Overall Study||4||
60082710|NCT00333814|76198289|FG002|NOT COMPLETED|Overall Study||5||
60082711|NCT01728584|76198301|FG000|STARTED|Overall Study|Randomized|36||
60082712|NCT01728584|76198302|FG001|STARTED|Overall Study|Randomized - NMB/pressure conditions were changed in 7 (2 to Std/Std, 4 to Deep/Std, 1 to Deep/Low)|30||
59552017|NCT01327976|75651733|FG001|COMPLETED|Overall Study||70||
59552018|NCT01327976|75651732|FG000|NOT COMPLETED|Overall Study||8||
59552019|NCT01327976|75651733|FG001|NOT COMPLETED|Overall Study||7||
59552020|NCT01263938|75651741|FG000|STARTED|Overall Study||5||
59552021|NCT01263938|75651741|FG000|COMPLETED|Overall Study||5||
59552022|NCT01263938|75651741|FG000|NOT COMPLETED|Overall Study||0||
59552023|NCT01789775|75651748|FG000|STARTED|Overall Study||55||
59552024|NCT01789775|75651749|FG001|STARTED|Overall Study||57||
59552025|NCT01789775|75651748|FG000|COMPLETED|Overall Study||53||
59552026|NCT01789775|75651749|FG001|COMPLETED|Overall Study||50||
59552027|NCT01789775|75651748|FG000|NOT COMPLETED|Overall Study||2||
59552028|NCT01789775|75651749|FG001|NOT COMPLETED|Overall Study||7||
59552029|NCT02327741|75651757|FG000|STARTED|Overall Study||502||
59552030|NCT02327741|75651758|FG001|STARTED|Overall Study||508||
59552031|NCT02327741|75651757|FG000|COMPLETED|Overall Study||502||
59552032|NCT02327741|75651758|FG001|COMPLETED|Overall Study||508||
59552033|NCT02327741|75651757|FG000|NOT COMPLETED|Overall Study||0||
59552034|NCT02327741|75651758|FG001|NOT COMPLETED|Overall Study||0||
60082713|NCT01728584|76198303|FG002|STARTED|Overall Study|Randomized|31||
60082714|NCT01728584|76198304|FG003|STARTED|Overall Study|Randomized - NMB/pressure conditions were changed in 5 (all to Deep/Std)|30||
59552035|NCT01264952|75651767|FG000|STARTED|Overall Study||6||
59552036|NCT01264952|75651768|FG001|STARTED|Overall Study||2||
59552037|NCT01264952|75651769|FG002|STARTED|Overall Study||8||
59552038|NCT01264952|75651767|FG000|COMPLETED|Overall Study||6||
59816458|NCT00525512|75938880|FG000|NOT COMPLETED|Open-Label Phase||0||
59552039|NCT01264952|75651768|FG001|COMPLETED|Overall Study||2||
59552040|NCT01264952|75651769|FG002|COMPLETED|Overall Study||8||
59552041|NCT01264952|75651767|FG000|NOT COMPLETED|Overall Study||0||
59552042|NCT01264952|75651768|FG001|NOT COMPLETED|Overall Study||0||
59552043|NCT01264952|75651769|FG002|NOT COMPLETED|Overall Study||0||
59552044|NCT01810289|75651779|FG000|STARTED|Overall Study||7277||
59552045|NCT01810289|75651780|FG001|STARTED|Overall Study||4747||
59552046|NCT01810289|75651779|FG000|COMPLETED|Overall Study||7277||
59552047|NCT01810289|75651780|FG001|COMPLETED|Overall Study||4747||
59552048|NCT01810289|75651779|FG000|NOT COMPLETED|Overall Study||0||
59552049|NCT01810289|75651780|FG001|NOT COMPLETED|Overall Study||0||
59552050|NCT01265966|75651789|FG000|STARTED|Overall Study||47||
59552051|NCT01265966|75651790|FG001|STARTED|Overall Study||41||
59552052|NCT01265966|75651791|FG002|STARTED|Overall Study||29||
59552053|NCT01265966|75651789|FG000|Analyzed Separately|Overall Study|Patients taking inhaled or intranasal corticosteroids were analyzed separately.|3||
59552054|NCT01265966|75651790|FG001|Analyzed Separately|Overall Study|Patients taking inhaled or intranasal corticosteroids were analyzed separately.|2||
59552055|NCT01265966|75651791|FG002|Analyzed Separately|Overall Study|Patients taking inhaled or intranasal corticosteroids were analyzed separately.|2||
59552056|NCT01265966|75651789|FG000|COMPLETED|Overall Study||44||
59552057|NCT01265966|75651790|FG001|COMPLETED|Overall Study||39||
59552058|NCT01265966|75651791|FG002|COMPLETED|Overall Study||27||
59552059|NCT01265966|75651789|FG000|NOT COMPLETED|Overall Study||3||
59552060|NCT01265966|75651790|FG001|NOT COMPLETED|Overall Study||2||
59552061|NCT01265966|75651791|FG002|NOT COMPLETED|Overall Study||2||
59552062|NCT01733069|75651801|FG000|STARTED|Overall Study||264||
59552063|NCT01733069|75651802|FG001|STARTED|Overall Study||1598||
59552064|NCT01733069|75651801|FG000|COMPLETED|Overall Study||264||
59552065|NCT01733069|75651802|FG001|COMPLETED|Overall Study||1598||
59552066|NCT01733069|75651801|FG000|NOT COMPLETED|Overall Study||0||
59552067|NCT01733069|75651802|FG001|NOT COMPLETED|Overall Study||0||
59552068|NCT02634177|75651810|FG000|STARTED|Overall Study||151||
59552069|NCT02634177|75651811|FG001|STARTED|Overall Study||153||
59552070|NCT02634177|75651810|FG000|COMPLETED|Overall Study||140||
59552071|NCT02634177|75651811|FG001|COMPLETED|Overall Study||141||
59552072|NCT02634177|75651810|FG000|NOT COMPLETED|Overall Study||11||
59552073|NCT02634177|75651811|FG001|NOT COMPLETED|Overall Study||12||
59552074|NCT01329380|75651817|FG000|STARTED|Overall Study||403|Participants who were registered|
59552075|NCT01329380|75651817|FG000|Safety Population|Overall Study||396|Excludes duplicate participants and participants starting treatment prior to study registration|
59552076|NCT01329380|75651817|FG000|COMPLETED|Overall Study||374|Participants with available efficacy data at 12 weeks or 24 weeks after the start of treatment|
59552077|NCT01329380|75651817|FG000|NOT COMPLETED|Overall Study||29||
59552078|NCT02635035|75651823|FG000|STARTED|Overall Study||17||
59552079|NCT02635035|75651824|FG001|STARTED|Overall Study||21||
59552080|NCT02635035|75651823|FG000|COMPLETED|Overall Study||17||
59552081|NCT02635035|75651824|FG001|COMPLETED|Overall Study||21||
59552082|NCT02635035|75651823|FG000|NOT COMPLETED|Overall Study||0||
59552083|NCT02635035|75651824|FG001|NOT COMPLETED|Overall Study||0||
59552084|NCT01369706|75651830|FG000|STARTED|Overall Study||388||
59552085|NCT01369706|75651830|FG000|COMPLETED|Overall Study||388||
59552086|NCT01369706|75651830|FG000|NOT COMPLETED|Overall Study||0||
59552087|NCT02635425|75651836|FG000|STARTED|Overall Study||15||
59552088|NCT02635425|75651837|FG001|STARTED|Overall Study||15||
59552089|NCT02635425|75651836|FG000|COMPLETED|Overall Study||15||
59552090|NCT02635425|75651837|FG001|COMPLETED|Overall Study||15||
59552091|NCT02635425|75651836|FG000|NOT COMPLETED|Overall Study||0||
59552092|NCT02635425|75651837|FG001|NOT COMPLETED|Overall Study||0||
59552093|NCT02636049|75651843|FG000|STARTED|Overall Study||12||
59552094|NCT02636049|75651843|FG000|Triferic 6 mg IV Over 3 Hours|Overall Study||12||
59552095|NCT02636049|75651843|FG000|Triferic 35 Micrograms/kg IV Push|Overall Study||12||
59552096|NCT02636049|75651843|FG000|COMPLETED|Overall Study||12||
59552097|NCT02636049|75651843|FG000|NOT COMPLETED|Overall Study||0||
59552098|NCT01370174|75651853|FG000|STARTED|Overall Study||25||
59552099|NCT01370174|75651854|FG001|STARTED|Overall Study||26||
59552100|NCT01370174|75651855|FG002|STARTED|Overall Study||25||
59552101|NCT01370174|75651856|FG003|STARTED|Overall Study||26||
59552102|NCT01370174|75651853|FG000|COMPLETED|Overall Study||18||
59552103|NCT01370174|75651854|FG001|COMPLETED|Overall Study||15||
59552104|NCT01370174|75651855|FG002|COMPLETED|Overall Study||13||
59552105|NCT01370174|75651856|FG003|COMPLETED|Overall Study||17||
59552106|NCT01370174|75651853|FG000|NOT COMPLETED|Overall Study||7||
59552107|NCT01370174|75651854|FG001|NOT COMPLETED|Overall Study||11||
59552108|NCT01370174|75651855|FG002|NOT COMPLETED|Overall Study||12||
59552109|NCT01370174|75651856|FG003|NOT COMPLETED|Overall Study||9||
59552110|NCT01329848|75651866|FG000|STARTED|Overall Study||83||
59552111|NCT01329848|75651866|FG000|COMPLETED|Overall Study||54||
59552112|NCT01329848|75651866|FG000|NOT COMPLETED|Overall Study||29||
59552113|NCT01267136|75651872|FG000|STARTED|Overall Study||42||
59552114|NCT01267136|75651873|FG001|STARTED|Overall Study||42||
59552115|NCT01267136|75651872|FG000|COMPLETED|Overall Study||38||
59552116|NCT01267136|75651873|FG001|COMPLETED|Overall Study||36||
59552117|NCT01267136|75651872|FG000|NOT COMPLETED|Overall Study||4||
59552118|NCT01267136|75651873|FG001|NOT COMPLETED|Overall Study||6||
59552119|NCT01370564|75651881|FG000|STARTED|Overall Study||21||
59552120|NCT01370564|75651881|FG000|COMPLETED|Overall Study||21||
59552121|NCT01370564|75651881|FG000|NOT COMPLETED|Overall Study||0||
59552122|NCT02637999|75651888|FG000|STARTED|Overall Study||8||
59552123|NCT02637999|75651889|FG001|STARTED|Overall Study||8||
59552124|NCT02637999|75651890|FG002|STARTED|Overall Study||8||
59552125|NCT02637999|75651888|FG000|COMPLETED|Overall Study||7||
59552126|NCT02637999|75651889|FG001|COMPLETED|Overall Study||6||
59552127|NCT02637999|75651890|FG002|COMPLETED|Overall Study||6||
59552128|NCT02637999|75651888|FG000|NOT COMPLETED|Overall Study||1||
59552129|NCT02637999|75651889|FG001|NOT COMPLETED|Overall Study||2||
59552130|NCT02637999|75651890|FG002|NOT COMPLETED|Overall Study||2||
59552131|NCT01790243|75651900|FG000|STARTED|Overall Study||1029||
59552132|NCT01790243|75651901|FG001|STARTED|Overall Study||160||
59552133|NCT01790243|75651900|FG000|COMPLETED|Overall Study||739||
59552134|NCT01790243|75651901|FG001|COMPLETED|Overall Study||117||
59552135|NCT01790243|75651900|FG000|NOT COMPLETED|Overall Study||290||
59552136|NCT01790243|75651901|FG001|NOT COMPLETED|Overall Study||43||
59552137|NCT03235479|75651909|FG000|STARTED|Overall Study||582|Randomized|
59552138|NCT03235479|75651910|FG001|STARTED|Overall Study||580|Randomized|
59552139|NCT03235479|75651909|FG000|Treated|Overall Study||546||
59552140|NCT03235479|75651910|FG001|Treated|Overall Study||549||
59552141|NCT03235479|75651909|FG000|COMPLETED|Overall Study||541||
59552142|NCT03235479|75651910|FG001|COMPLETED|Overall Study||540||
59552143|NCT03235479|75651909|FG000|NOT COMPLETED|Overall Study||41||
59552144|NCT03235479|75651910|FG001|NOT COMPLETED|Overall Study||40||
59552145|NCT01371110|75651918|FG000|STARTED|Overall Study||1||
59552146|NCT01371110|75651919|FG001|STARTED|Overall Study||2||
59552147|NCT01371110|75651918|FG000|COMPLETED|Overall Study||1||
59552148|NCT01371110|75651919|FG001|COMPLETED|Overall Study||2||
59552149|NCT01371110|75651918|FG000|NOT COMPLETED|Overall Study||0||
59552150|NCT01371110|75651919|FG001|NOT COMPLETED|Overall Study||0||
59552151|NCT01791491|75651925|FG000|STARTED|Overall Study|Reasons for enrollment and non-treatment: 1 withdrew consent and 6 no longer met study criteria.|9||
59552152|NCT01791491|75651925|FG000|COMPLETED|Overall Study||9||
59552153|NCT01791491|75651925|FG000|NOT COMPLETED|Overall Study||0||
59552154|NCT01810991|75651929|FG000|STARTED|Overall Study||19||
59552155|NCT01810991|75651929|FG000|COMPLETED|Overall Study||17||
59552156|NCT01810991|75651929|FG000|NOT COMPLETED|Overall Study||2||
59552157|NCT01372202|75651936|FG000|STARTED|Overall Study||13||
59552158|NCT01372202|75651937|FG001|STARTED|Overall Study||9||
59552159|NCT01372202|75651938|FG002|STARTED|Overall Study||9||
59552160|NCT01372202|75651936|FG000|COMPLETED|Overall Study||13||
59552161|NCT01372202|75651937|FG001|COMPLETED|Overall Study||9||
59552162|NCT01372202|75651938|FG002|COMPLETED|Overall Study||9||
59552163|NCT01372202|75651936|FG000|NOT COMPLETED|Overall Study||0||
59552164|NCT01372202|75651937|FG001|NOT COMPLETED|Overall Study||0||
59552165|NCT01372202|75651938|FG002|NOT COMPLETED|Overall Study||0||
59552166|NCT01269710|75651951|FG000|STARTED|Overall Study||4||
59552167|NCT01269710|75651951|FG000|Week 12|Overall Study||3||
59552168|NCT01269710|75651951|FG000|Week 36|Overall Study||2||
59552169|NCT01269710|75651951|FG000|COMPLETED|Overall Study|This refers to Week 52.|1||
59552170|NCT01269710|75651951|FG000|NOT COMPLETED|Overall Study||3||
59552171|NCT01792817|75651957|FG000|STARTED|Phase 1 Double Blind Period||77||
59552172|NCT01792817|75651958|FG001|STARTED|Phase 1 Double Blind Period||73||
59552173|NCT01792817|75651959|FG002|STARTED|Phase 1 Double Blind Period||0||
59552174|NCT01792817|75651957|FG000|COMPLETED|Phase 1 Double Blind Period||58||
59552175|NCT01792817|75651958|FG001|COMPLETED|Phase 1 Double Blind Period||42||
59552176|NCT01792817|75651959|FG002|COMPLETED|Phase 1 Double Blind Period||0||
59552177|NCT01792817|75651957|FG000|NOT COMPLETED|Phase 1 Double Blind Period||19||
59552178|NCT01792817|75651958|FG001|NOT COMPLETED|Phase 1 Double Blind Period||31||
59552179|NCT01792817|75651959|FG002|NOT COMPLETED|Phase 1 Double Blind Period||0||
59552180|NCT01792817|75651957|FG000|STARTED|Phase 2 Open Label||0||
59552181|NCT01792817|75651958|FG001|STARTED|Phase 2 Open Label||0||
59552182|NCT01792817|75651959|FG002|STARTED|Phase 2 Open Label||100||
59552183|NCT01792817|75651957|FG000|COMPLETED|Phase 2 Open Label||0||
59552184|NCT01792817|75651958|FG001|COMPLETED|Phase 2 Open Label||0||
59552185|NCT01792817|75651959|FG002|COMPLETED|Phase 2 Open Label||74||
59552186|NCT01792817|75651957|FG000|NOT COMPLETED|Phase 2 Open Label||0||
59552187|NCT01792817|75651958|FG001|NOT COMPLETED|Phase 2 Open Label||0||
59552188|NCT01792817|75651959|FG002|NOT COMPLETED|Phase 2 Open Label||26||
59552189|NCT03193437|75651966|FG000|STARTED|Overall Study||8||
59552190|NCT03193437|75651966|FG000|COMPLETED|Overall Study||0||
59552191|NCT03193437|75651966|FG000|NOT COMPLETED|Overall Study||8||
59816459|NCT00525512|75938881|FG001|NOT COMPLETED|Open-Label Phase||0||
59552192|NCT01811147|75651974|FG000|STARTED|Overall Study||51||
59552193|NCT01811147|75651975|FG001|STARTED|Overall Study||56||
59552194|NCT01811147|75651976|FG002|STARTED|Overall Study||49||
59816460|NCT00525512|75938882|FG002|NOT COMPLETED|Open-Label Phase||6||
59552195|NCT01811147|75651977|FG003|STARTED|Overall Study||33||
59552196|NCT01811147|75651974|FG000|COMPLETED|Overall Study||15||
59552197|NCT01811147|75651975|FG001|COMPLETED|Overall Study||11||
59552198|NCT01811147|75651976|FG002|COMPLETED|Overall Study||6||
59552199|NCT01811147|75651977|FG003|COMPLETED|Overall Study||4||
59816461|NCT00525512|75938883|FG003|NOT COMPLETED|Open-Label Phase||5||
59552200|NCT01811147|75651974|FG000|NOT COMPLETED|Overall Study||36||
59552201|NCT01811147|75651975|FG001|NOT COMPLETED|Overall Study||45||
59552202|NCT01811147|75651976|FG002|NOT COMPLETED|Overall Study||43||
59552203|NCT01811147|75651977|FG003|NOT COMPLETED|Overall Study||29||
59552204|NCT01373450|75651987|FG000|STARTED|Crossover Period 1||2||
59552205|NCT01373450|75651988|FG001|STARTED|Crossover Period 1||2||
59552206|NCT01373450|75651989|FG002|STARTED|Crossover Period 1||2||
59552207|NCT01373450|75651990|FG003|STARTED|Crossover Period 1||2||
59552208|NCT01373450|75651991|FG004|STARTED|Crossover Period 1||2||
59552209|NCT01373450|75651992|FG005|STARTED|Crossover Period 1||2||
59552210|NCT01373450|75651987|FG000|COMPLETED|Crossover Period 1||2||
59552211|NCT01373450|75651988|FG001|COMPLETED|Crossover Period 1||2||
59552212|NCT01373450|75651989|FG002|COMPLETED|Crossover Period 1||2||
59706880|NCT00996892|75825878|FG017|COMPLETED|Dose-Escalation Stage 1B||0||
59706881|NCT00996892|75825879|FG018|COMPLETED|Dose-Escalation Stage 1B||0||
59552213|NCT01373450|75651990|FG003|COMPLETED|Crossover Period 1||2||
59552214|NCT01373450|75651991|FG004|COMPLETED|Crossover Period 1||2||
59552215|NCT01373450|75651992|FG005|COMPLETED|Crossover Period 1||2||
59552216|NCT01373450|75651987|FG000|NOT COMPLETED|Crossover Period 1||0||
59552217|NCT01373450|75651988|FG001|NOT COMPLETED|Crossover Period 1||0||
59552218|NCT01373450|75651989|FG002|NOT COMPLETED|Crossover Period 1||0||
59706882|NCT00996892|75825880|FG019|COMPLETED|Dose-Escalation Stage 1B||0||
59706883|NCT00996892|75825861|FG000|NOT COMPLETED|Dose-Escalation Stage 1B||0||
59552219|NCT01373450|75651990|FG003|NOT COMPLETED|Crossover Period 1||0||
59552220|NCT01373450|75651991|FG004|NOT COMPLETED|Crossover Period 1||0||
59552221|NCT01373450|75651992|FG005|NOT COMPLETED|Crossover Period 1||0||
59706884|NCT00996892|75825862|FG001|NOT COMPLETED|Dose-Escalation Stage 1B||0||
59552222|NCT01373450|75651987|FG000|STARTED|7 Day Wash-out||2||
59552223|NCT01373450|75651988|FG001|STARTED|7 Day Wash-out||2||
59552224|NCT01373450|75651989|FG002|STARTED|7 Day Wash-out||2||
59552225|NCT01373450|75651990|FG003|STARTED|7 Day Wash-out||2||
59552226|NCT01373450|75651991|FG004|STARTED|7 Day Wash-out||2||
59552227|NCT01373450|75651992|FG005|STARTED|7 Day Wash-out||2||
59552228|NCT01373450|75651987|FG000|COMPLETED|7 Day Wash-out||2||
59552229|NCT01373450|75651988|FG001|COMPLETED|7 Day Wash-out||2||
59552230|NCT01373450|75651989|FG002|COMPLETED|7 Day Wash-out||2||
59552231|NCT01373450|75651990|FG003|COMPLETED|7 Day Wash-out||2||
59552232|NCT01373450|75651991|FG004|COMPLETED|7 Day Wash-out||2||
59552233|NCT01373450|75651992|FG005|COMPLETED|7 Day Wash-out||2||
59552234|NCT01373450|75651987|FG000|NOT COMPLETED|7 Day Wash-out||0||
59552235|NCT01373450|75651988|FG001|NOT COMPLETED|7 Day Wash-out||0||
59552236|NCT01373450|75651989|FG002|NOT COMPLETED|7 Day Wash-out||0||
59552237|NCT01373450|75651990|FG003|NOT COMPLETED|7 Day Wash-out||0||
59552238|NCT01373450|75651991|FG004|NOT COMPLETED|7 Day Wash-out||0||
59552239|NCT01373450|75651992|FG005|NOT COMPLETED|7 Day Wash-out||0||
59552240|NCT01373450|75651987|FG000|STARTED|Crossover Period 2||2||
59552241|NCT01373450|75651988|FG001|STARTED|Crossover Period 2||2||
59552242|NCT01373450|75651989|FG002|STARTED|Crossover Period 2||2||
59552243|NCT01373450|75651990|FG003|STARTED|Crossover Period 2||2||
59552244|NCT01373450|75651991|FG004|STARTED|Crossover Period 2||2||
59552245|NCT01373450|75651992|FG005|STARTED|Crossover Period 2||2||
59552246|NCT01373450|75651987|FG000|COMPLETED|Crossover Period 2||2||
59552247|NCT01373450|75651988|FG001|COMPLETED|Crossover Period 2||2||
59552248|NCT01373450|75651989|FG002|COMPLETED|Crossover Period 2||2||
59552249|NCT01373450|75651990|FG003|COMPLETED|Crossover Period 2||2||
59552250|NCT01373450|75651991|FG004|COMPLETED|Crossover Period 2||2||
59706885|NCT00996892|75825863|FG002|NOT COMPLETED|Dose-Escalation Stage 1B||0||
59706886|NCT00996892|75825864|FG003|NOT COMPLETED|Dose-Escalation Stage 1B||0||
59706887|NCT00996892|75825865|FG004|NOT COMPLETED|Dose-Escalation Stage 1B||0||
59552251|NCT01373450|75651992|FG005|COMPLETED|Crossover Period 2||2||
59552252|NCT01373450|75651987|FG000|NOT COMPLETED|Crossover Period 2||0||
59552253|NCT01373450|75651988|FG001|NOT COMPLETED|Crossover Period 2||0||
59552254|NCT01373450|75651989|FG002|NOT COMPLETED|Crossover Period 2||0||
59706888|NCT00996892|75825866|FG005|NOT COMPLETED|Dose-Escalation Stage 1B||0||
59706889|NCT00996892|75825867|FG006|NOT COMPLETED|Dose-Escalation Stage 1B||0||
59552255|NCT01373450|75651990|FG003|NOT COMPLETED|Crossover Period 2||0||
59552256|NCT01373450|75651991|FG004|NOT COMPLETED|Crossover Period 2||0||
59552257|NCT01373450|75651992|FG005|NOT COMPLETED|Crossover Period 2||0||
60082715|NCT01728584|76198301|FG000|COMPLETED|Overall Study||28||
60082716|NCT01728584|76198302|FG001|COMPLETED|Overall Study||30||
60082717|NCT01728584|76198303|FG002|COMPLETED|Overall Study||30||
60082718|NCT01728584|76198304|FG003|COMPLETED|Overall Study||29||
60082719|NCT01728584|76198301|FG000|NOT COMPLETED|Overall Study||8||
60082720|NCT01728584|76198302|FG001|NOT COMPLETED|Overall Study||0||
60082721|NCT01728584|76198303|FG002|NOT COMPLETED|Overall Study||1||
60082722|NCT01728584|76198304|FG003|NOT COMPLETED|Overall Study||1||
60082723|NCT00315328|76198322|FG000|STARTED|Overall Study|Includes subjects with moderate amblyopia only (20/40 to 20/100 at baseline)|98||
60082724|NCT00315328|76198323|FG001|STARTED|Overall Study|Includes subjects with moderate amblyopia only (20/40 to 20/100 at baseline)|95||
60082725|NCT00315328|76198324|FG002|STARTED|Overall Study|Includes subjects with severe amblyopia only (20/125 to 20/400 at baseline)|18||
60103821|NCT03774849|76222136|FG001|NOT COMPLETED|Overall Study||0||
59552258|NCT01373450|75651987|FG000|STARTED|7 Day Wash-out||2||
60103822|NCT03774849|76222137|FG002|NOT COMPLETED|Overall Study||0||
59552259|NCT01373450|75651988|FG001|STARTED|7 Day Wash-out||2||
60103823|NCT03746522|76222152|FG000|STARTED|Period 1: Double-Blind (14 Weeks)||27||
60103824|NCT03746522|76222153|FG001|STARTED|Period 1: Double-Blind (14 Weeks)||25||
60103825|NCT03746522|76222154|FG002|STARTED|Period 1: Double-Blind (14 Weeks)||0||
60103826|NCT03746522|76222152|FG000|COMPLETED|Period 1: Double-Blind (14 Weeks)||27||
60103827|NCT03746522|76222153|FG001|COMPLETED|Period 1: Double-Blind (14 Weeks)||23||
60103828|NCT03746522|76222154|FG002|COMPLETED|Period 1: Double-Blind (14 Weeks)||0||
60103829|NCT03746522|76222152|FG000|NOT COMPLETED|Period 1: Double-Blind (14 Weeks)||0||
60103830|NCT03746522|76222153|FG001|NOT COMPLETED|Period 1: Double-Blind (14 Weeks)||2||
60103831|NCT03746522|76222154|FG002|NOT COMPLETED|Period 1: Double-Blind (14 Weeks)||0||
59552260|NCT01373450|75651989|FG002|STARTED|7 Day Wash-out||2||
60082726|NCT00315328|76198325|FG003|STARTED|Overall Study|Includes subjects with severe amblyopia only (20/125 to 20/400 at baseline)|22||
60082727|NCT00315328|76198322|FG000|5 Week Visit|Overall Study||91||
59991412|NCT00928447|76106987|FG000|STARTED|Overall Study||22||176
59552261|NCT01373450|75651990|FG003|STARTED|7 Day Wash-out||2||
59552262|NCT01373450|75651991|FG004|STARTED|7 Day Wash-out||2||
59552263|NCT01373450|75651992|FG005|STARTED|7 Day Wash-out||2||
59552264|NCT01373450|75651987|FG000|COMPLETED|7 Day Wash-out||2||
59552265|NCT01373450|75651988|FG001|COMPLETED|7 Day Wash-out||2||
59552266|NCT01373450|75651989|FG002|COMPLETED|7 Day Wash-out||2||
59552267|NCT01373450|75651990|FG003|COMPLETED|7 Day Wash-out||2||
59552268|NCT01373450|75651991|FG004|COMPLETED|7 Day Wash-out||2||
59552269|NCT01373450|75651992|FG005|COMPLETED|7 Day Wash-out||2||
59552270|NCT01373450|75651987|FG000|NOT COMPLETED|7 Day Wash-out||0||
59552271|NCT01373450|75651988|FG001|NOT COMPLETED|7 Day Wash-out||0||
59552272|NCT01373450|75651989|FG002|NOT COMPLETED|7 Day Wash-out||0||
59552273|NCT01373450|75651990|FG003|NOT COMPLETED|7 Day Wash-out||0||
59552274|NCT01373450|75651991|FG004|NOT COMPLETED|7 Day Wash-out||0||
59552275|NCT01373450|75651992|FG005|NOT COMPLETED|7 Day Wash-out||0||
59552276|NCT01373450|75651987|FG000|STARTED|Crossover Period 3||2||
59552277|NCT01373450|75651988|FG001|STARTED|Crossover Period 3||2||
59552278|NCT01373450|75651989|FG002|STARTED|Crossover Period 3||2||
59552279|NCT01373450|75651990|FG003|STARTED|Crossover Period 3||2||
59552280|NCT01373450|75651991|FG004|STARTED|Crossover Period 3||2||
59816462|NCT00517634|75938895|FG000|STARTED|First Treatment Period||4||
59991413|NCT00928447|76106987|FG000|Received at Least 1 Dose of rHuPH20|Overall Study||21|One half of the participant's back received rHuPH20|168
59991414|NCT00928447|76106987|FG000|Received at Least 1 Dose of Placebo|Overall Study||21|One half of the participant's back received placebo|168
59991415|NCT00928447|76106987|FG000|COMPLETED|Overall Study||20||160
59991416|NCT00928447|76106987|FG000|NOT COMPLETED|Overall Study||2||16
59991417|NCT02224846|76106993|FG000|STARTED|Period 1 (Month 3)||211||
59991418|NCT02224846|76106994|FG001|STARTED|Period 1 (Month 3)||424||
59991419|NCT02224846|76106993|FG000|Received at Least One Dose of Study Drug|Period 1 (Month 3)||210||
59991420|NCT02224846|76106994|FG001|Received at Least One Dose of Study Drug|Period 1 (Month 3)||421||
59991421|NCT02224846|76106993|FG000|COMPLETED|Period 1 (Month 3)||192||
59991422|NCT02224846|76106994|FG001|COMPLETED|Period 1 (Month 3)||388||
59991423|NCT02224846|76106993|FG000|NOT COMPLETED|Period 1 (Month 3)||19||
59991424|NCT02224846|76106994|FG001|NOT COMPLETED|Period 1 (Month 3)||36||
59991425|NCT02224846|76106993|FG000|STARTED|Period 2 (Month 3 to Month 12)||192||
59991426|NCT02224846|76106994|FG001|STARTED|Period 2 (Month 3 to Month 12)||388||
60082728|NCT00315328|76198323|FG001|5 Week Visit|Overall Study||89||
60082729|NCT00315328|76198324|FG002|5 Week Visit|Overall Study||17||
60082730|NCT00315328|76198325|FG003|5 Week Visit|Overall Study||19||
60082731|NCT00315328|76198322|FG000|COMPLETED|Overall Study|Completed defined as completing 17 week primary outcome exam|84||
60082732|NCT00315328|76198323|FG001|COMPLETED|Overall Study|Completed defined as completing 17 week primary outcome exam|88||
60082733|NCT00315328|76198324|FG002|COMPLETED|Overall Study|Completed defined as completing 17 week primary outcome exam|13||
60082734|NCT00315328|76198325|FG003|COMPLETED|Overall Study|Completed defined as completing 17 week primary outcome exam|20||
60082735|NCT00315328|76198322|FG000|NOT COMPLETED|Overall Study||14||
60082736|NCT00315328|76198323|FG001|NOT COMPLETED|Overall Study||7||
60082737|NCT00315328|76198324|FG002|NOT COMPLETED|Overall Study||5||
59552281|NCT01373450|75651992|FG005|STARTED|Crossover Period 3||2||
59552282|NCT01373450|75651987|FG000|COMPLETED|Crossover Period 3||2||
59552283|NCT01373450|75651988|FG001|COMPLETED|Crossover Period 3||2||
59552284|NCT01373450|75651989|FG002|COMPLETED|Crossover Period 3||2||
59552285|NCT01373450|75651990|FG003|COMPLETED|Crossover Period 3||2||
59552286|NCT01373450|75651991|FG004|COMPLETED|Crossover Period 3||2||
59552287|NCT01373450|75651992|FG005|COMPLETED|Crossover Period 3||2||
59552288|NCT01373450|75651987|FG000|NOT COMPLETED|Crossover Period 3||0||
59552289|NCT01373450|75651988|FG001|NOT COMPLETED|Crossover Period 3||0||
59991427|NCT02224846|76106993|FG000|COMPLETED|Period 2 (Month 3 to Month 12)||173||
59552290|NCT01373450|75651989|FG002|NOT COMPLETED|Crossover Period 3||0||
59552291|NCT01373450|75651990|FG003|NOT COMPLETED|Crossover Period 3||0||
59552292|NCT01373450|75651991|FG004|NOT COMPLETED|Crossover Period 3||0||
59552293|NCT01373450|75651992|FG005|NOT COMPLETED|Crossover Period 3||0||
59552294|NCT01373450|75651987|FG000|STARTED|7 Day Wash-out||2||
59552295|NCT01373450|75651988|FG001|STARTED|7 Day Wash-out||2||
59552296|NCT01373450|75651989|FG002|STARTED|7 Day Wash-out||2||
60082738|NCT00315328|76198325|FG003|NOT COMPLETED|Overall Study||2||
60082739|NCT01522443|76198337|FG000|STARTED|Overall Study||61|Randomized|
60082740|NCT01522443|76198338|FG001|STARTED|Overall Study||58|Randomized|
60082741|NCT01522443|76198337|FG000|COMPLETED|Overall Study||8|Subjects still on study treatment at data cut-off date|
60082742|NCT01522443|76198338|FG001|COMPLETED|Overall Study||3|Subjects still on study treatment at data cut-off date|
60082743|NCT01522443|76198337|FG000|NOT COMPLETED|Overall Study||53||
60082744|NCT01522443|76198338|FG001|NOT COMPLETED|Overall Study||55||
60082745|NCT00334204|76198344|FG000|STARTED|Overall Study||58||
60082746|NCT00334204|76198344|FG000|COMPLETED|Overall Study||56||
60082747|NCT00334204|76198344|FG000|NOT COMPLETED|Overall Study||2||
60082748|NCT00336700|76198349|FG000|STARTED|Overall Study||25||
60082749|NCT00336700|76198349|FG000|COMPLETED|Overall Study||25||
60082750|NCT00336700|76198349|FG000|NOT COMPLETED|Overall Study||0||
60082751|NCT01468233|76198355|FG000|STARTED|Treatment Period 1||163||
60082752|NCT01468233|76198356|FG001|STARTED|Treatment Period 1||163||
60082753|NCT01468233|76198357|FG002|STARTED|Treatment Period 1||0||
60082754|NCT01468233|76198358|FG003|STARTED|Treatment Period 1||0||
60082755|NCT01468233|76198359|FG004|STARTED|Treatment Period 1||0||
60082756|NCT01468233|76198360|FG005|STARTED|Treatment Period 1||0||
60082757|NCT01468233|76198355|FG000|COMPLETED|Treatment Period 1||151||
60082758|NCT01468233|76198356|FG001|COMPLETED|Treatment Period 1||155||
60082759|NCT01468233|76198357|FG002|COMPLETED|Treatment Period 1||0||
60082760|NCT01468233|76198358|FG003|COMPLETED|Treatment Period 1||0||
60082761|NCT01468233|76198359|FG004|COMPLETED|Treatment Period 1||0||
60082762|NCT01468233|76198360|FG005|COMPLETED|Treatment Period 1||0||
60082763|NCT01468233|76198355|FG000|NOT COMPLETED|Treatment Period 1||12||
60082764|NCT01468233|76198356|FG001|NOT COMPLETED|Treatment Period 1||8||
60082765|NCT01468233|76198357|FG002|NOT COMPLETED|Treatment Period 1||0||
60082766|NCT01468233|76198358|FG003|NOT COMPLETED|Treatment Period 1||0||
60082767|NCT01468233|76198359|FG004|NOT COMPLETED|Treatment Period 1||0||
59552297|NCT01373450|75651990|FG003|STARTED|7 Day Wash-out||2||
59552298|NCT01373450|75651991|FG004|STARTED|7 Day Wash-out||2||
60082768|NCT01468233|76198360|FG005|NOT COMPLETED|Treatment Period 1||0||
60082769|NCT01468233|76198355|FG000|STARTED|Treatment Period 2||0||
60082770|NCT01468233|76198356|FG001|STARTED|Treatment Period 2||0||
59552299|NCT01373450|75651992|FG005|STARTED|7 Day Wash-out||2||
59552300|NCT01373450|75651987|FG000|COMPLETED|7 Day Wash-out||2||
60082771|NCT01468233|76198357|FG002|STARTED|Treatment Period 2||151||
60082772|NCT01468233|76198358|FG003|STARTED|Treatment Period 2||51||
60082773|NCT01468233|76198359|FG004|STARTED|Treatment Period 2||53||
60082774|NCT01468233|76198360|FG005|STARTED|Treatment Period 2||51||
60082775|NCT01468233|76198355|FG000|COMPLETED|Treatment Period 2||0||
60082776|NCT01468233|76198356|FG001|COMPLETED|Treatment Period 2||0||
59552301|NCT01373450|75651988|FG001|COMPLETED|7 Day Wash-out||2||
59552302|NCT01373450|75651989|FG002|COMPLETED|7 Day Wash-out||2||
59552303|NCT01373450|75651990|FG003|COMPLETED|7 Day Wash-out||2||
59552304|NCT01373450|75651991|FG004|COMPLETED|7 Day Wash-out||2||
59552305|NCT01373450|75651992|FG005|COMPLETED|7 Day Wash-out||2||
59552306|NCT01373450|75651987|FG000|NOT COMPLETED|7 Day Wash-out||0||
59552307|NCT01373450|75651988|FG001|NOT COMPLETED|7 Day Wash-out||0||
59552308|NCT01373450|75651989|FG002|NOT COMPLETED|7 Day Wash-out||0||
59552309|NCT01373450|75651990|FG003|NOT COMPLETED|7 Day Wash-out||0||
59552310|NCT01373450|75651991|FG004|NOT COMPLETED|7 Day Wash-out||0||
59991428|NCT02224846|76106994|FG001|COMPLETED|Period 2 (Month 3 to Month 12)||357||
59991429|NCT02224846|76106993|FG000|NOT COMPLETED|Period 2 (Month 3 to Month 12)||19||
60082777|NCT01468233|76198357|FG002|COMPLETED|Treatment Period 2||40||
60082778|NCT01468233|76198358|FG003|COMPLETED|Treatment Period 2||23||
59991430|NCT02224846|76106994|FG001|NOT COMPLETED|Period 2 (Month 3 to Month 12)||31||
59991431|NCT02224846|76106993|FG000|STARTED|Period 2 (Month 12 to Month 24)||173||
59991432|NCT02224846|76106994|FG001|STARTED|Period 2 (Month 12 to Month 24)||357||
59991433|NCT02224846|76106993|FG000|COMPLETED|Period 2 (Month 12 to Month 24)||131||
59991434|NCT02224846|76106994|FG001|COMPLETED|Period 2 (Month 12 to Month 24)||283||
59991435|NCT02224846|76106993|FG000|NOT COMPLETED|Period 2 (Month 12 to Month 24)||42||
59991436|NCT02224846|76106994|FG001|NOT COMPLETED|Period 2 (Month 12 to Month 24)||74||
59991437|NCT01632280|76107002|FG000|STARTED|Overall Study||6||
59991438|NCT01632280|76107003|FG001|STARTED|Overall Study||6||
59991439|NCT01632280|76107002|FG000|COMPLETED|Overall Study||5||
60082779|NCT01468233|76198359|FG004|COMPLETED|Treatment Period 2||25||
60082780|NCT01468233|76198360|FG005|COMPLETED|Treatment Period 2||28||
60082781|NCT01468233|76198355|FG000|NOT COMPLETED|Treatment Period 2||0||
60082782|NCT01468233|76198356|FG001|NOT COMPLETED|Treatment Period 2||0||
60082783|NCT01468233|76198357|FG002|NOT COMPLETED|Treatment Period 2||111||
60082784|NCT01468233|76198358|FG003|NOT COMPLETED|Treatment Period 2||28||
60082785|NCT01468233|76198359|FG004|NOT COMPLETED|Treatment Period 2||28||
60082786|NCT01468233|76198360|FG005|NOT COMPLETED|Treatment Period 2||23||
60082787|NCT01468077|76198380|FG000|STARTED|Overall Study||22||
60082788|NCT01468077|76198381|FG001|STARTED|Overall Study||25||
60082789|NCT01468077|76198380|FG000|COMPLETED|Overall Study||18||
60082790|NCT01468077|76198381|FG001|COMPLETED|Overall Study||22||
60082791|NCT01468077|76198380|FG000|NOT COMPLETED|Overall Study||4||
60082792|NCT01468077|76198381|FG001|NOT COMPLETED|Overall Study||3||
60082793|NCT01522365|76198389|FG000|STARTED|Overall Study||20|Split-mouth design, i.e. each subject is randomized to both treatments. 20 subjects in total were enrolled (same subject in both treatment arms).|41
60082794|NCT01522365|76198390|FG001|STARTED|Overall Study||20|Split-mouth design, i.e. each subject is randomized to both treatments. 20 subjects in total were enrolled (same subject in both treatment arms).|41
60082795|NCT01522365|76198389|FG000|Intention-to-Treat|Overall Study||19||38
60082796|NCT01522365|76198390|FG001|Intention-to-Treat|Overall Study||19||38
60082797|NCT01522365|76198389|FG000|COMPLETED|Overall Study||18|Split-mouth design, i.e. each subject is randomized to both treatments. 18 subjects in total completed the study (same subject in both treatment arms).|36
60103652|NCT00989781|76221896|FG001|STARTED|Adrenal Response ot ACTH|15 subjects that completed part 1 elected to participate in Part 2|18||
59991440|NCT01632280|76107003|FG001|COMPLETED|Overall Study||6||
59991441|NCT01632280|76107002|FG000|NOT COMPLETED|Overall Study||1||
59991442|NCT01632280|76107003|FG001|NOT COMPLETED|Overall Study||0||
60103653|NCT00989781|76221895|FG000|COMPLETED|Adrenal Response ot ACTH|Of 18 eligible, 15 consented. 2 dropped out and 13 completed study|13||
60103654|NCT00989781|76221896|FG001|COMPLETED|Adrenal Response ot ACTH|Of 18 eligible, 15 consented and completed study|15||
60103655|NCT00989781|76221895|FG000|NOT COMPLETED|Adrenal Response ot ACTH||5||
60103656|NCT00989781|76221896|FG001|NOT COMPLETED|Adrenal Response ot ACTH||3||
60103657|NCT01292746|76221903|FG000|STARTED|Overall Study||14||
60103658|NCT01292746|76221903|FG000|COMPLETED|Overall Study||14||
60103659|NCT01292746|76221903|FG000|NOT COMPLETED|Overall Study||0||
59552311|NCT01373450|75651992|FG005|NOT COMPLETED|7 Day Wash-out||0||
59552312|NCT01373450|75651987|FG000|STARTED|Crossover Period 4||2||
59552313|NCT01373450|75651988|FG001|STARTED|Crossover Period 4||2||
59552314|NCT01373450|75651989|FG002|STARTED|Crossover Period 4||2||
59552315|NCT01373450|75651990|FG003|STARTED|Crossover Period 4||2||
59552316|NCT01373450|75651991|FG004|STARTED|Crossover Period 4||2||
59552317|NCT01373450|75651992|FG005|STARTED|Crossover Period 4||2||
59552318|NCT01373450|75651987|FG000|COMPLETED|Crossover Period 4||2||
59552319|NCT01373450|75651988|FG001|COMPLETED|Crossover Period 4||2||
59552320|NCT01373450|75651989|FG002|COMPLETED|Crossover Period 4||2||
59552321|NCT01373450|75651990|FG003|COMPLETED|Crossover Period 4||2||
59552322|NCT01373450|75651991|FG004|COMPLETED|Crossover Period 4||2||
59552323|NCT01373450|75651992|FG005|COMPLETED|Crossover Period 4||2||
59552324|NCT01373450|75651987|FG000|NOT COMPLETED|Crossover Period 4||0||
59552325|NCT01373450|75651988|FG001|NOT COMPLETED|Crossover Period 4||0||
59552326|NCT01373450|75651989|FG002|NOT COMPLETED|Crossover Period 4||0||
59552327|NCT01373450|75651990|FG003|NOT COMPLETED|Crossover Period 4||0||
59552328|NCT01373450|75651991|FG004|NOT COMPLETED|Crossover Period 4||0||
59552329|NCT01373450|75651992|FG005|NOT COMPLETED|Crossover Period 4||0||
59552330|NCT02906787|75652008|FG000|STARTED|Overall Study||142||
59552331|NCT02906787|75652009|FG001|STARTED|Overall Study||146||
59552332|NCT02906787|75652008|FG000|EOT|Overall Study||106||
59552333|NCT02906787|75652009|FG001|EOT|Overall Study||112||
59552334|NCT02906787|75652008|FG000|3-month Follow-up|Overall Study||106||
59552335|NCT02906787|75652009|FG001|3-month Follow-up|Overall Study||114||
59552336|NCT02906787|75652008|FG000|COMPLETED|Overall Study||106||
59552337|NCT02906787|75652009|FG001|COMPLETED|Overall Study||114||
59552338|NCT02906787|75652008|FG000|NOT COMPLETED|Overall Study||36||
59552339|NCT02906787|75652009|FG001|NOT COMPLETED|Overall Study||32||
59552340|NCT01330394|75652017|FG000|STARTED|Overall Study||17||
59552341|NCT01330394|75652018|FG001|STARTED|Overall Study||16||
59552342|NCT01330394|75652017|FG000|COMPLETED|Overall Study||17||
59552343|NCT01330394|75652018|FG001|COMPLETED|Overall Study||16||
59552344|NCT01330394|75652017|FG000|NOT COMPLETED|Overall Study||0||
59552345|NCT01330394|75652018|FG001|NOT COMPLETED|Overall Study||0||
59552346|NCT01793285|75652024|FG000|STARTED|Overall Study||85||
59552347|NCT01793285|75652024|FG000|COMPLETED|Overall Study||85||
59552348|NCT01793285|75652024|FG000|NOT COMPLETED|Overall Study||0||
59552349|NCT01811693|75652031|FG000|STARTED|Overall Study||4||
59552350|NCT01811693|75652032|FG001|STARTED|Overall Study||0||
59552351|NCT01811693|75652033|FG002|STARTED|Overall Study||0||
59552352|NCT01811693|75652031|FG000|COMPLETED|Overall Study||4||
59552353|NCT01811693|75652032|FG001|COMPLETED|Overall Study||0||
59552354|NCT01811693|75652033|FG002|COMPLETED|Overall Study||0||
59552355|NCT01811693|75652031|FG000|NOT COMPLETED|Overall Study||0||
59552356|NCT01811693|75652032|FG001|NOT COMPLETED|Overall Study||0||
59552357|NCT01811693|75652033|FG002|NOT COMPLETED|Overall Study||0||
59552358|NCT02639637|75652040|FG000|STARTED|Overall Study||7||
59552359|NCT02639637|75652041|FG001|STARTED|Overall Study||6||
59552360|NCT02639637|75652042|FG002|STARTED|Overall Study||2||
59552361|NCT02639637|75652043|FG003|STARTED|Overall Study||3||
59552362|NCT02639637|75652040|FG000|COMPLETED|Overall Study||7||
59552363|NCT02639637|75652041|FG001|COMPLETED|Overall Study||6||
59552364|NCT02639637|75652042|FG002|COMPLETED|Overall Study||2||
59552365|NCT02639637|75652043|FG003|COMPLETED|Overall Study||3||
59552366|NCT02639637|75652040|FG000|NOT COMPLETED|Overall Study||0||
59552367|NCT02639637|75652041|FG001|NOT COMPLETED|Overall Study||0||
59552368|NCT02639637|75652042|FG002|NOT COMPLETED|Overall Study||0||
59552369|NCT02639637|75652043|FG003|NOT COMPLETED|Overall Study||0||
59552370|NCT01332188|75652063|FG000|STARTED|Overall Study||25||
59552371|NCT01332188|75652064|FG001|STARTED|Overall Study||26||
59552372|NCT01332188|75652065|FG002|STARTED|Overall Study||25||
59552373|NCT01332188|75652066|FG003|STARTED|Overall Study||25||
59552374|NCT01332188|75652063|FG000|COMPLETED|Overall Study||23||
59552375|NCT01332188|75652064|FG001|COMPLETED|Overall Study||25||
59552376|NCT01332188|75652065|FG002|COMPLETED|Overall Study||21||
59552377|NCT01332188|75652066|FG003|COMPLETED|Overall Study||25||
59552378|NCT01332188|75652063|FG000|NOT COMPLETED|Overall Study||2||
59552379|NCT01332188|75652064|FG001|NOT COMPLETED|Overall Study||1||
59706890|NCT00996892|75825868|FG007|NOT COMPLETED|Dose-Escalation Stage 1B||0||
59552380|NCT01332188|75652065|FG002|NOT COMPLETED|Overall Study||4||
59552381|NCT01332188|75652066|FG003|NOT COMPLETED|Overall Study||0||
59552382|NCT01794455|75652078|FG000|STARTED|Overall Study||0||
59552383|NCT01794455|75652079|FG001|STARTED|Overall Study||1||
59552384|NCT01794455|75652078|FG000|COMPLETED|Overall Study||0||
59552385|NCT01794455|75652079|FG001|COMPLETED|Overall Study||1||
59552386|NCT01794455|75652078|FG000|NOT COMPLETED|Overall Study||0||
59552387|NCT01794455|75652079|FG001|NOT COMPLETED|Overall Study||0||
59552388|NCT01795079|75652087|FG000|STARTED|Overall Study||16||
59552389|NCT01795079|75652088|FG001|STARTED|Overall Study||15||
59552390|NCT01795079|75652087|FG000|COMPLETED|Overall Study||13||
59552391|NCT01795079|75652088|FG001|COMPLETED|Overall Study||12||
59552392|NCT01795079|75652087|FG000|NOT COMPLETED|Overall Study||3||
59552393|NCT01795079|75652088|FG001|NOT COMPLETED|Overall Study||3||
59552394|NCT01271036|75652096|FG000|STARTED|Overall Study||62||
59552395|NCT01271036|75652097|FG001|STARTED|Overall Study||62||
59552396|NCT01271036|75652096|FG000|COMPLETED|Overall Study||62||
59552397|NCT01271036|75652097|FG001|COMPLETED|Overall Study||62||
59552398|NCT01271036|75652096|FG000|NOT COMPLETED|Overall Study||0||
59552399|NCT01271036|75652097|FG001|NOT COMPLETED|Overall Study||0||
59552400|NCT01332500|75652107|FG000|STARTED|Overall Study||13257||
59552401|NCT01332500|75652108|FG001|STARTED|Overall Study||39771||
59552402|NCT01332500|75652109|FG002|STARTED|Overall Study||2903||
59552403|NCT01332500|75652110|FG003|STARTED|Overall Study||5806||
59552404|NCT01332500|75652107|FG000|COMPLETED|Overall Study||13257||
59552405|NCT01332500|75652108|FG001|COMPLETED|Overall Study||39771||
59552406|NCT01332500|75652109|FG002|COMPLETED|Overall Study||2903||
59552407|NCT01332500|75652110|FG003|COMPLETED|Overall Study||5806||
59552408|NCT01332500|75652107|FG000|NOT COMPLETED|Overall Study||0||
59552409|NCT01332500|75652108|FG001|NOT COMPLETED|Overall Study||0||
59552410|NCT01332500|75652109|FG002|NOT COMPLETED|Overall Study||0||
59552411|NCT01332500|75652110|FG003|NOT COMPLETED|Overall Study||0||
59552412|NCT01812005|75652122|FG000|STARTED|Overall Study||1||
59552413|NCT01812005|75652123|FG001|STARTED|Overall Study||13||
59552414|NCT01812005|75652122|FG000|COMPLETED|Overall Study||1||
59552415|NCT01812005|75652123|FG001|COMPLETED|Overall Study||13||
59552416|NCT01812005|75652122|FG000|NOT COMPLETED|Overall Study||0||
59552417|NCT01812005|75652123|FG001|NOT COMPLETED|Overall Study||0||
59552418|NCT01332578|75652129|FG000|STARTED|Period I||12||
59552419|NCT01332578|75652130|FG001|STARTED|Period I||13||
59552420|NCT01332578|75652129|FG000|COMPLETED|Period I||12||
59552421|NCT01332578|75652130|FG001|COMPLETED|Period I||13||
59552422|NCT01332578|75652129|FG000|NOT COMPLETED|Period I||0||
59706891|NCT00996892|75825869|FG008|NOT COMPLETED|Dose-Escalation Stage 1B||0||
59706892|NCT00996892|75825870|FG009|NOT COMPLETED|Dose-Escalation Stage 1B||0||
59706893|NCT00996892|75825871|FG010|NOT COMPLETED|Dose-Escalation Stage 1B||0||
59706894|NCT00996892|75825872|FG011|NOT COMPLETED|Dose-Escalation Stage 1B||0||
59706895|NCT00996892|75825873|FG012|NOT COMPLETED|Dose-Escalation Stage 1B||0||
59706896|NCT00996892|75825874|FG013|NOT COMPLETED|Dose-Escalation Stage 1B||0||
59552423|NCT01332578|75652130|FG001|NOT COMPLETED|Period I||0||
59552424|NCT01332578|75652129|FG000|STARTED|Washout Period||12||
59552425|NCT01332578|75652130|FG001|STARTED|Washout Period||13||
59552426|NCT01332578|75652129|FG000|COMPLETED|Washout Period||12||
59552427|NCT01332578|75652130|FG001|COMPLETED|Washout Period||13||
59552428|NCT01332578|75652129|FG000|NOT COMPLETED|Washout Period||0||
59552429|NCT01332578|75652130|FG001|NOT COMPLETED|Washout Period||0||
59552430|NCT01332578|75652129|FG000|STARTED|Period II||12||
59552431|NCT01332578|75652130|FG001|STARTED|Period II||13||
59552432|NCT01332578|75652129|FG000|COMPLETED|Period II||12||
59552433|NCT01332578|75652130|FG001|COMPLETED|Period II||13||
59552434|NCT01332578|75652129|FG000|NOT COMPLETED|Period II||0||
59552435|NCT01332578|75652130|FG001|NOT COMPLETED|Period II||0||
59552436|NCT01795859|75652139|FG000|STARTED|Overall Study||45||
59706897|NCT00996892|75825875|FG014|NOT COMPLETED|Dose-Escalation Stage 1B||4||
59706898|NCT00996892|75825876|FG015|NOT COMPLETED|Dose-Escalation Stage 1B||3||
59706899|NCT00996892|75825877|FG016|NOT COMPLETED|Dose-Escalation Stage 1B||3||
59816463|NCT00517634|75938896|FG001|STARTED|First Treatment Period||4||
59552437|NCT01795859|75652140|FG001|STARTED|Overall Study||45||
59552438|NCT01795859|75652139|FG000|COMPLETED|Overall Study||44||
59552439|NCT01795859|75652140|FG001|COMPLETED|Overall Study||43||
59552440|NCT01795859|75652139|FG000|NOT COMPLETED|Overall Study||1||
59552441|NCT01795859|75652140|FG001|NOT COMPLETED|Overall Study||2||
59552442|NCT01333592|75652148|FG000|STARTED|Overall Study||67||
59552443|NCT01333592|75652149|FG001|STARTED|Overall Study||69||
59552444|NCT01333592|75652148|FG000|COMPLETED|Overall Study||58||
59552445|NCT01333592|75652149|FG001|COMPLETED|Overall Study||52||
59552446|NCT01333592|75652148|FG000|NOT COMPLETED|Overall Study||9||
59552447|NCT01333592|75652149|FG001|NOT COMPLETED|Overall Study||17||
59552448|NCT01812473|75652157|FG000|STARTED|Overall Study||22||
59552449|NCT01812473|75652158|FG001|STARTED|Overall Study||13||
59706900|NCT00996892|75825878|FG017|NOT COMPLETED|Dose-Escalation Stage 1B||5||
59706901|NCT00996892|75825879|FG018|NOT COMPLETED|Dose-Escalation Stage 1B||0||
59552450|NCT01812473|75652157|FG000|COMPLETED|Overall Study||22||
59552451|NCT01812473|75652158|FG001|COMPLETED|Overall Study||13||
59552452|NCT01812473|75652157|FG000|NOT COMPLETED|Overall Study||0||
59552453|NCT01812473|75652158|FG001|NOT COMPLETED|Overall Study||0||
59552454|NCT01375946|75652164|FG000|STARTED|Overall Study||4||
59552455|NCT01375946|75652165|FG001|STARTED|Overall Study||4||
59552456|NCT01375946|75652166|FG002|STARTED|Overall Study||4||
59552457|NCT01375946|75652167|FG003|STARTED|Overall Study||4||
59552458|NCT01375946|75652168|FG004|STARTED|Overall Study||4||
59552459|NCT01375946|75652169|FG005|STARTED|Overall Study||4||
59552460|NCT01375946|75652164|FG000|COMPLETED|Overall Study||4||
59552461|NCT01375946|75652165|FG001|COMPLETED|Overall Study||4||
59552462|NCT01375946|75652166|FG002|COMPLETED|Overall Study||4||
59552463|NCT01375946|75652167|FG003|COMPLETED|Overall Study||4||
59552464|NCT01375946|75652168|FG004|COMPLETED|Overall Study||4||
59552465|NCT01375946|75652169|FG005|COMPLETED|Overall Study||4||
59552466|NCT01375946|75652164|FG000|NOT COMPLETED|Overall Study||0||
59552467|NCT01375946|75652165|FG001|NOT COMPLETED|Overall Study||0||
59552468|NCT01375946|75652166|FG002|NOT COMPLETED|Overall Study||0||
59552469|NCT01375946|75652167|FG003|NOT COMPLETED|Overall Study||0||
59552470|NCT01375946|75652168|FG004|NOT COMPLETED|Overall Study||0||
59552471|NCT01375946|75652169|FG005|NOT COMPLETED|Overall Study||0||
59552472|NCT01371032|75652175|FG000|STARTED|Overall Study||14||
59552473|NCT01371032|75652176|FG001|STARTED|Overall Study||14||
59552474|NCT01371032|75652175|FG000|COMPLETED|Overall Study||14||
59552475|NCT01371032|75652176|FG001|COMPLETED|Overall Study||14||
59552476|NCT01371032|75652175|FG000|NOT COMPLETED|Overall Study||0||
59552477|NCT01371032|75652176|FG001|NOT COMPLETED|Overall Study||0||
59552478|NCT01267292|75652186|FG000|STARTED|Overall Study||24||
59552479|NCT01267292|75652187|FG001|STARTED|Overall Study||26||
59552480|NCT01267292|75652186|FG000|COMPLETED|Overall Study||20||
59552481|NCT01267292|75652187|FG001|COMPLETED|Overall Study||20||
59552482|NCT01267292|75652186|FG000|NOT COMPLETED|Overall Study||4||
59552483|NCT01267292|75652187|FG001|NOT COMPLETED|Overall Study||6||
59552484|NCT01797029|75652195|FG000|STARTED|Overall Study||1174||
59552485|NCT01797029|75652196|FG001|STARTED|Overall Study||587||
59552486|NCT01797029|75652195|FG000|COMPLETED|Overall Study||1015||
59552487|NCT01797029|75652196|FG001|COMPLETED|Overall Study||526||
59552488|NCT01797029|75652195|FG000|NOT COMPLETED|Overall Study||159||
59552489|NCT01797029|75652196|FG001|NOT COMPLETED|Overall Study||61||
59552490|NCT01377584|75652208|FG000|STARTED|Overall Study||8||
59552491|NCT01377584|75652209|FG001|STARTED|Overall Study||8||
59552492|NCT01377584|75652210|FG002|STARTED|Overall Study||10||
59552493|NCT01377584|75652211|FG003|STARTED|Overall Study||10||
59552494|NCT01377584|75652212|FG004|STARTED|Overall Study||12||
59552495|NCT01377584|75652213|FG005|STARTED|Overall Study||12||
59552496|NCT01377584|75652208|FG000|COMPLETED|Overall Study||5||
59552497|NCT01377584|75652209|FG001|COMPLETED|Overall Study||5||
59552498|NCT01377584|75652210|FG002|COMPLETED|Overall Study||6||
59552499|NCT01377584|75652211|FG003|COMPLETED|Overall Study||6||
59552500|NCT01377584|75652212|FG004|COMPLETED|Overall Study||9||
59552501|NCT01377584|75652213|FG005|COMPLETED|Overall Study||9||
59552502|NCT01377584|75652208|FG000|NOT COMPLETED|Overall Study||3||
59552503|NCT01377584|75652209|FG001|NOT COMPLETED|Overall Study||3||
59552504|NCT01377584|75652210|FG002|NOT COMPLETED|Overall Study||4||
59552505|NCT01377584|75652211|FG003|NOT COMPLETED|Overall Study||4||
59552506|NCT01377584|75652212|FG004|NOT COMPLETED|Overall Study||3||
59552507|NCT01377584|75652213|FG005|NOT COMPLETED|Overall Study||3||
59552508|NCT01734161|75652232|FG000|STARTED|Overall Study||61||
59552509|NCT01734161|75652233|FG001|STARTED|Overall Study||61||
59552510|NCT01734161|75652232|FG000|COMPLETED|Overall Study||55||
59552511|NCT01734161|75652233|FG001|COMPLETED|Overall Study||53||
59552512|NCT01734161|75652232|FG000|NOT COMPLETED|Overall Study||6||
59552513|NCT01734161|75652233|FG001|NOT COMPLETED|Overall Study||8||
59552514|NCT01272284|75652239|FG000|STARTED|3-month Follow-up Visit||113||
59552515|NCT01272284|75652239|FG000|COMPLETED|3-month Follow-up Visit||112||
59552516|NCT01272284|75652239|FG000|NOT COMPLETED|3-month Follow-up Visit||1||
59552517|NCT01272284|75652239|FG000|STARTED|6-month Follow-up Visit||112||
59552518|NCT01272284|75652239|FG000|COMPLETED|6-month Follow-up Visit||109||
59552519|NCT01272284|75652239|FG000|NOT COMPLETED|6-month Follow-up Visit||3||
59552520|NCT01272284|75652239|FG000|STARTED|12-month Follow-up Visit||109||
59552521|NCT01272284|75652239|FG000|COMPLETED|12-month Follow-up Visit||105||
59991443|NCT02224690|76107011|FG000|STARTED|Overall Study||86||
59991444|NCT02224690|76107012|FG001|STARTED|Overall Study||85||
59991445|NCT02224690|76107011|FG000|Safety Analysis Set|Overall Study||86|Received at least 1 dose of IMP; analyzed as per actual treatment received.|
59991446|NCT02224690|76107012|FG001|Safety Analysis Set|Overall Study||85|Received at least 1 dose of IMP; analyzed as per actual treatment received.|
59991447|NCT02224690|76107011|FG000|Intent to Treat (ITT) Analysis Set|Overall Study||86|Received at least 1 dose of IMP with at least 1 post-baseline efficacy endpoint measurement.|
59995122|NCT04925271|76110945|FG000|COMPLETED|Overall Study||20||
59552522|NCT01272284|75652239|FG000|NOT COMPLETED|12-month Follow-up Visit||4||
59552523|NCT01734239|75652246|FG000|STARTED|Overall Study||52||
59552524|NCT01734239|75652247|FG001|STARTED|Overall Study||50||
59552525|NCT01734239|75652246|FG000|COMPLETED|Overall Study||52||
59552526|NCT01734239|75652247|FG001|COMPLETED|Overall Study||50||
59552527|NCT01734239|75652246|FG000|NOT COMPLETED|Overall Study||0||
59552528|NCT01734239|75652247|FG001|NOT COMPLETED|Overall Study||0||
59552529|NCT01734317|75652252|FG000|STARTED|Overall Study||10||
59552530|NCT01734317|75652252|FG000|COMPLETED|Overall Study||10||
59552531|NCT01734317|75652252|FG000|NOT COMPLETED|Overall Study||0||
59552532|NCT01334216|75652259|FG000|STARTED|Overall Study||168||
59816464|NCT00517634|75938897|FG002|STARTED|First Treatment Period||4||
60082798|NCT01522365|76198390|FG001|COMPLETED|Overall Study||18|Split-mouth design, i.e. each subject is randomized to both treatments. 18 subjects in total completed the study (same subject in both treatment arms).|36
60082799|NCT01522365|76198389|FG000|NOT COMPLETED|Overall Study||2||5
60082800|NCT01522365|76198390|FG001|NOT COMPLETED|Overall Study||2||5
60082801|NCT01754402|76198400|FG000|STARTED|Overall Study||6||
60082802|NCT01754402|76198401|FG001|STARTED|Overall Study||2||
60082803|NCT01754402|76198402|FG002|STARTED|Overall Study||30||
60082804|NCT01754402|76198400|FG000|COMPLETED|Overall Study||4||
60082805|NCT01754402|76198401|FG001|COMPLETED|Overall Study||0||
60082806|NCT01754402|76198402|FG002|COMPLETED|Overall Study||26||
60082807|NCT01754402|76198400|FG000|NOT COMPLETED|Overall Study||2||
60082808|NCT01754402|76198401|FG001|NOT COMPLETED|Overall Study||2||
60082809|NCT01754402|76198402|FG002|NOT COMPLETED|Overall Study||4||
60082810|NCT01783418|76198413|FG000|STARTED|Overall Study||8||
60082811|NCT01783418|76198414|FG001|STARTED|Overall Study||6||
60082812|NCT01783418|76198413|FG000|COMPLETED|Overall Study||7||
60082813|NCT01783418|76198414|FG001|COMPLETED|Overall Study||6||
60082814|NCT01783418|76198413|FG000|NOT COMPLETED|Overall Study||1||
60082815|NCT01783418|76198414|FG001|NOT COMPLETED|Overall Study||0||
60082816|NCT01521897|76198420|FG000|STARTED|Overall Study||1143||
60082817|NCT01521897|76198420|FG000|COMPLETED|Overall Study||1120||
60082818|NCT01521897|76198420|FG000|NOT COMPLETED|Overall Study||23||
60082819|NCT01782872|76198428|FG000|STARTED|Overall Study||20||
60082820|NCT01782872|76198429|FG001|STARTED|Overall Study||20||
60082821|NCT01782872|76198430|FG002|STARTED|Overall Study||20||
60082822|NCT01782872|76198431|FG003|STARTED|Overall Study||20||
60082823|NCT01782872|76198428|FG000|COMPLETED|Overall Study||20||
60082824|NCT01782872|76198429|FG001|COMPLETED|Overall Study||19||
60082825|NCT01782872|76198430|FG002|COMPLETED|Overall Study||20||
60082826|NCT01782872|76198431|FG003|COMPLETED|Overall Study||19||
60082827|NCT01782872|76198428|FG000|NOT COMPLETED|Overall Study||0||
60082828|NCT01782872|76198429|FG001|NOT COMPLETED|Overall Study||1||
60082829|NCT01782872|76198430|FG002|NOT COMPLETED|Overall Study||0||
60082830|NCT01782872|76198431|FG003|NOT COMPLETED|Overall Study||1||
60082831|NCT01490697|76198443|FG000|STARTED|Overall Study||16||
60082832|NCT01490697|76198444|FG001|STARTED|Overall Study||18||
60082833|NCT01490697|76198443|FG000|COMPLETED|Overall Study||15||
60082834|NCT01490697|76198444|FG001|COMPLETED|Overall Study||16||
60082835|NCT01490697|76198443|FG000|NOT COMPLETED|Overall Study||1||
60082836|NCT01490697|76198444|FG001|NOT COMPLETED|Overall Study||2||
60082837|NCT01728194|76198452|FG000|STARTED|Overall Study||54||
60082838|NCT01728194|76198453|FG001|STARTED|Overall Study||67||
60082839|NCT01728194|76198452|FG000|COMPLETED|Overall Study||34||
59552533|NCT01334216|75652260|FG001|STARTED|Overall Study||194||
59552534|NCT01334216|75652259|FG000|COMPLETED|Overall Study||168||
59552535|NCT01334216|75652260|FG001|COMPLETED|Overall Study||194||
59552536|NCT01334216|75652259|FG000|NOT COMPLETED|Overall Study||0||
59552537|NCT01334216|75652260|FG001|NOT COMPLETED|Overall Study||0||
59552538|NCT02640807|75652269|FG000|STARTED|Overall Study||9||
59552539|NCT02640807|75652270|FG001|STARTED|Overall Study||8||
59552540|NCT02640807|75652271|FG002|STARTED|Overall Study||10||
59552541|NCT02640807|75652269|FG000|COMPLETED|Overall Study||9||
59552542|NCT02640807|75652270|FG001|COMPLETED|Overall Study||8||
59552543|NCT02640807|75652271|FG002|COMPLETED|Overall Study||10||
59552544|NCT02640807|75652269|FG000|NOT COMPLETED|Overall Study||0||
59552545|NCT02640807|75652270|FG001|NOT COMPLETED|Overall Study||0||
59552546|NCT02640807|75652271|FG002|NOT COMPLETED|Overall Study||0||
59552547|NCT01335230|75652283|FG000|STARTED|Overall Study|subjects|10||
59552548|NCT01335230|75652284|FG001|STARTED|Overall Study|subjects|10||
59552549|NCT01335230|75652285|FG002|STARTED|Overall Study|subjects|10||
59552550|NCT01335230|75652286|FG003|STARTED|Overall Study|subjects|10||
59552551|NCT01335230|75652283|FG000|COMPLETED|Overall Study|subjects|10||
59552552|NCT01335230|75652284|FG001|COMPLETED|Overall Study|subjects|10||
59552553|NCT01335230|75652285|FG002|COMPLETED|Overall Study|subjects|10||
59552554|NCT01335230|75652286|FG003|COMPLETED|Overall Study|subjects|10||
59552555|NCT01335230|75652283|FG000|NOT COMPLETED|Overall Study||0||
59552556|NCT01335230|75652284|FG001|NOT COMPLETED|Overall Study||0||
59552557|NCT01335230|75652285|FG002|NOT COMPLETED|Overall Study||0||
59552558|NCT01335230|75652286|FG003|NOT COMPLETED|Overall Study||0||
59552559|NCT01797575|75652300|FG000|STARTED|Baseline Allocation||5||
59552560|NCT01797575|75652301|FG001|STARTED|Baseline Allocation||9||
59552561|NCT01797575|75652302|FG002|STARTED|Baseline Allocation||9||
59552562|NCT01797575|75652303|FG003|STARTED|Baseline Allocation||15||
59552563|NCT01797575|75652300|FG000|COMPLETED|Baseline Allocation||4||
59552564|NCT01797575|75652301|FG001|COMPLETED|Baseline Allocation||8||
59552565|NCT01797575|75652302|FG002|COMPLETED|Baseline Allocation||4||
59552566|NCT01797575|75652303|FG003|COMPLETED|Baseline Allocation||8||
59552567|NCT01797575|75652300|FG000|NOT COMPLETED|Baseline Allocation||1||
59552568|NCT01797575|75652301|FG001|NOT COMPLETED|Baseline Allocation||1||
59552569|NCT01797575|75652302|FG002|NOT COMPLETED|Baseline Allocation||5||
59552570|NCT01797575|75652303|FG003|NOT COMPLETED|Baseline Allocation||7||
59552571|NCT01797575|75652300|FG000|STARTED|Week 8 Re-Randomization|Non-responders during Period 1 were re-randomized at week 8 into a new treatment arm.|4|Non-responders during Period 1 were re-randomized at week 8 into a new treatment arm.|
59552572|NCT01797575|75652301|FG001|STARTED|Week 8 Re-Randomization|Non-responders during Period 1 were re-randomized at week 8 into a new treatment arm.|5|Non-responders during Period 1 were re-randomized at week 8 into a new treatment arm.|
59565877|NCT04392219|75668301|FG011|COMPLETED|Overall Study||6||
59552573|NCT01797575|75652302|FG002|STARTED|Week 8 Re-Randomization|Non-responders during Period 1 were re-randomized at week 8 into a new treatment arm.|5|Non-responders during Period 1 were re-randomized at week 8 into a new treatment arm.|
59552574|NCT01797575|75652303|FG003|STARTED|Week 8 Re-Randomization|Non-responders during Period 1 were re-randomized at week 8 into a new treatment arm.|10|Non-responders during Period 1 were re-randomized at week 8 into a new treatment arm.|
59552575|NCT01797575|75652300|FG000|COMPLETED|Week 8 Re-Randomization||4||
59552576|NCT01797575|75652301|FG001|COMPLETED|Week 8 Re-Randomization||5||
59552577|NCT01797575|75652302|FG002|COMPLETED|Week 8 Re-Randomization||4||
59552578|NCT01797575|75652303|FG003|COMPLETED|Week 8 Re-Randomization||7||
59706902|NCT00996892|75825880|FG019|NOT COMPLETED|Dose-Escalation Stage 1B||0||
59706903|NCT00996892|75825861|FG000|STARTED|Expansion Stage 2||0||
59706904|NCT00996892|75825862|FG001|STARTED|Expansion Stage 2||0||
59706905|NCT00996892|75825863|FG002|STARTED|Expansion Stage 2||0||
59706906|NCT00996892|75825864|FG003|STARTED|Expansion Stage 2||0||
59991448|NCT02224690|76107012|FG001|Intent to Treat (ITT) Analysis Set|Overall Study||85|Received at least 1 dose of IMP with at least 1 post-baseline efficacy endpoint measurement.|
59991449|NCT02224690|76107011|FG000|COMPLETED|Overall Study||72||
59991450|NCT02224690|76107012|FG001|COMPLETED|Overall Study||84||
59991451|NCT02224690|76107011|FG000|NOT COMPLETED|Overall Study||14||
59991452|NCT02224690|76107012|FG001|NOT COMPLETED|Overall Study||1||
59991453|NCT01634152|76107021|FG000|STARTED|Overall Study||134||
59991454|NCT01634152|76107022|FG001|STARTED|Overall Study||137||
59991455|NCT01634152|76107023|FG002|STARTED|Overall Study||130||
59991456|NCT01634152|76107021|FG000|COMPLETED|Overall Study||130||
59991457|NCT01634152|76107022|FG001|COMPLETED|Overall Study||136||
59991458|NCT01634152|76107023|FG002|COMPLETED|Overall Study||126||
59991459|NCT01634152|76107021|FG000|NOT COMPLETED|Overall Study||4||
59991460|NCT01634152|76107022|FG001|NOT COMPLETED|Overall Study||1||
59991461|NCT01634152|76107023|FG002|NOT COMPLETED|Overall Study||4||
59991462|NCT03862807|76107031|FG000|STARTED|Overall Study||24||
59991463|NCT03862807|76107031|FG000|Treated|Overall Study||23||
59991464|NCT03862807|76107031|FG000|Completed Treatment|Overall Study||22||
59991465|NCT03862807|76107031|FG000|COMPLETED|Overall Study||23||
59991466|NCT03862807|76107031|FG000|NOT COMPLETED|Overall Study||1||
59991467|NCT05181657|76107037|FG000|STARTED|Overall Study||75||5
59991468|NCT05181657|76107038|FG001|STARTED|Overall Study||75||7
59991469|NCT05181657|76107037|FG000|Enrollment at the End of Week 1|Overall Study||0||0
59991470|NCT05181657|76107038|FG001|Enrollment at the End of Week 1|Overall Study||7||1
59991471|NCT05181657|76107037|FG000|Enrollment at the End of Week 2|Overall Study||4||1
59991472|NCT05181657|76107038|FG001|Enrollment at the End of Week 2|Overall Study||7||1
59991473|NCT05181657|76107037|FG000|Enrollment at the End of Week 3|Overall Study||4||1
59991474|NCT05181657|76107038|FG001|Enrollment at the End of Week 3|Overall Study||11||2
59991475|NCT05181657|76107037|FG000|Enrollment at the End of Week 4|Overall Study||22||2
59991476|NCT05181657|76107038|FG001|Enrollment at the End of Week 4|Overall Study||11||2
59995123|NCT04925271|76110946|FG001|COMPLETED|Overall Study||20||
59995124|NCT04925271|76110945|FG000|NOT COMPLETED|Overall Study||0||
59995125|NCT04925271|76110946|FG001|NOT COMPLETED|Overall Study||0||
59995126|NCT02649231|76110956|FG000|STARTED|Overall Study||24||
59995127|NCT02649231|76110957|FG001|STARTED|Overall Study||24||
59995128|NCT02649231|76110958|FG002|STARTED|Overall Study||23||
59995129|NCT02649231|76110959|FG003|STARTED|Overall Study||25||
59995130|NCT02649231|76110956|FG000|COMPLETED|Overall Study||20||
59995131|NCT02649231|76110957|FG001|COMPLETED|Overall Study||21||
59995132|NCT02649231|76110958|FG002|COMPLETED|Overall Study||21||
59995133|NCT02649231|76110959|FG003|COMPLETED|Overall Study||23||
59995134|NCT02649231|76110956|FG000|NOT COMPLETED|Overall Study||4||
59995135|NCT02649231|76110957|FG001|NOT COMPLETED|Overall Study||3||
59995136|NCT02649231|76110958|FG002|NOT COMPLETED|Overall Study||2||
59995137|NCT02649231|76110959|FG003|NOT COMPLETED|Overall Study||2||
59995138|NCT01376245|76110973|FG000|STARTED|2-wk Single-blind Placebo Run-in Period||744||
59995139|NCT01376245|76110974|FG001|STARTED|2-wk Single-blind Placebo Run-in Period||0||
59995140|NCT01376245|76110975|FG002|STARTED|2-wk Single-blind Placebo Run-in Period||0||
59995141|NCT01376245|76110976|FG003|STARTED|2-wk Single-blind Placebo Run-in Period||0||
59995142|NCT01376245|76110977|FG004|STARTED|2-wk Single-blind Placebo Run-in Period||0||
59995143|NCT01376245|76110973|FG000|COMPLETED|2-wk Single-blind Placebo Run-in Period||643||
59995144|NCT01376245|76110974|FG001|COMPLETED|2-wk Single-blind Placebo Run-in Period||0||
59995145|NCT01376245|76110975|FG002|COMPLETED|2-wk Single-blind Placebo Run-in Period||0||
59995146|NCT01376245|76110976|FG003|COMPLETED|2-wk Single-blind Placebo Run-in Period||0||
59995147|NCT01376245|76110977|FG004|COMPLETED|2-wk Single-blind Placebo Run-in Period||0||
59995148|NCT01376245|76110973|FG000|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||101||
59995149|NCT01376245|76110974|FG001|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||0||
59995150|NCT01376245|76110975|FG002|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||0||
59995151|NCT01376245|76110976|FG003|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||0||
59995152|NCT01376245|76110977|FG004|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||0||
59995153|NCT01376245|76110973|FG000|STARTED|24-week, Double-blind Treatment Period||0||
59995154|NCT01376245|76110974|FG001|STARTED|24-week, Double-blind Treatment Period||162||
59995155|NCT01376245|76110975|FG002|STARTED|24-week, Double-blind Treatment Period||160||
59552579|NCT01797575|75652300|FG000|NOT COMPLETED|Week 8 Re-Randomization||0||
59552580|NCT01797575|75652301|FG001|NOT COMPLETED|Week 8 Re-Randomization||0||
59552581|NCT01797575|75652302|FG002|NOT COMPLETED|Week 8 Re-Randomization||1||
59552582|NCT01797575|75652303|FG003|NOT COMPLETED|Week 8 Re-Randomization||3||
59552583|NCT02641353|75652317|FG000|STARTED|Overall Study||5||
59552584|NCT02641353|75652318|FG001|STARTED|Overall Study||5||
59552585|NCT02641353|75652319|FG002|STARTED|Overall Study||6||
59552586|NCT02641353|75652320|FG003|STARTED|Overall Study||6||
59552587|NCT02641353|75652321|FG004|STARTED|Overall Study||6||
59552588|NCT02641353|75652322|FG005|STARTED|Overall Study||6||
59552589|NCT02641353|75652317|FG000|COMPLETED|Overall Study||5||
59552590|NCT02641353|75652318|FG001|COMPLETED|Overall Study||5||
59552591|NCT02641353|75652319|FG002|COMPLETED|Overall Study||6||
59552592|NCT02641353|75652320|FG003|COMPLETED|Overall Study||6||
59552593|NCT02641353|75652321|FG004|COMPLETED|Overall Study||6||
59552594|NCT02641353|75652322|FG005|COMPLETED|Overall Study||6||
59552595|NCT02641353|75652317|FG000|NOT COMPLETED|Overall Study||0||
59552596|NCT02641353|75652318|FG001|NOT COMPLETED|Overall Study||0||
59552597|NCT02641353|75652319|FG002|NOT COMPLETED|Overall Study||0||
59552598|NCT02641353|75652320|FG003|NOT COMPLETED|Overall Study||0||
59552599|NCT02641353|75652321|FG004|NOT COMPLETED|Overall Study||0||
59552600|NCT02641353|75652322|FG005|NOT COMPLETED|Overall Study||0||
59552601|NCT01335542|75652335|FG000|STARTED|Overall Study||45||
59552602|NCT01335542|75652336|FG001|STARTED|Overall Study||45||
59552603|NCT01335542|75652335|FG000|COMPLETED|Overall Study||45||
59552604|NCT01335542|75652336|FG001|COMPLETED|Overall Study||45||
59552605|NCT01335542|75652335|FG000|NOT COMPLETED|Overall Study||0||
59552606|NCT01335542|75652336|FG001|NOT COMPLETED|Overall Study||0||
59552607|NCT01378520|75652342|FG000|STARTED|First Intervention (Day 2-3)||10||
59552608|NCT01378520|75652343|FG001|STARTED|First Intervention (Day 2-3)||10||
59552609|NCT01378520|75652342|FG000|COMPLETED|First Intervention (Day 2-3)||10||
59552610|NCT01378520|75652343|FG001|COMPLETED|First Intervention (Day 2-3)||10||
59552611|NCT01378520|75652342|FG000|NOT COMPLETED|First Intervention (Day 2-3)||0||
59552612|NCT01378520|75652343|FG001|NOT COMPLETED|First Intervention (Day 2-3)||0||
59552613|NCT01378520|75652342|FG000|STARTED|Second Intervention (Day 4-6)||10||
59552614|NCT01378520|75652343|FG001|STARTED|Second Intervention (Day 4-6)||10||
59552615|NCT01378520|75652342|FG000|COMPLETED|Second Intervention (Day 4-6)||10||
59552616|NCT01378520|75652343|FG001|COMPLETED|Second Intervention (Day 4-6)||10||
59552617|NCT01378520|75652342|FG000|NOT COMPLETED|Second Intervention (Day 4-6)||0||
59552618|NCT01378520|75652343|FG001|NOT COMPLETED|Second Intervention (Day 4-6)||0||
59552619|NCT01378988|75652351|FG000|STARTED|Overall Study||2||
59552620|NCT01378988|75652352|FG001|STARTED|Overall Study||3||
59552621|NCT01378988|75652351|FG000|COMPLETED|Overall Study||2||
59706907|NCT00996892|75825865|FG004|STARTED|Expansion Stage 2||0||
59706908|NCT00996892|75825866|FG005|STARTED|Expansion Stage 2||0||
59706909|NCT00996892|75825867|FG006|STARTED|Expansion Stage 2||0||
59706910|NCT00996892|75825868|FG007|STARTED|Expansion Stage 2||0||
59706911|NCT00996892|75825869|FG008|STARTED|Expansion Stage 2||0||
59991477|NCT05181657|76107037|FG000|Enrollment at the End of Week 5|Overall Study||22||2
59991478|NCT05181657|76107038|FG001|Enrollment at the End of Week 5|Overall Study||23||3
59991479|NCT05181657|76107037|FG000|Enrollment at the End of Week 6|Overall Study||39||3
59991480|NCT05181657|76107038|FG001|Enrollment at the End of Week 6|Overall Study||23||3
59991481|NCT05181657|76107037|FG000|Enrollment at the End of Week 7|Overall Study||39||3
59991482|NCT05181657|76107038|FG001|Enrollment at the End of Week 7|Overall Study||39||4
59991483|NCT05181657|76107037|FG000|Enrollment at the End of Week 8|Overall Study||50||4
59991484|NCT05181657|76107038|FG001|Enrollment at the End of Week 8|Overall Study||39||4
59991485|NCT05181657|76107037|FG000|Enrollment at the End of Week 9|Overall Study||50||4
59991486|NCT05181657|76107038|FG001|Enrollment at the End of Week 9|Overall Study||60||5
59991487|NCT05181657|76107037|FG000|Enrollment at the End of Week 10|Overall Study||75||5
59995470|NCT02155946|76111289|FG002|NOT COMPLETED|Overall Study||0||
59552622|NCT01378988|75652352|FG001|COMPLETED|Overall Study||3||
59552623|NCT01378988|75652351|FG000|NOT COMPLETED|Overall Study||0||
59552624|NCT01378988|75652352|FG001|NOT COMPLETED|Overall Study||0||
59552625|NCT01335620|75652358|FG000|STARTED|Overall Study||19||
59552626|NCT01335620|75652358|FG000|COMPLETED|Overall Study||19||
59552627|NCT01335620|75652358|FG000|NOT COMPLETED|Overall Study||0||
59552628|NCT01272830|75652364|FG000|STARTED|Overall Study||25||
59552629|NCT01272830|75652365|FG001|STARTED|Overall Study||26||
59552630|NCT01272830|75652364|FG000|COMPLETED|Overall Study||17||
59552631|NCT01272830|75652365|FG001|COMPLETED|Overall Study||21||
59552632|NCT01272830|75652364|FG000|NOT COMPLETED|Overall Study||8||
59552633|NCT01272830|75652365|FG001|NOT COMPLETED|Overall Study||5||
59552634|NCT01335932|75652373|FG000|STARTED|Overall Study||84||
59552635|NCT01335932|75652374|FG001|STARTED|Overall Study||76||
59706912|NCT00996892|75825870|FG009|STARTED|Expansion Stage 2||0||
59995471|NCT02155946|76111290|FG003|NOT COMPLETED|Overall Study||0||
59995472|NCT02152995|76111309|FG000|STARTED|Overall Study||25||
59995473|NCT02152995|76111310|FG001|STARTED|Overall Study||9||
59995474|NCT02152995|76111309|FG000|Participants Who Continued Treatment With Trametinib Only|Overall Study||5||
59995475|NCT02152995|76111310|FG001|Participants Who Continued Treatment With Trametinib Only|Overall Study||2||
59552636|NCT01335932|75652373|FG000|COMPLETED|Overall Study||84||
59552637|NCT01335932|75652374|FG001|COMPLETED|Overall Study||72||
59552638|NCT01335932|75652373|FG000|NOT COMPLETED|Overall Study||0||
59552639|NCT01335932|75652374|FG001|NOT COMPLETED|Overall Study||4||
59565878|NCT04392219|75668302|FG012|COMPLETED|Overall Study||6||
59565879|NCT04392219|75668303|FG013|COMPLETED|Overall Study||6||
59565880|NCT04392219|75668304|FG014|COMPLETED|Overall Study||6||
59565881|NCT04392219|75668305|FG015|COMPLETED|Overall Study||6||
59565882|NCT04392219|75668306|FG016|COMPLETED|Overall Study||6||
59565883|NCT04392219|75668307|FG017|COMPLETED|Overall Study||6||
59565884|NCT04392219|75668290|FG000|NOT COMPLETED|Overall Study||0||
59565885|NCT04392219|75668291|FG001|NOT COMPLETED|Overall Study||0||
59565886|NCT04392219|75668292|FG002|NOT COMPLETED|Overall Study||0||
59565887|NCT04392219|75668293|FG003|NOT COMPLETED|Overall Study||0||
59565888|NCT04392219|75668294|FG004|NOT COMPLETED|Overall Study||0||
59565889|NCT04392219|75668295|FG005|NOT COMPLETED|Overall Study||0||
59565890|NCT04392219|75668296|FG006|NOT COMPLETED|Overall Study||0||
59565891|NCT04392219|75668297|FG007|NOT COMPLETED|Overall Study||0||
59565892|NCT04392219|75668298|FG008|NOT COMPLETED|Overall Study||0||
59565893|NCT04392219|75668299|FG009|NOT COMPLETED|Overall Study||0||
59565894|NCT04392219|75668300|FG010|NOT COMPLETED|Overall Study||0||
59565895|NCT04392219|75668301|FG011|NOT COMPLETED|Overall Study||0||
59565896|NCT04392219|75668302|FG012|NOT COMPLETED|Overall Study||0||
59565897|NCT04392219|75668303|FG013|NOT COMPLETED|Overall Study||0||
59565898|NCT04392219|75668304|FG014|NOT COMPLETED|Overall Study||0||
59565899|NCT04392219|75668305|FG015|NOT COMPLETED|Overall Study||0||
59565900|NCT04392219|75668306|FG016|NOT COMPLETED|Overall Study||0||
59565901|NCT04392219|75668307|FG017|NOT COMPLETED|Overall Study||0||
59565902|NCT03649815|75668345|FG000|STARTED|Overall Study||38||
59565903|NCT03649815|75668345|FG000|COMPLETED|Overall Study||38||
59565904|NCT03649815|75668345|FG000|NOT COMPLETED|Overall Study||0||
59565905|NCT04365153|75668352|FG000|STARTED|Overall Study||15||
59565906|NCT04365153|75668353|FG001|STARTED|Overall Study||14||
59565907|NCT04365153|75668354|FG002|STARTED|Overall Study||16||
59565908|NCT04365153|75668352|FG000|COMPLETED|Overall Study||15||
59565909|NCT04365153|75668353|FG001|COMPLETED|Overall Study||14||
59565910|NCT04365153|75668354|FG002|COMPLETED|Overall Study||16||
59565911|NCT04365153|75668352|FG000|NOT COMPLETED|Overall Study||0||
59565912|NCT04365153|75668353|FG001|NOT COMPLETED|Overall Study||0||
59565913|NCT04365153|75668354|FG002|NOT COMPLETED|Overall Study||0||
59565914|NCT03654417|75668365|FG000|STARTED|Overall Study||19||
59565915|NCT03654417|75668366|FG001|STARTED|Overall Study||18||
59565916|NCT03654417|75668365|FG000|COMPLETED|Overall Study||19||
59565917|NCT03654417|75668366|FG001|COMPLETED|Overall Study||18||
59565918|NCT03654417|75668365|FG000|NOT COMPLETED|Overall Study||0||
59565919|NCT03654417|75668366|FG001|NOT COMPLETED|Overall Study||0||
59565920|NCT04358991|75668372|FG000|STARTED|Overall Study||20||
59565921|NCT04358991|75668372|FG000|COMPLETED|Overall Study||20||
59565922|NCT04358991|75668372|FG000|NOT COMPLETED|Overall Study||0||
59565923|NCT04338009|75668378|FG000|STARTED|Overall Study||77||
59565924|NCT04338009|75668379|FG001|STARTED|Overall Study||75||
59565925|NCT04338009|75668378|FG000|COMPLETED|Overall Study||77||
59565926|NCT04338009|75668379|FG001|COMPLETED|Overall Study||75||
59565927|NCT04338009|75668378|FG000|NOT COMPLETED|Overall Study||0||
59565928|NCT04338009|75668379|FG001|NOT COMPLETED|Overall Study||0||
59565929|NCT03403491|75668385|FG000|STARTED|Overall Study||20||
59565930|NCT03403491|75668386|FG001|STARTED|Overall Study||23||
59565931|NCT03403491|75668385|FG000|COMPLETED|Overall Study||17|Definition: at least 21 days of patient-reported weight data|
59565932|NCT03403491|75668386|FG001|COMPLETED|Overall Study||18|Definition: at least 21 days of patient-reported weight data|
59565933|NCT03403491|75668385|FG000|NOT COMPLETED|Overall Study||3||
59565934|NCT03403491|75668386|FG001|NOT COMPLETED|Overall Study||5||
59565935|NCT02303574|75668405|FG000|STARTED|Part 1a (Fasted State)- SAD||6||
59565936|NCT02303574|75668406|FG001|STARTED|Part 1a (Fasted State)- SAD||6||
59565937|NCT02303574|75668407|FG002|STARTED|Part 1a (Fasted State)- SAD||6||
59565938|NCT02303574|75668408|FG003|STARTED|Part 1a (Fasted State)- SAD||6||
59565939|NCT02303574|75668409|FG004|STARTED|Part 1a (Fasted State)- SAD||6||
59565940|NCT02303574|75668410|FG005|STARTED|Part 1a (Fasted State)- SAD||0||
59565941|NCT02303574|75668411|FG006|STARTED|Part 1a (Fasted State)- SAD||0||
59565942|NCT02303574|75668412|FG007|STARTED|Part 1a (Fasted State)- SAD||0||
59565943|NCT02303574|75668413|FG008|STARTED|Part 1a (Fasted State)- SAD||0||
59565944|NCT02303574|75668414|FG009|STARTED|Part 1a (Fasted State)- SAD|Participants received AZD7986 matching placebo on Day 1 in fasted state.|15||
59565945|NCT02303574|75668405|FG000|COMPLETED|Part 1a (Fasted State)- SAD||6||
59565946|NCT02303574|75668406|FG001|COMPLETED|Part 1a (Fasted State)- SAD||6||
59565947|NCT02303574|75668407|FG002|COMPLETED|Part 1a (Fasted State)- SAD||5||
59565948|NCT02303574|75668408|FG003|COMPLETED|Part 1a (Fasted State)- SAD||6||
59565949|NCT02303574|75668409|FG004|COMPLETED|Part 1a (Fasted State)- SAD||6||
59565950|NCT02303574|75668410|FG005|COMPLETED|Part 1a (Fasted State)- SAD||0||
59565951|NCT02303574|75668411|FG006|COMPLETED|Part 1a (Fasted State)- SAD||0||
59565952|NCT02303574|75668412|FG007|COMPLETED|Part 1a (Fasted State)- SAD||0||
59565953|NCT02303574|75668413|FG008|COMPLETED|Part 1a (Fasted State)- SAD||0||
59552640|NCT01273766|75652383|FG000|STARTED|Overall Study||4||
59552641|NCT01273766|75652384|FG001|STARTED|Overall Study||7||
59552642|NCT01273766|75652385|FG002|STARTED|Overall Study||5||
59552643|NCT01273766|75652383|FG000|COMPLETED|Overall Study||4||
59552644|NCT01273766|75652384|FG001|COMPLETED|Overall Study||7||
59552645|NCT01273766|75652385|FG002|COMPLETED|Overall Study||5||
59552646|NCT01273766|75652383|FG000|NOT COMPLETED|Overall Study||0||
59552647|NCT01273766|75652384|FG001|NOT COMPLETED|Overall Study||0||
59552648|NCT01273766|75652385|FG002|NOT COMPLETED|Overall Study||0||
59552649|NCT01379222|75652392|FG000|STARTED|Overall Study||178||
59552650|NCT01379222|75652392|FG000|COMPLETED|Overall Study||105||
59552651|NCT01379222|75652392|FG000|NOT COMPLETED|Overall Study||73||
59552652|NCT01379924|75652398|FG000|STARTED|Baseline||72||
59552653|NCT01379924|75652399|FG001|STARTED|Baseline||68||
59552654|NCT01379924|75652398|FG000|COMPLETED|Baseline||72||
59552655|NCT01379924|75652399|FG001|COMPLETED|Baseline||68||
59552656|NCT01379924|75652398|FG000|NOT COMPLETED|Baseline||0||
59552657|NCT01379924|75652399|FG001|NOT COMPLETED|Baseline||0||
59552658|NCT01379924|75652398|FG000|STARTED|12-month Assessment||72||
59552659|NCT01379924|75652399|FG001|STARTED|12-month Assessment||68||
59552660|NCT01379924|75652398|FG000|COMPLETED|12-month Assessment||62||
59552661|NCT01379924|75652399|FG001|COMPLETED|12-month Assessment||55||
59552662|NCT01379924|75652398|FG000|NOT COMPLETED|12-month Assessment||10||
59552663|NCT01379924|75652399|FG001|NOT COMPLETED|12-month Assessment||13||
59552664|NCT01379924|75652398|FG000|STARTED|24-month Assessment||62||
59552665|NCT01379924|75652399|FG001|STARTED|24-month Assessment||55||
59552666|NCT01379924|75652398|FG000|COMPLETED|24-month Assessment||55||
59552667|NCT01379924|75652399|FG001|COMPLETED|24-month Assessment||52||
59552668|NCT01379924|75652398|FG000|NOT COMPLETED|24-month Assessment||7||
59552669|NCT01379924|75652399|FG001|NOT COMPLETED|24-month Assessment||3||
59552670|NCT01379924|75652398|FG000|STARTED|36-month Assessment||55||
59552671|NCT01379924|75652399|FG001|STARTED|36-month Assessment||52||
59552672|NCT01379924|75652398|FG000|COMPLETED|36-month Assessment||52||
59552673|NCT01379924|75652399|FG001|COMPLETED|36-month Assessment||48||
59552674|NCT01379924|75652398|FG000|NOT COMPLETED|36-month Assessment||3||
59552675|NCT01379924|75652399|FG001|NOT COMPLETED|36-month Assessment||4||
59552676|NCT01275092|75652408|FG000|STARTED|Overall Study||164||
59552677|NCT01275092|75652408|FG000|COMPLETED|Overall Study||164||
59552678|NCT01275092|75652408|FG000|NOT COMPLETED|Overall Study||0||
59552679|NCT02642835|75652412|FG000|STARTED|Overall Study||48||
59552680|NCT02642835|75652412|FG000|COMPLETED|Overall Study||48||
59552681|NCT02642835|75652412|FG000|NOT COMPLETED|Overall Study||0||
59552682|NCT01403090|75652416|FG000|STARTED|Overall Study||8||
59552683|NCT01403090|75652416|FG000|COMPLETED|Overall Study||8||
59552684|NCT01403090|75652416|FG000|NOT COMPLETED|Overall Study||0||
59552685|NCT02642991|75652420|FG000|STARTED|First Intervention||22||
59552686|NCT02642991|75652421|FG001|STARTED|First Intervention||22||
59552687|NCT02642991|75652420|FG000|COMPLETED|First Intervention||22||
59552688|NCT02642991|75652421|FG001|COMPLETED|First Intervention||22||
59552689|NCT02642991|75652420|FG000|NOT COMPLETED|First Intervention||0||
59552690|NCT02642991|75652421|FG001|NOT COMPLETED|First Intervention||0||
59552691|NCT02642991|75652420|FG000|STARTED|Second Intervention||22||
59552692|NCT02642991|75652421|FG001|STARTED|Second Intervention||22||
59552693|NCT02642991|75652420|FG000|COMPLETED|Second Intervention||22||
59552694|NCT02642991|75652421|FG001|COMPLETED|Second Intervention||22||
59552695|NCT02642991|75652420|FG000|NOT COMPLETED|Second Intervention||0||
59552696|NCT02642991|75652421|FG001|NOT COMPLETED|Second Intervention||0||
59552697|NCT01403246|75652430|FG000|STARTED|Overall Study||9||
59552698|NCT01403246|75652430|FG000|COMPLETED|Overall Study||9||
59552699|NCT01403246|75652430|FG000|NOT COMPLETED|Overall Study||0||
59552700|NCT01734551|75652436|FG000|STARTED|Overall Study||15||
59552701|NCT01734551|75652437|FG001|STARTED|Overall Study||16||
59552702|NCT01734551|75652436|FG000|COMPLETED|Overall Study||15||
59552703|NCT01734551|75652437|FG001|COMPLETED|Overall Study||16||
59552704|NCT01734551|75652436|FG000|NOT COMPLETED|Overall Study||0||
59552705|NCT01734551|75652437|FG001|NOT COMPLETED|Overall Study||0||
59552706|NCT01276184|75652445|FG000|STARTED|Overall Study||13||
59552707|NCT01276184|75652446|FG001|STARTED|Overall Study||9||
59552708|NCT01276184|75652445|FG000|COMPLETED|Overall Study||13||
59552709|NCT01276184|75652446|FG001|COMPLETED|Overall Study||9||
59552710|NCT01276184|75652445|FG000|NOT COMPLETED|Overall Study||0||
59552711|NCT01276184|75652446|FG001|NOT COMPLETED|Overall Study||0||
59552712|NCT01815515|75652452|FG000|STARTED|Overall Study||17||
59552713|NCT01815515|75652452|FG000|COMPLETED|Overall Study||17||
59552714|NCT01815515|75652452|FG000|NOT COMPLETED|Overall Study||0||
59552715|NCT01404260|75652458|FG000|STARTED|Overall Study||109||
59552716|NCT01404260|75652459|FG001|STARTED|Overall Study||110||
59552717|NCT01404260|75652458|FG000|COMPLETED|Overall Study||106||
59552718|NCT01404260|75652459|FG001|COMPLETED|Overall Study||101||
59552719|NCT01404260|75652458|FG000|NOT COMPLETED|Overall Study||3||
59552720|NCT01404260|75652459|FG001|NOT COMPLETED|Overall Study||9||
59552721|NCT01735877|75652467|FG000|STARTED|Overall Study||27||
59552722|NCT01735877|75652468|FG001|STARTED|Overall Study||21||
59552723|NCT01735877|75652467|FG000|COMPLETED|Overall Study||26||
59552724|NCT01735877|75652468|FG001|COMPLETED|Overall Study||21||
59706913|NCT00996892|75825871|FG010|STARTED|Expansion Stage 2||0||
59706914|NCT00996892|75825872|FG011|STARTED|Expansion Stage 2||0||
59706915|NCT00996892|75825873|FG012|STARTED|Expansion Stage 2||0||
59706916|NCT00996892|75825874|FG013|STARTED|Expansion Stage 2||0||
60082840|NCT01728194|76198453|FG001|COMPLETED|Overall Study||61||
60082841|NCT01728194|76198452|FG000|NOT COMPLETED|Overall Study||20||
60082842|NCT01728194|76198453|FG001|NOT COMPLETED|Overall Study||6||
60082843|NCT01782482|76198461|FG000|STARTED|Overall Study||281||
60082844|NCT01782482|76198462|FG001|STARTED|Overall Study||280||
60082845|NCT01782482|76198461|FG000|COMPLETED|Overall Study||271||
60082846|NCT01782482|76198462|FG001|COMPLETED|Overall Study||270||
60082847|NCT01782482|76198461|FG000|NOT COMPLETED|Overall Study||10||
60082848|NCT01782482|76198462|FG001|NOT COMPLETED|Overall Study||10||
60082849|NCT01466673|76198470|FG000|STARTED|Overall Study||100||
60082850|NCT01466673|76198471|FG001|STARTED|Overall Study||101||
60082851|NCT01466673|76198470|FG000|COMPLETED|Overall Study||93||
60082852|NCT01466673|76198471|FG001|COMPLETED|Overall Study||95||
60082853|NCT01466673|76198470|FG000|NOT COMPLETED|Overall Study||7||
60082854|NCT01466673|76198471|FG001|NOT COMPLETED|Overall Study||6||
60082855|NCT01753856|76198479|FG000|STARTED|Overall Study||33||
60082856|NCT01753856|76198480|FG001|STARTED|Overall Study||36||
60082857|NCT01753856|76198479|FG000|Received at Least 1 Dose of Study Drug|Overall Study||33||
60082858|NCT01753856|76198480|FG001|Received at Least 1 Dose of Study Drug|Overall Study||36||
60082859|NCT01753856|76198479|FG000|Completed 3-Month Bone Biopsy|Overall Study||31||
60082860|NCT01753856|76198480|FG001|Completed 3-Month Bone Biopsy|Overall Study||35||
60082861|NCT01753856|76198479|FG000|COMPLETED|Overall Study||30||
59706917|NCT00996892|75825875|FG014|STARTED|Expansion Stage 2||0||
60082862|NCT01753856|76198480|FG001|COMPLETED|Overall Study||34||
60082863|NCT01753856|76198479|FG000|NOT COMPLETED|Overall Study||3||
60082864|NCT01753856|76198480|FG001|NOT COMPLETED|Overall Study||2||
60082865|NCT01464333|76198489|FG000|STARTED|Overall Study||389||
60082866|NCT01464333|76198489|FG000|COMPLETED|Overall Study||226||
60082867|NCT01464333|76198489|FG000|NOT COMPLETED|Overall Study||163||
60082868|NCT01464255|76198495|FG000|STARTED|Overall Study||25||
60082869|NCT01464255|76198496|FG001|STARTED|Overall Study||25||
59552725|NCT01735877|75652467|FG000|NOT COMPLETED|Overall Study||1||
59552726|NCT01735877|75652468|FG001|NOT COMPLETED|Overall Study||0||
59552727|NCT01404572|75652474|FG000|STARTED|Overall Study||4||
59552728|NCT01404572|75652475|FG001|STARTED|Overall Study||4||
59552729|NCT01404572|75652476|FG002|STARTED|Overall Study||4||
59552730|NCT01404572|75652474|FG000|COMPLETED|Overall Study||4||
59552731|NCT01404572|75652475|FG001|COMPLETED|Overall Study||4||
59552732|NCT01404572|75652476|FG002|COMPLETED|Overall Study||4||
59552733|NCT01404572|75652474|FG000|NOT COMPLETED|Overall Study||0||
59552734|NCT01404572|75652475|FG001|NOT COMPLETED|Overall Study||0||
59552735|NCT01404572|75652476|FG002|NOT COMPLETED|Overall Study||0||
59552736|NCT01799135|75652487|FG000|STARTED|Overall Study||6||
59552737|NCT01799135|75652487|FG000|COMPLETED|Overall Study||6||
59552738|NCT01799135|75652487|FG000|NOT COMPLETED|Overall Study||0||
59552739|NCT01381172|75652493|FG000|STARTED|Overall Study||74||
59552740|NCT01381172|75652494|FG001|STARTED|Overall Study||86||
59552741|NCT01381172|75652493|FG000|COMPLETED|Overall Study||64||
59552742|NCT01381172|75652494|FG001|COMPLETED|Overall Study||73||
59552743|NCT01381172|75652493|FG000|NOT COMPLETED|Overall Study||10||
59552744|NCT01381172|75652494|FG001|NOT COMPLETED|Overall Study||13||
59552745|NCT01736267|75652500|FG000|STARTED|Overall Study||3||
59552746|NCT01736267|75652500|FG000|COMPLETED|Overall Study||3||
59552747|NCT01736267|75652500|FG000|NOT COMPLETED|Overall Study||0||
59552748|NCT01381406|75652506|FG000|STARTED|Overall Study||2481||
59552749|NCT01381406|75652507|FG001|STARTED|Overall Study||852||
59552750|NCT01381406|75652506|FG000|COMPLETED|Overall Study||2481||
59552751|NCT01381406|75652507|FG001|COMPLETED|Overall Study||852||
59552752|NCT01381406|75652506|FG000|NOT COMPLETED|Overall Study||0||
59552753|NCT01381406|75652507|FG001|NOT COMPLETED|Overall Study||0||
59552754|NCT01799213|75652515|FG000|STARTED|Overall Study||180||
59552755|NCT01799213|75652516|FG001|STARTED|Overall Study||184||
59552756|NCT01799213|75652515|FG000|COMPLETED|Overall Study||173||
59552757|NCT01799213|75652516|FG001|COMPLETED|Overall Study||178||
59552758|NCT01799213|75652515|FG000|NOT COMPLETED|Overall Study||7||
59552759|NCT01799213|75652516|FG001|NOT COMPLETED|Overall Study||6||
59552760|NCT01381952|75652528|FG000|STARTED|Overall Study||20||
59552761|NCT01381952|75652528|FG000|Collected Dose and Image Information|Overall Study||20||
59552762|NCT01381952|75652528|FG000|COMPLETED|Overall Study||20||
59552763|NCT01381952|75652528|FG000|NOT COMPLETED|Overall Study||0||
59552764|NCT01815671|75652536|FG000|STARTED|Overall Study||88||
59552765|NCT01815671|75652537|FG001|STARTED|Overall Study||85||
59552766|NCT01815671|75652536|FG000|COMPLETED|Overall Study||88||
59552767|NCT01815671|75652537|FG001|COMPLETED|Overall Study||85||
59552768|NCT01815671|75652536|FG000|NOT COMPLETED|Overall Study||0||
59552769|NCT01815671|75652537|FG001|NOT COMPLETED|Overall Study||0||
59552770|NCT01382108|75652545|FG000|STARTED|Overall Study||20||
59552771|NCT01382108|75652546|FG001|STARTED|Overall Study||19||
59552772|NCT01382108|75652545|FG000|COMPLETED|Overall Study||20||
59552773|NCT01382108|75652546|FG001|COMPLETED|Overall Study||19||
59552774|NCT01382108|75652545|FG000|NOT COMPLETED|Overall Study||0||
59552775|NCT01382108|75652546|FG001|NOT COMPLETED|Overall Study||0||
59552776|NCT01816451|75652556|FG000|STARTED|Overall Study||13||
59552777|NCT01816451|75652557|FG001|STARTED|Overall Study||11||
59552778|NCT01816451|75652558|FG002|STARTED|Overall Study||8||
59552779|NCT01816451|75652556|FG000|COMPLETED|Overall Study||13||
59552780|NCT01816451|75652557|FG001|COMPLETED|Overall Study||11||
59552781|NCT01816451|75652558|FG002|COMPLETED|Overall Study||8||
60082870|NCT01464255|76198495|FG000|COMPLETED|Overall Study||25||
59552782|NCT01816451|75652556|FG000|NOT COMPLETED|Overall Study||0||
59552783|NCT01816451|75652557|FG001|NOT COMPLETED|Overall Study||0||
59552784|NCT01816451|75652558|FG002|NOT COMPLETED|Overall Study||0||
59552785|NCT01382186|75652570|FG000|STARTED|Overall Study||33||
59552786|NCT01382186|75652571|FG001|STARTED|Overall Study||819||
59552787|NCT01382186|75652570|FG000|COMPLETED|Overall Study||32||
59552788|NCT01382186|75652571|FG001|COMPLETED|Overall Study||819||
59552789|NCT01382186|75652570|FG000|NOT COMPLETED|Overall Study||1||
59552790|NCT01382186|75652571|FG001|NOT COMPLETED|Overall Study||0||
59552791|NCT02107443|75652582|FG000|STARTED|Overall Study||296||
59552792|NCT02107443|75652583|FG001|STARTED|Overall Study||250||
59552793|NCT02107443|75652582|FG000|COMPLETED|Overall Study||198||
59552794|NCT02107443|75652583|FG001|COMPLETED|Overall Study||167||
59552795|NCT02107443|75652582|FG000|NOT COMPLETED|Overall Study||98||
59552796|NCT02107443|75652583|FG001|NOT COMPLETED|Overall Study||83||
59552797|NCT01383200|75652592|FG000|STARTED|Overall Study||5||
59706918|NCT00996892|75825876|FG015|STARTED|Expansion Stage 2||0||
59706919|NCT00996892|75825877|FG016|STARTED|Expansion Stage 2||0||
59706920|NCT00996892|75825878|FG017|STARTED|Expansion Stage 2||0||
59706921|NCT00996892|75825879|FG018|STARTED|Expansion Stage 2||35||
59706922|NCT00996892|75825880|FG019|STARTED|Expansion Stage 2||0||
59706923|NCT00996892|75825861|FG000|COMPLETED|Expansion Stage 2||0||
59552798|NCT01383200|75652593|FG001|STARTED|Overall Study||6||
59552799|NCT01383200|75652592|FG000|COMPLETED|Overall Study||5||
59552800|NCT01383200|75652593|FG001|COMPLETED|Overall Study||6||
59552801|NCT01383200|75652592|FG000|NOT COMPLETED|Overall Study||0||
59552802|NCT01383200|75652593|FG001|NOT COMPLETED|Overall Study||0||
59706924|NCT00996892|75825862|FG001|COMPLETED|Expansion Stage 2||0||
60082871|NCT01464255|76198496|FG001|COMPLETED|Overall Study||24||
59552803|NCT01404650|75652599|FG000|STARTED|Overall Study|Twenty-five patients received a median of 2 cycles of AUY922.|25||
59552804|NCT01404650|75652599|FG000|COMPLETED|Overall Study||25||
59706925|NCT00996892|75825863|FG002|COMPLETED|Expansion Stage 2||0||
59706926|NCT00996892|75825864|FG003|COMPLETED|Expansion Stage 2||0||
59552805|NCT01404650|75652599|FG000|NOT COMPLETED|Overall Study||0||
59552806|NCT01276652|75652606|FG000|STARTED|Period 1: Randomization||9||
59552807|NCT01276652|75652607|FG001|STARTED|Period 1: Randomization||8||
59552808|NCT01276652|75652608|FG002|STARTED|Period 1: Randomization|No subjects were enrolled in this arm during Period 1.|0||
59552809|NCT01276652|75652606|FG000|COMPLETED|Period 1: Randomization||9||
59552810|NCT01276652|75652607|FG001|COMPLETED|Period 1: Randomization||8||
59552811|NCT01276652|75652608|FG002|COMPLETED|Period 1: Randomization||0||
59552812|NCT01276652|75652606|FG000|NOT COMPLETED|Period 1: Randomization||0||
59552813|NCT01276652|75652607|FG001|NOT COMPLETED|Period 1: Randomization||0||
59552814|NCT01276652|75652608|FG002|NOT COMPLETED|Period 1: Randomization||0||
59552815|NCT01276652|75652606|FG000|STARTED|Period 2: Observational||9||
59552816|NCT01276652|75652607|FG001|STARTED|Period 2: Observational||8||
59552817|NCT01276652|75652608|FG002|STARTED|Period 2: Observational|Subjects were only enrolled in the Observational arm during Period 2.|5||
59552818|NCT01276652|75652606|FG000|COMPLETED|Period 2: Observational||9||
59552819|NCT01276652|75652607|FG001|COMPLETED|Period 2: Observational||8||
59552820|NCT01276652|75652608|FG002|COMPLETED|Period 2: Observational||5||
59552821|NCT01276652|75652606|FG000|NOT COMPLETED|Period 2: Observational||0||
59552822|NCT01276652|75652607|FG001|NOT COMPLETED|Period 2: Observational||0||
59552823|NCT01276652|75652608|FG002|NOT COMPLETED|Period 2: Observational||0||
59552824|NCT02194088|75652623|FG000|STARTED|Overall Study||75||
59552825|NCT02194088|75652624|FG001|STARTED|Overall Study||25||
59552826|NCT02194088|75652623|FG000|COMPLETED|Overall Study||75||
59552827|NCT02194088|75652624|FG001|COMPLETED|Overall Study||25||
59552828|NCT02194088|75652623|FG000|NOT COMPLETED|Overall Study||0||
59552829|NCT02194088|75652624|FG001|NOT COMPLETED|Overall Study||0||
59552830|NCT01406444|75652635|FG000|STARTED|Overall Study||33||
59552831|NCT01406444|75652636|FG001|STARTED|Overall Study||33||
59552832|NCT01406444|75652637|FG002|STARTED|Overall Study||16||
59552833|NCT01406444|75652635|FG000|COMPLETED|Overall Study||23||
59552834|NCT01406444|75652636|FG001|COMPLETED|Overall Study||24||
59552835|NCT01406444|75652637|FG002|COMPLETED|Overall Study||14||
59552836|NCT01406444|75652635|FG000|NOT COMPLETED|Overall Study||10||
59552837|NCT01406444|75652636|FG001|NOT COMPLETED|Overall Study||9||
59552838|NCT01406444|75652637|FG002|NOT COMPLETED|Overall Study||2||
59552839|NCT01406990|75652645|FG000|STARTED|Overall Study||15||
59552840|NCT01406990|75652645|FG000|COMPLETED|Overall Study||15||
59552841|NCT01406990|75652645|FG000|NOT COMPLETED|Overall Study||0||
59552842|NCT01407068|75652649|FG000|STARTED|Overall Study||60||
59552843|NCT01407068|75652649|FG000|COMPLETED|Overall Study||60||
59552844|NCT01407068|75652649|FG000|NOT COMPLETED|Overall Study||0||
59552845|NCT01385306|75652655|FG000|STARTED|Overall Study||6||
59552846|NCT01385306|75652655|FG000|COMPLETED|Overall Study||6||
59552847|NCT01385306|75652655|FG000|NOT COMPLETED|Overall Study||0||
59552848|NCT02685267|75652661|FG000|STARTED|Overall Study||5||
59552849|NCT02685267|75652662|FG001|STARTED|Overall Study||4||
59552850|NCT02685267|75652661|FG000|COMPLETED|Overall Study||5||
59552851|NCT02685267|75652662|FG001|COMPLETED|Overall Study||4||
59552852|NCT02685267|75652661|FG000|NOT COMPLETED|Overall Study||0||
59552853|NCT02685267|75652662|FG001|NOT COMPLETED|Overall Study||0||
59552854|NCT01277354|75652670|FG000|STARTED|Overall Study||1||
59552855|NCT01277354|75652671|FG001|STARTED|Overall Study||1||
59552856|NCT01277354|75652670|FG000|COMPLETED|Overall Study||1||
59552857|NCT01277354|75652671|FG001|COMPLETED|Overall Study||1||
59552858|NCT01277354|75652670|FG000|NOT COMPLETED|Overall Study||0||
59552859|NCT01277354|75652671|FG001|NOT COMPLETED|Overall Study||0||
59552860|NCT01280552|75652679|FG000|STARTED|Overall Study||81||
59552861|NCT01280552|75652680|FG001|STARTED|Overall Study||43||
59552862|NCT01280552|75652679|FG000|COMPLETED|Overall Study|Survival is still being assessed|75||
59552863|NCT01280552|75652680|FG001|COMPLETED|Overall Study||42||
59552864|NCT01280552|75652679|FG000|NOT COMPLETED|Overall Study||6||
59552865|NCT01280552|75652680|FG001|NOT COMPLETED|Overall Study||1||
59552866|NCT02257541|75652694|FG000|STARTED|Overall Study||3||
59552867|NCT02257541|75652695|FG001|STARTED|Overall Study||8||
59552868|NCT02257541|75652696|FG002|STARTED|Overall Study||1||
59552869|NCT02257541|75652697|FG003|STARTED|Overall Study||3||
59552870|NCT02257541|75652698|FG004|STARTED|Overall Study||1||
59552871|NCT02257541|75652694|FG000|COMPLETED|Overall Study||3||
59552872|NCT02257541|75652695|FG001|COMPLETED|Overall Study||8||
59552873|NCT02257541|75652696|FG002|COMPLETED|Overall Study||1||
59552874|NCT02257541|75652697|FG003|COMPLETED|Overall Study||3||
59552875|NCT02257541|75652698|FG004|COMPLETED|Overall Study||1||
59552876|NCT02257541|75652694|FG000|NOT COMPLETED|Overall Study||0||
59552877|NCT02257541|75652695|FG001|NOT COMPLETED|Overall Study||0||
59552878|NCT02257541|75652696|FG002|NOT COMPLETED|Overall Study||0||
59552879|NCT02257541|75652697|FG003|NOT COMPLETED|Overall Study||0||
59552880|NCT02257541|75652698|FG004|NOT COMPLETED|Overall Study||0||
59552881|NCT01385696|75652709|FG000|STARTED|Overall Study||66||
59565954|NCT02303574|75668414|FG009|COMPLETED|Part 1a (Fasted State)- SAD||15||
60082872|NCT01464255|76198495|FG000|NOT COMPLETED|Overall Study||0||
60082873|NCT01464255|76198496|FG001|NOT COMPLETED|Overall Study||1||
60082874|NCT01464021|76198503|FG000|STARTED|Overall Study||26||
60082875|NCT01464021|76198503|FG000|COMPLETED|Overall Study||0||
60082876|NCT01464021|76198503|FG000|NOT COMPLETED|Overall Study||26||
60082877|NCT01753310|76198509|FG000|STARTED|Overall Study||89||
60082878|NCT01753310|76198510|FG001|STARTED|Overall Study||45||
60082879|NCT01753310|76198509|FG000|COMPLETED|Overall Study||57||
60082880|NCT01753310|76198510|FG001|COMPLETED|Overall Study||21||
60082881|NCT01753310|76198509|FG000|NOT COMPLETED|Overall Study||32||
60082882|NCT01753310|76198510|FG001|NOT COMPLETED|Overall Study||24||
60082883|NCT01463631|76198520|FG000|STARTED|Overall Study||3||
60082884|NCT01463631|76198521|FG001|STARTED|Overall Study||4||
60082885|NCT01463631|76198522|FG002|STARTED|Overall Study||5||
60082886|NCT01463631|76198523|FG003|STARTED|Overall Study||15||
60082887|NCT01463631|76198520|FG000|Received at Least One Dose of Study Drug|Overall Study||3||
60082888|NCT01463631|76198521|FG001|Received at Least One Dose of Study Drug|Overall Study||4||
60082889|NCT01463631|76198522|FG002|Received at Least One Dose of Study Drug|Overall Study||5||
60082890|NCT01463631|76198523|FG003|Received at Least One Dose of Study Drug|Overall Study||15||
60082891|NCT01463631|76198520|FG000|COMPLETED|Overall Study||3||
60082892|NCT01463631|76198521|FG001|COMPLETED|Overall Study||4||
59816465|NCT00517634|75938898|FG003|STARTED|First Treatment Period||3||
59816466|NCT00517634|75938899|FG004|STARTED|First Treatment Period||4||
59816467|NCT00517634|75938900|FG005|STARTED|First Treatment Period||4||
59816468|NCT00517634|75938895|FG000|COMPLETED|First Treatment Period||4||
59816469|NCT00517634|75938896|FG001|COMPLETED|First Treatment Period||4||
59816470|NCT00517634|75938897|FG002|COMPLETED|First Treatment Period||4||
59816471|NCT00517634|75938898|FG003|COMPLETED|First Treatment Period||3||
59816472|NCT00517634|75938899|FG004|COMPLETED|First Treatment Period||4||
59816473|NCT00517634|75938900|FG005|COMPLETED|First Treatment Period||4||
59816474|NCT00517634|75938895|FG000|NOT COMPLETED|First Treatment Period||0||
59816475|NCT00517634|75938896|FG001|NOT COMPLETED|First Treatment Period||0||
59816476|NCT00517634|75938897|FG002|NOT COMPLETED|First Treatment Period||0||
59816477|NCT00517634|75938898|FG003|NOT COMPLETED|First Treatment Period||0||
59816478|NCT00517634|75938899|FG004|NOT COMPLETED|First Treatment Period||0||
59816479|NCT00517634|75938900|FG005|NOT COMPLETED|First Treatment Period||0||
59816480|NCT00517634|75938895|FG000|STARTED|Second Treatment Period||4||
59816481|NCT00517634|75938896|FG001|STARTED|Second Treatment Period||4||
60082893|NCT01463631|76198522|FG002|COMPLETED|Overall Study||4||
60082894|NCT01463631|76198523|FG003|COMPLETED|Overall Study||9||
60082895|NCT01463631|76198520|FG000|NOT COMPLETED|Overall Study||0||
60082896|NCT01463631|76198521|FG001|NOT COMPLETED|Overall Study||0||
60082897|NCT01463631|76198522|FG002|NOT COMPLETED|Overall Study||1||
60082898|NCT01463631|76198523|FG003|NOT COMPLETED|Overall Study||6||
60082899|NCT01521507|76198537|FG000|STARTED|Stage 1: Randomized Design||101||
60082900|NCT01521507|76198538|FG001|STARTED|Stage 1: Randomized Design||99||
60082901|NCT01521507|76198537|FG000|Received Initial Treatment (Tx)|Stage 1: Randomized Design||99||
60082902|NCT01521507|76198538|FG001|Received Initial Treatment (Tx)|Stage 1: Randomized Design||98||
60082903|NCT01521507|76198537|FG000|COMPLETED|Stage 1: Randomized Design||98||
60082904|NCT01521507|76198538|FG001|COMPLETED|Stage 1: Randomized Design||94||
60082905|NCT01521507|76198537|FG000|NOT COMPLETED|Stage 1: Randomized Design||3||
60082906|NCT01521507|76198538|FG001|NOT COMPLETED|Stage 1: Randomized Design||5||
60082907|NCT01521507|76198537|FG000|STARTED|Stage 2: Observational Design||98||
60082908|NCT01521507|76198538|FG001|STARTED|Stage 2: Observational Design||94||
60082909|NCT01521507|76198537|FG000|Received Crossover LipiFlow Tx|Stage 2: Observational Design||0||
60082910|NCT01521507|76198538|FG001|Received Crossover LipiFlow Tx|Stage 2: Observational Design||93||
59552882|NCT01385696|75652710|FG001|STARTED|Overall Study|1 patient used Handihaler® once only, Genuair® zero times, & was excluded from the safety population|64||
60082911|NCT01521507|76198537|FG000|Received Only One LipiFlow Tx at 12 Mo|Stage 2: Observational Design||81||
60082912|NCT01521507|76198538|FG001|Received Only One LipiFlow Tx at 12 Mo|Stage 2: Observational Design||82||
60082913|NCT01521507|76198537|FG000|Received Other MGD Treatment at 12 Mo|Stage 2: Observational Design||11||
60082914|NCT01521507|76198538|FG001|Received Other MGD Treatment at 12 Mo|Stage 2: Observational Design||9||
60082915|NCT01521507|76198537|FG000|Received 2nd LipiFlow Tx at 12 Mo|Stage 2: Observational Design||2||
59816482|NCT00517634|75938897|FG002|STARTED|Second Treatment Period||4||
59816483|NCT00517634|75938898|FG003|STARTED|Second Treatment Period||3||
59816484|NCT00517634|75938899|FG004|STARTED|Second Treatment Period||4||
59816485|NCT00517634|75938900|FG005|STARTED|Second Treatment Period||4||
59816486|NCT00517634|75938895|FG000|COMPLETED|Second Treatment Period||4||
59816487|NCT00517634|75938896|FG001|COMPLETED|Second Treatment Period||4||
59816488|NCT00517634|75938897|FG002|COMPLETED|Second Treatment Period||4||
59816489|NCT00517634|75938898|FG003|COMPLETED|Second Treatment Period||3||
59816490|NCT00517634|75938899|FG004|COMPLETED|Second Treatment Period||3||
60082916|NCT01521507|76198538|FG001|Received 2nd LipiFlow Tx at 12 Mo|Stage 2: Observational Design||1||
60082917|NCT01521507|76198537|FG000|COMPLETED|Stage 2: Observational Design||94||
60082918|NCT01521507|76198538|FG001|COMPLETED|Stage 2: Observational Design||92||
60082919|NCT01521507|76198537|FG000|NOT COMPLETED|Stage 2: Observational Design||4||
59706927|NCT00996892|75825865|FG004|COMPLETED|Expansion Stage 2||0||
59706928|NCT00996892|75825866|FG005|COMPLETED|Expansion Stage 2||0||
59706929|NCT00996892|75825867|FG006|COMPLETED|Expansion Stage 2||0||
59552883|NCT01385696|75652709|FG000|COMPLETED|Overall Study||66||
59552884|NCT01385696|75652710|FG001|COMPLETED|Overall Study||64||
59552885|NCT01385696|75652709|FG000|NOT COMPLETED|Overall Study||0||
59552886|NCT01385696|75652710|FG001|NOT COMPLETED|Overall Study||0||
59552887|NCT01817855|75652721|FG000|STARTED|Overall Study||23||
59552888|NCT01817855|75652722|FG001|STARTED|Overall Study||8||
59552889|NCT01817855|75652723|FG002|STARTED|Overall Study||11||
59552890|NCT01817855|75652724|FG003|STARTED|Overall Study||5||
59552891|NCT01817855|75652721|FG000|COMPLETED|Overall Study||23||
59552892|NCT01817855|75652722|FG001|COMPLETED|Overall Study||6||
59552893|NCT01817855|75652723|FG002|COMPLETED|Overall Study||9||
59552894|NCT01817855|75652724|FG003|COMPLETED|Overall Study||5||
59552895|NCT01817855|75652721|FG000|NOT COMPLETED|Overall Study||0||
59706930|NCT00996892|75825868|FG007|COMPLETED|Expansion Stage 2||0||
59706931|NCT00996892|75825869|FG008|COMPLETED|Expansion Stage 2||0||
59706932|NCT00996892|75825870|FG009|COMPLETED|Expansion Stage 2||0||
59706933|NCT00996892|75825871|FG010|COMPLETED|Expansion Stage 2||0||
59552896|NCT01817855|75652722|FG001|NOT COMPLETED|Overall Study||2||
59552897|NCT01817855|75652723|FG002|NOT COMPLETED|Overall Study||2||
59552898|NCT01817855|75652724|FG003|NOT COMPLETED|Overall Study||0||
59552899|NCT01801241|75652742|FG000|STARTED|Overall Study||29||
59552900|NCT01801241|75652743|FG001|STARTED|Overall Study||27||
59552901|NCT01801241|75652742|FG000|COMPLETED|Overall Study||21||
59552902|NCT01801241|75652743|FG001|COMPLETED|Overall Study||25||
59552903|NCT01801241|75652742|FG000|NOT COMPLETED|Overall Study||8||
59552904|NCT01801241|75652743|FG001|NOT COMPLETED|Overall Study||2||
59552905|NCT02686437|75652751|FG000|STARTED|Overall Study||16||
59552906|NCT02686437|75652752|FG001|STARTED|Overall Study||20||
59552907|NCT02686437|75652751|FG000|COMPLETED|Overall Study||13||
59552908|NCT02686437|75652752|FG001|COMPLETED|Overall Study||12||
59552909|NCT02686437|75652751|FG000|NOT COMPLETED|Overall Study||3||
59552910|NCT02686437|75652752|FG001|NOT COMPLETED|Overall Study||8||
59552911|NCT02687139|75652758|FG000|STARTED|Overall Study||34||
59552912|NCT02687139|75652758|FG000|COMPLETED|Overall Study||34||
59552913|NCT02687139|75652758|FG000|NOT COMPLETED|Overall Study||0||
59552914|NCT01818245|75652764|FG000|STARTED|Intervention A||30||
59552915|NCT01818245|75652765|FG001|STARTED|Intervention A|Participants didn't participate in separate interventions and received 1 dose of LY2605541 on Day 1.|22||
59552916|NCT01818245|75652764|FG000|Received One Dose of Study Drug|Intervention A||30||
59552917|NCT01818245|75652765|FG001|Received One Dose of Study Drug|Intervention A||22||
59552918|NCT01818245|75652764|FG000|COMPLETED|Intervention A||30||
59552919|NCT01818245|75652765|FG001|COMPLETED|Intervention A||22||
59552920|NCT01818245|75652764|FG000|NOT COMPLETED|Intervention A||0||
59552921|NCT01818245|75652765|FG001|NOT COMPLETED|Intervention A||0||
59552922|NCT01818245|75652764|FG000|STARTED|Washout (16-28 Days)||30||
59552923|NCT01818245|75652765|FG001|STARTED|Washout (16-28 Days)||0||
59552924|NCT01818245|75652764|FG000|COMPLETED|Washout (16-28 Days)||30||
59552925|NCT01818245|75652765|FG001|COMPLETED|Washout (16-28 Days)||0||
59552926|NCT01818245|75652764|FG000|NOT COMPLETED|Washout (16-28 Days)||0||
59552927|NCT01818245|75652765|FG001|NOT COMPLETED|Washout (16-28 Days)||0||
59552928|NCT01818245|75652764|FG000|STARTED|Intervention B||30||
59552929|NCT01818245|75652765|FG001|STARTED|Intervention B||0||
59552930|NCT01818245|75652764|FG000|COMPLETED|Intervention B||30||
59552931|NCT01818245|75652765|FG001|COMPLETED|Intervention B||0||
59552932|NCT01818245|75652764|FG000|NOT COMPLETED|Intervention B||0||
59552933|NCT01818245|75652765|FG001|NOT COMPLETED|Intervention B||0||
59552934|NCT01818245|75652764|FG000|STARTED|Washout (16-28 Days)||30||
59552935|NCT01818245|75652765|FG001|STARTED|Washout (16-28 Days)||0||
59552936|NCT01818245|75652764|FG000|COMPLETED|Washout (16-28 Days)||30||
59552937|NCT01818245|75652765|FG001|COMPLETED|Washout (16-28 Days)||0||
59552938|NCT01818245|75652764|FG000|NOT COMPLETED|Washout (16-28 Days)||0||
59552939|NCT01818245|75652765|FG001|NOT COMPLETED|Washout (16-28 Days)||0||
59552940|NCT01818245|75652764|FG000|STARTED|Intervention C||30||
59552941|NCT01818245|75652765|FG001|STARTED|Intervention C||0||
59552942|NCT01818245|75652764|FG000|COMPLETED|Intervention C||30||
59552943|NCT01818245|75652765|FG001|COMPLETED|Intervention C||0||
59552944|NCT01818245|75652764|FG000|NOT COMPLETED|Intervention C||0||
59552945|NCT01818245|75652765|FG001|NOT COMPLETED|Intervention C||0||
59552946|NCT02687217|75652778|FG000|STARTED|Overall Study||30||
59552947|NCT02687217|75652779|FG001|STARTED|Overall Study||30||
59552948|NCT02687217|75652778|FG000|COMPLETED|Overall Study||30||
59552949|NCT02687217|75652779|FG001|COMPLETED|Overall Study||30||
59552950|NCT02687217|75652778|FG000|NOT COMPLETED|Overall Study||0||
59552951|NCT02687217|75652779|FG001|NOT COMPLETED|Overall Study||0||
59552952|NCT01386632|75652787|FG000|STARTED|Overall Study||25||
59552953|NCT01386632|75652788|FG001|STARTED|Overall Study||25||
59552954|NCT01386632|75652787|FG000|COMPLETED|Overall Study||20||
59552955|NCT01386632|75652788|FG001|COMPLETED|Overall Study||21||
59991488|NCT05181657|76107038|FG001|Enrollment at the End of Week 10|Overall Study||60||5
60082920|NCT01521507|76198538|FG001|NOT COMPLETED|Stage 2: Observational Design||2||
60082921|NCT01521117|76198551|FG000|STARTED|First Intervention (6 Weeks)||10||
60082922|NCT01521117|76198552|FG001|STARTED|First Intervention (6 Weeks)||11||
60082923|NCT01521117|76198551|FG000|COMPLETED|First Intervention (6 Weeks)||5||
60082924|NCT01521117|76198552|FG001|COMPLETED|First Intervention (6 Weeks)||8||
60082925|NCT01521117|76198551|FG000|NOT COMPLETED|First Intervention (6 Weeks)||5||
60082926|NCT01521117|76198552|FG001|NOT COMPLETED|First Intervention (6 Weeks)||3||
60082927|NCT01521117|76198551|FG000|STARTED|Washout (4 Weeks)||5||
60082928|NCT01521117|76198552|FG001|STARTED|Washout (4 Weeks)||8||
60082929|NCT01521117|76198551|FG000|COMPLETED|Washout (4 Weeks)||5||
60082930|NCT01521117|76198552|FG001|COMPLETED|Washout (4 Weeks)||8||
59552956|NCT01386632|75652787|FG000|NOT COMPLETED|Overall Study||5||
59552957|NCT01386632|75652788|FG001|NOT COMPLETED|Overall Study||4||
59552958|NCT02266277|75652800|FG000|STARTED|Overall Study||5000||
59552959|NCT02266277|75652801|FG001|STARTED|Overall Study||5000||
59706934|NCT00996892|75825872|FG011|COMPLETED|Expansion Stage 2||0||
59706935|NCT00996892|75825873|FG012|COMPLETED|Expansion Stage 2||0||
59706936|NCT00996892|75825874|FG013|COMPLETED|Expansion Stage 2||0||
59706937|NCT00996892|75825875|FG014|COMPLETED|Expansion Stage 2||0||
59706938|NCT00996892|75825876|FG015|COMPLETED|Expansion Stage 2||0||
59706939|NCT00996892|75825877|FG016|COMPLETED|Expansion Stage 2||0||
59706940|NCT00996892|75825878|FG017|COMPLETED|Expansion Stage 2||0||
59816491|NCT00517634|75938900|FG005|COMPLETED|Second Treatment Period||4||
59816492|NCT00517634|75938895|FG000|NOT COMPLETED|Second Treatment Period||0||
59991489|NCT05181657|76107037|FG000|Enrollment at the End of Week 11|Overall Study||75||5
59991490|NCT05181657|76107038|FG001|Enrollment at the End of Week 11|Overall Study||72||6
59991491|NCT05181657|76107037|FG000|Enrollment at the End of Week 12|Overall Study||75||5
59991492|NCT05181657|76107038|FG001|Enrollment at the End of Week 12|Overall Study||75||7
59991493|NCT05181657|76107037|FG000|COMPLETED|Overall Study||75||5
59991494|NCT05181657|76107038|FG001|COMPLETED|Overall Study||75||7
59991495|NCT05181657|76107037|FG000|NOT COMPLETED|Overall Study||0||0
60082931|NCT01521117|76198551|FG000|NOT COMPLETED|Washout (4 Weeks)||0||
60082932|NCT01521117|76198552|FG001|NOT COMPLETED|Washout (4 Weeks)||0||
60082933|NCT01521117|76198551|FG000|STARTED|Second Intervention (6 Weeks)||5||
60082934|NCT01521117|76198552|FG001|STARTED|Second Intervention (6 Weeks)||8||
59706941|NCT00996892|75825879|FG018|COMPLETED|Expansion Stage 2||0||
59706942|NCT00996892|75825880|FG019|COMPLETED|Expansion Stage 2||0||
59706943|NCT00996892|75825861|FG000|NOT COMPLETED|Expansion Stage 2||0||
59816493|NCT00517634|75938896|FG001|NOT COMPLETED|Second Treatment Period||0||
59991496|NCT05181657|76107038|FG001|NOT COMPLETED|Overall Study||0||0
59552960|NCT02266277|75652802|FG002|STARTED|Overall Study||5000||
59552961|NCT02266277|75652803|FG003|STARTED|Overall Study||5000||
59552962|NCT02266277|75652804|FG004|STARTED|Overall Study||5000||
59552963|NCT02266277|75652805|FG005|STARTED|Overall Study||5000||
59552964|NCT02266277|75652800|FG000|COMPLETED|Overall Study||5000||
59552965|NCT02266277|75652801|FG001|COMPLETED|Overall Study||5000||
59552966|NCT02266277|75652802|FG002|COMPLETED|Overall Study||5000||
59552967|NCT02266277|75652803|FG003|COMPLETED|Overall Study||5000||
59552968|NCT02266277|75652804|FG004|COMPLETED|Overall Study||5000||
59552969|NCT02266277|75652805|FG005|COMPLETED|Overall Study||5000||
59552970|NCT02266277|75652800|FG000|NOT COMPLETED|Overall Study||0||
59552971|NCT02266277|75652801|FG001|NOT COMPLETED|Overall Study||0||
59552972|NCT02266277|75652802|FG002|NOT COMPLETED|Overall Study||0||
59552973|NCT02266277|75652803|FG003|NOT COMPLETED|Overall Study||0||
59552974|NCT02266277|75652804|FG004|NOT COMPLETED|Overall Study||0||
59552975|NCT02266277|75652805|FG005|NOT COMPLETED|Overall Study||0||
59552976|NCT02687529|75652823|FG000|STARTED|Overall Study||34||
59552977|NCT02687529|75652824|FG001|STARTED|Overall Study||32||
59552978|NCT02687529|75652823|FG000|COMPLETED|Overall Study||34||
60082935|NCT01521117|76198551|FG000|COMPLETED|Second Intervention (6 Weeks)||5||
60082936|NCT01521117|76198552|FG001|COMPLETED|Second Intervention (6 Weeks)||5||
60082937|NCT01521117|76198551|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0||
60082938|NCT01521117|76198552|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||3||
60082939|NCT01466595|76198560|FG000|STARTED|Overall Study||49||
60082940|NCT01466595|76198561|FG001|STARTED|Overall Study||24||
60082941|NCT01466595|76198560|FG000|COMPLETED|Overall Study||49||
60082942|NCT01466595|76198561|FG001|COMPLETED|Overall Study||23||
60082943|NCT01466595|76198560|FG000|NOT COMPLETED|Overall Study||0||
60082944|NCT01466595|76198561|FG001|NOT COMPLETED|Overall Study||1||
60082945|NCT02073747|76198569|FG000|STARTED|Overall Study||15||
60082946|NCT02073747|76198570|FG001|STARTED|Overall Study||15||
60082947|NCT02073747|76198569|FG000|COMPLETED|Overall Study||14||
60082948|NCT02073747|76198570|FG001|COMPLETED|Overall Study||14||
60082949|NCT02073747|76198569|FG000|NOT COMPLETED|Overall Study||1||
60082950|NCT02073747|76198570|FG001|NOT COMPLETED|Overall Study||1||
60082951|NCT01728116|76198578|FG000|STARTED|Overall Study|EndoBarrier mITT Subjects|213||
60082952|NCT01728116|76198579|FG001|STARTED|Overall Study|Sham mITT subjects|107||
59552979|NCT02687529|75652824|FG001|COMPLETED|Overall Study||32||
59552980|NCT02687529|75652823|FG000|NOT COMPLETED|Overall Study||0||
59552981|NCT02687529|75652824|FG001|NOT COMPLETED|Overall Study||0||
59552982|NCT01387178|75652832|FG000|STARTED|Overall Study||11582||
59552983|NCT01387178|75652833|FG001|STARTED|Overall Study||10641||
59552984|NCT01387178|75652832|FG000|COMPLETED|Overall Study||11582||
59552985|NCT01387178|75652833|FG001|COMPLETED|Overall Study||10641||
59552986|NCT01387178|75652832|FG000|NOT COMPLETED|Overall Study||0||
59552987|NCT01387178|75652833|FG001|NOT COMPLETED|Overall Study||0||
59552988|NCT01819415|75652844|FG000|STARTED|Overall Study||10||
59552989|NCT01819415|75652845|FG001|STARTED|Overall Study||10||
60082953|NCT01728116|76198578|FG000|COMPLETED|Overall Study|Completed to Week 78|52||
60082954|NCT01728116|76198579|FG001|COMPLETED|Overall Study|Completed to Week 52|60||
60082955|NCT01728116|76198578|FG000|NOT COMPLETED|Overall Study||161||
60082956|NCT01728116|76198579|FG001|NOT COMPLETED|Overall Study||47||
60082957|NCT01465659|76198590|FG000|STARTED|Completed 1 Cycle of Treatment||7||
60082958|NCT01465659|76198591|FG001|STARTED|Completed 1 Cycle of Treatment||5||
60082959|NCT01465659|76198592|FG002|STARTED|Completed 1 Cycle of Treatment||6||
60082960|NCT01465659|76198593|FG003|STARTED|Completed 1 Cycle of Treatment||11||
60082961|NCT01465659|76198590|FG000|Completed 1 Cycle of Treatment|Completed 1 Cycle of Treatment||7||
59552990|NCT01819415|75652846|FG002|STARTED|Overall Study||10||
59552991|NCT01819415|75652847|FG003|STARTED|Overall Study||10||
59552992|NCT01819415|75652844|FG000|COMPLETED|Overall Study||7||
59552993|NCT01819415|75652845|FG001|COMPLETED|Overall Study||6||
59552994|NCT01819415|75652846|FG002|COMPLETED|Overall Study||9||
59552995|NCT01819415|75652847|FG003|COMPLETED|Overall Study||8||
59552996|NCT01819415|75652844|FG000|NOT COMPLETED|Overall Study||3||
59552997|NCT01819415|75652845|FG001|NOT COMPLETED|Overall Study||4||
59552998|NCT01819415|75652846|FG002|NOT COMPLETED|Overall Study||1||
59552999|NCT01819415|75652847|FG003|NOT COMPLETED|Overall Study||2||
59553000|NCT01819883|75652859|FG000|STARTED|Overall Study||20||
59553001|NCT01819883|75652860|FG001|STARTED|Overall Study||20||
59553002|NCT01819883|75652859|FG000|COMPLETED|Overall Study||16||
59553003|NCT01819883|75652860|FG001|COMPLETED|Overall Study||20||
59553004|NCT01819883|75652859|FG000|NOT COMPLETED|Overall Study||4||
59553005|NCT01819883|75652860|FG001|NOT COMPLETED|Overall Study||0||
59553006|NCT01822301|75652865|FG000|STARTED|Overall Study||5||
59553007|NCT01822301|75652865|FG000|COMPLETED|Overall Study||5||
59553008|NCT01822301|75652865|FG000|NOT COMPLETED|Overall Study||0||
59553009|NCT01389284|75652878|FG000|STARTED|Overall Study||120||
59553010|NCT01389284|75652879|FG001|STARTED|Overall Study||120||
59553011|NCT01389284|75652880|FG002|STARTED|Overall Study||60||
59553012|NCT01389284|75652878|FG000|COMPLETED|Overall Study||120||
59553013|NCT01389284|75652879|FG001|COMPLETED|Overall Study||120||
59553014|NCT01389284|75652880|FG002|COMPLETED|Overall Study||60||
59553015|NCT01389284|75652878|FG000|NOT COMPLETED|Overall Study||0||
59553016|NCT01389284|75652879|FG001|NOT COMPLETED|Overall Study||0||
59553017|NCT01389284|75652880|FG002|NOT COMPLETED|Overall Study||0||
59553018|NCT01408862|75652888|FG000|STARTED|Overall Study||20||
59553019|NCT01408862|75652888|FG000|COMPLETED|Overall Study||20||
59553020|NCT01408862|75652888|FG000|NOT COMPLETED|Overall Study||0||
59553021|NCT01409096|75652895|FG000|STARTED|Overall Study||40||
59553022|NCT01409096|75652896|FG001|STARTED|Overall Study||40||
59553023|NCT01409096|75652895|FG000|COMPLETED|Overall Study||38||
59553024|NCT01409096|75652896|FG001|COMPLETED|Overall Study||35||
59553025|NCT01409096|75652895|FG000|NOT COMPLETED|Overall Study||2||
59553026|NCT01409096|75652896|FG001|NOT COMPLETED|Overall Study||5||
59553027|NCT01410812|75652905|FG000|STARTED|Overall Study||75||
59706944|NCT00996892|75825862|FG001|NOT COMPLETED|Expansion Stage 2||0||
59706945|NCT00996892|75825863|FG002|NOT COMPLETED|Expansion Stage 2||0||
59553028|NCT01410812|75652906|FG001|STARTED|Overall Study||75||
59553029|NCT01410812|75652907|FG002|STARTED|Overall Study||76||
59553030|NCT01410812|75652905|FG000|COMPLETED|Overall Study||75||
59553031|NCT01410812|75652906|FG001|COMPLETED|Overall Study||75||
59553032|NCT01410812|75652907|FG002|COMPLETED|Overall Study||76||
59553033|NCT01410812|75652905|FG000|NOT COMPLETED|Overall Study||0||
59553034|NCT01410812|75652906|FG001|NOT COMPLETED|Overall Study||0||
59553035|NCT01410812|75652907|FG002|NOT COMPLETED|Overall Study||0||
59553036|NCT01390064|75652917|FG000|STARTED|Overall Study||3||
59553037|NCT01390064|75652918|FG001|STARTED|Overall Study||3||
59553038|NCT01390064|75652917|FG000|COMPLETED|Overall Study||3||
59553039|NCT01390064|75652918|FG001|COMPLETED|Overall Study||3||
59553040|NCT01390064|75652917|FG000|NOT COMPLETED|Overall Study||0||
59553041|NCT01390064|75652918|FG001|NOT COMPLETED|Overall Study||0||
59553042|NCT01280942|75652926|FG000|STARTED|Overall Study||10120||
59553043|NCT01280942|75652927|FG001|STARTED|Overall Study||9911||
59553044|NCT01280942|75652926|FG000|COMPLETED|Overall Study||10120||
59553045|NCT01280942|75652927|FG001|COMPLETED|Overall Study||9911||
59553046|NCT01280942|75652926|FG000|NOT COMPLETED|Overall Study||0||
59706946|NCT00996892|75825864|FG003|NOT COMPLETED|Expansion Stage 2||0||
59553047|NCT01280942|75652927|FG001|NOT COMPLETED|Overall Study||0||
59553048|NCT01472822|75652935|FG000|STARTED|Overall Study||30||
59553049|NCT01472822|75652936|FG001|STARTED|Overall Study||30||
59553050|NCT01472822|75652935|FG000|COMPLETED|Overall Study||28||
59553051|NCT01472822|75652936|FG001|COMPLETED|Overall Study||28||
59553052|NCT01472822|75652935|FG000|NOT COMPLETED|Overall Study||2||
59553053|NCT01472822|75652936|FG001|NOT COMPLETED|Overall Study||2||
59553054|NCT01411592|75652944|FG000|STARTED|Overall Study||14||
59553055|NCT01411592|75652945|FG001|STARTED|Overall Study||16||
59553056|NCT01411592|75652944|FG000|5-Year Time Frame|Overall Study||14||
59553057|NCT01411592|75652945|FG001|5-Year Time Frame|Overall Study||16||
59553058|NCT01411592|75652944|FG000|COMPLETED|Overall Study||14||
59553059|NCT01411592|75652945|FG001|COMPLETED|Overall Study||16||
59553060|NCT01411592|75652944|FG000|NOT COMPLETED|Overall Study||0||
59553061|NCT01411592|75652945|FG001|NOT COMPLETED|Overall Study||0||
59553062|NCT01473368|75652955|FG000|STARTED|Overall Study||14||
59553063|NCT01473368|75652956|FG001|STARTED|Overall Study||12||
59553064|NCT01473368|75652957|FG002|STARTED|Overall Study||15||
59553065|NCT01473368|75652958|FG003|STARTED|Overall Study||12||
59553066|NCT01473368|75652955|FG000|COMPLETED|Overall Study||13||
59553067|NCT01473368|75652956|FG001|COMPLETED|Overall Study||12||
59553068|NCT01473368|75652957|FG002|COMPLETED|Overall Study||12||
59553069|NCT01473368|75652958|FG003|COMPLETED|Overall Study||12||
59553070|NCT01473368|75652955|FG000|NOT COMPLETED|Overall Study||1||
59553071|NCT01473368|75652956|FG001|NOT COMPLETED|Overall Study||0||
59553072|NCT01473368|75652957|FG002|NOT COMPLETED|Overall Study||3||
59553073|NCT01473368|75652958|FG003|NOT COMPLETED|Overall Study||0||
59553074|NCT01391312|75652986|FG000|STARTED|Overall Study||20||
59553075|NCT01391312|75652987|FG001|STARTED|Overall Study||20||
59553076|NCT01391312|75652986|FG000|COMPLETED|Overall Study||18||
59553077|NCT01391312|75652987|FG001|COMPLETED|Overall Study||19||
59553078|NCT01391312|75652986|FG000|NOT COMPLETED|Overall Study||2||
59553079|NCT01391312|75652987|FG001|NOT COMPLETED|Overall Study||1||
59553080|NCT01391468|75652995|FG000|STARTED|Overall Study||24||
59553081|NCT01391468|75652996|FG001|STARTED|Overall Study||23||
59553082|NCT01391468|75652995|FG000|COMPLETED|Overall Study||18||
59553083|NCT01391468|75652996|FG001|COMPLETED|Overall Study||21||
59553084|NCT01391468|75652995|FG000|NOT COMPLETED|Overall Study||6||
59553085|NCT01391468|75652996|FG001|NOT COMPLETED|Overall Study||2||
59553086|NCT01822457|75653009|FG000|STARTED|Overall Study||20||
59553087|NCT01822457|75653010|FG001|STARTED|Overall Study||17||
59553088|NCT01822457|75653009|FG000|COMPLETED|Overall Study||16||
59991497|NCT04906499|76107044|FG000|STARTED|Overall Study||7||
59991498|NCT04906499|76107044|FG000|COMPLETED|Overall Study||6||
59991499|NCT04906499|76107044|FG000|NOT COMPLETED|Overall Study||1||
59991500|NCT04757649|76107048|FG000|STARTED|Overall Study||9||
60082962|NCT01465659|76198591|FG001|Completed 1 Cycle of Treatment|Completed 1 Cycle of Treatment||4||
60082963|NCT01465659|76198592|FG002|Completed 1 Cycle of Treatment|Completed 1 Cycle of Treatment||6||
60082964|NCT01465659|76198593|FG003|Completed 1 Cycle of Treatment|Completed 1 Cycle of Treatment||11||
60082965|NCT01465659|76198590|FG000|COMPLETED|Completed 1 Cycle of Treatment||7||
60082966|NCT01465659|76198591|FG001|COMPLETED|Completed 1 Cycle of Treatment||4||
60082967|NCT01465659|76198592|FG002|COMPLETED|Completed 1 Cycle of Treatment||6||
60082968|NCT01465659|76198593|FG003|COMPLETED|Completed 1 Cycle of Treatment||10||
60082969|NCT01465659|76198590|FG000|NOT COMPLETED|Completed 1 Cycle of Treatment||0||
60082970|NCT01465659|76198591|FG001|NOT COMPLETED|Completed 1 Cycle of Treatment||1||
60082971|NCT01465659|76198592|FG002|NOT COMPLETED|Completed 1 Cycle of Treatment||0||
60082972|NCT01465659|76198593|FG003|NOT COMPLETED|Completed 1 Cycle of Treatment||1||
60082973|NCT01465659|76198590|FG000|STARTED|Completed 2 Cycles/Reached 1st Response||7||
59553089|NCT01822457|75653010|FG001|COMPLETED|Overall Study||12||
59553090|NCT01822457|75653009|FG000|NOT COMPLETED|Overall Study||4||
59553091|NCT01822457|75653010|FG001|NOT COMPLETED|Overall Study||5||
59553092|NCT01391858|75653018|FG000|STARTED|Overall Study||25||
59553093|NCT01391858|75653019|FG001|STARTED|Overall Study||24||
59553094|NCT01391858|75653018|FG000|COMPLETED|Overall Study||23||
59991501|NCT04757649|76107048|FG000|COMPLETED|Overall Study||7||
59991502|NCT04757649|76107048|FG000|NOT COMPLETED|Overall Study||2||
59991503|NCT04393779|76107052|FG000|STARTED|Overall Study||26||
59991504|NCT04393779|76107052|FG000|COMPLETED|Overall Study||21||
59991505|NCT04393779|76107052|FG000|NOT COMPLETED|Overall Study||5||
59991506|NCT03718884|76107056|FG000|STARTED|Period 1 (6 Days)||29||
59991507|NCT03718884|76107057|FG001|STARTED|Period 1 (6 Days)|Participants were assigned to this arm only during Period 2.|0||
59553095|NCT01391858|75653019|FG001|COMPLETED|Overall Study||24||
59553096|NCT01391858|75653018|FG000|NOT COMPLETED|Overall Study||2||
59553097|NCT01391858|75653019|FG001|NOT COMPLETED|Overall Study||0||
59553098|NCT02201420|75653025|FG000|STARTED|Overall Study||5||
59991508|NCT03718884|76107056|FG000|Received at Least One Dose of Study Drug|Period 1 (6 Days)||29||
59553099|NCT02201420|75653025|FG000|COMPLETED|Overall Study||5||
59553100|NCT02201420|75653025|FG000|NOT COMPLETED|Overall Study||0||
60082974|NCT01465659|76198591|FG001|STARTED|Completed 2 Cycles/Reached 1st Response||4||
60082975|NCT01465659|76198592|FG002|STARTED|Completed 2 Cycles/Reached 1st Response||6||
60082976|NCT01465659|76198593|FG003|STARTED|Completed 2 Cycles/Reached 1st Response||10||
60103660|NCT01347034|76221909|FG000|STARTED|Overall Study||6||
59553101|NCT02690181|75653035|FG000|STARTED|Overall Study||14||
59553102|NCT02690181|75653036|FG001|STARTED|Overall Study||14||
59553103|NCT02690181|75653037|FG002|STARTED|Overall Study||15||
59553104|NCT02690181|75653038|FG003|STARTED|Overall Study||10||
59553105|NCT02690181|75653039|FG004|STARTED|Overall Study||6||
59991509|NCT03718884|76107057|FG001|Received at Least One Dose of Study Drug|Period 1 (6 Days)||0||
59553106|NCT02690181|75653040|FG005|STARTED|Overall Study||21||
59553107|NCT02690181|75653035|FG000|COMPLETED|Overall Study||14||
59553108|NCT02690181|75653036|FG001|COMPLETED|Overall Study||14||
59553109|NCT02690181|75653037|FG002|COMPLETED|Overall Study||15||
59553110|NCT02690181|75653038|FG003|COMPLETED|Overall Study||10||
59553111|NCT02690181|75653039|FG004|COMPLETED|Overall Study||6||
59553112|NCT02690181|75653040|FG005|COMPLETED|Overall Study||21||
59553113|NCT02690181|75653035|FG000|NOT COMPLETED|Overall Study||0||
59553114|NCT02690181|75653036|FG001|NOT COMPLETED|Overall Study||0||
60082977|NCT01465659|76198590|FG000|Attempted 2 Cycles of Treatment|Completed 2 Cycles/Reached 1st Response||7||
60082978|NCT01465659|76198591|FG001|Attempted 2 Cycles of Treatment|Completed 2 Cycles/Reached 1st Response||4||
60082979|NCT01465659|76198592|FG002|Attempted 2 Cycles of Treatment|Completed 2 Cycles/Reached 1st Response||6||
60082980|NCT01465659|76198593|FG003|Attempted 2 Cycles of Treatment|Completed 2 Cycles/Reached 1st Response||10||
60082981|NCT01465659|76198590|FG000|Reached 1st Response|Completed 2 Cycles/Reached 1st Response||7||
60082982|NCT01465659|76198591|FG001|Reached 1st Response|Completed 2 Cycles/Reached 1st Response||4||
60082983|NCT01465659|76198592|FG002|Reached 1st Response|Completed 2 Cycles/Reached 1st Response||6||
60082984|NCT01465659|76198593|FG003|Reached 1st Response|Completed 2 Cycles/Reached 1st Response||10||
60082985|NCT01465659|76198590|FG000|Assessed to Move on to Next Cycle|Completed 2 Cycles/Reached 1st Response||7||
60082986|NCT01465659|76198591|FG001|Assessed to Move on to Next Cycle|Completed 2 Cycles/Reached 1st Response||4||
60082987|NCT01465659|76198592|FG002|Assessed to Move on to Next Cycle|Completed 2 Cycles/Reached 1st Response||4||
60082988|NCT01465659|76198593|FG003|Assessed to Move on to Next Cycle|Completed 2 Cycles/Reached 1st Response||10||
59553115|NCT02690181|75653037|FG002|NOT COMPLETED|Overall Study||0||
59553116|NCT02690181|75653038|FG003|NOT COMPLETED|Overall Study||0||
59553117|NCT02690181|75653039|FG004|NOT COMPLETED|Overall Study||0||
60082989|NCT01465659|76198590|FG000|COMPLETED|Completed 2 Cycles/Reached 1st Response||5||
60082990|NCT01465659|76198591|FG001|COMPLETED|Completed 2 Cycles/Reached 1st Response||4||
60082991|NCT01465659|76198592|FG002|COMPLETED|Completed 2 Cycles/Reached 1st Response||4||
60082992|NCT01465659|76198593|FG003|COMPLETED|Completed 2 Cycles/Reached 1st Response||9||
60082993|NCT01465659|76198590|FG000|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||2||
59553118|NCT02690181|75653040|FG005|NOT COMPLETED|Overall Study||0||
59553119|NCT01823861|75653056|FG000|STARTED|4 Month Follow up||249||
59553120|NCT01823861|75653057|FG001|STARTED|4 Month Follow up||251||
60082994|NCT01465659|76198591|FG001|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0||
60082995|NCT01465659|76198592|FG002|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||2||
60082996|NCT01465659|76198593|FG003|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||1||
60082997|NCT01465659|76198590|FG000|STARTED|Went on to Cycle 3 and Beyond||5||
60082998|NCT01465659|76198591|FG001|STARTED|Went on to Cycle 3 and Beyond||4||
60082999|NCT01465659|76198592|FG002|STARTED|Went on to Cycle 3 and Beyond||4||
60083000|NCT01465659|76198593|FG003|STARTED|Went on to Cycle 3 and Beyond||9||
59553121|NCT01823861|75653056|FG000|COMPLETED|4 Month Follow up||211||
59553122|NCT01823861|75653057|FG001|COMPLETED|4 Month Follow up||220||
59553123|NCT01823861|75653056|FG000|NOT COMPLETED|4 Month Follow up||38||
59553124|NCT01823861|75653057|FG001|NOT COMPLETED|4 Month Follow up||31||
59553125|NCT01823861|75653056|FG000|STARTED|12 Month Follow up||211||
59553126|NCT01823861|75653057|FG001|STARTED|12 Month Follow up||220||
59553127|NCT01823861|75653056|FG000|COMPLETED|12 Month Follow up||169||
59553128|NCT01823861|75653057|FG001|COMPLETED|12 Month Follow up||159||
59553129|NCT01823861|75653056|FG000|NOT COMPLETED|12 Month Follow up||42||
59553130|NCT01823861|75653057|FG001|NOT COMPLETED|12 Month Follow up||61||
59553131|NCT02273063|75653063|FG000|STARTED|Overall Study||40||
59553132|NCT02273063|75653063|FG000|COMPLETED|Overall Study||35||
59553133|NCT02273063|75653063|FG000|NOT COMPLETED|Overall Study||5||
59553134|NCT01825655|75653070|FG000|STARTED|Overall Study||0||
59553135|NCT01825655|75653071|FG001|STARTED|Overall Study||2||
59553136|NCT01825655|75653070|FG000|COMPLETED|Overall Study||0||
59553137|NCT01825655|75653071|FG001|COMPLETED|Overall Study||2||
59553138|NCT01825655|75653070|FG000|NOT COMPLETED|Overall Study||0||
59553139|NCT01825655|75653071|FG001|NOT COMPLETED|Overall Study||0||
59553140|NCT02692209|75653077|FG000|STARTED|Overall Study||298||
59553141|NCT02692209|75653077|FG000|COMPLETED|Overall Study||298||
59553142|NCT02692209|75653077|FG000|NOT COMPLETED|Overall Study||0||
59553143|NCT01825889|75653085|FG000|STARTED|Overall Study||10||
59553144|NCT01825889|75653086|FG001|STARTED|Overall Study||10||
59553145|NCT01825889|75653085|FG000|Received One Dose of Study Drug|Overall Study||10||
59553146|NCT01825889|75653086|FG001|Received One Dose of Study Drug|Overall Study||10||
59553147|NCT01825889|75653085|FG000|COMPLETED|Overall Study||10||
59553148|NCT01825889|75653086|FG001|COMPLETED|Overall Study||10||
59553149|NCT01825889|75653085|FG000|NOT COMPLETED|Overall Study||0||
59553150|NCT01825889|75653086|FG001|NOT COMPLETED|Overall Study||0||
59553151|NCT02202746|75653094|FG000|STARTED|Overall Study||109||
59553152|NCT02202746|75653095|FG001|STARTED|Overall Study||69||
59553153|NCT02202746|75653094|FG000|COMPLETED|Overall Study||109||
59553154|NCT02202746|75653095|FG001|COMPLETED|Overall Study||69||
59553155|NCT02202746|75653094|FG000|NOT COMPLETED|Overall Study||0||
59553156|NCT02202746|75653095|FG001|NOT COMPLETED|Overall Study||0||
60083001|NCT01465659|76198590|FG000|COMPLETED|Went on to Cycle 3 and Beyond||5||
60083002|NCT01465659|76198591|FG001|COMPLETED|Went on to Cycle 3 and Beyond||4||
60083003|NCT01465659|76198592|FG002|COMPLETED|Went on to Cycle 3 and Beyond||4||
60083004|NCT01465659|76198593|FG003|COMPLETED|Went on to Cycle 3 and Beyond||9||
60083005|NCT01465659|76198590|FG000|NOT COMPLETED|Went on to Cycle 3 and Beyond||0||
60083006|NCT01465659|76198591|FG001|NOT COMPLETED|Went on to Cycle 3 and Beyond||0||
60083007|NCT01465659|76198592|FG002|NOT COMPLETED|Went on to Cycle 3 and Beyond||0||
60083008|NCT01465659|76198593|FG003|NOT COMPLETED|Went on to Cycle 3 and Beyond||0||
60083009|NCT01465659|76198590|FG000|STARTED|Completed Follow for 1 Year||7|Any patient that is treated with study drug goes into follow up after treatment discontinuation.|
60083010|NCT01465659|76198591|FG001|STARTED|Completed Follow for 1 Year||4|Any patient that is treated with study drug goes into follow up after treatment discontinuation.|
60083011|NCT01465659|76198592|FG002|STARTED|Completed Follow for 1 Year||6|Any patient that is treated with study drug goes into follow up after treatment discontinuation.|
60083012|NCT01465659|76198593|FG003|STARTED|Completed Follow for 1 Year||11|Any patient that is treated with study drug goes into follow up after treatment discontinuation.|
60083013|NCT01465659|76198590|FG000|COMPLETED|Completed Follow for 1 Year||1||
60083014|NCT01465659|76198591|FG001|COMPLETED|Completed Follow for 1 Year||1||
60083015|NCT01465659|76198592|FG002|COMPLETED|Completed Follow for 1 Year||4||
60083016|NCT01465659|76198593|FG003|COMPLETED|Completed Follow for 1 Year||7||
60083017|NCT01465659|76198590|FG000|NOT COMPLETED|Completed Follow for 1 Year||6||
60083018|NCT01465659|76198591|FG001|NOT COMPLETED|Completed Follow for 1 Year||3||
60083019|NCT01465659|76198592|FG002|NOT COMPLETED|Completed Follow for 1 Year||2||
60083020|NCT01465659|76198593|FG003|NOT COMPLETED|Completed Follow for 1 Year||4||
60083021|NCT01753076|76198608|FG000|STARTED|Overall Study||151||
60083022|NCT01753076|76198609|FG001|STARTED|Overall Study||152||
60083023|NCT01753076|76198608|FG000|COMPLETED|Overall Study||110||
60083024|NCT01753076|76198609|FG001|COMPLETED|Overall Study||106||
60083025|NCT01753076|76198608|FG000|NOT COMPLETED|Overall Study||41||
60083026|NCT01753076|76198609|FG001|NOT COMPLETED|Overall Study||46||
60083027|NCT01463007|76198617|FG000|STARTED|Overall Study||41||
60083028|NCT01463007|76198617|FG000|COMPLETED|Overall Study||40||
60083029|NCT01463007|76198617|FG000|NOT COMPLETED|Overall Study||1||
60083030|NCT01462929|76198625|FG000|STARTED|Overall Study||171||
60083031|NCT01462929|76198626|FG001|STARTED|Overall Study||158||
60083032|NCT01462929|76198627|FG002|STARTED|Overall Study||85||
60083033|NCT01462929|76198625|FG000|COMPLETED|Overall Study||166||
59706947|NCT00996892|75825865|FG004|NOT COMPLETED|Expansion Stage 2||0||
59706948|NCT00996892|75825866|FG005|NOT COMPLETED|Expansion Stage 2||0||
60083034|NCT01462929|76198626|FG001|COMPLETED|Overall Study||154||
60083035|NCT01462929|76198627|FG002|COMPLETED|Overall Study||80||
60083036|NCT01462929|76198625|FG000|NOT COMPLETED|Overall Study||5||
60083037|NCT01462929|76198626|FG001|NOT COMPLETED|Overall Study||4||
60083038|NCT01462929|76198627|FG002|NOT COMPLETED|Overall Study||5||
60083039|NCT01462695|76198637|FG000|STARTED|Overall Study||17||
60083040|NCT01462695|76198638|FG001|STARTED|Overall Study||13||
60083041|NCT01462695|76198637|FG000|COMPLETED|Overall Study||0||
60083042|NCT01462695|76198638|FG001|COMPLETED|Overall Study||0||
60083043|NCT01462695|76198637|FG000|NOT COMPLETED|Overall Study||17||
60083044|NCT01462695|76198638|FG001|NOT COMPLETED|Overall Study||13||
60083045|NCT01465347|76198644|FG000|STARTED|Overall Study||3||
60083046|NCT01465347|76198645|FG001|STARTED|Overall Study||56||
60083047|NCT01465347|76198644|FG000|COMPLETED|Overall Study||2||
60083048|NCT01465347|76198645|FG001|COMPLETED|Overall Study||53||
60083049|NCT01465347|76198644|FG000|NOT COMPLETED|Overall Study||1||
59706949|NCT00996892|75825867|FG006|NOT COMPLETED|Expansion Stage 2||0||
59706950|NCT00996892|75825868|FG007|NOT COMPLETED|Expansion Stage 2||0||
59991510|NCT03718884|76107056|FG000|COMPLETED|Period 1 (6 Days)||29||
59991511|NCT03718884|76107057|FG001|COMPLETED|Period 1 (6 Days)|Participants were assigned to this arm only during Period 2.|0||
59991512|NCT03718884|76107056|FG000|NOT COMPLETED|Period 1 (6 Days)||0||
59991513|NCT03718884|76107057|FG001|NOT COMPLETED|Period 1 (6 Days)||0||
59991514|NCT03718884|76107056|FG000|STARTED|Period 2 (120 Days)|Participants were assigned to this arm only during Period 1.|0||
59991515|NCT03718884|76107057|FG001|STARTED|Period 2 (120 Days)|Participants were assigned to this arm only during Period 2.|29||
59991516|NCT03718884|76107056|FG000|COMPLETED|Period 2 (120 Days)|Participants were assigned to this arm only during Period 1.|0||
59991517|NCT03718884|76107057|FG001|COMPLETED|Period 2 (120 Days)||26||
59991518|NCT03718884|76107056|FG000|NOT COMPLETED|Period 2 (120 Days)||0||
59991519|NCT03718884|76107057|FG001|NOT COMPLETED|Period 2 (120 Days)||3||
59991520|NCT03509467|76107080|FG000|STARTED|Overall Study||227||
59991521|NCT03509467|76107081|FG001|STARTED|Overall Study||226||
59991522|NCT03509467|76107082|FG002|STARTED|Overall Study||339||
59991523|NCT03509467|76107083|FG003|STARTED|Overall Study||342||
59991524|NCT03509467|76107084|FG004|STARTED|Overall Study||195||
59991525|NCT03509467|76107085|FG005|STARTED|Overall Study||195||
59991526|NCT03509467|76107086|FG006|STARTED|Overall Study||262||
59991527|NCT03509467|76107087|FG007|STARTED|Overall Study||268||
59991528|NCT03509467|76107080|FG000|COMPLETED|Overall Study||222||
59991529|NCT03509467|76107081|FG001|COMPLETED|Overall Study||225||
59991530|NCT03509467|76107082|FG002|COMPLETED|Overall Study||331||
59991531|NCT03509467|76107083|FG003|COMPLETED|Overall Study||333||
59991532|NCT03509467|76107084|FG004|COMPLETED|Overall Study||184||
59991533|NCT03509467|76107085|FG005|COMPLETED|Overall Study||185||
59991534|NCT03509467|76107086|FG006|COMPLETED|Overall Study||251||
59991535|NCT03509467|76107087|FG007|COMPLETED|Overall Study||257||
59991536|NCT03509467|76107080|FG000|NOT COMPLETED|Overall Study||5||
59991537|NCT03509467|76107081|FG001|NOT COMPLETED|Overall Study||1||
59991538|NCT03509467|76107082|FG002|NOT COMPLETED|Overall Study||8||
59991539|NCT03509467|76107083|FG003|NOT COMPLETED|Overall Study||9||
59991540|NCT03509467|76107084|FG004|NOT COMPLETED|Overall Study||11||
59991541|NCT03509467|76107085|FG005|NOT COMPLETED|Overall Study||10||
59991542|NCT03509467|76107086|FG006|NOT COMPLETED|Overall Study||11||
59991543|NCT03509467|76107087|FG007|NOT COMPLETED|Overall Study||11||
59991544|NCT03406156|76107111|FG000|STARTED|Overall Study||84||
59991545|NCT03406156|76107112|FG001|STARTED|Overall Study||36||
59991546|NCT03406156|76107111|FG000|COMPLETED|Overall Study||77||
59991547|NCT03406156|76107112|FG001|COMPLETED|Overall Study||30||
59991548|NCT03406156|76107111|FG000|NOT COMPLETED|Overall Study||7||
59991549|NCT03406156|76107112|FG001|NOT COMPLETED|Overall Study||6||
59991550|NCT03021954|76107122|FG000|STARTED|Overall Study||43||
59991551|NCT03021954|76107123|FG001|STARTED|Overall Study|We excluded 43 subjects due to lost to follow-up, one subject had levator ani muscle avulsion. Therefore only 29 subjects in the control group finished all the examinations in this study.|73||
59991552|NCT03021954|76107122|FG000|COMPLETED|Overall Study||29||
59991553|NCT03021954|76107123|FG001|COMPLETED|Overall Study||29||
59991554|NCT03021954|76107122|FG000|NOT COMPLETED|Overall Study||14||
59991555|NCT03021954|76107123|FG001|NOT COMPLETED|Overall Study||44||
59991556|NCT02994927|76107133|FG000|STARTED|Overall Study||165||
60083050|NCT01465347|76198645|FG001|NOT COMPLETED|Overall Study||3||
60083051|NCT01465191|76198657|FG000|STARTED|Overall Study||56||
59991557|NCT02994927|76107134|FG001|STARTED|Overall Study||166||
59991558|NCT02994927|76107133|FG000|COMPLETED|Overall Study||150||
59991559|NCT02994927|76107134|FG001|COMPLETED|Overall Study||151||
59991560|NCT02994927|76107133|FG000|NOT COMPLETED|Overall Study||15||
59991561|NCT02994927|76107134|FG001|NOT COMPLETED|Overall Study||15||
60083052|NCT01465191|76198658|FG001|STARTED|Overall Study||63||
60083053|NCT01465191|76198659|FG002|STARTED|Overall Study||50||
60083054|NCT01465191|76198657|FG000|COMPLETED|Overall Study||47||
60083055|NCT01465191|76198658|FG001|COMPLETED|Overall Study||54||
59553157|NCT01826513|75653107|FG000|STARTED|Overall Study||5||
59553158|NCT01826513|75653108|FG001|STARTED|Overall Study||10||
59553159|NCT01826513|75653109|FG002|STARTED|Overall Study||10||
59553160|NCT01826513|75653107|FG000|COMPLETED|Overall Study||5||
59553161|NCT01826513|75653108|FG001|COMPLETED|Overall Study||10||
59553162|NCT01826513|75653109|FG002|COMPLETED|Overall Study||10||
59553163|NCT01826513|75653107|FG000|NOT COMPLETED|Overall Study||0||
59553164|NCT01826513|75653108|FG001|NOT COMPLETED|Overall Study||0||
59553165|NCT01826513|75653109|FG002|NOT COMPLETED|Overall Study||0||
59553166|NCT02692755|75653116|FG000|STARTED|Overall Study||35||
59553167|NCT02692755|75653116|FG000|COMPLETED|Overall Study||35||
59553168|NCT02692755|75653116|FG000|NOT COMPLETED|Overall Study||0||
59553169|NCT01829399|75653123|FG000|STARTED|Visit 1||12||
59553170|NCT01829399|75653124|FG001|STARTED|Visit 1||12||
59553171|NCT01829399|75653123|FG000|COMPLETED|Visit 1||12||
59553172|NCT01829399|75653124|FG001|COMPLETED|Visit 1||12||
59553173|NCT01829399|75653123|FG000|NOT COMPLETED|Visit 1||0||
59553174|NCT01829399|75653124|FG001|NOT COMPLETED|Visit 1||0||
59553175|NCT01829399|75653123|FG000|STARTED|Visit 2 (One Month Later)||12||
59553176|NCT01829399|75653124|FG001|STARTED|Visit 2 (One Month Later)||12||
59553177|NCT01829399|75653123|FG000|COMPLETED|Visit 2 (One Month Later)||12||
59553178|NCT01829399|75653124|FG001|COMPLETED|Visit 2 (One Month Later)||12||
59553179|NCT01829399|75653123|FG000|NOT COMPLETED|Visit 2 (One Month Later)||0||
59553180|NCT01829399|75653124|FG001|NOT COMPLETED|Visit 2 (One Month Later)||0||
59553181|NCT01394510|75653132|FG000|STARTED|Overall Study||13||
59553182|NCT01394510|75653132|FG000|COMPLETED|Overall Study||13||
59553183|NCT01394510|75653132|FG000|NOT COMPLETED|Overall Study||0||
59553184|NCT01396226|75653138|FG000|STARTED|Overall Study||12||
59553185|NCT01396226|75653139|FG001|STARTED|Overall Study||6||
59553186|NCT01396226|75653138|FG000|Patients Who Received Treatment|Overall Study||12||
59553187|NCT01396226|75653139|FG001|Patients Who Received Treatment|Overall Study||6||
59553188|NCT01396226|75653138|FG000|Patients Who Completed Treatment|Overall Study||12||
59553189|NCT01396226|75653139|FG001|Patients Who Completed Treatment|Overall Study||6||
59553190|NCT01396226|75653138|FG000|COMPLETED|Overall Study||12||
59553191|NCT01396226|75653139|FG001|COMPLETED|Overall Study||6||
59553192|NCT01396226|75653138|FG000|NOT COMPLETED|Overall Study||0||
59553193|NCT01396226|75653139|FG001|NOT COMPLETED|Overall Study||0||
59991562|NCT02718716|76107145|FG000|STARTED|Overall Study||15||
59991563|NCT02718716|76107146|FG001|STARTED|Overall Study||15||
59991564|NCT02718716|76107147|FG002|STARTED|Overall Study||12||
59991565|NCT02718716|76107148|FG003|STARTED|Overall Study||12||
59991566|NCT02718716|76107149|FG004|STARTED|Overall Study||12||
59991567|NCT02718716|76107145|FG000|COMPLETED|Overall Study||14||
59991568|NCT02718716|76107146|FG001|COMPLETED|Overall Study||15||
59991569|NCT02718716|76107147|FG002|COMPLETED|Overall Study||12||
60083056|NCT01465191|76198659|FG002|COMPLETED|Overall Study||43||
60083057|NCT01465191|76198657|FG000|NOT COMPLETED|Overall Study||9||
60083058|NCT01465191|76198658|FG001|NOT COMPLETED|Overall Study||9||
60083059|NCT01465191|76198659|FG002|NOT COMPLETED|Overall Study||7||
60083060|NCT01519947|76198674|FG000|STARTED|Overall Study||19||
60083061|NCT01519947|76198675|FG001|STARTED|Overall Study||11||
60083062|NCT01519947|76198676|FG002|STARTED|Overall Study||15||
60083063|NCT01519947|76198677|FG003|STARTED|Overall Study||42||
60083064|NCT01519947|76198674|FG000|COMPLETED|Overall Study||17||
60083065|NCT01519947|76198675|FG001|COMPLETED|Overall Study||7||
60083066|NCT01519947|76198676|FG002|COMPLETED|Overall Study||8||
59553194|NCT02694315|75653145|FG000|STARTED|Overall Study||200||
59553195|NCT02694315|75653145|FG000|COMPLETED|Overall Study||200||
59991570|NCT02718716|76107148|FG003|COMPLETED|Overall Study||12||
60083067|NCT01519947|76198677|FG003|COMPLETED|Overall Study||34||
60083068|NCT01519947|76198674|FG000|NOT COMPLETED|Overall Study||2||
60083069|NCT01519947|76198675|FG001|NOT COMPLETED|Overall Study||4||
60083070|NCT01519947|76198676|FG002|NOT COMPLETED|Overall Study||7||
60083071|NCT01519947|76198677|FG003|NOT COMPLETED|Overall Study||8||
60083072|NCT01462227|76198689|FG000|STARTED|First Assignment||4||
60083073|NCT01462227|76198690|FG001|STARTED|First Assignment||2||
60083074|NCT01462227|76198691|FG002|STARTED|First Assignment||6||
60083075|NCT01462227|76198692|FG003|STARTED|First Assignment||5||
60083076|NCT01462227|76198689|FG000|COMPLETED|First Assignment||4||
60083077|NCT01462227|76198690|FG001|COMPLETED|First Assignment||2||
59553196|NCT02694315|75653145|FG000|NOT COMPLETED|Overall Study||0||
59553197|NCT01396382|75653149|FG000|STARTED|Overall Study||97||
59553198|NCT01396382|75653149|FG000|COMPLETED|Overall Study||97||
59991571|NCT02718716|76107149|FG004|COMPLETED|Overall Study||12||
60083078|NCT01462227|76198691|FG002|COMPLETED|First Assignment||6||
60083079|NCT01462227|76198692|FG003|COMPLETED|First Assignment||5||
60083080|NCT01462227|76198689|FG000|NOT COMPLETED|First Assignment||0||
59553199|NCT01396382|75653149|FG000|NOT COMPLETED|Overall Study||0||
59553200|NCT01412372|75653156|FG000|STARTED|Overall Study||30||
59553201|NCT01412372|75653157|FG001|STARTED|Overall Study||31||
59553202|NCT01412372|75653156|FG000|COMPLETED|Overall Study||26||
59553203|NCT01412372|75653157|FG001|COMPLETED|Overall Study||28||
59553204|NCT01412372|75653156|FG000|NOT COMPLETED|Overall Study||4||
59553205|NCT01412372|75653157|FG001|NOT COMPLETED|Overall Study||3||
59553206|NCT01412918|75653165|FG000|STARTED|Overall Study||20||
59553207|NCT01412918|75653166|FG001|STARTED|Overall Study||1||
59553208|NCT01412918|75653165|FG000|COMPLETED|Overall Study||20||
59553209|NCT01412918|75653166|FG001|COMPLETED|Overall Study||1||
59553210|NCT01412918|75653165|FG000|NOT COMPLETED|Overall Study||0||
59553211|NCT01412918|75653166|FG001|NOT COMPLETED|Overall Study||0||
59553212|NCT01414010|75653177|FG000|STARTED|Overall Study||8||
59553213|NCT01414010|75653178|FG001|STARTED|Overall Study||8||
59553214|NCT01414010|75653179|FG002|STARTED|Overall Study||8||
59553215|NCT01414010|75653180|FG003|STARTED|Overall Study||8||
59553216|NCT01414010|75653177|FG000|COMPLETED|Overall Study||6||
59553217|NCT01414010|75653178|FG001|COMPLETED|Overall Study||8||
59553218|NCT01414010|75653179|FG002|COMPLETED|Overall Study||8||
59553219|NCT01414010|75653180|FG003|COMPLETED|Overall Study||8||
59553220|NCT01414010|75653177|FG000|NOT COMPLETED|Overall Study||2||
59553221|NCT01414010|75653178|FG001|NOT COMPLETED|Overall Study||0||
59553222|NCT01414010|75653179|FG002|NOT COMPLETED|Overall Study||0||
59553223|NCT01414010|75653180|FG003|NOT COMPLETED|Overall Study||0||
59553224|NCT01414244|75653198|FG000|STARTED|Overall Study||54||
59553225|NCT01414244|75653199|FG001|STARTED|Overall Study||52||
59553226|NCT01414244|75653198|FG000|COMPLETED|Overall Study||54||
59553227|NCT01414244|75653199|FG001|COMPLETED|Overall Study||52||
59553228|NCT01414244|75653198|FG000|NOT COMPLETED|Overall Study||0||
59553229|NCT01414244|75653199|FG001|NOT COMPLETED|Overall Study||0||
59553230|NCT01832753|75653208|FG000|STARTED|Observation Phase (Months 0-6)||5||
59553231|NCT01832753|75653209|FG001|STARTED|Observation Phase (Months 0-6)||4||
59553232|NCT01832753|75653210|FG002|STARTED|Observation Phase (Months 0-6)||3||
59553233|NCT01832753|75653208|FG000|COMPLETED|Observation Phase (Months 0-6)||5||
59553234|NCT01832753|75653209|FG001|COMPLETED|Observation Phase (Months 0-6)||4||
59553235|NCT01832753|75653210|FG002|COMPLETED|Observation Phase (Months 0-6)||1||
59553236|NCT01832753|75653208|FG000|NOT COMPLETED|Observation Phase (Months 0-6)||0||
59553237|NCT01832753|75653209|FG001|NOT COMPLETED|Observation Phase (Months 0-6)||0||
59553238|NCT01832753|75653210|FG002|NOT COMPLETED|Observation Phase (Months 0-6)||2||
59553239|NCT01832753|75653208|FG000|STARTED|Randomization Phase (Months 6-12)||5||
59553240|NCT01832753|75653209|FG001|STARTED|Randomization Phase (Months 6-12)||4||
59553241|NCT01832753|75653210|FG002|STARTED|Randomization Phase (Months 6-12)|1 subject was not randomized as they did not meet inclusion criteria at the end of observation phase|0||
59553242|NCT01832753|75653208|FG000|COMPLETED|Randomization Phase (Months 6-12)||4||
59553243|NCT01832753|75653209|FG001|COMPLETED|Randomization Phase (Months 6-12)||3||
59553244|NCT01832753|75653210|FG002|COMPLETED|Randomization Phase (Months 6-12)||0||
59553245|NCT01832753|75653208|FG000|NOT COMPLETED|Randomization Phase (Months 6-12)||1||
59553246|NCT01832753|75653209|FG001|NOT COMPLETED|Randomization Phase (Months 6-12)||1||
59553247|NCT01832753|75653210|FG002|NOT COMPLETED|Randomization Phase (Months 6-12)||0||
59553248|NCT01832753|75653208|FG000|STARTED|Open Label Dose Phase (Months 12-18)||3||
59553249|NCT01832753|75653209|FG001|STARTED|Open Label Dose Phase (Months 12-18)||3||
59553250|NCT01832753|75653210|FG002|STARTED|Open Label Dose Phase (Months 12-18)||0||
59553251|NCT01832753|75653208|FG000|COMPLETED|Open Label Dose Phase (Months 12-18)||3||
59553252|NCT01832753|75653209|FG001|COMPLETED|Open Label Dose Phase (Months 12-18)||3||
59553253|NCT01832753|75653210|FG002|COMPLETED|Open Label Dose Phase (Months 12-18)||0||
59553254|NCT01832753|75653208|FG000|NOT COMPLETED|Open Label Dose Phase (Months 12-18)||0||
59553255|NCT01832753|75653209|FG001|NOT COMPLETED|Open Label Dose Phase (Months 12-18)||0||
59553256|NCT01832753|75653210|FG002|NOT COMPLETED|Open Label Dose Phase (Months 12-18)||0||
59553257|NCT01414634|75653219|FG000|STARTED|Overall Study||1||
59553258|NCT01414634|75653220|FG001|STARTED|Overall Study||1||
59553259|NCT01414634|75653221|FG002|STARTED|Overall Study||1||
59553260|NCT01414634|75653222|FG003|STARTED|Overall Study||1||
59553261|NCT01414634|75653223|FG004|STARTED|Overall Study||1||
59553262|NCT01414634|75653224|FG005|STARTED|Overall Study||2||
59553263|NCT01414634|75653225|FG006|STARTED|Overall Study||1||
59553264|NCT01414634|75653226|FG007|STARTED|Overall Study||1||
59553265|NCT01414634|75653219|FG000|COMPLETED|Overall Study||1||
59553266|NCT01414634|75653220|FG001|COMPLETED|Overall Study||1||
59553267|NCT01414634|75653221|FG002|COMPLETED|Overall Study||1||
59553268|NCT01414634|75653222|FG003|COMPLETED|Overall Study||1||
59553269|NCT01414634|75653223|FG004|COMPLETED|Overall Study||1||
59553270|NCT01414634|75653224|FG005|COMPLETED|Overall Study||2||
60083081|NCT01462227|76198690|FG001|NOT COMPLETED|First Assignment||0||
60083082|NCT01462227|76198691|FG002|NOT COMPLETED|First Assignment||0||
60083083|NCT01462227|76198692|FG003|NOT COMPLETED|First Assignment||0||
60083084|NCT01462227|76198689|FG000|STARTED|Second Assignment||4||
60083085|NCT01462227|76198690|FG001|STARTED|Second Assignment||2||
60083086|NCT01462227|76198691|FG002|STARTED|Second Assignment||6||
60083087|NCT01462227|76198692|FG003|STARTED|Second Assignment||5||
60083088|NCT01462227|76198689|FG000|COMPLETED|Second Assignment||3||
60083089|NCT01462227|76198690|FG001|COMPLETED|Second Assignment||1||
60083090|NCT01462227|76198691|FG002|COMPLETED|Second Assignment||5||
60083091|NCT01462227|76198692|FG003|COMPLETED|Second Assignment||5||
60083092|NCT01462227|76198689|FG000|NOT COMPLETED|Second Assignment||1||
60083093|NCT01462227|76198690|FG001|NOT COMPLETED|Second Assignment||1||
60083094|NCT01462227|76198691|FG002|NOT COMPLETED|Second Assignment||1||
60083095|NCT01462227|76198692|FG003|NOT COMPLETED|Second Assignment||0||
60083096|NCT01464879|76198700|FG000|STARTED|Overall Study||20||
60083097|NCT01464879|76198700|FG000|Hand Application (2.50 mL)|Overall Study||20||
60083098|NCT01464879|76198700|FG000|Washout Period|Overall Study||20||
60083099|NCT01464879|76198700|FG000|Applicator Application (1.25 mL)|Overall Study|One subject discontinued due to non-compliance.|19||
60083100|NCT01464879|76198700|FG000|Applicator Application (2.50 mL)|Overall Study|One subject discontinued due to physician's decision.|18||
60083101|NCT01464879|76198700|FG000|Applicator Application (3.75 mL)|Overall Study||18||
60083102|NCT01464879|76198700|FG000|COMPLETED|Overall Study||18||
60083103|NCT01464879|76198700|FG000|NOT COMPLETED|Overall Study||2||
60083104|NCT01519869|76198710|FG000|STARTED|Overall Study||28||
60083105|NCT01519869|76198710|FG000|COMPLETED|Overall Study||27||
60083106|NCT01519869|76198710|FG000|NOT COMPLETED|Overall Study||1||
60083107|NCT01519791|76198716|FG000|STARTED|Overall Study||219||
60083108|NCT01519791|76198717|FG001|STARTED|Overall Study||660||
60083109|NCT01519791|76198716|FG000|Completed Week 52|Overall Study||143||
60083110|NCT01519791|76198717|FG001|Completed Week 52|Overall Study||500||
60083111|NCT01519791|76198716|FG000|COMPLETED|Overall Study||67||
60083112|NCT01519791|76198717|FG001|COMPLETED|Overall Study||292||
60083113|NCT01519791|76198716|FG000|NOT COMPLETED|Overall Study||152||
60083114|NCT01519791|76198717|FG001|NOT COMPLETED|Overall Study||368||
60083115|NCT01461993|76198728|FG000|STARTED|Overall Study||999||
60083116|NCT01461993|76198729|FG001|STARTED|Overall Study||998||
60083117|NCT01461993|76198730|FG002|STARTED|Overall Study||502||
60083118|NCT01461993|76198728|FG000|COMPLETED|Overall Study||848||
60083119|NCT01461993|76198729|FG001|COMPLETED|Overall Study||841||
60083120|NCT01461993|76198730|FG002|COMPLETED|Overall Study||438||
60083121|NCT01461993|76198728|FG000|NOT COMPLETED|Overall Study||151||
60083122|NCT01461993|76198729|FG001|NOT COMPLETED|Overall Study||157||
60083123|NCT01461993|76198730|FG002|NOT COMPLETED|Overall Study||64||
60083124|NCT01782326|76198741|FG000|STARTED|Planned Treatment Epoch||1680||
60083125|NCT01782326|76198742|FG001|STARTED|Planned Treatment Epoch||1682||
60083126|NCT01782326|76198741|FG000|Full Analysis Set (FAS)|Planned Treatment Epoch||1675||
60083127|NCT01782326|76198742|FG001|Full Analysis Set (FAS)|Planned Treatment Epoch||1679||
60083128|NCT01782326|76198741|FG000|Per-protocol Set (PPS)|Planned Treatment Epoch||1528||
60083129|NCT01782326|76198742|FG001|Per-protocol Set (PPS)|Planned Treatment Epoch||1556||
60083130|NCT01782326|76198741|FG000|Serial Spirometry Set|Planned Treatment Epoch||280||
60083131|NCT01782326|76198742|FG001|Serial Spirometry Set|Planned Treatment Epoch||279||
60083132|NCT01782326|76198741|FG000|Safety Set (SAF)|Planned Treatment Epoch||1678||
60083133|NCT01782326|76198742|FG001|Safety Set (SAF)|Planned Treatment Epoch||1680||
59553271|NCT01414634|75653225|FG006|COMPLETED|Overall Study||1||
59553272|NCT01414634|75653226|FG007|COMPLETED|Overall Study||1||
59553273|NCT01414634|75653219|FG000|NOT COMPLETED|Overall Study||0||
59553274|NCT01414634|75653220|FG001|NOT COMPLETED|Overall Study||0||
59553275|NCT01414634|75653221|FG002|NOT COMPLETED|Overall Study||0||
59553276|NCT01414634|75653222|FG003|NOT COMPLETED|Overall Study||0||
59553277|NCT01414634|75653223|FG004|NOT COMPLETED|Overall Study||0||
59553278|NCT01414634|75653224|FG005|NOT COMPLETED|Overall Study||0||
59553279|NCT01414634|75653225|FG006|NOT COMPLETED|Overall Study||0||
60083134|NCT01782326|76198741|FG000|Urine Cortisol Set|Planned Treatment Epoch||266||
59553280|NCT01414634|75653226|FG007|NOT COMPLETED|Overall Study||0||
60083135|NCT01782326|76198742|FG001|Urine Cortisol Set|Planned Treatment Epoch||269||
60083136|NCT01782326|76198741|FG000|COMPLETED|Planned Treatment Epoch||1478||
59553281|NCT02696967|75653241|FG000|STARTED|Overall Study||4|All randomized patients were included in the Full Analysis Set (FAS) and Safety Analysis Set (SAF).|
59553282|NCT02696967|75653242|FG001|STARTED|Overall Study||6|All randomized patients were included in the Full Analysis Set (FAS) and Safety Analysis Set (SAF).|
59553283|NCT02696967|75653243|FG002|STARTED|Overall Study||6|All randomized patients were included in the Full Analysis Set (FAS) and Safety Analysis Set (SAF).|
59553284|NCT02696967|75653244|FG003|STARTED|Overall Study||10|All randomized patients were included in the Full Analysis Set (FAS) and Safety Analysis Set (SAF).|
59553285|NCT02696967|75653241|FG000|Pharmacokinetic (PK) Analysis Set|Overall Study||4|At least one dose of study drug and one evaluable PK concentration measurement|
59553286|NCT02696967|75653242|FG001|Pharmacokinetic (PK) Analysis Set|Overall Study||6|At least one dose of study drug and one evaluable PK concentration measurement|
59553287|NCT02696967|75653243|FG002|Pharmacokinetic (PK) Analysis Set|Overall Study||4|At least one dose of study drug and one evaluable PK concentration measurement|
59553288|NCT02696967|75653244|FG003|Pharmacokinetic (PK) Analysis Set|Overall Study||0|At least one dose of study drug and one evaluable PK concentration measurement|
59553289|NCT02696967|75653241|FG000|COMPLETED|Overall Study||4||
59553290|NCT02696967|75653242|FG001|COMPLETED|Overall Study||6||
59553291|NCT02696967|75653243|FG002|COMPLETED|Overall Study||6||
59553292|NCT02696967|75653244|FG003|COMPLETED|Overall Study||10||
59553293|NCT02696967|75653241|FG000|NOT COMPLETED|Overall Study||0||
59553294|NCT02696967|75653242|FG001|NOT COMPLETED|Overall Study||0||
59553295|NCT02696967|75653243|FG002|NOT COMPLETED|Overall Study||0||
59553296|NCT02696967|75653244|FG003|NOT COMPLETED|Overall Study||0||
59553297|NCT01415960|75653254|FG000|STARTED|Overall Study||163||
59553298|NCT01415960|75653254|FG000|ITT|Overall Study||161||
59706951|NCT00996892|75825869|FG008|NOT COMPLETED|Expansion Stage 2||0||
59553299|NCT01415960|75653254|FG000|PK Subgroup|Overall Study||30||
59553300|NCT01415960|75653254|FG000|COMPLETED|Overall Study|Patients completed Study (151) Per protocol Patients (146)|151||
59553301|NCT01415960|75653254|FG000|NOT COMPLETED|Overall Study||12||
59553302|NCT01833845|75653258|FG000|STARTED|Overall Study||4||
59553303|NCT01833845|75653258|FG000|COMPLETED|Overall Study||4||
59553304|NCT01833845|75653258|FG000|NOT COMPLETED|Overall Study||0||
59553305|NCT01416194|75653265|FG000|STARTED|Overall Study||1111||
59553306|NCT01416194|75653266|FG001|STARTED|Overall Study||2720||
59553307|NCT01416194|75653267|FG002|STARTED|Overall Study||6666||
59553308|NCT01416194|75653265|FG000|COMPLETED|Overall Study||1111||
59553309|NCT01416194|75653266|FG001|COMPLETED|Overall Study||2720||
59553310|NCT01416194|75653267|FG002|COMPLETED|Overall Study||6666||
59553311|NCT01416194|75653265|FG000|NOT COMPLETED|Overall Study||0||
59553312|NCT01416194|75653266|FG001|NOT COMPLETED|Overall Study||0||
59553313|NCT01416194|75653267|FG002|NOT COMPLETED|Overall Study||0||
59553314|NCT01416584|75653280|FG000|STARTED|Overall Study||30||
59553315|NCT01416584|75653281|FG001|STARTED|Overall Study||35||
59706952|NCT00996892|75825870|FG009|NOT COMPLETED|Expansion Stage 2||0||
59706953|NCT00996892|75825871|FG010|NOT COMPLETED|Expansion Stage 2||0||
60083137|NCT01782326|76198742|FG001|COMPLETED|Planned Treatment Epoch||1474||
60083138|NCT01782326|76198741|FG000|NOT COMPLETED|Planned Treatment Epoch||202||
60083139|NCT01782326|76198742|FG001|NOT COMPLETED|Planned Treatment Epoch||208||
60083140|NCT01782326|76198741|FG000|STARTED|Double-blind Treatment||1678||
60083141|NCT01782326|76198742|FG001|STARTED|Double-blind Treatment||1680||
60083142|NCT01782326|76198741|FG000|COMPLETED|Double-blind Treatment||1400||
60083143|NCT01782326|76198742|FG001|COMPLETED|Double-blind Treatment||1360||
60083144|NCT01782326|76198741|FG000|NOT COMPLETED|Double-blind Treatment||278||
60083145|NCT01782326|76198742|FG001|NOT COMPLETED|Double-blind Treatment||320||
60083146|NCT01439373|76198750|FG000|STARTED|Monotherapy (Day 1)||11||
60083147|NCT01439373|76198751|FG001|STARTED|Monotherapy (Day 1)||5||
60083148|NCT01439373|76198750|FG000|COMPLETED|Monotherapy (Day 1)||11||
60083149|NCT01439373|76198751|FG001|COMPLETED|Monotherapy (Day 1)||4||
60083150|NCT01439373|76198750|FG000|NOT COMPLETED|Monotherapy (Day 1)||0||
60083151|NCT01439373|76198751|FG001|NOT COMPLETED|Monotherapy (Day 1)||1||
60083152|NCT01439373|76198750|FG000|STARTED|Combined With PEG and RIBA (Day 2 to 28)||11||
60083153|NCT01439373|76198751|FG001|STARTED|Combined With PEG and RIBA (Day 2 to 28)||4||
60083154|NCT01439373|76198750|FG000|COMPLETED|Combined With PEG and RIBA (Day 2 to 28)||9||
60083155|NCT01439373|76198751|FG001|COMPLETED|Combined With PEG and RIBA (Day 2 to 28)||4||
60083156|NCT01439373|76198750|FG000|NOT COMPLETED|Combined With PEG and RIBA (Day 2 to 28)||2||
60083157|NCT01439373|76198751|FG001|NOT COMPLETED|Combined With PEG and RIBA (Day 2 to 28)||0||
60083158|NCT01461369|76198764|FG000|STARTED|Overall Study||104||
60083159|NCT01461369|76198765|FG001|STARTED|Overall Study||98||
60083160|NCT01461369|76198766|FG002|STARTED|Overall Study||103||
60083161|NCT01461369|76198764|FG000|COMPLETED|Overall Study||91||
60083162|NCT01461369|76198765|FG001|COMPLETED|Overall Study||81||
60083163|NCT01461369|76198766|FG002|COMPLETED|Overall Study||86||
60083164|NCT01461369|76198764|FG000|NOT COMPLETED|Overall Study||13||
60083165|NCT01461369|76198765|FG001|NOT COMPLETED|Overall Study||17||
60083166|NCT01461369|76198766|FG002|NOT COMPLETED|Overall Study||17||
60083167|NCT01727258|76198777|FG000|STARTED|Overall Study||51||
60083168|NCT01727258|76198778|FG001|STARTED|Overall Study||51||
60083169|NCT01727258|76198779|FG002|STARTED|Overall Study||51||
60083170|NCT01727258|76198777|FG000|COMPLETED|Overall Study||49||
60083171|NCT01727258|76198778|FG001|COMPLETED|Overall Study||48||
60083172|NCT01727258|76198779|FG002|COMPLETED|Overall Study||50||
60083173|NCT01727258|76198777|FG000|NOT COMPLETED|Overall Study||2||
60083174|NCT01727258|76198778|FG001|NOT COMPLETED|Overall Study||3||
60083175|NCT01727258|76198779|FG002|NOT COMPLETED|Overall Study||1||
60083176|NCT01781390|76198790|FG000|STARTED|Overall Study||35||
60083177|NCT01781390|76198791|FG001|STARTED|Overall Study||35||
60083178|NCT01781390|76198792|FG002|STARTED|Overall Study||36||
60083179|NCT01781390|76198790|FG000|COMPLETED|Overall Study||32||
60083180|NCT01781390|76198791|FG001|COMPLETED|Overall Study||28||
60083181|NCT01781390|76198792|FG002|COMPLETED|Overall Study||32||
60083182|NCT01781390|76198790|FG000|NOT COMPLETED|Overall Study||3||
60083183|NCT01781390|76198791|FG001|NOT COMPLETED|Overall Study||7||
60083184|NCT01781390|76198792|FG002|NOT COMPLETED|Overall Study||4||
60083185|NCT01781234|76198802|FG000|STARTED|Overall Study||27||
60083186|NCT01781234|76198803|FG001|STARTED|Overall Study||24||
60083187|NCT01781234|76198802|FG000|COMPLETED|Overall Study||18||
60083188|NCT01781234|76198803|FG001|COMPLETED|Overall Study||21||
60083189|NCT01781234|76198802|FG000|NOT COMPLETED|Overall Study||9||
60083190|NCT01781234|76198803|FG001|NOT COMPLETED|Overall Study||3||
60083191|NCT01752842|76198813|FG000|STARTED|Overall Study||34||
60083192|NCT01752842|76198814|FG001|STARTED|Overall Study||36||
60083193|NCT01752842|76198813|FG000|COMPLETED|Overall Study||31||
60083194|NCT01752842|76198814|FG001|COMPLETED|Overall Study||34||
60083195|NCT01752842|76198813|FG000|NOT COMPLETED|Overall Study||3||
60083196|NCT01752842|76198814|FG001|NOT COMPLETED|Overall Study||2||
60083197|NCT01461057|76198822|FG000|STARTED|Overall Study||15||
60083198|NCT01461057|76198823|FG001|STARTED|Overall Study||15||
60083199|NCT01461057|76198822|FG000|COMPLETED|Overall Study||0||
60083200|NCT01461057|76198823|FG001|COMPLETED|Overall Study||0||
59553316|NCT01416584|75653282|FG002|STARTED|Overall Study||33||
59553317|NCT01416584|75653280|FG000|COMPLETED|Overall Study||27||
59553318|NCT01416584|75653281|FG001|COMPLETED|Overall Study||33||
59553319|NCT01416584|75653282|FG002|COMPLETED|Overall Study||32||
59553320|NCT01416584|75653280|FG000|NOT COMPLETED|Overall Study||3||
59553321|NCT01416584|75653281|FG001|NOT COMPLETED|Overall Study||2||
59553322|NCT01416584|75653282|FG002|NOT COMPLETED|Overall Study||1||
60083201|NCT01461057|76198822|FG000|NOT COMPLETED|Overall Study||15||
59553323|NCT02698215|75653298|FG000|STARTED|Overall Study||83||
59553324|NCT02698215|75653299|FG001|STARTED|Overall Study||82||
59553325|NCT02698215|75653298|FG000|COMPLETED|Overall Study||55||
59553326|NCT02698215|75653299|FG001|COMPLETED|Overall Study||64||
59553327|NCT02698215|75653298|FG000|NOT COMPLETED|Overall Study||28||
59553328|NCT02698215|75653299|FG001|NOT COMPLETED|Overall Study||18||
59553329|NCT01480232|75653309|FG000|STARTED|Overall Study||40||
59553330|NCT01480232|75653310|FG001|STARTED|Overall Study||41||
59553331|NCT01480232|75653311|FG002|STARTED|Overall Study||38||
59553332|NCT01480232|75653312|FG003|STARTED|Overall Study||41||
59706954|NCT00996892|75825872|FG011|NOT COMPLETED|Expansion Stage 2||0||
59991572|NCT02718716|76107145|FG000|NOT COMPLETED|Overall Study||1||
59553333|NCT01480232|75653309|FG000|COMPLETED|Overall Study||22||
59553334|NCT01480232|75653310|FG001|COMPLETED|Overall Study||19||
59553335|NCT01480232|75653311|FG002|COMPLETED|Overall Study||21||
59553336|NCT01480232|75653312|FG003|COMPLETED|Overall Study||22||
59553337|NCT01480232|75653309|FG000|NOT COMPLETED|Overall Study||18||
59553338|NCT01480232|75653310|FG001|NOT COMPLETED|Overall Study||22||
59553339|NCT01480232|75653311|FG002|NOT COMPLETED|Overall Study||17||
59553340|NCT01480232|75653312|FG003|NOT COMPLETED|Overall Study||19||
59553341|NCT02700165|75653322|FG000|STARTED|Overall Study||14||
59553342|NCT02700165|75653322|FG000|COMPLETED|Overall Study||14||
59991573|NCT02718716|76107146|FG001|NOT COMPLETED|Overall Study||0||
59991574|NCT02718716|76107147|FG002|NOT COMPLETED|Overall Study||0||
59991575|NCT02718716|76107148|FG003|NOT COMPLETED|Overall Study||0||
59991576|NCT02718716|76107149|FG004|NOT COMPLETED|Overall Study||0||
59991577|NCT02627742|76107163|FG000|STARTED|Overall Study||210||
59991578|NCT02627742|76107164|FG001|STARTED|Overall Study||209||
60083202|NCT01461057|76198823|FG001|NOT COMPLETED|Overall Study||15||
60083203|NCT01460901|76198829|FG000|STARTED|Overall Study|First enrollment|5||
60083204|NCT01460901|76198829|FG000|tV-CTL Infusion|Overall Study||3||
60083205|NCT01460901|76198829|FG000|COMPLETED|Overall Study|Follow-up completed|3||
60083206|NCT01460901|76198829|FG000|NOT COMPLETED|Overall Study||2||
60083207|NCT01519635|76198838|FG000|STARTED|Overall Study||12||
60083208|NCT01519635|76198839|FG001|STARTED|Overall Study||12||
60083209|NCT01519635|76198838|FG000|COMPLETED|Overall Study||11||
60083210|NCT01519635|76198839|FG001|COMPLETED|Overall Study||9||
60083211|NCT01519635|76198838|FG000|NOT COMPLETED|Overall Study||1||
60083212|NCT01519635|76198839|FG001|NOT COMPLETED|Overall Study||3||
60083213|NCT01519323|76198845|FG000|STARTED|Overall Study||3||
59553343|NCT02700165|75653322|FG000|NOT COMPLETED|Overall Study||0||
59553344|NCT01481558|75653329|FG000|STARTED|Overall Study||20||
59553345|NCT01481558|75653330|FG001|STARTED|Overall Study||20||
59553346|NCT01481558|75653329|FG000|COMPLETED|Overall Study||20||
59553347|NCT01481558|75653330|FG001|COMPLETED|Overall Study||20||
59553348|NCT01481558|75653329|FG000|NOT COMPLETED|Overall Study||0||
59553349|NCT01481558|75653330|FG001|NOT COMPLETED|Overall Study||0||
59553350|NCT01420016|75653338|FG000|STARTED|Primary Analysis||6970||
59553351|NCT01420016|75653339|FG001|STARTED|Primary Analysis||6411||
59553352|NCT01420016|75653340|FG002|STARTED|Primary Analysis||0||
59553353|NCT01420016|75653341|FG003|STARTED|Primary Analysis||0||
59553354|NCT01420016|75653338|FG000|COMPLETED|Primary Analysis|Reflects patient participants included in final analysis.|4043||
59553355|NCT01420016|75653339|FG001|COMPLETED|Primary Analysis|Reflects patient participants included in final analysis.|3871||
59553356|NCT01420016|75653340|FG002|COMPLETED|Primary Analysis||0||
59553357|NCT01420016|75653341|FG003|COMPLETED|Primary Analysis||0||
59553358|NCT01420016|75653338|FG000|NOT COMPLETED|Primary Analysis||2927||
59553359|NCT01420016|75653339|FG001|NOT COMPLETED|Primary Analysis||2540||
59991579|NCT02627742|76107163|FG000|COMPLETED|Overall Study||201||
59991580|NCT02627742|76107164|FG001|COMPLETED|Overall Study||202||
59991581|NCT02627742|76107163|FG000|NOT COMPLETED|Overall Study||9||
59991582|NCT02627742|76107164|FG001|NOT COMPLETED|Overall Study||7||
59991583|NCT02032823|76107172|FG000|STARTED|Overall Study||921||
59553360|NCT01420016|75653340|FG002|NOT COMPLETED|Primary Analysis||0||
59553361|NCT01420016|75653341|FG003|NOT COMPLETED|Primary Analysis||0||
59553362|NCT01420016|75653338|FG000|STARTED|Safety Analysis||0||
59553363|NCT01420016|75653339|FG001|STARTED|Safety Analysis||0||
59553364|NCT01420016|75653340|FG002|STARTED|Safety Analysis||6392||
59553365|NCT01420016|75653341|FG003|STARTED|Safety Analysis||5159||
59553366|NCT01420016|75653338|FG000|COMPLETED|Safety Analysis||0||
59553367|NCT01420016|75653339|FG001|COMPLETED|Safety Analysis||0||
59553368|NCT01420016|75653340|FG002|COMPLETED|Safety Analysis||6392||
59553369|NCT01420016|75653341|FG003|COMPLETED|Safety Analysis||5159||
59553370|NCT01420016|75653338|FG000|NOT COMPLETED|Safety Analysis||0||
59553371|NCT01420016|75653339|FG001|NOT COMPLETED|Safety Analysis||0||
59553372|NCT01420016|75653340|FG002|NOT COMPLETED|Safety Analysis||0||
59553373|NCT01420016|75653341|FG003|NOT COMPLETED|Safety Analysis||0||
59553374|NCT02701101|75653347|FG000|STARTED|Overall Study||189||
59553375|NCT02701101|75653347|FG000|COMPLETED|Overall Study||189||
59553376|NCT02701101|75653347|FG000|NOT COMPLETED|Overall Study||0||
59553377|NCT01398566|75653352|FG000|STARTED|Overall Study|20 enrolled|20|Enroll up to 20 participants|
59553378|NCT01398566|75653352|FG000|COMPLETED|Overall Study||20||
59553379|NCT01398566|75653352|FG000|NOT COMPLETED|Overall Study||0||
59553380|NCT01399268|75653358|FG000|STARTED|Overall Study||15||
59553381|NCT01399268|75653359|FG001|STARTED|Overall Study||15||
59553382|NCT01399268|75653358|FG000|COMPLETED|Overall Study||15||
59553383|NCT01399268|75653359|FG001|COMPLETED|Overall Study||15||
59553384|NCT01399268|75653358|FG000|NOT COMPLETED|Overall Study||0||
59553385|NCT01399268|75653359|FG001|NOT COMPLETED|Overall Study||0||
59553386|NCT01483352|75653365|FG000|STARTED|Overall Study||12||
59553387|NCT01483352|75653365|FG000|COMPLETED|Overall Study||12||
59553388|NCT01483352|75653365|FG000|NOT COMPLETED|Overall Study||0||
59553389|NCT02701257|75653374|FG000|STARTED|Overall Study||6||
59553390|NCT02701257|75653375|FG001|STARTED|Overall Study||6||
59553391|NCT02701257|75653376|FG002|STARTED|Overall Study||0||
59553392|NCT02701257|75653377|FG003|STARTED|Overall Study||4||
59553393|NCT02701257|75653378|FG004|STARTED|Overall Study||4||
59553394|NCT02701257|75653374|FG000|COMPLETED|Overall Study||6||
59553395|NCT02701257|75653375|FG001|COMPLETED|Overall Study||3||
59553396|NCT02701257|75653376|FG002|COMPLETED|Overall Study||0||
59553397|NCT02701257|75653377|FG003|COMPLETED|Overall Study||3||
59553398|NCT02701257|75653378|FG004|COMPLETED|Overall Study||1||
59553399|NCT02701257|75653374|FG000|NOT COMPLETED|Overall Study||0||
59553400|NCT02701257|75653375|FG001|NOT COMPLETED|Overall Study||3||
59553401|NCT02701257|75653376|FG002|NOT COMPLETED|Overall Study||0||
59553402|NCT02701257|75653377|FG003|NOT COMPLETED|Overall Study||1||
59553403|NCT02701257|75653378|FG004|NOT COMPLETED|Overall Study||3||
59553404|NCT01836029|75653396|FG000|STARTED|Overall Study||100||
59553405|NCT01836029|75653397|FG001|STARTED|Overall Study||95||
59553406|NCT01836029|75653396|FG000|COMPLETED|Overall Study||100||
59553407|NCT01836029|75653397|FG001|COMPLETED|Overall Study||95||
59553408|NCT01836029|75653396|FG000|NOT COMPLETED|Overall Study||0||
59553409|NCT01836029|75653397|FG001|NOT COMPLETED|Overall Study||0||
59553410|NCT02701647|75653406|FG000|STARTED|Overall Study||17||
59553411|NCT02701647|75653407|FG001|STARTED|Overall Study||17||
59553412|NCT02701647|75653408|FG002|STARTED|Overall Study||17||
59553413|NCT02701647|75653406|FG000|COMPLETED|Overall Study||17||
59553414|NCT02701647|75653407|FG001|COMPLETED|Overall Study||17||
59553415|NCT02701647|75653408|FG002|COMPLETED|Overall Study|One participant from sham-TT withdraw due a back injury unrelated to study.|16||
59553416|NCT02701647|75653406|FG000|NOT COMPLETED|Overall Study||0||
59553417|NCT02701647|75653407|FG001|NOT COMPLETED|Overall Study||0||
59553418|NCT02701647|75653408|FG002|NOT COMPLETED|Overall Study||1||
59553419|NCT02703909|75653426|FG000|STARTED|Overall Study||36||
59553420|NCT02703909|75653427|FG001|STARTED|Overall Study||37||
59553421|NCT02703909|75653428|FG002|STARTED|Overall Study||36||
59553422|NCT02703909|75653429|FG003|STARTED|Overall Study||35||
59553423|NCT02703909|75653426|FG000|COMPLETED|Overall Study||36||
59553424|NCT02703909|75653427|FG001|COMPLETED|Overall Study||37||
59553425|NCT02703909|75653428|FG002|COMPLETED|Overall Study||36||
59553426|NCT02703909|75653429|FG003|COMPLETED|Overall Study||35||
59553427|NCT02703909|75653426|FG000|NOT COMPLETED|Overall Study||0||
59553428|NCT02703909|75653427|FG001|NOT COMPLETED|Overall Study||0||
59553429|NCT02703909|75653428|FG002|NOT COMPLETED|Overall Study||0||
59553430|NCT02703909|75653429|FG003|NOT COMPLETED|Overall Study||0||
59553431|NCT02703987|75653443|FG000|STARTED|Visit 3 Intervention (1 Day)||14||
59553432|NCT02703987|75653444|FG001|STARTED|Visit 3 Intervention (1 Day)||14||
59553433|NCT02703987|75653443|FG000|COMPLETED|Visit 3 Intervention (1 Day)||13||
59553434|NCT02703987|75653444|FG001|COMPLETED|Visit 3 Intervention (1 Day)||11||
59553435|NCT02703987|75653443|FG000|NOT COMPLETED|Visit 3 Intervention (1 Day)||1||
59553436|NCT02703987|75653444|FG001|NOT COMPLETED|Visit 3 Intervention (1 Day)||3||
59553437|NCT02703987|75653443|FG000|STARTED|Washout (Minimum 5 Days)||13||
59553438|NCT02703987|75653444|FG001|STARTED|Washout (Minimum 5 Days)||11||
59553439|NCT02703987|75653443|FG000|COMPLETED|Washout (Minimum 5 Days)||13||
59553440|NCT02703987|75653444|FG001|COMPLETED|Washout (Minimum 5 Days)||11||
59553441|NCT02703987|75653443|FG000|NOT COMPLETED|Washout (Minimum 5 Days)||0||
59553442|NCT02703987|75653444|FG001|NOT COMPLETED|Washout (Minimum 5 Days)||0||
59553443|NCT02703987|75653443|FG000|STARTED|Visit 4 Intervention (1 Day)||13||
59553444|NCT02703987|75653444|FG001|STARTED|Visit 4 Intervention (1 Day)||11||
59553445|NCT02703987|75653443|FG000|COMPLETED|Visit 4 Intervention (1 Day)||12||
59553446|NCT02703987|75653444|FG001|COMPLETED|Visit 4 Intervention (1 Day)||10||
59553447|NCT02703987|75653443|FG000|NOT COMPLETED|Visit 4 Intervention (1 Day)||1||
59553448|NCT02703987|75653444|FG001|NOT COMPLETED|Visit 4 Intervention (1 Day)||1||
59553449|NCT01836185|75653454|FG000|STARTED|Overall Study||10||
59553450|NCT01836185|75653455|FG001|STARTED|Overall Study||8||
59553451|NCT01836185|75653456|FG002|STARTED|Overall Study||8||
59553452|NCT01836185|75653457|FG003|STARTED|Overall Study||6||
59553453|NCT01836185|75653454|FG000|Received Single Dose of Study Treatment|Overall Study||10||
59553454|NCT01836185|75653455|FG001|Received Single Dose of Study Treatment|Overall Study||8||
59553455|NCT01836185|75653456|FG002|Received Single Dose of Study Treatment|Overall Study||8||
59553456|NCT01836185|75653457|FG003|Received Single Dose of Study Treatment|Overall Study||6||
59553457|NCT01836185|75653454|FG000|COMPLETED|Overall Study||10||
59553458|NCT01836185|75653455|FG001|COMPLETED|Overall Study||8||
59553459|NCT01836185|75653456|FG002|COMPLETED|Overall Study||8||
59553460|NCT01836185|75653457|FG003|COMPLETED|Overall Study||6||
59553461|NCT01836185|75653454|FG000|NOT COMPLETED|Overall Study||0||
59553462|NCT01836185|75653455|FG001|NOT COMPLETED|Overall Study||0||
59553463|NCT01836185|75653456|FG002|NOT COMPLETED|Overall Study||0||
59553464|NCT01836185|75653457|FG003|NOT COMPLETED|Overall Study||0||
59553465|NCT02706249|75653469|FG000|STARTED|Overall Study||25|Patients consented|
59553466|NCT02706249|75653470|FG001|STARTED|Overall Study||25|Patients consented|
59553467|NCT02706249|75653469|FG000|COMPLETED|Overall Study||23|Evaluated for VTE and safety|
59706955|NCT00996892|75825873|FG012|NOT COMPLETED|Expansion Stage 2||0||
59706956|NCT00996892|75825874|FG013|NOT COMPLETED|Expansion Stage 2||0||
59706957|NCT00996892|75825875|FG014|NOT COMPLETED|Expansion Stage 2||0||
59706958|NCT00996892|75825876|FG015|NOT COMPLETED|Expansion Stage 2||0||
59706959|NCT00996892|75825877|FG016|NOT COMPLETED|Expansion Stage 2||0||
59706960|NCT00996892|75825878|FG017|NOT COMPLETED|Expansion Stage 2||0||
59706961|NCT00996892|75825879|FG018|NOT COMPLETED|Expansion Stage 2||35||
59706962|NCT00996892|75825880|FG019|NOT COMPLETED|Expansion Stage 2||0||
59991584|NCT02032823|76107173|FG001|STARTED|Overall Study||915||
59991585|NCT02032823|76107172|FG000|COMPLETED|Overall Study||0||
59991586|NCT02032823|76107173|FG001|COMPLETED|Overall Study||0||
59991587|NCT02032823|76107172|FG000|NOT COMPLETED|Overall Study||921||
59991588|NCT02032823|76107173|FG001|NOT COMPLETED|Overall Study||915||
59991589|NCT01708954|76107182|FG000|STARTED|Step 1||42||
59991590|NCT01708954|76107183|FG001|STARTED|Step 1||40||
59991591|NCT01708954|76107184|FG002|STARTED|Step 1||43||
59991592|NCT01708954|76107182|FG000|Started Protocol Therapy|Step 1||40||
59991593|NCT01708954|76107183|FG001|Started Protocol Therapy|Step 1||40||
59991594|NCT01708954|76107184|FG002|Started Protocol Therapy|Step 1||39||
59991595|NCT01708954|76107182|FG000|Eligible and Treated|Step 1||38||
59553468|NCT02706249|75653470|FG001|COMPLETED|Overall Study||24|Evaluated for VTE and safety|
59553469|NCT02706249|75653469|FG000|NOT COMPLETED|Overall Study||2||
59553470|NCT02706249|75653470|FG001|NOT COMPLETED|Overall Study||1||
59553471|NCT00559949|75653478|FG000|STARTED|Overall Study||39||
59553472|NCT00559949|75653478|FG000|COMPLETED|Overall Study||32||
59553473|NCT00559949|75653478|FG000|NOT COMPLETED|Overall Study||7||
59553474|NCT01837901|75653485|FG000|STARTED|Overall Study||22||
59553475|NCT01837901|75653486|FG001|STARTED|Overall Study||21||
59553476|NCT01837901|75653487|FG002|STARTED|Overall Study||20||
59706963|NCT00996892|75825861|FG000|STARTED|Expansion Stage 2A||0||
59991596|NCT01708954|76107183|FG001|Eligible and Treated|Step 1||38||
59991597|NCT01708954|76107184|FG002|Eligible and Treated|Step 1||35||
59991598|NCT01708954|76107182|FG000|Patients With MET Status Data Available|Step 1||30||
59991599|NCT01708954|76107183|FG001|Patients With MET Status Data Available|Step 1||32||
59991600|NCT01708954|76107184|FG002|Patients With MET Status Data Available|Step 1||24||
59991601|NCT01708954|76107182|FG000|COMPLETED|Step 1|Treatment continued until progressive disease or unacceptable toxicity.|0||
59991602|NCT01708954|76107183|FG001|COMPLETED|Step 1|Treatment continued until progressive disease or unacceptable toxicity.|0||
59991603|NCT01708954|76107184|FG002|COMPLETED|Step 1|Treatment continued until progressive disease or unacceptable toxicity.|0||
59706964|NCT00996892|75825862|FG001|STARTED|Expansion Stage 2A||0||
59706965|NCT00996892|75825863|FG002|STARTED|Expansion Stage 2A||0||
59706966|NCT00996892|75825864|FG003|STARTED|Expansion Stage 2A||0||
59706967|NCT00996892|75825865|FG004|STARTED|Expansion Stage 2A||0||
59553477|NCT01837901|75653485|FG000|COMPLETED|Overall Study||20||
59553478|NCT01837901|75653486|FG001|COMPLETED|Overall Study||15||
59553479|NCT01837901|75653487|FG002|COMPLETED|Overall Study||17||
59553480|NCT01837901|75653485|FG000|NOT COMPLETED|Overall Study||2||
59553481|NCT01837901|75653486|FG001|NOT COMPLETED|Overall Study||6||
59553482|NCT01837901|75653487|FG002|NOT COMPLETED|Overall Study||3||
59553483|NCT02708433|75653495|FG000|STARTED|First Intervention (Visit 1)||12||
59553484|NCT02708433|75653496|FG001|STARTED|First Intervention (Visit 1)||11||
59553485|NCT02708433|75653495|FG000|COMPLETED|First Intervention (Visit 1)||12||
59553486|NCT02708433|75653496|FG001|COMPLETED|First Intervention (Visit 1)||11||
59553487|NCT02708433|75653495|FG000|NOT COMPLETED|First Intervention (Visit 1)||0||
59553488|NCT02708433|75653496|FG001|NOT COMPLETED|First Intervention (Visit 1)||0||
59553489|NCT02708433|75653495|FG000|STARTED|Washout (at Least 1 Week)||12||
59553490|NCT02708433|75653496|FG001|STARTED|Washout (at Least 1 Week)||11||
59553491|NCT02708433|75653495|FG000|COMPLETED|Washout (at Least 1 Week)||12||
59553492|NCT02708433|75653496|FG001|COMPLETED|Washout (at Least 1 Week)||11||
59553493|NCT02708433|75653495|FG000|NOT COMPLETED|Washout (at Least 1 Week)||0||
59553494|NCT02708433|75653496|FG001|NOT COMPLETED|Washout (at Least 1 Week)||0||
59553495|NCT02708433|75653495|FG000|STARTED|Second Intervention (Visit 2)||12||
59553496|NCT02708433|75653496|FG001|STARTED|Second Intervention (Visit 2)||11||
59553497|NCT02708433|75653495|FG000|COMPLETED|Second Intervention (Visit 2)||12||
59553498|NCT02708433|75653496|FG001|COMPLETED|Second Intervention (Visit 2)||11||
59553499|NCT02708433|75653495|FG000|NOT COMPLETED|Second Intervention (Visit 2)||0||
59553500|NCT02708433|75653496|FG001|NOT COMPLETED|Second Intervention (Visit 2)||0||
59553501|NCT02708745|75653506|FG000|STARTED|Overall Study||91||
59553502|NCT02708745|75653507|FG001|STARTED|Overall Study||69||
59553503|NCT02708745|75653508|FG002|STARTED|Overall Study||204||
59553504|NCT02708745|75653509|FG003|STARTED|Overall Study||198||
59553505|NCT02708745|75653506|FG000|COMPLETED|Overall Study||91||
59553506|NCT02708745|75653507|FG001|COMPLETED|Overall Study||65||
59553507|NCT02708745|75653508|FG002|COMPLETED|Overall Study||121||
59553508|NCT02708745|75653509|FG003|COMPLETED|Overall Study||116||
59553509|NCT02708745|75653506|FG000|NOT COMPLETED|Overall Study||0||
59553510|NCT02708745|75653507|FG001|NOT COMPLETED|Overall Study||4||
59553511|NCT02708745|75653508|FG002|NOT COMPLETED|Overall Study||83||
59553512|NCT02708745|75653509|FG003|NOT COMPLETED|Overall Study||82||
59553513|NCT02712099|75653523|FG000|STARTED|Overall Study||30||
59553514|NCT02712099|75653524|FG001|STARTED|Overall Study||20||
59553515|NCT02712099|75653523|FG000|COMPLETED|Overall Study||30||
59553516|NCT02712099|75653524|FG001|COMPLETED|Overall Study||20||
59553517|NCT02712099|75653523|FG000|NOT COMPLETED|Overall Study||0||
59553518|NCT02712099|75653524|FG001|NOT COMPLETED|Overall Study||0||
59553519|NCT00559637|75653530|FG000|STARTED|Overall Study||184||
59553520|NCT00559637|75653530|FG000|COMPLETED|Overall Study||130||
59553521|NCT00559637|75653530|FG000|NOT COMPLETED|Overall Study||54||
59553522|NCT02713425|75653534|FG000|STARTED|Overall Study||20||
59553523|NCT02713425|75653534|FG000|COMPLETED|Overall Study||20||
59553524|NCT02713425|75653534|FG000|NOT COMPLETED|Overall Study||0||
59553525|NCT01840319|75653538|FG000|STARTED|Overall Study||156||
59553526|NCT01840319|75653538|FG000|COMPLETED|Overall Study||156||
59553527|NCT01840319|75653538|FG000|NOT COMPLETED|Overall Study||0||
59553528|NCT01841021|75653542|FG000|STARTED|Overall Study||1||
59553529|NCT01841021|75653542|FG000|COMPLETED|Overall Study||1||
59553530|NCT01841021|75653542|FG000|NOT COMPLETED|Overall Study||0||
59553531|NCT02713659|75653548|FG000|STARTED|Baseline||60||
59553532|NCT02713659|75653549|FG001|STARTED|Baseline||60||
59706968|NCT00996892|75825866|FG005|STARTED|Expansion Stage 2A||0||
59553533|NCT02713659|75653548|FG000|COMPLETED|Baseline||60||
59553534|NCT02713659|75653549|FG001|COMPLETED|Baseline||60||
59553535|NCT02713659|75653548|FG000|NOT COMPLETED|Baseline||0||
59553536|NCT02713659|75653549|FG001|NOT COMPLETED|Baseline||0||
59553537|NCT02713659|75653548|FG000|STARTED|6 Month Study Visit||60||
59553538|NCT02713659|75653549|FG001|STARTED|6 Month Study Visit||60||
59553539|NCT02713659|75653548|FG000|COMPLETED|6 Month Study Visit||53||
59553540|NCT02713659|75653549|FG001|COMPLETED|6 Month Study Visit||47||
59553541|NCT02713659|75653548|FG000|NOT COMPLETED|6 Month Study Visit||7||
59553542|NCT02713659|75653549|FG001|NOT COMPLETED|6 Month Study Visit||13||
59553543|NCT02713659|75653548|FG000|STARTED|12 Month Study Visit||57||
59553544|NCT02713659|75653549|FG001|STARTED|12 Month Study Visit||55||
59553545|NCT02713659|75653548|FG000|COMPLETED|12 Month Study Visit||54||
59553546|NCT02713659|75653549|FG001|COMPLETED|12 Month Study Visit||52||
59553547|NCT02713659|75653548|FG000|NOT COMPLETED|12 Month Study Visit||3||
59553548|NCT02713659|75653549|FG001|NOT COMPLETED|12 Month Study Visit||3||
59553549|NCT02713659|75653548|FG000|STARTED|18 Month Study Visit||58||
59553550|NCT02713659|75653549|FG001|STARTED|18 Month Study Visit||53||
59553551|NCT02713659|75653548|FG000|COMPLETED|18 Month Study Visit||50||
59553552|NCT02713659|75653549|FG001|COMPLETED|18 Month Study Visit||50||
59553553|NCT02713659|75653548|FG000|NOT COMPLETED|18 Month Study Visit||8||
59553554|NCT02713659|75653549|FG001|NOT COMPLETED|18 Month Study Visit||3||
59553555|NCT02713659|75653548|FG000|STARTED|24 Month Study Visit||57||
59553556|NCT02713659|75653549|FG001|STARTED|24 Month Study Visit||52||
59553557|NCT02713659|75653548|FG000|COMPLETED|24 Month Study Visit||49||
59553558|NCT02713659|75653549|FG001|COMPLETED|24 Month Study Visit||44||
59553559|NCT02713659|75653548|FG000|NOT COMPLETED|24 Month Study Visit||8||
59553560|NCT02713659|75653549|FG001|NOT COMPLETED|24 Month Study Visit||8||
59553561|NCT01842815|75653555|FG000|STARTED|Overall Study||20||26
59553562|NCT01842815|75653555|FG000|COMPLETED|Overall Study||16||22
59553563|NCT01842815|75653555|FG000|NOT COMPLETED|Overall Study||4||4
59553564|NCT02714283|75653562|FG000|STARTED|Overall Study||83589|Treatment episode start|
59553565|NCT02714283|75653563|FG001|STARTED|Overall Study||6500|Treatment episode start|
59816494|NCT00517634|75938897|FG002|NOT COMPLETED|Second Treatment Period||0||
59553566|NCT02714283|75653562|FG000|COMPLETED|Overall Study||83589|Earliest date: death, 1st outcome occurrence, study end, lost coverage, treatment stop or switch|
59553567|NCT02714283|75653563|FG001|COMPLETED|Overall Study||6500|Earliest date: death, 1st outcome occurrence, study end, lost coverage, treatment stop or switch|
59553568|NCT02714283|75653562|FG000|NOT COMPLETED|Overall Study||0||
59553569|NCT02714283|75653563|FG001|NOT COMPLETED|Overall Study||0||
59553570|NCT02718963|75653575|FG000|STARTED|Overall Study||10||
59553571|NCT02718963|75653576|FG001|STARTED|Overall Study||10||
59553572|NCT02718963|75653575|FG000|COMPLETED|Overall Study||9||
59553573|NCT02718963|75653576|FG001|COMPLETED|Overall Study||9||
59553574|NCT02718963|75653575|FG000|NOT COMPLETED|Overall Study||1||
59553575|NCT02718963|75653576|FG001|NOT COMPLETED|Overall Study||1||
59706969|NCT00996892|75825867|FG006|STARTED|Expansion Stage 2A||0||
59706970|NCT00996892|75825868|FG007|STARTED|Expansion Stage 2A||0||
59706971|NCT00996892|75825869|FG008|STARTED|Expansion Stage 2A||0||
59706972|NCT00996892|75825870|FG009|STARTED|Expansion Stage 2A||0||
59706973|NCT00996892|75825871|FG010|STARTED|Expansion Stage 2A||0||
59991604|NCT01708954|76107182|FG000|NOT COMPLETED|Step 1||42||
59991605|NCT01708954|76107183|FG001|NOT COMPLETED|Step 1||40||
59991606|NCT01708954|76107184|FG002|NOT COMPLETED|Step 1||43||
59991607|NCT01708954|76107182|FG000|STARTED|Step 2|Only patients with disease progression in Step 1 are eligible to register to Step 2.|13||
59706974|NCT00996892|75825872|FG011|STARTED|Expansion Stage 2A||0||
59706975|NCT00996892|75825873|FG012|STARTED|Expansion Stage 2A||0||
59706976|NCT00996892|75825874|FG013|STARTED|Expansion Stage 2A||0||
59991608|NCT01708954|76107183|FG001|STARTED|Step 2|Only patients with disease progression in Step 1 are eligible to register to Step 2.|7||
59553576|NCT02722239|75653584|FG000|STARTED|Overall Study||20||
59553577|NCT02722239|75653585|FG001|STARTED|Overall Study||20||
59553578|NCT02722239|75653584|FG000|First Intervention (1 Day)|Overall Study||20||
59553579|NCT02722239|75653585|FG001|First Intervention (1 Day)|Overall Study||20||
59553580|NCT02722239|75653584|FG000|Washout (7 Days)|Overall Study||20||
59553581|NCT02722239|75653585|FG001|Washout (7 Days)|Overall Study||20||
59553582|NCT02722239|75653584|FG000|Second Intervention (1 Day)|Overall Study||20||
59553583|NCT02722239|75653585|FG001|Second Intervention (1 Day)|Overall Study||20||
59553584|NCT02722239|75653584|FG000|COMPLETED|Overall Study||20||
59553585|NCT02722239|75653585|FG001|COMPLETED|Overall Study||20||
59553586|NCT02722239|75653584|FG000|NOT COMPLETED|Overall Study||0||
59553587|NCT02722239|75653585|FG001|NOT COMPLETED|Overall Study||0||
59553588|NCT01845155|75653594|FG000|STARTED|Overall Study||146||
60083214|NCT01519323|76198846|FG001|STARTED|Overall Study||3||
60083215|NCT01519323|76198845|FG000|COMPLETED|Overall Study||0||
60083216|NCT01519323|76198846|FG001|COMPLETED|Overall Study||0||
60083217|NCT01519323|76198845|FG000|NOT COMPLETED|Overall Study||3||
60083218|NCT01519323|76198846|FG001|NOT COMPLETED|Overall Study||3||
60083219|NCT01519245|76198854|FG000|STARTED|Overall Study||24||
60083220|NCT01519245|76198855|FG001|STARTED|Overall Study||20||
60083221|NCT01519245|76198854|FG000|Received Pre-pump IV TXA|Overall Study|Two patients included in in the final analysis did not receive pre-pump IV TXA.|21||
60083222|NCT01519245|76198855|FG001|Received Pre-pump IV TXA|Overall Study|All patients meeting inclusion criteria received appropriate dosing, as per protocol.|18||
60083223|NCT01519245|76198854|FG000|Received Post-pump IV TXA|Overall Study|A break in protocol, dosing was given in the operating room at the surgeon's preference.|6||
60083224|NCT01519245|76198855|FG001|Received Post-pump IV TXA|Overall Study|A break in protocol, dosing was given in the operating room at the surgeon's preference.|2||
60083225|NCT01519245|76198854|FG000|COMPLETED|Overall Study||23||
60083226|NCT01519245|76198855|FG001|COMPLETED|Overall Study||18||
60083227|NCT01519245|76198854|FG000|NOT COMPLETED|Overall Study||1||
59553589|NCT01845155|75653595|FG001|STARTED|Overall Study||144||
59553590|NCT01845155|75653594|FG000|COMPLETED|Overall Study||145||
59553591|NCT01845155|75653595|FG001|COMPLETED|Overall Study||144||
60083228|NCT01519245|76198855|FG001|NOT COMPLETED|Overall Study||2||
60083229|NCT01519167|76198865|FG000|STARTED|Overall Study||1||
60083230|NCT01519167|76198866|FG001|STARTED|Overall Study||89||
60083231|NCT01519167|76198865|FG000|COMPLETED|Overall Study||1||
60083232|NCT01519167|76198866|FG001|COMPLETED|Overall Study||81||
60083233|NCT01519167|76198865|FG000|NOT COMPLETED|Overall Study||0||
60083234|NCT01519167|76198866|FG001|NOT COMPLETED|Overall Study||8||
60083235|NCT00343564|76198883|FG000|STARTED|Overall Study||6||
60083236|NCT00343564|76198884|FG001|STARTED|Overall Study||7||
60083237|NCT00343564|76198885|FG002|STARTED|Overall Study||3||
60083238|NCT00343564|76198886|FG003|STARTED|Overall Study||7||
60083239|NCT00343564|76198887|FG004|STARTED|Overall Study||10||
60083240|NCT00343564|76198888|FG005|STARTED|Overall Study||9||
60083241|NCT00343564|76198889|FG006|STARTED|Overall Study||4||
60083242|NCT00343564|76198890|FG007|STARTED|Overall Study||3||
60083243|NCT00343564|76198891|FG008|STARTED|Overall Study||3||
60083244|NCT00343564|76198892|FG009|STARTED|Overall Study||8||
60083245|NCT00343564|76198893|FG010|STARTED|Overall Study||8||
60083246|NCT00343564|76198883|FG000|COMPLETED|Overall Study||6||
60083247|NCT00343564|76198884|FG001|COMPLETED|Overall Study||7||
60083248|NCT00343564|76198885|FG002|COMPLETED|Overall Study||3||
60083249|NCT00343564|76198886|FG003|COMPLETED|Overall Study||7||
60083250|NCT00343564|76198887|FG004|COMPLETED|Overall Study||10||
60083251|NCT00343564|76198888|FG005|COMPLETED|Overall Study||9||
60083252|NCT00343564|76198889|FG006|COMPLETED|Overall Study||4||
60083253|NCT00343564|76198890|FG007|COMPLETED|Overall Study||3||
60083254|NCT00343564|76198891|FG008|COMPLETED|Overall Study||3||
60083255|NCT00343564|76198892|FG009|COMPLETED|Overall Study||8||
60083256|NCT00343564|76198893|FG010|COMPLETED|Overall Study||8||
60083257|NCT00343564|76198883|FG000|NOT COMPLETED|Overall Study||0||
59553592|NCT01845155|75653594|FG000|NOT COMPLETED|Overall Study||1||
59553593|NCT01845155|75653595|FG001|NOT COMPLETED|Overall Study||0||
59553594|NCT02578641|75653603|FG000|STARTED|Overall Study||164||
59553595|NCT02578641|75653604|FG001|STARTED|Overall Study||166||
59553596|NCT02578641|75653603|FG000|Treatment Received: Gemcitabine/ Carboplatin|Overall Study||163||
59553597|NCT02578641|75653604|FG001|Treatment Received: Gemcitabine/ Carboplatin|Overall Study||162||
60083258|NCT00343564|76198884|FG001|NOT COMPLETED|Overall Study||0||
60083259|NCT00343564|76198885|FG002|NOT COMPLETED|Overall Study||0||
60083260|NCT00343564|76198886|FG003|NOT COMPLETED|Overall Study||0||
60083261|NCT00343564|76198887|FG004|NOT COMPLETED|Overall Study||0||
60083262|NCT00343564|76198888|FG005|NOT COMPLETED|Overall Study||0||
60083263|NCT00343564|76198889|FG006|NOT COMPLETED|Overall Study||0||
60083264|NCT00343564|76198890|FG007|NOT COMPLETED|Overall Study||0||
60083265|NCT00343564|76198891|FG008|NOT COMPLETED|Overall Study||0||
60083266|NCT00343564|76198892|FG009|NOT COMPLETED|Overall Study||0||
60083267|NCT00343564|76198893|FG010|NOT COMPLETED|Overall Study||0||
59553598|NCT02578641|75653603|FG000|Treatment Received: EBV-CTL|Overall Study||133||
59553599|NCT02578641|75653604|FG001|Treatment Received: EBV-CTL|Overall Study||0||
59553600|NCT02578641|75653603|FG000|COMPLETED|Overall Study||55||
59553601|NCT02578641|75653604|FG001|COMPLETED|Overall Study||99||
59553602|NCT02578641|75653603|FG000|NOT COMPLETED|Overall Study||109||
59816495|NCT00517634|75938898|FG003|NOT COMPLETED|Second Treatment Period||0||
59816496|NCT00517634|75938899|FG004|NOT COMPLETED|Second Treatment Period||1||
59816497|NCT00517634|75938900|FG005|NOT COMPLETED|Second Treatment Period||0||
59816498|NCT00517634|75938895|FG000|STARTED|Third Treatment Period||4||
59816499|NCT00517634|75938896|FG001|STARTED|Third Treatment Period||4||
59816500|NCT00517634|75938897|FG002|STARTED|Third Treatment Period||4||
59816501|NCT00517634|75938898|FG003|STARTED|Third Treatment Period||3||
59816502|NCT00517634|75938899|FG004|STARTED|Third Treatment Period||3||
59816503|NCT00517634|75938900|FG005|STARTED|Third Treatment Period||4||
59816504|NCT00517634|75938895|FG000|COMPLETED|Third Treatment Period||4||
59816505|NCT00517634|75938896|FG001|COMPLETED|Third Treatment Period||4||
59816506|NCT00517634|75938897|FG002|COMPLETED|Third Treatment Period||4||
59816507|NCT00517634|75938898|FG003|COMPLETED|Third Treatment Period||3||
59816508|NCT00517634|75938899|FG004|COMPLETED|Third Treatment Period||3||
59816509|NCT00517634|75938900|FG005|COMPLETED|Third Treatment Period||4||
59816510|NCT00517634|75938895|FG000|NOT COMPLETED|Third Treatment Period||0||
59816511|NCT00517634|75938896|FG001|NOT COMPLETED|Third Treatment Period||0||
59816512|NCT00517634|75938897|FG002|NOT COMPLETED|Third Treatment Period||0||
59816513|NCT00517634|75938898|FG003|NOT COMPLETED|Third Treatment Period||0||
59816514|NCT00517634|75938899|FG004|NOT COMPLETED|Third Treatment Period||0||
59816515|NCT00517634|75938900|FG005|NOT COMPLETED|Third Treatment Period||0||
59816516|NCT03683576|75938912|FG000|STARTED|Overall Study||120|Randomized and treated. One participant randomized to GB001 40 mg was never treated and was therefore excluded from the Intent-to-Treat (ITT) and Safety Analysis Populations.|
59816517|NCT03683576|75938913|FG001|STARTED|Overall Study||120|Randomized and treated. One participant randomized to GB001 40 mg was never treated and was therefore excluded from the Intent-to-Treat (ITT) and Safety Analysis Populations.|
59816518|NCT03683576|75938914|FG002|STARTED|Overall Study||118|Randomized and treated. One participant randomized to GB001 40 mg was never treated and was therefore excluded from the Intent-to-Treat (ITT) and Safety Analysis Populations.|
59816519|NCT03683576|75938915|FG003|STARTED|Overall Study||122|Randomized and treated. One participant randomized to GB001 40 mg was never treated and was therefore excluded from the Intent-to-Treat (ITT) and Safety Analysis Populations.|
59816520|NCT03683576|75938912|FG000|COMPLETED|Overall Study||114||
59816521|NCT03683576|75938913|FG001|COMPLETED|Overall Study||116||
59816522|NCT03683576|75938914|FG002|COMPLETED|Overall Study||106||
59816523|NCT03683576|75938915|FG003|COMPLETED|Overall Study||114||
59816524|NCT03683576|75938912|FG000|NOT COMPLETED|Overall Study||6||
59816525|NCT03683576|75938913|FG001|NOT COMPLETED|Overall Study||4||
59816526|NCT03683576|75938914|FG002|NOT COMPLETED|Overall Study||12||
59816527|NCT03683576|75938915|FG003|NOT COMPLETED|Overall Study||8||
59816528|NCT03863834|75938925|FG000|STARTED|Overall Study||12||
59816529|NCT03863834|75938925|FG000|COMPLETED|Overall Study||9||
59816530|NCT03863834|75938925|FG000|NOT COMPLETED|Overall Study||3||
59816531|NCT00430521|75938937|FG000|STARTED|Overall Study||63||
59816532|NCT00430521|75938938|FG001|STARTED|Overall Study||66||
59816533|NCT00430521|75938939|FG002|STARTED|Overall Study||64||
59816534|NCT00430521|75938940|FG003|STARTED|Overall Study||63||
59816535|NCT00430521|75938941|FG004|STARTED|Overall Study||64||
59816536|NCT00430521|75938942|FG005|STARTED|Overall Study||64||
59816537|NCT00430521|75938943|FG006|STARTED|Overall Study||65||
59816538|NCT00430521|75938944|FG007|STARTED|Overall Study||63||
59553603|NCT02578641|75653604|FG001|NOT COMPLETED|Overall Study||67||
59816539|NCT00430521|75938937|FG000|COMPLETED|Overall Study||52||
59706977|NCT00996892|75825875|FG014|STARTED|Expansion Stage 2A||0||
59706978|NCT00996892|75825876|FG015|STARTED|Expansion Stage 2A||0||
59706979|NCT00996892|75825877|FG016|STARTED|Expansion Stage 2A||0||
59706980|NCT00996892|75825878|FG017|STARTED|Expansion Stage 2A||0||
59706981|NCT00996892|75825879|FG018|STARTED|Expansion Stage 2A||0||
59706982|NCT00996892|75825880|FG019|STARTED|Expansion Stage 2A||45||
59706983|NCT00996892|75825861|FG000|COMPLETED|Expansion Stage 2A||0||
59706984|NCT00996892|75825862|FG001|COMPLETED|Expansion Stage 2A||0||
59706985|NCT00996892|75825863|FG002|COMPLETED|Expansion Stage 2A||0||
59706986|NCT00996892|75825864|FG003|COMPLETED|Expansion Stage 2A||0||
59706987|NCT00996892|75825865|FG004|COMPLETED|Expansion Stage 2A||0||
59706988|NCT00996892|75825866|FG005|COMPLETED|Expansion Stage 2A||0||
59706989|NCT00996892|75825867|FG006|COMPLETED|Expansion Stage 2A||0||
59706990|NCT00996892|75825868|FG007|COMPLETED|Expansion Stage 2A||0||
59706991|NCT00996892|75825869|FG008|COMPLETED|Expansion Stage 2A||0||
59706992|NCT00996892|75825870|FG009|COMPLETED|Expansion Stage 2A||0||
59706993|NCT00996892|75825871|FG010|COMPLETED|Expansion Stage 2A||0||
59706994|NCT00996892|75825872|FG011|COMPLETED|Expansion Stage 2A||0||
59706995|NCT00996892|75825873|FG012|COMPLETED|Expansion Stage 2A||0||
59706996|NCT00996892|75825874|FG013|COMPLETED|Expansion Stage 2A||0||
59706997|NCT00996892|75825875|FG014|COMPLETED|Expansion Stage 2A||0||
59706998|NCT00996892|75825876|FG015|COMPLETED|Expansion Stage 2A||0||
59706999|NCT00996892|75825877|FG016|COMPLETED|Expansion Stage 2A||0||
59707000|NCT00996892|75825878|FG017|COMPLETED|Expansion Stage 2A||0||
59707001|NCT00996892|75825879|FG018|COMPLETED|Expansion Stage 2A||0||
59707002|NCT00996892|75825880|FG019|COMPLETED|Expansion Stage 2A||0||
59707003|NCT00996892|75825861|FG000|NOT COMPLETED|Expansion Stage 2A||0||
59707004|NCT00996892|75825862|FG001|NOT COMPLETED|Expansion Stage 2A||0||
59707005|NCT00996892|75825863|FG002|NOT COMPLETED|Expansion Stage 2A||0||
59707006|NCT00996892|75825864|FG003|NOT COMPLETED|Expansion Stage 2A||0||
59707007|NCT00996892|75825865|FG004|NOT COMPLETED|Expansion Stage 2A||0||
59707008|NCT00996892|75825866|FG005|NOT COMPLETED|Expansion Stage 2A||0||
59707009|NCT00996892|75825867|FG006|NOT COMPLETED|Expansion Stage 2A||0||
59707010|NCT00996892|75825868|FG007|NOT COMPLETED|Expansion Stage 2A||0||
59707011|NCT00996892|75825869|FG008|NOT COMPLETED|Expansion Stage 2A||0||
59707012|NCT00996892|75825870|FG009|NOT COMPLETED|Expansion Stage 2A||0||
59707013|NCT00996892|75825871|FG010|NOT COMPLETED|Expansion Stage 2A||0||
59707014|NCT00996892|75825872|FG011|NOT COMPLETED|Expansion Stage 2A||0||
59707015|NCT00996892|75825873|FG012|NOT COMPLETED|Expansion Stage 2A||0||
59707016|NCT00996892|75825874|FG013|NOT COMPLETED|Expansion Stage 2A||0||
59707017|NCT00996892|75825875|FG014|NOT COMPLETED|Expansion Stage 2A||0||
59707018|NCT00996892|75825876|FG015|NOT COMPLETED|Expansion Stage 2A||0||
59707019|NCT00996892|75825877|FG016|NOT COMPLETED|Expansion Stage 2A||0||
59816540|NCT00430521|75938938|FG001|COMPLETED|Overall Study||57||
59816541|NCT00430521|75938939|FG002|COMPLETED|Overall Study||61||
59816542|NCT00430521|75938940|FG003|COMPLETED|Overall Study||55||
59816543|NCT00430521|75938941|FG004|COMPLETED|Overall Study||59||
59816544|NCT00430521|75938942|FG005|COMPLETED|Overall Study||59||
59816545|NCT00430521|75938943|FG006|COMPLETED|Overall Study||55||
59816546|NCT00430521|75938944|FG007|COMPLETED|Overall Study||51||
59816547|NCT00430521|75938937|FG000|NOT COMPLETED|Overall Study||11||
59816548|NCT00430521|75938938|FG001|NOT COMPLETED|Overall Study||9||
59816549|NCT00430521|75938939|FG002|NOT COMPLETED|Overall Study||3||
59816550|NCT00430521|75938940|FG003|NOT COMPLETED|Overall Study||8||
59816551|NCT00430521|75938941|FG004|NOT COMPLETED|Overall Study||5||
59816552|NCT00430521|75938942|FG005|NOT COMPLETED|Overall Study||5||
59816553|NCT00430521|75938943|FG006|NOT COMPLETED|Overall Study||10||
59816554|NCT00430521|75938944|FG007|NOT COMPLETED|Overall Study||12||
59816555|NCT00429663|75938977|FG000|STARTED|Overall Study||76||
59816556|NCT00429663|75938978|FG001|STARTED|Overall Study||80||
59816557|NCT00429663|75938977|FG000|COMPLETED|Overall Study||40||
59816558|NCT00429663|75938978|FG001|COMPLETED|Overall Study||41||
59816559|NCT00429663|75938977|FG000|NOT COMPLETED|Overall Study||36||
59816560|NCT00429663|75938978|FG001|NOT COMPLETED|Overall Study||39||
59816561|NCT00429585|75938986|FG000|STARTED|Overall Study||52||
59816562|NCT00429585|75938987|FG001|STARTED|Overall Study||47||
59816563|NCT00429585|75938986|FG000|COMPLETED|Overall Study||22||
59816564|NCT00429585|75938987|FG001|COMPLETED|Overall Study||27||
59816565|NCT00429585|75938986|FG000|NOT COMPLETED|Overall Study||30||
59816566|NCT00429585|75938987|FG001|NOT COMPLETED|Overall Study||20||
59816567|NCT05822921|75938995|FG000|STARTED|Overall Study||11||
59816568|NCT05822921|75938996|FG001|STARTED|Overall Study||9||
59816569|NCT05822921|75938995|FG000|COMPLETED|Overall Study||10||
59816570|NCT05822921|75938996|FG001|COMPLETED|Overall Study||8||
59553604|NCT01846871|75653610|FG000|STARTED|Overall Study||10||
59553605|NCT01846871|75653610|FG000|COMPLETED|Overall Study||10||
59553606|NCT01846871|75653610|FG000|NOT COMPLETED|Overall Study||0||
59553607|NCT02431260|75653632|FG000|STARTED|Overall Study||4||
59553608|NCT02431260|75653633|FG001|STARTED|Overall Study||5||
59553609|NCT02431260|75653634|FG002|STARTED|Overall Study||6||
59553610|NCT02431260|75653635|FG003|STARTED|Overall Study||5||
59553611|NCT02431260|75653636|FG004|STARTED|Overall Study||3||
59553612|NCT02431260|75653637|FG005|STARTED|Overall Study||4||
59553613|NCT02431260|75653638|FG006|STARTED|Overall Study||4||
59553614|NCT02431260|75653639|FG007|STARTED|Overall Study||3||
59553615|NCT02431260|75653640|FG008|STARTED|Overall Study||8||
59553616|NCT02431260|75653641|FG009|STARTED|Overall Study||8||
59553617|NCT02431260|75653642|FG010|STARTED|Overall Study||4||
59553618|NCT02431260|75653643|FG011|STARTED|Overall Study||4||
59553619|NCT02431260|75653644|FG012|STARTED|Overall Study||10||
59816571|NCT05822921|75938995|FG000|NOT COMPLETED|Overall Study||1||
59816572|NCT05822921|75938996|FG001|NOT COMPLETED|Overall Study||1||
59816573|NCT05160025|75939002|FG000|STARTED|Overall Study||22||
59816574|NCT05160025|75939002|FG000|COMPLETED|Overall Study||22||
59816575|NCT05160025|75939002|FG000|NOT COMPLETED|Overall Study||0||
59816576|NCT05094154|75939008|FG000|STARTED|Overall Study||1277||
59816577|NCT05094154|75939009|FG001|STARTED|Overall Study||1357||
59816578|NCT05094154|75939008|FG000|COMPLETED|Overall Study||1214||
59553620|NCT02431260|75653645|FG013|STARTED|Overall Study||1||
59553621|NCT02431260|75653632|FG000|COMPLETED|Overall Study||0||
59553622|NCT02431260|75653633|FG001|COMPLETED|Overall Study||0||
59553623|NCT02431260|75653634|FG002|COMPLETED|Overall Study||0||
59553624|NCT02431260|75653635|FG003|COMPLETED|Overall Study||0||
59553625|NCT02431260|75653636|FG004|COMPLETED|Overall Study||0||
59553626|NCT02431260|75653637|FG005|COMPLETED|Overall Study||0||
59553627|NCT02431260|75653638|FG006|COMPLETED|Overall Study||0||
59553628|NCT02431260|75653639|FG007|COMPLETED|Overall Study||0||
59816579|NCT05094154|75939009|FG001|COMPLETED|Overall Study||1297||
59816580|NCT05094154|75939008|FG000|NOT COMPLETED|Overall Study||63||
59707020|NCT00996892|75825878|FG017|NOT COMPLETED|Expansion Stage 2A||0||
59707021|NCT00996892|75825879|FG018|NOT COMPLETED|Expansion Stage 2A||0||
59707022|NCT00996892|75825880|FG019|NOT COMPLETED|Expansion Stage 2A||45||
59707023|NCT01257581|75825944|FG000|STARTED|Overall Study||22||
59707024|NCT01257581|75825945|FG001|STARTED|Overall Study||21||
60083268|NCT00318136|76198988|FG000|STARTED|Overall Study||47||
60083269|NCT00318136|76198988|FG000|COMPLETED|Overall Study||2||
60083270|NCT00318136|76198988|FG000|NOT COMPLETED|Overall Study||45||
60083271|NCT00318292|76198994|FG000|STARTED|Overall Study||45||
60083272|NCT00318292|76198995|FG001|STARTED|Overall Study||45||
60083273|NCT00318292|76198994|FG000|COMPLETED|Overall Study||45||
60083274|NCT00318292|76198995|FG001|COMPLETED|Overall Study||45||
60083275|NCT00318292|76198994|FG000|NOT COMPLETED|Overall Study||0||
60083276|NCT00318292|76198995|FG001|NOT COMPLETED|Overall Study||0||
60083277|NCT02105740|76199003|FG000|STARTED|Overall Study|Application of EVA and HADS scales and after that application of hypnosis intervention|12||
60083278|NCT02105740|76199004|FG001|STARTED|Overall Study|Application of EVA and HADS scales|12||
60083279|NCT02105740|76199003|FG000|Second|Overall Study|Intervention with hypnosis and application of EVA scales and HADS (n = 12)|12||
60083280|NCT02105740|76199004|FG001|Second|Overall Study|Application of EVA and HADS scales. One accompanying lost|11||
60083281|NCT02105740|76199003|FG000|COMPLETED|Overall Study|Application of EVA and HADS scales and data analysis|12||
60083282|NCT02105740|76199004|FG001|COMPLETED|Overall Study|Application of EVA and HADS scales and data analysis|11||
60083283|NCT02105740|76199003|FG000|NOT COMPLETED|Overall Study||0||
60083284|NCT02105740|76199004|FG001|NOT COMPLETED|Overall Study||1||
60083285|NCT00320242|76199012|FG000|STARTED|Overall Study||16||
60083286|NCT00320242|76199013|FG001|STARTED|Overall Study||16||
60083287|NCT00320242|76199012|FG000|COMPLETED|Overall Study||14||
60083288|NCT00320242|76199013|FG001|COMPLETED|Overall Study||12||
60083289|NCT00320242|76199012|FG000|NOT COMPLETED|Overall Study||2||
60083290|NCT00320242|76199013|FG001|NOT COMPLETED|Overall Study||4||
60083291|NCT00347308|76199020|FG000|STARTED|Overall Study||40||
60083292|NCT00347308|76199020|FG000|COMPLETED|Overall Study||40||
60083293|NCT00347308|76199020|FG000|NOT COMPLETED|Overall Study||0||
60083294|NCT00348946|76199026|FG000|STARTED|Overall Study||46||
60083295|NCT00348946|76199027|FG001|STARTED|Overall Study||47||
60083296|NCT00348946|76199026|FG000|COMPLETED|Overall Study||35||
60083297|NCT00348946|76199027|FG001|COMPLETED|Overall Study||35||
60083298|NCT00348946|76199026|FG000|NOT COMPLETED|Overall Study||11||
60083299|NCT00348946|76199027|FG001|NOT COMPLETED|Overall Study||12||
60083300|NCT00349336|76199037|FG000|STARTED|Overall Study||32||
60083301|NCT00349336|76199038|FG001|STARTED|Overall Study||32||
60083302|NCT00349336|76199037|FG000|COMPLETED|Overall Study||19||
60083303|NCT00349336|76199038|FG001|COMPLETED|Overall Study||18||
60083304|NCT00349336|76199037|FG000|NOT COMPLETED|Overall Study||13||
60083305|NCT00349336|76199038|FG001|NOT COMPLETED|Overall Study||14||
60083306|NCT00352612|76199046|FG000|STARTED|Overall Study||100||
60083307|NCT00352612|76199047|FG001|STARTED|Overall Study||100||
60083308|NCT00352612|76199046|FG000|COMPLETED|Overall Study||100||
60083309|NCT00352612|76199047|FG001|COMPLETED|Overall Study||100||
59707025|NCT01257581|75825946|FG002|STARTED|Overall Study||17||
59707026|NCT01257581|75825944|FG000|COMPLETED|Overall Study||17||
59707027|NCT01257581|75825945|FG001|COMPLETED|Overall Study||18||
59707028|NCT01257581|75825946|FG002|COMPLETED|Overall Study||11||
59707029|NCT01257581|75825944|FG000|NOT COMPLETED|Overall Study||5||
60083310|NCT00352612|76199046|FG000|NOT COMPLETED|Overall Study||0||
60083311|NCT00352612|76199047|FG001|NOT COMPLETED|Overall Study||0||
60083312|NCT00323284|76199055|FG000|STARTED|12 Months Follow-up||116||
59553629|NCT02431260|75653640|FG008|COMPLETED|Overall Study||0||
59553630|NCT02431260|75653641|FG009|COMPLETED|Overall Study||0||
59553631|NCT02431260|75653642|FG010|COMPLETED|Overall Study||0||
59553632|NCT02431260|75653643|FG011|COMPLETED|Overall Study||0||
59553633|NCT02431260|75653644|FG012|COMPLETED|Overall Study||0||
59553634|NCT02431260|75653645|FG013|COMPLETED|Overall Study||0||
59553635|NCT02431260|75653632|FG000|NOT COMPLETED|Overall Study||4||
59553636|NCT02431260|75653633|FG001|NOT COMPLETED|Overall Study||5||
59553637|NCT02431260|75653634|FG002|NOT COMPLETED|Overall Study||6||
59553638|NCT02431260|75653635|FG003|NOT COMPLETED|Overall Study||5||
59553639|NCT02431260|75653636|FG004|NOT COMPLETED|Overall Study||3||
59553640|NCT02431260|75653637|FG005|NOT COMPLETED|Overall Study||4||
59553641|NCT02431260|75653638|FG006|NOT COMPLETED|Overall Study||4||
59553642|NCT02431260|75653639|FG007|NOT COMPLETED|Overall Study||3||
59553643|NCT02431260|75653640|FG008|NOT COMPLETED|Overall Study||8||
59553644|NCT02431260|75653641|FG009|NOT COMPLETED|Overall Study||8||
59553645|NCT02431260|75653642|FG010|NOT COMPLETED|Overall Study||4||
59553646|NCT02431260|75653643|FG011|NOT COMPLETED|Overall Study||4||
59553647|NCT02431260|75653644|FG012|NOT COMPLETED|Overall Study||10||
59553648|NCT02431260|75653645|FG013|NOT COMPLETED|Overall Study||1||
59553649|NCT02722863|75653688|FG000|STARTED|Overall Study||908||
59553650|NCT02722863|75653688|FG000|COMPLETED|Overall Study||908||
59707030|NCT01257581|75825945|FG001|NOT COMPLETED|Overall Study||3||
59707031|NCT01257581|75825946|FG002|NOT COMPLETED|Overall Study||6||
60083313|NCT00323284|76199056|FG001|STARTED|12 Months Follow-up||123||
60083314|NCT00323284|76199055|FG000|COMPLETED|12 Months Follow-up||111||
60083315|NCT00323284|76199056|FG001|COMPLETED|12 Months Follow-up||114||
60083316|NCT00323284|76199055|FG000|NOT COMPLETED|12 Months Follow-up||5||
60083317|NCT00323284|76199056|FG001|NOT COMPLETED|12 Months Follow-up||9||
60083318|NCT00323284|76199055|FG000|STARTED|24 Months Follow-up||116||
60083319|NCT00323284|76199056|FG001|STARTED|24 Months Follow-up||123||
60083320|NCT00323284|76199055|FG000|COMPLETED|24 Months Follow-up||98||
60083321|NCT00323284|76199056|FG001|COMPLETED|24 Months Follow-up||101||
60083322|NCT00323284|76199055|FG000|NOT COMPLETED|24 Months Follow-up||18||
60083323|NCT00323284|76199056|FG001|NOT COMPLETED|24 Months Follow-up||22||
60083324|NCT00323362|76199062|FG000|STARTED|Overall Study||17||
60083325|NCT00323362|76199062|FG000|COMPLETED|Overall Study||17||
60083326|NCT00323362|76199062|FG000|NOT COMPLETED|Overall Study||0||
60083327|NCT00390364|76199066|FG000|STARTED|Overall Study||1||
60083328|NCT00390364|76199066|FG000|COMPLETED|Overall Study||1||
60083329|NCT00390364|76199066|FG000|NOT COMPLETED|Overall Study||0||
60083330|NCT00354484|76199072|FG000|STARTED|Overall Study||142||
60083331|NCT00354484|76199073|FG001|STARTED|Overall Study||147||
59553651|NCT02722863|75653688|FG000|NOT COMPLETED|Overall Study||0||
59553652|NCT01847027|75653695|FG000|STARTED|Overall Study||11||
59553653|NCT01847027|75653696|FG001|STARTED|Overall Study||12||
59553654|NCT01847027|75653695|FG000|COMPLETED|Overall Study||10||
59553655|NCT01847027|75653696|FG001|COMPLETED|Overall Study||10||
59553656|NCT01847027|75653695|FG000|NOT COMPLETED|Overall Study||1||
59553657|NCT01847027|75653696|FG001|NOT COMPLETED|Overall Study||2||
59553658|NCT02055963|75653704|FG000|STARTED|Overall Study||14||
60083332|NCT00354484|76199072|FG000|COMPLETED|Overall Study||138||
60083333|NCT00354484|76199073|FG001|COMPLETED|Overall Study||144||
60083334|NCT00354484|76199072|FG000|NOT COMPLETED|Overall Study||4||
60083335|NCT00354484|76199073|FG001|NOT COMPLETED|Overall Study||3||
60083336|NCT00354640|76199079|FG000|STARTED|Overall Study||11||
60083337|NCT00354640|76199079|FG000|COMPLETED|Overall Study||11||
60083338|NCT00354640|76199079|FG000|NOT COMPLETED|Overall Study||0||
60083339|NCT02107300|76199085|FG000|STARTED|Overall Study||16||
60083340|NCT02107300|76199086|FG001|STARTED|Overall Study||15||
59553659|NCT02055963|75653705|FG001|STARTED|Overall Study||16||
59553660|NCT02055963|75653704|FG000|COMPLETED|Overall Study||14||
59553661|NCT02055963|75653705|FG001|COMPLETED|Overall Study||16||
59553662|NCT02055963|75653704|FG000|NOT COMPLETED|Overall Study||0||
59553663|NCT02055963|75653705|FG001|NOT COMPLETED|Overall Study||0||
59553664|NCT01848041|75653714|FG000|STARTED|Overall Study||15||
59553665|NCT01848041|75653715|FG001|STARTED|Overall Study||16||
59553666|NCT01848041|75653716|FG002|STARTED|Overall Study||15||
60083341|NCT02107300|76199085|FG000|COMPLETED|Overall Study||16||
60083342|NCT02107300|76199086|FG001|COMPLETED|Overall Study||15||
60083343|NCT02107300|76199085|FG000|NOT COMPLETED|Overall Study||0||
60083344|NCT02107300|76199086|FG001|NOT COMPLETED|Overall Study||0||
59553667|NCT01848041|75653714|FG000|COMPLETED|Overall Study||15||
59553668|NCT01848041|75653715|FG001|COMPLETED|Overall Study||16||
59553669|NCT01848041|75653716|FG002|COMPLETED|Overall Study||15||
59553670|NCT01848041|75653714|FG000|NOT COMPLETED|Overall Study||0||
59553671|NCT01848041|75653715|FG001|NOT COMPLETED|Overall Study||0||
59553672|NCT01848041|75653716|FG002|NOT COMPLETED|Overall Study||0||
59553673|NCT02724033|75653730|FG000|STARTED|Overall Study||11||
59553674|NCT02724033|75653731|FG001|STARTED|Overall Study||14||
59553675|NCT02724033|75653732|FG002|STARTED|Overall Study||12||
59553676|NCT02724033|75653730|FG000|COMPLETED|Overall Study||11||
59553677|NCT02724033|75653731|FG001|COMPLETED|Overall Study||14||
59553678|NCT02724033|75653732|FG002|COMPLETED|Overall Study||12||
59553679|NCT02724033|75653730|FG000|NOT COMPLETED|Overall Study||0||
59553680|NCT02724033|75653731|FG001|NOT COMPLETED|Overall Study||0||
59553681|NCT02724033|75653732|FG002|NOT COMPLETED|Overall Study||0||
59553682|NCT02267447|75653742|FG000|STARTED|Overall Study||77251||
59553683|NCT02267447|75653743|FG001|STARTED|Overall Study||26968||
59553684|NCT02267447|75653742|FG000|COMPLETED|Overall Study||77251||
59553685|NCT02267447|75653743|FG001|COMPLETED|Overall Study||26968||
59553686|NCT02267447|75653742|FG000|NOT COMPLETED|Overall Study||0||
59553687|NCT02267447|75653743|FG001|NOT COMPLETED|Overall Study||0||
59553688|NCT02724423|75653750|FG000|STARTED|Overall Study||57||
59553689|NCT02724423|75653750|FG000|COMPLETED|Overall Study||54||
59553690|NCT02724423|75653750|FG000|NOT COMPLETED|Overall Study||3||
59553691|NCT02267837|75653757|FG000|STARTED|Overall Study||11||
59553692|NCT02267837|75653758|FG001|STARTED|Overall Study||9||
59553693|NCT02267837|75653757|FG000|COMPLETED|Overall Study||11||
59553694|NCT02267837|75653758|FG001|COMPLETED|Overall Study||9||
59553695|NCT02267837|75653757|FG000|NOT COMPLETED|Overall Study||0||
59553696|NCT02267837|75653758|FG001|NOT COMPLETED|Overall Study||0||
59553697|NCT02726451|75653766|FG000|STARTED|Overall Study||10||
59553698|NCT02726451|75653767|FG001|STARTED|Overall Study||10||
59553699|NCT02726451|75653766|FG000|COMPLETED|Overall Study||10||
59553700|NCT02726451|75653767|FG001|COMPLETED|Overall Study||10||
59553701|NCT02726451|75653766|FG000|NOT COMPLETED|Overall Study||0||
59553702|NCT02726451|75653767|FG001|NOT COMPLETED|Overall Study||0||
59553703|NCT02730663|75653773|FG000|STARTED|Overall Study||36|1 subject in screening failure(impossible to undergo the stent procedure)|
59553704|NCT02730663|75653773|FG000|COMPLETED|Overall Study||35||
59553705|NCT02730663|75653773|FG000|NOT COMPLETED|Overall Study||1||
59553706|NCT01848821|75653779|FG000|STARTED|Overall Study||7||10
59553707|NCT01848821|75653780|FG001|STARTED|Overall Study||7||10
59553708|NCT01848821|75653779|FG000|COMPLETED|Overall Study||7||10
59553709|NCT01848821|75653780|FG001|COMPLETED|Overall Study||7||10
59553710|NCT01848821|75653779|FG000|NOT COMPLETED|Overall Study||0||0
59553711|NCT01848821|75653780|FG001|NOT COMPLETED|Overall Study||0||0
59553712|NCT01848899|75653788|FG000|STARTED|Overall Study||50||
59553713|NCT01848899|75653789|FG001|STARTED|Overall Study||50||
59553714|NCT01848899|75653788|FG000|COMPLETED|Overall Study||50||
59553715|NCT01848899|75653789|FG001|COMPLETED|Overall Study||50||
59553716|NCT01848899|75653788|FG000|NOT COMPLETED|Overall Study||0||
59553717|NCT01848899|75653789|FG001|NOT COMPLETED|Overall Study||0||
59553718|NCT01848977|75653795|FG000|STARTED|Overall Study||20||
59553719|NCT01848977|75653795|FG000|COMPLETED|Overall Study||20||
59553720|NCT01848977|75653795|FG000|NOT COMPLETED|Overall Study||0||
59553721|NCT02731833|75653806|FG000|STARTED|Overall Study||111||
59553722|NCT02731833|75653807|FG001|STARTED|Overall Study||111||
59553723|NCT02731833|75653806|FG000|COMPLETED|Overall Study||111||
59553724|NCT02731833|75653807|FG001|COMPLETED|Overall Study||111||
59553725|NCT02731833|75653806|FG000|NOT COMPLETED|Overall Study||0||
59553726|NCT02731833|75653807|FG001|NOT COMPLETED|Overall Study||0||
59553727|NCT01852019|75653815|FG000|STARTED|Day 1||3||
59553728|NCT01852019|75653816|FG001|STARTED|Day 1||3||
59553729|NCT01852019|75653817|FG002|STARTED|Day 1||6||
59553730|NCT01852019|75653818|FG003|STARTED|Day 1||0||
59553731|NCT01852019|75653819|FG004|STARTED|Day 1||0||
59553732|NCT01852019|75653815|FG000|COMPLETED|Day 1||3||
59553733|NCT01852019|75653816|FG001|COMPLETED|Day 1||3||
59553734|NCT01852019|75653817|FG002|COMPLETED|Day 1||6||
59553735|NCT01852019|75653818|FG003|COMPLETED|Day 1||0||
59553736|NCT01852019|75653819|FG004|COMPLETED|Day 1||0||
59553737|NCT01852019|75653815|FG000|NOT COMPLETED|Day 1||0||
59553738|NCT01852019|75653816|FG001|NOT COMPLETED|Day 1||0||
59553739|NCT01852019|75653817|FG002|NOT COMPLETED|Day 1||0||
59553740|NCT01852019|75653818|FG003|NOT COMPLETED|Day 1||0||
59553741|NCT01852019|75653819|FG004|NOT COMPLETED|Day 1||0||
59553742|NCT01852019|75653815|FG000|STARTED|Day 8||0||
59553743|NCT01852019|75653816|FG001|STARTED|Day 8||0||
59553744|NCT01852019|75653817|FG002|STARTED|Day 8||0||
59553745|NCT01852019|75653818|FG003|STARTED|Day 8||6||
59553746|NCT01852019|75653819|FG004|STARTED|Day 8||6||
59553747|NCT01852019|75653815|FG000|COMPLETED|Day 8||0||
59553748|NCT01852019|75653816|FG001|COMPLETED|Day 8||0||
59553749|NCT01852019|75653817|FG002|COMPLETED|Day 8||0||
59553750|NCT01852019|75653818|FG003|COMPLETED|Day 8||6||
59553751|NCT01852019|75653819|FG004|COMPLETED|Day 8||6||
59553752|NCT01852019|75653815|FG000|NOT COMPLETED|Day 8||0||
59553753|NCT01852019|75653816|FG001|NOT COMPLETED|Day 8||0||
59553754|NCT01852019|75653817|FG002|NOT COMPLETED|Day 8||0||
59553755|NCT01852019|75653818|FG003|NOT COMPLETED|Day 8||0||
59553756|NCT01852019|75653819|FG004|NOT COMPLETED|Day 8||0||
59553757|NCT02430870|75653840|FG000|STARTED|Part 1||6||
59553758|NCT02430870|75653841|FG001|STARTED|Part 1||6||
59553759|NCT02430870|75653842|FG002|STARTED|Part 1||4||
59553760|NCT02430870|75653843|FG003|STARTED|Part 1||0||
59553761|NCT02430870|75653844|FG004|STARTED|Part 1||0||
59553762|NCT02430870|75653845|FG005|STARTED|Part 1||0||
59553763|NCT02430870|75653846|FG006|STARTED|Part 1||0||
59553764|NCT02430870|75653847|FG007|STARTED|Part 1||0||
59553765|NCT02430870|75653840|FG000|COMPLETED|Part 1||6||
59553766|NCT02430870|75653841|FG001|COMPLETED|Part 1||6||
59553767|NCT02430870|75653842|FG002|COMPLETED|Part 1||4||
59553768|NCT02430870|75653843|FG003|COMPLETED|Part 1||0||
59553769|NCT02430870|75653844|FG004|COMPLETED|Part 1||0||
59553770|NCT02430870|75653845|FG005|COMPLETED|Part 1||0||
59553771|NCT02430870|75653846|FG006|COMPLETED|Part 1||0||
59553772|NCT02430870|75653847|FG007|COMPLETED|Part 1||0||
59553773|NCT02430870|75653840|FG000|NOT COMPLETED|Part 1||0||
59553774|NCT02430870|75653841|FG001|NOT COMPLETED|Part 1||0||
59553775|NCT02430870|75653842|FG002|NOT COMPLETED|Part 1||0||
59553776|NCT02430870|75653843|FG003|NOT COMPLETED|Part 1||0||
59553777|NCT02430870|75653844|FG004|NOT COMPLETED|Part 1||0||
59553778|NCT02430870|75653845|FG005|NOT COMPLETED|Part 1||0||
59553779|NCT02430870|75653846|FG006|NOT COMPLETED|Part 1||0||
59553780|NCT02430870|75653847|FG007|NOT COMPLETED|Part 1||0||
59553781|NCT02430870|75653840|FG000|STARTED|Part 2||0||
59553782|NCT02430870|75653841|FG001|STARTED|Part 2||0||
59553783|NCT02430870|75653842|FG002|STARTED|Part 2||0||
59553784|NCT02430870|75653843|FG003|STARTED|Part 2||6||
59553785|NCT02430870|75653844|FG004|STARTED|Part 2||6||
59553786|NCT02430870|75653845|FG005|STARTED|Part 2||6||
59553787|NCT02430870|75653846|FG006|STARTED|Part 2||6||
59553788|NCT02430870|75653847|FG007|STARTED|Part 2||8||
59553789|NCT02430870|75653840|FG000|COMPLETED|Part 2||0||
59553790|NCT02430870|75653841|FG001|COMPLETED|Part 2||0||
59553791|NCT02430870|75653842|FG002|COMPLETED|Part 2||0||
59553792|NCT02430870|75653843|FG003|COMPLETED|Part 2||6||
59553793|NCT02430870|75653844|FG004|COMPLETED|Part 2||6||
59553794|NCT02430870|75653845|FG005|COMPLETED|Part 2||6||
59553795|NCT02430870|75653846|FG006|COMPLETED|Part 2||5||
59553796|NCT02430870|75653847|FG007|COMPLETED|Part 2||7||
59553797|NCT02430870|75653840|FG000|NOT COMPLETED|Part 2||0||
59553798|NCT02430870|75653841|FG001|NOT COMPLETED|Part 2||0||
59553799|NCT02430870|75653842|FG002|NOT COMPLETED|Part 2||0||
59553800|NCT02430870|75653843|FG003|NOT COMPLETED|Part 2||0||
59553801|NCT02430870|75653844|FG004|NOT COMPLETED|Part 2||0||
59553802|NCT02430870|75653845|FG005|NOT COMPLETED|Part 2||0||
59553803|NCT02430870|75653846|FG006|NOT COMPLETED|Part 2||1||
59553804|NCT02430870|75653847|FG007|NOT COMPLETED|Part 2||1||
59553805|NCT02732145|75653869|FG000|STARTED|Overall Study||82||
59553806|NCT02732145|75653870|FG001|STARTED|Overall Study||82||
59553807|NCT02732145|75653871|FG002|STARTED|Overall Study||82||
59553808|NCT02732145|75653872|FG003|STARTED|Overall Study||82||
59553809|NCT02732145|75653869|FG000|COMPLETED|Overall Study||82||
59553810|NCT02732145|75653870|FG001|COMPLETED|Overall Study||82||
59553811|NCT02732145|75653871|FG002|COMPLETED|Overall Study||82||
59553812|NCT02732145|75653872|FG003|COMPLETED|Overall Study||82||
59553813|NCT02732145|75653869|FG000|NOT COMPLETED|Overall Study||0||
59553814|NCT02732145|75653870|FG001|NOT COMPLETED|Overall Study||0||
59553815|NCT02732145|75653871|FG002|NOT COMPLETED|Overall Study||0||
59553816|NCT02732145|75653872|FG003|NOT COMPLETED|Overall Study||0||
59553817|NCT01852175|75653904|FG000|STARTED|Overall Study||55||
59553818|NCT01852175|75653905|FG001|STARTED|Overall Study||55||
59553819|NCT01852175|75653904|FG000|COMPLETED|Overall Study||55||
59553820|NCT01852175|75653905|FG001|COMPLETED|Overall Study||55||
59553821|NCT01852175|75653904|FG000|NOT COMPLETED|Overall Study||0||
59553822|NCT01852175|75653905|FG001|NOT COMPLETED|Overall Study||0||
59553823|NCT02429934|75653913|FG000|STARTED|Overall Study||15||
59553824|NCT02429934|75653914|FG001|STARTED|Overall Study||13||
59553825|NCT02429934|75653913|FG000|COMPLETED|Overall Study||11||
59553826|NCT02429934|75653914|FG001|COMPLETED|Overall Study||10||
59553827|NCT02429934|75653913|FG000|NOT COMPLETED|Overall Study||4||
59553828|NCT02429934|75653914|FG001|NOT COMPLETED|Overall Study||3||
59553829|NCT01852799|75653922|FG000|STARTED|Overall Study||18||
59553830|NCT01852799|75653922|FG000|COMPLETED|Overall Study||0||
59553831|NCT01852799|75653922|FG000|NOT COMPLETED|Overall Study||18||
59553832|NCT02429856|75653928|FG000|STARTED|Overall Study||49||
59553833|NCT02429856|75653929|FG001|STARTED|Overall Study||51||
59553834|NCT02429856|75653928|FG000|COMPLETED|Overall Study||30||
59553835|NCT02429856|75653929|FG001|COMPLETED|Overall Study||32||
59553836|NCT02429856|75653928|FG000|NOT COMPLETED|Overall Study||19||
59553837|NCT02429856|75653929|FG001|NOT COMPLETED|Overall Study||19||
59553838|NCT02429778|75653939|FG000|STARTED|Overall Study||20||
59553839|NCT02429778|75653940|FG001|STARTED|Overall Study||20||
59553840|NCT02429778|75653939|FG000|COMPLETED|Overall Study||13||
59553841|NCT02429778|75653940|FG001|COMPLETED|Overall Study||20||
59553842|NCT02429778|75653939|FG000|NOT COMPLETED|Overall Study||7||
59553843|NCT02429778|75653940|FG001|NOT COMPLETED|Overall Study||0||
60083345|NCT00392236|76199094|FG000|STARTED|Overall Study|1 subject post randomization was found to not meet inclusion criteria|20||
60083346|NCT00392236|76199095|FG001|STARTED|Overall Study|1 subject post randomization was found to not meet inclusion criteria|18||
60083347|NCT00392236|76199094|FG000|COMPLETED|Overall Study|Defined as having adherence data for month 6 of the study.|8||
59553844|NCT02403180|75653948|FG000|STARTED|Pre-Treatment Period||36||
59553845|NCT02403180|75653949|FG001|STARTED|Pre-Treatment Period||34||
59553846|NCT02403180|75653948|FG000|COMPLETED|Pre-Treatment Period||36||
59553847|NCT02403180|75653949|FG001|COMPLETED|Pre-Treatment Period||33||
59553848|NCT02403180|75653948|FG000|NOT COMPLETED|Pre-Treatment Period||0||
60083348|NCT00392236|76199095|FG001|COMPLETED|Overall Study|Defined as having adherence data for month 6 of the study.|12||
60083349|NCT00392236|76199094|FG000|NOT COMPLETED|Overall Study||12||
60083350|NCT00392236|76199095|FG001|NOT COMPLETED|Overall Study||6||
59553849|NCT02403180|75653949|FG001|NOT COMPLETED|Pre-Treatment Period||1||
59553850|NCT02403180|75653948|FG000|STARTED|Period 1 (5 Days)||36||
59553851|NCT02403180|75653949|FG001|STARTED|Period 1 (5 Days)||33||
59553852|NCT02403180|75653948|FG000|Randomized|Period 1 (5 Days)||36||
60083351|NCT00392392|76199101|FG000|STARTED|Overall Study||29||
60083352|NCT00392392|76199101|FG000|COMPLETED|Overall Study||9||
60083353|NCT00392392|76199101|FG000|NOT COMPLETED|Overall Study||20||
60083354|NCT01519089|76199107|FG000|STARTED|Overall Study||47||
60083355|NCT01519089|76199108|FG001|STARTED|Overall Study||48||
60083356|NCT01519089|76199107|FG000|Received Treatment|Overall Study||47||
60083357|NCT01519089|76199108|FG001|Received Treatment|Overall Study||47||
60083358|NCT01519089|76199107|FG000|COMPLETED|Overall Study||40||
60083359|NCT01519089|76199108|FG001|COMPLETED|Overall Study||33||
60083360|NCT01519089|76199107|FG000|NOT COMPLETED|Overall Study||7||
60083361|NCT01519089|76199108|FG001|NOT COMPLETED|Overall Study||15||
59553853|NCT02403180|75653949|FG001|Randomized|Period 1 (5 Days)||33||
59553854|NCT02403180|75653948|FG000|COMPLETED|Period 1 (5 Days)||36||
59553855|NCT02403180|75653949|FG001|COMPLETED|Period 1 (5 Days)||33||
59553856|NCT02403180|75653948|FG000|NOT COMPLETED|Period 1 (5 Days)||0||
59553857|NCT02403180|75653949|FG001|NOT COMPLETED|Period 1 (5 Days)||0||
59553858|NCT02403180|75653948|FG000|STARTED|Period 2 (5 Days)||36||
59553859|NCT02403180|75653949|FG001|STARTED|Period 2 (5 Days)||33||
59553860|NCT02403180|75653948|FG000|COMPLETED|Period 2 (5 Days)||36||
59553861|NCT02403180|75653949|FG001|COMPLETED|Period 2 (5 Days)||32||
59553862|NCT02403180|75653948|FG000|NOT COMPLETED|Period 2 (5 Days)||0||
59553863|NCT02403180|75653949|FG001|NOT COMPLETED|Period 2 (5 Days)||1||
59553864|NCT01852955|75653957|FG000|STARTED|Overall Study||35||
59553865|NCT01852955|75653958|FG001|STARTED|Overall Study||35||
59553866|NCT01852955|75653957|FG000|COMPLETED|Overall Study||33||
59553867|NCT01852955|75653958|FG001|COMPLETED|Overall Study||32||
59553868|NCT01852955|75653957|FG000|NOT COMPLETED|Overall Study||2||
59553869|NCT01852955|75653958|FG001|NOT COMPLETED|Overall Study||3||
59553870|NCT01854281|75653968|FG000|STARTED|Overall Study||15||
59553871|NCT01854281|75653969|FG001|STARTED|Overall Study||19||
59553872|NCT01854281|75653970|FG002|STARTED|Overall Study||5||
59553873|NCT01854281|75653971|FG003|STARTED|Overall Study||8||
59553874|NCT01854281|75653968|FG000|COMPLETED|Overall Study||15||
59553875|NCT01854281|75653969|FG001|COMPLETED|Overall Study||19||
59553876|NCT01854281|75653970|FG002|COMPLETED|Overall Study||5||
59553877|NCT01854281|75653971|FG003|COMPLETED|Overall Study||8||
59553878|NCT01854281|75653968|FG000|NOT COMPLETED|Overall Study||0||
59553879|NCT01854281|75653969|FG001|NOT COMPLETED|Overall Study||0||
59553880|NCT01854281|75653970|FG002|NOT COMPLETED|Overall Study||0||
59553881|NCT01854281|75653971|FG003|NOT COMPLETED|Overall Study||0||
59553882|NCT00558467|75653983|FG000|STARTED|Overall Study||20||
59553883|NCT00558467|75653984|FG001|STARTED|Overall Study||43||
59553884|NCT00558467|75653983|FG000|COMPLETED|Overall Study||19||
59553885|NCT00558467|75653984|FG001|COMPLETED|Overall Study||39||
59553886|NCT00558467|75653983|FG000|NOT COMPLETED|Overall Study||1||
59553887|NCT00558467|75653984|FG001|NOT COMPLETED|Overall Study||4||
59553888|NCT02402166|75653990|FG000|STARTED|Overall Study||24||
59553889|NCT02402166|75653990|FG000|COMPLETED|Overall Study||19||
59553890|NCT02402166|75653990|FG000|NOT COMPLETED|Overall Study||5||
59553891|NCT02378220|75654010|FG000|STARTED|Overall Study||53|Patients were enrolled from Feb 2015 to Dec 2015 with follow-up ending in Feb 2016.|
59553892|NCT02378220|75654011|FG001|STARTED|Overall Study||57|Patients were enrolled from Feb 2015 to Dec 2015 with follow-up ending in Feb 2016.|
59553893|NCT02378220|75654010|FG000|COMPLETED|Overall Study||47||
59553894|NCT02378220|75654011|FG001|COMPLETED|Overall Study||56||
59553895|NCT02378220|75654010|FG000|NOT COMPLETED|Overall Study||6||
59553896|NCT02378220|75654011|FG001|NOT COMPLETED|Overall Study||1||
59553897|NCT02401308|75654020|FG000|STARTED|Overall Study||0||
59553898|NCT02401308|75654021|FG001|STARTED|Overall Study||1||
59553899|NCT02401308|75654020|FG000|COMPLETED|Overall Study||0||
59553900|NCT02401308|75654021|FG001|COMPLETED|Overall Study||0||
59553901|NCT02401308|75654020|FG000|NOT COMPLETED|Overall Study||0||
59553902|NCT02401308|75654021|FG001|NOT COMPLETED|Overall Study||1||
59553903|NCT02401230|75654030|FG000|STARTED|Overall Study||26||
59553904|NCT02401230|75654031|FG001|STARTED|Overall Study||25||
59553905|NCT02401230|75654032|FG002|STARTED|Overall Study||25||
59553906|NCT02401230|75654030|FG000|COMPLETED|Overall Study||20||
59553907|NCT02401230|75654031|FG001|COMPLETED|Overall Study||19||
59553908|NCT02401230|75654032|FG002|COMPLETED|Overall Study||21||
59553909|NCT02401230|75654030|FG000|NOT COMPLETED|Overall Study||6||
59553910|NCT02401230|75654031|FG001|NOT COMPLETED|Overall Study||6||
59553911|NCT02401230|75654032|FG002|NOT COMPLETED|Overall Study||4||
59553912|NCT01854359|75654046|FG000|STARTED|Overall Study||31||
59553913|NCT01854359|75654047|FG001|STARTED|Overall Study||30||
59553914|NCT01854359|75654046|FG000|COMPLETED|Overall Study||26||
59553915|NCT01854359|75654047|FG001|COMPLETED|Overall Study||22||
59553916|NCT01854359|75654046|FG000|NOT COMPLETED|Overall Study||5||
59553917|NCT01854359|75654047|FG001|NOT COMPLETED|Overall Study||8||
59553918|NCT01854593|75654063|FG000|STARTED|Overall Study||34||
59553919|NCT01854593|75654064|FG001|STARTED|Overall Study||35||
59553920|NCT01854593|75654063|FG000|COMPLETED|Overall Study||32||
59553921|NCT01854593|75654064|FG001|COMPLETED|Overall Study||34||
59553922|NCT01854593|75654063|FG000|NOT COMPLETED|Overall Study||2||
59553923|NCT01854593|75654064|FG001|NOT COMPLETED|Overall Study||1||
59553924|NCT02429310|75654073|FG000|STARTED|Overall Study||22||
59553925|NCT02429310|75654074|FG001|STARTED|Overall Study||20||
59553926|NCT02429310|75654073|FG000|COMPLETED|Overall Study||20||
59553927|NCT02429310|75654074|FG001|COMPLETED|Overall Study||17||
59553928|NCT02429310|75654073|FG000|NOT COMPLETED|Overall Study||2||
59553929|NCT02429310|75654074|FG001|NOT COMPLETED|Overall Study||3||
59553930|NCT01854905|75654080|FG000|STARTED|Overall Study||400||
59553931|NCT01854905|75654080|FG000|COMPLETED|Overall Study||400||
59553932|NCT01854905|75654080|FG000|NOT COMPLETED|Overall Study||0||
59553933|NCT01855997|75654084|FG000|STARTED|Overall Study||1669||
59553934|NCT01855997|75654084|FG000|COMPLETED|Overall Study||1669||
59553935|NCT01855997|75654084|FG000|NOT COMPLETED|Overall Study||0||
59553936|NCT02734953|75654096|FG000|STARTED|Overall Study||10||
59553937|NCT02734953|75654096|FG000|COMPLETED|Overall Study||10||
59553938|NCT02734953|75654096|FG000|NOT COMPLETED|Overall Study||0||
59553939|NCT02428608|75654100|FG000|STARTED|Overall Study||570||
59553940|NCT02428608|75654100|FG000|COMPLETED|Overall Study||487||
60083362|NCT00392704|76199116|FG000|STARTED|Neoadjuvant Chemotherapy||60||
60083363|NCT00392704|76199116|FG000|COMPLETED|Neoadjuvant Chemotherapy||54||
60083364|NCT00392704|76199116|FG000|NOT COMPLETED|Neoadjuvant Chemotherapy||6||
60083365|NCT00392704|76199116|FG000|STARTED|Combined Modality Therapy||54||
60083366|NCT00392704|76199116|FG000|COMPLETED|Combined Modality Therapy||49||
60083367|NCT00392704|76199116|FG000|NOT COMPLETED|Combined Modality Therapy||5||
60083368|NCT00392782|76199120|FG000|STARTED|Overall Study||24||
60083369|NCT00392782|76199120|FG000|COMPLETED|Overall Study||24||
60083370|NCT00392782|76199120|FG000|NOT COMPLETED|Overall Study||0||
60083371|NCT01518699|76199130|FG000|STARTED|Period 1||10||
60083372|NCT01518699|76199131|FG001|STARTED|Period 1||9||
60083373|NCT01518699|76199132|FG002|STARTED|Period 1||9||
60083374|NCT01518699|76199133|FG003|STARTED|Period 1||10||
60083375|NCT01518699|76199134|FG004|STARTED|Period 1||10||
60083376|NCT01518699|76199135|FG005|STARTED|Period 1||9||
60083377|NCT01518699|76199130|FG000|COMPLETED|Period 1||10||
60083378|NCT01518699|76199131|FG001|COMPLETED|Period 1||9||
60083379|NCT01518699|76199132|FG002|COMPLETED|Period 1||9||
60083380|NCT01518699|76199133|FG003|COMPLETED|Period 1||10||
60083381|NCT01518699|76199134|FG004|COMPLETED|Period 1||10||
60083382|NCT01518699|76199135|FG005|COMPLETED|Period 1||9||
60083383|NCT01518699|76199130|FG000|NOT COMPLETED|Period 1||0||
60083384|NCT01518699|76199131|FG001|NOT COMPLETED|Period 1||0||
60083385|NCT01518699|76199132|FG002|NOT COMPLETED|Period 1||0||
60083386|NCT01518699|76199133|FG003|NOT COMPLETED|Period 1||0||
60083387|NCT01518699|76199134|FG004|NOT COMPLETED|Period 1||0||
60083388|NCT01518699|76199135|FG005|NOT COMPLETED|Period 1||0||
60083389|NCT01518699|76199130|FG000|STARTED|Period 2||10||
60083390|NCT01518699|76199131|FG001|STARTED|Period 2||9||
60083391|NCT01518699|76199132|FG002|STARTED|Period 2||9||
60083392|NCT01518699|76199133|FG003|STARTED|Period 2||10||
60083393|NCT01518699|76199134|FG004|STARTED|Period 2||10||
60083394|NCT01518699|76199135|FG005|STARTED|Period 2||9||
60083395|NCT01518699|76199130|FG000|COMPLETED|Period 2||8||
60083396|NCT01518699|76199131|FG001|COMPLETED|Period 2||7||
60083397|NCT01518699|76199132|FG002|COMPLETED|Period 2||9||
60083398|NCT01518699|76199133|FG003|COMPLETED|Period 2||10||
60083399|NCT01518699|76199134|FG004|COMPLETED|Period 2||10||
60083400|NCT01518699|76199135|FG005|COMPLETED|Period 2||9||
60083401|NCT01518699|76199130|FG000|NOT COMPLETED|Period 2||2||
60083402|NCT01518699|76199131|FG001|NOT COMPLETED|Period 2||2||
60083403|NCT01518699|76199132|FG002|NOT COMPLETED|Period 2||0||
60083404|NCT01518699|76199133|FG003|NOT COMPLETED|Period 2||0||
60083405|NCT01518699|76199134|FG004|NOT COMPLETED|Period 2||0||
60083406|NCT01518699|76199135|FG005|NOT COMPLETED|Period 2||0||
60083407|NCT01518699|76199130|FG000|STARTED|Period 3||8||
60083408|NCT01518699|76199131|FG001|STARTED|Period 3||7||
60083409|NCT01518699|76199132|FG002|STARTED|Period 3||9||
59553941|NCT02428608|75654100|FG000|NOT COMPLETED|Overall Study||83||
59553942|NCT02735187|75654107|FG000|STARTED|Overall Study||25||
59553943|NCT02735187|75654108|FG001|STARTED|Overall Study||26||
59553944|NCT02735187|75654107|FG000|COMPLETED|Overall Study||21||
59553945|NCT02735187|75654108|FG001|COMPLETED|Overall Study||25||
59553946|NCT02735187|75654107|FG000|NOT COMPLETED|Overall Study||4||
59553947|NCT02735187|75654108|FG001|NOT COMPLETED|Overall Study||1||
59553948|NCT02428296|75654120|FG000|STARTED|Overall Study||39||
59553949|NCT02428296|75654120|FG000|Treated|Overall Study||39||
59553950|NCT02428296|75654120|FG000|COMPLETED|Overall Study|Number of participants who completed the full course of treatment.|30||
59553951|NCT02428296|75654120|FG000|NOT COMPLETED|Overall Study||9||
59553952|NCT01856933|75654127|FG000|STARTED|Overall Study||6||
59553953|NCT01856933|75654127|FG000|COMPLETED|Overall Study||6||
59553954|NCT01856933|75654127|FG000|NOT COMPLETED|Overall Study||0||
59553955|NCT02427984|75654134|FG000|STARTED|Overall Study||53||
60083410|NCT01518699|76199133|FG003|STARTED|Period 3||10||
60083411|NCT01518699|76199134|FG004|STARTED|Period 3||10||
60083412|NCT01518699|76199135|FG005|STARTED|Period 3||9||
60083413|NCT01518699|76199130|FG000|COMPLETED|Period 3||8||
60083414|NCT01518699|76199131|FG001|COMPLETED|Period 3||7||
60083415|NCT01518699|76199132|FG002|COMPLETED|Period 3||9||
60083416|NCT01518699|76199133|FG003|COMPLETED|Period 3||10||
60083417|NCT01518699|76199134|FG004|COMPLETED|Period 3||10||
60083418|NCT01518699|76199135|FG005|COMPLETED|Period 3||9||
60083419|NCT01518699|76199130|FG000|NOT COMPLETED|Period 3||0||
60083420|NCT01518699|76199131|FG001|NOT COMPLETED|Period 3||0||
60083421|NCT01518699|76199132|FG002|NOT COMPLETED|Period 3||0||
60083422|NCT01518699|76199133|FG003|NOT COMPLETED|Period 3||0||
60083423|NCT01518699|76199134|FG004|NOT COMPLETED|Period 3||0||
60083424|NCT01518699|76199135|FG005|NOT COMPLETED|Period 3||0||
60083425|NCT01518309|76199143|FG000|STARTED|Overall Study||39||
60083426|NCT01518309|76199143|FG000|COMPLETED|Overall Study||0||
59553956|NCT02427984|75654135|FG001|STARTED|Overall Study||45||
59553957|NCT02427984|75654136|FG002|STARTED|Overall Study||50||
59553958|NCT02427984|75654134|FG000|COMPLETED|Overall Study||40||
59553959|NCT02427984|75654135|FG001|COMPLETED|Overall Study||40||
59553960|NCT02427984|75654136|FG002|COMPLETED|Overall Study||32||
59553961|NCT02427984|75654134|FG000|NOT COMPLETED|Overall Study||13||
59553962|NCT02427984|75654135|FG001|NOT COMPLETED|Overall Study||5||
59553963|NCT02427984|75654136|FG002|NOT COMPLETED|Overall Study||18||
59553964|NCT02643225|75654147|FG000|STARTED|Overall Study||40||
59553965|NCT02643225|75654148|FG001|STARTED|Overall Study||40||
59553966|NCT02643225|75654147|FG000|COMPLETED|Overall Study||40||
59553967|NCT02643225|75654148|FG001|COMPLETED|Overall Study||40||
59553968|NCT02643225|75654147|FG000|NOT COMPLETED|Overall Study||0||
59553969|NCT02643225|75654148|FG001|NOT COMPLETED|Overall Study||0||
59553970|NCT02264249|75654158|FG000|STARTED|Overall Study||21||
59553971|NCT02264249|75654159|FG001|STARTED|Overall Study||187||
59553972|NCT02264249|75654160|FG002|STARTED|Overall Study||241||
59553973|NCT02264249|75654158|FG000|COMPLETED|Overall Study||21||
59553974|NCT02264249|75654159|FG001|COMPLETED|Overall Study||187||
59553975|NCT02264249|75654160|FG002|COMPLETED|Overall Study||241||
59553976|NCT02264249|75654158|FG000|NOT COMPLETED|Overall Study||0||
59553977|NCT02264249|75654159|FG001|NOT COMPLETED|Overall Study||0||
59816581|NCT05094154|75939009|FG001|NOT COMPLETED|Overall Study||60||
59553978|NCT02264249|75654160|FG002|NOT COMPLETED|Overall Study||0||
59553979|NCT01857713|75654168|FG000|STARTED|Overall Study||95||
59553980|NCT01857713|75654168|FG000|COMPLETED|Overall Study||89||
59816582|NCT04915950|75939021|FG000|STARTED|Stage A: Treatment Period 1 (1 Day)||2||
59553981|NCT01857713|75654168|FG000|NOT COMPLETED|Overall Study||6||
59553982|NCT02643459|75654176|FG000|STARTED|Overall Study||7901||
59553983|NCT02643459|75654177|FG001|STARTED|Overall Study||8900||
59816583|NCT04915950|75939022|FG001|STARTED|Stage A: Treatment Period 1 (1 Day)||2||
59553984|NCT02643459|75654176|FG000|COMPLETED|Overall Study||7901||
59553985|NCT02643459|75654177|FG001|COMPLETED|Overall Study||8900||
59553986|NCT02643459|75654176|FG000|NOT COMPLETED|Overall Study||0||
59553987|NCT02643459|75654177|FG001|NOT COMPLETED|Overall Study||0||
59553988|NCT02643615|75654186|FG000|STARTED|Overall Study||9||
59553989|NCT02643615|75654187|FG001|STARTED|Overall Study||11||
59553990|NCT02643615|75654186|FG000|COMPLETED|Overall Study||9||
59553991|NCT02643615|75654187|FG001|COMPLETED|Overall Study||11||
59553992|NCT02643615|75654186|FG000|NOT COMPLETED|Overall Study||0||
59553993|NCT02643615|75654187|FG001|NOT COMPLETED|Overall Study||0||
59553994|NCT02643849|75654194|FG000|STARTED|Overall Study||107||
59553995|NCT02643849|75654194|FG000|COMPLETED|Overall Study||82||
59553996|NCT02643849|75654194|FG000|NOT COMPLETED|Overall Study||25||
59553997|NCT02265341|75654198|FG000|STARTED|Overall Study||12||
59553998|NCT02265341|75654198|FG000|COMPLETED|Overall Study||12||
59553999|NCT02265341|75654198|FG000|NOT COMPLETED|Overall Study||0||
59554000|NCT01859195|75654204|FG000|STARTED|Overall Study||24||
59554001|NCT01859195|75654205|FG001|STARTED|Overall Study||12||
59554002|NCT01859195|75654204|FG000|COMPLETED|Overall Study||24||
59554003|NCT01859195|75654205|FG001|COMPLETED|Overall Study||12||
59554004|NCT01859195|75654204|FG000|NOT COMPLETED|Overall Study||0||
59554005|NCT01859195|75654205|FG001|NOT COMPLETED|Overall Study||0||
59554006|NCT01421186|75654218|FG000|STARTED|Overall Study||31||
59554007|NCT01421186|75654219|FG001|STARTED|Overall Study||4||
59554008|NCT01421186|75654220|FG002|STARTED|Overall Study||18||
59554009|NCT01421186|75654221|FG003|STARTED|Overall Study||21||
59554010|NCT01421186|75654222|FG004|STARTED|Overall Study||17||
59554011|NCT01421186|75654218|FG000|COMPLETED|Overall Study||31||
59554012|NCT01421186|75654219|FG001|COMPLETED|Overall Study||4||
59554013|NCT01421186|75654220|FG002|COMPLETED|Overall Study||18||
59554014|NCT01421186|75654221|FG003|COMPLETED|Overall Study||21||
59554015|NCT01421186|75654222|FG004|COMPLETED|Overall Study||17||
59554016|NCT01421186|75654218|FG000|NOT COMPLETED|Overall Study||0||
59554017|NCT01421186|75654219|FG001|NOT COMPLETED|Overall Study||0||
59554018|NCT01421186|75654220|FG002|NOT COMPLETED|Overall Study||0||
59554019|NCT01421186|75654221|FG003|NOT COMPLETED|Overall Study||0||
59554020|NCT01421186|75654222|FG004|NOT COMPLETED|Overall Study||0||
59554021|NCT02645253|75654244|FG000|STARTED|Overall Study||7||
59554022|NCT02645253|75654245|FG001|STARTED|Overall Study||7||
59554023|NCT02645253|75654246|FG002|STARTED|Overall Study||7||
59554024|NCT02645253|75654247|FG003|STARTED|Overall Study||6||
59554025|NCT02645253|75654244|FG000|COMPLETED|Overall Study||7||
59554026|NCT02645253|75654245|FG001|COMPLETED|Overall Study||7||
59554027|NCT02645253|75654246|FG002|COMPLETED|Overall Study||7||
59554028|NCT02645253|75654247|FG003|COMPLETED|Overall Study||6||
59554029|NCT02645253|75654244|FG000|NOT COMPLETED|Overall Study||0||
59554030|NCT02645253|75654245|FG001|NOT COMPLETED|Overall Study||0||
59554031|NCT02645253|75654246|FG002|NOT COMPLETED|Overall Study||0||
59554032|NCT02645253|75654247|FG003|NOT COMPLETED|Overall Study||0||
59554033|NCT01484288|75654262|FG000|STARTED|Overall Study||11||
59554034|NCT01484288|75654262|FG000|COMPLETED|Overall Study||11||
59554035|NCT01484288|75654262|FG000|NOT COMPLETED|Overall Study||0||
59554036|NCT01860287|75654269|FG000|STARTED|Overall Study||18||
59554037|NCT01860287|75654270|FG001|STARTED|Overall Study||15||
59554038|NCT01860287|75654271|FG002|STARTED|Overall Study||15||
59554039|NCT01860287|75654269|FG000|COMPLETED|Overall Study||18||
59554040|NCT01860287|75654270|FG001|COMPLETED|Overall Study||15||
59554041|NCT01860287|75654271|FG002|COMPLETED|Overall Study||15||
59554042|NCT01860287|75654269|FG000|NOT COMPLETED|Overall Study||0||
59554043|NCT01860287|75654270|FG001|NOT COMPLETED|Overall Study||0||
59554044|NCT01860287|75654271|FG002|NOT COMPLETED|Overall Study||0||
59554045|NCT01421498|75654281|FG000|STARTED|Overall Study||293||
59554046|NCT01421498|75654282|FG001|STARTED|Overall Study||295||
59554047|NCT01421498|75654281|FG000|COMPLETED|Overall Study||281||
59554048|NCT01421498|75654282|FG001|COMPLETED|Overall Study||284||
59554049|NCT01421498|75654281|FG000|NOT COMPLETED|Overall Study||12||
59554050|NCT01421498|75654282|FG001|NOT COMPLETED|Overall Study||11||
59554051|NCT01421654|75654290|FG000|STARTED|Overall Study||11||
59554052|NCT01421654|75654291|FG001|STARTED|Overall Study||9||
59554053|NCT01421654|75654290|FG000|COMPLETED|Overall Study||11||
59554054|NCT01421654|75654291|FG001|COMPLETED|Overall Study|10 subjects completed study, but 1 subject was found to not meet IEC at the end; data was not used.|9||
59554055|NCT01421654|75654290|FG000|NOT COMPLETED|Overall Study||0||
59554056|NCT01421654|75654291|FG001|NOT COMPLETED|Overall Study||0||
59554057|NCT01422200|75654299|FG000|STARTED|Overall Study||11||
59554058|NCT01422200|75654300|FG001|STARTED|Overall Study||11||
59554059|NCT01422200|75654299|FG000|COMPLETED|Overall Study||11||
59554060|NCT01422200|75654300|FG001|COMPLETED|Overall Study||11||
59554061|NCT01422200|75654299|FG000|NOT COMPLETED|Overall Study||0||
59554062|NCT01422200|75654300|FG001|NOT COMPLETED|Overall Study||0||
59554063|NCT01422356|75654308|FG000|STARTED|Overall Study||200||
59554064|NCT01422356|75654308|FG000|COMPLETED|Overall Study||169||
59554065|NCT01422356|75654308|FG000|NOT COMPLETED|Overall Study||31||
59554066|NCT01860521|75654314|FG000|STARTED|Overall Study|September 2011|52||
59554067|NCT01860521|75654315|FG001|STARTED|Overall Study|September 2011|52||
59554068|NCT01860521|75654314|FG000|COMPLETED|Overall Study|June 2013|52||
59554069|NCT01860521|75654315|FG001|COMPLETED|Overall Study|June 2013|52||
59554070|NCT01860521|75654314|FG000|NOT COMPLETED|Overall Study||0||
59554071|NCT01860521|75654315|FG001|NOT COMPLETED|Overall Study||0||
59554072|NCT02648919|75654321|FG000|STARTED|Overall Study||6||
59554073|NCT02648919|75654321|FG000|COMPLETED|Overall Study||6||
59554074|NCT02648919|75654321|FG000|NOT COMPLETED|Overall Study||0||
59554075|NCT01400906|75654326|FG000|STARTED|Treatment Period 1||6||
59554076|NCT01400906|75654327|FG001|STARTED|Treatment Period 1||6||
59554077|NCT01400906|75654328|FG002|STARTED|Treatment Period 1||6||
59554078|NCT01400906|75654329|FG003|STARTED|Treatment Period 1||6||
59554079|NCT01400906|75654330|FG004|STARTED|Treatment Period 1||6||
59554080|NCT01400906|75654331|FG005|STARTED|Treatment Period 1||5||
59554081|NCT01400906|75654326|FG000|COMPLETED|Treatment Period 1||6||
59554082|NCT01400906|75654327|FG001|COMPLETED|Treatment Period 1||6||
59554083|NCT01400906|75654328|FG002|COMPLETED|Treatment Period 1||6||
59554084|NCT01400906|75654329|FG003|COMPLETED|Treatment Period 1||6||
59554085|NCT01400906|75654330|FG004|COMPLETED|Treatment Period 1||6||
59554086|NCT01400906|75654331|FG005|COMPLETED|Treatment Period 1||5||
59554087|NCT01400906|75654326|FG000|NOT COMPLETED|Treatment Period 1||0||
59554088|NCT01400906|75654327|FG001|NOT COMPLETED|Treatment Period 1||0||
59554089|NCT01400906|75654328|FG002|NOT COMPLETED|Treatment Period 1||0||
59554090|NCT01400906|75654329|FG003|NOT COMPLETED|Treatment Period 1||0||
59554091|NCT01400906|75654330|FG004|NOT COMPLETED|Treatment Period 1||0||
59554092|NCT01400906|75654331|FG005|NOT COMPLETED|Treatment Period 1||0||
59554093|NCT01400906|75654326|FG000|STARTED|Washout Period 1||6||
59554094|NCT01400906|75654327|FG001|STARTED|Washout Period 1||6||
59554095|NCT01400906|75654328|FG002|STARTED|Washout Period 1||6||
59554096|NCT01400906|75654329|FG003|STARTED|Washout Period 1||6||
59554097|NCT01400906|75654330|FG004|STARTED|Washout Period 1||6||
59554098|NCT01400906|75654331|FG005|STARTED|Washout Period 1||5||
59554099|NCT01400906|75654326|FG000|COMPLETED|Washout Period 1||6||
59554100|NCT01400906|75654327|FG001|COMPLETED|Washout Period 1||6||
59554101|NCT01400906|75654328|FG002|COMPLETED|Washout Period 1||6||
59554102|NCT01400906|75654329|FG003|COMPLETED|Washout Period 1||6||
59554103|NCT01400906|75654330|FG004|COMPLETED|Washout Period 1||6||
59554104|NCT01400906|75654331|FG005|COMPLETED|Washout Period 1||5||
59554105|NCT01400906|75654326|FG000|NOT COMPLETED|Washout Period 1||0||
59554106|NCT01400906|75654327|FG001|NOT COMPLETED|Washout Period 1||0||
59554107|NCT01400906|75654328|FG002|NOT COMPLETED|Washout Period 1||0||
59707032|NCT01257503|75825956|FG000|STARTED|Overall Study||133||
59554108|NCT01400906|75654329|FG003|NOT COMPLETED|Washout Period 1||0||
59554109|NCT01400906|75654330|FG004|NOT COMPLETED|Washout Period 1||0||
59554110|NCT01400906|75654331|FG005|NOT COMPLETED|Washout Period 1||0||
59554111|NCT01400906|75654326|FG000|STARTED|Treatment Period 2||6||
59554112|NCT01400906|75654327|FG001|STARTED|Treatment Period 2||6||
59554113|NCT01400906|75654328|FG002|STARTED|Treatment Period 2||6||
59554114|NCT01400906|75654329|FG003|STARTED|Treatment Period 2||6||
59707033|NCT01257503|75825957|FG001|STARTED|Overall Study||130||
59554115|NCT01400906|75654330|FG004|STARTED|Treatment Period 2||6||
59554116|NCT01400906|75654331|FG005|STARTED|Treatment Period 2||5||
59554117|NCT01400906|75654326|FG000|COMPLETED|Treatment Period 2||6||
59554118|NCT01400906|75654327|FG001|COMPLETED|Treatment Period 2||6||
59554119|NCT01400906|75654328|FG002|COMPLETED|Treatment Period 2||6||
59554120|NCT01400906|75654329|FG003|COMPLETED|Treatment Period 2||6||
59554121|NCT01400906|75654330|FG004|COMPLETED|Treatment Period 2||6||
59554122|NCT01400906|75654331|FG005|COMPLETED|Treatment Period 2||5||
59554123|NCT01400906|75654326|FG000|NOT COMPLETED|Treatment Period 2||0||
59554124|NCT01400906|75654327|FG001|NOT COMPLETED|Treatment Period 2||0||
59554125|NCT01400906|75654328|FG002|NOT COMPLETED|Treatment Period 2||0||
59554126|NCT01400906|75654329|FG003|NOT COMPLETED|Treatment Period 2||0||
59554127|NCT01400906|75654330|FG004|NOT COMPLETED|Treatment Period 2||0||
59554128|NCT01400906|75654331|FG005|NOT COMPLETED|Treatment Period 2||0||
59554129|NCT01400906|75654326|FG000|STARTED|Washout Period 2||6||
59554130|NCT01400906|75654327|FG001|STARTED|Washout Period 2||6||
59554131|NCT01400906|75654328|FG002|STARTED|Washout Period 2||6||
59554132|NCT01400906|75654329|FG003|STARTED|Washout Period 2||6||
59554133|NCT01400906|75654330|FG004|STARTED|Washout Period 2||6||
59554134|NCT01400906|75654331|FG005|STARTED|Washout Period 2||5||
59554135|NCT01400906|75654326|FG000|COMPLETED|Washout Period 2||6||
59554136|NCT01400906|75654327|FG001|COMPLETED|Washout Period 2||6||
59554137|NCT01400906|75654328|FG002|COMPLETED|Washout Period 2||6||
59554138|NCT01400906|75654329|FG003|COMPLETED|Washout Period 2||6||
59554139|NCT01400906|75654330|FG004|COMPLETED|Washout Period 2||6||
59707034|NCT01257503|75825956|FG000|Returned Symptom Diaries|Overall Study||80||
59707035|NCT01257503|75825957|FG001|Returned Symptom Diaries|Overall Study||83||
59991609|NCT01708954|76107184|FG002|STARTED|Step 2|Only patients with disease progression on Arms A and B were allowed to register to Step 2.|0||
59991610|NCT01708954|76107182|FG000|COMPLETED|Step 2|Treatment continued until progressive disease or unacceptable toxicity.|0||
59991611|NCT01708954|76107183|FG001|COMPLETED|Step 2|Treatment continued until progressive disease or unacceptable toxicity.|0||
59991612|NCT01708954|76107184|FG002|COMPLETED|Step 2||0||
60083427|NCT01518309|76199143|FG000|NOT COMPLETED|Overall Study||39||
60083428|NCT01419717|76199147|FG000|STARTED|Overall Study||129||
60083429|NCT01419717|76199147|FG000|Received Denosumab|Overall Study||128||
60083430|NCT01419717|76199147|FG000|COMPLETED|Overall Study||4||
60083431|NCT01419717|76199147|FG000|NOT COMPLETED|Overall Study||125||
60083432|NCT01458951|76199154|FG000|STARTED|Overall Study||429||
60083433|NCT01458951|76199155|FG001|STARTED|Overall Study||6||
60083434|NCT01458951|76199156|FG002|STARTED|Overall Study||112||
60083435|NCT01458951|76199154|FG000|COMPLETED|Overall Study||397||
60083436|NCT01458951|76199155|FG001|COMPLETED|Overall Study||5||
60083437|NCT01458951|76199156|FG002|COMPLETED|Overall Study||97||
60083438|NCT01458951|76199154|FG000|NOT COMPLETED|Overall Study||32||
60083439|NCT01458951|76199155|FG001|NOT COMPLETED|Overall Study||1||
60083440|NCT01458951|76199156|FG002|NOT COMPLETED|Overall Study||15||
60083441|NCT01458639|76199163|FG000|STARTED|Overall Study||18||
60083442|NCT01458639|76199163|FG000|COMPLETED|Overall Study||12||
60083443|NCT01458639|76199163|FG000|NOT COMPLETED|Overall Study||6||
60083444|NCT01437423|76199167|FG000|STARTED|Overall Study||662||
60083445|NCT01437423|76199167|FG000|COMPLETED|Overall Study||647||
60083446|NCT01437423|76199167|FG000|NOT COMPLETED|Overall Study||15||
60083447|NCT00393796|76199173|FG000|STARTED|Double Blind Period||26||
60083448|NCT00393796|76199174|FG001|STARTED|Double Blind Period||28||
60083449|NCT00393796|76199173|FG000|COMPLETED|Double Blind Period||26||
60083450|NCT00393796|76199174|FG001|COMPLETED|Double Blind Period||28||
60083451|NCT00393796|76199173|FG000|NOT COMPLETED|Double Blind Period||0||
60083452|NCT00393796|76199174|FG001|NOT COMPLETED|Double Blind Period||0||
60083453|NCT00393796|76199173|FG000|STARTED|Open Label Period - Placebo to SUTENT||0||
60083454|NCT00393796|76199174|FG001|STARTED|Open Label Period - Placebo to SUTENT||16||
60083455|NCT00393796|76199173|FG000|COMPLETED|Open Label Period - Placebo to SUTENT||0||
60083456|NCT00393796|76199174|FG001|COMPLETED|Open Label Period - Placebo to SUTENT||16||
60083457|NCT00393796|76199173|FG000|NOT COMPLETED|Open Label Period - Placebo to SUTENT||0||
60083458|NCT00393796|76199174|FG001|NOT COMPLETED|Open Label Period - Placebo to SUTENT||0||
60083459|NCT00393874|76199183|FG000|STARTED|Overall Study||18||
59554140|NCT01400906|75654331|FG005|COMPLETED|Washout Period 2||5||
59707036|NCT01257503|75825956|FG000|Returned Dosage Logbooks|Overall Study||75||
59707037|NCT01257503|75825957|FG001|Returned Dosage Logbooks|Overall Study||80||
59707038|NCT01257503|75825956|FG000|COMPLETED|Overall Study|Completed defined as participants who completed telephone follow-up at end of study period|125||
59554141|NCT01400906|75654326|FG000|NOT COMPLETED|Washout Period 2||0||
59554142|NCT01400906|75654327|FG001|NOT COMPLETED|Washout Period 2||0||
59554143|NCT01400906|75654328|FG002|NOT COMPLETED|Washout Period 2||0||
59554144|NCT01400906|75654329|FG003|NOT COMPLETED|Washout Period 2||0||
59554145|NCT01400906|75654330|FG004|NOT COMPLETED|Washout Period 2||0||
59554146|NCT01400906|75654331|FG005|NOT COMPLETED|Washout Period 2||0||
59554147|NCT01400906|75654326|FG000|STARTED|Treatment Period 3||6||
60083460|NCT00393874|76199184|FG001|STARTED|Overall Study||17||
60083461|NCT00393874|76199185|FG002|STARTED|Overall Study||15||
60083462|NCT00393874|76199183|FG000|COMPLETED|Overall Study||15||
60083463|NCT00393874|76199184|FG001|COMPLETED|Overall Study||13||
60083464|NCT00393874|76199185|FG002|COMPLETED|Overall Study||13||
60083465|NCT00393874|76199183|FG000|NOT COMPLETED|Overall Study||3||
59554148|NCT01400906|75654327|FG001|STARTED|Treatment Period 3||6||
59554149|NCT01400906|75654328|FG002|STARTED|Treatment Period 3||6||
59554150|NCT01400906|75654329|FG003|STARTED|Treatment Period 3||6||
59991613|NCT01708954|76107182|FG000|NOT COMPLETED|Step 2||13||
59991614|NCT01708954|76107183|FG001|NOT COMPLETED|Step 2||7||
59991615|NCT01708954|76107184|FG002|NOT COMPLETED|Step 2||0||
59554151|NCT01400906|75654330|FG004|STARTED|Treatment Period 3||6||
59554152|NCT01400906|75654331|FG005|STARTED|Treatment Period 3||5||
59554153|NCT01400906|75654326|FG000|COMPLETED|Treatment Period 3||6||
59554154|NCT01400906|75654327|FG001|COMPLETED|Treatment Period 3||6||
59554155|NCT01400906|75654328|FG002|COMPLETED|Treatment Period 3||6||
59554156|NCT01400906|75654329|FG003|COMPLETED|Treatment Period 3||6||
59554157|NCT01400906|75654330|FG004|COMPLETED|Treatment Period 3||6||
59554158|NCT01400906|75654331|FG005|COMPLETED|Treatment Period 3||5||
59554159|NCT01400906|75654326|FG000|NOT COMPLETED|Treatment Period 3||0||
59554160|NCT01400906|75654327|FG001|NOT COMPLETED|Treatment Period 3||0||
59554161|NCT01400906|75654328|FG002|NOT COMPLETED|Treatment Period 3||0||
59554162|NCT01400906|75654329|FG003|NOT COMPLETED|Treatment Period 3||0||
59554163|NCT01400906|75654330|FG004|NOT COMPLETED|Treatment Period 3||0||
59554164|NCT01400906|75654331|FG005|NOT COMPLETED|Treatment Period 3||0||
59554165|NCT01861301|75654339|FG000|STARTED|Overall Study||18||
59554166|NCT01861301|75654339|FG000|COMPLETED|Overall Study||18||
59554167|NCT01861301|75654339|FG000|NOT COMPLETED|Overall Study||0||
59554168|NCT01485380|75654344|FG000|STARTED|Overall Study||20||
59554169|NCT01485380|75654344|FG000|COMPLETED|Overall Study||17||
59554170|NCT01485380|75654344|FG000|NOT COMPLETED|Overall Study||3||
59554171|NCT01539980|75654348|FG000|STARTED|Overall Study||30||
59554172|NCT01539980|75654348|FG000|COMPLETED|Overall Study||30||
59554173|NCT01539980|75654348|FG000|NOT COMPLETED|Overall Study||0||
59554174|NCT00556673|75654354|FG000|STARTED|Overall Study||16||
59554175|NCT00556673|75654355|FG001|STARTED|Overall Study||15||
59554176|NCT00556673|75654354|FG000|Pharmacodynamic (PD) Population|Overall Study|4 patients inadvertently unblinded were not included in PD analysis population.|12||
59554177|NCT00556673|75654355|FG001|Pharmacodynamic (PD) Population|Overall Study|3 patients inadvertently unblinded were not included in PD analysis population.|12||
59554178|NCT00556673|75654354|FG000|COMPLETED|Overall Study||13||
59554179|NCT00556673|75654355|FG001|COMPLETED|Overall Study||13||
59554180|NCT00556673|75654354|FG000|NOT COMPLETED|Overall Study||3||
59554181|NCT00556673|75654355|FG001|NOT COMPLETED|Overall Study||2||
59554182|NCT01422434|75654366|FG000|STARTED|Overall Study||227||
59554183|NCT01422434|75654367|FG001|STARTED|Overall Study||226||
59554184|NCT01422434|75654368|FG002|STARTED|Overall Study||223||
59554185|NCT01422434|75654366|FG000|COMPLETED|Overall Study||216||
59554186|NCT01422434|75654367|FG001|COMPLETED|Overall Study||221||
59554187|NCT01422434|75654368|FG002|COMPLETED|Overall Study||217||
59554188|NCT01422434|75654366|FG000|NOT COMPLETED|Overall Study||11||
59554189|NCT01422434|75654367|FG001|NOT COMPLETED|Overall Study||5||
59554190|NCT01422434|75654368|FG002|NOT COMPLETED|Overall Study||6||
59554191|NCT02402322|75654379|FG000|STARTED|Pretreatment||27||
59707039|NCT01257503|75825957|FG001|COMPLETED|Overall Study|Completed defined as participants who completed telephone follow-up at end of study period|119||
59707040|NCT01257503|75825956|FG000|NOT COMPLETED|Overall Study||8||
59554192|NCT02402322|75654380|FG001|STARTED|Pretreatment||25||
59554193|NCT02402322|75654381|FG002|STARTED|Pretreatment||25||
59554194|NCT02402322|75654379|FG000|Posttreatment Measures|Pretreatment||24||
59554195|NCT02402322|75654380|FG001|Posttreatment Measures|Pretreatment||24||
59554196|NCT02402322|75654381|FG002|Posttreatment Measures|Pretreatment||24||
59554197|NCT02402322|75654379|FG000|COMPLETED|Pretreatment||24||
59554198|NCT02402322|75654380|FG001|COMPLETED|Pretreatment||24||
59554199|NCT02402322|75654381|FG002|COMPLETED|Pretreatment||24||
59554200|NCT02402322|75654379|FG000|NOT COMPLETED|Pretreatment||3||
59554201|NCT02402322|75654380|FG001|NOT COMPLETED|Pretreatment||1||
59554202|NCT02402322|75654381|FG002|NOT COMPLETED|Pretreatment||1||
59554203|NCT02402322|75654379|FG000|STARTED|Follow-up||24||
59554204|NCT02402322|75654380|FG001|STARTED|Follow-up||24||
59554205|NCT02402322|75654381|FG002|STARTED|Follow-up|These individuals were not evaluated at this follow-up as they started an alternative treatment.|24||
59554206|NCT02402322|75654379|FG000|COMPLETED|Follow-up||18||
59554207|NCT02402322|75654380|FG001|COMPLETED|Follow-up||21||
59554208|NCT02402322|75654381|FG002|COMPLETED|Follow-up||0||
59554209|NCT02402322|75654379|FG000|NOT COMPLETED|Follow-up||6||
59554210|NCT02402322|75654380|FG001|NOT COMPLETED|Follow-up||3||
59554211|NCT02402322|75654381|FG002|NOT COMPLETED|Follow-up||24||
59554212|NCT01861457|75654391|FG000|STARTED|Overall Study||20||
59554213|NCT01861457|75654392|FG001|STARTED|Overall Study||19||
59554214|NCT01861457|75654391|FG000|COMPLETED|Overall Study||20||
59554215|NCT01861457|75654392|FG001|COMPLETED|Overall Study||19||
59554216|NCT01861457|75654391|FG000|NOT COMPLETED|Overall Study||0||
59554217|NCT01861457|75654392|FG001|NOT COMPLETED|Overall Study||0||
59554218|NCT02651103|75654398|FG000|STARTED|Overall Study||30||
59554219|NCT02651103|75654398|FG000|COMPLETED|Overall Study||30||
59554220|NCT02651103|75654398|FG000|NOT COMPLETED|Overall Study||0||
59554221|NCT01861925|75654405|FG000|STARTED|Overall Study||34||
59554222|NCT01861925|75654406|FG001|STARTED|Overall Study||8||
59554223|NCT01861925|75654407|FG002|STARTED|Overall Study||8||
59554224|NCT01861925|75654405|FG000|COMPLETED|Overall Study||34||
59554225|NCT01861925|75654406|FG001|COMPLETED|Overall Study||8||
59554226|NCT01861925|75654407|FG002|COMPLETED|Overall Study||8||
59554227|NCT01861925|75654405|FG000|NOT COMPLETED|Overall Study||0||
59554228|NCT01861925|75654406|FG001|NOT COMPLETED|Overall Study||0||
59554229|NCT01861925|75654407|FG002|NOT COMPLETED|Overall Study||0||
59554230|NCT02269631|75654418|FG000|STARTED|Overall Study||7||
59554231|NCT02269631|75654419|FG001|STARTED|Overall Study||5||
59554232|NCT02269631|75654418|FG000|COMPLETED|Overall Study||7||
59554233|NCT02269631|75654419|FG001|COMPLETED|Overall Study||5||
59554234|NCT02269631|75654418|FG000|NOT COMPLETED|Overall Study||0||
59554235|NCT02269631|75654419|FG001|NOT COMPLETED|Overall Study||0||
59554236|NCT02270255|75654427|FG000|STARTED|Overall Study||22||
59554237|NCT02270255|75654428|FG001|STARTED|Overall Study||22||
59554238|NCT02270255|75654427|FG000|Complete Data at Discharge PACU|Overall Study||22||
59554239|NCT02270255|75654428|FG001|Complete Data at Discharge PACU|Overall Study||22||
59554240|NCT02270255|75654427|FG000|Complete Data From Home Survey|Overall Study||21||
59554241|NCT02270255|75654428|FG001|Complete Data From Home Survey|Overall Study||22||
59554242|NCT02270255|75654427|FG000|COMPLETED|Overall Study||21||
59554243|NCT02270255|75654428|FG001|COMPLETED|Overall Study||22||
59554244|NCT02270255|75654427|FG000|NOT COMPLETED|Overall Study||1||
59554245|NCT02270255|75654428|FG001|NOT COMPLETED|Overall Study||0||
59554246|NCT02270645|75654436|FG000|STARTED|Overall Study||8||11
59554247|NCT02270645|75654437|FG001|STARTED|Overall Study||4||5
59554248|NCT02270645|75654436|FG000|COMPLETED|Overall Study||6||9
59554249|NCT02270645|75654437|FG001|COMPLETED|Overall Study||4||5
59554250|NCT02270645|75654436|FG000|NOT COMPLETED|Overall Study||2||2
59554251|NCT02270645|75654437|FG001|NOT COMPLETED|Overall Study||0||0
59554252|NCT02651259|75654445|FG000|STARTED|Overall Study||25||
59554253|NCT02651259|75654446|FG001|STARTED|Overall Study||25||
59554254|NCT02651259|75654445|FG000|COMPLETED|Overall Study||25||
59554255|NCT02651259|75654446|FG001|COMPLETED|Overall Study||25||
59554256|NCT02651259|75654445|FG000|NOT COMPLETED|Overall Study||0||
59554257|NCT02651259|75654446|FG001|NOT COMPLETED|Overall Study||0||
59554258|NCT02271425|75654460|FG000|STARTED|Overall Study||8||
59554259|NCT02271425|75654460|FG000|COMPLETED|Overall Study||8||
59554260|NCT02271425|75654460|FG000|NOT COMPLETED|Overall Study||0||
59554261|NCT01862159|75654465|FG000|STARTED|Overall Study||25038||
59554262|NCT01862159|75654465|FG000|COMPLETED|Overall Study||25038||
60083466|NCT00393874|76199184|FG001|NOT COMPLETED|Overall Study||4||
60083467|NCT00393874|76199185|FG002|NOT COMPLETED|Overall Study||2||
60083468|NCT01458249|76199198|FG000|STARTED|Overall Study||52||
60083469|NCT01458249|76199198|FG000|Participants Treated|Overall Study||51||
60083470|NCT01458249|76199198|FG000|COMPLETED|Overall Study||44||
60083471|NCT01458249|76199198|FG000|NOT COMPLETED|Overall Study||8||
60083472|NCT00394888|76199206|FG000|STARTED|Overall Study||108||
59554263|NCT01862159|75654465|FG000|NOT COMPLETED|Overall Study||0||
59554264|NCT02651337|75654469|FG000|STARTED|Overall Study||5||
59554265|NCT02651337|75654469|FG000|COMPLETED|Overall Study||4||
59554266|NCT02651337|75654469|FG000|NOT COMPLETED|Overall Study||1||
59707041|NCT01257503|75825957|FG001|NOT COMPLETED|Overall Study||11||
60083473|NCT00394888|76199207|FG001|STARTED|Overall Study||48||
60083474|NCT00394888|76199208|FG002|STARTED|Overall Study||201||
59554267|NCT01863017|75654475|FG000|STARTED|Overall Study||12||
59554268|NCT01863017|75654476|FG001|STARTED|Overall Study||19||
59554269|NCT01863017|75654475|FG000|Normal Weight Participants|Overall Study||5||
59554270|NCT01863017|75654476|FG001|Normal Weight Participants|Overall Study||5||
59554271|NCT01863017|75654475|FG000|Obese Participants|Overall Study||4||
60083475|NCT00394888|76199206|FG000|COMPLETED|Overall Study||108||
60083476|NCT00394888|76199207|FG001|COMPLETED|Overall Study||48||
59554272|NCT01863017|75654476|FG001|Obese Participants|Overall Study||7||
59554273|NCT01863017|75654475|FG000|Participants With PWS|Overall Study||3|Prader-Willi syndrome (PWS)|
59554274|NCT01863017|75654476|FG001|Participants With PWS|Overall Study||7|Prader-Willi syndrome (PWS)|
59554275|NCT01863017|75654475|FG000|COMPLETED|Overall Study||12||
59554276|NCT01863017|75654476|FG001|COMPLETED|Overall Study||19||
59554277|NCT01863017|75654475|FG000|NOT COMPLETED|Overall Study||0||
59554278|NCT01863017|75654476|FG001|NOT COMPLETED|Overall Study||0||
59554279|NCT01423760|75654484|FG000|STARTED|Overall Study||14||
59554280|NCT01423760|75654485|FG001|STARTED|Overall Study||13||
59554281|NCT01423760|75654484|FG000|Number of Tecemotide Subjects|Overall Study||12||
59554282|NCT01423760|75654485|FG001|Number of Tecemotide Subjects|Overall Study||8||
59554283|NCT01423760|75654484|FG000|Number of Non-treatment Subjects|Overall Study||2||
59554284|NCT01423760|75654485|FG001|Number of Non-treatment Subjects|Overall Study||5||
59554285|NCT01423760|75654484|FG000|Safety Analysis Set|Overall Study||12||
59554286|NCT01423760|75654485|FG001|Safety Analysis Set|Overall Study||8||
59554287|NCT01423760|75654484|FG000|COMPLETED|Overall Study||14||
59554288|NCT01423760|75654485|FG001|COMPLETED|Overall Study||13||
59554289|NCT01423760|75654484|FG000|NOT COMPLETED|Overall Study||0||
59554290|NCT01423760|75654485|FG001|NOT COMPLETED|Overall Study||0||
59707042|NCT00995566|75825963|FG000|STARTED|Overall Study||54||
59707043|NCT00995566|75825963|FG000|COMPLETED|Overall Study||0||
59707044|NCT00995566|75825963|FG000|NOT COMPLETED|Overall Study||54||
59707045|NCT01257425|75825969|FG000|STARTED|Overall Study||52||
59707046|NCT01257425|75825970|FG001|STARTED|Overall Study||51||
59707047|NCT01257425|75825969|FG000|COMPLETED|Overall Study||46||
59707048|NCT01257425|75825970|FG001|COMPLETED|Overall Study||45||
59991616|NCT01267955|76107193|FG000|STARTED|Stage 1 (6 Months)||20||
59991617|NCT01267955|76107193|FG000|COMPLETED|Stage 1 (6 Months)||17|Subjects contributing data to the primary analysis are considered to have completed the study.|
59991618|NCT01267955|76107193|FG000|NOT COMPLETED|Stage 1 (6 Months)||3||
59991619|NCT01267955|76107193|FG000|STARTED|Stage 2 (6 Months)||45||
59991620|NCT01267955|76107193|FG000|COMPLETED|Stage 2 (6 Months)||39||
59991621|NCT01267955|76107193|FG000|NOT COMPLETED|Stage 2 (6 Months)||6||
59991622|NCT01251861|76107199|FG000|STARTED|Overall Study||54||
59991623|NCT01251861|76107200|FG001|STARTED|Overall Study||54||
59554291|NCT02651415|75654491|FG000|STARTED|Overall Study|12 patients were enrolled.|12||
59554292|NCT02651415|75654491|FG000|COMPLETED|Overall Study|10 patients were evaluable.|10||
59554293|NCT02651415|75654491|FG000|NOT COMPLETED|Overall Study||2||
59554294|NCT00555425|75654497|FG000|STARTED|Overall Study||57||
59554295|NCT00555425|75654498|FG001|STARTED|Overall Study||56||
59554296|NCT00555425|75654497|FG000|COMPLETED|Overall Study||6||
59707049|NCT01257425|75825969|FG000|NOT COMPLETED|Overall Study||6||
59707050|NCT01257425|75825970|FG001|NOT COMPLETED|Overall Study||6||
59707051|NCT00995488|75825976|FG000|STARTED|Overall Study||16||
59816584|NCT04915950|75939023|FG002|STARTED|Stage A: Treatment Period 1 (1 Day)||2||
59991624|NCT01251861|76107199|FG000|Pts Who Received Protocol Therapy|Overall Study||50||
59991625|NCT01251861|76107200|FG001|Pts Who Received Protocol Therapy|Overall Study||53||
59991626|NCT01251861|76107199|FG000|Pts w/ Follow-up PSA Lower Than Baseline|Overall Study||49||
59991627|NCT01251861|76107200|FG001|Pts w/ Follow-up PSA Lower Than Baseline|Overall Study||47||
59991628|NCT01251861|76107199|FG000|Pts With PSA Response|Overall Study||44||
59991629|NCT01251861|76107200|FG001|Pts With PSA Response|Overall Study||36||
59991630|NCT01251861|76107199|FG000|COMPLETED|Overall Study||36||
59991631|NCT01251861|76107200|FG001|COMPLETED|Overall Study||26||
59991632|NCT01251861|76107199|FG000|NOT COMPLETED|Overall Study||18||
59991633|NCT01251861|76107200|FG001|NOT COMPLETED|Overall Study||28||
59991634|NCT00890045|76107208|FG000|STARTED|Overall Study||20||
59995156|NCT01376245|76110976|FG003|STARTED|24-week, Double-blind Treatment Period||161||
59995157|NCT01376245|76110977|FG004|STARTED|24-week, Double-blind Treatment Period||160||
59995158|NCT01376245|76110973|FG000|COMPLETED|24-week, Double-blind Treatment Period||0||
59995159|NCT01376245|76110974|FG001|COMPLETED|24-week, Double-blind Treatment Period||130||
59995160|NCT01376245|76110975|FG002|COMPLETED|24-week, Double-blind Treatment Period||135||
59995161|NCT01376245|76110976|FG003|COMPLETED|24-week, Double-blind Treatment Period||138||
59995162|NCT01376245|76110977|FG004|COMPLETED|24-week, Double-blind Treatment Period||134||
59995163|NCT01376245|76110973|FG000|NOT COMPLETED|24-week, Double-blind Treatment Period||0||
59995164|NCT01376245|76110974|FG001|NOT COMPLETED|24-week, Double-blind Treatment Period||32||
59995165|NCT01376245|76110975|FG002|NOT COMPLETED|24-week, Double-blind Treatment Period||25||
59995166|NCT01376245|76110976|FG003|NOT COMPLETED|24-week, Double-blind Treatment Period||23||
59995167|NCT01376245|76110977|FG004|NOT COMPLETED|24-week, Double-blind Treatment Period||26||
59995168|NCT01674621|76110992|FG000|STARTED|Overall Study||50||
59554297|NCT00555425|75654498|FG001|COMPLETED|Overall Study||37||
59554298|NCT00555425|75654497|FG000|NOT COMPLETED|Overall Study||51||
59554299|NCT00555425|75654498|FG001|NOT COMPLETED|Overall Study||19||
59554300|NCT01485770|75654506|FG000|STARTED|First Intervention (2 Weeks)||17||
59554301|NCT01485770|75654507|FG001|STARTED|First Intervention (2 Weeks)||16||
59554302|NCT01485770|75654506|FG000|COMPLETED|First Intervention (2 Weeks)||17||
59554303|NCT01485770|75654507|FG001|COMPLETED|First Intervention (2 Weeks)||16||
59554304|NCT01485770|75654506|FG000|NOT COMPLETED|First Intervention (2 Weeks)||0||
59554305|NCT01485770|75654507|FG001|NOT COMPLETED|First Intervention (2 Weeks)||0||
59554306|NCT01485770|75654506|FG000|STARTED|Second Intervention (2 Weeks)||17||
59554307|NCT01485770|75654507|FG001|STARTED|Second Intervention (2 Weeks)||16||
59554308|NCT01485770|75654506|FG000|COMPLETED|Second Intervention (2 Weeks)||17||
59554309|NCT01485770|75654507|FG001|COMPLETED|Second Intervention (2 Weeks)||16||
59554310|NCT01485770|75654506|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||0||
59554311|NCT01485770|75654507|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||0||
59554312|NCT01863563|75654515|FG000|STARTED|Overall Study||100||
59554313|NCT01863563|75654515|FG000|COMPLETED|Overall Study||100||
59554314|NCT01863563|75654515|FG000|NOT COMPLETED|Overall Study||0||
59554315|NCT01424072|75654522|FG000|STARTED|Overall Study||27||
59554316|NCT01424072|75654523|FG001|STARTED|Overall Study||26||
59554317|NCT01424072|75654524|FG002|STARTED|Overall Study||22||
59554318|NCT01424072|75654522|FG000|COMPLETED|Overall Study||27||
59554319|NCT01424072|75654523|FG001|COMPLETED|Overall Study||26||
59554320|NCT01424072|75654524|FG002|COMPLETED|Overall Study||22||
59554321|NCT01424072|75654522|FG000|NOT COMPLETED|Overall Study||0||
59554322|NCT01424072|75654523|FG001|NOT COMPLETED|Overall Study||0||
59554323|NCT01424072|75654524|FG002|NOT COMPLETED|Overall Study||0||
59554324|NCT01540370|75654532|FG000|STARTED|Overall Study||102||
59554325|NCT01540370|75654532|FG000|COMPLETED|Overall Study||100||
59554326|NCT01540370|75654532|FG000|NOT COMPLETED|Overall Study||2||
59554327|NCT01866839|75654536|FG000|STARTED|Overall Study||40||
59707052|NCT00995488|75825976|FG000|COMPLETED|Overall Study||15||
59707053|NCT00995488|75825976|FG000|NOT COMPLETED|Overall Study||1||
59707054|NCT01256879|75825980|FG000|STARTED|Overall Study|25 started in this cross-over study but only 24 completed|25||
59991635|NCT00890045|76107209|FG001|STARTED|Overall Study|Of the 52 subjects randomized to the HeRO Graft, two implants were abandoned.|52||
59991636|NCT00890045|76107208|FG000|COMPLETED|Overall Study||15||
59991637|NCT00890045|76107209|FG001|COMPLETED|Overall Study||42||
59991638|NCT00890045|76107208|FG000|NOT COMPLETED|Overall Study||5||
59991639|NCT00890045|76107209|FG001|NOT COMPLETED|Overall Study||10||
60083477|NCT00394888|76199208|FG002|COMPLETED|Overall Study||201||
60083478|NCT00394888|76199206|FG000|NOT COMPLETED|Overall Study||0||
60083479|NCT00394888|76199207|FG001|NOT COMPLETED|Overall Study||0||
60083480|NCT00394888|76199208|FG002|NOT COMPLETED|Overall Study||0||
60083481|NCT01458171|76199214|FG000|STARTED|Overall Study||23||
60083482|NCT01458171|76199214|FG000|COMPLETED|Overall Study||22||
60083483|NCT01458171|76199214|FG000|NOT COMPLETED|Overall Study||1||
60083484|NCT00395044|76199222|FG000|STARTED|Overall Study||25||
60083485|NCT00395044|76199223|FG001|STARTED|Overall Study||25||
60083486|NCT00395044|76199222|FG000|COMPLETED|Overall Study||7||
60083487|NCT00395044|76199223|FG001|COMPLETED|Overall Study||11||
60083488|NCT00395044|76199222|FG000|NOT COMPLETED|Overall Study||18||
60083489|NCT00395044|76199223|FG001|NOT COMPLETED|Overall Study||14||
60083490|NCT01457703|76199231|FG000|STARTED|Overall Study||29||
60083491|NCT01457703|76199232|FG001|STARTED|Overall Study||33||
60083492|NCT01457703|76199231|FG000|COMPLETED|Overall Study||23||
60083493|NCT01457703|76199232|FG001|COMPLETED|Overall Study||22||
60083494|NCT01457703|76199231|FG000|NOT COMPLETED|Overall Study||6||
60083495|NCT01457703|76199232|FG001|NOT COMPLETED|Overall Study||11||
60083496|NCT00356434|76199242|FG000|STARTED|Overall Study||4||
59991640|NCT00630565|76107217|FG000|STARTED|Overall Study||12||
59991641|NCT00630565|76107218|FG001|STARTED|Overall Study||0||
59991642|NCT00630565|76107217|FG000|COMPLETED|Overall Study||12||
59991643|NCT00630565|76107218|FG001|COMPLETED|Overall Study||0||
59991644|NCT00630565|76107217|FG000|NOT COMPLETED|Overall Study||0||
59991645|NCT00630565|76107218|FG001|NOT COMPLETED|Overall Study||0||
59991646|NCT00598481|76107222|FG000|STARTED|Baseline||12||
59991647|NCT00598481|76107222|FG000|COMPLETED|Baseline||12||
59991648|NCT00598481|76107222|FG000|NOT COMPLETED|Baseline||0||
60083497|NCT00356434|76199243|FG001|STARTED|Overall Study||7||
60083498|NCT00356434|76199242|FG000|COMPLETED|Overall Study||4||
60083499|NCT00356434|76199243|FG001|COMPLETED|Overall Study||7||
59554328|NCT01866839|75654536|FG000|COMPLETED|Overall Study||30||
59554329|NCT01866839|75654536|FG000|NOT COMPLETED|Overall Study||10||
59554330|NCT01487954|75654542|FG000|STARTED|Overall Study||29||
59554331|NCT01487954|75654543|FG001|STARTED|Overall Study||16||
59554332|NCT01487954|75654542|FG000|Safety lead-in|Overall Study||10||
59554333|NCT01487954|75654543|FG001|Safety lead-in|Overall Study|Only the first 10 patients in the alkaline group were analyzed, as that was the experimental group.|0||
59554334|NCT01487954|75654542|FG000|COMPLETED|Overall Study||29||
59554335|NCT01487954|75654543|FG001|COMPLETED|Overall Study||16||
59554336|NCT01487954|75654542|FG000|NOT COMPLETED|Overall Study||0||
59554337|NCT01487954|75654543|FG001|NOT COMPLETED|Overall Study||0||
59554338|NCT01541384|75654552|FG000|STARTED|Overall Study||40||
59554339|NCT01541384|75654553|FG001|STARTED|Overall Study||40||
59554340|NCT01541384|75654554|FG002|STARTED|Overall Study||40||
59554341|NCT01541384|75654552|FG000|COMPLETED|Overall Study||40||
59554342|NCT01541384|75654553|FG001|COMPLETED|Overall Study||39||
59554343|NCT01541384|75654554|FG002|COMPLETED|Overall Study||38||
59554344|NCT01541384|75654552|FG000|NOT COMPLETED|Overall Study||0||
59554345|NCT01541384|75654553|FG001|NOT COMPLETED|Overall Study||1||
59554346|NCT01541384|75654554|FG002|NOT COMPLETED|Overall Study||2||
59554347|NCT01488188|75654564|FG000|STARTED|Overall Study||20||
59554348|NCT01488188|75654565|FG001|STARTED|Overall Study||20||
59554349|NCT01488188|75654564|FG000|COMPLETED|Overall Study||20||
59554350|NCT01488188|75654565|FG001|COMPLETED|Overall Study||20||
59554351|NCT01488188|75654564|FG000|NOT COMPLETED|Overall Study||0||
59554352|NCT01488188|75654565|FG001|NOT COMPLETED|Overall Study||0||
59554353|NCT01489670|75654571|FG000|STARTED|Overall Study||387||
59554354|NCT01489670|75654571|FG000|COMPLETED|Overall Study||334||
59554355|NCT01489670|75654571|FG000|NOT COMPLETED|Overall Study||53||
59554356|NCT01542398|75654577|FG000|STARTED|Overall Study||79||
59554357|NCT01542398|75654578|FG001|STARTED|Overall Study||80||
59554358|NCT01542398|75654577|FG000|Post-Intervention Assessment|Overall Study||78||
59554359|NCT01542398|75654578|FG001|Post-Intervention Assessment|Overall Study||80||
59554360|NCT01542398|75654577|FG000|COMPLETED|Overall Study||71||
59554361|NCT01542398|75654578|FG001|COMPLETED|Overall Study||67||
59554362|NCT01542398|75654577|FG000|NOT COMPLETED|Overall Study||8||
59554363|NCT01542398|75654578|FG001|NOT COMPLETED|Overall Study||13||
59554364|NCT02654691|75654586|FG000|STARTED|Overall Study||63||
59554365|NCT02654691|75654586|FG000|COMPLETED|Overall Study||63||
59554366|NCT02654691|75654586|FG000|NOT COMPLETED|Overall Study||0||
59554367|NCT01427504|75654596|FG000|STARTED|Overall Study||4||
59554368|NCT01427504|75654597|FG001|STARTED|Overall Study||3||
59554369|NCT01427504|75654598|FG002|STARTED|Overall Study||4||
59554370|NCT01427504|75654599|FG003|STARTED|Overall Study||6||
59554371|NCT01427504|75654600|FG004|STARTED|Overall Study||3||
59554372|NCT01427504|75654601|FG005|STARTED|Overall Study||6||
59554373|NCT01427504|75654596|FG000|Received Boceprevir|Overall Study||4||
59554374|NCT01427504|75654597|FG001|Received Boceprevir|Overall Study||3||
59554375|NCT01427504|75654598|FG002|Received Boceprevir|Overall Study||3||
59554376|NCT01427504|75654599|FG003|Received Boceprevir|Overall Study||5||
59707055|NCT01256879|75825980|FG000|CimTest-A|Overall Study|25 started this intervention but only 24 completed|25||
59707056|NCT01256879|75825980|FG000|CimTest-B|Overall Study|24 started this intervention and 24 completed|24||
59991649|NCT00598481|76107222|FG000|STARTED|Treatment||12||
59554377|NCT01427504|75654600|FG004|Received Boceprevir|Overall Study||2||
59554378|NCT01427504|75654601|FG005|Received Boceprevir|Overall Study||4||
59554379|NCT01427504|75654596|FG000|Received Etravirine|Overall Study||4||
59554380|NCT01427504|75654597|FG001|Received Etravirine|Overall Study||2||
59554381|NCT01427504|75654598|FG002|Received Etravirine|Overall Study||4||
59554382|NCT01427504|75654599|FG003|Received Etravirine|Overall Study||6||
59554383|NCT01427504|75654600|FG004|Received Etravirine|Overall Study||2||
59554384|NCT01427504|75654601|FG005|Received Etravirine|Overall Study||4||
59554385|NCT01427504|75654596|FG000|Received Combination|Overall Study||4||
59554386|NCT01427504|75654597|FG001|Received Combination|Overall Study||3||
59554387|NCT01427504|75654598|FG002|Received Combination|Overall Study||3||
59554388|NCT01427504|75654599|FG003|Received Combination|Overall Study||6||
59554389|NCT01427504|75654600|FG004|Received Combination|Overall Study||3||
59554390|NCT01427504|75654601|FG005|Received Combination|Overall Study||6||
59554391|NCT01427504|75654596|FG000|COMPLETED|Overall Study||4||
59554392|NCT01427504|75654597|FG001|COMPLETED|Overall Study||2||
59554393|NCT01427504|75654598|FG002|COMPLETED|Overall Study||3||
59554394|NCT01427504|75654599|FG003|COMPLETED|Overall Study||5||
59554395|NCT01427504|75654600|FG004|COMPLETED|Overall Study||2||
59554396|NCT01427504|75654601|FG005|COMPLETED|Overall Study||4||
59554397|NCT01427504|75654596|FG000|NOT COMPLETED|Overall Study||0||
60083500|NCT00356434|76199242|FG000|NOT COMPLETED|Overall Study||0||
60083501|NCT00356434|76199243|FG001|NOT COMPLETED|Overall Study||0||
60083502|NCT01419015|76199250|FG000|STARTED|Overall Study||17||
60083503|NCT01419015|76199250|FG000|COMPLETED|Overall Study||15||
60083504|NCT01419015|76199250|FG000|NOT COMPLETED|Overall Study||2||
60083505|NCT00357214|76199258|FG000|STARTED|Overall Study||43||
60083506|NCT00357214|76199259|FG001|STARTED|Overall Study||43||
60083507|NCT00357214|76199260|FG002|STARTED|Overall Study||42||
60083508|NCT00357214|76199261|FG003|STARTED|Overall Study||43||
60083509|NCT00357214|76199258|FG000|COMPLETED|Overall Study||39||
60083510|NCT00357214|76199259|FG001|COMPLETED|Overall Study||39||
60083511|NCT00357214|76199260|FG002|COMPLETED|Overall Study||42||
60083512|NCT00357214|76199261|FG003|COMPLETED|Overall Study||42||
60083513|NCT00357214|76199258|FG000|NOT COMPLETED|Overall Study||4||
60083514|NCT00357214|76199259|FG001|NOT COMPLETED|Overall Study||4||
60083515|NCT00357214|76199260|FG002|NOT COMPLETED|Overall Study||0||
60083516|NCT00357214|76199261|FG003|NOT COMPLETED|Overall Study||1||
60083517|NCT01418937|76199271|FG000|STARTED|Overall Study||164||
60083518|NCT01418937|76199271|FG000|COMPLETED|Overall Study||156||
60083519|NCT01418937|76199271|FG000|NOT COMPLETED|Overall Study||8||
60083520|NCT02076321|76199277|FG000|STARTED|Overall Study||51||
60083521|NCT02076321|76199278|FG001|STARTED|Overall Study||51||
60083522|NCT02076321|76199277|FG000|COMPLETED|Overall Study||46||
60083523|NCT02076321|76199278|FG001|COMPLETED|Overall Study||49||
60083524|NCT02076321|76199277|FG000|NOT COMPLETED|Overall Study||5||
60083525|NCT02076321|76199278|FG001|NOT COMPLETED|Overall Study||2||
60083526|NCT01417377|76199284|FG000|STARTED|Overall Study||22||
60083527|NCT01417377|76199284|FG000|Treated|Overall Study||21||
60083528|NCT01417377|76199284|FG000|COMPLETED|Overall Study||9||
60083529|NCT01417377|76199284|FG000|NOT COMPLETED|Overall Study||13||
60083530|NCT00358462|76199290|FG000|STARTED|Overall Study||304||
60083531|NCT00358462|76199291|FG001|STARTED|Overall Study||302||
60083532|NCT00358462|76199290|FG000|COMPLETED|Overall Study||245||
60083533|NCT00358462|76199291|FG001|COMPLETED|Overall Study||238||
60083534|NCT00358462|76199290|FG000|NOT COMPLETED|Overall Study||59||
60083535|NCT00358462|76199291|FG001|NOT COMPLETED|Overall Study||64||
60083536|NCT00396292|76199309|FG000|STARTED|Overall Study||174||
60083537|NCT00396292|76199310|FG001|STARTED|Overall Study||178||
60083538|NCT00396292|76199309|FG000|COMPLETED|Overall Study||165||
60083539|NCT00396292|76199310|FG001|COMPLETED|Overall Study||162||
60083540|NCT00396292|76199309|FG000|NOT COMPLETED|Overall Study||9||
60083541|NCT00396292|76199310|FG001|NOT COMPLETED|Overall Study||16||
60083542|NCT00397150|76199318|FG000|STARTED|Overall Study||1323||
60083543|NCT00397150|76199319|FG001|STARTED|Overall Study||1256||
60083544|NCT00397150|76199318|FG000|COMPLETED|Overall Study||1188||
60083545|NCT00397150|76199319|FG001|COMPLETED|Overall Study||1111||
60083546|NCT00397150|76199318|FG000|NOT COMPLETED|Overall Study||135||
60083547|NCT00397150|76199319|FG001|NOT COMPLETED|Overall Study||145||
60083548|NCT01437267|76199331|FG000|STARTED|Overall Study||20||
59554398|NCT01427504|75654597|FG001|NOT COMPLETED|Overall Study||1||
59554399|NCT01427504|75654598|FG002|NOT COMPLETED|Overall Study||1||
60083549|NCT01437267|76199332|FG001|STARTED|Overall Study||20||
60083550|NCT01437267|76199333|FG002|STARTED|Overall Study||20||
60083551|NCT01437267|76199334|FG003|STARTED|Overall Study||20||
60083552|NCT01437267|76199335|FG004|STARTED|Overall Study||20||
60083553|NCT01437267|76199336|FG005|STARTED|Overall Study||20||
59554400|NCT01427504|75654599|FG003|NOT COMPLETED|Overall Study||1||
59554401|NCT01427504|75654600|FG004|NOT COMPLETED|Overall Study||1||
59554402|NCT01427504|75654601|FG005|NOT COMPLETED|Overall Study||2||
59554403|NCT02265965|75654620|FG000|STARTED|Overall Study||7||
59554404|NCT02265965|75654621|FG001|STARTED|Overall Study||11||
59554405|NCT02265965|75654620|FG000|COMPLETED|Overall Study||7||
59554406|NCT02265965|75654621|FG001|COMPLETED|Overall Study||11||
59554407|NCT02265965|75654620|FG000|NOT COMPLETED|Overall Study||0||
59554408|NCT02265965|75654621|FG001|NOT COMPLETED|Overall Study||0||
59554409|NCT02654769|75654630|FG000|STARTED|Overall Study||149||
59554410|NCT02654769|75654631|FG001|STARTED|Overall Study||149||
59554411|NCT02654769|75654632|FG002|STARTED|Overall Study||143||
59554412|NCT02654769|75654630|FG000|COMPLETED|Overall Study||145||
59554413|NCT02654769|75654631|FG001|COMPLETED|Overall Study||148||
59554414|NCT02654769|75654632|FG002|COMPLETED|Overall Study||142||
59554415|NCT02654769|75654630|FG000|NOT COMPLETED|Overall Study||4||
59554416|NCT02654769|75654631|FG001|NOT COMPLETED|Overall Study||1||
59554417|NCT02654769|75654632|FG002|NOT COMPLETED|Overall Study||1||
59554418|NCT02656485|75654644|FG000|STARTED|Overall Study||9||
59554419|NCT02656485|75654645|FG001|STARTED|Overall Study||9||
59554420|NCT02656485|75654646|FG002|STARTED|Overall Study||9||
59554421|NCT02656485|75654647|FG003|STARTED|Overall Study||9||
59554422|NCT02656485|75654644|FG000|COMPLETED|Overall Study||7||
59554423|NCT02656485|75654645|FG001|COMPLETED|Overall Study||6||
59554424|NCT02656485|75654646|FG002|COMPLETED|Overall Study||7||
59554425|NCT02656485|75654647|FG003|COMPLETED|Overall Study||7||
59554426|NCT02656485|75654644|FG000|NOT COMPLETED|Overall Study||2||
59554427|NCT02656485|75654645|FG001|NOT COMPLETED|Overall Study||3||
59554428|NCT02656485|75654646|FG002|NOT COMPLETED|Overall Study||2||
59554429|NCT02656485|75654647|FG003|NOT COMPLETED|Overall Study||2||
59554430|NCT02656875|75654659|FG000|STARTED|Overall Study||768||
59554431|NCT02656875|75654659|FG000|COMPLETED|Overall Study||698||
59554432|NCT02656875|75654659|FG000|NOT COMPLETED|Overall Study||70||
59554433|NCT02660853|75654663|FG000|STARTED|Overall Study||25||
59554434|NCT02660853|75654663|FG000|COMPLETED|Overall Study||25||
59554435|NCT02660853|75654663|FG000|NOT COMPLETED|Overall Study||0||
59554436|NCT02662023|75654669|FG000|STARTED|Overall Study||12||
59554437|NCT02662023|75654670|FG001|STARTED|Overall Study||12||
59554438|NCT02662023|75654669|FG000|COMPLETED|Overall Study||12||
59554439|NCT02662023|75654670|FG001|COMPLETED|Overall Study||12||
59554440|NCT02662023|75654669|FG000|NOT COMPLETED|Overall Study||0||
59554441|NCT02662023|75654670|FG001|NOT COMPLETED|Overall Study||0||
59554442|NCT00554099|75654679|FG000|STARTED|Treatment Period (12 Weeks)||41||
59554443|NCT00554099|75654680|FG001|STARTED|Treatment Period (12 Weeks)||40||
59554444|NCT00554099|75654681|FG002|STARTED|Treatment Period (12 Weeks)||36||
59554445|NCT00554099|75654679|FG000|COMPLETED|Treatment Period (12 Weeks)||29||
59554446|NCT00554099|75654680|FG001|COMPLETED|Treatment Period (12 Weeks)||32||
59554447|NCT00554099|75654681|FG002|COMPLETED|Treatment Period (12 Weeks)||27||
59554448|NCT00554099|75654679|FG000|NOT COMPLETED|Treatment Period (12 Weeks)||12||
59554449|NCT00554099|75654680|FG001|NOT COMPLETED|Treatment Period (12 Weeks)||8||
59554450|NCT00554099|75654681|FG002|NOT COMPLETED|Treatment Period (12 Weeks)||9||
59554451|NCT00554099|75654679|FG000|STARTED|Non-Treatment Phase (9 Months)||29||
59554452|NCT00554099|75654680|FG001|STARTED|Non-Treatment Phase (9 Months)||32||
59554453|NCT00554099|75654681|FG002|STARTED|Non-Treatment Phase (9 Months)||27||
59554454|NCT00554099|75654679|FG000|COMPLETED|Non-Treatment Phase (9 Months)||22||
59554455|NCT00554099|75654680|FG001|COMPLETED|Non-Treatment Phase (9 Months)||27||
59554456|NCT00554099|75654681|FG002|COMPLETED|Non-Treatment Phase (9 Months)||24||
59554457|NCT00554099|75654679|FG000|NOT COMPLETED|Non-Treatment Phase (9 Months)||7||
59554458|NCT00554099|75654680|FG001|NOT COMPLETED|Non-Treatment Phase (9 Months)||5||
59554459|NCT00554099|75654681|FG002|NOT COMPLETED|Non-Treatment Phase (9 Months)||3||
59554460|NCT02664909|75654691|FG000|STARTED|Overall Study||17||
59554461|NCT02664909|75654692|FG001|STARTED|Overall Study||19||
59554462|NCT02664909|75654691|FG000|COMPLETED|Overall Study||15||
59554463|NCT02664909|75654692|FG001|COMPLETED|Overall Study||16||
59554464|NCT02664909|75654691|FG000|NOT COMPLETED|Overall Study||2||
59554465|NCT02664909|75654692|FG001|NOT COMPLETED|Overall Study||3||
59554466|NCT02664987|75654698|FG000|STARTED|Overall Study||462||
59554467|NCT02664987|75654698|FG000|COMPLETED|Overall Study||462||
59554468|NCT02664987|75654698|FG000|NOT COMPLETED|Overall Study||0||
59554469|NCT02377362|75654715|FG000|STARTED|Part A First Treatment||4||
59554470|NCT02377362|75654716|FG001|STARTED|Part A First Treatment||4||
59554471|NCT02377362|75654717|FG002|STARTED|Part A First Treatment||4||
59554472|NCT02377362|75654718|FG003|STARTED|Part A First Treatment||4||
59554473|NCT02377362|75654719|FG004|STARTED|Part A First Treatment||4||
59554474|NCT02377362|75654720|FG005|STARTED|Part A First Treatment||4||
59554475|NCT02377362|75654721|FG006|STARTED|Part A First Treatment||0||
59554476|NCT02377362|75654722|FG007|STARTED|Part A First Treatment||0||
59554477|NCT02377362|75654723|FG008|STARTED|Part A First Treatment||0||
59554478|NCT02377362|75654724|FG009|STARTED|Part A First Treatment||0||
59554479|NCT02377362|75654725|FG010|STARTED|Part A First Treatment||0||
59554480|NCT02377362|75654726|FG011|STARTED|Part A First Treatment||0||
59554481|NCT02377362|75654727|FG012|STARTED|Part A First Treatment||0||
59554482|NCT02377362|75654715|FG000|COMPLETED|Part A First Treatment||4||
59554483|NCT02377362|75654716|FG001|COMPLETED|Part A First Treatment||4||
59554484|NCT02377362|75654717|FG002|COMPLETED|Part A First Treatment||4||
59554485|NCT02377362|75654718|FG003|COMPLETED|Part A First Treatment||4||
59554486|NCT02377362|75654719|FG004|COMPLETED|Part A First Treatment||4||
59554487|NCT02377362|75654720|FG005|COMPLETED|Part A First Treatment||4||
59554488|NCT02377362|75654721|FG006|COMPLETED|Part A First Treatment||0||
59554489|NCT02377362|75654722|FG007|COMPLETED|Part A First Treatment||0||
59554490|NCT02377362|75654723|FG008|COMPLETED|Part A First Treatment||0||
59554491|NCT02377362|75654724|FG009|COMPLETED|Part A First Treatment||0||
59554492|NCT02377362|75654725|FG010|COMPLETED|Part A First Treatment||0||
59554493|NCT02377362|75654726|FG011|COMPLETED|Part A First Treatment||0||
59707057|NCT01256879|75825980|FG000|Sorbitol-free Cimetidine Solution|Overall Study|24 started this intervention and 24 completed|24||
59554494|NCT02377362|75654727|FG012|COMPLETED|Part A First Treatment||0||
59554495|NCT02377362|75654715|FG000|NOT COMPLETED|Part A First Treatment||0||
59554496|NCT02377362|75654716|FG001|NOT COMPLETED|Part A First Treatment||0||
59554497|NCT02377362|75654717|FG002|NOT COMPLETED|Part A First Treatment||0||
59554498|NCT02377362|75654718|FG003|NOT COMPLETED|Part A First Treatment||0||
59554499|NCT02377362|75654719|FG004|NOT COMPLETED|Part A First Treatment||0||
59554500|NCT02377362|75654720|FG005|NOT COMPLETED|Part A First Treatment||0||
59554501|NCT02377362|75654721|FG006|NOT COMPLETED|Part A First Treatment||0||
59554502|NCT02377362|75654722|FG007|NOT COMPLETED|Part A First Treatment||0||
59554503|NCT02377362|75654723|FG008|NOT COMPLETED|Part A First Treatment||0||
59554504|NCT02377362|75654724|FG009|NOT COMPLETED|Part A First Treatment||0||
59554505|NCT02377362|75654725|FG010|NOT COMPLETED|Part A First Treatment||0||
59554506|NCT02377362|75654726|FG011|NOT COMPLETED|Part A First Treatment||0||
59554507|NCT02377362|75654727|FG012|NOT COMPLETED|Part A First Treatment||0||
59554508|NCT02377362|75654715|FG000|STARTED|Part A Second Treatment||4||
59554509|NCT02377362|75654716|FG001|STARTED|Part A Second Treatment||4||
59554510|NCT02377362|75654717|FG002|STARTED|Part A Second Treatment||4||
59554511|NCT02377362|75654718|FG003|STARTED|Part A Second Treatment||4||
59554512|NCT02377362|75654719|FG004|STARTED|Part A Second Treatment||4||
59554513|NCT02377362|75654720|FG005|STARTED|Part A Second Treatment||4||
59554514|NCT02377362|75654721|FG006|STARTED|Part A Second Treatment||0||
59554515|NCT02377362|75654722|FG007|STARTED|Part A Second Treatment||0||
59554516|NCT02377362|75654723|FG008|STARTED|Part A Second Treatment||0||
59554517|NCT02377362|75654724|FG009|STARTED|Part A Second Treatment||0||
59707058|NCT01256879|75825980|FG000|Commercial Cimetidine Solution|Overall Study|24 started this intervention and 24 completed|24||
60083554|NCT01437267|76199331|FG000|COMPLETED|Overall Study||20||
60083555|NCT01437267|76199332|FG001|COMPLETED|Overall Study||19||
60083556|NCT01437267|76199333|FG002|COMPLETED|Overall Study||20||
60083557|NCT01437267|76199334|FG003|COMPLETED|Overall Study||19||
60083558|NCT01437267|76199335|FG004|COMPLETED|Overall Study||20||
60083559|NCT01437267|76199336|FG005|COMPLETED|Overall Study||20||
60083560|NCT01437267|76199331|FG000|NOT COMPLETED|Overall Study||0||
60083561|NCT01437267|76199332|FG001|NOT COMPLETED|Overall Study||1||
60083562|NCT01437267|76199333|FG002|NOT COMPLETED|Overall Study||0||
60083563|NCT01437267|76199334|FG003|NOT COMPLETED|Overall Study||1||
60083564|NCT01437267|76199335|FG004|NOT COMPLETED|Overall Study||0||
60083565|NCT01437267|76199336|FG005|NOT COMPLETED|Overall Study||0||
60083566|NCT00397462|76199353|FG000|STARTED|Overall Study||16||
60083567|NCT00397462|76199354|FG001|STARTED|Overall Study||13||
60083568|NCT00397462|76199355|FG002|STARTED|Overall Study||15||
60083569|NCT00397462|76199353|FG000|COMPLETED|Overall Study||16||
60083570|NCT00397462|76199354|FG001|COMPLETED|Overall Study||13||
60083571|NCT00397462|76199355|FG002|COMPLETED|Overall Study||15||
60083572|NCT00397462|76199353|FG000|NOT COMPLETED|Overall Study||0||
60083573|NCT00397462|76199354|FG001|NOT COMPLETED|Overall Study||0||
60083574|NCT00397462|76199355|FG002|NOT COMPLETED|Overall Study||0||
60083575|NCT01456221|76199365|FG000|STARTED|Overall Study||183||
60083576|NCT01456221|76199366|FG001|STARTED|Overall Study||183||
60083577|NCT01456221|76199365|FG000|COMPLETED|Overall Study||119||
60083578|NCT01456221|76199366|FG001|COMPLETED|Overall Study||126||
60083579|NCT01456221|76199365|FG000|NOT COMPLETED|Overall Study||64||
60083580|NCT01456221|76199366|FG001|NOT COMPLETED|Overall Study||57||
60083581|NCT01437111|76199372|FG000|STARTED|Overall Study||200||
60083582|NCT01437111|76199372|FG000|Treated Participants|Overall Study||198||
60083583|NCT01437111|76199372|FG000|COMPLETED|Overall Study||182||
60083584|NCT01437111|76199372|FG000|NOT COMPLETED|Overall Study||18||
60083585|NCT00359944|76199382|FG000|STARTED|Overall Study||50||
60083586|NCT00359944|76199383|FG001|STARTED|Overall Study||47||
60083587|NCT00359944|76199384|FG002|STARTED|Overall Study||57||
60083588|NCT00359944|76199382|FG000|COMPLETED|Overall Study||34||
60083589|NCT00359944|76199383|FG001|COMPLETED|Overall Study||28||
60083590|NCT00359944|76199384|FG002|COMPLETED|Overall Study||38||
60083591|NCT00359944|76199382|FG000|NOT COMPLETED|Overall Study||16||
60083592|NCT00359944|76199383|FG001|NOT COMPLETED|Overall Study||19||
60083593|NCT00359944|76199384|FG002|NOT COMPLETED|Overall Study||19||
60083594|NCT00360724|76199394|FG000|STARTED|Overall Study||33||
60083595|NCT00360724|76199395|FG001|STARTED|Overall Study||32||
60083596|NCT00360724|76199394|FG000|COMPLETED|Overall Study||29||
60083597|NCT00360724|76199395|FG001|COMPLETED|Overall Study||28||
60083598|NCT00360724|76199394|FG000|NOT COMPLETED|Overall Study||4||
60083599|NCT00360724|76199395|FG001|NOT COMPLETED|Overall Study||4||
60083600|NCT00398398|76199404|FG000|STARTED|Overall Study||44||
60083601|NCT00398398|76199404|FG000|COMPLETED|Overall Study||44||
60083602|NCT00398398|76199404|FG000|NOT COMPLETED|Overall Study||0||
60083603|NCT00398476|76199408|FG000|STARTED|Treatment Period 1||63||
60083604|NCT00398476|76199409|FG001|STARTED|Treatment Period 1||64||
60083605|NCT00398476|76199408|FG000|COMPLETED|Treatment Period 1||63||
60083606|NCT00398476|76199409|FG001|COMPLETED|Treatment Period 1||64||
60083607|NCT00398476|76199408|FG000|NOT COMPLETED|Treatment Period 1||0||
60083608|NCT00398476|76199409|FG001|NOT COMPLETED|Treatment Period 1||0||
60083609|NCT00398476|76199408|FG000|STARTED|Washout Period (20 Minutes)||63||
60083610|NCT00398476|76199409|FG001|STARTED|Washout Period (20 Minutes)||64||
60083611|NCT00398476|76199408|FG000|COMPLETED|Washout Period (20 Minutes)||63||
60083612|NCT00398476|76199409|FG001|COMPLETED|Washout Period (20 Minutes)||64||
60083613|NCT00398476|76199408|FG000|NOT COMPLETED|Washout Period (20 Minutes)||0||
60083614|NCT00398476|76199409|FG001|NOT COMPLETED|Washout Period (20 Minutes)||0||
60083615|NCT00398476|76199408|FG000|STARTED|Treatment Period 2||63||
60083616|NCT00398476|76199409|FG001|STARTED|Treatment Period 2||64||
60083617|NCT00398476|76199408|FG000|COMPLETED|Treatment Period 2||63||
60083618|NCT00398476|76199409|FG001|COMPLETED|Treatment Period 2||64||
60083619|NCT00398476|76199408|FG000|NOT COMPLETED|Treatment Period 2||0||
60083620|NCT00398476|76199409|FG001|NOT COMPLETED|Treatment Period 2||0||
60083621|NCT01436643|76199420|FG000|STARTED|2-week Pre-treatment||0||
60083622|NCT01436643|76199421|FG001|STARTED|2-week Pre-treatment||0||
60083623|NCT01436643|76199422|FG002|STARTED|2-week Pre-treatment||0||
60083624|NCT01436643|76199423|FG003|STARTED|2-week Pre-treatment||54||
60083625|NCT01436643|76199420|FG000|COMPLETED|2-week Pre-treatment||0||
60083626|NCT01436643|76199421|FG001|COMPLETED|2-week Pre-treatment||0||
60083627|NCT01436643|76199422|FG002|COMPLETED|2-week Pre-treatment||0||
60083628|NCT01436643|76199423|FG003|COMPLETED|2-week Pre-treatment||44||
60083629|NCT01436643|76199420|FG000|NOT COMPLETED|2-week Pre-treatment||0||
60083630|NCT01436643|76199421|FG001|NOT COMPLETED|2-week Pre-treatment||0||
60083631|NCT01436643|76199422|FG002|NOT COMPLETED|2-week Pre-treatment||0||
60083632|NCT01436643|76199423|FG003|NOT COMPLETED|2-week Pre-treatment||10||
60083633|NCT01436643|76199420|FG000|STARTED|Core Phase (16 Weeks)||17||
60083634|NCT01436643|76199421|FG001|STARTED|Core Phase (16 Weeks)||15||
60083635|NCT01436643|76199422|FG002|STARTED|Core Phase (16 Weeks)||20||
59554518|NCT02377362|75654725|FG010|STARTED|Part A Second Treatment||0||
59554519|NCT02377362|75654726|FG011|STARTED|Part A Second Treatment||0||
59554520|NCT02377362|75654727|FG012|STARTED|Part A Second Treatment||0||
59554521|NCT02377362|75654715|FG000|COMPLETED|Part A Second Treatment||4||
59554522|NCT02377362|75654716|FG001|COMPLETED|Part A Second Treatment||4||
59554523|NCT02377362|75654717|FG002|COMPLETED|Part A Second Treatment||4||
59554524|NCT02377362|75654718|FG003|COMPLETED|Part A Second Treatment||4||
59554525|NCT02377362|75654719|FG004|COMPLETED|Part A Second Treatment||3||
59554526|NCT02377362|75654720|FG005|COMPLETED|Part A Second Treatment||4||
59554527|NCT02377362|75654721|FG006|COMPLETED|Part A Second Treatment||0||
59554528|NCT02377362|75654722|FG007|COMPLETED|Part A Second Treatment||0||
59554529|NCT02377362|75654723|FG008|COMPLETED|Part A Second Treatment||0||
59554530|NCT02377362|75654724|FG009|COMPLETED|Part A Second Treatment||0||
59554531|NCT02377362|75654725|FG010|COMPLETED|Part A Second Treatment||0||
59554532|NCT02377362|75654726|FG011|COMPLETED|Part A Second Treatment||0||
59554533|NCT02377362|75654727|FG012|COMPLETED|Part A Second Treatment||0||
59554534|NCT02377362|75654715|FG000|NOT COMPLETED|Part A Second Treatment||0||
59554535|NCT02377362|75654716|FG001|NOT COMPLETED|Part A Second Treatment||0||
59554536|NCT02377362|75654717|FG002|NOT COMPLETED|Part A Second Treatment||0||
59554537|NCT02377362|75654718|FG003|NOT COMPLETED|Part A Second Treatment||0||
59554538|NCT02377362|75654719|FG004|NOT COMPLETED|Part A Second Treatment||1||
59554539|NCT02377362|75654720|FG005|NOT COMPLETED|Part A Second Treatment||0||
59554540|NCT02377362|75654721|FG006|NOT COMPLETED|Part A Second Treatment||0||
59554541|NCT02377362|75654722|FG007|NOT COMPLETED|Part A Second Treatment||0||
59554542|NCT02377362|75654723|FG008|NOT COMPLETED|Part A Second Treatment||0||
59554543|NCT02377362|75654724|FG009|NOT COMPLETED|Part A Second Treatment||0||
59554544|NCT02377362|75654725|FG010|NOT COMPLETED|Part A Second Treatment||0||
59554545|NCT02377362|75654726|FG011|NOT COMPLETED|Part A Second Treatment||0||
59554546|NCT02377362|75654727|FG012|NOT COMPLETED|Part A Second Treatment||0||
59554547|NCT02377362|75654715|FG000|STARTED|Part A Third Treatment||4||
59554548|NCT02377362|75654716|FG001|STARTED|Part A Third Treatment||4||
59554549|NCT02377362|75654717|FG002|STARTED|Part A Third Treatment||4||
60083636|NCT01436643|76199423|FG003|STARTED|Core Phase (16 Weeks)||0||
60083637|NCT01436643|76199420|FG000|COMPLETED|Core Phase (16 Weeks)||16||
60083638|NCT01436643|76199421|FG001|COMPLETED|Core Phase (16 Weeks)||11||
60083639|NCT01436643|76199422|FG002|COMPLETED|Core Phase (16 Weeks)||17||
60083640|NCT01436643|76199423|FG003|COMPLETED|Core Phase (16 Weeks)||0||
60083641|NCT01436643|76199420|FG000|NOT COMPLETED|Core Phase (16 Weeks)||1||
60083642|NCT01436643|76199421|FG001|NOT COMPLETED|Core Phase (16 Weeks)||4||
60083643|NCT01436643|76199422|FG002|NOT COMPLETED|Core Phase (16 Weeks)||3||
60083644|NCT01436643|76199423|FG003|NOT COMPLETED|Core Phase (16 Weeks)||0||
60083645|NCT00399880|76199435|FG000|STARTED|Overall Study||65||
60083646|NCT00399880|76199436|FG001|STARTED|Overall Study||65||
60083647|NCT00399880|76199435|FG000|COMPLETED|Overall Study||65||
60083648|NCT00399880|76199436|FG001|COMPLETED|Overall Study||65||
60083649|NCT00399880|76199435|FG000|NOT COMPLETED|Overall Study||0||
60083650|NCT00399880|76199436|FG001|NOT COMPLETED|Overall Study||0||
60083651|NCT00361972|76199444|FG000|STARTED|Overall Study||8||
60083652|NCT00361972|76199445|FG001|STARTED|Overall Study||9||
60083653|NCT00361972|76199444|FG000|COMPLETED|Overall Study||8||
60083654|NCT00361972|76199445|FG001|COMPLETED|Overall Study||9||
60083655|NCT00361972|76199444|FG000|NOT COMPLETED|Overall Study||0||
59554550|NCT02377362|75654718|FG003|STARTED|Part A Third Treatment||4||
59554551|NCT02377362|75654719|FG004|STARTED|Part A Third Treatment||3||
59554552|NCT02377362|75654720|FG005|STARTED|Part A Third Treatment||4||
59554553|NCT02377362|75654721|FG006|STARTED|Part A Third Treatment||0||
59554554|NCT02377362|75654722|FG007|STARTED|Part A Third Treatment||0||
59554555|NCT02377362|75654723|FG008|STARTED|Part A Third Treatment||0||
59554556|NCT02377362|75654724|FG009|STARTED|Part A Third Treatment||0||
59554557|NCT02377362|75654725|FG010|STARTED|Part A Third Treatment||0||
59554558|NCT02377362|75654726|FG011|STARTED|Part A Third Treatment||0||
59554559|NCT02377362|75654727|FG012|STARTED|Part A Third Treatment||0||
59554560|NCT02377362|75654715|FG000|COMPLETED|Part A Third Treatment||4||
59554561|NCT02377362|75654716|FG001|COMPLETED|Part A Third Treatment||4||
59554562|NCT02377362|75654717|FG002|COMPLETED|Part A Third Treatment||4||
59554563|NCT02377362|75654718|FG003|COMPLETED|Part A Third Treatment||0||
59554564|NCT02377362|75654719|FG004|COMPLETED|Part A Third Treatment||0||
59554565|NCT02377362|75654720|FG005|COMPLETED|Part A Third Treatment||0||
59554566|NCT02377362|75654721|FG006|COMPLETED|Part A Third Treatment||0||
59554567|NCT02377362|75654722|FG007|COMPLETED|Part A Third Treatment||0||
59554568|NCT02377362|75654723|FG008|COMPLETED|Part A Third Treatment||0||
59554569|NCT02377362|75654724|FG009|COMPLETED|Part A Third Treatment||0||
59554570|NCT02377362|75654725|FG010|COMPLETED|Part A Third Treatment||0||
59554571|NCT02377362|75654726|FG011|COMPLETED|Part A Third Treatment||0||
59554572|NCT02377362|75654727|FG012|COMPLETED|Part A Third Treatment||0||
59554573|NCT02377362|75654715|FG000|NOT COMPLETED|Part A Third Treatment||0||
60083656|NCT00361972|76199445|FG001|NOT COMPLETED|Overall Study||0||
60083657|NCT00362128|76199452|FG000|STARTED|Overall Study|Enrollment was initiated in 2007.|2072||
60083658|NCT00362128|76199452|FG000|COMPLETED|Overall Study|Enrollment was completed in October 2009.|2072||
60083659|NCT00362128|76199452|FG000|NOT COMPLETED|Overall Study||0||
59554574|NCT02377362|75654716|FG001|NOT COMPLETED|Part A Third Treatment||0||
59554575|NCT02377362|75654717|FG002|NOT COMPLETED|Part A Third Treatment||0||
60083660|NCT00362440|76199458|FG000|STARTED|Overall Study||5||
59554576|NCT02377362|75654718|FG003|NOT COMPLETED|Part A Third Treatment||4||
59554577|NCT02377362|75654719|FG004|NOT COMPLETED|Part A Third Treatment||3||
59554578|NCT02377362|75654720|FG005|NOT COMPLETED|Part A Third Treatment||4||
59554579|NCT02377362|75654721|FG006|NOT COMPLETED|Part A Third Treatment||0||
59554580|NCT02377362|75654722|FG007|NOT COMPLETED|Part A Third Treatment||0||
59707059|NCT01256879|75825980|FG000|COMPLETED|Overall Study||24||
59707060|NCT01256879|75825980|FG000|NOT COMPLETED|Overall Study||1||
60083661|NCT00362440|76199459|FG001|STARTED|Overall Study||4||
60083662|NCT00362440|76199458|FG000|COMPLETED|Overall Study||3||
60083663|NCT00362440|76199459|FG001|COMPLETED|Overall Study||3||
60083664|NCT00362440|76199458|FG000|NOT COMPLETED|Overall Study||2||
60083665|NCT00362440|76199459|FG001|NOT COMPLETED|Overall Study||1||
60083666|NCT00401518|76199468|FG000|STARTED|Overall Study||46||
60083667|NCT00401518|76199469|FG001|STARTED|Overall Study||227||
60083668|NCT00401518|76199470|FG002|STARTED|Overall Study||117||
60083669|NCT00401518|76199468|FG000|COMPLETED|Overall Study||40||
60083670|NCT00401518|76199469|FG001|COMPLETED|Overall Study||190||
60083671|NCT00401518|76199470|FG002|COMPLETED|Overall Study||94||
60083672|NCT00401518|76199468|FG000|NOT COMPLETED|Overall Study||6||
60083673|NCT00401518|76199469|FG001|NOT COMPLETED|Overall Study||37||
60083674|NCT00401518|76199470|FG002|NOT COMPLETED|Overall Study||23||
60083675|NCT02109640|76199480|FG000|STARTED|Overall Study||27||
60083676|NCT02109640|76199481|FG001|STARTED|Overall Study||23||
60083677|NCT02109640|76199480|FG000|COMPLETED|Overall Study||27||
60083678|NCT02109640|76199481|FG001|COMPLETED|Overall Study||23||
60083679|NCT02109640|76199480|FG000|NOT COMPLETED|Overall Study||0||
60083680|NCT02109640|76199481|FG001|NOT COMPLETED|Overall Study||0||
60083681|NCT00401986|76199487|FG000|STARTED|Overall Study||14||
60083682|NCT00401986|76199487|FG000|COMPLETED|Overall Study||12||
60083683|NCT00401986|76199487|FG000|NOT COMPLETED|Overall Study||2||
60083684|NCT00365872|76199499|FG000|STARTED|Overall Study||5||
60083685|NCT00365872|76199500|FG001|STARTED|Overall Study||6||
60083686|NCT00365872|76199501|FG002|STARTED|Overall Study||6||
60083687|NCT00365872|76199499|FG000|COMPLETED|Overall Study||5||
60083688|NCT00365872|76199500|FG001|COMPLETED|Overall Study||6||
60083689|NCT00365872|76199501|FG002|COMPLETED|Overall Study||6||
60083690|NCT00365872|76199499|FG000|NOT COMPLETED|Overall Study||0||
60083691|NCT00365872|76199500|FG001|NOT COMPLETED|Overall Study||0||
60083692|NCT00365872|76199501|FG002|NOT COMPLETED|Overall Study||0||
60083693|NCT00366028|76199510|FG000|STARTED|Overall Study||889||
60083694|NCT00366028|76199511|FG001|STARTED|Overall Study||735||
60083695|NCT00366028|76199510|FG000|COMPLETED|Overall Study||889||
60083696|NCT00366028|76199511|FG001|COMPLETED|Overall Study||735||
60083697|NCT00366028|76199510|FG000|NOT COMPLETED|Overall Study||0||
60083698|NCT00366028|76199511|FG001|NOT COMPLETED|Overall Study||0||
60083699|NCT01454739|76199521|FG000|STARTED|Overall Study|30 participants in <6 Years Old Age Cohort and 31 participants in 6 to <12 Years Old Age Cohort.|61||
60083700|NCT01454739|76199522|FG001|STARTED|Overall Study||179||
60083701|NCT01454739|76199521|FG000|Tailored Prophylaxis|Overall Study||59||
60083702|NCT01454739|76199522|FG001|Tailored Prophylaxis|Overall Study||131||
60083703|NCT01454739|76199521|FG000|Weekly Prophylaxis|Overall Study||0||
60083704|NCT01454739|76199522|FG001|Weekly Prophylaxis|Overall Study||34||
60083705|NCT01454739|76199521|FG000|Personalized Prophylaxis|Overall Study||3||
60083706|NCT01454739|76199522|FG001|Personalized Prophylaxis|Overall Study||23||
60083707|NCT01454739|76199521|FG000|Episodic|Overall Study||0||
60083708|NCT01454739|76199522|FG001|Episodic|Overall Study||13||
60083709|NCT01454739|76199521|FG000|Surgery Subgroup|Overall Study||2|Participants who have undergone major surgery or have major surgical/rehabilitation period in study.|
60083710|NCT01454739|76199522|FG001|Surgery Subgroup|Overall Study||26|Participants who have undergone major surgery or have major surgical/rehabilitation period in study.|
60083711|NCT01454739|76199521|FG000|COMPLETED|Overall Study||54||
59554581|NCT02377362|75654723|FG008|NOT COMPLETED|Part A Third Treatment||0||
59554582|NCT02377362|75654724|FG009|NOT COMPLETED|Part A Third Treatment||0||
59554583|NCT02377362|75654725|FG010|NOT COMPLETED|Part A Third Treatment||0||
59554584|NCT02377362|75654726|FG011|NOT COMPLETED|Part A Third Treatment||0||
59554585|NCT02377362|75654727|FG012|NOT COMPLETED|Part A Third Treatment||0||
60083712|NCT01454739|76199522|FG001|COMPLETED|Overall Study||158||
60083713|NCT01454739|76199521|FG000|NOT COMPLETED|Overall Study||7||
59554586|NCT02377362|75654715|FG000|STARTED|Part B Overall||0|Part A was a 3-period crossover study (2 escalating doses of GLWL and 1 dose of placebo)|
59707061|NCT01125189|75825993|FG000|STARTED|Treatment Period||159||
60083714|NCT01454739|76199522|FG001|NOT COMPLETED|Overall Study||21||
60083715|NCT00366106|76199535|FG000|STARTED|Overall Study||32||
60083716|NCT00366106|76199535|FG000|COMPLETED|Overall Study||32||
60083717|NCT00366106|76199535|FG000|NOT COMPLETED|Overall Study||0||
60083718|NCT00368290|76199541|FG000|STARTED|Overall Study||47||
60083719|NCT00368290|76199542|FG001|STARTED|Overall Study||47||
60083720|NCT00368290|76199541|FG000|COMPLETED|Overall Study||34||
59707062|NCT01125189|75825994|FG001|STARTED|Treatment Period||158||
60083721|NCT00368290|76199542|FG001|COMPLETED|Overall Study||37||
59554587|NCT02377362|75654716|FG001|STARTED|Part B Overall||0|Part A was a 3-period crossover study (2 escalating doses of GLWL and 1 dose of placebo)|
59554588|NCT02377362|75654717|FG002|STARTED|Part B Overall||0|Part A was a 3-period crossover study (2 escalating doses of GLWL and 1 dose of placebo)|
59554589|NCT02377362|75654718|FG003|STARTED|Part B Overall||0|Part A was a 3-period crossover study (2 escalating doses of GLWL and 1 dose of placebo)|
59554590|NCT02377362|75654719|FG004|STARTED|Part B Overall||0|Part A was a 3-period crossover study (2 escalating doses of GLWL and 1 dose of placebo)|
59554591|NCT02377362|75654720|FG005|STARTED|Part B Overall||0|Part A was a 3-period crossover study (2 escalating doses of GLWL and 1 dose of placebo)|
59554592|NCT02377362|75654721|FG006|STARTED|Part B Overall||6|Part A was a 3-period crossover study (2 escalating doses of GLWL and 1 dose of placebo)|
59554593|NCT02377362|75654722|FG007|STARTED|Part B Overall||6|Part A was a 3-period crossover study (2 escalating doses of GLWL and 1 dose of placebo)|
59554594|NCT02377362|75654723|FG008|STARTED|Part B Overall||6|Part A was a 3-period crossover study (2 escalating doses of GLWL and 1 dose of placebo)|
59554595|NCT02377362|75654724|FG009|STARTED|Part B Overall||7|Part A was a 3-period crossover study (2 escalating doses of GLWL and 1 dose of placebo)|
59554596|NCT02377362|75654725|FG010|STARTED|Part B Overall||6|Part A was a 3-period crossover study (2 escalating doses of GLWL and 1 dose of placebo)|
59554597|NCT02377362|75654726|FG011|STARTED|Part B Overall||7|Part A was a 3-period crossover study (2 escalating doses of GLWL and 1 dose of placebo)|
59554598|NCT02377362|75654727|FG012|STARTED|Part B Overall||12|Part A was a 3-period crossover study (2 escalating doses of GLWL and 1 dose of placebo)|
59554599|NCT02377362|75654715|FG000|COMPLETED|Part B Overall||0||
59554600|NCT02377362|75654716|FG001|COMPLETED|Part B Overall||0||
59554601|NCT02377362|75654717|FG002|COMPLETED|Part B Overall||0||
59554602|NCT02377362|75654718|FG003|COMPLETED|Part B Overall||0||
59554603|NCT02377362|75654719|FG004|COMPLETED|Part B Overall||0||
59554604|NCT02377362|75654720|FG005|COMPLETED|Part B Overall||0||
59554605|NCT02377362|75654721|FG006|COMPLETED|Part B Overall||4||
59554606|NCT02377362|75654722|FG007|COMPLETED|Part B Overall||5||
59554607|NCT02377362|75654723|FG008|COMPLETED|Part B Overall||6||
59554608|NCT02377362|75654724|FG009|COMPLETED|Part B Overall||6||
59554609|NCT02377362|75654725|FG010|COMPLETED|Part B Overall||6||
59554610|NCT02377362|75654726|FG011|COMPLETED|Part B Overall||6||
59554611|NCT02377362|75654727|FG012|COMPLETED|Part B Overall||12||
59554612|NCT02377362|75654715|FG000|NOT COMPLETED|Part B Overall||0||
59554613|NCT02377362|75654716|FG001|NOT COMPLETED|Part B Overall||0||
59554614|NCT02377362|75654717|FG002|NOT COMPLETED|Part B Overall||0||
59554615|NCT02377362|75654718|FG003|NOT COMPLETED|Part B Overall||0||
59554616|NCT02377362|75654719|FG004|NOT COMPLETED|Part B Overall||0||
59554617|NCT02377362|75654720|FG005|NOT COMPLETED|Part B Overall||0||
59554618|NCT02377362|75654721|FG006|NOT COMPLETED|Part B Overall||2||
59554619|NCT02377362|75654722|FG007|NOT COMPLETED|Part B Overall||1||
59554620|NCT02377362|75654723|FG008|NOT COMPLETED|Part B Overall||0||
60083722|NCT00368290|76199541|FG000|NOT COMPLETED|Overall Study||13||
60083723|NCT00368290|76199542|FG001|NOT COMPLETED|Overall Study||10||
60083724|NCT00369226|76199550|FG000|STARTED|Phase I (45 Days)||13||
60083725|NCT00369226|76199551|FG001|STARTED|Phase I (45 Days)||0||
60083726|NCT00369226|76199550|FG000|COMPLETED|Phase I (45 Days)|Once MTD established, additional 10 patients were accrued at MTD to better estimate toxicity.|13||
60083727|NCT00369226|76199551|FG001|COMPLETED|Phase I (45 Days)||0||
60083728|NCT00369226|76199550|FG000|NOT COMPLETED|Phase I (45 Days)||0||
60083729|NCT00369226|76199551|FG001|NOT COMPLETED|Phase I (45 Days)||0||
60083730|NCT00369226|76199550|FG000|STARTED|Phase II (45 Days)||0||
60083731|NCT00369226|76199551|FG001|STARTED|Phase II (45 Days)||32||
60083732|NCT00369226|76199550|FG000|COMPLETED|Phase II (45 Days)||0||
60083733|NCT00369226|76199551|FG001|COMPLETED|Phase II (45 Days)|This includes 10 patients treated at candidate MTD in Phase I.|32||
60083734|NCT00369226|76199550|FG000|NOT COMPLETED|Phase II (45 Days)||0||
60083735|NCT00369226|76199551|FG001|NOT COMPLETED|Phase II (45 Days)||0||
60083736|NCT01416441|76199560|FG000|STARTED|Overall Study||170||
60083737|NCT01416441|76199560|FG000|COMPLETED|Overall Study||89||
60083738|NCT01416441|76199560|FG000|NOT COMPLETED|Overall Study||81||
60083739|NCT00406276|76199564|FG000|STARTED|Overall Study||28||
60083740|NCT00406276|76199564|FG000|COMPLETED|Overall Study||24||
60083741|NCT00406276|76199564|FG000|NOT COMPLETED|Overall Study||4||
59554621|NCT02377362|75654724|FG009|NOT COMPLETED|Part B Overall||1||
59554622|NCT02377362|75654725|FG010|NOT COMPLETED|Part B Overall||0||
59554623|NCT02377362|75654726|FG011|NOT COMPLETED|Part B Overall||1||
59554624|NCT02377362|75654727|FG012|NOT COMPLETED|Part B Overall||0||
59554625|NCT00553631|75654767|FG000|STARTED|Overall Study|Intent-to-treat (ITT) population|17||
59554626|NCT00553631|75654768|FG001|STARTED|Overall Study|Intent-to-treat (ITT) population|17||
59554627|NCT00553631|75654767|FG000|COMPLETED|Overall Study||16||
59554628|NCT00553631|75654768|FG001|COMPLETED|Overall Study||16||
59554629|NCT00553631|75654767|FG000|NOT COMPLETED|Overall Study||1||
59554630|NCT00553631|75654768|FG001|NOT COMPLETED|Overall Study||1||
59554631|NCT00553319|75654777|FG000|STARTED|Overall Study||43||
59554632|NCT00553319|75654778|FG001|STARTED|Overall Study||40||
59554633|NCT00553319|75654779|FG002|STARTED|Overall Study||43||
59554634|NCT00553319|75654777|FG000|COMPLETED|Overall Study||29||
59554635|NCT00553319|75654778|FG001|COMPLETED|Overall Study||30||
59554636|NCT00553319|75654779|FG002|COMPLETED|Overall Study||34||
59554637|NCT00553319|75654777|FG000|NOT COMPLETED|Overall Study||14||
59554638|NCT00553319|75654778|FG001|NOT COMPLETED|Overall Study||10||
59554639|NCT00553319|75654779|FG002|NOT COMPLETED|Overall Study||9||
59554640|NCT01868633|75654789|FG000|STARTED|Overall Study||26||
59554641|NCT01868633|75654790|FG001|STARTED|Overall Study||26||
59554642|NCT01868633|75654789|FG000|COMPLETED|Overall Study||26||
59554643|NCT01868633|75654790|FG001|COMPLETED|Overall Study||26||
59554644|NCT01868633|75654789|FG000|NOT COMPLETED|Overall Study||0||
59554645|NCT01868633|75654790|FG001|NOT COMPLETED|Overall Study||0||
59554646|NCT01868789|75654798|FG000|STARTED|Overall Study||9||
59554647|NCT01868789|75654799|FG001|STARTED|Overall Study||14||
59554648|NCT01868789|75654798|FG000|COMPLETED|Overall Study||7||
59554649|NCT01868789|75654799|FG001|COMPLETED|Overall Study||12||
59554650|NCT01868789|75654798|FG000|NOT COMPLETED|Overall Study||2||
59554651|NCT01868789|75654799|FG001|NOT COMPLETED|Overall Study||2||
59554652|NCT01869647|75654808|FG000|STARTED|Overall Study||66||
59554653|NCT01869647|75654809|FG001|STARTED|Overall Study||136||
59554654|NCT01869647|75654810|FG002|STARTED|Overall Study||62||
59554655|NCT01869647|75654808|FG000|COMPLETED|Overall Study||65||
59554656|NCT01869647|75654809|FG001|COMPLETED|Overall Study||130||
59554657|NCT01869647|75654810|FG002|COMPLETED|Overall Study||62||
59554658|NCT01869647|75654808|FG000|NOT COMPLETED|Overall Study||1||
59554659|NCT01869647|75654809|FG001|NOT COMPLETED|Overall Study||6||
59554660|NCT01869647|75654810|FG002|NOT COMPLETED|Overall Study||0||
59554661|NCT02674659|75654820|FG000|STARTED|Overall Study||43||
59554662|NCT02674659|75654821|FG001|STARTED|Overall Study||44||
59554663|NCT02674659|75654820|FG000|COMPLETED|Overall Study||39||
59554664|NCT02674659|75654821|FG001|COMPLETED|Overall Study||40||
59554665|NCT02674659|75654820|FG000|NOT COMPLETED|Overall Study||4||
59554666|NCT02674659|75654821|FG001|NOT COMPLETED|Overall Study||4||
59554667|NCT02676375|75654830|FG000|STARTED|Overall Study||14||
59554668|NCT02676375|75654831|FG001|STARTED|Overall Study||14||
59554669|NCT02676375|75654832|FG002|STARTED|Overall Study||14||
59554670|NCT02676375|75654830|FG000|COMPLETED|Overall Study||13||
59554671|NCT02676375|75654831|FG001|COMPLETED|Overall Study||10||
59554672|NCT02676375|75654832|FG002|COMPLETED|Overall Study||11||
59554673|NCT02676375|75654830|FG000|NOT COMPLETED|Overall Study||1||
59554674|NCT02676375|75654831|FG001|NOT COMPLETED|Overall Study||4||
59554675|NCT02676375|75654832|FG002|NOT COMPLETED|Overall Study||3||
59554676|NCT01871441|75654840|FG000|STARTED|Overall Study||4||
59554677|NCT01871441|75654840|FG000|COMPLETED|Overall Study||4||
59554678|NCT01871441|75654840|FG000|NOT COMPLETED|Overall Study||0||
59554679|NCT02676843|75654845|FG000|STARTED|Overall Study||7||
59554680|NCT02676843|75654845|FG000|COMPLETED|Overall Study||7||
59554681|NCT02676843|75654845|FG000|NOT COMPLETED|Overall Study||0||
59554682|NCT01874951|75654852|FG000|STARTED|Overall Study||6||
59554683|NCT01874951|75654853|FG001|STARTED|Overall Study||6||
59554684|NCT01874951|75654852|FG000|COMPLETED|Overall Study||6||
59554685|NCT01874951|75654853|FG001|COMPLETED|Overall Study||6||
59554686|NCT01874951|75654852|FG000|NOT COMPLETED|Overall Study||0||
59554687|NCT01874951|75654853|FG001|NOT COMPLETED|Overall Study||0||
59554688|NCT01489826|75654871|FG000|STARTED|Overall Study||3||
59554689|NCT01489826|75654872|FG001|STARTED|Overall Study||3||
59554690|NCT01489826|75654873|FG002|STARTED|Overall Study||3||
59554691|NCT01489826|75654874|FG003|STARTED|Overall Study||7||
59554692|NCT01489826|75654875|FG004|STARTED|Overall Study||3||
59554693|NCT01489826|75654876|FG005|STARTED|Overall Study||3||
59554694|NCT01489826|75654877|FG006|STARTED|Overall Study||9||
59554695|NCT01489826|75654878|FG007|STARTED|Overall Study||3||
59554696|NCT01489826|75654879|FG008|STARTED|Overall Study||6||
59554697|NCT01489826|75654871|FG000|COMPLETED|Overall Study||3||
59554698|NCT01489826|75654872|FG001|COMPLETED|Overall Study||3||
59554699|NCT01489826|75654873|FG002|COMPLETED|Overall Study||3||
59554700|NCT01489826|75654874|FG003|COMPLETED|Overall Study||7||
59554701|NCT01489826|75654875|FG004|COMPLETED|Overall Study||3||
59554702|NCT01489826|75654876|FG005|COMPLETED|Overall Study||3||
59554703|NCT01489826|75654877|FG006|COMPLETED|Overall Study||9||
59554704|NCT01489826|75654878|FG007|COMPLETED|Overall Study||3||
59554705|NCT01489826|75654879|FG008|COMPLETED|Overall Study||6||
59554706|NCT01489826|75654871|FG000|NOT COMPLETED|Overall Study||0||
59554707|NCT01489826|75654872|FG001|NOT COMPLETED|Overall Study||0||
59554708|NCT01489826|75654873|FG002|NOT COMPLETED|Overall Study||0||
59554709|NCT01489826|75654874|FG003|NOT COMPLETED|Overall Study||0||
59554710|NCT01489826|75654875|FG004|NOT COMPLETED|Overall Study||0||
59554711|NCT01489826|75654876|FG005|NOT COMPLETED|Overall Study||0||
59554712|NCT01489826|75654877|FG006|NOT COMPLETED|Overall Study||0||
59554713|NCT01489826|75654878|FG007|NOT COMPLETED|Overall Study||0||
59554714|NCT01489826|75654879|FG008|NOT COMPLETED|Overall Study||0||
59554715|NCT02677623|75654911|FG000|STARTED|Overall Study||33||
59554716|NCT02677623|75654912|FG001|STARTED|Overall Study||32||
59554717|NCT02677623|75654913|FG002|STARTED|Overall Study||32||
59554718|NCT02677623|75654914|FG003|STARTED|Overall Study||33||
59554719|NCT02677623|75654911|FG000|COMPLETED|Overall Study||33||
59554720|NCT02677623|75654912|FG001|COMPLETED|Overall Study||32||
60083742|NCT01436253|76199569|FG000|STARTED|Overall Study||2196||
60083743|NCT01436253|76199569|FG000|COMPLETED|Overall Study||1897||
60083744|NCT01436253|76199569|FG000|NOT COMPLETED|Overall Study||299||
60083745|NCT00408070|76199573|FG000|STARTED|Overall Study||5||
60083746|NCT00408070|76199573|FG000|COMPLETED|Overall Study||5||
60083747|NCT00408070|76199573|FG000|NOT COMPLETED|Overall Study||0||
60083748|NCT00408460|76199577|FG000|STARTED|Overall Study||34||
59554721|NCT02677623|75654913|FG002|COMPLETED|Overall Study||32||
60083749|NCT00408460|76199577|FG000|COMPLETED|Overall Study||34||
60083750|NCT00408460|76199577|FG000|NOT COMPLETED|Overall Study||0||
60083751|NCT02111200|76199585|FG000|STARTED|Overall Study||3||
60083752|NCT02111200|76199586|FG001|STARTED|Overall Study||2||
60083753|NCT02111200|76199587|FG002|STARTED|Overall Study||1||
60083754|NCT02111200|76199588|FG003|STARTED|Overall Study||1||
60083755|NCT02111200|76199585|FG000|COMPLETED|Overall Study||3||
60083756|NCT02111200|76199586|FG001|COMPLETED|Overall Study||2||
60083757|NCT02111200|76199587|FG002|COMPLETED|Overall Study||1||
60083758|NCT02111200|76199588|FG003|COMPLETED|Overall Study||1||
60083759|NCT02111200|76199585|FG000|NOT COMPLETED|Overall Study||0||
60083760|NCT02111200|76199586|FG001|NOT COMPLETED|Overall Study||0||
60083761|NCT02111200|76199587|FG002|NOT COMPLETED|Overall Study||0||
60083762|NCT02111200|76199588|FG003|NOT COMPLETED|Overall Study||0||
60083763|NCT02111746|76199598|FG000|STARTED|Overall Study||172||
60083764|NCT02111746|76199599|FG001|STARTED|Overall Study||171||
60083765|NCT02111746|76199598|FG000|COMPLETED|Overall Study||169||
60083766|NCT02111746|76199599|FG001|COMPLETED|Overall Study||169||
60083767|NCT02111746|76199598|FG000|NOT COMPLETED|Overall Study||3||
60083768|NCT02111746|76199599|FG001|NOT COMPLETED|Overall Study||2||
60083769|NCT02111980|76199605|FG000|STARTED|Overall Study||50||
60083770|NCT02111980|76199605|FG000|COMPLETED|Overall Study||50||
60083771|NCT02111980|76199605|FG000|NOT COMPLETED|Overall Study||0||
60083772|NCT00369928|76199615|FG000|STARTED|Overall Study||85||
60083773|NCT00369928|76199616|FG001|STARTED|Overall Study||85||
60083774|NCT00369928|76199617|FG002|STARTED|Overall Study||86||
60083775|NCT00369928|76199615|FG000|COMPLETED|Overall Study||77||
60083776|NCT00369928|76199616|FG001|COMPLETED|Overall Study||69||
60083777|NCT00369928|76199617|FG002|COMPLETED|Overall Study||66||
60083778|NCT00369928|76199615|FG000|NOT COMPLETED|Overall Study||8||
60083779|NCT00369928|76199616|FG001|NOT COMPLETED|Overall Study||16||
60083780|NCT00369928|76199617|FG002|NOT COMPLETED|Overall Study||20||
60083781|NCT00409240|76199627|FG000|STARTED|Overall Study||53||
60083782|NCT00409240|76199628|FG001|STARTED|Overall Study||50||
60083783|NCT00409240|76199627|FG000|COMPLETED|Overall Study||50||
60083784|NCT00409240|76199628|FG001|COMPLETED|Overall Study||49||
60083785|NCT00409240|76199627|FG000|NOT COMPLETED|Overall Study||3||
60083786|NCT00409240|76199628|FG001|NOT COMPLETED|Overall Study||1||
60083787|NCT02110108|76199634|FG000|STARTED|Overall Study||10||
60083788|NCT02110108|76199634|FG000|RevLite Single Wavelength|Overall Study||10||
60083789|NCT02110108|76199634|FG000|RevLite Combo Wavelength|Overall Study||10||
60083790|NCT02110108|76199634|FG000|COMPLETED|Overall Study||7||
60083791|NCT02110108|76199634|FG000|NOT COMPLETED|Overall Study||3||
60083792|NCT00410488|76199644|FG000|STARTED|Overall Study||16||
60083793|NCT00410488|76199645|FG001|STARTED|Overall Study||34||
60083794|NCT00410488|76199644|FG000|COMPLETED|Overall Study||16||
60083795|NCT00410488|76199645|FG001|COMPLETED|Overall Study||34||
60083796|NCT00410488|76199644|FG000|NOT COMPLETED|Overall Study||0||
60083797|NCT00410488|76199645|FG001|NOT COMPLETED|Overall Study||0||
59554722|NCT02677623|75654914|FG003|COMPLETED|Overall Study||33||
59554723|NCT02677623|75654911|FG000|NOT COMPLETED|Overall Study||0||
60083798|NCT00412516|76199653|FG000|STARTED|Overall Study||93||
60083799|NCT00412516|76199654|FG001|STARTED|Overall Study||212||
60083800|NCT00412516|76199655|FG002|STARTED|Overall Study||214||
60083801|NCT00412516|76199653|FG000|COMPLETED|Overall Study||93||
60083802|NCT00412516|76199654|FG001|COMPLETED|Overall Study||212||
60083803|NCT00412516|76199655|FG002|COMPLETED|Overall Study||214||
60083804|NCT00412516|76199653|FG000|NOT COMPLETED|Overall Study||0||
60083805|NCT00412516|76199654|FG001|NOT COMPLETED|Overall Study||0||
60083806|NCT00412516|76199655|FG002|NOT COMPLETED|Overall Study||0||
60083807|NCT00414700|76199665|FG000|STARTED|Overall Study||57||
60083808|NCT00414700|76199666|FG001|STARTED|Overall Study||61||
60083809|NCT00414700|76199665|FG000|COMPLETED|Overall Study||51||
60083810|NCT00414700|76199666|FG001|COMPLETED|Overall Study||58||
60083811|NCT00414700|76199665|FG000|NOT COMPLETED|Overall Study||6||
60083812|NCT00414700|76199666|FG001|NOT COMPLETED|Overall Study||3||
60083813|NCT00415870|76199674|FG000|STARTED|Overall Study||32||
60083814|NCT00415870|76199675|FG001|STARTED|Overall Study||33||
60083815|NCT00415870|76199674|FG000|COMPLETED|Overall Study||26||
60083816|NCT00415870|76199675|FG001|COMPLETED|Overall Study||26||
60083817|NCT00415870|76199674|FG000|NOT COMPLETED|Overall Study||6||
59554724|NCT02677623|75654912|FG001|NOT COMPLETED|Overall Study||0||
60083818|NCT00415870|76199675|FG001|NOT COMPLETED|Overall Study||7||
59554725|NCT02677623|75654913|FG002|NOT COMPLETED|Overall Study||0||
59554726|NCT02677623|75654914|FG003|NOT COMPLETED|Overall Study||0||
59554727|NCT02677701|75654926|FG000|STARTED|Overall Study||62||
59554728|NCT02677701|75654927|FG001|STARTED|Overall Study||57||
59554729|NCT02677701|75654926|FG000|Treated|Overall Study||61|Participants receiving at least one dose of study drug|
59554730|NCT02677701|75654927|FG001|Treated|Overall Study||54|Participants receiving at least one dose of study drug|
59554731|NCT02677701|75654926|FG000|COMPLETED|Overall Study||56||
59554732|NCT02677701|75654927|FG001|COMPLETED|Overall Study||52||
59554733|NCT02677701|75654926|FG000|NOT COMPLETED|Overall Study||6||
59554734|NCT02677701|75654927|FG001|NOT COMPLETED|Overall Study||5||
59554735|NCT01543178|75654936|FG000|STARTED|Open-label Period|2583 subjects entered the open-label period, but 4 received no rifaximin; 2579 received rifaximin.|2583||
59554736|NCT01543178|75654937|FG001|STARTED|Open-label Period|The double-blind rifaximin arm/group is not applicable to the open-label period.|0||
59554737|NCT01543178|75654938|FG002|STARTED|Open-label Period|The double-blind placebo arm/group is not applicable to the open-label period.|0||
59554738|NCT01543178|75654936|FG000|COMPLETED|Open-label Period||636||
59554739|NCT01543178|75654937|FG001|COMPLETED|Open-label Period||0||
59554740|NCT01543178|75654938|FG002|COMPLETED|Open-label Period||0||
59554741|NCT01543178|75654936|FG000|NOT COMPLETED|Open-label Period||1947||
59554742|NCT01543178|75654937|FG001|NOT COMPLETED|Open-label Period||0||
59554743|NCT01543178|75654938|FG002|NOT COMPLETED|Open-label Period||0||
59554744|NCT01543178|75654936|FG000|STARTED|Double-blind Period|The open-label rifaximin arm/group is not applicable to the double-blind period.|0||
59554745|NCT01543178|75654937|FG001|STARTED|Double-blind Period|636 subjects had recurrence in open-label period; 328 randomized to rifaximin.|328||
59554746|NCT01543178|75654938|FG002|STARTED|Double-blind Period|636 subjects had recurrence in open-label period; 308 randomized to placebo.|308||
59554747|NCT01543178|75654936|FG000|COMPLETED|Double-blind Period||0||
59554748|NCT01543178|75654937|FG001|COMPLETED|Double-blind Period|295 completed 1st double-blind retreatment and 284 completed 2nd double-blind retreatment.|284||
59554749|NCT01543178|75654938|FG002|COMPLETED|Double-blind Period|283 completed 1st double-blind retreatment and 271 completed 2nd double-blind retreatment.|271||
59554750|NCT01543178|75654936|FG000|NOT COMPLETED|Double-blind Period||0||
59554751|NCT01543178|75654937|FG001|NOT COMPLETED|Double-blind Period||44||
59554752|NCT01543178|75654938|FG002|NOT COMPLETED|Double-blind Period||37||
59554753|NCT02677779|75654947|FG000|STARTED|Overall Study||10||
59554754|NCT02677779|75654948|FG001|STARTED|Overall Study||10||
59554755|NCT02677779|75654947|FG000|COMPLETED|Overall Study||10||
59554756|NCT02677779|75654948|FG001|COMPLETED|Overall Study||10||
59554757|NCT02677779|75654947|FG000|NOT COMPLETED|Overall Study||0||
59554758|NCT02677779|75654948|FG001|NOT COMPLETED|Overall Study||0||
59554759|NCT02679807|75654956|FG000|STARTED|Overall Study||165||
59554760|NCT02679807|75654957|FG001|STARTED|Overall Study||169||
59554761|NCT02679807|75654956|FG000|COMPLETED|Overall Study||143||
59554762|NCT02679807|75654957|FG001|COMPLETED|Overall Study||153||
59554763|NCT02679807|75654956|FG000|NOT COMPLETED|Overall Study||22||
59554764|NCT02679807|75654957|FG001|NOT COMPLETED|Overall Study||16||
59554765|NCT01649856|75654965|FG000|STARTED|Overall Study||369||
59554766|NCT01649856|75654966|FG001|STARTED|Overall Study||203||
59554767|NCT01649856|75654965|FG000|COMPLETED|Overall Study||230||
59554768|NCT01649856|75654966|FG001|COMPLETED|Overall Study||125||
59554769|NCT01649856|75654965|FG000|NOT COMPLETED|Overall Study||139||
59554770|NCT01649856|75654966|FG001|NOT COMPLETED|Overall Study||78||
59554771|NCT01543568|75654972|FG000|STARTED|Overall Study||46||
59554772|NCT01543568|75654972|FG000|COMPLETED|Overall Study||45||
59554773|NCT01543568|75654972|FG000|NOT COMPLETED|Overall Study||1||
59554774|NCT02681757|75654978|FG000|STARTED|Overall Study||47||
59554775|NCT02681757|75654979|FG001|STARTED|Overall Study||49||
59554776|NCT02681757|75654978|FG000|COMPLETED|Overall Study||47||
59554777|NCT02681757|75654979|FG001|COMPLETED|Overall Study||49||
59554778|NCT02681757|75654978|FG000|NOT COMPLETED|Overall Study||0||
59554779|NCT02681757|75654979|FG001|NOT COMPLETED|Overall Study||0||
59554780|NCT02375724|75654987|FG000|STARTED|Overall Study||135||
59554781|NCT02375724|75654988|FG001|STARTED|Overall Study||134||
59554782|NCT02375724|75654987|FG000|COMPLETED|Overall Study||129||
59554783|NCT02375724|75654988|FG001|COMPLETED|Overall Study||128||
59554784|NCT02375724|75654987|FG000|NOT COMPLETED|Overall Study||6||
59554785|NCT02375724|75654988|FG001|NOT COMPLETED|Overall Study||6||
59554786|NCT02398188|75654996|FG000|STARTED|Overall Study||398||
59554787|NCT02398188|75654997|FG001|STARTED|Overall Study||395||
59554788|NCT02398188|75654996|FG000|COMPLETED|Overall Study||371||
59554789|NCT02398188|75654997|FG001|COMPLETED|Overall Study||361||
59554790|NCT02398188|75654996|FG000|NOT COMPLETED|Overall Study||27||
59554791|NCT02398188|75654997|FG001|NOT COMPLETED|Overall Study||34||
59554792|NCT02426580|75655005|FG000|STARTED|Overall Study|April 2015|70||
59707063|NCT01125189|75825995|FG002|STARTED|Treatment Period||78||
59707064|NCT01125189|75825993|FG000|COMPLETED|Treatment Period||128||
59707065|NCT01125189|75825994|FG001|COMPLETED|Treatment Period||123||
60083819|NCT00416182|76199683|FG000|STARTED|Overall Study||8||
60083820|NCT00416182|76199684|FG001|STARTED|Overall Study||8||
60083821|NCT00416182|76199683|FG000|COMPLETED|Overall Study||5||
60083822|NCT00416182|76199684|FG001|COMPLETED|Overall Study||6||
59554793|NCT02426580|75655006|FG001|STARTED|Overall Study|January 2014|70||
60083823|NCT00416182|76199683|FG000|NOT COMPLETED|Overall Study||3||
60083824|NCT00416182|76199684|FG001|NOT COMPLETED|Overall Study||2||
60083825|NCT00416494|76199698|FG000|STARTED|Overall Study||19||
60083826|NCT00416494|76199699|FG001|STARTED|Overall Study||31||
60083827|NCT00416494|76199698|FG000|COMPLETED|Overall Study||19||
60083828|NCT00416494|76199699|FG001|COMPLETED|Overall Study||31||
60083829|NCT00416494|76199698|FG000|NOT COMPLETED|Overall Study||0||
60083830|NCT00416494|76199699|FG001|NOT COMPLETED|Overall Study||0||
60083831|NCT00416572|76199708|FG000|STARTED|Overall Study||83||
60083832|NCT00416572|76199709|FG001|STARTED|Overall Study||85||
60083833|NCT00416572|76199710|FG002|STARTED|Overall Study||84||
60083834|NCT00416572|76199708|FG000|COMPLETED|Overall Study||70||
60083835|NCT00416572|76199709|FG001|COMPLETED|Overall Study||78||
59554794|NCT02426580|75655005|FG000|COMPLETED|Overall Study|the last patient enrolled in this group in April 2017|59||
59554795|NCT02426580|75655006|FG001|COMPLETED|Overall Study|the last patient in this group enrolled in April 2017|54||
59554796|NCT02426580|75655005|FG000|NOT COMPLETED|Overall Study||11||
59554797|NCT02426580|75655006|FG001|NOT COMPLETED|Overall Study||16||
59554798|NCT01651260|75655012|FG000|STARTED|Overall Study||65||
59554799|NCT01651260|75655012|FG000|COMPLETED|Overall Study||62||
59554800|NCT01651260|75655012|FG000|NOT COMPLETED|Overall Study||3||
60083836|NCT00416572|76199710|FG002|COMPLETED|Overall Study||76||
60083837|NCT00416572|76199708|FG000|NOT COMPLETED|Overall Study||13||
59554801|NCT03110133|75655019|FG000|STARTED|Week 8||106||
59554802|NCT03110133|75655020|FG001|STARTED|Week 8||100||
59554803|NCT03110133|75655019|FG000|COMPLETED|Week 8||101||
59554804|NCT03110133|75655020|FG001|COMPLETED|Week 8||96||
59554805|NCT03110133|75655019|FG000|NOT COMPLETED|Week 8||5||
59554806|NCT03110133|75655020|FG001|NOT COMPLETED|Week 8||4||
59554807|NCT03110133|75655019|FG000|STARTED|Week 24||101||
59554808|NCT03110133|75655020|FG001|STARTED|Week 24||96||
59554809|NCT03110133|75655019|FG000|COMPLETED|Week 24||99||
59554810|NCT03110133|75655020|FG001|COMPLETED|Week 24||95||
59554811|NCT03110133|75655019|FG000|NOT COMPLETED|Week 24||2||
59554812|NCT03110133|75655020|FG001|NOT COMPLETED|Week 24||1||
59554813|NCT02682069|75655026|FG000|STARTED|Overall Study||30||
59554814|NCT02682069|75655026|FG000|COMPLETED|Overall Study||30||
59554815|NCT02682069|75655026|FG000|NOT COMPLETED|Overall Study||0||
59554816|NCT02425098|75655032|FG000|STARTED|Overall Study||176||
59554817|NCT02425098|75655033|FG001|STARTED|Overall Study||175||
59554818|NCT02425098|75655032|FG000|COMPLETED|Overall Study||163||
59554819|NCT02425098|75655033|FG001|COMPLETED|Overall Study||159||
59554820|NCT02425098|75655032|FG000|NOT COMPLETED|Overall Study||13||
59554821|NCT02425098|75655033|FG001|NOT COMPLETED|Overall Study||16||
59554822|NCT02424630|75655041|FG000|STARTED|Overall Study||25||
59554823|NCT02424630|75655042|FG001|STARTED|Overall Study||27||
60083838|NCT00416572|76199709|FG001|NOT COMPLETED|Overall Study||7||
60083839|NCT00416572|76199710|FG002|NOT COMPLETED|Overall Study||8||
60083840|NCT00417274|76199718|FG000|STARTED|Overall Study||31||
60083841|NCT00417274|76199718|FG000|COMPLETED|Overall Study||31||
60083842|NCT00417274|76199718|FG000|NOT COMPLETED|Overall Study||0||
60083843|NCT00422032|76199724|FG000|STARTED|Overall Study||37||
60083844|NCT00422032|76199725|FG001|STARTED|Overall Study||21||
60083845|NCT00422032|76199724|FG000|COMPLETED|Overall Study||37||
60083846|NCT00422032|76199725|FG001|COMPLETED|Overall Study||21||
60083847|NCT00422032|76199724|FG000|NOT COMPLETED|Overall Study||0||
60083848|NCT00422032|76199725|FG001|NOT COMPLETED|Overall Study||0||
60083849|NCT01856140|76199733|FG000|STARTED|Overall Study||6||
60083850|NCT01856140|76199734|FG001|STARTED|Overall Study||6||
60083851|NCT01856140|76199733|FG000|COMPLETED|Overall Study||6||
60083852|NCT01856140|76199734|FG001|COMPLETED|Overall Study||6||
60083853|NCT01856140|76199733|FG000|NOT COMPLETED|Overall Study||0||
60083854|NCT01856140|76199734|FG001|NOT COMPLETED|Overall Study||0||
60083855|NCT01388920|76199743|FG000|STARTED|Overall Study||1||
60083856|NCT01388920|76199744|FG001|STARTED|Overall Study||1||
60083857|NCT01388920|76199745|FG002|STARTED|Overall Study||0||
60083858|NCT01388920|76199743|FG000|COMPLETED|Overall Study||1||
60083859|NCT01388920|76199744|FG001|COMPLETED|Overall Study||1||
60083860|NCT01388920|76199745|FG002|COMPLETED|Overall Study||0||
60083861|NCT01388920|76199743|FG000|NOT COMPLETED|Overall Study||0||
60083862|NCT01388920|76199744|FG001|NOT COMPLETED|Overall Study||0||
60083863|NCT01388920|76199745|FG002|NOT COMPLETED|Overall Study||0||
60083864|NCT00422656|76199753|FG000|STARTED|Overall Study||37||
60083865|NCT00422656|76199753|FG000|COMPLETED|Overall Study||37||
60083866|NCT00422656|76199753|FG000|NOT COMPLETED|Overall Study||0||
60083867|NCT00422812|76199761|FG000|STARTED|Overall Study||98||
60083868|NCT00422812|76199762|FG001|STARTED|Overall Study||104||
60083869|NCT00422812|76199763|FG002|STARTED|Overall Study||93||
60083870|NCT00422812|76199764|FG003|STARTED|Overall Study||105||
60083871|NCT00422812|76199761|FG000|COMPLETED|Overall Study||98||
60083872|NCT00422812|76199762|FG001|COMPLETED|Overall Study||103||
60083873|NCT00422812|76199763|FG002|COMPLETED|Overall Study||91||
60083874|NCT00422812|76199764|FG003|COMPLETED|Overall Study||103||
60083875|NCT00422812|76199761|FG000|NOT COMPLETED|Overall Study||0||
60083876|NCT00422812|76199762|FG001|NOT COMPLETED|Overall Study||1||
60083877|NCT00422812|76199763|FG002|NOT COMPLETED|Overall Study||2||
60083878|NCT00422812|76199764|FG003|NOT COMPLETED|Overall Study||2||
60083879|NCT00423358|76199776|FG000|STARTED|Overall Study||11||
60083880|NCT00423358|76199777|FG001|STARTED|Overall Study||11||
60083881|NCT00423358|76199776|FG000|COMPLETED|Overall Study||11||
60083882|NCT00423358|76199777|FG001|COMPLETED|Overall Study||11||
60083883|NCT00423358|76199776|FG000|NOT COMPLETED|Overall Study||0||
60083884|NCT00423358|76199777|FG001|NOT COMPLETED|Overall Study||0||
60083885|NCT00423436|76199785|FG000|STARTED|Overall Study||35||
59554824|NCT02424630|75655041|FG000|COMPLETED|Overall Study||24||
59554825|NCT02424630|75655042|FG001|COMPLETED|Overall Study||24||
59554826|NCT02424630|75655041|FG000|NOT COMPLETED|Overall Study||1||
60083886|NCT00423436|76199786|FG001|STARTED|Overall Study||33||
60083887|NCT00423436|76199785|FG000|COMPLETED|Overall Study||35||
60083888|NCT00423436|76199786|FG001|COMPLETED|Overall Study||33||
60083889|NCT00423436|76199785|FG000|NOT COMPLETED|Overall Study||0||
60083890|NCT00423436|76199786|FG001|NOT COMPLETED|Overall Study||0||
60083891|NCT00424840|76199792|FG000|STARTED|Overall Study||3||
60083892|NCT00424840|76199793|FG001|STARTED|Overall Study||4||
60083893|NCT00424840|76199794|FG002|STARTED|Overall Study||5||
60083894|NCT00424840|76199792|FG000|COMPLETED|Overall Study||3||
60083895|NCT00424840|76199793|FG001|COMPLETED|Overall Study||4||
60083896|NCT00424840|76199794|FG002|COMPLETED|Overall Study||5||
60083897|NCT00424840|76199792|FG000|NOT COMPLETED|Overall Study||0||
60083898|NCT00424840|76199793|FG001|NOT COMPLETED|Overall Study||0||
60083899|NCT00424840|76199794|FG002|NOT COMPLETED|Overall Study||0||
60083900|NCT00425386|76199800|FG000|STARTED|Overall Study||46||
60083901|NCT00425386|76199800|FG000|COMPLETED|Overall Study||43||
60083902|NCT00425386|76199800|FG000|NOT COMPLETED|Overall Study||3||
60083903|NCT01164202|76199806|FG000|STARTED|Overall Study||39||
60083904|NCT01164202|76199807|FG001|STARTED|Overall Study||39||
60083905|NCT01164202|76199806|FG000|COMPLETED|Overall Study||38||
60083906|NCT01164202|76199807|FG001|COMPLETED|Overall Study||39||
60083907|NCT01164202|76199806|FG000|NOT COMPLETED|Overall Study||1||
60083908|NCT01164202|76199807|FG001|NOT COMPLETED|Overall Study||0||
60083909|NCT02112370|76199817|FG000|STARTED|Overall Study||74||
60083910|NCT02112370|76199818|FG001|STARTED|Overall Study||74||
60083911|NCT02112370|76199817|FG000|COMPLETED|Overall Study||74||
60083912|NCT02112370|76199818|FG001|COMPLETED|Overall Study||74||
60083913|NCT02112370|76199817|FG000|NOT COMPLETED|Overall Study||0||
60083914|NCT02112370|76199818|FG001|NOT COMPLETED|Overall Study||0||
60083915|NCT02112838|76199827|FG000|STARTED|Overall Study||25||
60083916|NCT02112838|76199828|FG001|STARTED|Overall Study||26||
60083917|NCT02112838|76199829|FG002|STARTED|Overall Study||25||
60083918|NCT02112838|76199827|FG000|COMPLETED|Overall Study||20||
60083919|NCT02112838|76199828|FG001|COMPLETED|Overall Study||24||
60083920|NCT02112838|76199829|FG002|COMPLETED|Overall Study||24||
60083921|NCT02112838|76199827|FG000|NOT COMPLETED|Overall Study||5||
60083922|NCT02112838|76199828|FG001|NOT COMPLETED|Overall Study||2||
60083923|NCT02112838|76199829|FG002|NOT COMPLETED|Overall Study||1||
60083924|NCT00427336|76199837|FG000|STARTED|Overall Study||9||
60083925|NCT00427336|76199837|FG000|COMPLETED|Overall Study||9||
60083926|NCT00427336|76199837|FG000|NOT COMPLETED|Overall Study||0||
60083927|NCT00371176|76199843|FG000|STARTED|Overall Study||13||
60083928|NCT00371176|76199844|FG001|STARTED|Overall Study||13||
60083929|NCT00371176|76199843|FG000|Completed Treatment|Overall Study||10||
60083930|NCT00371176|76199844|FG001|Completed Treatment|Overall Study||9||
60083931|NCT00371176|76199843|FG000|COMPLETED|Overall Study||8||
60083932|NCT00371176|76199844|FG001|COMPLETED|Overall Study||5||
60083933|NCT00371176|76199843|FG000|NOT COMPLETED|Overall Study||5||
60083934|NCT00371176|76199844|FG001|NOT COMPLETED|Overall Study||8||
60083935|NCT00371644|76199852|FG000|STARTED|Overall Study||72||
60083936|NCT00371644|76199853|FG001|STARTED|Overall Study||57||
60083937|NCT00371644|76199852|FG000|COMPLETED|Overall Study||44||
59816585|NCT04915950|75939024|FG003|STARTED|Stage A: Treatment Period 1 (1 Day)||2||
60083938|NCT00371644|76199853|FG001|COMPLETED|Overall Study||44||
60083939|NCT00371644|76199852|FG000|NOT COMPLETED|Overall Study||28||
60083940|NCT00371644|76199853|FG001|NOT COMPLETED|Overall Study||13||
60083941|NCT00428584|76199861|FG000|STARTED|Comparative Phase||65||
60083942|NCT00428584|76199862|FG001|STARTED|Comparative Phase||64||
60083943|NCT00428584|76199861|FG000|COMPLETED|Comparative Phase|Comparator Phase - new formulation of rebif and Betaseron|56||
60083944|NCT00428584|76199862|FG001|COMPLETED|Comparative Phase||63||
60083945|NCT00428584|76199861|FG000|NOT COMPLETED|Comparative Phase||9||
60083946|NCT00428584|76199862|FG001|NOT COMPLETED|Comparative Phase||1||
60083947|NCT00428584|76199861|FG000|STARTED|Extension Phase|Extension Phase - new formulation of rebif to new formulation of rebif|56||
60083948|NCT00428584|76199862|FG001|STARTED|Extension Phase||63||
60083949|NCT00428584|76199861|FG000|COMPLETED|Extension Phase||35||
60083950|NCT00428584|76199862|FG001|COMPLETED|Extension Phase||34||
60083951|NCT00428584|76199861|FG000|NOT COMPLETED|Extension Phase||21||
60083952|NCT00428584|76199862|FG001|NOT COMPLETED|Extension Phase||29||
60083953|NCT00428974|76199876|FG000|STARTED|Overall Study|one patient was randomized but never received study treatment|25||
60083954|NCT00428974|76199877|FG001|STARTED|Overall Study||17||
60083955|NCT00428974|76199878|FG002|STARTED|Overall Study||15||
60083956|NCT00428974|76199879|FG003|STARTED|Overall Study||19||
60083957|NCT00428974|76199876|FG000|COMPLETED|Overall Study||17||
60083958|NCT00428974|76199877|FG001|COMPLETED|Overall Study||17||
60083959|NCT00428974|76199878|FG002|COMPLETED|Overall Study||14||
60083960|NCT00428974|76199879|FG003|COMPLETED|Overall Study||16||
60083961|NCT00428974|76199876|FG000|NOT COMPLETED|Overall Study||8||
60083962|NCT00428974|76199877|FG001|NOT COMPLETED|Overall Study||0||
60083963|NCT00428974|76199878|FG002|NOT COMPLETED|Overall Study||1||
60083964|NCT00428974|76199879|FG003|NOT COMPLETED|Overall Study||3||
60083965|NCT00372970|76199892|FG000|STARTED|Overall Study||16||
60083966|NCT00372970|76199893|FG001|STARTED|Overall Study||16||
60083967|NCT00372970|76199892|FG000|COMPLETED|Overall Study||16||
60083968|NCT00372970|76199893|FG001|COMPLETED|Overall Study||16||
60083969|NCT00372970|76199892|FG000|NOT COMPLETED|Overall Study||0||
59554827|NCT02424630|75655042|FG001|NOT COMPLETED|Overall Study||3||
59554828|NCT02397408|75655048|FG000|STARTED|Overall Study||18||
59554829|NCT02397408|75655048|FG000|Completed Surgery Per Protocol|Overall Study||16||
59554830|NCT02397408|75655048|FG000|COMPLETED|Overall Study||12||
59554831|NCT02397408|75655048|FG000|NOT COMPLETED|Overall Study||6||
59554832|NCT02397096|75655054|FG000|STARTED|Day 1 to Week 24||447||
59554833|NCT02397096|75655055|FG001|STARTED|Day 1 to Week 24||223||
59554834|NCT02397096|75655054|FG000|COMPLETED|Day 1 to Week 24||427||
59554835|NCT02397096|75655055|FG001|COMPLETED|Day 1 to Week 24||209||
59554836|NCT02397096|75655054|FG000|NOT COMPLETED|Day 1 to Week 24||20||
59554837|NCT02397096|75655055|FG001|NOT COMPLETED|Day 1 to Week 24||14||
59554838|NCT02397096|75655054|FG000|STARTED|Week 24 to Week 48||427||
59554839|NCT02397096|75655055|FG001|STARTED|Week 24 to Week 48||209||
59554840|NCT02397096|75655054|FG000|COMPLETED|Week 24 to Week 48||407||
59554841|NCT02397096|75655055|FG001|COMPLETED|Week 24 to Week 48||202||
59554842|NCT02397096|75655054|FG000|NOT COMPLETED|Week 24 to Week 48||20||
59554843|NCT02397096|75655055|FG001|NOT COMPLETED|Week 24 to Week 48||7||
59554844|NCT02397096|75655054|FG000|STARTED|Study Extensions|The extension study is optional; not all eligible participants enrolled.|399||
59554845|NCT02397096|75655055|FG001|STARTED|Study Extensions|The extension study is optional; not all eligible participants enrolled.|202||
59554846|NCT02397096|75655054|FG000|COMPLETED|Study Extensions|The extension study is ongoing.|0||
59554847|NCT02397096|75655055|FG001|COMPLETED|Study Extensions|The extension study is ongoing.|0||
59554848|NCT02397096|75655054|FG000|NOT COMPLETED|Study Extensions||399||
59554849|NCT02397096|75655055|FG001|NOT COMPLETED|Study Extensions||202||
59554850|NCT02372058|75655065|FG000|STARTED|Overall Study||103||
59554851|NCT02372058|75655065|FG000|COMPLETED|Overall Study||100||
59554852|NCT02372058|75655065|FG000|NOT COMPLETED|Overall Study||3||
59554853|NCT02396316|75655073|FG000|STARTED|Overall Study||27||
59554854|NCT02396316|75655074|FG001|STARTED|Overall Study||27||
59554855|NCT02396316|75655073|FG000|Treated|Overall Study||27||
59554856|NCT02396316|75655074|FG001|Treated|Overall Study||27||
59554857|NCT02396316|75655073|FG000|Received Sham Injection at Week 1|Overall Study||10||
59554858|NCT02396316|75655074|FG001|Received Sham Injection at Week 1|Overall Study||0||
59554859|NCT02396316|75655073|FG000|Received AFL Injection at Week 1|Overall Study||0||
59554860|NCT02396316|75655074|FG001|Received AFL Injection at Week 1|Overall Study||22||
59554861|NCT02396316|75655073|FG000|Received Active Injection at Week 5|Overall Study||4||
59554862|NCT02396316|75655074|FG001|Received Active Injection at Week 5|Overall Study||4||
59554863|NCT02396316|75655073|FG000|Received Active Injection at Week 9|Overall Study||2||
59554864|NCT02396316|75655074|FG001|Received Active Injection at Week 9|Overall Study||1||
59554865|NCT02396316|75655073|FG000|COMPLETED|Overall Study||20||
59554866|NCT02396316|75655074|FG001|COMPLETED|Overall Study||22||
59554867|NCT02396316|75655073|FG000|NOT COMPLETED|Overall Study||7||
59554868|NCT02396316|75655074|FG001|NOT COMPLETED|Overall Study||5||
59554869|NCT02395536|75655084|FG000|STARTED|Overall Study||264||
59554870|NCT02395536|75655085|FG001|STARTED|Overall Study||257||
59554871|NCT02395536|75655084|FG000|REVEAL LINQ Insertion|Overall Study||251|Number of subjects randomized that actually had a REVEAL LINQ insertion attempt|
59554872|NCT02395536|75655085|FG001|REVEAL LINQ Insertion|Overall Study||231|Number of subjects randomized that actually had a REVEAL LINQ insertion attempt|
59554873|NCT02395536|75655084|FG000|COMPLETED|Overall Study||244||
59554874|NCT02395536|75655085|FG001|COMPLETED|Overall Study||227||
59554875|NCT02395536|75655084|FG000|NOT COMPLETED|Overall Study||20||
59554876|NCT02395536|75655085|FG001|NOT COMPLETED|Overall Study||30||
59554877|NCT00552929|75655101|FG000|STARTED|Overall Study||9|Randomized Participants|
59554878|NCT00552929|75655102|FG001|STARTED|Overall Study||10|Randomized Participants|
59707066|NCT01125189|75825995|FG002|COMPLETED|Treatment Period||37||
59816586|NCT04915950|75939025|FG004|STARTED|Stage A: Treatment Period 1 (1 Day)||3||
59816587|NCT04915950|75939026|FG005|STARTED|Stage A: Treatment Period 1 (1 Day)||2||
59816588|NCT04915950|75939021|FG000|COMPLETED|Stage A: Treatment Period 1 (1 Day)||2||
59816589|NCT04915950|75939022|FG001|COMPLETED|Stage A: Treatment Period 1 (1 Day)||2||
59816590|NCT04915950|75939023|FG002|COMPLETED|Stage A: Treatment Period 1 (1 Day)||2||
59816591|NCT04915950|75939024|FG003|COMPLETED|Stage A: Treatment Period 1 (1 Day)||2||
60083970|NCT00372970|76199893|FG001|NOT COMPLETED|Overall Study||0||
60083971|NCT00373360|76199899|FG000|STARTED|Overall Study||10||
59554879|NCT00552929|75655103|FG002|STARTED|Overall Study||10|Randomized Participants|
59554880|NCT00552929|75655104|FG003|STARTED|Overall Study||11|Randomized Participants|
59554881|NCT00552929|75655105|FG004|STARTED|Overall Study||10|Randomized Participants|
59554882|NCT00552929|75655106|FG005|STARTED|Overall Study||10|Randomized Participants|
59554883|NCT00552929|75655107|FG006|STARTED|Overall Study||10|Randomized Participants|
59554884|NCT00552929|75655108|FG007|STARTED|Overall Study||11|Randomized Participants|
59554885|NCT00552929|75655109|FG008|STARTED|Overall Study||10|Randomized Participants|
59554886|NCT00552929|75655110|FG009|STARTED|Overall Study||11|Randomized Participants|
59554887|NCT00552929|75655101|FG000|Participants as Treated|Overall Study|One participant randomized to sugammadex 0.5 mg/kg received sugammadex 3.7 mg/kg (4.0 mg\kg group)|9||
59554888|NCT00552929|75655102|FG001|Participants as Treated|Overall Study||10||
59554889|NCT00552929|75655103|FG002|Participants as Treated|Overall Study||10||
59554890|NCT00552929|75655104|FG003|Participants as Treated|Overall Study|One participant randomized to sugammadex 0.5 mg/kg received sugammadex 3.7 mg/kg (4.0 mg\kg group)|11||
59554891|NCT00552929|75655105|FG004|Participants as Treated|Overall Study||10||
59554892|NCT00552929|75655106|FG005|Participants as Treated|Overall Study||9||
59554893|NCT00552929|75655107|FG006|Participants as Treated|Overall Study||10||
59554894|NCT00552929|75655108|FG007|Participants as Treated|Overall Study||11||
59554895|NCT00552929|75655109|FG008|Participants as Treated|Overall Study||10||
59554896|NCT00552929|75655110|FG009|Participants as Treated|Overall Study||11||
59554897|NCT00552929|75655101|FG000|COMPLETED|Overall Study||9||
59554898|NCT00552929|75655102|FG001|COMPLETED|Overall Study||10||
59554899|NCT00552929|75655103|FG002|COMPLETED|Overall Study||10||
59554900|NCT00552929|75655104|FG003|COMPLETED|Overall Study||11||
59554901|NCT00552929|75655105|FG004|COMPLETED|Overall Study||10||
59554902|NCT00552929|75655106|FG005|COMPLETED|Overall Study||9||
59554903|NCT00552929|75655107|FG006|COMPLETED|Overall Study||10||
59554904|NCT00552929|75655108|FG007|COMPLETED|Overall Study||11||
59554905|NCT00552929|75655109|FG008|COMPLETED|Overall Study||9||
59554906|NCT00552929|75655110|FG009|COMPLETED|Overall Study||11||
59554907|NCT00552929|75655101|FG000|NOT COMPLETED|Overall Study||0||
59554908|NCT00552929|75655102|FG001|NOT COMPLETED|Overall Study||0||
59816592|NCT04915950|75939025|FG004|COMPLETED|Stage A: Treatment Period 1 (1 Day)||3||
59554909|NCT00552929|75655103|FG002|NOT COMPLETED|Overall Study||0||
59554910|NCT00552929|75655104|FG003|NOT COMPLETED|Overall Study||0||
59554911|NCT00552929|75655105|FG004|NOT COMPLETED|Overall Study||0||
59554912|NCT00552929|75655106|FG005|NOT COMPLETED|Overall Study||1||
59554913|NCT00552929|75655107|FG006|NOT COMPLETED|Overall Study||0||
59554914|NCT00552929|75655108|FG007|NOT COMPLETED|Overall Study||0||
59554915|NCT00552929|75655109|FG008|NOT COMPLETED|Overall Study||1||
59554916|NCT00552929|75655110|FG009|NOT COMPLETED|Overall Study||0||
59554917|NCT02395302|75655132|FG000|STARTED|Overall Study||28||
59554918|NCT02395302|75655132|FG000|COMPLETED|Overall Study||14||
59554919|NCT02395302|75655132|FG000|NOT COMPLETED|Overall Study||14||
59554920|NCT02682381|75655139|FG000|STARTED|Overall Study||24||
59554921|NCT02682381|75655140|FG001|STARTED|Overall Study||26||
59554922|NCT02682381|75655141|FG002|STARTED|Overall Study||9||
59554923|NCT02682381|75655139|FG000|COMPLETED|Overall Study||24||
59554924|NCT02682381|75655140|FG001|COMPLETED|Overall Study||26||
59554925|NCT02682381|75655141|FG002|COMPLETED|Overall Study||9||
59554926|NCT02682381|75655139|FG000|NOT COMPLETED|Overall Study||0||
59554927|NCT02682381|75655140|FG001|NOT COMPLETED|Overall Study||0||
59554928|NCT02682381|75655141|FG002|NOT COMPLETED|Overall Study||0||
59554929|NCT02683083|75655149|FG000|STARTED|Overall Study||9||
59554930|NCT02683083|75655149|FG000|COMPLETED|Overall Study||9||
59554931|NCT02683083|75655149|FG000|NOT COMPLETED|Overall Study||0||
59554932|NCT02683161|75655153|FG000|STARTED|Overall Study||5||
59554933|NCT02683161|75655153|FG000|COMPLETED|Overall Study||5||
59554934|NCT02683161|75655153|FG000|NOT COMPLETED|Overall Study||0||
59554935|NCT02683707|75655159|FG000|STARTED|Overall Study||105||
59554936|NCT02683707|75655160|FG001|STARTED|Overall Study||107||
59554937|NCT02683707|75655159|FG000|COMPLETED|Overall Study||105||
59554938|NCT02683707|75655160|FG001|COMPLETED|Overall Study||107||
59554939|NCT02683707|75655159|FG000|NOT COMPLETED|Overall Study||0||
59554940|NCT02683707|75655160|FG001|NOT COMPLETED|Overall Study||0||
59554941|NCT02371980|75655166|FG000|STARTED|Open-label Period||1106||
59554942|NCT02371980|75655167|FG001|STARTED|Open-label Period||0||
59554943|NCT02371980|75655168|FG002|STARTED|Open-label Period||0||
59554944|NCT02371980|75655169|FG003|STARTED|Open-label Period||0||
59554945|NCT02371980|75655170|FG004|STARTED|Open-label Period||0||
59554946|NCT02371980|75655166|FG000|COMPLETED|Open-label Period||580||
59554947|NCT02371980|75655167|FG001|COMPLETED|Open-label Period||0||
59554948|NCT02371980|75655168|FG002|COMPLETED|Open-label Period||0||
59554949|NCT02371980|75655169|FG003|COMPLETED|Open-label Period||0||
59554950|NCT02371980|75655170|FG004|COMPLETED|Open-label Period||0||
59554951|NCT02371980|75655166|FG000|NOT COMPLETED|Open-label Period||526||
59554952|NCT02371980|75655167|FG001|NOT COMPLETED|Open-label Period||0||
59554953|NCT02371980|75655168|FG002|NOT COMPLETED|Open-label Period||0||
59554954|NCT02371980|75655169|FG003|NOT COMPLETED|Open-label Period||0||
59554955|NCT02371980|75655170|FG004|NOT COMPLETED|Open-label Period||0||
59554956|NCT02371980|75655166|FG000|STARTED|Double-blind Period||0||
59554957|NCT02371980|75655167|FG001|STARTED|Double-blind Period||151||
59554958|NCT02371980|75655168|FG002|STARTED|Double-blind Period||140||
59554959|NCT02371980|75655169|FG003|STARTED|Double-blind Period||145||
59554960|NCT02371980|75655170|FG004|STARTED|Double-blind Period||144||
59554961|NCT02371980|75655166|FG000|COMPLETED|Double-blind Period||0||
59554962|NCT02371980|75655167|FG001|COMPLETED|Double-blind Period||70||
59554963|NCT02371980|75655168|FG002|COMPLETED|Double-blind Period||84||
59554964|NCT02371980|75655169|FG003|COMPLETED|Double-blind Period||96||
59554965|NCT02371980|75655170|FG004|COMPLETED|Double-blind Period||86||
59554966|NCT02371980|75655166|FG000|NOT COMPLETED|Double-blind Period||0||
59554967|NCT02371980|75655167|FG001|NOT COMPLETED|Double-blind Period||81||
59554968|NCT02371980|75655168|FG002|NOT COMPLETED|Double-blind Period||56||
59554969|NCT02371980|75655169|FG003|NOT COMPLETED|Double-blind Period||49||
59554970|NCT02371980|75655170|FG004|NOT COMPLETED|Double-blind Period||58||
59554971|NCT01429064|75655185|FG000|STARTED|Overall Study||19||
59554972|NCT01429064|75655186|FG001|STARTED|Overall Study||22||
59554973|NCT01429064|75655187|FG002|STARTED|Overall Study||19||
59554974|NCT01429064|75655188|FG003|STARTED|Overall Study||16||
59554975|NCT01429064|75655185|FG000|COMPLETED|Overall Study||19||
59554976|NCT01429064|75655186|FG001|COMPLETED|Overall Study||22||
59554977|NCT01429064|75655187|FG002|COMPLETED|Overall Study||19||
59554978|NCT01429064|75655188|FG003|COMPLETED|Overall Study||16||
59554979|NCT01429064|75655185|FG000|NOT COMPLETED|Overall Study||0||
59554980|NCT01429064|75655186|FG001|NOT COMPLETED|Overall Study||0||
59554981|NCT01429064|75655187|FG002|NOT COMPLETED|Overall Study||0||
59554982|NCT01429064|75655188|FG003|NOT COMPLETED|Overall Study||0||
59554983|NCT01490684|75655198|FG000|STARTED|Overall Study||162||
59554984|NCT01490684|75655198|FG000|COMPLETED|Overall Study||162||
59554985|NCT01490684|75655198|FG000|NOT COMPLETED|Overall Study||0||
59554986|NCT02204150|75655202|FG000|STARTED|Overall Study||56||
59554987|NCT02204150|75655202|FG000|COMPLETED|Overall Study||56||
59554988|NCT02204150|75655202|FG000|NOT COMPLETED|Overall Study||0||
59554989|NCT01493024|75655210|FG000|STARTED|Overall Study||30||
59554990|NCT01493024|75655211|FG001|STARTED|Overall Study||12||
59554991|NCT01493024|75655212|FG002|STARTED|Overall Study||24||
59554992|NCT01493024|75655213|FG003|STARTED|Overall Study||24||
59554993|NCT01493024|75655210|FG000|COMPLETED|Overall Study||30||
59554994|NCT01493024|75655211|FG001|COMPLETED|Overall Study||12||
59554995|NCT01493024|75655212|FG002|COMPLETED|Overall Study||24||
59554996|NCT01493024|75655213|FG003|COMPLETED|Overall Study||24||
59554997|NCT01493024|75655210|FG000|NOT COMPLETED|Overall Study||0||
59554998|NCT01493024|75655211|FG001|NOT COMPLETED|Overall Study||0||
59554999|NCT01493024|75655212|FG002|NOT COMPLETED|Overall Study||0||
59555000|NCT01493024|75655213|FG003|NOT COMPLETED|Overall Study||0||
59555001|NCT01429454|75655226|FG000|STARTED|Overall Study||62||
59555002|NCT01429454|75655227|FG001|STARTED|Overall Study||65||
59555003|NCT01429454|75655226|FG000|COMPLETED|Overall Study||35||
59555004|NCT01429454|75655227|FG001|COMPLETED|Overall Study||35||
59555005|NCT01429454|75655226|FG000|NOT COMPLETED|Overall Study||27||
59555006|NCT01429454|75655227|FG001|NOT COMPLETED|Overall Study||30||
59555007|NCT01429532|75655237|FG000|STARTED|Overall Study||40||
59555008|NCT01429532|75655238|FG001|STARTED|Overall Study||40||
59555009|NCT01429532|75655239|FG002|STARTED|Overall Study||40||
59555010|NCT01429532|75655237|FG000|COMPLETED|Overall Study||40||
59555011|NCT01429532|75655238|FG001|COMPLETED|Overall Study||40||
59555012|NCT01429532|75655239|FG002|COMPLETED|Overall Study||40||
59555013|NCT01429532|75655237|FG000|NOT COMPLETED|Overall Study||0||
59555014|NCT01429532|75655238|FG001|NOT COMPLETED|Overall Study||0||
59555015|NCT01429532|75655239|FG002|NOT COMPLETED|Overall Study||0||
59555016|NCT01546454|75655247|FG000|STARTED|Natural Menstrual Cycle||4||
59555017|NCT01546454|75655247|FG000|COMPLETED|Natural Menstrual Cycle||4||
59555018|NCT01546454|75655247|FG000|NOT COMPLETED|Natural Menstrual Cycle||0||
59555019|NCT01546454|75655247|FG000|STARTED|Oral Contraceptive Cycle||4||
59555020|NCT01546454|75655247|FG000|COMPLETED|Oral Contraceptive Cycle||4||
59555021|NCT01546454|75655247|FG000|NOT COMPLETED|Oral Contraceptive Cycle||0||
59555022|NCT01546454|75655247|FG000|STARTED|Eligard Treatment||4||
59555023|NCT01546454|75655247|FG000|COMPLETED|Eligard Treatment||4||
59555024|NCT01546454|75655247|FG000|NOT COMPLETED|Eligard Treatment||0||
59555025|NCT01546454|75655247|FG000|STARTED|Estrogen/Progesterone Replacement Cycle||4||
59555026|NCT01546454|75655247|FG000|COMPLETED|Estrogen/Progesterone Replacement Cycle||4||
59555027|NCT01546454|75655247|FG000|NOT COMPLETED|Estrogen/Progesterone Replacement Cycle||0||
59555028|NCT01547000|75655255|FG000|STARTED|Overall Study||18||
59555029|NCT01547000|75655256|FG001|STARTED|Overall Study||16||
59555030|NCT01547000|75655255|FG000|COMPLETED|Overall Study||18||
59555031|NCT01547000|75655256|FG001|COMPLETED|Overall Study||16||
59555032|NCT01547000|75655255|FG000|NOT COMPLETED|Overall Study||0||
59555033|NCT01547000|75655256|FG001|NOT COMPLETED|Overall Study||0||
60083972|NCT00373360|76199899|FG000|COMPLETED|Overall Study||10||
60083973|NCT00373360|76199899|FG000|NOT COMPLETED|Overall Study||0||
60083974|NCT00430768|76199906|FG000|STARTED|Overall Study||3||
60083975|NCT00430768|76199907|FG001|STARTED|Overall Study||3||
60083976|NCT00430768|76199908|FG002|STARTED|Overall Study||3||
60083977|NCT00430768|76199906|FG000|COMPLETED|Overall Study||3||
60083978|NCT00430768|76199907|FG001|COMPLETED|Overall Study||3||
60083979|NCT00430768|76199908|FG002|COMPLETED|Overall Study||3||
60083980|NCT00430768|76199906|FG000|NOT COMPLETED|Overall Study||0||
60083981|NCT00430768|76199907|FG001|NOT COMPLETED|Overall Study||0||
60083982|NCT00430768|76199908|FG002|NOT COMPLETED|Overall Study||0||
60083983|NCT00455650|76199924|FG000|STARTED|Week 1||10||
60083984|NCT00455650|76199925|FG001|STARTED|Week 1||10||
60083985|NCT00455650|76199926|FG002|STARTED|Week 1||10||
60083986|NCT00455650|76199927|FG003|STARTED|Week 1||14||
60083987|NCT00455650|76199928|FG004|STARTED|Week 1||14||
60083988|NCT00455650|76199929|FG005|STARTED|Week 1||13||
60083989|NCT00455650|76199924|FG000|COMPLETED|Week 1||10||
59555034|NCT01493180|75655264|FG000|STARTED|Overall Study||51||
60083990|NCT00455650|76199925|FG001|COMPLETED|Week 1||10||
60083991|NCT00455650|76199926|FG002|COMPLETED|Week 1||10||
60083992|NCT00455650|76199927|FG003|COMPLETED|Week 1||14||
60083993|NCT00455650|76199928|FG004|COMPLETED|Week 1||14||
59555035|NCT01493180|75655265|FG001|STARTED|Overall Study||51||
60083994|NCT00455650|76199929|FG005|COMPLETED|Week 1||13||
60083995|NCT00455650|76199924|FG000|NOT COMPLETED|Week 1||0||
60083996|NCT00455650|76199925|FG001|NOT COMPLETED|Week 1||0||
60083997|NCT00455650|76199926|FG002|NOT COMPLETED|Week 1||0||
59555036|NCT01493180|75655264|FG000|COMPLETED|Overall Study||48||
59555037|NCT01493180|75655265|FG001|COMPLETED|Overall Study||49||
59555038|NCT01493180|75655264|FG000|NOT COMPLETED|Overall Study||3||
59555039|NCT01493180|75655265|FG001|NOT COMPLETED|Overall Study||2||
59555040|NCT01431014|75655273|FG000|STARTED|Overall Study||34||
59555041|NCT01431014|75655274|FG001|STARTED|Overall Study||34||
59555042|NCT01431014|75655273|FG000|COMPLETED|Overall Study||31||
60083998|NCT00455650|76199927|FG003|NOT COMPLETED|Week 1||0||
59555043|NCT01431014|75655274|FG001|COMPLETED|Overall Study||25||
59555044|NCT01431014|75655273|FG000|NOT COMPLETED|Overall Study||3||
59555045|NCT01431014|75655274|FG001|NOT COMPLETED|Overall Study||9||
59555046|NCT01431170|75655282|FG000|STARTED|Overall Study||12||
59555047|NCT01431170|75655283|FG001|STARTED|Overall Study||12||
59555048|NCT01431170|75655282|FG000|COMPLETED|Overall Study||9||
59555049|NCT01431170|75655283|FG001|COMPLETED|Overall Study||11||
59555050|NCT01431170|75655282|FG000|NOT COMPLETED|Overall Study||3||
59555051|NCT01431170|75655283|FG001|NOT COMPLETED|Overall Study||1||
59555052|NCT01495286|75655299|FG000|STARTED|Overall Study||30||
59555053|NCT01495286|75655299|FG000|COMPLETED|Overall Study||30||
60083999|NCT00455650|76199928|FG004|NOT COMPLETED|Week 1||0||
60084000|NCT00455650|76199929|FG005|NOT COMPLETED|Week 1||0||
60084001|NCT00455650|76199924|FG000|STARTED|Week 2||10||
59555054|NCT01495286|75655299|FG000|NOT COMPLETED|Overall Study||0||
59555055|NCT02371746|75655310|FG000|STARTED|Overall Study||7||
59555056|NCT02371746|75655311|FG001|STARTED|Overall Study||10||
59555057|NCT02371746|75655312|FG002|STARTED|Overall Study||2||
59555058|NCT02371746|75655313|FG003|STARTED|Overall Study||2||
59555059|NCT02371746|75655314|FG004|STARTED|Overall Study||5||
59555060|NCT02371746|75655315|FG005|STARTED|Overall Study||6||
59555061|NCT02371746|75655316|FG006|STARTED|Overall Study||9||
59555062|NCT02371746|75655310|FG000|COMPLETED|Overall Study||7||
59555063|NCT02371746|75655311|FG001|COMPLETED|Overall Study||10||
59555064|NCT02371746|75655312|FG002|COMPLETED|Overall Study||2||
59555065|NCT02371746|75655313|FG003|COMPLETED|Overall Study||2||
59555066|NCT02371746|75655314|FG004|COMPLETED|Overall Study||5||
59555067|NCT02371746|75655315|FG005|COMPLETED|Overall Study||6||
59555068|NCT02371746|75655316|FG006|COMPLETED|Overall Study||8||
59555069|NCT02371746|75655310|FG000|NOT COMPLETED|Overall Study||0||
59555070|NCT02371746|75655311|FG001|NOT COMPLETED|Overall Study||0||
59555071|NCT02371746|75655312|FG002|NOT COMPLETED|Overall Study||0||
59555072|NCT02371746|75655313|FG003|NOT COMPLETED|Overall Study||0||
59555073|NCT02371746|75655314|FG004|NOT COMPLETED|Overall Study||0||
59555074|NCT02371746|75655315|FG005|NOT COMPLETED|Overall Study||0||
59555075|NCT02371746|75655316|FG006|NOT COMPLETED|Overall Study||1||
59555076|NCT01431794|75655337|FG000|STARTED|Overall Study||13||
59555077|NCT01431794|75655338|FG001|STARTED|Overall Study|not started due to early study's termination|0||
59555078|NCT01431794|75655339|FG002|STARTED|Overall Study|not started due to early study's termination|0||
59555079|NCT01431794|75655340|FG003|STARTED|Overall Study|not started due to early study's termination|0||
59555080|NCT01431794|75655341|FG004|STARTED|Overall Study|not started due to early study's termination|0||
59555081|NCT01431794|75655337|FG000|COMPLETED|Overall Study||13||
59555082|NCT01431794|75655338|FG001|COMPLETED|Overall Study|not started due to early study's termination|0||
59555083|NCT01431794|75655339|FG002|COMPLETED|Overall Study|not started due to early study's termination|0||
59555084|NCT01431794|75655340|FG003|COMPLETED|Overall Study|not started due to early study's termination|0||
59555085|NCT01431794|75655341|FG004|COMPLETED|Overall Study|not started due to early study's termination|0||
59555086|NCT01431794|75655337|FG000|NOT COMPLETED|Overall Study||0||
59555087|NCT01431794|75655338|FG001|NOT COMPLETED|Overall Study||0||
59555088|NCT01431794|75655339|FG002|NOT COMPLETED|Overall Study||0||
59555089|NCT01431794|75655340|FG003|NOT COMPLETED|Overall Study||0||
59555090|NCT01431794|75655341|FG004|NOT COMPLETED|Overall Study||0||
59555091|NCT01549340|75655353|FG000|STARTED|Overall Study|Advised to receive AIT|8790||
59555092|NCT01549340|75655353|FG000|Started AIT|Overall Study||3182||
60084002|NCT00455650|76199925|FG001|STARTED|Week 2||10||
60084003|NCT00455650|76199926|FG002|STARTED|Week 2||10||
60084004|NCT00455650|76199927|FG003|STARTED|Week 2||14||
60084005|NCT00455650|76199928|FG004|STARTED|Week 2||14||
60084006|NCT00455650|76199929|FG005|STARTED|Week 2||13||
60084007|NCT00455650|76199924|FG000|COMPLETED|Week 2||10||
60084008|NCT00455650|76199925|FG001|COMPLETED|Week 2||10||
60084009|NCT00455650|76199926|FG002|COMPLETED|Week 2||10||
60084010|NCT00455650|76199927|FG003|COMPLETED|Week 2||14||
60084011|NCT00455650|76199928|FG004|COMPLETED|Week 2||14||
59555093|NCT01549340|75655353|FG000|COMPLETED|Overall Study|Completed 5 years of AIT|385||
59555094|NCT01549340|75655353|FG000|NOT COMPLETED|Overall Study||8405||
59555095|NCT02421666|75655364|FG000|STARTED|Overall Study Baseline||272||
59555096|NCT02421666|75655365|FG001|STARTED|Overall Study Baseline||260||
59555097|NCT02421666|75655364|FG000|COMPLETED|Overall Study Baseline||272||
60084012|NCT00455650|76199929|FG005|COMPLETED|Week 2||13||
59555098|NCT02421666|75655365|FG001|COMPLETED|Overall Study Baseline||260||
60084013|NCT00455650|76199924|FG000|NOT COMPLETED|Week 2||0||
60084014|NCT00455650|76199925|FG001|NOT COMPLETED|Week 2||0||
60084015|NCT00455650|76199926|FG002|NOT COMPLETED|Week 2||0||
60084016|NCT00455650|76199927|FG003|NOT COMPLETED|Week 2||0||
59555099|NCT02421666|75655364|FG000|NOT COMPLETED|Overall Study Baseline||0||
59555100|NCT02421666|75655365|FG001|NOT COMPLETED|Overall Study Baseline||0||
59555101|NCT02421666|75655364|FG000|STARTED|6-month Follow-up||272||
59555102|NCT02421666|75655365|FG001|STARTED|6-month Follow-up||260||
59555103|NCT02421666|75655364|FG000|COMPLETED|6-month Follow-up||259||
59555104|NCT02421666|75655365|FG001|COMPLETED|6-month Follow-up||247||
59555105|NCT02421666|75655364|FG000|NOT COMPLETED|6-month Follow-up||13||
60084017|NCT00455650|76199928|FG004|NOT COMPLETED|Week 2||0||
59555106|NCT02421666|75655365|FG001|NOT COMPLETED|6-month Follow-up||13||
59555107|NCT02421666|75655364|FG000|STARTED|12-month Follow-up||259||
59555108|NCT02421666|75655365|FG001|STARTED|12-month Follow-up||247||
59555109|NCT02421666|75655364|FG000|COMPLETED|12-month Follow-up||248||
59555110|NCT02421666|75655365|FG001|COMPLETED|12-month Follow-up||231||
59555111|NCT02421666|75655364|FG000|NOT COMPLETED|12-month Follow-up||11||
59555112|NCT02421666|75655365|FG001|NOT COMPLETED|12-month Follow-up||16||
59555113|NCT01497860|75655371|FG000|STARTED|Overall Study||12||
59555114|NCT01497860|75655371|FG000|COMPLETED|Overall Study||12||
59555115|NCT01497860|75655371|FG000|NOT COMPLETED|Overall Study||0||
59555116|NCT02394756|75655375|FG000|STARTED|Period 1||7||
59555117|NCT02394756|75655376|FG001|STARTED|Period 1||7||
59555118|NCT02394756|75655377|FG002|STARTED|Period 1||7||
59555119|NCT02394756|75655378|FG003|STARTED|Period 1||7||
59555120|NCT02394756|75655379|FG004|STARTED|Period 1||7||
59555121|NCT02394756|75655380|FG005|STARTED|Period 1||7||
59555122|NCT02394756|75655375|FG000|COMPLETED|Period 1||7||
59555123|NCT02394756|75655376|FG001|COMPLETED|Period 1||6||
59555124|NCT02394756|75655377|FG002|COMPLETED|Period 1||6||
59555125|NCT02394756|75655378|FG003|COMPLETED|Period 1||6||
59555126|NCT02394756|75655379|FG004|COMPLETED|Period 1||7||
59555127|NCT02394756|75655380|FG005|COMPLETED|Period 1||6||
59555128|NCT02394756|75655375|FG000|NOT COMPLETED|Period 1||0||
59555129|NCT02394756|75655376|FG001|NOT COMPLETED|Period 1||1||
59555130|NCT02394756|75655377|FG002|NOT COMPLETED|Period 1||1||
59555131|NCT02394756|75655378|FG003|NOT COMPLETED|Period 1||1||
59555132|NCT02394756|75655379|FG004|NOT COMPLETED|Period 1||0||
59555133|NCT02394756|75655380|FG005|NOT COMPLETED|Period 1||1||
59555134|NCT02394756|75655375|FG000|STARTED|Period 2||7||
59555135|NCT02394756|75655376|FG001|STARTED|Period 2||6||
59555136|NCT02394756|75655377|FG002|STARTED|Period 2||6||
59555137|NCT02394756|75655378|FG003|STARTED|Period 2||6||
59555138|NCT02394756|75655379|FG004|STARTED|Period 2||7||
59816593|NCT04915950|75939026|FG005|COMPLETED|Stage A: Treatment Period 1 (1 Day)||2||
59816594|NCT04915950|75939021|FG000|NOT COMPLETED|Stage A: Treatment Period 1 (1 Day)||0||
59816595|NCT04915950|75939022|FG001|NOT COMPLETED|Stage A: Treatment Period 1 (1 Day)||0||
59816596|NCT04915950|75939023|FG002|NOT COMPLETED|Stage A: Treatment Period 1 (1 Day)||0||
60084018|NCT00455650|76199929|FG005|NOT COMPLETED|Week 2||0||
60084019|NCT00455650|76199924|FG000|STARTED|Week 3||10||
60084020|NCT00455650|76199925|FG001|STARTED|Week 3||10||
60084021|NCT00455650|76199926|FG002|STARTED|Week 3||10||
60084022|NCT00455650|76199927|FG003|STARTED|Week 3||14||
60084023|NCT00455650|76199928|FG004|STARTED|Week 3||14||
60084024|NCT00455650|76199929|FG005|STARTED|Week 3||13||
60084025|NCT00455650|76199924|FG000|COMPLETED|Week 3||10||
60084026|NCT00455650|76199925|FG001|COMPLETED|Week 3||10||
60084027|NCT00455650|76199926|FG002|COMPLETED|Week 3||10||
60084028|NCT00455650|76199927|FG003|COMPLETED|Week 3||14||
59555139|NCT02394756|75655380|FG005|STARTED|Period 2||6||
59555140|NCT02394756|75655375|FG000|COMPLETED|Period 2||7||
59555141|NCT02394756|75655376|FG001|COMPLETED|Period 2||6||
59555142|NCT02394756|75655377|FG002|COMPLETED|Period 2||6||
59555143|NCT02394756|75655378|FG003|COMPLETED|Period 2||6||
59555144|NCT02394756|75655379|FG004|COMPLETED|Period 2||6||
59555145|NCT02394756|75655380|FG005|COMPLETED|Period 2||6||
59555146|NCT02394756|75655375|FG000|NOT COMPLETED|Period 2||0||
59555147|NCT02394756|75655376|FG001|NOT COMPLETED|Period 2||0||
59555148|NCT02394756|75655377|FG002|NOT COMPLETED|Period 2||0||
59555149|NCT02394756|75655378|FG003|NOT COMPLETED|Period 2||0||
59555150|NCT02394756|75655379|FG004|NOT COMPLETED|Period 2||1||
59555151|NCT02394756|75655380|FG005|NOT COMPLETED|Period 2||0||
59555152|NCT02394756|75655375|FG000|STARTED|Period 3||7||
59555153|NCT02394756|75655376|FG001|STARTED|Period 3||6||
59555154|NCT02394756|75655377|FG002|STARTED|Period 3||6||
59555155|NCT02394756|75655378|FG003|STARTED|Period 3||6||
59707067|NCT01125189|75825993|FG000|NOT COMPLETED|Treatment Period||31||
59707068|NCT01125189|75825994|FG001|NOT COMPLETED|Treatment Period||35||
59707069|NCT01125189|75825995|FG002|NOT COMPLETED|Treatment Period||41||
59707070|NCT01125189|75825993|FG000|STARTED|Follow up Period|All participants who received treatment continued in the follow-up phase.|152||
59707071|NCT01125189|75825994|FG001|STARTED|Follow up Period|All participants who received treatment continued in the follow-up phase.|153||
59707072|NCT01125189|75825995|FG002|STARTED|Follow up Period|All participants who received treatment continued in the follow-up phase.|74||
59707073|NCT01125189|75825993|FG000|COMPLETED|Follow up Period||132||
60084029|NCT00455650|76199928|FG004|COMPLETED|Week 3||14||
60084030|NCT00455650|76199929|FG005|COMPLETED|Week 3||13||
60084031|NCT00455650|76199924|FG000|NOT COMPLETED|Week 3||0||
60084032|NCT00455650|76199925|FG001|NOT COMPLETED|Week 3||0||
60084033|NCT00455650|76199926|FG002|NOT COMPLETED|Week 3||0||
60084034|NCT00455650|76199927|FG003|NOT COMPLETED|Week 3||0||
60084035|NCT00455650|76199928|FG004|NOT COMPLETED|Week 3||0||
60084036|NCT00455650|76199929|FG005|NOT COMPLETED|Week 3||0||
60084037|NCT02114164|76199941|FG000|STARTED|Overall Study||50||
60084038|NCT02114164|76199942|FG001|STARTED|Overall Study||50||
60084039|NCT02114164|76199941|FG000|COMPLETED|Overall Study||50||
59555156|NCT02394756|75655379|FG004|STARTED|Period 3||6||
59555157|NCT02394756|75655380|FG005|STARTED|Period 3||6||
59555158|NCT02394756|75655375|FG000|COMPLETED|Period 3||7||
60084040|NCT02114164|76199942|FG001|COMPLETED|Overall Study||50||
60084041|NCT02114164|76199941|FG000|NOT COMPLETED|Overall Study||0||
60084042|NCT02114164|76199942|FG001|NOT COMPLETED|Overall Study||0||
60084043|NCT00374842|76199951|FG000|STARTED|Overall Study||100||
60084044|NCT00374842|76199952|FG001|STARTED|Overall Study||100||
60084045|NCT00374842|76199953|FG002|STARTED|Overall Study||100||
60084046|NCT00374842|76199951|FG000|COMPLETED|Overall Study||100||
60084047|NCT00374842|76199952|FG001|COMPLETED|Overall Study||100||
60084048|NCT00374842|76199953|FG002|COMPLETED|Overall Study||100||
60084049|NCT00374842|76199951|FG000|NOT COMPLETED|Overall Study||0||
60084050|NCT00374842|76199952|FG001|NOT COMPLETED|Overall Study||0||
60084051|NCT00374842|76199953|FG002|NOT COMPLETED|Overall Study||0||
60084052|NCT00431626|76199965|FG000|STARTED|Overall Study||4||
60084053|NCT00431626|76199966|FG001|STARTED|Overall Study||0||
60084054|NCT00431626|76199965|FG000|COMPLETED|Overall Study||4||
60084055|NCT00431626|76199966|FG001|COMPLETED|Overall Study||0||
60084056|NCT00431626|76199965|FG000|NOT COMPLETED|Overall Study||0||
60084057|NCT00431626|76199966|FG001|NOT COMPLETED|Overall Study||0||
60084058|NCT00376558|76199974|FG000|STARTED|Overall Study||25||
60084059|NCT00376558|76199975|FG001|STARTED|Overall Study||25||
60084060|NCT00376558|76199974|FG000|COMPLETED|Overall Study||25||
60084061|NCT00376558|76199975|FG001|COMPLETED|Overall Study||25||
60084062|NCT00376558|76199974|FG000|NOT COMPLETED|Overall Study||0||
60084063|NCT00376558|76199975|FG001|NOT COMPLETED|Overall Study||0||
60084064|NCT00455962|76199984|FG000|STARTED|Overall Study||10||
60084065|NCT00455962|76199985|FG001|STARTED|Overall Study||13||
60084066|NCT00455962|76199984|FG000|COMPLETED|Overall Study||10||
60084067|NCT00455962|76199985|FG001|COMPLETED|Overall Study||13||
60084068|NCT00455962|76199984|FG000|NOT COMPLETED|Overall Study||0||
60084069|NCT00455962|76199985|FG001|NOT COMPLETED|Overall Study||0||
60084070|NCT00434278|76199993|FG000|STARTED|Overall Study||14||
60084071|NCT00434278|76199994|FG001|STARTED|Overall Study||13||
60084072|NCT00434278|76199993|FG000|COMPLETED|Overall Study||12||
60084073|NCT00434278|76199994|FG001|COMPLETED|Overall Study||13||
60084074|NCT00434278|76199993|FG000|NOT COMPLETED|Overall Study||2||
60084075|NCT00434278|76199994|FG001|NOT COMPLETED|Overall Study||0||
60084076|NCT00434356|76200002|FG000|STARTED|Overall Study||23||
59707074|NCT01125189|75825994|FG001|COMPLETED|Follow up Period||138||
59707075|NCT01125189|75825995|FG002|COMPLETED|Follow up Period||58||
60084077|NCT00434356|76200003|FG001|STARTED|Overall Study||23||
60084078|NCT00434356|76200002|FG000|COMPLETED|Overall Study||0||
60084079|NCT00434356|76200003|FG001|COMPLETED|Overall Study||0||
60084080|NCT00434356|76200002|FG000|NOT COMPLETED|Overall Study||23||
60084081|NCT00434356|76200003|FG001|NOT COMPLETED|Overall Study||23||
60084082|NCT00376948|76200009|FG000|STARTED|Overall Study||20||
60084083|NCT00376948|76200009|FG000|COMPLETED|Overall Study||20||
60084084|NCT00376948|76200009|FG000|NOT COMPLETED|Overall Study||0||
60084085|NCT00438100|76200015|FG000|STARTED|Overall Study||73||
60084086|NCT00438100|76200016|FG001|STARTED|Overall Study||69||
60084087|NCT00438100|76200015|FG000|COMPLETED|Overall Study||71||
60084088|NCT00438100|76200016|FG001|COMPLETED|Overall Study||65||
60084089|NCT00438100|76200015|FG000|NOT COMPLETED|Overall Study||2||
60084090|NCT00438100|76200016|FG001|NOT COMPLETED|Overall Study||4||
60084091|NCT00438490|76200024|FG000|STARTED|Overall Study||12||
60084092|NCT00438490|76200025|FG001|STARTED|Overall Study||9||
60084093|NCT00438490|76200024|FG000|COMPLETED|Overall Study||12||
60084094|NCT00438490|76200025|FG001|COMPLETED|Overall Study||9||
60084095|NCT00438490|76200024|FG000|NOT COMPLETED|Overall Study||0||
60084096|NCT00438490|76200025|FG001|NOT COMPLETED|Overall Study||0||
60084097|NCT00456508|76200035|FG000|STARTED|Overall Study||147||
60084098|NCT00456508|76200035|FG000|COMPLETED|Overall Study||147||
60084099|NCT00456508|76200035|FG000|NOT COMPLETED|Overall Study||0||
60084100|NCT02115646|76200039|FG000|STARTED|Overall Study||29||
60084101|NCT02115646|76200039|FG000|COMPLETED|Overall Study||22||
60084102|NCT02115646|76200039|FG000|NOT COMPLETED|Overall Study||7||
60084103|NCT00457366|76200050|FG000|STARTED|Overall Study||40||
60084104|NCT00457366|76200051|FG001|STARTED|Overall Study||32||
60084105|NCT00457366|76200050|FG000|COMPLETED|Overall Study||40||
60084106|NCT00457366|76200051|FG001|COMPLETED|Overall Study||32||
60084107|NCT00457366|76200050|FG000|NOT COMPLETED|Overall Study||0||
60084108|NCT00457366|76200051|FG001|NOT COMPLETED|Overall Study||0||
60084109|NCT00458848|76200057|FG000|STARTED|Overall Study||51||
60084110|NCT00458848|76200057|FG000|COMPLETED|Overall Study||51||
60084111|NCT00458848|76200057|FG000|NOT COMPLETED|Overall Study||0||
60084112|NCT00459862|76200061|FG000|STARTED|Overall Study||34||
60084113|NCT00459862|76200061|FG000|COMPLETED|Overall Study||34||
60084114|NCT00459862|76200061|FG000|NOT COMPLETED|Overall Study||0||
60084115|NCT00461734|76200067|FG000|STARTED|Overall Study||120||
60084116|NCT00461734|76200068|FG001|STARTED|Overall Study||120||
60084117|NCT00461734|76200067|FG000|COMPLETED|Overall Study||62||
60084118|NCT00461734|76200068|FG001|COMPLETED|Overall Study||60||
60084119|NCT00461734|76200067|FG000|NOT COMPLETED|Overall Study||58||
60084120|NCT00461734|76200068|FG001|NOT COMPLETED|Overall Study||60||
60084121|NCT00438802|76200082|FG000|STARTED|Overall Study||6||
60084122|NCT00438802|76200083|FG001|STARTED|Overall Study||8||
60084123|NCT00438802|76200084|FG002|STARTED|Overall Study||9||
60084124|NCT00438802|76200082|FG000|COMPLETED|Overall Study||6||
60084125|NCT00438802|76200083|FG001|COMPLETED|Overall Study||8||
60084126|NCT00438802|76200084|FG002|COMPLETED|Overall Study||9||
60084127|NCT00438802|76200082|FG000|NOT COMPLETED|Overall Study||0||
60084128|NCT00438802|76200083|FG001|NOT COMPLETED|Overall Study||0||
60084129|NCT00438802|76200084|FG002|NOT COMPLETED|Overall Study||0||
60084130|NCT00377572|76200096|FG000|STARTED|Overall Study||208||
60084131|NCT00377572|76200097|FG001|STARTED|Overall Study||211||
60084132|NCT00377572|76200096|FG000|COMPLETED|Overall Study||155||
60084133|NCT00377572|76200097|FG001|COMPLETED|Overall Study||157||
60084134|NCT00377572|76200096|FG000|NOT COMPLETED|Overall Study||53||
60084135|NCT00377572|76200097|FG001|NOT COMPLETED|Overall Study||54||
60084136|NCT00438880|76200105|FG000|STARTED|Overall Study||30||
60084137|NCT00438880|76200106|FG001|STARTED|Overall Study||8||
60084138|NCT00438880|76200105|FG000|COMPLETED|Overall Study||30||
60084139|NCT00438880|76200106|FG001|COMPLETED|Overall Study||8||
60084140|NCT00438880|76200105|FG000|NOT COMPLETED|Overall Study||0||
60084141|NCT00438880|76200106|FG001|NOT COMPLETED|Overall Study||0||
60084142|NCT00462124|76200112|FG000|STARTED|Overall Study||7||
60084143|NCT00462124|76200112|FG000|COMPLETED|Overall Study|One implant was misplaced and was disacitivated by puncture.|6||
60084144|NCT00462124|76200112|FG000|NOT COMPLETED|Overall Study||1||
60084145|NCT00378352|76200119|FG000|STARTED|Dose Escalation 15,000 Units||20||
60084146|NCT00378352|76200120|FG001|STARTED|Dose Escalation 15,000 Units||0||
60084147|NCT00378352|76200121|FG002|STARTED|Dose Escalation 15,000 Units||0||
60084148|NCT00378352|76200122|FG003|STARTED|Dose Escalation 15,000 Units||11||
60084149|NCT00378352|76200123|FG004|STARTED|Dose Escalation 15,000 Units||0||
60084150|NCT00378352|76200124|FG005|STARTED|Dose Escalation 15,000 Units||0||
60084151|NCT00378352|76200119|FG000|Safety Analysis|Dose Escalation 15,000 Units||19||
60084152|NCT00378352|76200120|FG001|Safety Analysis|Dose Escalation 15,000 Units||0||
60084153|NCT00378352|76200121|FG002|Safety Analysis|Dose Escalation 15,000 Units||0||
60084154|NCT00378352|76200122|FG003|Safety Analysis|Dose Escalation 15,000 Units||11||
60084155|NCT00378352|76200123|FG004|Safety Analysis|Dose Escalation 15,000 Units||0||
60084156|NCT00378352|76200124|FG005|Safety Analysis|Dose Escalation 15,000 Units||0||
60084157|NCT00378352|76200119|FG000|COMPLETED|Dose Escalation 15,000 Units||15||
60084158|NCT00378352|76200120|FG001|COMPLETED|Dose Escalation 15,000 Units||0||
60084159|NCT00378352|76200121|FG002|COMPLETED|Dose Escalation 15,000 Units||0||
60084160|NCT00378352|76200122|FG003|COMPLETED|Dose Escalation 15,000 Units||10||
60084161|NCT00378352|76200123|FG004|COMPLETED|Dose Escalation 15,000 Units||0||
60084162|NCT00378352|76200124|FG005|COMPLETED|Dose Escalation 15,000 Units||0||
60084163|NCT00378352|76200119|FG000|NOT COMPLETED|Dose Escalation 15,000 Units||5||
60084164|NCT00378352|76200120|FG001|NOT COMPLETED|Dose Escalation 15,000 Units||0||
60084165|NCT00378352|76200121|FG002|NOT COMPLETED|Dose Escalation 15,000 Units||0||
60084166|NCT00378352|76200122|FG003|NOT COMPLETED|Dose Escalation 15,000 Units||1||
60084167|NCT00378352|76200123|FG004|NOT COMPLETED|Dose Escalation 15,000 Units||0||
60084168|NCT00378352|76200124|FG005|NOT COMPLETED|Dose Escalation 15,000 Units||0||
60084169|NCT00378352|76200119|FG000|STARTED|Dose Escalation 30,000 Units||0||
60084170|NCT00378352|76200120|FG001|STARTED|Dose Escalation 30,000 Units||19||
60084171|NCT00378352|76200121|FG002|STARTED|Dose Escalation 30,000 Units||0||
60084172|NCT00378352|76200122|FG003|STARTED|Dose Escalation 30,000 Units||11||
60084173|NCT00378352|76200123|FG004|STARTED|Dose Escalation 30,000 Units||0||
60084174|NCT00378352|76200124|FG005|STARTED|Dose Escalation 30,000 Units||0||
60084175|NCT00378352|76200119|FG000|Safety Analysis|Dose Escalation 30,000 Units||0||
60084176|NCT00378352|76200120|FG001|Safety Analysis|Dose Escalation 30,000 Units|One participant randomized to 60,000 units received 30,000 units|20||
60084177|NCT00378352|76200121|FG002|Safety Analysis|Dose Escalation 30,000 Units||0||
60084178|NCT00378352|76200122|FG003|Safety Analysis|Dose Escalation 30,000 Units||11||
60084179|NCT00378352|76200123|FG004|Safety Analysis|Dose Escalation 30,000 Units||0||
60084180|NCT00378352|76200124|FG005|Safety Analysis|Dose Escalation 30,000 Units||0||
60084181|NCT00378352|76200119|FG000|COMPLETED|Dose Escalation 30,000 Units||0||
60084182|NCT00378352|76200120|FG001|COMPLETED|Dose Escalation 30,000 Units||16||
60084183|NCT00378352|76200121|FG002|COMPLETED|Dose Escalation 30,000 Units||0||
60084184|NCT00378352|76200122|FG003|COMPLETED|Dose Escalation 30,000 Units||9||
60084185|NCT00378352|76200123|FG004|COMPLETED|Dose Escalation 30,000 Units||0||
60084186|NCT00378352|76200124|FG005|COMPLETED|Dose Escalation 30,000 Units||0||
60084187|NCT00378352|76200119|FG000|NOT COMPLETED|Dose Escalation 30,000 Units||0||
60084188|NCT00378352|76200120|FG001|NOT COMPLETED|Dose Escalation 30,000 Units||3||
60084189|NCT00378352|76200121|FG002|NOT COMPLETED|Dose Escalation 30,000 Units||0||
60084190|NCT00378352|76200122|FG003|NOT COMPLETED|Dose Escalation 30,000 Units||2||
60084191|NCT00378352|76200123|FG004|NOT COMPLETED|Dose Escalation 30,000 Units||0||
60084192|NCT00378352|76200124|FG005|NOT COMPLETED|Dose Escalation 30,000 Units||0||
60084193|NCT00378352|76200119|FG000|STARTED|Dose Escalation 60,000 Units||0||
60084194|NCT00378352|76200120|FG001|STARTED|Dose Escalation 60,000 Units||0||
60084195|NCT00378352|76200121|FG002|STARTED|Dose Escalation 60,000 Units||20||
60084196|NCT00378352|76200122|FG003|STARTED|Dose Escalation 60,000 Units||11||
60084197|NCT00378352|76200123|FG004|STARTED|Dose Escalation 60,000 Units||0||
60084198|NCT00378352|76200124|FG005|STARTED|Dose Escalation 60,000 Units||0||
60084199|NCT00378352|76200119|FG000|Safety Analysis|Dose Escalation 60,000 Units||0||
60084200|NCT00378352|76200120|FG001|Safety Analysis|Dose Escalation 60,000 Units||0||
60084201|NCT00378352|76200121|FG002|Safety Analysis|Dose Escalation 60,000 Units||19||
60084202|NCT00378352|76200122|FG003|Safety Analysis|Dose Escalation 60,000 Units||11||
60084203|NCT00378352|76200123|FG004|Safety Analysis|Dose Escalation 60,000 Units||0||
60084204|NCT00378352|76200124|FG005|Safety Analysis|Dose Escalation 60,000 Units||0||
60084205|NCT00378352|76200119|FG000|COMPLETED|Dose Escalation 60,000 Units||0||
60084206|NCT00378352|76200120|FG001|COMPLETED|Dose Escalation 60,000 Units||0||
60084207|NCT00378352|76200121|FG002|COMPLETED|Dose Escalation 60,000 Units||17||
60084208|NCT00378352|76200122|FG003|COMPLETED|Dose Escalation 60,000 Units||10||
60084209|NCT00378352|76200123|FG004|COMPLETED|Dose Escalation 60,000 Units||0||
60084210|NCT00378352|76200124|FG005|COMPLETED|Dose Escalation 60,000 Units||0||
60084211|NCT00378352|76200119|FG000|NOT COMPLETED|Dose Escalation 60,000 Units||0||
60084212|NCT00378352|76200120|FG001|NOT COMPLETED|Dose Escalation 60,000 Units||0||
60084213|NCT00378352|76200121|FG002|NOT COMPLETED|Dose Escalation 60,000 Units||3||
60084214|NCT00378352|76200122|FG003|NOT COMPLETED|Dose Escalation 60,000 Units||1||
60084215|NCT00378352|76200123|FG004|NOT COMPLETED|Dose Escalation 60,000 Units||0||
60084216|NCT00378352|76200124|FG005|NOT COMPLETED|Dose Escalation 60,000 Units||0||
60084217|NCT00378352|76200119|FG000|STARTED|Efficacy Phase||0||
60084218|NCT00378352|76200120|FG001|STARTED|Efficacy Phase||0||
60084219|NCT00378352|76200121|FG002|STARTED|Efficacy Phase||0||
60084220|NCT00378352|76200122|FG003|STARTED|Efficacy Phase||0||
60084221|NCT00378352|76200123|FG004|STARTED|Efficacy Phase||65||
60084222|NCT00378352|76200124|FG005|STARTED|Efficacy Phase||66||
60084223|NCT00378352|76200119|FG000|Safety Analysis|Efficacy Phase||0||
60084224|NCT00378352|76200120|FG001|Safety Analysis|Efficacy Phase||0||
60084225|NCT00378352|76200121|FG002|Safety Analysis|Efficacy Phase||0||
60084226|NCT00378352|76200122|FG003|Safety Analysis|Efficacy Phase||0||
60084227|NCT00378352|76200123|FG004|Safety Analysis|Efficacy Phase|Two participants randomized to placebo received 60,000 units Epoetin alfa|67||
60084228|NCT00378352|76200124|FG005|Safety Analysis|Efficacy Phase||64||
60084229|NCT00378352|76200119|FG000|COMPLETED|Efficacy Phase||0||
60084230|NCT00378352|76200120|FG001|COMPLETED|Efficacy Phase||0||
60084231|NCT00378352|76200121|FG002|COMPLETED|Efficacy Phase||0||
60084232|NCT00378352|76200122|FG003|COMPLETED|Efficacy Phase||0||
60084233|NCT00378352|76200123|FG004|COMPLETED|Efficacy Phase||54||
60084234|NCT00378352|76200124|FG005|COMPLETED|Efficacy Phase||59||
59555159|NCT02394756|75655376|FG001|COMPLETED|Period 3||6||
59555160|NCT02394756|75655377|FG002|COMPLETED|Period 3||6||
59555161|NCT02394756|75655378|FG003|COMPLETED|Period 3||6||
59555162|NCT02394756|75655379|FG004|COMPLETED|Period 3||6||
59555163|NCT02394756|75655380|FG005|COMPLETED|Period 3||6||
59555164|NCT02394756|75655375|FG000|NOT COMPLETED|Period 3||0||
60084235|NCT00378352|76200119|FG000|NOT COMPLETED|Efficacy Phase||0||
60084236|NCT00378352|76200120|FG001|NOT COMPLETED|Efficacy Phase||0||
60084237|NCT00378352|76200121|FG002|NOT COMPLETED|Efficacy Phase||0||
60084238|NCT00378352|76200122|FG003|NOT COMPLETED|Efficacy Phase||0||
60084239|NCT00378352|76200123|FG004|NOT COMPLETED|Efficacy Phase||11||
60084240|NCT00378352|76200124|FG005|NOT COMPLETED|Efficacy Phase||7||
60084241|NCT00462280|76200136|FG000|STARTED|Overall Study||34||
60084242|NCT00462280|76200137|FG001|STARTED|Overall Study||32||
60084243|NCT00462280|76200138|FG002|STARTED|Overall Study||7||
60084244|NCT00462280|76200139|FG003|STARTED|Overall Study||7||
60084245|NCT00462280|76200136|FG000|COMPLETED|Overall Study||24||
60084246|NCT00462280|76200137|FG001|COMPLETED|Overall Study||25||
60084247|NCT00462280|76200138|FG002|COMPLETED|Overall Study||7||
60084248|NCT00462280|76200139|FG003|COMPLETED|Overall Study||4||
60084249|NCT00462280|76200136|FG000|NOT COMPLETED|Overall Study||10||
60084250|NCT00462280|76200137|FG001|NOT COMPLETED|Overall Study||7||
60084251|NCT00462280|76200138|FG002|NOT COMPLETED|Overall Study||0||
60084252|NCT00462280|76200139|FG003|NOT COMPLETED|Overall Study||3||
60084253|NCT00381004|76200151|FG000|STARTED|Overall Study||60||
60084254|NCT00381004|76200151|FG000|COMPLETED|Overall Study||60||
60084255|NCT00381004|76200151|FG000|NOT COMPLETED|Overall Study||0||
60084256|NCT00440050|76200157|FG000|STARTED|Overall Study||164||
60084257|NCT00440050|76200158|FG001|STARTED|Overall Study||238||
60084258|NCT00440050|76200157|FG000|COMPLETED|Overall Study||124||
59555165|NCT02394756|75655376|FG001|NOT COMPLETED|Period 3||0||
59555166|NCT02394756|75655377|FG002|NOT COMPLETED|Period 3||0||
59555167|NCT02394756|75655378|FG003|NOT COMPLETED|Period 3||0||
60084259|NCT00440050|76200158|FG001|COMPLETED|Overall Study||171||
60084260|NCT00440050|76200157|FG000|NOT COMPLETED|Overall Study||40||
60084261|NCT00440050|76200158|FG001|NOT COMPLETED|Overall Study||67||
60084262|NCT00440596|76200166|FG000|STARTED|Overall Study||28||
60084263|NCT00440596|76200167|FG001|STARTED|Overall Study||28||
60084264|NCT00440596|76200166|FG000|COMPLETED|Overall Study||21||
60084265|NCT00440596|76200167|FG001|COMPLETED|Overall Study||17||
60084266|NCT00440596|76200166|FG000|NOT COMPLETED|Overall Study||7||
60084267|NCT00440596|76200167|FG001|NOT COMPLETED|Overall Study||11||
60084268|NCT00381550|76200175|FG000|STARTED|Overall Study||35||
60084269|NCT00381550|76200175|FG000|COMPLETED|Overall Study||35||
60084270|NCT00381550|76200175|FG000|NOT COMPLETED|Overall Study||0||
60084271|NCT00440830|76200183|FG000|STARTED|Overall Study||20||
60084272|NCT00440830|76200184|FG001|STARTED|Overall Study||8||
60084273|NCT00440830|76200185|FG002|STARTED|Overall Study||30||
60084274|NCT00440830|76200186|FG003|STARTED|Overall Study||10||
59555168|NCT02394756|75655379|FG004|NOT COMPLETED|Period 3||0||
59555169|NCT02394756|75655380|FG005|NOT COMPLETED|Period 3||0||
60084275|NCT00440830|76200183|FG000|COMPLETED|Overall Study||20||
60084276|NCT00440830|76200184|FG001|COMPLETED|Overall Study||8||
60084277|NCT00440830|76200185|FG002|COMPLETED|Overall Study||30||
60084278|NCT00440830|76200186|FG003|COMPLETED|Overall Study||10||
60084279|NCT00440830|76200183|FG000|NOT COMPLETED|Overall Study||0||
60084280|NCT00440830|76200184|FG001|NOT COMPLETED|Overall Study||0||
60084281|NCT00440830|76200185|FG002|NOT COMPLETED|Overall Study||0||
60084282|NCT00440830|76200186|FG003|NOT COMPLETED|Overall Study||0||
60084283|NCT00464464|76200202|FG000|STARTED|Overall Study||41||
60084284|NCT00464464|76200203|FG001|STARTED|Overall Study||39||
60084285|NCT00464464|76200202|FG000|COMPLETED|Overall Study||36||
60084286|NCT00464464|76200203|FG001|COMPLETED|Overall Study||36||
60084287|NCT00464464|76200202|FG000|NOT COMPLETED|Overall Study||5||
60084288|NCT00464464|76200203|FG001|NOT COMPLETED|Overall Study||3||
60084289|NCT00381628|76200213|FG000|STARTED|Overall Study||18||
60084290|NCT00381628|76200214|FG001|STARTED|Overall Study||27||
60084291|NCT00381628|76200215|FG002|STARTED|Overall Study||0||
60084292|NCT00381628|76200216|FG003|STARTED|Overall Study||14||
60084293|NCT00381628|76200213|FG000|COMPLETED|Overall Study||18||
60084294|NCT00381628|76200214|FG001|COMPLETED|Overall Study||27||
60084295|NCT00381628|76200215|FG002|COMPLETED|Overall Study||0||
59555170|NCT02213900|75655390|FG000|STARTED|Overall Study||68||
59555171|NCT02213900|75655391|FG001|STARTED|Overall Study||67||
60084296|NCT00381628|76200216|FG003|COMPLETED|Overall Study||14||
60084297|NCT00381628|76200213|FG000|NOT COMPLETED|Overall Study||0||
60084298|NCT00381628|76200214|FG001|NOT COMPLETED|Overall Study||0||
60084299|NCT00381628|76200215|FG002|NOT COMPLETED|Overall Study||0||
60084300|NCT00381628|76200216|FG003|NOT COMPLETED|Overall Study||0||
60084301|NCT00427804|76200228|FG000|STARTED|Overall Study||4||
60084302|NCT00427804|76200229|FG001|STARTED|Overall Study||5||
60084303|NCT00427804|76200228|FG000|COMPLETED|Overall Study||4||
60084304|NCT00427804|76200229|FG001|COMPLETED|Overall Study||5||
59707076|NCT01125189|75825993|FG000|NOT COMPLETED|Follow up Period||20||
59707077|NCT01125189|75825994|FG001|NOT COMPLETED|Follow up Period||15||
59707078|NCT01125189|75825995|FG002|NOT COMPLETED|Follow up Period||16||
59707079|NCT01256567|75826006|FG000|STARTED|Overall Study||7||
59707080|NCT01256567|75826006|FG000|Received at Least 1 Dose of Study Drug|Overall Study||7||
59707081|NCT01256567|75826006|FG000|COMPLETED|Overall Study||6||
59707082|NCT01256567|75826006|FG000|NOT COMPLETED|Overall Study||1||
59707083|NCT00996736|75826013|FG000|STARTED|Overall Study||162||
59707084|NCT00996736|75826014|FG001|STARTED|Overall Study||161||
60084305|NCT00427804|76200228|FG000|NOT COMPLETED|Overall Study||0||
60084306|NCT00427804|76200229|FG001|NOT COMPLETED|Overall Study||0||
60084307|NCT00381862|76200235|FG000|STARTED|Overall Study||54||
60084308|NCT00381862|76200235|FG000|COMPLETED|Overall Study||44||
60084309|NCT00381862|76200235|FG000|NOT COMPLETED|Overall Study||10||
60084310|NCT00464698|76200239|FG000|STARTED|Period 1: 30 mg||20||
60084311|NCT00464698|76200239|FG000|COMPLETED|Period 1: 30 mg||17||
60084312|NCT00464698|76200239|FG000|NOT COMPLETED|Period 1: 30 mg||3||
60084313|NCT00464698|76200239|FG000|STARTED|Period 2: 60 mg||17||
60084314|NCT00464698|76200239|FG000|COMPLETED|Period 2: 60 mg||17||
60084315|NCT00464698|76200239|FG000|NOT COMPLETED|Period 2: 60 mg||0||
60084316|NCT00464698|76200239|FG000|STARTED|Period 3: 120mg||14||
60084317|NCT00464698|76200239|FG000|COMPLETED|Period 3: 120mg||12||
60084318|NCT00464698|76200239|FG000|NOT COMPLETED|Period 3: 120mg||2||
60084319|NCT00383110|76200247|FG000|STARTED|Overall Study||150||
60084320|NCT00383110|76200248|FG001|STARTED|Overall Study||150||
60084321|NCT00383110|76200247|FG000|COMPLETED|Overall Study||150||
60084322|NCT00383110|76200248|FG001|COMPLETED|Overall Study||150||
60084323|NCT00383110|76200247|FG000|NOT COMPLETED|Overall Study||0||
60084324|NCT00383110|76200248|FG001|NOT COMPLETED|Overall Study||0||
60084325|NCT00465088|76200257|FG000|STARTED|Overall Study|For both arms, started means treated.|114||
60084326|NCT00465088|76200258|FG001|STARTED|Overall Study||79||
60084327|NCT00465088|76200257|FG000|COMPLETED|Overall Study||82||
60084328|NCT00465088|76200258|FG001|COMPLETED|Overall Study||70||
60084329|NCT00465088|76200257|FG000|NOT COMPLETED|Overall Study||32||
60084330|NCT00465088|76200258|FG001|NOT COMPLETED|Overall Study||9||
60084331|NCT00441766|76200268|FG000|STARTED|Overall Study||53||
60084332|NCT00441766|76200269|FG001|STARTED|Overall Study||53||
60084333|NCT00441766|76200270|FG002|STARTED|Overall Study||53||
60084334|NCT00441766|76200271|FG003|STARTED|Overall Study||54||
60084335|NCT00441766|76200268|FG000|COMPLETED|Overall Study||39||
60084336|NCT00441766|76200269|FG001|COMPLETED|Overall Study||46||
60084337|NCT00441766|76200270|FG002|COMPLETED|Overall Study||44||
60084338|NCT00441766|76200271|FG003|COMPLETED|Overall Study||48||
60084339|NCT00441766|76200268|FG000|NOT COMPLETED|Overall Study||14||
60084340|NCT00441766|76200269|FG001|NOT COMPLETED|Overall Study||7||
60084341|NCT00441766|76200270|FG002|NOT COMPLETED|Overall Study||9||
60084342|NCT00441766|76200271|FG003|NOT COMPLETED|Overall Study||6||
59555172|NCT02213900|75655390|FG000|COMPLETED|Overall Study||68||
59555173|NCT02213900|75655391|FG001|COMPLETED|Overall Study||67||
59707085|NCT00996736|75826013|FG000|3-week Visit|Overall Study|149 visited within pre-specified 3-week window (2.5-5 weeks); 6 had a second visit not within window|155||
59707086|NCT00996736|75826014|FG001|3-week Visit|Overall Study|144 visited within pre-specified 3-week window (2.5-5 weeks); 7 had a second visit not within window|151||
59707087|NCT00996736|75826013|FG000|3-month Visit|Overall Study||146||
60084343|NCT00466960|76200281|FG000|STARTED|Overall Study||21||
60084344|NCT00466960|76200281|FG000|COMPLETED|Overall Study||21||
60084345|NCT00466960|76200281|FG000|NOT COMPLETED|Overall Study||0||
60084346|NCT00383266|76200285|FG000|STARTED|Overall Study||9||
60084347|NCT00383266|76200285|FG000|COMPLETED|Overall Study||9||
60084348|NCT00383266|76200285|FG000|NOT COMPLETED|Overall Study||0||
60084349|NCT00384670|76200289|FG000|STARTED|Overall Study||7||
60084350|NCT00384670|76200289|FG000|COMPLETED|Overall Study||7||
60084351|NCT00384670|76200289|FG000|NOT COMPLETED|Overall Study||0||
60084352|NCT00467038|76200295|FG000|STARTED|Overall Study||11||
60084353|NCT00467038|76200296|FG001|STARTED|Overall Study||11||
60084354|NCT00467038|76200295|FG000|COMPLETED|Overall Study||11||
60084355|NCT00467038|76200296|FG001|COMPLETED|Overall Study||11||
59555174|NCT02213900|75655390|FG000|NOT COMPLETED|Overall Study||0||
59555175|NCT02213900|75655391|FG001|NOT COMPLETED|Overall Study||0||
59555176|NCT02370888|75655401|FG000|STARTED|Overall Study||9||
59555177|NCT02370888|75655401|FG000|Proceed to Treatment|Overall Study||3||
59555178|NCT02370888|75655401|FG000|COMPLETED|Overall Study||1||
59555179|NCT02370888|75655401|FG000|NOT COMPLETED|Overall Study||8||
59555180|NCT02214212|75655411|FG000|STARTED|Overall Study||66||
59555181|NCT02214212|75655412|FG001|STARTED|Overall Study||65||
59555182|NCT02214212|75655411|FG000|COMPLETED|Overall Study||57||
59555183|NCT02214212|75655412|FG001|COMPLETED|Overall Study||59||
59555184|NCT02214212|75655411|FG000|NOT COMPLETED|Overall Study||9||
59555185|NCT02214212|75655412|FG001|NOT COMPLETED|Overall Study||6||
59555186|NCT02394600|75655425|FG000|STARTED|Overall Study||47||
59555187|NCT02394600|75655426|FG001|STARTED|Overall Study||46||
59555188|NCT02394600|75655425|FG000|COMPLETED|Overall Study||43||
59555189|NCT02394600|75655426|FG001|COMPLETED|Overall Study||44||
59555190|NCT02394600|75655425|FG000|NOT COMPLETED|Overall Study||4||
59555191|NCT02394600|75655426|FG001|NOT COMPLETED|Overall Study||2||
59555192|NCT02214290|75655432|FG000|STARTED|First Intervention (7 Days)||8||
59555193|NCT02214290|75655433|FG001|STARTED|First Intervention (7 Days)||8||
59555194|NCT02214290|75655432|FG000|COMPLETED|First Intervention (7 Days)||8||
59555195|NCT02214290|75655433|FG001|COMPLETED|First Intervention (7 Days)||8||
59555196|NCT02214290|75655432|FG000|NOT COMPLETED|First Intervention (7 Days)||0||
59555197|NCT02214290|75655433|FG001|NOT COMPLETED|First Intervention (7 Days)||0||
59555198|NCT02214290|75655432|FG000|STARTED|Washout (14 Days)||8||
59555199|NCT02214290|75655433|FG001|STARTED|Washout (14 Days)||8||
59555200|NCT02214290|75655432|FG000|COMPLETED|Washout (14 Days)||8||
59555201|NCT02214290|75655433|FG001|COMPLETED|Washout (14 Days)||8||
59555202|NCT02214290|75655432|FG000|NOT COMPLETED|Washout (14 Days)||0||
59555203|NCT02214290|75655433|FG001|NOT COMPLETED|Washout (14 Days)||0||
59555204|NCT02214290|75655432|FG000|STARTED|Second Intervention (7 Days)||8||
59555205|NCT02214290|75655433|FG001|STARTED|Second Intervention (7 Days)||8||
59555206|NCT02214290|75655432|FG000|COMPLETED|Second Intervention (7 Days)||8||
59707088|NCT00996736|75826014|FG001|3-month Visit|Overall Study||146||
59707089|NCT00996736|75826013|FG000|COMPLETED|Overall Study||141||
59707090|NCT00996736|75826014|FG001|COMPLETED|Overall Study||143||
59707091|NCT00996736|75826013|FG000|NOT COMPLETED|Overall Study||21||
59707092|NCT00996736|75826014|FG001|NOT COMPLETED|Overall Study||18||
59707093|NCT00996658|75826022|FG000|STARTED|Overall Study||92||
59555207|NCT02214290|75655433|FG001|COMPLETED|Second Intervention (7 Days)||8||
59555208|NCT02214290|75655432|FG000|NOT COMPLETED|Second Intervention (7 Days)||0||
59555209|NCT02214290|75655433|FG001|NOT COMPLETED|Second Intervention (7 Days)||0||
59555210|NCT04685499|75655442|FG000|STARTED|Overall Study||1||
59555211|NCT04685499|75655442|FG000|COMPLETED|Overall Study||0||
59555212|NCT04685499|75655442|FG000|NOT COMPLETED|Overall Study||1||
59555213|NCT01432886|75655448|FG000|STARTED|Overall Study||6||
60084356|NCT00467038|76200295|FG000|NOT COMPLETED|Overall Study||0||
60084357|NCT00467038|76200296|FG001|NOT COMPLETED|Overall Study||0||
60084358|NCT00467350|76200305|FG000|STARTED|Overall Study||41||
60084359|NCT00467350|76200306|FG001|STARTED|Overall Study||39||
60084360|NCT00467350|76200305|FG000|COMPLETED|Overall Study||40||
60084361|NCT00467350|76200306|FG001|COMPLETED|Overall Study||39||
60084362|NCT00467350|76200305|FG000|NOT COMPLETED|Overall Study||1||
60084363|NCT00467350|76200306|FG001|NOT COMPLETED|Overall Study||0||
60084364|NCT00444028|76200318|FG000|STARTED|Overall Study||14||
60084365|NCT00444028|76200319|FG001|STARTED|Overall Study||7||
60084366|NCT00444028|76200320|FG002|STARTED|Overall Study||8||
60084367|NCT00444028|76200321|FG003|STARTED|Overall Study||6||
60084368|NCT00444028|76200322|FG004|STARTED|Overall Study||7||
60084369|NCT00444028|76200323|FG005|STARTED|Overall Study||8||
59555214|NCT01432886|75655449|FG001|STARTED|Overall Study||6||
59555215|NCT01432886|75655448|FG000|COMPLETED|Overall Study|Discontinuation met per discontinuation criteria|6||
59707094|NCT00996658|75826023|FG001|STARTED|Overall Study||186||
60084370|NCT00444028|76200318|FG000|COMPLETED|Overall Study||14||
59555216|NCT01432886|75655449|FG001|COMPLETED|Overall Study|Discontinuation met per discontinuation criteria|6||
59555217|NCT01432886|75655448|FG000|NOT COMPLETED|Overall Study||0||
60084371|NCT00444028|76200319|FG001|COMPLETED|Overall Study||7||
60084372|NCT00444028|76200320|FG002|COMPLETED|Overall Study||8||
59555218|NCT01432886|75655449|FG001|NOT COMPLETED|Overall Study||0||
59555219|NCT01433042|75655456|FG000|STARTED|Overall Study||225||
59555220|NCT01433042|75655456|FG000|COMPLETED|Overall Study||224||
59555221|NCT01433042|75655456|FG000|NOT COMPLETED|Overall Study||1||
59555222|NCT01551056|75655462|FG000|STARTED|Overall Study||46||
59555223|NCT01551056|75655463|FG001|STARTED|Overall Study||45||
59555224|NCT01551056|75655462|FG000|COMPLETED|Overall Study||44||
59555225|NCT01551056|75655463|FG001|COMPLETED|Overall Study||45||
59555226|NCT01551056|75655462|FG000|NOT COMPLETED|Overall Study||2||
59555227|NCT01551056|75655463|FG001|NOT COMPLETED|Overall Study||0||
59555228|NCT01435304|75655471|FG000|STARTED|Overall Study||50||
59555229|NCT01435304|75655472|FG001|STARTED|Overall Study||50||
59555230|NCT01435304|75655471|FG000|COMPLETED|Overall Study||50||
59555231|NCT01435304|75655472|FG001|COMPLETED|Overall Study||50||
59555232|NCT01435304|75655471|FG000|NOT COMPLETED|Overall Study||0||
59555233|NCT01435304|75655472|FG001|NOT COMPLETED|Overall Study||0||
59555234|NCT01499498|75655478|FG000|STARTED|Overall Study||13||
59555235|NCT01499498|75655478|FG000|COMPLETED|Overall Study||13||
59555236|NCT01499498|75655478|FG000|NOT COMPLETED|Overall Study||0||
59555237|NCT01436006|75655485|FG000|STARTED|Overall Study||6700||
59555238|NCT01436006|75655485|FG000|COMPLETED|Overall Study||6663||
59555239|NCT01436006|75655485|FG000|NOT COMPLETED|Overall Study||37||
59555240|NCT01499654|75655497|FG000|STARTED|Overall Study||64||
59707095|NCT00996658|75826022|FG000|COMPLETED|Overall Study||76||
59707096|NCT00996658|75826023|FG001|COMPLETED|Overall Study||165||
59707097|NCT00996658|75826022|FG000|NOT COMPLETED|Overall Study||16||
59707098|NCT00996658|75826023|FG001|NOT COMPLETED|Overall Study||21||
60084373|NCT00444028|76200321|FG003|COMPLETED|Overall Study||6||
60084374|NCT00444028|76200322|FG004|COMPLETED|Overall Study||7||
60084375|NCT00444028|76200323|FG005|COMPLETED|Overall Study||8||
60084376|NCT00444028|76200318|FG000|NOT COMPLETED|Overall Study||0||
60084377|NCT00444028|76200319|FG001|NOT COMPLETED|Overall Study||0||
60084378|NCT00444028|76200320|FG002|NOT COMPLETED|Overall Study||0||
60084379|NCT00444028|76200321|FG003|NOT COMPLETED|Overall Study||0||
60084380|NCT00444028|76200322|FG004|NOT COMPLETED|Overall Study||0||
60084381|NCT00444028|76200323|FG005|NOT COMPLETED|Overall Study||0||
60084382|NCT00444964|76200336|FG000|STARTED|Overall Study||11||
60084383|NCT00444964|76200336|FG000|COMPLETED|Overall Study||11||
60084384|NCT00444964|76200336|FG000|NOT COMPLETED|Overall Study||0||
60084385|NCT00445588|76200340|FG000|STARTED|Overall Study||56||
60084386|NCT00445588|76200340|FG000|COMPLETED|Overall Study||56||
60084387|NCT00445588|76200340|FG000|NOT COMPLETED|Overall Study||0||
60084388|NCT00445744|76200345|FG000|STARTED|Overall Study||52||
60084389|NCT00445744|76200345|FG000|COMPLETED|Overall Study||51||
60084390|NCT00445744|76200345|FG000|NOT COMPLETED|Overall Study||1||
60084391|NCT00468208|76200349|FG000|STARTED|Overall Study||20||
60084392|NCT00468208|76200349|FG000|COMPLETED|Overall Study|All patients reached common closing or early termination|20||
60084393|NCT00468208|76200349|FG000|NOT COMPLETED|Overall Study||0||
60084394|NCT00384748|76200355|FG000|STARTED|Overall Study||25||
60084395|NCT00384748|76200356|FG001|STARTED|Overall Study||23||
60084396|NCT00384748|76200355|FG000|COMPLETED|Overall Study||25||
59555241|NCT01499654|75655497|FG000|COMPLETED|Overall Study||64||
59707099|NCT01124643|75826029|FG000|STARTED|Overall Study||35||
59707100|NCT01124643|75826029|FG000|COMPLETED|Overall Study||34||
59707101|NCT01124643|75826029|FG000|NOT COMPLETED|Overall Study||1||
60084397|NCT00384748|76200356|FG001|COMPLETED|Overall Study||23||
60084398|NCT00384748|76200355|FG000|NOT COMPLETED|Overall Study||0||
60084399|NCT00384748|76200356|FG001|NOT COMPLETED|Overall Study||0||
60084400|NCT00385138|76200364|FG000|STARTED|Overall Study||2695||
60084401|NCT00385138|76200365|FG001|STARTED|Overall Study||2669||
60084402|NCT00385138|76200364|FG000|Intent-to-treat (ITT)|Overall Study|All patients randomized excluding two (2) who withdrew consent for using study data.|2693||
60084403|NCT00385138|76200365|FG001|Intent-to-treat (ITT)|Overall Study||2669||
59555242|NCT01499654|75655497|FG000|NOT COMPLETED|Overall Study||0||
59555243|NCT01500746|75655509|FG000|STARTED|Overall Study||4||
59555244|NCT01500746|75655510|FG001|STARTED|Overall Study||4||
59555245|NCT01500746|75655509|FG000|COMPLETED|Overall Study||4||
59555246|NCT01500746|75655510|FG001|COMPLETED|Overall Study||4||
59555247|NCT01500746|75655509|FG000|NOT COMPLETED|Overall Study||0||
59555248|NCT01500746|75655510|FG001|NOT COMPLETED|Overall Study||0||
59555249|NCT02421588|75655518|FG000|STARTED|Overall Study||221||
59555250|NCT02421588|75655519|FG001|STARTED|Overall Study||221||
59555251|NCT02421588|75655518|FG000|COMPLETED|Overall Study||0||
59555252|NCT02421588|75655519|FG001|COMPLETED|Overall Study||0||
59555253|NCT02421588|75655518|FG000|NOT COMPLETED|Overall Study||221||
60084404|NCT00385138|76200364|FG000|Modified Intent-to-treat (mITT)|Overall Study|Excludes 37 patients who either did not receive study drug or have PCI.|2656||
60084405|NCT00385138|76200365|FG001|Modified Intent-to-treat (mITT)|Overall Study|Excludes 24 patients who either did not received study drug or have PCI.|2645||
60103661|NCT01347034|76221910|FG001|STARTED|Overall Study||14||
59555254|NCT02421588|75655519|FG001|NOT COMPLETED|Overall Study||221||
59555255|NCT02421510|75655528|FG000|STARTED|Overall Study||258||
59555256|NCT02421510|75655529|FG001|STARTED|Overall Study||261||
59555257|NCT02421510|75655530|FG002|STARTED|Overall Study||263||
59555258|NCT02421510|75655528|FG000|Completed the 24 Week Treatment Period|Overall Study||236||
59555259|NCT02421510|75655529|FG001|Completed the 24 Week Treatment Period|Overall Study||239||
59555260|NCT02421510|75655530|FG002|Completed the 24 Week Treatment Period|Overall Study||240||
59555261|NCT02421510|75655528|FG000|COMPLETED|Overall Study||225|Participants who completed 52 week treatment (24 weeks + 28 extension weeks) period.|
59555262|NCT02421510|75655529|FG001|COMPLETED|Overall Study||226|Participants who completed 52 week treatment (24 weeks + 28 extension weeks) period.|
59555263|NCT02421510|75655530|FG002|COMPLETED|Overall Study||227|Participants who completed 52 week treatment (24 weeks + 28 extension weeks) period.|
59555264|NCT02421510|75655528|FG000|NOT COMPLETED|Overall Study||33||
59555265|NCT02421510|75655529|FG001|NOT COMPLETED|Overall Study||35||
59555266|NCT02421510|75655530|FG002|NOT COMPLETED|Overall Study||36||
59555267|NCT00552617|75655548|FG000|STARTED|Overall Study||10||
59555268|NCT00552617|75655549|FG001|STARTED|Overall Study||10||
59555269|NCT00552617|75655550|FG002|STARTED|Overall Study||10||
59555270|NCT00552617|75655551|FG003|STARTED|Overall Study||10||
59555271|NCT00552617|75655552|FG004|STARTED|Overall Study||10||
59555272|NCT00552617|75655553|FG005|STARTED|Overall Study||10||
59555273|NCT00552617|75655554|FG006|STARTED|Overall Study||10||
59555274|NCT00552617|75655555|FG007|STARTED|Overall Study||10||
59555275|NCT00552617|75655556|FG008|STARTED|Overall Study||10||
59555276|NCT00552617|75655557|FG009|STARTED|Overall Study||10||
59555277|NCT00552617|75655548|FG000|Treated|Overall Study||10||
59555278|NCT00552617|75655549|FG001|Treated|Overall Study||10||
59555279|NCT00552617|75655550|FG002|Treated|Overall Study||9||
59555280|NCT00552617|75655551|FG003|Treated|Overall Study||10||
59555281|NCT00552617|75655552|FG004|Treated|Overall Study||10||
59555282|NCT00552617|75655553|FG005|Treated|Overall Study||10||
59555283|NCT00552617|75655554|FG006|Treated|Overall Study||10||
59555284|NCT00552617|75655555|FG007|Treated|Overall Study||10||
59555285|NCT00552617|75655556|FG008|Treated|Overall Study||10||
59555286|NCT00552617|75655557|FG009|Treated|Overall Study||9||
59555287|NCT00552617|75655548|FG000|COMPLETED|Overall Study||10||
59555288|NCT00552617|75655549|FG001|COMPLETED|Overall Study||10||
59555289|NCT00552617|75655550|FG002|COMPLETED|Overall Study||9||
59555290|NCT00552617|75655551|FG003|COMPLETED|Overall Study||9||
59555291|NCT00552617|75655552|FG004|COMPLETED|Overall Study||10||
59555292|NCT00552617|75655553|FG005|COMPLETED|Overall Study||8||
59555293|NCT00552617|75655554|FG006|COMPLETED|Overall Study||10||
59555294|NCT00552617|75655555|FG007|COMPLETED|Overall Study||10||
59555295|NCT00552617|75655556|FG008|COMPLETED|Overall Study||8||
59555296|NCT00552617|75655557|FG009|COMPLETED|Overall Study||9||
59555297|NCT00552617|75655548|FG000|NOT COMPLETED|Overall Study||0||
59555298|NCT00552617|75655549|FG001|NOT COMPLETED|Overall Study||0||
60084406|NCT00385138|76200364|FG000|Safety Population|Overall Study|Includes all randomized patients who received at least one dose of study drug.|2662||
60084407|NCT00385138|76200365|FG001|Safety Population|Overall Study|Includes all randomized patients who received at least one dose of study drug.|2650||
60084408|NCT00385138|76200364|FG000|COMPLETED|Overall Study|"Completed means patient completed scheduled visits or developed a primary endpoint event."|2665||
60084409|NCT00385138|76200365|FG001|COMPLETED|Overall Study|"Completed means patient completed scheduled visits or developed a primary endpoint event."|2641||
60084410|NCT00385138|76200364|FG000|NOT COMPLETED|Overall Study||30||
60084411|NCT00385138|76200365|FG001|NOT COMPLETED|Overall Study||28||
60084412|NCT00446290|76200371|FG000|STARTED|Overall Study||22||
60084413|NCT00446290|76200371|FG000|COMPLETED|Overall Study||22||
60084414|NCT00446290|76200371|FG000|NOT COMPLETED|Overall Study||0||
60084415|NCT00385216|76200375|FG000|STARTED|First Intervention||11||
60084416|NCT00385216|76200376|FG001|STARTED|First Intervention||9||
60084417|NCT00385216|76200375|FG000|COMPLETED|First Intervention||11||
60084418|NCT00385216|76200376|FG001|COMPLETED|First Intervention||9||
60084419|NCT00385216|76200375|FG000|NOT COMPLETED|First Intervention||0||
60084420|NCT00385216|76200376|FG001|NOT COMPLETED|First Intervention||0||
60084421|NCT00385216|76200375|FG000|STARTED|Second Intervention||11||
60084422|NCT00385216|76200376|FG001|STARTED|Second Intervention||9||
60084423|NCT00385216|76200375|FG000|COMPLETED|Second Intervention||11||
60084424|NCT00385216|76200376|FG001|COMPLETED|Second Intervention||9||
60084425|NCT00385216|76200375|FG000|NOT COMPLETED|Second Intervention||0||
60084426|NCT00385216|76200376|FG001|NOT COMPLETED|Second Intervention||0||
60084427|NCT00385996|76200382|FG000|STARTED|Overall Study||22||
60084428|NCT00385996|76200382|FG000|COMPLETED|Overall Study||22||
60084429|NCT00385996|76200382|FG000|NOT COMPLETED|Overall Study||0||
60084430|NCT00470392|76200389|FG000|STARTED|Overall Study|Number of subjects enrolled, passed screening and assigned to this arm.|7||
60084431|NCT00470392|76200390|FG001|STARTED|Overall Study|Number of subjects enrolled, passed screening and assigned to this arm.|2||
60084432|NCT00470392|76200389|FG000|COMPLETED|Overall Study||7||
60084433|NCT00470392|76200390|FG001|COMPLETED|Overall Study||2||
60084434|NCT00470392|76200389|FG000|NOT COMPLETED|Overall Study||0||
60084435|NCT00470392|76200390|FG001|NOT COMPLETED|Overall Study||0||
60084436|NCT00470548|76200399|FG000|STARTED|Overall Study||3||
60084437|NCT00470548|76200400|FG001|STARTED|Overall Study||3||
60084438|NCT00470548|76200401|FG002|STARTED|Overall Study||6||
60084439|NCT00470548|76200402|FG003|STARTED|Overall Study||37||
60084440|NCT00470548|76200399|FG000|COMPLETED|Overall Study||3||
60084441|NCT00470548|76200400|FG001|COMPLETED|Overall Study||3||
60084442|NCT00470548|76200401|FG002|COMPLETED|Overall Study||6||
60084443|NCT00470548|76200402|FG003|COMPLETED|Overall Study||37||
60084444|NCT00470548|76200399|FG000|NOT COMPLETED|Overall Study||0||
60084445|NCT00470548|76200400|FG001|NOT COMPLETED|Overall Study||0||
60084446|NCT00470548|76200401|FG002|NOT COMPLETED|Overall Study||0||
60084447|NCT00470548|76200402|FG003|NOT COMPLETED|Overall Study||0||
60084448|NCT00472576|76200414|FG000|STARTED|First Intervention||2||
60084449|NCT00472576|76200415|FG001|STARTED|First Intervention||3||
59555299|NCT00552617|75655550|FG002|NOT COMPLETED|Overall Study||1||
59555300|NCT00552617|75655551|FG003|NOT COMPLETED|Overall Study||1||
59555301|NCT00552617|75655552|FG004|NOT COMPLETED|Overall Study||0||
60084450|NCT00472576|76200414|FG000|COMPLETED|First Intervention||2||
60084451|NCT00472576|76200415|FG001|COMPLETED|First Intervention||3||
60084452|NCT00472576|76200414|FG000|NOT COMPLETED|First Intervention||0||
60084453|NCT00472576|76200415|FG001|NOT COMPLETED|First Intervention||0||
59555302|NCT00552617|75655553|FG005|NOT COMPLETED|Overall Study||2||
59555303|NCT00552617|75655554|FG006|NOT COMPLETED|Overall Study||0||
59555304|NCT00552617|75655555|FG007|NOT COMPLETED|Overall Study||0||
59555305|NCT00552617|75655556|FG008|NOT COMPLETED|Overall Study||2||
59555306|NCT00552617|75655557|FG009|NOT COMPLETED|Overall Study||1||
59555307|NCT02421120|75655579|FG000|STARTED|Overall Study||21||
59555308|NCT02421120|75655579|FG000|COMPLETED|Overall Study||20||
59555309|NCT02421120|75655579|FG000|NOT COMPLETED|Overall Study||1||
59555310|NCT02420262|75655585|FG000|STARTED|Overall Study||252||
59555311|NCT02420262|75655586|FG001|STARTED|Overall Study||254||
59555312|NCT02420262|75655585|FG000|Exposed|Overall Study||252||
59555313|NCT02420262|75655586|FG001|Exposed|Overall Study|One subject withdrew consent before exposure to trial product due to personal reasons.|253||
59555314|NCT02420262|75655585|FG000|COMPLETED|Overall Study||250||
59555315|NCT02420262|75655586|FG001|COMPLETED|Overall Study||249||
59555316|NCT02420262|75655585|FG000|NOT COMPLETED|Overall Study||2||
59555317|NCT02420262|75655586|FG001|NOT COMPLETED|Overall Study||5||
59555318|NCT00552305|75655592|FG000|STARTED|Overall Study||370||
59555319|NCT00552305|75655592|FG000|COMPLETED|Overall Study||120||
59555320|NCT00552305|75655592|FG000|NOT COMPLETED|Overall Study||250||
59555321|NCT02277665|75655598|FG000|STARTED|Overall Study||33||
59555322|NCT02277665|75655599|FG001|STARTED|Overall Study||34||
59555323|NCT02277665|75655598|FG000|COMPLETED|Overall Study||33||
59555324|NCT02277665|75655599|FG001|COMPLETED|Overall Study||34||
59555325|NCT02277665|75655598|FG000|NOT COMPLETED|Overall Study||0||
59555326|NCT02277665|75655599|FG001|NOT COMPLETED|Overall Study||0||
59555327|NCT03150875|75655609|FG000|STARTED|Overall Study||145||
59555328|NCT03150875|75655610|FG001|STARTED|Overall Study||145||
59555329|NCT03150875|75655609|FG000|Treated|Overall Study||144||
59555330|NCT03150875|75655610|FG001|Treated|Overall Study||130||
59555331|NCT03150875|75655609|FG000|Crossover to Certain Treatment|Overall Study||0||
59555332|NCT03150875|75655610|FG001|Crossover to Certain Treatment|Overall Study||0||
59555333|NCT03150875|75655609|FG000|COMPLETED|Overall Study||0||
59555334|NCT03150875|75655610|FG001|COMPLETED|Overall Study||0||
59555335|NCT03150875|75655609|FG000|NOT COMPLETED|Overall Study||145||
59555336|NCT03150875|75655610|FG001|NOT COMPLETED|Overall Study||145||
59555337|NCT00552071|75655618|FG000|STARTED|Overall Study||10||
59555338|NCT00552071|75655619|FG001|STARTED|Overall Study||11||
59555339|NCT00552071|75655618|FG000|COMPLETED|Overall Study||6||
59555340|NCT00552071|75655619|FG001|COMPLETED|Overall Study||9||
59555341|NCT00552071|75655618|FG000|NOT COMPLETED|Overall Study||4||
59555342|NCT00552071|75655619|FG001|NOT COMPLETED|Overall Study||2||
59555343|NCT00551525|75655627|FG000|STARTED|Overall Study||67||
59555344|NCT00551525|75655627|FG000|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study|62||
59555345|NCT00551525|75655627|FG000|NOT COMPLETED|Overall Study||5||
59555346|NCT01437098|75655631|FG000|STARTED|Overall Study||55||
59555347|NCT01437098|75655631|FG000|30 Days|Overall Study||51||
59555348|NCT01437098|75655631|FG000|6 Months|Overall Study||47||
59555349|NCT01437098|75655631|FG000|12 Months|Overall Study||45||
59555350|NCT01437098|75655631|FG000|24 Months|Overall Study||42||
59555351|NCT01437098|75655631|FG000|36 Months|Overall Study||36||
59555352|NCT01437098|75655631|FG000|COMPLETED|Overall Study||42||
59555353|NCT01437098|75655631|FG000|NOT COMPLETED|Overall Study||13||
59555354|NCT01553708|75655645|FG000|STARTED|Overall Study||17||
59555355|NCT01553708|75655646|FG001|STARTED|Overall Study||17||
59555356|NCT01553708|75655645|FG000|COMPLETED|Overall Study||17||
59555357|NCT01553708|75655646|FG001|COMPLETED|Overall Study||17||
59555358|NCT01553708|75655645|FG000|NOT COMPLETED|Overall Study||0||
59555359|NCT01553708|75655646|FG001|NOT COMPLETED|Overall Study||0||
59555360|NCT02370498|75655654|FG000|STARTED|Overall Study||296||
59555361|NCT02370498|75655655|FG001|STARTED|Overall Study||296||
59555362|NCT02370498|75655654|FG000|Treated|Overall Study||294||
59555363|NCT02370498|75655655|FG001|Treated|Overall Study||276||
59555364|NCT02370498|75655654|FG000|PD-L1 Positive Participants|Overall Study||196||
59555365|NCT02370498|75655655|FG001|PD-L1 Positive Participants|Overall Study||199||
59555366|NCT02370498|75655654|FG000|COMPLETED|Overall Study||0||
59555367|NCT02370498|75655655|FG001|COMPLETED|Overall Study||0||
59555368|NCT02370498|75655654|FG000|NOT COMPLETED|Overall Study||296||
59555369|NCT02370498|75655655|FG001|NOT COMPLETED|Overall Study||296||
59555370|NCT01554488|75655664|FG000|STARTED|Overall Study||13||
59555371|NCT01554488|75655665|FG001|STARTED|Overall Study||12||
59555372|NCT01554488|75655664|FG000|COMPLETED|Overall Study||12||
59555373|NCT01554488|75655665|FG001|COMPLETED|Overall Study||9||
59555374|NCT01554488|75655664|FG000|NOT COMPLETED|Overall Study||1||
59555375|NCT01554488|75655665|FG001|NOT COMPLETED|Overall Study||3||
59555376|NCT01437488|75655671|FG000|STARTED|Overall Study||14||
59555377|NCT01437488|75655671|FG000|COMPLETED|Overall Study||14||
59555378|NCT01437488|75655671|FG000|NOT COMPLETED|Overall Study||0||
59555379|NCT02347332|75655680|FG000|STARTED|Overall Study||230||
59555380|NCT02347332|75655681|FG001|STARTED|Overall Study||229||
59555381|NCT02347332|75655680|FG000|COMPLETED|Overall Study|6 patients: suicide(1), unknown cause(5 - 4 at home +1 in city hospital).|0|Were considered as discontinued the 12 patients dead due to various or unknown reasons.|
59565955|NCT02303574|75668405|FG000|NOT COMPLETED|Part 1a (Fasted State)- SAD||0||
59555382|NCT02347332|75655681|FG001|COMPLETED|Overall Study|6 patients: unknown cause(2home), PDsuspect(1home+1hosp), sudden death(1home), hypercapnie(1hosp).|0|Were considered as discontinued the 12 patients dead due to various or unknown reasons.|
59555383|NCT02347332|75655680|FG000|NOT COMPLETED|Overall Study||230||
59555384|NCT02347332|75655681|FG001|NOT COMPLETED|Overall Study||229||
59555385|NCT01502306|75655690|FG000|STARTED|Overall Study||1004||
59555386|NCT01502306|75655691|FG001|STARTED|Overall Study||1405||
59555387|NCT01502306|75655692|FG002|STARTED|Overall Study||1407||
59555388|NCT01502306|75655690|FG000|COMPLETED|Overall Study||1004||
59555389|NCT01502306|75655691|FG001|COMPLETED|Overall Study||1405||
59555390|NCT01502306|75655692|FG002|COMPLETED|Overall Study||1407||
59555391|NCT01502306|75655690|FG000|NOT COMPLETED|Overall Study||0||
59555392|NCT01502306|75655691|FG001|NOT COMPLETED|Overall Study||0||
59555393|NCT01502306|75655692|FG002|NOT COMPLETED|Overall Study||0||
59555394|NCT02347176|75655704|FG000|STARTED|Overall Study||51||
59555395|NCT02347176|75655705|FG001|STARTED|Overall Study||50||
59555396|NCT02347176|75655706|FG002|STARTED|Overall Study||51||
59555397|NCT02347176|75655707|FG003|STARTED|Overall Study||52||
59555398|NCT02347176|75655704|FG000|COMPLETED|Overall Study||39||
59555399|NCT02347176|75655705|FG001|COMPLETED|Overall Study||40||
59555400|NCT02347176|75655706|FG002|COMPLETED|Overall Study||43||
59555401|NCT02347176|75655707|FG003|COMPLETED|Overall Study||48||
59555402|NCT02347176|75655704|FG000|NOT COMPLETED|Overall Study||12||
59555403|NCT02347176|75655705|FG001|NOT COMPLETED|Overall Study||10||
59555404|NCT02347176|75655706|FG002|NOT COMPLETED|Overall Study||8||
59555405|NCT02347176|75655707|FG003|NOT COMPLETED|Overall Study||4||
59555406|NCT02370420|75655719|FG000|STARTED|Overall Study||29||
59555407|NCT02370420|75655720|FG001|STARTED|Overall Study||27||
59555408|NCT02370420|75655719|FG000|COMPLETED|Overall Study||15||
59555409|NCT02370420|75655720|FG001|COMPLETED|Overall Study||15||
59555410|NCT02370420|75655719|FG000|NOT COMPLETED|Overall Study||14||
59555411|NCT02370420|75655720|FG001|NOT COMPLETED|Overall Study||12||
59555412|NCT02215070|75655728|FG000|STARTED|Overall Study||26||
59555413|NCT02215070|75655729|FG001|STARTED|Overall Study||52||
59555414|NCT02215070|75655728|FG000|COMPLETED|Overall Study||20||
59555415|NCT02215070|75655729|FG001|COMPLETED|Overall Study||52||
59555416|NCT02215070|75655728|FG000|NOT COMPLETED|Overall Study||6||
59555417|NCT02215070|75655729|FG001|NOT COMPLETED|Overall Study||0||
59555418|NCT02209064|75655735|FG000|STARTED|Overall Study||25||
59555419|NCT02209064|75655735|FG000|COMPLETED|Overall Study||25||
59555420|NCT02209064|75655735|FG000|NOT COMPLETED|Overall Study||0||
59555421|NCT02347098|75655742|FG000|STARTED|Overall Study||63||
59555422|NCT02347098|75655743|FG001|STARTED|Overall Study||66||
59555423|NCT02347098|75655742|FG000|COMPLETED|Overall Study||56||
59555424|NCT02347098|75655743|FG001|COMPLETED|Overall Study||58||
59555425|NCT02347098|75655742|FG000|NOT COMPLETED|Overall Study||7||
59555426|NCT02347098|75655743|FG001|NOT COMPLETED|Overall Study||8||
59555427|NCT01556204|75655751|FG000|STARTED|Overall Study||35||
59555428|NCT01556204|75655752|FG001|STARTED|Overall Study||38||
59555429|NCT01556204|75655751|FG000|COMPLETED|Overall Study||35||
59555430|NCT01556204|75655752|FG001|COMPLETED|Overall Study||38||
59555431|NCT01556204|75655751|FG000|NOT COMPLETED|Overall Study||0||
59555432|NCT01556204|75655752|FG001|NOT COMPLETED|Overall Study||0||
59555433|NCT02346708|75655760|FG000|STARTED|Overall Study||24||
59555434|NCT02346708|75655761|FG001|STARTED|Overall Study||25||
59555435|NCT02346708|75655760|FG000|COMPLETED|Overall Study||22||
59555436|NCT02346708|75655761|FG001|COMPLETED|Overall Study||24||
59555437|NCT02346708|75655760|FG000|NOT COMPLETED|Overall Study||2||
59555438|NCT02346708|75655761|FG001|NOT COMPLETED|Overall Study||1||
59555439|NCT02751879|75655770|FG000|STARTED|Overall Study||157||
59555440|NCT02751879|75655771|FG001|STARTED|Overall Study||71||
59555441|NCT02751879|75655770|FG000|On Treatment at Study Completion|Overall Study||81||
59555442|NCT02751879|75655771|FG001|On Treatment at Study Completion|Overall Study||41||
59555443|NCT02751879|75655770|FG000|COMPLETED|Overall Study||157||
59555444|NCT02751879|75655771|FG001|COMPLETED|Overall Study||71||
59555445|NCT02751879|75655770|FG000|NOT COMPLETED|Overall Study||0||
59555446|NCT02751879|75655771|FG001|NOT COMPLETED|Overall Study||0||
59991650|NCT00598481|76107222|FG000|COMPLETED|Treatment||11||
59555447|NCT01556594|75655783|FG000|STARTED|Overall Study||10||
59555448|NCT01556594|75655784|FG001|STARTED|Overall Study||2||
59555449|NCT01556594|75655785|FG002|STARTED|Overall Study||6||
59555450|NCT01556594|75655783|FG000|COMPLETED|Overall Study||10||
59555451|NCT01556594|75655784|FG001|COMPLETED|Overall Study||2||
59555452|NCT01556594|75655785|FG002|COMPLETED|Overall Study||6||
59555453|NCT01556594|75655783|FG000|NOT COMPLETED|Overall Study||0||
59555454|NCT01556594|75655784|FG001|NOT COMPLETED|Overall Study||0||
59555455|NCT01556594|75655785|FG002|NOT COMPLETED|Overall Study||0||
59555456|NCT01556906|75655795|FG000|STARTED|Overall Study||6||
59555457|NCT01556906|75655795|FG000|COMPLETED|Overall Study||6||
59555458|NCT01556906|75655795|FG000|NOT COMPLETED|Overall Study||0||
59555459|NCT01439594|75655799|FG000|STARTED|Overall Study||17||
59555460|NCT01439594|75655799|FG000|COMPLETED|Overall Study||17||
59555461|NCT01439594|75655799|FG000|NOT COMPLETED|Overall Study||0||
59555462|NCT01439672|75655803|FG000|STARTED|Overall Study||35||
59555463|NCT01439672|75655803|FG000|COMPLETED|Overall Study||11||
59555464|NCT01439672|75655803|FG000|NOT COMPLETED|Overall Study||24||
59555465|NCT02209532|75655809|FG000|STARTED|Overall Study||90||
59555466|NCT02209532|75655810|FG001|STARTED|Overall Study||90||
59555467|NCT02209532|75655809|FG000|COMPLETED|Overall Study||87||
59555468|NCT02209532|75655810|FG001|COMPLETED|Overall Study||89||
59555469|NCT02209532|75655809|FG000|NOT COMPLETED|Overall Study||3||
59555470|NCT02209532|75655810|FG001|NOT COMPLETED|Overall Study||1||
59555471|NCT02755935|75655817|FG000|STARTED|Overall Study||24||
59555472|NCT02755935|75655817|FG000|COMPLETED|Overall Study||22||
59555473|NCT02755935|75655817|FG000|NOT COMPLETED|Overall Study||2||
59555474|NCT01440764|75655823|FG000|STARTED|Test Day 1||4||
59555475|NCT01440764|75655824|FG001|STARTED|Test Day 1||2||
59555476|NCT01440764|75655825|FG002|STARTED|Test Day 1||6||
59555477|NCT01440764|75655826|FG003|STARTED|Test Day 1||1||
59555478|NCT01440764|75655827|FG004|STARTED|Test Day 1||3||
59555479|NCT01440764|75655828|FG005|STARTED|Test Day 1||5||
59555480|NCT01440764|75655829|FG006|STARTED|Test Day 1||3||
59555481|NCT01440764|75655823|FG000|COMPLETED|Test Day 1||4||
59555482|NCT01440764|75655824|FG001|COMPLETED|Test Day 1||2||
59555483|NCT01440764|75655825|FG002|COMPLETED|Test Day 1||6||
59555484|NCT01440764|75655826|FG003|COMPLETED|Test Day 1||1||
59555485|NCT01440764|75655827|FG004|COMPLETED|Test Day 1||3||
59555486|NCT01440764|75655828|FG005|COMPLETED|Test Day 1||5||
59555487|NCT01440764|75655829|FG006|COMPLETED|Test Day 1||3||
59555488|NCT01440764|75655823|FG000|NOT COMPLETED|Test Day 1||0||
59555489|NCT01440764|75655824|FG001|NOT COMPLETED|Test Day 1||0||
59555490|NCT01440764|75655825|FG002|NOT COMPLETED|Test Day 1||0||
59555491|NCT01440764|75655826|FG003|NOT COMPLETED|Test Day 1||0||
59555492|NCT01440764|75655827|FG004|NOT COMPLETED|Test Day 1||0||
59555493|NCT01440764|75655828|FG005|NOT COMPLETED|Test Day 1||0||
59555494|NCT01440764|75655829|FG006|NOT COMPLETED|Test Day 1||0||
59555495|NCT01440764|75655823|FG000|STARTED|Test Day 2|Following Test Day 1, 1 subject withdrew from the study before beginning Test Day 2.|3||
59555496|NCT01440764|75655824|FG001|STARTED|Test Day 2||2||
59555497|NCT01440764|75655825|FG002|STARTED|Test Day 2||6||
59555498|NCT01440764|75655826|FG003|STARTED|Test Day 2||1||
59555499|NCT01440764|75655827|FG004|STARTED|Test Day 2||3||
59555500|NCT01440764|75655828|FG005|STARTED|Test Day 2||5||
59555501|NCT01440764|75655829|FG006|STARTED|Test Day 2||3||
59555502|NCT01440764|75655823|FG000|COMPLETED|Test Day 2||3||
59555503|NCT01440764|75655824|FG001|COMPLETED|Test Day 2||2||
59555504|NCT01440764|75655825|FG002|COMPLETED|Test Day 2||6||
59555505|NCT01440764|75655826|FG003|COMPLETED|Test Day 2||1||
59555506|NCT01440764|75655827|FG004|COMPLETED|Test Day 2||3||
59555507|NCT01440764|75655828|FG005|COMPLETED|Test Day 2||5||
59555508|NCT01440764|75655829|FG006|COMPLETED|Test Day 2||3||
59555509|NCT01440764|75655823|FG000|NOT COMPLETED|Test Day 2||0||
59707102|NCT01256411|75826037|FG000|STARTED|Extension by Maximum Treatment||139||
59707103|NCT01256411|75826038|FG001|STARTED|Extension by Maximum Treatment||89||
59707104|NCT01256411|75826039|FG002|STARTED|Extension by Maximum Treatment||109||
59555510|NCT01440764|75655824|FG001|NOT COMPLETED|Test Day 2||0||
59555511|NCT01440764|75655825|FG002|NOT COMPLETED|Test Day 2||0||
59555512|NCT01440764|75655826|FG003|NOT COMPLETED|Test Day 2||0||
59555513|NCT01440764|75655827|FG004|NOT COMPLETED|Test Day 2||0||
59555514|NCT01440764|75655828|FG005|NOT COMPLETED|Test Day 2||0||
59555515|NCT01440764|75655829|FG006|NOT COMPLETED|Test Day 2||0||
59555516|NCT01440764|75655823|FG000|STARTED|Test Day 3||3||
59555517|NCT01440764|75655824|FG001|STARTED|Test Day 3||2||
59555518|NCT01440764|75655825|FG002|STARTED|Test Day 3||6||
59555519|NCT01440764|75655826|FG003|STARTED|Test Day 3||1||
59555520|NCT01440764|75655827|FG004|STARTED|Test Day 3||3||
59555521|NCT01440764|75655828|FG005|STARTED|Test Day 3||5||
59555522|NCT01440764|75655829|FG006|STARTED|Test Day 3||3||
59707105|NCT01256411|75826040|FG003|STARTED|Extension by Maximum Treatment||4||
59555523|NCT01440764|75655823|FG000|COMPLETED|Test Day 3||3||
59555524|NCT01440764|75655824|FG001|COMPLETED|Test Day 3||2||
59555525|NCT01440764|75655825|FG002|COMPLETED|Test Day 3||6||
59555526|NCT01440764|75655826|FG003|COMPLETED|Test Day 3||1||
59555527|NCT01440764|75655827|FG004|COMPLETED|Test Day 3||3||
59555528|NCT01440764|75655828|FG005|COMPLETED|Test Day 3||5||
59555529|NCT01440764|75655829|FG006|COMPLETED|Test Day 3||3||
59555530|NCT01440764|75655823|FG000|NOT COMPLETED|Test Day 3||0||
59555531|NCT01440764|75655824|FG001|NOT COMPLETED|Test Day 3||0||
59707106|NCT01256411|75826041|FG004|STARTED|Extension by Maximum Treatment||0||
59707107|NCT01256411|75826042|FG005|STARTED|Extension by Maximum Treatment||0||
59707108|NCT01256411|75826037|FG000|Down Titrated to 100 mg|Extension by Maximum Treatment||12||
59707109|NCT01256411|75826038|FG001|Down Titrated to 100 mg|Extension by Maximum Treatment||0||
59707110|NCT01256411|75826039|FG002|Down Titrated to 100 mg|Extension by Maximum Treatment||0||
59707111|NCT01256411|75826040|FG003|Down Titrated to 100 mg|Extension by Maximum Treatment||0||
59707112|NCT01256411|75826041|FG004|Down Titrated to 100 mg|Extension by Maximum Treatment||0||
59707113|NCT01256411|75826042|FG005|Down Titrated to 100 mg|Extension by Maximum Treatment||0||
59707114|NCT01256411|75826037|FG000|COMPLETED|Extension by Maximum Treatment||132||
59707115|NCT01256411|75826038|FG001|COMPLETED|Extension by Maximum Treatment||79||
59707116|NCT01256411|75826039|FG002|COMPLETED|Extension by Maximum Treatment||105||
59707117|NCT01256411|75826040|FG003|COMPLETED|Extension by Maximum Treatment||4||
59707118|NCT01256411|75826041|FG004|COMPLETED|Extension by Maximum Treatment||0||
59707119|NCT01256411|75826042|FG005|COMPLETED|Extension by Maximum Treatment||0||
59707120|NCT01256411|75826037|FG000|NOT COMPLETED|Extension by Maximum Treatment||7||
59707121|NCT01256411|75826038|FG001|NOT COMPLETED|Extension by Maximum Treatment||10||
59707122|NCT01256411|75826039|FG002|NOT COMPLETED|Extension by Maximum Treatment||4||
59707123|NCT01256411|75826040|FG003|NOT COMPLETED|Extension by Maximum Treatment||0||
59707124|NCT01256411|75826041|FG004|NOT COMPLETED|Extension by Maximum Treatment||0||
59707125|NCT01256411|75826042|FG005|NOT COMPLETED|Extension by Maximum Treatment||0||
59707126|NCT01256411|75826037|FG000|STARTED|Extension by Mono or Combination Therapy||0||
59707127|NCT01256411|75826038|FG001|STARTED|Extension by Mono or Combination Therapy||0||
59707128|NCT01256411|75826039|FG002|STARTED|Extension by Mono or Combination Therapy||0||
59707129|NCT01256411|75826040|FG003|STARTED|Extension by Mono or Combination Therapy||0||
59707130|NCT01256411|75826041|FG004|STARTED|Extension by Mono or Combination Therapy||228||
59707131|NCT01256411|75826042|FG005|STARTED|Extension by Mono or Combination Therapy||113||
59707132|NCT01256411|75826037|FG000|COMPLETED|Extension by Mono or Combination Therapy||0||
59707133|NCT01256411|75826038|FG001|COMPLETED|Extension by Mono or Combination Therapy||0||
59707134|NCT01256411|75826039|FG002|COMPLETED|Extension by Mono or Combination Therapy||0||
59707135|NCT01256411|75826040|FG003|COMPLETED|Extension by Mono or Combination Therapy||0||
59707136|NCT01256411|75826041|FG004|COMPLETED|Extension by Mono or Combination Therapy||211||
59707137|NCT01256411|75826042|FG005|COMPLETED|Extension by Mono or Combination Therapy||109||
59707138|NCT01256411|75826037|FG000|NOT COMPLETED|Extension by Mono or Combination Therapy||0||
59707139|NCT01256411|75826038|FG001|NOT COMPLETED|Extension by Mono or Combination Therapy||0||
59707140|NCT01256411|75826039|FG002|NOT COMPLETED|Extension by Mono or Combination Therapy||0||
59707141|NCT01256411|75826040|FG003|NOT COMPLETED|Extension by Mono or Combination Therapy||0||
59707142|NCT01256411|75826041|FG004|NOT COMPLETED|Extension by Mono or Combination Therapy||17||
59707143|NCT01256411|75826042|FG005|NOT COMPLETED|Extension by Mono or Combination Therapy||4||
59707144|NCT00996580|75826056|FG000|STARTED|Overall Study||3597||
59707145|NCT00996580|75826056|FG000|Pregnancy Intent-to-Treat Population|Overall Study||3019||
59707146|NCT00996580|75826056|FG000|COMPLETED|Overall Study||2144||
59707147|NCT00996580|75826056|FG000|NOT COMPLETED|Overall Study||1453||
59555532|NCT01440764|75655825|FG002|NOT COMPLETED|Test Day 3||0||
59555533|NCT01440764|75655826|FG003|NOT COMPLETED|Test Day 3||0||
59555534|NCT01440764|75655827|FG004|NOT COMPLETED|Test Day 3||0||
59555535|NCT01440764|75655828|FG005|NOT COMPLETED|Test Day 3||0||
59555536|NCT01440764|75655829|FG006|NOT COMPLETED|Test Day 3||0||
59555537|NCT01557452|75655847|FG000|STARTED|Overall Study||1||
59555538|NCT01557452|75655847|FG000|COMPLETED|Overall Study||1||
59555539|NCT01557452|75655847|FG000|NOT COMPLETED|Overall Study||0||
59555540|NCT01440920|75655855|FG000|STARTED|Overall Study||3||
59555541|NCT01440920|75655856|FG001|STARTED|Overall Study||3||
59555542|NCT01440920|75655857|FG002|STARTED|Overall Study||3||
59555543|NCT01440920|75655855|FG000|COMPLETED|Overall Study||3||
59555544|NCT01440920|75655856|FG001|COMPLETED|Overall Study||3||
59707148|NCT01124175|75826065|FG000|STARTED|First Intervention||40||
59707149|NCT01124175|75826066|FG001|STARTED|First Intervention||40||
59707150|NCT01124175|75826065|FG000|COMPLETED|First Intervention||40||
59707151|NCT01124175|75826066|FG001|COMPLETED|First Intervention||40||
59707152|NCT01124175|75826065|FG000|NOT COMPLETED|First Intervention||0||
59555545|NCT01440920|75655857|FG002|COMPLETED|Overall Study||3||
59555546|NCT01440920|75655855|FG000|NOT COMPLETED|Overall Study||0||
59555547|NCT01440920|75655856|FG001|NOT COMPLETED|Overall Study||0||
59555548|NCT01440920|75655857|FG002|NOT COMPLETED|Overall Study||0||
59707153|NCT01124175|75826066|FG001|NOT COMPLETED|First Intervention||0||
59991651|NCT00598481|76107222|FG000|NOT COMPLETED|Treatment||1||
59995169|NCT01674621|76110993|FG001|STARTED|Overall Study||51||
59995170|NCT01674621|76110994|FG002|STARTED|Overall Study||48||
59995171|NCT01674621|76110995|FG003|STARTED|Overall Study||51||
59995172|NCT01674621|76110996|FG004|STARTED|Overall Study||50||
59995173|NCT01674621|76110992|FG000|Modified Intent-to-Treat Population|Overall Study||47|Randomized participants with pretreatment and end-of-treatment evaluable radiologic assessments.|
59555549|NCT02209610|75655867|FG000|STARTED|Overall Study||16||
59555550|NCT02209610|75655868|FG001|STARTED|Overall Study||16||
59555551|NCT02209610|75655867|FG000|COMPLETED|Overall Study||16||
59555552|NCT02209610|75655868|FG001|COMPLETED|Overall Study||16||
59555553|NCT02209610|75655867|FG000|NOT COMPLETED|Overall Study||0||
59555554|NCT02209610|75655868|FG001|NOT COMPLETED|Overall Study||0||
59555555|NCT01441076|75655875|FG000|STARTED|Overall Study||6||
59555556|NCT01441076|75655875|FG000|COMPLETED|Overall Study||4||
59555557|NCT01441076|75655875|FG000|NOT COMPLETED|Overall Study||2||
59555558|NCT02756949|75655881|FG000|STARTED|Overall Study||181||
59555559|NCT02756949|75655882|FG001|STARTED|Overall Study||172||
59555560|NCT02756949|75655881|FG000|COMPLETED|Overall Study||181||
59555561|NCT02756949|75655882|FG001|COMPLETED|Overall Study||164||
59555562|NCT02756949|75655881|FG000|NOT COMPLETED|Overall Study||0||
59555563|NCT02756949|75655882|FG001|NOT COMPLETED|Overall Study||8||
59995174|NCT01674621|76110993|FG001|Modified Intent-to-Treat Population|Overall Study||46|Randomized participants with pretreatment and end-of-treatment evaluable radiologic assessments.|
59995175|NCT01674621|76110994|FG002|Modified Intent-to-Treat Population|Overall Study||43|Randomized participants with pretreatment and end-of-treatment evaluable radiologic assessments.|
59995176|NCT01674621|76110995|FG003|Modified Intent-to-Treat Population|Overall Study||49|Randomized participants with pretreatment and end-of-treatment evaluable radiologic assessments.|
59995177|NCT01674621|76110996|FG004|Modified Intent-to-Treat Population|Overall Study||46|Randomized participants with pretreatment and end-of-treatment evaluable radiologic assessments.|
59995178|NCT01674621|76110992|FG000|Safety Population|Overall Study||50|All participants who received 1 or more doses of study medication.|
59995179|NCT01674621|76110993|FG001|Safety Population|Overall Study||51|All participants who received 1 or more doses of study medication.|
59995180|NCT01674621|76110994|FG002|Safety Population|Overall Study||47|All participants who received 1 or more doses of study medication.|
59995181|NCT01674621|76110995|FG003|Safety Population|Overall Study||51|All participants who received 1 or more doses of study medication.|
59995182|NCT01674621|76110996|FG004|Safety Population|Overall Study||50|All participants who received 1 or more doses of study medication.|
60084454|NCT00472576|76200414|FG000|STARTED|Second Intervention||2||
60084455|NCT00472576|76200415|FG001|STARTED|Second Intervention||3||
59555564|NCT01504958|75655891|FG000|STARTED|Overall Study|Baseline clinical, cognitive, and behavioral assessments: TMS-EMG measures, MRI scan, randomization.|10||
59555565|NCT01504958|75655892|FG001|STARTED|Overall Study|Baseline clinical, cognitive, and behavioral assessments: TMS-EMG measures, MRI scan, randomization.|6||
59555566|NCT01504958|75655893|FG002|STARTED|Overall Study|Baseline clinical, cognitive, and behavioral assessments: TMS-EMG measures, MRI scan, randomization.|6||
59707154|NCT01124175|75826065|FG000|STARTED|Washout of 7 Days||40||
59707155|NCT01124175|75826066|FG001|STARTED|Washout of 7 Days||40||
59707156|NCT01124175|75826065|FG000|COMPLETED|Washout of 7 Days||40||
59707157|NCT01124175|75826066|FG001|COMPLETED|Washout of 7 Days||38||
59995183|NCT01674621|76110992|FG000|COMPLETED|Overall Study||45||
59995184|NCT01674621|76110993|FG001|COMPLETED|Overall Study||43||
59995185|NCT01674621|76110994|FG002|COMPLETED|Overall Study||41||
59995186|NCT01674621|76110995|FG003|COMPLETED|Overall Study||45||
59995187|NCT01674621|76110996|FG004|COMPLETED|Overall Study||44||
59995188|NCT01674621|76110992|FG000|NOT COMPLETED|Overall Study||5||
59995189|NCT01674621|76110993|FG001|NOT COMPLETED|Overall Study||8||
59995190|NCT01674621|76110994|FG002|NOT COMPLETED|Overall Study||7||
59995191|NCT01674621|76110995|FG003|NOT COMPLETED|Overall Study||6||
59991652|NCT03353233|76107231|FG000|STARTED|Overall Study||25||
59991653|NCT03353233|76107232|FG001|STARTED|Overall Study||25||
59991654|NCT03353233|76107231|FG000|COMPLETED|Overall Study||25||
59991655|NCT03353233|76107232|FG001|COMPLETED|Overall Study||25||
59991656|NCT03353233|76107231|FG000|NOT COMPLETED|Overall Study||0||
59991657|NCT03353233|76107232|FG001|NOT COMPLETED|Overall Study||0||
59991658|NCT01322971|76107240|FG000|STARTED|Overall Study||1||
59991659|NCT01322971|76107241|FG001|STARTED|Overall Study||1||
59991660|NCT01322971|76107240|FG000|COMPLETED|Overall Study||0||
59991661|NCT01322971|76107241|FG001|COMPLETED|Overall Study||0||
59991662|NCT01322971|76107240|FG000|NOT COMPLETED|Overall Study||1||
59991663|NCT01322971|76107241|FG001|NOT COMPLETED|Overall Study||1||
59991664|NCT01378429|76107249|FG000|STARTED|Overall Study||42||
59555567|NCT01504958|75655891|FG000|COMPLETED|Overall Study|1 Month Post-Treatment Follow Up|10||
59555568|NCT01504958|75655892|FG001|COMPLETED|Overall Study|1 Month Post-Treatment Follow Up|6||
59555569|NCT01504958|75655893|FG002|COMPLETED|Overall Study|1 Month Post-Treatment Follow Up|6||
59555570|NCT01504958|75655891|FG000|NOT COMPLETED|Overall Study||0||
59555571|NCT01504958|75655892|FG001|NOT COMPLETED|Overall Study||0||
59555572|NCT01504958|75655893|FG002|NOT COMPLETED|Overall Study||0||
59991665|NCT01378429|76107250|FG001|STARTED|Overall Study||47||
59991666|NCT01378429|76107249|FG000|COMPLETED|Overall Study||41||
59991667|NCT01378429|76107250|FG001|COMPLETED|Overall Study||47||
60084456|NCT00472576|76200414|FG000|COMPLETED|Second Intervention||2||
60084457|NCT00472576|76200415|FG001|COMPLETED|Second Intervention||3||
60084458|NCT00472576|76200414|FG000|NOT COMPLETED|Second Intervention||0||
60084459|NCT00472576|76200415|FG001|NOT COMPLETED|Second Intervention||0||
60084460|NCT00388414|76200423|FG000|STARTED|First Intervention (8 Weeks)||7||
60084461|NCT00388414|76200424|FG001|STARTED|First Intervention (8 Weeks)||7||
60084462|NCT00388414|76200423|FG000|COMPLETED|First Intervention (8 Weeks)||7||
60084463|NCT00388414|76200424|FG001|COMPLETED|First Intervention (8 Weeks)||7||
60084464|NCT00388414|76200423|FG000|NOT COMPLETED|First Intervention (8 Weeks)||0||
60084465|NCT00388414|76200424|FG001|NOT COMPLETED|First Intervention (8 Weeks)||0||
60084466|NCT00388414|76200423|FG000|STARTED|Washout (1 Week)||7||
60084467|NCT00388414|76200424|FG001|STARTED|Washout (1 Week)||7||
60084468|NCT00388414|76200423|FG000|COMPLETED|Washout (1 Week)||7||
60084469|NCT00388414|76200424|FG001|COMPLETED|Washout (1 Week)||7||
60084470|NCT00388414|76200423|FG000|NOT COMPLETED|Washout (1 Week)||0||
60084471|NCT00388414|76200424|FG001|NOT COMPLETED|Washout (1 Week)||0||
60084472|NCT00388414|76200423|FG000|STARTED|Second Intervention (8 Weeks)||7||
60084473|NCT00388414|76200424|FG001|STARTED|Second Intervention (8 Weeks)||7||
59555573|NCT01441466|75655903|FG000|STARTED|Overall Study||37||
59555574|NCT01441466|75655904|FG001|STARTED|Overall Study||11||
59555575|NCT01441466|75655903|FG000|COMPLETED|Overall Study||37||
59555576|NCT01441466|75655904|FG001|COMPLETED|Overall Study||11||
59555577|NCT01441466|75655903|FG000|NOT COMPLETED|Overall Study||0||
59555578|NCT01441466|75655904|FG001|NOT COMPLETED|Overall Study||0||
59555579|NCT01558700|75655913|FG000|STARTED|Overall Study||19||
59555580|NCT01558700|75655914|FG001|STARTED|Overall Study||21||
59555581|NCT01558700|75655913|FG000|COMPLETED|Overall Study||19||
59555582|NCT01558700|75655914|FG001|COMPLETED|Overall Study||21||
59555583|NCT01558700|75655913|FG000|NOT COMPLETED|Overall Study||0||
59555584|NCT01558700|75655914|FG001|NOT COMPLETED|Overall Study||0||
59555585|NCT01506362|75655920|FG000|STARTED|Overall Study||22||
59555586|NCT01506362|75655920|FG000|COMPLETED|Overall Study||16||
59555587|NCT01506362|75655920|FG000|NOT COMPLETED|Overall Study||6||
59555588|NCT02757105|75655926|FG000|STARTED|Overall Study||75||
59555589|NCT02757105|75655927|FG001|STARTED|Overall Study||52||
59555590|NCT02757105|75655926|FG000|Treated|Overall Study||75|1 patient in the placebo group was randomized and not treated.|
59555591|NCT02757105|75655927|FG001|Treated|Overall Study||51|1 patient in the placebo group was randomized and not treated.|
59555592|NCT02757105|75655926|FG000|COMPLETED|Overall Study||63|At least 7.6 weeks of treatment & end of study visit 28 +/- 11 days after last intake of study drug.|
59555593|NCT02757105|75655927|FG001|COMPLETED|Overall Study||41|At least 7.6 weeks of treatment & end of study visit 28 +/- 11 days after last intake of study drug.|
59555594|NCT02757105|75655926|FG000|NOT COMPLETED|Overall Study||12||
59555595|NCT02757105|75655927|FG001|NOT COMPLETED|Overall Study||11||
59991668|NCT01378429|76107249|FG000|NOT COMPLETED|Overall Study||1||
59991669|NCT01378429|76107250|FG001|NOT COMPLETED|Overall Study||0||
59991670|NCT01599754|76107261|FG000|STARTED|Overall Study||363||
59991671|NCT01599754|76107262|FG001|STARTED|Overall Study||361||
59991672|NCT01599754|76107261|FG000|Treated|Overall Study||360||
59991673|NCT01599754|76107262|FG001|Treated|Overall Study||360||
59991674|NCT01599754|76107261|FG000|COMPLETED|Overall Study||0||
59991675|NCT01599754|76107262|FG001|COMPLETED|Overall Study||1||
59991676|NCT01599754|76107261|FG000|NOT COMPLETED|Overall Study||363||
59991677|NCT01599754|76107262|FG001|NOT COMPLETED|Overall Study||360||
59991678|NCT02223754|76107270|FG000|STARTED|Period 1||163||
59991679|NCT02223754|76107271|FG001|STARTED|Period 1||159||
59991680|NCT02223754|76107270|FG000|COMPLETED|Period 1||159||
59991681|NCT02223754|76107271|FG001|COMPLETED|Period 1||144||
59991682|NCT02223754|76107270|FG000|NOT COMPLETED|Period 1||4||
59991683|NCT02223754|76107271|FG001|NOT COMPLETED|Period 1||15||
59991684|NCT02223754|76107270|FG000|STARTED|Period 2||159||
59991685|NCT02223754|76107271|FG001|STARTED|Period 2||144||
59991686|NCT02223754|76107270|FG000|COMPLETED|Period 2||156||
59991687|NCT02223754|76107271|FG001|COMPLETED|Period 2||141||
59991688|NCT02223754|76107270|FG000|NOT COMPLETED|Period 2||3||
59991689|NCT02223754|76107271|FG001|NOT COMPLETED|Period 2||3||
59991690|NCT02223364|76107281|FG000|STARTED|Overall Study||55||
59991691|NCT02223364|76107282|FG001|STARTED|Overall Study||55||
59991692|NCT02223364|76107283|FG002|STARTED|Overall Study||55||
59991693|NCT02223364|76107281|FG000|COMPLETED|Overall Study||50||
59991694|NCT02223364|76107282|FG001|COMPLETED|Overall Study||55||
59991695|NCT02223364|76107283|FG002|COMPLETED|Overall Study||52||
59991696|NCT02223364|76107281|FG000|NOT COMPLETED|Overall Study||5||
59991697|NCT02223364|76107282|FG001|NOT COMPLETED|Overall Study||0||
59991698|NCT02223364|76107283|FG002|NOT COMPLETED|Overall Study||3||
59991699|NCT01378975|76107293|FG000|STARTED|Overall Study||90||
59991700|NCT01378975|76107294|FG001|STARTED|Overall Study||56||
59991701|NCT01378975|76107293|FG000|COMPLETED|Overall Study||4||
59991702|NCT01378975|76107294|FG001|COMPLETED|Overall Study||6||
59991703|NCT01378975|76107293|FG000|NOT COMPLETED|Overall Study||86||
59991704|NCT01378975|76107294|FG001|NOT COMPLETED|Overall Study||50||
59991705|NCT02222896|76107301|FG000|STARTED|Abdomen||253||253
59991706|NCT02222896|76107302|FG001|STARTED|Abdomen||48||48
60084474|NCT00388414|76200423|FG000|COMPLETED|Second Intervention (8 Weeks)||7||
59555596|NCT01559948|75655936|FG000|STARTED|Overall Study||15||
59555597|NCT01559948|75655937|FG001|STARTED|Overall Study||15||
59555598|NCT01559948|75655936|FG000|COMPLETED|Overall Study||15||
59555599|NCT01559948|75655937|FG001|COMPLETED|Overall Study||15||
59555600|NCT01559948|75655936|FG000|NOT COMPLETED|Overall Study||0||
59555601|NCT01559948|75655937|FG001|NOT COMPLETED|Overall Study||0||
59555602|NCT02758119|75655949|FG000|STARTED|Overall Study||41||
59555603|NCT02758119|75655950|FG001|STARTED|Overall Study||41||
59991707|NCT02222896|76107303|FG002|STARTED|Abdomen||253||253
59991708|NCT02222896|76107301|FG000|COMPLETED|Abdomen||219|completed number is lower as some participants did not qualify for treatment day baseline|219
59991709|NCT02222896|76107302|FG001|COMPLETED|Abdomen||38|completed number is lower as some participants did not qualify for treatment day baseline|38
59991710|NCT02222896|76107303|FG002|COMPLETED|Abdomen||221|completed number is lower as some participants did not qualify for treatment day baseline|221
59991711|NCT02222896|76107301|FG000|NOT COMPLETED|Abdomen||34||34
59991712|NCT02222896|76107302|FG001|NOT COMPLETED|Abdomen||10||10
59991713|NCT02222896|76107303|FG002|NOT COMPLETED|Abdomen||32||32
59991714|NCT02222896|76107301|FG000|STARTED|Groin||254||254
59991715|NCT02222896|76107302|FG001|STARTED|Groin||48||48
59991716|NCT02222896|76107303|FG002|STARTED|Groin||250||250
59555604|NCT02758119|75655949|FG000|COMPLETED|Overall Study||39||
59555605|NCT02758119|75655950|FG001|COMPLETED|Overall Study||40||
59991717|NCT02222896|76107301|FG000|COMPLETED|Groin||211|completed number is lower as some participants did not qualify for treatment day baseline|211
59991718|NCT02222896|76107302|FG001|COMPLETED|Groin||39|completed number is lower as some participants did not qualify for treatment day baseline|39
59991719|NCT02222896|76107303|FG002|COMPLETED|Groin||210|completed number is lower as some participants did not qualify for treatment day baseline|210
59991720|NCT02222896|76107301|FG000|NOT COMPLETED|Groin||43||43
60084475|NCT00388414|76200424|FG001|COMPLETED|Second Intervention (8 Weeks)||7||
60084476|NCT00388414|76200423|FG000|NOT COMPLETED|Second Intervention (8 Weeks)||0||
59555606|NCT02758119|75655949|FG000|NOT COMPLETED|Overall Study||2||
59555607|NCT02758119|75655950|FG001|NOT COMPLETED|Overall Study||1||
59555608|NCT01443494|75655958|FG000|STARTED|Overall Study||19||
59555609|NCT01443494|75655958|FG000|COMPLETED|Overall Study||19||
59555610|NCT01443494|75655958|FG000|NOT COMPLETED|Overall Study||0||
59555611|NCT02758899|75655964|FG000|STARTED|Overall Study||11||
59555612|NCT02758899|75655965|FG001|STARTED|Overall Study||10||
59555613|NCT02758899|75655964|FG000|COMPLETED|Overall Study||9||
59555614|NCT02758899|75655965|FG001|COMPLETED|Overall Study||9||
60084477|NCT00388414|76200424|FG001|NOT COMPLETED|Second Intervention (8 Weeks)||0||
60084478|NCT00472732|76200434|FG000|STARTED|Overall Study||24||
60084479|NCT00472732|76200435|FG001|STARTED|Overall Study||22||
59555615|NCT02758899|75655964|FG000|NOT COMPLETED|Overall Study||2||
59555616|NCT02758899|75655965|FG001|NOT COMPLETED|Overall Study||1||
59991721|NCT02222896|76107302|FG001|NOT COMPLETED|Groin||9||9
59991722|NCT02222896|76107303|FG002|NOT COMPLETED|Groin||40||40
59991723|NCT02222818|76107316|FG000|STARTED|Period 1|Start of CAFR evaluation period|33||
60084480|NCT00472732|76200434|FG000|COMPLETED|Overall Study||24||
59555617|NCT01560260|75655971|FG000|STARTED|Overall Study||20||
59555618|NCT01560260|75655971|FG000|COMPLETED|Overall Study||20||
59555619|NCT01560260|75655971|FG000|NOT COMPLETED|Overall Study||0||
59555620|NCT01507220|75655979|FG000|STARTED|Overall Study||2||
59991724|NCT02222818|76107317|FG001|STARTED|Period 1|Start of CAFRPlus evaluation period|33||
59991725|NCT02222818|76107316|FG000|COMPLETED|Period 1|End of CAFR evaluation period|33||
59991726|NCT02222818|76107317|FG001|COMPLETED|Period 1|End of CAFRPlus evaluation period|30||
59991727|NCT02222818|76107316|FG000|NOT COMPLETED|Period 1||0||
59991728|NCT02222818|76107317|FG001|NOT COMPLETED|Period 1||3||
59991729|NCT02222818|76107316|FG000|STARTED|Period 2|Start of CAFRPlus evaluation period|33||
59991730|NCT02222818|76107317|FG001|STARTED|Period 2|Start of CAFR evaluation period|30||
59991731|NCT02222818|76107316|FG000|COMPLETED|Period 2|End of CAFRPlus evaluation period|33||
59991732|NCT02222818|76107317|FG001|COMPLETED|Period 2|End of CAFR evaluation period|30||
59991733|NCT02222818|76107316|FG000|NOT COMPLETED|Period 2||0||
59991734|NCT02222818|76107317|FG001|NOT COMPLETED|Period 2||0||
59991735|NCT01378195|76107324|FG000|STARTED|Overall Study||75||
59991736|NCT01378195|76107325|FG001|STARTED|Overall Study||75||
59991737|NCT01378195|76107324|FG000|COMPLETED|Overall Study||46||
59991738|NCT01378195|76107325|FG001|COMPLETED|Overall Study||57||
59991739|NCT01378195|76107324|FG000|NOT COMPLETED|Overall Study||29||
59991740|NCT01378195|76107325|FG001|NOT COMPLETED|Overall Study||18||
59991741|NCT01378117|76107334|FG000|STARTED|Overall Study||31||
59991742|NCT01378117|76107335|FG001|STARTED|Overall Study||30||
59991743|NCT01378117|76107336|FG002|STARTED|Overall Study||29||
59991744|NCT01378117|76107334|FG000|COMPLETED|Overall Study||27||
59991745|NCT01378117|76107335|FG001|COMPLETED|Overall Study||29||
59991746|NCT01378117|76107336|FG002|COMPLETED|Overall Study||26||
59991747|NCT01378117|76107334|FG000|NOT COMPLETED|Overall Study||4||
59991748|NCT01378117|76107335|FG001|NOT COMPLETED|Overall Study||1||
59991749|NCT01378117|76107336|FG002|NOT COMPLETED|Overall Study||3||
59991750|NCT04441931|76107353|FG000|STARTED|Overall Study||6||
59991751|NCT04441931|76107354|FG001|STARTED|Overall Study||7||
59991752|NCT04441931|76107355|FG002|STARTED|Overall Study||7||
59991753|NCT04441931|76107356|FG003|STARTED|Overall Study||6||
59991754|NCT04441931|76107353|FG000|Received at Least One Dose of Study Drug|Overall Study||6||
59991755|NCT04441931|76107354|FG001|Received at Least One Dose of Study Drug|Overall Study||7||
59991756|NCT04441931|76107355|FG002|Received at Least One Dose of Study Drug|Overall Study||7||
59991757|NCT04441931|76107356|FG003|Received at Least One Dose of Study Drug|Overall Study||6||
59991758|NCT04441931|76107353|FG000|COMPLETED|Overall Study||6||
59991759|NCT04441931|76107354|FG001|COMPLETED|Overall Study||7||
59991760|NCT04441931|76107355|FG002|COMPLETED|Overall Study||7||
59991761|NCT04441931|76107356|FG003|COMPLETED|Overall Study||6||
59991762|NCT04441931|76107353|FG000|NOT COMPLETED|Overall Study||0||
59991763|NCT04441931|76107354|FG001|NOT COMPLETED|Overall Study||0||
59991764|NCT04441931|76107355|FG002|NOT COMPLETED|Overall Study||0||
59555621|NCT01507220|75655980|FG001|STARTED|Overall Study||0||
59555622|NCT01507220|75655979|FG000|COMPLETED|Overall Study||2||
59555623|NCT01507220|75655980|FG001|COMPLETED|Overall Study||0||
59991765|NCT04441931|76107356|FG003|NOT COMPLETED|Overall Study||0||
59991766|NCT04254809|76107371|FG000|STARTED|Overall Study||48||
60084481|NCT00472732|76200435|FG001|COMPLETED|Overall Study||22||
60084482|NCT00472732|76200434|FG000|NOT COMPLETED|Overall Study||0||
60084483|NCT00472732|76200435|FG001|NOT COMPLETED|Overall Study||0||
60084484|NCT00475150|76200443|FG000|STARTED|Overall Study||23||
60084485|NCT00475150|76200444|FG001|STARTED|Overall Study||16||
60084486|NCT00475150|76200443|FG000|COMPLETED|Overall Study||23||
60084487|NCT00475150|76200444|FG001|COMPLETED|Overall Study||16||
60084488|NCT00475150|76200443|FG000|NOT COMPLETED|Overall Study||0||
60084489|NCT00475150|76200444|FG001|NOT COMPLETED|Overall Study||0||
60084490|NCT00450424|76200451|FG000|STARTED|Overall Study||122||
60084491|NCT00450424|76200452|FG001|STARTED|Overall Study||117||
60084492|NCT00450424|76200451|FG000|COMPLETED|Overall Study||102||
60084493|NCT00450424|76200452|FG001|COMPLETED|Overall Study||106||
59555624|NCT01507220|75655979|FG000|NOT COMPLETED|Overall Study||0||
59991767|NCT04254809|76107372|FG001|STARTED|Overall Study||48||
60084494|NCT00450424|76200451|FG000|NOT COMPLETED|Overall Study||20||
60084495|NCT00450424|76200452|FG001|NOT COMPLETED|Overall Study||11||
60084496|NCT00451048|76200458|FG000|STARTED|Overall Study||10||
60084497|NCT00451048|76200458|FG000|COMPLETED|Overall Study||10||
59991768|NCT04254809|76107371|FG000|COMPLETED|Overall Study||43||
59991769|NCT04254809|76107372|FG001|COMPLETED|Overall Study||38||
59991770|NCT04254809|76107371|FG000|NOT COMPLETED|Overall Study||5||
59991771|NCT04254809|76107372|FG001|NOT COMPLETED|Overall Study||10||
59991772|NCT02736409|76107382|FG000|STARTED|Overall Study||23||
59991773|NCT02736409|76107383|FG001|STARTED|Overall Study||25||
59991774|NCT02736409|76107384|FG002|STARTED|Overall Study||106||
59991775|NCT02736409|76107385|FG003|STARTED|Overall Study||65||
59991776|NCT02736409|76107382|FG000|COMPLETED|Overall Study||19||
59991777|NCT02736409|76107383|FG001|COMPLETED|Overall Study||22||
59991778|NCT02736409|76107384|FG002|COMPLETED|Overall Study||80||
59991779|NCT02736409|76107385|FG003|COMPLETED|Overall Study||53||
59991780|NCT02736409|76107382|FG000|NOT COMPLETED|Overall Study||4||
59991781|NCT02736409|76107383|FG001|NOT COMPLETED|Overall Study||3||
59991782|NCT02736409|76107384|FG002|NOT COMPLETED|Overall Study||26||
59991783|NCT02736409|76107385|FG003|NOT COMPLETED|Overall Study||12||
59991784|NCT03099707|76107398|FG000|STARTED|Overall Study||43||
59991785|NCT03099707|76107399|FG001|STARTED|Overall Study||41||
59991786|NCT03099707|76107398|FG000|COMPLETED|Overall Study||43||
59991787|NCT03099707|76107399|FG001|COMPLETED|Overall Study||37||
59991788|NCT03099707|76107398|FG000|NOT COMPLETED|Overall Study||0||
59991789|NCT03099707|76107399|FG001|NOT COMPLETED|Overall Study||4||
59991790|NCT02906033|76107407|FG000|STARTED|Baseline||231||
59991791|NCT02906033|76107408|FG001|STARTED|Baseline||222||
59991792|NCT02906033|76107407|FG000|15 D at Baseline|Baseline||211|Analyzed at baseline for 15 D|
59991793|NCT02906033|76107408|FG001|15 D at Baseline|Baseline||189|Analyzed at baseline for 15 D|
59991794|NCT02906033|76107407|FG000|STATE at Baseline|Baseline||199|Analyzed at baseline for STATE anxiety|
59991795|NCT02906033|76107408|FG001|STATE at Baseline|Baseline||190|Analyzed at baseline for STATE anxiety|
59991796|NCT02906033|76107407|FG000|TRAIT at Baseline|Baseline||194|Analyzed at baseline for TRAIT anxiety|
59991797|NCT02906033|76107408|FG001|TRAIT at Baseline|Baseline||189|Analyzed at baseline for TRAIT anxiety|
59991798|NCT02906033|76107407|FG000|COMPLETED|Baseline|Analyzed at baseline for 15 D and STATE anxiety and TRAIT anxiety|194||
59991799|NCT02906033|76107408|FG001|COMPLETED|Baseline|Analyzed at baseline for 15 D and STATE anxiety and TRAIT anxiety.|189||
59991800|NCT02906033|76107407|FG000|NOT COMPLETED|Baseline||37||
59991801|NCT02906033|76107408|FG001|NOT COMPLETED|Baseline||33||
59991802|NCT02906033|76107407|FG000|STARTED|Follow-up||194||
59991803|NCT02906033|76107408|FG001|STARTED|Follow-up||189||
59991804|NCT02906033|76107407|FG000|15 D at Follow-up|Follow-up||151|Analyzed for 15 D at follow-up|
59991805|NCT02906033|76107408|FG001|15 D at Follow-up|Follow-up||135|Analyzed for 15 D at follow-up|
59991806|NCT02906033|76107407|FG000|STATE at Follow-up|Follow-up||154|Analyzed for STATE anxiety at follow-up|
59991807|NCT02906033|76107408|FG001|STATE at Follow-up|Follow-up||135|Analyzed for STATE anxiety at follow-up|
59991808|NCT02906033|76107407|FG000|TRAIT at Follow-up|Follow-up||148|Analyzed for TRAIT anxiety at follow-up|
59816597|NCT04915950|75939024|FG003|NOT COMPLETED|Stage A: Treatment Period 1 (1 Day)||0||
59816598|NCT04915950|75939025|FG004|NOT COMPLETED|Stage A: Treatment Period 1 (1 Day)||0||
59707158|NCT01124175|75826065|FG000|NOT COMPLETED|Washout of 7 Days||0||
59707159|NCT01124175|75826066|FG001|NOT COMPLETED|Washout of 7 Days||2||
59707160|NCT01124175|75826065|FG000|STARTED|Second Intervention||40||
59707161|NCT01124175|75826066|FG001|STARTED|Second Intervention||38||
59707162|NCT01124175|75826065|FG000|COMPLETED|Second Intervention||40||
59707163|NCT01124175|75826066|FG001|COMPLETED|Second Intervention||38||
59555625|NCT01507220|75655980|FG001|NOT COMPLETED|Overall Study||0||
59991809|NCT02906033|76107408|FG001|TRAIT at Follow-up|Follow-up||127|Analyzed for TRAIT anxiety at follow-up|
59991810|NCT02906033|76107407|FG000|COMPLETED|Follow-up|Analyzed for 15 D and STATE anxiety and TRAIT anxiety at follow-up|148||
59991811|NCT02906033|76107408|FG001|COMPLETED|Follow-up|Analyzed at follow-up 15 D and STATE anxiety and TRAIT anxiety.|127||
59991812|NCT02906033|76107407|FG000|NOT COMPLETED|Follow-up||46||
59991813|NCT02906033|76107408|FG001|NOT COMPLETED|Follow-up||62||
59991814|NCT02221882|76107420|FG000|STARTED|Overall Study||3||
59991815|NCT02221882|76107421|FG001|STARTED|Overall Study||3||
59555626|NCT01507688|75655988|FG000|STARTED|Baseline to 6 Month Assessment||129||
59555627|NCT01507688|75655989|FG001|STARTED|Baseline to 6 Month Assessment||129||
59555628|NCT01507688|75655988|FG000|COMPLETED|Baseline to 6 Month Assessment||113||
59555629|NCT01507688|75655989|FG001|COMPLETED|Baseline to 6 Month Assessment||119||
59555630|NCT01507688|75655988|FG000|NOT COMPLETED|Baseline to 6 Month Assessment||16||
59555631|NCT01507688|75655989|FG001|NOT COMPLETED|Baseline to 6 Month Assessment||10||
59555632|NCT01507688|75655988|FG000|STARTED|6 Month to 12 Month Assessment||113||
59707164|NCT01124175|75826065|FG000|NOT COMPLETED|Second Intervention||0||
59707165|NCT01124175|75826066|FG001|NOT COMPLETED|Second Intervention||0||
59707166|NCT01256177|75826074|FG000|STARTED|Overall Study||148||
59707167|NCT01256177|75826075|FG001|STARTED|Overall Study||148||
59707168|NCT01256177|75826074|FG000|COMPLETED|Overall Study||98||
59707169|NCT01256177|75826075|FG001|COMPLETED|Overall Study||111||
59707170|NCT01256177|75826074|FG000|NOT COMPLETED|Overall Study||50||
59707171|NCT01256177|75826075|FG001|NOT COMPLETED|Overall Study||37||
59707172|NCT00999544|75826081|FG000|STARTED|Overall Study||9||
59707173|NCT00999544|75826081|FG000|COMPLETED|Overall Study||8||
59707174|NCT00999544|75826081|FG000|NOT COMPLETED|Overall Study||1||
59816599|NCT04915950|75939026|FG005|NOT COMPLETED|Stage A: Treatment Period 1 (1 Day)||0||
59816600|NCT04915950|75939021|FG000|STARTED|Stage A:Washout Period(72hours to 7days)||2||
59816601|NCT04915950|75939022|FG001|STARTED|Stage A:Washout Period(72hours to 7days)||2||
59816602|NCT04915950|75939023|FG002|STARTED|Stage A:Washout Period(72hours to 7days)||2||
59816603|NCT04915950|75939024|FG003|STARTED|Stage A:Washout Period(72hours to 7days)||2||
59991816|NCT02221882|76107422|FG002|STARTED|Overall Study||11||
59816604|NCT04915950|75939025|FG004|STARTED|Stage A:Washout Period(72hours to 7days)||3||
59991817|NCT02221882|76107423|FG003|STARTED|Overall Study||3||
59707175|NCT01124097|75826118|FG000|STARTED|Overall Study||60||
59707176|NCT01124097|75826119|FG001|STARTED|Overall Study||60||
59707177|NCT01124097|75826120|FG002|STARTED|Overall Study||60||
59707178|NCT01124097|75826121|FG003|STARTED|Overall Study||60||
59707179|NCT01124097|75826118|FG000|Safety Population|Overall Study||60||
59707180|NCT01124097|75826119|FG001|Safety Population|Overall Study||60||
59707181|NCT01124097|75826120|FG002|Safety Population|Overall Study||60||
60084498|NCT00451048|76200458|FG000|NOT COMPLETED|Overall Study||0||
60084499|NCT00388804|76200464|FG000|STARTED|Overall Study||17||
60084500|NCT00388804|76200465|FG001|STARTED|Overall Study||21||
60084501|NCT00388804|76200464|FG000|COMPLETED|Overall Study||17||
60084502|NCT00388804|76200465|FG001|COMPLETED|Overall Study||21||
60084503|NCT00388804|76200464|FG000|NOT COMPLETED|Overall Study||0||
60084504|NCT00388804|76200465|FG001|NOT COMPLETED|Overall Study||0||
60084505|NCT00389818|76200471|FG000|STARTED|Overall Study||43||
60084506|NCT00389818|76200471|FG000|COMPLETED|Overall Study||40||
60084507|NCT00389818|76200471|FG000|NOT COMPLETED|Overall Study||3||
60084508|NCT00452374|76200475|FG000|STARTED|Overall Study||48||
60084509|NCT00452374|76200475|FG000|COMPLETED|Overall Study||48||
60084510|NCT00452374|76200475|FG000|NOT COMPLETED|Overall Study||0||
60084511|NCT01454583|76200482|FG000|STARTED|1st Year|From initially 15337 pat. 351 withdrawed from the registry, 14986 pat. were assigned to the groups.|10177||
60084512|NCT01454583|76200483|FG001|STARTED|1st Year||2696||
60084513|NCT01454583|76200484|FG002|STARTED|1st Year||2113||
60084514|NCT01454583|76200482|FG000|COMPLETED|1st Year||9120||
60084515|NCT01454583|76200483|FG001|COMPLETED|1st Year||2378||
60084516|NCT01454583|76200484|FG002|COMPLETED|1st Year||1933||
59555633|NCT01507688|75655989|FG001|STARTED|6 Month to 12 Month Assessment||119||
59707182|NCT01124097|75826121|FG003|Safety Population|Overall Study||60||
59707183|NCT01124097|75826118|FG000|Efficacy Population|Overall Study||52||
59707184|NCT01124097|75826119|FG001|Efficacy Population|Overall Study||53||
59707185|NCT01124097|75826120|FG002|Efficacy Population|Overall Study||53||
59991818|NCT02221882|76107424|FG004|STARTED|Overall Study||5||
60084517|NCT01454583|76200482|FG000|NOT COMPLETED|1st Year||1057||
60084518|NCT01454583|76200483|FG001|NOT COMPLETED|1st Year||318||
59707186|NCT01124097|75826121|FG003|Efficacy Population|Overall Study||51||
59707187|NCT01124097|75826118|FG000|COMPLETED|Overall Study||26||
59707188|NCT01124097|75826119|FG001|COMPLETED|Overall Study||38||
59707189|NCT01124097|75826120|FG002|COMPLETED|Overall Study||40||
59707190|NCT01124097|75826121|FG003|COMPLETED|Overall Study||46||
59555634|NCT01507688|75655988|FG000|COMPLETED|6 Month to 12 Month Assessment||108||
59555635|NCT01507688|75655989|FG001|COMPLETED|6 Month to 12 Month Assessment||116||
59707191|NCT01124097|75826118|FG000|NOT COMPLETED|Overall Study||34||
59555636|NCT01507688|75655988|FG000|NOT COMPLETED|6 Month to 12 Month Assessment||5||
59555637|NCT01507688|75655989|FG001|NOT COMPLETED|6 Month to 12 Month Assessment||3||
59555638|NCT02366403|75655997|FG000|STARTED|Overall Study||41||
59707192|NCT01124097|75826119|FG001|NOT COMPLETED|Overall Study||22||
59707193|NCT01124097|75826120|FG002|NOT COMPLETED|Overall Study||20||
59707194|NCT01124097|75826121|FG003|NOT COMPLETED|Overall Study||14||
59707195|NCT01123941|75826133|FG000|STARTED|Overall Study||25||
59707196|NCT01123941|75826134|FG001|STARTED|Overall Study||25||
59707197|NCT01123941|75826133|FG000|COMPLETED|Overall Study||23||
59707198|NCT01123941|75826134|FG001|COMPLETED|Overall Study||24||
59707199|NCT01123941|75826133|FG000|NOT COMPLETED|Overall Study||2||
59707200|NCT01123941|75826134|FG001|NOT COMPLETED|Overall Study||1||
59707201|NCT01123395|75826140|FG000|STARTED|Period 1||8||
59707202|NCT01123395|75826141|FG001|STARTED|Period 1||8||
59707203|NCT01123395|75826140|FG000|COMPLETED|Period 1||8||
59707204|NCT01123395|75826141|FG001|COMPLETED|Period 1||8||
59707205|NCT01123395|75826140|FG000|NOT COMPLETED|Period 1||0||
59707206|NCT01123395|75826141|FG001|NOT COMPLETED|Period 1||0||
59707207|NCT01123395|75826140|FG000|STARTED|Washout Period of 14 Days||8||
59707208|NCT01123395|75826141|FG001|STARTED|Washout Period of 14 Days||8||
59707209|NCT01123395|75826140|FG000|COMPLETED|Washout Period of 14 Days||8||
59707210|NCT01123395|75826141|FG001|COMPLETED|Washout Period of 14 Days||7||
59707211|NCT01123395|75826140|FG000|NOT COMPLETED|Washout Period of 14 Days||0||
59707212|NCT01123395|75826141|FG001|NOT COMPLETED|Washout Period of 14 Days||1||
59707213|NCT01123395|75826140|FG000|STARTED|Period 2||8||
59991819|NCT02221882|76107425|FG005|STARTED|Overall Study||4||
59991820|NCT02221882|76107420|FG000|Received at Least One Dose of Study Drug|Overall Study||3||
59991821|NCT02221882|76107421|FG001|Received at Least One Dose of Study Drug|Overall Study||3||
59707214|NCT01123395|75826141|FG001|STARTED|Period 2||7||
59707215|NCT01123395|75826140|FG000|COMPLETED|Period 2||8||
59707216|NCT01123395|75826141|FG001|COMPLETED|Period 2||7||
59707217|NCT01123395|75826140|FG000|NOT COMPLETED|Period 2||0||
59991822|NCT02221882|76107422|FG002|Received at Least One Dose of Study Drug|Overall Study||11||
59991823|NCT02221882|76107423|FG003|Received at Least One Dose of Study Drug|Overall Study||3||
59991824|NCT02221882|76107424|FG004|Received at Least One Dose of Study Drug|Overall Study||5||
59991825|NCT02221882|76107425|FG005|Received at Least One Dose of Study Drug|Overall Study||4||
59991826|NCT02221882|76107420|FG000|COMPLETED|Overall Study||3||
59991827|NCT02221882|76107421|FG001|COMPLETED|Overall Study||2||
59991828|NCT02221882|76107422|FG002|COMPLETED|Overall Study||7||
59991829|NCT02221882|76107423|FG003|COMPLETED|Overall Study||1||
59991830|NCT02221882|76107424|FG004|COMPLETED|Overall Study||3||
59991831|NCT02221882|76107425|FG005|COMPLETED|Overall Study||2||
59991832|NCT02221882|76107420|FG000|NOT COMPLETED|Overall Study||0||
59991833|NCT02221882|76107421|FG001|NOT COMPLETED|Overall Study||1||
59991834|NCT02221882|76107422|FG002|NOT COMPLETED|Overall Study||4||
59991835|NCT02221882|76107423|FG003|NOT COMPLETED|Overall Study||2||
59991836|NCT02221882|76107424|FG004|NOT COMPLETED|Overall Study||2||
59991837|NCT02221882|76107425|FG005|NOT COMPLETED|Overall Study||2||
60084519|NCT01454583|76200484|FG002|NOT COMPLETED|1st Year||180||
60084520|NCT01454583|76200482|FG000|STARTED|2nd Year||10177||
60084521|NCT01454583|76200483|FG001|STARTED|2nd Year||2696||
60084522|NCT01454583|76200484|FG002|STARTED|2nd Year||2113||
60084523|NCT01454583|76200482|FG000|COMPLETED|2nd Year||6212||
60084524|NCT01454583|76200483|FG001|COMPLETED|2nd Year||1647||
60084525|NCT01454583|76200484|FG002|COMPLETED|2nd Year||1376||
60084526|NCT01454583|76200482|FG000|NOT COMPLETED|2nd Year||3965||
60084527|NCT01454583|76200483|FG001|NOT COMPLETED|2nd Year||1049||
60084528|NCT01454583|76200484|FG002|NOT COMPLETED|2nd Year||737||
60084529|NCT01454583|76200482|FG000|STARTED|3rd Year||3791||
60084530|NCT01454583|76200483|FG001|STARTED|3rd Year||982||
60084531|NCT01454583|76200484|FG002|STARTED|3rd Year||582||
60084532|NCT01454583|76200482|FG000|COMPLETED|3rd Year||1832||
60084533|NCT01454583|76200483|FG001|COMPLETED|3rd Year||470||
60084534|NCT01454583|76200484|FG002|COMPLETED|3rd Year||285||
60084535|NCT01454583|76200482|FG000|NOT COMPLETED|3rd Year||1959||
60084536|NCT01454583|76200483|FG001|NOT COMPLETED|3rd Year||512||
59707218|NCT01123395|75826141|FG001|NOT COMPLETED|Period 2||0||
59707219|NCT01255787|75826151|FG000|STARTED|Overall Study||152||
59707220|NCT01255787|75826152|FG001|STARTED|Overall Study||144||
59707221|NCT01255787|75826153|FG002|STARTED|Overall Study||150||
59991838|NCT02837783|76107446|FG000|STARTED|Overall Study||9||
59991839|NCT02837783|76107447|FG001|STARTED|Overall Study||11||
59991840|NCT02837783|76107446|FG000|Received >= 1 Dose of Study Drug|Overall Study||9||
59991841|NCT02837783|76107447|FG001|Received >= 1 Dose of Study Drug|Overall Study||10||
59991842|NCT02837783|76107446|FG000|COMPLETED|Overall Study||7||
59991843|NCT02837783|76107447|FG001|COMPLETED|Overall Study||9||
59991844|NCT02837783|76107446|FG000|NOT COMPLETED|Overall Study||2||
59991845|NCT02837783|76107447|FG001|NOT COMPLETED|Overall Study||2||
59707222|NCT01255787|75826154|FG003|STARTED|Overall Study||154||
59707223|NCT01255787|75826151|FG000|Treated|Overall Study||152||
59707224|NCT01255787|75826152|FG001|Treated|Overall Study||144||
59991846|NCT02221648|76107455|FG000|STARTED|Overall Study||22||
59991847|NCT02221648|76107456|FG001|STARTED|Overall Study||21||
60084537|NCT01454583|76200484|FG002|NOT COMPLETED|3rd Year||297||
60084538|NCT00476242|76200494|FG000|STARTED|Overall Study||27||
60084539|NCT00476242|76200495|FG001|STARTED|Overall Study||28||
59707225|NCT01255787|75826153|FG002|Treated|Overall Study||148||
59991848|NCT02221648|76107455|FG000|COMPLETED|Overall Study||19||
60084540|NCT00476242|76200494|FG000|COMPLETED|Overall Study||19||
60084541|NCT00476242|76200495|FG001|COMPLETED|Overall Study||12||
60084542|NCT00476242|76200494|FG000|NOT COMPLETED|Overall Study||8||
59991849|NCT02221648|76107456|FG001|COMPLETED|Overall Study||18||
59991850|NCT02221648|76107455|FG000|NOT COMPLETED|Overall Study||3||
59991851|NCT02221648|76107456|FG001|NOT COMPLETED|Overall Study||3||
59991852|NCT02220712|76107466|FG000|STARTED|Overall Study||17||
59991853|NCT02220712|76107466|FG000|COMPLETED|Overall Study||13||
59991854|NCT02220712|76107466|FG000|NOT COMPLETED|Overall Study||4||
59991855|NCT02219932|76107476|FG000|STARTED|Overall Study||319||
59991856|NCT02219932|76107477|FG001|STARTED|Overall Study||317||
59991857|NCT02219932|76107476|FG000|Randomized, Not Treated|Overall Study||0||
59991858|NCT02219932|76107477|FG001|Randomized, Not Treated|Overall Study||1||
59555639|NCT02366403|75655998|FG001|STARTED|Overall Study||44||
59555640|NCT02366403|75655997|FG000|COMPLETED|Overall Study||30||
59555641|NCT02366403|75655998|FG001|COMPLETED|Overall Study||29||
59555642|NCT02366403|75655997|FG000|NOT COMPLETED|Overall Study||11||
59555643|NCT02366403|75655998|FG001|NOT COMPLETED|Overall Study||15||
59555644|NCT01509404|75656008|FG000|STARTED|Overall Study||20||
59555645|NCT01509404|75656009|FG001|STARTED|Overall Study||20||
59555646|NCT01509404|75656008|FG000|COMPLETED|Overall Study||20||
59555647|NCT01509404|75656009|FG001|COMPLETED|Overall Study||20||
59555648|NCT01509404|75656008|FG000|NOT COMPLETED|Overall Study||0||
59555649|NCT01509404|75656009|FG001|NOT COMPLETED|Overall Study||0||
59555650|NCT01562132|75656017|FG000|STARTED|Overall Study||3||
59555651|NCT01562132|75656018|FG001|STARTED|Overall Study||3||
59555652|NCT01562132|75656017|FG000|COMPLETED|Overall Study||3||
59555653|NCT01562132|75656018|FG001|COMPLETED|Overall Study||3||
59555654|NCT01562132|75656017|FG000|NOT COMPLETED|Overall Study||0||
59555655|NCT01562132|75656018|FG001|NOT COMPLETED|Overall Study||0||
59555656|NCT02762331|75656026|FG000|STARTED|Overall Study||4||
59991859|NCT02219932|76107476|FG000|COMPLETED|Overall Study||254||
59991860|NCT02219932|76107477|FG001|COMPLETED|Overall Study||266||
59991861|NCT02219932|76107476|FG000|NOT COMPLETED|Overall Study||65||
59991862|NCT02219932|76107477|FG001|NOT COMPLETED|Overall Study||51||
59991863|NCT00846430|76107483|FG000|STARTED|Overall Study||9||
59555657|NCT02762331|75656027|FG001|STARTED|Overall Study||2||
59555658|NCT02762331|75656026|FG000|COMPLETED|Overall Study||4||
59555659|NCT02762331|75656027|FG001|COMPLETED|Overall Study||2||
59555660|NCT02762331|75656026|FG000|NOT COMPLETED|Overall Study||0||
59555661|NCT02762331|75656027|FG001|NOT COMPLETED|Overall Study||0||
59555662|NCT02762799|75656037|FG000|STARTED|Overall Study||18||
59555663|NCT02762799|75656038|FG001|STARTED|Overall Study||18||
59555664|NCT02762799|75656039|FG002|STARTED|Overall Study||12||
59555665|NCT02762799|75656040|FG003|STARTED|Overall Study||12||
59555666|NCT02762799|75656037|FG000|COMPLETED|Overall Study||18||
59991864|NCT00846430|76107483|FG000|COMPLETED|Overall Study||9||
59991865|NCT00846430|76107483|FG000|NOT COMPLETED|Overall Study||0||
59555667|NCT02762799|75656038|FG001|COMPLETED|Overall Study||18||
59555668|NCT02762799|75656039|FG002|COMPLETED|Overall Study||11||
59991866|NCT02219464|76107489|FG000|STARTED|Overall Study||30||
59991867|NCT02219464|76107490|FG001|STARTED|Overall Study||30||
59555669|NCT02762799|75656040|FG003|COMPLETED|Overall Study||12||
59555670|NCT02762799|75656037|FG000|NOT COMPLETED|Overall Study||0||
59707226|NCT01255787|75826154|FG003|Treated|Overall Study||150||
59555671|NCT02762799|75656038|FG001|NOT COMPLETED|Overall Study||0||
59555672|NCT02762799|75656039|FG002|NOT COMPLETED|Overall Study||1||
59555673|NCT02762799|75656040|FG003|NOT COMPLETED|Overall Study||0||
59555674|NCT02762877|75656054|FG000|STARTED|Overall Study||121||
59555675|NCT02762877|75656055|FG001|STARTED|Overall Study||19||
59555676|NCT02762877|75656054|FG000|COMPLETED|Overall Study||121||
59991868|NCT02219464|76107489|FG000|COMPLETED|Overall Study||27||
59991869|NCT02219464|76107490|FG001|COMPLETED|Overall Study||30||
59991870|NCT02219464|76107489|FG000|NOT COMPLETED|Overall Study||3||
59991871|NCT02219464|76107490|FG001|NOT COMPLETED|Overall Study||0||
59991872|NCT02219308|76107498|FG000|STARTED|Overall Study||32||
59991873|NCT02219308|76107499|FG001|STARTED|Overall Study||35||
59991874|NCT02219308|76107498|FG000|COMPLETED|Overall Study||31||
59991875|NCT02219308|76107499|FG001|COMPLETED|Overall Study||33||
59991876|NCT02219308|76107498|FG000|NOT COMPLETED|Overall Study||1||
59555677|NCT02762877|75656055|FG001|COMPLETED|Overall Study||19||
59555678|NCT02762877|75656054|FG000|NOT COMPLETED|Overall Study||0||
59555679|NCT02762877|75656055|FG001|NOT COMPLETED|Overall Study||0||
59555680|NCT02737917|75656064|FG000|STARTED|Overall Study||103||
59555681|NCT02737917|75656065|FG001|STARTED|Overall Study||103||
59555682|NCT02737917|75656064|FG000|COMPLETED|Overall Study||100||
59555683|NCT02737917|75656065|FG001|COMPLETED|Overall Study||100||
59555684|NCT02737917|75656064|FG000|NOT COMPLETED|Overall Study||3||
59555685|NCT02737917|75656065|FG001|NOT COMPLETED|Overall Study||3||
59555686|NCT02767011|75656073|FG000|STARTED|Overall Study||16||
59555687|NCT02767011|75656074|FG001|STARTED|Overall Study||14||
59555688|NCT02767011|75656073|FG000|COMPLETED|Overall Study||16||
59555689|NCT02767011|75656074|FG001|COMPLETED|Overall Study||14||
59555690|NCT02767011|75656073|FG000|NOT COMPLETED|Overall Study||0||
59555691|NCT02767011|75656074|FG001|NOT COMPLETED|Overall Study||0||
59555692|NCT01447706|75656082|FG000|STARTED|Overall Study||140||
59991877|NCT02219308|76107499|FG001|NOT COMPLETED|Overall Study||2||
59991878|NCT02218372|76107507|FG000|STARTED|Overall Study||100||
59555693|NCT01447706|75656083|FG001|STARTED|Overall Study|3 patients enrolled but not dosed|83||
59555694|NCT01447706|75656082|FG000|COMPLETED|Overall Study||140||
59555695|NCT01447706|75656083|FG001|COMPLETED|Overall Study||80||
59555696|NCT01447706|75656082|FG000|NOT COMPLETED|Overall Study||0||
59555697|NCT01447706|75656083|FG001|NOT COMPLETED|Overall Study||3||
59555698|NCT02739789|75656095|FG000|STARTED|First fMRI Scan||9||
59555699|NCT02739789|75656096|FG001|STARTED|First fMRI Scan||10||
59555700|NCT02739789|75656095|FG000|COMPLETED|First fMRI Scan||9||
59555701|NCT02739789|75656096|FG001|COMPLETED|First fMRI Scan||10||
59555702|NCT02739789|75656095|FG000|NOT COMPLETED|First fMRI Scan||0||
59555703|NCT02739789|75656096|FG001|NOT COMPLETED|First fMRI Scan||0||
59555704|NCT02739789|75656095|FG000|STARTED|~1 Week Waiting Period||9||
59555705|NCT02739789|75656096|FG001|STARTED|~1 Week Waiting Period||10||
59555706|NCT02739789|75656095|FG000|COMPLETED|~1 Week Waiting Period||9||
59555707|NCT02739789|75656096|FG001|COMPLETED|~1 Week Waiting Period||7||
59555708|NCT02739789|75656095|FG000|NOT COMPLETED|~1 Week Waiting Period||0||
59555709|NCT02739789|75656096|FG001|NOT COMPLETED|~1 Week Waiting Period||3||
59555710|NCT02739789|75656095|FG000|STARTED|Second fMRI Scan||9||
59555711|NCT02739789|75656096|FG001|STARTED|Second fMRI Scan||7||
59555712|NCT02739789|75656095|FG000|COMPLETED|Second fMRI Scan||9||
59555713|NCT02739789|75656096|FG001|COMPLETED|Second fMRI Scan||7||
59555714|NCT02739789|75656095|FG000|NOT COMPLETED|Second fMRI Scan||0||
59555715|NCT02739789|75656096|FG001|NOT COMPLETED|Second fMRI Scan||0||
59555716|NCT02740413|75656102|FG000|STARTED|Overall Study||86||
59707227|NCT01255787|75826151|FG000|COMPLETED|Overall Study||136||
59555717|NCT02740413|75656102|FG000|COMPLETED|Overall Study||86||
59555718|NCT02740413|75656102|FG000|NOT COMPLETED|Overall Study||0||
59555719|NCT01509638|75656112|FG000|STARTED|Overall Study||23||
59991879|NCT02218372|76107508|FG001|STARTED|Overall Study||48||
59991880|NCT02218372|76107507|FG000|Treated|Overall Study||98||
59991881|NCT02218372|76107508|FG001|Treated|Overall Study||44||
59991882|NCT02218372|76107507|FG000|COMPLETED|Overall Study||95||
59991883|NCT02218372|76107508|FG001|COMPLETED|Overall Study||42||
59555720|NCT01509638|75656113|FG001|STARTED|Overall Study||26||
59555721|NCT01509638|75656112|FG000|COMPLETED|Overall Study||20||
59555722|NCT01509638|75656113|FG001|COMPLETED|Overall Study||24||
59555723|NCT01509638|75656112|FG000|NOT COMPLETED|Overall Study||3||
59555724|NCT01509638|75656113|FG001|NOT COMPLETED|Overall Study||2||
59555725|NCT01448486|75656121|FG000|STARTED|Overall Study||3||
59555726|NCT01448486|75656122|FG001|STARTED|Overall Study||3||
59707228|NCT01255787|75826152|FG001|COMPLETED|Overall Study||127||
59555727|NCT01448486|75656121|FG000|COMPLETED|Overall Study||3||
59555728|NCT01448486|75656122|FG001|COMPLETED|Overall Study||3||
59555729|NCT01448486|75656121|FG000|NOT COMPLETED|Overall Study||0||
59555730|NCT01448486|75656122|FG001|NOT COMPLETED|Overall Study||0||
59555731|NCT01562678|75656130|FG000|STARTED|Overall Study||14||
59555732|NCT01562678|75656131|FG001|STARTED|Overall Study||14||
59555733|NCT01562678|75656130|FG000|COMPLETED|Overall Study||8||
59555734|NCT01562678|75656131|FG001|COMPLETED|Overall Study||12||
59555735|NCT01562678|75656130|FG000|NOT COMPLETED|Overall Study||6||
59555736|NCT01562678|75656131|FG001|NOT COMPLETED|Overall Study||2||
59555737|NCT01562756|75656137|FG000|STARTED|Overall Study||6||
59555738|NCT01562756|75656137|FG000|COMPLETED|Overall Study||6||
59555739|NCT01562756|75656137|FG000|NOT COMPLETED|Overall Study||0||
59555740|NCT02767869|75656143|FG000|STARTED|Overall Study||12||
59555741|NCT02767869|75656144|FG001|STARTED|Overall Study||12||
59555742|NCT02767869|75656143|FG000|COMPLETED|Overall Study||12||
59555743|NCT02767869|75656144|FG001|COMPLETED|Overall Study||12||
59555744|NCT02767869|75656143|FG000|NOT COMPLETED|Overall Study||0||
59555745|NCT02767869|75656144|FG001|NOT COMPLETED|Overall Study||0||
59555746|NCT01449266|75656150|FG000|STARTED|Overall Study||10||
59555747|NCT01449266|75656150|FG000|COMPLETED|Overall Study||10||
59555748|NCT01449266|75656150|FG000|NOT COMPLETED|Overall Study||0||
59555749|NCT01509872|75656156|FG000|STARTED|Overall Study||26||
59555750|NCT01509872|75656157|FG001|STARTED|Overall Study||24||
59555751|NCT01509872|75656156|FG000|Post-Intervention Assessment|Overall Study||26||
59555752|NCT01509872|75656157|FG001|Post-Intervention Assessment|Overall Study||24||
59555753|NCT01509872|75656156|FG000|COMPLETED|Overall Study||25||
59555754|NCT01509872|75656157|FG001|COMPLETED|Overall Study||24||
59555755|NCT01509872|75656156|FG000|NOT COMPLETED|Overall Study||1||
59555756|NCT01509872|75656157|FG001|NOT COMPLETED|Overall Study||0||
59555757|NCT02767947|75656167|FG000|STARTED|Overall Study||60||
59555758|NCT02767947|75656168|FG001|STARTED|Overall Study||15||
59555759|NCT02767947|75656167|FG000|Safety Population|Overall Study||60|Received at least 1 application of study drug.|
59555760|NCT02767947|75656168|FG001|Safety Population|Overall Study||15|Received at least 1 application of study drug.|
59555761|NCT02767947|75656167|FG000|Pharmacokinetic (PK) Population|Overall Study||12|Received at least 1 dose of study drug, and had blood samples obtained both pre and 6 hrs post-dose.|
59555762|NCT02767947|75656168|FG001|Pharmacokinetic (PK) Population|Overall Study||3|Received at least 1 dose of study drug, and had blood samples obtained both pre and 6 hrs post-dose.|
59555763|NCT02767947|75656167|FG000|COMPLETED|Overall Study||60||
59555764|NCT02767947|75656168|FG001|COMPLETED|Overall Study||15||
59555765|NCT02767947|75656167|FG000|NOT COMPLETED|Overall Study||0||
59555766|NCT02767947|75656168|FG001|NOT COMPLETED|Overall Study||0||
59555767|NCT01449734|75656174|FG000|STARTED|Overall Study||215||
59555768|NCT01449734|75656174|FG000|COMPLETED|Overall Study||215||
59555769|NCT01449734|75656174|FG000|NOT COMPLETED|Overall Study||0||
59555770|NCT01509950|75656180|FG000|STARTED|Overall Study||7||
59555771|NCT01509950|75656181|FG001|STARTED|Overall Study||8||
59555772|NCT01509950|75656182|FG002|STARTED|Overall Study||0||
59555773|NCT01509950|75656180|FG000|COMPLETED|Overall Study||7||
59555774|NCT01509950|75656181|FG001|COMPLETED|Overall Study||8||
59555775|NCT01509950|75656182|FG002|COMPLETED|Overall Study||0||
59555776|NCT01509950|75656180|FG000|NOT COMPLETED|Overall Study||0||
59555777|NCT01509950|75656181|FG001|NOT COMPLETED|Overall Study||0||
59555778|NCT01509950|75656182|FG002|NOT COMPLETED|Overall Study||0||
59555779|NCT02769351|75656188|FG000|STARTED|Overall Study|SP|46||
59555780|NCT02769351|75656188|FG000|COMPLETED|Overall Study|SP|4||
59555781|NCT02769351|75656188|FG000|NOT COMPLETED|Overall Study||42||
59555782|NCT02770287|75656193|FG000|STARTED|Overall Study||11||
59555783|NCT02770287|75656193|FG000|COMPLETED|Overall Study||11||
59555784|NCT02770287|75656193|FG000|NOT COMPLETED|Overall Study||0||
59555785|NCT02770365|75656203|FG000|STARTED|Overall Study||277||
59555786|NCT02770365|75656204|FG001|STARTED|Overall Study||279||
59555787|NCT02770365|75656205|FG002|STARTED|Overall Study||139||
59555788|NCT02770365|75656203|FG000|COMPLETED|Overall Study||272||
59555789|NCT02770365|75656204|FG001|COMPLETED|Overall Study||275||
59555790|NCT02770365|75656205|FG002|COMPLETED|Overall Study||139||
59555791|NCT02770365|75656203|FG000|NOT COMPLETED|Overall Study||5||
59555792|NCT02770365|75656204|FG001|NOT COMPLETED|Overall Study||4||
59555793|NCT02770365|75656205|FG002|NOT COMPLETED|Overall Study||0||
59555794|NCT01510652|75656215|FG000|STARTED|Overall Study||719||
59555795|NCT01510652|75656216|FG001|STARTED|Overall Study||355||
59555796|NCT01510652|75656215|FG000|Baseline|Overall Study||718||
59555797|NCT01510652|75656216|FG001|Baseline|Overall Study||348||
59555798|NCT01510652|75656215|FG000|COMPLETED|Overall Study||627||
59555799|NCT01510652|75656216|FG001|COMPLETED|Overall Study||288||
59555800|NCT01510652|75656215|FG000|NOT COMPLETED|Overall Study||92||
59555801|NCT01510652|75656216|FG001|NOT COMPLETED|Overall Study||67||
59555802|NCT02770521|75656224|FG000|STARTED|Period One||4||
59555803|NCT02770521|75656225|FG001|STARTED|Period One||4||
59555804|NCT02770521|75656226|FG002|STARTED|Period One||2||
59555805|NCT02770521|75656227|FG003|STARTED|Period One||2||
59555806|NCT02770521|75656228|FG004|STARTED|Period One||2||
59555807|NCT02770521|75656229|FG005|STARTED|Period One||9||
59555808|NCT02770521|75656224|FG000|Received Study Drug|Period One||4||
59555809|NCT02770521|75656225|FG001|Received Study Drug|Period One||4||
59555810|NCT02770521|75656226|FG002|Received Study Drug|Period One||2||
59555811|NCT02770521|75656227|FG003|Received Study Drug|Period One||2||
59555812|NCT02770521|75656228|FG004|Received Study Drug|Period One||2||
59707229|NCT01255787|75826153|FG002|COMPLETED|Overall Study||132||
59707230|NCT01255787|75826154|FG003|COMPLETED|Overall Study||132||
59707231|NCT01255787|75826151|FG000|NOT COMPLETED|Overall Study||16||
59555813|NCT02770521|75656229|FG005|Received Study Drug|Period One||9||
59555814|NCT02770521|75656224|FG000|COMPLETED|Period One||4||
59555815|NCT02770521|75656225|FG001|COMPLETED|Period One||4||
59555816|NCT02770521|75656226|FG002|COMPLETED|Period One||2||
59555817|NCT02770521|75656227|FG003|COMPLETED|Period One||2||
59555818|NCT02770521|75656228|FG004|COMPLETED|Period One||2||
59555819|NCT02770521|75656229|FG005|COMPLETED|Period One||9||
59555820|NCT02770521|75656224|FG000|NOT COMPLETED|Period One||0||
59555821|NCT02770521|75656225|FG001|NOT COMPLETED|Period One||0||
59555822|NCT02770521|75656226|FG002|NOT COMPLETED|Period One||0||
59707232|NCT01255787|75826152|FG001|NOT COMPLETED|Overall Study||17||
59555823|NCT02770521|75656227|FG003|NOT COMPLETED|Period One||0||
59555824|NCT02770521|75656228|FG004|NOT COMPLETED|Period One||0||
59555825|NCT02770521|75656229|FG005|NOT COMPLETED|Period One||0||
59555826|NCT02770521|75656224|FG000|STARTED|Period Two||4||
59555827|NCT02770521|75656225|FG001|STARTED|Period Two||4||
59555828|NCT02770521|75656226|FG002|STARTED|Period Two||2||
59555829|NCT02770521|75656227|FG003|STARTED|Period Two||2||
59555830|NCT02770521|75656228|FG004|STARTED|Period Two||2||
59555831|NCT02770521|75656229|FG005|STARTED|Period Two||9||
59555832|NCT02770521|75656224|FG000|Received Study Drug|Period Two||4||
59555833|NCT02770521|75656225|FG001|Received Study Drug|Period Two||4||
59555834|NCT02770521|75656226|FG002|Received Study Drug|Period Two||2||
59555835|NCT02770521|75656227|FG003|Received Study Drug|Period Two||2||
59555836|NCT02770521|75656228|FG004|Received Study Drug|Period Two||2||
59555837|NCT02770521|75656229|FG005|Received Study Drug|Period Two||9||
59555838|NCT02770521|75656224|FG000|COMPLETED|Period Two||4||
59555839|NCT02770521|75656225|FG001|COMPLETED|Period Two||4||
59555840|NCT02770521|75656226|FG002|COMPLETED|Period Two||2||
59555841|NCT02770521|75656227|FG003|COMPLETED|Period Two||2||
59555842|NCT02770521|75656228|FG004|COMPLETED|Period Two||2||
59555843|NCT02770521|75656229|FG005|COMPLETED|Period Two||9||
59555844|NCT02770521|75656224|FG000|NOT COMPLETED|Period Two||0||
59555845|NCT02770521|75656225|FG001|NOT COMPLETED|Period Two||0||
59555846|NCT02770521|75656226|FG002|NOT COMPLETED|Period Two||0||
59555847|NCT02770521|75656227|FG003|NOT COMPLETED|Period Two||0||
59555848|NCT02770521|75656228|FG004|NOT COMPLETED|Period Two||0||
59555849|NCT02770521|75656229|FG005|NOT COMPLETED|Period Two||0||
59555850|NCT02770521|75656224|FG000|STARTED|Period Three|Not applicable. Part A only had two periods.|0||
59555851|NCT02770521|75656225|FG001|STARTED|Period Three|Not applicable. Part A only had two periods.|0||
59555852|NCT02770521|75656226|FG002|STARTED|Period Three||2||
59555853|NCT02770521|75656227|FG003|STARTED|Period Three||2||
59555854|NCT02770521|75656228|FG004|STARTED|Period Three||2||
59555855|NCT02770521|75656229|FG005|STARTED|Period Three||9||
59555856|NCT02770521|75656224|FG000|Received Study Drug|Period Three||0||
59555857|NCT02770521|75656225|FG001|Received Study Drug|Period Three||0||
59555858|NCT02770521|75656226|FG002|Received Study Drug|Period Three||2||
59555859|NCT02770521|75656227|FG003|Received Study Drug|Period Three||2||
59555860|NCT02770521|75656228|FG004|Received Study Drug|Period Three||2||
59555861|NCT02770521|75656229|FG005|Received Study Drug|Period Three||9||
59555862|NCT02770521|75656224|FG000|COMPLETED|Period Three||0||
59555863|NCT02770521|75656225|FG001|COMPLETED|Period Three||0||
59555864|NCT02770521|75656226|FG002|COMPLETED|Period Three||2||
59555865|NCT02770521|75656227|FG003|COMPLETED|Period Three||2||
59555866|NCT02770521|75656228|FG004|COMPLETED|Period Three||2||
59555867|NCT02770521|75656229|FG005|COMPLETED|Period Three||9||
59555868|NCT02770521|75656224|FG000|NOT COMPLETED|Period Three||0||
59707233|NCT01255787|75826153|FG002|NOT COMPLETED|Overall Study||18||
59707234|NCT01255787|75826154|FG003|NOT COMPLETED|Overall Study||22||
59707235|NCT01123161|75826166|FG000|STARTED|Overall Study||57||
59707236|NCT01123161|75826167|FG001|STARTED|Overall Study||63||
59555869|NCT02770521|75656225|FG001|NOT COMPLETED|Period Three||0||
59555870|NCT02770521|75656226|FG002|NOT COMPLETED|Period Three||0||
59555871|NCT02770521|75656227|FG003|NOT COMPLETED|Period Three||0||
59555872|NCT02770521|75656228|FG004|NOT COMPLETED|Period Three||0||
59555873|NCT02770521|75656229|FG005|NOT COMPLETED|Period Three||0||
59555874|NCT02346240|75656251|FG000|STARTED|Initial Period (Baseline to Week 16)||57||
59555875|NCT02346240|75656252|FG001|STARTED|Initial Period (Baseline to Week 16)||170||
59555876|NCT02346240|75656253|FG002|STARTED|Initial Period (Baseline to Week 16)||165||
59555877|NCT02346240|75656254|FG003|STARTED|Initial Period (Baseline to Week 16)||167||
59555878|NCT02346240|75656255|FG004|STARTED|Initial Period (Baseline to Week 16)||0||
59555879|NCT02346240|75656256|FG005|STARTED|Initial Period (Baseline to Week 16)||0||
59555880|NCT02346240|75656257|FG006|STARTED|Initial Period (Baseline to Week 16)||0||
59555881|NCT02346240|75656258|FG007|STARTED|Initial Period (Baseline to Week 16)||0||
59555882|NCT02346240|75656259|FG008|STARTED|Initial Period (Baseline to Week 16)||0||
59555883|NCT02346240|75656260|FG009|STARTED|Initial Period (Baseline to Week 16)||0||
59555884|NCT02346240|75656261|FG010|STARTED|Initial Period (Baseline to Week 16)||0||
59555885|NCT02346240|75656262|FG011|STARTED|Initial Period (Baseline to Week 16)||0||
59555886|NCT02346240|75656263|FG012|STARTED|Initial Period (Baseline to Week 16)||0||
59555887|NCT02346240|75656264|FG013|STARTED|Initial Period (Baseline to Week 16)||0||
59555888|NCT02346240|75656265|FG014|STARTED|Initial Period (Baseline to Week 16)||0||
59555889|NCT02346240|75656266|FG015|STARTED|Initial Period (Baseline to Week 16)||0||
59555890|NCT02346240|75656267|FG016|STARTED|Initial Period (Baseline to Week 16)||0||
59555891|NCT02346240|75656268|FG017|STARTED|Initial Period (Baseline to Week 16)||0||
59555892|NCT02346240|75656269|FG018|STARTED|Initial Period (Baseline to Week 16)||0||
59555893|NCT02346240|75656270|FG019|STARTED|Initial Period (Baseline to Week 16)||0||
59555894|NCT02346240|75656271|FG020|STARTED|Initial Period (Baseline to Week 16)||0||
59555895|NCT02346240|75656272|FG021|STARTED|Initial Period (Baseline to Week 16)||0||
59555896|NCT02346240|75656273|FG022|STARTED|Initial Period (Baseline to Week 16)||0||
59555897|NCT02346240|75656274|FG023|STARTED|Initial Period (Baseline to Week 16)||0||
59555898|NCT02346240|75656251|FG000|Completed Week 16|Initial Period (Baseline to Week 16)||55||
59555899|NCT02346240|75656252|FG001|Completed Week 16|Initial Period (Baseline to Week 16)||159||
59555900|NCT02346240|75656253|FG002|Completed Week 16|Initial Period (Baseline to Week 16)||159||
59555901|NCT02346240|75656254|FG003|Completed Week 16|Initial Period (Baseline to Week 16)||162||
59555902|NCT02346240|75656255|FG004|Completed Week 16|Initial Period (Baseline to Week 16)||0||
59555903|NCT02346240|75656256|FG005|Completed Week 16|Initial Period (Baseline to Week 16)||0||
59555904|NCT02346240|75656257|FG006|Completed Week 16|Initial Period (Baseline to Week 16)||0||
59555905|NCT02346240|75656258|FG007|Completed Week 16|Initial Period (Baseline to Week 16)||0||
59555906|NCT02346240|75656259|FG008|Completed Week 16|Initial Period (Baseline to Week 16)||0||
59555907|NCT02346240|75656260|FG009|Completed Week 16|Initial Period (Baseline to Week 16)||0||
59555908|NCT02346240|75656261|FG010|Completed Week 16|Initial Period (Baseline to Week 16)||0||
59555909|NCT02346240|75656262|FG011|Completed Week 16|Initial Period (Baseline to Week 16)||0||
59555910|NCT02346240|75656263|FG012|Completed Week 16|Initial Period (Baseline to Week 16)||0||
59555911|NCT02346240|75656264|FG013|Completed Week 16|Initial Period (Baseline to Week 16)||0||
59555912|NCT02346240|75656265|FG014|Completed Week 16|Initial Period (Baseline to Week 16)||0||
59555913|NCT02346240|75656266|FG015|Completed Week 16|Initial Period (Baseline to Week 16)||0||
59555914|NCT02346240|75656267|FG016|Completed Week 16|Initial Period (Baseline to Week 16)||0||
59555915|NCT02346240|75656268|FG017|Completed Week 16|Initial Period (Baseline to Week 16)||0||
59555916|NCT02346240|75656269|FG018|Completed Week 16|Initial Period (Baseline to Week 16)||0||
59555917|NCT02346240|75656270|FG019|Completed Week 16|Initial Period (Baseline to Week 16)||0||
59555918|NCT02346240|75656271|FG020|Completed Week 16|Initial Period (Baseline to Week 16)||0||
59555919|NCT02346240|75656272|FG021|Completed Week 16|Initial Period (Baseline to Week 16)||0||
59555920|NCT02346240|75656273|FG022|Completed Week 16|Initial Period (Baseline to Week 16)||0||
59555921|NCT02346240|75656274|FG023|Completed Week 16|Initial Period (Baseline to Week 16)||0||
59555922|NCT02346240|75656251|FG000|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||55||
59555923|NCT02346240|75656252|FG001|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||159||
59555924|NCT02346240|75656253|FG002|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||159||
59555925|NCT02346240|75656254|FG003|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||160||
59555926|NCT02346240|75656255|FG004|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0||
59555927|NCT02346240|75656256|FG005|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0||
59555928|NCT02346240|75656257|FG006|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0||
59555929|NCT02346240|75656258|FG007|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0||
59707237|NCT01123161|75826166|FG000|COMPLETED|Overall Study||55||
59707238|NCT01123161|75826167|FG001|COMPLETED|Overall Study||63||
59816605|NCT04915950|75939026|FG005|STARTED|Stage A:Washout Period(72hours to 7days)||2||
59816606|NCT04915950|75939021|FG000|COMPLETED|Stage A:Washout Period(72hours to 7days)||2||
59816607|NCT04915950|75939022|FG001|COMPLETED|Stage A:Washout Period(72hours to 7days)||2||
59555930|NCT02346240|75656259|FG008|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0||
59555931|NCT02346240|75656260|FG009|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0||
59555932|NCT02346240|75656261|FG010|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0||
59555933|NCT02346240|75656262|FG011|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0||
59555934|NCT02346240|75656263|FG012|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0||
59555935|NCT02346240|75656264|FG013|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0||
59555936|NCT02346240|75656265|FG014|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0||
59555937|NCT02346240|75656266|FG015|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0||
59555938|NCT02346240|75656267|FG016|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0||
59555939|NCT02346240|75656268|FG017|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0||
59555940|NCT02346240|75656269|FG018|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0||
59555941|NCT02346240|75656270|FG019|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0||
59555942|NCT02346240|75656271|FG020|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0||
59555943|NCT02346240|75656272|FG021|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0||
59555944|NCT02346240|75656273|FG022|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0||
59555945|NCT02346240|75656274|FG023|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0||
59555946|NCT02346240|75656251|FG000|COMPLETED|Initial Period (Baseline to Week 16)||55||
59555947|NCT02346240|75656252|FG001|COMPLETED|Initial Period (Baseline to Week 16)||159||
59555948|NCT02346240|75656253|FG002|COMPLETED|Initial Period (Baseline to Week 16)||159||
59555949|NCT02346240|75656254|FG003|COMPLETED|Initial Period (Baseline to Week 16)||160||
59555950|NCT02346240|75656255|FG004|COMPLETED|Initial Period (Baseline to Week 16)||0||
59555951|NCT02346240|75656256|FG005|COMPLETED|Initial Period (Baseline to Week 16)||0||
59555952|NCT02346240|75656257|FG006|COMPLETED|Initial Period (Baseline to Week 16)||0||
59555953|NCT02346240|75656258|FG007|COMPLETED|Initial Period (Baseline to Week 16)||0||
59555954|NCT02346240|75656259|FG008|COMPLETED|Initial Period (Baseline to Week 16)||0||
59555955|NCT02346240|75656260|FG009|COMPLETED|Initial Period (Baseline to Week 16)||0||
59555956|NCT02346240|75656261|FG010|COMPLETED|Initial Period (Baseline to Week 16)||0||
59555957|NCT02346240|75656262|FG011|COMPLETED|Initial Period (Baseline to Week 16)||0||
59555958|NCT02346240|75656263|FG012|COMPLETED|Initial Period (Baseline to Week 16)||0||
59555959|NCT02346240|75656264|FG013|COMPLETED|Initial Period (Baseline to Week 16)||0||
59555960|NCT02346240|75656265|FG014|COMPLETED|Initial Period (Baseline to Week 16)||0||
59555961|NCT02346240|75656266|FG015|COMPLETED|Initial Period (Baseline to Week 16)||0||
59555962|NCT02346240|75656267|FG016|COMPLETED|Initial Period (Baseline to Week 16)||0||
59555963|NCT02346240|75656268|FG017|COMPLETED|Initial Period (Baseline to Week 16)||0||
59555964|NCT02346240|75656269|FG018|COMPLETED|Initial Period (Baseline to Week 16)||0||
59555965|NCT02346240|75656270|FG019|COMPLETED|Initial Period (Baseline to Week 16)||0||
59555966|NCT02346240|75656271|FG020|COMPLETED|Initial Period (Baseline to Week 16)||0||
59555967|NCT02346240|75656272|FG021|COMPLETED|Initial Period (Baseline to Week 16)||0||
59555968|NCT02346240|75656273|FG022|COMPLETED|Initial Period (Baseline to Week 16)||0||
59555969|NCT02346240|75656274|FG023|COMPLETED|Initial Period (Baseline to Week 16)||0||
59555970|NCT02346240|75656251|FG000|NOT COMPLETED|Initial Period (Baseline to Week 16)||2||
59555971|NCT02346240|75656252|FG001|NOT COMPLETED|Initial Period (Baseline to Week 16)||11||
59555972|NCT02346240|75656253|FG002|NOT COMPLETED|Initial Period (Baseline to Week 16)||6||
59555973|NCT02346240|75656254|FG003|NOT COMPLETED|Initial Period (Baseline to Week 16)||7||
59555974|NCT02346240|75656255|FG004|NOT COMPLETED|Initial Period (Baseline to Week 16)||0||
59555975|NCT02346240|75656256|FG005|NOT COMPLETED|Initial Period (Baseline to Week 16)||0||
59555976|NCT02346240|75656257|FG006|NOT COMPLETED|Initial Period (Baseline to Week 16)||0||
59555977|NCT02346240|75656258|FG007|NOT COMPLETED|Initial Period (Baseline to Week 16)||0||
59555978|NCT02346240|75656259|FG008|NOT COMPLETED|Initial Period (Baseline to Week 16)||0||
59555979|NCT02346240|75656260|FG009|NOT COMPLETED|Initial Period (Baseline to Week 16)||0||
59816608|NCT04915950|75939023|FG002|COMPLETED|Stage A:Washout Period(72hours to 7days)||2||
59555980|NCT02346240|75656261|FG010|NOT COMPLETED|Initial Period (Baseline to Week 16)||0||
59555981|NCT02346240|75656262|FG011|NOT COMPLETED|Initial Period (Baseline to Week 16)||0||
59555982|NCT02346240|75656263|FG012|NOT COMPLETED|Initial Period (Baseline to Week 16)||0||
59555983|NCT02346240|75656264|FG013|NOT COMPLETED|Initial Period (Baseline to Week 16)||0||
59555984|NCT02346240|75656265|FG014|NOT COMPLETED|Initial Period (Baseline to Week 16)||0||
59555985|NCT02346240|75656266|FG015|NOT COMPLETED|Initial Period (Baseline to Week 16)||0||
59555986|NCT02346240|75656267|FG016|NOT COMPLETED|Initial Period (Baseline to Week 16)||0||
59555987|NCT02346240|75656268|FG017|NOT COMPLETED|Initial Period (Baseline to Week 16)||0||
59555988|NCT02346240|75656269|FG018|NOT COMPLETED|Initial Period (Baseline to Week 16)||0||
59707239|NCT01123161|75826166|FG000|NOT COMPLETED|Overall Study||2||
59707240|NCT01123161|75826167|FG001|NOT COMPLETED|Overall Study||0||
59707241|NCT01255631|75826178|FG000|STARTED|Overall Study||13||
59707242|NCT01255631|75826179|FG001|STARTED|Overall Study||9||
59707243|NCT01255631|75826178|FG000|COMPLETED|Overall Study|study terminated due to poor enrollment|4||
59555989|NCT02346240|75656270|FG019|NOT COMPLETED|Initial Period (Baseline to Week 16)||0||
59555990|NCT02346240|75656271|FG020|NOT COMPLETED|Initial Period (Baseline to Week 16)||0||
59555991|NCT02346240|75656272|FG021|NOT COMPLETED|Initial Period (Baseline to Week 16)||0||
59555992|NCT02346240|75656273|FG022|NOT COMPLETED|Initial Period (Baseline to Week 16)||0||
59555993|NCT02346240|75656274|FG023|NOT COMPLETED|Initial Period (Baseline to Week 16)||0||
59555994|NCT02346240|75656251|FG000|STARTED|Maintenance Period (Week 16 to Week 48)||0||
59555995|NCT02346240|75656252|FG001|STARTED|Maintenance Period (Week 16 to Week 48)||0||
59555996|NCT02346240|75656253|FG002|STARTED|Maintenance Period (Week 16 to Week 48)||0||
59555997|NCT02346240|75656254|FG003|STARTED|Maintenance Period (Week 16 to Week 48)||0||
59555998|NCT02346240|75656255|FG004|STARTED|Maintenance Period (Week 16 to Week 48)||2||
59555999|NCT02346240|75656256|FG005|STARTED|Maintenance Period (Week 16 to Week 48)||24||
59556000|NCT02346240|75656257|FG006|STARTED|Maintenance Period (Week 16 to Week 48)||50||
59556001|NCT02346240|75656258|FG007|STARTED|Maintenance Period (Week 16 to Week 48)||22||
59556002|NCT02346240|75656259|FG008|STARTED|Maintenance Period (Week 16 to Week 48)||44||
59556003|NCT02346240|75656260|FG009|STARTED|Maintenance Period (Week 16 to Week 48)||44||
59556004|NCT02346240|75656261|FG010|STARTED|Maintenance Period (Week 16 to Week 48)||25||
59556005|NCT02346240|75656262|FG011|STARTED|Maintenance Period (Week 16 to Week 48)||50||
59556006|NCT02346240|75656263|FG012|STARTED|Maintenance Period (Week 16 to Week 48)||49||
59556007|NCT02346240|75656264|FG013|STARTED|Maintenance Period (Week 16 to Week 48)||53||
59556008|NCT02346240|75656265|FG014|STARTED|Maintenance Period (Week 16 to Week 48)||85||
59556009|NCT02346240|75656266|FG015|STARTED|Maintenance Period (Week 16 to Week 48)||49||
59556010|NCT02346240|75656267|FG016|STARTED|Maintenance Period (Week 16 to Week 48)||36||
59556011|NCT02346240|75656268|FG017|STARTED|Maintenance Period (Week 16 to Week 48)||0||
59556012|NCT02346240|75656269|FG018|STARTED|Maintenance Period (Week 16 to Week 48)||0||
59556013|NCT02346240|75656270|FG019|STARTED|Maintenance Period (Week 16 to Week 48)||0||
59556014|NCT02346240|75656271|FG020|STARTED|Maintenance Period (Week 16 to Week 48)||0||
59556015|NCT02346240|75656272|FG021|STARTED|Maintenance Period (Week 16 to Week 48)||0||
59556016|NCT02346240|75656273|FG022|STARTED|Maintenance Period (Week 16 to Week 48)||0||
59556017|NCT02346240|75656274|FG023|STARTED|Maintenance Period (Week 16 to Week 48)||0||
59556018|NCT02346240|75656251|FG000|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0||
59556019|NCT02346240|75656252|FG001|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0||
59556020|NCT02346240|75656253|FG002|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0||
59556021|NCT02346240|75656254|FG003|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0||
59556022|NCT02346240|75656255|FG004|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||2||
59556023|NCT02346240|75656256|FG005|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||23||
59556024|NCT02346240|75656257|FG006|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||48||
59556025|NCT02346240|75656258|FG007|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||20||
59556026|NCT02346240|75656259|FG008|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||40||
59556027|NCT02346240|75656260|FG009|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||43||
59556028|NCT02346240|75656261|FG010|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||23||
59556029|NCT02346240|75656262|FG011|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||47||
59556030|NCT02346240|75656263|FG012|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||49||
59556031|NCT02346240|75656264|FG013|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||46||
59556032|NCT02346240|75656265|FG014|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||71||
59556033|NCT02346240|75656266|FG015|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||36||
59991884|NCT02218372|76107507|FG000|NOT COMPLETED|Overall Study||5||
59707244|NCT01255631|75826179|FG001|COMPLETED|Overall Study|study terminated due to poor enrollment|3||
59707245|NCT01255631|75826178|FG000|NOT COMPLETED|Overall Study||9||
59707246|NCT01255631|75826179|FG001|NOT COMPLETED|Overall Study||6||
59707247|NCT00999466|75826188|FG000|STARTED|Pilot Part||6||
59707248|NCT00999466|75826189|FG001|STARTED|Pilot Part|AZD8848 nasal spray 60 μg group was not participated in the Pilot part|0||
59556034|NCT02346240|75656267|FG016|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||30||
59556035|NCT02346240|75656268|FG017|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0||
59556036|NCT02346240|75656269|FG018|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0||
59556037|NCT02346240|75656270|FG019|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0||
59816609|NCT04915950|75939024|FG003|COMPLETED|Stage A:Washout Period(72hours to 7days)||2||
59816610|NCT04915950|75939025|FG004|COMPLETED|Stage A:Washout Period(72hours to 7days)||3||
59816611|NCT04915950|75939026|FG005|COMPLETED|Stage A:Washout Period(72hours to 7days)||2||
59816612|NCT04915950|75939021|FG000|NOT COMPLETED|Stage A:Washout Period(72hours to 7days)||0||
59816613|NCT04915950|75939022|FG001|NOT COMPLETED|Stage A:Washout Period(72hours to 7days)||0||
59556038|NCT02346240|75656271|FG020|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0||
59556039|NCT02346240|75656272|FG021|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0||
59556040|NCT02346240|75656273|FG022|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0||
59556041|NCT02346240|75656274|FG023|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0||
59556042|NCT02346240|75656251|FG000|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0||
59556043|NCT02346240|75656252|FG001|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0||
59556044|NCT02346240|75656253|FG002|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0||
59556045|NCT02346240|75656254|FG003|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0||
59556046|NCT02346240|75656255|FG004|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||2||
59556047|NCT02346240|75656256|FG005|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||23||
59556048|NCT02346240|75656257|FG006|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||48||
59556049|NCT02346240|75656258|FG007|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||20||
59556050|NCT02346240|75656259|FG008|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||40||
59556051|NCT02346240|75656260|FG009|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||43||
59556052|NCT02346240|75656261|FG010|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||23||
59556053|NCT02346240|75656262|FG011|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||47||
59556054|NCT02346240|75656263|FG012|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||49||
59556055|NCT02346240|75656264|FG013|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||45||
59556056|NCT02346240|75656265|FG014|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||68||
59556057|NCT02346240|75656266|FG015|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||35||
59556058|NCT02346240|75656267|FG016|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||29||
59556059|NCT02346240|75656268|FG017|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0||
59556060|NCT02346240|75656269|FG018|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0||
59556061|NCT02346240|75656270|FG019|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0||
59556062|NCT02346240|75656271|FG020|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0||
59556063|NCT02346240|75656272|FG021|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0||
59556064|NCT02346240|75656273|FG022|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0||
59556065|NCT02346240|75656274|FG023|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0||
59556066|NCT02346240|75656251|FG000|COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
59556067|NCT02346240|75656252|FG001|COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
59556068|NCT02346240|75656253|FG002|COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
59556069|NCT02346240|75656254|FG003|COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
59556070|NCT02346240|75656255|FG004|COMPLETED|Maintenance Period (Week 16 to Week 48)||2||
59556071|NCT02346240|75656256|FG005|COMPLETED|Maintenance Period (Week 16 to Week 48)||23||
59556072|NCT02346240|75656257|FG006|COMPLETED|Maintenance Period (Week 16 to Week 48)||48||
59556073|NCT02346240|75656258|FG007|COMPLETED|Maintenance Period (Week 16 to Week 48)||20||
59556074|NCT02346240|75656259|FG008|COMPLETED|Maintenance Period (Week 16 to Week 48)||40||
59556075|NCT02346240|75656260|FG009|COMPLETED|Maintenance Period (Week 16 to Week 48)||43||
59556076|NCT02346240|75656261|FG010|COMPLETED|Maintenance Period (Week 16 to Week 48)||23||
59556077|NCT02346240|75656262|FG011|COMPLETED|Maintenance Period (Week 16 to Week 48)||47||
59816614|NCT04915950|75939023|FG002|NOT COMPLETED|Stage A:Washout Period(72hours to 7days)||0||
59816615|NCT04915950|75939024|FG003|NOT COMPLETED|Stage A:Washout Period(72hours to 7days)||0||
59816616|NCT04915950|75939025|FG004|NOT COMPLETED|Stage A:Washout Period(72hours to 7days)||0||
59816617|NCT04915950|75939026|FG005|NOT COMPLETED|Stage A:Washout Period(72hours to 7days)||0||
59556078|NCT02346240|75656263|FG012|COMPLETED|Maintenance Period (Week 16 to Week 48)||49||
59556079|NCT02346240|75656264|FG013|COMPLETED|Maintenance Period (Week 16 to Week 48)|1 subject completed the Maintenance Period but did not enter the Open-Label Period.|45||
59556080|NCT02346240|75656265|FG014|COMPLETED|Maintenance Period (Week 16 to Week 48)|3 subjects completed the Maintenance Period but did not enter the Open-Label Period.|68||
59556081|NCT02346240|75656266|FG015|COMPLETED|Maintenance Period (Week 16 to Week 48)|1 subject completed the Maintenance Period but did not enter the Open-Label Period.|35||
59556082|NCT02346240|75656267|FG016|COMPLETED|Maintenance Period (Week 16 to Week 48)|1 subject completed the Maintenance Period but did not enter the Open-Label Period.|29||
59556083|NCT02346240|75656268|FG017|COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
59556084|NCT02346240|75656269|FG018|COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
59556085|NCT02346240|75656270|FG019|COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
59556086|NCT02346240|75656271|FG020|COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
59556087|NCT02346240|75656272|FG021|COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
59556088|NCT02346240|75656273|FG022|COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
59556089|NCT02346240|75656274|FG023|COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
59556090|NCT02346240|75656251|FG000|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
59556091|NCT02346240|75656252|FG001|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
59556092|NCT02346240|75656253|FG002|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
59556093|NCT02346240|75656254|FG003|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
59556094|NCT02346240|75656255|FG004|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
59556095|NCT02346240|75656256|FG005|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||1||
59556096|NCT02346240|75656257|FG006|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||2||
59556097|NCT02346240|75656258|FG007|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||2||
59556098|NCT02346240|75656259|FG008|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||4||
59556099|NCT02346240|75656260|FG009|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||1||
59556100|NCT02346240|75656261|FG010|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||2||
59556101|NCT02346240|75656262|FG011|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||3||
59556102|NCT02346240|75656263|FG012|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
59556103|NCT02346240|75656264|FG013|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||8||
59556104|NCT02346240|75656265|FG014|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||17||
59556105|NCT02346240|75656266|FG015|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||14||
59556106|NCT02346240|75656267|FG016|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||7||
59556107|NCT02346240|75656268|FG017|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
59556108|NCT02346240|75656269|FG018|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
59556109|NCT02346240|75656270|FG019|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
59556110|NCT02346240|75656271|FG020|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
59556111|NCT02346240|75656272|FG021|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
59556112|NCT02346240|75656273|FG022|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
59556113|NCT02346240|75656274|FG023|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
59556114|NCT02346240|75656251|FG000|STARTED|Open-Label Period (Week 48 to Week 144)||0||
59556115|NCT02346240|75656252|FG001|STARTED|Open-Label Period (Week 48 to Week 144)||0||
59556116|NCT02346240|75656253|FG002|STARTED|Open-Label Period (Week 48 to Week 144)||0||
59556117|NCT02346240|75656254|FG003|STARTED|Open-Label Period (Week 48 to Week 144)||0||
59556118|NCT02346240|75656255|FG004|STARTED|Open-Label Period (Week 48 to Week 144)||0||
59556119|NCT02346240|75656256|FG005|STARTED|Open-Label Period (Week 48 to Week 144)||0||
59556120|NCT02346240|75656257|FG006|STARTED|Open-Label Period (Week 48 to Week 144)||0||
59556121|NCT02346240|75656258|FG007|STARTED|Open-Label Period (Week 48 to Week 144)||0||
59556122|NCT02346240|75656259|FG008|STARTED|Open-Label Period (Week 48 to Week 144)||0||
59556123|NCT02346240|75656260|FG009|STARTED|Open-Label Period (Week 48 to Week 144)||0||
59556124|NCT02346240|75656261|FG010|STARTED|Open-Label Period (Week 48 to Week 144)||0||
59556125|NCT02346240|75656262|FG011|STARTED|Open-Label Period (Week 48 to Week 144)||0||
59556126|NCT02346240|75656263|FG012|STARTED|Open-Label Period (Week 48 to Week 144)||0||
59556127|NCT02346240|75656264|FG013|STARTED|Open-Label Period (Week 48 to Week 144)||0||
59556128|NCT02346240|75656265|FG014|STARTED|Open-Label Period (Week 48 to Week 144)||0||
59556129|NCT02346240|75656266|FG015|STARTED|Open-Label Period (Week 48 to Week 144)||0||
59556130|NCT02346240|75656267|FG016|STARTED|Open-Label Period (Week 48 to Week 144)||0||
59556131|NCT02346240|75656268|FG017|STARTED|Open-Label Period (Week 48 to Week 144)||34||
59556132|NCT02346240|75656269|FG018|STARTED|Open-Label Period (Week 48 to Week 144)||122||
59556133|NCT02346240|75656270|FG019|STARTED|Open-Label Period (Week 48 to Week 144)||41||
59556134|NCT02346240|75656271|FG020|STARTED|Open-Label Period (Week 48 to Week 144)||48||
59556135|NCT02346240|75656272|FG021|STARTED|Open-Label Period (Week 48 to Week 144)||177||
59556136|NCT02346240|75656273|FG022|STARTED|Open-Label Period (Week 48 to Week 144)||34||
59556137|NCT02346240|75656274|FG023|STARTED|Open-Label Period (Week 48 to Week 144)||16||
59556138|NCT02346240|75656251|FG000|COMPLETED|Open-Label Period (Week 48 to Week 144)||0||
59556139|NCT02346240|75656252|FG001|COMPLETED|Open-Label Period (Week 48 to Week 144)||0||
59556140|NCT02346240|75656253|FG002|COMPLETED|Open-Label Period (Week 48 to Week 144)||0||
59556141|NCT02346240|75656254|FG003|COMPLETED|Open-Label Period (Week 48 to Week 144)||0||
59556142|NCT02346240|75656255|FG004|COMPLETED|Open-Label Period (Week 48 to Week 144)||0||
59556143|NCT02346240|75656256|FG005|COMPLETED|Open-Label Period (Week 48 to Week 144)||0||
59556144|NCT02346240|75656257|FG006|COMPLETED|Open-Label Period (Week 48 to Week 144)||0||
59556145|NCT02346240|75656258|FG007|COMPLETED|Open-Label Period (Week 48 to Week 144)||0||
59556146|NCT02346240|75656259|FG008|COMPLETED|Open-Label Period (Week 48 to Week 144)||0||
59556147|NCT02346240|75656260|FG009|COMPLETED|Open-Label Period (Week 48 to Week 144)||0||
59991885|NCT02218372|76107508|FG001|NOT COMPLETED|Overall Study||6||
59991886|NCT02218216|76107521|FG000|STARTED|Overall Study||14||
59991887|NCT02218216|76107522|FG001|STARTED|Overall Study||2||
59991888|NCT02218216|76107523|FG002|STARTED|Overall Study||3||
59991889|NCT02218216|76107521|FG000|COMPLETED|Overall Study||8||
59991890|NCT02218216|76107522|FG001|COMPLETED|Overall Study||2||
59991891|NCT02218216|76107523|FG002|COMPLETED|Overall Study||3||
59991892|NCT02218216|76107521|FG000|NOT COMPLETED|Overall Study||6||
59991893|NCT02218216|76107522|FG001|NOT COMPLETED|Overall Study||0||
59991894|NCT02218216|76107523|FG002|NOT COMPLETED|Overall Study||0||
59991895|NCT02217982|76107533|FG000|STARTED|Overall Study||1||
59991896|NCT02217982|76107534|FG001|STARTED|Overall Study||4||
59991897|NCT02217982|76107533|FG000|COMPLETED|Overall Study|Trial closed before patient finished|0||
59991898|NCT02217982|76107534|FG001|COMPLETED|Overall Study||3||
59991899|NCT02217982|76107533|FG000|NOT COMPLETED|Overall Study||1||
59556148|NCT02346240|75656261|FG010|COMPLETED|Open-Label Period (Week 48 to Week 144)||0||
59991900|NCT02217982|76107534|FG001|NOT COMPLETED|Overall Study||1||
59556149|NCT02346240|75656262|FG011|COMPLETED|Open-Label Period (Week 48 to Week 144)||0||
59556150|NCT02346240|75656263|FG012|COMPLETED|Open-Label Period (Week 48 to Week 144)||0||
59556151|NCT02346240|75656264|FG013|COMPLETED|Open-Label Period (Week 48 to Week 144)||0||
59556152|NCT02346240|75656265|FG014|COMPLETED|Open-Label Period (Week 48 to Week 144)||0||
59556153|NCT02346240|75656266|FG015|COMPLETED|Open-Label Period (Week 48 to Week 144)||0||
59556154|NCT02346240|75656267|FG016|COMPLETED|Open-Label Period (Week 48 to Week 144)||0||
59556155|NCT02346240|75656268|FG017|COMPLETED|Open-Label Period (Week 48 to Week 144)||31||
59556156|NCT02346240|75656269|FG018|COMPLETED|Open-Label Period (Week 48 to Week 144)||105||
59556157|NCT02346240|75656270|FG019|COMPLETED|Open-Label Period (Week 48 to Week 144)||34||
59556158|NCT02346240|75656271|FG020|COMPLETED|Open-Label Period (Week 48 to Week 144)||45||
59556159|NCT02346240|75656272|FG021|COMPLETED|Open-Label Period (Week 48 to Week 144)||146||
59556160|NCT02346240|75656273|FG022|COMPLETED|Open-Label Period (Week 48 to Week 144)||27||
59556161|NCT02346240|75656274|FG023|COMPLETED|Open-Label Period (Week 48 to Week 144)||8||
59556162|NCT02346240|75656251|FG000|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0||
59556163|NCT02346240|75656252|FG001|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0||
59556164|NCT02346240|75656253|FG002|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0||
59556165|NCT02346240|75656254|FG003|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0||
59556166|NCT02346240|75656255|FG004|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0||
59556167|NCT02346240|75656256|FG005|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0||
59556168|NCT02346240|75656257|FG006|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0||
59556169|NCT02346240|75656258|FG007|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0||
59556170|NCT02346240|75656259|FG008|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0||
59556171|NCT02346240|75656260|FG009|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0||
59556172|NCT02346240|75656261|FG010|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0||
59556173|NCT02346240|75656262|FG011|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0||
59556174|NCT02346240|75656263|FG012|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0||
59556175|NCT02346240|75656264|FG013|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0||
59556176|NCT02346240|75656265|FG014|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0||
59556177|NCT02346240|75656266|FG015|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0||
59556178|NCT02346240|75656267|FG016|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0||
59556179|NCT02346240|75656268|FG017|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||3||
59556180|NCT02346240|75656269|FG018|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||17||
59556181|NCT02346240|75656270|FG019|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||7||
59556182|NCT02346240|75656271|FG020|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||3||
59556183|NCT02346240|75656272|FG021|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||31||
59556184|NCT02346240|75656273|FG022|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||7||
59556185|NCT02346240|75656274|FG023|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||8||
59556186|NCT01511978|75656298|FG000|STARTED|Overall Study||14||
59556187|NCT01511978|75656299|FG001|STARTED|Overall Study||18||
59556188|NCT01511978|75656298|FG000|COMPLETED|Overall Study||14||
59556189|NCT01511978|75656299|FG001|COMPLETED|Overall Study||18||
59556190|NCT01511978|75656298|FG000|NOT COMPLETED|Overall Study||0||
59556191|NCT01511978|75656299|FG001|NOT COMPLETED|Overall Study||0||
59556192|NCT02772783|75656307|FG000|STARTED|Experimental Condition 1, 1 Day||8||
59556193|NCT02772783|75656308|FG001|STARTED|Experimental Condition 1, 1 Day||7||
59556194|NCT02772783|75656307|FG000|COMPLETED|Experimental Condition 1, 1 Day||8||
59556195|NCT02772783|75656308|FG001|COMPLETED|Experimental Condition 1, 1 Day||7||
59556196|NCT02772783|75656307|FG000|NOT COMPLETED|Experimental Condition 1, 1 Day||0||
59556197|NCT02772783|75656308|FG001|NOT COMPLETED|Experimental Condition 1, 1 Day||0||
59556198|NCT02772783|75656307|FG000|STARTED|Wash-out, 1 Week||8||
59556199|NCT02772783|75656308|FG001|STARTED|Wash-out, 1 Week||7||
59556200|NCT02772783|75656307|FG000|COMPLETED|Wash-out, 1 Week||8||
59556201|NCT02772783|75656308|FG001|COMPLETED|Wash-out, 1 Week||7||
59556202|NCT02772783|75656307|FG000|NOT COMPLETED|Wash-out, 1 Week||0||
59556203|NCT02772783|75656308|FG001|NOT COMPLETED|Wash-out, 1 Week||0||
59556204|NCT02772783|75656307|FG000|STARTED|Comparison Condition, 1 Day||8||
59556205|NCT02772783|75656308|FG001|STARTED|Comparison Condition, 1 Day||7||
59556206|NCT02772783|75656307|FG000|COMPLETED|Comparison Condition, 1 Day||8||
59556207|NCT02772783|75656308|FG001|COMPLETED|Comparison Condition, 1 Day||7||
59556208|NCT02772783|75656307|FG000|NOT COMPLETED|Comparison Condition, 1 Day||0||
59556209|NCT02772783|75656308|FG001|NOT COMPLETED|Comparison Condition, 1 Day||0||
59556210|NCT02772783|75656307|FG000|STARTED|Wash-out, 1 Week||8||
59556211|NCT02772783|75656308|FG001|STARTED|Wash-out, 1 Week||7||
59556212|NCT02772783|75656307|FG000|COMPLETED|Wash-out, 1 Week||8||
59556213|NCT02772783|75656308|FG001|COMPLETED|Wash-out, 1 Week||7||
59556214|NCT02772783|75656307|FG000|NOT COMPLETED|Wash-out, 1 Week||0||
59556215|NCT02772783|75656308|FG001|NOT COMPLETED|Wash-out, 1 Week||0||
59556216|NCT02772783|75656307|FG000|STARTED|Experimental Condition 2, 1 Day||8||
59556217|NCT02772783|75656308|FG001|STARTED|Experimental Condition 2, 1 Day||7||
59556218|NCT02772783|75656307|FG000|COMPLETED|Experimental Condition 2, 1 Day||8||
59556219|NCT02772783|75656308|FG001|COMPLETED|Experimental Condition 2, 1 Day||7||
59556220|NCT02772783|75656307|FG000|NOT COMPLETED|Experimental Condition 2, 1 Day||0||
59556221|NCT02772783|75656308|FG001|NOT COMPLETED|Experimental Condition 2, 1 Day||0||
59556222|NCT02774343|75656318|FG000|STARTED|Overall Study||15||
59556223|NCT02774343|75656319|FG001|STARTED|Overall Study||15||
59556224|NCT02774343|75656318|FG000|Received at Least One Capsule|Overall Study||12||
59556225|NCT02774343|75656319|FG001|Received at Least One Capsule|Overall Study||14||
59556226|NCT02774343|75656318|FG000|COMPLETED|Overall Study||9||
59556227|NCT02774343|75656319|FG001|COMPLETED|Overall Study||12||
59556228|NCT02774343|75656318|FG000|NOT COMPLETED|Overall Study||6||
59556229|NCT02774343|75656319|FG001|NOT COMPLETED|Overall Study||3||
59556230|NCT02392104|75656325|FG000|STARTED|Overall Study|one participant enrolled but was removed prior to starting study protocol|50||
59556231|NCT02392104|75656325|FG000|COMPLETED|Overall Study||39||
59556232|NCT02392104|75656325|FG000|NOT COMPLETED|Overall Study||11||
59556233|NCT01450826|75656331|FG000|STARTED|Overall Study||70||
59556234|NCT01450826|75656332|FG001|STARTED|Overall Study||66||
59556235|NCT01450826|75656331|FG000|COMPLETED|Overall Study||70||
59556236|NCT01450826|75656332|FG001|COMPLETED|Overall Study||66||
59556237|NCT01450826|75656331|FG000|NOT COMPLETED|Overall Study||0||
59556238|NCT01450826|75656332|FG001|NOT COMPLETED|Overall Study||0||
59707249|NCT00999466|75826190|FG002|STARTED|Pilot Part||3||
59707250|NCT00999466|75826188|FG000|COMPLETED|Pilot Part||6||
59556239|NCT02391948|75656343|FG000|STARTED|Baseline||227||
59556240|NCT02391948|75656344|FG001|STARTED|Baseline||161||
59707251|NCT00999466|75826189|FG001|COMPLETED|Pilot Part||0||
59556241|NCT02391948|75656345|FG002|STARTED|Baseline||80||
59556242|NCT02391948|75656346|FG003|STARTED|Baseline||129||
59556243|NCT02391948|75656347|FG004|STARTED|Baseline||111||
59556244|NCT02391948|75656343|FG000|COMPLETED|Baseline||227||
59556245|NCT02391948|75656344|FG001|COMPLETED|Baseline||161||
59556246|NCT02391948|75656345|FG002|COMPLETED|Baseline||80||
59556247|NCT02391948|75656346|FG003|COMPLETED|Baseline||129||
59556248|NCT02391948|75656347|FG004|COMPLETED|Baseline||111||
59556249|NCT02391948|75656343|FG000|NOT COMPLETED|Baseline||0||
59556250|NCT02391948|75656344|FG001|NOT COMPLETED|Baseline||0||
59556251|NCT02391948|75656345|FG002|NOT COMPLETED|Baseline||0||
59556252|NCT02391948|75656346|FG003|NOT COMPLETED|Baseline||0||
59556253|NCT02391948|75656347|FG004|NOT COMPLETED|Baseline||0||
59556254|NCT02391948|75656343|FG000|STARTED|6-month Assessment||227||
59556255|NCT02391948|75656344|FG001|STARTED|6-month Assessment||161||
59556256|NCT02391948|75656345|FG002|STARTED|6-month Assessment||80||
59556257|NCT02391948|75656346|FG003|STARTED|6-month Assessment||129||
59556258|NCT02391948|75656347|FG004|STARTED|6-month Assessment||111||
59556259|NCT02391948|75656343|FG000|COMPLETED|6-month Assessment||148||
59556260|NCT02391948|75656344|FG001|COMPLETED|6-month Assessment||105||
59556261|NCT02391948|75656345|FG002|COMPLETED|6-month Assessment||49||
59556262|NCT02391948|75656346|FG003|COMPLETED|6-month Assessment||84||
59556263|NCT02391948|75656347|FG004|COMPLETED|6-month Assessment||85||
59556264|NCT02391948|75656343|FG000|NOT COMPLETED|6-month Assessment||79||
59556265|NCT02391948|75656344|FG001|NOT COMPLETED|6-month Assessment||56||
59556266|NCT02391948|75656345|FG002|NOT COMPLETED|6-month Assessment||31||
59556267|NCT02391948|75656346|FG003|NOT COMPLETED|6-month Assessment||45||
59556268|NCT02391948|75656347|FG004|NOT COMPLETED|6-month Assessment||26||
59556269|NCT02391948|75656343|FG000|STARTED|12-month Assessment|Started at 12-month is not equal to Completed at 6-month: 77 of the Not Completed remained active.|225||
59556270|NCT02391948|75656344|FG001|STARTED|12-month Assessment|Started at 12-month is not equal to Completed at 6-month: 51 of the Not Completed remained active.|156||
59556271|NCT02391948|75656345|FG002|STARTED|12-month Assessment|Started at 12-month is not equal to Completed at 6-month: 28 of the Not Completed remained active.|77||
59556272|NCT02391948|75656346|FG003|STARTED|12-month Assessment|Started at 12-month is not equal to Completed at 6-month: 41 of the Not Completed remained active.|125||
59556273|NCT02391948|75656347|FG004|STARTED|12-month Assessment|Started at 12-month is not equal to Completed at 6-month: 24 of the Not Completed remained active.|109||
59556274|NCT02391948|75656343|FG000|COMPLETED|12-month Assessment||217||
59556275|NCT02391948|75656344|FG001|COMPLETED|12-month Assessment||147||
59556276|NCT02391948|75656345|FG002|COMPLETED|12-month Assessment||73||
59556277|NCT02391948|75656346|FG003|COMPLETED|12-month Assessment||116||
59556278|NCT02391948|75656347|FG004|COMPLETED|12-month Assessment||103||
59556279|NCT02391948|75656343|FG000|NOT COMPLETED|12-month Assessment||8||
59556280|NCT02391948|75656344|FG001|NOT COMPLETED|12-month Assessment||9||
59556281|NCT02391948|75656345|FG002|NOT COMPLETED|12-month Assessment||4||
59556282|NCT02391948|75656346|FG003|NOT COMPLETED|12-month Assessment||9||
59707252|NCT00999466|75826190|FG002|COMPLETED|Pilot Part||3||
59707253|NCT00999466|75826188|FG000|NOT COMPLETED|Pilot Part||0||
59556283|NCT02391948|75656347|FG004|NOT COMPLETED|12-month Assessment||6||
59556284|NCT02391948|75656343|FG000|STARTED|18-month Assessment|Started at 18-month is not equal to Completed at 12-month: 2 of the Not Completed remained active.|219||
59556285|NCT02391948|75656344|FG001|STARTED|18-month Assessment|Started at 18-month is not equal to Completed at 12-month: 4 of the Not Completed remained active.|151||
59556286|NCT02391948|75656345|FG002|STARTED|18-month Assessment|Started at 18-month is not equal to Completed at 12-month: 1 of the Not Completed remained active.|74||
59556287|NCT02391948|75656346|FG003|STARTED|18-month Assessment|Started at 18-month is not equal to Completed at 12-month: 3 of the Not Completed remained active.|119||
59556288|NCT02391948|75656347|FG004|STARTED|18-month Assessment|Started at 18-month is not equal to Completed at 12-month: 2 of the Not Completed remained active.|105||
59556289|NCT02391948|75656343|FG000|COMPLETED|18-month Assessment||147||
59556290|NCT02391948|75656344|FG001|COMPLETED|18-month Assessment||101||
59556291|NCT02391948|75656345|FG002|COMPLETED|18-month Assessment||48||
59556292|NCT02391948|75656346|FG003|COMPLETED|18-month Assessment||83||
59556293|NCT02391948|75656347|FG004|COMPLETED|18-month Assessment||75||
59556294|NCT02391948|75656343|FG000|NOT COMPLETED|18-month Assessment||72||
59556295|NCT02391948|75656344|FG001|NOT COMPLETED|18-month Assessment||50||
59556296|NCT02391948|75656345|FG002|NOT COMPLETED|18-month Assessment||26||
59556297|NCT02391948|75656346|FG003|NOT COMPLETED|18-month Assessment||36||
59556298|NCT02391948|75656347|FG004|NOT COMPLETED|18-month Assessment||30||
59707254|NCT00999466|75826189|FG001|NOT COMPLETED|Pilot Part||0||
59556299|NCT02391948|75656343|FG000|STARTED|24-month Assessment|Started at 24-month is not equal to Completed at 18-month: 2 of the Not Completed remained active.|149||
59565956|NCT02303574|75668406|FG001|NOT COMPLETED|Part 1a (Fasted State)- SAD||0||
59707255|NCT00999466|75826190|FG002|NOT COMPLETED|Pilot Part||0||
59707256|NCT00999466|75826188|FG000|STARTED|Main Part|AZD8848 nasal spray 30 μg group was not participated in the Main part|0||
59707257|NCT00999466|75826189|FG001|STARTED|Main Part||26||
59707258|NCT00999466|75826190|FG002|STARTED|Main Part||25||
59556300|NCT02391948|75656344|FG001|STARTED|24-month Assessment|Started at 24-month is not equal to Completed at 18-month: 6 of the Not Completed remained active.|107||
59556301|NCT02391948|75656345|FG002|STARTED|24-month Assessment|Started at 24-month is not equal to Completed at 18-month: 3 of the Not Completed remained active.|51||
59556302|NCT02391948|75656346|FG003|STARTED|24-month Assessment|Started at 24-month is not equal to Completed at 18-month: 1 of the Not Completed remained active.|84||
59556303|NCT02391948|75656347|FG004|STARTED|24-month Assessment|Started at 24-month is not equal to Completed at 18-month: 4 of the Not Completed remained active.|79||
59556304|NCT02391948|75656343|FG000|COMPLETED|24-month Assessment||135||
59556305|NCT02391948|75656344|FG001|COMPLETED|24-month Assessment||97||
59556306|NCT02391948|75656345|FG002|COMPLETED|24-month Assessment||48||
59556307|NCT02391948|75656346|FG003|COMPLETED|24-month Assessment||75||
59556308|NCT02391948|75656347|FG004|COMPLETED|24-month Assessment||69||
59556309|NCT02391948|75656343|FG000|NOT COMPLETED|24-month Assessment||14||
59556310|NCT02391948|75656344|FG001|NOT COMPLETED|24-month Assessment||10||
59556311|NCT02391948|75656345|FG002|NOT COMPLETED|24-month Assessment||3||
59556312|NCT02391948|75656346|FG003|NOT COMPLETED|24-month Assessment||9||
59556313|NCT02391948|75656347|FG004|NOT COMPLETED|24-month Assessment||10||
59556314|NCT01451372|75656362|FG000|STARTED|Overall Study||69||
59556315|NCT01451372|75656362|FG000|COMPLETED|Overall Study||69||
59556316|NCT01451372|75656362|FG000|NOT COMPLETED|Overall Study||0||
59556317|NCT01564628|75656366|FG000|STARTED|Overall Study||185||
59556318|NCT01564628|75656367|FG001|STARTED|Overall Study||58||
59556319|NCT01564628|75656368|FG002|STARTED|Overall Study||63||
59556320|NCT01564628|75656366|FG000|COMPLETED|Overall Study||181||
59556321|NCT01564628|75656367|FG001|COMPLETED|Overall Study||56||
59556322|NCT01564628|75656368|FG002|COMPLETED|Overall Study||61||
59556323|NCT01564628|75656366|FG000|NOT COMPLETED|Overall Study||4||
59556324|NCT01564628|75656367|FG001|NOT COMPLETED|Overall Study||2||
59556325|NCT01564628|75656368|FG002|NOT COMPLETED|Overall Study||2||
59556326|NCT01564706|75656372|FG000|STARTED|Overall Study||9||
59556327|NCT01564706|75656372|FG000|COMPLETED|Overall Study||9||
59556328|NCT01564706|75656372|FG000|NOT COMPLETED|Overall Study||0||
59556329|NCT01451996|75656380|FG000|STARTED|Overall Study||83||
59556330|NCT01451996|75656381|FG001|STARTED|Overall Study||87||
59556331|NCT01451996|75656382|FG002|STARTED|Overall Study||85||
59991901|NCT02254408|76107542|FG000|STARTED|Overall Study||96||
59556332|NCT01451996|75656383|FG003|STARTED|Overall Study||85||
59556333|NCT01451996|75656380|FG000|COMPLETED|Overall Study||83||
59991902|NCT02254408|76107543|FG001|STARTED|Overall Study||93||
59556334|NCT01451996|75656381|FG001|COMPLETED|Overall Study||87||
59556335|NCT01451996|75656382|FG002|COMPLETED|Overall Study||85||
59556336|NCT01451996|75656383|FG003|COMPLETED|Overall Study||85||
59556337|NCT01451996|75656380|FG000|NOT COMPLETED|Overall Study||0||
59556338|NCT01451996|75656381|FG001|NOT COMPLETED|Overall Study||0||
59991903|NCT02254408|76107542|FG000|COMPLETED|Overall Study||88||
59556339|NCT01451996|75656382|FG002|NOT COMPLETED|Overall Study||0||
59556340|NCT01451996|75656383|FG003|NOT COMPLETED|Overall Study||0||
59556341|NCT02742129|75656395|FG000|STARTED|Phase 1||53||
59556342|NCT02742129|75656396|FG001|STARTED|Phase 1||52||
59556343|NCT02742129|75656395|FG000|COMPLETED|Phase 1||51||
59556344|NCT02742129|75656396|FG001|COMPLETED|Phase 1||50||
59556345|NCT02742129|75656395|FG000|NOT COMPLETED|Phase 1||2||
59556346|NCT02742129|75656396|FG001|NOT COMPLETED|Phase 1||2||
59556347|NCT02742129|75656395|FG000|STARTED|Phase 2||51||
59556348|NCT02742129|75656396|FG001|STARTED|Phase 2||50||
59556349|NCT02742129|75656395|FG000|COMPLETED|Phase 2||50||
59556350|NCT02742129|75656396|FG001|COMPLETED|Phase 2||48||
59556351|NCT02742129|75656395|FG000|NOT COMPLETED|Phase 2||1||
59556352|NCT02742129|75656396|FG001|NOT COMPLETED|Phase 2||2||
59556353|NCT01512446|75656407|FG000|STARTED|Overall Study||221||
59556354|NCT01512446|75656408|FG001|STARTED|Overall Study||215||
59556355|NCT01512446|75656407|FG000|Safety Analysis Set|Overall Study||197|Received at least one dose of study medication|
59556356|NCT01512446|75656408|FG001|Safety Analysis Set|Overall Study||188|Received at least one dose of study medication|
59556357|NCT01512446|75656407|FG000|COMPLETED|Overall Study||0||
59556358|NCT01512446|75656408|FG001|COMPLETED|Overall Study||0||
59556359|NCT01512446|75656407|FG000|NOT COMPLETED|Overall Study||221||
59556360|NCT01512446|75656408|FG001|NOT COMPLETED|Overall Study||215||
59556361|NCT01565330|75656418|FG000|STARTED|Overall Study||5||
59556362|NCT01565330|75656419|FG001|STARTED|Overall Study||4||
59556363|NCT01565330|75656420|FG002|STARTED|Overall Study||4||
59556364|NCT01565330|75656421|FG003|STARTED|Overall Study||7||
59556365|NCT01565330|75656418|FG000|COMPLETED|Overall Study||5||
59556366|NCT01565330|75656419|FG001|COMPLETED|Overall Study||4||
59556367|NCT01565330|75656420|FG002|COMPLETED|Overall Study||4||
59556368|NCT01565330|75656421|FG003|COMPLETED|Overall Study||7||
59556369|NCT01565330|75656418|FG000|NOT COMPLETED|Overall Study||0||
59556370|NCT01565330|75656419|FG001|NOT COMPLETED|Overall Study||0||
59556371|NCT01565330|75656420|FG002|NOT COMPLETED|Overall Study||0||
59556372|NCT01565330|75656421|FG003|NOT COMPLETED|Overall Study||0||
59556373|NCT02742987|75656434|FG000|STARTED|Overall Study||21||
59556374|NCT02742987|75656435|FG001|STARTED|Overall Study||21||
59556375|NCT02742987|75656434|FG000|COMPLETED|Overall Study||21||
59556376|NCT02742987|75656435|FG001|COMPLETED|Overall Study||21||
59556377|NCT02742987|75656434|FG000|NOT COMPLETED|Overall Study||0||
59556378|NCT02742987|75656435|FG001|NOT COMPLETED|Overall Study||0||
59556379|NCT02743377|75656443|FG000|STARTED|Overall Study||9||
59556380|NCT02743377|75656444|FG001|STARTED|Overall Study||6||
59556381|NCT02743377|75656443|FG000|Brain PET With 11C Rolipram|Overall Study||8||
59556382|NCT02743377|75656444|FG001|Brain PET With 11C Rolipram|Overall Study||3||
59556383|NCT02743377|75656443|FG000|Whole Body PET Baseline With 11C Rolipra|Overall Study||5||
59556384|NCT02743377|75656444|FG001|Whole Body PET Baseline With 11C Rolipra|Overall Study||4||
59556385|NCT02743377|75656443|FG000|Whole Body PET Baseline & Blocked|Overall Study||0||
59556386|NCT02743377|75656444|FG001|Whole Body PET Baseline & Blocked|Overall Study||2||
59556387|NCT02743377|75656443|FG000|COMPLETED|Overall Study||7||
59556388|NCT02743377|75656444|FG001|COMPLETED|Overall Study||6||
59556389|NCT02743377|75656443|FG000|NOT COMPLETED|Overall Study||2||
59556390|NCT02743377|75656444|FG001|NOT COMPLETED|Overall Study||0||
59556391|NCT01512758|75656453|FG000|STARTED|Overall Study||30||
59556392|NCT01512758|75656454|FG001|STARTED|Overall Study||6||
59556393|NCT01512758|75656453|FG000|COMPLETED|Overall Study|Completed=Completed protocol-specified dosing and PK assessment.|30||
59707259|NCT00999466|75826188|FG000|COMPLETED|Main Part||0||
59707260|NCT00999466|75826189|FG001|COMPLETED|Main Part||22||
59707261|NCT00999466|75826190|FG002|COMPLETED|Main Part||21||
59556394|NCT01512758|75656454|FG001|COMPLETED|Overall Study||6||
59556395|NCT01512758|75656453|FG000|NOT COMPLETED|Overall Study||0||
59556396|NCT01512758|75656454|FG001|NOT COMPLETED|Overall Study||0||
59556397|NCT02746107|75656461|FG000|STARTED|Overall Study||968||
59556398|NCT02746107|75656461|FG000|2 Diagrams DA|Overall Study||482||
59556399|NCT02746107|75656461|FG000|1 Diagram DA|Overall Study||486||
59556400|NCT02746107|75656461|FG000|1year Risk Estimate|Overall Study||483||
59556401|NCT02746107|75656461|FG000|5year Risk Estimate|Overall Study||485||
59556402|NCT02746107|75656461|FG000|Target=Patient|Overall Study||486||
59556403|NCT02746107|75656461|FG000|Target=Physician|Overall Study||482||
59556404|NCT02746107|75656461|FG000|CHA2DS2-VASC Score = 1|Overall Study||195||
59556405|NCT02746107|75656461|FG000|CHA2DS2-VASC Score = 2|Overall Study||189||
59556406|NCT02746107|75656461|FG000|CHA2DS2-VASC Score = 3|Overall Study||195||
59556407|NCT02746107|75656461|FG000|CHA2DS2-VASC Score = 4|Overall Study||197||
59556408|NCT02746107|75656461|FG000|CHA2DS2-VASC Score = 5|Overall Study||192||
59556409|NCT02746107|75656461|FG000|COMPLETED|Overall Study||968||
59556410|NCT02746107|75656461|FG000|NOT COMPLETED|Overall Study||0||
59556411|NCT01513538|75656476|FG000|STARTED|Overall Study||578|Screening has been stopped after 578 patients agreed to participate to the study.|
59556412|NCT01513538|75656476|FG000|COMPLETED|Overall Study||573||
59556413|NCT01513538|75656476|FG000|NOT COMPLETED|Overall Study||5||
59556414|NCT01453166|75656483|FG000|STARTED|Overall Study||42||
59556415|NCT01453166|75656484|FG001|STARTED|Overall Study||41||
59556416|NCT01453166|75656485|FG002|STARTED|Overall Study||39||
59556417|NCT01453166|75656483|FG000|COMPLETED|Overall Study||40||
59556418|NCT01453166|75656484|FG001|COMPLETED|Overall Study||39||
59556419|NCT01453166|75656485|FG002|COMPLETED|Overall Study||38||
59556420|NCT01453166|75656483|FG000|NOT COMPLETED|Overall Study||2||
59556421|NCT01453166|75656484|FG001|NOT COMPLETED|Overall Study||2||
59556422|NCT01453166|75656485|FG002|NOT COMPLETED|Overall Study||1||
59556423|NCT01454258|75656493|FG000|STARTED|Overall Study||10100||
59556424|NCT01454258|75656493|FG000|COMPLETED|Overall Study||9103||
59556425|NCT01454258|75656493|FG000|NOT COMPLETED|Overall Study||997||
59556426|NCT01514162|75656499|FG000|STARTED|Overall Study||245||
59556427|NCT01514162|75656499|FG000|COMPLETED|Overall Study||160||
59556428|NCT01514162|75656499|FG000|NOT COMPLETED|Overall Study||85||
59556429|NCT02748525|75656503|FG000|STARTED|Overall Study||50||
59556430|NCT02748525|75656503|FG000|Completed Study Intervention|Overall Study||50||
59556431|NCT02748525|75656503|FG000|COMPLETED|Overall Study|Completed 6 months follow up|39||
59556432|NCT02748525|75656503|FG000|NOT COMPLETED|Overall Study||11||
59556433|NCT01454414|75656509|FG000|STARTED|Overall Study||79||
59556434|NCT01454414|75656510|FG001|STARTED|Overall Study||80||
59556435|NCT01454414|75656509|FG000|Baseline: Subjects That Sent Uniforms|Overall Study||67||
59556436|NCT01454414|75656510|FG001|Baseline: Subjects That Sent Uniforms|Overall Study||66||
59556437|NCT01454414|75656509|FG000|COMPLETED|Overall Study||66||
59556438|NCT01454414|75656510|FG001|COMPLETED|Overall Study||64||
59556439|NCT01454414|75656509|FG000|NOT COMPLETED|Overall Study||13||
59556440|NCT01454414|75656510|FG001|NOT COMPLETED|Overall Study||16||
59556441|NCT01566500|75656516|FG000|STARTED|Overall Study||140||
59556442|NCT01566500|75656516|FG000|COMPLETED|Overall Study||140||
59556443|NCT01566500|75656516|FG000|NOT COMPLETED|Overall Study||0||
59556444|NCT01514318|75656520|FG000|STARTED|Overall Study||8||
59556445|NCT01514318|75656520|FG000|COMPLETED|Overall Study||8||
59556446|NCT01514318|75656520|FG000|NOT COMPLETED|Overall Study||0||
59556447|NCT01514396|75656524|FG000|STARTED|Overall Study||8||
59556448|NCT01514396|75656524|FG000|COMPLETED|Overall Study||8||
59556449|NCT01514396|75656524|FG000|NOT COMPLETED|Overall Study||0||
59556450|NCT01514630|75656529|FG000|STARTED|Overall Study||14||
59556451|NCT01514630|75656529|FG000|COMPLETED|Overall Study||11||
59556452|NCT01514630|75656529|FG000|NOT COMPLETED|Overall Study||3||
59556453|NCT01568528|75656536|FG000|STARTED|Overall Study||19||
59556454|NCT01568528|75656537|FG001|STARTED|Overall Study||11||
59556455|NCT01568528|75656538|FG002|STARTED|Overall Study||9||
59556456|NCT01568528|75656536|FG000|COMPLETED|Overall Study||19||
59556457|NCT01568528|75656537|FG001|COMPLETED|Overall Study||11||
59556458|NCT01568528|75656538|FG002|COMPLETED|Overall Study||9||
59556459|NCT01568528|75656536|FG000|NOT COMPLETED|Overall Study||0||
59556460|NCT01568528|75656537|FG001|NOT COMPLETED|Overall Study||0||
59556461|NCT01568528|75656538|FG002|NOT COMPLETED|Overall Study||0||
59556462|NCT01568606|75656546|FG000|STARTED|Overall Study||20||
59556463|NCT01568606|75656546|FG000|COMPLETED|Overall Study||20||
59556464|NCT01568606|75656546|FG000|NOT COMPLETED|Overall Study||0||
59556465|NCT01460732|75656550|FG000|STARTED|Overall Study||81||
59556466|NCT01460732|75656550|FG000|COMPLETED|Overall Study||81||
59556467|NCT01460732|75656550|FG000|NOT COMPLETED|Overall Study||0||
59556468|NCT01514786|75656558|FG000|STARTED|Overall Study||286||
59556469|NCT01514786|75656559|FG001|STARTED|Overall Study||284||
59556470|NCT01514786|75656558|FG000|COMPLETED|Overall Study||286||
59556471|NCT01514786|75656559|FG001|COMPLETED|Overall Study||284||
59556472|NCT01514786|75656558|FG000|NOT COMPLETED|Overall Study||0||
59556473|NCT01514786|75656559|FG001|NOT COMPLETED|Overall Study||0||
59556474|NCT01461668|75656567|FG000|STARTED|Overall Study||27||
59556475|NCT01461668|75656568|FG001|STARTED|Overall Study||26||
59556476|NCT01461668|75656567|FG000|COMPLETED|Overall Study||25||
59556477|NCT01461668|75656568|FG001|COMPLETED|Overall Study||25||
59991904|NCT02254408|76107543|FG001|COMPLETED|Overall Study||83||
59991905|NCT02254408|76107542|FG000|NOT COMPLETED|Overall Study||8||
59991906|NCT02254408|76107543|FG001|NOT COMPLETED|Overall Study||10||
59991907|NCT02207608|76107551|FG000|STARTED|Overall Study||15||
59707262|NCT00999466|75826188|FG000|NOT COMPLETED|Main Part||0||
59556478|NCT01461668|75656567|FG000|NOT COMPLETED|Overall Study||2||
59556479|NCT01461668|75656568|FG001|NOT COMPLETED|Overall Study||1||
59556480|NCT01461824|75656577|FG000|STARTED|Overall Study||12||
59556481|NCT01461824|75656578|FG001|STARTED|Overall Study||11||
59991908|NCT02207608|76107552|FG001|STARTED|Overall Study||15||
59991909|NCT02207608|76107551|FG000|COMPLETED|Overall Study||14||
59556482|NCT01461824|75656579|FG002|STARTED|Overall Study||11||
59556483|NCT01461824|75656577|FG000|COMPLETED|Overall Study||10||
59556484|NCT01461824|75656578|FG001|COMPLETED|Overall Study||7||
59556485|NCT01461824|75656579|FG002|COMPLETED|Overall Study||8||
59556486|NCT01461824|75656577|FG000|NOT COMPLETED|Overall Study||2||
59556487|NCT01461824|75656578|FG001|NOT COMPLETED|Overall Study||4||
59556488|NCT01461824|75656579|FG002|NOT COMPLETED|Overall Study||3||
59556489|NCT02369874|75656590|FG000|STARTED|Overall Study||247||
59556490|NCT02369874|75656591|FG001|STARTED|Overall Study||240||
59556491|NCT02369874|75656592|FG002|STARTED|Overall Study||249||
59556492|NCT02369874|75656590|FG000|Received Treatment|Overall Study||246||
59556493|NCT02369874|75656591|FG001|Received Treatment|Overall Study||237||
59556494|NCT02369874|75656592|FG002|Received Treatment|Overall Study||240||
59556495|NCT02369874|75656590|FG000|COMPLETED|Overall Study||203||
59556496|NCT02369874|75656591|FG001|COMPLETED|Overall Study||183||
59556497|NCT02369874|75656592|FG002|COMPLETED|Overall Study||188||
59556498|NCT02369874|75656590|FG000|NOT COMPLETED|Overall Study||44||
59556499|NCT02369874|75656591|FG001|NOT COMPLETED|Overall Study||57||
59556500|NCT02369874|75656592|FG002|NOT COMPLETED|Overall Study||61||
59556501|NCT01462292|75656603|FG000|STARTED|Overall Study||16||
59556502|NCT01462292|75656604|FG001|STARTED|Overall Study||17||
59556503|NCT01462292|75656605|FG002|STARTED|Overall Study||18||
59556504|NCT01462292|75656603|FG000|COMPLETED|Overall Study||16||
59556505|NCT01462292|75656604|FG001|COMPLETED|Overall Study||17||
59556506|NCT01462292|75656605|FG002|COMPLETED|Overall Study||18||
59556507|NCT01462292|75656603|FG000|NOT COMPLETED|Overall Study||0||
59556508|NCT01462292|75656604|FG001|NOT COMPLETED|Overall Study||0||
59556509|NCT01462292|75656605|FG002|NOT COMPLETED|Overall Study||0||
59556510|NCT01515176|75656618|FG000|STARTED|Overall Study||4||
59556511|NCT01515176|75656619|FG001|STARTED|Overall Study||32||
59556512|NCT01515176|75656618|FG000|COMPLETED|Overall Study||4||
59556513|NCT01515176|75656619|FG001|COMPLETED|Overall Study||32||
59556514|NCT01515176|75656618|FG000|NOT COMPLETED|Overall Study||0||
59556515|NCT01515176|75656619|FG001|NOT COMPLETED|Overall Study||0||
59556516|NCT01515410|75656627|FG000|STARTED|Overall Study||19||
59556517|NCT01515410|75656628|FG001|STARTED|Overall Study||15||
59556518|NCT01515410|75656627|FG000|COMPLETED|Overall Study||19||
59556519|NCT01515410|75656628|FG001|COMPLETED|Overall Study||15||
59556520|NCT01515410|75656627|FG000|NOT COMPLETED|Overall Study||0||
59556521|NCT01515410|75656628|FG001|NOT COMPLETED|Overall Study||0||
59556522|NCT01515488|75656636|FG000|STARTED|Overall Study||200||
59556523|NCT01515488|75656637|FG001|STARTED|Overall Study||200||
59556524|NCT01515488|75656636|FG000|COMPLETED|Overall Study||200||
59556525|NCT01515488|75656637|FG001|COMPLETED|Overall Study||200||
59556526|NCT01515488|75656636|FG000|NOT COMPLETED|Overall Study||0||
59556527|NCT01515488|75656637|FG001|NOT COMPLETED|Overall Study||0||
59556528|NCT01515566|75656645|FG000|STARTED|Overall Study||10||
59556529|NCT01515566|75656646|FG001|STARTED|Overall Study||10||
59556530|NCT01515566|75656645|FG000|COMPLETED|Overall Study||10||
59556531|NCT01515566|75656646|FG001|COMPLETED|Overall Study||10||
59556532|NCT01515566|75656645|FG000|NOT COMPLETED|Overall Study||0||
59556533|NCT01515566|75656646|FG001|NOT COMPLETED|Overall Study||0||
59556534|NCT02777931|75656654|FG000|STARTED|Overall Study||49|All randomized subjects (Intent to Treat Population)|
59556535|NCT02777931|75656655|FG001|STARTED|Overall Study||52|All randomized subjects (Intent to Treat Population)|
59556536|NCT02777931|75656654|FG000|Safety Population|Overall Study||47|All randomized subjects who took at least 1 dose of study drug|
59556537|NCT02777931|75656655|FG001|Safety Population|Overall Study||50|All randomized subjects who took at least 1 dose of study drug|
59556538|NCT02777931|75656654|FG000|Modified Intent to Treat Population|Overall Study||46|Subjects who took at least 1 dose of study drug and have valid baseline and post baseline assessment|
59556539|NCT02777931|75656655|FG001|Modified Intent to Treat Population|Overall Study||50|Subjects who took at least 1 dose of study drug and have valid baseline and post baseline assessment|
59556540|NCT02777931|75656654|FG000|COMPLETED|Overall Study||37||
59556541|NCT02777931|75656655|FG001|COMPLETED|Overall Study||39||
59556542|NCT02777931|75656654|FG000|NOT COMPLETED|Overall Study||12||
59556543|NCT02777931|75656655|FG001|NOT COMPLETED|Overall Study||13||
59556544|NCT01515956|75656661|FG000|STARTED|Overall Study||15||
59556545|NCT01515956|75656661|FG000|COMPLETED|Overall Study||15||
59556546|NCT01515956|75656661|FG000|NOT COMPLETED|Overall Study||0||
59556547|NCT02779491|75656670|FG000|STARTED|Overall Study||32||
59556548|NCT02779491|75656671|FG001|STARTED|Overall Study||27||
59556549|NCT02779491|75656672|FG002|STARTED|Overall Study||18||
59556550|NCT02779491|75656673|FG003|STARTED|Overall Study||17||
59556551|NCT02779491|75656670|FG000|COMPLETED|Overall Study||32||
59556552|NCT02779491|75656671|FG001|COMPLETED|Overall Study||26||
59556553|NCT02779491|75656672|FG002|COMPLETED|Overall Study||17||
59556554|NCT02779491|75656673|FG003|COMPLETED|Overall Study||15||
59556555|NCT02779491|75656670|FG000|NOT COMPLETED|Overall Study||0||
59556556|NCT02779491|75656671|FG001|NOT COMPLETED|Overall Study||1||
59556557|NCT02779491|75656672|FG002|NOT COMPLETED|Overall Study||1||
59556558|NCT02779491|75656673|FG003|NOT COMPLETED|Overall Study||2||
59556559|NCT02207972|75656685|FG000|STARTED|Overall Study||22||
59556560|NCT02207972|75656686|FG001|STARTED|Overall Study||24||
59556561|NCT02207972|75656685|FG000|COMPLETED|Overall Study||22||
59556562|NCT02207972|75656686|FG001|COMPLETED|Overall Study||24||
59556563|NCT02207972|75656685|FG000|NOT COMPLETED|Overall Study||0||
59556564|NCT02207972|75656686|FG001|NOT COMPLETED|Overall Study||0||
59556565|NCT02780349|75656693|FG000|STARTED|Overall Study||103||
59556566|NCT02780349|75656693|FG000|COMPLETED|Overall Study||101||
59556567|NCT02780349|75656693|FG000|NOT COMPLETED|Overall Study||2||
59556568|NCT01516268|75656699|FG000|STARTED|Overall Study||25||
59556569|NCT01516268|75656700|FG001|STARTED|Overall Study||25||
60084543|NCT00476242|76200495|FG001|NOT COMPLETED|Overall Study||16||
59556570|NCT01516268|75656699|FG000|COMPLETED|Overall Study||25||
59556571|NCT01516268|75656700|FG001|COMPLETED|Overall Study||25||
59556572|NCT01516268|75656699|FG000|NOT COMPLETED|Overall Study||0||
59556573|NCT01516268|75656700|FG001|NOT COMPLETED|Overall Study||0||
59556574|NCT02780661|75656706|FG000|STARTED|Period 1||10||
59556575|NCT02780661|75656707|FG001|STARTED|Period 1||9||
59556576|NCT02780661|75656706|FG000|COMPLETED|Period 1||10||
59556577|NCT02780661|75656707|FG001|COMPLETED|Period 1||9||
59556578|NCT02780661|75656706|FG000|NOT COMPLETED|Period 1||0||
60084544|NCT00476788|76200503|FG000|STARTED|Overall Study||14||
60084545|NCT00476788|76200503|FG000|COMPLETED|Overall Study||11||
60084546|NCT00476788|76200503|FG000|NOT COMPLETED|Overall Study||3||
60084547|NCT01436175|76200507|FG000|STARTED|Overall Study||1570||
60084548|NCT01436175|76200507|FG000|COMPLETED|Overall Study||300||
60084549|NCT01436175|76200507|FG000|NOT COMPLETED|Overall Study||1270||
60084550|NCT00453388|76200516|FG000|STARTED|Overall Study||0||
60084551|NCT00453388|76200517|FG001|STARTED|Overall Study||5||
60084552|NCT00453388|76200518|FG002|STARTED|Overall Study||1||
60084553|NCT00453388|76200519|FG003|STARTED|Overall Study||0||
60084554|NCT00453388|76200516|FG000|COMPLETED|Overall Study||0||
60084555|NCT00453388|76200517|FG001|COMPLETED|Overall Study||5||
59556579|NCT02780661|75656707|FG001|NOT COMPLETED|Period 1||0||
59556580|NCT02780661|75656706|FG000|STARTED|Wash Out Period||10||
59556581|NCT02780661|75656707|FG001|STARTED|Wash Out Period||9||
59556582|NCT02780661|75656706|FG000|COMPLETED|Wash Out Period||10||
59556583|NCT02780661|75656707|FG001|COMPLETED|Wash Out Period||9||
59556584|NCT02780661|75656706|FG000|NOT COMPLETED|Wash Out Period||0||
59556585|NCT02780661|75656707|FG001|NOT COMPLETED|Wash Out Period||0||
59556586|NCT02780661|75656706|FG000|STARTED|Period 2||10||
59556587|NCT02780661|75656707|FG001|STARTED|Period 2||9||
59556588|NCT02780661|75656706|FG000|COMPLETED|Period 2||10||
59556589|NCT02780661|75656707|FG001|COMPLETED|Period 2||9||
59556590|NCT02780661|75656706|FG000|NOT COMPLETED|Period 2||0||
59556591|NCT02780661|75656707|FG001|NOT COMPLETED|Period 2||0||
59556592|NCT02781051|75656714|FG000|STARTED|Overall Study||16||
59556593|NCT02781051|75656714|FG000|COMPLETED|Overall Study||14||
59556594|NCT02781051|75656714|FG000|NOT COMPLETED|Overall Study||2||
59556595|NCT01516424|75656721|FG000|STARTED|Overall Study|the patient number of randomization for Blonanserin Group|131||
59556596|NCT01516424|75656722|FG001|STARTED|Overall Study|the patient number of randomization for Risperidone Group|136||
59556597|NCT01516424|75656721|FG000|COMPLETED|Overall Study||96||
59556598|NCT01516424|75656722|FG001|COMPLETED|Overall Study||114||
59556599|NCT01516424|75656721|FG000|NOT COMPLETED|Overall Study||35||
59556600|NCT01516424|75656722|FG001|NOT COMPLETED|Overall Study||22||
59556601|NCT02782065|75656728|FG000|STARTED|Overall Study||58||
59556602|NCT02782065|75656728|FG000|COMPLETED|Overall Study||58||
59707263|NCT00999466|75826189|FG001|NOT COMPLETED|Main Part||4||
59556603|NCT02782065|75656728|FG000|NOT COMPLETED|Overall Study||0||
59556604|NCT02368314|75656735|FG000|STARTED|Overall Study||64||
59556605|NCT02368314|75656736|FG001|STARTED|Overall Study||60||
59556606|NCT02368314|75656735|FG000|COMPLETED|Overall Study||61||
59556607|NCT02368314|75656736|FG001|COMPLETED|Overall Study||57||
59556608|NCT02368314|75656735|FG000|NOT COMPLETED|Overall Study||3||
59556609|NCT02368314|75656736|FG001|NOT COMPLETED|Overall Study||3||
59556610|NCT01518530|75656742|FG000|STARTED|Active Treatment Period||10||
59556611|NCT01518530|75656742|FG000|COMPLETED|Active Treatment Period||9||
59556612|NCT01518530|75656742|FG000|NOT COMPLETED|Active Treatment Period||1||
59556613|NCT01518530|75656742|FG000|STARTED|Post-Treatment Follow-up||9||
59556614|NCT01518530|75656742|FG000|COMPLETED|Post-Treatment Follow-up||9||
59707264|NCT00999466|75826190|FG002|NOT COMPLETED|Main Part||4||
59707265|NCT01255163|75826200|FG000|STARTED|Overall Study||13||
59707266|NCT01255163|75826201|FG001|STARTED|Overall Study||14||
59707267|NCT01255163|75826200|FG000|COMPLETED|Overall Study||9||
59707268|NCT01255163|75826201|FG001|COMPLETED|Overall Study||9||
59556615|NCT01518530|75656742|FG000|NOT COMPLETED|Post-Treatment Follow-up||0||
59556616|NCT02366910|75656746|FG000|STARTED|Overall Study||26||
59556617|NCT02366910|75656746|FG000|COMPLETED|Overall Study||21||
59556618|NCT02366910|75656746|FG000|NOT COMPLETED|Overall Study||5||
59556619|NCT02783469|75656752|FG000|STARTED|Overall Study||1915||
59556620|NCT02783469|75656752|FG000|COMPLETED|Overall Study||1915||
59556621|NCT02783469|75656752|FG000|NOT COMPLETED|Overall Study||0||
59556622|NCT01463384|75656756|FG000|STARTED|Overall Study||13||
59556623|NCT01463384|75656756|FG000|COMPLETED|Overall Study||13||
59556624|NCT01463384|75656756|FG000|NOT COMPLETED|Overall Study||0||
59556625|NCT01519466|75656764|FG000|STARTED|Overall Study||33||
59556626|NCT01519466|75656765|FG001|STARTED|Overall Study||16||
59556627|NCT01519466|75656764|FG000|COMPLETED|Overall Study||33||
59556628|NCT01519466|75656765|FG001|COMPLETED|Overall Study||16||
59556629|NCT01519466|75656764|FG000|NOT COMPLETED|Overall Study||0||
59556630|NCT01519466|75656765|FG001|NOT COMPLETED|Overall Study||0||
59556631|NCT02785185|75656775|FG000|STARTED|Overall Study||60||
59556632|NCT02785185|75656776|FG001|STARTED|Overall Study||57||
59556633|NCT02785185|75656777|FG002|STARTED|Overall Study||17||
59556634|NCT02785185|75656778|FG003|STARTED|Overall Study||16||
59556635|NCT02785185|75656775|FG000|COMPLETED|Overall Study||59||
59556636|NCT02785185|75656776|FG001|COMPLETED|Overall Study||56||
59556637|NCT02785185|75656777|FG002|COMPLETED|Overall Study||15||
59556638|NCT02785185|75656778|FG003|COMPLETED|Overall Study||16||
59556639|NCT02785185|75656775|FG000|NOT COMPLETED|Overall Study||1||
59556640|NCT02785185|75656776|FG001|NOT COMPLETED|Overall Study||1||
59556641|NCT02785185|75656777|FG002|NOT COMPLETED|Overall Study||2||
59556642|NCT02785185|75656778|FG003|NOT COMPLETED|Overall Study||0||
59556643|NCT02786355|75656788|FG000|STARTED|Overall Study||35||
59556644|NCT02786355|75656788|FG000|COMPLETED|Overall Study||35||
59556645|NCT02786355|75656788|FG000|NOT COMPLETED|Overall Study||0||
59556646|NCT02787057|75656797|FG000|STARTED|Overall Study||40||
59556647|NCT02787057|75656798|FG001|STARTED|Overall Study||40||
59556648|NCT02787057|75656797|FG000|COMPLETED|Overall Study||40||
59556649|NCT02787057|75656798|FG001|COMPLETED|Overall Study||40||
59556650|NCT02787057|75656797|FG000|NOT COMPLETED|Overall Study||0||
59556651|NCT02787057|75656798|FG001|NOT COMPLETED|Overall Study||0||
59556652|NCT01466972|75656804|FG000|STARTED|Overall Study||30||
59816618|NCT04915950|75939021|FG000|STARTED|Stage A: Treatment Period 2 (1 Day)||2||
59816619|NCT04915950|75939022|FG001|STARTED|Stage A: Treatment Period 2 (1 Day)||2||
59556653|NCT01466972|75656804|FG000|COMPLETED|Overall Study||30||
59816620|NCT04915950|75939023|FG002|STARTED|Stage A: Treatment Period 2 (1 Day)||2||
59816621|NCT04915950|75939024|FG003|STARTED|Stage A: Treatment Period 2 (1 Day)||2||
59816622|NCT04915950|75939025|FG004|STARTED|Stage A: Treatment Period 2 (1 Day)||3||
59556654|NCT01466972|75656804|FG000|NOT COMPLETED|Overall Study||0||
59556655|NCT02787291|75656808|FG000|STARTED|Overall Study||227||
59556656|NCT02787291|75656808|FG000|COMPLETED|Overall Study||227||
59556657|NCT02787291|75656808|FG000|NOT COMPLETED|Overall Study||0||
59556658|NCT02787681|75656812|FG000|STARTED|Overall Study||71||
59556659|NCT02787681|75656812|FG000|COMPLETED|Overall Study||69||
59556660|NCT02787681|75656812|FG000|NOT COMPLETED|Overall Study||2||
59556661|NCT02792049|75656818|FG000|STARTED|Overall Study||35||
59556662|NCT02792049|75656819|FG001|STARTED|Overall Study||35||
59556663|NCT02792049|75656818|FG000|COMPLETED|Overall Study||35||
59556664|NCT02792049|75656819|FG001|COMPLETED|Overall Study||35||
59816623|NCT04915950|75939026|FG005|STARTED|Stage A: Treatment Period 2 (1 Day)||2||
59991910|NCT02207608|76107552|FG001|COMPLETED|Overall Study||15||
59556665|NCT02792049|75656818|FG000|NOT COMPLETED|Overall Study||0||
59556666|NCT02792049|75656819|FG001|NOT COMPLETED|Overall Study||0||
59556667|NCT01520558|75656830|FG000|STARTED|Overall Study||3||
59556668|NCT01520558|75656831|FG001|STARTED|Overall Study||3||
59556669|NCT01520558|75656832|FG002|STARTED|Overall Study||6||
59556670|NCT01520558|75656830|FG000|COMPLETED|Overall Study||1||
59556671|NCT01520558|75656831|FG001|COMPLETED|Overall Study||1||
59556672|NCT01520558|75656832|FG002|COMPLETED|Overall Study||3||
59556673|NCT01520558|75656830|FG000|NOT COMPLETED|Overall Study||2||
59556674|NCT01520558|75656831|FG001|NOT COMPLETED|Overall Study||2||
59556675|NCT01520558|75656832|FG002|NOT COMPLETED|Overall Study||3||
59556676|NCT01468532|75656840|FG000|STARTED|Overall Study||18||
59556677|NCT01468532|75656840|FG000|COMPLETED|Overall Study||18||
59556678|NCT01468532|75656840|FG000|NOT COMPLETED|Overall Study||0||
59556679|NCT01469234|75656847|FG000|STARTED|Overall Study||85||
59556680|NCT01469234|75656848|FG001|STARTED|Overall Study||85||
59556681|NCT01469234|75656849|FG002|STARTED|Overall Study||85||
59556682|NCT01469234|75656847|FG000|COMPLETED|Overall Study||85||
59556683|NCT01469234|75656848|FG001|COMPLETED|Overall Study||85||
59556684|NCT01469234|75656849|FG002|COMPLETED|Overall Study||85||
59556685|NCT01469234|75656847|FG000|NOT COMPLETED|Overall Study||0||
59556686|NCT01469234|75656848|FG001|NOT COMPLETED|Overall Study||0||
59556687|NCT01469234|75656849|FG002|NOT COMPLETED|Overall Study||0||
59556688|NCT05608629|75656857|FG000|STARTED|Overall Study||17||
59556689|NCT05608629|75656857|FG000|COMPLETED|Overall Study||15||
59556690|NCT05608629|75656857|FG000|NOT COMPLETED|Overall Study||2||
59556691|NCT05180500|75656863|FG000|STARTED|Overall Study||33||
59556692|NCT05180500|75656864|FG001|STARTED|Overall Study||17||
59556693|NCT05180500|75656863|FG000|COMPLETED|Overall Study||30||
59556694|NCT05180500|75656864|FG001|COMPLETED|Overall Study||17||
59556695|NCT05180500|75656863|FG000|NOT COMPLETED|Overall Study||3||
59556696|NCT05180500|75656864|FG001|NOT COMPLETED|Overall Study||0||
59556697|NCT05001945|75656878|FG000|STARTED|Overall Study||30||
59556698|NCT05001945|75656879|FG001|STARTED|Overall Study|Following the completion of the planned interim analysis, the two lowest doses in Part 1 (i.e., 12.5 mg QD and 12.5 mg BID) were dropped from the study and no further subjects were enrolled in these treatment arms.|22||
59556699|NCT05001945|75656880|FG002|STARTED|Overall Study||30||
59556700|NCT05001945|75656881|FG003|STARTED|Overall Study|Following the completion of the planned interim analysis, the two lowest doses in Part 1 (i.e., 12.5 mg QD and 12.5 mg BID) were dropped from the study and no further subjects were enrolled in these treatment arms.|23||
59556701|NCT05001945|75656882|FG004|STARTED|Overall Study||28||
59556702|NCT05001945|75656883|FG005|STARTED|Overall Study||30||
59556703|NCT05001945|75656884|FG006|STARTED|Overall Study||6||
59556704|NCT05001945|75656885|FG007|STARTED|Overall Study||31||
59556705|NCT05001945|75656878|FG000|COMPLETED|Overall Study||29||
59556706|NCT05001945|75656879|FG001|COMPLETED|Overall Study||18||
59556707|NCT05001945|75656880|FG002|COMPLETED|Overall Study||28||
59556708|NCT05001945|75656881|FG003|COMPLETED|Overall Study||18||
59556709|NCT05001945|75656882|FG004|COMPLETED|Overall Study||26||
59556710|NCT05001945|75656883|FG005|COMPLETED|Overall Study||27||
59556711|NCT05001945|75656884|FG006|COMPLETED|Overall Study||6||
59556712|NCT05001945|75656885|FG007|COMPLETED|Overall Study||30||
59556713|NCT05001945|75656878|FG000|NOT COMPLETED|Overall Study||1||
59556714|NCT05001945|75656879|FG001|NOT COMPLETED|Overall Study||4||
59556715|NCT05001945|75656880|FG002|NOT COMPLETED|Overall Study||2||
59556716|NCT05001945|75656881|FG003|NOT COMPLETED|Overall Study||5||
59556717|NCT05001945|75656882|FG004|NOT COMPLETED|Overall Study||2||
59556718|NCT05001945|75656883|FG005|NOT COMPLETED|Overall Study||3||
59556719|NCT05001945|75656884|FG006|NOT COMPLETED|Overall Study||0||
59556720|NCT05001945|75656885|FG007|NOT COMPLETED|Overall Study||1||
59556721|NCT04995419|75656904|FG000|STARTED|Overall Study||40||
59556722|NCT04995419|75656904|FG000|COMPLETED|Overall Study||0||
59556723|NCT04995419|75656904|FG000|NOT COMPLETED|Overall Study||40||
59556724|NCT04955639|75656910|FG000|STARTED|Overall Study||94||
59556725|NCT04955639|75656911|FG001|STARTED|Overall Study||94||
59556726|NCT04955639|75656910|FG000|Completed Week 12 Survey|Overall Study||91||
59556727|NCT04955639|75656911|FG001|Completed Week 12 Survey|Overall Study||92||
59556728|NCT04955639|75656910|FG000|COMPLETED|Overall Study||90|n = 89 fully completed the week 26 questionnaire n = 1 partially completed the week 26 questionnaire|
59556729|NCT04955639|75656911|FG001|COMPLETED|Overall Study||90|n = 89 fully completed the week 26 questionnaire n = 1 partially completed the week 26 questionnaire|
59556730|NCT04955639|75656910|FG000|NOT COMPLETED|Overall Study||4||
59556731|NCT04955639|75656911|FG001|NOT COMPLETED|Overall Study||4||
59556732|NCT04919564|75656919|FG000|STARTED|Overall Study||45||
59556733|NCT04919564|75656920|FG001|STARTED|Overall Study||45||
59556734|NCT04919564|75656919|FG000|COMPLETED|Overall Study||43||
59556735|NCT04919564|75656920|FG001|COMPLETED|Overall Study||44||
59556736|NCT04919564|75656919|FG000|NOT COMPLETED|Overall Study||2||
59556737|NCT04919564|75656920|FG001|NOT COMPLETED|Overall Study||1||
59556738|NCT04908800|75656939|FG000|STARTED|Overall Study||12||
59556739|NCT04908800|75656940|FG001|STARTED|Overall Study||5||
59556740|NCT04908800|75656941|FG002|STARTED|Overall Study||6||
59556741|NCT04908800|75656942|FG003|STARTED|Overall Study||6||
59556742|NCT04908800|75656943|FG004|STARTED|Overall Study||6||
59816624|NCT04915950|75939021|FG000|COMPLETED|Stage A: Treatment Period 2 (1 Day)||2||
59556743|NCT04908800|75656944|FG005|STARTED|Overall Study||6||
59556744|NCT04908800|75656945|FG006|STARTED|Overall Study||6||
59556745|NCT04908800|75656946|FG007|STARTED|Overall Study||8||
59556746|NCT04908800|75656947|FG008|STARTED|Overall Study||8||
59556747|NCT04908800|75656948|FG009|STARTED|Overall Study||8||
59556748|NCT04908800|75656949|FG010|STARTED|Overall Study||8||
59556749|NCT04908800|75656950|FG011|STARTED|Overall Study||8||
59556750|NCT04908800|75656951|FG012|STARTED|Overall Study||12||
59556751|NCT04908800|75656939|FG000|COMPLETED|Overall Study||12||
59556752|NCT04908800|75656940|FG001|COMPLETED|Overall Study||5||
59556753|NCT04908800|75656941|FG002|COMPLETED|Overall Study||6||
59556754|NCT04908800|75656942|FG003|COMPLETED|Overall Study||6||
59556755|NCT04908800|75656943|FG004|COMPLETED|Overall Study||6||
59556756|NCT04908800|75656944|FG005|COMPLETED|Overall Study||6||
59556757|NCT04908800|75656945|FG006|COMPLETED|Overall Study||6||
59556758|NCT04908800|75656946|FG007|COMPLETED|Overall Study||8||
59556759|NCT04908800|75656947|FG008|COMPLETED|Overall Study||8||
59556760|NCT04908800|75656948|FG009|COMPLETED|Overall Study||8||
59556761|NCT04908800|75656949|FG010|COMPLETED|Overall Study||7||
59556762|NCT04908800|75656950|FG011|COMPLETED|Overall Study||8||
59556763|NCT04908800|75656951|FG012|COMPLETED|Overall Study||12||
59556764|NCT04908800|75656939|FG000|NOT COMPLETED|Overall Study||0||
59556765|NCT04908800|75656940|FG001|NOT COMPLETED|Overall Study||0||
59556766|NCT04908800|75656941|FG002|NOT COMPLETED|Overall Study||0||
59556767|NCT04908800|75656942|FG003|NOT COMPLETED|Overall Study||0||
59556768|NCT04908800|75656943|FG004|NOT COMPLETED|Overall Study||0||
59556769|NCT04908800|75656944|FG005|NOT COMPLETED|Overall Study||0||
59556770|NCT04908800|75656945|FG006|NOT COMPLETED|Overall Study||0||
59556771|NCT04908800|75656946|FG007|NOT COMPLETED|Overall Study||0||
59556772|NCT04908800|75656947|FG008|NOT COMPLETED|Overall Study||0||
59556773|NCT04908800|75656948|FG009|NOT COMPLETED|Overall Study||0||
59556774|NCT04908800|75656949|FG010|NOT COMPLETED|Overall Study||1||
59556775|NCT04908800|75656950|FG011|NOT COMPLETED|Overall Study||0||
59556776|NCT04908800|75656951|FG012|NOT COMPLETED|Overall Study||0||
59556777|NCT04889040|75656999|FG000|STARTED|Overall Study||73||
59556778|NCT04889040|75657000|FG001|STARTED|Overall Study||143||
59556779|NCT04889040|75656999|FG000|Received Treatment|Overall Study||71||
59556780|NCT04889040|75657000|FG001|Received Treatment|Overall Study||141||
59556781|NCT04889040|75656999|FG000|COMPLETED|Overall Study||68||
59556782|NCT04889040|75657000|FG001|COMPLETED|Overall Study||138||
59556783|NCT04889040|75656999|FG000|NOT COMPLETED|Overall Study||5||
59556784|NCT04889040|75657000|FG001|NOT COMPLETED|Overall Study||5||
59556785|NCT04794803|75657009|FG000|STARTED|Overall Study||37||
59556786|NCT04794803|75657010|FG001|STARTED|Overall Study||19||
59556787|NCT04794803|75657009|FG000|FAS Population|Overall Study||36||
59556788|NCT04794803|75657010|FG001|FAS Population|Overall Study||19||
59556789|NCT04794803|75657009|FG000|Safety Set|Overall Study||36||
59556790|NCT04794803|75657010|FG001|Safety Set|Overall Study||19||
59556791|NCT04794803|75657009|FG000|Per Protocol Set|Overall Study||17||
59556792|NCT04794803|75657010|FG001|Per Protocol Set|Overall Study||11||
59556793|NCT04794803|75657009|FG000|COMPLETED|Overall Study||27||
59556794|NCT04794803|75657010|FG001|COMPLETED|Overall Study||11||
59556795|NCT04794803|75657009|FG000|NOT COMPLETED|Overall Study||10||
59556796|NCT04794803|75657010|FG001|NOT COMPLETED|Overall Study||8||
59556797|NCT04729803|75657019|FG000|STARTED|Overall Study||13||
59556798|NCT04729803|75657020|FG001|STARTED|Overall Study||18||
59556799|NCT04729803|75657021|FG002|STARTED|Overall Study||22||
59556800|NCT04729803|75657019|FG000|Post-treatment|Overall Study||7||
59556801|NCT04729803|75657020|FG001|Post-treatment|Overall Study||15||
59556802|NCT04729803|75657021|FG002|Post-treatment|Overall Study||12||
59556803|NCT04729803|75657019|FG000|COMPLETED|Overall Study||6||
59556804|NCT04729803|75657020|FG001|COMPLETED|Overall Study||12||
59556805|NCT04729803|75657021|FG002|COMPLETED|Overall Study||9||
59556806|NCT04729803|75657019|FG000|NOT COMPLETED|Overall Study||7||
59556807|NCT04729803|75657020|FG001|NOT COMPLETED|Overall Study||6||
59556808|NCT04729803|75657021|FG002|NOT COMPLETED|Overall Study||13||
59556809|NCT04676152|75657029|FG000|STARTED|Overall Study||106||
59556810|NCT04676152|75657029|FG000|COMPLETED|Overall Study||97||
59556811|NCT04676152|75657029|FG000|NOT COMPLETED|Overall Study||9||
59556812|NCT04673630|75657033|FG000|STARTED|Overall Study||18||
59556813|NCT04673630|75657033|FG000|COMPLETED|Overall Study||18||
59556814|NCT04673630|75657033|FG000|NOT COMPLETED|Overall Study||0||
59556815|NCT04618471|75657037|FG000|STARTED|Overall Study||177||
59556816|NCT04618471|75657037|FG000|COMPLETED|Overall Study||20||
59556817|NCT04618471|75657037|FG000|NOT COMPLETED|Overall Study||157||
59556818|NCT04546425|75657045|FG000|STARTED|Overall Study||601||
59556819|NCT04546425|75657046|FG001|STARTED|Overall Study||603||
59556820|NCT04546425|75657047|FG002|STARTED|Overall Study||24||
59556821|NCT04546425|75657048|FG003|STARTED|Overall Study||27||
59556822|NCT04546425|75657045|FG000|Dose 1|Overall Study||601||
59556823|NCT04546425|75657046|FG001|Dose 1|Overall Study||603||
59556824|NCT04546425|75657047|FG002|Dose 1|Overall Study||24||
59556825|NCT04546425|75657048|FG003|Dose 1|Overall Study||27||
59556826|NCT04546425|75657045|FG000|Dose 2|Overall Study||593||
59556827|NCT04546425|75657046|FG001|Dose 2|Overall Study||598||
59556828|NCT04546425|75657047|FG002|Dose 2|Overall Study||24||
59556829|NCT04546425|75657048|FG003|Dose 2|Overall Study||27||
59556830|NCT04546425|75657045|FG000|Dose 3|Overall Study||588||
59556831|NCT04546425|75657046|FG001|Dose 3|Overall Study||594||
59556832|NCT04546425|75657047|FG002|Dose 3|Overall Study||22||
59556833|NCT04546425|75657048|FG003|Dose 3|Overall Study||25||
59556834|NCT04546425|75657045|FG000|COMPLETED|Overall Study||583||
59556835|NCT04546425|75657046|FG001|COMPLETED|Overall Study||590||
59556836|NCT04546425|75657047|FG002|COMPLETED|Overall Study||22||
59556837|NCT04546425|75657048|FG003|COMPLETED|Overall Study||25||
59556838|NCT04546425|75657045|FG000|NOT COMPLETED|Overall Study||18||
59556839|NCT04546425|75657046|FG001|NOT COMPLETED|Overall Study||13||
59556840|NCT04546425|75657047|FG002|NOT COMPLETED|Overall Study||2||
59556841|NCT04546425|75657048|FG003|NOT COMPLETED|Overall Study||2||
59556842|NCT04537949|75657066|FG000|STARTED|Treatment Phase||12||
59556843|NCT04537949|75657067|FG001|STARTED|Treatment Phase||12||
59556844|NCT04537949|75657068|FG002|STARTED|Treatment Phase||12||
59556845|NCT04537949|75657069|FG003|STARTED|Treatment Phase||12||
59556846|NCT04537949|75657070|FG004|STARTED|Treatment Phase||12||
59556847|NCT04537949|75657071|FG005|STARTED|Treatment Phase||12||
59556848|NCT04537949|75657072|FG006|STARTED|Treatment Phase||12||
59556849|NCT04537949|75657073|FG007|STARTED|Treatment Phase||12||
59556850|NCT04537949|75657066|FG000|COMPLETED|Treatment Phase||11||
59556851|NCT04537949|75657067|FG001|COMPLETED|Treatment Phase||12||
59556852|NCT04537949|75657068|FG002|COMPLETED|Treatment Phase||12||
59556853|NCT04537949|75657069|FG003|COMPLETED|Treatment Phase||12||
59556854|NCT04537949|75657070|FG004|COMPLETED|Treatment Phase||12||
59556855|NCT04537949|75657071|FG005|COMPLETED|Treatment Phase||12||
59556856|NCT04537949|75657072|FG006|COMPLETED|Treatment Phase||12||
59556857|NCT04537949|75657073|FG007|COMPLETED|Treatment Phase||12||
59556858|NCT04537949|75657066|FG000|NOT COMPLETED|Treatment Phase||1||
59556859|NCT04537949|75657067|FG001|NOT COMPLETED|Treatment Phase||0||
59556860|NCT04537949|75657068|FG002|NOT COMPLETED|Treatment Phase||0||
59556861|NCT04537949|75657069|FG003|NOT COMPLETED|Treatment Phase||0||
59556862|NCT04537949|75657070|FG004|NOT COMPLETED|Treatment Phase||0||
59556863|NCT04537949|75657071|FG005|NOT COMPLETED|Treatment Phase||0||
59556864|NCT04537949|75657072|FG006|NOT COMPLETED|Treatment Phase||0||
59556865|NCT04537949|75657073|FG007|NOT COMPLETED|Treatment Phase||0||
59556866|NCT04537949|75657066|FG000|STARTED|Follow-up Phase||11||
59556867|NCT04537949|75657067|FG001|STARTED|Follow-up Phase||12||
59556868|NCT04537949|75657068|FG002|STARTED|Follow-up Phase||12||
59556869|NCT04537949|75657069|FG003|STARTED|Follow-up Phase||12||
59556870|NCT04537949|75657070|FG004|STARTED|Follow-up Phase||12||
59556871|NCT04537949|75657071|FG005|STARTED|Follow-up Phase||12||
59556872|NCT04537949|75657072|FG006|STARTED|Follow-up Phase||12||
59556873|NCT04537949|75657073|FG007|STARTED|Follow-up Phase||12||
59556874|NCT04537949|75657066|FG000|COMPLETED|Follow-up Phase||8||
59556875|NCT04537949|75657067|FG001|COMPLETED|Follow-up Phase||8||
59556876|NCT04537949|75657068|FG002|COMPLETED|Follow-up Phase||12||
59556877|NCT04537949|75657069|FG003|COMPLETED|Follow-up Phase||9||
59556878|NCT04537949|75657070|FG004|COMPLETED|Follow-up Phase||9||
59556879|NCT04537949|75657071|FG005|COMPLETED|Follow-up Phase||11||
59556880|NCT04537949|75657072|FG006|COMPLETED|Follow-up Phase||7||
59556881|NCT04537949|75657073|FG007|COMPLETED|Follow-up Phase||6||
59556882|NCT04537949|75657066|FG000|NOT COMPLETED|Follow-up Phase||3||
59556883|NCT04537949|75657067|FG001|NOT COMPLETED|Follow-up Phase||4||
59556884|NCT04537949|75657068|FG002|NOT COMPLETED|Follow-up Phase||0||
59556885|NCT04537949|75657069|FG003|NOT COMPLETED|Follow-up Phase||3||
59556886|NCT04537949|75657070|FG004|NOT COMPLETED|Follow-up Phase||3||
59556887|NCT04537949|75657071|FG005|NOT COMPLETED|Follow-up Phase||1||
59556888|NCT04537949|75657072|FG006|NOT COMPLETED|Follow-up Phase||5||
59556889|NCT04537949|75657073|FG007|NOT COMPLETED|Follow-up Phase||6||
59556890|NCT04439201|75657091|FG000|STARTED|Overall Study||40||
59556891|NCT04439201|75657091|FG000|Eligible|Overall Study||37||
59556892|NCT04439201|75657091|FG000|Started Protocol Therapy|Overall Study||38||
59556893|NCT04439201|75657091|FG000|Eligible and Treated|Overall Study||36||
59556894|NCT04439201|75657091|FG000|Mutation Status Confirmed|Overall Study||36||
59556895|NCT04439201|75657091|FG000|Eligible, Treated and Mutation Status Confirmed|Overall Study||32|This is the primary analysis population.|
59556896|NCT04439201|75657091|FG000|COMPLETED|Overall Study||0|Treatment continued until disease progression or intolerability.|
59556897|NCT04439201|75657091|FG000|NOT COMPLETED|Overall Study||40||
59556898|NCT04425902|75657095|FG000|STARTED|Treatment Period 1 (Days 1 to 10)||20||
59556899|NCT04425902|75657095|FG000|COMPLETED|Treatment Period 1 (Days 1 to 10)||20||
60084556|NCT00453388|76200518|FG002|COMPLETED|Overall Study||1||
60084557|NCT00453388|76200519|FG003|COMPLETED|Overall Study||0||
59556900|NCT04425902|75657095|FG000|NOT COMPLETED|Treatment Period 1 (Days 1 to 10)||0||
59556901|NCT04425902|75657095|FG000|STARTED|Treatment Period 2 (Days 11 to 20)||20||
59556902|NCT04425902|75657095|FG000|COMPLETED|Treatment Period 2 (Days 11 to 20)||19||
59556903|NCT04425902|75657095|FG000|NOT COMPLETED|Treatment Period 2 (Days 11 to 20)||1||
59556904|NCT04425902|75657095|FG000|STARTED|Treatment Period 3 (Days 21 to 26)||19||
59556905|NCT04425902|75657095|FG000|COMPLETED|Treatment Period 3 (Days 21 to 26)||19||
59556906|NCT04425902|75657095|FG000|NOT COMPLETED|Treatment Period 3 (Days 21 to 26)||0||
60084558|NCT00453388|76200516|FG000|NOT COMPLETED|Overall Study||0||
60084559|NCT00453388|76200517|FG001|NOT COMPLETED|Overall Study||0||
59556907|NCT04421586|75657108|FG000|STARTED|Overall Study||30||5
59556908|NCT04421586|75657109|FG001|STARTED|Overall Study||30||5
59556909|NCT04421586|75657108|FG000|COMPLETED|Overall Study||25||5
59556910|NCT04421586|75657109|FG001|COMPLETED|Overall Study||24||5
59556911|NCT04421586|75657108|FG000|NOT COMPLETED|Overall Study||5||0
60084560|NCT00453388|76200518|FG002|NOT COMPLETED|Overall Study||0||
60084561|NCT00453388|76200519|FG003|NOT COMPLETED|Overall Study||0||
59816625|NCT04915950|75939022|FG001|COMPLETED|Stage A: Treatment Period 2 (1 Day)||2||
59556912|NCT04421586|75657109|FG001|NOT COMPLETED|Overall Study||6||0
59556913|NCT04407234|75657117|FG000|STARTED|Overall Study||18||
59556914|NCT04407234|75657118|FG001|STARTED|Overall Study||18||
59556915|NCT04407234|75657117|FG000|Received at Least One Dose of Study Drug|Overall Study||18||
59556916|NCT04407234|75657118|FG001|Received at Least One Dose of Study Drug|Overall Study||18||
59556917|NCT04407234|75657117|FG000|COMPLETED|Overall Study||15||
59556918|NCT04407234|75657118|FG001|COMPLETED|Overall Study||15||
59556919|NCT04407234|75657117|FG000|NOT COMPLETED|Overall Study||3||
59556920|NCT04407234|75657118|FG001|NOT COMPLETED|Overall Study||3||
59556921|NCT04337931|75657137|FG000|STARTED|Overall Study||12||
59556922|NCT04337931|75657138|FG001|STARTED|Overall Study||14||
59556923|NCT04337931|75657139|FG002|STARTED|Overall Study||19||
59556924|NCT04337931|75657137|FG000|Safety Population|Overall Study||12||
59556925|NCT04337931|75657138|FG001|Safety Population|Overall Study||13||
59556926|NCT04337931|75657139|FG002|Safety Population|Overall Study||19||
59556927|NCT04337931|75657137|FG000|Efficacy Population|Overall Study||11||
59556928|NCT04337931|75657138|FG001|Efficacy Population|Overall Study||13||
59556929|NCT04337931|75657139|FG002|Efficacy Population|Overall Study||19||
59556930|NCT04337931|75657137|FG000|COMPLETED|Overall Study||0||
59556931|NCT04337931|75657138|FG001|COMPLETED|Overall Study||0||
59556932|NCT04337931|75657139|FG002|COMPLETED|Overall Study||0||
59556933|NCT04337931|75657137|FG000|NOT COMPLETED|Overall Study||12||
59556934|NCT04337931|75657138|FG001|NOT COMPLETED|Overall Study||14||
59556935|NCT04337931|75657139|FG002|NOT COMPLETED|Overall Study||19||
59556936|NCT04270747|75657150|FG000|STARTED|Through Week 16||288||
59556937|NCT04270747|75657151|FG001|STARTED|Through Week 16||288||
59556938|NCT04270747|75657152|FG002|STARTED|Through Week 16||0||
59556939|NCT04270747|75657150|FG000|COMPLETED|Through Week 16||273|Completed through Week 16|
59556940|NCT04270747|75657151|FG001|COMPLETED|Through Week 16||270|Completed through Week 16|
59556941|NCT04270747|75657152|FG002|COMPLETED|Through Week 16||0|Completed through Week 16|
59556942|NCT04270747|75657150|FG000|NOT COMPLETED|Through Week 16||15||
59556943|NCT04270747|75657151|FG001|NOT COMPLETED|Through Week 16||18||
59556944|NCT04270747|75657152|FG002|NOT COMPLETED|Through Week 16||0||
59556945|NCT04270747|75657150|FG000|STARTED|Post Week 16||273||
59556946|NCT04270747|75657151|FG001|STARTED|Post Week 16||136||
59556947|NCT04270747|75657152|FG002|STARTED|Post Week 16||134||
59556948|NCT04270747|75657150|FG000|Received Treatment|Post Week 16||273||
59556949|NCT04270747|75657151|FG001|Received Treatment|Post Week 16||136||
59556950|NCT04270747|75657152|FG002|Received Treatment|Post Week 16||133||
59556951|NCT04270747|75657150|FG000|COMPLETED|Post Week 16||251||
59556952|NCT04270747|75657151|FG001|COMPLETED|Post Week 16||125||
59556953|NCT04270747|75657152|FG002|COMPLETED|Post Week 16||123||
59556954|NCT04270747|75657150|FG000|NOT COMPLETED|Post Week 16||22||
59556955|NCT04270747|75657151|FG001|NOT COMPLETED|Post Week 16||11||
59556956|NCT04270747|75657152|FG002|NOT COMPLETED|Post Week 16||11||
59556957|NCT04241627|75657173|FG000|STARTED|Overall Study||11||
59556958|NCT04241627|75657174|FG001|STARTED|Overall Study||12||
59556959|NCT04241627|75657175|FG002|STARTED|Overall Study||11||
59556960|NCT04241627|75657173|FG000|COMPLETED|Overall Study||11||
59556961|NCT04241627|75657174|FG001|COMPLETED|Overall Study||12||
59556962|NCT04241627|75657175|FG002|COMPLETED|Overall Study||11||
59556963|NCT04241627|75657173|FG000|NOT COMPLETED|Overall Study||0||
59556964|NCT04241627|75657174|FG001|NOT COMPLETED|Overall Study||0||
59816626|NCT04915950|75939023|FG002|COMPLETED|Stage A: Treatment Period 2 (1 Day)||2||
59556965|NCT04241627|75657175|FG002|NOT COMPLETED|Overall Study||0||
59556966|NCT04238728|75657183|FG000|STARTED|Overall Study||31||
59556967|NCT04238728|75657183|FG000|COMPLETED|Overall Study||28||
59556968|NCT04238728|75657183|FG000|NOT COMPLETED|Overall Study||3||
59556969|NCT04126278|75657189|FG000|STARTED|Overall Study||0||
59556970|NCT04126278|75657190|FG001|STARTED|Overall Study||4||
59556971|NCT04126278|75657189|FG000|COMPLETED|Overall Study||0||
59556972|NCT04126278|75657190|FG001|COMPLETED|Overall Study||4||
59556973|NCT04126278|75657189|FG000|NOT COMPLETED|Overall Study||0||
59556974|NCT04126278|75657190|FG001|NOT COMPLETED|Overall Study||0||
59556975|NCT04106557|75657199|FG000|STARTED|Overall Study||47||
59556976|NCT04106557|75657200|FG001|STARTED|Overall Study||50||
60084562|NCT00389974|76200529|FG000|STARTED|Overall Study||19||
60084563|NCT00389974|76200529|FG000|COMPLETED|Overall Study||19||
60084564|NCT00389974|76200529|FG000|NOT COMPLETED|Overall Study||0||
60084565|NCT01453725|76200535|FG000|STARTED|Overall Study||98||
60084566|NCT01453725|76200536|FG001|STARTED|Overall Study||100||
60084567|NCT01453725|76200535|FG000|COMPLETED|Overall Study||85||
60084568|NCT01453725|76200536|FG001|COMPLETED|Overall Study||89||
60084569|NCT01453725|76200535|FG000|NOT COMPLETED|Overall Study||13||
60084570|NCT01453725|76200536|FG001|NOT COMPLETED|Overall Study||11||
60084571|NCT00454324|76200546|FG000|STARTED|Overall Study||14||
60084572|NCT00454324|76200547|FG001|STARTED|Overall Study||13||
60084573|NCT00454324|76200546|FG000|COMPLETED|Overall Study||14||
59556977|NCT04106557|75657201|FG002|STARTED|Overall Study||7||
59556978|NCT04106557|75657199|FG000|COMPLETED|Overall Study||47||
59556979|NCT04106557|75657200|FG001|COMPLETED|Overall Study||48||
59556980|NCT04106557|75657201|FG002|COMPLETED|Overall Study||7||
59556981|NCT04106557|75657199|FG000|NOT COMPLETED|Overall Study||0||
59556982|NCT04106557|75657200|FG001|NOT COMPLETED|Overall Study||2||
59556983|NCT04106557|75657201|FG002|NOT COMPLETED|Overall Study||0||
59556984|NCT04085614|75657210|FG000|STARTED|Overall Study||188||
59556985|NCT04085614|75657211|FG001|STARTED|Overall Study||183||
59556986|NCT04085614|75657210|FG000|COMPLETED|Overall Study||179||
59556987|NCT04085614|75657211|FG001|COMPLETED|Overall Study||177||
59556988|NCT04085614|75657210|FG000|NOT COMPLETED|Overall Study||9||
59556989|NCT04085614|75657211|FG001|NOT COMPLETED|Overall Study||6||
59556990|NCT04056455|75657219|FG000|STARTED|Overall Study||14||
59556991|NCT04056455|75657220|FG001|STARTED|Overall Study||12||
59556992|NCT04056455|75657219|FG000|Safety Analysis Set|Overall Study||14|Safety Analysis Set included all participants who received the dose of study drug.|
59556993|NCT04056455|75657220|FG001|Safety Analysis Set|Overall Study||12|Safety Analysis Set included all participants who received the dose of study drug.|
59556994|NCT04056455|75657219|FG000|Pharmacokinetic (PK) Analysis Set|Overall Study||13|PK Analysis Set included all participants who complied sufficiently with the protocol and displayed an evaluable PK profile.|
59556995|NCT04056455|75657220|FG001|Pharmacokinetic (PK) Analysis Set|Overall Study||12|PK Analysis Set included all participants who complied sufficiently with the protocol and displayed an evaluable PK profile.|
59556996|NCT04056455|75657219|FG000|COMPLETED|Overall Study||13||
59556997|NCT04056455|75657220|FG001|COMPLETED|Overall Study||12||
59556998|NCT04056455|75657219|FG000|NOT COMPLETED|Overall Study||1||
59556999|NCT04056455|75657220|FG001|NOT COMPLETED|Overall Study||0||
59557000|NCT03980184|75657228|FG000|STARTED|Overall Study||38|Participants randomized|
59557001|NCT03980184|75657229|FG001|STARTED|Overall Study||36|Participants randomized|
59557002|NCT03980184|75657228|FG000|Began Treatment|Overall Study||36||
59557003|NCT03980184|75657229|FG001|Began Treatment|Overall Study||34||
59557004|NCT03980184|75657228|FG000|COMPLETED|Overall Study||25||
59557005|NCT03980184|75657229|FG001|COMPLETED|Overall Study||21||
59557006|NCT03980184|75657228|FG000|NOT COMPLETED|Overall Study||13||
59557007|NCT03980184|75657229|FG001|NOT COMPLETED|Overall Study||15||
60084574|NCT00454324|76200547|FG001|COMPLETED|Overall Study||13||
60084575|NCT00454324|76200546|FG000|NOT COMPLETED|Overall Study||0||
60084576|NCT00454324|76200547|FG001|NOT COMPLETED|Overall Study||0||
60084577|NCT02076399|76200555|FG000|STARTED|Overall Study||51||
60084578|NCT02076399|76200556|FG001|STARTED|Overall Study||25||
60084579|NCT02076399|76200555|FG000|COMPLETED|Overall Study||12||
60084580|NCT02076399|76200556|FG001|COMPLETED|Overall Study||1||
60084581|NCT02076399|76200555|FG000|NOT COMPLETED|Overall Study||39||
60084582|NCT02076399|76200556|FG001|NOT COMPLETED|Overall Study||24||
60084583|NCT02110264|76200565|FG000|STARTED|Overall Study||53||
60084584|NCT02110264|76200566|FG001|STARTED|Overall Study||50||
60084585|NCT02110264|76200567|FG002|STARTED|Overall Study||48||
60084586|NCT02110264|76200565|FG000|COMPLETED|Overall Study||35||
60084587|NCT02110264|76200566|FG001|COMPLETED|Overall Study||38||
60084588|NCT02110264|76200567|FG002|COMPLETED|Overall Study||39||
60084589|NCT02110264|76200565|FG000|NOT COMPLETED|Overall Study||18||
59557008|NCT03917459|75657237|FG000|STARTED|Overall Study||13||
59557009|NCT03917459|75657238|FG001|STARTED|Overall Study||14||
59557010|NCT03917459|75657237|FG000|COMPLETED|Overall Study||12||
59557011|NCT03917459|75657238|FG001|COMPLETED|Overall Study||13||
59557012|NCT03917459|75657237|FG000|NOT COMPLETED|Overall Study||1||
59557013|NCT03917459|75657238|FG001|NOT COMPLETED|Overall Study||1||
59557014|NCT03904693|75657248|FG000|STARTED|Overall Study||35||
59557015|NCT03904693|75657249|FG001|STARTED|Overall Study||44||
59557016|NCT03904693|75657250|FG002|STARTED|Overall Study||108||
59557017|NCT03904693|75657248|FG000|Treated (Safety Analysis Set)|Overall Study||35||
59557018|NCT03904693|75657249|FG001|Treated (Safety Analysis Set)|Overall Study||44||
59557019|NCT03904693|75657250|FG002|Treated (Safety Analysis Set)|Overall Study||107||
60084590|NCT02110264|76200566|FG001|NOT COMPLETED|Overall Study||12||
60084591|NCT02110264|76200567|FG002|NOT COMPLETED|Overall Study||9||
60084592|NCT01415349|76200575|FG000|STARTED|Treatment Period 1||21||
60084593|NCT01415349|76200576|FG001|STARTED|Treatment Period 1||21||
60084594|NCT01415349|76200575|FG000|COMPLETED|Treatment Period 1||21||
59557020|NCT03904693|75657248|FG000|Treatment Naive and Prior ERA Strata: M/T FDC|Overall Study||0||
59557021|NCT03904693|75657249|FG001|Treatment Naive and Prior ERA Strata: M/T FDC|Overall Study||0||
59557022|NCT03904693|75657250|FG002|Treatment Naive and Prior ERA Strata: M/T FDC|Overall Study||70||
59557023|NCT03904693|75657248|FG000|Treatment Naive and Prior PDE-5i Strata: M/T FDC|Overall Study||0||
59557024|NCT03904693|75657249|FG001|Treatment Naive and Prior PDE-5i Strata: M/T FDC|Overall Study||0||
59557025|NCT03904693|75657250|FG002|Treatment Naive and Prior PDE-5i Strata: M/T FDC|Overall Study||86||
59557026|NCT03904693|75657248|FG000|COMPLETED|Overall Study||35||
59557027|NCT03904693|75657249|FG001|COMPLETED|Overall Study||43||
59557028|NCT03904693|75657250|FG002|COMPLETED|Overall Study||99||
59557029|NCT03904693|75657248|FG000|NOT COMPLETED|Overall Study||0||
59557030|NCT03904693|75657249|FG001|NOT COMPLETED|Overall Study||1||
59557031|NCT03904693|75657250|FG002|NOT COMPLETED|Overall Study||9||
59557032|NCT03807778|75657264|FG000|STARTED|Overall Study||4||
59557033|NCT03807778|75657265|FG001|STARTED|Overall Study||4||
59557034|NCT03807778|75657266|FG002|STARTED|Overall Study||12||
59557035|NCT03807778|75657267|FG003|STARTED|Overall Study||33||
59557036|NCT03807778|75657264|FG000|COMPLETED|Overall Study||0||
59557037|NCT03807778|75657265|FG001|COMPLETED|Overall Study||0||
59557038|NCT03807778|75657266|FG002|COMPLETED|Overall Study||0||
59557039|NCT03807778|75657267|FG003|COMPLETED|Overall Study||0||
59557040|NCT03807778|75657264|FG000|NOT COMPLETED|Overall Study||4||
59557041|NCT03807778|75657265|FG001|NOT COMPLETED|Overall Study||4||
59557042|NCT03807778|75657266|FG002|NOT COMPLETED|Overall Study||12||
59557043|NCT03807778|75657267|FG003|NOT COMPLETED|Overall Study||33||
59557044|NCT03747939|75657282|FG000|STARTED|Placebo-controlled Phase (Weeks 0 - 24)||105||
59557045|NCT03747939|75657283|FG001|STARTED|Placebo-controlled Phase (Weeks 0 - 24)||203||
59557046|NCT03747939|75657284|FG002|STARTED|Placebo-controlled Phase (Weeks 0 - 24)||0||
59557047|NCT03747939|75657285|FG003|STARTED|Placebo-controlled Phase (Weeks 0 - 24)||0||
59991911|NCT02207608|76107551|FG000|NOT COMPLETED|Overall Study||1||
59991912|NCT02207608|76107552|FG001|NOT COMPLETED|Overall Study||0||
59991913|NCT03530995|76107560|FG000|STARTED|Part 1 Period 1; Part 2 Period 1||35||
59991914|NCT03530995|76107561|FG001|STARTED|Part 1 Period 1; Part 2 Period 1||38||
59991915|NCT03530995|76107560|FG000|COMPLETED|Part 1 Period 1; Part 2 Period 1||35||
59991916|NCT03530995|76107561|FG001|COMPLETED|Part 1 Period 1; Part 2 Period 1||38||
59991917|NCT03530995|76107560|FG000|NOT COMPLETED|Part 1 Period 1; Part 2 Period 1||0||
59991918|NCT03530995|76107561|FG001|NOT COMPLETED|Part 1 Period 1; Part 2 Period 1||0||
59991919|NCT03530995|76107560|FG000|STARTED|Part 1 Period 2; Part 2 Period 2||35||
59991920|NCT03530995|76107561|FG001|STARTED|Part 1 Period 2; Part 2 Period 2||38||
59991921|NCT03530995|76107560|FG000|COMPLETED|Part 1 Period 2; Part 2 Period 2||35||
59991922|NCT03530995|76107561|FG001|COMPLETED|Part 1 Period 2; Part 2 Period 2||38||
59991923|NCT03530995|76107560|FG000|NOT COMPLETED|Part 1 Period 2; Part 2 Period 2||0||
59991924|NCT03530995|76107561|FG001|NOT COMPLETED|Part 1 Period 2; Part 2 Period 2||0||
59991925|NCT03530995|76107560|FG000|STARTED|Part 1 Period 3||35||
59991926|NCT03530995|76107561|FG001|STARTED|Part 1 Period 3|Period 3 is not applicable to part 2 of the study.|0||
59557048|NCT03747939|75657282|FG000|Full Analysis Set|Placebo-controlled Phase (Weeks 0 - 24)||105||
59557049|NCT03747939|75657283|FG001|Full Analysis Set|Placebo-controlled Phase (Weeks 0 - 24)||203||
59557050|NCT03747939|75657284|FG002|Full Analysis Set|Placebo-controlled Phase (Weeks 0 - 24)||0||
59557051|NCT03747939|75657285|FG003|Full Analysis Set|Placebo-controlled Phase (Weeks 0 - 24)||0||
59991927|NCT03530995|76107560|FG000|COMPLETED|Part 1 Period 3||32||
59991928|NCT03530995|76107561|FG001|COMPLETED|Part 1 Period 3|Period 3 is not applicable to part 2 of the study.|0||
59557052|NCT03747939|75657282|FG000|Safety Analysis Set|Placebo-controlled Phase (Weeks 0 - 24)||104|Included participants according to the treatment they actually received.|
59565957|NCT02303574|75668407|FG002|NOT COMPLETED|Part 1a (Fasted State)- SAD||1||
59565958|NCT02303574|75668408|FG003|NOT COMPLETED|Part 1a (Fasted State)- SAD||0||
59557053|NCT03747939|75657283|FG001|Safety Analysis Set|Placebo-controlled Phase (Weeks 0 - 24)|1 participant randomized to placebo was treated with apremilast.|204|Included participants according to the treatment they actually received.|
59557054|NCT03747939|75657284|FG002|Safety Analysis Set|Placebo-controlled Phase (Weeks 0 - 24)||0|Included participants according to the treatment they actually received.|
59557055|NCT03747939|75657285|FG003|Safety Analysis Set|Placebo-controlled Phase (Weeks 0 - 24)||0|Included participants according to the treatment they actually received.|
59557056|NCT03747939|75657282|FG000|Escaped Early at Week 16|Placebo-controlled Phase (Weeks 0 - 24)||24||
59557057|NCT03747939|75657283|FG001|Escaped Early at Week 16|Placebo-controlled Phase (Weeks 0 - 24)||21||
59557058|NCT03747939|75657284|FG002|Escaped Early at Week 16|Placebo-controlled Phase (Weeks 0 - 24)||0||
59557059|NCT03747939|75657285|FG003|Escaped Early at Week 16|Placebo-controlled Phase (Weeks 0 - 24)||0||
59557060|NCT03747939|75657282|FG000|Completed Week 16 and Continued|Placebo-controlled Phase (Weeks 0 - 24)||92||
59557061|NCT03747939|75657283|FG001|Completed Week 16 and Continued|Placebo-controlled Phase (Weeks 0 - 24)||172||
59557062|NCT03747939|75657284|FG002|Completed Week 16 and Continued|Placebo-controlled Phase (Weeks 0 - 24)||0||
59557063|NCT03747939|75657285|FG003|Completed Week 16 and Continued|Placebo-controlled Phase (Weeks 0 - 24)||0||
59557064|NCT03747939|75657282|FG000|COMPLETED|Placebo-controlled Phase (Weeks 0 - 24)||87|Completed to Week 24 and continued to extension phase|
59557065|NCT03747939|75657283|FG001|COMPLETED|Placebo-controlled Phase (Weeks 0 - 24)||162|Completed to Week 24 and continued to extension phase|
59707269|NCT01255163|75826200|FG000|NOT COMPLETED|Overall Study||4||
59707270|NCT01255163|75826201|FG001|NOT COMPLETED|Overall Study||5||
59707271|NCT01123083|75826211|FG000|STARTED|Overall Study||61||
59707272|NCT01123083|75826212|FG001|STARTED|Overall Study||118||
59707273|NCT01123083|75826211|FG000|COMPLETED|Overall Study||50||
59707274|NCT01123083|75826212|FG001|COMPLETED|Overall Study||103||
59707275|NCT01123083|75826211|FG000|NOT COMPLETED|Overall Study||11||
59707276|NCT01123083|75826212|FG001|NOT COMPLETED|Overall Study||15||
59707277|NCT01254305|75826221|FG000|STARTED|Overall Study||93||
59707278|NCT01254305|75826222|FG001|STARTED|Overall Study||90||
59707279|NCT01254305|75826223|FG002|STARTED|Overall Study||79||
59557066|NCT03747939|75657284|FG002|COMPLETED|Placebo-controlled Phase (Weeks 0 - 24)||0|Completed to Week 24 and continued to extension phase|
59557067|NCT03747939|75657285|FG003|COMPLETED|Placebo-controlled Phase (Weeks 0 - 24)||0|Completed to Week 24 and continued to extension phase|
59557068|NCT03747939|75657282|FG000|NOT COMPLETED|Placebo-controlled Phase (Weeks 0 - 24)||18||
59557069|NCT03747939|75657283|FG001|NOT COMPLETED|Placebo-controlled Phase (Weeks 0 - 24)||41||
59557070|NCT03747939|75657284|FG002|NOT COMPLETED|Placebo-controlled Phase (Weeks 0 - 24)||0||
59557071|NCT03747939|75657285|FG003|NOT COMPLETED|Placebo-controlled Phase (Weeks 0 - 24)||0||
59557072|NCT03747939|75657282|FG000|STARTED|Apremilast Extension (Weeks 24 - 48)||0||
59557073|NCT03747939|75657283|FG001|STARTED|Apremilast Extension (Weeks 24 - 48)||0||
59557074|NCT03747939|75657284|FG002|STARTED|Apremilast Extension (Weeks 24 - 48)||87||
59557075|NCT03747939|75657285|FG003|STARTED|Apremilast Extension (Weeks 24 - 48)||162||
59557076|NCT03747939|75657282|FG000|Received 1 Dose of Investigational Product|Apremilast Extension (Weeks 24 - 48)||0||
59557077|NCT03747939|75657283|FG001|Received 1 Dose of Investigational Product|Apremilast Extension (Weeks 24 - 48)||0||
59557078|NCT03747939|75657284|FG002|Received 1 Dose of Investigational Product|Apremilast Extension (Weeks 24 - 48)||86||
60084595|NCT01415349|76200576|FG001|COMPLETED|Treatment Period 1||19||
59557079|NCT03747939|75657285|FG003|Received 1 Dose of Investigational Product|Apremilast Extension (Weeks 24 - 48)||160||
59557080|NCT03747939|75657282|FG000|COMPLETED|Apremilast Extension (Weeks 24 - 48)||0||
59557081|NCT03747939|75657283|FG001|COMPLETED|Apremilast Extension (Weeks 24 - 48)||0||
59557082|NCT03747939|75657284|FG002|COMPLETED|Apremilast Extension (Weeks 24 - 48)||77||
59557083|NCT03747939|75657285|FG003|COMPLETED|Apremilast Extension (Weeks 24 - 48)||133||
59557084|NCT03747939|75657282|FG000|NOT COMPLETED|Apremilast Extension (Weeks 24 - 48)||0||
59707280|NCT01254305|75826221|FG000|Safety Population|Overall Study||89||
59707281|NCT01254305|75826222|FG001|Safety Population|Overall Study||85||
59707282|NCT01254305|75826223|FG002|Safety Population|Overall Study||77||
59707283|NCT01254305|75826221|FG000|COMPLETED|Overall Study||71||
59707284|NCT01254305|75826222|FG001|COMPLETED|Overall Study||72||
59707285|NCT01254305|75826223|FG002|COMPLETED|Overall Study||62||
59707286|NCT01254305|75826221|FG000|NOT COMPLETED|Overall Study||22||
59707287|NCT01254305|75826222|FG001|NOT COMPLETED|Overall Study||18||
59557085|NCT03747939|75657283|FG001|NOT COMPLETED|Apremilast Extension (Weeks 24 - 48)||0||
59557086|NCT03747939|75657284|FG002|NOT COMPLETED|Apremilast Extension (Weeks 24 - 48)||10||
59557087|NCT03747939|75657285|FG003|NOT COMPLETED|Apremilast Extension (Weeks 24 - 48)||29||
59557088|NCT03712189|75657294|FG000|STARTED|Overall Study||15||
59557089|NCT03712189|75657295|FG001|STARTED|Overall Study||15||
59557090|NCT03712189|75657294|FG000|COMPLETED|Overall Study||15||
59707288|NCT01254305|75826223|FG002|NOT COMPLETED|Overall Study||17||
59707289|NCT01122927|75826234|FG000|STARTED|Period 1 - Conversion Phase||297||
59707290|NCT01122927|75826235|FG001|STARTED|Period 1 - Conversion Phase||0||
60084596|NCT01415349|76200575|FG000|NOT COMPLETED|Treatment Period 1||0||
60084597|NCT01415349|76200576|FG001|NOT COMPLETED|Treatment Period 1||2||
60084598|NCT01415349|76200575|FG000|STARTED|Treatment Period 2||21||
60084599|NCT01415349|76200576|FG001|STARTED|Treatment Period 2||19||
60084600|NCT01415349|76200575|FG000|COMPLETED|Treatment Period 2||21||
60084601|NCT01415349|76200576|FG001|COMPLETED|Treatment Period 2||19||
60084602|NCT01415349|76200575|FG000|NOT COMPLETED|Treatment Period 2||0||
60084603|NCT01415349|76200576|FG001|NOT COMPLETED|Treatment Period 2||0||
60084604|NCT00528190|76200584|FG000|STARTED|Overall Study||18||
60084605|NCT00528190|76200585|FG001|STARTED|Overall Study||17||
60084606|NCT00528190|76200584|FG000|COMPLETED|Overall Study||18||
60084607|NCT00528190|76200585|FG001|COMPLETED|Overall Study||16||
60084608|NCT00528190|76200584|FG000|NOT COMPLETED|Overall Study||0||
60084609|NCT00528190|76200585|FG001|NOT COMPLETED|Overall Study||1||
60084610|NCT02334813|76200593|FG000|STARTED|Overall Study||12||
60084611|NCT02334813|76200594|FG001|STARTED|Overall Study||14||
60084612|NCT02334813|76200593|FG000|COMPLETED|Overall Study||9||
60084613|NCT02334813|76200594|FG001|COMPLETED|Overall Study||13||
60084614|NCT02334813|76200593|FG000|NOT COMPLETED|Overall Study||3||
60084615|NCT02334813|76200594|FG001|NOT COMPLETED|Overall Study||1||
60084616|NCT00478036|76200603|FG000|STARTED|Overall Study||10||
60084617|NCT00478036|76200604|FG001|STARTED|Overall Study||7||
60084618|NCT00478036|76200605|FG002|STARTED|Overall Study||14||
60084619|NCT00478036|76200603|FG000|COMPLETED|Overall Study||10||
60084620|NCT00478036|76200604|FG001|COMPLETED|Overall Study||7||
60084621|NCT00478036|76200605|FG002|COMPLETED|Overall Study||14||
60084622|NCT00478036|76200603|FG000|NOT COMPLETED|Overall Study||0||
60084623|NCT00478036|76200604|FG001|NOT COMPLETED|Overall Study||0||
60084624|NCT00478036|76200605|FG002|NOT COMPLETED|Overall Study||0||
60084625|NCT04048863|76200617|FG000|STARTED|Overall Study||43||
60084626|NCT04048863|76200618|FG001|STARTED|Overall Study||0||
60084627|NCT04048863|76200619|FG002|STARTED|Overall Study||0||
60084628|NCT04048863|76200620|FG003|STARTED|Overall Study||0||
60084629|NCT04048863|76200617|FG000|COMPLETED|Overall Study||43||
59557091|NCT03712189|75657295|FG001|COMPLETED|Overall Study||15||
59557092|NCT03712189|75657294|FG000|NOT COMPLETED|Overall Study||0||
59557093|NCT03712189|75657295|FG001|NOT COMPLETED|Overall Study||0||
59557094|NCT03688620|75657304|FG000|STARTED|Overall Study||329||
59557095|NCT03688620|75657305|FG001|STARTED|Overall Study||278||
59557096|NCT03688620|75657306|FG002|STARTED|Overall Study||453||
59557097|NCT03688620|75657304|FG000|COMPLETED|Overall Study||313||
59557098|NCT03688620|75657305|FG001|COMPLETED|Overall Study||277||
59557099|NCT03688620|75657306|FG002|COMPLETED|Overall Study||445||
59557100|NCT03688620|75657304|FG000|NOT COMPLETED|Overall Study||16||
59557101|NCT03688620|75657305|FG001|NOT COMPLETED|Overall Study||1||
59557102|NCT03688620|75657306|FG002|NOT COMPLETED|Overall Study||8||
59557103|NCT03683173|75657318|FG000|STARTED|Enrolled and Completed Baseline Survey||627||7
59557104|NCT03683173|75657319|FG001|STARTED|Enrolled and Completed Baseline Survey||614||7
59557105|NCT03683173|75657318|FG000|COMPLETED|Enrolled and Completed Baseline Survey||627||7
59557106|NCT03683173|75657319|FG001|COMPLETED|Enrolled and Completed Baseline Survey||614||7
59557107|NCT03683173|75657318|FG000|NOT COMPLETED|Enrolled and Completed Baseline Survey||0||0
59557108|NCT03683173|75657319|FG001|NOT COMPLETED|Enrolled and Completed Baseline Survey||0||0
59557109|NCT03683173|75657318|FG000|STARTED|Completed Follow-up||627||7
59557110|NCT03683173|75657319|FG001|STARTED|Completed Follow-up||614||7
59557111|NCT03683173|75657318|FG000|COMPLETED|Completed Follow-up||240||7
59557112|NCT03683173|75657319|FG001|COMPLETED|Completed Follow-up||238||7
59557113|NCT03683173|75657318|FG000|NOT COMPLETED|Completed Follow-up||387||0
59557114|NCT03683173|75657319|FG001|NOT COMPLETED|Completed Follow-up||376||0
59557115|NCT03654209|75657328|FG000|STARTED|Overall Study||126||
59557116|NCT03654209|75657329|FG001|STARTED|Overall Study||126||
59557117|NCT03654209|75657330|FG002|STARTED|Overall Study||132||
59557118|NCT03654209|75657328|FG000|COMPLETED|Overall Study||103||
59557119|NCT03654209|75657329|FG001|COMPLETED|Overall Study||100||
59557120|NCT03654209|75657330|FG002|COMPLETED|Overall Study||105||
59707291|NCT01122927|75826234|FG000|COMPLETED|Period 1 - Conversion Phase||283||
59707292|NCT01122927|75826235|FG001|COMPLETED|Period 1 - Conversion Phase||0||
59707293|NCT01122927|75826234|FG000|NOT COMPLETED|Period 1 - Conversion Phase||14||
59707294|NCT01122927|75826235|FG001|NOT COMPLETED|Period 1 - Conversion Phase||0||
59707295|NCT01122927|75826234|FG000|STARTED|Period 2- Open-label Treatment Phase||0||
59557121|NCT03654209|75657328|FG000|NOT COMPLETED|Overall Study||23||
59991929|NCT03530995|76107560|FG000|NOT COMPLETED|Part 1 Period 3||3||
59557122|NCT03654209|75657329|FG001|NOT COMPLETED|Overall Study||26||
59557123|NCT03654209|75657330|FG002|NOT COMPLETED|Overall Study||27||
59557124|NCT03652961|75657338|FG000|STARTED|Overall Study||25||
59557125|NCT03652961|75657338|FG000|COMPLETED|Overall Study||21||
59557126|NCT03652961|75657338|FG000|NOT COMPLETED|Overall Study||4||
59557127|NCT03608670|75657342|FG000|STARTED|Overall Study||26||
59557128|NCT03608670|75657342|FG000|Implant Attempted|Overall Study||21||
59557129|NCT03608670|75657342|FG000|Successfully Implanted|Overall Study||17||
59557130|NCT03608670|75657342|FG000|2-week Follow-up|Overall Study||17||
59557131|NCT03608670|75657342|FG000|4-6 Weeks Follow-up|Overall Study||17||
59565959|NCT02303574|75668409|FG004|NOT COMPLETED|Part 1a (Fasted State)- SAD||0||
59707296|NCT01122927|75826235|FG001|STARTED|Period 2- Open-label Treatment Phase|362 were de novo participants and 148 had rolled over from study NCT01149655.|510||
59707297|NCT01122927|75826234|FG000|COMPLETED|Period 2- Open-label Treatment Phase||0||
59707298|NCT01122927|75826235|FG001|COMPLETED|Period 2- Open-label Treatment Phase|De novo participants who completed Month 24 visit or rolled over from study NCT01149655.|198||
59707299|NCT01122927|75826234|FG000|NOT COMPLETED|Period 2- Open-label Treatment Phase||0||
59707300|NCT01122927|75826235|FG001|NOT COMPLETED|Period 2- Open-label Treatment Phase||312||
59816627|NCT04915950|75939024|FG003|COMPLETED|Stage A: Treatment Period 2 (1 Day)||2||
59557132|NCT03608670|75657342|FG000|COMPLETED|Overall Study||16|Completed 3 Months follow-up for primary safety objective.|
59557133|NCT03608670|75657342|FG000|NOT COMPLETED|Overall Study||10||
59557134|NCT03535727|75657355|FG000|STARTED|Overall Study||3||
59557135|NCT03535727|75657356|FG001|STARTED|Overall Study||6||
59557136|NCT03535727|75657357|FG002|STARTED|Overall Study||6||
59557137|NCT03535727|75657358|FG003|STARTED|Overall Study||6||
59557138|NCT03535727|75657359|FG004|STARTED|Overall Study||6||
59557139|NCT03535727|75657360|FG005|STARTED|Overall Study||3||
59557140|NCT03535727|75657361|FG006|STARTED|Overall Study||3||
59557141|NCT03535727|75657362|FG007|STARTED|Overall Study||7||
59557142|NCT03535727|75657363|FG008|STARTED|Overall Study||8||
59557143|NCT03535727|75657355|FG000|COMPLETED|Overall Study||3||
59557144|NCT03535727|75657356|FG001|COMPLETED|Overall Study||6||
59557145|NCT03535727|75657357|FG002|COMPLETED|Overall Study||6||
59557146|NCT03535727|75657358|FG003|COMPLETED|Overall Study||6||
59557147|NCT03535727|75657359|FG004|COMPLETED|Overall Study||6||
59557148|NCT03535727|75657360|FG005|COMPLETED|Overall Study||3||
59557149|NCT03535727|75657361|FG006|COMPLETED|Overall Study||3||
59557150|NCT03535727|75657362|FG007|COMPLETED|Overall Study||7||
59557151|NCT03535727|75657363|FG008|COMPLETED|Overall Study||8||
59557152|NCT03535727|75657355|FG000|NOT COMPLETED|Overall Study||0||
59557153|NCT03535727|75657356|FG001|NOT COMPLETED|Overall Study||0||
59557154|NCT03535727|75657357|FG002|NOT COMPLETED|Overall Study||0||
59557155|NCT03535727|75657358|FG003|NOT COMPLETED|Overall Study||0||
59557156|NCT03535727|75657359|FG004|NOT COMPLETED|Overall Study||0||
59557157|NCT03535727|75657360|FG005|NOT COMPLETED|Overall Study||0||
59557158|NCT03535727|75657361|FG006|NOT COMPLETED|Overall Study||0||
59557159|NCT03535727|75657362|FG007|NOT COMPLETED|Overall Study||0||
59557160|NCT03535727|75657363|FG008|NOT COMPLETED|Overall Study||0||
59557161|NCT03492177|75657381|FG000|STARTED|Overall Study||22||
59557162|NCT03492177|75657382|FG001|STARTED|Overall Study||21||
59557163|NCT03492177|75657383|FG002|STARTED|Overall Study||20||
59557164|NCT03492177|75657381|FG000|COMPLETED|Overall Study||0||
59557165|NCT03492177|75657382|FG001|COMPLETED|Overall Study||0||
59557166|NCT03492177|75657383|FG002|COMPLETED|Overall Study||0||
59557167|NCT03492177|75657381|FG000|NOT COMPLETED|Overall Study||22||
59557168|NCT03492177|75657382|FG001|NOT COMPLETED|Overall Study||21||
59557169|NCT03492177|75657383|FG002|NOT COMPLETED|Overall Study||20||
59557170|NCT03484403|75657393|FG000|STARTED|Overall Study||34||
59557171|NCT03484403|75657394|FG001|STARTED|Overall Study||25||
59557172|NCT03484403|75657393|FG000|COMPLETED|Overall Study||28||
59557173|NCT03484403|75657394|FG001|COMPLETED|Overall Study||21||
59557174|NCT03484403|75657393|FG000|NOT COMPLETED|Overall Study||6||
59557175|NCT03484403|75657394|FG001|NOT COMPLETED|Overall Study||4||
59557176|NCT03462719|75657402|FG000|STARTED|Overall Study||106||
59557177|NCT03462719|75657403|FG001|STARTED|Overall Study||105||
59557178|NCT03462719|75657402|FG000|COMPLETED|Overall Study||15||
59557179|NCT03462719|75657403|FG001|COMPLETED|Overall Study||30||
59557180|NCT03462719|75657402|FG000|NOT COMPLETED|Overall Study||91||
59557181|NCT03462719|75657403|FG001|NOT COMPLETED|Overall Study||75||
59557182|NCT03431350|75657421|FG000|STARTED|Overall Study||6||
59816628|NCT04915950|75939025|FG004|COMPLETED|Stage A: Treatment Period 2 (1 Day)||3||
59816629|NCT04915950|75939026|FG005|COMPLETED|Stage A: Treatment Period 2 (1 Day)||2||
59816630|NCT04915950|75939021|FG000|NOT COMPLETED|Stage A: Treatment Period 2 (1 Day)||0||
59816631|NCT04915950|75939022|FG001|NOT COMPLETED|Stage A: Treatment Period 2 (1 Day)||0||
59557183|NCT03431350|75657422|FG001|STARTED|Overall Study||6||
59557184|NCT03431350|75657423|FG002|STARTED|Overall Study||21||
59557185|NCT03431350|75657424|FG003|STARTED|Overall Study||11||
59557186|NCT03431350|75657425|FG004|STARTED|Overall Study||8||
59816632|NCT04915950|75939023|FG002|NOT COMPLETED|Stage A: Treatment Period 2 (1 Day)||0||
59816633|NCT04915950|75939024|FG003|NOT COMPLETED|Stage A: Treatment Period 2 (1 Day)||0||
59816634|NCT04915950|75939025|FG004|NOT COMPLETED|Stage A: Treatment Period 2 (1 Day)||0||
59816635|NCT04915950|75939026|FG005|NOT COMPLETED|Stage A: Treatment Period 2 (1 Day)||0||
59707301|NCT01254227|75826245|FG000|STARTED|Overall Study||60||
59707302|NCT01254227|75826245|FG000|Completion of 12 Months|Overall Study||39||
59557187|NCT03431350|75657426|FG005|STARTED|Overall Study||9||
59557188|NCT03431350|75657427|FG006|STARTED|Overall Study||6||
59557189|NCT03431350|75657428|FG007|STARTED|Overall Study||1||
59557190|NCT03431350|75657429|FG008|STARTED|Overall Study||17||
59557191|NCT03431350|75657430|FG009|STARTED|Overall Study||17||
59557192|NCT03431350|75657431|FG010|STARTED|Overall Study||17||
59557193|NCT03431350|75657432|FG011|STARTED|Overall Study||17||
59557194|NCT03431350|75657421|FG000|COMPLETED|Overall Study||0||
59557195|NCT03431350|75657422|FG001|COMPLETED|Overall Study||0||
59816636|NCT04915950|75939021|FG000|STARTED|Stage A:Washout Period(72hours to 7days)||2||
59816637|NCT04915950|75939022|FG001|STARTED|Stage A:Washout Period(72hours to 7days)||2||
59816638|NCT04915950|75939023|FG002|STARTED|Stage A:Washout Period(72hours to 7days)||2||
59816639|NCT04915950|75939024|FG003|STARTED|Stage A:Washout Period(72hours to 7days)||2||
59816640|NCT04915950|75939025|FG004|STARTED|Stage A:Washout Period(72hours to 7days)||3||
59816641|NCT04915950|75939026|FG005|STARTED|Stage A:Washout Period(72hours to 7days)||2||
59816642|NCT04915950|75939021|FG000|COMPLETED|Stage A:Washout Period(72hours to 7days)||2||
59816643|NCT04915950|75939022|FG001|COMPLETED|Stage A:Washout Period(72hours to 7days)||2||
59816644|NCT04915950|75939023|FG002|COMPLETED|Stage A:Washout Period(72hours to 7days)||2||
59557196|NCT03431350|75657423|FG002|COMPLETED|Overall Study||0||
59557197|NCT03431350|75657424|FG003|COMPLETED|Overall Study||0||
59557198|NCT03431350|75657425|FG004|COMPLETED|Overall Study||0||
59707303|NCT01254227|75826245|FG000|Completion of 24 Months|Overall Study||34||
60084630|NCT04048863|76200618|FG001|COMPLETED|Overall Study||0||
60084631|NCT04048863|76200619|FG002|COMPLETED|Overall Study||0||
60084632|NCT04048863|76200620|FG003|COMPLETED|Overall Study||0||
60084633|NCT04048863|76200617|FG000|NOT COMPLETED|Overall Study||0||
60084634|NCT04048863|76200618|FG001|NOT COMPLETED|Overall Study||0||
60084635|NCT04048863|76200619|FG002|NOT COMPLETED|Overall Study||0||
60084636|NCT04048863|76200620|FG003|NOT COMPLETED|Overall Study||0||
60084637|NCT01453023|76200630|FG000|STARTED|Treatment Period (TP) 1||13||
60084638|NCT01453023|76200631|FG001|STARTED|Treatment Period (TP) 1||13||
60084639|NCT01453023|76200630|FG000|COMPLETED|Treatment Period (TP) 1||12||
60084640|NCT01453023|76200631|FG001|COMPLETED|Treatment Period (TP) 1||12||
60084641|NCT01453023|76200630|FG000|NOT COMPLETED|Treatment Period (TP) 1||1||
60084642|NCT01453023|76200631|FG001|NOT COMPLETED|Treatment Period (TP) 1||1||
60084643|NCT01453023|76200630|FG000|STARTED|Washout Period||12||
60084644|NCT01453023|76200631|FG001|STARTED|Washout Period||12||
60084645|NCT01453023|76200630|FG000|COMPLETED|Washout Period||12||
60084646|NCT01453023|76200631|FG001|COMPLETED|Washout Period||12||
60084647|NCT01453023|76200630|FG000|NOT COMPLETED|Washout Period||0||
60084648|NCT01453023|76200631|FG001|NOT COMPLETED|Washout Period||0||
60084649|NCT01453023|76200630|FG000|STARTED|Treatment Period 2||12||
60084650|NCT01453023|76200631|FG001|STARTED|Treatment Period 2||12||
60084651|NCT01453023|76200630|FG000|COMPLETED|Treatment Period 2||12||
60084652|NCT01453023|76200631|FG001|COMPLETED|Treatment Period 2||11||
60084653|NCT01453023|76200630|FG000|NOT COMPLETED|Treatment Period 2||0||
59557199|NCT03431350|75657426|FG005|COMPLETED|Overall Study||0||
59707304|NCT01254227|75826245|FG000|COMPLETED|Overall Study||34||
59707305|NCT01254227|75826245|FG000|NOT COMPLETED|Overall Study||26||
59707306|NCT00995410|75826249|FG000|STARTED|Overall Study||380||
59707307|NCT00995410|75826249|FG000|Treated|Overall Study||379||
59991930|NCT03530995|76107561|FG001|NOT COMPLETED|Part 1 Period 3||0||
59991931|NCT03530995|76107560|FG000|STARTED|Part 1 Period 4||32||
59991932|NCT03530995|76107561|FG001|STARTED|Part 1 Period 4|Period 4 is not applicable to part 2 of the study.|0||
59816645|NCT04915950|75939024|FG003|COMPLETED|Stage A:Washout Period(72hours to 7days)||2||
59816646|NCT04915950|75939025|FG004|COMPLETED|Stage A:Washout Period(72hours to 7days)||3||
59816647|NCT04915950|75939026|FG005|COMPLETED|Stage A:Washout Period(72hours to 7days)||2||
59991933|NCT03530995|76107560|FG000|COMPLETED|Part 1 Period 4||30||
59991934|NCT03530995|76107561|FG001|COMPLETED|Part 1 Period 4|Period 4 is not applicable to part 2 of the study.|0||
59991935|NCT03530995|76107560|FG000|NOT COMPLETED|Part 1 Period 4||2||
59991936|NCT03530995|76107561|FG001|NOT COMPLETED|Part 1 Period 4||0||
60084654|NCT01453023|76200631|FG001|NOT COMPLETED|Treatment Period 2||1||
60084655|NCT01452789|76200639|FG000|STARTED|Overall Study||33||
60084656|NCT01452789|76200640|FG001|STARTED|Overall Study||30||
60084657|NCT01452789|76200639|FG000|COMPLETED|Overall Study||30||
60084658|NCT01452789|76200640|FG001|COMPLETED|Overall Study||28||
60084659|NCT01452789|76200639|FG000|NOT COMPLETED|Overall Study||3||
60084660|NCT01452789|76200640|FG001|NOT COMPLETED|Overall Study||2||
59557200|NCT03431350|75657427|FG006|COMPLETED|Overall Study||0||
59707308|NCT00995410|75826249|FG000|COMPLETED|Overall Study||292||
59707309|NCT00995410|75826249|FG000|NOT COMPLETED|Overall Study||88||
59707310|NCT00995020|75826255|FG000|STARTED|Overall Study||51||
59707311|NCT00995020|75826256|FG001|STARTED|Overall Study||52||
59707312|NCT00995020|75826255|FG000|COMPLETED|Overall Study|"Reasons for not completed:~margin analysis not performed specimen fragmentation thermal damage"|48||
59709833|NCT01072149|75828527|FG007|STARTED|Treatment Period 2 (28 Days)||3||
59991937|NCT02217436|76107585|FG000|STARTED|Overall Study||40||
59991938|NCT02217436|76107586|FG001|STARTED|Overall Study||40||
60084661|NCT01451931|76200649|FG000|STARTED|Overall Study||909||
60084662|NCT01451931|76200650|FG001|STARTED|Overall Study||901||
60084663|NCT01451931|76200651|FG002|STARTED|Overall Study||966||
60084664|NCT01451931|76200649|FG000|Baseline Data Collection|Overall Study||908||
60084665|NCT01451931|76200650|FG001|Baseline Data Collection|Overall Study||893||
60084666|NCT01451931|76200651|FG002|Baseline Data Collection|Overall Study||958||
60084667|NCT01451931|76200649|FG000|6-month Follow up|Overall Study||876||
59557201|NCT03431350|75657428|FG007|COMPLETED|Overall Study||0||
60084668|NCT01451931|76200650|FG001|6-month Follow up|Overall Study||843||
60084669|NCT01451931|76200651|FG002|6-month Follow up|Overall Study||923||
60084670|NCT01451931|76200649|FG000|COMPLETED|Overall Study||876||
60084671|NCT01451931|76200650|FG001|COMPLETED|Overall Study||843||
60084672|NCT01451931|76200651|FG002|COMPLETED|Overall Study||923||
60084673|NCT01451931|76200649|FG000|NOT COMPLETED|Overall Study||33||
60084674|NCT01451931|76200650|FG001|NOT COMPLETED|Overall Study||58||
60084675|NCT01451931|76200651|FG002|NOT COMPLETED|Overall Study||43||
60084676|NCT00478192|76200663|FG000|STARTED|Overall Study||20||
60084677|NCT00478192|76200664|FG001|STARTED|Overall Study||20||
60084678|NCT00478192|76200665|FG002|STARTED|Overall Study||10||
60084679|NCT00478192|76200663|FG000|Full Analysis Set / Safety Analysis Set|Overall Study||20||
60084680|NCT00478192|76200664|FG001|Full Analysis Set / Safety Analysis Set|Overall Study||20||
60084681|NCT00478192|76200665|FG002|Full Analysis Set / Safety Analysis Set|Overall Study||9||
60084682|NCT00478192|76200663|FG000|End of Treatment|Overall Study||18||
60084683|NCT00478192|76200664|FG001|End of Treatment|Overall Study||16||
60084684|NCT00478192|76200665|FG002|End of Treatment|Overall Study||8||
60084685|NCT00478192|76200663|FG000|COMPLETED|Overall Study||16||
60084686|NCT00478192|76200664|FG001|COMPLETED|Overall Study||15||
60084687|NCT00478192|76200665|FG002|COMPLETED|Overall Study||8||
59557202|NCT03431350|75657429|FG008|COMPLETED|Overall Study||0||
60084688|NCT00478192|76200663|FG000|NOT COMPLETED|Overall Study||4||
60084689|NCT00478192|76200664|FG001|NOT COMPLETED|Overall Study||5||
60084690|NCT00478192|76200665|FG002|NOT COMPLETED|Overall Study||2||
60084691|NCT01414257|76200674|FG000|STARTED|Overall Study||2860||
60084692|NCT01414257|76200674|FG000|COMPLETED|Overall Study||2838||
60084693|NCT01414257|76200674|FG000|NOT COMPLETED|Overall Study||22||
60084694|NCT00528268|76200680|FG000|STARTED|Overall Study||6||
60084695|NCT00528268|76200681|FG001|STARTED|Overall Study||8||
60084696|NCT00528268|76200680|FG000|COMPLETED|Overall Study||5||
60084697|NCT00528268|76200681|FG001|COMPLETED|Overall Study||7||
60084698|NCT00528268|76200680|FG000|NOT COMPLETED|Overall Study||1||
60084699|NCT00528268|76200681|FG001|NOT COMPLETED|Overall Study||1||
59557203|NCT03431350|75657430|FG009|COMPLETED|Overall Study||0||
59557204|NCT03431350|75657431|FG010|COMPLETED|Overall Study||0||
59557205|NCT03431350|75657432|FG011|COMPLETED|Overall Study||0||
59557206|NCT03431350|75657421|FG000|NOT COMPLETED|Overall Study||6||
59557207|NCT03431350|75657422|FG001|NOT COMPLETED|Overall Study||6||
59557208|NCT03431350|75657423|FG002|NOT COMPLETED|Overall Study||21||
59557209|NCT03431350|75657424|FG003|NOT COMPLETED|Overall Study||11||
59557210|NCT03431350|75657425|FG004|NOT COMPLETED|Overall Study||8||
59557211|NCT03431350|75657426|FG005|NOT COMPLETED|Overall Study||9||
59557212|NCT03431350|75657427|FG006|NOT COMPLETED|Overall Study||6||
59557213|NCT03431350|75657428|FG007|NOT COMPLETED|Overall Study||1||
59557214|NCT03431350|75657429|FG008|NOT COMPLETED|Overall Study||17||
59557215|NCT03431350|75657430|FG009|NOT COMPLETED|Overall Study||17||
59557216|NCT03431350|75657431|FG010|NOT COMPLETED|Overall Study||17||
59557217|NCT03431350|75657432|FG011|NOT COMPLETED|Overall Study||17||
59557218|NCT03300427|75657459|FG000|STARTED|Overall Study||27||
59557219|NCT03300427|75657460|FG001|STARTED|Overall Study||28||
59557220|NCT03300427|75657459|FG000|COMPLETED|Overall Study||27||
59557221|NCT03300427|75657460|FG001|COMPLETED|Overall Study||28||
59557222|NCT03300427|75657459|FG000|NOT COMPLETED|Overall Study||0||
60084700|NCT00528580|76200689|FG000|STARTED|Overall Study||34||
60084701|NCT00528580|76200690|FG001|STARTED|Overall Study||34||
59557223|NCT03300427|75657460|FG001|NOT COMPLETED|Overall Study||0||
59557224|NCT03299049|75657468|FG000|STARTED|Overall Study||522||
59557225|NCT03299049|75657469|FG001|STARTED|Overall Study||523||
59557226|NCT03299049|75657468|FG000|COMPLETED|Overall Study||0||
59557227|NCT03299049|75657469|FG001|COMPLETED|Overall Study||0||
59557228|NCT03299049|75657468|FG000|NOT COMPLETED|Overall Study||522||
59557229|NCT03299049|75657469|FG001|NOT COMPLETED|Overall Study||523||
59557230|NCT03298022|75657482|FG000|STARTED|Overall Study||24||
59557231|NCT03298022|75657482|FG000|Number of Participants Who Received 8 Doses of ALTB-168|Overall Study||10||
59557232|NCT03298022|75657482|FG000|Number of Participants Who Received 10 Doses of ALTB-168|Overall Study||14||
59557233|NCT03298022|75657482|FG000|COMPLETED|Overall Study||11||
60084702|NCT00528580|76200689|FG000|COMPLETED|Overall Study||34||
60084703|NCT00528580|76200690|FG001|COMPLETED|Overall Study||34||
60084704|NCT00528580|76200689|FG000|NOT COMPLETED|Overall Study||0||
60084705|NCT00528580|76200690|FG001|NOT COMPLETED|Overall Study||0||
60084706|NCT00529126|76200700|FG000|STARTED|Overall Study||25||
60084707|NCT00529126|76200701|FG001|STARTED|Overall Study||25||
60084708|NCT00529126|76200702|FG002|STARTED|Overall Study||24||
60084709|NCT00529126|76200703|FG003|STARTED|Overall Study||26||
60084710|NCT00529126|76200700|FG000|COMPLETED|Overall Study||25||
60084711|NCT00529126|76200701|FG001|COMPLETED|Overall Study||25||
60084712|NCT00529126|76200702|FG002|COMPLETED|Overall Study||24||
60084713|NCT00529126|76200703|FG003|COMPLETED|Overall Study||26||
60084714|NCT00529126|76200700|FG000|NOT COMPLETED|Overall Study||0||
60084715|NCT00529126|76200701|FG001|NOT COMPLETED|Overall Study||0||
60084716|NCT00529126|76200702|FG002|NOT COMPLETED|Overall Study||0||
60084717|NCT00529126|76200703|FG003|NOT COMPLETED|Overall Study||0||
60084718|NCT01434693|76200717|FG000|STARTED|Overall Study||9||
60084719|NCT01434693|76200718|FG001|STARTED|Overall Study||9||
60084720|NCT01434693|76200719|FG002|STARTED|Overall Study||9||
60084721|NCT01434693|76200720|FG003|STARTED|Overall Study||9||
59707313|NCT00995020|75826256|FG001|COMPLETED|Overall Study|"Reasons for not completed:~margin analysis not performed specimen fragmentation thermal damage"|45||
59707314|NCT00995020|75826255|FG000|NOT COMPLETED|Overall Study||3||
59707315|NCT00995020|75826256|FG001|NOT COMPLETED|Overall Study||7||
59707316|NCT01122381|75826266|FG000|STARTED|Overall Study||1||
59707317|NCT01122381|75826267|FG001|STARTED|Overall Study||1||
59707318|NCT01122381|75826266|FG000|COMPLETED|Overall Study|Subject never took the drug per review of ESX levels after unblinding|1||
60084722|NCT01434693|76200717|FG000|COMPLETED|Overall Study||6||
60084723|NCT01434693|76200718|FG001|COMPLETED|Overall Study||9||
60084724|NCT01434693|76200719|FG002|COMPLETED|Overall Study||8||
60084725|NCT01434693|76200720|FG003|COMPLETED|Overall Study||8||
60084726|NCT01434693|76200717|FG000|NOT COMPLETED|Overall Study||3||
60084727|NCT01434693|76200718|FG001|NOT COMPLETED|Overall Study||0||
59707319|NCT01122381|75826267|FG001|COMPLETED|Overall Study||0||
59707320|NCT01122381|75826266|FG000|NOT COMPLETED|Overall Study||0||
59707321|NCT01122381|75826267|FG001|NOT COMPLETED|Overall Study||1||
59707322|NCT00996034|75826273|FG000|STARTED|Overall Study||14||
60084728|NCT01434693|76200719|FG002|NOT COMPLETED|Overall Study||1||
60084729|NCT01434693|76200720|FG003|NOT COMPLETED|Overall Study||1||
60084730|NCT00529204|76200730|FG000|STARTED|Overall Study||1||
59707323|NCT00996034|75826273|FG000|COMPLETED|Overall Study||11||
59707324|NCT00996034|75826273|FG000|NOT COMPLETED|Overall Study||3||
59707325|NCT01253447|75826277|FG000|STARTED|Overall Study||19||
60084731|NCT00529204|76200730|FG000|COMPLETED|Overall Study||1||
60084732|NCT00529204|76200730|FG000|NOT COMPLETED|Overall Study||0||
60084733|NCT01451541|76200737|FG000|STARTED|Overall Study||283||
60084734|NCT01451541|76200738|FG001|STARTED|Overall Study||282||
60084735|NCT01451541|76200739|FG002|STARTED|Overall Study|283 randomized. ITT = 281 (2 subjects discontinued prior to study medication).|281||
60084736|NCT01451541|76200737|FG000|COMPLETED|Overall Study||247||
59557234|NCT03298022|75657482|FG000|NOT COMPLETED|Overall Study||13||
59707326|NCT01253447|75826277|FG000|COMPLETED|Overall Study||17||
59707327|NCT01253447|75826277|FG000|NOT COMPLETED|Overall Study||2||
59707328|NCT01121991|75826282|FG000|STARTED|Overall Study|Number of participants treated|52||
59707329|NCT01121991|75826282|FG000|COMPLETED|Overall Study||46||
59707330|NCT01121991|75826282|FG000|NOT COMPLETED|Overall Study||6||
59707331|NCT00994240|75826288|FG000|STARTED|Overall Study||41||
59707332|NCT00994240|75826289|FG001|STARTED|Overall Study||44||
59707333|NCT00994240|75826288|FG000|COMPLETED|Overall Study||35||
59707334|NCT00994240|75826289|FG001|COMPLETED|Overall Study||39||
59707335|NCT00994240|75826288|FG000|NOT COMPLETED|Overall Study||6||
59707336|NCT00994240|75826289|FG001|NOT COMPLETED|Overall Study||5||
59707337|NCT01253369|75826295|FG000|STARTED|Overall Study||33||
59707338|NCT01253369|75826295|FG000|Evaluable|Overall Study|Evaluable pts were w/ measurable disease, min 1 cycle of trt rcvd and 1 on-trt disease assessment.|30||
59707339|NCT01253369|75826295|FG000|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0||
59707340|NCT01253369|75826295|FG000|NOT COMPLETED|Overall Study||33||
59707341|NCT01121913|75826299|FG000|STARTED|First Intervention Period||6||
59707342|NCT01121913|75826300|FG001|STARTED|First Intervention Period||6||
59707343|NCT01121913|75826301|FG002|STARTED|First Intervention Period||6||
59707344|NCT01121913|75826302|FG003|STARTED|First Intervention Period||6||
59707345|NCT01121913|75826299|FG000|COMPLETED|First Intervention Period||6||
59707346|NCT01121913|75826300|FG001|COMPLETED|First Intervention Period||6||
59707347|NCT01121913|75826301|FG002|COMPLETED|First Intervention Period||5||
59707348|NCT01121913|75826302|FG003|COMPLETED|First Intervention Period||6||
59707349|NCT01121913|75826299|FG000|NOT COMPLETED|First Intervention Period||0||
59707350|NCT01121913|75826300|FG001|NOT COMPLETED|First Intervention Period||0||
59707351|NCT01121913|75826301|FG002|NOT COMPLETED|First Intervention Period||1||
59707352|NCT01121913|75826302|FG003|NOT COMPLETED|First Intervention Period||0||
59707353|NCT01121913|75826299|FG000|STARTED|First Washout Period||6||
59707354|NCT01121913|75826300|FG001|STARTED|First Washout Period||6||
59707355|NCT01121913|75826301|FG002|STARTED|First Washout Period||5||
59707356|NCT01121913|75826302|FG003|STARTED|First Washout Period||6||
59707357|NCT01121913|75826299|FG000|COMPLETED|First Washout Period||5||
59707358|NCT01121913|75826300|FG001|COMPLETED|First Washout Period||6||
59707359|NCT01121913|75826301|FG002|COMPLETED|First Washout Period||5||
59707360|NCT01121913|75826302|FG003|COMPLETED|First Washout Period||6||
59707361|NCT01121913|75826299|FG000|NOT COMPLETED|First Washout Period||1||
59707362|NCT01121913|75826300|FG001|NOT COMPLETED|First Washout Period||0||
59707363|NCT01121913|75826301|FG002|NOT COMPLETED|First Washout Period||0||
59707364|NCT01121913|75826302|FG003|NOT COMPLETED|First Washout Period||0||
60084737|NCT01451541|76200738|FG001|COMPLETED|Overall Study||257||
60084738|NCT01451541|76200739|FG002|COMPLETED|Overall Study||254||
60084739|NCT01451541|76200737|FG000|NOT COMPLETED|Overall Study||36||
60084740|NCT01451541|76200738|FG001|NOT COMPLETED|Overall Study||25||
59557235|NCT03277105|75657494|FG000|STARTED|Overall Study||259||
59557236|NCT03277105|75657495|FG001|STARTED|Overall Study||263||
59557237|NCT03277105|75657494|FG000|Treated (Safety Analysis Set)|Overall Study||258||
59557238|NCT03277105|75657495|FG001|Treated (Safety Analysis Set)|Overall Study||260||
59557239|NCT03277105|75657494|FG000|COMPLETED|Overall Study||0||
59557240|NCT03277105|75657495|FG001|COMPLETED|Overall Study||0||
59707365|NCT01121913|75826299|FG000|STARTED|Second Intervention Period||5||
59707366|NCT01121913|75826300|FG001|STARTED|Second Intervention Period||6||
59707367|NCT01121913|75826301|FG002|STARTED|Second Intervention Period||5||
59707368|NCT01121913|75826302|FG003|STARTED|Second Intervention Period||6||
59707369|NCT01121913|75826299|FG000|COMPLETED|Second Intervention Period||5||
59707370|NCT01121913|75826300|FG001|COMPLETED|Second Intervention Period||6||
59707371|NCT01121913|75826301|FG002|COMPLETED|Second Intervention Period||4||
59707372|NCT01121913|75826302|FG003|COMPLETED|Second Intervention Period||6||
59707373|NCT01121913|75826299|FG000|NOT COMPLETED|Second Intervention Period||0||
59707374|NCT01121913|75826300|FG001|NOT COMPLETED|Second Intervention Period||0||
59707375|NCT01121913|75826301|FG002|NOT COMPLETED|Second Intervention Period||1||
60084741|NCT01451541|76200739|FG002|NOT COMPLETED|Overall Study||27||
60084742|NCT00530764|76200753|FG000|STARTED|Overall Study||90||
60084743|NCT00530764|76200754|FG001|STARTED|Overall Study||88||
60084744|NCT00530764|76200755|FG002|STARTED|Overall Study||91||
60084745|NCT00530764|76200756|FG003|STARTED|Overall Study||91||
60084746|NCT00530764|76200753|FG000|COMPLETED|Overall Study||59||
60084747|NCT00530764|76200754|FG001|COMPLETED|Overall Study||67||
60084748|NCT00530764|76200755|FG002|COMPLETED|Overall Study||71||
60084749|NCT00530764|76200756|FG003|COMPLETED|Overall Study||66||
60084750|NCT00530764|76200753|FG000|NOT COMPLETED|Overall Study||31||
60084751|NCT00530764|76200754|FG001|NOT COMPLETED|Overall Study||21||
60084752|NCT00530764|76200755|FG002|NOT COMPLETED|Overall Study||20||
60084753|NCT00530764|76200756|FG003|NOT COMPLETED|Overall Study||25||
60084754|NCT00532480|76200769|FG000|STARTED|Overall Study||10||
60084755|NCT00532480|76200769|FG000|COMPLETED|Overall Study||7||
60084756|NCT00532480|76200769|FG000|NOT COMPLETED|Overall Study||3||
60084757|NCT00483262|76200775|FG000|STARTED|Overall Study||20||
60084758|NCT00483262|76200776|FG001|STARTED|Overall Study||43||
60084759|NCT00483262|76200775|FG000|COMPLETED|Overall Study||20||
60084760|NCT00483262|76200776|FG001|COMPLETED|Overall Study||43||
60084761|NCT00483262|76200775|FG000|NOT COMPLETED|Overall Study||0||
60084762|NCT00483262|76200776|FG001|NOT COMPLETED|Overall Study||0||
60084763|NCT00483496|76200786|FG000|STARTED|Overall Study||16||
60084764|NCT00483496|76200786|FG000|COMPLETED|Overall Study||15||
60084765|NCT00483496|76200786|FG000|NOT COMPLETED|Overall Study||1||
60084766|NCT00484354|76200800|FG000|STARTED|Overall Study||64||
60084767|NCT00484354|76200801|FG001|STARTED|Overall Study||59||
60084768|NCT00484354|76200800|FG000|COMPLETED|Overall Study||63||
60084769|NCT00484354|76200801|FG001|COMPLETED|Overall Study||57||
60084770|NCT00484354|76200800|FG000|NOT COMPLETED|Overall Study||1||
60084771|NCT00484354|76200801|FG001|NOT COMPLETED|Overall Study||2||
60084772|NCT00485836|76200810|FG000|STARTED|Overall Study||130||
60084773|NCT00485836|76200811|FG001|STARTED|Overall Study||132||
60084774|NCT00485836|76200812|FG002|STARTED|Overall Study||130||
60084775|NCT00485836|76200810|FG000|Received Study Drug (Safety Population)|Overall Study||129||
60084776|NCT00485836|76200811|FG001|Received Study Drug (Safety Population)|Overall Study||132||
60084777|NCT00485836|76200812|FG002|Received Study Drug (Safety Population)|Overall Study||129||
60084778|NCT00485836|76200810|FG000|COMPLETED|Overall Study||115||
60084779|NCT00485836|76200811|FG001|COMPLETED|Overall Study||129||
60084780|NCT00485836|76200812|FG002|COMPLETED|Overall Study||119||
60084781|NCT00485836|76200810|FG000|NOT COMPLETED|Overall Study||15||
60084782|NCT00485836|76200811|FG001|NOT COMPLETED|Overall Study||3||
60084783|NCT00485836|76200812|FG002|NOT COMPLETED|Overall Study||11||
60084784|NCT00534118|76200822|FG000|STARTED|Overall Study||17||
60084785|NCT00534118|76200823|FG001|STARTED|Overall Study||22||
60084786|NCT00534118|76200822|FG000|COMPLETED|Overall Study||17||
60084787|NCT00534118|76200823|FG001|COMPLETED|Overall Study||22||
60084788|NCT00534118|76200822|FG000|NOT COMPLETED|Overall Study||0||
60084789|NCT00534118|76200823|FG001|NOT COMPLETED|Overall Study||0||
60084790|NCT00487396|76200831|FG000|STARTED|Overall Study||98||
60084791|NCT00487396|76200831|FG000|COMPLETED|Overall Study||95||
60084792|NCT00487396|76200831|FG000|NOT COMPLETED|Overall Study||3||
60084793|NCT00488488|76200840|FG000|STARTED|Overall Study||1028||
60084794|NCT00488488|76200840|FG000|Analyzed|Overall Study|3 participants were not analyzed due to retrospective documentation.|1025||
60084795|NCT00488488|76200840|FG000|COMPLETED|Overall Study|Excludes 4 participants with missing information.|760||
60084796|NCT00488488|76200840|FG000|NOT COMPLETED|Overall Study||268||
59557241|NCT03277105|75657494|FG000|NOT COMPLETED|Overall Study||259||
59557242|NCT03277105|75657495|FG001|NOT COMPLETED|Overall Study||263||
59557243|NCT03247413|75657501|FG000|STARTED|Overall Study||63||126
59557244|NCT03247413|75657501|FG000|Received Dexamethasone (4 mg/ml) Intervention|Overall Study||63||126
59557245|NCT03247413|75657501|FG000|Received Placebo (1 mg Saline) Intervention|Overall Study||63||126
59557246|NCT03247413|75657501|FG000|COMPLETED|Overall Study||35||70
59557247|NCT03247413|75657501|FG000|NOT COMPLETED|Overall Study||28||56
59557248|NCT03206203|75657509|FG000|STARTED|Treatment||56||
59557249|NCT03206203|75657510|FG001|STARTED|Treatment||50||
59557250|NCT03206203|75657511|FG002|STARTED|Treatment||0||
59557251|NCT03206203|75657509|FG000|COMPLETED|Treatment||5||
59557252|NCT03206203|75657510|FG001|COMPLETED|Treatment||2||
59557253|NCT03206203|75657511|FG002|COMPLETED|Treatment||0||
59557254|NCT03206203|75657509|FG000|NOT COMPLETED|Treatment||51||
59557255|NCT03206203|75657510|FG001|NOT COMPLETED|Treatment||48||
59557256|NCT03206203|75657511|FG002|NOT COMPLETED|Treatment||0||
59557257|NCT03206203|75657509|FG000|STARTED|Optional Cross-Over||0||
59557258|NCT03206203|75657510|FG001|STARTED|Optional Cross-Over||0||
59557259|NCT03206203|75657511|FG002|STARTED|Optional Cross-Over||19||
59557260|NCT03206203|75657509|FG000|COMPLETED|Optional Cross-Over||0||
59557261|NCT03206203|75657510|FG001|COMPLETED|Optional Cross-Over||0||
59557262|NCT03206203|75657511|FG002|COMPLETED|Optional Cross-Over||3||
59557263|NCT03206203|75657509|FG000|NOT COMPLETED|Optional Cross-Over||0||
59557264|NCT03206203|75657510|FG001|NOT COMPLETED|Optional Cross-Over||0||
59557265|NCT03206203|75657511|FG002|NOT COMPLETED|Optional Cross-Over||16||
59557266|NCT03201965|75657521|FG000|STARTED|Overall Study||28||
59557267|NCT03201965|75657522|FG001|STARTED|Overall Study||193||
59557268|NCT03201965|75657523|FG002|STARTED|Overall Study||195||
59557269|NCT03201965|75657521|FG000|Treated|Overall Study||28||
59557270|NCT03201965|75657522|FG001|Treated|Overall Study||188||
59557271|NCT03201965|75657523|FG002|Treated|Overall Study||193||
59557272|NCT03201965|75657521|FG000|COMPLETED|Overall Study||0||
59557273|NCT03201965|75657522|FG001|COMPLETED|Overall Study||0||
59557274|NCT03201965|75657523|FG002|COMPLETED|Overall Study||0||
59557275|NCT03201965|75657521|FG000|NOT COMPLETED|Overall Study||28||
59557276|NCT03201965|75657522|FG001|NOT COMPLETED|Overall Study||193||
59707376|NCT01121913|75826302|FG003|NOT COMPLETED|Second Intervention Period||0||
59707377|NCT01121913|75826299|FG000|STARTED|Second Washout Period||5||
59707378|NCT01121913|75826300|FG001|STARTED|Second Washout Period||6||
60084797|NCT00489268|76200849|FG000|STARTED|Overall Study||1||
60084798|NCT00489268|76200850|FG001|STARTED|Overall Study||10||
60084799|NCT00489268|76200851|FG002|STARTED|Overall Study||10||
60084800|NCT00489268|76200852|FG003|STARTED|Overall Study||11||
60084801|NCT00489268|76200853|FG004|STARTED|Overall Study||70||
60084802|NCT00489268|76200849|FG000|COMPLETED|Overall Study||1||
60084803|NCT00489268|76200850|FG001|COMPLETED|Overall Study||10||
60084804|NCT00489268|76200851|FG002|COMPLETED|Overall Study||9||
60084805|NCT00489268|76200852|FG003|COMPLETED|Overall Study||11||
60084806|NCT00489268|76200853|FG004|COMPLETED|Overall Study||50||
60084807|NCT00489268|76200849|FG000|NOT COMPLETED|Overall Study||0||
60084808|NCT00489268|76200850|FG001|NOT COMPLETED|Overall Study||0||
60084809|NCT00489268|76200851|FG002|NOT COMPLETED|Overall Study||1||
60084810|NCT00489268|76200852|FG003|NOT COMPLETED|Overall Study||0||
60084811|NCT00489268|76200853|FG004|NOT COMPLETED|Overall Study||20||
60084812|NCT01450761|76200867|FG000|STARTED|Randomization||566||
60084813|NCT01450761|76200868|FG001|STARTED|Randomization||566||
60084814|NCT01450761|76200867|FG000|COMPLETED|Randomization||562||
60084815|NCT01450761|76200868|FG001|COMPLETED|Randomization||561||
60084816|NCT01450761|76200867|FG000|NOT COMPLETED|Randomization||4||
60084817|NCT01450761|76200868|FG001|NOT COMPLETED|Randomization||5||
59557277|NCT03201965|75657523|FG002|NOT COMPLETED|Overall Study||195||
59557278|NCT03126019|75657532|FG000|STARTED|Overall Study||23||
59557279|NCT03126019|75657533|FG001|STARTED|Overall Study||103||
59557280|NCT03126019|75657532|FG000|COMPLETED|Overall Study||0||
59557281|NCT03126019|75657533|FG001|COMPLETED|Overall Study||0||
59557282|NCT03126019|75657532|FG000|NOT COMPLETED|Overall Study||23||
59557283|NCT03126019|75657533|FG001|NOT COMPLETED|Overall Study||103||
59557284|NCT03072862|75657540|FG000|STARTED|Overall Study||100||
59557285|NCT03072862|75657540|FG000|COMPLETED|Overall Study||82||
59557286|NCT03072862|75657540|FG000|NOT COMPLETED|Overall Study||18||
59557287|NCT03055221|75657544|FG000|STARTED|Overall Study||20||
59557288|NCT03055221|75657544|FG000|COMPLETED|Overall Study||0||
59557289|NCT03055221|75657544|FG000|NOT COMPLETED|Overall Study||20||
59557290|NCT02913482|75657552|FG000|STARTED|Overall Study||4||
59557291|NCT02913482|75657553|FG001|STARTED|Overall Study||17||
59707379|NCT01121913|75826301|FG002|STARTED|Second Washout Period||4||
59707380|NCT01121913|75826302|FG003|STARTED|Second Washout Period||6||
59557292|NCT02913482|75657554|FG002|STARTED|Overall Study||41||
60084818|NCT01450761|76200867|FG000|STARTED|Lead-in Chemotherapy||562||
60084819|NCT01450761|76200868|FG001|STARTED|Lead-in Chemotherapy||561||
60084820|NCT01450761|76200867|FG000|COMPLETED|Lead-in Chemotherapy||478||
60084821|NCT01450761|76200868|FG001|COMPLETED|Lead-in Chemotherapy||476||
60084822|NCT01450761|76200867|FG000|NOT COMPLETED|Lead-in Chemotherapy||84||
60084823|NCT01450761|76200868|FG001|NOT COMPLETED|Lead-in Chemotherapy||85||
59707381|NCT01121913|75826299|FG000|COMPLETED|Second Washout Period||5||
59557293|NCT02913482|75657552|FG000|COMPLETED|Overall Study|Participants remaining in the study at CCOD of 12 Nov 2020|3||
59557294|NCT02913482|75657553|FG001|COMPLETED|Overall Study|Participants remaining in the study at CCOD of 12 Nov 2020|14||
59557295|NCT02913482|75657554|FG002|COMPLETED|Overall Study|Participants remaining in the study at CCOD of 12 Nov 2020|38||
59557296|NCT02913482|75657552|FG000|NOT COMPLETED|Overall Study||1||
59707382|NCT01121913|75826300|FG001|COMPLETED|Second Washout Period||6||
59707383|NCT01121913|75826301|FG002|COMPLETED|Second Washout Period||3||
59707384|NCT01121913|75826302|FG003|COMPLETED|Second Washout Period||6||
59557297|NCT02913482|75657553|FG001|NOT COMPLETED|Overall Study||3||
59557298|NCT02913482|75657554|FG002|NOT COMPLETED|Overall Study||3||
59557299|NCT02838420|75657566|FG000|STARTED|Overall Study||125||
59557300|NCT02838420|75657567|FG001|STARTED|Overall Study||62||
59557301|NCT02838420|75657566|FG000|COMPLETED|Overall Study||0||
59557302|NCT02838420|75657567|FG001|COMPLETED|Overall Study||0||
59557303|NCT02838420|75657566|FG000|NOT COMPLETED|Overall Study||125||
59557304|NCT02838420|75657567|FG001|NOT COMPLETED|Overall Study||62||
59557305|NCT02728076|75657573|FG000|STARTED|Overall Study||39||
59557306|NCT02728076|75657573|FG000|COMPLETED|Overall Study||35||
59557307|NCT02728076|75657573|FG000|NOT COMPLETED|Overall Study||4||
59557308|NCT02632409|75657579|FG000|STARTED|Randomized||356|= Randomized|
59557309|NCT02632409|75657580|FG001|STARTED|Randomized||353|= Randomized|
59557310|NCT02632409|75657579|FG000|COMPLETED|Randomized||348|= Treated|
59557311|NCT02632409|75657580|FG001|COMPLETED|Randomized||351|= Treated|
59557312|NCT02632409|75657579|FG000|NOT COMPLETED|Randomized||8||
59707385|NCT01121913|75826299|FG000|NOT COMPLETED|Second Washout Period||0||
59707386|NCT01121913|75826300|FG001|NOT COMPLETED|Second Washout Period||0||
59707387|NCT01121913|75826301|FG002|NOT COMPLETED|Second Washout Period||1||
59707388|NCT01121913|75826302|FG003|NOT COMPLETED|Second Washout Period||0||
59707389|NCT01121913|75826299|FG000|STARTED|Third Intervention Period||5||
59707390|NCT01121913|75826300|FG001|STARTED|Third Intervention Period||6||
59707391|NCT01121913|75826301|FG002|STARTED|Third Intervention Period||3||
59707392|NCT01121913|75826302|FG003|STARTED|Third Intervention Period||6||
59707393|NCT01121913|75826299|FG000|COMPLETED|Third Intervention Period||5||
59707394|NCT01121913|75826300|FG001|COMPLETED|Third Intervention Period||6||
59557313|NCT02632409|75657580|FG001|NOT COMPLETED|Randomized||2||
59557314|NCT02632409|75657579|FG000|STARTED|Treatment Period||348|= Randomized and Treated|
59557315|NCT02632409|75657580|FG001|STARTED|Treatment Period||351|= Randomized and Treated|
59707395|NCT01121913|75826301|FG002|COMPLETED|Third Intervention Period||3||
59707396|NCT01121913|75826302|FG003|COMPLETED|Third Intervention Period||6||
59557316|NCT02632409|75657579|FG000|COMPLETED|Treatment Period||132||
59557317|NCT02632409|75657580|FG001|COMPLETED|Treatment Period||143||
59557318|NCT02632409|75657579|FG000|NOT COMPLETED|Treatment Period||216||
59707397|NCT01121913|75826299|FG000|NOT COMPLETED|Third Intervention Period||0||
59707398|NCT01121913|75826300|FG001|NOT COMPLETED|Third Intervention Period||0||
59707399|NCT01121913|75826301|FG002|NOT COMPLETED|Third Intervention Period||0||
59991939|NCT02217436|76107585|FG000|COMPLETED|Overall Study||39||
59991940|NCT02217436|76107586|FG001|COMPLETED|Overall Study||38||
59991941|NCT02217436|76107585|FG000|NOT COMPLETED|Overall Study||1||
59991942|NCT02217436|76107586|FG001|NOT COMPLETED|Overall Study||2||
59991943|NCT02207530|76107592|FG000|STARTED|Overall Study||112||
59991944|NCT02207530|76107592|FG000|COMPLETED|Overall Study||21||
59991945|NCT02207530|76107592|FG000|NOT COMPLETED|Overall Study||91||
59991946|NCT02207374|76107599|FG000|STARTED|Overall Study||239||
59991947|NCT02207374|76107600|FG001|STARTED|Overall Study||241||
59991948|NCT02207374|76107601|FG002|STARTED|Overall Study||121||
59991949|NCT02207374|76107599|FG000|Exposed|Overall Study||239||
59991950|NCT02207374|76107600|FG001|Exposed|Overall Study||241||
59557319|NCT02632409|75657580|FG001|NOT COMPLETED|Treatment Period||208||
59557320|NCT02489318|75657588|FG000|STARTED|Randomized||527||
59557321|NCT02489318|75657589|FG001|STARTED|Randomized||525||
59557322|NCT02489318|75657588|FG000|COMPLETED|Randomized||527||
59557323|NCT02489318|75657589|FG001|COMPLETED|Randomized||524||
59557324|NCT02489318|75657588|FG000|NOT COMPLETED|Randomized||0||
59557325|NCT02489318|75657589|FG001|NOT COMPLETED|Randomized||1||
59557326|NCT02489318|75657588|FG000|STARTED|Treated||527||
59557327|NCT02489318|75657589|FG001|STARTED|Treated||524||
59557328|NCT02489318|75657588|FG000|COMPLETED|Treated|Participants crossed over from placebo to apalutamide after positive results at interim analysis.|208||
59707400|NCT01121913|75826302|FG003|NOT COMPLETED|Third Intervention Period||0||
59707401|NCT01121913|75826299|FG000|STARTED|Third Washout Period||5||
59707402|NCT01121913|75826300|FG001|STARTED|Third Washout Period||6||
59707403|NCT01121913|75826301|FG002|STARTED|Third Washout Period||3||
59557329|NCT02489318|75657589|FG001|COMPLETED|Treated||0||
59557330|NCT02489318|75657588|FG000|NOT COMPLETED|Treated||319||
59557331|NCT02489318|75657589|FG001|NOT COMPLETED|Treated||524||
59557332|NCT02354963|75657598|FG000|STARTED|Overall Study||18||
59557333|NCT02354963|75657599|FG001|STARTED|Overall Study||16||
59557334|NCT02354963|75657598|FG000|COMPLETED|Overall Study||16||
59557335|NCT02354963|75657599|FG001|COMPLETED|Overall Study||15||
59557336|NCT02354963|75657598|FG000|NOT COMPLETED|Overall Study||2||
59991951|NCT02207374|76107601|FG002|Exposed|Overall Study||120||
59557337|NCT02354963|75657599|FG001|NOT COMPLETED|Overall Study||1||
59557338|NCT02333227|75657607|FG000|STARTED|Overall Study||5520|Enrolled and consented to the PPaX trial|4
59557339|NCT02333227|75657608|FG001|STARTED|Overall Study||4549|Enrolled and consented to the PPaX trial|4
59557340|NCT02333227|75657607|FG000|COMPLETED|Overall Study||5321|Analyzed for primary outcomes|4
59707404|NCT01121913|75826302|FG003|STARTED|Third Washout Period||6||
59557341|NCT02333227|75657608|FG001|COMPLETED|Overall Study||4349|Analyzed for primary outcomes|4
59557342|NCT02333227|75657607|FG000|NOT COMPLETED|Overall Study||199||0
59557343|NCT02333227|75657608|FG001|NOT COMPLETED|Overall Study||200||0
59557344|NCT02277444|75657614|FG000|STARTED|Overall Study||130||
59557345|NCT02277444|75657614|FG000|Treated|Overall Study||127||
59557346|NCT02277444|75657614|FG000|COMPLETED|Overall Study||0||
59557347|NCT02277444|75657614|FG000|NOT COMPLETED|Overall Study||130||
60084824|NCT01450761|76200867|FG000|STARTED|Treatment With Blinded Study Therapy||478||
60084825|NCT01450761|76200868|FG001|STARTED|Treatment With Blinded Study Therapy||476||
60084826|NCT01450761|76200867|FG000|COMPLETED|Treatment With Blinded Study Therapy||0|Completed = remaining on study therapy|
60084827|NCT01450761|76200868|FG001|COMPLETED|Treatment With Blinded Study Therapy||0|Completed = remaining on study therapy|
60084828|NCT01450761|76200867|FG000|NOT COMPLETED|Treatment With Blinded Study Therapy||478||
60084829|NCT01450761|76200868|FG001|NOT COMPLETED|Treatment With Blinded Study Therapy||476||
60084830|NCT02120716|76200876|FG000|STARTED|Overall Study||31||
60084831|NCT02120716|76200877|FG001|STARTED|Overall Study||19||
60084832|NCT02120716|76200876|FG000|COMPLETED|Overall Study||30||
60084833|NCT02120716|76200877|FG001|COMPLETED|Overall Study||19||
59557348|NCT02257736|75657620|FG000|STARTED|Overall Study||490||
59557349|NCT02257736|75657621|FG001|STARTED|Overall Study||492||
59557350|NCT02257736|75657620|FG000|COMPLETED|Overall Study||39||
59557351|NCT02257736|75657621|FG001|COMPLETED|Overall Study||45||
59557352|NCT02257736|75657620|FG000|NOT COMPLETED|Overall Study||451||
59557353|NCT02257736|75657621|FG001|NOT COMPLETED|Overall Study||447||
60084834|NCT02120716|76200876|FG000|NOT COMPLETED|Overall Study||1||
60084835|NCT02120716|76200877|FG001|NOT COMPLETED|Overall Study||0||
60084836|NCT00491374|76200885|FG000|STARTED|Overall Study||0||
60084837|NCT00491374|76200886|FG001|STARTED|Overall Study||0||
60084838|NCT00491374|76200885|FG000|COMPLETED|Overall Study||0||
60084839|NCT00491374|76200886|FG001|COMPLETED|Overall Study||0||
59557354|NCT02252172|75657629|FG000|STARTED|Overall Study||369||
59557355|NCT02252172|75657630|FG001|STARTED|Overall Study||368||
59557356|NCT02252172|75657629|FG000|Treated|Overall Study||365||
60084840|NCT00491374|76200885|FG000|NOT COMPLETED|Overall Study||0||
59557357|NCT02252172|75657630|FG001|Treated|Overall Study||364||
59557358|NCT02252172|75657629|FG000|COMPLETED|Overall Study||90|Participants who died or withdrew consent were considered as completed.|
59557359|NCT02252172|75657630|FG001|COMPLETED|Overall Study||69|Participants who died or withdrew consent were considered as completed.|
59557360|NCT02252172|75657629|FG000|NOT COMPLETED|Overall Study||279||
59557361|NCT02252172|75657630|FG001|NOT COMPLETED|Overall Study||299||
59557362|NCT02195479|75657638|FG000|STARTED|Overall Study||356||
59557363|NCT02195479|75657639|FG001|STARTED|Overall Study||350||
59557364|NCT02195479|75657638|FG000|Treated|Overall Study||354||
59557365|NCT02195479|75657639|FG001|Treated|Overall Study||346||
59557366|NCT02195479|75657638|FG000|COMPLETED|Overall Study|None of the participants completed the study as the study is still on-going.|0||
59557367|NCT02195479|75657639|FG001|COMPLETED|Overall Study|None of the participants completed the study as the study is still on-going.|0||
59557368|NCT02195479|75657638|FG000|NOT COMPLETED|Overall Study||356||
59557369|NCT02195479|75657639|FG001|NOT COMPLETED|Overall Study||350||
59557370|NCT02076009|75657647|FG000|STARTED|Overall Study||283||
59557371|NCT02076009|75657648|FG001|STARTED|Overall Study||286||
59557372|NCT02076009|75657647|FG000|Treated (Safety Population)|Overall Study||281||
59557373|NCT02076009|75657648|FG001|Treated (Safety Population)|Overall Study||283||
59557374|NCT02076009|75657647|FG000|COMPLETED|Overall Study||0||
59557375|NCT02076009|75657648|FG001|COMPLETED|Overall Study||0||
59557376|NCT02076009|75657647|FG000|NOT COMPLETED|Overall Study||283||
59557377|NCT02076009|75657648|FG001|NOT COMPLETED|Overall Study||286||
59557378|NCT01946204|75657656|FG000|STARTED|Overall Study||401||
59557379|NCT01946204|75657657|FG001|STARTED|Overall Study||806||
59557380|NCT01946204|75657656|FG000|Treated|Overall Study||398||
59557381|NCT01946204|75657657|FG001|Treated|Overall Study||803||
59557382|NCT01946204|75657656|FG000|COMPLETED|Overall Study||0||
59557383|NCT01946204|75657657|FG001|COMPLETED|Overall Study||0||
59557384|NCT01946204|75657656|FG000|NOT COMPLETED|Overall Study||401||
59557385|NCT01946204|75657657|FG001|NOT COMPLETED|Overall Study||806||
59557386|NCT01831635|75657666|FG000|STARTED|Overall Study||106||
59707405|NCT01121913|75826299|FG000|COMPLETED|Third Washout Period||4||
59707406|NCT01121913|75826300|FG001|COMPLETED|Third Washout Period||6||
59707407|NCT01121913|75826301|FG002|COMPLETED|Third Washout Period||3||
59707408|NCT01121913|75826302|FG003|COMPLETED|Third Washout Period||6||
59707409|NCT01121913|75826299|FG000|NOT COMPLETED|Third Washout Period||1||
59991952|NCT02207374|76107599|FG000|COMPLETED|Overall Study||233||
59991953|NCT02207374|76107600|FG001|COMPLETED|Overall Study||231||
59991954|NCT02207374|76107601|FG002|COMPLETED|Overall Study||115||
59991955|NCT02207374|76107599|FG000|NOT COMPLETED|Overall Study||6||
60084841|NCT00491374|76200886|FG001|NOT COMPLETED|Overall Study||0||
59991956|NCT02207374|76107600|FG001|NOT COMPLETED|Overall Study||10||
59991957|NCT02207374|76107601|FG002|NOT COMPLETED|Overall Study||6||
59991958|NCT02217280|76107609|FG000|STARTED|Overall Study||20||
59991959|NCT02217280|76107609|FG000|COMPLETED|Overall Study||16||
59991960|NCT02217280|76107609|FG000|NOT COMPLETED|Overall Study||4||
59991961|NCT02786537|76107620|FG000|STARTED|As Randomized||56||
59557387|NCT01831635|75657667|FG001|STARTED|Overall Study||47||
59557388|NCT01831635|75657668|FG002|STARTED|Overall Study||81||
59557389|NCT01831635|75657666|FG000|Methodological Pens|Overall Study|37 branded pens ; 32 unbranded pens|69|number of those receiving pens|
59557390|NCT01831635|75657667|FG001|Methodological Pens|Overall Study|11 branded pens; 18 unbranded pens|29|number of those receiving pens|
59557391|NCT01831635|75657668|FG002|Methodological Pens|Overall Study|28 branded pens; 26 unbranded|54|number of those receiving pens|
59557392|NCT01831635|75657666|FG000|Methodological Trolley Token|Overall Study||51||
59557393|NCT01831635|75657667|FG001|Methodological Trolley Token|Overall Study||16||
59557394|NCT01831635|75657668|FG002|Methodological Trolley Token|Overall Study||0||
59557395|NCT01831635|75657666|FG000|Methodological - £10 Cheque|Overall Study||57||
59557396|NCT01831635|75657667|FG001|Methodological - £10 Cheque|Overall Study||23||
59557397|NCT01831635|75657668|FG002|Methodological - £10 Cheque|Overall Study||42||
59557398|NCT01831635|75657666|FG000|Initial Contact - Consent|Overall Study||84|Initial contact was via letter from clinician (cases), GP (GP controls) or info sheet (FF control)|
59557399|NCT01831635|75657667|FG001|Initial Contact - Consent|Overall Study||35|Initial contact was via letter from clinician (cases), GP (GP controls) or info sheet (FF control)|
59557400|NCT01831635|75657668|FG002|Initial Contact - Consent|Overall Study||81|Initial contact was via letter from clinician (cases), GP (GP controls) or info sheet (FF control)|
59557401|NCT01831635|75657666|FG000|Second Invite - Consent|Overall Study|9 from letter followup; 13 from phone|22|Either telephone or letter as second means of contact|
59557402|NCT01831635|75657667|FG001|Second Invite - Consent|Overall Study|2 from letter follow up; 9 from phone|11|Either telephone or letter as second means of contact|
59557403|NCT01831635|75657668|FG002|Second Invite - Consent|Overall Study|No contact info for FF controls so no second means of contact|0|Either telephone or letter as second means of contact|
59557404|NCT01831635|75657666|FG000|COMPLETED|Overall Study||106||
59557405|NCT01831635|75657667|FG001|COMPLETED|Overall Study||45||
59557406|NCT01831635|75657668|FG002|COMPLETED|Overall Study||81||
59557407|NCT01831635|75657666|FG000|NOT COMPLETED|Overall Study||0||
59557408|NCT01831635|75657667|FG001|NOT COMPLETED|Overall Study||2||
59557409|NCT01831635|75657668|FG002|NOT COMPLETED|Overall Study||0||
59557410|NCT01776840|75657678|FG000|STARTED|Overall Study||261||
59557411|NCT01776840|75657679|FG001|STARTED|Overall Study||262||
59557412|NCT01776840|75657678|FG000|COMPLETED|Overall Study||103||
59557413|NCT01776840|75657679|FG001|COMPLETED|Overall Study||107||
59557414|NCT01776840|75657678|FG000|NOT COMPLETED|Overall Study||158||
59557415|NCT01776840|75657679|FG001|NOT COMPLETED|Overall Study||155||
59557416|NCT01615029|75657690|FG000|STARTED|Overall Study||3||
59557417|NCT01615029|75657691|FG001|STARTED|Overall Study||3||
59707410|NCT01121913|75826300|FG001|NOT COMPLETED|Third Washout Period||0||
59707411|NCT01121913|75826301|FG002|NOT COMPLETED|Third Washout Period||0||
59991962|NCT02786537|76107621|FG001|STARTED|As Randomized||644||
59991963|NCT02786537|76107622|FG002|STARTED|As Randomized||15||
59991964|NCT02786537|76107623|FG003|STARTED|As Randomized||413||
60084842|NCT00538642|76200894|FG000|STARTED|Overall Study||10||
59991965|NCT02786537|76107624|FG004|STARTED|As Randomized||99||
59991966|NCT02786537|76107625|FG005|STARTED|As Randomized||48||
59991967|NCT02786537|76107620|FG000|COMPLETED|As Randomized||50||
59991968|NCT02786537|76107621|FG001|COMPLETED|As Randomized||582||
59991969|NCT02786537|76107622|FG002|COMPLETED|As Randomized||15||
59557418|NCT01615029|75657692|FG002|STARTED|Overall Study||4||
59557419|NCT01615029|75657693|FG003|STARTED|Overall Study||3||
59557420|NCT01615029|75657694|FG004|STARTED|Overall Study||32||
59557421|NCT01615029|75657690|FG000|COMPLETED|Overall Study||0||
59557422|NCT01615029|75657691|FG001|COMPLETED|Overall Study||0||
59557423|NCT01615029|75657692|FG002|COMPLETED|Overall Study||0||
59557424|NCT01615029|75657693|FG003|COMPLETED|Overall Study||0||
59557425|NCT01615029|75657694|FG004|COMPLETED|Overall Study||0||
59991970|NCT02786537|76107623|FG003|COMPLETED|As Randomized||378||
59991971|NCT02786537|76107624|FG004|COMPLETED|As Randomized||87||
59991972|NCT02786537|76107625|FG005|COMPLETED|As Randomized||41||
59991973|NCT02786537|76107620|FG000|NOT COMPLETED|As Randomized||6||
59991974|NCT02786537|76107621|FG001|NOT COMPLETED|As Randomized||62||
59991975|NCT02786537|76107622|FG002|NOT COMPLETED|As Randomized||0||
59991976|NCT02786537|76107623|FG003|NOT COMPLETED|As Randomized||35||
59557426|NCT01615029|75657690|FG000|NOT COMPLETED|Overall Study||3||
59557427|NCT01615029|75657691|FG001|NOT COMPLETED|Overall Study||3||
59557428|NCT01615029|75657692|FG002|NOT COMPLETED|Overall Study||4||
59557429|NCT01615029|75657693|FG003|NOT COMPLETED|Overall Study||3||
59557430|NCT01615029|75657694|FG004|NOT COMPLETED|Overall Study||32||
59557431|NCT01606878|75657717|FG000|STARTED|Overall Study||6||
59557432|NCT01606878|75657718|FG001|STARTED|Overall Study||4||
59557433|NCT01606878|75657719|FG002|STARTED|Overall Study||5||
59557434|NCT01606878|75657720|FG003|STARTED|Overall Study||3||
59557435|NCT01606878|75657721|FG004|STARTED|Overall Study||3||
59991977|NCT02786537|76107624|FG004|NOT COMPLETED|As Randomized||12||
59557436|NCT01606878|75657722|FG005|STARTED|Overall Study||4||
59557437|NCT01606878|75657723|FG006|STARTED|Overall Study||6||
59557438|NCT01606878|75657724|FG007|STARTED|Overall Study||3||
59557439|NCT01606878|75657725|FG008|STARTED|Overall Study||6||
59557440|NCT01606878|75657726|FG009|STARTED|Overall Study||3||
59557441|NCT01606878|75657727|FG010|STARTED|Overall Study||3||
59991978|NCT02786537|76107625|FG005|NOT COMPLETED|As Randomized||7||
59995192|NCT01674621|76110996|FG004|NOT COMPLETED|Overall Study||6||
59557442|NCT01606878|75657717|FG000|COMPLETED|Overall Study||0||
59557443|NCT01606878|75657718|FG001|COMPLETED|Overall Study||0||
59557444|NCT01606878|75657719|FG002|COMPLETED|Overall Study||0||
59557445|NCT01606878|75657720|FG003|COMPLETED|Overall Study||0||
59557446|NCT01606878|75657721|FG004|COMPLETED|Overall Study||0||
59557447|NCT01606878|75657722|FG005|COMPLETED|Overall Study||0||
59557448|NCT01606878|75657723|FG006|COMPLETED|Overall Study||0||
59557449|NCT01606878|75657724|FG007|COMPLETED|Overall Study||0||
59557450|NCT01606878|75657725|FG008|COMPLETED|Overall Study||0||
59557451|NCT01606878|75657726|FG009|COMPLETED|Overall Study||0||
59557452|NCT01606878|75657727|FG010|COMPLETED|Overall Study||0||
59557453|NCT01606878|75657717|FG000|NOT COMPLETED|Overall Study||6||
59557454|NCT01606878|75657718|FG001|NOT COMPLETED|Overall Study||4||
59557455|NCT01606878|75657719|FG002|NOT COMPLETED|Overall Study||5||
59557456|NCT01606878|75657720|FG003|NOT COMPLETED|Overall Study||3||
59557457|NCT01606878|75657721|FG004|NOT COMPLETED|Overall Study||3||
59557458|NCT01606878|75657722|FG005|NOT COMPLETED|Overall Study||4||
59557459|NCT01606878|75657723|FG006|NOT COMPLETED|Overall Study||6||
59557460|NCT01606878|75657724|FG007|NOT COMPLETED|Overall Study||3||
59557461|NCT01606878|75657725|FG008|NOT COMPLETED|Overall Study||6||
59557462|NCT01606878|75657726|FG009|NOT COMPLETED|Overall Study||3||
59557463|NCT01606878|75657727|FG010|NOT COMPLETED|Overall Study||3||
59557464|NCT01467427|75657761|FG000|STARTED|Overall Study||12||
59557465|NCT01467427|75657762|FG001|STARTED|Overall Study||13||
59557466|NCT01467427|75657761|FG000|Completed Main Phase|Overall Study||11||
59557467|NCT01467427|75657762|FG001|Completed Main Phase|Overall Study||13||
59557468|NCT01467427|75657761|FG000|COMPLETED|Overall Study||0||
59557469|NCT01467427|75657762|FG001|COMPLETED|Overall Study||0||
59557470|NCT01467427|75657761|FG000|NOT COMPLETED|Overall Study||12||
59557471|NCT01467427|75657762|FG001|NOT COMPLETED|Overall Study||13||
59557472|NCT01314118|75657768|FG000|STARTED|Overall Study||131||
59557473|NCT01314118|75657768|FG000|COMPLETED|Overall Study||0||
59557474|NCT01314118|75657768|FG000|NOT COMPLETED|Overall Study||131||
59557475|NCT01175356|75657772|FG000|STARTED|Overall Study||99||
59557476|NCT01175356|75657772|FG000|COMPLETED|Overall Study||18||
59557477|NCT01175356|75657772|FG000|NOT COMPLETED|Overall Study||81||
59557478|NCT01171898|75657780|FG000|STARTED|Overall Study||30||
59557479|NCT01171898|75657781|FG001|STARTED|Overall Study||51||
59557480|NCT01171898|75657782|FG002|STARTED|Overall Study||25||
59557481|NCT01171898|75657783|FG003|STARTED|Overall Study||21||
59557482|NCT01171898|75657780|FG000|COMPLETED|Overall Study||26||
59557483|NCT01171898|75657781|FG001|COMPLETED|Overall Study||32||
59557484|NCT01171898|75657782|FG002|COMPLETED|Overall Study||13||
59557485|NCT01171898|75657783|FG003|COMPLETED|Overall Study||15||
59557486|NCT01171898|75657780|FG000|NOT COMPLETED|Overall Study||4||
59557487|NCT01171898|75657781|FG001|NOT COMPLETED|Overall Study||19||
59557488|NCT01171898|75657782|FG002|NOT COMPLETED|Overall Study||12||
59557489|NCT01171898|75657783|FG003|NOT COMPLETED|Overall Study||6||
59557490|NCT01005745|75657796|FG000|STARTED|Overall Study||19||
59557491|NCT01005745|75657796|FG000|COMPLETED|Overall Study||13||
59557492|NCT01005745|75657796|FG000|NOT COMPLETED|Overall Study||6||
59557493|NCT00980538|75657800|FG000|STARTED|Overall Study||180||
59557494|NCT00980538|75657800|FG000|COMPLETED|Overall Study||0||
59557495|NCT00980538|75657800|FG000|NOT COMPLETED|Overall Study||180||
59557496|NCT00676715|75657808|FG000|STARTED|Overall Study||54||
59557497|NCT00676715|75657809|FG001|STARTED|Overall Study||55||
59557498|NCT00676715|75657810|FG002|STARTED|Overall Study||55||
59557499|NCT00676715|75657811|FG003|STARTED|Overall Study||54||
59707412|NCT01121913|75826302|FG003|NOT COMPLETED|Third Washout Period||0||
59557500|NCT00676715|75657808|FG000|COMPLETED|Overall Study||14||
59557501|NCT00676715|75657809|FG001|COMPLETED|Overall Study||8||
59557502|NCT00676715|75657810|FG002|COMPLETED|Overall Study||14||
59557503|NCT00676715|75657811|FG003|COMPLETED|Overall Study||14||
59557504|NCT00676715|75657808|FG000|NOT COMPLETED|Overall Study||40||
59557505|NCT00676715|75657809|FG001|NOT COMPLETED|Overall Study||47||
59557506|NCT00676715|75657810|FG002|NOT COMPLETED|Overall Study||41||
59557507|NCT00676715|75657811|FG003|NOT COMPLETED|Overall Study||40||
59557508|NCT00295893|75657824|FG000|STARTED|Overall Study||37||
59557509|NCT00295893|75657825|FG001|STARTED|Overall Study||40||
59557510|NCT00295893|75657826|FG002|STARTED|Overall Study||44||
59557511|NCT00295893|75657824|FG000|COMPLETED|Overall Study||37||
59557512|NCT00295893|75657825|FG001|COMPLETED|Overall Study||40||
59557513|NCT00295893|75657826|FG002|COMPLETED|Overall Study||44||
59557514|NCT00295893|75657824|FG000|NOT COMPLETED|Overall Study||0||
59557515|NCT00295893|75657825|FG001|NOT COMPLETED|Overall Study||0||
59557516|NCT00295893|75657826|FG002|NOT COMPLETED|Overall Study||0||
59557517|NCT01470170|75657839|FG000|STARTED|Overall Study||34||
59557518|NCT01470170|75657840|FG001|STARTED|Overall Study||35||
59557519|NCT01470170|75657841|FG002|STARTED|Overall Study||34||
59557520|NCT01470170|75657842|FG003|STARTED|Overall Study||36||
59557521|NCT01470170|75657843|FG004|STARTED|Overall Study||34||
59557522|NCT01470170|75657839|FG000|COMPLETED|Overall Study||34||
59557523|NCT01470170|75657840|FG001|COMPLETED|Overall Study||35||
59557524|NCT01470170|75657841|FG002|COMPLETED|Overall Study||34||
59991979|NCT02786537|76107620|FG000|STARTED|As Treated||56|Numbers represent treatment regimen that study participant actually started (received).|
59991980|NCT02786537|76107621|FG001|STARTED|As Treated||664|Numbers represent treatment regimen that study participant actually started (received).|
59995193|NCT02730169|76111013|FG000|STARTED|Overall Study||67||
59557525|NCT01470170|75657842|FG003|COMPLETED|Overall Study||36||
59557526|NCT01470170|75657843|FG004|COMPLETED|Overall Study||34||
59557527|NCT01470170|75657839|FG000|NOT COMPLETED|Overall Study||0||
59557528|NCT01470170|75657840|FG001|NOT COMPLETED|Overall Study||0||
59557529|NCT01470170|75657841|FG002|NOT COMPLETED|Overall Study||0||
59557530|NCT01470170|75657842|FG003|NOT COMPLETED|Overall Study||0||
59557531|NCT01470170|75657843|FG004|NOT COMPLETED|Overall Study||0||
59557532|NCT01572428|75657857|FG000|STARTED|Overall Study||402||
59557533|NCT01572428|75657858|FG001|STARTED|Overall Study||402||
59557534|NCT01572428|75657857|FG000|COMPLETED|Overall Study||399||
59557535|NCT01572428|75657858|FG001|COMPLETED|Overall Study||401||
59557536|NCT01572428|75657857|FG000|NOT COMPLETED|Overall Study||3||
59557537|NCT01572428|75657858|FG001|NOT COMPLETED|Overall Study||1||
59557538|NCT01573052|75657866|FG000|STARTED|Overall Study||9||
59557539|NCT01573052|75657867|FG001|STARTED|Overall Study||17||
59557540|NCT01573052|75657866|FG000|COMPLETED|Overall Study||6||
59557541|NCT01573052|75657867|FG001|COMPLETED|Overall Study||11||
59816648|NCT04915950|75939021|FG000|NOT COMPLETED|Stage A:Washout Period(72hours to 7days)||0||
59816649|NCT04915950|75939022|FG001|NOT COMPLETED|Stage A:Washout Period(72hours to 7days)||0||
59816650|NCT04915950|75939023|FG002|NOT COMPLETED|Stage A:Washout Period(72hours to 7days)||0||
59557542|NCT01573052|75657866|FG000|NOT COMPLETED|Overall Study||3||
59557543|NCT01573052|75657867|FG001|NOT COMPLETED|Overall Study||6||
59557544|NCT01521260|75657876|FG000|STARTED|Overall Study||15||
59557545|NCT01521260|75657877|FG001|STARTED|Overall Study||15||
59557546|NCT01521260|75657876|FG000|COMPLETED|Overall Study||15||
59557547|NCT01521260|75657877|FG001|COMPLETED|Overall Study||15||
59557548|NCT01521260|75657876|FG000|NOT COMPLETED|Overall Study||0||
59557549|NCT01521260|75657877|FG001|NOT COMPLETED|Overall Study||0||
59557550|NCT01523834|75657883|FG000|STARTED|Overall Study|Started Induction Phase|35||
59557551|NCT01523834|75657883|FG000|Consolidation Phase|Overall Study|Started Consolidation Phase|7||
59557552|NCT01523834|75657883|FG000|Maintenance Phase|Overall Study|Started Maintenance Phase|6||
59557553|NCT01523834|75657883|FG000|COMPLETED|Overall Study||4||
59557554|NCT01523834|75657883|FG000|NOT COMPLETED|Overall Study||31||
59816651|NCT04915950|75939024|FG003|NOT COMPLETED|Stage A:Washout Period(72hours to 7days)||0||
59816652|NCT04915950|75939025|FG004|NOT COMPLETED|Stage A:Washout Period(72hours to 7days)||0||
59816653|NCT04915950|75939026|FG005|NOT COMPLETED|Stage A:Washout Period(72hours to 7days)||0||
59816654|NCT04915950|75939021|FG000|STARTED|Stage A: Treatment Period 3 (1 Day)||2||
59557555|NCT01575080|75657888|FG000|STARTED|Overall Study||102||
59557556|NCT01575080|75657888|FG000|COMPLETED|Overall Study||102||
59557557|NCT01575080|75657888|FG000|NOT COMPLETED|Overall Study||0||
59557558|NCT01472432|75657894|FG000|STARTED|Overall Study||53||
59557559|NCT01472432|75657895|FG001|STARTED|Overall Study||53||
59557560|NCT01472432|75657894|FG000|Ulcer Reduction|Overall Study||13||
59816655|NCT04915950|75939022|FG001|STARTED|Stage A: Treatment Period 3 (1 Day)||2||
59816656|NCT04915950|75939023|FG002|STARTED|Stage A: Treatment Period 3 (1 Day)||2||
59816657|NCT04915950|75939024|FG003|STARTED|Stage A: Treatment Period 3 (1 Day)||2||
59816658|NCT04915950|75939025|FG004|STARTED|Stage A: Treatment Period 3 (1 Day)||3||
59816659|NCT04915950|75939026|FG005|STARTED|Stage A: Treatment Period 3 (1 Day)||2||
59816660|NCT04915950|75939021|FG000|COMPLETED|Stage A: Treatment Period 3 (1 Day)||2||
59557561|NCT01472432|75657895|FG001|Ulcer Reduction|Overall Study||33||
59557562|NCT01472432|75657894|FG000|COMPLETED|Overall Study||53||
59557563|NCT01472432|75657895|FG001|COMPLETED|Overall Study||53||
59557564|NCT01472432|75657894|FG000|NOT COMPLETED|Overall Study||0||
59557565|NCT01472432|75657895|FG001|NOT COMPLETED|Overall Study||0||
59557566|NCT02797821|75657906|FG000|STARTED|Overall Study||8||
59557567|NCT02797821|75657907|FG001|STARTED|Overall Study||10||
59557568|NCT02797821|75657908|FG002|STARTED|Overall Study||9||
59557569|NCT02797821|75657906|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8||
59557570|NCT02797821|75657907|FG001|Received at Least 1 Dose of Study Drug|Overall Study||10||
59557571|NCT02797821|75657908|FG002|Received at Least 1 Dose of Study Drug|Overall Study||9||
59557572|NCT02797821|75657906|FG000|COMPLETED|Overall Study||8||
59557573|NCT02797821|75657907|FG001|COMPLETED|Overall Study||10||
59557574|NCT02797821|75657908|FG002|COMPLETED|Overall Study||9||
59557575|NCT02797821|75657906|FG000|NOT COMPLETED|Overall Study||0||
59557576|NCT02797821|75657907|FG001|NOT COMPLETED|Overall Study||0||
59557577|NCT02797821|75657908|FG002|NOT COMPLETED|Overall Study||0||
59557578|NCT02798289|75657916|FG000|STARTED|Overall Study||55||
59557579|NCT02798289|75657916|FG000|COMPLETED|Overall Study||55||
59557580|NCT02798289|75657916|FG000|NOT COMPLETED|Overall Study||0||
59557581|NCT01524302|75657922|FG000|STARTED|Overall Study||6||
59557582|NCT01524302|75657923|FG001|STARTED|Overall Study||6||
59557583|NCT01524302|75657922|FG000|COMPLETED|Overall Study||6||
59557584|NCT01524302|75657923|FG001|COMPLETED|Overall Study||6||
59557585|NCT01524302|75657922|FG000|NOT COMPLETED|Overall Study||0||
59557586|NCT01524302|75657923|FG001|NOT COMPLETED|Overall Study||0||
59557587|NCT01525862|75657933|FG000|STARTED|Overall Study||21||
59557588|NCT01525862|75657933|FG000|COMPLETED|Overall Study||21||
59816661|NCT04915950|75939022|FG001|COMPLETED|Stage A: Treatment Period 3 (1 Day)||2||
59816662|NCT04915950|75939023|FG002|COMPLETED|Stage A: Treatment Period 3 (1 Day)||2||
59816663|NCT04915950|75939024|FG003|COMPLETED|Stage A: Treatment Period 3 (1 Day)||2||
59816664|NCT04915950|75939025|FG004|COMPLETED|Stage A: Treatment Period 3 (1 Day)||3||
59816665|NCT04915950|75939026|FG005|COMPLETED|Stage A: Treatment Period 3 (1 Day)||2||
59816666|NCT04915950|75939021|FG000|NOT COMPLETED|Stage A: Treatment Period 3 (1 Day)||0||
60084843|NCT00538642|76200895|FG001|STARTED|Overall Study||14||
60084844|NCT00538642|76200894|FG000|COMPLETED|Overall Study||9||
59557589|NCT01525862|75657933|FG000|NOT COMPLETED|Overall Study||0||
59557590|NCT02802111|75657939|FG000|STARTED|First Intervention (5 Min of Drug)||12||
59557591|NCT02802111|75657940|FG001|STARTED|First Intervention (5 Min of Drug)||12||
59557592|NCT02802111|75657939|FG000|COMPLETED|First Intervention (5 Min of Drug)||12||
59557593|NCT02802111|75657940|FG001|COMPLETED|First Intervention (5 Min of Drug)||12||
59557594|NCT02802111|75657939|FG000|NOT COMPLETED|First Intervention (5 Min of Drug)||0||
59557595|NCT02802111|75657940|FG001|NOT COMPLETED|First Intervention (5 Min of Drug)||0||
59557596|NCT02802111|75657939|FG000|STARTED|Washout (4 Hours)||12||
60084845|NCT00538642|76200895|FG001|COMPLETED|Overall Study||9||
60084846|NCT00538642|76200894|FG000|NOT COMPLETED|Overall Study||1||
60084847|NCT00538642|76200895|FG001|NOT COMPLETED|Overall Study||5||
60084848|NCT00539110|76200903|FG000|STARTED|Overall Study||5||
60084849|NCT00539110|76200904|FG001|STARTED|Overall Study||5||
60084850|NCT00539110|76200903|FG000|COMPLETED|Overall Study||5||
60084851|NCT00539110|76200904|FG001|COMPLETED|Overall Study||5||
60084852|NCT00539110|76200903|FG000|NOT COMPLETED|Overall Study||0||
60084853|NCT00539110|76200904|FG001|NOT COMPLETED|Overall Study||0||
59557597|NCT02802111|75657940|FG001|STARTED|Washout (4 Hours)||12||
59557598|NCT02802111|75657939|FG000|COMPLETED|Washout (4 Hours)||12||
59557599|NCT02802111|75657940|FG001|COMPLETED|Washout (4 Hours)||12||
59991981|NCT02786537|76107622|FG002|STARTED|As Treated||15|Numbers represent treatment regimen that study participant actually started (received).|
59991982|NCT02786537|76107623|FG003|STARTED|As Treated||394|Numbers represent treatment regimen that study participant actually started (received).|
59991983|NCT02786537|76107624|FG004|STARTED|As Treated||99|Numbers represent treatment regimen that study participant actually started (received).|
59991984|NCT02786537|76107625|FG005|STARTED|As Treated||47|Numbers represent treatment regimen that study participant actually started (received).|
59991985|NCT02786537|76107620|FG000|COMPLETED|As Treated||50||
59991986|NCT02786537|76107621|FG001|COMPLETED|As Treated||602||
59557600|NCT02802111|75657939|FG000|NOT COMPLETED|Washout (4 Hours)||0||
59557601|NCT02802111|75657940|FG001|NOT COMPLETED|Washout (4 Hours)||0||
59557602|NCT02802111|75657939|FG000|STARTED|Second Intervention (5 Min of Drug)||12||
59557603|NCT02802111|75657940|FG001|STARTED|Second Intervention (5 Min of Drug)||12||
59557604|NCT02802111|75657939|FG000|COMPLETED|Second Intervention (5 Min of Drug)||12||
59557605|NCT02802111|75657940|FG001|COMPLETED|Second Intervention (5 Min of Drug)||12||
59557606|NCT02802111|75657939|FG000|NOT COMPLETED|Second Intervention (5 Min of Drug)||0||
59557607|NCT02802111|75657940|FG001|NOT COMPLETED|Second Intervention (5 Min of Drug)||0||
59557608|NCT01576874|75657948|FG000|STARTED|Overall Study||72||
59557609|NCT01576874|75657949|FG001|STARTED|Overall Study||72||
59991987|NCT02786537|76107622|FG002|COMPLETED|As Treated||15||
59991988|NCT02786537|76107623|FG003|COMPLETED|As Treated||359||
59991989|NCT02786537|76107624|FG004|COMPLETED|As Treated||87||
60084854|NCT00539656|76200910|FG000|STARTED|Overall Study||3||
59557610|NCT01576874|75657948|FG000|COMPLETED|Overall Study||72||
59557611|NCT01576874|75657949|FG001|COMPLETED|Overall Study||72||
60084855|NCT00539656|76200910|FG000|COMPLETED|Overall Study||3||
60084856|NCT00539656|76200910|FG000|NOT COMPLETED|Overall Study||0||
60084857|NCT01433991|76200918|FG000|STARTED|Pretreatment Phase (Single Agent Run-in)||5|30 participants enrolled in Pretreatment Phase (single agent run in period) and 28 went on to receive combination treatment in the Treatment Phase and 2 participants were discontinued after receiving only single-agent therapy in the Pretreatment Phase.|
60084858|NCT01433991|76200919|FG001|STARTED|Pretreatment Phase (Single Agent Run-in)||3|30 participants enrolled in Pretreatment Phase (single agent run in period) and 28 went on to receive combination treatment in the Treatment Phase and 2 participants were discontinued after receiving only single-agent therapy in the Pretreatment Phase.|
60084859|NCT01433991|76200920|FG002|STARTED|Pretreatment Phase (Single Agent Run-in)||14|30 participants enrolled in Pretreatment Phase (single agent run in period) and 28 went on to receive combination treatment in the Treatment Phase and 2 participants were discontinued after receiving only single-agent therapy in the Pretreatment Phase.|
59557612|NCT01576874|75657948|FG000|NOT COMPLETED|Overall Study||0||
59557613|NCT01576874|75657949|FG001|NOT COMPLETED|Overall Study||0||
59557614|NCT01528124|75657962|FG000|STARTED|Overall Study||6||
59557615|NCT01528124|75657963|FG001|STARTED|Overall Study||6||
59557616|NCT01528124|75657964|FG002|STARTED|Overall Study||6||
59557617|NCT01528124|75657965|FG003|STARTED|Overall Study||6||
59557618|NCT01528124|75657966|FG004|STARTED|Overall Study||5||
59557619|NCT01528124|75657967|FG005|STARTED|Overall Study||6||
59557620|NCT01528124|75657968|FG006|STARTED|Overall Study||6||
59557621|NCT01528124|75657962|FG000|Received Study Drug|Overall Study||6||
59557622|NCT01528124|75657963|FG001|Received Study Drug|Overall Study||6||
59557623|NCT01528124|75657964|FG002|Received Study Drug|Overall Study||6||
59557624|NCT01528124|75657965|FG003|Received Study Drug|Overall Study||6||
59557625|NCT01528124|75657966|FG004|Received Study Drug|Overall Study||5||
59557626|NCT01528124|75657967|FG005|Received Study Drug|Overall Study||6||
59557627|NCT01528124|75657968|FG006|Received Study Drug|Overall Study||6||
59557628|NCT01528124|75657962|FG000|COMPLETED|Overall Study||6||
59557629|NCT01528124|75657963|FG001|COMPLETED|Overall Study||6||
59557630|NCT01528124|75657964|FG002|COMPLETED|Overall Study||6||
59557631|NCT01528124|75657965|FG003|COMPLETED|Overall Study||6||
59557632|NCT01528124|75657966|FG004|COMPLETED|Overall Study||5||
59557633|NCT01528124|75657967|FG005|COMPLETED|Overall Study||6||
59557634|NCT01528124|75657968|FG006|COMPLETED|Overall Study||6||
59557635|NCT01528124|75657962|FG000|NOT COMPLETED|Overall Study||0||
59557636|NCT01528124|75657963|FG001|NOT COMPLETED|Overall Study||0||
59557637|NCT01528124|75657964|FG002|NOT COMPLETED|Overall Study||0||
59557638|NCT01528124|75657965|FG003|NOT COMPLETED|Overall Study||0||
59557639|NCT01528124|75657966|FG004|NOT COMPLETED|Overall Study||0||
59557640|NCT01528124|75657967|FG005|NOT COMPLETED|Overall Study||0||
59557641|NCT01528124|75657968|FG006|NOT COMPLETED|Overall Study||0||
59557642|NCT01576952|75657992|FG000|STARTED|Overall Study||180||
59816667|NCT04915950|75939022|FG001|NOT COMPLETED|Stage A: Treatment Period 3 (1 Day)||0||
59816668|NCT04915950|75939023|FG002|NOT COMPLETED|Stage A: Treatment Period 3 (1 Day)||0||
59816669|NCT04915950|75939024|FG003|NOT COMPLETED|Stage A: Treatment Period 3 (1 Day)||0||
59557643|NCT01576952|75657993|FG001|STARTED|Overall Study||88||
59557644|NCT01576952|75657992|FG000|Safety Population|Overall Study||169||
59557645|NCT01576952|75657993|FG001|Safety Population|Overall Study||85||
59557646|NCT01576952|75657992|FG000|mITT Population|Overall Study||168||
59816670|NCT04915950|75939025|FG004|NOT COMPLETED|Stage A: Treatment Period 3 (1 Day)||0||
59816671|NCT04915950|75939026|FG005|NOT COMPLETED|Stage A: Treatment Period 3 (1 Day)||0||
59816672|NCT04530448|75939038|FG000|STARTED|Overall Study||3||
59816673|NCT04530448|75939039|FG001|STARTED|Overall Study||0||
59816674|NCT04530448|75939038|FG000|COMPLETED|Overall Study||0||
59816675|NCT04530448|75939039|FG001|COMPLETED|Overall Study||0||
59816676|NCT04530448|75939038|FG000|NOT COMPLETED|Overall Study||3||
59816677|NCT04530448|75939039|FG001|NOT COMPLETED|Overall Study||0||
59816678|NCT04476030|75939047|FG000|STARTED|Overall Study||220||
59816679|NCT04476030|75939048|FG001|STARTED|Overall Study||220||
59816680|NCT04476030|75939047|FG000|Safety Population|Overall Study||218|Safety Set included all participants who administered blinded IP.|
59816681|NCT04476030|75939048|FG001|Safety Population|Overall Study||212|Safety Set included all participants who administered blinded IP.|
59816682|NCT04476030|75939047|FG000|COMPLETED|Overall Study||177||
59816683|NCT04476030|75939048|FG001|COMPLETED|Overall Study||180||
59816684|NCT04476030|75939047|FG000|NOT COMPLETED|Overall Study||43||
59557647|NCT01576952|75657993|FG001|mITT Population|Overall Study||85||
59557648|NCT01576952|75657992|FG000|COMPLETED|Overall Study||139||
59557649|NCT01576952|75657993|FG001|COMPLETED|Overall Study||33||
59557650|NCT01576952|75657992|FG000|NOT COMPLETED|Overall Study||41||
59557651|NCT01576952|75657993|FG001|NOT COMPLETED|Overall Study||55||
59557652|NCT01577108|75658001|FG000|STARTED|Overall Study||54||
59557653|NCT01577108|75658002|FG001|STARTED|Overall Study||56||
59557654|NCT01577108|75658001|FG000|COMPLETED|Overall Study||49||
59557655|NCT01577108|75658002|FG001|COMPLETED|Overall Study||50||
59557656|NCT01577108|75658001|FG000|NOT COMPLETED|Overall Study||5||
59557657|NCT01577108|75658002|FG001|NOT COMPLETED|Overall Study||6||
59557658|NCT01577732|75658008|FG000|STARTED|Overall Study||300||
59557659|NCT01577732|75658008|FG000|COMPLETED|Overall Study||300||
59557660|NCT01577732|75658008|FG000|NOT COMPLETED|Overall Study||0||
59557661|NCT01577966|75658012|FG000|STARTED|Overall Study||9||
59557662|NCT01577966|75658012|FG000|COMPLETED|Overall Study||9||
59557663|NCT01577966|75658012|FG000|NOT COMPLETED|Overall Study||0||
59557664|NCT01578044|75658018|FG000|STARTED|Overall Study||6||
59557665|NCT01578044|75658019|FG001|STARTED|Overall Study||6||
59557666|NCT01578044|75658018|FG000|COMPLETED|Overall Study||6||
59557667|NCT01578044|75658019|FG001|COMPLETED|Overall Study||6||
59557668|NCT01578044|75658018|FG000|NOT COMPLETED|Overall Study||0||
59557669|NCT01578044|75658019|FG001|NOT COMPLETED|Overall Study||0||
59557670|NCT02345226|75658027|FG000|STARTED|Double-Blind Phase||440||
59557671|NCT02345226|75658028|FG001|STARTED|Double-Blind Phase||441||
59557672|NCT02345226|75658027|FG000|COMPLETED|Double-Blind Phase||371||
59557673|NCT02345226|75658028|FG001|COMPLETED|Double-Blind Phase||370||
59557674|NCT02345226|75658027|FG000|NOT COMPLETED|Double-Blind Phase||69||
59557675|NCT02345226|75658028|FG001|NOT COMPLETED|Double-Blind Phase||71||
59557676|NCT02345226|75658027|FG000|STARTED|Open-Label Extension Phase|346 participants completed the Double-Blind Phase, but did not enter Open-Label Extension Phase.|25||
59557677|NCT02345226|75658028|FG001|STARTED|Open-Label Extension Phase|349 participants completed the Double-Blind Phase, but did not enter Open-Label Extension Phase.|21||
59557678|NCT02345226|75658027|FG000|COMPLETED|Open-Label Extension Phase||25||
59557679|NCT02345226|75658028|FG001|COMPLETED|Open-Label Extension Phase||20||
59557680|NCT02345226|75658027|FG000|NOT COMPLETED|Open-Label Extension Phase||0||
59557681|NCT02345226|75658028|FG001|NOT COMPLETED|Open-Label Extension Phase||1||
59557682|NCT02802501|75658039|FG000|STARTED|Double-blind (Up to Day 180)||50||
59557683|NCT02802501|75658040|FG001|STARTED|Double-blind (Up to Day 180)||50||
59557684|NCT02802501|75658041|FG002|STARTED|Double-blind (Up to Day 180)||50||
59557685|NCT02802501|75658039|FG000|COMPLETED|Double-blind (Up to Day 180)||50||
60084860|NCT01433991|76200921|FG003|STARTED|Pretreatment Phase (Single Agent Run-in)||8|30 participants enrolled in Pretreatment Phase (single agent run in period) and 28 went on to receive combination treatment in the Treatment Phase and 2 participants were discontinued after receiving only single-agent therapy in the Pretreatment Phase.|
60084861|NCT01433991|76200918|FG000|COMPLETED|Pretreatment Phase (Single Agent Run-in)||3||
60084862|NCT01433991|76200919|FG001|COMPLETED|Pretreatment Phase (Single Agent Run-in)||3||
60084863|NCT01433991|76200920|FG002|COMPLETED|Pretreatment Phase (Single Agent Run-in)||14||
60084864|NCT01433991|76200921|FG003|COMPLETED|Pretreatment Phase (Single Agent Run-in)||8||
60084865|NCT01433991|76200918|FG000|NOT COMPLETED|Pretreatment Phase (Single Agent Run-in)||2||
60084866|NCT01433991|76200919|FG001|NOT COMPLETED|Pretreatment Phase (Single Agent Run-in)||0||
60084867|NCT01433991|76200920|FG002|NOT COMPLETED|Pretreatment Phase (Single Agent Run-in)||0||
60084868|NCT01433991|76200921|FG003|NOT COMPLETED|Pretreatment Phase (Single Agent Run-in)||0||
60084869|NCT01433991|76200918|FG000|STARTED|Treatment Phase (Combination Agent)||3||
60084870|NCT01433991|76200919|FG001|STARTED|Treatment Phase (Combination Agent)||3||
60084871|NCT01433991|76200920|FG002|STARTED|Treatment Phase (Combination Agent)||14||
60084872|NCT01433991|76200921|FG003|STARTED|Treatment Phase (Combination Agent)||8||
60084873|NCT01433991|76200918|FG000|COMPLETED|Treatment Phase (Combination Agent)||1||
60084874|NCT01433991|76200919|FG001|COMPLETED|Treatment Phase (Combination Agent)||2||
60084875|NCT01433991|76200920|FG002|COMPLETED|Treatment Phase (Combination Agent)||8||
60084876|NCT01433991|76200921|FG003|COMPLETED|Treatment Phase (Combination Agent)||2||
60084877|NCT01433991|76200918|FG000|NOT COMPLETED|Treatment Phase (Combination Agent)||2||
60084878|NCT01433991|76200919|FG001|NOT COMPLETED|Treatment Phase (Combination Agent)||1||
60084879|NCT01433991|76200920|FG002|NOT COMPLETED|Treatment Phase (Combination Agent)||6||
60084880|NCT01433991|76200921|FG003|NOT COMPLETED|Treatment Phase (Combination Agent)||6||
60084881|NCT01450683|76200937|FG000|STARTED|Overall Study||4||
60084882|NCT01450683|76200937|FG000|COMPLETED|Overall Study||2||
60084883|NCT01450683|76200937|FG000|NOT COMPLETED|Overall Study||2||
60084884|NCT01433055|76200943|FG000|STARTED|Overall Study||29||
60084885|NCT01433055|76200944|FG001|STARTED|Overall Study||23||
60084886|NCT01433055|76200943|FG000|COMPLETED|Overall Study||27||
60084887|NCT01433055|76200944|FG001|COMPLETED|Overall Study||23||
60084888|NCT01433055|76200943|FG000|NOT COMPLETED|Overall Study||2||
60084889|NCT01433055|76200944|FG001|NOT COMPLETED|Overall Study||0||
60084890|NCT01450137|76200952|FG000|STARTED|Up to Week 12||20||
59557686|NCT02802501|75658040|FG001|COMPLETED|Double-blind (Up to Day 180)||50||
59557687|NCT02802501|75658041|FG002|COMPLETED|Double-blind (Up to Day 180)||50||
59557688|NCT02802501|75658039|FG000|NOT COMPLETED|Double-blind (Up to Day 180)||0||
59557689|NCT02802501|75658040|FG001|NOT COMPLETED|Double-blind (Up to Day 180)||0||
59557690|NCT02802501|75658041|FG002|NOT COMPLETED|Double-blind (Up to Day 180)||0||
59557691|NCT02802501|75658039|FG000|STARTED|Open-Label (Day 180 to Day 195)|Participants who had no relapse prior to Day 180 received open-label Primaquine|6||
59557692|NCT02802501|75658040|FG001|STARTED|Open-Label (Day 180 to Day 195)|Participants who had no relapse prior to Day 180 received open-label Primaquine|12||
59557693|NCT02802501|75658041|FG002|STARTED|Open-Label (Day 180 to Day 195)|Participants who had no relapse prior to Day 180 received open-label Primaquine|26||
59557694|NCT02802501|75658039|FG000|COMPLETED|Open-Label (Day 180 to Day 195)||6||
59557695|NCT02802501|75658040|FG001|COMPLETED|Open-Label (Day 180 to Day 195)||12||
59557696|NCT02802501|75658041|FG002|COMPLETED|Open-Label (Day 180 to Day 195)||26||
59557697|NCT02802501|75658039|FG000|NOT COMPLETED|Open-Label (Day 180 to Day 195)||0||
59557698|NCT02802501|75658040|FG001|NOT COMPLETED|Open-Label (Day 180 to Day 195)||0||
59557699|NCT02802501|75658041|FG002|NOT COMPLETED|Open-Label (Day 180 to Day 195)||0||
59557700|NCT01528592|75658054|FG000|STARTED|Overall Study||18||
59557701|NCT01528592|75658054|FG000|COMPLETED|Overall Study||18||
59557702|NCT01528592|75658054|FG000|NOT COMPLETED|Overall Study||0||
59557703|NCT01578278|75658062|FG000|STARTED|Overall Study||152||
59557704|NCT01578278|75658063|FG001|STARTED|Overall Study||152||
59557705|NCT01578278|75658064|FG002|STARTED|Overall Study||154||
59557706|NCT01578278|75658065|FG003|STARTED|Overall Study||148||
59557707|NCT01578278|75658062|FG000|COMPLETED|Overall Study||148||
59557708|NCT01578278|75658063|FG001|COMPLETED|Overall Study||150||
59557709|NCT01578278|75658064|FG002|COMPLETED|Overall Study||150||
59557710|NCT01578278|75658065|FG003|COMPLETED|Overall Study||139||
59557711|NCT01578278|75658062|FG000|NOT COMPLETED|Overall Study||4||
59557712|NCT01578278|75658063|FG001|NOT COMPLETED|Overall Study||2||
59557713|NCT01578278|75658064|FG002|NOT COMPLETED|Overall Study||4||
59557714|NCT01578278|75658065|FG003|NOT COMPLETED|Overall Study||9||
59557715|NCT01578902|75658075|FG000|STARTED|Overall Study||84||
59557716|NCT01578902|75658075|FG000|COMPLETED|Overall Study||84||
59557717|NCT01578902|75658075|FG000|NOT COMPLETED|Overall Study||0||
59557718|NCT02803749|75658084|FG000|STARTED|Overall Study||17||
59557719|NCT02803749|75658085|FG001|STARTED|Overall Study||4||
59557720|NCT02803749|75658084|FG000|COMPLETED|Overall Study||12||
59557721|NCT02803749|75658085|FG001|COMPLETED|Overall Study||4||
60084891|NCT01450137|76200953|FG001|STARTED|Up to Week 12||10||
60084892|NCT01450137|76200952|FG000|COMPLETED|Up to Week 12||18||
60084893|NCT01450137|76200953|FG001|COMPLETED|Up to Week 12||7||
60084894|NCT01450137|76200952|FG000|NOT COMPLETED|Up to Week 12||2||
60084895|NCT01450137|76200953|FG001|NOT COMPLETED|Up to Week 12||3||
60084896|NCT01450137|76200952|FG000|STARTED|Week 12 to Study End||18||
59557722|NCT02803749|75658084|FG000|NOT COMPLETED|Overall Study||5||
59557723|NCT02803749|75658085|FG001|NOT COMPLETED|Overall Study||0||
59557724|NCT01578980|75658091|FG000|STARTED|Overall Study||20||
59557725|NCT01578980|75658091|FG000|COMPLETED|Overall Study||20||
59557726|NCT01578980|75658091|FG000|NOT COMPLETED|Overall Study||0||
59557727|NCT01529060|75658097|FG000|STARTED|Overall Study||10||
59557728|NCT01529060|75658098|FG001|STARTED|Overall Study||10||
59557729|NCT01529060|75658097|FG000|COMPLETED|Overall Study||10||
60084897|NCT01450137|76200953|FG001|STARTED|Week 12 to Study End||7||
60084898|NCT01450137|76200952|FG000|COMPLETED|Week 12 to Study End||18||
59557730|NCT01529060|75658098|FG001|COMPLETED|Overall Study||10||
59557731|NCT01529060|75658097|FG000|NOT COMPLETED|Overall Study||0||
59557732|NCT01529060|75658098|FG001|NOT COMPLETED|Overall Study||0||
59557733|NCT01579214|75658107|FG000|STARTED|Overall Study||45||
59557734|NCT01579214|75658108|FG001|STARTED|Overall Study||138||
59557735|NCT01579214|75658107|FG000|COMPLETED|Overall Study||45||
59557736|NCT01579214|75658108|FG001|COMPLETED|Overall Study||138||
59557737|NCT01579214|75658107|FG000|NOT COMPLETED|Overall Study||0||
59557738|NCT01579214|75658108|FG001|NOT COMPLETED|Overall Study||0||
59557739|NCT02806869|75658116|FG000|STARTED|First Intervention (1 Day)||24||
59557740|NCT02806869|75658117|FG001|STARTED|First Intervention (1 Day)||24||
59557741|NCT02806869|75658116|FG000|COMPLETED|First Intervention (1 Day)||13||
59557742|NCT02806869|75658117|FG001|COMPLETED|First Intervention (1 Day)||12||
59557743|NCT02806869|75658116|FG000|NOT COMPLETED|First Intervention (1 Day)||11||
59557744|NCT02806869|75658117|FG001|NOT COMPLETED|First Intervention (1 Day)||12||
59557745|NCT02806869|75658116|FG000|STARTED|Washout (7 Days)||7||
59557746|NCT02806869|75658117|FG001|STARTED|Washout (7 Days)||7||
59557747|NCT02806869|75658116|FG000|COMPLETED|Washout (7 Days)||7||
59557748|NCT02806869|75658117|FG001|COMPLETED|Washout (7 Days)||7||
59557749|NCT02806869|75658116|FG000|NOT COMPLETED|Washout (7 Days)||0||
59557750|NCT02806869|75658117|FG001|NOT COMPLETED|Washout (7 Days)||0||
59557751|NCT02806869|75658116|FG000|STARTED|Second Intervention (1 Day)||7||
59557752|NCT02806869|75658117|FG001|STARTED|Second Intervention (1 Day)||7||
59557753|NCT02806869|75658116|FG000|COMPLETED|Second Intervention (1 Day)||7||
59557754|NCT02806869|75658117|FG001|COMPLETED|Second Intervention (1 Day)||5||
59557755|NCT02806869|75658116|FG000|NOT COMPLETED|Second Intervention (1 Day)||0||
59557756|NCT02806869|75658117|FG001|NOT COMPLETED|Second Intervention (1 Day)||2||
59557757|NCT02809911|75658125|FG000|STARTED|Overall Study|This is the Initial Treatment Population (subjects that started the Enrollment Visit / Visit 2)|22||
59557758|NCT02809911|75658126|FG001|STARTED|Overall Study|This is the Initial Treatment Population (subjects that started the Enrollment Visit / Visit 2)|19||
59557759|NCT02809911|75658125|FG000|COMPLETED|Overall Study|This is the Initial Treatment Population (subjects that completed the Enrollment Visit / Visit 2)|22||
59557760|NCT02809911|75658126|FG001|COMPLETED|Overall Study|This is the Initial Treatment Population (subjects that completed the Enrollment Visit / Visit 2)|19||
59557761|NCT02809911|75658125|FG000|NOT COMPLETED|Overall Study||0||
59557762|NCT02809911|75658126|FG001|NOT COMPLETED|Overall Study||0||
59557763|NCT01529450|75658134|FG000|STARTED|Overall Study||3||
59557764|NCT01529450|75658135|FG001|STARTED|Overall Study||8||
59557765|NCT01529450|75658134|FG000|COMPLETED|Overall Study||3||
59557766|NCT01529450|75658135|FG001|COMPLETED|Overall Study||6||
59557767|NCT01529450|75658134|FG000|NOT COMPLETED|Overall Study||0||
59557768|NCT01529450|75658135|FG001|NOT COMPLETED|Overall Study||2||
59557769|NCT01580072|75658145|FG000|STARTED|Overall Study||28||
59557770|NCT01580072|75658146|FG001|STARTED|Overall Study||37||
59557771|NCT01580072|75658147|FG002|STARTED|Overall Study||0||
59557772|NCT01580072|75658145|FG000|COMPLETED|Overall Study||16||
59557773|NCT01580072|75658146|FG001|COMPLETED|Overall Study||28||
59557774|NCT01580072|75658147|FG002|COMPLETED|Overall Study||0||
59557775|NCT01580072|75658145|FG000|NOT COMPLETED|Overall Study||12||
59557776|NCT01580072|75658146|FG001|NOT COMPLETED|Overall Study||9||
59557777|NCT01580072|75658147|FG002|NOT COMPLETED|Overall Study||0||
59557778|NCT01580306|75658159|FG000|STARTED|Overall Study||8||
59557779|NCT01580306|75658160|FG001|STARTED|Overall Study||8||
59557780|NCT01580306|75658161|FG002|STARTED|Overall Study||8||
59557781|NCT01580306|75658162|FG003|STARTED|Overall Study||8||
59557782|NCT01580306|75658159|FG000|COMPLETED|Overall Study||8||
59557783|NCT01580306|75658160|FG001|COMPLETED|Overall Study||8||
59557784|NCT01580306|75658161|FG002|COMPLETED|Overall Study||8||
59557785|NCT01580306|75658162|FG003|COMPLETED|Overall Study||8||
59557786|NCT01580306|75658159|FG000|NOT COMPLETED|Overall Study||0||
59557787|NCT01580306|75658160|FG001|NOT COMPLETED|Overall Study||0||
59557788|NCT01580306|75658161|FG002|NOT COMPLETED|Overall Study||0||
59557789|NCT01580306|75658162|FG003|NOT COMPLETED|Overall Study||0||
59557790|NCT02813265|75658174|FG000|STARTED|Overall Study||459||
59707413|NCT01121913|75826299|FG000|STARTED|Fourth Intervention Period||4||
59707414|NCT01121913|75826300|FG001|STARTED|Fourth Intervention Period||6||
59707415|NCT01121913|75826301|FG002|STARTED|Fourth Intervention Period||3||
59707416|NCT01121913|75826302|FG003|STARTED|Fourth Intervention Period||6||
59707417|NCT01121913|75826299|FG000|COMPLETED|Fourth Intervention Period||4||
59707418|NCT01121913|75826300|FG001|COMPLETED|Fourth Intervention Period||6||
59557791|NCT02813265|75658175|FG001|STARTED|Overall Study||456||
59557792|NCT02813265|75658174|FG000|COMPLETED|Overall Study||455||
59557793|NCT02813265|75658175|FG001|COMPLETED|Overall Study||453||
59557794|NCT02813265|75658174|FG000|NOT COMPLETED|Overall Study||4||
59557795|NCT02813265|75658175|FG001|NOT COMPLETED|Overall Study||3||
59557796|NCT02814279|75658183|FG000|STARTED|Overall Study||21||
59557797|NCT02814279|75658184|FG001|STARTED|Overall Study||21||
59557798|NCT02814279|75658183|FG000|COMPLETED|Overall Study||21||
59557799|NCT02814279|75658184|FG001|COMPLETED|Overall Study||21||
59557800|NCT02814279|75658183|FG000|NOT COMPLETED|Overall Study||0||
59557801|NCT02814279|75658184|FG001|NOT COMPLETED|Overall Study||0||
59557802|NCT01533038|75658192|FG000|STARTED|Overall Study||45||
59557803|NCT01533038|75658193|FG001|STARTED|Overall Study||35||
59557804|NCT01533038|75658192|FG000|COMPLETED|Overall Study||45||
59557805|NCT01533038|75658193|FG001|COMPLETED|Overall Study||34||
59557806|NCT01533038|75658192|FG000|NOT COMPLETED|Overall Study||0||
59557807|NCT01533038|75658193|FG001|NOT COMPLETED|Overall Study||1||
59557808|NCT02885025|75658203|FG000|STARTED|Overall Study||16||
59557809|NCT02885025|75658204|FG001|STARTED|Overall Study||14||
59557810|NCT02885025|75658205|FG002|STARTED|Overall Study||9||
59557811|NCT02885025|75658206|FG003|STARTED|Overall Study||8||
59557812|NCT02885025|75658203|FG000|COMPLETED|Overall Study||16||
59557813|NCT02885025|75658204|FG001|COMPLETED|Overall Study||12||
59557814|NCT02885025|75658205|FG002|COMPLETED|Overall Study||9||
59557815|NCT02885025|75658206|FG003|COMPLETED|Overall Study||8||
59557816|NCT02885025|75658203|FG000|NOT COMPLETED|Overall Study||0||
59557817|NCT02885025|75658204|FG001|NOT COMPLETED|Overall Study||2||
59557818|NCT02885025|75658205|FG002|NOT COMPLETED|Overall Study||0||
59557819|NCT02885025|75658206|FG003|NOT COMPLETED|Overall Study||0||
59557820|NCT01580618|75658222|FG000|STARTED|Overall Study||8||
59557821|NCT01580618|75658223|FG001|STARTED|Overall Study||12||
59557822|NCT01580618|75658222|FG000|COMPLETED|Overall Study|One patient was switched from the normal saline to TNKase arm at attending physician request.|7||
59557823|NCT01580618|75658223|FG001|COMPLETED|Overall Study||12||
59557824|NCT01580618|75658222|FG000|NOT COMPLETED|Overall Study||1||
59557825|NCT01580618|75658223|FG001|NOT COMPLETED|Overall Study||0||
59557826|NCT01581008|75658231|FG000|STARTED|Overall Study||17||
59557827|NCT01581008|75658232|FG001|STARTED|Overall Study||13||
59557828|NCT01581008|75658231|FG000|COMPLETED|Overall Study||16||
59557829|NCT01581008|75658232|FG001|COMPLETED|Overall Study||7||
59557830|NCT01581008|75658231|FG000|NOT COMPLETED|Overall Study||1||
59557831|NCT01581008|75658232|FG001|NOT COMPLETED|Overall Study||6||
59557832|NCT01581710|75658239|FG000|STARTED|First Intervention (14days)||18||
59557833|NCT01581710|75658240|FG001|STARTED|First Intervention (14days)||14||
59557834|NCT01581710|75658239|FG000|COMPLETED|First Intervention (14days)||18||
59557835|NCT01581710|75658240|FG001|COMPLETED|First Intervention (14days)||14||
59557836|NCT01581710|75658239|FG000|NOT COMPLETED|First Intervention (14days)||0||
59557837|NCT01581710|75658240|FG001|NOT COMPLETED|First Intervention (14days)||0||
59557838|NCT01581710|75658239|FG000|STARTED|Washout Period (14days)||18||
59557839|NCT01581710|75658240|FG001|STARTED|Washout Period (14days)||14||
59557840|NCT01581710|75658239|FG000|COMPLETED|Washout Period (14days)||18||
59557841|NCT01581710|75658240|FG001|COMPLETED|Washout Period (14days)||14||
59557842|NCT01581710|75658239|FG000|NOT COMPLETED|Washout Period (14days)||0||
59557843|NCT01581710|75658240|FG001|NOT COMPLETED|Washout Period (14days)||0||
59557844|NCT01581710|75658239|FG000|STARTED|Second Intervention (14days)||18||
59557845|NCT01581710|75658240|FG001|STARTED|Second Intervention (14days)||14||
59557846|NCT01581710|75658239|FG000|COMPLETED|Second Intervention (14days)||18||
59557847|NCT01581710|75658240|FG001|COMPLETED|Second Intervention (14days)||12||
59557848|NCT01581710|75658239|FG000|NOT COMPLETED|Second Intervention (14days)||0||
59557849|NCT01581710|75658240|FG001|NOT COMPLETED|Second Intervention (14days)||2||
59557850|NCT01582490|75658252|FG000|STARTED|Overall Study||9||
59557851|NCT01582490|75658253|FG001|STARTED|Overall Study||10||
59557852|NCT01582490|75658252|FG000|COMPLETED|Overall Study||8||
59557853|NCT01582490|75658253|FG001|COMPLETED|Overall Study||9||
59557854|NCT01582490|75658252|FG000|NOT COMPLETED|Overall Study||1||
59557855|NCT01582490|75658253|FG001|NOT COMPLETED|Overall Study||1||
59557856|NCT01582880|75658261|FG000|STARTED|Overall Study||1||
59557857|NCT01582880|75658261|FG000|COMPLETED|Overall Study||1||
59557858|NCT01582880|75658261|FG000|NOT COMPLETED|Overall Study||0||
59557859|NCT02889393|75658267|FG000|STARTED|Overall Study||3||
59816685|NCT04476030|75939048|FG001|NOT COMPLETED|Overall Study||40||
60084899|NCT01450137|76200953|FG001|COMPLETED|Week 12 to Study End||5||
60084900|NCT01450137|76200952|FG000|NOT COMPLETED|Week 12 to Study End||0||
60084901|NCT01450137|76200953|FG001|NOT COMPLETED|Week 12 to Study End||2||
60084902|NCT01412229|76200959|FG000|STARTED|Overall Study||39||
60084903|NCT01412229|76200959|FG000|COMPLETED|Overall Study||38||
60084904|NCT01412229|76200959|FG000|NOT COMPLETED|Overall Study||1||
60084905|NCT01412151|76200964|FG000|STARTED|Week 0 - 306 - Treatment Period||10||
60084906|NCT01412151|76200964|FG000|COMPLETED|Week 0 - 306 - Treatment Period||5||
59557860|NCT02889393|75658268|FG001|STARTED|Overall Study||3||
59557861|NCT02889393|75658267|FG000|COMPLETED|Overall Study||3||
59557862|NCT02889393|75658268|FG001|COMPLETED|Overall Study||3||
59557863|NCT02889393|75658267|FG000|NOT COMPLETED|Overall Study||0||
59557864|NCT02889393|75658268|FG001|NOT COMPLETED|Overall Study||0||
59557865|NCT02818569|75658275|FG000|STARTED|Overall Study||8|All 15 patients were enrolled in both study arms, undergoing sleep with oral dex and a placebo.|
59557866|NCT02818569|75658276|FG001|STARTED|Overall Study||7|All 15 patients were enrolled in both study arms, undergoing sleep with oral dex and a placebo.|
59557867|NCT02818569|75658275|FG000|COMPLETED|Overall Study||8||
59557868|NCT02818569|75658276|FG001|COMPLETED|Overall Study||7||
59557869|NCT02818569|75658275|FG000|NOT COMPLETED|Overall Study||0||
59557870|NCT02818569|75658276|FG001|NOT COMPLETED|Overall Study||0||
59557871|NCT02819973|75658288|FG000|STARTED|Overall Study||114||
59557872|NCT02819973|75658289|FG001|STARTED|Overall Study||114||
59557873|NCT02819973|75658290|FG002|STARTED|Overall Study||115||
59816686|NCT04447820|75939059|FG000|STARTED|Overall Study||32||
59816687|NCT04447820|75939060|FG001|STARTED|Overall Study||32||
59816688|NCT04447820|75939061|FG002|STARTED|Overall Study||32||
60084907|NCT01412151|76200964|FG000|NOT COMPLETED|Week 0 - 306 - Treatment Period||5||
60084908|NCT01412151|76200964|FG000|STARTED|Week 306 - 310 - Washout Period||5||
59557874|NCT02819973|75658288|FG000|COMPLETED|Overall Study|2 withdrawn by request, 4 determined after randomization to be not eligible|108||
59557875|NCT02819973|75658289|FG001|COMPLETED|Overall Study|3 determined after randomization to be not eligible|111||
59557876|NCT02819973|75658290|FG002|COMPLETED|Overall Study|2 withdrawn by request, 2 determined after randomization to be not eligible|111||
59557877|NCT02819973|75658288|FG000|NOT COMPLETED|Overall Study||6||
59557878|NCT02819973|75658289|FG001|NOT COMPLETED|Overall Study||3||
59557879|NCT02819973|75658290|FG002|NOT COMPLETED|Overall Study||4||
59557880|NCT01533116|75658308|FG000|STARTED|Overall Study||14||
59557881|NCT01533116|75658309|FG001|STARTED|Overall Study||13||
59557882|NCT01533116|75658310|FG002|STARTED|Overall Study||13||
59557883|NCT01533116|75658311|FG003|STARTED|Overall Study||12||
59557884|NCT01533116|75658308|FG000|COMPLETED|Overall Study||12||
59557885|NCT01533116|75658309|FG001|COMPLETED|Overall Study||12||
59557886|NCT01533116|75658310|FG002|COMPLETED|Overall Study||12||
59557887|NCT01533116|75658311|FG003|COMPLETED|Overall Study||12||
59557888|NCT01533116|75658308|FG000|NOT COMPLETED|Overall Study||2||
59557889|NCT01533116|75658309|FG001|NOT COMPLETED|Overall Study||1||
59557890|NCT01533116|75658310|FG002|NOT COMPLETED|Overall Study||1||
59557891|NCT01533116|75658311|FG003|NOT COMPLETED|Overall Study||0||
59557892|NCT02821455|75658321|FG000|STARTED|Overall Study||19||
59557893|NCT02821455|75658321|FG000|COMPLETED|Overall Study||19||
59557894|NCT02821455|75658321|FG000|NOT COMPLETED|Overall Study||0||
59557895|NCT01533974|75658327|FG000|STARTED|Overall Study||224||
59557896|NCT01533974|75658328|FG001|STARTED|Overall Study||226||
59557897|NCT01533974|75658327|FG000|COMPLETED|Overall Study||173||
59557898|NCT01533974|75658328|FG001|COMPLETED|Overall Study||176||
59557899|NCT01533974|75658327|FG000|NOT COMPLETED|Overall Study||51||
59557900|NCT01533974|75658328|FG001|NOT COMPLETED|Overall Study||50||
59557901|NCT01583894|75658334|FG000|STARTED|Overall Study||828||
59557902|NCT01583894|75658334|FG000|COMPLETED|Overall Study||813||
59557903|NCT01583894|75658334|FG000|NOT COMPLETED|Overall Study||15||
59816689|NCT04447820|75939059|FG000|COMPLETED|Overall Study||31||
60084909|NCT01412151|76200964|FG000|COMPLETED|Week 306 - 310 - Washout Period||3||
60084910|NCT01412151|76200964|FG000|NOT COMPLETED|Week 306 - 310 - Washout Period||2||
60084911|NCT01432275|76200970|FG000|STARTED|First BG Meter System (7 Days)||90||
59557904|NCT02899689|75658340|FG000|STARTED|Overall Study||209||
59557905|NCT02899689|75658341|FG001|STARTED|Overall Study||210||
59557906|NCT02899689|75658340|FG000|COMPLETED|Overall Study||209||
59557907|NCT02899689|75658341|FG001|COMPLETED|Overall Study||208||
59557908|NCT02899689|75658340|FG000|NOT COMPLETED|Overall Study||0||
59557909|NCT02899689|75658341|FG001|NOT COMPLETED|Overall Study||2||
59557910|NCT01534052|75658347|FG000|STARTED|Overall Study||52||
59557911|NCT01534052|75658347|FG000|Treatment Received|Overall Study||52||
59557912|NCT01534052|75658347|FG000|COMPLETED|Overall Study||52||
59557913|NCT01534052|75658347|FG000|NOT COMPLETED|Overall Study||0||
59557914|NCT01584518|75658353|FG000|STARTED|Overall Study||25||
59816690|NCT04447820|75939060|FG001|COMPLETED|Overall Study||31||
59816691|NCT04447820|75939061|FG002|COMPLETED|Overall Study||29||
59816692|NCT04447820|75939059|FG000|NOT COMPLETED|Overall Study||1||
59991990|NCT02786537|76107625|FG005|COMPLETED|As Treated||40||
59991991|NCT02786537|76107620|FG000|NOT COMPLETED|As Treated||6||
59991992|NCT02786537|76107621|FG001|NOT COMPLETED|As Treated||62||
59991993|NCT02786537|76107622|FG002|NOT COMPLETED|As Treated||0||
59991994|NCT02786537|76107623|FG003|NOT COMPLETED|As Treated||35||
59991995|NCT02786537|76107624|FG004|NOT COMPLETED|As Treated||12||
60084912|NCT01432275|76200971|FG001|STARTED|First BG Meter System (7 Days)||87||
60084913|NCT01432275|76200970|FG000|COMPLETED|First BG Meter System (7 Days)||90||
60084914|NCT01432275|76200971|FG001|COMPLETED|First BG Meter System (7 Days)||84||
60084915|NCT01432275|76200970|FG000|NOT COMPLETED|First BG Meter System (7 Days)||0||
60084916|NCT01432275|76200971|FG001|NOT COMPLETED|First BG Meter System (7 Days)||3||
60084917|NCT01432275|76200970|FG000|STARTED|Second BG Meter System (7 Days)||90||
60084918|NCT01432275|76200971|FG001|STARTED|Second BG Meter System (7 Days)||84||
60084919|NCT01432275|76200970|FG000|COMPLETED|Second BG Meter System (7 Days)||88||
59557915|NCT01584518|75658354|FG001|STARTED|Overall Study||25||
59557916|NCT01584518|75658353|FG000|COMPLETED|Overall Study||25||
59557917|NCT01584518|75658354|FG001|COMPLETED|Overall Study||25||
59816693|NCT04447820|75939060|FG001|NOT COMPLETED|Overall Study||1||
59991996|NCT02786537|76107625|FG005|NOT COMPLETED|As Treated||7||
59991997|NCT02216812|76107733|FG000|STARTED|Overall Study||67||
59991998|NCT02216812|76107734|FG001|STARTED|Overall Study||67||
59557918|NCT01584518|75658353|FG000|NOT COMPLETED|Overall Study||0||
59557919|NCT01584518|75658354|FG001|NOT COMPLETED|Overall Study||0||
59557920|NCT03138369|75658362|FG000|STARTED|Overall Study||11||
59557921|NCT03138369|75658363|FG001|STARTED|Overall Study||11||
59557922|NCT03138369|75658362|FG000|COMPLETED|Overall Study||8||
59557923|NCT03138369|75658363|FG001|COMPLETED|Overall Study||3||
59557924|NCT03138369|75658362|FG000|NOT COMPLETED|Overall Study||3||
59557925|NCT03138369|75658363|FG001|NOT COMPLETED|Overall Study||8||
59557926|NCT01534910|75658372|FG000|STARTED|Overall Study||33||
59557927|NCT01534910|75658373|FG001|STARTED|Overall Study||32||
59557928|NCT01534910|75658372|FG000|COMPLETED|Overall Study||29||
59557929|NCT01534910|75658373|FG001|COMPLETED|Overall Study||28||
59557930|NCT01534910|75658372|FG000|NOT COMPLETED|Overall Study||4||
59557931|NCT01534910|75658373|FG001|NOT COMPLETED|Overall Study||4||
59557932|NCT02901249|75658381|FG000|STARTED|Overall Study||68||
59557933|NCT02901249|75658381|FG000|COMPLETED|Overall Study|Primary and secondary outcomes are assessed just at the end of the protocol, not at each step|43||
59557934|NCT02901249|75658381|FG000|NOT COMPLETED|Overall Study||25||
59557935|NCT02212028|75658387|FG000|STARTED|Overall Study||26||
59557936|NCT02212028|75658388|FG001|STARTED|Overall Study||26||
59557937|NCT02212028|75658387|FG000|COMPLETED|Overall Study||26||
59557938|NCT02212028|75658388|FG001|COMPLETED|Overall Study||26||
59557939|NCT02212028|75658387|FG000|NOT COMPLETED|Overall Study||0||
59557940|NCT02212028|75658388|FG001|NOT COMPLETED|Overall Study||0||
59557941|NCT02901951|75658394|FG000|STARTED|Overall Study||103||
59557942|NCT02901951|75658394|FG000|COMPLETED|Overall Study||103||
59557943|NCT02901951|75658394|FG000|NOT COMPLETED|Overall Study||0||
59557944|NCT01586312|75658400|FG000|STARTED|Overall Study||15||
59557945|NCT01586312|75658401|FG001|STARTED|Overall Study||15||
59557946|NCT01586312|75658400|FG000|COMPLETED|Overall Study||15||
59557947|NCT01586312|75658401|FG001|COMPLETED|Overall Study||15||
59557948|NCT01586312|75658400|FG000|NOT COMPLETED|Overall Study||0||
59557949|NCT01586312|75658401|FG001|NOT COMPLETED|Overall Study||0||
59816694|NCT04447820|75939061|FG002|NOT COMPLETED|Overall Study||3||
59816695|NCT04431453|75939077|FG000|STARTED|Overall Study||12||
59816696|NCT04431453|75939078|FG001|STARTED|Overall Study||12||
59816697|NCT04431453|75939079|FG002|STARTED|Overall Study||12||
59557950|NCT02212106|75658409|FG000|STARTED|Overall Study||302||
59557951|NCT02212106|75658410|FG001|STARTED|Overall Study||100||
59557952|NCT02212106|75658409|FG000|COMPLETED|Overall Study||292||
59557953|NCT02212106|75658410|FG001|COMPLETED|Overall Study||96||
59557954|NCT02212106|75658409|FG000|NOT COMPLETED|Overall Study||10||
59557955|NCT02212106|75658410|FG001|NOT COMPLETED|Overall Study||4||
59557956|NCT02903121|75658419|FG000|STARTED|Overall Study||57||
59557957|NCT02903121|75658420|FG001|STARTED|Overall Study||52||
59557958|NCT02903121|75658419|FG000|COMPLETED|Overall Study||34||
59557959|NCT02903121|75658420|FG001|COMPLETED|Overall Study||38||
59557960|NCT02903121|75658419|FG000|NOT COMPLETED|Overall Study||23||
59557961|NCT02903121|75658420|FG001|NOT COMPLETED|Overall Study||14||
59557962|NCT02904057|75658428|FG000|STARTED|Overall Study||19||
59557963|NCT02904057|75658429|FG001|STARTED|Overall Study||10||
59557964|NCT02904057|75658428|FG000|COMPLETED|Overall Study||19||
59557965|NCT02904057|75658429|FG001|COMPLETED|Overall Study||10||
59557966|NCT02904057|75658428|FG000|NOT COMPLETED|Overall Study||0||
59557967|NCT02904057|75658429|FG001|NOT COMPLETED|Overall Study||0||
59557968|NCT02904915|75658437|FG000|STARTED|Overall Study||25||
59991999|NCT02216812|76107733|FG000|COMPLETED|Overall Study||57||
59992000|NCT02216812|76107734|FG001|COMPLETED|Overall Study||62||
59992001|NCT02216812|76107733|FG000|NOT COMPLETED|Overall Study||10||
59992002|NCT02216812|76107734|FG001|NOT COMPLETED|Overall Study||5||
59992003|NCT02252536|76107742|FG000|STARTED|Overall Study||173||
59992004|NCT02252536|76107743|FG001|STARTED|Overall Study||173||
59992005|NCT02252536|76107742|FG000|COMPLETED|Overall Study||168||
59992006|NCT02252536|76107743|FG001|COMPLETED|Overall Study||170||
59992007|NCT02252536|76107742|FG000|NOT COMPLETED|Overall Study||5||
59992008|NCT02252536|76107743|FG001|NOT COMPLETED|Overall Study||3||
59992009|NCT02206828|76107749|FG000|STARTED|Overall Study||100||
59992010|NCT02206828|76107749|FG000|COMPLETED|Overall Study||93||
59992011|NCT02206828|76107749|FG000|NOT COMPLETED|Overall Study||7||
59557969|NCT02904915|75658438|FG001|STARTED|Overall Study||25||
59557970|NCT02904915|75658437|FG000|COMPLETED|Overall Study||25||
59557971|NCT02904915|75658438|FG001|COMPLETED|Overall Study||25||
59992012|NCT01209767|76107776|FG000|STARTED|Overall Study||22||
59992013|NCT01209767|76107776|FG000|COMPLETED|Overall Study||18||
59992014|NCT01209767|76107776|FG000|NOT COMPLETED|Overall Study||4||
59557972|NCT02904915|75658437|FG000|NOT COMPLETED|Overall Study||0||
59557973|NCT02904915|75658438|FG001|NOT COMPLETED|Overall Study||0||
59557974|NCT02907489|75658446|FG000|STARTED|Overall Study||42||
59557975|NCT02907489|75658447|FG001|STARTED|Overall Study||42||
59557976|NCT02907489|75658446|FG000|COMPLETED|Overall Study||40||
59557977|NCT02907489|75658447|FG001|COMPLETED|Overall Study||41||
59557978|NCT02907489|75658446|FG000|NOT COMPLETED|Overall Study||2||
59816698|NCT04431453|75939080|FG003|STARTED|Overall Study||12||
59816699|NCT04431453|75939081|FG004|STARTED|Overall Study||4||
59816700|NCT04431453|75939082|FG005|STARTED|Overall Study||1||
59992015|NCT02252146|76107784|FG000|STARTED|Overall Study||6||
59557979|NCT02907489|75658447|FG001|NOT COMPLETED|Overall Study||1||
59557980|NCT01535924|75658459|FG000|STARTED|Overall Study||3||
60084920|NCT01432275|76200971|FG001|COMPLETED|Second BG Meter System (7 Days)||81||
59557981|NCT01535924|75658460|FG001|STARTED|Overall Study||3||
59557982|NCT01535924|75658461|FG002|STARTED|Overall Study||3||
59557983|NCT01535924|75658462|FG003|STARTED|Overall Study||4||
59557984|NCT01535924|75658463|FG004|STARTED|Overall Study||6||
59557985|NCT01535924|75658464|FG005|STARTED|Overall Study||7||
59557986|NCT01535924|75658459|FG000|COMPLETED|Overall Study||3||
59557987|NCT01535924|75658460|FG001|COMPLETED|Overall Study||3||
59557988|NCT01535924|75658461|FG002|COMPLETED|Overall Study||3||
59557989|NCT01535924|75658462|FG003|COMPLETED|Overall Study||4||
59557990|NCT01535924|75658463|FG004|COMPLETED|Overall Study||6||
59557991|NCT01535924|75658464|FG005|COMPLETED|Overall Study||7||
59557992|NCT01535924|75658459|FG000|NOT COMPLETED|Overall Study||0||
59557993|NCT01535924|75658460|FG001|NOT COMPLETED|Overall Study||0||
59557994|NCT01535924|75658461|FG002|NOT COMPLETED|Overall Study||0||
59557995|NCT01535924|75658462|FG003|NOT COMPLETED|Overall Study||0||
59557996|NCT01535924|75658463|FG004|NOT COMPLETED|Overall Study||0||
59557997|NCT01535924|75658464|FG005|NOT COMPLETED|Overall Study||0||
59557998|NCT02909439|75658481|FG000|STARTED|Overall Study||31||
59557999|NCT02909439|75658482|FG001|STARTED|Overall Study||31||
59558000|NCT02909439|75658481|FG000|COMPLETED|Overall Study||31||
59558001|NCT02909439|75658482|FG001|COMPLETED|Overall Study||31||
59558002|NCT02909439|75658481|FG000|NOT COMPLETED|Overall Study||0||
59558003|NCT02909439|75658482|FG001|NOT COMPLETED|Overall Study||0||
59558004|NCT01587950|75658488|FG000|STARTED|Period 1||12||
59558005|NCT01587950|75658488|FG000|Received 5% KNO3 Solution (5 Minutes)|Period 1||5||
60084921|NCT01432275|76200970|FG000|NOT COMPLETED|Second BG Meter System (7 Days)||2||
60084922|NCT01432275|76200971|FG001|NOT COMPLETED|Second BG Meter System (7 Days)||3||
60084923|NCT01432275|76200970|FG000|STARTED|ADC With Calculator (10 Days)||88||
60084924|NCT01432275|76200971|FG001|STARTED|ADC With Calculator (10 Days)||81||
60084925|NCT01432275|76200970|FG000|COMPLETED|ADC With Calculator (10 Days)||85||
60084926|NCT01432275|76200971|FG001|COMPLETED|ADC With Calculator (10 Days)||79||
60084927|NCT01432275|76200970|FG000|NOT COMPLETED|ADC With Calculator (10 Days)||3||
60084928|NCT01432275|76200971|FG001|NOT COMPLETED|ADC With Calculator (10 Days)||2||
59558006|NCT01587950|75658488|FG000|Received 5% KNO3 Solution (2 Minutes)|Period 1||3||
59558007|NCT01587950|75658488|FG000|Received Sterile Water (2 Minutes)|Period 1||2||
59558008|NCT01587950|75658488|FG000|Received 5% KNO3 Solution (10 Minutes)|Period 1||4||
59558009|NCT01587950|75658488|FG000|Received 2.5% KNO3 Solution (2 Minutes)|Period 1||4||
59558010|NCT01587950|75658488|FG000|Received 2.5% KNO3 Solution (10 Minutes)|Period 1||3||
59558011|NCT01587950|75658488|FG000|Received Sterile Water (10 Minutes)|Period 1||5||
59558012|NCT01587950|75658488|FG000|Received 2.5% KNO3 Solution (5 Minutes)|Period 1||5||
59558013|NCT01587950|75658488|FG000|Received Sterile Water (5 Minutes)|Period 1||5||
60084929|NCT01411995|76200979|FG000|STARTED|Overall Study||100||
59558014|NCT01587950|75658488|FG000|COMPLETED|Period 1||12||
59558015|NCT01587950|75658488|FG000|NOT COMPLETED|Period 1||0||
59558016|NCT01587950|75658488|FG000|STARTED|Washout 1||12||
59558017|NCT01587950|75658488|FG000|COMPLETED|Washout 1||12||
59558018|NCT01587950|75658488|FG000|NOT COMPLETED|Washout 1||0||
59558019|NCT01587950|75658488|FG000|STARTED|Period 2||12||
59558020|NCT01587950|75658488|FG000|Received Sterile Water (2 Minutes)|Period 2||8||
59558021|NCT01587950|75658488|FG000|Received 5% KNO3 Solution (10 Minutes)|Period 2||4||
59558022|NCT01587950|75658488|FG000|Received 2.5% KNO3 Solution (5 Minutes)|Period 2||2||
59558023|NCT01587950|75658488|FG000|Received 2.5% KNO3 Solution (10 Minutes)|Period 2||6||
59558024|NCT01587950|75658488|FG000|Received 5% KNO3 Solution (2 Minutes)|Period 2||6||
59558025|NCT01587950|75658488|FG000|Received Sterile Water (5 Minutes)|Period 2||2||
59558026|NCT01587950|75658488|FG000|Received 2.5% KNO3 Solution (2 Minutes)|Period 2||4||
59558027|NCT01587950|75658488|FG000|Received Sterile Water (10 Minutes)|Period 2||2||
59558028|NCT01587950|75658488|FG000|Received 5% KNO3 Solution (5 Minutes)|Period 2||2||
59558029|NCT01587950|75658488|FG000|COMPLETED|Period 2||12||
59558030|NCT01587950|75658488|FG000|NOT COMPLETED|Period 2||0||
59558031|NCT01587950|75658488|FG000|STARTED|Washout 2||12||
59558032|NCT01587950|75658488|FG000|COMPLETED|Washout 2||12||
59558033|NCT01587950|75658488|FG000|NOT COMPLETED|Washout 2||0||
59558034|NCT01587950|75658488|FG000|STARTED|Period 3||12||
59558035|NCT01587950|75658488|FG000|Received 2.5% KNO3 Solution (2 Minutes)|Period 3||4||
59558036|NCT01587950|75658488|FG000|Received Sterile Water (10 Minutes)|Period 3||5||
59558037|NCT01587950|75658488|FG000|Received Sterile Water (2 Minutes)|Period 3||2||
59558038|NCT01587950|75658488|FG000|Received 5% KNO3 Solution (10 Minutes)|Period 3||4||
59558039|NCT01587950|75658488|FG000|Received Sterile Water (5 Minutes)|Period 3||5||
59558040|NCT01587950|75658488|FG000|Received 5% KNO3 Solution (5 Minutes)|Period 3||5||
59558041|NCT01587950|75658488|FG000|Received 5% KNO3 Solution (2 Minutes)|Period 3||3||
59558042|NCT01587950|75658488|FG000|Received 2.5% KNO3 Solution (10 Minutes)|Period 3||3||
59558043|NCT01587950|75658488|FG000|Received 2.5% KNO3 Solution (5 Minutes)|Period 3||5||
59558044|NCT01587950|75658488|FG000|COMPLETED|Period 3||12||
59558045|NCT01587950|75658488|FG000|NOT COMPLETED|Period 3||0||
59558046|NCT02833857|75658501|FG000|STARTED|Overall Study||11||
59558047|NCT02833857|75658501|FG000|COMPLETED|Overall Study||11||
59558048|NCT02833857|75658501|FG000|NOT COMPLETED|Overall Study||0||
59558049|NCT01536938|75658508|FG000|STARTED|Overall Study||100||
59558050|NCT01536938|75658509|FG001|STARTED|Overall Study||101||
59558051|NCT01536938|75658510|FG002|STARTED|Overall Study||101||
59558052|NCT01536938|75658508|FG000|COMPLETED|Overall Study||94||
59558053|NCT01536938|75658509|FG001|COMPLETED|Overall Study||94||
59558054|NCT01536938|75658510|FG002|COMPLETED|Overall Study||93||
59558055|NCT01536938|75658508|FG000|NOT COMPLETED|Overall Study||6||
59558056|NCT01536938|75658509|FG001|NOT COMPLETED|Overall Study||7||
59558057|NCT01536938|75658510|FG002|NOT COMPLETED|Overall Study||8||
59558058|NCT01588418|75658518|FG000|STARTED|Overall Study||11||
59558059|NCT01588418|75658519|FG001|STARTED|Overall Study||4||
59558060|NCT01588418|75658518|FG000|COMPLETED|Overall Study||11||
59558061|NCT01588418|75658519|FG001|COMPLETED|Overall Study||4||
59558062|NCT01588418|75658518|FG000|NOT COMPLETED|Overall Study||0||
59558063|NCT01588418|75658519|FG001|NOT COMPLETED|Overall Study||0||
59558064|NCT02911857|75658528|FG000|STARTED|Overall Study||2||
59558065|NCT02911857|75658529|FG001|STARTED|Overall Study||1||
60084930|NCT01411995|76200980|FG001|STARTED|Overall Study||100||
60084931|NCT01411995|76200979|FG000|COMPLETED|Overall Study||100||
60084932|NCT01411995|76200980|FG001|COMPLETED|Overall Study||99||
59558066|NCT02911857|75658530|FG002|STARTED|Overall Study||1||
59707419|NCT01121913|75826301|FG002|COMPLETED|Fourth Intervention Period||3||
59707420|NCT01121913|75826302|FG003|COMPLETED|Fourth Intervention Period||6||
59707421|NCT01121913|75826299|FG000|NOT COMPLETED|Fourth Intervention Period||0||
59707422|NCT01121913|75826300|FG001|NOT COMPLETED|Fourth Intervention Period||0||
60084933|NCT01411995|76200979|FG000|NOT COMPLETED|Overall Study||0||
60084934|NCT01411995|76200980|FG001|NOT COMPLETED|Overall Study||1||
60084935|NCT01411917|76200988|FG000|STARTED|Overall Study||32||
60084936|NCT01411917|76200989|FG001|STARTED|Overall Study||37||
60084937|NCT01411917|76200988|FG000|COMPLETED|Overall Study||32||
60084938|NCT01411917|76200989|FG001|COMPLETED|Overall Study||36||
60084939|NCT01411917|76200988|FG000|NOT COMPLETED|Overall Study||0||
60084940|NCT01411917|76200989|FG001|NOT COMPLETED|Overall Study||1||
60084941|NCT01411839|76200997|FG000|STARTED|Overall Study||20||
60084942|NCT01411839|76200998|FG001|STARTED|Overall Study||20||
60084943|NCT01411839|76200997|FG000|COMPLETED|Overall Study||16||
60084944|NCT01411839|76200998|FG001|COMPLETED|Overall Study||17||
60084945|NCT01411839|76200997|FG000|NOT COMPLETED|Overall Study||4||
60084946|NCT01411839|76200998|FG001|NOT COMPLETED|Overall Study||3||
59707423|NCT01121913|75826301|FG002|NOT COMPLETED|Fourth Intervention Period||0||
59707424|NCT01121913|75826302|FG003|NOT COMPLETED|Fourth Intervention Period||0||
59558067|NCT02911857|75658528|FG000|COMPLETED|Overall Study||2||
59558068|NCT02911857|75658529|FG001|COMPLETED|Overall Study||1||
59558069|NCT02911857|75658530|FG002|COMPLETED|Overall Study||1||
59558070|NCT02911857|75658528|FG000|NOT COMPLETED|Overall Study||0||
59558071|NCT02911857|75658529|FG001|NOT COMPLETED|Overall Study||0||
59558072|NCT02911857|75658530|FG002|NOT COMPLETED|Overall Study||0||
59558073|NCT03004911|75658540|FG000|STARTED|Overall Study||20||
59558074|NCT03004911|75658541|FG001|STARTED|Overall Study||20||
59558075|NCT03004911|75658540|FG000|COMPLETED|Overall Study||19||
59558076|NCT03004911|75658541|FG001|COMPLETED|Overall Study||17||
59558077|NCT03004911|75658540|FG000|NOT COMPLETED|Overall Study||1||
59707425|NCT00994162|75826314|FG000|STARTED|Overall Study||153||
60084947|NCT01411215|76201006|FG000|STARTED|Overall Study||69||
59558078|NCT03004911|75658541|FG001|NOT COMPLETED|Overall Study||3||
59558079|NCT02914119|75658547|FG000|STARTED|Overall Study||30430||
59558080|NCT02914119|75658547|FG000|COMPLETED|Overall Study||30430||
59558081|NCT02914119|75658547|FG000|NOT COMPLETED|Overall Study||0||
60084948|NCT01411215|76201007|FG001|STARTED|Overall Study||91||
60084949|NCT01411215|76201006|FG000|Treated|Overall Study||69||
59558082|NCT01589510|75658551|FG000|STARTED|Overall Study||419||
59558083|NCT01589510|75658551|FG000|COMPLETED|Overall Study||386||
59558084|NCT01589510|75658551|FG000|NOT COMPLETED|Overall Study||33||
59558085|NCT02914509|75658557|FG000|STARTED|Overall Study||348||
59558086|NCT02914509|75658558|FG001|STARTED|Overall Study||217||
59558087|NCT02914509|75658557|FG000|COMPLETED|Overall Study||343||
59558088|NCT02914509|75658558|FG001|COMPLETED|Overall Study||211||
59558089|NCT02914509|75658557|FG000|NOT COMPLETED|Overall Study||5||
59558090|NCT02914509|75658558|FG001|NOT COMPLETED|Overall Study||6||
59558091|NCT02837913|75658568|FG000|STARTED|Overall Study||10||
59558092|NCT02837913|75658569|FG001|STARTED|Overall Study||9||
59558093|NCT02837913|75658568|FG000|COMPLETED|Overall Study||10||
59558094|NCT02837913|75658569|FG001|COMPLETED|Overall Study||9||
59558095|NCT02837913|75658568|FG000|NOT COMPLETED|Overall Study||0||
59558096|NCT02837913|75658569|FG001|NOT COMPLETED|Overall Study||0||
59558097|NCT02840097|75658578|FG000|STARTED|Overall Study||9||
59558098|NCT02840097|75658579|FG001|STARTED|Overall Study||10||
59558099|NCT02840097|75658580|FG002|STARTED|Overall Study||12||
59558100|NCT02840097|75658578|FG000|COMPLETED|Overall Study||9||
59558101|NCT02840097|75658579|FG001|COMPLETED|Overall Study||10||
59558102|NCT02840097|75658580|FG002|COMPLETED|Overall Study||12||
59558103|NCT02840097|75658578|FG000|NOT COMPLETED|Overall Study||0||
59558104|NCT02840097|75658579|FG001|NOT COMPLETED|Overall Study||0||
59558105|NCT02840097|75658580|FG002|NOT COMPLETED|Overall Study||0||
59558106|NCT02841033|75658591|FG000|STARTED|Overall Study||22||
59558107|NCT02841033|75658591|FG000|COMPLETED|Overall Study||22||
59558108|NCT02841033|75658591|FG000|NOT COMPLETED|Overall Study||0||
59558109|NCT02841189|75658595|FG000|STARTED|Overall Study||100||
59558110|NCT02841189|75658595|FG000|COMPLETED|Overall Study||65||
59558111|NCT02841189|75658595|FG000|NOT COMPLETED|Overall Study||35||
59558112|NCT00551369|75658599|FG000|STARTED|Overall Study||33||
59558113|NCT00551369|75658599|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study|26||
59558114|NCT00551369|75658599|FG000|NOT COMPLETED|Overall Study||7||
59558115|NCT01589978|75658603|FG000|STARTED|Overall Study||2681||
59558116|NCT01589978|75658603|FG000|COMPLETED|Overall Study||2681||
59558117|NCT01589978|75658603|FG000|NOT COMPLETED|Overall Study||0||
59558118|NCT01592006|75658608|FG000|STARTED|Overall Study||3||
59558119|NCT01592006|75658608|FG000|COMPLETED|Overall Study||3||
59816701|NCT04431453|75939083|FG006|STARTED|Overall Study||1||
59816702|NCT04431453|75939084|FG007|STARTED|Overall Study||5||
59816703|NCT04431453|75939077|FG000|COMPLETED|Overall Study||11||
59992016|NCT02252146|76107784|FG000|COMPLETED|Overall Study||0||
59992017|NCT02252146|76107784|FG000|NOT COMPLETED|Overall Study||6||
59992018|NCT02251990|76107790|FG000|STARTED|Period 1 (Double-blind [DB])||366||
59992019|NCT02251990|76107791|FG001|STARTED|Period 1 (Double-blind [DB])||123||
59992020|NCT02251990|76107790|FG000|Treated|Period 1 (Double-blind [DB])|Started Grazoprevir/Elbasvir|365||
59992021|NCT02251990|76107791|FG001|Treated|Period 1 (Double-blind [DB])|Started Placebo|123||
59992022|NCT02251990|76107790|FG000|COMPLETED|Period 1 (Double-blind [DB])|Completed 12 weeks of Grazoprevir/Elbasvir|358||
59992023|NCT02251990|76107791|FG001|COMPLETED|Period 1 (Double-blind [DB])|Completed 12 weeks of Placebo|122||
59992024|NCT02251990|76107790|FG000|NOT COMPLETED|Period 1 (Double-blind [DB])||8||
59992025|NCT02251990|76107791|FG001|NOT COMPLETED|Period 1 (Double-blind [DB])||1||
59992026|NCT02251990|76107790|FG000|STARTED|Period 2 (ITG Follow-up/DTG Open Label)|2 participants that did not complete Period 1 treatment were included in Follow-up.|360||
59992027|NCT02251990|76107791|FG001|STARTED|Period 2 (ITG Follow-up/DTG Open Label)|1 participant completing Period 1 was not eligible for Period 2 and was not treated.|121||
59995194|NCT02730169|76111014|FG001|STARTED|Overall Study||66||
59558120|NCT01592006|75658608|FG000|NOT COMPLETED|Overall Study||0||
59558121|NCT00551291|75658612|FG000|STARTED|Overall Study||10||
59558122|NCT00551291|75658612|FG000|COMPLETED|Overall Study||9||
59558123|NCT00551291|75658612|FG000|NOT COMPLETED|Overall Study||1||
59558124|NCT01592396|75658618|FG000|STARTED|Overall Study||10||
59558125|NCT01592396|75658619|FG001|STARTED|Overall Study||10||
59558126|NCT01592396|75658618|FG000|COMPLETED|Overall Study||10||
59558127|NCT01592396|75658619|FG001|COMPLETED|Overall Study||10||
59558128|NCT01592396|75658618|FG000|NOT COMPLETED|Overall Study||0||
59558129|NCT01592396|75658619|FG001|NOT COMPLETED|Overall Study||0||
59558130|NCT02278289|75658628|FG000|STARTED|Overall Study||30||
59558131|NCT02278289|75658629|FG001|STARTED|Overall Study||30||
59558132|NCT02278289|75658628|FG000|COMPLETED|Overall Study||24||
59558133|NCT02278289|75658629|FG001|COMPLETED|Overall Study||23||
59558134|NCT02278289|75658628|FG000|NOT COMPLETED|Overall Study||6||
59558135|NCT02278289|75658629|FG001|NOT COMPLETED|Overall Study||7||
59558136|NCT01593722|75658637|FG000|STARTED|Overall Study||6||
59558137|NCT01593722|75658638|FG001|STARTED|Overall Study||6||
59558138|NCT01593722|75658637|FG000|COMPLETED|Overall Study||6||
59558139|NCT01593722|75658638|FG001|COMPLETED|Overall Study||6||
59816704|NCT04431453|75939078|FG001|COMPLETED|Overall Study||11||
59816705|NCT04431453|75939079|FG002|COMPLETED|Overall Study||11||
59816706|NCT04431453|75939080|FG003|COMPLETED|Overall Study||9||
59558140|NCT01593722|75658637|FG000|NOT COMPLETED|Overall Study||0||
59558141|NCT01593722|75658638|FG001|NOT COMPLETED|Overall Study||0||
59558142|NCT01594424|75658646|FG000|STARTED|Overall Study||10||
59558143|NCT01594424|75658646|FG000|COMPLETED|Overall Study||8||
59558144|NCT01594424|75658646|FG000|NOT COMPLETED|Overall Study||2||
59558145|NCT01595282|75658652|FG000|STARTED|Overall Study||47||
59558146|NCT01595282|75658653|FG001|STARTED|Overall Study||47||
59558147|NCT01595282|75658652|FG000|COMPLETED|Overall Study||47||
59558148|NCT01595282|75658653|FG001|COMPLETED|Overall Study||47||
59558149|NCT01595282|75658652|FG000|NOT COMPLETED|Overall Study||0||
59558150|NCT01595282|75658653|FG001|NOT COMPLETED|Overall Study||0||
59558151|NCT01595516|75658662|FG000|STARTED|Overall Study||16||
59558152|NCT01595516|75658663|FG001|STARTED|Overall Study||16||
59558153|NCT01595516|75658664|FG002|STARTED|Overall Study||12||
59558154|NCT01595516|75658662|FG000|COMPLETED|Overall Study||16||
59558155|NCT01595516|75658663|FG001|COMPLETED|Overall Study||16||
59558156|NCT01595516|75658664|FG002|COMPLETED|Overall Study||12||
59992028|NCT02251990|76107790|FG000|COMPLETED|Period 2 (ITG Follow-up/DTG Open Label)|Completed 24 weeks of follow-up|360||
59558157|NCT01595516|75658662|FG000|NOT COMPLETED|Overall Study||0||
59558158|NCT01595516|75658663|FG001|NOT COMPLETED|Overall Study||0||
59558159|NCT01595516|75658664|FG002|NOT COMPLETED|Overall Study||0||
59558160|NCT01596842|75658688|FG000|STARTED|Overall Study||10||
59558161|NCT01596842|75658689|FG001|STARTED|Overall Study||7||
59558162|NCT01596842|75658688|FG000|COMPLETED|Overall Study||8||
59558163|NCT01596842|75658689|FG001|COMPLETED|Overall Study||7||
59558164|NCT01596842|75658688|FG000|NOT COMPLETED|Overall Study||2||
59558165|NCT01596842|75658689|FG001|NOT COMPLETED|Overall Study||0||
59558166|NCT02217800|75658695|FG000|STARTED|Overall Study||8||
59558167|NCT02217800|75658695|FG000|COMPLETED|Overall Study||8||
59558168|NCT02217800|75658695|FG000|NOT COMPLETED|Overall Study||0||
59558169|NCT02218190|75658709|FG000|STARTED|Overall Study||13||
59558170|NCT02218190|75658710|FG001|STARTED|Overall Study||13||
59558171|NCT02218190|75658709|FG000|COMPLETED|Overall Study||13||
59558172|NCT02218190|75658710|FG001|COMPLETED|Overall Study||13||
59558173|NCT02218190|75658709|FG000|NOT COMPLETED|Overall Study||0||
59558174|NCT02218190|75658710|FG001|NOT COMPLETED|Overall Study||0||
59992029|NCT02251990|76107791|FG001|COMPLETED|Period 2 (ITG Follow-up/DTG Open Label)|Completed 12 weeks of Grazoprevir/Elbasvir|118||
59992030|NCT02251990|76107790|FG000|NOT COMPLETED|Period 2 (ITG Follow-up/DTG Open Label)||0||
59992031|NCT02251990|76107791|FG001|NOT COMPLETED|Period 2 (ITG Follow-up/DTG Open Label)||3||
59992032|NCT02251990|76107790|FG000|STARTED|Period 3 (DTG Follow-up)|The ITG completed the study with Period 2|0||
59992033|NCT02251990|76107791|FG001|STARTED|Period 3 (DTG Follow-up)|3 participants that discontinued treatment in Period 2 were included in Follow-up.|121||
59992034|NCT02251990|76107790|FG000|COMPLETED|Period 3 (DTG Follow-up)||0||
59558175|NCT00551213|75658718|FG000|STARTED|Overall Study||50||
59558176|NCT00551213|75658719|FG001|STARTED|Overall Study||17||
59558177|NCT00551213|75658718|FG000|Treated|Overall Study||49||
59558178|NCT00551213|75658719|FG001|Treated|Overall Study||15||
59558179|NCT00551213|75658718|FG000|COMPLETED|Overall Study||0||
59558180|NCT00551213|75658719|FG001|COMPLETED|Overall Study||0||
59558181|NCT00551213|75658718|FG000|NOT COMPLETED|Overall Study||50||
59558182|NCT00551213|75658719|FG001|NOT COMPLETED|Overall Study||17||
59558183|NCT02841267|75658728|FG000|STARTED|Lead-in (Untreated)||4|Participants were observed for 16 weeks prior to treatment.|
59558184|NCT02841267|75658729|FG001|STARTED|Lead-in (Untreated)||7|Participants were observed for 16 weeks prior to treatment.|
59558185|NCT02841267|75658730|FG002|STARTED|Lead-in (Untreated)||8|Participants were observed for 16 weeks prior to treatment.|
59558186|NCT02841267|75658728|FG000|COMPLETED|Lead-in (Untreated)||4||
59558187|NCT02841267|75658729|FG001|COMPLETED|Lead-in (Untreated)||7||
59816707|NCT04431453|75939081|FG004|COMPLETED|Overall Study||3||
59992035|NCT02251990|76107791|FG001|COMPLETED|Period 3 (DTG Follow-up)|Completed 24 weeks of follow-up|121||
59992036|NCT02251990|76107790|FG000|NOT COMPLETED|Period 3 (DTG Follow-up)||0||
59992037|NCT02251990|76107791|FG001|NOT COMPLETED|Period 3 (DTG Follow-up)||0||
60084950|NCT01411215|76201007|FG001|Treated|Overall Study|1 participant was considered as screen failure and therefore not treated.|90||
60084951|NCT01411215|76201006|FG000|COMPLETED|Overall Study||3||
60084952|NCT01411215|76201007|FG001|COMPLETED|Overall Study||7||
60084953|NCT01411215|76201006|FG000|NOT COMPLETED|Overall Study||66||
60084954|NCT01411215|76201007|FG001|NOT COMPLETED|Overall Study||84||
60084955|NCT01449279|76201013|FG000|STARTED|Overall Study||22||
60084956|NCT01449279|76201013|FG000|COMPLETED|Overall Study||15||
60084957|NCT01449279|76201013|FG000|NOT COMPLETED|Overall Study||7||
60084958|NCT01447719|76201017|FG000|STARTED|Overall Study||152||
60084959|NCT01447719|76201017|FG000|Valid AV-45 Scan Acquired|Overall Study||147||
60084960|NCT01447719|76201017|FG000|Deceased <2 Years After AV-45 Scan|Overall Study||66||
60084961|NCT01447719|76201017|FG000|COMPLETED|Overall Study||59||
60084962|NCT01447719|76201017|FG000|NOT COMPLETED|Overall Study||93||
60084963|NCT01431963|76201026|FG000|STARTED|Overall Study||67||
60084964|NCT01431963|76201026|FG000|Begin Escalation Phase (EP; 6 Weeks)|Overall Study||67||
60084965|NCT01431963|76201026|FG000|Received Treatment|Overall Study||65||
60084966|NCT01431963|76201026|FG000|Complete EP (6 Weeks)|Overall Study||52||
59558188|NCT02841267|75658730|FG002|COMPLETED|Lead-in (Untreated)||8||
59558189|NCT02841267|75658728|FG000|NOT COMPLETED|Lead-in (Untreated)||0||
59558190|NCT02841267|75658729|FG001|NOT COMPLETED|Lead-in (Untreated)||0||
59558191|NCT02841267|75658730|FG002|NOT COMPLETED|Lead-in (Untreated)||0||
59558192|NCT02841267|75658728|FG000|STARTED|Treatment Period|Cohort 1 was invited to continue receiving 40mg/kg of study drug every 4 weeks for 28 weeks.|4||
59558193|NCT02841267|75658729|FG001|STARTED|Treatment Period||7||
59558194|NCT02841267|75658730|FG002|STARTED|Treatment Period||8||
59558195|NCT02841267|75658728|FG000|COMPLETED|Treatment Period||4||
59558196|NCT02841267|75658729|FG001|COMPLETED|Treatment Period||7||
59558197|NCT02841267|75658730|FG002|COMPLETED|Treatment Period||8||
59558198|NCT02841267|75658728|FG000|NOT COMPLETED|Treatment Period||0||
59558199|NCT02841267|75658729|FG001|NOT COMPLETED|Treatment Period||0||
59558200|NCT02841267|75658730|FG002|NOT COMPLETED|Treatment Period||0||
60084967|NCT01431963|76201026|FG000|Begin Maintenance Phase (MP; 24 Weeks)|Overall Study||52||
59558201|NCT02841267|75658728|FG000|STARTED|Extension Study|Cohort 1 was invited to continue receiving 40mg/kg of study drug every 4 weeks for 28 weeks.|4||
59558202|NCT02841267|75658729|FG001|STARTED|Extension Study|Cohort 2 was invited to continue receiving 40mg/kg of study drug every 4 weeks for 40 weeks.|6||
59558203|NCT02841267|75658730|FG002|STARTED|Extension Study|Cohort 3 was invited to continue receiving 40mg/kg of study drug every 4 weeks for 24 weeks.|6||
59558204|NCT02841267|75658728|FG000|COMPLETED|Extension Study||4||
59558205|NCT02841267|75658729|FG001|COMPLETED|Extension Study||6||
59558206|NCT02841267|75658730|FG002|COMPLETED|Extension Study||6||
59558207|NCT02841267|75658728|FG000|NOT COMPLETED|Extension Study||0||
59992038|NCT02251912|76107800|FG000|STARTED|Overall Study||12||
59992039|NCT02251912|76107801|FG001|STARTED|Overall Study||10||
59992040|NCT02251912|76107800|FG000|COMPLETED|Overall Study||10||
59558208|NCT02841267|75658729|FG001|NOT COMPLETED|Extension Study||0||
59558209|NCT02841267|75658730|FG002|NOT COMPLETED|Extension Study||0||
59558210|NCT03006471|75658748|FG000|STARTED|Overall Study||15||
59558211|NCT03006471|75658749|FG001|STARTED|Overall Study||15||
59558212|NCT03006471|75658748|FG000|COMPLETED|Overall Study|Two patients did not complete the study due to early withdrawal|13||
59558213|NCT03006471|75658749|FG001|COMPLETED|Overall Study|Two patients did not complete the study due to early withdrawal|13||
59558214|NCT03006471|75658748|FG000|NOT COMPLETED|Overall Study||2||
59558215|NCT03006471|75658749|FG001|NOT COMPLETED|Overall Study||2||
59558216|NCT03008889|75658757|FG000|STARTED|Overall Study||1||
59558217|NCT03008889|75658758|FG001|STARTED|Overall Study||1||
59558218|NCT03008889|75658757|FG000|COMPLETED|Overall Study||1||
59558219|NCT03008889|75658758|FG001|COMPLETED|Overall Study||1||
59558220|NCT03008889|75658757|FG000|NOT COMPLETED|Overall Study||0||
59558221|NCT03008889|75658758|FG001|NOT COMPLETED|Overall Study||0||
59558222|NCT03010137|75658767|FG000|STARTED|Overall Study||15||
59558223|NCT03010137|75658768|FG001|STARTED|Overall Study||15||
59558224|NCT03010137|75658767|FG000|COMPLETED|Overall Study||15||
59558225|NCT03010137|75658768|FG001|COMPLETED|Overall Study||15||
59558226|NCT03010137|75658767|FG000|NOT COMPLETED|Overall Study||0||
59558227|NCT03010137|75658768|FG001|NOT COMPLETED|Overall Study||0||
59558228|NCT03010683|75658776|FG000|STARTED|Overall Study||30||
59558229|NCT03010683|75658777|FG001|STARTED|Overall Study||30||
59558230|NCT03010683|75658776|FG000|COMPLETED|Overall Study||30||
59558231|NCT03010683|75658777|FG001|COMPLETED|Overall Study||30||
59558232|NCT03010683|75658776|FG000|NOT COMPLETED|Overall Study||0||
59558233|NCT03010683|75658777|FG001|NOT COMPLETED|Overall Study||0||
59558234|NCT02918097|75658783|FG000|STARTED|Overall Study||78||
59558235|NCT02918097|75658783|FG000|COMPLETED|Overall Study|Primary and secondary outcomes are assessed just at the end of the protocol, not at each step|58||
59558236|NCT02918097|75658783|FG000|NOT COMPLETED|Overall Study||20||
59558237|NCT03012477|75658787|FG000|STARTED|Overall Study||34||
59558238|NCT03012477|75658787|FG000|COMPLETED|Overall Study||34||
59558239|NCT03012477|75658787|FG000|NOT COMPLETED|Overall Study||0||
59992041|NCT02251912|76107801|FG001|COMPLETED|Overall Study||5||
59558240|NCT02276963|75658791|FG000|STARTED|Overall Study||6||
59558241|NCT02276963|75658791|FG000|COMPLETED|Overall Study||3||
59558242|NCT02276963|75658791|FG000|NOT COMPLETED|Overall Study||3||
59558243|NCT03017937|75658795|FG000|STARTED|Overall Study||155||
59558244|NCT03017937|75658795|FG000|COMPLETED|Overall Study||155||
59558245|NCT03017937|75658795|FG000|NOT COMPLETED|Overall Study||0||
59558246|NCT03019107|75658802|FG000|STARTED|Overall Study||1||
59558247|NCT03019107|75658803|FG001|STARTED|Overall Study||0||
59558248|NCT03019107|75658802|FG000|COMPLETED|Overall Study||1||
59558249|NCT03019107|75658803|FG001|COMPLETED|Overall Study||0||
59558250|NCT03019107|75658802|FG000|NOT COMPLETED|Overall Study||0||
59558251|NCT03019107|75658803|FG001|NOT COMPLETED|Overall Study||0||
59558252|NCT02919111|75658809|FG000|STARTED|Overall Study||299||
59558253|NCT02919111|75658809|FG000|COMPLETED|Overall Study||299||
59992042|NCT02251912|76107800|FG000|NOT COMPLETED|Overall Study||2||
59992043|NCT02251912|76107801|FG001|NOT COMPLETED|Overall Study||5||
59558254|NCT02919111|75658809|FG000|NOT COMPLETED|Overall Study||0||
60084968|NCT01431963|76201026|FG000|Complete MP (24 Weeks)|Overall Study||42||
59816708|NCT04431453|75939082|FG005|COMPLETED|Overall Study||1||
59816709|NCT04431453|75939083|FG006|COMPLETED|Overall Study||1||
59816710|NCT04431453|75939084|FG007|COMPLETED|Overall Study||4||
59816711|NCT04431453|75939077|FG000|NOT COMPLETED|Overall Study||1||
59816712|NCT04431453|75939078|FG001|NOT COMPLETED|Overall Study||1||
59816713|NCT04431453|75939079|FG002|NOT COMPLETED|Overall Study||1||
59558255|NCT02919423|75658815|FG000|STARTED|Overall Study||6||
59558256|NCT02919423|75658816|FG001|STARTED|Overall Study||25||
60103662|NCT01347034|76221909|FG000|COMPLETED|Overall Study||6||
60103663|NCT01347034|76221910|FG001|COMPLETED|Overall Study||14||
60103664|NCT01347034|76221909|FG000|NOT COMPLETED|Overall Study||0||
60103665|NCT01347034|76221910|FG001|NOT COMPLETED|Overall Study||0||
59558257|NCT02919423|75658815|FG000|COMPLETED|Overall Study||4||
59558258|NCT02919423|75658816|FG001|COMPLETED|Overall Study||16||
59558259|NCT02919423|75658815|FG000|NOT COMPLETED|Overall Study||2||
59558260|NCT02919423|75658816|FG001|NOT COMPLETED|Overall Study||9||
59558261|NCT02919657|75658822|FG000|STARTED|Overall Study|10 Participants|10||
59558262|NCT02919657|75658823|FG001|STARTED|Overall Study|10 Participants|10||
59558263|NCT02919657|75658822|FG000|COMPLETED|Overall Study|completed with the same initial 10 participants|10||
59558264|NCT02919657|75658823|FG001|COMPLETED|Overall Study|completed with the same initial 10 participants|10||
59558265|NCT02919657|75658822|FG000|NOT COMPLETED|Overall Study||0||
59558266|NCT02919657|75658823|FG001|NOT COMPLETED|Overall Study||0||
59558267|NCT02850159|75658831|FG000|STARTED|Overall Study||16||
59558268|NCT02850159|75658832|FG001|STARTED|Overall Study||16||
59558269|NCT02850159|75658831|FG000|COMPLETED|Overall Study||16||
59558270|NCT02850159|75658832|FG001|COMPLETED|Overall Study||16||
59558271|NCT02850159|75658831|FG000|NOT COMPLETED|Overall Study||0||
59558272|NCT02850159|75658832|FG001|NOT COMPLETED|Overall Study||0||
59558273|NCT03019887|75658838|FG000|STARTED|Overall Study||139||
59558274|NCT03019887|75658838|FG000|COMPLETED|Overall Study||130||
59558275|NCT03019887|75658838|FG000|NOT COMPLETED|Overall Study||9||
59558276|NCT02919813|75658844|FG000|STARTED|Overall Study||14||
59558277|NCT02919813|75658845|FG001|STARTED|Overall Study||17||
59558278|NCT02919813|75658844|FG000|COMPLETED|Overall Study||14||
59558279|NCT02919813|75658845|FG001|COMPLETED|Overall Study||17||
59558280|NCT02919813|75658844|FG000|NOT COMPLETED|Overall Study||0||
59558281|NCT02919813|75658845|FG001|NOT COMPLETED|Overall Study||0||
59558282|NCT00550043|75658856|FG000|STARTED|Overall Study||9||
59558283|NCT00550043|75658857|FG001|STARTED|Overall Study||12||
59558284|NCT00550043|75658858|FG002|STARTED|Overall Study||9||
59558285|NCT00550043|75658859|FG003|STARTED|Overall Study||10||
59558286|NCT00550043|75658860|FG004|STARTED|Overall Study||10||
59558287|NCT00550043|75658856|FG000|COMPLETED|Overall Study||9||
59558288|NCT00550043|75658857|FG001|COMPLETED|Overall Study||9||
59558289|NCT00550043|75658858|FG002|COMPLETED|Overall Study||8||
59558290|NCT00550043|75658859|FG003|COMPLETED|Overall Study||8||
59558291|NCT00550043|75658860|FG004|COMPLETED|Overall Study||9||
59558292|NCT00550043|75658856|FG000|NOT COMPLETED|Overall Study||0||
59558293|NCT00550043|75658857|FG001|NOT COMPLETED|Overall Study||3||
59558294|NCT00550043|75658858|FG002|NOT COMPLETED|Overall Study||1||
59558295|NCT00550043|75658859|FG003|NOT COMPLETED|Overall Study||2||
59558296|NCT00550043|75658860|FG004|NOT COMPLETED|Overall Study||1||
59558297|NCT02920749|75658876|FG000|STARTED|Overall Study||30||
59558298|NCT02920749|75658877|FG001|STARTED|Overall Study||30||
59558299|NCT02920749|75658878|FG002|STARTED|Overall Study||30||
59558300|NCT02920749|75658879|FG003|STARTED|Overall Study||30||
59558301|NCT02920749|75658876|FG000|COMPLETED|Overall Study||30||
59558302|NCT02920749|75658877|FG001|COMPLETED|Overall Study||30||
59558303|NCT02920749|75658878|FG002|COMPLETED|Overall Study||30||
59558304|NCT02920749|75658879|FG003|COMPLETED|Overall Study||30||
59558305|NCT02920749|75658876|FG000|NOT COMPLETED|Overall Study||0||
59558306|NCT02920749|75658877|FG001|NOT COMPLETED|Overall Study||0||
59558307|NCT02920749|75658878|FG002|NOT COMPLETED|Overall Study||0||
59558308|NCT02920749|75658879|FG003|NOT COMPLETED|Overall Study||0||
59558309|NCT02854059|75658895|FG000|STARTED|Overall Study||2||
59558310|NCT02854059|75658896|FG001|STARTED|Overall Study||0||
59558311|NCT02854059|75658895|FG000|COMPLETED|Overall Study||2||
59558312|NCT02854059|75658896|FG001|COMPLETED|Overall Study||0||
59558313|NCT02854059|75658895|FG000|NOT COMPLETED|Overall Study||0||
59558314|NCT02854059|75658896|FG001|NOT COMPLETED|Overall Study||0||
59558315|NCT03021759|75658905|FG000|STARTED|Overall Study||1566||
59558316|NCT03021759|75658906|FG001|STARTED|Overall Study||1743||
59558317|NCT03021759|75658907|FG002|STARTED|Overall Study||1465||
59558318|NCT03021759|75658905|FG000|COMPLETED|Overall Study|32 primary care physicians were randomized to this arm and analyzed.|1566||
59558319|NCT03021759|75658906|FG001|COMPLETED|Overall Study|32 primary care physicians were randomized to this arm and analyzed.|1743||
59558320|NCT03021759|75658907|FG002|COMPLETED|Overall Study|32 primary care physicians were randomized to this arm and analyzed.|1465||
59558321|NCT03021759|75658905|FG000|NOT COMPLETED|Overall Study||0||
59558322|NCT03021759|75658906|FG001|NOT COMPLETED|Overall Study||0||
59558323|NCT03021759|75658907|FG002|NOT COMPLETED|Overall Study||0||
59558324|NCT03004586|75658915|FG000|STARTED|Overall Study||31||200
59558325|NCT03004586|75658916|FG001|STARTED|Overall Study||30||200
59558326|NCT03004586|75658915|FG000|COMPLETED|Overall Study||31||200
59558327|NCT03004586|75658916|FG001|COMPLETED|Overall Study||30||200
59558328|NCT03004586|75658915|FG000|NOT COMPLETED|Overall Study||0||0
59558329|NCT03004586|75658916|FG001|NOT COMPLETED|Overall Study||0||0
59558330|NCT02921061|75658924|FG000|STARTED|Overall Study||28||
59558331|NCT02921061|75658924|FG000|COMPLETED|Overall Study||28||
59558332|NCT02921061|75658924|FG000|NOT COMPLETED|Overall Study||0||
59558333|NCT02921295|75658928|FG000|STARTED|Sidekicks||1||
59558334|NCT02921295|75658928|FG000|COMPLETED|Sidekicks||1||
59558335|NCT02921295|75658928|FG000|NOT COMPLETED|Sidekicks||0||
59558336|NCT02921295|75658928|FG000|STARTED|Conventional Prostheses||1||
59558337|NCT02921295|75658928|FG000|COMPLETED|Conventional Prostheses||1||
59558338|NCT02921295|75658928|FG000|NOT COMPLETED|Conventional Prostheses||0||
59558339|NCT03023553|75658939|FG000|STARTED|Overall Study||4||
59558340|NCT03023553|75658940|FG001|STARTED|Overall Study||9||
59558341|NCT03023553|75658939|FG000|COMPLETED|Overall Study||4||
59558342|NCT03023553|75658940|FG001|COMPLETED|Overall Study||8||
59558343|NCT03023553|75658939|FG000|NOT COMPLETED|Overall Study||0||
59558344|NCT03023553|75658940|FG001|NOT COMPLETED|Overall Study||1||
59558345|NCT02921841|75658948|FG000|STARTED|Overall Study||68||
59558346|NCT02921841|75658949|FG001|STARTED|Overall Study||57||
59558347|NCT02921841|75658948|FG000|COMPLETED|Overall Study||52||
59558348|NCT02921841|75658949|FG001|COMPLETED|Overall Study||44||
59558349|NCT02921841|75658948|FG000|NOT COMPLETED|Overall Study||16||
59558350|NCT02921841|75658949|FG001|NOT COMPLETED|Overall Study||13||
59558351|NCT02281409|75658959|FG000|STARTED|Overall Study||3||
59558352|NCT02281409|75658960|FG001|STARTED|Overall Study||3||
59558353|NCT02281409|75658961|FG002|STARTED|Overall Study||5||
59558354|NCT02281409|75658962|FG003|STARTED|Overall Study||6||
59558355|NCT02281409|75658959|FG000|COMPLETED|Overall Study||3||
59558356|NCT02281409|75658960|FG001|COMPLETED|Overall Study||3||
59558357|NCT02281409|75658961|FG002|COMPLETED|Overall Study||5||
59558358|NCT02281409|75658962|FG003|COMPLETED|Overall Study||6||
59558359|NCT02281409|75658959|FG000|NOT COMPLETED|Overall Study||0||
59558360|NCT02281409|75658960|FG001|NOT COMPLETED|Overall Study||0||
59558361|NCT02281409|75658961|FG002|NOT COMPLETED|Overall Study||0||
59558362|NCT02281409|75658962|FG003|NOT COMPLETED|Overall Study||0||
59558363|NCT02858349|75658973|FG000|STARTED|Overall Study||10||
59707426|NCT00994162|75826314|FG000|Participants Receiving Treatment|Overall Study||152||
60084969|NCT01431963|76201026|FG000|Begin Extension Phase (ExP; gt= 24weeks)|Overall Study|Only Japanese participants in ExP,lamotrigine monotherapy was available in Korea. (>=24weeks)|19||
60084970|NCT01431963|76201026|FG000|Complete ExP (gt= 24 Weeks)|Overall Study|(>=24 weeks); gt= abbreviation for greater than or equal to|19||
60084971|NCT01431963|76201026|FG000|COMPLETED|Overall Study||32||
60084972|NCT01431963|76201026|FG000|NOT COMPLETED|Overall Study||35||
60084973|NCT01447407|76201034|FG000|STARTED|Overall Study||41||
60084974|NCT01447407|76201035|FG001|STARTED|Overall Study||40||
60084975|NCT01447407|76201036|FG002|STARTED|Overall Study||41||
60084976|NCT01447407|76201037|FG003|STARTED|Overall Study||42||
60084977|NCT01447407|76201034|FG000|COMPLETED|Overall Study||39||
60084978|NCT01447407|76201035|FG001|COMPLETED|Overall Study||40||
60084979|NCT01447407|76201036|FG002|COMPLETED|Overall Study||40||
60084980|NCT01447407|76201037|FG003|COMPLETED|Overall Study||40||
60084981|NCT01447407|76201034|FG000|NOT COMPLETED|Overall Study||2||
60084982|NCT01447407|76201035|FG001|NOT COMPLETED|Overall Study||0||
60084983|NCT01447407|76201036|FG002|NOT COMPLETED|Overall Study||1||
60084984|NCT01447407|76201037|FG003|NOT COMPLETED|Overall Study||2||
60084985|NCT01446237|76201047|FG000|STARTED|Overall Study||125||
60084986|NCT01446237|76201047|FG000|COMPLETED|Overall Study||115||
60084987|NCT01446237|76201047|FG000|NOT COMPLETED|Overall Study||10||
60084988|NCT00540982|76201051|FG000|STARTED|Overall Study||47||
59558364|NCT02858349|75658973|FG000|COMPLETED|Overall Study||10||
59558365|NCT02858349|75658973|FG000|NOT COMPLETED|Overall Study||0||
59558366|NCT02282111|75658979|FG000|STARTED|Overall Study||26||
59558367|NCT02282111|75658980|FG001|STARTED|Overall Study||30||
59558368|NCT02282111|75658979|FG000|COMPLETED|Overall Study||19||
59558369|NCT02282111|75658980|FG001|COMPLETED|Overall Study||22||
59558370|NCT02282111|75658979|FG000|NOT COMPLETED|Overall Study||7||
59558371|NCT02282111|75658980|FG001|NOT COMPLETED|Overall Study||8||
59558372|NCT03023709|75658988|FG000|STARTED|Overall Study||3||
59558373|NCT03023709|75658989|FG001|STARTED|Overall Study||0||
59558374|NCT03023709|75658988|FG000|COMPLETED|Overall Study||3||
59558375|NCT03023709|75658989|FG001|COMPLETED|Overall Study||0||
59558376|NCT03023709|75658988|FG000|NOT COMPLETED|Overall Study||0||
59558377|NCT03023709|75658989|FG001|NOT COMPLETED|Overall Study||0||
59558378|NCT02859441|75658997|FG000|STARTED|Overall Study||3||
59558379|NCT02859441|75658997|FG000|COMPLETED|Overall Study||3||
60084989|NCT00540982|76201051|FG000|Normal Liver Function|Overall Study||11||
60084990|NCT00540982|76201051|FG000|Mild Liver Dysfunction|Overall Study||6||
60084991|NCT00540982|76201051|FG000|Moderate Liver Dysfunction|Overall Study||18||
60084992|NCT00540982|76201051|FG000|Severe Liver Dysfunction|Overall Study||12||
59558380|NCT02859441|75658997|FG000|NOT COMPLETED|Overall Study||0||
59558381|NCT02859597|75659020|FG000|STARTED|Overall Study|started Dec 2016|22||
59558382|NCT02859597|75659021|FG001|STARTED|Overall Study|Started Dec 2016|19||
59558383|NCT02859597|75659020|FG000|COMPLETED|Overall Study|September 2018|22||
59558384|NCT02859597|75659021|FG001|COMPLETED|Overall Study|September 2018|19||
59558385|NCT02859597|75659020|FG000|NOT COMPLETED|Overall Study||0||
59558386|NCT02859597|75659021|FG001|NOT COMPLETED|Overall Study||0||
59558387|NCT01880099|75659032|FG000|STARTED|Overall Study||17||
59558388|NCT01880099|75659033|FG001|STARTED|Overall Study||21||
59558389|NCT01880099|75659034|FG002|STARTED|Overall Study||22||
59558390|NCT01880099|75659032|FG000|COMPLETED|Overall Study||9||
59558391|NCT01880099|75659033|FG001|COMPLETED|Overall Study||11||
59558392|NCT01880099|75659034|FG002|COMPLETED|Overall Study||15||
59558393|NCT01880099|75659032|FG000|NOT COMPLETED|Overall Study||8||
59558394|NCT01880099|75659033|FG001|NOT COMPLETED|Overall Study||10||
59558395|NCT01880099|75659034|FG002|NOT COMPLETED|Overall Study||7||
59558396|NCT02860845|75659044|FG000|STARTED|Overall Study||24||
59558397|NCT02860845|75659045|FG001|STARTED|Overall Study||24||
59558398|NCT02860845|75659044|FG000|Analyzed Patients|Overall Study||22||
59558399|NCT02860845|75659045|FG001|Analyzed Patients|Overall Study||23||
59558400|NCT02860845|75659044|FG000|COMPLETED|Overall Study||22||
59558401|NCT02860845|75659045|FG001|COMPLETED|Overall Study||23||
59558402|NCT02860845|75659044|FG000|NOT COMPLETED|Overall Study||2||
59558403|NCT02860845|75659045|FG001|NOT COMPLETED|Overall Study||1||
59558404|NCT02923167|75659055|FG000|STARTED|Overall Study||6||
59558405|NCT02923167|75659055|FG000|COMPLETED|Overall Study||4||
59558406|NCT02923167|75659055|FG000|NOT COMPLETED|Overall Study||2||
59558407|NCT01881113|75659062|FG000|STARTED|Overall Study||51||
59558408|NCT01881113|75659063|FG001|STARTED|Overall Study||50||
59558409|NCT01881113|75659062|FG000|COMPLETED|Overall Study||43||
59558410|NCT01881113|75659063|FG001|COMPLETED|Overall Study||44||
59558411|NCT01881113|75659062|FG000|NOT COMPLETED|Overall Study||8||
59558412|NCT01881113|75659063|FG001|NOT COMPLETED|Overall Study||6||
59558413|NCT01883141|75659069|FG000|STARTED|Overall Study||31||
59558414|NCT01883141|75659069|FG000|Passing Eligibility|Overall Study||30|Passing inclusion and exlcusion criteria|
59558415|NCT01883141|75659069|FG000|EP Study Performed|Overall Study||30||
59558416|NCT01883141|75659069|FG000|Usable EP Data|Overall Study||26|Electrical instability (N=1), Technical failure (N=2), No veins available for lead placement (N=1)|
59707427|NCT00994162|75826314|FG000|COMPLETED|Overall Study||125||
59707428|NCT00994162|75826314|FG000|NOT COMPLETED|Overall Study||28||
59558417|NCT01883141|75659069|FG000|BiV Pacing-Distal|Overall Study||24||
59558418|NCT01883141|75659069|FG000|BiV Pacing-Mid|Overall Study||25||
59558419|NCT01883141|75659069|FG000|BiV Pacing-Standard Therapy|Overall Study||26|Proximal pacing|
59558420|NCT01883141|75659069|FG000|Multispot-pacing|Overall Study||24||
59558421|NCT01883141|75659069|FG000|BiV Pacing-Anterior|Overall Study||23||
59558422|NCT01883141|75659069|FG000|Biv Pacing-Posterior|Overall Study||22||
59558423|NCT01883141|75659069|FG000|Multivein|Overall Study||23||
59558424|NCT01883141|75659069|FG000|COMPLETED|Overall Study|Exit form with exit reason available|31||
59558425|NCT01883141|75659069|FG000|NOT COMPLETED|Overall Study||0||
59558426|NCT03028467|75659077|FG000|STARTED|Overall Study||4||
59558427|NCT03028467|75659078|FG001|STARTED|Overall Study||3||
59558428|NCT03028467|75659079|FG002|STARTED|Overall Study||4||
59558429|NCT03028467|75659080|FG003|STARTED|Overall Study||4||
59558430|NCT03028467|75659077|FG000|COMPLETED|Overall Study||4||
59558431|NCT03028467|75659078|FG001|COMPLETED|Overall Study||3||
59558432|NCT03028467|75659079|FG002|COMPLETED|Overall Study||4||
59558433|NCT03028467|75659080|FG003|COMPLETED|Overall Study||4||
59558434|NCT03028467|75659077|FG000|NOT COMPLETED|Overall Study||0||
59558435|NCT03028467|75659078|FG001|NOT COMPLETED|Overall Study||0||
59558436|NCT03028467|75659079|FG002|NOT COMPLETED|Overall Study||0||
59558437|NCT03028467|75659080|FG003|NOT COMPLETED|Overall Study||0||
59558438|NCT01883999|75659093|FG000|STARTED|Overall Study||64||
59558439|NCT01883999|75659093|FG000|COMPLETED|Overall Study||61||
59558440|NCT01883999|75659093|FG000|NOT COMPLETED|Overall Study||3||
59558441|NCT02218424|75659099|FG000|STARTED|Overall Study||30||
59558442|NCT02218424|75659100|FG001|STARTED|Overall Study||30||
59558443|NCT02218424|75659099|FG000|COMPLETED|Overall Study||30||
59558444|NCT02218424|75659100|FG001|COMPLETED|Overall Study||30||
59558445|NCT02218424|75659099|FG000|NOT COMPLETED|Overall Study||0||
59558446|NCT02218424|75659100|FG001|NOT COMPLETED|Overall Study||0||
59558447|NCT02861937|75659109|FG000|STARTED|Overall Study||10||
59558448|NCT02861937|75659110|FG001|STARTED|Overall Study||12||
59558449|NCT02861937|75659111|FG002|STARTED|Overall Study||12||
59558450|NCT02861937|75659109|FG000|COMPLETED|Overall Study||10||
59558451|NCT02861937|75659110|FG001|COMPLETED|Overall Study||12||
59558452|NCT02861937|75659111|FG002|COMPLETED|Overall Study||12||
59558453|NCT02861937|75659109|FG000|NOT COMPLETED|Overall Study||0||
59558454|NCT02861937|75659110|FG001|NOT COMPLETED|Overall Study||0||
59558455|NCT02861937|75659111|FG002|NOT COMPLETED|Overall Study||0||
59558456|NCT01885871|75659120|FG000|STARTED|Overall Study||20||
59558457|NCT01885871|75659120|FG000|COMPLETED|Overall Study||20||
59558458|NCT01885871|75659120|FG000|NOT COMPLETED|Overall Study||0||
59558459|NCT02222870|75659126|FG000|STARTED|Overall Study||30||
59558460|NCT02222870|75659127|FG001|STARTED|Overall Study||30||
59558461|NCT02222870|75659126|FG000|COMPLETED|Overall Study||30||
59558462|NCT02222870|75659127|FG001|COMPLETED|Overall Study||30||
59558463|NCT02222870|75659126|FG000|NOT COMPLETED|Overall Study||0||
59558464|NCT02222870|75659127|FG001|NOT COMPLETED|Overall Study||0||
59558465|NCT02223260|75659133|FG000|STARTED|Overall Study||8||
59558466|NCT02223260|75659133|FG000|COMPLETED|Overall Study||8||
59558467|NCT02223260|75659133|FG000|NOT COMPLETED|Overall Study||0||
59558468|NCT02863263|75659139|FG000|STARTED|Overall Study||3||
59558469|NCT02863263|75659140|FG001|STARTED|Overall Study||2||
59558470|NCT02863263|75659139|FG000|COMPLETED|Overall Study||2||
59558471|NCT02863263|75659140|FG001|COMPLETED|Overall Study||1||
59558472|NCT02863263|75659139|FG000|NOT COMPLETED|Overall Study||1||
59558473|NCT02863263|75659140|FG001|NOT COMPLETED|Overall Study||1||
59558474|NCT01886807|75659149|FG000|STARTED|Overall Study||164||
59558475|NCT01886807|75659150|FG001|STARTED|Overall Study||155||
59558476|NCT01886807|75659151|FG002|STARTED|Overall Study||163||
59816714|NCT04431453|75939080|FG003|NOT COMPLETED|Overall Study||3||
59558477|NCT01886807|75659149|FG000|COMPLETED|Overall Study||159||
59558478|NCT01886807|75659150|FG001|COMPLETED|Overall Study||145||
59558479|NCT01886807|75659151|FG002|COMPLETED|Overall Study||153||
59558480|NCT01886807|75659149|FG000|NOT COMPLETED|Overall Study||5||
59558481|NCT01886807|75659150|FG001|NOT COMPLETED|Overall Study||10||
59558482|NCT01886807|75659151|FG002|NOT COMPLETED|Overall Study||10||
59558483|NCT02223338|75659164|FG000|STARTED|Overall Study||60||
59816715|NCT04431453|75939081|FG004|NOT COMPLETED|Overall Study||1||
59816716|NCT04431453|75939082|FG005|NOT COMPLETED|Overall Study||0||
59816717|NCT04431453|75939083|FG006|NOT COMPLETED|Overall Study||0||
60084993|NCT00540982|76201051|FG000|COMPLETED|Overall Study||47||
59558484|NCT02223338|75659165|FG001|STARTED|Overall Study||60||
59558485|NCT02223338|75659164|FG000|COMPLETED|Overall Study||60||
59558486|NCT02223338|75659165|FG001|COMPLETED|Overall Study||60||
59558487|NCT02223338|75659164|FG000|NOT COMPLETED|Overall Study||0||
59558488|NCT02223338|75659165|FG001|NOT COMPLETED|Overall Study||0||
59558489|NCT01887587|75659171|FG000|STARTED|Overall Study||5||
59558490|NCT01887587|75659171|FG000|COMPLETED|Overall Study||5||
59558491|NCT01887587|75659171|FG000|NOT COMPLETED|Overall Study||0||
59558492|NCT03029091|75659178|FG000|STARTED|Overall Study||8||
59558493|NCT03029091|75659179|FG001|STARTED|Overall Study||7||
59558494|NCT03029091|75659178|FG000|COMPLETED|Overall Study||8||
59558495|NCT03029091|75659179|FG001|COMPLETED|Overall Study||7||
59558496|NCT03029091|75659178|FG000|NOT COMPLETED|Overall Study||0||
59558497|NCT03029091|75659179|FG001|NOT COMPLETED|Overall Study||0||
59558498|NCT02864355|75659189|FG000|STARTED|Overall Study||25||
59558499|NCT02864355|75659190|FG001|STARTED|Overall Study||28||
59558500|NCT02864355|75659189|FG000|COMPLETED|Overall Study||23||
59558501|NCT02864355|75659190|FG001|COMPLETED|Overall Study||25||
59558502|NCT02864355|75659189|FG000|NOT COMPLETED|Overall Study||2||
59558503|NCT02864355|75659190|FG001|NOT COMPLETED|Overall Study||3||
59558504|NCT03029715|75659198|FG000|STARTED|Overall Study||50||
59558505|NCT03029715|75659199|FG001|STARTED|Overall Study||50||
59558506|NCT03029715|75659198|FG000|COMPLETED|Overall Study||50||
59558507|NCT03029715|75659199|FG001|COMPLETED|Overall Study||50||
59558508|NCT03029715|75659198|FG000|NOT COMPLETED|Overall Study||0||
59558509|NCT03029715|75659199|FG001|NOT COMPLETED|Overall Study||0||
59558510|NCT03035487|75659205|FG000|STARTED|Overall Study||9||
59558511|NCT03035487|75659205|FG000|COMPLETED|Overall Study||9||
59558512|NCT03035487|75659205|FG000|NOT COMPLETED|Overall Study||0||
60084994|NCT00540982|76201051|FG000|NOT COMPLETED|Overall Study||0||
60084995|NCT00542620|76201075|FG000|STARTED|Overall Study||13||
60084996|NCT00542620|76201076|FG001|STARTED|Overall Study||12||
60084997|NCT00542620|76201075|FG000|Exposed to Drug|Overall Study|One subject randomly assigned to receive mixed injections, but received a separate injection mode|12||
60084998|NCT00542620|76201076|FG001|Exposed to Drug|Overall Study|One subject randomly assigned to receive mixed injections, but received a separate injection mode|13||
60084999|NCT00542620|76201075|FG000|COMPLETED|Overall Study||13||
60085000|NCT00542620|76201076|FG001|COMPLETED|Overall Study||12||
59558513|NCT02926677|75659212|FG000|STARTED|Overall Study||25||
59558514|NCT02926677|75659213|FG001|STARTED|Overall Study||22||
59558515|NCT02926677|75659214|FG002|STARTED|Overall Study||26||
59558516|NCT02926677|75659212|FG000|COMPLETED|Overall Study||8||
59558517|NCT02926677|75659213|FG001|COMPLETED|Overall Study||8||
59558518|NCT02926677|75659214|FG002|COMPLETED|Overall Study||6||
59558519|NCT02926677|75659212|FG000|NOT COMPLETED|Overall Study||17||
59558520|NCT02926677|75659213|FG001|NOT COMPLETED|Overall Study||14||
59558521|NCT02926677|75659214|FG002|NOT COMPLETED|Overall Study||20||
59558522|NCT03035955|75659225|FG000|STARTED|Overall Study||10||
59558523|NCT03035955|75659226|FG001|STARTED|Overall Study||10||
59558524|NCT03035955|75659225|FG000|COMPLETED|Overall Study||9||
59558525|NCT03035955|75659226|FG001|COMPLETED|Overall Study||9||
59558526|NCT03035955|75659225|FG000|NOT COMPLETED|Overall Study||1||
59558527|NCT03035955|75659226|FG001|NOT COMPLETED|Overall Study||1||
59558528|NCT02927223|75659232|FG000|STARTED|Overall Study||6||
59558529|NCT02927223|75659232|FG000|COMPLETED|Overall Study||6||
59558530|NCT02927223|75659232|FG000|NOT COMPLETED|Overall Study||0||
59558531|NCT02927457|75659240|FG000|STARTED|Overall Study||0||
59558532|NCT02927457|75659241|FG001|STARTED|Overall Study||11||
59558533|NCT02927457|75659240|FG000|COMPLETED|Overall Study||0||
59558534|NCT02927457|75659241|FG001|COMPLETED|Overall Study||11||
59558535|NCT02927457|75659240|FG000|NOT COMPLETED|Overall Study||0||
59558536|NCT02927457|75659241|FG001|NOT COMPLETED|Overall Study||0||
59558537|NCT01891331|75659255|FG000|STARTED|Overall Study||14||
59558538|NCT01891331|75659256|FG001|STARTED|Overall Study||12||
59558539|NCT01891331|75659257|FG002|STARTED|Overall Study||14||
59558540|NCT01891331|75659258|FG003|STARTED|Overall Study||15||
59558541|NCT01891331|75659255|FG000|COMPLETED|Overall Study||12||
59558542|NCT01891331|75659256|FG001|COMPLETED|Overall Study||10||
60085001|NCT00542620|76201075|FG000|NOT COMPLETED|Overall Study||0||
59558543|NCT01891331|75659257|FG002|COMPLETED|Overall Study||13||
59558544|NCT01891331|75659258|FG003|COMPLETED|Overall Study||13||
59558545|NCT01891331|75659255|FG000|NOT COMPLETED|Overall Study||2||
59558546|NCT01891331|75659256|FG001|NOT COMPLETED|Overall Study||2||
59558547|NCT01891331|75659257|FG002|NOT COMPLETED|Overall Study||1||
59558548|NCT01891331|75659258|FG003|NOT COMPLETED|Overall Study||2||
59558549|NCT02867163|75659268|FG000|STARTED|Overall Study||25||
59558550|NCT02867163|75659268|FG000|COMPLETED|Overall Study||25||
59558551|NCT02867163|75659268|FG000|NOT COMPLETED|Overall Study||0||
59558552|NCT03037203|75659275|FG000|STARTED|Overall Study||28||
60085002|NCT00542620|76201076|FG001|NOT COMPLETED|Overall Study||0||
60085003|NCT00543400|76201086|FG000|STARTED|Overall Study||151||
59558553|NCT03037203|75659276|FG001|STARTED|Overall Study||28||
60085004|NCT00543400|76201087|FG001|STARTED|Overall Study||44||
59558554|NCT03037203|75659277|FG002|STARTED|Overall Study||10||
60085005|NCT00543400|76201088|FG002|STARTED|Overall Study||152||
59558555|NCT03037203|75659275|FG000|COMPLETED|Overall Study||27||
59558556|NCT03037203|75659276|FG001|COMPLETED|Overall Study||26||
59558557|NCT03037203|75659277|FG002|COMPLETED|Overall Study||9||
59558558|NCT03037203|75659275|FG000|NOT COMPLETED|Overall Study||1||
59558559|NCT03037203|75659276|FG001|NOT COMPLETED|Overall Study||2||
59558560|NCT03037203|75659277|FG002|NOT COMPLETED|Overall Study||1||
59558561|NCT01892267|75659297|FG000|STARTED|Overall Study||9||
59558562|NCT01892267|75659298|FG001|STARTED|Overall Study||10||
59558563|NCT01892267|75659297|FG000|COMPLETED|Overall Study||9||
59558564|NCT01892267|75659298|FG001|COMPLETED|Overall Study||10||
59558565|NCT01892267|75659297|FG000|NOT COMPLETED|Overall Study||0||
59558566|NCT01892267|75659298|FG001|NOT COMPLETED|Overall Study||0||
59558567|NCT03037281|75659306|FG000|STARTED|Overall Study||6||
59558568|NCT03037281|75659307|FG001|STARTED|Overall Study||8||
59558569|NCT03037281|75659306|FG000|COMPLETED|Overall Study||6||
59558570|NCT03037281|75659307|FG001|COMPLETED|Overall Study||8||
59558571|NCT03037281|75659306|FG000|NOT COMPLETED|Overall Study||0||
59558572|NCT03037281|75659307|FG001|NOT COMPLETED|Overall Study||0||
59707429|NCT00993928|75826321|FG000|STARTED|Overall Study||48||
59707430|NCT00993928|75826322|FG001|STARTED|Overall Study||45||
59707431|NCT00993928|75826321|FG000|COMPLETED|Overall Study||43||
59707432|NCT00993928|75826322|FG001|COMPLETED|Overall Study||38||
59558573|NCT03037905|75659320|FG000|STARTED|Overall Study||50||
59558574|NCT03037905|75659321|FG001|STARTED|Overall Study||50||
59558575|NCT03037905|75659320|FG000|COMPLETED|Overall Study||50||
59558576|NCT03037905|75659321|FG001|COMPLETED|Overall Study||50||
59558577|NCT03037905|75659320|FG000|NOT COMPLETED|Overall Study||0||
59558578|NCT03037905|75659321|FG001|NOT COMPLETED|Overall Study||0||
59558579|NCT01893983|75659331|FG000|STARTED|Overall Study||140||
59558580|NCT01893983|75659332|FG001|STARTED|Overall Study||140||
59558581|NCT01893983|75659331|FG000|COMPLETED|Overall Study||130||
59558582|NCT01893983|75659332|FG001|COMPLETED|Overall Study||134||
59707433|NCT00993928|75826321|FG000|NOT COMPLETED|Overall Study||5||
59707434|NCT00993928|75826322|FG001|NOT COMPLETED|Overall Study||7||
59707435|NCT01253291|75826337|FG000|STARTED|Overall Study||6||
59558583|NCT01893983|75659331|FG000|NOT COMPLETED|Overall Study||10||
59558584|NCT01893983|75659332|FG001|NOT COMPLETED|Overall Study||6||
59558585|NCT03037983|75659340|FG000|STARTED|Overall Study||5||
59558586|NCT03037983|75659341|FG001|STARTED|Overall Study||4||
59558587|NCT03037983|75659340|FG000|COMPLETED|Overall Study||5||
59558588|NCT03037983|75659341|FG001|COMPLETED|Overall Study||4||
59558589|NCT03037983|75659340|FG000|NOT COMPLETED|Overall Study||0||
59558590|NCT03037983|75659341|FG001|NOT COMPLETED|Overall Study||0||
59558591|NCT03039543|75659349|FG000|STARTED|Overall Study||54||
59558592|NCT03039543|75659350|FG001|STARTED|Overall Study||54||
59558593|NCT03039543|75659349|FG000|COMPLETED|Overall Study||53||
59558594|NCT03039543|75659350|FG001|COMPLETED|Overall Study||51||
59558595|NCT03039543|75659349|FG000|NOT COMPLETED|Overall Study||1||
59558596|NCT03039543|75659350|FG001|NOT COMPLETED|Overall Study||3||
59558597|NCT02870205|75659360|FG000|STARTED|Overall Study||294||
59558598|NCT02870205|75659361|FG001|STARTED|Overall Study||294||
59558599|NCT02870205|75659362|FG002|STARTED|Overall Study||294||
59558600|NCT02870205|75659363|FG003|STARTED|Overall Study||294||
59558601|NCT02870205|75659360|FG000|COMPLETED|Overall Study||284||
59558602|NCT02870205|75659361|FG001|COMPLETED|Overall Study||289||
59558603|NCT02870205|75659362|FG002|COMPLETED|Overall Study||287||
59558604|NCT02870205|75659363|FG003|COMPLETED|Overall Study||287||
59558605|NCT02870205|75659360|FG000|NOT COMPLETED|Overall Study||10||
59558606|NCT02870205|75659361|FG001|NOT COMPLETED|Overall Study||5||
59558607|NCT02870205|75659362|FG002|NOT COMPLETED|Overall Study||7||
59558608|NCT02870205|75659363|FG003|NOT COMPLETED|Overall Study||7||
59558609|NCT02328755|75659375|FG000|STARTED|Overall Study||3||
59558610|NCT02328755|75659376|FG001|STARTED|Overall Study||33||
59558611|NCT02328755|75659375|FG000|COMPLETED|Overall Study|Evaluable for the phase II primary endpoint of relapse at 6-months post-HCT|0|Evaluable for the phase II primary endpoint of relapse at 6-months post-HCT|
59558612|NCT02328755|75659376|FG001|COMPLETED|Overall Study||31|Evaluable for the phase II primary endpoint of relapse at 6-months post-HCT|
59558613|NCT02328755|75659375|FG000|NOT COMPLETED|Overall Study||3||
59558614|NCT02328755|75659376|FG001|NOT COMPLETED|Overall Study||2||
59558615|NCT02870283|75659391|FG000|STARTED|Overall Study||38||
59707436|NCT01253291|75826338|FG001|STARTED|Overall Study||6||
59558616|NCT02870283|75659392|FG001|STARTED|Overall Study||35||
59558617|NCT02870283|75659393|FG002|STARTED|Overall Study||34||
59558618|NCT02870283|75659391|FG000|COMPLETED|Overall Study||35||
59707437|NCT01253291|75826339|FG002|STARTED|Overall Study||4||
59558619|NCT02870283|75659392|FG001|COMPLETED|Overall Study||26||
59558620|NCT02870283|75659393|FG002|COMPLETED|Overall Study||15||
59558621|NCT02870283|75659391|FG000|NOT COMPLETED|Overall Study||3||
59558622|NCT02870283|75659392|FG001|NOT COMPLETED|Overall Study||9||
59558623|NCT02870283|75659393|FG002|NOT COMPLETED|Overall Study||19||
59558624|NCT02224508|75659403|FG000|STARTED|Overall Study|Number of patients surveyed in intervention segment of the health plan (group practice).|935||
59565960|NCT02303574|75668410|FG005|NOT COMPLETED|Part 1a (Fasted State)- SAD||0||
59707438|NCT01253291|75826340|FG003|STARTED|Overall Study||5||
59707439|NCT01253291|75826341|FG004|STARTED|Overall Study||5||
59558625|NCT02224508|75659404|FG001|STARTED|Overall Study|Number of patients surveyed in the control segment of the health plan (contracted care).|653||
59558626|NCT02224508|75659403|FG000|COMPLETED|Overall Study||935||
59558627|NCT02224508|75659404|FG001|COMPLETED|Overall Study||653||
59558628|NCT02224508|75659403|FG000|NOT COMPLETED|Overall Study||0||
59558629|NCT02224508|75659404|FG001|NOT COMPLETED|Overall Study||0||
59558630|NCT02931045|75659413|FG000|STARTED|Overall Study||30||
59558631|NCT02931045|75659414|FG001|STARTED|Overall Study||30||
59558632|NCT02931045|75659413|FG000|COMPLETED|Overall Study||27||
59558633|NCT02931045|75659414|FG001|COMPLETED|Overall Study||28||
59558634|NCT02931045|75659413|FG000|NOT COMPLETED|Overall Study||3||
59558635|NCT02931045|75659414|FG001|NOT COMPLETED|Overall Study||2||
59558636|NCT02224820|75659420|FG000|STARTED|Overall Study||8||
59558637|NCT02224820|75659420|FG000|COMPLETED|Overall Study|One patient did not receive full dose|8||
59558638|NCT02224820|75659420|FG000|NOT COMPLETED|Overall Study||0||
59558639|NCT03040011|75659427|FG000|STARTED|Received Randomized Study Intervention||25||
59558640|NCT03040011|75659428|FG001|STARTED|Received Randomized Study Intervention||25||
59558641|NCT03040011|75659429|FG002|STARTED|Received Randomized Study Intervention||25||
59558642|NCT03040011|75659427|FG000|COMPLETED|Received Randomized Study Intervention||25||
59558643|NCT03040011|75659428|FG001|COMPLETED|Received Randomized Study Intervention||25||
60085006|NCT00543400|76201089|FG003|STARTED|Overall Study||156||
60085007|NCT00543400|76201086|FG000|COMPLETED|Overall Study||146||
60085008|NCT00543400|76201087|FG001|COMPLETED|Overall Study||43||
60085009|NCT00543400|76201088|FG002|COMPLETED|Overall Study||148||
60085010|NCT00543400|76201089|FG003|COMPLETED|Overall Study||151||
60085011|NCT00543400|76201086|FG000|NOT COMPLETED|Overall Study||5||
60085012|NCT00543400|76201087|FG001|NOT COMPLETED|Overall Study||1||
59558644|NCT03040011|75659429|FG002|COMPLETED|Received Randomized Study Intervention||25||
59558645|NCT03040011|75659427|FG000|NOT COMPLETED|Received Randomized Study Intervention||0||
59558646|NCT03040011|75659428|FG001|NOT COMPLETED|Received Randomized Study Intervention||0||
59558647|NCT03040011|75659429|FG002|NOT COMPLETED|Received Randomized Study Intervention||0||
59558648|NCT03040011|75659427|FG000|STARTED|Primary Outcome Follow Up||25||
59558649|NCT03040011|75659428|FG001|STARTED|Primary Outcome Follow Up||25||
59558650|NCT03040011|75659429|FG002|STARTED|Primary Outcome Follow Up||25||
59558651|NCT03040011|75659427|FG000|COMPLETED|Primary Outcome Follow Up|Postoperative day one pain score not available for four patients|21|Outcome data are provided for all patients who underwent study intervention by intention to treat.|
59558652|NCT03040011|75659428|FG001|COMPLETED|Primary Outcome Follow Up|Postoperative day one pain score not available for one patient|24|Outcome data are provided for all patients who underwent study intervention by intention to treat.|
59558653|NCT03040011|75659429|FG002|COMPLETED|Primary Outcome Follow Up|Postoperative day one pain score not available for one patient|24|Outcome data are provided for all patients who underwent study intervention by intention to treat.|
59558654|NCT03040011|75659427|FG000|NOT COMPLETED|Primary Outcome Follow Up||4||
59558655|NCT03040011|75659428|FG001|NOT COMPLETED|Primary Outcome Follow Up||1||
59558656|NCT03040011|75659429|FG002|NOT COMPLETED|Primary Outcome Follow Up||1||
59558657|NCT02225132|75659437|FG000|STARTED|Overall Study||10||
59558658|NCT02225132|75659437|FG000|COMPLETED|Overall Study||10||
59558659|NCT02225132|75659437|FG000|NOT COMPLETED|Overall Study||0||
59558660|NCT03598166|75659443|FG000|STARTED|Overall Study||178||
59558661|NCT03598166|75659444|FG001|STARTED|Overall Study||181||
59558662|NCT03598166|75659443|FG000|COMPLETED|Overall Study||178||
59558663|NCT03598166|75659444|FG001|COMPLETED|Overall Study||181||
59558664|NCT03598166|75659443|FG000|NOT COMPLETED|Overall Study||0||
59558665|NCT03598166|75659444|FG001|NOT COMPLETED|Overall Study||0||
59558666|NCT02223650|75659459|FG000|STARTED|Overall Study||27||
59558667|NCT02223650|75659460|FG001|STARTED|Overall Study||31||
59558668|NCT02223650|75659459|FG000|COMPLETED|Overall Study||27||
59558669|NCT02223650|75659460|FG001|COMPLETED|Overall Study||31||
59558670|NCT02223650|75659459|FG000|NOT COMPLETED|Overall Study||0||
59558671|NCT02223650|75659460|FG001|NOT COMPLETED|Overall Study||0||
59558672|NCT03040479|75659471|FG000|STARTED|Overall Study||8||
59558673|NCT03040479|75659472|FG001|STARTED|Overall Study||8||
59558674|NCT03040479|75659473|FG002|STARTED|Overall Study||8||
59558675|NCT03040479|75659471|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8||
60085013|NCT00543400|76201088|FG002|NOT COMPLETED|Overall Study||4||
60085014|NCT00543400|76201089|FG003|NOT COMPLETED|Overall Study||5||
60085015|NCT00492544|76201099|FG000|STARTED|Overall Study||100||
60085016|NCT00492544|76201099|FG000|COMPLETED|Overall Study||100||
60085017|NCT00492544|76201099|FG000|NOT COMPLETED|Overall Study||0||
59558676|NCT03040479|75659472|FG001|Received at Least 1 Dose of Study Drug|Overall Study||8||
59558677|NCT03040479|75659473|FG002|Received at Least 1 Dose of Study Drug|Overall Study||8||
59558678|NCT03040479|75659471|FG000|COMPLETED|Overall Study||8||
59558679|NCT03040479|75659472|FG001|COMPLETED|Overall Study||8||
59558680|NCT03040479|75659473|FG002|COMPLETED|Overall Study||8||
59558681|NCT03040479|75659471|FG000|NOT COMPLETED|Overall Study||0||
59558682|NCT03040479|75659472|FG001|NOT COMPLETED|Overall Study||0||
59558683|NCT03040479|75659473|FG002|NOT COMPLETED|Overall Study||0||
59558684|NCT01895855|75659485|FG000|STARTED|Overall Study||95||
59558685|NCT01895855|75659486|FG001|STARTED|Overall Study||102||
60085018|NCT00492622|76201103|FG000|STARTED|Overall Study|all subjects received the immediate release formulation|12||
60085019|NCT00492622|76201103|FG000|COMPLETED|Overall Study||12||
59558686|NCT01895855|75659485|FG000|COMPLETED|Overall Study||95||
59558687|NCT01895855|75659486|FG001|COMPLETED|Overall Study||102||
59558688|NCT01895855|75659485|FG000|NOT COMPLETED|Overall Study||0||
59558689|NCT01895855|75659486|FG001|NOT COMPLETED|Overall Study||0||
59558690|NCT03442400|75659496|FG000|STARTED|Overall Study||5||
59558691|NCT03442400|75659496|FG000|COMPLETED|Overall Study||5||
59558692|NCT03442400|75659496|FG000|NOT COMPLETED|Overall Study||0||
59558693|NCT02872857|75659502|FG000|STARTED|Phase 1||15||
59558694|NCT02872857|75659503|FG001|STARTED|Phase 1||15||
59558695|NCT02872857|75659504|FG002|STARTED|Phase 1||0||
59558696|NCT02872857|75659505|FG003|STARTED|Phase 1||0||
59558697|NCT02872857|75659502|FG000|COMPLETED|Phase 1||15||
59558698|NCT02872857|75659503|FG001|COMPLETED|Phase 1||15||
59558699|NCT02872857|75659504|FG002|COMPLETED|Phase 1||0||
59558700|NCT02872857|75659505|FG003|COMPLETED|Phase 1||0||
59558701|NCT02872857|75659502|FG000|NOT COMPLETED|Phase 1||0||
59558702|NCT02872857|75659503|FG001|NOT COMPLETED|Phase 1||0||
59558703|NCT02872857|75659504|FG002|NOT COMPLETED|Phase 1||0||
59558704|NCT02872857|75659505|FG003|NOT COMPLETED|Phase 1||0||
59558705|NCT02872857|75659502|FG000|STARTED|Phase 2||0||
59558706|NCT02872857|75659503|FG001|STARTED|Phase 2||0||
59558707|NCT02872857|75659504|FG002|STARTED|Phase 2||15||
59558708|NCT02872857|75659505|FG003|STARTED|Phase 2||15||
59558709|NCT02872857|75659502|FG000|COMPLETED|Phase 2||0||
59558710|NCT02872857|75659503|FG001|COMPLETED|Phase 2||0||
59558711|NCT02872857|75659504|FG002|COMPLETED|Phase 2||15||
59558712|NCT02872857|75659505|FG003|COMPLETED|Phase 2||15||
59558713|NCT02872857|75659502|FG000|NOT COMPLETED|Phase 2||0||
59558714|NCT02872857|75659503|FG001|NOT COMPLETED|Phase 2||0||
59558715|NCT02872857|75659504|FG002|NOT COMPLETED|Phase 2||0||
59558716|NCT02872857|75659505|FG003|NOT COMPLETED|Phase 2||0||
59707440|NCT01253291|75826337|FG000|Received Study Drug During BCDL|Overall Study||6||
59707441|NCT01253291|75826338|FG001|Received Study Drug During BCDL|Overall Study||6||
59707442|NCT01253291|75826339|FG002|Received Study Drug During BCDL|Overall Study||4||
59707443|NCT01253291|75826340|FG003|Received Study Drug During BCDL|Overall Study||5||
59707444|NCT01253291|75826341|FG004|Received Study Drug During BCDL|Overall Study||5||
59707445|NCT01253291|75826337|FG000|COMPLETED|Overall Study||2||
59558717|NCT02219282|75659513|FG000|STARTED|Overall Study||33||
59558718|NCT02219282|75659514|FG001|STARTED|Overall Study||33||
59707446|NCT01253291|75826338|FG001|COMPLETED|Overall Study||4||
59707447|NCT01253291|75826339|FG002|COMPLETED|Overall Study||4||
59558719|NCT02219282|75659513|FG000|COMPLETED|Overall Study||32||
59558720|NCT02219282|75659514|FG001|COMPLETED|Overall Study||32||
59558721|NCT02219282|75659513|FG000|NOT COMPLETED|Overall Study||1||
59558722|NCT02219282|75659514|FG001|NOT COMPLETED|Overall Study||1||
59558723|NCT02873481|75659526|FG000|STARTED|Overall Study||15||
59558724|NCT02873481|75659527|FG001|STARTED|Overall Study||17||
59558725|NCT02873481|75659526|FG000|COMPLETED|Overall Study||15||
59558726|NCT02873481|75659527|FG001|COMPLETED|Overall Study||17||
59558727|NCT02873481|75659526|FG000|NOT COMPLETED|Overall Study||0||
59558728|NCT02873481|75659527|FG001|NOT COMPLETED|Overall Study||0||
59558729|NCT02876055|75659536|FG000|STARTED|Overall Study||42||
59558730|NCT02876055|75659537|FG001|STARTED|Overall Study||41||
59558731|NCT02876055|75659538|FG002|STARTED|Overall Study||42||
59558732|NCT02876055|75659536|FG000|COMPLETED|Overall Study||42||
59558733|NCT02876055|75659537|FG001|COMPLETED|Overall Study||41||
59558734|NCT02876055|75659538|FG002|COMPLETED|Overall Study||42||
59558735|NCT02876055|75659536|FG000|NOT COMPLETED|Overall Study||0||
59558736|NCT02876055|75659537|FG001|NOT COMPLETED|Overall Study||0||
59558737|NCT02876055|75659538|FG002|NOT COMPLETED|Overall Study||0||
59558738|NCT01897025|75659548|FG000|STARTED|Overall Study||10||
59558739|NCT01897025|75659549|FG001|STARTED|Overall Study||9||
59558740|NCT01897025|75659548|FG000|COMPLETED|Overall Study||10||
59558741|NCT01897025|75659549|FG001|COMPLETED|Overall Study||9||
59558742|NCT01897025|75659548|FG000|NOT COMPLETED|Overall Study||0||
59558743|NCT01897025|75659549|FG001|NOT COMPLETED|Overall Study||0||
59558744|NCT02934555|75659557|FG000|STARTED|Overall Study||23||
59558745|NCT02934555|75659558|FG001|STARTED|Overall Study||25||
59558746|NCT02934555|75659557|FG000|COMPLETED|Overall Study||21|Endpoint measurements available|
59558747|NCT02934555|75659558|FG001|COMPLETED|Overall Study||22|Endpoint measurements available|
59558748|NCT02934555|75659557|FG000|NOT COMPLETED|Overall Study||2||
59558749|NCT02934555|75659558|FG001|NOT COMPLETED|Overall Study||3||
59558750|NCT02935179|75659566|FG000|STARTED|Overall Study||30||
59558751|NCT02935179|75659567|FG001|STARTED|Overall Study||30||
59558752|NCT02935179|75659566|FG000|COMPLETED|Overall Study||29||
59558753|NCT02935179|75659567|FG001|COMPLETED|Overall Study||29||
59558754|NCT02935179|75659566|FG000|NOT COMPLETED|Overall Study||1||
59558755|NCT02935179|75659567|FG001|NOT COMPLETED|Overall Study||1||
59558756|NCT01898429|75659573|FG000|STARTED|Phase 1||5||
59558757|NCT01898429|75659574|FG001|STARTED|Phase 1||0||
59558758|NCT01898429|75659575|FG002|STARTED|Phase 1||0||
59558759|NCT01898429|75659573|FG000|COMPLETED|Phase 1||5||
59558760|NCT01898429|75659574|FG001|COMPLETED|Phase 1||0||
59558761|NCT01898429|75659575|FG002|COMPLETED|Phase 1||0||
59558762|NCT01898429|75659573|FG000|NOT COMPLETED|Phase 1||0||
59558763|NCT01898429|75659574|FG001|NOT COMPLETED|Phase 1||0||
59558764|NCT01898429|75659575|FG002|NOT COMPLETED|Phase 1||0||
59558765|NCT01898429|75659573|FG000|STARTED|Phase 2||0||
59558766|NCT01898429|75659574|FG001|STARTED|Phase 2||5||
59558767|NCT01898429|75659575|FG002|STARTED|Phase 2||0||
59558768|NCT01898429|75659573|FG000|COMPLETED|Phase 2||0||
59558769|NCT01898429|75659574|FG001|COMPLETED|Phase 2||5||
59558770|NCT01898429|75659575|FG002|COMPLETED|Phase 2||0||
59558771|NCT01898429|75659573|FG000|NOT COMPLETED|Phase 2||0||
59558772|NCT01898429|75659574|FG001|NOT COMPLETED|Phase 2||0||
59558773|NCT01898429|75659575|FG002|NOT COMPLETED|Phase 2||0||
59558774|NCT01898429|75659573|FG000|STARTED|Phase 3||0||
59558775|NCT01898429|75659574|FG001|STARTED|Phase 3||0||
59558776|NCT01898429|75659575|FG002|STARTED|Phase 3||5||
59558777|NCT01898429|75659573|FG000|COMPLETED|Phase 3||0||
59558778|NCT01898429|75659574|FG001|COMPLETED|Phase 3||0||
59558779|NCT01898429|75659575|FG002|COMPLETED|Phase 3||5||
59558780|NCT01898429|75659573|FG000|NOT COMPLETED|Phase 3||0||
59558781|NCT01898429|75659574|FG001|NOT COMPLETED|Phase 3||0||
59558782|NCT01898429|75659575|FG002|NOT COMPLETED|Phase 3||0||
59558783|NCT03188822|75659579|FG000|STARTED|Overall Study||9||
59558784|NCT03188822|75659579|FG000|COMPLETED|Overall Study||2||
59558785|NCT03188822|75659579|FG000|NOT COMPLETED|Overall Study||7||
59558786|NCT01899677|75659585|FG000|STARTED|Overall Study||35||
59558787|NCT01899677|75659586|FG001|STARTED|Overall Study||35||
59558788|NCT01899677|75659585|FG000|COMPLETED|Overall Study||25||
59558789|NCT01899677|75659586|FG001|COMPLETED|Overall Study||28||
59558790|NCT01899677|75659585|FG000|NOT COMPLETED|Overall Study||10||
59558791|NCT01899677|75659586|FG001|NOT COMPLETED|Overall Study||7||
59558792|NCT03044691|75659594|FG000|STARTED|Overall Study||0||
59558793|NCT03044691|75659595|FG001|STARTED|Overall Study||84||
59558794|NCT03044691|75659594|FG000|COMPLETED|Overall Study||0||
59558795|NCT03044691|75659595|FG001|COMPLETED|Overall Study||84||
59558796|NCT03044691|75659594|FG000|NOT COMPLETED|Overall Study||0||
59558797|NCT03044691|75659595|FG001|NOT COMPLETED|Overall Study||0||
59558798|NCT01899911|75659601|FG000|STARTED|Overall Study||12||
59707448|NCT01253291|75826340|FG003|COMPLETED|Overall Study||5||
59558799|NCT01899911|75659601|FG000|COMPLETED|Overall Study||12||
59558800|NCT01899911|75659601|FG000|NOT COMPLETED|Overall Study||0||
59558801|NCT01900067|75659607|FG000|STARTED|Overall Study||134||
59558802|NCT01900067|75659608|FG001|STARTED|Overall Study||137||
59558803|NCT01900067|75659607|FG000|COMPLETED|Overall Study||122||
59558804|NCT01900067|75659608|FG001|COMPLETED|Overall Study||124||
59558805|NCT01900067|75659607|FG000|NOT COMPLETED|Overall Study||12||
59558806|NCT01900067|75659608|FG001|NOT COMPLETED|Overall Study||13||
59558807|NCT01902953|75659614|FG000|STARTED|Overall Study||16||
59558808|NCT01902953|75659614|FG000|COMPLETED|Overall Study||16||
59558809|NCT01902953|75659614|FG000|NOT COMPLETED|Overall Study||0||
59558810|NCT02219438|75659620|FG000|STARTED|Overall Study||13||
59558811|NCT02219438|75659621|FG001|STARTED|Overall Study||11||
59558812|NCT02219438|75659620|FG000|COMPLETED|Overall Study||13||
59558813|NCT02219438|75659621|FG001|COMPLETED|Overall Study||11||
59558814|NCT02219438|75659620|FG000|NOT COMPLETED|Overall Study||0||
59558815|NCT02219438|75659621|FG001|NOT COMPLETED|Overall Study||0||
59558816|NCT03045861|75659633|FG000|STARTED|Part A (Up to 10 Days)||0||
59558817|NCT03045861|75659634|FG001|STARTED|Part A (Up to 10 Days)||0||
59558818|NCT03045861|75659635|FG002|STARTED|Part A (Up to 10 Days)||10||
59558819|NCT03045861|75659636|FG003|STARTED|Part A (Up to 10 Days)||0||
59558820|NCT03045861|75659633|FG000|COMPLETED|Part A (Up to 10 Days)||0||
59558821|NCT03045861|75659634|FG001|COMPLETED|Part A (Up to 10 Days)||0||
59558822|NCT03045861|75659635|FG002|COMPLETED|Part A (Up to 10 Days)||10||
59558823|NCT03045861|75659636|FG003|COMPLETED|Part A (Up to 10 Days)||0||
59558824|NCT03045861|75659633|FG000|NOT COMPLETED|Part A (Up to 10 Days)||0||
59558825|NCT03045861|75659634|FG001|NOT COMPLETED|Part A (Up to 10 Days)||0||
59558826|NCT03045861|75659635|FG002|NOT COMPLETED|Part A (Up to 10 Days)||0||
59558827|NCT03045861|75659636|FG003|NOT COMPLETED|Part A (Up to 10 Days)||0||
59558828|NCT03045861|75659633|FG000|STARTED|Part B (Up to 10 Days)||7||
59558829|NCT03045861|75659634|FG001|STARTED|Part B (Up to 10 Days)||8||
59558830|NCT03045861|75659635|FG002|STARTED|Part B (Up to 10 Days)||0||
59558831|NCT03045861|75659636|FG003|STARTED|Part B (Up to 10 Days)||8||
59558832|NCT03045861|75659633|FG000|COMPLETED|Part B (Up to 10 Days)||7||
59558833|NCT03045861|75659634|FG001|COMPLETED|Part B (Up to 10 Days)||8||
59558834|NCT03045861|75659635|FG002|COMPLETED|Part B (Up to 10 Days)||0||
59558835|NCT03045861|75659636|FG003|COMPLETED|Part B (Up to 10 Days)||8||
59558836|NCT03045861|75659633|FG000|NOT COMPLETED|Part B (Up to 10 Days)||0||
59558837|NCT03045861|75659634|FG001|NOT COMPLETED|Part B (Up to 10 Days)||0||
59558838|NCT03045861|75659635|FG002|NOT COMPLETED|Part B (Up to 10 Days)||0||
59558839|NCT03045861|75659636|FG003|NOT COMPLETED|Part B (Up to 10 Days)||0||
59558840|NCT01903187|75659649|FG000|STARTED|Procedure||2||
59558841|NCT01903187|75659650|FG001|STARTED|Procedure||2||
59558842|NCT01903187|75659649|FG000|COMPLETED|Procedure||2||
59558843|NCT01903187|75659650|FG001|COMPLETED|Procedure||2||
59558844|NCT01903187|75659649|FG000|NOT COMPLETED|Procedure||0||
59558845|NCT01903187|75659650|FG001|NOT COMPLETED|Procedure||0||
59558846|NCT01903187|75659649|FG000|STARTED|1 Month||2||
59558847|NCT01903187|75659650|FG001|STARTED|1 Month||2||
59558848|NCT01903187|75659649|FG000|COMPLETED|1 Month||2||
59558849|NCT01903187|75659650|FG001|COMPLETED|1 Month||2||
59558850|NCT01903187|75659649|FG000|NOT COMPLETED|1 Month||0||
59558851|NCT01903187|75659650|FG001|NOT COMPLETED|1 Month||0||
59558852|NCT01903187|75659649|FG000|STARTED|3 Month||2||
59558853|NCT01903187|75659650|FG001|STARTED|3 Month||0||
59558854|NCT01903187|75659649|FG000|COMPLETED|3 Month||2||
59558855|NCT01903187|75659650|FG001|COMPLETED|3 Month||0||
59558856|NCT01903187|75659649|FG000|NOT COMPLETED|3 Month||0||
59558857|NCT01903187|75659650|FG001|NOT COMPLETED|3 Month||0||
59558858|NCT01903187|75659649|FG000|STARTED|6 Month||2||
59558859|NCT01903187|75659650|FG001|STARTED|6 Month||0||
59558860|NCT01903187|75659649|FG000|COMPLETED|6 Month||2||
59558861|NCT01903187|75659650|FG001|COMPLETED|6 Month||0||
59558862|NCT01903187|75659649|FG000|NOT COMPLETED|6 Month||0||
59558863|NCT01903187|75659650|FG001|NOT COMPLETED|6 Month||0||
59558864|NCT01903187|75659649|FG000|STARTED|12 Month||2||
59558865|NCT01903187|75659650|FG001|STARTED|12 Month||0||
59558866|NCT01903187|75659649|FG000|COMPLETED|12 Month||2||
59558867|NCT01903187|75659650|FG001|COMPLETED|12 Month||0||
59558868|NCT01903187|75659649|FG000|NOT COMPLETED|12 Month||0||
59558869|NCT01903187|75659650|FG001|NOT COMPLETED|12 Month||0||
59558870|NCT01903265|75659659|FG000|STARTED|Overall Study||103||
59558871|NCT01903265|75659660|FG001|STARTED|Overall Study||102||
59558872|NCT01903265|75659659|FG000|COMPLETED|Overall Study||89||
59558873|NCT01903265|75659660|FG001|COMPLETED|Overall Study||85||
59558874|NCT01903265|75659659|FG000|NOT COMPLETED|Overall Study||14||
59558875|NCT01903265|75659660|FG001|NOT COMPLETED|Overall Study||17||
59558876|NCT03049215|75659668|FG000|STARTED|Overall Study||1||
59558877|NCT03049215|75659669|FG001|STARTED|Overall Study||0||
59992044|NCT01976273|76107809|FG000|STARTED|Overall Study||10||
59992045|NCT01976273|76107810|FG001|STARTED|Overall Study||10||
59558878|NCT03049215|75659668|FG000|COMPLETED|Overall Study||1||
59558879|NCT03049215|75659669|FG001|COMPLETED|Overall Study||0||
59558880|NCT03049215|75659668|FG000|NOT COMPLETED|Overall Study||0||
59558881|NCT03049215|75659669|FG001|NOT COMPLETED|Overall Study||0||
59558882|NCT01907321|75659675|FG000|STARTED|Overall Study||14||
59558883|NCT01907321|75659675|FG000|COMPLETED|Overall Study||12||
59558884|NCT01907321|75659675|FG000|NOT COMPLETED|Overall Study||2||
59558885|NCT02940249|75659679|FG000|STARTED|Overall Study||34||
59558886|NCT02940249|75659679|FG000|COMPLETED|Overall Study||30||
59558887|NCT02940249|75659679|FG000|NOT COMPLETED|Overall Study||4||
59558888|NCT02219516|75659693|FG000|STARTED|Overall Study||8||
59558889|NCT02219516|75659694|FG001|STARTED|Overall Study||8||
59558890|NCT02219516|75659695|FG002|STARTED|Overall Study||7||
59558891|NCT02219516|75659696|FG003|STARTED|Overall Study||8||
59558892|NCT02219516|75659693|FG000|COMPLETED|Overall Study||8||
59558893|NCT02219516|75659694|FG001|COMPLETED|Overall Study||8||
59558894|NCT02219516|75659695|FG002|COMPLETED|Overall Study||7||
59558895|NCT02219516|75659696|FG003|COMPLETED|Overall Study||8||
59558896|NCT02219516|75659693|FG000|NOT COMPLETED|Overall Study||0||
59558897|NCT02219516|75659694|FG001|NOT COMPLETED|Overall Study||0||
59558898|NCT02219516|75659695|FG002|NOT COMPLETED|Overall Study||0||
59558899|NCT02219516|75659696|FG003|NOT COMPLETED|Overall Study||0||
59558900|NCT02940327|75659706|FG000|STARTED|Overall Study||24||
59558901|NCT02940327|75659706|FG000|COMPLETED|Overall Study||24||
59558902|NCT02940327|75659706|FG000|NOT COMPLETED|Overall Study||0||
59558903|NCT04976777|75659713|FG000|STARTED|Overall Study||36||
59558904|NCT04976777|75659714|FG001|STARTED|Overall Study||18||
59558905|NCT04976777|75659713|FG000|COMPLETED|Overall Study||35||
59992046|NCT01976273|76107809|FG000|COMPLETED|Overall Study||9||
59992047|NCT01976273|76107810|FG001|COMPLETED|Overall Study||9||
59992048|NCT01976273|76107809|FG000|NOT COMPLETED|Overall Study||1||
59992049|NCT01976273|76107810|FG001|NOT COMPLETED|Overall Study||1||
59992050|NCT02206048|76107816|FG000|STARTED|Overall Study||9||
59992051|NCT02206048|76107816|FG000|COMPLETED|Overall Study||8||
59992052|NCT02206048|76107816|FG000|NOT COMPLETED|Overall Study||1||
59992053|NCT00793169|76107820|FG000|STARTED|Overall Study||19||
59992054|NCT00793169|76107820|FG000|COMPLETED|Overall Study||19||
59992055|NCT00793169|76107820|FG000|NOT COMPLETED|Overall Study||0||
59992056|NCT02205814|76107828|FG000|STARTED|Overall Study||110||
59992057|NCT02205814|76107829|FG001|STARTED|Overall Study||110||
59992058|NCT02205814|76107830|FG002|STARTED|Overall Study||108||
59558906|NCT04976777|75659714|FG001|COMPLETED|Overall Study||18||
59558907|NCT04976777|75659713|FG000|NOT COMPLETED|Overall Study||1||
59558908|NCT04976777|75659714|FG001|NOT COMPLETED|Overall Study||0||
59558909|NCT03049917|75659725|FG000|STARTED|Overall Study||90||
59558910|NCT03049917|75659726|FG001|STARTED|Overall Study||89||
59558911|NCT03049917|75659727|FG002|STARTED|Overall Study||93||
59558912|NCT03049917|75659728|FG003|STARTED|Overall Study||92||
59558913|NCT03049917|75659729|FG004|STARTED|Overall Study||88||
59558914|NCT03049917|75659725|FG000|COMPLETED|Overall Study||31||
59558915|NCT03049917|75659726|FG001|COMPLETED|Overall Study||31||
59558916|NCT03049917|75659727|FG002|COMPLETED|Overall Study||44||
59558917|NCT03049917|75659728|FG003|COMPLETED|Overall Study||51||
59558918|NCT03049917|75659729|FG004|COMPLETED|Overall Study||54||
59558919|NCT03049917|75659725|FG000|NOT COMPLETED|Overall Study||59||
59558920|NCT03049917|75659726|FG001|NOT COMPLETED|Overall Study||58||
59558921|NCT03049917|75659727|FG002|NOT COMPLETED|Overall Study||49||
59558922|NCT03049917|75659728|FG003|NOT COMPLETED|Overall Study||41||
59992059|NCT02205814|76107831|FG003|STARTED|Overall Study||108||
59992060|NCT02205814|76107828|FG000|COMPLETED|Overall Study||108||
59992061|NCT02205814|76107829|FG001|COMPLETED|Overall Study||109||
59992062|NCT02205814|76107830|FG002|COMPLETED|Overall Study||103||
59992063|NCT02205814|76107831|FG003|COMPLETED|Overall Study||104||
59992064|NCT02205814|76107828|FG000|NOT COMPLETED|Overall Study||2||
59992065|NCT02205814|76107829|FG001|NOT COMPLETED|Overall Study||1||
59558923|NCT03049917|75659729|FG004|NOT COMPLETED|Overall Study||34||
59558924|NCT03050541|75659766|FG000|STARTED|Overall Study||28||
59558925|NCT03050541|75659767|FG001|STARTED|Overall Study||28||
59558926|NCT03050541|75659768|FG002|STARTED|Overall Study||28||
59558927|NCT03050541|75659766|FG000|COMPLETED|Overall Study||20||
59558928|NCT03050541|75659767|FG001|COMPLETED|Overall Study||20||
59558929|NCT03050541|75659768|FG002|COMPLETED|Overall Study||20||
59558930|NCT03050541|75659766|FG000|NOT COMPLETED|Overall Study||8||
59558931|NCT03050541|75659767|FG001|NOT COMPLETED|Overall Study||8||
59558932|NCT03050541|75659768|FG002|NOT COMPLETED|Overall Study||8||
59558933|NCT01910831|75659776|FG000|STARTED|Overall Study||20||
59558934|NCT01910831|75659776|FG000|COMPLETED|Overall Study||19||
59558935|NCT01910831|75659776|FG000|NOT COMPLETED|Overall Study||1||
59558936|NCT03050619|75659787|FG000|STARTED|Overall Study||129||
59558937|NCT03050619|75659788|FG001|STARTED|Overall Study||3926||
59558938|NCT03050619|75659789|FG002|STARTED|Overall Study||6416||
59558939|NCT03050619|75659790|FG003|STARTED|Overall Study||14007||
59558940|NCT03050619|75659791|FG004|STARTED|Overall Study||6079||
59558941|NCT03050619|75659792|FG005|STARTED|Overall Study||1351||
59558942|NCT03050619|75659787|FG000|COMPLETED|Overall Study||129||
59558943|NCT03050619|75659788|FG001|COMPLETED|Overall Study||3926||
59558944|NCT03050619|75659789|FG002|COMPLETED|Overall Study||6416||
59558945|NCT03050619|75659790|FG003|COMPLETED|Overall Study||14007||
59558946|NCT03050619|75659791|FG004|COMPLETED|Overall Study||6079||
59558947|NCT03050619|75659792|FG005|COMPLETED|Overall Study||1351||
59558948|NCT03050619|75659787|FG000|NOT COMPLETED|Overall Study||0||
59558949|NCT03050619|75659788|FG001|NOT COMPLETED|Overall Study||0||
59558950|NCT03050619|75659789|FG002|NOT COMPLETED|Overall Study||0||
59558951|NCT03050619|75659790|FG003|NOT COMPLETED|Overall Study||0||
59558952|NCT03050619|75659791|FG004|NOT COMPLETED|Overall Study||0||
59558953|NCT03050619|75659792|FG005|NOT COMPLETED|Overall Study||0||
59558954|NCT01911065|75659808|FG000|STARTED|Overall Study||45||
59558955|NCT01911065|75659809|FG001|STARTED|Overall Study||9||
59558956|NCT01911065|75659808|FG000|COMPLETED|Overall Study||45||
59558957|NCT01911065|75659809|FG001|COMPLETED|Overall Study||9||
59558958|NCT01911065|75659808|FG000|NOT COMPLETED|Overall Study||0||
59558959|NCT01911065|75659809|FG001|NOT COMPLETED|Overall Study||0||
59558960|NCT01911221|75659815|FG000|STARTED|Overall Study||13||
59558961|NCT01911221|75659815|FG000|COMPLETED|Overall Study||13||
59558962|NCT01911221|75659815|FG000|NOT COMPLETED|Overall Study||0||
59558963|NCT03050697|75659819|FG000|STARTED|Overall Study||12||17
59558964|NCT03050697|75659819|FG000|COMPLETED|Overall Study||12||17
59558965|NCT03050697|75659819|FG000|NOT COMPLETED|Overall Study||0||0
59558966|NCT01911689|75659837|FG000|STARTED|Overall Study||117||
59558967|NCT01911689|75659838|FG001|STARTED|Overall Study||51||
59558968|NCT01911689|75659837|FG000|COMPLETED|Overall Study||117||
59558969|NCT01911689|75659838|FG001|COMPLETED|Overall Study||51||
59558970|NCT01911689|75659837|FG000|NOT COMPLETED|Overall Study||0||
59558971|NCT01911689|75659838|FG001|NOT COMPLETED|Overall Study||0||
59558972|NCT03050775|75659853|FG000|STARTED|Overall Study||35||
59558973|NCT03050775|75659854|FG001|STARTED|Overall Study||35||
59558974|NCT03050775|75659853|FG000|COMPLETED|Overall Study||35||
59558975|NCT03050775|75659854|FG001|COMPLETED|Overall Study||35||
59558976|NCT03050775|75659853|FG000|NOT COMPLETED|Overall Study||0||
59558977|NCT03050775|75659854|FG001|NOT COMPLETED|Overall Study||0||
59558978|NCT03051633|75659862|FG000|STARTED|Overall Study||342||
59558979|NCT03051633|75659863|FG001|STARTED|Overall Study||186||
59558980|NCT03051633|75659862|FG000|COMPLETED|Overall Study||249||
59558981|NCT03051633|75659863|FG001|COMPLETED|Overall Study||179||
59558982|NCT03051633|75659862|FG000|NOT COMPLETED|Overall Study||93||
59558983|NCT03051633|75659863|FG001|NOT COMPLETED|Overall Study||7||
59558984|NCT02227316|75659873|FG000|STARTED|Overall Study||4||
59558985|NCT02227316|75659874|FG001|STARTED|Overall Study||4||
59558986|NCT02227316|75659875|FG002|STARTED|Overall Study||16||
59558987|NCT02227316|75659876|FG003|STARTED|Overall Study||16||
59558988|NCT02227316|75659873|FG000|COMPLETED|Overall Study||4||
59558989|NCT02227316|75659874|FG001|COMPLETED|Overall Study||4||
59558990|NCT02227316|75659875|FG002|COMPLETED|Overall Study||16||
59558991|NCT02227316|75659876|FG003|COMPLETED|Overall Study||16||
59558992|NCT02227316|75659873|FG000|NOT COMPLETED|Overall Study||0||
59558993|NCT02227316|75659874|FG001|NOT COMPLETED|Overall Study||0||
59558994|NCT02227316|75659875|FG002|NOT COMPLETED|Overall Study||0||
59558995|NCT02227316|75659876|FG003|NOT COMPLETED|Overall Study||0||
59558996|NCT00555971|75659888|FG000|STARTED|Overall Study||5||
59558997|NCT00555971|75659889|FG001|STARTED|Overall Study||8||
59558998|NCT00555971|75659888|FG000|COMPLETED|Overall Study||4||
59558999|NCT00555971|75659889|FG001|COMPLETED|Overall Study||7||
59559000|NCT00555971|75659888|FG000|NOT COMPLETED|Overall Study||1||
59559001|NCT00555971|75659889|FG001|NOT COMPLETED|Overall Study||1||
59559002|NCT02943213|75659895|FG000|STARTED|Treatment Period 1||20||
59559003|NCT02943213|75659895|FG000|COMPLETED|Treatment Period 1||20||
59559004|NCT02943213|75659895|FG000|NOT COMPLETED|Treatment Period 1||0||
59559005|NCT02943213|75659895|FG000|STARTED|Treatment Period 2||20||
59559006|NCT02943213|75659895|FG000|COMPLETED|Treatment Period 2||20||
59559007|NCT02943213|75659895|FG000|NOT COMPLETED|Treatment Period 2||0||
60085020|NCT00492622|76201103|FG000|NOT COMPLETED|Overall Study||0||
60085021|NCT00494494|76201113|FG000|STARTED|Overall Study||40||
59559008|NCT03052257|75659903|FG000|STARTED|Overall Study||100||
59707449|NCT01253291|75826341|FG004|COMPLETED|Overall Study||3||
59707450|NCT01253291|75826337|FG000|NOT COMPLETED|Overall Study||4||
60085022|NCT00494494|76201114|FG001|STARTED|Overall Study||39||
60085023|NCT00494494|76201113|FG000|COMPLETED|Overall Study||40||
60085024|NCT00494494|76201114|FG001|COMPLETED|Overall Study||39||
60085025|NCT00494494|76201113|FG000|NOT COMPLETED|Overall Study||0||
60085026|NCT00494494|76201114|FG001|NOT COMPLETED|Overall Study||0||
60085027|NCT00494806|76201122|FG000|STARTED|Overall Study||34||
60085028|NCT00494806|76201123|FG001|STARTED|Overall Study||32||
60085029|NCT00494806|76201122|FG000|COMPLETED|Overall Study||34||
60085030|NCT00494806|76201123|FG001|COMPLETED|Overall Study||32||
60085031|NCT00494806|76201122|FG000|NOT COMPLETED|Overall Study||0||
60085032|NCT00494806|76201123|FG001|NOT COMPLETED|Overall Study||0||
60085033|NCT03837496|76201131|FG000|STARTED|Overall Study||50||
60085034|NCT03837496|76201132|FG001|STARTED|Overall Study||50||
60085035|NCT03837496|76201131|FG000|COMPLETED|Overall Study||45||
60085036|NCT03837496|76201132|FG001|COMPLETED|Overall Study||47||
60085037|NCT03837496|76201131|FG000|NOT COMPLETED|Overall Study||5||
60085038|NCT03837496|76201132|FG001|NOT COMPLETED|Overall Study||3||
60085039|NCT00497770|76201142|FG000|STARTED|Overall Study||304||
60085040|NCT00497770|76201143|FG001|STARTED|Overall Study||65||
60085041|NCT00497770|76201144|FG002|STARTED|Overall Study||37||
60085042|NCT00497770|76201145|FG003|STARTED|Overall Study||28||
60085043|NCT00497770|76201142|FG000|COMPLETED|Overall Study||304||
60085044|NCT00497770|76201143|FG001|COMPLETED|Overall Study||65||
59559009|NCT03052257|75659904|FG001|STARTED|Overall Study||100||
59559010|NCT03052257|75659903|FG000|COMPLETED|Overall Study||95||
59559011|NCT03052257|75659904|FG001|COMPLETED|Overall Study||97||
59707451|NCT01253291|75826338|FG001|NOT COMPLETED|Overall Study||2||
59707452|NCT01253291|75826339|FG002|NOT COMPLETED|Overall Study||0||
59707453|NCT01253291|75826340|FG003|NOT COMPLETED|Overall Study||0||
59707454|NCT01253291|75826341|FG004|NOT COMPLETED|Overall Study||2||
59707455|NCT01121757|75826356|FG000|STARTED|First Drug||6||
59816718|NCT04431453|75939084|FG007|NOT COMPLETED|Overall Study||1||
60085045|NCT00497770|76201144|FG002|COMPLETED|Overall Study||37||
60085046|NCT00497770|76201145|FG003|COMPLETED|Overall Study||28||
60085047|NCT00497770|76201142|FG000|NOT COMPLETED|Overall Study||0||
60085048|NCT00497770|76201143|FG001|NOT COMPLETED|Overall Study||0||
60085049|NCT00497770|76201144|FG002|NOT COMPLETED|Overall Study||0||
60085050|NCT00497770|76201145|FG003|NOT COMPLETED|Overall Study||0||
60085051|NCT00498550|76201158|FG000|STARTED|Overall Study||15||
59559012|NCT03052257|75659903|FG000|NOT COMPLETED|Overall Study||5||
59559013|NCT03052257|75659904|FG001|NOT COMPLETED|Overall Study||3||
59559014|NCT03054051|75659912|FG000|STARTED|Overall Study||30||
59559015|NCT03054051|75659913|FG001|STARTED|Overall Study||30||
59559016|NCT03054051|75659912|FG000|COMPLETED|Overall Study||30||
59559017|NCT03054051|75659913|FG001|COMPLETED|Overall Study||30||
59559018|NCT03054051|75659912|FG000|NOT COMPLETED|Overall Study||0||
59559019|NCT03054051|75659913|FG001|NOT COMPLETED|Overall Study||0||
59559020|NCT02944461|75659921|FG000|STARTED|Overall Study||20||
59559021|NCT02944461|75659921|FG000|COMPLETED|Overall Study||15||
59559022|NCT02944461|75659921|FG000|NOT COMPLETED|Overall Study||5||
59559023|NCT02945553|75659927|FG000|STARTED|Overall Study||14||
59559024|NCT02945553|75659928|FG001|STARTED|Overall Study||11||
59559025|NCT02945553|75659927|FG000|COMPLETED|Overall Study|Included in analysis for primary aim.|11||
59559026|NCT02945553|75659928|FG001|COMPLETED|Overall Study|Included in analysis for primary aim.|9||
59559027|NCT02945553|75659927|FG000|NOT COMPLETED|Overall Study||3||
59559028|NCT02945553|75659928|FG001|NOT COMPLETED|Overall Study||2||
59559029|NCT02946021|75659940|FG000|STARTED|Overall Study||6||
59559030|NCT02946021|75659941|FG001|STARTED|Overall Study||5||
59559031|NCT02946021|75659940|FG000|COMPLETED|Overall Study||6||
59559032|NCT02946021|75659941|FG001|COMPLETED|Overall Study||5||
59559033|NCT02946021|75659940|FG000|NOT COMPLETED|Overall Study||0||
59559034|NCT02946021|75659941|FG001|NOT COMPLETED|Overall Study||0||
59559035|NCT03110601|75659947|FG000|STARTED|Conventional SCS Parameters||25||
59559036|NCT03110601|75659947|FG000|COMPLETED|Conventional SCS Parameters||24||
59559037|NCT03110601|75659947|FG000|NOT COMPLETED|Conventional SCS Parameters||1||
59559038|NCT03110601|75659947|FG000|STARTED|Washout Period||24||
59559039|NCT03110601|75659947|FG000|COMPLETED|Washout Period||23||
59559040|NCT03110601|75659947|FG000|NOT COMPLETED|Washout Period||1||
59816719|NCT04382612|75939108|FG000|STARTED|Overall Study||42||
59816720|NCT04382612|75939108|FG000|COMPLETED|Overall Study||41||
59816721|NCT04382612|75939108|FG000|NOT COMPLETED|Overall Study||1||
60085052|NCT00498550|76201159|FG001|STARTED|Overall Study||16||
60085053|NCT00498550|76201158|FG000|COMPLETED|Overall Study|13 of 15 received clozapine all 12 visits, two discontinued clozapine early but remained in study.|15||
60085054|NCT00498550|76201159|FG001|COMPLETED|Overall Study||15||
60085055|NCT00498550|76201158|FG000|NOT COMPLETED|Overall Study||0||
59816722|NCT04200911|75939112|FG000|STARTED|Overall Study||10||
59816723|NCT04200911|75939112|FG000|COMPLETED|Overall Study||10||
59816724|NCT04200911|75939112|FG000|NOT COMPLETED|Overall Study||0||
59816725|NCT04158687|75939120|FG000|STARTED|Overall Study||81||
60085056|NCT00498550|76201159|FG001|NOT COMPLETED|Overall Study||1||
60085057|NCT00498628|76201167|FG000|STARTED|Overall Study||105||
60085058|NCT00498628|76201168|FG001|STARTED|Overall Study||113||
60085059|NCT00498628|76201167|FG000|COMPLETED|Overall Study||90||
60085060|NCT00498628|76201168|FG001|COMPLETED|Overall Study||92||
60085061|NCT00498628|76201167|FG000|NOT COMPLETED|Overall Study||15||
60085062|NCT00498628|76201168|FG001|NOT COMPLETED|Overall Study||21||
60085063|NCT00498706|76201178|FG000|STARTED|Overall Study||163||
60085064|NCT00498706|76201179|FG001|STARTED|Overall Study||162||
60085065|NCT00498706|76201178|FG000|Post Treatment Week 18|Overall Study||163||
60085066|NCT00498706|76201179|FG001|Post Treatment Week 18|Overall Study||162||
60085067|NCT00498706|76201178|FG000|COMPLETED|Overall Study||163||
60085068|NCT00498706|76201179|FG001|COMPLETED|Overall Study||162||
60085069|NCT00498706|76201178|FG000|NOT COMPLETED|Overall Study||0||
60085070|NCT00498706|76201179|FG001|NOT COMPLETED|Overall Study||0||
60085071|NCT01446159|76201191|FG000|STARTED|Overall Study||3||
60085072|NCT01446159|76201192|FG001|STARTED|Overall Study||3||
60085073|NCT01446159|76201193|FG002|STARTED|Overall Study||92||
60085074|NCT01446159|76201194|FG003|STARTED|Overall Study||85||
60085075|NCT01446159|76201191|FG000|COMPLETED|Overall Study||0||
60085076|NCT01446159|76201192|FG001|COMPLETED|Overall Study||0||
60085077|NCT01446159|76201193|FG002|COMPLETED|Overall Study||21||
60085078|NCT01446159|76201194|FG003|COMPLETED|Overall Study||23||
60085079|NCT01446159|76201191|FG000|NOT COMPLETED|Overall Study||3||
60085080|NCT01446159|76201192|FG001|NOT COMPLETED|Overall Study||3||
60085081|NCT01446159|76201193|FG002|NOT COMPLETED|Overall Study||71||
59816726|NCT04158687|75939121|FG001|STARTED|Overall Study||81||
59816727|NCT04158687|75939122|FG002|STARTED|Overall Study||85||
59816728|NCT04158687|75939123|FG003|STARTED|Overall Study||79||
60085082|NCT01446159|76201194|FG003|NOT COMPLETED|Overall Study||62||
60085083|NCT00498940|76201208|FG000|STARTED|Overall Study||30||
60085084|NCT00498940|76201209|FG001|STARTED|Overall Study||31||
59559041|NCT03110601|75659947|FG000|STARTED|Stimgenics SCS Parameters||23||
59559042|NCT03110601|75659947|FG000|COMPLETED|Stimgenics SCS Parameters||20||
59559043|NCT03110601|75659947|FG000|NOT COMPLETED|Stimgenics SCS Parameters||3||
59559044|NCT03111381|75659956|FG000|STARTED|Overall Study||46||
59559045|NCT03111381|75659957|FG001|STARTED|Overall Study||48||
59559046|NCT03111381|75659956|FG000|COMPLETED|Overall Study||46||
59559047|NCT03111381|75659957|FG001|COMPLETED|Overall Study||48||
59559048|NCT03111381|75659956|FG000|NOT COMPLETED|Overall Study||0||
59559049|NCT03111381|75659957|FG001|NOT COMPLETED|Overall Study||0||
59559050|NCT02946489|75659963|FG000|STARTED|Overall Study||8||
59559051|NCT02946489|75659963|FG000|COMPLETED|Overall Study||8||
59559052|NCT02946489|75659963|FG000|NOT COMPLETED|Overall Study||0||
59559053|NCT03059901|75659969|FG000|STARTED|Overall Study||30||
59559054|NCT03059901|75659970|FG001|STARTED|Overall Study||30||
59707456|NCT01121757|75826357|FG001|STARTED|First Drug||3||
60085085|NCT00498940|76201208|FG000|COMPLETED|Overall Study||30||
60085086|NCT00498940|76201209|FG001|COMPLETED|Overall Study||31||
60085087|NCT00498940|76201208|FG000|NOT COMPLETED|Overall Study||0||
60085088|NCT00498940|76201209|FG001|NOT COMPLETED|Overall Study||0||
60085089|NCT00499096|76201217|FG000|STARTED|Overall Study||58||
60085090|NCT00499096|76201218|FG001|STARTED|Overall Study||60||
60085091|NCT00499096|76201217|FG000|COMPLETED|Overall Study||35||
60085092|NCT00499096|76201218|FG001|COMPLETED|Overall Study||40||
60085093|NCT00499096|76201217|FG000|NOT COMPLETED|Overall Study||23||
60085094|NCT00499096|76201218|FG001|NOT COMPLETED|Overall Study||20||
60085095|NCT00499408|76201226|FG000|STARTED|Overall Study||26||
60085096|NCT00499408|76201226|FG000|COMPLETED|Overall Study|Three patients did not have adequate testing to be evaluable for a response.|26||
60085097|NCT00499408|76201226|FG000|NOT COMPLETED|Overall Study||0||
60085098|NCT01446003|76201230|FG000|STARTED|Period 1||16||
60085099|NCT01446003|76201231|FG001|STARTED|Period 1||15||
60085100|NCT01446003|76201230|FG000|COMPLETED|Period 1||14||
60085101|NCT01446003|76201231|FG001|COMPLETED|Period 1||15||
60085102|NCT01446003|76201230|FG000|NOT COMPLETED|Period 1||2||
60085103|NCT01446003|76201231|FG001|NOT COMPLETED|Period 1||0||
59559055|NCT03059901|75659969|FG000|COMPLETED|Overall Study||26||
59559056|NCT03059901|75659970|FG001|COMPLETED|Overall Study||28||
59559057|NCT03059901|75659969|FG000|NOT COMPLETED|Overall Study||4||
59707457|NCT01121757|75826356|FG000|COMPLETED|First Drug|Completed a minimum of 4 cycles of Azacitidine.|5||
59992066|NCT02205814|76107830|FG002|NOT COMPLETED|Overall Study||5||
59992067|NCT02205814|76107831|FG003|NOT COMPLETED|Overall Study||4||
59992068|NCT02662985|76107843|FG000|STARTED|Treatment Period 1||83||
59992069|NCT02662985|76107844|FG001|STARTED|Treatment Period 1||83||
59992070|NCT02662985|76107843|FG000|COMPLETED|Treatment Period 1||82||
59992071|NCT02662985|76107844|FG001|COMPLETED|Treatment Period 1||79||
59992072|NCT02662985|76107843|FG000|NOT COMPLETED|Treatment Period 1||1||
59992073|NCT02662985|76107844|FG001|NOT COMPLETED|Treatment Period 1||4||
59992074|NCT02662985|76107843|FG000|STARTED|Treatment Period 2||82||
59992075|NCT02662985|76107844|FG001|STARTED|Treatment Period 2||79||
59992076|NCT02662985|76107843|FG000|COMPLETED|Treatment Period 2||81||
59992077|NCT02662985|76107844|FG001|COMPLETED|Treatment Period 2||78||
59559058|NCT03059901|75659970|FG001|NOT COMPLETED|Overall Study||2||
59559059|NCT02949141|75659976|FG000|STARTED|Overall Study||62||
59559060|NCT02949141|75659976|FG000|COMPLETED|Overall Study||62||
59559061|NCT02949141|75659976|FG000|NOT COMPLETED|Overall Study||0||
59559062|NCT03112473|75659987|FG000|STARTED|Overall Study||30||
59559063|NCT03112473|75659988|FG001|STARTED|Overall Study||30||
59559064|NCT03112473|75659989|FG002|STARTED|Overall Study||30||
59559065|NCT03112473|75659990|FG003|STARTED|Overall Study||30||
59559066|NCT03112473|75659987|FG000|COMPLETED|Overall Study||30||
59559067|NCT03112473|75659988|FG001|COMPLETED|Overall Study||30||
59559068|NCT03112473|75659989|FG002|COMPLETED|Overall Study||30||
59559069|NCT03112473|75659990|FG003|COMPLETED|Overall Study||30||
59559070|NCT03112473|75659987|FG000|NOT COMPLETED|Overall Study||0||
59559071|NCT03112473|75659988|FG001|NOT COMPLETED|Overall Study||0||
59559072|NCT03112473|75659989|FG002|NOT COMPLETED|Overall Study||0||
59559073|NCT03112473|75659990|FG003|NOT COMPLETED|Overall Study||0||
59559074|NCT02227706|75660005|FG000|STARTED|Overall Study||20||
59559075|NCT02227706|75660006|FG001|STARTED|Overall Study||20||
59559076|NCT02227706|75660005|FG000|COMPLETED|Overall Study||20||
59559077|NCT02227706|75660006|FG001|COMPLETED|Overall Study||20||
59559078|NCT02227706|75660005|FG000|NOT COMPLETED|Overall Study||0||
59559079|NCT02227706|75660006|FG001|NOT COMPLETED|Overall Study||0||
59559080|NCT03112863|75660014|FG000|STARTED|Overall Study||21||
59559081|NCT03112863|75660015|FG001|STARTED|Overall Study||23||
59559082|NCT03112863|75660014|FG000|COMPLETED|Overall Study||21||
59559083|NCT03112863|75660015|FG001|COMPLETED|Overall Study||23||
59559084|NCT03112863|75660014|FG000|NOT COMPLETED|Overall Study||0||
59559085|NCT03112863|75660015|FG001|NOT COMPLETED|Overall Study||0||
59559086|NCT02228174|75660021|FG000|STARTED|Overall Study||147||
59559087|NCT02228174|75660021|FG000|Full Analysis Population|Overall Study|Subjects who didn't become pregnant or diagnosed with an interfering medical condition at 12-months|143||
59559088|NCT02228174|75660021|FG000|COMPLETED|Overall Study||142||
59559089|NCT02228174|75660021|FG000|NOT COMPLETED|Overall Study||5||
59559090|NCT02950467|75660025|FG000|STARTED|Open-label Treatment||18||
59559091|NCT02950467|75660025|FG000|COMPLETED|Open-label Treatment|1 participant completed study period but missed some visits due to an adverse event (AE).|18||
59559092|NCT02950467|75660025|FG000|NOT COMPLETED|Open-label Treatment||0||
59559093|NCT02950467|75660025|FG000|STARTED|3-month Follow-up||18||
59559094|NCT02950467|75660025|FG000|COMPLETED|3-month Follow-up|All participants completed the safety follow-up assessment, but not all completed outcomes measures.|18||
59559095|NCT02950467|75660025|FG000|NOT COMPLETED|3-month Follow-up||0||
59559096|NCT02280317|75660034|FG000|STARTED|Overall Study|Patients receiving at least one dose.|1||
59559097|NCT02280317|75660035|FG001|STARTED|Overall Study|Patients receiving at least one dose.|1||
59559098|NCT02280317|75660036|FG002|STARTED|Overall Study|Patients receiving at least one dose.|3||
59559099|NCT02280317|75660037|FG003|STARTED|Overall Study|Patients receiving at least one dose.|5||
59559100|NCT02280317|75660038|FG004|STARTED|Overall Study|Patients receiving at least one dose.|2||
59559101|NCT02280317|75660034|FG000|COMPLETED|Overall Study|Patients completing six cycles.|1||
59559102|NCT02280317|75660035|FG001|COMPLETED|Overall Study|Patients completing six cycles.|1||
59559103|NCT02280317|75660036|FG002|COMPLETED|Overall Study|Patients completing six cycles.|0||
59559104|NCT02280317|75660037|FG003|COMPLETED|Overall Study|Patients completing six cycles.|2||
59559105|NCT02280317|75660038|FG004|COMPLETED|Overall Study|Patients completing six cycles.|0||
59559106|NCT02280317|75660034|FG000|NOT COMPLETED|Overall Study||0||
59559107|NCT02280317|75660035|FG001|NOT COMPLETED|Overall Study||0||
59559108|NCT02280317|75660036|FG002|NOT COMPLETED|Overall Study||3||
59559109|NCT02280317|75660037|FG003|NOT COMPLETED|Overall Study||3||
59559110|NCT02280317|75660038|FG004|NOT COMPLETED|Overall Study||2||
59559111|NCT01930487|75660061|FG000|STARTED|First Intervention (30 Days)||21||
59559112|NCT01930487|75660062|FG001|STARTED|First Intervention (30 Days)||25||
59559113|NCT01930487|75660061|FG000|COMPLETED|First Intervention (30 Days)||19||
60085104|NCT01446003|76201230|FG000|STARTED|Period 2||14||
60085105|NCT01446003|76201231|FG001|STARTED|Period 2||15||
60085106|NCT01446003|76201230|FG000|COMPLETED|Period 2||13||
60085107|NCT01446003|76201231|FG001|COMPLETED|Period 2||15||
60085108|NCT01446003|76201230|FG000|NOT COMPLETED|Period 2||1||
60085109|NCT01446003|76201231|FG001|NOT COMPLETED|Period 2||0||
60085110|NCT00500578|76201239|FG000|STARTED|Overall Study||18||
60085111|NCT00500578|76201240|FG001|STARTED|Overall Study||32||
60085112|NCT00500578|76201239|FG000|COMPLETED|Overall Study|All completed|18||
60085113|NCT00500578|76201240|FG001|COMPLETED|Overall Study|All completed|32||
60085114|NCT00500578|76201239|FG000|NOT COMPLETED|Overall Study||0||
60085115|NCT00500578|76201240|FG001|NOT COMPLETED|Overall Study||0||
60085116|NCT01430559|76201248|FG000|STARTED|Overall Study||146||
60085117|NCT01430559|76201249|FG001|STARTED|Overall Study||147||
60085118|NCT01430559|76201248|FG000|Treated|Overall Study||143||
60085119|NCT01430559|76201249|FG001|Treated|Overall Study||144||
60085120|NCT01430559|76201248|FG000|COMPLETED|Overall Study||126||
60085121|NCT01430559|76201249|FG001|COMPLETED|Overall Study||135||
60085122|NCT01430559|76201248|FG000|NOT COMPLETED|Overall Study||20||
59559114|NCT01930487|75660062|FG001|COMPLETED|First Intervention (30 Days)||23||
59559115|NCT01930487|75660061|FG000|NOT COMPLETED|First Intervention (30 Days)||2||
59559116|NCT01930487|75660062|FG001|NOT COMPLETED|First Intervention (30 Days)||2||
59559117|NCT01930487|75660061|FG000|STARTED|Washout Period (3 Weeks)||19||
59559118|NCT01930487|75660062|FG001|STARTED|Washout Period (3 Weeks)||23||
59559119|NCT01930487|75660061|FG000|COMPLETED|Washout Period (3 Weeks)||19||
59559120|NCT01930487|75660062|FG001|COMPLETED|Washout Period (3 Weeks)||23||
59559121|NCT01930487|75660061|FG000|NOT COMPLETED|Washout Period (3 Weeks)||0||
59559122|NCT01930487|75660062|FG001|NOT COMPLETED|Washout Period (3 Weeks)||0||
59707458|NCT01121757|75826357|FG001|COMPLETED|First Drug|Completed a minimum of 4 cycles of Lenalidomide|1||
59707459|NCT01121757|75826356|FG000|NOT COMPLETED|First Drug||1||
59707460|NCT01121757|75826357|FG001|NOT COMPLETED|First Drug||2||
60085123|NCT01430559|76201249|FG001|NOT COMPLETED|Overall Study||12||
60085124|NCT01410357|76201262|FG000|STARTED|Overall Study||100||
60085125|NCT01410357|76201263|FG001|STARTED|Overall Study||100||
60085126|NCT01410357|76201262|FG000|COMPLETED|Overall Study||74||
60085127|NCT01410357|76201263|FG001|COMPLETED|Overall Study||76||
60085128|NCT01410357|76201262|FG000|NOT COMPLETED|Overall Study||26||
60085129|NCT01410357|76201263|FG001|NOT COMPLETED|Overall Study||24||
60085130|NCT00500656|76201275|FG000|STARTED|Controlled Phase||36||
60085131|NCT00500656|76201276|FG001|STARTED|Controlled Phase||38||
60085132|NCT00500656|76201277|FG002|STARTED|Controlled Phase||3||
60085133|NCT00500656|76201278|FG003|STARTED|Controlled Phase||8||
60085134|NCT00500656|76201275|FG000|COMPLETED|Controlled Phase||26||
60085135|NCT00500656|76201276|FG001|COMPLETED|Controlled Phase||28||
60085136|NCT00500656|76201277|FG002|COMPLETED|Controlled Phase||2||
60085137|NCT00500656|76201278|FG003|COMPLETED|Controlled Phase||0||
60085138|NCT00500656|76201275|FG000|NOT COMPLETED|Controlled Phase||10||
60085139|NCT00500656|76201276|FG001|NOT COMPLETED|Controlled Phase||10||
60085140|NCT00500656|76201277|FG002|NOT COMPLETED|Controlled Phase||1||
60085141|NCT00500656|76201278|FG003|NOT COMPLETED|Controlled Phase||8||
60085142|NCT00500656|76201275|FG000|STARTED|Open Label Extension (OLE) Phase|3 Subjects did not experience an angioedema attack after their first attack in the controlled phase|23||
60085143|NCT00500656|76201276|FG001|STARTED|Open Label Extension (OLE) Phase|7 Subjects did not experience an angioedema attack after their first attack in the controlled phase|21||
60085144|NCT00500656|76201277|FG002|STARTED|Open Label Extension (OLE) Phase||2||
60085145|NCT00500656|76201278|FG003|STARTED|Open Label Extension (OLE) Phase|Subjects did not experience an angioedema attack during the controlled phase|8||
60085146|NCT00500656|76201275|FG000|COMPLETED|Open Label Extension (OLE) Phase||16||
60085147|NCT00500656|76201276|FG001|COMPLETED|Open Label Extension (OLE) Phase||9||
59559123|NCT01930487|75660061|FG000|STARTED|Second Intervention (30 Days)||19||
59559124|NCT01930487|75660062|FG001|STARTED|Second Intervention (30 Days)||23||
59559125|NCT01930487|75660061|FG000|COMPLETED|Second Intervention (30 Days)||19||
59559126|NCT01930487|75660062|FG001|COMPLETED|Second Intervention (30 Days)||23||
59559127|NCT01930487|75660061|FG000|NOT COMPLETED|Second Intervention (30 Days)||0||
59559128|NCT01930487|75660062|FG001|NOT COMPLETED|Second Intervention (30 Days)||0||
59559129|NCT03060759|75660070|FG000|STARTED|Overall Study||20||
59559130|NCT03060759|75660071|FG001|STARTED|Overall Study||15||
59559131|NCT03060759|75660070|FG000|COMPLETED|Overall Study||15||
59559132|NCT03060759|75660071|FG001|COMPLETED|Overall Study||12||
59559133|NCT03060759|75660070|FG000|NOT COMPLETED|Overall Study||5||
59559134|NCT03060759|75660071|FG001|NOT COMPLETED|Overall Study||3||
59559135|NCT03063255|75660079|FG000|STARTED|Overall Study||30||
59559136|NCT03063255|75660080|FG001|STARTED|Overall Study||30||
59559137|NCT03063255|75660079|FG000|COMPLETED|Overall Study||29||
59559138|NCT03063255|75660080|FG001|COMPLETED|Overall Study||30||
59559139|NCT03063255|75660079|FG000|NOT COMPLETED|Overall Study||1||
59559140|NCT03063255|75660080|FG001|NOT COMPLETED|Overall Study||0||
59559141|NCT03065205|75660086|FG000|STARTED|Overall Study||65||
59559142|NCT03065205|75660086|FG000|COMPLETED|Overall Study||53||
59559143|NCT03065205|75660086|FG000|NOT COMPLETED|Overall Study||12||
59559144|NCT01930643|75660093|FG000|STARTED|Overall Study||7||
59559145|NCT01930643|75660094|FG001|STARTED|Overall Study||6||
59559146|NCT01930643|75660093|FG000|COMPLETED|Overall Study||7||
59559147|NCT01930643|75660094|FG001|COMPLETED|Overall Study||6||
60085148|NCT00500656|76201277|FG002|COMPLETED|Open Label Extension (OLE) Phase||1||
60085149|NCT00500656|76201278|FG003|COMPLETED|Open Label Extension (OLE) Phase||6||
60085150|NCT00500656|76201275|FG000|NOT COMPLETED|Open Label Extension (OLE) Phase||7||
60085151|NCT00500656|76201276|FG001|NOT COMPLETED|Open Label Extension (OLE) Phase||12||
60085152|NCT00500656|76201277|FG002|NOT COMPLETED|Open Label Extension (OLE) Phase||1||
60085153|NCT00500656|76201278|FG003|NOT COMPLETED|Open Label Extension (OLE) Phase||2||
60085154|NCT01409811|76201288|FG000|STARTED|Overall Study||9||
60085155|NCT01409811|76201288|FG000|COMPLETED|Overall Study||8||
60085156|NCT01409811|76201288|FG000|NOT COMPLETED|Overall Study||1||
59559148|NCT01930643|75660093|FG000|NOT COMPLETED|Overall Study||0||
59559149|NCT01930643|75660094|FG001|NOT COMPLETED|Overall Study||0||
59559150|NCT03115827|75660100|FG000|STARTED|Overall Study||15||
59559151|NCT03115827|75660100|FG000|COMPLETED|Overall Study||12||
59559152|NCT03115827|75660100|FG000|NOT COMPLETED|Overall Study||3||
59559153|NCT01915823|75660106|FG000|STARTED|Overall Study||173||
59559154|NCT01915823|75660107|FG001|STARTED|Overall Study||175||
59559155|NCT01915823|75660106|FG000|COMPLETED|Overall Study||171||
59559156|NCT01915823|75660107|FG001|COMPLETED|Overall Study||173||
59559157|NCT01915823|75660106|FG000|NOT COMPLETED|Overall Study||2||
59559158|NCT01915823|75660107|FG001|NOT COMPLETED|Overall Study||2||
60085157|NCT01445847|76201294|FG000|STARTED|Overall Study||50||
60085158|NCT01445847|76201295|FG001|STARTED|Overall Study||50||
60085159|NCT01445847|76201294|FG000|COMPLETED|Overall Study||36||
60085160|NCT01445847|76201295|FG001|COMPLETED|Overall Study||36||
59559159|NCT03065283|75660115|FG000|STARTED|Overall Study||50||
59559160|NCT03065283|75660116|FG001|STARTED|Overall Study||25||
59559161|NCT03065283|75660115|FG000|COMPLETED|Overall Study||50|Outcomes were measured at baseline and after intervention. There was no dropoput of sample.|
59559162|NCT03065283|75660116|FG001|COMPLETED|Overall Study||25|Outcomes were measured at baseline and after intervention. There was no dropoput of sample.|
59559163|NCT03065283|75660115|FG000|NOT COMPLETED|Overall Study||0||
59559164|NCT03065283|75660116|FG001|NOT COMPLETED|Overall Study||0||
59559165|NCT03068091|75660122|FG000|STARTED|Overall Study||25||
59559166|NCT03068091|75660122|FG000|COMPLETED|Overall Study||24||
59559167|NCT03068091|75660122|FG000|NOT COMPLETED|Overall Study||1||
59559168|NCT03116841|75660127|FG000|STARTED|Overall Study||3||
59559169|NCT03116841|75660127|FG000|COMPLETED|Overall Study||3||
59559170|NCT03116841|75660127|FG000|NOT COMPLETED|Overall Study||0||
59559171|NCT01916681|75660135|FG000|STARTED|Overall Study||123||
59559172|NCT01916681|75660136|FG001|STARTED|Overall Study||120||
60085161|NCT01445847|76201294|FG000|NOT COMPLETED|Overall Study||14||
60085162|NCT01445847|76201295|FG001|NOT COMPLETED|Overall Study||14||
59559173|NCT01916681|75660137|FG002|STARTED|Overall Study||123||
59559174|NCT01916681|75660138|FG003|STARTED|Overall Study||125||
59559175|NCT01916681|75660135|FG000|COMPLETED|Overall Study||123||
59559176|NCT01916681|75660136|FG001|COMPLETED|Overall Study||120||
59559177|NCT01916681|75660137|FG002|COMPLETED|Overall Study||123||
59559178|NCT01916681|75660138|FG003|COMPLETED|Overall Study||125||
59559179|NCT01916681|75660135|FG000|NOT COMPLETED|Overall Study||0||
59559180|NCT01916681|75660136|FG001|NOT COMPLETED|Overall Study||0||
59559181|NCT01916681|75660137|FG002|NOT COMPLETED|Overall Study||0||
59559182|NCT01916681|75660138|FG003|NOT COMPLETED|Overall Study||0||
60085163|NCT00501592|76201304|FG000|STARTED|Overall Study||20||
60085164|NCT00501592|76201305|FG001|STARTED|Overall Study||21||
60085165|NCT00501592|76201306|FG002|STARTED|Overall Study||23||
60085166|NCT00501592|76201304|FG000|COMPLETED|Overall Study||20||
60085167|NCT00501592|76201305|FG001|COMPLETED|Overall Study||16||
60085168|NCT00501592|76201306|FG002|COMPLETED|Overall Study||20||
60085169|NCT00501592|76201304|FG000|NOT COMPLETED|Overall Study||0||
60085170|NCT00501592|76201305|FG001|NOT COMPLETED|Overall Study||5||
60085171|NCT00501592|76201306|FG002|NOT COMPLETED|Overall Study||3||
60085172|NCT01445769|76201314|FG000|STARTED|Overall Study||45||
60085173|NCT01445769|76201314|FG000|COMPLETED|Overall Study||37||
60085174|NCT01445769|76201314|FG000|NOT COMPLETED|Overall Study||8||
60085175|NCT00502216|76201322|FG000|STARTED|Overall Study||21||
60085176|NCT00502216|76201323|FG001|STARTED|Overall Study||19||
60085177|NCT00502216|76201322|FG000|COMPLETED|Overall Study||21||
59559183|NCT01917773|75660149|FG000|STARTED|Overall Study||13||
59559184|NCT01917773|75660149|FG000|COMPLETED|Overall Study||13||
59559185|NCT01917773|75660149|FG000|NOT COMPLETED|Overall Study||0||
60085178|NCT00502216|76201323|FG001|COMPLETED|Overall Study||19||
60085179|NCT00502216|76201322|FG000|NOT COMPLETED|Overall Study||0||
60085180|NCT00502216|76201323|FG001|NOT COMPLETED|Overall Study||0||
60085181|NCT00545662|76201331|FG000|STARTED|Overall Study||606||
60085182|NCT00545662|76201332|FG001|STARTED|Overall Study||607||
60085183|NCT00545662|76201331|FG000|COMPLETED|Overall Study||521||
60085184|NCT00545662|76201332|FG001|COMPLETED|Overall Study||528||
60085185|NCT00545662|76201331|FG000|NOT COMPLETED|Overall Study||85||
60085186|NCT00545662|76201332|FG001|NOT COMPLETED|Overall Study||79||
60085187|NCT00545974|76201340|FG000|STARTED|Overall Study|subjects randomized to memantine cohort|39||
60085188|NCT00545974|76201341|FG001|STARTED|Overall Study|subjects randomized to placebo cohort|42||
60085189|NCT00545974|76201340|FG000|COMPLETED|Overall Study|subjects completed 26 weeks treatment in memantine cohort|37||
60085190|NCT00545974|76201341|FG001|COMPLETED|Overall Study|subjects completed 26 weeks treatment in placebo cohort|39||
60085191|NCT00545974|76201340|FG000|NOT COMPLETED|Overall Study||2||
60085192|NCT00545974|76201341|FG001|NOT COMPLETED|Overall Study||3||
60085193|NCT00507208|76201349|FG000|STARTED|Overall Study||27||
60085194|NCT00507208|76201350|FG001|STARTED|Overall Study||26||
60085195|NCT00507208|76201349|FG000|Received Dynasplint in Crossover|Overall Study||0||
60085196|NCT00507208|76201350|FG001|Received Dynasplint in Crossover|Overall Study||3||
60085197|NCT00507208|76201349|FG000|COMPLETED|Overall Study||27||
59559186|NCT02283749|75660155|FG000|STARTED|Overall Study||5||
59559187|NCT02283749|75660155|FG000|COMPLETED|Overall Study||5||
59559188|NCT02283749|75660155|FG000|NOT COMPLETED|Overall Study||0||
59559189|NCT01934231|75660159|FG000|STARTED|Overall Study||27||
59559190|NCT01934231|75660159|FG000|COMPLETED|Overall Study||27||
59559191|NCT01934231|75660159|FG000|NOT COMPLETED|Overall Study||0||
60085198|NCT00507208|76201350|FG001|COMPLETED|Overall Study||26||
60085199|NCT00507208|76201349|FG000|NOT COMPLETED|Overall Study||0||
60085200|NCT00507208|76201350|FG001|NOT COMPLETED|Overall Study||0||
60085201|NCT00548470|76201356|FG000|STARTED|Overall Study||14||
60085202|NCT00548470|76201356|FG000|COMPLETED|Overall Study||12||
60085203|NCT00548470|76201356|FG000|NOT COMPLETED|Overall Study||2||
59559192|NCT01935791|75660163|FG000|STARTED|Period 1||4||
59559193|NCT01935791|75660164|FG001|STARTED|Period 1||4||
59559194|NCT01935791|75660165|FG002|STARTED|Period 1||3||
59559195|NCT01935791|75660166|FG003|STARTED|Period 1||0||
59559196|NCT01935791|75660167|FG004|STARTED|Period 1||0||
59559197|NCT01935791|75660168|FG005|STARTED|Period 1||0||
60085204|NCT00548860|76201362|FG000|STARTED|Overall Study||996||
60085205|NCT00548860|76201363|FG001|STARTED|Overall Study||1022||
59559198|NCT01935791|75660169|FG006|STARTED|Period 1||0||
59559199|NCT01935791|75660170|FG007|STARTED|Period 1||0||
59559200|NCT01935791|75660171|FG008|STARTED|Period 1||0||
59559201|NCT01935791|75660163|FG000|COMPLETED|Period 1||4||
59559202|NCT01935791|75660164|FG001|COMPLETED|Period 1||4||
59559203|NCT01935791|75660165|FG002|COMPLETED|Period 1||3||
59559204|NCT01935791|75660166|FG003|COMPLETED|Period 1||0||
59559205|NCT01935791|75660167|FG004|COMPLETED|Period 1||0||
59559206|NCT01935791|75660168|FG005|COMPLETED|Period 1||0||
60085206|NCT00548860|76201362|FG000|COMPLETED|Overall Study||860||
60085207|NCT00548860|76201363|FG001|COMPLETED|Overall Study||847||
60085208|NCT00548860|76201362|FG000|NOT COMPLETED|Overall Study||136||
60085209|NCT00548860|76201363|FG001|NOT COMPLETED|Overall Study||175||
60085210|NCT00508300|76201371|FG000|STARTED|Overall Study||67||
59559207|NCT01935791|75660169|FG006|COMPLETED|Period 1||0||
59559208|NCT01935791|75660170|FG007|COMPLETED|Period 1||0||
59559209|NCT01935791|75660171|FG008|COMPLETED|Period 1||0||
59559210|NCT01935791|75660163|FG000|NOT COMPLETED|Period 1||0||
59559211|NCT01935791|75660164|FG001|NOT COMPLETED|Period 1||0||
59559212|NCT01935791|75660165|FG002|NOT COMPLETED|Period 1||0||
59559213|NCT01935791|75660166|FG003|NOT COMPLETED|Period 1||0||
59559214|NCT01935791|75660167|FG004|NOT COMPLETED|Period 1||0||
59559215|NCT01935791|75660168|FG005|NOT COMPLETED|Period 1||0||
59559216|NCT01935791|75660169|FG006|NOT COMPLETED|Period 1||0||
59559217|NCT01935791|75660170|FG007|NOT COMPLETED|Period 1||0||
59559218|NCT01935791|75660171|FG008|NOT COMPLETED|Period 1||0||
59559219|NCT01935791|75660163|FG000|STARTED|Period 2||0||
59559220|NCT01935791|75660164|FG001|STARTED|Period 2||0||
59559221|NCT01935791|75660165|FG002|STARTED|Period 2||0||
59559222|NCT01935791|75660166|FG003|STARTED|Period 2||2||
59559223|NCT01935791|75660167|FG004|STARTED|Period 2||3||
59559224|NCT01935791|75660168|FG005|STARTED|Period 2||1||
59559225|NCT01935791|75660169|FG006|STARTED|Period 2||1||
59559226|NCT01935791|75660170|FG007|STARTED|Period 2||3||
59559227|NCT01935791|75660171|FG008|STARTED|Period 2||1||
59559228|NCT01935791|75660163|FG000|COMPLETED|Period 2||0||
59559229|NCT01935791|75660164|FG001|COMPLETED|Period 2||0||
59559230|NCT01935791|75660165|FG002|COMPLETED|Period 2||0||
59559231|NCT01935791|75660166|FG003|COMPLETED|Period 2||2||
59559232|NCT01935791|75660167|FG004|COMPLETED|Period 2||3||
59559233|NCT01935791|75660168|FG005|COMPLETED|Period 2||1||
59559234|NCT01935791|75660169|FG006|COMPLETED|Period 2||1||
59559235|NCT01935791|75660170|FG007|COMPLETED|Period 2||3||
59559236|NCT01935791|75660171|FG008|COMPLETED|Period 2||1||
59559237|NCT01935791|75660163|FG000|NOT COMPLETED|Period 2||0||
59559238|NCT01935791|75660164|FG001|NOT COMPLETED|Period 2||0||
59559239|NCT01935791|75660165|FG002|NOT COMPLETED|Period 2||0||
59559240|NCT01935791|75660166|FG003|NOT COMPLETED|Period 2||0||
59559241|NCT01935791|75660167|FG004|NOT COMPLETED|Period 2||0||
59559242|NCT01935791|75660168|FG005|NOT COMPLETED|Period 2||0||
59816729|NCT04158687|75939120|FG000|Safety Population|Overall Study||81|Safety population included all participants who received at least one dose of study medication.|
59816730|NCT04158687|75939121|FG001|Safety Population|Overall Study||81|Safety population included all participants who received at least one dose of study medication.|
59816731|NCT04158687|75939122|FG002|Safety Population|Overall Study||85|Safety population included all participants who received at least one dose of study medication.|
59992078|NCT02662985|76107843|FG000|NOT COMPLETED|Treatment Period 2||1||
59992079|NCT02662985|76107844|FG001|NOT COMPLETED|Treatment Period 2||1||
59992080|NCT02662985|76107843|FG000|STARTED|Treatment Period 3 (Extension Period)||81||
59992081|NCT02662985|76107844|FG001|STARTED|Treatment Period 3 (Extension Period)||78||
59992082|NCT02662985|76107843|FG000|COMPLETED|Treatment Period 3 (Extension Period)||75||
59992083|NCT02662985|76107844|FG001|COMPLETED|Treatment Period 3 (Extension Period)||69||
59992084|NCT02662985|76107843|FG000|NOT COMPLETED|Treatment Period 3 (Extension Period)||6||
59992085|NCT02662985|76107844|FG001|NOT COMPLETED|Treatment Period 3 (Extension Period)||9||
59992086|NCT01631812|76107850|FG000|STARTED|Overall Study||130||
59992087|NCT01631812|76107850|FG000|COMPLETED|Overall Study||93||
59992088|NCT01631812|76107850|FG000|NOT COMPLETED|Overall Study||37||
59992089|NCT02323295|76107856|FG000|STARTED|Overall Study||2||
59992090|NCT02323295|76107857|FG001|STARTED|Overall Study||10||
59992091|NCT02323295|76107856|FG000|COMPLETED|Overall Study||2||
59992092|NCT02323295|76107857|FG001|COMPLETED|Overall Study||7||
59992093|NCT02323295|76107856|FG000|NOT COMPLETED|Overall Study||0||
59992094|NCT02323295|76107857|FG001|NOT COMPLETED|Overall Study||3||
59992095|NCT02215954|76107866|FG000|STARTED|Overall Study||214||
59992096|NCT02215954|76107867|FG001|STARTED|Overall Study||212||
60085211|NCT00508300|76201372|FG001|STARTED|Overall Study||61||
60085212|NCT00508300|76201371|FG000|COMPLETED|Overall Study||65||
60085213|NCT00508300|76201372|FG001|COMPLETED|Overall Study||57||
60085214|NCT00508300|76201371|FG000|NOT COMPLETED|Overall Study||2||
60085215|NCT00508300|76201372|FG001|NOT COMPLETED|Overall Study||4||
60085216|NCT00509002|76201378|FG000|STARTED|Overall Study||37||
60085217|NCT00509002|76201378|FG000|COMPLETED|Overall Study||37||
60085218|NCT00509002|76201378|FG000|NOT COMPLETED|Overall Study||0||
60085219|NCT00509392|76201384|FG000|STARTED|Overall Study||32||42
60085220|NCT00509392|76201385|FG001|STARTED|Overall Study||33||37
60085221|NCT00509392|76201386|FG002|STARTED|Overall Study||4||8
60085222|NCT00509392|76201384|FG000|COMPLETED|Overall Study||32||42
59559243|NCT01935791|75660169|FG006|NOT COMPLETED|Period 2||0||
59559244|NCT01935791|75660170|FG007|NOT COMPLETED|Period 2||0||
59559245|NCT01935791|75660171|FG008|NOT COMPLETED|Period 2||0||
59559246|NCT01936259|75660187|FG000|STARTED|Overall Study||130||133
59559247|NCT01936259|75660188|FG001|STARTED|Overall Study||131||132
59559248|NCT01936259|75660187|FG000|COMPLETED|Overall Study||118||121
59559249|NCT01936259|75660188|FG001|COMPLETED|Overall Study||111||112
59559250|NCT01936259|75660187|FG000|NOT COMPLETED|Overall Study||12||12
59559251|NCT01936259|75660188|FG001|NOT COMPLETED|Overall Study||20||20
59559252|NCT01937195|75660194|FG000|STARTED|Overall Study||95||
59559253|NCT01937195|75660194|FG000|COMPLETED|Overall Study||95||
59559254|NCT01937195|75660194|FG000|NOT COMPLETED|Overall Study||0||
59559255|NCT03068949|75660202|FG000|STARTED|Overall Study||113||
59559256|NCT03068949|75660203|FG001|STARTED|Overall Study||102||
59559257|NCT03068949|75660204|FG002|STARTED|Overall Study||122||
59559258|NCT03068949|75660205|FG003|STARTED|Overall Study||76||
59559259|NCT03068949|75660202|FG000|COMPLETED|Overall Study||105||
59559260|NCT03068949|75660203|FG001|COMPLETED|Overall Study||90||
59559261|NCT03068949|75660204|FG002|COMPLETED|Overall Study||113||
59559262|NCT03068949|75660205|FG003|COMPLETED|Overall Study||63||
59559263|NCT03068949|75660202|FG000|NOT COMPLETED|Overall Study||8||
59559264|NCT03068949|75660203|FG001|NOT COMPLETED|Overall Study||12||
59559265|NCT03068949|75660204|FG002|NOT COMPLETED|Overall Study||9||
59559266|NCT03068949|75660205|FG003|NOT COMPLETED|Overall Study||13||
59559267|NCT03074409|75660217|FG000|STARTED|Overall Study||41||
59559268|NCT03074409|75660218|FG001|STARTED|Overall Study||42||
59559269|NCT03074409|75660217|FG000|COMPLETED|Overall Study||37||
59559270|NCT03074409|75660218|FG001|COMPLETED|Overall Study||38||
59559271|NCT03074409|75660217|FG000|NOT COMPLETED|Overall Study||4||
59559272|NCT03074409|75660218|FG001|NOT COMPLETED|Overall Study||4||
59559273|NCT02955147|75660224|FG000|STARTED|Overall Study||13||
59559274|NCT02955147|75660224|FG000|COMPLETED|Overall Study||13||
59559275|NCT02955147|75660224|FG000|NOT COMPLETED|Overall Study||0||
59559276|NCT03119025|75660228|FG000|STARTED|Overall Study||10||
59559277|NCT03119025|75660228|FG000|COMPLETED|Overall Study||10||
59559278|NCT03119025|75660228|FG000|NOT COMPLETED|Overall Study||0||
59559279|NCT03119181|75660234|FG000|STARTED|Overall Study||19||
59559280|NCT03119181|75660235|FG001|STARTED|Overall Study||21||
59559281|NCT03119181|75660234|FG000|COMPLETED|Overall Study||19||
59559282|NCT03119181|75660235|FG001|COMPLETED|Overall Study||21||
59559283|NCT03119181|75660234|FG000|NOT COMPLETED|Overall Study||0||
59707461|NCT01121757|75826356|FG000|STARTED|Second Drug|1 subject did not start drug 2 due to disease progression|4||
59707462|NCT01121757|75826357|FG001|STARTED|Second Drug||1||
59707463|NCT01121757|75826356|FG000|COMPLETED|Second Drug||4||
60085223|NCT00509392|76201385|FG001|COMPLETED|Overall Study||33||37
60085224|NCT00509392|76201386|FG002|COMPLETED|Overall Study||4||8
60085225|NCT00509392|76201384|FG000|NOT COMPLETED|Overall Study||0||0
60085226|NCT00509392|76201385|FG001|NOT COMPLETED|Overall Study||0||0
60085227|NCT00509392|76201386|FG002|NOT COMPLETED|Overall Study||0||0
60085228|NCT00550654|76201392|FG000|STARTED|Overall Study||1||
60085229|NCT00550654|76201392|FG000|COMPLETED|Overall Study||1||
60085230|NCT00550654|76201392|FG000|NOT COMPLETED|Overall Study||0||
60085231|NCT01445613|76201396|FG000|STARTED|30-day Follow-up||1200||
60085232|NCT01445613|76201396|FG000|COMPLETED|30-day Follow-up||1165||
60085233|NCT01445613|76201396|FG000|NOT COMPLETED|30-day Follow-up||35||
60085234|NCT01445613|76201396|FG000|STARTED|1-year Follow-up||1165||
60085235|NCT01445613|76201396|FG000|COMPLETED|1-year Follow-up||1088||
60085236|NCT01445613|76201396|FG000|NOT COMPLETED|1-year Follow-up||77||
60085237|NCT00551200|76201406|FG000|STARTED|Overall Study||14||
60085238|NCT00551200|76201406|FG000|COMPLETED|Overall Study||10||
60085239|NCT00551200|76201406|FG000|NOT COMPLETED|Overall Study||4||
60085240|NCT00557284|76201418|FG000|STARTED|Overall Study||9||
60085241|NCT00557284|76201419|FG001|STARTED|Overall Study||11||
60085242|NCT00557284|76201418|FG000|COMPLETED|Overall Study||9||
60085243|NCT00557284|76201419|FG001|COMPLETED|Overall Study||11||
60085244|NCT00557284|76201418|FG000|NOT COMPLETED|Overall Study||0||
59559284|NCT03119181|75660235|FG001|NOT COMPLETED|Overall Study||0||
59559285|NCT03119571|75660243|FG000|STARTED|Overall Study||31||
59559286|NCT03119571|75660244|FG001|STARTED|Overall Study||34||
59559287|NCT03119571|75660243|FG000|COMPLETED|Overall Study||31||
59707464|NCT01121757|75826357|FG001|COMPLETED|Second Drug||1||
59707465|NCT01121757|75826356|FG000|NOT COMPLETED|Second Drug||0||
59707466|NCT01121757|75826357|FG001|NOT COMPLETED|Second Drug||0||
59707467|NCT01121757|75826356|FG000|STARTED|Combination|2 subjects did not start combination drug. 1 elected surgery 1 had a complete response after drug 2.|2||
59707468|NCT01121757|75826357|FG001|STARTED|Combination||1||
60085245|NCT00557284|76201419|FG001|NOT COMPLETED|Overall Study||0||
59559288|NCT03119571|75660244|FG001|COMPLETED|Overall Study||34||
59559289|NCT03119571|75660243|FG000|NOT COMPLETED|Overall Study||0||
59559290|NCT03119571|75660244|FG001|NOT COMPLETED|Overall Study||0||
59559291|NCT01691534|75660257|FG000|STARTED|Overall Study||15||
59559292|NCT01691534|75660258|FG001|STARTED|Overall Study||15||
60085246|NCT00551746|76201427|FG000|STARTED|Overall Study||36||
60085247|NCT00551746|76201428|FG001|STARTED|Overall Study||34||
60085248|NCT00551746|76201427|FG000|COMPLETED|Overall Study||25||
60085249|NCT00551746|76201428|FG001|COMPLETED|Overall Study||26||
60085250|NCT00551746|76201427|FG000|NOT COMPLETED|Overall Study||11||
59559293|NCT01691534|75660259|FG002|STARTED|Overall Study||15||
59559294|NCT01691534|75660260|FG003|STARTED|Overall Study||15||
59559295|NCT01691534|75660261|FG004|STARTED|Overall Study||15||
59559296|NCT01691534|75660262|FG005|STARTED|Overall Study||15||
59559297|NCT01691534|75660263|FG006|STARTED|Overall Study||15||
59559298|NCT01691534|75660257|FG000|COMPLETED|Overall Study||15||
59559299|NCT01691534|75660258|FG001|COMPLETED|Overall Study||14||
59559300|NCT01691534|75660259|FG002|COMPLETED|Overall Study||14||
59559301|NCT01691534|75660260|FG003|COMPLETED|Overall Study||14||
59559302|NCT01691534|75660261|FG004|COMPLETED|Overall Study||15||
59559303|NCT01691534|75660262|FG005|COMPLETED|Overall Study||14||
59559304|NCT01691534|75660263|FG006|COMPLETED|Overall Study||14||
59559305|NCT01691534|75660257|FG000|NOT COMPLETED|Overall Study||0||
59559306|NCT01691534|75660258|FG001|NOT COMPLETED|Overall Study||1||
59559307|NCT01691534|75660259|FG002|NOT COMPLETED|Overall Study||1||
59559308|NCT01691534|75660260|FG003|NOT COMPLETED|Overall Study||1||
59559309|NCT01691534|75660261|FG004|NOT COMPLETED|Overall Study||0||
59559310|NCT01691534|75660262|FG005|NOT COMPLETED|Overall Study||1||
59559311|NCT01691534|75660263|FG006|NOT COMPLETED|Overall Study||1||
59559312|NCT01691690|75660282|FG000|STARTED|Overall Study||125||
59559313|NCT01691690|75660283|FG001|STARTED|Overall Study||125||
59559314|NCT01691690|75660282|FG000|COMPLETED|Overall Study||118||
59559315|NCT01691690|75660283|FG001|COMPLETED|Overall Study||121||
59559316|NCT01691690|75660282|FG000|NOT COMPLETED|Overall Study||7||
59559317|NCT01691690|75660283|FG001|NOT COMPLETED|Overall Study||4||
59559318|NCT01694108|75660294|FG000|STARTED|Overall Study||2129||
59559319|NCT01694108|75660295|FG001|STARTED|Overall Study||2133||
59559320|NCT01694108|75660294|FG000|COMPLETED|Overall Study|100% follow-up|2129||
59559321|NCT01694108|75660295|FG001|COMPLETED|Overall Study|100% follow-up|2133||
59559322|NCT01694108|75660294|FG000|NOT COMPLETED|Overall Study||0||
59559323|NCT01694108|75660295|FG001|NOT COMPLETED|Overall Study||0||
59559324|NCT01694186|75660310|FG000|STARTED|Overall Study|Two investigators each site Investigator 1 unmasked treating and investigator 2 masked follow up.|42||
59559325|NCT01694186|75660311|FG001|STARTED|Overall Study|Two investigators each site Investigator 1 unmasked treating and investigator 2 masked follow up.|87||
59559326|NCT01694186|75660310|FG000|COMPLETED|Overall Study|Two investigators each site Investigator 1 unmasked treating and investigator 2 masked follow up.|36||
59559327|NCT01694186|75660311|FG001|COMPLETED|Overall Study|Two investigators each site Investigator 1 unmasked treating and investigator 2 masked follow up.|80||
59559328|NCT01694186|75660310|FG000|NOT COMPLETED|Overall Study||6||
59559329|NCT01694186|75660311|FG001|NOT COMPLETED|Overall Study||7||
59559330|NCT02283827|75660319|FG000|STARTED|Overall Study||16||
59559331|NCT02283827|75660320|FG001|STARTED|Overall Study||16||
59559332|NCT02283827|75660319|FG000|COMPLETED|Overall Study||15||
59559333|NCT02283827|75660320|FG001|COMPLETED|Overall Study||13||
59559334|NCT02283827|75660319|FG000|NOT COMPLETED|Overall Study||1||
59559335|NCT02283827|75660320|FG001|NOT COMPLETED|Overall Study||3||
59559336|NCT01626092|75660332|FG000|STARTED|Overall Study||3||
59559337|NCT01626092|75660332|FG000|COMPLETED|Overall Study||3||
59559338|NCT01626092|75660332|FG000|NOT COMPLETED|Overall Study||0||
59559339|NCT01694966|75660339|FG000|STARTED|Overall Study||504||
59559340|NCT01694966|75660340|FG001|STARTED|Overall Study||247||
59559341|NCT01694966|75660341|FG002|STARTED|Overall Study||498||
59559342|NCT01694966|75660339|FG000|COMPLETED|Overall Study||470||
59559343|NCT01694966|75660340|FG001|COMPLETED|Overall Study||232||
59559344|NCT01694966|75660341|FG002|COMPLETED|Overall Study||464||
59559345|NCT01694966|75660339|FG000|NOT COMPLETED|Overall Study||34||
59559346|NCT01694966|75660340|FG001|NOT COMPLETED|Overall Study||15||
59559347|NCT01694966|75660341|FG002|NOT COMPLETED|Overall Study||34||
59559348|NCT01937975|75660352|FG000|STARTED|Overall Study||8||
59559349|NCT01937975|75660353|FG001|STARTED|Overall Study||8||
59559350|NCT01937975|75660354|FG002|STARTED|Overall Study||8||
59559351|NCT01937975|75660352|FG000|COMPLETED|Overall Study||8||
59559352|NCT01937975|75660353|FG001|COMPLETED|Overall Study||8||
59559353|NCT01937975|75660354|FG002|COMPLETED|Overall Study||8||
59559354|NCT01937975|75660352|FG000|NOT COMPLETED|Overall Study||0||
59559355|NCT01937975|75660353|FG001|NOT COMPLETED|Overall Study||0||
59559356|NCT01937975|75660354|FG002|NOT COMPLETED|Overall Study||0||
59559357|NCT01628042|75660370|FG000|STARTED|Overall Study||8||
59559358|NCT01628042|75660371|FG001|STARTED|Overall Study||8||
59559359|NCT01628042|75660372|FG002|STARTED|Overall Study||8||
59559360|NCT01628042|75660373|FG003|STARTED|Overall Study||8||
59559361|NCT01628042|75660370|FG000|COMPLETED|Overall Study||8||
59559362|NCT01628042|75660371|FG001|COMPLETED|Overall Study||8||
59559363|NCT01628042|75660372|FG002|COMPLETED|Overall Study||8||
59559364|NCT01628042|75660373|FG003|COMPLETED|Overall Study||8||
59559365|NCT01628042|75660370|FG000|NOT COMPLETED|Overall Study||0||
59559366|NCT01628042|75660371|FG001|NOT COMPLETED|Overall Study||0||
60085251|NCT00551746|76201428|FG001|NOT COMPLETED|Overall Study||8||
60085252|NCT00552448|76201436|FG000|STARTED|Overall Study||20||
60085253|NCT00552448|76201437|FG001|STARTED|Overall Study||16||
60085254|NCT00552448|76201436|FG000|COMPLETED|Overall Study||19||
60085255|NCT00552448|76201437|FG001|COMPLETED|Overall Study||16||
60085256|NCT00552448|76201436|FG000|NOT COMPLETED|Overall Study||1||
60085257|NCT00552448|76201437|FG001|NOT COMPLETED|Overall Study||0||
60085258|NCT00557362|76201447|FG000|STARTED|Overall Study||30||
60085259|NCT00557362|76201448|FG001|STARTED|Overall Study||30||
60085260|NCT00557362|76201449|FG002|STARTED|Overall Study||30||
60085261|NCT00557362|76201450|FG003|STARTED|Overall Study||30||
60085262|NCT00557362|76201447|FG000|COMPLETED|Overall Study||28||
60085263|NCT00557362|76201448|FG001|COMPLETED|Overall Study||28||
60085264|NCT00557362|76201449|FG002|COMPLETED|Overall Study||26||
60085265|NCT00557362|76201450|FG003|COMPLETED|Overall Study||27||
60085266|NCT00557362|76201447|FG000|NOT COMPLETED|Overall Study||2||
60085267|NCT00557362|76201448|FG001|NOT COMPLETED|Overall Study||2||
60085268|NCT00557362|76201449|FG002|NOT COMPLETED|Overall Study||4||
60085269|NCT00557362|76201450|FG003|NOT COMPLETED|Overall Study||3||
60085270|NCT00558844|76201468|FG000|STARTED|Overall Study||15||
60085271|NCT00558844|76201469|FG001|STARTED|Overall Study||7||
60085272|NCT00558844|76201470|FG002|STARTED|Overall Study||7||
60085273|NCT00558844|76201471|FG003|STARTED|Overall Study||5||
60085274|NCT00558844|76201472|FG004|STARTED|Overall Study||7||
60085275|NCT00558844|76201468|FG000|COMPLETED|Overall Study||12|completed follow up off treatment|
60085276|NCT00558844|76201469|FG001|COMPLETED|Overall Study||7|completed follow up off treatment|
60085277|NCT00558844|76201470|FG002|COMPLETED|Overall Study||6|completed follow up off treatment|
60085278|NCT00558844|76201471|FG003|COMPLETED|Overall Study||5|completed follow up off treatment|
60085279|NCT00558844|76201472|FG004|COMPLETED|Overall Study||6|completed follow up off treatment|
60085280|NCT00558844|76201468|FG000|NOT COMPLETED|Overall Study||3||
60085281|NCT00558844|76201469|FG001|NOT COMPLETED|Overall Study||0||
60085282|NCT00558844|76201470|FG002|NOT COMPLETED|Overall Study||1||
60085283|NCT00558844|76201471|FG003|NOT COMPLETED|Overall Study||0||
60085284|NCT00558844|76201472|FG004|NOT COMPLETED|Overall Study||1||
60085285|NCT00512278|76201487|FG000|STARTED|Overall Study||73||
60085286|NCT00512278|76201488|FG001|STARTED|Overall Study||73||
60085287|NCT00512278|76201487|FG000|COMPLETED|Overall Study||45||
60085288|NCT00512278|76201488|FG001|COMPLETED|Overall Study||56||
60085289|NCT00512278|76201487|FG000|NOT COMPLETED|Overall Study||28||
60085290|NCT00512278|76201488|FG001|NOT COMPLETED|Overall Study||17||
60085291|NCT01445535|76201500|FG000|STARTED|Overall Study||3||
60085292|NCT01445535|76201501|FG001|STARTED|Overall Study||3||
60085293|NCT01445535|76201502|FG002|STARTED|Overall Study||3||
60085294|NCT01445535|76201503|FG003|STARTED|Overall Study||6||
60085295|NCT01445535|76201500|FG000|COMPLETED|Overall Study||2||
60085296|NCT01445535|76201501|FG001|COMPLETED|Overall Study||3||
60085297|NCT01445535|76201502|FG002|COMPLETED|Overall Study||2||
60085298|NCT01445535|76201503|FG003|COMPLETED|Overall Study||4||
60085299|NCT01445535|76201500|FG000|NOT COMPLETED|Overall Study||1||
60085300|NCT01445535|76201501|FG001|NOT COMPLETED|Overall Study||0||
60085301|NCT01445535|76201502|FG002|NOT COMPLETED|Overall Study||1||
60085302|NCT01445535|76201503|FG003|NOT COMPLETED|Overall Study||2||
60085303|NCT01445301|76201517|FG000|STARTED|Overall Study||204||
60085304|NCT01445301|76201518|FG001|STARTED|Overall Study||297||
60085305|NCT01445301|76201519|FG002|STARTED|Overall Study||299||
59559367|NCT01628042|75660372|FG002|NOT COMPLETED|Overall Study||0||
59559368|NCT01628042|75660373|FG003|NOT COMPLETED|Overall Study||0||
59559369|NCT01628588|75660383|FG000|STARTED|Overall Study||854||
60085306|NCT01445301|76201517|FG000|COMPLETED|Overall Study||183||
59559370|NCT01628588|75660383|FG000|COMPLETED|Overall Study||838||
59559371|NCT01628588|75660383|FG000|NOT COMPLETED|Overall Study||16||
59559372|NCT03119649|75660392|FG000|STARTED|Overall Study||11||
60085307|NCT01445301|76201518|FG001|COMPLETED|Overall Study||262||
60085308|NCT01445301|76201519|FG002|COMPLETED|Overall Study||290||
60085309|NCT01445301|76201517|FG000|NOT COMPLETED|Overall Study||21||
60085310|NCT01445301|76201518|FG001|NOT COMPLETED|Overall Study||35||
60085311|NCT01445301|76201519|FG002|NOT COMPLETED|Overall Study||9||
60085312|NCT01409031|76201529|FG000|STARTED|Overall Study||1||
60085313|NCT01409031|76201530|FG001|STARTED|Overall Study||2||
60085314|NCT01409031|76201529|FG000|COMPLETED|Overall Study||0||
60085315|NCT01409031|76201530|FG001|COMPLETED|Overall Study||2||
60085316|NCT01409031|76201529|FG000|NOT COMPLETED|Overall Study||1||
60085317|NCT01409031|76201530|FG001|NOT COMPLETED|Overall Study||0||
60085318|NCT01430403|76201539|FG000|STARTED|Overall Study|Intent-to-treat|259||
60085319|NCT01430403|76201540|FG001|STARTED|Overall Study|Intent-to-treat|130||
60085320|NCT01430403|76201541|FG002|STARTED|Overall Study|Intent-to-treat|89||
59559373|NCT03119649|75660393|FG001|STARTED|Overall Study||10||
59707469|NCT01121757|75826356|FG000|COMPLETED|Combination||0||
59992097|NCT02215954|76107868|FG002|STARTED|Overall Study||211||
59992098|NCT02215954|76107866|FG000|Intention-To-Treat (ITT) Analysis Set|Overall Study||214||
59992099|NCT02215954|76107867|FG001|Intention-To-Treat (ITT) Analysis Set|Overall Study||212||
59992100|NCT02215954|76107868|FG002|Intention-To-Treat (ITT) Analysis Set|Overall Study||211||
59992101|NCT02215954|76107866|FG000|Per Protocol (PP) Analysis Set|Overall Study||212||
59992102|NCT02215954|76107867|FG001|Per Protocol (PP) Analysis Set|Overall Study||208||
59992103|NCT02215954|76107868|FG002|Per Protocol (PP) Analysis Set|Overall Study||205||
59992104|NCT02215954|76107866|FG000|Safety Analysis Set|Overall Study||213||
59992105|NCT02215954|76107867|FG001|Safety Analysis Set|Overall Study||211||
59992106|NCT02215954|76107868|FG002|Safety Analysis Set|Overall Study||208||
59992107|NCT02215954|76107866|FG000|COMPLETED|Overall Study||213||
60085321|NCT01430403|76201539|FG000|COMPLETED|Overall Study||242||
60085322|NCT01430403|76201540|FG001|COMPLETED|Overall Study||121||
60085323|NCT01430403|76201541|FG002|COMPLETED|Overall Study||81||
60085324|NCT01430403|76201539|FG000|NOT COMPLETED|Overall Study||17||
60085325|NCT01430403|76201540|FG001|NOT COMPLETED|Overall Study||9||
60085326|NCT01430403|76201541|FG002|NOT COMPLETED|Overall Study||8||
60085327|NCT01429623|76201556|FG000|STARTED|Overall Study|103 allocated, 1 withdrew consent prior to first dose, 4 lacked post baseline data|102||
60085328|NCT01429623|76201557|FG001|STARTED|Overall Study|107 allocated, 4 lacked post baseline data|107||
60085329|NCT01429623|76201556|FG000|Converted to Alzheimer's|Overall Study|14 of 99|14|Upon conversion to Alzheimer's disease, the primary endpoint, subjects removed from study|
60085330|NCT01429623|76201557|FG001|Converted to Alzheimer's|Overall Study|21 of 103|21|Upon conversion to Alzheimer's disease, the primary endpoint, subjects removed from study|
60085331|NCT01429623|76201556|FG000|COMPLETED|Overall Study||51||
60085332|NCT01429623|76201557|FG001|COMPLETED|Overall Study||48||
60085333|NCT01429623|76201556|FG000|NOT COMPLETED|Overall Study||51||
60085334|NCT01429623|76201557|FG001|NOT COMPLETED|Overall Study||59||
60085335|NCT01408641|76201565|FG000|STARTED|Overall Study||1||
60085336|NCT01408641|76201566|FG001|STARTED|Overall Study||0||
59992108|NCT02215954|76107867|FG001|COMPLETED|Overall Study||211||
59992109|NCT02215954|76107868|FG002|COMPLETED|Overall Study||205||
59992110|NCT02215954|76107866|FG000|NOT COMPLETED|Overall Study||1||
60085337|NCT01408641|76201565|FG000|COMPLETED|Overall Study||0||
60085338|NCT01408641|76201566|FG001|COMPLETED|Overall Study||0||
60085339|NCT01408641|76201565|FG000|NOT COMPLETED|Overall Study||1||
60085340|NCT01408641|76201566|FG001|NOT COMPLETED|Overall Study||0||
60085341|NCT01429077|76201574|FG000|STARTED|Overall Study||19||
60085342|NCT01429077|76201575|FG001|STARTED|Overall Study||17||
60085343|NCT01429077|76201574|FG000|Completed 6-week Intervention|Overall Study||19||
60085344|NCT01429077|76201575|FG001|Completed 6-week Intervention|Overall Study||17||
60085345|NCT01429077|76201574|FG000|COMPLETED|Overall Study||19||
60085346|NCT01429077|76201575|FG001|COMPLETED|Overall Study||14||
60085347|NCT01429077|76201574|FG000|NOT COMPLETED|Overall Study||0||
59992111|NCT02215954|76107867|FG001|NOT COMPLETED|Overall Study||1||
59559374|NCT03119649|75660394|FG002|STARTED|Overall Study||10||
59559375|NCT03119649|75660395|FG003|STARTED|Overall Study||14||
59559376|NCT03119649|75660396|FG004|STARTED|Overall Study||14||
59992112|NCT02215954|76107868|FG002|NOT COMPLETED|Overall Study||6||
59992113|NCT01941719|76107879|FG000|STARTED|Overall Study||48||
59992114|NCT01941719|76107880|FG001|STARTED|Overall Study||51||
59992115|NCT01941719|76107879|FG000|Month 1|Overall Study||43||
59992116|NCT01941719|76107880|FG001|Month 1|Overall Study||48||
60085348|NCT01429077|76201575|FG001|NOT COMPLETED|Overall Study||3||
60085349|NCT01428453|76201583|FG000|STARTED|Overall Study||62||
60085350|NCT01428453|76201584|FG001|STARTED|Overall Study||61||
60085351|NCT01428453|76201583|FG000|COMPLETED|Overall Study||56||
60085352|NCT01428453|76201584|FG001|COMPLETED|Overall Study||52||
59559377|NCT03119649|75660392|FG000|COMPLETED|Overall Study||11||
59559378|NCT03119649|75660393|FG001|COMPLETED|Overall Study||10||
59559379|NCT03119649|75660394|FG002|COMPLETED|Overall Study||10||
59559380|NCT03119649|75660395|FG003|COMPLETED|Overall Study||14||
59559381|NCT03119649|75660396|FG004|COMPLETED|Overall Study||14||
59559382|NCT03119649|75660392|FG000|NOT COMPLETED|Overall Study||0||
59559383|NCT03119649|75660393|FG001|NOT COMPLETED|Overall Study||0||
59559384|NCT03119649|75660394|FG002|NOT COMPLETED|Overall Study||0||
59559385|NCT03119649|75660395|FG003|NOT COMPLETED|Overall Study||0||
59559386|NCT03119649|75660396|FG004|NOT COMPLETED|Overall Study||0||
59559387|NCT01695044|75660414|FG000|STARTED|Overall Study||119||
59559388|NCT01695044|75660414|FG000|COMPLETED|Overall Study||17||
59559389|NCT01695044|75660414|FG000|NOT COMPLETED|Overall Study||102||
59559390|NCT03121365|75660424|FG000|STARTED|Baseline||55||
59559391|NCT03121365|75660425|FG001|STARTED|Baseline||49||
59559392|NCT03121365|75660424|FG000|COMPLETED|Baseline||54||
59559393|NCT03121365|75660425|FG001|COMPLETED|Baseline||48||
59559394|NCT03121365|75660424|FG000|NOT COMPLETED|Baseline||1||
59559395|NCT03121365|75660425|FG001|NOT COMPLETED|Baseline||1||
59559396|NCT03121365|75660424|FG000|STARTED|1 Months||54||
59559397|NCT03121365|75660425|FG001|STARTED|1 Months||48||
59559398|NCT03121365|75660424|FG000|COMPLETED|1 Months||52||
59559399|NCT03121365|75660425|FG001|COMPLETED|1 Months||45||
59559400|NCT03121365|75660424|FG000|NOT COMPLETED|1 Months||2||
59559401|NCT03121365|75660425|FG001|NOT COMPLETED|1 Months||3||
59559402|NCT03121365|75660424|FG000|STARTED|4 Months||54||
59559403|NCT03121365|75660425|FG001|STARTED|4 Months||45||
59559404|NCT03121365|75660424|FG000|COMPLETED|4 Months||51||
59559405|NCT03121365|75660425|FG001|COMPLETED|4 Months||44||
59559406|NCT03121365|75660424|FG000|NOT COMPLETED|4 Months||3||
59559407|NCT03121365|75660425|FG001|NOT COMPLETED|4 Months||1||
59559408|NCT03121365|75660424|FG000|STARTED|7 Months||54||
59559409|NCT03121365|75660425|FG001|STARTED|7 Months||45||
59559410|NCT03121365|75660424|FG000|COMPLETED|7 Months||44||
59559411|NCT03121365|75660425|FG001|COMPLETED|7 Months||37||
59559412|NCT03121365|75660424|FG000|NOT COMPLETED|7 Months||10||
59559413|NCT03121365|75660425|FG001|NOT COMPLETED|7 Months||8||
59559414|NCT01695668|75660435|FG000|STARTED|Overall Study||38||
59559415|NCT01695668|75660436|FG001|STARTED|Overall Study||37||
59559416|NCT01695668|75660435|FG000|COMPLETED|Overall Study||23||
59559417|NCT01695668|75660436|FG001|COMPLETED|Overall Study||20||
59559418|NCT01695668|75660435|FG000|NOT COMPLETED|Overall Study||15||
59559419|NCT01695668|75660436|FG001|NOT COMPLETED|Overall Study||17||
60085353|NCT01428453|76201583|FG000|NOT COMPLETED|Overall Study||6||
60085354|NCT01428453|76201584|FG001|NOT COMPLETED|Overall Study||9||
60085355|NCT01408563|76201592|FG000|STARTED|Overall Study||33||
60085356|NCT01408563|76201592|FG000|Received Transplant|Overall Study||31||
60085357|NCT01408563|76201592|FG000|COMPLETED|Overall Study||31||
60085358|NCT01408563|76201592|FG000|NOT COMPLETED|Overall Study||2||
60085359|NCT01442493|76201598|FG000|STARTED|Overall Study||149||
60085360|NCT01442493|76201599|FG001|STARTED|Overall Study||151||
60085361|NCT01442493|76201598|FG000|COMPLETED|Overall Study||146||
60085362|NCT01442493|76201599|FG001|COMPLETED|Overall Study||149||
60085363|NCT01442493|76201598|FG000|NOT COMPLETED|Overall Study||3||
60085364|NCT01442493|76201599|FG001|NOT COMPLETED|Overall Study||2||
60085365|NCT01442181|76201607|FG000|STARTED|Overall Study||14||
60085366|NCT01442181|76201608|FG001|STARTED|Overall Study||11||
60085367|NCT01442181|76201607|FG000|COMPLETED|Overall Study||10||
60085368|NCT01442181|76201608|FG001|COMPLETED|Overall Study||8||
60085369|NCT01442181|76201607|FG000|NOT COMPLETED|Overall Study||4||
60085370|NCT01442181|76201608|FG001|NOT COMPLETED|Overall Study||3||
60085371|NCT01442103|76201615|FG000|STARTED|Overall Study||10||
59559420|NCT01921751|75660445|FG000|STARTED|Overall Study||4||
59559421|NCT01921751|75660446|FG001|STARTED|Overall Study||4||
59559422|NCT01921751|75660447|FG002|STARTED|Overall Study||5||
59559423|NCT01921751|75660445|FG000|COMPLETED|Overall Study|All randomized patients are reported here.|4||
59559424|NCT01921751|75660446|FG001|COMPLETED|Overall Study|All randomized patients are reported here.|4||
59559425|NCT01921751|75660447|FG002|COMPLETED|Overall Study|All randomized patients are reported here.|5||
59559426|NCT01921751|75660445|FG000|NOT COMPLETED|Overall Study||0||
59559427|NCT01921751|75660446|FG001|NOT COMPLETED|Overall Study||0||
59559428|NCT01921751|75660447|FG002|NOT COMPLETED|Overall Study||0||
59559429|NCT02958345|75660458|FG000|STARTED|Overall Study||14||
59559430|NCT02958345|75660459|FG001|STARTED|Overall Study||14||
59559431|NCT02958345|75660458|FG000|COMPLETED|Overall Study||13||
59559432|NCT02958345|75660459|FG001|COMPLETED|Overall Study||13||
59559433|NCT02958345|75660458|FG000|NOT COMPLETED|Overall Study||1||
59559434|NCT02958345|75660459|FG001|NOT COMPLETED|Overall Study||1||
59559435|NCT01629134|75660465|FG000|STARTED|Overall Study||62||
59559436|NCT01629134|75660465|FG000|COMPLETED|Overall Study||62||
59559437|NCT01629134|75660465|FG000|NOT COMPLETED|Overall Study||0||
60085372|NCT01442103|76201615|FG000|COMPLETED|Overall Study||8||
60085373|NCT01442103|76201615|FG000|NOT COMPLETED|Overall Study||2||
59559438|NCT01922219|75660469|FG000|STARTED|Overall Study||37||
60085374|NCT01428219|76201619|FG000|STARTED|Overall Study||25||
60085375|NCT01428219|76201619|FG000|COMPLETED|Overall Study||22||
59559439|NCT01922219|75660469|FG000|COMPLETED|Overall Study||28||
59559440|NCT01922219|75660469|FG000|NOT COMPLETED|Overall Study||9||
59559441|NCT01629290|75660473|FG000|STARTED|Overall Study||15||
59559442|NCT01629290|75660473|FG000|COMPLETED|Overall Study||15||
59559443|NCT01629290|75660473|FG000|NOT COMPLETED|Overall Study||0||
59559444|NCT03076359|75660485|FG000|STARTED|Overall Study||170||
59559445|NCT03076359|75660486|FG001|STARTED|Overall Study||150||
59559446|NCT03076359|75660485|FG000|COMPLETED|Overall Study||170||
59559447|NCT03076359|75660486|FG001|COMPLETED|Overall Study||150||
59559448|NCT03076359|75660485|FG000|NOT COMPLETED|Overall Study||0||
59559449|NCT03076359|75660486|FG001|NOT COMPLETED|Overall Study||0||
59559450|NCT01696760|75660496|FG000|STARTED|Overall Study||9||
59559451|NCT01696760|75660497|FG001|STARTED|Overall Study||3||
59559452|NCT01696760|75660496|FG000|COMPLETED|Overall Study||9||
59559453|NCT01696760|75660497|FG001|COMPLETED|Overall Study||3||
59559454|NCT01696760|75660496|FG000|NOT COMPLETED|Overall Study||0||
59559455|NCT01696760|75660497|FG001|NOT COMPLETED|Overall Study||0||
59559456|NCT01924169|75660503|FG000|STARTED|Overall Study||3||
59559457|NCT01924169|75660503|FG000|COMPLETED|Overall Study||3||
59559458|NCT01924169|75660503|FG000|NOT COMPLETED|Overall Study||0||
59559459|NCT02958969|75660507|FG000|STARTED|Overall Study||50||
59559460|NCT02958969|75660507|FG000|COMPLETED|Overall Study||50||
59559461|NCT02958969|75660507|FG000|NOT COMPLETED|Overall Study||0||
59559462|NCT02238782|75660511|FG000|STARTED|Overall Study||12||
59559463|NCT02238782|75660511|FG000|Subjects Treated|Overall Study||12||
59559464|NCT02238782|75660511|FG000|COMPLETED|Overall Study||12||
59559465|NCT02238782|75660511|FG000|NOT COMPLETED|Overall Study||0||
59559466|NCT01924559|75660515|FG000|STARTED|Overall Study|All 37 participants were scored under the same six scenarios, resulting in 222 observations.|37||
59559467|NCT01924559|75660515|FG000|COMPLETED|Overall Study|The order in which subjects started scenarios (in biohazard gear vs street clothing) was randomized|37||
59559468|NCT01924559|75660515|FG000|NOT COMPLETED|Overall Study||0||
59559469|NCT02959827|75660529|FG000|STARTED|Overall Study||2320||
59559470|NCT02959827|75660529|FG000|COMPLETED|Overall Study||2320||
59559471|NCT02959827|75660529|FG000|NOT COMPLETED|Overall Study||0||
59559472|NCT01630694|75660539|FG000|STARTED|Overall Study||12||
59559473|NCT01630694|75660540|FG001|STARTED|Overall Study||16||
59559474|NCT01630694|75660539|FG000|COMPLETED|Overall Study||12||
59559475|NCT01630694|75660540|FG001|COMPLETED|Overall Study||16||
59559476|NCT01630694|75660539|FG000|NOT COMPLETED|Overall Study||0||
59559477|NCT01630694|75660540|FG001|NOT COMPLETED|Overall Study||0||
59559478|NCT01924871|75660548|FG000|STARTED|Overall Study||31||
59559479|NCT01924871|75660549|FG001|STARTED|Overall Study||31||
59559480|NCT01924871|75660548|FG000|COMPLETED|Overall Study||25||
59559481|NCT01924871|75660549|FG001|COMPLETED|Overall Study||29||
59559482|NCT01924871|75660548|FG000|NOT COMPLETED|Overall Study||6||
59559483|NCT01924871|75660549|FG001|NOT COMPLETED|Overall Study||2||
59559484|NCT03076983|75660557|FG000|STARTED|Overall Study||55||
59559485|NCT03076983|75660558|FG001|STARTED|Overall Study||25||
59559486|NCT03076983|75660557|FG000|COMPLETED|Overall Study||55||
59559487|NCT03076983|75660558|FG001|COMPLETED|Overall Study||25||
59559488|NCT03076983|75660557|FG000|NOT COMPLETED|Overall Study||0||
59559489|NCT03076983|75660558|FG001|NOT COMPLETED|Overall Study||0||
59559490|NCT01698710|75660564|FG000|STARTED|Overall Study||5||
59559491|NCT01698710|75660564|FG000|COMPLETED|Overall Study||5||
59559492|NCT01698710|75660564|FG000|NOT COMPLETED|Overall Study||0||
59559493|NCT01924949|75660568|FG000|STARTED|Overall Study||5||
59559494|NCT01924949|75660568|FG000|COMPLETED|Overall Study||5||
59559495|NCT01924949|75660568|FG000|NOT COMPLETED|Overall Study||0||
59559496|NCT01938989|75660572|FG000|STARTED|Overall Study||77||
59559497|NCT01938989|75660573|FG001|STARTED|Overall Study||77||
59559498|NCT01938989|75660572|FG000|COMPLETED|Overall Study||77||
59559499|NCT01938989|75660573|FG001|COMPLETED|Overall Study||77||
59559500|NCT01938989|75660572|FG000|NOT COMPLETED|Overall Study||0||
59559501|NCT01938989|75660573|FG001|NOT COMPLETED|Overall Study||0||
59559502|NCT02960295|75660579|FG000|STARTED|Overall Study||10||
59559503|NCT02960295|75660579|FG000|COMPLETED|Overall Study||10||
59559504|NCT02960295|75660579|FG000|NOT COMPLETED|Overall Study||0||
59559505|NCT01939145|75660586|FG000|STARTED|Overall Study||49||
59559506|NCT01939145|75660587|FG001|STARTED|Overall Study||51||
59559507|NCT01939145|75660586|FG000|COMPLETED|Overall Study||47||
59559508|NCT01939145|75660587|FG001|COMPLETED|Overall Study||44||
59559509|NCT01939145|75660586|FG000|NOT COMPLETED|Overall Study||2||
59559510|NCT01939145|75660587|FG001|NOT COMPLETED|Overall Study||7||
59559511|NCT01939301|75660595|FG000|STARTED|Overall Study||39||
59559512|NCT01939301|75660596|FG001|STARTED|Overall Study||39||
59559513|NCT01939301|75660595|FG000|COMPLETED|Overall Study||38||
59559514|NCT01939301|75660596|FG001|COMPLETED|Overall Study||38||
59559515|NCT01939301|75660595|FG000|NOT COMPLETED|Overall Study||1||
59559516|NCT01939301|75660596|FG001|NOT COMPLETED|Overall Study||1||
59559517|NCT01941485|75660602|FG000|STARTED|Overall Study||59||
59559518|NCT01941485|75660602|FG000|COMPLETED|Overall Study||59||
59559519|NCT01941485|75660602|FG000|NOT COMPLETED|Overall Study||0||
59559520|NCT03078075|75660626|FG000|STARTED|Overall Study||111||
59559521|NCT03078075|75660627|FG001|STARTED|Overall Study||114||
59559522|NCT03078075|75660628|FG002|STARTED|Overall Study||59||
59559523|NCT03078075|75660629|FG003|STARTED|Overall Study||10||
59559524|NCT03078075|75660630|FG004|STARTED|Overall Study||109||
59559525|NCT03078075|75660626|FG000|COMPLETED|Overall Study||106||
60085376|NCT01428219|76201619|FG000|NOT COMPLETED|Overall Study||3||
60085377|NCT01428063|76201626|FG000|STARTED|Overall Study||99||
60085378|NCT01428063|76201627|FG001|STARTED|Overall Study||122||
60085379|NCT01428063|76201628|FG002|STARTED|Overall Study||6||
60085380|NCT01428063|76201626|FG000|COMPLETED|Overall Study||89||
60085381|NCT01428063|76201627|FG001|COMPLETED|Overall Study||112||
60085382|NCT01428063|76201628|FG002|COMPLETED|Overall Study||5||
60085383|NCT01428063|76201626|FG000|NOT COMPLETED|Overall Study||10||
60085384|NCT01428063|76201627|FG001|NOT COMPLETED|Overall Study||10||
60085385|NCT01428063|76201628|FG002|NOT COMPLETED|Overall Study||1||
60085386|NCT00513292|76201649|FG000|STARTED|Overall Study||138||
60085387|NCT00513292|76201650|FG001|STARTED|Overall Study||142||
60085388|NCT00513292|76201649|FG000|COMPLETED|Overall Study||138||
60085389|NCT00513292|76201650|FG001|COMPLETED|Overall Study||142||
59559526|NCT03078075|75660627|FG001|COMPLETED|Overall Study||103||
59559527|NCT03078075|75660628|FG002|COMPLETED|Overall Study||19||
59559528|NCT03078075|75660629|FG003|COMPLETED|Overall Study||9||
59559529|NCT03078075|75660630|FG004|COMPLETED|Overall Study||78||
59559530|NCT03078075|75660626|FG000|NOT COMPLETED|Overall Study||5||
59559531|NCT03078075|75660627|FG001|NOT COMPLETED|Overall Study||11||
59559532|NCT03078075|75660628|FG002|NOT COMPLETED|Overall Study||40||
59559533|NCT03078075|75660629|FG003|NOT COMPLETED|Overall Study||1||
59559534|NCT03078075|75660630|FG004|NOT COMPLETED|Overall Study||31||
59559535|NCT01926977|75660655|FG000|STARTED|Overall Study||47||
59559536|NCT01926977|75660656|FG001|STARTED|Overall Study||53||
59559537|NCT01926977|75660655|FG000|COMPLETED|Overall Study||47||
59559538|NCT01926977|75660656|FG001|COMPLETED|Overall Study||53||
60085390|NCT00513292|76201649|FG000|NOT COMPLETED|Overall Study||0||
60085391|NCT00513292|76201650|FG001|NOT COMPLETED|Overall Study||0||
59559539|NCT01926977|75660655|FG000|NOT COMPLETED|Overall Study||0||
59559540|NCT01926977|75660656|FG001|NOT COMPLETED|Overall Study||0||
59559541|NCT01928693|75660665|FG000|STARTED|Overall Study||0||
60085392|NCT00513370|76201656|FG000|STARTED|Overall Study||203||
60085393|NCT00513370|76201656|FG000|COMPLETED|Overall Study||179||
59559542|NCT01928693|75660666|FG001|STARTED|Overall Study||1||
59559543|NCT01928693|75660667|FG002|STARTED|Overall Study||1||
59559544|NCT01928693|75660665|FG000|COMPLETED|Overall Study||0||
59707470|NCT01121757|75826357|FG001|COMPLETED|Combination||0||
59707471|NCT01121757|75826356|FG000|NOT COMPLETED|Combination||2||
59707472|NCT01121757|75826357|FG001|NOT COMPLETED|Combination||1||
59707473|NCT01253135|75826365|FG000|STARTED|Original Protocol||15||
59707474|NCT01253135|75826365|FG000|COMPLETED|Original Protocol||0||
59707475|NCT01253135|75826365|FG000|NOT COMPLETED|Original Protocol||15||
59707476|NCT01253135|75826365|FG000|STARTED|Amended Protocol||25||
59707477|NCT01253135|75826365|FG000|COMPLETED|Amended Protocol||24||
59707478|NCT01253135|75826365|FG000|NOT COMPLETED|Amended Protocol||1||
59707479|NCT00993616|75826373|FG000|STARTED|Overall Study||29||
59707480|NCT00993616|75826373|FG000|COMPLETED|Overall Study|Number of eligible and evaluable participants|27||
59707481|NCT00993616|75826373|FG000|NOT COMPLETED|Overall Study||2||
59707482|NCT01120899|75826383|FG000|STARTED|Overall Study||6||
59707483|NCT01120899|75826383|FG000|Month 6|Overall Study||5||
59707484|NCT01120899|75826383|FG000|Month 12|Overall Study||3||
59707485|NCT01120899|75826383|FG000|Month 18|Overall Study||3||
59707486|NCT01120899|75826383|FG000|COMPLETED|Overall Study||3||
59707487|NCT01120899|75826383|FG000|NOT COMPLETED|Overall Study||3||
59707488|NCT01120275|75826387|FG000|STARTED|Overall Study||36||
59707489|NCT01120275|75826387|FG000|Eligible and Treated|Overall Study||32||
59707490|NCT01120275|75826387|FG000|COMPLETED|Overall Study||0||
59707491|NCT01120275|75826387|FG000|NOT COMPLETED|Overall Study||36||
59707492|NCT00991510|75826394|FG000|STARTED|Period I (Days 1-14)||22||
59707493|NCT00991510|75826395|FG001|STARTED|Period I (Days 1-14)||21||
59707494|NCT00991510|75826394|FG000|COMPLETED|Period I (Days 1-14)||21||
59992117|NCT01941719|76107879|FG000|Month 3|Overall Study||38||
59707495|NCT00991510|75826395|FG001|COMPLETED|Period I (Days 1-14)||21||
59707496|NCT00991510|75826394|FG000|NOT COMPLETED|Period I (Days 1-14)||1||
59559545|NCT01928693|75660666|FG001|COMPLETED|Overall Study||1||
59707497|NCT00991510|75826395|FG001|NOT COMPLETED|Period I (Days 1-14)||0||
59707498|NCT00991510|75826394|FG000|STARTED|Period II (Days 15-28)||21||
59707499|NCT00991510|75826395|FG001|STARTED|Period II (Days 15-28)||21||
59707500|NCT00991510|75826394|FG000|COMPLETED|Period II (Days 15-28)||21||
59707501|NCT00991510|75826395|FG001|COMPLETED|Period II (Days 15-28)||21||
59707502|NCT00991510|75826394|FG000|NOT COMPLETED|Period II (Days 15-28)||0||
59707503|NCT00991510|75826395|FG001|NOT COMPLETED|Period II (Days 15-28)||0||
59707504|NCT00991510|75826394|FG000|STARTED|Period III (Days 29-112)||21||
59707505|NCT00991510|75826395|FG001|STARTED|Period III (Days 29-112)||21||
59707506|NCT00991510|75826394|FG000|COMPLETED|Period III (Days 29-112)||20||
59817938|NCT04488770|75940338|FG012|COMPLETED|Part 1-Cohort 2: Period 2 (Up to 5 Days)||0||
59559546|NCT01928693|75660667|FG002|COMPLETED|Overall Study||1||
59559547|NCT01928693|75660665|FG000|NOT COMPLETED|Overall Study||0||
59559548|NCT01928693|75660666|FG001|NOT COMPLETED|Overall Study||0||
59559549|NCT01928693|75660667|FG002|NOT COMPLETED|Overall Study||0||
59559550|NCT01928849|75660677|FG000|STARTED|Overall Study||66||
59559551|NCT01928849|75660678|FG001|STARTED|Overall Study||62||
59559552|NCT01928849|75660677|FG000|COMPLETED|Overall Study||52||
59559553|NCT01928849|75660678|FG001|COMPLETED|Overall Study||55||
59559554|NCT01928849|75660677|FG000|NOT COMPLETED|Overall Study||14||
59559555|NCT01928849|75660678|FG001|NOT COMPLETED|Overall Study||7||
59559556|NCT01631552|75660688|FG000|STARTED|Overall Study||83||
59559557|NCT01631552|75660689|FG001|STARTED|Overall Study||420||
59559558|NCT01631552|75660690|FG002|STARTED|Overall Study||9||
59559559|NCT01631552|75660691|FG003|STARTED|Overall Study||3||
59559560|NCT01631552|75660688|FG000|Enrolled and Treated|Overall Study||81||
59559561|NCT01631552|75660689|FG001|Enrolled and Treated|Overall Study||402||
59559562|NCT01631552|75660690|FG002|Enrolled and Treated|Overall Study||9||
59559563|NCT01631552|75660691|FG003|Enrolled and Treated|Overall Study||3||
59559564|NCT01631552|75660688|FG000|COMPLETED|Overall Study||81||
59559565|NCT01631552|75660689|FG001|COMPLETED|Overall Study||400||
59559566|NCT01631552|75660690|FG002|COMPLETED|Overall Study||9||
59559567|NCT01631552|75660691|FG003|COMPLETED|Overall Study||3||
59559568|NCT01631552|75660688|FG000|NOT COMPLETED|Overall Study||2||
59559569|NCT01631552|75660689|FG001|NOT COMPLETED|Overall Study||20||
59559570|NCT01631552|75660690|FG002|NOT COMPLETED|Overall Study||0||
59559571|NCT01631552|75660691|FG003|NOT COMPLETED|Overall Study||0||
59559572|NCT03081117|75660705|FG000|STARTED|Overall Study||10||
59559573|NCT03081117|75660706|FG001|STARTED|Overall Study||11||
59559574|NCT03081117|75660705|FG000|Primary Outcome 1 (SAE)|Overall Study||10|Participants who received at least 12 weeks of follow-up monitoring to collect serious adverse event (SAE) data.|
59559575|NCT03081117|75660706|FG001|Primary Outcome 1 (SAE)|Overall Study||11|Participants who received at least 12 weeks of follow-up monitoring to collect serious adverse event (SAE) data.|
59559576|NCT03081117|75660705|FG000|Secondary Measures Collected at Week 24|Overall Study||8|Participants with at least secondary measures collected at 24 weeks.|
59559577|NCT03081117|75660706|FG001|Secondary Measures Collected at Week 24|Overall Study||9|Participants with at least secondary measures collected at 24 weeks.|
59559578|NCT03081117|75660705|FG000|Completed (ITT): Primary Outcome 2 (GDS)|Overall Study||7|Participants who completed neurocognitive test measures with valid Global Deficit Score (GDS) at 24 weeks.|
59559579|NCT03081117|75660706|FG001|Completed (ITT): Primary Outcome 2 (GDS)|Overall Study||9|Participants who completed neurocognitive test measures with valid Global Deficit Score (GDS) at 24 weeks.|
60085394|NCT00513370|76201656|FG000|NOT COMPLETED|Overall Study||24||
60085395|NCT00559468|76201664|FG000|STARTED|Overall Study||26||
60085396|NCT00559468|76201665|FG001|STARTED|Overall Study||26||
60085397|NCT00559468|76201664|FG000|Treated|Overall Study||26||
60085398|NCT00559468|76201665|FG001|Treated|Overall Study||25||
60085399|NCT00559468|76201664|FG000|COMPLETED|Overall Study||26||
60085400|NCT00559468|76201665|FG001|COMPLETED|Overall Study||25||
60085401|NCT00559468|76201664|FG000|NOT COMPLETED|Overall Study||0||
59559580|NCT03081117|75660705|FG000|COMPLETED|Overall Study||6|Valid primary outcome measures and compliance with study intervention >66% (16 Weeks).|
59559581|NCT03081117|75660706|FG001|COMPLETED|Overall Study||8|Valid primary outcome measures and compliance with study intervention >66% (16 Weeks).|
59559582|NCT03081117|75660705|FG000|NOT COMPLETED|Overall Study||4||
59559583|NCT03081117|75660706|FG001|NOT COMPLETED|Overall Study||3||
59559584|NCT01929473|75660712|FG000|STARTED|Overall Study|0 day|3830||
59559585|NCT01929473|75660712|FG000|365 Day|Overall Study||3589||
60085402|NCT00559468|76201665|FG001|NOT COMPLETED|Overall Study||1||
60085403|NCT00560560|76201673|FG000|STARTED|Overall Study||85||
60085404|NCT00560560|76201674|FG001|STARTED|Overall Study||83||
60085405|NCT00560560|76201673|FG000|COMPLETED|Overall Study||0||
60085406|NCT00560560|76201674|FG001|COMPLETED|Overall Study||0||
59559586|NCT01929473|75660712|FG000|COMPLETED|Overall Study||3243||
59559587|NCT01929473|75660712|FG000|NOT COMPLETED|Overall Study||587||
59559588|NCT03124797|75660716|FG000|STARTED|Overall Study||18||
59559589|NCT03124797|75660716|FG000|COMPLETED|Overall Study||18||
59559590|NCT03124797|75660716|FG000|NOT COMPLETED|Overall Study||0||
59559591|NCT01944293|75660722|FG000|STARTED|Overall Study||7||
59559592|NCT01944293|75660723|FG001|STARTED|Overall Study||9||
59559593|NCT01944293|75660722|FG000|COMPLETED|Overall Study||7||
59559594|NCT01944293|75660723|FG001|COMPLETED|Overall Study||9||
59559595|NCT01944293|75660722|FG000|NOT COMPLETED|Overall Study||0||
59559596|NCT01944293|75660723|FG001|NOT COMPLETED|Overall Study||0||
59559597|NCT03083379|75660731|FG000|STARTED|Overall Study||15||
59559598|NCT03083379|75660732|FG001|STARTED|Overall Study||15||
59559599|NCT03083379|75660731|FG000|COMPLETED|Overall Study||15||
59559600|NCT03083379|75660732|FG001|COMPLETED|Overall Study||15||
59559601|NCT03083379|75660731|FG000|NOT COMPLETED|Overall Study||0||
59559602|NCT03083379|75660732|FG001|NOT COMPLETED|Overall Study||0||
59559603|NCT01944371|75660741|FG000|STARTED|Overall Study||10||
59559604|NCT01944371|75660742|FG001|STARTED|Overall Study||10||
59559605|NCT01944371|75660743|FG002|STARTED|Overall Study||10||
59559606|NCT01944371|75660741|FG000|COMPLETED|Overall Study||10||
59559607|NCT01944371|75660742|FG001|COMPLETED|Overall Study||10||
59559608|NCT01944371|75660743|FG002|COMPLETED|Overall Study||10||
60085407|NCT00560560|76201673|FG000|NOT COMPLETED|Overall Study||85||
60085408|NCT00560560|76201674|FG001|NOT COMPLETED|Overall Study||83||
60085409|NCT00561418|76201680|FG000|STARTED|Overall Study||23||
60085410|NCT00561418|76201680|FG000|COMPLETED|Overall Study||23||
60085411|NCT00561418|76201680|FG000|NOT COMPLETED|Overall Study||0||
60085412|NCT00514852|76201686|FG000|STARTED|Overall Study||157||
60085413|NCT00514852|76201687|FG001|STARTED|Overall Study||159||
60085414|NCT00514852|76201686|FG000|COMPLETED|Overall Study||152||
60085415|NCT00514852|76201687|FG001|COMPLETED|Overall Study||154||
60085416|NCT00514852|76201686|FG000|NOT COMPLETED|Overall Study||5||
60085417|NCT00514852|76201687|FG001|NOT COMPLETED|Overall Study||5||
60085418|NCT00555880|76201695|FG000|STARTED|Treatment Period 1 (1 Day)||13||
60085419|NCT00555880|76201696|FG001|STARTED|Treatment Period 1 (1 Day)||11||
60085420|NCT00555880|76201695|FG000|COMPLETED|Treatment Period 1 (1 Day)||13||
60085421|NCT00555880|76201696|FG001|COMPLETED|Treatment Period 1 (1 Day)||11||
60085422|NCT00555880|76201695|FG000|NOT COMPLETED|Treatment Period 1 (1 Day)||0||
60085423|NCT00555880|76201696|FG001|NOT COMPLETED|Treatment Period 1 (1 Day)||0||
60085424|NCT00555880|76201695|FG000|STARTED|Washout (1 Day)||13||
60085425|NCT00555880|76201696|FG001|STARTED|Washout (1 Day)||11||
60085426|NCT00555880|76201695|FG000|COMPLETED|Washout (1 Day)||13||
60085427|NCT00555880|76201696|FG001|COMPLETED|Washout (1 Day)||11||
60085428|NCT00555880|76201695|FG000|NOT COMPLETED|Washout (1 Day)||0||
60085429|NCT00555880|76201696|FG001|NOT COMPLETED|Washout (1 Day)||0||
60085430|NCT00555880|76201695|FG000|STARTED|Treatment Period 2 (1 Day)||13||
60085431|NCT00555880|76201696|FG001|STARTED|Treatment Period 2 (1 Day)||11||
60085432|NCT00555880|76201695|FG000|COMPLETED|Treatment Period 2 (1 Day)||13||
60085433|NCT00555880|76201696|FG001|COMPLETED|Treatment Period 2 (1 Day)||11||
60085434|NCT00555880|76201695|FG000|NOT COMPLETED|Treatment Period 2 (1 Day)||0||
60085435|NCT00555880|76201696|FG001|NOT COMPLETED|Treatment Period 2 (1 Day)||0||
60085436|NCT00563290|76201705|FG000|STARTED|Overall Study||3||
60085437|NCT00563290|76201706|FG001|STARTED|Overall Study||4||
59559609|NCT01944371|75660741|FG000|NOT COMPLETED|Overall Study||0||
60085438|NCT00563290|76201705|FG000|COMPLETED|Overall Study||3||
60085439|NCT00563290|76201706|FG001|COMPLETED|Overall Study||4||
60085440|NCT00563290|76201705|FG000|NOT COMPLETED|Overall Study||0||
60085441|NCT00563290|76201706|FG001|NOT COMPLETED|Overall Study||0||
60085442|NCT00556504|76201716|FG000|STARTED|Overall Study||42||
60085443|NCT00556504|76201717|FG001|STARTED|Overall Study||42||
60085444|NCT00556504|76201716|FG000|Intend-to Treat Population|Overall Study||42||
60085445|NCT00556504|76201717|FG001|Intend-to Treat Population|Overall Study||42||
60085446|NCT00556504|76201716|FG000|Safety Population|Overall Study||41||
59559610|NCT01944371|75660742|FG001|NOT COMPLETED|Overall Study||0||
59559611|NCT01944371|75660743|FG002|NOT COMPLETED|Overall Study||0||
59559612|NCT02343120|75660756|FG000|STARTED|Part 1: Dose Escalation||3||
59559613|NCT02343120|75660757|FG001|STARTED|Part 1: Dose Escalation||4||
59559614|NCT02343120|75660758|FG002|STARTED|Part 1: Dose Escalation||5||
59559615|NCT02343120|75660759|FG003|STARTED|Part 1: Dose Escalation||4||
59559616|NCT02343120|75660760|FG004|STARTED|Part 1: Dose Escalation||1||
59559617|NCT02343120|75660756|FG000|COMPLETED|Part 1: Dose Escalation||0||
59559618|NCT02343120|75660757|FG001|COMPLETED|Part 1: Dose Escalation||0||
59559619|NCT02343120|75660758|FG002|COMPLETED|Part 1: Dose Escalation||0||
60085447|NCT00556504|76201717|FG001|Safety Population|Overall Study||42||
60085448|NCT00556504|76201716|FG000|COMPLETED|Overall Study||34||
60085449|NCT00556504|76201717|FG001|COMPLETED|Overall Study||33||
60085450|NCT00556504|76201716|FG000|NOT COMPLETED|Overall Study||8||
60085451|NCT00556504|76201717|FG001|NOT COMPLETED|Overall Study||9||
60085452|NCT02127892|76201727|FG000|STARTED|Overall Study||7||
60085453|NCT02127892|76201728|FG001|STARTED|Overall Study||2||
60085454|NCT02127892|76201729|FG002|STARTED|Overall Study||0||
60085455|NCT02127892|76201730|FG003|STARTED|Overall Study||0||
60085456|NCT02127892|76201727|FG000|COMPLETED|Overall Study||6||
60085457|NCT02127892|76201728|FG001|COMPLETED|Overall Study||1||
60085458|NCT02127892|76201729|FG002|COMPLETED|Overall Study||0||
60085459|NCT02127892|76201730|FG003|COMPLETED|Overall Study||0||
60085460|NCT02127892|76201727|FG000|NOT COMPLETED|Overall Study||1||
60085461|NCT02127892|76201728|FG001|NOT COMPLETED|Overall Study||1||
60085462|NCT02127892|76201729|FG002|NOT COMPLETED|Overall Study||0||
60085463|NCT02127892|76201730|FG003|NOT COMPLETED|Overall Study||0||
60085464|NCT02128828|76201740|FG000|STARTED|Overall Study||20||
60085465|NCT02128828|76201740|FG000|COMPLETED|Overall Study||17||
60085466|NCT02128828|76201740|FG000|NOT COMPLETED|Overall Study||3||
60085467|NCT00520234|76201746|FG000|STARTED|Overall Study||118||
60085468|NCT00520234|76201747|FG001|STARTED|Overall Study||104||
60085469|NCT00520234|76201746|FG000|COMPLETED|Overall Study||117||
60085470|NCT00520234|76201747|FG001|COMPLETED|Overall Study||102||
60085471|NCT00520234|76201746|FG000|NOT COMPLETED|Overall Study||1||
60085472|NCT00520234|76201747|FG001|NOT COMPLETED|Overall Study||2||
60085473|NCT00520468|76201754|FG000|STARTED|Overall Study||14||
60085474|NCT00520468|76201754|FG000|COMPLETED|Overall Study||14||
60085475|NCT00520468|76201754|FG000|NOT COMPLETED|Overall Study||0||
59817939|NCT04488770|75940326|FG000|NOT COMPLETED|Part 1-Cohort 2: Period 2 (Up to 5 Days)||0||
59992118|NCT01941719|76107880|FG001|Month 3|Overall Study||44||
59992119|NCT01941719|76107879|FG000|Month 6|Overall Study||34||
59992120|NCT01941719|76107880|FG001|Month 6|Overall Study||42||
59992121|NCT01941719|76107879|FG000|Month 9|Overall Study||29||
59992122|NCT01941719|76107880|FG001|Month 9|Overall Study||37||
59992123|NCT01941719|76107879|FG000|Month 12|Overall Study||28||
59992124|NCT01941719|76107880|FG001|Month 12|Overall Study||32||
59992125|NCT01941719|76107879|FG000|COMPLETED|Overall Study||28||
59992126|NCT01941719|76107880|FG001|COMPLETED|Overall Study||32||
59992127|NCT01941719|76107879|FG000|NOT COMPLETED|Overall Study||20||
59992128|NCT01941719|76107880|FG001|NOT COMPLETED|Overall Study||19||
59992129|NCT02215252|76107890|FG000|STARTED|Overall Study||44||
59992130|NCT02215252|76107891|FG001|STARTED|Overall Study||46||
59992131|NCT02215252|76107892|FG002|STARTED|Overall Study||45||
59992132|NCT02215252|76107890|FG000|COMPLETED|Overall Study||42||
59992133|NCT02215252|76107891|FG001|COMPLETED|Overall Study||38||
59992134|NCT02215252|76107892|FG002|COMPLETED|Overall Study||41||
59992135|NCT02215252|76107890|FG000|NOT COMPLETED|Overall Study||2||
59992136|NCT02215252|76107891|FG001|NOT COMPLETED|Overall Study||8||
59992137|NCT02215252|76107892|FG002|NOT COMPLETED|Overall Study||4||
59992138|NCT04630093|76107900|FG000|STARTED|Overall Study||100||
59992139|NCT04630093|76107900|FG000|COMPLETED|Overall Study||99||
59992140|NCT04630093|76107900|FG000|NOT COMPLETED|Overall Study||1||
59992141|NCT02204410|76107904|FG000|STARTED|Overall Study||21||
59992142|NCT02204410|76107904|FG000|COMPLETED|Overall Study||10||
59992143|NCT02204410|76107904|FG000|NOT COMPLETED|Overall Study||11||
59992144|NCT02250274|76107910|FG000|STARTED|Overall Study||85||
59992145|NCT02250274|76107911|FG001|STARTED|Overall Study||46||
59992146|NCT02250274|76107910|FG000|COMPLETED|Overall Study||78||
59992147|NCT02250274|76107911|FG001|COMPLETED|Overall Study||40||
59992148|NCT02250274|76107910|FG000|NOT COMPLETED|Overall Study||7||
59992149|NCT02250274|76107911|FG001|NOT COMPLETED|Overall Study||6||
59992150|NCT02213458|76107925|FG000|STARTED|Overall Study||1024||
59992151|NCT02213458|76107926|FG001|STARTED|Overall Study||536||
59992152|NCT02213458|76107925|FG000|COMPLETED|Overall Study||970||
59992153|NCT02213458|76107926|FG001|COMPLETED|Overall Study||526||
59992154|NCT02213458|76107925|FG000|NOT COMPLETED|Overall Study||54||
59992155|NCT02213458|76107926|FG001|NOT COMPLETED|Overall Study||10||
60085476|NCT02338960|76201760|FG000|STARTED|Core Study||306||
60085477|NCT02338960|76201761|FG001|STARTED|Core Study||308||
60085478|NCT02338960|76201760|FG000|Received Intervention|Core Study||303||
59992156|NCT02213380|76107934|FG000|STARTED|Underwent Randomization||476||
59992157|NCT02213380|76107935|FG001|STARTED|Underwent Randomization||474||
59992158|NCT02213380|76107934|FG000|COMPLETED|Underwent Randomization||471||
59992159|NCT02213380|76107935|FG001|COMPLETED|Underwent Randomization||471||
59992160|NCT02213380|76107934|FG000|NOT COMPLETED|Underwent Randomization||5||
60085479|NCT02338960|76201761|FG001|Received Intervention|Core Study||301||
60085480|NCT02338960|76201760|FG000|COMPLETED|Core Study||219||
60085481|NCT02338960|76201761|FG001|COMPLETED|Core Study||173||
60085482|NCT02338960|76201760|FG000|NOT COMPLETED|Core Study||87||
60085483|NCT02338960|76201761|FG001|NOT COMPLETED|Core Study||135||
60085484|NCT02338960|76201760|FG000|STARTED|Open Label Extension||191|321/392 Subjects who completed the Core Study continued into the optional OLE study.|
60085485|NCT02338960|76201761|FG001|STARTED|Open Label Extension||130|321/392 Subjects who completed the Core Study continued into the optional OLE study.|
60085486|NCT02338960|76201760|FG000|COMPLETED|Open Label Extension||77||
60085487|NCT02338960|76201761|FG001|COMPLETED|Open Label Extension||51||
60085488|NCT02338960|76201760|FG000|NOT COMPLETED|Open Label Extension||114||
60085489|NCT02338960|76201761|FG001|NOT COMPLETED|Open Label Extension||79||
60085490|NCT02121418|76201772|FG000|STARTED|Overall Study||12||
59559620|NCT02343120|75660759|FG003|COMPLETED|Part 1: Dose Escalation||0||
59559621|NCT02343120|75660760|FG004|COMPLETED|Part 1: Dose Escalation||0||
59559622|NCT02343120|75660756|FG000|NOT COMPLETED|Part 1: Dose Escalation||3||
59559623|NCT02343120|75660757|FG001|NOT COMPLETED|Part 1: Dose Escalation||4||
59559624|NCT02343120|75660758|FG002|NOT COMPLETED|Part 1: Dose Escalation||5||
59559625|NCT02343120|75660759|FG003|NOT COMPLETED|Part 1: Dose Escalation||4||
59559626|NCT02343120|75660760|FG004|NOT COMPLETED|Part 1: Dose Escalation||1||
59559627|NCT02343120|75660756|FG000|STARTED|Part 2: Expansion||0||
59559628|NCT02343120|75660757|FG001|STARTED|Part 2: Expansion||0||
59559629|NCT02343120|75660758|FG002|STARTED|Part 2: Expansion||0||
59559630|NCT02343120|75660759|FG003|STARTED|Part 2: Expansion||274||
59559631|NCT02343120|75660760|FG004|STARTED|Part 2: Expansion||94||
59559632|NCT02343120|75660756|FG000|COMPLETED|Part 2: Expansion||0||
59559633|NCT02343120|75660757|FG001|COMPLETED|Part 2: Expansion||0||
59559634|NCT02343120|75660758|FG002|COMPLETED|Part 2: Expansion||0||
59559635|NCT02343120|75660759|FG003|COMPLETED|Part 2: Expansion||0||
59559636|NCT02343120|75660760|FG004|COMPLETED|Part 2: Expansion||0||
59559637|NCT02343120|75660756|FG000|NOT COMPLETED|Part 2: Expansion||0||
59559638|NCT02343120|75660757|FG001|NOT COMPLETED|Part 2: Expansion||0||
59559639|NCT02343120|75660758|FG002|NOT COMPLETED|Part 2: Expansion||0||
59559640|NCT02343120|75660759|FG003|NOT COMPLETED|Part 2: Expansion||274||
59559641|NCT02343120|75660760|FG004|NOT COMPLETED|Part 2: Expansion||94||
59559642|NCT03125031|75660779|FG000|STARTED|Overall Study||44||
59559643|NCT03125031|75660780|FG001|STARTED|Overall Study||44||
59559644|NCT03125031|75660779|FG000|COMPLETED|Overall Study||44||
59559645|NCT03125031|75660780|FG001|COMPLETED|Overall Study||44||
59559646|NCT03125031|75660779|FG000|NOT COMPLETED|Overall Study||0||
59559647|NCT03125031|75660780|FG001|NOT COMPLETED|Overall Study||0||
59559648|NCT03083769|75660787|FG000|STARTED|Overall Study||839||
59559649|NCT03083769|75660788|FG001|STARTED|Overall Study||663||
59559650|NCT03083769|75660787|FG000|COMPLETED|Overall Study||819||
59559651|NCT03083769|75660788|FG001|COMPLETED|Overall Study||631||
59707507|NCT00991510|75826395|FG001|COMPLETED|Period III (Days 29-112)||20||
59707508|NCT00991510|75826394|FG000|NOT COMPLETED|Period III (Days 29-112)||1||
59559652|NCT03083769|75660787|FG000|NOT COMPLETED|Overall Study||20||
59559653|NCT03083769|75660788|FG001|NOT COMPLETED|Overall Study||32||
59707509|NCT00991510|75826395|FG001|NOT COMPLETED|Period III (Days 29-112)||1||
59559654|NCT01946243|75660794|FG000|STARTED|Overall Study||96||
59559655|NCT01946243|75660794|FG000|COMPLETED|Overall Study||96||
59559656|NCT01946243|75660794|FG000|NOT COMPLETED|Overall Study||0||
59559657|NCT03086265|75660802|FG000|STARTED|Overall Study||10||
59559658|NCT03086265|75660803|FG001|STARTED|Overall Study||10||
59816732|NCT04158687|75939123|FG003|Safety Population|Overall Study||78|Safety population included all participants who received at least one dose of study medication.|
59816733|NCT04158687|75939120|FG000|Efficacy Population|Overall Study||80|Efficacy population included all participants who received the study medication and had at least one available post-baseline Positive and Negative Syndrome Scale (PANSS) assessment.|
59817918|NCT04488770|75940331|FG005|STARTED|Part 1-Cohort 2: Period 2 (Up to 5 Days)|New participant enrolled and dosed as a replacement of withdrawn participant|2||
59559659|NCT03086265|75660802|FG000|COMPLETED|Overall Study||10||
59559660|NCT03086265|75660803|FG001|COMPLETED|Overall Study||10||
59559661|NCT03086265|75660802|FG000|NOT COMPLETED|Overall Study||0||
59559662|NCT03086265|75660803|FG001|NOT COMPLETED|Overall Study||0||
59559663|NCT01631630|75660811|FG000|STARTED|Overall Study||8||
59559664|NCT01631630|75660812|FG001|STARTED|Overall Study||8||
59559665|NCT01631630|75660811|FG000|COMPLETED|Overall Study||5||
59559666|NCT01631630|75660812|FG001|COMPLETED|Overall Study||8||
59559667|NCT01631630|75660811|FG000|NOT COMPLETED|Overall Study||3||
59559668|NCT01631630|75660812|FG001|NOT COMPLETED|Overall Study||0||
59559669|NCT01947335|75660820|FG000|STARTED|Overall Study||42||
59559670|NCT01947335|75660821|FG001|STARTED|Overall Study||41||
59559671|NCT01947335|75660820|FG000|COMPLETED|Overall Study||42||
59559672|NCT01947335|75660821|FG001|COMPLETED|Overall Study||41||
59559673|NCT01947335|75660820|FG000|NOT COMPLETED|Overall Study||0||
59559674|NCT01947335|75660821|FG001|NOT COMPLETED|Overall Study||0||
59559675|NCT01947647|75660829|FG000|STARTED|Treatment Phase||46||
59559676|NCT01947647|75660830|FG001|STARTED|Treatment Phase||47||
59559677|NCT01947647|75660829|FG000|COMPLETED|Treatment Phase||29||
59559678|NCT01947647|75660830|FG001|COMPLETED|Treatment Phase||21||
59559679|NCT01947647|75660829|FG000|NOT COMPLETED|Treatment Phase||17||
59559680|NCT01947647|75660830|FG001|NOT COMPLETED|Treatment Phase||26||
59559681|NCT01947647|75660829|FG000|STARTED|6-month Followup Phase||29||
59559682|NCT01947647|75660830|FG001|STARTED|6-month Followup Phase||21||
59559683|NCT01947647|75660829|FG000|COMPLETED|6-month Followup Phase||20||
59559684|NCT01947647|75660830|FG001|COMPLETED|6-month Followup Phase||13||
59559685|NCT01947647|75660829|FG000|NOT COMPLETED|6-month Followup Phase||9||
59559686|NCT01947647|75660830|FG001|NOT COMPLETED|6-month Followup Phase||8||
59559687|NCT02289989|75660838|FG000|STARTED|Overall Study||0||
59559688|NCT02289989|75660839|FG001|STARTED|Overall Study||1||
59559689|NCT02289989|75660838|FG000|COMPLETED|Overall Study||0||
59559690|NCT02289989|75660839|FG001|COMPLETED|Overall Study||1||
59559691|NCT02289989|75660838|FG000|NOT COMPLETED|Overall Study||0||
59559692|NCT02289989|75660839|FG001|NOT COMPLETED|Overall Study||0||
59559693|NCT03091179|75660847|FG000|STARTED|Overall Study||10||
59559694|NCT03091179|75660848|FG001|STARTED|Overall Study||10||
59559695|NCT03091179|75660847|FG000|COMPLETED|Overall Study||10||
59559696|NCT03091179|75660848|FG001|COMPLETED|Overall Study||10||
59559697|NCT03091179|75660847|FG000|NOT COMPLETED|Overall Study||0||
59559698|NCT03091179|75660848|FG001|NOT COMPLETED|Overall Study||0||
59559699|NCT03129945|75660856|FG000|STARTED|Overall Study||15||
59559700|NCT03129945|75660857|FG001|STARTED|Overall Study||21||
59559701|NCT03129945|75660856|FG000|COMPLETED|Overall Study||15||
59559702|NCT03129945|75660857|FG001|COMPLETED|Overall Study||21||
59559703|NCT03129945|75660856|FG000|NOT COMPLETED|Overall Study||0||
59559704|NCT03129945|75660857|FG001|NOT COMPLETED|Overall Study||0||
59559705|NCT01948739|75660863|FG000|STARTED|Overall Study||18||
59559706|NCT01948739|75660863|FG000|Received Intervention|Overall Study||10||
59559707|NCT01948739|75660863|FG000|COMPLETED|Overall Study||10||
59559708|NCT01948739|75660863|FG000|NOT COMPLETED|Overall Study||8||
59559709|NCT01700036|75660867|FG000|STARTED|Overall Study||40||
59559710|NCT01700036|75660867|FG000|COMPLETED|Overall Study||40||
59559711|NCT01700036|75660867|FG000|NOT COMPLETED|Overall Study||0||
59559712|NCT02965989|75660873|FG000|STARTED|Overall Study||26||
59559713|NCT02965989|75660874|FG001|STARTED|Overall Study||22||
59559714|NCT02965989|75660873|FG000|COMPLETED|Overall Study||26||
59559715|NCT02965989|75660874|FG001|COMPLETED|Overall Study||22||
59559716|NCT02965989|75660873|FG000|NOT COMPLETED|Overall Study||0||
59559717|NCT02965989|75660874|FG001|NOT COMPLETED|Overall Study||0||
59559718|NCT01700816|75660888|FG000|STARTED|Overall Study||21||
59559719|NCT01700816|75660889|FG001|STARTED|Overall Study||19||
59559720|NCT01700816|75660888|FG000|COMPLETED|Overall Study||21||
59559721|NCT01700816|75660889|FG001|COMPLETED|Overall Study||19||
59559722|NCT01700816|75660888|FG000|NOT COMPLETED|Overall Study||0||
59559723|NCT01700816|75660889|FG001|NOT COMPLETED|Overall Study||0||
59559724|NCT01950299|75660898|FG000|STARTED|Overall Study||33||
59559725|NCT01950299|75660899|FG001|STARTED|Overall Study||31||
59559726|NCT01950299|75660900|FG002|STARTED|Overall Study||35||
59559727|NCT01950299|75660898|FG000|COMPLETED|Overall Study||22||
59559728|NCT01950299|75660899|FG001|COMPLETED|Overall Study||27||
59559729|NCT01950299|75660900|FG002|COMPLETED|Overall Study||28||
59559730|NCT01950299|75660898|FG000|NOT COMPLETED|Overall Study||11||
59559731|NCT01950299|75660899|FG001|NOT COMPLETED|Overall Study||4||
59559732|NCT01950299|75660900|FG002|NOT COMPLETED|Overall Study||7||
59559733|NCT02967393|75660910|FG000|STARTED|Overall Study||20||
59559734|NCT02967393|75660911|FG001|STARTED|Overall Study||20||
59559735|NCT02967393|75660910|FG000|COMPLETED|Overall Study||20||
59559736|NCT02967393|75660911|FG001|COMPLETED|Overall Study||20||
59559737|NCT02967393|75660910|FG000|NOT COMPLETED|Overall Study||0||
59559738|NCT02967393|75660911|FG001|NOT COMPLETED|Overall Study||0||
59559739|NCT03093207|75660921|FG000|STARTED|Overall Study||17||
59559740|NCT03093207|75660922|FG001|STARTED|Overall Study||17||
59559741|NCT03093207|75660921|FG000|COMPLETED|Overall Study||17||
59559742|NCT03093207|75660922|FG001|COMPLETED|Overall Study||17||
59559743|NCT03093207|75660921|FG000|NOT COMPLETED|Overall Study||0||
59559744|NCT03093207|75660922|FG001|NOT COMPLETED|Overall Study||0||
59559745|NCT01703702|75660930|FG000|STARTED|Overall Study||308||
59559746|NCT01703702|75660931|FG001|STARTED|Overall Study||310||
59559747|NCT01703702|75660930|FG000|COMPLETED|Overall Study||272||
59559748|NCT01703702|75660931|FG001|COMPLETED|Overall Study||288||
59559749|NCT01703702|75660930|FG000|NOT COMPLETED|Overall Study||36||
59559750|NCT01703702|75660931|FG001|NOT COMPLETED|Overall Study||22||
59559751|NCT03096873|75660944|FG000|STARTED|Overall Study||20||
59559752|NCT03096873|75660945|FG001|STARTED|Overall Study||20||
59559753|NCT03096873|75660944|FG000|COMPLETED|Overall Study||20||
59559754|NCT03096873|75660945|FG001|COMPLETED|Overall Study||20||
59559755|NCT03096873|75660944|FG000|NOT COMPLETED|Overall Study||0||
59559756|NCT03096873|75660945|FG001|NOT COMPLETED|Overall Study||0||
59559757|NCT02969031|75660955|FG000|STARTED|Enrolled and Randomized||73||
59559758|NCT02969031|75660956|FG001|STARTED|Enrolled and Randomized||75||
59559759|NCT02969031|75660955|FG000|COMPLETED|Enrolled and Randomized||73||
59559760|NCT02969031|75660956|FG001|COMPLETED|Enrolled and Randomized||75||
59559761|NCT02969031|75660955|FG000|NOT COMPLETED|Enrolled and Randomized||0||
59559762|NCT02969031|75660956|FG001|NOT COMPLETED|Enrolled and Randomized||0||
59559763|NCT02969031|75660955|FG000|STARTED|Collection of Baseline Surveys||73||
59559764|NCT02969031|75660956|FG001|STARTED|Collection of Baseline Surveys||75||
59559765|NCT02969031|75660955|FG000|COMPLETED|Collection of Baseline Surveys||34||
59559766|NCT02969031|75660956|FG001|COMPLETED|Collection of Baseline Surveys||23||
59559767|NCT02969031|75660955|FG000|NOT COMPLETED|Collection of Baseline Surveys||39||
59559768|NCT02969031|75660956|FG001|NOT COMPLETED|Collection of Baseline Surveys||52||
59559769|NCT02969031|75660955|FG000|STARTED|Collection of Baseline Recordings||34||
59559770|NCT02969031|75660956|FG001|STARTED|Collection of Baseline Recordings||23||
59559771|NCT02969031|75660955|FG000|COMPLETED|Collection of Baseline Recordings||22||
59559772|NCT02969031|75660956|FG001|COMPLETED|Collection of Baseline Recordings||18||
59559773|NCT02969031|75660955|FG000|NOT COMPLETED|Collection of Baseline Recordings||12||
59559774|NCT02969031|75660956|FG001|NOT COMPLETED|Collection of Baseline Recordings||5||
59559775|NCT02969031|75660955|FG000|STARTED|Completed Intervention||22||
59559776|NCT02969031|75660956|FG001|STARTED|Completed Intervention||18||
59559777|NCT02969031|75660955|FG000|COMPLETED|Completed Intervention||15||
59559778|NCT02969031|75660956|FG001|COMPLETED|Completed Intervention||14||
59559779|NCT02969031|75660955|FG000|NOT COMPLETED|Completed Intervention||7||
59559780|NCT02969031|75660956|FG001|NOT COMPLETED|Completed Intervention||4||
59559781|NCT02969031|75660955|FG000|STARTED|Collection of Follow-Up Surveys||15||
59559782|NCT02969031|75660956|FG001|STARTED|Collection of Follow-Up Surveys||14||
59559783|NCT02969031|75660955|FG000|COMPLETED|Collection of Follow-Up Surveys||15||
59559784|NCT02969031|75660956|FG001|COMPLETED|Collection of Follow-Up Surveys||12||
59559785|NCT02969031|75660955|FG000|NOT COMPLETED|Collection of Follow-Up Surveys||0||
59559786|NCT02969031|75660956|FG001|NOT COMPLETED|Collection of Follow-Up Surveys||2||
59559787|NCT02969031|75660955|FG000|STARTED|Collection of Follow-Up Recordings||15||
59559788|NCT02969031|75660956|FG001|STARTED|Collection of Follow-Up Recordings||12||
59559789|NCT02969031|75660955|FG000|COMPLETED|Collection of Follow-Up Recordings||15||
59559790|NCT02969031|75660956|FG001|COMPLETED|Collection of Follow-Up Recordings||12||
59559791|NCT02969031|75660955|FG000|NOT COMPLETED|Collection of Follow-Up Recordings||0||
59559792|NCT02969031|75660956|FG001|NOT COMPLETED|Collection of Follow-Up Recordings||0||
59559793|NCT02969031|75660955|FG000|STARTED|Completed and Analyzed||15||
59816734|NCT04158687|75939121|FG001|Efficacy Population|Overall Study||81|Efficacy population included all participants who received the study medication and had at least one available post-baseline Positive and Negative Syndrome Scale (PANSS) assessment.|
60085491|NCT02121418|76201772|FG000|COMPLETED|Overall Study||12||
60085492|NCT02121418|76201772|FG000|NOT COMPLETED|Overall Study||0||
60085493|NCT01441635|76201786|FG000|STARTED|Overall Study||32||
60085494|NCT01441635|76201787|FG001|STARTED|Overall Study||33||
60085495|NCT01441635|76201788|FG002|STARTED|Overall Study||16||
60085496|NCT01441635|76201789|FG003|STARTED|Overall Study||35||
60085497|NCT01441635|76201790|FG004|STARTED|Overall Study||18||
60085498|NCT01441635|76201791|FG005|STARTED|Overall Study||34||
60085499|NCT01441635|76201792|FG006|STARTED|Overall Study||30||
60085500|NCT01441635|76201793|FG007|STARTED|Overall Study||30||
60085501|NCT01441635|76201794|FG008|STARTED|Overall Study||16||
60085502|NCT01441635|76201795|FG009|STARTED|Overall Study||27||
60085503|NCT01441635|76201786|FG000|COMPLETED|Overall Study||26||
60085504|NCT01441635|76201787|FG001|COMPLETED|Overall Study||27||
60085505|NCT01441635|76201788|FG002|COMPLETED|Overall Study||13||
59559794|NCT02969031|75660956|FG001|STARTED|Completed and Analyzed||12||
59559795|NCT02969031|75660955|FG000|COMPLETED|Completed and Analyzed||15||
59559796|NCT02969031|75660956|FG001|COMPLETED|Completed and Analyzed||12||
59559797|NCT02969031|75660955|FG000|NOT COMPLETED|Completed and Analyzed||0||
60085506|NCT01441635|76201789|FG003|COMPLETED|Overall Study||28||
60085507|NCT01441635|76201790|FG004|COMPLETED|Overall Study||16||
60085508|NCT01441635|76201791|FG005|COMPLETED|Overall Study||29||
60085509|NCT01441635|76201792|FG006|COMPLETED|Overall Study||24||
59559798|NCT02969031|75660956|FG001|NOT COMPLETED|Completed and Analyzed||0||
59559799|NCT02969421|75660964|FG000|STARTED|Overall Study||33||
59559800|NCT02969421|75660965|FG001|STARTED|Overall Study||33||
59559801|NCT02969421|75660964|FG000|COMPLETED|Overall Study||33||
59559802|NCT02969421|75660965|FG001|COMPLETED|Overall Study||33||
59559803|NCT02969421|75660964|FG000|NOT COMPLETED|Overall Study||0||
59559804|NCT02969421|75660965|FG001|NOT COMPLETED|Overall Study||0||
59559805|NCT03134313|75660971|FG000|STARTED|Overall Study||25||
59559806|NCT03134313|75660971|FG000|COMPLETED|Overall Study||25||
59559807|NCT03134313|75660971|FG000|NOT COMPLETED|Overall Study||0||
59559808|NCT02228408|75660977|FG000|STARTED|Overall Study||7||
59559809|NCT02228408|75660978|FG001|STARTED|Overall Study||10||
59559810|NCT02228408|75660977|FG000|COMPLETED|Overall Study||7||
59559811|NCT02228408|75660978|FG001|COMPLETED|Overall Study||10||
59559812|NCT02228408|75660977|FG000|NOT COMPLETED|Overall Study||0||
59559813|NCT02228408|75660978|FG001|NOT COMPLETED|Overall Study||0||
59559814|NCT01951391|75660986|FG000|STARTED|Overall Study||5||
59559815|NCT01951391|75660987|FG001|STARTED|Overall Study||5||
59559816|NCT01951391|75660986|FG000|COMPLETED|Overall Study||5||
59559817|NCT01951391|75660987|FG001|COMPLETED|Overall Study||5||
59559818|NCT01951391|75660986|FG000|NOT COMPLETED|Overall Study||0||
59559819|NCT01951391|75660987|FG001|NOT COMPLETED|Overall Study||0||
59559820|NCT01953575|75660998|FG000|STARTED|Overall Study||10||
59992161|NCT02213380|76107935|FG001|NOT COMPLETED|Underwent Randomization||3||
59992162|NCT02213380|76107934|FG000|STARTED|Per-protocol Analysis||471||
59559821|NCT01953575|75660999|FG001|STARTED|Overall Study||10||
59559822|NCT01953575|75661000|FG002|STARTED|Overall Study||10||
59992163|NCT02213380|76107935|FG001|STARTED|Per-protocol Analysis||471||
59559823|NCT01953575|75660998|FG000|COMPLETED|Overall Study||10||
59559824|NCT01953575|75660999|FG001|COMPLETED|Overall Study||10||
59559825|NCT01953575|75661000|FG002|COMPLETED|Overall Study||10||
59992164|NCT02213380|76107934|FG000|COMPLETED|Per-protocol Analysis||439||
59992165|NCT02213380|76107935|FG001|COMPLETED|Per-protocol Analysis||435||
59992166|NCT02213380|76107934|FG000|NOT COMPLETED|Per-protocol Analysis||32||
59559826|NCT01953575|75660998|FG000|NOT COMPLETED|Overall Study||0||
59559827|NCT01953575|75660999|FG001|NOT COMPLETED|Overall Study||0||
59559828|NCT01953575|75661000|FG002|NOT COMPLETED|Overall Study||0||
59559829|NCT01955369|75661008|FG000|STARTED|Overall Study||200||
59559830|NCT01955369|75661008|FG000|COMPLETED|Overall Study||200||
59559831|NCT01955369|75661008|FG000|NOT COMPLETED|Overall Study||0||
59559832|NCT02342886|75661017|FG000|STARTED|Overall Study||65||
59559833|NCT02342886|75661018|FG001|STARTED|Overall Study||71||
59559834|NCT02342886|75661019|FG002|STARTED|Overall Study||67||
59559835|NCT02342886|75661020|FG003|STARTED|Overall Study||68||
59559836|NCT02342886|75661021|FG004|STARTED|Overall Study||13||
59559837|NCT02342886|75661017|FG000|Completed Month 12 Follow-Up|Overall Study||43||
59559838|NCT02342886|75661018|FG001|Completed Month 12 Follow-Up|Overall Study||52||
59559839|NCT02342886|75661019|FG002|Completed Month 12 Follow-Up|Overall Study||49||
59559840|NCT02342886|75661020|FG003|Completed Month 12 Follow-Up|Overall Study||57||
59559841|NCT02342886|75661021|FG004|Completed Month 12 Follow-Up|Overall Study||10||
59559842|NCT02342886|75661017|FG000|Completed Month 24 Follow-Up|Overall Study||40||
59559843|NCT02342886|75661018|FG001|Completed Month 24 Follow-Up|Overall Study||47||
59559844|NCT02342886|75661019|FG002|Completed Month 24 Follow-Up|Overall Study||46||
59559845|NCT02342886|75661020|FG003|Completed Month 24 Follow-Up|Overall Study||53||
59559846|NCT02342886|75661021|FG004|Completed Month 24 Follow-Up|Overall Study||10||
59559847|NCT02342886|75661017|FG000|COMPLETED|Overall Study||57|Completed Treatment|
59559848|NCT02342886|75661018|FG001|COMPLETED|Overall Study||63|Completed Treatment|
59559849|NCT02342886|75661019|FG002|COMPLETED|Overall Study||52|Completed Treatment|
59559850|NCT02342886|75661020|FG003|COMPLETED|Overall Study||59|Completed Treatment|
59559851|NCT02342886|75661021|FG004|COMPLETED|Overall Study||10|Completed Treatment|
59559852|NCT02342886|75661017|FG000|NOT COMPLETED|Overall Study||8||
59559853|NCT02342886|75661018|FG001|NOT COMPLETED|Overall Study||8||
59559854|NCT02342886|75661019|FG002|NOT COMPLETED|Overall Study||15||
59559855|NCT02342886|75661020|FG003|NOT COMPLETED|Overall Study||9||
60085510|NCT01441635|76201793|FG007|COMPLETED|Overall Study||26||
60085511|NCT01441635|76201794|FG008|COMPLETED|Overall Study||14||
60085512|NCT01441635|76201795|FG009|COMPLETED|Overall Study||25||
60085513|NCT01441635|76201786|FG000|NOT COMPLETED|Overall Study||6||
60085514|NCT01441635|76201787|FG001|NOT COMPLETED|Overall Study||6||
60085515|NCT01441635|76201788|FG002|NOT COMPLETED|Overall Study||3||
60085516|NCT01441635|76201789|FG003|NOT COMPLETED|Overall Study||7||
60085517|NCT01441635|76201790|FG004|NOT COMPLETED|Overall Study||2||
60085518|NCT01441635|76201791|FG005|NOT COMPLETED|Overall Study||5||
60085519|NCT01441635|76201792|FG006|NOT COMPLETED|Overall Study||6||
60085520|NCT01441635|76201793|FG007|NOT COMPLETED|Overall Study||4||
60085521|NCT01441635|76201794|FG008|NOT COMPLETED|Overall Study||2||
60085522|NCT01441635|76201795|FG009|NOT COMPLETED|Overall Study||2||
59559856|NCT02342886|75661021|FG004|NOT COMPLETED|Overall Study||3||
59707510|NCT01119963|75826407|FG000|STARTED|Overall Study||74||
59707511|NCT01119963|75826408|FG001|STARTED|Overall Study||78||
60085523|NCT01408485|76201817|FG000|STARTED|Overall Study||200||
60085524|NCT01408485|76201817|FG000|COMPLETED|Overall Study||179||
60085525|NCT01408485|76201817|FG000|NOT COMPLETED|Overall Study||21||
60085526|NCT01427907|76201823|FG000|STARTED|Overall Study|Randomized|20||
60085527|NCT01427907|76201824|FG001|STARTED|Overall Study|Randomized|18||
60085528|NCT01427907|76201823|FG000|COMPLETED|Overall Study|Completed study|17||
60085529|NCT01427907|76201824|FG001|COMPLETED|Overall Study|Completed study|14||
60085530|NCT01427907|76201823|FG000|NOT COMPLETED|Overall Study||3||
60085531|NCT01427907|76201824|FG001|NOT COMPLETED|Overall Study||4||
59559857|NCT03097341|75661038|FG000|STARTED|Overall Study||4||
59559858|NCT03097341|75661039|FG001|STARTED|Overall Study||4||
59559859|NCT03097341|75661040|FG002|STARTED|Overall Study||4||
59559860|NCT03097341|75661041|FG003|STARTED|Overall Study||4||
59559861|NCT03097341|75661042|FG004|STARTED|Overall Study||5||
60085532|NCT01427751|76201832|FG000|STARTED|Overall Study||154||
60085533|NCT01427751|76201833|FG001|STARTED|Overall Study||153||
59559862|NCT03097341|75661038|FG000|COMPLETED|Overall Study||4||
60085534|NCT01427751|76201832|FG000|COMPLETED|Overall Study||112||
60085535|NCT01427751|76201833|FG001|COMPLETED|Overall Study||139||
60085536|NCT01427751|76201832|FG000|NOT COMPLETED|Overall Study||42||
60085537|NCT01427751|76201833|FG001|NOT COMPLETED|Overall Study||14||
59559863|NCT03097341|75661039|FG001|COMPLETED|Overall Study||4||
59992167|NCT02213380|76107935|FG001|NOT COMPLETED|Per-protocol Analysis||36||
59992168|NCT02202850|76107943|FG000|STARTED|Overall Study||70||
60085538|NCT01920061|76201859|FG000|STARTED|Overall Study||4||
60085539|NCT01920061|76201860|FG001|STARTED|Overall Study||5||
60085540|NCT01920061|76201861|FG002|STARTED|Overall Study||3||
60085541|NCT01920061|76201862|FG003|STARTED|Overall Study||4||
60085542|NCT01920061|76201863|FG004|STARTED|Overall Study||5||
60085543|NCT01920061|76201864|FG005|STARTED|Overall Study||4||
60085544|NCT01920061|76201865|FG006|STARTED|Overall Study||3||
60085545|NCT01920061|76201866|FG007|STARTED|Overall Study||3||
60085546|NCT01920061|76201867|FG008|STARTED|Overall Study||3||
60085547|NCT01920061|76201868|FG009|STARTED|Overall Study||3||
60085548|NCT01920061|76201869|FG010|STARTED|Overall Study||10||
60085549|NCT01920061|76201870|FG011|STARTED|Overall Study||5||
60085550|NCT01920061|76201871|FG012|STARTED|Overall Study||3||
60085551|NCT01920061|76201872|FG013|STARTED|Overall Study||16||
59992169|NCT02202850|76107944|FG001|STARTED|Overall Study||14||
59992170|NCT02202850|76107943|FG000|COMPLETED|Overall Study||46||
59992171|NCT02202850|76107944|FG001|COMPLETED|Overall Study||8||
59992172|NCT02202850|76107943|FG000|NOT COMPLETED|Overall Study||24||
59992173|NCT02202850|76107944|FG001|NOT COMPLETED|Overall Study||6||
59992174|NCT02212678|76107950|FG000|STARTED|Overall Study||8||
59992175|NCT02212678|76107950|FG000|COMPLETED|Overall Study||7||
59992176|NCT02212678|76107950|FG000|NOT COMPLETED|Overall Study||1||
59992177|NCT03104075|76107956|FG000|STARTED|Overall Study||20||
59992178|NCT03104075|76107957|FG001|STARTED|Overall Study||20||
60085552|NCT01920061|76201873|FG014|STARTED|Overall Study||4||
60085553|NCT01920061|76201874|FG015|STARTED|Overall Study||7||
59559864|NCT03097341|75661040|FG002|COMPLETED|Overall Study||4||
59559865|NCT03097341|75661041|FG003|COMPLETED|Overall Study||4||
60085554|NCT01920061|76201875|FG016|STARTED|Overall Study||3||
60085555|NCT01920061|76201876|FG017|STARTED|Overall Study||3||
60085556|NCT01920061|76201877|FG018|STARTED|Overall Study||10||
59992179|NCT03104075|76107956|FG000|COMPLETED|Overall Study||19||
60085557|NCT01920061|76201878|FG019|STARTED|Overall Study||12||
60085558|NCT01920061|76201859|FG000|Received Treatment|Overall Study||4||
59559866|NCT03097341|75661042|FG004|COMPLETED|Overall Study||5||
59559867|NCT03097341|75661038|FG000|NOT COMPLETED|Overall Study||0||
59559868|NCT03097341|75661039|FG001|NOT COMPLETED|Overall Study||0||
59559869|NCT03097341|75661040|FG002|NOT COMPLETED|Overall Study||0||
59559870|NCT03097341|75661041|FG003|NOT COMPLETED|Overall Study||0||
59559871|NCT03097341|75661042|FG004|NOT COMPLETED|Overall Study||0||
59559872|NCT02390076|75661057|FG000|STARTED|Overall Study||18||
59559873|NCT02390076|75661058|FG001|STARTED|Overall Study||18||
59559874|NCT02390076|75661059|FG002|STARTED|Overall Study||15||
59559875|NCT02390076|75661057|FG000|COMPLETED|Overall Study||16||
59559876|NCT02390076|75661058|FG001|COMPLETED|Overall Study||17||
59559877|NCT02390076|75661059|FG002|COMPLETED|Overall Study||11||
59559878|NCT02390076|75661057|FG000|NOT COMPLETED|Overall Study||2||
59559879|NCT02390076|75661058|FG001|NOT COMPLETED|Overall Study||1||
59559880|NCT02390076|75661059|FG002|NOT COMPLETED|Overall Study||4||
59559881|NCT03097653|75661069|FG000|STARTED|Overall Study||472||
59559882|NCT03097653|75661070|FG001|STARTED|Overall Study||529||
59559883|NCT03097653|75661069|FG000|COMPLETED|Overall Study||472||
59559884|NCT03097653|75661070|FG001|COMPLETED|Overall Study||529||
59559885|NCT03097653|75661069|FG000|NOT COMPLETED|Overall Study||0||
59559886|NCT03097653|75661070|FG001|NOT COMPLETED|Overall Study||0||
59559887|NCT02389998|75661078|FG000|STARTED|Overall Study||16||
59559888|NCT02389998|75661079|FG001|STARTED|Overall Study||15||
59559889|NCT02389998|75661078|FG000|COMPLETED|Overall Study||15||
59559890|NCT02389998|75661079|FG001|COMPLETED|Overall Study||15||
59559891|NCT02389998|75661078|FG000|NOT COMPLETED|Overall Study||1||
59559892|NCT02389998|75661079|FG001|NOT COMPLETED|Overall Study||0||
59559893|NCT02330627|75661089|FG000|STARTED|Overall Study||16||
59559894|NCT02330627|75661090|FG001|STARTED|Overall Study||13||
59559895|NCT02330627|75661089|FG000|COMPLETED|Overall Study||15||
59559896|NCT02330627|75661090|FG001|COMPLETED|Overall Study||12||
59559897|NCT02330627|75661089|FG000|NOT COMPLETED|Overall Study||1||
60085559|NCT01920061|76201860|FG001|Received Treatment|Overall Study||5||
60085560|NCT01920061|76201861|FG002|Received Treatment|Overall Study||3||
60085561|NCT01920061|76201862|FG003|Received Treatment|Overall Study||3||
60085562|NCT01920061|76201863|FG004|Received Treatment|Overall Study||5||
60085563|NCT01920061|76201864|FG005|Received Treatment|Overall Study||4||
60085564|NCT01920061|76201865|FG006|Received Treatment|Overall Study||3||
60085565|NCT01920061|76201866|FG007|Received Treatment|Overall Study||3||
60085566|NCT01920061|76201867|FG008|Received Treatment|Overall Study||3||
60085567|NCT01920061|76201868|FG009|Received Treatment|Overall Study||3||
60085568|NCT01920061|76201869|FG010|Received Treatment|Overall Study||10||
60085569|NCT01920061|76201870|FG011|Received Treatment|Overall Study||5||
60085570|NCT01920061|76201871|FG012|Received Treatment|Overall Study||2||
60085571|NCT01920061|76201872|FG013|Received Treatment|Overall Study||15||
60085572|NCT01920061|76201873|FG014|Received Treatment|Overall Study||4||
60085573|NCT01920061|76201874|FG015|Received Treatment|Overall Study||7||
60085574|NCT01920061|76201875|FG016|Received Treatment|Overall Study||3||
60085575|NCT01920061|76201876|FG017|Received Treatment|Overall Study||3||
60085576|NCT01920061|76201877|FG018|Received Treatment|Overall Study||10||
60085577|NCT01920061|76201878|FG019|Received Treatment|Overall Study||12||
60085578|NCT01920061|76201859|FG000|COMPLETED|Overall Study||2||
60085579|NCT01920061|76201860|FG001|COMPLETED|Overall Study||1||
60085580|NCT01920061|76201861|FG002|COMPLETED|Overall Study||1||
60085581|NCT01920061|76201862|FG003|COMPLETED|Overall Study||2||
60085582|NCT01920061|76201863|FG004|COMPLETED|Overall Study||3||
60085583|NCT01920061|76201864|FG005|COMPLETED|Overall Study||2||
60085584|NCT01920061|76201865|FG006|COMPLETED|Overall Study||2||
60085585|NCT01920061|76201866|FG007|COMPLETED|Overall Study||2||
60085586|NCT01920061|76201867|FG008|COMPLETED|Overall Study||2||
60085587|NCT01920061|76201868|FG009|COMPLETED|Overall Study||1||
60085588|NCT01920061|76201869|FG010|COMPLETED|Overall Study||5||
60085589|NCT01920061|76201870|FG011|COMPLETED|Overall Study||2||
60085590|NCT01920061|76201871|FG012|COMPLETED|Overall Study||1||
60085591|NCT01920061|76201872|FG013|COMPLETED|Overall Study||10||
60085592|NCT01920061|76201873|FG014|COMPLETED|Overall Study||3||
60085593|NCT01920061|76201874|FG015|COMPLETED|Overall Study||4||
60085594|NCT01920061|76201875|FG016|COMPLETED|Overall Study||1||
60085595|NCT01920061|76201876|FG017|COMPLETED|Overall Study||1||
60085596|NCT01920061|76201877|FG018|COMPLETED|Overall Study||4||
60085597|NCT01920061|76201878|FG019|COMPLETED|Overall Study||8||
60085598|NCT01920061|76201859|FG000|NOT COMPLETED|Overall Study||2||
59559898|NCT02330627|75661090|FG001|NOT COMPLETED|Overall Study||1||
59559899|NCT02128958|75661098|FG000|STARTED|Overall Study||50||
59559900|NCT02128958|75661099|FG001|STARTED|Overall Study||28||
59559901|NCT02128958|75661098|FG000|COMPLETED|Overall Study||29||
59559902|NCT02128958|75661099|FG001|COMPLETED|Overall Study||18||
59559903|NCT02128958|75661098|FG000|NOT COMPLETED|Overall Study||21||
59559904|NCT02128958|75661099|FG001|NOT COMPLETED|Overall Study||10||
59559905|NCT02389764|75661105|FG000|STARTED|Overall Study||9||
59559906|NCT02389764|75661105|FG000|COMPLETED|Overall Study||0||
59559907|NCT02389764|75661105|FG000|NOT COMPLETED|Overall Study||9||
59559908|NCT03135015|75661111|FG000|STARTED|Overall Study||11||
59559909|NCT03135015|75661112|FG001|STARTED|Overall Study||11||
59559910|NCT03135015|75661111|FG000|Water Control|Overall Study||9||
59559911|NCT03135015|75661112|FG001|Water Control|Overall Study||11||
59559912|NCT03135015|75661111|FG000|Placebo Capsules|Overall Study||9||
59559913|NCT03135015|75661112|FG001|Placebo Capsules|Overall Study||11||
59559914|NCT03135015|75661111|FG000|2g Capsules|Overall Study||9||
59559915|NCT03135015|75661112|FG001|2g Capsules|Overall Study||11||
59559916|NCT03135015|75661111|FG000|4g Capsules|Overall Study||9||
59559917|NCT03135015|75661112|FG001|4g Capsules|Overall Study||11||
59559918|NCT03135015|75661111|FG000|2g Tablets|Overall Study||9||
59559919|NCT03135015|75661112|FG001|2g Tablets|Overall Study||11||
59559920|NCT03135015|75661111|FG000|4g Tablets|Overall Study||9||
59559921|NCT03135015|75661112|FG001|4g Tablets|Overall Study||11||
59559922|NCT03135015|75661111|FG000|COMPLETED|Overall Study||9||
59559923|NCT03135015|75661112|FG001|COMPLETED|Overall Study||11||
59559924|NCT03135015|75661111|FG000|NOT COMPLETED|Overall Study||2||
59559925|NCT03135015|75661112|FG001|NOT COMPLETED|Overall Study||0||
59559926|NCT01597856|75661165|FG000|STARTED|Overall Study||85||
59559927|NCT01597856|75661166|FG001|STARTED|Overall Study||87||
59559928|NCT01597856|75661167|FG002|STARTED|Overall Study||174||
59559929|NCT01597856|75661165|FG000|Week 4 Follow-up|Overall Study||62||
59559930|NCT01597856|75661166|FG001|Week 4 Follow-up|Overall Study||67||
59559931|NCT01597856|75661167|FG002|Week 4 Follow-up|Overall Study||129||
59559932|NCT01597856|75661165|FG000|COMPLETED|Overall Study||63||
59559933|NCT01597856|75661166|FG001|COMPLETED|Overall Study||61||
59559934|NCT01597856|75661167|FG002|COMPLETED|Overall Study||120||
59559935|NCT01597856|75661165|FG000|NOT COMPLETED|Overall Study||22||
59559936|NCT01597856|75661166|FG001|NOT COMPLETED|Overall Study||26||
59559937|NCT01597856|75661167|FG002|NOT COMPLETED|Overall Study||54||
59817919|NCT04488770|75940332|FG006|STARTED|Part 1-Cohort 2: Period 2 (Up to 5 Days)|New participant enrolled and dosed as a replacement of withdrawn participant|2||
59559938|NCT02366130|75661176|FG000|STARTED|Overall Study||45||
59559939|NCT02366130|75661176|FG000|COMPLETED|Overall Study||36||
59559940|NCT02366130|75661176|FG000|NOT COMPLETED|Overall Study||9||
59559941|NCT01633892|75661180|FG000|STARTED|Overall Study||5||
59559942|NCT01633892|75661180|FG000|COMPLETED|Overall Study||5||
59559943|NCT01633892|75661180|FG000|NOT COMPLETED|Overall Study||0||
59559944|NCT03098745|75661184|FG000|STARTED|Day 1||7||
59559945|NCT03098745|75661185|FG001|STARTED|Day 1||3||
59559946|NCT03098745|75661186|FG002|STARTED|Day 1||8||
59559947|NCT03098745|75661187|FG003|STARTED|Day 1||8||
59559948|NCT03098745|75661188|FG004|STARTED|Day 1||10||
59559949|NCT03098745|75661189|FG005|STARTED|Day 1||4||
59559950|NCT03098745|75661184|FG000|COMPLETED|Day 1||7||
59559951|NCT03098745|75661185|FG001|COMPLETED|Day 1||3||
59559952|NCT03098745|75661186|FG002|COMPLETED|Day 1||8||
59559953|NCT03098745|75661187|FG003|COMPLETED|Day 1||8||
59559954|NCT03098745|75661188|FG004|COMPLETED|Day 1||10||
59559955|NCT03098745|75661189|FG005|COMPLETED|Day 1||4||
59559956|NCT03098745|75661184|FG000|NOT COMPLETED|Day 1||0||
59559957|NCT03098745|75661185|FG001|NOT COMPLETED|Day 1||0||
59559958|NCT03098745|75661186|FG002|NOT COMPLETED|Day 1||0||
59559959|NCT03098745|75661187|FG003|NOT COMPLETED|Day 1||0||
59559960|NCT03098745|75661188|FG004|NOT COMPLETED|Day 1||0||
59559961|NCT03098745|75661189|FG005|NOT COMPLETED|Day 1||0||
59559962|NCT03098745|75661184|FG000|STARTED|Day 2||7||
59559963|NCT03098745|75661185|FG001|STARTED|Day 2||3||
59559964|NCT03098745|75661186|FG002|STARTED|Day 2||8||
59559965|NCT03098745|75661187|FG003|STARTED|Day 2||8||
59559966|NCT03098745|75661188|FG004|STARTED|Day 2||10||
59559967|NCT03098745|75661189|FG005|STARTED|Day 2||4||
59559968|NCT03098745|75661184|FG000|COMPLETED|Day 2||7||
59707512|NCT01119963|75826407|FG000|COMPLETED|Overall Study||73||
59559969|NCT03098745|75661185|FG001|COMPLETED|Day 2||3||
59559970|NCT03098745|75661186|FG002|COMPLETED|Day 2||8||
59559971|NCT03098745|75661187|FG003|COMPLETED|Day 2||8||
59559972|NCT03098745|75661188|FG004|COMPLETED|Day 2||10||
59559973|NCT03098745|75661189|FG005|COMPLETED|Day 2||4||
59559974|NCT03098745|75661184|FG000|NOT COMPLETED|Day 2||0||
59559975|NCT03098745|75661185|FG001|NOT COMPLETED|Day 2||0||
59559976|NCT03098745|75661186|FG002|NOT COMPLETED|Day 2||0||
59559977|NCT03098745|75661187|FG003|NOT COMPLETED|Day 2||0||
59559978|NCT03098745|75661188|FG004|NOT COMPLETED|Day 2||0||
59559979|NCT03098745|75661189|FG005|NOT COMPLETED|Day 2||0||
59559980|NCT03098745|75661184|FG000|STARTED|Day 3||7||
59559981|NCT03098745|75661185|FG001|STARTED|Day 3||3||
59559982|NCT03098745|75661186|FG002|STARTED|Day 3||8||
59559983|NCT03098745|75661187|FG003|STARTED|Day 3||8||
59559984|NCT03098745|75661188|FG004|STARTED|Day 3||10||
59559985|NCT03098745|75661189|FG005|STARTED|Day 3||4||
59559986|NCT03098745|75661184|FG000|COMPLETED|Day 3||7||
59559987|NCT03098745|75661185|FG001|COMPLETED|Day 3||3||
59559988|NCT03098745|75661186|FG002|COMPLETED|Day 3||8||
59559989|NCT03098745|75661187|FG003|COMPLETED|Day 3||8||
59559990|NCT03098745|75661188|FG004|COMPLETED|Day 3||10||
59559991|NCT03098745|75661189|FG005|COMPLETED|Day 3||4||
59559992|NCT03098745|75661184|FG000|NOT COMPLETED|Day 3||0||
59559993|NCT03098745|75661185|FG001|NOT COMPLETED|Day 3||0||
59559994|NCT03098745|75661186|FG002|NOT COMPLETED|Day 3||0||
59559995|NCT03098745|75661187|FG003|NOT COMPLETED|Day 3||0||
59559996|NCT03098745|75661188|FG004|NOT COMPLETED|Day 3||0||
59559997|NCT03098745|75661189|FG005|NOT COMPLETED|Day 3||0||
59559998|NCT01635062|75661200|FG000|STARTED|Overall Study||9||
59559999|NCT01635062|75661201|FG001|STARTED|Overall Study||9||
59560000|NCT01635062|75661200|FG000|Sodium Restriction Baseline Visit|Overall Study||9|The first study visit was a pre-randomization assessment while sodium restricted (Baseline)|
59560001|NCT01635062|75661201|FG001|Sodium Restriction Baseline Visit|Overall Study||9|The first study visit was a pre-randomization assessment while sodium restricted (Baseline)|
59707513|NCT01119963|75826408|FG001|COMPLETED|Overall Study||77||
59560002|NCT01635062|75661200|FG000|Sodium Loading Baseline Visit|Overall Study||9|The second study visit was a pre-randomization assessment while sodium loaded (Baseline)|
59560003|NCT01635062|75661201|FG001|Sodium Loading Baseline Visit|Overall Study||9|The second study visit was a pre-randomization assessment while sodium loaded (Baseline)|
59707514|NCT01119963|75826407|FG000|NOT COMPLETED|Overall Study||1||
59560004|NCT01635062|75661200|FG000|Post-randomization Sodium Restriction|Overall Study||9|This visit was an assessment while sodium restricted and following 3 weeks of study medication|
59560005|NCT01635062|75661201|FG001|Post-randomization Sodium Restriction|Overall Study||9|This visit was an assessment while sodium restricted and following 3 weeks of study medication|
59560006|NCT01635062|75661200|FG000|Post-Randomization Sodium Loaded|Overall Study||9|This visit was an assessment while sodium loaded and following 3 weeks of study medication|
59560007|NCT01635062|75661201|FG001|Post-Randomization Sodium Loaded|Overall Study||9|This visit was an assessment while sodium loaded and following 3 weeks of study medication|
59560008|NCT01635062|75661200|FG000|COMPLETED|Overall Study||9||
59560009|NCT01635062|75661201|FG001|COMPLETED|Overall Study||9||
59560010|NCT01635062|75661200|FG000|NOT COMPLETED|Overall Study||0||
59560011|NCT01635062|75661201|FG001|NOT COMPLETED|Overall Study||0||
59560012|NCT02969499|75661211|FG000|STARTED|Overall Study||33||
59560013|NCT02969499|75661211|FG000|COMPLETED|Overall Study||33||
59560014|NCT02969499|75661211|FG000|NOT COMPLETED|Overall Study||0||
59560015|NCT03099369|75661217|FG000|STARTED|Overall Study||11||
59560016|NCT03099369|75661218|FG001|STARTED|Overall Study||9||
59560017|NCT03099369|75661217|FG000|COMPLETED|Overall Study||5||
59560018|NCT03099369|75661218|FG001|COMPLETED|Overall Study||5||
59560019|NCT03099369|75661217|FG000|NOT COMPLETED|Overall Study||6||
59560020|NCT03099369|75661218|FG001|NOT COMPLETED|Overall Study||4||
59560021|NCT01637090|75661225|FG000|STARTED|Overall Study||3||
60085599|NCT01920061|76201860|FG001|NOT COMPLETED|Overall Study||4||
60085600|NCT01920061|76201861|FG002|NOT COMPLETED|Overall Study||2||
60085601|NCT01920061|76201862|FG003|NOT COMPLETED|Overall Study||2||
60085602|NCT01920061|76201863|FG004|NOT COMPLETED|Overall Study||2||
60085603|NCT01920061|76201864|FG005|NOT COMPLETED|Overall Study||2||
60085604|NCT01920061|76201865|FG006|NOT COMPLETED|Overall Study||1||
60085605|NCT01920061|76201866|FG007|NOT COMPLETED|Overall Study||1||
60085606|NCT01920061|76201867|FG008|NOT COMPLETED|Overall Study||1||
60085607|NCT01920061|76201868|FG009|NOT COMPLETED|Overall Study||2||
60085608|NCT01920061|76201869|FG010|NOT COMPLETED|Overall Study||5||
60085609|NCT01920061|76201870|FG011|NOT COMPLETED|Overall Study||3||
60085610|NCT01920061|76201871|FG012|NOT COMPLETED|Overall Study||2||
60085611|NCT01920061|76201872|FG013|NOT COMPLETED|Overall Study||6||
60085612|NCT01920061|76201873|FG014|NOT COMPLETED|Overall Study||1||
60085613|NCT01920061|76201874|FG015|NOT COMPLETED|Overall Study||3||
60085614|NCT01920061|76201875|FG016|NOT COMPLETED|Overall Study||2||
60085615|NCT01920061|76201876|FG017|NOT COMPLETED|Overall Study||2||
60085616|NCT01920061|76201877|FG018|NOT COMPLETED|Overall Study||6||
60085617|NCT01920061|76201878|FG019|NOT COMPLETED|Overall Study||4||
59560022|NCT01637090|75661225|FG000|COMPLETED|Overall Study||0||
59560023|NCT01637090|75661225|FG000|NOT COMPLETED|Overall Study||3||
60085618|NCT01426425|76201941|FG000|STARTED|Overall Study||572||
60085619|NCT01426425|76201941|FG000|EP Study|Overall Study|EP study used to assess inclusion and exclusion criteria.|550||
60085620|NCT01426425|76201941|FG000|Intent to Treat|Overall Study|Met all inclusion and no exclusion criteria.|399||
60085621|NCT01426425|76201941|FG000|COMPLETED|Overall Study|The pre-specified modified intent-to-treat analysis set was used for the primary objectives.|397||
60085622|NCT01426425|76201941|FG000|NOT COMPLETED|Overall Study||175||
59560024|NCT03102411|75661229|FG000|STARTED|Overall Study||1881||
59560025|NCT03102411|75661229|FG000|COMPLETED|Overall Study||1718||
59560026|NCT03102411|75661229|FG000|NOT COMPLETED|Overall Study||163||
59560027|NCT01637246|75661234|FG000|STARTED|Overall Study||4385||
59560028|NCT01637246|75661234|FG000|COMPLETED|Overall Study||2246||
59560029|NCT01637246|75661234|FG000|NOT COMPLETED|Overall Study||2139||
59560030|NCT02389452|75661238|FG000|STARTED|Overall Study||394||
59560031|NCT02389452|75661238|FG000|Participants Received Repeat Injection|Overall Study|Repeat injection based on physician's assessment of efficacy and safety at Week 26, 39 or 52.|11||
59560032|NCT02389452|75661238|FG000|COMPLETED|Overall Study||369||
59560033|NCT02389452|75661238|FG000|NOT COMPLETED|Overall Study||25||
59560034|NCT01637870|75661243|FG000|STARTED|Overall Study||110||
59560035|NCT01637870|75661243|FG000|COMPLETED|Overall Study||110||
59560036|NCT01637870|75661243|FG000|NOT COMPLETED|Overall Study||0||
59560037|NCT01955837|75661249|FG000|STARTED|Overall Study||271||
59560038|NCT01955837|75661250|FG001|STARTED|Overall Study||135||
59560039|NCT01955837|75661249|FG000|COMPLETED|Overall Study||271||
59560040|NCT01955837|75661250|FG001|COMPLETED|Overall Study||135||
59560041|NCT01955837|75661249|FG000|NOT COMPLETED|Overall Study||0||
59560042|NCT01955837|75661250|FG001|NOT COMPLETED|Overall Study||0||
59560043|NCT01638416|75661258|FG000|STARTED|Overall Study||2490||
59560044|NCT01638416|75661259|FG001|STARTED|Overall Study||2504||
59560045|NCT01638416|75661258|FG000|COMPLETED|Overall Study||2457||
59560046|NCT01638416|75661259|FG001|COMPLETED|Overall Study||2462||
59560047|NCT01638416|75661258|FG000|NOT COMPLETED|Overall Study||33||
59992180|NCT03104075|76107957|FG001|COMPLETED|Overall Study||20||
59992181|NCT03104075|76107956|FG000|NOT COMPLETED|Overall Study||1||
59992182|NCT03104075|76107957|FG001|NOT COMPLETED|Overall Study||0||
59992183|NCT03038087|76107964|FG000|STARTED|Overall Study||10||
59992184|NCT03038087|76107964|FG000|COMPLETED|Overall Study||9||
59992185|NCT03038087|76107964|FG000|NOT COMPLETED|Overall Study||1||
59992186|NCT02249182|76107975|FG000|STARTED|PK Lead-In Phase||10||
59992187|NCT02249182|76107976|FG001|STARTED|PK Lead-In Phase||12||
59992188|NCT02249182|76107977|FG002|STARTED|PK Lead-In Phase||0||
59992189|NCT02249182|76107978|FG003|STARTED|PK Lead-In Phase||0||
59992190|NCT02249182|76107979|FG004|STARTED|PK Lead-In Phase||17||
59992191|NCT02249182|76107975|FG000|COMPLETED|PK Lead-In Phase||10||
59992192|NCT02249182|76107976|FG001|COMPLETED|PK Lead-In Phase||12||
59992193|NCT02249182|76107977|FG002|COMPLETED|PK Lead-In Phase||0||
59992194|NCT02249182|76107978|FG003|COMPLETED|PK Lead-In Phase||0||
59992195|NCT02249182|76107979|FG004|COMPLETED|PK Lead-In Phase||17||
59992196|NCT02249182|76107975|FG000|NOT COMPLETED|PK Lead-In Phase||0||
59992197|NCT02249182|76107976|FG001|NOT COMPLETED|PK Lead-In Phase||0||
59992198|NCT02249182|76107977|FG002|NOT COMPLETED|PK Lead-In Phase||0||
59992199|NCT02249182|76107978|FG003|NOT COMPLETED|PK Lead-In Phase||0||
59992200|NCT02249182|76107979|FG004|NOT COMPLETED|PK Lead-In Phase||0||
59992201|NCT02249182|76107975|FG000|STARTED|Treatment Phase|90 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|100||
59992202|NCT02249182|76107976|FG001|STARTED|Treatment Phase|77 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|89||
59992203|NCT02249182|76107977|FG002|STARTED|Treatment Phase|1 participant enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|1||
59992204|NCT02249182|76107978|FG003|STARTED|Treatment Phase|2 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|2||
59992205|NCT02249182|76107979|FG004|STARTED|Treatment Phase|17 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|34||
59992206|NCT02249182|76107975|FG000|COMPLETED|Treatment Phase||96||
59992207|NCT02249182|76107976|FG001|COMPLETED|Treatment Phase||89||
59992208|NCT02249182|76107977|FG002|COMPLETED|Treatment Phase||1||
59992209|NCT02249182|76107978|FG003|COMPLETED|Treatment Phase||2||
59992210|NCT02249182|76107979|FG004|COMPLETED|Treatment Phase||34||
59992211|NCT02249182|76107975|FG000|NOT COMPLETED|Treatment Phase||4||
59992212|NCT02249182|76107976|FG001|NOT COMPLETED|Treatment Phase||0||
59992213|NCT02249182|76107977|FG002|NOT COMPLETED|Treatment Phase||0||
59992214|NCT02249182|76107978|FG003|NOT COMPLETED|Treatment Phase||0||
59992215|NCT02249182|76107979|FG004|NOT COMPLETED|Treatment Phase||0||
59992216|NCT03641339|76108010|FG000|STARTED|Overall Study||16||
59992217|NCT03641339|76108011|FG001|STARTED|Overall Study||17||
59992218|NCT03641339|76108012|FG002|STARTED|Overall Study||15||
59992219|NCT03641339|76108013|FG003|STARTED|Overall Study||16||
59992220|NCT03641339|76108014|FG004|STARTED|Overall Study||15||
59992221|NCT03641339|76108015|FG005|STARTED|Overall Study||16||
59992222|NCT03641339|76108010|FG000|COMPLETED|Overall Study||15||
59992223|NCT03641339|76108011|FG001|COMPLETED|Overall Study||15||
59992224|NCT03641339|76108012|FG002|COMPLETED|Overall Study||15||
59992225|NCT03641339|76108013|FG003|COMPLETED|Overall Study||14||
59992226|NCT03641339|76108014|FG004|COMPLETED|Overall Study||15||
59992227|NCT03641339|76108015|FG005|COMPLETED|Overall Study||15||
59992228|NCT03641339|76108010|FG000|NOT COMPLETED|Overall Study||1||
59992229|NCT03641339|76108011|FG001|NOT COMPLETED|Overall Study||2||
59992230|NCT03641339|76108012|FG002|NOT COMPLETED|Overall Study||0||
59992231|NCT03641339|76108013|FG003|NOT COMPLETED|Overall Study||2||
59992232|NCT03641339|76108014|FG004|NOT COMPLETED|Overall Study||0||
59992233|NCT03641339|76108015|FG005|NOT COMPLETED|Overall Study||1||
59992234|NCT02248480|76108031|FG000|STARTED|Overall Study||178||
59992235|NCT02248480|76108032|FG001|STARTED|Overall Study||176||
59992236|NCT02248480|76108031|FG000|Efficacy Population|Overall Study||177||
59992237|NCT02248480|76108032|FG001|Efficacy Population|Overall Study||176||
59992238|NCT02248480|76108031|FG000|COMPLETED|Overall Study||161||
59992239|NCT02248480|76108032|FG001|COMPLETED|Overall Study||162||
59992240|NCT02248480|76108031|FG000|NOT COMPLETED|Overall Study||17||
59560048|NCT01638416|75661259|FG001|NOT COMPLETED|Overall Study||42||
59560049|NCT02971293|75661266|FG000|STARTED|Overall Study||42|3-way, complete crossover. Each patient received all 3 treatments in turn; randomised sequence.|
59560050|NCT02971293|75661266|FG000|COMPLETED|Overall Study||31||
59560051|NCT02971293|75661266|FG000|NOT COMPLETED|Overall Study||11||
59560052|NCT02365584|75661276|FG000|STARTED|Overall Study||21||
59560053|NCT02365584|75661277|FG001|STARTED|Overall Study||22||
59560054|NCT02365584|75661276|FG000|COMPLETED|Overall Study||9||
59560055|NCT02365584|75661277|FG001|COMPLETED|Overall Study||8||
59560056|NCT02365584|75661276|FG000|NOT COMPLETED|Overall Study||12||
59560057|NCT02365584|75661277|FG001|NOT COMPLETED|Overall Study||14||
59560058|NCT01956071|75661283|FG000|STARTED|Overall Study||44||
59560059|NCT01956071|75661283|FG000|COMPLETED|Overall Study||44||
59560060|NCT01956071|75661283|FG000|NOT COMPLETED|Overall Study||0||
59560061|NCT02342418|75661289|FG000|STARTED|Overall Study||9||
59560062|NCT02342418|75661290|FG001|STARTED|Overall Study||10||
59560063|NCT02342418|75661289|FG000|COMPLETED|Overall Study||9||
59560064|NCT02342418|75661290|FG001|COMPLETED|Overall Study||9||
59560065|NCT02342418|75661289|FG000|NOT COMPLETED|Overall Study||0||
59560066|NCT02342418|75661290|FG001|NOT COMPLETED|Overall Study||1||
59560067|NCT01957085|75661296|FG000|STARTED|Overall Study|Per Institutional Review Board requirements, exact dates are not to be reported|366||
59560068|NCT01957085|75661296|FG000|COMPLETED|Overall Study|Per Institutional Review Board, exact dates are not to be reported|366||
59560069|NCT01957085|75661296|FG000|NOT COMPLETED|Overall Study||0||
59560070|NCT03102645|75661303|FG000|STARTED|Overall Study||8||
59560071|NCT03102645|75661304|FG001|STARTED|Overall Study||8||
59560072|NCT03102645|75661303|FG000|COMPLETED|Overall Study||8||
59560073|NCT03102645|75661304|FG001|COMPLETED|Overall Study||8||
59560074|NCT03102645|75661303|FG000|NOT COMPLETED|Overall Study||0||
59560075|NCT03102645|75661304|FG001|NOT COMPLETED|Overall Study||0||
59560076|NCT01639352|75661311|FG000|STARTED|Overall Study||20||
59560077|NCT01639352|75661311|FG000|COMPLETED|Overall Study||20||
59560078|NCT01639352|75661311|FG000|NOT COMPLETED|Overall Study||0||
59560079|NCT03102879|75661317|FG000|STARTED|Overall Study||18||
59560080|NCT03102879|75661318|FG001|STARTED|Overall Study||18||
59560081|NCT03102879|75661317|FG000|COMPLETED|Overall Study||18||
59560082|NCT03102879|75661318|FG001|COMPLETED|Overall Study||18||
59560083|NCT03102879|75661317|FG000|NOT COMPLETED|Overall Study||0||
59560084|NCT03102879|75661318|FG001|NOT COMPLETED|Overall Study||0||
59560085|NCT02365506|75661331|FG000|STARTED|Overall Study||4||
59560086|NCT02365506|75661332|FG001|STARTED|Overall Study||4||
59560087|NCT02365506|75661333|FG002|STARTED|Overall Study||5||
60085623|NCT02074995|76201946|FG000|STARTED|Overall Study||1||
60085624|NCT02074995|76201947|FG001|STARTED|Overall Study||0||
60085625|NCT02074995|76201948|FG002|STARTED|Overall Study||0||
60085626|NCT02074995|76201946|FG000|COMPLETED|Overall Study||1||
60085627|NCT02074995|76201947|FG001|COMPLETED|Overall Study||0||
60085628|NCT02074995|76201948|FG002|COMPLETED|Overall Study||0||
60085629|NCT02074995|76201946|FG000|NOT COMPLETED|Overall Study||0||
60085630|NCT02074995|76201947|FG001|NOT COMPLETED|Overall Study||0||
60085631|NCT02074995|76201948|FG002|NOT COMPLETED|Overall Study||0||
60085632|NCT01426347|76201954|FG000|STARTED|Overall Study||41||
59560088|NCT02365506|75661331|FG000|COMPLETED|Overall Study||4||
59560089|NCT02365506|75661332|FG001|COMPLETED|Overall Study||4||
59560090|NCT02365506|75661333|FG002|COMPLETED|Overall Study||4||
59560091|NCT02365506|75661331|FG000|NOT COMPLETED|Overall Study||0||
59560092|NCT02365506|75661332|FG001|NOT COMPLETED|Overall Study||0||
59560093|NCT02365506|75661333|FG002|NOT COMPLETED|Overall Study||1||
59560094|NCT01639664|75661343|FG000|STARTED|Overall Study||63||
59560095|NCT01639664|75661344|FG001|STARTED|Overall Study||52||
59560096|NCT01639664|75661343|FG000|COMPLETED|Overall Study||63||
59560097|NCT01639664|75661344|FG001|COMPLETED|Overall Study||52||
59560098|NCT01639664|75661343|FG000|NOT COMPLETED|Overall Study||0||
59560099|NCT01639664|75661344|FG001|NOT COMPLETED|Overall Study||0||
59560100|NCT03104985|75661353|FG000|STARTED|Overall Study||34||
59560101|NCT03104985|75661354|FG001|STARTED|Overall Study||34||
59560102|NCT03104985|75661353|FG000|COMPLETED|Overall Study||34||
60085633|NCT01426347|76201955|FG001|STARTED|Overall Study||42||
60085634|NCT01426347|76201954|FG000|COMPLETED|Overall Study||34||
60085635|NCT01426347|76201955|FG001|COMPLETED|Overall Study||39||
60085636|NCT01426347|76201954|FG000|NOT COMPLETED|Overall Study||7||
60085637|NCT01426347|76201955|FG001|NOT COMPLETED|Overall Study||3||
60085638|NCT01882465|76201961|FG000|STARTED|Period 1||6||
60085639|NCT01882465|76201962|FG001|STARTED|Period 1||6||
60085640|NCT01882465|76201963|FG002|STARTED|Period 1||5||
59560103|NCT03104985|75661354|FG001|COMPLETED|Overall Study||34||
59560104|NCT03104985|75661353|FG000|NOT COMPLETED|Overall Study||0||
59560105|NCT03104985|75661354|FG001|NOT COMPLETED|Overall Study||0||
59560106|NCT01705496|75661360|FG000|STARTED|Overall Study||23||
59560107|NCT01705496|75661360|FG000|COMPLETED|Overall Study||19||
59560108|NCT01705496|75661360|FG000|NOT COMPLETED|Overall Study||4||
59560109|NCT02287415|75661364|FG000|STARTED|Overall Study||13||
59560110|NCT02287415|75661364|FG000|COMPLETED|Overall Study||13||
59560111|NCT02287415|75661364|FG000|NOT COMPLETED|Overall Study||0||
59560112|NCT02312934|75661370|FG000|STARTED|Overall Study||11||
59560113|NCT02312934|75661371|FG001|STARTED|Overall Study||11||
59560114|NCT02312934|75661370|FG000|COMPLETED|Overall Study||9|Number Completed|
59560115|NCT02312934|75661371|FG001|COMPLETED|Overall Study||11|Number Completed|
60085641|NCT01882465|76201964|FG003|STARTED|Period 1||6||
60085642|NCT01882465|76201965|FG004|STARTED|Period 1||5||
60085643|NCT01882465|76201966|FG005|STARTED|Period 1||5||
60085644|NCT01882465|76201967|FG006|STARTED|Period 1||1||
60085645|NCT01882465|76201961|FG000|COMPLETED|Period 1||6||
60085646|NCT01882465|76201962|FG001|COMPLETED|Period 1||6||
60085647|NCT01882465|76201963|FG002|COMPLETED|Period 1||5||
60085648|NCT01882465|76201964|FG003|COMPLETED|Period 1||5||
60085649|NCT01882465|76201965|FG004|COMPLETED|Period 1||5||
60085650|NCT01882465|76201966|FG005|COMPLETED|Period 1||5||
59560116|NCT02312934|75661370|FG000|NOT COMPLETED|Overall Study||2||
59560117|NCT02312934|75661371|FG001|NOT COMPLETED|Overall Study||0||
59560118|NCT01602068|75661380|FG000|STARTED|Overall Study|Day before surgery|23||
59560119|NCT01602068|75661381|FG001|STARTED|Overall Study|Day before surgery|22||
59560120|NCT01602068|75661380|FG000|COMPLETED|Overall Study||23||
59560121|NCT01602068|75661381|FG001|COMPLETED|Overall Study||22||
59560122|NCT01602068|75661380|FG000|NOT COMPLETED|Overall Study||0||
59560123|NCT01602068|75661381|FG001|NOT COMPLETED|Overall Study||0||
59560124|NCT02978157|75661389|FG000|STARTED|Overall Study||52||
59560125|NCT02978157|75661390|FG001|STARTED|Overall Study||50||
59560126|NCT02978157|75661389|FG000|COMPLETED|Overall Study||52||
60085651|NCT01882465|76201967|FG006|COMPLETED|Period 1||0||
60085652|NCT01882465|76201961|FG000|NOT COMPLETED|Period 1||0||
59560127|NCT02978157|75661390|FG001|COMPLETED|Overall Study||50||
60085653|NCT01882465|76201962|FG001|NOT COMPLETED|Period 1||0||
60085654|NCT01882465|76201963|FG002|NOT COMPLETED|Period 1||0||
60085655|NCT01882465|76201964|FG003|NOT COMPLETED|Period 1||1||
60085656|NCT01882465|76201965|FG004|NOT COMPLETED|Period 1||0||
60085657|NCT01882465|76201966|FG005|NOT COMPLETED|Period 1||0||
60085658|NCT01882465|76201967|FG006|NOT COMPLETED|Period 1||1||
60085659|NCT01882465|76201961|FG000|STARTED|Period 2||6||
59560128|NCT02978157|75661389|FG000|NOT COMPLETED|Overall Study||0||
59560129|NCT02978157|75661390|FG001|NOT COMPLETED|Overall Study||0||
59560130|NCT01705964|75661398|FG000|STARTED|Overall Study||25||
60085660|NCT01882465|76201962|FG001|STARTED|Period 2||6||
60085661|NCT01882465|76201963|FG002|STARTED|Period 2||5||
60085662|NCT01882465|76201964|FG003|STARTED|Period 2||5||
59560131|NCT01705964|75661399|FG001|STARTED|Overall Study||24||
59560132|NCT01705964|75661398|FG000|COMPLETED|Overall Study||25||
59560133|NCT01705964|75661399|FG001|COMPLETED|Overall Study||24||
59560134|NCT01705964|75661398|FG000|NOT COMPLETED|Overall Study||0||
59560135|NCT01705964|75661399|FG001|NOT COMPLETED|Overall Study||0||
59560136|NCT02341482|75661405|FG000|STARTED|Overall Study||13||
59560137|NCT02341482|75661405|FG000|COMPLETED|Overall Study||12||
59560138|NCT02341482|75661405|FG000|NOT COMPLETED|Overall Study||1||
59560139|NCT03140631|75661416|FG000|STARTED|Overall Study||73||
59560140|NCT03140631|75661417|FG001|STARTED|Overall Study||77||
59560141|NCT03140631|75661416|FG000|COMPLETED|Overall Study||73||
59560142|NCT03140631|75661417|FG001|COMPLETED|Overall Study||77||
59560143|NCT03140631|75661416|FG000|NOT COMPLETED|Overall Study||0||
59560144|NCT03140631|75661417|FG001|NOT COMPLETED|Overall Study||0||
59707515|NCT01119963|75826408|FG001|NOT COMPLETED|Overall Study||1||
59707516|NCT01252667|75826422|FG000|STARTED|Overall Study||3||
59707517|NCT01252667|75826423|FG001|STARTED|Overall Study||3||
59992241|NCT02248480|76108032|FG001|NOT COMPLETED|Overall Study||14||
59992242|NCT01653158|76108039|FG000|STARTED|Overall Study||3||
59992243|NCT01653158|76108040|FG001|STARTED|Overall Study||3||
59992244|NCT01653158|76108041|FG002|STARTED|Overall Study||3||
60085663|NCT01882465|76201965|FG004|STARTED|Period 2||5||
60085664|NCT01882465|76201966|FG005|STARTED|Period 2||5||
60085665|NCT01882465|76201967|FG006|STARTED|Period 2||0||
60085666|NCT01882465|76201961|FG000|COMPLETED|Period 2||6||
60085667|NCT01882465|76201962|FG001|COMPLETED|Period 2||6||
60085668|NCT01882465|76201963|FG002|COMPLETED|Period 2||5||
60085669|NCT01882465|76201964|FG003|COMPLETED|Period 2||5||
60085670|NCT01882465|76201965|FG004|COMPLETED|Period 2||4||
60085671|NCT01882465|76201966|FG005|COMPLETED|Period 2||5||
60085672|NCT01882465|76201967|FG006|COMPLETED|Period 2||0||
60085673|NCT01882465|76201961|FG000|NOT COMPLETED|Period 2||0||
60085674|NCT01882465|76201962|FG001|NOT COMPLETED|Period 2||0||
60085675|NCT01882465|76201963|FG002|NOT COMPLETED|Period 2||0||
60085676|NCT01882465|76201964|FG003|NOT COMPLETED|Period 2||0||
60085677|NCT01882465|76201965|FG004|NOT COMPLETED|Period 2||1||
60085678|NCT01882465|76201966|FG005|NOT COMPLETED|Period 2||0||
60085679|NCT01882465|76201967|FG006|NOT COMPLETED|Period 2||0||
60085680|NCT01882465|76201961|FG000|STARTED|Period 3||6||
59560145|NCT01602614|75661428|FG000|STARTED|Overall Study||0||
59560146|NCT01602614|75661429|FG001|STARTED|Overall Study||10||
59992245|NCT01653158|76108042|FG003|STARTED|Overall Study||3||
59992246|NCT01653158|76108043|FG004|STARTED|Overall Study||3||
59992247|NCT01653158|76108044|FG005|STARTED|Overall Study||3||
59992248|NCT01653158|76108045|FG006|STARTED|Overall Study||9||
59992249|NCT01653158|76108046|FG007|STARTED|Overall Study|Six (6) and 13 participants were enrolled in dose escalation and expansion cohorts, respectively.|19||
59992250|NCT01653158|76108039|FG000|COMPLETED|Overall Study||2||
59992251|NCT01653158|76108040|FG001|COMPLETED|Overall Study||3||
60085681|NCT01882465|76201962|FG001|STARTED|Period 3||6||
59560147|NCT01602614|75661430|FG002|STARTED|Overall Study||8||
59560148|NCT01602614|75661431|FG003|STARTED|Overall Study||0||
59707518|NCT01252667|75826424|FG002|STARTED|Overall Study||3||
60085682|NCT01882465|76201963|FG002|STARTED|Period 3||5||
59992252|NCT01653158|76108041|FG002|COMPLETED|Overall Study||3||
60085683|NCT01882465|76201964|FG003|STARTED|Period 3||5||
60085684|NCT01882465|76201965|FG004|STARTED|Period 3||4||
60085685|NCT01882465|76201966|FG005|STARTED|Period 3||5||
59560149|NCT01602614|75661428|FG000|COMPLETED|Overall Study||0||
59560150|NCT01602614|75661429|FG001|COMPLETED|Overall Study||10||
59560151|NCT01602614|75661430|FG002|COMPLETED|Overall Study||8||
59560152|NCT01602614|75661431|FG003|COMPLETED|Overall Study||0||
59707519|NCT01252667|75826425|FG003|STARTED|Overall Study||0||
60085686|NCT01882465|76201967|FG006|STARTED|Period 3||0||
60085687|NCT01882465|76201961|FG000|COMPLETED|Period 3||6||
60085688|NCT01882465|76201962|FG001|COMPLETED|Period 3||6||
60085689|NCT01882465|76201963|FG002|COMPLETED|Period 3||5||
60085690|NCT01882465|76201964|FG003|COMPLETED|Period 3||5||
60085691|NCT01882465|76201965|FG004|COMPLETED|Period 3||4||
60085692|NCT01882465|76201966|FG005|COMPLETED|Period 3||5||
60085693|NCT01882465|76201967|FG006|COMPLETED|Period 3||0||
60085694|NCT01882465|76201961|FG000|NOT COMPLETED|Period 3||0||
60085695|NCT01882465|76201962|FG001|NOT COMPLETED|Period 3||0||
60085696|NCT01882465|76201963|FG002|NOT COMPLETED|Period 3||0||
60085697|NCT01882465|76201964|FG003|NOT COMPLETED|Period 3||0||
60085698|NCT01882465|76201965|FG004|NOT COMPLETED|Period 3||0||
60085699|NCT01882465|76201966|FG005|NOT COMPLETED|Period 3||0||
60085700|NCT01882465|76201967|FG006|NOT COMPLETED|Period 3||0||
60085701|NCT01426269|76201975|FG000|STARTED|Period 1: 12 Weeks||235||
60085702|NCT01426269|76201976|FG001|STARTED|Period 1: 12 Weeks||0||
60085703|NCT01426269|76201977|FG002|STARTED|Period 1: 12 Weeks||0||
60085704|NCT01426269|76201975|FG000|COMPLETED|Period 1: 12 Weeks||180||
60085705|NCT01426269|76201976|FG001|COMPLETED|Period 1: 12 Weeks||0||
59560153|NCT01602614|75661428|FG000|NOT COMPLETED|Overall Study||0||
59560154|NCT01602614|75661429|FG001|NOT COMPLETED|Overall Study||0||
59707520|NCT01252667|75826426|FG004|STARTED|Overall Study||0||
59992253|NCT01653158|76108042|FG003|COMPLETED|Overall Study||1||
59992254|NCT01653158|76108043|FG004|COMPLETED|Overall Study||2||
59992255|NCT01653158|76108044|FG005|COMPLETED|Overall Study||2||
60085706|NCT01426269|76201977|FG002|COMPLETED|Period 1: 12 Weeks||0||
60085707|NCT01426269|76201975|FG000|NOT COMPLETED|Period 1: 12 Weeks||55||
60085708|NCT01426269|76201976|FG001|NOT COMPLETED|Period 1: 12 Weeks||0||
59992256|NCT01653158|76108045|FG006|COMPLETED|Overall Study||7||
59992257|NCT01653158|76108046|FG007|COMPLETED|Overall Study||4||
59992258|NCT01653158|76108039|FG000|NOT COMPLETED|Overall Study||1||
59992259|NCT01653158|76108040|FG001|NOT COMPLETED|Overall Study||0||
59992260|NCT01653158|76108041|FG002|NOT COMPLETED|Overall Study||0||
60085709|NCT01426269|76201977|FG002|NOT COMPLETED|Period 1: 12 Weeks||0||
60085710|NCT01426269|76201975|FG000|STARTED|Eligibility for Period 2, Randomization||180||
60085711|NCT01426269|76201976|FG001|STARTED|Eligibility for Period 2, Randomization||0||
60085712|NCT01426269|76201977|FG002|STARTED|Eligibility for Period 2, Randomization||0||
60085713|NCT01426269|76201975|FG000|COMPLETED|Eligibility for Period 2, Randomization||130||
60085714|NCT01426269|76201976|FG001|COMPLETED|Eligibility for Period 2, Randomization||0||
60085715|NCT01426269|76201977|FG002|COMPLETED|Eligibility for Period 2, Randomization||0||
60085716|NCT01426269|76201975|FG000|NOT COMPLETED|Eligibility for Period 2, Randomization||50||
60085717|NCT01426269|76201976|FG001|NOT COMPLETED|Eligibility for Period 2, Randomization||0||
60085718|NCT01426269|76201977|FG002|NOT COMPLETED|Eligibility for Period 2, Randomization||0||
60085719|NCT01426269|76201975|FG000|STARTED|Period 2: 40 Weeks||0||
60085720|NCT01426269|76201976|FG001|STARTED|Period 2: 40 Weeks||65||
60085721|NCT01426269|76201977|FG002|STARTED|Period 2: 40 Weeks||65||
60085722|NCT01426269|76201975|FG000|COMPLETED|Period 2: 40 Weeks||0||
60085723|NCT01426269|76201976|FG001|COMPLETED|Period 2: 40 Weeks||27||
60085724|NCT01426269|76201977|FG002|COMPLETED|Period 2: 40 Weeks||18||
60085725|NCT01426269|76201975|FG000|NOT COMPLETED|Period 2: 40 Weeks||0||
60085726|NCT01426269|76201976|FG001|NOT COMPLETED|Period 2: 40 Weeks||38||
60085727|NCT01426269|76201977|FG002|NOT COMPLETED|Period 2: 40 Weeks||47||
59992261|NCT01653158|76108042|FG003|NOT COMPLETED|Overall Study||2||
59992262|NCT01653158|76108043|FG004|NOT COMPLETED|Overall Study||1||
59992263|NCT01653158|76108044|FG005|NOT COMPLETED|Overall Study||1||
59992264|NCT01653158|76108045|FG006|NOT COMPLETED|Overall Study||2||
59992265|NCT01653158|76108046|FG007|NOT COMPLETED|Overall Study||15||
60085728|NCT01426113|76201990|FG000|STARTED|Overall Study||3||
60085729|NCT01426113|76201991|FG001|STARTED|Overall Study||3||
60085730|NCT01426113|76201990|FG000|COMPLETED|Overall Study||2||
60085731|NCT01426113|76201991|FG001|COMPLETED|Overall Study||1||
60085732|NCT01426113|76201990|FG000|NOT COMPLETED|Overall Study||1||
60085733|NCT01426113|76201991|FG001|NOT COMPLETED|Overall Study||2||
60085734|NCT01864603|76201999|FG000|STARTED|Stage 1|Describes # of participants who were residents and aged 15+yrs at baseline|79818||16
60085735|NCT01864603|76202000|FG001|STARTED|Stage 1|Describes # of participants who were residents and aged 15+yrs at baseline|70577||16
59560155|NCT01602614|75661430|FG002|NOT COMPLETED|Overall Study||0||
59992266|NCT02247466|76108071|FG000|STARTED|Overall Study||19||
59992267|NCT02247466|76108072|FG001|STARTED|Overall Study||18||
60085736|NCT01864603|76201999|FG000|COMPLETED|Stage 1||71028||16
60085737|NCT01864603|76202000|FG001|COMPLETED|Stage 1||62912||16
59560156|NCT01602614|75661431|FG003|NOT COMPLETED|Overall Study||0||
59560157|NCT02312856|75661445|FG000|STARTED|Overall Study||34|10/22/2014|
59560158|NCT02312856|75661445|FG000|COMPLETED|Overall Study||30|11/07/2015|
59560159|NCT02312856|75661445|FG000|NOT COMPLETED|Overall Study||4||
59560160|NCT01706588|75661454|FG000|STARTED|Overall Study||15||
59560161|NCT01706588|75661455|FG001|STARTED|Overall Study||15||
59560162|NCT01706588|75661456|FG002|STARTED|Overall Study||15||
59560163|NCT01706588|75661457|FG003|STARTED|Overall Study||14||
59560164|NCT01706588|75661458|FG004|STARTED|Overall Study||16||
59560165|NCT01706588|75661454|FG000|COMPLETED|Overall Study||15||
59560166|NCT01706588|75661455|FG001|COMPLETED|Overall Study||15||
59560167|NCT01706588|75661456|FG002|COMPLETED|Overall Study||15||
59560168|NCT01706588|75661457|FG003|COMPLETED|Overall Study||14||
59560169|NCT01706588|75661458|FG004|COMPLETED|Overall Study||16||
59560170|NCT01706588|75661454|FG000|NOT COMPLETED|Overall Study||0||
59560171|NCT01706588|75661455|FG001|NOT COMPLETED|Overall Study||0||
60085738|NCT01864603|76201999|FG000|NOT COMPLETED|Stage 1||8790||0
60085739|NCT01864603|76202000|FG001|NOT COMPLETED|Stage 1||7665||0
60085740|NCT01864603|76201999|FG000|STARTED|Stage 2|Describes # of participants who were residents and aged 15+yrs at the start of Stage 2|91533||16
60085741|NCT01864603|76202000|FG001|STARTED|Stage 2|Describes # of participants who were residents and aged 15+yrs at the start of Stage 2|92558||16
60085742|NCT01864603|76201999|FG000|COMPLETED|Stage 2||5477||16
60085743|NCT01864603|76202000|FG001|COMPLETED|Stage 2||0||0
60085744|NCT01864603|76201999|FG000|NOT COMPLETED|Stage 2||86056||0
60085745|NCT01864603|76202000|FG001|NOT COMPLETED|Stage 2||92558||16
60085746|NCT01892293|76202011|FG000|STARTED|Overall Study||6||
60085747|NCT01892293|76202011|FG000|Received T-cell|Overall Study||2||
60085748|NCT01892293|76202011|FG000|COMPLETED|Overall Study||2||
60085749|NCT01892293|76202011|FG000|NOT COMPLETED|Overall Study||4||
60085750|NCT01393899|76202018|FG000|STARTED|Overall Study||59||
60085751|NCT01393899|76202019|FG001|STARTED|Overall Study||60||
60085752|NCT01393899|76202020|FG002|STARTED|Overall Study||61||
60085753|NCT01393899|76202018|FG000|COMPLETED|Overall Study||27||
60085754|NCT01393899|76202019|FG001|COMPLETED|Overall Study||32||
60085755|NCT01393899|76202020|FG002|COMPLETED|Overall Study||38||
60085756|NCT01393899|76202018|FG000|NOT COMPLETED|Overall Study||32||
60085757|NCT01393899|76202019|FG001|NOT COMPLETED|Overall Study||28||
59560172|NCT01706588|75661456|FG002|NOT COMPLETED|Overall Study||0||
59560173|NCT01706588|75661457|FG003|NOT COMPLETED|Overall Study||0||
59560174|NCT01706588|75661458|FG004|NOT COMPLETED|Overall Study||0||
59560175|NCT01602692|75661472|FG000|STARTED|Overall Study||20||
59560176|NCT01602692|75661473|FG001|STARTED|Overall Study||20||
59560177|NCT01602692|75661472|FG000|COMPLETED|Overall Study||20||
60085758|NCT01393899|76202020|FG002|NOT COMPLETED|Overall Study||23||
60085759|NCT01393743|76202032|FG000|STARTED|Core Study|Treated|82||
60085760|NCT01393743|76202033|FG001|STARTED|Core Study|Treated|81||
60085761|NCT01393743|76202034|FG002|STARTED|Core Study||0||
60085762|NCT01393743|76202032|FG000|COMPLETED|Core Study||72||
60085763|NCT01393743|76202033|FG001|COMPLETED|Core Study||68||
60085764|NCT01393743|76202034|FG002|COMPLETED|Core Study||0||
60085765|NCT01393743|76202032|FG000|NOT COMPLETED|Core Study||10||
60085766|NCT01393743|76202033|FG001|NOT COMPLETED|Core Study||13||
60085767|NCT01393743|76202034|FG002|NOT COMPLETED|Core Study||0||
60085768|NCT01393743|76202032|FG000|STARTED|Extension Phase||0||
60085769|NCT01393743|76202033|FG001|STARTED|Extension Phase||0||
60085770|NCT01393743|76202034|FG002|STARTED|Extension Phase|Continuation into the Extension Phase was optional.|138||
60085771|NCT01393743|76202032|FG000|COMPLETED|Extension Phase||0||
60085772|NCT01393743|76202033|FG001|COMPLETED|Extension Phase||0||
60085773|NCT01393743|76202034|FG002|COMPLETED|Extension Phase||78||
60085774|NCT01393743|76202032|FG000|NOT COMPLETED|Extension Phase||0||
60085775|NCT01393743|76202033|FG001|NOT COMPLETED|Extension Phase||0||
60085776|NCT01393743|76202034|FG002|NOT COMPLETED|Extension Phase||60||
60085777|NCT02078193|76202045|FG000|STARTED|Overall Study||3||
60085778|NCT02078193|76202045|FG000|COMPLETED|Overall Study||3||
60085779|NCT02078193|76202045|FG000|NOT COMPLETED|Overall Study||0||
60085780|NCT01405911|76202053|FG000|STARTED|Overall Study||83||
59560178|NCT01602692|75661473|FG001|COMPLETED|Overall Study||20||
59560179|NCT01602692|75661472|FG000|NOT COMPLETED|Overall Study||0||
59560180|NCT01602692|75661473|FG001|NOT COMPLETED|Overall Study||0||
59560181|NCT02984709|75661485|FG000|STARTED|Overall Study|We enrolled 24 adolescent-parent dyads.|24||
59707521|NCT01252667|75826427|FG005|STARTED|Overall Study||35||
60085781|NCT01405911|76202054|FG001|STARTED|Overall Study||82||
60085782|NCT01405911|76202055|FG002|STARTED|Overall Study||77||
60085783|NCT01405911|76202053|FG000|Treated|Overall Study||82||
60085784|NCT01405911|76202054|FG001|Treated|Overall Study|1 participant received study drug but was discontinued due to pre-treatment lab AE.|82||
60085785|NCT01405911|76202055|FG002|Treated|Overall Study||77||
60085786|NCT01405911|76202053|FG000|COMPLETED|Overall Study||79||
60085787|NCT01405911|76202054|FG001|COMPLETED|Overall Study||79||
60085788|NCT01405911|76202055|FG002|COMPLETED|Overall Study||76||
60085789|NCT01405911|76202053|FG000|NOT COMPLETED|Overall Study||4||
60085790|NCT01405911|76202054|FG001|NOT COMPLETED|Overall Study||3||
60085791|NCT01405911|76202055|FG002|NOT COMPLETED|Overall Study||1||
60085792|NCT01425801|76202063|FG000|STARTED|Period 1||9||
60085793|NCT01425801|76202064|FG001|STARTED|Period 1||9||
60085794|NCT01425801|76202065|FG002|STARTED|Period 1||9||
60085795|NCT01425801|76202066|FG003|STARTED|Period 1||12||
60085796|NCT01425801|76202067|FG004|STARTED|Period 1||13||
60085797|NCT01425801|76202068|FG005|STARTED|Period 1||10||
60085798|NCT01425801|76202063|FG000|COMPLETED|Period 1||9||
60085799|NCT01425801|76202064|FG001|COMPLETED|Period 1||9||
60085800|NCT01425801|76202065|FG002|COMPLETED|Period 1||9||
60085801|NCT01425801|76202066|FG003|COMPLETED|Period 1||12||
60085802|NCT01425801|76202067|FG004|COMPLETED|Period 1||12||
60085803|NCT01425801|76202068|FG005|COMPLETED|Period 1||10||
60085804|NCT01425801|76202063|FG000|NOT COMPLETED|Period 1||0||
60085805|NCT01425801|76202064|FG001|NOT COMPLETED|Period 1||0||
60085806|NCT01425801|76202065|FG002|NOT COMPLETED|Period 1||0||
60085807|NCT01425801|76202066|FG003|NOT COMPLETED|Period 1||0||
60085808|NCT01425801|76202067|FG004|NOT COMPLETED|Period 1||1||
60085809|NCT01425801|76202068|FG005|NOT COMPLETED|Period 1||0||
60085810|NCT01425801|76202063|FG000|STARTED|Period 2||9||
60085811|NCT01425801|76202064|FG001|STARTED|Period 2||9||
60085812|NCT01425801|76202065|FG002|STARTED|Period 2||9||
60085813|NCT01425801|76202066|FG003|STARTED|Period 2||12||
60085814|NCT01425801|76202067|FG004|STARTED|Period 2||12||
60085815|NCT01425801|76202068|FG005|STARTED|Period 2||10||
60085816|NCT01425801|76202063|FG000|COMPLETED|Period 2||9||
60085817|NCT01425801|76202064|FG001|COMPLETED|Period 2||9||
60085818|NCT01425801|76202065|FG002|COMPLETED|Period 2||9||
60085819|NCT01425801|76202066|FG003|COMPLETED|Period 2||12||
60085820|NCT01425801|76202067|FG004|COMPLETED|Period 2||11||
60085821|NCT01425801|76202068|FG005|COMPLETED|Period 2||10||
60085822|NCT01425801|76202063|FG000|NOT COMPLETED|Period 2||0||
60085823|NCT01425801|76202064|FG001|NOT COMPLETED|Period 2||0||
60085824|NCT01425801|76202065|FG002|NOT COMPLETED|Period 2||0||
60085825|NCT01425801|76202066|FG003|NOT COMPLETED|Period 2||0||
60085826|NCT01425801|76202067|FG004|NOT COMPLETED|Period 2||1||
60085827|NCT01425801|76202068|FG005|NOT COMPLETED|Period 2||0||
60085828|NCT01425801|76202063|FG000|STARTED|Period 3||9||
60085829|NCT01425801|76202064|FG001|STARTED|Period 3||9||
60085830|NCT01425801|76202065|FG002|STARTED|Period 3||9||
60085831|NCT01425801|76202066|FG003|STARTED|Period 3||12||
59560182|NCT02984709|75661486|FG001|STARTED|Overall Study|We enrolled 24 adolescent-parent dyads.|24||
59560183|NCT02984709|75661485|FG000|COMPLETED|Overall Study||24||
59560184|NCT02984709|75661486|FG001|COMPLETED|Overall Study||24||
59560185|NCT02984709|75661485|FG000|NOT COMPLETED|Overall Study||0||
59560186|NCT02984709|75661486|FG001|NOT COMPLETED|Overall Study||0||
59560187|NCT01603940|75661496|FG000|STARTED|Overall Study||16||
59560188|NCT01603940|75661497|FG001|STARTED|Overall Study||14||
59560189|NCT01603940|75661496|FG000|COMPLETED|Overall Study||16||
59560190|NCT01603940|75661497|FG001|COMPLETED|Overall Study||14||
59560191|NCT01603940|75661496|FG000|NOT COMPLETED|Overall Study||0||
59560192|NCT01603940|75661497|FG001|NOT COMPLETED|Overall Study||0||
59560193|NCT01605032|75661503|FG000|STARTED|Overall Study||19||
59560194|NCT01605032|75661503|FG000|COMPLETED|Overall Study||18||
59560195|NCT01605032|75661503|FG000|NOT COMPLETED|Overall Study||1||
59560196|NCT01706666|75661510|FG000|STARTED|Overall Study||1||
59560197|NCT01706666|75661511|FG001|STARTED|Overall Study||1||
59560198|NCT01706666|75661512|FG002|STARTED|Overall Study||1||
59992268|NCT02247466|76108071|FG000|COMPLETED|Overall Study||19||
59992269|NCT02247466|76108072|FG001|COMPLETED|Overall Study||15||
60085832|NCT01425801|76202067|FG004|STARTED|Period 3||11||
60085833|NCT01425801|76202068|FG005|STARTED|Period 3||10||
60085834|NCT01425801|76202063|FG000|COMPLETED|Period 3||9||
60085835|NCT01425801|76202064|FG001|COMPLETED|Period 3||9||
60085836|NCT01425801|76202065|FG002|COMPLETED|Period 3||8||
60085837|NCT01425801|76202066|FG003|COMPLETED|Period 3||12||
59992270|NCT02247466|76108071|FG000|NOT COMPLETED|Overall Study||0||
59992271|NCT02247466|76108072|FG001|NOT COMPLETED|Overall Study||3||
59992272|NCT03317795|76108080|FG000|STARTED|Overall Study||9||
59992273|NCT03317795|76108081|FG001|STARTED|Overall Study||9||
59992274|NCT03317795|76108080|FG000|COMPLETED|Overall Study||7||
59992275|NCT03317795|76108081|FG001|COMPLETED|Overall Study||2||
59992276|NCT03317795|76108080|FG000|NOT COMPLETED|Overall Study||2||
59992277|NCT03317795|76108081|FG001|NOT COMPLETED|Overall Study||7||
60085838|NCT01425801|76202067|FG004|COMPLETED|Period 3||11||
60085839|NCT01425801|76202068|FG005|COMPLETED|Period 3||10||
60085840|NCT01425801|76202063|FG000|NOT COMPLETED|Period 3||0||
60085841|NCT01425801|76202064|FG001|NOT COMPLETED|Period 3||0||
60085842|NCT01425801|76202065|FG002|NOT COMPLETED|Period 3||1||
60085843|NCT01425801|76202066|FG003|NOT COMPLETED|Period 3||0||
60085844|NCT01425801|76202067|FG004|NOT COMPLETED|Period 3||0||
60085845|NCT01425801|76202068|FG005|NOT COMPLETED|Period 3||0||
60085846|NCT01425801|76202063|FG000|STARTED|Period 4||9||
60085847|NCT01425801|76202064|FG001|STARTED|Period 4||9||
60085848|NCT01425801|76202065|FG002|STARTED|Period 4||8||
60085849|NCT01425801|76202066|FG003|STARTED|Period 4||12||
60085850|NCT01425801|76202067|FG004|STARTED|Period 4||11||
60085851|NCT01425801|76202068|FG005|STARTED|Period 4||10||
60085852|NCT01425801|76202063|FG000|COMPLETED|Period 4||9||
60085853|NCT01425801|76202064|FG001|COMPLETED|Period 4||9||
60085854|NCT01425801|76202065|FG002|COMPLETED|Period 4||7||
60085855|NCT01425801|76202066|FG003|COMPLETED|Period 4||12||
60085856|NCT01425801|76202067|FG004|COMPLETED|Period 4||11||
60085857|NCT01425801|76202068|FG005|COMPLETED|Period 4||10||
60085858|NCT01425801|76202063|FG000|NOT COMPLETED|Period 4||0||
60085859|NCT01425801|76202064|FG001|NOT COMPLETED|Period 4||0||
60085860|NCT01425801|76202065|FG002|NOT COMPLETED|Period 4||1||
60085861|NCT01425801|76202066|FG003|NOT COMPLETED|Period 4||0||
59560199|NCT01706666|75661510|FG000|COMPLETED|Overall Study||1||
59560200|NCT01706666|75661511|FG001|COMPLETED|Overall Study||1||
59560201|NCT01706666|75661512|FG002|COMPLETED|Overall Study||1||
59560202|NCT01706666|75661510|FG000|NOT COMPLETED|Overall Study||0||
59560203|NCT01706666|75661511|FG001|NOT COMPLETED|Overall Study||0||
59560204|NCT01706666|75661512|FG002|NOT COMPLETED|Overall Study||0||
59560205|NCT03149991|75661522|FG000|STARTED|Overall Study||25||
59560206|NCT03149991|75661523|FG001|STARTED|Overall Study||26||
59560207|NCT03149991|75661522|FG000|Completed Primary Endpoint (Day 14)|Overall Study||25||
59560208|NCT03149991|75661523|FG001|Completed Primary Endpoint (Day 14)|Overall Study||24||
59992278|NCT02202616|76108087|FG000|STARTED|Overall Study||401||
59992279|NCT02202616|76108087|FG000|Intent to Treat Set (ITT)|Overall Study||338||
59560209|NCT03149991|75661522|FG000|Exited|Overall Study||4||
59560210|NCT03149991|75661523|FG001|Exited|Overall Study||2||
59560211|NCT03149991|75661522|FG000|COMPLETED|Overall Study||21||
59560212|NCT03149991|75661523|FG001|COMPLETED|Overall Study||24||
59560213|NCT03149991|75661522|FG000|NOT COMPLETED|Overall Study||4||
59992280|NCT02202616|76108087|FG000|COMPLETED|Overall Study||301||
59992281|NCT02202616|76108087|FG000|NOT COMPLETED|Overall Study||100||
60085862|NCT01425801|76202067|FG004|NOT COMPLETED|Period 4||0||
60085863|NCT01425801|76202068|FG005|NOT COMPLETED|Period 4||0||
60085864|NCT01425801|76202063|FG000|STARTED|Period 5||9||
60085865|NCT01425801|76202064|FG001|STARTED|Period 5||9||
60085866|NCT01425801|76202065|FG002|STARTED|Period 5||7||
60085867|NCT01425801|76202066|FG003|STARTED|Period 5||12||
60085868|NCT01425801|76202067|FG004|STARTED|Period 5||11||
60085869|NCT01425801|76202068|FG005|STARTED|Period 5||10||
60085870|NCT01425801|76202063|FG000|COMPLETED|Period 5||9||
60085871|NCT01425801|76202064|FG001|COMPLETED|Period 5||9||
60085872|NCT01425801|76202065|FG002|COMPLETED|Period 5||7||
59560214|NCT03149991|75661523|FG001|NOT COMPLETED|Overall Study||2||
59560215|NCT01706822|75661529|FG000|STARTED|Overall Study||8||
59560216|NCT01706822|75661529|FG000|COMPLETED|Overall Study||8||
59560217|NCT01706822|75661529|FG000|NOT COMPLETED|Overall Study||0||
59560218|NCT01706978|75661535|FG000|STARTED|Overall Study||47||
59560219|NCT01706978|75661536|FG001|STARTED|Overall Study||41||
59560220|NCT01706978|75661535|FG000|COMPLETED|Overall Study||38||
59560221|NCT01706978|75661536|FG001|COMPLETED|Overall Study||35||
59560222|NCT01706978|75661535|FG000|NOT COMPLETED|Overall Study||9||
60085873|NCT01425801|76202066|FG003|COMPLETED|Period 5||12||
60085874|NCT01425801|76202067|FG004|COMPLETED|Period 5||11||
60085875|NCT01425801|76202068|FG005|COMPLETED|Period 5||10||
60085876|NCT01425801|76202063|FG000|NOT COMPLETED|Period 5||0||
60085877|NCT01425801|76202064|FG001|NOT COMPLETED|Period 5||0||
60085878|NCT01425801|76202065|FG002|NOT COMPLETED|Period 5||0||
60085879|NCT01425801|76202066|FG003|NOT COMPLETED|Period 5||0||
60085880|NCT01425801|76202067|FG004|NOT COMPLETED|Period 5||0||
60085881|NCT01425801|76202068|FG005|NOT COMPLETED|Period 5||0||
60085882|NCT01425801|76202063|FG000|STARTED|Period 6||9||
59560223|NCT01706978|75661536|FG001|NOT COMPLETED|Overall Study||6||
59560224|NCT01707368|75661542|FG000|STARTED|Overall Study||561||
59560225|NCT01707368|75661542|FG000|COMPLETED|Overall Study||393||
59560226|NCT01707368|75661542|FG000|NOT COMPLETED|Overall Study||168||
59560227|NCT01605890|75661546|FG000|STARTED|Overall Study||30||
59560228|NCT01605890|75661546|FG000|COMPLETED|Overall Study||28||
59707522|NCT01252667|75826422|FG000|COMPLETED|Overall Study||3||
59560229|NCT01605890|75661546|FG000|NOT COMPLETED|Overall Study||2||
59560230|NCT02288273|75661552|FG000|STARTED|Overall Study||61||
59560231|NCT02288273|75661553|FG001|STARTED|Overall Study||56||
60085883|NCT01425801|76202064|FG001|STARTED|Period 6||9||
60085884|NCT01425801|76202065|FG002|STARTED|Period 6||7||
60085885|NCT01425801|76202066|FG003|STARTED|Period 6||12||
60085886|NCT01425801|76202067|FG004|STARTED|Period 6||11||
60085887|NCT01425801|76202068|FG005|STARTED|Period 6||10||
60085888|NCT01425801|76202063|FG000|COMPLETED|Period 6||9||
60085889|NCT01425801|76202064|FG001|COMPLETED|Period 6||9||
60085890|NCT01425801|76202065|FG002|COMPLETED|Period 6||7||
60085891|NCT01425801|76202066|FG003|COMPLETED|Period 6||12||
60085892|NCT01425801|76202067|FG004|COMPLETED|Period 6||11||
60085893|NCT01425801|76202068|FG005|COMPLETED|Period 6||10||
60085894|NCT01425801|76202063|FG000|NOT COMPLETED|Period 6||0||
60085895|NCT01425801|76202064|FG001|NOT COMPLETED|Period 6||0||
60085896|NCT01425801|76202065|FG002|NOT COMPLETED|Period 6||0||
60085897|NCT01425801|76202066|FG003|NOT COMPLETED|Period 6||0||
60085898|NCT01425801|76202067|FG004|NOT COMPLETED|Period 6||0||
60085899|NCT01425801|76202068|FG005|NOT COMPLETED|Period 6||0||
60085900|NCT02335125|76202084|FG000|STARTED|Overall Study||20||
60085901|NCT02335125|76202085|FG001|STARTED|Overall Study||20||
59560232|NCT02288273|75661552|FG000|COMPLETED|Overall Study||53||
59560233|NCT02288273|75661553|FG001|COMPLETED|Overall Study||48||
59560234|NCT02288273|75661552|FG000|NOT COMPLETED|Overall Study||8||
59560235|NCT02288273|75661553|FG001|NOT COMPLETED|Overall Study||8||
59560236|NCT03160287|75661559|FG000|STARTED|Overall Study||24||
60085902|NCT02335125|76202084|FG000|COMPLETED|Overall Study||20||
60085903|NCT02335125|76202085|FG001|COMPLETED|Overall Study||20||
60085904|NCT02335125|76202084|FG000|NOT COMPLETED|Overall Study||0||
60085905|NCT02335125|76202085|FG001|NOT COMPLETED|Overall Study||0||
60085906|NCT01425723|76202093|FG000|STARTED|Overall Study|13 participants in <6 Years Old Age Cohort and 14 participants in 6 to <12 Years Old Age Cohort.|27||
60085907|NCT01425723|76202094|FG001|STARTED|Overall Study||93||
60085908|NCT01425723|76202093|FG000|Weekly Prophylaxis|Overall Study||23||
60085909|NCT01425723|76202094|FG001|Weekly Prophylaxis|Overall Study||51||
60085910|NCT01425723|76202093|FG000|Individualized Prophylaxis|Overall Study||5||
60085911|NCT01425723|76202094|FG001|Individualized Prophylaxis|Overall Study||31||
60085912|NCT01425723|76202093|FG000|Personalized Prophylaxis|Overall Study||2||
60085913|NCT01425723|76202094|FG001|Personalized Prophylaxis|Overall Study||17||
60085914|NCT01425723|76202093|FG000|Episodic|Overall Study||0||
60085915|NCT01425723|76202094|FG001|Episodic|Overall Study||15||
60085916|NCT01425723|76202093|FG000|Surgery Subgroup|Overall Study||1|Participants who have undergone major surgery or have major surgical/rehabilitation period in study.|
60085917|NCT01425723|76202094|FG001|Surgery Subgroup|Overall Study||15|Participants who have undergone major surgery or have major surgical/rehabilitation period in study.|
60085918|NCT01425723|76202093|FG000|COMPLETED|Overall Study||23||
60085919|NCT01425723|76202094|FG001|COMPLETED|Overall Study||75||
60085920|NCT01425723|76202093|FG000|NOT COMPLETED|Overall Study||4||
60085921|NCT01425723|76202094|FG001|NOT COMPLETED|Overall Study||18||
60085922|NCT02076243|76202109|FG000|STARTED|Overall Study||2||
60085923|NCT02076243|76202109|FG000|COMPLETED|Overall Study||0||
60085924|NCT02076243|76202109|FG000|NOT COMPLETED|Overall Study||2||
60085925|NCT01424397|76202125|FG000|STARTED|Period-1 (8 Days)||7||
60085926|NCT01424397|76202126|FG001|STARTED|Period-1 (8 Days)||8||
59560237|NCT03160287|75661559|FG000|COMPLETED|Overall Study||22||
59992282|NCT02455388|76108094|FG000|STARTED|Overall Study||18||
59992283|NCT02455388|76108095|FG001|STARTED|Overall Study||15||
59992284|NCT02455388|76108096|FG002|STARTED|Overall Study||337||
59992285|NCT02455388|76108094|FG000|COMPLETED|Overall Study||17||
59992286|NCT02455388|76108095|FG001|COMPLETED|Overall Study||15||
60085927|NCT01424397|76202127|FG002|STARTED|Period-1 (8 Days)||8||
60085928|NCT01424397|76202128|FG003|STARTED|Period-1 (8 Days)||8||
60085929|NCT01424397|76202129|FG004|STARTED|Period-1 (8 Days)||8||
60085930|NCT01424397|76202130|FG005|STARTED|Period-1 (8 Days)||8||
60085931|NCT01424397|76202131|FG006|STARTED|Period-1 (8 Days)||4||
60085932|NCT01424397|76202132|FG007|STARTED|Period-1 (8 Days)||4||
60085933|NCT01424397|76202133|FG008|STARTED|Period-1 (8 Days)||4||
60085934|NCT01424397|76202134|FG009|STARTED|Period-1 (8 Days)||3||
59560238|NCT03160287|75661559|FG000|NOT COMPLETED|Overall Study||2||
59560239|NCT01606124|75661565|FG000|STARTED|Overall Study||19||
59560240|NCT01606124|75661566|FG001|STARTED|Overall Study||20||
59560241|NCT01606124|75661565|FG000|COMPLETED|Overall Study||19||
59992287|NCT02455388|76108096|FG002|COMPLETED|Overall Study||326||
59992288|NCT02455388|76108094|FG000|NOT COMPLETED|Overall Study||1||
59992289|NCT02455388|76108095|FG001|NOT COMPLETED|Overall Study||0||
59992290|NCT02455388|76108096|FG002|NOT COMPLETED|Overall Study||11||
59992291|NCT02455076|76108109|FG000|STARTED|Inpatient||47||
59992292|NCT02455076|76108110|FG001|STARTED|Inpatient||51||
59992293|NCT02455076|76108111|FG002|STARTED|Inpatient||52||
59992294|NCT02455076|76108112|FG003|STARTED|Inpatient||0||
60085935|NCT01424397|76202135|FG010|STARTED|Period-1 (8 Days)||4||
60085936|NCT01424397|76202136|FG011|STARTED|Period-1 (8 Days)||4||
60085937|NCT01424397|76202125|FG000|COMPLETED|Period-1 (8 Days)||7||
60085938|NCT01424397|76202126|FG001|COMPLETED|Period-1 (8 Days)||8||
60085939|NCT01424397|76202127|FG002|COMPLETED|Period-1 (8 Days)||8||
60085940|NCT01424397|76202128|FG003|COMPLETED|Period-1 (8 Days)||8||
60085941|NCT01424397|76202129|FG004|COMPLETED|Period-1 (8 Days)||8||
60085942|NCT01424397|76202130|FG005|COMPLETED|Period-1 (8 Days)||8||
59560242|NCT01606124|75661566|FG001|COMPLETED|Overall Study||20||
59560243|NCT01606124|75661565|FG000|NOT COMPLETED|Overall Study||0||
59560244|NCT01606124|75661566|FG001|NOT COMPLETED|Overall Study||0||
60085943|NCT01424397|76202131|FG006|COMPLETED|Period-1 (8 Days)||4||
60085944|NCT01424397|76202132|FG007|COMPLETED|Period-1 (8 Days)||4||
60085945|NCT01424397|76202133|FG008|COMPLETED|Period-1 (8 Days)||4||
60085946|NCT01424397|76202134|FG009|COMPLETED|Period-1 (8 Days)||3||
60085947|NCT01424397|76202135|FG010|COMPLETED|Period-1 (8 Days)||4||
60085948|NCT01424397|76202136|FG011|COMPLETED|Period-1 (8 Days)||4||
60085949|NCT01424397|76202125|FG000|NOT COMPLETED|Period-1 (8 Days)||0||
60085950|NCT01424397|76202126|FG001|NOT COMPLETED|Period-1 (8 Days)||0||
60085951|NCT01424397|76202127|FG002|NOT COMPLETED|Period-1 (8 Days)||0||
60085952|NCT01424397|76202128|FG003|NOT COMPLETED|Period-1 (8 Days)||0||
60085953|NCT01424397|76202129|FG004|NOT COMPLETED|Period-1 (8 Days)||0||
60085954|NCT01424397|76202130|FG005|NOT COMPLETED|Period-1 (8 Days)||0||
60085955|NCT01424397|76202131|FG006|NOT COMPLETED|Period-1 (8 Days)||0||
60085956|NCT01424397|76202132|FG007|NOT COMPLETED|Period-1 (8 Days)||0||
60085957|NCT01424397|76202133|FG008|NOT COMPLETED|Period-1 (8 Days)||0||
60085958|NCT01424397|76202134|FG009|NOT COMPLETED|Period-1 (8 Days)||0||
60085959|NCT01424397|76202135|FG010|NOT COMPLETED|Period-1 (8 Days)||0||
60085960|NCT01424397|76202136|FG011|NOT COMPLETED|Period-1 (8 Days)||0||
60085961|NCT01424397|76202125|FG000|STARTED|Washout Period-1 (14-20 Days)||7||
60085962|NCT01424397|76202126|FG001|STARTED|Washout Period-1 (14-20 Days)||8||
60085963|NCT01424397|76202127|FG002|STARTED|Washout Period-1 (14-20 Days)||8||
60085964|NCT01424397|76202128|FG003|STARTED|Washout Period-1 (14-20 Days)||8||
60085965|NCT01424397|76202129|FG004|STARTED|Washout Period-1 (14-20 Days)||8||
60085966|NCT01424397|76202130|FG005|STARTED|Washout Period-1 (14-20 Days)||8||
60085967|NCT01424397|76202131|FG006|STARTED|Washout Period-1 (14-20 Days)||4||
60085968|NCT01424397|76202132|FG007|STARTED|Washout Period-1 (14-20 Days)||4||
60085969|NCT01424397|76202133|FG008|STARTED|Washout Period-1 (14-20 Days)||4||
60085970|NCT01424397|76202134|FG009|STARTED|Washout Period-1 (14-20 Days)||3||
60085971|NCT01424397|76202135|FG010|STARTED|Washout Period-1 (14-20 Days)||4||
60085972|NCT01424397|76202136|FG011|STARTED|Washout Period-1 (14-20 Days)||4||
60085973|NCT01424397|76202125|FG000|COMPLETED|Washout Period-1 (14-20 Days)||7||
60085974|NCT01424397|76202126|FG001|COMPLETED|Washout Period-1 (14-20 Days)||8||
60085975|NCT01424397|76202127|FG002|COMPLETED|Washout Period-1 (14-20 Days)||8||
60085976|NCT01424397|76202128|FG003|COMPLETED|Washout Period-1 (14-20 Days)||8||
60085977|NCT01424397|76202129|FG004|COMPLETED|Washout Period-1 (14-20 Days)||8||
60085978|NCT01424397|76202130|FG005|COMPLETED|Washout Period-1 (14-20 Days)||8||
60085979|NCT01424397|76202131|FG006|COMPLETED|Washout Period-1 (14-20 Days)||4||
60085980|NCT01424397|76202132|FG007|COMPLETED|Washout Period-1 (14-20 Days)||4||
60085981|NCT01424397|76202133|FG008|COMPLETED|Washout Period-1 (14-20 Days)||4||
60085982|NCT01424397|76202134|FG009|COMPLETED|Washout Period-1 (14-20 Days)||3||
60085983|NCT01424397|76202135|FG010|COMPLETED|Washout Period-1 (14-20 Days)||4||
60085984|NCT01424397|76202136|FG011|COMPLETED|Washout Period-1 (14-20 Days)||4||
60085985|NCT01424397|76202125|FG000|NOT COMPLETED|Washout Period-1 (14-20 Days)||0||
60085986|NCT01424397|76202126|FG001|NOT COMPLETED|Washout Period-1 (14-20 Days)||0||
60085987|NCT01424397|76202127|FG002|NOT COMPLETED|Washout Period-1 (14-20 Days)||0||
60085988|NCT01424397|76202128|FG003|NOT COMPLETED|Washout Period-1 (14-20 Days)||0||
60085989|NCT01424397|76202129|FG004|NOT COMPLETED|Washout Period-1 (14-20 Days)||0||
60085990|NCT01424397|76202130|FG005|NOT COMPLETED|Washout Period-1 (14-20 Days)||0||
60085991|NCT01424397|76202131|FG006|NOT COMPLETED|Washout Period-1 (14-20 Days)||0||
60085992|NCT01424397|76202132|FG007|NOT COMPLETED|Washout Period-1 (14-20 Days)||0||
60085993|NCT01424397|76202133|FG008|NOT COMPLETED|Washout Period-1 (14-20 Days)||0||
60085994|NCT01424397|76202134|FG009|NOT COMPLETED|Washout Period-1 (14-20 Days)||0||
60085995|NCT01424397|76202135|FG010|NOT COMPLETED|Washout Period-1 (14-20 Days)||0||
60085996|NCT01424397|76202136|FG011|NOT COMPLETED|Washout Period-1 (14-20 Days)||0||
60085997|NCT01424397|76202125|FG000|STARTED|Period-2 (8 Days)||7||
60085998|NCT01424397|76202126|FG001|STARTED|Period-2 (8 Days)||8||
60085999|NCT01424397|76202127|FG002|STARTED|Period-2 (8 Days)||8||
60086000|NCT01424397|76202128|FG003|STARTED|Period-2 (8 Days)||8||
60086001|NCT01424397|76202129|FG004|STARTED|Period-2 (8 Days)||8||
59560245|NCT03163017|75661572|FG000|STARTED|Overall Study||30||
60086002|NCT01424397|76202130|FG005|STARTED|Period-2 (8 Days)||8||
60086003|NCT01424397|76202131|FG006|STARTED|Period-2 (8 Days)||4||
60086004|NCT01424397|76202132|FG007|STARTED|Period-2 (8 Days)||4||
60086005|NCT01424397|76202133|FG008|STARTED|Period-2 (8 Days)||4||
60086006|NCT01424397|76202134|FG009|STARTED|Period-2 (8 Days)||3||
60086007|NCT01424397|76202135|FG010|STARTED|Period-2 (8 Days)||4||
60086008|NCT01424397|76202136|FG011|STARTED|Period-2 (8 Days)||4||
60086009|NCT01424397|76202125|FG000|COMPLETED|Period-2 (8 Days)||7||
60086010|NCT01424397|76202126|FG001|COMPLETED|Period-2 (8 Days)||8||
60086011|NCT01424397|76202127|FG002|COMPLETED|Period-2 (8 Days)||7||
60086012|NCT01424397|76202128|FG003|COMPLETED|Period-2 (8 Days)||8||
60086013|NCT01424397|76202129|FG004|COMPLETED|Period-2 (8 Days)||8||
60086014|NCT01424397|76202130|FG005|COMPLETED|Period-2 (8 Days)||8||
60086015|NCT01424397|76202131|FG006|COMPLETED|Period-2 (8 Days)||4||
60086016|NCT01424397|76202132|FG007|COMPLETED|Period-2 (8 Days)||4||
60086017|NCT01424397|76202133|FG008|COMPLETED|Period-2 (8 Days)||4||
60086018|NCT01424397|76202134|FG009|COMPLETED|Period-2 (8 Days)||3||
60086019|NCT01424397|76202135|FG010|COMPLETED|Period-2 (8 Days)||4||
60086020|NCT01424397|76202136|FG011|COMPLETED|Period-2 (8 Days)||4||
60086021|NCT01424397|76202125|FG000|NOT COMPLETED|Period-2 (8 Days)||0||
60086022|NCT01424397|76202126|FG001|NOT COMPLETED|Period-2 (8 Days)||0||
60086023|NCT01424397|76202127|FG002|NOT COMPLETED|Period-2 (8 Days)||1||
60086024|NCT01424397|76202128|FG003|NOT COMPLETED|Period-2 (8 Days)||0||
60086025|NCT01424397|76202129|FG004|NOT COMPLETED|Period-2 (8 Days)||0||
60086026|NCT01424397|76202130|FG005|NOT COMPLETED|Period-2 (8 Days)||0||
60086027|NCT01424397|76202131|FG006|NOT COMPLETED|Period-2 (8 Days)||0||
60086028|NCT01424397|76202132|FG007|NOT COMPLETED|Period-2 (8 Days)||0||
60086029|NCT01424397|76202133|FG008|NOT COMPLETED|Period-2 (8 Days)||0||
60086030|NCT01424397|76202134|FG009|NOT COMPLETED|Period-2 (8 Days)||0||
60086031|NCT01424397|76202135|FG010|NOT COMPLETED|Period-2 (8 Days)||0||
60086032|NCT01424397|76202136|FG011|NOT COMPLETED|Period-2 (8 Days)||0||
60086033|NCT01424397|76202125|FG000|STARTED|Washout Period-2 (14-20 Days)||7||
60086034|NCT01424397|76202126|FG001|STARTED|Washout Period-2 (14-20 Days)||8||
60086035|NCT01424397|76202127|FG002|STARTED|Washout Period-2 (14-20 Days)||7||
60086036|NCT01424397|76202128|FG003|STARTED|Washout Period-2 (14-20 Days)||8||
60086037|NCT01424397|76202129|FG004|STARTED|Washout Period-2 (14-20 Days)||8||
60086038|NCT01424397|76202130|FG005|STARTED|Washout Period-2 (14-20 Days)||8||
60086039|NCT01424397|76202131|FG006|STARTED|Washout Period-2 (14-20 Days)||4||
60086040|NCT01424397|76202132|FG007|STARTED|Washout Period-2 (14-20 Days)||4||
60086041|NCT01424397|76202133|FG008|STARTED|Washout Period-2 (14-20 Days)||4||
60086042|NCT01424397|76202134|FG009|STARTED|Washout Period-2 (14-20 Days)||3||
60086043|NCT01424397|76202135|FG010|STARTED|Washout Period-2 (14-20 Days)||4||
60086044|NCT01424397|76202136|FG011|STARTED|Washout Period-2 (14-20 Days)||4||
60086045|NCT01424397|76202125|FG000|COMPLETED|Washout Period-2 (14-20 Days)||7||
60086046|NCT01424397|76202126|FG001|COMPLETED|Washout Period-2 (14-20 Days)||8||
60086047|NCT01424397|76202127|FG002|COMPLETED|Washout Period-2 (14-20 Days)||7||
60086048|NCT01424397|76202128|FG003|COMPLETED|Washout Period-2 (14-20 Days)||8||
60086049|NCT01424397|76202129|FG004|COMPLETED|Washout Period-2 (14-20 Days)||8||
60086050|NCT01424397|76202130|FG005|COMPLETED|Washout Period-2 (14-20 Days)||8||
60086051|NCT01424397|76202131|FG006|COMPLETED|Washout Period-2 (14-20 Days)||4||
60086052|NCT01424397|76202132|FG007|COMPLETED|Washout Period-2 (14-20 Days)||4||
60086053|NCT01424397|76202133|FG008|COMPLETED|Washout Period-2 (14-20 Days)||4||
60086054|NCT01424397|76202134|FG009|COMPLETED|Washout Period-2 (14-20 Days)||3||
60086055|NCT01424397|76202135|FG010|COMPLETED|Washout Period-2 (14-20 Days)||4||
60086056|NCT01424397|76202136|FG011|COMPLETED|Washout Period-2 (14-20 Days)||4||
60086057|NCT01424397|76202125|FG000|NOT COMPLETED|Washout Period-2 (14-20 Days)||0||
60086058|NCT01424397|76202126|FG001|NOT COMPLETED|Washout Period-2 (14-20 Days)||0||
60086059|NCT01424397|76202127|FG002|NOT COMPLETED|Washout Period-2 (14-20 Days)||0||
59560246|NCT03163017|75661572|FG000|COMPLETED|Overall Study||30||
60086060|NCT01424397|76202128|FG003|NOT COMPLETED|Washout Period-2 (14-20 Days)||0||
60086061|NCT01424397|76202129|FG004|NOT COMPLETED|Washout Period-2 (14-20 Days)||0||
60086062|NCT01424397|76202130|FG005|NOT COMPLETED|Washout Period-2 (14-20 Days)||0||
60086063|NCT01424397|76202131|FG006|NOT COMPLETED|Washout Period-2 (14-20 Days)||0||
60086064|NCT01424397|76202132|FG007|NOT COMPLETED|Washout Period-2 (14-20 Days)||0||
60086065|NCT01424397|76202133|FG008|NOT COMPLETED|Washout Period-2 (14-20 Days)||0||
60086066|NCT01424397|76202134|FG009|NOT COMPLETED|Washout Period-2 (14-20 Days)||0||
60086067|NCT01424397|76202135|FG010|NOT COMPLETED|Washout Period-2 (14-20 Days)||0||
60086068|NCT01424397|76202136|FG011|NOT COMPLETED|Washout Period-2 (14-20 Days)||0||
60086069|NCT01424397|76202125|FG000|STARTED|Period-3 (8 Days)||7||
60086070|NCT01424397|76202126|FG001|STARTED|Period-3 (8 Days)||8||
60086071|NCT01424397|76202127|FG002|STARTED|Period-3 (8 Days)||7||
60086072|NCT01424397|76202128|FG003|STARTED|Period-3 (8 Days)||8||
59560247|NCT03163017|75661572|FG000|NOT COMPLETED|Overall Study||0||
59560248|NCT01607450|75661583|FG000|STARTED|Overall Study||6||
59560249|NCT01607450|75661584|FG001|STARTED|Overall Study||8||
59707523|NCT01252667|75826423|FG001|COMPLETED|Overall Study||3||
60086073|NCT01424397|76202129|FG004|STARTED|Period-3 (8 Days)||8||
60086074|NCT01424397|76202130|FG005|STARTED|Period-3 (8 Days)||8||
60086075|NCT01424397|76202131|FG006|STARTED|Period-3 (8 Days)||4||
60086076|NCT01424397|76202132|FG007|STARTED|Period-3 (8 Days)||4||
60086077|NCT01424397|76202133|FG008|STARTED|Period-3 (8 Days)||4||
60086078|NCT01424397|76202134|FG009|STARTED|Period-3 (8 Days)||3||
60086079|NCT01424397|76202135|FG010|STARTED|Period-3 (8 Days)||4||
60086080|NCT01424397|76202136|FG011|STARTED|Period-3 (8 Days)||4||
60086081|NCT01424397|76202125|FG000|COMPLETED|Period-3 (8 Days)||7||
59707524|NCT01252667|75826424|FG002|COMPLETED|Overall Study||3||
59707525|NCT01252667|75826425|FG003|COMPLETED|Overall Study||0||
60086082|NCT01424397|76202126|FG001|COMPLETED|Period-3 (8 Days)||8||
60086083|NCT01424397|76202127|FG002|COMPLETED|Period-3 (8 Days)||7||
59560250|NCT01607450|75661585|FG002|STARTED|Overall Study||7||
59560251|NCT01607450|75661586|FG003|STARTED|Overall Study||11||
59560252|NCT01607450|75661587|FG004|STARTED|Overall Study||1||
59707526|NCT01252667|75826426|FG004|COMPLETED|Overall Study||0||
59707527|NCT01252667|75826427|FG005|COMPLETED|Overall Study||34||
60086084|NCT01424397|76202128|FG003|COMPLETED|Period-3 (8 Days)||8||
60086085|NCT01424397|76202129|FG004|COMPLETED|Period-3 (8 Days)||8||
60086086|NCT01424397|76202130|FG005|COMPLETED|Period-3 (8 Days)||8||
60086087|NCT01424397|76202131|FG006|COMPLETED|Period-3 (8 Days)||4||
60086088|NCT01424397|76202132|FG007|COMPLETED|Period-3 (8 Days)||4||
60086089|NCT01424397|76202133|FG008|COMPLETED|Period-3 (8 Days)||4||
60086090|NCT01424397|76202134|FG009|COMPLETED|Period-3 (8 Days)||3||
60086091|NCT01424397|76202135|FG010|COMPLETED|Period-3 (8 Days)||4||
60086092|NCT01424397|76202136|FG011|COMPLETED|Period-3 (8 Days)||4||
60086093|NCT01424397|76202125|FG000|NOT COMPLETED|Period-3 (8 Days)||0||
60086094|NCT01424397|76202126|FG001|NOT COMPLETED|Period-3 (8 Days)||0||
60086095|NCT01424397|76202127|FG002|NOT COMPLETED|Period-3 (8 Days)||0||
60086096|NCT01424397|76202128|FG003|NOT COMPLETED|Period-3 (8 Days)||0||
60086097|NCT01424397|76202129|FG004|NOT COMPLETED|Period-3 (8 Days)||0||
60086098|NCT01424397|76202130|FG005|NOT COMPLETED|Period-3 (8 Days)||0||
60086099|NCT01424397|76202131|FG006|NOT COMPLETED|Period-3 (8 Days)||0||
60086100|NCT01424397|76202132|FG007|NOT COMPLETED|Period-3 (8 Days)||0||
60086101|NCT01424397|76202133|FG008|NOT COMPLETED|Period-3 (8 Days)||0||
60086102|NCT01424397|76202134|FG009|NOT COMPLETED|Period-3 (8 Days)||0||
59707528|NCT01252667|75826422|FG000|NOT COMPLETED|Overall Study||0||
59992295|NCT02455076|76108113|FG004|STARTED|Inpatient||0||
59992296|NCT02455076|76108109|FG000|COMPLETED|Inpatient||43||
59992297|NCT02455076|76108110|FG001|COMPLETED|Inpatient||50||
59992298|NCT02455076|76108111|FG002|COMPLETED|Inpatient||52||
59992299|NCT02455076|76108112|FG003|COMPLETED|Inpatient||0||
59992300|NCT02455076|76108113|FG004|COMPLETED|Inpatient||0||
59992301|NCT02455076|76108109|FG000|NOT COMPLETED|Inpatient||4||
59992302|NCT02455076|76108110|FG001|NOT COMPLETED|Inpatient||1||
59992303|NCT02455076|76108111|FG002|NOT COMPLETED|Inpatient||0||
59992304|NCT02455076|76108112|FG003|NOT COMPLETED|Inpatient||0||
59992305|NCT02455076|76108113|FG004|NOT COMPLETED|Inpatient||0||
59992306|NCT02455076|76108109|FG000|STARTED|Outpatient||0||
59992307|NCT02455076|76108110|FG001|STARTED|Outpatient||0||
59992308|NCT02455076|76108111|FG002|STARTED|Outpatient||0||
59992309|NCT02455076|76108112|FG003|STARTED|Outpatient||48||
59992310|NCT02455076|76108113|FG004|STARTED|Outpatient||55||
59992311|NCT02455076|76108109|FG000|COMPLETED|Outpatient||0||
59992312|NCT02455076|76108110|FG001|COMPLETED|Outpatient||0||
59992313|NCT02455076|76108111|FG002|COMPLETED|Outpatient||0||
59992314|NCT02455076|76108112|FG003|COMPLETED|Outpatient||42||
59992315|NCT02455076|76108113|FG004|COMPLETED|Outpatient||43||
59992316|NCT02455076|76108109|FG000|NOT COMPLETED|Outpatient||0||
59992317|NCT02455076|76108110|FG001|NOT COMPLETED|Outpatient||0||
59992318|NCT02455076|76108111|FG002|NOT COMPLETED|Outpatient||0||
59992319|NCT02455076|76108112|FG003|NOT COMPLETED|Outpatient||6||
59992320|NCT02455076|76108113|FG004|NOT COMPLETED|Outpatient||12||
59992321|NCT02433080|76108127|FG000|STARTED|Overall Study||26||
59992322|NCT02433080|76108128|FG001|STARTED|Overall Study||28||
59992323|NCT02433080|76108127|FG000|8 Weeks|Overall Study||25||
59992324|NCT02433080|76108128|FG001|8 Weeks|Overall Study||24||
59992325|NCT02433080|76108127|FG000|COMPLETED|Overall Study||25|24 weeks and analyzed|
59992326|NCT02433080|76108128|FG001|COMPLETED|Overall Study||24|24 weeks and analyzed|
59992327|NCT02433080|76108127|FG000|NOT COMPLETED|Overall Study||1||
59992328|NCT02433080|76108128|FG001|NOT COMPLETED|Overall Study||4||
59992329|NCT03092219|76108137|FG000|STARTED|Overall Study||150|Randomized|
59992330|NCT03092219|76108138|FG001|STARTED|Overall Study||52|Randomized|
59992331|NCT03092219|76108137|FG000|Baseline / ITT Population|Overall Study||150|Visit 1 - Week 0|
59992332|NCT03092219|76108138|FG001|Baseline / ITT Population|Overall Study|Subject randomized to No Treatment group but received treatment at Visit 1.|51|Visit 1 - Week 0|
59992333|NCT03092219|76108137|FG000|Primary Analysis Endpoint|Overall Study||150|Visit 4 - Week 8 after last treatment|
59992334|NCT03092219|76108138|FG001|Primary Analysis Endpoint|Overall Study||51|Visit 4 - Week 8 after last treatment|
59992335|NCT03092219|76108137|FG000|Pooled SAFT Population|Overall Study||150|Visit 8 - Week 36 after last treatment|
59992336|NCT03092219|76108138|FG001|Pooled SAFT Population|Overall Study|2 subjects did not receive treatment at Visit 1b.|50|Visit 8 - Week 36 after last treatment|
59992337|NCT03092219|76108137|FG000|COMPLETED|Overall Study||143|Per Protocol Population|
59992338|NCT03092219|76108138|FG001|COMPLETED|Overall Study||48|Per Protocol Population|
60086103|NCT01424397|76202135|FG010|NOT COMPLETED|Period-3 (8 Days)||0||
60086104|NCT01424397|76202136|FG011|NOT COMPLETED|Period-3 (8 Days)||0||
60086105|NCT01392963|76202152|FG000|STARTED|Week 0 (First Intervention)||11||
60086106|NCT01392963|76202153|FG001|STARTED|Week 0 (First Intervention)||19||
60086107|NCT01392963|76202152|FG000|COMPLETED|Week 0 (First Intervention)||11||
59707529|NCT01252667|75826423|FG001|NOT COMPLETED|Overall Study||0||
59707530|NCT01252667|75826424|FG002|NOT COMPLETED|Overall Study||0||
60086108|NCT01392963|76202153|FG001|COMPLETED|Week 0 (First Intervention)||17||
59707531|NCT01252667|75826425|FG003|NOT COMPLETED|Overall Study||0||
59992339|NCT03092219|76108137|FG000|NOT COMPLETED|Overall Study||7||
60086109|NCT01392963|76202152|FG000|NOT COMPLETED|Week 0 (First Intervention)||0||
60086110|NCT01392963|76202153|FG001|NOT COMPLETED|Week 0 (First Intervention)||2||
60086111|NCT01392963|76202152|FG000|STARTED|Week 12 (Second Intervention)||11||
59707532|NCT01252667|75826426|FG004|NOT COMPLETED|Overall Study||0||
59707533|NCT01252667|75826427|FG005|NOT COMPLETED|Overall Study||1||
59707534|NCT01119105|75826444|FG000|STARTED|Overall Study||70||
59707535|NCT01119105|75826445|FG001|STARTED|Overall Study||72||
59816735|NCT04158687|75939122|FG002|Efficacy Population|Overall Study||83|Efficacy population included all participants who received the study medication and had at least one available post-baseline Positive and Negative Syndrome Scale (PANSS) assessment.|
60086112|NCT01392963|76202153|FG001|STARTED|Week 12 (Second Intervention)||17||
60086113|NCT01392963|76202152|FG000|COMPLETED|Week 12 (Second Intervention)||11||
60086114|NCT01392963|76202153|FG001|COMPLETED|Week 12 (Second Intervention)||17||
60086115|NCT01392963|76202152|FG000|NOT COMPLETED|Week 12 (Second Intervention)||0||
60086116|NCT01392963|76202153|FG001|NOT COMPLETED|Week 12 (Second Intervention)||0||
60086117|NCT01392963|76202152|FG000|STARTED|Week 24 Follow-up||11||
60086118|NCT01392963|76202153|FG001|STARTED|Week 24 Follow-up||17||
60086119|NCT01392963|76202152|FG000|COMPLETED|Week 24 Follow-up||9||
60086120|NCT01392963|76202153|FG001|COMPLETED|Week 24 Follow-up||17||
60086121|NCT01392963|76202152|FG000|NOT COMPLETED|Week 24 Follow-up||2||
60086122|NCT01392963|76202153|FG001|NOT COMPLETED|Week 24 Follow-up||0||
60086123|NCT01392573|76202163|FG000|STARTED|Overall Study||207||
60086124|NCT01392573|76202164|FG001|STARTED|Overall Study||206||
60086125|NCT01392573|76202163|FG000|Exposed|Overall Study||207||
60086126|NCT01392573|76202164|FG001|Exposed|Overall Study||206||
60086127|NCT01392573|76202163|FG000|COMPLETED|Overall Study||175||
60086128|NCT01392573|76202164|FG001|COMPLETED|Overall Study||171||
60086129|NCT01392573|76202163|FG000|NOT COMPLETED|Overall Study||32||
60086130|NCT01392573|76202164|FG001|NOT COMPLETED|Overall Study||35||
60086131|NCT01392495|76202170|FG000|STARTED|Overall Study||17||
60086132|NCT01392495|76202170|FG000|Received 200 mg|Overall Study||4||
59560253|NCT01607450|75661588|FG005|STARTED|Overall Study||0||
59560254|NCT01607450|75661589|FG006|STARTED|Overall Study||0||
59560255|NCT01607450|75661583|FG000|COMPLETED|Overall Study||6||
59560256|NCT01607450|75661584|FG001|COMPLETED|Overall Study||8||
59560257|NCT01607450|75661585|FG002|COMPLETED|Overall Study||7||
59560258|NCT01607450|75661586|FG003|COMPLETED|Overall Study||11||
59560259|NCT01607450|75661587|FG004|COMPLETED|Overall Study||1||
59560260|NCT01607450|75661588|FG005|COMPLETED|Overall Study||0||
59560261|NCT01607450|75661589|FG006|COMPLETED|Overall Study||0||
59707536|NCT01119105|75826446|FG002|STARTED|Overall Study||68||
59707537|NCT01119105|75826444|FG000|COMPLETED|Overall Study||66||
59707538|NCT01119105|75826445|FG001|COMPLETED|Overall Study||66||
59707539|NCT01119105|75826446|FG002|COMPLETED|Overall Study||60||
59707540|NCT01119105|75826444|FG000|NOT COMPLETED|Overall Study||4||
59707541|NCT01119105|75826445|FG001|NOT COMPLETED|Overall Study||6||
59707542|NCT01119105|75826446|FG002|NOT COMPLETED|Overall Study||8||
59817920|NCT04488770|75940333|FG007|STARTED|Part 1-Cohort 2: Period 2 (Up to 5 Days)||2||
59992340|NCT03092219|76108138|FG001|NOT COMPLETED|Overall Study||4||
59992341|NCT02432846|76108153|FG000|STARTED|Overall Study (4 Arms/Strata)||17||
59707543|NCT01118949|75826454|FG000|STARTED|Overall Study||49||
59707544|NCT01118949|75826454|FG000|COMPLETED|Overall Study||40||
59707545|NCT01118949|75826454|FG000|NOT COMPLETED|Overall Study||9||
59707546|NCT01252355|75826461|FG000|STARTED|Overall Study|Randomized.|177||
59707547|NCT01252355|75826462|FG001|STARTED|Overall Study|Randomized.|178||
59707548|NCT01252355|75826463|FG002|STARTED|Overall Study|Randomized.|179||
59992342|NCT02432846|76108154|FG001|STARTED|Overall Study (4 Arms/Strata)||8||
59992343|NCT02432846|76108155|FG002|STARTED|Overall Study (4 Arms/Strata)||41||
59992344|NCT02432846|76108156|FG003|STARTED|Overall Study (4 Arms/Strata)||22||
59992345|NCT02432846|76108157|FG004|STARTED|Overall Study (4 Arms/Strata)||0||
59992346|NCT02432846|76108158|FG005|STARTED|Overall Study (4 Arms/Strata)||0||
59992347|NCT02432846|76108153|FG000|COMPLETED|Overall Study (4 Arms/Strata)||2||
59992348|NCT02432846|76108154|FG001|COMPLETED|Overall Study (4 Arms/Strata)||0||
59992349|NCT02432846|76108155|FG002|COMPLETED|Overall Study (4 Arms/Strata)||17||
59992350|NCT02432846|76108156|FG003|COMPLETED|Overall Study (4 Arms/Strata)||8||
59992351|NCT02432846|76108157|FG004|COMPLETED|Overall Study (4 Arms/Strata)||0||
59992352|NCT02432846|76108158|FG005|COMPLETED|Overall Study (4 Arms/Strata)||0||
60086133|NCT01392495|76202170|FG000|Received 400 mg|Overall Study||13||
59560262|NCT01607450|75661583|FG000|NOT COMPLETED|Overall Study||0||
59560263|NCT01607450|75661584|FG001|NOT COMPLETED|Overall Study||0||
59560264|NCT01607450|75661585|FG002|NOT COMPLETED|Overall Study||0||
59707549|NCT01252355|75826461|FG000|Treated|Overall Study||175||
59707550|NCT01252355|75826462|FG001|Treated|Overall Study||178||
59707551|NCT01252355|75826463|FG002|Treated|Overall Study|One participant received teriflunomide 7 mg.|179||
59707552|NCT01252355|75826461|FG000|COMPLETED|Overall Study||0||
59707553|NCT01252355|75826462|FG001|COMPLETED|Overall Study||0||
59707554|NCT01252355|75826463|FG002|COMPLETED|Overall Study||0||
59560265|NCT01607450|75661586|FG003|NOT COMPLETED|Overall Study||0||
59707555|NCT01252355|75826461|FG000|NOT COMPLETED|Overall Study||177||
59707556|NCT01252355|75826462|FG001|NOT COMPLETED|Overall Study||178||
59560266|NCT01607450|75661587|FG004|NOT COMPLETED|Overall Study||0||
60086134|NCT01392495|76202170|FG000|COMPLETED|Overall Study||1||
60086135|NCT01392495|76202170|FG000|NOT COMPLETED|Overall Study||16||
60086136|NCT01405053|76202178|FG000|STARTED|Overall Study||25||
60086137|NCT01405053|76202179|FG001|STARTED|Overall Study||12||
60086138|NCT01405053|76202178|FG000|COMPLETED|Overall Study||15||
60086139|NCT01405053|76202179|FG001|COMPLETED|Overall Study||4||
60086140|NCT01405053|76202178|FG000|NOT COMPLETED|Overall Study||10||
60086141|NCT01405053|76202179|FG001|NOT COMPLETED|Overall Study||8||
60086142|NCT01403805|76202187|FG000|STARTED|Overall Study||94||
60086143|NCT01403805|76202188|FG001|STARTED|Overall Study||105||
60086144|NCT01403805|76202187|FG000|Pneumonia Diagnosis|Overall Study||21||
60086145|NCT01403805|76202188|FG001|Pneumonia Diagnosis|Overall Study||2||
60086146|NCT01403805|76202187|FG000|COMPLETED|Overall Study||94||
60086147|NCT01403805|76202188|FG001|COMPLETED|Overall Study||98||
60086148|NCT01403805|76202187|FG000|NOT COMPLETED|Overall Study||0||
60086149|NCT01403805|76202188|FG001|NOT COMPLETED|Overall Study||7||
60086150|NCT01423617|76202200|FG000|STARTED|Overall Study||46||
60086151|NCT01423617|76202201|FG001|STARTED|Overall Study||46||
60086152|NCT01423617|76202200|FG000|COMPLETED|Overall Study||46||
60086153|NCT01423617|76202201|FG001|COMPLETED|Overall Study||45||
60086154|NCT01423617|76202200|FG000|NOT COMPLETED|Overall Study||0||
60086155|NCT01423617|76202201|FG001|NOT COMPLETED|Overall Study||1||
60086156|NCT01392183|76202209|FG000|STARTED|First Drug Administration||35||
60086157|NCT01392183|76202210|FG001|STARTED|First Drug Administration||34||
60086158|NCT01392183|76202209|FG000|Eligible to Cross Over to 2nd Drug|First Drug Administration||29|29 participants were eligible to cross over, 8 out of those 29 eligible participants withdrew consent.|
60086159|NCT01392183|76202210|FG001|Eligible to Cross Over to 2nd Drug|First Drug Administration||31|29 participants were eligible to cross over, 8 out of those 29 eligible participants withdrew consent.|
60086160|NCT01392183|76202209|FG000|COMPLETED|First Drug Administration||21||
60086161|NCT01392183|76202210|FG001|COMPLETED|First Drug Administration||15||
60086162|NCT01392183|76202209|FG000|NOT COMPLETED|First Drug Administration||14||
60086163|NCT01392183|76202210|FG001|NOT COMPLETED|First Drug Administration||19||
60086164|NCT01392183|76202209|FG000|STARTED|Second Drug Administration||21||
60086165|NCT01392183|76202210|FG001|STARTED|Second Drug Administration||15||
60086166|NCT01392183|76202209|FG000|Treatment Ended: Progression|Second Drug Administration||18||
60086167|NCT01392183|76202210|FG001|Treatment Ended: Progression|Second Drug Administration||11||
60086168|NCT01392183|76202209|FG000|Treatment Ended: Adverse Events|Second Drug Administration||1||
60086169|NCT01392183|76202210|FG001|Treatment Ended: Adverse Events|Second Drug Administration||2||
60086170|NCT01392183|76202209|FG000|Treatment Ended: Participant Withdrew|Second Drug Administration||2||
60086171|NCT01392183|76202210|FG001|Treatment Ended: Participant Withdrew|Second Drug Administration||1||
60086172|NCT01392183|76202209|FG000|Treatment Ended: Death|Second Drug Administration||0||
60086173|NCT01392183|76202210|FG001|Treatment Ended: Death|Second Drug Administration||1||
60086174|NCT01392183|76202209|FG000|COMPLETED|Second Drug Administration||21||
60086175|NCT01392183|76202210|FG001|COMPLETED|Second Drug Administration||15||
60086176|NCT01392183|76202209|FG000|NOT COMPLETED|Second Drug Administration||0||
60086177|NCT01392183|76202210|FG001|NOT COMPLETED|Second Drug Administration||0||
60086178|NCT01402947|76202220|FG000|STARTED|First Intervention||15||
60086179|NCT01402947|76202221|FG001|STARTED|First Intervention||15||
60086180|NCT01402947|76202220|FG000|COMPLETED|First Intervention||15||
60086181|NCT01402947|76202221|FG001|COMPLETED|First Intervention||14||
60086182|NCT01402947|76202220|FG000|NOT COMPLETED|First Intervention||0||
60086183|NCT01402947|76202221|FG001|NOT COMPLETED|First Intervention||1||
60086184|NCT01402947|76202220|FG000|STARTED|Second Intervention||15||
60086185|NCT01402947|76202221|FG001|STARTED|Second Intervention||14||
60086186|NCT01402947|76202220|FG000|COMPLETED|Second Intervention||15||
60086187|NCT01402947|76202221|FG001|COMPLETED|Second Intervention||14||
60086188|NCT01402947|76202220|FG000|NOT COMPLETED|Second Intervention||0||
60086189|NCT01402947|76202221|FG001|NOT COMPLETED|Second Intervention||0||
60086190|NCT01402869|76202230|FG000|STARTED|Overall Study||30||
60086191|NCT01402869|76202231|FG001|STARTED|Overall Study||30||
60086192|NCT01402869|76202232|FG002|STARTED|Overall Study||31||
60086193|NCT01402869|76202230|FG000|COMPLETED|Overall Study||30||
60086194|NCT01402869|76202231|FG001|COMPLETED|Overall Study||30||
60086195|NCT01402869|76202232|FG002|COMPLETED|Overall Study||30||
60086196|NCT01402869|76202230|FG000|NOT COMPLETED|Overall Study||0||
60086197|NCT01402869|76202231|FG001|NOT COMPLETED|Overall Study||0||
60086198|NCT01402869|76202232|FG002|NOT COMPLETED|Overall Study||1||
60086199|NCT01391793|76202242|FG000|STARTED|Overall Study||271|Randomized to the treatment group|
60086200|NCT01391793|76202243|FG001|STARTED|Overall Study||275|Randomized to the treatment group|
60086201|NCT01391793|76202242|FG000|Had a Positive Urine Culture|Overall Study||197||
60086202|NCT01391793|76202243|FG001|Had a Positive Urine Culture|Overall Study||188||
60086203|NCT01391793|76202242|FG000|COMPLETED|Overall Study||124|Had an outcome Dimercaptosuccinic Acid (DMSA) renal scan 5-24 months from enrollment|
60086204|NCT01391793|76202243|FG001|COMPLETED|Overall Study||131|Had an outcome Dimercaptosuccinic Acid (DMSA) renal scan 5-24 months from enrollment|
60086205|NCT01391793|76202242|FG000|NOT COMPLETED|Overall Study||147||
60086206|NCT01391793|76202243|FG001|NOT COMPLETED|Overall Study||144||
60086207|NCT01422915|76202249|FG000|STARTED|Overall Study|1 subject with abnormal liver chemistries removed during the first period.|4||
60086208|NCT01422915|76202249|FG000|COMPLETED|Overall Study||3||
60086209|NCT01422915|76202249|FG000|NOT COMPLETED|Overall Study||1||
60086210|NCT01727024|76202254|FG000|STARTED|Period 1||71||
60086211|NCT01727024|76202255|FG001|STARTED|Period 1||68||
60086212|NCT01727024|76202254|FG000|COMPLETED|Period 1||68||
60086213|NCT01727024|76202255|FG001|COMPLETED|Period 1||64||
60086214|NCT01727024|76202254|FG000|NOT COMPLETED|Period 1||3||
60086215|NCT01727024|76202255|FG001|NOT COMPLETED|Period 1||4||
60086216|NCT01727024|76202254|FG000|STARTED|Period 2||68||
60086217|NCT01727024|76202255|FG001|STARTED|Period 2||64||
60086218|NCT01727024|76202254|FG000|COMPLETED|Period 2||68||
60086219|NCT01727024|76202255|FG001|COMPLETED|Period 2||64||
60086220|NCT01727024|76202254|FG000|NOT COMPLETED|Period 2||0||
60086221|NCT01727024|76202255|FG001|NOT COMPLETED|Period 2||0||
60086222|NCT01422213|76202264|FG000|STARTED|Overall Study||196||
60086223|NCT01422213|76202265|FG001|STARTED|Overall Study||195||
60086224|NCT01422213|76202266|FG002|STARTED|Overall Study||207||
60086225|NCT01422213|76202264|FG000|COMPLETED|Overall Study||163||
60086226|NCT01422213|76202265|FG001|COMPLETED|Overall Study||173||
60086227|NCT01422213|76202266|FG002|COMPLETED|Overall Study||178||
60086228|NCT01422213|76202264|FG000|NOT COMPLETED|Overall Study||33||
60086229|NCT01422213|76202265|FG001|NOT COMPLETED|Overall Study||22||
59560267|NCT01607450|75661588|FG005|NOT COMPLETED|Overall Study||0||
59560268|NCT01607450|75661589|FG006|NOT COMPLETED|Overall Study||0||
60086230|NCT01422213|76202266|FG002|NOT COMPLETED|Overall Study||29||
60086231|NCT01390857|76202274|FG000|STARTED|Overall Study||379||
60086232|NCT01390857|76202274|FG000|COMPLETED|Overall Study||369||
60086233|NCT01390857|76202274|FG000|NOT COMPLETED|Overall Study||10||
60086234|NCT01725386|76202280|FG000|STARTED|Overall Study||188||
60086235|NCT01725386|76202281|FG001|STARTED|Overall Study||63||
60086236|NCT01725386|76202280|FG000|COMPLETED|Overall Study||13||
60086237|NCT01725386|76202281|FG001|COMPLETED|Overall Study||17||
60086238|NCT01725386|76202280|FG000|NOT COMPLETED|Overall Study||175||
60086239|NCT01725386|76202281|FG001|NOT COMPLETED|Overall Study||46||
60086240|NCT01402011|76202290|FG000|STARTED|Delayed Treatment Period||29||
60086241|NCT01402011|76202291|FG001|STARTED|Delayed Treatment Period||23||
60086242|NCT01402011|76202292|FG002|STARTED|Delayed Treatment Period||26||
60086243|NCT01402011|76202290|FG000|COMPLETED|Delayed Treatment Period|One patient with needle phobia declined to be treated before the 1st set of injections|28||
59560269|NCT01709474|75661612|FG000|STARTED|Overall Study||3||
59560270|NCT01709474|75661613|FG001|STARTED|Overall Study||4||
60086244|NCT01402011|76202291|FG001|COMPLETED|Delayed Treatment Period||23||
60086245|NCT01402011|76202292|FG002|COMPLETED|Delayed Treatment Period||26||
60086246|NCT01402011|76202290|FG000|NOT COMPLETED|Delayed Treatment Period||1||
60086247|NCT01402011|76202291|FG001|NOT COMPLETED|Delayed Treatment Period||0||
60086248|NCT01402011|76202292|FG002|NOT COMPLETED|Delayed Treatment Period||0||
60086249|NCT01402011|76202290|FG000|STARTED|Active Treatment Period||28||
60086250|NCT01402011|76202291|FG001|STARTED|Active Treatment Period||23||
60086251|NCT01402011|76202292|FG002|STARTED|Active Treatment Period||26||
60086252|NCT01402011|76202290|FG000|COMPLETED|Active Treatment Period||27|Patients who quit the study did so because they found the injections too painful.|
60086253|NCT01402011|76202291|FG001|COMPLETED|Active Treatment Period||20|Patients who quit the study did so because they found the injections too painful.|
60086254|NCT01402011|76202292|FG002|COMPLETED|Active Treatment Period||26|Patients who quit the study did so because they found the injections too painful.|
60086255|NCT01402011|76202290|FG000|NOT COMPLETED|Active Treatment Period||1||
60086256|NCT01402011|76202291|FG001|NOT COMPLETED|Active Treatment Period||3||
60086257|NCT01402011|76202292|FG002|NOT COMPLETED|Active Treatment Period||0||
60086258|NCT01402011|76202290|FG000|STARTED|Nine Month Follow-up||27||
60086259|NCT01402011|76202291|FG001|STARTED|Nine Month Follow-up||20||
59560271|NCT01709474|75661612|FG000|COMPLETED|Overall Study||3||
60086260|NCT01402011|76202292|FG002|STARTED|Nine Month Follow-up||26||
60086261|NCT01402011|76202290|FG000|COMPLETED|Nine Month Follow-up||27||
60086262|NCT01402011|76202291|FG001|COMPLETED|Nine Month Follow-up||19||
60086263|NCT01402011|76202292|FG002|COMPLETED|Nine Month Follow-up||26||
60086264|NCT01402011|76202290|FG000|NOT COMPLETED|Nine Month Follow-up||0||
60086265|NCT01402011|76202291|FG001|NOT COMPLETED|Nine Month Follow-up||1||
59560272|NCT01709474|75661613|FG001|COMPLETED|Overall Study||4||
59560273|NCT01709474|75661612|FG000|NOT COMPLETED|Overall Study||0||
59560274|NCT01709474|75661613|FG001|NOT COMPLETED|Overall Study||0||
60086266|NCT01402011|76202292|FG002|NOT COMPLETED|Nine Month Follow-up||0||
60086267|NCT01421667|76202307|FG000|STARTED|Overall Study||35||
60086268|NCT01421667|76202308|FG001|STARTED|Overall Study||68||
59560275|NCT02331095|75661621|FG000|STARTED|Overall Study||11||
60086269|NCT01421667|76202309|FG002|STARTED|Overall Study||53||
60086270|NCT01421667|76202310|FG003|STARTED|Overall Study||16||
60086271|NCT01421667|76202307|FG000|COMPLETED|Overall Study|Completed per protocol due to death [24] or study termination by sponsor [11]|35||
60086272|NCT01421667|76202308|FG001|COMPLETED|Overall Study|Completed per protocol due to death [45] or study termination by sponsor [21]|66||
60086273|NCT01421667|76202309|FG002|COMPLETED|Overall Study|Completed per protocol due to death [33] or study termination by sponsor [18]|51||
60086274|NCT01421667|76202310|FG003|COMPLETED|Overall Study|Completed per protocol due to death [7] or study termination by sponsor [8]|15||
60086275|NCT01421667|76202307|FG000|NOT COMPLETED|Overall Study||0||
60086276|NCT01421667|76202308|FG001|NOT COMPLETED|Overall Study||2||
60086277|NCT01421667|76202309|FG002|NOT COMPLETED|Overall Study||2||
60086278|NCT01421667|76202310|FG003|NOT COMPLETED|Overall Study||1||
60086279|NCT01390779|76202328|FG000|STARTED|Overall Study||33||
60086280|NCT01390779|76202328|FG000|COMPLETED|Overall Study||32||
60086281|NCT01390779|76202328|FG000|NOT COMPLETED|Overall Study||1||
60086282|NCT01891669|76202342|FG000|STARTED|Overall Study||2||
60086283|NCT01891669|76202343|FG001|STARTED|Overall Study||2||
60086284|NCT01891669|76202344|FG002|STARTED|Overall Study||2||
60086285|NCT01891669|76202345|FG003|STARTED|Overall Study||2||
60086286|NCT01891669|76202346|FG004|STARTED|Overall Study||2||
60086287|NCT01891669|76202347|FG005|STARTED|Overall Study||2||
60086288|NCT01891669|76202348|FG006|STARTED|Overall Study||2||
60086289|NCT01891669|76202349|FG007|STARTED|Overall Study||6||
60086290|NCT01891669|76202350|FG008|STARTED|Overall Study||3||
60086291|NCT01891669|76202351|FG009|STARTED|Overall Study||3||
60086292|NCT01891669|76202342|FG000|COMPLETED|Overall Study||0||
60086293|NCT01891669|76202343|FG001|COMPLETED|Overall Study||1||
60086294|NCT01891669|76202344|FG002|COMPLETED|Overall Study||2||
60086295|NCT01891669|76202345|FG003|COMPLETED|Overall Study||2||
60086296|NCT01891669|76202346|FG004|COMPLETED|Overall Study||2||
60086297|NCT01891669|76202347|FG005|COMPLETED|Overall Study||2||
60086298|NCT01891669|76202348|FG006|COMPLETED|Overall Study||1||
60086299|NCT01891669|76202349|FG007|COMPLETED|Overall Study||2||
60086300|NCT01891669|76202350|FG008|COMPLETED|Overall Study||2||
60086301|NCT01891669|76202351|FG009|COMPLETED|Overall Study||1||
60086302|NCT01891669|76202342|FG000|NOT COMPLETED|Overall Study||2||
60086303|NCT01891669|76202343|FG001|NOT COMPLETED|Overall Study||1||
60086304|NCT01891669|76202344|FG002|NOT COMPLETED|Overall Study||0||
60086305|NCT01891669|76202345|FG003|NOT COMPLETED|Overall Study||0||
60086306|NCT01891669|76202346|FG004|NOT COMPLETED|Overall Study||0||
60086307|NCT01891669|76202347|FG005|NOT COMPLETED|Overall Study||0||
60086308|NCT01891669|76202348|FG006|NOT COMPLETED|Overall Study||1||
60086309|NCT01891669|76202349|FG007|NOT COMPLETED|Overall Study||4||
60086310|NCT01891669|76202350|FG008|NOT COMPLETED|Overall Study||1||
60086311|NCT01891669|76202351|FG009|NOT COMPLETED|Overall Study||2||
60086312|NCT01421511|76202384|FG000|STARTED|Overall Study||332||
59560276|NCT02331095|75661622|FG001|STARTED|Overall Study||10||
59560277|NCT02331095|75661621|FG000|COMPLETED|Overall Study||7||
59992353|NCT02432846|76108153|FG000|NOT COMPLETED|Overall Study (4 Arms/Strata)||15||
59992354|NCT02432846|76108154|FG001|NOT COMPLETED|Overall Study (4 Arms/Strata)||8||
59992355|NCT02432846|76108155|FG002|NOT COMPLETED|Overall Study (4 Arms/Strata)||24||
59992356|NCT02432846|76108156|FG003|NOT COMPLETED|Overall Study (4 Arms/Strata)||14||
59992357|NCT02432846|76108157|FG004|NOT COMPLETED|Overall Study (4 Arms/Strata)||0||
59992358|NCT02432846|76108158|FG005|NOT COMPLETED|Overall Study (4 Arms/Strata)||0||
59992359|NCT02432846|76108153|FG000|STARTED|Overall Study (2 Total/Combined Groups)||0||
59992360|NCT02432846|76108154|FG001|STARTED|Overall Study (2 Total/Combined Groups)||0||
60086313|NCT01421511|76202385|FG001|STARTED|Overall Study||334||
60086314|NCT01421511|76202384|FG000|COMPLETED|Overall Study||313||
60086315|NCT01421511|76202385|FG001|COMPLETED|Overall Study||306||
59560278|NCT02331095|75661622|FG001|COMPLETED|Overall Study||9||
59560279|NCT02331095|75661621|FG000|NOT COMPLETED|Overall Study||4||
59560280|NCT02331095|75661622|FG001|NOT COMPLETED|Overall Study||1||
59707557|NCT01252355|75826463|FG002|NOT COMPLETED|Overall Study||179||
60086316|NCT01421511|76202384|FG000|NOT COMPLETED|Overall Study||19||
59560281|NCT01640834|75661635|FG000|STARTED|Overall Study||8||
60086317|NCT01421511|76202385|FG001|NOT COMPLETED|Overall Study||28||
60086318|NCT01864525|76202394|FG000|STARTED|Overall Study||10||
60086319|NCT01864525|76202395|FG001|STARTED|Overall Study||7||
60086320|NCT01864525|76202394|FG000|COMPLETED|Overall Study||9||
60086321|NCT01864525|76202395|FG001|COMPLETED|Overall Study||7||
60086322|NCT01864525|76202394|FG000|NOT COMPLETED|Overall Study||1||
60086323|NCT01864525|76202395|FG001|NOT COMPLETED|Overall Study||0||
60086324|NCT01421277|76202403|FG000|STARTED|Overall Study||25||
60086325|NCT01421277|76202404|FG001|STARTED|Overall Study||191||
60086326|NCT01421277|76202403|FG000|COMPLETED|Overall Study|Completed the online survey for at least one migraine attack.|25||
60086327|NCT01421277|76202404|FG001|COMPLETED|Overall Study|Completed the online survey for at least one migraine attack.|99||
60086328|NCT01421277|76202403|FG000|NOT COMPLETED|Overall Study||0||
60086329|NCT01421277|76202404|FG001|NOT COMPLETED|Overall Study||92||
60086330|NCT01891357|76202410|FG000|STARTED|Overall Study||64||
60086331|NCT01891357|76202410|FG000|COMPLETED|Overall Study||61||
60086332|NCT01891357|76202410|FG000|NOT COMPLETED|Overall Study||3||
60086333|NCT01420965|76202417|FG000|STARTED|Overall Study||2||
60086334|NCT01420965|76202418|FG001|STARTED|Overall Study||2||
60086335|NCT01420965|76202419|FG002|STARTED|Overall Study||3||
60086336|NCT01420965|76202417|FG000|COMPLETED|Overall Study||1||
59992361|NCT02432846|76108155|FG002|STARTED|Overall Study (2 Total/Combined Groups)||0||
59992362|NCT02432846|76108156|FG003|STARTED|Overall Study (2 Total/Combined Groups)||0||
59992363|NCT02432846|76108157|FG004|STARTED|Overall Study (2 Total/Combined Groups)||58||
59992364|NCT02432846|76108158|FG005|STARTED|Overall Study (2 Total/Combined Groups)||30||
59992365|NCT02432846|76108153|FG000|COMPLETED|Overall Study (2 Total/Combined Groups)||0||
59992366|NCT02432846|76108154|FG001|COMPLETED|Overall Study (2 Total/Combined Groups)||0||
59992367|NCT02432846|76108155|FG002|COMPLETED|Overall Study (2 Total/Combined Groups)||0||
60086337|NCT01420965|76202418|FG001|COMPLETED|Overall Study||1||
60086338|NCT01420965|76202419|FG002|COMPLETED|Overall Study||3||
60086339|NCT01420965|76202417|FG000|NOT COMPLETED|Overall Study||1||
60086340|NCT01420965|76202418|FG001|NOT COMPLETED|Overall Study||1||
60086341|NCT01420965|76202419|FG002|NOT COMPLETED|Overall Study||0||
60086342|NCT01390389|76202429|FG000|STARTED|Overall Study||10||
60086343|NCT01390389|76202430|FG001|STARTED|Overall Study||9||
60086344|NCT01390389|76202429|FG000|COMPLETED|Overall Study||6||
60086345|NCT01390389|76202430|FG001|COMPLETED|Overall Study||8||
60086346|NCT01390389|76202429|FG000|NOT COMPLETED|Overall Study||4||
60086347|NCT01390389|76202430|FG001|NOT COMPLETED|Overall Study||1||
60086348|NCT01401465|76202442|FG000|STARTED|Treatment Period 1||165||
60086349|NCT01401465|76202443|FG001|STARTED|Treatment Period 1||162||
60086350|NCT01401465|76202442|FG000|COMPLETED|Treatment Period 1||150||
60086351|NCT01401465|76202443|FG001|COMPLETED|Treatment Period 1||146||
60086352|NCT01401465|76202442|FG000|NOT COMPLETED|Treatment Period 1||15||
60086353|NCT01401465|76202443|FG001|NOT COMPLETED|Treatment Period 1||16||
60086354|NCT01401465|76202442|FG000|STARTED|Washout||150||
60086355|NCT01401465|76202443|FG001|STARTED|Washout||146||
60086356|NCT01401465|76202442|FG000|COMPLETED|Washout||150||
60086357|NCT01401465|76202443|FG001|COMPLETED|Washout||146||
59992368|NCT02432846|76108156|FG003|COMPLETED|Overall Study (2 Total/Combined Groups)||0||
59992369|NCT02432846|76108157|FG004|COMPLETED|Overall Study (2 Total/Combined Groups)||19||
60086358|NCT01401465|76202442|FG000|NOT COMPLETED|Washout||0||
60086359|NCT01401465|76202443|FG001|NOT COMPLETED|Washout||0||
59992370|NCT02432846|76108158|FG005|COMPLETED|Overall Study (2 Total/Combined Groups)||8||
60086360|NCT01401465|76202442|FG000|STARTED|Treatment Period 2||150||
60086361|NCT01401465|76202443|FG001|STARTED|Treatment Period 2||146||
60086362|NCT01401465|76202442|FG000|COMPLETED|Treatment Period 2||150||
60086363|NCT01401465|76202443|FG001|COMPLETED|Treatment Period 2||144||
60086364|NCT01401465|76202442|FG000|NOT COMPLETED|Treatment Period 2||0||
60086365|NCT01401465|76202443|FG001|NOT COMPLETED|Treatment Period 2||2||
60086366|NCT01401153|76202454|FG000|STARTED|First Test Day||66||
60086367|NCT01401153|76202455|FG001|STARTED|First Test Day||55||
60086368|NCT01401153|76202454|FG000|COMPLETED|First Test Day||65||
60086369|NCT01401153|76202455|FG001|COMPLETED|First Test Day||45||
60086370|NCT01401153|76202454|FG000|NOT COMPLETED|First Test Day||1||
60086371|NCT01401153|76202455|FG001|NOT COMPLETED|First Test Day||10||
60086372|NCT01401153|76202454|FG000|STARTED|Second Test Day||45||
60086373|NCT01401153|76202455|FG001|STARTED|Second Test Day||65||
60086374|NCT01401153|76202454|FG000|COMPLETED|Second Test Day||45||
60086375|NCT01401153|76202455|FG001|COMPLETED|Second Test Day||60||
60086376|NCT01401153|76202454|FG000|NOT COMPLETED|Second Test Day||0||
60086377|NCT01401153|76202455|FG001|NOT COMPLETED|Second Test Day||5||
60086378|NCT01890967|76202468|FG000|STARTED|Overall Study||88||
60086379|NCT01890967|76202469|FG001|STARTED|Overall Study||88||
60086380|NCT01890967|76202470|FG002|STARTED|Overall Study||88||
59560282|NCT01640834|75661636|FG001|STARTED|Overall Study||8||
59560283|NCT01640834|75661637|FG002|STARTED|Overall Study||4||
59560284|NCT01640834|75661635|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8||
59560285|NCT01640834|75661636|FG001|Received at Least 1 Dose of Study Drug|Overall Study||8||
59560286|NCT01640834|75661637|FG002|Received at Least 1 Dose of Study Drug|Overall Study||4||
59560287|NCT01640834|75661635|FG000|COMPLETED|Overall Study||8||
59560288|NCT01640834|75661636|FG001|COMPLETED|Overall Study||8||
59707558|NCT01118325|75826474|FG000|STARTED|Overall Study||50||
60086381|NCT01890967|76202471|FG003|STARTED|Overall Study||88||
60086382|NCT01890967|76202472|FG004|STARTED|Overall Study||87||
60086383|NCT01890967|76202473|FG005|STARTED|Overall Study||88||
60086384|NCT01890967|76202468|FG000|Received at Least One Dose of Study Drug|Overall Study||87||
60086385|NCT01890967|76202469|FG001|Received at Least One Dose of Study Drug|Overall Study||87||
60086386|NCT01890967|76202470|FG002|Received at Least One Dose of Study Drug|Overall Study||86||
60086387|NCT01890967|76202471|FG003|Received at Least One Dose of Study Drug|Overall Study||86||
60086388|NCT01890967|76202472|FG004|Received at Least One Dose of Study Drug|Overall Study||86||
60086389|NCT01890967|76202473|FG005|Received at Least One Dose of Study Drug|Overall Study||87||
59707559|NCT01118325|75826475|FG001|STARTED|Overall Study||43||
59560289|NCT01640834|75661637|FG002|COMPLETED|Overall Study||4||
59707560|NCT01118325|75826476|FG002|STARTED|Overall Study||46||
59707561|NCT01118325|75826474|FG000|COMPLETED|Overall Study||49||
60086390|NCT01890967|76202468|FG000|COMPLETED|Overall Study||78||
60086391|NCT01890967|76202469|FG001|COMPLETED|Overall Study||77||
60086392|NCT01890967|76202470|FG002|COMPLETED|Overall Study||78||
60086393|NCT01890967|76202471|FG003|COMPLETED|Overall Study||77||
60086394|NCT01890967|76202472|FG004|COMPLETED|Overall Study||77||
60086395|NCT01890967|76202473|FG005|COMPLETED|Overall Study||75||
60086396|NCT01890967|76202468|FG000|NOT COMPLETED|Overall Study||10||
60086397|NCT01890967|76202469|FG001|NOT COMPLETED|Overall Study||11||
60086398|NCT01890967|76202470|FG002|NOT COMPLETED|Overall Study||10||
60086399|NCT01890967|76202471|FG003|NOT COMPLETED|Overall Study||11||
60086400|NCT01890967|76202472|FG004|NOT COMPLETED|Overall Study||10||
60086401|NCT01890967|76202473|FG005|NOT COMPLETED|Overall Study||13||
60086402|NCT01400919|76202492|FG000|STARTED|Overall Study||75||
60086403|NCT01400919|76202492|FG000|COMPLETED|Overall Study||67||
60086404|NCT01400919|76202492|FG000|NOT COMPLETED|Overall Study||8||
60086405|NCT01864291|76202496|FG000|STARTED|Overall Study||9||
60086406|NCT01864291|76202496|FG000|COMPLETED|Overall Study|7/9 subjects had a minimum of one year followup since enrollment.|7||
60086407|NCT01864291|76202496|FG000|NOT COMPLETED|Overall Study||2||
60086408|NCT01400841|76202500|FG000|STARTED|Initial Study Phase (6 Months)|2 of the 18 consented subjects did not receive the device|16||
60086409|NCT01400841|76202500|FG000|COMPLETED|Initial Study Phase (6 Months)||15||
60086410|NCT01400841|76202500|FG000|NOT COMPLETED|Initial Study Phase (6 Months)||1||
60086411|NCT01400841|76202500|FG000|STARTED|Extended Study Phase (2 Years)|"1 subject refused further participation~1 subject death prior to agreeing to extended follow-up"|13||
60086412|NCT01400841|76202500|FG000|COMPLETED|Extended Study Phase (2 Years)||11||
60086413|NCT01400841|76202500|FG000|NOT COMPLETED|Extended Study Phase (2 Years)||2||
60086414|NCT01863667|76202506|FG000|STARTED|Overall Study||33||
60086415|NCT01863667|76202507|FG001|STARTED|Overall Study||32||
60086416|NCT01863667|76202506|FG000|COMPLETED|Overall Study||0||
60086417|NCT01863667|76202507|FG001|COMPLETED|Overall Study||0||
60086418|NCT01863667|76202506|FG000|NOT COMPLETED|Overall Study||33||
60086419|NCT01863667|76202507|FG001|NOT COMPLETED|Overall Study||32||
60086420|NCT01614769|76202513|FG000|STARTED|Period 1||2||
60086421|NCT01614769|76202514|FG001|STARTED|Period 1||1||
60086422|NCT01614769|76202515|FG002|STARTED|Period 1||2||
60086423|NCT01614769|76202516|FG003|STARTED|Period 1||2||
60086424|NCT01614769|76202517|FG004|STARTED|Period 1||1||
60086425|NCT01614769|76202518|FG005|STARTED|Period 1||2||
60086426|NCT01614769|76202513|FG000|COMPLETED|Period 1||1||
60086427|NCT01614769|76202514|FG001|COMPLETED|Period 1||1||
60086428|NCT01614769|76202515|FG002|COMPLETED|Period 1||2||
60086429|NCT01614769|76202516|FG003|COMPLETED|Period 1||0||
60086430|NCT01614769|76202517|FG004|COMPLETED|Period 1||1||
60086431|NCT01614769|76202518|FG005|COMPLETED|Period 1||1||
60086432|NCT01614769|76202513|FG000|NOT COMPLETED|Period 1||1||
60086433|NCT01614769|76202514|FG001|NOT COMPLETED|Period 1||0||
59560290|NCT01640834|75661635|FG000|NOT COMPLETED|Overall Study||0||
59560291|NCT01640834|75661636|FG001|NOT COMPLETED|Overall Study||0||
59560292|NCT01640834|75661637|FG002|NOT COMPLETED|Overall Study||0||
59560293|NCT01641380|75661649|FG000|STARTED|First Injection Cycle||50||
59560294|NCT01641380|75661650|FG001|STARTED|First Injection Cycle||50||
59560295|NCT01641380|75661649|FG000|COMPLETED|First Injection Cycle||43||
59560296|NCT01641380|75661650|FG001|COMPLETED|First Injection Cycle||44||
59560297|NCT01641380|75661649|FG000|NOT COMPLETED|First Injection Cycle||7||
59560298|NCT01641380|75661650|FG001|NOT COMPLETED|First Injection Cycle||6||
59560299|NCT01641380|75661649|FG000|STARTED|Second Injection Cycle||43||
59560300|NCT01641380|75661650|FG001|STARTED|Second Injection Cycle||44||
59560301|NCT01641380|75661649|FG000|COMPLETED|Second Injection Cycle||39||
59560302|NCT01641380|75661650|FG001|COMPLETED|Second Injection Cycle||38||
59560303|NCT01641380|75661649|FG000|NOT COMPLETED|Second Injection Cycle||4||
59560304|NCT01641380|75661650|FG001|NOT COMPLETED|Second Injection Cycle||6||
59560305|NCT01641380|75661649|FG000|STARTED|Third Injection Cycle||39||
60086434|NCT01614769|76202515|FG002|NOT COMPLETED|Period 1||0||
60086435|NCT01614769|76202516|FG003|NOT COMPLETED|Period 1||2||
60086436|NCT01614769|76202517|FG004|NOT COMPLETED|Period 1||0||
59992371|NCT02432846|76108153|FG000|NOT COMPLETED|Overall Study (2 Total/Combined Groups)||0||
59992372|NCT02432846|76108154|FG001|NOT COMPLETED|Overall Study (2 Total/Combined Groups)||0||
59992373|NCT02432846|76108155|FG002|NOT COMPLETED|Overall Study (2 Total/Combined Groups)||0||
59992374|NCT02432846|76108156|FG003|NOT COMPLETED|Overall Study (2 Total/Combined Groups)||0||
59992375|NCT02432846|76108157|FG004|NOT COMPLETED|Overall Study (2 Total/Combined Groups)||39||
59992376|NCT02432846|76108158|FG005|NOT COMPLETED|Overall Study (2 Total/Combined Groups)||22||
59992377|NCT02432144|76108171|FG000|STARTED|Overall Study||12||
59992378|NCT02432144|76108171|FG000|COMPLETED|Overall Study||11|Includes 8 participants who switched to commercially available vestronidase alfa before Week 144.|
60086437|NCT01614769|76202518|FG005|NOT COMPLETED|Period 1||1||
60086438|NCT01614769|76202513|FG000|STARTED|7-Day Washout||1||
60086439|NCT01614769|76202514|FG001|STARTED|7-Day Washout||1||
60086440|NCT01614769|76202515|FG002|STARTED|7-Day Washout||2||
60086441|NCT01614769|76202516|FG003|STARTED|7-Day Washout||0||
60086442|NCT01614769|76202517|FG004|STARTED|7-Day Washout||1||
60086443|NCT01614769|76202518|FG005|STARTED|7-Day Washout||1||
60086444|NCT01614769|76202513|FG000|COMPLETED|7-Day Washout||1||
59992379|NCT02432144|76108171|FG000|NOT COMPLETED|Overall Study||1||
59992380|NCT02246998|76108179|FG000|STARTED|Overall Study||18||
60086445|NCT01614769|76202514|FG001|COMPLETED|7-Day Washout||1||
60086446|NCT01614769|76202515|FG002|COMPLETED|7-Day Washout||2||
60086447|NCT01614769|76202516|FG003|COMPLETED|7-Day Washout||0||
60086448|NCT01614769|76202517|FG004|COMPLETED|7-Day Washout||1||
59560306|NCT01641380|75661650|FG001|STARTED|Third Injection Cycle||38||
59560307|NCT01641380|75661649|FG000|COMPLETED|Third Injection Cycle||36||
59560308|NCT01641380|75661650|FG001|COMPLETED|Third Injection Cycle||33||
59560309|NCT01641380|75661649|FG000|NOT COMPLETED|Third Injection Cycle||3||
59560310|NCT01641380|75661650|FG001|NOT COMPLETED|Third Injection Cycle||5||
59560311|NCT01709786|75661657|FG000|STARTED|Overall Study||88||
59560312|NCT01709786|75661657|FG000|COMPLETED|Overall Study||88||
60086449|NCT01614769|76202518|FG005|COMPLETED|7-Day Washout||1||
60086450|NCT01614769|76202513|FG000|NOT COMPLETED|7-Day Washout||0||
60086451|NCT01614769|76202514|FG001|NOT COMPLETED|7-Day Washout||0||
60086452|NCT01614769|76202515|FG002|NOT COMPLETED|7-Day Washout||0||
60086453|NCT01614769|76202516|FG003|NOT COMPLETED|7-Day Washout||0||
60086454|NCT01614769|76202517|FG004|NOT COMPLETED|7-Day Washout||0||
60086455|NCT01614769|76202518|FG005|NOT COMPLETED|7-Day Washout||0||
60086456|NCT01614769|76202513|FG000|STARTED|Period 2||1||
60086457|NCT01614769|76202514|FG001|STARTED|Period 2||1||
60086458|NCT01614769|76202515|FG002|STARTED|Period 2||2||
60086459|NCT01614769|76202516|FG003|STARTED|Period 2||0||
60086460|NCT01614769|76202517|FG004|STARTED|Period 2||1||
60086461|NCT01614769|76202518|FG005|STARTED|Period 2||1||
60086462|NCT01614769|76202513|FG000|COMPLETED|Period 2||1||
59560313|NCT01709786|75661657|FG000|NOT COMPLETED|Overall Study||0||
59560314|NCT01642082|75661663|FG000|STARTED|Overall Study||28||
59560315|NCT01642082|75661663|FG000|COMPLETED|Overall Study||28||
59560316|NCT01642082|75661663|FG000|NOT COMPLETED|Overall Study||0||
59560317|NCT02288819|75661674|FG000|STARTED|Overall Study||50||
59560318|NCT02288819|75661674|FG000|COMPLETED|Overall Study||50||
59560319|NCT02288819|75661674|FG000|NOT COMPLETED|Overall Study||0||
59560320|NCT01642238|75661678|FG000|STARTED|First Intervention (1 Day)||7||
59560321|NCT01642238|75661679|FG001|STARTED|First Intervention (1 Day)||8||
59560322|NCT01642238|75661678|FG000|COMPLETED|First Intervention (1 Day)||7||
60086463|NCT01614769|76202514|FG001|COMPLETED|Period 2||1||
60086464|NCT01614769|76202515|FG002|COMPLETED|Period 2||2||
59560323|NCT01642238|75661679|FG001|COMPLETED|First Intervention (1 Day)||8||
59560324|NCT01642238|75661678|FG000|NOT COMPLETED|First Intervention (1 Day)||0||
59560325|NCT01642238|75661679|FG001|NOT COMPLETED|First Intervention (1 Day)||0||
59560326|NCT01642238|75661678|FG000|STARTED|Washout (1-2 Weeks)||7||
59560327|NCT01642238|75661679|FG001|STARTED|Washout (1-2 Weeks)||8||
59560328|NCT01642238|75661678|FG000|COMPLETED|Washout (1-2 Weeks)||7||
59992381|NCT02246998|76108180|FG001|STARTED|Overall Study||18||
59992382|NCT02246998|76108181|FG002|STARTED|Overall Study||18||
59992383|NCT02246998|76108182|FG003|STARTED|Overall Study||18||
59992384|NCT02246998|76108179|FG000|COMPLETED|Overall Study||16||
59992385|NCT02246998|76108180|FG001|COMPLETED|Overall Study||15||
59992386|NCT02246998|76108181|FG002|COMPLETED|Overall Study||15||
59992387|NCT02246998|76108182|FG003|COMPLETED|Overall Study||16||
59992388|NCT02246998|76108179|FG000|NOT COMPLETED|Overall Study||2||
59992389|NCT02246998|76108180|FG001|NOT COMPLETED|Overall Study||3||
59992390|NCT02246998|76108181|FG002|NOT COMPLETED|Overall Study||3||
59992391|NCT02246998|76108182|FG003|NOT COMPLETED|Overall Study||2||
59992392|NCT02486588|76108201|FG000|STARTED|Overall Study||1188||
59992393|NCT02486588|76108202|FG001|STARTED|Overall Study||1252||
59992394|NCT02486588|76108203|FG002|STARTED|Overall Study||1220||
59992395|NCT02486588|76108204|FG003|STARTED|Overall Study||1206||
59992396|NCT02486588|76108205|FG004|STARTED|Overall Study||1243||
59992397|NCT02486588|76108206|FG005|STARTED|Overall Study||1205||
59992398|NCT02486588|76108201|FG000|COMPLETED|Overall Study||450||
59992399|NCT02486588|76108202|FG001|COMPLETED|Overall Study||502||
59992400|NCT02486588|76108203|FG002|COMPLETED|Overall Study||465||
60086465|NCT01614769|76202516|FG003|COMPLETED|Period 2||0||
60086466|NCT01614769|76202517|FG004|COMPLETED|Period 2||1||
60086467|NCT01614769|76202518|FG005|COMPLETED|Period 2||1||
60086468|NCT01614769|76202513|FG000|NOT COMPLETED|Period 2||0||
60086469|NCT01614769|76202514|FG001|NOT COMPLETED|Period 2||0||
60086470|NCT01614769|76202515|FG002|NOT COMPLETED|Period 2||0||
60086471|NCT01614769|76202516|FG003|NOT COMPLETED|Period 2||0||
60086472|NCT01614769|76202517|FG004|NOT COMPLETED|Period 2||0||
60086473|NCT01614769|76202518|FG005|NOT COMPLETED|Period 2||0||
60086474|NCT01614769|76202513|FG000|STARTED|7-Day Washout||1||
60086475|NCT01614769|76202514|FG001|STARTED|7-Day Washout||1||
59560329|NCT01642238|75661679|FG001|COMPLETED|Washout (1-2 Weeks)||8||
59560330|NCT01642238|75661678|FG000|NOT COMPLETED|Washout (1-2 Weeks)||0||
59560331|NCT01642238|75661679|FG001|NOT COMPLETED|Washout (1-2 Weeks)||0||
59560332|NCT01642238|75661678|FG000|STARTED|Second Intervention (1 Day)||7||
59817921|NCT04488770|75940334|FG008|STARTED|Part 1-Cohort 2: Period 2 (Up to 5 Days)||0||
59992401|NCT02486588|76108204|FG003|COMPLETED|Overall Study||468||
59992402|NCT02486588|76108205|FG004|COMPLETED|Overall Study||497||
59992403|NCT02486588|76108206|FG005|COMPLETED|Overall Study||459||
59992404|NCT02486588|76108201|FG000|NOT COMPLETED|Overall Study||738||
59992405|NCT02486588|76108202|FG001|NOT COMPLETED|Overall Study||750||
59992406|NCT02486588|76108203|FG002|NOT COMPLETED|Overall Study||755||
60086476|NCT01614769|76202515|FG002|STARTED|7-Day Washout||2||
60086477|NCT01614769|76202516|FG003|STARTED|7-Day Washout||0||
60086478|NCT01614769|76202517|FG004|STARTED|7-Day Washout||1||
60086479|NCT01614769|76202518|FG005|STARTED|7-Day Washout||1||
60086480|NCT01614769|76202513|FG000|COMPLETED|7-Day Washout||1||
60086481|NCT01614769|76202514|FG001|COMPLETED|7-Day Washout||1||
60086482|NCT01614769|76202515|FG002|COMPLETED|7-Day Washout||2||
60086483|NCT01614769|76202516|FG003|COMPLETED|7-Day Washout||0||
60086484|NCT01614769|76202517|FG004|COMPLETED|7-Day Washout||1||
60086485|NCT01614769|76202518|FG005|COMPLETED|7-Day Washout||1||
60086486|NCT01614769|76202513|FG000|NOT COMPLETED|7-Day Washout||0||
59992407|NCT02486588|76108204|FG003|NOT COMPLETED|Overall Study||738||
59992408|NCT02486588|76108205|FG004|NOT COMPLETED|Overall Study||746||
60086487|NCT01614769|76202514|FG001|NOT COMPLETED|7-Day Washout||0||
60086488|NCT01614769|76202515|FG002|NOT COMPLETED|7-Day Washout||0||
60086489|NCT01614769|76202516|FG003|NOT COMPLETED|7-Day Washout||0||
60086490|NCT01614769|76202517|FG004|NOT COMPLETED|7-Day Washout||0||
60086491|NCT01614769|76202518|FG005|NOT COMPLETED|7-Day Washout||0||
60086492|NCT01614769|76202513|FG000|STARTED|Period 3||1||
60086493|NCT01614769|76202514|FG001|STARTED|Period 3||1||
60086494|NCT01614769|76202515|FG002|STARTED|Period 3||2||
60086495|NCT01614769|76202516|FG003|STARTED|Period 3||0||
60086496|NCT01614769|76202517|FG004|STARTED|Period 3||1||
60086497|NCT01614769|76202518|FG005|STARTED|Period 3||1||
60086498|NCT01614769|76202513|FG000|COMPLETED|Period 3||1||
60086499|NCT01614769|76202514|FG001|COMPLETED|Period 3||1||
60086500|NCT01614769|76202515|FG002|COMPLETED|Period 3||1||
60086501|NCT01614769|76202516|FG003|COMPLETED|Period 3||0||
60086502|NCT01614769|76202517|FG004|COMPLETED|Period 3||1||
60086503|NCT01614769|76202518|FG005|COMPLETED|Period 3||1||
60086504|NCT01614769|76202513|FG000|NOT COMPLETED|Period 3||0||
59707562|NCT01118325|75826475|FG001|COMPLETED|Overall Study||43||
59707563|NCT01118325|75826476|FG002|COMPLETED|Overall Study||45||
60086505|NCT01614769|76202514|FG001|NOT COMPLETED|Period 3||0||
60086506|NCT01614769|76202515|FG002|NOT COMPLETED|Period 3||1||
60086507|NCT01614769|76202516|FG003|NOT COMPLETED|Period 3||0||
60086508|NCT01614769|76202517|FG004|NOT COMPLETED|Period 3||0||
59560333|NCT01642238|75661679|FG001|STARTED|Second Intervention (1 Day)||8||
59560334|NCT01642238|75661678|FG000|COMPLETED|Second Intervention (1 Day)||7||
59560335|NCT01642238|75661679|FG001|COMPLETED|Second Intervention (1 Day)||8||
59560336|NCT01642238|75661678|FG000|NOT COMPLETED|Second Intervention (1 Day)||0||
59560337|NCT01642238|75661679|FG001|NOT COMPLETED|Second Intervention (1 Day)||0||
59707564|NCT01118325|75826474|FG000|NOT COMPLETED|Overall Study||1||
59707565|NCT01118325|75826475|FG001|NOT COMPLETED|Overall Study||0||
59707566|NCT01118325|75826476|FG002|NOT COMPLETED|Overall Study||1||
59707567|NCT01117857|75826497|FG000|STARTED|Overall Study||22||
59707568|NCT01117857|75826497|FG000|COMPLETED|Overall Study||13||
59707569|NCT01117857|75826497|FG000|NOT COMPLETED|Overall Study||9||
59707570|NCT01251887|75826504|FG000|STARTED|Overall Study||18||
59707571|NCT01251887|75826505|FG001|STARTED|Overall Study||29||
59707572|NCT01251887|75826506|FG002|STARTED|Overall Study||18||
59707573|NCT01251887|75826504|FG000|COMPLETED|Overall Study||17||
59707574|NCT01251887|75826505|FG001|COMPLETED|Overall Study||26||
59707575|NCT01251887|75826506|FG002|COMPLETED|Overall Study||16||
59707576|NCT01251887|75826504|FG000|NOT COMPLETED|Overall Study||1||
59707577|NCT01251887|75826505|FG001|NOT COMPLETED|Overall Study||3||
59707578|NCT01251887|75826506|FG002|NOT COMPLETED|Overall Study||2||
59707579|NCT00991276|75826520|FG000|STARTED|First Intervention Period||15||
59992409|NCT02486588|76108206|FG005|NOT COMPLETED|Overall Study||746||
59992410|NCT00805961|76108225|FG000|STARTED|Modality Therapy||68||
60086509|NCT01614769|76202518|FG005|NOT COMPLETED|Period 3||0||
60086510|NCT01614457|76202528|FG000|STARTED|Overall Study||34||
60086511|NCT01614457|76202529|FG001|STARTED|Overall Study||35||
60086512|NCT01614457|76202528|FG000|COMPLETED|Overall Study||32||
60086513|NCT01614457|76202529|FG001|COMPLETED|Overall Study||35||
60086514|NCT01614457|76202528|FG000|NOT COMPLETED|Overall Study||2||
60086515|NCT01614457|76202529|FG001|NOT COMPLETED|Overall Study||0||
60086516|NCT01863433|76202535|FG000|STARTED|Overall Study||120||
60086517|NCT01863433|76202535|FG000|COMPLETED|Overall Study|1 subject was withdrawn from the study due to evidence of substance abuse.|119||
60086518|NCT01863433|76202535|FG000|NOT COMPLETED|Overall Study||1||
60086519|NCT01862029|76202539|FG000|STARTED|Overall Study||9||
60086520|NCT01862029|76202539|FG000|COMPLETED|Overall Study||8||
60086521|NCT01862029|76202539|FG000|NOT COMPLETED|Overall Study||1||
60086522|NCT01835431|76202546|FG000|STARTED|Overall Study||182||
60086523|NCT01835431|76202547|FG001|STARTED|Overall Study||180||
60086524|NCT01835431|76202546|FG000|Exposed|Overall Study|One subject was withdrawn before exposure.|181||
60086525|NCT01835431|76202547|FG001|Exposed|Overall Study|One subject was withdrawn before exposure|179||
60086526|NCT01835431|76202546|FG000|COMPLETED|Overall Study||174||
60086527|NCT01835431|76202547|FG001|COMPLETED|Overall Study||168||
59707580|NCT00991276|75826521|FG001|STARTED|First Intervention Period||13||
60086528|NCT01835431|76202546|FG000|NOT COMPLETED|Overall Study||8||
60086529|NCT01835431|76202547|FG001|NOT COMPLETED|Overall Study||12||
60086530|NCT01880593|76202555|FG000|STARTED|Overall Study||18||
60086531|NCT01880593|76202556|FG001|STARTED|Overall Study||16||
60086532|NCT01880593|76202555|FG000|COMPLETED|Overall Study||10||
60086533|NCT01880593|76202556|FG001|COMPLETED|Overall Study||10||
60086534|NCT01880593|76202555|FG000|NOT COMPLETED|Overall Study||8||
60086535|NCT01880593|76202556|FG001|NOT COMPLETED|Overall Study||6||
60086536|NCT01400451|76202565|FG000|STARTED|28 Day Lead In With Vemurafenib Alone||6||
60086537|NCT01400451|76202566|FG001|STARTED|28 Day Lead In With Vemurafenib Alone||4||
60086538|NCT01400451|76202567|FG002|STARTED|28 Day Lead In With Vemurafenib Alone||2||
60086539|NCT01400451|76202565|FG000|COMPLETED|28 Day Lead In With Vemurafenib Alone||6||
60086540|NCT01400451|76202566|FG001|COMPLETED|28 Day Lead In With Vemurafenib Alone||4||
60086541|NCT01400451|76202567|FG002|COMPLETED|28 Day Lead In With Vemurafenib Alone||2||
60086542|NCT01400451|76202565|FG000|NOT COMPLETED|28 Day Lead In With Vemurafenib Alone||0||
60086543|NCT01400451|76202566|FG001|NOT COMPLETED|28 Day Lead In With Vemurafenib Alone||0||
60086544|NCT01400451|76202567|FG002|NOT COMPLETED|28 Day Lead In With Vemurafenib Alone||0||
60086545|NCT01400451|76202565|FG000|STARTED|Combination Treatment (or Intended)||6||
60086546|NCT01400451|76202566|FG001|STARTED|Combination Treatment (or Intended)||4||
60086547|NCT01400451|76202567|FG002|STARTED|Combination Treatment (or Intended)|Did not start Ipilimumab but remained on vemurafenib alone.|2||
60086548|NCT01400451|76202565|FG000|COMPLETED|Combination Treatment (or Intended)||0||
60086549|NCT01400451|76202566|FG001|COMPLETED|Combination Treatment (or Intended)||0||
60086550|NCT01400451|76202567|FG002|COMPLETED|Combination Treatment (or Intended)||0||
60086551|NCT01400451|76202565|FG000|NOT COMPLETED|Combination Treatment (or Intended)||6||
60086552|NCT01400451|76202566|FG001|NOT COMPLETED|Combination Treatment (or Intended)||4||
60086553|NCT01400451|76202567|FG002|NOT COMPLETED|Combination Treatment (or Intended)||2||
60086554|NCT01400139|76202580|FG000|STARTED|HYD Core Study||922||
60086555|NCT01400139|76202580|FG000|COMPLETED|HYD Core Study||410||
60086556|NCT01400139|76202580|FG000|NOT COMPLETED|HYD Core Study||512||
60086557|NCT01400139|76202580|FG000|STARTED|HYD Extension Period|Subjects completing the Core Study were offered an option to enter the 24-week open-label Extension|106||
60086558|NCT01400139|76202580|FG000|COMPLETED|HYD Extension Period||83||
60086559|NCT01400139|76202580|FG000|NOT COMPLETED|HYD Extension Period||23||
60086560|NCT01399905|76202588|FG000|STARTED|Overall Study||7||
60086561|NCT01399905|76202589|FG001|STARTED|Overall Study||7||
60086562|NCT01399905|76202588|FG000|COMPLETED|Overall Study|Subject withdrew from the study before receiving treatment.|6||
60086563|NCT01399905|76202589|FG001|COMPLETED|Overall Study|Subject was treated at least one dose of carbidopa before withdrawing from the study.|6||
60086564|NCT01399905|76202588|FG000|NOT COMPLETED|Overall Study||1||
60086565|NCT01399905|76202589|FG001|NOT COMPLETED|Overall Study||1||
60086566|NCT01725308|76202603|FG000|STARTED|Treatment Period I||178||
60086567|NCT01725308|76202604|FG001|STARTED|Treatment Period I||74||
60086568|NCT01725308|76202605|FG002|STARTED|Treatment Period I||179||
60086569|NCT01725308|76202603|FG000|Treated|Treatment Period I||177||
60086570|NCT01725308|76202604|FG001|Treated|Treatment Period I||74||
60086571|NCT01725308|76202605|FG002|Treated|Treatment Period I||179||
60086572|NCT01725308|76202603|FG000|COMPLETED|Treatment Period I||134||
60086573|NCT01725308|76202604|FG001|COMPLETED|Treatment Period I||60||
60086574|NCT01725308|76202605|FG002|COMPLETED|Treatment Period I||138||
60086575|NCT01725308|76202603|FG000|NOT COMPLETED|Treatment Period I||44||
60086576|NCT01725308|76202604|FG001|NOT COMPLETED|Treatment Period I||14||
60086577|NCT01725308|76202605|FG002|NOT COMPLETED|Treatment Period I||41||
60086578|NCT01725308|76202603|FG000|STARTED|Treatment Period II||134||
60086579|NCT01725308|76202604|FG001|STARTED|Treatment Period II||60||
60086580|NCT01725308|76202605|FG002|STARTED|Treatment Period II||138||
60086581|NCT01725308|76202603|FG000|Treated|Treatment Period II||120||
60086582|NCT01725308|76202604|FG001|Treated|Treatment Period II||53||
60086583|NCT01725308|76202605|FG002|Treated|Treatment Period II||130||
60086584|NCT01725308|76202603|FG000|COMPLETED|Treatment Period II||79||
60086585|NCT01725308|76202604|FG001|COMPLETED|Treatment Period II||31||
60086586|NCT01725308|76202605|FG002|COMPLETED|Treatment Period II||74||
60086587|NCT01725308|76202603|FG000|NOT COMPLETED|Treatment Period II||55||
60086588|NCT01725308|76202604|FG001|NOT COMPLETED|Treatment Period II||29||
60086589|NCT01725308|76202605|FG002|NOT COMPLETED|Treatment Period II||64||
60086590|NCT01724528|76202622|FG000|STARTED|Overall Study||173||
59560338|NCT01643876|75661685|FG000|STARTED|Overall Study||48||
59560339|NCT01643876|75661685|FG000|COMPLETED|Overall Study||48||
59560340|NCT01643876|75661685|FG000|NOT COMPLETED|Overall Study||0||
59560341|NCT02290613|75661691|FG000|STARTED|Overall Study||19||
59560342|NCT02290613|75661692|FG001|STARTED|Overall Study||19||
60086591|NCT01724528|76202623|FG001|STARTED|Overall Study||173||
60086592|NCT01724528|76202622|FG000|COMPLETED|Overall Study||169||
60086593|NCT01724528|76202623|FG001|COMPLETED|Overall Study||170||
60086594|NCT01724528|76202622|FG000|NOT COMPLETED|Overall Study||4||
60086595|NCT01724528|76202623|FG001|NOT COMPLETED|Overall Study||3||
60086596|NCT01779440|76202631|FG000|STARTED|Overall Study||30||
60086597|NCT01779440|76202632|FG001|STARTED|Overall Study||28||
60086598|NCT01779440|76202631|FG000|COMPLETED|Overall Study||27||
60086599|NCT01779440|76202632|FG001|COMPLETED|Overall Study||23||
60086600|NCT01779440|76202631|FG000|NOT COMPLETED|Overall Study||3||
60086601|NCT01779440|76202632|FG001|NOT COMPLETED|Overall Study||5||
60086602|NCT01750346|76202641|FG000|STARTED|Overall Study||3||
60086603|NCT01750346|76202642|FG001|STARTED|Overall Study||2||
60086604|NCT01750346|76202643|FG002|STARTED|Overall Study||3||
60086605|NCT01750346|76202641|FG000|COMPLETED|Overall Study||2||
60086606|NCT01750346|76202642|FG001|COMPLETED|Overall Study||2||
59560343|NCT02290613|75661691|FG000|COMPLETED|Overall Study||17||
59560344|NCT02290613|75661692|FG001|COMPLETED|Overall Study||15||
60086607|NCT01750346|76202643|FG002|COMPLETED|Overall Study||3||
60086608|NCT01750346|76202641|FG000|NOT COMPLETED|Overall Study||1||
60086609|NCT01750346|76202642|FG001|NOT COMPLETED|Overall Study||0||
60086610|NCT01750346|76202643|FG002|NOT COMPLETED|Overall Study||0||
60086611|NCT01750268|76202653|FG000|STARTED|Overall Study||15||
60086612|NCT01750268|76202654|FG001|STARTED|Overall Study||17||
60086613|NCT01750268|76202653|FG000|COMPLETED|Overall Study||13||
60086614|NCT01750268|76202654|FG001|COMPLETED|Overall Study||12||
60086615|NCT01750268|76202653|FG000|NOT COMPLETED|Overall Study||2||
60086616|NCT01750268|76202654|FG001|NOT COMPLETED|Overall Study||5||
59816736|NCT04158687|75939123|FG003|Efficacy Population|Overall Study||77|Efficacy population included all participants who received the study medication and had at least one available post-baseline Positive and Negative Syndrome Scale (PANSS) assessment.|
59816737|NCT04158687|75939120|FG000|COMPLETED|Overall Study||64||
59816738|NCT04158687|75939121|FG001|COMPLETED|Overall Study||54||
59816739|NCT04158687|75939122|FG002|COMPLETED|Overall Study||65||
59816740|NCT04158687|75939123|FG003|COMPLETED|Overall Study||66||
59816741|NCT04158687|75939120|FG000|NOT COMPLETED|Overall Study||17||
59816742|NCT04158687|75939121|FG001|NOT COMPLETED|Overall Study||27||
59816743|NCT04158687|75939122|FG002|NOT COMPLETED|Overall Study||20||
59816744|NCT04158687|75939123|FG003|NOT COMPLETED|Overall Study||13||
59816745|NCT04090749|75939136|FG000|STARTED|Open Label Pilot||3||
59816746|NCT04090749|75939137|FG001|STARTED|Open Label Pilot||0||
59816747|NCT04090749|75939138|FG002|STARTED|Open Label Pilot||0||
60086617|NCT01880437|76202663|FG000|STARTED|Overall Study||15||
60086618|NCT01880437|76202664|FG001|STARTED|Overall Study||4||
60086619|NCT01880437|76202665|FG002|STARTED|Overall Study||19||
60086620|NCT01880437|76202663|FG000|COMPLETED|Overall Study||0||
60086621|NCT01880437|76202664|FG001|COMPLETED|Overall Study||0||
60086622|NCT01880437|76202665|FG002|COMPLETED|Overall Study||0||
60086623|NCT01880437|76202663|FG000|NOT COMPLETED|Overall Study||15||
60086624|NCT01880437|76202664|FG001|NOT COMPLETED|Overall Study||4||
60086625|NCT01880437|76202665|FG002|NOT COMPLETED|Overall Study||19||
60086626|NCT01861717|76202675|FG000|STARTED|Overall Study||4|started = signed consent|
60086627|NCT01861717|76202675|FG000|COMPLETED|Overall Study||2||
60086628|NCT01861717|76202675|FG000|NOT COMPLETED|Overall Study||2||
60086629|NCT01834729|76202684|FG000|STARTED|Overall Study||18||
60086630|NCT01834729|76202685|FG001|STARTED|Overall Study||20||
60086631|NCT01834729|76202686|FG002|STARTED|Overall Study||18||
60086632|NCT01834729|76202687|FG003|STARTED|Overall Study||18||
60086633|NCT01834729|76202684|FG000|COMPLETED|Overall Study||17||
60086634|NCT01834729|76202685|FG001|COMPLETED|Overall Study||19||
60086635|NCT01834729|76202686|FG002|COMPLETED|Overall Study||15||
60086636|NCT01834729|76202687|FG003|COMPLETED|Overall Study||16||
60086637|NCT01834729|76202684|FG000|NOT COMPLETED|Overall Study||1||
60086638|NCT01834729|76202685|FG001|NOT COMPLETED|Overall Study||1||
60086639|NCT01834729|76202686|FG002|NOT COMPLETED|Overall Study||3||
60086640|NCT01834729|76202687|FG003|NOT COMPLETED|Overall Study||2||
60086641|NCT01860703|76202698|FG000|STARTED|Overall Study||13||
60086642|NCT01860703|76202699|FG001|STARTED|Overall Study||13||
60086643|NCT01860703|76202700|FG002|STARTED|Overall Study||12||
60086644|NCT01860703|76202701|FG003|STARTED|Overall Study||12||
60086645|NCT01860703|76202698|FG000|COMPLETED|Overall Study||11||
60086646|NCT01860703|76202699|FG001|COMPLETED|Overall Study||8||
60086647|NCT01860703|76202700|FG002|COMPLETED|Overall Study||11||
60086648|NCT01860703|76202701|FG003|COMPLETED|Overall Study||10||
60086649|NCT01860703|76202698|FG000|NOT COMPLETED|Overall Study||2||
60086650|NCT01860703|76202699|FG001|NOT COMPLETED|Overall Study||5||
60086651|NCT01860703|76202700|FG002|NOT COMPLETED|Overall Study||1||
60086652|NCT01860703|76202701|FG003|NOT COMPLETED|Overall Study||2||
60086653|NCT01399593|76202719|FG000|STARTED|Overall Study||51||
60086654|NCT01399593|76202720|FG001|STARTED|Overall Study||51||
60086655|NCT01399593|76202719|FG000|COMPLETED|Overall Study||48||
60086656|NCT01399593|76202720|FG001|COMPLETED|Overall Study||49||
60086657|NCT01399593|76202719|FG000|NOT COMPLETED|Overall Study||3||
60086658|NCT01399593|76202720|FG001|NOT COMPLETED|Overall Study||2||
60086659|NCT01833169|76202726|FG000|STARTED|Overall Study||146||
60086660|NCT01833169|76202726|FG000|Consented to be Followed for Survival|Overall Study||128||
60086661|NCT01833169|76202726|FG000|COMPLETED|Overall Study||0||
60086662|NCT01833169|76202726|FG000|NOT COMPLETED|Overall Study||146||
60086663|NCT01860079|76202732|FG000|STARTED|Overall Study||384||
60086664|NCT01860079|76202733|FG001|STARTED|Overall Study||385||
60086665|NCT01860079|76202732|FG000|COMPLETED|Overall Study||370||
60086666|NCT01860079|76202733|FG001|COMPLETED|Overall Study||363||
60086667|NCT01860079|76202732|FG000|NOT COMPLETED|Overall Study||14||
60086668|NCT01860079|76202733|FG001|NOT COMPLETED|Overall Study||22||
60086669|NCT01388985|76202741|FG000|STARTED|Overall Study|1 participant (from the 250 enrolled) did not receive any vaccination because of consent withdrawal.|249||
60086670|NCT01388985|76202742|FG001|STARTED|Overall Study|1 participant (from the 250 enrolled) did not receive any vaccination because of consent withdrawal.|249||
60086671|NCT01388985|76202741|FG000|Primary Vaccination Period|Overall Study||231||
60086672|NCT01388985|76202742|FG001|Primary Vaccination Period|Overall Study||238||
60086673|NCT01388985|76202741|FG000|COMPLETED|Overall Study|From those 200, 15 were excluded from the per protocol analysis.|200||
59816748|NCT04090749|75939136|FG000|COMPLETED|Open Label Pilot||2||
59816749|NCT04090749|75939137|FG001|COMPLETED|Open Label Pilot||0||
59816750|NCT04090749|75939138|FG002|COMPLETED|Open Label Pilot||0||
60086674|NCT01388985|76202742|FG001|COMPLETED|Overall Study|From those 200, 28 were excluded from the per protocol analysis.|211||
59816751|NCT04090749|75939136|FG000|NOT COMPLETED|Open Label Pilot||1||
59816752|NCT04090749|75939137|FG001|NOT COMPLETED|Open Label Pilot||0||
60086675|NCT01388985|76202741|FG000|NOT COMPLETED|Overall Study||49||
60086676|NCT01388985|76202742|FG001|NOT COMPLETED|Overall Study||38||
60086677|NCT01388907|76202750|FG000|STARTED|Overall Study||33||
60086678|NCT01388907|76202751|FG001|STARTED|Overall Study||28||
60086679|NCT01388907|76202750|FG000|COMPLETED|Overall Study||31||
60086680|NCT01388907|76202751|FG001|COMPLETED|Overall Study||28||
60086681|NCT01388907|76202750|FG000|NOT COMPLETED|Overall Study||2||
60086682|NCT01388907|76202751|FG001|NOT COMPLETED|Overall Study||0||
60086683|NCT01388361|76202762|FG000|STARTED|Overall Study||236||
60086684|NCT01388361|76202763|FG001|STARTED|Overall Study||88||
60086685|NCT01388361|76202764|FG002|STARTED|Overall Study||89||
60086686|NCT01388361|76202762|FG000|Exposed|Overall Study|Two subjects withdrew prior to exposure to IDeg during NN1250-3948|234||
60086687|NCT01388361|76202763|FG001|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug.|87||
60086688|NCT01388361|76202764|FG002|Exposed|Overall Study|Three subjects withdrew prior to exposure to trial drug.|86||
60086689|NCT01388361|76202762|FG000|COMPLETED|Overall Study||224||
60086690|NCT01388361|76202763|FG001|COMPLETED|Overall Study||76||
60086691|NCT01388361|76202764|FG002|COMPLETED|Overall Study||75||
60086692|NCT01388361|76202762|FG000|NOT COMPLETED|Overall Study||12||
60086693|NCT01388361|76202763|FG001|NOT COMPLETED|Overall Study||12||
60086694|NCT01388361|76202764|FG002|NOT COMPLETED|Overall Study||14||
60086695|NCT01399125|76202774|FG000|STARTED|Overall Study||248||
60086696|NCT01399125|76202775|FG001|STARTED|Overall Study||253||
60086697|NCT01399125|76202774|FG000|Per Protocol (PP) Population|Overall Study||192||
60086698|NCT01399125|76202775|FG001|Per Protocol (PP) Population|Overall Study||188||
60086699|NCT01399125|76202774|FG000|COMPLETED|Overall Study||197||
60086700|NCT01399125|76202775|FG001|COMPLETED|Overall Study||193||
60086701|NCT01399125|76202774|FG000|NOT COMPLETED|Overall Study||51||
60086702|NCT01399125|76202775|FG001|NOT COMPLETED|Overall Study||60||
60086703|NCT01399047|76202783|FG000|STARTED|Overall Study||10||
60086704|NCT01399047|76202784|FG001|STARTED|Overall Study||9||
60086705|NCT01399047|76202783|FG000|COMPLETED|Overall Study||10||
60086706|NCT01399047|76202784|FG001|COMPLETED|Overall Study||8||
60086707|NCT01399047|76202783|FG000|NOT COMPLETED|Overall Study||0||
60086708|NCT01399047|76202784|FG001|NOT COMPLETED|Overall Study||1||
60086709|NCT01387737|76202794|FG000|STARTED|Overall Study||584||
60086710|NCT01387737|76202795|FG001|STARTED|Overall Study||715||
60086711|NCT01387737|76202794|FG000|COMPLETED|Overall Study||532||
60086712|NCT01387737|76202795|FG001|COMPLETED|Overall Study||641||
60086713|NCT01387737|76202794|FG000|NOT COMPLETED|Overall Study||52||
60086714|NCT01387737|76202795|FG001|NOT COMPLETED|Overall Study||74||
60086715|NCT01387347|76202803|FG000|STARTED|Overall Study||36||
60086716|NCT01387347|76202804|FG001|STARTED|Overall Study||36||
60086717|NCT01387347|76202803|FG000|COMPLETED|Overall Study||34||
60086718|NCT01387347|76202804|FG001|COMPLETED|Overall Study||35||
60086719|NCT01387347|76202803|FG000|NOT COMPLETED|Overall Study||2||
60086720|NCT01387347|76202804|FG001|NOT COMPLETED|Overall Study||1||
60086721|NCT01859923|76202818|FG000|STARTED|Overall Study||7||
60086722|NCT01859923|76202819|FG001|STARTED|Overall Study||6||
60086723|NCT01859923|76202820|FG002|STARTED|Overall Study||12||
60086724|NCT01859923|76202821|FG003|STARTED|Overall Study||12||
60086725|NCT01859923|76202818|FG000|COMPLETED|Overall Study||7||
60086726|NCT01859923|76202819|FG001|COMPLETED|Overall Study||6||
60086727|NCT01859923|76202820|FG002|COMPLETED|Overall Study||11||
60086728|NCT01859923|76202821|FG003|COMPLETED|Overall Study||11||
60086729|NCT01859923|76202818|FG000|NOT COMPLETED|Overall Study||0||
60086730|NCT01859923|76202819|FG001|NOT COMPLETED|Overall Study||0||
60086731|NCT01859923|76202820|FG002|NOT COMPLETED|Overall Study||1||
60086732|NCT01859923|76202821|FG003|NOT COMPLETED|Overall Study||1||
60086733|NCT01832155|76202836|FG000|STARTED|Beginning of Study: Baseline at 0 Week||18||
60086734|NCT01832155|76202837|FG001|STARTED|Beginning of Study: Baseline at 0 Week||18||
60086735|NCT01832155|76202836|FG000|COMPLETED|Beginning of Study: Baseline at 0 Week||17||
60086736|NCT01832155|76202837|FG001|COMPLETED|Beginning of Study: Baseline at 0 Week||18||
60086737|NCT01832155|76202836|FG000|NOT COMPLETED|Beginning of Study: Baseline at 0 Week||1||
60086738|NCT01832155|76202837|FG001|NOT COMPLETED|Beginning of Study: Baseline at 0 Week||0||
60086739|NCT01832155|76202836|FG000|STARTED|Mid-point of Study: 0 - 4 Weeks||17||
60086740|NCT01832155|76202837|FG001|STARTED|Mid-point of Study: 0 - 4 Weeks||18||
60086741|NCT01832155|76202836|FG000|COMPLETED|Mid-point of Study: 0 - 4 Weeks||16||
60086742|NCT01832155|76202837|FG001|COMPLETED|Mid-point of Study: 0 - 4 Weeks||18||
60086743|NCT01832155|76202836|FG000|NOT COMPLETED|Mid-point of Study: 0 - 4 Weeks||1||
60086744|NCT01832155|76202837|FG001|NOT COMPLETED|Mid-point of Study: 0 - 4 Weeks||0||
60086745|NCT01832155|76202836|FG000|STARTED|End of Study: 4 - 8 Weeks||16||
60086746|NCT01832155|76202837|FG001|STARTED|End of Study: 4 - 8 Weeks||18||
60086747|NCT01832155|76202836|FG000|COMPLETED|End of Study: 4 - 8 Weeks||16||
60086748|NCT01832155|76202837|FG001|COMPLETED|End of Study: 4 - 8 Weeks||18||
60086749|NCT01832155|76202836|FG000|NOT COMPLETED|End of Study: 4 - 8 Weeks||0||
60086750|NCT01832155|76202837|FG001|NOT COMPLETED|End of Study: 4 - 8 Weeks||0||
60086751|NCT01879579|76202851|FG000|STARTED|Overall Study||33||
60086752|NCT01879579|76202852|FG001|STARTED|Overall Study||28||
60086753|NCT01879579|76202851|FG000|COMPLETED|Overall Study||28||
60086754|NCT01879579|76202852|FG001|COMPLETED|Overall Study||26||
60086755|NCT01879579|76202851|FG000|NOT COMPLETED|Overall Study||5||
60086756|NCT01879579|76202852|FG001|NOT COMPLETED|Overall Study||2||
60086757|NCT01386645|76202864|FG000|STARTED|Overall Study||18||
60086758|NCT01386645|76202865|FG001|STARTED|Overall Study||19||
60086759|NCT01386645|76202866|FG002|STARTED|Overall Study||19||
60086760|NCT01386645|76202864|FG000|COMPLETED|Overall Study||18||
60086761|NCT01386645|76202865|FG001|COMPLETED|Overall Study||18||
60086762|NCT01386645|76202866|FG002|COMPLETED|Overall Study||17||
60086763|NCT01386645|76202864|FG000|NOT COMPLETED|Overall Study||0||
60086764|NCT01386645|76202865|FG001|NOT COMPLETED|Overall Study||1||
60086765|NCT01386645|76202866|FG002|NOT COMPLETED|Overall Study||2||
60086766|NCT01387269|76202876|FG000|STARTED|Overall Study||323||
60086767|NCT01387269|76202877|FG001|STARTED|Overall Study||161||
60086768|NCT01387269|76202876|FG000|ITT Population|Overall Study||323||
60086769|NCT01387269|76202877|FG001|ITT Population|Overall Study||161||
60086770|NCT01387269|76202876|FG000|MITT Population|Overall Study||284||
60086771|NCT01387269|76202877|FG001|MITT Population|Overall Study||141||
60086772|NCT01387269|76202876|FG000|Safety Population|Overall Study||320||
60086773|NCT01387269|76202877|FG001|Safety Population|Overall Study||161||
60086774|NCT01387269|76202876|FG000|COMPLETED|Overall Study||231|A patient was considered to have completed the study if the patient completed Week 12/Day 85 Visit.|
60086775|NCT01387269|76202877|FG001|COMPLETED|Overall Study||121|A patient was considered to have completed the study if the patient completed Week 12/Day 85 Visit.|
60086776|NCT01387269|76202876|FG000|NOT COMPLETED|Overall Study||92||
60086777|NCT01387269|76202877|FG001|NOT COMPLETED|Overall Study||40||
60086778|NCT01859143|76202885|FG000|STARTED|Overall Study||240||
60086779|NCT01859143|76202886|FG001|STARTED|Overall Study|One participant in this group received trivalent influenza vaccine on Day 1.|60||
60086780|NCT01859143|76202885|FG000|COMPLETED|Overall Study||238||
60086781|NCT01859143|76202886|FG001|COMPLETED|Overall Study||60||
60086782|NCT01859143|76202885|FG000|NOT COMPLETED|Overall Study||2||
60086783|NCT01859143|76202886|FG001|NOT COMPLETED|Overall Study||0||
60086784|NCT01878253|76202893|FG000|STARTED|Overall Study||95||
60086785|NCT01878253|76202893|FG000|Pre-Operative|Overall Study||95||
60086786|NCT01878253|76202893|FG000|6 Weeks|Overall Study||95||
60086787|NCT01878253|76202893|FG000|6 Months|Overall Study||90||
60086788|NCT01878253|76202893|FG000|1 Year|Overall Study||88||
60086789|NCT01878253|76202893|FG000|2 Year|Overall Study||86||
60086790|NCT01878253|76202893|FG000|COMPLETED|Overall Study||86||
60086791|NCT01878253|76202893|FG000|NOT COMPLETED|Overall Study||9||
60086792|NCT01878175|76202902|FG000|STARTED|Overall Study||15||
60086793|NCT01878175|76202902|FG000|COMPLETED|Overall Study||13||
60086794|NCT01878175|76202902|FG000|NOT COMPLETED|Overall Study||2||
60086795|NCT01878097|76202909|FG000|STARTED|Baseline|number of students in 13 intervention schools completing anonymous surveys with non missing data|10725||13
60086796|NCT01878097|76202910|FG001|STARTED|Baseline|number of students in 13 control schools completing anonymous surveys with non missing data|10081||13
60086797|NCT01878097|76202909|FG000|COMPLETED|Baseline|Anonymous surveys so only last year data provided as annual completed.|8228|Anonymous surveys; sum of all completed surveys.|13
60086798|NCT01878097|76202910|FG001|COMPLETED|Baseline|Anonymous surveys; sum of all completed surveys.|8281|Anonymous surveys; sum of all completed surveys.|13
60086799|NCT01878097|76202909|FG000|NOT COMPLETED|Baseline||2497||0
60086800|NCT01878097|76202910|FG001|NOT COMPLETED|Baseline||1800||0
60086801|NCT01878097|76202909|FG000|STARTED|Implementation Year 1||11742||13
60086802|NCT01878097|76202910|FG001|STARTED|Implementation Year 1||9866||12
60086803|NCT01878097|76202909|FG000|COMPLETED|Implementation Year 1||8540||13
60086804|NCT01878097|76202910|FG001|COMPLETED|Implementation Year 1||7317||12
60086805|NCT01878097|76202909|FG000|NOT COMPLETED|Implementation Year 1||3202||0
60086806|NCT01878097|76202910|FG001|NOT COMPLETED|Implementation Year 1||2549||0
60086807|NCT01878097|76202909|FG000|STARTED|Implementation Year 2||11567||13
60086808|NCT01878097|76202910|FG001|STARTED|Implementation Year 2||9611||12
60086809|NCT01878097|76202909|FG000|COMPLETED|Implementation Year 2||8286||13
60086810|NCT01878097|76202910|FG001|COMPLETED|Implementation Year 2||6770||12
60086811|NCT01878097|76202909|FG000|NOT COMPLETED|Implementation Year 2||3281||0
60086812|NCT01878097|76202910|FG001|NOT COMPLETED|Implementation Year 2||2841||0
60086813|NCT01878097|76202909|FG000|STARTED|Implementation Year 3||10540||13
60086814|NCT01878097|76202910|FG001|STARTED|Implementation Year 3||9750||12
60086815|NCT01878097|76202909|FG000|COMPLETED|Implementation Year 3||7046||13
59560345|NCT02290613|75661691|FG000|NOT COMPLETED|Overall Study||2||
59560346|NCT02290613|75661692|FG001|NOT COMPLETED|Overall Study||4||
59560347|NCT02331407|75661698|FG000|STARTED|Overall Study||9||
60086816|NCT01878097|76202910|FG001|COMPLETED|Implementation Year 3||6770||12
60086817|NCT01878097|76202909|FG000|NOT COMPLETED|Implementation Year 3||3494||0
60086818|NCT01878097|76202910|FG001|NOT COMPLETED|Implementation Year 3||2980||0
60086819|NCT01878097|76202909|FG000|STARTED|Implementation Year 4||10585||12
60086820|NCT01878097|76202910|FG001|STARTED|Implementation Year 4||9614||12
60086821|NCT01878097|76202909|FG000|COMPLETED|Implementation Year 4||6981||12
60086822|NCT01878097|76202910|FG001|COMPLETED|Implementation Year 4||6607||12
60086823|NCT01878097|76202909|FG000|NOT COMPLETED|Implementation Year 4||3604||0
60086824|NCT01878097|76202910|FG001|NOT COMPLETED|Implementation Year 4||3007||0
60086825|NCT01750190|76202918|FG000|STARTED|Overall Study||616|Intent-to-Treat (ITT) Population: All randomized/enrolled participants.|
60086826|NCT01750190|76202919|FG001|STARTED|Overall Study||306|Intent-to-Treat (ITT) Population: All randomized/enrolled participants.|
59560348|NCT02331407|75661698|FG000|COMPLETED|Overall Study||9||
59560349|NCT02331407|75661698|FG000|NOT COMPLETED|Overall Study||0||
59560350|NCT01610570|75661706|FG000|STARTED|Ph I >/= 12 mo. Children & Adolescents||0||
59560351|NCT01610570|75661707|FG001|STARTED|Ph I >/= 12 mo. Children & Adolescents||2||
59560352|NCT01610570|75661708|FG002|STARTED|Ph I >/= 12 mo. Children & Adolescents||0||
59560353|NCT01610570|75661709|FG003|STARTED|Ph I >/= 12 mo. Children & Adolescents||0||
59560354|NCT01610570|75661706|FG000|COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0||
59560355|NCT01610570|75661707|FG001|COMPLETED|Ph I >/= 12 mo. Children & Adolescents||2||
59560356|NCT01610570|75661708|FG002|COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0||
59560357|NCT01610570|75661709|FG003|COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0||
59560358|NCT01610570|75661706|FG000|NOT COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0||
59560359|NCT01610570|75661707|FG001|NOT COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0||
59560360|NCT01610570|75661708|FG002|NOT COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0||
59560361|NCT01610570|75661709|FG003|NOT COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0||
59560362|NCT01610570|75661706|FG000|STARTED|Ph II >/= 18yrs of Age at Enrollment||0||
59560363|NCT01610570|75661707|FG001|STARTED|Ph II >/= 18yrs of Age at Enrollment||0||
59560364|NCT01610570|75661708|FG002|STARTED|Ph II >/= 18yrs of Age at Enrollment||0||
59560365|NCT01610570|75661709|FG003|STARTED|Ph II >/= 18yrs of Age at Enrollment||6||
59560366|NCT01610570|75661706|FG000|COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0||
59560367|NCT01610570|75661707|FG001|COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0||
59560368|NCT01610570|75661708|FG002|COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0||
59560369|NCT01610570|75661709|FG003|COMPLETED|Ph II >/= 18yrs of Age at Enrollment||6||
59560370|NCT01610570|75661706|FG000|NOT COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0||
59560371|NCT01610570|75661707|FG001|NOT COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0||
59560372|NCT01610570|75661708|FG002|NOT COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0||
59560373|NCT01610570|75661709|FG003|NOT COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0||
59560374|NCT01610570|75661706|FG000|STARTED|Ph II >/= 12 mo. & </=17yrs||0||
59560375|NCT01610570|75661707|FG001|STARTED|Ph II >/= 12 mo. & </=17yrs||0||
59560376|NCT01610570|75661708|FG002|STARTED|Ph II >/= 12 mo. & </=17yrs||0||
59560377|NCT01610570|75661709|FG003|STARTED|Ph II >/= 12 mo. & </=17yrs||0||
59560378|NCT01610570|75661706|FG000|COMPLETED|Ph II >/= 12 mo. & </=17yrs||0||
59560379|NCT01610570|75661707|FG001|COMPLETED|Ph II >/= 12 mo. & </=17yrs||0||
59560380|NCT01610570|75661708|FG002|COMPLETED|Ph II >/= 12 mo. & </=17yrs||0||
59560381|NCT01610570|75661709|FG003|COMPLETED|Ph II >/= 12 mo. & </=17yrs||0||
59560382|NCT01610570|75661706|FG000|NOT COMPLETED|Ph II >/= 12 mo. & </=17yrs||0||
59707581|NCT00991276|75826522|FG002|STARTED|First Intervention Period||14||
59560383|NCT01610570|75661707|FG001|NOT COMPLETED|Ph II >/= 12 mo. & </=17yrs||0||
59560384|NCT01610570|75661708|FG002|NOT COMPLETED|Ph II >/= 12 mo. & </=17yrs||0||
59560385|NCT01610570|75661709|FG003|NOT COMPLETED|Ph II >/= 12 mo. & </=17yrs||0||
59560386|NCT01611662|75661725|FG000|STARTED|Overall Study||32||
59560387|NCT01611662|75661725|FG000|COMPLETED|Overall Study||31||
59560388|NCT01611662|75661725|FG000|NOT COMPLETED|Overall Study||1||
59560389|NCT02239562|75661735|FG000|STARTED|Overall Study||6||
59560390|NCT02239562|75661736|FG001|STARTED|Overall Study||6||
59560391|NCT02239562|75661737|FG002|STARTED|Overall Study||6||
59560392|NCT02239562|75661738|FG003|STARTED|Overall Study||6||
59560393|NCT02239562|75661739|FG004|STARTED|Overall Study||6||
59560394|NCT02239562|75661740|FG005|STARTED|Overall Study||6||
59560395|NCT02239562|75661735|FG000|COMPLETED|Overall Study||6||
59560396|NCT02239562|75661736|FG001|COMPLETED|Overall Study||6||
59560397|NCT02239562|75661737|FG002|COMPLETED|Overall Study||6||
59560398|NCT02239562|75661738|FG003|COMPLETED|Overall Study||6||
59560399|NCT02239562|75661739|FG004|COMPLETED|Overall Study||6||
59560400|NCT02239562|75661740|FG005|COMPLETED|Overall Study||6||
59560401|NCT02239562|75661735|FG000|NOT COMPLETED|Overall Study||0||
59560402|NCT02239562|75661736|FG001|NOT COMPLETED|Overall Study||0||
59707582|NCT00991276|75826523|FG003|STARTED|First Intervention Period||15||
59707583|NCT00991276|75826524|FG004|STARTED|First Intervention Period||15||
59992411|NCT00805961|76108225|FG000|COMPLETED|Modality Therapy||64||
59992412|NCT00805961|76108225|FG000|NOT COMPLETED|Modality Therapy||4||
59992413|NCT00805961|76108225|FG000|STARTED|Treatment-Free Interval||64||
59992414|NCT00805961|76108225|FG000|COMPLETED|Treatment-Free Interval||57||
59992415|NCT00805961|76108225|FG000|NOT COMPLETED|Treatment-Free Interval||7||
59992416|NCT00805961|76108225|FG000|STARTED|Maintenance Treatment||57||
59992417|NCT00805961|76108225|FG000|COMPLETED|Maintenance Treatment||23||
60086827|NCT01750190|76202918|FG000|Safety Population|Overall Study||611|All randomized/enrolled participants who received at least 1 dose of study drug.|
60086828|NCT01750190|76202919|FG001|Safety Population|Overall Study||305|All randomized/enrolled participants who received at least 1 dose of study drug.|
60086829|NCT01750190|76202918|FG000|Full Analysis Set (FAS)|Overall Study||608|All randomized/enrolled participants who received at least 1 dose of study drug and have baseline and at least 1 postdose Hb assessment.|
60086830|NCT01750190|76202919|FG001|Full Analysis Set (FAS)|Overall Study||305|All randomized/enrolled participants who received at least 1 dose of study drug and have baseline and at least 1 postdose Hb assessment.|
60086831|NCT01750190|76202918|FG000|COMPLETED|Overall Study||349||
60086832|NCT01750190|76202919|FG001|COMPLETED|Overall Study||98||
60086833|NCT01750190|76202918|FG000|NOT COMPLETED|Overall Study||267||
60086834|NCT01750190|76202919|FG001|NOT COMPLETED|Overall Study||208||
60086835|NCT01831765|76202928|FG000|STARTED|Overall Study||381||
60086836|NCT01831765|76202929|FG001|STARTED|Overall Study||382||
60086837|NCT01831765|76202930|FG002|STARTED|Overall Study||380||
60086838|NCT01831765|76202928|FG000|Completed 26 Weeks|Overall Study||351||
60086839|NCT01831765|76202929|FG001|Completed 26 Weeks|Overall Study||355||
60086840|NCT01831765|76202930|FG002|Completed 26 Weeks|Overall Study||356||
60086841|NCT01831765|76202928|FG000|Completed 52 Weeks|Overall Study||337||
60086842|NCT01831765|76202929|FG001|Completed 52 Weeks|Overall Study|This arm did not continue in the trial after 26 weeks ( 26 to 52 weeks).|0||
60086843|NCT01831765|76202930|FG002|Completed 52 Weeks|Overall Study||338||
60086844|NCT01831765|76202928|FG000|COMPLETED|Overall Study||337||
60086845|NCT01831765|76202929|FG001|COMPLETED|Overall Study||355||
60086846|NCT01831765|76202930|FG002|COMPLETED|Overall Study||338||
60086847|NCT01831765|76202928|FG000|NOT COMPLETED|Overall Study||44||
60086848|NCT01831765|76202929|FG001|NOT COMPLETED|Overall Study||27||
60086849|NCT01831765|76202930|FG002|NOT COMPLETED|Overall Study||42||
60086850|NCT01749800|76202943|FG000|STARTED|Overall Study|3 subjects did not show significant attention span deficit (required inclusion criterion)|6||
60086851|NCT01749800|76202944|FG001|STARTED|Overall Study|1 subject showed significant motor impairments but decided to undergo therapy (exclusion criterion)|1||
60086852|NCT01749800|76202945|FG002|STARTED|Overall Study||0||
60086853|NCT01749800|76202943|FG000|COMPLETED|Overall Study||3||
60086854|NCT01749800|76202944|FG001|COMPLETED|Overall Study||0||
60086855|NCT01749800|76202945|FG002|COMPLETED|Overall Study||0||
60086856|NCT01749800|76202943|FG000|NOT COMPLETED|Overall Study||3||
60086857|NCT01749800|76202944|FG001|NOT COMPLETED|Overall Study||1||
60086858|NCT01749800|76202945|FG002|NOT COMPLETED|Overall Study||0||
60086859|NCT01830595|76202953|FG000|STARTED|First Period||26||
60086860|NCT01830595|76202954|FG001|STARTED|First Period||28||
59560403|NCT02239562|75661737|FG002|NOT COMPLETED|Overall Study||0||
59992418|NCT00805961|76108225|FG000|NOT COMPLETED|Maintenance Treatment||34||
59992419|NCT02202538|76108229|FG000|STARTED|Overall Study||53||
59992420|NCT02202538|76108229|FG000|Screen Failure|Overall Study||2||
59992421|NCT02202538|76108229|FG000|COMPLETED|Overall Study||45||
59560404|NCT02239562|75661738|FG003|NOT COMPLETED|Overall Study||0||
59560405|NCT02239562|75661739|FG004|NOT COMPLETED|Overall Study||0||
59560406|NCT02239562|75661740|FG005|NOT COMPLETED|Overall Study||0||
59560407|NCT01613768|75661756|FG000|STARTED|Overall Study||29||
59707584|NCT00991276|75826525|FG005|STARTED|First Intervention Period||13||
59992422|NCT02202538|76108229|FG000|NOT COMPLETED|Overall Study||8||
60086861|NCT01830595|76202953|FG000|Received at Least One Dose|First Period||26||
60086862|NCT01830595|76202954|FG001|Received at Least One Dose|First Period||28||
60086863|NCT01830595|76202953|FG000|COMPLETED|First Period||25||
59560408|NCT01613768|75661756|FG000|COMPLETED|Overall Study||29||
59560409|NCT01613768|75661756|FG000|NOT COMPLETED|Overall Study||0||
59560410|NCT01614392|75661763|FG000|STARTED|Overall Study||25||
59560411|NCT01614392|75661764|FG001|STARTED|Overall Study||27||
59560412|NCT01614392|75661763|FG000|COMPLETED|Overall Study||24||
59560413|NCT01614392|75661764|FG001|COMPLETED|Overall Study||24||
59560414|NCT01614392|75661763|FG000|NOT COMPLETED|Overall Study||1||
59560415|NCT01614392|75661764|FG001|NOT COMPLETED|Overall Study||3||
59560416|NCT02233478|75661770|FG000|STARTED|First Intervention (1 Day)||3||
59560417|NCT02233478|75661771|FG001|STARTED|First Intervention (1 Day)||3||
59560418|NCT02233478|75661772|FG002|STARTED|First Intervention (1 Day)||3||
59560419|NCT02233478|75661773|FG003|STARTED|First Intervention (1 Day)||3||
59560420|NCT02233478|75661774|FG004|STARTED|First Intervention (1 Day)||3||
59560421|NCT02233478|75661775|FG005|STARTED|First Intervention (1 Day)||3||
60086864|NCT01830595|76202954|FG001|COMPLETED|First Period||25||
60086865|NCT01830595|76202953|FG000|NOT COMPLETED|First Period||1||
60086866|NCT01830595|76202954|FG001|NOT COMPLETED|First Period||3||
60086867|NCT01830595|76202953|FG000|STARTED|Washout||25||
60086868|NCT01830595|76202954|FG001|STARTED|Washout||25||
60086869|NCT01830595|76202953|FG000|COMPLETED|Washout||23||
60086870|NCT01830595|76202954|FG001|COMPLETED|Washout||23||
60086871|NCT01830595|76202953|FG000|NOT COMPLETED|Washout||2||
60086872|NCT01830595|76202954|FG001|NOT COMPLETED|Washout||2||
60086873|NCT01830595|76202953|FG000|STARTED|Second Period||23||
60086874|NCT01830595|76202954|FG001|STARTED|Second Period||23||
60086875|NCT01830595|76202953|FG000|COMPLETED|Second Period||23||
60086876|NCT01830595|76202954|FG001|COMPLETED|Second Period||23||
60086877|NCT01830595|76202953|FG000|NOT COMPLETED|Second Period||0||
60086878|NCT01830595|76202954|FG001|NOT COMPLETED|Second Period||0||
60086879|NCT01748552|76202972|FG000|STARTED|Intervention Period 1 and Washout||3||
60086880|NCT01748552|76202973|FG001|STARTED|Intervention Period 1 and Washout||3||
60086881|NCT01748552|76202974|FG002|STARTED|Intervention Period 1 and Washout||3||
60086882|NCT01748552|76202975|FG003|STARTED|Intervention Period 1 and Washout||3||
60086883|NCT01748552|76202976|FG004|STARTED|Intervention Period 1 and Washout||3||
60086884|NCT01748552|76202977|FG005|STARTED|Intervention Period 1 and Washout||3||
60086885|NCT01748552|76202978|FG006|STARTED|Intervention Period 1 and Washout||3||
60086886|NCT01748552|76202979|FG007|STARTED|Intervention Period 1 and Washout||3||
60086887|NCT01748552|76202980|FG008|STARTED|Intervention Period 1 and Washout||3||
60086888|NCT01748552|76202981|FG009|STARTED|Intervention Period 1 and Washout||3||
60086889|NCT01748552|76202982|FG010|STARTED|Intervention Period 1 and Washout||3||
60086890|NCT01748552|76202983|FG011|STARTED|Intervention Period 1 and Washout||3||
60086891|NCT01748552|76202972|FG000|COMPLETED|Intervention Period 1 and Washout||3||
60086892|NCT01748552|76202973|FG001|COMPLETED|Intervention Period 1 and Washout||3||
60086893|NCT01748552|76202974|FG002|COMPLETED|Intervention Period 1 and Washout||3||
60086894|NCT01748552|76202975|FG003|COMPLETED|Intervention Period 1 and Washout||3||
60086895|NCT01748552|76202976|FG004|COMPLETED|Intervention Period 1 and Washout||3||
60086896|NCT01748552|76202977|FG005|COMPLETED|Intervention Period 1 and Washout||3||
60086897|NCT01748552|76202978|FG006|COMPLETED|Intervention Period 1 and Washout||3||
60086898|NCT01748552|76202979|FG007|COMPLETED|Intervention Period 1 and Washout||3||
60086899|NCT01748552|76202980|FG008|COMPLETED|Intervention Period 1 and Washout||3||
60086900|NCT01748552|76202981|FG009|COMPLETED|Intervention Period 1 and Washout||3||
60086901|NCT01748552|76202982|FG010|COMPLETED|Intervention Period 1 and Washout||3||
60086902|NCT01748552|76202983|FG011|COMPLETED|Intervention Period 1 and Washout||3||
60086903|NCT01748552|76202972|FG000|NOT COMPLETED|Intervention Period 1 and Washout||0||
60086904|NCT01748552|76202973|FG001|NOT COMPLETED|Intervention Period 1 and Washout||0||
60086905|NCT01748552|76202974|FG002|NOT COMPLETED|Intervention Period 1 and Washout||0||
60086906|NCT01748552|76202975|FG003|NOT COMPLETED|Intervention Period 1 and Washout||0||
60086907|NCT01748552|76202976|FG004|NOT COMPLETED|Intervention Period 1 and Washout||0||
60086908|NCT01748552|76202977|FG005|NOT COMPLETED|Intervention Period 1 and Washout||0||
60086909|NCT01748552|76202978|FG006|NOT COMPLETED|Intervention Period 1 and Washout||0||
60086910|NCT01748552|76202979|FG007|NOT COMPLETED|Intervention Period 1 and Washout||0||
60086911|NCT01748552|76202980|FG008|NOT COMPLETED|Intervention Period 1 and Washout||0||
60086912|NCT01748552|76202981|FG009|NOT COMPLETED|Intervention Period 1 and Washout||0||
59560422|NCT02233478|75661770|FG000|COMPLETED|First Intervention (1 Day)||3||
59560423|NCT02233478|75661771|FG001|COMPLETED|First Intervention (1 Day)||3||
59560424|NCT02233478|75661772|FG002|COMPLETED|First Intervention (1 Day)||3||
59560425|NCT02233478|75661773|FG003|COMPLETED|First Intervention (1 Day)||3||
59560426|NCT02233478|75661774|FG004|COMPLETED|First Intervention (1 Day)||3||
60086913|NCT01748552|76202982|FG010|NOT COMPLETED|Intervention Period 1 and Washout||0||
60086914|NCT01748552|76202983|FG011|NOT COMPLETED|Intervention Period 1 and Washout||0||
60086915|NCT01748552|76202972|FG000|STARTED|Intervention Period 2 and Washout||3||
60086916|NCT01748552|76202973|FG001|STARTED|Intervention Period 2 and Washout||3||
60086917|NCT01748552|76202974|FG002|STARTED|Intervention Period 2 and Washout||3||
60086918|NCT01748552|76202975|FG003|STARTED|Intervention Period 2 and Washout||3||
60086919|NCT01748552|76202976|FG004|STARTED|Intervention Period 2 and Washout||3||
60086920|NCT01748552|76202977|FG005|STARTED|Intervention Period 2 and Washout||3||
60086921|NCT01748552|76202978|FG006|STARTED|Intervention Period 2 and Washout||3||
59560427|NCT02233478|75661775|FG005|COMPLETED|First Intervention (1 Day)||3||
59560428|NCT02233478|75661770|FG000|NOT COMPLETED|First Intervention (1 Day)||0||
59560429|NCT02233478|75661771|FG001|NOT COMPLETED|First Intervention (1 Day)||0||
59560430|NCT02233478|75661772|FG002|NOT COMPLETED|First Intervention (1 Day)||0||
59560431|NCT02233478|75661773|FG003|NOT COMPLETED|First Intervention (1 Day)||0||
59560432|NCT02233478|75661774|FG004|NOT COMPLETED|First Intervention (1 Day)||0||
59560433|NCT02233478|75661775|FG005|NOT COMPLETED|First Intervention (1 Day)||0||
59992423|NCT02454608|76108236|FG000|STARTED|Double-Blind Period||15||
59992424|NCT02454608|76108237|FG001|STARTED|Double-Blind Period||14||
59992425|NCT02454608|76108238|FG002|STARTED|Double-Blind Period|This arm is not part of this period of the study|0||
59992426|NCT02454608|76108236|FG000|COMPLETED|Double-Blind Period||15||
59992427|NCT02454608|76108237|FG001|COMPLETED|Double-Blind Period||12||
59992428|NCT02454608|76108238|FG002|COMPLETED|Double-Blind Period|This arm is not part of this period of the study|0||
59992429|NCT02454608|76108236|FG000|NOT COMPLETED|Double-Blind Period||0||
60086922|NCT01748552|76202979|FG007|STARTED|Intervention Period 2 and Washout||3||
60086923|NCT01748552|76202980|FG008|STARTED|Intervention Period 2 and Washout||3||
60086924|NCT01748552|76202981|FG009|STARTED|Intervention Period 2 and Washout||3||
60086925|NCT01748552|76202982|FG010|STARTED|Intervention Period 2 and Washout||3||
60086926|NCT01748552|76202983|FG011|STARTED|Intervention Period 2 and Washout||3||
60086927|NCT01748552|76202972|FG000|COMPLETED|Intervention Period 2 and Washout||3||
60086928|NCT01748552|76202973|FG001|COMPLETED|Intervention Period 2 and Washout||3||
60086929|NCT01748552|76202974|FG002|COMPLETED|Intervention Period 2 and Washout||2||
60086930|NCT01748552|76202975|FG003|COMPLETED|Intervention Period 2 and Washout||3||
60086931|NCT01748552|76202976|FG004|COMPLETED|Intervention Period 2 and Washout||3||
60086932|NCT01748552|76202977|FG005|COMPLETED|Intervention Period 2 and Washout||3||
60086933|NCT01748552|76202978|FG006|COMPLETED|Intervention Period 2 and Washout||0||
60086934|NCT01748552|76202979|FG007|COMPLETED|Intervention Period 2 and Washout||0||
60086935|NCT01748552|76202980|FG008|COMPLETED|Intervention Period 2 and Washout||0||
60086936|NCT01748552|76202981|FG009|COMPLETED|Intervention Period 2 and Washout||3||
60086937|NCT01748552|76202982|FG010|COMPLETED|Intervention Period 2 and Washout||3||
60086938|NCT01748552|76202983|FG011|COMPLETED|Intervention Period 2 and Washout||3||
59560434|NCT02233478|75661770|FG000|STARTED|Washout (7 Days)||3||
59560435|NCT02233478|75661771|FG001|STARTED|Washout (7 Days)||3||
59560436|NCT02233478|75661772|FG002|STARTED|Washout (7 Days)||3||
59560437|NCT02233478|75661773|FG003|STARTED|Washout (7 Days)||3||
59992430|NCT02454608|76108237|FG001|NOT COMPLETED|Double-Blind Period||2||
60086939|NCT01748552|76202972|FG000|NOT COMPLETED|Intervention Period 2 and Washout||0||
60086940|NCT01748552|76202973|FG001|NOT COMPLETED|Intervention Period 2 and Washout||0||
59560438|NCT02233478|75661774|FG004|STARTED|Washout (7 Days)||3||
59992431|NCT02454608|76108238|FG002|NOT COMPLETED|Double-Blind Period||0||
59992432|NCT02454608|76108236|FG000|STARTED|Open Label Period|This arm is not part of this period of the study|0||
59992433|NCT02454608|76108237|FG001|STARTED|Open Label Period|This arm is not part of this period of the study|0||
59992434|NCT02454608|76108238|FG002|STARTED|Open Label Period||29||
59992435|NCT02454608|76108236|FG000|COMPLETED|Open Label Period|This arm is not part of this period of the study|0||
59992436|NCT02454608|76108237|FG001|COMPLETED|Open Label Period|This arm is not part of this period of the study|0||
59992437|NCT02454608|76108238|FG002|COMPLETED|Open Label Period||10||
59992438|NCT02454608|76108236|FG000|NOT COMPLETED|Open Label Period||0||
59992439|NCT02454608|76108237|FG001|NOT COMPLETED|Open Label Period||0||
59992440|NCT02454608|76108238|FG002|NOT COMPLETED|Open Label Period||19||
60086941|NCT01748552|76202974|FG002|NOT COMPLETED|Intervention Period 2 and Washout||1||
60086942|NCT01748552|76202975|FG003|NOT COMPLETED|Intervention Period 2 and Washout||0||
60086943|NCT01748552|76202976|FG004|NOT COMPLETED|Intervention Period 2 and Washout||0||
60086944|NCT01748552|76202977|FG005|NOT COMPLETED|Intervention Period 2 and Washout||0||
60086945|NCT01748552|76202978|FG006|NOT COMPLETED|Intervention Period 2 and Washout||3||
60086946|NCT01748552|76202979|FG007|NOT COMPLETED|Intervention Period 2 and Washout||3||
60086947|NCT01748552|76202980|FG008|NOT COMPLETED|Intervention Period 2 and Washout||3||
60086948|NCT01748552|76202981|FG009|NOT COMPLETED|Intervention Period 2 and Washout||0||
60086949|NCT01748552|76202982|FG010|NOT COMPLETED|Intervention Period 2 and Washout||0||
59992441|NCT02246764|76108249|FG000|STARTED|Overall Study||34||
60086950|NCT01748552|76202983|FG011|NOT COMPLETED|Intervention Period 2 and Washout||0||
60086951|NCT01748552|76202972|FG000|STARTED|Intervention Period 3 and Washout||3||
60086952|NCT01748552|76202973|FG001|STARTED|Intervention Period 3 and Washout||3||
60086953|NCT01748552|76202974|FG002|STARTED|Intervention Period 3 and Washout||2||
60086954|NCT01748552|76202975|FG003|STARTED|Intervention Period 3 and Washout||3||
60086955|NCT01748552|76202976|FG004|STARTED|Intervention Period 3 and Washout||3||
60086956|NCT01748552|76202977|FG005|STARTED|Intervention Period 3 and Washout||3||
60086957|NCT01748552|76202978|FG006|STARTED|Intervention Period 3 and Washout||0||
60086958|NCT01748552|76202979|FG007|STARTED|Intervention Period 3 and Washout||0||
60086959|NCT01748552|76202980|FG008|STARTED|Intervention Period 3 and Washout||0||
60086960|NCT01748552|76202981|FG009|STARTED|Intervention Period 3 and Washout||3||
60086961|NCT01748552|76202982|FG010|STARTED|Intervention Period 3 and Washout||3||
60086962|NCT01748552|76202983|FG011|STARTED|Intervention Period 3 and Washout||3||
60086963|NCT01748552|76202972|FG000|COMPLETED|Intervention Period 3 and Washout||3||
60086964|NCT01748552|76202973|FG001|COMPLETED|Intervention Period 3 and Washout||3||
60086965|NCT01748552|76202974|FG002|COMPLETED|Intervention Period 3 and Washout||2||
60086966|NCT01748552|76202975|FG003|COMPLETED|Intervention Period 3 and Washout||3||
60086967|NCT01748552|76202976|FG004|COMPLETED|Intervention Period 3 and Washout||3||
60086968|NCT01748552|76202977|FG005|COMPLETED|Intervention Period 3 and Washout||3||
60086969|NCT01748552|76202978|FG006|COMPLETED|Intervention Period 3 and Washout||0||
60086970|NCT01748552|76202979|FG007|COMPLETED|Intervention Period 3 and Washout||0||
60086971|NCT01748552|76202980|FG008|COMPLETED|Intervention Period 3 and Washout||0||
60086972|NCT01748552|76202981|FG009|COMPLETED|Intervention Period 3 and Washout||3||
60086973|NCT01748552|76202982|FG010|COMPLETED|Intervention Period 3 and Washout||3||
60086974|NCT01748552|76202983|FG011|COMPLETED|Intervention Period 3 and Washout||3||
60086975|NCT01748552|76202972|FG000|NOT COMPLETED|Intervention Period 3 and Washout||0||
60086976|NCT01748552|76202973|FG001|NOT COMPLETED|Intervention Period 3 and Washout||0||
60086977|NCT01748552|76202974|FG002|NOT COMPLETED|Intervention Period 3 and Washout||0||
60086978|NCT01748552|76202975|FG003|NOT COMPLETED|Intervention Period 3 and Washout||0||
60086979|NCT01748552|76202976|FG004|NOT COMPLETED|Intervention Period 3 and Washout||0||
60086980|NCT01748552|76202977|FG005|NOT COMPLETED|Intervention Period 3 and Washout||0||
60086981|NCT01748552|76202978|FG006|NOT COMPLETED|Intervention Period 3 and Washout||0||
60086982|NCT01748552|76202979|FG007|NOT COMPLETED|Intervention Period 3 and Washout||0||
60086983|NCT01748552|76202980|FG008|NOT COMPLETED|Intervention Period 3 and Washout||0||
60086984|NCT01748552|76202981|FG009|NOT COMPLETED|Intervention Period 3 and Washout||0||
59992442|NCT02246764|76108250|FG001|STARTED|Overall Study||36||
59992443|NCT02246764|76108251|FG002|STARTED|Overall Study||23||
59992444|NCT02246764|76108249|FG000|COMPLETED|Overall Study||16||
59992445|NCT02246764|76108250|FG001|COMPLETED|Overall Study||4||
60086985|NCT01748552|76202982|FG010|NOT COMPLETED|Intervention Period 3 and Washout||0||
60086986|NCT01748552|76202983|FG011|NOT COMPLETED|Intervention Period 3 and Washout||0||
60086987|NCT01748162|76203025|FG000|STARTED|Overall Study||5||
60086988|NCT01748162|76203026|FG001|STARTED|Overall Study||5||
60086989|NCT01748162|76203025|FG000|Started 6 Month Initial Treatment Plan|Overall Study||2||
60086990|NCT01748162|76203026|FG001|Started 6 Month Initial Treatment Plan|Overall Study||2||
60086991|NCT01748162|76203025|FG000|Completed 6 Month Initial Treatment|Overall Study||0||
60086992|NCT01748162|76203026|FG001|Completed 6 Month Initial Treatment|Overall Study||0||
60086993|NCT01748162|76203025|FG000|Started 6 Month Followup|Overall Study|No participants in either arm had additional croup episodes in the first 6 months; study terminated.|0||
60086994|NCT01748162|76203026|FG001|Started 6 Month Followup|Overall Study|No participants in either arm had additional croup episodes in the first 6 months; study terminated.|0||
59707585|NCT00991276|75826520|FG000|COMPLETED|First Intervention Period||15||
60086995|NCT01748162|76203025|FG000|COMPLETED|Overall Study||0||
60086996|NCT01748162|76203026|FG001|COMPLETED|Overall Study||0||
59707586|NCT00991276|75826521|FG001|COMPLETED|First Intervention Period||10||
59707587|NCT00991276|75826522|FG002|COMPLETED|First Intervention Period||14||
60086997|NCT01748162|76203025|FG000|NOT COMPLETED|Overall Study||5||
60086998|NCT01748162|76203026|FG001|NOT COMPLETED|Overall Study||5||
60086999|NCT01724216|76203032|FG000|STARTED|Overall Study||11||
60087000|NCT01724216|76203032|FG000|COMPLETED|Overall Study||10||
60087001|NCT01724216|76203032|FG000|NOT COMPLETED|Overall Study||1||
60087002|NCT01723904|76203036|FG000|STARTED|Overall Study||90||
60087003|NCT01723904|76203036|FG000|COMPLETED|Overall Study||79||
60087004|NCT01723904|76203036|FG000|NOT COMPLETED|Overall Study||11||
60087005|NCT01747772|76203040|FG000|STARTED|Overall Study||180||
59560439|NCT02233478|75661775|FG005|STARTED|Washout (7 Days)||3||
59560440|NCT02233478|75661770|FG000|COMPLETED|Washout (7 Days)||3||
59560441|NCT02233478|75661771|FG001|COMPLETED|Washout (7 Days)||3||
59560442|NCT02233478|75661772|FG002|COMPLETED|Washout (7 Days)||3||
59560443|NCT02233478|75661773|FG003|COMPLETED|Washout (7 Days)||3||
59560444|NCT02233478|75661774|FG004|COMPLETED|Washout (7 Days)||3||
59560445|NCT02233478|75661775|FG005|COMPLETED|Washout (7 Days)||3||
59560446|NCT02233478|75661770|FG000|NOT COMPLETED|Washout (7 Days)||0||
59560447|NCT02233478|75661771|FG001|NOT COMPLETED|Washout (7 Days)||0||
59560448|NCT02233478|75661772|FG002|NOT COMPLETED|Washout (7 Days)||0||
59560449|NCT02233478|75661773|FG003|NOT COMPLETED|Washout (7 Days)||0||
59560450|NCT02233478|75661774|FG004|NOT COMPLETED|Washout (7 Days)||0||
59560451|NCT02233478|75661775|FG005|NOT COMPLETED|Washout (7 Days)||0||
59560452|NCT02233478|75661770|FG000|STARTED|Second Intervention (1 Day)||3||
59560453|NCT02233478|75661771|FG001|STARTED|Second Intervention (1 Day)||3||
60087006|NCT01747772|76203040|FG000|Analysis Population|Overall Study|All participants who completed the study and had adequate SWE and liver biopsy data.|164||
60087007|NCT01747772|76203040|FG000|COMPLETED|Overall Study||171||
60087008|NCT01747772|76203040|FG000|NOT COMPLETED|Overall Study||9||
60087009|NCT01830127|76203050|FG000|STARTED|Overall Study||18||
60087010|NCT01830127|76203051|FG001|STARTED|Overall Study||17||
60087011|NCT01830127|76203050|FG000|COMPLETED|Overall Study||13||
60087012|NCT01830127|76203051|FG001|COMPLETED|Overall Study||8||
60087013|NCT01830127|76203050|FG000|NOT COMPLETED|Overall Study||5||
60087014|NCT01830127|76203051|FG001|NOT COMPLETED|Overall Study||9||
60087015|NCT01614067|76203059|FG000|STARTED|Overall Study||15|Arm randomization assignment prior to starting clinical treatment cycle|
60087016|NCT01614067|76203060|FG001|STARTED|Overall Study||15|Arm randomization assignment prior to starting clinical treatment cycle|
60087017|NCT01614067|76203059|FG000|COMPLETED|Overall Study||0||
60087018|NCT01614067|76203060|FG001|COMPLETED|Overall Study||0||
60087019|NCT01614067|76203059|FG000|NOT COMPLETED|Overall Study||15||
60087020|NCT01614067|76203060|FG001|NOT COMPLETED|Overall Study||15||
60087021|NCT01777490|76203070|FG000|STARTED|Overall Study||123||
60087022|NCT01777490|76203071|FG001|STARTED|Overall Study||123||
60087023|NCT01777490|76203072|FG002|STARTED|Overall Study||119||
60087024|NCT01777490|76203073|FG003|STARTED|Overall Study||119||
60087025|NCT01777490|76203070|FG000|COMPLETED|Overall Study||123|Primary outcome is gathered from medical records. Survey outcomes have lower completion rates.|
60087026|NCT01777490|76203071|FG001|COMPLETED|Overall Study||123|Primary outcome is gathered from medical records. Survey outcomes have lower completion rates.|
60087027|NCT01777490|76203072|FG002|COMPLETED|Overall Study||118|Primary outcome is gathered from medical records. Survey outcomes have lower completion rates.|
60087028|NCT01777490|76203073|FG003|COMPLETED|Overall Study||118|Primary outcome is gathered from medical records. Survey outcomes have lower completion rates.|
60087029|NCT01777490|76203070|FG000|NOT COMPLETED|Overall Study||0||
60087030|NCT01777490|76203071|FG001|NOT COMPLETED|Overall Study||0||
60087031|NCT01777490|76203072|FG002|NOT COMPLETED|Overall Study||1||
60087032|NCT01777490|76203073|FG003|NOT COMPLETED|Overall Study||1||
60087033|NCT01397409|76203095|FG000|STARTED|Stage 1||9||
60087034|NCT01397409|76203096|FG001|STARTED|Stage 1||6||
60087035|NCT01397409|76203097|FG002|STARTED|Stage 1||6||
60087036|NCT01397409|76203098|FG003|STARTED|Stage 1||3||
60087037|NCT01397409|76203099|FG004|STARTED|Stage 1||0||
60087038|NCT01397409|76203100|FG005|STARTED|Stage 1||0||
60087039|NCT01397409|76203101|FG006|STARTED|Stage 1||0||
60087040|NCT01397409|76203102|FG007|STARTED|Stage 1||0||
60087041|NCT01397409|76203103|FG008|STARTED|Stage 1||0||
60087042|NCT01397409|76203104|FG009|STARTED|Stage 1||0||
60087043|NCT01397409|76203095|FG000|COMPLETED|Stage 1||9||
60087044|NCT01397409|76203096|FG001|COMPLETED|Stage 1||6||
60087045|NCT01397409|76203097|FG002|COMPLETED|Stage 1||6||
60087046|NCT01397409|76203098|FG003|COMPLETED|Stage 1||3||
60087047|NCT01397409|76203099|FG004|COMPLETED|Stage 1||0||
60087048|NCT01397409|76203100|FG005|COMPLETED|Stage 1||0||
60087049|NCT01397409|76203101|FG006|COMPLETED|Stage 1||0||
60087050|NCT01397409|76203102|FG007|COMPLETED|Stage 1||0||
60087051|NCT01397409|76203103|FG008|COMPLETED|Stage 1||0||
60087052|NCT01397409|76203104|FG009|COMPLETED|Stage 1||0||
60087053|NCT01397409|76203095|FG000|NOT COMPLETED|Stage 1||0||
60087054|NCT01397409|76203096|FG001|NOT COMPLETED|Stage 1||0||
60087055|NCT01397409|76203097|FG002|NOT COMPLETED|Stage 1||0||
59560454|NCT02233478|75661772|FG002|STARTED|Second Intervention (1 Day)||3||
59560455|NCT02233478|75661773|FG003|STARTED|Second Intervention (1 Day)||3||
59560456|NCT02233478|75661774|FG004|STARTED|Second Intervention (1 Day)||3||
59560457|NCT02233478|75661775|FG005|STARTED|Second Intervention (1 Day)||3||
59560458|NCT02233478|75661770|FG000|COMPLETED|Second Intervention (1 Day)||3||
59560459|NCT02233478|75661771|FG001|COMPLETED|Second Intervention (1 Day)||3||
59560460|NCT02233478|75661772|FG002|COMPLETED|Second Intervention (1 Day)||3||
59560461|NCT02233478|75661773|FG003|COMPLETED|Second Intervention (1 Day)||3||
59560462|NCT02233478|75661774|FG004|COMPLETED|Second Intervention (1 Day)||3||
59560463|NCT02233478|75661775|FG005|COMPLETED|Second Intervention (1 Day)||3||
59560464|NCT02233478|75661770|FG000|NOT COMPLETED|Second Intervention (1 Day)||0||
59560465|NCT02233478|75661771|FG001|NOT COMPLETED|Second Intervention (1 Day)||0||
60087056|NCT01397409|76203098|FG003|NOT COMPLETED|Stage 1||0||
60087057|NCT01397409|76203099|FG004|NOT COMPLETED|Stage 1||0||
60087058|NCT01397409|76203100|FG005|NOT COMPLETED|Stage 1||0||
60087059|NCT01397409|76203101|FG006|NOT COMPLETED|Stage 1||0||
60087060|NCT01397409|76203102|FG007|NOT COMPLETED|Stage 1||0||
60087061|NCT01397409|76203103|FG008|NOT COMPLETED|Stage 1||0||
60087062|NCT01397409|76203104|FG009|NOT COMPLETED|Stage 1||0||
60087063|NCT01397409|76203095|FG000|STARTED|Stage 2||0||
60087064|NCT01397409|76203096|FG001|STARTED|Stage 2||0||
60087065|NCT01397409|76203097|FG002|STARTED|Stage 2||0||
60087066|NCT01397409|76203098|FG003|STARTED|Stage 2||0||
60087067|NCT01397409|76203099|FG004|STARTED|Stage 2||67||
60087068|NCT01397409|76203100|FG005|STARTED|Stage 2||58||
60087069|NCT01397409|76203101|FG006|STARTED|Stage 2||58||
60087070|NCT01397409|76203102|FG007|STARTED|Stage 2||0||
60087071|NCT01397409|76203103|FG008|STARTED|Stage 2||0||
60087072|NCT01397409|76203104|FG009|STARTED|Stage 2||0||
60087073|NCT01397409|76203095|FG000|COMPLETED|Stage 2||0||
60087074|NCT01397409|76203096|FG001|COMPLETED|Stage 2||0||
60087075|NCT01397409|76203097|FG002|COMPLETED|Stage 2||0||
60087076|NCT01397409|76203098|FG003|COMPLETED|Stage 2||0||
60087077|NCT01397409|76203099|FG004|COMPLETED|Stage 2||59||
60087078|NCT01397409|76203100|FG005|COMPLETED|Stage 2||54||
60087079|NCT01397409|76203101|FG006|COMPLETED|Stage 2||58||
60087080|NCT01397409|76203102|FG007|COMPLETED|Stage 2||0||
60087081|NCT01397409|76203103|FG008|COMPLETED|Stage 2||0||
60087082|NCT01397409|76203104|FG009|COMPLETED|Stage 2||0||
60087083|NCT01397409|76203095|FG000|NOT COMPLETED|Stage 2||0||
60087084|NCT01397409|76203096|FG001|NOT COMPLETED|Stage 2||0||
60087085|NCT01397409|76203097|FG002|NOT COMPLETED|Stage 2||0||
60087086|NCT01397409|76203098|FG003|NOT COMPLETED|Stage 2||0||
60087087|NCT01397409|76203099|FG004|NOT COMPLETED|Stage 2||8||
60087088|NCT01397409|76203100|FG005|NOT COMPLETED|Stage 2||4||
60087089|NCT01397409|76203101|FG006|NOT COMPLETED|Stage 2||0||
59560466|NCT02233478|75661772|FG002|NOT COMPLETED|Second Intervention (1 Day)||0||
59560467|NCT02233478|75661773|FG003|NOT COMPLETED|Second Intervention (1 Day)||0||
59560468|NCT02233478|75661774|FG004|NOT COMPLETED|Second Intervention (1 Day)||0||
59560469|NCT02233478|75661775|FG005|NOT COMPLETED|Second Intervention (1 Day)||0||
60087090|NCT01397409|76203102|FG007|NOT COMPLETED|Stage 2||0||
60087091|NCT01397409|76203103|FG008|NOT COMPLETED|Stage 2||0||
60087092|NCT01397409|76203104|FG009|NOT COMPLETED|Stage 2||0||
60087093|NCT01397409|76203095|FG000|STARTED|Stage 3||0||
60087094|NCT01397409|76203096|FG001|STARTED|Stage 3||0||
60087095|NCT01397409|76203097|FG002|STARTED|Stage 3||0||
60087096|NCT01397409|76203098|FG003|STARTED|Stage 3||0||
60087097|NCT01397409|76203099|FG004|STARTED|Stage 3||0||
60087098|NCT01397409|76203100|FG005|STARTED|Stage 3||0||
60087099|NCT01397409|76203101|FG006|STARTED|Stage 3||0||
60087100|NCT01397409|76203102|FG007|STARTED|Stage 3||23||
60087101|NCT01397409|76203103|FG008|STARTED|Stage 3||25||
60087102|NCT01397409|76203104|FG009|STARTED|Stage 3||16||
60087103|NCT01397409|76203095|FG000|COMPLETED|Stage 3||0||
60087104|NCT01397409|76203096|FG001|COMPLETED|Stage 3||0||
60087105|NCT01397409|76203097|FG002|COMPLETED|Stage 3||0||
60087106|NCT01397409|76203098|FG003|COMPLETED|Stage 3||0||
60087107|NCT01397409|76203099|FG004|COMPLETED|Stage 3||0||
60087108|NCT01397409|76203100|FG005|COMPLETED|Stage 3||0||
60087109|NCT01397409|76203101|FG006|COMPLETED|Stage 3||0||
60087110|NCT01397409|76203102|FG007|COMPLETED|Stage 3||21||
60087111|NCT01397409|76203103|FG008|COMPLETED|Stage 3||25||
60087112|NCT01397409|76203104|FG009|COMPLETED|Stage 3||16||
60087113|NCT01397409|76203095|FG000|NOT COMPLETED|Stage 3||0||
60087114|NCT01397409|76203096|FG001|NOT COMPLETED|Stage 3||0||
60087115|NCT01397409|76203097|FG002|NOT COMPLETED|Stage 3||0||
60087116|NCT01397409|76203098|FG003|NOT COMPLETED|Stage 3||0||
60087117|NCT01397409|76203099|FG004|NOT COMPLETED|Stage 3||0||
60087118|NCT01397409|76203100|FG005|NOT COMPLETED|Stage 3||0||
59560470|NCT02233478|75661770|FG000|STARTED|Washout (7 Days)||3||
59560471|NCT02233478|75661771|FG001|STARTED|Washout (7 Days)||3||
59560472|NCT02233478|75661772|FG002|STARTED|Washout (7 Days)||3||
59560473|NCT02233478|75661773|FG003|STARTED|Washout (7 Days)||3||
59560474|NCT02233478|75661774|FG004|STARTED|Washout (7 Days)||3||
59560475|NCT02233478|75661775|FG005|STARTED|Washout (7 Days)||3||
59560476|NCT02233478|75661770|FG000|COMPLETED|Washout (7 Days)||3||
59560477|NCT02233478|75661771|FG001|COMPLETED|Washout (7 Days)||3||
59560478|NCT02233478|75661772|FG002|COMPLETED|Washout (7 Days)||3||
59992446|NCT02246764|76108251|FG002|COMPLETED|Overall Study||19||
59992447|NCT02246764|76108249|FG000|NOT COMPLETED|Overall Study||18||
59992448|NCT02246764|76108250|FG001|NOT COMPLETED|Overall Study||32||
59992449|NCT02246764|76108251|FG002|NOT COMPLETED|Overall Study||4||
59992450|NCT02454530|76108261|FG000|STARTED|Overall Study||552||
60087119|NCT01397409|76203101|FG006|NOT COMPLETED|Stage 3||0||
60087120|NCT01397409|76203102|FG007|NOT COMPLETED|Stage 3||2||
60087121|NCT01397409|76203103|FG008|NOT COMPLETED|Stage 3||0||
60087122|NCT01397409|76203104|FG009|NOT COMPLETED|Stage 3||0||
60087123|NCT01397253|76203129|FG000|STARTED|Overall Study||443||
60087124|NCT01397253|76203130|FG001|STARTED|Overall Study||392||
60087125|NCT01397253|76203129|FG000|COMPLETED|Overall Study|Primary analysis, remaining patients included in a sensitivity analysis|317||
60087126|NCT01397253|76203130|FG001|COMPLETED|Overall Study|Primary analysis, remaining patients included in a sensitivity analysis|243||
59560479|NCT02233478|75661773|FG003|COMPLETED|Washout (7 Days)||3||
59560480|NCT02233478|75661774|FG004|COMPLETED|Washout (7 Days)||3||
59992451|NCT02454530|76108262|FG001|STARTED|Overall Study||608||
59992452|NCT02454530|76108261|FG000|COMPLETED|Overall Study||482||
59992453|NCT02454530|76108262|FG001|COMPLETED|Overall Study||481||
60087127|NCT01397253|76203129|FG000|NOT COMPLETED|Overall Study||126||
60087128|NCT01397253|76203130|FG001|NOT COMPLETED|Overall Study||149||
60087129|NCT01777334|76203138|FG000|STARTED|Overall Study||454||
60087130|NCT01777334|76203139|FG001|STARTED|Overall Study||451||
60087131|NCT01777334|76203138|FG000|COMPLETED|Overall Study||401||
60087132|NCT01777334|76203139|FG001|COMPLETED|Overall Study||388||
59992454|NCT02454530|76108261|FG000|NOT COMPLETED|Overall Study||70||
60087133|NCT01777334|76203138|FG000|NOT COMPLETED|Overall Study||53||
60087134|NCT01777334|76203139|FG001|NOT COMPLETED|Overall Study||63||
59560481|NCT02233478|75661775|FG005|COMPLETED|Washout (7 Days)||3||
60087135|NCT01383993|76203148|FG000|STARTED|Overall Study||15||
60087136|NCT01383993|76203149|FG001|STARTED|Overall Study||4||
59560482|NCT02233478|75661770|FG000|NOT COMPLETED|Washout (7 Days)||0||
59560483|NCT02233478|75661771|FG001|NOT COMPLETED|Washout (7 Days)||0||
59816753|NCT04090749|75939138|FG002|NOT COMPLETED|Open Label Pilot||0||
59992455|NCT02454530|76108262|FG001|NOT COMPLETED|Overall Study||127||
60087137|NCT01383993|76203150|FG002|STARTED|Overall Study||2||
60087138|NCT01383993|76203148|FG000|COMPLETED|Overall Study||12||
59560484|NCT02233478|75661772|FG002|NOT COMPLETED|Washout (7 Days)||0||
59560485|NCT02233478|75661773|FG003|NOT COMPLETED|Washout (7 Days)||0||
59560486|NCT02233478|75661774|FG004|NOT COMPLETED|Washout (7 Days)||0||
59992456|NCT02431676|76108272|FG000|STARTED|Overall Study||40||
59992457|NCT02431676|76108273|FG001|STARTED|Overall Study||39||
59992458|NCT02431676|76108274|FG002|STARTED|Overall Study||42||
59992459|NCT02431676|76108272|FG000|COMPLETED|Overall Study||40||
60087139|NCT01383993|76203149|FG001|COMPLETED|Overall Study||3||
60087140|NCT01383993|76203150|FG002|COMPLETED|Overall Study||1||
59560487|NCT02233478|75661775|FG005|NOT COMPLETED|Washout (7 Days)||0||
59560488|NCT02233478|75661770|FG000|STARTED|Third Intervention (1 Day)||3||
59992460|NCT02431676|76108273|FG001|COMPLETED|Overall Study||38||
59992461|NCT02431676|76108274|FG002|COMPLETED|Overall Study||40||
59992462|NCT02431676|76108272|FG000|NOT COMPLETED|Overall Study||0||
59992463|NCT02431676|76108273|FG001|NOT COMPLETED|Overall Study||1||
59992464|NCT02431676|76108274|FG002|NOT COMPLETED|Overall Study||2||
59992465|NCT01654250|76108284|FG000|STARTED|Overall Study||44||
59992466|NCT01654250|76108285|FG001|STARTED|Overall Study||42||
59992467|NCT01654250|76108284|FG000|COMPLETED|Overall Study||43||
60087141|NCT01383993|76203148|FG000|NOT COMPLETED|Overall Study||3||
60087142|NCT01383993|76203149|FG001|NOT COMPLETED|Overall Study||1||
60087143|NCT01383993|76203150|FG002|NOT COMPLETED|Overall Study||1||
60087144|NCT01396395|76203161|FG000|STARTED|Overall Study||200||
60087145|NCT01396395|76203162|FG001|STARTED|Overall Study||202||
60087146|NCT01396395|76203161|FG000|Safety Analysis Set|Overall Study|1 subject randomized to standard was included in standard+nicorandil as nicorandil was received.|197||
60087147|NCT01396395|76203162|FG001|Safety Analysis Set|Overall Study|4 subjects randomized to standard+nicorandil were included in standard as no nicorandil was received|205||
60087148|NCT01396395|76203161|FG000|COMPLETED|Overall Study||160||
60087149|NCT01396395|76203162|FG001|COMPLETED|Overall Study||175||
60087150|NCT01396395|76203161|FG000|NOT COMPLETED|Overall Study||40||
60087151|NCT01396395|76203162|FG001|NOT COMPLETED|Overall Study||27||
60087152|NCT01396317|76203172|FG000|STARTED|Overall Study||10||
60087153|NCT01396317|76203173|FG001|STARTED|Overall Study||10||
60087154|NCT01396317|76203172|FG000|COMPLETED|Overall Study||9||
60087155|NCT01396317|76203173|FG001|COMPLETED|Overall Study||10||
60087156|NCT01396317|76203172|FG000|NOT COMPLETED|Overall Study||1||
60087157|NCT01396317|76203173|FG001|NOT COMPLETED|Overall Study||0||
60087158|NCT01396161|76203188|FG000|STARTED|Overall Study||12||
60087159|NCT01396161|76203189|FG001|STARTED|Overall Study||5||
60087160|NCT01396161|76203190|FG002|STARTED|Overall Study||9||
60087161|NCT01396161|76203191|FG003|STARTED|Overall Study||9||
60087162|NCT01396161|76203192|FG004|STARTED|Overall Study||9||
60087163|NCT01396161|76203193|FG005|STARTED|Overall Study||9||
60087164|NCT01396161|76203194|FG006|STARTED|Overall Study||11||
60087165|NCT01396161|76203188|FG000|COMPLETED|Overall Study||12||
59992468|NCT01654250|76108285|FG001|COMPLETED|Overall Study||42||
59992469|NCT01654250|76108284|FG000|NOT COMPLETED|Overall Study||1||
59992470|NCT01654250|76108285|FG001|NOT COMPLETED|Overall Study||0||
59992471|NCT01652690|76108294|FG000|STARTED|Overall Study||300||
59992472|NCT01652690|76108295|FG001|STARTED|Overall Study||300||
59992473|NCT01652690|76108294|FG000|COMPLETED|Overall Study||265||
59992474|NCT01652690|76108295|FG001|COMPLETED|Overall Study||279||
59992475|NCT01652690|76108294|FG000|NOT COMPLETED|Overall Study||35||
59992476|NCT01652690|76108295|FG001|NOT COMPLETED|Overall Study||21||
59992477|NCT02429258|76108303|FG000|STARTED|Overall Study||50||
59992478|NCT02429258|76108304|FG001|STARTED|Overall Study||50||
59992479|NCT02429258|76108303|FG000|COMPLETED|Overall Study||48||
59992480|NCT02429258|76108304|FG001|COMPLETED|Overall Study||49||
59992481|NCT02429258|76108303|FG000|NOT COMPLETED|Overall Study||2||
59992482|NCT02429258|76108304|FG001|NOT COMPLETED|Overall Study||1||
59992483|NCT02201524|76108314|FG000|STARTED|Overall Study||14||
59992484|NCT02201524|76108315|FG001|STARTED|Overall Study||15||
59992485|NCT02201524|76108316|FG002|STARTED|Overall Study||16||
59992486|NCT02201524|76108317|FG003|STARTED|Overall Study||14||
59992487|NCT02201524|76108314|FG000|COMPLETED|Overall Study||12||
60087166|NCT01396161|76203189|FG001|COMPLETED|Overall Study||5||
60087167|NCT01396161|76203190|FG002|COMPLETED|Overall Study||9||
60087168|NCT01396161|76203191|FG003|COMPLETED|Overall Study||9||
60087169|NCT01396161|76203192|FG004|COMPLETED|Overall Study||8||
60087170|NCT01396161|76203193|FG005|COMPLETED|Overall Study||9||
60087171|NCT01396161|76203194|FG006|COMPLETED|Overall Study||10||
60087172|NCT01396161|76203188|FG000|NOT COMPLETED|Overall Study||0||
60087173|NCT01396161|76203189|FG001|NOT COMPLETED|Overall Study||0||
60087174|NCT01396161|76203190|FG002|NOT COMPLETED|Overall Study||0||
59992488|NCT02201524|76108315|FG001|COMPLETED|Overall Study||12||
59992489|NCT02201524|76108316|FG002|COMPLETED|Overall Study||12||
60087175|NCT01396161|76203191|FG003|NOT COMPLETED|Overall Study||0||
59992490|NCT02201524|76108317|FG003|COMPLETED|Overall Study||10||
60087176|NCT01396161|76203192|FG004|NOT COMPLETED|Overall Study||1||
60087177|NCT01396161|76203193|FG005|NOT COMPLETED|Overall Study||0||
60087178|NCT01396161|76203194|FG006|NOT COMPLETED|Overall Study||1||
60087179|NCT01396083|76203217|FG000|STARTED|Overall Study||124||
60087180|NCT01396083|76203218|FG001|STARTED|Overall Study||119||
60087181|NCT01396083|76203217|FG000|COMPLETED|Overall Study||113||
60087182|NCT01396083|76203218|FG001|COMPLETED|Overall Study||72||
60087183|NCT01396083|76203217|FG000|NOT COMPLETED|Overall Study||11||
59560489|NCT02233478|75661771|FG001|STARTED|Third Intervention (1 Day)||3||
59560490|NCT02233478|75661772|FG002|STARTED|Third Intervention (1 Day)||3||
59560491|NCT02233478|75661773|FG003|STARTED|Third Intervention (1 Day)||3||
59560492|NCT02233478|75661774|FG004|STARTED|Third Intervention (1 Day)||3||
59992491|NCT02201524|76108314|FG000|NOT COMPLETED|Overall Study||2||
59992492|NCT02201524|76108315|FG001|NOT COMPLETED|Overall Study||3||
59560493|NCT02233478|75661775|FG005|STARTED|Third Intervention (1 Day)||3||
59560494|NCT02233478|75661770|FG000|COMPLETED|Third Intervention (1 Day)||3||
59560495|NCT02233478|75661771|FG001|COMPLETED|Third Intervention (1 Day)||3||
59560496|NCT02233478|75661772|FG002|COMPLETED|Third Intervention (1 Day)||3||
59560497|NCT02233478|75661773|FG003|COMPLETED|Third Intervention (1 Day)||3||
59992493|NCT02201524|76108316|FG002|NOT COMPLETED|Overall Study||4||
59992494|NCT02201524|76108317|FG003|NOT COMPLETED|Overall Study||4||
59992495|NCT02453048|76108332|FG000|STARTED|Overall Study||12||
59992496|NCT02453048|76108333|FG001|STARTED|Overall Study||12||
59992497|NCT02453048|76108334|FG002|STARTED|Overall Study||12||
60087184|NCT01396083|76203218|FG001|NOT COMPLETED|Overall Study||47||
60087185|NCT01723826|76203228|FG000|STARTED|Overall Study||47||
60087186|NCT01723826|76203229|FG001|STARTED|Overall Study||63||
60087187|NCT01723826|76203230|FG002|STARTED|Overall Study||101||
60087188|NCT01723826|76203231|FG003|STARTED|Overall Study||149||
60087189|NCT01723826|76203228|FG000|COMPLETED|Overall Study||20||
60087190|NCT01723826|76203229|FG001|COMPLETED|Overall Study||27||
60087191|NCT01723826|76203230|FG002|COMPLETED|Overall Study||44||
60087192|NCT01723826|76203231|FG003|COMPLETED|Overall Study||59||
60087193|NCT01723826|76203228|FG000|NOT COMPLETED|Overall Study||27||
60087194|NCT01723826|76203229|FG001|NOT COMPLETED|Overall Study||36||
60087195|NCT01723826|76203230|FG002|NOT COMPLETED|Overall Study||57||
60087196|NCT01723826|76203231|FG003|NOT COMPLETED|Overall Study||90||
60087197|NCT01721954|76203243|FG000|STARTED|Overall Study||105||
60087198|NCT01721954|76203244|FG001|STARTED|Overall Study||104||
60087199|NCT01721954|76203243|FG000|COMPLETED|Overall Study||35||
60087200|NCT01721954|76203244|FG001|COMPLETED|Overall Study||35||
59816754|NCT04090749|75939136|FG000|STARTED|Pilot Trial||0||
59992498|NCT02453048|76108335|FG003|STARTED|Overall Study||12||
59992499|NCT02453048|76108336|FG004|STARTED|Overall Study||6||
59992500|NCT02453048|76108332|FG000|6-month Follow-up|Overall Study||12||
59992501|NCT02453048|76108333|FG001|6-month Follow-up|Overall Study||12||
59992502|NCT02453048|76108334|FG002|6-month Follow-up|Overall Study||12||
60087201|NCT01721954|76203243|FG000|NOT COMPLETED|Overall Study||70||
60087202|NCT01721954|76203244|FG001|NOT COMPLETED|Overall Study||69||
60087203|NCT01776554|76203252|FG000|STARTED|Overall Study||332||
59560498|NCT02233478|75661774|FG004|COMPLETED|Third Intervention (1 Day)||3||
59992503|NCT02453048|76108335|FG003|6-month Follow-up|Overall Study||12||
59992504|NCT02453048|76108336|FG004|6-month Follow-up|Overall Study||6||
59992505|NCT02453048|76108332|FG000|COMPLETED|Overall Study||12||
60087204|NCT01776554|76203253|FG001|STARTED|Overall Study||330||
60087205|NCT01776554|76203252|FG000|COMPLETED|Overall Study||315||
60087206|NCT01776554|76203253|FG001|COMPLETED|Overall Study||307||
60087207|NCT01776554|76203252|FG000|NOT COMPLETED|Overall Study||17||
60087208|NCT01776554|76203253|FG001|NOT COMPLETED|Overall Study||23||
60087209|NCT01776008|76203260|FG000|STARTED|Overall Study||16||
60087210|NCT01776008|76203260|FG000|COMPLETED|Overall Study||14||
60087211|NCT01776008|76203260|FG000|NOT COMPLETED|Overall Study||2||
60087212|NCT01746368|76203266|FG000|STARTED|Overall Study||33||
60087213|NCT01746368|76203267|FG001|STARTED|Overall Study||17||
60087214|NCT01746368|76203266|FG000|Recieved Allocated Intervention|Overall Study||31||
60087215|NCT01746368|76203267|FG001|Recieved Allocated Intervention|Overall Study||8||
60087216|NCT01746368|76203266|FG000|Assessment Completed|Overall Study||31||
60087217|NCT01746368|76203267|FG001|Assessment Completed|Overall Study||16||
60087218|NCT01746368|76203266|FG000|Analyzed for AD Completion Rate|Overall Study||32||
59992506|NCT02453048|76108333|FG001|COMPLETED|Overall Study||11||
59992507|NCT02453048|76108334|FG002|COMPLETED|Overall Study||10||
59992508|NCT02453048|76108335|FG003|COMPLETED|Overall Study||12||
59992509|NCT02453048|76108336|FG004|COMPLETED|Overall Study||0||
59992510|NCT02453048|76108332|FG000|NOT COMPLETED|Overall Study||0||
59992511|NCT02453048|76108333|FG001|NOT COMPLETED|Overall Study||1||
59992512|NCT02453048|76108334|FG002|NOT COMPLETED|Overall Study||2||
59992513|NCT02453048|76108335|FG003|NOT COMPLETED|Overall Study||0||
59992514|NCT02453048|76108336|FG004|NOT COMPLETED|Overall Study||6||
60087219|NCT01746368|76203267|FG001|Analyzed for AD Completion Rate|Overall Study||17||
60087220|NCT01746368|76203266|FG000|Analyzed for Satisfaction|Overall Study||30||
60087221|NCT01746368|76203267|FG001|Analyzed for Satisfaction|Overall Study||16||
60087222|NCT01746368|76203266|FG000|COMPLETED|Overall Study||31||
60087223|NCT01746368|76203267|FG001|COMPLETED|Overall Study||16||
59992515|NCT02137252|76108350|FG000|STARTED|Overall Study||2|Represents intervention phase|
59992516|NCT02137252|76108351|FG001|STARTED|Overall Study||1|Represents intervention phase|
60087224|NCT01746368|76203266|FG000|NOT COMPLETED|Overall Study||2||
60087225|NCT01746368|76203267|FG001|NOT COMPLETED|Overall Study||1||
60087226|NCT01381575|76203276|FG000|STARTED|Overall Study||550||
60087227|NCT01381575|76203277|FG001|STARTED|Overall Study||482||
60087228|NCT01381575|76203278|FG002|STARTED|Overall Study||415||
60087229|NCT01381575|76203276|FG000|COMPLETED|Overall Study||524||
60087230|NCT01381575|76203277|FG001|COMPLETED|Overall Study||443||
60087231|NCT01381575|76203278|FG002|COMPLETED|Overall Study||395||
60087232|NCT01381575|76203276|FG000|NOT COMPLETED|Overall Study||26||
60087233|NCT01381575|76203277|FG001|NOT COMPLETED|Overall Study||39||
60087234|NCT01381575|76203278|FG002|NOT COMPLETED|Overall Study||20||
60087235|NCT01858363|76203289|FG000|STARTED|Overall Study||222||254
60087236|NCT01858363|76203290|FG001|STARTED|Overall Study||72||79
60087237|NCT01858363|76203289|FG000|Pre-discharge Visit|Overall Study||219||251
60087238|NCT01858363|76203290|FG001|Pre-discharge Visit|Overall Study||72||79
60087239|NCT01858363|76203289|FG000|1-month Visit|Overall Study||214||246
59560499|NCT02233478|75661775|FG005|COMPLETED|Third Intervention (1 Day)||3||
59560500|NCT02233478|75661770|FG000|NOT COMPLETED|Third Intervention (1 Day)||0||
59560501|NCT02233478|75661771|FG001|NOT COMPLETED|Third Intervention (1 Day)||0||
59560502|NCT02233478|75661772|FG002|NOT COMPLETED|Third Intervention (1 Day)||0||
59560503|NCT02233478|75661773|FG003|NOT COMPLETED|Third Intervention (1 Day)||0||
59560504|NCT02233478|75661774|FG004|NOT COMPLETED|Third Intervention (1 Day)||0||
59560505|NCT02233478|75661775|FG005|NOT COMPLETED|Third Intervention (1 Day)||0||
59560506|NCT02324972|75661785|FG000|STARTED|Overall Study||26||
59560507|NCT02324972|75661786|FG001|STARTED|Overall Study||28||
59560508|NCT02324972|75661785|FG000|COMPLETED|Overall Study||19||
59560509|NCT02324972|75661786|FG001|COMPLETED|Overall Study||23||
59560510|NCT02324972|75661785|FG000|NOT COMPLETED|Overall Study||7||
59560511|NCT02324972|75661786|FG001|NOT COMPLETED|Overall Study||5||
59560512|NCT01615484|75661794|FG000|STARTED|Overall Study||0||
59560513|NCT01615484|75661795|FG001|STARTED|Overall Study||24||
59560514|NCT01615484|75661794|FG000|COMPLETED|Overall Study||0||
59560515|NCT01615484|75661795|FG001|COMPLETED|Overall Study||24||
59560516|NCT01615484|75661794|FG000|NOT COMPLETED|Overall Study||0||
59560517|NCT01615484|75661795|FG001|NOT COMPLETED|Overall Study||0||
59560518|NCT01616576|75661803|FG000|STARTED|Overall Study||18||
59560519|NCT01616576|75661804|FG001|STARTED|Overall Study||18||
59560520|NCT01616576|75661803|FG000|COMPLETED|Overall Study||18||
60087240|NCT01858363|76203290|FG001|1-month Visit|Overall Study||68||75
60087241|NCT01858363|76203289|FG000|6-month Visit|Overall Study||208||239
60087242|NCT01858363|76203290|FG001|6-month Visit|Overall Study||64||71
60087243|NCT01858363|76203289|FG000|12-month Vist|Overall Study||205||235
60087244|NCT01858363|76203290|FG001|12-month Vist|Overall Study||61||67
60087245|NCT01858363|76203289|FG000|24-month Visit|Overall Study||184||209
60087246|NCT01858363|76203290|FG001|24-month Visit|Overall Study||58||64
59560521|NCT01616576|75661804|FG001|COMPLETED|Overall Study||18||
59560522|NCT01616576|75661803|FG000|NOT COMPLETED|Overall Study||0||
59560523|NCT01616576|75661804|FG001|NOT COMPLETED|Overall Study||0||
59560524|NCT01646762|75661813|FG000|STARTED|Overall Study||13||
59560525|NCT01646762|75661813|FG000|COMPLETED|Overall Study||13||
59560526|NCT01646762|75661813|FG000|NOT COMPLETED|Overall Study||0||
59560527|NCT01647464|75661817|FG000|STARTED|Overall Study||10||
59560528|NCT01647464|75661817|FG000|COMPLETED|Overall Study||10||
59560529|NCT01647464|75661817|FG000|NOT COMPLETED|Overall Study||0||
60087247|NCT01858363|76203289|FG000|36-month Visit|Overall Study||169||194
60087248|NCT01858363|76203290|FG001|36-month Visit|Overall Study||53||59
60087249|NCT01858363|76203289|FG000|48-month Visit|Overall Study||157||179
59707588|NCT00991276|75826523|FG003|COMPLETED|First Intervention Period||11||
59707589|NCT00991276|75826524|FG004|COMPLETED|First Intervention Period||11||
59707590|NCT00991276|75826525|FG005|COMPLETED|First Intervention Period||12||
59707591|NCT00991276|75826520|FG000|NOT COMPLETED|First Intervention Period||0||
59707592|NCT00991276|75826521|FG001|NOT COMPLETED|First Intervention Period||3||
59707593|NCT00991276|75826522|FG002|NOT COMPLETED|First Intervention Period||0||
59707594|NCT00991276|75826523|FG003|NOT COMPLETED|First Intervention Period||4||
59707595|NCT00991276|75826524|FG004|NOT COMPLETED|First Intervention Period||4||
59707596|NCT00991276|75826525|FG005|NOT COMPLETED|First Intervention Period||1||
59707597|NCT00991276|75826520|FG000|STARTED|Placebo Wash-out Period (7 Days)||15||
59707598|NCT00991276|75826521|FG001|STARTED|Placebo Wash-out Period (7 Days)||10||
59707599|NCT00991276|75826522|FG002|STARTED|Placebo Wash-out Period (7 Days)||14||
59707600|NCT00991276|75826523|FG003|STARTED|Placebo Wash-out Period (7 Days)||11||
60087250|NCT01858363|76203290|FG001|48-month Visit|Overall Study||53||59
60087251|NCT01858363|76203289|FG000|COMPLETED|Overall Study||146||167
60087252|NCT01858363|76203290|FG001|COMPLETED|Overall Study||46||51
60087253|NCT01858363|76203289|FG000|NOT COMPLETED|Overall Study||76||87
60087254|NCT01858363|76203290|FG001|NOT COMPLETED|Overall Study||26||28
60087255|NCT01877551|76203298|FG000|STARTED|Overall Study||13||
60087256|NCT01877551|76203299|FG001|STARTED|Overall Study||14||
60087257|NCT01877551|76203298|FG000|COMPLETED|Overall Study||13||
60087258|NCT01877551|76203299|FG001|COMPLETED|Overall Study||13||
60087259|NCT01877551|76203298|FG000|NOT COMPLETED|Overall Study||0||
59560530|NCT02289755|75661821|FG000|STARTED|Baseline Period [No Treatment, 3 Days]||16||
59560531|NCT02289755|75661821|FG000|COMPLETED|Baseline Period [No Treatment, 3 Days]||16||
59560532|NCT02289755|75661821|FG000|NOT COMPLETED|Baseline Period [No Treatment, 3 Days]||0||
59560533|NCT02289755|75661821|FG000|STARTED|ALLN-177 Treatment Period [4 Days]||16||
59560534|NCT02289755|75661821|FG000|COMPLETED|ALLN-177 Treatment Period [4 Days]||16||
59560535|NCT02289755|75661821|FG000|NOT COMPLETED|ALLN-177 Treatment Period [4 Days]||0||
59707601|NCT00991276|75826524|FG004|STARTED|Placebo Wash-out Period (7 Days)||11||
59707602|NCT00991276|75826525|FG005|STARTED|Placebo Wash-out Period (7 Days)||12||
59707603|NCT00991276|75826520|FG000|COMPLETED|Placebo Wash-out Period (7 Days)||15||
60087260|NCT01877551|76203299|FG001|NOT COMPLETED|Overall Study||1||
60087261|NCT01396005|76203307|FG000|STARTED|Overall Study||10||
60087262|NCT01396005|76203308|FG001|STARTED|Overall Study||11||
60087263|NCT01396005|76203307|FG000|COMPLETED|Overall Study||10||
60087264|NCT01396005|76203308|FG001|COMPLETED|Overall Study||9||
59560536|NCT02289755|75661821|FG000|STARTED|Follow up Period [4 Days]||16||
59560537|NCT02289755|75661821|FG000|COMPLETED|Follow up Period [4 Days]||16||
60087265|NCT01396005|76203307|FG000|NOT COMPLETED|Overall Study||0||
60087266|NCT01396005|76203308|FG001|NOT COMPLETED|Overall Study||2||
60087267|NCT01877239|76203316|FG000|STARTED|Overall Study||111||
60087268|NCT01877239|76203316|FG000|Treated|Overall Study||76||
60087269|NCT01877239|76203316|FG000|COMPLETED|Overall Study||61||
60087270|NCT01877239|76203316|FG000|NOT COMPLETED|Overall Study||50||
60103666|NCT01349140|76221916|FG000|STARTED|Overall Study|"We enrolled 14 subjects, and therefore Protocol Enrollment is 14. However, each leg of each subject was treated separately with a different dose of liposomal bupivacaine (Exparel); and, therefore the number of units for each subject was 2 and the total number of units analyzed was 28."|14||28
60103667|NCT01349140|76221916|FG000|COMPLETED|Overall Study|"We enrolled 14 subjects, and therefore Protocol Enrollment is 14. However, each leg of each subject was treated separately with a different dose of liposomal bupivacaine (Exparel); and, therefore the number of units for each subject was 2 and the total number of units analyzed was 28."|14||28
60103668|NCT01349140|76221916|FG000|NOT COMPLETED|Overall Study||0||0
60103669|NCT01349920|76221920|FG000|STARTED|Overall Study||15||
60103670|NCT01349920|76221920|FG000|COMPLETED|Overall Study||15||
60103671|NCT01349920|76221920|FG000|NOT COMPLETED|Overall Study||0||
60103672|NCT01252732|76221928|FG000|STARTED|Overall Study|Randomized|509||
60103673|NCT01252732|76221929|FG001|STARTED|Overall Study|Randomized|510||
60103674|NCT01252732|76221928|FG000|Modified Intent to Treat Population|Overall Study||503||
60103675|NCT01252732|76221929|FG001|Modified Intent to Treat Population|Overall Study||502||
60103676|NCT01252732|76221928|FG000|COMPLETED|Overall Study||455||
60103677|NCT01252732|76221929|FG001|COMPLETED|Overall Study||446||
60103678|NCT01252732|76221928|FG000|NOT COMPLETED|Overall Study||54||
60103679|NCT01252732|76221929|FG001|NOT COMPLETED|Overall Study||64||
60103680|NCT00989235|76221937|FG000|STARTED|Overall Study||58||
60103681|NCT00989235|76221938|FG001|STARTED|Overall Study||50||
60103682|NCT00989235|76221937|FG000|Number Rescued to Open-Label Treatment|Overall Study||4||
60103683|NCT00989235|76221938|FG001|Number Rescued to Open-Label Treatment|Overall Study|Of these, 1 was discontinued from open-label treatment (lost to follow-up).|4||
60103684|NCT00989235|76221937|FG000|Number Completing Double-Blind Treatment|Overall Study||51||
60103685|NCT00989235|76221938|FG001|Number Completing Double-Blind Treatment|Overall Study||41||
60103686|NCT00989235|76221937|FG000|COMPLETED|Overall Study||55||
60103687|NCT00989235|76221938|FG001|COMPLETED|Overall Study||44||
60103688|NCT00989235|76221937|FG000|NOT COMPLETED|Overall Study||3||
60103689|NCT00989235|76221938|FG001|NOT COMPLETED|Overall Study||6||
60103690|NCT05532891|76221949|FG000|STARTED|Overall Study||8615||
60103691|NCT05532891|76221950|FG001|STARTED|Overall Study||2930||
60103692|NCT05532891|76221949|FG000|COMPLETED|Overall Study||8615||
60103693|NCT05532891|76221950|FG001|COMPLETED|Overall Study||2930||
60103694|NCT05532891|76221949|FG000|NOT COMPLETED|Overall Study||0||
60103695|NCT05532891|76221950|FG001|NOT COMPLETED|Overall Study||0||
60103696|NCT04969198|76221958|FG000|STARTED|Overall Study||232||
60103697|NCT04969198|76221958|FG000|Number Participants for 2 Weeks Pre-quit Timepoint Analysis|Overall Study||218||
60103698|NCT04969198|76221958|FG000|Number Participants for 1 Week Pre-quit Timepoint Analysis|Overall Study||208||
60103699|NCT04969198|76221958|FG000|Number Participants for 1-3 Days Pre-quit Timepoint Analysis|Overall Study||199||
60103700|NCT04969198|76221958|FG000|Number Participants for 1-2 Days Post-quit Timepoint Analysis|Overall Study||198||
60103701|NCT04969198|76221958|FG000|Number Participants for 1 Week Post-quit Timepoint Analysis|Overall Study||195||
60103702|NCT04969198|76221958|FG000|Number Participants for 2 Weeks Post-quit Timepoint Analysis|Overall Study||186||
60103703|NCT04969198|76221958|FG000|Number Participants for 9 Weeks Post-quit Timepoint Analysis|Overall Study||176||
60103704|NCT04969198|76221958|FG000|COMPLETED|Overall Study||176||
60103705|NCT04969198|76221958|FG000|NOT COMPLETED|Overall Study||56||
60103706|NCT04836312|76221964|FG000|STARTED|Overall Study||20||
60103707|NCT04836312|76221965|FG001|STARTED|Overall Study||17||
60103708|NCT04836312|76221964|FG000|COMPLETED|Overall Study||20||
60103709|NCT04836312|76221965|FG001|COMPLETED|Overall Study||17||
60103710|NCT04836312|76221964|FG000|NOT COMPLETED|Overall Study||0||
60103711|NCT04836312|76221965|FG001|NOT COMPLETED|Overall Study||0||
60103712|NCT04778709|76221973|FG000|STARTED|Overall Study||2||4
60087271|NCT01877083|76203320|FG000|STARTED|Treatment Phase||25||
60087272|NCT01877083|76203320|FG000|COMPLETED|Treatment Phase||5||
60087273|NCT01877083|76203320|FG000|NOT COMPLETED|Treatment Phase||20||
60087274|NCT01877083|76203320|FG000|STARTED|Extension Phase||5||
60087275|NCT01877083|76203320|FG000|COMPLETED|Extension Phase||0||
60087276|NCT01877083|76203320|FG000|NOT COMPLETED|Extension Phase||5||
60087277|NCT01380327|76203327|FG000|STARTED|Overall Study|Number in intent-to-treat having reached maximum tolerated dose with =/> 1 one post-baseline measure|30||
60087278|NCT01380327|76203328|FG001|STARTED|Overall Study|Number in intent-to-treat having reached maximum tolerated dose with =/> 1 one post-baseline measure|31||
60087279|NCT01380327|76203329|FG002|STARTED|Overall Study|Number in intent-to-treat having reached maximum tolerated dose with =/> 1 one post-baseline measure|28||
60087280|NCT01380327|76203327|FG000|COMPLETED|Overall Study||27||
60087281|NCT01380327|76203328|FG001|COMPLETED|Overall Study||28||
60087282|NCT01380327|76203329|FG002|COMPLETED|Overall Study||21||
60087283|NCT01380327|76203327|FG000|NOT COMPLETED|Overall Study||3||
60087284|NCT01380327|76203328|FG001|NOT COMPLETED|Overall Study||3||
60087285|NCT01380327|76203329|FG002|NOT COMPLETED|Overall Study||7||
60087286|NCT01829425|76203339|FG000|STARTED|Overall Study||78||
59992517|NCT02137252|76108350|FG000|COMPLETED|Overall Study||0||
59992518|NCT02137252|76108351|FG001|COMPLETED|Overall Study||0||
59992519|NCT02137252|76108350|FG000|NOT COMPLETED|Overall Study||2||
59992520|NCT02137252|76108351|FG001|NOT COMPLETED|Overall Study||1||
59992521|NCT02201290|76108357|FG000|STARTED|Overall Study||9||
59992522|NCT02201290|76108357|FG000|COMPLETED|Overall Study||4||
59992523|NCT02201290|76108357|FG000|NOT COMPLETED|Overall Study||5||
59992524|NCT02200510|76108363|FG000|STARTED|Overall Study|Number who only completed self-management or completed it before portal (could do 6 months later).|31||
59992525|NCT02200510|76108364|FG001|STARTED|Overall Study|Number who only completed portal or completed it before self-management (could do 6 months later).|47||
59992526|NCT02200510|76108363|FG000|COMPLETED|Overall Study|This is the number of participants with baseline and post data.|22||
59992527|NCT02200510|76108364|FG001|COMPLETED|Overall Study|This number is the number of participants with both baseline and post data.|44||
60087287|NCT01829425|76203340|FG001|STARTED|Overall Study||74||
60087288|NCT01829425|76203339|FG000|COMPLETED|Overall Study|completed primary outcome 2 month f/u N=72|72||
60087289|NCT01829425|76203340|FG001|COMPLETED|Overall Study|completed primary outcome 2 month f/u N=70|70||
60087290|NCT01829425|76203339|FG000|NOT COMPLETED|Overall Study||6||
60087291|NCT01829425|76203340|FG001|NOT COMPLETED|Overall Study||4||
60087292|NCT03796689|76203348|FG000|STARTED|Overall Study||1051||
60087293|NCT03796689|76203349|FG001|STARTED|Overall Study||1050||
60087294|NCT03796689|76203348|FG000|COMPLETED|Overall Study||1051||
60087295|NCT03796689|76203349|FG001|COMPLETED|Overall Study||1050||
59992528|NCT02200510|76108363|FG000|NOT COMPLETED|Overall Study||9||
59992529|NCT02200510|76108364|FG001|NOT COMPLETED|Overall Study||3||
59992530|NCT02452892|76108374|FG000|STARTED|Week 1 Initial Randommization||41|Week 1 subjects were randomized 1:1:1 allocation to LFMS Sham, LFMS 20min,or LFMS 60min|
59995195|NCT02730169|76111015|FG002|STARTED|Overall Study||67||
60087296|NCT03796689|76203348|FG000|NOT COMPLETED|Overall Study||0||
60087297|NCT03796689|76203349|FG001|NOT COMPLETED|Overall Study||0||
60087298|NCT01394991|76203357|FG000|STARTED|Overall Study||242||
60087299|NCT01394991|76203358|FG001|STARTED|Overall Study||262||
60087300|NCT01394991|76203357|FG000|COMPLETED|Overall Study||183||
60087301|NCT01394991|76203358|FG001|COMPLETED|Overall Study||190||
60087302|NCT01394991|76203357|FG000|NOT COMPLETED|Overall Study||59||
60087303|NCT01394991|76203358|FG001|NOT COMPLETED|Overall Study||72||
60087304|NCT01829347|76203366|FG000|STARTED|VTI-210||9||
60087305|NCT01829347|76203367|FG001|STARTED|VTI-210||9||
60087306|NCT01829347|76203366|FG000|COMPLETED|VTI-210||3||
60087307|NCT01829347|76203367|FG001|COMPLETED|VTI-210||6||
60087308|NCT01829347|76203366|FG000|NOT COMPLETED|VTI-210||6||
60087309|NCT01829347|76203367|FG001|NOT COMPLETED|VTI-210||3||
60087310|NCT01829347|76203366|FG000|STARTED|VTI-210E||3||
60087311|NCT01829347|76203367|FG001|STARTED|VTI-210E||6||
60087312|NCT01829347|76203366|FG000|COMPLETED|VTI-210E||0||
60087313|NCT01829347|76203367|FG001|COMPLETED|VTI-210E||0||
60087314|NCT01829347|76203366|FG000|NOT COMPLETED|VTI-210E||3||
60087315|NCT01829347|76203367|FG001|NOT COMPLETED|VTI-210E||6||
60087316|NCT01394523|76203376|FG000|STARTED|Overall Study||13||
60087317|NCT01394523|76203377|FG001|STARTED|Overall Study||13||
60087318|NCT01394523|76203378|FG002|STARTED|Overall Study||13||
60087319|NCT01394523|76203376|FG000|COMPLETED|Overall Study||12||
60087320|NCT01394523|76203377|FG001|COMPLETED|Overall Study||13||
60087321|NCT01394523|76203378|FG002|COMPLETED|Overall Study||13||
60087322|NCT01394523|76203376|FG000|NOT COMPLETED|Overall Study||1||
60087323|NCT01394523|76203377|FG001|NOT COMPLETED|Overall Study||0||
60087324|NCT01394523|76203378|FG002|NOT COMPLETED|Overall Study||0||
60087325|NCT01857973|76203386|FG000|STARTED|Overall Study||78||
60087326|NCT01857973|76203386|FG000|Exploratory A Phase|Overall Study||9||
60087327|NCT01857973|76203386|FG000|Xploratory B Phase|Overall Study||9||
60087328|NCT01857973|76203386|FG000|Phase 1|Overall Study||17||
60087329|NCT01857973|76203386|FG000|Phase 2|Overall Study||14||
60087330|NCT01857973|76203386|FG000|Phase 3|Overall Study||10||
60087331|NCT01857973|76203386|FG000|Phase 4|Overall Study||10||
60087332|NCT01857973|76203386|FG000|Phase 6|Overall Study||4||
60087333|NCT01857973|76203386|FG000|Phase 7|Overall Study||4||
60087334|NCT01857973|76203386|FG000|COMPLETED|Overall Study||73||
60087335|NCT01857973|76203386|FG000|NOT COMPLETED|Overall Study||5||
60087336|NCT01857583|76203394|FG000|STARTED|Overall Study||30||
60087337|NCT01857583|76203395|FG001|STARTED|Overall Study||7||
60087338|NCT01857583|76203396|FG002|STARTED|Overall Study||22||
60087339|NCT01857583|76203397|FG003|STARTED|Overall Study||21||
60087340|NCT01857583|76203394|FG000|Safety Analysis Population|Overall Study||30||
60087341|NCT01857583|76203395|FG001|Safety Analysis Population|Overall Study||7||
60087342|NCT01857583|76203396|FG002|Safety Analysis Population|Overall Study||22||
60087343|NCT01857583|76203397|FG003|Safety Analysis Population|Overall Study||20||
60087344|NCT01857583|76203394|FG000|COMPLETED|Overall Study||29||
60087345|NCT01857583|76203395|FG001|COMPLETED|Overall Study||6||
60087346|NCT01857583|76203396|FG002|COMPLETED|Overall Study||19||
60087347|NCT01857583|76203397|FG003|COMPLETED|Overall Study||17||
60087348|NCT01857583|76203394|FG000|NOT COMPLETED|Overall Study||1||
60087349|NCT01857583|76203395|FG001|NOT COMPLETED|Overall Study||1||
60087350|NCT01857583|76203396|FG002|NOT COMPLETED|Overall Study||3||
60087351|NCT01857583|76203397|FG003|NOT COMPLETED|Overall Study||4||
60087352|NCT01829191|76203409|FG000|STARTED|Overall Study||63||
60087353|NCT01829191|76203410|FG001|STARTED|Overall Study||64||
60087354|NCT01829191|76203409|FG000|COMPLETED|Overall Study||56||
60087355|NCT01829191|76203410|FG001|COMPLETED|Overall Study||50||
60087356|NCT01829191|76203409|FG000|NOT COMPLETED|Overall Study||7||
60087357|NCT01829191|76203410|FG001|NOT COMPLETED|Overall Study||14||
60087358|NCT00211185|76203415|FG000|STARTED|Overall Study||49||
60087359|NCT00211185|76203415|FG000|COMPLETED|Overall Study||29||
60087360|NCT00211185|76203415|FG000|NOT COMPLETED|Overall Study||20||
60087361|NCT00210639|76203421|FG000|STARTED|Overall Study||124||
60087362|NCT00210639|76203422|FG001|STARTED|Overall Study||83||
60087363|NCT00210639|76203421|FG000|COMPLETED|Overall Study||61||
60087364|NCT00210639|76203422|FG001|COMPLETED|Overall Study||41||
60087365|NCT00210639|76203421|FG000|NOT COMPLETED|Overall Study||63||
60087366|NCT00210639|76203422|FG001|NOT COMPLETED|Overall Study||42||
60087367|NCT01829113|76203430|FG000|STARTED|Overall Study|Three patients were enrolled and randomized but never received treatment.|77||
60087368|NCT01829113|76203431|FG001|STARTED|Overall Study|Two patients were enrolled and randomized but never received treatment.|78||
60087369|NCT01829113|76203430|FG000|COMPLETED|Overall Study||0||
60087370|NCT01829113|76203431|FG001|COMPLETED|Overall Study||0||
60087371|NCT01829113|76203430|FG000|NOT COMPLETED|Overall Study||77||
60087372|NCT01829113|76203431|FG001|NOT COMPLETED|Overall Study||78||
60087373|NCT01857271|76203439|FG000|STARTED|Overall Study||3||
60087374|NCT01857271|76203439|FG000|COMPLETED|Overall Study||2||
60087375|NCT01857271|76203439|FG000|NOT COMPLETED|Overall Study||1||
60087376|NCT01745120|76203445|FG000|STARTED|Overall Study||11|Started = ITT|
60087377|NCT01745120|76203446|FG001|STARTED|Overall Study||8|Started = ITT|
60087378|NCT01745120|76203445|FG000|COMPLETED|Overall Study||10||
60087379|NCT01745120|76203446|FG001|COMPLETED|Overall Study||8||
60087380|NCT01745120|76203445|FG000|NOT COMPLETED|Overall Study||1||
60087381|NCT01745120|76203446|FG001|NOT COMPLETED|Overall Study||0||
60087382|NCT01828567|76203457|FG000|STARTED|Overall Study||208||
60087383|NCT01828567|76203458|FG001|STARTED|Overall Study||209||
60087384|NCT01828567|76203457|FG000|1 Month|Overall Study||172||
60087385|NCT01828567|76203458|FG001|1 Month|Overall Study||192||
60087386|NCT01828567|76203457|FG000|COMPLETED|Overall Study||177||
60087387|NCT01828567|76203458|FG001|COMPLETED|Overall Study||199||
60087388|NCT01828567|76203457|FG000|NOT COMPLETED|Overall Study||31||
60087389|NCT01828567|76203458|FG001|NOT COMPLETED|Overall Study||10||
60087390|NCT01721486|76203466|FG000|STARTED|Overall Study||21||
60087391|NCT01721486|76203467|FG001|STARTED|Overall Study||20||
60087392|NCT01721486|76203466|FG000|COMPLETED|Overall Study||20||
60087393|NCT01721486|76203467|FG001|COMPLETED|Overall Study||19||
60087394|NCT01721486|76203466|FG000|NOT COMPLETED|Overall Study||1||
60087395|NCT01721486|76203467|FG001|NOT COMPLETED|Overall Study||1||
60087396|NCT01775930|76203473|FG000|STARTED|Overall Study||10||
60087397|NCT01775930|76203473|FG000|COMPLETED|Overall Study||9||
60087398|NCT01775930|76203473|FG000|NOT COMPLETED|Overall Study||1||
60087399|NCT01856569|76203477|FG000|STARTED|Overall Study||152||
60087400|NCT01856569|76203477|FG000|Full Analysis Set|Overall Study||144||
60087401|NCT01856569|76203477|FG000|COMPLETED|Overall Study||139||
60087402|NCT01856569|76203477|FG000|NOT COMPLETED|Overall Study||13||
60087403|NCT01721408|76203483|FG000|STARTED|Overall Study|Number of participants treated.|232||
60087404|NCT01721408|76203484|FG001|STARTED|Overall Study|Number of participants treated.|231||
60087405|NCT01721408|76203483|FG000|COMPLETED|Overall Study||196||
60087406|NCT01721408|76203484|FG001|COMPLETED|Overall Study||207||
60087407|NCT01721408|76203483|FG000|NOT COMPLETED|Overall Study||36||
60087408|NCT01721408|76203484|FG001|NOT COMPLETED|Overall Study||24||
60087409|NCT01744496|76203492|FG000|STARTED|Titration Period||33||
60087410|NCT01744496|76203493|FG001|STARTED|Titration Period||35||
60087411|NCT01744496|76203492|FG000|COMPLETED|Titration Period||31||
60087412|NCT01744496|76203493|FG001|COMPLETED|Titration Period||33||
60087413|NCT01744496|76203492|FG000|NOT COMPLETED|Titration Period||2||
60087414|NCT01744496|76203493|FG001|NOT COMPLETED|Titration Period||2||
60087415|NCT01744496|76203492|FG000|STARTED|Maintenance Period||31||
60087416|NCT01744496|76203493|FG001|STARTED|Maintenance Period||33||
60087417|NCT01744496|76203492|FG000|COMPLETED|Maintenance Period||27||
60087418|NCT01744496|76203493|FG001|COMPLETED|Maintenance Period||29||
60087419|NCT01744496|76203492|FG000|NOT COMPLETED|Maintenance Period||4||
60087420|NCT01744496|76203493|FG001|NOT COMPLETED|Maintenance Period||4||
60087421|NCT01721330|76203501|FG000|STARTED|Overall Study||1||
60087422|NCT01721330|76203502|FG001|STARTED|Overall Study||2||
60087423|NCT01721330|76203501|FG000|COMPLETED|Overall Study||1||
60087424|NCT01721330|76203502|FG001|COMPLETED|Overall Study||1||
60087425|NCT01721330|76203501|FG000|NOT COMPLETED|Overall Study||0||
60087426|NCT01721330|76203502|FG001|NOT COMPLETED|Overall Study||1||
60087427|NCT02079987|76203510|FG000|STARTED|Overall Study||557||
60087428|NCT02079987|76203511|FG001|STARTED|Overall Study||544||
60087429|NCT02079987|76203510|FG000|COMPLETED|Overall Study||557||
60087430|NCT02079987|76203511|FG001|COMPLETED|Overall Study||544||
60087431|NCT02079987|76203510|FG000|NOT COMPLETED|Overall Study||0||
60087432|NCT02079987|76203511|FG001|NOT COMPLETED|Overall Study||0||
60087433|NCT01828021|76203518|FG000|STARTED|Overall Study||25||
60087434|NCT01828021|76203518|FG000|COMPLETED|Overall Study||0||
60087435|NCT01828021|76203518|FG000|NOT COMPLETED|Overall Study||25||
60087436|NCT01827943|76203522|FG000|STARTED|Overall Study||54||
60087437|NCT01827943|76203522|FG000|Safety Population|Overall Study||53|Safety population included patients with at least one administration of treatment|
60087438|NCT01827943|76203522|FG000|COMPLETED|Overall Study||45||
60087439|NCT01827943|76203522|FG000|NOT COMPLETED|Overall Study||9||
60087440|NCT00217971|76203528|FG000|STARTED|Overall Study||79||
60087441|NCT00217971|76203529|FG001|STARTED|Overall Study||77||
60087442|NCT00217971|76203528|FG000|COMPLETED|Overall Study||55||
60087443|NCT00217971|76203529|FG001|COMPLETED|Overall Study||44||
60087444|NCT00217971|76203528|FG000|NOT COMPLETED|Overall Study||24||
60087445|NCT00217971|76203529|FG001|NOT COMPLETED|Overall Study||33||
60087446|NCT00217581|76203535|FG000|STARTED|Overall Study||39||
60087447|NCT00217581|76203535|FG000|COMPLETED|Overall Study||38||
60087448|NCT00217581|76203535|FG000|NOT COMPLETED|Overall Study||1||
60087449|NCT01856257|76203543|FG000|STARTED|Overall Study||29||
60087450|NCT01856257|76203544|FG001|STARTED|Overall Study||29||
60087451|NCT01856257|76203545|FG002|STARTED|Overall Study||11||
60087452|NCT01856257|76203546|FG003|STARTED|Overall Study||2||
60087453|NCT01856257|76203543|FG000|COMPLETED|Overall Study||26||
60087454|NCT01856257|76203544|FG001|COMPLETED|Overall Study||28||
60087455|NCT01856257|76203545|FG002|COMPLETED|Overall Study||11||
60087456|NCT01856257|76203546|FG003|COMPLETED|Overall Study||0||
60087457|NCT01856257|76203543|FG000|NOT COMPLETED|Overall Study||3||
60087458|NCT01856257|76203544|FG001|NOT COMPLETED|Overall Study||1||
60087459|NCT01856257|76203545|FG002|NOT COMPLETED|Overall Study||0||
60087460|NCT01856257|76203546|FG003|NOT COMPLETED|Overall Study||2||
60087461|NCT00215943|76203557|FG000|STARTED|Overall Study||36||
60087462|NCT00215943|76203558|FG001|STARTED|Overall Study||37||
60087463|NCT00215943|76203557|FG000|COMPLETED|Overall Study||27||
60087464|NCT00215943|76203558|FG001|COMPLETED|Overall Study||23||
60087465|NCT00215943|76203557|FG000|NOT COMPLETED|Overall Study||9||
60087466|NCT00215943|76203558|FG001|NOT COMPLETED|Overall Study||14||
60087467|NCT01827319|76203564|FG000|STARTED|Overall Study||203||
59560538|NCT02289755|75661821|FG000|NOT COMPLETED|Follow up Period [4 Days]||0||
59560539|NCT01648322|75661829|FG000|STARTED|Overall Study||35||
59560540|NCT01648322|75661830|FG001|STARTED|Overall Study||67||
59560541|NCT01648322|75661831|FG002|STARTED|Overall Study||65||
59560542|NCT01648322|75661832|FG003|STARTED|Overall Study||65||
59560543|NCT01648322|75661829|FG000|COMPLETED|Overall Study||33||
60087468|NCT01827319|76203564|FG000|COMPLETED|Overall Study||200||
60087469|NCT01827319|76203564|FG000|NOT COMPLETED|Overall Study||3||
60087470|NCT01827163|76203568|FG000|STARTED|Overall Study||20||
60087471|NCT01827163|76203568|FG000|COMPLETED|Overall Study||9||
60087472|NCT01827163|76203568|FG000|NOT COMPLETED|Overall Study||11||
60087473|NCT00215553|76203579|FG000|STARTED|Overall Study||5||
60087474|NCT00215553|76203580|FG001|STARTED|Overall Study||6||
60087475|NCT00215553|76203581|FG002|STARTED|Overall Study||6||
60087476|NCT00215553|76203582|FG003|STARTED|Overall Study||5||
60087477|NCT00215553|76203583|FG004|STARTED|Overall Study||28||
60087478|NCT00215553|76203584|FG005|STARTED|Overall Study||38||
60087479|NCT00215553|76203585|FG006|STARTED|Overall Study||36||
60087480|NCT00215553|76203579|FG000|COMPLETED|Overall Study||5||
60087481|NCT00215553|76203580|FG001|COMPLETED|Overall Study||5||
60087482|NCT00215553|76203581|FG002|COMPLETED|Overall Study||4||
60087483|NCT00215553|76203582|FG003|COMPLETED|Overall Study||4||
60087484|NCT00215553|76203583|FG004|COMPLETED|Overall Study||26||
60087485|NCT00215553|76203584|FG005|COMPLETED|Overall Study||32||
60087486|NCT00215553|76203585|FG006|COMPLETED|Overall Study||36||
60087487|NCT00215553|76203579|FG000|NOT COMPLETED|Overall Study||0||
60087488|NCT00215553|76203580|FG001|NOT COMPLETED|Overall Study||1||
60087489|NCT00215553|76203581|FG002|NOT COMPLETED|Overall Study||2||
60087490|NCT00215553|76203582|FG003|NOT COMPLETED|Overall Study||1||
60087491|NCT00215553|76203583|FG004|NOT COMPLETED|Overall Study||2||
60087492|NCT00215553|76203584|FG005|NOT COMPLETED|Overall Study||6||
60087493|NCT00215553|76203585|FG006|NOT COMPLETED|Overall Study||0||
60087494|NCT00214461|76203605|FG000|STARTED|Overall Study||12||
60087495|NCT00214461|76203606|FG001|STARTED|Overall Study||12||
60087496|NCT00214461|76203607|FG002|STARTED|Overall Study||12||
60087497|NCT00214461|76203608|FG003|STARTED|Overall Study||12||
60087498|NCT00214461|76203605|FG000|COMPLETED|Overall Study||12||
60087499|NCT00214461|76203606|FG001|COMPLETED|Overall Study||12||
60087500|NCT00214461|76203607|FG002|COMPLETED|Overall Study||10||
60087501|NCT00214461|76203608|FG003|COMPLETED|Overall Study||11||
60087502|NCT00214461|76203605|FG000|NOT COMPLETED|Overall Study||0||
60087503|NCT00214461|76203606|FG001|NOT COMPLETED|Overall Study||0||
60087504|NCT00214461|76203607|FG002|NOT COMPLETED|Overall Study||2||
60087505|NCT00214461|76203608|FG003|NOT COMPLETED|Overall Study||1||
60087506|NCT00214383|76203620|FG000|STARTED|Overall Study||148||
60087507|NCT00214383|76203621|FG001|STARTED|Overall Study||153||
60087508|NCT00214383|76203620|FG000|COMPLETED|Overall Study||132||
60087509|NCT00214383|76203621|FG001|COMPLETED|Overall Study||127||
60087510|NCT00214383|76203620|FG000|NOT COMPLETED|Overall Study||16||
60087511|NCT00214383|76203621|FG001|NOT COMPLETED|Overall Study||26||
60087512|NCT00212355|76203627|FG000|STARTED|Overall Study||37||
60087513|NCT00212355|76203627|FG000|COMPLETED|Overall Study||34||
60087514|NCT00212355|76203627|FG000|NOT COMPLETED|Overall Study||3||
60087515|NCT00211887|76203634|FG000|STARTED|Overall Study||499||
60087516|NCT00211887|76203635|FG001|STARTED|Overall Study||250||
60087517|NCT00211887|76203636|FG002|STARTED|Overall Study||259||
60087518|NCT00211887|76203634|FG000|COMPLETED|Overall Study||397||
60087519|NCT00211887|76203635|FG001|COMPLETED|Overall Study||194||
60087520|NCT00211887|76203636|FG002|COMPLETED|Overall Study||223||
60087521|NCT00211887|76203634|FG000|NOT COMPLETED|Overall Study||102||
60087522|NCT00211887|76203635|FG001|NOT COMPLETED|Overall Study||56||
60087523|NCT00211887|76203636|FG002|NOT COMPLETED|Overall Study||36||
60087524|NCT01855945|76203656|FG000|STARTED|Overall Study||54||
60087525|NCT01855945|76203657|FG001|STARTED|Overall Study||55||
60087526|NCT01855945|76203658|FG002|STARTED|Overall Study||51||
60087527|NCT01855945|76203659|FG003|STARTED|Overall Study||53||
60087528|NCT01855945|76203660|FG004|STARTED|Overall Study||51||
60087529|NCT01855945|76203661|FG005|STARTED|Overall Study||53||
60087530|NCT01855945|76203662|FG006|STARTED|Overall Study||53||
60087531|NCT01855945|76203663|FG007|STARTED|Overall Study||55||
60087532|NCT01855945|76203664|FG008|STARTED|Overall Study||48||
60087533|NCT01855945|76203665|FG009|STARTED|Overall Study||51||
60087534|NCT01855945|76203666|FG010|STARTED|Overall Study||51||
60087535|NCT01855945|76203667|FG011|STARTED|Overall Study||52||
60087536|NCT01855945|76203656|FG000|COMPLETED|Overall Study||38||
60087537|NCT01855945|76203657|FG001|COMPLETED|Overall Study||44||
60087538|NCT01855945|76203658|FG002|COMPLETED|Overall Study||39||
60087539|NCT01855945|76203659|FG003|COMPLETED|Overall Study||49||
60087540|NCT01855945|76203660|FG004|COMPLETED|Overall Study||50||
60087541|NCT01855945|76203661|FG005|COMPLETED|Overall Study||50||
60087542|NCT01855945|76203662|FG006|COMPLETED|Overall Study||43||
60087543|NCT01855945|76203663|FG007|COMPLETED|Overall Study||47||
60087544|NCT01855945|76203664|FG008|COMPLETED|Overall Study||46||
60087545|NCT01855945|76203665|FG009|COMPLETED|Overall Study||49||
60087546|NCT01855945|76203666|FG010|COMPLETED|Overall Study||46||
60087547|NCT01855945|76203667|FG011|COMPLETED|Overall Study||49||
60087548|NCT01855945|76203656|FG000|NOT COMPLETED|Overall Study||16||
60087549|NCT01855945|76203657|FG001|NOT COMPLETED|Overall Study||11||
60087550|NCT01855945|76203658|FG002|NOT COMPLETED|Overall Study||12||
60087551|NCT01855945|76203659|FG003|NOT COMPLETED|Overall Study||4||
60087552|NCT01855945|76203660|FG004|NOT COMPLETED|Overall Study||1||
60087553|NCT01855945|76203661|FG005|NOT COMPLETED|Overall Study||3||
60087554|NCT01855945|76203662|FG006|NOT COMPLETED|Overall Study||10||
60087555|NCT01855945|76203663|FG007|NOT COMPLETED|Overall Study||8||
60087556|NCT01855945|76203664|FG008|NOT COMPLETED|Overall Study||2||
60087557|NCT01855945|76203665|FG009|NOT COMPLETED|Overall Study||2||
60087558|NCT01855945|76203666|FG010|NOT COMPLETED|Overall Study||5||
60087559|NCT01855945|76203667|FG011|NOT COMPLETED|Overall Study||3||
60087560|NCT01855789|76203730|FG000|STARTED|1) Baseline up to Week 24||718||
60087561|NCT01855789|76203731|FG001|STARTED|1) Baseline up to Week 24||0||
60087562|NCT01855789|76203732|FG002|STARTED|1) Baseline up to Week 24||0||
60087563|NCT01855789|76203733|FG003|STARTED|1) Baseline up to Week 24||0||
60087564|NCT01855789|76203730|FG000|COMPLETED|1) Baseline up to Week 24||602||
60087565|NCT01855789|76203731|FG001|COMPLETED|1) Baseline up to Week 24||0||
60087566|NCT01855789|76203732|FG002|COMPLETED|1) Baseline up to Week 24||0||
60087567|NCT01855789|76203733|FG003|COMPLETED|1) Baseline up to Week 24||0||
60087568|NCT01855789|76203730|FG000|NOT COMPLETED|1) Baseline up to Week 24||116||
60087569|NCT01855789|76203731|FG001|NOT COMPLETED|1) Baseline up to Week 24||0||
60087570|NCT01855789|76203732|FG002|NOT COMPLETED|1) Baseline up to Week 24||0||
60087571|NCT01855789|76203733|FG003|NOT COMPLETED|1) Baseline up to Week 24||0||
60087572|NCT01855789|76203730|FG000|STARTED|2) Week 24 up to End of Study||0||
60087573|NCT01855789|76203731|FG001|STARTED|2) Week 24 up to End of Study||147||
60087574|NCT01855789|76203732|FG002|STARTED|2) Week 24 up to End of Study||147||
60087575|NCT01855789|76203733|FG003|STARTED|2) Week 24 up to End of Study||308||
60087576|NCT01855789|76203730|FG000|COMPLETED|2) Week 24 up to End of Study||0||
60087577|NCT01855789|76203731|FG001|COMPLETED|2) Week 24 up to End of Study||132||
60087578|NCT01855789|76203732|FG002|COMPLETED|2) Week 24 up to End of Study||129||
59707604|NCT00991276|75826521|FG001|COMPLETED|Placebo Wash-out Period (7 Days)||10||
60087579|NCT01855789|76203733|FG003|COMPLETED|2) Week 24 up to End of Study||250||
60087580|NCT01855789|76203730|FG000|NOT COMPLETED|2) Week 24 up to End of Study||0||
60087581|NCT01855789|76203731|FG001|NOT COMPLETED|2) Week 24 up to End of Study||15||
60087582|NCT01855789|76203732|FG002|NOT COMPLETED|2) Week 24 up to End of Study||18||
60087583|NCT01855789|76203733|FG003|NOT COMPLETED|2) Week 24 up to End of Study||58||
60087584|NCT01610791|76203739|FG000|STARTED|Overall Study||121||
60087585|NCT01610791|76203739|FG000|COMPLETED|Overall Study||100||
60087586|NCT01610791|76203739|FG000|NOT COMPLETED|Overall Study||21||
60087587|NCT01876381|76203743|FG000|STARTED|Overall Study||23||
60087588|NCT01876381|76203743|FG000|COMPLETED|Overall Study||16||
60087589|NCT01876381|76203743|FG000|NOT COMPLETED|Overall Study||7||
60087590|NCT03984513|76203749|FG000|STARTED|Overall Study||29||
60087591|NCT03984513|76203750|FG001|STARTED|Overall Study||29||
60087592|NCT03984513|76203749|FG000|COMPLETED|Overall Study||26||
60087593|NCT03984513|76203750|FG001|COMPLETED|Overall Study||22||
60087594|NCT03984513|76203749|FG000|NOT COMPLETED|Overall Study||3||
60087595|NCT03984513|76203750|FG001|NOT COMPLETED|Overall Study||7||
60087596|NCT01855399|76203758|FG000|STARTED|6 Month||146||
60087597|NCT01855399|76203759|FG001|STARTED|6 Month||144||
60087598|NCT01855399|76203758|FG000|COMPLETED|6 Month||126||
60087599|NCT01855399|76203759|FG001|COMPLETED|6 Month||129||
60087600|NCT01855399|76203758|FG000|NOT COMPLETED|6 Month||20||
60087601|NCT01855399|76203759|FG001|NOT COMPLETED|6 Month||15||
60087602|NCT01855399|76203758|FG000|STARTED|12 Month||126||
60087603|NCT01855399|76203759|FG001|STARTED|12 Month||129||
60087604|NCT01855399|76203758|FG000|COMPLETED|12 Month||119||
60087605|NCT01855399|76203759|FG001|COMPLETED|12 Month||118||
60087606|NCT01855399|76203758|FG000|NOT COMPLETED|12 Month||7||
60087607|NCT01855399|76203759|FG001|NOT COMPLETED|12 Month||11||
60087608|NCT01875991|76203767|FG000|STARTED|Overall Study||108||
60087609|NCT01875991|76203768|FG001|STARTED|Overall Study||109||
60087610|NCT01875991|76203767|FG000|Received Etanercept in Period 1|Overall Study||108||
60087611|NCT01875991|76203768|FG001|Received Etanercept in Period 1|Overall Study||108||
60087612|NCT01875991|76203767|FG000|Received Etanercept in Period 2|Overall Study||102||
60087613|NCT01875991|76203768|FG001|Received Etanercept in Period 2|Overall Study||103||
60087614|NCT01875991|76203767|FG000|COMPLETED|Overall Study||101||
60087615|NCT01875991|76203768|FG001|COMPLETED|Overall Study||103||
60087616|NCT01875991|76203767|FG000|NOT COMPLETED|Overall Study||7||
60087617|NCT01875991|76203768|FG001|NOT COMPLETED|Overall Study||6||
60087618|NCT01855243|76203780|FG000|STARTED|Overall Study||20||
60087619|NCT01855243|76203781|FG001|STARTED|Overall Study||21||
60087620|NCT01855243|76203782|FG002|STARTED|Overall Study||22||
60087621|NCT01855243|76203780|FG000|COMPLETED|Overall Study||19||
60087622|NCT01855243|76203781|FG001|COMPLETED|Overall Study||21||
60087623|NCT01855243|76203782|FG002|COMPLETED|Overall Study||22||
60087624|NCT01855243|76203780|FG000|NOT COMPLETED|Overall Study||1||
60087625|NCT01855243|76203781|FG001|NOT COMPLETED|Overall Study||0||
60087626|NCT01855243|76203782|FG002|NOT COMPLETED|Overall Study||0||
60087627|NCT01825837|76203794|FG000|STARTED|PART I||0||
59992531|NCT02452892|76108375|FG001|STARTED|Week 1 Initial Randommization||40|Week 1 subjects were randomized 1:1:1 allocation to LFMS Sham, LFMS 20min,or LFMS 60min|
59992532|NCT02452892|76108376|FG002|STARTED|Week 1 Initial Randommization||41|Week 1 subjects were randomized 1:1:1 allocation to LFMS Sham, LFMS 20min,or LFMS 60min|
60087628|NCT01825837|76203795|FG001|STARTED|PART I||0||
60087629|NCT01825837|76203796|FG002|STARTED|PART I||0||
60087630|NCT01825837|76203797|FG003|STARTED|PART I||104||
60087631|NCT01825837|76203794|FG000|Enrolled|PART I||0||
60087632|NCT01825837|76203795|FG001|Enrolled|PART I||0||
60087633|NCT01825837|76203796|FG002|Enrolled|PART I||0||
60087634|NCT01825837|76203797|FG003|Enrolled|PART I||104||
60087635|NCT01825837|76203794|FG000|Safety Population (Open-Label)|PART I||0||
60087636|NCT01825837|76203795|FG001|Safety Population (Open-Label)|PART I||0||
60087637|NCT01825837|76203796|FG002|Safety Population (Open-Label)|PART I||0||
60087638|NCT01825837|76203797|FG003|Safety Population (Open-Label)|PART I||104||
60087639|NCT01825837|76203794|FG000|COMPLETED|PART I||0||
60087640|NCT01825837|76203795|FG001|COMPLETED|PART I||0||
60087641|NCT01825837|76203796|FG002|COMPLETED|PART I||0||
60087642|NCT01825837|76203797|FG003|COMPLETED|PART I||87||
60087643|NCT01825837|76203794|FG000|NOT COMPLETED|PART I||0||
60087644|NCT01825837|76203795|FG001|NOT COMPLETED|PART I||0||
60087645|NCT01825837|76203796|FG002|NOT COMPLETED|PART I||0||
60087646|NCT01825837|76203797|FG003|NOT COMPLETED|PART I||17||
60087647|NCT01825837|76203794|FG000|STARTED|PART II||35||
60087648|NCT01825837|76203795|FG001|STARTED|PART II||26||
60087649|NCT01825837|76203796|FG002|STARTED|PART II||26||
60087650|NCT01825837|76203797|FG003|STARTED|PART II||0||
60087651|NCT01825837|76203794|FG000|Randomized Patients|PART II||35||
60087652|NCT01825837|76203795|FG001|Randomized Patients|PART II||26||
60087653|NCT01825837|76203796|FG002|Randomized Patients|PART II||26||
60087654|NCT01825837|76203797|FG003|Randomized Patients|PART II||0||
60087655|NCT01825837|76203794|FG000|Safety Population (Double-Blind)|PART II||35||
60087656|NCT01825837|76203795|FG001|Safety Population (Double-Blind)|PART II||26||
60087657|NCT01825837|76203796|FG002|Safety Population (Double-Blind)|PART II||26||
60087658|NCT01825837|76203797|FG003|Safety Population (Double-Blind)|PART II||0||
60087659|NCT01825837|76203794|FG000|Intent-to-Treat Population|PART II||34||
60087660|NCT01825837|76203795|FG001|Intent-to-Treat Population|PART II||25||
59816755|NCT04090749|75939137|FG001|STARTED|Pilot Trial||12||
59816756|NCT04090749|75939138|FG002|STARTED|Pilot Trial||12||
59816757|NCT04090749|75939136|FG000|COMPLETED|Pilot Trial||0||
59992533|NCT02452892|76108377|FG003|STARTED|Week 1 Initial Randommization||0|Week 1 subjects were randomized 1:1:1 allocation to LFMS Sham, LFMS 20min,or LFMS 60min|
59992534|NCT02452892|76108374|FG000|COMPLETED|Week 1 Initial Randommization||40||
59992535|NCT02452892|76108375|FG001|COMPLETED|Week 1 Initial Randommization||40||
59992536|NCT02452892|76108376|FG002|COMPLETED|Week 1 Initial Randommization||40||
59992537|NCT02452892|76108377|FG003|COMPLETED|Week 1 Initial Randommization||0||
59992538|NCT02452892|76108374|FG000|NOT COMPLETED|Week 1 Initial Randommization||1||
59992539|NCT02452892|76108375|FG001|NOT COMPLETED|Week 1 Initial Randommization||0||
60087661|NCT01825837|76203796|FG002|Intent-to-Treat Population|PART II||26||
60087662|NCT01825837|76203797|FG003|Intent-to-Treat Population|PART II||0||
60087663|NCT01825837|76203794|FG000|Per-Protocol Population|PART II||32||
60087664|NCT01825837|76203795|FG001|Per-Protocol Population|PART II||23||
59992540|NCT02452892|76108376|FG002|NOT COMPLETED|Week 1 Initial Randommization||1||
59992541|NCT02452892|76108377|FG003|NOT COMPLETED|Week 1 Initial Randommization||0||
60087665|NCT01825837|76203796|FG002|Per-Protocol Population|PART II||24||
60087666|NCT01825837|76203797|FG003|Per-Protocol Population|PART II||0||
59816758|NCT04090749|75939137|FG001|COMPLETED|Pilot Trial||10||
59816759|NCT04090749|75939138|FG002|COMPLETED|Pilot Trial||11||
60087667|NCT01825837|76203794|FG000|COMPLETED|PART II||16||
60087668|NCT01825837|76203795|FG001|COMPLETED|PART II||12||
60087669|NCT01825837|76203796|FG002|COMPLETED|PART II||7||
60087670|NCT01825837|76203797|FG003|COMPLETED|PART II||0||
60087671|NCT01825837|76203794|FG000|NOT COMPLETED|PART II||19||
60087672|NCT01825837|76203795|FG001|NOT COMPLETED|PART II||14||
60087673|NCT01825837|76203796|FG002|NOT COMPLETED|PART II||19||
60087674|NCT01825837|76203797|FG003|NOT COMPLETED|PART II||0||
60087675|NCT01854697|76203810|FG000|STARTED|Overall Study||69||
60087676|NCT01854697|76203811|FG001|STARTED|Overall Study||34||
60087677|NCT01854697|76203812|FG002|STARTED|Overall Study||84||
60087678|NCT01854697|76203813|FG003|STARTED|Overall Study||83||
60087679|NCT01854697|76203814|FG004|STARTED|Overall Study||41||
60087680|NCT01854697|76203810|FG000|COMPLETED|Overall Study||63||
60087681|NCT01854697|76203811|FG001|COMPLETED|Overall Study||31||
60087682|NCT01854697|76203812|FG002|COMPLETED|Overall Study||82||
60087683|NCT01854697|76203813|FG003|COMPLETED|Overall Study||80||
59560544|NCT01648322|75661830|FG001|COMPLETED|Overall Study||62||
59560545|NCT01648322|75661831|FG002|COMPLETED|Overall Study||60||
59560546|NCT01648322|75661832|FG003|COMPLETED|Overall Study||61||
59560547|NCT01648322|75661829|FG000|NOT COMPLETED|Overall Study||2||
59560548|NCT01648322|75661830|FG001|NOT COMPLETED|Overall Study||5||
60087684|NCT01854697|76203814|FG004|COMPLETED|Overall Study||39||
60087685|NCT01854697|76203810|FG000|NOT COMPLETED|Overall Study||6||
60087686|NCT01854697|76203811|FG001|NOT COMPLETED|Overall Study||3||
60087687|NCT01854697|76203812|FG002|NOT COMPLETED|Overall Study||2||
60087688|NCT01854697|76203813|FG003|NOT COMPLETED|Overall Study||3||
60087689|NCT01854697|76203814|FG004|NOT COMPLETED|Overall Study||2||
60087690|NCT01824979|76203826|FG000|STARTED|Overall Study||50||
60087691|NCT01824979|76203827|FG001|STARTED|Overall Study||50||
60087692|NCT01824979|76203826|FG000|COMPLETED|Overall Study||37||
60087693|NCT01824979|76203827|FG001|COMPLETED|Overall Study||37||
60087694|NCT01824979|76203826|FG000|NOT COMPLETED|Overall Study||13||
60087695|NCT01824979|76203827|FG001|NOT COMPLETED|Overall Study||13||
60087696|NCT01824823|76203835|FG000|STARTED|Overall Study||2||
60087697|NCT01824823|76203836|FG001|STARTED|Overall Study||1||
60087698|NCT01824823|76203835|FG000|COMPLETED|Overall Study||0||
60087699|NCT01824823|76203836|FG001|COMPLETED|Overall Study||0||
60087700|NCT01824823|76203835|FG000|NOT COMPLETED|Overall Study||2||
60087701|NCT01824823|76203836|FG001|NOT COMPLETED|Overall Study||1||
60087702|NCT01875367|76203844|FG000|STARTED|Overall Study||81||
60087703|NCT01875367|76203845|FG001|STARTED|Overall Study||85||
60087704|NCT01875367|76203844|FG000|COMPLETED|Overall Study||76||
60087705|NCT01875367|76203845|FG001|COMPLETED|Overall Study||83||
60087706|NCT01875367|76203844|FG000|NOT COMPLETED|Overall Study||5||
60087707|NCT01875367|76203845|FG001|NOT COMPLETED|Overall Study||2||
60087708|NCT01853839|76203855|FG000|STARTED|Overall Study||2092||
60087709|NCT01853839|76203855|FG000|COMPLETED|Overall Study||1663||
60087710|NCT01853839|76203855|FG000|NOT COMPLETED|Overall Study||429||
60087711|NCT01874665|76203865|FG000|STARTED|Overall Study||30||
60087712|NCT01874665|76203866|FG001|STARTED|Overall Study||15||
60087713|NCT01874665|76203865|FG000|COMPLETED|Overall Study||0||
60087714|NCT01874665|76203866|FG001|COMPLETED|Overall Study||0||
60087715|NCT01874665|76203865|FG000|NOT COMPLETED|Overall Study||30||
59560549|NCT01648322|75661831|FG002|NOT COMPLETED|Overall Study||5||
59560550|NCT01648322|75661832|FG003|NOT COMPLETED|Overall Study||4||
59816760|NCT04090749|75939136|FG000|NOT COMPLETED|Pilot Trial||0||
59560551|NCT01649180|75661858|FG000|STARTED|Overall Study||3||
59560552|NCT01649180|75661858|FG000|COMPLETED|Overall Study||3||
59560553|NCT01649180|75661858|FG000|NOT COMPLETED|Overall Study||0||
59560554|NCT01619774|75661862|FG000|STARTED|Overall Study||23||
59560555|NCT01619774|75661862|FG000|COMPLETED|Overall Study||23||
60087716|NCT01874665|76203866|FG001|NOT COMPLETED|Overall Study||15||
60087717|NCT01874431|76203881|FG000|STARTED|Overall Study||96||
60087718|NCT01874431|76203882|FG001|STARTED|Overall Study||92||
60087719|NCT01874431|76203883|FG002|STARTED|Overall Study||100||
60087720|NCT01874431|76203884|FG003|STARTED|Overall Study||98||
60087721|NCT01874431|76203885|FG004|STARTED|Overall Study||98||
60087722|NCT01874431|76203886|FG005|STARTED|Overall Study||125||
60087723|NCT01874431|76203887|FG006|STARTED|Overall Study||120||
60087724|NCT01874431|76203888|FG007|STARTED|Overall Study||94||
60087725|NCT01874431|76203881|FG000|Participants Received Treatment|Overall Study||96||
60087726|NCT01874431|76203882|FG001|Participants Received Treatment|Overall Study||92||
60087727|NCT01874431|76203883|FG002|Participants Received Treatment|Overall Study||100||
60103713|NCT04778709|76221974|FG001|STARTED|Overall Study||2||4
60103714|NCT04778709|76221973|FG000|COMPLETED|Overall Study||0||0
60103715|NCT04778709|76221974|FG001|COMPLETED|Overall Study||0||0
60103716|NCT04778709|76221973|FG000|NOT COMPLETED|Overall Study||2||4
60103717|NCT04778709|76221974|FG001|NOT COMPLETED|Overall Study||2||4
60103718|NCT04778059|76221985|FG000|STARTED|Overall Study||3||
60103719|NCT04778059|76221986|FG001|STARTED|Overall Study||3||
60103720|NCT04778059|76221987|FG002|STARTED|Overall Study||3||
60103721|NCT04778059|76221988|FG003|STARTED|Overall Study||2||
60087728|NCT01874431|76203884|FG003|Participants Received Treatment|Overall Study||97||
60087729|NCT01874431|76203885|FG004|Participants Received Treatment|Overall Study||98||
60087730|NCT01874431|76203886|FG005|Participants Received Treatment|Overall Study||125||
60087731|NCT01874431|76203887|FG006|Participants Received Treatment|Overall Study||119||
60087732|NCT01874431|76203888|FG007|Participants Received Treatment|Overall Study||94||
60087733|NCT01874431|76203881|FG000|COMPLETED|Overall Study||90||
60087734|NCT01874431|76203882|FG001|COMPLETED|Overall Study||87||
60087735|NCT01874431|76203883|FG002|COMPLETED|Overall Study||90||
60087736|NCT01874431|76203884|FG003|COMPLETED|Overall Study||91||
60087737|NCT01874431|76203885|FG004|COMPLETED|Overall Study||90||
60087738|NCT01874431|76203886|FG005|COMPLETED|Overall Study||114||
60087739|NCT01874431|76203887|FG006|COMPLETED|Overall Study||112||
60087740|NCT01874431|76203888|FG007|COMPLETED|Overall Study||90||
60087741|NCT01874431|76203881|FG000|NOT COMPLETED|Overall Study||6||
60087742|NCT01874431|76203882|FG001|NOT COMPLETED|Overall Study||5||
60087743|NCT01874431|76203883|FG002|NOT COMPLETED|Overall Study||10||
60087744|NCT01874431|76203884|FG003|NOT COMPLETED|Overall Study||7||
60087745|NCT01874431|76203885|FG004|NOT COMPLETED|Overall Study||8||
60087746|NCT01874431|76203886|FG005|NOT COMPLETED|Overall Study||11||
60087747|NCT01874431|76203887|FG006|NOT COMPLETED|Overall Study||8||
60087748|NCT01874431|76203888|FG007|NOT COMPLETED|Overall Study||4||
60087749|NCT01824355|76203906|FG000|STARTED|Overall Study||113||
60087750|NCT01824355|76203906|FG000|COMPLETED|Overall Study||110||
60087751|NCT01824355|76203906|FG000|NOT COMPLETED|Overall Study||3||
60087752|NCT04042623|76203910|FG000|STARTED|Overall Study||1||
60087753|NCT04042623|76203910|FG000|COMPLETED|Overall Study||0||
60087754|NCT04042623|76203910|FG000|NOT COMPLETED|Overall Study||1||
60087755|NCT01823341|76203914|FG000|STARTED|Overall Study||97||
60087756|NCT01823341|76203914|FG000|COMPLETED|Overall Study||82||
60087757|NCT01823341|76203914|FG000|NOT COMPLETED|Overall Study||15||
60087758|NCT01853137|76203923|FG000|STARTED|Overall Study||25||
60087759|NCT01853137|76203924|FG001|STARTED|Overall Study||18||
60087760|NCT01853137|76203923|FG000|COMPLETED|Overall Study||21||
60087761|NCT01853137|76203924|FG001|COMPLETED|Overall Study||17||
60087762|NCT01853137|76203923|FG000|NOT COMPLETED|Overall Study||4||
60087763|NCT01853137|76203924|FG001|NOT COMPLETED|Overall Study||1||
60087764|NCT01823107|76203931|FG000|STARTED|Overall Study||25||
60087765|NCT01823107|76203931|FG000|COMPLETED|Overall Study||24||
60087766|NCT01823107|76203931|FG000|NOT COMPLETED|Overall Study||1||
60087767|NCT01874275|76203937|FG000|STARTED|Overall Study||4||
60087768|NCT01874275|76203938|FG001|STARTED|Overall Study||2||
60087769|NCT01874275|76203937|FG000|COMPLETED|Overall Study||3||
60087770|NCT01874275|76203938|FG001|COMPLETED|Overall Study||2||
60087771|NCT01874275|76203937|FG000|NOT COMPLETED|Overall Study||1||
60087772|NCT01874275|76203938|FG001|NOT COMPLETED|Overall Study||0||
60087773|NCT01873729|76203950|FG000|STARTED|Overall Study||3||
60087774|NCT01873729|76203950|FG000|COMPLETED|Overall Study||2||
60087775|NCT01873729|76203950|FG000|NOT COMPLETED|Overall Study||1||
60087776|NCT01873495|76203954|FG000|STARTED|Overall Study||7||
60087777|NCT01873495|76203954|FG000|COMPLETED|Overall Study||0||
60087778|NCT01873495|76203954|FG000|NOT COMPLETED|Overall Study||7||
60087779|NCT01852825|76203961|FG000|STARTED|Overall Study||16||
60087780|NCT01852825|76203962|FG001|STARTED|Overall Study||7||
60087781|NCT01852825|76203963|FG002|STARTED|Overall Study||3||
60087782|NCT01852825|76203961|FG000|COMPLETED|Overall Study||14||
60087783|NCT01852825|76203962|FG001|COMPLETED|Overall Study||7||
60087784|NCT01852825|76203963|FG002|COMPLETED|Overall Study||3||
60087785|NCT01852825|76203961|FG000|NOT COMPLETED|Overall Study||2||
60087786|NCT01852825|76203962|FG001|NOT COMPLETED|Overall Study||0||
60087787|NCT01852825|76203963|FG002|NOT COMPLETED|Overall Study||0||
60087788|NCT01822561|76203971|FG000|STARTED|Overall Study||15||15
60087789|NCT01822561|76203971|FG000|COMPLETED|Overall Study||13||13
60087790|NCT01822561|76203971|FG000|NOT COMPLETED|Overall Study||2||2
60087791|NCT02080455|76203981|FG000|STARTED|Overall Study||16||
60087792|NCT02080455|76203982|FG001|STARTED|Overall Study||16||
59707605|NCT00991276|75826522|FG002|COMPLETED|Placebo Wash-out Period (7 Days)||14||
60087793|NCT02080455|76203981|FG000|COMPLETED|Overall Study||16||
60087794|NCT02080455|76203982|FG001|COMPLETED|Overall Study||16||
60087795|NCT02080455|76203981|FG000|NOT COMPLETED|Overall Study||0||
60087796|NCT02080455|76203982|FG001|NOT COMPLETED|Overall Study||0||
60087797|NCT01852591|76203996|FG000|STARTED|Overall Study||8||
60087798|NCT01852591|76203996|FG000|COMPLETED|Overall Study||5||
60087799|NCT01852591|76203996|FG000|NOT COMPLETED|Overall Study||3||
60087800|NCT01852045|76204003|FG000|STARTED|Overall Study||39||
60087801|NCT01852045|76204004|FG001|STARTED|Overall Study||45||
60087802|NCT01852045|76204005|FG002|STARTED|Overall Study||30||
60087803|NCT01852045|76204003|FG000|mITT Population|Overall Study||38||
60087804|NCT01852045|76204004|FG001|mITT Population|Overall Study||45||
60087805|NCT01852045|76204005|FG002|mITT Population|Overall Study||30||
60087806|NCT01852045|76204003|FG000|Safety Population|Overall Study||38||
60087807|NCT01852045|76204004|FG001|Safety Population|Overall Study||45||
60087808|NCT01852045|76204005|FG002|Safety Population|Overall Study||30||
60087809|NCT01852045|76204003|FG000|COMPLETED|Overall Study||33||
60087810|NCT01852045|76204004|FG001|COMPLETED|Overall Study||41||
60087811|NCT01852045|76204005|FG002|COMPLETED|Overall Study||26||
60087812|NCT01852045|76204003|FG000|NOT COMPLETED|Overall Study||6||
60087813|NCT01852045|76204004|FG001|NOT COMPLETED|Overall Study||4||
60087814|NCT01852045|76204005|FG002|NOT COMPLETED|Overall Study||4||
60087815|NCT03960957|76204015|FG000|STARTED|Overall Study||224||
60087816|NCT03960957|76204016|FG001|STARTED|Overall Study||77||
60087817|NCT03960957|76204015|FG000|COMPLETED|Overall Study||216||
60087818|NCT03960957|76204016|FG001|COMPLETED|Overall Study||71||
60087819|NCT03960957|76204015|FG000|NOT COMPLETED|Overall Study||8||
60087820|NCT03960957|76204016|FG001|NOT COMPLETED|Overall Study||6||
60087821|NCT01821937|76204024|FG000|STARTED|Overall Study||10||
60087822|NCT01821937|76204025|FG001|STARTED|Overall Study||15||
60087823|NCT01821937|76204024|FG000|COMPLETED|Overall Study||10||
60087824|NCT01821937|76204025|FG001|COMPLETED|Overall Study|2 patients discontinued during Single dose period,1 Patient discontinued during Multiple dose period|12||
60087825|NCT01821937|76204024|FG000|NOT COMPLETED|Overall Study||0||
60087826|NCT01821937|76204025|FG001|NOT COMPLETED|Overall Study||3||
60087827|NCT01821625|76204033|FG000|STARTED|Overall Study||7||
60087828|NCT01821625|76204033|FG000|COMPLETED|Overall Study||1||
60087829|NCT01821625|76204033|FG000|NOT COMPLETED|Overall Study||6||
60087830|NCT01821391|76204039|FG000|STARTED|Overall Study||108||
60087831|NCT01821391|76204040|FG001|STARTED|Overall Study||23||
60087832|NCT01821391|76204039|FG000|COMPLETED|Overall Study||107||
60087833|NCT01821391|76204040|FG001|COMPLETED|Overall Study||23||
60087834|NCT01821391|76204039|FG000|NOT COMPLETED|Overall Study||1||
60087835|NCT01821391|76204040|FG001|NOT COMPLETED|Overall Study||0||
60087836|NCT01873417|76204048|FG000|STARTED|Overall Study||237||
60087837|NCT01873417|76204048|FG000|Safety Population|Overall Study|Participants who received at least 1 dose of dimethyl fumarate (DMF), recorded in diary data.|233||
59560556|NCT01619774|75661862|FG000|NOT COMPLETED|Overall Study||0||
59816761|NCT04090749|75939137|FG001|NOT COMPLETED|Pilot Trial||2||
60087838|NCT01873417|76204048|FG000|COMPLETED|Overall Study||202||
60087839|NCT01873417|76204048|FG000|NOT COMPLETED|Overall Study||35||
60087840|NCT01872715|76204052|FG000|STARTED|Overall Study||24||
60087841|NCT01872715|76204052|FG000|COMPLETED|Overall Study||20||
60087842|NCT01872715|76204052|FG000|NOT COMPLETED|Overall Study||4||
60087843|NCT01871545|76204068|FG000|STARTED|Overall Study||73||
60087844|NCT01871545|76204069|FG001|STARTED|Overall Study||11||
60087845|NCT01871545|76204068|FG000|COMPLETED|Overall Study||56||
60087846|NCT01871545|76204069|FG001|COMPLETED|Overall Study||8||
60087847|NCT01871545|76204068|FG000|NOT COMPLETED|Overall Study||17||
60087848|NCT01871545|76204069|FG001|NOT COMPLETED|Overall Study||3||
60087849|NCT01613599|76204078|FG000|STARTED|Overall Study||97||
60087850|NCT01613599|76204078|FG000|COMPLETED|Overall Study||72||
60087851|NCT01613599|76204078|FG000|NOT COMPLETED|Overall Study||25||
60087852|NCT01850641|76204082|FG000|STARTED|Overall Study||35||
60087853|NCT01850641|76204082|FG000|COMPLETED|Overall Study||30||
60087854|NCT01850641|76204082|FG000|NOT COMPLETED|Overall Study||5||
60087855|NCT01850563|76204088|FG000|STARTED|Overall Study||22||
60087856|NCT01850563|76204089|FG001|STARTED|Overall Study||19||
60087857|NCT01850563|76204088|FG000|HBO Treatment Completed|Overall Study||19||
60087858|NCT01850563|76204089|FG001|HBO Treatment Completed|Overall Study||0||
60087859|NCT01850563|76204088|FG000|COMPLETED|Overall Study||19|SRS treatment completed|
60087860|NCT01850563|76204089|FG001|COMPLETED|Overall Study||19|SRS treatment completed|
60087861|NCT01850563|76204088|FG000|NOT COMPLETED|Overall Study||3||
60087862|NCT01850563|76204089|FG001|NOT COMPLETED|Overall Study||0||
60087863|NCT03930771|76204096|FG000|STARTED|Overall Study||1||
60087864|NCT03930771|76204096|FG000|COMPLETED|Overall Study||1||
60087865|NCT03930771|76204096|FG000|NOT COMPLETED|Overall Study||0||
60087866|NCT05544734|76204102|FG000|STARTED|Overall Study||10||
60087867|NCT05544734|76204103|FG001|STARTED|Overall Study||10||
60087868|NCT05544734|76204102|FG000|COMPLETED|Overall Study||10||
60087869|NCT05544734|76204103|FG001|COMPLETED|Overall Study||10||
60087870|NCT05544734|76204102|FG000|NOT COMPLETED|Overall Study||0||
60087871|NCT05544734|76204103|FG001|NOT COMPLETED|Overall Study||0||
60087872|NCT05293392|76204111|FG000|STARTED|Phase 1: Community-Tailored Handouts||268||2
60087873|NCT05293392|76204112|FG001|STARTED|Phase 1: Community-Tailored Handouts||406||2
60087874|NCT05293392|76204111|FG000|COMPLETED|Phase 1: Community-Tailored Handouts||268||2
60087875|NCT05293392|76204112|FG001|COMPLETED|Phase 1: Community-Tailored Handouts||406||2
60087876|NCT05293392|76204111|FG000|NOT COMPLETED|Phase 1: Community-Tailored Handouts||0||0
60087877|NCT05293392|76204112|FG001|NOT COMPLETED|Phase 1: Community-Tailored Handouts||0||0
60087878|NCT05293392|76204111|FG000|STARTED|Phase 2: Videos Featuring Local Families||281||2
60087879|NCT05293392|76204112|FG001|STARTED|Phase 2: Videos Featuring Local Families||476||2
60087880|NCT05293392|76204111|FG000|COMPLETED|Phase 2: Videos Featuring Local Families||281||2
60087881|NCT05293392|76204112|FG001|COMPLETED|Phase 2: Videos Featuring Local Families||476||2
60087882|NCT05293392|76204111|FG000|NOT COMPLETED|Phase 2: Videos Featuring Local Families||0||0
60087883|NCT05293392|76204112|FG001|NOT COMPLETED|Phase 2: Videos Featuring Local Families||0||0
60087884|NCT05293392|76204111|FG000|STARTED|Phase 3: Family-Centered Communication||442||2
60087885|NCT05293392|76204112|FG001|STARTED|Phase 3: Family-Centered Communication||628||2
60087886|NCT05293392|76204111|FG000|COMPLETED|Phase 3: Family-Centered Communication||442||2
60087887|NCT05293392|76204112|FG001|COMPLETED|Phase 3: Family-Centered Communication||628||2
60087888|NCT05293392|76204111|FG000|NOT COMPLETED|Phase 3: Family-Centered Communication||0||0
60087889|NCT05293392|76204112|FG001|NOT COMPLETED|Phase 3: Family-Centered Communication||0||0
60087890|NCT05293392|76204111|FG000|STARTED|Phase 4:Community Health Worker Outreach||1230||2
60087891|NCT05293392|76204112|FG001|STARTED|Phase 4:Community Health Worker Outreach||2019||2
60087892|NCT05293392|76204111|FG000|COMPLETED|Phase 4:Community Health Worker Outreach||1230||2
60087893|NCT05293392|76204112|FG001|COMPLETED|Phase 4:Community Health Worker Outreach||2019||2
60087894|NCT05293392|76204111|FG000|NOT COMPLETED|Phase 4:Community Health Worker Outreach||0||0
60087895|NCT05293392|76204112|FG001|NOT COMPLETED|Phase 4:Community Health Worker Outreach||0||0
60087896|NCT05082142|76204120|FG000|STARTED|Overall Study||55||
60087897|NCT05082142|76204121|FG001|STARTED|Overall Study||55||
60087898|NCT05082142|76204120|FG000|COMPLETED|Overall Study||55||
59707606|NCT00991276|75826523|FG003|COMPLETED|Placebo Wash-out Period (7 Days)||11||
59707607|NCT00991276|75826524|FG004|COMPLETED|Placebo Wash-out Period (7 Days)||11||
59816762|NCT04090749|75939138|FG002|NOT COMPLETED|Pilot Trial||1||
60087899|NCT05082142|76204121|FG001|COMPLETED|Overall Study||55||
60087900|NCT05082142|76204120|FG000|NOT COMPLETED|Overall Study||0||
60087901|NCT05082142|76204121|FG001|NOT COMPLETED|Overall Study||0||
60087902|NCT05044195|76204129|FG000|STARTED|Overall Study||1027||
60087903|NCT05044195|76204130|FG001|STARTED|Overall Study||1017||
60087904|NCT05044195|76204129|FG000|Received Study Vaccine|Overall Study||1027||
60087905|NCT05044195|76204130|FG001|Received Study Vaccine|Overall Study||1016||
60087906|NCT05044195|76204129|FG000|COMPLETED|Overall Study||982||
60087907|NCT05044195|76204130|FG001|COMPLETED|Overall Study||989||
60087908|NCT05044195|76204129|FG000|NOT COMPLETED|Overall Study||45||
60087909|NCT05044195|76204130|FG001|NOT COMPLETED|Overall Study||28||
60087910|NCT04999839|76204141|FG000|STARTED|Overall Study||52||
60087911|NCT04999839|76204142|FG001|STARTED|Overall Study||50||
60087912|NCT04999839|76204143|FG002|STARTED|Overall Study||52||
60087913|NCT04999839|76204144|FG003|STARTED|Overall Study||53||
60087914|NCT04999839|76204145|FG004|STARTED|Overall Study||52||
60087915|NCT04999839|76204141|FG000|COMPLETED|Overall Study||43||
60087916|NCT04999839|76204142|FG001|COMPLETED|Overall Study||42||
60087917|NCT04999839|76204143|FG002|COMPLETED|Overall Study||45||
60087918|NCT04999839|76204144|FG003|COMPLETED|Overall Study||46||
60087919|NCT04999839|76204145|FG004|COMPLETED|Overall Study||47||
60087920|NCT04999839|76204141|FG000|NOT COMPLETED|Overall Study||9||
60087921|NCT04999839|76204142|FG001|NOT COMPLETED|Overall Study||8||
60087922|NCT04999839|76204143|FG002|NOT COMPLETED|Overall Study||7||
60087923|NCT04999839|76204144|FG003|NOT COMPLETED|Overall Study||7||
60087924|NCT04999839|76204145|FG004|NOT COMPLETED|Overall Study||5||
60087925|NCT04936061|76204164|FG000|STARTED|Overall Study||6||
60087926|NCT04936061|76204165|FG001|STARTED|Overall Study||9||
60087927|NCT04936061|76204166|FG002|STARTED|Overall Study||9||
60087928|NCT04936061|76204164|FG000|COMPLETED|Overall Study||6||
60087929|NCT04936061|76204165|FG001|COMPLETED|Overall Study||9||
60087930|NCT04936061|76204166|FG002|COMPLETED|Overall Study||9||
60087931|NCT04936061|76204164|FG000|NOT COMPLETED|Overall Study||0||
60087932|NCT04936061|76204165|FG001|NOT COMPLETED|Overall Study||0||
60087933|NCT04936061|76204166|FG002|NOT COMPLETED|Overall Study||0||
59707608|NCT00991276|75826525|FG005|COMPLETED|Placebo Wash-out Period (7 Days)||12||
60087934|NCT04792970|76204176|FG000|STARTED|Overall Study||2||
60087935|NCT04792970|76204177|FG001|STARTED|Overall Study||2||
60087936|NCT04792970|76204176|FG000|COMPLETED|Overall Study||1||
60087937|NCT04792970|76204177|FG001|COMPLETED|Overall Study||1||
60087938|NCT04792970|76204176|FG000|NOT COMPLETED|Overall Study||1||
60087939|NCT04792970|76204177|FG001|NOT COMPLETED|Overall Study||1||
59707609|NCT00991276|75826520|FG000|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0||
59707610|NCT00991276|75826521|FG001|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0||
59707611|NCT00991276|75826522|FG002|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0||
59707612|NCT00991276|75826523|FG003|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0||
59707613|NCT00991276|75826524|FG004|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0||
59707614|NCT00991276|75826525|FG005|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0||
59707615|NCT00991276|75826520|FG000|STARTED|Second Intervention Period||15||
59707616|NCT00991276|75826521|FG001|STARTED|Second Intervention Period||10||
60087940|NCT04721808|76204183|FG000|STARTED|Overall Study||1712||
60087941|NCT04721808|76204183|FG000|COMPLETED|Overall Study||1712||
60087942|NCT04721808|76204183|FG000|NOT COMPLETED|Overall Study||0||
60087943|NCT04696146|76204189|FG000|STARTED|Overall Study||21||
60087944|NCT04696146|76204190|FG001|STARTED|Overall Study||24||
59816763|NCT04076059|75939148|FG000|STARTED|Double Blind Phase||120||
59816764|NCT04076059|75939149|FG001|STARTED|Double Blind Phase||60||
59816765|NCT04076059|75939150|FG002|STARTED|Double Blind Phase||0||
59816766|NCT04076059|75939148|FG000|Ongoing Participants|Double Blind Phase||82||
59816767|NCT04076059|75939149|FG001|Ongoing Participants|Double Blind Phase||18||
59816768|NCT04076059|75939150|FG002|Ongoing Participants|Double Blind Phase||0||
59816769|NCT04076059|75939148|FG000|Participants Who Received at Least One Dose of Study Drug|Double Blind Phase||119||
59816770|NCT04076059|75939149|FG001|Participants Who Received at Least One Dose of Study Drug|Double Blind Phase||59||
59992542|NCT02452892|76108374|FG000|STARTED|Week 2 Stratification & Re-Randomization|Week 1 Participants that started LFMS sham (27), LFMS 20min (19), and LFMS 60min (19)|65|Subjects stratified by response & re-randomized to LFMS Sham, LFMS 20min, LFMS 60min, or LFMS 120min|
59992543|NCT02452892|76108375|FG001|STARTED|Week 2 Stratification & Re-Randomization|Week 1 Participants that Started LFMS Sham (0), LFMS 20min (7), and LFMS 60min(0).|7|Subjects stratified by response & re-randomized to LFMS Sham, LFMS 20min, LFMS 60min, or LFMS 120min|
59992544|NCT02452892|76108376|FG002|STARTED|Week 2 Stratification & Re-Randomization|Week 1 Participants that Started LFMS Sham (0),LFMS 20min (0), LFMS 60min (7)|7|Subjects stratified by response & re-randomized to LFMS Sham, LFMS 20min, LFMS 60min, or LFMS 120min|
59992545|NCT02452892|76108377|FG003|STARTED|Week 2 Stratification & Re-Randomization|Week 1 Participants that Started LFMS Sham (13), LFMS 20min (14), and LFMS 60 min (14).|41|Subjects stratified by response & re-randomized to LFMS Sham, LFMS 20min, LFMS 60min, or LFMS 120min|
59992546|NCT02452892|76108374|FG000|Non-reponders|Week 2 Stratification & Re-Randomization||38||
59992547|NCT02452892|76108375|FG001|Non-reponders|Week 2 Stratification & Re-Randomization||0||
59992548|NCT02452892|76108376|FG002|Non-reponders|Week 2 Stratification & Re-Randomization||0||
59992549|NCT02452892|76108377|FG003|Non-reponders|Week 2 Stratification & Re-Randomization||41||
59992550|NCT02452892|76108374|FG000|Responders|Week 2 Stratification & Re-Randomization||27||
59992551|NCT02452892|76108375|FG001|Responders|Week 2 Stratification & Re-Randomization||7||
59992552|NCT02452892|76108376|FG002|Responders|Week 2 Stratification & Re-Randomization||7||
59992553|NCT02452892|76108377|FG003|Responders|Week 2 Stratification & Re-Randomization||0||
59992554|NCT02452892|76108374|FG000|COMPLETED|Week 2 Stratification & Re-Randomization||63||
59992555|NCT02452892|76108375|FG001|COMPLETED|Week 2 Stratification & Re-Randomization||7||
59992556|NCT02452892|76108376|FG002|COMPLETED|Week 2 Stratification & Re-Randomization||7||
59992557|NCT02452892|76108377|FG003|COMPLETED|Week 2 Stratification & Re-Randomization||39||
59992558|NCT02452892|76108374|FG000|NOT COMPLETED|Week 2 Stratification & Re-Randomization||2||
59992559|NCT02452892|76108375|FG001|NOT COMPLETED|Week 2 Stratification & Re-Randomization||0||
59992560|NCT02452892|76108376|FG002|NOT COMPLETED|Week 2 Stratification & Re-Randomization||0||
59992561|NCT02452892|76108377|FG003|NOT COMPLETED|Week 2 Stratification & Re-Randomization||2||
59992562|NCT02452892|76108374|FG000|STARTED|Follow-up||63||
59992563|NCT02452892|76108375|FG001|STARTED|Follow-up||7||
59992564|NCT02452892|76108376|FG002|STARTED|Follow-up||7||
59992565|NCT02452892|76108377|FG003|STARTED|Follow-up||39||
59992566|NCT02452892|76108374|FG000|COMPLETED|Follow-up||62||
59992567|NCT02452892|76108375|FG001|COMPLETED|Follow-up||7||
59560557|NCT01650584|75661868|FG000|STARTED|Overall Study|Each participant received one of 2 treatments in each eye.|35||70
59560558|NCT01650584|75661868|FG000|COMPLETED|Overall Study||35||70
59560559|NCT01650584|75661868|FG000|NOT COMPLETED|Overall Study||0||0
59560560|NCT01651442|75661875|FG000|STARTED|Phase I Treatment||104||
59560561|NCT01651442|75661876|FG001|STARTED|Phase I Treatment||107||
59560562|NCT01651442|75661877|FG002|STARTED|Phase I Treatment||0||
59560563|NCT01651442|75661878|FG003|STARTED|Phase I Treatment||0||
59560564|NCT01651442|75661879|FG004|STARTED|Phase I Treatment||0||
59560565|NCT01651442|75661880|FG005|STARTED|Phase I Treatment||0||
59560566|NCT01651442|75661875|FG000|COMPLETED|Phase I Treatment||88||
59560567|NCT01651442|75661876|FG001|COMPLETED|Phase I Treatment||80||
59560568|NCT01651442|75661877|FG002|COMPLETED|Phase I Treatment||0||
59560569|NCT01651442|75661878|FG003|COMPLETED|Phase I Treatment||0||
59560570|NCT01651442|75661879|FG004|COMPLETED|Phase I Treatment||0||
59560571|NCT01651442|75661880|FG005|COMPLETED|Phase I Treatment||0||
59560572|NCT01651442|75661875|FG000|NOT COMPLETED|Phase I Treatment||16||
59560573|NCT01651442|75661876|FG001|NOT COMPLETED|Phase I Treatment||27||
59560574|NCT01651442|75661877|FG002|NOT COMPLETED|Phase I Treatment||0||
59560575|NCT01651442|75661878|FG003|NOT COMPLETED|Phase I Treatment||0||
59560576|NCT01651442|75661879|FG004|NOT COMPLETED|Phase I Treatment||0||
59560577|NCT01651442|75661880|FG005|NOT COMPLETED|Phase I Treatment||0||
59560578|NCT01651442|75661875|FG000|STARTED|Phase II Treatment||0||
59560579|NCT01651442|75661876|FG001|STARTED|Phase II Treatment||0||
59560580|NCT01651442|75661877|FG002|STARTED|Phase II Treatment||27||
59560581|NCT01651442|75661878|FG003|STARTED|Phase II Treatment||27||
59560582|NCT01651442|75661879|FG004|STARTED|Phase II Treatment||27||
59560583|NCT01651442|75661880|FG005|STARTED|Phase II Treatment||27||
59560584|NCT01651442|75661875|FG000|COMPLETED|Phase II Treatment||0||
59992568|NCT02452892|76108376|FG002|COMPLETED|Follow-up||7||
59992569|NCT02452892|76108377|FG003|COMPLETED|Follow-up||38||
59992570|NCT02452892|76108374|FG000|NOT COMPLETED|Follow-up||1||
59992571|NCT02452892|76108375|FG001|NOT COMPLETED|Follow-up||0||
59992572|NCT02452892|76108376|FG002|NOT COMPLETED|Follow-up||0||
59992573|NCT02452892|76108377|FG003|NOT COMPLETED|Follow-up||1||
59992574|NCT02135848|76108392|FG000|STARTED|Overall Study||26||
59992575|NCT02135848|76108393|FG001|STARTED|Overall Study||20||
59992576|NCT02135848|76108392|FG000|COMPLETED|Overall Study||23||
59992577|NCT02135848|76108393|FG001|COMPLETED|Overall Study||19||
59992578|NCT02135848|76108392|FG000|NOT COMPLETED|Overall Study||3||
59992579|NCT02135848|76108393|FG001|NOT COMPLETED|Overall Study||1||
59992580|NCT02568449|76108406|FG000|STARTED|Overall Study||20||
59992581|NCT02568449|76108406|FG000|COMPLETED|Overall Study||20||
59992582|NCT02568449|76108406|FG000|NOT COMPLETED|Overall Study||0||
59992583|NCT02738333|76108413|FG000|STARTED|Overall Study||106||
59992584|NCT02738333|76108414|FG001|STARTED|Overall Study||108||
59992585|NCT02738333|76108415|FG002|STARTED|Overall Study||25||
59992586|NCT02738333|76108413|FG000|COMPLETED|Overall Study||104||
59992587|NCT02738333|76108414|FG001|COMPLETED|Overall Study||108||
59992588|NCT02738333|76108415|FG002|COMPLETED|Overall Study||25||
59992589|NCT02738333|76108413|FG000|NOT COMPLETED|Overall Study||2||
59992590|NCT02738333|76108414|FG001|NOT COMPLETED|Overall Study||0||
59992591|NCT02738333|76108415|FG002|NOT COMPLETED|Overall Study||0||
59992592|NCT02135692|76108423|FG000|STARTED|Overall Study||339||
59992593|NCT02135692|76108423|FG000|COMPLETED|Overall Study||0||
59992594|NCT02135692|76108423|FG000|NOT COMPLETED|Overall Study||339||
59992595|NCT02429414|76108429|FG000|STARTED|Overall Study||42||
59992596|NCT02429414|76108430|FG001|STARTED|Overall Study||38||
59560585|NCT01651442|75661876|FG001|COMPLETED|Phase II Treatment||0||
59560586|NCT01651442|75661877|FG002|COMPLETED|Phase II Treatment||25||
59560587|NCT01651442|75661878|FG003|COMPLETED|Phase II Treatment||15||
59560588|NCT01651442|75661879|FG004|COMPLETED|Phase II Treatment||21||
59992597|NCT02429414|76108429|FG000|COMPLETED|Overall Study||42||
59992598|NCT02429414|76108430|FG001|COMPLETED|Overall Study||37||
59992599|NCT02429414|76108429|FG000|NOT COMPLETED|Overall Study||0||
59992600|NCT02429414|76108430|FG001|NOT COMPLETED|Overall Study||1||
59992601|NCT02135614|76108438|FG000|STARTED|Overall Study||94||
59992602|NCT02135614|76108439|FG001|STARTED|Overall Study||95||
59992603|NCT02135614|76108438|FG000|COMPLETED|Overall Study||86||
59992604|NCT02135614|76108439|FG001|COMPLETED|Overall Study||90||
59992605|NCT02135614|76108438|FG000|NOT COMPLETED|Overall Study||8||
59992606|NCT02135614|76108439|FG001|NOT COMPLETED|Overall Study||5||
59992607|NCT02168842|76108447|FG000|STARTED|Overall Study||170||
59992608|NCT02168842|76108448|FG001|STARTED|Overall Study||166||
59560589|NCT01651442|75661880|FG005|COMPLETED|Phase II Treatment||17||
59560590|NCT01651442|75661875|FG000|NOT COMPLETED|Phase II Treatment||0||
59560591|NCT01651442|75661876|FG001|NOT COMPLETED|Phase II Treatment||0||
59560592|NCT01651442|75661877|FG002|NOT COMPLETED|Phase II Treatment||2||
59560593|NCT01651442|75661878|FG003|NOT COMPLETED|Phase II Treatment||12||
59560594|NCT01651442|75661879|FG004|NOT COMPLETED|Phase II Treatment||6||
59560595|NCT01651442|75661880|FG005|NOT COMPLETED|Phase II Treatment||10||
59560596|NCT01654796|75661895|FG000|STARTED|Overall Study||26||
59560597|NCT01654796|75661896|FG001|STARTED|Overall Study||29||
59560598|NCT01654796|75661897|FG002|STARTED|Overall Study||29||
59560599|NCT01654796|75661895|FG000|COMPLETED|Overall Study||25||
59560600|NCT01654796|75661896|FG001|COMPLETED|Overall Study||26||
59560601|NCT01654796|75661897|FG002|COMPLETED|Overall Study||28||
59560602|NCT01654796|75661895|FG000|NOT COMPLETED|Overall Study||1||
59560603|NCT01654796|75661896|FG001|NOT COMPLETED|Overall Study||3||
59560604|NCT01654796|75661897|FG002|NOT COMPLETED|Overall Study||1||
59560605|NCT01602120|75661910|FG000|STARTED|Overall Study||29||
59560606|NCT01602120|75661911|FG001|STARTED|Overall Study||60||
59560607|NCT01602120|75661912|FG002|STARTED|Overall Study||17||
59560608|NCT01602120|75661913|FG003|STARTED|Overall Study||53||
59560609|NCT01602120|75661910|FG000|COMPLETED|Overall Study||0||
59560610|NCT01602120|75661911|FG001|COMPLETED|Overall Study||0||
59560611|NCT01602120|75661912|FG002|COMPLETED|Overall Study||0||
59560612|NCT01602120|75661913|FG003|COMPLETED|Overall Study||0||
59560613|NCT01602120|75661910|FG000|NOT COMPLETED|Overall Study||29||
59560614|NCT01602120|75661911|FG001|NOT COMPLETED|Overall Study||60||
59560615|NCT01602120|75661912|FG002|NOT COMPLETED|Overall Study||17||
59560616|NCT01602120|75661913|FG003|NOT COMPLETED|Overall Study||53||
59560617|NCT01658228|75661927|FG000|STARTED|Overall Study||30||
59560618|NCT01658228|75661928|FG001|STARTED|Overall Study||31||
59560619|NCT01658228|75661927|FG000|COMPLETED|Overall Study||23||
59560620|NCT01658228|75661928|FG001|COMPLETED|Overall Study||23||
59560621|NCT01658228|75661927|FG000|NOT COMPLETED|Overall Study||7||
59560622|NCT01658228|75661928|FG001|NOT COMPLETED|Overall Study||8||
60087945|NCT04696146|76204189|FG000|COMPLETED|Overall Study||20||
60087946|NCT04696146|76204190|FG001|COMPLETED|Overall Study||20||
60087947|NCT04696146|76204189|FG000|NOT COMPLETED|Overall Study||1||
60087948|NCT04696146|76204190|FG001|NOT COMPLETED|Overall Study||4||
60087949|NCT04658940|76204196|FG000|STARTED|Overall Study||115||
60087950|NCT04658940|76204196|FG000|COMPLETED|Overall Study||114||
60087951|NCT04658940|76204196|FG000|NOT COMPLETED|Overall Study||1||
60087952|NCT04629066|76204202|FG000|STARTED|Overall Study||7||
60087953|NCT04629066|76204203|FG001|STARTED|Overall Study||6||
60087954|NCT04629066|76204202|FG000|COMPLETED|Overall Study||4||
60087955|NCT04629066|76204203|FG001|COMPLETED|Overall Study||4||
60087956|NCT04629066|76204202|FG000|NOT COMPLETED|Overall Study||3||
60087957|NCT04629066|76204203|FG001|NOT COMPLETED|Overall Study||2||
60087958|NCT04598269|76204211|FG000|STARTED|Overall Study||25||
60087959|NCT04598269|76204212|FG001|STARTED|Overall Study||25||
60087960|NCT04598269|76204211|FG000|Received at Least 1 Dose of Study Drug|Overall Study||23||
60087961|NCT04598269|76204212|FG001|Received at Least 1 Dose of Study Drug|Overall Study||25||
60087962|NCT04598269|76204211|FG000|COMPLETED|Overall Study||21||
60087963|NCT04598269|76204212|FG001|COMPLETED|Overall Study||18||
60087964|NCT04598269|76204211|FG000|NOT COMPLETED|Overall Study||4||
60087965|NCT04598269|76204212|FG001|NOT COMPLETED|Overall Study||7||
60087966|NCT04591015|76204220|FG000|STARTED|Overall Study||86||
60087967|NCT04591015|76204221|FG001|STARTED|Overall Study||86||
60087968|NCT04591015|76204220|FG000|COMPLETED|Overall Study||58||
60087969|NCT04591015|76204221|FG001|COMPLETED|Overall Study||68||
60087970|NCT04591015|76204220|FG000|NOT COMPLETED|Overall Study||28||
60087971|NCT04591015|76204221|FG001|NOT COMPLETED|Overall Study||18||
60087972|NCT04566692|76204229|FG000|STARTED|Overall Study||27||
60087973|NCT04566692|76204230|FG001|STARTED|Overall Study||6||
60087974|NCT04566692|76204229|FG000|Safety Population|Overall Study||27|Safety population included all participants who received at least 1 dose of IGSC 20%.|
60087975|NCT04566692|76204230|FG001|Safety Population|Overall Study||6|Safety population included all participants who received at least 1 dose of IGSC 20%.|
60087976|NCT04566692|76204229|FG000|Efficacy Evaluable Population|Overall Study||27|Efficacy evaluable population included all participants who received at least 1 dose of IGSC 20%.|
60087977|NCT04566692|76204230|FG001|Efficacy Evaluable Population|Overall Study||6|Efficacy evaluable population included all participants who received at least 1 dose of IGSC 20%.|
60087978|NCT04566692|76204229|FG000|IgG Population|Overall Study||27|IgG population included all participants who received at least 1 dose of IGSC 20%.|
60103722|NCT04778059|76221989|FG004|STARTED|Overall Study||10||
59560623|NCT01659866|75661936|FG000|STARTED|Overall Study||430||
59707617|NCT00991276|75826522|FG002|STARTED|Second Intervention Period||14||
59560624|NCT01659866|75661937|FG001|STARTED|Overall Study||80||
59560625|NCT01659866|75661936|FG000|COMPLETED|Overall Study||430||
59560626|NCT01659866|75661937|FG001|COMPLETED|Overall Study||80||
59560627|NCT01659866|75661936|FG000|NOT COMPLETED|Overall Study||0||
59560628|NCT01659866|75661937|FG001|NOT COMPLETED|Overall Study||0||
59560629|NCT01660802|75661945|FG000|STARTED|Overall Study||130||
59560630|NCT01660802|75661946|FG001|STARTED|Overall Study||132||
59560631|NCT01660802|75661945|FG000|COMPLETED|Overall Study||126||
59560632|NCT01660802|75661946|FG001|COMPLETED|Overall Study||121||
59560633|NCT01660802|75661945|FG000|NOT COMPLETED|Overall Study||4||
59560634|NCT01660802|75661946|FG001|NOT COMPLETED|Overall Study||11||
59560635|NCT02296853|75661954|FG000|STARTED|Overall Study||10||
59560636|NCT02296853|75661955|FG001|STARTED|Overall Study||10||
60087979|NCT04566692|76204230|FG001|IgG Population|Overall Study||6|IgG population included all participants who received at least 1 dose of IGSC 20%.|
60087980|NCT04566692|76204229|FG000|Pharmacokinetic (PK) Population|Overall Study||25|PK population included all the participants who had sufficient PK concentration data to have at least one of the PK parameters: area under the concentration time curve (AUC) (0-7 days), maximum concentration (Cmax), or time to reach Cmax (Tmax).|
60087981|NCT04566692|76204230|FG001|Pharmacokinetic (PK) Population|Overall Study||0|PK population included all the participants who had sufficient PK concentration data to have at least one of the PK parameters: area under the concentration time curve (AUC) (0-7 days), maximum concentration (Cmax), or time to reach Cmax (Tmax).|
60087982|NCT04566692|76204229|FG000|COMPLETED|Overall Study||24||
60087983|NCT04566692|76204230|FG001|COMPLETED|Overall Study||5||
60087984|NCT04566692|76204229|FG000|NOT COMPLETED|Overall Study||3||
60087985|NCT04566692|76204230|FG001|NOT COMPLETED|Overall Study||1||
60087986|NCT04533412|76204245|FG000|STARTED|Overall Study||30||
60087987|NCT04533412|76204246|FG001|STARTED|Overall Study||29||
60087988|NCT04533412|76204245|FG000|COMPLETED|Overall Study||28||
60087989|NCT04533412|76204246|FG001|COMPLETED|Overall Study||24||
60087990|NCT04533412|76204245|FG000|NOT COMPLETED|Overall Study||2||
60087991|NCT04533412|76204246|FG001|NOT COMPLETED|Overall Study||5||
60087992|NCT04515147|76204258|FG000|STARTED|Overall Study||12||
60087993|NCT04515147|76204259|FG001|STARTED|Overall Study||11||
60087994|NCT04515147|76204260|FG002|STARTED|Overall Study||289||
59560637|NCT02296853|75661954|FG000|COMPLETED|Overall Study||10||
59560638|NCT02296853|75661955|FG001|COMPLETED|Overall Study||10||
59560639|NCT02296853|75661954|FG000|NOT COMPLETED|Overall Study||0||
59560640|NCT02296853|75661955|FG001|NOT COMPLETED|Overall Study||0||
59560641|NCT01661114|75661961|FG000|STARTED|Overall Study||39||
59560642|NCT01661114|75661961|FG000|COMPLETED|Overall Study||39||
59560643|NCT01661114|75661961|FG000|NOT COMPLETED|Overall Study||0||
59560644|NCT02683265|75661967|FG000|STARTED|Open-label Treatment Phase||119||
59560645|NCT02683265|75661968|FG001|STARTED|Open-label Treatment Phase||0||
60087995|NCT04515147|76204261|FG003|STARTED|Overall Study||295||
60087996|NCT04515147|76204262|FG004|STARTED|Overall Study||31||
60087997|NCT04515147|76204263|FG005|STARTED|Overall Study||30||
60087998|NCT04515147|76204258|FG000|COMPLETED|Overall Study||11||
60087999|NCT04515147|76204259|FG001|COMPLETED|Overall Study||10||
60088000|NCT04515147|76204260|FG002|COMPLETED|Overall Study||274||
60088001|NCT04515147|76204261|FG003|COMPLETED|Overall Study||268||
60088002|NCT04515147|76204262|FG004|COMPLETED|Overall Study||28||
60088003|NCT04515147|76204263|FG005|COMPLETED|Overall Study||20||
60088004|NCT04515147|76204258|FG000|NOT COMPLETED|Overall Study||1||
60088005|NCT04515147|76204259|FG001|NOT COMPLETED|Overall Study||1||
60088006|NCT04515147|76204260|FG002|NOT COMPLETED|Overall Study||15||
60088007|NCT04515147|76204261|FG003|NOT COMPLETED|Overall Study||27||
60088008|NCT04515147|76204262|FG004|NOT COMPLETED|Overall Study||3||
59560646|NCT02683265|75661969|FG002|STARTED|Open-label Treatment Phase||0||
59560647|NCT02683265|75661967|FG000|COMPLETED|Open-label Treatment Phase||90|The number who completed the Open-label Treatment Phase were randomized to 1 of 2 groups in the Double-blind Treatment Phase.|
59565961|NCT02303574|75668411|FG006|NOT COMPLETED|Part 1a (Fasted State)- SAD||0||
59565962|NCT02303574|75668412|FG007|NOT COMPLETED|Part 1a (Fasted State)- SAD||0||
59992609|NCT02168842|76108447|FG000|COMPLETED|Overall Study||162||
59992610|NCT02168842|76108448|FG001|COMPLETED|Overall Study||158||
59992611|NCT02168842|76108447|FG000|NOT COMPLETED|Overall Study||8||
59992612|NCT02168842|76108448|FG001|NOT COMPLETED|Overall Study||8||
59992613|NCT02200042|76108458|FG000|STARTED|Overall Study||0||
59992614|NCT02200042|76108459|FG001|STARTED|Overall Study||1||
59992615|NCT02200042|76108458|FG000|COMPLETED|Overall Study||0||
60088009|NCT04515147|76204263|FG005|NOT COMPLETED|Overall Study||10||
60088010|NCT04479618|76204285|FG000|STARTED|Overall Study||18||
60088011|NCT04479618|76204286|FG001|STARTED|Overall Study||14||
60088012|NCT04479618|76204287|FG002|STARTED|Overall Study||16||
60088013|NCT04479618|76204285|FG000|COMPLETED|Overall Study||16||
60088014|NCT04479618|76204286|FG001|COMPLETED|Overall Study||13||
60088015|NCT04479618|76204287|FG002|COMPLETED|Overall Study||11||
60088016|NCT04479618|76204285|FG000|NOT COMPLETED|Overall Study||2||
60088017|NCT04479618|76204286|FG001|NOT COMPLETED|Overall Study||1||
60088018|NCT04479618|76204287|FG002|NOT COMPLETED|Overall Study||5||
60088019|NCT04476043|76204302|FG000|STARTED|Overall Study||52||
60088020|NCT04476043|76204303|FG001|STARTED|Overall Study||52||
59992616|NCT02200042|76108459|FG001|COMPLETED|Overall Study||0||
59992617|NCT02200042|76108458|FG000|NOT COMPLETED|Overall Study||0||
59992618|NCT02200042|76108459|FG001|NOT COMPLETED|Overall Study||1||
59992619|NCT02199028|76108467|FG000|STARTED|Week 1||15||
60088021|NCT04476043|76204304|FG002|STARTED|Overall Study||52||
60088022|NCT04476043|76204305|FG003|STARTED|Overall Study||53||
60088023|NCT04476043|76204302|FG000|COMPLETED|Overall Study||48||
60088024|NCT04476043|76204303|FG001|COMPLETED|Overall Study||47||
60088025|NCT04476043|76204304|FG002|COMPLETED|Overall Study||45||
60088026|NCT04476043|76204305|FG003|COMPLETED|Overall Study||51||
60088027|NCT04476043|76204302|FG000|NOT COMPLETED|Overall Study||4||
60088028|NCT04476043|76204303|FG001|NOT COMPLETED|Overall Study||5||
60088029|NCT04476043|76204304|FG002|NOT COMPLETED|Overall Study||7||
60088030|NCT04476043|76204305|FG003|NOT COMPLETED|Overall Study||2||
60088031|NCT04418765|76204318|FG000|STARTED|Placebo-controlled Period (24 Weeks)||299||
60088032|NCT04418765|76204319|FG001|STARTED|Placebo-controlled Period (24 Weeks)||299||
59992620|NCT02199028|76108468|FG001|STARTED|Week 1||15||
59992621|NCT02199028|76108467|FG000|COMPLETED|Week 1||14||
59992622|NCT02199028|76108468|FG001|COMPLETED|Week 1||15||
59992623|NCT02199028|76108467|FG000|NOT COMPLETED|Week 1||1||
60088033|NCT04418765|76204320|FG002|STARTED|Placebo-controlled Period (24 Weeks)||294||
60103723|NCT04778059|76221985|FG000|COMPLETED|Overall Study||1||
60103724|NCT04778059|76221986|FG001|COMPLETED|Overall Study||1||
60103725|NCT04778059|76221987|FG002|COMPLETED|Overall Study||2||
60103726|NCT04778059|76221988|FG003|COMPLETED|Overall Study||1||
60103727|NCT04778059|76221989|FG004|COMPLETED|Overall Study||7||
60103728|NCT04778059|76221985|FG000|NOT COMPLETED|Overall Study||2||
60103729|NCT04778059|76221986|FG001|NOT COMPLETED|Overall Study||2||
60103730|NCT04778059|76221987|FG002|NOT COMPLETED|Overall Study||1||
60103731|NCT04778059|76221988|FG003|NOT COMPLETED|Overall Study||1||
60103732|NCT04778059|76221989|FG004|NOT COMPLETED|Overall Study||3||
60088034|NCT04418765|76204318|FG000|Received at Least 1 Dose of Study Drug|Placebo-controlled Period (24 Weeks)||298||
60088035|NCT04418765|76204319|FG001|Received at Least 1 Dose of Study Drug|Placebo-controlled Period (24 Weeks)||299||
60088036|NCT04418765|76204320|FG002|Received at Least 1 Dose of Study Drug|Placebo-controlled Period (24 Weeks)||294||
60088037|NCT04418765|76204318|FG000|COMPLETED|Placebo-controlled Period (24 Weeks)||293||
60088038|NCT04418765|76204319|FG001|COMPLETED|Placebo-controlled Period (24 Weeks)||288||
60088039|NCT04418765|76204320|FG002|COMPLETED|Placebo-controlled Period (24 Weeks)||284||
60088040|NCT04418765|76204318|FG000|NOT COMPLETED|Placebo-controlled Period (24 Weeks)||6||
60088041|NCT04418765|76204319|FG001|NOT COMPLETED|Placebo-controlled Period (24 Weeks)||11||
60088042|NCT04418765|76204320|FG002|NOT COMPLETED|Placebo-controlled Period (24 Weeks)||10||
60088043|NCT04418765|76204318|FG000|STARTED|Extension Period (48 Weeks)||0||
60088044|NCT04418765|76204319|FG001|STARTED|Extension Period (48 Weeks)|145 participants assigned to placebo in the Placebo-controlled Period were randomized to eptinezumab 100 mg.|433||
60088045|NCT04418765|76204320|FG002|STARTED|Extension Period (48 Weeks)|148 participants assigned to placebo in the Placebo-controlled Period were randomized to eptinezumab 300 mg.|432||
60088046|NCT04418765|76204318|FG000|Received at Least 1 Dose of Study Drug|Extension Period (48 Weeks)||0||
60088047|NCT04418765|76204319|FG001|Received at Least 1 Dose of Study Drug|Extension Period (48 Weeks)||433||
60088048|NCT04418765|76204320|FG002|Received at Least 1 Dose of Study Drug|Extension Period (48 Weeks)||432||
60088049|NCT04418765|76204318|FG000|COMPLETED|Extension Period (48 Weeks)||0||
60088050|NCT04418765|76204319|FG001|COMPLETED|Extension Period (48 Weeks)||392||
60088051|NCT04418765|76204320|FG002|COMPLETED|Extension Period (48 Weeks)||390||
60088052|NCT04418765|76204318|FG000|NOT COMPLETED|Extension Period (48 Weeks)||0||
60088053|NCT04418765|76204319|FG001|NOT COMPLETED|Extension Period (48 Weeks)||41||
60088054|NCT04418765|76204320|FG002|NOT COMPLETED|Extension Period (48 Weeks)||42||
60088055|NCT04266795|76204338|FG000|STARTED|Overall Study||81||
60088056|NCT04266795|76204339|FG001|STARTED|Overall Study||83||
60088057|NCT04266795|76204338|FG000|Safety Population|Overall Study||80|Safety population was defined as all participants who received at least 1 dose of any of the study medications (pevonedistat, venetoclax, or azacitidine).|
60088058|NCT04266795|76204339|FG001|Safety Population|Overall Study||81|Safety population was defined as all participants who received at least 1 dose of any of the study medications (pevonedistat, venetoclax, or azacitidine).|
60088059|NCT04266795|76204338|FG000|COMPLETED|Overall Study||0||
60088060|NCT04266795|76204339|FG001|COMPLETED|Overall Study||0||
60088061|NCT04266795|76204338|FG000|NOT COMPLETED|Overall Study||81||
60088062|NCT04266795|76204339|FG001|NOT COMPLETED|Overall Study||83||
60088063|NCT04212169|76204349|FG000|STARTED|Overall Study||56||
60088064|NCT04212169|76204350|FG001|STARTED|Overall Study||19||
60088065|NCT04212169|76204351|FG002|STARTED|Overall Study||18||
60088066|NCT04212169|76204352|FG003|STARTED|Overall Study||55||
60088067|NCT04212169|76204349|FG000|COMPLETED|Overall Study||42||
60088068|NCT04212169|76204350|FG001|COMPLETED|Overall Study||16||
60088069|NCT04212169|76204351|FG002|COMPLETED|Overall Study||13||
60088070|NCT04212169|76204352|FG003|COMPLETED|Overall Study||42||
59992624|NCT02199028|76108468|FG001|NOT COMPLETED|Week 1||0||
59992625|NCT02199028|76108467|FG000|STARTED|Week 2||14||
59992626|NCT02199028|76108468|FG001|STARTED|Week 2||15||
59992627|NCT02199028|76108467|FG000|COMPLETED|Week 2||14||
59992628|NCT02199028|76108468|FG001|COMPLETED|Week 2||15||
60088071|NCT04212169|76204349|FG000|NOT COMPLETED|Overall Study||14||
60088072|NCT04212169|76204350|FG001|NOT COMPLETED|Overall Study||3||
60088073|NCT04212169|76204351|FG002|NOT COMPLETED|Overall Study||5||
60088074|NCT04212169|76204352|FG003|NOT COMPLETED|Overall Study||13||
60088075|NCT04205643|76204368|FG000|STARTED|Induction Phase||548||
60088076|NCT04205643|76204369|FG001|STARTED|Induction Phase||0||
60088077|NCT04205643|76204370|FG002|STARTED|Induction Phase||0||
60088078|NCT04205643|76204368|FG000|COMPLETED|Induction Phase||438||
60088079|NCT04205643|76204369|FG001|COMPLETED|Induction Phase||0||
60088080|NCT04205643|76204370|FG002|COMPLETED|Induction Phase||0||
60088081|NCT04205643|76204368|FG000|NOT COMPLETED|Induction Phase||110||
60088082|NCT04205643|76204369|FG001|NOT COMPLETED|Induction Phase||0||
59707618|NCT00991276|75826523|FG003|STARTED|Second Intervention Period||11||
59707619|NCT00991276|75826524|FG004|STARTED|Second Intervention Period||11||
59707620|NCT00991276|75826525|FG005|STARTED|Second Intervention Period||12||
59707621|NCT00991276|75826520|FG000|COMPLETED|Second Intervention Period||14||
59707622|NCT00991276|75826521|FG001|COMPLETED|Second Intervention Period||8||
59992629|NCT02199028|76108467|FG000|NOT COMPLETED|Week 2||0||
59992630|NCT02199028|76108468|FG001|NOT COMPLETED|Week 2||0||
59992631|NCT02199028|76108467|FG000|STARTED|Week 3||14||
59992632|NCT02199028|76108468|FG001|STARTED|Week 3||15||
59707623|NCT00991276|75826522|FG002|COMPLETED|Second Intervention Period||14||
59707624|NCT00991276|75826523|FG003|COMPLETED|Second Intervention Period||9||
59707625|NCT00991276|75826524|FG004|COMPLETED|Second Intervention Period||10||
59707626|NCT00991276|75826525|FG005|COMPLETED|Second Intervention Period||11||
59707627|NCT00991276|75826520|FG000|NOT COMPLETED|Second Intervention Period||1||
59992633|NCT02199028|76108467|FG000|COMPLETED|Week 3||13||
59992634|NCT02199028|76108468|FG001|COMPLETED|Week 3||15||
59992635|NCT02199028|76108467|FG000|NOT COMPLETED|Week 3||1||
59992636|NCT02199028|76108468|FG001|NOT COMPLETED|Week 3||0||
59992637|NCT02199028|76108467|FG000|STARTED|Week 4||13||
59992638|NCT02199028|76108468|FG001|STARTED|Week 4||15||
60088083|NCT04205643|76204370|FG002|NOT COMPLETED|Induction Phase||0||
60088084|NCT04205643|76204368|FG000|STARTED|Maintenance Phase||0||
60088085|NCT04205643|76204369|FG001|STARTED|Maintenance Phase||294||
60088086|NCT04205643|76204370|FG002|STARTED|Maintenance Phase||144||
60088087|NCT04205643|76204368|FG000|COMPLETED|Maintenance Phase||0||
60088088|NCT04205643|76204369|FG001|COMPLETED|Maintenance Phase||240||
60088089|NCT04205643|76204370|FG002|COMPLETED|Maintenance Phase||113||
60088090|NCT04205643|76204368|FG000|NOT COMPLETED|Maintenance Phase||0||
60088091|NCT04205643|76204369|FG001|NOT COMPLETED|Maintenance Phase||54||
60088092|NCT04205643|76204370|FG002|NOT COMPLETED|Maintenance Phase||31||
60088093|NCT04169282|76204377|FG000|STARTED|Overall Study||10||
60088094|NCT04169282|76204377|FG000|COMPLETED|Overall Study||9||
60088095|NCT04169282|76204377|FG000|NOT COMPLETED|Overall Study||1||
60088096|NCT04109313|76204381|FG000|STARTED|Overall Study||229||
60088097|NCT04109313|76204381|FG000|Treatment-free Cohort|Overall Study||68|Participants with UAS7<16 at Week 16 of CLOU064A2201 were followed up to 12 weeks without receiving treatment (observational period). If participants relapsed (UAS7≥16 at least once), they were transitioned to the treatment period. Otherwise, the|
60088098|NCT04109313|76204381|FG000|Treatment Cohort|Overall Study||194|Participants with a UAS7≥16 at Week 12 or Week 16 in the CLOU064A2201, as well as participants who experienced a relapse during the 12-week observational period, were administered 100 mg of LOU064 b.i.d. open-label for up to 52 weeks.|
60088099|NCT04109313|76204381|FG000|COMPLETED|Overall Study||188||
60088100|NCT04109313|76204381|FG000|NOT COMPLETED|Overall Study||41||
60088101|NCT04089865|76204390|FG000|STARTED|Overall Study||100||
60088102|NCT04089865|76204391|FG001|STARTED|Overall Study||100||
60088103|NCT04089865|76204392|FG002|STARTED|Overall Study||100||
60088104|NCT04089865|76204393|FG003|STARTED|Overall Study||100||
60088105|NCT04089865|76204390|FG000|COMPLETED|Overall Study||98||
60088106|NCT04089865|76204391|FG001|COMPLETED|Overall Study||98||
60088107|NCT04089865|76204392|FG002|COMPLETED|Overall Study||93||
60088108|NCT04089865|76204393|FG003|COMPLETED|Overall Study||98||
60088109|NCT04089865|76204390|FG000|NOT COMPLETED|Overall Study||2||
60088110|NCT04089865|76204391|FG001|NOT COMPLETED|Overall Study||2||
60088111|NCT04089865|76204392|FG002|NOT COMPLETED|Overall Study||7||
60088112|NCT04089865|76204393|FG003|NOT COMPLETED|Overall Study||2||
60088113|NCT04029129|76204406|FG000|STARTED|First Intervention (2 Hours)||30||
60088114|NCT04029129|76204407|FG001|STARTED|First Intervention (2 Hours)||28||
60088115|NCT04029129|76204408|FG002|STARTED|First Intervention (2 Hours)||19||
60088116|NCT04029129|76204406|FG000|COMPLETED|First Intervention (2 Hours)||30||
60088117|NCT04029129|76204407|FG001|COMPLETED|First Intervention (2 Hours)||28||
60088118|NCT04029129|76204408|FG002|COMPLETED|First Intervention (2 Hours)||19||
60088119|NCT04029129|76204406|FG000|NOT COMPLETED|First Intervention (2 Hours)||0||
60088120|NCT04029129|76204407|FG001|NOT COMPLETED|First Intervention (2 Hours)||0||
60088121|NCT04029129|76204408|FG002|NOT COMPLETED|First Intervention (2 Hours)||0||
60088122|NCT04029129|76204406|FG000|STARTED|Wash Out (1 Week)||30||
60088123|NCT04029129|76204407|FG001|STARTED|Wash Out (1 Week)||28||
60088124|NCT04029129|76204408|FG002|STARTED|Wash Out (1 Week)||19||
60088125|NCT04029129|76204406|FG000|COMPLETED|Wash Out (1 Week)||30||
60088126|NCT04029129|76204407|FG001|COMPLETED|Wash Out (1 Week)||28||
60088127|NCT04029129|76204408|FG002|COMPLETED|Wash Out (1 Week)||19||
60088128|NCT04029129|76204406|FG000|NOT COMPLETED|Wash Out (1 Week)||0||
60088129|NCT04029129|76204407|FG001|NOT COMPLETED|Wash Out (1 Week)||0||
60088130|NCT04029129|76204408|FG002|NOT COMPLETED|Wash Out (1 Week)||0||
60088131|NCT04029129|76204406|FG000|STARTED|Third Intervention (2 Hours)||30||
60088132|NCT04029129|76204407|FG001|STARTED|Third Intervention (2 Hours)||28||
60088133|NCT04029129|76204408|FG002|STARTED|Third Intervention (2 Hours)||19||
60088134|NCT04029129|76204406|FG000|COMPLETED|Third Intervention (2 Hours)||30||
60088135|NCT04029129|76204407|FG001|COMPLETED|Third Intervention (2 Hours)||28||
60088136|NCT04029129|76204408|FG002|COMPLETED|Third Intervention (2 Hours)||19||
60088137|NCT04029129|76204406|FG000|NOT COMPLETED|Third Intervention (2 Hours)||0||
60088138|NCT04029129|76204407|FG001|NOT COMPLETED|Third Intervention (2 Hours)||0||
60088139|NCT04029129|76204408|FG002|NOT COMPLETED|Third Intervention (2 Hours)||0||
60088140|NCT04017832|76204421|FG000|STARTED|Overall Study||361||
60088141|NCT04017832|76204422|FG001|STARTED|Overall Study||360||
60088142|NCT04017832|76204423|FG002|STARTED|Overall Study||361||
60088143|NCT04017832|76204424|FG003|STARTED|Overall Study||359||
60088144|NCT04017832|76204421|FG000|Full Analysis Set|Overall Study||361||
60088145|NCT04017832|76204422|FG001|Full Analysis Set|Overall Study||360||
60088146|NCT04017832|76204423|FG002|Full Analysis Set|Overall Study||361||
60088147|NCT04017832|76204424|FG003|Full Analysis Set|Overall Study||359||
60088148|NCT04017832|76204421|FG000|Safety Analysis Set|Overall Study||361||
60088149|NCT04017832|76204422|FG001|Safety Analysis Set|Overall Study||358||
60088150|NCT04017832|76204423|FG002|Safety Analysis Set|Overall Study||361||
60088151|NCT04017832|76204424|FG003|Safety Analysis Set|Overall Study||358||
60088152|NCT04017832|76204421|FG000|COMPLETED|Overall Study||345||
60088153|NCT04017832|76204422|FG001|COMPLETED|Overall Study||342||
60088154|NCT04017832|76204423|FG002|COMPLETED|Overall Study||335||
60088155|NCT04017832|76204424|FG003|COMPLETED|Overall Study||350||
60088156|NCT04017832|76204421|FG000|NOT COMPLETED|Overall Study||16||
60088157|NCT04017832|76204422|FG001|NOT COMPLETED|Overall Study||18||
60088158|NCT04017832|76204423|FG002|NOT COMPLETED|Overall Study||26||
60088159|NCT04017832|76204424|FG003|NOT COMPLETED|Overall Study||9||
60088160|NCT03999515|76204434|FG000|STARTED|Overall Study||3||
59707628|NCT00991276|75826521|FG001|NOT COMPLETED|Second Intervention Period||2||
59992639|NCT02199028|76108467|FG000|COMPLETED|Week 4||13||
59992640|NCT02199028|76108468|FG001|COMPLETED|Week 4||15||
59992641|NCT02199028|76108467|FG000|NOT COMPLETED|Week 4||0||
59992642|NCT02199028|76108468|FG001|NOT COMPLETED|Week 4||0||
59992643|NCT03347123|76108477|FG000|STARTED|Overall Study||5||
59992644|NCT03347123|76108478|FG001|STARTED|Overall Study||6||
59992645|NCT03347123|76108479|FG002|STARTED|Overall Study||0||
59992646|NCT03347123|76108480|FG003|STARTED|Overall Study||0||
59992647|NCT03347123|76108481|FG004|STARTED|Overall Study||0||
59992648|NCT03347123|76108482|FG005|STARTED|Overall Study||0||
59992649|NCT03347123|76108483|FG006|STARTED|Overall Study||0||
59992650|NCT03347123|76108477|FG000|COMPLETED|Overall Study||0||
59992651|NCT03347123|76108478|FG001|COMPLETED|Overall Study||0||
59992652|NCT03347123|76108479|FG002|COMPLETED|Overall Study||0||
59992653|NCT03347123|76108480|FG003|COMPLETED|Overall Study||0||
59992654|NCT03347123|76108481|FG004|COMPLETED|Overall Study||0||
59992655|NCT03347123|76108482|FG005|COMPLETED|Overall Study||0||
59992656|NCT03347123|76108483|FG006|COMPLETED|Overall Study||0||
59992657|NCT03347123|76108477|FG000|NOT COMPLETED|Overall Study||5||
59992658|NCT03347123|76108478|FG001|NOT COMPLETED|Overall Study||6||
59992659|NCT03347123|76108479|FG002|NOT COMPLETED|Overall Study||0||
59992660|NCT03347123|76108480|FG003|NOT COMPLETED|Overall Study||0||
59992661|NCT03347123|76108481|FG004|NOT COMPLETED|Overall Study||0||
59992662|NCT03347123|76108482|FG005|NOT COMPLETED|Overall Study||0||
59992663|NCT03347123|76108483|FG006|NOT COMPLETED|Overall Study||0||
59992664|NCT02198794|76108494|FG000|STARTED|Part A: Open-Label (158 Weeks)||337||
59992665|NCT02198794|76108495|FG001|STARTED|Part A: Open-Label (158 Weeks)||0||
59992666|NCT02198794|76108496|FG002|STARTED|Part A: Open-Label (158 Weeks)||0||
59992667|NCT02198794|76108497|FG003|STARTED|Part A: Open-Label (158 Weeks)||0||
59992668|NCT02198794|76108494|FG000|Received at Least 1 Dose of Study Drug|Part A: Open-Label (158 Weeks)||337||
59992669|NCT02198794|76108495|FG001|Received at Least 1 Dose of Study Drug|Part A: Open-Label (158 Weeks)||0||
59992670|NCT02198794|76108496|FG002|Received at Least 1 Dose of Study Drug|Part A: Open-Label (158 Weeks)||0||
59992671|NCT02198794|76108497|FG003|Received at Least 1 Dose of Study Drug|Part A: Open-Label (158 Weeks)||0||
59992672|NCT02198794|76108494|FG000|Intent-to-Treat (ITT) Population|Part A: Open-Label (158 Weeks)||337|All participants who enrolled in the study, regardless of whether or not received study drug.|
59992673|NCT02198794|76108495|FG001|Intent-to-Treat (ITT) Population|Part A: Open-Label (158 Weeks)||0|All participants who enrolled in the study, regardless of whether or not received study drug.|
59992674|NCT02198794|76108496|FG002|Intent-to-Treat (ITT) Population|Part A: Open-Label (158 Weeks)||0|All participants who enrolled in the study, regardless of whether or not received study drug.|
60088161|NCT03999515|76204434|FG000|COMPLETED|Overall Study||3||
60088162|NCT03999515|76204434|FG000|NOT COMPLETED|Overall Study||0||
60088163|NCT03952806|76204440|FG000|STARTED|Randomization Phase (Weeks 1 Through 48)||168||
60088164|NCT03952806|76204441|FG001|STARTED|Randomization Phase (Weeks 1 Through 48)||168||
60088165|NCT03952806|76204440|FG000|COMPLETED|Randomization Phase (Weeks 1 Through 48)||127||
60088166|NCT03952806|76204441|FG001|COMPLETED|Randomization Phase (Weeks 1 Through 48)||146||
59707629|NCT00991276|75826522|FG002|NOT COMPLETED|Second Intervention Period||0||
59707630|NCT00991276|75826523|FG003|NOT COMPLETED|Second Intervention Period||2||
59992675|NCT02198794|76108497|FG003|Intent-to-Treat (ITT) Population|Part A: Open-Label (158 Weeks)||0|All participants who enrolled in the study, regardless of whether or not received study drug.|
59992676|NCT02198794|76108494|FG000|Participants Who Participated in Part A But Not in Part B|Part A: Open-Label (158 Weeks)||195||
60088167|NCT03952806|76204440|FG000|NOT COMPLETED|Randomization Phase (Weeks 1 Through 48)||41||
60088168|NCT03952806|76204441|FG001|NOT COMPLETED|Randomization Phase (Weeks 1 Through 48)||22||
59992677|NCT02198794|76108495|FG001|Participants Who Participated in Part A But Not in Part B|Part A: Open-Label (158 Weeks)||0||
60103733|NCT04621227|76222001|FG000|STARTED|Period 1 (5 Days)||16||
60103734|NCT04621227|76222001|FG000|COMPLETED|Period 1 (5 Days)||16||
60103735|NCT04621227|76222001|FG000|NOT COMPLETED|Period 1 (5 Days)||0||
60103736|NCT04621227|76222001|FG000|STARTED|Period 2 (2 Days)||16||
60103737|NCT04621227|76222001|FG000|COMPLETED|Period 2 (2 Days)||16||
60103738|NCT04621227|76222001|FG000|NOT COMPLETED|Period 2 (2 Days)||0||
60103739|NCT04621227|76222001|FG000|STARTED|Period 3 (29 Days)||16||
60103740|NCT04621227|76222001|FG000|COMPLETED|Period 3 (29 Days)||14||
60103741|NCT04621227|76222001|FG000|NOT COMPLETED|Period 3 (29 Days)||2||
60088169|NCT03952806|76204440|FG000|STARTED|OLE Phase (48 Weeks)|Participants who continued into the extension phase.|123||
60088170|NCT03952806|76204441|FG001|STARTED|OLE Phase (48 Weeks)|Participants who continued into the extension phase.|140||
60088171|NCT03952806|76204440|FG000|COMPLETED|OLE Phase (48 Weeks)||44||
60088172|NCT03952806|76204441|FG001|COMPLETED|OLE Phase (48 Weeks)||46||
60088173|NCT03952806|76204440|FG000|NOT COMPLETED|OLE Phase (48 Weeks)||79||
60088174|NCT03952806|76204441|FG001|NOT COMPLETED|OLE Phase (48 Weeks)||94||
60088175|NCT03932799|76204455|FG000|STARTED|Overall Study||4632||
60088176|NCT03932799|76204456|FG001|STARTED|Overall Study||779||
60088177|NCT03932799|76204455|FG000|COMPLETED|Overall Study||4632||
60088178|NCT03932799|76204456|FG001|COMPLETED|Overall Study||779||
60088179|NCT03932799|76204455|FG000|NOT COMPLETED|Overall Study||0||
60088180|NCT03932799|76204456|FG001|NOT COMPLETED|Overall Study||0||
60088181|NCT03924947|76204466|FG000|STARTED|Part 1: Open Label Pre-Randomization||26||
60088182|NCT03924947|76204467|FG001|STARTED|Part 1: Open Label Pre-Randomization||0||
60088183|NCT03924947|76204468|FG002|STARTED|Part 1: Open Label Pre-Randomization||0||
60088184|NCT03924947|76204469|FG003|STARTED|Part 1: Open Label Pre-Randomization||0||
60088185|NCT03924947|76204470|FG004|STARTED|Part 1: Open Label Pre-Randomization||0||
60088186|NCT03924947|76204471|FG005|STARTED|Part 1: Open Label Pre-Randomization||0||
60088187|NCT03924947|76204466|FG000|COMPLETED|Part 1: Open Label Pre-Randomization||26||
60088188|NCT03924947|76204467|FG001|COMPLETED|Part 1: Open Label Pre-Randomization||0||
60088189|NCT03924947|76204468|FG002|COMPLETED|Part 1: Open Label Pre-Randomization||0||
60088190|NCT03924947|76204469|FG003|COMPLETED|Part 1: Open Label Pre-Randomization||0||
60088191|NCT03924947|76204470|FG004|COMPLETED|Part 1: Open Label Pre-Randomization||0||
59565963|NCT02303574|75668413|FG008|NOT COMPLETED|Part 1a (Fasted State)- SAD||0||
60088192|NCT03924947|76204471|FG005|COMPLETED|Part 1: Open Label Pre-Randomization||0||
60088193|NCT03924947|76204466|FG000|NOT COMPLETED|Part 1: Open Label Pre-Randomization||0||
59560648|NCT02683265|75661968|FG001|COMPLETED|Open-label Treatment Phase||0|The number who completed the Open-label Treatment Phase were randomized to 1 of 2 groups in the Double-blind Treatment Phase.|
59992678|NCT02198794|76108496|FG002|Participants Who Participated in Part A But Not in Part B|Part A: Open-Label (158 Weeks)||0||
59992679|NCT02198794|76108497|FG003|Participants Who Participated in Part A But Not in Part B|Part A: Open-Label (158 Weeks)||0||
59992680|NCT02198794|76108494|FG000|Participants Who Agreed to Continue in Part B|Part A: Open-Label (158 Weeks)||142||
59992681|NCT02198794|76108495|FG001|Participants Who Agreed to Continue in Part B|Part A: Open-Label (158 Weeks)||0||
59992682|NCT02198794|76108496|FG002|Participants Who Agreed to Continue in Part B|Part A: Open-Label (158 Weeks)||0||
59992683|NCT02198794|76108497|FG003|Participants Who Agreed to Continue in Part B|Part A: Open-Label (158 Weeks)||0||
59992684|NCT02198794|76108494|FG000|COMPLETED|Part A: Open-Label (158 Weeks)||32|"Participants who are noted as Completed for Part A: completed the study in Part A (Week 158) plus continued in Part B."|
60088194|NCT03924947|76204467|FG001|NOT COMPLETED|Part 1: Open Label Pre-Randomization||0||
60088195|NCT03924947|76204468|FG002|NOT COMPLETED|Part 1: Open Label Pre-Randomization||0||
60088196|NCT03924947|76204469|FG003|NOT COMPLETED|Part 1: Open Label Pre-Randomization||0||
60088197|NCT03924947|76204470|FG004|NOT COMPLETED|Part 1: Open Label Pre-Randomization||0||
60088198|NCT03924947|76204471|FG005|NOT COMPLETED|Part 1: Open Label Pre-Randomization||0||
60088199|NCT03924947|76204466|FG000|STARTED|Part 1: Double Blind Period 1||0||
60088200|NCT03924947|76204467|FG001|STARTED|Part 1: Double Blind Period 1||13||
60088201|NCT03924947|76204468|FG002|STARTED|Part 1: Double Blind Period 1||13||
60088202|NCT03924947|76204469|FG003|STARTED|Part 1: Double Blind Period 1||0||
60088203|NCT03924947|76204470|FG004|STARTED|Part 1: Double Blind Period 1||0||
60088204|NCT03924947|76204471|FG005|STARTED|Part 1: Double Blind Period 1||0||
60088205|NCT03924947|76204466|FG000|COMPLETED|Part 1: Double Blind Period 1||0||
60088206|NCT03924947|76204467|FG001|COMPLETED|Part 1: Double Blind Period 1||13||
60088207|NCT03924947|76204468|FG002|COMPLETED|Part 1: Double Blind Period 1||12||
60088208|NCT03924947|76204469|FG003|COMPLETED|Part 1: Double Blind Period 1||0||
60088209|NCT03924947|76204470|FG004|COMPLETED|Part 1: Double Blind Period 1||0||
60088210|NCT03924947|76204471|FG005|COMPLETED|Part 1: Double Blind Period 1||0||
60088211|NCT03924947|76204466|FG000|NOT COMPLETED|Part 1: Double Blind Period 1||0||
60088212|NCT03924947|76204467|FG001|NOT COMPLETED|Part 1: Double Blind Period 1||0||
60088213|NCT03924947|76204468|FG002|NOT COMPLETED|Part 1: Double Blind Period 1||1||
60088214|NCT03924947|76204469|FG003|NOT COMPLETED|Part 1: Double Blind Period 1||0||
60088215|NCT03924947|76204470|FG004|NOT COMPLETED|Part 1: Double Blind Period 1||0||
60088216|NCT03924947|76204471|FG005|NOT COMPLETED|Part 1: Double Blind Period 1||0||
60088217|NCT03924947|76204466|FG000|STARTED|Part 1: Double Blind Period 2||0||
60088218|NCT03924947|76204467|FG001|STARTED|Part 1: Double Blind Period 2||13||
60088219|NCT03924947|76204468|FG002|STARTED|Part 1: Double Blind Period 2||12||
60088220|NCT03924947|76204469|FG003|STARTED|Part 1: Double Blind Period 2||0||
60088221|NCT03924947|76204470|FG004|STARTED|Part 1: Double Blind Period 2||0||
60088222|NCT03924947|76204471|FG005|STARTED|Part 1: Double Blind Period 2||0||
60088223|NCT03924947|76204466|FG000|COMPLETED|Part 1: Double Blind Period 2||0||
60088224|NCT03924947|76204467|FG001|COMPLETED|Part 1: Double Blind Period 2||13||
60088225|NCT03924947|76204468|FG002|COMPLETED|Part 1: Double Blind Period 2||12||
60088226|NCT03924947|76204469|FG003|COMPLETED|Part 1: Double Blind Period 2||0||
60088227|NCT03924947|76204470|FG004|COMPLETED|Part 1: Double Blind Period 2||0||
60088228|NCT03924947|76204471|FG005|COMPLETED|Part 1: Double Blind Period 2||0||
60088229|NCT03924947|76204466|FG000|NOT COMPLETED|Part 1: Double Blind Period 2||0||
60088230|NCT03924947|76204467|FG001|NOT COMPLETED|Part 1: Double Blind Period 2||0||
60088231|NCT03924947|76204468|FG002|NOT COMPLETED|Part 1: Double Blind Period 2||0||
60088232|NCT03924947|76204469|FG003|NOT COMPLETED|Part 1: Double Blind Period 2||0||
60088233|NCT03924947|76204470|FG004|NOT COMPLETED|Part 1: Double Blind Period 2||0||
60088234|NCT03924947|76204471|FG005|NOT COMPLETED|Part 1: Double Blind Period 2||0||
60088235|NCT03924947|76204466|FG000|STARTED|Part 2: Open Label Pre-Randomization||0||
60088236|NCT03924947|76204467|FG001|STARTED|Part 2: Open Label Pre-Randomization||0||
60088237|NCT03924947|76204468|FG002|STARTED|Part 2: Open Label Pre-Randomization||0||
60088238|NCT03924947|76204469|FG003|STARTED|Part 2: Open Label Pre-Randomization|All Part 2 participants with a record of OL Creon in the pre-randomization period; includes 20 randomized participants and 4 screen failures (who received OL Creon in the pre-randomization period but were not randomized). Does not include 3 randomized participants who have no record of OL Creon in the pre-randomization period (note that, per protocol, participants could skip OL pre-randomization period for Part 2 if they started Part 2 within 30 days of the last dose of study drug in Part 1).|24||
60088239|NCT03924947|76204470|FG004|STARTED|Part 2: Open Label Pre-Randomization||0||
60088240|NCT03924947|76204471|FG005|STARTED|Part 2: Open Label Pre-Randomization||0||
60088241|NCT03924947|76204466|FG000|COMPLETED|Part 2: Open Label Pre-Randomization||0||
60088242|NCT03924947|76204467|FG001|COMPLETED|Part 2: Open Label Pre-Randomization||0||
60088243|NCT03924947|76204468|FG002|COMPLETED|Part 2: Open Label Pre-Randomization||0||
59560649|NCT02683265|75661969|FG002|COMPLETED|Open-label Treatment Phase||0|The number who completed the Open-label Treatment Phase were randomized to 1 of 2 groups in the Double-blind Treatment Phase.|
59560650|NCT02683265|75661967|FG000|NOT COMPLETED|Open-label Treatment Phase||29||
60088244|NCT03924947|76204469|FG003|COMPLETED|Part 2: Open Label Pre-Randomization||24||
60088245|NCT03924947|76204470|FG004|COMPLETED|Part 2: Open Label Pre-Randomization||0||
60088246|NCT03924947|76204471|FG005|COMPLETED|Part 2: Open Label Pre-Randomization||0||
60088247|NCT03924947|76204466|FG000|NOT COMPLETED|Part 2: Open Label Pre-Randomization||0||
60088248|NCT03924947|76204467|FG001|NOT COMPLETED|Part 2: Open Label Pre-Randomization||0||
60088249|NCT03924947|76204468|FG002|NOT COMPLETED|Part 2: Open Label Pre-Randomization||0||
60088250|NCT03924947|76204469|FG003|NOT COMPLETED|Part 2: Open Label Pre-Randomization||0||
60088251|NCT03924947|76204470|FG004|NOT COMPLETED|Part 2: Open Label Pre-Randomization||0||
60088252|NCT03924947|76204471|FG005|NOT COMPLETED|Part 2: Open Label Pre-Randomization||0||
60088253|NCT03924947|76204466|FG000|STARTED|Part 2: Double Blind Period 1||0||
60088254|NCT03924947|76204467|FG001|STARTED|Part 2: Double Blind Period 1||0||
60088255|NCT03924947|76204468|FG002|STARTED|Part 2: Double Blind Period 1||0||
60088256|NCT03924947|76204469|FG003|STARTED|Part 2: Double Blind Period 1||0||
60088257|NCT03924947|76204470|FG004|STARTED|Part 2: Double Blind Period 1||11||
60088258|NCT03924947|76204471|FG005|STARTED|Part 2: Double Blind Period 1||12||
60088259|NCT03924947|76204466|FG000|COMPLETED|Part 2: Double Blind Period 1||0||
60088260|NCT03924947|76204467|FG001|COMPLETED|Part 2: Double Blind Period 1||0||
60088261|NCT03924947|76204468|FG002|COMPLETED|Part 2: Double Blind Period 1||0||
60088262|NCT03924947|76204469|FG003|COMPLETED|Part 2: Double Blind Period 1||0||
59560651|NCT02683265|75661968|FG001|NOT COMPLETED|Open-label Treatment Phase||0||
59560652|NCT02683265|75661969|FG002|NOT COMPLETED|Open-label Treatment Phase||0||
59560653|NCT02683265|75661967|FG000|STARTED|Double-blind Treatment Phase||0||
59560654|NCT02683265|75661968|FG001|STARTED|Double-blind Treatment Phase||40||
59560655|NCT02683265|75661969|FG002|STARTED|Double-blind Treatment Phase||50||
59560656|NCT02683265|75661967|FG000|COMPLETED|Double-blind Treatment Phase||0||
59560657|NCT02683265|75661968|FG001|COMPLETED|Double-blind Treatment Phase||38||
59560658|NCT02683265|75661969|FG002|COMPLETED|Double-blind Treatment Phase||48||
59560659|NCT02683265|75661967|FG000|NOT COMPLETED|Double-blind Treatment Phase||0||
59560660|NCT02683265|75661968|FG001|NOT COMPLETED|Double-blind Treatment Phase||2||
59560661|NCT02683265|75661969|FG002|NOT COMPLETED|Double-blind Treatment Phase||2||
59560662|NCT02987829|75661982|FG000|STARTED|Overall Study||1||
59560663|NCT02987829|75661983|FG001|STARTED|Overall Study||1||
59707631|NCT00991276|75826524|FG004|NOT COMPLETED|Second Intervention Period||1||
59707632|NCT00991276|75826525|FG005|NOT COMPLETED|Second Intervention Period||1||
59707633|NCT00991276|75826520|FG000|STARTED|Placebo Wash-out Period (7 Days)||14||
59992685|NCT02198794|76108495|FG001|COMPLETED|Part A: Open-Label (158 Weeks)||0|"Participants who are noted as Completed for Part A: completed the study in Part A (Week 158) plus continued in Part B."|
59992686|NCT02198794|76108496|FG002|COMPLETED|Part A: Open-Label (158 Weeks)||0|"Participants who are noted as Completed for Part A: completed the study in Part A (Week 158) plus continued in Part B."|
59992687|NCT02198794|76108497|FG003|COMPLETED|Part A: Open-Label (158 Weeks)||0|"Participants who are noted as Completed for Part A: completed the study in Part A (Week 158) plus continued in Part B."|
59992688|NCT02198794|76108494|FG000|NOT COMPLETED|Part A: Open-Label (158 Weeks)||305||
59992689|NCT02198794|76108495|FG001|NOT COMPLETED|Part A: Open-Label (158 Weeks)||0||
59992690|NCT02198794|76108496|FG002|NOT COMPLETED|Part A: Open-Label (158 Weeks)||0||
59992691|NCT02198794|76108497|FG003|NOT COMPLETED|Part A: Open-Label (158 Weeks)||0||
59992692|NCT02198794|76108494|FG000|STARTED|Part B: Randomized (13 Weeks)||0|Randomized withdrawal ITT population|
59992693|NCT02198794|76108495|FG001|STARTED|Part B: Randomized (13 Weeks)|Participants of Part A who agreed to participate in Part B|71|Randomized withdrawal ITT population|
59992694|NCT02198794|76108496|FG002|STARTED|Part B: Randomized (13 Weeks)|Participants of Part A who agreed to participate in Part B|71|Randomized withdrawal ITT population|
59992695|NCT02198794|76108497|FG003|STARTED|Part B: Randomized (13 Weeks)||0|Randomized withdrawal ITT population|
59992696|NCT02198794|76108494|FG000|Randomized Withdrawal mITT Population|Part B: Randomized (13 Weeks)||0||
59992697|NCT02198794|76108495|FG001|Randomized Withdrawal mITT Population|Part B: Randomized (13 Weeks)||63||
59992698|NCT02198794|76108496|FG002|Randomized Withdrawal mITT Population|Part B: Randomized (13 Weeks)||65||
59992699|NCT02198794|76108497|FG003|Randomized Withdrawal mITT Population|Part B: Randomized (13 Weeks)||0||
59992700|NCT02198794|76108494|FG000|COMPLETED|Part B: Randomized (13 Weeks)||0||
59992701|NCT02198794|76108495|FG001|COMPLETED|Part B: Randomized (13 Weeks)||66||
59992702|NCT02198794|76108496|FG002|COMPLETED|Part B: Randomized (13 Weeks)||68||
59992703|NCT02198794|76108497|FG003|COMPLETED|Part B: Randomized (13 Weeks)||0||
59992704|NCT02198794|76108494|FG000|NOT COMPLETED|Part B: Randomized (13 Weeks)||0||
59992705|NCT02198794|76108495|FG001|NOT COMPLETED|Part B: Randomized (13 Weeks)||5||
59992706|NCT02198794|76108496|FG002|NOT COMPLETED|Part B: Randomized (13 Weeks)||3||
59992707|NCT02198794|76108497|FG003|NOT COMPLETED|Part B: Randomized (13 Weeks)||0||
59992708|NCT02198794|76108494|FG000|STARTED|Part C: Safety Assessment (52 Weeks)||0||
59992709|NCT02198794|76108495|FG001|STARTED|Part C: Safety Assessment (52 Weeks)||0||
60088263|NCT03924947|76204470|FG004|COMPLETED|Part 2: Double Blind Period 1||11||
60088264|NCT03924947|76204471|FG005|COMPLETED|Part 2: Double Blind Period 1||12||
60088265|NCT03924947|76204466|FG000|NOT COMPLETED|Part 2: Double Blind Period 1||0||
60088266|NCT03924947|76204467|FG001|NOT COMPLETED|Part 2: Double Blind Period 1||0||
60088267|NCT03924947|76204468|FG002|NOT COMPLETED|Part 2: Double Blind Period 1||0||
60088268|NCT03924947|76204469|FG003|NOT COMPLETED|Part 2: Double Blind Period 1||0||
60088269|NCT03924947|76204470|FG004|NOT COMPLETED|Part 2: Double Blind Period 1||0||
60088270|NCT03924947|76204471|FG005|NOT COMPLETED|Part 2: Double Blind Period 1||0||
60088271|NCT03924947|76204466|FG000|STARTED|Part 2: Double Blind Period 2||0||
60088272|NCT03924947|76204467|FG001|STARTED|Part 2: Double Blind Period 2||0||
60088273|NCT03924947|76204468|FG002|STARTED|Part 2: Double Blind Period 2||0||
60088274|NCT03924947|76204469|FG003|STARTED|Part 2: Double Blind Period 2||0||
60088275|NCT03924947|76204470|FG004|STARTED|Part 2: Double Blind Period 2||11||
60088276|NCT03924947|76204471|FG005|STARTED|Part 2: Double Blind Period 2||12||
60088277|NCT03924947|76204466|FG000|COMPLETED|Part 2: Double Blind Period 2||0||
60088278|NCT03924947|76204467|FG001|COMPLETED|Part 2: Double Blind Period 2||0||
60088279|NCT03924947|76204468|FG002|COMPLETED|Part 2: Double Blind Period 2||0||
60088280|NCT03924947|76204469|FG003|COMPLETED|Part 2: Double Blind Period 2||0||
60088281|NCT03924947|76204470|FG004|COMPLETED|Part 2: Double Blind Period 2||11||
60088282|NCT03924947|76204471|FG005|COMPLETED|Part 2: Double Blind Period 2||11||
60088283|NCT03924947|76204466|FG000|NOT COMPLETED|Part 2: Double Blind Period 2||0||
60088284|NCT03924947|76204467|FG001|NOT COMPLETED|Part 2: Double Blind Period 2||0||
60088285|NCT03924947|76204468|FG002|NOT COMPLETED|Part 2: Double Blind Period 2||0||
60088286|NCT03924947|76204469|FG003|NOT COMPLETED|Part 2: Double Blind Period 2||0||
60088287|NCT03924947|76204470|FG004|NOT COMPLETED|Part 2: Double Blind Period 2||0||
60088288|NCT03924947|76204471|FG005|NOT COMPLETED|Part 2: Double Blind Period 2||1||
60088289|NCT03871556|76204489|FG000|STARTED|Overall Study||40||
60088290|NCT03871556|76204489|FG000|COMPLETED|Overall Study||40||
60088291|NCT03871556|76204489|FG000|NOT COMPLETED|Overall Study||0||
60088292|NCT03845985|76204496|FG000|STARTED|Overall Study||9||
60088293|NCT03845985|76204497|FG001|STARTED|Overall Study||7||
60088294|NCT03845985|76204496|FG000|COMPLETED|Overall Study||2||
60088295|NCT03845985|76204497|FG001|COMPLETED|Overall Study||5||
60088296|NCT03845985|76204496|FG000|NOT COMPLETED|Overall Study||7||
60088297|NCT03845985|76204497|FG001|NOT COMPLETED|Overall Study||2||
60088298|NCT03745651|76204506|FG000|STARTED|Vehicle Control Period (Day 1 to Week 8)||124||
60088299|NCT03745651|76204507|FG001|STARTED|Vehicle Control Period (Day 1 to Week 8)||248||
60088300|NCT03745651|76204508|FG002|STARTED|Vehicle Control Period (Day 1 to Week 8)||246||
60088301|NCT03745651|76204509|FG003|STARTED|Vehicle Control Period (Day 1 to Week 8)||0||
60088302|NCT03745651|76204510|FG004|STARTED|Vehicle Control Period (Day 1 to Week 8)||0||
60088303|NCT03745651|76204511|FG005|STARTED|Vehicle Control Period (Day 1 to Week 8)||0||
60088304|NCT03745651|76204512|FG006|STARTED|Vehicle Control Period (Day 1 to Week 8)||0||
60088305|NCT03745651|76204506|FG000|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||105||
60088306|NCT03745651|76204507|FG001|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||209||
60088307|NCT03745651|76204508|FG002|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||224||
60088308|NCT03745651|76204509|FG003|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0||
60088309|NCT03745651|76204510|FG004|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0||
60088310|NCT03745651|76204511|FG005|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0||
60088311|NCT03745651|76204512|FG006|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0||
60088312|NCT03745651|76204506|FG000|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||19||
60088313|NCT03745651|76204507|FG001|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||39||
60088314|NCT03745651|76204508|FG002|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||22||
60088315|NCT03745651|76204509|FG003|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0||
60088316|NCT03745651|76204510|FG004|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0||
60088317|NCT03745651|76204511|FG005|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0||
60088318|NCT03745651|76204512|FG006|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0||
60088319|NCT03745651|76204506|FG000|STARTED|Long-Term Safety Period (Weeks 8 to 52)||0||
60088320|NCT03745651|76204507|FG001|STARTED|Long-Term Safety Period (Weeks 8 to 52)||0||
60088321|NCT03745651|76204508|FG002|STARTED|Long-Term Safety Period (Weeks 8 to 52)||0||
60088322|NCT03745651|76204509|FG003|STARTED|Long-Term Safety Period (Weeks 8 to 52)||53||
60088323|NCT03745651|76204510|FG004|STARTED|Long-Term Safety Period (Weeks 8 to 52)||52||
60088324|NCT03745651|76204511|FG005|STARTED|Long-Term Safety Period (Weeks 8 to 52)||204||
60088325|NCT03745651|76204512|FG006|STARTED|Long-Term Safety Period (Weeks 8 to 52)||221||
60088326|NCT03745651|76204506|FG000|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0||
60088327|NCT03745651|76204507|FG001|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0||
60088328|NCT03745651|76204508|FG002|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0||
60088329|NCT03745651|76204509|FG003|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||33||
60088330|NCT03745651|76204510|FG004|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||41||
60088331|NCT03745651|76204511|FG005|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||151||
60088332|NCT03745651|76204512|FG006|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||170||
60088333|NCT03745651|76204506|FG000|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0||
60088334|NCT03745651|76204507|FG001|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0||
60103742|NCT04621227|76222001|FG000|STARTED|Period 4 (4 Days)||14||
59560664|NCT02987829|75661984|FG002|STARTED|Overall Study||2||
59560665|NCT02987829|75661985|FG003|STARTED|Overall Study||7||
60088335|NCT03745651|76204508|FG002|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0||
60088336|NCT03745651|76204509|FG003|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||20||
60088337|NCT03745651|76204510|FG004|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||11||
60088338|NCT03745651|76204511|FG005|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||53||
60088339|NCT03745651|76204512|FG006|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||51||
60088340|NCT03745638|76204531|FG000|STARTED|Vehicle Control Period (Day 1 to Week 8)||126||
60088341|NCT03745638|76204532|FG001|STARTED|Vehicle Control Period (Day 1 to Week 8)||252||
60088342|NCT03745638|76204533|FG002|STARTED|Vehicle Control Period (Day 1 to Week 8)||253||
60088343|NCT03745638|76204534|FG003|STARTED|Vehicle Control Period (Day 1 to Week 8)||0||
60088344|NCT03745638|76204535|FG004|STARTED|Vehicle Control Period (Day 1 to Week 8)||0||
60088345|NCT03745638|76204536|FG005|STARTED|Vehicle Control Period (Day 1 to Week 8)||0||
60088346|NCT03745638|76204537|FG006|STARTED|Vehicle Control Period (Day 1 to Week 8)||0||
59560666|NCT02987829|75661986|FG004|STARTED|Overall Study||51||
59560667|NCT02987829|75661987|FG005|STARTED|Overall Study||10||
59560668|NCT02987829|75661982|FG000|COMPLETED|Overall Study||1||
59560669|NCT02987829|75661983|FG001|COMPLETED|Overall Study||1||
59560670|NCT02987829|75661984|FG002|COMPLETED|Overall Study||2||
59560671|NCT02987829|75661985|FG003|COMPLETED|Overall Study||7||
59560672|NCT02987829|75661986|FG004|COMPLETED|Overall Study||51||
60088347|NCT03745638|76204531|FG000|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||95||
60088348|NCT03745638|76204532|FG001|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||222||
60088349|NCT03745638|76204533|FG002|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||225||
60088350|NCT03745638|76204534|FG003|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0||
60088351|NCT03745638|76204535|FG004|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0||
60088352|NCT03745638|76204536|FG005|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0||
60088353|NCT03745638|76204537|FG006|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0||
60088354|NCT03745638|76204531|FG000|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||31||
60088355|NCT03745638|76204532|FG001|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||30||
60088356|NCT03745638|76204533|FG002|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||28||
60088357|NCT03745638|76204534|FG003|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0||
60088358|NCT03745638|76204535|FG004|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0||
60088359|NCT03745638|76204536|FG005|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0||
60088360|NCT03745638|76204537|FG006|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0||
60088361|NCT03745638|76204531|FG000|STARTED|Long-Term Safety Period (Weeks 8 to 52)||0||
59817922|NCT04488770|75940335|FG009|STARTED|Part 1-Cohort 2: Period 2 (Up to 5 Days)||0||
60088362|NCT03745638|76204532|FG001|STARTED|Long-Term Safety Period (Weeks 8 to 52)||0||
60088363|NCT03745638|76204533|FG002|STARTED|Long-Term Safety Period (Weeks 8 to 52)||0||
60088364|NCT03745638|76204534|FG003|STARTED|Long-Term Safety Period (Weeks 8 to 52)||48||
60088365|NCT03745638|76204535|FG004|STARTED|Long-Term Safety Period (Weeks 8 to 52)||47||
60088366|NCT03745638|76204536|FG005|STARTED|Long-Term Safety Period (Weeks 8 to 52)||222||
60088367|NCT03745638|76204537|FG006|STARTED|Long-Term Safety Period (Weeks 8 to 52)||225||
60088368|NCT03745638|76204531|FG000|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0||
60088369|NCT03745638|76204532|FG001|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0||
59560673|NCT02987829|75661987|FG005|COMPLETED|Overall Study||10||
59560674|NCT02987829|75661982|FG000|NOT COMPLETED|Overall Study||0||
60088370|NCT03745638|76204533|FG002|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0||
60088371|NCT03745638|76204534|FG003|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||37||
60088372|NCT03745638|76204535|FG004|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||38||
60088373|NCT03745638|76204536|FG005|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||176||
60088374|NCT03745638|76204537|FG006|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||174||
60088375|NCT03745638|76204531|FG000|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0||
60088376|NCT03745638|76204532|FG001|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0||
60088377|NCT03745638|76204533|FG002|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0||
60088378|NCT03745638|76204534|FG003|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||11||
60088379|NCT03745638|76204535|FG004|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||9||
60088380|NCT03745638|76204536|FG005|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||46||
60088381|NCT03745638|76204537|FG006|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||51||
60088382|NCT03704948|76204557|FG000|STARTED|Overall Study||22||
60088383|NCT03704948|76204558|FG001|STARTED|Overall Study||23||
60088384|NCT03704948|76204559|FG002|STARTED|Overall Study||10||
60088385|NCT03704948|76204557|FG000|COMPLETED|Overall Study||20||
60088386|NCT03704948|76204558|FG001|COMPLETED|Overall Study||22||
60088387|NCT03704948|76204559|FG002|COMPLETED|Overall Study||9||
60088388|NCT03704948|76204557|FG000|NOT COMPLETED|Overall Study||2||
60088389|NCT03704948|76204558|FG001|NOT COMPLETED|Overall Study||1||
60088390|NCT03704948|76204559|FG002|NOT COMPLETED|Overall Study||1||
60088391|NCT03699475|76204567|FG000|STARTED|Overall Study|Only a single patient was enrolled to this study which was to the phase 2: Cohort 1 and then the study was terminated early by the Sponsor and no other participants were enrolled in this study in any other group. Therefore, total study participant number is 1.|1||
60088392|NCT03699475|76204567|FG000|COMPLETED|Overall Study||0||
60088393|NCT03699475|76204567|FG000|NOT COMPLETED|Overall Study||1||
60088394|NCT03668613|76204573|FG000|STARTED|Overall Study||42||
60088395|NCT03668613|76204574|FG001|STARTED|Overall Study||42||
60088396|NCT03668613|76204573|FG000|COMPLETED|Overall Study||42||
60088397|NCT03668613|76204574|FG001|COMPLETED|Overall Study||39||
60088398|NCT03668613|76204573|FG000|NOT COMPLETED|Overall Study||0||
60088399|NCT03668613|76204574|FG001|NOT COMPLETED|Overall Study||3||
60088400|NCT03650413|76204581|FG000|STARTED|Overall Study||143||
60088401|NCT03650413|76204581|FG000|COMPLETED|Overall Study||82||
60088402|NCT03650413|76204581|FG000|NOT COMPLETED|Overall Study||61||
60088403|NCT03613909|76204585|FG000|STARTED|First Take Home Use of CP950||23||
60088404|NCT03613909|76204585|FG000|COMPLETED|First Take Home Use of CP950||20||
59816771|NCT04076059|75939150|FG002|Participants Who Received at Least One Dose of Study Drug|Double Blind Phase||0||
60088405|NCT03613909|76204585|FG000|NOT COMPLETED|First Take Home Use of CP950||3||
60088406|NCT03613909|76204585|FG000|STARTED|First In Booth Testing of CP950||20||
60088407|NCT03613909|76204585|FG000|COMPLETED|First In Booth Testing of CP950||20||
60088408|NCT03613909|76204585|FG000|NOT COMPLETED|First In Booth Testing of CP950||0||
60088409|NCT03613909|76204585|FG000|STARTED|Second Take Home Use of CP950||20||
60088410|NCT03613909|76204585|FG000|COMPLETED|Second Take Home Use of CP950||20||
59560675|NCT02987829|75661983|FG001|NOT COMPLETED|Overall Study||0||
59560676|NCT02987829|75661984|FG002|NOT COMPLETED|Overall Study||0||
59560677|NCT02987829|75661985|FG003|NOT COMPLETED|Overall Study||0||
59560678|NCT02987829|75661986|FG004|NOT COMPLETED|Overall Study||0||
59560679|NCT02987829|75661987|FG005|NOT COMPLETED|Overall Study||0||
59560680|NCT02988843|75662004|FG000|STARTED|Overall Study||1||
59560681|NCT02988843|75662004|FG000|COMPLETED|Overall Study||1||
59560682|NCT02988843|75662004|FG000|NOT COMPLETED|Overall Study||0||
59560683|NCT02989545|75662008|FG000|STARTED|Control Period - no Intervention||20||
59560684|NCT02989545|75662008|FG000|COMPLETED|Control Period - no Intervention||20||
59560685|NCT02989545|75662008|FG000|NOT COMPLETED|Control Period - no Intervention||0||
59560686|NCT02989545|75662008|FG000|STARTED|Treatment Period - Anal Tape Provided||20||
60088411|NCT03613909|76204585|FG000|NOT COMPLETED|Second Take Home Use of CP950||0||
60088412|NCT03613909|76204585|FG000|STARTED|Second In Booth Testing of CP950||20||
60088413|NCT03613909|76204585|FG000|COMPLETED|Second In Booth Testing of CP950||20||
60088414|NCT03613909|76204585|FG000|NOT COMPLETED|Second In Booth Testing of CP950||0||
60088415|NCT03596242|76204591|FG000|STARTED|Overall Study||12||
60088416|NCT03596242|76204592|FG001|STARTED|Overall Study||12||
60088417|NCT03596242|76204591|FG000|COMPLETED|Overall Study||10||
60088418|NCT03596242|76204592|FG001|COMPLETED|Overall Study||10||
60088419|NCT03596242|76204591|FG000|NOT COMPLETED|Overall Study||2||
59992710|NCT02198794|76108496|FG002|STARTED|Part C: Safety Assessment (52 Weeks)||0||
59992711|NCT02198794|76108497|FG003|STARTED|Part C: Safety Assessment (52 Weeks)||80||
59992712|NCT02198794|76108494|FG000|COMPLETED|Part C: Safety Assessment (52 Weeks)||0||
59992713|NCT02198794|76108495|FG001|COMPLETED|Part C: Safety Assessment (52 Weeks)||0||
59992714|NCT02198794|76108496|FG002|COMPLETED|Part C: Safety Assessment (52 Weeks)||0||
59992715|NCT02198794|76108497|FG003|COMPLETED|Part C: Safety Assessment (52 Weeks)||73||
59992716|NCT02198794|76108494|FG000|NOT COMPLETED|Part C: Safety Assessment (52 Weeks)||0||
59992717|NCT02198794|76108495|FG001|NOT COMPLETED|Part C: Safety Assessment (52 Weeks)||0||
60088420|NCT03596242|76204592|FG001|NOT COMPLETED|Overall Study||2||
60088421|NCT03514017|76204598|FG000|STARTED|Overall Study||5||
60088422|NCT03514017|76204598|FG000|COMPLETED|Overall Study||3||
60088423|NCT03514017|76204598|FG000|NOT COMPLETED|Overall Study||2||
60088424|NCT03471078|76204604|FG000|STARTED|Overall Study||82||
60088425|NCT03471078|76204605|FG001|STARTED|Overall Study||40||
60088426|NCT03471078|76204604|FG000|COMPLETED|Overall Study||61||
60088427|NCT03471078|76204605|FG001|COMPLETED|Overall Study||34||
60088428|NCT03471078|76204604|FG000|NOT COMPLETED|Overall Study||21||
60088429|NCT03471078|76204605|FG001|NOT COMPLETED|Overall Study||6||
60088430|NCT03465748|76204613|FG000|STARTED|Overall Study||27||
60088431|NCT03465748|76204614|FG001|STARTED|Overall Study||18||
60088432|NCT03465748|76204613|FG000|COMPLETED|Overall Study||15||
60088433|NCT03465748|76204614|FG001|COMPLETED|Overall Study||7||
60088434|NCT03465748|76204613|FG000|NOT COMPLETED|Overall Study||12||
60088435|NCT03465748|76204614|FG001|NOT COMPLETED|Overall Study||11||
60088436|NCT03421145|76204624|FG000|STARTED|Overall Study||50||
60088437|NCT03421145|76204625|FG001|STARTED|Overall Study||50||
60088438|NCT03421145|76204626|FG002|STARTED|Overall Study||50||
60088439|NCT03421145|76204627|FG003|STARTED|Overall Study||50||
60088440|NCT03421145|76204624|FG000|COMPLETED|Overall Study||47||
60088441|NCT03421145|76204625|FG001|COMPLETED|Overall Study||48||
60088442|NCT03421145|76204626|FG002|COMPLETED|Overall Study||45||
60088443|NCT03421145|76204627|FG003|COMPLETED|Overall Study||47||
60088444|NCT03421145|76204624|FG000|NOT COMPLETED|Overall Study||3||
60088445|NCT03421145|76204625|FG001|NOT COMPLETED|Overall Study||2||
60088446|NCT03421145|76204626|FG002|NOT COMPLETED|Overall Study||5||
60088447|NCT03421145|76204627|FG003|NOT COMPLETED|Overall Study||3||
60088448|NCT03326726|76204637|FG000|STARTED|Overall Study||30||
60088449|NCT03326726|76204637|FG000|COMPLETED|Overall Study||30||
60088450|NCT03326726|76204637|FG000|NOT COMPLETED|Overall Study||0||
60088451|NCT03308188|76204643|FG000|STARTED|Overall Study||202||
60088452|NCT03308188|76204644|FG001|STARTED|Overall Study||200||
60088453|NCT03308188|76204643|FG000|COMPLETED|Overall Study|The baseline morphine equivalent dose for one participant was an unusable outlier. MED, morphine equivalent dose; TAU, treatment as usual.|202||
60088454|NCT03308188|76204644|FG001|COMPLETED|Overall Study||196||
60088455|NCT03308188|76204643|FG000|NOT COMPLETED|Overall Study||0||
60088456|NCT03308188|76204644|FG001|NOT COMPLETED|Overall Study||4||
60088457|NCT03300336|76204652|FG000|STARTED|Overall Study||7134||
59560687|NCT02989545|75662008|FG000|COMPLETED|Treatment Period - Anal Tape Provided||20||
59560688|NCT02989545|75662008|FG000|NOT COMPLETED|Treatment Period - Anal Tape Provided||0||
59560689|NCT02991729|75662018|FG000|STARTED|Overall Study||105||
59560690|NCT02991729|75662019|FG001|STARTED|Overall Study||92||
59560691|NCT02991729|75662018|FG000|COMPLETED|Overall Study||105||
59560692|NCT02991729|75662019|FG001|COMPLETED|Overall Study||92||
59560693|NCT02991729|75662018|FG000|NOT COMPLETED|Overall Study||0||
59560694|NCT02991729|75662019|FG001|NOT COMPLETED|Overall Study||0||
59560695|NCT02992197|75662029|FG000|STARTED|Overall Study||110||
59560696|NCT02992197|75662030|FG001|STARTED|Overall Study||110||
59560697|NCT02992197|75662029|FG000|COMPLETED|Overall Study||99||
59560698|NCT02992197|75662030|FG001|COMPLETED|Overall Study||103||
60088458|NCT03300336|76204653|FG001|STARTED|Overall Study||6723||
59560699|NCT02992197|75662029|FG000|NOT COMPLETED|Overall Study||11||
59560700|NCT02992197|75662030|FG001|NOT COMPLETED|Overall Study||7||
59560701|NCT02993445|75662038|FG000|STARTED|First Intervention (5 Minutes)||6||12
59560702|NCT02993445|75662039|FG001|STARTED|First Intervention (5 Minutes)||5||10
59560703|NCT02993445|75662038|FG000|COMPLETED|First Intervention (5 Minutes)||6||12
59560704|NCT02993445|75662039|FG001|COMPLETED|First Intervention (5 Minutes)||5||10
59560705|NCT02993445|75662038|FG000|NOT COMPLETED|First Intervention (5 Minutes)||0||0
59560706|NCT02993445|75662039|FG001|NOT COMPLETED|First Intervention (5 Minutes)||0||0
59560707|NCT02993445|75662038|FG000|STARTED|Washout (2 Weeks)||6||12
59560708|NCT02993445|75662039|FG001|STARTED|Washout (2 Weeks)||5||10
59560709|NCT02993445|75662038|FG000|COMPLETED|Washout (2 Weeks)||6||12
59560710|NCT02993445|75662039|FG001|COMPLETED|Washout (2 Weeks)||5||10
59560711|NCT02993445|75662038|FG000|NOT COMPLETED|Washout (2 Weeks)||0||0
60088459|NCT03300336|76204652|FG000|COMPLETED|Overall Study||7134||
60088460|NCT03300336|76204653|FG001|COMPLETED|Overall Study||6723||
60088461|NCT03300336|76204652|FG000|NOT COMPLETED|Overall Study||0||
60088462|NCT03300336|76204653|FG001|NOT COMPLETED|Overall Study||0||
60088463|NCT03130439|76204659|FG000|STARTED|Overall Study||27||
60088464|NCT03130439|76204659|FG000|COMPLETED|Overall Study||27||
59560712|NCT02993445|75662039|FG001|NOT COMPLETED|Washout (2 Weeks)||0||0
59560713|NCT02993445|75662038|FG000|STARTED|Second Intervention (5 Mins)||6||12
59560714|NCT02993445|75662039|FG001|STARTED|Second Intervention (5 Mins)||5||10
59560715|NCT02993445|75662038|FG000|COMPLETED|Second Intervention (5 Mins)||6||12
59560716|NCT02993445|75662039|FG001|COMPLETED|Second Intervention (5 Mins)||5||10
59560717|NCT02993445|75662038|FG000|NOT COMPLETED|Second Intervention (5 Mins)||0||0
59560718|NCT02993445|75662039|FG001|NOT COMPLETED|Second Intervention (5 Mins)||0||0
59560719|NCT01661270|75662047|FG000|STARTED|Overall Study||109||
59560720|NCT01661270|75662048|FG001|STARTED|Overall Study||223||
59560721|NCT01661270|75662047|FG000|Adverse Event|Overall Study|Met end of treatment (EOT) criteria.|26||
59560722|NCT01661270|75662048|FG001|Adverse Event|Overall Study|Met EOT criteria|47||
59560723|NCT01661270|75662047|FG000|Disease Progression|Overall Study|Met EOT criteria|67||
59560724|NCT01661270|75662048|FG001|Disease Progression|Overall Study|Met EOT criteria|118||
59560725|NCT01661270|75662047|FG000|Physician Decision|Overall Study|Met EOT criteria|1||
59707634|NCT00991276|75826521|FG001|STARTED|Placebo Wash-out Period (7 Days)||8||
59707635|NCT00991276|75826522|FG002|STARTED|Placebo Wash-out Period (7 Days)||14||
59816772|NCT04076059|75939148|FG000|COMPLETED|Double Blind Phase||0||
60088465|NCT03130439|76204659|FG000|NOT COMPLETED|Overall Study||0||
60088466|NCT03113968|76204665|FG000|STARTED|Overall Study||203||
60088467|NCT03113968|76204666|FG001|STARTED|Overall Study||200||
60088468|NCT03113968|76204665|FG000|COMPLETED|Overall Study||172||
60088469|NCT03113968|76204666|FG001|COMPLETED|Overall Study||196||
60088470|NCT03113968|76204665|FG000|NOT COMPLETED|Overall Study||31||
60088471|NCT03113968|76204666|FG001|NOT COMPLETED|Overall Study||4||
60088472|NCT02864251|76204675|FG000|STARTED|Pre-Treatment||144|Started = Randomized|
60088473|NCT02864251|76204676|FG001|STARTED|Pre-Treatment||73|Started = Randomized|
60088474|NCT02864251|76204677|FG002|STARTED|Pre-Treatment||150|Started = Randomized|
60088475|NCT02864251|76204675|FG000|COMPLETED|Pre-Treatment||141|Completed = Started Treatment|
60088476|NCT02864251|76204676|FG001|COMPLETED|Pre-Treatment||71|Completed = Started Treatment|
60088477|NCT02864251|76204677|FG002|COMPLETED|Pre-Treatment||143|Completed = Started Treatment|
59560726|NCT01661270|75662048|FG001|Physician Decision|Overall Study|Met EOT criteria|8||
59560727|NCT01661270|75662047|FG000|Participant's Request|Overall Study|Met EOT criteria|15||
59560728|NCT01661270|75662048|FG001|Participant's Request|Overall Study|Met EOT criteria|48||
59560729|NCT01661270|75662047|FG000|Other Reasons|Overall Study||0||
59560730|NCT01661270|75662048|FG001|Other Reasons|Overall Study||2||
59560731|NCT01661270|75662047|FG000|COMPLETED|Overall Study|Treatment until disease progression/death, toxicity, consent withdrawal or Investigator's decision.|109||
59560732|NCT01661270|75662048|FG001|COMPLETED|Overall Study|Treatment until disease progression/death, toxicity, consent withdrawal or Investigator's decision.|223||
59560733|NCT01661270|75662047|FG000|NOT COMPLETED|Overall Study||0||
59560734|NCT01661270|75662048|FG001|NOT COMPLETED|Overall Study||0||
59707636|NCT00991276|75826523|FG003|STARTED|Placebo Wash-out Period (7 Days)||9||
59707637|NCT00991276|75826524|FG004|STARTED|Placebo Wash-out Period (7 Days)||10||
59560735|NCT02997735|75662057|FG000|STARTED|Overall Study||233||
59560736|NCT02997735|75662058|FG001|STARTED|Overall Study||251||
59560737|NCT02997735|75662057|FG000|COMPLETED|Overall Study||233||
59560738|NCT02997735|75662058|FG001|COMPLETED|Overall Study||251||
60088478|NCT02864251|76204675|FG000|NOT COMPLETED|Pre-Treatment||3||
60088479|NCT02864251|76204676|FG001|NOT COMPLETED|Pre-Treatment||2||
60088480|NCT02864251|76204677|FG002|NOT COMPLETED|Pre-Treatment||7||
60088481|NCT02864251|76204675|FG000|STARTED|Treatment||141|Started Treatment|
60088482|NCT02864251|76204676|FG001|STARTED|Treatment||71|Started Treatment|
60088483|NCT02864251|76204677|FG002|STARTED|Treatment||143|Started Treatment|
59560739|NCT02997735|75662057|FG000|NOT COMPLETED|Overall Study||0||
59560740|NCT02997735|75662058|FG001|NOT COMPLETED|Overall Study||0||
59560741|NCT01662752|75662064|FG000|STARTED|Overall Study||30||
60088484|NCT02864251|76204675|FG000|COMPLETED|Treatment||3|Completed Treatment|
60088485|NCT02864251|76204676|FG001|COMPLETED|Treatment||5|Completed Treatment|
60088486|NCT02864251|76204677|FG002|COMPLETED|Treatment||0|Completed Treatment|
60088487|NCT02864251|76204675|FG000|NOT COMPLETED|Treatment||138||
60088488|NCT02864251|76204676|FG001|NOT COMPLETED|Treatment||66||
60088489|NCT02864251|76204677|FG002|NOT COMPLETED|Treatment||143||
60088490|NCT02774148|76204687|FG000|STARTED|Overall Study||0||
60088491|NCT02774148|76204688|FG001|STARTED|Overall Study||0||
60088492|NCT02774148|76204687|FG000|COMPLETED|Overall Study||0||
60088493|NCT02774148|76204688|FG001|COMPLETED|Overall Study||0||
60088494|NCT02774148|76204687|FG000|NOT COMPLETED|Overall Study||0||
60088495|NCT02774148|76204688|FG001|NOT COMPLETED|Overall Study||0||
60088496|NCT02771197|76204694|FG000|STARTED|Overall Study||20||
60088497|NCT02771197|76204694|FG000|COMPLETED|Overall Study||15||
59560742|NCT01662752|75662064|FG000|COMPLETED|Overall Study||30||
59560743|NCT01662752|75662064|FG000|NOT COMPLETED|Overall Study||0||
59560744|NCT02999763|75662068|FG000|STARTED|Overall Study||70||
60088498|NCT02771197|76204694|FG000|NOT COMPLETED|Overall Study||5||
60088499|NCT02767388|76204701|FG000|STARTED|Overall Study||15||
60088500|NCT02767388|76204702|FG001|STARTED|Overall Study||15||
60088501|NCT02767388|76204703|FG002|STARTED|Overall Study||15||
60088502|NCT02767388|76204701|FG000|COMPLETED|Overall Study||8||
60088503|NCT02767388|76204702|FG001|COMPLETED|Overall Study||10||
60088504|NCT02767388|76204703|FG002|COMPLETED|Overall Study||12||
59560745|NCT02999763|75662068|FG000|COMPLETED|Overall Study||58||
60088505|NCT02767388|76204701|FG000|NOT COMPLETED|Overall Study||7||
60088506|NCT02767388|76204702|FG001|NOT COMPLETED|Overall Study||5||
60088507|NCT02767388|76204703|FG002|NOT COMPLETED|Overall Study||3||
60088508|NCT02570113|76204711|FG000|STARTED|Overall Study||45||
60088509|NCT02570113|76204711|FG000|COMPLETED|Overall Study||42||
60088510|NCT02570113|76204711|FG000|NOT COMPLETED|Overall Study||3||
60088511|NCT02565914|76204715|FG000|STARTED|Part A (Up to 96 Weeks)||1044||
60088512|NCT02565914|76204715|FG000|Safety Set|Part A (Up to 96 Weeks)||1042|Received at least 1 dose of TEZ/IVA|
60088513|NCT02565914|76204715|FG000|COMPLETED|Part A (Up to 96 Weeks)||951||
60088514|NCT02565914|76204715|FG000|NOT COMPLETED|Part A (Up to 96 Weeks)||93||
60088515|NCT02565914|76204715|FG000|STARTED|Part B (Up to 96 Weeks)|Out of 464 participants in Part B, 377 participants rolled over from Part A and 87 participants rolled over directly from parent studies.|464||
60088516|NCT02565914|76204715|FG000|Safety Set|Part B (Up to 96 Weeks)||463|Received at least 1 dose of TEZ/IVA|
60088517|NCT02565914|76204715|FG000|COMPLETED|Part B (Up to 96 Weeks)||228||
60088518|NCT02565914|76204715|FG000|NOT COMPLETED|Part B (Up to 96 Weeks)||236||
60088519|NCT02565914|76204715|FG000|STARTED|Part C (Up to 192 Weeks)|Out of 464 participants in Part B, 204 participants rolled over to Part C.|204||
60088520|NCT02565914|76204715|FG000|Safety Set|Part C (Up to 192 Weeks)||204||
60088521|NCT02565914|76204715|FG000|COMPLETED|Part C (Up to 192 Weeks)||7||
60088522|NCT02565914|76204715|FG000|NOT COMPLETED|Part C (Up to 192 Weeks)||197||
59560746|NCT02999763|75662068|FG000|NOT COMPLETED|Overall Study||12||
59560747|NCT03000309|75662072|FG000|STARTED|Overall Study||20||
59560748|NCT03000309|75662072|FG000|COMPLETED|Overall Study||19||
60088523|NCT02248701|76204725|FG000|STARTED|Overall Study||7||
60088524|NCT02248701|76204726|FG001|STARTED|Overall Study||5||
60088525|NCT02248701|76204725|FG000|COMPLETED|Overall Study||3||
60088526|NCT02248701|76204726|FG001|COMPLETED|Overall Study||3||
60088527|NCT02248701|76204725|FG000|NOT COMPLETED|Overall Study||4||
60088528|NCT02248701|76204726|FG001|NOT COMPLETED|Overall Study||2||
60088529|NCT02204982|76204734|FG000|STARTED|Overall Study||6||
60088530|NCT02204982|76204735|FG001|STARTED|Overall Study||7||
59560749|NCT03000309|75662072|FG000|NOT COMPLETED|Overall Study||1||
59560750|NCT03165981|75662078|FG000|STARTED|Overall Study||110|Intent-to-treat Population: enrolled, randomized and received at least one study vaccine at V1|
59560751|NCT03165981|75662079|FG001|STARTED|Overall Study||111|Intent-to-treat Population: enrolled, randomized and received at least one study vaccine at V1|
59560752|NCT03165981|75662078|FG000|Per Protocol Population|Overall Study||99|Excludes those w/o valid temperature data on D1-2 following V1-2 or with major protocol violations|
59560753|NCT03165981|75662079|FG001|Per Protocol Population|Overall Study||107|Excludes those w/o valid temperature data on D1-2 following V1-2 or with major protocol violations|
59560754|NCT03165981|75662078|FG000|COMPLETED|Overall Study||99||
59560755|NCT03165981|75662079|FG001|COMPLETED|Overall Study||107||
60088531|NCT02204982|76204734|FG000|COMPLETED|Overall Study||2||
60088532|NCT02204982|76204735|FG001|COMPLETED|Overall Study||0||
60088533|NCT02204982|76204734|FG000|NOT COMPLETED|Overall Study||4||
60088534|NCT02204982|76204735|FG001|NOT COMPLETED|Overall Study||7||
60088535|NCT02101385|76204743|FG000|STARTED|Study Treatment||71||
60088536|NCT02101385|76204744|FG001|STARTED|Study Treatment||122||
59560756|NCT03165981|75662078|FG000|NOT COMPLETED|Overall Study||11||
59560757|NCT03165981|75662079|FG001|NOT COMPLETED|Overall Study||4||
59560758|NCT03167541|75662085|FG000|STARTED|First Intervention||9||
59560759|NCT03167541|75662086|FG001|STARTED|First Intervention||9||
59560760|NCT03167541|75662085|FG000|COMPLETED|First Intervention||9||
59560761|NCT03167541|75662086|FG001|COMPLETED|First Intervention||9||
59560762|NCT03167541|75662085|FG000|NOT COMPLETED|First Intervention||0||
59560763|NCT03167541|75662086|FG001|NOT COMPLETED|First Intervention||0||
59560764|NCT03167541|75662085|FG000|STARTED|Washout: 5-8 Days||9||
59707638|NCT00991276|75826525|FG005|STARTED|Placebo Wash-out Period (7 Days)||11||
59707639|NCT00991276|75826520|FG000|COMPLETED|Placebo Wash-out Period (7 Days)||14||
60088537|NCT02101385|76204743|FG000|COMPLETED|Study Treatment||45||
60088538|NCT02101385|76204744|FG001|COMPLETED|Study Treatment||110||
60088539|NCT02101385|76204743|FG000|NOT COMPLETED|Study Treatment||26||
60088540|NCT02101385|76204744|FG001|NOT COMPLETED|Study Treatment||12||
60088541|NCT02101385|76204743|FG000|STARTED|Follow up||70|Treatment and Follow up both are at different time period. Therefore, the number of subjects to start follow up is not equal to the number of subjects who have completed treatment.|
60088542|NCT02101385|76204744|FG001|STARTED|Follow up||122|Treatment and Follow up both are at different time period. Therefore, the number of subjects to start follow up is not equal to the number of subjects who have completed treatment.|
60088543|NCT02101385|76204743|FG000|COMPLETED|Follow up||3||
60088544|NCT02101385|76204744|FG001|COMPLETED|Follow up||9||
60088545|NCT02101385|76204743|FG000|NOT COMPLETED|Follow up||67||
60088546|NCT02101385|76204744|FG001|NOT COMPLETED|Follow up||113||
60088547|NCT02086175|76204752|FG000|STARTED|Overall Study||25||
60088548|NCT02086175|76204752|FG000|COMPLETED|Overall Study||25||
60088549|NCT02086175|76204752|FG000|NOT COMPLETED|Overall Study||0||
60088550|NCT02068443|76204759|FG000|STARTED|Overall Study||71||
60088551|NCT02068443|76204760|FG001|STARTED|Overall Study||152||
60088552|NCT02068443|76204761|FG002|STARTED|Overall Study||151||
60088553|NCT02068443|76204759|FG000|COMPLETED|Overall Study||64||
60088554|NCT02068443|76204760|FG001|COMPLETED|Overall Study||146||
60088555|NCT02068443|76204761|FG002|COMPLETED|Overall Study||148||
60088556|NCT02068443|76204759|FG000|NOT COMPLETED|Overall Study||7||
60088557|NCT02068443|76204760|FG001|NOT COMPLETED|Overall Study||6||
59560765|NCT03167541|75662086|FG001|STARTED|Washout: 5-8 Days||9||
59560766|NCT03167541|75662085|FG000|COMPLETED|Washout: 5-8 Days||9||
59560767|NCT03167541|75662086|FG001|COMPLETED|Washout: 5-8 Days||9||
60088558|NCT02068443|76204761|FG002|NOT COMPLETED|Overall Study||3||
60088559|NCT02065869|76204769|FG000|STARTED|Overall Study||184|Patients receiving HSCT graft (HSCT Safety population)|
60088560|NCT02065869|76204769|FG000|Patients Receiving Rivogenlecleucel (BPX-501 Safety Population)|Overall Study||171||
60088561|NCT02065869|76204769|FG000|ITT Population|Overall Study||142||
60088562|NCT02065869|76204769|FG000|Patients Receiving at Least 1 Dose of Rimiducid|Overall Study||16||
60088563|NCT02065869|76204769|FG000|COMPLETED|Overall Study||149||
60088564|NCT02065869|76204769|FG000|NOT COMPLETED|Overall Study||35||
60088565|NCT02018861|76204784|FG000|STARTED|Parsaclisib Monotherapy: 21-day Cycles||1||
60088566|NCT02018861|76204785|FG001|STARTED|Parsaclisib Monotherapy: 21-day Cycles||3||
60088567|NCT02018861|76204786|FG002|STARTED|Parsaclisib Monotherapy: 21-day Cycles||3||
60088568|NCT02018861|76204787|FG003|STARTED|Parsaclisib Monotherapy: 21-day Cycles||34||
59560768|NCT03167541|75662085|FG000|NOT COMPLETED|Washout: 5-8 Days||0||
59560769|NCT03167541|75662086|FG001|NOT COMPLETED|Washout: 5-8 Days||0||
59560770|NCT03167541|75662085|FG000|STARTED|Second Intervention||9||
59560771|NCT03167541|75662086|FG001|STARTED|Second Intervention||9||
59560772|NCT03167541|75662085|FG000|COMPLETED|Second Intervention||9||
59560773|NCT03167541|75662086|FG001|COMPLETED|Second Intervention||9||
59560774|NCT03167541|75662085|FG000|NOT COMPLETED|Second Intervention||0||
59560775|NCT03167541|75662086|FG001|NOT COMPLETED|Second Intervention||0||
59560776|NCT03168321|75662095|FG000|STARTED|Overall Study||402||
59560777|NCT03168321|75662096|FG001|STARTED|Overall Study||411||
59560778|NCT03168321|75662095|FG000|COMPLETED|Overall Study||347||
59560779|NCT03168321|75662096|FG001|COMPLETED|Overall Study||356||
59560780|NCT03168321|75662095|FG000|NOT COMPLETED|Overall Study||55||
59560781|NCT03168321|75662096|FG001|NOT COMPLETED|Overall Study||55||
59560782|NCT03170661|75662104|FG000|STARTED|Overall Study||49||
59560783|NCT03170661|75662105|FG001|STARTED|Overall Study||49||
59560784|NCT03170661|75662104|FG000|COMPLETED|Overall Study||49||
59560785|NCT03170661|75662105|FG001|COMPLETED|Overall Study||49||
59560786|NCT03170661|75662104|FG000|NOT COMPLETED|Overall Study||0||
59560787|NCT03170661|75662105|FG001|NOT COMPLETED|Overall Study||0||
59560788|NCT03171051|75662113|FG000|STARTED|Overall Study||10||
59560789|NCT03171051|75662113|FG000|COMPLETED|Overall Study||10||
59560790|NCT03171051|75662113|FG000|NOT COMPLETED|Overall Study||0||
59560791|NCT03175731|75662120|FG000|STARTED|Overall Study||53||
59560792|NCT03175731|75662121|FG001|STARTED|Overall Study||53||
59560793|NCT03175731|75662120|FG000|COMPLETED|Overall Study||46||
59560794|NCT03175731|75662121|FG001|COMPLETED|Overall Study||48||
59560795|NCT03175731|75662120|FG000|NOT COMPLETED|Overall Study||7||
59560796|NCT03175731|75662121|FG001|NOT COMPLETED|Overall Study||5||
59560797|NCT01662908|75662129|FG000|STARTED|Overall Study||56||
59560798|NCT01662908|75662130|FG001|STARTED|Overall Study||28||
59560799|NCT01662908|75662129|FG000|COMPLETED|Overall Study||50||
59560800|NCT01662908|75662130|FG001|COMPLETED|Overall Study||23||
59992718|NCT02198794|76108496|FG002|NOT COMPLETED|Part C: Safety Assessment (52 Weeks)||0||
59992719|NCT02198794|76108497|FG003|NOT COMPLETED|Part C: Safety Assessment (52 Weeks)||7||
59992720|NCT02133664|76108508|FG000|STARTED|Overall Study||26||
59992721|NCT02133664|76108509|FG001|STARTED|Overall Study||28||
59992722|NCT02133664|76108508|FG000|COMPLETED|Overall Study||21||
59992723|NCT02133664|76108509|FG001|COMPLETED|Overall Study||21||
59992724|NCT02133664|76108508|FG000|NOT COMPLETED|Overall Study||5||
60088569|NCT02018861|76204788|FG004|STARTED|Parsaclisib Monotherapy: 21-day Cycles||27||
60088570|NCT02018861|76204789|FG005|STARTED|Parsaclisib Monotherapy: 21-day Cycles||4||
60088571|NCT02018861|76204790|FG006|STARTED|Parsaclisib Monotherapy: 21-day Cycles||0||
60088572|NCT02018861|76204791|FG007|STARTED|Parsaclisib Monotherapy: 21-day Cycles||0||
59560801|NCT01662908|75662129|FG000|NOT COMPLETED|Overall Study||6||
59560802|NCT01662908|75662130|FG001|NOT COMPLETED|Overall Study||5||
59992725|NCT02133664|76108509|FG001|NOT COMPLETED|Overall Study||7||
59992726|NCT02133508|76108515|FG000|STARTED|Overall Study||156||
60088573|NCT02018861|76204792|FG008|STARTED|Parsaclisib Monotherapy: 21-day Cycles||0||
60088574|NCT02018861|76204793|FG009|STARTED|Parsaclisib Monotherapy: 21-day Cycles||0||
60088575|NCT02018861|76204784|FG000|COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||0||
60088576|NCT02018861|76204785|FG001|COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||0||
60088577|NCT02018861|76204786|FG002|COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||0||
59992727|NCT02133508|76108515|FG000|COMPLETED|Overall Study||141||
59992728|NCT02133508|76108515|FG000|NOT COMPLETED|Overall Study||15||
60088578|NCT02018861|76204787|FG003|COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||4||
60088579|NCT02018861|76204788|FG004|COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||0||
60088580|NCT02018861|76204789|FG005|COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||0||
60088581|NCT02018861|76204790|FG006|COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||0||
60088582|NCT02018861|76204791|FG007|COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||0||
60088583|NCT02018861|76204792|FG008|COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||0||
60088584|NCT02018861|76204793|FG009|COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||0||
60088585|NCT02018861|76204784|FG000|NOT COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||1||
60088586|NCT02018861|76204785|FG001|NOT COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||3||
60088587|NCT02018861|76204786|FG002|NOT COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||3||
60088588|NCT02018861|76204787|FG003|NOT COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||30||
60088589|NCT02018861|76204788|FG004|NOT COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||27||
59560803|NCT02234180|75662136|FG000|STARTED|Overall Study||2||
59560804|NCT02234180|75662137|FG001|STARTED|Overall Study||1||
59560805|NCT02234180|75662136|FG000|COMPLETED|Overall Study||2||
59560806|NCT02234180|75662137|FG001|COMPLETED|Overall Study||1||
59560807|NCT02234180|75662136|FG000|NOT COMPLETED|Overall Study||0||
60088590|NCT02018861|76204789|FG005|NOT COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||4||
60088591|NCT02018861|76204790|FG006|NOT COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||0||
60088592|NCT02018861|76204791|FG007|NOT COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||0||
60088593|NCT02018861|76204792|FG008|NOT COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||0||
60088594|NCT02018861|76204793|FG009|NOT COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||0||
60088595|NCT02018861|76204784|FG000|STARTED|Parsaclisib + Itacitinib; 21-day Cycles||0||
60088596|NCT02018861|76204785|FG001|STARTED|Parsaclisib + Itacitinib; 21-day Cycles||0||
60088597|NCT02018861|76204786|FG002|STARTED|Parsaclisib + Itacitinib; 21-day Cycles||0||
59816773|NCT04076059|75939149|FG001|COMPLETED|Double Blind Phase||0||
59816774|NCT04076059|75939150|FG002|COMPLETED|Double Blind Phase||0||
59816775|NCT04076059|75939148|FG000|NOT COMPLETED|Double Blind Phase||120||
59816776|NCT04076059|75939149|FG001|NOT COMPLETED|Double Blind Phase||60||
60088598|NCT02018861|76204787|FG003|STARTED|Parsaclisib + Itacitinib; 21-day Cycles||0||
60088599|NCT02018861|76204788|FG004|STARTED|Parsaclisib + Itacitinib; 21-day Cycles||0||
60088600|NCT02018861|76204789|FG005|STARTED|Parsaclisib + Itacitinib; 21-day Cycles||0||
60088601|NCT02018861|76204790|FG006|STARTED|Parsaclisib + Itacitinib; 21-day Cycles||8||
60088602|NCT02018861|76204791|FG007|STARTED|Parsaclisib + Itacitinib; 21-day Cycles||3||
60088603|NCT02018861|76204792|FG008|STARTED|Parsaclisib + Itacitinib; 21-day Cycles||0||
60088604|NCT02018861|76204793|FG009|STARTED|Parsaclisib + Itacitinib; 21-day Cycles||0||
60088605|NCT02018861|76204784|FG000|COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||0||
60088606|NCT02018861|76204785|FG001|COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||0||
60088607|NCT02018861|76204786|FG002|COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||0||
60088608|NCT02018861|76204787|FG003|COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||0||
60088609|NCT02018861|76204788|FG004|COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||0||
60088610|NCT02018861|76204789|FG005|COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||0||
60088611|NCT02018861|76204790|FG006|COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||0||
60088612|NCT02018861|76204791|FG007|COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||0||
60088613|NCT02018861|76204792|FG008|COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||0||
60088614|NCT02018861|76204793|FG009|COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||0||
60088615|NCT02018861|76204784|FG000|NOT COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||0||
60088616|NCT02018861|76204785|FG001|NOT COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||0||
60088617|NCT02018861|76204786|FG002|NOT COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||0||
60088618|NCT02018861|76204787|FG003|NOT COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||0||
60088619|NCT02018861|76204788|FG004|NOT COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||0||
60088620|NCT02018861|76204789|FG005|NOT COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||0||
60088621|NCT02018861|76204790|FG006|NOT COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||8||
60088622|NCT02018861|76204791|FG007|NOT COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||3||
60088623|NCT02018861|76204792|FG008|NOT COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||0||
60088624|NCT02018861|76204793|FG009|NOT COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||0||
60088625|NCT02018861|76204784|FG000|STARTED|Parsaclisib + R-ICE; 21-day Cycles||0||
60088626|NCT02018861|76204785|FG001|STARTED|Parsaclisib + R-ICE; 21-day Cycles||0||
60088627|NCT02018861|76204786|FG002|STARTED|Parsaclisib + R-ICE; 21-day Cycles||0||
60088628|NCT02018861|76204787|FG003|STARTED|Parsaclisib + R-ICE; 21-day Cycles||0||
60088629|NCT02018861|76204788|FG004|STARTED|Parsaclisib + R-ICE; 21-day Cycles||0||
60088630|NCT02018861|76204789|FG005|STARTED|Parsaclisib + R-ICE; 21-day Cycles||0||
60088631|NCT02018861|76204790|FG006|STARTED|Parsaclisib + R-ICE; 21-day Cycles||0||
60088632|NCT02018861|76204791|FG007|STARTED|Parsaclisib + R-ICE; 21-day Cycles||0||
60088633|NCT02018861|76204792|FG008|STARTED|Parsaclisib + R-ICE; 21-day Cycles||4||
59816777|NCT04076059|75939150|FG002|NOT COMPLETED|Double Blind Phase||0||
59817923|NCT04488770|75940336|FG010|STARTED|Part 1-Cohort 2: Period 2 (Up to 5 Days)||0||
59816778|NCT04076059|75939148|FG000|STARTED|Open Label Phase|Only participants who received placebo in the double blind Phase received enzalutamide plus ADT in Open -label Phase.|0||
60088634|NCT02018861|76204793|FG009|STARTED|Parsaclisib + R-ICE; 21-day Cycles||1||
60088635|NCT02018861|76204784|FG000|COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||0||
59560808|NCT02234180|75662137|FG001|NOT COMPLETED|Overall Study||0||
59560809|NCT03177603|75662145|FG000|STARTED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||4||
59560810|NCT03177603|75662146|FG001|STARTED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0||
59560811|NCT03177603|75662147|FG002|STARTED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0||
59560812|NCT03177603|75662148|FG003|STARTED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0||
59560813|NCT03177603|75662145|FG000|COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||4||
59560814|NCT03177603|75662146|FG001|COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0||
59560815|NCT03177603|75662147|FG002|COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0||
59560816|NCT03177603|75662148|FG003|COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0||
60088636|NCT02018861|76204785|FG001|COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||0||
60088637|NCT02018861|76204786|FG002|COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||0||
60088638|NCT02018861|76204787|FG003|COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||0||
60088639|NCT02018861|76204788|FG004|COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||0||
60088640|NCT02018861|76204789|FG005|COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||0||
60088641|NCT02018861|76204790|FG006|COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||0||
59560817|NCT03177603|75662145|FG000|NOT COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0||
59560818|NCT03177603|75662146|FG001|NOT COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0||
59560819|NCT03177603|75662147|FG002|NOT COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0||
59707640|NCT00991276|75826521|FG001|COMPLETED|Placebo Wash-out Period (7 Days)||8||
60088642|NCT02018861|76204791|FG007|COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||0||
60088643|NCT02018861|76204792|FG008|COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||1||
60088644|NCT02018861|76204793|FG009|COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||1||
60088645|NCT02018861|76204784|FG000|NOT COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||0||
60088646|NCT02018861|76204785|FG001|NOT COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||0||
60088647|NCT02018861|76204786|FG002|NOT COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||0||
60088648|NCT02018861|76204787|FG003|NOT COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||0||
60088649|NCT02018861|76204788|FG004|NOT COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||0||
60088650|NCT02018861|76204789|FG005|NOT COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||0||
60088651|NCT02018861|76204790|FG006|NOT COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||0||
60088652|NCT02018861|76204791|FG007|NOT COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||0||
60088653|NCT02018861|76204792|FG008|NOT COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||3||
60088654|NCT02018861|76204793|FG009|NOT COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||0||
60088655|NCT01949337|76204824|FG000|STARTED|Overall Study||657||
59707641|NCT00991276|75826522|FG002|COMPLETED|Placebo Wash-out Period (7 Days)||14||
59707642|NCT00991276|75826523|FG003|COMPLETED|Placebo Wash-out Period (7 Days)||9||
59707643|NCT00991276|75826524|FG004|COMPLETED|Placebo Wash-out Period (7 Days)||10||
59707644|NCT00991276|75826525|FG005|COMPLETED|Placebo Wash-out Period (7 Days)||11||
59992729|NCT02133352|76108519|FG000|STARTED|Main Study (180 Day)||10||
59992730|NCT02133352|76108519|FG000|COMPLETED|Main Study (180 Day)||10||
59707645|NCT00991276|75826520|FG000|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0||
59707646|NCT00991276|75826521|FG001|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0||
59707647|NCT00991276|75826522|FG002|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0||
59707648|NCT00991276|75826523|FG003|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0||
59707649|NCT00991276|75826524|FG004|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0||
59707650|NCT00991276|75826525|FG005|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0||
59992731|NCT02133352|76108519|FG000|NOT COMPLETED|Main Study (180 Day)||0||
59992732|NCT02133352|76108519|FG000|STARTED|Longer Term Extension||10||
59992733|NCT02133352|76108519|FG000|COMPLETED|Longer Term Extension||4|4 of the initial 10 subjects agreed/consented to participate in the longer term extension|
59560820|NCT03177603|75662148|FG003|NOT COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0||
59560821|NCT03177603|75662145|FG000|STARTED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0||
59560822|NCT03177603|75662146|FG001|STARTED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||5||
59560823|NCT03177603|75662147|FG002|STARTED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0||
59560824|NCT03177603|75662148|FG003|STARTED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0||
59560825|NCT03177603|75662145|FG000|COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0||
59560826|NCT03177603|75662146|FG001|COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||5||
59560827|NCT03177603|75662147|FG002|COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0||
59560828|NCT03177603|75662148|FG003|COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0||
59560829|NCT03177603|75662145|FG000|NOT COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0||
59560830|NCT03177603|75662146|FG001|NOT COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0||
59560831|NCT03177603|75662147|FG002|NOT COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0||
59560832|NCT03177603|75662148|FG003|NOT COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0||
59560833|NCT03177603|75662145|FG000|STARTED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0||
59560834|NCT03177603|75662146|FG001|STARTED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0||
59560835|NCT03177603|75662147|FG002|STARTED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||6||
59560836|NCT03177603|75662148|FG003|STARTED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0||
59560837|NCT03177603|75662145|FG000|COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0||
59560838|NCT03177603|75662146|FG001|COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0||
59560839|NCT03177603|75662147|FG002|COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||6||
59560840|NCT03177603|75662148|FG003|COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0||
59560841|NCT03177603|75662145|FG000|NOT COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0||
59560842|NCT03177603|75662146|FG001|NOT COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0||
59560843|NCT03177603|75662147|FG002|NOT COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0||
59560844|NCT03177603|75662148|FG003|NOT COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0||
59560845|NCT03177603|75662145|FG000|STARTED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0||
59560846|NCT03177603|75662146|FG001|STARTED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0||
59560847|NCT03177603|75662147|FG002|STARTED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0||
59560848|NCT03177603|75662148|FG003|STARTED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||8||
59560849|NCT03177603|75662145|FG000|COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0||
59560850|NCT03177603|75662146|FG001|COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0||
59560851|NCT03177603|75662147|FG002|COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0||
59560852|NCT03177603|75662148|FG003|COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||8||
59560853|NCT03177603|75662145|FG000|NOT COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0||
59560854|NCT03177603|75662146|FG001|NOT COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0||
59816779|NCT04076059|75939149|FG001|STARTED|Open Label Phase|Only participants who received placebo in the double blind Phase received enzalutamide plus ADT in Open -label Phase.|0||
59816780|NCT04076059|75939150|FG002|STARTED|Open Label Phase|Eligible participants who provided consent took part in open-label period|23||
59816781|NCT04076059|75939148|FG000|COMPLETED|Open Label Phase||0||
59816782|NCT04076059|75939149|FG001|COMPLETED|Open Label Phase||0||
59816783|NCT04076059|75939150|FG002|COMPLETED|Open Label Phase||0||
59816784|NCT04076059|75939148|FG000|NOT COMPLETED|Open Label Phase||0||
59816785|NCT04076059|75939149|FG001|NOT COMPLETED|Open Label Phase||0||
59816786|NCT04076059|75939150|FG002|NOT COMPLETED|Open Label Phase||23||
59816787|NCT04047420|75939157|FG000|STARTED|Enrollment (Pre-dose) Period||23||
59816788|NCT04047420|75939157|FG000|COMPLETED|Enrollment (Pre-dose) Period||21||
59816789|NCT04047420|75939157|FG000|NOT COMPLETED|Enrollment (Pre-dose) Period||2||
59816790|NCT04047420|75939157|FG000|STARTED|One TAF/EVG Insert Dose||21||
59816791|NCT04047420|75939157|FG000|COMPLETED|One TAF/EVG Insert Dose||21||
59816792|NCT04047420|75939157|FG000|NOT COMPLETED|One TAF/EVG Insert Dose||0||
59816793|NCT04047420|75939157|FG000|STARTED|Washout Period||21||
59816794|NCT04047420|75939157|FG000|COMPLETED|Washout Period||19||
59816795|NCT04047420|75939157|FG000|NOT COMPLETED|Washout Period||2||
59816796|NCT04047420|75939157|FG000|STARTED|Two TAF/EVG Inserts Dose||19||
59816797|NCT04047420|75939157|FG000|COMPLETED|Two TAF/EVG Inserts Dose||19||
59816798|NCT04047420|75939157|FG000|NOT COMPLETED|Two TAF/EVG Inserts Dose||0||
59816799|NCT04003636|75939166|FG000|STARTED|Overall Study||533||
59816800|NCT04003636|75939167|FG001|STARTED|Overall Study||536||
59816801|NCT04003636|75939166|FG000|COMPLETED|Overall Study||0||
59816802|NCT04003636|75939167|FG001|COMPLETED|Overall Study||0||
59816803|NCT04003636|75939166|FG000|NOT COMPLETED|Overall Study||533||
60088656|NCT01949337|76204825|FG001|STARTED|Overall Study||654||
60088657|NCT01949337|76204824|FG000|COMPLETED|Overall Study||657||
60088658|NCT01949337|76204825|FG001|COMPLETED|Overall Study||654||
60088659|NCT01949337|76204824|FG000|NOT COMPLETED|Overall Study||0||
60088660|NCT01949337|76204825|FG001|NOT COMPLETED|Overall Study||0||
60088661|NCT01827384|76204845|FG000|STARTED|Overall Study||13||
60088662|NCT01827384|76204846|FG001|STARTED|Overall Study||1||
59816804|NCT04003636|75939167|FG001|NOT COMPLETED|Overall Study||536||
59816805|NCT03958045|75939174|FG000|STARTED|Overall Study||33||
60088663|NCT01827384|76204847|FG002|STARTED|Overall Study||9||
60088664|NCT01827384|76204848|FG003|STARTED|Overall Study||1||
60088665|NCT01827384|76204849|FG004|STARTED|Overall Study||1||
60088666|NCT01827384|76204850|FG005|STARTED|Overall Study||22||
60088667|NCT01827384|76204851|FG006|STARTED|Overall Study||2||
60088668|NCT01827384|76204852|FG007|STARTED|Overall Study||1||
60088669|NCT01827384|76204853|FG008|STARTED|Overall Study||2||
60088670|NCT01827384|76204854|FG009|STARTED|Overall Study||15||
59816806|NCT03958045|75939174|FG000|COMPLETED|Overall Study||32||
59816807|NCT03958045|75939174|FG000|NOT COMPLETED|Overall Study||1||
59816808|NCT03806179|75939180|FG000|STARTED|Overall Study|Includes one participant who received 10 MBq/kg instead of 15 MBq/kg in error|4||
59816809|NCT03806179|75939181|FG001|STARTED|Overall Study||3||
59816810|NCT03806179|75939180|FG000|COMPLETED|Overall Study||4||
59816811|NCT03806179|75939181|FG001|COMPLETED|Overall Study||1||
60088671|NCT01827384|76204855|FG010|STARTED|Overall Study||7||
60088672|NCT01827384|76204856|FG011|STARTED|Overall Study||1||
60088673|NCT01827384|76204857|FG012|STARTED|Overall Study||2||
60088674|NCT01827384|76204858|FG013|STARTED|Overall Study||131||
59816812|NCT03806179|75939180|FG000|NOT COMPLETED|Overall Study||0||
60088675|NCT01827384|76204845|FG000|COMPLETED|Overall Study||13||
59707651|NCT00991276|75826520|FG000|STARTED|Third Intervention Period||14||
59560855|NCT03177603|75662147|FG002|NOT COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0||
59560856|NCT03177603|75662148|FG003|NOT COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0||
59560857|NCT02234570|75662166|FG000|STARTED|Overall Study||8||
59560858|NCT02234570|75662167|FG001|STARTED|Overall Study||8||
59560859|NCT02234570|75662168|FG002|STARTED|Overall Study||8||
59560860|NCT02234570|75662169|FG003|STARTED|Overall Study||8||
59560861|NCT02234570|75662170|FG004|STARTED|Overall Study||8||
59560862|NCT02234570|75662171|FG005|STARTED|Overall Study||8||
59560863|NCT02234570|75662172|FG006|STARTED|Overall Study||8||
59560864|NCT02234570|75662173|FG007|STARTED|Overall Study||14||
59560865|NCT02234570|75662166|FG000|COMPLETED|Overall Study||8||
59560866|NCT02234570|75662167|FG001|COMPLETED|Overall Study||8||
59560867|NCT02234570|75662168|FG002|COMPLETED|Overall Study||8||
59560868|NCT02234570|75662169|FG003|COMPLETED|Overall Study||8||
59560869|NCT02234570|75662170|FG004|COMPLETED|Overall Study||8||
59560870|NCT02234570|75662171|FG005|COMPLETED|Overall Study||8||
59560871|NCT02234570|75662172|FG006|COMPLETED|Overall Study||8||
59560872|NCT02234570|75662173|FG007|COMPLETED|Overall Study||14||
59560873|NCT02234570|75662166|FG000|NOT COMPLETED|Overall Study||0||
59560874|NCT02234570|75662167|FG001|NOT COMPLETED|Overall Study||0||
59560875|NCT02234570|75662168|FG002|NOT COMPLETED|Overall Study||0||
59560876|NCT02234570|75662169|FG003|NOT COMPLETED|Overall Study||0||
59560877|NCT02234570|75662170|FG004|NOT COMPLETED|Overall Study||0||
59560878|NCT02234570|75662171|FG005|NOT COMPLETED|Overall Study||0||
59560879|NCT02234570|75662172|FG006|NOT COMPLETED|Overall Study||0||
59560880|NCT02234570|75662173|FG007|NOT COMPLETED|Overall Study||0||
59560881|NCT02240030|75662194|FG000|STARTED|Overall Study||113||
59560882|NCT02240030|75662195|FG001|STARTED|Overall Study||114||
59560883|NCT02240030|75662196|FG002|STARTED|Overall Study||112||
59560884|NCT02240030|75662194|FG000|COMPLETED|Overall Study||96||
59560885|NCT02240030|75662195|FG001|COMPLETED|Overall Study||97||
59560886|NCT02240030|75662196|FG002|COMPLETED|Overall Study||97||
59560887|NCT02240030|75662194|FG000|NOT COMPLETED|Overall Study||17||
59560888|NCT02240030|75662195|FG001|NOT COMPLETED|Overall Study||17||
59560889|NCT02240030|75662196|FG002|NOT COMPLETED|Overall Study||15||
59560890|NCT01663922|75662206|FG000|STARTED|First Intervention (14 Days or 5 Days)||8||
59560891|NCT01663922|75662207|FG001|STARTED|First Intervention (14 Days or 5 Days)||9||
59560892|NCT01663922|75662206|FG000|COMPLETED|First Intervention (14 Days or 5 Days)||8||
59560893|NCT01663922|75662207|FG001|COMPLETED|First Intervention (14 Days or 5 Days)||9||
59560894|NCT01663922|75662206|FG000|NOT COMPLETED|First Intervention (14 Days or 5 Days)||0||
59560895|NCT01663922|75662207|FG001|NOT COMPLETED|First Intervention (14 Days or 5 Days)||0||
59560896|NCT01663922|75662206|FG000|STARTED|Washout (7 Days)||8||
59560897|NCT01663922|75662207|FG001|STARTED|Washout (7 Days)||9||
59560898|NCT01663922|75662206|FG000|COMPLETED|Washout (7 Days)||8||
59560899|NCT01663922|75662207|FG001|COMPLETED|Washout (7 Days)||9||
59560900|NCT01663922|75662206|FG000|NOT COMPLETED|Washout (7 Days)||0||
59560901|NCT01663922|75662207|FG001|NOT COMPLETED|Washout (7 Days)||0||
59560902|NCT01663922|75662206|FG000|STARTED|Second Intervention (14 Days)||8||
59560903|NCT01663922|75662207|FG001|STARTED|Second Intervention (14 Days)||9||
59560904|NCT01663922|75662206|FG000|COMPLETED|Second Intervention (14 Days)||8||
59560905|NCT01663922|75662207|FG001|COMPLETED|Second Intervention (14 Days)||9||
59560906|NCT01663922|75662206|FG000|NOT COMPLETED|Second Intervention (14 Days)||0||
59560907|NCT01663922|75662207|FG001|NOT COMPLETED|Second Intervention (14 Days)||0||
59560908|NCT01663922|75662206|FG000|STARTED|Washout (7 Days)||8||
59560909|NCT01663922|75662207|FG001|STARTED|Washout (7 Days)||9||
59560910|NCT01663922|75662206|FG000|COMPLETED|Washout (7 Days)||8||
59560911|NCT01663922|75662207|FG001|COMPLETED|Washout (7 Days)||9||
59560912|NCT01663922|75662206|FG000|NOT COMPLETED|Washout (7 Days)||0||
59560913|NCT01663922|75662207|FG001|NOT COMPLETED|Washout (7 Days)||0||
59560914|NCT01663922|75662206|FG000|STARTED|Third Intervention (14 Days or 5 Days)||8||
59560915|NCT01663922|75662207|FG001|STARTED|Third Intervention (14 Days or 5 Days)||9||
59560916|NCT01663922|75662206|FG000|COMPLETED|Third Intervention (14 Days or 5 Days)||8||
59560917|NCT01663922|75662207|FG001|COMPLETED|Third Intervention (14 Days or 5 Days)||9||
59992734|NCT02133352|76108519|FG000|NOT COMPLETED|Longer Term Extension||6||
60088676|NCT01827384|76204846|FG001|COMPLETED|Overall Study||1||
60088677|NCT01827384|76204847|FG002|COMPLETED|Overall Study||9||
59560918|NCT01663922|75662206|FG000|NOT COMPLETED|Third Intervention (14 Days or 5 Days)||0||
59560919|NCT01663922|75662207|FG001|NOT COMPLETED|Third Intervention (14 Days or 5 Days)||0||
59560920|NCT03180489|75662214|FG000|STARTED|Overall Study||33||
59560921|NCT03180489|75662215|FG001|STARTED|Overall Study||29||
59707652|NCT00991276|75826521|FG001|STARTED|Third Intervention Period||8||
59992735|NCT02167594|76108526|FG000|STARTED|Overall Study||20||
59992736|NCT02167594|76108527|FG001|STARTED|Overall Study||6||
59992737|NCT02167594|76108528|FG002|STARTED|Overall Study||3||
59992738|NCT02167594|76108526|FG000|COMPLETED|Overall Study||18|Completed = 9 month flortaucipir PET scan acquired|
59992739|NCT02167594|76108527|FG001|COMPLETED|Overall Study||5|Completed = 9 month flortaucipir PET scan acquired|
59992740|NCT02167594|76108528|FG002|COMPLETED|Overall Study||3|Completed = 9 month flortaucipir PET scan acquired|
59992741|NCT02167594|76108526|FG000|NOT COMPLETED|Overall Study||2||
59992742|NCT02167594|76108527|FG001|NOT COMPLETED|Overall Study||1||
60088678|NCT01827384|76204848|FG003|COMPLETED|Overall Study||1||
60088679|NCT01827384|76204849|FG004|COMPLETED|Overall Study||1||
60088680|NCT01827384|76204850|FG005|COMPLETED|Overall Study||22||
60088681|NCT01827384|76204851|FG006|COMPLETED|Overall Study||2||
60088682|NCT01827384|76204852|FG007|COMPLETED|Overall Study||1||
60088683|NCT01827384|76204853|FG008|COMPLETED|Overall Study||2||
60088684|NCT01827384|76204854|FG009|COMPLETED|Overall Study||15||
60088685|NCT01827384|76204855|FG010|COMPLETED|Overall Study||7||
60088686|NCT01827384|76204856|FG011|COMPLETED|Overall Study||1||
60088687|NCT01827384|76204857|FG012|COMPLETED|Overall Study||2||
60088688|NCT01827384|76204858|FG013|COMPLETED|Overall Study||0||
60088689|NCT01827384|76204845|FG000|NOT COMPLETED|Overall Study||0||
60088690|NCT01827384|76204846|FG001|NOT COMPLETED|Overall Study||0||
60088691|NCT01827384|76204847|FG002|NOT COMPLETED|Overall Study||0||
60088692|NCT01827384|76204848|FG003|NOT COMPLETED|Overall Study||0||
59560922|NCT03180489|75662214|FG000|COMPLETED|Overall Study||25||
59560923|NCT03180489|75662215|FG001|COMPLETED|Overall Study||25||
59560924|NCT03180489|75662214|FG000|NOT COMPLETED|Overall Study||8||
60088693|NCT01827384|76204849|FG004|NOT COMPLETED|Overall Study||0||
60088694|NCT01827384|76204850|FG005|NOT COMPLETED|Overall Study||0||
60088695|NCT01827384|76204851|FG006|NOT COMPLETED|Overall Study||0||
60088696|NCT01827384|76204852|FG007|NOT COMPLETED|Overall Study||0||
60088697|NCT01827384|76204853|FG008|NOT COMPLETED|Overall Study||0||
60088698|NCT01827384|76204854|FG009|NOT COMPLETED|Overall Study||0||
60088699|NCT01827384|76204855|FG010|NOT COMPLETED|Overall Study||0||
60088700|NCT01827384|76204856|FG011|NOT COMPLETED|Overall Study||0||
60088701|NCT01827384|76204857|FG012|NOT COMPLETED|Overall Study||0||
60088702|NCT01827384|76204858|FG013|NOT COMPLETED|Overall Study||131||
60088703|NCT01704157|76204888|FG000|STARTED|Overall Study||33||
60088704|NCT01704157|76204888|FG000|COMPLETED|Overall Study||33||
60088705|NCT01704157|76204888|FG000|NOT COMPLETED|Overall Study||0||
60088706|NCT01585194|76204893|FG000|STARTED|Overall Study||39||
60088707|NCT01585194|76204893|FG000|COMPLETED|Overall Study||35||
60088708|NCT01585194|76204893|FG000|NOT COMPLETED|Overall Study||4||
60088709|NCT01377389|76204897|FG000|STARTED|Overall Study||30||
60088710|NCT01377389|76204897|FG000|COMPLETED|Overall Study||27||
60088711|NCT01377389|76204897|FG000|NOT COMPLETED|Overall Study||3||
60088712|NCT01287611|76204903|FG000|STARTED|Overall Study||84||
60088713|NCT01287611|76204904|FG001|STARTED|Overall Study||84||
60088714|NCT01287611|76204903|FG000|The Number of Patients Who Underwent C/S|Overall Study||84||
60088715|NCT01287611|76204904|FG001|The Number of Patients Who Underwent C/S|Overall Study||84||
60088716|NCT01287611|76204903|FG000|COMPLETED|Overall Study||51||
60088717|NCT01287611|76204904|FG001|COMPLETED|Overall Study||65||
60088718|NCT01287611|76204903|FG000|NOT COMPLETED|Overall Study||33||
60088719|NCT01287611|76204904|FG001|NOT COMPLETED|Overall Study||19||
60088720|NCT01194271|76204912|FG000|STARTED|Overall Study||19||
60088721|NCT01194271|76204912|FG000|COMPLETED|Overall Study||16||
60088722|NCT01194271|76204912|FG000|NOT COMPLETED|Overall Study||3||
60088723|NCT01172418|76204918|FG000|STARTED|Overall Study||100||
60088724|NCT01172418|76204919|FG001|STARTED|Overall Study||100||
60088725|NCT01172418|76204918|FG000|COMPLETED|Overall Study||100||
60088726|NCT01172418|76204919|FG001|COMPLETED|Overall Study||100||
60088727|NCT01172418|76204918|FG000|NOT COMPLETED|Overall Study||0||
60088728|NCT01172418|76204919|FG001|NOT COMPLETED|Overall Study||0||
60088729|NCT01119508|76204927|FG000|STARTED|Overall Study||64||
60088730|NCT01119508|76204927|FG000|Received Four Induction Doses|Overall Study||45||
60088731|NCT01119508|76204927|FG000|Received Fifth Consolidation Dose week12|Overall Study||32||
60088732|NCT01119508|76204927|FG000|COMPLETED|Overall Study||5||
60088733|NCT01119508|76204927|FG000|NOT COMPLETED|Overall Study||59||
60088734|NCT01074814|76204931|FG000|STARTED|Overall Study||25||
60088735|NCT01074814|76204931|FG000|COMPLETED|Overall Study||25||
60088736|NCT01074814|76204931|FG000|NOT COMPLETED|Overall Study||0||
60088737|NCT00754338|76204939|FG000|STARTED|First Intervention for Phase1&Phase2||17||
60088738|NCT00754338|76204940|FG001|STARTED|First Intervention for Phase1&Phase2||21||
60088739|NCT00754338|76204941|FG002|STARTED|First Intervention for Phase1&Phase2||19||
60088740|NCT00754338|76204942|FG003|STARTED|First Intervention for Phase1&Phase2||19||
59560925|NCT03180489|75662215|FG001|NOT COMPLETED|Overall Study||4||
59560926|NCT02240186|75662221|FG000|STARTED|Overall Study||50||
59560927|NCT02240186|75662221|FG000|COMPLETED|Overall Study||23||
59560928|NCT02240186|75662221|FG000|NOT COMPLETED|Overall Study||27||
59560929|NCT01664858|75662231|FG000|STARTED|Overall Study||481||
59560930|NCT01664858|75662232|FG001|STARTED|Overall Study||481||
59560931|NCT01664858|75662233|FG002|STARTED|Overall Study||240||
59560932|NCT01664858|75662231|FG000|COMPLETED|Overall Study||467||
60088741|NCT00754338|76204939|FG000|COMPLETED|First Intervention for Phase1&Phase2||17||
60088742|NCT00754338|76204940|FG001|COMPLETED|First Intervention for Phase1&Phase2||18||
60088743|NCT00754338|76204941|FG002|COMPLETED|First Intervention for Phase1&Phase2||16||
60088744|NCT00754338|76204942|FG003|COMPLETED|First Intervention for Phase1&Phase2||19||
60088745|NCT00754338|76204939|FG000|NOT COMPLETED|First Intervention for Phase1&Phase2||0||
60088746|NCT00754338|76204940|FG001|NOT COMPLETED|First Intervention for Phase1&Phase2||3||
60088747|NCT00754338|76204941|FG002|NOT COMPLETED|First Intervention for Phase1&Phase2||3||
59560933|NCT01664858|75662232|FG001|COMPLETED|Overall Study||468||
59992743|NCT02167594|76108528|FG002|NOT COMPLETED|Overall Study||0||
59992744|NCT02555657|76108539|FG000|STARTED|Overall Study||312||
59992745|NCT02555657|76108540|FG001|STARTED|Overall Study||310||
60088748|NCT00754338|76204942|FG003|NOT COMPLETED|First Intervention for Phase1&Phase2||0||
60088749|NCT00754338|76204939|FG000|STARTED|Second Intervention for Phase1&Phase2||17||
60088750|NCT00754338|76204940|FG001|STARTED|Second Intervention for Phase1&Phase2||18||
60088751|NCT00754338|76204941|FG002|STARTED|Second Intervention for Phase1&Phase2||16||
60088752|NCT00754338|76204942|FG003|STARTED|Second Intervention for Phase1&Phase2||19||
60088753|NCT00754338|76204939|FG000|COMPLETED|Second Intervention for Phase1&Phase2||17||
60088754|NCT00754338|76204940|FG001|COMPLETED|Second Intervention for Phase1&Phase2||17||
60088755|NCT00754338|76204941|FG002|COMPLETED|Second Intervention for Phase1&Phase2||16||
60088756|NCT00754338|76204942|FG003|COMPLETED|Second Intervention for Phase1&Phase2||18||
60088757|NCT00754338|76204939|FG000|NOT COMPLETED|Second Intervention for Phase1&Phase2||0||
60088758|NCT00754338|76204940|FG001|NOT COMPLETED|Second Intervention for Phase1&Phase2||1||
60088759|NCT00754338|76204941|FG002|NOT COMPLETED|Second Intervention for Phase1&Phase2||0||
59992746|NCT02555657|76108539|FG000|Treated|Overall Study||309||
59992747|NCT02555657|76108540|FG001|Treated|Overall Study||292||
59992748|NCT02555657|76108539|FG000|COMPLETED|Overall Study||0||
59992749|NCT02555657|76108540|FG001|COMPLETED|Overall Study||0||
59992750|NCT02555657|76108539|FG000|NOT COMPLETED|Overall Study||312||
60088760|NCT00754338|76204942|FG003|NOT COMPLETED|Second Intervention for Phase1&Phase2||1||
60088761|NCT00745134|76204956|FG000|STARTED|Overall Study||15||
60088762|NCT00745134|76204957|FG001|STARTED|Overall Study||7||
60088763|NCT00745134|76204956|FG000|COMPLETED|Overall Study||15||
60088764|NCT00745134|76204957|FG001|COMPLETED|Overall Study||7||
60088765|NCT00745134|76204956|FG000|NOT COMPLETED|Overall Study||0||
60088766|NCT00745134|76204957|FG001|NOT COMPLETED|Overall Study||0||
60088767|NCT00610883|76204964|FG000|STARTED|Overall Study||17||
60088768|NCT00610883|76204964|FG000|COMPLETED|Overall Study||17||
60088769|NCT00610883|76204964|FG000|NOT COMPLETED|Overall Study||0||
60088770|NCT00574496|76204968|FG000|STARTED|Overall Study||25||
60088771|NCT00574496|76204968|FG000|COMPLETED|Overall Study||24||
60088772|NCT00574496|76204968|FG000|NOT COMPLETED|Overall Study||1||
60088773|NCT00499083|76204972|FG000|STARTED|Overall Study||17||
60088774|NCT00499083|76204972|FG000|Participants at UNMC|Overall Study||3||
60088775|NCT00499083|76204972|FG000|Participants at Moffitt Cancer Center|Overall Study||14||
60088776|NCT00499083|76204972|FG000|COMPLETED|Overall Study||14||
60088777|NCT00499083|76204972|FG000|NOT COMPLETED|Overall Study||3||
60088778|NCT00418886|76204978|FG000|STARTED|Overall Study|randomised patients|256||
60088779|NCT00418886|76204979|FG001|STARTED|Overall Study|randomised patients|278||
60088780|NCT00418886|76204978|FG000|COMPLETED|Overall Study|ongoing study treatment at data cut-off|30||
60088781|NCT00418886|76204979|FG001|COMPLETED|Overall Study|ongoing study treatment at data cut-off|23||
60088782|NCT00418886|76204978|FG000|NOT COMPLETED|Overall Study||226||
60088783|NCT00418886|76204979|FG001|NOT COMPLETED|Overall Study||255||
60088784|NCT00089024|76204985|FG000|STARTED|Overall Study||29||
60088785|NCT00089024|76204985|FG000|Treated Subjects|Overall Study||29||
60088786|NCT00089024|76204985|FG000|COMPLETED|Overall Study||24||
60088787|NCT00089024|76204985|FG000|NOT COMPLETED|Overall Study||5||
60088788|NCT01819129|76204991|FG000|STARTED|Overall Study||345||
60088789|NCT01819129|76204992|FG001|STARTED|Overall Study||344||
60088790|NCT01819129|76204991|FG000|Exposed|Overall Study||341||
60088791|NCT01819129|76204992|FG001|Exposed|Overall Study||341||
60088792|NCT01819129|76204991|FG000|COMPLETED|Overall Study||301||
60088793|NCT01819129|76204992|FG001|COMPLETED|Overall Study||305||
60088794|NCT01819129|76204991|FG000|NOT COMPLETED|Overall Study||44||
60088795|NCT01819129|76204992|FG001|NOT COMPLETED|Overall Study||39||
60088796|NCT04022889|76205000|FG000|STARTED|Stage 1: Period 1||9|Consented Subjects|
60088797|NCT04022889|76205001|FG001|STARTED|Stage 1: Period 1||6|Consented Subjects|
60088798|NCT04022889|76205002|FG002|STARTED|Stage 1: Period 1||0|Consented Subjects|
60088799|NCT04022889|76205000|FG000|Met Screening Criteria|Stage 1: Period 1||9||
60088800|NCT04022889|76205001|FG001|Met Screening Criteria|Stage 1: Period 1||6||
59992751|NCT02555657|76108540|FG001|NOT COMPLETED|Overall Study||310||
59992752|NCT00908687|76108553|FG000|STARTED|Overall Study||50||
59992753|NCT00908687|76108554|FG001|STARTED|Overall Study||100||
60088801|NCT04022889|76205002|FG002|Met Screening Criteria|Stage 1: Period 1||0||
60088802|NCT04022889|76205000|FG000|Successful Apheresis Collection|Stage 1: Period 1||8||
60088803|NCT04022889|76205001|FG001|Successful Apheresis Collection|Stage 1: Period 1||6||
60088804|NCT04022889|76205002|FG002|Successful Apheresis Collection|Stage 1: Period 1||0||
60088805|NCT04022889|76205000|FG000|Completed 7-days Storage of Test Platelet Component|Stage 1: Period 1||7||
59560934|NCT01664858|75662233|FG002|COMPLETED|Overall Study||234||
59560935|NCT01664858|75662231|FG000|NOT COMPLETED|Overall Study||14||
59560936|NCT01664858|75662232|FG001|NOT COMPLETED|Overall Study||13||
59560937|NCT01664858|75662233|FG002|NOT COMPLETED|Overall Study||6||
59560938|NCT01665092|75662248|FG000|STARTED|Overall Study||75||
59560939|NCT01665092|75662249|FG001|STARTED|Overall Study||35||
59560940|NCT01665092|75662250|FG002|STARTED|Overall Study||34||
59560941|NCT01665092|75662251|FG003|STARTED|Overall Study||106||
59560942|NCT01665092|75662248|FG000|COMPLETED|Overall Study||75||
59560943|NCT01665092|75662249|FG001|COMPLETED|Overall Study||35||
59560944|NCT01665092|75662250|FG002|COMPLETED|Overall Study||32||
59560945|NCT01665092|75662251|FG003|COMPLETED|Overall Study||105||
59560946|NCT01665092|75662248|FG000|NOT COMPLETED|Overall Study||0||
59560947|NCT01665092|75662249|FG001|NOT COMPLETED|Overall Study||0||
59560948|NCT01665092|75662250|FG002|NOT COMPLETED|Overall Study||2||
59560949|NCT01665092|75662251|FG003|NOT COMPLETED|Overall Study||1||
59560950|NCT01665170|75662263|FG000|STARTED|Overall Study|First patient in|30||
59560951|NCT01665170|75662264|FG001|STARTED|Overall Study||30||
59560952|NCT01665170|75662263|FG000|Bevore TSST|Overall Study||30||
59560953|NCT01665170|75662264|FG001|Bevore TSST|Overall Study||30||
59560954|NCT01665170|75662263|FG000|During TSST|Overall Study||30||
59560955|NCT01665170|75662264|FG001|During TSST|Overall Study||30||
59560956|NCT01665170|75662263|FG000|After TSST|Overall Study||30||
59560957|NCT01665170|75662264|FG001|After TSST|Overall Study||30||
59560958|NCT01665170|75662263|FG000|COMPLETED|Overall Study|Last TSST/ last patient out|30||
59560959|NCT01665170|75662264|FG001|COMPLETED|Overall Study||30||
59560960|NCT01665170|75662263|FG000|NOT COMPLETED|Overall Study||0||
59560961|NCT01665170|75662264|FG001|NOT COMPLETED|Overall Study||0||
59560962|NCT01665872|75662274|FG000|STARTED|Screening||172|Eligibility based on CES-D score, live in public housing site or receive section 8 or RAP.|
59560963|NCT01665872|75662275|FG001|STARTED|Screening||172|Eligibility based on CES-D score, live in public housing site or receive section 8 or RAP.|
59560964|NCT01665872|75662274|FG000|COMPLETED|Screening||172|All participants completed screening.|
59560965|NCT01665872|75662275|FG001|COMPLETED|Screening||172|All participants completed screening.|
59560966|NCT01665872|75662274|FG000|NOT COMPLETED|Screening||0||
59560967|NCT01665872|75662275|FG001|NOT COMPLETED|Screening||0||
59560968|NCT01665872|75662274|FG000|STARTED|Treatment||87|Participants who started treatment completed an intake (only a subset of those screened).|
59560969|NCT01665872|75662275|FG001|STARTED|Treatment||67|Participants who started treatment completed an intake (only a subset of those screened).|
59560970|NCT01665872|75662274|FG000|COMPLETED|Treatment||72|Attended at least 2 classes in the 8 class Stress Management course|
59560971|NCT01665872|75662275|FG001|COMPLETED|Treatment||50|Attended at least 2 classes in the 8 class Stress Management course|
59560972|NCT01665872|75662274|FG000|NOT COMPLETED|Treatment||15||
59560973|NCT01665872|75662275|FG001|NOT COMPLETED|Treatment||17||
59560974|NCT01665872|75662274|FG000|STARTED|6 Month Follow-up||72|Those eligible for 6 month follow-up, were class completers (as defined above).|
59560975|NCT01665872|75662275|FG001|STARTED|6 Month Follow-up||50|Those eligible for 6 month follow-up, were class completers (as defined above).|
59560976|NCT01665872|75662274|FG000|COMPLETED|6 Month Follow-up||66|Attended and completed the 6 month follow-up assessment.|
59560977|NCT01665872|75662275|FG001|COMPLETED|6 Month Follow-up||49|Attended and completed the 6 month follow-up assessment.|
59560978|NCT01665872|75662274|FG000|NOT COMPLETED|6 Month Follow-up||6||
59560979|NCT01665872|75662275|FG001|NOT COMPLETED|6 Month Follow-up||1||
59560980|NCT01665872|75662274|FG000|STARTED|12 Month Follow-up||72|Those eligible for 12 month follow-up, were class completers (as defined above).|
59560981|NCT01665872|75662275|FG001|STARTED|12 Month Follow-up||50|Those eligible for 12 month follow-up, were class completers (as defined above).|
59560982|NCT01665872|75662274|FG000|COMPLETED|12 Month Follow-up||58|Attended and completed the 12 month follow-up assessment.|
59560983|NCT01665872|75662275|FG001|COMPLETED|12 Month Follow-up||47|Attended and completed the 12 month follow-up assessment.|
59560984|NCT01665872|75662274|FG000|NOT COMPLETED|12 Month Follow-up||14||
59560985|NCT01665872|75662275|FG001|NOT COMPLETED|12 Month Follow-up||3||
59560986|NCT02298491|75662281|FG000|STARTED|Overall Study||4||
59560987|NCT02298491|75662281|FG000|COMPLETED|Overall Study||3||
59560988|NCT02298491|75662281|FG000|NOT COMPLETED|Overall Study||1||
59560989|NCT01665950|75662288|FG000|STARTED|Overall Study||2||
59560990|NCT01665950|75662289|FG001|STARTED|Overall Study||0||
59560991|NCT01665950|75662290|FG002|STARTED|Overall Study||2||
59560992|NCT01665950|75662288|FG000|COMPLETED|Overall Study||1||
59560993|NCT01665950|75662289|FG001|COMPLETED|Overall Study||0||
59560994|NCT01665950|75662290|FG002|COMPLETED|Overall Study||1||
59560995|NCT01665950|75662288|FG000|NOT COMPLETED|Overall Study||1||
59560996|NCT01665950|75662289|FG001|NOT COMPLETED|Overall Study||0||
59560997|NCT01665950|75662290|FG002|NOT COMPLETED|Overall Study||1||
59560998|NCT01667978|75662300|FG000|STARTED|Overall Study||18||
59560999|NCT01667978|75662301|FG001|STARTED|Overall Study||17||
59561000|NCT01667978|75662300|FG000|COMPLETED|Overall Study||16||
59561001|NCT01667978|75662301|FG001|COMPLETED|Overall Study||17||
59561002|NCT01667978|75662300|FG000|NOT COMPLETED|Overall Study||2||
59561003|NCT01667978|75662301|FG001|NOT COMPLETED|Overall Study||0||
59561004|NCT01668602|75662309|FG000|STARTED|Overall Study||2||
59561005|NCT01668602|75662310|FG001|STARTED|Overall Study||22||
59561006|NCT01668602|75662309|FG000|Cohort 2 - Began FastFES Sessions|Overall Study|This milestone does not apply to Cohort 1.|0||
59561007|NCT01668602|75662310|FG001|Cohort 2 - Began FastFES Sessions|Overall Study||20||
59561008|NCT01668602|75662309|FG000|Cohort 2 - Completed 3 Sessions of FastFES|Overall Study|This milestone does not apply to Cohort 1.|0||
59561009|NCT01668602|75662310|FG001|Cohort 2 - Completed 3 Sessions of FastFES|Overall Study||19||
59561010|NCT01668602|75662309|FG000|Cohort 2 - Began Fast Walking Sessions|Overall Study|This milestone does not apply to Cohort 1.|0||
59561011|NCT01668602|75662310|FG001|Cohort 2 - Began Fast Walking Sessions|Overall Study||20||
59561012|NCT01668602|75662309|FG000|Cohort 2 - Completed 3 Sessions of Fast Walking|Overall Study|This milestone does not apply to Cohort 1.|0||
59561013|NCT01668602|75662310|FG001|Cohort 2 - Completed 3 Sessions of Fast Walking|Overall Study||18||
59561014|NCT01668602|75662309|FG000|COMPLETED|Overall Study||2||
59561015|NCT01668602|75662310|FG001|COMPLETED|Overall Study||18||
59561016|NCT01668602|75662309|FG000|NOT COMPLETED|Overall Study||0||
59561017|NCT01668602|75662310|FG001|NOT COMPLETED|Overall Study||4||
59561018|NCT01668836|75662322|FG000|STARTED|Overall Study||12||
59561019|NCT01668836|75662323|FG001|STARTED|Overall Study||12||
59561020|NCT01668836|75662324|FG002|STARTED|Overall Study||12||
59561021|NCT01668836|75662325|FG003|STARTED|Overall Study||12||
59561022|NCT01668836|75662322|FG000|COMPLETED|Overall Study||12||
59561023|NCT01668836|75662323|FG001|COMPLETED|Overall Study||12||
59561024|NCT01668836|75662324|FG002|COMPLETED|Overall Study||12||
59561025|NCT01668836|75662325|FG003|COMPLETED|Overall Study||12||
59561026|NCT01668836|75662322|FG000|NOT COMPLETED|Overall Study||0||
59561027|NCT01668836|75662323|FG001|NOT COMPLETED|Overall Study||0||
59561028|NCT01668836|75662324|FG002|NOT COMPLETED|Overall Study||0||
59561029|NCT01668836|75662325|FG003|NOT COMPLETED|Overall Study||0||
59561030|NCT01669538|75662343|FG000|STARTED|Overall Study||40||
59561031|NCT01669538|75662344|FG001|STARTED|Overall Study||42||
59561032|NCT01669538|75662343|FG000|COMPLETED|Overall Study||28||
59561033|NCT01669538|75662344|FG001|COMPLETED|Overall Study||33||
59561034|NCT01669538|75662343|FG000|NOT COMPLETED|Overall Study||12||
59561035|NCT01669538|75662344|FG001|NOT COMPLETED|Overall Study||9||
59561036|NCT01671176|75662350|FG000|STARTED|Overall Study||30||
59992754|NCT00908687|76108555|FG002|STARTED|Overall Study||102||
59992755|NCT00908687|76108556|FG003|STARTED|Overall Study||50||
59992756|NCT00908687|76108557|FG004|STARTED|Overall Study||98||
59992757|NCT00908687|76108558|FG005|STARTED|Overall Study||100||
59992758|NCT00908687|76108553|FG000|COMPLETED|Overall Study||49||
59992759|NCT00908687|76108554|FG001|COMPLETED|Overall Study||99||
59992760|NCT00908687|76108555|FG002|COMPLETED|Overall Study||99||
59992761|NCT00908687|76108556|FG003|COMPLETED|Overall Study||47||
59992762|NCT00908687|76108557|FG004|COMPLETED|Overall Study||94||
60088806|NCT04022889|76205001|FG001|Completed 7-days Storage of Test Platelet Component|Stage 1: Period 1||6||
60088807|NCT04022889|76205002|FG002|Completed 7-days Storage of Test Platelet Component|Stage 1: Period 1||0||
60088808|NCT04022889|76205000|FG000|Completed Post Infusion Sampling|Stage 1: Period 1||7||
60088809|NCT04022889|76205001|FG001|Completed Post Infusion Sampling|Stage 1: Period 1||6||
60088810|NCT04022889|76205002|FG002|Completed Post Infusion Sampling|Stage 1: Period 1||0||
60088811|NCT04022889|76205000|FG000|COMPLETED|Stage 1: Period 1||7||
60088812|NCT04022889|76205001|FG001|COMPLETED|Stage 1: Period 1||6||
60088813|NCT04022889|76205002|FG002|COMPLETED|Stage 1: Period 1||0||
60088814|NCT04022889|76205000|FG000|NOT COMPLETED|Stage 1: Period 1||2||
60088815|NCT04022889|76205001|FG001|NOT COMPLETED|Stage 1: Period 1||0||
60088816|NCT04022889|76205002|FG002|NOT COMPLETED|Stage 1: Period 1||0||
60088817|NCT04022889|76205000|FG000|STARTED|Stage 1: Period 2||7||
60088818|NCT04022889|76205001|FG001|STARTED|Stage 1: Period 2||6||
59992763|NCT00908687|76108558|FG005|COMPLETED|Overall Study||94||
59992764|NCT00908687|76108553|FG000|NOT COMPLETED|Overall Study||1||
59992765|NCT00908687|76108554|FG001|NOT COMPLETED|Overall Study||1||
60088819|NCT04022889|76205002|FG002|STARTED|Stage 1: Period 2||0||
60088820|NCT04022889|76205000|FG000|Met Screening Criteria|Stage 1: Period 2||7||
60088821|NCT04022889|76205001|FG001|Met Screening Criteria|Stage 1: Period 2||6||
60088822|NCT04022889|76205002|FG002|Met Screening Criteria|Stage 1: Period 2||0||
60088823|NCT04022889|76205000|FG000|Successful Apheresis Collection|Stage 1: Period 2||7||
60088824|NCT04022889|76205001|FG001|Successful Apheresis Collection|Stage 1: Period 2||6||
59561037|NCT01671176|75662350|FG000|COMPLETED|Overall Study||30||
60088825|NCT04022889|76205002|FG002|Successful Apheresis Collection|Stage 1: Period 2||0||
60088826|NCT04022889|76205000|FG000|Completed 7-days Storage of Test Platelet Component|Stage 1: Period 2||7||
60088827|NCT04022889|76205001|FG001|Completed 7-days Storage of Test Platelet Component|Stage 1: Period 2||6||
60088828|NCT04022889|76205002|FG002|Completed 7-days Storage of Test Platelet Component|Stage 1: Period 2||0||
60088829|NCT04022889|76205000|FG000|Completed Post Infusion Sampling|Stage 1: Period 2||6||
60088830|NCT04022889|76205001|FG001|Completed Post Infusion Sampling|Stage 1: Period 2||5||
60088831|NCT04022889|76205002|FG002|Completed Post Infusion Sampling|Stage 1: Period 2||0||
60088832|NCT04022889|76205000|FG000|COMPLETED|Stage 1: Period 2||6||
60088833|NCT04022889|76205001|FG001|COMPLETED|Stage 1: Period 2||5||
59707653|NCT00991276|75826522|FG002|STARTED|Third Intervention Period||14||
60088834|NCT04022889|76205002|FG002|COMPLETED|Stage 1: Period 2||0||
60088835|NCT04022889|76205000|FG000|NOT COMPLETED|Stage 1: Period 2||1||
60088836|NCT04022889|76205001|FG001|NOT COMPLETED|Stage 1: Period 2||1||
60088837|NCT04022889|76205002|FG002|NOT COMPLETED|Stage 1: Period 2||0||
60088838|NCT04022889|76205000|FG000|STARTED|Stage 2|Subjects with Stage 1 Variant 1 data that was included in Stage 2 analysis|7||
60088839|NCT04022889|76205001|FG001|STARTED|Stage 2|Subjects with Stage 1 Variant 1 data that was included in Stage 2 analysis|6||
60088840|NCT04022889|76205002|FG002|STARTED|Stage 2|Includes only subjects enrolled during Stage 2|22||
60088841|NCT04022889|76205000|FG000|Met Screening Criteria|Stage 2||7||
60088842|NCT04022889|76205001|FG001|Met Screening Criteria|Stage 2||6||
60088843|NCT04022889|76205002|FG002|Met Screening Criteria|Stage 2||19||
60088844|NCT04022889|76205000|FG000|Successful Apheresis Collection|Stage 2||7||
60088845|NCT04022889|76205001|FG001|Successful Apheresis Collection|Stage 2||6||
60088846|NCT04022889|76205002|FG002|Successful Apheresis Collection|Stage 2||15||
60088847|NCT04022889|76205000|FG000|Completed 7-days Storage of Test Platelet Component|Stage 2||7||
60088848|NCT04022889|76205001|FG001|Completed 7-days Storage of Test Platelet Component|Stage 2||6||
60088849|NCT04022889|76205002|FG002|Completed 7-days Storage of Test Platelet Component|Stage 2||14||
60088850|NCT04022889|76205000|FG000|Completed Post Infusion Sampling|Stage 2||6||
60088851|NCT04022889|76205001|FG001|Completed Post Infusion Sampling|Stage 2||6||
60088852|NCT04022889|76205002|FG002|Completed Post Infusion Sampling|Stage 2||14||
60088853|NCT04022889|76205000|FG000|COMPLETED|Stage 2||6||
60088854|NCT04022889|76205001|FG001|COMPLETED|Stage 2||6||
60088855|NCT04022889|76205002|FG002|COMPLETED|Stage 2|Data from 3 completed subjects was not evaluable due to a protocol deviation|14||
60088856|NCT04022889|76205000|FG000|NOT COMPLETED|Stage 2||1||
60088857|NCT04022889|76205001|FG001|NOT COMPLETED|Stage 2||0||
60088858|NCT04022889|76205002|FG002|NOT COMPLETED|Stage 2||8||
60088859|NCT01849783|76205020|FG000|STARTED|Overall Study||41||
60088860|NCT01849783|76205020|FG000|COMPLETED|Overall Study||19||
60088861|NCT01849783|76205020|FG000|NOT COMPLETED|Overall Study||22||
60088862|NCT01611883|76205032|FG000|STARTED|Overall Study||75||
60088863|NCT01611883|76205033|FG001|STARTED|Overall Study||77||
60088864|NCT01611883|76205032|FG000|COMPLETED|Overall Study||74||
60088865|NCT01611883|76205033|FG001|COMPLETED|Overall Study||76||
60088866|NCT01611883|76205032|FG000|NOT COMPLETED|Overall Study||1||
60088867|NCT01611883|76205033|FG001|NOT COMPLETED|Overall Study||1||
60088868|NCT01848457|76205043|FG000|STARTED|Overall Study||4||
60088869|NCT01848457|76205044|FG001|STARTED|Overall Study||3||
60088870|NCT01848457|76205045|FG002|STARTED|Overall Study||3||
60088871|NCT01848457|76205046|FG003|STARTED|Overall Study||3||
60088872|NCT01848457|76205043|FG000|Baseline|Overall Study||4||
60088873|NCT01848457|76205044|FG001|Baseline|Overall Study||3||
60088874|NCT01848457|76205045|FG002|Baseline|Overall Study||3||
60088875|NCT01848457|76205046|FG003|Baseline|Overall Study||3||
60088876|NCT01848457|76205043|FG000|Cycle 1|Overall Study||4||
60088877|NCT01848457|76205044|FG001|Cycle 1|Overall Study||3||
60088878|NCT01848457|76205045|FG002|Cycle 1|Overall Study||3||
60088879|NCT01848457|76205046|FG003|Cycle 1|Overall Study||3||
60088880|NCT01848457|76205043|FG000|Cycle 2|Overall Study||3||
60088881|NCT01848457|76205044|FG001|Cycle 2|Overall Study||3||
60088882|NCT01848457|76205045|FG002|Cycle 2|Overall Study||3||
60088883|NCT01848457|76205046|FG003|Cycle 2|Overall Study||3||
60088884|NCT01848457|76205043|FG000|Cycle 3|Overall Study||3||
60088885|NCT01848457|76205044|FG001|Cycle 3|Overall Study||3||
60088886|NCT01848457|76205045|FG002|Cycle 3|Overall Study||3||
60088887|NCT01848457|76205046|FG003|Cycle 3|Overall Study||3||
60088888|NCT01848457|76205043|FG000|Cycle 4|Overall Study||3||
60088889|NCT01848457|76205044|FG001|Cycle 4|Overall Study||3||
60088890|NCT01848457|76205045|FG002|Cycle 4|Overall Study||3||
60088891|NCT01848457|76205046|FG003|Cycle 4|Overall Study||3||
60088892|NCT01848457|76205043|FG000|COMPLETED|Overall Study||3||
60088893|NCT01848457|76205044|FG001|COMPLETED|Overall Study||3||
60088894|NCT01848457|76205045|FG002|COMPLETED|Overall Study||3||
60088895|NCT01848457|76205046|FG003|COMPLETED|Overall Study||3||
60088896|NCT01848457|76205043|FG000|NOT COMPLETED|Overall Study||1||
60088897|NCT01848457|76205044|FG001|NOT COMPLETED|Overall Study||0||
60088898|NCT01848457|76205045|FG002|NOT COMPLETED|Overall Study||0||
60088899|NCT01848457|76205046|FG003|NOT COMPLETED|Overall Study||0||
60088900|NCT01817725|76205064|FG000|STARTED|Overall Study||20||
60088901|NCT01817725|76205064|FG000|COMPLETED|Overall Study||19||
60088902|NCT01817725|76205064|FG000|NOT COMPLETED|Overall Study||1||
59561038|NCT01671176|75662350|FG000|NOT COMPLETED|Overall Study||0||
59561039|NCT01672658|75662356|FG000|STARTED|Overall Study||16||
59561040|NCT01672658|75662357|FG001|STARTED|Overall Study||15||
59561041|NCT01672658|75662356|FG000|COMPLETED|Overall Study||16||
59561042|NCT01672658|75662357|FG001|COMPLETED|Overall Study||14||
59561043|NCT01672658|75662356|FG000|NOT COMPLETED|Overall Study||0||
59561044|NCT01672658|75662357|FG001|NOT COMPLETED|Overall Study||1||
59561045|NCT01673828|75662365|FG000|STARTED|Overall Study||7||
59561046|NCT01673828|75662366|FG001|STARTED|Overall Study||6||
60088903|NCT01870999|76205071|FG000|STARTED|Overall Study||14||
60088904|NCT01870999|76205072|FG001|STARTED|Overall Study||16||
60088905|NCT01870999|76205073|FG002|STARTED|Overall Study||11||
60088906|NCT01870999|76205071|FG000|Safety Population; Received Study Drug|Overall Study||14||
60088907|NCT01870999|76205072|FG001|Safety Population; Received Study Drug|Overall Study||15||
60088908|NCT01870999|76205073|FG002|Safety Population; Received Study Drug|Overall Study||10||
59561047|NCT01673828|75662365|FG000|COMPLETED|Overall Study||7||
59561048|NCT01673828|75662366|FG001|COMPLETED|Overall Study||6||
59561049|NCT01673828|75662365|FG000|NOT COMPLETED|Overall Study||0||
59561050|NCT01673828|75662366|FG001|NOT COMPLETED|Overall Study||0||
59561051|NCT02296775|75662375|FG000|STARTED|Treatment and Evaluation||91||
59561052|NCT02296775|75662376|FG001|STARTED|Treatment and Evaluation||92||
59561053|NCT02296775|75662377|FG002|STARTED|Treatment and Evaluation||93||
59561054|NCT02296775|75662375|FG000|COMPLETED|Treatment and Evaluation||87||
59561055|NCT02296775|75662376|FG001|COMPLETED|Treatment and Evaluation||84||
59561056|NCT02296775|75662377|FG002|COMPLETED|Treatment and Evaluation||83||
59561057|NCT02296775|75662375|FG000|NOT COMPLETED|Treatment and Evaluation||4||
59561058|NCT02296775|75662376|FG001|NOT COMPLETED|Treatment and Evaluation||8||
59561059|NCT02296775|75662377|FG002|NOT COMPLETED|Treatment and Evaluation||10||
59561060|NCT02296775|75662375|FG000|STARTED|Recovery and Follow-up||87||
59561061|NCT02296775|75662376|FG001|STARTED|Recovery and Follow-up||84||
59561062|NCT02296775|75662377|FG002|STARTED|Recovery and Follow-up||83||
59561063|NCT02296775|75662375|FG000|COMPLETED|Recovery and Follow-up||82||
59561064|NCT02296775|75662376|FG001|COMPLETED|Recovery and Follow-up||79||
59561065|NCT02296775|75662377|FG002|COMPLETED|Recovery and Follow-up||79||
59561066|NCT02296775|75662375|FG000|NOT COMPLETED|Recovery and Follow-up||5||
59561067|NCT02296775|75662376|FG001|NOT COMPLETED|Recovery and Follow-up||5||
59561068|NCT02296775|75662377|FG002|NOT COMPLETED|Recovery and Follow-up||4||
59561069|NCT01675778|75662385|FG000|STARTED|Overall Study||174||
59561070|NCT01675778|75662385|FG000|COMPLETED|Overall Study||174||
59561071|NCT01675778|75662385|FG000|NOT COMPLETED|Overall Study||0||
59816813|NCT03806179|75939181|FG001|NOT COMPLETED|Overall Study||2||
60088909|NCT01870999|76205071|FG000|COMPLETED|Overall Study||10||
60088910|NCT01870999|76205072|FG001|COMPLETED|Overall Study||8||
60088911|NCT01870999|76205073|FG002|COMPLETED|Overall Study||4||
60088912|NCT01870999|76205071|FG000|NOT COMPLETED|Overall Study||4||
60088913|NCT01870999|76205072|FG001|NOT COMPLETED|Overall Study||8||
60088914|NCT01870999|76205073|FG002|NOT COMPLETED|Overall Study||7||
60088915|NCT01870921|76205081|FG000|STARTED|Overall Study||2004||
60088916|NCT01870921|76205081|FG000|COMPLETED|Overall Study||1914||
60088917|NCT01870921|76205081|FG000|NOT COMPLETED|Overall Study||90||
60088918|NCT00526474|76205087|FG000|STARTED|Overall Study||13224||
59561072|NCT02594111|75662392|FG000|STARTED|Overall Study||366||
59561073|NCT02594111|75662393|FG001|STARTED|Overall Study||348||
59561074|NCT02594111|75662392|FG000|COMPLETED|Overall Study||366||
60088919|NCT00526474|76205088|FG001|STARTED|Overall Study||13225||
60088920|NCT00526474|76205087|FG000|Received Study Drug|Overall Study||13166||
60088921|NCT00526474|76205088|FG001|Received Study Drug|Overall Study||13186||
60088922|NCT00526474|76205087|FG000|COMPLETED|Overall Study||12932||
60088923|NCT00526474|76205088|FG001|COMPLETED|Overall Study||12953||
60088924|NCT00526474|76205087|FG000|NOT COMPLETED|Overall Study||292||
60088925|NCT00526474|76205088|FG001|NOT COMPLETED|Overall Study||272||
60088926|NCT01848145|76205094|FG000|STARTED|Infusion 1: Week 1, Day 1 - 226 Minutes||34||
60088927|NCT01848145|76205094|FG000|Completed Within 15min of Infusion Time|Infusion 1: Week 1, Day 1 - 226 Minutes|Number of patients who completed within 15 minutes (min) of infusion time.|1||
60088928|NCT01848145|76205094|FG000|COMPLETED|Infusion 1: Week 1, Day 1 - 226 Minutes|Includes participants that completed Infusion 1 and proceeded to the next infusion, Infusion 2.|33||
59816814|NCT03759587|75939187|FG000|STARTED|Overall Study||19||
59561075|NCT02594111|75662393|FG001|COMPLETED|Overall Study||348||
59561076|NCT02594111|75662392|FG000|NOT COMPLETED|Overall Study||0||
59561077|NCT02594111|75662393|FG001|NOT COMPLETED|Overall Study||0||
59561078|NCT03186261|75662401|FG000|STARTED|Overall Study||22||22
59561079|NCT03186261|75662402|FG001|STARTED|Overall Study||22||22
59561080|NCT03186261|75662401|FG000|COMPLETED|Overall Study||22||22
59561081|NCT03186261|75662402|FG001|COMPLETED|Overall Study||22||22
59817924|NCT04488770|75940337|FG011|STARTED|Part 1-Cohort 2: Period 2 (Up to 5 Days)||0||
59561082|NCT03186261|75662401|FG000|NOT COMPLETED|Overall Study||0||0
59561083|NCT03186261|75662402|FG001|NOT COMPLETED|Overall Study||0||0
59561084|NCT02298803|75662410|FG000|STARTED|Overall Study||30||
59816815|NCT03759587|75939187|FG000|Response Evaluable Set|Overall Study||5|Response-evaluable analysis set includes participants who had measurable disease at baseline.|
59816816|NCT03759587|75939187|FG000|COMPLETED|Overall Study||0||
59816817|NCT03759587|75939187|FG000|NOT COMPLETED|Overall Study||19||
59816818|NCT03737851|75939194|FG000|STARTED|Overall Study||70||
59816819|NCT03737851|75939195|FG001|STARTED|Overall Study||69||
59816820|NCT03737851|75939196|FG002|STARTED|Overall Study||69||
59816821|NCT03737851|75939194|FG000|COMPLETED|Overall Study||62||
59816822|NCT03737851|75939195|FG001|COMPLETED|Overall Study||63||
59816823|NCT03737851|75939196|FG002|COMPLETED|Overall Study||57||
59816824|NCT03737851|75939194|FG000|NOT COMPLETED|Overall Study||8||
59816825|NCT03737851|75939195|FG001|NOT COMPLETED|Overall Study||6||
59816826|NCT03737851|75939196|FG002|NOT COMPLETED|Overall Study||12||
59816827|NCT03735121|75939209|FG000|STARTED|Overall Study||13||
59816828|NCT03735121|75939210|FG001|STARTED|Overall Study||15||
59992766|NCT00908687|76108555|FG002|NOT COMPLETED|Overall Study||3||
59992767|NCT00908687|76108556|FG003|NOT COMPLETED|Overall Study||3||
59816829|NCT03735121|75939211|FG002|STARTED|Overall Study||39||
59992768|NCT00908687|76108557|FG004|NOT COMPLETED|Overall Study||4||
59992769|NCT00908687|76108558|FG005|NOT COMPLETED|Overall Study||6||
59992770|NCT02195518|76108572|FG000|STARTED|Overall Study||213||
59561085|NCT02298803|75662410|FG000|COMPLETED|Overall Study||30||
59561086|NCT02298803|75662410|FG000|NOT COMPLETED|Overall Study||0||
59561087|NCT01676714|75662419|FG000|STARTED|Overall Study||10||
59561088|NCT01676714|75662419|FG000|COMPLETED|Overall Study||10||
59561089|NCT01676714|75662419|FG000|NOT COMPLETED|Overall Study||0||
59561090|NCT03187119|75662426|FG000|STARTED|Overall Study||22||
59561091|NCT03187119|75662427|FG001|STARTED|Overall Study||23||
59561092|NCT03187119|75662426|FG000|COMPLETED|Overall Study||20||
59561093|NCT03187119|75662427|FG001|COMPLETED|Overall Study||18||
59561094|NCT03187119|75662426|FG000|NOT COMPLETED|Overall Study||2||
59816830|NCT03735121|75939212|FG003|STARTED|Overall Study||124||
59816831|NCT03735121|75939213|FG004|STARTED|Overall Study||247||
60088929|NCT01848145|76205094|FG000|NOT COMPLETED|Infusion 1: Week 1, Day 1 - 226 Minutes||1||
60088930|NCT01848145|76205094|FG000|STARTED|Infusion 2: Week 1, Day 3 - 167 Minutes||33||
60088931|NCT01848145|76205094|FG000|Completed Within 15min of Infusion Time|Infusion 2: Week 1, Day 3 - 167 Minutes||24||
60088932|NCT01848145|76205094|FG000|COMPLETED|Infusion 2: Week 1, Day 3 - 167 Minutes|Includes participants that completed Infusion 2 and proceeded to the next infusion, Infusion 3.|31||
60088933|NCT01848145|76205094|FG000|NOT COMPLETED|Infusion 2: Week 1, Day 3 - 167 Minutes||2||
60088934|NCT01848145|76205094|FG000|STARTED|Infusion 3: Week 2, Day 1 - 120 Minutes||31||
60088935|NCT01848145|76205094|FG000|Completed Within 15min of Infusion Time|Infusion 3: Week 2, Day 1 - 120 Minutes||26||
60088936|NCT01848145|76205094|FG000|COMPLETED|Infusion 3: Week 2, Day 1 - 120 Minutes||30|Includes participants that completed Infusion 3 and proceeded to subsequent infusions.|
60088937|NCT01848145|76205094|FG000|NOT COMPLETED|Infusion 3: Week 2, Day 1 - 120 Minutes||1||
59561095|NCT03187119|75662427|FG001|NOT COMPLETED|Overall Study||5||
59561096|NCT01678196|75662435|FG000|STARTED|Overall Study||34||
59561097|NCT01678196|75662436|FG001|STARTED|Overall Study||32||
59561098|NCT01678196|75662435|FG000|COMPLETED|Overall Study|Primary outcome data was from the electronic medical record and was available for all participants.|34||
59561099|NCT01678196|75662436|FG001|COMPLETED|Overall Study|Primary outcome data was from the electronic medical record and was available for all participants.|32||
59561100|NCT01678196|75662435|FG000|NOT COMPLETED|Overall Study||0||
59561101|NCT01678196|75662436|FG001|NOT COMPLETED|Overall Study||0||
60088938|NCT01848145|76205094|FG000|STARTED|Subsequent Infusions: Weeks 3-8||30||
60088939|NCT01848145|76205094|FG000|COMPLETED|Subsequent Infusions: Weeks 3-8||20||
60088940|NCT01848145|76205094|FG000|NOT COMPLETED|Subsequent Infusions: Weeks 3-8||10||
60088941|NCT01847755|76205098|FG000|STARTED|Overall Study||18||
59561102|NCT01678976|75662444|FG000|STARTED|First Period||6||
59561103|NCT01678976|75662445|FG001|STARTED|First Period||7||
60088942|NCT01847755|76205098|FG000|COMPLETED|Overall Study||13||
60088943|NCT01847755|76205098|FG000|NOT COMPLETED|Overall Study||5||
60088944|NCT00527098|76205104|FG000|STARTED|Overall Study||36||
60088945|NCT00527098|76205105|FG001|STARTED|Overall Study||83||
60088946|NCT00527098|76205104|FG000|COMPLETED|Overall Study||36||
59561104|NCT01678976|75662444|FG000|COMPLETED|First Period||6||
59561105|NCT01678976|75662445|FG001|COMPLETED|First Period||6||
60088947|NCT00527098|76205105|FG001|COMPLETED|Overall Study||83||
60088948|NCT00527098|76205104|FG000|NOT COMPLETED|Overall Study||0||
60088949|NCT00527098|76205105|FG001|NOT COMPLETED|Overall Study||0||
59561106|NCT01678976|75662444|FG000|NOT COMPLETED|First Period||0||
59561107|NCT01678976|75662445|FG001|NOT COMPLETED|First Period||1||
59561108|NCT01678976|75662444|FG000|STARTED|Second Period||6||
59561109|NCT01678976|75662445|FG001|STARTED|Second Period||6||
59561110|NCT01678976|75662444|FG000|COMPLETED|Second Period||6||
59561111|NCT01678976|75662445|FG001|COMPLETED|Second Period||6||
59561112|NCT01678976|75662444|FG000|NOT COMPLETED|Second Period||0||
59561113|NCT01678976|75662445|FG001|NOT COMPLETED|Second Period||0||
59561114|NCT03188523|75662456|FG000|STARTED|Overall Study||6||
59561115|NCT03188523|75662457|FG001|STARTED|Overall Study||6||
60088950|NCT00527566|76205110|FG000|STARTED|Overall Study||10||
60088951|NCT00527566|76205110|FG000|COMPLETED|Overall Study||10||
60088952|NCT00527566|76205110|FG000|NOT COMPLETED|Overall Study||0||
60088953|NCT00527644|76205116|FG000|STARTED|Overall Study||14||
60088954|NCT00527644|76205116|FG000|COMPLETED|Overall Study||14||
59707654|NCT00991276|75826523|FG003|STARTED|Third Intervention Period||9||
60088955|NCT00527644|76205116|FG000|NOT COMPLETED|Overall Study||0||
60088956|NCT00527722|76205122|FG000|STARTED|Overall Study||22||
60088957|NCT00527722|76205123|FG001|STARTED|Overall Study||25||
60088958|NCT00527722|76205122|FG000|COMPLETED|Overall Study||22||
60088959|NCT00527722|76205123|FG001|COMPLETED|Overall Study||25||
60088960|NCT00527722|76205122|FG000|NOT COMPLETED|Overall Study||0||
60088961|NCT00527722|76205123|FG001|NOT COMPLETED|Overall Study||0||
60088962|NCT01847443|76205129|FG000|STARTED|Study Period 1||21||
60088963|NCT01847443|76205130|FG001|STARTED|Study Period 1||21||
60088964|NCT01847443|76205131|FG002|STARTED|Study Period 1||21||
60088965|NCT01847443|76205132|FG003|STARTED|Study Period 1||21||
60088966|NCT01847443|76205129|FG000|COMPLETED|Study Period 1||21||
60088967|NCT01847443|76205130|FG001|COMPLETED|Study Period 1||20||
60088968|NCT01847443|76205131|FG002|COMPLETED|Study Period 1||21||
60088969|NCT01847443|76205132|FG003|COMPLETED|Study Period 1||21||
60088970|NCT01847443|76205129|FG000|NOT COMPLETED|Study Period 1||0||
60088971|NCT01847443|76205130|FG001|NOT COMPLETED|Study Period 1||1||
60088972|NCT01847443|76205131|FG002|NOT COMPLETED|Study Period 1||0||
60088973|NCT01847443|76205132|FG003|NOT COMPLETED|Study Period 1||0||
60088974|NCT01847443|76205129|FG000|STARTED|Washout Period Before Study Period 2||21||
60088975|NCT01847443|76205130|FG001|STARTED|Washout Period Before Study Period 2||20||
60088976|NCT01847443|76205131|FG002|STARTED|Washout Period Before Study Period 2||21||
60088977|NCT01847443|76205132|FG003|STARTED|Washout Period Before Study Period 2||21||
60088978|NCT01847443|76205129|FG000|COMPLETED|Washout Period Before Study Period 2||19||
60088979|NCT01847443|76205130|FG001|COMPLETED|Washout Period Before Study Period 2||19||
60088980|NCT01847443|76205131|FG002|COMPLETED|Washout Period Before Study Period 2||21||
60088981|NCT01847443|76205132|FG003|COMPLETED|Washout Period Before Study Period 2||21||
60088982|NCT01847443|76205129|FG000|NOT COMPLETED|Washout Period Before Study Period 2||2||
60088983|NCT01847443|76205130|FG001|NOT COMPLETED|Washout Period Before Study Period 2||1||
60088984|NCT01847443|76205131|FG002|NOT COMPLETED|Washout Period Before Study Period 2||0||
60088985|NCT01847443|76205132|FG003|NOT COMPLETED|Washout Period Before Study Period 2||0||
60088986|NCT01847443|76205129|FG000|STARTED|Study Period 2||19||
59561116|NCT03188523|75662458|FG002|STARTED|Overall Study||0||
59561117|NCT03188523|75662459|FG003|STARTED|Overall Study||0||
59561118|NCT03188523|75662456|FG000|COMPLETED|Overall Study||6||
59707655|NCT00991276|75826524|FG004|STARTED|Third Intervention Period||10||
59707656|NCT00991276|75826525|FG005|STARTED|Third Intervention Period||11||
59707657|NCT00991276|75826520|FG000|COMPLETED|Third Intervention Period||13||
59707658|NCT00991276|75826521|FG001|COMPLETED|Third Intervention Period||8||
59707659|NCT00991276|75826522|FG002|COMPLETED|Third Intervention Period||13||
59561119|NCT03188523|75662457|FG001|COMPLETED|Overall Study||6||
59561120|NCT03188523|75662458|FG002|COMPLETED|Overall Study||0||
60088987|NCT01847443|76205130|FG001|STARTED|Study Period 2||19||
60088988|NCT01847443|76205131|FG002|STARTED|Study Period 2||21||
60088989|NCT01847443|76205132|FG003|STARTED|Study Period 2||21||
60088990|NCT01847443|76205129|FG000|COMPLETED|Study Period 2||19||
60088991|NCT01847443|76205130|FG001|COMPLETED|Study Period 2||19||
60088992|NCT01847443|76205131|FG002|COMPLETED|Study Period 2||21||
60088993|NCT01847443|76205132|FG003|COMPLETED|Study Period 2||21||
60088994|NCT01847443|76205129|FG000|NOT COMPLETED|Study Period 2||0||
60088995|NCT01847443|76205130|FG001|NOT COMPLETED|Study Period 2||0||
60088996|NCT01847443|76205131|FG002|NOT COMPLETED|Study Period 2||0||
60088997|NCT01847443|76205132|FG003|NOT COMPLETED|Study Period 2||0||
60088998|NCT01847443|76205129|FG000|STARTED|Washout Period Before Study Period 3||19||
60088999|NCT01847443|76205130|FG001|STARTED|Washout Period Before Study Period 3||19||
60089000|NCT01847443|76205131|FG002|STARTED|Washout Period Before Study Period 3||21||
60089001|NCT01847443|76205132|FG003|STARTED|Washout Period Before Study Period 3||21||
60089002|NCT01847443|76205129|FG000|COMPLETED|Washout Period Before Study Period 3||18||
60089003|NCT01847443|76205130|FG001|COMPLETED|Washout Period Before Study Period 3||19||
60089004|NCT01847443|76205131|FG002|COMPLETED|Washout Period Before Study Period 3||21||
60089005|NCT01847443|76205132|FG003|COMPLETED|Washout Period Before Study Period 3||21||
60089006|NCT01847443|76205129|FG000|NOT COMPLETED|Washout Period Before Study Period 3||1||
60089007|NCT01847443|76205130|FG001|NOT COMPLETED|Washout Period Before Study Period 3||0||
60089008|NCT01847443|76205131|FG002|NOT COMPLETED|Washout Period Before Study Period 3||0||
60089009|NCT01847443|76205132|FG003|NOT COMPLETED|Washout Period Before Study Period 3||0||
60089010|NCT01847443|76205129|FG000|STARTED|Study Period 3||18||
60089011|NCT01847443|76205130|FG001|STARTED|Study Period 3||19||
60089012|NCT01847443|76205131|FG002|STARTED|Study Period 3||21||
60089013|NCT01847443|76205132|FG003|STARTED|Study Period 3||21||
60089014|NCT01847443|76205129|FG000|COMPLETED|Study Period 3||18||
60089015|NCT01847443|76205130|FG001|COMPLETED|Study Period 3||19||
60089016|NCT01847443|76205131|FG002|COMPLETED|Study Period 3||21||
60089017|NCT01847443|76205132|FG003|COMPLETED|Study Period 3||21||
60089018|NCT01847443|76205129|FG000|NOT COMPLETED|Study Period 3||0||
60089019|NCT01847443|76205130|FG001|NOT COMPLETED|Study Period 3||0||
60089020|NCT01847443|76205131|FG002|NOT COMPLETED|Study Period 3||0||
60089021|NCT01847443|76205132|FG003|NOT COMPLETED|Study Period 3||0||
60089022|NCT01847443|76205129|FG000|STARTED|Washout Period Before Study Period 4||18||
60089023|NCT01847443|76205130|FG001|STARTED|Washout Period Before Study Period 4||19||
60089024|NCT01847443|76205131|FG002|STARTED|Washout Period Before Study Period 4||21||
60089025|NCT01847443|76205132|FG003|STARTED|Washout Period Before Study Period 4||21||
60089026|NCT01847443|76205129|FG000|COMPLETED|Washout Period Before Study Period 4||16||
60089027|NCT01847443|76205130|FG001|COMPLETED|Washout Period Before Study Period 4||19||
60089028|NCT01847443|76205131|FG002|COMPLETED|Washout Period Before Study Period 4||21||
60089029|NCT01847443|76205132|FG003|COMPLETED|Washout Period Before Study Period 4||21||
60089030|NCT01847443|76205129|FG000|NOT COMPLETED|Washout Period Before Study Period 4||2||
60089031|NCT01847443|76205130|FG001|NOT COMPLETED|Washout Period Before Study Period 4||0||
60089032|NCT01847443|76205131|FG002|NOT COMPLETED|Washout Period Before Study Period 4||0||
60089033|NCT01847443|76205132|FG003|NOT COMPLETED|Washout Period Before Study Period 4||0||
60089034|NCT01847443|76205129|FG000|STARTED|Study Period 4||16||
60089035|NCT01847443|76205130|FG001|STARTED|Study Period 4||19||
60089036|NCT01847443|76205131|FG002|STARTED|Study Period 4||21||
60089037|NCT01847443|76205132|FG003|STARTED|Study Period 4||21||
60089038|NCT01847443|76205129|FG000|COMPLETED|Study Period 4||16||
60089039|NCT01847443|76205130|FG001|COMPLETED|Study Period 4||19||
60089040|NCT01847443|76205131|FG002|COMPLETED|Study Period 4||21||
60089041|NCT01847443|76205132|FG003|COMPLETED|Study Period 4||21||
60089042|NCT01847443|76205129|FG000|NOT COMPLETED|Study Period 4||0||
60089043|NCT01847443|76205130|FG001|NOT COMPLETED|Study Period 4||0||
60089044|NCT01847443|76205131|FG002|NOT COMPLETED|Study Period 4||0||
60089045|NCT01847443|76205132|FG003|NOT COMPLETED|Study Period 4||0||
60089046|NCT00527878|76205144|FG000|STARTED|Intervention 1||7||
60089047|NCT00527878|76205145|FG001|STARTED|Intervention 1||7||
60089048|NCT00527878|76205144|FG000|COMPLETED|Intervention 1||5||
60089049|NCT00527878|76205145|FG001|COMPLETED|Intervention 1||4||
60089050|NCT00527878|76205144|FG000|NOT COMPLETED|Intervention 1||2||
60089051|NCT00527878|76205145|FG001|NOT COMPLETED|Intervention 1||3||
60089052|NCT00527878|76205144|FG000|STARTED|Intervention 2||5||
60089053|NCT00527878|76205145|FG001|STARTED|Intervention 2||4||
60089054|NCT00527878|76205144|FG000|COMPLETED|Intervention 2||5||
60089055|NCT00527878|76205145|FG001|COMPLETED|Intervention 2||4||
60089056|NCT00527878|76205144|FG000|NOT COMPLETED|Intervention 2||0||
59561121|NCT03188523|75662459|FG003|COMPLETED|Overall Study||0||
59561122|NCT03188523|75662456|FG000|NOT COMPLETED|Overall Study||0||
59707660|NCT00991276|75826523|FG003|COMPLETED|Third Intervention Period||8||
60089057|NCT00527878|76205145|FG001|NOT COMPLETED|Intervention 2||0||
60089058|NCT01847209|76205151|FG000|STARTED|Overall Study||25||
60089059|NCT01847209|76205151|FG000|COMPLETED|Overall Study||23||
60089060|NCT01847209|76205151|FG000|NOT COMPLETED|Overall Study||2||
60089061|NCT01846741|76205155|FG000|STARTED|Baseline Visit||22||
59561123|NCT03188523|75662457|FG001|NOT COMPLETED|Overall Study||0||
59707661|NCT00991276|75826524|FG004|COMPLETED|Third Intervention Period||10||
59707662|NCT00991276|75826525|FG005|COMPLETED|Third Intervention Period||10||
59992771|NCT02195518|76108572|FG000|COMPLETED|Overall Study||204||
59992772|NCT02195518|76108572|FG000|NOT COMPLETED|Overall Study||9||
59992773|NCT03461861|76108578|FG000|STARTED|Overall Study||13||
59992774|NCT03461861|76108579|FG001|STARTED|Overall Study||13||
59992775|NCT03461861|76108578|FG000|COMPLETED|Overall Study||13||
59992776|NCT03461861|76108579|FG001|COMPLETED|Overall Study||13||
59561124|NCT03188523|75662458|FG002|NOT COMPLETED|Overall Study||0||
59561125|NCT03188523|75662459|FG003|NOT COMPLETED|Overall Study||0||
59561126|NCT01679600|75662467|FG000|STARTED|Overall Study||7||
59561127|NCT01679600|75662468|FG001|STARTED|Overall Study||7||
59561128|NCT01679600|75662467|FG000|COMPLETED|Overall Study||7||
59561129|NCT01679600|75662468|FG001|COMPLETED|Overall Study||7||
59561130|NCT01679600|75662467|FG000|NOT COMPLETED|Overall Study||0||
59992777|NCT03461861|76108578|FG000|NOT COMPLETED|Overall Study||0||
59992778|NCT03461861|76108579|FG001|NOT COMPLETED|Overall Study||0||
59992779|NCT02952365|76108585|FG000|STARTED|Overall Study||2||2
59992780|NCT02952365|76108585|FG000|COMPLETED|Overall Study||2||2
59992781|NCT02952365|76108585|FG000|NOT COMPLETED|Overall Study||0||0
59992782|NCT02287493|76108591|FG000|STARTED|Overall Study||19||
59992783|NCT02287493|76108592|FG001|STARTED|Overall Study||16||
59992784|NCT02287493|76108591|FG000|COMPLETED|Overall Study||19||
59992785|NCT02287493|76108592|FG001|COMPLETED|Overall Study||16||
59992786|NCT02287493|76108591|FG000|NOT COMPLETED|Overall Study||0||
60089062|NCT01846741|76205155|FG000|COMPLETED|Baseline Visit||20||
60089063|NCT01846741|76205155|FG000|NOT COMPLETED|Baseline Visit||2||
60089064|NCT01846741|76205155|FG000|STARTED|Implantation to 18-Month/End of Study||20||
60089065|NCT01846741|76205155|FG000|COMPLETED|Implantation to 18-Month/End of Study||20||
60089066|NCT01846741|76205155|FG000|NOT COMPLETED|Implantation to 18-Month/End of Study||0||
60089067|NCT01870843|76205194|FG000|STARTED|Overall Study||261||
60089068|NCT01870843|76205194|FG000|COMPLETED|Overall Study||208||
60089069|NCT01870843|76205194|FG000|NOT COMPLETED|Overall Study||53||
60089070|NCT01816477|76205200|FG000|STARTED|Overall Study||43||
60089071|NCT01816477|76205201|FG001|STARTED|Overall Study||42||
60089072|NCT01816477|76205200|FG000|COMPLETED|Overall Study||27||
60089073|NCT01816477|76205201|FG001|COMPLETED|Overall Study||41||
60089074|NCT01816477|76205200|FG000|NOT COMPLETED|Overall Study||16||
60089075|NCT01816477|76205201|FG001|NOT COMPLETED|Overall Study||1||
60089076|NCT01846507|76205207|FG000|STARTED|Overall Study||32||
60089077|NCT01846507|76205207|FG000|COMPLETED|Overall Study||25||
60089078|NCT01846507|76205207|FG000|NOT COMPLETED|Overall Study||7||
60089079|NCT01846039|76205213|FG000|STARTED|Overall Study||29||
60089080|NCT01846039|76205213|FG000|COMPLETED|Overall Study||27||
60089081|NCT01846039|76205213|FG000|NOT COMPLETED|Overall Study||2||
60089082|NCT01610167|76205220|FG000|STARTED|Overall Study||52||
59561131|NCT01679600|75662468|FG001|NOT COMPLETED|Overall Study||0||
59561132|NCT03190005|75662481|FG000|STARTED|Overall Study||5||
59561133|NCT03190005|75662482|FG001|STARTED|Overall Study||5||
59992787|NCT02287493|76108592|FG001|NOT COMPLETED|Overall Study||0||
59992788|NCT02133742|76108602|FG000|STARTED|Period 1: Dose Finding Phase (6 Months)||11||
59992789|NCT02133742|76108602|FG000|COMPLETED|Period 1: Dose Finding Phase (6 Months)||11||
59992790|NCT02133742|76108602|FG000|NOT COMPLETED|Period 1: Dose Finding Phase (6 Months)||0||
59992791|NCT02133742|76108602|FG000|STARTED|Period 2:Dose Expansion Phase (1344days)|Participants participated in dose finding phase continued treatment in dose expansion phase.|52||
59992792|NCT02133742|76108602|FG000|COMPLETED|Period 2:Dose Expansion Phase (1344days)||0||
59992793|NCT02133742|76108602|FG000|NOT COMPLETED|Period 2:Dose Expansion Phase (1344days)||52||
60089083|NCT01610167|76205221|FG001|STARTED|Overall Study||49||
60089084|NCT01610167|76205222|FG002|STARTED|Overall Study||50||
60089085|NCT01610167|76205220|FG000|COMPLETED|Overall Study||52||
60089086|NCT01610167|76205221|FG001|COMPLETED|Overall Study||49||
60089087|NCT01610167|76205222|FG002|COMPLETED|Overall Study||48||
59561134|NCT03190005|75662483|FG002|STARTED|Overall Study||5||
59561135|NCT03190005|75662484|FG003|STARTED|Overall Study||5||
59561136|NCT03190005|75662485|FG004|STARTED|Overall Study||5||
60089088|NCT01610167|76205220|FG000|NOT COMPLETED|Overall Study||0||
60089089|NCT01610167|76205221|FG001|NOT COMPLETED|Overall Study||0||
60089090|NCT01610167|76205222|FG002|NOT COMPLETED|Overall Study||2||
60089091|NCT01816243|76205230|FG000|STARTED|Overall Study||39||
60089092|NCT01816243|76205230|FG000|COMPLETED|Overall Study||27||
60089093|NCT01816243|76205230|FG000|NOT COMPLETED|Overall Study||12||
60089094|NCT01845805|76205236|FG000|STARTED|Overall Study||24||
60089095|NCT01845805|76205237|FG001|STARTED|Overall Study||25||
60089096|NCT01845805|76205236|FG000|COMPLETED|Overall Study||6||
59561137|NCT03190005|75662486|FG005|STARTED|Overall Study||5||
59816832|NCT03735121|75939209|FG000|COMPLETED|Overall Study||6||
60089097|NCT01845805|76205237|FG001|COMPLETED|Overall Study||9||
60089098|NCT01845805|76205236|FG000|NOT COMPLETED|Overall Study||18||
60089099|NCT01845805|76205237|FG001|NOT COMPLETED|Overall Study||16||
60089100|NCT01845025|76205245|FG000|STARTED|Overall Study||411||
60089101|NCT01845025|76205246|FG001|STARTED|Overall Study||409||
60089102|NCT01845025|76205245|FG000|COMPLETED|Overall Study||326||
60089103|NCT01845025|76205246|FG001|COMPLETED|Overall Study||332||
60089104|NCT01845025|76205245|FG000|NOT COMPLETED|Overall Study||85||
60089105|NCT01845025|76205246|FG001|NOT COMPLETED|Overall Study||77||
60089106|NCT02124304|76205254|FG000|STARTED|Overall Study||15||
60089107|NCT02124304|76205255|FG001|STARTED|Overall Study||15||
60089108|NCT02124304|76205254|FG000|COMPLETED|Overall Study||15||
60089109|NCT02124304|76205255|FG001|COMPLETED|Overall Study||15||
60089110|NCT02124304|76205254|FG000|NOT COMPLETED|Overall Study||0||
60089111|NCT02124304|76205255|FG001|NOT COMPLETED|Overall Study||0||
60089112|NCT02124460|76205263|FG000|STARTED|Overall Study||361||
60089113|NCT02124460|76205264|FG001|STARTED|Overall Study||360||
60089114|NCT02124460|76205263|FG000|COMPLETED|Overall Study||328||
60089115|NCT02124460|76205264|FG001|COMPLETED|Overall Study||336||
60089116|NCT02124460|76205263|FG000|NOT COMPLETED|Overall Study||33||
60089117|NCT02124460|76205264|FG001|NOT COMPLETED|Overall Study||24||
59561138|NCT03190005|75662487|FG006|STARTED|Overall Study||5||
59561139|NCT03190005|75662481|FG000|COMPLETED|Overall Study||5||
59561140|NCT03190005|75662482|FG001|COMPLETED|Overall Study||5||
60089118|NCT04148872|76205273|FG000|STARTED|Overall Study||7||
60089119|NCT04148872|76205274|FG001|STARTED|Overall Study|8 participants were consented and assigned to this arm; however, 1 never attended clinic visits and therefore no data was collected from or about this participant.|8||
60089120|NCT04148872|76205273|FG000|COMPLETED|Overall Study||5||
59707663|NCT00991276|75826520|FG000|NOT COMPLETED|Third Intervention Period||1||
59707664|NCT00991276|75826521|FG001|NOT COMPLETED|Third Intervention Period||0||
59816833|NCT03735121|75939210|FG001|COMPLETED|Overall Study||5||
60089121|NCT04148872|76205274|FG001|COMPLETED|Overall Study||7||
60089122|NCT04148872|76205273|FG000|NOT COMPLETED|Overall Study||2||
60089123|NCT04148872|76205274|FG001|NOT COMPLETED|Overall Study||1||
60089124|NCT01870297|76205287|FG000|STARTED|Overall Study||11||
60089125|NCT01870297|76205288|FG001|STARTED|Overall Study||15||
60089126|NCT01870297|76205289|FG002|STARTED|Overall Study||8||
60089127|NCT01870297|76205290|FG003|STARTED|Overall Study||9||
60089128|NCT01870297|76205291|FG004|STARTED|Overall Study||10||
60089129|NCT01870297|76205292|FG005|STARTED|Overall Study||9||
59561141|NCT03190005|75662483|FG002|COMPLETED|Overall Study||5||
59707665|NCT00991276|75826522|FG002|NOT COMPLETED|Third Intervention Period||1||
59816834|NCT03735121|75939211|FG002|COMPLETED|Overall Study||1||
59707666|NCT00991276|75826523|FG003|NOT COMPLETED|Third Intervention Period||1||
59707667|NCT00991276|75826524|FG004|NOT COMPLETED|Third Intervention Period||0||
59707668|NCT00991276|75826525|FG005|NOT COMPLETED|Third Intervention Period||1||
59707669|NCT00990652|75826534|FG000|STARTED|Pre-surgical Bortezomib||10||
59707670|NCT00990652|75826534|FG000|COMPLETED|Pre-surgical Bortezomib||9||
59707671|NCT00990652|75826534|FG000|NOT COMPLETED|Pre-surgical Bortezomib||1||
59707672|NCT00990652|75826534|FG000|STARTED|Surgical Resection||9||
59707673|NCT00990652|75826534|FG000|COMPLETED|Surgical Resection||9||
59707674|NCT00990652|75826534|FG000|NOT COMPLETED|Surgical Resection||0||
59707675|NCT00990652|75826534|FG000|STARTED|Post-sugery Bortezomib + Temozolomide||9||
59707676|NCT00990652|75826534|FG000|COMPLETED|Post-sugery Bortezomib + Temozolomide||8||
59707677|NCT00990652|75826534|FG000|NOT COMPLETED|Post-sugery Bortezomib + Temozolomide||1||
59707678|NCT00990340|75826541|FG000|STARTED|First 14-day Treatment||27||
59707679|NCT00990340|75826542|FG001|STARTED|First 14-day Treatment||25||
59707680|NCT00990340|75826541|FG000|COMPLETED|First 14-day Treatment||21||
59707681|NCT00990340|75826542|FG001|COMPLETED|First 14-day Treatment||21||
59707682|NCT00990340|75826541|FG000|NOT COMPLETED|First 14-day Treatment||6||
59707683|NCT00990340|75826542|FG001|NOT COMPLETED|First 14-day Treatment||4||
60089130|NCT01870297|76205293|FG006|STARTED|Overall Study||10||
60089131|NCT01870297|76205287|FG000|COMPLETED|Overall Study||11||
60089132|NCT01870297|76205288|FG001|COMPLETED|Overall Study||8||
60089133|NCT01870297|76205289|FG002|COMPLETED|Overall Study||7||
60089134|NCT01870297|76205290|FG003|COMPLETED|Overall Study||9||
60089135|NCT01870297|76205291|FG004|COMPLETED|Overall Study||7||
60089136|NCT01870297|76205292|FG005|COMPLETED|Overall Study||8||
59707684|NCT00990340|75826541|FG000|STARTED|Second 14-day Treatment||21||
59707685|NCT00990340|75826542|FG001|STARTED|Second 14-day Treatment||21||
59707686|NCT00990340|75826541|FG000|COMPLETED|Second 14-day Treatment||21||
59707687|NCT00990340|75826542|FG001|COMPLETED|Second 14-day Treatment||21||
59707688|NCT00990340|75826541|FG000|NOT COMPLETED|Second 14-day Treatment||0||
59707689|NCT00990340|75826542|FG001|NOT COMPLETED|Second 14-day Treatment||0||
59707690|NCT01207440|75826557|FG000|STARTED|Overall Study||203||
60089137|NCT01870297|76205293|FG006|COMPLETED|Overall Study||8||
59707691|NCT01207440|75826558|FG001|STARTED|Overall Study||64||
59707692|NCT01207440|75826559|FG002|STARTED|Overall Study||65||
60089138|NCT01870297|76205287|FG000|NOT COMPLETED|Overall Study||0||
60089139|NCT01870297|76205288|FG001|NOT COMPLETED|Overall Study||7||
59561142|NCT03190005|75662484|FG003|COMPLETED|Overall Study||5||
59561143|NCT03190005|75662485|FG004|COMPLETED|Overall Study||5||
59561144|NCT03190005|75662486|FG005|COMPLETED|Overall Study||5||
59561145|NCT03190005|75662487|FG006|COMPLETED|Overall Study||5||
59561146|NCT03190005|75662481|FG000|NOT COMPLETED|Overall Study||0||
59561147|NCT03190005|75662482|FG001|NOT COMPLETED|Overall Study||0||
59561148|NCT03190005|75662483|FG002|NOT COMPLETED|Overall Study||0||
59561149|NCT03190005|75662484|FG003|NOT COMPLETED|Overall Study||0||
59561150|NCT03190005|75662485|FG004|NOT COMPLETED|Overall Study||0||
59561151|NCT03190005|75662486|FG005|NOT COMPLETED|Overall Study||0||
59561152|NCT03190005|75662487|FG006|NOT COMPLETED|Overall Study||0||
59561153|NCT01680848|75662503|FG000|STARTED|Overall Study||282||
59561154|NCT01680848|75662503|FG000|COMPLETED|Overall Study||189||
59561155|NCT01680848|75662503|FG000|NOT COMPLETED|Overall Study||93||
59561156|NCT03190083|75662507|FG000|STARTED|Overall Study||16||
59561157|NCT03190083|75662507|FG000|COMPLETED|Overall Study||16||
59561158|NCT03190083|75662507|FG000|NOT COMPLETED|Overall Study||0||
59561159|NCT03193593|75662518|FG000|STARTED|Overall Study||18||
59707693|NCT01207440|75826560|FG003|STARTED|Overall Study||18||
59561160|NCT03193593|75662519|FG001|STARTED|Overall Study||4||
59561161|NCT03193593|75662520|FG002|STARTED|Overall Study||4||
59561162|NCT03193593|75662521|FG003|STARTED|Overall Study||4||
59561163|NCT03193593|75662522|FG004|STARTED|Overall Study||8||
59561164|NCT03193593|75662523|FG005|STARTED|Overall Study||16||
59561165|NCT03193593|75662524|FG006|STARTED|Overall Study||12||
59561166|NCT03193593|75662518|FG000|COMPLETED|Overall Study||14||
59561167|NCT03193593|75662519|FG001|COMPLETED|Overall Study||3||
59561168|NCT03193593|75662520|FG002|COMPLETED|Overall Study||3||
59561169|NCT03193593|75662521|FG003|COMPLETED|Overall Study||4||
59707694|NCT01207440|75826561|FG004|STARTED|Overall Study||48||
59561170|NCT03193593|75662522|FG004|COMPLETED|Overall Study||7||
59561171|NCT03193593|75662523|FG005|COMPLETED|Overall Study||13||
59561172|NCT03193593|75662524|FG006|COMPLETED|Overall Study||8||
59707695|NCT01207440|75826562|FG005|STARTED|Overall Study||46||
59707696|NCT01207440|75826563|FG006|STARTED|Overall Study||5||
59561173|NCT03193593|75662518|FG000|NOT COMPLETED|Overall Study||4||
59561174|NCT03193593|75662519|FG001|NOT COMPLETED|Overall Study||1||
59561175|NCT03193593|75662520|FG002|NOT COMPLETED|Overall Study||1||
59561176|NCT03193593|75662521|FG003|NOT COMPLETED|Overall Study||0||
59561177|NCT03193593|75662522|FG004|NOT COMPLETED|Overall Study||1||
59561178|NCT03193593|75662523|FG005|NOT COMPLETED|Overall Study||3||
59561179|NCT03193593|75662524|FG006|NOT COMPLETED|Overall Study||4||
59561180|NCT01682642|75662542|FG000|STARTED|Overall Study||61||
59561181|NCT01682642|75662543|FG001|STARTED|Overall Study||59||
59561182|NCT01682642|75662542|FG000|COMPLETED|Overall Study||61||
59561183|NCT01682642|75662543|FG001|COMPLETED|Overall Study||58||
59561184|NCT01682642|75662542|FG000|NOT COMPLETED|Overall Study||0||
59561185|NCT01682642|75662543|FG001|NOT COMPLETED|Overall Study||1||
59707697|NCT01207440|75826557|FG000|COMPLETED|Overall Study||0||
59561186|NCT01682954|75662557|FG000|STARTED|Overall Study||40||
59561187|NCT01682954|75662558|FG001|STARTED|Overall Study||38||
59561188|NCT01682954|75662557|FG000|COMPLETED|Overall Study||35||
59561189|NCT01682954|75662558|FG001|COMPLETED|Overall Study||33||
60089140|NCT01870297|76205289|FG002|NOT COMPLETED|Overall Study||1||
60089141|NCT01870297|76205290|FG003|NOT COMPLETED|Overall Study||0||
60089142|NCT01870297|76205291|FG004|NOT COMPLETED|Overall Study||3||
60089143|NCT01870297|76205292|FG005|NOT COMPLETED|Overall Study||1||
60089144|NCT01870297|76205293|FG006|NOT COMPLETED|Overall Study||2||
60089145|NCT01814761|76205320|FG000|STARTED|Overall Study||42||
60089146|NCT01814761|76205321|FG001|STARTED|Overall Study||270||
60089147|NCT01814761|76205320|FG000|COMPLETED|Overall Study||34||
60089148|NCT01814761|76205321|FG001|COMPLETED|Overall Study||240||
60089149|NCT01814761|76205320|FG000|NOT COMPLETED|Overall Study||8||
60089150|NCT01814761|76205321|FG001|NOT COMPLETED|Overall Study||30||
60089151|NCT01843933|76205329|FG000|STARTED|Overall Study||104||
60089152|NCT01843933|76205330|FG001|STARTED|Overall Study||107||
60089153|NCT01843933|76205329|FG000|COMPLETED|Overall Study||98||
60089154|NCT01843933|76205330|FG001|COMPLETED|Overall Study||103||
60089155|NCT01843933|76205329|FG000|NOT COMPLETED|Overall Study||6||
60089156|NCT01843933|76205330|FG001|NOT COMPLETED|Overall Study||4||
60089157|NCT01814371|76205338|FG000|STARTED|Overall Study||248||
60089158|NCT01814371|76205339|FG001|STARTED|Overall Study||226||
60089159|NCT01814371|76205338|FG000|COMPLETED|Overall Study||218||
60089160|NCT01814371|76205339|FG001|COMPLETED|Overall Study||199||
60089161|NCT01814371|76205338|FG000|NOT COMPLETED|Overall Study||30||
60089162|NCT01814371|76205339|FG001|NOT COMPLETED|Overall Study||27||
60089163|NCT02131402|76205348|FG000|STARTED|Overall Study||60||
60089164|NCT02131402|76205348|FG000|COMPLETED|Overall Study||60||
60089165|NCT02131402|76205348|FG000|NOT COMPLETED|Overall Study||0||
60089166|NCT01814137|76205413|FG000|STARTED|Overall Study||20||
60089167|NCT01814137|76205414|FG001|STARTED|Overall Study||20||
60089168|NCT01814137|76205413|FG000|COMPLETED|Overall Study||15||
60089169|NCT01814137|76205414|FG001|COMPLETED|Overall Study||15||
60089170|NCT01814137|76205413|FG000|NOT COMPLETED|Overall Study||5||
60089171|NCT01814137|76205414|FG001|NOT COMPLETED|Overall Study||5||
60089172|NCT04084288|76205420|FG000|STARTED|Overall Study||41||
60089173|NCT04084288|76205420|FG000|COMPLETED|Overall Study||41||
60089174|NCT04084288|76205420|FG000|NOT COMPLETED|Overall Study||0||
60089175|NCT01813435|76205431|FG000|STARTED|Overall Study|12 participants withdrew consent or objected to use further use of data|7980||
60089176|NCT01813435|76205432|FG001|STARTED|Overall Study|11 participants withdrew consent or objected to use further use of data|7988||
60089177|NCT01813435|76205431|FG000|COMPLETED|Overall Study||5810||
60089178|NCT01813435|76205432|FG001|COMPLETED|Overall Study||6981||
60089179|NCT01813435|76205431|FG000|NOT COMPLETED|Overall Study||2170||
60089180|NCT01813435|76205432|FG001|NOT COMPLETED|Overall Study||1007||
60089181|NCT01813357|76205440|FG000|STARTED|Overall Study||40||
60089182|NCT01813357|76205441|FG001|STARTED|Overall Study||44||
60089183|NCT01813357|76205440|FG000|COMPLETED|Overall Study||35||
60089184|NCT01813357|76205441|FG001|COMPLETED|Overall Study||38||
60089185|NCT01813357|76205440|FG000|NOT COMPLETED|Overall Study||5||
60089186|NCT01813357|76205441|FG001|NOT COMPLETED|Overall Study||6||
60089187|NCT01812655|76205450|FG000|STARTED|Overall Study|Virtual Reality-Patients used an interactive VR program during their burn wound care procedure.|9||
60089188|NCT01812655|76205451|FG001|STARTED|Overall Study|Passive Distraction-Patients watched a movie during their burn wound care.|11||
60089189|NCT01812655|76205452|FG002|STARTED|Overall Study|Nurses provided their usual, standard care throughout the entire burn wound care.|10||
60089190|NCT01812655|76205450|FG000|COMPLETED|Overall Study||8||
60089191|NCT01812655|76205451|FG001|COMPLETED|Overall Study||10||
60089192|NCT01812655|76205452|FG002|COMPLETED|Overall Study||10||
60089193|NCT01812655|76205450|FG000|NOT COMPLETED|Overall Study||1||
60089194|NCT01812655|76205451|FG001|NOT COMPLETED|Overall Study||1||
60089195|NCT01812655|76205452|FG002|NOT COMPLETED|Overall Study||0||
60089196|NCT02346526|76205463|FG000|STARTED|Overall Study||22||
60089197|NCT02346526|76205463|FG000|COMPLETED|Overall Study||22||
60089198|NCT02346526|76205463|FG000|NOT COMPLETED|Overall Study||0||
60089199|NCT01812109|76205473|FG000|STARTED|Overall Study||154||
60089200|NCT01812109|76205473|FG000|With Torsion|Overall Study||36||
60089201|NCT01812109|76205473|FG000|Without Torsion|Overall Study||85||
60089202|NCT01812109|76205473|FG000|COMPLETED|Overall Study||121||
60089203|NCT01812109|76205473|FG000|NOT COMPLETED|Overall Study||33||
60089204|NCT01811953|76205483|FG000|STARTED|Overall Study||6||
60089205|NCT01811953|76205484|FG001|STARTED|Overall Study||6||
60089206|NCT01811953|76205485|FG002|STARTED|Overall Study||6||
60089207|NCT01811953|76205486|FG003|STARTED|Overall Study||6||
60089208|NCT01811953|76205487|FG004|STARTED|Overall Study||12||
60089209|NCT01811953|76205488|FG005|STARTED|Overall Study||12||
60089210|NCT01811953|76205483|FG000|COMPLETED|Overall Study||6||
60089211|NCT01811953|76205484|FG001|COMPLETED|Overall Study||6||
60089212|NCT01811953|76205485|FG002|COMPLETED|Overall Study||6||
60089213|NCT01811953|76205486|FG003|COMPLETED|Overall Study||5||
60089214|NCT01811953|76205487|FG004|COMPLETED|Overall Study||11||
60089215|NCT01811953|76205488|FG005|COMPLETED|Overall Study||11||
60089216|NCT01811953|76205483|FG000|NOT COMPLETED|Overall Study||0||
60089217|NCT01811953|76205484|FG001|NOT COMPLETED|Overall Study||0||
60089218|NCT01811953|76205485|FG002|NOT COMPLETED|Overall Study||0||
60089219|NCT01811953|76205486|FG003|NOT COMPLETED|Overall Study||1||
60089220|NCT01811953|76205487|FG004|NOT COMPLETED|Overall Study||1||
60089221|NCT01811953|76205488|FG005|NOT COMPLETED|Overall Study||1||
60089222|NCT01811563|76205504|FG000|STARTED|Overall Study||25||
59561190|NCT01682954|75662557|FG000|NOT COMPLETED|Overall Study||5||
59561191|NCT01682954|75662558|FG001|NOT COMPLETED|Overall Study||5||
59561192|NCT01683422|75662564|FG000|STARTED|Overall Study||9||
59561193|NCT01683422|75662564|FG000|COMPLETED|Overall Study||9||
59561194|NCT01683422|75662564|FG000|NOT COMPLETED|Overall Study||0||
59561195|NCT03194373|75662568|FG000|STARTED|Overall Study||20||
59561196|NCT03194373|75662568|FG000|Received Palbociclib and Carboplatin|Overall Study||19|One participant received carboplatin but never received palbociclib|
59561197|NCT03194373|75662568|FG000|COMPLETED|Overall Study||18|Evaluable for response|
59561198|NCT03194373|75662568|FG000|NOT COMPLETED|Overall Study||2||
59561199|NCT02240654|75662577|FG000|STARTED|Overall Study||1706||
59561200|NCT02240654|75662578|FG001|STARTED|Overall Study||2813||
60089223|NCT01811563|76205505|FG001|STARTED|Overall Study||23||
60089224|NCT01811563|76205504|FG000|COMPLETED|Overall Study||20||
60089225|NCT01811563|76205505|FG001|COMPLETED|Overall Study||20||
60089226|NCT01811563|76205504|FG000|NOT COMPLETED|Overall Study||5||
60089227|NCT01811563|76205505|FG001|NOT COMPLETED|Overall Study||3||
60089228|NCT01811485|76205514|FG000|STARTED|Overall Study|"Started indicates randomized patients"|56||
60089229|NCT01811485|76205515|FG001|STARTED|Overall Study||59||
60089230|NCT01811485|76205516|FG002|STARTED|Overall Study||56||
60089231|NCT01811485|76205514|FG000|COMPLETED|Overall Study||54||
60089232|NCT01811485|76205515|FG001|COMPLETED|Overall Study||55||
59561201|NCT02240654|75662579|FG002|STARTED|Overall Study||28619||
59561202|NCT02240654|75662580|FG003|STARTED|Overall Study||2150||
59561203|NCT02240654|75662581|FG004|STARTED|Overall Study||1285||
60089233|NCT01811485|76205516|FG002|COMPLETED|Overall Study||51||
60089234|NCT01811485|76205514|FG000|NOT COMPLETED|Overall Study||2||
60089235|NCT01811485|76205515|FG001|NOT COMPLETED|Overall Study||4||
60089236|NCT01811485|76205516|FG002|NOT COMPLETED|Overall Study||5||
60089237|NCT01810939|76205527|FG000|STARTED|Part A Treatment Period||243||
60089238|NCT01810939|76205528|FG001|STARTED|Part A Treatment Period||0||
59561204|NCT02240654|75662577|FG000|COMPLETED|Overall Study||1706||
59561205|NCT02240654|75662578|FG001|COMPLETED|Overall Study||2813||
59816835|NCT03735121|75939212|FG003|COMPLETED|Overall Study||0||
59816836|NCT03735121|75939213|FG004|COMPLETED|Overall Study||0||
59816837|NCT03735121|75939209|FG000|NOT COMPLETED|Overall Study||7||
59816838|NCT03735121|75939210|FG001|NOT COMPLETED|Overall Study||10||
59992794|NCT03032705|76108610|FG000|STARTED|Overall Study|"Number of participants are same (repeated) for both groups~unit = teeth"|51|"Each participant was analyzed for both groups therefore the total number of participants is equal to participants in both groups, not the sum of both groups which is 51.~Each participants contributed 2 randomly selected teeth for each study group therefore 1 participant contributing 2 study teeth in each case."|51
60089239|NCT01810939|76205529|FG002|STARTED|Part A Treatment Period||0||
60089240|NCT01810939|76205527|FG000|COMPLETED|Part A Treatment Period||219||
60089241|NCT01810939|76205528|FG001|COMPLETED|Part A Treatment Period||0||
60089242|NCT01810939|76205529|FG002|COMPLETED|Part A Treatment Period||0||
60089243|NCT01810939|76205527|FG000|NOT COMPLETED|Part A Treatment Period||24||
60089244|NCT01810939|76205528|FG001|NOT COMPLETED|Part A Treatment Period||0||
60089245|NCT01810939|76205529|FG002|NOT COMPLETED|Part A Treatment Period||0||
60089246|NCT01810939|76205527|FG000|STARTED|Part B Placebo-Controlled Withdrawal||0||
60089247|NCT01810939|76205528|FG001|STARTED|Part B Placebo-Controlled Withdrawal|Part A participants with Part A baseline serum potassium ≥ 5.5 mEq/L who responded to treatment|55||
60089248|NCT01810939|76205529|FG002|STARTED|Part B Placebo-Controlled Withdrawal|Part A participants with Part A baseline serum potassium ≥ 5.5 mEq/L who responded to treatment|52||
60089249|NCT01810939|76205527|FG000|COMPLETED|Part B Placebo-Controlled Withdrawal||0||
60089250|NCT01810939|76205528|FG001|COMPLETED|Part B Placebo-Controlled Withdrawal||45||
60089251|NCT01810939|76205529|FG002|COMPLETED|Part B Placebo-Controlled Withdrawal||30||
60089252|NCT01810939|76205527|FG000|NOT COMPLETED|Part B Placebo-Controlled Withdrawal||0||
60089253|NCT01810939|76205528|FG001|NOT COMPLETED|Part B Placebo-Controlled Withdrawal||10||
59561206|NCT02240654|75662579|FG002|COMPLETED|Overall Study||28619||
59816839|NCT03735121|75939211|FG002|NOT COMPLETED|Overall Study||38||
59992795|NCT03032705|76108611|FG001|STARTED|Overall Study|"Number of participants are same (repeated) for both groups~unit = teeth"|51|"Each participant was analyzed for both groups therefore the total number of participants is equal to participants in both groups, not the sum of both groups which is 51.~Each participants contributed 2 randomly selected teeth for each study group therefore 1 participant contributing 2 study teeth in each case."|51
59992796|NCT03032705|76108610|FG000|Completion of Restorations (V2)|Overall Study|"Number of participants are same (repeated) for both groups~unit = teeth"|45|45 participants total for both groups|45
59995196|NCT02730169|76111016|FG003|STARTED|Overall Study||71||
59995197|NCT02730169|76111013|FG000|COMPLETED|Overall Study||53||
60089254|NCT01810939|76205529|FG002|NOT COMPLETED|Part B Placebo-Controlled Withdrawal||22||
60089255|NCT00565084|76205538|FG000|STARTED|First Treatment Period||11||
59816840|NCT03735121|75939212|FG003|NOT COMPLETED|Overall Study||124||
59816841|NCT03735121|75939213|FG004|NOT COMPLETED|Overall Study||247||
59561207|NCT02240654|75662580|FG003|COMPLETED|Overall Study||2150||
59561208|NCT02240654|75662581|FG004|COMPLETED|Overall Study||1285||
59561209|NCT02240654|75662577|FG000|NOT COMPLETED|Overall Study||0||
59561210|NCT02240654|75662578|FG001|NOT COMPLETED|Overall Study||0||
59561211|NCT02240654|75662579|FG002|NOT COMPLETED|Overall Study||0||
59561212|NCT02240654|75662580|FG003|NOT COMPLETED|Overall Study||0||
60089256|NCT00565084|76205539|FG001|STARTED|First Treatment Period||11||
60089257|NCT00565084|76205540|FG002|STARTED|First Treatment Period||11||
60089258|NCT00565084|76205538|FG000|COMPLETED|First Treatment Period||11||
59561213|NCT02240654|75662581|FG004|NOT COMPLETED|Overall Study||0||
60089259|NCT00565084|76205539|FG001|COMPLETED|First Treatment Period||11||
60089260|NCT00565084|76205540|FG002|COMPLETED|First Treatment Period||11||
60089261|NCT00565084|76205538|FG000|NOT COMPLETED|First Treatment Period||0||
60089262|NCT00565084|76205539|FG001|NOT COMPLETED|First Treatment Period||0||
60089263|NCT00565084|76205540|FG002|NOT COMPLETED|First Treatment Period||0||
60089264|NCT00565084|76205538|FG000|STARTED|Second Treatment Period||11||
60089265|NCT00565084|76205539|FG001|STARTED|Second Treatment Period||11||
60089266|NCT00565084|76205540|FG002|STARTED|Second Treatment Period||11||
60089267|NCT00565084|76205538|FG000|COMPLETED|Second Treatment Period||11||
59561214|NCT02240810|75662595|FG000|STARTED|Overall Study||1501||
59561215|NCT02240810|75662596|FG001|STARTED|Overall Study|correct typo|2681||
59561216|NCT02240810|75662595|FG000|COMPLETED|Overall Study||1441||
59561217|NCT02240810|75662596|FG001|COMPLETED|Overall Study||2621||
59561218|NCT02240810|75662595|FG000|NOT COMPLETED|Overall Study||60||
59561219|NCT02240810|75662596|FG001|NOT COMPLETED|Overall Study||60||
59707698|NCT01207440|75826558|FG001|COMPLETED|Overall Study||0||
60089268|NCT00565084|76205539|FG001|COMPLETED|Second Treatment Period||11||
60089269|NCT00565084|76205540|FG002|COMPLETED|Second Treatment Period||11||
60089270|NCT00565084|76205538|FG000|NOT COMPLETED|Second Treatment Period||0||
59561220|NCT01683812|75662603|FG000|STARTED|Overall Study||23||
59561221|NCT01683812|75662603|FG000|COMPLETED|Overall Study||23||
59707699|NCT01207440|75826559|FG002|COMPLETED|Overall Study||0||
59707700|NCT01207440|75826560|FG003|COMPLETED|Overall Study||0||
59707701|NCT01207440|75826561|FG004|COMPLETED|Overall Study||0||
59707702|NCT01207440|75826562|FG005|COMPLETED|Overall Study||0||
60089271|NCT00565084|76205539|FG001|NOT COMPLETED|Second Treatment Period||0||
60089272|NCT00565084|76205540|FG002|NOT COMPLETED|Second Treatment Period||0||
60089273|NCT00565084|76205538|FG000|STARTED|Third Treatment Period||11||
60089274|NCT00565084|76205539|FG001|STARTED|Third Treatment Period||11||
60089275|NCT00565084|76205540|FG002|STARTED|Third Treatment Period||11||
60089276|NCT00565084|76205538|FG000|COMPLETED|Third Treatment Period||11||
60089277|NCT00565084|76205539|FG001|COMPLETED|Third Treatment Period||11||
60089278|NCT00565084|76205540|FG002|COMPLETED|Third Treatment Period||11||
60089279|NCT00565084|76205538|FG000|NOT COMPLETED|Third Treatment Period||0||
60089280|NCT00565084|76205539|FG001|NOT COMPLETED|Third Treatment Period||0||
60089281|NCT00565084|76205540|FG002|NOT COMPLETED|Third Treatment Period||0||
60089282|NCT01810783|76205548|FG000|STARTED|Overall Study||210||
59561222|NCT01683812|75662603|FG000|NOT COMPLETED|Overall Study||0||
59561223|NCT03197025|75662607|FG000|STARTED|Overall Study||1||
59561224|NCT03197025|75662607|FG000|COMPLETED|Overall Study||1||
59707703|NCT01207440|75826563|FG006|COMPLETED|Overall Study||0||
59707704|NCT01207440|75826557|FG000|NOT COMPLETED|Overall Study||203||
60089283|NCT01810783|76205548|FG000|COMPLETED|Overall Study||101||
60089284|NCT01810783|76205548|FG000|NOT COMPLETED|Overall Study||109||
60089285|NCT00565864|76205555|FG000|STARTED|Overall Study||58||
60089286|NCT00565864|76205556|FG001|STARTED|Overall Study||59||
60089287|NCT00565864|76205557|FG002|STARTED|Overall Study||56||
60089288|NCT00565864|76205555|FG000|COMPLETED|Overall Study||46||
60089289|NCT00565864|76205556|FG001|COMPLETED|Overall Study||47||
60089290|NCT00565864|76205557|FG002|COMPLETED|Overall Study||45||
60089291|NCT00565864|76205555|FG000|NOT COMPLETED|Overall Study||12||
60089292|NCT00565864|76205556|FG001|NOT COMPLETED|Overall Study||12||
60089293|NCT00565864|76205557|FG002|NOT COMPLETED|Overall Study||11||
60089294|NCT01808209|76205569|FG000|STARTED|Overall Study||33||
60089295|NCT01808209|76205570|FG001|STARTED|Overall Study||27||
60089296|NCT01808209|76205569|FG000|COMPLETED|Overall Study||33||
60089297|NCT01808209|76205570|FG001|COMPLETED|Overall Study||26||
60089298|NCT01808209|76205569|FG000|NOT COMPLETED|Overall Study||0||
60089299|NCT01808209|76205570|FG001|NOT COMPLETED|Overall Study||1||
60089300|NCT01807117|76205580|FG000|STARTED|Overall Study||15||
60089301|NCT01807117|76205580|FG000|COMPLETED|Overall Study||12||
60089302|NCT01807117|76205580|FG000|NOT COMPLETED|Overall Study||3||
60089303|NCT01806961|76205586|FG000|STARTED|Overall Study||16||
60089304|NCT01806961|76205586|FG000|COMPLETED|Overall Study||0||
60089305|NCT01806961|76205586|FG000|NOT COMPLETED|Overall Study||16||
60089306|NCT01613131|76205592|FG000|STARTED|Overall Study||20||
60089307|NCT01613131|76205593|FG001|STARTED|Overall Study||18||
60089308|NCT01613131|76205592|FG000|COMPLETED|Overall Study||17||
60089309|NCT01613131|76205593|FG001|COMPLETED|Overall Study||13||
60089310|NCT01613131|76205592|FG000|NOT COMPLETED|Overall Study||3||
60089311|NCT01613131|76205593|FG001|NOT COMPLETED|Overall Study||5||
60089312|NCT01868893|76205599|FG000|STARTED|Overall Study||20||
60089313|NCT01868893|76205599|FG000|COMPLETED|Overall Study||0||
60089314|NCT01868893|76205599|FG000|NOT COMPLETED|Overall Study||20||
60089315|NCT01868503|76205605|FG000|STARTED|Overall Study||7||
60089316|NCT01868503|76205605|FG000|COMPLETED|Overall Study||5||
60089317|NCT01868503|76205605|FG000|NOT COMPLETED|Overall Study||2||
60089318|NCT02132572|76205611|FG000|STARTED|Overall Study||201||
60089319|NCT02132572|76205611|FG000|COMPLETED|Overall Study||201||
60089320|NCT02132572|76205611|FG000|NOT COMPLETED|Overall Study||0||
60089321|NCT01868035|76205615|FG000|STARTED|Overall Study||15||
60089322|NCT01868035|76205615|FG000|COMPLETED|Overall Study|These participants completed 10 years of follow-up.|8||
60089323|NCT01868035|76205615|FG000|NOT COMPLETED|Overall Study||7||
60089324|NCT01609933|76205619|FG000|STARTED|Overall Study||32||
60089325|NCT01609933|76205619|FG000|COMPLETED|Overall Study||28||
60089326|NCT01609933|76205619|FG000|NOT COMPLETED|Overall Study||4||
60089327|NCT01843777|76205627|FG000|STARTED|Overall Study|Number of participants randomized to standard-of-care.|11||
60089328|NCT01843777|76205628|FG001|STARTED|Overall Study|Number of participants randomized to treatment.|10||
60089329|NCT01843777|76205627|FG000|Per Protocol Population|Overall Study||11||
60089330|NCT01843777|76205628|FG001|Per Protocol Population|Overall Study|A subject was randomized to treatment but received standard of care and is not in the analyses.|9||
60089331|NCT01843777|76205627|FG000|COMPLETED|Overall Study|Final number of standard-of-care participants.|10||
60089332|NCT01843777|76205628|FG001|COMPLETED|Overall Study|Number of subjects who received the treatment that completed collection of outcome measures|10||
60089333|NCT01843777|76205627|FG000|NOT COMPLETED|Overall Study||1||
60089334|NCT01843777|76205628|FG001|NOT COMPLETED|Overall Study||0||
60089335|NCT01842607|76205634|FG000|STARTED|Overall Study||651||
60089336|NCT01842607|76205634|FG000|COMPLETED|Overall Study||585||
60089337|NCT01842607|76205634|FG000|NOT COMPLETED|Overall Study||66||
60089338|NCT01803607|76205640|FG000|STARTED|Overall Study||68||
60089339|NCT01803607|76205641|FG001|STARTED|Overall Study||67||
60089340|NCT01803607|76205640|FG000|COMPLETED|Overall Study||0||
60089341|NCT01803607|76205641|FG001|COMPLETED|Overall Study||0||
60089342|NCT01803607|76205640|FG000|NOT COMPLETED|Overall Study||68||
60089343|NCT01803607|76205641|FG001|NOT COMPLETED|Overall Study||67||
60089344|NCT01867021|76205649|FG000|STARTED|Overall Study||1452||
60089345|NCT01867021|76205650|FG001|STARTED|Overall Study||1450||
60089346|NCT01867021|76205649|FG000|COMPLETED|Overall Study||1450||
60089347|NCT01867021|76205650|FG001|COMPLETED|Overall Study||1440||
60089348|NCT01867021|76205649|FG000|NOT COMPLETED|Overall Study||2||
60089349|NCT01867021|76205650|FG001|NOT COMPLETED|Overall Study||10||
60089350|NCT01866709|76205663|FG000|STARTED|Overall Study||15||
60089351|NCT01866709|76205664|FG001|STARTED|Overall Study||17||
60089352|NCT01866709|76205663|FG000|COMPLETED|Overall Study||14||
60089353|NCT01866709|76205664|FG001|COMPLETED|Overall Study||17||
60089354|NCT01866709|76205663|FG000|NOT COMPLETED|Overall Study||1||
60089355|NCT01866709|76205664|FG001|NOT COMPLETED|Overall Study||0||
60089356|NCT01841593|76205672|FG000|STARTED|First Intervention (Days 1 to 7)||12||
60089357|NCT01841593|76205673|FG001|STARTED|First Intervention (Days 1 to 7)||7||
60089358|NCT01841593|76205672|FG000|COMPLETED|First Intervention (Days 1 to 7)||12||
60089359|NCT01841593|76205673|FG001|COMPLETED|First Intervention (Days 1 to 7)||6||
60089360|NCT01841593|76205672|FG000|NOT COMPLETED|First Intervention (Days 1 to 7)||0||
60089361|NCT01841593|76205673|FG001|NOT COMPLETED|First Intervention (Days 1 to 7)||1||
60089362|NCT01841593|76205672|FG000|STARTED|Second Intervention (Days 8 to 14)||12||
60089363|NCT01841593|76205673|FG001|STARTED|Second Intervention (Days 8 to 14)||6||
60089364|NCT01841593|76205672|FG000|COMPLETED|Second Intervention (Days 8 to 14)||11||
60089365|NCT01841593|76205673|FG001|COMPLETED|Second Intervention (Days 8 to 14)||6||
60089366|NCT01841593|76205672|FG000|NOT COMPLETED|Second Intervention (Days 8 to 14)||1||
60089367|NCT01841593|76205673|FG001|NOT COMPLETED|Second Intervention (Days 8 to 14)||0||
60089368|NCT01841593|76205672|FG000|STARTED|Third Intervention (Days 15 to 21)||11||
60089369|NCT01841593|76205673|FG001|STARTED|Third Intervention (Days 15 to 21)||6||
60089370|NCT01841593|76205672|FG000|COMPLETED|Third Intervention (Days 15 to 21)||11||
60089371|NCT01841593|76205673|FG001|COMPLETED|Third Intervention (Days 15 to 21)||6||
60089372|NCT01841593|76205672|FG000|NOT COMPLETED|Third Intervention (Days 15 to 21)||0||
60089373|NCT01841593|76205673|FG001|NOT COMPLETED|Third Intervention (Days 15 to 21)||0||
60089374|NCT02132650|76205685|FG000|STARTED|Overall Study||20|Baseline Assessment|
60089375|NCT02132650|76205686|FG001|STARTED|Overall Study||18|Baseline Assessment|
60089376|NCT02132650|76205685|FG000|Post-Intervention Assessment|Overall Study||19||
60089377|NCT02132650|76205686|FG001|Post-Intervention Assessment|Overall Study||17||
60089378|NCT02132650|76205685|FG000|COMPLETED|Overall Study||17|3-Month Follow Up Assessment|
60089379|NCT02132650|76205686|FG001|COMPLETED|Overall Study||14|3-Month Follow Up Assessment|
60089380|NCT02132650|76205685|FG000|NOT COMPLETED|Overall Study||3||
60089381|NCT02132650|76205686|FG001|NOT COMPLETED|Overall Study||4||
60089382|NCT02339038|76205692|FG000|STARTED|Overall Study||600||
60089383|NCT02339038|76205692|FG000|COMPLETED|Overall Study||0||
60089384|NCT02339038|76205692|FG000|NOT COMPLETED|Overall Study||600||
60089385|NCT02136004|76205698|FG000|STARTED|Overall Study|Enrollment commenced on May 20, 2014 and the last subject completed follow-up on February 28, 2015|220||
60089386|NCT02136004|76205698|FG000|COMPLETED|Overall Study||219||
60089387|NCT02136004|76205698|FG000|NOT COMPLETED|Overall Study||1||
60089388|NCT00569530|76205704|FG000|STARTED|Overall Study||43||
60089389|NCT00569530|76205705|FG001|STARTED|Overall Study||42||
60089390|NCT00569530|76205704|FG000|COMPLETED|Overall Study||43||
60089391|NCT00569530|76205705|FG001|COMPLETED|Overall Study||42||
60089392|NCT00569530|76205704|FG000|NOT COMPLETED|Overall Study||0||
60089393|NCT00569530|76205705|FG001|NOT COMPLETED|Overall Study||0||
60089394|NCT02137486|76205713|FG000|STARTED|Overall Study||112||
60089395|NCT02137486|76205714|FG001|STARTED|Overall Study||102||
60089396|NCT02137486|76205713|FG000|COMPLETED|Overall Study||112||
60089397|NCT02137486|76205714|FG001|COMPLETED|Overall Study||102||
60089398|NCT02137486|76205713|FG000|NOT COMPLETED|Overall Study||0||
60089399|NCT02137486|76205714|FG001|NOT COMPLETED|Overall Study||0||
60089400|NCT00570700|76205724|FG000|STARTED|Overall Study||38||
60089401|NCT00570700|76205724|FG000|COMPLETED|Overall Study||27||
60089402|NCT00570700|76205724|FG000|NOT COMPLETED|Overall Study||11||
60089403|NCT00571324|76205728|FG000|STARTED|Intervention 1 (7 Hours)||5||
60089404|NCT00571324|76205729|FG001|STARTED|Intervention 1 (7 Hours)||4||
60089405|NCT00571324|76205728|FG000|COMPLETED|Intervention 1 (7 Hours)||5||
60089406|NCT00571324|76205729|FG001|COMPLETED|Intervention 1 (7 Hours)||4||
60089407|NCT00571324|76205728|FG000|NOT COMPLETED|Intervention 1 (7 Hours)||0||
60089408|NCT00571324|76205729|FG001|NOT COMPLETED|Intervention 1 (7 Hours)||0||
60089409|NCT00571324|76205728|FG000|STARTED|Intervention 2 (7 Hours)||5||
60089410|NCT00571324|76205729|FG001|STARTED|Intervention 2 (7 Hours)||4||
60089411|NCT00571324|76205728|FG000|COMPLETED|Intervention 2 (7 Hours)||5||
60089412|NCT00571324|76205729|FG001|COMPLETED|Intervention 2 (7 Hours)||4||
60089413|NCT00571324|76205728|FG000|NOT COMPLETED|Intervention 2 (7 Hours)||0||
60089414|NCT00571324|76205729|FG001|NOT COMPLETED|Intervention 2 (7 Hours)||0||
60089415|NCT00573508|76205737|FG000|STARTED|Overall Study||382||
60089416|NCT00573508|76205738|FG001|STARTED|Overall Study||386||
59992797|NCT03032705|76108611|FG001|Completion of Restorations (V2)|Overall Study|"Number of participants are same (repeated) for both groups~unit = teeth"|45|45 participants total for both groups|45
59992798|NCT03032705|76108610|FG000|COMPLETED|Overall Study|"Number of participants are same (repeated) for both groups~unit = teeth"|29|Completion of 18 month follow up visit (Visit #5) 29 participants for SonicFill2 group 28 particiants for Filtek Supreme group|29
59992799|NCT03032705|76108611|FG001|COMPLETED|Overall Study|"Number of participants are same (repeated) for both groups~unit = teeth"|28|Completion of 18 month follow up visit (Visit #5) 29 participants for SonicFill2 group 28 particiants for Filtek Supreme group|28
59992800|NCT03032705|76108610|FG000|NOT COMPLETED|Overall Study||22||22
59992801|NCT03032705|76108611|FG001|NOT COMPLETED|Overall Study||23||23
59992802|NCT04476251|76108617|FG000|STARTED|Overall Study||1||
59992803|NCT04476251|76108617|FG000|COMPLETED|Overall Study||0||
59707705|NCT01207440|75826558|FG001|NOT COMPLETED|Overall Study||64||
59707706|NCT01207440|75826559|FG002|NOT COMPLETED|Overall Study||65||
60089417|NCT00573508|76205737|FG000|Full Analysis Set (FAS)|Overall Study|Patients who took >= 1 dose of double-blind study drug, had a baseline OAB-q & >= 1 subsequent visit|374||
60089418|NCT00573508|76205738|FG001|Full Analysis Set (FAS)|Overall Study|Patients who took >= 1 dose of double-blind study drug, had a baseline OAB-q & >= 1 subsequent visit|377||
60089419|NCT00573508|76205737|FG000|COMPLETED|Overall Study||318||
60089420|NCT00573508|76205738|FG001|COMPLETED|Overall Study||345||
60089421|NCT00573508|76205737|FG000|NOT COMPLETED|Overall Study||64||
60089422|NCT00573508|76205738|FG001|NOT COMPLETED|Overall Study||41||
60089423|NCT00574834|76205747|FG000|STARTED|Overall Study||9||
60089424|NCT00574834|76205748|FG001|STARTED|Overall Study||4||
60089425|NCT00574834|76205749|FG002|STARTED|Overall Study||4||
59561225|NCT03197025|75662607|FG000|NOT COMPLETED|Overall Study||0||
59561226|NCT01684436|75662611|FG000|STARTED|Overall Study||30||
59561227|NCT01684436|75662611|FG000|COMPLETED|Overall Study||29||
59561228|NCT01684436|75662611|FG000|NOT COMPLETED|Overall Study||1||
59561229|NCT02303093|75662615|FG000|STARTED|Overall Study||344||
59561230|NCT02303093|75662615|FG000|COMPLETED|Overall Study||344||
59561231|NCT02303093|75662615|FG000|NOT COMPLETED|Overall Study||0||
59561232|NCT01684592|75662633|FG000|STARTED|Overall Study||64|No intake data for two participants, thus only 128 were randomized.|
59561233|NCT01684592|75662634|FG001|STARTED|Overall Study||64|No intake data for two participants, thus only 128 were randomized.|
59561234|NCT01684592|75662633|FG000|COMPLETED|Overall Study||38||
59561235|NCT01684592|75662634|FG001|COMPLETED|Overall Study||40||
59561236|NCT01684592|75662633|FG000|NOT COMPLETED|Overall Study||26||
59561237|NCT01684592|75662634|FG001|NOT COMPLETED|Overall Study||24||
59561238|NCT02333045|75662642|FG000|STARTED|Overall Study||1||
59561239|NCT02333045|75662643|FG001|STARTED|Overall Study||3||
59561240|NCT02333045|75662642|FG000|COMPLETED|Overall Study||1||
59561241|NCT02333045|75662643|FG001|COMPLETED|Overall Study||3||
59561242|NCT02333045|75662642|FG000|NOT COMPLETED|Overall Study||0||
59561243|NCT02333045|75662643|FG001|NOT COMPLETED|Overall Study||0||
59561244|NCT01684748|75662651|FG000|STARTED|First Intervention - 8 Weeks||10||
59561245|NCT01684748|75662652|FG001|STARTED|First Intervention - 8 Weeks||10||
59561246|NCT01684748|75662651|FG000|COMPLETED|First Intervention - 8 Weeks||8||
59561247|NCT01684748|75662652|FG001|COMPLETED|First Intervention - 8 Weeks||8||
59992804|NCT04476251|76108617|FG000|NOT COMPLETED|Overall Study||1||
59992805|NCT03795233|76108623|FG000|STARTED|Overall Study||4||
59992806|NCT03795233|76108624|FG001|STARTED|Overall Study||1||
59992807|NCT03795233|76108623|FG000|COMPLETED|Overall Study||0||
59992808|NCT03795233|76108624|FG001|COMPLETED|Overall Study||0||
59992809|NCT03795233|76108623|FG000|NOT COMPLETED|Overall Study||4||
59992810|NCT03795233|76108624|FG001|NOT COMPLETED|Overall Study||1||
59992811|NCT03564119|76108632|FG000|STARTED|Overall Study||250||
59992812|NCT03564119|76108633|FG001|STARTED|Overall Study||122||
59992813|NCT03564119|76108632|FG000|Received at Least 1 Dose of Study Drug|Overall Study||249||
59992814|NCT03564119|76108633|FG001|Received at Least 1 Dose of Study Drug|Overall Study||120||
59992815|NCT03564119|76108632|FG000|COMPLETED|Overall Study||235||
59992816|NCT03564119|76108633|FG001|COMPLETED|Overall Study||113||
59992817|NCT03564119|76108632|FG000|NOT COMPLETED|Overall Study||15||
59992818|NCT03564119|76108633|FG001|NOT COMPLETED|Overall Study||9||
59992819|NCT04531241|76108639|FG000|STARTED|Period 1||68||
59992820|NCT04531241|76108640|FG001|STARTED|Period 1||67||
59992821|NCT04531241|76108639|FG000|COMPLETED|Period 1||64||
59992822|NCT04531241|76108640|FG001|COMPLETED|Period 1||65||
59992823|NCT04531241|76108639|FG000|NOT COMPLETED|Period 1||4||
59992824|NCT04531241|76108640|FG001|NOT COMPLETED|Period 1||2||
59992825|NCT04531241|76108639|FG000|STARTED|Period 2||64||
59992826|NCT04531241|76108640|FG001|STARTED|Period 2||65||
59992827|NCT04531241|76108639|FG000|COMPLETED|Period 2||63||
59992828|NCT04531241|76108640|FG001|COMPLETED|Period 2||64||
59992829|NCT04531241|76108639|FG000|NOT COMPLETED|Period 2||1||
59992830|NCT04531241|76108640|FG001|NOT COMPLETED|Period 2||1||
59992831|NCT03181529|76108648|FG000|STARTED|Overall Study||15||
59992832|NCT03181529|76108649|FG001|STARTED|Overall Study||12||
59992833|NCT03181529|76108648|FG000|COMPLETED|Overall Study||13||
59561248|NCT01684748|75662651|FG000|NOT COMPLETED|First Intervention - 8 Weeks||2||
59561249|NCT01684748|75662652|FG001|NOT COMPLETED|First Intervention - 8 Weeks||2||
59561250|NCT01684748|75662651|FG000|STARTED|Second Intervention - 8 Weeks||8||
59816842|NCT03730194|75939239|FG000|STARTED|First Stage Treatment||20||
60089426|NCT00574834|76205747|FG000|COMPLETED|Overall Study||9||
60089427|NCT00574834|76205748|FG001|COMPLETED|Overall Study||4||
60089428|NCT00574834|76205749|FG002|COMPLETED|Overall Study||4||
60089429|NCT00574834|76205747|FG000|NOT COMPLETED|Overall Study||0||
60089430|NCT00574834|76205748|FG001|NOT COMPLETED|Overall Study||0||
60089431|NCT00574834|76205749|FG002|NOT COMPLETED|Overall Study||0||
60089432|NCT00574990|76205760|FG000|STARTED|Overall Study||12||
60089433|NCT00574990|76205761|FG001|STARTED|Overall Study||19||
60089434|NCT00574990|76205762|FG002|STARTED|Overall Study||8||
60089435|NCT00574990|76205760|FG000|COMPLETED|Overall Study||12||
60089436|NCT00574990|76205761|FG001|COMPLETED|Overall Study||19||
60089437|NCT00574990|76205762|FG002|COMPLETED|Overall Study||8||
60089438|NCT00574990|76205760|FG000|NOT COMPLETED|Overall Study||0||
60089439|NCT00574990|76205761|FG001|NOT COMPLETED|Overall Study||0||
60089440|NCT00574990|76205762|FG002|NOT COMPLETED|Overall Study||0||
60089441|NCT00575146|76205773|FG000|STARTED|Overall Study||20||
60089442|NCT00575146|76205773|FG000|COMPLETED|Overall Study||17||
60089443|NCT00575146|76205773|FG000|NOT COMPLETED|Overall Study||3||
60089444|NCT00604552|76205779|FG000|STARTED|Overall Study||189||
59561251|NCT01684748|75662652|FG001|STARTED|Second Intervention - 8 Weeks||8||
59561252|NCT01684748|75662651|FG000|COMPLETED|Second Intervention - 8 Weeks||8||
60089445|NCT00604552|76205780|FG001|STARTED|Overall Study||160||
60089446|NCT00604552|76205779|FG000|COMPLETED|Overall Study||189||
60089447|NCT00604552|76205780|FG001|COMPLETED|Overall Study||160||
60089448|NCT00604552|76205779|FG000|NOT COMPLETED|Overall Study||0||
60089449|NCT00604552|76205780|FG001|NOT COMPLETED|Overall Study||0||
60089450|NCT00605644|76205793|FG000|STARTED|Overall Study||29||
60089451|NCT00605644|76205794|FG001|STARTED|Overall Study||19||
60089452|NCT00605644|76205795|FG002|STARTED|Overall Study||20||
60089453|NCT00605644|76205796|FG003|STARTED|Overall Study||30||
60089454|NCT00605644|76205797|FG004|STARTED|Overall Study||30||
60089455|NCT00605644|76205793|FG000|COMPLETED|Overall Study||28||
60089456|NCT00605644|76205794|FG001|COMPLETED|Overall Study||18||
60089457|NCT00605644|76205795|FG002|COMPLETED|Overall Study||18||
60089458|NCT00605644|76205796|FG003|COMPLETED|Overall Study||25||
60089459|NCT00605644|76205797|FG004|COMPLETED|Overall Study||22||
60089460|NCT00605644|76205793|FG000|NOT COMPLETED|Overall Study||1||
60089461|NCT00605644|76205794|FG001|NOT COMPLETED|Overall Study||1||
60089462|NCT00605644|76205795|FG002|NOT COMPLETED|Overall Study||2||
59561253|NCT01684748|75662652|FG001|COMPLETED|Second Intervention - 8 Weeks||8||
59707707|NCT01207440|75826560|FG003|NOT COMPLETED|Overall Study||18||
59707708|NCT01207440|75826561|FG004|NOT COMPLETED|Overall Study||48||
59707709|NCT01207440|75826562|FG005|NOT COMPLETED|Overall Study||46||
59561254|NCT01684748|75662651|FG000|NOT COMPLETED|Second Intervention - 8 Weeks||0||
59561255|NCT01684748|75662652|FG001|NOT COMPLETED|Second Intervention - 8 Weeks||0||
59561256|NCT03200535|75662662|FG000|STARTED|Overall Study||1863||
59561257|NCT03200535|75662663|FG001|STARTED|Overall Study||1863||
59561258|NCT03200535|75662664|FG002|STARTED|Overall Study||1862||
59707710|NCT01207440|75826563|FG006|NOT COMPLETED|Overall Study||5||
59707711|NCT00990184|75826585|FG000|STARTED|Overall Study||21||
59992834|NCT03181529|76108649|FG001|COMPLETED|Overall Study||11||
59992835|NCT03181529|76108648|FG000|NOT COMPLETED|Overall Study||2||
59992836|NCT03181529|76108649|FG001|NOT COMPLETED|Overall Study||1||
59992837|NCT02259725|76108655|FG000|STARTED|Overall Study||3||
59992838|NCT02259725|76108655|FG000|COMPLETED|Overall Study||3||
59992839|NCT02259725|76108655|FG000|NOT COMPLETED|Overall Study||0||
59992840|NCT03470441|76108663|FG000|STARTED|Overall Study||29||
59992841|NCT03470441|76108664|FG001|STARTED|Overall Study||31||
59992842|NCT03470441|76108665|FG002|STARTED|Overall Study||31||
59992843|NCT03470441|76108666|FG003|STARTED|Overall Study||29||
59992844|NCT03470441|76108663|FG000|COMPLETED|Overall Study||28||
59992845|NCT03470441|76108664|FG001|COMPLETED|Overall Study||26||
59992846|NCT03470441|76108665|FG002|COMPLETED|Overall Study||29||
59992847|NCT03470441|76108666|FG003|COMPLETED|Overall Study||25||
59992848|NCT03470441|76108663|FG000|NOT COMPLETED|Overall Study||1||
59992849|NCT03470441|76108664|FG001|NOT COMPLETED|Overall Study||5||
59992850|NCT03470441|76108665|FG002|NOT COMPLETED|Overall Study||2||
59992851|NCT03470441|76108666|FG003|NOT COMPLETED|Overall Study||4||
59992852|NCT03361865|76108678|FG000|STARTED|Overall Study||44||
59992853|NCT03361865|76108679|FG001|STARTED|Overall Study||49||
60089463|NCT00605644|76205796|FG003|NOT COMPLETED|Overall Study||5||
60089464|NCT00605644|76205797|FG004|NOT COMPLETED|Overall Study||8||
60089465|NCT00578734|76205811|FG000|STARTED|Overall Study||84||
60089466|NCT00578734|76205812|FG001|STARTED|Overall Study||81||
60089467|NCT00578734|76205811|FG000|COMPLETED|Overall Study||84||
60089468|NCT00578734|76205812|FG001|COMPLETED|Overall Study||81||
59992854|NCT03361865|76108678|FG000|Intention-to-Treat (ITT)|Overall Study||44||
59992855|NCT03361865|76108679|FG001|Intention-to-Treat (ITT)|Overall Study||49||
60089469|NCT00578734|76205811|FG000|NOT COMPLETED|Overall Study||0||
60089470|NCT00578734|76205812|FG001|NOT COMPLETED|Overall Study||0||
60089471|NCT00578968|76205821|FG000|STARTED|Baseline (Prior to Intervention)||12||
60089472|NCT00578968|76205822|FG001|STARTED|Baseline (Prior to Intervention)||12||
60089473|NCT00578968|76205823|FG002|STARTED|Baseline (Prior to Intervention)||12||
60089474|NCT00578968|76205821|FG000|COMPLETED|Baseline (Prior to Intervention)||12||
60089475|NCT00578968|76205822|FG001|COMPLETED|Baseline (Prior to Intervention)||12||
60089476|NCT00578968|76205823|FG002|COMPLETED|Baseline (Prior to Intervention)||12||
60089477|NCT00578968|76205821|FG000|NOT COMPLETED|Baseline (Prior to Intervention)||0||
60089478|NCT00578968|76205822|FG001|NOT COMPLETED|Baseline (Prior to Intervention)||0||
60089479|NCT00578968|76205823|FG002|NOT COMPLETED|Baseline (Prior to Intervention)||0||
60089480|NCT00578968|76205821|FG000|STARTED|Intervention||12||
60089481|NCT00578968|76205822|FG001|STARTED|Intervention||12||
60089482|NCT00578968|76205823|FG002|STARTED|Intervention||0||
59707712|NCT00990184|75826585|FG000|COMPLETED|Overall Study||20||
59707713|NCT00990184|75826585|FG000|NOT COMPLETED|Overall Study||1||
59992856|NCT03361865|76108678|FG000|All Participants as Treated (APaT)|Overall Study||43||
59561259|NCT03200535|75662665|FG003|STARTED|Overall Study||1000||
59561260|NCT03200535|75662662|FG000|COMPLETED|Overall Study||1863||
59561261|NCT03200535|75662663|FG001|COMPLETED|Overall Study||1863||
59561262|NCT03200535|75662664|FG002|COMPLETED|Overall Study||1862||
59561263|NCT03200535|75662665|FG003|COMPLETED|Overall Study||1000||
59561264|NCT03200535|75662662|FG000|NOT COMPLETED|Overall Study||0||
59561265|NCT03200535|75662663|FG001|NOT COMPLETED|Overall Study||0||
59561266|NCT03200535|75662664|FG002|NOT COMPLETED|Overall Study||0||
59561267|NCT03200535|75662665|FG003|NOT COMPLETED|Overall Study||0||
59561268|NCT03200925|75662677|FG000|STARTED|Overall Study||120||
60089483|NCT00578968|76205821|FG000|COMPLETED|Intervention||12||
60089484|NCT00578968|76205822|FG001|COMPLETED|Intervention||12||
60089485|NCT00578968|76205823|FG002|COMPLETED|Intervention||0||
60089486|NCT00578968|76205821|FG000|NOT COMPLETED|Intervention||0||
60089487|NCT00578968|76205822|FG001|NOT COMPLETED|Intervention||0||
60089488|NCT00578968|76205823|FG002|NOT COMPLETED|Intervention||0||
60089489|NCT00579280|76205835|FG000|STARTED|Overall Study||49||
60089490|NCT00579280|76205836|FG001|STARTED|Overall Study||49||
60089491|NCT00579280|76205837|FG002|STARTED|Overall Study||51||
60089492|NCT00579280|76205835|FG000|COMPLETED|Overall Study|LOCF evaluable sample|47||
60089493|NCT00579280|76205836|FG001|COMPLETED|Overall Study|LOCF evaluable sample|46||
60089494|NCT00579280|76205837|FG002|COMPLETED|Overall Study|LOCF evaluable sample|51||
60089495|NCT00579280|76205835|FG000|NOT COMPLETED|Overall Study||2||
60089496|NCT00579280|76205836|FG001|NOT COMPLETED|Overall Study||3||
60089497|NCT00579280|76205837|FG002|NOT COMPLETED|Overall Study||0||
60089498|NCT00579436|76205847|FG000|STARTED|Overall Study||19||
60089499|NCT00579436|76205848|FG001|STARTED|Overall Study||14||
60089500|NCT00579436|76205847|FG000|COMPLETED|Overall Study||19||
60089501|NCT00579436|76205848|FG001|COMPLETED|Overall Study||14||
60089502|NCT00579436|76205847|FG000|NOT COMPLETED|Overall Study||0||
60089503|NCT00579436|76205848|FG001|NOT COMPLETED|Overall Study||0||
60089504|NCT00580138|76205854|FG000|STARTED|Overall Study||30||
60089505|NCT00580138|76205854|FG000|COMPLETED|Overall Study||30||
60089506|NCT00580138|76205854|FG000|NOT COMPLETED|Overall Study||0||
60089507|NCT00580294|76205858|FG000|STARTED|Overall Study||12||
60089508|NCT00580294|76205858|FG000|COMPLETED|Overall Study||12||
59561269|NCT03200925|75662678|FG001|STARTED|Overall Study||120||
59561270|NCT03200925|75662677|FG000|COMPLETED|Overall Study||120||
59561271|NCT03200925|75662678|FG001|COMPLETED|Overall Study||120||
59561272|NCT03200925|75662677|FG000|NOT COMPLETED|Overall Study||0||
59561273|NCT03200925|75662678|FG001|NOT COMPLETED|Overall Study||0||
59816843|NCT03730194|75939240|FG001|STARTED|First Stage Treatment||20||
60089509|NCT00580294|76205858|FG000|NOT COMPLETED|Overall Study||0||
60089510|NCT00580372|76205862|FG000|STARTED|Overall Study||231||
60089511|NCT00580372|76205862|FG000|COMPLETED|Overall Study||231||
60089512|NCT00580372|76205862|FG000|NOT COMPLETED|Overall Study||0||
59561274|NCT01685684|75662686|FG000|STARTED|Titration Phase||740||
59561275|NCT01685684|75662687|FG001|STARTED|Titration Phase||0||
59561276|NCT01685684|75662688|FG002|STARTED|Titration Phase||0||
59561277|NCT01685684|75662686|FG000|COMPLETED|Titration Phase||389||
59561278|NCT01685684|75662687|FG001|COMPLETED|Titration Phase||0||
59561279|NCT01685684|75662688|FG002|COMPLETED|Titration Phase||0||
59561280|NCT01685684|75662686|FG000|NOT COMPLETED|Titration Phase||351||
59561281|NCT01685684|75662687|FG001|NOT COMPLETED|Titration Phase||0||
59561282|NCT01685684|75662688|FG002|NOT COMPLETED|Titration Phase||0||
59561283|NCT01685684|75662686|FG000|STARTED|Double-blind Maintenance Phase||0||
59561284|NCT01685684|75662687|FG001|STARTED|Double-blind Maintenance Phase||193||
59561285|NCT01685684|75662688|FG002|STARTED|Double-blind Maintenance Phase||196||
59561286|NCT01685684|75662686|FG000|COMPLETED|Double-blind Maintenance Phase||0||
59561287|NCT01685684|75662687|FG001|COMPLETED|Double-blind Maintenance Phase||122||
59561288|NCT01685684|75662688|FG002|COMPLETED|Double-blind Maintenance Phase||100||
59561289|NCT01685684|75662686|FG000|NOT COMPLETED|Double-blind Maintenance Phase||0||
59561290|NCT01685684|75662687|FG001|NOT COMPLETED|Double-blind Maintenance Phase||71||
59707714|NCT00986830|75826591|FG000|STARTED|Overall Study||74||
59707715|NCT00986830|75826591|FG000|Treated|Overall Study||69||
59707716|NCT00986830|75826591|FG000|COMPLETED|Overall Study||66||
60089513|NCT00581230|76205866|FG000|STARTED|Overall Study||51||
60089514|NCT00581230|76205866|FG000|Laryngoscopy Without RAMP|Overall Study||51||
60089515|NCT00581230|76205866|FG000|Laryngoscopy With RAMP|Overall Study||51||
60089516|NCT00581230|76205866|FG000|COMPLETED|Overall Study||51||
60089517|NCT00581230|76205866|FG000|NOT COMPLETED|Overall Study||0||
60089518|NCT00581386|76205876|FG000|STARTED|Overall Study|05/30/2007|73||
60089519|NCT00581386|76205877|FG001|STARTED|Overall Study|05/30/2007|73||
60089520|NCT00581386|76205878|FG002|STARTED|Overall Study|05/30/2007|72||
60089521|NCT00581386|76205876|FG000|COMPLETED|Overall Study|04/15/2009|73||
60089522|NCT00581386|76205877|FG001|COMPLETED|Overall Study|04/15/2009|73||
60089523|NCT00581386|76205878|FG002|COMPLETED|Overall Study|04/15/2009|72||
60089524|NCT00581386|76205876|FG000|NOT COMPLETED|Overall Study||0||
60089525|NCT00581386|76205877|FG001|NOT COMPLETED|Overall Study||0||
59561291|NCT01685684|75662688|FG002|NOT COMPLETED|Double-blind Maintenance Phase||96||
59561292|NCT01685996|75662698|FG000|STARTED|Overall Study||34||
59561293|NCT01685996|75662699|FG001|STARTED|Overall Study||40||
59707717|NCT00986830|75826591|FG000|NOT COMPLETED|Overall Study||8||
59707718|NCT00990106|75826597|FG000|STARTED|Overall Study||32||
59707719|NCT00990106|75826598|FG001|STARTED|Overall Study||35||
59561294|NCT01685996|75662698|FG000|COMPLETED|Overall Study||18||
59561295|NCT01685996|75662699|FG001|COMPLETED|Overall Study||27||
59561296|NCT01685996|75662698|FG000|NOT COMPLETED|Overall Study||16||
59561297|NCT01685996|75662699|FG001|NOT COMPLETED|Overall Study||13||
59561298|NCT03207399|75662705|FG000|STARTED|Overall Study||1||
59561299|NCT03207399|75662705|FG000|COMPLETED|Overall Study||1||
59561300|NCT03207399|75662705|FG000|NOT COMPLETED|Overall Study||0||
59561301|NCT01687088|75662711|FG000|STARTED|Overall Study||50||
59561302|NCT01687088|75662712|FG001|STARTED|Overall Study||50||
59561303|NCT01687088|75662711|FG000|COMPLETED|Overall Study||50||
59561304|NCT01687088|75662712|FG001|COMPLETED|Overall Study||50||
60089526|NCT00581386|76205878|FG002|NOT COMPLETED|Overall Study||0||
60089527|NCT02134210|76205888|FG000|STARTED|Part One: Weeks 0-12||260||
60089528|NCT02134210|76205889|FG001|STARTED|Part One: Weeks 0-12||261||
60089529|NCT02134210|76205888|FG000|COMPLETED|Part One: Weeks 0-12||241||
60089530|NCT02134210|76205889|FG001|COMPLETED|Part One: Weeks 0-12||255||
60089531|NCT02134210|76205888|FG000|NOT COMPLETED|Part One: Weeks 0-12||19||
60089532|NCT02134210|76205889|FG001|NOT COMPLETED|Part One: Weeks 0-12||6||
60089533|NCT02134210|76205888|FG000|STARTED|Part Two: Weeks 13-48||241||
60089534|NCT02134210|76205889|FG001|STARTED|Part Two: Weeks 13-48||255||
60089535|NCT02134210|76205888|FG000|COMPLETED|Part Two: Weeks 13-48||211||
60089536|NCT02134210|76205889|FG001|COMPLETED|Part Two: Weeks 13-48||227||
60089537|NCT02134210|76205888|FG000|NOT COMPLETED|Part Two: Weeks 13-48||30||
60089538|NCT02134210|76205889|FG001|NOT COMPLETED|Part Two: Weeks 13-48||28||
60089539|NCT02134522|76205895|FG000|STARTED|Overall Study||1||
60089540|NCT02134522|76205895|FG000|COMPLETED|Overall Study||1||
60089541|NCT02134522|76205895|FG000|NOT COMPLETED|Overall Study||0||
60089542|NCT02134756|76205901|FG000|STARTED|Overall Study||15||
60089543|NCT02134756|76205902|FG001|STARTED|Overall Study||15||
60089544|NCT02134756|76205901|FG000|COMPLETED|Overall Study||14||
60089545|NCT02134756|76205902|FG001|COMPLETED|Overall Study||13||
60089546|NCT02134756|76205901|FG000|NOT COMPLETED|Overall Study||1||
60089547|NCT02134756|76205902|FG001|NOT COMPLETED|Overall Study||2||
60089548|NCT00607126|76205910|FG000|STARTED|Overall Study||17||
60089549|NCT00607126|76205911|FG001|STARTED|Overall Study||19||
60089550|NCT00607126|76205910|FG000|COMPLETED|Overall Study||17||
60089551|NCT00607126|76205911|FG001|COMPLETED|Overall Study||19||
60089552|NCT00607126|76205910|FG000|NOT COMPLETED|Overall Study||0||
60089553|NCT00607126|76205911|FG001|NOT COMPLETED|Overall Study||0||
60089554|NCT00607594|76205917|FG000|STARTED|Overall Study||21||
60089555|NCT00607594|76205917|FG000|COMPLETED|Overall Study||21||
60089556|NCT00607594|76205917|FG000|NOT COMPLETED|Overall Study||0||
60089557|NCT01866319|76205926|FG000|STARTED|Overall Study||278||
60089558|NCT01866319|76205927|FG001|STARTED|Overall Study||279||
60089559|NCT01866319|76205928|FG002|STARTED|Overall Study||277||
60089560|NCT01866319|76205926|FG000|Treated|Overall Study||256||
60089561|NCT01866319|76205927|FG001|Treated|Overall Study||278||
60089562|NCT01866319|76205928|FG002|Treated|Overall Study||277||
60089563|NCT01866319|76205926|FG000|COMPLETED|Overall Study||71||
60089564|NCT01866319|76205927|FG001|COMPLETED|Overall Study||101||
60089565|NCT01866319|76205928|FG002|COMPLETED|Overall Study||97||
60089566|NCT01866319|76205926|FG000|NOT COMPLETED|Overall Study||207||
60089567|NCT01866319|76205927|FG001|NOT COMPLETED|Overall Study||178||
60089568|NCT01866319|76205928|FG002|NOT COMPLETED|Overall Study||180||
60089569|NCT00607672|76205939|FG000|STARTED|Overall Study||32||
60089570|NCT00607672|76205940|FG001|STARTED|Overall Study||27||
60089571|NCT00607672|76205941|FG002|STARTED|Overall Study||27||
60089572|NCT00607672|76205939|FG000|COMPLETED|Overall Study||28||
60089573|NCT00607672|76205940|FG001|COMPLETED|Overall Study||24||
60089574|NCT00607672|76205941|FG002|COMPLETED|Overall Study||22||
60089575|NCT00607672|76205939|FG000|NOT COMPLETED|Overall Study||4||
59561305|NCT01687088|75662711|FG000|NOT COMPLETED|Overall Study||0||
60089576|NCT00607672|76205940|FG001|NOT COMPLETED|Overall Study||3||
60089577|NCT00607672|76205941|FG002|NOT COMPLETED|Overall Study||5||
60089578|NCT01802515|76205955|FG000|STARTED|Overall Study||5||
60089579|NCT01802515|76205956|FG001|STARTED|Overall Study||5||
60089580|NCT01802515|76205957|FG002|STARTED|Overall Study||4||
60089581|NCT01802515|76205955|FG000|COMPLETED|Overall Study||2||
59707720|NCT00990106|75826597|FG000|COMPLETED|Overall Study||23||
59707721|NCT00990106|75826598|FG001|COMPLETED|Overall Study||23||
59707722|NCT00990106|75826597|FG000|NOT COMPLETED|Overall Study||9||
59707723|NCT00990106|75826598|FG001|NOT COMPLETED|Overall Study||12||
59707724|NCT00983476|75826607|FG000|STARTED|Overall Study||95||
59707725|NCT00983476|75826608|FG001|STARTED|Overall Study||93||
59707726|NCT00983476|75826609|FG002|STARTED|Overall Study||88||
59707727|NCT00983476|75826607|FG000|6 Month Follow up Assessment|Overall Study||71||
59707728|NCT00983476|75826608|FG001|6 Month Follow up Assessment|Overall Study||62||
59707729|NCT00983476|75826609|FG002|6 Month Follow up Assessment|Overall Study||74||
59561306|NCT01687088|75662712|FG001|NOT COMPLETED|Overall Study||0||
59561307|NCT04543955|75662720|FG000|STARTED|Overall Study||1||
59561308|NCT04543955|75662721|FG001|STARTED|Overall Study||0||
59561309|NCT04543955|75662720|FG000|COMPLETED|Overall Study||0||
59561310|NCT04543955|75662721|FG001|COMPLETED|Overall Study||0||
59561311|NCT04543955|75662720|FG000|NOT COMPLETED|Overall Study||1||
59561312|NCT04543955|75662721|FG001|NOT COMPLETED|Overall Study||0||
59561313|NCT03209505|75662727|FG000|STARTED|Overall Study||10||20
59561314|NCT03209505|75662728|FG001|STARTED|Overall Study||10||20
59561315|NCT03209505|75662727|FG000|COMPLETED|Overall Study||10||20
59561316|NCT03209505|75662728|FG001|COMPLETED|Overall Study||10||20
59561317|NCT03209505|75662727|FG000|NOT COMPLETED|Overall Study||0||0
59561318|NCT03209505|75662728|FG001|NOT COMPLETED|Overall Study||0||0
59561319|NCT03213405|75662738|FG000|STARTED|Overall Study||6||
59561320|NCT03213405|75662739|FG001|STARTED|Overall Study||6||
59561321|NCT03213405|75662740|FG002|STARTED|Overall Study||6||
59561322|NCT03213405|75662741|FG003|STARTED|Overall Study||6||
59561323|NCT03213405|75662738|FG000|COMPLETED|Overall Study||6||
59561324|NCT03213405|75662739|FG001|COMPLETED|Overall Study||6||
59561325|NCT03213405|75662740|FG002|COMPLETED|Overall Study||6||
59561326|NCT03213405|75662741|FG003|COMPLETED|Overall Study||6||
60089582|NCT01802515|76205956|FG001|COMPLETED|Overall Study||5||
60089583|NCT01802515|76205957|FG002|COMPLETED|Overall Study||4||
59561327|NCT03213405|75662738|FG000|NOT COMPLETED|Overall Study||0||
59561328|NCT03213405|75662739|FG001|NOT COMPLETED|Overall Study||0||
59561329|NCT03213405|75662740|FG002|NOT COMPLETED|Overall Study||0||
59561330|NCT03213405|75662741|FG003|NOT COMPLETED|Overall Study||0||
59561331|NCT03215901|75662754|FG000|STARTED|Overall Study||199||
59561332|NCT03215901|75662755|FG001|STARTED|Overall Study||112||
59561333|NCT03215901|75662756|FG002|STARTED|Overall Study||116||
59561334|NCT03215901|75662754|FG000|COMPLETED|Overall Study||199||
59561335|NCT03215901|75662755|FG001|COMPLETED|Overall Study||112||
59992857|NCT03361865|76108679|FG001|All Participants as Treated (APaT)|Overall Study||49||
59992858|NCT03361865|76108678|FG000|COMPLETED|Overall Study||25|Refers to participants that discontinued study with amendment 4, and didn't require follow-up.|
59992859|NCT03361865|76108679|FG001|COMPLETED|Overall Study||22|Refers to participants that discontinued study with amendment 4, and didn't require follow-up.|
59992860|NCT03361865|76108678|FG000|NOT COMPLETED|Overall Study||19||
59992861|NCT03361865|76108679|FG001|NOT COMPLETED|Overall Study||27||
59992862|NCT02149121|76108693|FG000|STARTED|Main Study Period||161||
59992863|NCT02149121|76108694|FG001|STARTED|Main Study Period||151||
59992864|NCT02149121|76108695|FG002|STARTED|Main Study Period||60||
59992865|NCT02149121|76108696|FG003|STARTED|Main Study Period||0||
59992866|NCT02149121|76108697|FG004|STARTED|Main Study Period||0||
60089584|NCT01802515|76205955|FG000|NOT COMPLETED|Overall Study||3||
60089585|NCT01802515|76205956|FG001|NOT COMPLETED|Overall Study||0||
60089586|NCT01802515|76205957|FG002|NOT COMPLETED|Overall Study||0||
60089587|NCT01802437|76205967|FG000|STARTED|Overall Study||20||
60089588|NCT01802437|76205968|FG001|STARTED|Overall Study||20||
60089589|NCT01802437|76205967|FG000|COMPLETED|Overall Study||16||
60089590|NCT01802437|76205968|FG001|COMPLETED|Overall Study||16||
60089591|NCT01802437|76205967|FG000|NOT COMPLETED|Overall Study||4||
59561336|NCT03215901|75662756|FG002|COMPLETED|Overall Study||116||
59561337|NCT03215901|75662754|FG000|NOT COMPLETED|Overall Study||0||
59561338|NCT03215901|75662755|FG001|NOT COMPLETED|Overall Study||0||
59561339|NCT03215901|75662756|FG002|NOT COMPLETED|Overall Study||0||
59561340|NCT03285555|75662766|FG000|STARTED|Overall Study||30||
59561341|NCT03285555|75662767|FG001|STARTED|Overall Study||30||
59561342|NCT03285555|75662766|FG000|COMPLETED|Overall Study||30||
59561343|NCT03285555|75662767|FG001|COMPLETED|Overall Study||30||
59561344|NCT03285555|75662766|FG000|NOT COMPLETED|Overall Study||0||
59561345|NCT03285555|75662767|FG001|NOT COMPLETED|Overall Study||0||
59992867|NCT02149121|76108698|FG005|STARTED|Main Study Period||0||
59992868|NCT02149121|76108699|FG006|STARTED|Main Study Period||0||
60089592|NCT01802437|76205968|FG001|NOT COMPLETED|Overall Study||4||
60089593|NCT00608062|76205980|FG000|STARTED|Overall Study|25 women completed baseline testing, 4 women withdrew prior to randomization|12|Randomization to group assignment occurred following GnRHant alone.|
59561346|NCT03221595|75662775|FG000|STARTED|Overall Study||51||
59561347|NCT03221595|75662776|FG001|STARTED|Overall Study||59||
59561348|NCT03221595|75662775|FG000|COMPLETED|Overall Study||51||
59561349|NCT03221595|75662776|FG001|COMPLETED|Overall Study||59||
59561350|NCT03221595|75662775|FG000|NOT COMPLETED|Overall Study||0||
59816844|NCT03730194|75939241|FG002|STARTED|First Stage Treatment||0||
59816845|NCT03730194|75939242|FG003|STARTED|First Stage Treatment||0||
59816846|NCT03730194|75939243|FG004|STARTED|First Stage Treatment||0||
59816847|NCT03730194|75939244|FG005|STARTED|First Stage Treatment||0||
59816848|NCT03730194|75939239|FG000|COMPLETED|First Stage Treatment||16|"This study utilizes a SMART Design.~1 participant from the Melatonin Only group withdrew from the study. 1 participant from the Bedtime Bank Only group withdrew from the study.~3 participants in the Melatonin Only group & 3 participants in the Bedtime Bank Only group did not complete all study requirements (e.g., minimum actigraph days). These 6 participants remained in the pilot SMART study (did not want to withdraw), and repeated there assigned treatment in the Second Stage."|
59816849|NCT03730194|75939240|FG001|COMPLETED|First Stage Treatment||16|"This study utilizes a SMART Design.~1 participant from the Melatonin Only group withdrew from the study. 1 participant from the Bedtime Bank Only group withdrew from the study.~3 participants in the Melatonin Only group & 3 participants in the Bedtime Bank Only group did not complete all study requirements (e.g., minimum actigraph days). These 6 participants remained in the pilot SMART study (did not want to withdraw), and repeated there assigned treatment in the Second Stage."|
59817925|NCT04488770|75940338|FG012|STARTED|Part 1-Cohort 2: Period 2 (Up to 5 Days)||0||
59561351|NCT03221595|75662776|FG001|NOT COMPLETED|Overall Study||0||
59561352|NCT03425019|75662782|FG000|STARTED|Overall Study||20||
59561353|NCT03425019|75662782|FG000|COMPLETED|Overall Study||20||
60089594|NCT00608062|76205981|FG001|STARTED|Overall Study||12|Randomization to group assignment occurred following GnRHant alone.|
60089595|NCT00608062|76205982|FG002|STARTED|Overall Study|43 women completed baseline testing, 3 women withdrew prior to randomization|19|Randomization to group assignment occurred following GnRHant alone.|
60089596|NCT00608062|76205983|FG003|STARTED|Overall Study||21|Randomization to group assignment occurred following GnRHant alone.|
60089597|NCT00608062|76205984|FG004|STARTED|Overall Study||13|Randomization to group assignment occurred following GnRHant alone.|
60089598|NCT00608062|76205985|FG005|STARTED|Overall Study||15|Randomization to group assignment occurred following GnRHant alone.|
60089599|NCT00608062|76205980|FG000|COMPLETED|Overall Study||12||
60089600|NCT00608062|76205981|FG001|COMPLETED|Overall Study||12||
60089601|NCT00608062|76205982|FG002|COMPLETED|Overall Study||19||
60089602|NCT00608062|76205983|FG003|COMPLETED|Overall Study||21||
60089603|NCT00608062|76205984|FG004|COMPLETED|Overall Study||13||
60089604|NCT00608062|76205985|FG005|COMPLETED|Overall Study||15||
60089605|NCT00608062|76205980|FG000|NOT COMPLETED|Overall Study||0||
60089606|NCT00608062|76205981|FG001|NOT COMPLETED|Overall Study||0||
60089607|NCT00608062|76205982|FG002|NOT COMPLETED|Overall Study||0||
60089608|NCT00608062|76205983|FG003|NOT COMPLETED|Overall Study||0||
60089609|NCT00608062|76205984|FG004|NOT COMPLETED|Overall Study||0||
60089610|NCT00608062|76205985|FG005|NOT COMPLETED|Overall Study||0||
60089611|NCT02138578|76206004|FG000|STARTED|Overall Study||1||
60089612|NCT02138578|76206005|FG001|STARTED|Overall Study||0||
60089613|NCT02138578|76206006|FG002|STARTED|Overall Study||3||
60089614|NCT02138578|76206004|FG000|COMPLETED|Overall Study||1||
60089615|NCT02138578|76206005|FG001|COMPLETED|Overall Study||0||
60089616|NCT02138578|76206006|FG002|COMPLETED|Overall Study||3||
59561354|NCT03425019|75662782|FG000|NOT COMPLETED|Overall Study||0||
59992869|NCT02149121|76108693|FG000|COMPLETED|Main Study Period||140||
59561355|NCT01687244|75662789|FG000|STARTED|Overall Study||21||
59992870|NCT02149121|76108694|FG001|COMPLETED|Main Study Period||134||
59992871|NCT02149121|76108695|FG002|COMPLETED|Main Study Period||56||
59992872|NCT02149121|76108696|FG003|COMPLETED|Main Study Period||0||
59992873|NCT02149121|76108697|FG004|COMPLETED|Main Study Period||0||
59992874|NCT02149121|76108698|FG005|COMPLETED|Main Study Period||0||
59992875|NCT02149121|76108699|FG006|COMPLETED|Main Study Period||0||
59992876|NCT02149121|76108693|FG000|NOT COMPLETED|Main Study Period||21||
59992877|NCT02149121|76108694|FG001|NOT COMPLETED|Main Study Period||17||
59992878|NCT02149121|76108695|FG002|NOT COMPLETED|Main Study Period||4||
59992879|NCT02149121|76108696|FG003|NOT COMPLETED|Main Study Period||0||
59992880|NCT02149121|76108697|FG004|NOT COMPLETED|Main Study Period||0||
59992881|NCT02149121|76108698|FG005|NOT COMPLETED|Main Study Period||0||
60089617|NCT02138578|76206004|FG000|NOT COMPLETED|Overall Study||0||
60089618|NCT02138578|76206005|FG001|NOT COMPLETED|Overall Study||0||
60089619|NCT02138578|76206006|FG002|NOT COMPLETED|Overall Study||0||
60089620|NCT00608140|76206016|FG000|STARTED|Overall Study||1||
60089621|NCT00608140|76206017|FG001|STARTED|Overall Study||1||
60089622|NCT00608140|76206016|FG000|COMPLETED|Overall Study|Study ended early due to low enrollment|0||
60089623|NCT00608140|76206017|FG001|COMPLETED|Overall Study|Study ended early due to low enrollment|0||
60089624|NCT00608140|76206016|FG000|NOT COMPLETED|Overall Study||1||
60089625|NCT00608140|76206017|FG001|NOT COMPLETED|Overall Study||1||
60089626|NCT02135146|76206034|FG000|STARTED|Overall Study||20||
60089627|NCT02135146|76206035|FG001|STARTED|Overall Study||20||
60089628|NCT02135146|76206034|FG000|COMPLETED|Overall Study||20||
60089629|NCT02135146|76206035|FG001|COMPLETED|Overall Study||20||
60089630|NCT02135146|76206034|FG000|NOT COMPLETED|Overall Study||0||
60089631|NCT02135146|76206035|FG001|NOT COMPLETED|Overall Study||0||
60089632|NCT00581854|76206041|FG000|STARTED|Overall Study||22||
60089633|NCT00581854|76206041|FG000|COMPLETED|Overall Study||22||
60089634|NCT00581854|76206041|FG000|NOT COMPLETED|Overall Study||0||
60089635|NCT00610480|76206047|FG000|STARTED|Overall Study|10 assigned patients x 2 interventions.|10||
60089636|NCT00610480|76206048|FG001|STARTED|Overall Study|10 assigned patients x 2 interventions.|10||
60089637|NCT00610480|76206047|FG000|COMPLETED|Overall Study|10 assigned patients x 2 interventions.|10||
60089638|NCT00610480|76206048|FG001|COMPLETED|Overall Study|10 assigned patients x 2 interventions.|10||
60089639|NCT00610480|76206047|FG000|NOT COMPLETED|Overall Study||0||
60089640|NCT00610480|76206048|FG001|NOT COMPLETED|Overall Study||0||
60089641|NCT00582400|76206054|FG000|STARTED|Overall Study||9||
60089642|NCT00582400|76206054|FG000|COMPLETED|Overall Study||6||
60089643|NCT00582400|76206054|FG000|NOT COMPLETED|Overall Study||3||
60089644|NCT00582946|76206058|FG000|STARTED|Overall Study||16||
60089645|NCT00582946|76206058|FG000|COMPLETED|Overall Study||16||
60089646|NCT00582946|76206058|FG000|NOT COMPLETED|Overall Study||0||
60089647|NCT00583414|76206062|FG000|STARTED|Overall Study||401||
60089648|NCT00583414|76206062|FG000|COMPLETED|Overall Study||401||
60089649|NCT00583414|76206062|FG000|NOT COMPLETED|Overall Study||0||
60089650|NCT00583492|76206068|FG000|STARTED|Overall Study||21||
60089651|NCT00583492|76206069|FG001|STARTED|Overall Study||23||
60089652|NCT00583492|76206068|FG000|COMPLETED|Overall Study||21||
60089653|NCT00583492|76206069|FG001|COMPLETED|Overall Study||23||
60089654|NCT00583492|76206068|FG000|NOT COMPLETED|Overall Study||0||
60089655|NCT00583492|76206069|FG001|NOT COMPLETED|Overall Study||0||
60089656|NCT01801735|76206075|FG000|STARTED|Overall Study||600||
60089657|NCT01801735|76206075|FG000|COMPLETED|Overall Study||390||
60089658|NCT01801735|76206075|FG000|NOT COMPLETED|Overall Study||210||
60089659|NCT00612430|76206081|FG000|STARTED|Overall Study||32||
60089660|NCT00612430|76206082|FG001|STARTED|Overall Study||27||
60089661|NCT00612430|76206081|FG000|COMPLETED|Overall Study||32||
60089662|NCT00612430|76206082|FG001|COMPLETED|Overall Study||27||
60089663|NCT00612430|76206081|FG000|NOT COMPLETED|Overall Study||0||
60089664|NCT00612430|76206082|FG001|NOT COMPLETED|Overall Study||0||
60089665|NCT00614458|76206090|FG000|STARTED|Overall Study||6||
60089666|NCT00614458|76206090|FG000|COMPLETED|Overall Study||6||
60089667|NCT00614458|76206090|FG000|NOT COMPLETED|Overall Study||0||
60089668|NCT00615472|76206096|FG000|STARTED|Overall Study||30||
60089669|NCT00615472|76206097|FG001|STARTED|Overall Study||28||
60089670|NCT00615472|76206096|FG000|COMPLETED|Overall Study||30||
60089671|NCT00615472|76206097|FG001|COMPLETED|Overall Study||28||
60089672|NCT00615472|76206096|FG000|NOT COMPLETED|Overall Study||0||
60089673|NCT00615472|76206097|FG001|NOT COMPLETED|Overall Study||0||
60089674|NCT00615784|76206103|FG000|STARTED|Overall Study||24||
60089675|NCT00615784|76206103|FG000|COMPLETED|Overall Study||24||
60089676|NCT00615784|76206103|FG000|NOT COMPLETED|Overall Study||0||
60089677|NCT00585910|76206107|FG000|STARTED|Atomoxetine (ATMX) Alone|This is the number of subjects who were exposed to ATMX in Phase I of the study.|72||
60089678|NCT00585910|76206107|FG000|COMPLETED|Atomoxetine (ATMX) Alone|Number of subjects who completed Phase I. 15 completed only Phase I. 40 proceeded onto Phase II.|55||
60089679|NCT00585910|76206107|FG000|NOT COMPLETED|Atomoxetine (ATMX) Alone||17||
60089680|NCT00585910|76206107|FG000|STARTED|ATMX + Osmotic-Release Methylphenidate|Number of participants to add OROS MPH to their ATMX regimen|50||
60089681|NCT00585910|76206107|FG000|COMPLETED|ATMX + Osmotic-Release Methylphenidate||41||
60089682|NCT00585910|76206107|FG000|NOT COMPLETED|ATMX + Osmotic-Release Methylphenidate||9||
60089683|NCT00617188|76206112|FG000|STARTED|Overall Study||26||
60089684|NCT00617188|76206112|FG000|COMPLETED|Overall Study||26||
60089685|NCT00617188|76206112|FG000|NOT COMPLETED|Overall Study||0||
60089686|NCT00618436|76206118|FG000|STARTED|Overall Study||34||
60089687|NCT00618436|76206119|FG001|STARTED|Overall Study||18||
60089688|NCT00618436|76206118|FG000|COMPLETED|Overall Study||34||
60089689|NCT00618436|76206119|FG001|COMPLETED|Overall Study||18||
60089690|NCT00618436|76206118|FG000|NOT COMPLETED|Overall Study||0||
60089691|NCT00618436|76206119|FG001|NOT COMPLETED|Overall Study||0||
60089692|NCT00619060|76206125|FG000|STARTED|Overall Study||10||
60089693|NCT00619060|76206126|FG001|STARTED|Overall Study||12||
60089694|NCT00619060|76206125|FG000|COMPLETED|Overall Study||10||
60089695|NCT00619060|76206126|FG001|COMPLETED|Overall Study||12||
60089696|NCT00619060|76206125|FG000|NOT COMPLETED|Overall Study||0||
59816850|NCT03730194|75939241|FG002|COMPLETED|First Stage Treatment||0|"This study utilizes a SMART Design.~1 participant from the Melatonin Only group withdrew from the study. 1 participant from the Bedtime Bank Only group withdrew from the study.~3 participants in the Melatonin Only group & 3 participants in the Bedtime Bank Only group did not complete all study requirements (e.g., minimum actigraph days). These 6 participants remained in the pilot SMART study (did not want to withdraw), and repeated there assigned treatment in the Second Stage."|
59817926|NCT04488770|75940326|FG000|COMPLETED|Part 1-Cohort 2: Period 2 (Up to 5 Days)||0||
59992882|NCT02149121|76108699|FG006|NOT COMPLETED|Main Study Period||0||
59992883|NCT02149121|76108693|FG000|STARTED|Extension Study Period|This group is for the Main Study Period, not for the Extension Study Period.|0||
59992884|NCT02149121|76108694|FG001|STARTED|Extension Study Period|This group is for the Main Study Period, not for the Extension Study Period.|0||
59992885|NCT02149121|76108695|FG002|STARTED|Extension Study Period|This group is for the Main Study Period, not for the Extension Study Period.|0||
60089697|NCT00619060|76206126|FG001|NOT COMPLETED|Overall Study||0||
60089698|NCT00619684|76206134|FG000|STARTED|Overall Study||18||
60089699|NCT00619684|76206134|FG000|COMPLETED|Overall Study||18||
60089700|NCT00619684|76206134|FG000|NOT COMPLETED|Overall Study||0||
60089701|NCT00619762|76206138|FG000|STARTED|Overall Study|(29 breasts) First patient implanted 10/23/2007|17||
60089702|NCT00619762|76206138|FG000|COMPLETED|Overall Study|(25 breasts) last patient visit 11/09/2009|14||
60089703|NCT00619762|76206138|FG000|NOT COMPLETED|Overall Study||3||
60089704|NCT00620698|76206143|FG000|STARTED|Overall Study||89||
60089705|NCT00620698|76206143|FG000|COMPLETED|Overall Study||60||
60089706|NCT00620698|76206143|FG000|NOT COMPLETED|Overall Study||29||
60089707|NCT00588406|76206149|FG000|STARTED|Overall Study||46||
60089708|NCT00588406|76206150|FG001|STARTED|Overall Study||49||
60089709|NCT00588406|76206149|FG000|COMPLETED|Overall Study||46||
60089710|NCT00588406|76206150|FG001|COMPLETED|Overall Study||49||
60089711|NCT00588406|76206149|FG000|NOT COMPLETED|Overall Study||0||
60089712|NCT00588406|76206150|FG001|NOT COMPLETED|Overall Study||0||
60089713|NCT00668434|76206158|FG000|STARTED|Primary Outcome Time Point (3 Weeks)|Baseline|181||
60089714|NCT00668434|76206159|FG001|STARTED|Primary Outcome Time Point (3 Weeks)|Baseline|88||
60089715|NCT00668434|76206158|FG000|COMPLETED|Primary Outcome Time Point (3 Weeks)||179||
60089716|NCT00668434|76206159|FG001|COMPLETED|Primary Outcome Time Point (3 Weeks)||88||
60089717|NCT00668434|76206158|FG000|NOT COMPLETED|Primary Outcome Time Point (3 Weeks)||2||
60089718|NCT00668434|76206159|FG001|NOT COMPLETED|Primary Outcome Time Point (3 Weeks)||0||
60089719|NCT00668434|76206158|FG000|STARTED|Secondary Outcome Time Point (52 Weeks)|Baseline|179||
60089720|NCT00668434|76206159|FG001|STARTED|Secondary Outcome Time Point (52 Weeks)|Baseline|88||
60089721|NCT00668434|76206158|FG000|COMPLETED|Secondary Outcome Time Point (52 Weeks)||157||
60089722|NCT00668434|76206159|FG001|COMPLETED|Secondary Outcome Time Point (52 Weeks)||77||
60089723|NCT00668434|76206158|FG000|NOT COMPLETED|Secondary Outcome Time Point (52 Weeks)||22||
60089724|NCT00668434|76206159|FG001|NOT COMPLETED|Secondary Outcome Time Point (52 Weeks)||11||
60089725|NCT00668902|76206168|FG000|STARTED|Overall Study||10||
60089726|NCT00668902|76206169|FG001|STARTED|Overall Study||10||
60089727|NCT00668902|76206170|FG002|STARTED|Overall Study||5||
60089728|NCT00668902|76206168|FG000|COMPLETED|Overall Study||10||
60089729|NCT00668902|76206169|FG001|COMPLETED|Overall Study||10||
60089730|NCT00668902|76206170|FG002|COMPLETED|Overall Study||5||
60089731|NCT00668902|76206168|FG000|NOT COMPLETED|Overall Study||0||
60089732|NCT00668902|76206169|FG001|NOT COMPLETED|Overall Study||0||
59992886|NCT02149121|76108696|FG003|STARTED|Extension Study Period|"Some participants did not initiate the Extension Study Period (CT-P10: 19, Rituxan: 8, MabThera: 9).~From 19 patients in CT-P10 who did not initiate the extension study period, one patient did not initiate the treatment course but had been included to extension period and was monitored up to week 48"|122||
59992887|NCT02149121|76108697|FG004|STARTED|Extension Study Period|Some participants did not initiate the Extension Study Period (CT-P10: 19, Rituxan: 8, MabThera: 9)|64||
59992888|NCT02149121|76108698|FG005|STARTED|Extension Study Period|Some participants did not initiate the Extension Study Period (CT-P10: 19, Rituxan: 8, MabThera: 9)|62||
59992889|NCT02149121|76108699|FG006|STARTED|Extension Study Period|Some participants did not initiate the Extension Study Period (CT-P10: 19, Rituxan: 8, MabThera: 9)|47||
59992890|NCT02149121|76108693|FG000|COMPLETED|Extension Study Period||0||
59992891|NCT02149121|76108694|FG001|COMPLETED|Extension Study Period||0||
59992892|NCT02149121|76108695|FG002|COMPLETED|Extension Study Period||0||
59992893|NCT02149121|76108696|FG003|COMPLETED|Extension Study Period||121||
59992894|NCT02149121|76108697|FG004|COMPLETED|Extension Study Period||64||
59992895|NCT02149121|76108698|FG005|COMPLETED|Extension Study Period||60||
60089733|NCT00668902|76206170|FG002|NOT COMPLETED|Overall Study||0||
60089734|NCT00669214|76206180|FG000|STARTED|Double-Blind Treatment Period (Week 12)||27||
60089735|NCT00669214|76206181|FG001|STARTED|Double-Blind Treatment Period (Week 12)||62||
60089736|NCT00669214|76206180|FG000|COMPLETED|Double-Blind Treatment Period (Week 12)||22||
60089737|NCT00669214|76206181|FG001|COMPLETED|Double-Blind Treatment Period (Week 12)||55||
60089738|NCT00669214|76206180|FG000|NOT COMPLETED|Double-Blind Treatment Period (Week 12)||5||
60089739|NCT00669214|76206181|FG001|NOT COMPLETED|Double-Blind Treatment Period (Week 12)||7||
60089740|NCT00669214|76206180|FG000|STARTED|Open-Label Treatment Period (Week 24)||22||
60089741|NCT00669214|76206181|FG001|STARTED|Open-Label Treatment Period (Week 24)||55||
60089742|NCT00669214|76206180|FG000|COMPLETED|Open-Label Treatment Period (Week 24)||18||
60089743|NCT00669214|76206181|FG001|COMPLETED|Open-Label Treatment Period (Week 24)||46||
60089744|NCT00669214|76206180|FG000|NOT COMPLETED|Open-Label Treatment Period (Week 24)||4||
60089745|NCT00669214|76206181|FG001|NOT COMPLETED|Open-Label Treatment Period (Week 24)||9||
60089746|NCT00589888|76206191|FG000|STARTED|Normal Saline @ 40cc/Hour|the same 13 patients did each of the 5 arms at 5 different visits|13||
60089747|NCT00589888|76206192|FG001|STARTED|Normal Saline @ 40cc/Hour||0||
60089748|NCT00589888|76206193|FG002|STARTED|Normal Saline @ 40cc/Hour||0||
60089749|NCT00589888|76206194|FG003|STARTED|Normal Saline @ 40cc/Hour||0||
60089750|NCT00589888|76206195|FG004|STARTED|Normal Saline @ 40cc/Hour||0||
60089751|NCT00589888|76206191|FG000|COMPLETED|Normal Saline @ 40cc/Hour||13||
60089752|NCT00589888|76206192|FG001|COMPLETED|Normal Saline @ 40cc/Hour||0||
60089753|NCT00589888|76206193|FG002|COMPLETED|Normal Saline @ 40cc/Hour||0||
60089754|NCT00589888|76206194|FG003|COMPLETED|Normal Saline @ 40cc/Hour||0||
60089755|NCT00589888|76206195|FG004|COMPLETED|Normal Saline @ 40cc/Hour||0||
60089756|NCT00589888|76206191|FG000|NOT COMPLETED|Normal Saline @ 40cc/Hour||0||
60089757|NCT00589888|76206192|FG001|NOT COMPLETED|Normal Saline @ 40cc/Hour||0||
60089758|NCT00589888|76206193|FG002|NOT COMPLETED|Normal Saline @ 40cc/Hour||0||
60089759|NCT00589888|76206194|FG003|NOT COMPLETED|Normal Saline @ 40cc/Hour||0||
60089760|NCT00589888|76206195|FG004|NOT COMPLETED|Normal Saline @ 40cc/Hour||0||
60089761|NCT00589888|76206191|FG000|STARTED|Intralipid 20% @ 20cc/hr|the same 13 patients did each of the 5 arms at 5 different visits|0||
60089762|NCT00589888|76206192|FG001|STARTED|Intralipid 20% @ 20cc/hr||13||
60089763|NCT00589888|76206193|FG002|STARTED|Intralipid 20% @ 20cc/hr||0||
60089764|NCT00589888|76206194|FG003|STARTED|Intralipid 20% @ 20cc/hr||0||
60089765|NCT00589888|76206195|FG004|STARTED|Intralipid 20% @ 20cc/hr||0||
60089766|NCT00589888|76206191|FG000|COMPLETED|Intralipid 20% @ 20cc/hr||0||
60089767|NCT00589888|76206192|FG001|COMPLETED|Intralipid 20% @ 20cc/hr||13||
60089768|NCT00589888|76206193|FG002|COMPLETED|Intralipid 20% @ 20cc/hr||0||
60089769|NCT00589888|76206194|FG003|COMPLETED|Intralipid 20% @ 20cc/hr||0||
60089770|NCT00589888|76206195|FG004|COMPLETED|Intralipid 20% @ 20cc/hr||0||
60089771|NCT00589888|76206191|FG000|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0||
60089772|NCT00589888|76206192|FG001|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0||
60089773|NCT00589888|76206193|FG002|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0||
60089774|NCT00589888|76206194|FG003|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0||
60089775|NCT00589888|76206195|FG004|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0||
60089776|NCT00589888|76206191|FG000|STARTED|Intralipid 20% @ 40cc/Hour||0||
60089777|NCT00589888|76206192|FG001|STARTED|Intralipid 20% @ 40cc/Hour|the same 13 patients did each of the 5 arms at 5 different visits|0||
60089778|NCT00589888|76206193|FG002|STARTED|Intralipid 20% @ 40cc/Hour|the same 13 patients did each of the 5 arms at 5 different visits|13||
60089779|NCT00589888|76206194|FG003|STARTED|Intralipid 20% @ 40cc/Hour||0||
59561356|NCT01687244|75662790|FG001|STARTED|Overall Study||19||
59561357|NCT01687244|75662789|FG000|COMPLETED|Overall Study||21||
59561358|NCT01687244|75662790|FG001|COMPLETED|Overall Study||19||
59707730|NCT00983476|75826607|FG000|COMPLETED|Overall Study||78||
59707731|NCT00983476|75826608|FG001|COMPLETED|Overall Study||71||
59992896|NCT02149121|76108699|FG006|COMPLETED|Extension Study Period||47||
59992897|NCT02149121|76108693|FG000|NOT COMPLETED|Extension Study Period||0||
59992898|NCT02149121|76108694|FG001|NOT COMPLETED|Extension Study Period||0||
59992899|NCT02149121|76108695|FG002|NOT COMPLETED|Extension Study Period||0||
59992900|NCT02149121|76108696|FG003|NOT COMPLETED|Extension Study Period||1||
59992901|NCT02149121|76108697|FG004|NOT COMPLETED|Extension Study Period||0||
59992902|NCT02149121|76108698|FG005|NOT COMPLETED|Extension Study Period||2||
59992903|NCT02149121|76108699|FG006|NOT COMPLETED|Extension Study Period||0||
59992904|NCT03561701|76108722|FG000|STARTED|Overall Study||220||
59992905|NCT03561701|76108723|FG001|STARTED|Overall Study||110||
59992906|NCT03561701|76108722|FG000|COMPLETED|Overall Study||191||
59992907|NCT03561701|76108723|FG001|COMPLETED|Overall Study||91||
59992908|NCT03561701|76108722|FG000|NOT COMPLETED|Overall Study||29||
60089780|NCT00589888|76206195|FG004|STARTED|Intralipid 20% @ 40cc/Hour||0||
60089781|NCT00589888|76206191|FG000|COMPLETED|Intralipid 20% @ 40cc/Hour||0||
60089782|NCT00589888|76206192|FG001|COMPLETED|Intralipid 20% @ 40cc/Hour||0||
60089783|NCT00589888|76206193|FG002|COMPLETED|Intralipid 20% @ 40cc/Hour||13||
60089784|NCT00589888|76206194|FG003|COMPLETED|Intralipid 20% @ 40cc/Hour||0||
60089785|NCT00589888|76206195|FG004|COMPLETED|Intralipid 20% @ 40cc/Hour||0||
60089786|NCT00589888|76206191|FG000|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0||
60089787|NCT00589888|76206192|FG001|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0||
60089788|NCT00589888|76206193|FG002|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0||
59561359|NCT01687244|75662789|FG000|NOT COMPLETED|Overall Study||0||
59561360|NCT01687244|75662790|FG001|NOT COMPLETED|Overall Study||0||
60089789|NCT00589888|76206194|FG003|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0||
60089790|NCT00589888|76206195|FG004|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0||
60089791|NCT00589888|76206191|FG000|STARTED|32-gram Oral Fat Load||0||
60089792|NCT00589888|76206192|FG001|STARTED|32-gram Oral Fat Load||0||
60089793|NCT00589888|76206193|FG002|STARTED|32-gram Oral Fat Load|the same 13 patients did each of the 5 arms at 5 different visits|0||
60089794|NCT00589888|76206194|FG003|STARTED|32-gram Oral Fat Load|the same 13 patients did each of the 5 arms at 5 different visits|13||
60089795|NCT00589888|76206195|FG004|STARTED|32-gram Oral Fat Load||0||
60089796|NCT00589888|76206191|FG000|COMPLETED|32-gram Oral Fat Load||0||
60089797|NCT00589888|76206192|FG001|COMPLETED|32-gram Oral Fat Load||0||
60089798|NCT00589888|76206193|FG002|COMPLETED|32-gram Oral Fat Load||0||
60089799|NCT00589888|76206194|FG003|COMPLETED|32-gram Oral Fat Load||13||
60089800|NCT00589888|76206195|FG004|COMPLETED|32-gram Oral Fat Load||0||
60089801|NCT00589888|76206191|FG000|NOT COMPLETED|32-gram Oral Fat Load||0||
60089802|NCT00589888|76206192|FG001|NOT COMPLETED|32-gram Oral Fat Load||0||
60089803|NCT00589888|76206193|FG002|NOT COMPLETED|32-gram Oral Fat Load||0||
60089804|NCT00589888|76206194|FG003|NOT COMPLETED|32-gram Oral Fat Load||0||
60089805|NCT00589888|76206195|FG004|NOT COMPLETED|32-gram Oral Fat Load||0||
60089806|NCT00589888|76206191|FG000|STARTED|64-gram Oral Fat Load||0||
60089807|NCT00589888|76206192|FG001|STARTED|64-gram Oral Fat Load||0||
60089808|NCT00589888|76206193|FG002|STARTED|64-gram Oral Fat Load||0||
60089809|NCT00589888|76206194|FG003|STARTED|64-gram Oral Fat Load|the same 13 patients did each of the 5 arms at 5 different visits|0||
60089810|NCT00589888|76206195|FG004|STARTED|64-gram Oral Fat Load|the same 13 patients did each of the 5 arms at 5 different visits|13||
60089811|NCT00589888|76206191|FG000|COMPLETED|64-gram Oral Fat Load||0||
60089812|NCT00589888|76206192|FG001|COMPLETED|64-gram Oral Fat Load||0||
60089813|NCT00589888|76206193|FG002|COMPLETED|64-gram Oral Fat Load||0||
60089814|NCT00589888|76206194|FG003|COMPLETED|64-gram Oral Fat Load||0||
60089815|NCT00589888|76206195|FG004|COMPLETED|64-gram Oral Fat Load||13||
60089816|NCT00589888|76206191|FG000|NOT COMPLETED|64-gram Oral Fat Load||0||
60089817|NCT00589888|76206192|FG001|NOT COMPLETED|64-gram Oral Fat Load||0||
60089818|NCT00589888|76206193|FG002|NOT COMPLETED|64-gram Oral Fat Load||0||
60089819|NCT00589888|76206194|FG003|NOT COMPLETED|64-gram Oral Fat Load||0||
60089820|NCT00589888|76206195|FG004|NOT COMPLETED|64-gram Oral Fat Load||0||
60089821|NCT00669682|76206212|FG000|STARTED|Overall Study||9||
60089822|NCT00669682|76206212|FG000|COMPLETED|Overall Study||9||
60089823|NCT00669682|76206212|FG000|NOT COMPLETED|Overall Study||0||
60089824|NCT00669916|76206219|FG000|STARTED|Overall Study||18||
60089825|NCT00669916|76206220|FG001|STARTED|Overall Study||18||
60089826|NCT00669916|76206219|FG000|COMPLETED|Overall Study||18||
60089827|NCT00669916|76206220|FG001|COMPLETED|Overall Study||18||
60089828|NCT00669916|76206219|FG000|NOT COMPLETED|Overall Study||0||
60089829|NCT00669916|76206220|FG001|NOT COMPLETED|Overall Study||0||
60089830|NCT00621946|76206228|FG000|STARTED|Overall Study||13||
60089831|NCT00621946|76206229|FG001|STARTED|Overall Study||13||
60089832|NCT00621946|76206228|FG000|COMPLETED|Overall Study||13||
60089833|NCT00621946|76206229|FG001|COMPLETED|Overall Study||12||
60089834|NCT00621946|76206228|FG000|NOT COMPLETED|Overall Study||0||
60089835|NCT00621946|76206229|FG001|NOT COMPLETED|Overall Study||1||
60089836|NCT00591760|76206238|FG000|STARTED|Overall Study||28||
60089837|NCT00591760|76206239|FG001|STARTED|Overall Study||28||
60089838|NCT00591760|76206238|FG000|COMPLETED|Overall Study||28||
60089839|NCT00591760|76206239|FG001|COMPLETED|Overall Study||28||
60089840|NCT00591760|76206238|FG000|NOT COMPLETED|Overall Study||0||
60089841|NCT00591760|76206239|FG001|NOT COMPLETED|Overall Study||0||
60089842|NCT00623506|76206247|FG000|STARTED|Overall Study||15||
60089843|NCT00623506|76206248|FG001|STARTED|Overall Study||15||
60089844|NCT00623506|76206247|FG000|Week 4|Overall Study||11||
60089845|NCT00623506|76206248|FG001|Week 4|Overall Study||11||
60089846|NCT00623506|76206247|FG000|COMPLETED|Overall Study||11||
60089847|NCT00623506|76206248|FG001|COMPLETED|Overall Study||11||
60089848|NCT00623506|76206247|FG000|NOT COMPLETED|Overall Study||4||
60089849|NCT00623506|76206248|FG001|NOT COMPLETED|Overall Study||4||
60089850|NCT02139358|76206254|FG000|STARTED|Overall Study||15||
60089851|NCT02139358|76206254|FG000|COMPLETED|Overall Study||15||
60089852|NCT02139358|76206254|FG000|NOT COMPLETED|Overall Study||0||
60089853|NCT02140372|76206258|FG000|STARTED|Overall Study||10||
60089854|NCT02140372|76206258|FG000|COMPLETED|Overall Study||10||
60089855|NCT02140372|76206258|FG000|NOT COMPLETED|Overall Study||0||
60089856|NCT00624442|76206267|FG000|STARTED|Overall Study||8||
60089857|NCT00624442|76206268|FG001|STARTED|Overall Study||9||
60089858|NCT00624442|76206269|FG002|STARTED|Overall Study||10||
60089859|NCT00624442|76206270|FG003|STARTED|Overall Study||8||
60089860|NCT00624442|76206271|FG004|STARTED|Overall Study||10||
60089861|NCT00624442|76206267|FG000|COMPLETED|Overall Study||8||
60089862|NCT00624442|76206268|FG001|COMPLETED|Overall Study|One patient was discontinued after inadvertant overdose.|8||
60089863|NCT00624442|76206269|FG002|COMPLETED|Overall Study|Two patients discontinued after meeting termination criteria during dosing.|8||
60089864|NCT00624442|76206270|FG003|COMPLETED|Overall Study||8||
60089865|NCT00624442|76206271|FG004|COMPLETED|Overall Study|Two patients discontinued after meeting termination criteria during dosing.|8||
60089866|NCT00624442|76206267|FG000|NOT COMPLETED|Overall Study||0||
60089867|NCT00624442|76206268|FG001|NOT COMPLETED|Overall Study||1||
60089868|NCT00624442|76206269|FG002|NOT COMPLETED|Overall Study||2||
60089869|NCT00624442|76206270|FG003|NOT COMPLETED|Overall Study||0||
60089870|NCT00624442|76206271|FG004|NOT COMPLETED|Overall Study||2||
60089871|NCT00670462|76206306|FG000|STARTED|Overall Study||106||
60089872|NCT00670462|76206307|FG001|STARTED|Overall Study||107||
60089873|NCT00670462|76206306|FG000|COMPLETED|Overall Study||76||
60089874|NCT00670462|76206307|FG001|COMPLETED|Overall Study||76||
60089875|NCT00670462|76206306|FG000|NOT COMPLETED|Overall Study||30||
60089876|NCT00670462|76206307|FG001|NOT COMPLETED|Overall Study||31||
60089877|NCT00670774|76206315|FG000|STARTED|Overall Study||26||
60089878|NCT00670774|76206315|FG000|COMPLETED|Overall Study||26||
60089879|NCT00670774|76206315|FG000|NOT COMPLETED|Overall Study||0||
60089880|NCT00672100|76206322|FG000|STARTED|Overall Study||12||
60089881|NCT00672100|76206323|FG001|STARTED|Overall Study||12||
60089882|NCT00672100|76206324|FG002|STARTED|Overall Study||12||
60089883|NCT00672100|76206322|FG000|PACU (Within 8 Hours)|Overall Study||12||
60089884|NCT00672100|76206323|FG001|PACU (Within 8 Hours)|Overall Study||12||
60089885|NCT00672100|76206324|FG002|PACU (Within 8 Hours)|Overall Study||12||
60089886|NCT00672100|76206322|FG000|COMPLETED|Overall Study||12||
60089887|NCT00672100|76206323|FG001|COMPLETED|Overall Study||12||
60089888|NCT00672100|76206324|FG002|COMPLETED|Overall Study||12||
60089889|NCT00672100|76206322|FG000|NOT COMPLETED|Overall Study||0||
60089890|NCT00672100|76206323|FG001|NOT COMPLETED|Overall Study||0||
60089891|NCT00672100|76206324|FG002|NOT COMPLETED|Overall Study||0||
60089892|NCT00593866|76206336|FG000|STARTED|Overall Study||50||
60089893|NCT00593866|76206336|FG000|COMPLETED|Overall Study||50||
60089894|NCT00593866|76206336|FG000|NOT COMPLETED|Overall Study||0||
60089895|NCT00624910|76206343|FG000|STARTED|Overall Study||28||
60089896|NCT00624910|76206344|FG001|STARTED|Overall Study||15||
60089897|NCT00624910|76206345|FG002|STARTED|Overall Study||11||
60089898|NCT00624910|76206343|FG000|COMPLETED|Overall Study||28||
60089899|NCT00624910|76206344|FG001|COMPLETED|Overall Study||15||
60089900|NCT00624910|76206345|FG002|COMPLETED|Overall Study||11||
60089901|NCT00624910|76206343|FG000|NOT COMPLETED|Overall Study||0||
60089902|NCT00624910|76206344|FG001|NOT COMPLETED|Overall Study||0||
60089903|NCT00624910|76206345|FG002|NOT COMPLETED|Overall Study||0||
60089904|NCT00594022|76206355|FG000|STARTED|Overall Study||176||
60089905|NCT00594022|76206356|FG001|STARTED|Overall Study||173||
60089906|NCT00594022|76206355|FG000|COMPLETED|Overall Study||176||
60089907|NCT00594022|76206356|FG001|COMPLETED|Overall Study||173||
60089908|NCT00594022|76206355|FG000|NOT COMPLETED|Overall Study||0||
60089909|NCT00594022|76206356|FG001|NOT COMPLETED|Overall Study||0||
60089910|NCT00626626|76206364|FG000|STARTED|Overall Study||5||
60089911|NCT00626626|76206365|FG001|STARTED|Overall Study||3||
60089912|NCT00626626|76206364|FG000|COMPLETED|Overall Study||5||
60089913|NCT00626626|76206365|FG001|COMPLETED|Overall Study||3||
60089914|NCT00626626|76206364|FG000|NOT COMPLETED|Overall Study||0||
60089915|NCT00626626|76206365|FG001|NOT COMPLETED|Overall Study||0||
60089916|NCT00673114|76206372|FG000|STARTED|Overall Study||3||
60089917|NCT00673114|76206372|FG000|COMPLETED|Overall Study||3||
60089918|NCT00673114|76206372|FG000|NOT COMPLETED|Overall Study||0||
60089919|NCT00626782|76206378|FG000|STARTED|Overall Study||12||
60089920|NCT00626782|76206379|FG001|STARTED|Overall Study||12||
60089921|NCT00626782|76206378|FG000|COMPLETED|Overall Study||12||
60089922|NCT00626782|76206379|FG001|COMPLETED|Overall Study||12||
60089923|NCT00626782|76206378|FG000|NOT COMPLETED|Overall Study||0||
60089924|NCT00626782|76206379|FG001|NOT COMPLETED|Overall Study||0||
60089925|NCT00594256|76206387|FG000|STARTED|Overall Study||8||
60089926|NCT00594256|76206387|FG000|COMPLETED|Overall Study||8||
60089927|NCT00594256|76206387|FG000|NOT COMPLETED|Overall Study||0||
60089928|NCT00595114|76206394|FG000|STARTED|Overall Study||24||
60089929|NCT00595114|76206395|FG001|STARTED|Overall Study||19||
60089930|NCT00595114|76206394|FG000|COMPLETED|Overall Study||24||
60089931|NCT00595114|76206395|FG001|COMPLETED|Overall Study||19||
60089932|NCT00595114|76206394|FG000|NOT COMPLETED|Overall Study||0||
60089933|NCT00595114|76206395|FG001|NOT COMPLETED|Overall Study||0||
60089934|NCT00627406|76206405|FG000|STARTED|Overall Study||60||
60089935|NCT00627406|76206406|FG001|STARTED|Overall Study||58||
60089936|NCT00627406|76206407|FG002|STARTED|Overall Study||125||
60089937|NCT00627406|76206408|FG003|STARTED|Overall Study||141||
60089938|NCT00627406|76206405|FG000|COMPLETED|Overall Study||60||
60089939|NCT00627406|76206406|FG001|COMPLETED|Overall Study||58||
60089940|NCT00627406|76206407|FG002|COMPLETED|Overall Study||125||
60089941|NCT00627406|76206408|FG003|COMPLETED|Overall Study||141||
60089942|NCT00627406|76206405|FG000|NOT COMPLETED|Overall Study||0||
60089943|NCT00627406|76206406|FG001|NOT COMPLETED|Overall Study||0||
60089944|NCT00627406|76206407|FG002|NOT COMPLETED|Overall Study||0||
60089945|NCT00627406|76206408|FG003|NOT COMPLETED|Overall Study||0||
60089946|NCT00673738|76206418|FG000|STARTED|Overall Study||27||
60089947|NCT00673738|76206418|FG000|COMPLETED|Overall Study||27||
59561361|NCT03224403|75662808|FG000|STARTED|Overall Study||59||
59561362|NCT03224403|75662809|FG001|STARTED|Overall Study||249||
59561363|NCT03224403|75662810|FG002|STARTED|Overall Study||232||
59561364|NCT03224403|75662811|FG003|STARTED|Overall Study||124||
59561365|NCT03224403|75662808|FG000|COMPLETED|Overall Study||59||
60089948|NCT00673738|76206418|FG000|NOT COMPLETED|Overall Study||0||
60089949|NCT00674206|76206422|FG000|STARTED|Overall Study||6||
60089950|NCT00674206|76206422|FG000|COMPLETED|Overall Study||6||
60089951|NCT00674206|76206422|FG000|NOT COMPLETED|Overall Study||0||
60089952|NCT00595270|76206429|FG000|STARTED|Overall Study||116||
60089953|NCT00595270|76206430|FG001|STARTED|Overall Study||117||
60089954|NCT00595270|76206431|FG002|STARTED|Overall Study||116||
60089955|NCT00595270|76206429|FG000|COMPLETED|Overall Study||110||
60089956|NCT00595270|76206430|FG001|COMPLETED|Overall Study||107||
60089957|NCT00595270|76206431|FG002|COMPLETED|Overall Study||108||
60089958|NCT00595270|76206429|FG000|NOT COMPLETED|Overall Study||6||
59561366|NCT03224403|75662809|FG001|COMPLETED|Overall Study||249||
59561367|NCT03224403|75662810|FG002|COMPLETED|Overall Study||232||
59561368|NCT03224403|75662811|FG003|COMPLETED|Overall Study||124||
59561369|NCT03224403|75662808|FG000|NOT COMPLETED|Overall Study||0||
59561370|NCT03224403|75662809|FG001|NOT COMPLETED|Overall Study||0||
59561371|NCT03224403|75662810|FG002|NOT COMPLETED|Overall Study||0||
59561372|NCT03224403|75662811|FG003|NOT COMPLETED|Overall Study||0||
59561373|NCT02334059|75662824|FG000|STARTED|Overall Study||37||
59561374|NCT02334059|75662825|FG001|STARTED|Overall Study||34||
59561375|NCT02334059|75662826|FG002|STARTED|Overall Study||37||
59561376|NCT02334059|75662824|FG000|COMPLETED|Overall Study||37||
59561377|NCT02334059|75662825|FG001|COMPLETED|Overall Study||34||
59561378|NCT02334059|75662826|FG002|COMPLETED|Overall Study||37||
59561379|NCT02334059|75662824|FG000|NOT COMPLETED|Overall Study||0||
59561380|NCT02334059|75662825|FG001|NOT COMPLETED|Overall Study||0||
60089959|NCT00595270|76206430|FG001|NOT COMPLETED|Overall Study||10||
60089960|NCT00595270|76206431|FG002|NOT COMPLETED|Overall Study||8||
60089961|NCT00628498|76206439|FG000|STARTED|Overall Study||1206||
60089962|NCT00628498|76206439|FG000|COMPLETED|Overall Study||1154||
60089963|NCT00628498|76206439|FG000|NOT COMPLETED|Overall Study||52||
60089964|NCT00629122|76206445|FG000|STARTED|First Period: Day 1- 3 (Sublingual)||2||
60089965|NCT00629122|76206446|FG001|STARTED|First Period: Day 1- 3 (Sublingual)||3||
60089966|NCT00629122|76206445|FG000|COMPLETED|First Period: Day 1- 3 (Sublingual)||2||
60089967|NCT00629122|76206446|FG001|COMPLETED|First Period: Day 1- 3 (Sublingual)||3||
60089968|NCT00629122|76206445|FG000|NOT COMPLETED|First Period: Day 1- 3 (Sublingual)||0||
60089969|NCT00629122|76206446|FG001|NOT COMPLETED|First Period: Day 1- 3 (Sublingual)||0||
60089970|NCT00629122|76206445|FG000|STARTED|Second Period: Day 3-5 (Washout)||2||
60089971|NCT00629122|76206446|FG001|STARTED|Second Period: Day 3-5 (Washout)||3||
60089972|NCT00629122|76206445|FG000|COMPLETED|Second Period: Day 3-5 (Washout)||2||
60089973|NCT00629122|76206446|FG001|COMPLETED|Second Period: Day 3-5 (Washout)||3||
60089974|NCT00629122|76206445|FG000|NOT COMPLETED|Second Period: Day 3-5 (Washout)||0||
60089975|NCT00629122|76206446|FG001|NOT COMPLETED|Second Period: Day 3-5 (Washout)||0||
60089976|NCT00629122|76206445|FG000|STARTED|Third Period: Day 6-8 (Oral)||2||
60089977|NCT00629122|76206446|FG001|STARTED|Third Period: Day 6-8 (Oral)||3||
60089978|NCT00629122|76206445|FG000|COMPLETED|Third Period: Day 6-8 (Oral)||2||
60089979|NCT00629122|76206446|FG001|COMPLETED|Third Period: Day 6-8 (Oral)||3||
60089980|NCT00629122|76206445|FG000|NOT COMPLETED|Third Period: Day 6-8 (Oral)||0||
60089981|NCT00629122|76206446|FG001|NOT COMPLETED|Third Period: Day 6-8 (Oral)||0||
60089982|NCT00596440|76206454|FG000|STARTED|Overall Study||113||
60089983|NCT00596440|76206455|FG001|STARTED|Overall Study||121||
59561381|NCT02334059|75662826|FG002|NOT COMPLETED|Overall Study||0||
59561382|NCT02242994|75662834|FG000|STARTED|Overall Study||5||
59707732|NCT00983476|75826609|FG002|COMPLETED|Overall Study||88||
60089984|NCT00596440|76206454|FG000|Showed to Eligibility Visit|Overall Study||85||
60089985|NCT00596440|76206455|FG001|Showed to Eligibility Visit|Overall Study||72||
59561383|NCT02242994|75662834|FG000|COMPLETED|Overall Study||5||
60089986|NCT00596440|76206454|FG000|Showed to First Treatment Session|Overall Study||61||
60089987|NCT00596440|76206455|FG001|Showed to First Treatment Session|Overall Study||52||
60089988|NCT00596440|76206454|FG000|COMPLETED|Overall Study||48||
60089989|NCT00596440|76206455|FG001|COMPLETED|Overall Study||41||
60089990|NCT00596440|76206454|FG000|NOT COMPLETED|Overall Study||65||
60089991|NCT00596440|76206455|FG001|NOT COMPLETED|Overall Study||80||
59707733|NCT00983476|75826607|FG000|NOT COMPLETED|Overall Study||17||
60089992|NCT00599014|76206461|FG000|STARTED|Overall Study||335||
60089993|NCT00599014|76206461|FG000|COMPLETED|Overall Study||335||
60089994|NCT00599014|76206461|FG000|NOT COMPLETED|Overall Study||0||
60089995|NCT00631852|76206465|FG000|STARTED|Overall Study|Seventeen subjects were consented and 16 were considered enrolled and treated under the protocol. One was a screen fail.|16||
60089996|NCT00631852|76206465|FG000|COMPLETED|Overall Study|2 patients were administratively withdrawn after treatment had been completed as they declined sharing of data after PI transfer.|16||
60089997|NCT00631852|76206465|FG000|NOT COMPLETED|Overall Study||0||
60089998|NCT00632632|76206471|FG000|STARTED|Overall Study||13||
60089999|NCT00632632|76206472|FG001|STARTED|Overall Study||12||
60090000|NCT00632632|76206471|FG000|COMPLETED|Overall Study||13||
60090001|NCT00632632|76206472|FG001|COMPLETED|Overall Study||9||
60090002|NCT00632632|76206471|FG000|NOT COMPLETED|Overall Study||0||
60090003|NCT00632632|76206472|FG001|NOT COMPLETED|Overall Study||3||
60090004|NCT00633256|76206480|FG000|STARTED|Overall Study||12||
60090005|NCT00633256|76206481|FG001|STARTED|Overall Study||13||
60090006|NCT00633256|76206480|FG000|COMPLETED|Overall Study||8||
59992909|NCT03561701|76108723|FG001|NOT COMPLETED|Overall Study||19||
59992910|NCT03205553|76108731|FG000|STARTED|Overall Study||2||
59992911|NCT03205553|76108732|FG001|STARTED|Overall Study||1||
59992912|NCT03205553|76108731|FG000|COMPLETED|Overall Study||2||
59992913|NCT03205553|76108732|FG001|COMPLETED|Overall Study||1||
59992914|NCT03205553|76108731|FG000|NOT COMPLETED|Overall Study||0||
59992915|NCT03205553|76108732|FG001|NOT COMPLETED|Overall Study||0||
60090007|NCT00633256|76206481|FG001|COMPLETED|Overall Study||10||
60090008|NCT00633256|76206480|FG000|NOT COMPLETED|Overall Study||4||
60090009|NCT00633256|76206481|FG001|NOT COMPLETED|Overall Study||3||
60090010|NCT00634270|76206489|FG000|STARTED|Overall Study|February 12, 2008|49||
60090011|NCT00634270|76206490|FG001|STARTED|Overall Study||13||
60090012|NCT00634270|76206489|FG000|COMPLETED|Overall Study||46||
60090013|NCT00634270|76206490|FG001|COMPLETED|Overall Study||12||
60090014|NCT00634270|76206489|FG000|NOT COMPLETED|Overall Study||3||
60090015|NCT00634270|76206490|FG001|NOT COMPLETED|Overall Study||1||
60090016|NCT00635128|76206504|FG000|STARTED|Overall Study||351||
60090017|NCT00635128|76206505|FG001|STARTED|Overall Study||64||
60090018|NCT00635128|76206504|FG000|COMPLETED|Overall Study||351||
60090019|NCT00635128|76206505|FG001|COMPLETED|Overall Study||64||
60090020|NCT00635128|76206504|FG000|NOT COMPLETED|Overall Study||0||
60090021|NCT00635128|76206505|FG001|NOT COMPLETED|Overall Study||0||
60090022|NCT00676780|76206513|FG000|STARTED|Overall Study||33||
60090023|NCT00676780|76206513|FG000|COMPLETED|Overall Study||26||
60090024|NCT00676780|76206513|FG000|NOT COMPLETED|Overall Study||7||
60090025|NCT00678418|76206521|FG000|STARTED|Part A (Double Blind)||126||
60090026|NCT00678418|76206522|FG001|STARTED|Part A (Double Blind)||124||
60090027|NCT00678418|76206521|FG000|COMPLETED|Part A (Double Blind)||67||
60090028|NCT00678418|76206522|FG001|COMPLETED|Part A (Double Blind)||47||
60090029|NCT00678418|76206521|FG000|NOT COMPLETED|Part A (Double Blind)||59||
60090030|NCT00678418|76206522|FG001|NOT COMPLETED|Part A (Double Blind)||77||
60090031|NCT00678418|76206521|FG000|STARTED|Part B (Open Label)|All participants who received placebo in Part A were switched to open-label VIVITROL in Part B.|114||
60090032|NCT00678418|76206522|FG001|STARTED|Part B (Open Label)||0||
60090033|NCT00678418|76206521|FG000|COMPLETED|Part B (Open Label)||71||
60090034|NCT00678418|76206522|FG001|COMPLETED|Part B (Open Label)||0||
60090035|NCT00678418|76206521|FG000|NOT COMPLETED|Part B (Open Label)||43||
60090036|NCT00678418|76206522|FG001|NOT COMPLETED|Part B (Open Label)||0||
60090037|NCT00678496|76206530|FG000|STARTED|Overall Study||12||
60090038|NCT00678496|76206531|FG001|STARTED|Overall Study||12||
60090039|NCT00678496|76206530|FG000|Completed 8 Weeks Follow-up|Overall Study||9||
60090040|NCT00678496|76206531|FG001|Completed 8 Weeks Follow-up|Overall Study||12||
60090041|NCT00678496|76206530|FG000|COMPLETED|Overall Study||10||
60090042|NCT00678496|76206531|FG001|COMPLETED|Overall Study||8||
60090043|NCT00678496|76206530|FG000|NOT COMPLETED|Overall Study||2||
60090044|NCT00678496|76206531|FG001|NOT COMPLETED|Overall Study||4||
60090045|NCT00599248|76206541|FG000|STARTED|Overall Study||3||
60090046|NCT00599248|76206542|FG001|STARTED|Overall Study||3||
60090047|NCT00599248|76206543|FG002|STARTED|Overall Study||3||
60090048|NCT00599248|76206544|FG003|STARTED|Overall Study||3||
60090049|NCT00599248|76206541|FG000|COMPLETED|Overall Study||3||
60090050|NCT00599248|76206542|FG001|COMPLETED|Overall Study||3||
60090051|NCT00599248|76206543|FG002|COMPLETED|Overall Study||3||
60090052|NCT00599248|76206544|FG003|COMPLETED|Overall Study||3||
60090053|NCT00599248|76206541|FG000|NOT COMPLETED|Overall Study||0||
60090054|NCT00599248|76206542|FG001|NOT COMPLETED|Overall Study||0||
60090055|NCT00599248|76206543|FG002|NOT COMPLETED|Overall Study||0||
60090056|NCT00599248|76206544|FG003|NOT COMPLETED|Overall Study||0||
59992916|NCT01865617|76108751|FG000|STARTED|Overall Study||39||
59992917|NCT01865617|76108752|FG001|STARTED|Overall Study||5||
59992918|NCT01865617|76108753|FG002|STARTED|Overall Study||2||
59992919|NCT01865617|76108754|FG003|STARTED|Overall Study||1||
59992920|NCT01865617|76108755|FG004|STARTED|Overall Study||18||
59992921|NCT01865617|76108756|FG005|STARTED|Overall Study||5||
60090057|NCT00599872|76206555|FG000|STARTED|Overall Study||216||
60090058|NCT00599872|76206556|FG001|STARTED|Overall Study||214||
60090059|NCT00599872|76206555|FG000|COMPLETED|Overall Study||167||
60090060|NCT00599872|76206556|FG001|COMPLETED|Overall Study||181||
60090061|NCT00599872|76206555|FG000|NOT COMPLETED|Overall Study||49||
60090062|NCT00599872|76206556|FG001|NOT COMPLETED|Overall Study||33||
60090063|NCT00600340|76206568|FG000|STARTED|Overall Study||285||
60090064|NCT00600340|76206569|FG001|STARTED|Overall Study||279||
60090065|NCT00600340|76206568|FG000|COMPLETED|Overall Study||285||
60090066|NCT00600340|76206569|FG001|COMPLETED|Overall Study||279||
60090067|NCT00600340|76206568|FG000|NOT COMPLETED|Overall Study||0||
60090068|NCT00600340|76206569|FG001|NOT COMPLETED|Overall Study||0||
60090069|NCT00602290|76206578|FG000|STARTED|Overall Study||48||
60090070|NCT00602290|76206579|FG001|STARTED|Overall Study||48||
60090071|NCT00602290|76206580|FG002|STARTED|Overall Study||47||
60090072|NCT00602290|76206578|FG000|COMPLETED|Overall Study||46||
60090073|NCT00602290|76206579|FG001|COMPLETED|Overall Study||46||
60090074|NCT00602290|76206580|FG002|COMPLETED|Overall Study||46||
60090075|NCT00602290|76206578|FG000|NOT COMPLETED|Overall Study||2||
60090076|NCT00602290|76206579|FG001|NOT COMPLETED|Overall Study||2||
60090077|NCT00602290|76206580|FG002|NOT COMPLETED|Overall Study||1||
60090078|NCT00636220|76206588|FG000|STARTED|Overall Study||101||
60090079|NCT00636220|76206588|FG000|COMPLETED|Overall Study||101||
60090080|NCT00636220|76206588|FG000|NOT COMPLETED|Overall Study||0||
60090081|NCT00637780|76206592|FG000|STARTED|Overall Study||2||
60090082|NCT00637780|76206592|FG000|COMPLETED|Overall Study||2||
60090083|NCT00637780|76206592|FG000|NOT COMPLETED|Overall Study||0||
60090084|NCT00638014|76206598|FG000|STARTED|Overall Study||23||
60090085|NCT00638014|76206599|FG001|STARTED|Overall Study||28||
60090086|NCT00638014|76206598|FG000|COMPLETED|Overall Study||23||
60090087|NCT00638014|76206599|FG001|COMPLETED|Overall Study||28||
60090088|NCT00638014|76206598|FG000|NOT COMPLETED|Overall Study||0||
60090089|NCT00638014|76206599|FG001|NOT COMPLETED|Overall Study||0||
60090090|NCT00680524|76206605|FG000|STARTED|Overall Study||20||
60090091|NCT00680524|76206605|FG000|COMPLETED|Overall Study||17||
60090092|NCT00680524|76206605|FG000|NOT COMPLETED|Overall Study||3||
60090093|NCT00602446|76206609|FG000|STARTED|Overall Study||3||
60090094|NCT00602446|76206609|FG000|COMPLETED|Overall Study||3||
60090095|NCT00602446|76206609|FG000|NOT COMPLETED|Overall Study||0||
60090096|NCT00635830|76206615|FG000|STARTED|Overall Study||20||
60090097|NCT00635830|76206616|FG001|STARTED|Overall Study||20||
60090098|NCT00635830|76206615|FG000|COMPLETED|Overall Study||20||
60090099|NCT00635830|76206616|FG001|COMPLETED|Overall Study||20||
60090100|NCT00635830|76206615|FG000|NOT COMPLETED|Overall Study||0||
60090101|NCT00635830|76206616|FG001|NOT COMPLETED|Overall Study||0||
60090102|NCT00638716|76206625|FG000|STARTED|Overall Study||50||
60090103|NCT00638716|76206626|FG001|STARTED|Overall Study||52||
60090104|NCT00638716|76206627|FG002|STARTED|Overall Study||58||
60090105|NCT00638716|76206625|FG000|COMPLETED|Overall Study||43||
60090106|NCT00638716|76206626|FG001|COMPLETED|Overall Study||37||
60090107|NCT00638716|76206627|FG002|COMPLETED|Overall Study||46||
60090108|NCT00638716|76206625|FG000|NOT COMPLETED|Overall Study||7||
60090109|NCT00638716|76206626|FG001|NOT COMPLETED|Overall Study||15||
60090110|NCT00638716|76206627|FG002|NOT COMPLETED|Overall Study||12||
60090111|NCT00602836|76206635|FG000|STARTED|Overall Study||44||
60090112|NCT00602836|76206635|FG000|COMPLETED|Overall Study||39||
60090113|NCT00602836|76206635|FG000|NOT COMPLETED|Overall Study||5||
60090114|NCT00683020|76206641|FG000|STARTED|Overall Study||182||
60090115|NCT00683020|76206642|FG001|STARTED|Overall Study||180||
60090116|NCT00683020|76206641|FG000|COMPLETED|Overall Study||127||
60090117|NCT00683020|76206642|FG001|COMPLETED|Overall Study||125||
60090118|NCT00683020|76206641|FG000|NOT COMPLETED|Overall Study||55||
60090119|NCT00683020|76206642|FG001|NOT COMPLETED|Overall Study||55||
60090120|NCT00683332|76206648|FG000|STARTED|Overall Study||621||
60090121|NCT00683332|76206648|FG000|COMPLETED|Overall Study||621||
60090122|NCT00683332|76206648|FG000|NOT COMPLETED|Overall Study||0||
60090123|NCT00683410|76206652|FG000|STARTED|Overall Study||3366||
60090124|NCT00683410|76206652|FG000|Vaccinated Dose 1|Overall Study||3240||
60090125|NCT00683410|76206652|FG000|Vaccinated Dose 2|Overall Study||1623||
60090126|NCT00683410|76206652|FG000|Vaccinated Dose 3|Overall Study||817||
60090127|NCT00683410|76206652|FG000|Vaccinated Dose 4|Overall Study||175||
60090128|NCT00683410|76206652|FG000|COMPLETED|Overall Study||3366||
60090129|NCT00683410|76206652|FG000|NOT COMPLETED|Overall Study||0||
60090130|NCT00639418|76206660|FG000|STARTED|Overall Study||28101||
60090131|NCT00639418|76206661|FG001|STARTED|Overall Study||35967||
60090132|NCT00639418|76206662|FG002|STARTED|Overall Study||36496||
60090133|NCT00639418|76206663|FG003|STARTED|Overall Study||46930||
60090134|NCT00639418|76206660|FG000|COMPLETED|Overall Study||28101||
60090135|NCT00639418|76206661|FG001|COMPLETED|Overall Study||35967||
59707734|NCT00983476|75826608|FG001|NOT COMPLETED|Overall Study||22||
59707735|NCT00983476|75826609|FG002|NOT COMPLETED|Overall Study||0||
59707736|NCT02868034|75826631|FG000|STARTED|Overall Study||30||
59707737|NCT02868034|75826632|FG001|STARTED|Overall Study||29||
59707738|NCT02868034|75826633|FG002|STARTED|Overall Study||30||
59707739|NCT02868034|75826634|FG003|STARTED|Overall Study||31||
60090136|NCT00639418|76206662|FG002|COMPLETED|Overall Study||36496||
60090137|NCT00639418|76206663|FG003|COMPLETED|Overall Study||46930||
60090138|NCT00639418|76206660|FG000|NOT COMPLETED|Overall Study||0||
60090139|NCT00639418|76206661|FG001|NOT COMPLETED|Overall Study||0||
60090140|NCT00639418|76206662|FG002|NOT COMPLETED|Overall Study||0||
60090141|NCT00639418|76206663|FG003|NOT COMPLETED|Overall Study||0||
60090142|NCT00640822|76206680|FG000|STARTED|Overall Study||322||
60090143|NCT00640822|76206681|FG001|STARTED|Overall Study||317||
60090144|NCT00640822|76206682|FG002|STARTED|Overall Study||102||
60090145|NCT00640822|76206680|FG000|COMPLETED|Overall Study||279||
60090146|NCT00640822|76206681|FG001|COMPLETED|Overall Study||258||
60090147|NCT00640822|76206682|FG002|COMPLETED|Overall Study||77||
60090148|NCT00640822|76206680|FG000|NOT COMPLETED|Overall Study||43||
60090149|NCT00640822|76206681|FG001|NOT COMPLETED|Overall Study||59||
60090150|NCT00640822|76206682|FG002|NOT COMPLETED|Overall Study||25||
60090151|NCT00642694|76206692|FG000|STARTED|Overall Study||14||
59707740|NCT02868034|75826635|FG004|STARTED|Overall Study||30||
59707741|NCT02868034|75826636|FG005|STARTED|Overall Study||29||
60090152|NCT00642694|76206693|FG001|STARTED|Overall Study||15||
60090153|NCT00642694|76206692|FG000|COMPLETED|Overall Study||8||
60090154|NCT00642694|76206693|FG001|COMPLETED|Overall Study||11||
60090155|NCT00642694|76206692|FG000|NOT COMPLETED|Overall Study||6||
60090156|NCT00642694|76206693|FG001|NOT COMPLETED|Overall Study||4||
60090157|NCT00705874|76206706|FG000|STARTED|Overall Study||12||
60090158|NCT00705874|76206707|FG001|STARTED|Overall Study||9||
60090159|NCT00705874|76206708|FG002|STARTED|Overall Study||34||
60090160|NCT00705874|76206709|FG003|STARTED|Overall Study||34||
60090161|NCT00705874|76206710|FG004|STARTED|Overall Study||48||
60090162|NCT00705874|76206711|FG005|STARTED|Overall Study||32||
60090163|NCT00705874|76206712|FG006|STARTED|Overall Study||3||
60090164|NCT00705874|76206706|FG000|COMPLETED|Overall Study||10||
60090165|NCT00705874|76206707|FG001|COMPLETED|Overall Study||8||
60090166|NCT00705874|76206708|FG002|COMPLETED|Overall Study||32||
60090167|NCT00705874|76206709|FG003|COMPLETED|Overall Study||33||
60090168|NCT00705874|76206710|FG004|COMPLETED|Overall Study||36||
60090169|NCT00705874|76206711|FG005|COMPLETED|Overall Study||28||
60090170|NCT00705874|76206712|FG006|COMPLETED|Overall Study||3||
60090171|NCT00705874|76206706|FG000|NOT COMPLETED|Overall Study||2||
60090172|NCT00705874|76206707|FG001|NOT COMPLETED|Overall Study||1||
60090173|NCT00705874|76206708|FG002|NOT COMPLETED|Overall Study||2||
60090174|NCT00705874|76206709|FG003|NOT COMPLETED|Overall Study||1||
60090175|NCT00705874|76206710|FG004|NOT COMPLETED|Overall Study||12||
60090176|NCT00705874|76206711|FG005|NOT COMPLETED|Overall Study||4||
60090177|NCT00705874|76206712|FG006|NOT COMPLETED|Overall Study||0||
60090178|NCT00645970|76206730|FG000|STARTED|Overall Study||141||
60090179|NCT00645970|76206731|FG001|STARTED|Overall Study||218||
60090180|NCT00645970|76206730|FG000|6 Months|Overall Study||58||
60090181|NCT00645970|76206731|FG001|6 Months|Overall Study||97||
60090182|NCT00645970|76206730|FG000|1 Year|Overall Study||37||
60090183|NCT00645970|76206731|FG001|1 Year|Overall Study||42||
60090184|NCT00645970|76206730|FG000|COMPLETED|Overall Study||32||
60090185|NCT00645970|76206731|FG001|COMPLETED|Overall Study||32||
60090186|NCT00645970|76206730|FG000|NOT COMPLETED|Overall Study||109||
60090187|NCT00645970|76206731|FG001|NOT COMPLETED|Overall Study||186||
60090188|NCT00646048|76206737|FG000|STARTED|Overall Study||43||
60090189|NCT00646048|76206737|FG000|COMPLETED|Overall Study||27||
60090190|NCT00646048|76206737|FG000|NOT COMPLETED|Overall Study||16||
60090191|NCT00647998|76206743|FG000|STARTED|Overall Study||9||
60090192|NCT00647998|76206744|FG001|STARTED|Overall Study||9||
60090193|NCT00647998|76206743|FG000|COMPLETED|Overall Study||9||
60090194|NCT00647998|76206744|FG001|COMPLETED|Overall Study||9||
60090195|NCT00647998|76206743|FG000|NOT COMPLETED|Overall Study||0||
60090196|NCT00647998|76206744|FG001|NOT COMPLETED|Overall Study||0||
60090197|NCT00649792|76206752|FG000|STARTED|Overall Study||214||
60090198|NCT00649792|76206752|FG000|COMPLETED|Overall Study||146||
60090199|NCT00649792|76206752|FG000|NOT COMPLETED|Overall Study||68||
60090200|NCT00685516|76206759|FG000|STARTED|Overall Study||42||
60090201|NCT00685516|76206760|FG001|STARTED|Overall Study||38||
60090202|NCT00685516|76206761|FG002|STARTED|Overall Study||33||
60090203|NCT00685516|76206759|FG000|COMPLETED|Overall Study||34||
60090204|NCT00685516|76206760|FG001|COMPLETED|Overall Study||33||
60090205|NCT00685516|76206761|FG002|COMPLETED|Overall Study||26||
60090206|NCT00685516|76206759|FG000|NOT COMPLETED|Overall Study||8||
60090207|NCT00685516|76206760|FG001|NOT COMPLETED|Overall Study||5||
60090208|NCT00685516|76206761|FG002|NOT COMPLETED|Overall Study||7||
60090209|NCT00686842|76206772|FG000|STARTED|Overall Study||17||
60090210|NCT00686842|76206772|FG000|COMPLETED|Overall Study||17||
60090211|NCT00686842|76206772|FG000|NOT COMPLETED|Overall Study||0||
60090212|NCT00687076|76206778|FG000|STARTED|Overall Study||51||
60090213|NCT00687076|76206779|FG001|STARTED|Overall Study||51||
60090214|NCT00687076|76206778|FG000|COMPLETED|Overall Study||19||
60090215|NCT00687076|76206779|FG001|COMPLETED|Overall Study||21||
60090216|NCT00687076|76206778|FG000|NOT COMPLETED|Overall Study||32||
60090217|NCT00687076|76206779|FG001|NOT COMPLETED|Overall Study||30||
60090218|NCT00687544|76206785|FG000|STARTED|Overall Study||11||
60090219|NCT00687544|76206785|FG000|COMPLETED|Overall Study||0||
60090220|NCT00687544|76206785|FG000|NOT COMPLETED|Overall Study||11||
60090221|NCT02143648|76206792|FG000|STARTED|Overall Study||128||
60090222|NCT02143648|76206793|FG001|STARTED|Overall Study||120||
60090223|NCT02143648|76206794|FG002|STARTED|Overall Study||125||
60090224|NCT02143648|76206792|FG000|COMPLETED|Overall Study||74||
60090225|NCT02143648|76206793|FG001|COMPLETED|Overall Study||78||
60090226|NCT02143648|76206794|FG002|COMPLETED|Overall Study||101||
60090227|NCT02143648|76206792|FG000|NOT COMPLETED|Overall Study||54||
60090228|NCT02143648|76206793|FG001|NOT COMPLETED|Overall Study||42||
60090229|NCT02143648|76206794|FG002|NOT COMPLETED|Overall Study||24||
60090230|NCT00689260|76206804|FG000|STARTED|Overall Study||21||
60090231|NCT00689260|76206805|FG001|STARTED|Overall Study||21||
60090232|NCT00689260|76206804|FG000|COMPLETED|Overall Study||19||
60090233|NCT00689260|76206805|FG001|COMPLETED|Overall Study||21||
60090234|NCT00689260|76206804|FG000|NOT COMPLETED|Overall Study||2||
60090235|NCT00689260|76206805|FG001|NOT COMPLETED|Overall Study||0||
60090236|NCT00689572|76206816|FG000|STARTED|Overall Study||53||
60090237|NCT00689572|76206817|FG001|STARTED|Overall Study||55||
60090238|NCT00689572|76206816|FG000|COMPLETED|Overall Study||39||
60090239|NCT00689572|76206817|FG001|COMPLETED|Overall Study||34||
60090240|NCT00689572|76206816|FG000|NOT COMPLETED|Overall Study||14||
60090241|NCT00689572|76206817|FG001|NOT COMPLETED|Overall Study||21||
60090242|NCT01840579|76206833|FG000|STARTED|Overall Study||3||
60090243|NCT01840579|76206834|FG001|STARTED|Overall Study||7||
60090244|NCT01840579|76206835|FG002|STARTED|Overall Study||6||
60090245|NCT01840579|76206836|FG003|STARTED|Overall Study||6||
60090246|NCT01840579|76206837|FG004|STARTED|Overall Study||8||
60090247|NCT01840579|76206838|FG005|STARTED|Overall Study||6||
60090248|NCT01840579|76206839|FG006|STARTED|Overall Study||6||
60090249|NCT01840579|76206840|FG007|STARTED|Overall Study||6||
60090250|NCT01840579|76206841|FG008|STARTED|Overall Study||6||
60090251|NCT01840579|76206842|FG009|STARTED|Overall Study||3||
60090252|NCT01840579|76206833|FG000|COMPLETED|Overall Study||0||
60090253|NCT01840579|76206834|FG001|COMPLETED|Overall Study||0||
60090254|NCT01840579|76206835|FG002|COMPLETED|Overall Study||4||
60090255|NCT01840579|76206836|FG003|COMPLETED|Overall Study||3||
60090256|NCT01840579|76206837|FG004|COMPLETED|Overall Study||4||
60090257|NCT01840579|76206838|FG005|COMPLETED|Overall Study||2||
60090258|NCT01840579|76206839|FG006|COMPLETED|Overall Study||4||
60090259|NCT01840579|76206840|FG007|COMPLETED|Overall Study||3||
60090260|NCT01840579|76206841|FG008|COMPLETED|Overall Study||3||
60090261|NCT01840579|76206842|FG009|COMPLETED|Overall Study||0||
60090262|NCT01840579|76206833|FG000|NOT COMPLETED|Overall Study||3||
60090263|NCT01840579|76206834|FG001|NOT COMPLETED|Overall Study||7||
59992922|NCT01865617|76108757|FG006|STARTED|Overall Study||22||
59992923|NCT01865617|76108758|FG007|STARTED|Overall Study||1||
59992924|NCT01865617|76108759|FG008|STARTED|Overall Study||20||
59992925|NCT01865617|76108760|FG009|STARTED|Overall Study||5||
59992926|NCT01865617|76108761|FG010|STARTED|Overall Study||49||
60090264|NCT01840579|76206835|FG002|NOT COMPLETED|Overall Study||2||
60090265|NCT01840579|76206836|FG003|NOT COMPLETED|Overall Study||3||
60090266|NCT01840579|76206837|FG004|NOT COMPLETED|Overall Study||4||
60090267|NCT01840579|76206838|FG005|NOT COMPLETED|Overall Study||4||
60090268|NCT01840579|76206839|FG006|NOT COMPLETED|Overall Study||2||
60090269|NCT01840579|76206840|FG007|NOT COMPLETED|Overall Study||3||
60090270|NCT01840579|76206841|FG008|NOT COMPLETED|Overall Study||3||
60090271|NCT01840579|76206842|FG009|NOT COMPLETED|Overall Study||3||
60090272|NCT00690040|76206878|FG000|STARTED|Overall Study||145||
60090273|NCT00690040|76206879|FG001|STARTED|Overall Study||148||
60090274|NCT00690040|76206878|FG000|COMPLETED|Overall Study||145||
60090275|NCT00690040|76206879|FG001|COMPLETED|Overall Study||148||
60090276|NCT00690040|76206878|FG000|NOT COMPLETED|Overall Study||0||
60090277|NCT00690040|76206879|FG001|NOT COMPLETED|Overall Study||0||
60090278|NCT00690274|76206887|FG000|STARTED|Overall Study||29||
60090279|NCT00690274|76206888|FG001|STARTED|Overall Study||23||
60090280|NCT00690274|76206887|FG000|COMPLETED|Overall Study||23||
60090281|NCT00690274|76206888|FG001|COMPLETED|Overall Study||15||
60090282|NCT00690274|76206887|FG000|NOT COMPLETED|Overall Study||6||
60090283|NCT00690274|76206888|FG001|NOT COMPLETED|Overall Study||8||
60090284|NCT00650260|76206896|FG000|STARTED|Overall Study||21||
60090285|NCT00650260|76206897|FG001|STARTED|Overall Study||21||
60090286|NCT00650260|76206896|FG000|COMPLETED|Overall Study||21||
60090287|NCT00650260|76206897|FG001|COMPLETED|Overall Study||21||
60090288|NCT00650260|76206896|FG000|NOT COMPLETED|Overall Study||0||
60090289|NCT00650260|76206897|FG001|NOT COMPLETED|Overall Study||0||
60090290|NCT00651040|76206905|FG000|STARTED|Overall Study||16||
60090291|NCT00651040|76206906|FG001|STARTED|Overall Study||15||
60090292|NCT00651040|76206905|FG000|COMPLETED|Overall Study||13||
60090293|NCT00651040|76206906|FG001|COMPLETED|Overall Study||14||
60090294|NCT00651040|76206905|FG000|NOT COMPLETED|Overall Study||3||
60090295|NCT00651040|76206906|FG001|NOT COMPLETED|Overall Study||1||
60090296|NCT00654784|76206914|FG000|STARTED|Overall Study||13||
60090297|NCT00654784|76206915|FG001|STARTED|Overall Study||8||
60090298|NCT00654784|76206914|FG000|COMPLETED|Overall Study||13||
60090299|NCT00654784|76206915|FG001|COMPLETED|Overall Study||8||
60090300|NCT00654784|76206914|FG000|NOT COMPLETED|Overall Study||0||
59992927|NCT01865617|76108762|FG011|STARTED|Overall Study||10||
59992928|NCT01865617|76108763|FG012|STARTED|Overall Study||20||
59992929|NCT01865617|76108751|FG000|COMPLETED|Overall Study||9||
59992930|NCT01865617|76108752|FG001|COMPLETED|Overall Study||2||
60090301|NCT00654784|76206915|FG001|NOT COMPLETED|Overall Study||0||
60090302|NCT01801111|76206921|FG000|STARTED|Overall Study||138||
59707742|NCT02868034|75826637|FG006|STARTED|Overall Study||30||
59707743|NCT02868034|75826638|FG007|STARTED|Overall Study||32||
59992931|NCT01865617|76108753|FG002|COMPLETED|Overall Study||1||
59992932|NCT01865617|76108754|FG003|COMPLETED|Overall Study||0||
59992933|NCT01865617|76108755|FG004|COMPLETED|Overall Study||11||
60090303|NCT01801111|76206921|FG000|COMPLETED|Overall Study||0||
60090304|NCT01801111|76206921|FG000|NOT COMPLETED|Overall Study||138||
60090305|NCT00691600|76206927|FG000|STARTED|Overall Study||12||
60090306|NCT00691600|76206928|FG001|STARTED|Overall Study||11||
60090307|NCT00691600|76206927|FG000|COMPLETED|Overall Study||12||
60090308|NCT00691600|76206928|FG001|COMPLETED|Overall Study||11||
60090309|NCT00691600|76206927|FG000|NOT COMPLETED|Overall Study||0||
60090310|NCT00691600|76206928|FG001|NOT COMPLETED|Overall Study||0||
60090311|NCT00655642|76206938|FG000|STARTED|Overall Study||42||
60090312|NCT00655642|76206939|FG001|STARTED|Overall Study||43||
60090313|NCT00655642|76206940|FG002|STARTED|Overall Study||45||
60090314|NCT00655642|76206941|FG003|STARTED|Overall Study||41||
60090315|NCT00655642|76206938|FG000|COMPLETED|Overall Study|1 patient withdrawn by treating physician after consent|41||
60090316|NCT00655642|76206939|FG001|COMPLETED|Overall Study|1 patient given drug orally rather than intravenous(iv);1 patient refused iv; 1 pt lost to follow-up|40||
60090317|NCT00655642|76206940|FG002|COMPLETED|Overall Study|1 patient left the ED prior to receiving drug; 1 patient's nausea resolved prior to receiving drug|43||
60090318|NCT00655642|76206941|FG003|COMPLETED|Overall Study|1 patient's initial Visual analog scale (VAS)<40; 1 patient was withdrawn by treating physician|39||
60090319|NCT00655642|76206938|FG000|NOT COMPLETED|Overall Study||1||
60090320|NCT00655642|76206939|FG001|NOT COMPLETED|Overall Study||3||
60090321|NCT00655642|76206940|FG002|NOT COMPLETED|Overall Study||2||
60090322|NCT00655642|76206941|FG003|NOT COMPLETED|Overall Study||2||
60090323|NCT01773967|76206953|FG000|STARTED|Overall Study||483||
60090324|NCT01773967|76206954|FG001|STARTED|Overall Study||488||
60090325|NCT01773967|76206953|FG000|COMPLETED|Overall Study||468||
60090326|NCT01773967|76206954|FG001|COMPLETED|Overall Study||475||
60090327|NCT01773967|76206953|FG000|NOT COMPLETED|Overall Study||15||
60090328|NCT01773967|76206954|FG001|NOT COMPLETED|Overall Study||13||
60090329|NCT00656656|76206960|FG000|STARTED|Overall Study||23||
60090330|NCT00656656|76206960|FG000|COMPLETED|Overall Study||23||
60090331|NCT00656656|76206960|FG000|NOT COMPLETED|Overall Study||0||
60090332|NCT01773889|76206964|FG000|STARTED|Overall Study||2||
60090333|NCT01773889|76206964|FG000|COMPLETED|Overall Study||0||
60090334|NCT01773889|76206964|FG000|NOT COMPLETED|Overall Study||2||
60090335|NCT00656968|76206970|FG000|STARTED|Overall Study||115||
60090336|NCT00656968|76206971|FG001|STARTED|Overall Study||117||
60090337|NCT00656968|76206970|FG000|COMPLETED|Overall Study||115||
60090338|NCT00656968|76206971|FG001|COMPLETED|Overall Study||117||
60090339|NCT00656968|76206970|FG000|NOT COMPLETED|Overall Study||0||
60090340|NCT00656968|76206971|FG001|NOT COMPLETED|Overall Study||0||
60090341|NCT00657280|76206977|FG000|STARTED|Overall Study||16||
60090342|NCT00657280|76206977|FG000|COMPLETED|Overall Study||16||
60090343|NCT00657280|76206977|FG000|NOT COMPLETED|Overall Study||0||
60090344|NCT00692692|76206981|FG000|STARTED|Overall Study||20||
60090345|NCT00692692|76206982|FG001|STARTED|Overall Study||16||
60090346|NCT00692692|76206981|FG000|COMPLETED|Overall Study||20||
60090347|NCT00692692|76206982|FG001|COMPLETED|Overall Study||16||
60090348|NCT00692692|76206981|FG000|NOT COMPLETED|Overall Study||0||
60090349|NCT00692692|76206982|FG001|NOT COMPLETED|Overall Study||0||
60090350|NCT00693160|76206990|FG000|STARTED|Overall Study||14||
60090351|NCT00693160|76206991|FG001|STARTED|Overall Study||16||
60090352|NCT00693160|76206990|FG000|COMPLETED|Overall Study||14||
60090353|NCT00693160|76206991|FG001|COMPLETED|Overall Study||16||
60090354|NCT00693160|76206990|FG000|NOT COMPLETED|Overall Study||0||
60090355|NCT00693160|76206991|FG001|NOT COMPLETED|Overall Study||0||
60090356|NCT00694018|76206999|FG000|STARTED|Overall Study||118||
60090357|NCT00694018|76207000|FG001|STARTED|Overall Study||111||
60090358|NCT00694018|76206999|FG000|6 Months|Overall Study||106||
60090359|NCT00694018|76207000|FG001|6 Months|Overall Study||101||
60090360|NCT00694018|76206999|FG000|COMPLETED|Overall Study||105||
60090361|NCT00694018|76207000|FG001|COMPLETED|Overall Study||102||
60090362|NCT00694018|76206999|FG000|NOT COMPLETED|Overall Study||13||
60090363|NCT00694018|76207000|FG001|NOT COMPLETED|Overall Study||9||
60090364|NCT00694564|76207006|FG000|STARTED|Overall Study||8||
60090365|NCT00694564|76207006|FG000|COMPLETED|Overall Study||6||
60090366|NCT00694564|76207006|FG000|NOT COMPLETED|Overall Study||2||
60090367|NCT00695188|76207012|FG000|STARTED|Overall Study||10||
60090368|NCT00695188|76207013|FG001|STARTED|Overall Study||9||
60090369|NCT00695188|76207012|FG000|COMPLETED|Overall Study||10||
60090370|NCT00695188|76207013|FG001|COMPLETED|Overall Study||9||
60090371|NCT00695188|76207012|FG000|NOT COMPLETED|Overall Study||0||
60090372|NCT00695188|76207013|FG001|NOT COMPLETED|Overall Study||0||
60090373|NCT00658138|76207019|FG000|STARTED|Overall Study||61||
60090374|NCT00658138|76207019|FG000|COMPLETED|Overall Study||40||
60090375|NCT00658138|76207019|FG000|NOT COMPLETED|Overall Study||21||
60090376|NCT00706264|76207026|FG000|STARTED|Overall Study||193||
60090377|NCT00706264|76207027|FG001|STARTED|Overall Study||192||
60090378|NCT00706264|76207026|FG000|COMPLETED|Overall Study||190||
60090379|NCT00706264|76207027|FG001|COMPLETED|Overall Study||190||
60090380|NCT00706264|76207026|FG000|NOT COMPLETED|Overall Study||3||
60090381|NCT00706264|76207027|FG001|NOT COMPLETED|Overall Study||2||
60090382|NCT00695500|76207037|FG000|STARTED|Overall Study||24||
60090383|NCT00695500|76207038|FG001|STARTED|Overall Study||22||
60090384|NCT00695500|76207037|FG000|COMPLETED|Overall Study||21||
60090385|NCT00695500|76207038|FG001|COMPLETED|Overall Study||17||
60090386|NCT00695500|76207037|FG000|NOT COMPLETED|Overall Study||3||
60090387|NCT00695500|76207038|FG001|NOT COMPLETED|Overall Study||5||
60090388|NCT00695578|76207046|FG000|STARTED|Overall Study||10||
60090389|NCT00695578|76207047|FG001|STARTED|Overall Study||10||
60090390|NCT00695578|76207046|FG000|COMPLETED|Overall Study||10||
60090391|NCT00695578|76207047|FG001|COMPLETED|Overall Study||10||
60090392|NCT00695578|76207046|FG000|NOT COMPLETED|Overall Study||0||
60090393|NCT00695578|76207047|FG001|NOT COMPLETED|Overall Study||0||
60090394|NCT00699010|76207055|FG000|STARTED|Overall Study||15||
60090395|NCT00699010|76207056|FG001|STARTED|Overall Study||15||
60090396|NCT00699010|76207055|FG000|COMPLETED|Overall Study||15||
60090397|NCT00699010|76207056|FG001|COMPLETED|Overall Study||15||
60090398|NCT00699010|76207055|FG000|NOT COMPLETED|Overall Study||0||
60090399|NCT00699010|76207056|FG001|NOT COMPLETED|Overall Study||0||
60090400|NCT00699400|76207065|FG000|STARTED|Overall Study||42||
60090401|NCT00699400|76207066|FG001|STARTED|Overall Study||3||
60090402|NCT00699400|76207067|FG002|STARTED|Overall Study||138||
60090403|NCT00699400|76207068|FG003|STARTED|Overall Study||6||
60090404|NCT00699400|76207069|FG004|STARTED|Overall Study||4||
60090405|NCT00699400|76207070|FG005|STARTED|Overall Study||11||
60090406|NCT00699400|76207065|FG000|COMPLETED|Overall Study||42||
60090407|NCT00699400|76207066|FG001|COMPLETED|Overall Study||3||
60090408|NCT00699400|76207067|FG002|COMPLETED|Overall Study||138||
60090409|NCT00699400|76207068|FG003|COMPLETED|Overall Study||6||
60090410|NCT00699400|76207069|FG004|COMPLETED|Overall Study||4||
60090411|NCT00699400|76207070|FG005|COMPLETED|Overall Study||0||
60090412|NCT00699400|76207065|FG000|NOT COMPLETED|Overall Study||0||
60090413|NCT00699400|76207066|FG001|NOT COMPLETED|Overall Study||0||
60090414|NCT00699400|76207067|FG002|NOT COMPLETED|Overall Study||0||
60090415|NCT00699400|76207068|FG003|NOT COMPLETED|Overall Study||0||
60090416|NCT00699400|76207069|FG004|NOT COMPLETED|Overall Study||0||
60090417|NCT00699400|76207070|FG005|NOT COMPLETED|Overall Study||11||
60090418|NCT00661570|76207078|FG000|STARTED|Overall Study||26||
60090419|NCT00661570|76207078|FG000|COMPLETED|Overall Study||26||
60090420|NCT00661570|76207078|FG000|NOT COMPLETED|Overall Study||0||
60090421|NCT00706810|76207082|FG000|STARTED|Overall Study||8||
60090422|NCT00706810|76207082|FG000|COMPLETED|Overall Study||7||
60090423|NCT00706810|76207082|FG000|NOT COMPLETED|Overall Study||1||
60090424|NCT00661960|76207090|FG000|STARTED|Overall Study||5||
60090425|NCT00661960|76207091|FG001|STARTED|Overall Study||10||
60090426|NCT00661960|76207092|FG002|STARTED|Overall Study||10||
60090427|NCT00661960|76207090|FG000|COMPLETED|Overall Study||5||
60090428|NCT00661960|76207091|FG001|COMPLETED|Overall Study||7||
60090429|NCT00661960|76207092|FG002|COMPLETED|Overall Study||9||
60090430|NCT00661960|76207090|FG000|NOT COMPLETED|Overall Study||0||
60090431|NCT00661960|76207091|FG001|NOT COMPLETED|Overall Study||3||
60090432|NCT00661960|76207092|FG002|NOT COMPLETED|Overall Study||1||
60090433|NCT00662818|76207102|FG000|STARTED|Period 1 (6 Weeks)||84||
60090434|NCT00662818|76207103|FG001|STARTED|Period 1 (6 Weeks)||81||
60090435|NCT00662818|76207102|FG000|Treated|Period 1 (6 Weeks)||56||
60090436|NCT00662818|76207103|FG001|Treated|Period 1 (6 Weeks)||58||
60090437|NCT00662818|76207102|FG000|COMPLETED|Period 1 (6 Weeks)||56||
60090438|NCT00662818|76207103|FG001|COMPLETED|Period 1 (6 Weeks)||58||
60090439|NCT00662818|76207102|FG000|NOT COMPLETED|Period 1 (6 Weeks)||28||
60090440|NCT00662818|76207103|FG001|NOT COMPLETED|Period 1 (6 Weeks)||23||
60090441|NCT00662818|76207102|FG000|STARTED|Wash-Out (14 Days)||56||
60090442|NCT00662818|76207103|FG001|STARTED|Wash-Out (14 Days)||58||
60090443|NCT00662818|76207102|FG000|COMPLETED|Wash-Out (14 Days)||51||
60090444|NCT00662818|76207103|FG001|COMPLETED|Wash-Out (14 Days)||53||
60090445|NCT00662818|76207102|FG000|NOT COMPLETED|Wash-Out (14 Days)||5||
60090446|NCT00662818|76207103|FG001|NOT COMPLETED|Wash-Out (14 Days)||5||
60090447|NCT00662818|76207102|FG000|STARTED|Period 2 (6 Weeks)||51||
60090448|NCT00662818|76207103|FG001|STARTED|Period 2 (6 Weeks)||53||
60090449|NCT00662818|76207102|FG000|COMPLETED|Period 2 (6 Weeks)||38||
60090450|NCT00662818|76207103|FG001|COMPLETED|Period 2 (6 Weeks)||41||
60090451|NCT00662818|76207102|FG000|NOT COMPLETED|Period 2 (6 Weeks)||13||
60090452|NCT00662818|76207103|FG001|NOT COMPLETED|Period 2 (6 Weeks)||12||
60090453|NCT00699556|76207111|FG000|STARTED|First Intervention (1 Day)||11||
60090454|NCT00699556|76207112|FG001|STARTED|First Intervention (1 Day)||11||
60090455|NCT00699556|76207111|FG000|COMPLETED|First Intervention (1 Day)||11||
60090456|NCT00699556|76207112|FG001|COMPLETED|First Intervention (1 Day)||11||
60090457|NCT00699556|76207111|FG000|NOT COMPLETED|First Intervention (1 Day)||0||
60090458|NCT00699556|76207112|FG001|NOT COMPLETED|First Intervention (1 Day)||0||
60090459|NCT00699556|76207111|FG000|STARTED|Second Intervention (1 Day)||11||
60090460|NCT00699556|76207112|FG001|STARTED|Second Intervention (1 Day)||11||
60090461|NCT00699556|76207111|FG000|COMPLETED|Second Intervention (1 Day)||11||
60090462|NCT00699556|76207112|FG001|COMPLETED|Second Intervention (1 Day)||11||
60090463|NCT00699556|76207111|FG000|NOT COMPLETED|Second Intervention (1 Day)||0||
60090464|NCT00699556|76207112|FG001|NOT COMPLETED|Second Intervention (1 Day)||0||
60090465|NCT00700336|76207122|FG000|STARTED|Overall Study||40||
60090466|NCT00700336|76207123|FG001|STARTED|Overall Study||23||
60090467|NCT00700336|76207124|FG002|STARTED|Overall Study||6||
60090468|NCT00700336|76207122|FG000|COMPLETED|Overall Study||40||
60090469|NCT00700336|76207123|FG001|COMPLETED|Overall Study||23||
60090470|NCT00700336|76207124|FG002|COMPLETED|Overall Study||6||
60090471|NCT00700336|76207122|FG000|NOT COMPLETED|Overall Study||0||
60090472|NCT00700336|76207123|FG001|NOT COMPLETED|Overall Study||0||
60090473|NCT00700336|76207124|FG002|NOT COMPLETED|Overall Study||0||
60090474|NCT00701896|76207133|FG000|STARTED|Overall Study|Includes those eligible but declined to participate|143||
60090475|NCT00701896|76207134|FG001|STARTED|Overall Study|Includes those eligible but declined to participate|151||
60090476|NCT00701896|76207133|FG000|COMPLETED|Overall Study||110||
60090477|NCT00701896|76207134|FG001|COMPLETED|Overall Study||118||
60090478|NCT00701896|76207133|FG000|NOT COMPLETED|Overall Study||33||
60090479|NCT00701896|76207134|FG001|NOT COMPLETED|Overall Study||33||
60090480|NCT01839487|76207142|FG000|STARTED|Run-in Phase (Maximum Exposure:295 Days)||16||
60090481|NCT01839487|76207143|FG001|STARTED|Run-in Phase (Maximum Exposure:295 Days)||7||
60090482|NCT01839487|76207144|FG002|STARTED|Run-in Phase (Maximum Exposure:295 Days)||0||
60090483|NCT01839487|76207145|FG003|STARTED|Run-in Phase (Maximum Exposure:295 Days)||0||
60090484|NCT01839487|76207146|FG004|STARTED|Run-in Phase (Maximum Exposure:295 Days)||0||
60090485|NCT01839487|76207147|FG005|STARTED|Run-in Phase (Maximum Exposure:295 Days)||0||
60090486|NCT01839487|76207142|FG000|COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0||
60090487|NCT01839487|76207143|FG001|COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0||
60090488|NCT01839487|76207144|FG002|COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0||
60090489|NCT01839487|76207145|FG003|COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0||
60090490|NCT01839487|76207146|FG004|COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0||
60090491|NCT01839487|76207147|FG005|COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0||
60090492|NCT01839487|76207142|FG000|NOT COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||16||
60090493|NCT01839487|76207143|FG001|NOT COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||7||
60090494|NCT01839487|76207144|FG002|NOT COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0||
59707744|NCT02868034|75826631|FG000|COMPLETED|Overall Study||22||
59707745|NCT02868034|75826632|FG001|COMPLETED|Overall Study||23||
59707746|NCT02868034|75826633|FG002|COMPLETED|Overall Study||26||
59707747|NCT02868034|75826634|FG003|COMPLETED|Overall Study||27||
59707748|NCT02868034|75826635|FG004|COMPLETED|Overall Study||24||
59707749|NCT02868034|75826636|FG005|COMPLETED|Overall Study||26||
59707750|NCT02868034|75826637|FG006|COMPLETED|Overall Study||24||
59707751|NCT02868034|75826638|FG007|COMPLETED|Overall Study||26||
59707752|NCT02868034|75826631|FG000|NOT COMPLETED|Overall Study||8||
59707753|NCT02868034|75826632|FG001|NOT COMPLETED|Overall Study||6||
59707754|NCT02868034|75826633|FG002|NOT COMPLETED|Overall Study||4||
59707755|NCT02868034|75826634|FG003|NOT COMPLETED|Overall Study||4||
59707756|NCT02868034|75826635|FG004|NOT COMPLETED|Overall Study||6||
60090495|NCT01839487|76207145|FG003|NOT COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0||
60090496|NCT01839487|76207146|FG004|NOT COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0||
60090497|NCT01839487|76207147|FG005|NOT COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0||
60090498|NCT01839487|76207142|FG000|STARTED|Phase 2 (Maximum Exposure:935 Days)||0||
60090499|NCT01839487|76207143|FG001|STARTED|Phase 2 (Maximum Exposure:935 Days)||0||
60090500|NCT01839487|76207144|FG002|STARTED|Phase 2 (Maximum Exposure:935 Days)||61||
60090501|NCT01839487|76207145|FG003|STARTED|Phase 2 (Maximum Exposure:935 Days)||62||
60103743|NCT04621227|76222001|FG000|COMPLETED|Period 4 (4 Days)||14||
60103744|NCT04621227|76222001|FG000|NOT COMPLETED|Period 4 (4 Days)||0||
59561384|NCT02242994|75662834|FG000|NOT COMPLETED|Overall Study||0||
59707757|NCT02868034|75826636|FG005|NOT COMPLETED|Overall Study||3||
59707758|NCT02868034|75826637|FG006|NOT COMPLETED|Overall Study||6||
60090502|NCT01839487|76207146|FG004|STARTED|Phase 2 (Maximum Exposure:935 Days)||89||
60090503|NCT01839487|76207147|FG005|STARTED|Phase 2 (Maximum Exposure:935 Days)||44||
60090504|NCT01839487|76207142|FG000|COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0||
60090505|NCT01839487|76207143|FG001|COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0||
60090506|NCT01839487|76207144|FG002|COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0||
60090507|NCT01839487|76207145|FG003|COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0||
60090508|NCT01839487|76207146|FG004|COMPLETED|Phase 2 (Maximum Exposure:935 Days)||1||
60090509|NCT01839487|76207147|FG005|COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0||
60090510|NCT01839487|76207142|FG000|NOT COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0||
60090511|NCT01839487|76207143|FG001|NOT COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0||
60090512|NCT01839487|76207144|FG002|NOT COMPLETED|Phase 2 (Maximum Exposure:935 Days)||61||
60090513|NCT01839487|76207145|FG003|NOT COMPLETED|Phase 2 (Maximum Exposure:935 Days)||62||
60090514|NCT01839487|76207146|FG004|NOT COMPLETED|Phase 2 (Maximum Exposure:935 Days)||88||
60090515|NCT01839487|76207147|FG005|NOT COMPLETED|Phase 2 (Maximum Exposure:935 Days)||44||
60090516|NCT00665470|76207157|FG000|STARTED|Overall Study||10||
60090517|NCT00665470|76207158|FG001|STARTED|Overall Study||0||
60090518|NCT00665470|76207157|FG000|COMPLETED|Overall Study||10||
60090519|NCT00665470|76207158|FG001|COMPLETED|Overall Study||0||
60090520|NCT00665470|76207157|FG000|NOT COMPLETED|Overall Study||0||
60090521|NCT00665470|76207158|FG001|NOT COMPLETED|Overall Study||0||
60090522|NCT00665704|76207164|FG000|STARTED|Overall Study||9||
60090523|NCT00665704|76207164|FG000|COMPLETED|Overall Study||9||
60090524|NCT00665704|76207164|FG000|NOT COMPLETED|Overall Study||0||
60090525|NCT00666406|76207168|FG000|STARTED|First PK Infusion||6||
60090526|NCT00666406|76207169|FG001|STARTED|First PK Infusion||3||
60090527|NCT00666406|76207168|FG000|COMPLETED|First PK Infusion||6||
60090528|NCT00666406|76207169|FG001|COMPLETED|First PK Infusion||3||
60090529|NCT00666406|76207168|FG000|NOT COMPLETED|First PK Infusion||0||
60090530|NCT00666406|76207169|FG001|NOT COMPLETED|First PK Infusion||0||
60090531|NCT00666406|76207168|FG000|STARTED|Second PK Infusion||6||
60090532|NCT00666406|76207169|FG001|STARTED|Second PK Infusion||3||
60090533|NCT00666406|76207168|FG000|COMPLETED|Second PK Infusion||6||
60090534|NCT00666406|76207169|FG001|COMPLETED|Second PK Infusion||3||
60090535|NCT00666406|76207168|FG000|NOT COMPLETED|Second PK Infusion||0||
60090536|NCT00666406|76207169|FG001|NOT COMPLETED|Second PK Infusion||0||
60090537|NCT01799941|76207174|FG000|STARTED|Overall Study||367||
60090538|NCT01799941|76207174|FG000|COMPLETED|Overall Study||271||
60090539|NCT01799941|76207174|FG000|NOT COMPLETED|Overall Study||96||
60090540|NCT00702364|76207186|FG000|STARTED|Overall Study||26||
60090541|NCT00702364|76207187|FG001|STARTED|Overall Study||29||
60090542|NCT00702364|76207186|FG000|COMPLETED|Overall Study||24||
60090543|NCT00702364|76207187|FG001|COMPLETED|Overall Study||25||
60090544|NCT00702364|76207186|FG000|NOT COMPLETED|Overall Study||2||
60090545|NCT00702364|76207187|FG001|NOT COMPLETED|Overall Study||4||
60090546|NCT00667186|76207195|FG000|STARTED|Overall Study||4692||
60090547|NCT00667186|76207196|FG001|STARTED|Overall Study||4880||
60090548|NCT00667186|76207195|FG000|COMPLETED|Overall Study||4692||
60090549|NCT00667186|76207196|FG001|COMPLETED|Overall Study||4880||
60090550|NCT00667186|76207195|FG000|NOT COMPLETED|Overall Study||0||
60090551|NCT00667186|76207196|FG001|NOT COMPLETED|Overall Study||0||
60090552|NCT01799239|76207202|FG000|STARTED|Period 1 (7 Days)|It was uncertain in which order the product were tested for 1 subject. Subject is excl from analysis|15||
60090553|NCT01799239|76207203|FG001|STARTED|Period 1 (7 Days)|It was uncertain in which order the product were tested for 1 subject. Subject is excl from analysis|16||
60090554|NCT01799239|76207202|FG000|COMPLETED|Period 1 (7 Days)||12||
60090555|NCT01799239|76207203|FG001|COMPLETED|Period 1 (7 Days)||15||
60090556|NCT01799239|76207202|FG000|NOT COMPLETED|Period 1 (7 Days)||3||
60090557|NCT01799239|76207203|FG001|NOT COMPLETED|Period 1 (7 Days)||1||
60090558|NCT01799239|76207202|FG000|STARTED|Period 2 (7 Days)||13||
60090559|NCT01799239|76207203|FG001|STARTED|Period 2 (7 Days)||15||
60090560|NCT01799239|76207202|FG000|COMPLETED|Period 2 (7 Days)||11||
60090561|NCT01799239|76207203|FG001|COMPLETED|Period 2 (7 Days)||14||
60090562|NCT01799239|76207202|FG000|NOT COMPLETED|Period 2 (7 Days)||2||
60090563|NCT01799239|76207203|FG001|NOT COMPLETED|Period 2 (7 Days)||1||
60103745|NCT04621227|76222001|FG000|STARTED|Period 5 (1 Day)||14||
60103746|NCT04621227|76222001|FG000|COMPLETED|Period 5 (1 Day)||14||
59707759|NCT02868034|75826638|FG007|NOT COMPLETED|Overall Study||6||
60090564|NCT00713284|76207209|FG000|STARTED|Overall Study|29 participants were screened but only 13 eligible for conversion and continue in the study.|29||
60090565|NCT00713284|76207209|FG000|COMPLETED|Overall Study||13||
60090566|NCT00713284|76207209|FG000|NOT COMPLETED|Overall Study||16||
60090567|NCT00702754|76207213|FG000|STARTED|MYOBLOC Treatment Session 1 (Time 0)||502||
60090568|NCT00702754|76207213|FG000|COMPLETED|MYOBLOC Treatment Session 1 (Time 0)|Approximately 70% of subjects completed at least 2 years of treatment.|495||
60090569|NCT00702754|76207213|FG000|NOT COMPLETED|MYOBLOC Treatment Session 1 (Time 0)||7||
60090570|NCT00702754|76207213|FG000|STARTED|MYOBLOC Treatment Session 2 (App 12 Wks)||495||
60090571|NCT00702754|76207213|FG000|COMPLETED|MYOBLOC Treatment Session 2 (App 12 Wks)||475||
60090572|NCT00702754|76207213|FG000|NOT COMPLETED|MYOBLOC Treatment Session 2 (App 12 Wks)||20||
60090573|NCT00702754|76207213|FG000|STARTED|MYOBLOC Treatment Session 3 (App 24 Wks)||475||
60090574|NCT00702754|76207213|FG000|COMPLETED|MYOBLOC Treatment Session 3 (App 24 Wks)||450||
60090575|NCT00702754|76207213|FG000|NOT COMPLETED|MYOBLOC Treatment Session 3 (App 24 Wks)||25||
60090576|NCT00702754|76207213|FG000|STARTED|MYOBLOC Treatment Session 4 (App 36 Wks)||450||
60090577|NCT00702754|76207213|FG000|COMPLETED|MYOBLOC Treatment Session 4 (App 36 Wks)||428||
60090578|NCT00702754|76207213|FG000|NOT COMPLETED|MYOBLOC Treatment Session 4 (App 36 Wks)||22||
60090579|NCT00702754|76207213|FG000|STARTED|MYOBLOC Treatment Session 5 (App 48 Wks)||428||
60090580|NCT00702754|76207213|FG000|COMPLETED|MYOBLOC Treatment Session 5 (App 48 Wks)||396||
60090581|NCT00702754|76207213|FG000|NOT COMPLETED|MYOBLOC Treatment Session 5 (App 48 Wks)||32||
60090582|NCT00702754|76207213|FG000|STARTED|MYOBLOC Treatment Session 6 (App 60 Wks)||396||
60090583|NCT00702754|76207213|FG000|COMPLETED|MYOBLOC Treatment Session 6 (App 60 Wks)||377||
60090584|NCT00702754|76207213|FG000|NOT COMPLETED|MYOBLOC Treatment Session 6 (App 60 Wks)||19||
60090585|NCT00702754|76207213|FG000|STARTED|MYOBLOC Treatment Session 7 (App 72 Wks)||377||
60090586|NCT00702754|76207213|FG000|COMPLETED|MYOBLOC Treatment Session 7 (App 72 Wks)||353||
60090587|NCT00702754|76207213|FG000|NOT COMPLETED|MYOBLOC Treatment Session 7 (App 72 Wks)||24||
60090588|NCT00702754|76207213|FG000|STARTED|MYOBLOC Treatment Session 8 (App 84 Wks)||353||
60090589|NCT00702754|76207213|FG000|COMPLETED|MYOBLOC Treatment Session 8 (App 84 Wks)||329||
60090590|NCT00702754|76207213|FG000|NOT COMPLETED|MYOBLOC Treatment Session 8 (App 84 Wks)||24||
60090591|NCT02999854|76207219|FG000|STARTED|Active Study Phase (up to 18 Months)||32||
60090592|NCT02999854|76207220|FG001|STARTED|Active Study Phase (up to 18 Months)||31||
60090593|NCT02999854|76207219|FG000|COMPLETED|Active Study Phase (up to 18 Months)||8||
60090594|NCT02999854|76207220|FG001|COMPLETED|Active Study Phase (up to 18 Months)||22||
60090595|NCT02999854|76207219|FG000|NOT COMPLETED|Active Study Phase (up to 18 Months)||24||
60090596|NCT02999854|76207220|FG001|NOT COMPLETED|Active Study Phase (up to 18 Months)||9||
60090597|NCT02999854|76207219|FG000|STARTED|Long Term Safety FU (up to 24 Months)||8||
60090598|NCT02999854|76207220|FG001|STARTED|Long Term Safety FU (up to 24 Months)||22||
60090599|NCT02999854|76207219|FG000|COMPLETED|Long Term Safety FU (up to 24 Months)||5||
60090600|NCT02999854|76207220|FG001|COMPLETED|Long Term Safety FU (up to 24 Months)||19||
60090601|NCT02999854|76207219|FG000|NOT COMPLETED|Long Term Safety FU (up to 24 Months)||3||
60090602|NCT02999854|76207220|FG001|NOT COMPLETED|Long Term Safety FU (up to 24 Months)||3||
60090603|NCT00704938|76207228|FG000|STARTED|Overall Study||2||
60090604|NCT00704938|76207229|FG001|STARTED|Overall Study||1||
60090605|NCT00704938|76207228|FG000|COMPLETED|Overall Study||2||
60090606|NCT00704938|76207229|FG001|COMPLETED|Overall Study||1||
60090607|NCT00704938|76207228|FG000|NOT COMPLETED|Overall Study||0||
60090608|NCT00704938|76207229|FG001|NOT COMPLETED|Overall Study||0||
60090609|NCT00715390|76207235|FG000|STARTED|Overall Study|114,209 Anesthetic records were screened to identify 234 records.|234||
60090610|NCT00715390|76207235|FG000|Eligible|Overall Study||234||
60090611|NCT00715390|76207235|FG000|COMPLETED|Overall Study|These were broken down to different types of dysrhythymia.|234||
60090612|NCT00715390|76207235|FG000|NOT COMPLETED|Overall Study||0||
60090613|NCT00709306|76207243|FG000|STARTED|Overall Study||48||
60090614|NCT00709306|76207244|FG001|STARTED|Overall Study||44||
60090615|NCT00709306|76207245|FG002|STARTED|Overall Study||58||
60090616|NCT00709306|76207246|FG003|STARTED|Overall Study||47||
60090617|NCT00709306|76207243|FG000|COMPLETED|Overall Study||39||
60090618|NCT00709306|76207244|FG001|COMPLETED|Overall Study||30||
60090619|NCT00709306|76207245|FG002|COMPLETED|Overall Study||48||
60090620|NCT00709306|76207246|FG003|COMPLETED|Overall Study||37||
60090621|NCT00709306|76207243|FG000|NOT COMPLETED|Overall Study||9||
60090622|NCT00709306|76207244|FG001|NOT COMPLETED|Overall Study||14||
60090623|NCT00709306|76207245|FG002|NOT COMPLETED|Overall Study||10||
59561385|NCT01933295|75662841|FG000|STARTED|Overall Study||50||
59707760|NCT00982228|75826653|FG000|STARTED|Main: Week 0 to 52 (NN1250-3583)||472||
59707761|NCT00982228|75826654|FG001|STARTED|Main: Week 0 to 52 (NN1250-3583)||157||
59707762|NCT00982228|75826653|FG000|Full Analysis Set|Main: Week 0 to 52 (NN1250-3583)||472||
60090624|NCT00709306|76207246|FG003|NOT COMPLETED|Overall Study||10||
60090625|NCT00725530|76207256|FG000|STARTED|First Intervention, 7 Days (+0/-1)||27||
60090626|NCT00725530|76207257|FG001|STARTED|First Intervention, 7 Days (+0/-1)||27||
60090627|NCT00725530|76207256|FG000|COMPLETED|First Intervention, 7 Days (+0/-1)||27||
60090628|NCT00725530|76207257|FG001|COMPLETED|First Intervention, 7 Days (+0/-1)||27||
60090629|NCT00725530|76207256|FG000|NOT COMPLETED|First Intervention, 7 Days (+0/-1)||0||
60090630|NCT00725530|76207257|FG001|NOT COMPLETED|First Intervention, 7 Days (+0/-1)||0||
60090631|NCT00725530|76207256|FG000|STARTED|Second Intervention, 7 Days (+0/-1)||27||
60090632|NCT00725530|76207257|FG001|STARTED|Second Intervention, 7 Days (+0/-1)||27||
60090633|NCT00725530|76207256|FG000|COMPLETED|Second Intervention, 7 Days (+0/-1)||27||
60090634|NCT00725530|76207257|FG001|COMPLETED|Second Intervention, 7 Days (+0/-1)||27||
60090635|NCT00725530|76207256|FG000|NOT COMPLETED|Second Intervention, 7 Days (+0/-1)||0||
60090636|NCT00725530|76207257|FG001|NOT COMPLETED|Second Intervention, 7 Days (+0/-1)||0||
60090637|NCT00727636|76207265|FG000|STARTED|Overall Study||37||
60090638|NCT00727636|76207266|FG001|STARTED|Overall Study||15||
60090639|NCT00727636|76207265|FG000|COMPLETED|Overall Study||33||
60090640|NCT00727636|76207266|FG001|COMPLETED|Overall Study||15||
60090641|NCT00727636|76207265|FG000|NOT COMPLETED|Overall Study||4||
60090642|NCT00727636|76207266|FG001|NOT COMPLETED|Overall Study||0||
60090643|NCT00709696|76207274|FG000|STARTED|Overall Study||4||
60090644|NCT00709696|76207275|FG001|STARTED|Overall Study||3||
60090645|NCT00709696|76207274|FG000|COMPLETED|Overall Study||4||
60090646|NCT00709696|76207275|FG001|COMPLETED|Overall Study||3||
60090647|NCT00709696|76207274|FG000|NOT COMPLETED|Overall Study||0||
60090648|NCT00709696|76207275|FG001|NOT COMPLETED|Overall Study||0||
60090649|NCT00710944|76207284|FG000|STARTED|Overall Study||55||
60090650|NCT00710944|76207285|FG001|STARTED|Overall Study||58||
59816851|NCT03730194|75939242|FG003|COMPLETED|First Stage Treatment||0|"This study utilizes a SMART Design.~1 participant from the Melatonin Only group withdrew from the study. 1 participant from the Bedtime Bank Only group withdrew from the study.~3 participants in the Melatonin Only group & 3 participants in the Bedtime Bank Only group did not complete all study requirements (e.g., minimum actigraph days). These 6 participants remained in the pilot SMART study (did not want to withdraw), and repeated there assigned treatment in the Second Stage."|
59817927|NCT04488770|75940327|FG001|COMPLETED|Part 1-Cohort 2: Period 2 (Up to 5 Days)||0||
59817928|NCT04488770|75940328|FG002|COMPLETED|Part 1-Cohort 2: Period 2 (Up to 5 Days)||0||
59817929|NCT04488770|75940329|FG003|COMPLETED|Part 1-Cohort 2: Period 2 (Up to 5 Days)||0||
60090651|NCT00710944|76207286|FG002|STARTED|Overall Study||19||
60090652|NCT00710944|76207284|FG000|COMPLETED|Overall Study||45||
60090653|NCT00710944|76207285|FG001|COMPLETED|Overall Study||49||
60090654|NCT00710944|76207286|FG002|COMPLETED|Overall Study||17||
60090655|NCT00710944|76207284|FG000|NOT COMPLETED|Overall Study||10||
60090656|NCT00710944|76207285|FG001|NOT COMPLETED|Overall Study||9||
60090657|NCT00710944|76207286|FG002|NOT COMPLETED|Overall Study||2||
60090658|NCT00728260|76207294|FG000|STARTED|Overall Study||1421||
60090659|NCT00728260|76207294|FG000|COMPLETED|Overall Study||1421||
60090660|NCT00728260|76207294|FG000|NOT COMPLETED|Overall Study||0||
60090661|NCT00711022|76207298|FG000|STARTED|Overall Study||51||
60090662|NCT00711022|76207298|FG000|COMPLETED|Overall Study||40||
60090663|NCT00711022|76207298|FG000|NOT COMPLETED|Overall Study||11||
60090664|NCT00728728|76207304|FG000|STARTED|Overall Study||42||
60090665|NCT00728728|76207305|FG001|STARTED|Overall Study||46||
60090666|NCT00728728|76207304|FG000|COMPLETED|Overall Study||38||
60090667|NCT00728728|76207305|FG001|COMPLETED|Overall Study||34||
60090668|NCT00728728|76207304|FG000|NOT COMPLETED|Overall Study||4||
60090669|NCT00728728|76207305|FG001|NOT COMPLETED|Overall Study||12||
60090670|NCT00717418|76207316|FG000|STARTED|Baseline||180||
60090671|NCT00717418|76207317|FG001|STARTED|Baseline||74||
60090672|NCT00717418|76207318|FG002|STARTED|Baseline||508||
60090673|NCT00717418|76207319|FG003|STARTED|Baseline||19||
60090674|NCT00717418|76207316|FG000|COMPLETED|Baseline||180||
60090675|NCT00717418|76207317|FG001|COMPLETED|Baseline||74||
60090676|NCT00717418|76207318|FG002|COMPLETED|Baseline||508||
60090677|NCT00717418|76207319|FG003|COMPLETED|Baseline||4||
60090678|NCT00717418|76207316|FG000|NOT COMPLETED|Baseline||0||
60090679|NCT00717418|76207317|FG001|NOT COMPLETED|Baseline||0||
60090680|NCT00717418|76207318|FG002|NOT COMPLETED|Baseline||0||
60090681|NCT00717418|76207319|FG003|NOT COMPLETED|Baseline||15||
60090682|NCT00717418|76207316|FG000|STARTED|1-Year Follow-Up||180||
60090683|NCT00717418|76207317|FG001|STARTED|1-Year Follow-Up||74||
60090684|NCT00717418|76207318|FG002|STARTED|1-Year Follow-Up||508||
60090685|NCT00717418|76207319|FG003|STARTED|1-Year Follow-Up||4||
60090686|NCT00717418|76207316|FG000|COMPLETED|1-Year Follow-Up||33||
60090687|NCT00717418|76207317|FG001|COMPLETED|1-Year Follow-Up||23||
60090688|NCT00717418|76207318|FG002|COMPLETED|1-Year Follow-Up||74||
60090689|NCT00717418|76207319|FG003|COMPLETED|1-Year Follow-Up||0||
60090690|NCT00717418|76207316|FG000|NOT COMPLETED|1-Year Follow-Up||147||
60090691|NCT00717418|76207317|FG001|NOT COMPLETED|1-Year Follow-Up||51||
60090692|NCT00717418|76207318|FG002|NOT COMPLETED|1-Year Follow-Up||434||
60090693|NCT00717418|76207319|FG003|NOT COMPLETED|1-Year Follow-Up||4||
60090694|NCT00717574|76207325|FG000|STARTED|Overall Study||16||
60090695|NCT00717574|76207326|FG001|STARTED|Overall Study||16||
60090696|NCT00717574|76207325|FG000|COMPLETED|Overall Study||14||
60090697|NCT00717574|76207326|FG001|COMPLETED|Overall Study||14||
60090698|NCT00717574|76207325|FG000|NOT COMPLETED|Overall Study||2||
60090699|NCT00717574|76207326|FG001|NOT COMPLETED|Overall Study||2||
60090700|NCT00718120|76207334|FG000|STARTED|Overall Study||55||
60090701|NCT00718120|76207335|FG001|STARTED|Overall Study||55||
60090702|NCT00718120|76207334|FG000|COMPLETED|Overall Study||55||
60090703|NCT00718120|76207335|FG001|COMPLETED|Overall Study||55||
60090704|NCT00718120|76207334|FG000|NOT COMPLETED|Overall Study||0||
60090705|NCT00718120|76207335|FG001|NOT COMPLETED|Overall Study||0||
60090706|NCT00719134|76207341|FG000|STARTED|Overall Study||76||
60090707|NCT00719134|76207341|FG000|COMPLETED|Overall Study||66||
60090708|NCT00719134|76207341|FG000|NOT COMPLETED|Overall Study||10||
60090709|NCT04146363|76207348|FG000|STARTED|Induction Period||141||
60090710|NCT04146363|76207349|FG001|STARTED|Induction Period||283||
60090711|NCT04146363|76207350|FG002|STARTED|Induction Period||0||
60090712|NCT04146363|76207351|FG003|STARTED|Induction Period||0||
60090713|NCT04146363|76207352|FG004|STARTED|Induction Period||0||
60090714|NCT04146363|76207353|FG005|STARTED|Induction Period||0||
60090715|NCT04146363|76207354|FG006|STARTED|Induction Period||0||
60090716|NCT04146363|76207355|FG007|STARTED|Induction Period||0||
60090717|NCT04146363|76207356|FG008|STARTED|Induction Period||0||
60090718|NCT04146363|76207357|FG009|STARTED|Induction Period||0||
60090719|NCT04146363|76207358|FG010|STARTED|Induction Period||0||
60090720|NCT04146363|76207348|FG000|Received at Least One Dose of Study Drug|Induction Period||141||
60090721|NCT04146363|76207349|FG001|Received at Least One Dose of Study Drug|Induction Period||282||
60090722|NCT04146363|76207350|FG002|Received at Least One Dose of Study Drug|Induction Period||0||
60090723|NCT04146363|76207351|FG003|Received at Least One Dose of Study Drug|Induction Period||0||
60090724|NCT04146363|76207352|FG004|Received at Least One Dose of Study Drug|Induction Period||0||
60090725|NCT04146363|76207353|FG005|Received at Least One Dose of Study Drug|Induction Period||0||
60090726|NCT04146363|76207354|FG006|Received at Least One Dose of Study Drug|Induction Period||0||
60090727|NCT04146363|76207355|FG007|Received at Least One Dose of Study Drug|Induction Period||0||
60090728|NCT04146363|76207356|FG008|Received at Least One Dose of Study Drug|Induction Period||0||
60090729|NCT04146363|76207357|FG009|Received at Least One Dose of Study Drug|Induction Period||0||
60090730|NCT04146363|76207358|FG010|Received at Least One Dose of Study Drug|Induction Period||0||
60090731|NCT04146363|76207348|FG000|COMPLETED|Induction Period|Completed includes Responders n=24; Nonresponders n=96|120||
60090732|NCT04146363|76207349|FG001|COMPLETED|Induction Period|Completed includes Responders n=157; Nonresponders n=106|263||
60090733|NCT04146363|76207350|FG002|COMPLETED|Induction Period||0||
60090734|NCT04146363|76207351|FG003|COMPLETED|Induction Period||0||
60090735|NCT04146363|76207352|FG004|COMPLETED|Induction Period||0||
60090736|NCT04146363|76207353|FG005|COMPLETED|Induction Period||0||
60090737|NCT04146363|76207354|FG006|COMPLETED|Induction Period||0||
60090738|NCT04146363|76207355|FG007|COMPLETED|Induction Period||0||
60090739|NCT04146363|76207356|FG008|COMPLETED|Induction Period||0||
60090740|NCT04146363|76207357|FG009|COMPLETED|Induction Period||0||
60090741|NCT04146363|76207358|FG010|COMPLETED|Induction Period||0||
60090742|NCT04146363|76207348|FG000|NOT COMPLETED|Induction Period||21||
60090743|NCT04146363|76207349|FG001|NOT COMPLETED|Induction Period||20||
60090744|NCT04146363|76207350|FG002|NOT COMPLETED|Induction Period||0||
60090745|NCT04146363|76207351|FG003|NOT COMPLETED|Induction Period||0||
60090746|NCT04146363|76207352|FG004|NOT COMPLETED|Induction Period||0||
60090747|NCT04146363|76207353|FG005|NOT COMPLETED|Induction Period||0||
60090748|NCT04146363|76207354|FG006|NOT COMPLETED|Induction Period||0||
60090749|NCT04146363|76207355|FG007|NOT COMPLETED|Induction Period||0||
60090750|NCT04146363|76207356|FG008|NOT COMPLETED|Induction Period||0||
60090751|NCT04146363|76207357|FG009|NOT COMPLETED|Induction Period||0||
60090752|NCT04146363|76207358|FG010|NOT COMPLETED|Induction Period||0||
60090753|NCT04146363|76207348|FG000|STARTED|Maintenance Blinded Treatment Period|Participants were assigned to this arm only during Induction Period.|0||
59992934|NCT01865617|76108756|FG005|COMPLETED|Overall Study||4||
60090754|NCT04146363|76207349|FG001|STARTED|Maintenance Blinded Treatment Period|Participants were assigned to this arm only during Induction Period.|0||
60090755|NCT04146363|76207350|FG002|STARTED|Maintenance Blinded Treatment Period|Participants who responded to treatment, defined as and IGA of 0 or 1 or a 75% reduction in EASI from baseline to Week 16 entered the Maintenance Period and re-randomized to the following treatment groups: lebrikizumab 250 mg Q2W, lebrikizumab 250 mg Q4W, or placebo Q2W.|4||
60090756|NCT04146363|76207351|FG003|STARTED|Maintenance Blinded Treatment Period|Participants who responded to treatment, defined as and IGA of 0 or 1 or a 75% reduction in EASI from baseline to Week 16 entered the Maintenance Period and re-randomized to the following treatment groups: lebrikizumab 250 mg Q2W, lebrikizumab 250 mg Q4W, or placebo Q2W.|10||
60090757|NCT04146363|76207352|FG004|STARTED|Maintenance Blinded Treatment Period|Participants who responded to treatment, defined as and IGA of 0 or 1 or a 75% reduction in EASI from baseline to Week 16 entered the Maintenance Period and re-randomized to the following treatment groups: lebrikizumab 250 mg Q2W, lebrikizumab 250 mg Q4W, or placebo Q2W.|10||
60090758|NCT04146363|76207353|FG005|STARTED|Maintenance Blinded Treatment Period|Participants who responded to treatment, defined as and IGA of 0 or 1 or a 75% reduction in EASI from baseline to Week 16 entered the Maintenance Period and re-randomized to the following treatment groups: lebrikizumab 250 mg Q2W, lebrikizumab 250 mg Q4W, or placebo Q2W.|32||
60090759|NCT04146363|76207354|FG006|STARTED|Maintenance Blinded Treatment Period|Participants who responded to treatment, defined as and IGA of 0 or 1 or a 75% reduction in EASI from baseline to Week 16 entered the Maintenance Period and re-randomized to the following treatment groups: lebrikizumab 250 mg Q2W, lebrikizumab 250 mg Q4W, or placebo Q2W.|63||
60103747|NCT04621227|76222001|FG000|NOT COMPLETED|Period 5 (1 Day)||0||
60103748|NCT04621227|76222001|FG000|STARTED|Period 6 (16 Days)||14||
60103749|NCT04621227|76222001|FG000|COMPLETED|Period 6 (16 Days)||14||
59561386|NCT01933295|75662842|FG001|STARTED|Overall Study||52||
59561387|NCT01933295|75662843|FG002|STARTED|Overall Study||52||
59561388|NCT01933295|75662841|FG000|COMPLETED|Overall Study||43||
59561389|NCT01933295|75662842|FG001|COMPLETED|Overall Study||41||
59561390|NCT01933295|75662843|FG002|COMPLETED|Overall Study||42||
59561391|NCT01933295|75662841|FG000|NOT COMPLETED|Overall Study||7||
59561392|NCT01933295|75662842|FG001|NOT COMPLETED|Overall Study||11||
59561393|NCT01933295|75662843|FG002|NOT COMPLETED|Overall Study||10||
59561394|NCT03425097|75662853|FG000|STARTED|Treatment Period 1 (2 Weeks)||6||
59707763|NCT00982228|75826654|FG001|Full Analysis Set|Main: Week 0 to 52 (NN1250-3583)||157||
59707764|NCT00982228|75826653|FG000|Exposed|Main: Week 0 to 52 (NN1250-3583)||472||
59707765|NCT00982228|75826654|FG001|Exposed|Main: Week 0 to 52 (NN1250-3583)|Three subjects withdrew prior to exposure to trial drug|154||
59992935|NCT01865617|76108757|FG006|COMPLETED|Overall Study||10||
59992936|NCT01865617|76108758|FG007|COMPLETED|Overall Study||0||
59992937|NCT01865617|76108759|FG008|COMPLETED|Overall Study||9||
59992938|NCT01865617|76108760|FG009|COMPLETED|Overall Study||2||
59992939|NCT01865617|76108761|FG010|COMPLETED|Overall Study||17||
59992940|NCT01865617|76108762|FG011|COMPLETED|Overall Study||4||
59561395|NCT03425097|75662854|FG001|STARTED|Treatment Period 1 (2 Weeks)||5||
59707766|NCT00982228|75826653|FG000|COMPLETED|Main: Week 0 to 52 (NN1250-3583)||404||
59992941|NCT01865617|76108763|FG012|COMPLETED|Overall Study||7||
59992942|NCT01865617|76108751|FG000|NOT COMPLETED|Overall Study||30||
59992943|NCT01865617|76108752|FG001|NOT COMPLETED|Overall Study||3||
59992944|NCT01865617|76108753|FG002|NOT COMPLETED|Overall Study||1||
59992945|NCT01865617|76108754|FG003|NOT COMPLETED|Overall Study||1||
59992946|NCT01865617|76108755|FG004|NOT COMPLETED|Overall Study||7||
59992947|NCT01865617|76108756|FG005|NOT COMPLETED|Overall Study||1||
59992948|NCT01865617|76108757|FG006|NOT COMPLETED|Overall Study||12||
59992949|NCT01865617|76108758|FG007|NOT COMPLETED|Overall Study||1||
59992950|NCT01865617|76108759|FG008|NOT COMPLETED|Overall Study||11||
59992951|NCT01865617|76108760|FG009|NOT COMPLETED|Overall Study||3||
59992952|NCT01865617|76108761|FG010|NOT COMPLETED|Overall Study||32||
59992953|NCT01865617|76108762|FG011|NOT COMPLETED|Overall Study||6||
59992954|NCT01865617|76108763|FG012|NOT COMPLETED|Overall Study||13||
59992955|NCT02458313|76108796|FG000|STARTED|Overall Study||30||
59992956|NCT02458313|76108797|FG001|STARTED|Overall Study||31||
59992957|NCT02458313|76108796|FG000|COMPLETED|Overall Study||23||
59992958|NCT02458313|76108797|FG001|COMPLETED|Overall Study||21||
59992959|NCT02458313|76108796|FG000|NOT COMPLETED|Overall Study||7||
59992960|NCT02458313|76108797|FG001|NOT COMPLETED|Overall Study||10||
59992961|NCT02322593|76108805|FG000|STARTED|Overall Study||356||
60090760|NCT04146363|76207355|FG007|STARTED|Maintenance Blinded Treatment Period|Participants who responded to treatment, defined as and IGA of 0 or 1 or a 75% reduction in EASI from baseline to Week 16 entered the Maintenance Period and re-randomized to the following treatment groups: lebrikizumab 250 mg Q2W, lebrikizumab 250 mg Q4W, or placebo Q2W.|62||
60090761|NCT04146363|76207356|FG008|STARTED|Maintenance Blinded Treatment Period||0||
60090762|NCT04146363|76207357|FG009|STARTED|Maintenance Blinded Treatment Period||0||
60090763|NCT04146363|76207358|FG010|STARTED|Maintenance Blinded Treatment Period||0||
60090764|NCT04146363|76207348|FG000|COMPLETED|Maintenance Blinded Treatment Period||0||
60090765|NCT04146363|76207349|FG001|COMPLETED|Maintenance Blinded Treatment Period||0||
60090766|NCT04146363|76207350|FG002|COMPLETED|Maintenance Blinded Treatment Period||2||
60090767|NCT04146363|76207351|FG003|COMPLETED|Maintenance Blinded Treatment Period||10||
60090768|NCT04146363|76207352|FG004|COMPLETED|Maintenance Blinded Treatment Period||9||
60090769|NCT04146363|76207353|FG005|COMPLETED|Maintenance Blinded Treatment Period||22||
60090770|NCT04146363|76207354|FG006|COMPLETED|Maintenance Blinded Treatment Period||54||
60090771|NCT04146363|76207355|FG007|COMPLETED|Maintenance Blinded Treatment Period||48||
60090772|NCT04146363|76207356|FG008|COMPLETED|Maintenance Blinded Treatment Period||0||
60090773|NCT04146363|76207357|FG009|COMPLETED|Maintenance Blinded Treatment Period||0||
60090774|NCT04146363|76207358|FG010|COMPLETED|Maintenance Blinded Treatment Period||0||
60090775|NCT04146363|76207348|FG000|NOT COMPLETED|Maintenance Blinded Treatment Period||0||
60090776|NCT04146363|76207349|FG001|NOT COMPLETED|Maintenance Blinded Treatment Period||0||
60090777|NCT04146363|76207350|FG002|NOT COMPLETED|Maintenance Blinded Treatment Period||2||
60090778|NCT04146363|76207351|FG003|NOT COMPLETED|Maintenance Blinded Treatment Period||0||
60090779|NCT04146363|76207352|FG004|NOT COMPLETED|Maintenance Blinded Treatment Period||1||
60090780|NCT04146363|76207353|FG005|NOT COMPLETED|Maintenance Blinded Treatment Period||10||
60090781|NCT04146363|76207354|FG006|NOT COMPLETED|Maintenance Blinded Treatment Period||9||
60090782|NCT04146363|76207355|FG007|NOT COMPLETED|Maintenance Blinded Treatment Period||14||
60090783|NCT04146363|76207356|FG008|NOT COMPLETED|Maintenance Blinded Treatment Period||0||
60090784|NCT04146363|76207357|FG009|NOT COMPLETED|Maintenance Blinded Treatment Period||0||
60090785|NCT04146363|76207358|FG010|NOT COMPLETED|Maintenance Blinded Treatment Period||0||
60090786|NCT04146363|76207348|FG000|STARTED|Maintenance Open Label Escape Arm||0||
60090787|NCT04146363|76207349|FG001|STARTED|Maintenance Open Label Escape Arm||0||
60090788|NCT04146363|76207350|FG002|STARTED|Maintenance Open Label Escape Arm|Maintenance period responders did not enter Maintenance Open Label Escape Arm.|0||
60090789|NCT04146363|76207351|FG003|STARTED|Maintenance Open Label Escape Arm|Maintenance period responders did not enter Maintenance Open Label Escape Arm.|0||
60090790|NCT04146363|76207352|FG004|STARTED|Maintenance Open Label Escape Arm|Maintenance period responders did not enter Maintenance Open Label Escape Arm.|0||
60090791|NCT04146363|76207353|FG005|STARTED|Maintenance Open Label Escape Arm|Maintenance period responders did not enter Maintenance Open Label Escape Arm.|0||
60090792|NCT04146363|76207354|FG006|STARTED|Maintenance Open Label Escape Arm|Maintenance period responders did not enter Maintenance Open Label Escape Arm.|0||
60090793|NCT04146363|76207355|FG007|STARTED|Maintenance Open Label Escape Arm|Maintenance period responders did not enter Maintenance Open Label Escape Arm.|0||
60090794|NCT04146363|76207356|FG008|STARTED|Maintenance Open Label Escape Arm|Only participants who did not achieve an IGA score of 0 or 1 nor an EASI-75 at Week 16 or who received any rescue therapy between Baseline to Week 16 were assigned to an Escape Arm at Week 16.|96||
60090795|NCT04146363|76207357|FG009|STARTED|Maintenance Open Label Escape Arm|Only participants who did not achieve an IGA score of 0 or 1 nor an EASI-75 at Week 16 or who received any rescue therapy between Baseline to Week 16 were assigned to an Escape Arm at Week 16.|106||
60090796|NCT04146363|76207358|FG010|STARTED|Maintenance Open Label Escape Arm|Following rerandomization at Week 16, participants not maintaining an EASI 50 response at Weeks 24, 32, 40, or 48 were assigned to an Escape Arm and received open label lebrikizumab 250 mg Q2W through Week 52.|18||
60090797|NCT04146363|76207348|FG000|COMPLETED|Maintenance Open Label Escape Arm||0||
60090798|NCT04146363|76207349|FG001|COMPLETED|Maintenance Open Label Escape Arm||0||
60090799|NCT04146363|76207350|FG002|COMPLETED|Maintenance Open Label Escape Arm||0||
60090800|NCT04146363|76207351|FG003|COMPLETED|Maintenance Open Label Escape Arm||0||
60090801|NCT04146363|76207352|FG004|COMPLETED|Maintenance Open Label Escape Arm||0||
60090802|NCT04146363|76207353|FG005|COMPLETED|Maintenance Open Label Escape Arm||0||
60090803|NCT04146363|76207354|FG006|COMPLETED|Maintenance Open Label Escape Arm||0||
60090804|NCT04146363|76207355|FG007|COMPLETED|Maintenance Open Label Escape Arm||0||
60090805|NCT04146363|76207356|FG008|COMPLETED|Maintenance Open Label Escape Arm||77||
60090806|NCT04146363|76207357|FG009|COMPLETED|Maintenance Open Label Escape Arm||77||
60090807|NCT04146363|76207358|FG010|COMPLETED|Maintenance Open Label Escape Arm||15||
59561396|NCT03425097|75662853|FG000|COMPLETED|Treatment Period 1 (2 Weeks)||6||
59561397|NCT03425097|75662854|FG001|COMPLETED|Treatment Period 1 (2 Weeks)||5||
59561398|NCT03425097|75662853|FG000|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0||
59561399|NCT03425097|75662854|FG001|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0||
60090808|NCT04146363|76207348|FG000|NOT COMPLETED|Maintenance Open Label Escape Arm||0||
60090809|NCT04146363|76207349|FG001|NOT COMPLETED|Maintenance Open Label Escape Arm||0||
60090810|NCT04146363|76207350|FG002|NOT COMPLETED|Maintenance Open Label Escape Arm||0||
60090811|NCT04146363|76207351|FG003|NOT COMPLETED|Maintenance Open Label Escape Arm||0||
59561400|NCT03425097|75662853|FG000|STARTED|Washout Period (1 Week)||6||
59561401|NCT03425097|75662854|FG001|STARTED|Washout Period (1 Week)||5||
60090812|NCT04146363|76207352|FG004|NOT COMPLETED|Maintenance Open Label Escape Arm||0||
60090813|NCT04146363|76207353|FG005|NOT COMPLETED|Maintenance Open Label Escape Arm||0||
60090814|NCT04146363|76207354|FG006|NOT COMPLETED|Maintenance Open Label Escape Arm||0||
60090815|NCT04146363|76207355|FG007|NOT COMPLETED|Maintenance Open Label Escape Arm||0||
60090816|NCT04146363|76207356|FG008|NOT COMPLETED|Maintenance Open Label Escape Arm||19||
60090817|NCT04146363|76207357|FG009|NOT COMPLETED|Maintenance Open Label Escape Arm||29||
60090818|NCT04146363|76207358|FG010|NOT COMPLETED|Maintenance Open Label Escape Arm||3||
60090819|NCT00721162|76207379|FG000|STARTED|Overall Study||60||
60090820|NCT00721162|76207379|FG000|Received Any Amount of Study Drug|Overall Study||60||
60090821|NCT00721162|76207379|FG000|COMPLETED|Overall Study||60||
60090822|NCT00721162|76207379|FG000|NOT COMPLETED|Overall Study||0||
60090823|NCT01838941|76207383|FG000|STARTED|Overall Study||12||
60090824|NCT01838941|76207383|FG000|COMPLETED|Overall Study||10||
60090825|NCT01838941|76207383|FG000|NOT COMPLETED|Overall Study||2||
60090826|NCT01773109|76207388|FG000|STARTED|Overall Study||40||
60090827|NCT01773109|76207388|FG000|COMPLETED|Overall Study||37||
60090828|NCT01773109|76207388|FG000|NOT COMPLETED|Overall Study||3||
60090829|NCT01772719|76207392|FG000|STARTED|Overall Study||7||
60090830|NCT01772719|76207392|FG000|COMPLETED|Overall Study||0||
60090831|NCT01772719|76207392|FG000|NOT COMPLETED|Overall Study||7||
60090832|NCT01798927|76207399|FG000|STARTED|Overall Study||4||
60090833|NCT01798927|76207399|FG000|COMPLETED|Overall Study||3||
60090834|NCT01798927|76207399|FG000|NOT COMPLETED|Overall Study||1||
60090835|NCT00729430|76207405|FG000|STARTED|Overall Study||180||
60090836|NCT00729430|76207406|FG001|STARTED|Overall Study||178||
60090837|NCT00729430|76207405|FG000|COMPLETED|Overall Study||133||
60090838|NCT00729430|76207406|FG001|COMPLETED|Overall Study||128||
60090839|NCT00729430|76207405|FG000|NOT COMPLETED|Overall Study||47||
60090840|NCT00729430|76207406|FG001|NOT COMPLETED|Overall Study||50||
60090841|NCT00722020|76207415|FG000|STARTED|Overall Study||19||
60090842|NCT00722020|76207416|FG001|STARTED|Overall Study||24||
60090843|NCT00722020|76207415|FG000|COMPLETED|Overall Study||19||
60090844|NCT00722020|76207416|FG001|COMPLETED|Overall Study||24||
60090845|NCT00722020|76207415|FG000|NOT COMPLETED|Overall Study||0||
60090846|NCT00722020|76207416|FG001|NOT COMPLETED|Overall Study||0||
60090847|NCT00730522|76207426|FG000|STARTED|Overall Study||28||
60090848|NCT00730522|76207427|FG001|STARTED|Overall Study||27||
60090849|NCT00730522|76207426|FG000|COMPLETED|Overall Study||28||
60090850|NCT00730522|76207427|FG001|COMPLETED|Overall Study||27||
60090851|NCT00730522|76207426|FG000|NOT COMPLETED|Overall Study||0||
60090852|NCT00730522|76207427|FG001|NOT COMPLETED|Overall Study||0||
60090853|NCT00731614|76207437|FG000|STARTED|Overall Study||23||
60090854|NCT00731614|76207438|FG001|STARTED|Overall Study||31||
60090855|NCT00731614|76207437|FG000|End of Treatment|Overall Study||16||
60090856|NCT00731614|76207438|FG001|End of Treatment|Overall Study||24||
60090857|NCT00731614|76207437|FG000|12 Weeks Posttreatment|Overall Study||18||
60090858|NCT00731614|76207438|FG001|12 Weeks Posttreatment|Overall Study||23||
60090859|NCT00731614|76207437|FG000|COMPLETED|Overall Study||16||
60090860|NCT00731614|76207438|FG001|COMPLETED|Overall Study||18||
60090861|NCT00731614|76207437|FG000|NOT COMPLETED|Overall Study||7||
60090862|NCT00731614|76207438|FG001|NOT COMPLETED|Overall Study||13||
60090863|NCT00733096|76207447|FG000|STARTED|Overall Study||28||
60090864|NCT00733096|76207448|FG001|STARTED|Overall Study||26||
59707767|NCT00982228|75826654|FG001|COMPLETED|Main: Week 0 to 52 (NN1250-3583)||137||
60090865|NCT00733096|76207449|FG002|STARTED|Overall Study||30||
60090866|NCT00733096|76207447|FG000|COMPLETED|Overall Study||28||
60090867|NCT00733096|76207448|FG001|COMPLETED|Overall Study||26||
60090868|NCT00733096|76207449|FG002|COMPLETED|Overall Study||30||
59707768|NCT00982228|75826653|FG000|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3583)||68||
60090869|NCT00733096|76207447|FG000|NOT COMPLETED|Overall Study||0||
60090870|NCT00733096|76207448|FG001|NOT COMPLETED|Overall Study||0||
60090871|NCT00733096|76207449|FG002|NOT COMPLETED|Overall Study||0||
60090872|NCT00733330|76207459|FG000|STARTED|Overall Study||32||
60090873|NCT00733330|76207460|FG001|STARTED|Overall Study||52||
59561402|NCT03425097|75662853|FG000|COMPLETED|Washout Period (1 Week)||6||
60090874|NCT00733330|76207459|FG000|COMPLETED|Overall Study||30||
60090875|NCT00733330|76207460|FG001|COMPLETED|Overall Study||48||
60090876|NCT00733330|76207459|FG000|NOT COMPLETED|Overall Study||2||
60090877|NCT00733330|76207460|FG001|NOT COMPLETED|Overall Study||4||
60090878|NCT01276288|76207468|FG000|STARTED|Overall Study||7||
60090879|NCT01276288|76207469|FG001|STARTED|Overall Study||6||
60090880|NCT01276288|76207470|FG002|STARTED|Overall Study||5||
60090881|NCT01276288|76207471|FG003|STARTED|Overall Study||5||
60090882|NCT01276288|76207468|FG000|Received EMPA|Overall Study||6||
60090883|NCT01276288|76207469|FG001|Received EMPA|Overall Study||5||
60090884|NCT01276288|76207470|FG002|Received EMPA|Overall Study||5||
60090885|NCT01276288|76207471|FG003|Received EMPA|Overall Study||5||
60090886|NCT01276288|76207468|FG000|Received EMPA+HCT|Overall Study||5||
60090887|NCT01276288|76207469|FG001|Received EMPA+HCT|Overall Study||5||
60090888|NCT01276288|76207470|FG002|Received EMPA+HCT|Overall Study||0||
60090889|NCT01276288|76207471|FG003|Received EMPA+HCT|Overall Study||0||
60090890|NCT01276288|76207468|FG000|Received EMPA+TOR|Overall Study||0||
60090891|NCT01276288|76207469|FG001|Received EMPA+TOR|Overall Study||0||
60090892|NCT01276288|76207470|FG002|Received EMPA+TOR|Overall Study||5||
60090893|NCT01276288|76207471|FG003|Received EMPA+TOR|Overall Study||5||
60090894|NCT01276288|76207468|FG000|COMPLETED|Overall Study||5||
60090895|NCT01276288|76207469|FG001|COMPLETED|Overall Study||5||
60090896|NCT01276288|76207470|FG002|COMPLETED|Overall Study||5||
60090897|NCT01276288|76207471|FG003|COMPLETED|Overall Study||5||
60090898|NCT01276288|76207468|FG000|NOT COMPLETED|Overall Study||2||
60090899|NCT01276288|76207469|FG001|NOT COMPLETED|Overall Study||1||
60090900|NCT01276288|76207470|FG002|NOT COMPLETED|Overall Study||0||
60090901|NCT01276288|76207471|FG003|NOT COMPLETED|Overall Study||0||
60090902|NCT02702271|76207495|FG000|STARTED|Overall Study||400||
60090903|NCT02702271|76207496|FG001|STARTED|Overall Study||58||
60090904|NCT02702271|76207495|FG000|COMPLETED|Overall Study||337||
60090905|NCT02702271|76207496|FG001|COMPLETED|Overall Study||49||
60090906|NCT02702271|76207495|FG000|NOT COMPLETED|Overall Study||63||
60090907|NCT02702271|76207496|FG001|NOT COMPLETED|Overall Study||9||
60090908|NCT00722566|76207504|FG000|STARTED|Overall Study|One patient randomized and not dosed|148||
60090909|NCT00722566|76207505|FG001|STARTED|Overall Study||74||
60090910|NCT00722566|76207504|FG000|COMPLETED|Overall Study|Completed 8 cycles|81||
60090911|NCT00722566|76207505|FG001|COMPLETED|Overall Study|Completed 8 cycles|39||
60090912|NCT00722566|76207504|FG000|NOT COMPLETED|Overall Study||67||
60090913|NCT00722566|76207505|FG001|NOT COMPLETED|Overall Study||35||
60090914|NCT00722722|76207516|FG000|STARTED|Overall Study||3||
60090915|NCT00722722|76207517|FG001|STARTED|Overall Study||5||
60090916|NCT00722722|76207518|FG002|STARTED|Overall Study||10||
60090917|NCT00722722|76207516|FG000|COMPLETED|Overall Study||3||
60090918|NCT00722722|76207517|FG001|COMPLETED|Overall Study||5||
60090919|NCT00722722|76207518|FG002|COMPLETED|Overall Study||10||
60090920|NCT00722722|76207516|FG000|NOT COMPLETED|Overall Study||0||
60090921|NCT00722722|76207517|FG001|NOT COMPLETED|Overall Study||0||
60090922|NCT00722722|76207518|FG002|NOT COMPLETED|Overall Study||0||
60090923|NCT00723580|76207526|FG000|STARTED|Overall Study|Study was extended with continued repeated measurements.|1||
60090924|NCT00723580|76207526|FG000|Baseline Measurements|Overall Study|Actigraphic, Psychometric and Observational Baseline Data Collected.|1||
60090925|NCT00723580|76207526|FG000|COMPLETED|Overall Study|Completion of repeated Measurements|1||
60090926|NCT00723580|76207526|FG000|NOT COMPLETED|Overall Study||0||
60090927|NCT00734344|76207532|FG000|STARTED|Overall Study||9||
60090928|NCT00734344|76207533|FG001|STARTED|Overall Study||9||
60090929|NCT00734344|76207532|FG000|COMPLETED|Overall Study||9||
60090930|NCT00734344|76207533|FG001|COMPLETED|Overall Study||9||
60090931|NCT00734344|76207532|FG000|NOT COMPLETED|Overall Study||0||
60090932|NCT00734344|76207533|FG001|NOT COMPLETED|Overall Study||0||
60090933|NCT00734500|76207541|FG000|STARTED|Overall Study||15||
60090934|NCT00734500|76207541|FG000|COMPLETED|Overall Study||14||
60090935|NCT00734500|76207541|FG000|NOT COMPLETED|Overall Study||1||
60090936|NCT00734734|76207545|FG000|STARTED|Overall Study||64||
60090937|NCT00734734|76207545|FG000|COMPLETED|Overall Study||64||
60090938|NCT00734734|76207545|FG000|NOT COMPLETED|Overall Study||0||
60090939|NCT00734968|76207552|FG000|STARTED|Overall Study||77||
60090940|NCT00734968|76207553|FG001|STARTED|Overall Study||76||
60090941|NCT00734968|76207552|FG000|COMPLETED|Overall Study||76||
60090942|NCT00734968|76207553|FG001|COMPLETED|Overall Study||75||
60090943|NCT00734968|76207552|FG000|NOT COMPLETED|Overall Study||1||
60090944|NCT00734968|76207553|FG001|NOT COMPLETED|Overall Study||1||
60090945|NCT00735436|76207559|FG000|STARTED|Overall Study||18||
60090946|NCT00735436|76207559|FG000|COMPLETED|Overall Study||18||
60090947|NCT00735436|76207559|FG000|NOT COMPLETED|Overall Study||0||
60090948|NCT00735670|76207566|FG000|STARTED|Overall Study||10||
60090949|NCT00735670|76207567|FG001|STARTED|Overall Study||11||
60090950|NCT00735670|76207566|FG000|COMPLETED|Overall Study||6||
60090951|NCT00735670|76207567|FG001|COMPLETED|Overall Study||6||
60090952|NCT00735670|76207566|FG000|NOT COMPLETED|Overall Study||4||
60090953|NCT00735670|76207567|FG001|NOT COMPLETED|Overall Study||5||
60090954|NCT00735826|76207573|FG000|STARTED|Overall Study||10||
60090955|NCT00735826|76207573|FG000|COMPLETED|Overall Study||10||
60090956|NCT00735826|76207573|FG000|NOT COMPLETED|Overall Study||0||
60090957|NCT01276054|76207581|FG000|STARTED|Overall Study||2||
60090958|NCT01276054|76207582|FG001|STARTED|Overall Study||2||
60090959|NCT01276054|76207581|FG000|COMPLETED|Overall Study||0||
60090960|NCT01276054|76207582|FG001|COMPLETED|Overall Study||0||
60090961|NCT01276054|76207581|FG000|NOT COMPLETED|Overall Study||2||
60090962|NCT01276054|76207582|FG001|NOT COMPLETED|Overall Study||2||
60090963|NCT01798849|76207591|FG000|STARTED|Overall Study||8||
60090964|NCT01798849|76207592|FG001|STARTED|Overall Study||8||
60090965|NCT01798849|76207593|FG002|STARTED|Overall Study|1 participant discontinued after Period 1 and was replaced for Periods 2-4|9||
60090966|NCT01798849|76207591|FG000|COMPLETED|Overall Study||8||
60090967|NCT01798849|76207592|FG001|COMPLETED|Overall Study||8||
60090968|NCT01798849|76207593|FG002|COMPLETED|Overall Study||8||
60090969|NCT01798849|76207591|FG000|NOT COMPLETED|Overall Study||0||
60090970|NCT01798849|76207592|FG001|NOT COMPLETED|Overall Study||0||
60090971|NCT01798849|76207593|FG002|NOT COMPLETED|Overall Study||1||
60090972|NCT00724594|76207634|FG000|STARTED|Overall Study||12||
60090973|NCT00724594|76207635|FG001|STARTED|Overall Study||12||
60090974|NCT00724594|76207636|FG002|STARTED|Overall Study||11||
60090975|NCT00724594|76207637|FG003|STARTED|Overall Study||11||
60090976|NCT00724594|76207634|FG000|COMPLETED|Overall Study||12||
60090977|NCT00724594|76207635|FG001|COMPLETED|Overall Study||12||
60090978|NCT00724594|76207636|FG002|COMPLETED|Overall Study||11||
60090979|NCT00724594|76207637|FG003|COMPLETED|Overall Study||10||
60090980|NCT00724594|76207634|FG000|NOT COMPLETED|Overall Study||0||
60090981|NCT00724594|76207635|FG001|NOT COMPLETED|Overall Study||0||
60090982|NCT00724594|76207636|FG002|NOT COMPLETED|Overall Study||0||
60090983|NCT00724594|76207637|FG003|NOT COMPLETED|Overall Study||1||
60090984|NCT00724750|76207664|FG000|STARTED|Overall Study||45||
60090985|NCT00724750|76207665|FG001|STARTED|Overall Study||42||
60090986|NCT00724750|76207664|FG000|COMPLETED|Overall Study||45||
60090987|NCT00724750|76207665|FG001|COMPLETED|Overall Study||42||
60090988|NCT00724750|76207664|FG000|NOT COMPLETED|Overall Study||0||
60090989|NCT00724750|76207665|FG001|NOT COMPLETED|Overall Study||0||
60090990|NCT01797835|76207673|FG000|STARTED|Overall Study||153||
60090991|NCT01797835|76207674|FG001|STARTED|Overall Study||141||
60090992|NCT01797835|76207673|FG000|COMPLETED|Overall Study||122||
60090993|NCT01797835|76207674|FG001|COMPLETED|Overall Study||114||
60090994|NCT01797835|76207673|FG000|NOT COMPLETED|Overall Study||31||
60090995|NCT01797835|76207674|FG001|NOT COMPLETED|Overall Study||27||
60090996|NCT01275430|76207680|FG000|STARTED|Overall Study||27||
60090997|NCT01275430|76207680|FG000|COMPLETED|Overall Study||18||
60090998|NCT01275430|76207680|FG000|NOT COMPLETED|Overall Study||9||
60090999|NCT01838551|76207685|FG000|STARTED|Overall Study|94 subjects were enrolled and received at least 1 dose of levoketoconazole|94||
60091000|NCT01838551|76207685|FG000|COMPLETED|Overall Study|46 subjects completed the Extended Evaluation phase|46||
60091001|NCT01838551|76207685|FG000|NOT COMPLETED|Overall Study||48||
60091002|NCT01797445|76207691|FG000|STARTED|Double-Blind Phase||435||
60091003|NCT01797445|76207692|FG001|STARTED|Double-Blind Phase||437||
60091004|NCT01797445|76207691|FG000|COMPLETED|Double-Blind Phase||348||
60091005|NCT01797445|76207692|FG001|COMPLETED|Double-Blind Phase||348||
60091006|NCT01797445|76207691|FG000|NOT COMPLETED|Double-Blind Phase||87||
60091007|NCT01797445|76207692|FG001|NOT COMPLETED|Double-Blind Phase||89||
60091008|NCT01797445|76207691|FG000|STARTED|Open-Label Extension Phase|207 participants completed the Double-Blind Phase, but did not enter the Open-Label Extension Phase.|141||
60091009|NCT01797445|76207692|FG001|STARTED|Open-Label Extension Phase|229 participants completed the Double-Blind Phase, but did not enter the Open-Label Extension Phase.|119||
60091010|NCT01797445|76207691|FG000|COMPLETED|Open-Label Extension Phase||140||
60091011|NCT01797445|76207692|FG001|COMPLETED|Open-Label Extension Phase||119||
60091012|NCT01797445|76207691|FG000|NOT COMPLETED|Open-Label Extension Phase||1||
60091013|NCT01797445|76207692|FG001|NOT COMPLETED|Open-Label Extension Phase||0||
60091014|NCT01611259|76207700|FG000|STARTED|Overall Study||48||
60091015|NCT01611259|76207700|FG000|COMPLETED|Overall Study||34||
60091016|NCT01611259|76207700|FG000|NOT COMPLETED|Overall Study||14||
60091017|NCT01795495|76207707|FG000|STARTED|Overall Study||20||
60091018|NCT01795495|76207708|FG001|STARTED|Overall Study||22||
60091019|NCT01795495|76207709|FG002|STARTED|Overall Study||21||
60091020|NCT01795495|76207707|FG000|COMPLETED|Overall Study||19||
60091021|NCT01795495|76207708|FG001|COMPLETED|Overall Study||22||
60091022|NCT01795495|76207709|FG002|COMPLETED|Overall Study||19||
60091023|NCT01795495|76207707|FG000|NOT COMPLETED|Overall Study||1||
60091024|NCT01795495|76207708|FG001|NOT COMPLETED|Overall Study||0||
60091025|NCT01795495|76207709|FG002|NOT COMPLETED|Overall Study||2||
60091026|NCT01794949|76207719|FG000|STARTED|Overall Study||7||
60091027|NCT01794949|76207720|FG001|STARTED|Overall Study||1||
60091028|NCT01794949|76207719|FG000|6 Month Follow-up|Overall Study||6||
60091029|NCT01794949|76207720|FG001|6 Month Follow-up|Overall Study||1||
60091030|NCT01794949|76207719|FG000|COMPLETED|Overall Study||6||
60091031|NCT01794949|76207720|FG001|COMPLETED|Overall Study||1||
60091032|NCT01794949|76207719|FG000|NOT COMPLETED|Overall Study||1||
60091033|NCT01794949|76207720|FG001|NOT COMPLETED|Overall Study||0||
60091034|NCT01770379|76207729|FG000|STARTED|Overall Study||80||
60091035|NCT01770379|76207730|FG001|STARTED|Overall Study||81||
60091036|NCT01770379|76207731|FG002|STARTED|Overall Study||81||
60091037|NCT01770379|76207729|FG000|COMPLETED|Overall Study||41||
60091038|NCT01770379|76207730|FG001|COMPLETED|Overall Study||37||
60091039|NCT01770379|76207731|FG002|COMPLETED|Overall Study||39||
60091040|NCT01770379|76207729|FG000|NOT COMPLETED|Overall Study||39||
60091041|NCT01770379|76207730|FG001|NOT COMPLETED|Overall Study||44||
60091042|NCT01770379|76207731|FG002|NOT COMPLETED|Overall Study||42||
60091043|NCT01986881|76207744|FG000|STARTED|Overall Study||2752||
60091044|NCT01986881|76207745|FG001|STARTED|Overall Study||2747||
60091045|NCT01986881|76207746|FG002|STARTED|Overall Study||2747||
60091046|NCT01986881|76207744|FG000|Treated|Overall Study||2746||
60091047|NCT01986881|76207745|FG001|Treated|Overall Study||2747||
60091048|NCT01986881|76207746|FG002|Treated|Overall Study||2745||
60091049|NCT01986881|76207744|FG000|Participants Enrolled in the Insulin +/- Metformin Glycemic Sub-Study|Overall Study||348||
60091050|NCT01986881|76207745|FG001|Participants Enrolled in the Insulin +/- Metformin Glycemic Sub-Study|Overall Study||370||
60091051|NCT01986881|76207746|FG002|Participants Enrolled in the Insulin +/- Metformin Glycemic Sub-Study|Overall Study||347||
60091052|NCT01986881|76207744|FG000|Participants Enrolled in the Sulfonylurea Monotherapy Glycemic Sub-Study|Overall Study||55||
60091053|NCT01986881|76207745|FG001|Participants Enrolled in the Sulfonylurea Monotherapy Glycemic Sub-Study|Overall Study||54||
60091054|NCT01986881|76207746|FG002|Participants Enrolled in the Sulfonylurea Monotherapy Glycemic Sub-Study|Overall Study||48||
60091055|NCT01986881|76207744|FG000|Participants Enrolled in the Metformin With Sulfonylurea Glycemic Sub-Study|Overall Study||100||
60091056|NCT01986881|76207745|FG001|Participants Enrolled in the Metformin With Sulfonylurea Glycemic Sub-Study|Overall Study||113||
60091057|NCT01986881|76207746|FG002|Participants Enrolled in the Metformin With Sulfonylurea Glycemic Sub-Study|Overall Study||117||
60091058|NCT01986881|76207744|FG000|COMPLETED|Overall Study||2422||
60091059|NCT01986881|76207745|FG001|COMPLETED|Overall Study||2401||
60091060|NCT01986881|76207746|FG002|COMPLETED|Overall Study||2389||
60091061|NCT01986881|76207744|FG000|NOT COMPLETED|Overall Study||330||
60091062|NCT01986881|76207745|FG001|NOT COMPLETED|Overall Study||346||
60091063|NCT01986881|76207746|FG002|NOT COMPLETED|Overall Study||358||
60091064|NCT01609543|76207777|FG000|STARTED|Overall Study||62||
60091065|NCT01609543|76207777|FG000|COMPLETED|Overall Study||20||
60091066|NCT01609543|76207777|FG000|NOT COMPLETED|Overall Study||42||
60091067|NCT02003183|76207784|FG000|STARTED|Overall Study||7||
60091068|NCT02003183|76207785|FG001|STARTED|Overall Study||17||
60091069|NCT02003183|76207784|FG000|COMPLETED|Overall Study||7||
60091070|NCT02003183|76207785|FG001|COMPLETED|Overall Study||15||
60091071|NCT02003183|76207784|FG000|NOT COMPLETED|Overall Study||0||
60091072|NCT02003183|76207785|FG001|NOT COMPLETED|Overall Study||2||
60091073|NCT01986647|76207795|FG000|STARTED|Overall Study||152||
60091074|NCT01986647|76207796|FG001|STARTED|Overall Study||146||
60091075|NCT01986647|76207797|FG002|STARTED|Overall Study||49||
60091076|NCT01986647|76207798|FG003|STARTED|Overall Study||77||
60091077|NCT01986647|76207795|FG000|COMPLETED|Overall Study||142||
60091078|NCT01986647|76207796|FG001|COMPLETED|Overall Study||139||
60091079|NCT01986647|76207797|FG002|COMPLETED|Overall Study||37||
60091080|NCT01986647|76207798|FG003|COMPLETED|Overall Study||66||
60091081|NCT01986647|76207795|FG000|NOT COMPLETED|Overall Study||10||
60091082|NCT01986647|76207796|FG001|NOT COMPLETED|Overall Study||7||
60091083|NCT01986647|76207797|FG002|NOT COMPLETED|Overall Study||12||
60091084|NCT01986647|76207798|FG003|NOT COMPLETED|Overall Study||11||
60091085|NCT02002091|76207814|FG000|STARTED|Screening||122||
60091086|NCT02002091|76207815|FG001|STARTED|Screening||205||
60091087|NCT02002091|76207814|FG000|COMPLETED|Screening||109||
60091088|NCT02002091|76207815|FG001|COMPLETED|Screening||191||
60091089|NCT02002091|76207814|FG000|NOT COMPLETED|Screening||13||
60091090|NCT02002091|76207815|FG001|NOT COMPLETED|Screening||14||
60091091|NCT02002091|76207814|FG000|STARTED|One Year Follow up||109||
60091092|NCT02002091|76207815|FG001|STARTED|One Year Follow up||191||
60091093|NCT02002091|76207814|FG000|COMPLETED|One Year Follow up||109||
60091094|NCT02002091|76207815|FG001|COMPLETED|One Year Follow up||191||
60091095|NCT02002091|76207814|FG000|NOT COMPLETED|One Year Follow up||0||
60091096|NCT02002091|76207815|FG001|NOT COMPLETED|One Year Follow up||0||
60091097|NCT01985321|76207852|FG000|STARTED|Overall Study|This is Treatment Eligible Subjects only|90||
60091098|NCT01985321|76207853|FG001|STARTED|Overall Study|This is treatment eligible subjects only|83||
60091099|NCT01985321|76207852|FG000|COMPLETED|Overall Study||79||
60091100|NCT01985321|76207853|FG001|COMPLETED|Overall Study||78||
60091101|NCT01985321|76207852|FG000|NOT COMPLETED|Overall Study||11||
60091102|NCT01985321|76207853|FG001|NOT COMPLETED|Overall Study||5||
60091103|NCT02000921|76207862|FG000|STARTED|Overall Study||27||
60091104|NCT02000921|76207863|FG001|STARTED|Overall Study||53||
60091105|NCT02000921|76207864|FG002|STARTED|Overall Study||56||
60091106|NCT02000921|76207862|FG000|COMPLETED|Overall Study||22||
60091107|NCT02000921|76207863|FG001|COMPLETED|Overall Study||37||
60091108|NCT02000921|76207864|FG002|COMPLETED|Overall Study||46||
60091109|NCT02000921|76207862|FG000|NOT COMPLETED|Overall Study||5||
60091110|NCT02000921|76207863|FG001|NOT COMPLETED|Overall Study||16||
60091111|NCT02000921|76207864|FG002|NOT COMPLETED|Overall Study||10||
60091112|NCT00724984|76207878|FG000|STARTED|Overall Study||5||
60091113|NCT00724984|76207879|FG001|STARTED|Overall Study||8||
60091114|NCT00724984|76207880|FG002|STARTED|Overall Study||3||
60091115|NCT00724984|76207881|FG003|STARTED|Overall Study||9||
60091116|NCT00724984|76207882|FG004|STARTED|Overall Study||16||
60091117|NCT00724984|76207883|FG005|STARTED|Overall Study||14||
60091118|NCT00724984|76207878|FG000|COMPLETED|Overall Study||4||
60091119|NCT00724984|76207879|FG001|COMPLETED|Overall Study||7||
60091120|NCT00724984|76207880|FG002|COMPLETED|Overall Study||3||
60091121|NCT00724984|76207881|FG003|COMPLETED|Overall Study||7||
60091122|NCT00724984|76207882|FG004|COMPLETED|Overall Study||12||
60091123|NCT00724984|76207883|FG005|COMPLETED|Overall Study||9||
60091124|NCT00724984|76207878|FG000|NOT COMPLETED|Overall Study||1||
60091125|NCT00724984|76207879|FG001|NOT COMPLETED|Overall Study||1||
60091126|NCT00724984|76207880|FG002|NOT COMPLETED|Overall Study||0||
60091127|NCT00724984|76207881|FG003|NOT COMPLETED|Overall Study||2||
60091128|NCT00724984|76207882|FG004|NOT COMPLETED|Overall Study||4||
60091129|NCT00724984|76207883|FG005|NOT COMPLETED|Overall Study||5||
60091130|NCT02753751|76207899|FG000|STARTED|Overall Study||2971||
60091131|NCT02753751|76207900|FG001|STARTED|Overall Study||3059||
60091132|NCT02753751|76207899|FG000|COMPLETED|Overall Study||2971||
60091133|NCT02753751|76207900|FG001|COMPLETED|Overall Study||3059||
60091134|NCT02753751|76207899|FG000|NOT COMPLETED|Overall Study||0||
60091135|NCT02753751|76207900|FG001|NOT COMPLETED|Overall Study||0||
60091136|NCT01836523|76207910|FG000|STARTED|Overall Study||351||
60091137|NCT01836523|76207911|FG001|STARTED|Overall Study||350||
60091138|NCT01836523|76207912|FG002|STARTED|Overall Study||349||
60091139|NCT01836523|76207913|FG003|STARTED|Overall Study||348||
60091140|NCT01836523|76207910|FG000|Exposed|Overall Study||350||
60091141|NCT01836523|76207911|FG001|Exposed|Overall Study||348||
60091142|NCT01836523|76207912|FG002|Exposed|Overall Study||347||
60091143|NCT01836523|76207913|FG003|Exposed|Overall Study||348||
60091144|NCT01836523|76207910|FG000|COMPLETED|Overall Study||300||
60091145|NCT01836523|76207911|FG001|COMPLETED|Overall Study||265||
60091146|NCT01836523|76207912|FG002|COMPLETED|Overall Study||258||
60091147|NCT01836523|76207913|FG003|COMPLETED|Overall Study||274||
60091148|NCT01836523|76207910|FG000|NOT COMPLETED|Overall Study||51||
60091149|NCT01836523|76207911|FG001|NOT COMPLETED|Overall Study||85||
60091150|NCT01836523|76207912|FG002|NOT COMPLETED|Overall Study||91||
60091151|NCT01836523|76207913|FG003|NOT COMPLETED|Overall Study||74||
60091152|NCT01275196|76207925|FG000|STARTED|Overall Study||133||
60091153|NCT01275196|76207926|FG001|STARTED|Overall Study||134||
60091154|NCT01275196|76207925|FG000|Intended to Continue Into Extension|Overall Study||112||
60091155|NCT01275196|76207926|FG001|Intended to Continue Into Extension|Overall Study||113||
60091156|NCT01275196|76207925|FG000|COMPLETED|Overall Study||113||
60091157|NCT01275196|76207926|FG001|COMPLETED|Overall Study||113||
60091158|NCT01275196|76207925|FG000|NOT COMPLETED|Overall Study||20||
60091159|NCT01275196|76207926|FG001|NOT COMPLETED|Overall Study||21||
60091160|NCT01984697|76207939|FG000|STARTED|Overall Study||301||
60091161|NCT01984697|76207940|FG001|STARTED|Overall Study||301||
60091162|NCT01984697|76207941|FG002|STARTED|Overall Study||301||
60091163|NCT01984697|76207942|FG003|STARTED|Overall Study||301||
60091164|NCT01984697|76207943|FG004|STARTED|Overall Study||314||
60091165|NCT01984697|76207939|FG000|Vaccination 1|Overall Study||301||
60091166|NCT01984697|76207940|FG001|Vaccination 1|Overall Study||301||
60091167|NCT01984697|76207941|FG002|Vaccination 1|Overall Study||300||
60091168|NCT01984697|76207942|FG003|Vaccination 1|Overall Study||300||
60091169|NCT01984697|76207943|FG004|Vaccination 1|Overall Study||314||
60091170|NCT01984697|76207939|FG000|Vaccination 2|Overall Study||293||
60091171|NCT01984697|76207940|FG001|Vaccination 2|Overall Study||296||
60091172|NCT01984697|76207941|FG002|Vaccination 2|Overall Study||291||
60091173|NCT01984697|76207942|FG003|Vaccination 2|Overall Study||298||
60091174|NCT01984697|76207943|FG004|Vaccination 2|Overall Study||313||
60091175|NCT01984697|76207939|FG000|Vaccination 3|Overall Study||0||
60091176|NCT01984697|76207940|FG001|Vaccination 3|Overall Study||0||
60091177|NCT01984697|76207941|FG002|Vaccination 3|Overall Study||0||
60091178|NCT01984697|76207942|FG003|Vaccination 3|Overall Study||293||
60091179|NCT01984697|76207943|FG004|Vaccination 3|Overall Study||311||
60091180|NCT01984697|76207939|FG000|Month 36 Vaccination|Overall Study||270||
60091181|NCT01984697|76207940|FG001|Month 36 Vaccination|Overall Study||281||
60091182|NCT01984697|76207941|FG002|Month 36 Vaccination|Overall Study||280||
60091183|NCT01984697|76207942|FG003|Month 36 Vaccination|Overall Study||9||
60091184|NCT01984697|76207943|FG004|Month 36 Vaccination|Overall Study||31||
60091185|NCT01984697|76207939|FG000|COMPLETED|Overall Study||258||
60091186|NCT01984697|76207940|FG001|COMPLETED|Overall Study||270||
60091187|NCT01984697|76207941|FG002|COMPLETED|Overall Study||272||
60091188|NCT01984697|76207942|FG003|COMPLETED|Overall Study||280||
60091189|NCT01984697|76207943|FG004|COMPLETED|Overall Study||279||
60091190|NCT01984697|76207939|FG000|NOT COMPLETED|Overall Study||43||
60091191|NCT01984697|76207940|FG001|NOT COMPLETED|Overall Study||31||
60091192|NCT01984697|76207941|FG002|NOT COMPLETED|Overall Study||29||
60091193|NCT01984697|76207942|FG003|NOT COMPLETED|Overall Study||21||
60091194|NCT01984697|76207943|FG004|NOT COMPLETED|Overall Study||35||
60091195|NCT02000531|76207957|FG000|STARTED|Overall Study||21||
60091196|NCT02000531|76207958|FG001|STARTED|Overall Study||24||
60091197|NCT02000531|76207957|FG000|Safety Population|Overall Study||21||
60091198|NCT02000531|76207958|FG001|Safety Population|Overall Study||24||
60091199|NCT02000531|76207957|FG000|COMPLETED|Overall Study||17||
60091200|NCT02000531|76207958|FG001|COMPLETED|Overall Study||16||
60091201|NCT02000531|76207957|FG000|NOT COMPLETED|Overall Study||4||
60091202|NCT02000531|76207958|FG001|NOT COMPLETED|Overall Study||8||
60091203|NCT01609231|76207966|FG000|STARTED|Overall Study||6||
60091204|NCT01609231|76207967|FG001|STARTED|Overall Study||5||
60091205|NCT01609231|76207966|FG000|COMPLETED|Overall Study||3||
60091206|NCT01609231|76207967|FG001|COMPLETED|Overall Study||2||
60091207|NCT01609231|76207966|FG000|NOT COMPLETED|Overall Study||3||
60091208|NCT01609231|76207967|FG001|NOT COMPLETED|Overall Study||3||
60091209|NCT01793935|76207975|FG000|STARTED|Overall Study||34||
60091210|NCT01793935|76207976|FG001|STARTED|Overall Study||34||
60091211|NCT01793935|76207975|FG000|COMPLETED|Overall Study||28||
60091212|NCT01793935|76207976|FG001|COMPLETED|Overall Study||31||
60091213|NCT01793935|76207975|FG000|NOT COMPLETED|Overall Study||6||
60091214|NCT01793935|76207976|FG001|NOT COMPLETED|Overall Study||3||
60091215|NCT02092025|76207982|FG000|STARTED|Overall Study||3437||
60091216|NCT02092025|76207982|FG000|COMPLETED|Overall Study||3369||
60091217|NCT02092025|76207982|FG000|NOT COMPLETED|Overall Study||68||
60091218|NCT01769443|76207988|FG000|STARTED|Overall Study||1||
60091219|NCT01769443|76207989|FG001|STARTED|Overall Study||1||
60091220|NCT01769443|76207988|FG000|COMPLETED|Overall Study||0||
60091221|NCT01769443|76207989|FG001|COMPLETED|Overall Study||1||
60091222|NCT01769443|76207988|FG000|NOT COMPLETED|Overall Study||1||
60091223|NCT01769443|76207989|FG001|NOT COMPLETED|Overall Study||0||
60091224|NCT01768117|76207996|FG000|STARTED|Overall Study||13||
60091225|NCT01768117|76207996|FG000|COMPLETED|Overall Study||7||
60091226|NCT01768117|76207996|FG000|NOT COMPLETED|Overall Study||6||
60091227|NCT01767493|76208000|FG000|STARTED|Overall Study||19||
60091228|NCT01767493|76208000|FG000|COMPLETED|Overall Study||16||
60091229|NCT01767493|76208000|FG000|NOT COMPLETED|Overall Study||3||
60091230|NCT01274182|76208007|FG000|STARTED|Overall Study||133||
60091231|NCT01274182|76208008|FG001|STARTED|Overall Study||87||
60091232|NCT01274182|76208009|FG002|STARTED|Overall Study||92||
60091233|NCT01274182|76208007|FG000|24 Weeks|Overall Study||123||
60091234|NCT01274182|76208008|FG001|24 Weeks|Overall Study||83||
59561403|NCT03425097|75662854|FG001|COMPLETED|Washout Period (1 Week)||5||
59561404|NCT03425097|75662853|FG000|NOT COMPLETED|Washout Period (1 Week)||0||
59561405|NCT03425097|75662854|FG001|NOT COMPLETED|Washout Period (1 Week)||0||
59561406|NCT03425097|75662853|FG000|STARTED|Second Treatment Period (2 Weeks)||6||
59561407|NCT03425097|75662854|FG001|STARTED|Second Treatment Period (2 Weeks)||5||
59561408|NCT03425097|75662853|FG000|COMPLETED|Second Treatment Period (2 Weeks)||6||
59561409|NCT03425097|75662854|FG001|COMPLETED|Second Treatment Period (2 Weeks)||5||
59561410|NCT03425097|75662853|FG000|NOT COMPLETED|Second Treatment Period (2 Weeks)||0||
59561411|NCT03425097|75662854|FG001|NOT COMPLETED|Second Treatment Period (2 Weeks)||0||
59561412|NCT01926041|75662865|FG000|STARTED|Overall Study||279||
59561413|NCT01926041|75662866|FG001|STARTED|Overall Study||310||
59561414|NCT01926041|75662865|FG000|COMPLETED|Overall Study||270||
59561415|NCT01926041|75662866|FG001|COMPLETED|Overall Study||262||
59561416|NCT01926041|75662865|FG000|NOT COMPLETED|Overall Study||9||
59561417|NCT01926041|75662866|FG001|NOT COMPLETED|Overall Study||48||
59561418|NCT03225573|75662872|FG000|STARTED|Overall Study||60||198
59992962|NCT02322593|76108806|FG001|STARTED|Overall Study||355||
60091235|NCT01274182|76208009|FG002|24 Weeks|Overall Study||84||
60091236|NCT01274182|76208007|FG000|COMPLETED|Overall Study||112||
60091237|NCT01274182|76208008|FG001|COMPLETED|Overall Study||69||
60091238|NCT01274182|76208009|FG002|COMPLETED|Overall Study||80||
60091239|NCT01274182|76208007|FG000|NOT COMPLETED|Overall Study||21||
60091240|NCT01274182|76208008|FG001|NOT COMPLETED|Overall Study||18||
60091241|NCT01274182|76208009|FG002|NOT COMPLETED|Overall Study||12||
60091242|NCT01984229|76208023|FG000|STARTED|Period 1||6||
60091243|NCT01984229|76208024|FG001|STARTED|Period 1||17||
60091244|NCT01984229|76208023|FG000|COMPLETED|Period 1||6||
60091245|NCT01984229|76208024|FG001|COMPLETED|Period 1||17||
60091246|NCT01984229|76208023|FG000|NOT COMPLETED|Period 1||0||
60091247|NCT01984229|76208024|FG001|NOT COMPLETED|Period 1||0||
60091248|NCT01984229|76208023|FG000|STARTED|Period 2||6||
60091249|NCT01984229|76208024|FG001|STARTED|Period 2||17||
60091250|NCT01984229|76208023|FG000|COMPLETED|Period 2||6||
60091251|NCT01984229|76208024|FG001|COMPLETED|Period 2||17||
60091252|NCT01984229|76208023|FG000|NOT COMPLETED|Period 2||0||
60091253|NCT01984229|76208024|FG001|NOT COMPLETED|Period 2||0||
60091254|NCT01984229|76208023|FG000|STARTED|Period 3||6||
60091255|NCT01984229|76208024|FG001|STARTED|Period 3||17||
60091256|NCT01984229|76208023|FG000|COMPLETED|Period 3||6||
60091257|NCT01984229|76208024|FG001|COMPLETED|Period 3||17||
60091258|NCT01984229|76208023|FG000|NOT COMPLETED|Period 3||0||
60091259|NCT01984229|76208024|FG001|NOT COMPLETED|Period 3||0||
60091260|NCT01984229|76208023|FG000|STARTED|Safety Follow-up Period||6||
60091261|NCT01984229|76208024|FG001|STARTED|Safety Follow-up Period||17||
60091262|NCT01984229|76208023|FG000|COMPLETED|Safety Follow-up Period||4||
60091263|NCT01984229|76208024|FG001|COMPLETED|Safety Follow-up Period||16||
60091264|NCT01984229|76208023|FG000|NOT COMPLETED|Safety Follow-up Period||2||
60091265|NCT01984229|76208024|FG001|NOT COMPLETED|Safety Follow-up Period||1||
60091266|NCT01835899|76208039|FG000|STARTED|Overall Study||6||
60091267|NCT01835899|76208040|FG001|STARTED|Overall Study||9||
60091268|NCT01835899|76208041|FG002|STARTED|Overall Study||9||
60091269|NCT01835899|76208039|FG000|COMPLETED|Overall Study||6||
60091270|NCT01835899|76208040|FG001|COMPLETED|Overall Study||8||
60091271|NCT01835899|76208041|FG002|COMPLETED|Overall Study||8||
59561419|NCT03225573|75662872|FG000|COMPLETED|Overall Study||60||198
59561420|NCT03225573|75662872|FG000|NOT COMPLETED|Overall Study||0||0
59561421|NCT03294213|75662876|FG000|STARTED|Overall Study||176||
59561422|NCT03294213|75662876|FG000|COMPLETED|Overall Study||176||
59992963|NCT02322593|76108805|FG000|COMPLETED|Overall Study||356||
59992964|NCT02322593|76108806|FG001|COMPLETED|Overall Study||355||
59992965|NCT02322593|76108805|FG000|NOT COMPLETED|Overall Study||0||
59992966|NCT02322593|76108806|FG001|NOT COMPLETED|Overall Study||0||
59992967|NCT01328431|76108814|FG000|STARTED|Baseline||390||
59992968|NCT01328431|76108815|FG001|STARTED|Baseline||390||
59992969|NCT01328431|76108814|FG000|COMPLETED|Baseline||390||
59992970|NCT01328431|76108815|FG001|COMPLETED|Baseline|Two subjects enrolled in study twice. Protocol violation.|388||
59992971|NCT01328431|76108814|FG000|NOT COMPLETED|Baseline||0||
59992972|NCT01328431|76108815|FG001|NOT COMPLETED|Baseline||2||
59992973|NCT01328431|76108814|FG000|STARTED|1 Month (1M)||390||
60091272|NCT01835899|76208039|FG000|NOT COMPLETED|Overall Study||0||
60091273|NCT01835899|76208040|FG001|NOT COMPLETED|Overall Study||1||
60091274|NCT01835899|76208041|FG002|NOT COMPLETED|Overall Study||1||
60091275|NCT01766401|76208053|FG000|STARTED|Overall Study||198||
60091276|NCT01766401|76208054|FG001|STARTED|Overall Study||200||
60091277|NCT01766401|76208053|FG000|COMPLETED|Overall Study||161||
60091278|NCT01766401|76208054|FG001|COMPLETED|Overall Study||144||
60091279|NCT01766401|76208053|FG000|NOT COMPLETED|Overall Study||37||
60091280|NCT01766401|76208054|FG001|NOT COMPLETED|Overall Study||56||
60091281|NCT01272934|76208062|FG000|STARTED|Overall Study||102||
60091282|NCT01272934|76208063|FG001|STARTED|Overall Study||103||
60091283|NCT01272934|76208062|FG000|COMPLETED|Overall Study||102||
60091284|NCT01272934|76208063|FG001|COMPLETED|Overall Study||101||
60091285|NCT01272934|76208062|FG000|NOT COMPLETED|Overall Study||0||
60091286|NCT01272934|76208063|FG001|NOT COMPLETED|Overall Study||2||
60091287|NCT00739336|76208072|FG000|STARTED|Overall Study||21||
60091288|NCT00739336|76208073|FG001|STARTED|Overall Study||24||
60091289|NCT00739336|76208072|FG000|COMPLETED|Overall Study||17||
60091290|NCT00739336|76208073|FG001|COMPLETED|Overall Study||24||
60091291|NCT00739336|76208072|FG000|NOT COMPLETED|Overall Study||4||
60091292|NCT00739336|76208073|FG001|NOT COMPLETED|Overall Study||0||
60091293|NCT01983683|76208081|FG000|STARTED|Overall Study||298||
60091294|NCT01983683|76208082|FG001|STARTED|Overall Study||311||
60091295|NCT01983683|76208081|FG000|COMPLETED|Overall Study||260|Include subjects who completed the main study + subjects who completed the re-treatment extension|
60091296|NCT01983683|76208082|FG001|COMPLETED|Overall Study||260|Include subjects who completed the main study + subjects who completed the re-treatment extension|
60091297|NCT01983683|76208081|FG000|NOT COMPLETED|Overall Study||38||
60091298|NCT01983683|76208082|FG001|NOT COMPLETED|Overall Study||51||
60091299|NCT01998893|76208088|FG000|STARTED|Overall Study||38||
60091300|NCT01998893|76208088|FG000|1st Treatment Cycle Completed Until PD|Overall Study|Progressive disease (PD)|30||
60091301|NCT01998893|76208088|FG000|2nd Treatment Cycle Started|Overall Study||5||
60091302|NCT01998893|76208088|FG000|2nd Treatment Cycle Completed Until PD|Overall Study||3||
60091303|NCT01998893|76208088|FG000|COMPLETED|Overall Study||21||
60091304|NCT01998893|76208088|FG000|NOT COMPLETED|Overall Study||17||
59561423|NCT03294213|75662876|FG000|NOT COMPLETED|Overall Study||0||
59561424|NCT03434457|75662880|FG000|STARTED|Overall Study||630||
59561425|NCT03434457|75662880|FG000|COMPLETED|Overall Study||630||
59561426|NCT03434457|75662880|FG000|NOT COMPLETED|Overall Study||0||
59992974|NCT01328431|76108815|FG001|STARTED|1 Month (1M)||388||
60091305|NCT01791985|76208092|FG000|STARTED|Overall Study||52||
60091306|NCT01791985|76208092|FG000|COMPLETED|Overall Study|Eight patients (8) discontinued study treatment prior to 12 weeks or disease disease progression|44||
60091307|NCT01791985|76208092|FG000|NOT COMPLETED|Overall Study||8||
60091308|NCT01998737|76208099|FG000|STARTED|Overall Study||911||
60091309|NCT01998737|76208100|FG001|STARTED|Overall Study||100||
60091310|NCT01998737|76208099|FG000|COMPLETED|Overall Study||888||
60091311|NCT01998737|76208100|FG001|COMPLETED|Overall Study||100||
60091312|NCT01998737|76208099|FG000|NOT COMPLETED|Overall Study||23||
60091313|NCT01998737|76208100|FG001|NOT COMPLETED|Overall Study||0||
60091314|NCT01791517|76208109|FG000|STARTED|Phase I: Period 1||19||
60091315|NCT01791517|76208110|FG001|STARTED|Phase I: Period 1||20||
60091316|NCT01791517|76208111|FG002|STARTED|Phase I: Period 1||20||
60091317|NCT01791517|76208112|FG003|STARTED|Phase I: Period 1||19||
60091318|NCT01791517|76208113|FG004|STARTED|Phase I: Period 1||20||
60091319|NCT01791517|76208114|FG005|STARTED|Phase I: Period 1||20||
60091320|NCT01791517|76208115|FG006|STARTED|Phase I: Period 1||20||
60091321|NCT01791517|76208116|FG007|STARTED|Phase I: Period 1||20||
60091322|NCT01791517|76208117|FG008|STARTED|Phase I: Period 1||20||
60091323|NCT01791517|76208118|FG009|STARTED|Phase I: Period 1||20||
60091324|NCT01791517|76208119|FG010|STARTED|Phase I: Period 1||18||
60091325|NCT01791517|76208120|FG011|STARTED|Phase I: Period 1||20||
59992975|NCT01328431|76108814|FG000|COMPLETED|1 Month (1M)||335||
59992976|NCT01328431|76108815|FG001|COMPLETED|1 Month (1M)||330||
59992977|NCT01328431|76108814|FG000|NOT COMPLETED|1 Month (1M)||55||
59992978|NCT01328431|76108815|FG001|NOT COMPLETED|1 Month (1M)||58||
59992979|NCT01328431|76108814|FG000|STARTED|3 Month (3M)|Attempted to contact all subjects for 3M follow-up, regardless of whether they completed 1M.|390||
59992980|NCT01328431|76108815|FG001|STARTED|3 Month (3M)|Attempted to contact all subjects for 3M follow-up, regardless of whether they completed 1M.|388||
59992981|NCT01328431|76108814|FG000|COMPLETED|3 Month (3M)||313||
59561427|NCT02299349|75662886|FG000|STARTED|Overall Study||35||
59561428|NCT02299349|75662887|FG001|STARTED|Overall Study||35||
59992982|NCT01328431|76108815|FG001|COMPLETED|3 Month (3M)||316||
60091326|NCT01791517|76208109|FG000|COMPLETED|Phase I: Period 1||18||
59561429|NCT02299349|75662886|FG000|COMPLETED|Overall Study||35||
60091327|NCT01791517|76208110|FG001|COMPLETED|Phase I: Period 1||18||
60091328|NCT01791517|76208111|FG002|COMPLETED|Phase I: Period 1||18||
60091329|NCT01791517|76208112|FG003|COMPLETED|Phase I: Period 1||17||
60091330|NCT01791517|76208113|FG004|COMPLETED|Phase I: Period 1||19||
60091331|NCT01791517|76208114|FG005|COMPLETED|Phase I: Period 1||19||
60091332|NCT01791517|76208115|FG006|COMPLETED|Phase I: Period 1||19||
60091333|NCT01791517|76208116|FG007|COMPLETED|Phase I: Period 1||20||
60091334|NCT01791517|76208117|FG008|COMPLETED|Phase I: Period 1||19||
60091335|NCT01791517|76208118|FG009|COMPLETED|Phase I: Period 1||19||
60091336|NCT01791517|76208119|FG010|COMPLETED|Phase I: Period 1||18||
60091337|NCT01791517|76208120|FG011|COMPLETED|Phase I: Period 1||19||
60091338|NCT01791517|76208109|FG000|NOT COMPLETED|Phase I: Period 1||1||
60091339|NCT01791517|76208110|FG001|NOT COMPLETED|Phase I: Period 1||2||
60091340|NCT01791517|76208111|FG002|NOT COMPLETED|Phase I: Period 1||2||
60091341|NCT01791517|76208112|FG003|NOT COMPLETED|Phase I: Period 1||2||
60091342|NCT01791517|76208113|FG004|NOT COMPLETED|Phase I: Period 1||1||
60091343|NCT01791517|76208114|FG005|NOT COMPLETED|Phase I: Period 1||1||
60091344|NCT01791517|76208115|FG006|NOT COMPLETED|Phase I: Period 1||1||
60091345|NCT01791517|76208116|FG007|NOT COMPLETED|Phase I: Period 1||0||
60091346|NCT01791517|76208117|FG008|NOT COMPLETED|Phase I: Period 1||1||
60091347|NCT01791517|76208118|FG009|NOT COMPLETED|Phase I: Period 1||1||
60091348|NCT01791517|76208119|FG010|NOT COMPLETED|Phase I: Period 1||0||
60091349|NCT01791517|76208120|FG011|NOT COMPLETED|Phase I: Period 1||1||
60091350|NCT01791517|76208109|FG000|STARTED|Phase I: Period 2||18||
60091351|NCT01791517|76208110|FG001|STARTED|Phase I: Period 2||18||
60091352|NCT01791517|76208111|FG002|STARTED|Phase I: Period 2||18||
60091353|NCT01791517|76208112|FG003|STARTED|Phase I: Period 2||17||
60091354|NCT01791517|76208113|FG004|STARTED|Phase I: Period 2||19||
60091355|NCT01791517|76208114|FG005|STARTED|Phase I: Period 2||19||
60091356|NCT01791517|76208115|FG006|STARTED|Phase I: Period 2||19||
60091357|NCT01791517|76208116|FG007|STARTED|Phase I: Period 2||20||
60091358|NCT01791517|76208117|FG008|STARTED|Phase I: Period 2||19||
60091359|NCT01791517|76208118|FG009|STARTED|Phase I: Period 2||19||
60091360|NCT01791517|76208119|FG010|STARTED|Phase I: Period 2||18||
60091361|NCT01791517|76208120|FG011|STARTED|Phase I: Period 2||19||
60091362|NCT01791517|76208109|FG000|COMPLETED|Phase I: Period 2||17||
60091363|NCT01791517|76208110|FG001|COMPLETED|Phase I: Period 2||15||
60091364|NCT01791517|76208111|FG002|COMPLETED|Phase I: Period 2||16||
60091365|NCT01791517|76208112|FG003|COMPLETED|Phase I: Period 2||16||
60091366|NCT01791517|76208113|FG004|COMPLETED|Phase I: Period 2||19||
60091367|NCT01791517|76208114|FG005|COMPLETED|Phase I: Period 2||18||
60091368|NCT01791517|76208115|FG006|COMPLETED|Phase I: Period 2||19||
60091369|NCT01791517|76208116|FG007|COMPLETED|Phase I: Period 2||20||
60091370|NCT01791517|76208117|FG008|COMPLETED|Phase I: Period 2||19||
60091371|NCT01791517|76208118|FG009|COMPLETED|Phase I: Period 2||18||
60091372|NCT01791517|76208119|FG010|COMPLETED|Phase I: Period 2||16||
60091373|NCT01791517|76208120|FG011|COMPLETED|Phase I: Period 2||19||
60091374|NCT01791517|76208109|FG000|NOT COMPLETED|Phase I: Period 2||1||
60091375|NCT01791517|76208110|FG001|NOT COMPLETED|Phase I: Period 2||3||
60091376|NCT01791517|76208111|FG002|NOT COMPLETED|Phase I: Period 2||2||
60091377|NCT01791517|76208112|FG003|NOT COMPLETED|Phase I: Period 2||1||
60091378|NCT01791517|76208113|FG004|NOT COMPLETED|Phase I: Period 2||0||
60091379|NCT01791517|76208114|FG005|NOT COMPLETED|Phase I: Period 2||1||
60091380|NCT01791517|76208115|FG006|NOT COMPLETED|Phase I: Period 2||0||
60091381|NCT01791517|76208116|FG007|NOT COMPLETED|Phase I: Period 2||0||
60091382|NCT01791517|76208117|FG008|NOT COMPLETED|Phase I: Period 2||0||
60091383|NCT01791517|76208118|FG009|NOT COMPLETED|Phase I: Period 2||1||
60091384|NCT01791517|76208119|FG010|NOT COMPLETED|Phase I: Period 2||2||
60091385|NCT01791517|76208120|FG011|NOT COMPLETED|Phase I: Period 2||0||
60091386|NCT01791517|76208109|FG000|STARTED|Phase I: Period 3||17||
60091387|NCT01791517|76208110|FG001|STARTED|Phase I: Period 3||15||
60091388|NCT01791517|76208111|FG002|STARTED|Phase I: Period 3||16||
60091389|NCT01791517|76208112|FG003|STARTED|Phase I: Period 3||16||
60091390|NCT01791517|76208113|FG004|STARTED|Phase I: Period 3||19||
60091391|NCT01791517|76208114|FG005|STARTED|Phase I: Period 3||18||
60091392|NCT01791517|76208115|FG006|STARTED|Phase I: Period 3||19||
60091393|NCT01791517|76208116|FG007|STARTED|Phase I: Period 3||20||
60091394|NCT01791517|76208117|FG008|STARTED|Phase I: Period 3||19||
60091395|NCT01791517|76208118|FG009|STARTED|Phase I: Period 3||18||
60091396|NCT01791517|76208119|FG010|STARTED|Phase I: Period 3||16||
60091397|NCT01791517|76208120|FG011|STARTED|Phase I: Period 3||19||
60091398|NCT01791517|76208109|FG000|COMPLETED|Phase I: Period 3||17||
60091399|NCT01791517|76208110|FG001|COMPLETED|Phase I: Period 3||14||
60091400|NCT01791517|76208111|FG002|COMPLETED|Phase I: Period 3||16||
60091401|NCT01791517|76208112|FG003|COMPLETED|Phase I: Period 3||15||
60091402|NCT01791517|76208113|FG004|COMPLETED|Phase I: Period 3||18||
60091403|NCT01791517|76208114|FG005|COMPLETED|Phase I: Period 3||18||
60091404|NCT01791517|76208115|FG006|COMPLETED|Phase I: Period 3||19||
60091405|NCT01791517|76208116|FG007|COMPLETED|Phase I: Period 3||20||
60091406|NCT01791517|76208117|FG008|COMPLETED|Phase I: Period 3||19||
60091407|NCT01791517|76208118|FG009|COMPLETED|Phase I: Period 3||18||
60091408|NCT01791517|76208119|FG010|COMPLETED|Phase I: Period 3||16||
60091409|NCT01791517|76208120|FG011|COMPLETED|Phase I: Period 3||18||
60091410|NCT01791517|76208109|FG000|NOT COMPLETED|Phase I: Period 3||0||
60091411|NCT01791517|76208110|FG001|NOT COMPLETED|Phase I: Period 3||1||
60091412|NCT01791517|76208111|FG002|NOT COMPLETED|Phase I: Period 3||0||
60091413|NCT01791517|76208112|FG003|NOT COMPLETED|Phase I: Period 3||1||
60091414|NCT01791517|76208113|FG004|NOT COMPLETED|Phase I: Period 3||1||
60091415|NCT01791517|76208114|FG005|NOT COMPLETED|Phase I: Period 3||0||
60091416|NCT01791517|76208115|FG006|NOT COMPLETED|Phase I: Period 3||0||
60091417|NCT01791517|76208116|FG007|NOT COMPLETED|Phase I: Period 3||0||
60091418|NCT01791517|76208117|FG008|NOT COMPLETED|Phase I: Period 3||0||
60091419|NCT01791517|76208118|FG009|NOT COMPLETED|Phase I: Period 3||0||
60091420|NCT01791517|76208119|FG010|NOT COMPLETED|Phase I: Period 3||0||
60091421|NCT01791517|76208120|FG011|NOT COMPLETED|Phase I: Period 3||1||
60091422|NCT01791517|76208109|FG000|STARTED|Phase I: Period 4||17||
60091423|NCT01791517|76208110|FG001|STARTED|Phase I: Period 4||14||
60091424|NCT01791517|76208111|FG002|STARTED|Phase I: Period 4||16||
60091425|NCT01791517|76208112|FG003|STARTED|Phase I: Period 4||15||
60091426|NCT01791517|76208113|FG004|STARTED|Phase I: Period 4||18||
60091427|NCT01791517|76208114|FG005|STARTED|Phase I: Period 4||18||
60091428|NCT01791517|76208115|FG006|STARTED|Phase I: Period 4||19||
60091429|NCT01791517|76208116|FG007|STARTED|Phase I: Period 4||20||
60091430|NCT01791517|76208117|FG008|STARTED|Phase I: Period 4||19||
60091431|NCT01791517|76208118|FG009|STARTED|Phase I: Period 4||18||
60091432|NCT01791517|76208119|FG010|STARTED|Phase I: Period 4||16||
60091433|NCT01791517|76208120|FG011|STARTED|Phase I: Period 4||18||
60091434|NCT01791517|76208109|FG000|COMPLETED|Phase I: Period 4||17||
60091435|NCT01791517|76208110|FG001|COMPLETED|Phase I: Period 4||14||
60091436|NCT01791517|76208111|FG002|COMPLETED|Phase I: Period 4||16||
60091437|NCT01791517|76208112|FG003|COMPLETED|Phase I: Period 4||15||
60091438|NCT01791517|76208113|FG004|COMPLETED|Phase I: Period 4||18||
60091439|NCT01791517|76208114|FG005|COMPLETED|Phase I: Period 4||18||
60091440|NCT01791517|76208115|FG006|COMPLETED|Phase I: Period 4||19||
60091441|NCT01791517|76208116|FG007|COMPLETED|Phase I: Period 4||20||
60091442|NCT01791517|76208117|FG008|COMPLETED|Phase I: Period 4||19||
60091443|NCT01791517|76208118|FG009|COMPLETED|Phase I: Period 4||18||
60091444|NCT01791517|76208119|FG010|COMPLETED|Phase I: Period 4||16||
60091445|NCT01791517|76208120|FG011|COMPLETED|Phase I: Period 4||18||
60091446|NCT01791517|76208109|FG000|NOT COMPLETED|Phase I: Period 4||0||
60091447|NCT01791517|76208110|FG001|NOT COMPLETED|Phase I: Period 4||0||
60091448|NCT01791517|76208111|FG002|NOT COMPLETED|Phase I: Period 4||0||
60091449|NCT01791517|76208112|FG003|NOT COMPLETED|Phase I: Period 4||0||
60091450|NCT01791517|76208113|FG004|NOT COMPLETED|Phase I: Period 4||0||
60091451|NCT01791517|76208114|FG005|NOT COMPLETED|Phase I: Period 4||0||
60091452|NCT01791517|76208115|FG006|NOT COMPLETED|Phase I: Period 4||0||
60091453|NCT01791517|76208116|FG007|NOT COMPLETED|Phase I: Period 4||0||
60091454|NCT01791517|76208117|FG008|NOT COMPLETED|Phase I: Period 4||0||
60091455|NCT01791517|76208118|FG009|NOT COMPLETED|Phase I: Period 4||0||
60091456|NCT01791517|76208119|FG010|NOT COMPLETED|Phase I: Period 4||0||
60091457|NCT01791517|76208120|FG011|NOT COMPLETED|Phase I: Period 4||0||
60091458|NCT01791517|76208109|FG000|STARTED|Phase II||17||
60091459|NCT01791517|76208110|FG001|STARTED|Phase II||14||
60091460|NCT01791517|76208111|FG002|STARTED|Phase II||16||
60091461|NCT01791517|76208112|FG003|STARTED|Phase II||15||
60091462|NCT01791517|76208113|FG004|STARTED|Phase II||18||
60091463|NCT01791517|76208114|FG005|STARTED|Phase II||18||
60091464|NCT01791517|76208115|FG006|STARTED|Phase II||19||
60091465|NCT01791517|76208116|FG007|STARTED|Phase II||20||
60091466|NCT01791517|76208117|FG008|STARTED|Phase II||19||
60091467|NCT01791517|76208118|FG009|STARTED|Phase II||18||
60091468|NCT01791517|76208119|FG010|STARTED|Phase II||16||
60091469|NCT01791517|76208120|FG011|STARTED|Phase II||18||
60091470|NCT01791517|76208109|FG000|COMPLETED|Phase II||15||
60091471|NCT01791517|76208110|FG001|COMPLETED|Phase II||14||
60091472|NCT01791517|76208111|FG002|COMPLETED|Phase II||15||
60091473|NCT01791517|76208112|FG003|COMPLETED|Phase II||15||
60091474|NCT01791517|76208113|FG004|COMPLETED|Phase II||16||
60091475|NCT01791517|76208114|FG005|COMPLETED|Phase II||14||
60091476|NCT01791517|76208115|FG006|COMPLETED|Phase II||17||
59707769|NCT00982228|75826654|FG001|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3583)||20||
59707770|NCT00982228|75826653|FG000|STARTED|Extension: Week 53 to 104 (NN1250-3644)|Fifty-three subjects from the main trial did not continue into the extension|351||
59707771|NCT00982228|75826654|FG001|STARTED|Extension: Week 53 to 104 (NN1250-3644)|Nineteen subjects from the main trial did not continue into the extension|118||
59707772|NCT00982228|75826653|FG000|COMPLETED|Extension: Week 53 to 104 (NN1250-3644)||330||
59707773|NCT00982228|75826654|FG001|COMPLETED|Extension: Week 53 to 104 (NN1250-3644)||113||
60091477|NCT01791517|76208116|FG007|COMPLETED|Phase II||17||
60091478|NCT01791517|76208117|FG008|COMPLETED|Phase II||17||
60091479|NCT01791517|76208118|FG009|COMPLETED|Phase II||15||
60091480|NCT01791517|76208119|FG010|COMPLETED|Phase II||15||
60091481|NCT01791517|76208120|FG011|COMPLETED|Phase II||17||
60091482|NCT01791517|76208109|FG000|NOT COMPLETED|Phase II||2||
60091483|NCT01791517|76208110|FG001|NOT COMPLETED|Phase II||0||
60091484|NCT01791517|76208111|FG002|NOT COMPLETED|Phase II||1||
60091485|NCT01791517|76208112|FG003|NOT COMPLETED|Phase II||0||
60091486|NCT01791517|76208113|FG004|NOT COMPLETED|Phase II||2||
60091487|NCT01791517|76208114|FG005|NOT COMPLETED|Phase II||4||
60091488|NCT01791517|76208115|FG006|NOT COMPLETED|Phase II||2||
60091489|NCT01791517|76208116|FG007|NOT COMPLETED|Phase II||3||
60091490|NCT01791517|76208117|FG008|NOT COMPLETED|Phase II||2||
60091491|NCT01791517|76208118|FG009|NOT COMPLETED|Phase II||3||
60091492|NCT01791517|76208119|FG010|NOT COMPLETED|Phase II||1||
60091493|NCT01791517|76208120|FG011|NOT COMPLETED|Phase II||1||
60091494|NCT01998581|76208140|FG000|STARTED|Overall Study||169||
60091495|NCT01998581|76208141|FG001|STARTED|Overall Study||56||
60091496|NCT01998581|76208140|FG000|COMPLETED|Overall Study||123||
60091497|NCT01998581|76208141|FG001|COMPLETED|Overall Study||44||
60091498|NCT01998581|76208140|FG000|NOT COMPLETED|Overall Study||46||
60091499|NCT01998581|76208141|FG001|NOT COMPLETED|Overall Study||12||
60091500|NCT01983293|76208150|FG000|STARTED|Overall Study||161||
60091501|NCT01983293|76208151|FG001|STARTED|Overall Study||81||
60091502|NCT01983293|76208150|FG000|COMPLETED|Overall Study||128||
60091503|NCT01983293|76208151|FG001|COMPLETED|Overall Study||62||
60091504|NCT01983293|76208150|FG000|NOT COMPLETED|Overall Study||33||
60091505|NCT01983293|76208151|FG001|NOT COMPLETED|Overall Study||19||
60091506|NCT01791205|76208159|FG000|STARTED|Phase I||152||
60091507|NCT01791205|76208160|FG001|STARTED|Phase I||152||
60091508|NCT01791205|76208159|FG000|COMPLETED|Phase I||152||
60091509|NCT01791205|76208160|FG001|COMPLETED|Phase I||152||
60091510|NCT01791205|76208159|FG000|NOT COMPLETED|Phase I||0||
60091511|NCT01791205|76208160|FG001|NOT COMPLETED|Phase I||0||
60091512|NCT01791205|76208159|FG000|STARTED|Phase II|Participants who received tocilizumab monotherapy in Phase I was observed in Phase II.|104||
60091513|NCT01791205|76208160|FG001|STARTED|Phase II||0||
60091514|NCT01791205|76208159|FG000|COMPLETED|Phase II||92||
60091515|NCT01791205|76208160|FG001|COMPLETED|Phase II||0||
60091516|NCT01791205|76208159|FG000|NOT COMPLETED|Phase II||12||
60091517|NCT01791205|76208160|FG001|NOT COMPLETED|Phase II||0||
60091518|NCT01272232|76208169|FG000|STARTED|Weeks 0-56||423||
60091519|NCT01272232|76208170|FG001|STARTED|Weeks 0-56||211||
60091520|NCT01272232|76208171|FG002|STARTED|Weeks 0-56||212||
60091521|NCT01272232|76208169|FG000|Exposed|Weeks 0-56|1 subject dropped out after randomisation and before exposure to trial drug.|422||
60091522|NCT01272232|76208170|FG001|Exposed|Weeks 0-56|1 subject dropped out after randomisation and before exposure to trial drug.|210||
60091523|NCT01272232|76208171|FG002|Exposed|Weeks 0-56||212||
59707774|NCT00982228|75826653|FG000|NOT COMPLETED|Extension: Week 53 to 104 (NN1250-3644)||21||
59707775|NCT00982228|75826654|FG001|NOT COMPLETED|Extension: Week 53 to 104 (NN1250-3644)||5||
59707776|NCT01260350|75826680|FG000|STARTED|Overall Study||10||
59707777|NCT01260350|75826681|FG001|STARTED|Overall Study||9||
59707778|NCT01260350|75826682|FG002|STARTED|Overall Study||10||
59707779|NCT01260350|75826683|FG003|STARTED|Overall Study||11||
59707780|NCT01260350|75826684|FG004|STARTED|Overall Study||10||
59707781|NCT01260350|75826685|FG005|STARTED|Overall Study||10||
59707782|NCT01260350|75826686|FG006|STARTED|Overall Study||10||
60091524|NCT01272232|76208169|FG000|COMPLETED|Weeks 0-56||324||
60091525|NCT01272232|76208170|FG001|COMPLETED|Weeks 0-56||164||
60091526|NCT01272232|76208171|FG002|COMPLETED|Weeks 0-56||140||
60091527|NCT01272232|76208169|FG000|NOT COMPLETED|Weeks 0-56||99||
60091528|NCT01272232|76208170|FG001|NOT COMPLETED|Weeks 0-56||47||
60091529|NCT01272232|76208171|FG002|NOT COMPLETED|Weeks 0-56||72||
60091530|NCT01272232|76208169|FG000|STARTED|Off Drug Follow-up Period (Weeks 56-68)||324||
60091531|NCT01272232|76208170|FG001|STARTED|Off Drug Follow-up Period (Weeks 56-68)||164||
60091532|NCT01272232|76208171|FG002|STARTED|Off Drug Follow-up Period (Weeks 56-68)||140||
60091533|NCT01272232|76208169|FG000|COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||310||
60091534|NCT01272232|76208170|FG001|COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||154||
60091535|NCT01272232|76208171|FG002|COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||135||
60103750|NCT04621227|76222001|FG000|NOT COMPLETED|Period 6 (16 Days)||0||
59992983|NCT01328431|76108814|FG000|NOT COMPLETED|3 Month (3M)||77||
59992984|NCT01328431|76108815|FG001|NOT COMPLETED|3 Month (3M)||72||
59992985|NCT01328431|76108814|FG000|STARTED|12 Month (12M)|Attempted to contact all subjects at 12M follow-up. Deceased subjects excluded.|388||
59992986|NCT01328431|76108815|FG001|STARTED|12 Month (12M)|Attempted to contact all subjects at 12M follow-up. Deceased subjects excluded.|386||
59992987|NCT01328431|76108814|FG000|COMPLETED|12 Month (12M)||304||
59992988|NCT01328431|76108815|FG001|COMPLETED|12 Month (12M)||289||
59992989|NCT01328431|76108814|FG000|NOT COMPLETED|12 Month (12M)||84||
59992990|NCT01328431|76108815|FG001|NOT COMPLETED|12 Month (12M)||97||
59992991|NCT00893789|76108825|FG000|STARTED|Overall Study||29||
59992992|NCT00893789|76108826|FG001|STARTED|Overall Study||30||
59992993|NCT00893789|76108827|FG002|STARTED|Overall Study||29||
59992994|NCT00893789|76108828|FG003|STARTED|Overall Study||29||
59992995|NCT00893789|76108825|FG000|Safety Analysis Set (SAS)|Overall Study|SAS = all participants who received 1 or more doses of study drug.|29||
59992996|NCT00893789|76108826|FG001|Safety Analysis Set (SAS)|Overall Study||30||
59992997|NCT00893789|76108827|FG002|Safety Analysis Set (SAS)|Overall Study||29||
59992998|NCT00893789|76108828|FG003|Safety Analysis Set (SAS)|Overall Study||29||
59992999|NCT00893789|76108825|FG000|Full Analysis Set (FAS)|Overall Study|FAS = participants in the safety analysis set with ≥1 postbaseline primary efficacy assessment.|29||
59993000|NCT00893789|76108826|FG001|Full Analysis Set (FAS)|Overall Study||29||
59993001|NCT00893789|76108827|FG002|Full Analysis Set (FAS)|Overall Study||28||
59993002|NCT00893789|76108828|FG003|Full Analysis Set (FAS)|Overall Study||27||
59993003|NCT00893789|76108825|FG000|COMPLETED|Overall Study||23||
59993004|NCT00893789|76108826|FG001|COMPLETED|Overall Study||26||
59993005|NCT00893789|76108827|FG002|COMPLETED|Overall Study||22||
59993006|NCT00893789|76108828|FG003|COMPLETED|Overall Study||16||
59993007|NCT00893789|76108825|FG000|NOT COMPLETED|Overall Study||6||
59993008|NCT00893789|76108826|FG001|NOT COMPLETED|Overall Study||4||
59993009|NCT00893789|76108827|FG002|NOT COMPLETED|Overall Study||7||
59993010|NCT00893789|76108828|FG003|NOT COMPLETED|Overall Study||13||
59993011|NCT02164864|76108841|FG000|STARTED|Overall Study|Started are the Randomised/entered patients.|981||
59993012|NCT02164864|76108842|FG001|STARTED|Overall Study|Started are the Randomised/entered patients.|763||
59993013|NCT02164864|76108843|FG002|STARTED|Overall Study|Started are the Randomised/entered patients.|981||
59817930|NCT04488770|75940330|FG004|COMPLETED|Part 1-Cohort 2: Period 2 (Up to 5 Days)||1||
59993014|NCT02164864|76108841|FG000|COMPLETED|Overall Study||886||
59993015|NCT02164864|76108842|FG001|COMPLETED|Overall Study||703||
59993016|NCT02164864|76108843|FG002|COMPLETED|Overall Study||849||
59993017|NCT02164864|76108841|FG000|NOT COMPLETED|Overall Study||95||
59993018|NCT02164864|76108842|FG001|NOT COMPLETED|Overall Study||60||
59993019|NCT02164864|76108843|FG002|NOT COMPLETED|Overall Study||132||
59993020|NCT02419807|76108854|FG000|STARTED|Overall Study||102||
59993021|NCT02419807|76108854|FG000|COMPLETED|Overall Study||92||
59993022|NCT02419807|76108854|FG000|NOT COMPLETED|Overall Study||10||
59993023|NCT03857867|76108858|FG000|STARTED|Overall Study||7||
59993024|NCT03857867|76108858|FG000|COMPLETED|Overall Study||6||
59993025|NCT03857867|76108858|FG000|NOT COMPLETED|Overall Study||1||
59993026|NCT01628926|76108866|FG000|STARTED|Overall Study||168||
59993027|NCT01628926|76108867|FG001|STARTED|Overall Study||167||
59993028|NCT01628926|76108868|FG002|STARTED|Overall Study||85||
59993029|NCT01628926|76108866|FG000|COMPLETED|Overall Study||142||
59993030|NCT01628926|76108867|FG001|COMPLETED|Overall Study||144||
59993031|NCT01628926|76108868|FG002|COMPLETED|Overall Study||68||
59993032|NCT01628926|76108866|FG000|NOT COMPLETED|Overall Study||26||
59993033|NCT01628926|76108867|FG001|NOT COMPLETED|Overall Study||23||
59993034|NCT01628926|76108868|FG002|NOT COMPLETED|Overall Study||17||
59993035|NCT01628848|76108879|FG000|STARTED|Overall Study||87||
59993036|NCT01628848|76108880|FG001|STARTED|Overall Study||87||
59993037|NCT01628848|76108879|FG000|COMPLETED|Overall Study||75||
59993038|NCT01628848|76108880|FG001|COMPLETED|Overall Study||73||
59993039|NCT01628848|76108879|FG000|NOT COMPLETED|Overall Study||12||
59993040|NCT01628848|76108880|FG001|NOT COMPLETED|Overall Study||14||
59993041|NCT02164318|76108890|FG000|STARTED|Overall Study||4||
59993042|NCT02164318|76108891|FG001|STARTED|Overall Study||3||
59993043|NCT02164318|76108892|FG002|STARTED|Overall Study||1||
59993044|NCT02164318|76108893|FG003|STARTED|Overall Study||3||
59993045|NCT02164318|76108890|FG000|COMPLETED|Overall Study||4||
59993046|NCT02164318|76108891|FG001|COMPLETED|Overall Study||2||
59707783|NCT01260350|75826687|FG007|STARTED|Overall Study||25||
59707784|NCT01260350|75826688|FG008|STARTED|Overall Study||25||
59707785|NCT01260350|75826689|FG009|STARTED|Overall Study||25||
59707786|NCT01260350|75826690|FG010|STARTED|Overall Study||10||
59707787|NCT01260350|75826691|FG011|STARTED|Overall Study||9||
59707788|NCT01260350|75826692|FG012|STARTED|Overall Study||25||
59707789|NCT01260350|75826693|FG013|STARTED|Overall Study||10||
59707790|NCT01260350|75826694|FG014|STARTED|Overall Study||25||
59707791|NCT01260350|75826695|FG015|STARTED|Overall Study||10||
59707792|NCT01260350|75826696|FG016|STARTED|Overall Study||9||
59707793|NCT01260350|75826697|FG017|STARTED|Overall Study||10||
59707794|NCT01260350|75826698|FG018|STARTED|Overall Study||0||
59707795|NCT01260350|75826699|FG019|STARTED|Overall Study||14||
59707796|NCT01260350|75826700|FG020|STARTED|Overall Study||25||
59707797|NCT01260350|75826701|FG021|STARTED|Overall Study||0||
60091536|NCT01272232|76208169|FG000|NOT COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||14||
60091537|NCT01272232|76208170|FG001|NOT COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||10||
60091538|NCT01272232|76208171|FG002|NOT COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||5||
60091539|NCT01791127|76208179|FG000|STARTED|Overall Study||1758||
60091540|NCT01791127|76208179|FG000|COMPLETED|Overall Study||286||
60091541|NCT01791127|76208179|FG000|NOT COMPLETED|Overall Study||1472||
60091542|NCT00739960|76208196|FG000|STARTED|Overall Study||1||
60091543|NCT00739960|76208196|FG000|COMPLETED|Overall Study||1||
60091544|NCT00739960|76208196|FG000|NOT COMPLETED|Overall Study||0||
60091545|NCT00751972|76208202|FG000|STARTED|Overall Study||140||
60091546|NCT00751972|76208203|FG001|STARTED|Overall Study||499||
60091547|NCT00751972|76208202|FG000|COMPLETED|Overall Study||140||
60091548|NCT00751972|76208203|FG001|COMPLETED|Overall Study||499||
60091549|NCT00751972|76208202|FG000|NOT COMPLETED|Overall Study||0||
60091550|NCT00751972|76208203|FG001|NOT COMPLETED|Overall Study||0||
60091551|NCT01997333|76208210|FG000|STARTED|Randomization and Treatment||109||
60091552|NCT01997333|76208211|FG001|STARTED|Randomization and Treatment||218||
60091553|NCT01997333|76208210|FG000|COMPLETED|Randomization and Treatment||6|Completed = continuing to receive treatment at time of analysis|
60091554|NCT01997333|76208211|FG001|COMPLETED|Randomization and Treatment||15|Completed = continuing to receive treatment at time of analysis|
60091555|NCT01997333|76208210|FG000|NOT COMPLETED|Randomization and Treatment||103||
60091556|NCT01997333|76208211|FG001|NOT COMPLETED|Randomization and Treatment||203||
60091557|NCT01997333|76208210|FG000|STARTED|Survival Follow up||92|Only patients who received treatment are included in survival follow up.|
60091558|NCT01997333|76208211|FG001|STARTED|Survival Follow up||213|Only patients who received treatment are included in survival follow up.|
60091559|NCT01997333|76208210|FG000|COMPLETED|Survival Follow up||76||
60091560|NCT01997333|76208211|FG001|COMPLETED|Survival Follow up||199||
60091561|NCT01997333|76208210|FG000|NOT COMPLETED|Survival Follow up||16||
60091562|NCT01997333|76208211|FG001|NOT COMPLETED|Survival Follow up||14||
60091563|NCT00746122|76208221|FG000|STARTED|Overall Study||297||
60091564|NCT00746122|76208222|FG001|STARTED|Overall Study|After 600 recruitment target 13 more patients were randomised before sites could be closed down.|316||
60091565|NCT00746122|76208221|FG000|COMPLETED|Overall Study||297||
60091566|NCT00746122|76208222|FG001|COMPLETED|Overall Study||316||
60091567|NCT00746122|76208221|FG000|NOT COMPLETED|Overall Study||0||
60091568|NCT00746122|76208222|FG001|NOT COMPLETED|Overall Study||0||
60091569|NCT00746512|76208232|FG000|STARTED|Overall Study||8||
60091570|NCT00746512|76208233|FG001|STARTED|Overall Study||10||
60091571|NCT00746512|76208234|FG002|STARTED|Overall Study||18||
60091572|NCT00746512|76208235|FG003|STARTED|Overall Study||9||
60091573|NCT00746512|76208232|FG000|COMPLETED|Overall Study||8||
60091574|NCT00746512|76208233|FG001|COMPLETED|Overall Study||10||
60091575|NCT00746512|76208234|FG002|COMPLETED|Overall Study||18||
60091576|NCT00746512|76208235|FG003|COMPLETED|Overall Study||9||
60091577|NCT00746512|76208232|FG000|NOT COMPLETED|Overall Study||0||
59993047|NCT02164318|76108892|FG002|COMPLETED|Overall Study||1||
59993048|NCT02164318|76108893|FG003|COMPLETED|Overall Study||2||
59993049|NCT02164318|76108890|FG000|NOT COMPLETED|Overall Study||0||
59993050|NCT02164318|76108891|FG001|NOT COMPLETED|Overall Study||1||
59993051|NCT02164318|76108892|FG002|NOT COMPLETED|Overall Study||0||
60091578|NCT00746512|76208233|FG001|NOT COMPLETED|Overall Study||0||
60091579|NCT00746512|76208234|FG002|NOT COMPLETED|Overall Study||0||
60091580|NCT00746512|76208235|FG003|NOT COMPLETED|Overall Study||0||
60091581|NCT00746668|76208245|FG000|STARTED|Overall Study||6||
60091582|NCT00746668|76208246|FG001|STARTED|Overall Study||5||
60091583|NCT00746668|76208247|FG002|STARTED|Overall Study||5||
60091584|NCT00746668|76208248|FG003|STARTED|Overall Study||5||
60091585|NCT00746668|76208249|FG004|STARTED|Overall Study||5||
60091586|NCT00746668|76208250|FG005|STARTED|Overall Study||5||
59707798|NCT01260350|75826680|FG000|COMPLETED|Overall Study||10||
59993052|NCT02164318|76108893|FG003|NOT COMPLETED|Overall Study||1||
59993053|NCT03436199|76108906|FG000|STARTED|Overall Study||187||
59993054|NCT03436199|76108907|FG001|STARTED|Overall Study||185||
59993055|NCT03436199|76108908|FG002|STARTED|Overall Study||186||
60091587|NCT00746668|76208251|FG006|STARTED|Overall Study||5||
60091588|NCT00746668|76208245|FG000|COMPLETED|Overall Study||6||
60091589|NCT00746668|76208246|FG001|COMPLETED|Overall Study||5||
60091590|NCT00746668|76208247|FG002|COMPLETED|Overall Study||5||
60091591|NCT00746668|76208248|FG003|COMPLETED|Overall Study||5||
60091592|NCT00746668|76208249|FG004|COMPLETED|Overall Study||5||
60091593|NCT00746668|76208250|FG005|COMPLETED|Overall Study||5||
60091594|NCT00746668|76208251|FG006|COMPLETED|Overall Study||5||
59707799|NCT01260350|75826681|FG001|COMPLETED|Overall Study||9||
59707800|NCT01260350|75826682|FG002|COMPLETED|Overall Study||10||
59707801|NCT01260350|75826683|FG003|COMPLETED|Overall Study||11||
59707802|NCT01260350|75826684|FG004|COMPLETED|Overall Study||10||
59707803|NCT01260350|75826685|FG005|COMPLETED|Overall Study||10||
59993056|NCT03436199|76108906|FG000|COMPLETED|Overall Study||165||
59993057|NCT03436199|76108907|FG001|COMPLETED|Overall Study||132||
59993058|NCT03436199|76108908|FG002|COMPLETED|Overall Study||174||
59993059|NCT03436199|76108906|FG000|NOT COMPLETED|Overall Study||22||
60091595|NCT00746668|76208245|FG000|NOT COMPLETED|Overall Study||0||
60091596|NCT00746668|76208246|FG001|NOT COMPLETED|Overall Study||0||
60091597|NCT00746668|76208247|FG002|NOT COMPLETED|Overall Study||0||
60091598|NCT00746668|76208248|FG003|NOT COMPLETED|Overall Study||0||
60091599|NCT00746668|76208249|FG004|NOT COMPLETED|Overall Study||0||
60091600|NCT00746668|76208250|FG005|NOT COMPLETED|Overall Study||0||
60091601|NCT00746668|76208251|FG006|NOT COMPLETED|Overall Study||0||
60091602|NCT00752908|76208266|FG000|STARTED|Overall Study||14||
60091603|NCT00752908|76208267|FG001|STARTED|Overall Study||13||
60091604|NCT00752908|76208266|FG000|COMPLETED|Overall Study||14||
60091605|NCT00752908|76208267|FG001|COMPLETED|Overall Study||13||
60091606|NCT00752908|76208266|FG000|NOT COMPLETED|Overall Study||0||
60091607|NCT00752908|76208267|FG001|NOT COMPLETED|Overall Study||0||
60091608|NCT01982435|76208275|FG000|STARTED|Overall Study||15||
60091609|NCT01982435|76208276|FG001|STARTED|Overall Study||12||
60091610|NCT01982435|76208275|FG000|COMPLETED|Overall Study||14||
60091611|NCT01982435|76208276|FG001|COMPLETED|Overall Study||12||
60091612|NCT01982435|76208275|FG000|NOT COMPLETED|Overall Study||1||
60091613|NCT01982435|76208276|FG001|NOT COMPLETED|Overall Study||0||
60091614|NCT00747214|76208284|FG000|STARTED|Overall Study||27||
60091615|NCT00747214|76208285|FG001|STARTED|Overall Study||32||
60091616|NCT00747214|76208284|FG000|COMPLETED|Overall Study||19||
60091617|NCT00747214|76208285|FG001|COMPLETED|Overall Study||29||
60091618|NCT00747214|76208284|FG000|NOT COMPLETED|Overall Study||8||
60091619|NCT00747214|76208285|FG001|NOT COMPLETED|Overall Study||3||
60091620|NCT00753142|76208294|FG000|STARTED|Overall Study||8||
60091621|NCT00753142|76208295|FG001|STARTED|Overall Study||7||
60091622|NCT00753142|76208296|FG002|STARTED|Overall Study||13||
60091623|NCT00753142|76208294|FG000|COMPLETED|Overall Study||8||
60091624|NCT00753142|76208295|FG001|COMPLETED|Overall Study||7||
60091625|NCT00753142|76208296|FG002|COMPLETED|Overall Study||13||
60091626|NCT00753142|76208294|FG000|NOT COMPLETED|Overall Study||0||
60091627|NCT00753142|76208295|FG001|NOT COMPLETED|Overall Study||0||
60091628|NCT00753142|76208296|FG002|NOT COMPLETED|Overall Study||0||
60091629|NCT00762424|76208306|FG000|STARTED|Overall Study||28||
60091630|NCT00762424|76208307|FG001|STARTED|Overall Study||25||
60091631|NCT00762424|76208306|FG000|COMPLETED|Overall Study||28||
60091632|NCT00762424|76208307|FG001|COMPLETED|Overall Study||25||
60091633|NCT00762424|76208306|FG000|NOT COMPLETED|Overall Study||0||
60091634|NCT00762424|76208307|FG001|NOT COMPLETED|Overall Study||0||
60091635|NCT01620983|76208316|FG000|STARTED|Overall Study||130||
60091636|NCT01620983|76208317|FG001|STARTED|Overall Study||135||
60091637|NCT01620983|76208318|FG002|STARTED|Overall Study||137||
60091638|NCT01620983|76208316|FG000|COMPLETED|Overall Study||111||
60091639|NCT01620983|76208317|FG001|COMPLETED|Overall Study||113||
60091640|NCT01620983|76208318|FG002|COMPLETED|Overall Study||122||
60091641|NCT01620983|76208316|FG000|NOT COMPLETED|Overall Study||19||
60091642|NCT01620983|76208317|FG001|NOT COMPLETED|Overall Study||22||
60091643|NCT01620983|76208318|FG002|NOT COMPLETED|Overall Study||15||
60091644|NCT01996709|76208328|FG000|STARTED|Overall Study||66||
60091645|NCT01996709|76208329|FG001|STARTED|Overall Study||68||
60091646|NCT01996709|76208328|FG000|COMPLETED|Overall Study||61||
60091647|NCT01996709|76208329|FG001|COMPLETED|Overall Study||67||
60091648|NCT01996709|76208328|FG000|NOT COMPLETED|Overall Study||5||
60091649|NCT01996709|76208329|FG001|NOT COMPLETED|Overall Study||1||
60091650|NCT00753220|76208339|FG000|STARTED|Overall Study||7||
60091651|NCT00753220|76208339|FG000|COMPLETED|Overall Study||2||
60091652|NCT00753220|76208339|FG000|NOT COMPLETED|Overall Study||5||
60091653|NCT00753298|76208345|FG000|STARTED|Overall Study||97||
60091654|NCT00753298|76208346|FG001|STARTED|Overall Study||98||
60091655|NCT00753298|76208345|FG000|COMPLETED|Overall Study||89||
60091656|NCT00753298|76208346|FG001|COMPLETED|Overall Study||94||
60091657|NCT00753298|76208345|FG000|NOT COMPLETED|Overall Study||8||
60091658|NCT00753298|76208346|FG001|NOT COMPLETED|Overall Study||4||
60091659|NCT01996319|76208354|FG000|STARTED|Overall Study||96||
60091660|NCT01996319|76208355|FG001|STARTED|Overall Study||98||
60091661|NCT01996319|76208354|FG000|COMPLETED|Overall Study||88||
60091662|NCT01996319|76208355|FG001|COMPLETED|Overall Study||95||
60091663|NCT01996319|76208354|FG000|NOT COMPLETED|Overall Study||8||
60091664|NCT01996319|76208355|FG001|NOT COMPLETED|Overall Study||3||
60091665|NCT01279486|76208361|FG000|STARTED|Overall Study||120||
60091666|NCT01279486|76208361|FG000|COMPLETED|Overall Study|1 result questionnaire was not returned so 119 volunteers results were used for consumer accuracy.|119||
60091667|NCT01279486|76208361|FG000|NOT COMPLETED|Overall Study||1||
60091668|NCT01279954|76208367|FG000|STARTED|Overall Study||5||
60091669|NCT01279954|76208368|FG001|STARTED|Overall Study||5||
60091670|NCT01279954|76208367|FG000|COMPLETED|Overall Study||2||
60091671|NCT01279954|76208368|FG001|COMPLETED|Overall Study||1||
60091672|NCT01279954|76208367|FG000|NOT COMPLETED|Overall Study||3||
60091673|NCT01279954|76208368|FG001|NOT COMPLETED|Overall Study||4||
60091674|NCT01278862|76208379|FG000|STARTED|Overall Study||45|Total # of participants equaled 77; Some subjects received more than one crown (max, of 2).|50
60091675|NCT01278862|76208380|FG001|STARTED|Overall Study||43|Total # of participants equaled 77; Some subjects received more than one crown (max, of 2).|50
60103751|NCT04621227|76222001|FG000|STARTED|Period 7 (4 Days)||14||
60103752|NCT04621227|76222001|FG000|COMPLETED|Period 7 (4 Days)||14||
60091676|NCT01278862|76208379|FG000|COMPLETED|Overall Study||44|1 subject with one of each crown placed was lost follow-up|49
60091677|NCT01278862|76208380|FG001|COMPLETED|Overall Study||42|1 subject with one of each crown placed was lost follow-up|49
60091678|NCT01278862|76208379|FG000|NOT COMPLETED|Overall Study||1||1
60091679|NCT01278862|76208380|FG001|NOT COMPLETED|Overall Study||1||1
60091680|NCT00763048|76208388|FG000|STARTED|Overall Study||21||
60091681|NCT00763048|76208389|FG001|STARTED|Overall Study||18||
60091682|NCT00763048|76208388|FG000|COMPLETED|Overall Study||21||
60091683|NCT00763048|76208389|FG001|COMPLETED|Overall Study||18||
60091684|NCT00763048|76208388|FG000|NOT COMPLETED|Overall Study||0||
60091685|NCT00763048|76208389|FG001|NOT COMPLETED|Overall Study||0||
60091686|NCT01278394|76208395|FG000|STARTED|Overall Study||29||
60091687|NCT01278394|76208395|FG000|COMPLETED|Overall Study||28||
60091688|NCT01278394|76208395|FG000|NOT COMPLETED|Overall Study||1||
60091689|NCT01981187|76208399|FG000|STARTED|Overall Study||12||
60091690|NCT01981187|76208399|FG000|COMPLETED|Overall Study||0||
60091691|NCT01981187|76208399|FG000|NOT COMPLETED|Overall Study||12||
60091692|NCT01278160|76208405|FG000|STARTED|Overall Study||89||
60091693|NCT01278160|76208406|FG001|STARTED|Overall Study||90||
60091694|NCT01278160|76208405|FG000|COMPLETED|Overall Study||84||
60091695|NCT01278160|76208406|FG001|COMPLETED|Overall Study||84||
60091696|NCT01278160|76208405|FG000|NOT COMPLETED|Overall Study||5||
60091697|NCT01278160|76208406|FG001|NOT COMPLETED|Overall Study||6||
60091698|NCT01996241|76208414|FG000|STARTED|Overall Study||1164||40
60091699|NCT01996241|76208415|FG001|STARTED|Overall Study||1111||40
60091700|NCT01996241|76208414|FG000|COMPLETED|Overall Study||912||40
60091701|NCT01996241|76208415|FG001|COMPLETED|Overall Study||876||40
60091702|NCT01996241|76208414|FG000|NOT COMPLETED|Overall Study||252||0
60091703|NCT01996241|76208415|FG001|NOT COMPLETED|Overall Study||235||0
60091704|NCT02091869|76208425|FG000|STARTED|Overall Study||17||
60091705|NCT02091869|76208426|FG001|STARTED|Overall Study||17||
60091706|NCT02091869|76208425|FG000|COMPLETED|Overall Study||17||
60091707|NCT02091869|76208426|FG001|COMPLETED|Overall Study||14||
60091708|NCT02091869|76208425|FG000|NOT COMPLETED|Overall Study||0||
60091709|NCT02091869|76208426|FG001|NOT COMPLETED|Overall Study||3||
60091710|NCT00748072|76208434|FG000|STARTED|Overall Study||82||
60091711|NCT00748072|76208435|FG001|STARTED|Overall Study||80||
60091712|NCT00748072|76208434|FG000|COMPLETED|Overall Study||82||
60091713|NCT00748072|76208435|FG001|COMPLETED|Overall Study||80||
60091714|NCT00748072|76208434|FG000|NOT COMPLETED|Overall Study||0||
60091715|NCT00748072|76208435|FG001|NOT COMPLETED|Overall Study||0||
60091716|NCT01981109|76208441|FG000|STARTED|Overall Study||225||
60091717|NCT01981109|76208441|FG000|COMPLETED|Overall Study||1||
60091718|NCT01981109|76208441|FG000|NOT COMPLETED|Overall Study||224||
60091719|NCT00248794|76208449|FG000|STARTED|Overall Study||25||
60091720|NCT00248794|76208450|FG001|STARTED|Overall Study||24||
60091721|NCT00248794|76208451|FG002|STARTED|Overall Study||10||
60091722|NCT00248794|76208449|FG000|COMPLETED|Overall Study||19||
60091723|NCT00248794|76208450|FG001|COMPLETED|Overall Study||16||
60091724|NCT00248794|76208451|FG002|COMPLETED|Overall Study||7||
60091725|NCT00248794|76208449|FG000|NOT COMPLETED|Overall Study||6||
60091726|NCT00248794|76208450|FG001|NOT COMPLETED|Overall Study||8||
60091727|NCT00248794|76208451|FG002|NOT COMPLETED|Overall Study||3||
60091728|NCT01995539|76208465|FG000|STARTED|Overall Study||181||
60091729|NCT01995539|76208465|FG000|COMPLETED|Overall Study||148||
60091730|NCT01995539|76208465|FG000|NOT COMPLETED|Overall Study||33||
60091731|NCT01835587|76208473|FG000|STARTED|Overall Study||3|Participants who received study treatment.|
60091732|NCT01835587|76208474|FG001|STARTED|Overall Study||4|Participants who received study treatment.|
59707804|NCT01260350|75826686|FG006|COMPLETED|Overall Study||10||
60091733|NCT01835587|76208475|FG002|STARTED|Overall Study||4|Participants who received study treatment.|
60091734|NCT01835587|76208476|FG003|STARTED|Overall Study||19|Participants who received study treatment.|
60091735|NCT01835587|76208473|FG000|COMPLETED|Overall Study||1|Completed entire study treatment|
60091736|NCT01835587|76208474|FG001|COMPLETED|Overall Study||0|Completed entire study treatment|
60091737|NCT01835587|76208475|FG002|COMPLETED|Overall Study||2|Completed entire study treatment|
60091738|NCT01835587|76208476|FG003|COMPLETED|Overall Study||10|Completed entire study treatment|
60091739|NCT01835587|76208473|FG000|NOT COMPLETED|Overall Study||2||
60091740|NCT01835587|76208474|FG001|NOT COMPLETED|Overall Study||4||
60091741|NCT01835587|76208475|FG002|NOT COMPLETED|Overall Study||2||
60091742|NCT01835587|76208476|FG003|NOT COMPLETED|Overall Study||9||
60091743|NCT01736917|76208493|FG000|STARTED|Overall Study||65||
60091744|NCT01736917|76208493|FG000|COMPLETED|Overall Study||54||
60091745|NCT01736917|76208493|FG000|NOT COMPLETED|Overall Study||11||
60091746|NCT01277302|76208502|FG000|STARTED|7-Month Fixed Treatment Period||85||
60091747|NCT01277302|76208503|FG001|STARTED|7-Month Fixed Treatment Period||86||
60091748|NCT01277302|76208504|FG002|STARTED|7-Month Fixed Treatment Period||31||
60091749|NCT01277302|76208502|FG000|COMPLETED|7-Month Fixed Treatment Period||85||
60091750|NCT01277302|76208503|FG001|COMPLETED|7-Month Fixed Treatment Period||86||
60091751|NCT01277302|76208504|FG002|COMPLETED|7-Month Fixed Treatment Period||19||
60091752|NCT01277302|76208502|FG000|NOT COMPLETED|7-Month Fixed Treatment Period||0||
60091753|NCT01277302|76208503|FG001|NOT COMPLETED|7-Month Fixed Treatment Period||0||
60091754|NCT01277302|76208504|FG002|NOT COMPLETED|7-Month Fixed Treatment Period||12||
60091755|NCT01277302|76208502|FG000|STARTED|8-Month Alternate Dose Regimen Period||85||
60091756|NCT01277302|76208503|FG001|STARTED|8-Month Alternate Dose Regimen Period||86||
60091757|NCT01277302|76208504|FG002|STARTED|8-Month Alternate Dose Regimen Period||19||
60091758|NCT01277302|76208502|FG000|COMPLETED|8-Month Alternate Dose Regimen Period||80||
60091759|NCT01277302|76208503|FG001|COMPLETED|8-Month Alternate Dose Regimen Period||82||
60091760|NCT01277302|76208504|FG002|COMPLETED|8-Month Alternate Dose Regimen Period||13||
60091761|NCT01277302|76208502|FG000|NOT COMPLETED|8-Month Alternate Dose Regimen Period||5||
60091762|NCT01277302|76208503|FG001|NOT COMPLETED|8-Month Alternate Dose Regimen Period||4||
60091763|NCT01277302|76208504|FG002|NOT COMPLETED|8-Month Alternate Dose Regimen Period||6||
60091764|NCT01980875|76208515|FG000|STARTED|Overall Study||8||
60091765|NCT01980875|76208516|FG001|STARTED|Overall Study||25||
60091766|NCT01980875|76208517|FG002|STARTED|Overall Study||24||
60091767|NCT01980875|76208515|FG000|COMPLETED|Overall Study||0||
60091768|NCT01980875|76208516|FG001|COMPLETED|Overall Study||0||
60091769|NCT01980875|76208517|FG002|COMPLETED|Overall Study||0||
60091770|NCT01980875|76208515|FG000|NOT COMPLETED|Overall Study||8||
60091771|NCT01980875|76208516|FG001|NOT COMPLETED|Overall Study||25||
60091772|NCT01980875|76208517|FG002|NOT COMPLETED|Overall Study||24||
60091773|NCT01995461|76208525|FG000|STARTED|Overall Study||26||
60091774|NCT01995461|76208525|FG000|COMPLETED|Overall Study||21||
60091775|NCT01995461|76208525|FG000|NOT COMPLETED|Overall Study||5||
60091776|NCT01980095|76208531|FG000|STARTED|Overall Study|Protocol planned for 90 patients, protocol amendment increase up to 120 patients.|78||
60091777|NCT01980095|76208532|FG001|STARTED|Overall Study|Protocol planned for 90 patients, protocol amendment increase up to 120 patients.|41||
60091778|NCT01980095|76208531|FG000|Treated|Overall Study|Of 78 patients randomized, 1 patient erroneously randomized and not treated|77||
59707805|NCT01260350|75826687|FG007|COMPLETED|Overall Study||25||
59707806|NCT01260350|75826688|FG008|COMPLETED|Overall Study||24||
59707807|NCT01260350|75826689|FG009|COMPLETED|Overall Study||25||
60091779|NCT01980095|76208532|FG001|Treated|Overall Study||41||
60091780|NCT01980095|76208531|FG000|COMPLETED|Overall Study||63||
60091781|NCT01980095|76208532|FG001|COMPLETED|Overall Study||30||
60091782|NCT01980095|76208531|FG000|NOT COMPLETED|Overall Study||15||
59707808|NCT01260350|75826690|FG010|COMPLETED|Overall Study||10||
59707809|NCT01260350|75826691|FG011|COMPLETED|Overall Study||9||
60091783|NCT01980095|76208532|FG001|NOT COMPLETED|Overall Study||11||
60091784|NCT01980017|76208542|FG000|STARTED|Overall Study||114||
60091785|NCT01980017|76208543|FG001|STARTED|Overall Study||199||
60091786|NCT01980017|76208542|FG000|COMPLETED|Overall Study||84||
60091787|NCT01980017|76208543|FG001|COMPLETED|Overall Study||177||
60091788|NCT01980017|76208542|FG000|NOT COMPLETED|Overall Study||30||
60091789|NCT01980017|76208543|FG001|NOT COMPLETED|Overall Study||22||
60091790|NCT01978145|76208552|FG000|STARTED|Treatment Period 1||214||
60091791|NCT01978145|76208553|FG001|STARTED|Treatment Period 1||212||
60091792|NCT01978145|76208552|FG000|COMPLETED|Treatment Period 1||205||
60091793|NCT01978145|76208553|FG001|COMPLETED|Treatment Period 1||196||
60091794|NCT01978145|76208552|FG000|NOT COMPLETED|Treatment Period 1||9||
60091795|NCT01978145|76208553|FG001|NOT COMPLETED|Treatment Period 1||16||
60091796|NCT01978145|76208552|FG000|STARTED|Washout Period 1||205||
60091797|NCT01978145|76208553|FG001|STARTED|Washout Period 1||196||
60091798|NCT01978145|76208552|FG000|COMPLETED|Washout Period 1||204||
60091799|NCT01978145|76208553|FG001|COMPLETED|Washout Period 1||193||
60091800|NCT01978145|76208552|FG000|NOT COMPLETED|Washout Period 1||1||
60091801|NCT01978145|76208553|FG001|NOT COMPLETED|Washout Period 1||3||
60091802|NCT01978145|76208552|FG000|STARTED|Treatment Period 2||204||
60091803|NCT01978145|76208553|FG001|STARTED|Treatment Period 2||193||
60091804|NCT01978145|76208552|FG000|COMPLETED|Treatment Period 2||185||
60091805|NCT01978145|76208553|FG001|COMPLETED|Treatment Period 2||179||
60091806|NCT01978145|76208552|FG000|NOT COMPLETED|Treatment Period 2||19||
60091807|NCT01978145|76208553|FG001|NOT COMPLETED|Treatment Period 2||14||
60091808|NCT01967537|76208559|FG000|STARTED|Overall Study||341||
60091809|NCT01967537|76208559|FG000|COMPLETED|Overall Study||281||
60091810|NCT01967537|76208559|FG000|NOT COMPLETED|Overall Study||60||
60091811|NCT01967225|76208567|FG000|STARTED|Overall Study||84||
60091812|NCT01967225|76208568|FG001|STARTED|Overall Study||41||
60091813|NCT01967225|76208567|FG000|Participants Received Treatment|Overall Study||83||
60091814|NCT01967225|76208568|FG001|Participants Received Treatment|Overall Study||41||
60091815|NCT01967225|76208567|FG000|COMPLETED|Overall Study||72||
60091816|NCT01967225|76208568|FG001|COMPLETED|Overall Study||38||
60091817|NCT01967225|76208567|FG000|NOT COMPLETED|Overall Study||12||
60091818|NCT01967225|76208568|FG001|NOT COMPLETED|Overall Study||3||
60091819|NCT01967147|76208578|FG000|STARTED|Overall Study||112||
60091820|NCT01967147|76208579|FG001|STARTED|Overall Study||102||
60091821|NCT01967147|76208578|FG000|COMPLETED|Overall Study||99||
60091822|NCT01967147|76208579|FG001|COMPLETED|Overall Study||82||
60091823|NCT01967147|76208578|FG000|NOT COMPLETED|Overall Study||13||
60091824|NCT01967147|76208579|FG001|NOT COMPLETED|Overall Study||20||
60091825|NCT01967069|76208588|FG000|STARTED|Overall Study||182||
60091826|NCT01967069|76208589|FG001|STARTED|Overall Study||95||
60091827|NCT01967069|76208588|FG000|COMPLETED|Overall Study||174||
60091828|NCT01967069|76208589|FG001|COMPLETED|Overall Study||87||
60091829|NCT01967069|76208588|FG000|NOT COMPLETED|Overall Study||8||
60091830|NCT01967069|76208589|FG001|NOT COMPLETED|Overall Study||8||
60091831|NCT01790503|76208606|FG000|STARTED|Overall Study||3||
60091832|NCT01790503|76208607|FG001|STARTED|Overall Study||1||
60091833|NCT01790503|76208608|FG002|STARTED|Overall Study||1||
60091834|NCT01790503|76208609|FG003|STARTED|Overall Study||2||
60091835|NCT01790503|76208610|FG004|STARTED|Overall Study||5||
60091836|NCT01790503|76208611|FG005|STARTED|Overall Study||5||
60091837|NCT01790503|76208612|FG006|STARTED|Overall Study||1||
60091838|NCT01790503|76208613|FG007|STARTED|Overall Study||1||
60091839|NCT01790503|76208614|FG008|STARTED|Overall Study||3||
60091840|NCT01790503|76208615|FG009|STARTED|Overall Study||27||
60091841|NCT01790503|76208616|FG010|STARTED|Overall Study||16||
60091842|NCT01790503|76208606|FG000|COMPLETED|Overall Study||0||
60091843|NCT01790503|76208607|FG001|COMPLETED|Overall Study||0||
60091844|NCT01790503|76208608|FG002|COMPLETED|Overall Study||0||
60091845|NCT01790503|76208609|FG003|COMPLETED|Overall Study||0||
60091846|NCT01790503|76208610|FG004|COMPLETED|Overall Study||0||
60091847|NCT01790503|76208611|FG005|COMPLETED|Overall Study||0||
60091848|NCT01790503|76208612|FG006|COMPLETED|Overall Study||0||
60091849|NCT01790503|76208613|FG007|COMPLETED|Overall Study||0||
60091850|NCT01790503|76208614|FG008|COMPLETED|Overall Study||0||
60091851|NCT01790503|76208615|FG009|COMPLETED|Overall Study||1||
60091852|NCT01790503|76208616|FG010|COMPLETED|Overall Study||0||
60091853|NCT01790503|76208606|FG000|NOT COMPLETED|Overall Study||3||
60091854|NCT01790503|76208607|FG001|NOT COMPLETED|Overall Study||1||
60091855|NCT01790503|76208608|FG002|NOT COMPLETED|Overall Study||1||
60091856|NCT01790503|76208609|FG003|NOT COMPLETED|Overall Study||2||
60091857|NCT01790503|76208610|FG004|NOT COMPLETED|Overall Study||5||
60091858|NCT01790503|76208611|FG005|NOT COMPLETED|Overall Study||5||
60091859|NCT01790503|76208612|FG006|NOT COMPLETED|Overall Study||1||
60091860|NCT01790503|76208613|FG007|NOT COMPLETED|Overall Study||1||
60091861|NCT01790503|76208614|FG008|NOT COMPLETED|Overall Study||3||
60091862|NCT01790503|76208615|FG009|NOT COMPLETED|Overall Study||26||
60091863|NCT01790503|76208616|FG010|NOT COMPLETED|Overall Study||16||
60091864|NCT01790113|76208655|FG000|STARTED|Overall Study||79||
60091865|NCT01790113|76208656|FG001|STARTED|Overall Study||224||
60091866|NCT01790113|76208655|FG000|COMPLETED|Overall Study||76||
60091867|NCT01790113|76208656|FG001|COMPLETED|Overall Study||149||
60091868|NCT01790113|76208655|FG000|NOT COMPLETED|Overall Study||3||
60091869|NCT01790113|76208656|FG001|NOT COMPLETED|Overall Study||75||
60091870|NCT01789567|76208662|FG000|STARTED|Overall Study||20||
60091871|NCT01789567|76208662|FG000|COMPLETED|Overall Study||14||
60091872|NCT01789567|76208662|FG000|NOT COMPLETED|Overall Study||6||
60091873|NCT01765543|76208666|FG000|STARTED|Overall Study||27||
60091874|NCT01765543|76208666|FG000|COMPLETED|Overall Study||24||
60091875|NCT01765543|76208666|FG000|NOT COMPLETED|Overall Study||3||
60091876|NCT01765153|76208676|FG000|STARTED|Training Phase 1||10||
60091877|NCT01765153|76208677|FG001|STARTED|Training Phase 1||11||
59993060|NCT03436199|76108907|FG001|NOT COMPLETED|Overall Study||53||
59993061|NCT03436199|76108908|FG002|NOT COMPLETED|Overall Study||12||
59993062|NCT02131636|76108918|FG000|STARTED|Overall Study||222||
59993063|NCT02131636|76108919|FG001|STARTED|Overall Study||218||
59993064|NCT02131636|76108918|FG000|COMPLETED|Overall Study||210||
59993065|NCT02131636|76108919|FG001|COMPLETED|Overall Study||213||
59993066|NCT02131636|76108918|FG000|NOT COMPLETED|Overall Study||12||
59993067|NCT02131636|76108919|FG001|NOT COMPLETED|Overall Study||5||
59993068|NCT02131324|76108927|FG000|STARTED|Overall Study|2 subjects randomized into Comp01 not included in analysis as there was no post-baseline information|24||
59993069|NCT02131324|76108928|FG001|STARTED|Overall Study|2 subjects randomized into DFD-06 not included in analysis as there was no post-baseline information|26||
59993070|NCT02131324|76108927|FG000|Analyzed|Overall Study||22||
59993071|NCT02131324|76108928|FG001|Analyzed|Overall Study||24||
59993072|NCT02131324|76108927|FG000|COMPLETED|Overall Study||22||
59993073|NCT02131324|76108928|FG001|COMPLETED|Overall Study||23||
59993074|NCT02131324|76108927|FG000|NOT COMPLETED|Overall Study||2||
59993075|NCT02131324|76108928|FG001|NOT COMPLETED|Overall Study||3||
59993076|NCT02734693|76108937|FG000|STARTED|Overall Study||56||
59993077|NCT02734693|76108938|FG001|STARTED|Overall Study||56||
59993078|NCT02734693|76108939|FG002|STARTED|Overall Study||20||
59993079|NCT02734693|76108937|FG000|COMPLETED|Overall Study||50||
59993080|NCT02734693|76108938|FG001|COMPLETED|Overall Study||53||
59993081|NCT02734693|76108939|FG002|COMPLETED|Overall Study||17||
59993082|NCT02734693|76108937|FG000|NOT COMPLETED|Overall Study||6||
59993083|NCT02734693|76108938|FG001|NOT COMPLETED|Overall Study||3||
59993084|NCT02734693|76108939|FG002|NOT COMPLETED|Overall Study||3||
59993085|NCT02193880|76108947|FG000|STARTED|Overall Study||7||
59993086|NCT02193880|76108947|FG000|COMPLETED|Overall Study||4||
59993087|NCT02193880|76108947|FG000|NOT COMPLETED|Overall Study||3||
59993088|NCT01378325|76108953|FG000|STARTED|Overall Study||40||
59993089|NCT01378325|76108954|FG001|STARTED|Overall Study||40||
59993090|NCT01378325|76108953|FG000|COMPLETED|Overall Study||40||
59993091|NCT01378325|76108954|FG001|COMPLETED|Overall Study||39||
59993092|NCT01378325|76108953|FG000|NOT COMPLETED|Overall Study||0||
59993093|NCT01378325|76108954|FG001|NOT COMPLETED|Overall Study||1||
59993094|NCT01093573|76108963|FG000|STARTED|Overall Study||3||
59993095|NCT01093573|76108964|FG001|STARTED|Overall Study||3||
59993096|NCT01093573|76108965|FG002|STARTED|Overall Study||28||
59993097|NCT01093573|76108963|FG000|COMPLETED|Overall Study||3||
59993098|NCT01093573|76108964|FG001|COMPLETED|Overall Study||3||
59993099|NCT01093573|76108965|FG002|COMPLETED|Overall Study||26||
59993100|NCT01093573|76108963|FG000|NOT COMPLETED|Overall Study||0||
59993101|NCT01093573|76108964|FG001|NOT COMPLETED|Overall Study||0||
59993102|NCT01093573|76108965|FG002|NOT COMPLETED|Overall Study||2||
59993103|NCT04155203|76108979|FG000|STARTED|Overall Study||219||
59993104|NCT04155203|76108980|FG001|STARTED|Overall Study||219||
60091878|NCT01765153|76208676|FG000|COMPLETED|Training Phase 1||9||
60091879|NCT01765153|76208677|FG001|COMPLETED|Training Phase 1||10||
60091880|NCT01765153|76208676|FG000|NOT COMPLETED|Training Phase 1||1||
60091881|NCT01765153|76208677|FG001|NOT COMPLETED|Training Phase 1||1||
60091882|NCT01765153|76208676|FG000|STARTED|Rest Phase 1||9||
60091883|NCT01765153|76208677|FG001|STARTED|Rest Phase 1||10||
60091884|NCT01765153|76208676|FG000|COMPLETED|Rest Phase 1||9||
60091885|NCT01765153|76208677|FG001|COMPLETED|Rest Phase 1||9||
60091886|NCT01765153|76208676|FG000|NOT COMPLETED|Rest Phase 1||0||
60091887|NCT01765153|76208677|FG001|NOT COMPLETED|Rest Phase 1||1||
60091888|NCT01765153|76208676|FG000|STARTED|Training Phase 2|1st subject didn't use same training(phase 1) as subsequent participants Phase 1 and 2 data removed.|10||
60091889|NCT01765153|76208677|FG001|STARTED|Training Phase 2||9||
59993105|NCT04155203|76108981|FG002|STARTED|Overall Study||219||
60091890|NCT01765153|76208676|FG000|COMPLETED|Training Phase 2||10||
60091891|NCT01765153|76208677|FG001|COMPLETED|Training Phase 2||8||
60091892|NCT01765153|76208676|FG000|NOT COMPLETED|Training Phase 2||0||
60091893|NCT01765153|76208677|FG001|NOT COMPLETED|Training Phase 2||1||
60091894|NCT01765153|76208676|FG000|STARTED|Rest Phase 2||10||
60091895|NCT01765153|76208677|FG001|STARTED|Rest Phase 2||8||
60091896|NCT01765153|76208676|FG000|COMPLETED|Rest Phase 2||8||
60091897|NCT01765153|76208677|FG001|COMPLETED|Rest Phase 2||7||
60091898|NCT01765153|76208676|FG000|NOT COMPLETED|Rest Phase 2||2||
60091899|NCT01765153|76208677|FG001|NOT COMPLETED|Rest Phase 2||1||
60091900|NCT00248170|76208689|FG000|STARTED|Overall Study||2078||
59993106|NCT04155203|76108979|FG000|COMPLETED|Overall Study||165||
59993107|NCT04155203|76108980|FG001|COMPLETED|Overall Study||184||
59993108|NCT04155203|76108981|FG002|COMPLETED|Overall Study||165||
59993109|NCT04155203|76108979|FG000|NOT COMPLETED|Overall Study||54||
60091901|NCT00248170|76208690|FG001|STARTED|Overall Study||2094||
60091902|NCT00248170|76208689|FG000|Intent-to-treat (ITT)|Overall Study||2061||
60091903|NCT00248170|76208690|FG001|Intent-to-treat (ITT)|Overall Study||2075||
60091904|NCT00248170|76208689|FG000|Safety Set|Overall Study||2049||
60091905|NCT00248170|76208690|FG001|Safety Set|Overall Study||2062||
60091906|NCT00248170|76208689|FG000|COMPLETED|Overall Study||1317||
60091907|NCT00248170|76208690|FG001|COMPLETED|Overall Study||1286||
60091908|NCT00248170|76208689|FG000|NOT COMPLETED|Overall Study||761||
60091909|NCT00248170|76208690|FG001|NOT COMPLETED|Overall Study||808||
60091910|NCT01764997|76208701|FG000|STARTED|Run-in Period||776||
60091911|NCT01764997|76208702|FG001|STARTED|Run-in Period||0||
60091912|NCT01764997|76208703|FG002|STARTED|Run-in Period||0||
60091913|NCT01764997|76208704|FG003|STARTED|Run-in Period||0||
60091914|NCT01764997|76208705|FG004|STARTED|Run-in Period||0||
60091915|NCT01764997|76208701|FG000|COMPLETED|Run-in Period|43 participants proceeded to randomized treatment and 322 proceeded to open-label sub-study.|738||
60091916|NCT01764997|76208702|FG001|COMPLETED|Run-in Period||0||
60091917|NCT01764997|76208703|FG002|COMPLETED|Run-in Period||0||
60091918|NCT01764997|76208704|FG003|COMPLETED|Run-in Period||0||
60091919|NCT01764997|76208705|FG004|COMPLETED|Run-in Period||0||
60091920|NCT01764997|76208701|FG000|NOT COMPLETED|Run-in Period||38||
60091921|NCT01764997|76208702|FG001|NOT COMPLETED|Run-in Period||0||
60091922|NCT01764997|76208703|FG002|NOT COMPLETED|Run-in Period||0||
60091923|NCT01764997|76208704|FG003|NOT COMPLETED|Run-in Period||0||
60091924|NCT01764997|76208705|FG004|NOT COMPLETED|Run-in Period||0||
60091925|NCT01764997|76208701|FG000|STARTED|Study Drug Treatment Period||0||
60091926|NCT01764997|76208702|FG001|STARTED|Study Drug Treatment Period||17||
59561430|NCT02299349|75662887|FG001|COMPLETED|Overall Study||35||
59707810|NCT01260350|75826692|FG012|COMPLETED|Overall Study||25||
59707811|NCT01260350|75826693|FG013|COMPLETED|Overall Study||10||
59993110|NCT04155203|76108980|FG001|NOT COMPLETED|Overall Study||35||
59993111|NCT04155203|76108981|FG002|NOT COMPLETED|Overall Study||54||
59993112|NCT03057613|76108989|FG000|STARTED|Overall Study||18||
59993113|NCT03057613|76108989|FG000|COMPLETED|Overall Study||18||
59993114|NCT03057613|76108989|FG000|NOT COMPLETED|Overall Study||0||
59993115|NCT02733367|76108993|FG000|STARTED|Overall Study||18||
59993116|NCT02733367|76108993|FG000|COMPLETED|Overall Study||12||
59993117|NCT02733367|76108993|FG000|NOT COMPLETED|Overall Study||6||
59993118|NCT03688555|76109000|FG000|STARTED|Run-in Period||10||
59993119|NCT03688555|76109001|FG001|STARTED|Run-in Period||0||
59993120|NCT03688555|76109002|FG002|STARTED|Run-in Period||0||
59993121|NCT03688555|76109000|FG000|COMPLETED|Run-in Period||10||
59993122|NCT03688555|76109001|FG001|COMPLETED|Run-in Period||0||
59993123|NCT03688555|76109002|FG002|COMPLETED|Run-in Period||0||
59993124|NCT03688555|76109000|FG000|NOT COMPLETED|Run-in Period||0||
59993125|NCT03688555|76109001|FG001|NOT COMPLETED|Run-in Period||0||
59993126|NCT03688555|76109002|FG002|NOT COMPLETED|Run-in Period||0||
59993127|NCT03688555|76109000|FG000|STARTED|Treatment Period|All 10 participants that completed the run-in period were eligible to be randomized to ACT-774312 or placebo.|0||
59993128|NCT03688555|76109001|FG001|STARTED|Treatment Period||7||
59993129|NCT03688555|76109002|FG002|STARTED|Treatment Period||3||
59993130|NCT03688555|76109000|FG000|COMPLETED|Treatment Period||0||
59993131|NCT03688555|76109001|FG001|COMPLETED|Treatment Period||7||
59993132|NCT03688555|76109002|FG002|COMPLETED|Treatment Period||2||
59993133|NCT03688555|76109000|FG000|NOT COMPLETED|Treatment Period||0||
59993134|NCT03688555|76109001|FG001|NOT COMPLETED|Treatment Period||0||
59993135|NCT03688555|76109002|FG002|NOT COMPLETED|Treatment Period||1||
60091927|NCT01764997|76208703|FG002|STARTED|Study Drug Treatment Period||13||
60091928|NCT01764997|76208704|FG003|STARTED|Study Drug Treatment Period||13||
60091929|NCT01764997|76208705|FG004|STARTED|Study Drug Treatment Period||322||
60091930|NCT01764997|76208701|FG000|COMPLETED|Study Drug Treatment Period||0||
60091931|NCT01764997|76208702|FG001|COMPLETED|Study Drug Treatment Period||16||
60091932|NCT01764997|76208703|FG002|COMPLETED|Study Drug Treatment Period||13||
60091933|NCT01764997|76208704|FG003|COMPLETED|Study Drug Treatment Period||13||
60091934|NCT01764997|76208705|FG004|COMPLETED|Study Drug Treatment Period||286||
60091935|NCT01764997|76208701|FG000|NOT COMPLETED|Study Drug Treatment Period||0||
60091936|NCT01764997|76208702|FG001|NOT COMPLETED|Study Drug Treatment Period||1||
60091937|NCT01764997|76208703|FG002|NOT COMPLETED|Study Drug Treatment Period||0||
60091938|NCT01764997|76208704|FG003|NOT COMPLETED|Study Drug Treatment Period||0||
60091939|NCT01764997|76208705|FG004|NOT COMPLETED|Study Drug Treatment Period||36||
60091940|NCT01276756|76208717|FG000|STARTED|Overall Study||50||
60091941|NCT01276756|76208718|FG001|STARTED|Overall Study||50||
60091942|NCT01276756|76208717|FG000|COMPLETED|Overall Study||45||
60091943|NCT01276756|76208718|FG001|COMPLETED|Overall Study||48||
60091944|NCT01276756|76208717|FG000|NOT COMPLETED|Overall Study||5||
60091945|NCT01276756|76208718|FG001|NOT COMPLETED|Overall Study||2||
60091946|NCT00246376|76208729|FG000|STARTED|Overall Study||41||
60091947|NCT00246376|76208730|FG001|STARTED|Overall Study||43||
60091948|NCT00246376|76208731|FG002|STARTED|Overall Study||45||
59993136|NCT03349723|76109017|FG000|STARTED|Overall Study||6|Started are the Treated|
59993137|NCT03349723|76109018|FG001|STARTED|Overall Study||6|Started are the Treated|
59993138|NCT03349723|76109019|FG002|STARTED|Overall Study||6|Started are the Treated|
59993139|NCT03349723|76109020|FG003|STARTED|Overall Study||6|Started are the Treated|
59993140|NCT03349723|76109021|FG004|STARTED|Overall Study||6|Started are the Treated|
59993141|NCT03349723|76109022|FG005|STARTED|Overall Study||6|Started are the Treated|
59993142|NCT03349723|76109023|FG006|STARTED|Overall Study||6|Started are the Treated|
59993143|NCT03349723|76109024|FG007|STARTED|Overall Study||14|Started are the Treated|
60091949|NCT00246376|76208732|FG003|STARTED|Overall Study||47||
60091950|NCT00246376|76208733|FG004|STARTED|Overall Study||45||
60091951|NCT00246376|76208729|FG000|After Dietary run-in at Two Weeks|Overall Study||30||
60091952|NCT00246376|76208730|FG001|After Dietary run-in at Two Weeks|Overall Study||38||
60091953|NCT00246376|76208731|FG002|After Dietary run-in at Two Weeks|Overall Study||41||
60091954|NCT00246376|76208732|FG003|After Dietary run-in at Two Weeks|Overall Study||40||
60091955|NCT00246376|76208733|FG004|After Dietary run-in at Two Weeks|Overall Study||42||
60091956|NCT00246376|76208729|FG000|COMPLETED|Overall Study||26||
60091957|NCT00246376|76208730|FG001|COMPLETED|Overall Study||24||
60091958|NCT00246376|76208731|FG002|COMPLETED|Overall Study||29||
60091959|NCT00246376|76208732|FG003|COMPLETED|Overall Study||21||
60091960|NCT00246376|76208733|FG004|COMPLETED|Overall Study||28||
60091961|NCT00246376|76208729|FG000|NOT COMPLETED|Overall Study||15||
60091962|NCT00246376|76208730|FG001|NOT COMPLETED|Overall Study||19||
60091963|NCT00246376|76208731|FG002|NOT COMPLETED|Overall Study||16||
60091964|NCT00246376|76208732|FG003|NOT COMPLETED|Overall Study||26||
60091965|NCT00246376|76208733|FG004|NOT COMPLETED|Overall Study||17||
60091966|NCT00754156|76208753|FG000|STARTED|Overall Study||8||
60091967|NCT00754156|76208754|FG001|STARTED|Overall Study||6||
60091968|NCT00754156|76208753|FG000|COMPLETED|Overall Study||8||
60091969|NCT00754156|76208754|FG001|COMPLETED|Overall Study||6||
60091970|NCT00754156|76208753|FG000|NOT COMPLETED|Overall Study||0||
60091971|NCT00754156|76208754|FG001|NOT COMPLETED|Overall Study||0||
60091972|NCT00754468|76208768|FG000|STARTED|Overall Study||4||
60091973|NCT00754468|76208769|FG001|STARTED|Overall Study||3||
60091974|NCT00754468|76208768|FG000|COMPLETED|Overall Study||4||
60091975|NCT00754468|76208769|FG001|COMPLETED|Overall Study||3||
60091976|NCT00754468|76208768|FG000|NOT COMPLETED|Overall Study||0||
60091977|NCT00754468|76208769|FG001|NOT COMPLETED|Overall Study||0||
60091978|NCT00754546|76208777|FG000|STARTED|Overall Study||20||
60091979|NCT00754546|76208777|FG000|COMPLETED|Overall Study||20||
60091980|NCT00754546|76208777|FG000|NOT COMPLETED|Overall Study||0||
60091981|NCT01764841|76208791|FG000|STARTED|Overall Study||141||
60091982|NCT01764841|76208792|FG001|STARTED|Overall Study||137||
60091983|NCT01764841|76208793|FG002|STARTED|Overall Study||70||
60091984|NCT01764841|76208794|FG003|STARTED|Overall Study||68||
60091985|NCT01764841|76208791|FG000|Participants Received Treatment|Overall Study|safety population|141||
60091986|NCT01764841|76208792|FG001|Participants Received Treatment|Overall Study|safety population|136||
60091987|NCT01764841|76208793|FG002|Participants Received Treatment|Overall Study|safety population|69||
60091988|NCT01764841|76208794|FG003|Participants Received Treatment|Overall Study|safety population|68||
59993144|NCT03349723|76109017|FG000|COMPLETED|Overall Study||6||
60091989|NCT01764841|76208791|FG000|COMPLETED|Overall Study||118||
60091990|NCT01764841|76208792|FG001|COMPLETED|Overall Study||111||
60091991|NCT01764841|76208793|FG002|COMPLETED|Overall Study||56||
60091992|NCT01764841|76208794|FG003|COMPLETED|Overall Study||49||
60091993|NCT01764841|76208791|FG000|NOT COMPLETED|Overall Study||23||
60091994|NCT01764841|76208792|FG001|NOT COMPLETED|Overall Study||26||
60091995|NCT01764841|76208793|FG002|NOT COMPLETED|Overall Study||14||
60091996|NCT01764841|76208794|FG003|NOT COMPLETED|Overall Study||19||
60091997|NCT00245050|76208806|FG000|STARTED|Overall Study||18||
60091998|NCT00245050|76208807|FG001|STARTED|Overall Study||16||
60091999|NCT00245050|76208806|FG000|COMPLETED|Overall Study||15||
60092000|NCT00245050|76208807|FG001|COMPLETED|Overall Study||14||
60092001|NCT00245050|76208806|FG000|NOT COMPLETED|Overall Study||3||
60092002|NCT00245050|76208807|FG001|NOT COMPLETED|Overall Study||2||
60092003|NCT00778648|76208815|FG000|STARTED|Overall Study||272||
60092004|NCT00778648|76208816|FG001|STARTED|Overall Study||271||
60092005|NCT00778648|76208815|FG000|COMPLETED|Overall Study||263||
60092006|NCT00778648|76208816|FG001|COMPLETED|Overall Study||266||
60092007|NCT00778648|76208815|FG000|NOT COMPLETED|Overall Study||9||
60092008|NCT00778648|76208816|FG001|NOT COMPLETED|Overall Study||5||
60092009|NCT00763360|76208825|FG000|STARTED|Overall Study||61||
60092010|NCT00763360|76208826|FG001|STARTED|Overall Study||60||
60092011|NCT00763360|76208827|FG002|STARTED|Overall Study||63||
60092012|NCT00763360|76208825|FG000|COMPLETED|Overall Study||61||
59993145|NCT03349723|76109018|FG001|COMPLETED|Overall Study||6||
59993146|NCT03349723|76109019|FG002|COMPLETED|Overall Study||6||
59993147|NCT03349723|76109020|FG003|COMPLETED|Overall Study||6||
59993148|NCT03349723|76109021|FG004|COMPLETED|Overall Study||6||
59993149|NCT03349723|76109022|FG005|COMPLETED|Overall Study||6||
59707812|NCT01260350|75826694|FG014|COMPLETED|Overall Study||25||
59707813|NCT01260350|75826695|FG015|COMPLETED|Overall Study||10||
59707814|NCT01260350|75826696|FG016|COMPLETED|Overall Study||9||
59707815|NCT01260350|75826697|FG017|COMPLETED|Overall Study||9||
59707816|NCT01260350|75826698|FG018|COMPLETED|Overall Study||0||
59707817|NCT01260350|75826699|FG019|COMPLETED|Overall Study||14||
59707818|NCT01260350|75826700|FG020|COMPLETED|Overall Study||22||
59707819|NCT01260350|75826701|FG021|COMPLETED|Overall Study||0||
59707820|NCT01260350|75826680|FG000|NOT COMPLETED|Overall Study||0||
59707821|NCT01260350|75826681|FG001|NOT COMPLETED|Overall Study||0||
59707822|NCT01260350|75826682|FG002|NOT COMPLETED|Overall Study||0||
59707823|NCT01260350|75826683|FG003|NOT COMPLETED|Overall Study||0||
59707824|NCT01260350|75826684|FG004|NOT COMPLETED|Overall Study||0||
59707825|NCT01260350|75826685|FG005|NOT COMPLETED|Overall Study||0||
59707826|NCT01260350|75826686|FG006|NOT COMPLETED|Overall Study||0||
59707827|NCT01260350|75826687|FG007|NOT COMPLETED|Overall Study||0||
59707828|NCT01260350|75826688|FG008|NOT COMPLETED|Overall Study||1||
59707829|NCT01260350|75826689|FG009|NOT COMPLETED|Overall Study||0||
59707830|NCT01260350|75826690|FG010|NOT COMPLETED|Overall Study||0||
59707831|NCT01260350|75826691|FG011|NOT COMPLETED|Overall Study||0||
59707832|NCT01260350|75826692|FG012|NOT COMPLETED|Overall Study||0||
59707833|NCT01260350|75826693|FG013|NOT COMPLETED|Overall Study||0||
59707834|NCT01260350|75826694|FG014|NOT COMPLETED|Overall Study||0||
59707835|NCT01260350|75826695|FG015|NOT COMPLETED|Overall Study||0||
59707836|NCT01260350|75826696|FG016|NOT COMPLETED|Overall Study||0||
59707837|NCT01260350|75826697|FG017|NOT COMPLETED|Overall Study||1||
59707838|NCT01260350|75826698|FG018|NOT COMPLETED|Overall Study||0||
59707839|NCT01260350|75826699|FG019|NOT COMPLETED|Overall Study||0||
59707840|NCT01260350|75826700|FG020|NOT COMPLETED|Overall Study||3||
59993150|NCT03349723|76109023|FG006|COMPLETED|Overall Study||6||
59993151|NCT03349723|76109024|FG007|COMPLETED|Overall Study||14||
60092013|NCT00763360|76208826|FG001|COMPLETED|Overall Study||58||
60092014|NCT00763360|76208827|FG002|COMPLETED|Overall Study||63||
60092015|NCT00763360|76208825|FG000|NOT COMPLETED|Overall Study||0||
59707841|NCT01260350|75826701|FG021|NOT COMPLETED|Overall Study||0||
59707842|NCT01260194|75826755|FG000|STARTED|Overall Study||4||
59707843|NCT01260194|75826755|FG000|COMPLETED|Overall Study||3||
59707844|NCT01260194|75826755|FG000|NOT COMPLETED|Overall Study||1||
59707845|NCT01259726|75826763|FG000|STARTED|Overall Study||43||
59707846|NCT01259726|75826764|FG001|STARTED|Overall Study||41||
59707847|NCT01259726|75826765|FG002|STARTED|Overall Study||43||
59993152|NCT03349723|76109017|FG000|NOT COMPLETED|Overall Study||0||
59993153|NCT03349723|76109018|FG001|NOT COMPLETED|Overall Study||0||
60092016|NCT00763360|76208826|FG001|NOT COMPLETED|Overall Study||2||
60092017|NCT00763360|76208827|FG002|NOT COMPLETED|Overall Study||0||
60092018|NCT00763750|76208835|FG000|STARTED|Overall Study||25||
60092019|NCT00763750|76208835|FG000|COMPLETED|Overall Study||25||
60092020|NCT00763750|76208835|FG000|NOT COMPLETED|Overall Study||0||
60092021|NCT00756106|76208839|FG000|STARTED|Overall Study||15||
60092022|NCT00756106|76208839|FG000|COMPLETED|Overall Study||3||
60092023|NCT00756106|76208839|FG000|NOT COMPLETED|Overall Study||12||
60092024|NCT00243412|76208845|FG000|STARTED|Overall Study|Intent to treat|21||
60092025|NCT00243412|76208846|FG001|STARTED|Overall Study|Intent to treat|21||
59993154|NCT03349723|76109019|FG002|NOT COMPLETED|Overall Study||0||
59993155|NCT03349723|76109020|FG003|NOT COMPLETED|Overall Study||0||
59993156|NCT03349723|76109021|FG004|NOT COMPLETED|Overall Study||0||
60092026|NCT00243412|76208845|FG000|Safety Evaluable|Overall Study||21||
60092027|NCT00243412|76208846|FG001|Safety Evaluable|Overall Study||20||
60092028|NCT00243412|76208845|FG000|COMPLETED|Overall Study|Completed Week 104|11||
60092029|NCT00243412|76208846|FG001|COMPLETED|Overall Study|Completed Week 104|10||
60092030|NCT00243412|76208845|FG000|NOT COMPLETED|Overall Study||10||
59707848|NCT01259726|75826766|FG003|STARTED|Overall Study||41||
59707849|NCT01259726|75826763|FG000|Treated|Overall Study||40||
59707850|NCT01259726|75826764|FG001|Treated|Overall Study||37||
59707851|NCT01259726|75826765|FG002|Treated|Overall Study||41||
59707852|NCT01259726|75826766|FG003|Treated|Overall Study||39||
59707853|NCT01259726|75826763|FG000|COMPLETED|Overall Study||38||
59707854|NCT01259726|75826764|FG001|COMPLETED|Overall Study||37||
59707855|NCT01259726|75826765|FG002|COMPLETED|Overall Study||39||
59707856|NCT01259726|75826766|FG003|COMPLETED|Overall Study||36||
59993157|NCT03349723|76109022|FG005|NOT COMPLETED|Overall Study||0||
60092031|NCT00243412|76208846|FG001|NOT COMPLETED|Overall Study||11||
60092032|NCT00765232|76208854|FG000|STARTED|Overall Study||57||
60092033|NCT00765232|76208855|FG001|STARTED|Overall Study||54||
60092034|NCT00765232|76208854|FG000|COMPLETED|Overall Study||57||
60092035|NCT00765232|76208855|FG001|COMPLETED|Overall Study||54||
60092036|NCT00765232|76208854|FG000|NOT COMPLETED|Overall Study||0||
60092037|NCT00765232|76208855|FG001|NOT COMPLETED|Overall Study||0||
60092038|NCT03805750|76208861|FG000|STARTED|First Intervention - 4 Weeks||3||
60092039|NCT03805750|76208862|FG001|STARTED|First Intervention - 4 Weeks||4||
60092040|NCT03805750|76208861|FG000|COMPLETED|First Intervention - 4 Weeks||3||
60092041|NCT03805750|76208862|FG001|COMPLETED|First Intervention - 4 Weeks||4||
60092042|NCT03805750|76208861|FG000|NOT COMPLETED|First Intervention - 4 Weeks||0||
60092043|NCT03805750|76208862|FG001|NOT COMPLETED|First Intervention - 4 Weeks||0||
60092044|NCT03805750|76208861|FG000|STARTED|Second Intervention - 4 Weeks||3||
60092045|NCT03805750|76208862|FG001|STARTED|Second Intervention - 4 Weeks||4||
60092046|NCT03805750|76208861|FG000|COMPLETED|Second Intervention - 4 Weeks||3||
60092047|NCT03805750|76208862|FG001|COMPLETED|Second Intervention - 4 Weeks||2||
60092048|NCT03805750|76208861|FG000|NOT COMPLETED|Second Intervention - 4 Weeks||0||
60092049|NCT03805750|76208862|FG001|NOT COMPLETED|Second Intervention - 4 Weeks||2||
60092050|NCT03804268|76208870|FG000|STARTED|Overall Study||160||
60092051|NCT03804268|76208871|FG001|STARTED|Overall Study||163||
60092052|NCT03804268|76208870|FG000|COMPLETED|Overall Study||153||
60092053|NCT03804268|76208871|FG001|COMPLETED|Overall Study||161||
60092054|NCT03804268|76208870|FG000|NOT COMPLETED|Overall Study||7||
60092055|NCT03804268|76208871|FG001|NOT COMPLETED|Overall Study||2||
60092056|NCT00765856|76208878|FG000|STARTED|Titration Period||27||
60092057|NCT00765856|76208878|FG000|COMPLETED|Titration Period||24||
60092058|NCT00765856|76208878|FG000|NOT COMPLETED|Titration Period||3||
60092059|NCT00765856|76208878|FG000|STARTED|Maintenance Period||24||
60092060|NCT00765856|76208878|FG000|COMPLETED|Maintenance Period||18||
60092061|NCT00765856|76208878|FG000|NOT COMPLETED|Maintenance Period||6||
60092062|NCT00756496|76208885|FG000|STARTED|Overall Study||442||
60092063|NCT00756496|76208885|FG000|COMPLETED|Overall Study||442||
60092064|NCT00756496|76208885|FG000|NOT COMPLETED|Overall Study||0||
60092065|NCT00780208|76208890|FG000|STARTED|Overall Study||14||
60092066|NCT00780208|76208890|FG000|COMPLETED|Overall Study||8||
60092067|NCT00780208|76208890|FG000|NOT COMPLETED|Overall Study||6||
60092068|NCT00243022|76208896|FG000|STARTED|Overall Study||7||
60092069|NCT00243022|76208897|FG001|STARTED|Overall Study||5||
60092070|NCT00243022|76208896|FG000|COMPLETED|Overall Study||5||
60092071|NCT00243022|76208897|FG001|COMPLETED|Overall Study||4||
60092072|NCT00243022|76208896|FG000|NOT COMPLETED|Overall Study||2||
60092073|NCT00243022|76208897|FG001|NOT COMPLETED|Overall Study||1||
60092074|NCT00756964|76208906|FG000|STARTED|Overall Study||13||
60092075|NCT00756964|76208907|FG001|STARTED|Overall Study||13||
60092076|NCT00756964|76208906|FG000|COMPLETED|Overall Study||13||
60092077|NCT00756964|76208907|FG001|COMPLETED|Overall Study||13||
60092078|NCT00756964|76208906|FG000|NOT COMPLETED|Overall Study||0||
60092079|NCT00756964|76208907|FG001|NOT COMPLETED|Overall Study||0||
60092080|NCT00780442|76208915|FG000|STARTED|Overall Study||12||
60092081|NCT00780442|76208916|FG001|STARTED|Overall Study||15||
60092082|NCT00780442|76208915|FG000|COMPLETED|Overall Study||12||
60092083|NCT00780442|76208916|FG001|COMPLETED|Overall Study||15||
60092084|NCT00780442|76208915|FG000|NOT COMPLETED|Overall Study||0||
60092085|NCT00780442|76208916|FG001|NOT COMPLETED|Overall Study||0||
60092086|NCT00767338|76208926|FG000|STARTED|Overall Study||1||
60092087|NCT00767338|76208927|FG001|STARTED|Overall Study||2||
60092088|NCT00767338|76208928|FG002|STARTED|Overall Study||0||
60092089|NCT00767338|76208929|FG003|STARTED|Overall Study||0||
60092090|NCT00767338|76208926|FG000|COMPLETED|Overall Study||0||
60092091|NCT00767338|76208927|FG001|COMPLETED|Overall Study||0||
60092092|NCT00767338|76208928|FG002|COMPLETED|Overall Study||0||
60092093|NCT00767338|76208929|FG003|COMPLETED|Overall Study||0||
60092094|NCT00767338|76208926|FG000|NOT COMPLETED|Overall Study||1||
60092095|NCT00767338|76208927|FG001|NOT COMPLETED|Overall Study||2||
60092096|NCT00767338|76208928|FG002|NOT COMPLETED|Overall Study||0||
60092097|NCT00767338|76208929|FG003|NOT COMPLETED|Overall Study||0||
60092098|NCT00767572|76208939|FG000|STARTED|First Intervention (12 Weeks)||12||
60092099|NCT00767572|76208939|FG000|COMPLETED|First Intervention (12 Weeks)||12||
60092100|NCT00767572|76208939|FG000|NOT COMPLETED|First Intervention (12 Weeks)||0||
60092101|NCT00767572|76208939|FG000|STARTED|Washout (4 Weeks)||12||
60092102|NCT00767572|76208939|FG000|COMPLETED|Washout (4 Weeks)||12||
60092103|NCT00767572|76208939|FG000|NOT COMPLETED|Washout (4 Weeks)||0||
60092104|NCT00767572|76208939|FG000|STARTED|Second Intervention (12 Weeks)||12||
60092105|NCT00767572|76208939|FG000|COMPLETED|Second Intervention (12 Weeks)||12||
60092106|NCT00767572|76208939|FG000|NOT COMPLETED|Second Intervention (12 Weeks)||0||
60092107|NCT00780676|76208950|FG000|STARTED|Overall Study||9||
60092108|NCT00780676|76208951|FG001|STARTED|Overall Study||8||
59993158|NCT03349723|76109023|FG006|NOT COMPLETED|Overall Study||0||
59993159|NCT03349723|76109024|FG007|NOT COMPLETED|Overall Study||0||
59993160|NCT01328951|76109044|FG000|STARTED|Overall Study||321||
59993161|NCT01328951|76109045|FG001|STARTED|Overall Study||322||
59993162|NCT01328951|76109044|FG000|COMPLETED|Overall Study||0||
59561431|NCT02299349|75662886|FG000|NOT COMPLETED|Overall Study||0||
59993163|NCT01328951|76109045|FG001|COMPLETED|Overall Study||0||
60092109|NCT00780676|76208952|FG002|STARTED|Overall Study||13||
60092110|NCT00780676|76208953|FG003|STARTED|Overall Study||0||
60092111|NCT00780676|76208954|FG004|STARTED|Overall Study||0||
60092112|NCT00780676|76208950|FG000|COMPLETED|Overall Study||9||
60092113|NCT00780676|76208951|FG001|COMPLETED|Overall Study||8||
60092114|NCT00780676|76208952|FG002|COMPLETED|Overall Study||13||
60092115|NCT00780676|76208953|FG003|COMPLETED|Overall Study||0||
60092116|NCT00780676|76208954|FG004|COMPLETED|Overall Study||0||
60092117|NCT00780676|76208950|FG000|NOT COMPLETED|Overall Study||0||
60092118|NCT00780676|76208951|FG001|NOT COMPLETED|Overall Study||0||
60092119|NCT00780676|76208952|FG002|NOT COMPLETED|Overall Study||0||
60092120|NCT00780676|76208953|FG003|NOT COMPLETED|Overall Study||0||
60092121|NCT00780676|76208954|FG004|NOT COMPLETED|Overall Study||0||
60092122|NCT00768118|76208960|FG000|STARTED|Overall Study||11||
60092123|NCT00768118|76208960|FG000|COMPLETED|Overall Study||11||
60092124|NCT00768118|76208960|FG000|NOT COMPLETED|Overall Study||0||
60092125|NCT00757666|76208966|FG000|STARTED|Overall Study||34|566 subjects enrolled, of which 68 had all visits completed at the time of study termination.|
60092126|NCT00757666|76208967|FG001|STARTED|Overall Study||34|566 subjects enrolled, of which 68 had all visits completed at the time of study termination.|
60092127|NCT00757666|76208966|FG000|COMPLETED|Overall Study|Number of patients with complete CPX test results from 1 month and 2 month visits|12||
60092128|NCT00757666|76208967|FG001|COMPLETED|Overall Study|Number of patients with complete CPX test results from 1 month and 2 month visits|11||
60092129|NCT00757666|76208966|FG000|NOT COMPLETED|Overall Study||22||
60092130|NCT00757666|76208967|FG001|NOT COMPLETED|Overall Study||23||
60092131|NCT01736683|76208982|FG000|STARTED|Overall Study||7||
60092132|NCT01736683|76208983|FG001|STARTED|Overall Study||6||
60092133|NCT01736683|76208984|FG002|STARTED|Overall Study||21||
60092134|NCT01736683|76208985|FG003|STARTED|Overall Study||35||
60092135|NCT01736683|76208986|FG004|STARTED|Overall Study||5||
60092136|NCT01736683|76208982|FG000|COMPLETED|Overall Study|# who completed treatment|0||
60092137|NCT01736683|76208983|FG001|COMPLETED|Overall Study|# who completed treatment|0||
60092138|NCT01736683|76208984|FG002|COMPLETED|Overall Study|# who completed treatment|0||
60092139|NCT01736683|76208985|FG003|COMPLETED|Overall Study|# who completed treatment|0||
60092140|NCT01736683|76208986|FG004|COMPLETED|Overall Study|# who completed treatment|0||
60092141|NCT01736683|76208982|FG000|NOT COMPLETED|Overall Study||7||
59993164|NCT01328951|76109044|FG000|NOT COMPLETED|Overall Study||321||
59993165|NCT01328951|76109045|FG001|NOT COMPLETED|Overall Study||322||
59993166|NCT02611817|76109058|FG000|STARTED|Open-label Induction Phase||644||
59993167|NCT02611817|76109059|FG001|STARTED|Open-label Induction Phase||0||
60092142|NCT01736683|76208983|FG001|NOT COMPLETED|Overall Study||6||
60092143|NCT01736683|76208984|FG002|NOT COMPLETED|Overall Study||21||
60092144|NCT01736683|76208985|FG003|NOT COMPLETED|Overall Study||35||
60092145|NCT01736683|76208986|FG004|NOT COMPLETED|Overall Study||5||
60092146|NCT01788943|76209002|FG000|STARTED|Overall Study|Recruitment for study began.|13||
60092147|NCT01788943|76209003|FG001|STARTED|Overall Study||12||
60092148|NCT01788943|76209002|FG000|COMPLETED|Overall Study|2FA-PET Brain Image Analysis Completion Date|12||
60092149|NCT01788943|76209003|FG001|COMPLETED|Overall Study||12||
60092150|NCT01788943|76209002|FG000|NOT COMPLETED|Overall Study||1||
60092151|NCT01788943|76209003|FG001|NOT COMPLETED|Overall Study||0||
59993168|NCT02611817|76109060|FG002|STARTED|Open-label Induction Phase||0||
60092152|NCT00757822|76209011|FG000|STARTED|Overall Study||92||
60092153|NCT00757822|76209012|FG001|STARTED|Overall Study||88||
60092154|NCT00757822|76209011|FG000|Day of Surgery (DOS) Assessment|Overall Study||92||
60092155|NCT00757822|76209012|FG001|Day of Surgery (DOS) Assessment|Overall Study||88||
60103753|NCT04621227|76222001|FG000|NOT COMPLETED|Period 7 (4 Days)||0||
60103754|NCT04621227|76222001|FG000|STARTED|Period 8 (2 Days)||14||
60103755|NCT04621227|76222001|FG000|COMPLETED|Period 8 (2 Days)||13||
60103756|NCT04621227|76222001|FG000|NOT COMPLETED|Period 8 (2 Days)||1||
59995198|NCT02730169|76111014|FG001|COMPLETED|Overall Study||45||
60103757|NCT04597918|76222025|FG000|STARTED|Overall Study||99||
60103758|NCT04597918|76222025|FG000|COMPLETED|Overall Study||89||
60103759|NCT04597918|76222025|FG000|NOT COMPLETED|Overall Study||10||
60103760|NCT04317586|76222029|FG000|STARTED|Overall Study||16||17
60092156|NCT00757822|76209011|FG000|Withdrawal by Subject-no Intervention|Overall Study||1||
60092157|NCT00757822|76209012|FG001|Withdrawal by Subject-no Intervention|Overall Study||3||
60092158|NCT00757822|76209011|FG000|DOS Withdrawn by Investigator|Overall Study|No longer met inclusion criteria or developed exclusion criteria on DOS|6||
60092159|NCT00757822|76209012|FG001|DOS Withdrawn by Investigator|Overall Study|No longer met inclusion criteria or developed exclusion criteria on DOS|11||
60092160|NCT00757822|76209011|FG000|Received Study Intervention|Overall Study||85||
60092161|NCT00757822|76209012|FG001|Received Study Intervention|Overall Study||74||
60092162|NCT00757822|76209011|FG000|DOS: Post-operative Assessments|Overall Study||85||
60092163|NCT00757822|76209012|FG001|DOS: Post-operative Assessments|Overall Study||74||
60092164|NCT00757822|76209011|FG000|24-48 hr Telephone Assessment|Overall Study||85||
60092165|NCT00757822|76209012|FG001|24-48 hr Telephone Assessment|Overall Study||74||
60092166|NCT00757822|76209011|FG000|2-6 wk Post-op Assessment|Overall Study||85||
60092167|NCT00757822|76209012|FG001|2-6 wk Post-op Assessment|Overall Study||74||
60092168|NCT00757822|76209011|FG000|Data Entry, QC Assessment|Overall Study||85||
60092169|NCT00757822|76209012|FG001|Data Entry, QC Assessment|Overall Study||74||
60092170|NCT00757822|76209011|FG000|Withdrawn-low-risk for PONV|Overall Study|K score for PONV risk<2|12||
60092171|NCT00757822|76209012|FG001|Withdrawn-low-risk for PONV|Overall Study|K score for PONV risk < 2|9||
60092172|NCT00757822|76209011|FG000|Withdrawn-protocol Deviation|Overall Study||9||
60092173|NCT00757822|76209012|FG001|Withdrawn-protocol Deviation|Overall Study||8||
60092174|NCT00757822|76209011|FG000|Data Lock, Unblinding Analysis|Overall Study||64||
60092175|NCT00757822|76209012|FG001|Data Lock, Unblinding Analysis|Overall Study||57||
60092176|NCT00757822|76209011|FG000|COMPLETED|Overall Study||64||
60092177|NCT00757822|76209012|FG001|COMPLETED|Overall Study||57||
60092178|NCT00757822|76209011|FG000|NOT COMPLETED|Overall Study||28||
60092179|NCT00757822|76209012|FG001|NOT COMPLETED|Overall Study||31||
60092180|NCT01788163|76209030|FG000|STARTED|Overall Study||1458||
60092181|NCT01788163|76209031|FG001|STARTED|Overall Study||271||
60092182|NCT01788163|76209032|FG002|STARTED|Overall Study||62||
60092183|NCT01788163|76209033|FG003|STARTED|Overall Study||71||
60092184|NCT01788163|76209034|FG004|STARTED|Overall Study||94||
60092185|NCT01788163|76209035|FG005|STARTED|Overall Study||102||
60092186|NCT01788163|76209036|FG006|STARTED|Overall Study||50||
60092187|NCT01788163|76209037|FG007|STARTED|Overall Study||302||
60092188|NCT01788163|76209038|FG008|STARTED|Overall Study||972||
60092189|NCT01788163|76209030|FG000|COMPLETED|Overall Study||1403||
60092190|NCT01788163|76209031|FG001|COMPLETED|Overall Study||271||
60092191|NCT01788163|76209032|FG002|COMPLETED|Overall Study||62||
60092192|NCT01788163|76209033|FG003|COMPLETED|Overall Study||71||
60092193|NCT01788163|76209034|FG004|COMPLETED|Overall Study||94||
60092194|NCT01788163|76209035|FG005|COMPLETED|Overall Study||95||
60092195|NCT01788163|76209036|FG006|COMPLETED|Overall Study||49||
60092196|NCT01788163|76209037|FG007|COMPLETED|Overall Study||254||
60092197|NCT01788163|76209038|FG008|COMPLETED|Overall Study||956||
60092198|NCT01788163|76209030|FG000|NOT COMPLETED|Overall Study||55||
60092199|NCT01788163|76209031|FG001|NOT COMPLETED|Overall Study||0||
60092200|NCT01788163|76209032|FG002|NOT COMPLETED|Overall Study||0||
60092201|NCT01788163|76209033|FG003|NOT COMPLETED|Overall Study||0||
60092202|NCT01788163|76209034|FG004|NOT COMPLETED|Overall Study||0||
60092203|NCT01788163|76209035|FG005|NOT COMPLETED|Overall Study||7||
60092204|NCT01788163|76209036|FG006|NOT COMPLETED|Overall Study||1||
60092205|NCT01788163|76209037|FG007|NOT COMPLETED|Overall Study||48||
60092206|NCT01788163|76209038|FG008|NOT COMPLETED|Overall Study||16||
60092207|NCT00758758|76209125|FG000|STARTED|Overall Study||14||
60092208|NCT00758758|76209126|FG001|STARTED|Overall Study||74||
60092209|NCT00758758|76209127|FG002|STARTED|Overall Study||53||
60092210|NCT00758758|76209128|FG003|STARTED|Overall Study||6||
60092211|NCT00758758|76209129|FG004|STARTED|Overall Study||3||
60092212|NCT00758758|76209130|FG005|STARTED|Overall Study||50||
60092213|NCT00758758|76209131|FG006|STARTED|Overall Study||31||
60092214|NCT00758758|76209132|FG007|STARTED|Overall Study||0||
60092215|NCT00758758|76209125|FG000|COMPLETED|Overall Study||11||
60092216|NCT00758758|76209126|FG001|COMPLETED|Overall Study||49||
60092217|NCT00758758|76209127|FG002|COMPLETED|Overall Study||35||
60092218|NCT00758758|76209128|FG003|COMPLETED|Overall Study||4||
60092219|NCT00758758|76209129|FG004|COMPLETED|Overall Study||1||
60092220|NCT00758758|76209130|FG005|COMPLETED|Overall Study||36||
60092221|NCT00758758|76209131|FG006|COMPLETED|Overall Study||17||
60092222|NCT00758758|76209132|FG007|COMPLETED|Overall Study||0||
60092223|NCT00758758|76209125|FG000|NOT COMPLETED|Overall Study||3||
60092224|NCT00758758|76209126|FG001|NOT COMPLETED|Overall Study||25||
60092225|NCT00758758|76209127|FG002|NOT COMPLETED|Overall Study||18||
60092226|NCT00758758|76209128|FG003|NOT COMPLETED|Overall Study||2||
60092227|NCT00758758|76209129|FG004|NOT COMPLETED|Overall Study||2||
60092228|NCT00758758|76209130|FG005|NOT COMPLETED|Overall Study||14||
60092229|NCT00758758|76209131|FG006|NOT COMPLETED|Overall Study||14||
60092230|NCT00758758|76209132|FG007|NOT COMPLETED|Overall Study||0||
60092231|NCT00783952|76209158|FG000|STARTED|Overall Study||8||
60092232|NCT00783952|76209158|FG000|COMPLETED|Overall Study||8||
60092233|NCT00783952|76209158|FG000|NOT COMPLETED|Overall Study||0||
60092234|NCT00784030|76209165|FG000|STARTED|Overall Study||13||
60092235|NCT00784030|76209166|FG001|STARTED|Overall Study||10||
60092236|NCT00784030|76209165|FG000|COMPLETED|Overall Study||13||
60092237|NCT00784030|76209166|FG001|COMPLETED|Overall Study||10||
60092238|NCT00784030|76209165|FG000|NOT COMPLETED|Overall Study||0||
60092239|NCT00784030|76209166|FG001|NOT COMPLETED|Overall Study||0||
60092240|NCT01787461|76209174|FG000|STARTED|Overall Study||96||
60092241|NCT01787461|76209175|FG001|STARTED|Overall Study||98||
60092242|NCT01787461|76209174|FG000|COMPLETED|Overall Study||82||
60092243|NCT01787461|76209175|FG001|COMPLETED|Overall Study||89||
60092244|NCT01787461|76209174|FG000|NOT COMPLETED|Overall Study||14||
60092245|NCT01787461|76209175|FG001|NOT COMPLETED|Overall Study||9||
60092246|NCT00758836|76209185|FG000|STARTED|Overall Study||171||
60092247|NCT00758836|76209186|FG001|STARTED|Overall Study||171||
60092248|NCT00758836|76209187|FG002|STARTED|Overall Study||171||
60092249|NCT00758836|76209188|FG003|STARTED|Overall Study||170||
60092250|NCT00758836|76209185|FG000|Treated|Overall Study||147||
60092251|NCT00758836|76209186|FG001|Treated|Overall Study||145||
60092252|NCT00758836|76209187|FG002|Treated|Overall Study||133||
60092253|NCT00758836|76209188|FG003|Treated|Overall Study||138||
60092254|NCT00758836|76209185|FG000|COMPLETED|Overall Study||147||
60092255|NCT00758836|76209186|FG001|COMPLETED|Overall Study||145||
60092256|NCT00758836|76209187|FG002|COMPLETED|Overall Study||133||
60092257|NCT00758836|76209188|FG003|COMPLETED|Overall Study||138||
60092258|NCT00758836|76209185|FG000|NOT COMPLETED|Overall Study||24||
60092259|NCT00758836|76209186|FG001|NOT COMPLETED|Overall Study||26||
60092260|NCT00758836|76209187|FG002|NOT COMPLETED|Overall Study||38||
60092261|NCT00758836|76209188|FG003|NOT COMPLETED|Overall Study||32||
60092262|NCT01786993|76209200|FG000|STARTED|Overall Study||201||
60092263|NCT01786993|76209201|FG001|STARTED|Overall Study||180||
60092264|NCT01786993|76209200|FG000|Per Protocol Population at 9 Months|Overall Study||189||
60092265|NCT01786993|76209201|FG001|Per Protocol Population at 9 Months|Overall Study||170||
60092266|NCT01786993|76209200|FG000|COMPLETED|Overall Study||189||
60092267|NCT01786993|76209201|FG001|COMPLETED|Overall Study||170||
60092268|NCT01786993|76209200|FG000|NOT COMPLETED|Overall Study||12||
60092269|NCT01786993|76209201|FG001|NOT COMPLETED|Overall Study||10||
60092270|NCT00769600|76209210|FG000|STARTED|Overall Study||15||
60092271|NCT00769600|76209211|FG001|STARTED|Overall Study||8||
60092272|NCT00769600|76209210|FG000|COMPLETED|Overall Study||15||
60092273|NCT00769600|76209211|FG001|COMPLETED|Overall Study||8||
60092274|NCT00769600|76209210|FG000|NOT COMPLETED|Overall Study||0||
60092275|NCT00769600|76209211|FG001|NOT COMPLETED|Overall Study||0||
60092276|NCT01966445|76209226|FG000|STARTED|Part1 (Median Exposure of 6.143 Weeks)||1||
60092277|NCT01966445|76209227|FG001|STARTED|Part1 (Median Exposure of 6.143 Weeks)||3||
60092278|NCT01966445|76209228|FG002|STARTED|Part1 (Median Exposure of 6.143 Weeks)||2||
60092279|NCT01966445|76209229|FG003|STARTED|Part1 (Median Exposure of 6.143 Weeks)||5||
60092280|NCT01966445|76209230|FG004|STARTED|Part1 (Median Exposure of 6.143 Weeks)||4||
60092281|NCT01966445|76209231|FG005|STARTED|Part1 (Median Exposure of 6.143 Weeks)||5||
60092282|NCT01966445|76209232|FG006|STARTED|Part1 (Median Exposure of 6.143 Weeks)||0||
60092283|NCT01966445|76209226|FG000|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||1||
60092284|NCT01966445|76209227|FG001|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||1||
60092285|NCT01966445|76209228|FG002|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||1||
60092286|NCT01966445|76209229|FG003|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||2||
60092287|NCT01966445|76209230|FG004|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||1||
60092288|NCT01966445|76209231|FG005|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||4||
60092289|NCT01966445|76209232|FG006|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||0||
60092290|NCT01966445|76209226|FG000|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||0||
60092291|NCT01966445|76209227|FG001|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||2||
60092292|NCT01966445|76209228|FG002|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||1||
60092293|NCT01966445|76209229|FG003|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||3||
60092294|NCT01966445|76209230|FG004|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||3||
60092295|NCT01966445|76209231|FG005|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||1||
60092296|NCT01966445|76209232|FG006|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||0||
60092297|NCT01966445|76209226|FG000|STARTED|Part2 (Median Exposure of 7.143 Weeks)||0||
60092298|NCT01966445|76209227|FG001|STARTED|Part2 (Median Exposure of 7.143 Weeks)||0||
60092299|NCT01966445|76209228|FG002|STARTED|Part2 (Median Exposure of 7.143 Weeks)||0||
60092300|NCT01966445|76209229|FG003|STARTED|Part2 (Median Exposure of 7.143 Weeks)||0||
60092301|NCT01966445|76209230|FG004|STARTED|Part2 (Median Exposure of 7.143 Weeks)||0||
60092302|NCT01966445|76209231|FG005|STARTED|Part2 (Median Exposure of 7.143 Weeks)||0||
60092303|NCT01966445|76209232|FG006|STARTED|Part2 (Median Exposure of 7.143 Weeks)||9||
60092304|NCT01966445|76209226|FG000|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0||
60092305|NCT01966445|76209227|FG001|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0||
60092306|NCT01966445|76209228|FG002|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0||
60092307|NCT01966445|76209229|FG003|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0||
60092308|NCT01966445|76209230|FG004|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0||
60092309|NCT01966445|76209231|FG005|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0||
60092310|NCT01966445|76209232|FG006|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||4||
60092311|NCT01966445|76209226|FG000|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0||
60092312|NCT01966445|76209227|FG001|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0||
60092313|NCT01966445|76209228|FG002|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0||
60092314|NCT01966445|76209229|FG003|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0||
60092315|NCT01966445|76209230|FG004|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0||
60092316|NCT01966445|76209231|FG005|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0||
60092317|NCT01966445|76209232|FG006|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||5||
60092318|NCT01763905|76209252|FG000|STARTED|Overall Study||51||
60092319|NCT01763905|76209253|FG001|STARTED|Overall Study||51||
60092320|NCT01763905|76209254|FG002|STARTED|Overall Study||103||
60092321|NCT01763905|76209255|FG003|STARTED|Overall Study||102||
60092322|NCT01763905|76209252|FG000|COMPLETED|Overall Study||45||
60092323|NCT01763905|76209253|FG001|COMPLETED|Overall Study||50||
60092324|NCT01763905|76209254|FG002|COMPLETED|Overall Study||94||
60092325|NCT01763905|76209255|FG003|COMPLETED|Overall Study||101||
60092326|NCT01763905|76209252|FG000|NOT COMPLETED|Overall Study||6||
60092327|NCT01763905|76209253|FG001|NOT COMPLETED|Overall Study||1||
60092328|NCT01763905|76209254|FG002|NOT COMPLETED|Overall Study||9||
60092329|NCT01763905|76209255|FG003|NOT COMPLETED|Overall Study||1||
60092330|NCT02091167|76209267|FG000|STARTED|Overall Study||19||
60092331|NCT02091167|76209268|FG001|STARTED|Overall Study||16||
60092332|NCT02091167|76209267|FG000|COMPLETED|Overall Study||19||
60092333|NCT02091167|76209268|FG001|COMPLETED|Overall Study||14||
60092334|NCT02091167|76209267|FG000|NOT COMPLETED|Overall Study||0||
60092335|NCT02091167|76209268|FG001|NOT COMPLETED|Overall Study||2||
60092336|NCT02091089|76209274|FG000|STARTED|Overall Study||20||
60092337|NCT02091089|76209274|FG000|COMPLETED|Overall Study||18||
60092338|NCT02091089|76209274|FG000|NOT COMPLETED|Overall Study||2||
60092339|NCT00759772|76209280|FG000|STARTED|Overall Study||12||
60092340|NCT00759772|76209281|FG001|STARTED|Overall Study||11||
60092341|NCT00759772|76209280|FG000|COMPLETED|Overall Study||12||
60092342|NCT00759772|76209281|FG001|COMPLETED|Overall Study||11||
60092343|NCT00759772|76209280|FG000|NOT COMPLETED|Overall Study||0||
60092344|NCT00759772|76209281|FG001|NOT COMPLETED|Overall Study||0||
59561432|NCT02299349|75662887|FG001|NOT COMPLETED|Overall Study||0||
59561433|NCT03750461|75662895|FG000|STARTED|Overall Study||20||
59561434|NCT03750461|75662896|FG001|STARTED|Overall Study||92||
59561435|NCT03750461|75662895|FG000|Primary Endpoint|Overall Study||20||
59561436|NCT03750461|75662896|FG001|Primary Endpoint|Overall Study|Considered study completion for the Historical Controls.|92||
59561437|NCT03750461|75662895|FG000|Secondary Endpoint|Overall Study||19||
59561438|NCT03750461|75662896|FG001|Secondary Endpoint|Overall Study|Not applicable for the historical controls.|0||
59561439|NCT03750461|75662895|FG000|COMPLETED|Overall Study||19|Ongoing Follow-up|
59561440|NCT03750461|75662896|FG001|COMPLETED|Overall Study|Not applicable for the historical controls; no follow-up data was collected.|0|Ongoing Follow-up|
59561441|NCT03750461|75662895|FG000|NOT COMPLETED|Overall Study||1||
59561442|NCT03750461|75662896|FG001|NOT COMPLETED|Overall Study||92||
59561443|NCT03296163|75662904|FG000|STARTED|Combination Therapy||315||
59561444|NCT03296163|75662905|FG001|STARTED|Combination Therapy||312||
59561445|NCT03296163|75662904|FG000|COMPLETED|Combination Therapy||207||
59561446|NCT03296163|75662905|FG001|COMPLETED|Combination Therapy||220||
59561447|NCT03296163|75662904|FG000|NOT COMPLETED|Combination Therapy||108||
59561448|NCT03296163|75662905|FG001|NOT COMPLETED|Combination Therapy||92||
59561449|NCT03296163|75662904|FG000|STARTED|Monotherapy||207||
59561450|NCT03296163|75662905|FG001|STARTED|Monotherapy||220||
59561451|NCT03296163|75662904|FG000|COMPLETED|Monotherapy||68||
60092345|NCT01763203|76209289|FG000|STARTED|Overall Study||241||
60092346|NCT01763203|76209290|FG001|STARTED|Overall Study||246||
60092347|NCT01763203|76209289|FG000|COMPLETED|Overall Study||208||
60092348|NCT01763203|76209290|FG001|COMPLETED|Overall Study||204||
60092349|NCT01763203|76209289|FG000|NOT COMPLETED|Overall Study||33||
60092350|NCT01763203|76209290|FG001|NOT COMPLETED|Overall Study||42||
60092351|NCT00771238|76209298|FG000|STARTED|Overall Study||31||
59561452|NCT03296163|75662905|FG001|COMPLETED|Monotherapy||74||
59561453|NCT03296163|75662904|FG000|NOT COMPLETED|Monotherapy||139||
59561454|NCT03296163|75662905|FG001|NOT COMPLETED|Monotherapy||146||
59561455|NCT01987349|75662919|FG000|STARTED|Overall Study||6||
59561456|NCT01987349|75662920|FG001|STARTED|Overall Study||6||
59561457|NCT01987349|75662921|FG002|STARTED|Overall Study||8||
59561458|NCT01987349|75662922|FG003|STARTED|Overall Study||6||
60092352|NCT00771238|76209299|FG001|STARTED|Overall Study||21||
60092353|NCT00771238|76209298|FG000|COMPLETED|Overall Study||31||
60092354|NCT00771238|76209299|FG001|COMPLETED|Overall Study||21||
60092355|NCT00771238|76209298|FG000|NOT COMPLETED|Overall Study||0||
60092356|NCT00771238|76209299|FG001|NOT COMPLETED|Overall Study||0||
60092357|NCT01763047|76209307|FG000|STARTED|Period 1||139||
60092358|NCT01763047|76209308|FG001|STARTED|Period 1||137||
60092359|NCT01763047|76209307|FG000|Myopes|Period 1||77||
60092360|NCT01763047|76209308|FG001|Myopes|Period 1||76||
60092361|NCT01763047|76209307|FG000|Hyperopes|Period 1||62||
60092362|NCT01763047|76209308|FG001|Hyperopes|Period 1||61||
60092363|NCT01763047|76209307|FG000|COMPLETED|Period 1||130||
60092364|NCT01763047|76209308|FG001|COMPLETED|Period 1||126||
60092365|NCT01763047|76209307|FG000|NOT COMPLETED|Period 1||9||
60092366|NCT01763047|76209308|FG001|NOT COMPLETED|Period 1||11||
60092367|NCT01763047|76209307|FG000|STARTED|Period 2||130||
59561459|NCT01987349|75662923|FG004|STARTED|Overall Study||6||
59561460|NCT01987349|75662924|FG005|STARTED|Overall Study||6||
59561461|NCT01987349|75662925|FG006|STARTED|Overall Study||10||
59561462|NCT01987349|75662926|FG007|STARTED|Overall Study||25||
60092368|NCT01763047|76209308|FG001|STARTED|Period 2||126||
59561463|NCT01987349|75662919|FG000|COMPLETED|Overall Study||6||
59707857|NCT01259726|75826763|FG000|NOT COMPLETED|Overall Study||5||
59707858|NCT01259726|75826764|FG001|NOT COMPLETED|Overall Study||4||
59707859|NCT01259726|75826765|FG002|NOT COMPLETED|Overall Study||4||
59707860|NCT01259726|75826766|FG003|NOT COMPLETED|Overall Study||5||
59707861|NCT01259492|75826780|FG000|STARTED|Period 1 (9 Weeks)||181||
59707862|NCT01259492|75826781|FG001|STARTED|Period 1 (9 Weeks)||182||
59707863|NCT01259492|75826782|FG002|STARTED|Period 1 (9 Weeks)||181||
59707864|NCT01259492|75826783|FG003|STARTED|Period 1 (9 Weeks)||181||
59707865|NCT01259492|75826780|FG000|Full Analysis Set|Period 1 (9 Weeks)||174||
59707866|NCT01259492|75826781|FG001|Full Analysis Set|Period 1 (9 Weeks)||175||
59707867|NCT01259492|75826782|FG002|Full Analysis Set|Period 1 (9 Weeks)||179||
59707868|NCT01259492|75826783|FG003|Full Analysis Set|Period 1 (9 Weeks)||172||
59707869|NCT01259492|75826780|FG000|COMPLETED|Period 1 (9 Weeks)|"Completed indicates patients entered Period 2."|152||
59707870|NCT01259492|75826781|FG001|COMPLETED|Period 1 (9 Weeks)|Completed = entered Period 2|141||
59707871|NCT01259492|75826782|FG002|COMPLETED|Period 1 (9 Weeks)|Completed = entered Period 2|138||
59707872|NCT01259492|75826783|FG003|COMPLETED|Period 1 (9 Weeks)|Completed = entered Period 2|153||
60092369|NCT01763047|76209307|FG000|Myopes|Period 2||74||
60092370|NCT01763047|76209308|FG001|Myopes|Period 2||72||
59707873|NCT01259492|75826780|FG000|NOT COMPLETED|Period 1 (9 Weeks)||29||
59707874|NCT01259492|75826781|FG001|NOT COMPLETED|Period 1 (9 Weeks)||41||
59707875|NCT01259492|75826782|FG002|NOT COMPLETED|Period 1 (9 Weeks)||43||
59707876|NCT01259492|75826783|FG003|NOT COMPLETED|Period 1 (9 Weeks)||28||
59707877|NCT01259492|75826780|FG000|STARTED|Period 2 (Week 10 to Week 14)|Treatment arms including Placebo indicate patients belong to respective treatment arms in Period 1|152||
59707878|NCT01259492|75826781|FG001|STARTED|Period 2 (Week 10 to Week 14)||141||
59707879|NCT01259492|75826782|FG002|STARTED|Period 2 (Week 10 to Week 14)||138||
59707880|NCT01259492|75826783|FG003|STARTED|Period 2 (Week 10 to Week 14)||153||
59707881|NCT01259492|75826780|FG000|COMPLETED|Period 2 (Week 10 to Week 14)|Completed = entered Period 3|127||
59707882|NCT01259492|75826781|FG001|COMPLETED|Period 2 (Week 10 to Week 14)|Completed = entered Period 3|123||
59707883|NCT01259492|75826782|FG002|COMPLETED|Period 2 (Week 10 to Week 14)|Completed = entered Period 3|114||
59707884|NCT01259492|75826783|FG003|COMPLETED|Period 2 (Week 10 to Week 14)|Completed = entered Period 3|125||
59707885|NCT01259492|75826780|FG000|NOT COMPLETED|Period 2 (Week 10 to Week 14)||25||
59707886|NCT01259492|75826781|FG001|NOT COMPLETED|Period 2 (Week 10 to Week 14)||18||
59707887|NCT01259492|75826782|FG002|NOT COMPLETED|Period 2 (Week 10 to Week 14)||24||
59707888|NCT01259492|75826783|FG003|NOT COMPLETED|Period 2 (Week 10 to Week 14)||28||
59707889|NCT01259492|75826780|FG000|STARTED|Period 3 (Week 15 to End of Week 40)|In period 3, all 489 patients who completed period 2 were re-randomized to 4 arms.|114||
59707890|NCT01259492|75826781|FG001|STARTED|Period 3 (Week 15 to End of Week 40)||132||
59707891|NCT01259492|75826782|FG002|STARTED|Period 3 (Week 15 to End of Week 40)||120||
59707892|NCT01259492|75826783|FG003|STARTED|Period 3 (Week 15 to End of Week 40)||123||
59707893|NCT01259492|75826780|FG000|Full Analysis Set|Period 3 (Week 15 to End of Week 40)||110||
59707894|NCT01259492|75826781|FG001|Full Analysis Set|Period 3 (Week 15 to End of Week 40)||128||
59707895|NCT01259492|75826782|FG002|Full Analysis Set|Period 3 (Week 15 to End of Week 40)||114||
59707896|NCT01259492|75826783|FG003|Full Analysis Set|Period 3 (Week 15 to End of Week 40)||115||
59993169|NCT02611817|76109058|FG000|COMPLETED|Open-label Induction Phase||594|Completers included participants who received OL vedolizumab IV and had Week 14 visit.|
59993170|NCT02611817|76109059|FG001|COMPLETED|Open-label Induction Phase||0|Completers included participants who received OL vedolizumab IV and had Week 14 visit.|
59993171|NCT02611817|76109060|FG002|COMPLETED|Open-label Induction Phase||0|Completers included participants who received OL vedolizumab IV and had Week 14 visit.|
59993172|NCT02611817|76109058|FG000|NOT COMPLETED|Open-label Induction Phase||50||
59707897|NCT01259492|75826780|FG000|COMPLETED|Period 3 (Week 15 to End of Week 40)|completed study|60||
59993173|NCT02611817|76109059|FG001|NOT COMPLETED|Open-label Induction Phase||0||
59993174|NCT02611817|76109060|FG002|NOT COMPLETED|Open-label Induction Phase||0||
59993175|NCT02611817|76109058|FG000|STARTED|Double-blind Maintenance Phase||0|Participants who achieved clinical response at Week 6 entered the Maintenance Phase.|
60092371|NCT01763047|76209307|FG000|Hyperopes|Period 2||56||
60092372|NCT01763047|76209308|FG001|Hyperopes|Period 2||54||
60092373|NCT01763047|76209307|FG000|COMPLETED|Period 2||126||
60092374|NCT01763047|76209308|FG001|COMPLETED|Period 2||121||
60092375|NCT01763047|76209307|FG000|NOT COMPLETED|Period 2||4||
60092376|NCT01763047|76209308|FG001|NOT COMPLETED|Period 2||5||
60092377|NCT01977677|76209320|FG000|STARTED|Overall Study||3||
60092378|NCT01977677|76209321|FG001|STARTED|Overall Study||6||
60092379|NCT01977677|76209322|FG002|STARTED|Overall Study||21||
60092380|NCT01977677|76209320|FG000|COMPLETED|Overall Study||3||
60092381|NCT01977677|76209321|FG001|COMPLETED|Overall Study||6||
60092382|NCT01977677|76209322|FG002|COMPLETED|Overall Study||20||
60092383|NCT01977677|76209320|FG000|NOT COMPLETED|Overall Study||0||
60092384|NCT01977677|76209321|FG001|NOT COMPLETED|Overall Study||0||
60092385|NCT01977677|76209322|FG002|NOT COMPLETED|Overall Study||1||
60092386|NCT01762345|76209330|FG000|STARTED|Overall Study||83||
60092387|NCT01762345|76209330|FG000|COMPLETED|Overall Study||76||
60092388|NCT01762345|76209330|FG000|NOT COMPLETED|Overall Study||7||
60092389|NCT02090855|76209335|FG000|STARTED|Overall Study||108||
60092390|NCT02090855|76209335|FG000|COMPLETED|Overall Study||106||
60092391|NCT02090855|76209335|FG000|NOT COMPLETED|Overall Study||2||
59816852|NCT03730194|75939243|FG004|COMPLETED|First Stage Treatment||0|"This study utilizes a SMART Design.~1 participant from the Melatonin Only group withdrew from the study. 1 participant from the Bedtime Bank Only group withdrew from the study.~3 participants in the Melatonin Only group & 3 participants in the Bedtime Bank Only group did not complete all study requirements (e.g., minimum actigraph days). These 6 participants remained in the pilot SMART study (did not want to withdraw), and repeated there assigned treatment in the Second Stage."|
59816853|NCT03730194|75939244|FG005|COMPLETED|First Stage Treatment||0|"This study utilizes a SMART Design.~1 participant from the Melatonin Only group withdrew from the study. 1 participant from the Bedtime Bank Only group withdrew from the study.~3 participants in the Melatonin Only group & 3 participants in the Bedtime Bank Only group did not complete all study requirements (e.g., minimum actigraph days). These 6 participants remained in the pilot SMART study (did not want to withdraw), and repeated there assigned treatment in the Second Stage."|
59816854|NCT03730194|75939239|FG000|NOT COMPLETED|First Stage Treatment||4||
59816855|NCT03730194|75939240|FG001|NOT COMPLETED|First Stage Treatment||4||
59816856|NCT03730194|75939241|FG002|NOT COMPLETED|First Stage Treatment||0||
59816857|NCT03730194|75939242|FG003|NOT COMPLETED|First Stage Treatment||0||
59816858|NCT03730194|75939243|FG004|NOT COMPLETED|First Stage Treatment||0||
59816859|NCT03730194|75939244|FG005|NOT COMPLETED|First Stage Treatment||0||
59816860|NCT03730194|75939239|FG000|STARTED|Second Stage Treatment|** 3 participants did not complete all study requirements during the first stage intervention (noted as protocol violation). Melatonin intervention repeated.|7||
59816861|NCT03730194|75939240|FG001|STARTED|Second Stage Treatment|** 3 participants did not complete all study requirements during the first stage intervention (noted as protocol violation). The Bedtime Bank intervention repeated.|5||
59816862|NCT03730194|75939241|FG002|STARTED|Second Stage Treatment||6||
59816863|NCT03730194|75939242|FG003|STARTED|Second Stage Treatment||6||
60092392|NCT01761565|76209342|FG000|STARTED|Single Dose of SUF NT 15 mcg||40||
60092393|NCT01761565|76209342|FG000|COMPLETED|Single Dose of SUF NT 15 mcg||40||
60092394|NCT01761565|76209342|FG000|NOT COMPLETED|Single Dose of SUF NT 15 mcg||0||
60092395|NCT01761565|76209342|FG000|STARTED|40 Consecutive Doses of SUF 15 mcg|Subject was withdrawn from the study prior to the second arm/period due to non-compliance|39||
60092396|NCT01761565|76209342|FG000|COMPLETED|40 Consecutive Doses of SUF 15 mcg||38||
60092397|NCT01761565|76209342|FG000|NOT COMPLETED|40 Consecutive Doses of SUF 15 mcg||1||
60092398|NCT01619579|76209352|FG000|STARTED|Overall Study||5||
60092399|NCT01619579|76209353|FG001|STARTED|Overall Study||17||
60092400|NCT01619579|76209352|FG000|COMPLETED|Overall Study||5||
60092401|NCT01619579|76209353|FG001|COMPLETED|Overall Study||14||
59816864|NCT03730194|75939243|FG004|STARTED|Second Stage Treatment||7||
59816865|NCT03730194|75939244|FG005|STARTED|Second Stage Treatment||7||
59816866|NCT03730194|75939239|FG000|COMPLETED|Second Stage Treatment||7||
59816867|NCT03730194|75939240|FG001|COMPLETED|Second Stage Treatment||5||
59816868|NCT03730194|75939241|FG002|COMPLETED|Second Stage Treatment||6||
60092402|NCT01619579|76209352|FG000|NOT COMPLETED|Overall Study||0||
60092403|NCT01619579|76209353|FG001|NOT COMPLETED|Overall Study||3||
60092404|NCT01736215|76209359|FG000|STARTED|Overall Study||33||
60092405|NCT01736215|76209359|FG000|Treated|Overall Study||25||
60092406|NCT01736215|76209359|FG000|COMPLETED|Overall Study||19||
60092407|NCT01736215|76209359|FG000|NOT COMPLETED|Overall Study||14||
60092408|NCT01786603|76209365|FG000|STARTED|Overall Study||60||
60092409|NCT01786603|76209366|FG001|STARTED|Overall Study||20||
60092410|NCT01786603|76209365|FG000|COMPLETED|Overall Study||42||
60092411|NCT01786603|76209366|FG001|COMPLETED|Overall Study||8||
60092412|NCT01786603|76209365|FG000|NOT COMPLETED|Overall Study||18||
60092413|NCT01786603|76209366|FG001|NOT COMPLETED|Overall Study||12||
60092414|NCT00786916|76209375|FG000|STARTED|Overall Study||39||
60092415|NCT00786916|76209376|FG001|STARTED|Overall Study||36||
60092416|NCT00786916|76209377|FG002|STARTED|Overall Study||34||
60092417|NCT00786916|76209375|FG000|COMPLETED|Overall Study||39||
60092418|NCT00786916|76209376|FG001|COMPLETED|Overall Study||36||
60092419|NCT00786916|76209377|FG002|COMPLETED|Overall Study||34||
60092420|NCT00786916|76209375|FG000|NOT COMPLETED|Overall Study||0||
60092421|NCT00786916|76209376|FG001|NOT COMPLETED|Overall Study||0||
60092422|NCT00786916|76209377|FG002|NOT COMPLETED|Overall Study||0||
60092423|NCT01619423|76209389|FG000|STARTED|Part 1 (Dose Escalation)||0||
60092424|NCT01619423|76209390|FG001|STARTED|Part 1 (Dose Escalation)||5||
60092425|NCT01619423|76209391|FG002|STARTED|Part 1 (Dose Escalation)||3||
60092426|NCT01619423|76209392|FG003|STARTED|Part 1 (Dose Escalation)||5||
60092427|NCT01619423|76209389|FG000|COMPLETED|Part 1 (Dose Escalation)||0||
60092428|NCT01619423|76209390|FG001|COMPLETED|Part 1 (Dose Escalation)||3||
60092429|NCT01619423|76209391|FG002|COMPLETED|Part 1 (Dose Escalation)||3||
59816869|NCT03730194|75939242|FG003|COMPLETED|Second Stage Treatment||6||
60092430|NCT01619423|76209392|FG003|COMPLETED|Part 1 (Dose Escalation)||5||
60092431|NCT01619423|76209389|FG000|NOT COMPLETED|Part 1 (Dose Escalation)||0||
60092432|NCT01619423|76209390|FG001|NOT COMPLETED|Part 1 (Dose Escalation)||2||
60092433|NCT01619423|76209391|FG002|NOT COMPLETED|Part 1 (Dose Escalation)||0||
60092434|NCT01619423|76209392|FG003|NOT COMPLETED|Part 1 (Dose Escalation)||0||
60092435|NCT01619423|76209389|FG000|STARTED|Part 2a||15||
60092436|NCT01619423|76209390|FG001|STARTED|Part 2a||13||
60092437|NCT01619423|76209391|FG002|STARTED|Part 2a||0||
60092438|NCT01619423|76209392|FG003|STARTED|Part 2a||11||
60092439|NCT01619423|76209389|FG000|COMPLETED|Part 2a||15||
60092440|NCT01619423|76209390|FG001|COMPLETED|Part 2a||13||
60092441|NCT01619423|76209391|FG002|COMPLETED|Part 2a||0||
60092442|NCT01619423|76209392|FG003|COMPLETED|Part 2a||11||
60092443|NCT01619423|76209389|FG000|NOT COMPLETED|Part 2a||0||
60092444|NCT01619423|76209390|FG001|NOT COMPLETED|Part 2a||0||
60092445|NCT01619423|76209391|FG002|NOT COMPLETED|Part 2a||0||
60092446|NCT01619423|76209392|FG003|NOT COMPLETED|Part 2a||0||
60092447|NCT01619423|76209389|FG000|STARTED|Part 2b||45||
60092448|NCT01619423|76209390|FG001|STARTED|Part 2b||44||
59816870|NCT03730194|75939243|FG004|COMPLETED|Second Stage Treatment||7||
59816871|NCT03730194|75939244|FG005|COMPLETED|Second Stage Treatment||7||
59816872|NCT03730194|75939239|FG000|NOT COMPLETED|Second Stage Treatment||0||
59816873|NCT03730194|75939240|FG001|NOT COMPLETED|Second Stage Treatment||0||
59993176|NCT02611817|76109059|FG001|STARTED|Double-blind Maintenance Phase||135|Participants who achieved clinical response at Week 6 entered the Maintenance Phase.|
59993177|NCT02611817|76109060|FG002|STARTED|Double-blind Maintenance Phase||275|Participants who achieved clinical response at Week 6 entered the Maintenance Phase.|
59993178|NCT02611817|76109058|FG000|COMPLETED|Double-blind Maintenance Phase||0||
59993179|NCT02611817|76109059|FG001|COMPLETED|Double-blind Maintenance Phase||73||
59993180|NCT02611817|76109060|FG002|COMPLETED|Double-blind Maintenance Phase||168||
59993181|NCT02611817|76109058|FG000|NOT COMPLETED|Double-blind Maintenance Phase||0||
59993182|NCT02611817|76109059|FG001|NOT COMPLETED|Double-blind Maintenance Phase||62||
59993183|NCT02611817|76109060|FG002|NOT COMPLETED|Double-blind Maintenance Phase||107||
59993184|NCT02735915|76109067|FG000|STARTED|Overall Study||70|Started=Number of subjects enrolled into the study (Total enrolled cohort for persistence phase)|
59993185|NCT02735915|76109067|FG000|Vaccinated|Overall Study||62|Vaccinated=Number of subjects that started the Total Vaccinated Cohort (TVc) for revaccination phase|
60092449|NCT01619423|76209391|FG002|STARTED|Part 2b||45||
60092450|NCT01619423|76209392|FG003|STARTED|Part 2b||0||
60092451|NCT01619423|76209389|FG000|COMPLETED|Part 2b||45||
60092452|NCT01619423|76209390|FG001|COMPLETED|Part 2b||44||
60092453|NCT01619423|76209391|FG002|COMPLETED|Part 2b||45||
60092454|NCT01619423|76209392|FG003|COMPLETED|Part 2b||0||
60092455|NCT01619423|76209389|FG000|NOT COMPLETED|Part 2b||0||
60092456|NCT01619423|76209390|FG001|NOT COMPLETED|Part 2b||0||
60092457|NCT01619423|76209391|FG002|NOT COMPLETED|Part 2b||0||
60092458|NCT01619423|76209392|FG003|NOT COMPLETED|Part 2b||0||
60092459|NCT01735279|76209405|FG000|STARTED|Overall Study||29||
60092460|NCT01735279|76209406|FG001|STARTED|Overall Study||29||
60092461|NCT01735279|76209405|FG000|COMPLETED|Overall Study||18||
60092462|NCT01735279|76209406|FG001|COMPLETED|Overall Study||21||
60092463|NCT01735279|76209405|FG000|NOT COMPLETED|Overall Study||11||
60092464|NCT01735279|76209406|FG001|NOT COMPLETED|Overall Study||8||
60092465|NCT01759381|76209414|FG000|STARTED|Overall Study||8||
60092466|NCT01759381|76209415|FG001|STARTED|Overall Study||11||
60092467|NCT01759381|76209414|FG000|COMPLETED|Overall Study||7||
60092468|NCT01759381|76209415|FG001|COMPLETED|Overall Study||11||
60092469|NCT01759381|76209414|FG000|NOT COMPLETED|Overall Study||1||
60092470|NCT01759381|76209415|FG001|NOT COMPLETED|Overall Study||0||
60092471|NCT04662671|76209423|FG000|STARTED|Overall Study||20||
60092472|NCT04662671|76209424|FG001|STARTED|Overall Study||11||
60092473|NCT04662671|76209423|FG000|COMPLETED|Overall Study||20||
60092474|NCT04662671|76209424|FG001|COMPLETED|Overall Study||11||
60092475|NCT04662671|76209423|FG000|NOT COMPLETED|Overall Study||0||
60092476|NCT04662671|76209424|FG001|NOT COMPLETED|Overall Study||0||
60092477|NCT01758523|76209434|FG000|STARTED|Overall Study||74||
60092478|NCT01758523|76209435|FG001|STARTED|Overall Study||68||
60092479|NCT01758523|76209434|FG000|Attended >/= 1 Visit Post-randomization|Overall Study||68||
60092480|NCT01758523|76209435|FG001|Attended >/= 1 Visit Post-randomization|Overall Study||67||
60092481|NCT01758523|76209434|FG000|COMPLETED|Overall Study||53||
59816874|NCT03730194|75939241|FG002|NOT COMPLETED|Second Stage Treatment||0||
59816875|NCT03730194|75939242|FG003|NOT COMPLETED|Second Stage Treatment||0||
59816876|NCT03730194|75939243|FG004|NOT COMPLETED|Second Stage Treatment||0||
60092482|NCT01758523|76209435|FG001|COMPLETED|Overall Study||54||
60092483|NCT01758523|76209434|FG000|NOT COMPLETED|Overall Study||21||
60092484|NCT01758523|76209435|FG001|NOT COMPLETED|Overall Study||14||
60092485|NCT00773422|76209448|FG000|STARTED|Overall Study||11||
60092486|NCT00773422|76209449|FG001|STARTED|Overall Study||9||
60092487|NCT00773422|76209450|FG002|STARTED|Overall Study||10||
60092488|NCT00773422|76209448|FG000|COMPLETED|Overall Study||11||
59993186|NCT02735915|76109067|FG000|COMPLETED|Overall Study||59||
60092489|NCT00773422|76209449|FG001|COMPLETED|Overall Study||9||
60092490|NCT00773422|76209450|FG002|COMPLETED|Overall Study||10||
59707898|NCT01259492|75826781|FG001|COMPLETED|Period 3 (Week 15 to End of Week 40)|completed study|63||
59707899|NCT01259492|75826782|FG002|COMPLETED|Period 3 (Week 15 to End of Week 40)|completed study|70||
59707900|NCT01259492|75826783|FG003|COMPLETED|Period 3 (Week 15 to End of Week 40)|completed study|42||
59707901|NCT01259492|75826780|FG000|NOT COMPLETED|Period 3 (Week 15 to End of Week 40)||54||
59707902|NCT01259492|75826781|FG001|NOT COMPLETED|Period 3 (Week 15 to End of Week 40)||69||
59707903|NCT01259492|75826782|FG002|NOT COMPLETED|Period 3 (Week 15 to End of Week 40)||50||
59707904|NCT01259492|75826783|FG003|NOT COMPLETED|Period 3 (Week 15 to End of Week 40)||81||
59816877|NCT03730194|75939244|FG005|NOT COMPLETED|Second Stage Treatment||0||
59816878|NCT03559400|75939253|FG000|STARTED|Overall Study||45||
59816879|NCT03559400|75939254|FG001|STARTED|Overall Study||55||
59816880|NCT03559400|75939253|FG000|COMPLETED|Overall Study||36||
59816881|NCT03559400|75939254|FG001|COMPLETED|Overall Study||46||
60092491|NCT00773422|76209448|FG000|NOT COMPLETED|Overall Study||0||
60092492|NCT00773422|76209449|FG001|NOT COMPLETED|Overall Study||0||
60092493|NCT00773422|76209450|FG002|NOT COMPLETED|Overall Study||0||
60092494|NCT01758289|76209458|FG000|STARTED|Overall Study||105||
60092495|NCT01758289|76209458|FG000|COMPLETED|Overall Study||52||
60092496|NCT01758289|76209458|FG000|NOT COMPLETED|Overall Study||53||
60092497|NCT00786994|76209470|FG000|STARTED|Overall Study||57||
60092498|NCT00786994|76209471|FG001|STARTED|Overall Study||54||
60092499|NCT00786994|76209472|FG002|STARTED|Overall Study||26||
60092500|NCT00786994|76209473|FG003|STARTED|Overall Study||28||
60092501|NCT00786994|76209470|FG000|ITT|Overall Study||53||
60092502|NCT00786994|76209471|FG001|ITT|Overall Study||51||
60092503|NCT00786994|76209472|FG002|ITT|Overall Study||25||
60092504|NCT00786994|76209473|FG003|ITT|Overall Study||28||
60092505|NCT00786994|76209470|FG000|COMPLETED|Overall Study||47||
60092506|NCT00786994|76209471|FG001|COMPLETED|Overall Study||39||
60092507|NCT00786994|76209472|FG002|COMPLETED|Overall Study||24||
60092508|NCT00786994|76209473|FG003|COMPLETED|Overall Study||22||
60092509|NCT00786994|76209470|FG000|NOT COMPLETED|Overall Study||10||
60092510|NCT00786994|76209471|FG001|NOT COMPLETED|Overall Study||15||
60092511|NCT00786994|76209472|FG002|NOT COMPLETED|Overall Study||2||
60092512|NCT00786994|76209473|FG003|NOT COMPLETED|Overall Study||6||
60092513|NCT01757821|76209482|FG000|STARTED|Overall Study|11 subjects|11||
60092514|NCT01757821|76209482|FG000|COMPLETED|Overall Study|10 subjects|10||
60092515|NCT01757821|76209482|FG000|NOT COMPLETED|Overall Study||1||
60092516|NCT00774202|76209492|FG000|STARTED|Overall Study||9||
60092517|NCT00774202|76209493|FG001|STARTED|Overall Study||8||
60092518|NCT00774202|76209492|FG000|COMPLETED|Overall Study||9||
60092519|NCT00774202|76209493|FG001|COMPLETED|Overall Study||8||
60092520|NCT00774202|76209492|FG000|NOT COMPLETED|Overall Study||0||
60092521|NCT00774202|76209493|FG001|NOT COMPLETED|Overall Study||0||
60092522|NCT01735201|76209511|FG000|STARTED|Overall Study||45||
60092523|NCT01735201|76209512|FG001|STARTED|Overall Study||44||
60092524|NCT01735201|76209513|FG002|STARTED|Overall Study||44||
60092525|NCT01735201|76209514|FG003|STARTED|Overall Study||44||
60092526|NCT01735201|76209515|FG004|STARTED|Overall Study||45||
60092527|NCT01735201|76209516|FG005|STARTED|Overall Study||45||
60092528|NCT01735201|76209517|FG006|STARTED|Overall Study||45||
60092529|NCT01735201|76209518|FG007|STARTED|Overall Study||44||
60092530|NCT01735201|76209511|FG000|COMPLETED|Overall Study||42||
60092531|NCT01735201|76209512|FG001|COMPLETED|Overall Study||43||
60092532|NCT01735201|76209513|FG002|COMPLETED|Overall Study||44||
59707905|NCT01117623|75826800|FG000|STARTED|Overall Study||3||
59707906|NCT01117623|75826801|FG001|STARTED|Overall Study||8||
59707907|NCT01117623|75826802|FG002|STARTED|Overall Study||11||
59707908|NCT01117623|75826803|FG003|STARTED|Overall Study||6||
60092533|NCT01735201|76209514|FG003|COMPLETED|Overall Study||42||
60092534|NCT01735201|76209515|FG004|COMPLETED|Overall Study||44||
60092535|NCT01735201|76209516|FG005|COMPLETED|Overall Study||40||
60092536|NCT01735201|76209517|FG006|COMPLETED|Overall Study||42||
60092537|NCT01735201|76209518|FG007|COMPLETED|Overall Study||42||
59707909|NCT01117623|75826804|FG004|STARTED|Overall Study||10||
59707910|NCT01117623|75826805|FG005|STARTED|Overall Study||16||
59707911|NCT01117623|75826806|FG006|STARTED|Overall Study||6||
59816882|NCT03559400|75939253|FG000|NOT COMPLETED|Overall Study||9||
59816883|NCT03559400|75939254|FG001|NOT COMPLETED|Overall Study||9||
59816884|NCT03483012|75939261|FG000|STARTED|Overall Study||6||
59816885|NCT03483012|75939261|FG000|COMPLETED|Overall Study||0||
59816886|NCT03483012|75939261|FG000|NOT COMPLETED|Overall Study||6||
60092538|NCT01735201|76209511|FG000|NOT COMPLETED|Overall Study||3||
60092539|NCT01735201|76209512|FG001|NOT COMPLETED|Overall Study||1||
60092540|NCT01735201|76209513|FG002|NOT COMPLETED|Overall Study||0||
60092541|NCT01735201|76209514|FG003|NOT COMPLETED|Overall Study||2||
60092542|NCT01735201|76209515|FG004|NOT COMPLETED|Overall Study||1||
60092543|NCT01735201|76209516|FG005|NOT COMPLETED|Overall Study||5||
60092544|NCT01735201|76209517|FG006|NOT COMPLETED|Overall Study||3||
60092545|NCT01735201|76209518|FG007|NOT COMPLETED|Overall Study||2||
60092546|NCT01734811|76209538|FG000|STARTED|Overall Study||58||
60092547|NCT01734811|76209539|FG001|STARTED|Overall Study||62||
60092548|NCT01734811|76209538|FG000|COMPLETED|Overall Study||54||
60092549|NCT01734811|76209539|FG001|COMPLETED|Overall Study||59||
60092550|NCT01734811|76209538|FG000|NOT COMPLETED|Overall Study||4||
60092551|NCT01734811|76209539|FG001|NOT COMPLETED|Overall Study||3||
60092552|NCT01757275|76209547|FG000|STARTED|Overall Study||111||
60092553|NCT01757275|76209548|FG001|STARTED|Overall Study||111||
60092554|NCT01757275|76209547|FG000|COMPLETED|Overall Study||102||
60092555|NCT01757275|76209548|FG001|COMPLETED|Overall Study||98||
60092556|NCT01757275|76209547|FG000|NOT COMPLETED|Overall Study||9||
60092557|NCT01757275|76209548|FG001|NOT COMPLETED|Overall Study||13||
60092558|NCT00787852|76209556|FG000|STARTED|Overall Study||6||
60092559|NCT00787852|76209557|FG001|STARTED|Overall Study|The study was terminated prior to enrolled to group 2|5||
60092560|NCT00787852|76209556|FG000|COMPLETED|Overall Study|1 patient withdrew consent prior to starting|5||
60092561|NCT00787852|76209557|FG001|COMPLETED|Overall Study||5||
60092562|NCT00787852|76209556|FG000|NOT COMPLETED|Overall Study||1||
60092563|NCT00787852|76209557|FG001|NOT COMPLETED|Overall Study||0||
60092564|NCT01757197|76209563|FG000|STARTED|Overall Study||2||
60092565|NCT01757197|76209563|FG000|COMPLETED|Overall Study||0||
60092566|NCT01757197|76209563|FG000|NOT COMPLETED|Overall Study||2||
60092567|NCT00788008|76209569|FG000|STARTED|Overall Study||98||
60092568|NCT00788008|76209570|FG001|STARTED|Overall Study||101||
60092569|NCT00788008|76209569|FG000|COMPLETED|Overall Study||98||
60092570|NCT00788008|76209570|FG001|COMPLETED|Overall Study||101||
60092571|NCT00788008|76209569|FG000|NOT COMPLETED|Overall Study||0||
60092572|NCT00788008|76209570|FG001|NOT COMPLETED|Overall Study||0||
60092573|NCT00760006|76209578|FG000|STARTED|Overall Study||86||
60092574|NCT00760006|76209579|FG001|STARTED|Overall Study||138||
59816887|NCT03455673|75939265|FG000|STARTED|Overall Study||3160|Potentially eligible patients|
59816888|NCT03455673|75939265|FG000|Patients With an ATE Score|Overall Study||3099||
59816889|NCT03455673|75939265|FG000|COMPLETED|Overall Study||3072||
59816890|NCT03455673|75939265|FG000|NOT COMPLETED|Overall Study||88||
59816891|NCT03231709|75939271|FG000|STARTED|Treatment Period 1||30||
59816892|NCT03231709|75939272|FG001|STARTED|Treatment Period 1||30||
59816893|NCT03231709|75939271|FG000|COMPLETED|Treatment Period 1||30||
59816894|NCT03231709|75939272|FG001|COMPLETED|Treatment Period 1||29||
59816895|NCT03231709|75939271|FG000|NOT COMPLETED|Treatment Period 1||0||
59816896|NCT03231709|75939272|FG001|NOT COMPLETED|Treatment Period 1||1||
59816897|NCT03231709|75939271|FG000|STARTED|Treatment Period 2||30||
59816898|NCT03231709|75939272|FG001|STARTED|Treatment Period 2||29||
59816899|NCT03231709|75939271|FG000|COMPLETED|Treatment Period 2||30||
59816900|NCT03231709|75939272|FG001|COMPLETED|Treatment Period 2||28||
59816901|NCT03231709|75939271|FG000|NOT COMPLETED|Treatment Period 2||0||
59816902|NCT03231709|75939272|FG001|NOT COMPLETED|Treatment Period 2||1||
59993187|NCT02735915|76109067|FG000|NOT COMPLETED|Overall Study||11||
59993188|NCT02557139|76109076|FG000|STARTED|Overall Study||8||
59993189|NCT02557139|76109077|FG001|STARTED|Overall Study||8||
59993190|NCT02557139|76109078|FG002|STARTED|Overall Study||7||
59993191|NCT02557139|76109076|FG000|COMPLETED|Overall Study||6||
60092575|NCT00760006|76209578|FG000|COMPLETED|Overall Study||86||
60092576|NCT00760006|76209579|FG001|COMPLETED|Overall Study||138||
60092577|NCT00760006|76209578|FG000|NOT COMPLETED|Overall Study||0||
60092578|NCT00760006|76209579|FG001|NOT COMPLETED|Overall Study||0||
60092579|NCT01784965|76209587|FG000|STARTED|Overall Study||33||
60092580|NCT01784965|76209588|FG001|STARTED|Overall Study||35||
60092581|NCT01784965|76209587|FG000|COMPLETED|Overall Study||27||
60092582|NCT01784965|76209588|FG001|COMPLETED|Overall Study||24||
60092583|NCT01784965|76209587|FG000|NOT COMPLETED|Overall Study||6||
60092584|NCT01784965|76209588|FG001|NOT COMPLETED|Overall Study||11||
59993192|NCT02557139|76109077|FG001|COMPLETED|Overall Study||8||
59993193|NCT02557139|76109078|FG002|COMPLETED|Overall Study||5||
59993194|NCT02557139|76109076|FG000|NOT COMPLETED|Overall Study||2||
59993195|NCT02557139|76109077|FG001|NOT COMPLETED|Overall Study||0||
59993196|NCT02557139|76109078|FG002|NOT COMPLETED|Overall Study||2||
59993197|NCT01328717|76109095|FG000|STARTED|Overall Study||78||
59993198|NCT01328717|76109095|FG000|COMPLETED|Overall Study||77||
59993199|NCT01328717|76109095|FG000|NOT COMPLETED|Overall Study||1||
59993200|NCT01677741|76109107|FG000|STARTED|Overall Study||3|All subjects who received at least one dose of study treatment were included in All treated population and Safety population|
59993201|NCT01677741|76109108|FG001|STARTED|Overall Study||10|All subjects who received at least one dose of study treatment were included in All treated population and Safety population|
60092585|NCT01784419|76209596|FG000|STARTED|Overall Study||10||
60092586|NCT01784419|76209596|FG000|COMPLETED|Overall Study||7||
60092587|NCT01784419|76209596|FG000|NOT COMPLETED|Overall Study||3||
60092588|NCT01784029|76209603|FG000|STARTED|Overall Study||61||
60092589|NCT01784029|76209604|FG001|STARTED|Overall Study||59||
60092590|NCT01784029|76209605|FG002|STARTED|Overall Study||63||
60092591|NCT01784029|76209603|FG000|COMPLETED|Overall Study||42||
60092592|NCT01784029|76209604|FG001|COMPLETED|Overall Study||39||
59993202|NCT01677741|76109109|FG002|STARTED|Overall Study||8|All subjects who received at least one dose of study treatment were included in All treated population and Safety population|
60092593|NCT01784029|76209605|FG002|COMPLETED|Overall Study||41||
60092594|NCT01784029|76209603|FG000|NOT COMPLETED|Overall Study||19||
60092595|NCT01784029|76209604|FG001|NOT COMPLETED|Overall Study||20||
60092596|NCT01784029|76209605|FG002|NOT COMPLETED|Overall Study||22||
60092597|NCT00789256|76209615|FG000|STARTED|Overall Study||14||
60092598|NCT00789256|76209616|FG001|STARTED|Overall Study||12||
60092599|NCT00789256|76209615|FG000|COMPLETED|Overall Study|Strata 1 had 5 responders and continued accrual, but the study was closed due to low accrual.|14||
60092600|NCT00789256|76209616|FG001|COMPLETED|Overall Study||12||
59816915|NCT03014479|75939302|FG000|STARTED|Overall Study||110||
59816916|NCT03014479|75939303|FG001|STARTED|Overall Study||109||
59816917|NCT03014479|75939302|FG000|COMPLETED|Overall Study||110||
59816918|NCT03014479|75939303|FG001|COMPLETED|Overall Study||105||
59816919|NCT03014479|75939302|FG000|NOT COMPLETED|Overall Study||0||
59816920|NCT03014479|75939303|FG001|NOT COMPLETED|Overall Study||4||
59816921|NCT02937818|75939313|FG000|STARTED|Overall Study||21||
59816922|NCT02937818|75939314|FG001|STARTED|Overall Study||20||
59816923|NCT02937818|75939315|FG002|STARTED|Overall Study||10||
60092601|NCT00789256|76209615|FG000|NOT COMPLETED|Overall Study||0||
60092602|NCT00789256|76209616|FG001|NOT COMPLETED|Overall Study||0||
60092603|NCT01733329|76209627|FG000|STARTED|Overall Study||62||
60092604|NCT01733329|76209628|FG001|STARTED|Overall Study||61||
60092605|NCT01733329|76209627|FG000|COMPLETED|Overall Study||60||
60092606|NCT01733329|76209628|FG001|COMPLETED|Overall Study||60||
60092607|NCT01733329|76209627|FG000|NOT COMPLETED|Overall Study||2||
60092608|NCT01733329|76209628|FG001|NOT COMPLETED|Overall Study||1||
60092609|NCT01783483|76209636|FG000|STARTED|Overall Study||120||
60092610|NCT01783483|76209637|FG001|STARTED|Overall Study||116||
60092611|NCT01783483|76209636|FG000|COMPLETED|Overall Study||100||
60092612|NCT01783483|76209637|FG001|COMPLETED|Overall Study||101||
60092613|NCT01783483|76209636|FG000|NOT COMPLETED|Overall Study||20||
60092614|NCT01783483|76209637|FG001|NOT COMPLETED|Overall Study||15||
60092615|NCT02145676|76209646|FG000|STARTED|Overall Study||17||
60092616|NCT02145676|76209647|FG001|STARTED|Overall Study||18||
60092617|NCT02145676|76209648|FG002|STARTED|Overall Study||18||
60092618|NCT02145676|76209646|FG000|COMPLETED|Overall Study||17||
60092619|NCT02145676|76209647|FG001|COMPLETED|Overall Study||18||
60092620|NCT02145676|76209648|FG002|COMPLETED|Overall Study||18||
60092621|NCT02145676|76209646|FG000|NOT COMPLETED|Overall Study||0||
59707912|NCT01117623|75826807|FG007|STARTED|Overall Study||26||
59707913|NCT01117623|75826800|FG000|ITT Efficacy Analysis Population|Overall Study||3||
59707914|NCT01117623|75826801|FG001|ITT Efficacy Analysis Population|Overall Study||8||
59707915|NCT01117623|75826802|FG002|ITT Efficacy Analysis Population|Overall Study||11||
59707916|NCT01117623|75826803|FG003|ITT Efficacy Analysis Population|Overall Study||5||
59707917|NCT01117623|75826804|FG004|ITT Efficacy Analysis Population|Overall Study||10||
59707918|NCT01117623|75826805|FG005|ITT Efficacy Analysis Population|Overall Study||16||
59707919|NCT01117623|75826806|FG006|ITT Efficacy Analysis Population|Overall Study||6||
59707920|NCT01117623|75826807|FG007|ITT Efficacy Analysis Population|Overall Study||22||
59707921|NCT01117623|75826800|FG000|PK Population|Overall Study||3||
59707922|NCT01117623|75826801|FG001|PK Population|Overall Study||8||
59707923|NCT01117623|75826802|FG002|PK Population|Overall Study||10||
59707924|NCT01117623|75826803|FG003|PK Population|Overall Study||6||
59707925|NCT01117623|75826804|FG004|PK Population|Overall Study||10||
59707926|NCT01117623|75826805|FG005|PK Population|Overall Study||14||
59816924|NCT02937818|75939316|FG003|STARTED|Overall Study||21||
59816925|NCT02937818|75939313|FG000|COMPLETED|Overall Study||0||
59816926|NCT02937818|75939314|FG001|COMPLETED|Overall Study||0||
59816927|NCT02937818|75939315|FG002|COMPLETED|Overall Study||0||
59993203|NCT01677741|76109110|FG003|STARTED|Overall Study||6|All subjects who received at least one dose of study treatment were included in All treated population and Safety population|
59993204|NCT01677741|76109111|FG004|STARTED|Overall Study||17|All subjects who received at least one dose of study treatment were included in All treated population and Safety population|
59993205|NCT01677741|76109112|FG005|STARTED|Overall Study||28|All subjects who received at least one dose of study treatment were included in All treated population and Safety population|
59993206|NCT01677741|76109113|FG006|STARTED|Overall Study||11|All subjects who received at least one dose of study treatment were included in All treated population and Safety population|
59995199|NCT02730169|76111015|FG002|COMPLETED|Overall Study||50||
60092622|NCT02145676|76209647|FG001|NOT COMPLETED|Overall Study||0||
60092623|NCT02145676|76209648|FG002|NOT COMPLETED|Overall Study||0||
60092624|NCT01607593|76209656|FG000|STARTED|Overall Study||122||
59816928|NCT02937818|75939316|FG003|COMPLETED|Overall Study||0||
59995200|NCT02730169|76111016|FG003|COMPLETED|Overall Study||55||
59561464|NCT01987349|75662920|FG001|COMPLETED|Overall Study||6||
59561465|NCT01987349|75662921|FG002|COMPLETED|Overall Study||8||
59993207|NCT01677741|76109114|FG007|STARTED|Overall Study||2|All subjects who received at least one dose of study treatment were included in All treated population and Safety population|
59993208|NCT01677741|76109107|FG000|DLT Evaluable Population|Overall Study||3|Part 1 subjects fulfilling the All Treated population criteria, and having received an adequate treatment for the first 28 days to enable an appropriate evaluation of study drug related DLTs|
59993209|NCT01677741|76109108|FG001|DLT Evaluable Population|Overall Study||10|Part 1 subjects fulfilling the All Treated population criteria, and having received an adequate treatment for the first 28 days to enable an appropriate evaluation of study drug related DLTs|
59995201|NCT02730169|76111013|FG000|NOT COMPLETED|Overall Study||14||
59561466|NCT01987349|75662922|FG003|COMPLETED|Overall Study||6||
59561467|NCT01987349|75662923|FG004|COMPLETED|Overall Study||6||
59561468|NCT01987349|75662924|FG005|COMPLETED|Overall Study||6||
59561469|NCT01987349|75662925|FG006|COMPLETED|Overall Study||10||
59561470|NCT01987349|75662926|FG007|COMPLETED|Overall Study||24||
59561471|NCT01987349|75662919|FG000|NOT COMPLETED|Overall Study||0||
59561472|NCT01987349|75662920|FG001|NOT COMPLETED|Overall Study||0||
59561473|NCT01987349|75662921|FG002|NOT COMPLETED|Overall Study||0||
59561474|NCT01987349|75662922|FG003|NOT COMPLETED|Overall Study||0||
59561475|NCT01987349|75662923|FG004|NOT COMPLETED|Overall Study||0||
59561476|NCT01987349|75662924|FG005|NOT COMPLETED|Overall Study||0||
59561477|NCT01987349|75662925|FG006|NOT COMPLETED|Overall Study||0||
59561478|NCT01987349|75662926|FG007|NOT COMPLETED|Overall Study||1||
59561479|NCT01987583|75662950|FG000|STARTED|Overall Study||40||
59561480|NCT01987583|75662951|FG001|STARTED|Overall Study||40||
59561481|NCT01987583|75662950|FG000|COMPLETED|Overall Study||37||
59561482|NCT01987583|75662951|FG001|COMPLETED|Overall Study||38||
59561483|NCT01987583|75662950|FG000|NOT COMPLETED|Overall Study||3||
59561484|NCT01987583|75662951|FG001|NOT COMPLETED|Overall Study||2||
59561485|NCT03435783|75662959|FG000|STARTED|Overall Study||20||
59561486|NCT03435783|75662960|FG001|STARTED|Overall Study||20||
59561487|NCT03435783|75662959|FG000|COMPLETED|Overall Study||20||
59561488|NCT03435783|75662960|FG001|COMPLETED|Overall Study||19||
59561489|NCT03435783|75662959|FG000|NOT COMPLETED|Overall Study||0||
59561490|NCT03435783|75662960|FG001|NOT COMPLETED|Overall Study||1||
59707927|NCT01117623|75826806|FG006|PK Population|Overall Study||6||
59707928|NCT01117623|75826807|FG007|PK Population|Overall Study||24||
59707929|NCT01117623|75826800|FG000|COMPLETED|Overall Study||0||
59707930|NCT01117623|75826801|FG001|COMPLETED|Overall Study||0||
59707931|NCT01117623|75826802|FG002|COMPLETED|Overall Study||0||
59707932|NCT01117623|75826803|FG003|COMPLETED|Overall Study||0||
59707933|NCT01117623|75826804|FG004|COMPLETED|Overall Study||0||
59707934|NCT01117623|75826805|FG005|COMPLETED|Overall Study||0||
59707935|NCT01117623|75826806|FG006|COMPLETED|Overall Study||0||
59707936|NCT01117623|75826807|FG007|COMPLETED|Overall Study||0||
59707937|NCT01117623|75826800|FG000|NOT COMPLETED|Overall Study||3||
59707938|NCT01117623|75826801|FG001|NOT COMPLETED|Overall Study||8||
59707939|NCT01117623|75826802|FG002|NOT COMPLETED|Overall Study||11||
59707940|NCT01117623|75826803|FG003|NOT COMPLETED|Overall Study||6||
59561491|NCT01988129|75662968|FG000|STARTED|Overall Study|Intervention participant data obtained from department. Individuals not enrolled for primary aim.|601||
59561492|NCT01988129|75662969|FG001|STARTED|Overall Study|Control participant data obtained from department. Individuals were not enrolled.|588||
59561493|NCT01988129|75662968|FG000|Attended Education Session|Overall Study||542||
59561494|NCT01988129|75662969|FG001|Attended Education Session|Overall Study||18||
59561495|NCT01988129|75662968|FG000|Screened for Sleep Disorders|Overall Study||416||
59561496|NCT01988129|75662969|FG001|Screened for Sleep Disorders|Overall Study||15||
59561497|NCT01988129|75662968|FG000|Completed 1-year Follow-up Survey|Overall Study||100||
59561498|NCT01988129|75662969|FG001|Completed 1-year Follow-up Survey|Overall Study||4||
59561499|NCT01988129|75662968|FG000|COMPLETED|Overall Study||601||
59561500|NCT01988129|75662969|FG001|COMPLETED|Overall Study||588||
59561501|NCT01988129|75662968|FG000|NOT COMPLETED|Overall Study||0||
59561502|NCT01988129|75662969|FG001|NOT COMPLETED|Overall Study||0||
59561503|NCT02300285|75662980|FG000|STARTED|Overall Study||3||
59561504|NCT02300285|75662981|FG001|STARTED|Overall Study||3||
59561505|NCT02300285|75662980|FG000|COMPLETED|Overall Study||3||
59561506|NCT02300285|75662981|FG001|COMPLETED|Overall Study||3||
59707941|NCT01117623|75826804|FG004|NOT COMPLETED|Overall Study||10||
59707942|NCT01117623|75826805|FG005|NOT COMPLETED|Overall Study||16||
59707943|NCT01117623|75826806|FG006|NOT COMPLETED|Overall Study||6||
59707944|NCT01117623|75826807|FG007|NOT COMPLETED|Overall Study||26||
59561507|NCT02300285|75662980|FG000|NOT COMPLETED|Overall Study||0||
59561508|NCT02300285|75662981|FG001|NOT COMPLETED|Overall Study||0||
59561509|NCT01989221|75662987|FG000|STARTED|Overall Study||14||
59561510|NCT01989221|75662987|FG000|COMPLETED|Overall Study||14||
59561511|NCT01989221|75662987|FG000|NOT COMPLETED|Overall Study||0||
59561512|NCT03226899|75662993|FG000|STARTED|Overall Study||118||
59561513|NCT03226899|75662994|FG001|STARTED|Overall Study||124||
59561514|NCT03226899|75662993|FG000|COMPLETED|Overall Study||0|completed the study/24 months of treatment|
59561515|NCT03226899|75662994|FG001|COMPLETED|Overall Study||0|completed the study/24 months of treatment|
59561516|NCT03226899|75662993|FG000|NOT COMPLETED|Overall Study||118||
59561517|NCT03226899|75662994|FG001|NOT COMPLETED|Overall Study||124||
59816929|NCT02937818|75939313|FG000|NOT COMPLETED|Overall Study||21||
59816930|NCT02937818|75939314|FG001|NOT COMPLETED|Overall Study||20||
59816931|NCT02937818|75939315|FG002|NOT COMPLETED|Overall Study||10||
59561518|NCT01990703|75663002|FG000|STARTED|Overall Study||147||
59561519|NCT01990703|75663003|FG001|STARTED|Overall Study||138||
59561520|NCT01990703|75663002|FG000|COMPLETED|Overall Study||108||
59561521|NCT01990703|75663003|FG001|COMPLETED|Overall Study||93||
59561522|NCT01990703|75663002|FG000|NOT COMPLETED|Overall Study||39||
59561523|NCT01990703|75663003|FG001|NOT COMPLETED|Overall Study||45||
59561524|NCT01958645|75663012|FG000|STARTED|Overall Study||4||
59561525|NCT01958645|75663013|FG001|STARTED|Overall Study||4||
59561526|NCT01958645|75663014|FG002|STARTED|Overall Study||4||
59561527|NCT01958645|75663012|FG000|COMPLETED|Overall Study||4||
59561528|NCT01958645|75663013|FG001|COMPLETED|Overall Study||4||
59561529|NCT01958645|75663014|FG002|COMPLETED|Overall Study||4||
59561530|NCT01958645|75663012|FG000|NOT COMPLETED|Overall Study||0||
59561531|NCT01958645|75663013|FG001|NOT COMPLETED|Overall Study||0||
59561532|NCT01958645|75663014|FG002|NOT COMPLETED|Overall Study||0||
59561533|NCT03437031|75663026|FG000|STARTED|Overall Study||19||
59561534|NCT03437031|75663027|FG001|STARTED|Overall Study||21||
59561535|NCT03437031|75663026|FG000|COMPLETED|Overall Study||19||
59561536|NCT03437031|75663027|FG001|COMPLETED|Overall Study||21||
59561537|NCT03437031|75663026|FG000|NOT COMPLETED|Overall Study||0||
59561538|NCT03437031|75663027|FG001|NOT COMPLETED|Overall Study||0||
59561539|NCT01959113|75663035|FG000|STARTED|Overall Study||5||10
59561540|NCT01959113|75663035|FG000|COMPLETED|Overall Study||5||10
59561541|NCT01959113|75663035|FG000|NOT COMPLETED|Overall Study||0||0
59561542|NCT03438045|75663041|FG000|STARTED|Overall Study||75||
59561543|NCT03438045|75663041|FG000|COMPLETED|Overall Study||75||
59561544|NCT03438045|75663041|FG000|NOT COMPLETED|Overall Study||0||
59561545|NCT02301299|75663045|FG000|STARTED|Overall Study||1322||
59561546|NCT02301299|75663045|FG000|COMPLETED|Overall Study||1322||
59561547|NCT02301299|75663045|FG000|NOT COMPLETED|Overall Study||0||
59561548|NCT03230175|75663052|FG000|STARTED|Overall Study||32||
59561549|NCT03230175|75663052|FG000|COMPLETED|Overall Study||30||
59561550|NCT03230175|75663052|FG000|NOT COMPLETED|Overall Study||2||
59561551|NCT01992185|75663058|FG000|STARTED|Overall Study||7||
59561552|NCT01992185|75663059|FG001|STARTED|Overall Study||8||
59561553|NCT01992185|75663058|FG000|COMPLETED|Overall Study||7||
59561554|NCT01992185|75663059|FG001|COMPLETED|Overall Study||8||
59561555|NCT01992185|75663058|FG000|NOT COMPLETED|Overall Study||0||
59561556|NCT01992185|75663059|FG001|NOT COMPLETED|Overall Study||0||
59561557|NCT03231345|75663065|FG000|STARTED|Overall Study||35||
59561558|NCT03231345|75663065|FG000|COMPLETED|Overall Study||35||
59561559|NCT03231345|75663065|FG000|NOT COMPLETED|Overall Study||0||
59561560|NCT03296787|75663073|FG000|STARTED|Overall Study||8||
59561561|NCT03296787|75663074|FG001|STARTED|Overall Study||8||
59561562|NCT03296787|75663075|FG002|STARTED|Overall Study||9||
59561563|NCT03296787|75663076|FG003|STARTED|Overall Study||7||
59561564|NCT03296787|75663073|FG000|COMPLETED|Overall Study||8||
59561565|NCT03296787|75663074|FG001|COMPLETED|Overall Study||8||
59561566|NCT03296787|75663075|FG002|COMPLETED|Overall Study||9||
59561567|NCT03296787|75663076|FG003|COMPLETED|Overall Study||7||
59561568|NCT03296787|75663073|FG000|NOT COMPLETED|Overall Study||0||
59561569|NCT03296787|75663074|FG001|NOT COMPLETED|Overall Study||0||
59561570|NCT03296787|75663075|FG002|NOT COMPLETED|Overall Study||0||
59561571|NCT03296787|75663076|FG003|NOT COMPLETED|Overall Study||0||
59561572|NCT02301377|75663089|FG000|STARTED|Overall Study||3||
59561573|NCT02301377|75663090|FG001|STARTED|Overall Study||2||
59561574|NCT02301377|75663089|FG000|COMPLETED|Overall Study||3||
59561575|NCT02301377|75663090|FG001|COMPLETED|Overall Study||2||
59561576|NCT02301377|75663089|FG000|NOT COMPLETED|Overall Study||0||
59561577|NCT02301377|75663090|FG001|NOT COMPLETED|Overall Study||0||
59561578|NCT03440229|75663098|FG000|STARTED|Overall Study||9||
59561579|NCT03440229|75663099|FG001|STARTED|Overall Study||7||
59816932|NCT02937818|75939316|FG003|NOT COMPLETED|Overall Study||21||
59816933|NCT02927691|75939331|FG000|STARTED|Overall Study||34||
59816934|NCT02927691|75939332|FG001|STARTED|Overall Study||31||
59816935|NCT02927691|75939331|FG000|COMPLETED|Overall Study||30||
59816936|NCT02927691|75939332|FG001|COMPLETED|Overall Study||28||
59561580|NCT03440229|75663098|FG000|COMPLETED|Overall Study||9||
59561581|NCT03440229|75663099|FG001|COMPLETED|Overall Study||7||
59561582|NCT03440229|75663098|FG000|NOT COMPLETED|Overall Study||0||
59561583|NCT03440229|75663099|FG001|NOT COMPLETED|Overall Study||0||
59561584|NCT01961921|75663105|FG000|STARTED|Overall Study||27||
59561585|NCT01961921|75663105|FG000|COMPLETED|Overall Study||25||
59561586|NCT01961921|75663105|FG000|NOT COMPLETED|Overall Study||2||
59561587|NCT01963091|75663111|FG000|STARTED|Overall Study||17||
59561588|NCT01963091|75663112|FG001|STARTED|Overall Study||16||
59561589|NCT01963091|75663111|FG000|COMPLETED|Overall Study||17||
59561590|NCT01963091|75663112|FG001|COMPLETED|Overall Study||16||
59561591|NCT01963091|75663111|FG000|NOT COMPLETED|Overall Study||0||
59561592|NCT01963091|75663112|FG001|NOT COMPLETED|Overall Study||0||
59561593|NCT01963169|75663121|FG000|STARTED|Overall Study||301||
59561594|NCT01963169|75663122|FG001|STARTED|Overall Study||302||
59561595|NCT01963169|75663123|FG002|STARTED|Overall Study||263||
59561596|NCT01963169|75663121|FG000|COMPLETED|Overall Study||242||
59561597|NCT01963169|75663122|FG001|COMPLETED|Overall Study||220||
59561598|NCT01963169|75663123|FG002|COMPLETED|Overall Study||237||
59561599|NCT01963169|75663121|FG000|NOT COMPLETED|Overall Study||59||
59561600|NCT01963169|75663122|FG001|NOT COMPLETED|Overall Study||82||
59561601|NCT01963169|75663123|FG002|NOT COMPLETED|Overall Study||26||
59561602|NCT03298035|75663133|FG000|STARTED|Overall Study||10||
59561603|NCT03298035|75663134|FG001|STARTED|Overall Study||9||
59561604|NCT03298035|75663133|FG000|Received Intervention|Overall Study||9||
59561605|NCT03298035|75663134|FG001|Received Intervention|Overall Study||7||
59561606|NCT03298035|75663133|FG000|COMPLETED|Overall Study||9||
59561607|NCT03298035|75663134|FG001|COMPLETED|Overall Study||7||
59561608|NCT03298035|75663133|FG000|NOT COMPLETED|Overall Study||1||
59561609|NCT03298035|75663134|FG001|NOT COMPLETED|Overall Study||2||
59561610|NCT02306759|75663142|FG000|STARTED|Overall Study||30||
59561611|NCT02306759|75663143|FG001|STARTED|Overall Study||30||
59561612|NCT02306759|75663142|FG000|COMPLETED|Overall Study||30||
59561613|NCT02306759|75663143|FG001|COMPLETED|Overall Study||30||
59561614|NCT02306759|75663142|FG000|NOT COMPLETED|Overall Study||0||
59561615|NCT02306759|75663143|FG001|NOT COMPLETED|Overall Study||0||
59561616|NCT03298113|75663153|FG000|STARTED|Overall Study|10 subjects were treated w/ Cavilon Advanced Skin Protectant. Study terminated due to low enrollment|10||
59561617|NCT03298113|75663154|FG001|STARTED|Overall Study|10 subjects were treated with IAD Hospital Standard Care. Study terminated due to low enrollment.|10||
59561618|NCT03298113|75663153|FG000|IAD 1A|Overall Study||3||
59561619|NCT03298113|75663154|FG001|IAD 1A|Overall Study||4||
59561620|NCT03298113|75663153|FG000|IAD 2A|Overall Study||7||
59561621|NCT03298113|75663154|FG001|IAD 2A|Overall Study||6||
59561622|NCT03298113|75663153|FG000|COMPLETED|Overall Study||10||
59561623|NCT03298113|75663154|FG001|COMPLETED|Overall Study||10||
59561624|NCT03298113|75663153|FG000|NOT COMPLETED|Overall Study||0||
59561625|NCT03298113|75663154|FG001|NOT COMPLETED|Overall Study||0||
59561626|NCT03440619|75663160|FG000|STARTED|Overall Study||28||
59561627|NCT03440619|75663160|FG000|COMPLETED|Overall Study||28||
59561628|NCT03440619|75663160|FG000|NOT COMPLETED|Overall Study||0||
59707945|NCT01116687|75826827|FG000|STARTED|Overall Study||37||
59707946|NCT01116687|75826827|FG000|COMPLETED|Overall Study||33||
59707947|NCT01116687|75826827|FG000|NOT COMPLETED|Overall Study||4||
59707948|NCT01114737|75826833|FG000|STARTED|Randomized Treatment Period||108||
59993210|NCT01677741|76109109|FG002|DLT Evaluable Population|Overall Study||8|Part 1 subjects fulfilling the All Treated population criteria, and having received an adequate treatment for the first 28 days to enable an appropriate evaluation of study drug related DLTs|
59993211|NCT01677741|76109110|FG003|DLT Evaluable Population|Overall Study||6|Part 1 subjects fulfilling the All Treated population criteria, and having received an adequate treatment for the first 28 days to enable an appropriate evaluation of study drug related DLTs|
60092625|NCT01607593|76209656|FG000|COMPLETED|Overall Study||29||
59561629|NCT03232749|75663164|FG000|STARTED|Overall Study||25||
59707949|NCT01114737|75826834|FG001|STARTED|Randomized Treatment Period||98||
59707950|NCT01114737|75826833|FG000|COMPLETED|Randomized Treatment Period||105||
59993212|NCT01677741|76109111|FG004|DLT Evaluable Population|Overall Study||0|Part 1 subjects fulfilling the All Treated population criteria, and having received an adequate treatment for the first 28 days to enable an appropriate evaluation of study drug related DLTs|
60092626|NCT01607593|76209656|FG000|NOT COMPLETED|Overall Study||93||
59561630|NCT03232749|75663164|FG000|COMPLETED|Overall Study||21||
59561631|NCT03232749|75663164|FG000|NOT COMPLETED|Overall Study||4||
59561632|NCT03232827|75663168|FG000|STARTED|Flavored-sweetened (FS)||80||
59561633|NCT03232827|75663168|FG000|COMPLETED|Flavored-sweetened (FS)||80||
59561634|NCT03232827|75663168|FG000|NOT COMPLETED|Flavored-sweetened (FS)||0||
59561635|NCT03232827|75663168|FG000|STARTED|Unflavored-sweetened (US)||86||
59561636|NCT03232827|75663168|FG000|COMPLETED|Unflavored-sweetened (US)||86||
59561637|NCT03232827|75663168|FG000|NOT COMPLETED|Unflavored-sweetened (US)||0||
59561638|NCT03232827|75663168|FG000|STARTED|Unflavored-very Low Sweetened (UU)||66||
59561639|NCT03232827|75663168|FG000|COMPLETED|Unflavored-very Low Sweetened (UU)||66||
59561640|NCT03232827|75663168|FG000|NOT COMPLETED|Unflavored-very Low Sweetened (UU)||0||
59561641|NCT03232827|75663168|FG000|STARTED|Flavored-very Low Sweetened||66||
59561642|NCT03232827|75663168|FG000|COMPLETED|Flavored-very Low Sweetened||66||
59561643|NCT03232827|75663168|FG000|NOT COMPLETED|Flavored-very Low Sweetened||0||
59561644|NCT01687400|75663178|FG000|STARTED|Overall Study||114||
59707951|NCT01114737|75826834|FG001|COMPLETED|Randomized Treatment Period||97||
60092627|NCT00789724|76209662|FG000|STARTED|Overall Study||5||
60092628|NCT00789724|76209663|FG001|STARTED|Overall Study||5||
60092629|NCT00789724|76209662|FG000|COMPLETED|Overall Study||5||
60092630|NCT00789724|76209663|FG001|COMPLETED|Overall Study||5||
60092631|NCT00789724|76209662|FG000|NOT COMPLETED|Overall Study||0||
60092632|NCT00789724|76209663|FG001|NOT COMPLETED|Overall Study||0||
60092633|NCT01755637|76209669|FG000|STARTED|Period 1||28||
60092634|NCT01755637|76209670|FG001|STARTED|Period 1||28||
60092635|NCT01755637|76209669|FG000|COMPLETED|Period 1||28||
60092636|NCT01755637|76209670|FG001|COMPLETED|Period 1||27||
60092637|NCT01755637|76209669|FG000|NOT COMPLETED|Period 1||0||
60092638|NCT01755637|76209670|FG001|NOT COMPLETED|Period 1||1||
60092639|NCT01755637|76209669|FG000|STARTED|Period 2||28||
60092640|NCT01755637|76209670|FG001|STARTED|Period 2||27||
60092641|NCT01755637|76209669|FG000|COMPLETED|Period 2||28||
60092642|NCT01755637|76209670|FG001|COMPLETED|Period 2||27||
60092643|NCT01755637|76209669|FG000|NOT COMPLETED|Period 2||0||
60092644|NCT01755637|76209670|FG001|NOT COMPLETED|Period 2||0||
60092645|NCT02145754|76209682|FG000|STARTED|Overall Study||235||
60092646|NCT02145754|76209682|FG000|COMPLETED|Overall Study||235||
60092647|NCT02145754|76209682|FG000|NOT COMPLETED|Overall Study||0||
60092648|NCT01732549|76209688|FG000|STARTED|Overall Study||71||
60092649|NCT01732549|76209689|FG001|STARTED|Overall Study||73||
60092650|NCT01732549|76209688|FG000|Ongoing in Treatment Period:Data Cut-off|Overall Study||12||
60092651|NCT01732549|76209689|FG001|Ongoing in Treatment Period:Data Cut-off|Overall Study||12||
60092652|NCT01732549|76209688|FG000|Withdrawn During Treatment:Data Cut-off|Overall Study|Withdrawn during treatment period 59 (AE 13, Consent withdrawn 13, Disease progression 31, Other 2)|59||
60092653|NCT01732549|76209689|FG001|Withdrawn During Treatment:Data Cut-off|Overall Study|Withdrawn during treatment period 61 (AE 3, Consent withdrawn 6, Disease progression 46, Other 6)|61||
60092654|NCT01732549|76209688|FG000|Ongoing Treatment Period:Final Analysis|Overall Study||0||
60092655|NCT01732549|76209689|FG001|Ongoing Treatment Period:Final Analysis|Overall Study||0||
60092656|NCT01732549|76209688|FG000|Withdrawn During Treatment:Final Analysi|Overall Study||71||
60092657|NCT01732549|76209689|FG001|Withdrawn During Treatment:Final Analysi|Overall Study||73||
60092658|NCT01732549|76209688|FG000|COMPLETED|Overall Study||0||
60092659|NCT01732549|76209689|FG001|COMPLETED|Overall Study||0||
60092660|NCT01732549|76209688|FG000|NOT COMPLETED|Overall Study||71||
60092661|NCT01732549|76209689|FG001|NOT COMPLETED|Overall Study||73||
60092662|NCT02148874|76209698|FG000|STARTED|Overall Study||201||
60092663|NCT02148874|76209699|FG001|STARTED|Overall Study||86||
60092664|NCT02148874|76209698|FG000|COMPLETED|Overall Study||194||
60092665|NCT02148874|76209699|FG001|COMPLETED|Overall Study||84||
60092666|NCT02148874|76209698|FG000|NOT COMPLETED|Overall Study||7||
60092667|NCT02148874|76209699|FG001|NOT COMPLETED|Overall Study||2||
60092668|NCT01755091|76209708|FG000|STARTED|Overall Study||26||
60092669|NCT01755091|76209709|FG001|STARTED|Overall Study||22||
60092670|NCT01755091|76209710|FG002|STARTED|Overall Study||27||
60092671|NCT01755091|76209708|FG000|COMPLETED|Overall Study||17||
60092672|NCT01755091|76209709|FG001|COMPLETED|Overall Study||19||
60092673|NCT01755091|76209710|FG002|COMPLETED|Overall Study||20||
60092674|NCT01755091|76209708|FG000|NOT COMPLETED|Overall Study||9||
60092675|NCT01755091|76209709|FG001|NOT COMPLETED|Overall Study||3||
60092676|NCT01755091|76209710|FG002|NOT COMPLETED|Overall Study||7||
60092677|NCT00789802|76209721|FG000|STARTED|Overall Study||44||
60092678|NCT00789802|76209722|FG001|STARTED|Overall Study||42||
60092679|NCT00789802|76209723|FG002|STARTED|Overall Study||43||
60092680|NCT00789802|76209721|FG000|COMPLETED|Overall Study||34||
60092681|NCT00789802|76209722|FG001|COMPLETED|Overall Study||35||
60092682|NCT00789802|76209723|FG002|COMPLETED|Overall Study||37||
60092683|NCT00789802|76209721|FG000|NOT COMPLETED|Overall Study||10||
60092684|NCT00789802|76209722|FG001|NOT COMPLETED|Overall Study||7||
60092685|NCT00789802|76209723|FG002|NOT COMPLETED|Overall Study||6||
60092686|NCT04567225|76209736|FG000|STARTED|Overall Study||39||
60092687|NCT04567225|76209737|FG001|STARTED|Overall Study||0||
60092688|NCT04567225|76209736|FG000|COMPLETED|Overall Study|Study withdrawn. The study was closed due to lack of proper resource availability. Since study could not be completed as planned, participants did not complete follow-up.|0||
60092689|NCT04567225|76209737|FG001|COMPLETED|Overall Study|The study was closed due to lack of proper resource availability. Since study could not be completed as planned, this chart review portion was not completed and no analysis was performed.|0||
60092690|NCT04567225|76209736|FG000|NOT COMPLETED|Overall Study||39||
60092691|NCT04567225|76209737|FG001|NOT COMPLETED|Overall Study||0||
60092692|NCT01754467|76209743|FG000|STARTED|Overall Study||9||
60092693|NCT01754467|76209743|FG000|COMPLETED|Overall Study||8||
60092694|NCT01754467|76209743|FG000|NOT COMPLETED|Overall Study||1||
60092695|NCT01753999|76209747|FG000|STARTED|Period 1 - Initial Assignment||155||
60092696|NCT01753999|76209748|FG001|STARTED|Period 1 - Initial Assignment||162||
60092697|NCT01753999|76209747|FG000|Received Intervention|Period 1 - Initial Assignment||144||
60092698|NCT01753999|76209748|FG001|Received Intervention|Period 1 - Initial Assignment||146||
60092699|NCT01753999|76209747|FG000|COMPLETED|Period 1 - Initial Assignment||116||
60092700|NCT01753999|76209748|FG001|COMPLETED|Period 1 - Initial Assignment||112||
60092701|NCT01753999|76209747|FG000|NOT COMPLETED|Period 1 - Initial Assignment||39||
60092702|NCT01753999|76209748|FG001|NOT COMPLETED|Period 1 - Initial Assignment||50||
60092703|NCT01753999|76209747|FG000|STARTED|Period 2 -Cross to Alternate Arm||116||
60092704|NCT01753999|76209748|FG001|STARTED|Period 2 -Cross to Alternate Arm||112||
60092705|NCT01753999|76209747|FG000|Received Intervention|Period 2 -Cross to Alternate Arm||103||
60092706|NCT01753999|76209748|FG001|Received Intervention|Period 2 -Cross to Alternate Arm||95||
60092707|NCT01753999|76209747|FG000|COMPLETED|Period 2 -Cross to Alternate Arm||99||
60092708|NCT01753999|76209748|FG001|COMPLETED|Period 2 -Cross to Alternate Arm||89||
60092709|NCT01753999|76209747|FG000|NOT COMPLETED|Period 2 -Cross to Alternate Arm||17||
60092710|NCT01753999|76209748|FG001|NOT COMPLETED|Period 2 -Cross to Alternate Arm||23||
60092711|NCT02149342|76209759|FG000|STARTED|Overall Study|14 patients|14||
60092712|NCT02149342|76209759|FG000|COMPLETED|Overall Study|14 patients|14||
60092713|NCT02149342|76209759|FG000|NOT COMPLETED|Overall Study||0||
60092714|NCT01783015|76209768|FG000|STARTED|Blinded Treatment||11||
60092715|NCT01783015|76209769|FG001|STARTED|Blinded Treatment||5||
60092716|NCT01783015|76209770|FG002|STARTED|Blinded Treatment||0||
60092717|NCT01783015|76209768|FG000|Treated|Blinded Treatment||11||
60092718|NCT01783015|76209769|FG001|Treated|Blinded Treatment||5||
60092719|NCT01783015|76209770|FG002|Treated|Blinded Treatment||0||
60092720|NCT01783015|76209768|FG000|COMPLETED|Blinded Treatment||9||
60092721|NCT01783015|76209769|FG001|COMPLETED|Blinded Treatment||2||
60092722|NCT01783015|76209770|FG002|COMPLETED|Blinded Treatment||0||
60092723|NCT01783015|76209768|FG000|NOT COMPLETED|Blinded Treatment||2||
60092724|NCT01783015|76209769|FG001|NOT COMPLETED|Blinded Treatment||3||
60092725|NCT01783015|76209770|FG002|NOT COMPLETED|Blinded Treatment||0||
60092726|NCT01783015|76209768|FG000|STARTED|Open Label Treatment||0||
60092727|NCT01783015|76209769|FG001|STARTED|Open Label Treatment||0||
60092728|NCT01783015|76209770|FG002|STARTED|Open Label Treatment||11||
60092729|NCT01783015|76209768|FG000|COMPLETED|Open Label Treatment||0||
60092730|NCT01783015|76209769|FG001|COMPLETED|Open Label Treatment||0||
60092731|NCT01783015|76209770|FG002|COMPLETED|Open Label Treatment||5||
60092732|NCT01783015|76209768|FG000|NOT COMPLETED|Open Label Treatment||0||
60092733|NCT01783015|76209769|FG001|NOT COMPLETED|Open Label Treatment||0||
60092734|NCT01783015|76209770|FG002|NOT COMPLETED|Open Label Treatment||6||
60092735|NCT01782859|76209780|FG000|STARTED|Overall Study||20||
60092736|NCT01782859|76209781|FG001|STARTED|Overall Study||20||
60092737|NCT01782859|76209780|FG000|COMPLETED|Overall Study||14||
60092738|NCT01782859|76209781|FG001|COMPLETED|Overall Study||13||
60092739|NCT01782859|76209780|FG000|NOT COMPLETED|Overall Study||6||
60092740|NCT01782859|76209781|FG001|NOT COMPLETED|Overall Study||7||
60092741|NCT01782469|76209788|FG000|STARTED|Overall Study||16||
60092742|NCT01782469|76209788|FG000|COMPLETED|Overall Study||15||
60092743|NCT01782469|76209788|FG000|NOT COMPLETED|Overall Study||1||
60092744|NCT01782313|76209792|FG000|STARTED|Reached First Response/Completed 2 Cycle||58||
60092745|NCT01782313|76209792|FG000|COMPLETED|Reached First Response/Completed 2 Cycle||52||
60092746|NCT01782313|76209792|FG000|NOT COMPLETED|Reached First Response/Completed 2 Cycle||6||
60092747|NCT01782313|76209792|FG000|STARTED|Treated Cycle 3||52||
60092748|NCT01782313|76209792|FG000|COMPLETED|Treated Cycle 3||31||
60092749|NCT01782313|76209792|FG000|NOT COMPLETED|Treated Cycle 3||21||
60092750|NCT01782313|76209792|FG000|STARTED|Treated Cycle 4/Reached 16 Week Response||31||
60092751|NCT01782313|76209792|FG000|COMPLETED|Treated Cycle 4/Reached 16 Week Response||25||
60092752|NCT01782313|76209792|FG000|NOT COMPLETED|Treated Cycle 4/Reached 16 Week Response||6||
60092753|NCT01782313|76209792|FG000|STARTED|Continued Treatment After 16 Weeks||25||
59561645|NCT01687400|75663178|FG000|COMPLETED|Overall Study||114||
59561646|NCT01687400|75663178|FG000|NOT COMPLETED|Overall Study||0||
59561647|NCT01687790|75663187|FG000|STARTED|Overall Study||60||
59561648|NCT01687790|75663187|FG000|COMPLETED|Overall Study||60||
59561649|NCT01687790|75663187|FG000|NOT COMPLETED|Overall Study||0||
59561650|NCT01688102|75663194|FG000|STARTED|Overall Study||60||
59561651|NCT01688102|75663195|FG001|STARTED|Overall Study||58||
59993213|NCT01677741|76109112|FG005|DLT Evaluable Population|Overall Study||0|Part 1 subjects fulfilling the All Treated population criteria, and having received an adequate treatment for the first 28 days to enable an appropriate evaluation of study drug related DLTs|
59993214|NCT01677741|76109113|FG006|DLT Evaluable Population|Overall Study||0|Part 1 subjects fulfilling the All Treated population criteria, and having received an adequate treatment for the first 28 days to enable an appropriate evaluation of study drug related DLTs|
59993215|NCT01677741|76109114|FG007|DLT Evaluable Population|Overall Study||0|Part 1 subjects fulfilling the All Treated population criteria, and having received an adequate treatment for the first 28 days to enable an appropriate evaluation of study drug related DLTs|
59993216|NCT01677741|76109107|FG000|PK Population|Overall Study||3|Subjects fulfilling the All Treated population criteria and for whom pharmacokinetic sample(s) were obtained and analyzed|
59993217|NCT01677741|76109108|FG001|PK Population|Overall Study||10|Subjects fulfilling the All Treated population criteria and for whom pharmacokinetic sample(s) were obtained and analyzed|
59993218|NCT01677741|76109109|FG002|PK Population|Overall Study||8|Subjects fulfilling the All Treated population criteria and for whom pharmacokinetic sample(s) were obtained and analyzed|
59995202|NCT02730169|76111014|FG001|NOT COMPLETED|Overall Study||21||
60092754|NCT01782313|76209792|FG000|COMPLETED|Continued Treatment After 16 Weeks||18||
60092755|NCT01782313|76209792|FG000|NOT COMPLETED|Continued Treatment After 16 Weeks||7||
60092756|NCT01782313|76209792|FG000|STARTED|Survival Follow up||58||
59561652|NCT01688102|75663194|FG000|COMPLETED|Overall Study||44||
59561653|NCT01688102|75663195|FG001|COMPLETED|Overall Study||40||
59561654|NCT01688102|75663194|FG000|NOT COMPLETED|Overall Study||16||
59561655|NCT01688102|75663195|FG001|NOT COMPLETED|Overall Study||18||
60092757|NCT01782313|76209792|FG000|COMPLETED|Survival Follow up||57||
60092758|NCT01782313|76209792|FG000|NOT COMPLETED|Survival Follow up||1||
60092759|NCT00790192|76209800|FG000|STARTED|Overall Study||125||
60092760|NCT00790192|76209801|FG001|STARTED|Overall Study||121||
60092761|NCT00790192|76209802|FG002|STARTED|Overall Study||120||
60092762|NCT00790192|76209803|FG003|STARTED|Overall Study||122||
60092763|NCT00790192|76209800|FG000|COMPLETED|Overall Study||89||
60092764|NCT00790192|76209801|FG001|COMPLETED|Overall Study||93||
60092765|NCT00790192|76209802|FG002|COMPLETED|Overall Study||97||
60092766|NCT00790192|76209803|FG003|COMPLETED|Overall Study||74||
60092767|NCT00790192|76209800|FG000|NOT COMPLETED|Overall Study||36||
60092768|NCT00790192|76209801|FG001|NOT COMPLETED|Overall Study||28||
60092769|NCT00790192|76209802|FG002|NOT COMPLETED|Overall Study||23||
60092770|NCT00790192|76209803|FG003|NOT COMPLETED|Overall Study||48||
60092771|NCT01781611|76209815|FG000|STARTED|Overall Study||13||
60092772|NCT01781611|76209816|FG001|STARTED|Overall Study||5||
60092773|NCT01781611|76209815|FG000|COMPLETED|Overall Study||9||
60092774|NCT01781611|76209816|FG001|COMPLETED|Overall Study||5||
60092775|NCT01781611|76209815|FG000|NOT COMPLETED|Overall Study||4||
60092776|NCT01781611|76209816|FG001|NOT COMPLETED|Overall Study||0||
60092777|NCT00777634|76209824|FG000|STARTED|Overall Study||134||
60092778|NCT00777634|76209825|FG001|STARTED|Overall Study||134||
60092779|NCT00777634|76209824|FG000|COMPLETED|Overall Study||129||
60092780|NCT00777634|76209825|FG001|COMPLETED|Overall Study||133||
60092781|NCT00777634|76209824|FG000|NOT COMPLETED|Overall Study||5||
60092782|NCT00777634|76209825|FG001|NOT COMPLETED|Overall Study||1||
60092783|NCT01781299|76209833|FG000|STARTED|Overall Study||4||
60092784|NCT01781299|76209834|FG001|STARTED|Overall Study||5||
60092785|NCT01781299|76209833|FG000|COMPLETED|Overall Study||4||
60092786|NCT01781299|76209834|FG001|COMPLETED|Overall Study||4||
60092787|NCT01781299|76209833|FG000|NOT COMPLETED|Overall Study||0||
60092788|NCT01781299|76209834|FG001|NOT COMPLETED|Overall Study||1||
60092789|NCT01732471|76209840|FG000|STARTED|Overall Study||90||
60092790|NCT01732471|76209840|FG000|COMPLETED|Overall Study||89||
60092791|NCT01732471|76209840|FG000|NOT COMPLETED|Overall Study||1||
60092792|NCT00790270|76209847|FG000|STARTED|Overall Study||21||
60092793|NCT00790270|76209848|FG001|STARTED|Overall Study||20||
60092794|NCT00790270|76209849|FG002|STARTED|Overall Study||20||
60092795|NCT00790270|76209847|FG000|COMPLETED|Overall Study||21||
60092796|NCT00790270|76209848|FG001|COMPLETED|Overall Study||20||
60092797|NCT00790270|76209849|FG002|COMPLETED|Overall Study||20||
60092798|NCT00790270|76209847|FG000|NOT COMPLETED|Overall Study||0||
60092799|NCT00790270|76209848|FG001|NOT COMPLETED|Overall Study||0||
60092800|NCT00790270|76209849|FG002|NOT COMPLETED|Overall Study||0||
59707952|NCT01114737|75826833|FG000|NOT COMPLETED|Randomized Treatment Period||3||
59993219|NCT01677741|76109110|FG003|PK Population|Overall Study||6|Subjects fulfilling the All Treated population criteria and for whom pharmacokinetic sample(s) were obtained and analyzed|
59993220|NCT01677741|76109111|FG004|PK Population|Overall Study||17|Subjects fulfilling the All Treated population criteria and for whom pharmacokinetic sample(s) were obtained and analyzed|
59993221|NCT01677741|76109112|FG005|PK Population|Overall Study||28|Subjects fulfilling the All Treated population criteria and for whom pharmacokinetic sample(s) were obtained and analyzed|
59993222|NCT01677741|76109113|FG006|PK Population|Overall Study||11|Subjects fulfilling the All Treated population criteria and for whom pharmacokinetic sample(s) were obtained and analyzed|
59993223|NCT01677741|76109114|FG007|PK Population|Overall Study||2|Subjects fulfilling the All Treated population criteria and for whom pharmacokinetic sample(s) were obtained and analyzed|
59993224|NCT01677741|76109107|FG000|COMPLETED|Overall Study||0||
59993225|NCT01677741|76109108|FG001|COMPLETED|Overall Study||0||
59993226|NCT01677741|76109109|FG002|COMPLETED|Overall Study||0||
59993227|NCT01677741|76109110|FG003|COMPLETED|Overall Study||0||
59993228|NCT01677741|76109111|FG004|COMPLETED|Overall Study||0||
60092801|NCT01780987|76209859|FG000|STARTED|Overall Study||40||
60092802|NCT01780987|76209860|FG001|STARTED|Overall Study|Including one participant who withdrew from the study prior to receiving any study medication.|40||
60092803|NCT01780987|76209859|FG000|COMPLETED|Overall Study||37||
60092804|NCT01780987|76209860|FG001|COMPLETED|Overall Study||34||
59993229|NCT01677741|76109112|FG005|COMPLETED|Overall Study||0||
59993230|NCT01677741|76109113|FG006|COMPLETED|Overall Study||0||
59993231|NCT01677741|76109114|FG007|COMPLETED|Overall Study||0||
60092805|NCT01780987|76209859|FG000|NOT COMPLETED|Overall Study||3||
60092806|NCT01780987|76209860|FG001|NOT COMPLETED|Overall Study||6||
60092807|NCT00790738|76209868|FG000|STARTED|Overall Study||5||
60092808|NCT00790738|76209869|FG001|STARTED|Overall Study||6||
60092809|NCT00790738|76209868|FG000|COMPLETED|Overall Study||3||
60092810|NCT00790738|76209869|FG001|COMPLETED|Overall Study||3||
60092811|NCT00790738|76209868|FG000|NOT COMPLETED|Overall Study||2||
60092812|NCT00790738|76209869|FG001|NOT COMPLETED|Overall Study||3||
60092813|NCT00777790|76209878|FG000|STARTED|Overall Study||76||
60092814|NCT00777790|76209879|FG001|STARTED|Overall Study||77||
60092815|NCT00777790|76209880|FG002|STARTED|Overall Study||88||
60092816|NCT00777790|76209878|FG000|COMPLETED|Overall Study||76||
60092817|NCT00777790|76209879|FG001|COMPLETED|Overall Study||77||
60092818|NCT00777790|76209880|FG002|COMPLETED|Overall Study||88||
60092819|NCT00777790|76209878|FG000|NOT COMPLETED|Overall Study||0||
60092820|NCT00777790|76209879|FG001|NOT COMPLETED|Overall Study||0||
60092821|NCT00777790|76209880|FG002|NOT COMPLETED|Overall Study||0||
60092822|NCT00808834|76209888|FG000|STARTED|Period 1||97||
60092823|NCT00808834|76209889|FG001|STARTED|Period 1||99||
60092824|NCT00808834|76209888|FG000|COMPLETED|Period 1||97||
60092825|NCT00808834|76209889|FG001|COMPLETED|Period 1||99||
60092826|NCT00808834|76209888|FG000|NOT COMPLETED|Period 1||0||
60092827|NCT00808834|76209889|FG001|NOT COMPLETED|Period 1||0||
60092828|NCT00808834|76209888|FG000|STARTED|Period 2||97||
60092829|NCT00808834|76209889|FG001|STARTED|Period 2||99||
60092830|NCT00808834|76209888|FG000|COMPLETED|Period 2||97||
60092831|NCT00808834|76209889|FG001|COMPLETED|Period 2||99||
60092832|NCT00808834|76209888|FG000|NOT COMPLETED|Period 2||0||
60092833|NCT00808834|76209889|FG001|NOT COMPLETED|Period 2||0||
60092834|NCT00809146|76209897|FG000|STARTED|Overall Study||448||
60092835|NCT00809146|76209898|FG001|STARTED|Overall Study||445||
60092836|NCT00809146|76209897|FG000|COMPLETED|Overall Study||448||
60092837|NCT00809146|76209898|FG001|COMPLETED|Overall Study||445||
60092838|NCT00809146|76209897|FG000|NOT COMPLETED|Overall Study||0||
60092839|NCT00809146|76209898|FG001|NOT COMPLETED|Overall Study||0||
60092840|NCT00791908|76209904|FG000|STARTED|Overall Study||15||
60092841|NCT00791908|76209904|FG000|COMPLETED|Overall Study||15||
60092842|NCT00791908|76209904|FG000|NOT COMPLETED|Overall Study||0||
60092843|NCT00794170|76209914|FG000|STARTED|Overall Study||157||
60092844|NCT00794170|76209915|FG001|STARTED|Overall Study||155||
60092845|NCT00794170|76209914|FG000|COMPLETED|Overall Study||150||
60092846|NCT00794170|76209915|FG001|COMPLETED|Overall Study||152||
60092847|NCT00794170|76209914|FG000|NOT COMPLETED|Overall Study||7||
60092848|NCT00794170|76209915|FG001|NOT COMPLETED|Overall Study||3||
60092849|NCT00809848|76209926|FG000|STARTED|Overall Study||36||
60092850|NCT00809848|76209927|FG001|STARTED|Overall Study||34||
60092851|NCT00809848|76209928|FG002|STARTED|Overall Study||34||
60092852|NCT00809848|76209929|FG003|STARTED|Overall Study||31||
60092853|NCT00809848|76209930|FG004|STARTED|Overall Study||37||
60092854|NCT00809848|76209926|FG000|COMPLETED|Overall Study||36||
60092855|NCT00809848|76209927|FG001|COMPLETED|Overall Study||34||
60092856|NCT00809848|76209928|FG002|COMPLETED|Overall Study||34||
60092857|NCT00809848|76209929|FG003|COMPLETED|Overall Study||30||
60092858|NCT00809848|76209930|FG004|COMPLETED|Overall Study||34||
60092859|NCT00809848|76209926|FG000|NOT COMPLETED|Overall Study||0||
60092860|NCT00809848|76209927|FG001|NOT COMPLETED|Overall Study||0||
60092861|NCT00809848|76209928|FG002|NOT COMPLETED|Overall Study||0||
60092862|NCT00809848|76209929|FG003|NOT COMPLETED|Overall Study||1||
60092863|NCT00809848|76209930|FG004|NOT COMPLETED|Overall Study||3||
60092864|NCT01730053|76209949|FG000|STARTED|Overall Study||48||
60092865|NCT01730053|76209950|FG001|STARTED|Overall Study||48||
60092866|NCT01730053|76209951|FG002|STARTED|Overall Study||49||
59561656|NCT01994993|75663206|FG000|STARTED|Overall Study||63||
59561657|NCT01994993|75663207|FG001|STARTED|Overall Study||47||
60092867|NCT01730053|76209952|FG003|STARTED|Overall Study||53||
60092868|NCT01730053|76209953|FG004|STARTED|Overall Study||53||
60092869|NCT01730053|76209954|FG005|STARTED|Overall Study||54||
60092870|NCT01730053|76209949|FG000|Treated|Overall Study||48||
59561658|NCT01994993|75663208|FG002|STARTED|Overall Study||70||
59561659|NCT01994993|75663209|FG003|STARTED|Overall Study||55||
59561660|NCT01994993|75663210|FG004|STARTED|Overall Study||24||
59561661|NCT01994993|75663206|FG000|COMPLETED|Overall Study||28||
59561662|NCT01994993|75663207|FG001|COMPLETED|Overall Study||12||
60092871|NCT01730053|76209950|FG001|Treated|Overall Study||48||
60092872|NCT01730053|76209951|FG002|Treated|Overall Study||49||
60092873|NCT01730053|76209952|FG003|Treated|Overall Study||53||
60092874|NCT01730053|76209953|FG004|Treated|Overall Study||53||
60092875|NCT01730053|76209954|FG005|Treated|Overall Study||54||
60092876|NCT01730053|76209949|FG000|COMPLETED|Overall Study||43||
60092877|NCT01730053|76209950|FG001|COMPLETED|Overall Study||34||
59561663|NCT01994993|75663208|FG002|COMPLETED|Overall Study||23||
60092878|NCT01730053|76209951|FG002|COMPLETED|Overall Study||38||
60092879|NCT01730053|76209952|FG003|COMPLETED|Overall Study||45||
60092880|NCT01730053|76209953|FG004|COMPLETED|Overall Study||44||
60092881|NCT01730053|76209954|FG005|COMPLETED|Overall Study||41||
60092882|NCT01730053|76209949|FG000|NOT COMPLETED|Overall Study||5||
60092883|NCT01730053|76209950|FG001|NOT COMPLETED|Overall Study||14||
60092884|NCT01730053|76209951|FG002|NOT COMPLETED|Overall Study||11||
60092885|NCT01730053|76209952|FG003|NOT COMPLETED|Overall Study||8||
60092886|NCT01730053|76209953|FG004|NOT COMPLETED|Overall Study||9||
60092887|NCT01730053|76209954|FG005|NOT COMPLETED|Overall Study||13||
60092888|NCT00794560|76209973|FG000|STARTED|Overall Study||36||
60092889|NCT00794560|76209974|FG001|STARTED|Overall Study||36||
59561664|NCT01994993|75663209|FG003|COMPLETED|Overall Study||9||
60092890|NCT00794560|76209975|FG002|STARTED|Overall Study||44||
60092891|NCT00794560|76209976|FG003|STARTED|Overall Study||38||
60092892|NCT00794560|76209973|FG000|COMPLETED|Overall Study||33||
60092893|NCT00794560|76209974|FG001|COMPLETED|Overall Study||32||
60092894|NCT00794560|76209975|FG002|COMPLETED|Overall Study||40||
60092895|NCT00794560|76209976|FG003|COMPLETED|Overall Study||34||
60092896|NCT00794560|76209973|FG000|NOT COMPLETED|Overall Study||3||
60092897|NCT00794560|76209974|FG001|NOT COMPLETED|Overall Study||4||
60092898|NCT00794560|76209975|FG002|NOT COMPLETED|Overall Study||4||
60092899|NCT00794560|76209976|FG003|NOT COMPLETED|Overall Study||4||
60092900|NCT01752985|76209989|FG000|STARTED|Treatment Period||29||
60092901|NCT01752985|76209990|FG001|STARTED|Treatment Period||30||
60092902|NCT01752985|76209991|FG002|STARTED|Treatment Period||29||
60092903|NCT01752985|76209989|FG000|COMPLETED|Treatment Period||25||
60092904|NCT01752985|76209990|FG001|COMPLETED|Treatment Period||27||
60092905|NCT01752985|76209991|FG002|COMPLETED|Treatment Period||24||
60092906|NCT01752985|76209989|FG000|NOT COMPLETED|Treatment Period||4||
60092907|NCT01752985|76209990|FG001|NOT COMPLETED|Treatment Period||3||
60092908|NCT01752985|76209991|FG002|NOT COMPLETED|Treatment Period||5||
60092909|NCT01752985|76209989|FG000|STARTED|Follow-up Period|Includes 25 participants in this period and 3 participants re-joined for follow-up|28||
59561665|NCT01994993|75663210|FG004|COMPLETED|Overall Study||22||
59561666|NCT01994993|75663206|FG000|NOT COMPLETED|Overall Study||35||
59561667|NCT01994993|75663207|FG001|NOT COMPLETED|Overall Study||35||
59561668|NCT01994993|75663208|FG002|NOT COMPLETED|Overall Study||47||
59561669|NCT01994993|75663209|FG003|NOT COMPLETED|Overall Study||46||
59561670|NCT01994993|75663210|FG004|NOT COMPLETED|Overall Study||2||
59561671|NCT01688336|75663222|FG000|STARTED|Overall Study||9||
59561672|NCT01688336|75663222|FG000|COMPLETED|Overall Study||9||
59561673|NCT01688336|75663222|FG000|NOT COMPLETED|Overall Study||0||
59561674|NCT03300843|75663227|FG000|STARTED|Overall Study||1||
59561675|NCT03300843|75663227|FG000|COMPLETED|Overall Study||1||
59561676|NCT03300843|75663227|FG000|NOT COMPLETED|Overall Study||0||
59561677|NCT01963481|75663231|FG000|STARTED|Overall Study||23||
59561678|NCT01963481|75663231|FG000|COMPLETED|Overall Study||23||
59561679|NCT01963481|75663231|FG000|NOT COMPLETED|Overall Study||0||
59561680|NCT03301779|75663235|FG000|STARTED|Overall Study||48||
59561681|NCT03301779|75663236|FG001|STARTED|Overall Study||52||
59561682|NCT03301779|75663235|FG000|COMPLETED|Overall Study||40||
59561683|NCT03301779|75663236|FG001|COMPLETED|Overall Study||45||
59561684|NCT03301779|75663235|FG000|NOT COMPLETED|Overall Study||8||
59561685|NCT03301779|75663236|FG001|NOT COMPLETED|Overall Study||7||
59561686|NCT01689350|75663244|FG000|STARTED|Overall Study||47||
59561687|NCT01689350|75663245|FG001|STARTED|Overall Study||45||
59561688|NCT01689350|75663244|FG000|COMPLETED|Overall Study||47||
59561689|NCT01689350|75663245|FG001|COMPLETED|Overall Study||45||
59561690|NCT01689350|75663244|FG000|NOT COMPLETED|Overall Study||0||
59561691|NCT01689350|75663245|FG001|NOT COMPLETED|Overall Study||0||
59561692|NCT03302091|75663253|FG000|STARTED|Overall Study||10|Started are treated|
59561693|NCT03302091|75663254|FG001|STARTED|Overall Study||10|Started are treated|
59561694|NCT03302091|75663253|FG000|COMPLETED|Overall Study||10||
59561695|NCT03302091|75663254|FG001|COMPLETED|Overall Study||10||
59561696|NCT03302091|75663253|FG000|NOT COMPLETED|Overall Study||0||
59561697|NCT03302091|75663254|FG001|NOT COMPLETED|Overall Study||0||
59561698|NCT03442725|75663262|FG000|STARTED|Overall Study||8||
59561699|NCT03442725|75663263|FG001|STARTED|Overall Study||8||
59561700|NCT03442725|75663262|FG000|COMPLETED|Overall Study||8||
59561701|NCT03442725|75663263|FG001|COMPLETED|Overall Study||8||
59561702|NCT03442725|75663262|FG000|NOT COMPLETED|Overall Study||0||
59561703|NCT03442725|75663263|FG001|NOT COMPLETED|Overall Study||0||
59561704|NCT04436744|75663271|FG000|STARTED|Overall Study||112||
59561705|NCT04436744|75663272|FG001|STARTED|Overall Study||109||
59561706|NCT04436744|75663271|FG000|COMPLETED|Overall Study||108||
59561707|NCT04436744|75663272|FG001|COMPLETED|Overall Study||98||
59561708|NCT04436744|75663271|FG000|NOT COMPLETED|Overall Study||4||
59561709|NCT04436744|75663272|FG001|NOT COMPLETED|Overall Study||11||
59561710|NCT03447015|75663281|FG000|STARTED|Overall Study||140||
59561711|NCT03447015|75663282|FG001|STARTED|Overall Study||150||
59993232|NCT01677741|76109107|FG000|NOT COMPLETED|Overall Study||3||
59993233|NCT01677741|76109108|FG001|NOT COMPLETED|Overall Study||10||
59993234|NCT01677741|76109109|FG002|NOT COMPLETED|Overall Study||8||
59993235|NCT01677741|76109110|FG003|NOT COMPLETED|Overall Study||6||
59993236|NCT01677741|76109111|FG004|NOT COMPLETED|Overall Study||17||
59993237|NCT01677741|76109112|FG005|NOT COMPLETED|Overall Study||28||
59993238|NCT01677741|76109113|FG006|NOT COMPLETED|Overall Study||11||
59993239|NCT01677741|76109114|FG007|NOT COMPLETED|Overall Study||2||
59993240|NCT01709981|76109150|FG000|STARTED|Overall Study||141||
59993241|NCT01709981|76109151|FG001|STARTED|Overall Study||139||
60092910|NCT01752985|76209990|FG001|STARTED|Follow-up Period||27||
59561712|NCT03447015|75663281|FG000|COMPLETED|Overall Study||95||
59561713|NCT03447015|75663282|FG001|COMPLETED|Overall Study||106||
60092911|NCT01752985|76209991|FG002|STARTED|Follow-up Period|Includes 24 participants in this period and 2 participants re-joined for follow-up|26||
59561714|NCT03447015|75663281|FG000|NOT COMPLETED|Overall Study||45||
59561715|NCT03447015|75663282|FG001|NOT COMPLETED|Overall Study||44||
59707953|NCT01114737|75826834|FG001|NOT COMPLETED|Randomized Treatment Period||1||
60092912|NCT01752985|76209989|FG000|COMPLETED|Follow-up Period||28||
60092913|NCT01752985|76209990|FG001|COMPLETED|Follow-up Period||27||
60092914|NCT01752985|76209991|FG002|COMPLETED|Follow-up Period||26||
60092915|NCT01752985|76209989|FG000|NOT COMPLETED|Follow-up Period||0||
60092916|NCT01752985|76209990|FG001|NOT COMPLETED|Follow-up Period||0||
60092917|NCT01752985|76209991|FG002|NOT COMPLETED|Follow-up Period||0||
60092918|NCT01751113|76209999|FG000|STARTED|Treatment Period 1 (4 Weeks)||8||
60092919|NCT01751113|76210000|FG001|STARTED|Treatment Period 1 (4 Weeks)||8||
59561716|NCT03302793|75663288|FG000|STARTED|Overall Study||6||
59561717|NCT03302793|75663289|FG001|STARTED|Overall Study||6||
59561718|NCT03302793|75663288|FG000|COMPLETED|Overall Study||6||
59561719|NCT03302793|75663289|FG001|COMPLETED|Overall Study||4||
59561720|NCT03302793|75663288|FG000|NOT COMPLETED|Overall Study||0||
59561721|NCT03302793|75663289|FG001|NOT COMPLETED|Overall Study||2||
60092920|NCT01751113|76210001|FG002|STARTED|Treatment Period 1 (4 Weeks)||9||
60092921|NCT01751113|76210002|FG003|STARTED|Treatment Period 1 (4 Weeks)||9||
60092922|NCT01751113|76210003|FG004|STARTED|Treatment Period 1 (4 Weeks)||9||
60092923|NCT01751113|76210004|FG005|STARTED|Treatment Period 1 (4 Weeks)||10||
60092924|NCT01751113|76209999|FG000|COMPLETED|Treatment Period 1 (4 Weeks)||8||
60092925|NCT01751113|76210000|FG001|COMPLETED|Treatment Period 1 (4 Weeks)||8||
60092926|NCT01751113|76210001|FG002|COMPLETED|Treatment Period 1 (4 Weeks)||9||
60092927|NCT01751113|76210002|FG003|COMPLETED|Treatment Period 1 (4 Weeks)||8||
60092928|NCT01751113|76210003|FG004|COMPLETED|Treatment Period 1 (4 Weeks)||8||
60092929|NCT01751113|76210004|FG005|COMPLETED|Treatment Period 1 (4 Weeks)||10||
60092930|NCT01751113|76209999|FG000|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0||
60092931|NCT01751113|76210000|FG001|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0||
60092932|NCT01751113|76210001|FG002|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0||
60092933|NCT01751113|76210002|FG003|NOT COMPLETED|Treatment Period 1 (4 Weeks)||1||
60092934|NCT01751113|76210003|FG004|NOT COMPLETED|Treatment Period 1 (4 Weeks)||1||
60092935|NCT01751113|76210004|FG005|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0||
60092936|NCT01751113|76209999|FG000|STARTED|Washout Period 1 (2 Weeks)||8||
60092937|NCT01751113|76210000|FG001|STARTED|Washout Period 1 (2 Weeks)||8||
60092938|NCT01751113|76210001|FG002|STARTED|Washout Period 1 (2 Weeks)||9||
60092939|NCT01751113|76210002|FG003|STARTED|Washout Period 1 (2 Weeks)||8||
60092940|NCT01751113|76210003|FG004|STARTED|Washout Period 1 (2 Weeks)||8||
60092941|NCT01751113|76210004|FG005|STARTED|Washout Period 1 (2 Weeks)||10||
60092942|NCT01751113|76209999|FG000|COMPLETED|Washout Period 1 (2 Weeks)||8||
59561722|NCT01963793|75663295|FG000|STARTED|Overall Study||20||
60092943|NCT01751113|76210000|FG001|COMPLETED|Washout Period 1 (2 Weeks)||8||
60092944|NCT01751113|76210001|FG002|COMPLETED|Washout Period 1 (2 Weeks)||9||
59561723|NCT01963793|75663295|FG000|COMPLETED|Overall Study||20||
59561724|NCT01963793|75663295|FG000|NOT COMPLETED|Overall Study||0||
59707954|NCT01114737|75826833|FG000|STARTED|Open-Label Treatment Period|One subject did not receive a single dose of the study drug|105||
59707955|NCT01114737|75826834|FG001|STARTED|Open-Label Treatment Period|Two subjects did not receive a single dose of the study drug|97||
59707956|NCT01114737|75826833|FG000|COMPLETED|Open-Label Treatment Period||100||
59707957|NCT01114737|75826834|FG001|COMPLETED|Open-Label Treatment Period||95||
59816937|NCT02927691|75939331|FG000|NOT COMPLETED|Overall Study||4||
59561725|NCT03449433|75663312|FG000|STARTED|Period 1||17||
59561726|NCT03449433|75663313|FG001|STARTED|Period 1||16||
59561727|NCT03449433|75663314|FG002|STARTED|Period 1||18||
60092945|NCT01751113|76210002|FG003|COMPLETED|Washout Period 1 (2 Weeks)||8||
60092946|NCT01751113|76210003|FG004|COMPLETED|Washout Period 1 (2 Weeks)||8||
60092947|NCT01751113|76210004|FG005|COMPLETED|Washout Period 1 (2 Weeks)||10||
60092948|NCT01751113|76209999|FG000|NOT COMPLETED|Washout Period 1 (2 Weeks)||0||
60092949|NCT01751113|76210000|FG001|NOT COMPLETED|Washout Period 1 (2 Weeks)||0||
60092950|NCT01751113|76210001|FG002|NOT COMPLETED|Washout Period 1 (2 Weeks)||0||
60092951|NCT01751113|76210002|FG003|NOT COMPLETED|Washout Period 1 (2 Weeks)||0||
60092952|NCT01751113|76210003|FG004|NOT COMPLETED|Washout Period 1 (2 Weeks)||0||
60092953|NCT01751113|76210004|FG005|NOT COMPLETED|Washout Period 1 (2 Weeks)||0||
60092954|NCT01751113|76209999|FG000|STARTED|Treatment Period 2 (4 Weeks)||8||
60092955|NCT01751113|76210000|FG001|STARTED|Treatment Period 2 (4 Weeks)||8||
60092956|NCT01751113|76210001|FG002|STARTED|Treatment Period 2 (4 Weeks)||9||
60092957|NCT01751113|76210002|FG003|STARTED|Treatment Period 2 (4 Weeks)||8||
60092958|NCT01751113|76210003|FG004|STARTED|Treatment Period 2 (4 Weeks)||8||
60092959|NCT01751113|76210004|FG005|STARTED|Treatment Period 2 (4 Weeks)||10||
60092960|NCT01751113|76209999|FG000|COMPLETED|Treatment Period 2 (4 Weeks)||8||
60092961|NCT01751113|76210000|FG001|COMPLETED|Treatment Period 2 (4 Weeks)||8||
60092962|NCT01751113|76210001|FG002|COMPLETED|Treatment Period 2 (4 Weeks)||9||
60092963|NCT01751113|76210002|FG003|COMPLETED|Treatment Period 2 (4 Weeks)||8||
60092964|NCT01751113|76210003|FG004|COMPLETED|Treatment Period 2 (4 Weeks)||8||
60092965|NCT01751113|76210004|FG005|COMPLETED|Treatment Period 2 (4 Weeks)||10||
60092966|NCT01751113|76209999|FG000|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0||
60092967|NCT01751113|76210000|FG001|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0||
60092968|NCT01751113|76210001|FG002|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0||
60092969|NCT01751113|76210002|FG003|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0||
60092970|NCT01751113|76210003|FG004|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0||
60092971|NCT01751113|76210004|FG005|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0||
60092972|NCT01751113|76209999|FG000|STARTED|Washout Period 2 (2 Weeks)||8||
60092973|NCT01751113|76210000|FG001|STARTED|Washout Period 2 (2 Weeks)||8||
60092974|NCT01751113|76210001|FG002|STARTED|Washout Period 2 (2 Weeks)||9||
60092975|NCT01751113|76210002|FG003|STARTED|Washout Period 2 (2 Weeks)||8||
60092976|NCT01751113|76210003|FG004|STARTED|Washout Period 2 (2 Weeks)||8||
60092977|NCT01751113|76210004|FG005|STARTED|Washout Period 2 (2 Weeks)||10||
60092978|NCT01751113|76209999|FG000|COMPLETED|Washout Period 2 (2 Weeks)||8||
60092979|NCT01751113|76210000|FG001|COMPLETED|Washout Period 2 (2 Weeks)||8||
60092980|NCT01751113|76210001|FG002|COMPLETED|Washout Period 2 (2 Weeks)||9||
60092981|NCT01751113|76210002|FG003|COMPLETED|Washout Period 2 (2 Weeks)||8||
60092982|NCT01751113|76210003|FG004|COMPLETED|Washout Period 2 (2 Weeks)||8||
60092983|NCT01751113|76210004|FG005|COMPLETED|Washout Period 2 (2 Weeks)||10||
60092984|NCT01751113|76209999|FG000|NOT COMPLETED|Washout Period 2 (2 Weeks)||0||
60092985|NCT01751113|76210000|FG001|NOT COMPLETED|Washout Period 2 (2 Weeks)||0||
60092986|NCT01751113|76210001|FG002|NOT COMPLETED|Washout Period 2 (2 Weeks)||0||
60092987|NCT01751113|76210002|FG003|NOT COMPLETED|Washout Period 2 (2 Weeks)||0||
60092988|NCT01751113|76210003|FG004|NOT COMPLETED|Washout Period 2 (2 Weeks)||0||
60092989|NCT01751113|76210004|FG005|NOT COMPLETED|Washout Period 2 (2 Weeks)||0||
60092990|NCT01751113|76209999|FG000|STARTED|Treatment Period 3 (4 Weeks)||8||
60092991|NCT01751113|76210000|FG001|STARTED|Treatment Period 3 (4 Weeks)||8||
60092992|NCT01751113|76210001|FG002|STARTED|Treatment Period 3 (4 Weeks)||9||
60092993|NCT01751113|76210002|FG003|STARTED|Treatment Period 3 (4 Weeks)||8||
60092994|NCT01751113|76210003|FG004|STARTED|Treatment Period 3 (4 Weeks)||8||
60092995|NCT01751113|76210004|FG005|STARTED|Treatment Period 3 (4 Weeks)||10||
59561728|NCT03449433|75663315|FG003|STARTED|Period 1||17||
59561729|NCT03449433|75663316|FG004|STARTED|Period 1||12||
59561730|NCT03449433|75663312|FG000|Received at Least 1 Dose of Study Drug|Period 1||17||
59707958|NCT01114737|75826833|FG000|NOT COMPLETED|Open-Label Treatment Period||5||
59707959|NCT01114737|75826834|FG001|NOT COMPLETED|Open-Label Treatment Period||2||
60092996|NCT01751113|76209999|FG000|COMPLETED|Treatment Period 3 (4 Weeks)||8||
60092997|NCT01751113|76210000|FG001|COMPLETED|Treatment Period 3 (4 Weeks)||8||
60092998|NCT01751113|76210001|FG002|COMPLETED|Treatment Period 3 (4 Weeks)||9||
60092999|NCT01751113|76210002|FG003|COMPLETED|Treatment Period 3 (4 Weeks)||8||
60093000|NCT01751113|76210003|FG004|COMPLETED|Treatment Period 3 (4 Weeks)||8||
60093001|NCT01751113|76210004|FG005|COMPLETED|Treatment Period 3 (4 Weeks)||9||
60093002|NCT01751113|76209999|FG000|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0||
59707960|NCT03258008|75826851|FG000|STARTED|Overall Study||2||
60093003|NCT01751113|76210000|FG001|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0||
60093004|NCT01751113|76210001|FG002|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0||
59561731|NCT03449433|75663313|FG001|Received at Least 1 Dose of Study Drug|Period 1||16||
59561732|NCT03449433|75663314|FG002|Received at Least 1 Dose of Study Drug|Period 1||18||
60093005|NCT01751113|76210002|FG003|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0||
60093006|NCT01751113|76210003|FG004|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0||
60093007|NCT01751113|76210004|FG005|NOT COMPLETED|Treatment Period 3 (4 Weeks)||1||
59707961|NCT03258008|75826851|FG000|COMPLETED|Overall Study||2||
59561733|NCT03449433|75663315|FG003|Received at Least 1 Dose of Study Drug|Period 1||17||
59707962|NCT03258008|75826851|FG000|NOT COMPLETED|Overall Study||0||
59707963|NCT01113879|75826857|FG000|STARTED|Period 1: Block 1||7||
60093008|NCT01750879|76210015|FG000|STARTED|Overall Study||30||
60093009|NCT01750879|76210016|FG001|STARTED|Overall Study||11||
60093010|NCT01750879|76210015|FG000|DBPCFC2|Overall Study||20||
60093011|NCT01750879|76210016|FG001|DBPCFC2|Overall Study||8||
60093012|NCT01750879|76210015|FG000|DBPCFC3|Overall Study||20||
60093013|NCT01750879|76210016|FG001|DBPCFC3|Overall Study||0||
60093014|NCT01750879|76210015|FG000|COMPLETED|Overall Study||20||
60093015|NCT01750879|76210016|FG001|COMPLETED|Overall Study||8||
60093016|NCT01750879|76210015|FG000|NOT COMPLETED|Overall Study||10||
60093017|NCT01750879|76210016|FG001|NOT COMPLETED|Overall Study||3||
60093018|NCT01719380|76210042|FG000|STARTED|Overall Study||2||
60093019|NCT01719380|76210043|FG001|STARTED|Overall Study||7||
60093020|NCT01719380|76210044|FG002|STARTED|Overall Study||9||
60093021|NCT01719380|76210045|FG003|STARTED|Overall Study||8||
60093022|NCT01719380|76210046|FG004|STARTED|Overall Study||3||
60093023|NCT01719380|76210047|FG005|STARTED|Overall Study||8||
60093024|NCT01719380|76210048|FG006|STARTED|Overall Study||10||
60093025|NCT01719380|76210049|FG007|STARTED|Overall Study||7||
60093026|NCT01719380|76210050|FG008|STARTED|Overall Study||50||
60093027|NCT01719380|76210051|FG009|STARTED|Overall Study||52||
60093028|NCT01719380|76210042|FG000|COMPLETED|Overall Study||0||
60093029|NCT01719380|76210043|FG001|COMPLETED|Overall Study||0||
60093030|NCT01719380|76210044|FG002|COMPLETED|Overall Study||0||
60093031|NCT01719380|76210045|FG003|COMPLETED|Overall Study||0||
60093032|NCT01719380|76210046|FG004|COMPLETED|Overall Study||0||
60093033|NCT01719380|76210047|FG005|COMPLETED|Overall Study||0||
60093034|NCT01719380|76210048|FG006|COMPLETED|Overall Study||0||
60093035|NCT01719380|76210049|FG007|COMPLETED|Overall Study||0||
60093036|NCT01719380|76210050|FG008|COMPLETED|Overall Study||0||
60093037|NCT01719380|76210051|FG009|COMPLETED|Overall Study||1||
60093038|NCT01719380|76210042|FG000|NOT COMPLETED|Overall Study||2||
60093039|NCT01719380|76210043|FG001|NOT COMPLETED|Overall Study||7||
60093040|NCT01719380|76210044|FG002|NOT COMPLETED|Overall Study||9||
60093041|NCT01719380|76210045|FG003|NOT COMPLETED|Overall Study||8||
60093042|NCT01719380|76210046|FG004|NOT COMPLETED|Overall Study||3||
60093043|NCT01719380|76210047|FG005|NOT COMPLETED|Overall Study||8||
60093044|NCT01719380|76210048|FG006|NOT COMPLETED|Overall Study||10||
59561734|NCT03449433|75663316|FG004|Received at Least 1 Dose of Study Drug|Period 1||0||
59561735|NCT03449433|75663312|FG000|COMPLETED|Period 1||17||
59561736|NCT03449433|75663313|FG001|COMPLETED|Period 1||16||
59561737|NCT03449433|75663314|FG002|COMPLETED|Period 1||18||
59561738|NCT03449433|75663315|FG003|COMPLETED|Period 1||17||
59561739|NCT03449433|75663316|FG004|COMPLETED|Period 1||12||
59561740|NCT03449433|75663312|FG000|NOT COMPLETED|Period 1||0||
59561741|NCT03449433|75663313|FG001|NOT COMPLETED|Period 1||0||
59561742|NCT03449433|75663314|FG002|NOT COMPLETED|Period 1||0||
59561743|NCT03449433|75663315|FG003|NOT COMPLETED|Period 1||0||
59561744|NCT03449433|75663316|FG004|NOT COMPLETED|Period 1||0||
59561745|NCT03449433|75663312|FG000|STARTED|Period 2||17||
59561746|NCT03449433|75663313|FG001|STARTED|Period 2||16||
59561747|NCT03449433|75663314|FG002|STARTED|Period 2||18||
59561748|NCT03449433|75663315|FG003|STARTED|Period 2||17||
59561749|NCT03449433|75663316|FG004|STARTED|Period 2||12||
59561750|NCT03449433|75663312|FG000|Received at Least 1 Dose of Study Drug|Period 2||17||
59561751|NCT03449433|75663313|FG001|Received at Least 1 Dose of Study Drug|Period 2||16||
59561752|NCT03449433|75663314|FG002|Received at Least 1 Dose of Study Drug|Period 2||18||
59561753|NCT03449433|75663315|FG003|Received at Least 1 Dose of Study Drug|Period 2||17||
59561754|NCT03449433|75663316|FG004|Received at Least 1 Dose of Study Drug|Period 2||0||
59561755|NCT03449433|75663312|FG000|COMPLETED|Period 2||17||
59561756|NCT03449433|75663313|FG001|COMPLETED|Period 2||16||
59561757|NCT03449433|75663314|FG002|COMPLETED|Period 2||18||
59561758|NCT03449433|75663315|FG003|COMPLETED|Period 2||17||
60093045|NCT01719380|76210049|FG007|NOT COMPLETED|Overall Study||7||
59561759|NCT03449433|75663316|FG004|COMPLETED|Period 2||12||
59561760|NCT03449433|75663312|FG000|NOT COMPLETED|Period 2||0||
59561761|NCT03449433|75663313|FG001|NOT COMPLETED|Period 2||0||
60093046|NCT01719380|76210050|FG008|NOT COMPLETED|Overall Study||50||
60093047|NCT01719380|76210051|FG009|NOT COMPLETED|Overall Study||51||
60093048|NCT00792142|76210080|FG000|STARTED|Overall Study||45||
60093049|NCT00792142|76210080|FG000|COMPLETED|Overall Study||45||
59561762|NCT03449433|75663314|FG002|NOT COMPLETED|Period 2||0||
59561763|NCT03449433|75663315|FG003|NOT COMPLETED|Period 2||0||
59707964|NCT01113879|75826858|FG001|STARTED|Period 1: Block 1||2||
60093050|NCT00792142|76210080|FG000|NOT COMPLETED|Overall Study||0||
60093051|NCT00792610|76210084|FG000|STARTED|Overall Study||127||
60093052|NCT00792610|76210084|FG000|Youths|Overall Study||127||
60093053|NCT00792610|76210084|FG000|COMPLETED|Overall Study||127||
60093054|NCT00792610|76210084|FG000|NOT COMPLETED|Overall Study||0||
60093055|NCT00792688|76210091|FG000|STARTED|Overall Study||9||
60093056|NCT00792688|76210092|FG001|STARTED|Overall Study||8||
60093057|NCT00792688|76210093|FG002|STARTED|Overall Study||9||
60093058|NCT00792688|76210091|FG000|COMPLETED|Overall Study||9||
60093059|NCT00792688|76210092|FG001|COMPLETED|Overall Study||8||
59561764|NCT03449433|75663316|FG004|NOT COMPLETED|Period 2||0||
60093060|NCT00792688|76210093|FG002|COMPLETED|Overall Study||9||
60093061|NCT00792688|76210091|FG000|NOT COMPLETED|Overall Study||0||
60093062|NCT00792688|76210092|FG001|NOT COMPLETED|Overall Study||0||
60093063|NCT00792688|76210093|FG002|NOT COMPLETED|Overall Study||0||
60093064|NCT01743560|76210101|FG000|STARTED|Overall Study||52||
60093065|NCT01743560|76210101|FG000|Full Analysis Set (FAS)|Overall Study|≥ 1 dose study drug|49||
60093066|NCT01743560|76210101|FG000|Safety Analysis Set (SAF)|Overall Study|≥ 1 dose study drug +1 post baseline safety assessment|49||
60093067|NCT01743560|76210101|FG000|COMPLETED|Overall Study||9||
60093068|NCT01743560|76210101|FG000|NOT COMPLETED|Overall Study||43||
60093069|NCT00796744|76210117|FG000|STARTED|Overall Study||24||
60093070|NCT00796744|76210118|FG001|STARTED|Overall Study||26||
60093071|NCT00796744|76210119|FG002|STARTED|Overall Study||28||
60093072|NCT00796744|76210117|FG000|COMPLETED|Overall Study||24||
60093073|NCT00796744|76210118|FG001|COMPLETED|Overall Study||26||
60093074|NCT00796744|76210119|FG002|COMPLETED|Overall Study||27||
60093075|NCT00796744|76210117|FG000|NOT COMPLETED|Overall Study||0||
60093076|NCT00796744|76210118|FG001|NOT COMPLETED|Overall Study||0||
60093077|NCT00796744|76210119|FG002|NOT COMPLETED|Overall Study||1||
60093078|NCT01743092|76210131|FG000|STARTED|Overall Study||33||
60093079|NCT01743092|76210132|FG001|STARTED|Overall Study||26||
60093080|NCT01743092|76210131|FG000|COMPLETED|Overall Study||19||
60093081|NCT01743092|76210132|FG001|COMPLETED|Overall Study||11||
60093082|NCT01743092|76210131|FG000|NOT COMPLETED|Overall Study||14||
60093083|NCT01743092|76210132|FG001|NOT COMPLETED|Overall Study||15||
60093084|NCT00797212|76210138|FG000|STARTED|Overall Study||50||
60093085|NCT00797212|76210138|FG000|COMPLETED|Overall Study||50||
60093086|NCT00797212|76210138|FG000|NOT COMPLETED|Overall Study||0||
60093087|NCT00792922|76210146|FG000|STARTED|At Baseline|the trial was conducted at community level and data reported per community basis|||32
60093088|NCT00792922|76210147|FG001|STARTED|At Baseline|the trial was conducted at community level and data reported per community basis|||32
60093089|NCT00792922|76210148|FG002|STARTED|At Baseline|the trial was conducted at community level and data reported per community basis|||32
60093090|NCT00792922|76210149|FG003|STARTED|At Baseline|the trial was conducted at community level and data reported per community basis|||32
60093091|NCT00792922|76210146|FG000|Niger|At Baseline|the trial was conducted at community level and data reported per community basis|||12
60093092|NCT00792922|76210147|FG001|Niger|At Baseline|the trial was conducted at community level and data reported per community basis|||12
60093093|NCT00792922|76210148|FG002|Niger|At Baseline|the trial was conducted at community level and data reported per community basis|||12
60093094|NCT00792922|76210149|FG003|Niger|At Baseline|the trial was conducted at community level and data reported per community basis|||12
60093095|NCT00792922|76210146|FG000|Gambia|At Baseline|the trial was conducted at community level and data reported per community basis|||12
60093096|NCT00792922|76210147|FG001|Gambia|At Baseline|the trial was conducted at community level and data reported per community basis|||12
60093097|NCT00792922|76210148|FG002|Gambia|At Baseline|the trial was conducted at community level and data reported per community basis|||12
60093098|NCT00792922|76210149|FG003|Gambia|At Baseline|the trial was conducted at community level and data reported per community basis|||12
60093099|NCT00792922|76210146|FG000|Tanzania|At Baseline|the trial was conducted at community level and data reported per community basis|||8
60093100|NCT00792922|76210147|FG001|Tanzania|At Baseline|the trial was conducted at community level and data reported per community basis|||8
60093101|NCT00792922|76210148|FG002|Tanzania|At Baseline|the trial was conducted at community level and data reported per community basis|||8
60093102|NCT00792922|76210149|FG003|Tanzania|At Baseline|the trial was conducted at community level and data reported per community basis|||8
60093103|NCT00792922|76210146|FG000|COMPLETED|At Baseline|the trial was conducted at community level and data reported per community basis|||32
60093104|NCT00792922|76210147|FG001|COMPLETED|At Baseline|the trial was conducted at community level and data reported per community basis|||32
60093105|NCT00792922|76210148|FG002|COMPLETED|At Baseline|the trial was conducted at community level and data reported per community basis|||32
60093106|NCT00792922|76210149|FG003|COMPLETED|At Baseline|the trial was conducted at community level and data reported per community basis|||32
60093107|NCT00792922|76210146|FG000|NOT COMPLETED|At Baseline||||0
60093108|NCT00792922|76210147|FG001|NOT COMPLETED|At Baseline||||0
60093109|NCT00792922|76210148|FG002|NOT COMPLETED|At Baseline||||0
60093110|NCT00792922|76210149|FG003|NOT COMPLETED|At Baseline||||0
59707965|NCT01113879|75826857|FG000|COMPLETED|Period 1: Block 1||5||
60093111|NCT00792922|76210146|FG000|STARTED|At 3 Years|"In Tanzania, units in treatment arm analyzed with antibiotic arm as tf rate was not <5% by 18 months~the trial was conducted at community level and data reported per community basis"|||40
60093112|NCT00792922|76210147|FG001|STARTED|At 3 Years|"In Tanzania, units in treatment arm analyzed with antibiotic arm as tf rate was not <5% by 18 months~the trial was conducted at community level and data reported per community basis"|||40
60093113|NCT00792922|76210148|FG002|STARTED|At 3 Years|"In Tanzania, units in treatment arm analyzed with antibiotic arm as tf rate was not <5% by 18 months~the trial was conducted at community level and data reported per community basis"|||24
60093114|NCT00792922|76210149|FG003|STARTED|At 3 Years|"In Tanzania, units in treatment arm analyzed with antibiotic arm as tf rate was not <5% by 18 months~the trial was conducted at community level and data reported per community basis"|||24
60093115|NCT00792922|76210146|FG000|Niger|At 3 Years|the trial was conducted at community level and data reported per community basis|||12
60093116|NCT00792922|76210147|FG001|Niger|At 3 Years|the trial was conducted at community level and data reported per community basis|||12
60093117|NCT00792922|76210148|FG002|Niger|At 3 Years|the trial was conducted at community level and data reported per community basis|||12
60093118|NCT00792922|76210149|FG003|Niger|At 3 Years|the trial was conducted at community level and data reported per community basis|||12
60093119|NCT00792922|76210146|FG000|Gambia|At 3 Years|the trial was conducted at community level and data reported per community basis|||12
60093120|NCT00792922|76210147|FG001|Gambia|At 3 Years|the trial was conducted at community level and data reported per community basis|||12
60093121|NCT00792922|76210148|FG002|Gambia|At 3 Years|the trial was conducted at community level and data reported per community basis|||12
60093122|NCT00792922|76210149|FG003|Gambia|At 3 Years|the trial was conducted at community level and data reported per community basis|||12
60093123|NCT00792922|76210146|FG000|Tanzania|At 3 Years|the trial was conducted at community level and data reported per community basis|||16
60093124|NCT00792922|76210147|FG001|Tanzania|At 3 Years|the trial was conducted at community level and data reported per community basis|||16
60093125|NCT00792922|76210148|FG002|Tanzania|At 3 Years|the trial was conducted at community level and data reported per community basis|||0
60093126|NCT00792922|76210149|FG003|Tanzania|At 3 Years|the trial was conducted at community level and data reported per community basis|||0
60093127|NCT00792922|76210146|FG000|COMPLETED|At 3 Years|the trial was conducted at community level and data reported per community basis|||40
60093128|NCT00792922|76210147|FG001|COMPLETED|At 3 Years|the trial was conducted at community level and data reported per community basis|||40
60093129|NCT00792922|76210148|FG002|COMPLETED|At 3 Years|the trial was conducted at community level and data reported per community basis|||24
60093130|NCT00792922|76210149|FG003|COMPLETED|At 3 Years|the trial was conducted at community level and data reported per community basis|||24
60093131|NCT00792922|76210146|FG000|NOT COMPLETED|At 3 Years||||0
60093132|NCT00792922|76210147|FG001|NOT COMPLETED|At 3 Years||||0
60093133|NCT00792922|76210148|FG002|NOT COMPLETED|At 3 Years||||0
60093134|NCT00792922|76210149|FG003|NOT COMPLETED|At 3 Years||||0
60093135|NCT01780831|76210165|FG000|STARTED|Overall Study||10||
60093136|NCT01780831|76210166|FG001|STARTED|Overall Study||6||
60093137|NCT01780831|76210167|FG002|STARTED|Overall Study||26||
60093138|NCT01780831|76210168|FG003|STARTED|Overall Study||10||
60093139|NCT01780831|76210165|FG000|COMPLETED|Overall Study||10||
60093140|NCT01780831|76210166|FG001|COMPLETED|Overall Study||6||
60093141|NCT01780831|76210167|FG002|COMPLETED|Overall Study||22||
60093142|NCT01780831|76210168|FG003|COMPLETED|Overall Study||9||
60093143|NCT01780831|76210165|FG000|NOT COMPLETED|Overall Study||0||
60093144|NCT01780831|76210166|FG001|NOT COMPLETED|Overall Study||0||
60093145|NCT01780831|76210167|FG002|NOT COMPLETED|Overall Study||4||
60093146|NCT01780831|76210168|FG003|NOT COMPLETED|Overall Study||1||
60093147|NCT01778023|76210227|FG000|STARTED|Overall Study||36||
60093148|NCT01778023|76210228|FG001|STARTED|Overall Study||18||
60093149|NCT01778023|76210227|FG000|Exposed|Overall Study||36||
60093150|NCT01778023|76210228|FG001|Exposed|Overall Study||15||
60093151|NCT01778023|76210227|FG000|COMPLETED|Overall Study||36||
60093152|NCT01778023|76210228|FG001|COMPLETED|Overall Study||15||
60093153|NCT01778023|76210227|FG000|NOT COMPLETED|Overall Study||0||
60093154|NCT01778023|76210228|FG001|NOT COMPLETED|Overall Study||3||
60093155|NCT01753297|76210236|FG000|STARTED|Overall Study||117||
60093156|NCT01753297|76210237|FG001|STARTED|Overall Study||109||
60093157|NCT01753297|76210236|FG000|Received Triptorelin Treatment|Overall Study||0||
60093158|NCT01753297|76210237|FG001|Received Triptorelin Treatment|Overall Study||105||
60093159|NCT01753297|76210236|FG000|COMPLETED|Overall Study||76|Completed study at Month 36 or completed Follow-up|
60093160|NCT01753297|76210237|FG001|COMPLETED|Overall Study||73|Completed study at Month 36 or completed Follow-up|
60093161|NCT01753297|76210236|FG000|NOT COMPLETED|Overall Study||41||
60093162|NCT01753297|76210237|FG001|NOT COMPLETED|Overall Study||36||
60093163|NCT01777321|76210247|FG000|STARTED|Overall Study||30||
60093164|NCT01777321|76210248|FG001|STARTED|Overall Study||30||
60093165|NCT01777321|76210247|FG000|COMPLETED|Overall Study||30||
60093166|NCT01777321|76210248|FG001|COMPLETED|Overall Study||29||
60093167|NCT01777321|76210247|FG000|NOT COMPLETED|Overall Study||0||
60093168|NCT01777321|76210248|FG001|NOT COMPLETED|Overall Study||1||
60093169|NCT01729819|76210256|FG000|STARTED|Overall Study||49|The ITT comprised of all randomised patients (49 in combination group and 57 in tolterodine group)|
60093170|NCT01729819|76210257|FG001|STARTED|Overall Study||57|The ITT comprised of all randomised patients (49 in combination group and 57 in tolterodine group)|
60093171|NCT01729819|76210256|FG000|COMPLETED|Overall Study||43||
60093172|NCT01729819|76210257|FG001|COMPLETED|Overall Study||50||
60093173|NCT01729819|76210256|FG000|NOT COMPLETED|Overall Study||6||
60093174|NCT01729819|76210257|FG001|NOT COMPLETED|Overall Study||7||
60093175|NCT01776541|76210268|FG000|STARTED|Overall Study||488||
60093176|NCT01776541|76210269|FG001|STARTED|Overall Study||491||
60093177|NCT01776541|76210268|FG000|COMPLETED|Overall Study||432||
60093178|NCT01776541|76210269|FG001|COMPLETED|Overall Study||416||
59561765|NCT03449433|75663312|FG000|STARTED|Period 3||17||
59561766|NCT03449433|75663313|FG001|STARTED|Period 3||16||
59561767|NCT03449433|75663314|FG002|STARTED|Period 3||18||
59561768|NCT03449433|75663315|FG003|STARTED|Period 3||17||
59561769|NCT03449433|75663316|FG004|STARTED|Period 3||12||
59561770|NCT03449433|75663312|FG000|Received at Least 1 Dose of Study Drug|Period 3||17||
59561771|NCT03449433|75663313|FG001|Received at Least 1 Dose of Study Drug|Period 3||15||
59561772|NCT03449433|75663314|FG002|Received at Least 1 Dose of Study Drug|Period 3||18||
59561773|NCT03449433|75663315|FG003|Received at Least 1 Dose of Study Drug|Period 3||17||
59561774|NCT03449433|75663316|FG004|Received at Least 1 Dose of Study Drug|Period 3||0||
59561775|NCT03449433|75663312|FG000|COMPLETED|Period 3||17||
59993242|NCT01709981|76109150|FG000|COMPLETED|Overall Study||141||
59993243|NCT01709981|76109151|FG001|COMPLETED|Overall Study||139||
59993244|NCT01709981|76109150|FG000|NOT COMPLETED|Overall Study||0||
59993245|NCT01709981|76109151|FG001|NOT COMPLETED|Overall Study||0||
59993246|NCT04458467|76109159|FG000|STARTED|Overall Study||35||
59993247|NCT04458467|76109160|FG001|STARTED|Overall Study||35||
59993248|NCT04458467|76109159|FG000|COMPLETED|Overall Study||35||
59993249|NCT04458467|76109160|FG001|COMPLETED|Overall Study||35||
59993250|NCT04458467|76109159|FG000|NOT COMPLETED|Overall Study||0||
59993251|NCT04458467|76109160|FG001|NOT COMPLETED|Overall Study||0||
60093179|NCT01776541|76210268|FG000|NOT COMPLETED|Overall Study||56||
60093180|NCT01776541|76210269|FG001|NOT COMPLETED|Overall Study||75||
59561776|NCT03449433|75663313|FG001|COMPLETED|Period 3||15||
59561777|NCT03449433|75663314|FG002|COMPLETED|Period 3||18||
59561778|NCT03449433|75663315|FG003|COMPLETED|Period 3||17||
59561779|NCT03449433|75663316|FG004|COMPLETED|Period 3||12||
59561780|NCT03449433|75663312|FG000|NOT COMPLETED|Period 3||0||
59561781|NCT03449433|75663313|FG001|NOT COMPLETED|Period 3||1||
59561782|NCT03449433|75663314|FG002|NOT COMPLETED|Period 3||0||
59561783|NCT03449433|75663315|FG003|NOT COMPLETED|Period 3||0||
59561784|NCT03449433|75663316|FG004|NOT COMPLETED|Period 3||0||
59561785|NCT03449433|75663312|FG000|STARTED|Period 4||17||
59561786|NCT03449433|75663313|FG001|STARTED|Period 4||15||
59561787|NCT03449433|75663314|FG002|STARTED|Period 4||18||
59561788|NCT03449433|75663315|FG003|STARTED|Period 4||17||
59561789|NCT03449433|75663316|FG004|STARTED|Period 4||12||
59561790|NCT03449433|75663312|FG000|Received at Least 1 Dose of Study Drug|Period 4||17||
59561791|NCT03449433|75663313|FG001|Received at Least 1 Dose of Study Drug|Period 4||15||
59561792|NCT03449433|75663314|FG002|Received at Least 1 Dose of Study Drug|Period 4||18||
59561793|NCT03449433|75663315|FG003|Received at Least 1 Dose of Study Drug|Period 4||17||
59561794|NCT03449433|75663316|FG004|Received at Least 1 Dose of Study Drug|Period 4||0||
59561795|NCT03449433|75663312|FG000|COMPLETED|Period 4||17||
59561796|NCT03449433|75663313|FG001|COMPLETED|Period 4||15||
59561797|NCT03449433|75663314|FG002|COMPLETED|Period 4||18||
59561798|NCT03449433|75663315|FG003|COMPLETED|Period 4||17||
59561799|NCT03449433|75663316|FG004|COMPLETED|Period 4||12||
59561800|NCT03449433|75663312|FG000|NOT COMPLETED|Period 4||0||
59561801|NCT03449433|75663313|FG001|NOT COMPLETED|Period 4||0||
59561802|NCT03449433|75663314|FG002|NOT COMPLETED|Period 4||0||
59561803|NCT03449433|75663315|FG003|NOT COMPLETED|Period 4||0||
60093181|NCT00811564|76210278|FG000|STARTED|Overall Study||73||
60093182|NCT00811564|76210279|FG001|STARTED|Overall Study||75||
60093183|NCT00811564|76210278|FG000|COMPLETED|Overall Study||64||
60093184|NCT00811564|76210279|FG001|COMPLETED|Overall Study||73||
60093185|NCT00811564|76210278|FG000|NOT COMPLETED|Overall Study||9||
60093186|NCT00811564|76210279|FG001|NOT COMPLETED|Overall Study||2||
60093187|NCT00811798|76210285|FG000|STARTED|Overall Study||92||
60093188|NCT00811798|76210285|FG000|COMPLETED|Overall Study||92||
60093189|NCT00811798|76210285|FG000|NOT COMPLETED|Overall Study||0||
60093190|NCT01742078|76210298|FG000|STARTED|Overall Study||6||
59561804|NCT03449433|75663316|FG004|NOT COMPLETED|Period 4||0||
59816938|NCT02927691|75939332|FG001|NOT COMPLETED|Overall Study||3||
59816939|NCT02864394|75939340|FG000|STARTED|Overall Study||213||
59816940|NCT02864394|75939341|FG001|STARTED|Overall Study||212||
59816941|NCT02864394|75939340|FG000|Treated|Overall Study||213||
59816942|NCT02864394|75939341|FG001|Treated|Overall Study||198||
59816943|NCT02864394|75939340|FG000|Received Second Course Pembrolizumab Treatment|Overall Study||10||
59816944|NCT02864394|75939341|FG001|Received Second Course Pembrolizumab Treatment|Overall Study||0||
59816945|NCT02864394|75939340|FG000|COMPLETED|Overall Study||0||
59816946|NCT02864394|75939341|FG001|COMPLETED|Overall Study||0||
59816947|NCT02864394|75939340|FG000|NOT COMPLETED|Overall Study||213||
59816948|NCT02864394|75939341|FG001|NOT COMPLETED|Overall Study||212||
59816949|NCT02836418|75939348|FG000|STARTED|Overall Study||8||
59816950|NCT02836418|75939348|FG000|Received at Least One Dose of Study Drug|Overall Study||8||
59816951|NCT02836418|75939348|FG000|COMPLETED|Overall Study||8||
59816952|NCT02836418|75939348|FG000|NOT COMPLETED|Overall Study||0||
59816953|NCT02773849|75939354|FG000|STARTED|Overall Study||157||
59816954|NCT02773849|75939354|FG000|COMPLETED|Overall Study||63||
59816955|NCT02773849|75939354|FG000|NOT COMPLETED|Overall Study||94||
59816956|NCT02542839|75939364|FG000|STARTED|Overall Study||5||
59816957|NCT02542839|75939365|FG001|STARTED|Overall Study||4||
59816958|NCT02542839|75939364|FG000|COMPLETED|Overall Study||5||
59816959|NCT02542839|75939365|FG001|COMPLETED|Overall Study||4||
59561805|NCT03241485|75663332|FG000|STARTED|Overall Study||42||
59561806|NCT03241485|75663333|FG001|STARTED|Overall Study||37||
59561807|NCT03241485|75663332|FG000|COMPLETED|Overall Study||37||
59561808|NCT03241485|75663333|FG001|COMPLETED|Overall Study||33||
59707966|NCT01113879|75826858|FG001|COMPLETED|Period 1: Block 1||2||
59707967|NCT01113879|75826857|FG000|NOT COMPLETED|Period 1: Block 1||2||
59707968|NCT01113879|75826858|FG001|NOT COMPLETED|Period 1: Block 1||0||
59707969|NCT01113879|75826857|FG000|STARTED|Period 2: Block 2||5||
59707970|NCT01113879|75826858|FG001|STARTED|Period 2: Block 2||2||
59707971|NCT01113879|75826857|FG000|COMPLETED|Period 2: Block 2||5||
59707972|NCT01113879|75826858|FG001|COMPLETED|Period 2: Block 2||2||
60093191|NCT01742078|76210299|FG001|STARTED|Overall Study||6||
60093192|NCT01742078|76210300|FG002|STARTED|Overall Study||6||
59561809|NCT03241485|75663332|FG000|NOT COMPLETED|Overall Study||5||
59707973|NCT01113879|75826857|FG000|NOT COMPLETED|Period 2: Block 2||0||
59707974|NCT01113879|75826858|FG001|NOT COMPLETED|Period 2: Block 2||0||
59707975|NCT00979576|75826869|FG000|STARTED|Combination Treatment Phase||3||
59707976|NCT00979576|75826870|FG001|STARTED|Combination Treatment Phase||6||
60093193|NCT01742078|76210301|FG003|STARTED|Overall Study||6||
60093194|NCT01742078|76210302|FG004|STARTED|Overall Study||6||
59561810|NCT03241485|75663333|FG001|NOT COMPLETED|Overall Study||4||
59561811|NCT01965665|75663343|FG000|STARTED|Overall Study||20||
59561812|NCT01965665|75663343|FG000|COMPLETED|Overall Study||19||
59561813|NCT01965665|75663343|FG000|NOT COMPLETED|Overall Study||1||
59561814|NCT03304119|75663349|FG000|STARTED|Overall Study||37||
60093195|NCT01742078|76210303|FG005|STARTED|Overall Study||6||
60093196|NCT01742078|76210304|FG006|STARTED|Overall Study||6||
60093197|NCT01742078|76210305|FG007|STARTED|Overall Study||6||
60093198|NCT01742078|76210306|FG008|STARTED|Overall Study||12||
60093199|NCT01742078|76210298|FG000|RECEIVED STUDY DRUG|Overall Study||6||
60093200|NCT01742078|76210299|FG001|RECEIVED STUDY DRUG|Overall Study||6||
60093201|NCT01742078|76210300|FG002|RECEIVED STUDY DRUG|Overall Study||6||
60093202|NCT01742078|76210301|FG003|RECEIVED STUDY DRUG|Overall Study||6||
60093203|NCT01742078|76210302|FG004|RECEIVED STUDY DRUG|Overall Study||6||
60093204|NCT01742078|76210303|FG005|RECEIVED STUDY DRUG|Overall Study||6||
60093205|NCT01742078|76210304|FG006|RECEIVED STUDY DRUG|Overall Study||6||
60093206|NCT01742078|76210305|FG007|RECEIVED STUDY DRUG|Overall Study||6||
60093207|NCT01742078|76210306|FG008|RECEIVED STUDY DRUG|Overall Study||12||
60093208|NCT01742078|76210298|FG000|COMPLETED|Overall Study||6||
60093209|NCT01742078|76210299|FG001|COMPLETED|Overall Study||6||
60093210|NCT01742078|76210300|FG002|COMPLETED|Overall Study||6||
60093211|NCT01742078|76210301|FG003|COMPLETED|Overall Study||5||
60093212|NCT01742078|76210302|FG004|COMPLETED|Overall Study||6||
60093213|NCT01742078|76210303|FG005|COMPLETED|Overall Study||6||
60093214|NCT01742078|76210304|FG006|COMPLETED|Overall Study||6||
60093215|NCT01742078|76210305|FG007|COMPLETED|Overall Study||6||
60093216|NCT01742078|76210306|FG008|COMPLETED|Overall Study||12||
60093217|NCT01742078|76210298|FG000|NOT COMPLETED|Overall Study||0||
60093218|NCT01742078|76210299|FG001|NOT COMPLETED|Overall Study||0||
60093219|NCT01742078|76210300|FG002|NOT COMPLETED|Overall Study||0||
60093220|NCT01742078|76210301|FG003|NOT COMPLETED|Overall Study||1||
60093221|NCT01742078|76210302|FG004|NOT COMPLETED|Overall Study||0||
60093222|NCT01742078|76210303|FG005|NOT COMPLETED|Overall Study||0||
60093223|NCT01742078|76210304|FG006|NOT COMPLETED|Overall Study||0||
60093224|NCT01742078|76210305|FG007|NOT COMPLETED|Overall Study||0||
60093225|NCT01742078|76210306|FG008|NOT COMPLETED|Overall Study||0||
60093226|NCT01741688|76210328|FG000|STARTED|Overall Study||16||
60093227|NCT01741688|76210328|FG000|COMPLETED|Overall Study||13||
60093228|NCT01741688|76210328|FG000|NOT COMPLETED|Overall Study||3||
60093229|NCT01709084|76210335|FG000|STARTED|Overall Study||213||
60093230|NCT01709084|76210336|FG001|STARTED|Overall Study||213||
60093231|NCT01709084|76210335|FG000|Treated|Overall Study||213||
60093232|NCT01709084|76210336|FG001|Treated|Overall Study||211||
60093233|NCT01709084|76210335|FG000|COMPLETED|Overall Study||197||
60093234|NCT01709084|76210336|FG001|COMPLETED|Overall Study||198||
60093235|NCT01709084|76210335|FG000|NOT COMPLETED|Overall Study||16||
60093236|NCT01709084|76210336|FG001|NOT COMPLETED|Overall Study||15||
60093237|NCT01729039|76210344|FG000|STARTED|Overall Study||23||
60093238|NCT01729039|76210345|FG001|STARTED|Overall Study||26||
60093239|NCT01729039|76210344|FG000|COMPLETED|Overall Study||13||
60093240|NCT01729039|76210345|FG001|COMPLETED|Overall Study||14||
60093241|NCT01729039|76210344|FG000|NOT COMPLETED|Overall Study||10||
59707977|NCT00979576|75826871|FG002|STARTED|Combination Treatment Phase||9||
59707978|NCT00979576|75826869|FG000|COMPLETED|Combination Treatment Phase||0||
59707979|NCT00979576|75826870|FG001|COMPLETED|Combination Treatment Phase||0||
59707980|NCT00979576|75826871|FG002|COMPLETED|Combination Treatment Phase||0||
59707981|NCT00979576|75826869|FG000|NOT COMPLETED|Combination Treatment Phase||3||
59707982|NCT00979576|75826870|FG001|NOT COMPLETED|Combination Treatment Phase||6||
59707983|NCT00979576|75826871|FG002|NOT COMPLETED|Combination Treatment Phase||9||
59707984|NCT00979576|75826869|FG000|STARTED|Combination Followed by Monotherapy||0||
59707985|NCT00979576|75826870|FG001|STARTED|Combination Followed by Monotherapy||2||
59707986|NCT00979576|75826871|FG002|STARTED|Combination Followed by Monotherapy||1||
59707987|NCT00979576|75826869|FG000|COMPLETED|Combination Followed by Monotherapy||0||
60093242|NCT01729039|76210345|FG001|NOT COMPLETED|Overall Study||12||
60093243|NCT01775995|76210356|FG000|STARTED|Overall Study||21||
60093244|NCT01775995|76210357|FG001|STARTED|Overall Study||14||
60093245|NCT01775995|76210356|FG000|COMPLETED|Overall Study|One experimental participant was unable to reach at 26 week follow up|20||
59707988|NCT00979576|75826870|FG001|COMPLETED|Combination Followed by Monotherapy||0||
59707989|NCT00979576|75826871|FG002|COMPLETED|Combination Followed by Monotherapy||0||
60093246|NCT01775995|76210357|FG001|COMPLETED|Overall Study|One control participant was unable to reach at 26 week follow up|13||
60093247|NCT01775995|76210356|FG000|NOT COMPLETED|Overall Study||1||
60093248|NCT01775995|76210357|FG001|NOT COMPLETED|Overall Study||1||
60093249|NCT01741532|76210365|FG000|STARTED|Overall Study||59||
60093250|NCT01741532|76210366|FG001|STARTED|Overall Study||30||
59707990|NCT00979576|75826869|FG000|NOT COMPLETED|Combination Followed by Monotherapy||0||
59707991|NCT00979576|75826870|FG001|NOT COMPLETED|Combination Followed by Monotherapy||2||
60093251|NCT01741532|76210365|FG000|Exposed|Overall Study||58||
60093252|NCT01741532|76210366|FG001|Exposed|Overall Study||30||
60093253|NCT01741532|76210365|FG000|Provided Post-baseline Efficacy Data|Overall Study||58||
60093254|NCT01741532|76210366|FG001|Provided Post-baseline Efficacy Data|Overall Study||28||
60093255|NCT01741532|76210365|FG000|COMPLETED|Overall Study||49||
60093256|NCT01741532|76210366|FG001|COMPLETED|Overall Study||27||
60093257|NCT01741532|76210365|FG000|NOT COMPLETED|Overall Study||10||
59707992|NCT00979576|75826871|FG002|NOT COMPLETED|Combination Followed by Monotherapy||1||
60093258|NCT01741532|76210366|FG001|NOT COMPLETED|Overall Study||3||
60093259|NCT01719224|76210376|FG000|STARTED|Intervention 1: Sleeping Position 1||18||
60093260|NCT01719224|76210377|FG001|STARTED|Intervention 1: Sleeping Position 1||18||
60093261|NCT01719224|76210376|FG000|COMPLETED|Intervention 1: Sleeping Position 1||14||
60093262|NCT01719224|76210377|FG001|COMPLETED|Intervention 1: Sleeping Position 1||16||
60093263|NCT01719224|76210376|FG000|NOT COMPLETED|Intervention 1: Sleeping Position 1||4||
60093264|NCT01719224|76210377|FG001|NOT COMPLETED|Intervention 1: Sleeping Position 1||2||
60093265|NCT01719224|76210376|FG000|STARTED|Intervention 2: Position Change(At 3.5h)||14||
60093266|NCT01719224|76210377|FG001|STARTED|Intervention 2: Position Change(At 3.5h)||16||
60093267|NCT01719224|76210376|FG000|COMPLETED|Intervention 2: Position Change(At 3.5h)||14||
60093268|NCT01719224|76210377|FG001|COMPLETED|Intervention 2: Position Change(At 3.5h)||16||
60093269|NCT01719224|76210376|FG000|NOT COMPLETED|Intervention 2: Position Change(At 3.5h)||0||
60093270|NCT01719224|76210377|FG001|NOT COMPLETED|Intervention 2: Position Change(At 3.5h)||0||
60093271|NCT01717976|76210388|FG000|STARTED|Overall Study||257||
60093272|NCT01717976|76210389|FG001|STARTED|Overall Study||257||
59561815|NCT03304119|75663350|FG001|STARTED|Overall Study||55||
59561816|NCT03304119|75663349|FG000|COMPLETED|Overall Study||37||
59561817|NCT03304119|75663350|FG001|COMPLETED|Overall Study||55||
59561818|NCT03304119|75663349|FG000|NOT COMPLETED|Overall Study||0||
59561819|NCT03304119|75663350|FG001|NOT COMPLETED|Overall Study||0||
59561820|NCT01965899|75663356|FG000|STARTED|Overall Study||151||
59561821|NCT01965899|75663356|FG000|COMPLETED|Overall Study||145||
60093273|NCT01717976|76210388|FG000|COMPLETED|Overall Study||257||
60093274|NCT01717976|76210389|FG001|COMPLETED|Overall Study||256||
60093275|NCT01717976|76210388|FG000|NOT COMPLETED|Overall Study||0||
60093276|NCT01717976|76210389|FG001|NOT COMPLETED|Overall Study||1||
60093277|NCT01740440|76210395|FG000|STARTED|Overall Study||30||
60093278|NCT01740440|76210395|FG000|COMPLETED|Overall Study||27||
60093279|NCT01740440|76210395|FG000|NOT COMPLETED|Overall Study||3||
60093280|NCT01740128|76210402|FG000|STARTED|Overall Study||10||
60093281|NCT01740128|76210403|FG001|STARTED|Overall Study||11||
60093282|NCT01740128|76210402|FG000|COMPLETED|Overall Study||4||
60093283|NCT01740128|76210403|FG001|COMPLETED|Overall Study||4||
60093284|NCT01740128|76210402|FG000|NOT COMPLETED|Overall Study||6||
60093285|NCT01740128|76210403|FG001|NOT COMPLETED|Overall Study||7||
60093286|NCT01976741|76210419|FG000|STARTED|Overall Study||4||
60093287|NCT01976741|76210420|FG001|STARTED|Overall Study||4||
60093288|NCT01976741|76210421|FG002|STARTED|Overall Study||4||
60093289|NCT01976741|76210422|FG003|STARTED|Overall Study||3||
60093290|NCT01976741|76210423|FG004|STARTED|Overall Study||4||
60093291|NCT01976741|76210424|FG005|STARTED|Overall Study||4||
60093292|NCT01976741|76210425|FG006|STARTED|Overall Study||23||
60093293|NCT01976741|76210426|FG007|STARTED|Overall Study||74||
60093294|NCT01976741|76210427|FG008|STARTED|Overall Study||8||
60093295|NCT01976741|76210428|FG009|STARTED|Overall Study||40||
60093296|NCT01976741|76210419|FG000|COMPLETED|Overall Study||3||
60093297|NCT01976741|76210420|FG001|COMPLETED|Overall Study||4||
60093298|NCT01976741|76210421|FG002|COMPLETED|Overall Study||1||
60093299|NCT01976741|76210422|FG003|COMPLETED|Overall Study||2||
60093300|NCT01976741|76210423|FG004|COMPLETED|Overall Study||4||
60093301|NCT01976741|76210424|FG005|COMPLETED|Overall Study||4||
60093302|NCT01976741|76210425|FG006|COMPLETED|Overall Study||19||
60093303|NCT01976741|76210426|FG007|COMPLETED|Overall Study||62||
59561822|NCT01965899|75663356|FG000|NOT COMPLETED|Overall Study||6||
59561823|NCT03450369|75663363|FG000|STARTED|Overall Study||5||
59561824|NCT03450369|75663364|FG001|STARTED|Overall Study||5||
59561825|NCT03450369|75663363|FG000|COMPLETED|Overall Study||5||
60093304|NCT01976741|76210427|FG008|COMPLETED|Overall Study||7||
60093305|NCT01976741|76210428|FG009|COMPLETED|Overall Study||36||
59561826|NCT03450369|75663364|FG001|COMPLETED|Overall Study||5||
59561827|NCT03450369|75663363|FG000|NOT COMPLETED|Overall Study||0||
60093306|NCT01976741|76210419|FG000|NOT COMPLETED|Overall Study||1||
60093307|NCT01976741|76210420|FG001|NOT COMPLETED|Overall Study||0||
60093308|NCT01976741|76210421|FG002|NOT COMPLETED|Overall Study||3||
60093309|NCT01976741|76210422|FG003|NOT COMPLETED|Overall Study||1||
60093310|NCT01976741|76210423|FG004|NOT COMPLETED|Overall Study||0||
60093311|NCT01976741|76210424|FG005|NOT COMPLETED|Overall Study||0||
60093312|NCT01976741|76210425|FG006|NOT COMPLETED|Overall Study||4||
60093313|NCT01976741|76210426|FG007|NOT COMPLETED|Overall Study||12||
60093314|NCT01976741|76210427|FG008|NOT COMPLETED|Overall Study||1||
60093315|NCT01976741|76210428|FG009|NOT COMPLETED|Overall Study||4||
60093316|NCT01727713|76210462|FG000|STARTED|Overall Study||110||
60093317|NCT01727713|76210462|FG000|COMPLETED|Overall Study||75||
60093318|NCT01727713|76210462|FG000|NOT COMPLETED|Overall Study||35||
60093319|NCT01965431|76210466|FG000|STARTED|Overall Study|Started are actually Treated subjects|8||
60093320|NCT01965431|76210467|FG001|STARTED|Overall Study||8||
59707993|NCT00979420|75826884|FG000|STARTED|Overall Study||178||
60093321|NCT01965431|76210468|FG002|STARTED|Overall Study||8||
60093322|NCT01965431|76210469|FG003|STARTED|Overall Study||8||
60093323|NCT01965431|76210470|FG004|STARTED|Overall Study||8||
59561828|NCT03450369|75663364|FG001|NOT COMPLETED|Overall Study||0||
59561829|NCT01996943|75663372|FG000|STARTED|Overall Study||50||
60093324|NCT01965431|76210471|FG005|STARTED|Overall Study||8||
60093325|NCT01965431|76210466|FG000|COMPLETED|Overall Study||2||
60093326|NCT01965431|76210467|FG001|COMPLETED|Overall Study||2||
60093327|NCT01965431|76210468|FG002|COMPLETED|Overall Study||2||
60093328|NCT01965431|76210469|FG003|COMPLETED|Overall Study||2||
60093329|NCT01965431|76210470|FG004|COMPLETED|Overall Study||2||
60093330|NCT01965431|76210471|FG005|COMPLETED|Overall Study||2||
60093331|NCT01965431|76210466|FG000|NOT COMPLETED|Overall Study||6||
60093332|NCT01965431|76210467|FG001|NOT COMPLETED|Overall Study||6||
60093333|NCT01965431|76210468|FG002|NOT COMPLETED|Overall Study||6||
60093334|NCT01965431|76210469|FG003|NOT COMPLETED|Overall Study||6||
60093335|NCT01965431|76210470|FG004|NOT COMPLETED|Overall Study||6||
60093336|NCT01965431|76210471|FG005|NOT COMPLETED|Overall Study||6||
60093337|NCT01976663|76210481|FG000|STARTED|Overall Study||126||
60093338|NCT01976663|76210481|FG000|Received Touch-up Treatment|Overall Study||63||
60093339|NCT01976663|76210481|FG000|Received Asymmetry Correction|Overall Study||45||
60093340|NCT01976663|76210481|FG000|Received Repeat Treatment|Overall Study||85||
60093341|NCT01976663|76210481|FG000|COMPLETED|Overall Study||84||
60093342|NCT01976663|76210481|FG000|NOT COMPLETED|Overall Study||42||
60093343|NCT01775137|76210489|FG000|STARTED|Overall Study||45||
60093344|NCT01775137|76210489|FG000|COMPLETED|Overall Study||34||
60093345|NCT01775137|76210489|FG000|NOT COMPLETED|Overall Study||11||
60093346|NCT01976507|76210496|FG000|STARTED|Overall Study||101||
60093347|NCT01976507|76210496|FG000|Received Initial Dose of Dabigatran|Overall Study||100||
60093348|NCT01976507|76210496|FG000|COMPLETED|Overall Study||94||
60093349|NCT01976507|76210496|FG000|NOT COMPLETED|Overall Study||7||
60093350|NCT01964963|76210500|FG000|STARTED|Overall Study||19192||
60093351|NCT01964963|76210500|FG000|COMPLETED|Overall Study||18249||
60093352|NCT01964963|76210500|FG000|NOT COMPLETED|Overall Study||943||
60093353|NCT01964105|76210507|FG000|STARTED|Overall Study||15||
60093354|NCT01964105|76210508|FG001|STARTED|Overall Study||75||
60093355|NCT01964105|76210509|FG002|STARTED|Overall Study||10||
60093356|NCT01964105|76210507|FG000|COMPLETED|Overall Study||13||
60093357|NCT01964105|76210508|FG001|COMPLETED|Overall Study||62||
60093358|NCT01964105|76210509|FG002|COMPLETED|Overall Study||10||
60093359|NCT01964105|76210507|FG000|NOT COMPLETED|Overall Study||2||
60093360|NCT01964105|76210508|FG001|NOT COMPLETED|Overall Study||13||
60093361|NCT01964105|76210509|FG002|NOT COMPLETED|Overall Study||0||
60093362|NCT01974323|76210519|FG000|STARTED|Overall Study||1118||
60093363|NCT01974323|76210520|FG001|STARTED|Overall Study||1120||
60093364|NCT01974323|76210519|FG000|COMPLETED|Overall Study||1026||
60093365|NCT01974323|76210520|FG001|COMPLETED|Overall Study||1027||
60093366|NCT01974323|76210519|FG000|NOT COMPLETED|Overall Study||92||
60093367|NCT01974323|76210520|FG001|NOT COMPLETED|Overall Study||93||
60093368|NCT01963403|76210528|FG000|STARTED|Overall Study||13||
60093369|NCT01963403|76210529|FG001|STARTED|Overall Study||13||
60093370|NCT01963403|76210528|FG000|COMPLETED|Overall Study|Follow-up over three months|11||
60093371|NCT01963403|76210529|FG001|COMPLETED|Overall Study|Follow-up over three months|9||
60093372|NCT01963403|76210528|FG000|NOT COMPLETED|Overall Study||2||
60093373|NCT01963403|76210529|FG001|NOT COMPLETED|Overall Study||4||
60093374|NCT01973387|76210539|FG000|STARTED|Overall Study||106||
60093375|NCT01973387|76210540|FG001|STARTED|Overall Study||54||
60093376|NCT01973387|76210539|FG000|Treated|Overall Study||104||
60093377|NCT01973387|76210540|FG001|Treated|Overall Study||52||
60093378|NCT01973387|76210539|FG000|COMPLETED|Overall Study||0||
60093379|NCT01973387|76210540|FG001|COMPLETED|Overall Study||36||
60093380|NCT01973387|76210539|FG000|NOT COMPLETED|Overall Study||106||
60093381|NCT01973387|76210540|FG001|NOT COMPLETED|Overall Study||18||
60093382|NCT01973231|76210548|FG000|STARTED|Overall Study||202||
60093383|NCT01973231|76210549|FG001|STARTED|Overall Study||202||
60093384|NCT01973231|76210548|FG000|COMPLETED|Overall Study||191||
60093385|NCT01973231|76210549|FG001|COMPLETED|Overall Study||190||
60093386|NCT01973231|76210548|FG000|NOT COMPLETED|Overall Study||11||
60093387|NCT01973231|76210549|FG001|NOT COMPLETED|Overall Study||12||
60093388|NCT01961687|76210555|FG000|STARTED|Overall Study||121||
60093389|NCT01961687|76210555|FG000|COMPLETED|Overall Study||60||
60093390|NCT01961687|76210555|FG000|NOT COMPLETED|Overall Study||61||
60093391|NCT02151994|76210562|FG000|STARTED|Single Ascending Dose (SAD)||18||
60093392|NCT02151994|76210563|FG001|STARTED|Single Ascending Dose (SAD)||6||
60093393|NCT02151994|76210564|FG002|STARTED|Single Ascending Dose (SAD)||6||
60093394|NCT02151994|76210565|FG003|STARTED|Single Ascending Dose (SAD)||6||
60093395|NCT02151994|76210566|FG004|STARTED|Single Ascending Dose (SAD)||6||
60093396|NCT02151994|76210567|FG005|STARTED|Single Ascending Dose (SAD)||6||
60093397|NCT02151994|76210568|FG006|STARTED|Single Ascending Dose (SAD)||6||
60093398|NCT02151994|76210569|FG007|STARTED|Single Ascending Dose (SAD)||6||
60093399|NCT02151994|76210570|FG008|STARTED|Single Ascending Dose (SAD)||0||
60093400|NCT02151994|76210571|FG009|STARTED|Single Ascending Dose (SAD)||6||
60093401|NCT02151994|76210572|FG010|STARTED|Single Ascending Dose (SAD)||6||
60093402|NCT02151994|76210573|FG011|STARTED|Single Ascending Dose (SAD)||0||
60093403|NCT02151994|76210574|FG012|STARTED|Single Ascending Dose (SAD)||0||
60093404|NCT02151994|76210562|FG000|COMPLETED|Single Ascending Dose (SAD)||18||
60093405|NCT02151994|76210563|FG001|COMPLETED|Single Ascending Dose (SAD)||6||
60093406|NCT02151994|76210564|FG002|COMPLETED|Single Ascending Dose (SAD)||6||
60093407|NCT02151994|76210565|FG003|COMPLETED|Single Ascending Dose (SAD)||6||
60093408|NCT02151994|76210566|FG004|COMPLETED|Single Ascending Dose (SAD)||6||
60093409|NCT02151994|76210567|FG005|COMPLETED|Single Ascending Dose (SAD)||6||
60093410|NCT02151994|76210568|FG006|COMPLETED|Single Ascending Dose (SAD)||6||
60093411|NCT02151994|76210569|FG007|COMPLETED|Single Ascending Dose (SAD)||6||
60093412|NCT02151994|76210570|FG008|COMPLETED|Single Ascending Dose (SAD)||0||
60093413|NCT02151994|76210571|FG009|COMPLETED|Single Ascending Dose (SAD)||6||
60093414|NCT02151994|76210572|FG010|COMPLETED|Single Ascending Dose (SAD)||6||
60093415|NCT02151994|76210573|FG011|COMPLETED|Single Ascending Dose (SAD)||0||
60093416|NCT02151994|76210574|FG012|COMPLETED|Single Ascending Dose (SAD)||0||
60093417|NCT02151994|76210562|FG000|NOT COMPLETED|Single Ascending Dose (SAD)||0||
60093418|NCT02151994|76210563|FG001|NOT COMPLETED|Single Ascending Dose (SAD)||0||
60093419|NCT02151994|76210564|FG002|NOT COMPLETED|Single Ascending Dose (SAD)||0||
60093420|NCT02151994|76210565|FG003|NOT COMPLETED|Single Ascending Dose (SAD)||0||
60093421|NCT02151994|76210566|FG004|NOT COMPLETED|Single Ascending Dose (SAD)||0||
60093422|NCT02151994|76210567|FG005|NOT COMPLETED|Single Ascending Dose (SAD)||0||
60093423|NCT02151994|76210568|FG006|NOT COMPLETED|Single Ascending Dose (SAD)||0||
60093424|NCT02151994|76210569|FG007|NOT COMPLETED|Single Ascending Dose (SAD)||0||
60093425|NCT02151994|76210570|FG008|NOT COMPLETED|Single Ascending Dose (SAD)||0||
60093426|NCT02151994|76210571|FG009|NOT COMPLETED|Single Ascending Dose (SAD)||0||
60093427|NCT02151994|76210572|FG010|NOT COMPLETED|Single Ascending Dose (SAD)||0||
60093428|NCT02151994|76210573|FG011|NOT COMPLETED|Single Ascending Dose (SAD)||0||
60093429|NCT02151994|76210574|FG012|NOT COMPLETED|Single Ascending Dose (SAD)||0||
60093430|NCT02151994|76210562|FG000|STARTED|Multiple Ascending Dose (MAD)||10||
60093431|NCT02151994|76210563|FG001|STARTED|Multiple Ascending Dose (MAD)||0||
60093432|NCT02151994|76210564|FG002|STARTED|Multiple Ascending Dose (MAD)||0||
60093433|NCT02151994|76210565|FG003|STARTED|Multiple Ascending Dose (MAD)||6||
60093434|NCT02151994|76210566|FG004|STARTED|Multiple Ascending Dose (MAD)||6||
60093435|NCT02151994|76210567|FG005|STARTED|Multiple Ascending Dose (MAD)||6||
60093436|NCT02151994|76210568|FG006|STARTED|Multiple Ascending Dose (MAD)||6||
60093437|NCT02151994|76210569|FG007|STARTED|Multiple Ascending Dose (MAD)||0||
60093438|NCT02151994|76210570|FG008|STARTED|Multiple Ascending Dose (MAD)||6||
60093439|NCT02151994|76210571|FG009|STARTED|Multiple Ascending Dose (MAD)||0||
60093440|NCT02151994|76210572|FG010|STARTED|Multiple Ascending Dose (MAD)||0||
60093441|NCT02151994|76210573|FG011|STARTED|Multiple Ascending Dose (MAD)||0||
60093442|NCT02151994|76210574|FG012|STARTED|Multiple Ascending Dose (MAD)||0||
60093443|NCT02151994|76210562|FG000|COMPLETED|Multiple Ascending Dose (MAD)||10||
60093444|NCT02151994|76210563|FG001|COMPLETED|Multiple Ascending Dose (MAD)||0||
60093445|NCT02151994|76210564|FG002|COMPLETED|Multiple Ascending Dose (MAD)||0||
60093446|NCT02151994|76210565|FG003|COMPLETED|Multiple Ascending Dose (MAD)||6||
60093447|NCT02151994|76210566|FG004|COMPLETED|Multiple Ascending Dose (MAD)||6||
60093448|NCT02151994|76210567|FG005|COMPLETED|Multiple Ascending Dose (MAD)||6||
60093449|NCT02151994|76210568|FG006|COMPLETED|Multiple Ascending Dose (MAD)||6||
60093450|NCT02151994|76210569|FG007|COMPLETED|Multiple Ascending Dose (MAD)||0||
60093451|NCT02151994|76210570|FG008|COMPLETED|Multiple Ascending Dose (MAD)||6||
60093452|NCT02151994|76210571|FG009|COMPLETED|Multiple Ascending Dose (MAD)||0||
60093453|NCT02151994|76210572|FG010|COMPLETED|Multiple Ascending Dose (MAD)||0||
60093454|NCT02151994|76210573|FG011|COMPLETED|Multiple Ascending Dose (MAD)||0||
60093455|NCT02151994|76210574|FG012|COMPLETED|Multiple Ascending Dose (MAD)||0||
60093456|NCT02151994|76210562|FG000|NOT COMPLETED|Multiple Ascending Dose (MAD)||0||
60093457|NCT02151994|76210563|FG001|NOT COMPLETED|Multiple Ascending Dose (MAD)||0||
60093458|NCT02151994|76210564|FG002|NOT COMPLETED|Multiple Ascending Dose (MAD)||0||
60093459|NCT02151994|76210565|FG003|NOT COMPLETED|Multiple Ascending Dose (MAD)||0||
60093460|NCT02151994|76210566|FG004|NOT COMPLETED|Multiple Ascending Dose (MAD)||0||
60093461|NCT02151994|76210567|FG005|NOT COMPLETED|Multiple Ascending Dose (MAD)||0||
60093462|NCT02151994|76210568|FG006|NOT COMPLETED|Multiple Ascending Dose (MAD)||0||
60093463|NCT02151994|76210569|FG007|NOT COMPLETED|Multiple Ascending Dose (MAD)||0||
60093464|NCT02151994|76210570|FG008|NOT COMPLETED|Multiple Ascending Dose (MAD)||0||
60093465|NCT02151994|76210571|FG009|NOT COMPLETED|Multiple Ascending Dose (MAD)||0||
60093466|NCT02151994|76210572|FG010|NOT COMPLETED|Multiple Ascending Dose (MAD)||0||
60093467|NCT02151994|76210573|FG011|NOT COMPLETED|Multiple Ascending Dose (MAD)||0||
60093468|NCT02151994|76210574|FG012|NOT COMPLETED|Multiple Ascending Dose (MAD)||0||
60093469|NCT02151994|76210562|FG000|STARTED|Food Effect (FE): Fasted||0||
60093470|NCT02151994|76210563|FG001|STARTED|Food Effect (FE): Fasted||0||
60093471|NCT02151994|76210564|FG002|STARTED|Food Effect (FE): Fasted||0||
60093472|NCT02151994|76210565|FG003|STARTED|Food Effect (FE): Fasted||0||
60093473|NCT02151994|76210566|FG004|STARTED|Food Effect (FE): Fasted||0||
60093474|NCT02151994|76210567|FG005|STARTED|Food Effect (FE): Fasted||0||
60093475|NCT02151994|76210568|FG006|STARTED|Food Effect (FE): Fasted||0||
60093476|NCT02151994|76210569|FG007|STARTED|Food Effect (FE): Fasted||0||
60093477|NCT02151994|76210570|FG008|STARTED|Food Effect (FE): Fasted||0||
60093478|NCT02151994|76210571|FG009|STARTED|Food Effect (FE): Fasted||0||
60093479|NCT02151994|76210572|FG010|STARTED|Food Effect (FE): Fasted||0||
60093480|NCT02151994|76210573|FG011|STARTED|Food Effect (FE): Fasted||12||
60093481|NCT02151994|76210574|FG012|STARTED|Food Effect (FE): Fasted||0||
60093482|NCT02151994|76210562|FG000|COMPLETED|Food Effect (FE): Fasted||0||
60093483|NCT02151994|76210563|FG001|COMPLETED|Food Effect (FE): Fasted||0||
60093484|NCT02151994|76210564|FG002|COMPLETED|Food Effect (FE): Fasted||0||
60093485|NCT02151994|76210565|FG003|COMPLETED|Food Effect (FE): Fasted||0||
60093486|NCT02151994|76210566|FG004|COMPLETED|Food Effect (FE): Fasted||0||
60093487|NCT02151994|76210567|FG005|COMPLETED|Food Effect (FE): Fasted||0||
60093488|NCT02151994|76210568|FG006|COMPLETED|Food Effect (FE): Fasted||0||
60093489|NCT02151994|76210569|FG007|COMPLETED|Food Effect (FE): Fasted||0||
60093490|NCT02151994|76210570|FG008|COMPLETED|Food Effect (FE): Fasted||0||
60093491|NCT02151994|76210571|FG009|COMPLETED|Food Effect (FE): Fasted||0||
60093492|NCT02151994|76210572|FG010|COMPLETED|Food Effect (FE): Fasted||0||
60093493|NCT02151994|76210573|FG011|COMPLETED|Food Effect (FE): Fasted||12||
60093494|NCT02151994|76210574|FG012|COMPLETED|Food Effect (FE): Fasted||0||
60093495|NCT02151994|76210562|FG000|NOT COMPLETED|Food Effect (FE): Fasted||0||
60093496|NCT02151994|76210563|FG001|NOT COMPLETED|Food Effect (FE): Fasted||0||
60093497|NCT02151994|76210564|FG002|NOT COMPLETED|Food Effect (FE): Fasted||0||
60093498|NCT02151994|76210565|FG003|NOT COMPLETED|Food Effect (FE): Fasted||0||
60093499|NCT02151994|76210566|FG004|NOT COMPLETED|Food Effect (FE): Fasted||0||
60093500|NCT02151994|76210567|FG005|NOT COMPLETED|Food Effect (FE): Fasted||0||
60093501|NCT02151994|76210568|FG006|NOT COMPLETED|Food Effect (FE): Fasted||0||
60093502|NCT02151994|76210569|FG007|NOT COMPLETED|Food Effect (FE): Fasted||0||
60093503|NCT02151994|76210570|FG008|NOT COMPLETED|Food Effect (FE): Fasted||0||
60093504|NCT02151994|76210571|FG009|NOT COMPLETED|Food Effect (FE): Fasted||0||
60093505|NCT02151994|76210572|FG010|NOT COMPLETED|Food Effect (FE): Fasted||0||
60093506|NCT02151994|76210573|FG011|NOT COMPLETED|Food Effect (FE): Fasted||0||
60093507|NCT02151994|76210574|FG012|NOT COMPLETED|Food Effect (FE): Fasted||0||
60093508|NCT02151994|76210562|FG000|STARTED|Food Effect (FE): Fed||0||
60093509|NCT02151994|76210563|FG001|STARTED|Food Effect (FE): Fed||0||
60093510|NCT02151994|76210564|FG002|STARTED|Food Effect (FE): Fed||0||
60093511|NCT02151994|76210565|FG003|STARTED|Food Effect (FE): Fed||0||
60093512|NCT02151994|76210566|FG004|STARTED|Food Effect (FE): Fed||0||
60093513|NCT02151994|76210567|FG005|STARTED|Food Effect (FE): Fed||0||
60093514|NCT02151994|76210568|FG006|STARTED|Food Effect (FE): Fed||0||
59561830|NCT01996943|75663373|FG001|STARTED|Overall Study||50||
59561831|NCT01996943|75663372|FG000|COMPLETED|Overall Study||50||
59561832|NCT01996943|75663373|FG001|COMPLETED|Overall Study||50||
59561833|NCT01996943|75663372|FG000|NOT COMPLETED|Overall Study||0||
59561834|NCT01996943|75663373|FG001|NOT COMPLETED|Overall Study||0||
59561835|NCT01997411|75663384|FG000|STARTED|Overall Study||6||
60093515|NCT02151994|76210569|FG007|STARTED|Food Effect (FE): Fed||0||
60093516|NCT02151994|76210570|FG008|STARTED|Food Effect (FE): Fed||0||
60093517|NCT02151994|76210571|FG009|STARTED|Food Effect (FE): Fed||0||
60093518|NCT02151994|76210572|FG010|STARTED|Food Effect (FE): Fed||0||
60093519|NCT02151994|76210573|FG011|STARTED|Food Effect (FE): Fed||0||
60093520|NCT02151994|76210574|FG012|STARTED|Food Effect (FE): Fed||12||
60093521|NCT02151994|76210562|FG000|COMPLETED|Food Effect (FE): Fed||0||
60093522|NCT02151994|76210563|FG001|COMPLETED|Food Effect (FE): Fed||0||
60093523|NCT02151994|76210564|FG002|COMPLETED|Food Effect (FE): Fed||0||
60093524|NCT02151994|76210565|FG003|COMPLETED|Food Effect (FE): Fed||0||
60093525|NCT02151994|76210566|FG004|COMPLETED|Food Effect (FE): Fed||0||
60093526|NCT02151994|76210567|FG005|COMPLETED|Food Effect (FE): Fed||0||
60093527|NCT02151994|76210568|FG006|COMPLETED|Food Effect (FE): Fed||0||
60093528|NCT02151994|76210569|FG007|COMPLETED|Food Effect (FE): Fed||0||
60093529|NCT02151994|76210570|FG008|COMPLETED|Food Effect (FE): Fed||0||
60093530|NCT02151994|76210571|FG009|COMPLETED|Food Effect (FE): Fed||0||
59561836|NCT01997411|75663385|FG001|STARTED|Overall Study||6||
60093531|NCT02151994|76210572|FG010|COMPLETED|Food Effect (FE): Fed||0||
59561837|NCT01997411|75663386|FG002|STARTED|Overall Study||6||
59561838|NCT01997411|75663387|FG003|STARTED|Overall Study||6||
59561839|NCT01997411|75663388|FG004|STARTED|Overall Study||6||
59561840|NCT01997411|75663389|FG005|STARTED|Overall Study||6||
59561841|NCT01997411|75663390|FG006|STARTED|Overall Study||6||
59561842|NCT01997411|75663391|FG007|STARTED|Overall Study||6||
59561843|NCT01997411|75663384|FG000|COMPLETED|Overall Study||6||
59561844|NCT01997411|75663385|FG001|COMPLETED|Overall Study||6||
59561845|NCT01997411|75663386|FG002|COMPLETED|Overall Study||6||
59561846|NCT01997411|75663387|FG003|COMPLETED|Overall Study||6||
59561847|NCT01997411|75663388|FG004|COMPLETED|Overall Study||6||
59561848|NCT01997411|75663389|FG005|COMPLETED|Overall Study||5||
59561849|NCT01997411|75663390|FG006|COMPLETED|Overall Study||6||
59561850|NCT01997411|75663391|FG007|COMPLETED|Overall Study||6||
59561851|NCT01997411|75663384|FG000|NOT COMPLETED|Overall Study||0||
59561852|NCT01997411|75663385|FG001|NOT COMPLETED|Overall Study||0||
59561853|NCT01997411|75663386|FG002|NOT COMPLETED|Overall Study||0||
59561854|NCT01997411|75663387|FG003|NOT COMPLETED|Overall Study||0||
59561855|NCT01997411|75663388|FG004|NOT COMPLETED|Overall Study||0||
59561856|NCT01997411|75663389|FG005|NOT COMPLETED|Overall Study||1||
59561857|NCT01997411|75663390|FG006|NOT COMPLETED|Overall Study||0||
59561858|NCT01997411|75663391|FG007|NOT COMPLETED|Overall Study||0||
59561859|NCT01997723|75663409|FG000|STARTED|Overall Study||75||
59561860|NCT01997723|75663409|FG000|COMPLETED|Overall Study||75||
59561861|NCT01997723|75663409|FG000|NOT COMPLETED|Overall Study||0||
59707994|NCT00979420|75826885|FG001|STARTED|Overall Study||57||
59707995|NCT00979420|75826886|FG002|STARTED|Overall Study||60||
59707996|NCT00979420|75826887|FG003|STARTED|Overall Study||61||
59707997|NCT00979420|75826884|FG000|COMPLETED|Overall Study||171||
59993252|NCT01677507|76109166|FG000|STARTED|Initial Assignment||63||
59993253|NCT01677507|76109167|FG001|STARTED|Initial Assignment||58||
60093532|NCT02151994|76210573|FG011|COMPLETED|Food Effect (FE): Fed||0||
60093533|NCT02151994|76210574|FG012|COMPLETED|Food Effect (FE): Fed||12||
60093534|NCT02151994|76210562|FG000|NOT COMPLETED|Food Effect (FE): Fed||0||
60093535|NCT02151994|76210563|FG001|NOT COMPLETED|Food Effect (FE): Fed||0||
60093536|NCT02151994|76210564|FG002|NOT COMPLETED|Food Effect (FE): Fed||0||
60093537|NCT02151994|76210565|FG003|NOT COMPLETED|Food Effect (FE): Fed||0||
60093538|NCT02151994|76210566|FG004|NOT COMPLETED|Food Effect (FE): Fed||0||
60093539|NCT02151994|76210567|FG005|NOT COMPLETED|Food Effect (FE): Fed||0||
60093540|NCT02151994|76210568|FG006|NOT COMPLETED|Food Effect (FE): Fed||0||
60093541|NCT02151994|76210569|FG007|NOT COMPLETED|Food Effect (FE): Fed||0||
59993254|NCT01677507|76109166|FG000|COMPLETED|Initial Assignment||63||
59993255|NCT01677507|76109167|FG001|COMPLETED|Initial Assignment||56||
60093542|NCT02151994|76210570|FG008|NOT COMPLETED|Food Effect (FE): Fed||0||
59561862|NCT01998269|75663413|FG000|STARTED|Overall Study||193||
59561863|NCT01998269|75663413|FG000|COMPLETED|Overall Study||193||
59561864|NCT01998269|75663413|FG000|NOT COMPLETED|Overall Study||0||
59561865|NCT02243306|75663419|FG000|STARTED|Overall Study||1||
59561866|NCT02243306|75663420|FG001|STARTED|Overall Study||7||
59561867|NCT02243306|75663419|FG000|COMPLETED|Overall Study||1||
59561868|NCT02243306|75663420|FG001|COMPLETED|Overall Study||4||
59561869|NCT02243306|75663419|FG000|NOT COMPLETED|Overall Study||0||
59561870|NCT02243306|75663420|FG001|NOT COMPLETED|Overall Study||3||
59561871|NCT01999517|75663429|FG000|STARTED|Overall Study||68||
59561872|NCT01999517|75663430|FG001|STARTED|Overall Study||54||
59561873|NCT01999517|75663429|FG000|COMPLETED|Overall Study||68||
59561874|NCT01999517|75663430|FG001|COMPLETED|Overall Study||54||
59561875|NCT01999517|75663429|FG000|NOT COMPLETED|Overall Study||0||
59561876|NCT01999517|75663430|FG001|NOT COMPLETED|Overall Study||0||
59707998|NCT00979420|75826885|FG001|COMPLETED|Overall Study||57||
59707999|NCT00979420|75826886|FG002|COMPLETED|Overall Study||59||
59993256|NCT01677507|76109166|FG000|NOT COMPLETED|Initial Assignment||0||
59993257|NCT01677507|76109167|FG001|NOT COMPLETED|Initial Assignment||2||
59993258|NCT01677507|76109166|FG000|STARTED|Second Assigment||63||
59993259|NCT01677507|76109167|FG001|STARTED|Second Assigment||56||
59993260|NCT01677507|76109166|FG000|COMPLETED|Second Assigment||60||
59993261|NCT01677507|76109167|FG001|COMPLETED|Second Assigment||51||
59993262|NCT01677507|76109166|FG000|NOT COMPLETED|Second Assigment||3||
59993263|NCT01677507|76109167|FG001|NOT COMPLETED|Second Assigment||5||
59993264|NCT03329079|76109177|FG000|STARTED|Overall Study||40||
59993265|NCT03329079|76109178|FG001|STARTED|Overall Study||40||
59993266|NCT03329079|76109177|FG000|COMPLETED|Overall Study||36||
60093543|NCT02151994|76210571|FG009|NOT COMPLETED|Food Effect (FE): Fed||0||
60093544|NCT02151994|76210572|FG010|NOT COMPLETED|Food Effect (FE): Fed||0||
59561877|NCT01999985|75663436|FG000|STARTED|Overall Study||8||
59561878|NCT01999985|75663437|FG001|STARTED|Overall Study||3||
59561879|NCT01999985|75663438|FG002|STARTED|Overall Study||14||
59561880|NCT01999985|75663436|FG000|COMPLETED|Overall Study||8||
59561881|NCT01999985|75663437|FG001|COMPLETED|Overall Study||3||
59561882|NCT01999985|75663438|FG002|COMPLETED|Overall Study||14||
59561883|NCT01999985|75663436|FG000|NOT COMPLETED|Overall Study||0||
59561884|NCT01999985|75663437|FG001|NOT COMPLETED|Overall Study||0||
59561885|NCT01999985|75663438|FG002|NOT COMPLETED|Overall Study||0||
59561886|NCT01968317|75663446|FG000|STARTED|Overall Study||76||
60093545|NCT02151994|76210573|FG011|NOT COMPLETED|Food Effect (FE): Fed||0||
60093546|NCT02151994|76210574|FG012|NOT COMPLETED|Food Effect (FE): Fed||0||
60093547|NCT00812110|76210611|FG000|STARTED|Overall Study||292||
60093548|NCT00812110|76210611|FG000|COMPLETED|Overall Study||292||
60093549|NCT00812110|76210611|FG000|NOT COMPLETED|Overall Study||0||
60093550|NCT01961609|76210617|FG000|STARTED|Initiation||119||
60093551|NCT01961609|76210618|FG001|STARTED|Initiation||116||
60093552|NCT01961609|76210619|FG002|STARTED|Initiation||0||
60093553|NCT01961609|76210620|FG003|STARTED|Initiation||0||
60093554|NCT01961609|76210617|FG000|Safety Set|Initiation||118||
60093555|NCT01961609|76210618|FG001|Safety Set|Initiation||115||
60093556|NCT01961609|76210619|FG002|Safety Set|Initiation||0||
60093557|NCT01961609|76210620|FG003|Safety Set|Initiation||0||
60093558|NCT01961609|76210617|FG000|Full Analysis Set|Initiation||118||
60093559|NCT01961609|76210618|FG001|Full Analysis Set|Initiation||115||
60093560|NCT01961609|76210619|FG002|Full Analysis Set|Initiation||0||
60093561|NCT01961609|76210620|FG003|Full Analysis Set|Initiation||0||
60093562|NCT01961609|76210617|FG000|COMPLETED|Initiation||107||
60093563|NCT01961609|76210618|FG001|COMPLETED|Initiation||103||
60093564|NCT01961609|76210619|FG002|COMPLETED|Initiation||0||
60093565|NCT01961609|76210620|FG003|COMPLETED|Initiation||0||
60093566|NCT01961609|76210617|FG000|NOT COMPLETED|Initiation||12||
59561887|NCT01968317|75663447|FG001|STARTED|Overall Study||74||
59561888|NCT01968317|75663446|FG000|COMPLETED|Overall Study||76||
59561889|NCT01968317|75663447|FG001|COMPLETED|Overall Study||74||
60093567|NCT01961609|76210618|FG001|NOT COMPLETED|Initiation||13||
60093568|NCT01961609|76210619|FG002|NOT COMPLETED|Initiation||0||
60093569|NCT01961609|76210620|FG003|NOT COMPLETED|Initiation||0||
60093570|NCT01961609|76210617|FG000|STARTED|Maintenance 1 (Weeks 17 - 48)||107||
60093571|NCT01961609|76210618|FG001|STARTED|Maintenance 1 (Weeks 17 - 48)||66||
60093572|NCT01961609|76210619|FG002|STARTED|Maintenance 1 (Weeks 17 - 48)||37||
60093573|NCT01961609|76210620|FG003|STARTED|Maintenance 1 (Weeks 17 - 48)||0||
60093574|NCT01961609|76210617|FG000|Full Analysis Set|Maintenance 1 (Weeks 17 - 48)||107||
60093575|NCT01961609|76210618|FG001|Full Analysis Set|Maintenance 1 (Weeks 17 - 48)||66||
60093576|NCT01961609|76210619|FG002|Full Analysis Set|Maintenance 1 (Weeks 17 - 48)||37||
60093577|NCT01961609|76210620|FG003|Full Analysis Set|Maintenance 1 (Weeks 17 - 48)||0||
60093578|NCT01961609|76210617|FG000|Safety Set|Maintenance 1 (Weeks 17 - 48)||107||
60093579|NCT01961609|76210618|FG001|Safety Set|Maintenance 1 (Weeks 17 - 48)||66||
60093580|NCT01961609|76210619|FG002|Safety Set|Maintenance 1 (Weeks 17 - 48)||37||
60093581|NCT01961609|76210620|FG003|Safety Set|Maintenance 1 (Weeks 17 - 48)||0||
60093582|NCT01961609|76210617|FG000|COMPLETED|Maintenance 1 (Weeks 17 - 48)||84||
60093583|NCT01961609|76210618|FG001|COMPLETED|Maintenance 1 (Weeks 17 - 48)||55||
60093584|NCT01961609|76210619|FG002|COMPLETED|Maintenance 1 (Weeks 17 - 48)||18||
60093585|NCT01961609|76210620|FG003|COMPLETED|Maintenance 1 (Weeks 17 - 48)||0||
60093586|NCT01961609|76210617|FG000|NOT COMPLETED|Maintenance 1 (Weeks 17 - 48)||23||
60093587|NCT01961609|76210618|FG001|NOT COMPLETED|Maintenance 1 (Weeks 17 - 48)||11||
60093588|NCT01961609|76210619|FG002|NOT COMPLETED|Maintenance 1 (Weeks 17 - 48)||19||
60093589|NCT01961609|76210620|FG003|NOT COMPLETED|Maintenance 1 (Weeks 17 - 48)||0||
60093590|NCT01961609|76210617|FG000|STARTED|Maintanence 2 (Weeks 49 - 72)||83||
60093591|NCT01961609|76210618|FG001|STARTED|Maintanence 2 (Weeks 49 - 72)||31||
60093592|NCT01961609|76210619|FG002|STARTED|Maintanence 2 (Weeks 49 - 72)||16||
59561890|NCT01968317|75663446|FG000|NOT COMPLETED|Overall Study||0||
59561891|NCT01968317|75663447|FG001|NOT COMPLETED|Overall Study||0||
59561892|NCT02002871|75663453|FG000|STARTED|Overall Study||21||
59561893|NCT02002871|75663453|FG000|COMPLETED|Overall Study||20||
59561894|NCT02002871|75663453|FG000|NOT COMPLETED|Overall Study||1||
59561895|NCT03450915|75663460|FG000|STARTED|Overall Study||6230||
59561896|NCT03450915|75663461|FG001|STARTED|Overall Study||6230||
59708000|NCT00979420|75826887|FG003|COMPLETED|Overall Study||59||
59708001|NCT00979420|75826884|FG000|NOT COMPLETED|Overall Study||7||
59708002|NCT00979420|75826885|FG001|NOT COMPLETED|Overall Study||0||
59708003|NCT00979420|75826886|FG002|NOT COMPLETED|Overall Study||1||
60093593|NCT01961609|76210620|FG003|STARTED|Maintanence 2 (Weeks 49 - 72)||24||
60093594|NCT01961609|76210617|FG000|Safety Set|Maintanence 2 (Weeks 49 - 72)||83||
60093595|NCT01961609|76210618|FG001|Safety Set|Maintanence 2 (Weeks 49 - 72)||31||
60093596|NCT01961609|76210619|FG002|Safety Set|Maintanence 2 (Weeks 49 - 72)||16||
60093597|NCT01961609|76210620|FG003|Safety Set|Maintanence 2 (Weeks 49 - 72)||24||
60093598|NCT01961609|76210617|FG000|Full Analysis Set|Maintanence 2 (Weeks 49 - 72)||83||
60093599|NCT01961609|76210618|FG001|Full Analysis Set|Maintanence 2 (Weeks 49 - 72)||31||
60093600|NCT01961609|76210619|FG002|Full Analysis Set|Maintanence 2 (Weeks 49 - 72)||16||
60093601|NCT01961609|76210620|FG003|Full Analysis Set|Maintanence 2 (Weeks 49 - 72)||24||
60093602|NCT01961609|76210617|FG000|COMPLETED|Maintanence 2 (Weeks 49 - 72)||71||
60093603|NCT01961609|76210618|FG001|COMPLETED|Maintanence 2 (Weeks 49 - 72)||25||
60093604|NCT01961609|76210619|FG002|COMPLETED|Maintanence 2 (Weeks 49 - 72)||12||
59561897|NCT03450915|75663460|FG000|COMPLETED|Overall Study||5827||
59561898|NCT03450915|75663461|FG001|COMPLETED|Overall Study||5855||
59561899|NCT03450915|75663460|FG000|NOT COMPLETED|Overall Study||403||
59561900|NCT03450915|75663461|FG001|NOT COMPLETED|Overall Study||375||
59561901|NCT02004977|75663469|FG000|STARTED|Overall Study||463||
59561902|NCT02004977|75663470|FG001|STARTED|Overall Study||441||
59561903|NCT02004977|75663469|FG000|COMPLETED|Overall Study||409||
59561904|NCT02004977|75663470|FG001|COMPLETED|Overall Study||436||
59561905|NCT02004977|75663469|FG000|NOT COMPLETED|Overall Study||54||
59561906|NCT02004977|75663470|FG001|NOT COMPLETED|Overall Study||5||
59561907|NCT01971593|75663476|FG000|STARTED|Overall Study||14||
59561908|NCT01971593|75663477|FG001|STARTED|Overall Study||12||
59561909|NCT01971593|75663476|FG000|COMPLETED|Overall Study||9||
59561910|NCT01971593|75663477|FG001|COMPLETED|Overall Study||8||
59561911|NCT01971593|75663476|FG000|NOT COMPLETED|Overall Study||5||
59561912|NCT01971593|75663477|FG001|NOT COMPLETED|Overall Study||4||
59561913|NCT03454581|75663484|FG000|STARTED|Overall Study||18||
59561914|NCT03454581|75663485|FG001|STARTED|Overall Study||16||
59561915|NCT03454581|75663486|FG002|STARTED|Overall Study||17||
59561916|NCT03454581|75663484|FG000|COMPLETED|Overall Study||14||
59561917|NCT03454581|75663485|FG001|COMPLETED|Overall Study||13||
59561918|NCT03454581|75663486|FG002|COMPLETED|Overall Study||14||
59561919|NCT03454581|75663484|FG000|NOT COMPLETED|Overall Study||4||
59561920|NCT03454581|75663485|FG001|NOT COMPLETED|Overall Study||3||
59561921|NCT03454581|75663486|FG002|NOT COMPLETED|Overall Study||3||
59561922|NCT01972061|75663498|FG000|STARTED|Overall Study||1||
59561923|NCT01972061|75663499|FG001|STARTED|Overall Study||23||
59561924|NCT01972061|75663500|FG002|STARTED|Overall Study||20||
59561925|NCT01972061|75663498|FG000|COMPLETED|Overall Study||1||
59561926|NCT01972061|75663499|FG001|COMPLETED|Overall Study||23||
59561927|NCT01972061|75663500|FG002|COMPLETED|Overall Study||20||
59561928|NCT01972061|75663498|FG000|NOT COMPLETED|Overall Study||0||
60093605|NCT01961609|76210620|FG003|COMPLETED|Maintanence 2 (Weeks 49 - 72)||17||
60093606|NCT01961609|76210617|FG000|NOT COMPLETED|Maintanence 2 (Weeks 49 - 72)||12||
60093607|NCT01961609|76210618|FG001|NOT COMPLETED|Maintanence 2 (Weeks 49 - 72)||6||
60093608|NCT01961609|76210619|FG002|NOT COMPLETED|Maintanence 2 (Weeks 49 - 72)||4||
60093609|NCT01961609|76210620|FG003|NOT COMPLETED|Maintanence 2 (Weeks 49 - 72)||7||
60093610|NCT00799474|76210637|FG000|STARTED|Overall Study||609||
60093611|NCT00799474|76210637|FG000|COMPLETED|Overall Study||609||
60093612|NCT00799474|76210637|FG000|NOT COMPLETED|Overall Study||0||
60093613|NCT00800254|76210643|FG000|STARTED|Overall Study||35||
60093614|NCT00800254|76210644|FG001|STARTED|Overall Study||31||
60093615|NCT00800254|76210643|FG000|3.5 Weeks Post-operatively|Overall Study||31||
60093616|NCT00800254|76210644|FG001|3.5 Weeks Post-operatively|Overall Study||31||
60093617|NCT00800254|76210643|FG000|COMPLETED|Overall Study||30||
60093618|NCT00800254|76210644|FG001|COMPLETED|Overall Study||25||
60093619|NCT00800254|76210643|FG000|NOT COMPLETED|Overall Study||5||
60093620|NCT00800254|76210644|FG001|NOT COMPLETED|Overall Study||6||
60093621|NCT02152540|76210652|FG000|STARTED|Overall Study||17||
60093622|NCT02152540|76210653|FG001|STARTED|Overall Study||16||
60093623|NCT02152540|76210652|FG000|COMPLETED|Overall Study||17||
60093624|NCT02152540|76210653|FG001|COMPLETED|Overall Study||16||
60093625|NCT02152540|76210652|FG000|NOT COMPLETED|Overall Study||0||
60093626|NCT02152540|76210653|FG001|NOT COMPLETED|Overall Study||0||
60093627|NCT03088930|76210666|FG000|STARTED|Overall Study||3||
60093628|NCT03088930|76210666|FG000|COMPLETED|Overall Study||3||
60093629|NCT03088930|76210666|FG000|NOT COMPLETED|Overall Study||0||
60093630|NCT02152696|76210673|FG000|STARTED|Overall Study||86||
60093631|NCT02152696|76210674|FG001|STARTED|Overall Study||87||
60093632|NCT02152696|76210675|FG002|STARTED|Overall Study||82||
60093633|NCT02152696|76210673|FG000|COMPLETED|Overall Study||86||
60093634|NCT02152696|76210674|FG001|COMPLETED|Overall Study||86||
60093635|NCT02152696|76210675|FG002|COMPLETED|Overall Study||81||
59561929|NCT01972061|75663499|FG001|NOT COMPLETED|Overall Study||0||
59561930|NCT01972061|75663500|FG002|NOT COMPLETED|Overall Study||0||
59561931|NCT03243981|75663508|FG000|STARTED|Overall Study||5||
59561932|NCT03243981|75663508|FG000|COMPLETED|Overall Study||5||
59561933|NCT03243981|75663508|FG000|NOT COMPLETED|Overall Study||0||
59561934|NCT03458871|75663517|FG000|STARTED|Overall Study||16||
60093636|NCT02152696|76210673|FG000|NOT COMPLETED|Overall Study||0||
60093637|NCT02152696|76210674|FG001|NOT COMPLETED|Overall Study||1||
60093638|NCT02152696|76210675|FG002|NOT COMPLETED|Overall Study||1||
60093639|NCT02153476|76210685|FG000|STARTED|Overall Study||23||
59561935|NCT03458871|75663517|FG000|COMPLETED|Overall Study||16||
59561936|NCT03458871|75663517|FG000|NOT COMPLETED|Overall Study||0||
59561937|NCT01973777|75663521|FG000|STARTED|Overall Study|January 2014|51||
59561938|NCT01973777|75663521|FG000|One Year Follow-up|Overall Study||44||
59561939|NCT01973777|75663521|FG000|COMPLETED|Overall Study||44||
59561940|NCT01973777|75663521|FG000|NOT COMPLETED|Overall Study||7||
60093640|NCT02153476|76210686|FG001|STARTED|Overall Study||22||
60093641|NCT02153476|76210685|FG000|COMPLETED|Overall Study||22||
60093642|NCT02153476|76210686|FG001|COMPLETED|Overall Study||22||
60093643|NCT02153476|76210685|FG000|NOT COMPLETED|Overall Study||1||
59561941|NCT01974089|75663527|FG000|STARTED|Overall Study||53||
59561942|NCT01974089|75663528|FG001|STARTED|Overall Study||101||
59561943|NCT01974089|75663527|FG000|COMPLETED|Overall Study||53||
59561944|NCT01974089|75663528|FG001|COMPLETED|Overall Study||101||
60093644|NCT02153476|76210686|FG001|NOT COMPLETED|Overall Study||0||
60093645|NCT00802204|76210694|FG000|STARTED|Overall Study||9||
60093646|NCT00802204|76210695|FG001|STARTED|Overall Study||19||
60093647|NCT00802204|76210694|FG000|COMPLETED|Overall Study||8||
59561945|NCT01974089|75663527|FG000|NOT COMPLETED|Overall Study||0||
59561946|NCT01974089|75663528|FG001|NOT COMPLETED|Overall Study||0||
59561947|NCT03245463|75663538|FG000|STARTED|Overall Study||12||
59561948|NCT03245463|75663539|FG001|STARTED|Overall Study||12||
59561949|NCT03245463|75663538|FG000|COMPLETED|Overall Study||12||
59561950|NCT03245463|75663539|FG001|COMPLETED|Overall Study||12||
59561951|NCT03245463|75663538|FG000|NOT COMPLETED|Overall Study||0||
59561952|NCT03245463|75663539|FG001|NOT COMPLETED|Overall Study||0||
59561953|NCT01974245|75663547|FG000|STARTED|Overall Study||27||
60093648|NCT00802204|76210695|FG001|COMPLETED|Overall Study||18||
60093649|NCT00802204|76210694|FG000|NOT COMPLETED|Overall Study||1||
60093650|NCT00802204|76210695|FG001|NOT COMPLETED|Overall Study||1||
60093651|NCT01256086|76210708|FG000|STARTED|Treatment Day 1||11||
60093652|NCT01256086|76210709|FG001|STARTED|Treatment Day 1||11||
60093653|NCT01256086|76210710|FG002|STARTED|Treatment Day 1||11||
59561954|NCT01974245|75663548|FG001|STARTED|Overall Study||28||
59561955|NCT01974245|75663547|FG000|COMPLETED|Overall Study||18||
59561956|NCT01974245|75663548|FG001|COMPLETED|Overall Study||20||
59561957|NCT01974245|75663547|FG000|NOT COMPLETED|Overall Study||9||
59561958|NCT01974245|75663548|FG001|NOT COMPLETED|Overall Study||8||
59561959|NCT03307005|75663556|FG000|STARTED|Overall Study||3||
59561960|NCT03307005|75663557|FG001|STARTED|Overall Study||2||
59561961|NCT03307005|75663556|FG000|COMPLETED|Overall Study||3||
59561962|NCT03307005|75663557|FG001|COMPLETED|Overall Study||2||
59561963|NCT03307005|75663556|FG000|NOT COMPLETED|Overall Study||0||
59561964|NCT03307005|75663557|FG001|NOT COMPLETED|Overall Study||0||
59561965|NCT02005601|75663567|FG000|STARTED|Overall Study||53||
59561966|NCT02005601|75663568|FG001|STARTED|Overall Study||53||
59561967|NCT02005601|75663567|FG000|COMPLETED|Overall Study||53||
60093654|NCT01256086|76210711|FG003|STARTED|Treatment Day 1||11||
60093655|NCT01256086|76210708|FG000|COMPLETED|Treatment Day 1||11||
60093656|NCT01256086|76210709|FG001|COMPLETED|Treatment Day 1||11||
60093657|NCT01256086|76210710|FG002|COMPLETED|Treatment Day 1||11||
60093658|NCT01256086|76210711|FG003|COMPLETED|Treatment Day 1||11||
60093659|NCT01256086|76210708|FG000|NOT COMPLETED|Treatment Day 1||0||
60093660|NCT01256086|76210709|FG001|NOT COMPLETED|Treatment Day 1||0||
60093661|NCT01256086|76210710|FG002|NOT COMPLETED|Treatment Day 1||0||
60093662|NCT01256086|76210711|FG003|NOT COMPLETED|Treatment Day 1||0||
60093663|NCT01256086|76210708|FG000|STARTED|Treatment Day 2||11||
60093664|NCT01256086|76210709|FG001|STARTED|Treatment Day 2||10||
60093665|NCT01256086|76210710|FG002|STARTED|Treatment Day 2||9||
60093666|NCT01256086|76210711|FG003|STARTED|Treatment Day 2||11||
60093667|NCT01256086|76210708|FG000|COMPLETED|Treatment Day 2||11||
60093668|NCT01256086|76210709|FG001|COMPLETED|Treatment Day 2||10||
60093669|NCT01256086|76210710|FG002|COMPLETED|Treatment Day 2||9||
60093670|NCT01256086|76210711|FG003|COMPLETED|Treatment Day 2||11||
59561968|NCT02005601|75663568|FG001|COMPLETED|Overall Study||53||
59561969|NCT02005601|75663567|FG000|NOT COMPLETED|Overall Study||0||
59561970|NCT02005601|75663568|FG001|NOT COMPLETED|Overall Study||0||
59561971|NCT03214679|75663576|FG000|STARTED|Overall Study||84||
59561972|NCT03214679|75663577|FG001|STARTED|Overall Study||83||
59561973|NCT03214679|75663576|FG000|COMPLETED|Overall Study||70||
59561974|NCT03214679|75663577|FG001|COMPLETED|Overall Study||69||
59561975|NCT03214679|75663576|FG000|NOT COMPLETED|Overall Study||14||
59561976|NCT03214679|75663577|FG001|NOT COMPLETED|Overall Study||14||
59561977|NCT03308097|75663585|FG000|STARTED|Overall Study||33||
59561978|NCT03308097|75663586|FG001|STARTED|Overall Study||32||
59561979|NCT03308097|75663585|FG000|COMPLETED|Overall Study||31||
59561980|NCT03308097|75663586|FG001|COMPLETED|Overall Study||31||
59561981|NCT03308097|75663585|FG000|NOT COMPLETED|Overall Study||2||
59561982|NCT03308097|75663586|FG001|NOT COMPLETED|Overall Study||1||
59708004|NCT00979420|75826887|FG003|NOT COMPLETED|Overall Study||2||
60093671|NCT01256086|76210708|FG000|NOT COMPLETED|Treatment Day 2||0||
60093672|NCT01256086|76210709|FG001|NOT COMPLETED|Treatment Day 2||0||
60093673|NCT01256086|76210710|FG002|NOT COMPLETED|Treatment Day 2||0||
60093674|NCT01256086|76210711|FG003|NOT COMPLETED|Treatment Day 2||0||
60093675|NCT01256086|76210708|FG000|STARTED|Treatment Day 3||11||
60093676|NCT01256086|76210709|FG001|STARTED|Treatment Day 3||10||
60093677|NCT01256086|76210710|FG002|STARTED|Treatment Day 3||9||
60093678|NCT01256086|76210711|FG003|STARTED|Treatment Day 3||11||
60093679|NCT01256086|76210708|FG000|COMPLETED|Treatment Day 3||11||
60093680|NCT01256086|76210709|FG001|COMPLETED|Treatment Day 3||10||
60093681|NCT01256086|76210710|FG002|COMPLETED|Treatment Day 3||9||
60093682|NCT01256086|76210711|FG003|COMPLETED|Treatment Day 3||11||
60093683|NCT01256086|76210708|FG000|NOT COMPLETED|Treatment Day 3||0||
60093684|NCT01256086|76210709|FG001|NOT COMPLETED|Treatment Day 3||0||
60093685|NCT01256086|76210710|FG002|NOT COMPLETED|Treatment Day 3||0||
60093686|NCT01256086|76210711|FG003|NOT COMPLETED|Treatment Day 3||0||
60093687|NCT01256086|76210708|FG000|STARTED|Treatment Day 4||11||
60093688|NCT01256086|76210709|FG001|STARTED|Treatment Day 4||10||
60093689|NCT01256086|76210710|FG002|STARTED|Treatment Day 4||9||
60093690|NCT01256086|76210711|FG003|STARTED|Treatment Day 4||11||
60093691|NCT01256086|76210708|FG000|COMPLETED|Treatment Day 4||11||
60093692|NCT01256086|76210709|FG001|COMPLETED|Treatment Day 4||10||
60093693|NCT01256086|76210710|FG002|COMPLETED|Treatment Day 4||9||
60093694|NCT01256086|76210711|FG003|COMPLETED|Treatment Day 4||11||
60093695|NCT01256086|76210708|FG000|NOT COMPLETED|Treatment Day 4||0||
60093696|NCT01256086|76210709|FG001|NOT COMPLETED|Treatment Day 4||0||
60093697|NCT01256086|76210710|FG002|NOT COMPLETED|Treatment Day 4||0||
60093698|NCT01256086|76210711|FG003|NOT COMPLETED|Treatment Day 4||0||
60093699|NCT01774981|76210729|FG000|STARTED|Overall Study||3||
60093700|NCT01774981|76210730|FG001|STARTED|Overall Study||4||
60093701|NCT01774981|76210731|FG002|STARTED|Overall Study||4||
60093702|NCT01774981|76210732|FG003|STARTED|Overall Study||4||
60093703|NCT01774981|76210733|FG004|STARTED|Overall Study||6||
60093704|NCT01774981|76210734|FG005|STARTED|Overall Study||14||
60093705|NCT01774981|76210735|FG006|STARTED|Overall Study||13||
60093706|NCT01774981|76210736|FG007|STARTED|Overall Study||12||
60093707|NCT01774981|76210729|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3||
60093708|NCT01774981|76210730|FG001|Received at Least 1 Dose of Study Drug|Overall Study||4||
60093709|NCT01774981|76210731|FG002|Received at Least 1 Dose of Study Drug|Overall Study||4||
60093710|NCT01774981|76210732|FG003|Received at Least 1 Dose of Study Drug|Overall Study||4||
60093711|NCT01774981|76210733|FG004|Received at Least 1 Dose of Study Drug|Overall Study||6||
60093712|NCT01774981|76210734|FG005|Received at Least 1 Dose of Study Drug|Overall Study||14||
60093713|NCT01774981|76210735|FG006|Received at Least 1 Dose of Study Drug|Overall Study||13||
60093714|NCT01774981|76210736|FG007|Received at Least 1 Dose of Study Drug|Overall Study||12||
60093715|NCT01774981|76210729|FG000|COMPLETED|Overall Study||3||
60093716|NCT01774981|76210730|FG001|COMPLETED|Overall Study||4||
60093717|NCT01774981|76210731|FG002|COMPLETED|Overall Study||4||
60093718|NCT01774981|76210732|FG003|COMPLETED|Overall Study||4||
60093719|NCT01774981|76210733|FG004|COMPLETED|Overall Study||5||
59561983|NCT02007863|75663592|FG000|STARTED|Overall Study||2||
59561984|NCT02007863|75663592|FG000|COMPLETED|Overall Study||2||
59561985|NCT02007863|75663592|FG000|NOT COMPLETED|Overall Study||0||
59561986|NCT03460899|75663596|FG000|STARTED|Euglycaemic Clamp|First Euglycaemic Clamp completed: 05. March 2018|14||
59708005|NCT02702180|75826898|FG000|STARTED|Double-blind Treatment Period||46||
59708006|NCT02702180|75826899|FG001|STARTED|Double-blind Treatment Period||45||
59708007|NCT02702180|75826900|FG002|STARTED|Double-blind Treatment Period||47||
60093720|NCT01774981|76210734|FG005|COMPLETED|Overall Study||13||
60093721|NCT01774981|76210735|FG006|COMPLETED|Overall Study||13||
60093722|NCT01774981|76210736|FG007|COMPLETED|Overall Study||11||
60093723|NCT01774981|76210729|FG000|NOT COMPLETED|Overall Study||0||
60093724|NCT01774981|76210730|FG001|NOT COMPLETED|Overall Study||0||
60093725|NCT01774981|76210731|FG002|NOT COMPLETED|Overall Study||0||
60093726|NCT01774981|76210732|FG003|NOT COMPLETED|Overall Study||0||
60093727|NCT01774981|76210733|FG004|NOT COMPLETED|Overall Study||1||
60093728|NCT01774981|76210734|FG005|NOT COMPLETED|Overall Study||1||
60093729|NCT01774981|76210735|FG006|NOT COMPLETED|Overall Study||0||
60093730|NCT01774981|76210736|FG007|NOT COMPLETED|Overall Study||1||
60093731|NCT01972841|76210765|FG000|STARTED|Overall Study||447||
60093732|NCT01972841|76210766|FG001|STARTED|Overall Study||441||
60093733|NCT01972841|76210767|FG002|STARTED|Overall Study||437||
60093734|NCT01972841|76210768|FG003|STARTED|Overall Study||434||
60093735|NCT01972841|76210769|FG004|STARTED|Overall Study||885||
60093736|NCT01972841|76210770|FG005|STARTED|Overall Study||883||
60093737|NCT01972841|76210765|FG000|COMPLETED|Overall Study||404||
60093738|NCT01972841|76210766|FG001|COMPLETED|Overall Study||397||
60093739|NCT01972841|76210767|FG002|COMPLETED|Overall Study||387||
60093740|NCT01972841|76210768|FG003|COMPLETED|Overall Study||397||
60093741|NCT01972841|76210769|FG004|COMPLETED|Overall Study||802||
60093742|NCT01972841|76210770|FG005|COMPLETED|Overall Study||798||
60093743|NCT01972841|76210765|FG000|NOT COMPLETED|Overall Study||43||
60093744|NCT01972841|76210766|FG001|NOT COMPLETED|Overall Study||44||
60093745|NCT01972841|76210767|FG002|NOT COMPLETED|Overall Study||50||
60093746|NCT01972841|76210768|FG003|NOT COMPLETED|Overall Study||37||
60093747|NCT01972841|76210769|FG004|NOT COMPLETED|Overall Study||83||
60093748|NCT01972841|76210770|FG005|NOT COMPLETED|Overall Study||85||
60093749|NCT01774903|76210784|FG000|STARTED|Overall Study||45||
60093750|NCT01774903|76210784|FG000|COMPLETED|Overall Study||34||
60093751|NCT01774903|76210784|FG000|NOT COMPLETED|Overall Study||11||
60093752|NCT01774591|76210791|FG000|STARTED|Overall Study||10||
60093753|NCT01774591|76210792|FG001|STARTED|Overall Study||11||
60093754|NCT01774591|76210791|FG000|COMPLETED|Overall Study||9||
60093755|NCT01774591|76210792|FG001|COMPLETED|Overall Study||7||
60093756|NCT01774591|76210791|FG000|NOT COMPLETED|Overall Study||1||
60093757|NCT01774591|76210792|FG001|NOT COMPLETED|Overall Study||4||
60093758|NCT01708915|76210802|FG000|STARTED|Overall Study||204||
60093759|NCT01708915|76210803|FG001|STARTED|Overall Study||201||
60093760|NCT01708915|76210804|FG002|STARTED|Overall Study||198||
60093761|NCT01708915|76210805|FG003|STARTED|Overall Study||202||
60093762|NCT01708915|76210802|FG000|COMPLETED|Overall Study||118||
60093763|NCT01708915|76210803|FG001|COMPLETED|Overall Study||139||
60093764|NCT01708915|76210804|FG002|COMPLETED|Overall Study||152||
60093765|NCT01708915|76210805|FG003|COMPLETED|Overall Study||169||
60093766|NCT01708915|76210802|FG000|NOT COMPLETED|Overall Study||86||
60093767|NCT01708915|76210803|FG001|NOT COMPLETED|Overall Study||62||
60093768|NCT01708915|76210804|FG002|NOT COMPLETED|Overall Study||46||
60093769|NCT01708915|76210805|FG003|NOT COMPLETED|Overall Study||33||
60093770|NCT01708291|76210817|FG000|STARTED|Overall Study||21||
60093771|NCT01708291|76210818|FG001|STARTED|Overall Study||21||
60093772|NCT01708291|76210817|FG000|COMPLETED|Overall Study||19||
60093773|NCT01708291|76210818|FG001|COMPLETED|Overall Study||20||
60093774|NCT01708291|76210817|FG000|NOT COMPLETED|Overall Study||2||
60093775|NCT01708291|76210818|FG001|NOT COMPLETED|Overall Study||1||
60093776|NCT01708057|76210824|FG000|STARTED|Overall Study||1||
60093777|NCT01708057|76210825|FG001|STARTED|Overall Study||1||
60093778|NCT01708057|76210826|FG002|STARTED|Overall Study||1||
60093779|NCT01708057|76210824|FG000|COMPLETED|Overall Study||0||
60093780|NCT01708057|76210825|FG001|COMPLETED|Overall Study||0||
60093781|NCT01708057|76210826|FG002|COMPLETED|Overall Study||0||
60093782|NCT01708057|76210824|FG000|NOT COMPLETED|Overall Study||1||
60093783|NCT01708057|76210825|FG001|NOT COMPLETED|Overall Study||1||
60093784|NCT01708057|76210826|FG002|NOT COMPLETED|Overall Study||1||
60093785|NCT01748071|76210843|FG000|STARTED|Overall Study||40||
60093786|NCT01748071|76210844|FG001|STARTED|Overall Study||40||
60093787|NCT01748071|76210845|FG002|STARTED|Overall Study||40||
60093788|NCT01748071|76210843|FG000|COMPLETED|Overall Study||38||
60093789|NCT01748071|76210844|FG001|COMPLETED|Overall Study||38||
60093790|NCT01748071|76210845|FG002|COMPLETED|Overall Study||40||
60093791|NCT01748071|76210843|FG000|NOT COMPLETED|Overall Study||2||
60093792|NCT01748071|76210844|FG001|NOT COMPLETED|Overall Study||2||
60093793|NCT01748071|76210845|FG002|NOT COMPLETED|Overall Study||0||
60093794|NCT01972529|76210857|FG000|STARTED|Overall Study||48||
60093795|NCT01972529|76210858|FG001|STARTED|Overall Study||90||
60093796|NCT01972529|76210859|FG002|STARTED|Overall Study||34||
60093797|NCT01972529|76210860|FG003|STARTED|Overall Study||59||
60093798|NCT01972529|76210857|FG000|COMPLETED|Overall Study||46||
60093799|NCT01972529|76210858|FG001|COMPLETED|Overall Study||85||
60093800|NCT01972529|76210859|FG002|COMPLETED|Overall Study||32||
60093801|NCT01972529|76210860|FG003|COMPLETED|Overall Study||55||
60093802|NCT01972529|76210857|FG000|NOT COMPLETED|Overall Study||2||
60093803|NCT01972529|76210858|FG001|NOT COMPLETED|Overall Study||5||
60093804|NCT01972529|76210859|FG002|NOT COMPLETED|Overall Study||2||
60093805|NCT01972529|76210860|FG003|NOT COMPLETED|Overall Study||4||
60093806|NCT01747915|76210874|FG000|STARTED|Overall Study||75||
60093807|NCT01747915|76210875|FG001|STARTED|Overall Study||72||
60093808|NCT01747915|76210876|FG002|STARTED|Overall Study||72||
60093809|NCT01747915|76210874|FG000|COMPLETED|Overall Study||60||
60093810|NCT01747915|76210875|FG001|COMPLETED|Overall Study||61||
60093811|NCT01747915|76210876|FG002|COMPLETED|Overall Study||66||
60093812|NCT01747915|76210874|FG000|NOT COMPLETED|Overall Study||15||
59993267|NCT03329079|76109178|FG001|COMPLETED|Overall Study||38||
59993268|NCT03329079|76109177|FG000|NOT COMPLETED|Overall Study||4||
59993269|NCT03329079|76109178|FG001|NOT COMPLETED|Overall Study||2||
59993270|NCT02732951|76109186|FG000|STARTED|Overall Study||53|Randomised and treated|
59993271|NCT02732951|76109187|FG001|STARTED|Overall Study||52|Randomised and treated|
59993272|NCT02732951|76109186|FG000|COMPLETED|Overall Study||48|Completed trial|
59993273|NCT02732951|76109187|FG001|COMPLETED|Overall Study||46|Completed trial|
59993274|NCT02732951|76109186|FG000|NOT COMPLETED|Overall Study||5||
59993275|NCT02732951|76109187|FG001|NOT COMPLETED|Overall Study||6||
59993276|NCT01377233|76109198|FG000|STARTED|Open-label||46||
59993277|NCT01377233|76109199|FG001|STARTED|Open-label||0||
59993278|NCT01377233|76109200|FG002|STARTED|Open-label||0||
59993279|NCT01377233|76109201|FG003|STARTED|Open-label||0||
59993280|NCT01377233|76109202|FG004|STARTED|Open-label||0||
59993281|NCT01377233|76109198|FG000|COMPLETED|Open-label||42||
60093813|NCT01747915|76210875|FG001|NOT COMPLETED|Overall Study||11||
60093814|NCT01747915|76210876|FG002|NOT COMPLETED|Overall Study||6||
60093815|NCT01961297|76210886|FG000|STARTED|Overall Study||30||
60093816|NCT01961297|76210887|FG001|STARTED|Overall Study||23||
59993282|NCT01377233|76109199|FG001|COMPLETED|Open-label||0||
60093817|NCT01961297|76210886|FG000|COMPLETED|Overall Study||28||
60093818|NCT01961297|76210887|FG001|COMPLETED|Overall Study||22||
60093819|NCT01961297|76210886|FG000|NOT COMPLETED|Overall Study||2||
60093820|NCT01961297|76210887|FG001|NOT COMPLETED|Overall Study||1||
60093821|NCT01960907|76210895|FG000|STARTED|Overall Study||158||
60093822|NCT01960907|76210896|FG001|STARTED|Overall Study||154||
60093823|NCT01960907|76210895|FG000|COMPLETED|Overall Study||122||
60093824|NCT01960907|76210896|FG001|COMPLETED|Overall Study||109||
60093825|NCT01960907|76210895|FG000|NOT COMPLETED|Overall Study||36||
60093826|NCT01960907|76210896|FG001|NOT COMPLETED|Overall Study||45||
60093827|NCT01747837|76210907|FG000|STARTED|Overall Study||25||
60093828|NCT01747837|76210908|FG001|STARTED|Overall Study||23||
60093829|NCT01747837|76210907|FG000|COMPLETED|Overall Study||16||
60093830|NCT01747837|76210908|FG001|COMPLETED|Overall Study||17||
60093831|NCT01747837|76210907|FG000|NOT COMPLETED|Overall Study||9||
60093832|NCT01747837|76210908|FG001|NOT COMPLETED|Overall Study||6||
60093833|NCT01971203|76210916|FG000|STARTED|Overall Study||26||
60093834|NCT01971203|76210917|FG001|STARTED|Overall Study||29||
60093835|NCT01971203|76210916|FG000|COMPLETED|Overall Study||17||
60093836|NCT01971203|76210917|FG001|COMPLETED|Overall Study||21||
60093837|NCT01971203|76210916|FG000|NOT COMPLETED|Overall Study||9||
60093838|NCT01971203|76210917|FG001|NOT COMPLETED|Overall Study||8||
60093839|NCT01605877|76210923|FG000|STARTED|Overall Study||64||
60093840|NCT01605877|76210923|FG000|COMPLETED|Overall Study||63||
60093841|NCT01605877|76210923|FG000|NOT COMPLETED|Overall Study||1||
60093842|NCT01970501|76210947|FG000|STARTED|Overall Study||134||
60093843|NCT01970501|76210948|FG001|STARTED|Overall Study||133||
60093844|NCT01970501|76210947|FG000|Randomization (Visit 2)|Overall Study||134|Blinding will be accomplished by providing study drug (i.e., bucindolol or metoprolol tablets) in capsules that are visually indistinguishable and provided in numbered kits. Only the numbers of the kits to be administered to a given patient, and not the identity of the study drug, will be provided to sites. Investigators, site personnel, and patients will not be informed of the blinded study drug assignment at the time of study completion.|
60093845|NCT01970501|76210948|FG001|Randomization (Visit 2)|Overall Study||133|Blinding will be accomplished by providing study drug (i.e., bucindolol or metoprolol tablets) in capsules that are visually indistinguishable and provided in numbered kits. Only the numbers of the kits to be administered to a given patient, and not the identity of the study drug, will be provided to sites. Investigators, site personnel, and patients will not be informed of the blinded study drug assignment at the time of study completion.|
60093846|NCT01970501|76210947|FG000|Initial Dose Level 1|Overall Study||35|Either Bucindolol 6.25mg BID or Metoprolol XL 25mg QD|
60093847|NCT01970501|76210948|FG001|Initial Dose Level 1|Overall Study||45|Either Bucindolol 6.25mg BID or Metoprolol XL 25mg QD|
60093848|NCT01970501|76210947|FG000|Initial Dose Level 2|Overall Study||45|Either Bucindolol 12.5 mg BID or Metoprolol XL 50 mg QD|
60093849|NCT01970501|76210948|FG001|Initial Dose Level 2|Overall Study||38|Either Bucindolol 12.5 mg BID or Metoprolol XL 50 mg QD|
60093850|NCT01970501|76210947|FG000|Initial Dose Level 3|Overall Study||51|Either Bucindolol 25 mg BID or Metoprolol XL 100 mg QD|
60093851|NCT01970501|76210948|FG001|Initial Dose Level 3|Overall Study||45|Either Bucindolol 25 mg BID or Metoprolol XL 100 mg QD|
60093852|NCT01970501|76210947|FG000|Initial Dose Level 4|Overall Study||3|Either Bucindolol 50 mg BID or Metoprolol XL 200 mg QD|
60093853|NCT01970501|76210948|FG001|Initial Dose Level 4|Overall Study||5|Either Bucindolol 50 mg BID or Metoprolol XL 200 mg QD|
60093854|NCT01970501|76210947|FG000|Drug Lead-in Period|Overall Study||134|Bucindolol taken twice daily. Starting dose of 6.25 mg, 12.5 mg, 25 mg, or 50 mg bid depending upon pre-study beta-blocker dose. Sites instructed to uptitrate to target dose of 50 mg bid (subjects < 75 kg) or 100 mg bid (subjects >= 75 kg). Metoprolol succinate taken once per day and a placebo capsule taken once per day. Metoprolol succinate starting dose is 25 mg daily with dose titrations until 200 mg once daily or the maximum tolerated dose is achieved.|
60093855|NCT01970501|76210948|FG001|Drug Lead-in Period|Overall Study||133|Bucindolol taken twice daily. Starting dose of 6.25 mg, 12.5 mg, 25 mg, or 50 mg bid depending upon pre-study beta-blocker dose. Sites instructed to uptitrate to target dose of 50 mg bid (subjects < 75 kg) or 100 mg bid (subjects >= 75 kg). Metoprolol succinate taken once per day and a placebo capsule taken once per day. Metoprolol succinate starting dose is 25 mg daily with dose titrations until 200 mg once daily or the maximum tolerated dose is achieved.|
60093856|NCT01970501|76210947|FG000|Attained Target Dose|Overall Study||112||
60093857|NCT01970501|76210948|FG001|Attained Target Dose|Overall Study||96||
60093858|NCT01970501|76210947|FG000|24-Week Follow Up Period|Overall Study||132|Sponsor requested that the last visit be between Aug-Dec 2017 and therefore a number of participants completed this arm prior to 24 week and are noted as sponsor or investigator initiated.|
60093859|NCT01970501|76210948|FG001|24-Week Follow Up Period|Overall Study||126|Sponsor requested that the last visit be between Aug-Dec 2017 and therefore a number of participants completed this arm prior to 24 week and are noted as sponsor or investigator initiated.|
60093860|NCT01970501|76210947|FG000|Treatment Extension Period|Overall Study||77|Sponsor requested that the last visit be between Aug-Dec 2017 and therefore a majority of participants were not enrolled in this treatment extension period.|
60093861|NCT01970501|76210948|FG001|Treatment Extension Period|Overall Study||64|Sponsor requested that the last visit be between Aug-Dec 2017 and therefore a majority of participants were not enrolled in this treatment extension period.|
60093862|NCT01970501|76210947|FG000|COMPLETED|Overall Study||107||
60093863|NCT01970501|76210948|FG001|COMPLETED|Overall Study||105||
60093864|NCT01970501|76210947|FG000|NOT COMPLETED|Overall Study||27||
60093865|NCT01970501|76210948|FG001|NOT COMPLETED|Overall Study||28||
60093866|NCT01969799|76210956|FG000|STARTED|Overall Study||71||
60093867|NCT01969799|76210957|FG001|STARTED|Overall Study||72||
60093868|NCT01969799|76210956|FG000|COMPLETED|Overall Study||54||
60093869|NCT01969799|76210957|FG001|COMPLETED|Overall Study||58||
60093870|NCT01969799|76210956|FG000|NOT COMPLETED|Overall Study||17||
60093871|NCT01969799|76210957|FG001|NOT COMPLETED|Overall Study||14||
60093872|NCT01969721|76210963|FG000|STARTED|Overall Study||58||
60093873|NCT01969721|76210964|FG001|STARTED|Overall Study||69||
60093874|NCT01969721|76210965|FG002|STARTED|Overall Study||50||
60093875|NCT01969721|76210966|FG003|STARTED|Overall Study||52||
60093876|NCT01969721|76210963|FG000|COMPLETED|Overall Study||54||
60093877|NCT01969721|76210964|FG001|COMPLETED|Overall Study||57||
60093878|NCT01969721|76210965|FG002|COMPLETED|Overall Study||45||
60093879|NCT01969721|76210966|FG003|COMPLETED|Overall Study||46||
60093880|NCT01969721|76210963|FG000|NOT COMPLETED|Overall Study||4||
60093881|NCT01969721|76210964|FG001|NOT COMPLETED|Overall Study||12||
60093882|NCT01969721|76210965|FG002|NOT COMPLETED|Overall Study||5||
60093883|NCT01969721|76210966|FG003|NOT COMPLETED|Overall Study||6||
60093884|NCT01969565|76210976|FG000|STARTED|Overall Study||1||
60093885|NCT01969565|76210976|FG000|COMPLETED|Overall Study||0||
60093886|NCT01969565|76210976|FG000|NOT COMPLETED|Overall Study||1||
60093887|NCT01968707|76210989|FG000|STARTED|Overall Study||247||247
60093888|NCT01968707|76210990|FG001|STARTED|Overall Study||74||74
60093889|NCT01968707|76210991|FG002|STARTED|Overall Study||246||246
60093890|NCT01968707|76210992|FG003|STARTED|Overall Study||245||245
60093891|NCT01968707|76210993|FG004|STARTED|Overall Study||236||236
60093892|NCT01968707|76210994|FG005|STARTED|Overall Study||70||70
60093893|NCT01968707|76210995|FG006|STARTED|Overall Study||238||238
60093894|NCT01968707|76210996|FG007|STARTED|Overall Study||238||238
60093895|NCT01968707|76210989|FG000|COMPLETED|Overall Study||198||198
60093896|NCT01968707|76210990|FG001|COMPLETED|Overall Study||62||62
60093897|NCT01968707|76210991|FG002|COMPLETED|Overall Study||205||205
60093898|NCT01968707|76210992|FG003|COMPLETED|Overall Study||201||201
60093899|NCT01968707|76210993|FG004|COMPLETED|Overall Study||200||200
60093900|NCT01968707|76210994|FG005|COMPLETED|Overall Study||59||59
60093901|NCT01968707|76210995|FG006|COMPLETED|Overall Study||204||204
60093902|NCT01968707|76210996|FG007|COMPLETED|Overall Study||203||203
60093903|NCT01968707|76210989|FG000|NOT COMPLETED|Overall Study||49||49
60093904|NCT01968707|76210990|FG001|NOT COMPLETED|Overall Study||12||12
60093905|NCT01968707|76210991|FG002|NOT COMPLETED|Overall Study||41||41
60093906|NCT01968707|76210992|FG003|NOT COMPLETED|Overall Study||44||44
60093907|NCT01968707|76210993|FG004|NOT COMPLETED|Overall Study||36||36
60093908|NCT01968707|76210994|FG005|NOT COMPLETED|Overall Study||11||11
60093909|NCT01968707|76210995|FG006|NOT COMPLETED|Overall Study||34||34
60093910|NCT01968707|76210996|FG007|NOT COMPLETED|Overall Study||35||35
60093911|NCT01959581|76211029|FG000|STARTED|Overall Study||30||
60093912|NCT01959581|76211029|FG000|COMPLETED|Overall Study||25||
60093913|NCT01959581|76211029|FG000|NOT COMPLETED|Overall Study||5||
60093914|NCT01746901|76211033|FG000|STARTED|Naloxone Challenge Phase||75||
60093915|NCT01746901|76211034|FG001|STARTED|Naloxone Challenge Phase||0||
60093916|NCT01746901|76211035|FG002|STARTED|Naloxone Challenge Phase||0||
60093917|NCT01746901|76211036|FG003|STARTED|Naloxone Challenge Phase||0||
60093918|NCT01746901|76211037|FG004|STARTED|Naloxone Challenge Phase||0||
60093919|NCT01746901|76211038|FG005|STARTED|Naloxone Challenge Phase||0||
60093920|NCT01746901|76211039|FG006|STARTED|Naloxone Challenge Phase||0||
60093921|NCT01746901|76211040|FG007|STARTED|Naloxone Challenge Phase||0||
60093922|NCT01746901|76211041|FG008|STARTED|Naloxone Challenge Phase||0||
60093923|NCT01746901|76211033|FG000|COMPLETED|Naloxone Challenge Phase||72||
60093924|NCT01746901|76211034|FG001|COMPLETED|Naloxone Challenge Phase||0||
60093925|NCT01746901|76211035|FG002|COMPLETED|Naloxone Challenge Phase||0||
60093926|NCT01746901|76211036|FG003|COMPLETED|Naloxone Challenge Phase||0||
60093927|NCT01746901|76211037|FG004|COMPLETED|Naloxone Challenge Phase||0||
60093928|NCT01746901|76211038|FG005|COMPLETED|Naloxone Challenge Phase||0||
60093929|NCT01746901|76211039|FG006|COMPLETED|Naloxone Challenge Phase||0||
60093930|NCT01746901|76211040|FG007|COMPLETED|Naloxone Challenge Phase||0||
60093931|NCT01746901|76211041|FG008|COMPLETED|Naloxone Challenge Phase||0||
60093932|NCT01746901|76211033|FG000|NOT COMPLETED|Naloxone Challenge Phase||3||
60093933|NCT01746901|76211034|FG001|NOT COMPLETED|Naloxone Challenge Phase||0||
60093934|NCT01746901|76211035|FG002|NOT COMPLETED|Naloxone Challenge Phase||0||
60093935|NCT01746901|76211036|FG003|NOT COMPLETED|Naloxone Challenge Phase||0||
60093936|NCT01746901|76211037|FG004|NOT COMPLETED|Naloxone Challenge Phase||0||
60093937|NCT01746901|76211038|FG005|NOT COMPLETED|Naloxone Challenge Phase||0||
60093938|NCT01746901|76211039|FG006|NOT COMPLETED|Naloxone Challenge Phase||0||
60093939|NCT01746901|76211040|FG007|NOT COMPLETED|Naloxone Challenge Phase||0||
60093940|NCT01746901|76211041|FG008|NOT COMPLETED|Naloxone Challenge Phase||0||
60093941|NCT01746901|76211033|FG000|STARTED|Drug Discrimination Phase: Day 1||0||
60093942|NCT01746901|76211034|FG001|STARTED|Drug Discrimination Phase: Day 1||36||
60093943|NCT01746901|76211035|FG002|STARTED|Drug Discrimination Phase: Day 1||36||
60093944|NCT01746901|76211036|FG003|STARTED|Drug Discrimination Phase: Day 1||0||
60093945|NCT01746901|76211037|FG004|STARTED|Drug Discrimination Phase: Day 1||0||
60093946|NCT01746901|76211038|FG005|STARTED|Drug Discrimination Phase: Day 1||0||
60093947|NCT01746901|76211039|FG006|STARTED|Drug Discrimination Phase: Day 1||0||
60093948|NCT01746901|76211040|FG007|STARTED|Drug Discrimination Phase: Day 1||0||
60093949|NCT01746901|76211041|FG008|STARTED|Drug Discrimination Phase: Day 1||0||
60093950|NCT01746901|76211033|FG000|COMPLETED|Drug Discrimination Phase: Day 1||0||
60093951|NCT01746901|76211034|FG001|COMPLETED|Drug Discrimination Phase: Day 1||33||
60093952|NCT01746901|76211035|FG002|COMPLETED|Drug Discrimination Phase: Day 1||36||
60093953|NCT01746901|76211036|FG003|COMPLETED|Drug Discrimination Phase: Day 1||0||
60093954|NCT01746901|76211037|FG004|COMPLETED|Drug Discrimination Phase: Day 1||0||
60093955|NCT01746901|76211038|FG005|COMPLETED|Drug Discrimination Phase: Day 1||0||
60093956|NCT01746901|76211039|FG006|COMPLETED|Drug Discrimination Phase: Day 1||0||
60093957|NCT01746901|76211040|FG007|COMPLETED|Drug Discrimination Phase: Day 1||0||
60093958|NCT01746901|76211041|FG008|COMPLETED|Drug Discrimination Phase: Day 1||0||
60093959|NCT01746901|76211033|FG000|NOT COMPLETED|Drug Discrimination Phase: Day 1||0||
60093960|NCT01746901|76211034|FG001|NOT COMPLETED|Drug Discrimination Phase: Day 1||3||
60093961|NCT01746901|76211035|FG002|NOT COMPLETED|Drug Discrimination Phase: Day 1||0||
60093962|NCT01746901|76211036|FG003|NOT COMPLETED|Drug Discrimination Phase: Day 1||0||
60093963|NCT01746901|76211037|FG004|NOT COMPLETED|Drug Discrimination Phase: Day 1||0||
60093964|NCT01746901|76211038|FG005|NOT COMPLETED|Drug Discrimination Phase: Day 1||0||
60093965|NCT01746901|76211039|FG006|NOT COMPLETED|Drug Discrimination Phase: Day 1||0||
60093966|NCT01746901|76211040|FG007|NOT COMPLETED|Drug Discrimination Phase: Day 1||0||
60093967|NCT01746901|76211041|FG008|NOT COMPLETED|Drug Discrimination Phase: Day 1||0||
60093968|NCT01746901|76211033|FG000|STARTED|Drug Discrimination Phase: Day 2||0||
60093969|NCT01746901|76211034|FG001|STARTED|Drug Discrimination Phase: Day 2||33||
60093970|NCT01746901|76211035|FG002|STARTED|Drug Discrimination Phase: Day 2||36||
60093971|NCT01746901|76211036|FG003|STARTED|Drug Discrimination Phase: Day 2||0||
60093972|NCT01746901|76211037|FG004|STARTED|Drug Discrimination Phase: Day 2||0||
60093973|NCT01746901|76211038|FG005|STARTED|Drug Discrimination Phase: Day 2||0||
60093974|NCT01746901|76211039|FG006|STARTED|Drug Discrimination Phase: Day 2||0||
60093975|NCT01746901|76211040|FG007|STARTED|Drug Discrimination Phase: Day 2||0||
60093976|NCT01746901|76211041|FG008|STARTED|Drug Discrimination Phase: Day 2||0||
60093977|NCT01746901|76211033|FG000|COMPLETED|Drug Discrimination Phase: Day 2||0||
60093978|NCT01746901|76211034|FG001|COMPLETED|Drug Discrimination Phase: Day 2||19||
60093979|NCT01746901|76211035|FG002|COMPLETED|Drug Discrimination Phase: Day 2||22||
60093980|NCT01746901|76211036|FG003|COMPLETED|Drug Discrimination Phase: Day 2||0||
60093981|NCT01746901|76211037|FG004|COMPLETED|Drug Discrimination Phase: Day 2||0||
60093982|NCT01746901|76211038|FG005|COMPLETED|Drug Discrimination Phase: Day 2||0||
60093983|NCT01746901|76211039|FG006|COMPLETED|Drug Discrimination Phase: Day 2||0||
60093984|NCT01746901|76211040|FG007|COMPLETED|Drug Discrimination Phase: Day 2||0||
60093985|NCT01746901|76211041|FG008|COMPLETED|Drug Discrimination Phase: Day 2||0||
60093986|NCT01746901|76211033|FG000|NOT COMPLETED|Drug Discrimination Phase: Day 2||0||
59561987|NCT03460899|75663596|FG000|COMPLETED|Euglycaemic Clamp|Last Euglycaemic clamp completed: 23. May 2018|14||
59561988|NCT03460899|75663596|FG000|NOT COMPLETED|Euglycaemic Clamp||0||
59561989|NCT03460899|75663596|FG000|STARTED|Hyperinsulinaemic/Hypoglycaemic Clamp|First Hyperinsulinaemic/Hypoglycaemic Clamp completed: 15. March 2018|14||
59561990|NCT03460899|75663596|FG000|COMPLETED|Hyperinsulinaemic/Hypoglycaemic Clamp|Last Hyperinsulinaemic/Hypoglycaemic Clamp completed: 05. June 2018|14||
59561991|NCT03460899|75663596|FG000|NOT COMPLETED|Hyperinsulinaemic/Hypoglycaemic Clamp||0||
59561992|NCT02009501|75663602|FG000|STARTED|Overall Study||9||
59561993|NCT02009501|75663603|FG001|STARTED|Overall Study||11||
59561994|NCT02009501|75663602|FG000|COMPLETED|Overall Study||9||
59561995|NCT02009501|75663603|FG001|COMPLETED|Overall Study||11||
59561996|NCT02009501|75663602|FG000|NOT COMPLETED|Overall Study||0||
59561997|NCT02009501|75663603|FG001|NOT COMPLETED|Overall Study||0||
59561998|NCT03308799|75663612|FG000|STARTED|Overall Study||342||
59561999|NCT03308799|75663613|FG001|STARTED|Overall Study||337||
59562000|NCT03308799|75663614|FG002|STARTED|Overall Study||115||
59562001|NCT03308799|75663612|FG000|COMPLETED|Overall Study||320||
59562002|NCT03308799|75663613|FG001|COMPLETED|Overall Study||309||
59562003|NCT03308799|75663614|FG002|COMPLETED|Overall Study||94||
59562004|NCT03308799|75663612|FG000|NOT COMPLETED|Overall Study||22||
59562005|NCT03308799|75663613|FG001|NOT COMPLETED|Overall Study||28||
59562006|NCT03308799|75663614|FG002|NOT COMPLETED|Overall Study||21||
59562007|NCT02305277|75663628|FG000|STARTED|Overall Study||15||
59562008|NCT02305277|75663629|FG001|STARTED|Overall Study||14||
59562009|NCT02305277|75663630|FG002|STARTED|Overall Study||14||
59562010|NCT02305277|75663631|FG003|STARTED|Overall Study||14||
59562011|NCT02305277|75663632|FG004|STARTED|Overall Study||14||
59562012|NCT02305277|75663633|FG005|STARTED|Overall Study||14||
59562013|NCT02305277|75663628|FG000|Received CM|Overall Study||15||
59562014|NCT02305277|75663629|FG001|Received CM|Overall Study||14||
59708008|NCT02702180|75826898|FG000|COMPLETED|Double-blind Treatment Period||45||
59562015|NCT02305277|75663630|FG002|Received CM|Overall Study||14||
59562016|NCT02305277|75663631|FG003|Received CM|Overall Study||14||
59708009|NCT02702180|75826899|FG001|COMPLETED|Double-blind Treatment Period||44||
59708010|NCT02702180|75826900|FG002|COMPLETED|Double-blind Treatment Period||43||
59708011|NCT02702180|75826898|FG000|NOT COMPLETED|Double-blind Treatment Period||1||
60093987|NCT01746901|76211034|FG001|NOT COMPLETED|Drug Discrimination Phase: Day 2||14||
60093988|NCT01746901|76211035|FG002|NOT COMPLETED|Drug Discrimination Phase: Day 2||14||
60093989|NCT01746901|76211036|FG003|NOT COMPLETED|Drug Discrimination Phase: Day 2||0||
60093990|NCT01746901|76211037|FG004|NOT COMPLETED|Drug Discrimination Phase: Day 2||0||
60093991|NCT01746901|76211038|FG005|NOT COMPLETED|Drug Discrimination Phase: Day 2||0||
59562017|NCT02305277|75663632|FG004|Received CM|Overall Study||14||
59708012|NCT02702180|75826899|FG001|NOT COMPLETED|Double-blind Treatment Period||1||
60093992|NCT01746901|76211039|FG006|NOT COMPLETED|Drug Discrimination Phase: Day 2||0||
60093993|NCT01746901|76211040|FG007|NOT COMPLETED|Drug Discrimination Phase: Day 2||0||
60093994|NCT01746901|76211041|FG008|NOT COMPLETED|Drug Discrimination Phase: Day 2||0||
60093995|NCT01746901|76211033|FG000|STARTED|Treatment Phase: First Intervention||0||
60093996|NCT01746901|76211034|FG001|STARTED|Treatment Phase: First Intervention||0||
60093997|NCT01746901|76211035|FG002|STARTED|Treatment Phase: First Intervention||0||
60093998|NCT01746901|76211036|FG003|STARTED|Treatment Phase: First Intervention||6||
60093999|NCT01746901|76211037|FG004|STARTED|Treatment Phase: First Intervention||6||
60094000|NCT01746901|76211038|FG005|STARTED|Treatment Phase: First Intervention||7||
60094001|NCT01746901|76211039|FG006|STARTED|Treatment Phase: First Intervention||8||
60094002|NCT01746901|76211040|FG007|STARTED|Treatment Phase: First Intervention||7||
60094003|NCT01746901|76211041|FG008|STARTED|Treatment Phase: First Intervention||7||
60094004|NCT01746901|76211033|FG000|COMPLETED|Treatment Phase: First Intervention||0||
60094005|NCT01746901|76211034|FG001|COMPLETED|Treatment Phase: First Intervention||0||
60094006|NCT01746901|76211035|FG002|COMPLETED|Treatment Phase: First Intervention||0||
60094007|NCT01746901|76211036|FG003|COMPLETED|Treatment Phase: First Intervention||6||
60094008|NCT01746901|76211037|FG004|COMPLETED|Treatment Phase: First Intervention||6||
60094009|NCT01746901|76211038|FG005|COMPLETED|Treatment Phase: First Intervention||7||
60094010|NCT01746901|76211039|FG006|COMPLETED|Treatment Phase: First Intervention||7||
60094011|NCT01746901|76211040|FG007|COMPLETED|Treatment Phase: First Intervention||7||
60094012|NCT01746901|76211041|FG008|COMPLETED|Treatment Phase: First Intervention||7||
60094013|NCT01746901|76211033|FG000|NOT COMPLETED|Treatment Phase: First Intervention||0||
60094014|NCT01746901|76211034|FG001|NOT COMPLETED|Treatment Phase: First Intervention||0||
60094015|NCT01746901|76211035|FG002|NOT COMPLETED|Treatment Phase: First Intervention||0||
60094016|NCT01746901|76211036|FG003|NOT COMPLETED|Treatment Phase: First Intervention||0||
60094017|NCT01746901|76211037|FG004|NOT COMPLETED|Treatment Phase: First Intervention||0||
60094018|NCT01746901|76211038|FG005|NOT COMPLETED|Treatment Phase: First Intervention||0||
60094019|NCT01746901|76211039|FG006|NOT COMPLETED|Treatment Phase: First Intervention||1||
60094020|NCT01746901|76211040|FG007|NOT COMPLETED|Treatment Phase: First Intervention||0||
60094021|NCT01746901|76211041|FG008|NOT COMPLETED|Treatment Phase: First Intervention||0||
60094022|NCT01746901|76211033|FG000|STARTED|Treatment Phase: Washout Period 1||0||
60094023|NCT01746901|76211034|FG001|STARTED|Treatment Phase: Washout Period 1||0||
60094024|NCT01746901|76211035|FG002|STARTED|Treatment Phase: Washout Period 1||0||
60094025|NCT01746901|76211036|FG003|STARTED|Treatment Phase: Washout Period 1||6||
60094026|NCT01746901|76211037|FG004|STARTED|Treatment Phase: Washout Period 1||6||
60094027|NCT01746901|76211038|FG005|STARTED|Treatment Phase: Washout Period 1||7||
60094028|NCT01746901|76211039|FG006|STARTED|Treatment Phase: Washout Period 1||7||
60094029|NCT01746901|76211040|FG007|STARTED|Treatment Phase: Washout Period 1||7||
60094030|NCT01746901|76211041|FG008|STARTED|Treatment Phase: Washout Period 1||7||
60094031|NCT01746901|76211033|FG000|COMPLETED|Treatment Phase: Washout Period 1||0||
60094032|NCT01746901|76211034|FG001|COMPLETED|Treatment Phase: Washout Period 1||0||
60094033|NCT01746901|76211035|FG002|COMPLETED|Treatment Phase: Washout Period 1||0||
60094034|NCT01746901|76211036|FG003|COMPLETED|Treatment Phase: Washout Period 1||6||
60094035|NCT01746901|76211037|FG004|COMPLETED|Treatment Phase: Washout Period 1||6||
60094036|NCT01746901|76211038|FG005|COMPLETED|Treatment Phase: Washout Period 1||7||
60094037|NCT01746901|76211039|FG006|COMPLETED|Treatment Phase: Washout Period 1||7||
60094038|NCT01746901|76211040|FG007|COMPLETED|Treatment Phase: Washout Period 1||7||
60094039|NCT01746901|76211041|FG008|COMPLETED|Treatment Phase: Washout Period 1||7||
60094040|NCT01746901|76211033|FG000|NOT COMPLETED|Treatment Phase: Washout Period 1||0||
60094041|NCT01746901|76211034|FG001|NOT COMPLETED|Treatment Phase: Washout Period 1||0||
60094042|NCT01746901|76211035|FG002|NOT COMPLETED|Treatment Phase: Washout Period 1||0||
60094043|NCT01746901|76211036|FG003|NOT COMPLETED|Treatment Phase: Washout Period 1||0||
60094044|NCT01746901|76211037|FG004|NOT COMPLETED|Treatment Phase: Washout Period 1||0||
60094045|NCT01746901|76211038|FG005|NOT COMPLETED|Treatment Phase: Washout Period 1||0||
60094046|NCT01746901|76211039|FG006|NOT COMPLETED|Treatment Phase: Washout Period 1||0||
60094047|NCT01746901|76211040|FG007|NOT COMPLETED|Treatment Phase: Washout Period 1||0||
60094048|NCT01746901|76211041|FG008|NOT COMPLETED|Treatment Phase: Washout Period 1||0||
60094049|NCT01746901|76211033|FG000|STARTED|Treatment Phase: Second Intervention||0||
60094050|NCT01746901|76211034|FG001|STARTED|Treatment Phase: Second Intervention||0||
60094051|NCT01746901|76211035|FG002|STARTED|Treatment Phase: Second Intervention||0||
60094052|NCT01746901|76211036|FG003|STARTED|Treatment Phase: Second Intervention||6||
60094053|NCT01746901|76211037|FG004|STARTED|Treatment Phase: Second Intervention||6||
60094054|NCT01746901|76211038|FG005|STARTED|Treatment Phase: Second Intervention||7||
60094055|NCT01746901|76211039|FG006|STARTED|Treatment Phase: Second Intervention||7||
60094056|NCT01746901|76211040|FG007|STARTED|Treatment Phase: Second Intervention||7||
60094057|NCT01746901|76211041|FG008|STARTED|Treatment Phase: Second Intervention||7||
60094058|NCT01746901|76211033|FG000|COMPLETED|Treatment Phase: Second Intervention||0||
60094059|NCT01746901|76211034|FG001|COMPLETED|Treatment Phase: Second Intervention||0||
60094060|NCT01746901|76211035|FG002|COMPLETED|Treatment Phase: Second Intervention||0||
60094061|NCT01746901|76211036|FG003|COMPLETED|Treatment Phase: Second Intervention||6||
60094062|NCT01746901|76211037|FG004|COMPLETED|Treatment Phase: Second Intervention||6||
59708013|NCT02702180|75826900|FG002|NOT COMPLETED|Double-blind Treatment Period||4||
59993283|NCT01377233|76109200|FG002|COMPLETED|Open-label||0||
59993284|NCT01377233|76109201|FG003|COMPLETED|Open-label||0||
59993285|NCT01377233|76109202|FG004|COMPLETED|Open-label||0||
59993286|NCT01377233|76109198|FG000|NOT COMPLETED|Open-label||4||
59993287|NCT01377233|76109199|FG001|NOT COMPLETED|Open-label||0||
59993288|NCT01377233|76109200|FG002|NOT COMPLETED|Open-label||0||
59993289|NCT01377233|76109201|FG003|NOT COMPLETED|Open-label||0||
59993290|NCT01377233|76109202|FG004|NOT COMPLETED|Open-label||0||
59993291|NCT01377233|76109198|FG000|STARTED|Double-blind||0||
59993292|NCT01377233|76109199|FG001|STARTED|Double-blind||11||
59993293|NCT01377233|76109200|FG002|STARTED|Double-blind||10||
59993294|NCT01377233|76109201|FG003|STARTED|Double-blind||11||
59993295|NCT01377233|76109202|FG004|STARTED|Double-blind||10||
59993296|NCT01377233|76109198|FG000|COMPLETED|Double-blind||0||
59993297|NCT01377233|76109199|FG001|COMPLETED|Double-blind||10||
59993298|NCT01377233|76109200|FG002|COMPLETED|Double-blind||8||
59993299|NCT01377233|76109201|FG003|COMPLETED|Double-blind||7||
59993300|NCT01377233|76109202|FG004|COMPLETED|Double-blind||8||
59993301|NCT01377233|76109198|FG000|NOT COMPLETED|Double-blind||0||
59993302|NCT01377233|76109199|FG001|NOT COMPLETED|Double-blind||1||
59993303|NCT01377233|76109200|FG002|NOT COMPLETED|Double-blind||2||
59993304|NCT01377233|76109201|FG003|NOT COMPLETED|Double-blind||4||
59993305|NCT01377233|76109202|FG004|NOT COMPLETED|Double-blind||2||
59993306|NCT03248531|76109221|FG000|STARTED|Overall Study||22|Completed screening period (2-4 Weeks) and Randomized|
59993307|NCT03248531|76109222|FG001|STARTED|Overall Study||22|Completed screening period (2-4 Weeks) and Randomized|
59993308|NCT03248531|76109223|FG002|STARTED|Overall Study||46|Completed screening period (2-4 Weeks) and Randomized|
59993309|NCT03248531|76109221|FG000|Completed Week 12|Overall Study||19|Completed treatment period (12 Weeks)|
59993310|NCT03248531|76109222|FG001|Completed Week 12|Overall Study||18|Completed treatment period (12 Weeks)|
59993311|NCT03248531|76109223|FG002|Completed Week 12|Overall Study||42|Completed treatment period (12 Weeks)|
59993312|NCT03248531|76109221|FG000|COMPLETED|Overall Study||18|Study completed (including safety follow-up period [20 weeks after last dose])|
59993313|NCT03248531|76109222|FG001|COMPLETED|Overall Study||17|Study completed (including safety follow-up period [20 weeks after last dose])|
59993314|NCT03248531|76109223|FG002|COMPLETED|Overall Study||38|Study completed (including safety follow-up period [20 weeks after last dose])|
59993315|NCT03248531|76109221|FG000|NOT COMPLETED|Overall Study||4||
59993316|NCT03248531|76109222|FG001|NOT COMPLETED|Overall Study||5||
59993317|NCT03248531|76109223|FG002|NOT COMPLETED|Overall Study||8||
59993318|NCT02656329|76109240|FG000|STARTED|Overall Study||164||
59993319|NCT02656329|76109241|FG001|STARTED|Overall Study||157||
59993320|NCT02656329|76109240|FG000|COMPLETED|Overall Study||0||
59993321|NCT02656329|76109241|FG001|COMPLETED|Overall Study||0||
59993322|NCT02656329|76109240|FG000|NOT COMPLETED|Overall Study||164||
59993323|NCT02656329|76109241|FG001|NOT COMPLETED|Overall Study||157||
59993324|NCT02712905|76109266|FG000|STARTED|Monotherapy||3||
59993325|NCT02712905|76109267|FG001|STARTED|Monotherapy||6||
59993326|NCT02712905|76109268|FG002|STARTED|Monotherapy||1||
59993327|NCT02712905|76109269|FG003|STARTED|Monotherapy||5||
59993328|NCT02712905|76109270|FG004|STARTED|Monotherapy||18||
59993329|NCT02712905|76109271|FG005|STARTED|Monotherapy||2||
59993330|NCT02712905|76109272|FG006|STARTED|Monotherapy||3||
59993331|NCT02712905|76109273|FG007|STARTED|Monotherapy||3||
59993332|NCT02712905|76109274|FG008|STARTED|Monotherapy||1||
59993333|NCT02712905|76109275|FG009|STARTED|Monotherapy||36||
59993334|NCT02712905|76109276|FG010|STARTED|Monotherapy||3||
59993335|NCT02712905|76109277|FG011|STARTED|Monotherapy||7||
59993336|NCT02712905|76109278|FG012|STARTED|Monotherapy||0||
59993337|NCT02712905|76109279|FG013|STARTED|Monotherapy||0||
59993338|NCT02712905|76109280|FG014|STARTED|Monotherapy||0||
59993339|NCT02712905|76109281|FG015|STARTED|Monotherapy||0||
59993340|NCT02712905|76109282|FG016|STARTED|Monotherapy||0||
59993341|NCT02712905|76109283|FG017|STARTED|Monotherapy||0||
59993342|NCT02712905|76109266|FG000|COMPLETED|Monotherapy||0||
59993343|NCT02712905|76109267|FG001|COMPLETED|Monotherapy||0||
59993344|NCT02712905|76109268|FG002|COMPLETED|Monotherapy||0||
59993345|NCT02712905|76109269|FG003|COMPLETED|Monotherapy||0||
59993346|NCT02712905|76109270|FG004|COMPLETED|Monotherapy||0||
59993347|NCT02712905|76109271|FG005|COMPLETED|Monotherapy||0||
59993348|NCT02712905|76109272|FG006|COMPLETED|Monotherapy||0||
59993349|NCT02712905|76109273|FG007|COMPLETED|Monotherapy||0||
59993350|NCT02712905|76109274|FG008|COMPLETED|Monotherapy||0||
59993351|NCT02712905|76109275|FG009|COMPLETED|Monotherapy||0||
59993352|NCT02712905|76109276|FG010|COMPLETED|Monotherapy||0||
59993353|NCT02712905|76109277|FG011|COMPLETED|Monotherapy||0||
59993354|NCT02712905|76109278|FG012|COMPLETED|Monotherapy||0||
59993355|NCT02712905|76109279|FG013|COMPLETED|Monotherapy||0||
59993356|NCT02712905|76109280|FG014|COMPLETED|Monotherapy||0||
59993357|NCT02712905|76109281|FG015|COMPLETED|Monotherapy||0||
59993358|NCT02712905|76109282|FG016|COMPLETED|Monotherapy||0||
60094063|NCT01746901|76211038|FG005|COMPLETED|Treatment Phase: Second Intervention||7||
60094064|NCT01746901|76211039|FG006|COMPLETED|Treatment Phase: Second Intervention||7||
60094065|NCT01746901|76211040|FG007|COMPLETED|Treatment Phase: Second Intervention||6||
60094066|NCT01746901|76211041|FG008|COMPLETED|Treatment Phase: Second Intervention||7||
60094067|NCT01746901|76211033|FG000|NOT COMPLETED|Treatment Phase: Second Intervention||0||
60094068|NCT01746901|76211034|FG001|NOT COMPLETED|Treatment Phase: Second Intervention||0||
60094069|NCT01746901|76211035|FG002|NOT COMPLETED|Treatment Phase: Second Intervention||0||
60094070|NCT01746901|76211036|FG003|NOT COMPLETED|Treatment Phase: Second Intervention||0||
60094071|NCT01746901|76211037|FG004|NOT COMPLETED|Treatment Phase: Second Intervention||0||
60094072|NCT01746901|76211038|FG005|NOT COMPLETED|Treatment Phase: Second Intervention||0||
60094073|NCT01746901|76211039|FG006|NOT COMPLETED|Treatment Phase: Second Intervention||0||
60094074|NCT01746901|76211040|FG007|NOT COMPLETED|Treatment Phase: Second Intervention||1||
60094075|NCT01746901|76211041|FG008|NOT COMPLETED|Treatment Phase: Second Intervention||0||
60094076|NCT01746901|76211033|FG000|STARTED|Treatment Phase: Washout Period 2||0||
60094077|NCT01746901|76211034|FG001|STARTED|Treatment Phase: Washout Period 2||0||
60094078|NCT01746901|76211035|FG002|STARTED|Treatment Phase: Washout Period 2||0||
60094079|NCT01746901|76211036|FG003|STARTED|Treatment Phase: Washout Period 2||6||
60094080|NCT01746901|76211037|FG004|STARTED|Treatment Phase: Washout Period 2||6||
59562018|NCT02305277|75663633|FG005|Received CM|Overall Study||14||
59562019|NCT02305277|75663628|FG000|Received TBM|Overall Study||15||
59562020|NCT02305277|75663629|FG001|Received TBM|Overall Study||14||
59562021|NCT02305277|75663630|FG002|Received TBM|Overall Study||14||
59562022|NCT02305277|75663631|FG003|Received TBM|Overall Study||14||
59562023|NCT02305277|75663632|FG004|Received TBM|Overall Study||14||
59562024|NCT02305277|75663633|FG005|Received TBM|Overall Study||14||
59562025|NCT02305277|75663628|FG000|COMPLETED|Overall Study||14||
59562026|NCT02305277|75663629|FG001|COMPLETED|Overall Study||14||
59708014|NCT02702180|75826898|FG000|STARTED|Open-label Treatment Period||45||
59708015|NCT02702180|75826899|FG001|STARTED|Open-label Treatment Period||43||
59708016|NCT02702180|75826900|FG002|STARTED|Open-label Treatment Period||43||
59993359|NCT02712905|76109283|FG017|COMPLETED|Monotherapy||0||
59993360|NCT02712905|76109266|FG000|NOT COMPLETED|Monotherapy||3||
59993361|NCT02712905|76109267|FG001|NOT COMPLETED|Monotherapy||6||
59993362|NCT02712905|76109268|FG002|NOT COMPLETED|Monotherapy||1||
59993363|NCT02712905|76109269|FG003|NOT COMPLETED|Monotherapy||5||
59993364|NCT02712905|76109270|FG004|NOT COMPLETED|Monotherapy||18||
59993365|NCT02712905|76109271|FG005|NOT COMPLETED|Monotherapy||2||
59993366|NCT02712905|76109272|FG006|NOT COMPLETED|Monotherapy||3||
59993367|NCT02712905|76109273|FG007|NOT COMPLETED|Monotherapy||3||
59993368|NCT02712905|76109274|FG008|NOT COMPLETED|Monotherapy||1||
60094081|NCT01746901|76211038|FG005|STARTED|Treatment Phase: Washout Period 2||7||
60094082|NCT01746901|76211039|FG006|STARTED|Treatment Phase: Washout Period 2||7||
60094083|NCT01746901|76211040|FG007|STARTED|Treatment Phase: Washout Period 2||6||
60094084|NCT01746901|76211041|FG008|STARTED|Treatment Phase: Washout Period 2||7||
60094085|NCT01746901|76211033|FG000|COMPLETED|Treatment Phase: Washout Period 2||0||
60094086|NCT01746901|76211034|FG001|COMPLETED|Treatment Phase: Washout Period 2||0||
60094087|NCT01746901|76211035|FG002|COMPLETED|Treatment Phase: Washout Period 2||0||
60094088|NCT01746901|76211036|FG003|COMPLETED|Treatment Phase: Washout Period 2||6||
60094089|NCT01746901|76211037|FG004|COMPLETED|Treatment Phase: Washout Period 2||6||
60094090|NCT01746901|76211038|FG005|COMPLETED|Treatment Phase: Washout Period 2||7||
60094091|NCT01746901|76211039|FG006|COMPLETED|Treatment Phase: Washout Period 2||7||
60094092|NCT01746901|76211040|FG007|COMPLETED|Treatment Phase: Washout Period 2||6||
60094093|NCT01746901|76211041|FG008|COMPLETED|Treatment Phase: Washout Period 2||7||
60094094|NCT01746901|76211033|FG000|NOT COMPLETED|Treatment Phase: Washout Period 2||0||
60094095|NCT01746901|76211034|FG001|NOT COMPLETED|Treatment Phase: Washout Period 2||0||
60094096|NCT01746901|76211035|FG002|NOT COMPLETED|Treatment Phase: Washout Period 2||0||
60094097|NCT01746901|76211036|FG003|NOT COMPLETED|Treatment Phase: Washout Period 2||0||
60094098|NCT01746901|76211037|FG004|NOT COMPLETED|Treatment Phase: Washout Period 2||0||
60094099|NCT01746901|76211038|FG005|NOT COMPLETED|Treatment Phase: Washout Period 2||0||
60094100|NCT01746901|76211039|FG006|NOT COMPLETED|Treatment Phase: Washout Period 2||0||
60094101|NCT01746901|76211040|FG007|NOT COMPLETED|Treatment Phase: Washout Period 2||0||
60094102|NCT01746901|76211041|FG008|NOT COMPLETED|Treatment Phase: Washout Period 2||0||
60094103|NCT01746901|76211033|FG000|STARTED|Treatment Phase: Third Intervention||0||
60094104|NCT01746901|76211034|FG001|STARTED|Treatment Phase: Third Intervention||0||
60094105|NCT01746901|76211035|FG002|STARTED|Treatment Phase: Third Intervention||0||
60094106|NCT01746901|76211036|FG003|STARTED|Treatment Phase: Third Intervention||6||
60094107|NCT01746901|76211037|FG004|STARTED|Treatment Phase: Third Intervention||6||
60094108|NCT01746901|76211038|FG005|STARTED|Treatment Phase: Third Intervention||7||
60094109|NCT01746901|76211039|FG006|STARTED|Treatment Phase: Third Intervention||7||
59562027|NCT02305277|75663630|FG002|COMPLETED|Overall Study||14||
59562028|NCT02305277|75663631|FG003|COMPLETED|Overall Study||14||
59562029|NCT02305277|75663632|FG004|COMPLETED|Overall Study||13||
59562030|NCT02305277|75663633|FG005|COMPLETED|Overall Study||14||
59708017|NCT02702180|75826898|FG000|COMPLETED|Open-label Treatment Period||45||
59993369|NCT02712905|76109275|FG009|NOT COMPLETED|Monotherapy||36||
60094110|NCT01746901|76211040|FG007|STARTED|Treatment Phase: Third Intervention||6||
60094111|NCT01746901|76211041|FG008|STARTED|Treatment Phase: Third Intervention||7||
60094112|NCT01746901|76211033|FG000|COMPLETED|Treatment Phase: Third Intervention||0||
60094113|NCT01746901|76211034|FG001|COMPLETED|Treatment Phase: Third Intervention||0||
60094114|NCT01746901|76211035|FG002|COMPLETED|Treatment Phase: Third Intervention||0||
60094115|NCT01746901|76211036|FG003|COMPLETED|Treatment Phase: Third Intervention||6||
60094116|NCT01746901|76211037|FG004|COMPLETED|Treatment Phase: Third Intervention||6||
60094117|NCT01746901|76211038|FG005|COMPLETED|Treatment Phase: Third Intervention||6||
60094118|NCT01746901|76211039|FG006|COMPLETED|Treatment Phase: Third Intervention||6||
60094119|NCT01746901|76211040|FG007|COMPLETED|Treatment Phase: Third Intervention||6||
60094120|NCT01746901|76211041|FG008|COMPLETED|Treatment Phase: Third Intervention||7||
60094121|NCT01746901|76211033|FG000|NOT COMPLETED|Treatment Phase: Third Intervention||0||
60094122|NCT01746901|76211034|FG001|NOT COMPLETED|Treatment Phase: Third Intervention||0||
60094123|NCT01746901|76211035|FG002|NOT COMPLETED|Treatment Phase: Third Intervention||0||
60094124|NCT01746901|76211036|FG003|NOT COMPLETED|Treatment Phase: Third Intervention||0||
60094125|NCT01746901|76211037|FG004|NOT COMPLETED|Treatment Phase: Third Intervention||0||
60094126|NCT01746901|76211038|FG005|NOT COMPLETED|Treatment Phase: Third Intervention||1||
60094127|NCT01746901|76211039|FG006|NOT COMPLETED|Treatment Phase: Third Intervention||1||
60094128|NCT01746901|76211040|FG007|NOT COMPLETED|Treatment Phase: Third Intervention||0||
60094129|NCT01746901|76211041|FG008|NOT COMPLETED|Treatment Phase: Third Intervention||0||
60094130|NCT01746901|76211033|FG000|STARTED|Treatment Phase: Washout Period 3||0||
60094131|NCT01746901|76211034|FG001|STARTED|Treatment Phase: Washout Period 3||0||
60094132|NCT01746901|76211035|FG002|STARTED|Treatment Phase: Washout Period 3||0||
60094133|NCT01746901|76211036|FG003|STARTED|Treatment Phase: Washout Period 3||6||
60094134|NCT01746901|76211037|FG004|STARTED|Treatment Phase: Washout Period 3||6||
60094135|NCT01746901|76211038|FG005|STARTED|Treatment Phase: Washout Period 3||6||
60094136|NCT01746901|76211039|FG006|STARTED|Treatment Phase: Washout Period 3||6||
60094137|NCT01746901|76211040|FG007|STARTED|Treatment Phase: Washout Period 3||6||
60094138|NCT01746901|76211041|FG008|STARTED|Treatment Phase: Washout Period 3||7||
60094139|NCT01746901|76211033|FG000|COMPLETED|Treatment Phase: Washout Period 3||0||
60094140|NCT01746901|76211034|FG001|COMPLETED|Treatment Phase: Washout Period 3||0||
60094141|NCT01746901|76211035|FG002|COMPLETED|Treatment Phase: Washout Period 3||0||
59562031|NCT02305277|75663628|FG000|NOT COMPLETED|Overall Study||1||
59562032|NCT02305277|75663629|FG001|NOT COMPLETED|Overall Study||0||
59562033|NCT02305277|75663630|FG002|NOT COMPLETED|Overall Study||0||
59562034|NCT02305277|75663631|FG003|NOT COMPLETED|Overall Study||0||
59562035|NCT02305277|75663632|FG004|NOT COMPLETED|Overall Study||1||
59708018|NCT02702180|75826899|FG001|COMPLETED|Open-label Treatment Period||42||
59708019|NCT02702180|75826900|FG002|COMPLETED|Open-label Treatment Period||41||
59708020|NCT02702180|75826898|FG000|NOT COMPLETED|Open-label Treatment Period||0||
59708021|NCT02702180|75826899|FG001|NOT COMPLETED|Open-label Treatment Period||1||
59708022|NCT02702180|75826900|FG002|NOT COMPLETED|Open-label Treatment Period||2||
59708023|NCT00980980|75826912|FG000|STARTED|Overall Study||16||
59708024|NCT00980980|75826913|FG001|STARTED|Overall Study||14||
60094142|NCT01746901|76211036|FG003|COMPLETED|Treatment Phase: Washout Period 3||6||
60094143|NCT01746901|76211037|FG004|COMPLETED|Treatment Phase: Washout Period 3||6||
60094144|NCT01746901|76211038|FG005|COMPLETED|Treatment Phase: Washout Period 3||6||
60094145|NCT01746901|76211039|FG006|COMPLETED|Treatment Phase: Washout Period 3||6||
60094146|NCT01746901|76211040|FG007|COMPLETED|Treatment Phase: Washout Period 3||6||
60094147|NCT01746901|76211041|FG008|COMPLETED|Treatment Phase: Washout Period 3||7||
60094148|NCT01746901|76211033|FG000|NOT COMPLETED|Treatment Phase: Washout Period 3||0||
60094149|NCT01746901|76211034|FG001|NOT COMPLETED|Treatment Phase: Washout Period 3||0||
60094150|NCT01746901|76211035|FG002|NOT COMPLETED|Treatment Phase: Washout Period 3||0||
60094151|NCT01746901|76211036|FG003|NOT COMPLETED|Treatment Phase: Washout Period 3||0||
60094152|NCT01746901|76211037|FG004|NOT COMPLETED|Treatment Phase: Washout Period 3||0||
60094153|NCT01746901|76211038|FG005|NOT COMPLETED|Treatment Phase: Washout Period 3||0||
60094154|NCT01746901|76211039|FG006|NOT COMPLETED|Treatment Phase: Washout Period 3||0||
60094155|NCT01746901|76211040|FG007|NOT COMPLETED|Treatment Phase: Washout Period 3||0||
60094156|NCT01746901|76211041|FG008|NOT COMPLETED|Treatment Phase: Washout Period 3||0||
60094157|NCT01746901|76211033|FG000|STARTED|Treatment Phase: Fourth Intervention||0||
60094158|NCT01746901|76211034|FG001|STARTED|Treatment Phase: Fourth Intervention||0||
60094159|NCT01746901|76211035|FG002|STARTED|Treatment Phase: Fourth Intervention||0||
60094160|NCT01746901|76211036|FG003|STARTED|Treatment Phase: Fourth Intervention||6||
60094161|NCT01746901|76211037|FG004|STARTED|Treatment Phase: Fourth Intervention||6||
60094162|NCT01746901|76211038|FG005|STARTED|Treatment Phase: Fourth Intervention||6||
60094163|NCT01746901|76211039|FG006|STARTED|Treatment Phase: Fourth Intervention||6||
60094164|NCT01746901|76211040|FG007|STARTED|Treatment Phase: Fourth Intervention||6||
59562036|NCT02305277|75663633|FG005|NOT COMPLETED|Overall Study||0||
59562037|NCT03462927|75663649|FG000|STARTED|Overall Study||32||
59562038|NCT03462927|75663650|FG001|STARTED|Overall Study||31||
59708025|NCT00980980|75826914|FG002|STARTED|Overall Study||13||
59708026|NCT00980980|75826912|FG000|COMPLETED|Overall Study||16||
59562039|NCT03462927|75663649|FG000|COMPLETED|Overall Study||26||
60094165|NCT01746901|76211041|FG008|STARTED|Treatment Phase: Fourth Intervention||7||
60094166|NCT01746901|76211033|FG000|COMPLETED|Treatment Phase: Fourth Intervention||0||
60094167|NCT01746901|76211034|FG001|COMPLETED|Treatment Phase: Fourth Intervention||0||
60094168|NCT01746901|76211035|FG002|COMPLETED|Treatment Phase: Fourth Intervention||0||
60094169|NCT01746901|76211036|FG003|COMPLETED|Treatment Phase: Fourth Intervention||5||
60094170|NCT01746901|76211037|FG004|COMPLETED|Treatment Phase: Fourth Intervention||6||
60094171|NCT01746901|76211038|FG005|COMPLETED|Treatment Phase: Fourth Intervention||5||
60094172|NCT01746901|76211039|FG006|COMPLETED|Treatment Phase: Fourth Intervention||5||
60094173|NCT01746901|76211040|FG007|COMPLETED|Treatment Phase: Fourth Intervention||6||
60094174|NCT01746901|76211041|FG008|COMPLETED|Treatment Phase: Fourth Intervention||5||
60094175|NCT01746901|76211033|FG000|NOT COMPLETED|Treatment Phase: Fourth Intervention||0||
60094176|NCT01746901|76211034|FG001|NOT COMPLETED|Treatment Phase: Fourth Intervention||0||
60094177|NCT01746901|76211035|FG002|NOT COMPLETED|Treatment Phase: Fourth Intervention||0||
60094178|NCT01746901|76211036|FG003|NOT COMPLETED|Treatment Phase: Fourth Intervention||1||
60094179|NCT01746901|76211037|FG004|NOT COMPLETED|Treatment Phase: Fourth Intervention||0||
60094180|NCT01746901|76211038|FG005|NOT COMPLETED|Treatment Phase: Fourth Intervention||1||
60094181|NCT01746901|76211039|FG006|NOT COMPLETED|Treatment Phase: Fourth Intervention||1||
60094182|NCT01746901|76211040|FG007|NOT COMPLETED|Treatment Phase: Fourth Intervention||0||
60094183|NCT01746901|76211041|FG008|NOT COMPLETED|Treatment Phase: Fourth Intervention||2||
60094184|NCT01746901|76211033|FG000|STARTED|Treatment Phase: Washout Period 4||0||
60094185|NCT01746901|76211034|FG001|STARTED|Treatment Phase: Washout Period 4||0||
60094186|NCT01746901|76211035|FG002|STARTED|Treatment Phase: Washout Period 4||0||
60094187|NCT01746901|76211036|FG003|STARTED|Treatment Phase: Washout Period 4||5||
60094188|NCT01746901|76211037|FG004|STARTED|Treatment Phase: Washout Period 4||6||
60094189|NCT01746901|76211038|FG005|STARTED|Treatment Phase: Washout Period 4||5||
60094190|NCT01746901|76211039|FG006|STARTED|Treatment Phase: Washout Period 4||5||
60094191|NCT01746901|76211040|FG007|STARTED|Treatment Phase: Washout Period 4||6||
60094192|NCT01746901|76211041|FG008|STARTED|Treatment Phase: Washout Period 4||5||
60094193|NCT01746901|76211033|FG000|COMPLETED|Treatment Phase: Washout Period 4||0||
60103761|NCT04317586|76222029|FG000|COMPLETED|Overall Study||0||0
60103762|NCT04317586|76222029|FG000|NOT COMPLETED|Overall Study||16||17
60103763|NCT04102098|76222035|FG000|STARTED|Main Study Period||334||
60103764|NCT04102098|76222036|FG001|STARTED|Main Study Period||334||
60103765|NCT04102098|76222035|FG000|COMPLETED|Main Study Period||0||
60103766|NCT04102098|76222036|FG001|COMPLETED|Main Study Period||0||
60103767|NCT04102098|76222035|FG000|NOT COMPLETED|Main Study Period||334||
60103768|NCT04102098|76222036|FG001|NOT COMPLETED|Main Study Period||334||
60103769|NCT04102098|76222035|FG000|STARTED|Crossover: AS Who Crossed Over||81||
60103770|NCT04102098|76222036|FG001|STARTED|Crossover: AS Who Crossed Over||0||
60103771|NCT04102098|76222035|FG000|COMPLETED|Crossover: AS Who Crossed Over||0||
60094194|NCT01746901|76211034|FG001|COMPLETED|Treatment Phase: Washout Period 4||0||
60094195|NCT01746901|76211035|FG002|COMPLETED|Treatment Phase: Washout Period 4||0||
60094196|NCT01746901|76211036|FG003|COMPLETED|Treatment Phase: Washout Period 4||5||
60094197|NCT01746901|76211037|FG004|COMPLETED|Treatment Phase: Washout Period 4||6||
60094198|NCT01746901|76211038|FG005|COMPLETED|Treatment Phase: Washout Period 4||5||
60094199|NCT01746901|76211039|FG006|COMPLETED|Treatment Phase: Washout Period 4||5||
60094200|NCT01746901|76211040|FG007|COMPLETED|Treatment Phase: Washout Period 4||6||
60094201|NCT01746901|76211041|FG008|COMPLETED|Treatment Phase: Washout Period 4||5||
60094202|NCT01746901|76211033|FG000|NOT COMPLETED|Treatment Phase: Washout Period 4||0||
60094203|NCT01746901|76211034|FG001|NOT COMPLETED|Treatment Phase: Washout Period 4||0||
60094204|NCT01746901|76211035|FG002|NOT COMPLETED|Treatment Phase: Washout Period 4||0||
60094205|NCT01746901|76211036|FG003|NOT COMPLETED|Treatment Phase: Washout Period 4||0||
60094206|NCT01746901|76211037|FG004|NOT COMPLETED|Treatment Phase: Washout Period 4||0||
60094207|NCT01746901|76211038|FG005|NOT COMPLETED|Treatment Phase: Washout Period 4||0||
60094208|NCT01746901|76211039|FG006|NOT COMPLETED|Treatment Phase: Washout Period 4||0||
60094209|NCT01746901|76211040|FG007|NOT COMPLETED|Treatment Phase: Washout Period 4||0||
60094210|NCT01746901|76211041|FG008|NOT COMPLETED|Treatment Phase: Washout Period 4||0||
60094211|NCT01746901|76211033|FG000|STARTED|Treatment Phase: Fifth Intervention||0||
60094212|NCT01746901|76211034|FG001|STARTED|Treatment Phase: Fifth Intervention||0||
60094213|NCT01746901|76211035|FG002|STARTED|Treatment Phase: Fifth Intervention||0||
60094214|NCT01746901|76211036|FG003|STARTED|Treatment Phase: Fifth Intervention||5||
59562040|NCT03462927|75663650|FG001|COMPLETED|Overall Study||29||
59562041|NCT03462927|75663649|FG000|NOT COMPLETED|Overall Study||6||
59562042|NCT03462927|75663650|FG001|NOT COMPLETED|Overall Study||2||
59562043|NCT03309657|75663658|FG000|STARTED|Overall Study||10||
59562044|NCT03309657|75663658|FG000|COMPLETED|Overall Study||10||
59562045|NCT03309657|75663658|FG000|NOT COMPLETED|Overall Study||0||
60094215|NCT01746901|76211037|FG004|STARTED|Treatment Phase: Fifth Intervention||6||
60094216|NCT01746901|76211038|FG005|STARTED|Treatment Phase: Fifth Intervention||5||
60094217|NCT01746901|76211039|FG006|STARTED|Treatment Phase: Fifth Intervention||5||
60094218|NCT01746901|76211040|FG007|STARTED|Treatment Phase: Fifth Intervention||6||
60094219|NCT01746901|76211041|FG008|STARTED|Treatment Phase: Fifth Intervention||5||
60094220|NCT01746901|76211033|FG000|COMPLETED|Treatment Phase: Fifth Intervention||0||
60094221|NCT01746901|76211034|FG001|COMPLETED|Treatment Phase: Fifth Intervention||0||
60094222|NCT01746901|76211035|FG002|COMPLETED|Treatment Phase: Fifth Intervention||0||
60094223|NCT01746901|76211036|FG003|COMPLETED|Treatment Phase: Fifth Intervention||5||
60094224|NCT01746901|76211037|FG004|COMPLETED|Treatment Phase: Fifth Intervention||6||
60094225|NCT01746901|76211038|FG005|COMPLETED|Treatment Phase: Fifth Intervention||5||
60094226|NCT01746901|76211039|FG006|COMPLETED|Treatment Phase: Fifth Intervention||5||
60094227|NCT01746901|76211040|FG007|COMPLETED|Treatment Phase: Fifth Intervention||6||
60094228|NCT01746901|76211041|FG008|COMPLETED|Treatment Phase: Fifth Intervention||5||
60094229|NCT01746901|76211033|FG000|NOT COMPLETED|Treatment Phase: Fifth Intervention||0||
60094230|NCT01746901|76211034|FG001|NOT COMPLETED|Treatment Phase: Fifth Intervention||0||
60094231|NCT01746901|76211035|FG002|NOT COMPLETED|Treatment Phase: Fifth Intervention||0||
60094232|NCT01746901|76211036|FG003|NOT COMPLETED|Treatment Phase: Fifth Intervention||0||
60094233|NCT01746901|76211037|FG004|NOT COMPLETED|Treatment Phase: Fifth Intervention||0||
60094234|NCT01746901|76211038|FG005|NOT COMPLETED|Treatment Phase: Fifth Intervention||0||
60094235|NCT01746901|76211039|FG006|NOT COMPLETED|Treatment Phase: Fifth Intervention||0||
60094236|NCT01746901|76211040|FG007|NOT COMPLETED|Treatment Phase: Fifth Intervention||0||
60094237|NCT01746901|76211041|FG008|NOT COMPLETED|Treatment Phase: Fifth Intervention||0||
60094238|NCT01746901|76211033|FG000|STARTED|Treatment Phase: Washout Period 5||0||
60094239|NCT01746901|76211034|FG001|STARTED|Treatment Phase: Washout Period 5||0||
60094240|NCT01746901|76211035|FG002|STARTED|Treatment Phase: Washout Period 5||0||
59562046|NCT03463161|75663662|FG000|STARTED|Overall Study||2||
59562047|NCT03463161|75663662|FG000|COMPLETED|Overall Study||2||
59562048|NCT03463161|75663662|FG000|NOT COMPLETED|Overall Study||0||
59562049|NCT03463941|75663666|FG000|STARTED|Overall Study||80||
60094241|NCT01746901|76211036|FG003|STARTED|Treatment Phase: Washout Period 5||5||
60094242|NCT01746901|76211037|FG004|STARTED|Treatment Phase: Washout Period 5||6||
60094243|NCT01746901|76211038|FG005|STARTED|Treatment Phase: Washout Period 5||5||
60094244|NCT01746901|76211039|FG006|STARTED|Treatment Phase: Washout Period 5||5||
60094245|NCT01746901|76211040|FG007|STARTED|Treatment Phase: Washout Period 5||6||
60094246|NCT01746901|76211041|FG008|STARTED|Treatment Phase: Washout Period 5||5||
60094247|NCT01746901|76211033|FG000|COMPLETED|Treatment Phase: Washout Period 5||0||
60094248|NCT01746901|76211034|FG001|COMPLETED|Treatment Phase: Washout Period 5||0||
60094249|NCT01746901|76211035|FG002|COMPLETED|Treatment Phase: Washout Period 5||0||
60094250|NCT01746901|76211036|FG003|COMPLETED|Treatment Phase: Washout Period 5||5||
60094251|NCT01746901|76211037|FG004|COMPLETED|Treatment Phase: Washout Period 5||6||
60094252|NCT01746901|76211038|FG005|COMPLETED|Treatment Phase: Washout Period 5||5||
59562050|NCT03463941|75663666|FG000|COMPLETED|Overall Study||62||
59562051|NCT03463941|75663666|FG000|NOT COMPLETED|Overall Study||18||
59708027|NCT00980980|75826913|FG001|COMPLETED|Overall Study||13||
60094253|NCT01746901|76211039|FG006|COMPLETED|Treatment Phase: Washout Period 5||5||
60094254|NCT01746901|76211040|FG007|COMPLETED|Treatment Phase: Washout Period 5||6||
60094255|NCT01746901|76211041|FG008|COMPLETED|Treatment Phase: Washout Period 5||5||
60094256|NCT01746901|76211033|FG000|NOT COMPLETED|Treatment Phase: Washout Period 5||0||
60094257|NCT01746901|76211034|FG001|NOT COMPLETED|Treatment Phase: Washout Period 5||0||
60094258|NCT01746901|76211035|FG002|NOT COMPLETED|Treatment Phase: Washout Period 5||0||
60094259|NCT01746901|76211036|FG003|NOT COMPLETED|Treatment Phase: Washout Period 5||0||
60094260|NCT01746901|76211037|FG004|NOT COMPLETED|Treatment Phase: Washout Period 5||0||
60094261|NCT01746901|76211038|FG005|NOT COMPLETED|Treatment Phase: Washout Period 5||0||
60094262|NCT01746901|76211039|FG006|NOT COMPLETED|Treatment Phase: Washout Period 5||0||
60094263|NCT01746901|76211040|FG007|NOT COMPLETED|Treatment Phase: Washout Period 5||0||
60094264|NCT01746901|76211041|FG008|NOT COMPLETED|Treatment Phase: Washout Period 5||0||
60094265|NCT01746901|76211033|FG000|STARTED|Treatment Phase: Sixth Intervention||0||
60094266|NCT01746901|76211034|FG001|STARTED|Treatment Phase: Sixth Intervention||0||
60094267|NCT01746901|76211035|FG002|STARTED|Treatment Phase: Sixth Intervention||0||
60094268|NCT01746901|76211036|FG003|STARTED|Treatment Phase: Sixth Intervention||5||
59562052|NCT03466047|75663671|FG000|STARTED|Protein Stomach (1day)|The same 8 patients were studied in all interventions|8||
59562053|NCT03466047|75663671|FG000|COMPLETED|Protein Stomach (1day)|The same 8 patients were studied in all interventions|8||
59562054|NCT03466047|75663671|FG000|NOT COMPLETED|Protein Stomach (1day)||0||
59562055|NCT03466047|75663671|FG000|STARTED|Protein Small Intestine (1 Day)||8||
59562056|NCT03466047|75663671|FG000|COMPLETED|Protein Small Intestine (1 Day)||8||
59562057|NCT03466047|75663671|FG000|NOT COMPLETED|Protein Small Intestine (1 Day)||0||
60094269|NCT01746901|76211037|FG004|STARTED|Treatment Phase: Sixth Intervention||6||
60094270|NCT01746901|76211038|FG005|STARTED|Treatment Phase: Sixth Intervention||5||
60094271|NCT01746901|76211039|FG006|STARTED|Treatment Phase: Sixth Intervention||5||
60094272|NCT01746901|76211040|FG007|STARTED|Treatment Phase: Sixth Intervention||6||
60094273|NCT01746901|76211041|FG008|STARTED|Treatment Phase: Sixth Intervention||5||
60094274|NCT01746901|76211033|FG000|COMPLETED|Treatment Phase: Sixth Intervention||0||
59562058|NCT03466047|75663671|FG000|STARTED|CHO Stomach (1 Day)||8||
59562059|NCT03466047|75663671|FG000|COMPLETED|CHO Stomach (1 Day)||8||
59562060|NCT03466047|75663671|FG000|NOT COMPLETED|CHO Stomach (1 Day)||0||
60094275|NCT01746901|76211034|FG001|COMPLETED|Treatment Phase: Sixth Intervention||0||
60094276|NCT01746901|76211035|FG002|COMPLETED|Treatment Phase: Sixth Intervention||0||
60094277|NCT01746901|76211036|FG003|COMPLETED|Treatment Phase: Sixth Intervention||5||
60094278|NCT01746901|76211037|FG004|COMPLETED|Treatment Phase: Sixth Intervention||6||
60094279|NCT01746901|76211038|FG005|COMPLETED|Treatment Phase: Sixth Intervention||5||
60094280|NCT01746901|76211039|FG006|COMPLETED|Treatment Phase: Sixth Intervention||5||
60094281|NCT01746901|76211040|FG007|COMPLETED|Treatment Phase: Sixth Intervention||6||
59562061|NCT03466047|75663671|FG000|STARTED|CHO Small Intestine (1 Day)||8||
59562062|NCT03466047|75663671|FG000|COMPLETED|CHO Small Intestine (1 Day)||8||
59562063|NCT03466047|75663671|FG000|NOT COMPLETED|CHO Small Intestine (1 Day)||0||
59562064|NCT03466047|75663671|FG000|STARTED|Fat Stomach (1 Day)||8||
59562065|NCT03466047|75663671|FG000|COMPLETED|Fat Stomach (1 Day)||8||
59562066|NCT03466047|75663671|FG000|NOT COMPLETED|Fat Stomach (1 Day)||0||
59562067|NCT03466047|75663671|FG000|STARTED|Fat Small Intestine (1 Day)||8||
60094282|NCT01746901|76211041|FG008|COMPLETED|Treatment Phase: Sixth Intervention||5||
60094283|NCT01746901|76211033|FG000|NOT COMPLETED|Treatment Phase: Sixth Intervention||0||
60094284|NCT01746901|76211034|FG001|NOT COMPLETED|Treatment Phase: Sixth Intervention||0||
60094285|NCT01746901|76211035|FG002|NOT COMPLETED|Treatment Phase: Sixth Intervention||0||
60094286|NCT01746901|76211036|FG003|NOT COMPLETED|Treatment Phase: Sixth Intervention||0||
60094287|NCT01746901|76211037|FG004|NOT COMPLETED|Treatment Phase: Sixth Intervention||0||
59562068|NCT03466047|75663671|FG000|COMPLETED|Fat Small Intestine (1 Day)||8||
59562069|NCT03466047|75663671|FG000|NOT COMPLETED|Fat Small Intestine (1 Day)||0||
59562070|NCT03467685|75663699|FG000|STARTED|Overall Study||52||
59816960|NCT02542839|75939364|FG000|NOT COMPLETED|Overall Study||0||
60094288|NCT01746901|76211038|FG005|NOT COMPLETED|Treatment Phase: Sixth Intervention||0||
60094289|NCT01746901|76211039|FG006|NOT COMPLETED|Treatment Phase: Sixth Intervention||0||
60094290|NCT01746901|76211040|FG007|NOT COMPLETED|Treatment Phase: Sixth Intervention||0||
60094291|NCT01746901|76211041|FG008|NOT COMPLETED|Treatment Phase: Sixth Intervention||0||
60094292|NCT01968551|76211080|FG000|STARTED|Open Label Phase (48 Weeks)||22||
60094293|NCT01968551|76211081|FG001|STARTED|Open Label Phase (48 Weeks)||90||
60094294|NCT01968551|76211082|FG002|STARTED|Open Label Phase (48 Weeks)||46||
60094295|NCT01968551|76211080|FG000|COMPLETED|Open Label Phase (48 Weeks)||20||
60094296|NCT01968551|76211081|FG001|COMPLETED|Open Label Phase (48 Weeks)||87||
60094297|NCT01968551|76211082|FG002|COMPLETED|Open Label Phase (48 Weeks)||41||
60094298|NCT01968551|76211080|FG000|NOT COMPLETED|Open Label Phase (48 Weeks)||2||
60094299|NCT01968551|76211081|FG001|NOT COMPLETED|Open Label Phase (48 Weeks)||3||
60094300|NCT01968551|76211082|FG002|NOT COMPLETED|Open Label Phase (48 Weeks)||5||
60094301|NCT01968551|76211080|FG000|STARTED|Extension Phase||20||
60094302|NCT01968551|76211081|FG001|STARTED|Extension Phase||87||
60094303|NCT01968551|76211082|FG002|STARTED|Extension Phase|7 participant completed the Open-Label Phase, but did not enter in the Extension Phase|34||
60094304|NCT01968551|76211080|FG000|COMPLETED|Extension Phase||19||
59562071|NCT03467685|75663700|FG001|STARTED|Overall Study||49||
60094305|NCT01968551|76211081|FG001|COMPLETED|Extension Phase||86||
60094306|NCT01968551|76211082|FG002|COMPLETED|Extension Phase||30||
60094307|NCT01968551|76211080|FG000|NOT COMPLETED|Extension Phase||1||
60094308|NCT01968551|76211081|FG001|NOT COMPLETED|Extension Phase||1||
60094309|NCT01968551|76211082|FG002|NOT COMPLETED|Extension Phase||4||
60094310|NCT01707992|76211097|FG000|STARTED|Placebo-Controlled Phase (24 Months)||740||
60094311|NCT01707992|76211098|FG001|STARTED|Placebo-Controlled Phase (24 Months)||727||
60094312|NCT01707992|76211099|FG002|STARTED|Placebo-Controlled Phase (24 Months)||732||
60094313|NCT01707992|76211100|FG003|STARTED|Placebo-Controlled Phase (24 Months)||0||
60094314|NCT01707992|76211101|FG004|STARTED|Placebo-Controlled Phase (24 Months)||0||
60094315|NCT01707992|76211102|FG005|STARTED|Placebo-Controlled Phase (24 Months)||0||
60094316|NCT01707992|76211097|FG000|COMPLETED|Placebo-Controlled Phase (24 Months)||596||
60094317|NCT01707992|76211098|FG001|COMPLETED|Placebo-Controlled Phase (24 Months)||623||
60094318|NCT01707992|76211099|FG002|COMPLETED|Placebo-Controlled Phase (24 Months)||532||
60094319|NCT01707992|76211100|FG003|COMPLETED|Placebo-Controlled Phase (24 Months)||0||
60094320|NCT01707992|76211101|FG004|COMPLETED|Placebo-Controlled Phase (24 Months)||0||
60094321|NCT01707992|76211102|FG005|COMPLETED|Placebo-Controlled Phase (24 Months)||0||
60094322|NCT01707992|76211097|FG000|NOT COMPLETED|Placebo-Controlled Phase (24 Months)||144||
60094323|NCT01707992|76211098|FG001|NOT COMPLETED|Placebo-Controlled Phase (24 Months)||104||
60094324|NCT01707992|76211099|FG002|NOT COMPLETED|Placebo-Controlled Phase (24 Months)||200||
60094325|NCT01707992|76211100|FG003|NOT COMPLETED|Placebo-Controlled Phase (24 Months)||0||
60094326|NCT01707992|76211101|FG004|NOT COMPLETED|Placebo-Controlled Phase (24 Months)||0||
60094327|NCT01707992|76211102|FG005|NOT COMPLETED|Placebo-Controlled Phase (24 Months)||0||
60094328|NCT01707992|76211097|FG000|STARTED|Active Treatment Phase (24 Months)||0||
60094329|NCT01707992|76211098|FG001|STARTED|Active Treatment Phase (24 Months)||0||
60094330|NCT01707992|76211099|FG002|STARTED|Active Treatment Phase (24 Months)||0||
60094331|NCT01707992|76211100|FG003|STARTED|Active Treatment Phase (24 Months)||891||
60094332|NCT01707992|76211101|FG004|STARTED|Active Treatment Phase (24 Months)||504||
60094333|NCT01707992|76211102|FG005|STARTED|Active Treatment Phase (24 Months)||215||
60094334|NCT01707992|76211097|FG000|COMPLETED|Active Treatment Phase (24 Months)||0||
60094335|NCT01707992|76211098|FG001|COMPLETED|Active Treatment Phase (24 Months)||0||
60094336|NCT01707992|76211099|FG002|COMPLETED|Active Treatment Phase (24 Months)||0||
60094337|NCT01707992|76211100|FG003|COMPLETED|Active Treatment Phase (24 Months)||7||
60094338|NCT01707992|76211101|FG004|COMPLETED|Active Treatment Phase (24 Months)||10||
60094339|NCT01707992|76211102|FG005|COMPLETED|Active Treatment Phase (24 Months)||0||
59562072|NCT03467685|75663699|FG000|COMPLETED|Overall Study||52||
59562073|NCT03467685|75663700|FG001|COMPLETED|Overall Study||49||
60094340|NCT01707992|76211097|FG000|NOT COMPLETED|Active Treatment Phase (24 Months)||0||
60094341|NCT01707992|76211098|FG001|NOT COMPLETED|Active Treatment Phase (24 Months)||0||
60094342|NCT01707992|76211099|FG002|NOT COMPLETED|Active Treatment Phase (24 Months)||0||
60094343|NCT01707992|76211100|FG003|NOT COMPLETED|Active Treatment Phase (24 Months)||884||
60094344|NCT01707992|76211101|FG004|NOT COMPLETED|Active Treatment Phase (24 Months)||494||
60094345|NCT01707992|76211102|FG005|NOT COMPLETED|Active Treatment Phase (24 Months)||215||
59562074|NCT03467685|75663699|FG000|NOT COMPLETED|Overall Study||0||
59708028|NCT00980980|75826914|FG002|COMPLETED|Overall Study||13||
60094346|NCT01946165|76211119|FG000|STARTED|Overall Study||45||
60094347|NCT01946165|76211120|FG001|STARTED|Overall Study||23||
60094348|NCT01946165|76211119|FG000|COMPLETED|Overall Study||43||
60094349|NCT01946165|76211120|FG001|COMPLETED|Overall Study||21||
60094350|NCT01946165|76211119|FG000|NOT COMPLETED|Overall Study||2||
60094351|NCT01946165|76211120|FG001|NOT COMPLETED|Overall Study||2||
60094352|NCT01707667|76211129|FG000|STARTED|Period 1||7||
60094353|NCT01707667|76211130|FG001|STARTED|Period 1||6||
60094354|NCT01707667|76211129|FG000|COMPLETED|Period 1||6||
60094355|NCT01707667|76211130|FG001|COMPLETED|Period 1||6||
60094356|NCT01707667|76211129|FG000|NOT COMPLETED|Period 1||1||
60094357|NCT01707667|76211130|FG001|NOT COMPLETED|Period 1||0||
60094358|NCT01707667|76211129|FG000|STARTED|Period 2||6||
60094359|NCT01707667|76211130|FG001|STARTED|Period 2||6||
60094360|NCT01707667|76211129|FG000|COMPLETED|Period 2||6||
60094361|NCT01707667|76211130|FG001|COMPLETED|Period 2||6||
60094362|NCT01707667|76211129|FG000|NOT COMPLETED|Period 2||0||
59708029|NCT00980980|75826912|FG000|NOT COMPLETED|Overall Study||0||
59708030|NCT00980980|75826913|FG001|NOT COMPLETED|Overall Study||1||
60094363|NCT01707667|76211130|FG001|NOT COMPLETED|Period 2||0||
60094364|NCT01959503|76211138|FG000|STARTED|Overall Study||107||
59708031|NCT00980980|75826914|FG002|NOT COMPLETED|Overall Study||0||
59708032|NCT00980200|75826925|FG000|STARTED|7-day Treatment Period 1||15||
60094365|NCT01959503|76211139|FG001|STARTED|Overall Study||51||
60094366|NCT01959503|76211138|FG000|COMPLETED|Overall Study||104||
60094367|NCT01959503|76211139|FG001|COMPLETED|Overall Study||49||
60094368|NCT01959503|76211138|FG000|NOT COMPLETED|Overall Study||3||
60094369|NCT01959503|76211139|FG001|NOT COMPLETED|Overall Study||2||
60094370|NCT01605799|76211147|FG000|STARTED|Overall Study||17||
60094371|NCT01605799|76211148|FG001|STARTED|Overall Study||16||
60094372|NCT01605799|76211147|FG000|COMPLETED|Overall Study||15||
60094373|NCT01605799|76211148|FG001|COMPLETED|Overall Study||15||
60094374|NCT01605799|76211147|FG000|NOT COMPLETED|Overall Study||2||
60094375|NCT01605799|76211148|FG001|NOT COMPLETED|Overall Study||1||
60094376|NCT01706575|76211154|FG000|STARTED|Overall Study||76||
60094377|NCT01706575|76211154|FG000|Treated|Overall Study||70||
60094378|NCT01706575|76211154|FG000|COMPLETED|Overall Study||64||
60094379|NCT01706575|76211154|FG000|NOT COMPLETED|Overall Study||12||
60094380|NCT01959425|76211160|FG000|STARTED|Overall Study||32||
60094381|NCT01959425|76211161|FG001|STARTED|Overall Study||31||
60094382|NCT01959425|76211160|FG000|COMPLETED|Overall Study||20||
60094383|NCT01959425|76211161|FG001|COMPLETED|Overall Study||23||
60094384|NCT01959425|76211160|FG000|NOT COMPLETED|Overall Study||12||
60094385|NCT01959425|76211161|FG001|NOT COMPLETED|Overall Study||8||
60094386|NCT01725529|76211170|FG000|STARTED|Overall Study||152||
60094387|NCT01725529|76211171|FG001|STARTED|Overall Study||153||
60094388|NCT01725529|76211172|FG002|STARTED|Overall Study||152||
60094389|NCT01725529|76211170|FG000|COMPLETED|Overall Study||137||
60094390|NCT01725529|76211171|FG001|COMPLETED|Overall Study||137||
60094391|NCT01725529|76211172|FG002|COMPLETED|Overall Study||142||
60094392|NCT01725529|76211170|FG000|NOT COMPLETED|Overall Study||15||
60094393|NCT01725529|76211171|FG001|NOT COMPLETED|Overall Study||16||
60094394|NCT01725529|76211172|FG002|NOT COMPLETED|Overall Study||10||
60094395|NCT01605097|76211180|FG000|STARTED|Overall Study|One patient consented but was ineligible due to lack of lesion visible on mpMRI|26||
60094396|NCT01605097|76211180|FG000|COMPLETED|Overall Study||25||
60094397|NCT01605097|76211180|FG000|NOT COMPLETED|Overall Study||1||
60094398|NCT01605019|76211187|FG000|STARTED|Overall Study||4||
60094399|NCT01605019|76211188|FG001|STARTED|Overall Study||0||
60094400|NCT01605019|76211187|FG000|COMPLETED|Overall Study||1||
60094401|NCT01605019|76211188|FG001|COMPLETED|Overall Study||0||
60094402|NCT01605019|76211187|FG000|NOT COMPLETED|Overall Study||3||
60094403|NCT01605019|76211188|FG001|NOT COMPLETED|Overall Study||0||
60094404|NCT01705717|76211196|FG000|STARTED|Overall Study||37||
60094405|NCT01705717|76211197|FG001|STARTED|Overall Study||12||
60094406|NCT01705717|76211196|FG000|COMPLETED|Overall Study||35||
60094407|NCT01705717|76211197|FG001|COMPLETED|Overall Study||7||
60094408|NCT01705717|76211196|FG000|NOT COMPLETED|Overall Study||2||
60094409|NCT01705717|76211197|FG001|NOT COMPLETED|Overall Study||5||
60094410|NCT01744483|76211205|FG000|STARTED|Overall Study||44||
60094411|NCT01744483|76211206|FG001|STARTED|Overall Study||35||
60094412|NCT01744483|76211207|FG002|STARTED|Overall Study||38||
60094413|NCT01744483|76211205|FG000|COMPLETED|Overall Study||15||
60094414|NCT01744483|76211206|FG001|COMPLETED|Overall Study||13||
60094415|NCT01744483|76211207|FG002|COMPLETED|Overall Study||10||
60094416|NCT01744483|76211205|FG000|NOT COMPLETED|Overall Study||29||
60094417|NCT01744483|76211206|FG001|NOT COMPLETED|Overall Study||22||
60094418|NCT01744483|76211207|FG002|NOT COMPLETED|Overall Study||28||
60094419|NCT01744093|76211217|FG000|STARTED|Overall Study||18||
60094420|NCT01744093|76211218|FG001|STARTED|Overall Study||9||
60094421|NCT01744093|76211217|FG000|Treated|Overall Study||16||
60094422|NCT01744093|76211218|FG001|Treated|Overall Study||8||
60094423|NCT01744093|76211217|FG000|COMPLETED|Overall Study||12||
60094424|NCT01744093|76211218|FG001|COMPLETED|Overall Study||8||
60094425|NCT01744093|76211217|FG000|NOT COMPLETED|Overall Study||6||
60094426|NCT01744093|76211218|FG001|NOT COMPLETED|Overall Study||1||
60094427|NCT01725451|76211232|FG000|STARTED|Period 1||8||
60094428|NCT01725451|76211233|FG001|STARTED|Period 1||7||
60094429|NCT01725451|76211234|FG002|STARTED|Period 1||8||
60094430|NCT01725451|76211235|FG003|STARTED|Period 1||7||
60094431|NCT01725451|76211232|FG000|COMPLETED|Period 1||7||
60094432|NCT01725451|76211233|FG001|COMPLETED|Period 1||7||
60094433|NCT01725451|76211234|FG002|COMPLETED|Period 1||8||
60094434|NCT01725451|76211235|FG003|COMPLETED|Period 1||7||
60094435|NCT01725451|76211232|FG000|NOT COMPLETED|Period 1||1||
60094436|NCT01725451|76211233|FG001|NOT COMPLETED|Period 1||0||
60094437|NCT01725451|76211234|FG002|NOT COMPLETED|Period 1||0||
60094438|NCT01725451|76211235|FG003|NOT COMPLETED|Period 1||0||
60094439|NCT01725451|76211232|FG000|STARTED|Washout From Period 1||7||
60094440|NCT01725451|76211233|FG001|STARTED|Washout From Period 1||7||
60094441|NCT01725451|76211234|FG002|STARTED|Washout From Period 1||8||
60094442|NCT01725451|76211235|FG003|STARTED|Washout From Period 1||7||
60094443|NCT01725451|76211232|FG000|COMPLETED|Washout From Period 1||7||
60094444|NCT01725451|76211233|FG001|COMPLETED|Washout From Period 1||7||
60094445|NCT01725451|76211234|FG002|COMPLETED|Washout From Period 1||8||
60094446|NCT01725451|76211235|FG003|COMPLETED|Washout From Period 1||7||
60094447|NCT01725451|76211232|FG000|NOT COMPLETED|Washout From Period 1||0||
60094448|NCT01725451|76211233|FG001|NOT COMPLETED|Washout From Period 1||0||
60094449|NCT01725451|76211234|FG002|NOT COMPLETED|Washout From Period 1||0||
60094450|NCT01725451|76211235|FG003|NOT COMPLETED|Washout From Period 1||0||
60094451|NCT01725451|76211232|FG000|STARTED|Period 2||7||
60094452|NCT01725451|76211233|FG001|STARTED|Period 2||7||
60094453|NCT01725451|76211234|FG002|STARTED|Period 2||8||
60094454|NCT01725451|76211235|FG003|STARTED|Period 2||7||
60094455|NCT01725451|76211232|FG000|COMPLETED|Period 2||7||
60094456|NCT01725451|76211233|FG001|COMPLETED|Period 2||7||
60094457|NCT01725451|76211234|FG002|COMPLETED|Period 2||8||
60094458|NCT01725451|76211235|FG003|COMPLETED|Period 2||7||
60094459|NCT01725451|76211232|FG000|NOT COMPLETED|Period 2||0||
60094460|NCT01725451|76211233|FG001|NOT COMPLETED|Period 2||0||
60094461|NCT01725451|76211234|FG002|NOT COMPLETED|Period 2||0||
60094462|NCT01725451|76211235|FG003|NOT COMPLETED|Period 2||0||
60094463|NCT01725451|76211232|FG000|STARTED|Washout From Period 2||7||
60094464|NCT01725451|76211233|FG001|STARTED|Washout From Period 2||7||
60094465|NCT01725451|76211234|FG002|STARTED|Washout From Period 2||8||
60094466|NCT01725451|76211235|FG003|STARTED|Washout From Period 2||7||
60094467|NCT01725451|76211232|FG000|COMPLETED|Washout From Period 2||7||
60094468|NCT01725451|76211233|FG001|COMPLETED|Washout From Period 2||7||
60094469|NCT01725451|76211234|FG002|COMPLETED|Washout From Period 2||8||
60094470|NCT01725451|76211235|FG003|COMPLETED|Washout From Period 2||7||
60094471|NCT01725451|76211232|FG000|NOT COMPLETED|Washout From Period 2||0||
60094472|NCT01725451|76211233|FG001|NOT COMPLETED|Washout From Period 2||0||
60094473|NCT01725451|76211234|FG002|NOT COMPLETED|Washout From Period 2||0||
60094474|NCT01725451|76211235|FG003|NOT COMPLETED|Washout From Period 2||0||
60094475|NCT01725451|76211232|FG000|STARTED|Period 3||7||
60094476|NCT01725451|76211233|FG001|STARTED|Period 3||7||
60094477|NCT01725451|76211234|FG002|STARTED|Period 3||8||
60094478|NCT01725451|76211235|FG003|STARTED|Period 3||7||
60094479|NCT01725451|76211232|FG000|COMPLETED|Period 3||7||
60094480|NCT01725451|76211233|FG001|COMPLETED|Period 3||7||
60094481|NCT01725451|76211234|FG002|COMPLETED|Period 3||8||
60094482|NCT01725451|76211235|FG003|COMPLETED|Period 3||7||
60094483|NCT01725451|76211232|FG000|NOT COMPLETED|Period 3||0||
60094484|NCT01725451|76211233|FG001|NOT COMPLETED|Period 3||0||
60094485|NCT01725451|76211234|FG002|NOT COMPLETED|Period 3||0||
60094486|NCT01725451|76211235|FG003|NOT COMPLETED|Period 3||0||
60094487|NCT01725451|76211232|FG000|STARTED|Washout From Period 3||7||
60094488|NCT01725451|76211233|FG001|STARTED|Washout From Period 3||7||
60094489|NCT01725451|76211234|FG002|STARTED|Washout From Period 3||8||
60094490|NCT01725451|76211235|FG003|STARTED|Washout From Period 3||7||
60094491|NCT01725451|76211232|FG000|COMPLETED|Washout From Period 3||7||
60094492|NCT01725451|76211233|FG001|COMPLETED|Washout From Period 3||6||
60094493|NCT01725451|76211234|FG002|COMPLETED|Washout From Period 3||7||
60094494|NCT01725451|76211235|FG003|COMPLETED|Washout From Period 3||7||
60094495|NCT01725451|76211232|FG000|NOT COMPLETED|Washout From Period 3||0||
60094496|NCT01725451|76211233|FG001|NOT COMPLETED|Washout From Period 3||1||
60094497|NCT01725451|76211234|FG002|NOT COMPLETED|Washout From Period 3||1||
60094498|NCT01725451|76211235|FG003|NOT COMPLETED|Washout From Period 3||0||
60094499|NCT01725451|76211232|FG000|STARTED|Period 4||7||
60094500|NCT01725451|76211233|FG001|STARTED|Period 4||6||
60094501|NCT01725451|76211234|FG002|STARTED|Period 4||7||
60094502|NCT01725451|76211235|FG003|STARTED|Period 4||7||
60094503|NCT01725451|76211232|FG000|COMPLETED|Period 4||7||
60094504|NCT01725451|76211233|FG001|COMPLETED|Period 4||6||
60094505|NCT01725451|76211234|FG002|COMPLETED|Period 4||6||
60094506|NCT01725451|76211235|FG003|COMPLETED|Period 4||7||
60094507|NCT01725451|76211232|FG000|NOT COMPLETED|Period 4||0||
60094508|NCT01725451|76211233|FG001|NOT COMPLETED|Period 4||0||
60094509|NCT01725451|76211234|FG002|NOT COMPLETED|Period 4||1||
60094510|NCT01725451|76211235|FG003|NOT COMPLETED|Period 4||0||
60094511|NCT01725451|76211232|FG000|STARTED|Washout From Period 4||7||
60094512|NCT01725451|76211233|FG001|STARTED|Washout From Period 4||6||
60094513|NCT01725451|76211234|FG002|STARTED|Washout From Period 4||6||
60094514|NCT01725451|76211235|FG003|STARTED|Washout From Period 4||7||
60094515|NCT01725451|76211232|FG000|COMPLETED|Washout From Period 4||7||
60094516|NCT01725451|76211233|FG001|COMPLETED|Washout From Period 4||6||
60094517|NCT01725451|76211234|FG002|COMPLETED|Washout From Period 4||6||
60094518|NCT01725451|76211235|FG003|COMPLETED|Washout From Period 4||7||
60094519|NCT01725451|76211232|FG000|NOT COMPLETED|Washout From Period 4||0||
60094520|NCT01725451|76211233|FG001|NOT COMPLETED|Washout From Period 4||0||
60094521|NCT01725451|76211234|FG002|NOT COMPLETED|Washout From Period 4||0||
60094522|NCT01725451|76211235|FG003|NOT COMPLETED|Washout From Period 4||0||
60094523|NCT01725451|76211232|FG000|STARTED|Period 5||7||
60094524|NCT01725451|76211233|FG001|STARTED|Period 5||6||
60094525|NCT01725451|76211234|FG002|STARTED|Period 5||6||
60094526|NCT01725451|76211235|FG003|STARTED|Period 5||7||
60094527|NCT01725451|76211232|FG000|COMPLETED|Period 5||7||
60094528|NCT01725451|76211233|FG001|COMPLETED|Period 5||6||
60094529|NCT01725451|76211234|FG002|COMPLETED|Period 5||6||
60094530|NCT01725451|76211235|FG003|COMPLETED|Period 5||7||
60094531|NCT01725451|76211232|FG000|NOT COMPLETED|Period 5||0||
60094532|NCT01725451|76211233|FG001|NOT COMPLETED|Period 5||0||
60094533|NCT01725451|76211234|FG002|NOT COMPLETED|Period 5||0||
60094534|NCT01725451|76211235|FG003|NOT COMPLETED|Period 5||0||
60094535|NCT01725451|76211232|FG000|STARTED|Washout From Period 5||7||
60094536|NCT01725451|76211233|FG001|STARTED|Washout From Period 5||6||
60094537|NCT01725451|76211234|FG002|STARTED|Washout From Period 5||6||
60094538|NCT01725451|76211235|FG003|STARTED|Washout From Period 5||7||
60094539|NCT01725451|76211232|FG000|COMPLETED|Washout From Period 5||7||
60094540|NCT01725451|76211233|FG001|COMPLETED|Washout From Period 5||6||
60094541|NCT01725451|76211234|FG002|COMPLETED|Washout From Period 5||6||
60094542|NCT01725451|76211235|FG003|COMPLETED|Washout From Period 5||7||
60094543|NCT01725451|76211232|FG000|NOT COMPLETED|Washout From Period 5||0||
60094544|NCT01725451|76211233|FG001|NOT COMPLETED|Washout From Period 5||0||
60094545|NCT01725451|76211234|FG002|NOT COMPLETED|Washout From Period 5||0||
60094546|NCT01725451|76211235|FG003|NOT COMPLETED|Washout From Period 5||0||
60094547|NCT01725451|76211232|FG000|STARTED|Period 6||7||
60094548|NCT01725451|76211233|FG001|STARTED|Period 6||6||
60094549|NCT01725451|76211234|FG002|STARTED|Period 6||6||
60094550|NCT01725451|76211235|FG003|STARTED|Period 6||7||
60094551|NCT01725451|76211232|FG000|COMPLETED|Period 6||7||
60094552|NCT01725451|76211233|FG001|COMPLETED|Period 6||6||
60094553|NCT01725451|76211234|FG002|COMPLETED|Period 6||6||
60094554|NCT01725451|76211235|FG003|COMPLETED|Period 6||7||
59562075|NCT03467685|75663700|FG001|NOT COMPLETED|Overall Study||0||
59562076|NCT03468075|75663706|FG000|STARTED|Overall Study||10||
59562077|NCT03468075|75663706|FG000|COMPLETED|Overall Study||10||
59562078|NCT03468075|75663706|FG000|NOT COMPLETED|Overall Study||0||
59562079|NCT03250689|75663712|FG000|STARTED|Overall Study||5||
59562080|NCT03250689|75663713|FG001|STARTED|Overall Study||14||
59562081|NCT03250689|75663712|FG000|COMPLETED|Overall Study||5||
59562082|NCT03250689|75663713|FG001|COMPLETED|Overall Study||14||
59562083|NCT03250689|75663712|FG000|NOT COMPLETED|Overall Study||0||
59562084|NCT03250689|75663713|FG001|NOT COMPLETED|Overall Study||0||
59708033|NCT00980200|75826926|FG001|STARTED|7-day Treatment Period 1||14||
60094555|NCT01725451|76211232|FG000|NOT COMPLETED|Period 6||0||
60094556|NCT01725451|76211233|FG001|NOT COMPLETED|Period 6||0||
60094557|NCT01725451|76211234|FG002|NOT COMPLETED|Period 6||0||
60094558|NCT01725451|76211235|FG003|NOT COMPLETED|Period 6||0||
60094559|NCT01707290|76211252|FG000|STARTED|Overall Study||121||
60094560|NCT01707290|76211253|FG001|STARTED|Overall Study||4||
60094561|NCT01707290|76211252|FG000|COMPLETED|Overall Study||35||
60094562|NCT01707290|76211253|FG001|COMPLETED|Overall Study||3||
60094563|NCT01707290|76211252|FG000|NOT COMPLETED|Overall Study||86||
60094564|NCT01707290|76211253|FG001|NOT COMPLETED|Overall Study||1||
60094565|NCT01717040|76211264|FG000|STARTED|Overall Study||17||
60094566|NCT01717040|76211265|FG001|STARTED|Overall Study||20||
60094567|NCT01717040|76211264|FG000|COMPLETED|Overall Study||12||
60094568|NCT01717040|76211265|FG001|COMPLETED|Overall Study||15||
60094569|NCT01717040|76211264|FG000|NOT COMPLETED|Overall Study||5||
60094570|NCT01717040|76211265|FG001|NOT COMPLETED|Overall Study||5||
60094571|NCT00803062|76211275|FG000|STARTED|Overall Study||114||
60094572|NCT00803062|76211276|FG001|STARTED|Overall Study||115||
60094573|NCT00803062|76211277|FG002|STARTED|Overall Study||111||
60094574|NCT00803062|76211278|FG003|STARTED|Overall Study||112||
60094575|NCT00803062|76211275|FG000|COMPLETED|Overall Study||114||
60094576|NCT00803062|76211276|FG001|COMPLETED|Overall Study||115||
60094577|NCT00803062|76211277|FG002|COMPLETED|Overall Study||111||
60094578|NCT00803062|76211278|FG003|COMPLETED|Overall Study||112||
60094579|NCT00803062|76211275|FG000|NOT COMPLETED|Overall Study||0||
60094580|NCT00803062|76211276|FG001|NOT COMPLETED|Overall Study||0||
59562085|NCT03250845|75663720|FG000|STARTED|Multigam 5% Infusion (Baseline)||30||
59562086|NCT03250845|75663720|FG000|COMPLETED|Multigam 5% Infusion (Baseline)||30||
59708034|NCT00980200|75826927|FG002|STARTED|7-day Treatment Period 1||15||
59708035|NCT00980200|75826928|FG003|STARTED|7-day Treatment Period 1||16||
59816961|NCT02542839|75939365|FG001|NOT COMPLETED|Overall Study||0||
60094581|NCT00803062|76211277|FG002|NOT COMPLETED|Overall Study||0||
60094582|NCT00803062|76211278|FG003|NOT COMPLETED|Overall Study||0||
60094583|NCT01743469|76211292|FG000|STARTED|Active Treatment Phase||53||
60094584|NCT01743469|76211293|FG001|STARTED|Active Treatment Phase||55||
60094585|NCT01743469|76211294|FG002|STARTED|Active Treatment Phase||38||
60094586|NCT01743469|76211295|FG003|STARTED|Active Treatment Phase||21||
60094587|NCT01743469|76211292|FG000|COMPLETED|Active Treatment Phase||0||
59562087|NCT03250845|75663720|FG000|NOT COMPLETED|Multigam 5% Infusion (Baseline)||0||
59562088|NCT03250845|75663720|FG000|STARTED|Multigam 10% Infusion (3-4 Weeks Later)||30||
59562089|NCT03250845|75663720|FG000|COMPLETED|Multigam 10% Infusion (3-4 Weeks Later)||30||
60094588|NCT01743469|76211293|FG001|COMPLETED|Active Treatment Phase||0||
60094589|NCT01743469|76211294|FG002|COMPLETED|Active Treatment Phase||0||
60094590|NCT01743469|76211295|FG003|COMPLETED|Active Treatment Phase||0||
60094591|NCT01743469|76211292|FG000|NOT COMPLETED|Active Treatment Phase||53||
60094592|NCT01743469|76211293|FG001|NOT COMPLETED|Active Treatment Phase||55||
60094593|NCT01743469|76211294|FG002|NOT COMPLETED|Active Treatment Phase||38||
60094594|NCT01743469|76211295|FG003|NOT COMPLETED|Active Treatment Phase||21||
60094595|NCT01743469|76211292|FG000|STARTED|Follow-up Period - Post-Treatment||51|Entered into follow-up after last treatment with study drug|
60094596|NCT01743469|76211293|FG001|STARTED|Follow-up Period - Post-Treatment||53|Entered into follow-up after last treatment with study drug|
60094597|NCT01743469|76211294|FG002|STARTED|Follow-up Period - Post-Treatment||37|Entered into follow-up after last treatment with study drug|
60094598|NCT01743469|76211295|FG003|STARTED|Follow-up Period - Post-Treatment||21|Entered into follow-up after last treatment with study drug|
60094599|NCT01743469|76211292|FG000|COMPLETED|Follow-up Period - Post-Treatment||6||
60094600|NCT01743469|76211293|FG001|COMPLETED|Follow-up Period - Post-Treatment||5||
60094601|NCT01743469|76211294|FG002|COMPLETED|Follow-up Period - Post-Treatment||14||
60094602|NCT01743469|76211295|FG003|COMPLETED|Follow-up Period - Post-Treatment||5||
60094603|NCT01743469|76211292|FG000|NOT COMPLETED|Follow-up Period - Post-Treatment||45||
60094604|NCT01743469|76211293|FG001|NOT COMPLETED|Follow-up Period - Post-Treatment||48||
60094605|NCT01743469|76211294|FG002|NOT COMPLETED|Follow-up Period - Post-Treatment||23||
60094606|NCT01743469|76211295|FG003|NOT COMPLETED|Follow-up Period - Post-Treatment||16||
60094607|NCT01743001|76211307|FG000|STARTED|Overall Study||114||
60094608|NCT01743001|76211308|FG001|STARTED|Overall Study||112||
60094609|NCT01743001|76211307|FG000|COMPLETED|Overall Study||111||
59562090|NCT03250845|75663720|FG000|NOT COMPLETED|Multigam 10% Infusion (3-4 Weeks Later)||0||
59562091|NCT03468933|75663728|FG000|STARTED|Overall Study||16||
59562092|NCT03468933|75663729|FG001|STARTED|Overall Study||16||
59562093|NCT03468933|75663728|FG000|COMPLETED|Overall Study||16||
59562094|NCT03468933|75663729|FG001|COMPLETED|Overall Study||16||
59562095|NCT03468933|75663728|FG000|NOT COMPLETED|Overall Study||0||
59562096|NCT03468933|75663729|FG001|NOT COMPLETED|Overall Study||0||
59562097|NCT03470493|75663735|FG000|STARTED|Overall Study||130||
59562098|NCT03470493|75663735|FG000|Met Primary Endpoint|Overall Study||80||
59562099|NCT03470493|75663735|FG000|COMPLETED|Overall Study||130||
59562100|NCT03470493|75663735|FG000|NOT COMPLETED|Overall Study||0||
59562101|NCT03471975|75663741|FG000|STARTED|Overall Study||17||
59562102|NCT03471975|75663742|FG001|STARTED|Overall Study||20||
59562103|NCT03471975|75663741|FG000|COMPLETED|Overall Study||17||
59562104|NCT03471975|75663742|FG001|COMPLETED|Overall Study||20||
59562105|NCT03471975|75663741|FG000|NOT COMPLETED|Overall Study||0||
59562106|NCT03471975|75663742|FG001|NOT COMPLETED|Overall Study||0||
59562107|NCT03472287|75663750|FG000|STARTED|Overall Study||8||
59562108|NCT03472287|75663751|FG001|STARTED|Overall Study||3||
59562109|NCT03472287|75663750|FG000|COMPLETED|Overall Study||8||
59562110|NCT03472287|75663751|FG001|COMPLETED|Overall Study||3||
59562111|NCT03472287|75663750|FG000|NOT COMPLETED|Overall Study||0||
59562112|NCT03472287|75663751|FG001|NOT COMPLETED|Overall Study||0||
59562113|NCT03258645|75663757|FG000|STARTED|Overall Study||1489||
59562114|NCT03258645|75663757|FG000|COMPLETED|Overall Study||1489||
59562115|NCT03258645|75663757|FG000|NOT COMPLETED|Overall Study||0||
59562116|NCT02248766|75663767|FG000|STARTED|Overall Study||30||
59562117|NCT02248766|75663767|FG000|COMPLETED|Overall Study||30||
59562118|NCT02248766|75663767|FG000|NOT COMPLETED|Overall Study||0||
59562119|NCT03477279|75663780|FG000|STARTED|Overall Study||250||
59562120|NCT03477279|75663781|FG001|STARTED|Overall Study||250||
59562121|NCT03477279|75663782|FG002|STARTED|Overall Study||98||
59562122|NCT03477279|75663783|FG003|STARTED|Overall Study||168||
59562123|NCT03477279|75663784|FG004|STARTED|Overall Study||350||
59562124|NCT03477279|75663780|FG000|COMPLETED|Overall Study||203||
59562125|NCT03477279|75663781|FG001|COMPLETED|Overall Study||202||
59562126|NCT03477279|75663782|FG002|COMPLETED|Overall Study||98||
59562127|NCT03477279|75663783|FG003|COMPLETED|Overall Study||136||
59562128|NCT03477279|75663784|FG004|COMPLETED|Overall Study||349||
59562129|NCT03477279|75663780|FG000|NOT COMPLETED|Overall Study||47||
59562130|NCT03477279|75663781|FG001|NOT COMPLETED|Overall Study||48||
59562131|NCT03477279|75663782|FG002|NOT COMPLETED|Overall Study||0||
59562132|NCT03477279|75663783|FG003|NOT COMPLETED|Overall Study||32||
59562133|NCT03477279|75663784|FG004|NOT COMPLETED|Overall Study||1||
59562134|NCT02248922|75663799|FG000|STARTED|Overall Study||5||
59562135|NCT02248922|75663800|FG001|STARTED|Overall Study||12||
59562136|NCT02248922|75663799|FG000|COMPLETED|Overall Study||5||
59562137|NCT02248922|75663800|FG001|COMPLETED|Overall Study||12||
59562138|NCT02248922|75663799|FG000|NOT COMPLETED|Overall Study||0||
59816962|NCT02516241|75939376|FG000|STARTED|Overall Study||342||
60094610|NCT01743001|76211308|FG001|COMPLETED|Overall Study||112||
60094611|NCT01743001|76211307|FG000|NOT COMPLETED|Overall Study||3||
60094612|NCT01743001|76211308|FG001|NOT COMPLETED|Overall Study||0||
60094613|NCT00821626|76211316|FG000|STARTED|Overall Study||60||
60094614|NCT00821626|76211317|FG001|STARTED|Overall Study||33||
60094615|NCT00821626|76211316|FG000|COMPLETED|Overall Study||60||
60094616|NCT00821626|76211317|FG001|COMPLETED|Overall Study||33||
59562139|NCT02248922|75663800|FG001|NOT COMPLETED|Overall Study||0||
59562140|NCT03319173|75663807|FG000|STARTED|Overall Study||48||
59562141|NCT03319173|75663808|FG001|STARTED|Overall Study||50||
59562142|NCT03319173|75663807|FG000|COMPLETED|Overall Study||48||
59562143|NCT03319173|75663808|FG001|COMPLETED|Overall Study||50||
59562144|NCT03319173|75663807|FG000|NOT COMPLETED|Overall Study||0||
59562145|NCT03319173|75663808|FG001|NOT COMPLETED|Overall Study||0||
59562146|NCT03482583|75663821|FG000|STARTED|Overall Study||37||
59562147|NCT03482583|75663822|FG001|STARTED|Overall Study||14||
59562148|NCT03482583|75663823|FG002|STARTED|Overall Study||39||
59562149|NCT03482583|75663821|FG000|COMPLETED|Overall Study||12||
60094617|NCT00821626|76211316|FG000|NOT COMPLETED|Overall Study||0||
60094618|NCT00821626|76211317|FG001|NOT COMPLETED|Overall Study||0||
60094619|NCT01704079|76211327|FG000|STARTED|Overall Study||72||
59708036|NCT00980200|75826929|FG004|STARTED|7-day Treatment Period 1||15||
59708037|NCT00980200|75826925|FG000|COMPLETED|7-day Treatment Period 1||15||
59708038|NCT00980200|75826926|FG001|COMPLETED|7-day Treatment Period 1||13||
60094620|NCT01704079|76211328|FG001|STARTED|Overall Study||144||
60094621|NCT01704079|76211327|FG000|Entered Extension Study|Overall Study||53||
60094622|NCT01704079|76211328|FG001|Entered Extension Study|Overall Study||102||
60094623|NCT01704079|76211327|FG000|COMPLETED|Overall Study||58||
60094624|NCT01704079|76211328|FG001|COMPLETED|Overall Study||121||
60094625|NCT01704079|76211327|FG000|NOT COMPLETED|Overall Study||14||
60094626|NCT01704079|76211328|FG001|NOT COMPLETED|Overall Study||23||
60094627|NCT01703845|76211336|FG000|STARTED|Overall Study|started are actually the randomized|16||
60094628|NCT01703845|76211337|FG001|STARTED|Overall Study|started are actually the randomized|16||
60094629|NCT01703845|76211336|FG000|COMPLETED|Overall Study||13||
60094630|NCT01703845|76211337|FG001|COMPLETED|Overall Study||16||
60094631|NCT01703845|76211336|FG000|NOT COMPLETED|Overall Study||3||
60094632|NCT01703845|76211337|FG001|NOT COMPLETED|Overall Study||0||
60094633|NCT01724359|76211345|FG000|STARTED|Overall Study||95||
60094634|NCT01724359|76211345|FG000|COMPLETED|Overall Study||64||
60094635|NCT01724359|76211345|FG000|NOT COMPLETED|Overall Study||31||
60094636|NCT01703221|76211354|FG000|STARTED|Phase A (Up to 24 Weeks)||166||
60094637|NCT01703221|76211355|FG001|STARTED|Phase A (Up to 24 Weeks)||165||
60094638|NCT01703221|76211356|FG002|STARTED|Phase A (Up to 24 Weeks)||83||
60094639|NCT01703221|76211354|FG000|COMPLETED|Phase A (Up to 24 Weeks)||159||
60094640|NCT01703221|76211355|FG001|COMPLETED|Phase A (Up to 24 Weeks)||161||
60094641|NCT01703221|76211356|FG002|COMPLETED|Phase A (Up to 24 Weeks)||80||
60094642|NCT01703221|76211354|FG000|NOT COMPLETED|Phase A (Up to 24 Weeks)||7||
60094643|NCT01703221|76211355|FG001|NOT COMPLETED|Phase A (Up to 24 Weeks)||4||
60094644|NCT01703221|76211356|FG002|NOT COMPLETED|Phase A (Up to 24 Weeks)||3||
60094645|NCT01703221|76211354|FG000|STARTED|Phase B - (Week 25 to 52)||159||
60094646|NCT01703221|76211355|FG001|STARTED|Phase B - (Week 25 to 52)||161||
60094647|NCT01703221|76211356|FG002|STARTED|Phase B - (Week 25 to 52)||80||
60094648|NCT01703221|76211354|FG000|COMPLETED|Phase B - (Week 25 to 52)||143||
60094649|NCT01703221|76211355|FG001|COMPLETED|Phase B - (Week 25 to 52)||147||
60094650|NCT01703221|76211356|FG002|COMPLETED|Phase B - (Week 25 to 52)||75||
60094651|NCT01703221|76211354|FG000|NOT COMPLETED|Phase B - (Week 25 to 52)||16||
60094652|NCT01703221|76211355|FG001|NOT COMPLETED|Phase B - (Week 25 to 52)||14||
60094653|NCT01703221|76211356|FG002|NOT COMPLETED|Phase B - (Week 25 to 52)||5||
60094654|NCT01722877|76211370|FG000|STARTED|Overall Study||29||32
60094655|NCT01722877|76211370|FG000|COMPLETED|Overall Study||27||29
60094656|NCT01722877|76211370|FG000|NOT COMPLETED|Overall Study||2||3
60094657|NCT00822094|76211378|FG000|STARTED|Overall Study||81||
60094658|NCT00822094|76211379|FG001|STARTED|Overall Study||45||
60094659|NCT00822094|76211378|FG000|COMPLETED|Overall Study||37||
60094660|NCT00822094|76211379|FG001|COMPLETED|Overall Study||20||
60094661|NCT00822094|76211378|FG000|NOT COMPLETED|Overall Study||44||
60094662|NCT00822094|76211379|FG001|NOT COMPLETED|Overall Study||25||
60094663|NCT00822328|76211387|FG000|STARTED|Overall Study||12||
60094664|NCT00822328|76211388|FG001|STARTED|Overall Study||12||
60094665|NCT00822328|76211387|FG000|COMPLETED|Overall Study||12||
60094666|NCT00822328|76211388|FG001|COMPLETED|Overall Study||12||
60094667|NCT00822328|76211387|FG000|NOT COMPLETED|Overall Study||0||
60094668|NCT00822328|76211388|FG001|NOT COMPLETED|Overall Study||0||
60094669|NCT00803686|76211398|FG000|STARTED|Part 1, Period 1||6||
60094670|NCT00803686|76211399|FG001|STARTED|Part 1, Period 1||6||
60094671|NCT00803686|76211400|FG002|STARTED|Part 1, Period 1||0||
60094672|NCT00803686|76211401|FG003|STARTED|Part 1, Period 1||0||
60094673|NCT00803686|76211398|FG000|COMPLETED|Part 1, Period 1||6||
60094674|NCT00803686|76211399|FG001|COMPLETED|Part 1, Period 1||6||
60094675|NCT00803686|76211400|FG002|COMPLETED|Part 1, Period 1||0||
60094676|NCT00803686|76211401|FG003|COMPLETED|Part 1, Period 1||0||
60094677|NCT00803686|76211398|FG000|NOT COMPLETED|Part 1, Period 1||0||
60094678|NCT00803686|76211399|FG001|NOT COMPLETED|Part 1, Period 1||0||
60094679|NCT00803686|76211400|FG002|NOT COMPLETED|Part 1, Period 1||0||
60094680|NCT00803686|76211401|FG003|NOT COMPLETED|Part 1, Period 1||0||
60094681|NCT00803686|76211398|FG000|STARTED|Part 1, Period 2||6||
60094682|NCT00803686|76211399|FG001|STARTED|Part 1, Period 2||6||
60094683|NCT00803686|76211400|FG002|STARTED|Part 1, Period 2|No subjects were to be treated until after Periods 1 and 2.|0||
60094684|NCT00803686|76211401|FG003|STARTED|Part 1, Period 2|No subjects were to be treated until after Periods 1 and 2.|0||
60094685|NCT00803686|76211398|FG000|COMPLETED|Part 1, Period 2||6||
60094686|NCT00803686|76211399|FG001|COMPLETED|Part 1, Period 2||6||
60094687|NCT00803686|76211400|FG002|COMPLETED|Part 1, Period 2|No subjects treated.|0||
60094688|NCT00803686|76211401|FG003|COMPLETED|Part 1, Period 2|No subjects treated.|0||
60094689|NCT00803686|76211398|FG000|NOT COMPLETED|Part 1, Period 2||0||
60094690|NCT00803686|76211399|FG001|NOT COMPLETED|Part 1, Period 2||0||
60094691|NCT00803686|76211400|FG002|NOT COMPLETED|Part 1, Period 2||0||
60094692|NCT00803686|76211401|FG003|NOT COMPLETED|Part 1, Period 2||0||
60094693|NCT00803686|76211398|FG000|STARTED|Part 2, Period 3|No subjects were treated in this period|0||
60094694|NCT00803686|76211399|FG001|STARTED|Part 2, Period 3|No subjects were treated in this period.|0||
60094695|NCT00803686|76211400|FG002|STARTED|Part 2, Period 3|Of the 6 eligible, 1 elected not to continue into Period 3.|5||
60094696|NCT00803686|76211401|FG003|STARTED|Part 2, Period 3|Of the 6 eligible, 2 elected not to continue into Period 3.|4||
60094697|NCT00803686|76211398|FG000|COMPLETED|Part 2, Period 3|No subjects were treated in this period|0||
60094698|NCT00803686|76211399|FG001|COMPLETED|Part 2, Period 3|No subjects were treated in this period.|0||
60094699|NCT00803686|76211400|FG002|COMPLETED|Part 2, Period 3|All who started this period completed|5||
60094700|NCT00803686|76211401|FG003|COMPLETED|Part 2, Period 3|All who started this period completed|4||
60094701|NCT00803686|76211398|FG000|NOT COMPLETED|Part 2, Period 3||0||
60094702|NCT00803686|76211399|FG001|NOT COMPLETED|Part 2, Period 3||0||
60094703|NCT00803686|76211400|FG002|NOT COMPLETED|Part 2, Period 3||0||
60094704|NCT00803686|76211401|FG003|NOT COMPLETED|Part 2, Period 3||0||
60094705|NCT01703065|76211415|FG000|STARTED|Overall Study||9||
60094706|NCT01703065|76211416|FG001|STARTED|Overall Study||0||
60094707|NCT01703065|76211415|FG000|COMPLETED|Overall Study||8||
60094708|NCT01703065|76211416|FG001|COMPLETED|Overall Study||0||
60094709|NCT01703065|76211415|FG000|NOT COMPLETED|Overall Study||1||
60094710|NCT01703065|76211416|FG001|NOT COMPLETED|Overall Study||0||
60094711|NCT00823966|76211423|FG000|STARTED|Overall Study||3||
60094712|NCT00823966|76211423|FG000|COMPLETED|Overall Study||3||
60094713|NCT00823966|76211423|FG000|NOT COMPLETED|Overall Study||0||
60094714|NCT01702987|76211429|FG000|STARTED|Overall Study||10||
60094715|NCT01702987|76211430|FG001|STARTED|Overall Study||12||
60094716|NCT01702987|76211429|FG000|COMPLETED|Overall Study||9||
60094717|NCT01702987|76211430|FG001|COMPLETED|Overall Study||12||
60094718|NCT01702987|76211429|FG000|NOT COMPLETED|Overall Study||1||
60094719|NCT01702987|76211430|FG001|NOT COMPLETED|Overall Study||0||
60094720|NCT00824044|76211438|FG000|STARTED|Overall Study||23||
60094721|NCT00824044|76211439|FG001|STARTED|Overall Study||16||
60094722|NCT00824044|76211438|FG000|COMPLETED|Overall Study||14||
60094723|NCT00824044|76211439|FG001|COMPLETED|Overall Study||10||
60094724|NCT00824044|76211438|FG000|NOT COMPLETED|Overall Study||9||
60094725|NCT00824044|76211439|FG001|NOT COMPLETED|Overall Study||6||
60094726|NCT01702519|76211451|FG000|STARTED|Period 1||20||
60094727|NCT01702519|76211452|FG001|STARTED|Period 1||20||
60094728|NCT01702519|76211451|FG000|COMPLETED|Period 1||20||
60094729|NCT01702519|76211452|FG001|COMPLETED|Period 1||20||
60094730|NCT01702519|76211451|FG000|NOT COMPLETED|Period 1||0||
60094731|NCT01702519|76211452|FG001|NOT COMPLETED|Period 1||0||
59708039|NCT00980200|75826927|FG002|COMPLETED|7-day Treatment Period 1||15||
59708040|NCT00980200|75826928|FG003|COMPLETED|7-day Treatment Period 1||16||
60094732|NCT01702519|76211451|FG000|STARTED|Washout Period||20||
60094733|NCT01702519|76211452|FG001|STARTED|Washout Period||20||
60094734|NCT01702519|76211451|FG000|COMPLETED|Washout Period||19||
60094735|NCT01702519|76211452|FG001|COMPLETED|Washout Period||18||
60094736|NCT01702519|76211451|FG000|NOT COMPLETED|Washout Period||1||
60094737|NCT01702519|76211452|FG001|NOT COMPLETED|Washout Period||2||
60094738|NCT01702519|76211451|FG000|STARTED|Period 2||19||
60094739|NCT01702519|76211452|FG001|STARTED|Period 2||18||
60094740|NCT01702519|76211451|FG000|COMPLETED|Period 2||19||
60094741|NCT01702519|76211452|FG001|COMPLETED|Period 2||18||
60094742|NCT01702519|76211451|FG000|NOT COMPLETED|Period 2||0||
60094743|NCT01702519|76211452|FG001|NOT COMPLETED|Period 2||0||
60094744|NCT01739803|76211464|FG000|STARTED|Overall Study||76||
60094745|NCT01739803|76211465|FG001|STARTED|Overall Study||74||
60094746|NCT01739803|76211464|FG000|COMPLETED|Overall Study||67||
60094747|NCT01739803|76211465|FG001|COMPLETED|Overall Study||68||
60094748|NCT01739803|76211464|FG000|NOT COMPLETED|Overall Study||9||
60094749|NCT01739803|76211465|FG001|NOT COMPLETED|Overall Study||6||
59708041|NCT00980200|75826929|FG004|COMPLETED|7-day Treatment Period 1||15||
60094750|NCT00824434|76211471|FG000|STARTED|Overall Study||100||
60094751|NCT00824434|76211471|FG000|COMPLETED|Overall Study||100||
60094752|NCT00824434|76211471|FG000|NOT COMPLETED|Overall Study||0||
60094753|NCT01739335|76211477|FG000|STARTED|Overall Study||41||
60094754|NCT01739335|76211478|FG001|STARTED|Overall Study||40||
60094755|NCT01739335|76211477|FG000|COMPLETED|Overall Study||34||
60094756|NCT01739335|76211478|FG001|COMPLETED|Overall Study||35||
60094757|NCT01739335|76211477|FG000|NOT COMPLETED|Overall Study||7||
60094758|NCT01739335|76211478|FG001|NOT COMPLETED|Overall Study||5||
60094759|NCT00824512|76211490|FG000|STARTED|Overall Study||11||
59816963|NCT02516241|75939377|FG001|STARTED|Overall Study||346||
60094760|NCT00824512|76211491|FG001|STARTED|Overall Study||11||
60094761|NCT00824512|76211490|FG000|COMPLETED|Overall Study||11||
60094762|NCT00824512|76211491|FG001|COMPLETED|Overall Study||11||
60094763|NCT00824512|76211490|FG000|NOT COMPLETED|Overall Study||0||
60094764|NCT00824512|76211491|FG001|NOT COMPLETED|Overall Study||0||
60094765|NCT00824746|76211497|FG000|STARTED|Overall Study||23||
60094766|NCT00824746|76211497|FG000|COMPLETED|Overall Study||23||
60094767|NCT00824746|76211497|FG000|NOT COMPLETED|Overall Study||0||
60094768|NCT01702363|76211503|FG000|STARTED|Overall Study||131||
60094769|NCT01702363|76211503|FG000|COMPLETED|Overall Study||111||
60094770|NCT01702363|76211503|FG000|NOT COMPLETED|Overall Study||20||
60094771|NCT01722097|76211510|FG000|STARTED|Overall Study||55||
60094772|NCT01722097|76211511|FG001|STARTED|Overall Study||55||
60094773|NCT01722097|76211510|FG000|COMPLETED|Overall Study||49||
60094774|NCT01722097|76211511|FG001|COMPLETED|Overall Study||50||
60094775|NCT01722097|76211510|FG000|NOT COMPLETED|Overall Study||6||
60094776|NCT01722097|76211511|FG001|NOT COMPLETED|Overall Study||5||
60094777|NCT00824824|76211519|FG000|STARTED|Overall Study||4||
60094778|NCT00824824|76211520|FG001|STARTED|Overall Study||3||
60094779|NCT00824824|76211519|FG000|COMPLETED|Overall Study||4||
60094780|NCT00824824|76211520|FG001|COMPLETED|Overall Study||3||
60094781|NCT00824824|76211519|FG000|NOT COMPLETED|Overall Study||0||
60094782|NCT00824824|76211520|FG001|NOT COMPLETED|Overall Study||0||
60094783|NCT01701973|76211526|FG000|STARTED|Aim 1: First Intervention (1 Day)||23||
60094784|NCT01701973|76211527|FG001|STARTED|Aim 1: First Intervention (1 Day)||21||
60094785|NCT01701973|76211528|FG002|STARTED|Aim 1: First Intervention (1 Day)||0||
60094786|NCT01701973|76211529|FG003|STARTED|Aim 1: First Intervention (1 Day)||0||
60094787|NCT01701973|76211530|FG004|STARTED|Aim 1: First Intervention (1 Day)||0||
60094788|NCT01701973|76211531|FG005|STARTED|Aim 1: First Intervention (1 Day)||0||
60094789|NCT01701973|76211532|FG006|STARTED|Aim 1: First Intervention (1 Day)||0||
60094790|NCT01701973|76211533|FG007|STARTED|Aim 1: First Intervention (1 Day)||0||
60094791|NCT01701973|76211526|FG000|COMPLETED|Aim 1: First Intervention (1 Day)||23||
60094792|NCT01701973|76211527|FG001|COMPLETED|Aim 1: First Intervention (1 Day)||20||
60094793|NCT01701973|76211528|FG002|COMPLETED|Aim 1: First Intervention (1 Day)||0||
60094794|NCT01701973|76211529|FG003|COMPLETED|Aim 1: First Intervention (1 Day)||0||
60094795|NCT01701973|76211530|FG004|COMPLETED|Aim 1: First Intervention (1 Day)||0||
60094796|NCT01701973|76211531|FG005|COMPLETED|Aim 1: First Intervention (1 Day)||0||
60094797|NCT01701973|76211532|FG006|COMPLETED|Aim 1: First Intervention (1 Day)||0||
60094798|NCT01701973|76211533|FG007|COMPLETED|Aim 1: First Intervention (1 Day)||0||
60094799|NCT01701973|76211526|FG000|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0||
60094800|NCT01701973|76211527|FG001|NOT COMPLETED|Aim 1: First Intervention (1 Day)||1||
60094801|NCT01701973|76211528|FG002|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0||
60094802|NCT01701973|76211529|FG003|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0||
60094803|NCT01701973|76211530|FG004|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0||
60094804|NCT01701973|76211531|FG005|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0||
60094805|NCT01701973|76211532|FG006|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0||
60094806|NCT01701973|76211533|FG007|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0||
60094807|NCT01701973|76211526|FG000|STARTED|Aim 1: Second Intervention (1 Day)|1 subject was lost to follow-up in between Periods 1 and 2.|22||
60094808|NCT01701973|76211527|FG001|STARTED|Aim 1: Second Intervention (1 Day)|3 subjects were lost to follow-up in between Periods 1 and 2.|17||
60094809|NCT01701973|76211528|FG002|STARTED|Aim 1: Second Intervention (1 Day)||0||
60094810|NCT01701973|76211529|FG003|STARTED|Aim 1: Second Intervention (1 Day)||0||
60094811|NCT01701973|76211530|FG004|STARTED|Aim 1: Second Intervention (1 Day)||0||
60094812|NCT01701973|76211531|FG005|STARTED|Aim 1: Second Intervention (1 Day)||0||
60094813|NCT01701973|76211532|FG006|STARTED|Aim 1: Second Intervention (1 Day)||0||
60094814|NCT01701973|76211533|FG007|STARTED|Aim 1: Second Intervention (1 Day)||0||
60094815|NCT01701973|76211526|FG000|COMPLETED|Aim 1: Second Intervention (1 Day)||22||
60094816|NCT01701973|76211527|FG001|COMPLETED|Aim 1: Second Intervention (1 Day)||17||
60094817|NCT01701973|76211528|FG002|COMPLETED|Aim 1: Second Intervention (1 Day)||0||
60094818|NCT01701973|76211529|FG003|COMPLETED|Aim 1: Second Intervention (1 Day)||0||
60094819|NCT01701973|76211530|FG004|COMPLETED|Aim 1: Second Intervention (1 Day)||0||
60094820|NCT01701973|76211531|FG005|COMPLETED|Aim 1: Second Intervention (1 Day)||0||
60094821|NCT01701973|76211532|FG006|COMPLETED|Aim 1: Second Intervention (1 Day)||0||
59562150|NCT03482583|75663822|FG001|COMPLETED|Overall Study||5||
59562151|NCT03482583|75663823|FG002|COMPLETED|Overall Study||18||
59562152|NCT03482583|75663821|FG000|NOT COMPLETED|Overall Study||25||
60094822|NCT01701973|76211533|FG007|COMPLETED|Aim 1: Second Intervention (1 Day)||0||
59562153|NCT03482583|75663822|FG001|NOT COMPLETED|Overall Study||9||
59562154|NCT03482583|75663823|FG002|NOT COMPLETED|Overall Study||21||
60094823|NCT01701973|76211526|FG000|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0||
60094824|NCT01701973|76211527|FG001|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0||
60094825|NCT01701973|76211528|FG002|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0||
60094826|NCT01701973|76211529|FG003|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0||
60094827|NCT01701973|76211530|FG004|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0||
60094828|NCT01701973|76211531|FG005|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0||
60094829|NCT01701973|76211532|FG006|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0||
59562155|NCT02010203|75663837|FG000|STARTED|Overall Study||10||
59562156|NCT02010203|75663838|FG001|STARTED|Overall Study||26||
59562157|NCT02010203|75663839|FG002|STARTED|Overall Study||26||
60094830|NCT01701973|76211533|FG007|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0||
60094831|NCT01701973|76211526|FG000|STARTED|Aim 2: First Intervention (1 Day)||0||
60094832|NCT01701973|76211527|FG001|STARTED|Aim 2: First Intervention (1 Day)||0||
60094833|NCT01701973|76211528|FG002|STARTED|Aim 2: First Intervention (1 Day)||5||
60094834|NCT01701973|76211529|FG003|STARTED|Aim 2: First Intervention (1 Day)||4||
60094835|NCT01701973|76211530|FG004|STARTED|Aim 2: First Intervention (1 Day)||2||
60094836|NCT01701973|76211531|FG005|STARTED|Aim 2: First Intervention (1 Day)||3||
60094837|NCT01701973|76211532|FG006|STARTED|Aim 2: First Intervention (1 Day)||5||
60094838|NCT01701973|76211533|FG007|STARTED|Aim 2: First Intervention (1 Day)||4||
60094839|NCT01701973|76211526|FG000|COMPLETED|Aim 2: First Intervention (1 Day)||0||
60094840|NCT01701973|76211527|FG001|COMPLETED|Aim 2: First Intervention (1 Day)||0||
60094841|NCT01701973|76211528|FG002|COMPLETED|Aim 2: First Intervention (1 Day)||5||
60094842|NCT01701973|76211529|FG003|COMPLETED|Aim 2: First Intervention (1 Day)||4||
60094843|NCT01701973|76211530|FG004|COMPLETED|Aim 2: First Intervention (1 Day)||2||
60094844|NCT01701973|76211531|FG005|COMPLETED|Aim 2: First Intervention (1 Day)||3||
60094845|NCT01701973|76211532|FG006|COMPLETED|Aim 2: First Intervention (1 Day)||5||
60094846|NCT01701973|76211533|FG007|COMPLETED|Aim 2: First Intervention (1 Day)||4||
60094847|NCT01701973|76211526|FG000|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0||
60094848|NCT01701973|76211527|FG001|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0||
60094849|NCT01701973|76211528|FG002|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0||
60094850|NCT01701973|76211529|FG003|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0||
59816964|NCT02516241|75939378|FG002|STARTED|Overall Study||344||
59993370|NCT02712905|76109276|FG010|NOT COMPLETED|Monotherapy||3||
59993371|NCT02712905|76109277|FG011|NOT COMPLETED|Monotherapy||7||
59993372|NCT02712905|76109278|FG012|NOT COMPLETED|Monotherapy||0||
60094851|NCT01701973|76211530|FG004|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0||
60094852|NCT01701973|76211531|FG005|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0||
60094853|NCT01701973|76211532|FG006|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0||
60094854|NCT01701973|76211533|FG007|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0||
60094855|NCT01701973|76211526|FG000|STARTED|Aim 2: Second Intervention (1 Day)||0||
60094856|NCT01701973|76211527|FG001|STARTED|Aim 2: Second Intervention (1 Day)||0||
60094857|NCT01701973|76211528|FG002|STARTED|Aim 2: Second Intervention (1 Day)||5||
60094858|NCT01701973|76211529|FG003|STARTED|Aim 2: Second Intervention (1 Day)||4||
60094859|NCT01701973|76211530|FG004|STARTED|Aim 2: Second Intervention (1 Day)||2||
60094860|NCT01701973|76211531|FG005|STARTED|Aim 2: Second Intervention (1 Day)||3||
59993373|NCT02712905|76109279|FG013|NOT COMPLETED|Monotherapy||0||
59993374|NCT02712905|76109280|FG014|NOT COMPLETED|Monotherapy||0||
59993375|NCT02712905|76109281|FG015|NOT COMPLETED|Monotherapy||0||
59993376|NCT02712905|76109282|FG016|NOT COMPLETED|Monotherapy||0||
59993377|NCT02712905|76109283|FG017|NOT COMPLETED|Monotherapy||0||
59993378|NCT02712905|76109266|FG000|STARTED|Combination Therapy||0||
59993379|NCT02712905|76109267|FG001|STARTED|Combination Therapy||0||
59993380|NCT02712905|76109268|FG002|STARTED|Combination Therapy||0||
59993381|NCT02712905|76109269|FG003|STARTED|Combination Therapy||0||
59993382|NCT02712905|76109270|FG004|STARTED|Combination Therapy||0||
59993383|NCT02712905|76109271|FG005|STARTED|Combination Therapy||0||
59993384|NCT02712905|76109272|FG006|STARTED|Combination Therapy||0||
59993385|NCT02712905|76109273|FG007|STARTED|Combination Therapy||0||
60094861|NCT01701973|76211532|FG006|STARTED|Aim 2: Second Intervention (1 Day)||5||
60094862|NCT01701973|76211533|FG007|STARTED|Aim 2: Second Intervention (1 Day)|1 subject was lost to follow-up in between Periods 3 and 4.|3||
59993386|NCT02712905|76109274|FG008|STARTED|Combination Therapy||0||
59993387|NCT02712905|76109275|FG009|STARTED|Combination Therapy||0||
60094863|NCT01701973|76211526|FG000|COMPLETED|Aim 2: Second Intervention (1 Day)||0||
60094864|NCT01701973|76211527|FG001|COMPLETED|Aim 2: Second Intervention (1 Day)||0||
60094865|NCT01701973|76211528|FG002|COMPLETED|Aim 2: Second Intervention (1 Day)||5||
60094866|NCT01701973|76211529|FG003|COMPLETED|Aim 2: Second Intervention (1 Day)||4||
60094867|NCT01701973|76211530|FG004|COMPLETED|Aim 2: Second Intervention (1 Day)||2||
59816965|NCT02516241|75939376|FG000|Received Treatment|Overall Study||340||
59993388|NCT02712905|76109276|FG010|STARTED|Combination Therapy||0||
59993389|NCT02712905|76109277|FG011|STARTED|Combination Therapy||0||
59993390|NCT02712905|76109278|FG012|STARTED|Combination Therapy||5||
59993391|NCT02712905|76109279|FG013|STARTED|Combination Therapy||7||
59993392|NCT02712905|76109280|FG014|STARTED|Combination Therapy||1||
59993393|NCT02712905|76109281|FG015|STARTED|Combination Therapy||7||
59993394|NCT02712905|76109282|FG016|STARTED|Combination Therapy||1||
59993395|NCT02712905|76109283|FG017|STARTED|Combination Therapy||6||
59993396|NCT02712905|76109266|FG000|COMPLETED|Combination Therapy||0||
59993397|NCT02712905|76109267|FG001|COMPLETED|Combination Therapy||0||
59993398|NCT02712905|76109268|FG002|COMPLETED|Combination Therapy||0||
59993399|NCT02712905|76109269|FG003|COMPLETED|Combination Therapy||0||
59993400|NCT02712905|76109270|FG004|COMPLETED|Combination Therapy||0||
60094868|NCT01701973|76211531|FG005|COMPLETED|Aim 2: Second Intervention (1 Day)||3||
60094869|NCT01701973|76211532|FG006|COMPLETED|Aim 2: Second Intervention (1 Day)||5||
59993401|NCT02712905|76109271|FG005|COMPLETED|Combination Therapy||0||
60094870|NCT01701973|76211533|FG007|COMPLETED|Aim 2: Second Intervention (1 Day)||3||
60094871|NCT01701973|76211526|FG000|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0||
60094872|NCT01701973|76211527|FG001|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0||
60094873|NCT01701973|76211528|FG002|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0||
60094874|NCT01701973|76211529|FG003|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0||
60094875|NCT01701973|76211530|FG004|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0||
60094876|NCT01701973|76211531|FG005|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0||
60094877|NCT01701973|76211532|FG006|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0||
60094878|NCT01701973|76211533|FG007|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0||
60094879|NCT00825370|76211575|FG000|STARTED|Overall Study||175||
60094880|NCT00825370|76211576|FG001|STARTED|Overall Study||175||
60094881|NCT00825370|76211575|FG000|COMPLETED|Overall Study||175||
60094882|NCT00825370|76211576|FG001|COMPLETED|Overall Study||175||
60094883|NCT00825370|76211575|FG000|NOT COMPLETED|Overall Study||0||
60094884|NCT00825370|76211576|FG001|NOT COMPLETED|Overall Study||0||
60094885|NCT01721317|76211584|FG000|STARTED|Overall Study||2||
60094886|NCT01721317|76211585|FG001|STARTED|Overall Study||4||
60094887|NCT01721317|76211584|FG000|COMPLETED|Overall Study||0||
60094888|NCT01721317|76211585|FG001|COMPLETED|Overall Study||0||
60094889|NCT01721317|76211584|FG000|NOT COMPLETED|Overall Study||2||
60094890|NCT01721317|76211585|FG001|NOT COMPLETED|Overall Study||4||
60094891|NCT01701193|76211595|FG000|STARTED|Overall Study||18||
60094892|NCT01701193|76211596|FG001|STARTED|Overall Study||19||
60094893|NCT01701193|76211597|FG002|STARTED|Overall Study||5||
60094894|NCT01701193|76211598|FG003|STARTED|Overall Study||5||
60094895|NCT01701193|76211595|FG000|COMPLETED|Overall Study||15||
60094896|NCT01701193|76211596|FG001|COMPLETED|Overall Study||17||
60094897|NCT01701193|76211597|FG002|COMPLETED|Overall Study||4||
60094898|NCT01701193|76211598|FG003|COMPLETED|Overall Study||3||
60094899|NCT01701193|76211595|FG000|NOT COMPLETED|Overall Study||3||
60094900|NCT01701193|76211596|FG001|NOT COMPLETED|Overall Study||2||
60094901|NCT01701193|76211597|FG002|NOT COMPLETED|Overall Study||1||
60094902|NCT01701193|76211598|FG003|NOT COMPLETED|Overall Study||2||
60094903|NCT00826150|76211614|FG000|STARTED|Overall Study||8||
60094904|NCT00826150|76211615|FG001|STARTED|Overall Study||3||
60094905|NCT00826150|76211616|FG002|STARTED|Overall Study||3||
60094906|NCT00826150|76211614|FG000|COMPLETED|Overall Study||2||
59562158|NCT02010203|75663840|FG003|STARTED|Overall Study||26||
59562159|NCT02010203|75663841|FG004|STARTED|Overall Study||16||
59562160|NCT02010203|75663837|FG000|COMPLETED|Overall Study||10||
59562161|NCT02010203|75663838|FG001|COMPLETED|Overall Study||17||
59562162|NCT02010203|75663839|FG002|COMPLETED|Overall Study||16||
59562163|NCT02010203|75663840|FG003|COMPLETED|Overall Study||23||
59562164|NCT02010203|75663841|FG004|COMPLETED|Overall Study||3||
59562165|NCT02010203|75663837|FG000|NOT COMPLETED|Overall Study||0||
59562166|NCT02010203|75663838|FG001|NOT COMPLETED|Overall Study||9||
59562167|NCT02010203|75663839|FG002|NOT COMPLETED|Overall Study||10||
59562168|NCT02010203|75663840|FG003|NOT COMPLETED|Overall Study||3||
59562169|NCT02010203|75663841|FG004|NOT COMPLETED|Overall Study||13||
59562170|NCT03323307|75663853|FG000|STARTED|Overall Study||70||
60094907|NCT00826150|76211615|FG001|COMPLETED|Overall Study||1||
60094908|NCT00826150|76211616|FG002|COMPLETED|Overall Study||0||
60094909|NCT00826150|76211614|FG000|NOT COMPLETED|Overall Study||6||
60094910|NCT00826150|76211615|FG001|NOT COMPLETED|Overall Study||2||
60094911|NCT00826150|76211616|FG002|NOT COMPLETED|Overall Study||3||
60094912|NCT00827944|76211628|FG000|STARTED|Overall Study||304||
60094913|NCT00827944|76211629|FG001|STARTED|Overall Study||299||
60094914|NCT00827944|76211628|FG000|COMPLETED|Overall Study||241||
60094915|NCT00827944|76211629|FG001|COMPLETED|Overall Study||240||
60094916|NCT00827944|76211628|FG000|NOT COMPLETED|Overall Study||63||
60094917|NCT00827944|76211629|FG001|NOT COMPLETED|Overall Study||59||
60094918|NCT02153710|76211637|FG000|STARTED|Overall Study||28||
60094919|NCT02153710|76211638|FG001|STARTED|Overall Study||30||
60094920|NCT02153710|76211637|FG000|COMPLETED|Overall Study||28||
60094921|NCT02153710|76211638|FG001|COMPLETED|Overall Study||30||
60094922|NCT02153710|76211637|FG000|NOT COMPLETED|Overall Study||0||
60094923|NCT02153710|76211638|FG001|NOT COMPLETED|Overall Study||0||
60094924|NCT01959347|76211646|FG000|STARTED|Overall Study||238||
59562171|NCT03323307|75663853|FG000|COMPLETED|Overall Study||70||
60094925|NCT01959347|76211647|FG001|STARTED|Overall Study||242||
60094926|NCT01959347|76211646|FG000|COMPLETED|Overall Study||229||
60094927|NCT01959347|76211647|FG001|COMPLETED|Overall Study||235||
60094928|NCT01959347|76211646|FG000|NOT COMPLETED|Overall Study||9||
60094929|NCT01959347|76211647|FG001|NOT COMPLETED|Overall Study||7||
59562172|NCT03323307|75663853|FG000|NOT COMPLETED|Overall Study||0||
60094930|NCT00828178|76211655|FG000|STARTED|Overall Study||42||
59562173|NCT03323853|75663859|FG000|STARTED|Overall Study||213||
60094931|NCT00828178|76211656|FG001|STARTED|Overall Study|Eighty seven participants were randomized.|45||
60094932|NCT00828178|76211655|FG000|COMPLETED|Overall Study||42||
60094933|NCT00828178|76211656|FG001|COMPLETED|Overall Study|Two patients did not complete the study.|43||
60094934|NCT00828178|76211655|FG000|NOT COMPLETED|Overall Study||0||
60094935|NCT00828178|76211656|FG001|NOT COMPLETED|Overall Study||2||
60094936|NCT00828412|76211666|FG000|STARTED|Overall Study||50||
60094937|NCT00828412|76211667|FG001|STARTED|Overall Study||50||
60094938|NCT00828412|76211666|FG000|COMPLETED|Overall Study||41||
60094939|NCT00828412|76211667|FG001|COMPLETED|Overall Study||48||
60094940|NCT00828412|76211666|FG000|NOT COMPLETED|Overall Study||9||
60094941|NCT00828412|76211667|FG001|NOT COMPLETED|Overall Study||2||
60094942|NCT01959035|76211673|FG000|STARTED|Overall Study||88||
60094943|NCT01959035|76211673|FG000|COMPLETED|Overall Study||77||
60094944|NCT01959035|76211673|FG000|NOT COMPLETED|Overall Study||11||
60094945|NCT01700959|76211683|FG000|STARTED|Overall Study||89||
60094946|NCT01700959|76211684|FG001|STARTED|Overall Study||88||
60094947|NCT01700959|76211685|FG002|STARTED|Overall Study||105||
60094948|NCT01700959|76211686|FG003|STARTED|Overall Study||105||
60094949|NCT01700959|76211687|FG004|STARTED|Overall Study||96||
60094950|NCT01700959|76211688|FG005|STARTED|Overall Study||97||
60094951|NCT01700959|76211683|FG000|COMPLETED|Overall Study||62||
60094952|NCT01700959|76211684|FG001|COMPLETED|Overall Study||64||
60094953|NCT01700959|76211685|FG002|COMPLETED|Overall Study||65||
60094954|NCT01700959|76211686|FG003|COMPLETED|Overall Study||70||
60094955|NCT01700959|76211687|FG004|COMPLETED|Overall Study||69||
60094956|NCT01700959|76211688|FG005|COMPLETED|Overall Study||72||
60094957|NCT01700959|76211683|FG000|NOT COMPLETED|Overall Study||27||
60094958|NCT01700959|76211684|FG001|NOT COMPLETED|Overall Study||24||
60094959|NCT01700959|76211685|FG002|NOT COMPLETED|Overall Study||40||
60094960|NCT01700959|76211686|FG003|NOT COMPLETED|Overall Study||35||
60094961|NCT01700959|76211687|FG004|NOT COMPLETED|Overall Study||27||
60094962|NCT01700959|76211688|FG005|NOT COMPLETED|Overall Study||25||
60094963|NCT00829036|76211704|FG000|STARTED|Overall Study||24||
60094964|NCT00829036|76211704|FG000|COMPLETED|Overall Study||24||
60094965|NCT00829036|76211704|FG000|NOT COMPLETED|Overall Study||0||
60094966|NCT01738477|76211710|FG000|STARTED|Overall Study||37||
60094967|NCT01738477|76211711|FG001|STARTED|Overall Study||128||
60094968|NCT01738477|76211710|FG000|COMPLETED|Overall Study||36||
60094969|NCT01738477|76211711|FG001|COMPLETED|Overall Study||124||
60094970|NCT01738477|76211710|FG000|NOT COMPLETED|Overall Study||1||
60094971|NCT01738477|76211711|FG001|NOT COMPLETED|Overall Study||4||
60094972|NCT00829738|76211719|FG000|STARTED|Overall Study||4188||
60094973|NCT00829738|76211719|FG000|COMPLETED|Overall Study||4180||
60094974|NCT00829738|76211719|FG000|NOT COMPLETED|Overall Study||8||
60094975|NCT01737931|76211727|FG000|STARTED|Overall Study||38||
60094976|NCT01737931|76211728|FG001|STARTED|Overall Study||40||
60094977|NCT01737931|76211729|FG002|STARTED|Overall Study||39||
60094978|NCT01737931|76211727|FG000|COMPLETED|Overall Study||38||
60094979|NCT01737931|76211728|FG001|COMPLETED|Overall Study||38||
60094980|NCT01737931|76211729|FG002|COMPLETED|Overall Study||38||
60094981|NCT01737931|76211727|FG000|NOT COMPLETED|Overall Study||0||
60094982|NCT01737931|76211728|FG001|NOT COMPLETED|Overall Study||2||
60094983|NCT01737931|76211729|FG002|NOT COMPLETED|Overall Study||1||
60094984|NCT01958489|76211735|FG000|STARTED|Period 1||24||
60094985|NCT01958489|76211736|FG001|STARTED|Period 1||0||
60094986|NCT01958489|76211735|FG000|Received at Least 1 Dose of Study Drug|Period 1||24||
60094987|NCT01958489|76211736|FG001|Received at Least 1 Dose of Study Drug|Period 1||0||
60094988|NCT01958489|76211735|FG000|COMPLETED|Period 1||24||
60094989|NCT01958489|76211736|FG001|COMPLETED|Period 1||0||
60094990|NCT01958489|76211735|FG000|NOT COMPLETED|Period 1||0||
60094991|NCT01958489|76211736|FG001|NOT COMPLETED|Period 1||0||
60094992|NCT01958489|76211735|FG000|STARTED|Period 2|Participants who completed Period 1 treatment crossed over to Period 2 treatment|0||
60094993|NCT01958489|76211736|FG001|STARTED|Period 2|Participants who started Period 2 treatment crossed over from Period 1 treatment|24||
60094994|NCT01958489|76211735|FG000|Received at Least 1 Dose of Study Drug|Period 2||0||
60094995|NCT01958489|76211736|FG001|Received at Least 1 Dose of Study Drug|Period 2||24||
60094996|NCT01958489|76211735|FG000|COMPLETED|Period 2||0||
60094997|NCT01958489|76211736|FG001|COMPLETED|Period 2||23||
60094998|NCT01958489|76211735|FG000|NOT COMPLETED|Period 2||0||
60094999|NCT01958489|76211736|FG001|NOT COMPLETED|Period 2||1||
60095000|NCT01721161|76211749|FG000|STARTED|Overall Study||41||
60095001|NCT01721161|76211750|FG001|STARTED|Overall Study||41||
60095002|NCT01721161|76211749|FG000|COMPLETED|Overall Study||37||
60095003|NCT01721161|76211750|FG001|COMPLETED|Overall Study||34||
60095004|NCT01721161|76211749|FG000|NOT COMPLETED|Overall Study||4||
60095005|NCT01721161|76211750|FG001|NOT COMPLETED|Overall Study||7||
60095006|NCT01699867|76211757|FG000|STARTED|Overall Study||50||
60095007|NCT01699867|76211757|FG000|COMPLETED|Overall Study||47||
60095008|NCT01699867|76211757|FG000|NOT COMPLETED|Overall Study||3||
60095009|NCT00830284|76211761|FG000|STARTED|Overall Study|The study was started in our Medical Surgical ICU October of 2008.|12||
60095010|NCT00830284|76211761|FG000|COMPLETED|Overall Study||10||
60095011|NCT00830284|76211761|FG000|NOT COMPLETED|Overall Study||2||
60095012|NCT00830362|76211767|FG000|STARTED|Overall Study|They received Propranolol and completed Test Session (Session 1). One subject left after day 1.|27||
60095013|NCT00830362|76211768|FG001|STARTED|Overall Study|They received Propranolol and completed Test Session (Session 1). One subject left after day 1.|24||
60095014|NCT00830362|76211767|FG000|Completed Sessions 1 and 2|Overall Study|Received propranolol and completed both Test and Retrieval sessions (Session 1 and 2).|26||
60103772|NCT04102098|76222036|FG001|COMPLETED|Crossover: AS Who Crossed Over||0||
60095015|NCT00830362|76211768|FG001|Completed Sessions 1 and 2|Overall Study|Received palcebo and completed both Test and Retrieval sessions (Session 1 and 2).|24||
60095016|NCT00830362|76211767|FG000|COMPLETED|Overall Study|The enrolled subjects that completed all 3 testing sessions (were not lost to follow-up).|23||
60095017|NCT00830362|76211768|FG001|COMPLETED|Overall Study|The enrolled subjects that completed all 3 testing sessions (were not lost to follow-up).|20||
60095018|NCT00830362|76211767|FG000|NOT COMPLETED|Overall Study||4||
60095019|NCT00830362|76211768|FG001|NOT COMPLETED|Overall Study||4||
60095020|NCT01699789|76211776|FG000|STARTED|Overall Study|606 eligible clients enrolled and contacted by telephone for baseline or follow-up survey in RS arm|606||
60095021|NCT01699789|76211777|FG001|STARTED|Overall Study|640 eligible clients enrolled and contacted by telephone for baseline or follow-up survey in CEP arm|640||
60095022|NCT01699789|76211776|FG000|Baseline|Overall Study||492||
60095023|NCT01699789|76211777|FG001|Baseline|Overall Study||489||
60095024|NCT01699789|76211776|FG000|6-Month Follow-Up|Overall Study||380||
60095025|NCT01699789|76211777|FG001|6-Month Follow-Up|Overall Study||379||
60095026|NCT01699789|76211776|FG000|12-Month Follow-Up|Overall Study||364||
60095027|NCT01699789|76211777|FG001|12-Month Follow-Up|Overall Study||369||
60095028|NCT01699789|76211776|FG000|3-Year Follow-up|Overall Study||293||
60095029|NCT01699789|76211777|FG001|3-Year Follow-up|Overall Study||307||
60095030|NCT01699789|76211776|FG000|4-Year Follow-up|Overall Study||143|We attempted to contact 598 3-year participants who did not decline follow-up|
60095031|NCT01699789|76211777|FG001|4-Year Follow-up|Overall Study||140|We attempted to contact 598 3-year participants who did not decline follow-up|
60095032|NCT01699789|76211776|FG000|COMPLETED|Overall Study|Clients in 44 programs with completed at least 1 data point at baseline, 6, or 12 mo FUP analyzed|504|Analytic sample comprises 1018 individuals who completed 1 or more surveys at baseline, 6 or 12 months with item level imputation for missing data and wave-level imputation for missing surveys.|
60095033|NCT01699789|76211777|FG001|COMPLETED|Overall Study|Clients in 46 programs with completed at least 1 data point at baseline, 6, or 12 mo FUP analyzed|514|Analytic sample comprises 1018 individuals who completed 1 or more surveys at baseline, 6 or 12 months with item level imputation for missing data and wave-level imputation for missing surveys.|
60095034|NCT01699789|76211776|FG000|NOT COMPLETED|Overall Study||102||
60095035|NCT01699789|76211777|FG001|NOT COMPLETED|Overall Study||126||
60095036|NCT00830596|76211788|FG000|STARTED|Overall Study||74||
60095037|NCT00830596|76211789|FG001|STARTED|Overall Study||74||
59708042|NCT00980200|75826925|FG000|NOT COMPLETED|7-day Treatment Period 1||0||
59708043|NCT00980200|75826926|FG001|NOT COMPLETED|7-day Treatment Period 1||1||
59708044|NCT00980200|75826927|FG002|NOT COMPLETED|7-day Treatment Period 1||0||
59708045|NCT00980200|75826928|FG003|NOT COMPLETED|7-day Treatment Period 1||0||
59708046|NCT00980200|75826929|FG004|NOT COMPLETED|7-day Treatment Period 1||0||
59708047|NCT00980200|75826925|FG000|STARTED|7-day Washout Period 1||15||
59708048|NCT00980200|75826926|FG001|STARTED|7-day Washout Period 1||13||
59708049|NCT00980200|75826927|FG002|STARTED|7-day Washout Period 1||15||
60095038|NCT00830596|76211790|FG002|STARTED|Overall Study||73||
60095039|NCT00830596|76211788|FG000|COMPLETED|Overall Study||72||
60095040|NCT00830596|76211789|FG001|COMPLETED|Overall Study||72||
60095041|NCT00830596|76211790|FG002|COMPLETED|Overall Study||67||
60095042|NCT00830596|76211788|FG000|NOT COMPLETED|Overall Study||2||
60095043|NCT00830596|76211789|FG001|NOT COMPLETED|Overall Study||2||
60095044|NCT00830596|76211790|FG002|NOT COMPLETED|Overall Study||6||
60095045|NCT01944839|76211800|FG000|STARTED|Overall Study||309||
60095046|NCT01944839|76211801|FG001|STARTED|Overall Study||310||
60095047|NCT01944839|76211800|FG000|COMPLETED|Overall Study||287||
60095048|NCT01944839|76211801|FG001|COMPLETED|Overall Study||282||
60095049|NCT01944839|76211800|FG000|NOT COMPLETED|Overall Study||22||
60095050|NCT01944839|76211801|FG001|NOT COMPLETED|Overall Study||28||
60095051|NCT00805870|76211809|FG000|STARTED|Overall Study||10||
60095052|NCT00805870|76211810|FG001|STARTED|Overall Study||10||
60095053|NCT00805870|76211809|FG000|COMPLETED|Overall Study||10||
59708050|NCT00980200|75826928|FG003|STARTED|7-day Washout Period 1||16||
60095054|NCT00805870|76211810|FG001|COMPLETED|Overall Study||10||
60095055|NCT00805870|76211809|FG000|NOT COMPLETED|Overall Study||0||
60095056|NCT00805870|76211810|FG001|NOT COMPLETED|Overall Study||0||
60095057|NCT01944059|76211816|FG000|STARTED|Overall Study||31||
60095058|NCT01944059|76211816|FG000|COMPLETED|Overall Study||24||
60095059|NCT01944059|76211816|FG000|NOT COMPLETED|Overall Study||7||
60095060|NCT01720225|76211823|FG000|STARTED|Overall Study||73||
60095061|NCT01720225|76211824|FG001|STARTED|Overall Study||40||
60095062|NCT01720225|76211823|FG000|COMPLETED|Overall Study||70||
60095063|NCT01720225|76211824|FG001|COMPLETED|Overall Study||39||
60095064|NCT01720225|76211823|FG000|NOT COMPLETED|Overall Study||3||
60095065|NCT01720225|76211824|FG001|NOT COMPLETED|Overall Study||1||
60095066|NCT01943591|76211832|FG000|STARTED|Overall Study||104||
60095067|NCT01943591|76211833|FG001|STARTED|Overall Study||106||
60095068|NCT01943591|76211832|FG000|COMPLETED|Overall Study||99||
60095069|NCT01943591|76211833|FG001|COMPLETED|Overall Study||95||
60095070|NCT01943591|76211832|FG000|NOT COMPLETED|Overall Study||5||
60095071|NCT01943591|76211833|FG001|NOT COMPLETED|Overall Study||11||
60095072|NCT01699087|76211839|FG000|STARTED|Overall Study||176||
60095073|NCT01699087|76211839|FG000|Treated|Overall Study||161||
60095074|NCT01699087|76211839|FG000|COMPLETED|Overall Study||152||
60095075|NCT01699087|76211839|FG000|NOT COMPLETED|Overall Study||24||
60095076|NCT01943435|76211847|FG000|STARTED|Baseline Eligibility and Randomization||88||
60095077|NCT01943435|76211848|FG001|STARTED|Baseline Eligibility and Randomization||84||
60095078|NCT01943435|76211849|FG002|STARTED|Baseline Eligibility and Randomization||87||
60095079|NCT01943435|76211847|FG000|COMPLETED|Baseline Eligibility and Randomization||84||
60095080|NCT01943435|76211848|FG001|COMPLETED|Baseline Eligibility and Randomization||72||
60095081|NCT01943435|76211849|FG002|COMPLETED|Baseline Eligibility and Randomization||84||
60095082|NCT01943435|76211847|FG000|NOT COMPLETED|Baseline Eligibility and Randomization||4||
60095083|NCT01943435|76211848|FG001|NOT COMPLETED|Baseline Eligibility and Randomization||12||
60095084|NCT01943435|76211849|FG002|NOT COMPLETED|Baseline Eligibility and Randomization||3||
60095085|NCT01943435|76211847|FG000|STARTED|Intervention Period||84||
60095086|NCT01943435|76211848|FG001|STARTED|Intervention Period||72||
60095087|NCT01943435|76211849|FG002|STARTED|Intervention Period||84||
60095088|NCT01943435|76211847|FG000|COMPLETED|Intervention Period||81||
60095089|NCT01943435|76211848|FG001|COMPLETED|Intervention Period||69||
60095090|NCT01943435|76211849|FG002|COMPLETED|Intervention Period||80||
60095091|NCT01943435|76211847|FG000|NOT COMPLETED|Intervention Period||3||
60095092|NCT01943435|76211848|FG001|NOT COMPLETED|Intervention Period||3||
60095093|NCT01943435|76211849|FG002|NOT COMPLETED|Intervention Period||4||
60095094|NCT01943435|76211847|FG000|STARTED|2 Month Follow up||81||
60095095|NCT01943435|76211848|FG001|STARTED|2 Month Follow up||69||
60095096|NCT01943435|76211849|FG002|STARTED|2 Month Follow up||80||
60095097|NCT01943435|76211847|FG000|COMPLETED|2 Month Follow up||79||
60095098|NCT01943435|76211848|FG001|COMPLETED|2 Month Follow up||66||
60095099|NCT01943435|76211849|FG002|COMPLETED|2 Month Follow up||80||
60095100|NCT01943435|76211847|FG000|NOT COMPLETED|2 Month Follow up||2||
60095101|NCT01943435|76211848|FG001|NOT COMPLETED|2 Month Follow up||3||
60095102|NCT01943435|76211849|FG002|NOT COMPLETED|2 Month Follow up||0||
59562174|NCT03323853|75663860|FG001|STARTED|Overall Study||238||
59562175|NCT03323853|75663859|FG000|COMPLETED|Overall Study||213||
59562176|NCT03323853|75663860|FG001|COMPLETED|Overall Study||238||
59562177|NCT03323853|75663859|FG000|NOT COMPLETED|Overall Study||0||
59562178|NCT03323853|75663860|FG001|NOT COMPLETED|Overall Study||0||
59562179|NCT03460587|75663866|FG000|STARTED|Overall Study||13||
59816966|NCT02516241|75939377|FG001|Received Treatment|Overall Study||345||
60095103|NCT01943435|76211847|FG000|STARTED|6 Month Follow up||79||
60095104|NCT01943435|76211848|FG001|STARTED|6 Month Follow up||66||
60095105|NCT01943435|76211849|FG002|STARTED|6 Month Follow up||80||
60095106|NCT01943435|76211847|FG000|COMPLETED|6 Month Follow up||67||
60095107|NCT01943435|76211848|FG001|COMPLETED|6 Month Follow up||59||
60095108|NCT01943435|76211849|FG002|COMPLETED|6 Month Follow up||65||
59562180|NCT03460587|75663866|FG000|COMPLETED|Overall Study||13||
60095109|NCT01943435|76211847|FG000|NOT COMPLETED|6 Month Follow up||12||
60095110|NCT01943435|76211848|FG001|NOT COMPLETED|6 Month Follow up||7||
60095111|NCT01943435|76211849|FG002|NOT COMPLETED|6 Month Follow up||15||
60095112|NCT00805948|76211859|FG000|STARTED|Overall Study||154||
60095113|NCT00805948|76211860|FG001|STARTED|Overall Study||195||
59562181|NCT03460587|75663866|FG000|NOT COMPLETED|Overall Study||0||
59562182|NCT03260595|75663873|FG000|STARTED|Overall Study||20||
59562183|NCT03260595|75663874|FG001|STARTED|Overall Study||10||
59562184|NCT03260595|75663875|FG002|STARTED|Overall Study||2||
60095114|NCT00805948|76211859|FG000|COMPLETED|Overall Study||86||
60095115|NCT00805948|76211860|FG001|COMPLETED|Overall Study||99||
60095116|NCT00805948|76211859|FG000|NOT COMPLETED|Overall Study||68||
60095117|NCT00805948|76211860|FG001|NOT COMPLETED|Overall Study||96||
60095118|NCT01942733|76211867|FG000|STARTED|Overall Study||44||
60095119|NCT01942733|76211867|FG000|COMPLETED|Overall Study||41||
60095120|NCT01942733|76211867|FG000|NOT COMPLETED|Overall Study||3||
60095121|NCT00807586|76211873|FG000|STARTED|Overall Study||60||
60095122|NCT00807586|76211874|FG001|STARTED|Overall Study||59||
60095123|NCT00807586|76211873|FG000|COMPLETED|Overall Study||54||
60095124|NCT00807586|76211874|FG001|COMPLETED|Overall Study||58||
60095125|NCT00807586|76211873|FG000|NOT COMPLETED|Overall Study||6||
60095126|NCT00807586|76211874|FG001|NOT COMPLETED|Overall Study||1||
60095127|NCT01957865|76211883|FG000|STARTED|Overall Study||21||
60095128|NCT01957865|76211884|FG001|STARTED|Overall Study||20||
60095129|NCT01957865|76211885|FG002|STARTED|Overall Study||22||
60095130|NCT01957865|76211883|FG000|COMPLETED|Overall Study||21||
60095131|NCT01957865|76211884|FG001|COMPLETED|Overall Study||18||
60095132|NCT01957865|76211885|FG002|COMPLETED|Overall Study||19||
60095133|NCT01957865|76211883|FG000|NOT COMPLETED|Overall Study||0||
60095134|NCT01957865|76211884|FG001|NOT COMPLETED|Overall Study||2||
60095135|NCT01957865|76211885|FG002|NOT COMPLETED|Overall Study||3||
60095136|NCT01957787|76211894|FG000|STARTED|Overall Study|Participant who was withdrawn prior to study treatment was not included in Number of Index Tumors.|131||226
60095137|NCT01957787|76211894|FG000|Intent-to-Treat (ITT) Population|Overall Study||130|Participants for whom cryoablation via Galil Medical Cryoablation System was attempted or performed.|226
60095138|NCT01957787|76211894|FG000|Modified ITT (mITT) Population|Overall Study||128|Participants in the ITT population and met all study entry criteria.|224
60095139|NCT01957787|76211894|FG000|COMPLETED|Overall Study||95||170
60095140|NCT01957787|76211894|FG000|NOT COMPLETED|Overall Study||36||56
60095141|NCT01698775|76211900|FG000|STARTED|Phase A||107||
60095142|NCT01698775|76211901|FG001|STARTED|Phase A||106||
60095143|NCT01698775|76211900|FG000|COMPLETED|Phase A||98||
60095144|NCT01698775|76211901|FG001|COMPLETED|Phase A||97||
60095145|NCT01698775|76211900|FG000|NOT COMPLETED|Phase A||9||
60095146|NCT01698775|76211901|FG001|NOT COMPLETED|Phase A||9||
59562185|NCT03260595|75663873|FG000|COMPLETED|Overall Study||20||
59562186|NCT03260595|75663874|FG001|COMPLETED|Overall Study||10||
59562187|NCT03260595|75663875|FG002|COMPLETED|Overall Study||2||
59562188|NCT03260595|75663873|FG000|NOT COMPLETED|Overall Study||0||
59562189|NCT03260595|75663874|FG001|NOT COMPLETED|Overall Study||0||
59562190|NCT03260595|75663875|FG002|NOT COMPLETED|Overall Study||0||
59562191|NCT03261999|75663883|FG000|STARTED|Overall Study||144||
59562192|NCT03261999|75663883|FG000|ITT|Overall Study||144||
59562193|NCT03261999|75663883|FG000|PP|Overall Study||132||
59993402|NCT02712905|76109272|FG006|COMPLETED|Combination Therapy||0||
59993403|NCT02712905|76109273|FG007|COMPLETED|Combination Therapy||0||
59993404|NCT02712905|76109274|FG008|COMPLETED|Combination Therapy||0||
60095147|NCT01698775|76211900|FG000|STARTED|Phase B||98||
60095148|NCT01698775|76211901|FG001|STARTED|Phase B||97||
60095149|NCT01698775|76211900|FG000|COMPLETED|Phase B||84||
60095150|NCT01698775|76211901|FG001|COMPLETED|Phase B||86||
60095151|NCT01698775|76211900|FG000|NOT COMPLETED|Phase B||14||
60095152|NCT01698775|76211901|FG001|NOT COMPLETED|Phase B||11||
60095153|NCT01941095|76211911|FG000|STARTED|Overall Study||97||
60095154|NCT01941095|76211911|FG000|COMPLETED|Overall Study||41||
60095155|NCT01941095|76211911|FG000|NOT COMPLETED|Overall Study||56||
60095156|NCT00831766|76211918|FG000|STARTED|Overall Study||23||
60095157|NCT00831766|76211919|FG001|STARTED|Overall Study||28||
59562194|NCT03261999|75663883|FG000|COMPLETED|Overall Study||129||
59562195|NCT03261999|75663883|FG000|NOT COMPLETED|Overall Study||15||
59562196|NCT03482973|75663889|FG000|STARTED|Overall Study||40||
59562197|NCT03482973|75663890|FG001|STARTED|Overall Study||40||
59562198|NCT03482973|75663889|FG000|COMPLETED|Overall Study||40||
59562199|NCT03482973|75663890|FG001|COMPLETED|Overall Study||40||
59993405|NCT02712905|76109275|FG009|COMPLETED|Combination Therapy||0||
59993406|NCT02712905|76109276|FG010|COMPLETED|Combination Therapy||0||
59993407|NCT02712905|76109277|FG011|COMPLETED|Combination Therapy||0||
59993408|NCT02712905|76109278|FG012|COMPLETED|Combination Therapy||0||
59993409|NCT02712905|76109279|FG013|COMPLETED|Combination Therapy||0||
60095158|NCT00831766|76211918|FG000|COMPLETED|Overall Study||23||
60095159|NCT00831766|76211919|FG001|COMPLETED|Overall Study||28||
59562200|NCT03482973|75663889|FG000|NOT COMPLETED|Overall Study||0||
59993410|NCT02712905|76109280|FG014|COMPLETED|Combination Therapy||0||
59993411|NCT02712905|76109281|FG015|COMPLETED|Combination Therapy||0||
59993412|NCT02712905|76109282|FG016|COMPLETED|Combination Therapy||0||
59993413|NCT02712905|76109283|FG017|COMPLETED|Combination Therapy||0||
60095160|NCT00831766|76211918|FG000|NOT COMPLETED|Overall Study||0||
60095161|NCT00831766|76211919|FG001|NOT COMPLETED|Overall Study||0||
60095162|NCT01957709|76211926|FG000|STARTED|Overall Study||8||
60095163|NCT01957709|76211926|FG000|COMPLETED|Overall Study||7||
60095164|NCT01957709|76211926|FG000|NOT COMPLETED|Overall Study||1||
60095165|NCT00832390|76211933|FG000|STARTED|Overall Study||12||
60095166|NCT00832390|76211934|FG001|STARTED|Overall Study||16||
60095167|NCT00832390|76211935|FG002|STARTED|Overall Study||1||
60095168|NCT00832390|76211933|FG000|COMPLETED|Overall Study||12||
60095169|NCT00832390|76211934|FG001|COMPLETED|Overall Study||16||
60095170|NCT00832390|76211935|FG002|COMPLETED|Overall Study||1||
60095171|NCT00832390|76211933|FG000|NOT COMPLETED|Overall Study||0||
60095172|NCT00832390|76211934|FG001|NOT COMPLETED|Overall Study||0||
60095173|NCT00832390|76211935|FG002|NOT COMPLETED|Overall Study||0||
60095174|NCT01957553|76211943|FG000|STARTED|Test Period 1 (21 +- 1 Days)||61||
60095175|NCT01957553|76211944|FG001|STARTED|Test Period 1 (21 +- 1 Days)||66||
60095176|NCT01957553|76211943|FG000|COMPLETED|Test Period 1 (21 +- 1 Days)||54||
60095177|NCT01957553|76211944|FG001|COMPLETED|Test Period 1 (21 +- 1 Days)||63||
60095178|NCT01957553|76211943|FG000|NOT COMPLETED|Test Period 1 (21 +- 1 Days)||7||
60095179|NCT01957553|76211944|FG001|NOT COMPLETED|Test Period 1 (21 +- 1 Days)||3||
60095180|NCT01957553|76211943|FG000|STARTED|Test Period 2 (21 +- 1 Days)||54||
60095181|NCT01957553|76211944|FG001|STARTED|Test Period 2 (21 +- 1 Days)||63||
60095182|NCT01957553|76211943|FG000|COMPLETED|Test Period 2 (21 +- 1 Days)||51||
60095183|NCT01957553|76211944|FG001|COMPLETED|Test Period 2 (21 +- 1 Days)||56||
60095184|NCT01957553|76211943|FG000|NOT COMPLETED|Test Period 2 (21 +- 1 Days)||3||
60095185|NCT01957553|76211944|FG001|NOT COMPLETED|Test Period 2 (21 +- 1 Days)||7||
60095186|NCT00807664|76211952|FG000|STARTED|Overall Study||88||
60095187|NCT00807664|76211953|FG001|STARTED|Overall Study||94||
60095188|NCT00807664|76211952|FG000|COMPLETED|Overall Study||77||
60095189|NCT00807664|76211953|FG001|COMPLETED|Overall Study||75||
60095190|NCT00807664|76211952|FG000|NOT COMPLETED|Overall Study||11||
60095191|NCT00807664|76211953|FG001|NOT COMPLETED|Overall Study||19||
60095192|NCT00843622|76211962|FG000|STARTED|Overall Study||125||
59562201|NCT03482973|75663890|FG001|NOT COMPLETED|Overall Study||0||
59562202|NCT02302157|75663901|FG000|STARTED|Overall Study||3||
59562203|NCT02302157|75663902|FG001|STARTED|Overall Study||6||
59562204|NCT02302157|75663903|FG002|STARTED|Overall Study||6||
59562205|NCT02302157|75663904|FG003|STARTED|Overall Study||6||
59562206|NCT02302157|75663905|FG004|STARTED|Overall Study||4||
59562207|NCT02302157|75663901|FG000|COMPLETED|Overall Study||3||
59562208|NCT02302157|75663902|FG001|COMPLETED|Overall Study||6||
59562209|NCT02302157|75663903|FG002|COMPLETED|Overall Study||6||
59562210|NCT02302157|75663904|FG003|COMPLETED|Overall Study||6||
59562211|NCT02302157|75663905|FG004|COMPLETED|Overall Study||4||
59562212|NCT02302157|75663901|FG000|NOT COMPLETED|Overall Study||0||
59562213|NCT02302157|75663902|FG001|NOT COMPLETED|Overall Study||0||
59562214|NCT02302157|75663903|FG002|NOT COMPLETED|Overall Study||0||
59562215|NCT02302157|75663904|FG003|NOT COMPLETED|Overall Study||0||
59562216|NCT02302157|75663905|FG004|NOT COMPLETED|Overall Study||0||
59562217|NCT01602380|75663924|FG000|STARTED|Overall Study||230||
59708051|NCT00980200|75826929|FG004|STARTED|7-day Washout Period 1||15||
59708052|NCT00980200|75826925|FG000|COMPLETED|7-day Washout Period 1||15||
59708053|NCT00980200|75826926|FG001|COMPLETED|7-day Washout Period 1||13||
59993414|NCT02712905|76109266|FG000|NOT COMPLETED|Combination Therapy||0||
59993415|NCT02712905|76109267|FG001|NOT COMPLETED|Combination Therapy||0||
59993416|NCT02712905|76109268|FG002|NOT COMPLETED|Combination Therapy||0||
59993417|NCT02712905|76109269|FG003|NOT COMPLETED|Combination Therapy||0||
59993418|NCT02712905|76109270|FG004|NOT COMPLETED|Combination Therapy||0||
60095193|NCT00843622|76211963|FG001|STARTED|Overall Study||125||
60095194|NCT00843622|76211962|FG000|COMPLETED|Overall Study||82||
60095195|NCT00843622|76211963|FG001|COMPLETED|Overall Study||70||
60095196|NCT00843622|76211962|FG000|NOT COMPLETED|Overall Study||43||
60095197|NCT00843622|76211963|FG001|NOT COMPLETED|Overall Study||55||
60095198|NCT01957475|76211969|FG000|STARTED|Test Period 1||10||
60095199|NCT01957475|76211970|FG001|STARTED|Test Period 1||10||
60095200|NCT01957475|76211969|FG000|COMPLETED|Test Period 1||8||
60095201|NCT01957475|76211970|FG001|COMPLETED|Test Period 1||9||
59562218|NCT01602380|75663925|FG001|STARTED|Overall Study||232||
59562219|NCT01602380|75663924|FG000|COMPLETED|Overall Study|Completed: number of patients ongoing in the study at data cut-off for the primary analysis|137||
59708054|NCT00980200|75826927|FG002|COMPLETED|7-day Washout Period 1||15||
59993419|NCT02712905|76109271|FG005|NOT COMPLETED|Combination Therapy||0||
59993420|NCT02712905|76109272|FG006|NOT COMPLETED|Combination Therapy||0||
59993421|NCT02712905|76109273|FG007|NOT COMPLETED|Combination Therapy||0||
59993422|NCT02712905|76109274|FG008|NOT COMPLETED|Combination Therapy||0||
59993423|NCT02712905|76109275|FG009|NOT COMPLETED|Combination Therapy||0||
59993424|NCT02712905|76109276|FG010|NOT COMPLETED|Combination Therapy||0||
59993425|NCT02712905|76109277|FG011|NOT COMPLETED|Combination Therapy||0||
59993426|NCT02712905|76109278|FG012|NOT COMPLETED|Combination Therapy||5||
60095202|NCT01957475|76211969|FG000|NOT COMPLETED|Test Period 1||2||
60095203|NCT01957475|76211970|FG001|NOT COMPLETED|Test Period 1||1||
60095204|NCT01957475|76211969|FG000|STARTED|Test Period 2||9||
60095205|NCT01957475|76211970|FG001|STARTED|Test Period 2||8||
60095206|NCT01957475|76211969|FG000|COMPLETED|Test Period 2||8||
60095207|NCT01957475|76211970|FG001|COMPLETED|Test Period 2||8||
60095208|NCT01957475|76211969|FG000|NOT COMPLETED|Test Period 2||1||
60095209|NCT01957475|76211970|FG001|NOT COMPLETED|Test Period 2||0||
60095210|NCT01940939|76211978|FG000|STARTED|Overall Study||35||
60095211|NCT01940939|76211979|FG001|STARTED|Overall Study||35||
60095212|NCT01940939|76211978|FG000|COMPLETED|Overall Study||33||
60095213|NCT01940939|76211979|FG001|COMPLETED|Overall Study||27||
60095214|NCT01940939|76211978|FG000|NOT COMPLETED|Overall Study||2||
60095215|NCT01940939|76211979|FG001|NOT COMPLETED|Overall Study||8||
60095216|NCT01957397|76211985|FG000|STARTED|Baseline Own Product||13||
60095217|NCT01957397|76211986|FG001|STARTED|Baseline Own Product||13||
60095218|NCT01957397|76211985|FG000|COMPLETED|Baseline Own Product||13||
60095219|NCT01957397|76211986|FG001|COMPLETED|Baseline Own Product||13||
60095220|NCT01957397|76211985|FG000|NOT COMPLETED|Baseline Own Product||0||
60095221|NCT01957397|76211986|FG001|NOT COMPLETED|Baseline Own Product||0||
60095222|NCT01957397|76211985|FG000|STARTED|Test Period 1||13||
60095223|NCT01957397|76211986|FG001|STARTED|Test Period 1||13||
60095224|NCT01957397|76211985|FG000|COMPLETED|Test Period 1||11||
60095225|NCT01957397|76211986|FG001|COMPLETED|Test Period 1||12||
60095226|NCT01957397|76211985|FG000|NOT COMPLETED|Test Period 1||2||
60095227|NCT01957397|76211986|FG001|NOT COMPLETED|Test Period 1||1||
60095228|NCT01957397|76211985|FG000|STARTED|Test Period 2||11||
60095229|NCT01957397|76211986|FG001|STARTED|Test Period 2||12||
60095230|NCT01957397|76211985|FG000|COMPLETED|Test Period 2||11||
60095231|NCT01957397|76211986|FG001|COMPLETED|Test Period 2||11||
60095232|NCT01957397|76211985|FG000|NOT COMPLETED|Test Period 2||0||
60095233|NCT01957397|76211986|FG001|NOT COMPLETED|Test Period 2||1||
60095234|NCT01957397|76211985|FG000|STARTED|Test Period 3||11||
60095235|NCT01957397|76211986|FG001|STARTED|Test Period 3||11||
60095236|NCT01957397|76211985|FG000|COMPLETED|Test Period 3||9||
60095237|NCT01957397|76211986|FG001|COMPLETED|Test Period 3||9||
60095238|NCT01957397|76211985|FG000|NOT COMPLETED|Test Period 3||2||
60095239|NCT01957397|76211986|FG001|NOT COMPLETED|Test Period 3||2||
60095240|NCT01940705|76212000|FG000|STARTED|Overall Study||66||
60095241|NCT01940705|76212001|FG001|STARTED|Overall Study||67||
60095242|NCT01940705|76212002|FG002|STARTED|Overall Study||69||
60095243|NCT01940705|76212003|FG003|STARTED|Overall Study||67||
60095244|NCT01940705|76212000|FG000|COMPLETED|Overall Study||62||
60095245|NCT01940705|76212001|FG001|COMPLETED|Overall Study||59||
60095246|NCT01940705|76212002|FG002|COMPLETED|Overall Study||61||
60095247|NCT01940705|76212003|FG003|COMPLETED|Overall Study||63||
60095248|NCT01940705|76212000|FG000|NOT COMPLETED|Overall Study||4||
60095249|NCT01940705|76212001|FG001|NOT COMPLETED|Overall Study||8||
60095250|NCT01940705|76212002|FG002|NOT COMPLETED|Overall Study||8||
60095251|NCT01940705|76212003|FG003|NOT COMPLETED|Overall Study||4||
60095252|NCT00834106|76212018|FG000|STARTED|Base Study (Day 1 to Month 30)|Randomized participants|1503||
60095253|NCT00834106|76212019|FG001|STARTED|Base Study (Day 1 to Month 30)|Randomized participants|1503||
60095254|NCT00834106|76212018|FG000|Vaccinated|Base Study (Day 1 to Month 30)||1503||
60095255|NCT00834106|76212019|FG001|Vaccinated|Base Study (Day 1 to Month 30)||1503||
60095256|NCT00834106|76212018|FG000|Completed Vaccinations|Base Study (Day 1 to Month 30)||1473||
60095257|NCT00834106|76212019|FG001|Completed Vaccinations|Base Study (Day 1 to Month 30)||1463||
60095258|NCT00834106|76212018|FG000|COMPLETED|Base Study (Day 1 to Month 30)|Completed Month 30 follow-up|1401||
60095259|NCT00834106|76212019|FG001|COMPLETED|Base Study (Day 1 to Month 30)|Completed Month 30 follow-up|1358||
60095260|NCT00834106|76212018|FG000|NOT COMPLETED|Base Study (Day 1 to Month 30)||102||
60095261|NCT00834106|76212019|FG001|NOT COMPLETED|Base Study (Day 1 to Month 30)||145||
60095262|NCT00834106|76212018|FG000|STARTED|Extension Study (Month 42 to Month 90)|Some participants missed the Month 30 visit but returned for the Month 42 visit|1404||
60095263|NCT00834106|76212019|FG001|STARTED|Extension Study (Month 42 to Month 90)|Some participants missed the Month 30 visit but returned for the Month 42 visit|1368||
60095264|NCT00834106|76212018|FG000|COMPLETED|Extension Study (Month 42 to Month 90)||1308||
60095265|NCT00834106|76212019|FG001|COMPLETED|Extension Study (Month 42 to Month 90)||1294||
60095266|NCT00834106|76212018|FG000|NOT COMPLETED|Extension Study (Month 42 to Month 90)||96||
60095267|NCT00834106|76212019|FG001|NOT COMPLETED|Extension Study (Month 42 to Month 90)||74||
60095268|NCT01957163|76212028|FG000|STARTED|Overall Study||206||
60095269|NCT01957163|76212029|FG001|STARTED|Overall Study||206||
60095270|NCT01957163|76212030|FG002|STARTED|Overall Study||207||
60095271|NCT01957163|76212028|FG000|COMPLETED|Overall Study||191||
60095272|NCT01957163|76212029|FG001|COMPLETED|Overall Study||195||
59562220|NCT01602380|75663925|FG001|COMPLETED|Overall Study|Completed: number of patients ongoing in the study at data cut-off for the primary analysis|131||
59562221|NCT01602380|75663924|FG000|NOT COMPLETED|Overall Study||93||
59562222|NCT01602380|75663925|FG001|NOT COMPLETED|Overall Study||101||
59562223|NCT02010359|75663933|FG000|STARTED|Overall Study||15||
60095273|NCT01957163|76212030|FG002|COMPLETED|Overall Study||189||
60095274|NCT01957163|76212028|FG000|NOT COMPLETED|Overall Study||15||
59708055|NCT00980200|75826928|FG003|COMPLETED|7-day Washout Period 1||16||
59708056|NCT00980200|75826929|FG004|COMPLETED|7-day Washout Period 1||15||
60095275|NCT01957163|76212029|FG001|NOT COMPLETED|Overall Study||11||
60095276|NCT01957163|76212030|FG002|NOT COMPLETED|Overall Study||18||
60095277|NCT00844090|76212040|FG000|STARTED|Overall Study||52||
60095278|NCT00844090|76212041|FG001|STARTED|Overall Study||54||
60095279|NCT00844090|76212040|FG000|COMPLETED|Overall Study||46||
59562224|NCT02010359|75663934|FG001|STARTED|Overall Study||14||
60095280|NCT00844090|76212041|FG001|COMPLETED|Overall Study||46||
60095281|NCT00844090|76212040|FG000|NOT COMPLETED|Overall Study||6||
60095282|NCT00844090|76212041|FG001|NOT COMPLETED|Overall Study||8||
60095283|NCT00844714|76212047|FG000|STARTED|Overall Study||20||
60095284|NCT00844714|76212047|FG000|COMPLETED|Overall Study||20||
59562225|NCT02010359|75663933|FG000|COMPLETED|Overall Study||13||
59562226|NCT02010359|75663934|FG001|COMPLETED|Overall Study||12||
59562227|NCT02010359|75663933|FG000|NOT COMPLETED|Overall Study||2||
59562228|NCT02010359|75663934|FG001|NOT COMPLETED|Overall Study||2||
59562229|NCT01976819|75663940|FG000|STARTED|Overall Study||16||
59562230|NCT01976819|75663940|FG000|COMPLETED|Overall Study||11||
60095285|NCT00844714|76212047|FG000|NOT COMPLETED|Overall Study||0||
60095286|NCT00834652|76212053|FG000|STARTED|Overall Study||104||
60095287|NCT00834652|76212054|FG001|STARTED|Overall Study||102||
59562231|NCT01976819|75663940|FG000|NOT COMPLETED|Overall Study||5||
59562232|NCT01976975|75663951|FG000|STARTED|Overall Study||226||
59562233|NCT01976975|75663952|FG001|STARTED|Overall Study||44||
59562234|NCT01976975|75663951|FG000|COMPLETED|Overall Study||79||
59562235|NCT01976975|75663952|FG001|COMPLETED|Overall Study||32||
60095288|NCT00834652|76212053|FG000|COMPLETED|Overall Study||66||
60095289|NCT00834652|76212054|FG001|COMPLETED|Overall Study||62||
60095290|NCT00834652|76212053|FG000|NOT COMPLETED|Overall Study||38||
60095291|NCT00834652|76212054|FG001|NOT COMPLETED|Overall Study||40||
60095292|NCT00834808|76212063|FG000|STARTED|Treatment Period 1 (Day 1)||9||
60095293|NCT00834808|76212064|FG001|STARTED|Treatment Period 1 (Day 1)||9||
60095294|NCT00834808|76212065|FG002|STARTED|Treatment Period 1 (Day 1)||9||
60095295|NCT00834808|76212063|FG000|COMPLETED|Treatment Period 1 (Day 1)||9||
60095296|NCT00834808|76212064|FG001|COMPLETED|Treatment Period 1 (Day 1)||9||
60095297|NCT00834808|76212065|FG002|COMPLETED|Treatment Period 1 (Day 1)||9||
60095298|NCT00834808|76212063|FG000|NOT COMPLETED|Treatment Period 1 (Day 1)||0||
60095299|NCT00834808|76212064|FG001|NOT COMPLETED|Treatment Period 1 (Day 1)||0||
60095300|NCT00834808|76212065|FG002|NOT COMPLETED|Treatment Period 1 (Day 1)||0||
60095301|NCT00834808|76212063|FG000|STARTED|Treatment Period 2 (Day 8)||9||
60095302|NCT00834808|76212064|FG001|STARTED|Treatment Period 2 (Day 8)||9||
60095303|NCT00834808|76212065|FG002|STARTED|Treatment Period 2 (Day 8)||9||
60095304|NCT00834808|76212063|FG000|COMPLETED|Treatment Period 2 (Day 8)||9||
60095305|NCT00834808|76212064|FG001|COMPLETED|Treatment Period 2 (Day 8)||9||
60095306|NCT00834808|76212065|FG002|COMPLETED|Treatment Period 2 (Day 8)||9||
60095307|NCT00834808|76212063|FG000|NOT COMPLETED|Treatment Period 2 (Day 8)||0||
60095308|NCT00834808|76212064|FG001|NOT COMPLETED|Treatment Period 2 (Day 8)||0||
60095309|NCT00834808|76212065|FG002|NOT COMPLETED|Treatment Period 2 (Day 8)||0||
60095310|NCT00834808|76212063|FG000|STARTED|Treatment Period 3 (Day 15)||9||
60095311|NCT00834808|76212064|FG001|STARTED|Treatment Period 3 (Day 15)||9||
60095312|NCT00834808|76212065|FG002|STARTED|Treatment Period 3 (Day 15)||9||
60095313|NCT00834808|76212063|FG000|COMPLETED|Treatment Period 3 (Day 15)||9||
60095314|NCT00834808|76212064|FG001|COMPLETED|Treatment Period 3 (Day 15)||9||
59562236|NCT01976975|75663951|FG000|NOT COMPLETED|Overall Study||147||
59562237|NCT01976975|75663952|FG001|NOT COMPLETED|Overall Study||12||
60095315|NCT00834808|76212065|FG002|COMPLETED|Treatment Period 3 (Day 15)||9||
60095316|NCT00834808|76212063|FG000|NOT COMPLETED|Treatment Period 3 (Day 15)||0||
60095317|NCT00834808|76212064|FG001|NOT COMPLETED|Treatment Period 3 (Day 15)||0||
60095318|NCT00834808|76212065|FG002|NOT COMPLETED|Treatment Period 3 (Day 15)||0||
60095319|NCT00850096|76212075|FG000|STARTED|Overall Study||47||
60095320|NCT00850096|76212076|FG001|STARTED|Overall Study||47||
60095321|NCT00850096|76212075|FG000|COMPLETED|Overall Study||44||
60095322|NCT00850096|76212076|FG001|COMPLETED|Overall Study||45||
60095323|NCT00850096|76212075|FG000|NOT COMPLETED|Overall Study||3||
60095324|NCT00850096|76212076|FG001|NOT COMPLETED|Overall Study||2||
60095325|NCT01939223|76212084|FG000|STARTED|Overall Study||14||
60095326|NCT01939223|76212085|FG001|STARTED|Overall Study||11||
60095327|NCT01939223|76212084|FG000|Participants Received Treatment|Overall Study||14||
59562238|NCT03483675|75663960|FG000|STARTED|Overall Study||9||
59562239|NCT03483675|75663961|FG001|STARTED|Overall Study||8||
60095328|NCT01939223|76212085|FG001|Participants Received Treatment|Overall Study||11||
60095329|NCT01939223|76212084|FG000|COMPLETED|Overall Study||1||
60095330|NCT01939223|76212085|FG001|COMPLETED|Overall Study||0||
60095331|NCT01939223|76212084|FG000|NOT COMPLETED|Overall Study||13||
60095332|NCT01939223|76212085|FG001|NOT COMPLETED|Overall Study||11||
60095333|NCT00834886|76212095|FG000|STARTED|Overall Study||10||
60095334|NCT00834886|76212096|FG001|STARTED|Overall Study||10||
60095335|NCT00834886|76212097|FG002|STARTED|Overall Study||10||
60095336|NCT00834886|76212098|FG003|STARTED|Overall Study||10||
60095337|NCT00834886|76212095|FG000|COMPLETED|Overall Study||10||
60095338|NCT00834886|76212096|FG001|COMPLETED|Overall Study||9||
60095339|NCT00834886|76212097|FG002|COMPLETED|Overall Study||9||
60095340|NCT00834886|76212098|FG003|COMPLETED|Overall Study||10||
60095341|NCT00834886|76212095|FG000|NOT COMPLETED|Overall Study||0||
60095342|NCT00834886|76212096|FG001|NOT COMPLETED|Overall Study||1||
60095343|NCT00834886|76212097|FG002|NOT COMPLETED|Overall Study||1||
60095344|NCT00834886|76212098|FG003|NOT COMPLETED|Overall Study||0||
60095345|NCT00835198|76212110|FG000|STARTED|Overall Study||82||
60095346|NCT00835198|76212111|FG001|STARTED|Overall Study||81||
60095347|NCT00835198|76212110|FG000|COMPLETED|Overall Study||74||
60095348|NCT00835198|76212111|FG001|COMPLETED|Overall Study||74||
60095349|NCT00835198|76212110|FG000|NOT COMPLETED|Overall Study||8||
60095350|NCT00835198|76212111|FG001|NOT COMPLETED|Overall Study||7||
60095351|NCT00835510|76212120|FG000|STARTED|Overall Study||219||
60095352|NCT00835510|76212121|FG001|STARTED|Overall Study||221||
60095353|NCT00835510|76212122|FG002|STARTED|Overall Study||108||
60095354|NCT00835510|76212120|FG000|Positive Fungal Culture|Overall Study||149||
60095355|NCT00835510|76212121|FG001|Positive Fungal Culture|Overall Study||155||
60095356|NCT00835510|76212122|FG002|Positive Fungal Culture|Overall Study||71||
60095357|NCT00835510|76212120|FG000|COMPLETED|Overall Study||143||
60095358|NCT00835510|76212121|FG001|COMPLETED|Overall Study||152||
60095359|NCT00835510|76212122|FG002|COMPLETED|Overall Study||70||
60095360|NCT00835510|76212120|FG000|NOT COMPLETED|Overall Study||76||
60095361|NCT00835510|76212121|FG001|NOT COMPLETED|Overall Study||69||
60095362|NCT00835510|76212122|FG002|NOT COMPLETED|Overall Study||38||
60095363|NCT01954745|76212130|FG000|STARTED|Overall Study||19||
60095364|NCT01954745|76212130|FG000|COMPLETED|Overall Study||0||
60095365|NCT01954745|76212130|FG000|NOT COMPLETED|Overall Study||19||
60095366|NCT00835900|76212136|FG000|STARTED|Overall Study||32||
60095367|NCT00835900|76212137|FG001|STARTED|Overall Study||28||
60095368|NCT00835900|76212136|FG000|COMPLETED|Overall Study||27||
60095369|NCT00835900|76212137|FG001|COMPLETED|Overall Study||22||
60095370|NCT00835900|76212136|FG000|NOT COMPLETED|Overall Study||5||
60095371|NCT00835900|76212137|FG001|NOT COMPLETED|Overall Study||6||
60095372|NCT01954121|76212145|FG000|STARTED|Overall Study||220||
60095373|NCT01954121|76212146|FG001|STARTED|Overall Study||216||
60095374|NCT01954121|76212145|FG000|COMPLETED|Overall Study||93||
60095375|NCT01954121|76212146|FG001|COMPLETED|Overall Study||125||
60095376|NCT01954121|76212145|FG000|NOT COMPLETED|Overall Study||127||
60095377|NCT01954121|76212146|FG001|NOT COMPLETED|Overall Study||91||
60095378|NCT00850642|76212154|FG000|STARTED|Overall Study||3||
59562240|NCT03483675|75663960|FG000|COMPLETED|Overall Study||9||
59562241|NCT03483675|75663961|FG001|COMPLETED|Overall Study||8||
59562242|NCT03483675|75663960|FG000|NOT COMPLETED|Overall Study||0||
59562243|NCT03483675|75663961|FG001|NOT COMPLETED|Overall Study||0||
59562244|NCT02057081|75663970|FG000|STARTED|Overall Study||136|Includes both veteran and partner participants|
59562245|NCT02057081|75663971|FG001|STARTED|Overall Study||112|Includes both veteran and partner participants|
59562246|NCT02057081|75663970|FG000|Completed Baseline|Overall Study||88|Veterans and partners who were consented, randomized, completed baseline and deemed eligible|
59562247|NCT02057081|75663971|FG001|Completed Baseline|Overall Study||80|Veterans and partners who were consented, randomized, completed baseline and deemed eligible|
59562248|NCT02057081|75663970|FG000|Post-Treatment Assessment|Overall Study||58|Includes both veteran and partner participants|
59565964|NCT02303574|75668414|FG009|NOT COMPLETED|Part 1a (Fasted State)- SAD||0||
60095379|NCT00850642|76212155|FG001|STARTED|Overall Study||4||
60095380|NCT00850642|76212154|FG000|COMPLETED|Overall Study||3||
60095381|NCT00850642|76212155|FG001|COMPLETED|Overall Study||4||
60095382|NCT00850642|76212154|FG000|NOT COMPLETED|Overall Study||0||
60095383|NCT00850642|76212155|FG001|NOT COMPLETED|Overall Study||0||
60095384|NCT00836758|76212166|FG000|STARTED|Overall Study||115||148
60095385|NCT00836758|76212166|FG000|COMPLETED|Overall Study||115||148
60095386|NCT00836758|76212166|FG000|NOT COMPLETED|Overall Study||0||0
60095387|NCT00852592|76212174|FG000|STARTED|Overall Study||23||
60095388|NCT00852592|76212175|FG001|STARTED|Overall Study||23||
60095389|NCT00852592|76212174|FG000|COMPLETED|Overall Study||20||
60095390|NCT00852592|76212175|FG001|COMPLETED|Overall Study||19||
60095391|NCT00852592|76212174|FG000|NOT COMPLETED|Overall Study||3||
60095392|NCT00852592|76212175|FG001|NOT COMPLETED|Overall Study||4||
60095393|NCT01952015|76212181|FG000|STARTED|Induction||12||
60095394|NCT01952015|76212181|FG000|COMPLETED|Induction||11||
60095395|NCT01952015|76212181|FG000|NOT COMPLETED|Induction||1||
60095396|NCT01952015|76212181|FG000|STARTED|Maintenance||11||
60095397|NCT01952015|76212181|FG000|COMPLETED|Maintenance||9||
60095398|NCT01952015|76212181|FG000|NOT COMPLETED|Maintenance||2||
60095399|NCT01952015|76212181|FG000|STARTED|Treatment Period 3||9||
60095400|NCT01952015|76212181|FG000|COMPLETED|Treatment Period 3||0||
60095401|NCT01952015|76212181|FG000|NOT COMPLETED|Treatment Period 3||9||
59562249|NCT02057081|75663971|FG001|Post-Treatment Assessment|Overall Study||52|Includes both veteran and partner participants|
59562250|NCT02057081|75663970|FG000|COMPLETED|Overall Study||46|Includes both veteran and partner participants|
59562251|NCT02057081|75663971|FG001|COMPLETED|Overall Study||44|Includes both veteran and partner participants|
59562252|NCT02057081|75663970|FG000|NOT COMPLETED|Overall Study||90||
59562253|NCT02057081|75663971|FG001|NOT COMPLETED|Overall Study||68||
59562254|NCT01977599|75663979|FG000|STARTED|Overall Study||1118||
60095402|NCT00838006|76212200|FG000|STARTED|Overall Study||102||
60095403|NCT00838006|76212201|FG001|STARTED|Overall Study||98||
60095404|NCT00838006|76212202|FG002|STARTED|Overall Study||142||
59562255|NCT01977599|75663980|FG001|STARTED|Overall Study||1122||
59562256|NCT01977599|75663979|FG000|COMPLETED|Overall Study||1118||
59562257|NCT01977599|75663980|FG001|COMPLETED|Overall Study||1122||
59562258|NCT01977599|75663979|FG000|NOT COMPLETED|Overall Study||0||
59562259|NCT01977599|75663980|FG001|NOT COMPLETED|Overall Study||0||
59562260|NCT03493815|75663988|FG000|STARTED|Overall Study||42||
59562261|NCT03493815|75663989|FG001|STARTED|Overall Study||43||
59562262|NCT03493815|75663988|FG000|COMPLETED|Overall Study||33||
59562263|NCT03493815|75663989|FG001|COMPLETED|Overall Study||32||
59562264|NCT03493815|75663988|FG000|NOT COMPLETED|Overall Study||9||
59562265|NCT03493815|75663989|FG001|NOT COMPLETED|Overall Study||11||
59562266|NCT01979159|75663995|FG000|STARTED|Overall Study||4||
59562267|NCT01979159|75663995|FG000|COMPLETED|Overall Study||4||
59562268|NCT01979159|75663995|FG000|NOT COMPLETED|Overall Study||0||
59562269|NCT03273543|75664003|FG000|STARTED|Overall Study||10||
59562270|NCT03273543|75664004|FG001|STARTED|Overall Study||10||
59562271|NCT03273543|75664003|FG000|COMPLETED|Overall Study||10||
59562272|NCT03273543|75664004|FG001|COMPLETED|Overall Study||10||
59562273|NCT03273543|75664003|FG000|NOT COMPLETED|Overall Study||0||
59562274|NCT03273543|75664004|FG001|NOT COMPLETED|Overall Study||0||
59562275|NCT03326895|75664010|FG000|STARTED|Overall Study||168|168|
59562276|NCT03326895|75664010|FG000|COMPLETED|Overall Study||168|168|
60095405|NCT00838006|76212200|FG000|3-month Post-deployment Follow-up|Overall Study||92||
60095406|NCT00838006|76212201|FG001|3-month Post-deployment Follow-up|Overall Study||80||
60095407|NCT00838006|76212202|FG002|3-month Post-deployment Follow-up|Overall Study||135||
60095408|NCT00838006|76212200|FG000|COMPLETED|Overall Study||68||
60095409|NCT00838006|76212201|FG001|COMPLETED|Overall Study||72||
60095410|NCT00838006|76212202|FG002|COMPLETED|Overall Study||94||
60095411|NCT00838006|76212200|FG000|NOT COMPLETED|Overall Study||34||
60095412|NCT00838006|76212201|FG001|NOT COMPLETED|Overall Study||26||
60095413|NCT00838006|76212202|FG002|NOT COMPLETED|Overall Study||48||
60095414|NCT01951703|76212214|FG000|STARTED|First Intervention||64||
60095415|NCT01951703|76212215|FG001|STARTED|First Intervention||63||
60095416|NCT01951703|76212214|FG000|COMPLETED|First Intervention||61||
60095417|NCT01951703|76212215|FG001|COMPLETED|First Intervention||62||
60095418|NCT01951703|76212214|FG000|NOT COMPLETED|First Intervention||3||
60095419|NCT01951703|76212215|FG001|NOT COMPLETED|First Intervention||1||
60095420|NCT01951703|76212214|FG000|STARTED|Second Intervention||61||
60095421|NCT01951703|76212215|FG001|STARTED|Second Intervention||62||
60095422|NCT01951703|76212214|FG000|COMPLETED|Second Intervention||61||
60095423|NCT01951703|76212215|FG001|COMPLETED|Second Intervention||60||
59708057|NCT00980200|75826925|FG000|NOT COMPLETED|7-day Washout Period 1||0||
59562277|NCT03326895|75664010|FG000|NOT COMPLETED|Overall Study||0||
59562278|NCT03327051|75664016|FG000|STARTED|Overall Study||19||
59562279|NCT03327051|75664017|FG001|STARTED|Overall Study||20||
59562280|NCT03327051|75664016|FG000|Received Treatment|Overall Study||16||
60095424|NCT01951703|76212214|FG000|NOT COMPLETED|Second Intervention||0||
60095425|NCT01951703|76212215|FG001|NOT COMPLETED|Second Intervention||2||
60095426|NCT00838162|76212226|FG000|STARTED|Overall Study||9||
60095427|NCT00838162|76212227|FG001|STARTED|Overall Study||8||
60095428|NCT00838162|76212228|FG002|STARTED|Overall Study||8||
60095429|NCT00838162|76212229|FG003|STARTED|Overall Study||8||
60095430|NCT00838162|76212226|FG000|COMPLETED|Overall Study||9||
60095431|NCT00838162|76212227|FG001|COMPLETED|Overall Study||8||
60095432|NCT00838162|76212228|FG002|COMPLETED|Overall Study||8||
60095433|NCT00838162|76212229|FG003|COMPLETED|Overall Study||8||
60095434|NCT00838162|76212226|FG000|NOT COMPLETED|Overall Study||0||
60095435|NCT00838162|76212227|FG001|NOT COMPLETED|Overall Study||0||
60095436|NCT00838162|76212228|FG002|NOT COMPLETED|Overall Study||0||
60095437|NCT00838162|76212229|FG003|NOT COMPLETED|Overall Study||0||
60095438|NCT01937351|76212241|FG000|STARTED|Overall Study||134|Intention-to-Treat|
60095439|NCT01937351|76212242|FG001|STARTED|Overall Study||28|Intention-to-Treat|
60095440|NCT01937351|76212241|FG000|Treated w Study Device|Overall Study||130|Per Protocol|
60095441|NCT01937351|76212242|FG001|Treated w Study Device|Overall Study||28|Per Protocol|
60095442|NCT01937351|76212241|FG000|30-Day Follow-up|Overall Study||128||
60095443|NCT01937351|76212242|FG001|30-Day Follow-up|Overall Study||27||
60095444|NCT01937351|76212241|FG000|6-Month Follow-up|Overall Study||125||
60095445|NCT01937351|76212242|FG001|6-Month Follow-up|Overall Study||26||
60095446|NCT01937351|76212241|FG000|COMPLETED|Overall Study||125||
60095447|NCT01937351|76212242|FG001|COMPLETED|Overall Study||26||
60095448|NCT01937351|76212241|FG000|NOT COMPLETED|Overall Study||9||
60095449|NCT01937351|76212242|FG001|NOT COMPLETED|Overall Study||2||
60095450|NCT00853606|76212247|FG000|STARTED|Overall Study||712||
60095451|NCT00853606|76212247|FG000|COMPLETED|Overall Study||492||
60095452|NCT00853606|76212247|FG000|NOT COMPLETED|Overall Study||220||
60095453|NCT00841204|76212253|FG000|STARTED|Overall Study||25||
60095454|NCT00841204|76212254|FG001|STARTED|Overall Study||25||
60095455|NCT00841204|76212253|FG000|COMPLETED|Overall Study||25||
60095456|NCT00841204|76212254|FG001|COMPLETED|Overall Study||25||
60095457|NCT00841204|76212253|FG000|NOT COMPLETED|Overall Study||0||
60095458|NCT00841204|76212254|FG001|NOT COMPLETED|Overall Study||0||
60095459|NCT00853840|76212262|FG000|STARTED|Period 1||9||
60095460|NCT00853840|76212263|FG001|STARTED|Period 1||9||
60095461|NCT00853840|76212262|FG000|Maraviroc (Days 1 - 4)|Period 1||9||
60095462|NCT00853840|76212263|FG001|Maraviroc (Days 1 - 4)|Period 1||9||
60095463|NCT00853840|76212262|FG000|Vardenafil or Placebo (Day 4)|Period 1|Administered 1 hour post Maraviroc dosing|9||
60095464|NCT00853840|76212263|FG001|Vardenafil or Placebo (Day 4)|Period 1|Administered 1 hour post Maraviroc dosing|9||
60095465|NCT00853840|76212262|FG000|COMPLETED|Period 1||9||
60095466|NCT00853840|76212263|FG001|COMPLETED|Period 1||9||
60095467|NCT00853840|76212262|FG000|NOT COMPLETED|Period 1||0||
60095468|NCT00853840|76212263|FG001|NOT COMPLETED|Period 1||0||
60095469|NCT00853840|76212262|FG000|STARTED|Period 2||9||
60095470|NCT00853840|76212263|FG001|STARTED|Period 2||9||
60095471|NCT00853840|76212262|FG000|Maraviroc (Days 1 - 3)|Period 2||9||
60095472|NCT00853840|76212263|FG001|Maraviroc (Days 1 - 3)|Period 2||9||
60095473|NCT00853840|76212262|FG000|Vardenafil or Placebo (Day 3)|Period 2|Administered 1 hour post Maraviroc dosing|9||
60095474|NCT00853840|76212263|FG001|Vardenafil or Placebo (Day 3)|Period 2|Administered 1 hour post Maraviroc dosing|9||
60095475|NCT00853840|76212262|FG000|COMPLETED|Period 2||9||
60095476|NCT00853840|76212263|FG001|COMPLETED|Period 2||9||
60095477|NCT00853840|76212262|FG000|NOT COMPLETED|Period 2||0||
60095478|NCT00853840|76212263|FG001|NOT COMPLETED|Period 2||0||
60095479|NCT01737697|76212275|FG000|STARTED|Acute Phase-Initial 48 Hours||158||
60095480|NCT01737697|76212276|FG001|STARTED|Acute Phase-Initial 48 Hours||154||
60095481|NCT01737697|76212277|FG002|STARTED|Acute Phase-Initial 48 Hours||141||
60095482|NCT01737697|76212278|FG003|STARTED|Acute Phase-Initial 48 Hours||158||
60095483|NCT01737697|76212279|FG004|STARTED|Acute Phase-Initial 48 Hours||143||
60095484|NCT01737697|76212280|FG005|STARTED|Acute Phase-Initial 48 Hours||0||
60095485|NCT01737697|76212281|FG006|STARTED|Acute Phase-Initial 48 Hours||0||
60095486|NCT01737697|76212282|FG007|STARTED|Acute Phase-Initial 48 Hours||0||
60095487|NCT01737697|76212283|FG008|STARTED|Acute Phase-Initial 48 Hours||0||
60095488|NCT01737697|76212284|FG009|STARTED|Acute Phase-Initial 48 Hours||0||
60095489|NCT01737697|76212285|FG010|STARTED|Acute Phase-Initial 48 Hours||0||
60095490|NCT01737697|76212286|FG011|STARTED|Acute Phase-Initial 48 Hours||0||
60095491|NCT01737697|76212287|FG012|STARTED|Acute Phase-Initial 48 Hours||0||
60095492|NCT01737697|76212288|FG013|STARTED|Acute Phase-Initial 48 Hours||0||
60095493|NCT01737697|76212289|FG014|STARTED|Acute Phase-Initial 48 Hours||0||
60095494|NCT01737697|76212275|FG000|COMPLETED|Acute Phase-Initial 48 Hours||157||
60095495|NCT01737697|76212276|FG001|COMPLETED|Acute Phase-Initial 48 Hours||150||
60095496|NCT01737697|76212277|FG002|COMPLETED|Acute Phase-Initial 48 Hours||137||
60095497|NCT01737697|76212278|FG003|COMPLETED|Acute Phase-Initial 48 Hours||152||
60095498|NCT01737697|76212279|FG004|COMPLETED|Acute Phase-Initial 48 Hours||140||
60095499|NCT01737697|76212280|FG005|COMPLETED|Acute Phase-Initial 48 Hours||0||
60095500|NCT01737697|76212281|FG006|COMPLETED|Acute Phase-Initial 48 Hours||0||
60095501|NCT01737697|76212282|FG007|COMPLETED|Acute Phase-Initial 48 Hours||0||
60095502|NCT01737697|76212283|FG008|COMPLETED|Acute Phase-Initial 48 Hours||0||
60095503|NCT01737697|76212284|FG009|COMPLETED|Acute Phase-Initial 48 Hours||0||
60095504|NCT01737697|76212285|FG010|COMPLETED|Acute Phase-Initial 48 Hours||0||
60095505|NCT01737697|76212286|FG011|COMPLETED|Acute Phase-Initial 48 Hours||0||
60095506|NCT01737697|76212287|FG012|COMPLETED|Acute Phase-Initial 48 Hours||0||
60095507|NCT01737697|76212288|FG013|COMPLETED|Acute Phase-Initial 48 Hours||0||
60095508|NCT01737697|76212289|FG014|COMPLETED|Acute Phase-Initial 48 Hours||0||
59562281|NCT03327051|75664017|FG001|Received Treatment|Overall Study||16||
59562282|NCT03327051|75664016|FG000|Attended Visit 2 (Week 0)|Overall Study||15||
60095509|NCT01737697|76212275|FG000|NOT COMPLETED|Acute Phase-Initial 48 Hours||1||
60095510|NCT01737697|76212276|FG001|NOT COMPLETED|Acute Phase-Initial 48 Hours||4||
60095511|NCT01737697|76212277|FG002|NOT COMPLETED|Acute Phase-Initial 48 Hours||4||
60095512|NCT01737697|76212278|FG003|NOT COMPLETED|Acute Phase-Initial 48 Hours||6||
60095513|NCT01737697|76212279|FG004|NOT COMPLETED|Acute Phase-Initial 48 Hours||3||
60095514|NCT01737697|76212280|FG005|NOT COMPLETED|Acute Phase-Initial 48 Hours||0||
60095515|NCT01737697|76212281|FG006|NOT COMPLETED|Acute Phase-Initial 48 Hours||0||
60095516|NCT01737697|76212282|FG007|NOT COMPLETED|Acute Phase-Initial 48 Hours||0||
60095517|NCT01737697|76212283|FG008|NOT COMPLETED|Acute Phase-Initial 48 Hours||0||
60095518|NCT01737697|76212284|FG009|NOT COMPLETED|Acute Phase-Initial 48 Hours||0||
60095519|NCT01737697|76212285|FG010|NOT COMPLETED|Acute Phase-Initial 48 Hours||0||
60095520|NCT01737697|76212286|FG011|NOT COMPLETED|Acute Phase-Initial 48 Hours||0||
60095521|NCT01737697|76212287|FG012|NOT COMPLETED|Acute Phase-Initial 48 Hours||0||
60095522|NCT01737697|76212288|FG013|NOT COMPLETED|Acute Phase-Initial 48 Hours||0||
60095523|NCT01737697|76212289|FG014|NOT COMPLETED|Acute Phase-Initial 48 Hours||0||
60095524|NCT01737697|76212275|FG000|STARTED|Subacute Phase||0||
60095525|NCT01737697|76212276|FG001|STARTED|Subacute Phase||0||
60095526|NCT01737697|76212277|FG002|STARTED|Subacute Phase||0||
60095527|NCT01737697|76212278|FG003|STARTED|Subacute Phase||0||
60095528|NCT01737697|76212279|FG004|STARTED|Subacute Phase||0||
60095529|NCT01737697|76212280|FG005|STARTED|Subacute Phase||41||
60095530|NCT01737697|76212281|FG006|STARTED|Subacute Phase||49||
60095531|NCT01737697|76212282|FG007|STARTED|Subacute Phase||46||
60095532|NCT01737697|76212283|FG008|STARTED|Subacute Phase||54||
60095533|NCT01737697|76212284|FG009|STARTED|Subacute Phase||68||
60095534|NCT01737697|76212285|FG010|STARTED|Subacute Phase||65||
60095535|NCT01737697|76212286|FG011|STARTED|Subacute Phase||61||
60095536|NCT01737697|76212287|FG012|STARTED|Subacute Phase||63||
60095537|NCT01737697|76212288|FG013|STARTED|Subacute Phase||46||
60095538|NCT01737697|76212289|FG014|STARTED|Subacute Phase||50||
59562283|NCT03327051|75664017|FG001|Attended Visit 2 (Week 0)|Overall Study||15||
60095539|NCT01737697|76212275|FG000|COMPLETED|Subacute Phase||0||
60095540|NCT01737697|76212276|FG001|COMPLETED|Subacute Phase||0||
60095541|NCT01737697|76212277|FG002|COMPLETED|Subacute Phase||0||
59562284|NCT03327051|75664016|FG000|COMPLETED|Overall Study||14||
59816967|NCT02516241|75939378|FG002|Received Treatment|Overall Study||313||
60095542|NCT01737697|76212278|FG003|COMPLETED|Subacute Phase||0||
60095543|NCT01737697|76212279|FG004|COMPLETED|Subacute Phase||0||
60095544|NCT01737697|76212280|FG005|COMPLETED|Subacute Phase||38||
60095545|NCT01737697|76212281|FG006|COMPLETED|Subacute Phase||48||
60095546|NCT01737697|76212282|FG007|COMPLETED|Subacute Phase||43||
60095547|NCT01737697|76212283|FG008|COMPLETED|Subacute Phase||52||
60095548|NCT01737697|76212284|FG009|COMPLETED|Subacute Phase||66||
60095549|NCT01737697|76212285|FG010|COMPLETED|Subacute Phase||59||
60095550|NCT01737697|76212286|FG011|COMPLETED|Subacute Phase||58||
60095551|NCT01737697|76212287|FG012|COMPLETED|Subacute Phase||61||
60095552|NCT01737697|76212288|FG013|COMPLETED|Subacute Phase||44||
60095553|NCT01737697|76212289|FG014|COMPLETED|Subacute Phase||49||
60095554|NCT01737697|76212275|FG000|NOT COMPLETED|Subacute Phase||0||
60095555|NCT01737697|76212276|FG001|NOT COMPLETED|Subacute Phase||0||
60095556|NCT01737697|76212277|FG002|NOT COMPLETED|Subacute Phase||0||
60095557|NCT01737697|76212278|FG003|NOT COMPLETED|Subacute Phase||0||
60095558|NCT01737697|76212279|FG004|NOT COMPLETED|Subacute Phase||0||
60095559|NCT01737697|76212280|FG005|NOT COMPLETED|Subacute Phase||3||
60095560|NCT01737697|76212281|FG006|NOT COMPLETED|Subacute Phase||1||
60095561|NCT01737697|76212282|FG007|NOT COMPLETED|Subacute Phase||3||
60095562|NCT01737697|76212283|FG008|NOT COMPLETED|Subacute Phase||2||
60095563|NCT01737697|76212284|FG009|NOT COMPLETED|Subacute Phase||2||
60095564|NCT01737697|76212285|FG010|NOT COMPLETED|Subacute Phase||6||
60095565|NCT01737697|76212286|FG011|NOT COMPLETED|Subacute Phase||3||
60095566|NCT01737697|76212287|FG012|NOT COMPLETED|Subacute Phase||2||
60095567|NCT01737697|76212288|FG013|NOT COMPLETED|Subacute Phase||2||
60095568|NCT01737697|76212289|FG014|NOT COMPLETED|Subacute Phase||1||
60095569|NCT00853996|76212322|FG000|STARTED|Overall Study||25||
60095570|NCT00853996|76212322|FG000|COMPLETED|Overall Study||25||
60095571|NCT00853996|76212322|FG000|NOT COMPLETED|Overall Study||0||
60095572|NCT00841828|76212328|FG000|STARTED|Overall Study||52||
60095573|NCT00841828|76212329|FG001|STARTED|Overall Study||50||
60095574|NCT00841828|76212328|FG000|COMPLETED|Overall Study||42||
60095575|NCT00841828|76212329|FG001|COMPLETED|Overall Study||48||
60095576|NCT00841828|76212328|FG000|NOT COMPLETED|Overall Study||10||
60095577|NCT00841828|76212329|FG001|NOT COMPLETED|Overall Study||2||
60095578|NCT00855010|76212339|FG000|STARTED|Overall Study||23||
60095579|NCT00855010|76212340|FG001|STARTED|Overall Study||19||
60095580|NCT00855010|76212339|FG000|COMPLETED|Overall Study||19||
60095581|NCT00855010|76212340|FG001|COMPLETED|Overall Study||18||
60095582|NCT00855010|76212339|FG000|NOT COMPLETED|Overall Study||4||
60095583|NCT00855010|76212340|FG001|NOT COMPLETED|Overall Study||1||
60095584|NCT00855868|76212352|FG000|STARTED|Overall Study||13||
60095585|NCT00855868|76212353|FG001|STARTED|Overall Study||15||
60095586|NCT00855868|76212352|FG000|COMPLETED|Overall Study||12||
60095587|NCT00855868|76212353|FG001|COMPLETED|Overall Study||14||
60095588|NCT00855868|76212352|FG000|NOT COMPLETED|Overall Study||1||
60095589|NCT00855868|76212353|FG001|NOT COMPLETED|Overall Study||1||
60095590|NCT00842296|76212359|FG000|STARTED|Overall Study||326||396
60095591|NCT00842296|76212359|FG000|COMPLETED|Overall Study||326||396
60095592|NCT00842296|76212359|FG000|NOT COMPLETED|Overall Study||0||0
59562285|NCT03327051|75664017|FG001|COMPLETED|Overall Study||15||
59562286|NCT03327051|75664016|FG000|NOT COMPLETED|Overall Study||5||
59708058|NCT00980200|75826926|FG001|NOT COMPLETED|7-day Washout Period 1||0||
60095593|NCT00842608|76212367|FG000|STARTED|Overall Study||174||
60095594|NCT00842608|76212368|FG001|STARTED|Overall Study||177||
60095595|NCT00842608|76212369|FG002|STARTED|Overall Study||99||
60095596|NCT00842608|76212370|FG003|STARTED|Overall Study||101||
60095597|NCT00842608|76212367|FG000|COMPLETED|Overall Study||170||
60095598|NCT00842608|76212368|FG001|COMPLETED|Overall Study||176||
60095599|NCT00842608|76212369|FG002|COMPLETED|Overall Study||99||
60095600|NCT00842608|76212370|FG003|COMPLETED|Overall Study||100||
60095601|NCT00842608|76212367|FG000|NOT COMPLETED|Overall Study||4||
60095602|NCT00842608|76212368|FG001|NOT COMPLETED|Overall Study||1||
60095603|NCT00842608|76212369|FG002|NOT COMPLETED|Overall Study||0||
60095604|NCT00842608|76212370|FG003|NOT COMPLETED|Overall Study||1||
60095605|NCT00856024|76212380|FG000|STARTED|Overall Study||902||
60095606|NCT00856024|76212380|FG000|COMPLETED|Overall Study||902||
60095607|NCT00856024|76212380|FG000|NOT COMPLETED|Overall Study||0||
60095608|NCT00856414|76212386|FG000|STARTED|Overall Study||45||
60095609|NCT00856414|76212386|FG000|COMPLETED|Overall Study||45||
60095610|NCT00856414|76212386|FG000|NOT COMPLETED|Overall Study||0||
59708059|NCT00980200|75826927|FG002|NOT COMPLETED|7-day Washout Period 1||0||
59708060|NCT00980200|75826928|FG003|NOT COMPLETED|7-day Washout Period 1||0||
59708061|NCT00980200|75826929|FG004|NOT COMPLETED|7-day Washout Period 1||0||
60095611|NCT00843466|76212392|FG000|STARTED|Overall Study||24||
60095612|NCT00843466|76212393|FG001|STARTED|Overall Study||18||
60095613|NCT00843466|76212392|FG000|COMPLETED|Overall Study||24||
60095614|NCT00843466|76212393|FG001|COMPLETED|Overall Study||18||
59562287|NCT03327051|75664017|FG001|NOT COMPLETED|Overall Study||5||
59562288|NCT02057939|75664024|FG000|STARTED|Overall Study||38||
60095615|NCT00843466|76212392|FG000|NOT COMPLETED|Overall Study||0||
59562289|NCT02057939|75664024|FG000|COMPLETED|Overall Study||37||
60095616|NCT00843466|76212393|FG001|NOT COMPLETED|Overall Study||0||
60095617|NCT00856726|76212399|FG000|STARTED|Overall Study||26||
60095618|NCT00856726|76212399|FG000|COMPLETED|Overall Study||26||
60095619|NCT00856726|76212399|FG000|NOT COMPLETED|Overall Study||0||
60095620|NCT00857272|76212405|FG000|STARTED|Overall Study|Includes 6 non-ITT patients that withdrew consent|154||
60095621|NCT00857272|76212406|FG001|STARTED|Overall Study|Includes 7 non-ITT patients that withdrew consent|154||
60095622|NCT00857272|76212405|FG000|COMPLETED|Overall Study||145||
60095623|NCT00857272|76212406|FG001|COMPLETED|Overall Study||145||
60095624|NCT00857272|76212405|FG000|NOT COMPLETED|Overall Study||9||
60095625|NCT00857272|76212406|FG001|NOT COMPLETED|Overall Study||9||
60095626|NCT00857506|76212415|FG000|STARTED|Overall Study||31||
60095627|NCT00857506|76212416|FG001|STARTED|Overall Study||52||
60095628|NCT00857506|76212417|FG002|STARTED|Overall Study||69||
59562290|NCT02057939|75664024|FG000|NOT COMPLETED|Overall Study||1||
59562291|NCT03496467|75664030|FG000|STARTED|Overall Study||38||
59562292|NCT03496467|75664031|FG001|STARTED|Overall Study||18||
60095629|NCT00857506|76212415|FG000|COMPLETED|Overall Study||16||
60095630|NCT00857506|76212416|FG001|COMPLETED|Overall Study||37||
60095631|NCT00857506|76212417|FG002|COMPLETED|Overall Study||51||
60095632|NCT00857506|76212415|FG000|NOT COMPLETED|Overall Study||15||
60095633|NCT00857506|76212416|FG001|NOT COMPLETED|Overall Study||15||
60095634|NCT00857506|76212417|FG002|NOT COMPLETED|Overall Study||18||
60095635|NCT00858130|76212437|FG000|STARTED|Overall Study||12||
60095636|NCT00858130|76212437|FG000|COMPLETED|Overall Study||12||
60095637|NCT00858130|76212437|FG000|NOT COMPLETED|Overall Study||0||
60095638|NCT01682863|76212445|FG000|STARTED|Overall Study||204||
60095639|NCT01682863|76212446|FG001|STARTED|Overall Study||204||
60095640|NCT01682863|76212447|FG002|STARTED|Overall Study||207||
60095641|NCT01682863|76212445|FG000|Safety Set|Overall Study||204||
60095642|NCT01682863|76212446|FG001|Safety Set|Overall Study||204||
60095643|NCT01682863|76212447|FG002|Safety Set|Overall Study||206||
60095644|NCT01682863|76212445|FG000|Full Analysis Set (FAS)|Overall Study|included all randomized patients who received at least one dose of study medication|204||
60095645|NCT01682863|76212446|FG001|Full Analysis Set (FAS)|Overall Study||204||
60095646|NCT01682863|76212447|FG002|Full Analysis Set (FAS)|Overall Study||206||
60095647|NCT01682863|76212445|FG000|Randomized Set|Overall Study||204||
60095648|NCT01682863|76212446|FG001|Randomized Set|Overall Study||204||
60095649|NCT01682863|76212447|FG002|Randomized Set|Overall Study|1 randomized patient was not treated; experienced an AE prior to receiving any study drug|207||
60095650|NCT01682863|76212445|FG000|COMPLETED|Overall Study||177||
60095651|NCT01682863|76212446|FG001|COMPLETED|Overall Study||187||
60095652|NCT01682863|76212447|FG002|COMPLETED|Overall Study||183||
60095653|NCT01682863|76212445|FG000|NOT COMPLETED|Overall Study||27||
60095654|NCT01682863|76212446|FG001|NOT COMPLETED|Overall Study||17||
60095655|NCT01682863|76212447|FG002|NOT COMPLETED|Overall Study||24||
60095656|NCT01951625|76212460|FG000|STARTED|Treatment Period||92||
60095657|NCT01951625|76212461|FG001|STARTED|Treatment Period||91||
60095658|NCT01951625|76212462|FG002|STARTED|Treatment Period||91||
60095659|NCT01951625|76212463|FG003|STARTED|Treatment Period||91||
60095660|NCT01951625|76212464|FG004|STARTED|Treatment Period||91||
60095661|NCT01951625|76212460|FG000|COMPLETED|Treatment Period||73||
60095662|NCT01951625|76212461|FG001|COMPLETED|Treatment Period||70||
59562293|NCT03496467|75664030|FG000|COMPLETED|Overall Study||34||
59562294|NCT03496467|75664031|FG001|COMPLETED|Overall Study||14||
59562295|NCT03496467|75664030|FG000|NOT COMPLETED|Overall Study||4||
59562296|NCT03496467|75664031|FG001|NOT COMPLETED|Overall Study||4||
59562297|NCT02058251|75664039|FG000|STARTED|Overall Study||35||
59562298|NCT02058251|75664040|FG001|STARTED|Overall Study||38||
59562299|NCT02058251|75664039|FG000|COMPLETED|Overall Study||35||
59562300|NCT02058251|75664040|FG001|COMPLETED|Overall Study||38||
59562301|NCT02058251|75664039|FG000|NOT COMPLETED|Overall Study||0||
59562302|NCT02058251|75664040|FG001|NOT COMPLETED|Overall Study||0||
59562303|NCT03329937|75664046|FG000|STARTED|Overall Study||21||
59562304|NCT03329937|75664046|FG000|COMPLETED|Overall Study||21||
59562305|NCT03329937|75664046|FG000|NOT COMPLETED|Overall Study||0||
59562306|NCT02308787|75664050|FG000|STARTED|Overall Study|Data were collected from 20 PLTD procedures performed in 12 subjects|12||
59562307|NCT02308787|75664050|FG000|COMPLETED|Overall Study|Data were collected from 20 PLTD procedures performed in 12 subjects|12||
59562308|NCT02308787|75664050|FG000|NOT COMPLETED|Overall Study||0||
59562309|NCT01710254|75664054|FG000|STARTED|Overall Study||30||
59562310|NCT01710254|75664054|FG000|COMPLETED|Overall Study||30||
59562311|NCT01710254|75664054|FG000|NOT COMPLETED|Overall Study||0||
59562312|NCT03496545|75664060|FG000|STARTED|Overall Study||21||
60095663|NCT01951625|76212462|FG002|COMPLETED|Treatment Period||76||
60095664|NCT01951625|76212463|FG003|COMPLETED|Treatment Period||69||
60095665|NCT01951625|76212464|FG004|COMPLETED|Treatment Period||74||
60095666|NCT01951625|76212460|FG000|NOT COMPLETED|Treatment Period||19||
60095667|NCT01951625|76212461|FG001|NOT COMPLETED|Treatment Period||21||
60095668|NCT01951625|76212462|FG002|NOT COMPLETED|Treatment Period||15||
60095669|NCT01951625|76212463|FG003|NOT COMPLETED|Treatment Period||22||
60095670|NCT01951625|76212464|FG004|NOT COMPLETED|Treatment Period||17||
60095671|NCT01951625|76212460|FG000|STARTED|Follow Up Period||87||
60095672|NCT01951625|76212461|FG001|STARTED|Follow Up Period||88||
60095673|NCT01951625|76212462|FG002|STARTED|Follow Up Period||88||
60095674|NCT01951625|76212463|FG003|STARTED|Follow Up Period||87||
60095675|NCT01951625|76212464|FG004|STARTED|Follow Up Period||88||
60095676|NCT01951625|76212460|FG000|COMPLETED|Follow Up Period||79||
60095677|NCT01951625|76212461|FG001|COMPLETED|Follow Up Period||79||
60095678|NCT01951625|76212462|FG002|COMPLETED|Follow Up Period||84||
60095679|NCT01951625|76212463|FG003|COMPLETED|Follow Up Period||76||
60095680|NCT01951625|76212464|FG004|COMPLETED|Follow Up Period||78||
60095681|NCT01951625|76212460|FG000|NOT COMPLETED|Follow Up Period||8||
60095682|NCT01951625|76212461|FG001|NOT COMPLETED|Follow Up Period||9||
60095683|NCT01951625|76212462|FG002|NOT COMPLETED|Follow Up Period||4||
60095684|NCT01951625|76212463|FG003|NOT COMPLETED|Follow Up Period||11||
60095685|NCT01951625|76212464|FG004|NOT COMPLETED|Follow Up Period||10||
60095686|NCT04400890|76212479|FG000|STARTED|Overall Study||53|Intent-to-treat Population|
60095687|NCT04400890|76212480|FG001|STARTED|Overall Study||52|Intent-to-treat Population|
60095688|NCT04400890|76212479|FG000|Treated Per Protocol Population|Overall Study||50|Completed participation through 21-day primary outcome measures.|
60095689|NCT04400890|76212480|FG001|Treated Per Protocol Population|Overall Study||50|Completed participation through 21-day primary outcome measures.|
60095690|NCT04400890|76212479|FG000|COMPLETED|Overall Study||50||
60095691|NCT04400890|76212480|FG001|COMPLETED|Overall Study||50||
60095692|NCT04400890|76212479|FG000|NOT COMPLETED|Overall Study||3||
60095693|NCT04400890|76212480|FG001|NOT COMPLETED|Overall Study||2||
60095694|NCT01936649|76212486|FG000|STARTED|Overall Study||63||
60095695|NCT01936649|76212486|FG000|Treated|Overall Study||51||
59562313|NCT03496545|75664061|FG001|STARTED|Overall Study||26||
59562314|NCT03496545|75664060|FG000|COMPLETED|Overall Study||20||
59562315|NCT03496545|75664061|FG001|COMPLETED|Overall Study||24||
59562316|NCT03496545|75664060|FG000|NOT COMPLETED|Overall Study||1||
59562317|NCT03496545|75664061|FG001|NOT COMPLETED|Overall Study||2||
59562318|NCT01710332|75664069|FG000|STARTED|Overall Study||6||
59562319|NCT01710332|75664070|FG001|STARTED|Overall Study||6||
59562320|NCT01710332|75664069|FG000|COMPLETED|Overall Study||6||
59562321|NCT01710332|75664070|FG001|COMPLETED|Overall Study||6||
59562322|NCT01710332|75664069|FG000|NOT COMPLETED|Overall Study||0||
59562323|NCT01710332|75664070|FG001|NOT COMPLETED|Overall Study||0||
59562324|NCT02309489|75664078|FG000|STARTED|Overall Study||583||
59562325|NCT02309489|75664079|FG001|STARTED|Overall Study||561||
59562326|NCT02309489|75664078|FG000|Follow-up at 3 Months Postpartum|Overall Study||560||
59562327|NCT02309489|75664079|FG001|Follow-up at 3 Months Postpartum|Overall Study||541||
59562328|NCT02309489|75664078|FG000|COMPLETED|Overall Study||568|Follow-up at 8 months postpartum|
59562329|NCT02309489|75664079|FG001|COMPLETED|Overall Study||547|Follow-up at 8 months postpartum|
59562330|NCT02309489|75664078|FG000|NOT COMPLETED|Overall Study||15||
59562331|NCT02309489|75664079|FG001|NOT COMPLETED|Overall Study||14||
59562332|NCT01711424|75664085|FG000|STARTED|Overall Study||1209||
59562333|NCT01711424|75664085|FG000|COMPLETED|Overall Study||1209||
59562334|NCT01711424|75664085|FG000|NOT COMPLETED|Overall Study||0||
59562335|NCT02311907|75664091|FG000|STARTED|Overall Study||94||
59562336|NCT02311907|75664092|FG001|STARTED|Overall Study||91||
59562337|NCT02311907|75664091|FG000|COMPLETED|Overall Study||94||
59562338|NCT02311907|75664092|FG001|COMPLETED|Overall Study||91||
59562339|NCT02311907|75664091|FG000|NOT COMPLETED|Overall Study||0||
59562340|NCT02311907|75664092|FG001|NOT COMPLETED|Overall Study||0||
60095696|NCT01936649|76212486|FG000|COMPLETED|Overall Study||50||
60095697|NCT01936649|76212486|FG000|NOT COMPLETED|Overall Study||13||
60095698|NCT01720069|76212493|FG000|STARTED|Overall Study||62||
60095699|NCT01720069|76212494|FG001|STARTED|Overall Study||71||
60095700|NCT01720069|76212495|FG002|STARTED|Overall Study||63||
60095701|NCT01720069|76212493|FG000|Full Anaylsis Set|Overall Study||62||
60095702|NCT01720069|76212494|FG001|Full Anaylsis Set|Overall Study||71||
60095703|NCT01720069|76212495|FG002|Full Anaylsis Set|Overall Study||63||
60095704|NCT01720069|76212493|FG000|COMPLETED|Overall Study||57||
60095705|NCT01720069|76212494|FG001|COMPLETED|Overall Study||56||
60095706|NCT01720069|76212495|FG002|COMPLETED|Overall Study||48||
59562341|NCT02012621|75664098|FG000|STARTED|Overall Study||807||
59562342|NCT02012621|75664098|FG000|Visit 1 Completed|Overall Study||807||
59562343|NCT02012621|75664098|FG000|Visit 2 Completed|Overall Study||688||
59562344|NCT02012621|75664098|FG000|Visit 3 Completed|Overall Study||444||
59562345|NCT02012621|75664098|FG000|COMPLETED|Overall Study||807||
59562346|NCT02012621|75664098|FG000|NOT COMPLETED|Overall Study||0||
59562347|NCT02013245|75664106|FG000|STARTED|Overall Study||9||
60095707|NCT01720069|76212493|FG000|NOT COMPLETED|Overall Study||5||
60095708|NCT01720069|76212494|FG001|NOT COMPLETED|Overall Study||15||
60095709|NCT01720069|76212495|FG002|NOT COMPLETED|Overall Study||15||
60095710|NCT00860314|76212505|FG000|STARTED|Overall Study||48||
60095711|NCT00860314|76212506|FG001|STARTED|Overall Study||48||
60095712|NCT00860314|76212505|FG000|COMPLETED|Overall Study||48||
60095713|NCT00860314|76212506|FG001|COMPLETED|Overall Study||48||
60095714|NCT00860314|76212505|FG000|NOT COMPLETED|Overall Study||0||
60095715|NCT00860314|76212506|FG001|NOT COMPLETED|Overall Study||0||
60095716|NCT00890656|76212512|FG000|STARTED|Overall Study||90||
60095717|NCT00890656|76212512|FG000|COMPLETED|Overall Study||90||
60095718|NCT00890656|76212512|FG000|NOT COMPLETED|Overall Study||0||
60095719|NCT00814138|76212518|FG000|STARTED|Overall Study||25||
60095720|NCT00814138|76212519|FG001|STARTED|Overall Study||25||
60095721|NCT00814138|76212518|FG000|COMPLETED|Overall Study||24||
60095722|NCT00814138|76212519|FG001|COMPLETED|Overall Study||18||
60095723|NCT00814138|76212518|FG000|NOT COMPLETED|Overall Study||1||
60095724|NCT00814138|76212519|FG001|NOT COMPLETED|Overall Study||7||
60095725|NCT00860938|76212529|FG000|STARTED|Overall Study||45||
60095726|NCT00860938|76212530|FG001|STARTED|Overall Study||45||
60095727|NCT00860938|76212529|FG000|COMPLETED|Overall Study||31||
60095728|NCT00860938|76212530|FG001|COMPLETED|Overall Study||37||
60095729|NCT00860938|76212529|FG000|NOT COMPLETED|Overall Study||14||
60095730|NCT00860938|76212530|FG001|NOT COMPLETED|Overall Study||8||
60095731|NCT00862186|76212536|FG000|STARTED|Overall Study||15||
60095732|NCT00862186|76212536|FG000|COMPLETED|Overall Study||15||
60095733|NCT00862186|76212536|FG000|NOT COMPLETED|Overall Study||0||
60095734|NCT01719757|76212541|FG000|STARTED|Overall Study||359||
60095735|NCT01719757|76212541|FG000|COMPLETED|Overall Study||258||
60095736|NCT01719757|76212541|FG000|NOT COMPLETED|Overall Study||101||
60095737|NCT01718509|76212549|FG000|STARTED|Overall Study||195||
60095738|NCT01718509|76212550|FG001|STARTED|Overall Study||195||
60095739|NCT01718509|76212549|FG000|COMPLETED|Overall Study||147||
60095740|NCT01718509|76212550|FG001|COMPLETED|Overall Study||147||
60095741|NCT01718509|76212549|FG000|NOT COMPLETED|Overall Study||48||
60095742|NCT01718509|76212550|FG001|NOT COMPLETED|Overall Study||48||
60095743|NCT00862810|76212558|FG000|STARTED|Overall Study||33||
60095744|NCT00862810|76212559|FG001|STARTED|Overall Study||39||
60095745|NCT00862810|76212558|FG000|COMPLETED|Overall Study||29||
60095746|NCT00862810|76212559|FG001|COMPLETED|Overall Study||35||
60095747|NCT00862810|76212558|FG000|NOT COMPLETED|Overall Study||4||
60095748|NCT00862810|76212559|FG001|NOT COMPLETED|Overall Study||4||
60095749|NCT00815698|76212567|FG000|STARTED|Overall Study||163||
60095750|NCT00815698|76212568|FG001|STARTED|Overall Study||171||
60095751|NCT00815698|76212567|FG000|COMPLETED|Overall Study||163||
60095752|NCT00815698|76212568|FG001|COMPLETED|Overall Study||171||
60095753|NCT00815698|76212567|FG000|NOT COMPLETED|Overall Study||0||
60095754|NCT00815698|76212568|FG001|NOT COMPLETED|Overall Study||0||
60095755|NCT00863122|76212576|FG000|STARTED|Overall Study||19||
59562348|NCT02013245|75664107|FG001|STARTED|Overall Study||9||
60095756|NCT00863122|76212577|FG001|STARTED|Overall Study||7||
60095757|NCT00863122|76212576|FG000|COMPLETED|Overall Study||19||
60095758|NCT00863122|76212577|FG001|COMPLETED|Overall Study||7||
60095759|NCT00863122|76212576|FG000|NOT COMPLETED|Overall Study||0||
60095760|NCT00863122|76212577|FG001|NOT COMPLETED|Overall Study||0||
60095761|NCT01604941|76212589|FG000|STARTED|Overall Study||11||
60095762|NCT01604941|76212590|FG001|STARTED|Overall Study||4||
60095763|NCT01604941|76212591|FG002|STARTED|Overall Study||3||
60095764|NCT01604941|76212592|FG003|STARTED|Overall Study||3||
60095765|NCT01604941|76212593|FG004|STARTED|Overall Study||4||
60095766|NCT01604941|76212594|FG005|STARTED|Overall Study||7||
60095767|NCT01604941|76212589|FG000|COMPLETED|Overall Study||0||
60095768|NCT01604941|76212590|FG001|COMPLETED|Overall Study||0||
60095769|NCT01604941|76212591|FG002|COMPLETED|Overall Study||0||
60095770|NCT01604941|76212592|FG003|COMPLETED|Overall Study||0||
60095771|NCT01604941|76212593|FG004|COMPLETED|Overall Study||3||
60095772|NCT01604941|76212594|FG005|COMPLETED|Overall Study||0||
60095773|NCT01604941|76212589|FG000|NOT COMPLETED|Overall Study||11||
60095774|NCT01604941|76212590|FG001|NOT COMPLETED|Overall Study||4||
60095775|NCT01604941|76212591|FG002|NOT COMPLETED|Overall Study||3||
60095776|NCT01604941|76212592|FG003|NOT COMPLETED|Overall Study||3||
60095777|NCT01604941|76212593|FG004|NOT COMPLETED|Overall Study||1||
60095778|NCT01604941|76212594|FG005|NOT COMPLETED|Overall Study||7||
59562349|NCT02013245|75664108|FG002|STARTED|Overall Study||9||
59562350|NCT02013245|75664109|FG003|STARTED|Overall Study||9||
59562351|NCT02013245|75664106|FG000|COMPLETED|Overall Study||9||
59562352|NCT02013245|75664107|FG001|COMPLETED|Overall Study||8||
59562353|NCT02013245|75664108|FG002|COMPLETED|Overall Study||9||
59562354|NCT02013245|75664109|FG003|COMPLETED|Overall Study||9||
59562355|NCT02013245|75664106|FG000|NOT COMPLETED|Overall Study||0||
59562356|NCT02013245|75664107|FG001|NOT COMPLETED|Overall Study||1||
59562357|NCT02013245|75664108|FG002|NOT COMPLETED|Overall Study||0||
59562358|NCT02013245|75664109|FG003|NOT COMPLETED|Overall Study||0||
59562359|NCT01980485|75664121|FG000|STARTED|Overall Study||120||
59562360|NCT01980485|75664122|FG001|STARTED|Overall Study||105||
59562361|NCT01980485|75664121|FG000|COMPLETED|Overall Study||84||
59562362|NCT01980485|75664122|FG001|COMPLETED|Overall Study||80||
59562363|NCT01980485|75664121|FG000|NOT COMPLETED|Overall Study||36||
59562364|NCT01980485|75664122|FG001|NOT COMPLETED|Overall Study||25||
59562365|NCT01981967|75664132|FG000|STARTED|Overall Study||6851||
60095779|NCT01604785|76212602|FG000|STARTED|Overall Study||37||
60095780|NCT01604785|76212603|FG001|STARTED|Overall Study||37||
60095781|NCT01604785|76212602|FG000|COMPLETED|Overall Study||30||
60095782|NCT01604785|76212603|FG001|COMPLETED|Overall Study||36||
60095783|NCT01604785|76212602|FG000|NOT COMPLETED|Overall Study||7||
60095784|NCT01604785|76212603|FG001|NOT COMPLETED|Overall Study||1||
60095785|NCT01681849|76212612|FG000|STARTED|Overall Study||15||
59562366|NCT01981967|75664133|FG001|STARTED|Overall Study||3149||
59562367|NCT01981967|75664132|FG000|COMPLETED|Overall Study||6851||
60095786|NCT01681849|76212613|FG001|STARTED|Overall Study||13||
60095787|NCT01681849|76212614|FG002|STARTED|Overall Study||56||
60095788|NCT01681849|76212612|FG000|COMPLETED|Overall Study||7||
60095789|NCT01681849|76212613|FG001|COMPLETED|Overall Study||6||
60095790|NCT01681849|76212614|FG002|COMPLETED|Overall Study||17||
60095791|NCT01681849|76212612|FG000|NOT COMPLETED|Overall Study||8||
60095792|NCT01681849|76212613|FG001|NOT COMPLETED|Overall Study||7||
60095793|NCT01681849|76212614|FG002|NOT COMPLETED|Overall Study||39||
60095794|NCT01681771|76212623|FG000|STARTED|Overall Study||25||
60095795|NCT01681771|76212624|FG001|STARTED|Overall Study||25||
60095796|NCT01681771|76212623|FG000|COMPLETED|Overall Study||21||
60095797|NCT01681771|76212624|FG001|COMPLETED|Overall Study||23||
60095798|NCT01681771|76212623|FG000|NOT COMPLETED|Overall Study||4||
60095799|NCT01681771|76212624|FG001|NOT COMPLETED|Overall Study||2||
60095800|NCT04250350|76212630|FG000|STARTED|Overall Study||206||
60095801|NCT04250350|76212630|FG000|COMPLETED|Overall Study||172||
60095802|NCT04250350|76212630|FG000|NOT COMPLETED|Overall Study||34||
60095803|NCT00863356|76212635|FG000|STARTED|Overall Study||20||
60095804|NCT00863356|76212635|FG000|COMPLETED|Overall Study||20||
60095805|NCT00863356|76212635|FG000|NOT COMPLETED|Overall Study||0||
60095806|NCT00863434|76212639|FG000|STARTED|Overall Study||2||
60095807|NCT00863434|76212639|FG000|COMPLETED|Overall Study||2||
60095808|NCT00863434|76212639|FG000|NOT COMPLETED|Overall Study||0||
60095809|NCT00815776|76212646|FG000|STARTED|Overall Study||60||
60095810|NCT00815776|76212647|FG001|STARTED|Overall Study||64||
60095811|NCT00815776|76212648|FG002|STARTED|Overall Study||28||
60095812|NCT00815776|76212646|FG000|COMPLETED|Overall Study||52||
60095813|NCT00815776|76212647|FG001|COMPLETED|Overall Study||56||
60095814|NCT00815776|76212648|FG002|COMPLETED|Overall Study||22||
60095815|NCT00815776|76212646|FG000|NOT COMPLETED|Overall Study||8||
60095816|NCT00815776|76212647|FG001|NOT COMPLETED|Overall Study||8||
60095817|NCT00815776|76212648|FG002|NOT COMPLETED|Overall Study||6||
60095818|NCT01718353|76212661|FG000|STARTED|Overall Study||41||
60095819|NCT01718353|76212662|FG001|STARTED|Overall Study||22||
60095820|NCT01718353|76212661|FG000|Treated|Overall Study||39||
60095821|NCT01718353|76212662|FG001|Treated|Overall Study||22||
60095822|NCT01718353|76212661|FG000|Treated up to End of Cycle 4|Overall Study|7 participants discontinued before Cycle 5|32||
60095823|NCT01718353|76212662|FG001|Treated up to End of Cycle 4|Overall Study|6 participants discontinued before Cycle 5|16||
60095824|NCT01718353|76212661|FG000|Treated From Cycle 5|Overall Study|12 participants switched from Treatment A to B & 3 participants switched from Treatment B to A.|23||
60095825|NCT01718353|76212662|FG001|Treated From Cycle 5|Overall Study|3 participants switched from Treatment B to A & 12 participants switched from Treatment A to B.|25||
60095826|NCT01718353|76212661|FG000|COMPLETED|Overall Study|Participants at study cut-off, Adverse Event (AE), DP & consent withdrawn were considered completed.|29||
60095827|NCT01718353|76212662|FG001|COMPLETED|Overall Study|Participants at study cut-off, AE, DP and consent withdrawn were considered completed.|17||
60095828|NCT01718353|76212661|FG000|NOT COMPLETED|Overall Study||12||
60095829|NCT01718353|76212662|FG001|NOT COMPLETED|Overall Study||5||
60095830|NCT01716715|76212672|FG000|STARTED|Overall Study||57||
60095831|NCT01716715|76212673|FG001|STARTED|Overall Study||54||
60095832|NCT01716715|76212672|FG000|COMPLETED|Overall Study||55||
60095833|NCT01716715|76212673|FG001|COMPLETED|Overall Study||50||
60095834|NCT01716715|76212672|FG000|NOT COMPLETED|Overall Study||2||
60095835|NCT01716715|76212673|FG001|NOT COMPLETED|Overall Study||4||
60095836|NCT01697449|76212681|FG000|STARTED|Overall Study||191||
60095837|NCT01697449|76212681|FG000|COMPLETED|Overall Study||101||
60095838|NCT01697449|76212681|FG000|NOT COMPLETED|Overall Study||90||
60095839|NCT01696279|76212688|FG000|STARTED|Part 1: Single Dose Lanthanum Carbonate||20||
60095840|NCT01696279|76212689|FG001|STARTED|Part 1: Single Dose Lanthanum Carbonate||0||
60095841|NCT01696279|76212690|FG002|STARTED|Part 1: Single Dose Lanthanum Carbonate||0||
60095842|NCT01696279|76212691|FG003|STARTED|Part 1: Single Dose Lanthanum Carbonate||0||
60095843|NCT01696279|76212688|FG000|Safety Analysis Set 1|Part 1: Single Dose Lanthanum Carbonate||20||
60095844|NCT01696279|76212689|FG001|Safety Analysis Set 1|Part 1: Single Dose Lanthanum Carbonate||0||
60095845|NCT01696279|76212690|FG002|Safety Analysis Set 1|Part 1: Single Dose Lanthanum Carbonate||0||
60095846|NCT01696279|76212691|FG003|Safety Analysis Set 1|Part 1: Single Dose Lanthanum Carbonate||0||
59708062|NCT00980200|75826925|FG000|STARTED|7-day Treatment Period 2||15||
59708063|NCT00980200|75826926|FG001|STARTED|7-day Treatment Period 2||13||
59993427|NCT02712905|76109279|FG013|NOT COMPLETED|Combination Therapy||7||
59993428|NCT02712905|76109280|FG014|NOT COMPLETED|Combination Therapy||1||
59993429|NCT02712905|76109281|FG015|NOT COMPLETED|Combination Therapy||7||
59993430|NCT02712905|76109282|FG016|NOT COMPLETED|Combination Therapy||1||
59993431|NCT02712905|76109283|FG017|NOT COMPLETED|Combination Therapy||6||
60095847|NCT01696279|76212688|FG000|Entered Part 2a|Part 1: Single Dose Lanthanum Carbonate||19||
60095848|NCT01696279|76212689|FG001|Entered Part 2a|Part 1: Single Dose Lanthanum Carbonate||0||
60095849|NCT01696279|76212690|FG002|Entered Part 2a|Part 1: Single Dose Lanthanum Carbonate||0||
60095850|NCT01696279|76212691|FG003|Entered Part 2a|Part 1: Single Dose Lanthanum Carbonate||0||
60095851|NCT01696279|76212688|FG000|COMPLETED|Part 1: Single Dose Lanthanum Carbonate||19||
60095852|NCT01696279|76212689|FG001|COMPLETED|Part 1: Single Dose Lanthanum Carbonate||0||
59708064|NCT00980200|75826927|FG002|STARTED|7-day Treatment Period 2||15||
59993432|NCT03776357|76109321|FG000|STARTED|Overall Study||9||
59993433|NCT03776357|76109321|FG000|COMPLETED|Overall Study||6||
59816968|NCT02516241|75939376|FG000|COMPLETED|Overall Study||0||
59993434|NCT03776357|76109321|FG000|NOT COMPLETED|Overall Study||3||
59993435|NCT04520997|76109327|FG000|STARTED|Overall Study||32||
59993436|NCT04520997|76109328|FG001|STARTED|Overall Study||30||
59993437|NCT04520997|76109327|FG000|Treated|Overall Study||31|One participant randomized in Down-up but not treated.|
59995203|NCT02730169|76111015|FG002|NOT COMPLETED|Overall Study||17||
60095853|NCT01696279|76212690|FG002|COMPLETED|Part 1: Single Dose Lanthanum Carbonate||0||
60095854|NCT01696279|76212691|FG003|COMPLETED|Part 1: Single Dose Lanthanum Carbonate||0||
60095855|NCT01696279|76212688|FG000|NOT COMPLETED|Part 1: Single Dose Lanthanum Carbonate||1||
60095856|NCT01696279|76212689|FG001|NOT COMPLETED|Part 1: Single Dose Lanthanum Carbonate||0||
60095857|NCT01696279|76212690|FG002|NOT COMPLETED|Part 1: Single Dose Lanthanum Carbonate||0||
60095858|NCT01696279|76212691|FG003|NOT COMPLETED|Part 1: Single Dose Lanthanum Carbonate||0||
60095859|NCT01696279|76212688|FG000|STARTED|Part 2a: Calcium Carbonate + Lanthanum||0||
60095860|NCT01696279|76212689|FG001|STARTED|Part 2a: Calcium Carbonate + Lanthanum|19 participants enrolled from Part 1 and 34 new participants enrolled in Part 2a|53||
60095861|NCT01696279|76212690|FG002|STARTED|Part 2a: Calcium Carbonate + Lanthanum||0||
60095862|NCT01696279|76212691|FG003|STARTED|Part 2a: Calcium Carbonate + Lanthanum||0||
60095863|NCT01696279|76212688|FG000|Safety Completer Set|Part 2a: Calcium Carbonate + Lanthanum||0||
60095864|NCT01696279|76212689|FG001|Safety Completer Set|Part 2a: Calcium Carbonate + Lanthanum||37||
60095865|NCT01696279|76212690|FG002|Safety Completer Set|Part 2a: Calcium Carbonate + Lanthanum||0||
60095866|NCT01696279|76212691|FG003|Safety Completer Set|Part 2a: Calcium Carbonate + Lanthanum||0||
60095867|NCT01696279|76212688|FG000|Full Analysis Set|Part 2a: Calcium Carbonate + Lanthanum||0||
60095868|NCT01696279|76212689|FG001|Full Analysis Set|Part 2a: Calcium Carbonate + Lanthanum||53||
60095869|NCT01696279|76212690|FG002|Full Analysis Set|Part 2a: Calcium Carbonate + Lanthanum||0||
60095870|NCT01696279|76212691|FG003|Full Analysis Set|Part 2a: Calcium Carbonate + Lanthanum||0||
60095871|NCT01696279|76212688|FG000|Per-protocol Set 1|Part 2a: Calcium Carbonate + Lanthanum||0||
60095872|NCT01696279|76212689|FG001|Per-protocol Set 1|Part 2a: Calcium Carbonate + Lanthanum||17||
60095873|NCT01696279|76212690|FG002|Per-protocol Set 1|Part 2a: Calcium Carbonate + Lanthanum||0||
60095874|NCT01696279|76212691|FG003|Per-protocol Set 1|Part 2a: Calcium Carbonate + Lanthanum||0||
60095875|NCT01696279|76212688|FG000|Per-protocol Set 2|Part 2a: Calcium Carbonate + Lanthanum||0||
60095876|NCT01696279|76212689|FG001|Per-protocol Set 2|Part 2a: Calcium Carbonate + Lanthanum||25||
60095877|NCT01696279|76212690|FG002|Per-protocol Set 2|Part 2a: Calcium Carbonate + Lanthanum||0||
60095878|NCT01696279|76212691|FG003|Per-protocol Set 2|Part 2a: Calcium Carbonate + Lanthanum||0||
60095879|NCT01696279|76212688|FG000|Entered Part 3|Part 2a: Calcium Carbonate + Lanthanum||0||
60095880|NCT01696279|76212689|FG001|Entered Part 3|Part 2a: Calcium Carbonate + Lanthanum||34||
60095881|NCT01696279|76212690|FG002|Entered Part 3|Part 2a: Calcium Carbonate + Lanthanum||0||
60095882|NCT01696279|76212691|FG003|Entered Part 3|Part 2a: Calcium Carbonate + Lanthanum||0||
60095883|NCT01696279|76212688|FG000|COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||0||
60095884|NCT01696279|76212689|FG001|COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||34||
60095885|NCT01696279|76212690|FG002|COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||0||
60095886|NCT01696279|76212691|FG003|COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||0||
60095887|NCT01696279|76212688|FG000|NOT COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||0||
60095888|NCT01696279|76212689|FG001|NOT COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||19||
60095889|NCT01696279|76212690|FG002|NOT COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||0||
60095890|NCT01696279|76212691|FG003|NOT COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||0||
60095891|NCT01696279|76212688|FG000|STARTED|Part 2b: Lanthanum Carbonate (8 Weeks)||0||
60095892|NCT01696279|76212689|FG001|STARTED|Part 2b: Lanthanum Carbonate (8 Weeks)||0||
60095893|NCT01696279|76212690|FG002|STARTED|Part 2b: Lanthanum Carbonate (8 Weeks)|9 new participants were enrolled in Part 2b|9||
60095894|NCT01696279|76212691|FG003|STARTED|Part 2b: Lanthanum Carbonate (8 Weeks)||0||
60095895|NCT01696279|76212688|FG000|Safety Completer Set|Part 2b: Lanthanum Carbonate (8 Weeks)||0||
60095896|NCT01696279|76212689|FG001|Safety Completer Set|Part 2b: Lanthanum Carbonate (8 Weeks)||0||
60095897|NCT01696279|76212690|FG002|Safety Completer Set|Part 2b: Lanthanum Carbonate (8 Weeks)||9||
60095898|NCT01696279|76212691|FG003|Safety Completer Set|Part 2b: Lanthanum Carbonate (8 Weeks)||0||
60095899|NCT01696279|76212688|FG000|Full Analysis Set|Part 2b: Lanthanum Carbonate (8 Weeks)||0||
60095900|NCT01696279|76212689|FG001|Full Analysis Set|Part 2b: Lanthanum Carbonate (8 Weeks)||0||
60095901|NCT01696279|76212690|FG002|Full Analysis Set|Part 2b: Lanthanum Carbonate (8 Weeks)||9||
60095902|NCT01696279|76212691|FG003|Full Analysis Set|Part 2b: Lanthanum Carbonate (8 Weeks)||0||
60095903|NCT01696279|76212688|FG000|Per-protocol Set 1|Part 2b: Lanthanum Carbonate (8 Weeks)||0||
60095904|NCT01696279|76212689|FG001|Per-protocol Set 1|Part 2b: Lanthanum Carbonate (8 Weeks)||0||
60095905|NCT01696279|76212690|FG002|Per-protocol Set 1|Part 2b: Lanthanum Carbonate (8 Weeks)||0||
60095906|NCT01696279|76212691|FG003|Per-protocol Set 1|Part 2b: Lanthanum Carbonate (8 Weeks)||0||
60095907|NCT01696279|76212688|FG000|Per-protocol Set 2|Part 2b: Lanthanum Carbonate (8 Weeks)||0||
60095908|NCT01696279|76212689|FG001|Per-protocol Set 2|Part 2b: Lanthanum Carbonate (8 Weeks)||0||
60095909|NCT01696279|76212690|FG002|Per-protocol Set 2|Part 2b: Lanthanum Carbonate (8 Weeks)||9||
60095910|NCT01696279|76212691|FG003|Per-protocol Set 2|Part 2b: Lanthanum Carbonate (8 Weeks)||0||
60095911|NCT01696279|76212688|FG000|COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||0||
60095912|NCT01696279|76212689|FG001|COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||0||
60095913|NCT01696279|76212690|FG002|COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||8||
60095914|NCT01696279|76212691|FG003|COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||0||
60095915|NCT01696279|76212688|FG000|NOT COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||0||
60095916|NCT01696279|76212689|FG001|NOT COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||0||
60095917|NCT01696279|76212690|FG002|NOT COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||1||
60095918|NCT01696279|76212691|FG003|NOT COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||0||
60095919|NCT01696279|76212688|FG000|STARTED|Part 3: Lanthanum Carbonate (6 Months)||0||
60095920|NCT01696279|76212689|FG001|STARTED|Part 3: Lanthanum Carbonate (6 Months)||0||
60095921|NCT01696279|76212690|FG002|STARTED|Part 3: Lanthanum Carbonate (6 Months)||0||
60095922|NCT01696279|76212691|FG003|STARTED|Part 3: Lanthanum Carbonate (6 Months)|34 participants from Part 2a and 8 participants from Part 2b continued to Part 3|42||
60095923|NCT01696279|76212688|FG000|COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||0||
60095924|NCT01696279|76212689|FG001|COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||0||
60095925|NCT01696279|76212690|FG002|COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||0||
60095926|NCT01696279|76212691|FG003|COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||34||
60095927|NCT01696279|76212688|FG000|NOT COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||0||
60095928|NCT01696279|76212689|FG001|NOT COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||0||
60095929|NCT01696279|76212690|FG002|NOT COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||0||
60095930|NCT01696279|76212691|FG003|NOT COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||8||
60095931|NCT01681069|76212702|FG000|STARTED|Overall Study||60||
60095932|NCT01681069|76212703|FG001|STARTED|Overall Study||60||
60095933|NCT01681069|76212702|FG000|Full Analysis Set (FAS)|Overall Study||57||
60095934|NCT01681069|76212703|FG001|Full Analysis Set (FAS)|Overall Study||60||
60095935|NCT01681069|76212702|FG000|COMPLETED|Overall Study|Valid Case Analysis Set (VAS)|55||
60095936|NCT01681069|76212703|FG001|COMPLETED|Overall Study|Valid Case Analysis Set (VAS)|53||
60095937|NCT01681069|76212702|FG000|NOT COMPLETED|Overall Study||5||
60095938|NCT01681069|76212703|FG001|NOT COMPLETED|Overall Study||7||
60095939|NCT01716559|76212709|FG000|STARTED|Overall Study||160||
60095940|NCT01716559|76212709|FG000|COMPLETED|Overall Study||49||
60095941|NCT01716559|76212709|FG000|NOT COMPLETED|Overall Study||111||
60095942|NCT01936181|76212715|FG000|STARTED|Randomised, Double-blind||291||
60095943|NCT01936181|76212716|FG001|STARTED|Randomised, Double-blind||293||
60095944|NCT01936181|76212717|FG002|STARTED|Randomised, Double-blind||0||
60095945|NCT01936181|76212718|FG003|STARTED|Randomised, Double-blind||0||
60095946|NCT01936181|76212715|FG000|COMPLETED|Randomised, Double-blind||227||
60095947|NCT01936181|76212716|FG001|COMPLETED|Randomised, Double-blind||225||
60095948|NCT01936181|76212717|FG002|COMPLETED|Randomised, Double-blind||0||
60095949|NCT01936181|76212718|FG003|COMPLETED|Randomised, Double-blind||0||
60095950|NCT01936181|76212715|FG000|NOT COMPLETED|Randomised, Double-blind||64||
60095951|NCT01936181|76212716|FG001|NOT COMPLETED|Randomised, Double-blind||68||
60095952|NCT01936181|76212717|FG002|NOT COMPLETED|Randomised, Double-blind||0||
60095953|NCT01936181|76212718|FG003|NOT COMPLETED|Randomised, Double-blind||0||
60095954|NCT01936181|76212715|FG000|STARTED|Transition-extension||201||
60095955|NCT01936181|76212716|FG001|STARTED|Transition-extension||0||
60095956|NCT01936181|76212717|FG002|STARTED|Transition-extension||94||
60095957|NCT01936181|76212718|FG003|STARTED|Transition-extension||101||
60095958|NCT01936181|76212715|FG000|COMPLETED|Transition-extension||186||
60095959|NCT01936181|76212716|FG001|COMPLETED|Transition-extension||0||
60095960|NCT01936181|76212717|FG002|COMPLETED|Transition-extension||88||
60095961|NCT01936181|76212718|FG003|COMPLETED|Transition-extension||96||
60095962|NCT01936181|76212715|FG000|NOT COMPLETED|Transition-extension||15||
60095963|NCT01936181|76212716|FG001|NOT COMPLETED|Transition-extension||0||
60095964|NCT01936181|76212717|FG002|NOT COMPLETED|Transition-extension||6||
60095965|NCT01936181|76212718|FG003|NOT COMPLETED|Transition-extension||5||
60095966|NCT01696045|76212731|FG000|STARTED|Overall Study||4||
60095967|NCT01696045|76212732|FG001|STARTED|Overall Study||8||
60095968|NCT01696045|76212731|FG000|COMPLETED|Overall Study||1||
60095969|NCT01696045|76212732|FG001|COMPLETED|Overall Study||1||
60095970|NCT01696045|76212731|FG000|NOT COMPLETED|Overall Study||3||
60095971|NCT01696045|76212732|FG001|NOT COMPLETED|Overall Study||7||
60095972|NCT01716169|76212738|FG000|STARTED|Overall Study||10||
60095973|NCT01716169|76212738|FG000|Standard of Care Dressings Used|Overall Study||7||
60095974|NCT01716169|76212738|FG000|COMPLETED|Overall Study||6||
60095975|NCT01716169|76212738|FG000|NOT COMPLETED|Overall Study||4||
60095976|NCT01935947|76212747|FG000|STARTED|Overall Study||4||
60095977|NCT01935947|76212748|FG001|STARTED|Overall Study||4||
60095978|NCT01935947|76212749|FG002|STARTED|Overall Study||2||
60095979|NCT01935947|76212747|FG000|Epigenetic Therapy|Overall Study||4||
60095980|NCT01935947|76212748|FG001|Epigenetic Therapy|Overall Study||4||
60095981|NCT01935947|76212749|FG002|Epigenetic Therapy|Overall Study||0||
60095982|NCT01935947|76212747|FG000|Cytotoxic Therapy|Overall Study||3||
60095983|NCT01935947|76212748|FG001|Cytotoxic Therapy|Overall Study||3||
60095984|NCT01935947|76212749|FG002|Cytotoxic Therapy|Overall Study||2||
60095985|NCT01935947|76212747|FG000|COMPLETED|Overall Study||1||
60095986|NCT01935947|76212748|FG001|COMPLETED|Overall Study||0||
60095987|NCT01935947|76212749|FG002|COMPLETED|Overall Study||0||
60095988|NCT01935947|76212747|FG000|NOT COMPLETED|Overall Study||3||
60095989|NCT01935947|76212748|FG001|NOT COMPLETED|Overall Study||4||
60095990|NCT01935947|76212749|FG002|NOT COMPLETED|Overall Study||2||
60095991|NCT01618019|76212762|FG000|STARTED|Overall Study||55||
60095992|NCT01618019|76212763|FG001|STARTED|Overall Study||54||
60095993|NCT01618019|76212762|FG000|COMPLETED|Overall Study||41||
60095994|NCT01618019|76212763|FG001|COMPLETED|Overall Study||40||
60095995|NCT01618019|76212762|FG000|NOT COMPLETED|Overall Study||14||
60095996|NCT01618019|76212763|FG001|NOT COMPLETED|Overall Study||14||
60095997|NCT01593787|76212772|FG000|STARTED|Overall Study||6||
60095998|NCT01593787|76212773|FG001|STARTED|Overall Study||8||
59993438|NCT04520997|76109328|FG001|Treated|Overall Study|One participant was randomized to Top-down but was treated as Down-up. So, analysed according to the treatment received that is (i.e.), Down-up.|29|One participant randomized in Down-up but not treated.|
59993439|NCT04520997|76109327|FG000|Safety Population|Overall Study||32||
59993440|NCT04520997|76109328|FG001|Safety Population|Overall Study||29||
59993441|NCT04520997|76109327|FG000|MITT (Modified Intention-to-treat) Population|Overall Study||31|One participant was withdrawn after first treatment in Down-up and therefore not included in MITT population.|
59993442|NCT04520997|76109328|FG001|MITT (Modified Intention-to-treat) Population|Overall Study||29|One participant was withdrawn after first treatment in Down-up and therefore not included in MITT population.|
60095999|NCT01593787|76212774|FG002|STARTED|Overall Study||18||
60096000|NCT01593787|76212772|FG000|COMPLETED|Overall Study||5||
60096001|NCT01593787|76212773|FG001|COMPLETED|Overall Study||8||
60096002|NCT01593787|76212774|FG002|COMPLETED|Overall Study||18||
59562368|NCT01981967|75664133|FG001|COMPLETED|Overall Study||3149||
59562369|NCT01981967|75664132|FG000|NOT COMPLETED|Overall Study||0||
59993443|NCT04520997|76109327|FG000|COMPLETED|Overall Study||30||
59993444|NCT04520997|76109328|FG001|COMPLETED|Overall Study||28||
60096003|NCT01593787|76212772|FG000|NOT COMPLETED|Overall Study||1||
60096004|NCT01593787|76212773|FG001|NOT COMPLETED|Overall Study||0||
60096005|NCT01593787|76212774|FG002|NOT COMPLETED|Overall Study||0||
60096006|NCT01951157|76212787|FG000|STARTED|Overall Study||22||
60096007|NCT01951157|76212788|FG001|STARTED|Overall Study||22||
60096008|NCT01951157|76212789|FG002|STARTED|Overall Study||25||
60096009|NCT01951157|76212787|FG000|COMPLETED|Overall Study||0||
60096010|NCT01951157|76212788|FG001|COMPLETED|Overall Study||0||
60096011|NCT01951157|76212789|FG002|COMPLETED|Overall Study||0||
60096012|NCT01951157|76212787|FG000|NOT COMPLETED|Overall Study||22||
60096013|NCT01951157|76212788|FG001|NOT COMPLETED|Overall Study||22||
60096014|NCT01951157|76212789|FG002|NOT COMPLETED|Overall Study||25||
60096015|NCT01363349|76212800|FG000|STARTED|Overall Study||133||
60096016|NCT01363349|76212801|FG001|STARTED|Overall Study||136||
60096017|NCT01363349|76212800|FG000|Randomized|Overall Study||133||
60096018|NCT01363349|76212801|FG001|Randomized|Overall Study||136||
60096019|NCT01363349|76212800|FG000|COMPLETED|Overall Study||66||
60096020|NCT01363349|76212801|FG001|COMPLETED|Overall Study||66||
60096021|NCT01363349|76212800|FG000|NOT COMPLETED|Overall Study||67||
60096022|NCT01363349|76212801|FG001|NOT COMPLETED|Overall Study||70||
60096023|NCT00867100|76212820|FG000|STARTED|Overall Study||5||
60096024|NCT00867100|76212821|FG001|STARTED|Overall Study||5||
60096025|NCT00867100|76212822|FG002|STARTED|Overall Study||8||
60096026|NCT00867100|76212823|FG003|STARTED|Overall Study||8||
60096027|NCT00867100|76212824|FG004|STARTED|Overall Study||14||
60096028|NCT00867100|76212825|FG005|STARTED|Overall Study||6||
60096029|NCT00867100|76212826|FG006|STARTED|Overall Study||7||
60096030|NCT00867100|76212827|FG007|STARTED|Overall Study||3||
60096031|NCT00867100|76212828|FG008|STARTED|Overall Study||6||
60096032|NCT00867100|76212829|FG009|STARTED|Overall Study||6||
60096033|NCT00867100|76212830|FG010|STARTED|Overall Study||4||
60096034|NCT00867100|76212831|FG011|STARTED|Overall Study||6||
60096035|NCT00867100|76212832|FG012|STARTED|Overall Study||6||
60096036|NCT00867100|76212820|FG000|COMPLETED|Overall Study||5||
60096037|NCT00867100|76212821|FG001|COMPLETED|Overall Study||4||
60096038|NCT00867100|76212822|FG002|COMPLETED|Overall Study||8||
59993445|NCT04520997|76109327|FG000|NOT COMPLETED|Overall Study||2||
59993446|NCT04520997|76109328|FG001|NOT COMPLETED|Overall Study||2||
60096039|NCT00867100|76212823|FG003|COMPLETED|Overall Study||8||
60096040|NCT00867100|76212824|FG004|COMPLETED|Overall Study||14||
60096041|NCT00867100|76212825|FG005|COMPLETED|Overall Study||6||
60096042|NCT00867100|76212826|FG006|COMPLETED|Overall Study||6||
60096043|NCT00867100|76212827|FG007|COMPLETED|Overall Study||3||
60096044|NCT00867100|76212828|FG008|COMPLETED|Overall Study||6||
60096045|NCT00867100|76212829|FG009|COMPLETED|Overall Study||6||
60096046|NCT00867100|76212830|FG010|COMPLETED|Overall Study||3||
60096047|NCT00867100|76212831|FG011|COMPLETED|Overall Study||6||
60096048|NCT00867100|76212832|FG012|COMPLETED|Overall Study||6||
60096049|NCT00867100|76212820|FG000|NOT COMPLETED|Overall Study||0||
60096050|NCT00867100|76212821|FG001|NOT COMPLETED|Overall Study||1||
60096051|NCT00867100|76212822|FG002|NOT COMPLETED|Overall Study||0||
60096052|NCT00867100|76212823|FG003|NOT COMPLETED|Overall Study||0||
60096053|NCT00867100|76212824|FG004|NOT COMPLETED|Overall Study||0||
60096054|NCT00867100|76212825|FG005|NOT COMPLETED|Overall Study||0||
60096055|NCT00867100|76212826|FG006|NOT COMPLETED|Overall Study||1||
60096056|NCT00867100|76212827|FG007|NOT COMPLETED|Overall Study||0||
60096057|NCT00867100|76212828|FG008|NOT COMPLETED|Overall Study||0||
60096058|NCT00867100|76212829|FG009|NOT COMPLETED|Overall Study||0||
60096059|NCT00867100|76212830|FG010|NOT COMPLETED|Overall Study||1||
60096060|NCT00867100|76212831|FG011|NOT COMPLETED|Overall Study||0||
60096061|NCT00867100|76212832|FG012|NOT COMPLETED|Overall Study||0||
60096062|NCT00817804|76212866|FG000|STARTED|Overall Study||1||
60096063|NCT00817804|76212867|FG001|STARTED|Overall Study||2||
60096064|NCT00817804|76212866|FG000|COMPLETED|Overall Study||1||
60096065|NCT00817804|76212867|FG001|COMPLETED|Overall Study||2||
60096066|NCT00817804|76212866|FG000|NOT COMPLETED|Overall Study||0||
60096067|NCT00817804|76212867|FG001|NOT COMPLETED|Overall Study||0||
60096068|NCT00818116|76212873|FG000|STARTED|Overall Study||34||
60096069|NCT00818116|76212873|FG000|COMPLETED|Overall Study||34||
60096070|NCT00818116|76212873|FG000|NOT COMPLETED|Overall Study||0||
60096071|NCT00818272|76212877|FG000|STARTED|Overall Study||148||
60096072|NCT00818272|76212877|FG000|COMPLETED|Overall Study||74||
60096073|NCT00818272|76212877|FG000|NOT COMPLETED|Overall Study||74||
60096074|NCT00868348|76212883|FG000|STARTED|Overall Study||30||
60096075|NCT00868348|76212884|FG001|STARTED|Overall Study||30||
60096076|NCT00868348|76212883|FG000|COMPLETED|Overall Study||30||
60096077|NCT00868348|76212884|FG001|COMPLETED|Overall Study||30||
60096078|NCT00868348|76212883|FG000|NOT COMPLETED|Overall Study||0||
60096079|NCT00868348|76212884|FG001|NOT COMPLETED|Overall Study||0||
60096080|NCT01933919|76212892|FG000|STARTED|Double-blind Placebo-controlled Phase||19||
60096081|NCT01933919|76212893|FG001|STARTED|Double-blind Placebo-controlled Phase||19||
60096082|NCT01933919|76212892|FG000|Received Study Drug|Double-blind Placebo-controlled Phase||19||
60096083|NCT01933919|76212893|FG001|Received Study Drug|Double-blind Placebo-controlled Phase||19||
60096084|NCT01933919|76212892|FG000|COMPLETED|Double-blind Placebo-controlled Phase||19||
60096085|NCT01933919|76212893|FG001|COMPLETED|Double-blind Placebo-controlled Phase||15||
60096086|NCT01933919|76212892|FG000|NOT COMPLETED|Double-blind Placebo-controlled Phase||0||
60096087|NCT01933919|76212893|FG001|NOT COMPLETED|Double-blind Placebo-controlled Phase||4||
60096088|NCT01933919|76212892|FG000|STARTED|Open-label Long-term Phase||19||
60096089|NCT01933919|76212893|FG001|STARTED|Open-label Long-term Phase||15||
60096090|NCT01933919|76212892|FG000|COMPLETED|Open-label Long-term Phase||12||
60096091|NCT01933919|76212893|FG001|COMPLETED|Open-label Long-term Phase||9||
60096092|NCT01933919|76212892|FG000|NOT COMPLETED|Open-label Long-term Phase||7||
60096093|NCT01933919|76212893|FG001|NOT COMPLETED|Open-label Long-term Phase||6||
60096094|NCT00819286|76212913|FG000|STARTED|Overall Study||70||
60096095|NCT00819286|76212914|FG001|STARTED|Overall Study||70||
60096096|NCT00819286|76212913|FG000|COMPLETED|Overall Study||56||
60096097|NCT00819286|76212914|FG001|COMPLETED|Overall Study||45||
60096098|NCT00819286|76212913|FG000|NOT COMPLETED|Overall Study||14||
60096099|NCT00819286|76212914|FG001|NOT COMPLETED|Overall Study||25||
60096100|NCT01933217|76212922|FG000|STARTED|Randomization (4 Weeks)||12||
60096101|NCT01933217|76212923|FG001|STARTED|Randomization (4 Weeks)||14||
60096102|NCT01933217|76212922|FG000|COMPLETED|Randomization (4 Weeks)||10||
60096103|NCT01933217|76212923|FG001|COMPLETED|Randomization (4 Weeks)||10||
60096104|NCT01933217|76212922|FG000|NOT COMPLETED|Randomization (4 Weeks)||2||
60096105|NCT01933217|76212923|FG001|NOT COMPLETED|Randomization (4 Weeks)||4||
60096106|NCT01933217|76212922|FG000|STARTED|Crossover (4 Weeks)||10||
60096107|NCT01933217|76212923|FG001|STARTED|Crossover (4 Weeks)||10||
60096108|NCT01933217|76212922|FG000|COMPLETED|Crossover (4 Weeks)||10||
60096109|NCT01933217|76212923|FG001|COMPLETED|Crossover (4 Weeks)||10||
60096110|NCT01933217|76212922|FG000|NOT COMPLETED|Crossover (4 Weeks)||0||
60096111|NCT01933217|76212923|FG001|NOT COMPLETED|Crossover (4 Weeks)||0||
60096112|NCT01932437|76212933|FG000|STARTED|Cohort 1 - ETI-204 4 mg/kg or Placebo||1||
60096113|NCT01932437|76212934|FG001|STARTED|Cohort 1 - ETI-204 4 mg/kg or Placebo||3||
60096114|NCT01932437|76212935|FG002|STARTED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0||
60096115|NCT01932437|76212936|FG003|STARTED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0||
60096116|NCT01932437|76212937|FG004|STARTED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0||
60096117|NCT01932437|76212938|FG005|STARTED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0||
60096118|NCT01932437|76212933|FG000|COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||1||
60096119|NCT01932437|76212934|FG001|COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||3||
60096120|NCT01932437|76212935|FG002|COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0||
60096121|NCT01932437|76212936|FG003|COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0||
60096122|NCT01932437|76212937|FG004|COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0||
60096123|NCT01932437|76212938|FG005|COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0||
60096124|NCT01932437|76212933|FG000|NOT COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0||
60096125|NCT01932437|76212934|FG001|NOT COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0||
60096126|NCT01932437|76212935|FG002|NOT COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0||
60096127|NCT01932437|76212936|FG003|NOT COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0||
60096128|NCT01932437|76212937|FG004|NOT COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0||
60096129|NCT01932437|76212938|FG005|NOT COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0||
60096130|NCT01932437|76212933|FG000|STARTED|Cohort 2 - ETI-204 8 mg/kg or Placebo||2||
60096131|NCT01932437|76212934|FG001|STARTED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0||
60096132|NCT01932437|76212935|FG002|STARTED|Cohort 2 - ETI-204 8 mg/kg or Placebo||6||
60096133|NCT01932437|76212936|FG003|STARTED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0||
60096134|NCT01932437|76212937|FG004|STARTED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0||
60096135|NCT01932437|76212938|FG005|STARTED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0||
60096136|NCT01932437|76212933|FG000|COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||2||
60096137|NCT01932437|76212934|FG001|COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0||
60096138|NCT01932437|76212935|FG002|COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||6||
60096139|NCT01932437|76212936|FG003|COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0||
60096140|NCT01932437|76212937|FG004|COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0||
60096141|NCT01932437|76212938|FG005|COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0||
60096142|NCT01932437|76212933|FG000|NOT COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0||
60096143|NCT01932437|76212934|FG001|NOT COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0||
60096144|NCT01932437|76212935|FG002|NOT COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0||
60096145|NCT01932437|76212936|FG003|NOT COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0||
60096146|NCT01932437|76212937|FG004|NOT COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0||
60096147|NCT01932437|76212938|FG005|NOT COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0||
60096148|NCT01932437|76212933|FG000|STARTED|Cohort 3 - ETI-204 16 mg/kg or Placebo||2||
60096149|NCT01932437|76212934|FG001|STARTED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0||
60096150|NCT01932437|76212935|FG002|STARTED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0||
60096151|NCT01932437|76212936|FG003|STARTED|Cohort 3 - ETI-204 16 mg/kg or Placebo||6||
60096152|NCT01932437|76212937|FG004|STARTED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0||
60096153|NCT01932437|76212938|FG005|STARTED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0||
60096154|NCT01932437|76212933|FG000|COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||2||
60096155|NCT01932437|76212934|FG001|COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0||
60096156|NCT01932437|76212935|FG002|COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0||
60096157|NCT01932437|76212936|FG003|COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||6||
60096158|NCT01932437|76212937|FG004|COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0||
60096159|NCT01932437|76212938|FG005|COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0||
60096160|NCT01932437|76212933|FG000|NOT COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0||
60096161|NCT01932437|76212934|FG001|NOT COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0||
60096162|NCT01932437|76212935|FG002|NOT COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0||
59562370|NCT01981967|75664133|FG001|NOT COMPLETED|Overall Study||0||
59708065|NCT00980200|75826928|FG003|STARTED|7-day Treatment Period 2||16||
59708066|NCT00980200|75826929|FG004|STARTED|7-day Treatment Period 2||15||
59708067|NCT00980200|75826925|FG000|COMPLETED|7-day Treatment Period 2||15||
59708068|NCT00980200|75826926|FG001|COMPLETED|7-day Treatment Period 2||13||
59708069|NCT00980200|75826927|FG002|COMPLETED|7-day Treatment Period 2||15||
59708070|NCT00980200|75826928|FG003|COMPLETED|7-day Treatment Period 2||16||
59708071|NCT00980200|75826929|FG004|COMPLETED|7-day Treatment Period 2||15||
59708072|NCT00980200|75826925|FG000|NOT COMPLETED|7-day Treatment Period 2||0||
59708073|NCT00980200|75826926|FG001|NOT COMPLETED|7-day Treatment Period 2||0||
59708074|NCT00980200|75826927|FG002|NOT COMPLETED|7-day Treatment Period 2||0||
59708075|NCT00980200|75826928|FG003|NOT COMPLETED|7-day Treatment Period 2||0||
59708076|NCT00980200|75826929|FG004|NOT COMPLETED|7-day Treatment Period 2||0||
59993447|NCT02734433|76109339|FG000|STARTED|Overall Study||3||
59993448|NCT02734433|76109340|FG001|STARTED|Overall Study||8||
59993449|NCT02734433|76109339|FG000|COMPLETED|Overall Study||1||
59993450|NCT02734433|76109340|FG001|COMPLETED|Overall Study||0||
59993451|NCT02734433|76109339|FG000|NOT COMPLETED|Overall Study||2||
59993452|NCT02734433|76109340|FG001|NOT COMPLETED|Overall Study||8||
59993453|NCT01709123|76109348|FG000|STARTED|Overall Study||31||
59993454|NCT01709123|76109349|FG001|STARTED|Overall Study||31||
59993455|NCT01709123|76109348|FG000|COMPLETED|Overall Study||22||
59993456|NCT01709123|76109349|FG001|COMPLETED|Overall Study||22||
59993457|NCT01709123|76109348|FG000|NOT COMPLETED|Overall Study||9||
59993458|NCT01709123|76109349|FG001|NOT COMPLETED|Overall Study||9||
59993459|NCT02452424|76109366|FG000|STARTED|Overall Study||4||
59993460|NCT02452424|76109367|FG001|STARTED|Overall Study||3||
59993461|NCT02452424|76109368|FG002|STARTED|Overall Study||7||
59993462|NCT02452424|76109369|FG003|STARTED|Overall Study||9||
59993463|NCT02452424|76109370|FG004|STARTED|Overall Study||4||
59993464|NCT02452424|76109371|FG005|STARTED|Overall Study||6||
59993465|NCT02452424|76109372|FG006|STARTED|Overall Study||13||
59993466|NCT02452424|76109373|FG007|STARTED|Overall Study||8||
59993467|NCT02452424|76109374|FG008|STARTED|Overall Study||15||
59993468|NCT02452424|76109375|FG009|STARTED|Overall Study||3||
59993469|NCT02452424|76109376|FG010|STARTED|Overall Study||6||
59993470|NCT02452424|76109366|FG000|COMPLETED|Overall Study||2||
59993471|NCT02452424|76109367|FG001|COMPLETED|Overall Study||0||
59708077|NCT00980200|75826925|FG000|STARTED|7-day Washout Period 2||15||
59708078|NCT00980200|75826926|FG001|STARTED|7-day Washout Period 2||13||
59708079|NCT00980200|75826927|FG002|STARTED|7-day Washout Period 2||15||
59708080|NCT00980200|75826928|FG003|STARTED|7-day Washout Period 2||16||
59708081|NCT00980200|75826929|FG004|STARTED|7-day Washout Period 2||15||
59708082|NCT00980200|75826925|FG000|COMPLETED|7-day Washout Period 2||15||
59708083|NCT00980200|75826926|FG001|COMPLETED|7-day Washout Period 2||13||
59708084|NCT00980200|75826927|FG002|COMPLETED|7-day Washout Period 2||15||
59708085|NCT00980200|75826928|FG003|COMPLETED|7-day Washout Period 2||16||
59708086|NCT00980200|75826929|FG004|COMPLETED|7-day Washout Period 2||15||
59993472|NCT02452424|76109368|FG002|COMPLETED|Overall Study||0||
59993473|NCT02452424|76109369|FG003|COMPLETED|Overall Study||1||
59993474|NCT02452424|76109370|FG004|COMPLETED|Overall Study||2||
59993475|NCT02452424|76109371|FG005|COMPLETED|Overall Study||5||
59993476|NCT02452424|76109372|FG006|COMPLETED|Overall Study||3||
59993477|NCT02452424|76109373|FG007|COMPLETED|Overall Study||4||
59708087|NCT00980200|75826925|FG000|NOT COMPLETED|7-day Washout Period 2||0||
59708088|NCT00980200|75826926|FG001|NOT COMPLETED|7-day Washout Period 2||0||
59708089|NCT00980200|75826927|FG002|NOT COMPLETED|7-day Washout Period 2||0||
59708090|NCT00980200|75826928|FG003|NOT COMPLETED|7-day Washout Period 2||0||
59708091|NCT00980200|75826929|FG004|NOT COMPLETED|7-day Washout Period 2||0||
60096163|NCT01932437|76212936|FG003|NOT COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0||
60096164|NCT01932437|76212937|FG004|NOT COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0||
60096165|NCT01932437|76212938|FG005|NOT COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0||
60096166|NCT01932437|76212933|FG000|STARTED|Cohort 4 - ETI-204 20 mg/kg or Placebo||2||
60096167|NCT01932437|76212934|FG001|STARTED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0||
60096168|NCT01932437|76212935|FG002|STARTED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0||
60096169|NCT01932437|76212936|FG003|STARTED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0||
60096170|NCT01932437|76212937|FG004|STARTED|Cohort 4 - ETI-204 20 mg/kg or Placebo||6||
60096171|NCT01932437|76212938|FG005|STARTED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0||
60096172|NCT01932437|76212933|FG000|COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||2||
59708092|NCT00980200|75826925|FG000|STARTED|7-day Treatment Period 3||15||
59708093|NCT00980200|75826926|FG001|STARTED|7-day Treatment Period 3||13||
59708094|NCT00980200|75826927|FG002|STARTED|7-day Treatment Period 3||15||
59993478|NCT02452424|76109374|FG008|COMPLETED|Overall Study||9||
59993479|NCT02452424|76109375|FG009|COMPLETED|Overall Study||1||
59993480|NCT02452424|76109376|FG010|COMPLETED|Overall Study||4||
59993481|NCT02452424|76109366|FG000|NOT COMPLETED|Overall Study||2||
59993482|NCT02452424|76109367|FG001|NOT COMPLETED|Overall Study||3||
59993483|NCT02452424|76109368|FG002|NOT COMPLETED|Overall Study||7||
59993484|NCT02452424|76109369|FG003|NOT COMPLETED|Overall Study||8||
59993485|NCT02452424|76109370|FG004|NOT COMPLETED|Overall Study||2||
59993486|NCT02452424|76109371|FG005|NOT COMPLETED|Overall Study||1||
59993487|NCT02452424|76109372|FG006|NOT COMPLETED|Overall Study||10||
59993488|NCT02452424|76109373|FG007|NOT COMPLETED|Overall Study||4||
59993489|NCT02452424|76109374|FG008|NOT COMPLETED|Overall Study||6||
59993490|NCT02452424|76109375|FG009|NOT COMPLETED|Overall Study||2||
59993491|NCT02452424|76109376|FG010|NOT COMPLETED|Overall Study||2||
59993492|NCT02419508|76109404|FG000|STARTED|Overall Study||96||
59993493|NCT02419508|76109405|FG001|STARTED|Overall Study||92||
59993494|NCT02419508|76109404|FG000|Full Analysis Set|Overall Study||95||
59993495|NCT02419508|76109405|FG001|Full Analysis Set|Overall Study||92||
59993496|NCT02419508|76109404|FG000|Safety Analysis Set|Overall Study||95||
59993497|NCT02419508|76109405|FG001|Safety Analysis Set|Overall Study||92||
59993498|NCT02419508|76109404|FG000|COMPLETED|Overall Study||86||
59993499|NCT02419508|76109405|FG001|COMPLETED|Overall Study||88||
60096173|NCT01932437|76212934|FG001|COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0||
60096174|NCT01932437|76212935|FG002|COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0||
60096175|NCT01932437|76212936|FG003|COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0||
60096176|NCT01932437|76212937|FG004|COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||6||
60096177|NCT01932437|76212938|FG005|COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0||
60096178|NCT01932437|76212933|FG000|NOT COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0||
60096179|NCT01932437|76212934|FG001|NOT COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0||
60096180|NCT01932437|76212935|FG002|NOT COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0||
60096181|NCT01932437|76212936|FG003|NOT COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0||
60096182|NCT01932437|76212937|FG004|NOT COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0||
60096183|NCT01932437|76212938|FG005|NOT COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0||
60096184|NCT01932437|76212933|FG000|STARTED|Cohort 5 - ETI-204 24 mg/kg or Placebo||2||
60096185|NCT01932437|76212934|FG001|STARTED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0||
60096186|NCT01932437|76212935|FG002|STARTED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0||
59993500|NCT02419508|76109404|FG000|NOT COMPLETED|Overall Study||10||
59993501|NCT02419508|76109405|FG001|NOT COMPLETED|Overall Study||4||
59993502|NCT01328249|76109413|FG000|STARTED|Overall Study||55||
59993503|NCT01328249|76109414|FG001|STARTED|Overall Study||26||
59993504|NCT01328249|76109413|FG000|COMPLETED|Overall Study||48||
59562371|NCT01982123|75664139|FG000|STARTED|Overall Study||12||
59562372|NCT01982123|75664139|FG000|COMPLETED|Overall Study||12||
59708095|NCT00980200|75826928|FG003|STARTED|7-day Treatment Period 3||16||
59993505|NCT01328249|76109414|FG001|COMPLETED|Overall Study||23||
59993506|NCT01328249|76109413|FG000|NOT COMPLETED|Overall Study||7||
59993507|NCT01328249|76109414|FG001|NOT COMPLETED|Overall Study||3||
59993508|NCT01651052|76109422|FG000|STARTED|Overall Study||133||
59993509|NCT01651052|76109422|FG000|Study Valve Group|Overall Study||133||
59993510|NCT01651052|76109422|FG000|COMPLETED|Overall Study||107||
59993511|NCT01651052|76109422|FG000|NOT COMPLETED|Overall Study||26||
60096187|NCT01932437|76212936|FG003|STARTED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0||
60096188|NCT01932437|76212937|FG004|STARTED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0||
60096189|NCT01932437|76212938|FG005|STARTED|Cohort 5 - ETI-204 24 mg/kg or Placebo||6||
60096190|NCT01932437|76212933|FG000|COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||2||
60096191|NCT01932437|76212934|FG001|COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0||
60096192|NCT01932437|76212935|FG002|COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0||
60096193|NCT01932437|76212936|FG003|COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0||
59993512|NCT02388074|76109426|FG000|STARTED|Overall Study||25||
59993513|NCT02388074|76109426|FG000|COMPLETED|Overall Study||22||
59993514|NCT02388074|76109426|FG000|NOT COMPLETED|Overall Study||3||
59993515|NCT01602549|76109432|FG000|STARTED|Overall Study||19||
59993516|NCT01602549|76109433|FG001|STARTED|Overall Study||38||
59993517|NCT01602549|76109432|FG000|COMPLETED|Overall Study||18||
59993518|NCT01602549|76109433|FG001|COMPLETED|Overall Study||37||
59993519|NCT01602549|76109432|FG000|NOT COMPLETED|Overall Study||1||
60096194|NCT01932437|76212937|FG004|COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0||
60096195|NCT01932437|76212938|FG005|COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||5||
59993520|NCT01602549|76109433|FG001|NOT COMPLETED|Overall Study||1||
60096196|NCT01932437|76212933|FG000|NOT COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0||
60096197|NCT01932437|76212934|FG001|NOT COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0||
59993521|NCT02427464|76109443|FG000|STARTED|Overall Study||338||
59993522|NCT02427464|76109444|FG001|STARTED|Overall Study||169||
59993523|NCT02427464|76109443|FG000|Intent-to-Treat Population|Overall Study||336||
60096198|NCT01932437|76212935|FG002|NOT COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0||
59562373|NCT01982123|75664139|FG000|NOT COMPLETED|Overall Study||0||
59562374|NCT02061683|75664143|FG000|STARTED|Overall Study||263||
59562375|NCT02061683|75664143|FG000|COMPLETED|Overall Study||203||
59562376|NCT02061683|75664143|FG000|NOT COMPLETED|Overall Study||60||
59562377|NCT01983839|75664147|FG000|STARTED|Overall Study||18||
59562378|NCT01983839|75664147|FG000|COMPLETED|Overall Study||18||
59562379|NCT01983839|75664147|FG000|NOT COMPLETED|Overall Study||0||
59562380|NCT02063087|75664153|FG000|STARTED|Emergency Department Intervention||493||
59562381|NCT02063087|75664154|FG001|STARTED|Emergency Department Intervention||478||
59562382|NCT02063087|75664153|FG000|COMPLETED|Emergency Department Intervention||493||
60096199|NCT01932437|76212936|FG003|NOT COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0||
60096200|NCT01932437|76212937|FG004|NOT COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0||
60096201|NCT01932437|76212938|FG005|NOT COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||1||
60096202|NCT01949051|76212959|FG000|STARTED|Treatment Period 1 (7 Days)||13||
60096203|NCT01949051|76212960|FG001|STARTED|Treatment Period 1 (7 Days)||13||
60096204|NCT01949051|76212961|FG002|STARTED|Treatment Period 1 (7 Days)||13||
60096205|NCT01949051|76212962|FG003|STARTED|Treatment Period 1 (7 Days)||13||
60096206|NCT01949051|76212963|FG004|STARTED|Treatment Period 1 (7 Days)||13||
60096207|NCT01949051|76212964|FG005|STARTED|Treatment Period 1 (7 Days)||13||
60096208|NCT01949051|76212959|FG000|COMPLETED|Treatment Period 1 (7 Days)||11||
60096209|NCT01949051|76212960|FG001|COMPLETED|Treatment Period 1 (7 Days)||13||
60096210|NCT01949051|76212961|FG002|COMPLETED|Treatment Period 1 (7 Days)||13||
60096211|NCT01949051|76212962|FG003|COMPLETED|Treatment Period 1 (7 Days)||12||
60096212|NCT01949051|76212963|FG004|COMPLETED|Treatment Period 1 (7 Days)||13||
60096213|NCT01949051|76212964|FG005|COMPLETED|Treatment Period 1 (7 Days)||13||
60096214|NCT01949051|76212959|FG000|NOT COMPLETED|Treatment Period 1 (7 Days)||2||
60096215|NCT01949051|76212960|FG001|NOT COMPLETED|Treatment Period 1 (7 Days)||0||
60096216|NCT01949051|76212961|FG002|NOT COMPLETED|Treatment Period 1 (7 Days)||0||
60096217|NCT01949051|76212962|FG003|NOT COMPLETED|Treatment Period 1 (7 Days)||1||
60096218|NCT01949051|76212963|FG004|NOT COMPLETED|Treatment Period 1 (7 Days)||0||
60096219|NCT01949051|76212964|FG005|NOT COMPLETED|Treatment Period 1 (7 Days)||0||
60096220|NCT01949051|76212959|FG000|STARTED|Washout Period 1 (14 to 20 Days)||11||
60096221|NCT01949051|76212960|FG001|STARTED|Washout Period 1 (14 to 20 Days)||13||
60096222|NCT01949051|76212961|FG002|STARTED|Washout Period 1 (14 to 20 Days)||13||
60096223|NCT01949051|76212962|FG003|STARTED|Washout Period 1 (14 to 20 Days)||12||
59562383|NCT02063087|75664154|FG001|COMPLETED|Emergency Department Intervention||478||
59562384|NCT02063087|75664153|FG000|NOT COMPLETED|Emergency Department Intervention||0||
59562385|NCT02063087|75664154|FG001|NOT COMPLETED|Emergency Department Intervention||0||
60096224|NCT01949051|76212963|FG004|STARTED|Washout Period 1 (14 to 20 Days)||13||
60096225|NCT01949051|76212964|FG005|STARTED|Washout Period 1 (14 to 20 Days)||13||
60096226|NCT01949051|76212959|FG000|COMPLETED|Washout Period 1 (14 to 20 Days)||11||
60096227|NCT01949051|76212960|FG001|COMPLETED|Washout Period 1 (14 to 20 Days)||13||
60096228|NCT01949051|76212961|FG002|COMPLETED|Washout Period 1 (14 to 20 Days)||13||
60096229|NCT01949051|76212962|FG003|COMPLETED|Washout Period 1 (14 to 20 Days)||12||
60096230|NCT01949051|76212963|FG004|COMPLETED|Washout Period 1 (14 to 20 Days)||13||
60096231|NCT01949051|76212964|FG005|COMPLETED|Washout Period 1 (14 to 20 Days)||13||
60096232|NCT01949051|76212959|FG000|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0||
60096233|NCT01949051|76212960|FG001|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0||
60096234|NCT01949051|76212961|FG002|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0||
60096235|NCT01949051|76212962|FG003|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0||
60096236|NCT01949051|76212963|FG004|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0||
60096237|NCT01949051|76212964|FG005|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0||
60096238|NCT01949051|76212959|FG000|STARTED|Treatment Period 2 (7 Days)||11||
60096239|NCT01949051|76212960|FG001|STARTED|Treatment Period 2 (7 Days)||13||
60096240|NCT01949051|76212961|FG002|STARTED|Treatment Period 2 (7 Days)||13||
60096241|NCT01949051|76212962|FG003|STARTED|Treatment Period 2 (7 Days)||12||
60096242|NCT01949051|76212963|FG004|STARTED|Treatment Period 2 (7 Days)||13||
60096243|NCT01949051|76212964|FG005|STARTED|Treatment Period 2 (7 Days)||13||
60096244|NCT01949051|76212959|FG000|COMPLETED|Treatment Period 2 (7 Days)||11||
60096245|NCT01949051|76212960|FG001|COMPLETED|Treatment Period 2 (7 Days)||12||
60096246|NCT01949051|76212961|FG002|COMPLETED|Treatment Period 2 (7 Days)||12||
60096247|NCT01949051|76212962|FG003|COMPLETED|Treatment Period 2 (7 Days)||12||
59562386|NCT02063087|75664153|FG000|STARTED|7 Day Follow-up||493||
59562387|NCT02063087|75664154|FG001|STARTED|7 Day Follow-up||478||
59562388|NCT02063087|75664153|FG000|COMPLETED|7 Day Follow-up||493||
59562389|NCT02063087|75664154|FG001|COMPLETED|7 Day Follow-up||478||
59562390|NCT02063087|75664153|FG000|NOT COMPLETED|7 Day Follow-up||0||
59708096|NCT00980200|75826929|FG004|STARTED|7-day Treatment Period 3||15||
59708097|NCT00980200|75826925|FG000|COMPLETED|7-day Treatment Period 3||15||
59708098|NCT00980200|75826926|FG001|COMPLETED|7-day Treatment Period 3||12||
59708099|NCT00980200|75826927|FG002|COMPLETED|7-day Treatment Period 3||15||
59708100|NCT00980200|75826928|FG003|COMPLETED|7-day Treatment Period 3||16||
60096248|NCT01949051|76212963|FG004|COMPLETED|Treatment Period 2 (7 Days)||13||
60096249|NCT01949051|76212964|FG005|COMPLETED|Treatment Period 2 (7 Days)||12||
60096250|NCT01949051|76212959|FG000|NOT COMPLETED|Treatment Period 2 (7 Days)||0||
60096251|NCT01949051|76212960|FG001|NOT COMPLETED|Treatment Period 2 (7 Days)||1||
60096252|NCT01949051|76212961|FG002|NOT COMPLETED|Treatment Period 2 (7 Days)||1||
60096253|NCT01949051|76212962|FG003|NOT COMPLETED|Treatment Period 2 (7 Days)||0||
60096254|NCT01949051|76212963|FG004|NOT COMPLETED|Treatment Period 2 (7 Days)||0||
60096255|NCT01949051|76212964|FG005|NOT COMPLETED|Treatment Period 2 (7 Days)||1||
60096256|NCT01949051|76212959|FG000|STARTED|Washout Period 2 (14 to 20 Days)||11||
60096257|NCT01949051|76212960|FG001|STARTED|Washout Period 2 (14 to 20 Days)||12||
60096258|NCT01949051|76212961|FG002|STARTED|Washout Period 2 (14 to 20 Days)||12||
60096259|NCT01949051|76212962|FG003|STARTED|Washout Period 2 (14 to 20 Days)||12||
60096260|NCT01949051|76212963|FG004|STARTED|Washout Period 2 (14 to 20 Days)||13||
59562391|NCT02063087|75664154|FG001|NOT COMPLETED|7 Day Follow-up||0||
59562392|NCT02395991|75664160|FG000|STARTED|Overall Study||60||
60096261|NCT01949051|76212964|FG005|STARTED|Washout Period 2 (14 to 20 Days)||12||
59562393|NCT02395991|75664160|FG000|COMPLETED|Overall Study||59||
60096262|NCT01949051|76212959|FG000|COMPLETED|Washout Period 2 (14 to 20 Days)||11||
60096263|NCT01949051|76212960|FG001|COMPLETED|Washout Period 2 (14 to 20 Days)||12||
60096264|NCT01949051|76212961|FG002|COMPLETED|Washout Period 2 (14 to 20 Days)||12||
60096265|NCT01949051|76212962|FG003|COMPLETED|Washout Period 2 (14 to 20 Days)||12||
60096266|NCT01949051|76212963|FG004|COMPLETED|Washout Period 2 (14 to 20 Days)||13||
60096267|NCT01949051|76212964|FG005|COMPLETED|Washout Period 2 (14 to 20 Days)||12||
60096268|NCT01949051|76212959|FG000|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0||
60096269|NCT01949051|76212960|FG001|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0||
60096270|NCT01949051|76212961|FG002|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0||
60096271|NCT01949051|76212962|FG003|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0||
60096272|NCT01949051|76212963|FG004|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0||
60096273|NCT01949051|76212964|FG005|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0||
60096274|NCT01949051|76212959|FG000|STARTED|Treatment Period 3 (7 Days)||11||
60096275|NCT01949051|76212960|FG001|STARTED|Treatment Period 3 (7 Days)||12||
60096276|NCT01949051|76212961|FG002|STARTED|Treatment Period 3 (7 Days)||12||
60096277|NCT01949051|76212962|FG003|STARTED|Treatment Period 3 (7 Days)||12||
60096278|NCT01949051|76212963|FG004|STARTED|Treatment Period 3 (7 Days)||13||
60096279|NCT01949051|76212964|FG005|STARTED|Treatment Period 3 (7 Days)||12||
60096280|NCT01949051|76212959|FG000|COMPLETED|Treatment Period 3 (7 Days)||11||
60096281|NCT01949051|76212960|FG001|COMPLETED|Treatment Period 3 (7 Days)||12||
60096282|NCT01949051|76212961|FG002|COMPLETED|Treatment Period 3 (7 Days)||12||
60096283|NCT01949051|76212962|FG003|COMPLETED|Treatment Period 3 (7 Days)||12||
60096284|NCT01949051|76212963|FG004|COMPLETED|Treatment Period 3 (7 Days)||13||
60096285|NCT01949051|76212964|FG005|COMPLETED|Treatment Period 3 (7 Days)||12||
60096286|NCT01949051|76212959|FG000|NOT COMPLETED|Treatment Period 3 (7 Days)||0||
60096287|NCT01949051|76212960|FG001|NOT COMPLETED|Treatment Period 3 (7 Days)||0||
60096288|NCT01949051|76212961|FG002|NOT COMPLETED|Treatment Period 3 (7 Days)||0||
60096289|NCT01949051|76212962|FG003|NOT COMPLETED|Treatment Period 3 (7 Days)||0||
60096290|NCT01949051|76212963|FG004|NOT COMPLETED|Treatment Period 3 (7 Days)||0||
60096291|NCT01949051|76212964|FG005|NOT COMPLETED|Treatment Period 3 (7 Days)||0||
60096292|NCT01948427|76212977|FG000|STARTED|Overall Study||49||
60096293|NCT01948427|76212978|FG001|STARTED|Overall Study||89||
60096294|NCT01948427|76212979|FG002|STARTED|Overall Study||4||
60096295|NCT01948427|76212980|FG003|STARTED|Overall Study||1||
60096296|NCT01948427|76212981|FG004|STARTED|Overall Study||60||
60096297|NCT01948427|76212977|FG000|COMPLETED|Overall Study||42||
60096298|NCT01948427|76212978|FG001|COMPLETED|Overall Study||72||
60096299|NCT01948427|76212979|FG002|COMPLETED|Overall Study||4||
60096300|NCT01948427|76212980|FG003|COMPLETED|Overall Study||1||
60096301|NCT01948427|76212981|FG004|COMPLETED|Overall Study||46||
60096302|NCT01948427|76212977|FG000|NOT COMPLETED|Overall Study||7||
60096303|NCT01948427|76212978|FG001|NOT COMPLETED|Overall Study||17||
60096304|NCT01948427|76212979|FG002|NOT COMPLETED|Overall Study||0||
60096305|NCT01948427|76212980|FG003|NOT COMPLETED|Overall Study||0||
60096306|NCT01948427|76212981|FG004|NOT COMPLETED|Overall Study||14||
60096307|NCT01948193|76212998|FG000|STARTED|Overall Study||177||
60096308|NCT01948193|76212998|FG000|COMPLETED|Overall Study||168||
60096309|NCT01948193|76212998|FG000|NOT COMPLETED|Overall Study||9||
60096310|NCT01694485|76213008|FG000|STARTED|Overall Study||117||
60096311|NCT01694485|76213009|FG001|STARTED|Overall Study||22||
60096312|NCT01694485|76213010|FG002|STARTED|Overall Study||40||
60096313|NCT01694485|76213011|FG003|STARTED|Overall Study||100||
60096314|NCT01694485|76213012|FG004|STARTED|Overall Study||80||
60096315|NCT01694485|76213008|FG000|Received Treatment|Overall Study||116||
60096316|NCT01694485|76213009|FG001|Received Treatment|Overall Study||21||
60096317|NCT01694485|76213010|FG002|Received Treatment|Overall Study||40||
60096318|NCT01694485|76213011|FG003|Received Treatment|Overall Study||98||
60096319|NCT01694485|76213012|FG004|Received Treatment|Overall Study||79||
60096320|NCT01694485|76213008|FG000|Completed Week 8 Assessment|Overall Study||106||
60096321|NCT01694485|76213009|FG001|Completed Week 8 Assessment|Overall Study||18||
60096322|NCT01694485|76213010|FG002|Completed Week 8 Assessment|Overall Study||38||
60096323|NCT01694485|76213011|FG003|Completed Week 8 Assessment|Overall Study||94||
60096324|NCT01694485|76213012|FG004|Completed Week 8 Assessment|Overall Study||76||
60096325|NCT01694485|76213008|FG000|Entered Open-label Period|Overall Study||100||
60096326|NCT01694485|76213009|FG001|Entered Open-label Period|Overall Study||19||
60096327|NCT01694485|76213010|FG002|Entered Open-label Period|Overall Study||36||
60096328|NCT01694485|76213011|FG003|Entered Open-label Period|Overall Study||88||
60096329|NCT01694485|76213012|FG004|Entered Open-label Period|Overall Study||68||
60096330|NCT01694485|76213008|FG000|COMPLETED|Overall Study||84|Defined as participants who completed the safety follow-up period|
60096331|NCT01694485|76213009|FG001|COMPLETED|Overall Study||15|Defined as participants who completed the safety follow-up period|
60096332|NCT01694485|76213010|FG002|COMPLETED|Overall Study||27|Defined as participants who completed the safety follow-up period|
60096333|NCT01694485|76213011|FG003|COMPLETED|Overall Study||62|Defined as participants who completed the safety follow-up period|
60096334|NCT01694485|76213012|FG004|COMPLETED|Overall Study||55|Defined as participants who completed the safety follow-up period|
60096335|NCT01694485|76213008|FG000|NOT COMPLETED|Overall Study||33||
59993524|NCT02427464|76109444|FG001|Intent-to-Treat Population|Overall Study||164||
59993525|NCT02427464|76109443|FG000|COMPLETED|Overall Study||288||
59993526|NCT02427464|76109444|FG001|COMPLETED|Overall Study||145||
59993527|NCT02427464|76109443|FG000|NOT COMPLETED|Overall Study||50||
59993528|NCT02427464|76109444|FG001|NOT COMPLETED|Overall Study||24||
59993529|NCT02426918|76109453|FG000|STARTED|Overall Study||110||
59562394|NCT02395991|75664160|FG000|NOT COMPLETED|Overall Study||1||
59708101|NCT00980200|75826929|FG004|COMPLETED|7-day Treatment Period 3||14||
59993530|NCT02426918|76109454|FG001|STARTED|Overall Study||109||
59993531|NCT02426918|76109455|FG002|STARTED|Overall Study||111||
59993532|NCT02426918|76109453|FG000|Safety Population|Overall Study||110||
59993533|NCT02426918|76109454|FG001|Safety Population|Overall Study||107||
59993534|NCT02426918|76109455|FG002|Safety Population|Overall Study||107||
59993535|NCT02426918|76109453|FG000|COMPLETED|Overall Study||93||
59562395|NCT01712360|75664169|FG000|STARTED|Overall Study||22||
59562396|NCT01712360|75664170|FG001|STARTED|Overall Study||22||
59562397|NCT01712360|75664171|FG002|STARTED|Overall Study||6||
60096336|NCT01694485|76213009|FG001|NOT COMPLETED|Overall Study||7||
60096337|NCT01694485|76213010|FG002|NOT COMPLETED|Overall Study||13||
60096338|NCT01694485|76213011|FG003|NOT COMPLETED|Overall Study||38||
60096339|NCT01694485|76213012|FG004|NOT COMPLETED|Overall Study||25||
60096340|NCT01931735|76213033|FG000|STARTED|Randomized Phase||4||
59562398|NCT01712360|75664172|FG003|STARTED|Overall Study||6||
59562399|NCT01712360|75664169|FG000|COMPLETED|Overall Study||22||
59562400|NCT01712360|75664170|FG001|COMPLETED|Overall Study||21||
59562401|NCT01712360|75664171|FG002|COMPLETED|Overall Study||6||
59562402|NCT01712360|75664172|FG003|COMPLETED|Overall Study||4||
59562403|NCT01712360|75664169|FG000|NOT COMPLETED|Overall Study||0||
59562404|NCT01712360|75664170|FG001|NOT COMPLETED|Overall Study||1||
59562405|NCT01712360|75664171|FG002|NOT COMPLETED|Overall Study||0||
59562406|NCT01712360|75664172|FG003|NOT COMPLETED|Overall Study||2||
59562407|NCT02396147|75664190|FG000|STARTED|Period 1||27||
59562408|NCT02396147|75664191|FG001|STARTED|Period 1||27||
59562409|NCT02396147|75664190|FG000|COMPLETED|Period 1||27||
59562410|NCT02396147|75664191|FG001|COMPLETED|Period 1||27||
60096341|NCT01931735|76213034|FG001|STARTED|Randomized Phase||3||
60096342|NCT01931735|76213035|FG002|STARTED|Randomized Phase||9||
60096343|NCT01931735|76213036|FG003|STARTED|Randomized Phase||0||
59562411|NCT02396147|75664190|FG000|NOT COMPLETED|Period 1||0||
59562412|NCT02396147|75664191|FG001|NOT COMPLETED|Period 1||0||
59562413|NCT02396147|75664190|FG000|STARTED|Period 2||27||
59562414|NCT02396147|75664191|FG001|STARTED|Period 2||27||
59562415|NCT02396147|75664190|FG000|COMPLETED|Period 2||27||
59562416|NCT02396147|75664191|FG001|COMPLETED|Period 2||27||
59562417|NCT02396147|75664190|FG000|NOT COMPLETED|Period 2||0||
59562418|NCT02396147|75664191|FG001|NOT COMPLETED|Period 2||0||
59562419|NCT02396147|75664190|FG000|STARTED|Period 3||27||
59708102|NCT00980200|75826925|FG000|NOT COMPLETED|7-day Treatment Period 3||0||
60096344|NCT01931735|76213033|FG000|COMPLETED|Randomized Phase||2||
60096345|NCT01931735|76213034|FG001|COMPLETED|Randomized Phase||1||
60096346|NCT01931735|76213035|FG002|COMPLETED|Randomized Phase||4||
59562420|NCT02396147|75664191|FG001|STARTED|Period 3||27||
59562421|NCT02396147|75664190|FG000|COMPLETED|Period 3||27||
59708103|NCT00980200|75826926|FG001|NOT COMPLETED|7-day Treatment Period 3||1||
59708104|NCT00980200|75826927|FG002|NOT COMPLETED|7-day Treatment Period 3||0||
60096347|NCT01931735|76213036|FG003|COMPLETED|Randomized Phase||0||
60096348|NCT01931735|76213033|FG000|NOT COMPLETED|Randomized Phase||2||
60096349|NCT01931735|76213034|FG001|NOT COMPLETED|Randomized Phase||2||
60096350|NCT01931735|76213035|FG002|NOT COMPLETED|Randomized Phase||5||
60096351|NCT01931735|76213036|FG003|NOT COMPLETED|Randomized Phase||0||
60096352|NCT01931735|76213033|FG000|STARTED|Observational Non-Randomized Phase|Participants continued from the randomized phase|2||
60096353|NCT01931735|76213034|FG001|STARTED|Observational Non-Randomized Phase|Participants continued from the randomized phase|1||
60096354|NCT01931735|76213035|FG002|STARTED|Observational Non-Randomized Phase||0||
60096355|NCT01931735|76213036|FG003|STARTED|Observational Non-Randomized Phase|Participants recruited post-amendment|11||
60096356|NCT01931735|76213033|FG000|COMPLETED|Observational Non-Randomized Phase||2||
60096357|NCT01931735|76213034|FG001|COMPLETED|Observational Non-Randomized Phase||1||
60096358|NCT01931735|76213035|FG002|COMPLETED|Observational Non-Randomized Phase||0||
60096359|NCT01931735|76213036|FG003|COMPLETED|Observational Non-Randomized Phase||9||
60096360|NCT01931735|76213033|FG000|NOT COMPLETED|Observational Non-Randomized Phase||0||
60096361|NCT01931735|76213034|FG001|NOT COMPLETED|Observational Non-Randomized Phase||0||
60096362|NCT01931735|76213035|FG002|NOT COMPLETED|Observational Non-Randomized Phase||0||
60096363|NCT01931735|76213036|FG003|NOT COMPLETED|Observational Non-Randomized Phase||2||
60096364|NCT01930799|76213046|FG000|STARTED|Overall Study||120||
60096365|NCT01930799|76213046|FG000|COMPLETED|Overall Study||112||
60096366|NCT01930799|76213046|FG000|NOT COMPLETED|Overall Study||8||
60096367|NCT01947491|76213054|FG000|STARTED|Overall Study||174||
60096368|NCT01947491|76213055|FG001|STARTED|Overall Study||87||
60096369|NCT01947491|76213056|FG002|STARTED|Overall Study||90||
60096370|NCT01947491|76213057|FG003|STARTED|Overall Study||43||
60096371|NCT01947491|76213054|FG000|COMPLETED|Overall Study||166||
60096372|NCT01947491|76213055|FG001|COMPLETED|Overall Study||81||
60096373|NCT01947491|76213056|FG002|COMPLETED|Overall Study||88||
60096374|NCT01947491|76213057|FG003|COMPLETED|Overall Study||38||
60096375|NCT01947491|76213054|FG000|NOT COMPLETED|Overall Study||8||
60096376|NCT01947491|76213055|FG001|NOT COMPLETED|Overall Study||6||
60096377|NCT01947491|76213056|FG002|NOT COMPLETED|Overall Study||2||
60096378|NCT01947491|76213057|FG003|NOT COMPLETED|Overall Study||5||
60096379|NCT01715857|76213067|FG000|STARTED|Overall Study||4100||
60096380|NCT01715857|76213067|FG000|COMPLETED|Overall Study||4004||
60096381|NCT01715857|76213067|FG000|NOT COMPLETED|Overall Study||96||
60096382|NCT01692301|76213073|FG000|STARTED|Overall Study|"Started indicates patients in randomized, full analysis and safety set"|229||
60096383|NCT01692301|76213074|FG001|STARTED|Overall Study||225||
60096384|NCT01692301|76213073|FG000|COMPLETED|Overall Study||184||
60096385|NCT01692301|76213074|FG001|COMPLETED|Overall Study||183||
60096386|NCT01692301|76213073|FG000|NOT COMPLETED|Overall Study||45||
60096387|NCT01692301|76213074|FG001|NOT COMPLETED|Overall Study||42||
60096388|NCT01592773|76213080|FG000|STARTED|Overall Study|All enrolled patients received at least 1 dose of investigational product (Safety Population).|747||
60096389|NCT01592773|76213080|FG000|COMPLETED|Overall Study||81||
60096390|NCT01592773|76213080|FG000|NOT COMPLETED|Overall Study||666||
60096391|NCT01930175|76213087|FG000|STARTED|Core Study||7||
60096392|NCT01930175|76213088|FG001|STARTED|Core Study||2||
60096393|NCT01930175|76213089|FG002|STARTED|Core Study||4||
60096394|NCT01930175|76213087|FG000|Safety Analysis Set|Core Study||7|Patients that received study drug|
60096395|NCT01930175|76213088|FG001|Safety Analysis Set|Core Study||2|Patients that received study drug|
60096396|NCT01930175|76213089|FG002|Safety Analysis Set|Core Study||4|Patients that received study drug|
60096397|NCT01930175|76213087|FG000|Pharmacokinetics (PK) Analysis Set|Core Study||7|Patients with at least one PK measurement and no major protocol deviations affecting PK|
60096398|NCT01930175|76213088|FG001|Pharmacokinetics (PK) Analysis Set|Core Study||2|Patients with at least one PK measurement and no major protocol deviations affecting PK|
60096399|NCT01930175|76213089|FG002|Pharmacokinetics (PK) Analysis Set|Core Study|Placebo patients were excluded from the PK analyses|0|Patients with at least one PK measurement and no major protocol deviations affecting PK|
60096400|NCT01930175|76213087|FG000|COMPLETED|Core Study||7||
60096401|NCT01930175|76213088|FG001|COMPLETED|Core Study||1||
60096402|NCT01930175|76213089|FG002|COMPLETED|Core Study||3||
60096403|NCT01930175|76213087|FG000|NOT COMPLETED|Core Study||0||
60096404|NCT01930175|76213088|FG001|NOT COMPLETED|Core Study||1||
60096405|NCT01930175|76213089|FG002|NOT COMPLETED|Core Study||1||
60096406|NCT01930175|76213087|FG000|STARTED|Open Label VAY736 10 mg/kg at Week 24|Only patients originally randomized to Placebo were allowed to enter this Period.|0||
60096407|NCT01930175|76213088|FG001|STARTED|Open Label VAY736 10 mg/kg at Week 24|Only patients originally randomized to Placebo were allowed to enter this Period.|0||
60096408|NCT01930175|76213089|FG002|STARTED|Open Label VAY736 10 mg/kg at Week 24|Only patients originally randomized to Placebo were allowed to enter this Period.|3||
60096409|NCT01930175|76213087|FG000|COMPLETED|Open Label VAY736 10 mg/kg at Week 24||0||
60096410|NCT01930175|76213088|FG001|COMPLETED|Open Label VAY736 10 mg/kg at Week 24||0||
60096411|NCT01930175|76213089|FG002|COMPLETED|Open Label VAY736 10 mg/kg at Week 24||3||
60096412|NCT01930175|76213087|FG000|NOT COMPLETED|Open Label VAY736 10 mg/kg at Week 24||0||
60096413|NCT01930175|76213088|FG001|NOT COMPLETED|Open Label VAY736 10 mg/kg at Week 24||0||
60096414|NCT01930175|76213089|FG002|NOT COMPLETED|Open Label VAY736 10 mg/kg at Week 24||0||
60096415|NCT01592695|76213100|FG000|STARTED|Overall Study||31||
60096416|NCT01592695|76213101|FG001|STARTED|Overall Study||32||
60096417|NCT01592695|76213100|FG000|COMPLETED|Overall Study||23||
60096418|NCT01592695|76213101|FG001|COMPLETED|Overall Study||28||
60096419|NCT01592695|76213100|FG000|NOT COMPLETED|Overall Study||8||
60096420|NCT01592695|76213101|FG001|NOT COMPLETED|Overall Study||4||
60096421|NCT01929863|76213107|FG000|STARTED|Period 1:Intervention Period 1 (7 Days)||7||
60096422|NCT01929863|76213108|FG001|STARTED|Period 1:Intervention Period 1 (7 Days)||8||
60096423|NCT01929863|76213107|FG000|COMPLETED|Period 1:Intervention Period 1 (7 Days)||6||
60096424|NCT01929863|76213108|FG001|COMPLETED|Period 1:Intervention Period 1 (7 Days)||7||
60096425|NCT01929863|76213107|FG000|NOT COMPLETED|Period 1:Intervention Period 1 (7 Days)||1||
60096426|NCT01929863|76213108|FG001|NOT COMPLETED|Period 1:Intervention Period 1 (7 Days)||1||
60096427|NCT01929863|76213107|FG000|STARTED|Period 2:Washout Period (13-15 Days)||6||
60096428|NCT01929863|76213108|FG001|STARTED|Period 2:Washout Period (13-15 Days)||7||
60096429|NCT01929863|76213107|FG000|COMPLETED|Period 2:Washout Period (13-15 Days)||6||
60096430|NCT01929863|76213108|FG001|COMPLETED|Period 2:Washout Period (13-15 Days)||7||
60096431|NCT01929863|76213107|FG000|NOT COMPLETED|Period 2:Washout Period (13-15 Days)||0||
60096432|NCT01929863|76213108|FG001|NOT COMPLETED|Period 2:Washout Period (13-15 Days)||0||
60096433|NCT01929863|76213107|FG000|STARTED|Period 3:Intervention Period 2 (7 Days)||6||
60096434|NCT01929863|76213108|FG001|STARTED|Period 3:Intervention Period 2 (7 Days)||7||
60096435|NCT01929863|76213107|FG000|COMPLETED|Period 3:Intervention Period 2 (7 Days)||6||
60096436|NCT01929863|76213108|FG001|COMPLETED|Period 3:Intervention Period 2 (7 Days)||6||
60096437|NCT01929863|76213107|FG000|NOT COMPLETED|Period 3:Intervention Period 2 (7 Days)||0||
60096438|NCT01929863|76213108|FG001|NOT COMPLETED|Period 3:Intervention Period 2 (7 Days)||1||
60096439|NCT01929863|76213107|FG000|STARTED|Period 4:Follow-up-Metformin (7-10 Days)||6||
60096440|NCT01929863|76213108|FG001|STARTED|Period 4:Follow-up-Metformin (7-10 Days)||6||
60096441|NCT01929863|76213107|FG000|COMPLETED|Period 4:Follow-up-Metformin (7-10 Days)||0||
60096442|NCT01929863|76213108|FG001|COMPLETED|Period 4:Follow-up-Metformin (7-10 Days)||0||
60096443|NCT01929863|76213107|FG000|NOT COMPLETED|Period 4:Follow-up-Metformin (7-10 Days)||6||
60096444|NCT01929863|76213108|FG001|NOT COMPLETED|Period 4:Follow-up-Metformin (7-10 Days)||6||
60096445|NCT01918085|76213121|FG000|STARTED|Test Period 1: Strata Strip||10||
60096446|NCT01918085|76213122|FG001|STARTED|Test Period 1: Strata Strip||12||
60096447|NCT01918085|76213121|FG000|COMPLETED|Test Period 1: Strata Strip||10||
60096448|NCT01918085|76213122|FG001|COMPLETED|Test Period 1: Strata Strip||11||
60096449|NCT01918085|76213121|FG000|NOT COMPLETED|Test Period 1: Strata Strip||0||
60096450|NCT01918085|76213122|FG001|NOT COMPLETED|Test Period 1: Strata Strip||1||
60096451|NCT01918085|76213121|FG000|STARTED|Test Period 1: Hydrocolloid Strip||10||
60096452|NCT01918085|76213122|FG001|STARTED|Test Period 1: Hydrocolloid Strip||11||
60096453|NCT01918085|76213121|FG000|COMPLETED|Test Period 1: Hydrocolloid Strip||10||
60096454|NCT01918085|76213122|FG001|COMPLETED|Test Period 1: Hydrocolloid Strip||11||
60096455|NCT01918085|76213121|FG000|NOT COMPLETED|Test Period 1: Hydrocolloid Strip||0||
60096456|NCT01918085|76213122|FG001|NOT COMPLETED|Test Period 1: Hydrocolloid Strip||0||
60096457|NCT01918085|76213121|FG000|STARTED|Test Period 2: Strata Strip||10||
60096458|NCT01918085|76213122|FG001|STARTED|Test Period 2: Strata Strip||11||
60096459|NCT01918085|76213121|FG000|COMPLETED|Test Period 2: Strata Strip||10||
60096460|NCT01918085|76213122|FG001|COMPLETED|Test Period 2: Strata Strip||11||
60096461|NCT01918085|76213121|FG000|NOT COMPLETED|Test Period 2: Strata Strip||0||
60096462|NCT01918085|76213122|FG001|NOT COMPLETED|Test Period 2: Strata Strip||0||
60096463|NCT01918085|76213121|FG000|STARTED|Test Period 2: Hydrocolloid Strip||10||
60096464|NCT01918085|76213122|FG001|STARTED|Test Period 2: Hydrocolloid Strip||11||
60096465|NCT01918085|76213121|FG000|COMPLETED|Test Period 2: Hydrocolloid Strip||10||
60096466|NCT01918085|76213122|FG001|COMPLETED|Test Period 2: Hydrocolloid Strip||11||
60096467|NCT01918085|76213121|FG000|NOT COMPLETED|Test Period 2: Hydrocolloid Strip||0||
60096468|NCT01918085|76213122|FG001|NOT COMPLETED|Test Period 2: Hydrocolloid Strip||0||
60096469|NCT01714687|76213132|FG000|STARTED|Overall Study||29||
60096470|NCT01714687|76213133|FG001|STARTED|Overall Study||30||
60096471|NCT01714687|76213132|FG000|COMPLETED|Overall Study||26||
60096472|NCT01714687|76213133|FG001|COMPLETED|Overall Study||26||
60096473|NCT01714687|76213132|FG000|NOT COMPLETED|Overall Study||3||
60096474|NCT01714687|76213133|FG001|NOT COMPLETED|Overall Study||4||
60096475|NCT01714609|76213143|FG000|STARTED|Overall Study||5||
60096476|NCT01714609|76213144|FG001|STARTED|Overall Study||5||
60096477|NCT01714609|76213143|FG000|COMPLETED|Overall Study||4||
60096478|NCT01714609|76213144|FG001|COMPLETED|Overall Study||5||
60096479|NCT01714609|76213143|FG000|NOT COMPLETED|Overall Study||1||
60096480|NCT01714609|76213144|FG001|NOT COMPLETED|Overall Study||0||
60096481|NCT01929707|76213150|FG000|STARTED|Intervention Period 1||6||
60096482|NCT01929707|76213151|FG001|STARTED|Intervention Period 1||8||
60096483|NCT01929707|76213152|FG002|STARTED|Intervention Period 1||12||
60096484|NCT01929707|76213153|FG003|STARTED|Intervention Period 1||10||
60096485|NCT01929707|76213154|FG004|STARTED|Intervention Period 1||0||
60096486|NCT01929707|76213155|FG005|STARTED|Intervention Period 1||0||
60096487|NCT01929707|76213156|FG006|STARTED|Intervention Period 1||0||
60096488|NCT01929707|76213157|FG007|STARTED|Intervention Period 1||0||
60096489|NCT01929707|76213150|FG000|Received at Least 1 Dose of Study Drug|Intervention Period 1||6||
60096490|NCT01929707|76213151|FG001|Received at Least 1 Dose of Study Drug|Intervention Period 1||8||
60096491|NCT01929707|76213152|FG002|Received at Least 1 Dose of Study Drug|Intervention Period 1||12||
60096492|NCT01929707|76213153|FG003|Received at Least 1 Dose of Study Drug|Intervention Period 1||10||
59562422|NCT02396147|75664191|FG001|COMPLETED|Period 3||27||
59562423|NCT02396147|75664190|FG000|NOT COMPLETED|Period 3||0||
59562424|NCT02396147|75664191|FG001|NOT COMPLETED|Period 3||0||
59562425|NCT01713608|75664209|FG000|STARTED|Overall Study||8||
59562426|NCT01713608|75664210|FG001|STARTED|Overall Study||6||
59562427|NCT01713608|75664211|FG002|STARTED|Overall Study||8||
59562428|NCT01713608|75664212|FG003|STARTED|Overall Study||12||
59562429|NCT01713608|75664209|FG000|COMPLETED|Overall Study||8||
59993536|NCT02426918|76109454|FG001|COMPLETED|Overall Study||90||
59562430|NCT01713608|75664210|FG001|COMPLETED|Overall Study||6||
59562431|NCT01713608|75664211|FG002|COMPLETED|Overall Study||8||
59562432|NCT01713608|75664212|FG003|COMPLETED|Overall Study||12||
59993537|NCT02426918|76109455|FG002|COMPLETED|Overall Study||97||
59993538|NCT02426918|76109453|FG000|NOT COMPLETED|Overall Study||17||
59993539|NCT02426918|76109454|FG001|NOT COMPLETED|Overall Study||19||
59993540|NCT02426918|76109455|FG002|NOT COMPLETED|Overall Study||14||
59993541|NCT02387840|76109469|FG000|STARTED|Overall Study||4||
59993542|NCT02387840|76109470|FG001|STARTED|Overall Study||6||
59993543|NCT02387840|76109471|FG002|STARTED|Overall Study||6||
59993544|NCT02387840|76109472|FG003|STARTED|Overall Study||8||
59993545|NCT02387840|76109473|FG004|STARTED|Overall Study||4||
60096493|NCT01929707|76213154|FG004|Received at Least 1 Dose of Study Drug|Intervention Period 1||0||
60096494|NCT01929707|76213155|FG005|Received at Least 1 Dose of Study Drug|Intervention Period 1||0||
60096495|NCT01929707|76213156|FG006|Received at Least 1 Dose of Study Drug|Intervention Period 1||0||
59562433|NCT01713608|75664209|FG000|NOT COMPLETED|Overall Study||0||
60096496|NCT01929707|76213157|FG007|Received at Least 1 Dose of Study Drug|Intervention Period 1||0||
59562434|NCT01713608|75664210|FG001|NOT COMPLETED|Overall Study||0||
59993546|NCT02387840|76109474|FG005|STARTED|Overall Study||6||
59993547|NCT02387840|76109469|FG000|COMPLETED|Overall Study||4||
59993548|NCT02387840|76109470|FG001|COMPLETED|Overall Study||6||
60096497|NCT01929707|76213150|FG000|COMPLETED|Intervention Period 1||6||
60096498|NCT01929707|76213151|FG001|COMPLETED|Intervention Period 1||8||
60096499|NCT01929707|76213152|FG002|COMPLETED|Intervention Period 1||12||
60096500|NCT01929707|76213153|FG003|COMPLETED|Intervention Period 1|Two discontinued participants were replaced in Period 2|7||
60096501|NCT01929707|76213154|FG004|COMPLETED|Intervention Period 1||0||
60096502|NCT01929707|76213155|FG005|COMPLETED|Intervention Period 1||0||
60096503|NCT01929707|76213156|FG006|COMPLETED|Intervention Period 1||0||
60096504|NCT01929707|76213157|FG007|COMPLETED|Intervention Period 1||0||
60096505|NCT01929707|76213150|FG000|NOT COMPLETED|Intervention Period 1||0||
60096506|NCT01929707|76213151|FG001|NOT COMPLETED|Intervention Period 1||0||
60096507|NCT01929707|76213152|FG002|NOT COMPLETED|Intervention Period 1||0||
60096508|NCT01929707|76213153|FG003|NOT COMPLETED|Intervention Period 1||3||
60096509|NCT01929707|76213154|FG004|NOT COMPLETED|Intervention Period 1||0||
59562435|NCT01713608|75664211|FG002|NOT COMPLETED|Overall Study||0||
59562436|NCT01713608|75664212|FG003|NOT COMPLETED|Overall Study||0||
60096510|NCT01929707|76213155|FG005|NOT COMPLETED|Intervention Period 1||0||
60096511|NCT01929707|76213156|FG006|NOT COMPLETED|Intervention Period 1||0||
60096512|NCT01929707|76213157|FG007|NOT COMPLETED|Intervention Period 1||0||
60096513|NCT01929707|76213150|FG000|STARTED|Washout Period ≥7 Days||6||
60096514|NCT01929707|76213151|FG001|STARTED|Washout Period ≥7 Days||8||
60096515|NCT01929707|76213152|FG002|STARTED|Washout Period ≥7 Days||12||
60096516|NCT01929707|76213153|FG003|STARTED|Washout Period ≥7 Days||7||
60096517|NCT01929707|76213154|FG004|STARTED|Washout Period ≥7 Days||0||
60096518|NCT01929707|76213155|FG005|STARTED|Washout Period ≥7 Days||0||
60096519|NCT01929707|76213156|FG006|STARTED|Washout Period ≥7 Days||0||
60096520|NCT01929707|76213157|FG007|STARTED|Washout Period ≥7 Days||0||
60096521|NCT01929707|76213150|FG000|COMPLETED|Washout Period ≥7 Days||6||
60096522|NCT01929707|76213151|FG001|COMPLETED|Washout Period ≥7 Days||8||
60096523|NCT01929707|76213152|FG002|COMPLETED|Washout Period ≥7 Days||12||
60096524|NCT01929707|76213153|FG003|COMPLETED|Washout Period ≥7 Days||7||
60096525|NCT01929707|76213154|FG004|COMPLETED|Washout Period ≥7 Days||0||
59562437|NCT02018315|75664221|FG000|STARTED|Overall Study||14||
59562438|NCT02018315|75664221|FG000|COMPLETED|Overall Study||14||
59562439|NCT02018315|75664221|FG000|NOT COMPLETED|Overall Study||0||
59562440|NCT02018627|75664227|FG000|STARTED|Overall Study||7||
59562441|NCT02018627|75664228|FG001|STARTED|Overall Study||6||
59562442|NCT02018627|75664227|FG000|COMPLETED|Overall Study||7||
59562443|NCT02018627|75664228|FG001|COMPLETED|Overall Study||6||
59562444|NCT02018627|75664227|FG000|NOT COMPLETED|Overall Study||0||
59562445|NCT02018627|75664228|FG001|NOT COMPLETED|Overall Study||0||
59993549|NCT02387840|76109471|FG002|COMPLETED|Overall Study||6||
59993550|NCT02387840|76109472|FG003|COMPLETED|Overall Study||8||
59993551|NCT02387840|76109473|FG004|COMPLETED|Overall Study||4||
59993552|NCT02387840|76109474|FG005|COMPLETED|Overall Study||5||
59993553|NCT02387840|76109469|FG000|NOT COMPLETED|Overall Study||0||
60096526|NCT01929707|76213155|FG005|COMPLETED|Washout Period ≥7 Days||0||
60096527|NCT01929707|76213156|FG006|COMPLETED|Washout Period ≥7 Days||0||
60096528|NCT01929707|76213157|FG007|COMPLETED|Washout Period ≥7 Days||0||
60096529|NCT01929707|76213150|FG000|NOT COMPLETED|Washout Period ≥7 Days||0||
60096530|NCT01929707|76213151|FG001|NOT COMPLETED|Washout Period ≥7 Days||0||
60096531|NCT01929707|76213152|FG002|NOT COMPLETED|Washout Period ≥7 Days||0||
60096532|NCT01929707|76213153|FG003|NOT COMPLETED|Washout Period ≥7 Days||0||
60096533|NCT01929707|76213154|FG004|NOT COMPLETED|Washout Period ≥7 Days||0||
60096534|NCT01929707|76213155|FG005|NOT COMPLETED|Washout Period ≥7 Days||0||
60096535|NCT01929707|76213156|FG006|NOT COMPLETED|Washout Period ≥7 Days||0||
60096536|NCT01929707|76213157|FG007|NOT COMPLETED|Washout Period ≥7 Days||0||
60096537|NCT01929707|76213150|FG000|STARTED|Intervention Period 2|Incomplete-crossover design|0||
60096538|NCT01929707|76213151|FG001|STARTED|Intervention Period 2|Incomplete-crossover design|0||
60096539|NCT01929707|76213152|FG002|STARTED|Intervention Period 2|Incomplete-crossover design|0||
60096540|NCT01929707|76213153|FG003|STARTED|Intervention Period 2|Incomplete-crossover design|5||
59993554|NCT02387840|76109470|FG001|NOT COMPLETED|Overall Study||0||
59993555|NCT02387840|76109471|FG002|NOT COMPLETED|Overall Study||0||
59993556|NCT02387840|76109472|FG003|NOT COMPLETED|Overall Study||0||
59993557|NCT02387840|76109473|FG004|NOT COMPLETED|Overall Study||0||
59993558|NCT02387840|76109474|FG005|NOT COMPLETED|Overall Study||1||
59993559|NCT02387762|76109496|FG000|STARTED|Overall Study||16||
60096541|NCT01929707|76213154|FG004|STARTED|Intervention Period 2|Incomplete-crossover design|6||
60096542|NCT01929707|76213155|FG005|STARTED|Intervention Period 2|Incomplete-crossover design|8||
60096543|NCT01929707|76213156|FG006|STARTED|Intervention Period 2|Incomplete-crossover design|12||
59562446|NCT01714232|75664234|FG000|STARTED|Overall Study||106||
59993560|NCT02387762|76109497|FG001|STARTED|Overall Study||15||
60096544|NCT01929707|76213157|FG007|STARTED|Intervention Period 2|Incomplete-crossover design|4||
60096545|NCT01929707|76213150|FG000|COMPLETED|Intervention Period 2||0||
60096546|NCT01929707|76213151|FG001|COMPLETED|Intervention Period 2||0||
59562447|NCT01714232|75664234|FG000|COMPLETED|Overall Study||106||
59562448|NCT01714232|75664234|FG000|NOT COMPLETED|Overall Study||0||
59562449|NCT02019563|75664240|FG000|STARTED|Overall Study|100 incisors were treated in the MTA/FS pulpotomy group|40||
59562450|NCT02019563|75664241|FG001|STARTED|Overall Study|72 incisors were treated in the RCT group|30||
59993561|NCT02387762|76109496|FG000|COMPLETED|Overall Study||15||
59993562|NCT02387762|76109497|FG001|COMPLETED|Overall Study||15||
59993563|NCT02387762|76109496|FG000|NOT COMPLETED|Overall Study||1||
60096547|NCT01929707|76213152|FG002|COMPLETED|Intervention Period 2||0||
60096548|NCT01929707|76213153|FG003|COMPLETED|Intervention Period 2||5||
60096549|NCT01929707|76213154|FG004|COMPLETED|Intervention Period 2||6||
60096550|NCT01929707|76213155|FG005|COMPLETED|Intervention Period 2||6||
60096551|NCT01929707|76213156|FG006|COMPLETED|Intervention Period 2||12||
60096552|NCT01929707|76213157|FG007|COMPLETED|Intervention Period 2||4||
60096553|NCT01929707|76213150|FG000|NOT COMPLETED|Intervention Period 2||0||
60096554|NCT01929707|76213151|FG001|NOT COMPLETED|Intervention Period 2||0||
60096555|NCT01929707|76213152|FG002|NOT COMPLETED|Intervention Period 2||0||
60096556|NCT01929707|76213153|FG003|NOT COMPLETED|Intervention Period 2||0||
60096557|NCT01929707|76213154|FG004|NOT COMPLETED|Intervention Period 2||0||
60096558|NCT01929707|76213155|FG005|NOT COMPLETED|Intervention Period 2||2||
59993564|NCT02387762|76109497|FG001|NOT COMPLETED|Overall Study||0||
59993565|NCT02418182|76109505|FG000|STARTED|Overall Study||49||
59993566|NCT02418182|76109506|FG001|STARTED|Overall Study||50||
59993567|NCT02418182|76109505|FG000|COMPLETED|Overall Study||31||
59993568|NCT02418182|76109506|FG001|COMPLETED|Overall Study||33||
59993569|NCT02418182|76109505|FG000|NOT COMPLETED|Overall Study||18||
60096559|NCT01929707|76213156|FG006|NOT COMPLETED|Intervention Period 2||0||
60096560|NCT01929707|76213157|FG007|NOT COMPLETED|Intervention Period 2||0||
60096561|NCT01714063|76213178|FG000|STARTED|Overall Study||34||
60096562|NCT01714063|76213178|FG000|COMPLETED|Overall Study||32||
60096563|NCT01714063|76213178|FG000|NOT COMPLETED|Overall Study||2||
60096564|NCT01929395|76213189|FG000|STARTED|Overall Study||19||
60096565|NCT01929395|76213190|FG001|STARTED|Overall Study||70||
60096566|NCT01929395|76213191|FG002|STARTED|Overall Study||70||
60096567|NCT01929395|76213189|FG000|COMPLETED|Overall Study||18||
60096568|NCT01929395|76213190|FG001|COMPLETED|Overall Study||69||
60096569|NCT01929395|76213191|FG002|COMPLETED|Overall Study||69||
60096570|NCT01929395|76213189|FG000|NOT COMPLETED|Overall Study||1||
60096571|NCT01929395|76213190|FG001|NOT COMPLETED|Overall Study||1||
60096572|NCT01929395|76213191|FG002|NOT COMPLETED|Overall Study||1||
60096573|NCT01713283|76213203|FG000|STARTED|Overall Study||31||
60096574|NCT01713283|76213204|FG001|STARTED|Overall Study||29||
60096575|NCT01713283|76213203|FG000|COMPLETED|Overall Study||20||
60096576|NCT01713283|76213204|FG001|COMPLETED|Overall Study||26||
60096577|NCT01713283|76213203|FG000|NOT COMPLETED|Overall Study||11||
60096578|NCT01713283|76213204|FG001|NOT COMPLETED|Overall Study||3||
60096579|NCT01592383|76213214|FG000|STARTED|Overall Study||2||
60096580|NCT01592383|76213214|FG000|COMPLETED|Overall Study||1||
60096581|NCT01592383|76213214|FG000|NOT COMPLETED|Overall Study||1||
60096582|NCT01691521|76213222|FG000|STARTED|Overall Study||191||
60096583|NCT01691521|76213223|FG001|STARTED|Overall Study||191||
60096584|NCT01691521|76213224|FG002|STARTED|Overall Study||194||
60096585|NCT01691521|76213222|FG000|COMPLETED|Overall Study||179||
60096586|NCT01691521|76213223|FG001|COMPLETED|Overall Study||175||
60096587|NCT01691521|76213224|FG002|COMPLETED|Overall Study||185||
60096588|NCT01691521|76213222|FG000|NOT COMPLETED|Overall Study||12||
60096589|NCT01691521|76213223|FG001|NOT COMPLETED|Overall Study||16||
60096590|NCT01691521|76213224|FG002|NOT COMPLETED|Overall Study||9||
60096591|NCT01929317|76213235|FG000|STARTED|Dose Increase Effect Verification Phase||61||
60096592|NCT01929317|76213236|FG001|STARTED|Dose Increase Effect Verification Phase||20||
60096593|NCT01929317|76213235|FG000|COMPLETED|Dose Increase Effect Verification Phase||52||
60096594|NCT01929317|76213236|FG001|COMPLETED|Dose Increase Effect Verification Phase||19||
60096595|NCT01929317|76213235|FG000|NOT COMPLETED|Dose Increase Effect Verification Phase||9||
60096596|NCT01929317|76213236|FG001|NOT COMPLETED|Dose Increase Effect Verification Phase||1||
60096597|NCT01929317|76213235|FG000|STARTED|Long-term Phase||44||
59993570|NCT02418182|76109506|FG001|NOT COMPLETED|Overall Study||17||
59993571|NCT04884191|76109515|FG000|STARTED|Overall Study||55||
59993572|NCT04884191|76109516|FG001|STARTED|Overall Study||55||
59993573|NCT04884191|76109517|FG002|STARTED|Overall Study||55||
60096598|NCT01929317|76213236|FG001|STARTED|Long-term Phase||18||
60096599|NCT01929317|76213235|FG000|COMPLETED|Long-term Phase||25||
60096600|NCT01929317|76213236|FG001|COMPLETED|Long-term Phase||14||
60096601|NCT01929317|76213235|FG000|NOT COMPLETED|Long-term Phase||19||
60096602|NCT01929317|76213236|FG001|NOT COMPLETED|Long-term Phase||4||
60096603|NCT01711879|76213250|FG000|STARTED|Overall Study||3||
60096604|NCT01711879|76213251|FG001|STARTED|Overall Study||4||
60096605|NCT01711879|76213250|FG000|COMPLETED|Overall Study||2||
60096606|NCT01711879|76213251|FG001|COMPLETED|Overall Study||4||
60096607|NCT01711879|76213250|FG000|NOT COMPLETED|Overall Study||1||
60096608|NCT01711879|76213251|FG001|NOT COMPLETED|Overall Study||0||
60096609|NCT00869206|76213261|FG000|STARTED|Overall Study||911||
59993574|NCT04884191|76109515|FG000|COMPLETED|Overall Study||52||
59993575|NCT04884191|76109516|FG001|COMPLETED|Overall Study||55||
60096610|NCT00869206|76213262|FG001|STARTED|Overall Study||911||
60096611|NCT00869206|76213261|FG000|COMPLETED|Overall Study||882||
60096612|NCT00869206|76213262|FG001|COMPLETED|Overall Study||884||
60096613|NCT00869206|76213261|FG000|NOT COMPLETED|Overall Study||29||
60096614|NCT00869206|76213262|FG001|NOT COMPLETED|Overall Study||27||
60096615|NCT01689649|76213274|FG000|STARTED|Overall Study||139||
60096616|NCT01689649|76213274|FG000|COMPLETED|Overall Study||117||
60096617|NCT01689649|76213274|FG000|NOT COMPLETED|Overall Study||22||
59708105|NCT00980200|75826928|FG003|NOT COMPLETED|7-day Treatment Period 3||0||
59816969|NCT02516241|75939377|FG001|COMPLETED|Overall Study||0||
60096618|NCT01929083|76213278|FG000|STARTED|Intervention 1|Number of patients randomized to receive progesterone first|10||
60096619|NCT01929083|76213279|FG001|STARTED|Intervention 1||9||
60096620|NCT01929083|76213278|FG000|Returned for 1st Ibutilide Administratio|Intervention 1||7||
60096621|NCT01929083|76213279|FG001|Returned for 1st Ibutilide Administratio|Intervention 1||9||
60096622|NCT01929083|76213278|FG000|COMPLETED|Intervention 1||7||
60096623|NCT01929083|76213279|FG001|COMPLETED|Intervention 1||9||
60096624|NCT01929083|76213278|FG000|NOT COMPLETED|Intervention 1||3||
60096625|NCT01929083|76213279|FG001|NOT COMPLETED|Intervention 1||0||
60096626|NCT01929083|76213278|FG000|STARTED|Intervention 2||7||
60096627|NCT01929083|76213279|FG001|STARTED|Intervention 2||9||
59562451|NCT02019563|75664240|FG000|COMPLETED|Overall Study|100 incisors were treated in the MTA/FS pulpotomy group|40||
59562452|NCT02019563|75664241|FG001|COMPLETED|Overall Study|72 incisors were treated in the RCT group|30||
59562453|NCT02019563|75664240|FG000|NOT COMPLETED|Overall Study||0||
59562454|NCT02019563|75664241|FG001|NOT COMPLETED|Overall Study||0||
59562455|NCT02063867|75664251|FG000|STARTED|Overall Study||156889||26
60096628|NCT01929083|76213278|FG000|Returned for 2nd Ibutilide Administratio|Intervention 2||7||
60096629|NCT01929083|76213279|FG001|Returned for 2nd Ibutilide Administratio|Intervention 2||8||
60096630|NCT01929083|76213278|FG000|COMPLETED|Intervention 2||7||
60096631|NCT01929083|76213279|FG001|COMPLETED|Intervention 2||8||
60096632|NCT01929083|76213278|FG000|NOT COMPLETED|Intervention 2||0||
60096633|NCT01929083|76213279|FG001|NOT COMPLETED|Intervention 2||1||
60096634|NCT01689337|76213285|FG000|STARTED|Overall Study||1||
60096635|NCT01689337|76213285|FG000|COMPLETED|Overall Study||0||
60096636|NCT01689337|76213285|FG000|NOT COMPLETED|Overall Study||1||
60096637|NCT01688635|76213291|FG000|STARTED|Period 1||45||
60096638|NCT01688635|76213292|FG001|STARTED|Period 1||46||
60096639|NCT01688635|76213291|FG000|Received at Least 1 Dose of Study Drug|Period 1||45||
60096640|NCT01688635|76213292|FG001|Received at Least 1 Dose of Study Drug|Period 1||46||
60096641|NCT01688635|76213291|FG000|COMPLETED|Period 1||45||
60096642|NCT01688635|76213292|FG001|COMPLETED|Period 1||46||
60096643|NCT01688635|76213291|FG000|NOT COMPLETED|Period 1||0||
60096644|NCT01688635|76213292|FG001|NOT COMPLETED|Period 1||0||
60096645|NCT01688635|76213291|FG000|STARTED|Washout 1||45||
60096646|NCT01688635|76213292|FG001|STARTED|Washout 1||46||
60096647|NCT01688635|76213291|FG000|COMPLETED|Washout 1||44||
60096648|NCT01688635|76213292|FG001|COMPLETED|Washout 1||44||
60096649|NCT01688635|76213291|FG000|NOT COMPLETED|Washout 1||1||
60096650|NCT01688635|76213292|FG001|NOT COMPLETED|Washout 1||2||
60096651|NCT01688635|76213291|FG000|STARTED|Period 2||44||
60096652|NCT01688635|76213292|FG001|STARTED|Period 2||44||
60096653|NCT01688635|76213291|FG000|COMPLETED|Period 2||44||
60096654|NCT01688635|76213292|FG001|COMPLETED|Period 2||44||
59562456|NCT02063867|75664252|FG001|STARTED|Overall Study||183013||27
59562457|NCT02063867|75664251|FG000|COMPLETED|Overall Study||152598||24
60096655|NCT01688635|76213291|FG000|NOT COMPLETED|Period 2||0||
60096656|NCT01688635|76213292|FG001|NOT COMPLETED|Period 2||0||
60096657|NCT01688635|76213291|FG000|STARTED|Washout 2||44||
60096658|NCT01688635|76213292|FG001|STARTED|Washout 2||44||
60096659|NCT01688635|76213291|FG000|COMPLETED|Washout 2||41||
60096660|NCT01688635|76213292|FG001|COMPLETED|Washout 2||42||
60096661|NCT01688635|76213291|FG000|NOT COMPLETED|Washout 2||3||
60096662|NCT01688635|76213292|FG001|NOT COMPLETED|Washout 2||2||
60096663|NCT01688635|76213291|FG000|STARTED|Period 3||41||
60096664|NCT01688635|76213292|FG001|STARTED|Period 3||42||
60096665|NCT01688635|76213291|FG000|COMPLETED|Period 3||41||
60096666|NCT01688635|76213292|FG001|COMPLETED|Period 3||42||
60096667|NCT01688635|76213291|FG000|NOT COMPLETED|Period 3||0||
60096668|NCT01688635|76213292|FG001|NOT COMPLETED|Period 3||0||
60096669|NCT01688635|76213291|FG000|STARTED|Washout 3||41||
60096670|NCT01688635|76213292|FG001|STARTED|Washout 3||42||
60096671|NCT01688635|76213291|FG000|COMPLETED|Washout 3||40||
60096672|NCT01688635|76213292|FG001|COMPLETED|Washout 3||42||
60096673|NCT01688635|76213291|FG000|NOT COMPLETED|Washout 3||1||
60096674|NCT01688635|76213292|FG001|NOT COMPLETED|Washout 3||0||
60096675|NCT01688635|76213291|FG000|STARTED|Period 4||40||
60096676|NCT01688635|76213292|FG001|STARTED|Period 4||42||
60096677|NCT01688635|76213291|FG000|COMPLETED|Period 4||40||
60096678|NCT01688635|76213292|FG001|COMPLETED|Period 4||42||
60096679|NCT01688635|76213291|FG000|NOT COMPLETED|Period 4||0||
60096680|NCT01688635|76213292|FG001|NOT COMPLETED|Period 4||0||
60096681|NCT01591681|76213299|FG000|STARTED|Overall Study||49||
60096682|NCT01591681|76213299|FG000|COMPLETED|Overall Study||45||
60096683|NCT01591681|76213299|FG000|NOT COMPLETED|Overall Study||4||
60096684|NCT00891436|76213307|FG000|STARTED|Overall Study||10||
60096685|NCT00891436|76213308|FG001|STARTED|Overall Study||10||
60096686|NCT00891436|76213307|FG000|COMPLETED|Overall Study||10||
60096687|NCT00891436|76213308|FG001|COMPLETED|Overall Study||10||
60096688|NCT00891436|76213307|FG000|NOT COMPLETED|Overall Study||0||
60096689|NCT00891436|76213308|FG001|NOT COMPLETED|Overall Study||0||
60096690|NCT01711645|76213314|FG000|STARTED|Overall Study||55||
60096691|NCT01711645|76213314|FG000|COMPLETED|Overall Study||36||
60096692|NCT01711645|76213314|FG000|NOT COMPLETED|Overall Study||19||
60096693|NCT00820534|76213320|FG000|STARTED|Overall Study||64||
60096694|NCT00820534|76213321|FG001|STARTED|Overall Study||62||
60096695|NCT00820534|76213320|FG000|COMPLETED|Overall Study||64||
60096696|NCT00820534|76213321|FG001|COMPLETED|Overall Study||62||
60096697|NCT00820534|76213320|FG000|NOT COMPLETED|Overall Study||0||
60096698|NCT00820534|76213321|FG001|NOT COMPLETED|Overall Study||0||
60096699|NCT01590433|76213329|FG000|STARTED|Overall Study||127||
60096700|NCT01590433|76213330|FG001|STARTED|Overall Study||55||
60096701|NCT01590433|76213329|FG000|COMPLETED|Overall Study||75||
60096702|NCT01590433|76213330|FG001|COMPLETED|Overall Study||33||
60096703|NCT01590433|76213329|FG000|NOT COMPLETED|Overall Study||52||
60096704|NCT01590433|76213330|FG001|NOT COMPLETED|Overall Study||22||
60096705|NCT00820612|76213338|FG000|STARTED|Overall Study||307||
60096706|NCT00820612|76213339|FG001|STARTED|Overall Study||295||
60096707|NCT00820612|76213338|FG000|COMPLETED|Overall Study||307||
60096708|NCT00820612|76213339|FG001|COMPLETED|Overall Study||295||
60096709|NCT00820612|76213338|FG000|NOT COMPLETED|Overall Study||0||
60096710|NCT00820612|76213339|FG001|NOT COMPLETED|Overall Study||0||
60096711|NCT01928927|76213347|FG000|STARTED|Overall Study||29||
60096712|NCT01928927|76213348|FG001|STARTED|Overall Study||15||
60096713|NCT01928927|76213347|FG000|COMPLETED|Overall Study||27||
60096714|NCT01928927|76213348|FG001|COMPLETED|Overall Study||14||
60096715|NCT01928927|76213347|FG000|NOT COMPLETED|Overall Study||2||
60096716|NCT01928927|76213348|FG001|NOT COMPLETED|Overall Study||1||
60096717|NCT00871624|76213360|FG000|STARTED|Overall Study||18||
60096718|NCT00871624|76213361|FG001|STARTED|Overall Study||18||
60096719|NCT00871624|76213360|FG000|COMPLETED|Overall Study||16||
60096720|NCT00871624|76213361|FG001|COMPLETED|Overall Study||17||
60096721|NCT00871624|76213360|FG000|NOT COMPLETED|Overall Study||2||
60096722|NCT00871624|76213361|FG001|NOT COMPLETED|Overall Study||1||
60096723|NCT01710709|76213369|FG000|STARTED|Overall Study||464||
60096724|NCT01710709|76213369|FG000|COMPLETED|Overall Study||291||
60096725|NCT01710709|76213369|FG000|NOT COMPLETED|Overall Study||173||
60096726|NCT01617629|76213374|FG000|STARTED|Overall Study||9||
60096727|NCT01617629|76213374|FG000|COMPLETED|Overall Study||3||
60096728|NCT01617629|76213374|FG000|NOT COMPLETED|Overall Study||6||
60096729|NCT00874510|76213380|FG000|STARTED|Year 1||88||
60096730|NCT00874510|76213381|FG001|STARTED|Year 1||85||
60096731|NCT00874510|76213380|FG000|COMPLETED|Year 1||88||
60096732|NCT00874510|76213381|FG001|COMPLETED|Year 1||85||
60096733|NCT00874510|76213380|FG000|NOT COMPLETED|Year 1||0||
60096734|NCT00874510|76213381|FG001|NOT COMPLETED|Year 1||0||
60096735|NCT00874510|76213380|FG000|STARTED|Year 2||92||
60096736|NCT00874510|76213381|FG001|STARTED|Year 2||87||
60096737|NCT00874510|76213380|FG000|COMPLETED|Year 2||92||
60096738|NCT00874510|76213381|FG001|COMPLETED|Year 2||87||
60096739|NCT00874510|76213380|FG000|NOT COMPLETED|Year 2||0||
60096740|NCT00874510|76213381|FG001|NOT COMPLETED|Year 2||0||
60096741|NCT01686373|76213389|FG000|STARTED|Overall Study||34||
60096742|NCT01686373|76213390|FG001|STARTED|Overall Study||40||
60096743|NCT01686373|76213389|FG000|Received 15 Treatment Sessions|Overall Study||33||
60096744|NCT01686373|76213390|FG001|Received 15 Treatment Sessions|Overall Study||39||
60096745|NCT01686373|76213389|FG000|COMPLETED|Overall Study||31||
60096746|NCT01686373|76213390|FG001|COMPLETED|Overall Study||38||
60096747|NCT01686373|76213389|FG000|NOT COMPLETED|Overall Study||3||
60096748|NCT01686373|76213390|FG001|NOT COMPLETED|Overall Study||2||
59562458|NCT02063867|75664252|FG001|COMPLETED|Overall Study||180048||24
59562459|NCT02063867|75664251|FG000|NOT COMPLETED|Overall Study||4291||2
59562460|NCT02063867|75664252|FG001|NOT COMPLETED|Overall Study||2965||3
59562461|NCT01715948|75664258|FG000|STARTED|Overall Study||9||
59562462|NCT01715948|75664258|FG000|COMPLETED|Overall Study||8||
59562463|NCT01715948|75664258|FG000|NOT COMPLETED|Overall Study||1||
59562464|NCT02021669|75664279|FG000|STARTED|Overall Study||71||
59562465|NCT02021669|75664280|FG001|STARTED|Overall Study||73||
59562466|NCT02021669|75664279|FG000|COMPLETED|Overall Study||64||
60096749|NCT01709695|76213398|FG000|STARTED|Overall Study||13||
60096750|NCT01709695|76213399|FG001|STARTED|Overall Study||14||
60096751|NCT01709695|76213398|FG000|COMPLETED|Overall Study||12||
60096752|NCT01709695|76213399|FG001|COMPLETED|Overall Study||13||
60096753|NCT01709695|76213398|FG000|NOT COMPLETED|Overall Study||1||
60096754|NCT01709695|76213399|FG001|NOT COMPLETED|Overall Study||1||
60096755|NCT02150044|76213405|FG000|STARTED|Overall Study||29||
60096756|NCT02150044|76213405|FG000|Lead-In Subjects|Overall Study||16||
60096757|NCT02150044|76213405|FG000|Study Cohort|Overall Study||13||
60096758|NCT02150044|76213405|FG000|COMPLETED|Overall Study||29||
60096759|NCT02150044|76213405|FG000|NOT COMPLETED|Overall Study||0||
60096760|NCT01685983|76213409|FG000|STARTED|Overall Study||82||
60096761|NCT01685983|76213409|FG000|COMPLETED|Overall Study||0||
60096762|NCT01685983|76213409|FG000|NOT COMPLETED|Overall Study||82||
60096763|NCT02151448|76213413|FG000|STARTED|Phase 1||9||
60096764|NCT02151448|76213413|FG000|COMPLETED|Phase 1||9||
60096765|NCT02151448|76213413|FG000|NOT COMPLETED|Phase 1||0||
60096766|NCT02151448|76213413|FG000|STARTED|Phase 2||55||
60096767|NCT02151448|76213413|FG000|COMPLETED|Phase 2||55||
60096768|NCT02151448|76213413|FG000|NOT COMPLETED|Phase 2||0||
60096769|NCT01685437|76213421|FG000|STARTED|Overall Study||189||
60096770|NCT01685437|76213421|FG000|COMPLETED|Overall Study||158||
60096771|NCT01685437|76213421|FG000|NOT COMPLETED|Overall Study||31||
60096772|NCT00875212|76213425|FG000|STARTED|Placebo Dentifrice||12||
60096773|NCT00875212|76213425|FG000|COMPLETED|Placebo Dentifrice|all participants completed this group|12||
60096774|NCT00875212|76213425|FG000|NOT COMPLETED|Placebo Dentifrice||0||
60096775|NCT00875212|76213425|FG000|STARTED|CaGP Only Dentifrice||12||
60096776|NCT00875212|76213425|FG000|COMPLETED|CaGP Only Dentifrice||12||
60096777|NCT00875212|76213425|FG000|NOT COMPLETED|CaGP Only Dentifrice||0||
60096778|NCT00875212|76213425|FG000|STARTED|Fluoride Only Dentifrice||12||
59562467|NCT02021669|75664280|FG001|COMPLETED|Overall Study||70||
60096779|NCT00875212|76213425|FG000|COMPLETED|Fluoride Only Dentifrice||12||
60096780|NCT00875212|76213425|FG000|NOT COMPLETED|Fluoride Only Dentifrice||0||
60096781|NCT00875212|76213425|FG000|STARTED|CaGP and Fluoride Dentifrice||12||
60096782|NCT00875212|76213425|FG000|COMPLETED|CaGP and Fluoride Dentifrice||12||
60096783|NCT00875212|76213425|FG000|NOT COMPLETED|CaGP and Fluoride Dentifrice||0||
60096784|NCT00875836|76213438|FG000|STARTED|Overall Study||88||
60096785|NCT00875836|76213439|FG001|STARTED|Overall Study||87||
60096786|NCT00875836|76213438|FG000|COMPLETED|Overall Study||45||
60096787|NCT00875836|76213439|FG001|COMPLETED|Overall Study||47||
60096788|NCT00875836|76213438|FG000|NOT COMPLETED|Overall Study||43||
60096789|NCT00875836|76213439|FG001|NOT COMPLETED|Overall Study||40||
60096790|NCT00891982|76213447|FG000|STARTED|Overall Study||30||
60096791|NCT00891982|76213448|FG001|STARTED|Overall Study||31||
60096792|NCT00891982|76213447|FG000|COMPLETED|Overall Study||28||
60096793|NCT00891982|76213448|FG001|COMPLETED|Overall Study||30||
60096794|NCT00891982|76213447|FG000|NOT COMPLETED|Overall Study||2||
60096795|NCT00891982|76213448|FG001|NOT COMPLETED|Overall Study||1||
60096796|NCT01685203|76213461|FG000|STARTED|Overall Study||44||
60096797|NCT01685203|76213462|FG001|STARTED|Overall Study||42||
60096798|NCT01685203|76213463|FG002|STARTED|Overall Study||40||
60096799|NCT01685203|76213464|FG003|STARTED|Overall Study||42||
60096800|NCT01685203|76213465|FG004|STARTED|Overall Study||49||
60096801|NCT01685203|76213466|FG005|STARTED|Overall Study||47||
60096802|NCT01685203|76213467|FG006|STARTED|Overall Study||52||
60096803|NCT01685203|76213461|FG000|Completed Study Drug|Overall Study||42||
60096804|NCT01685203|76213462|FG001|Completed Study Drug|Overall Study||40||
60096805|NCT01685203|76213463|FG002|Completed Study Drug|Overall Study||39||
60096806|NCT01685203|76213464|FG003|Completed Study Drug|Overall Study||42||
60096807|NCT01685203|76213465|FG004|Completed Study Drug|Overall Study||49||
60096808|NCT01685203|76213466|FG005|Completed Study Drug|Overall Study||43||
60096809|NCT01685203|76213467|FG006|Completed Study Drug|Overall Study||52||
60096810|NCT01685203|76213461|FG000|COMPLETED|Overall Study||40||
60096811|NCT01685203|76213462|FG001|COMPLETED|Overall Study||39||
60096812|NCT01685203|76213463|FG002|COMPLETED|Overall Study||40||
60096813|NCT01685203|76213464|FG003|COMPLETED|Overall Study||41||
60096814|NCT01685203|76213465|FG004|COMPLETED|Overall Study||49||
60096815|NCT01685203|76213466|FG005|COMPLETED|Overall Study||44||
60096816|NCT01685203|76213467|FG006|COMPLETED|Overall Study||52||
60096817|NCT01685203|76213461|FG000|NOT COMPLETED|Overall Study||4||
60096818|NCT01685203|76213462|FG001|NOT COMPLETED|Overall Study||3||
60096819|NCT01685203|76213463|FG002|NOT COMPLETED|Overall Study||0||
60096820|NCT01685203|76213464|FG003|NOT COMPLETED|Overall Study||1||
59562468|NCT02021669|75664279|FG000|NOT COMPLETED|Overall Study||7||
59562469|NCT02021669|75664280|FG001|NOT COMPLETED|Overall Study||3||
59562470|NCT01717742|75664288|FG000|STARTED|Overall Study||48||
60096821|NCT01685203|76213465|FG004|NOT COMPLETED|Overall Study||0||
60096822|NCT01685203|76213466|FG005|NOT COMPLETED|Overall Study||3||
60096823|NCT01685203|76213467|FG006|NOT COMPLETED|Overall Study||0||
60096824|NCT01928771|76213486|FG000|STARTED|Overall Study||400||
60096825|NCT01928771|76213487|FG001|STARTED|Overall Study||398||
60096826|NCT01928771|76213488|FG002|STARTED|Overall Study||407||
60096827|NCT01928771|76213486|FG000|Received Treatment|Overall Study||399||
59562471|NCT01717742|75664289|FG001|STARTED|Overall Study||49||
59562472|NCT01717742|75664288|FG000|COMPLETED|Overall Study||43||
60096828|NCT01928771|76213487|FG001|Received Treatment|Overall Study||398||
60096829|NCT01928771|76213488|FG002|Received Treatment|Overall Study||407||
60096830|NCT01928771|76213486|FG000|COMPLETED|Overall Study||354||
60096831|NCT01928771|76213487|FG001|COMPLETED|Overall Study||358||
60096832|NCT01928771|76213488|FG002|COMPLETED|Overall Study||367||
60096833|NCT01928771|76213486|FG000|NOT COMPLETED|Overall Study||46||
60096834|NCT01928771|76213487|FG001|NOT COMPLETED|Overall Study||40||
60096835|NCT01928771|76213488|FG002|NOT COMPLETED|Overall Study||40||
60096836|NCT01589653|76213498|FG000|STARTED|Overall Study||76||
60096837|NCT01589653|76213499|FG001|STARTED|Overall Study||79||
59562473|NCT01717742|75664289|FG001|COMPLETED|Overall Study||47||
60096838|NCT01589653|76213498|FG000|Exposed|Overall Study||76||
60096839|NCT01589653|76213499|FG001|Exposed|Overall Study||78||
60096840|NCT01589653|76213498|FG000|COMPLETED|Overall Study||69||
60096841|NCT01589653|76213499|FG001|COMPLETED|Overall Study||68||
59562474|NCT01717742|75664288|FG000|NOT COMPLETED|Overall Study||5||
59562475|NCT01717742|75664289|FG001|NOT COMPLETED|Overall Study||2||
59562476|NCT01717898|75664295|FG000|STARTED|Overall Study||6||
59562477|NCT01717898|75664296|FG001|STARTED|Overall Study|Study was terminated during Phase I, Dose level 1 due to toxicity.|0||
60096842|NCT01589653|76213498|FG000|NOT COMPLETED|Overall Study||7||
60096843|NCT01589653|76213499|FG001|NOT COMPLETED|Overall Study||11||
60096844|NCT01928615|76213505|FG000|STARTED|Overall Study||2||
60096845|NCT01928615|76213505|FG000|COMPLETED|Overall Study||0||
60096846|NCT01928615|76213505|FG000|NOT COMPLETED|Overall Study||2||
60096847|NCT01589497|76213514|FG000|STARTED|Overall Study||18||
60096848|NCT01589497|76213515|FG001|STARTED|Overall Study||17||
60096849|NCT01589497|76213516|FG002|STARTED|Overall Study||16||
60096850|NCT01589497|76213517|FG003|STARTED|Overall Study||18||
60096851|NCT01589497|76213514|FG000|COMPLETED|Overall Study|1 participant who completed study but had insufficient sputum volume was excluded from the analyses|17||
60096852|NCT01589497|76213515|FG001|COMPLETED|Overall Study|1 participant who completed study but had insufficient sputum volume was excluded from the analyses|16||
60096853|NCT01589497|76213516|FG002|COMPLETED|Overall Study||15||
60096854|NCT01589497|76213517|FG003|COMPLETED|Overall Study||17||
60096855|NCT01589497|76213514|FG000|NOT COMPLETED|Overall Study||1||
59565965|NCT02303574|75668405|FG000|STARTED|Part 1b (Fed State) - SAD||0||
60096856|NCT01589497|76213515|FG001|NOT COMPLETED|Overall Study||1||
60096857|NCT01589497|76213516|FG002|NOT COMPLETED|Overall Study||1||
60096858|NCT01589497|76213517|FG003|NOT COMPLETED|Overall Study||1||
59562478|NCT01717898|75664297|FG002|STARTED|Overall Study|Study was terminated during Phase I, Dose level 1 due to toxicity.|0||
59562479|NCT01717898|75664298|FG003|STARTED|Overall Study|Study was terminated during Phase I, Dose level 1 due to toxicity.|0||
59562480|NCT01717898|75664295|FG000|COMPLETED|Overall Study|Study was terminated during Phase I, Dose level 1 due to toxicity.|0||
59562481|NCT01717898|75664296|FG001|COMPLETED|Overall Study||0||
59562482|NCT01717898|75664297|FG002|COMPLETED|Overall Study||0||
59562483|NCT01717898|75664298|FG003|COMPLETED|Overall Study||0||
59562484|NCT01717898|75664295|FG000|NOT COMPLETED|Overall Study||6||
59562485|NCT01717898|75664296|FG001|NOT COMPLETED|Overall Study||0||
60096859|NCT01928381|76213532|FG000|STARTED|Screening for Pain Training||143||
60096860|NCT01928381|76213533|FG001|STARTED|Screening for Pain Training||0||
60096861|NCT01928381|76213534|FG002|STARTED|Screening for Pain Training||0||
60096862|NCT01928381|76213535|FG003|STARTED|Screening for Pain Training||0||
60096863|NCT01928381|76213536|FG004|STARTED|Screening for Pain Training||0||
60096864|NCT01928381|76213537|FG005|STARTED|Screening for Pain Training||0||
60096865|NCT01928381|76213538|FG006|STARTED|Screening for Pain Training||0||
60096866|NCT01928381|76213532|FG000|COMPLETED|Screening for Pain Training||83||
60096867|NCT01928381|76213533|FG001|COMPLETED|Screening for Pain Training||0||
60096868|NCT01928381|76213534|FG002|COMPLETED|Screening for Pain Training||0||
59562486|NCT01717898|75664297|FG002|NOT COMPLETED|Overall Study||0||
59562487|NCT01717898|75664298|FG003|NOT COMPLETED|Overall Study||0||
59562488|NCT01718522|75664308|FG000|STARTED|Overall Study||75||
59562489|NCT01718522|75664308|FG000|COMPLETED|Overall Study||67||
59562490|NCT01718522|75664308|FG000|NOT COMPLETED|Overall Study||8||
59562491|NCT02064959|75664317|FG000|STARTED|Overall Study||16||
59562492|NCT02064959|75664318|FG001|STARTED|Overall Study||16||
59562493|NCT02064959|75664317|FG000|COMPLETED|Overall Study||16||
59562494|NCT02064959|75664318|FG001|COMPLETED|Overall Study||16||
59562495|NCT02064959|75664317|FG000|NOT COMPLETED|Overall Study||0||
59562496|NCT02064959|75664318|FG001|NOT COMPLETED|Overall Study||0||
59562497|NCT01736930|75664324|FG000|STARTED|Overall Study|Each night randomized to have either Predictive Low Glucose suspend or inactive (control).|20||
59562498|NCT01736930|75664324|FG000|COMPLETED|Overall Study|Each night randomized to have either Predictive Low Glucose suspend or inactive (control).|19||
59562499|NCT01736930|75664324|FG000|NOT COMPLETED|Overall Study||1||
59562500|NCT02397707|75664333|FG000|STARTED|Overall Study||14||
59562501|NCT02397707|75664334|FG001|STARTED|Overall Study||10||
59562502|NCT02397707|75664335|FG002|STARTED|Overall Study||9||
59562503|NCT02397707|75664333|FG000|COMPLETED|Overall Study||14||
59562504|NCT02397707|75664334|FG001|COMPLETED|Overall Study||10||
59562505|NCT02397707|75664335|FG002|COMPLETED|Overall Study||9||
59562506|NCT02397707|75664333|FG000|NOT COMPLETED|Overall Study||0||
59562507|NCT02397707|75664334|FG001|NOT COMPLETED|Overall Study||0||
59562508|NCT02397707|75664335|FG002|NOT COMPLETED|Overall Study||0||
59562509|NCT01737944|75664348|FG000|STARTED|Overall Study||9||
59562510|NCT01737944|75664349|FG001|STARTED|Overall Study||9||
59562511|NCT01737944|75664350|FG002|STARTED|Overall Study|10 patients randomized, one patient discontinued before first study drug dose|9||
59562512|NCT01737944|75664351|FG003|STARTED|Overall Study|10 patients randomized, one patient discontinued before first study drug dose|9||
59562513|NCT01737944|75664348|FG000|COMPLETED|Overall Study||9||
59562514|NCT01737944|75664349|FG001|COMPLETED|Overall Study||9||
59562515|NCT01737944|75664350|FG002|COMPLETED|Overall Study||9||
59562516|NCT01737944|75664351|FG003|COMPLETED|Overall Study||9||
59562517|NCT01737944|75664348|FG000|NOT COMPLETED|Overall Study||0||
59562518|NCT01737944|75664349|FG001|NOT COMPLETED|Overall Study||0||
60096869|NCT01928381|76213535|FG003|COMPLETED|Screening for Pain Training||0||
60096870|NCT01928381|76213536|FG004|COMPLETED|Screening for Pain Training||0||
60096871|NCT01928381|76213537|FG005|COMPLETED|Screening for Pain Training||0||
60096872|NCT01928381|76213538|FG006|COMPLETED|Screening for Pain Training||0||
60096873|NCT01928381|76213532|FG000|NOT COMPLETED|Screening for Pain Training||60||
60096874|NCT01928381|76213533|FG001|NOT COMPLETED|Screening for Pain Training||0||
60096875|NCT01928381|76213534|FG002|NOT COMPLETED|Screening for Pain Training||0||
60096876|NCT01928381|76213535|FG003|NOT COMPLETED|Screening for Pain Training||0||
60096877|NCT01928381|76213536|FG004|NOT COMPLETED|Screening for Pain Training||0||
60096878|NCT01928381|76213537|FG005|NOT COMPLETED|Screening for Pain Training||0||
60096879|NCT01928381|76213538|FG006|NOT COMPLETED|Screening for Pain Training||0||
60096880|NCT01928381|76213532|FG000|STARTED|Part 1 - Pain Training||83||
60096881|NCT01928381|76213533|FG001|STARTED|Part 1 - Pain Training||0||
60096882|NCT01928381|76213534|FG002|STARTED|Part 1 - Pain Training||0||
60096883|NCT01928381|76213535|FG003|STARTED|Part 1 - Pain Training||0||
60096884|NCT01928381|76213536|FG004|STARTED|Part 1 - Pain Training||0||
60096885|NCT01928381|76213537|FG005|STARTED|Part 1 - Pain Training||0||
60096886|NCT01928381|76213538|FG006|STARTED|Part 1 - Pain Training||0||
60096887|NCT01928381|76213532|FG000|COMPLETED|Part 1 - Pain Training||48||
60096888|NCT01928381|76213533|FG001|COMPLETED|Part 1 - Pain Training||0||
60096889|NCT01928381|76213534|FG002|COMPLETED|Part 1 - Pain Training||0||
60096890|NCT01928381|76213535|FG003|COMPLETED|Part 1 - Pain Training||0||
60096891|NCT01928381|76213536|FG004|COMPLETED|Part 1 - Pain Training||0||
60096892|NCT01928381|76213537|FG005|COMPLETED|Part 1 - Pain Training||0||
60096893|NCT01928381|76213538|FG006|COMPLETED|Part 1 - Pain Training||0||
60096894|NCT01928381|76213532|FG000|NOT COMPLETED|Part 1 - Pain Training||35||
60096895|NCT01928381|76213533|FG001|NOT COMPLETED|Part 1 - Pain Training||0||
60096896|NCT01928381|76213534|FG002|NOT COMPLETED|Part 1 - Pain Training||0||
60096897|NCT01928381|76213535|FG003|NOT COMPLETED|Part 1 - Pain Training||0||
60096898|NCT01928381|76213536|FG004|NOT COMPLETED|Part 1 - Pain Training||0||
60096899|NCT01928381|76213537|FG005|NOT COMPLETED|Part 1 - Pain Training||0||
60096900|NCT01928381|76213538|FG006|NOT COMPLETED|Part 1 - Pain Training||0||
60096901|NCT01928381|76213532|FG000|STARTED|Placebo run-in & Part 2 Eligibility||48||
60096902|NCT01928381|76213533|FG001|STARTED|Placebo run-in & Part 2 Eligibility||0||
60096903|NCT01928381|76213534|FG002|STARTED|Placebo run-in & Part 2 Eligibility||0||
60096904|NCT01928381|76213535|FG003|STARTED|Placebo run-in & Part 2 Eligibility||0||
60096905|NCT01928381|76213536|FG004|STARTED|Placebo run-in & Part 2 Eligibility||0||
60096906|NCT01928381|76213537|FG005|STARTED|Placebo run-in & Part 2 Eligibility||0||
60096907|NCT01928381|76213538|FG006|STARTED|Placebo run-in & Part 2 Eligibility||0||
60096908|NCT01928381|76213532|FG000|COMPLETED|Placebo run-in & Part 2 Eligibility||34||
60096909|NCT01928381|76213533|FG001|COMPLETED|Placebo run-in & Part 2 Eligibility||0||
60096910|NCT01928381|76213534|FG002|COMPLETED|Placebo run-in & Part 2 Eligibility||0||
60096911|NCT01928381|76213535|FG003|COMPLETED|Placebo run-in & Part 2 Eligibility||0||
60096912|NCT01928381|76213536|FG004|COMPLETED|Placebo run-in & Part 2 Eligibility||0||
60096913|NCT01928381|76213537|FG005|COMPLETED|Placebo run-in & Part 2 Eligibility||0||
60096914|NCT01928381|76213538|FG006|COMPLETED|Placebo run-in & Part 2 Eligibility||0||
60096915|NCT01928381|76213532|FG000|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||14||
60096916|NCT01928381|76213533|FG001|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0||
60096917|NCT01928381|76213534|FG002|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0||
60096918|NCT01928381|76213535|FG003|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0||
60096919|NCT01928381|76213536|FG004|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0||
60096920|NCT01928381|76213537|FG005|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0||
60096921|NCT01928381|76213538|FG006|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0||
60096922|NCT01928381|76213532|FG000|STARTED|Part 2 - First Intervention||0||
59562519|NCT01737944|75664350|FG002|NOT COMPLETED|Overall Study||0||
59708106|NCT00980200|75826929|FG004|NOT COMPLETED|7-day Treatment Period 3||1||
59708107|NCT00980200|75826925|FG000|STARTED|7-day Washout Period 3||15||
60096923|NCT01928381|76213533|FG001|STARTED|Part 2 - First Intervention||6||
60096924|NCT01928381|76213534|FG002|STARTED|Part 2 - First Intervention||6||
60096925|NCT01928381|76213535|FG003|STARTED|Part 2 - First Intervention||6||
60096926|NCT01928381|76213536|FG004|STARTED|Part 2 - First Intervention||4||
60096927|NCT01928381|76213537|FG005|STARTED|Part 2 - First Intervention||6||
60096928|NCT01928381|76213538|FG006|STARTED|Part 2 - First Intervention||6||
60096929|NCT01928381|76213532|FG000|COMPLETED|Part 2 - First Intervention||0||
60096930|NCT01928381|76213533|FG001|COMPLETED|Part 2 - First Intervention||6||
60096931|NCT01928381|76213534|FG002|COMPLETED|Part 2 - First Intervention||4||
60096932|NCT01928381|76213535|FG003|COMPLETED|Part 2 - First Intervention||5||
60096933|NCT01928381|76213536|FG004|COMPLETED|Part 2 - First Intervention||4||
60096934|NCT01928381|76213537|FG005|COMPLETED|Part 2 - First Intervention||5||
60096935|NCT01928381|76213538|FG006|COMPLETED|Part 2 - First Intervention||5||
60096936|NCT01928381|76213532|FG000|NOT COMPLETED|Part 2 - First Intervention||0||
60096937|NCT01928381|76213533|FG001|NOT COMPLETED|Part 2 - First Intervention||0||
60096938|NCT01928381|76213534|FG002|NOT COMPLETED|Part 2 - First Intervention||2||
60096939|NCT01928381|76213535|FG003|NOT COMPLETED|Part 2 - First Intervention||1||
60096940|NCT01928381|76213536|FG004|NOT COMPLETED|Part 2 - First Intervention||0||
60096941|NCT01928381|76213537|FG005|NOT COMPLETED|Part 2 - First Intervention||1||
60096942|NCT01928381|76213538|FG006|NOT COMPLETED|Part 2 - First Intervention||1||
60096943|NCT01928381|76213532|FG000|STARTED|Washout First Intervention||0||
60096944|NCT01928381|76213533|FG001|STARTED|Washout First Intervention||6||
60096945|NCT01928381|76213534|FG002|STARTED|Washout First Intervention||4||
60096946|NCT01928381|76213535|FG003|STARTED|Washout First Intervention||5||
60096947|NCT01928381|76213536|FG004|STARTED|Washout First Intervention||4||
60096948|NCT01928381|76213537|FG005|STARTED|Washout First Intervention||5||
60096949|NCT01928381|76213538|FG006|STARTED|Washout First Intervention||5||
59708108|NCT00980200|75826926|FG001|STARTED|7-day Washout Period 3||12||
59708109|NCT00980200|75826927|FG002|STARTED|7-day Washout Period 3||15||
60096950|NCT01928381|76213532|FG000|COMPLETED|Washout First Intervention||0||
60096951|NCT01928381|76213533|FG001|COMPLETED|Washout First Intervention||6||
60096952|NCT01928381|76213534|FG002|COMPLETED|Washout First Intervention||4||
60096953|NCT01928381|76213535|FG003|COMPLETED|Washout First Intervention||5||
60096954|NCT01928381|76213536|FG004|COMPLETED|Washout First Intervention||3||
60096955|NCT01928381|76213537|FG005|COMPLETED|Washout First Intervention||5||
60096956|NCT01928381|76213538|FG006|COMPLETED|Washout First Intervention||5||
60096957|NCT01928381|76213532|FG000|NOT COMPLETED|Washout First Intervention||0||
60096958|NCT01928381|76213533|FG001|NOT COMPLETED|Washout First Intervention||0||
60096959|NCT01928381|76213534|FG002|NOT COMPLETED|Washout First Intervention||0||
60096960|NCT01928381|76213535|FG003|NOT COMPLETED|Washout First Intervention||0||
60096961|NCT01928381|76213536|FG004|NOT COMPLETED|Washout First Intervention||1||
59708110|NCT00980200|75826928|FG003|STARTED|7-day Washout Period 3||16||
59708111|NCT00980200|75826929|FG004|STARTED|7-day Washout Period 3||14||
59708112|NCT00980200|75826925|FG000|COMPLETED|7-day Washout Period 3||15||
59708113|NCT00980200|75826926|FG001|COMPLETED|7-day Washout Period 3||12||
59708114|NCT00980200|75826927|FG002|COMPLETED|7-day Washout Period 3||15||
59708115|NCT00980200|75826928|FG003|COMPLETED|7-day Washout Period 3||16||
59708116|NCT00980200|75826929|FG004|COMPLETED|7-day Washout Period 3||14||
59708117|NCT00980200|75826925|FG000|NOT COMPLETED|7-day Washout Period 3||0||
59708118|NCT00980200|75826926|FG001|NOT COMPLETED|7-day Washout Period 3||0||
59708119|NCT00980200|75826927|FG002|NOT COMPLETED|7-day Washout Period 3||0||
59708120|NCT00980200|75826928|FG003|NOT COMPLETED|7-day Washout Period 3||0||
59708121|NCT00980200|75826929|FG004|NOT COMPLETED|7-day Washout Period 3||0||
59708122|NCT00980200|75826925|FG000|STARTED|7-day Treatment Period 4||15||
59708123|NCT00980200|75826926|FG001|STARTED|7-day Treatment Period 4||12||
59708124|NCT00980200|75826927|FG002|STARTED|7-day Treatment Period 4||15||
59708125|NCT00980200|75826928|FG003|STARTED|7-day Treatment Period 4||16||
59708126|NCT00980200|75826929|FG004|STARTED|7-day Treatment Period 4||14||
59708127|NCT00980200|75826925|FG000|COMPLETED|7-day Treatment Period 4||15||
59708128|NCT00980200|75826926|FG001|COMPLETED|7-day Treatment Period 4||12||
59993576|NCT04884191|76109517|FG002|COMPLETED|Overall Study||54||
59993577|NCT04884191|76109515|FG000|NOT COMPLETED|Overall Study||3||
59993578|NCT04884191|76109516|FG001|NOT COMPLETED|Overall Study||0||
59993579|NCT04884191|76109517|FG002|NOT COMPLETED|Overall Study||1||
59993580|NCT02387372|76109527|FG000|STARTED|Overall Study||27||
59993581|NCT02387372|76109528|FG001|STARTED|Overall Study||10||
59993582|NCT02387372|76109527|FG000|Treated|Overall Study||26||
60096962|NCT01928381|76213537|FG005|NOT COMPLETED|Washout First Intervention||0||
60096963|NCT01928381|76213538|FG006|NOT COMPLETED|Washout First Intervention||0||
60096964|NCT01928381|76213532|FG000|STARTED|Part 2 - Second Intervention||0||
60096965|NCT01928381|76213533|FG001|STARTED|Part 2 - Second Intervention||6||
60096966|NCT01928381|76213534|FG002|STARTED|Part 2 - Second Intervention||4||
60096967|NCT01928381|76213535|FG003|STARTED|Part 2 - Second Intervention||5||
60096968|NCT01928381|76213536|FG004|STARTED|Part 2 - Second Intervention||3||
60096969|NCT01928381|76213537|FG005|STARTED|Part 2 - Second Intervention||5||
60096970|NCT01928381|76213538|FG006|STARTED|Part 2 - Second Intervention||5||
60096971|NCT01928381|76213532|FG000|COMPLETED|Part 2 - Second Intervention||0||
60096972|NCT01928381|76213533|FG001|COMPLETED|Part 2 - Second Intervention||5||
60096973|NCT01928381|76213534|FG002|COMPLETED|Part 2 - Second Intervention||4||
60096974|NCT01928381|76213535|FG003|COMPLETED|Part 2 - Second Intervention||4||
60096975|NCT01928381|76213536|FG004|COMPLETED|Part 2 - Second Intervention||3||
59562520|NCT01737944|75664351|FG003|NOT COMPLETED|Overall Study||0||
59562521|NCT02397785|75664362|FG000|STARTED|Overall Study||24||
59562522|NCT02397785|75664363|FG001|STARTED|Overall Study||34||
59562523|NCT02397785|75664362|FG000|COMPLETED|Overall Study||22||
59562524|NCT02397785|75664363|FG001|COMPLETED|Overall Study||25||
59562525|NCT02397785|75664362|FG000|NOT COMPLETED|Overall Study||2||
59562526|NCT02397785|75664363|FG001|NOT COMPLETED|Overall Study||9||
59562527|NCT01740206|75664371|FG000|STARTED|Overall Study||14||
59993583|NCT02387372|76109528|FG001|Treated|Overall Study||10||
60096976|NCT01928381|76213537|FG005|COMPLETED|Part 2 - Second Intervention||5||
60096977|NCT01928381|76213538|FG006|COMPLETED|Part 2 - Second Intervention||5||
60096978|NCT01928381|76213532|FG000|NOT COMPLETED|Part 2 - Second Intervention||0||
60096979|NCT01928381|76213533|FG001|NOT COMPLETED|Part 2 - Second Intervention||1||
60096980|NCT01928381|76213534|FG002|NOT COMPLETED|Part 2 - Second Intervention||0||
60096981|NCT01928381|76213535|FG003|NOT COMPLETED|Part 2 - Second Intervention||1||
60096982|NCT01928381|76213536|FG004|NOT COMPLETED|Part 2 - Second Intervention||0||
59562528|NCT01740206|75664372|FG001|STARTED|Overall Study||34||
59562529|NCT01740206|75664371|FG000|COMPLETED|Overall Study||14||
59562530|NCT01740206|75664372|FG001|COMPLETED|Overall Study||34||
59562531|NCT01740206|75664371|FG000|NOT COMPLETED|Overall Study||0||
59562532|NCT01740206|75664372|FG001|NOT COMPLETED|Overall Study||0||
59562533|NCT01740362|75664382|FG000|STARTED|Overall Study||6||
59562534|NCT01740362|75664383|FG001|STARTED|Overall Study||6||
59708129|NCT00980200|75826927|FG002|COMPLETED|7-day Treatment Period 4||15||
59708130|NCT00980200|75826928|FG003|COMPLETED|7-day Treatment Period 4||16||
59708131|NCT00980200|75826929|FG004|COMPLETED|7-day Treatment Period 4||14||
59708132|NCT00980200|75826925|FG000|NOT COMPLETED|7-day Treatment Period 4||0||
59993584|NCT02387372|76109527|FG000|COMPLETED|Overall Study||26||
59708133|NCT00980200|75826926|FG001|NOT COMPLETED|7-day Treatment Period 4||0||
59993585|NCT02387372|76109528|FG001|COMPLETED|Overall Study||10||
59993586|NCT02387372|76109527|FG000|NOT COMPLETED|Overall Study||1||
60096983|NCT01928381|76213537|FG005|NOT COMPLETED|Part 2 - Second Intervention||0||
60096984|NCT01928381|76213538|FG006|NOT COMPLETED|Part 2 - Second Intervention||0||
60096985|NCT01928381|76213532|FG000|STARTED|Washout Second Intervention||0||
60096986|NCT01928381|76213533|FG001|STARTED|Washout Second Intervention||5||
60096987|NCT01928381|76213534|FG002|STARTED|Washout Second Intervention||4||
60096988|NCT01928381|76213535|FG003|STARTED|Washout Second Intervention||4||
60096989|NCT01928381|76213536|FG004|STARTED|Washout Second Intervention||3||
60096990|NCT01928381|76213537|FG005|STARTED|Washout Second Intervention||5||
60096991|NCT01928381|76213538|FG006|STARTED|Washout Second Intervention||5||
60096992|NCT01928381|76213532|FG000|COMPLETED|Washout Second Intervention||0||
60096993|NCT01928381|76213533|FG001|COMPLETED|Washout Second Intervention||5||
60096994|NCT01928381|76213534|FG002|COMPLETED|Washout Second Intervention||4||
60096995|NCT01928381|76213535|FG003|COMPLETED|Washout Second Intervention||4||
60096996|NCT01928381|76213536|FG004|COMPLETED|Washout Second Intervention||3||
60096997|NCT01928381|76213537|FG005|COMPLETED|Washout Second Intervention||5||
60096998|NCT01928381|76213538|FG006|COMPLETED|Washout Second Intervention||5||
60096999|NCT01928381|76213532|FG000|NOT COMPLETED|Washout Second Intervention||0||
60097000|NCT01928381|76213533|FG001|NOT COMPLETED|Washout Second Intervention||0||
60097001|NCT01928381|76213534|FG002|NOT COMPLETED|Washout Second Intervention||0||
60097002|NCT01928381|76213535|FG003|NOT COMPLETED|Washout Second Intervention||0||
60097003|NCT01928381|76213536|FG004|NOT COMPLETED|Washout Second Intervention||0||
60097004|NCT01928381|76213537|FG005|NOT COMPLETED|Washout Second Intervention||0||
60097005|NCT01928381|76213538|FG006|NOT COMPLETED|Washout Second Intervention||0||
59562535|NCT01740362|75664384|FG002|STARTED|Overall Study||6||
59562536|NCT01740362|75664385|FG003|STARTED|Overall Study||6||
60097006|NCT01928381|76213532|FG000|STARTED|Part 2 - Third Intervention||0||
60097007|NCT01928381|76213533|FG001|STARTED|Part 2 - Third Intervention||5||
60097008|NCT01928381|76213534|FG002|STARTED|Part 2 - Third Intervention||4||
60097009|NCT01928381|76213535|FG003|STARTED|Part 2 - Third Intervention||4||
60097010|NCT01928381|76213536|FG004|STARTED|Part 2 - Third Intervention||3||
60097011|NCT01928381|76213537|FG005|STARTED|Part 2 - Third Intervention||5||
60097012|NCT01928381|76213538|FG006|STARTED|Part 2 - Third Intervention||5||
60097013|NCT01928381|76213532|FG000|COMPLETED|Part 2 - Third Intervention||0||
60097014|NCT01928381|76213533|FG001|COMPLETED|Part 2 - Third Intervention||5||
60097015|NCT01928381|76213534|FG002|COMPLETED|Part 2 - Third Intervention||4||
60097016|NCT01928381|76213535|FG003|COMPLETED|Part 2 - Third Intervention||4||
60097017|NCT01928381|76213536|FG004|COMPLETED|Part 2 - Third Intervention||3||
59562537|NCT01740362|75664382|FG000|COMPLETED|Overall Study||6||
59562538|NCT01740362|75664383|FG001|COMPLETED|Overall Study||6||
59562539|NCT01740362|75664384|FG002|COMPLETED|Overall Study||6||
59562540|NCT01740362|75664385|FG003|COMPLETED|Overall Study||6||
59562541|NCT01740362|75664382|FG000|NOT COMPLETED|Overall Study||0||
59562542|NCT01740362|75664383|FG001|NOT COMPLETED|Overall Study||0||
59562543|NCT01740362|75664384|FG002|NOT COMPLETED|Overall Study||0||
59562544|NCT01740362|75664385|FG003|NOT COMPLETED|Overall Study||0||
59562545|NCT03251937|75664395|FG000|STARTED|Overall Study||40||
59562546|NCT03251937|75664395|FG000|COMPLETED|Overall Study||37||
60097018|NCT01928381|76213537|FG005|COMPLETED|Part 2 - Third Intervention||5||
60097019|NCT01928381|76213538|FG006|COMPLETED|Part 2 - Third Intervention||5||
60097020|NCT01928381|76213532|FG000|NOT COMPLETED|Part 2 - Third Intervention||0||
60097021|NCT01928381|76213533|FG001|NOT COMPLETED|Part 2 - Third Intervention||0||
60097022|NCT01928381|76213534|FG002|NOT COMPLETED|Part 2 - Third Intervention||0||
60097023|NCT01928381|76213535|FG003|NOT COMPLETED|Part 2 - Third Intervention||0||
60097024|NCT01928381|76213536|FG004|NOT COMPLETED|Part 2 - Third Intervention||0||
60097025|NCT01928381|76213537|FG005|NOT COMPLETED|Part 2 - Third Intervention||0||
60097026|NCT01928381|76213538|FG006|NOT COMPLETED|Part 2 - Third Intervention||0||
60097027|NCT01928381|76213532|FG000|STARTED|Part 2 - Post Third Intervention||0||
59562547|NCT03251937|75664395|FG000|NOT COMPLETED|Overall Study||3||
59562548|NCT02068157|75664399|FG000|STARTED|Overall Study||3||
59562549|NCT02068157|75664399|FG000|COMPLETED|Overall Study||3||
59562550|NCT02068157|75664399|FG000|NOT COMPLETED|Overall Study||0||
60097028|NCT01928381|76213533|FG001|STARTED|Part 2 - Post Third Intervention||5||
60097029|NCT01928381|76213534|FG002|STARTED|Part 2 - Post Third Intervention||4||
60097030|NCT01928381|76213535|FG003|STARTED|Part 2 - Post Third Intervention||4||
60097031|NCT01928381|76213536|FG004|STARTED|Part 2 - Post Third Intervention||3||
60097032|NCT01928381|76213537|FG005|STARTED|Part 2 - Post Third Intervention||5||
60097033|NCT01928381|76213538|FG006|STARTED|Part 2 - Post Third Intervention||5||
60097034|NCT01928381|76213532|FG000|COMPLETED|Part 2 - Post Third Intervention||0||
60097035|NCT01928381|76213533|FG001|COMPLETED|Part 2 - Post Third Intervention||5||
60097036|NCT01928381|76213534|FG002|COMPLETED|Part 2 - Post Third Intervention||3||
60097037|NCT01928381|76213535|FG003|COMPLETED|Part 2 - Post Third Intervention||4||
60097038|NCT01928381|76213536|FG004|COMPLETED|Part 2 - Post Third Intervention||3||
60097039|NCT01928381|76213537|FG005|COMPLETED|Part 2 - Post Third Intervention||5||
60097040|NCT01928381|76213538|FG006|COMPLETED|Part 2 - Post Third Intervention||5||
60097041|NCT01928381|76213532|FG000|NOT COMPLETED|Part 2 - Post Third Intervention||0||
60097042|NCT01928381|76213533|FG001|NOT COMPLETED|Part 2 - Post Third Intervention||0||
60097043|NCT01928381|76213534|FG002|NOT COMPLETED|Part 2 - Post Third Intervention||1||
59562551|NCT02398409|75664405|FG000|STARTED|Overall Study||69||
59562552|NCT02398409|75664406|FG001|STARTED|Overall Study||68||
59708134|NCT00980200|75826927|FG002|NOT COMPLETED|7-day Treatment Period 4||0||
59708135|NCT00980200|75826928|FG003|NOT COMPLETED|7-day Treatment Period 4||0||
59708136|NCT00980200|75826929|FG004|NOT COMPLETED|7-day Treatment Period 4||0||
60097044|NCT01928381|76213535|FG003|NOT COMPLETED|Part 2 - Post Third Intervention||0||
60097045|NCT01928381|76213536|FG004|NOT COMPLETED|Part 2 - Post Third Intervention||0||
60097046|NCT01928381|76213537|FG005|NOT COMPLETED|Part 2 - Post Third Intervention||0||
60097047|NCT01928381|76213538|FG006|NOT COMPLETED|Part 2 - Post Third Intervention||0||
60097048|NCT01928225|76213550|FG000|STARTED|Overall Study||90||
60097049|NCT01928225|76213551|FG001|STARTED|Overall Study||90||
60097050|NCT01928225|76213550|FG000|COMPLETED|Overall Study||87||
60097051|NCT01928225|76213551|FG001|COMPLETED|Overall Study||87||
59562553|NCT02398409|75664405|FG000|COMPLETED|Overall Study||67||
59562554|NCT02398409|75664406|FG001|COMPLETED|Overall Study||63||
59562555|NCT02398409|75664405|FG000|NOT COMPLETED|Overall Study||2||
59708137|NCT00980200|75826925|FG000|STARTED|7-day Washout Period 4||15||
59708138|NCT00980200|75826926|FG001|STARTED|7-day Washout Period 4||12||
60097052|NCT01928225|76213550|FG000|NOT COMPLETED|Overall Study||3||
59562556|NCT02398409|75664406|FG001|NOT COMPLETED|Overall Study||5||
59562557|NCT01741454|75664416|FG000|STARTED|Overall Study||49||
59816970|NCT02516241|75939378|FG002|COMPLETED|Overall Study||0||
59816971|NCT02516241|75939376|FG000|NOT COMPLETED|Overall Study||342||
59816972|NCT02516241|75939377|FG001|NOT COMPLETED|Overall Study||346||
60097053|NCT01928225|76213551|FG001|NOT COMPLETED|Overall Study||3||
60097054|NCT01927757|76213558|FG000|STARTED|Overall Study||90||
60097055|NCT01927757|76213558|FG000|Received Etanercept|Overall Study||88||
60097056|NCT01927757|76213558|FG000|COMPLETED|Overall Study||67||
60097057|NCT01927757|76213558|FG000|NOT COMPLETED|Overall Study||23||
60097058|NCT01927367|76213568|FG000|STARTED|Overall Study||597||
60097059|NCT01927367|76213569|FG001|STARTED|Overall Study||548||
60097060|NCT01927367|76213568|FG000|COMPLETED|Overall Study||590||
60097061|NCT01927367|76213569|FG001|COMPLETED|Overall Study||543||
60097062|NCT01927367|76213568|FG000|NOT COMPLETED|Overall Study||7||
60097063|NCT01927367|76213569|FG001|NOT COMPLETED|Overall Study||5||
60097064|NCT01913639|76213575|FG000|STARTED|Overall Study||39||
60097065|NCT01913639|76213575|FG000|COMPLETED|Overall Study||36||
60097066|NCT01913639|76213575|FG000|NOT COMPLETED|Overall Study||3||
60097067|NCT01913483|76213581|FG000|STARTED|Overall Study||367|All participants who were randomized to the study were included in the Intent-to-Treat Population.|
60097068|NCT01913483|76213582|FG001|STARTED|Overall Study||365|All participants who were randomized to the study were included in the Intent-to-Treat Population.|
60097069|NCT01913483|76213581|FG000|Received at Least 1 Dose of Study Drug|Overall Study||335|The 656 participants were the same participants for both the Safety Population and mITT Population.|
60097070|NCT01913483|76213582|FG001|Received at Least 1 Dose of Study Drug|Overall Study||321|The 656 participants were the same participants for both the Safety Population and mITT Population.|
60097071|NCT01913483|76213581|FG000|COMPLETED|Overall Study||346|One participant in the Bivalirudin and UFH Arms each died before receiving study drug.|
60097072|NCT01913483|76213582|FG001|COMPLETED|Overall Study||343|One participant in the Bivalirudin and UFH Arms each died before receiving study drug.|
60097073|NCT01913483|76213581|FG000|NOT COMPLETED|Overall Study||21||
60097074|NCT01913483|76213582|FG001|NOT COMPLETED|Overall Study||22||
60097075|NCT01913405|76213588|FG000|STARTED|Overall Study||22||
60097076|NCT01913405|76213588|FG000|COMPLETED|Overall Study||20||
60097077|NCT01913405|76213588|FG000|NOT COMPLETED|Overall Study||2||
60097078|NCT01927055|76213608|FG000|STARTED|Open-label||61||
60097079|NCT01927055|76213609|FG001|STARTED|Open-label||0||
60097080|NCT01927055|76213610|FG002|STARTED|Open-label||0||
60097081|NCT01927055|76213608|FG000|COMPLETED|Open-label||45||
60097082|NCT01927055|76213609|FG001|COMPLETED|Open-label||0||
60097083|NCT01927055|76213610|FG002|COMPLETED|Open-label||0||
60097084|NCT01927055|76213608|FG000|NOT COMPLETED|Open-label||16||
60097085|NCT01927055|76213609|FG001|NOT COMPLETED|Open-label||0||
60097086|NCT01927055|76213610|FG002|NOT COMPLETED|Open-label||0||
60097087|NCT01927055|76213608|FG000|STARTED|Double-Blind||0||
60097088|NCT01927055|76213609|FG001|STARTED|Double-Blind||22||
60097089|NCT01927055|76213610|FG002|STARTED|Double-Blind||23||
60097090|NCT01927055|76213608|FG000|COMPLETED|Double-Blind||0||
60097091|NCT01927055|76213609|FG001|COMPLETED|Double-Blind||11||
60097092|NCT01927055|76213610|FG002|COMPLETED|Double-Blind||10||
60097093|NCT01927055|76213608|FG000|NOT COMPLETED|Double-Blind||0||
60097094|NCT01927055|76213609|FG001|NOT COMPLETED|Double-Blind||11||
60097095|NCT01927055|76213610|FG002|NOT COMPLETED|Double-Blind||13||
60097096|NCT01913327|76213619|FG000|STARTED|Overall Study||1||
60097097|NCT01913327|76213620|FG001|STARTED|Overall Study||2||
60097098|NCT01913327|76213619|FG000|COMPLETED|Overall Study||1||
60097099|NCT01913327|76213620|FG001|COMPLETED|Overall Study||1||
60097100|NCT01913327|76213619|FG000|NOT COMPLETED|Overall Study||0||
60097101|NCT01913327|76213620|FG001|NOT COMPLETED|Overall Study||1||
60097102|NCT01926509|76213630|FG000|STARTED|Overall Study||6||
60097103|NCT01926509|76213631|FG001|STARTED|Overall Study||6||
59816973|NCT02516241|75939378|FG002|NOT COMPLETED|Overall Study||344||
59993587|NCT02387372|76109528|FG001|NOT COMPLETED|Overall Study||0||
59993588|NCT02426138|76109544|FG000|STARTED|First Intervention (12 Weeks)||21||
59993589|NCT02426138|76109545|FG001|STARTED|First Intervention (12 Weeks)||23||
59993590|NCT02426138|76109544|FG000|COMPLETED|First Intervention (12 Weeks)||20||
59993591|NCT02426138|76109545|FG001|COMPLETED|First Intervention (12 Weeks)||22||
59993592|NCT02426138|76109544|FG000|NOT COMPLETED|First Intervention (12 Weeks)||1||
59993593|NCT02426138|76109545|FG001|NOT COMPLETED|First Intervention (12 Weeks)||1||
59993594|NCT02426138|76109544|FG000|STARTED|Second Intervention (12 Weeks)||20||
59993595|NCT02426138|76109545|FG001|STARTED|Second Intervention (12 Weeks)||22||
59993596|NCT02426138|76109544|FG000|COMPLETED|Second Intervention (12 Weeks)||20||
60097104|NCT01926509|76213632|FG002|STARTED|Overall Study||5||
60097105|NCT01926509|76213633|FG003|STARTED|Overall Study||6||
60097106|NCT01926509|76213630|FG000|COMPLETED|Overall Study||5||
60097107|NCT01926509|76213631|FG001|COMPLETED|Overall Study||6||
60097108|NCT01926509|76213632|FG002|COMPLETED|Overall Study||5||
60097109|NCT01926509|76213633|FG003|COMPLETED|Overall Study||6||
60097110|NCT01926509|76213630|FG000|NOT COMPLETED|Overall Study||1||
59993597|NCT02426138|76109545|FG001|COMPLETED|Second Intervention (12 Weeks)||22||
60097111|NCT01926509|76213631|FG001|NOT COMPLETED|Overall Study||0||
60097112|NCT01926509|76213632|FG002|NOT COMPLETED|Overall Study||0||
60097113|NCT01926509|76213633|FG003|NOT COMPLETED|Overall Study||0||
60097114|NCT01926119|76213643|FG000|STARTED|Overall Study||4||
60097115|NCT01926119|76213643|FG000|COMPLETED|Overall Study||3||
60097116|NCT01926119|76213643|FG000|NOT COMPLETED|Overall Study||1||
60097117|NCT01912781|76213649|FG000|STARTED|Overall Study||71||
60097118|NCT01912781|76213650|FG001|STARTED|Overall Study||35||
60097119|NCT01912781|76213649|FG000|COMPLETED|Overall Study||69||
60097120|NCT01912781|76213650|FG001|COMPLETED|Overall Study||35||
60097121|NCT01912781|76213649|FG000|NOT COMPLETED|Overall Study||2||
60097122|NCT01912781|76213650|FG001|NOT COMPLETED|Overall Study||0||
60097123|NCT01925417|76213657|FG000|STARTED|Overall Study||34||
60097124|NCT01925417|76213657|FG000|COMPLETED|Overall Study||31||
60097125|NCT01925417|76213657|FG000|NOT COMPLETED|Overall Study||3||
59993598|NCT02426138|76109544|FG000|NOT COMPLETED|Second Intervention (12 Weeks)||0||
59993599|NCT02426138|76109545|FG001|NOT COMPLETED|Second Intervention (12 Weeks)||0||
59993600|NCT02426138|76109544|FG000|STARTED|Intent to Treat Population Milestone||20||
59993601|NCT02426138|76109545|FG001|STARTED|Intent to Treat Population Milestone||22||
59993602|NCT02426138|76109544|FG000|COMPLETED|Intent to Treat Population Milestone||20||
59993603|NCT02426138|76109545|FG001|COMPLETED|Intent to Treat Population Milestone||22||
59993604|NCT02426138|76109544|FG000|NOT COMPLETED|Intent to Treat Population Milestone||0||
59993605|NCT02426138|76109545|FG001|NOT COMPLETED|Intent to Treat Population Milestone||0||
59993606|NCT04881149|76109553|FG000|STARTED|Overall Study||7||14
59993607|NCT04881149|76109553|FG000|Control Biopsy|Overall Study||7||7
59993608|NCT04881149|76109553|FG000|Treatment Biopsy|Overall Study||7||7
59993609|NCT04881149|76109553|FG000|COMPLETED|Overall Study||7||14
59993610|NCT04881149|76109553|FG000|NOT COMPLETED|Overall Study||0||0
59993611|NCT02426684|76109558|FG000|STARTED|Overall Study||17||
59993612|NCT02426684|76109558|FG000|COMPLETED|Overall Study||16||
59993613|NCT02426684|76109558|FG000|NOT COMPLETED|Overall Study||1||
59993614|NCT02656173|76109564|FG000|STARTED|Overall Study||285||
59993615|NCT02656173|76109565|FG001|STARTED|Overall Study||283||
59993616|NCT02656173|76109564|FG000|Received Treatment|Overall Study||284||
59993617|NCT02656173|76109565|FG001|Received Treatment|Overall Study||282||
59993618|NCT02656173|76109564|FG000|COMPLETED|Overall Study||272||
60097126|NCT01911845|76213662|FG000|STARTED|Overall Study||38||
60097127|NCT01911845|76213662|FG000|Completed Study Drug|Overall Study||37||
60097128|NCT01911845|76213662|FG000|COMPLETED|Overall Study||32||
60097129|NCT01911845|76213662|FG000|NOT COMPLETED|Overall Study||6||
60097130|NCT01925183|76213670|FG000|STARTED|Overall Study||3||
60097131|NCT01925183|76213671|FG001|STARTED|Overall Study||3||
60097132|NCT01925183|76213670|FG000|COMPLETED|Overall Study||2||
60097133|NCT01925183|76213671|FG001|COMPLETED|Overall Study||3||
60097134|NCT01925183|76213670|FG000|NOT COMPLETED|Overall Study||1||
60097135|NCT01925183|76213671|FG001|NOT COMPLETED|Overall Study||0||
60097136|NCT01910519|76213679|FG000|STARTED|Overall Study||35||
60097137|NCT01910519|76213680|FG001|STARTED|Overall Study||15||
60097138|NCT01910519|76213679|FG000|COMPLETED|Overall Study||31||
60097139|NCT01910519|76213680|FG001|COMPLETED|Overall Study||15||
60097140|NCT01910519|76213679|FG000|NOT COMPLETED|Overall Study||4||
60097141|NCT01910519|76213680|FG001|NOT COMPLETED|Overall Study||0||
60097142|NCT01910441|76213688|FG000|STARTED|Overall Study||48||
60097143|NCT01910441|76213689|FG001|STARTED|Overall Study||47||
60097144|NCT01910441|76213688|FG000|COMPLETED|Overall Study||41||
60097145|NCT01910441|76213689|FG001|COMPLETED|Overall Study||37||
60097146|NCT01910441|76213688|FG000|NOT COMPLETED|Overall Study||7||
60097147|NCT01910441|76213689|FG001|NOT COMPLETED|Overall Study||10||
60097148|NCT01923467|76213695|FG000|STARTED|Overall Study|Offered stop smoking program|767||
60097149|NCT01923467|76213695|FG000|Baseline Completed, Enrolled|Overall Study||288||
60097150|NCT01923467|76213695|FG000|COMPLETED|Overall Study|Completed 3-month follow up survey|226||
60097151|NCT01923467|76213695|FG000|NOT COMPLETED|Overall Study||541||
60097152|NCT01910129|76213701|FG000|STARTED|Run-in Period Phase 1||0||
60097153|NCT01910129|76213702|FG001|STARTED|Run-in Period Phase 1||0||
60097154|NCT01910129|76213703|FG002|STARTED|Run-in Period Phase 1||13||
60097155|NCT01910129|76213701|FG000|COMPLETED|Run-in Period Phase 1||0||
60097156|NCT01910129|76213702|FG001|COMPLETED|Run-in Period Phase 1||0||
60097157|NCT01910129|76213703|FG002|COMPLETED|Run-in Period Phase 1||13||
60097158|NCT01910129|76213701|FG000|NOT COMPLETED|Run-in Period Phase 1||0||
60097159|NCT01910129|76213702|FG001|NOT COMPLETED|Run-in Period Phase 1||0||
60097160|NCT01910129|76213703|FG002|NOT COMPLETED|Run-in Period Phase 1||0||
60097161|NCT01910129|76213701|FG000|STARTED|Randomized Phase 2||7||
60097162|NCT01910129|76213702|FG001|STARTED|Randomized Phase 2||6||
60097163|NCT01910129|76213703|FG002|STARTED|Randomized Phase 2||0||
60097164|NCT01910129|76213701|FG000|COMPLETED|Randomized Phase 2||5||
60097165|NCT01910129|76213702|FG001|COMPLETED|Randomized Phase 2||5||
60097166|NCT01910129|76213703|FG002|COMPLETED|Randomized Phase 2||0||
60097167|NCT01910129|76213701|FG000|NOT COMPLETED|Randomized Phase 2||2||
60097168|NCT01910129|76213702|FG001|NOT COMPLETED|Randomized Phase 2||1||
60097169|NCT01910129|76213703|FG002|NOT COMPLETED|Randomized Phase 2||0||
59993619|NCT02656173|76109565|FG001|COMPLETED|Overall Study||272||
59993620|NCT02656173|76109564|FG000|NOT COMPLETED|Overall Study||13||
59993621|NCT02656173|76109565|FG001|NOT COMPLETED|Overall Study||11||
60097170|NCT01910129|76213701|FG000|STARTED|Randomized Phase 3||5||
60097171|NCT01910129|76213702|FG001|STARTED|Randomized Phase 3||5||
60097172|NCT01910129|76213703|FG002|STARTED|Randomized Phase 3||0||
60097173|NCT01910129|76213701|FG000|COMPLETED|Randomized Phase 3||5||
60097174|NCT01910129|76213702|FG001|COMPLETED|Randomized Phase 3||4||
60097175|NCT01910129|76213703|FG002|COMPLETED|Randomized Phase 3||0||
60097176|NCT01910129|76213701|FG000|NOT COMPLETED|Randomized Phase 3||0||
60097177|NCT01910129|76213702|FG001|NOT COMPLETED|Randomized Phase 3||1||
60097178|NCT01910129|76213703|FG002|NOT COMPLETED|Randomized Phase 3||0||
60097179|NCT01909973|76213723|FG000|STARTED|Overall Study||8||
60097180|NCT01909973|76213724|FG001|STARTED|Overall Study||7||
60097181|NCT01909973|76213723|FG000|COMPLETED|Overall Study||7||
60097182|NCT01909973|76213724|FG001|COMPLETED|Overall Study||7||
60097183|NCT01909973|76213723|FG000|NOT COMPLETED|Overall Study||1||
60097184|NCT01909973|76213724|FG001|NOT COMPLETED|Overall Study||0||
60097185|NCT01617005|76213730|FG000|STARTED|Overall Study||50||
60097186|NCT01617005|76213730|FG000|COMPLETED|Overall Study||48||
60097187|NCT01617005|76213730|FG000|NOT COMPLETED|Overall Study||2||
60097188|NCT01925339|76213736|FG000|STARTED|Overall Study||20||
60097189|NCT01925339|76213737|FG001|STARTED|Overall Study||20||
60097190|NCT01925339|76213736|FG000|COMPLETED|Overall Study||18||
60097191|NCT01925339|76213737|FG001|COMPLETED|Overall Study||20||
60097192|NCT01925339|76213736|FG000|NOT COMPLETED|Overall Study||2||
60097193|NCT01925339|76213737|FG001|NOT COMPLETED|Overall Study||0||
60097194|NCT01908803|76213745|FG000|STARTED|Overall Study||46||
60097195|NCT01908803|76213746|FG001|STARTED|Overall Study||24||
60097196|NCT01908803|76213745|FG000|Treated|Overall Study|Two randomized subjects discontinued prior to receiving investigational product.|44||
60097197|NCT01908803|76213746|FG001|Treated|Overall Study||24||
60097198|NCT01908803|76213745|FG000|COMPLETED|Overall Study||42||
60097199|NCT01908803|76213746|FG001|COMPLETED|Overall Study||23||
60097200|NCT01908803|76213745|FG000|NOT COMPLETED|Overall Study||4||
60097201|NCT01908803|76213746|FG001|NOT COMPLETED|Overall Study||1||
59993622|NCT02656017|76109575|FG000|STARTED|Overall Study||49||
59993623|NCT02656017|76109576|FG001|STARTED|Overall Study||48||
59993624|NCT02656017|76109575|FG000|COMPLETED|Overall Study||40||
59993625|NCT02656017|76109576|FG001|COMPLETED|Overall Study||42||
59993626|NCT02656017|76109575|FG000|NOT COMPLETED|Overall Study||9||
59993627|NCT02656017|76109576|FG001|NOT COMPLETED|Overall Study||6||
59708139|NCT00980200|75826927|FG002|STARTED|7-day Washout Period 4||15||
59708140|NCT00980200|75826928|FG003|STARTED|7-day Washout Period 4||16||
59993628|NCT02657343|76109588|FG000|STARTED|Overall Study||3||
59993629|NCT02657343|76109589|FG001|STARTED|Overall Study||3||
59993630|NCT02657343|76109590|FG002|STARTED|Overall Study||3||
59993631|NCT02657343|76109591|FG003|STARTED|Overall Study||3||
59993632|NCT02657343|76109592|FG004|STARTED|Overall Study||13||
59993633|NCT02657343|76109593|FG005|STARTED|Overall Study||0||
59993634|NCT02657343|76109588|FG000|COMPLETED|Overall Study||2||
59993635|NCT02657343|76109589|FG001|COMPLETED|Overall Study||1||
59993636|NCT02657343|76109590|FG002|COMPLETED|Overall Study||3||
59993637|NCT02657343|76109591|FG003|COMPLETED|Overall Study||3||
59993638|NCT02657343|76109592|FG004|COMPLETED|Overall Study||12||
59993639|NCT02657343|76109593|FG005|COMPLETED|Overall Study||0||
59993640|NCT02657343|76109588|FG000|NOT COMPLETED|Overall Study||1||
59993641|NCT02657343|76109589|FG001|NOT COMPLETED|Overall Study||2||
59993642|NCT02657343|76109590|FG002|NOT COMPLETED|Overall Study||0||
59993643|NCT02657343|76109591|FG003|NOT COMPLETED|Overall Study||0||
59993644|NCT02657343|76109592|FG004|NOT COMPLETED|Overall Study||1||
59993645|NCT02657343|76109593|FG005|NOT COMPLETED|Overall Study||0||
59993646|NCT02655237|76109609|FG000|STARTED|Overall Study||139||
59993647|NCT02655237|76109610|FG001|STARTED|Overall Study||142||
60097202|NCT01908101|76213753|FG000|STARTED|Overall Study||68||
60097203|NCT01908101|76213753|FG000|COMPLETED|Overall Study||59||
60097204|NCT01908101|76213753|FG000|NOT COMPLETED|Overall Study||9||
60097205|NCT01923389|76213759|FG000|STARTED|Overall Study||2||
60097206|NCT01923389|76213760|FG001|STARTED|Overall Study||2||
60097207|NCT01923389|76213759|FG000|COMPLETED|Overall Study||1||
60097208|NCT01923389|76213760|FG001|COMPLETED|Overall Study||2||
60097209|NCT01923389|76213759|FG000|NOT COMPLETED|Overall Study||1||
60097210|NCT01923389|76213760|FG001|NOT COMPLETED|Overall Study||0||
60097211|NCT01907087|76213767|FG000|STARTED|Overall Study||24||
59708141|NCT00980200|75826929|FG004|STARTED|7-day Washout Period 4||14||
59708142|NCT00980200|75826925|FG000|COMPLETED|7-day Washout Period 4||15||
59708143|NCT00980200|75826926|FG001|COMPLETED|7-day Washout Period 4||12||
59993648|NCT02655237|76109609|FG000|COMPLETED|Overall Study||122||
59993649|NCT02655237|76109610|FG001|COMPLETED|Overall Study||131||
60097212|NCT01907087|76213767|FG000|COMPLETED|Overall Study||23||
60097213|NCT01907087|76213767|FG000|NOT COMPLETED|Overall Study||1||
59993650|NCT02655237|76109609|FG000|NOT COMPLETED|Overall Study||17||
59993651|NCT02655237|76109610|FG001|NOT COMPLETED|Overall Study||11||
59993652|NCT02657031|76109618|FG000|STARTED|Overall Study||29||
59993653|NCT02657031|76109619|FG001|STARTED|Overall Study||25||
59993654|NCT02657031|76109618|FG000|COMPLETED|Overall Study||28||
59993655|NCT02657031|76109619|FG001|COMPLETED|Overall Study||23||
59993656|NCT02657031|76109618|FG000|NOT COMPLETED|Overall Study||1||
60097214|NCT01616771|76213771|FG000|STARTED|Macintosh Laryngoscopy for 5 Sec||23||
60097215|NCT01616771|76213771|FG000|COMPLETED|Macintosh Laryngoscopy for 5 Sec||23||
60097216|NCT01616771|76213771|FG000|NOT COMPLETED|Macintosh Laryngoscopy for 5 Sec||0||
60097217|NCT01616771|76213771|FG000|STARTED|GVL Selected by Weight for 5 Sec||23||
60097218|NCT01616771|76213771|FG000|COMPLETED|GVL Selected by Weight for 5 Sec||23||
60097219|NCT01616771|76213771|FG000|NOT COMPLETED|GVL Selected by Weight for 5 Sec||0||
60097220|NCT01616771|76213771|FG000|STARTED|Smaller Sized GVL for 5 Sec|Four of 23 patients could not be evaluated by smaller sized GVL, because there was no smaller one.|23||
60097221|NCT01616771|76213771|FG000|COMPLETED|Smaller Sized GVL for 5 Sec||19||
60097222|NCT01616771|76213771|FG000|NOT COMPLETED|Smaller Sized GVL for 5 Sec||4||
60097223|NCT01589185|76213785|FG000|STARTED|Overall Study||6||
60097224|NCT01589185|76213786|FG001|STARTED|Overall Study||8||
60097225|NCT01589185|76213787|FG002|STARTED|Overall Study||10||
60097226|NCT01589185|76213788|FG003|STARTED|Overall Study||8||
60097227|NCT01589185|76213789|FG004|STARTED|Overall Study||16||
60097228|NCT01589185|76213785|FG000|COMPLETED|Overall Study||4||
60097229|NCT01589185|76213786|FG001|COMPLETED|Overall Study||6||
60097230|NCT01589185|76213787|FG002|COMPLETED|Overall Study||6||
60097231|NCT01589185|76213788|FG003|COMPLETED|Overall Study||5||
60097232|NCT01589185|76213789|FG004|COMPLETED|Overall Study||15||
60097233|NCT01589185|76213785|FG000|NOT COMPLETED|Overall Study||2||
60097234|NCT01589185|76213786|FG001|NOT COMPLETED|Overall Study||2||
60097235|NCT01589185|76213787|FG002|NOT COMPLETED|Overall Study||4||
60097236|NCT01589185|76213788|FG003|NOT COMPLETED|Overall Study||3||
60097237|NCT01589185|76213789|FG004|NOT COMPLETED|Overall Study||1||
60097238|NCT01588951|76213805|FG000|STARTED|Overall Study||2||
60097239|NCT01588951|76213806|FG001|STARTED|Overall Study||2||
60097240|NCT01588951|76213807|FG002|STARTED|Overall Study||6||
60097241|NCT01588951|76213805|FG000|COMPLETED|Overall Study||2||
60097242|NCT01588951|76213806|FG001|COMPLETED|Overall Study||2||
60097243|NCT01588951|76213807|FG002|COMPLETED|Overall Study||5||
60097244|NCT01588951|76213805|FG000|NOT COMPLETED|Overall Study||0||
60097245|NCT01588951|76213806|FG001|NOT COMPLETED|Overall Study||0||
60097246|NCT01588951|76213807|FG002|NOT COMPLETED|Overall Study||1||
60097247|NCT01709383|76213817|FG000|STARTED|Overall Study||24||
60097248|NCT01709383|76213818|FG001|STARTED|Overall Study||14||
60097249|NCT01709383|76213817|FG000|Completed Treatment|Overall Study||24||
60097250|NCT01709383|76213818|FG001|Completed Treatment|Overall Study||14||
60097251|NCT01709383|76213817|FG000|Completed Follow-ups|Overall Study||23||
60097252|NCT01709383|76213818|FG001|Completed Follow-ups|Overall Study||14||
60097253|NCT01709383|76213817|FG000|Included in Analysis|Overall Study||22||
60097254|NCT01709383|76213818|FG001|Included in Analysis|Overall Study||13||
60097255|NCT01709383|76213817|FG000|COMPLETED|Overall Study||23||
60097256|NCT01709383|76213818|FG001|COMPLETED|Overall Study||14||
60097257|NCT01709383|76213817|FG000|NOT COMPLETED|Overall Study||1||
60097258|NCT01709383|76213818|FG001|NOT COMPLETED|Overall Study||0||
60097259|NCT01588405|76213826|FG000|STARTED|Overall Study||33||
60097260|NCT01588405|76213826|FG000|COMPLETED|Overall Study||31||
60097261|NCT01588405|76213826|FG000|NOT COMPLETED|Overall Study||2||
60097262|NCT01923311|76213835|FG000|STARTED|Overall Study||17||
60097263|NCT01923311|76213836|FG001|STARTED|Overall Study||14||
60097264|NCT01923311|76213835|FG000|COMPLETED|Overall Study||0||
60097265|NCT01923311|76213836|FG001|COMPLETED|Overall Study||13||
60097266|NCT01923311|76213835|FG000|NOT COMPLETED|Overall Study||17||
60097267|NCT01923311|76213836|FG001|NOT COMPLETED|Overall Study||1||
60097268|NCT01603615|76213843|FG000|STARTED|Overall Study||220||
60097269|NCT01603615|76213843|FG000|Safety Population (Treated)|Overall Study||213||
60097270|NCT01603615|76213843|FG000|COMPLETED|Overall Study||186||
60097271|NCT01603615|76213843|FG000|NOT COMPLETED|Overall Study||34||
60097272|NCT01685047|76213847|FG000|STARTED|Overall Study|481 subjects signed the consent. 1 subject was withdrawn prior to the baseline visit.|481||
60097273|NCT01685047|76213847|FG000|COMPLETED|Overall Study||396||
60097274|NCT01685047|76213847|FG000|NOT COMPLETED|Overall Study||85||
60097275|NCT01905683|76213851|FG000|STARTED|Overall Study||370||
60097276|NCT01905683|76213851|FG000|COMPLETED|Overall Study||319||
60097277|NCT01905683|76213851|FG000|NOT COMPLETED|Overall Study||51||
60097278|NCT01921829|76213857|FG000|STARTED|Overall Study||10||
60097279|NCT01921829|76213858|FG001|STARTED|Overall Study||9||
60097280|NCT01921829|76213857|FG000|COMPLETED|Overall Study||10||
60097281|NCT01921829|76213858|FG001|COMPLETED|Overall Study||8||
60097282|NCT01921829|76213857|FG000|NOT COMPLETED|Overall Study||0||
60097283|NCT01921829|76213858|FG001|NOT COMPLETED|Overall Study||1||
60097284|NCT01904903|76213864|FG000|STARTED|Overall Study||31||
60097285|NCT01904903|76213864|FG000|COMPLETED|Overall Study||30||
60097286|NCT01904903|76213864|FG000|NOT COMPLETED|Overall Study||1||
60097287|NCT01921517|76213870|FG000|STARTED|Overall Study||42||
60097288|NCT01921517|76213871|FG001|STARTED|Overall Study||38||
60097289|NCT01921517|76213870|FG000|COMPLETED|Overall Study||27||
60097290|NCT01921517|76213871|FG001|COMPLETED|Overall Study||29||
60097291|NCT01921517|76213870|FG000|NOT COMPLETED|Overall Study||15||
60097292|NCT01921517|76213871|FG001|NOT COMPLETED|Overall Study||9||
60097293|NCT01921205|76213879|FG000|STARTED|Overall Study||172||
60097294|NCT01921205|76213880|FG001|STARTED|Overall Study||171||
60097295|NCT01921205|76213879|FG000|COMPLETED|Overall Study||151||
60097296|NCT01921205|76213880|FG001|COMPLETED|Overall Study||151||
60097297|NCT01921205|76213879|FG000|NOT COMPLETED|Overall Study||21||
60097298|NCT01921205|76213880|FG001|NOT COMPLETED|Overall Study||20||
60097299|NCT01920893|76213888|FG000|STARTED|Overall Study||30||
60097300|NCT01920893|76213889|FG001|STARTED|Overall Study||30||
60097301|NCT01920893|76213888|FG000|Treated (Safety Population)|Overall Study||30||
60097302|NCT01920893|76213889|FG001|Treated (Safety Population)|Overall Study||30||
60097303|NCT01920893|76213888|FG000|COMPLETED|Overall Study||23||
60097304|NCT01920893|76213889|FG001|COMPLETED|Overall Study||28||
60097305|NCT01920893|76213888|FG000|NOT COMPLETED|Overall Study||7||
60097306|NCT01920893|76213889|FG001|NOT COMPLETED|Overall Study||2||
60097307|NCT01709305|76213896|FG000|STARTED|Phase 1||5570||
60097308|NCT01709305|76213897|FG001|STARTED|Phase 1||0||
60097309|NCT01709305|76213898|FG002|STARTED|Phase 1||0||
60097310|NCT01709305|76213899|FG003|STARTED|Phase 1||0||
60097311|NCT01709305|76213900|FG004|STARTED|Phase 1||0||
60097312|NCT01709305|76213896|FG000|COMPLETED|Phase 1||4933||
60097313|NCT01709305|76213897|FG001|COMPLETED|Phase 1||0||
60097314|NCT01709305|76213898|FG002|COMPLETED|Phase 1||0||
60097315|NCT01709305|76213899|FG003|COMPLETED|Phase 1||0||
60097316|NCT01709305|76213900|FG004|COMPLETED|Phase 1||0||
60097317|NCT01709305|76213896|FG000|NOT COMPLETED|Phase 1||637||
60097318|NCT01709305|76213897|FG001|NOT COMPLETED|Phase 1||0||
60097319|NCT01709305|76213898|FG002|NOT COMPLETED|Phase 1||0||
60097320|NCT01709305|76213899|FG003|NOT COMPLETED|Phase 1||0||
60097321|NCT01709305|76213900|FG004|NOT COMPLETED|Phase 1||0||
60097322|NCT01709305|76213896|FG000|STARTED|Phase 2||0||
60097323|NCT01709305|76213897|FG001|STARTED|Phase 2||552||
60097324|NCT01709305|76213898|FG002|STARTED|Phase 2||550||
60097325|NCT01709305|76213899|FG003|STARTED|Phase 2||556||
60097326|NCT01709305|76213900|FG004|STARTED|Phase 2||554||
60097327|NCT01709305|76213896|FG000|COMPLETED|Phase 2||0||
60097328|NCT01709305|76213897|FG001|COMPLETED|Phase 2||500||
60097329|NCT01709305|76213898|FG002|COMPLETED|Phase 2||505||
60097330|NCT01709305|76213899|FG003|COMPLETED|Phase 2||508||
60097331|NCT01709305|76213900|FG004|COMPLETED|Phase 2||507||
60097332|NCT01709305|76213896|FG000|NOT COMPLETED|Phase 2||0||
60097333|NCT01709305|76213897|FG001|NOT COMPLETED|Phase 2||52||
60097334|NCT01709305|76213898|FG002|NOT COMPLETED|Phase 2||45||
60097335|NCT01709305|76213899|FG003|NOT COMPLETED|Phase 2||48||
60097336|NCT01709305|76213900|FG004|NOT COMPLETED|Phase 2||47||
60097337|NCT01684423|76213920|FG000|STARTED|Overall Study||11||
60097338|NCT01684423|76213921|FG001|STARTED|Overall Study||13||
60097339|NCT01684423|76213922|FG002|STARTED|Overall Study||13||
60097340|NCT01684423|76213923|FG003|STARTED|Overall Study||19||
60097341|NCT01684423|76213924|FG004|STARTED|Overall Study||7||
60097342|NCT01684423|76213920|FG000|COMPLETED|Overall Study||11||
60097343|NCT01684423|76213921|FG001|COMPLETED|Overall Study||13||
60097344|NCT01684423|76213922|FG002|COMPLETED|Overall Study||12||
60097345|NCT01684423|76213923|FG003|COMPLETED|Overall Study||19||
60097346|NCT01684423|76213924|FG004|COMPLETED|Overall Study||7||
60097347|NCT01684423|76213920|FG000|NOT COMPLETED|Overall Study||0||
60097348|NCT01684423|76213921|FG001|NOT COMPLETED|Overall Study||0||
60097349|NCT01684423|76213922|FG002|NOT COMPLETED|Overall Study||1||
60097350|NCT01684423|76213923|FG003|NOT COMPLETED|Overall Study||0||
60097351|NCT01684423|76213924|FG004|NOT COMPLETED|Overall Study||0||
60097352|NCT01709227|76213940|FG000|STARTED|Overall Study||32||
60097353|NCT01709227|76213941|FG001|STARTED|Overall Study||41||
60097354|NCT01709227|76213940|FG000|COMPLETED|Overall Study||31||
60097355|NCT01709227|76213941|FG001|COMPLETED|Overall Study||32||
60097356|NCT01709227|76213940|FG000|NOT COMPLETED|Overall Study||1||
60097357|NCT01709227|76213941|FG001|NOT COMPLETED|Overall Study||9||
60097358|NCT01684033|76213948|FG000|STARTED|Period 1, First 30 Days||99||
60097359|NCT01684033|76213949|FG001|STARTED|Period 1, First 30 Days||99||
60097360|NCT01684033|76213948|FG000|COMPLETED|Period 1, First 30 Days||95||
60097361|NCT01684033|76213949|FG001|COMPLETED|Period 1, First 30 Days||98||
60097362|NCT01684033|76213948|FG000|NOT COMPLETED|Period 1, First 30 Days||4||
60097363|NCT01684033|76213949|FG001|NOT COMPLETED|Period 1, First 30 Days||1||
60097364|NCT01684033|76213948|FG000|STARTED|Period 2, Second 30 Days||95||
60097365|NCT01684033|76213949|FG001|STARTED|Period 2, Second 30 Days||98||
60097366|NCT01684033|76213948|FG000|COMPLETED|Period 2, Second 30 Days||94||
60097367|NCT01684033|76213949|FG001|COMPLETED|Period 2, Second 30 Days||98||
60097368|NCT01684033|76213948|FG000|NOT COMPLETED|Period 2, Second 30 Days||1||
60097369|NCT01684033|76213949|FG001|NOT COMPLETED|Period 2, Second 30 Days||0||
60097370|NCT00878644|76213957|FG000|STARTED|Overall Study||155||
60097371|NCT00878644|76213958|FG001|STARTED|Overall Study||140||
60097372|NCT00878644|76213957|FG000|COMPLETED|Overall Study||151||
60097373|NCT00878644|76213958|FG001|COMPLETED|Overall Study||136||
60097374|NCT00878644|76213957|FG000|NOT COMPLETED|Overall Study||4||
60097375|NCT00878644|76213958|FG001|NOT COMPLETED|Overall Study||4||
60097376|NCT00878878|76213966|FG000|STARTED|Overall Study||15||
60097377|NCT00878878|76213967|FG001|STARTED|Overall Study||15||
60097378|NCT00878878|76213966|FG000|COMPLETED|Overall Study||15||
60097379|NCT00878878|76213967|FG001|COMPLETED|Overall Study||15||
60097380|NCT00878878|76213966|FG000|NOT COMPLETED|Overall Study||0||
60097381|NCT00878878|76213967|FG001|NOT COMPLETED|Overall Study||0||
60097382|NCT00879034|76213975|FG000|STARTED|Overall Study||5||
60097383|NCT00879034|76213975|FG000|Received Treatment|Overall Study||4|One patient did not receive a zoledronic acid infusion during study.|
60097384|NCT00879034|76213975|FG000|COMPLETED|Overall Study||5||
60097385|NCT00879034|76213975|FG000|NOT COMPLETED|Overall Study||0||
60097386|NCT00879190|76213981|FG000|STARTED|Overall Study||43||
60097387|NCT00879190|76213982|FG001|STARTED|Overall Study||49||
60097388|NCT00879190|76213981|FG000|COMPLETED|Overall Study||43||
60097389|NCT00879190|76213982|FG001|COMPLETED|Overall Study||49||
60097390|NCT00879190|76213981|FG000|NOT COMPLETED|Overall Study||0||
60097391|NCT00879190|76213982|FG001|NOT COMPLETED|Overall Study||0||
60097392|NCT01903811|76213990|FG000|STARTED|Overall Study||72||
60097393|NCT01903811|76213991|FG001|STARTED|Overall Study||71||
60097394|NCT01903811|76213990|FG000|Crossover to Arm II|Overall Study|Following disease progression on Arm I. Note: these patients are also counted in 'Completed'.|16||
60097395|NCT01903811|76213991|FG001|Crossover to Arm II|Overall Study||0||
60097396|NCT01903811|76213990|FG000|COMPLETED|Overall Study||64|Completed implies patients were eligible for study treatment and analyzable for study endpoints.|
60097397|NCT01903811|76213991|FG001|COMPLETED|Overall Study||57|Completed implies patients were eligible for study treatment and analyzable for study endpoints.|
60097398|NCT01903811|76213990|FG000|NOT COMPLETED|Overall Study||8||
60097399|NCT01903811|76213991|FG001|NOT COMPLETED|Overall Study||14||
60097400|NCT00880360|76214000|FG000|STARTED|Overall Study||19||
60097401|NCT00880360|76214000|FG000|COMPLETED|Overall Study||19||
60097402|NCT00880360|76214000|FG000|NOT COMPLETED|Overall Study||0||
60097403|NCT01709149|76214008|FG000|STARTED|Open-label Lead-in Phase||711||
60097404|NCT01709149|76214009|FG001|STARTED|Open-label Lead-in Phase||0||
60097405|NCT01709149|76214010|FG002|STARTED|Open-label Lead-in Phase||0||
60097406|NCT01709149|76214008|FG000|COMPLETED|Open-label Lead-in Phase||596||
60097407|NCT01709149|76214009|FG001|COMPLETED|Open-label Lead-in Phase||0||
60097408|NCT01709149|76214010|FG002|COMPLETED|Open-label Lead-in Phase||0||
60097409|NCT01709149|76214008|FG000|NOT COMPLETED|Open-label Lead-in Phase||115||
60097410|NCT01709149|76214009|FG001|NOT COMPLETED|Open-label Lead-in Phase||0||
60097411|NCT01709149|76214010|FG002|NOT COMPLETED|Open-label Lead-in Phase||0||
60097412|NCT01709149|76214008|FG000|STARTED|Double-blind, Placebo-controlled Phase||0||
60097413|NCT01709149|76214009|FG001|STARTED|Double-blind, Placebo-controlled Phase||295||
60097414|NCT01709149|76214010|FG002|STARTED|Double-blind, Placebo-controlled Phase||301||
59562558|NCT01741454|75664417|FG001|STARTED|Overall Study||50||
60097415|NCT01709149|76214008|FG000|COMPLETED|Double-blind, Placebo-controlled Phase||0||
60097416|NCT01709149|76214009|FG001|COMPLETED|Double-blind, Placebo-controlled Phase||269||
60097417|NCT01709149|76214010|FG002|COMPLETED|Double-blind, Placebo-controlled Phase||204||
60097418|NCT01709149|76214008|FG000|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0||
60097419|NCT01709149|76214009|FG001|NOT COMPLETED|Double-blind, Placebo-controlled Phase||26||
60097420|NCT01709149|76214010|FG002|NOT COMPLETED|Double-blind, Placebo-controlled Phase||97||
60097421|NCT01568593|76214019|FG000|STARTED|Overall Study||48||
60097422|NCT01568593|76214020|FG001|STARTED|Overall Study||45||
60097423|NCT01568593|76214019|FG000|COMPLETED|Overall Study||41||
60097424|NCT01568593|76214020|FG001|COMPLETED|Overall Study||42||
60097425|NCT01568593|76214019|FG000|NOT COMPLETED|Overall Study||7||
60097426|NCT01568593|76214020|FG001|NOT COMPLETED|Overall Study||3||
60097427|NCT01683565|76214028|FG000|STARTED|Overall Study||15||
60097428|NCT01683565|76214029|FG001|STARTED|Overall Study||16||
59562559|NCT01741454|75664418|FG002|STARTED|Overall Study||39||
60097429|NCT01683565|76214028|FG000|COMPLETED|Overall Study||12||
60097430|NCT01683565|76214029|FG001|COMPLETED|Overall Study||15||
59562560|NCT01741454|75664419|FG003|STARTED|Overall Study||43||
60097431|NCT01683565|76214028|FG000|NOT COMPLETED|Overall Study||3||
60097432|NCT01683565|76214029|FG001|NOT COMPLETED|Overall Study||1||
60097433|NCT00882778|76214037|FG000|STARTED|Overall Study||86||
60097434|NCT00882778|76214037|FG000|COMPLETED|Overall Study||86||
60097435|NCT00882778|76214037|FG000|NOT COMPLETED|Overall Study||0||
60097436|NCT00892606|76214043|FG000|STARTED|Overall Study||38||
60097437|NCT00892606|76214044|FG001|STARTED|Overall Study||37||
60097438|NCT00892606|76214043|FG000|COMPLETED|Overall Study||33||
60097439|NCT00892606|76214044|FG001|COMPLETED|Overall Study||33||
60097440|NCT00892606|76214043|FG000|NOT COMPLETED|Overall Study||5||
60097441|NCT00892606|76214044|FG001|NOT COMPLETED|Overall Study||4||
60097442|NCT01903031|76214053|FG000|STARTED|Overall Study||27||
60097443|NCT01903031|76214054|FG001|STARTED|Overall Study||28||
60097444|NCT01903031|76214055|FG002|STARTED|Overall Study||29||
60097445|NCT01903031|76214053|FG000|COMPLETED|Overall Study||25||
60097446|NCT01903031|76214054|FG001|COMPLETED|Overall Study||25||
60097447|NCT01903031|76214055|FG002|COMPLETED|Overall Study||24||
60097448|NCT01903031|76214053|FG000|NOT COMPLETED|Overall Study||2||
60097449|NCT01903031|76214054|FG001|NOT COMPLETED|Overall Study||3||
60097450|NCT01903031|76214055|FG002|NOT COMPLETED|Overall Study||5||
60097451|NCT00883168|76214070|FG000|STARTED|Overall Study||448||
60097452|NCT00883168|76214071|FG001|STARTED|Overall Study||445||
60097453|NCT00883168|76214072|FG002|STARTED|Overall Study||450||
60097454|NCT00883168|76214073|FG003|STARTED|Overall Study||448||
60097455|NCT00883168|76214070|FG000|COMPLETED|Overall Study||434||
60097456|NCT00883168|76214071|FG001|COMPLETED|Overall Study||430||
60097457|NCT00883168|76214072|FG002|COMPLETED|Overall Study||431||
60097458|NCT00883168|76214073|FG003|COMPLETED|Overall Study||433||
60097459|NCT00883168|76214070|FG000|NOT COMPLETED|Overall Study||14||
60097460|NCT00883168|76214071|FG001|NOT COMPLETED|Overall Study||15||
60097461|NCT00883168|76214072|FG002|NOT COMPLETED|Overall Study||19||
60097462|NCT00883168|76214073|FG003|NOT COMPLETED|Overall Study||15||
60097463|NCT01616693|76214087|FG000|STARTED|Evaluated for Safety||155||
60097464|NCT01616693|76214088|FG001|STARTED|Evaluated for Safety||155||
60097465|NCT01616693|76214089|FG002|STARTED|Evaluated for Safety||155||
60097466|NCT01616693|76214090|FG003|STARTED|Evaluated for Safety||155||
60097467|NCT01616693|76214087|FG000|COMPLETED|Evaluated for Safety||154||
60097468|NCT01616693|76214088|FG001|COMPLETED|Evaluated for Safety||155||
60097469|NCT01616693|76214089|FG002|COMPLETED|Evaluated for Safety||154||
60097470|NCT01616693|76214090|FG003|COMPLETED|Evaluated for Safety||155||
60097471|NCT01616693|76214087|FG000|NOT COMPLETED|Evaluated for Safety||1||
60097472|NCT01616693|76214088|FG001|NOT COMPLETED|Evaluated for Safety||0||
60097473|NCT01616693|76214089|FG002|NOT COMPLETED|Evaluated for Safety||1||
60097474|NCT01616693|76214090|FG003|NOT COMPLETED|Evaluated for Safety||0||
60097475|NCT01616693|76214087|FG000|STARTED|Received Both Vaccines||154||
60097476|NCT01616693|76214088|FG001|STARTED|Received Both Vaccines||155||
60097477|NCT01616693|76214089|FG002|STARTED|Received Both Vaccines||154||
60097478|NCT01616693|76214090|FG003|STARTED|Received Both Vaccines||155||
60097479|NCT01616693|76214087|FG000|COMPLETED|Received Both Vaccines||141||
60097480|NCT01616693|76214088|FG001|COMPLETED|Received Both Vaccines||145||
60097481|NCT01616693|76214089|FG002|COMPLETED|Received Both Vaccines||142||
60097482|NCT01616693|76214090|FG003|COMPLETED|Received Both Vaccines||136||
60097483|NCT01616693|76214087|FG000|NOT COMPLETED|Received Both Vaccines||13||
60097484|NCT01616693|76214088|FG001|NOT COMPLETED|Received Both Vaccines||10||
60097485|NCT01616693|76214089|FG002|NOT COMPLETED|Received Both Vaccines||12||
60097486|NCT01616693|76214090|FG003|NOT COMPLETED|Received Both Vaccines||19||
60097487|NCT01616693|76214087|FG000|STARTED|Blood Analyzed for Immunogenicity||141||
60097488|NCT01616693|76214088|FG001|STARTED|Blood Analyzed for Immunogenicity||145||
60097489|NCT01616693|76214089|FG002|STARTED|Blood Analyzed for Immunogenicity||142||
60097490|NCT01616693|76214090|FG003|STARTED|Blood Analyzed for Immunogenicity||136||
60097491|NCT01616693|76214087|FG000|COMPLETED|Blood Analyzed for Immunogenicity||137||
60097492|NCT01616693|76214088|FG001|COMPLETED|Blood Analyzed for Immunogenicity||143||
60097493|NCT01616693|76214089|FG002|COMPLETED|Blood Analyzed for Immunogenicity||136||
60097494|NCT01616693|76214090|FG003|COMPLETED|Blood Analyzed for Immunogenicity||135||
60097495|NCT01616693|76214087|FG000|NOT COMPLETED|Blood Analyzed for Immunogenicity||4||
60097496|NCT01616693|76214088|FG001|NOT COMPLETED|Blood Analyzed for Immunogenicity||2||
60097497|NCT01616693|76214089|FG002|NOT COMPLETED|Blood Analyzed for Immunogenicity||6||
60097498|NCT01616693|76214090|FG003|NOT COMPLETED|Blood Analyzed for Immunogenicity||1||
60097499|NCT00883246|76214104|FG000|STARTED|Overall Study||799||
60097500|NCT00883246|76214104|FG000|COMPLETED|Overall Study||626||
60097501|NCT00883246|76214104|FG000|NOT COMPLETED|Overall Study||173||
60097502|NCT00893074|76214114|FG000|STARTED|Overall Study||24||
60097503|NCT00893074|76214114|FG000|COMPLETED|Overall Study||13||
60097504|NCT00893074|76214114|FG000|NOT COMPLETED|Overall Study||11||
60097505|NCT00884806|76214129|FG000|STARTED|Overall Study||110||
60097506|NCT00884806|76214129|FG000|COMPLETED|Overall Study||110||
60097507|NCT00884806|76214129|FG000|NOT COMPLETED|Overall Study||0||
60097508|NCT00893152|76214135|FG000|STARTED|Overall Study||47||
60097509|NCT00893152|76214136|FG001|STARTED|Overall Study||36||
60097510|NCT00893152|76214135|FG000|COMPLETED|Overall Study||47||
60097511|NCT00893152|76214136|FG001|COMPLETED|Overall Study||36||
60097512|NCT00893152|76214135|FG000|NOT COMPLETED|Overall Study||0||
60097513|NCT00893152|76214136|FG001|NOT COMPLETED|Overall Study||0||
60097514|NCT00885742|76214142|FG000|STARTED|Overall Study||41||
60097515|NCT00885742|76214142|FG000|COMPLETED|Overall Study||41||
60097516|NCT00885742|76214142|FG000|NOT COMPLETED|Overall Study||0||
59816974|NCT02464878|75939391|FG000|STARTED|Overall Study||2||
60097517|NCT00887458|76214148|FG000|STARTED|Overall Study||17||
60097518|NCT00887458|76214149|FG001|STARTED|Overall Study||29||
60097519|NCT00887458|76214148|FG000|COMPLETED|Overall Study||17||
60097520|NCT00887458|76214149|FG001|COMPLETED|Overall Study||25||
60097521|NCT00887458|76214148|FG000|NOT COMPLETED|Overall Study||0||
60097522|NCT00887458|76214149|FG001|NOT COMPLETED|Overall Study||4||
60097523|NCT00888628|76214157|FG000|STARTED|Overall Study||7||
60097524|NCT00888628|76214157|FG000|Enrolled|Overall Study||7||
60097525|NCT00888628|76214157|FG000|Screen Failure|Overall Study||2||
60097526|NCT00888628|76214157|FG000|Withdrawn|Overall Study||1||
60097527|NCT00888628|76214157|FG000|Transplanted|Overall Study||4||
60097528|NCT00888628|76214157|FG000|COMPLETED|Overall Study||4||
60097529|NCT00888628|76214157|FG000|NOT COMPLETED|Overall Study||3||
60097530|NCT00889330|76214163|FG000|STARTED|Overall Study||30||
60097531|NCT00889330|76214164|FG001|STARTED|Overall Study||30||
60097532|NCT00889330|76214163|FG000|COMPLETED|Overall Study||30||
60097533|NCT00889330|76214164|FG001|COMPLETED|Overall Study||30||
60097534|NCT00889330|76214163|FG000|NOT COMPLETED|Overall Study||0||
60097535|NCT00889330|76214164|FG001|NOT COMPLETED|Overall Study||0||
60097536|NCT00896038|76214172|FG000|STARTED|Overall Study||30||
60097537|NCT00896038|76214173|FG001|STARTED|Overall Study||28||
60097538|NCT00896038|76214172|FG000|COMPLETED|Overall Study||26||
60097539|NCT00896038|76214173|FG001|COMPLETED|Overall Study||27||
60097540|NCT00896038|76214172|FG000|NOT COMPLETED|Overall Study||4||
60097541|NCT00896038|76214173|FG001|NOT COMPLETED|Overall Study||1||
60097542|NCT00897676|76214179|FG000|STARTED|Intervention 1(6 Hours)||9||
60097543|NCT00897676|76214180|FG001|STARTED|Intervention 1(6 Hours)||7||
60097544|NCT00897676|76214179|FG000|COMPLETED|Intervention 1(6 Hours)||9||
60097545|NCT00897676|76214180|FG001|COMPLETED|Intervention 1(6 Hours)||7||
60097546|NCT00897676|76214179|FG000|NOT COMPLETED|Intervention 1(6 Hours)||0||
60097547|NCT00897676|76214180|FG001|NOT COMPLETED|Intervention 1(6 Hours)||0||
60097548|NCT00897676|76214179|FG000|STARTED|Intervention 2(6 Hours)||9||
60097549|NCT00897676|76214180|FG001|STARTED|Intervention 2(6 Hours)||7||
60097550|NCT00897676|76214179|FG000|COMPLETED|Intervention 2(6 Hours)||9||
60097551|NCT00897676|76214180|FG001|COMPLETED|Intervention 2(6 Hours)||7||
60097552|NCT00897676|76214179|FG000|NOT COMPLETED|Intervention 2(6 Hours)||0||
60097553|NCT00897676|76214180|FG001|NOT COMPLETED|Intervention 2(6 Hours)||0||
60097554|NCT01616459|76214197|FG000|STARTED|Overall Study||240||
60097555|NCT01616459|76214198|FG001|STARTED|Overall Study||240||
60097556|NCT01616459|76214199|FG002|STARTED|Overall Study||230||
60097557|NCT01616459|76214200|FG003|STARTED|Overall Study||241||
60097558|NCT01616459|76214197|FG000|COMPLETED|Overall Study||236||
60097559|NCT01616459|76214198|FG001|COMPLETED|Overall Study||223||
60097560|NCT01616459|76214199|FG002|COMPLETED|Overall Study||220||
60097561|NCT01616459|76214200|FG003|COMPLETED|Overall Study||233||
60097562|NCT01616459|76214197|FG000|NOT COMPLETED|Overall Study||4||
60097563|NCT01616459|76214198|FG001|NOT COMPLETED|Overall Study||17||
60097564|NCT01616459|76214199|FG002|NOT COMPLETED|Overall Study||10||
60097565|NCT01616459|76214200|FG003|NOT COMPLETED|Overall Study||8||
60097566|NCT01919801|76214217|FG000|STARTED|Overall Study||61||
60097567|NCT01919801|76214218|FG001|STARTED|Overall Study||60||
60097568|NCT01919801|76214217|FG000|COMPLETED|Overall Study||60||
60097569|NCT01919801|76214218|FG001|COMPLETED|Overall Study||57||
60097570|NCT01919801|76214217|FG000|NOT COMPLETED|Overall Study||1||
60097571|NCT01919801|76214218|FG001|NOT COMPLETED|Overall Study||3||
60097572|NCT01919723|76214226|FG000|STARTED|Overall Study||35||
60097573|NCT01919723|76214227|FG001|STARTED|Overall Study||35||
60097574|NCT01919723|76214226|FG000|COMPLETED|Overall Study||33||
59562561|NCT01741454|75664416|FG000|COMPLETED|Overall Study||36||
59562562|NCT01741454|75664417|FG001|COMPLETED|Overall Study||44||
59562563|NCT01741454|75664418|FG002|COMPLETED|Overall Study||22||
59562564|NCT01741454|75664419|FG003|COMPLETED|Overall Study||21||
59816975|NCT02464878|75939391|FG000|COMPLETED|Overall Study||2||
60097575|NCT01919723|76214227|FG001|COMPLETED|Overall Study||33||
60097576|NCT01919723|76214226|FG000|NOT COMPLETED|Overall Study||2||
60097577|NCT01919723|76214227|FG001|NOT COMPLETED|Overall Study||2||
60097578|NCT01919489|76214235|FG000|STARTED|Overall Study||136||
60097579|NCT01919489|76214236|FG001|STARTED|Overall Study||137||
60097580|NCT01919489|76214235|FG000|COMPLETED|Overall Study||80||
60097581|NCT01919489|76214236|FG001|COMPLETED|Overall Study||93||
60097582|NCT01919489|76214235|FG000|NOT COMPLETED|Overall Study||56||
60097583|NCT01919489|76214236|FG001|NOT COMPLETED|Overall Study||44||
60097584|NCT01919411|76214244|FG000|STARTED|Overall Study||43||
60097585|NCT01919411|76214245|FG001|STARTED|Overall Study||46||
60097586|NCT01919411|76214244|FG000|COMPLETED|Overall Study||38||
60097587|NCT01919411|76214245|FG001|COMPLETED|Overall Study||41||
59562565|NCT01741454|75664416|FG000|NOT COMPLETED|Overall Study||13||
59562566|NCT01741454|75664417|FG001|NOT COMPLETED|Overall Study||6||
59816976|NCT02464878|75939391|FG000|NOT COMPLETED|Overall Study||0||
60097588|NCT01919411|76214244|FG000|NOT COMPLETED|Overall Study||5||
60097589|NCT01919411|76214245|FG001|NOT COMPLETED|Overall Study||5||
59708144|NCT00980200|75826927|FG002|COMPLETED|7-day Washout Period 4||15||
60097590|NCT01901393|76214253|FG000|STARTED|Overall Study||51||
60097591|NCT01901393|76214254|FG001|STARTED|Overall Study||49||
59562567|NCT01741454|75664418|FG002|NOT COMPLETED|Overall Study||17||
59708145|NCT00980200|75826928|FG003|COMPLETED|7-day Washout Period 4||16||
59562568|NCT01741454|75664419|FG003|NOT COMPLETED|Overall Study||22||
59562569|NCT01720316|75664435|FG000|STARTED|Double-Blind Glycine Placebo Crossover||1||
59562570|NCT01720316|75664436|FG001|STARTED|Double-Blind Glycine Placebo Crossover||1||
59562571|NCT01720316|75664435|FG000|COMPLETED|Double-Blind Glycine Placebo Crossover||1||
59562572|NCT01720316|75664436|FG001|COMPLETED|Double-Blind Glycine Placebo Crossover||1||
59562573|NCT01720316|75664435|FG000|NOT COMPLETED|Double-Blind Glycine Placebo Crossover||0||
59562574|NCT01720316|75664436|FG001|NOT COMPLETED|Double-Blind Glycine Placebo Crossover||0||
59562575|NCT01720316|75664435|FG000|STARTED|Open-label Glycine||1||
59562576|NCT01720316|75664436|FG001|STARTED|Open-label Glycine||1||
59562577|NCT01720316|75664435|FG000|COMPLETED|Open-label Glycine||1||
59562578|NCT01720316|75664436|FG001|COMPLETED|Open-label Glycine||1||
59562579|NCT01720316|75664435|FG000|NOT COMPLETED|Open-label Glycine||0||
59562580|NCT01720316|75664436|FG001|NOT COMPLETED|Open-label Glycine||0||
59562581|NCT02399345|75664468|FG000|STARTED|Overall Study||10||
59562582|NCT02399345|75664468|FG000|COMPLETED|Overall Study||10||
59562583|NCT02399345|75664468|FG000|NOT COMPLETED|Overall Study||0||
59562584|NCT02400437|75664472|FG000|STARTED|Overall Study||26||
59562585|NCT02400437|75664472|FG000|COMPLETED|Overall Study||26||
59562586|NCT02400437|75664472|FG000|NOT COMPLETED|Overall Study||0||
59562587|NCT02402153|75664478|FG000|STARTED|Overall Study||18||
59562588|NCT02402153|75664478|FG000|COMPLETED|Overall Study||18||
59562589|NCT02402153|75664478|FG000|NOT COMPLETED|Overall Study||0||
59562590|NCT02024165|75664482|FG000|STARTED|Overall Study||71||
59562591|NCT02024165|75664482|FG000|COMPLETED|Overall Study||71||
59562592|NCT02024165|75664482|FG000|NOT COMPLETED|Overall Study||0||
59562593|NCT02024477|75664489|FG000|STARTED|Overall Study||21||
59562594|NCT02024477|75664490|FG001|STARTED|Overall Study||21||
59562595|NCT02024477|75664489|FG000|COMPLETED|Overall Study||21||
60097592|NCT01901393|76214253|FG000|COMPLETED|Overall Study||50||
60097593|NCT01901393|76214254|FG001|COMPLETED|Overall Study||49||
60097594|NCT01901393|76214253|FG000|NOT COMPLETED|Overall Study||1||
60097595|NCT01901393|76214254|FG001|NOT COMPLETED|Overall Study||0||
60097596|NCT01890707|76214262|FG000|STARTED|Overall Study||11||
60097597|NCT01890707|76214263|FG001|STARTED|Overall Study||8||
60097598|NCT01890707|76214262|FG000|COMPLETED|Overall Study||10||
60097599|NCT01890707|76214263|FG001|COMPLETED|Overall Study||7||
60097600|NCT01890707|76214262|FG000|NOT COMPLETED|Overall Study||1||
60097601|NCT01890707|76214263|FG001|NOT COMPLETED|Overall Study||1||
60097602|NCT01900691|76214269|FG000|STARTED|Overall Study||130||
60097603|NCT01900691|76214269|FG000|COMPLETED|Overall Study||111||
59562596|NCT02024477|75664490|FG001|COMPLETED|Overall Study||21||
59562597|NCT02024477|75664489|FG000|NOT COMPLETED|Overall Study||0||
59562598|NCT02024477|75664490|FG001|NOT COMPLETED|Overall Study||0||
59562599|NCT02024711|75664498|FG000|STARTED|Overall Study||130||
59562600|NCT02024711|75664499|FG001|STARTED|Overall Study||132||
59562601|NCT02024711|75664498|FG000|COMPLETED|Overall Study||129||
59562602|NCT02024711|75664499|FG001|COMPLETED|Overall Study||128||
60097604|NCT01900691|76214269|FG000|NOT COMPLETED|Overall Study||19||
60097605|NCT01890473|76214276|FG000|STARTED|Overall Study||111||
60097606|NCT01890473|76214277|FG001|STARTED|Overall Study||113||
60097607|NCT01890473|76214276|FG000|COMPLETED|Overall Study||109||
59562603|NCT02024711|75664498|FG000|NOT COMPLETED|Overall Study||1||
59562604|NCT02024711|75664499|FG001|NOT COMPLETED|Overall Study||4||
59562605|NCT02071823|75664507|FG000|STARTED|Overall Study||6||
59562606|NCT02071823|75664508|FG001|STARTED|Overall Study||6||
60097608|NCT01890473|76214277|FG001|COMPLETED|Overall Study||113||
60097609|NCT01890473|76214276|FG000|NOT COMPLETED|Overall Study||2||
60097610|NCT01890473|76214277|FG001|NOT COMPLETED|Overall Study||0||
60097611|NCT01889069|76214287|FG000|STARTED|Overall Study||158|All Enrolled Participants|
60097612|NCT01889069|76214287|FG000|COMPLETED|Overall Study||113||
60097613|NCT01889069|76214287|FG000|NOT COMPLETED|Overall Study||45||
60097614|NCT02533180|76214299|FG000|STARTED|Overall Study||39||
60097615|NCT02533180|76214300|FG001|STARTED|Overall Study||61||
59562607|NCT02071823|75664507|FG000|COMPLETED|Overall Study||5||
59562608|NCT02071823|75664508|FG001|COMPLETED|Overall Study||6||
60097616|NCT02533180|76214299|FG000|COMPLETED|Overall Study||0||
60097617|NCT02533180|76214300|FG001|COMPLETED|Overall Study||50||
60097618|NCT02533180|76214299|FG000|NOT COMPLETED|Overall Study||39||
59562609|NCT02071823|75664507|FG000|NOT COMPLETED|Overall Study||1||
59562610|NCT02071823|75664508|FG001|NOT COMPLETED|Overall Study||0||
59562611|NCT02025647|75664516|FG000|STARTED|Overall Study||139||
59993657|NCT02657031|76109619|FG001|NOT COMPLETED|Overall Study||2||
59993658|NCT03579693|76109631|FG000|STARTED|First Intervention (6 Weeks)||4||
59993659|NCT03579693|76109632|FG001|STARTED|First Intervention (6 Weeks)||5||
59562612|NCT02025647|75664516|FG000|Session 1 (Narrative Module)|Overall Study||139||
59562613|NCT02025647|75664516|FG000|Immediate Retest (Rating Module: 5 Min)|Overall Study|"27 did not generate IRS~15 technology issues or administered wrong session"|97||
59562614|NCT02025647|75664516|FG000|Session 2 (Narrative Module: 24-48 Hrs)|Overall Study|"19 lost to follow up or technology issues~3 administered wrong session"|117||
59562615|NCT02025647|75664516|FG000|Session 3 (Rating Module: 30-45 Days)|Overall Study|"27 did not generate IRS~36 lost to follow up"|76||
59562616|NCT02025647|75664516|FG000|COMPLETED|Overall Study||139||
59562617|NCT02025647|75664516|FG000|NOT COMPLETED|Overall Study||0||
59562618|NCT02026193|75664522|FG000|STARTED|Overall Study||3||
59562619|NCT02026193|75664523|FG001|STARTED|Overall Study||8||
59562620|NCT02026193|75664522|FG000|COMPLETED|Overall Study||3||
59562621|NCT02026193|75664523|FG001|COMPLETED|Overall Study||8||
59993660|NCT03579693|76109633|FG002|STARTED|First Intervention (6 Weeks)||5||
59993661|NCT03579693|76109634|FG003|STARTED|First Intervention (6 Weeks)||4||
59993662|NCT03579693|76109635|FG004|STARTED|First Intervention (6 Weeks)||4||
59993663|NCT03579693|76109636|FG005|STARTED|First Intervention (6 Weeks)||4||
59993664|NCT03579693|76109631|FG000|COMPLETED|First Intervention (6 Weeks)||4||
60097619|NCT02533180|76214300|FG001|NOT COMPLETED|Overall Study||11||
60097620|NCT00898222|76214312|FG000|STARTED|Overall Study||4||
60097621|NCT00898222|76214312|FG000|COMPLETED|Overall Study||4||
60097622|NCT00898222|76214312|FG000|NOT COMPLETED|Overall Study||0||
60097623|NCT00903448|76214316|FG000|STARTED|Period 1: 5 Days Then 10 Day Washout||20||
60097624|NCT00903448|76214317|FG001|STARTED|Period 1: 5 Days Then 10 Day Washout||20||
60097625|NCT00903448|76214316|FG000|COMPLETED|Period 1: 5 Days Then 10 Day Washout||20||
60097626|NCT00903448|76214317|FG001|COMPLETED|Period 1: 5 Days Then 10 Day Washout||20||
59562622|NCT02026193|75664522|FG000|NOT COMPLETED|Overall Study||0||
59562623|NCT02026193|75664523|FG001|NOT COMPLETED|Overall Study||0||
59562624|NCT02029703|75664531|FG000|STARTED|Overall Study||20||
59562625|NCT02029703|75664532|FG001|STARTED|Overall Study||22||
59562626|NCT02029703|75664531|FG000|COMPLETED|Overall Study||20||
59562627|NCT02029703|75664532|FG001|COMPLETED|Overall Study||22||
59562628|NCT02029703|75664531|FG000|NOT COMPLETED|Overall Study||0||
59562629|NCT02029703|75664532|FG001|NOT COMPLETED|Overall Study||0||
59562630|NCT02405195|75664538|FG000|STARTED|Overall Study||18||
59562631|NCT02405195|75664538|FG000|COMPLETED|Overall Study||18||
59993665|NCT03579693|76109632|FG001|COMPLETED|First Intervention (6 Weeks)||5||
59993666|NCT03579693|76109633|FG002|COMPLETED|First Intervention (6 Weeks)||5||
59993667|NCT03579693|76109634|FG003|COMPLETED|First Intervention (6 Weeks)||4||
59993668|NCT03579693|76109635|FG004|COMPLETED|First Intervention (6 Weeks)||4||
60097627|NCT00903448|76214316|FG000|NOT COMPLETED|Period 1: 5 Days Then 10 Day Washout||0||
60097628|NCT00903448|76214317|FG001|NOT COMPLETED|Period 1: 5 Days Then 10 Day Washout||0||
60097629|NCT00903448|76214316|FG000|STARTED|Period 2: 5 Days Then 10 Day Washout||20||
60097630|NCT00903448|76214317|FG001|STARTED|Period 2: 5 Days Then 10 Day Washout||20||
60097631|NCT00903448|76214316|FG000|COMPLETED|Period 2: 5 Days Then 10 Day Washout||20||
60097632|NCT00903448|76214317|FG001|COMPLETED|Period 2: 5 Days Then 10 Day Washout||20||
60097633|NCT00903448|76214316|FG000|NOT COMPLETED|Period 2: 5 Days Then 10 Day Washout||0||
60097634|NCT00903448|76214317|FG001|NOT COMPLETED|Period 2: 5 Days Then 10 Day Washout||0||
60097635|NCT00903448|76214316|FG000|STARTED|Period 3: 5 Days||20||
60097636|NCT00903448|76214317|FG001|STARTED|Period 3: 5 Days||20||
60097637|NCT00903448|76214316|FG000|COMPLETED|Period 3: 5 Days||20||
60097638|NCT00903448|76214317|FG001|COMPLETED|Period 3: 5 Days||20||
60097639|NCT00903448|76214316|FG000|NOT COMPLETED|Period 3: 5 Days||0||
60097640|NCT00903448|76214317|FG001|NOT COMPLETED|Period 3: 5 Days||0||
60097641|NCT00895180|76214325|FG000|STARTED|Overall Study||40||
60097642|NCT00895180|76214326|FG001|STARTED|Overall Study||40||
60097643|NCT00895180|76214325|FG000|Received at Least 1 Dose of Study Drug|Overall Study||40||
60097644|NCT00895180|76214326|FG001|Received at Least 1 Dose of Study Drug|Overall Study||40||
60097645|NCT00895180|76214325|FG000|COMPLETED|Overall Study||40||
60097646|NCT00895180|76214326|FG001|COMPLETED|Overall Study||40||
59708146|NCT00980200|75826929|FG004|COMPLETED|7-day Washout Period 4||14||
59562632|NCT02405195|75664538|FG000|NOT COMPLETED|Overall Study||0||
59708147|NCT00980200|75826925|FG000|NOT COMPLETED|7-day Washout Period 4||0||
60097647|NCT00895180|76214325|FG000|NOT COMPLETED|Overall Study||0||
60097648|NCT00895180|76214326|FG001|NOT COMPLETED|Overall Study||0||
60097649|NCT01739348|76214338|FG000|STARTED|Part I (Base Study)||703||
60097650|NCT01739348|76214339|FG001|STARTED|Part I (Base Study)||700||
60097651|NCT01739348|76214340|FG002|STARTED|Part I (Base Study)||103||
60097652|NCT01739348|76214341|FG003|STARTED|Part I (Base Study)||705||
60097653|NCT01739348|76214338|FG000|Treated|Part I (Base Study)||702||
60097654|NCT01739348|76214339|FG001|Treated|Part I (Base Study)||700||
59708148|NCT00980200|75826926|FG001|NOT COMPLETED|7-day Washout Period 4||0||
60097655|NCT01739348|76214340|FG002|Treated|Part I (Base Study)||103||
60097656|NCT01739348|76214341|FG003|Treated|Part I (Base Study)||705||
60097657|NCT01739348|76214338|FG000|COMPLETED|Part I (Base Study)||501||
60097658|NCT01739348|76214339|FG001|COMPLETED|Part I (Base Study)||497||
60097659|NCT01739348|76214340|FG002|COMPLETED|Part I (Base Study)||77||
60097660|NCT01739348|76214341|FG003|COMPLETED|Part I (Base Study)||516||
60097661|NCT01739348|76214338|FG000|NOT COMPLETED|Part I (Base Study)||202||
60097662|NCT01739348|76214339|FG001|NOT COMPLETED|Part I (Base Study)||203||
60097663|NCT01739348|76214340|FG002|NOT COMPLETED|Part I (Base Study)||26||
60097664|NCT01739348|76214341|FG003|NOT COMPLETED|Part I (Base Study)||189||
60097665|NCT01739348|76214338|FG000|STARTED|Part II (Extension Study)|Number started refers only to participants completing Part I, volunteering to continue to Part II.|379||
60097666|NCT01739348|76214339|FG001|STARTED|Part II (Extension Study)|Number started refers only to participants completing Part I, volunteering to continue to Part II.|366||
60097667|NCT01739348|76214340|FG002|STARTED|Part II (Extension Study)|Number started refers only to participants completing Part I, volunteering to continue to Part II.|61||
60097668|NCT01739348|76214341|FG003|STARTED|Part II (Extension Study)|Number started refers only to participants completing Part I, volunteering to continue to Part II.|396||
60097669|NCT01739348|76214338|FG000|Treated|Part II (Extension Study)||379||
60097670|NCT01739348|76214339|FG001|Treated|Part II (Extension Study)||365||
60097671|NCT01739348|76214340|FG002|Treated|Part II (Extension Study)||61||
60097672|NCT01739348|76214341|FG003|Treated|Part II (Extension Study)||394||
60097673|NCT01739348|76214338|FG000|COMPLETED|Part II (Extension Study)||0||
60097674|NCT01739348|76214339|FG001|COMPLETED|Part II (Extension Study)||0||
60097675|NCT01739348|76214340|FG002|COMPLETED|Part II (Extension Study)||0||
60097676|NCT01739348|76214341|FG003|COMPLETED|Part II (Extension Study)||0||
60097677|NCT01739348|76214338|FG000|NOT COMPLETED|Part II (Extension Study)||379||
60097678|NCT01739348|76214339|FG001|NOT COMPLETED|Part II (Extension Study)||366||
60097679|NCT01739348|76214340|FG002|NOT COMPLETED|Part II (Extension Study)||61||
60097680|NCT01739348|76214341|FG003|NOT COMPLETED|Part II (Extension Study)||396||
60097681|NCT00899470|76214355|FG000|STARTED|First Therapy||6||
60097682|NCT00899470|76214356|FG001|STARTED|First Therapy||6||
60097683|NCT00899470|76214357|FG002|STARTED|First Therapy||6||
60097684|NCT00899470|76214358|FG003|STARTED|First Therapy||6||
59993669|NCT03579693|76109636|FG005|COMPLETED|First Intervention (6 Weeks)||3||
59993670|NCT03579693|76109631|FG000|NOT COMPLETED|First Intervention (6 Weeks)||0||
59993671|NCT03579693|76109632|FG001|NOT COMPLETED|First Intervention (6 Weeks)||0||
59993672|NCT03579693|76109633|FG002|NOT COMPLETED|First Intervention (6 Weeks)||0||
59993673|NCT03579693|76109634|FG003|NOT COMPLETED|First Intervention (6 Weeks)||0||
59993674|NCT03579693|76109635|FG004|NOT COMPLETED|First Intervention (6 Weeks)||0||
59993675|NCT03579693|76109636|FG005|NOT COMPLETED|First Intervention (6 Weeks)||1||
59993676|NCT03579693|76109631|FG000|STARTED|Washout (1 Week)||4||
59993677|NCT03579693|76109632|FG001|STARTED|Washout (1 Week)||5||
59993678|NCT03579693|76109633|FG002|STARTED|Washout (1 Week)||5||
59993679|NCT03579693|76109634|FG003|STARTED|Washout (1 Week)||4||
60097685|NCT00899470|76214355|FG000|COMPLETED|First Therapy||6||
60097686|NCT00899470|76214356|FG001|COMPLETED|First Therapy||6||
60097687|NCT00899470|76214357|FG002|COMPLETED|First Therapy||6||
60097688|NCT00899470|76214358|FG003|COMPLETED|First Therapy||6||
60097689|NCT00899470|76214355|FG000|NOT COMPLETED|First Therapy||0||
60097690|NCT00899470|76214356|FG001|NOT COMPLETED|First Therapy||0||
60097691|NCT00899470|76214357|FG002|NOT COMPLETED|First Therapy||0||
60097692|NCT00899470|76214358|FG003|NOT COMPLETED|First Therapy||0||
60097693|NCT00899470|76214355|FG000|STARTED|First Washout Period||6||
60097694|NCT00899470|76214356|FG001|STARTED|First Washout Period||6||
60097695|NCT00899470|76214357|FG002|STARTED|First Washout Period||6||
60097696|NCT00899470|76214358|FG003|STARTED|First Washout Period||6||
60097697|NCT00899470|76214355|FG000|COMPLETED|First Washout Period||6||
60097698|NCT00899470|76214356|FG001|COMPLETED|First Washout Period||6||
60097699|NCT00899470|76214357|FG002|COMPLETED|First Washout Period||6||
60097700|NCT00899470|76214358|FG003|COMPLETED|First Washout Period||6||
60097701|NCT00899470|76214355|FG000|NOT COMPLETED|First Washout Period||0||
60097702|NCT00899470|76214356|FG001|NOT COMPLETED|First Washout Period||0||
60097703|NCT00899470|76214357|FG002|NOT COMPLETED|First Washout Period||0||
60097704|NCT00899470|76214358|FG003|NOT COMPLETED|First Washout Period||0||
60097705|NCT00899470|76214355|FG000|STARTED|Second Therapy||6||
60097706|NCT00899470|76214356|FG001|STARTED|Second Therapy||6||
60097707|NCT00899470|76214357|FG002|STARTED|Second Therapy||6||
60097708|NCT00899470|76214358|FG003|STARTED|Second Therapy||6||
59993680|NCT03579693|76109635|FG004|STARTED|Washout (1 Week)||4||
60097709|NCT00899470|76214355|FG000|COMPLETED|Second Therapy||6||
60097710|NCT00899470|76214356|FG001|COMPLETED|Second Therapy||6||
60097711|NCT00899470|76214357|FG002|COMPLETED|Second Therapy||6||
60097712|NCT00899470|76214358|FG003|COMPLETED|Second Therapy||6||
60097713|NCT00899470|76214355|FG000|NOT COMPLETED|Second Therapy||0||
60097714|NCT00899470|76214356|FG001|NOT COMPLETED|Second Therapy||0||
60097715|NCT00899470|76214357|FG002|NOT COMPLETED|Second Therapy||0||
59993681|NCT03579693|76109636|FG005|STARTED|Washout (1 Week)||3||
59993682|NCT03579693|76109631|FG000|COMPLETED|Washout (1 Week)||4||
59993683|NCT03579693|76109632|FG001|COMPLETED|Washout (1 Week)||5||
59993684|NCT03579693|76109633|FG002|COMPLETED|Washout (1 Week)||5||
59993685|NCT03579693|76109634|FG003|COMPLETED|Washout (1 Week)||4||
59993686|NCT03579693|76109635|FG004|COMPLETED|Washout (1 Week)||4||
59993687|NCT03579693|76109636|FG005|COMPLETED|Washout (1 Week)||3||
59993688|NCT03579693|76109631|FG000|NOT COMPLETED|Washout (1 Week)||0||
60097716|NCT00899470|76214358|FG003|NOT COMPLETED|Second Therapy||0||
60097717|NCT00899470|76214355|FG000|STARTED|Second Washout||6||
60097718|NCT00899470|76214356|FG001|STARTED|Second Washout||6||
60097719|NCT00899470|76214357|FG002|STARTED|Second Washout||6||
59562633|NCT02405429|75664542|FG000|STARTED|Overall Study||49||
59562634|NCT02405429|75664542|FG000|COMPLETED|Overall Study||49||
59562635|NCT02405429|75664542|FG000|NOT COMPLETED|Overall Study||0||
59562636|NCT02406443|75664548|FG000|STARTED|Overall Study||18||
59562637|NCT02406443|75664549|FG001|STARTED|Overall Study||18||
59562638|NCT02406443|75664548|FG000|COMPLETED|Overall Study||16||
59562639|NCT02406443|75664549|FG001|COMPLETED|Overall Study||16||
59562640|NCT02406443|75664548|FG000|NOT COMPLETED|Overall Study||2||
59562641|NCT02406443|75664549|FG001|NOT COMPLETED|Overall Study||2||
59562642|NCT02339831|75664557|FG000|STARTED|Overall Study||58||
59562643|NCT02339831|75664558|FG001|STARTED|Overall Study||52||
59562644|NCT02339831|75664557|FG000|Lost to Follow Up|Overall Study||20||
59562645|NCT02339831|75664558|FG001|Lost to Follow Up|Overall Study||7||
59993689|NCT03579693|76109632|FG001|NOT COMPLETED|Washout (1 Week)||0||
59562646|NCT02339831|75664557|FG000|COMPLETED|Overall Study||38||
59562647|NCT02339831|75664558|FG001|COMPLETED|Overall Study||45||
59562648|NCT02339831|75664557|FG000|NOT COMPLETED|Overall Study||20||
59562649|NCT02339831|75664558|FG001|NOT COMPLETED|Overall Study||7||
59562650|NCT02340299|75664566|FG000|STARTED|Overall Study||4||
59562651|NCT02340299|75664567|FG001|STARTED|Overall Study||2||
59993690|NCT03579693|76109633|FG002|NOT COMPLETED|Washout (1 Week)||0||
59993691|NCT03579693|76109634|FG003|NOT COMPLETED|Washout (1 Week)||0||
59993692|NCT03579693|76109635|FG004|NOT COMPLETED|Washout (1 Week)||0||
59993693|NCT03579693|76109636|FG005|NOT COMPLETED|Washout (1 Week)||0||
59993694|NCT03579693|76109631|FG000|STARTED|Second Intervention (6 Weeks)||4||
59993695|NCT03579693|76109632|FG001|STARTED|Second Intervention (6 Weeks)||5||
59993696|NCT03579693|76109633|FG002|STARTED|Second Intervention (6 Weeks)||5||
59993697|NCT03579693|76109634|FG003|STARTED|Second Intervention (6 Weeks)||4||
59993698|NCT03579693|76109635|FG004|STARTED|Second Intervention (6 Weeks)||4||
59993699|NCT03579693|76109636|FG005|STARTED|Second Intervention (6 Weeks)||3||
59993700|NCT03579693|76109631|FG000|COMPLETED|Second Intervention (6 Weeks)||4||
59993701|NCT03579693|76109632|FG001|COMPLETED|Second Intervention (6 Weeks)||4||
59993702|NCT03579693|76109633|FG002|COMPLETED|Second Intervention (6 Weeks)||5||
59993703|NCT03579693|76109634|FG003|COMPLETED|Second Intervention (6 Weeks)||4||
59562652|NCT02340299|75664566|FG000|COMPLETED|Overall Study||4||
59562653|NCT02340299|75664567|FG001|COMPLETED|Overall Study||2||
59562654|NCT02340299|75664566|FG000|NOT COMPLETED|Overall Study||0||
59562655|NCT02340299|75664567|FG001|NOT COMPLETED|Overall Study||0||
59562656|NCT02409329|75664576|FG000|STARTED|Overall Study||127||
59993704|NCT03579693|76109635|FG004|COMPLETED|Second Intervention (6 Weeks)||4||
59993705|NCT03579693|76109636|FG005|COMPLETED|Second Intervention (6 Weeks)||3||
59995204|NCT02730169|76111016|FG003|NOT COMPLETED|Overall Study||16||
60097720|NCT00899470|76214358|FG003|STARTED|Second Washout||6||
60097721|NCT00899470|76214355|FG000|COMPLETED|Second Washout||6||
60097722|NCT00899470|76214356|FG001|COMPLETED|Second Washout||6||
60097723|NCT00899470|76214357|FG002|COMPLETED|Second Washout||6||
60097724|NCT00899470|76214358|FG003|COMPLETED|Second Washout||6||
59562657|NCT02409329|75664577|FG001|STARTED|Overall Study||126||
59562658|NCT02409329|75664578|FG002|STARTED|Overall Study||253||
59562659|NCT02409329|75664576|FG000|COMPLETED|Overall Study||122||
59562660|NCT02409329|75664577|FG001|COMPLETED|Overall Study||120||
59562661|NCT02409329|75664578|FG002|COMPLETED|Overall Study||244||
59562662|NCT02409329|75664576|FG000|NOT COMPLETED|Overall Study||5||
60097725|NCT00899470|76214355|FG000|NOT COMPLETED|Second Washout||0||
60097726|NCT00899470|76214356|FG001|NOT COMPLETED|Second Washout||0||
60097727|NCT00899470|76214357|FG002|NOT COMPLETED|Second Washout||0||
60097728|NCT00899470|76214358|FG003|NOT COMPLETED|Second Washout||0||
60097729|NCT00899470|76214355|FG000|STARTED|Third Therapy||6||
60097730|NCT00899470|76214356|FG001|STARTED|Third Therapy||6||
60097731|NCT00899470|76214357|FG002|STARTED|Third Therapy||6||
59562663|NCT02409329|75664577|FG001|NOT COMPLETED|Overall Study||6||
60097732|NCT00899470|76214358|FG003|STARTED|Third Therapy||6||
60097733|NCT00899470|76214355|FG000|COMPLETED|Third Therapy||6||
60097734|NCT00899470|76214356|FG001|COMPLETED|Third Therapy||6||
60097735|NCT00899470|76214357|FG002|COMPLETED|Third Therapy||6||
60097736|NCT00899470|76214358|FG003|COMPLETED|Third Therapy||6||
60097737|NCT00899470|76214355|FG000|NOT COMPLETED|Third Therapy||0||
60097738|NCT00899470|76214356|FG001|NOT COMPLETED|Third Therapy||0||
59993706|NCT03579693|76109631|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0||
59993707|NCT03579693|76109632|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||1||
59993708|NCT03579693|76109633|FG002|NOT COMPLETED|Second Intervention (6 Weeks)||0||
59993709|NCT03579693|76109634|FG003|NOT COMPLETED|Second Intervention (6 Weeks)||0||
59993710|NCT03579693|76109635|FG004|NOT COMPLETED|Second Intervention (6 Weeks)||0||
59993711|NCT03579693|76109636|FG005|NOT COMPLETED|Second Intervention (6 Weeks)||0||
59993712|NCT03579693|76109631|FG000|STARTED|Second Washout (1 Week)||4||
60097739|NCT00899470|76214357|FG002|NOT COMPLETED|Third Therapy||0||
60097740|NCT00899470|76214358|FG003|NOT COMPLETED|Third Therapy||0||
60097741|NCT00899470|76214355|FG000|STARTED|Third Washout||6||
60097742|NCT00899470|76214356|FG001|STARTED|Third Washout||6||
60097743|NCT00899470|76214357|FG002|STARTED|Third Washout||6||
60097744|NCT00899470|76214358|FG003|STARTED|Third Washout||6||
60097745|NCT00899470|76214355|FG000|COMPLETED|Third Washout||6||
60097746|NCT00899470|76214356|FG001|COMPLETED|Third Washout||6||
60097747|NCT00899470|76214357|FG002|COMPLETED|Third Washout||6||
60097748|NCT00899470|76214358|FG003|COMPLETED|Third Washout||6||
59562664|NCT02409329|75664578|FG002|NOT COMPLETED|Overall Study||9||
59993713|NCT03579693|76109632|FG001|STARTED|Second Washout (1 Week)||5||
60097749|NCT00899470|76214355|FG000|NOT COMPLETED|Third Washout||0||
60097750|NCT00899470|76214356|FG001|NOT COMPLETED|Third Washout||0||
60097751|NCT00899470|76214357|FG002|NOT COMPLETED|Third Washout||0||
60097752|NCT00899470|76214358|FG003|NOT COMPLETED|Third Washout||0||
59562665|NCT02032433|75664589|FG000|STARTED|Overall Study||283||
60097753|NCT00899470|76214355|FG000|STARTED|Fourth Therapy||6||
60097754|NCT00899470|76214356|FG001|STARTED|Fourth Therapy||6||
59562666|NCT02032433|75664590|FG001|STARTED|Overall Study||287||
59562667|NCT02032433|75664589|FG000|COMPLETED|Overall Study||205||
59562668|NCT02032433|75664590|FG001|COMPLETED|Overall Study||225||
59993714|NCT03579693|76109633|FG002|STARTED|Second Washout (1 Week)||5||
60097755|NCT00899470|76214357|FG002|STARTED|Fourth Therapy||6||
60097756|NCT00899470|76214358|FG003|STARTED|Fourth Therapy||6||
60097757|NCT00899470|76214355|FG000|COMPLETED|Fourth Therapy||6||
60097758|NCT00899470|76214356|FG001|COMPLETED|Fourth Therapy||6||
60097759|NCT00899470|76214357|FG002|COMPLETED|Fourth Therapy||6||
60097760|NCT00899470|76214358|FG003|COMPLETED|Fourth Therapy||6||
59562669|NCT02032433|75664589|FG000|NOT COMPLETED|Overall Study||78||
59562670|NCT02032433|75664590|FG001|NOT COMPLETED|Overall Study||62||
59708149|NCT00980200|75826927|FG002|NOT COMPLETED|7-day Washout Period 4||0||
59993715|NCT03579693|76109634|FG003|STARTED|Second Washout (1 Week)||4||
59993716|NCT03579693|76109635|FG004|STARTED|Second Washout (1 Week)||4||
59993717|NCT03579693|76109636|FG005|STARTED|Second Washout (1 Week)||3||
59993718|NCT03579693|76109631|FG000|COMPLETED|Second Washout (1 Week)||4||
59993719|NCT03579693|76109632|FG001|COMPLETED|Second Washout (1 Week)||5||
59993720|NCT03579693|76109633|FG002|COMPLETED|Second Washout (1 Week)||5||
59993721|NCT03579693|76109634|FG003|COMPLETED|Second Washout (1 Week)||4||
59993722|NCT03579693|76109635|FG004|COMPLETED|Second Washout (1 Week)||4||
59993723|NCT03579693|76109636|FG005|COMPLETED|Second Washout (1 Week)||3||
59993724|NCT03579693|76109631|FG000|NOT COMPLETED|Second Washout (1 Week)||0||
59993725|NCT03579693|76109632|FG001|NOT COMPLETED|Second Washout (1 Week)||0||
59993726|NCT03579693|76109633|FG002|NOT COMPLETED|Second Washout (1 Week)||0||
60097761|NCT00899470|76214355|FG000|NOT COMPLETED|Fourth Therapy||0||
60097762|NCT00899470|76214356|FG001|NOT COMPLETED|Fourth Therapy||0||
60097763|NCT00899470|76214357|FG002|NOT COMPLETED|Fourth Therapy||0||
60097764|NCT00899470|76214358|FG003|NOT COMPLETED|Fourth Therapy||0||
60097765|NCT01738646|76214373|FG000|STARTED|Overall Study||40||
60097766|NCT01738646|76214373|FG000|COMPLETED|Overall Study|Participants who discontinued study drug for any reason.|38||
60097767|NCT01738646|76214373|FG000|NOT COMPLETED|Overall Study||2||
60097768|NCT01716104|76214380|FG000|STARTED|Overall Study||125||
60097769|NCT01716104|76214381|FG001|STARTED|Overall Study||124||
60097770|NCT01716104|76214380|FG000|COMPLETED|Overall Study||119||
60097771|NCT01716104|76214381|FG001|COMPLETED|Overall Study||117||
60097772|NCT01716104|76214380|FG000|NOT COMPLETED|Overall Study||6||
60097773|NCT01716104|76214381|FG001|NOT COMPLETED|Overall Study||7||
60097774|NCT00904618|76214387|FG000|STARTED|Overall Study||48||
60097775|NCT00904618|76214387|FG000|COMPLETED|Overall Study||48||
60097776|NCT00904618|76214387|FG000|NOT COMPLETED|Overall Study||0||
60097777|NCT00906958|76214394|FG000|STARTED|Overall Study||10||
60097778|NCT00906958|76214395|FG001|STARTED|Overall Study||10||
60097779|NCT00906958|76214394|FG000|COMPLETED|Overall Study||10||
60097780|NCT00906958|76214395|FG001|COMPLETED|Overall Study||10||
60097781|NCT00906958|76214394|FG000|NOT COMPLETED|Overall Study||0||
60097782|NCT00906958|76214395|FG001|NOT COMPLETED|Overall Study||0||
60097783|NCT00907426|76214406|FG000|STARTED|Treatment Period 1 (0 to 6 Months)||215||
60097784|NCT00907426|76214407|FG001|STARTED|Treatment Period 1 (0 to 6 Months)||60||
60097785|NCT00907426|76214408|FG002|STARTED|Treatment Period 1 (0 to 6 Months)||93||
60097786|NCT00907426|76214406|FG000|COMPLETED|Treatment Period 1 (0 to 6 Months)||195||
60097787|NCT00907426|76214407|FG001|COMPLETED|Treatment Period 1 (0 to 6 Months)||55||
60097788|NCT00907426|76214408|FG002|COMPLETED|Treatment Period 1 (0 to 6 Months)||84||
60097789|NCT00907426|76214406|FG000|NOT COMPLETED|Treatment Period 1 (0 to 6 Months)||20||
60097790|NCT00907426|76214407|FG001|NOT COMPLETED|Treatment Period 1 (0 to 6 Months)||5||
59562671|NCT01721096|75664598|FG000|STARTED|Overall Study||323||
59993727|NCT03579693|76109634|FG003|NOT COMPLETED|Second Washout (1 Week)||0||
59993728|NCT03579693|76109635|FG004|NOT COMPLETED|Second Washout (1 Week)||0||
59562672|NCT01721096|75664599|FG001|STARTED|Overall Study||213||
59562673|NCT01721096|75664598|FG000|COMPLETED|Overall Study||3||
59562674|NCT01721096|75664599|FG001|COMPLETED|Overall Study||9||
59562675|NCT01721096|75664598|FG000|NOT COMPLETED|Overall Study||320||
59562676|NCT01721096|75664599|FG001|NOT COMPLETED|Overall Study||204||
59562677|NCT02403479|75664609|FG000|STARTED|Overall Study||10||
59562678|NCT02403479|75664610|FG001|STARTED|Overall Study||12||
59562679|NCT02403479|75664609|FG000|COMPLETED|Overall Study||8||
60097791|NCT00907426|76214408|FG002|NOT COMPLETED|Treatment Period 1 (0 to 6 Months)||9||
60097792|NCT00907426|76214406|FG000|STARTED|Treatment Period 2 (6 to 12 Months)||195||
60097793|NCT00907426|76214407|FG001|STARTED|Treatment Period 2 (6 to 12 Months)||55||
60097794|NCT00907426|76214408|FG002|STARTED|Treatment Period 2 (6 to 12 Months)||84||
60097795|NCT00907426|76214406|FG000|COMPLETED|Treatment Period 2 (6 to 12 Months)||184||
60097796|NCT00907426|76214407|FG001|COMPLETED|Treatment Period 2 (6 to 12 Months)||52||
59562680|NCT02403479|75664610|FG001|COMPLETED|Overall Study||12||
59562681|NCT02403479|75664609|FG000|NOT COMPLETED|Overall Study||2||
59816977|NCT02372097|75939397|FG000|STARTED|First Intervention Period (8 Days)||12||
60097797|NCT00907426|76214408|FG002|COMPLETED|Treatment Period 2 (6 to 12 Months)||77||
60097798|NCT00907426|76214406|FG000|NOT COMPLETED|Treatment Period 2 (6 to 12 Months)||11||
60097799|NCT00907426|76214407|FG001|NOT COMPLETED|Treatment Period 2 (6 to 12 Months)||3||
60097800|NCT00907426|76214408|FG002|NOT COMPLETED|Treatment Period 2 (6 to 12 Months)||7||
60097801|NCT00908830|76214417|FG000|STARTED|Overall Study||5||
60097802|NCT00908830|76214418|FG001|STARTED|Overall Study||5||
60097803|NCT00908830|76214417|FG000|COMPLETED|Overall Study||5||
60097804|NCT00908830|76214418|FG001|COMPLETED|Overall Study||5||
59562682|NCT02403479|75664610|FG001|NOT COMPLETED|Overall Study||0||
59562683|NCT02340767|75664627|FG000|STARTED|Overall Study||28||
59562684|NCT02340767|75664628|FG001|STARTED|Overall Study||28||
59562685|NCT02340767|75664629|FG002|STARTED|Overall Study||29||
59708150|NCT00980200|75826928|FG003|NOT COMPLETED|7-day Washout Period 4||0||
59708151|NCT00980200|75826929|FG004|NOT COMPLETED|7-day Washout Period 4||0||
59993729|NCT03579693|76109636|FG005|NOT COMPLETED|Second Washout (1 Week)||0||
59993730|NCT03579693|76109631|FG000|STARTED|Third Intervention (6 Weeks)||4||
59993731|NCT03579693|76109632|FG001|STARTED|Third Intervention (6 Weeks)||5||
59993732|NCT03579693|76109633|FG002|STARTED|Third Intervention (6 Weeks)||5||
60097805|NCT00908830|76214417|FG000|NOT COMPLETED|Overall Study||0||
60097806|NCT00908830|76214418|FG001|NOT COMPLETED|Overall Study||0||
60097807|NCT00908908|76214424|FG000|STARTED|Overall Study||6||
60097808|NCT00908908|76214424|FG000|Adverse Event|Overall Study||0||
60097809|NCT00908908|76214424|FG000|Withdrawl by Subject|Overall Study||0||
60097810|NCT00908908|76214424|FG000|Administrative/Other|Overall Study||0||
60097811|NCT00908908|76214424|FG000|Physician Decision|Overall Study||0||
60097812|NCT00908908|76214424|FG000|COMPLETED|Overall Study||6||
60097813|NCT00908908|76214424|FG000|NOT COMPLETED|Overall Study||0||
60097814|NCT00909064|76214428|FG000|STARTED|Overall Study||114||
60097815|NCT00909064|76214428|FG000|COMPLETED|Overall Study||114||
60097816|NCT00909064|76214428|FG000|NOT COMPLETED|Overall Study||0||
60097817|NCT00909220|76214434|FG000|STARTED|Overall Study|Started enrolling participants May 2009|41||
60097818|NCT00909220|76214435|FG001|STARTED|Overall Study|Started enrolling participants May 2009|36||
60097819|NCT00909220|76214434|FG000|Data Entry|Overall Study||41||
60097820|NCT00909220|76214435|FG001|Data Entry|Overall Study||36||
60097821|NCT00909220|76214434|FG000|Data Analyses|Overall Study||41||
60097822|NCT00909220|76214435|FG001|Data Analyses|Overall Study||36||
60097823|NCT00909220|76214434|FG000|Submission for Publication|Overall Study||41||
60097824|NCT00909220|76214435|FG001|Submission for Publication|Overall Study||36||
60097825|NCT00909220|76214434|FG000|COMPLETED|Overall Study||41||
60097826|NCT00909220|76214435|FG001|COMPLETED|Overall Study||36||
59562686|NCT02340767|75664630|FG003|STARTED|Overall Study||500||
59562687|NCT02340767|75664631|FG004|STARTED|Overall Study||474||
59562688|NCT02340767|75664632|FG005|STARTED|Overall Study||526||
59562689|NCT02340767|75664633|FG006|STARTED|Overall Study||525||
59562690|NCT02340767|75664634|FG007|STARTED|Overall Study||444||
59562691|NCT02340767|75664635|FG008|STARTED|Overall Study||531||
59562692|NCT02340767|75664627|FG000|COMPLETED|Overall Study||28||
59562693|NCT02340767|75664628|FG001|COMPLETED|Overall Study||28||
59562694|NCT02340767|75664629|FG002|COMPLETED|Overall Study||29||
59562695|NCT02340767|75664630|FG003|COMPLETED|Overall Study||500||
59562696|NCT02340767|75664631|FG004|COMPLETED|Overall Study||474||
59562697|NCT02340767|75664632|FG005|COMPLETED|Overall Study||526||
59562698|NCT02340767|75664633|FG006|COMPLETED|Overall Study||525||
60097827|NCT00909220|76214434|FG000|NOT COMPLETED|Overall Study||0||
60097828|NCT00909220|76214435|FG001|NOT COMPLETED|Overall Study||0||
60097829|NCT04426695|76214461|FG000|STARTED|Overall Study||21||
60097830|NCT04426695|76214462|FG001|STARTED|Overall Study||19||
60097831|NCT04426695|76214463|FG002|STARTED|Overall Study||20||
60097832|NCT04426695|76214464|FG003|STARTED|Overall Study||208||
60097833|NCT04426695|76214465|FG004|STARTED|Overall Study||211||
60097834|NCT04426695|76214466|FG005|STARTED|Overall Study||210||
60097835|NCT04426695|76214467|FG006|STARTED|Overall Study||251||
60097836|NCT04426695|76214468|FG007|STARTED|Overall Study||252||
60097837|NCT04426695|76214469|FG008|STARTED|Overall Study||252||
60097838|NCT04426695|76214470|FG009|STARTED|Overall Study||201||
59562699|NCT02340767|75664634|FG007|COMPLETED|Overall Study||444||
59708152|NCT00980200|75826925|FG000|STARTED|7-day Treatment Period 5||15||
59708153|NCT00980200|75826926|FG001|STARTED|7-day Treatment Period 5||12||
59708154|NCT00980200|75826927|FG002|STARTED|7-day Treatment Period 5||15||
59708155|NCT00980200|75826928|FG003|STARTED|7-day Treatment Period 5||16||
59708156|NCT00980200|75826929|FG004|STARTED|7-day Treatment Period 5||14||
59708157|NCT00980200|75826925|FG000|COMPLETED|7-day Treatment Period 5||15||
59708158|NCT00980200|75826926|FG001|COMPLETED|7-day Treatment Period 5||12||
59708159|NCT00980200|75826927|FG002|COMPLETED|7-day Treatment Period 5||15||
59708160|NCT00980200|75826928|FG003|COMPLETED|7-day Treatment Period 5||16||
59708161|NCT00980200|75826929|FG004|COMPLETED|7-day Treatment Period 5||14||
59993733|NCT03579693|76109634|FG003|STARTED|Third Intervention (6 Weeks)||4||
59993734|NCT03579693|76109635|FG004|STARTED|Third Intervention (6 Weeks)||4||
59993735|NCT03579693|76109636|FG005|STARTED|Third Intervention (6 Weeks)||3||
59993736|NCT03579693|76109631|FG000|COMPLETED|Third Intervention (6 Weeks)||4||
59993737|NCT03579693|76109632|FG001|COMPLETED|Third Intervention (6 Weeks)||5||
59993738|NCT03579693|76109633|FG002|COMPLETED|Third Intervention (6 Weeks)||5||
59993739|NCT03579693|76109634|FG003|COMPLETED|Third Intervention (6 Weeks)||4||
59993740|NCT03579693|76109635|FG004|COMPLETED|Third Intervention (6 Weeks)||4||
59993741|NCT03579693|76109636|FG005|COMPLETED|Third Intervention (6 Weeks)||3||
59993742|NCT03579693|76109631|FG000|NOT COMPLETED|Third Intervention (6 Weeks)||0||
59993743|NCT03579693|76109632|FG001|NOT COMPLETED|Third Intervention (6 Weeks)||0||
59993744|NCT03579693|76109633|FG002|NOT COMPLETED|Third Intervention (6 Weeks)||0||
59993745|NCT03579693|76109634|FG003|NOT COMPLETED|Third Intervention (6 Weeks)||0||
59993746|NCT03579693|76109635|FG004|NOT COMPLETED|Third Intervention (6 Weeks)||0||
59993747|NCT03579693|76109636|FG005|NOT COMPLETED|Third Intervention (6 Weeks)||0||
59993748|NCT04375397|76109647|FG000|STARTED|Overall Study||22||
59993749|NCT04375397|76109648|FG001|STARTED|Overall Study||24||
59993750|NCT04375397|76109647|FG000|COMPLETED|Overall Study||13||
59993751|NCT04375397|76109648|FG001|COMPLETED|Overall Study||18||
59993752|NCT04375397|76109647|FG000|NOT COMPLETED|Overall Study||9||
59993753|NCT04375397|76109648|FG001|NOT COMPLETED|Overall Study||6||
59993754|NCT02387216|76109656|FG000|STARTED|Overall Study||103|One patient was inappropriately enrolled into the Sherloc study hence why 152 participants started and not 153|
59993755|NCT02387216|76109657|FG001|STARTED|Overall Study||49|One patient was inappropriately enrolled into the Sherloc study hence why 152 participants started and not 153|
59993756|NCT02387216|76109656|FG000|COMPLETED|Overall Study||3|Safety population: includes patients receiving at least one dose of study medication|
59993757|NCT02387216|76109657|FG001|COMPLETED|Overall Study||2|Safety population: includes patients receiving at least one dose of study medication|
59993758|NCT02387216|76109656|FG000|NOT COMPLETED|Overall Study||100||
59993759|NCT02387216|76109657|FG001|NOT COMPLETED|Overall Study||47||
59708162|NCT00980200|75826925|FG000|NOT COMPLETED|7-day Treatment Period 5||0||
59562700|NCT02340767|75664635|FG008|COMPLETED|Overall Study||531||
59562701|NCT02340767|75664627|FG000|NOT COMPLETED|Overall Study||0||
59562702|NCT02340767|75664628|FG001|NOT COMPLETED|Overall Study||0||
59562703|NCT02340767|75664629|FG002|NOT COMPLETED|Overall Study||0||
59708163|NCT00980200|75826926|FG001|NOT COMPLETED|7-day Treatment Period 5||0||
59708164|NCT00980200|75826927|FG002|NOT COMPLETED|7-day Treatment Period 5||0||
59708165|NCT00980200|75826928|FG003|NOT COMPLETED|7-day Treatment Period 5||0||
59708166|NCT00980200|75826929|FG004|NOT COMPLETED|7-day Treatment Period 5||0||
59708167|NCT00979654|75826941|FG000|STARTED|Overall Study||103||
59708168|NCT00979654|75826941|FG000|COMPLETED|Overall Study||67||
59816978|NCT02372097|75939398|FG001|STARTED|First Intervention Period (8 Days)||12||
59816979|NCT02372097|75939397|FG000|COMPLETED|First Intervention Period (8 Days)||12||
59993760|NCT02417246|76109665|FG000|STARTED|Phase 1 Brand Name Metoprolol ER||24||
59993761|NCT02417246|76109666|FG001|STARTED|Phase 1 Brand Name Metoprolol ER||24||
60097839|NCT04426695|76214471|FG010|STARTED|Overall Study||205||
60097840|NCT04426695|76214472|FG011|STARTED|Overall Study||203||
59993762|NCT02417246|76109665|FG000|COMPLETED|Phase 1 Brand Name Metoprolol ER||20||
59993763|NCT02417246|76109666|FG001|COMPLETED|Phase 1 Brand Name Metoprolol ER||20||
59993764|NCT02417246|76109665|FG000|NOT COMPLETED|Phase 1 Brand Name Metoprolol ER||4||
59993765|NCT02417246|76109666|FG001|NOT COMPLETED|Phase 1 Brand Name Metoprolol ER||4||
59993766|NCT02417246|76109665|FG000|STARTED|Phase 2 1st Generic Administered||20||
59993767|NCT02417246|76109666|FG001|STARTED|Phase 2 1st Generic Administered||20||
59993768|NCT02417246|76109665|FG000|COMPLETED|Phase 2 1st Generic Administered||19||
59993769|NCT02417246|76109666|FG001|COMPLETED|Phase 2 1st Generic Administered||20||
59993770|NCT02417246|76109665|FG000|NOT COMPLETED|Phase 2 1st Generic Administered||1||
59993771|NCT02417246|76109666|FG001|NOT COMPLETED|Phase 2 1st Generic Administered||0||
59993772|NCT02417246|76109665|FG000|STARTED|Phase 3 Brand Name Metoprolol ER #2||19|One patient completed Phase 2 but did not start Phase 3. His data were included in analysis.|
60097841|NCT04426695|76214473|FG012|STARTED|Overall Study||52||
60097842|NCT04426695|76214474|FG013|STARTED|Overall Study||58||
60097843|NCT04426695|76214475|FG014|STARTED|Overall Study||54||
60097844|NCT04426695|76214476|FG015|STARTED|Overall Study||12||
60097845|NCT04426695|76214477|FG016|STARTED|Overall Study||12||
60097846|NCT04426695|76214478|FG017|STARTED|Overall Study||11||
60097847|NCT04426695|76214461|FG000|Treated|Overall Study||18||
60097848|NCT04426695|76214462|FG001|Treated|Overall Study||18||
60097849|NCT04426695|76214463|FG002|Treated|Overall Study||20||
60097850|NCT04426695|76214464|FG003|Treated|Overall Study||204||
60097851|NCT04426695|76214465|FG004|Treated|Overall Study||206||
60097852|NCT04426695|76214466|FG005|Treated|Overall Study||205||
60097853|NCT04426695|76214467|FG006|Treated|Overall Study||247||
60097854|NCT04426695|76214468|FG007|Treated|Overall Study||246||
59993773|NCT02417246|76109666|FG001|STARTED|Phase 3 Brand Name Metoprolol ER #2||20|One patient completed Phase 2 but did not start Phase 3. His data were included in analysis.|
60097855|NCT04426695|76214469|FG008|Treated|Overall Study||246||
59816980|NCT02372097|75939398|FG001|COMPLETED|First Intervention Period (8 Days)||12||
59816981|NCT02372097|75939397|FG000|NOT COMPLETED|First Intervention Period (8 Days)||0||
59816982|NCT02372097|75939398|FG001|NOT COMPLETED|First Intervention Period (8 Days)||0||
59816983|NCT02372097|75939397|FG000|STARTED|Wash Out Period (13 Days)||12||
59816984|NCT02372097|75939398|FG001|STARTED|Wash Out Period (13 Days)||12||
59816985|NCT02372097|75939397|FG000|COMPLETED|Wash Out Period (13 Days)||12||
59816986|NCT02372097|75939398|FG001|COMPLETED|Wash Out Period (13 Days)||12||
59816987|NCT02372097|75939397|FG000|NOT COMPLETED|Wash Out Period (13 Days)||0||
59816988|NCT02372097|75939398|FG001|NOT COMPLETED|Wash Out Period (13 Days)||0||
59816989|NCT02372097|75939397|FG000|STARTED|Second Intervention Period (8 Days)||12||
59993774|NCT02417246|76109665|FG000|COMPLETED|Phase 3 Brand Name Metoprolol ER #2||18||
59993775|NCT02417246|76109666|FG001|COMPLETED|Phase 3 Brand Name Metoprolol ER #2||20||
59993776|NCT02417246|76109665|FG000|NOT COMPLETED|Phase 3 Brand Name Metoprolol ER #2||1||
59993777|NCT02417246|76109666|FG001|NOT COMPLETED|Phase 3 Brand Name Metoprolol ER #2||0||
59993778|NCT02417246|76109665|FG000|STARTED|Phase 4 2nd Generic Administered||18||
59993779|NCT02417246|76109666|FG001|STARTED|Phase 4 2nd Generic Administered||20||
59993780|NCT02417246|76109665|FG000|COMPLETED|Phase 4 2nd Generic Administered||18||
59993781|NCT02417246|76109666|FG001|COMPLETED|Phase 4 2nd Generic Administered||20||
60097856|NCT04426695|76214470|FG009|Treated|Overall Study||198||
60097857|NCT04426695|76214471|FG010|Treated|Overall Study||202||
60097858|NCT04426695|76214472|FG011|Treated|Overall Study||197||
60097859|NCT04426695|76214473|FG012|Treated|Overall Study||51||
60097860|NCT04426695|76214474|FG013|Treated|Overall Study||56||
60097861|NCT04426695|76214475|FG014|Treated|Overall Study||54||
60097862|NCT04426695|76214476|FG015|Treated|Overall Study||12||
60097863|NCT04426695|76214477|FG016|Treated|Overall Study||12||
60097864|NCT04426695|76214478|FG017|Treated|Overall Study||11||
60097865|NCT04426695|76214461|FG000|COMPLETED|Overall Study||13||
60097866|NCT04426695|76214462|FG001|COMPLETED|Overall Study||12||
60097867|NCT04426695|76214463|FG002|COMPLETED|Overall Study||16||
60097868|NCT04426695|76214464|FG003|COMPLETED|Overall Study||146||
60097869|NCT04426695|76214465|FG004|COMPLETED|Overall Study||153||
60097870|NCT04426695|76214466|FG005|COMPLETED|Overall Study||148||
60097871|NCT04426695|76214467|FG006|COMPLETED|Overall Study||186||
60097872|NCT04426695|76214468|FG007|COMPLETED|Overall Study||195||
60097873|NCT04426695|76214469|FG008|COMPLETED|Overall Study||189||
60097874|NCT04426695|76214470|FG009|COMPLETED|Overall Study||157||
60097875|NCT04426695|76214471|FG010|COMPLETED|Overall Study||165||
60097876|NCT04426695|76214472|FG011|COMPLETED|Overall Study||166||
60097877|NCT04426695|76214473|FG012|COMPLETED|Overall Study||33||
60097878|NCT04426695|76214474|FG013|COMPLETED|Overall Study||28||
60097879|NCT04426695|76214475|FG014|COMPLETED|Overall Study||31||
60097880|NCT04426695|76214476|FG015|COMPLETED|Overall Study||5||
59993782|NCT02417246|76109665|FG000|NOT COMPLETED|Phase 4 2nd Generic Administered||0||
59562704|NCT02340767|75664630|FG003|NOT COMPLETED|Overall Study||0||
59562705|NCT02340767|75664631|FG004|NOT COMPLETED|Overall Study||0||
59993783|NCT02417246|76109666|FG001|NOT COMPLETED|Phase 4 2nd Generic Administered||0||
59993784|NCT02424734|76109677|FG000|STARTED|Overall Study||4||
59993785|NCT02424734|76109678|FG001|STARTED|Overall Study||5||
59993786|NCT02424734|76109679|FG002|STARTED|Overall Study||2||
59993787|NCT02424734|76109677|FG000|Treated|Overall Study||4||
59993788|NCT02424734|76109678|FG001|Treated|Overall Study||5||
59993789|NCT02424734|76109679|FG002|Treated|Overall Study||2||
59993790|NCT02424734|76109677|FG000|COMPLETED|Overall Study||2||
59993791|NCT02424734|76109678|FG001|COMPLETED|Overall Study||3||
59993792|NCT02424734|76109679|FG002|COMPLETED|Overall Study||2||
59993793|NCT02424734|76109677|FG000|NOT COMPLETED|Overall Study||2||
59993794|NCT02424734|76109678|FG001|NOT COMPLETED|Overall Study||2||
59993795|NCT02424734|76109679|FG002|NOT COMPLETED|Overall Study||0||
59993796|NCT02424578|76109690|FG000|STARTED|Overall Study||15||
59993797|NCT02424578|76109691|FG001|STARTED|Overall Study||15||
59562706|NCT02340767|75664632|FG005|NOT COMPLETED|Overall Study||0||
59562707|NCT02340767|75664633|FG006|NOT COMPLETED|Overall Study||0||
59562708|NCT02340767|75664634|FG007|NOT COMPLETED|Overall Study||0||
59562709|NCT02340767|75664635|FG008|NOT COMPLETED|Overall Study||0||
59562710|NCT02341859|75664650|FG000|STARTED|First Intervention (1 Day)||10||
59562711|NCT02341859|75664651|FG001|STARTED|First Intervention (1 Day)||9||
59562712|NCT02341859|75664650|FG000|COMPLETED|First Intervention (1 Day)||10||
59562713|NCT02341859|75664651|FG001|COMPLETED|First Intervention (1 Day)||9||
59708169|NCT00979654|75826941|FG000|NOT COMPLETED|Overall Study||36||
60097881|NCT04426695|76214477|FG016|COMPLETED|Overall Study||4||
60097882|NCT04426695|76214478|FG017|COMPLETED|Overall Study||7||
60097883|NCT04426695|76214461|FG000|NOT COMPLETED|Overall Study||8||
60097884|NCT04426695|76214462|FG001|NOT COMPLETED|Overall Study||7||
60097885|NCT04426695|76214463|FG002|NOT COMPLETED|Overall Study||4||
60097886|NCT04426695|76214464|FG003|NOT COMPLETED|Overall Study||62||
60097887|NCT04426695|76214465|FG004|NOT COMPLETED|Overall Study||58||
60097888|NCT04426695|76214466|FG005|NOT COMPLETED|Overall Study||62||
60097889|NCT04426695|76214467|FG006|NOT COMPLETED|Overall Study||65||
60097890|NCT04426695|76214468|FG007|NOT COMPLETED|Overall Study||57||
60097891|NCT04426695|76214469|FG008|NOT COMPLETED|Overall Study||63||
60097892|NCT04426695|76214470|FG009|NOT COMPLETED|Overall Study||44||
60097893|NCT04426695|76214471|FG010|NOT COMPLETED|Overall Study||40||
60097894|NCT04426695|76214472|FG011|NOT COMPLETED|Overall Study||37||
60097895|NCT04426695|76214473|FG012|NOT COMPLETED|Overall Study||19||
60097896|NCT04426695|76214474|FG013|NOT COMPLETED|Overall Study||30||
60097897|NCT04426695|76214475|FG014|NOT COMPLETED|Overall Study||23||
60097898|NCT04426695|76214476|FG015|NOT COMPLETED|Overall Study||7||
60097899|NCT04426695|76214477|FG016|NOT COMPLETED|Overall Study||8||
60097900|NCT04426695|76214478|FG017|NOT COMPLETED|Overall Study||4||
60097901|NCT01838200|76214555|FG000|STARTED|Overall Study||3||
60097902|NCT01838200|76214556|FG001|STARTED|Overall Study||2||
60097903|NCT01838200|76214555|FG000|COMPLETED|Overall Study||0||
60097904|NCT01838200|76214556|FG001|COMPLETED|Overall Study||0||
60097905|NCT01838200|76214555|FG000|NOT COMPLETED|Overall Study||3||
60097906|NCT01838200|76214556|FG001|NOT COMPLETED|Overall Study||2||
60097907|NCT01833754|76214565|FG000|STARTED|Overall Study||8||
60097908|NCT01833754|76214566|FG001|STARTED|Overall Study||8||
60097909|NCT01833754|76214567|FG002|STARTED|Overall Study||8||
60097910|NCT01833754|76214565|FG000|COMPLETED|Overall Study||8||
60097911|NCT01833754|76214566|FG001|COMPLETED|Overall Study||8||
60097912|NCT01833754|76214567|FG002|COMPLETED|Overall Study||8||
60097913|NCT01833754|76214565|FG000|NOT COMPLETED|Overall Study||0||
60097914|NCT01833754|76214566|FG001|NOT COMPLETED|Overall Study||0||
59708170|NCT00978562|75826945|FG000|STARTED|Overall Study||14||
59708171|NCT00978562|75826945|FG000|COMPLETED|Overall Study||12||
59708172|NCT00978562|75826945|FG000|NOT COMPLETED|Overall Study||2||
59708173|NCT02865460|75826953|FG000|STARTED|Overall Study||51||
59816990|NCT02372097|75939398|FG001|STARTED|Second Intervention Period (8 Days)||12||
59562714|NCT02341859|75664650|FG000|NOT COMPLETED|First Intervention (1 Day)||0||
59708174|NCT02865460|75826954|FG001|STARTED|Overall Study||49||
59708175|NCT02865460|75826953|FG000|COMPLETED|Overall Study||41||
59708176|NCT02865460|75826954|FG001|COMPLETED|Overall Study||43||
59816991|NCT02372097|75939397|FG000|COMPLETED|Second Intervention Period (8 Days)||12||
59816992|NCT02372097|75939398|FG001|COMPLETED|Second Intervention Period (8 Days)||12||
59816993|NCT02372097|75939397|FG000|NOT COMPLETED|Second Intervention Period (8 Days)||0||
59816994|NCT02372097|75939398|FG001|NOT COMPLETED|Second Intervention Period (8 Days)||0||
60097915|NCT01833754|76214567|FG002|NOT COMPLETED|Overall Study||0||
60097916|NCT00911326|76214575|FG000|STARTED|Overall Study||101||
60097917|NCT00911326|76214575|FG000|COMPLETED|Overall Study||85||
60097918|NCT00911326|76214575|FG000|NOT COMPLETED|Overall Study||16||
60097919|NCT00905554|76214581|FG000|STARTED|Overall Study||116||
60097920|NCT00905554|76214582|FG001|STARTED|Overall Study||114||
60097921|NCT00905554|76214581|FG000|COMPLETED|Overall Study||116||
60097922|NCT00905554|76214582|FG001|COMPLETED|Overall Study||114||
60097923|NCT00905554|76214581|FG000|NOT COMPLETED|Overall Study||0||
60097924|NCT00905554|76214582|FG001|NOT COMPLETED|Overall Study||0||
60097925|NCT00906178|76214590|FG000|STARTED|Overall Study||183||
60097926|NCT00906178|76214591|FG001|STARTED|Overall Study||183||
60097927|NCT00906178|76214590|FG000|COMPLETED|Overall Study||168||
60097928|NCT00906178|76214591|FG001|COMPLETED|Overall Study||167||
60097929|NCT00906178|76214590|FG000|NOT COMPLETED|Overall Study||15||
59993798|NCT02424578|76109690|FG000|COMPLETED|Overall Study||15||
59993799|NCT02424578|76109691|FG001|COMPLETED|Overall Study||14||
59993800|NCT02424578|76109690|FG000|NOT COMPLETED|Overall Study||0||
59993801|NCT02424578|76109691|FG001|NOT COMPLETED|Overall Study||1||
59993802|NCT02416934|76109699|FG000|STARTED|Overall Study||36||
60097930|NCT00906178|76214591|FG001|NOT COMPLETED|Overall Study||16||
59993803|NCT02416934|76109700|FG001|STARTED|Overall Study||38||
59562715|NCT02341859|75664651|FG001|NOT COMPLETED|First Intervention (1 Day)||0||
59562716|NCT02341859|75664650|FG000|STARTED|Second Intervention (1 Day)||10||
59562717|NCT02341859|75664651|FG001|STARTED|Second Intervention (1 Day)||9||
59562718|NCT02341859|75664650|FG000|COMPLETED|Second Intervention (1 Day)||10||
59562719|NCT02341859|75664651|FG001|COMPLETED|Second Intervention (1 Day)||9||
59562720|NCT02341859|75664650|FG000|NOT COMPLETED|Second Intervention (1 Day)||0||
59562721|NCT02341859|75664651|FG001|NOT COMPLETED|Second Intervention (1 Day)||0||
59562722|NCT02250092|75664666|FG000|STARTED|Overall Study||10||
59562723|NCT02250092|75664667|FG001|STARTED|Overall Study||10||
59562724|NCT02250092|75664666|FG000|COMPLETED|Overall Study||10||
59562725|NCT02250092|75664667|FG001|COMPLETED|Overall Study||10||
59562726|NCT02250092|75664666|FG000|NOT COMPLETED|Overall Study||0||
59562727|NCT02250092|75664667|FG001|NOT COMPLETED|Overall Study||0||
59562728|NCT01742936|75664675|FG000|STARTED|Overall Study||50||
59562729|NCT01742936|75664676|FG001|STARTED|Overall Study||50||
59562730|NCT01742936|75664675|FG000|COMPLETED|Overall Study||50||
59562731|NCT01742936|75664676|FG001|COMPLETED|Overall Study||50||
59562732|NCT01742936|75664675|FG000|NOT COMPLETED|Overall Study||0||
59562733|NCT01742936|75664676|FG001|NOT COMPLETED|Overall Study||0||
59562734|NCT02312765|75664684|FG000|STARTED|Overall Study||74||
59562735|NCT02312765|75664685|FG001|STARTED|Overall Study||72||
59562736|NCT02312765|75664684|FG000|COMPLETED|Overall Study||19||
59562737|NCT02312765|75664685|FG001|COMPLETED|Overall Study||36||
59562738|NCT02312765|75664684|FG000|NOT COMPLETED|Overall Study||55||
59993804|NCT02416934|76109699|FG000|Double Blind (0-52 Weeks)|Overall Study||36||
59993805|NCT02416934|76109700|FG001|Double Blind (0-52 Weeks)|Overall Study||38||
59993806|NCT02416934|76109699|FG000|Last Participant Completed 1 yr|Overall Study||33||
59993807|NCT02416934|76109700|FG001|Last Participant Completed 1 yr|Overall Study||31||
59993808|NCT02416934|76109699|FG000|COMPLETED|Overall Study||33||
59993809|NCT02416934|76109700|FG001|COMPLETED|Overall Study||31||
59993810|NCT02416934|76109699|FG000|NOT COMPLETED|Overall Study||3||
59993811|NCT02416934|76109700|FG001|NOT COMPLETED|Overall Study||7||
59993812|NCT02819635|76109720|FG000|STARTED|Substudy 1 and Substudy 2, Part 1||46||
60097931|NCT03219034|76214599|FG000|STARTED|Overall Study||31||
60097932|NCT03219034|76214600|FG001|STARTED|Overall Study||31||
60097933|NCT03219034|76214599|FG000|COMPLETED|Overall Study||20||
60097934|NCT03219034|76214600|FG001|COMPLETED|Overall Study||16||
59562739|NCT02312765|75664685|FG001|NOT COMPLETED|Overall Study||36||
60097935|NCT03219034|76214599|FG000|NOT COMPLETED|Overall Study||11||
60097936|NCT03219034|76214600|FG001|NOT COMPLETED|Overall Study||15||
60097937|NCT02463981|76214610|FG000|STARTED|Overall Study||21||
60097938|NCT02463981|76214611|FG001|STARTED|Overall Study||16||
59562740|NCT02252666|75664691|FG000|STARTED|Overall Study||6||
59562741|NCT02252666|75664691|FG000|COMPLETED|Overall Study||6||
60097939|NCT02463981|76214610|FG000|COMPLETED|Overall Study||18||
60097940|NCT02463981|76214611|FG001|COMPLETED|Overall Study||14||
60097941|NCT02463981|76214610|FG000|NOT COMPLETED|Overall Study||3||
60097942|NCT02463981|76214611|FG001|NOT COMPLETED|Overall Study||2||
60097943|NCT00915148|76214617|FG000|STARTED|Overall Study|October 2009|110||
60097944|NCT00915148|76214617|FG000|COMPLETED|Overall Study|August 2010|110||
60097945|NCT00915148|76214617|FG000|NOT COMPLETED|Overall Study||0||
60097946|NCT01706198|76214624|FG000|STARTED|Overall Study||2119||
60097947|NCT01706198|76214625|FG001|STARTED|Overall Study||2114||
60097948|NCT01706198|76214624|FG000|COMPLETED|Overall Study||1946||
60097949|NCT01706198|76214625|FG001|COMPLETED|Overall Study||1920||
60097950|NCT01706198|76214624|FG000|NOT COMPLETED|Overall Study||173||
60097951|NCT01706198|76214625|FG001|NOT COMPLETED|Overall Study||194||
60097952|NCT01705730|76214631|FG000|STARTED|Overall Study|Participants who received study drug|68||
60097953|NCT01705730|76214631|FG000|COMPLETED|Overall Study||59||
59562742|NCT02252666|75664691|FG000|NOT COMPLETED|Overall Study||0||
59562743|NCT02342015|75664695|FG000|STARTED|Overall Study||20||
59562744|NCT02342015|75664695|FG000|COMPLETED|Overall Study||20||
60097954|NCT01705730|76214631|FG000|NOT COMPLETED|Overall Study||9||
60097955|NCT01705652|76214637|FG000|STARTED|Overall Study||9||
60097956|NCT01705652|76214638|FG001|STARTED|Overall Study||12||
60097957|NCT01705652|76214637|FG000|COMPLETED|Overall Study||6||
60097958|NCT01705652|76214638|FG001|COMPLETED|Overall Study||9||
59562745|NCT02342015|75664695|FG000|NOT COMPLETED|Overall Study||0||
59562746|NCT02342327|75664701|FG000|STARTED|Overall Study||60||
60097959|NCT01705652|76214637|FG000|NOT COMPLETED|Overall Study||3||
60097960|NCT01705652|76214638|FG001|NOT COMPLETED|Overall Study||3||
60097961|NCT00915538|76214646|FG000|STARTED|Overall Study||8||
60097962|NCT00915538|76214647|FG001|STARTED|Overall Study||8||
60097963|NCT00915538|76214646|FG000|COMPLETED|Overall Study||8||
60097964|NCT00915538|76214647|FG001|COMPLETED|Overall Study||8||
60097965|NCT00915538|76214646|FG000|NOT COMPLETED|Overall Study||0||
60097966|NCT00915538|76214647|FG001|NOT COMPLETED|Overall Study||0||
60097967|NCT00913510|76214657|FG000|STARTED|Overall Study||13||
60097968|NCT00913510|76214658|FG001|STARTED|Overall Study||7||
60097969|NCT00913510|76214657|FG000|COMPLETED|Overall Study||5||
60097970|NCT00913510|76214658|FG001|COMPLETED|Overall Study||3||
60097971|NCT00913510|76214657|FG000|NOT COMPLETED|Overall Study||8||
60097972|NCT00913510|76214658|FG001|NOT COMPLETED|Overall Study||4||
60097973|NCT01705574|76214666|FG000|STARTED|Double-Blind Phase||293||
60097974|NCT01705574|76214667|FG001|STARTED|Double-Blind Phase||290||
60097975|NCT01705574|76214668|FG002|STARTED|Double-Blind Phase||0||
60097976|NCT01705574|76214669|FG003|STARTED|Double-Blind Phase||0||
60097977|NCT01705574|76214666|FG000|COMPLETED|Double-Blind Phase||260||
60097978|NCT01705574|76214667|FG001|COMPLETED|Double-Blind Phase||249||
60097979|NCT01705574|76214668|FG002|COMPLETED|Double-Blind Phase||0||
60097980|NCT01705574|76214669|FG003|COMPLETED|Double-Blind Phase||0||
59562747|NCT02342327|75664702|FG001|STARTED|Overall Study||62||
59562748|NCT02342327|75664701|FG000|Completed Quit Day Visit|Overall Study||54||
59562749|NCT02342327|75664702|FG001|Completed Quit Day Visit|Overall Study||53||
59562750|NCT02342327|75664701|FG000|COMPLETED|Overall Study||39||
59562751|NCT02342327|75664702|FG001|COMPLETED|Overall Study||40||
59562752|NCT02342327|75664701|FG000|NOT COMPLETED|Overall Study||21||
59562753|NCT02342327|75664702|FG001|NOT COMPLETED|Overall Study||22||
59562754|NCT01721564|75664708|FG000|STARTED|Overall Study||8||
60097981|NCT01705574|76214666|FG000|NOT COMPLETED|Double-Blind Phase||33||
60097982|NCT01705574|76214667|FG001|NOT COMPLETED|Double-Blind Phase||41||
60097983|NCT01705574|76214668|FG002|NOT COMPLETED|Double-Blind Phase||0||
60097984|NCT01705574|76214669|FG003|NOT COMPLETED|Double-Blind Phase||0||
60097985|NCT01705574|76214666|FG000|STARTED|Open-Label Extension Phase||246|14 participants did not enter the OLE STB arm.|
60097986|NCT01705574|76214667|FG001|STARTED|Open-Label Extension Phase|Participants either entered the OL GEN arm or OL ATV+RTV+TVD arm.|0|14 participants did not enter the OLE STB arm.|
60097987|NCT01705574|76214668|FG002|STARTED|Open-Label Extension Phase|159 participants entered from the DB ATV+RTV+TVD arm.|159|14 participants did not enter the OLE STB arm.|
60097988|NCT01705574|76214669|FG003|STARTED|Open-Label Extension Phase|53 participants entered from the DB ATV+ RTV + TVD arm.|53|14 participants did not enter the OLE STB arm.|
60097989|NCT01705574|76214666|FG000|COMPLETED|Open-Label Extension Phase||231||
59562755|NCT01721564|75664708|FG000|COMPLETED|Overall Study||8||
60097990|NCT01705574|76214667|FG001|COMPLETED|Open-Label Extension Phase||0||
60097991|NCT01705574|76214668|FG002|COMPLETED|Open-Label Extension Phase||148||
60097992|NCT01705574|76214669|FG003|COMPLETED|Open-Label Extension Phase||48||
60097993|NCT01705574|76214666|FG000|NOT COMPLETED|Open-Label Extension Phase||15||
60097994|NCT01705574|76214667|FG001|NOT COMPLETED|Open-Label Extension Phase||0||
60097995|NCT01705574|76214668|FG002|NOT COMPLETED|Open-Label Extension Phase||11||
60097996|NCT01705574|76214669|FG003|NOT COMPLETED|Open-Label Extension Phase||5||
60097997|NCT01737710|76214690|FG000|STARTED|Overall Study||114||
60097998|NCT01737710|76214691|FG001|STARTED|Overall Study||105||
60097999|NCT01737710|76214692|FG002|STARTED|Overall Study||105||
60098000|NCT01737710|76214693|FG003|STARTED|Overall Study||23||
60098001|NCT01737710|76214694|FG004|STARTED|Overall Study||21||
60098002|NCT01737710|76214690|FG000|COMPLETED|Overall Study||112||
60098003|NCT01737710|76214691|FG001|COMPLETED|Overall Study||101||
60098004|NCT01737710|76214692|FG002|COMPLETED|Overall Study||102||
60098005|NCT01737710|76214693|FG003|COMPLETED|Overall Study||23||
60098006|NCT01737710|76214694|FG004|COMPLETED|Overall Study||21||
60098007|NCT01737710|76214690|FG000|NOT COMPLETED|Overall Study||2||
60098008|NCT01737710|76214691|FG001|NOT COMPLETED|Overall Study||4||
60098009|NCT01737710|76214692|FG002|NOT COMPLETED|Overall Study||3||
60098010|NCT01737710|76214693|FG003|NOT COMPLETED|Overall Study||0||
60098011|NCT01737710|76214694|FG004|NOT COMPLETED|Overall Study||0||
60098012|NCT01682876|76214709|FG000|STARTED|Overall Study||176||
60098013|NCT01682876|76214710|FG001|STARTED|Overall Study||183||
60098014|NCT01682876|76214711|FG002|STARTED|Overall Study||180||
60098015|NCT01682876|76214712|FG003|STARTED|Overall Study||176||
60098016|NCT01682876|76214709|FG000|COMPLETED|Overall Study||155||
60098017|NCT01682876|76214710|FG001|COMPLETED|Overall Study||163||
60098018|NCT01682876|76214711|FG002|COMPLETED|Overall Study||169||
60098019|NCT01682876|76214712|FG003|COMPLETED|Overall Study||157||
60098020|NCT01682876|76214709|FG000|NOT COMPLETED|Overall Study||21||
60098021|NCT01682876|76214710|FG001|NOT COMPLETED|Overall Study||20||
60098022|NCT01682876|76214711|FG002|NOT COMPLETED|Overall Study||11||
60098023|NCT01682876|76214712|FG003|NOT COMPLETED|Overall Study||19||
60098024|NCT01682720|76214729|FG000|STARTED|Overall Study||85||
60098025|NCT01682720|76214730|FG001|STARTED|Overall Study||74||
60098026|NCT01682720|76214731|FG002|STARTED|Overall Study||12||
60098027|NCT01682720|76214732|FG003|STARTED|Overall Study||250||
60098028|NCT01682720|76214729|FG000|Included in Full Analysis Set|Overall Study||0||
60098029|NCT01682720|76214730|FG001|Included in Full Analysis Set|Overall Study||73||
60098030|NCT01682720|76214731|FG002|Included in Full Analysis Set|Overall Study||11||
60098031|NCT01682720|76214732|FG003|Included in Full Analysis Set|Overall Study||250||
60098032|NCT01682720|76214729|FG000|COMPLETED|Overall Study||0||
60098033|NCT01682720|76214730|FG001|COMPLETED|Overall Study||69||
60098034|NCT01682720|76214731|FG002|COMPLETED|Overall Study||5||
60098035|NCT01682720|76214732|FG003|COMPLETED|Overall Study||211||
60098036|NCT01682720|76214729|FG000|NOT COMPLETED|Overall Study||85||
60098037|NCT01682720|76214730|FG001|NOT COMPLETED|Overall Study||5||
60098038|NCT01682720|76214731|FG002|NOT COMPLETED|Overall Study||7||
60098039|NCT01682720|76214732|FG003|NOT COMPLETED|Overall Study||39||
60098040|NCT04551014|76214744|FG000|STARTED|Overall Study||105||142
60098041|NCT04551014|76214745|FG001|STARTED|Overall Study||109||149
60098042|NCT04551014|76214744|FG000|COMPLETED|Overall Study||105||142
60098043|NCT04551014|76214745|FG001|COMPLETED|Overall Study||109||149
60098044|NCT04551014|76214744|FG000|NOT COMPLETED|Overall Study||0||0
60098045|NCT04551014|76214745|FG001|NOT COMPLETED|Overall Study||0||0
60098046|NCT01714544|76214751|FG000|STARTED|Overall Study||60||
60098047|NCT01714544|76214751|FG000|COMPLETED|Overall Study||57||
60098048|NCT01714544|76214751|FG000|NOT COMPLETED|Overall Study||3||
60098049|NCT01703858|76214758|FG000|STARTED|Overall Study||5||
60098050|NCT01703858|76214759|FG001|STARTED|Overall Study||5||
60098051|NCT01703858|76214760|FG002|STARTED|Overall Study||5||
60098052|NCT01703858|76214758|FG000|COMPLETED|Overall Study||5||
60098053|NCT01703858|76214759|FG001|COMPLETED|Overall Study||4||
60098054|NCT01703858|76214760|FG002|COMPLETED|Overall Study||5||
60098055|NCT01703858|76214758|FG000|NOT COMPLETED|Overall Study||0||
60098056|NCT01703858|76214759|FG001|NOT COMPLETED|Overall Study||1||
60098057|NCT01703858|76214760|FG002|NOT COMPLETED|Overall Study||0||
60098058|NCT01714310|76214776|FG000|STARTED|Open Lisdexamfetamine Titration||0||
60098059|NCT01714310|76214777|FG001|STARTED|Open Lisdexamfetamine Titration||0||
60098060|NCT01714310|76214778|FG002|STARTED|Open Lisdexamfetamine Titration||34||
60098061|NCT01714310|76214776|FG000|COMPLETED|Open Lisdexamfetamine Titration||0||
60098062|NCT01714310|76214777|FG001|COMPLETED|Open Lisdexamfetamine Titration||0||
60098063|NCT01714310|76214778|FG002|COMPLETED|Open Lisdexamfetamine Titration||30||
60098064|NCT01714310|76214776|FG000|NOT COMPLETED|Open Lisdexamfetamine Titration||0||
60098065|NCT01714310|76214777|FG001|NOT COMPLETED|Open Lisdexamfetamine Titration||0||
60098066|NCT01714310|76214778|FG002|NOT COMPLETED|Open Lisdexamfetamine Titration||4||
60098067|NCT01714310|76214776|FG000|STARTED|Double Blind Adjunctive Treatment|Adjunctive fluoxetine treatment was initiated at beginning of Period 2, at study week 4.|12||
60098068|NCT01714310|76214777|FG001|STARTED|Double Blind Adjunctive Treatment|Adjunctive placebo was initiated at beginning of Period 2, at study week 4.|14||
60098069|NCT01714310|76214778|FG002|STARTED|Double Blind Adjunctive Treatment|No one remained on lisdexamfetamine alone in Period 2.|0||
60098070|NCT01714310|76214776|FG000|COMPLETED|Double Blind Adjunctive Treatment||10||
60098071|NCT01714310|76214777|FG001|COMPLETED|Double Blind Adjunctive Treatment||11||
60098072|NCT01714310|76214778|FG002|COMPLETED|Double Blind Adjunctive Treatment||0||
60098073|NCT01714310|76214776|FG000|NOT COMPLETED|Double Blind Adjunctive Treatment||2||
60098074|NCT01714310|76214777|FG001|NOT COMPLETED|Double Blind Adjunctive Treatment||3||
60098075|NCT01714310|76214778|FG002|NOT COMPLETED|Double Blind Adjunctive Treatment||0||
60098076|NCT01713998|76214799|FG000|STARTED|Overall Study||16||
60098077|NCT01713998|76214800|FG001|STARTED|Overall Study||15||
60098078|NCT01713998|76214801|FG002|STARTED|Overall Study||16||
60098079|NCT01713998|76214799|FG000|COMPLETED|Overall Study||13||
60098080|NCT01713998|76214800|FG001|COMPLETED|Overall Study||15||
60098081|NCT01713998|76214801|FG002|COMPLETED|Overall Study||14||
60098082|NCT01713998|76214799|FG000|NOT COMPLETED|Overall Study||3||
60098083|NCT01713998|76214800|FG001|NOT COMPLETED|Overall Study||0||
60098084|NCT01713998|76214801|FG002|NOT COMPLETED|Overall Study||2||
60098085|NCT01681628|76214811|FG000|STARTED|Time 1 (Entry) to Time 2 One Week Later.||128||
59562756|NCT01721564|75664708|FG000|NOT COMPLETED|Overall Study||0||
60098086|NCT01681628|76214812|FG001|STARTED|Time 1 (Entry) to Time 2 One Week Later.||128||
60098087|NCT01681628|76214811|FG000|COMPLETED|Time 1 (Entry) to Time 2 One Week Later.||114||
60098088|NCT01681628|76214812|FG001|COMPLETED|Time 1 (Entry) to Time 2 One Week Later.||122||
60098089|NCT01681628|76214811|FG000|NOT COMPLETED|Time 1 (Entry) to Time 2 One Week Later.||14||
59562757|NCT02033213|75664714|FG000|STARTED|Overall Study||8||
60098090|NCT01681628|76214812|FG001|NOT COMPLETED|Time 1 (Entry) to Time 2 One Week Later.||6||
60098091|NCT01681628|76214811|FG000|STARTED|Time 2 to Time 3 (One Week Later).|Only wait list group studied in this period.|0||
60098092|NCT01681628|76214812|FG001|STARTED|Time 2 to Time 3 (One Week Later).||122||
59562758|NCT02033213|75664715|FG001|STARTED|Overall Study||8||
59562759|NCT02033213|75664714|FG000|COMPLETED|Overall Study||8||
59562760|NCT02033213|75664715|FG001|COMPLETED|Overall Study||8||
59562761|NCT02033213|75664714|FG000|NOT COMPLETED|Overall Study||0||
60098093|NCT01681628|76214811|FG000|COMPLETED|Time 2 to Time 3 (One Week Later).|Only wait list group studied in this period.|0||
60098094|NCT01681628|76214812|FG001|COMPLETED|Time 2 to Time 3 (One Week Later).||107||
60098095|NCT01681628|76214811|FG000|NOT COMPLETED|Time 2 to Time 3 (One Week Later).||0||
60098096|NCT01681628|76214812|FG001|NOT COMPLETED|Time 2 to Time 3 (One Week Later).||15||
60098097|NCT01681628|76214811|FG000|STARTED|19 Months Follow-up||114||
60098098|NCT01681628|76214812|FG001|STARTED|19 Months Follow-up||107||
60098099|NCT01681628|76214811|FG000|COMPLETED|19 Months Follow-up||52||
60098100|NCT01681628|76214812|FG001|COMPLETED|19 Months Follow-up||64||
60098101|NCT01681628|76214811|FG000|NOT COMPLETED|19 Months Follow-up||62||
60098102|NCT01681628|76214812|FG001|NOT COMPLETED|19 Months Follow-up||43||
60098103|NCT03409120|76214821|FG000|STARTED|Overall Study||38||
60098104|NCT03409120|76214821|FG000|COMPLETED|Overall Study||38||
60098105|NCT03409120|76214821|FG000|NOT COMPLETED|Overall Study||0||
60098106|NCT03405142|76214827|FG000|STARTED|Overall Study||2||
60098107|NCT03405142|76214828|FG001|STARTED|Overall Study||1||
60098108|NCT03405142|76214827|FG000|COMPLETED|Overall Study||2||
60098109|NCT03405142|76214828|FG001|COMPLETED|Overall Study||1||
60098110|NCT03405142|76214827|FG000|NOT COMPLETED|Overall Study||0||
60098111|NCT03405142|76214828|FG001|NOT COMPLETED|Overall Study||0||
60098112|NCT00016354|76214834|FG000|STARTED|Overall Study||1||
60098113|NCT00016354|76214835|FG001|STARTED|Overall Study||1||
60098114|NCT00016354|76214836|FG002|STARTED|Overall Study||1||
60098115|NCT00016354|76214837|FG003|STARTED|Overall Study||1||
60098116|NCT00016354|76214838|FG004|STARTED|Overall Study||1||
60098117|NCT00016354|76214839|FG005|STARTED|Overall Study||1||
60098118|NCT00016354|76214840|FG006|STARTED|Overall Study||6||
60098119|NCT00016354|76214841|FG007|STARTED|Overall Study||7||
60098120|NCT00016354|76214834|FG000|COMPLETED|Overall Study||1||
60098121|NCT00016354|76214835|FG001|COMPLETED|Overall Study||1||
60098122|NCT00016354|76214836|FG002|COMPLETED|Overall Study||1||
60098123|NCT00016354|76214837|FG003|COMPLETED|Overall Study||1||
60098124|NCT00016354|76214838|FG004|COMPLETED|Overall Study||1||
60098125|NCT00016354|76214839|FG005|COMPLETED|Overall Study||1||
60098126|NCT00016354|76214840|FG006|COMPLETED|Overall Study||6||
60098127|NCT00016354|76214841|FG007|COMPLETED|Overall Study||6||
60098128|NCT00016354|76214834|FG000|NOT COMPLETED|Overall Study||0||
60098129|NCT00016354|76214835|FG001|NOT COMPLETED|Overall Study||0||
60098130|NCT00016354|76214836|FG002|NOT COMPLETED|Overall Study||0||
60098131|NCT00016354|76214837|FG003|NOT COMPLETED|Overall Study||0||
60098132|NCT00016354|76214838|FG004|NOT COMPLETED|Overall Study||0||
60098133|NCT00016354|76214839|FG005|NOT COMPLETED|Overall Study||0||
60098134|NCT00016354|76214840|FG006|NOT COMPLETED|Overall Study||0||
60098135|NCT00016354|76214841|FG007|NOT COMPLETED|Overall Study||1||
60098136|NCT01681472|76214849|FG000|STARTED|Overall Study||8||
60098137|NCT01681472|76214850|FG001|STARTED|Overall Study||8||
60098138|NCT01681472|76214851|FG002|STARTED|Overall Study||8||
60098139|NCT01681472|76214852|FG003|STARTED|Overall Study||8||
60098140|NCT01681472|76214849|FG000|COMPLETED|Overall Study||8||
60098141|NCT01681472|76214850|FG001|COMPLETED|Overall Study||7||
60098142|NCT01681472|76214851|FG002|COMPLETED|Overall Study||8||
60098143|NCT01681472|76214852|FG003|COMPLETED|Overall Study||8||
60098144|NCT01681472|76214849|FG000|NOT COMPLETED|Overall Study||0||
60098145|NCT01681472|76214850|FG001|NOT COMPLETED|Overall Study||1||
60098146|NCT01681472|76214851|FG002|NOT COMPLETED|Overall Study||0||
60098147|NCT01681472|76214852|FG003|NOT COMPLETED|Overall Study||0||
60098148|NCT00915928|76214873|FG000|STARTED|Overall Study||25||
60098149|NCT00915928|76214874|FG001|STARTED|Overall Study||22||
60098150|NCT00915928|76214873|FG000|COMPLETED|Overall Study||25||
59562762|NCT02033213|75664715|FG001|NOT COMPLETED|Overall Study||0||
59562763|NCT02410967|75664725|FG000|STARTED|Treatment Phase (4 Weeks)||27||
59816995|NCT02162810|75939406|FG000|STARTED|Overall Study||17||
59816996|NCT02162810|75939407|FG001|STARTED|Overall Study||11||
60098151|NCT00915928|76214874|FG001|COMPLETED|Overall Study||22||
60098152|NCT00915928|76214873|FG000|NOT COMPLETED|Overall Study||0||
60098153|NCT00915928|76214874|FG001|NOT COMPLETED|Overall Study||0||
60098154|NCT01049308|76214881|FG000|STARTED|Evaluation of Cognitive Impairment||251||
60098155|NCT01049308|76214881|FG000|COMPLETED|Evaluation of Cognitive Impairment||251||
60098156|NCT01049308|76214881|FG000|NOT COMPLETED|Evaluation of Cognitive Impairment||0||
60098157|NCT01049308|76214881|FG000|STARTED|Pill Counts||251||
60098158|NCT01049308|76214881|FG000|COMPLETED|Pill Counts||168||
60098159|NCT01049308|76214881|FG000|NOT COMPLETED|Pill Counts||83||
60098160|NCT01713686|76214888|FG000|STARTED|Overall Study|129 enrolled, 125 treated. 2 withdrew consent prior to treatment; 2 excluded after enrollment.|125||
60098161|NCT01713686|76214888|FG000|COMPLETED|Overall Study||110||
60098162|NCT01713686|76214888|FG000|NOT COMPLETED|Overall Study||15||
60098163|NCT01047436|76214894|FG000|STARTED|Overall Study||16||
60098164|NCT01047436|76214895|FG001|STARTED|Overall Study||15||
60098165|NCT01047436|76214894|FG000|COMPLETED|Overall Study||15||
59562764|NCT02410967|75664726|FG001|STARTED|Treatment Phase (4 Weeks)||26||
59562765|NCT02410967|75664725|FG000|COMPLETED|Treatment Phase (4 Weeks)||26||
59562766|NCT02410967|75664726|FG001|COMPLETED|Treatment Phase (4 Weeks)||22||
59562767|NCT02410967|75664725|FG000|NOT COMPLETED|Treatment Phase (4 Weeks)||1||
59562768|NCT02410967|75664726|FG001|NOT COMPLETED|Treatment Phase (4 Weeks)||4||
59562769|NCT02410967|75664725|FG000|STARTED|Follow-up Phase (8 Weeks)||26||
59562770|NCT02410967|75664726|FG001|STARTED|Follow-up Phase (8 Weeks)||22||
59562771|NCT02410967|75664725|FG000|COMPLETED|Follow-up Phase (8 Weeks)||22||
59562772|NCT02410967|75664726|FG001|COMPLETED|Follow-up Phase (8 Weeks)||16||
59562773|NCT02410967|75664725|FG000|NOT COMPLETED|Follow-up Phase (8 Weeks)||4||
59562774|NCT02410967|75664726|FG001|NOT COMPLETED|Follow-up Phase (8 Weeks)||6||
59562775|NCT02342561|75664732|FG000|STARTED|Overall Study||20||
59562776|NCT02342561|75664732|FG000|COMPLETED|Overall Study||20||
59562777|NCT02342561|75664732|FG000|NOT COMPLETED|Overall Study||0||
59562778|NCT02343575|75664742|FG000|STARTED|Overall Study||1||
59562779|NCT02343575|75664743|FG001|STARTED|Overall Study||2||
59562780|NCT02343575|75664742|FG000|COMPLETED|Overall Study||1||
59562781|NCT02343575|75664743|FG001|COMPLETED|Overall Study||2||
59562782|NCT02343575|75664742|FG000|NOT COMPLETED|Overall Study||0||
59562783|NCT02343575|75664743|FG001|NOT COMPLETED|Overall Study||0||
59562784|NCT01744340|75664751|FG000|STARTED|Overall Study||8||
59562785|NCT01744340|75664752|FG001|STARTED|Overall Study||15||
59562786|NCT01744340|75664751|FG000|COMPLETED|Overall Study||8||
59562787|NCT01744340|75664752|FG001|COMPLETED|Overall Study||15||
59562788|NCT01744340|75664751|FG000|NOT COMPLETED|Overall Study||0||
59562789|NCT01744340|75664752|FG001|NOT COMPLETED|Overall Study||0||
59562790|NCT01744574|75664762|FG000|STARTED|Overall Study||57||
59562791|NCT01744574|75664763|FG001|STARTED|Overall Study||56||
59562792|NCT01744574|75664764|FG002|STARTED|Overall Study||52||
59562793|NCT01744574|75664765|FG003|STARTED|Overall Study||51||
59562794|NCT01744574|75664762|FG000|COMPLETED|Overall Study||33||
59562795|NCT01744574|75664763|FG001|COMPLETED|Overall Study||31||
59562796|NCT01744574|75664764|FG002|COMPLETED|Overall Study||32||
59562797|NCT01744574|75664765|FG003|COMPLETED|Overall Study||40||
59562798|NCT01744574|75664762|FG000|NOT COMPLETED|Overall Study||24||
59562799|NCT01744574|75664763|FG001|NOT COMPLETED|Overall Study||25||
59562800|NCT01744574|75664764|FG002|NOT COMPLETED|Overall Study||20||
59562801|NCT01744574|75664765|FG003|NOT COMPLETED|Overall Study||11||
59562802|NCT01744730|75664780|FG000|STARTED|Overall Study||4||
59562803|NCT01744730|75664781|FG001|STARTED|Overall Study||3||
59562804|NCT01744730|75664782|FG002|STARTED|Overall Study||4||
59562805|NCT01744730|75664783|FG003|STARTED|Overall Study||11||
59562806|NCT01744730|75664784|FG004|STARTED|Overall Study|Please note this study (NCT01431326) is ongoing and data only represents a subset of this study.|178||
59562807|NCT01744730|75664780|FG000|COMPLETED|Overall Study||4||
59562808|NCT01744730|75664781|FG001|COMPLETED|Overall Study||3||
59562809|NCT01744730|75664782|FG002|COMPLETED|Overall Study||4||
59562810|NCT01744730|75664783|FG003|COMPLETED|Overall Study||11||
59562811|NCT01744730|75664784|FG004|COMPLETED|Overall Study|Please note this study (NCT01431326) is ongoing and data only represents a subset of this study.|178||
59562812|NCT01744730|75664780|FG000|NOT COMPLETED|Overall Study||0||
59562813|NCT01744730|75664781|FG001|NOT COMPLETED|Overall Study||0||
59562814|NCT01744730|75664782|FG002|NOT COMPLETED|Overall Study||0||
59562815|NCT01744730|75664783|FG003|NOT COMPLETED|Overall Study||0||
59562816|NCT01744730|75664784|FG004|NOT COMPLETED|Overall Study||0||
59562817|NCT01722734|75664800|FG000|STARTED|Overall Study||554||
59562818|NCT01722734|75664801|FG001|STARTED|Overall Study||277||
59562819|NCT01722734|75664802|FG002|STARTED|Overall Study||309||
59562820|NCT01722734|75664800|FG000|COMPLETED|Overall Study||552||
59562821|NCT01722734|75664801|FG001|COMPLETED|Overall Study||276||
59562822|NCT01722734|75664802|FG002|COMPLETED|Overall Study||307||
59562823|NCT01722734|75664800|FG000|NOT COMPLETED|Overall Study||2||
59562824|NCT01722734|75664801|FG001|NOT COMPLETED|Overall Study||1||
59562825|NCT01722734|75664802|FG002|NOT COMPLETED|Overall Study||2||
59562826|NCT02413151|75664812|FG000|STARTED|Overall Study||32||
59562827|NCT02413151|75664813|FG001|STARTED|Overall Study||30||
59562828|NCT02413151|75664812|FG000|COMPLETED|Overall Study||22||
59562829|NCT02413151|75664813|FG001|COMPLETED|Overall Study||28||
59562830|NCT02413151|75664812|FG000|NOT COMPLETED|Overall Study||10||
59562831|NCT02413151|75664813|FG001|NOT COMPLETED|Overall Study||2||
59562832|NCT02346383|75664820|FG000|STARTED|Overall Study||40||
59562833|NCT02346383|75664820|FG000|COMPLETED|Overall Study||40||
59562834|NCT02346383|75664820|FG000|NOT COMPLETED|Overall Study||0||
59562835|NCT02413463|75664830|FG000|STARTED|Overall Study||30||
59562836|NCT02413463|75664831|FG001|STARTED|Overall Study||30||
59562837|NCT02413463|75664830|FG000|COMPLETED|Overall Study||25||
59562838|NCT02413463|75664831|FG001|COMPLETED|Overall Study||28||
59562839|NCT02413463|75664830|FG000|NOT COMPLETED|Overall Study||5||
59562840|NCT02413463|75664831|FG001|NOT COMPLETED|Overall Study||2||
59562841|NCT02037347|75664837|FG000|STARTED|Overall Study||1||
59562842|NCT02037347|75664837|FG000|COMPLETED|Overall Study||1||
59562843|NCT02037347|75664837|FG000|NOT COMPLETED|Overall Study||0||
59562844|NCT02037425|75664841|FG000|STARTED|Overall Study||44||
59562845|NCT02037425|75664841|FG000|Randomized to Treatment|Overall Study||32||
59562846|NCT02037425|75664841|FG000|COMPLETED|Overall Study||18||
59562847|NCT02037425|75664841|FG000|NOT COMPLETED|Overall Study||26||
59562848|NCT02346461|75664849|FG000|STARTED|Overall Study||6||
59562849|NCT02346461|75664850|FG001|STARTED|Overall Study||6||
59562850|NCT02346461|75664849|FG000|COMPLETED|Overall Study||6||
59562851|NCT02346461|75664850|FG001|COMPLETED|Overall Study||6||
59562852|NCT02346461|75664849|FG000|NOT COMPLETED|Overall Study||0||
59562853|NCT02346461|75664850|FG001|NOT COMPLETED|Overall Study||0||
59562854|NCT01349465|75664859|FG000|STARTED|Overall Study||200||
59562855|NCT01349465|75664860|FG001|STARTED|Overall Study||49||
59562856|NCT01349465|75664859|FG000|COMPLETED|Overall Study||182||
59562857|NCT01349465|75664860|FG001|COMPLETED|Overall Study||27||
59562858|NCT01349465|75664859|FG000|NOT COMPLETED|Overall Study||18||
59562859|NCT01349465|75664860|FG001|NOT COMPLETED|Overall Study||22||
59562860|NCT02414243|75664870|FG000|STARTED|Overall Study||19|41 randomized but 1 patient left study after randomization|
59562861|NCT02414243|75664871|FG001|STARTED|Overall Study||21|41 randomized but 1 patient left study after randomization|
59562862|NCT02414243|75664870|FG000|Moved to the Other Group|Overall Study||17||
59562863|NCT02414243|75664871|FG001|Moved to the Other Group|Overall Study||20||
59562864|NCT02414243|75664870|FG000|Entered Open Challenge at Home|Overall Study||17||
59562865|NCT02414243|75664871|FG001|Entered Open Challenge at Home|Overall Study||20||
59562866|NCT02414243|75664870|FG000|COMPLETED|Overall Study||13||
59562867|NCT02414243|75664871|FG001|COMPLETED|Overall Study||17||
59562868|NCT02414243|75664870|FG000|NOT COMPLETED|Overall Study||6||
59562869|NCT02414243|75664871|FG001|NOT COMPLETED|Overall Study||4||
59562870|NCT02414633|75664878|FG000|STARTED|Overall Study||148||
59562871|NCT02414633|75664878|FG000|COMPLETED|Overall Study||148||
59562872|NCT02414633|75664878|FG000|NOT COMPLETED|Overall Study||0||
59562873|NCT02037893|75664886|FG000|STARTED|Overall Study||32||
59562874|NCT02037893|75664887|FG001|STARTED|Overall Study||25||
59562875|NCT02037893|75664888|FG002|STARTED|Overall Study||27||
59562876|NCT02037893|75664889|FG003|STARTED|Overall Study||28||
59562877|NCT02037893|75664886|FG000|COMPLETED|Overall Study||32||
59562878|NCT02037893|75664887|FG001|COMPLETED|Overall Study||25||
59562879|NCT02037893|75664888|FG002|COMPLETED|Overall Study||26||
59562880|NCT02037893|75664889|FG003|COMPLETED|Overall Study||28||
59562881|NCT02037893|75664886|FG000|NOT COMPLETED|Overall Study||0||
59562882|NCT02037893|75664887|FG001|NOT COMPLETED|Overall Study||0||
59562883|NCT02037893|75664888|FG002|NOT COMPLETED|Overall Study||1||
59562884|NCT02037893|75664889|FG003|NOT COMPLETED|Overall Study||0||
59562885|NCT02353091|75664901|FG000|STARTED|Overall Study||13||
59562886|NCT02353091|75664902|FG001|STARTED|Overall Study||13||
59562887|NCT02353091|75664901|FG000|COMPLETED|Overall Study||13||
59562888|NCT02353091|75664902|FG001|COMPLETED|Overall Study||13||
59562889|NCT02353091|75664901|FG000|NOT COMPLETED|Overall Study||0||
59562890|NCT02353091|75664902|FG001|NOT COMPLETED|Overall Study||0||
59562891|NCT02040077|75664920|FG000|STARTED|Overall Study||27||
59562892|NCT02040077|75664921|FG001|STARTED|Overall Study||24||
59562893|NCT02040077|75664922|FG002|STARTED|Overall Study||25||
59562894|NCT02040077|75664920|FG000|COMPLETED|Overall Study||27|Completed primary intervention|
59562895|NCT02040077|75664921|FG001|COMPLETED|Overall Study||24|Completed primary intervention|
59562896|NCT02040077|75664922|FG002|COMPLETED|Overall Study||25|Completed primary intervention|
59562897|NCT02040077|75664920|FG000|NOT COMPLETED|Overall Study||0||
59562898|NCT02040077|75664921|FG001|NOT COMPLETED|Overall Study||0||
59562899|NCT02040077|75664922|FG002|NOT COMPLETED|Overall Study||0||
59562900|NCT02040623|75664934|FG000|STARTED|Overall Study||11||
59562901|NCT02040623|75664935|FG001|STARTED|Overall Study||12||
59562902|NCT02040623|75664936|FG002|STARTED|Overall Study||12||
59562903|NCT02040623|75664934|FG000|COMPLETED|Overall Study||7||
59562904|NCT02040623|75664935|FG001|COMPLETED|Overall Study||6||
59562905|NCT02040623|75664936|FG002|COMPLETED|Overall Study||10||
59562906|NCT02040623|75664934|FG000|NOT COMPLETED|Overall Study||4||
59562907|NCT02040623|75664935|FG001|NOT COMPLETED|Overall Study||6||
59562908|NCT02040623|75664936|FG002|NOT COMPLETED|Overall Study||2||
59562909|NCT02041325|75664946|FG000|STARTED|Overall Study||22||
59562910|NCT02041325|75664947|FG001|STARTED|Overall Study||16||
59562911|NCT02041325|75664946|FG000|COMPLETED|Overall Study||19||
59562912|NCT02041325|75664947|FG001|COMPLETED|Overall Study||13||
59562913|NCT02041325|75664946|FG000|NOT COMPLETED|Overall Study||3||
59562914|NCT02041325|75664947|FG001|NOT COMPLETED|Overall Study||3||
59562915|NCT02043197|75664957|FG000|STARTED|Overall Study||300||
59562916|NCT02043197|75664957|FG000|COMPLETED|Overall Study||292||
59562917|NCT02043197|75664957|FG000|NOT COMPLETED|Overall Study||8||
59562918|NCT01723514|75664969|FG000|STARTED|Overall Study||8||
59562919|NCT01723514|75664970|FG001|STARTED|Overall Study||6||
59562920|NCT01723514|75664971|FG002|STARTED|Overall Study||6||
59562921|NCT01723514|75664972|FG003|STARTED|Overall Study||6||
59562922|NCT01723514|75664973|FG004|STARTED|Overall Study||6||
59562923|NCT01723514|75664974|FG005|STARTED|Overall Study||4||
59562924|NCT01723514|75664975|FG006|STARTED|Overall Study||6||
59562925|NCT01723514|75664976|FG007|STARTED|Overall Study||6||
59562926|NCT01723514|75664969|FG000|COMPLETED|Overall Study||8||
59562927|NCT01723514|75664970|FG001|COMPLETED|Overall Study||6||
59562928|NCT01723514|75664971|FG002|COMPLETED|Overall Study||6||
60098166|NCT01047436|76214895|FG001|COMPLETED|Overall Study||15||
60098167|NCT01047436|76214894|FG000|NOT COMPLETED|Overall Study||1||
60098168|NCT01047436|76214895|FG001|NOT COMPLETED|Overall Study||0||
60098169|NCT01681004|76214903|FG000|STARTED|Primary Endpoint: 6 Months||102||
60098170|NCT01681004|76214904|FG001|STARTED|Primary Endpoint: 6 Months||46||
60098171|NCT01681004|76214903|FG000|Crossover to Surgical Treatment|Primary Endpoint: 6 Months||0||
60098172|NCT01681004|76214904|FG001|Crossover to Surgical Treatment|Primary Endpoint: 6 Months|Crossover to surgical treatment allowed per study protocol after the 6-month visit was complete.|39||
60098173|NCT01681004|76214903|FG000|COMPLETED|Primary Endpoint: 6 Months||101||
60098174|NCT01681004|76214904|FG001|COMPLETED|Primary Endpoint: 6 Months||44||
60098175|NCT01681004|76214903|FG000|NOT COMPLETED|Primary Endpoint: 6 Months||1||
60098176|NCT01681004|76214904|FG001|NOT COMPLETED|Primary Endpoint: 6 Months||2||
60098177|NCT01681004|76214903|FG000|STARTED|Study Completion||101||
59816997|NCT02162810|75939406|FG000|COMPLETED|Overall Study||12||
59816998|NCT02162810|75939407|FG001|COMPLETED|Overall Study||10||
60098178|NCT01681004|76214904|FG001|STARTED|Study Completion||44||
60098179|NCT01681004|76214903|FG000|COMPLETED|Study Completion||89||
60098180|NCT01681004|76214904|FG001|COMPLETED|Study Completion||36||
60098181|NCT01681004|76214903|FG000|NOT COMPLETED|Study Completion||12||
60098182|NCT01681004|76214904|FG001|NOT COMPLETED|Study Completion||8||
60098183|NCT01046110|76214916|FG000|STARTED|Overall Study||229||
60098184|NCT01046110|76214917|FG001|STARTED|Overall Study||229||
60098185|NCT01046110|76214916|FG000|Exposed|Overall Study|2 subjects were randomised in error and 1 subject did not want to take insulin|226||
60098186|NCT01046110|76214917|FG001|Exposed|Overall Study|1 subject was randomised in error|228||
60098187|NCT01046110|76214916|FG000|COMPLETED|Overall Study||174||
60098188|NCT01046110|76214917|FG001|COMPLETED|Overall Study||174||
60098189|NCT01046110|76214916|FG000|NOT COMPLETED|Overall Study||55||
60098190|NCT01046110|76214917|FG001|NOT COMPLETED|Overall Study||55||
60098191|NCT01713530|76214925|FG000|STARTED|Overall Study||138||
60098192|NCT01713530|76214926|FG001|STARTED|Overall Study||136||
60098193|NCT01713530|76214925|FG000|Exposed|Overall Study|One (1) subject was randomised in error and 1 subject withdrew consent|136||
60098194|NCT01713530|76214926|FG001|Exposed|Overall Study|One (1) subject was withdrawn by the investigator|135||
60098195|NCT01713530|76214925|FG000|COMPLETED|Overall Study||113||
60098196|NCT01713530|76214926|FG001|COMPLETED|Overall Study||117||
60098197|NCT01713530|76214925|FG000|NOT COMPLETED|Overall Study||25||
60098198|NCT01713530|76214926|FG001|NOT COMPLETED|Overall Study||19||
60098199|NCT01045798|76214934|FG000|STARTED|Overall Study||6||
60098200|NCT01045798|76214935|FG001|STARTED|Overall Study||9||
59562929|NCT01723514|75664972|FG003|COMPLETED|Overall Study||6||
59562930|NCT01723514|75664973|FG004|COMPLETED|Overall Study||6||
59562931|NCT01723514|75664974|FG005|COMPLETED|Overall Study||4||
59562932|NCT01723514|75664975|FG006|COMPLETED|Overall Study||6||
59562933|NCT01723514|75664976|FG007|COMPLETED|Overall Study||6||
59562934|NCT01723514|75664969|FG000|NOT COMPLETED|Overall Study||0||
59562935|NCT01723514|75664970|FG001|NOT COMPLETED|Overall Study||0||
59562936|NCT01723514|75664971|FG002|NOT COMPLETED|Overall Study||0||
59562937|NCT01723514|75664972|FG003|NOT COMPLETED|Overall Study||0||
59562938|NCT01723514|75664973|FG004|NOT COMPLETED|Overall Study||0||
59562939|NCT01723514|75664974|FG005|NOT COMPLETED|Overall Study||0||
59562940|NCT01723514|75664975|FG006|NOT COMPLETED|Overall Study||0||
59562941|NCT01723514|75664976|FG007|NOT COMPLETED|Overall Study||0||
59562942|NCT02044367|75664994|FG000|STARTED|Overall Study||9||
59562943|NCT02044367|75664995|FG001|STARTED|Overall Study||9||
59562944|NCT02044367|75664996|FG002|STARTED|Overall Study||9||
59562945|NCT02044367|75664997|FG003|STARTED|Overall Study||9||
59562946|NCT02044367|75664998|FG004|STARTED|Overall Study||9||
59562947|NCT02044367|75664999|FG005|STARTED|Overall Study||9||
59562948|NCT02044367|75664994|FG000|COMPLETED|Overall Study||9||
59562949|NCT02044367|75664995|FG001|COMPLETED|Overall Study||9||
59562950|NCT02044367|75664996|FG002|COMPLETED|Overall Study||9||
59562951|NCT02044367|75664997|FG003|COMPLETED|Overall Study||9||
59562952|NCT02044367|75664998|FG004|COMPLETED|Overall Study||9||
59562953|NCT02044367|75664999|FG005|COMPLETED|Overall Study||9||
59562954|NCT02044367|75664994|FG000|NOT COMPLETED|Overall Study||0||
59562955|NCT02044367|75664995|FG001|NOT COMPLETED|Overall Study||0||
59562956|NCT02044367|75664996|FG002|NOT COMPLETED|Overall Study||0||
59562957|NCT02044367|75664997|FG003|NOT COMPLETED|Overall Study||0||
59562958|NCT02044367|75664998|FG004|NOT COMPLETED|Overall Study||0||
59562959|NCT02044367|75664999|FG005|NOT COMPLETED|Overall Study||0||
59562960|NCT02044991|75665013|FG000|STARTED|Overall Study||2||
59562961|NCT02044991|75665014|FG001|STARTED|Overall Study||0||
59562962|NCT02044991|75665013|FG000|COMPLETED|Overall Study||2||
59562963|NCT02044991|75665014|FG001|COMPLETED|Overall Study||0||
59562964|NCT02044991|75665013|FG000|NOT COMPLETED|Overall Study||0||
59562965|NCT02044991|75665014|FG001|NOT COMPLETED|Overall Study||0||
59562966|NCT01745822|75665022|FG000|STARTED|Overall Study|168 mothers and 163 infants|331||
59562967|NCT01745822|75665023|FG001|STARTED|Overall Study|163 mothers and 160 infants|323||
59562968|NCT01745822|75665022|FG000|COMPLETED|Overall Study||331||
59562969|NCT01745822|75665023|FG001|COMPLETED|Overall Study||323||
59993813|NCT02819635|76109721|FG001|STARTED|Substudy 1 and Substudy 2, Part 1||47||
59993814|NCT02819635|76109722|FG002|STARTED|Substudy 1 and Substudy 2, Part 1||49||
59993815|NCT02819635|76109723|FG003|STARTED|Substudy 1 and Substudy 2, Part 1||117||
59993816|NCT02819635|76109724|FG004|STARTED|Substudy 1 and Substudy 2, Part 1||123||
59993817|NCT02819635|76109725|FG005|STARTED|Substudy 1 and Substudy 2, Part 1||155||
59993818|NCT02819635|76109726|FG006|STARTED|Substudy 1 and Substudy 2, Part 1||319||
59562970|NCT01745822|75665022|FG000|NOT COMPLETED|Overall Study||0||
59562971|NCT01745822|75665023|FG001|NOT COMPLETED|Overall Study||0||
59993819|NCT02819635|76109727|FG007|STARTED|Substudy 1 and Substudy 2, Part 1||446||
60098201|NCT01045798|76214934|FG000|COMPLETED|Overall Study||4||
60098202|NCT01045798|76214935|FG001|COMPLETED|Overall Study||5||
60098203|NCT01045798|76214934|FG000|NOT COMPLETED|Overall Study||2||
60098204|NCT01045798|76214935|FG001|NOT COMPLETED|Overall Study||4||
60098205|NCT02156674|76214941|FG000|STARTED|Overall Study||1||
60098206|NCT02156674|76214941|FG000|COMPLETED|Overall Study||1||
59562972|NCT02354339|75665031|FG000|STARTED|Overall Study||12||
60098207|NCT02156674|76214941|FG000|NOT COMPLETED|Overall Study||0||
60098208|NCT01712984|76214948|FG000|STARTED|Overall Study||1672||
60098209|NCT01712984|76214949|FG001|STARTED|Overall Study||837||
60098210|NCT01712984|76214950|FG002|STARTED|Overall Study||846||
60098211|NCT01712984|76214948|FG000|COMPLETED|Overall Study||1656||
60098212|NCT01712984|76214949|FG001|COMPLETED|Overall Study||821||
59562973|NCT02354339|75665032|FG001|STARTED|Overall Study||12||
59993820|NCT02819635|76109728|FG008|STARTED|Substudy 1 and Substudy 2, Part 1||0||
59993821|NCT02819635|76109729|FG009|STARTED|Substudy 1 and Substudy 2, Part 1||0||
59993822|NCT02819635|76109730|FG010|STARTED|Substudy 1 and Substudy 2, Part 1||0||
59993823|NCT02819635|76109731|FG011|STARTED|Substudy 1 and Substudy 2, Part 1||0||
59993824|NCT02819635|76109720|FG000|COMPLETED|Substudy 1 and Substudy 2, Part 1||41||
59993825|NCT02819635|76109721|FG001|COMPLETED|Substudy 1 and Substudy 2, Part 1||45||
60098213|NCT01712984|76214950|FG002|COMPLETED|Overall Study||836||
60098214|NCT01712984|76214948|FG000|NOT COMPLETED|Overall Study||16||
60098215|NCT01712984|76214949|FG001|NOT COMPLETED|Overall Study||16||
59562974|NCT02354339|75665031|FG000|COMPLETED|Overall Study||12||
59562975|NCT02354339|75665032|FG001|COMPLETED|Overall Study||12||
59562976|NCT02354339|75665031|FG000|NOT COMPLETED|Overall Study||0||
59562977|NCT02354339|75665032|FG001|NOT COMPLETED|Overall Study||0||
59562978|NCT01747850|75665041|FG000|STARTED|Overall Study||5||
59562979|NCT01747850|75665042|FG001|STARTED|Overall Study||20||
59562980|NCT01747850|75665043|FG002|STARTED|Overall Study||20||
59562981|NCT01747850|75665041|FG000|COMPLETED|Overall Study||4||
59708177|NCT02865460|75826953|FG000|NOT COMPLETED|Overall Study||10||
60098216|NCT01712984|76214950|FG002|NOT COMPLETED|Overall Study||10||
59708178|NCT02865460|75826954|FG001|NOT COMPLETED|Overall Study||6||
60098217|NCT01042678|76214961|FG000|STARTED|Overall Study||6||
60098218|NCT01042678|76214962|FG001|STARTED|Overall Study||6||
60098219|NCT01042678|76214963|FG002|STARTED|Overall Study||6||
60098220|NCT01042678|76214964|FG003|STARTED|Overall Study||0||
60098221|NCT01042678|76214965|FG004|STARTED|Overall Study||0||
60098222|NCT01042678|76214966|FG005|STARTED|Overall Study||0||
60098223|NCT01042678|76214961|FG000|COMPLETED|Overall Study||5||
60098224|NCT01042678|76214962|FG001|COMPLETED|Overall Study||6||
60098225|NCT01042678|76214963|FG002|COMPLETED|Overall Study||6||
60098226|NCT01042678|76214964|FG003|COMPLETED|Overall Study||0||
60098227|NCT01042678|76214965|FG004|COMPLETED|Overall Study||0||
60098228|NCT01042678|76214966|FG005|COMPLETED|Overall Study||0||
60098229|NCT01042678|76214961|FG000|NOT COMPLETED|Overall Study||1||
60098230|NCT01042678|76214962|FG001|NOT COMPLETED|Overall Study||0||
60098231|NCT01042678|76214963|FG002|NOT COMPLETED|Overall Study||0||
59708179|NCT01206816|75826967|FG000|STARTED|Overall Study|Started=Treated|3||
59708180|NCT01206816|75826968|FG001|STARTED|Overall Study|Started=Treated|3||
60098232|NCT01042678|76214964|FG003|NOT COMPLETED|Overall Study||0||
60098233|NCT01042678|76214965|FG004|NOT COMPLETED|Overall Study||0||
60098234|NCT01042678|76214966|FG005|NOT COMPLETED|Overall Study||0||
59562982|NCT01747850|75665042|FG001|COMPLETED|Overall Study||13||
59562983|NCT01747850|75665043|FG002|COMPLETED|Overall Study||14||
59708181|NCT01206816|75826969|FG002|STARTED|Overall Study|Started=Treated|20||
59708182|NCT01206816|75826970|FG003|STARTED|Overall Study|Started=Treated|3||
60098235|NCT01042600|76214976|FG000|STARTED|Overall Study||31||
60098236|NCT01042600|76214977|FG001|STARTED|Overall Study||30||
60098237|NCT01042600|76214976|FG000|COMPLETED|Overall Study||30||
59708183|NCT01206816|75826971|FG004|STARTED|Overall Study|Started=Treated|3||
59708184|NCT01206816|75826972|FG005|STARTED|Overall Study|Started=Treated|19||
60098238|NCT01042600|76214977|FG001|COMPLETED|Overall Study||30||
60098239|NCT01042600|76214976|FG000|NOT COMPLETED|Overall Study||1||
59562984|NCT01747850|75665041|FG000|NOT COMPLETED|Overall Study||1||
59562985|NCT01747850|75665042|FG001|NOT COMPLETED|Overall Study||7||
59562986|NCT01747850|75665043|FG002|NOT COMPLETED|Overall Study||6||
59562987|NCT02046005|75665066|FG000|STARTED|Overall Study||80||
60098240|NCT01042600|76214977|FG001|NOT COMPLETED|Overall Study||0||
60098241|NCT01041976|76214986|FG000|STARTED|Overall Study||42||
60098242|NCT01041976|76214987|FG001|STARTED|Overall Study||42||
60098243|NCT01041976|76214986|FG000|6 Month Follow-up|Overall Study||39||
60098244|NCT01041976|76214987|FG001|6 Month Follow-up|Overall Study||41||
60098245|NCT01041976|76214986|FG000|12 Month Follow-up|Overall Study||37||
60098246|NCT01041976|76214987|FG001|12 Month Follow-up|Overall Study||38||
60098247|NCT01041976|76214986|FG000|18 Month Follow-up|Overall Study||37||
60098248|NCT01041976|76214987|FG001|18 Month Follow-up|Overall Study||38||
60098249|NCT01041976|76214986|FG000|COMPLETED|Overall Study||37||
60098250|NCT01041976|76214987|FG001|COMPLETED|Overall Study||38||
60098251|NCT01041976|76214986|FG000|NOT COMPLETED|Overall Study||5||
60098252|NCT01041976|76214987|FG001|NOT COMPLETED|Overall Study||4||
60098253|NCT00921310|76214995|FG000|STARTED|Overall Study||2||
60098254|NCT00921310|76214996|FG001|STARTED|Overall Study||6||
60098255|NCT00921310|76214997|FG002|STARTED|Overall Study||4||
60098256|NCT00921310|76214995|FG000|COMPLETED|Overall Study||2||
60098257|NCT00921310|76214996|FG001|COMPLETED|Overall Study||6||
60098258|NCT00921310|76214997|FG002|COMPLETED|Overall Study||4||
60098259|NCT00921310|76214995|FG000|NOT COMPLETED|Overall Study||0||
60098260|NCT00921310|76214996|FG001|NOT COMPLETED|Overall Study||0||
60098261|NCT00921310|76214997|FG002|NOT COMPLETED|Overall Study||0||
60098262|NCT01712516|76215013|FG000|STARTED|Overall Study||250||
60098263|NCT01712516|76215014|FG001|STARTED|Overall Study||251||
60098264|NCT01712516|76215015|FG002|STARTED|Overall Study||251||
60098265|NCT01712516|76215016|FG003|STARTED|Overall Study||249||
60098266|NCT01712516|76215013|FG000|Safety Set|Overall Study||250||
60098267|NCT01712516|76215014|FG001|Safety Set|Overall Study||251||
60098268|NCT01712516|76215015|FG002|Safety Set|Overall Study||251||
60098269|NCT01712516|76215016|FG003|Safety Set|Overall Study||248||
60098270|NCT01712516|76215013|FG000|Full Analysis Set|Overall Study||250||
60098271|NCT01712516|76215014|FG001|Full Analysis Set|Overall Study||251||
60098272|NCT01712516|76215015|FG002|Full Analysis Set|Overall Study||250||
60098273|NCT01712516|76215016|FG003|Full Analysis Set|Overall Study||247||
60098274|NCT01712516|76215013|FG000|COMPLETED|Overall Study||244||
60098275|NCT01712516|76215014|FG001|COMPLETED|Overall Study||241||
60098276|NCT01712516|76215015|FG002|COMPLETED|Overall Study||245||
60098277|NCT01712516|76215016|FG003|COMPLETED|Overall Study||236||
60098278|NCT01712516|76215013|FG000|NOT COMPLETED|Overall Study||6||
60098279|NCT01712516|76215014|FG001|NOT COMPLETED|Overall Study||10||
60098280|NCT01712516|76215015|FG002|NOT COMPLETED|Overall Study||6||
60098281|NCT01712516|76215016|FG003|NOT COMPLETED|Overall Study||13||
60098282|NCT01703000|76215026|FG000|STARTED|Overall Study||100||
60098283|NCT01703000|76215026|FG000|COMPLETED|Overall Study||99||
60098284|NCT01703000|76215026|FG000|NOT COMPLETED|Overall Study||1||
60098285|NCT01040728|76215030|FG000|STARTED|Overall Study||31||
60098286|NCT01040728|76215031|FG001|STARTED|Overall Study||30||
60098287|NCT01040728|76215032|FG002|STARTED|Overall Study||31||
60098288|NCT01040728|76215033|FG003|STARTED|Overall Study||30||
60098289|NCT01040728|76215030|FG000|COMPLETED|Overall Study||27||
60098290|NCT01040728|76215031|FG001|COMPLETED|Overall Study||19||
60098291|NCT01040728|76215032|FG002|COMPLETED|Overall Study||30||
60098292|NCT01040728|76215033|FG003|COMPLETED|Overall Study||24||
60098293|NCT01040728|76215030|FG000|NOT COMPLETED|Overall Study||4||
60098294|NCT01040728|76215031|FG001|NOT COMPLETED|Overall Study||11||
60098295|NCT01040728|76215032|FG002|NOT COMPLETED|Overall Study||1||
60098296|NCT01040728|76215033|FG003|NOT COMPLETED|Overall Study||6||
60098297|NCT01593020|76215051|FG000|STARTED|Overall Study||28||
60098298|NCT01593020|76215052|FG001|STARTED|Overall Study||23||
59562988|NCT02046005|75665067|FG001|STARTED|Overall Study||78||
59562989|NCT02046005|75665068|FG002|STARTED|Overall Study||80||
59708185|NCT01206816|75826973|FG006|STARTED|Overall Study|Started=Treated|6||
59708186|NCT01206816|75826967|FG000|COMPLETED|Overall Study||0||
59708187|NCT01206816|75826968|FG001|COMPLETED|Overall Study||0||
59562990|NCT02046005|75665066|FG000|COMPLETED|Overall Study||72||
59562991|NCT02046005|75665067|FG001|COMPLETED|Overall Study||71||
59562992|NCT02046005|75665068|FG002|COMPLETED|Overall Study||70||
59708188|NCT01206816|75826969|FG002|COMPLETED|Overall Study|1pt dist.due to 'Other AE' for vol& since 'other' from aftb.1pt 'PD' for vol& since,'DLT' from aftb|0||
59708189|NCT01206816|75826970|FG003|COMPLETED|Overall Study|1pt discontinue (dist.)due to 'PD' for vol.& since, 'Other AE' from aftb|0||
59708190|NCT01206816|75826971|FG004|COMPLETED|Overall Study||0||
59708191|NCT01206816|75826972|FG005|COMPLETED|Overall Study|1pt dist. due to 'PD' for vol & since, 'Other AE' from aftb|0||
59708192|NCT01206816|75826973|FG006|COMPLETED|Overall Study|1pt dist. due to 'other AE' & 1pt 'other' for vol & since,'PD' from aftb.|0||
59562993|NCT02046005|75665066|FG000|NOT COMPLETED|Overall Study||8||
59562994|NCT02046005|75665067|FG001|NOT COMPLETED|Overall Study||7||
59562995|NCT02046005|75665068|FG002|NOT COMPLETED|Overall Study||10||
59565966|NCT02303574|75668406|FG001|STARTED|Part 1b (Fed State) - SAD||0||
59562996|NCT01747928|75665084|FG000|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6||
59562997|NCT01747928|75665085|FG001|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6||
59562998|NCT01747928|75665086|FG002|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6||
59708193|NCT01206816|75826967|FG000|NOT COMPLETED|Overall Study||3||
60098299|NCT01593020|76215051|FG000|COMPLETED|Overall Study||26||
60098300|NCT01593020|76215052|FG001|COMPLETED|Overall Study||21||
60098301|NCT01593020|76215051|FG000|NOT COMPLETED|Overall Study||2||
60098302|NCT01593020|76215052|FG001|NOT COMPLETED|Overall Study||2||
60098303|NCT01040260|76215060|FG000|STARTED|Overall Study||53||
60098304|NCT01040260|76215061|FG001|STARTED|Overall Study||50||
60098305|NCT01040260|76215060|FG000|COMPLETED|Overall Study||38||
60098306|NCT01040260|76215061|FG001|COMPLETED|Overall Study||39||
60098307|NCT01040260|76215060|FG000|NOT COMPLETED|Overall Study||15||
60098308|NCT01040260|76215061|FG001|NOT COMPLETED|Overall Study||11||
60098309|NCT01712438|76215067|FG000|STARTED|Overall Study||110||
60098310|NCT01712438|76215067|FG000|SAF Population|Overall Study||108|SAF population = study population of patients in safety analysis|
60098311|NCT01712438|76215067|FG000|ITT Population|Overall Study||108|ITT population = intent-to-treat population|
60098312|NCT01712438|76215067|FG000|PP Population|Overall Study||95|PP Population = per-protocol population|
60098313|NCT01712438|76215067|FG000|PROPH Population|Overall Study||103|PROPH population = study population of patients receiving prophylaxis|
60098314|NCT01712438|76215067|FG000|BLEED Population|Overall Study||94|BLEED population = study population of Bleeding Events (BEs)|
60098315|NCT01712438|76215067|FG000|SURG Population|Overall Study||24|SURG population = study population of patients undergoing surgery treated with Human-cl rhFVIII|
60098316|NCT01712438|76215067|FG000|COMPLETED|Overall Study||73||
60098317|NCT01712438|76215067|FG000|NOT COMPLETED|Overall Study||37||
60098318|NCT01712204|76215078|FG000|STARTED|Overall Study||41||
59565967|NCT02303574|75668407|FG002|STARTED|Part 1b (Fed State) - SAD||0||
59708194|NCT01206816|75826968|FG001|NOT COMPLETED|Overall Study||3||
60098319|NCT01712204|76215079|FG001|STARTED|Overall Study||41||
60098320|NCT01712204|76215078|FG000|COMPLETED|Overall Study||33||
60098321|NCT01712204|76215079|FG001|COMPLETED|Overall Study||36||
60098322|NCT01712204|76215078|FG000|NOT COMPLETED|Overall Study||8||
60098323|NCT01712204|76215079|FG001|NOT COMPLETED|Overall Study||5||
60098324|NCT01592864|76215087|FG000|STARTED|Overall Study||60||
60098325|NCT01592864|76215088|FG001|STARTED|Overall Study||58||
60098326|NCT01592864|76215087|FG000|COMPLETED|Overall Study||60||
60098327|NCT01592864|76215088|FG001|COMPLETED|Overall Study||57||
60098328|NCT01592864|76215087|FG000|NOT COMPLETED|Overall Study||0||
60098329|NCT01592864|76215088|FG001|NOT COMPLETED|Overall Study||1||
59562999|NCT01747928|75665087|FG003|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6||
59563000|NCT01747928|75665088|FG004|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6||
60098330|NCT01592786|76215094|FG000|STARTED|Overall Study|Participants in the Safety Population are being presented.|903||
60098331|NCT01592786|76215094|FG000|COMPLETED|Overall Study||765||
60098332|NCT01592786|76215094|FG000|NOT COMPLETED|Overall Study||138||
60098333|NCT01711736|76215100|FG000|STARTED|Overall Study||299||
60098334|NCT01711736|76215101|FG001|STARTED|Overall Study||302||
60098335|NCT01711736|76215100|FG000|COMPLETED|Overall Study|Up to Day 180|287||
60098336|NCT01711736|76215101|FG001|COMPLETED|Overall Study|Up to Day 180|294||
60098337|NCT01711736|76215100|FG000|NOT COMPLETED|Overall Study||12||
60098338|NCT01711736|76215101|FG001|NOT COMPLETED|Overall Study||8||
60098339|NCT01592708|76215110|FG000|STARTED|Overall Study||96||
60098340|NCT01592708|76215111|FG001|STARTED|Overall Study||137||
60098341|NCT01592708|76215110|FG000|COMPLETED|Overall Study||93||
60098342|NCT01592708|76215111|FG001|COMPLETED|Overall Study||137||
60098343|NCT01592708|76215110|FG000|NOT COMPLETED|Overall Study||3||
60098344|NCT01592708|76215111|FG001|NOT COMPLETED|Overall Study||0||
60098345|NCT01042522|76215122|FG000|STARTED|Overall Study||31||
60098346|NCT01042522|76215123|FG001|STARTED|Overall Study||32||
60098347|NCT01042522|76215122|FG000|COMPLETED|Overall Study|Completed 6 cycles of protocol regimen|23||
60098348|NCT01042522|76215123|FG001|COMPLETED|Overall Study|Completed 4 cycles of protocol regimen|26||
60098349|NCT01042522|76215122|FG000|NOT COMPLETED|Overall Study||8||
60098350|NCT01042522|76215123|FG001|NOT COMPLETED|Overall Study||6||
60098351|NCT01702844|76215129|FG000|STARTED|Overall Study||42||
60098352|NCT01702844|76215129|FG000|Disease Progression|Overall Study||23||
60098353|NCT01702844|76215129|FG000|COMPLETED|Overall Study||23||
60098354|NCT01702844|76215129|FG000|NOT COMPLETED|Overall Study||19||
59993826|NCT02819635|76109722|FG002|COMPLETED|Substudy 1 and Substudy 2, Part 1||45||
59993827|NCT02819635|76109723|FG003|COMPLETED|Substudy 1 and Substudy 2, Part 1||105||
59563001|NCT01747928|75665089|FG005|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6||
59563002|NCT01747928|75665090|FG006|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6||
59563003|NCT01747928|75665091|FG007|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6||
59993828|NCT02819635|76109724|FG004|COMPLETED|Substudy 1 and Substudy 2, Part 1||113||
59993829|NCT02819635|76109725|FG005|COMPLETED|Substudy 1 and Substudy 2, Part 1||135||
59993830|NCT02819635|76109726|FG006|COMPLETED|Substudy 1 and Substudy 2, Part 1||306||
59993831|NCT02819635|76109727|FG007|COMPLETED|Substudy 1 and Substudy 2, Part 1||446||
59993832|NCT02819635|76109728|FG008|COMPLETED|Substudy 1 and Substudy 2, Part 1||0||
59993833|NCT02819635|76109729|FG009|COMPLETED|Substudy 1 and Substudy 2, Part 1||0||
59993834|NCT02819635|76109730|FG010|COMPLETED|Substudy 1 and Substudy 2, Part 1||0||
60098355|NCT01702532|76215135|FG000|STARTED|Overall Study||161||
60098356|NCT01702532|76215136|FG001|STARTED|Overall Study||161||
60098357|NCT01702532|76215135|FG000|Safety Population|Overall Study||161||
60098358|NCT01702532|76215136|FG001|Safety Population|Overall Study|One subject randomized but did not receive the study treatment.|160||
60098359|NCT01702532|76215135|FG000|COMPLETED|Overall Study||161||
60098360|NCT01702532|76215136|FG001|COMPLETED|Overall Study||160||
60098361|NCT01702532|76215135|FG000|NOT COMPLETED|Overall Study||0||
60098362|NCT01702532|76215136|FG001|NOT COMPLETED|Overall Study||1||
60098363|NCT01702454|76215145|FG000|STARTED|Overall Study||241||
60098364|NCT01702454|76215146|FG001|STARTED|Overall Study||229||
60098365|NCT01702454|76215145|FG000|COMPLETED|Overall Study||238||
60098366|NCT01702454|76215146|FG001|COMPLETED|Overall Study||221||
59563004|NCT01747928|75665084|FG000|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6||
59563005|NCT01747928|75665085|FG001|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6||
59563006|NCT01747928|75665086|FG002|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6||
59563007|NCT01747928|75665087|FG003|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6||
59563008|NCT01747928|75665088|FG004|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6||
59563009|NCT01747928|75665089|FG005|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6||
59993835|NCT02819635|76109731|FG011|COMPLETED|Substudy 1 and Substudy 2, Part 1||0||
59993836|NCT02819635|76109720|FG000|NOT COMPLETED|Substudy 1 and Substudy 2, Part 1||5||
59993837|NCT02819635|76109721|FG001|NOT COMPLETED|Substudy 1 and Substudy 2, Part 1||2||
59993838|NCT02819635|76109722|FG002|NOT COMPLETED|Substudy 1 and Substudy 2, Part 1||4||
60098367|NCT01702454|76215145|FG000|NOT COMPLETED|Overall Study||3||
60098368|NCT01702454|76215146|FG001|NOT COMPLETED|Overall Study||8||
60098369|NCT00921934|76215155|FG000|STARTED|Overall Study||68||
59563010|NCT01747928|75665090|FG006|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6||
59563011|NCT01747928|75665091|FG007|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6||
59563012|NCT01747928|75665084|FG000|NOT COMPLETED|Overall Study||0||
59563013|NCT01747928|75665085|FG001|NOT COMPLETED|Overall Study||0||
59563014|NCT01747928|75665086|FG002|NOT COMPLETED|Overall Study||0||
59563015|NCT01747928|75665087|FG003|NOT COMPLETED|Overall Study||0||
59563016|NCT01747928|75665088|FG004|NOT COMPLETED|Overall Study||0||
59563017|NCT01747928|75665089|FG005|NOT COMPLETED|Overall Study||0||
59563018|NCT01747928|75665090|FG006|NOT COMPLETED|Overall Study||0||
59563019|NCT01747928|75665091|FG007|NOT COMPLETED|Overall Study||0||
59563020|NCT02046317|75665112|FG000|STARTED|Overall Study||4||
59708195|NCT01206816|75826969|FG002|NOT COMPLETED|Overall Study||20||
59708196|NCT01206816|75826970|FG003|NOT COMPLETED|Overall Study||3||
59993839|NCT02819635|76109723|FG003|NOT COMPLETED|Substudy 1 and Substudy 2, Part 1||12||
59993840|NCT02819635|76109724|FG004|NOT COMPLETED|Substudy 1 and Substudy 2, Part 1||10||
59993841|NCT02819635|76109725|FG005|NOT COMPLETED|Substudy 1 and Substudy 2, Part 1||20||
59993842|NCT02819635|76109726|FG006|NOT COMPLETED|Substudy 1 and Substudy 2, Part 1||13||
59993843|NCT02819635|76109727|FG007|NOT COMPLETED|Substudy 1 and Substudy 2, Part 1||0||
59993844|NCT02819635|76109728|FG008|NOT COMPLETED|Substudy 1 and Substudy 2, Part 1||0||
59993845|NCT02819635|76109729|FG009|NOT COMPLETED|Substudy 1 and Substudy 2, Part 1||0||
59993846|NCT02819635|76109730|FG010|NOT COMPLETED|Substudy 1 and Substudy 2, Part 1||0||
59993847|NCT02819635|76109731|FG011|NOT COMPLETED|Substudy 1 and Substudy 2, Part 1||0||
59993848|NCT02819635|76109720|FG000|STARTED|Substudy 2, Part 2||0||
59993849|NCT02819635|76109721|FG001|STARTED|Substudy 2, Part 2||0||
59993850|NCT02819635|76109722|FG002|STARTED|Substudy 2, Part 2||0||
59993851|NCT02819635|76109723|FG003|STARTED|Substudy 2, Part 2||0||
59993852|NCT02819635|76109724|FG004|STARTED|Substudy 2, Part 2||0||
59993853|NCT02819635|76109725|FG005|STARTED|Substudy 2, Part 2||85||
59708197|NCT01206816|75826971|FG004|NOT COMPLETED|Overall Study||3||
59993854|NCT02819635|76109726|FG006|STARTED|Substudy 2, Part 2||59||
59993855|NCT02819635|76109727|FG007|STARTED|Substudy 2, Part 2||0||
59993856|NCT02819635|76109728|FG008|STARTED|Substudy 2, Part 2||0||
60098370|NCT00921934|76215155|FG000|COMPLETED|Overall Study||68||
60098371|NCT00921934|76215155|FG000|NOT COMPLETED|Overall Study||0||
59993857|NCT02819635|76109729|FG009|STARTED|Substudy 2, Part 2||0||
59993858|NCT02819635|76109730|FG010|STARTED|Substudy 2, Part 2||0||
59993859|NCT02819635|76109731|FG011|STARTED|Substudy 2, Part 2||0||
59993860|NCT02819635|76109720|FG000|COMPLETED|Substudy 2, Part 2||0||
59993861|NCT02819635|76109721|FG001|COMPLETED|Substudy 2, Part 2||0||
59993862|NCT02819635|76109722|FG002|COMPLETED|Substudy 2, Part 2||0||
59993863|NCT02819635|76109723|FG003|COMPLETED|Substudy 2, Part 2||0||
59993864|NCT02819635|76109724|FG004|COMPLETED|Substudy 2, Part 2||0||
59993865|NCT02819635|76109725|FG005|COMPLETED|Substudy 2, Part 2||74||
59993866|NCT02819635|76109726|FG006|COMPLETED|Substudy 2, Part 2||47||
59993867|NCT02819635|76109727|FG007|COMPLETED|Substudy 2, Part 2||0||
59993868|NCT02819635|76109728|FG008|COMPLETED|Substudy 2, Part 2||0||
59993869|NCT02819635|76109729|FG009|COMPLETED|Substudy 2, Part 2||0||
59993870|NCT02819635|76109730|FG010|COMPLETED|Substudy 2, Part 2||0||
59993871|NCT02819635|76109731|FG011|COMPLETED|Substudy 2, Part 2||0||
59993872|NCT02819635|76109720|FG000|NOT COMPLETED|Substudy 2, Part 2||0||
59993873|NCT02819635|76109721|FG001|NOT COMPLETED|Substudy 2, Part 2||0||
59993874|NCT02819635|76109722|FG002|NOT COMPLETED|Substudy 2, Part 2||0||
59993875|NCT02819635|76109723|FG003|NOT COMPLETED|Substudy 2, Part 2||0||
59993876|NCT02819635|76109724|FG004|NOT COMPLETED|Substudy 2, Part 2||0||
59993877|NCT02819635|76109725|FG005|NOT COMPLETED|Substudy 2, Part 2||11||
59993878|NCT02819635|76109726|FG006|NOT COMPLETED|Substudy 2, Part 2||12||
59993879|NCT02819635|76109727|FG007|NOT COMPLETED|Substudy 2, Part 2||0||
60098372|NCT01702298|76215159|FG000|STARTED|Overall Study||42||
60098373|NCT01702298|76215159|FG000|COMPLETED|Overall Study||41||
60098374|NCT01702298|76215159|FG000|NOT COMPLETED|Overall Study||1||
60098375|NCT01701362|76215165|FG000|STARTED|Overall Study||275||
60098376|NCT01701362|76215166|FG001|STARTED|Overall Study||267||
60098377|NCT01701362|76215165|FG000|TREATED|Overall Study||274||
60098378|NCT01701362|76215166|FG001|TREATED|Overall Study||265||
60098379|NCT01701362|76215165|FG000|COMPLETED|Overall Study||233||
60098380|NCT01701362|76215166|FG001|COMPLETED|Overall Study||211||
60098381|NCT01701362|76215165|FG000|NOT COMPLETED|Overall Study||42||
60098382|NCT01701362|76215166|FG001|NOT COMPLETED|Overall Study||56||
60098383|NCT03159195|76215174|FG000|STARTED|Overall Study||360||
60098384|NCT03159195|76215175|FG001|STARTED|Overall Study||292||
60098385|NCT03159195|76215174|FG000|COMPLETED|Overall Study||360||
60098386|NCT03159195|76215175|FG001|COMPLETED|Overall Study||292||
60098387|NCT03159195|76215174|FG000|NOT COMPLETED|Overall Study||0||
60098388|NCT03159195|76215175|FG001|NOT COMPLETED|Overall Study||0||
60098389|NCT00919126|76215184|FG000|STARTED|Overall Study||32||
60098390|NCT00919126|76215185|FG001|STARTED|Overall Study||37||
60098391|NCT00919126|76215186|FG002|STARTED|Overall Study||33||
60098392|NCT00919126|76215184|FG000|COMPLETED|Overall Study||31||
60098393|NCT00919126|76215185|FG001|COMPLETED|Overall Study||32||
60098394|NCT00919126|76215186|FG002|COMPLETED|Overall Study||32||
60098395|NCT00919126|76215184|FG000|NOT COMPLETED|Overall Study||1||
60098396|NCT00919126|76215185|FG001|NOT COMPLETED|Overall Study||5||
60098397|NCT00919126|76215186|FG002|NOT COMPLETED|Overall Study||1||
60098398|NCT01710800|76215195|FG000|STARTED|Overall Study|63 patients consented to be part of the study|63||
60098399|NCT01710800|76215195|FG000|Received PPI Intervention|Overall Study||44||
60098400|NCT01710800|76215195|FG000|Received Placebo Intervention|Overall Study||45||
60098401|NCT01710800|76215195|FG000|COMPLETED|Overall Study|22 drop outs(consented but did not participate, refused 2nd intervention)|41||
60098402|NCT01710800|76215195|FG000|NOT COMPLETED|Overall Study||22||
60098403|NCT01710020|76215201|FG000|STARTED|Period 1||12||
60098404|NCT01710020|76215201|FG000|COMPLETED|Period 1||11||
60098405|NCT01710020|76215201|FG000|NOT COMPLETED|Period 1||1||
59993880|NCT02819635|76109728|FG008|NOT COMPLETED|Substudy 2, Part 2||0||
59993881|NCT02819635|76109729|FG009|NOT COMPLETED|Substudy 2, Part 2||0||
59993882|NCT02819635|76109730|FG010|NOT COMPLETED|Substudy 2, Part 2||0||
59993883|NCT02819635|76109731|FG011|NOT COMPLETED|Substudy 2, Part 2||0||
59993884|NCT02819635|76109720|FG000|STARTED|Substudy 3||0||
59993885|NCT02819635|76109721|FG001|STARTED|Substudy 3||0||
59993886|NCT02819635|76109722|FG002|STARTED|Substudy 3||0||
59993887|NCT02819635|76109723|FG003|STARTED|Substudy 3||0||
59993888|NCT02819635|76109724|FG004|STARTED|Substudy 3||0||
59993889|NCT02819635|76109725|FG005|STARTED|Substudy 3||0||
59993890|NCT02819635|76109726|FG006|STARTED|Substudy 3||0||
59993891|NCT02819635|76109727|FG007|STARTED|Substudy 3||0||
60098406|NCT01710020|76215201|FG000|STARTED|Washout Period (at Least 14 Days)||11||
60098407|NCT01710020|76215201|FG000|COMPLETED|Washout Period (at Least 14 Days)||11||
60098408|NCT01710020|76215201|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0||
60098409|NCT01710020|76215201|FG000|STARTED|Period 2||11||
60098410|NCT01710020|76215201|FG000|COMPLETED|Period 2||11||
60098411|NCT01710020|76215201|FG000|NOT COMPLETED|Period 2||0||
60098412|NCT01700348|76215207|FG000|STARTED|Overall Study||116||
60098413|NCT01700348|76215207|FG000|COMPLETED|Overall Study||93||
60098414|NCT01700348|76215207|FG000|NOT COMPLETED|Overall Study||23||
60098415|NCT01700192|76215215|FG000|STARTED|Overall Study||741||
60098416|NCT01700192|76215216|FG001|STARTED|Overall Study||741||
60098417|NCT01700192|76215215|FG000|Treated|Overall Study||740||
60098418|NCT01700192|76215216|FG001|Treated|Overall Study||741||
60098419|NCT01700192|76215215|FG000|All Participants as Treated (APaT)|Overall Study|Three participants randomized to receive placebo were given MK-8237 12 DU.|743||
60098420|NCT01700192|76215216|FG001|All Participants as Treated (APaT)|Overall Study|Three participants randomized to receive placebo were given MK-8237 12 DU.|738||
60098421|NCT01700192|76215215|FG000|COMPLETED|Overall Study||561||
60098422|NCT01700192|76215216|FG001|COMPLETED|Overall Study||613||
60098423|NCT01700192|76215215|FG000|NOT COMPLETED|Overall Study||180||
60098424|NCT01700192|76215216|FG001|NOT COMPLETED|Overall Study||128||
60098425|NCT00924118|76215224|FG000|STARTED|Overall Study||15||
60098426|NCT00924118|76215225|FG001|STARTED|Overall Study||15||
60098427|NCT00924118|76215224|FG000|COMPLETED|Overall Study||15||
60098428|NCT00924118|76215225|FG001|COMPLETED|Overall Study||15||
60098429|NCT00924118|76215224|FG000|NOT COMPLETED|Overall Study||0||
60098430|NCT00924118|76215225|FG001|NOT COMPLETED|Overall Study||0||
60098431|NCT01709864|76215233|FG000|STARTED|Overall Study||222||
60098432|NCT01709864|76215234|FG001|STARTED|Overall Study||219||
60098433|NCT01709864|76215233|FG000|Full Analysis Set (FAS)|Overall Study|FAS included all randomized patients who received at least one dose of trial drug.|222||
60098434|NCT01709864|76215234|FG001|Full Analysis Set (FAS)|Overall Study|FAS included all randomized patients who received at least one dose of trial drug.|216||
60098435|NCT01709864|76215233|FG000|Per Protocol Set (PPS)|Overall Study|PPS included all patients in the FAS who did not have any major protocol deviations.|204||
60098436|NCT01709864|76215234|FG001|Per Protocol Set (PPS)|Overall Study|PPS included all patients in the FAS who did not have any major protocol deviations.|201||
60098437|NCT01709864|76215233|FG000|COMPLETED|Overall Study||215||
60098438|NCT01709864|76215234|FG001|COMPLETED|Overall Study||208||
60098439|NCT01709864|76215233|FG000|NOT COMPLETED|Overall Study||7||
60098440|NCT01709864|76215234|FG001|NOT COMPLETED|Overall Study||11||
60098441|NCT01709708|76215242|FG000|STARTED|Overall Study||27||
60098442|NCT01709708|76215243|FG001|STARTED|Overall Study||14||
60098443|NCT01709708|76215242|FG000|COMPLETED|Overall Study||26||
60098444|NCT01709708|76215243|FG001|COMPLETED|Overall Study||12||
60098445|NCT01709708|76215242|FG000|NOT COMPLETED|Overall Study||1||
60098446|NCT01709708|76215243|FG001|NOT COMPLETED|Overall Study||2||
60098447|NCT00920374|76215252|FG000|STARTED|Overall Study||61||
60098448|NCT00920374|76215253|FG001|STARTED|Overall Study||57||
60098449|NCT00920374|76215252|FG000|COMPLETED|Overall Study||61||
60098450|NCT00920374|76215253|FG001|COMPLETED|Overall Study||57||
60098451|NCT00920374|76215252|FG000|NOT COMPLETED|Overall Study||0||
60098452|NCT00920374|76215253|FG001|NOT COMPLETED|Overall Study||0||
60098453|NCT01709318|76215266|FG000|STARTED|Overall Study||82||
60098454|NCT01709318|76215267|FG001|STARTED|Overall Study||85||
60098455|NCT01709318|76215268|FG002|STARTED|Overall Study||77||
60098456|NCT01709318|76215269|FG003|STARTED|Overall Study||78||
60098457|NCT01709318|76215270|FG004|STARTED|Overall Study||78||
59563021|NCT02046317|75665113|FG001|STARTED|Overall Study||8||
59563022|NCT02046317|75665112|FG000|COMPLETED|Overall Study||4||
59708198|NCT01206816|75826972|FG005|NOT COMPLETED|Overall Study||19||
60098458|NCT01709318|76215271|FG005|STARTED|Overall Study||84||
60098459|NCT01709318|76215272|FG006|STARTED|Overall Study||182||
60098460|NCT01709318|76215266|FG000|Treated|Overall Study||79||
60098461|NCT01709318|76215267|FG001|Treated|Overall Study||85||
60098462|NCT01709318|76215268|FG002|Treated|Overall Study||78||
60098463|NCT01709318|76215269|FG003|Treated|Overall Study||77||
60098464|NCT01709318|76215270|FG004|Treated|Overall Study||77||
60098465|NCT01709318|76215271|FG005|Treated|Overall Study||86||
60098466|NCT01709318|76215272|FG006|Treated|Overall Study||178||
60098467|NCT01709318|76215266|FG000|COMPLETED|Overall Study||73||
60098468|NCT01709318|76215267|FG001|COMPLETED|Overall Study||78||
60098469|NCT01709318|76215268|FG002|COMPLETED|Overall Study||71||
60098470|NCT01709318|76215269|FG003|COMPLETED|Overall Study||72||
60098471|NCT01709318|76215270|FG004|COMPLETED|Overall Study||74||
60098472|NCT01709318|76215271|FG005|COMPLETED|Overall Study||80||
60098473|NCT01709318|76215272|FG006|COMPLETED|Overall Study||171||
60098474|NCT01709318|76215266|FG000|NOT COMPLETED|Overall Study||9||
60098475|NCT01709318|76215267|FG001|NOT COMPLETED|Overall Study||7||
60098476|NCT01709318|76215268|FG002|NOT COMPLETED|Overall Study||6||
59708199|NCT01206816|75826973|FG006|NOT COMPLETED|Overall Study||6||
60098477|NCT01709318|76215269|FG003|NOT COMPLETED|Overall Study||6||
60098478|NCT01709318|76215270|FG004|NOT COMPLETED|Overall Study||4||
59563023|NCT02046317|75665113|FG001|COMPLETED|Overall Study||8||
59708200|NCT01206582|75826995|FG000|STARTED|Overall Study||11||
59708201|NCT01206582|75826996|FG001|STARTED|Overall Study||9||
59708202|NCT01206582|75826995|FG000|COMPLETED|Overall Study||9||
59708203|NCT01206582|75826996|FG001|COMPLETED|Overall Study||7||
60098479|NCT01709318|76215271|FG005|NOT COMPLETED|Overall Study||4||
60098480|NCT01709318|76215272|FG006|NOT COMPLETED|Overall Study||11||
60098481|NCT01699178|76215290|FG000|STARTED|Overall Study||88||
60098482|NCT01699178|76215291|FG001|STARTED|Overall Study||94||
60098483|NCT01699178|76215290|FG000|COMPLETED|Overall Study||69||
60098484|NCT01699178|76215291|FG001|COMPLETED|Overall Study||62||
60098485|NCT01699178|76215290|FG000|NOT COMPLETED|Overall Study||19||
59563024|NCT02046317|75665112|FG000|NOT COMPLETED|Overall Study||0||
59563025|NCT02046317|75665113|FG001|NOT COMPLETED|Overall Study||0||
59563026|NCT02355275|75665119|FG000|STARTED|Overall Study||22||
59563027|NCT02355275|75665119|FG000|COMPLETED|Overall Study||14||
59563028|NCT02355275|75665119|FG000|NOT COMPLETED|Overall Study||8||
59563029|NCT01724060|75665131|FG000|STARTED|Overall Study||10||
60098486|NCT01699178|76215291|FG001|NOT COMPLETED|Overall Study||32||
60098487|NCT01683409|76215302|FG000|STARTED|Treatment Period (Weeks 1-24)||27||
60098488|NCT01683409|76215303|FG001|STARTED|Treatment Period (Weeks 1-24)||25||
59563030|NCT01724060|75665132|FG001|STARTED|Overall Study||10||
59563031|NCT01724060|75665133|FG002|STARTED|Overall Study||10||
59563032|NCT01724060|75665134|FG003|STARTED|Overall Study||10||
59563033|NCT01724060|75665135|FG004|STARTED|Overall Study||10||
60098489|NCT01683409|76215304|FG002|STARTED|Treatment Period (Weeks 1-24)||27||
60098490|NCT01683409|76215305|FG003|STARTED|Treatment Period (Weeks 1-24)||26||
59563034|NCT01724060|75665136|FG005|STARTED|Overall Study||10||
59563035|NCT01724060|75665137|FG006|STARTED|Overall Study||10||
59563036|NCT01724060|75665138|FG007|STARTED|Overall Study||10||
59563037|NCT01724060|75665131|FG000|COMPLETED|Overall Study||10||
59563038|NCT01724060|75665132|FG001|COMPLETED|Overall Study||10||
59563039|NCT01724060|75665133|FG002|COMPLETED|Overall Study||10||
59563040|NCT01724060|75665134|FG003|COMPLETED|Overall Study||10||
59563041|NCT01724060|75665135|FG004|COMPLETED|Overall Study||10||
59563042|NCT01724060|75665136|FG005|COMPLETED|Overall Study||10||
59563043|NCT01724060|75665137|FG006|COMPLETED|Overall Study||10||
59563044|NCT01724060|75665138|FG007|COMPLETED|Overall Study||10||
59563045|NCT01724060|75665131|FG000|NOT COMPLETED|Overall Study||0||
59563046|NCT01724060|75665132|FG001|NOT COMPLETED|Overall Study||0||
59563047|NCT01724060|75665133|FG002|NOT COMPLETED|Overall Study||0||
59563048|NCT01724060|75665134|FG003|NOT COMPLETED|Overall Study||0||
59563049|NCT01724060|75665135|FG004|NOT COMPLETED|Overall Study||0||
59563050|NCT01724060|75665136|FG005|NOT COMPLETED|Overall Study||0||
59563051|NCT01724060|75665137|FG006|NOT COMPLETED|Overall Study||0||
59563052|NCT01724060|75665138|FG007|NOT COMPLETED|Overall Study||0||
59563053|NCT02046863|75665156|FG000|STARTED|Overall Study||7||
59563054|NCT02046863|75665156|FG000|COMPLETED|Overall Study||7||
59563055|NCT02046863|75665156|FG000|NOT COMPLETED|Overall Study||0||
59563056|NCT01727180|75665160|FG000|STARTED|Overall Study||108||
59563057|NCT01727180|75665160|FG000|COMPLETED|Overall Study||108||
59563058|NCT01727180|75665160|FG000|NOT COMPLETED|Overall Study||0||
59563059|NCT02046941|75665164|FG000|STARTED|Overall Study||17||
59708204|NCT01206582|75826995|FG000|NOT COMPLETED|Overall Study||2||
60098491|NCT01683409|76215306|FG004|STARTED|Treatment Period (Weeks 1-24)||25||
60098492|NCT01683409|76215302|FG000|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||27||
60098493|NCT01683409|76215303|FG001|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||25||
59563060|NCT02046941|75665164|FG000|COMPLETED|Overall Study||10||
59563061|NCT02046941|75665164|FG000|NOT COMPLETED|Overall Study||7||
59563062|NCT01727414|75665170|FG000|STARTED|Overall Study||126||
59563063|NCT01727414|75665171|FG001|STARTED|Overall Study||45||
59563064|NCT01727414|75665170|FG000|COMPLETED|Overall Study||123||
59563065|NCT01727414|75665171|FG001|COMPLETED|Overall Study||45||
59563066|NCT01727414|75665170|FG000|NOT COMPLETED|Overall Study||3||
59563067|NCT01727414|75665171|FG001|NOT COMPLETED|Overall Study||0||
59563068|NCT02047643|75665177|FG000|STARTED|Overall Study||9||
60098494|NCT01683409|76215304|FG002|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||26||
59563069|NCT02047643|75665178|FG001|STARTED|Overall Study||9||
59563070|NCT02047643|75665177|FG000|COMPLETED|Overall Study||9||
59563071|NCT02047643|75665178|FG001|COMPLETED|Overall Study||9||
59563072|NCT02047643|75665177|FG000|NOT COMPLETED|Overall Study||0||
59563073|NCT02047643|75665178|FG001|NOT COMPLETED|Overall Study||0||
59563074|NCT02048891|75665186|FG000|STARTED|Overall Study||2||
60098495|NCT01683409|76215305|FG003|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||26||
60098496|NCT01683409|76215306|FG004|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||25||
60098497|NCT01683409|76215302|FG000|COMPLETED|Treatment Period (Weeks 1-24)||27||
60098498|NCT01683409|76215303|FG001|COMPLETED|Treatment Period (Weeks 1-24)||21||
60098499|NCT01683409|76215304|FG002|COMPLETED|Treatment Period (Weeks 1-24)||26||
60098500|NCT01683409|76215305|FG003|COMPLETED|Treatment Period (Weeks 1-24)||24||
60098501|NCT01683409|76215306|FG004|COMPLETED|Treatment Period (Weeks 1-24)||23||
60098502|NCT01683409|76215302|FG000|NOT COMPLETED|Treatment Period (Weeks 1-24)||0||
60098503|NCT01683409|76215303|FG001|NOT COMPLETED|Treatment Period (Weeks 1-24)||4||
60098504|NCT01683409|76215304|FG002|NOT COMPLETED|Treatment Period (Weeks 1-24)||1||
60098505|NCT01683409|76215305|FG003|NOT COMPLETED|Treatment Period (Weeks 1-24)||2||
60098506|NCT01683409|76215306|FG004|NOT COMPLETED|Treatment Period (Weeks 1-24)||2||
60098507|NCT01683409|76215302|FG000|STARTED|Washout Period 1 (Weeks 25-28)||27||
60098508|NCT01683409|76215303|FG001|STARTED|Washout Period 1 (Weeks 25-28)||21||
60098509|NCT01683409|76215304|FG002|STARTED|Washout Period 1 (Weeks 25-28)||26||
60098510|NCT01683409|76215305|FG003|STARTED|Washout Period 1 (Weeks 25-28)||24||
60098511|NCT01683409|76215306|FG004|STARTED|Washout Period 1 (Weeks 25-28)||23||
60098512|NCT01683409|76215302|FG000|COMPLETED|Washout Period 1 (Weeks 25-28)||24||
60098513|NCT01683409|76215303|FG001|COMPLETED|Washout Period 1 (Weeks 25-28)||17||
60098514|NCT01683409|76215304|FG002|COMPLETED|Washout Period 1 (Weeks 25-28)||25||
60098515|NCT01683409|76215305|FG003|COMPLETED|Washout Period 1 (Weeks 25-28)||22||
59563075|NCT02048891|75665187|FG001|STARTED|Overall Study||1||
59563076|NCT02048891|75665186|FG000|COMPLETED|Overall Study||2||
59563077|NCT02048891|75665187|FG001|COMPLETED|Overall Study||1||
59563078|NCT02048891|75665186|FG000|NOT COMPLETED|Overall Study||0||
59708205|NCT01206582|75826996|FG001|NOT COMPLETED|Overall Study||2||
59708206|NCT01259102|75827007|FG000|STARTED|Overall Study||13||
59708207|NCT01259102|75827008|FG001|STARTED|Overall Study||14||
59816999|NCT02162810|75939406|FG000|NOT COMPLETED|Overall Study||5||
60098516|NCT01683409|76215306|FG004|COMPLETED|Washout Period 1 (Weeks 25-28)||20||
60098517|NCT01683409|76215302|FG000|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||3||
60098518|NCT01683409|76215303|FG001|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||4||
60098519|NCT01683409|76215304|FG002|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||1||
60098520|NCT01683409|76215305|FG003|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||2||
60098521|NCT01683409|76215306|FG004|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||3||
60098522|NCT01683409|76215302|FG000|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 18 participants.|6||
60098523|NCT01683409|76215303|FG001|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 11 participants.|6||
60098524|NCT01683409|76215304|FG002|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 17 participants.|8||
60098525|NCT01683409|76215305|FG003|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 16 participants.|6||
59563079|NCT02048891|75665187|FG001|NOT COMPLETED|Overall Study||0||
59563080|NCT01727726|75665196|FG000|STARTED|Overall Study||197||
59563081|NCT01727726|75665197|FG001|STARTED|Overall Study||100||
59708208|NCT01259102|75827009|FG002|STARTED|Overall Study||15||
59708209|NCT01259102|75827010|FG003|STARTED|Overall Study||14||
59708210|NCT01259102|75827011|FG004|STARTED|Overall Study||14||
59708211|NCT01259102|75827007|FG000|COMPLETED|Overall Study||12||
59708212|NCT01259102|75827008|FG001|COMPLETED|Overall Study||14||
59708213|NCT01259102|75827009|FG002|COMPLETED|Overall Study||13||
59563082|NCT01727726|75665198|FG002|STARTED|Overall Study||206||
59563083|NCT01727726|75665196|FG000|COMPLETED|Overall Study||171||
59563084|NCT01727726|75665197|FG001|COMPLETED|Overall Study||86||
59563085|NCT01727726|75665198|FG002|COMPLETED|Overall Study||186||
59563086|NCT01727726|75665196|FG000|NOT COMPLETED|Overall Study||26||
59563087|NCT01727726|75665197|FG001|NOT COMPLETED|Overall Study||14||
59563088|NCT01727726|75665198|FG002|NOT COMPLETED|Overall Study||20||
59563089|NCT02355821|75665208|FG000|STARTED|Overall Study||57||
59563090|NCT02355821|75665209|FG001|STARTED|Overall Study||57||
59563091|NCT02355821|75665208|FG000|COMPLETED|Overall Study||57||
59563092|NCT02355821|75665209|FG001|COMPLETED|Overall Study||57||
59708214|NCT01259102|75827010|FG003|COMPLETED|Overall Study||12||
60098526|NCT01683409|76215306|FG004|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 8 participants.|12||
60098527|NCT01683409|76215302|FG000|COMPLETED|Washout Period 2 (Weeks 29-32)||6||
60098528|NCT01683409|76215303|FG001|COMPLETED|Washout Period 2 (Weeks 29-32)||6||
60098529|NCT01683409|76215304|FG002|COMPLETED|Washout Period 2 (Weeks 29-32)||7||
60098530|NCT01683409|76215305|FG003|COMPLETED|Washout Period 2 (Weeks 29-32)||6||
60098531|NCT01683409|76215306|FG004|COMPLETED|Washout Period 2 (Weeks 29-32)||9||
60098532|NCT01683409|76215302|FG000|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||0||
59708215|NCT01259102|75827011|FG004|COMPLETED|Overall Study||13||
59817000|NCT02162810|75939407|FG001|NOT COMPLETED|Overall Study||1||
59708216|NCT01259102|75827007|FG000|NOT COMPLETED|Overall Study||1||
59563093|NCT02355821|75665208|FG000|NOT COMPLETED|Overall Study||0||
59563094|NCT02355821|75665209|FG001|NOT COMPLETED|Overall Study||0||
59563095|NCT02252744|75665215|FG000|STARTED|Overall Study||286||
59563096|NCT02252744|75665215|FG000|COMPLETED|Overall Study||286||
59563097|NCT02252744|75665215|FG000|NOT COMPLETED|Overall Study||0||
59563098|NCT01748240|75665219|FG000|STARTED|Overall Study||21||
59817001|NCT02040857|75939413|FG000|STARTED|Overall Study||162||
59993892|NCT02819635|76109728|FG008|STARTED|Substudy 3||386||
59993893|NCT02819635|76109729|FG009|STARTED|Substudy 3||20||
59993894|NCT02819635|76109730|FG010|STARTED|Substudy 3||324||
59993895|NCT02819635|76109731|FG011|STARTED|Substudy 3||316||
59993896|NCT02819635|76109720|FG000|COMPLETED|Substudy 3||0||
59993897|NCT02819635|76109721|FG001|COMPLETED|Substudy 3||0||
59993898|NCT02819635|76109722|FG002|COMPLETED|Substudy 3||0||
59993899|NCT02819635|76109723|FG003|COMPLETED|Substudy 3||0||
60098533|NCT01683409|76215303|FG001|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||0||
60098534|NCT01683409|76215304|FG002|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||1||
60098535|NCT01683409|76215305|FG003|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||0||
60098536|NCT01683409|76215306|FG004|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||3||
60098537|NCT01699022|76215332|FG000|STARTED|Overall Study||17||
60098538|NCT01699022|76215332|FG000|COMPLETED|Overall Study||14||
60098539|NCT01699022|76215332|FG000|NOT COMPLETED|Overall Study||3||
60098540|NCT01683019|76215340|FG000|STARTED|Overall Study||18||
60098541|NCT01683019|76215341|FG001|STARTED|Overall Study||15||
60098542|NCT01683019|76215342|FG002|STARTED|Overall Study||19||
60098543|NCT01683019|76215340|FG000|COMPLETED|Overall Study||16||
60098544|NCT01683019|76215341|FG001|COMPLETED|Overall Study||14||
60098545|NCT01683019|76215342|FG002|COMPLETED|Overall Study||15||
60098546|NCT01683019|76215340|FG000|NOT COMPLETED|Overall Study||2||
60098547|NCT01683019|76215341|FG001|NOT COMPLETED|Overall Study||1||
60098548|NCT01683019|76215342|FG002|NOT COMPLETED|Overall Study||4||
60098549|NCT01709162|76215352|FG000|STARTED|Overall Study|Randomized|18||
60098550|NCT01709162|76215353|FG001|STARTED|Overall Study|Randomized|5||
60098551|NCT01709162|76215352|FG000|Received Treatment|Overall Study||18||
60098552|NCT01709162|76215353|FG001|Received Treatment|Overall Study||4||
60098553|NCT01709162|76215352|FG000|Still Receiving Treatment|Overall Study||0||
60098554|NCT01709162|76215353|FG001|Still Receiving Treatment|Overall Study||0||
60098555|NCT01709162|76215352|FG000|COMPLETED|Overall Study|Completed treatment as per protocol|12||
60098556|NCT01709162|76215353|FG001|COMPLETED|Overall Study|Completed treatment as per protocol|0||
60098557|NCT01709162|76215352|FG000|NOT COMPLETED|Overall Study||6||
60098558|NCT01709162|76215353|FG001|NOT COMPLETED|Overall Study||5||
60098559|NCT01698554|76215363|FG000|STARTED|Overall Study||153||
60098560|NCT01698554|76215364|FG001|STARTED|Overall Study||157||
60098561|NCT01698554|76215365|FG002|STARTED|Overall Study||75||
59708217|NCT01259102|75827008|FG001|NOT COMPLETED|Overall Study||0||
59708218|NCT01259102|75827009|FG002|NOT COMPLETED|Overall Study||2||
59708219|NCT01259102|75827010|FG003|NOT COMPLETED|Overall Study||2||
59708220|NCT01259102|75827011|FG004|NOT COMPLETED|Overall Study||1||
59708221|NCT00978250|75827027|FG000|STARTED|Overall Study||25||
59708222|NCT00978250|75827028|FG001|STARTED|Overall Study||30||
59708223|NCT00978250|75827029|FG002|STARTED|Overall Study||18||
59708224|NCT00978250|75827030|FG003|STARTED|Overall Study||22||
59708225|NCT00978250|75827027|FG000|COMPLETED|Overall Study||25||
59708226|NCT00978250|75827028|FG001|COMPLETED|Overall Study||29||
59817931|NCT04488770|75940331|FG005|COMPLETED|Part 1-Cohort 2: Period 2 (Up to 5 Days)||2||
59993900|NCT02819635|76109724|FG004|COMPLETED|Substudy 3||0||
59993901|NCT02819635|76109725|FG005|COMPLETED|Substudy 3||0||
59993902|NCT02819635|76109726|FG006|COMPLETED|Substudy 3||0||
59993903|NCT02819635|76109727|FG007|COMPLETED|Substudy 3||0||
59993904|NCT02819635|76109728|FG008|COMPLETED|Substudy 3||140||
59993905|NCT02819635|76109729|FG009|COMPLETED|Substudy 3||11||
59993906|NCT02819635|76109730|FG010|COMPLETED|Substudy 3||218||
59993907|NCT02819635|76109731|FG011|COMPLETED|Substudy 3||248||
59993908|NCT02819635|76109720|FG000|NOT COMPLETED|Substudy 3||0||
59993909|NCT02819635|76109721|FG001|NOT COMPLETED|Substudy 3||0||
59993910|NCT02819635|76109722|FG002|NOT COMPLETED|Substudy 3||0||
59993911|NCT02819635|76109723|FG003|NOT COMPLETED|Substudy 3||0||
59993912|NCT02819635|76109724|FG004|NOT COMPLETED|Substudy 3||0||
59993913|NCT02819635|76109725|FG005|NOT COMPLETED|Substudy 3||0||
60098562|NCT01698554|76215366|FG003|STARTED|Overall Study||79||
60098563|NCT01698554|76215363|FG000|COMPLETED|Overall Study||147||
60098564|NCT01698554|76215364|FG001|COMPLETED|Overall Study||147||
60098565|NCT01698554|76215365|FG002|COMPLETED|Overall Study||73||
60098566|NCT01698554|76215366|FG003|COMPLETED|Overall Study||77||
60098567|NCT01698554|76215363|FG000|NOT COMPLETED|Overall Study||6||
60098568|NCT01698554|76215364|FG001|NOT COMPLETED|Overall Study||10||
60098569|NCT01698554|76215365|FG002|NOT COMPLETED|Overall Study||2||
60098570|NCT01698554|76215366|FG003|NOT COMPLETED|Overall Study||2||
60098571|NCT01698320|76215378|FG000|STARTED|Run-In Period (Week -1 to Day 0)||364||
60098572|NCT01698320|76215379|FG001|STARTED|Run-In Period (Week -1 to Day 0)||0||
60098573|NCT01698320|76215380|FG002|STARTED|Run-In Period (Week -1 to Day 0)||0||
60098574|NCT01698320|76215378|FG000|COMPLETED|Run-In Period (Week -1 to Day 0)||337||
60098575|NCT01698320|76215379|FG001|COMPLETED|Run-In Period (Week -1 to Day 0)||0||
60098576|NCT01698320|76215380|FG002|COMPLETED|Run-In Period (Week -1 to Day 0)||0||
60098577|NCT01698320|76215378|FG000|NOT COMPLETED|Run-In Period (Week -1 to Day 0)||27||
59563099|NCT01748240|75665219|FG000|COMPLETED|Overall Study||21||
59563100|NCT01748240|75665219|FG000|NOT COMPLETED|Overall Study||0||
59563101|NCT02049749|75665225|FG000|STARTED|Overall Study|40 children plus 40 caregivers|80||
59563102|NCT02049749|75665226|FG001|STARTED|Overall Study|80 children plus 80 caregivers|160||
59563103|NCT02049749|75665225|FG000|COMPLETED|Overall Study||80||
60098578|NCT01698320|76215379|FG001|NOT COMPLETED|Run-In Period (Week -1 to Day 0)||0||
60098579|NCT01698320|76215380|FG002|NOT COMPLETED|Run-In Period (Week -1 to Day 0)||0||
60098580|NCT01698320|76215378|FG000|STARTED|12-Week Double-Blind Period||0||
60098581|NCT01698320|76215379|FG001|STARTED|12-Week Double-Blind Period||169||
60098582|NCT01698320|76215380|FG002|STARTED|12-Week Double-Blind Period||168||
59563104|NCT02049749|75665226|FG001|COMPLETED|Overall Study|80 children plus 80 caregivers|160||
59563105|NCT02049749|75665225|FG000|NOT COMPLETED|Overall Study||0||
60098583|NCT01698320|76215378|FG000|Safety Population|12-Week Double-Blind Period||0||
60098584|NCT01698320|76215379|FG001|Safety Population|12-Week Double-Blind Period|One participant took both placebo and albuterol so is counted in both treatment groups for safety.|170||
60098585|NCT01698320|76215380|FG002|Safety Population|12-Week Double-Blind Period||168||
60098586|NCT01698320|76215378|FG000|COMPLETED|12-Week Double-Blind Period||0||
60098587|NCT01698320|76215379|FG001|COMPLETED|12-Week Double-Blind Period||165||
60098588|NCT01698320|76215380|FG002|COMPLETED|12-Week Double-Blind Period||156||
60098589|NCT01698320|76215378|FG000|NOT COMPLETED|12-Week Double-Blind Period||0||
60098590|NCT01698320|76215379|FG001|NOT COMPLETED|12-Week Double-Blind Period||4||
60098591|NCT01698320|76215380|FG002|NOT COMPLETED|12-Week Double-Blind Period||12||
60098592|NCT01698320|76215378|FG000|STARTED|40-Week Open-Label Period||0||
60098593|NCT01698320|76215379|FG001|STARTED|40-Week Open-Label Period||165||
60098594|NCT01698320|76215380|FG002|STARTED|40-Week Open-Label Period||156||
60098595|NCT01698320|76215378|FG000|COMPLETED|40-Week Open-Label Period||0||
60098596|NCT01698320|76215379|FG001|COMPLETED|40-Week Open-Label Period||146||
60098597|NCT01698320|76215380|FG002|COMPLETED|40-Week Open-Label Period||146||
60098598|NCT01698320|76215378|FG000|NOT COMPLETED|40-Week Open-Label Period||0||
60098599|NCT01698320|76215379|FG001|NOT COMPLETED|40-Week Open-Label Period||19||
60098600|NCT01698320|76215380|FG002|NOT COMPLETED|40-Week Open-Label Period||10||
60098601|NCT00924352|76215388|FG000|STARTED|Overall Study||12||
60098602|NCT00924352|76215389|FG001|STARTED|Overall Study||44||
60098603|NCT00924352|76215388|FG000|COMPLETED|Overall Study||12||
60098604|NCT00924352|76215389|FG001|COMPLETED|Overall Study||44||
60098605|NCT00924352|76215388|FG000|NOT COMPLETED|Overall Study||0||
60098606|NCT00924352|76215389|FG001|NOT COMPLETED|Overall Study||0||
60098607|NCT01697696|76215398|FG000|STARTED|Overall Study||254||
60098608|NCT01697696|76215399|FG001|STARTED|Overall Study||257||
60098609|NCT01697696|76215398|FG000|Safety Set|Overall Study||251||
60098610|NCT01697696|76215399|FG001|Safety Set|Overall Study|Safety set included a patient that was treated, but not randomized|256||
60098611|NCT01697696|76215398|FG000|Full Analysis Set (FAS)|Overall Study||251||
60098612|NCT01697696|76215399|FG001|Full Analysis Set (FAS)|Overall Study||255||
60098613|NCT01697696|76215398|FG000|COMPLETED|Overall Study||207||
60098614|NCT01697696|76215399|FG001|COMPLETED|Overall Study||210||
60098615|NCT01697696|76215398|FG000|NOT COMPLETED|Overall Study||47||
60098616|NCT01697696|76215399|FG001|NOT COMPLETED|Overall Study||47||
60098617|NCT01569152|76215407|FG000|STARTED|Phase IIa, Period 1||41||
60098618|NCT01569152|76215408|FG001|STARTED|Phase IIa, Period 1||41||
60098619|NCT01569152|76215409|FG002|STARTED|Phase IIa, Period 1||0||
60098620|NCT01569152|76215407|FG000|COMPLETED|Phase IIa, Period 1||20||
60098621|NCT01569152|76215408|FG001|COMPLETED|Phase IIa, Period 1||9||
60098622|NCT01569152|76215409|FG002|COMPLETED|Phase IIa, Period 1||0||
60098623|NCT01569152|76215407|FG000|NOT COMPLETED|Phase IIa, Period 1||21||
60098624|NCT01569152|76215408|FG001|NOT COMPLETED|Phase IIa, Period 1||32||
60098625|NCT01569152|76215409|FG002|NOT COMPLETED|Phase IIa, Period 1||0||
60098626|NCT01569152|76215407|FG000|STARTED|Safety Extension, Period 3||0||
60098627|NCT01569152|76215408|FG001|STARTED|Safety Extension, Period 3||0||
60098628|NCT01569152|76215409|FG002|STARTED|Safety Extension, Period 3|Includes 29 completers and 26 early escapees from Base Study Phase IIa|55||
60098629|NCT01569152|76215407|FG000|COMPLETED|Safety Extension, Period 3||0||
60098630|NCT01569152|76215408|FG001|COMPLETED|Safety Extension, Period 3||0||
60098631|NCT01569152|76215409|FG002|COMPLETED|Safety Extension, Period 3||0||
59563106|NCT02049749|75665226|FG001|NOT COMPLETED|Overall Study||0||
59563107|NCT01748942|75665235|FG000|STARTED|Overall Study||39||
59563108|NCT01748942|75665236|FG001|STARTED|Overall Study||37||
59563109|NCT01748942|75665235|FG000|COMPLETED|Overall Study||35||
59563110|NCT01748942|75665236|FG001|COMPLETED|Overall Study||33||
59563111|NCT01748942|75665235|FG000|NOT COMPLETED|Overall Study||4||
59563112|NCT01748942|75665236|FG001|NOT COMPLETED|Overall Study||4||
60098632|NCT01569152|76215407|FG000|NOT COMPLETED|Safety Extension, Period 3||0||
60098633|NCT01569152|76215408|FG001|NOT COMPLETED|Safety Extension, Period 3||0||
60098634|NCT01569152|76215409|FG002|NOT COMPLETED|Safety Extension, Period 3||55||
60098635|NCT02082717|76215418|FG000|STARTED|Overall Study||8||
60098636|NCT02082717|76215419|FG001|STARTED|Overall Study||9||
60098637|NCT02082717|76215418|FG000|COMPLETED|Overall Study||8||
60098638|NCT02082717|76215419|FG001|COMPLETED|Overall Study||9||
60098639|NCT02082717|76215418|FG000|NOT COMPLETED|Overall Study||0||
60098640|NCT02082717|76215419|FG001|NOT COMPLETED|Overall Study||0||
60098641|NCT01569074|76215434|FG000|STARTED|Overall Study|Patients who received treatment|31||
60098642|NCT01569074|76215435|FG001|STARTED|Overall Study|Patients who received treatment|33||
60098643|NCT01569074|76215436|FG002|STARTED|Overall Study|Patients who received treatment|33||
59563113|NCT02050841|75665242|FG000|STARTED|Overall Study||50||
59563114|NCT02050841|75665242|FG000|COMPLETED|Overall Study||49||
59563115|NCT02050841|75665242|FG000|NOT COMPLETED|Overall Study||1||
59563116|NCT02355977|75665255|FG000|STARTED|Overall Study||21||
59563117|NCT02355977|75665256|FG001|STARTED|Overall Study||26||
59563118|NCT02355977|75665257|FG002|STARTED|Overall Study||23||
59563119|NCT02355977|75665255|FG000|COMPLETED|Overall Study||21||
59817932|NCT04488770|75940332|FG006|COMPLETED|Part 1-Cohort 2: Period 2 (Up to 5 Days)||2||
60098644|NCT01569074|76215437|FG003|STARTED|Overall Study|Patients who received treatment|33||
59563120|NCT02355977|75665256|FG001|COMPLETED|Overall Study||26||
59563121|NCT02355977|75665257|FG002|COMPLETED|Overall Study||23||
59563122|NCT02355977|75665255|FG000|NOT COMPLETED|Overall Study||0||
60098645|NCT01569074|76215438|FG004|STARTED|Overall Study|Patients who received treatment|33||
60098646|NCT01569074|76215434|FG000|Randomised But Did Not Receive Treatment|Overall Study||0||
60098647|NCT01569074|76215435|FG001|Randomised But Did Not Receive Treatment|Overall Study||0||
60098648|NCT01569074|76215436|FG002|Randomised But Did Not Receive Treatment|Overall Study||0||
60098649|NCT01569074|76215437|FG003|Randomised But Did Not Receive Treatment|Overall Study||0||
60098650|NCT01569074|76215438|FG004|Randomised But Did Not Receive Treatment|Overall Study||0||
60098651|NCT01569074|76215434|FG000|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|24||
59563123|NCT02355977|75665256|FG001|NOT COMPLETED|Overall Study||0||
59563124|NCT02355977|75665257|FG002|NOT COMPLETED|Overall Study||0||
59563125|NCT01749410|75665265|FG000|STARTED|Overall Study||33||
60098652|NCT01569074|76215435|FG001|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|24||
60098653|NCT01569074|76215436|FG002|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|21||
60098654|NCT01569074|76215437|FG003|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|25||
60098655|NCT01569074|76215438|FG004|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|25||
60098656|NCT01569074|76215434|FG000|NOT COMPLETED|Overall Study||7||
60098657|NCT01569074|76215435|FG001|NOT COMPLETED|Overall Study||9||
60098658|NCT01569074|76215436|FG002|NOT COMPLETED|Overall Study||12||
60098659|NCT01569074|76215437|FG003|NOT COMPLETED|Overall Study||8||
60098660|NCT01569074|76215438|FG004|NOT COMPLETED|Overall Study||8||
60098661|NCT01604408|76215456|FG000|STARTED|Treatment Period 1||102||
60098662|NCT01604408|76215457|FG001|STARTED|Treatment Period 1||99||
60098663|NCT01604408|76215456|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 1||102||
60098664|NCT01604408|76215457|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 1||99||
59993914|NCT02819635|76109726|FG006|NOT COMPLETED|Substudy 3||0||
59993915|NCT02819635|76109727|FG007|NOT COMPLETED|Substudy 3||0||
60098665|NCT01604408|76215456|FG000|COMPLETED|Treatment Period 1||102||
60098666|NCT01604408|76215457|FG001|COMPLETED|Treatment Period 1||98||
60098667|NCT01604408|76215456|FG000|NOT COMPLETED|Treatment Period 1||0||
59993916|NCT02819635|76109728|FG008|NOT COMPLETED|Substudy 3||246||
59993917|NCT02819635|76109729|FG009|NOT COMPLETED|Substudy 3||9||
59993918|NCT02819635|76109730|FG010|NOT COMPLETED|Substudy 3||106||
60098668|NCT01604408|76215457|FG001|NOT COMPLETED|Treatment Period 1||1||
60098669|NCT01604408|76215456|FG000|STARTED|Treatment Period 2||102||
59563126|NCT01749410|75665265|FG000|COMPLETED|Overall Study||33||
59563127|NCT01749410|75665265|FG000|NOT COMPLETED|Overall Study||0||
59563128|NCT02359955|75665271|FG000|STARTED|Overall Study||10||
59993919|NCT02819635|76109731|FG011|NOT COMPLETED|Substudy 3||68||
59993920|NCT03874325|76109759|FG000|STARTED|Overall Study||17||
59993921|NCT03874325|76109760|FG001|STARTED|Overall Study||0||
59993922|NCT03874325|76109759|FG000|COMPLETED|Overall Study||17||
60098670|NCT01604408|76215457|FG001|STARTED|Treatment Period 2||98||
60098671|NCT01604408|76215456|FG000|COMPLETED|Treatment Period 2||100||
60098672|NCT01604408|76215457|FG001|COMPLETED|Treatment Period 2||96||
60098673|NCT01604408|76215456|FG000|NOT COMPLETED|Treatment Period 2||2||
60098674|NCT01604408|76215457|FG001|NOT COMPLETED|Treatment Period 2||2||
60098675|NCT01604408|76215456|FG000|STARTED|Treatment Period 3||100||
60098676|NCT01604408|76215457|FG001|STARTED|Treatment Period 3||96||
60098677|NCT01604408|76215456|FG000|COMPLETED|Treatment Period 3||95||
60098678|NCT01604408|76215457|FG001|COMPLETED|Treatment Period 3||91||
60098679|NCT01604408|76215456|FG000|NOT COMPLETED|Treatment Period 3||5||
60098680|NCT01604408|76215457|FG001|NOT COMPLETED|Treatment Period 3||5||
60098681|NCT01604408|76215456|FG000|STARTED|Treatment Period 4||95||
60098682|NCT01604408|76215457|FG001|STARTED|Treatment Period 4||91||
60098683|NCT01604408|76215456|FG000|COMPLETED|Treatment Period 4||92||
60098684|NCT01604408|76215457|FG001|COMPLETED|Treatment Period 4||89||
60098685|NCT01604408|76215456|FG000|NOT COMPLETED|Treatment Period 4||3||
60098686|NCT01604408|76215457|FG001|NOT COMPLETED|Treatment Period 4||2||
60098687|NCT01604408|76215456|FG000|STARTED|Treatment Period 5||92||
60098688|NCT01604408|76215457|FG001|STARTED|Treatment Period 5||89||
60098689|NCT01604408|76215456|FG000|COMPLETED|Treatment Period 5||88||
60098690|NCT01604408|76215457|FG001|COMPLETED|Treatment Period 5||89||
60098691|NCT01604408|76215456|FG000|NOT COMPLETED|Treatment Period 5||4||
60098692|NCT01604408|76215457|FG001|NOT COMPLETED|Treatment Period 5||0||
60098693|NCT01604408|76215456|FG000|STARTED|Treatment Period 6||88||
60098694|NCT01604408|76215457|FG001|STARTED|Treatment Period 6||89||
60098695|NCT01604408|76215456|FG000|COMPLETED|Treatment Period 6||86||
60098696|NCT01604408|76215457|FG001|COMPLETED|Treatment Period 6||87||
60098697|NCT01604408|76215456|FG000|NOT COMPLETED|Treatment Period 6||2||
60098698|NCT01604408|76215457|FG001|NOT COMPLETED|Treatment Period 6||2||
60098699|NCT01604408|76215456|FG000|STARTED|Observation Period||86||
60098700|NCT01604408|76215457|FG001|STARTED|Observation Period||87||
60098701|NCT01604408|76215456|FG000|COMPLETED|Observation Period||85||
60098702|NCT01604408|76215457|FG001|COMPLETED|Observation Period||84||
60098703|NCT01604408|76215456|FG000|NOT COMPLETED|Observation Period||1||
60098704|NCT01604408|76215457|FG001|NOT COMPLETED|Observation Period||3||
60098705|NCT01567826|76215465|FG000|STARTED|Overall Study||43||
60098706|NCT01567826|76215466|FG001|STARTED|Overall Study||44||
60098707|NCT01567826|76215465|FG000|COMPLETED|Overall Study||40||
60098708|NCT01567826|76215466|FG001|COMPLETED|Overall Study||42||
60098709|NCT01567826|76215465|FG000|NOT COMPLETED|Overall Study||3||
60098710|NCT01567826|76215466|FG001|NOT COMPLETED|Overall Study||2||
60098711|NCT01697462|76215474|FG000|STARTED|Overall Study||258||
60098712|NCT01697462|76215474|FG000|COMPLETED|Overall Study||181||
60098713|NCT01697462|76215474|FG000|NOT COMPLETED|Overall Study||77||
60098714|NCT00003459|76215478|FG000|STARTED|Overall Study||40||
60098715|NCT00003459|76215478|FG000|COMPLETED|Overall Study|Nine patients were not evaluable.|31||
60098716|NCT00003459|76215478|FG000|NOT COMPLETED|Overall Study||9||
60098717|NCT02083107|76215485|FG000|STARTED|Overall Study|212 women received 2 tablets of Misotac® sublingually and 2 placebo tablets rectally.|212||
60098718|NCT02083107|76215486|FG001|STARTED|Overall Study|212 women received 2 tablets of placebo sublingually and 2 placebo tablets rectally.|212||
60098719|NCT02083107|76215487|FG002|STARTED|Overall Study|212 women received 2 tablets of Misotac® rectally and 2 placebo tablets sublingually.|212||
60098720|NCT02083107|76215485|FG000|COMPLETED|Overall Study|212 women received 2 tablets of Misotac® sublingually and 2 placebo tablets rectally.|212||
60098721|NCT02083107|76215486|FG001|COMPLETED|Overall Study|212 women received 2 tablets of placebo sublingually and 2 placebo tablets rectally.|212||
60098722|NCT02083107|76215487|FG002|COMPLETED|Overall Study|212 women received 2 tablets of Misotac® rectally and 2 placebo tablets sublingually.|212||
60098723|NCT02083107|76215485|FG000|NOT COMPLETED|Overall Study||0||
60098724|NCT02083107|76215486|FG001|NOT COMPLETED|Overall Study||0||
60098725|NCT02083107|76215487|FG002|NOT COMPLETED|Overall Study||0||
60098726|NCT00925054|76215500|FG000|STARTED|Overall Study||7||
60098727|NCT00925054|76215501|FG001|STARTED|Overall Study||9||
60098728|NCT00925054|76215502|FG002|STARTED|Overall Study||13||
60098729|NCT00925054|76215503|FG003|STARTED|Overall Study||1||
60098730|NCT00925054|76215504|FG004|STARTED|Overall Study||10||
60098731|NCT00925054|76215500|FG000|COMPLETED|Overall Study||7||
60098732|NCT00925054|76215501|FG001|COMPLETED|Overall Study||8||
60098733|NCT00925054|76215502|FG002|COMPLETED|Overall Study||12||
60098734|NCT00925054|76215503|FG003|COMPLETED|Overall Study||0||
60098735|NCT00925054|76215504|FG004|COMPLETED|Overall Study||10||
60098736|NCT00925054|76215500|FG000|NOT COMPLETED|Overall Study||0||
60098737|NCT00925054|76215501|FG001|NOT COMPLETED|Overall Study||1||
60098738|NCT00925054|76215502|FG002|NOT COMPLETED|Overall Study||1||
59563129|NCT02359955|75665272|FG001|STARTED|Overall Study||10||
59708227|NCT00978250|75827029|FG002|COMPLETED|Overall Study||18||
59993923|NCT03874325|76109760|FG001|COMPLETED|Overall Study||0||
59993924|NCT03874325|76109759|FG000|NOT COMPLETED|Overall Study||0||
59993925|NCT03874325|76109760|FG001|NOT COMPLETED|Overall Study||0||
59993926|NCT02424344|76109766|FG000|STARTED|Overall Study||134||
59993927|NCT02424344|76109767|FG001|STARTED|Overall Study||133||
59993928|NCT02424344|76109766|FG000|COMPLETED|Overall Study||127||
59993929|NCT02424344|76109767|FG001|COMPLETED|Overall Study||123||
59993930|NCT02424344|76109766|FG000|NOT COMPLETED|Overall Study||7||
60098739|NCT00925054|76215503|FG003|NOT COMPLETED|Overall Study||1||
60098740|NCT00925054|76215504|FG004|NOT COMPLETED|Overall Study||0||
60098741|NCT02335905|76215517|FG000|STARTED|Overall Study||11||
60098742|NCT02335905|76215517|FG000|COMPLETED|Overall Study||7||
59708228|NCT00978250|75827030|FG003|COMPLETED|Overall Study||21||
59708229|NCT00978250|75827027|FG000|NOT COMPLETED|Overall Study||0||
59708230|NCT00978250|75827028|FG001|NOT COMPLETED|Overall Study||1||
59708231|NCT00978250|75827029|FG002|NOT COMPLETED|Overall Study||0||
59708232|NCT00978250|75827030|FG003|NOT COMPLETED|Overall Study||1||
59993931|NCT02424344|76109767|FG001|NOT COMPLETED|Overall Study||10||
59993932|NCT02423798|76109773|FG000|STARTED|Overall Study||24||
59993933|NCT02423798|76109773|FG000|COMPLETED|Overall Study||21||
59993934|NCT02423798|76109773|FG000|NOT COMPLETED|Overall Study||3||
59993935|NCT03861611|76109781|FG000|STARTED|Overall Study||66||
59563130|NCT02359955|75665271|FG000|COMPLETED|Overall Study||10||
59563131|NCT02359955|75665272|FG001|COMPLETED|Overall Study||10||
59563132|NCT02359955|75665271|FG000|NOT COMPLETED|Overall Study||0||
59563133|NCT02359955|75665272|FG001|NOT COMPLETED|Overall Study||0||
60098743|NCT02335905|76215517|FG000|NOT COMPLETED|Overall Study||4||
60098744|NCT00925756|76215521|FG000|STARTED|Overall Study||32||
59563134|NCT01729598|75665290|FG000|STARTED|Overall Study||10||
59563135|NCT01729598|75665291|FG001|STARTED|Overall Study||4||
60098745|NCT00925756|76215521|FG000|COMPLETED|Overall Study||32||
60098746|NCT00925756|76215521|FG000|NOT COMPLETED|Overall Study||0||
60098747|NCT02083809|76215527|FG000|STARTED|Overall Study||82||
60098748|NCT02083809|76215528|FG001|STARTED|Overall Study||84||
60098749|NCT02083809|76215527|FG000|COMPLETED|Overall Study||78||
60098750|NCT02083809|76215528|FG001|COMPLETED|Overall Study||82||
60098751|NCT02083809|76215527|FG000|NOT COMPLETED|Overall Study||4||
60098752|NCT02083809|76215528|FG001|NOT COMPLETED|Overall Study||2||
60098753|NCT00954915|76215534|FG000|STARTED|Overall Study||1||
60098754|NCT00954915|76215534|FG000|COMPLETED|Overall Study||1||
59563136|NCT01729598|75665290|FG000|COMPLETED|Overall Study||10||
59563137|NCT01729598|75665291|FG001|COMPLETED|Overall Study||4||
59563138|NCT01729598|75665290|FG000|NOT COMPLETED|Overall Study||0||
59563139|NCT01729598|75665291|FG001|NOT COMPLETED|Overall Study||0||
59563140|NCT01730846|75665300|FG000|STARTED|Overall Study||11||
60098755|NCT00954915|76215534|FG000|NOT COMPLETED|Overall Study||0||
60098756|NCT00926380|76215542|FG000|STARTED|Year 1||33||
60098757|NCT00926380|76215543|FG001|STARTED|Year 1||31||
60098758|NCT00926380|76215544|FG002|STARTED|Year 1||30||
60098759|NCT00926380|76215542|FG000|COMPLETED|Year 1||33||
59563141|NCT01730846|75665301|FG001|STARTED|Overall Study||11||
60098760|NCT00926380|76215543|FG001|COMPLETED|Year 1||30||
59563142|NCT01730846|75665302|FG002|STARTED|Overall Study||13||
59563143|NCT01730846|75665300|FG000|COMPLETED|Overall Study||11||
59563144|NCT01730846|75665301|FG001|COMPLETED|Overall Study||11||
60098761|NCT00926380|76215544|FG002|COMPLETED|Year 1||29||
60098762|NCT00926380|76215542|FG000|NOT COMPLETED|Year 1||0||
59563145|NCT01730846|75665302|FG002|COMPLETED|Overall Study||13||
59563146|NCT01730846|75665300|FG000|NOT COMPLETED|Overall Study||0||
59563147|NCT01730846|75665301|FG001|NOT COMPLETED|Overall Study||0||
59563148|NCT01730846|75665302|FG002|NOT COMPLETED|Overall Study||0||
59563149|NCT01732406|75665313|FG000|STARTED|Overall Study||31||
59563150|NCT01732406|75665314|FG001|STARTED|Overall Study||60||
59563151|NCT01732406|75665315|FG002|STARTED|Overall Study||35||
59563152|NCT01732406|75665313|FG000|COMPLETED|Overall Study||31||
59708233|NCT01259024|75827042|FG000|STARTED|Overall Study||1||
59708234|NCT01259024|75827042|FG000|COMPLETED|Overall Study||0||
59993936|NCT03861611|76109782|FG001|STARTED|Overall Study||66||
59993937|NCT03861611|76109783|FG002|STARTED|Overall Study||66||
59563153|NCT01732406|75665314|FG001|COMPLETED|Overall Study||60||
59563154|NCT01732406|75665315|FG002|COMPLETED|Overall Study||35||
59563155|NCT01732406|75665313|FG000|NOT COMPLETED|Overall Study||0||
59563156|NCT01732406|75665314|FG001|NOT COMPLETED|Overall Study||0||
59563157|NCT01732406|75665315|FG002|NOT COMPLETED|Overall Study||0||
59563158|NCT02314403|75665327|FG000|STARTED|Overall Study||2||
59993938|NCT03861611|76109781|FG000|COMPLETED|Overall Study||59||
59993939|NCT03861611|76109782|FG001|COMPLETED|Overall Study||61||
59993940|NCT03861611|76109783|FG002|COMPLETED|Overall Study||62||
59993941|NCT03861611|76109781|FG000|NOT COMPLETED|Overall Study||7||
59993942|NCT03861611|76109782|FG001|NOT COMPLETED|Overall Study||5||
59993943|NCT03861611|76109783|FG002|NOT COMPLETED|Overall Study||4||
59993944|NCT02383940|76109796|FG000|STARTED|Overall Study||44||
59993945|NCT02383940|76109797|FG001|STARTED|Overall Study||43||
59993946|NCT02383940|76109796|FG000|Treated|Overall Study||42||
59708235|NCT01259024|75827042|FG000|NOT COMPLETED|Overall Study||1||
59708236|NCT01257698|75827048|FG000|STARTED|Overall Study||12||
59708237|NCT01257698|75827049|FG001|STARTED|Overall Study||9||
59708238|NCT01257698|75827048|FG000|COMPLETED|Overall Study||8||
59708239|NCT01257698|75827049|FG001|COMPLETED|Overall Study||9||
59708240|NCT01257698|75827048|FG000|NOT COMPLETED|Overall Study||4||
59708241|NCT01257698|75827049|FG001|NOT COMPLETED|Overall Study||0||
59708242|NCT01257542|75827057|FG000|STARTED|Overall Study||55||
59708243|NCT01257542|75827058|FG001|STARTED|Overall Study||52||
59708244|NCT01257542|75827057|FG000|COMPLETED|Overall Study||52||
59708245|NCT01257542|75827058|FG001|COMPLETED|Overall Study||45||
59708246|NCT01257542|75827057|FG000|NOT COMPLETED|Overall Study||3||
59993947|NCT02383940|76109797|FG001|Treated|Overall Study||43||
59993948|NCT02383940|76109796|FG000|COMPLETED|Overall Study||35||
59993949|NCT02383940|76109797|FG001|COMPLETED|Overall Study||40||
59993950|NCT02383940|76109796|FG000|NOT COMPLETED|Overall Study||9||
59563159|NCT02314403|75665327|FG000|COMPLETED|Overall Study||2||
59563160|NCT02314403|75665327|FG000|NOT COMPLETED|Overall Study||0||
59563161|NCT02052557|75665333|FG000|STARTED|Overall Study||26||
59563162|NCT02052557|75665334|FG001|STARTED|Overall Study||25||
59563163|NCT02052557|75665333|FG000|COMPLETED|Overall Study||26||
59563164|NCT02052557|75665334|FG001|COMPLETED|Overall Study||25||
59563165|NCT02052557|75665333|FG000|NOT COMPLETED|Overall Study||0||
59563166|NCT02052557|75665334|FG001|NOT COMPLETED|Overall Study||0||
59563167|NCT02052635|75665344|FG000|STARTED|Overall Study||7||
59563168|NCT02052635|75665345|FG001|STARTED|Overall Study||6||
59563169|NCT02052635|75665344|FG000|COMPLETED|Overall Study||7||
59563170|NCT02052635|75665345|FG001|COMPLETED|Overall Study||6||
59563171|NCT02052635|75665344|FG000|NOT COMPLETED|Overall Study||0||
59563172|NCT02052635|75665345|FG001|NOT COMPLETED|Overall Study||0||
59563173|NCT01732718|75665351|FG000|STARTED|First Intervention||7||
59563174|NCT01732718|75665352|FG001|STARTED|First Intervention||6||
59563175|NCT01732718|75665351|FG000|COMPLETED|First Intervention||7||
59563176|NCT01732718|75665352|FG001|COMPLETED|First Intervention||6||
59563177|NCT01732718|75665351|FG000|NOT COMPLETED|First Intervention||0||
59563178|NCT01732718|75665352|FG001|NOT COMPLETED|First Intervention||0||
59563179|NCT01732718|75665351|FG000|STARTED|Washout (4 Weeks)||7||
59563180|NCT01732718|75665352|FG001|STARTED|Washout (4 Weeks)||6||
59563181|NCT01732718|75665351|FG000|COMPLETED|Washout (4 Weeks)||7||
59563182|NCT01732718|75665352|FG001|COMPLETED|Washout (4 Weeks)||6||
59563183|NCT01732718|75665351|FG000|NOT COMPLETED|Washout (4 Weeks)||0||
59563184|NCT01732718|75665352|FG001|NOT COMPLETED|Washout (4 Weeks)||0||
59563185|NCT01732718|75665351|FG000|STARTED|Second Intervention||7||
59563186|NCT01732718|75665352|FG001|STARTED|Second Intervention||6||
59563187|NCT01732718|75665351|FG000|COMPLETED|Second Intervention||7||
59563188|NCT01732718|75665352|FG001|COMPLETED|Second Intervention||6||
59563189|NCT01732718|75665351|FG000|NOT COMPLETED|Second Intervention||0||
59563190|NCT01732718|75665352|FG001|NOT COMPLETED|Second Intervention||0||
59563191|NCT02053259|75665368|FG000|STARTED|Overall Study||25||
59563192|NCT02053259|75665369|FG001|STARTED|Overall Study||24||
59563193|NCT02053259|75665370|FG002|STARTED|Overall Study||24||
59563194|NCT02053259|75665371|FG003|STARTED|Overall Study||23||
59563195|NCT02053259|75665368|FG000|COMPLETED|Overall Study||25||
59563196|NCT02053259|75665369|FG001|COMPLETED|Overall Study||24||
59563197|NCT02053259|75665370|FG002|COMPLETED|Overall Study||24||
59563198|NCT02053259|75665371|FG003|COMPLETED|Overall Study||23||
59993951|NCT02383940|76109797|FG001|NOT COMPLETED|Overall Study||3||
60098763|NCT00926380|76215543|FG001|NOT COMPLETED|Year 1||1||
60098764|NCT00926380|76215544|FG002|NOT COMPLETED|Year 1||1||
60098765|NCT00926380|76215542|FG000|STARTED|Year 2||33||
60098766|NCT00926380|76215543|FG001|STARTED|Year 2||30||
60098767|NCT00926380|76215544|FG002|STARTED|Year 2||29||
60098768|NCT00926380|76215542|FG000|COMPLETED|Year 2||31||
60098769|NCT00926380|76215543|FG001|COMPLETED|Year 2||28||
60098770|NCT00926380|76215544|FG002|COMPLETED|Year 2||24||
60098771|NCT00926380|76215542|FG000|NOT COMPLETED|Year 2||2||
60098772|NCT00926380|76215543|FG001|NOT COMPLETED|Year 2||2||
60098773|NCT00926380|76215544|FG002|NOT COMPLETED|Year 2||5||
60098774|NCT00929344|76215555|FG000|STARTED|Overall Study||50||
60098775|NCT00929344|76215556|FG001|STARTED|Overall Study||50||
60098776|NCT00929344|76215557|FG002|STARTED|Overall Study||50||
60098777|NCT00929344|76215555|FG000|COMPLETED|Overall Study||28||
60098778|NCT00929344|76215556|FG001|COMPLETED|Overall Study||37||
60098779|NCT00929344|76215557|FG002|COMPLETED|Overall Study||29||
60098780|NCT00929344|76215555|FG000|NOT COMPLETED|Overall Study||22||
60098781|NCT00929344|76215556|FG001|NOT COMPLETED|Overall Study||13||
60098782|NCT00929344|76215557|FG002|NOT COMPLETED|Overall Study||21||
60098783|NCT00929500|76215567|FG000|STARTED|Overall Study||8||
59563199|NCT02053259|75665368|FG000|NOT COMPLETED|Overall Study||0||
59563200|NCT02053259|75665369|FG001|NOT COMPLETED|Overall Study||0||
59563201|NCT02053259|75665370|FG002|NOT COMPLETED|Overall Study||0||
59993952|NCT02383862|76109805|FG000|STARTED|Baseline||151||
59993953|NCT02383862|76109806|FG001|STARTED|Baseline||149||
59993954|NCT02383862|76109805|FG000|COMPLETED|Baseline||151||
59993955|NCT02383862|76109806|FG001|COMPLETED|Baseline||149||
59993956|NCT02383862|76109805|FG000|NOT COMPLETED|Baseline||0||
59993957|NCT02383862|76109806|FG001|NOT COMPLETED|Baseline||0||
59993958|NCT02383862|76109805|FG000|STARTED|3 Month Follow up||151||
59993959|NCT02383862|76109806|FG001|STARTED|3 Month Follow up||149||
59993960|NCT02383862|76109805|FG000|COMPLETED|3 Month Follow up||128||
59993961|NCT02383862|76109806|FG001|COMPLETED|3 Month Follow up||128||
60098784|NCT00929500|76215568|FG001|STARTED|Overall Study||4||
60098785|NCT00929500|76215567|FG000|COMPLETED|Overall Study||4||
60098786|NCT00929500|76215568|FG001|COMPLETED|Overall Study||4||
60098787|NCT00929500|76215567|FG000|NOT COMPLETED|Overall Study||4||
60098788|NCT00929500|76215568|FG001|NOT COMPLETED|Overall Study||0||
60098789|NCT00929578|76215574|FG000|STARTED|Overall Study||15||
60098790|NCT00929578|76215574|FG000|COMPLETED|Overall Study||15||
60098791|NCT00929578|76215574|FG000|NOT COMPLETED|Overall Study||0||
60098792|NCT00927160|76215585|FG000|STARTED|Overall Study||173||
60098793|NCT00927160|76215586|FG001|STARTED|Overall Study||173||
60098794|NCT00927160|76215585|FG000|COMPLETED|Overall Study||173||
60098795|NCT00927160|76215586|FG001|COMPLETED|Overall Study||173||
60098796|NCT00927160|76215585|FG000|NOT COMPLETED|Overall Study||0||
60098797|NCT00927160|76215586|FG001|NOT COMPLETED|Overall Study||0||
60098798|NCT02156908|76215594|FG000|STARTED|Overall Study||5||
60098799|NCT02156908|76215595|FG001|STARTED|Overall Study||3||
60098800|NCT02156908|76215594|FG000|COMPLETED|Overall Study||5||
60098801|NCT02156908|76215595|FG001|COMPLETED|Overall Study||3||
60098802|NCT02156908|76215594|FG000|NOT COMPLETED|Overall Study||0||
60098803|NCT02156908|76215595|FG001|NOT COMPLETED|Overall Study||0||
60098804|NCT00004143|76215602|FG000|STARTED|Overall Study||2||
60098805|NCT00004143|76215602|FG000|COMPLETED|Overall Study||2||
60098806|NCT00004143|76215602|FG000|NOT COMPLETED|Overall Study||0||
60098807|NCT03700047|76215609|FG000|STARTED|Overall Study||142||
60098808|NCT03700047|76215610|FG001|STARTED|Overall Study||60||
60098809|NCT03700047|76215611|FG002|STARTED|Overall Study||68||
60098810|NCT03700047|76215609|FG000|COMPLETED|Overall Study||126||
60098811|NCT03700047|76215610|FG001|COMPLETED|Overall Study||50||
60098812|NCT03700047|76215611|FG002|COMPLETED|Overall Study||58||
60098813|NCT03700047|76215609|FG000|NOT COMPLETED|Overall Study||16||
60098814|NCT03700047|76215610|FG001|NOT COMPLETED|Overall Study||10||
60098815|NCT03700047|76215611|FG002|NOT COMPLETED|Overall Study||10||
60098816|NCT00924040|76215619|FG000|STARTED|Overall Study||1||
60098817|NCT00924040|76215619|FG000|COMPLETED|Overall Study||1||
60098818|NCT00924040|76215619|FG000|NOT COMPLETED|Overall Study||0||
60098819|NCT01592240|76215630|FG000|STARTED|Overall Study||50||
60098820|NCT01592240|76215631|FG001|STARTED|Overall Study||50||
60098821|NCT01592240|76215632|FG002|STARTED|Overall Study||52||
60098822|NCT01592240|76215633|FG003|STARTED|Overall Study||50||
60098823|NCT01592240|76215634|FG004|STARTED|Overall Study||51||
60098824|NCT01592240|76215635|FG005|STARTED|Overall Study||50||
60098825|NCT01592240|76215636|FG006|STARTED|Overall Study||51||
60098826|NCT01592240|76215630|FG000|COMPLETED|Overall Study||47||
60098827|NCT01592240|76215631|FG001|COMPLETED|Overall Study||39||
60098828|NCT01592240|76215632|FG002|COMPLETED|Overall Study||45||
59563202|NCT02053259|75665371|FG003|NOT COMPLETED|Overall Study||0||
59563203|NCT02362373|75665381|FG000|STARTED|Overall Study||20||
59563204|NCT02362373|75665381|FG000|COMPLETED|Overall Study||20||
59708247|NCT01257542|75827058|FG001|NOT COMPLETED|Overall Study||7||
59708248|NCT01257230|75827067|FG000|STARTED|Overall Study||138||
59708249|NCT01257230|75827068|FG001|STARTED|Overall Study||125||
59708250|NCT01257230|75827069|FG002|STARTED|Overall Study||135||
59708251|NCT01257230|75827067|FG000|COMPLETED|Overall Study||132||
59708252|NCT01257230|75827068|FG001|COMPLETED|Overall Study||115||
59708253|NCT01257230|75827069|FG002|COMPLETED|Overall Study||129||
59708254|NCT01257230|75827067|FG000|NOT COMPLETED|Overall Study||6||
59708255|NCT01257230|75827068|FG001|NOT COMPLETED|Overall Study||10||
59708256|NCT01257230|75827069|FG002|NOT COMPLETED|Overall Study||6||
59708257|NCT01113801|75827082|FG000|STARTED|Overall Study||103||
59708258|NCT01113801|75827083|FG001|STARTED|Overall Study||105||
59563205|NCT02362373|75665381|FG000|NOT COMPLETED|Overall Study||0||
59563206|NCT02363621|75665387|FG000|STARTED|Overall Study||51||
59563207|NCT02363621|75665388|FG001|STARTED|Overall Study||50||
59563208|NCT02363621|75665387|FG000|COMPLETED|Overall Study||50||
59563209|NCT02363621|75665388|FG001|COMPLETED|Overall Study||50||
59708259|NCT01113801|75827084|FG002|STARTED|Overall Study||103||
59563210|NCT02363621|75665387|FG000|NOT COMPLETED|Overall Study||1||
59708260|NCT01113801|75827085|FG003|STARTED|Overall Study||106||
59708261|NCT01113801|75827082|FG000|Received at Least One Dose of Drug|Overall Study||103||
59708262|NCT01113801|75827083|FG001|Received at Least One Dose of Drug|Overall Study||105||
59563211|NCT02363621|75665388|FG001|NOT COMPLETED|Overall Study||0||
59563212|NCT01749956|75665394|FG000|STARTED|Overall Study||39||
60098829|NCT01592240|76215633|FG003|COMPLETED|Overall Study||47||
59563213|NCT01749956|75665394|FG000|COMPLETED|Overall Study||24||
59563214|NCT01749956|75665394|FG000|NOT COMPLETED|Overall Study||15||
59708263|NCT01113801|75827084|FG002|Received at Least One Dose of Drug|Overall Study||103||
60098830|NCT01592240|76215634|FG004|COMPLETED|Overall Study||44||
60098831|NCT01592240|76215635|FG005|COMPLETED|Overall Study||47||
60098832|NCT01592240|76215636|FG006|COMPLETED|Overall Study||48||
60098833|NCT01592240|76215630|FG000|NOT COMPLETED|Overall Study||3||
60098834|NCT01592240|76215631|FG001|NOT COMPLETED|Overall Study||11||
60098835|NCT01592240|76215632|FG002|NOT COMPLETED|Overall Study||7||
60098836|NCT01592240|76215633|FG003|NOT COMPLETED|Overall Study||3||
60098837|NCT01592240|76215634|FG004|NOT COMPLETED|Overall Study||7||
60098838|NCT01592240|76215635|FG005|NOT COMPLETED|Overall Study||3||
60098839|NCT01592240|76215636|FG006|NOT COMPLETED|Overall Study||3||
60098840|NCT00937378|76215659|FG000|STARTED|Overall Study||167||
60098841|NCT00937378|76215660|FG001|STARTED|Overall Study||159||
59817933|NCT04488770|75940333|FG007|COMPLETED|Part 1-Cohort 2: Period 2 (Up to 5 Days)||2||
60098842|NCT00937378|76215659|FG000|COMPLETED|Overall Study||149||
59563215|NCT02363933|75665399|FG000|STARTED|Overall Study||8||
60098843|NCT00937378|76215660|FG001|COMPLETED|Overall Study||141||
60098844|NCT00937378|76215659|FG000|NOT COMPLETED|Overall Study||18||
59563216|NCT02363933|75665399|FG000|COMPLETED|Overall Study||2||
59563217|NCT02363933|75665399|FG000|NOT COMPLETED|Overall Study||6||
59563218|NCT01750502|75665405|FG000|STARTED|Overall Study||70||
59563219|NCT01750502|75665406|FG001|STARTED|Overall Study||186||
59563220|NCT01750502|75665405|FG000|COMPLETED|Overall Study||70||
59563221|NCT01750502|75665406|FG001|COMPLETED|Overall Study||186||
59563222|NCT01750502|75665405|FG000|NOT COMPLETED|Overall Study||0||
60098845|NCT00937378|76215660|FG001|NOT COMPLETED|Overall Study||18||
60098846|NCT00005901|76215668|FG000|STARTED|Overall Study||19||
60098847|NCT00005901|76215669|FG001|STARTED|Overall Study||15||
60098848|NCT00005901|76215668|FG000|COMPLETED|Overall Study||19||
60098849|NCT00005901|76215669|FG001|COMPLETED|Overall Study||15||
60098850|NCT00005901|76215668|FG000|NOT COMPLETED|Overall Study||0||
60098851|NCT00005901|76215669|FG001|NOT COMPLETED|Overall Study||0||
60098852|NCT03590457|76215675|FG000|STARTED|Overall Study||18||
60098853|NCT03590457|76215675|FG000|COMPLETED|Overall Study||18||
60098854|NCT03590457|76215675|FG000|NOT COMPLETED|Overall Study||0||
60098855|NCT01591616|76215679|FG000|STARTED|Overall Study||16||
60098856|NCT01591616|76215679|FG000|COMPLETED|Overall Study||15||
60098857|NCT01591616|76215679|FG000|NOT COMPLETED|Overall Study||1||
59563223|NCT01750502|75665406|FG001|NOT COMPLETED|Overall Study||0||
59563224|NCT02365961|75665419|FG000|STARTED|Overall Study||41||
59563225|NCT02365961|75665420|FG001|STARTED|Overall Study||43||
59563226|NCT02365961|75665419|FG000|COMPLETED|Overall Study||41||
59563227|NCT02365961|75665420|FG001|COMPLETED|Overall Study||43||
59563228|NCT02365961|75665419|FG000|NOT COMPLETED|Overall Study||0||
59563229|NCT02365961|75665420|FG001|NOT COMPLETED|Overall Study||0||
59563230|NCT02366663|75665428|FG000|STARTED|Overall Study||2||
59563231|NCT02366663|75665429|FG001|STARTED|Overall Study||1||
59563232|NCT02366663|75665428|FG000|COMPLETED|Overall Study||2||
60098858|NCT00938314|76215822|FG000|STARTED|Cohort 1||24||
60098859|NCT00938314|76215823|FG001|STARTED|Cohort 1||0||
60098860|NCT00938314|76215824|FG002|STARTED|Cohort 1||0||
60098861|NCT00938314|76215825|FG003|STARTED|Cohort 1||8||
60098862|NCT00938314|76215822|FG000|COMPLETED|Cohort 1||22||
60098863|NCT00938314|76215823|FG001|COMPLETED|Cohort 1||0||
60098864|NCT00938314|76215824|FG002|COMPLETED|Cohort 1||0||
60098865|NCT00938314|76215825|FG003|COMPLETED|Cohort 1||6||
60098866|NCT00938314|76215822|FG000|NOT COMPLETED|Cohort 1||2||
60098867|NCT00938314|76215823|FG001|NOT COMPLETED|Cohort 1||0||
60098868|NCT00938314|76215824|FG002|NOT COMPLETED|Cohort 1||0||
60098869|NCT00938314|76215825|FG003|NOT COMPLETED|Cohort 1||2||
60098870|NCT00938314|76215822|FG000|STARTED|Cohort 2||0||
60098871|NCT00938314|76215823|FG001|STARTED|Cohort 2||24||
60098872|NCT00938314|76215824|FG002|STARTED|Cohort 2||0||
60098873|NCT00938314|76215825|FG003|STARTED|Cohort 2||8||
60098874|NCT00938314|76215822|FG000|COMPLETED|Cohort 2||0||
60098875|NCT00938314|76215823|FG001|COMPLETED|Cohort 2||18||
60098876|NCT00938314|76215824|FG002|COMPLETED|Cohort 2||0||
60098877|NCT00938314|76215825|FG003|COMPLETED|Cohort 2||6||
60098878|NCT00938314|76215822|FG000|NOT COMPLETED|Cohort 2||0||
60098879|NCT00938314|76215823|FG001|NOT COMPLETED|Cohort 2||6||
60098880|NCT00938314|76215824|FG002|NOT COMPLETED|Cohort 2||0||
60098881|NCT00938314|76215825|FG003|NOT COMPLETED|Cohort 2||2||
60098882|NCT00938314|76215822|FG000|STARTED|Cohort 3||0||
59563233|NCT02366663|75665429|FG001|COMPLETED|Overall Study||1||
59563234|NCT02366663|75665428|FG000|NOT COMPLETED|Overall Study||0||
59563235|NCT02366663|75665429|FG001|NOT COMPLETED|Overall Study||0||
59563236|NCT01754480|75665437|FG000|STARTED|Part I + Part II (Overall Study)||163||
60098883|NCT00938314|76215823|FG001|STARTED|Cohort 3||0||
60098884|NCT00938314|76215824|FG002|STARTED|Cohort 3||24||
60098885|NCT00938314|76215825|FG003|STARTED|Cohort 3||8||
59563237|NCT01754480|75665438|FG001|STARTED|Part I + Part II (Overall Study)||162||
59563238|NCT01754480|75665437|FG000|Completed Study up to Week 6|Part I + Part II (Overall Study)||147||
60098886|NCT00938314|76215822|FG000|COMPLETED|Cohort 3||0||
59563239|NCT01754480|75665438|FG001|Completed Study up to Week 6|Part I + Part II (Overall Study)||153||
59565968|NCT02303574|75668408|FG003|STARTED|Part 1b (Fed State) - SAD||0||
59565969|NCT02303574|75668409|FG004|STARTED|Part 1b (Fed State) - SAD||0||
60098887|NCT00938314|76215823|FG001|COMPLETED|Cohort 3||0||
60098888|NCT00938314|76215824|FG002|COMPLETED|Cohort 3||20||
60098889|NCT00938314|76215825|FG003|COMPLETED|Cohort 3||7||
60098890|NCT00938314|76215822|FG000|NOT COMPLETED|Cohort 3||0||
60098891|NCT00938314|76215823|FG001|NOT COMPLETED|Cohort 3||0||
60098892|NCT00938314|76215824|FG002|NOT COMPLETED|Cohort 3||4||
60098893|NCT00938314|76215825|FG003|NOT COMPLETED|Cohort 3||1||
60098894|NCT01591460|76215835|FG000|STARTED|Overall Study|Those with elevated (Week 12) or detectable (Week 24) virus discontinued due to the Futility Rule.|165||
60098895|NCT01591460|76215835|FG000|COMPLETED|Overall Study|The number who completed PEG-IFN, as scheduled according to response-guided treatment, is presented.|139||
60098896|NCT01591460|76215835|FG000|NOT COMPLETED|Overall Study||26||
60098897|NCT03678675|76215847|FG000|STARTED|Overall Study||74||
60098898|NCT03678675|76215848|FG001|STARTED|Overall Study||74||
60098899|NCT03678675|76215847|FG000|COMPLETED|Overall Study||74||
60098900|NCT03678675|76215848|FG001|COMPLETED|Overall Study||74||
60098901|NCT03678675|76215847|FG000|NOT COMPLETED|Overall Study||0||
60098902|NCT03678675|76215848|FG001|NOT COMPLETED|Overall Study||0||
60098903|NCT01591382|76215858|FG000|STARTED|Overall Study||32||
60098904|NCT01591382|76215859|FG001|STARTED|Overall Study||32||
60098905|NCT01591382|76215858|FG000|COMPLETED|Overall Study||29||
60098906|NCT01591382|76215859|FG001|COMPLETED|Overall Study||30||
60098907|NCT01591382|76215858|FG000|NOT COMPLETED|Overall Study||3||
60098908|NCT01591382|76215859|FG001|NOT COMPLETED|Overall Study||2||
59563240|NCT01754480|75665437|FG000|COMPLETED|Part I + Part II (Overall Study)|Completed Virology follow-up visit at Month 3 or Month 6 (not required for 2 pediatric subjects)|138||
59563241|NCT01754480|75665438|FG001|COMPLETED|Part I + Part II (Overall Study)|Completed Virology follow-up visit at Month 3 or Month 6 (not required for 3 pediatric subjects)|139||
59563242|NCT01754480|75665437|FG000|NOT COMPLETED|Part I + Part II (Overall Study)||25||
59563243|NCT01754480|75665438|FG001|NOT COMPLETED|Part I + Part II (Overall Study)||23||
59563244|NCT01754480|75665437|FG000|STARTED|Primary Part II||111||
59563245|NCT01754480|75665438|FG001|STARTED|Primary Part II||113||
59563246|NCT01754480|75665437|FG000|Completed Study up to Week 6|Primary Part II||100||
59993962|NCT02383862|76109805|FG000|NOT COMPLETED|3 Month Follow up||23||
59993963|NCT02383862|76109806|FG001|NOT COMPLETED|3 Month Follow up||21||
59563247|NCT01754480|75665438|FG001|Completed Study up to Week 6|Primary Part II||108||
59563248|NCT01754480|75665437|FG000|COMPLETED|Primary Part II|Completed Virology follow-up visit at Month 3 or Month 6 (not required for pediatric subjects)|96||
59563249|NCT01754480|75665438|FG001|COMPLETED|Primary Part II|Completed Virology follow-up visit at Month 3 or Month 6 (not required for pediatric subjects)|102||
59563250|NCT01754480|75665437|FG000|NOT COMPLETED|Primary Part II||15||
59563251|NCT01754480|75665438|FG001|NOT COMPLETED|Primary Part II||11||
59563252|NCT02367599|75665447|FG000|STARTED|Overall Study||48||
59563253|NCT02367599|75665448|FG001|STARTED|Overall Study||48||
59563254|NCT02367599|75665447|FG000|COMPLETED|Overall Study||48||
59563255|NCT02367599|75665448|FG001|COMPLETED|Overall Study||48||
59563256|NCT02367599|75665447|FG000|NOT COMPLETED|Overall Study||0||
59563257|NCT02367599|75665448|FG001|NOT COMPLETED|Overall Study||0||
59563258|NCT02368457|75665456|FG000|STARTED|Overall Study||12||
59563259|NCT02368457|75665457|FG001|STARTED|Overall Study||12||
59563260|NCT02368457|75665456|FG000|COMPLETED|Overall Study||12||
59563261|NCT02368457|75665457|FG001|COMPLETED|Overall Study||12||
59563262|NCT02368457|75665456|FG000|NOT COMPLETED|Overall Study||0||
59563263|NCT02368457|75665457|FG001|NOT COMPLETED|Overall Study||0||
59993964|NCT02383472|76109821|FG000|STARTED|Overall Study||23||
59993965|NCT02383472|76109822|FG001|STARTED|Overall Study||30||
59993966|NCT02383472|76109821|FG000|COMPLETED|Overall Study||22||
59993967|NCT02383472|76109822|FG001|COMPLETED|Overall Study||29||
59993968|NCT02383472|76109821|FG000|NOT COMPLETED|Overall Study||1||
59993969|NCT02383472|76109822|FG001|NOT COMPLETED|Overall Study||1||
59993970|NCT02234323|76109830|FG000|STARTED|All Enrolled||108||
59993971|NCT02234323|76109830|FG000|COMPLETED|All Enrolled|These participants received at least one dose of study drug.|103||
59993972|NCT02234323|76109830|FG000|NOT COMPLETED|All Enrolled||5||
59993973|NCT02234323|76109830|FG000|STARTED|All Treated||103||
59993974|NCT02234323|76109830|FG000|Episodic Treatment Regimen|All Treated|Participants were treated in more than one regimen and counted in all categories wherever applicable|81||
59993975|NCT02234323|76109830|FG000|Prophylactic Treatment Regimen|All Treated|69 participants among the 81 who started in episodic regimen, switched to the prophylactic regimen.|89||
59995205|NCT02648217|76111028|FG000|STARTED|Overall Study||131||
59563264|NCT01754714|75665468|FG000|STARTED|Overall Study||27||
59563265|NCT01754714|75665469|FG001|STARTED|Overall Study||27||
59563266|NCT01754714|75665470|FG002|STARTED|Overall Study||26||
59563267|NCT01754714|75665471|FG003|STARTED|Overall Study||28||
59563268|NCT01754714|75665468|FG000|COMPLETED|Overall Study||27||
59563269|NCT01754714|75665469|FG001|COMPLETED|Overall Study||26||
59563270|NCT01754714|75665470|FG002|COMPLETED|Overall Study||24||
59563271|NCT01754714|75665471|FG003|COMPLETED|Overall Study||27||
59563272|NCT01754714|75665468|FG000|NOT COMPLETED|Overall Study||0||
59563273|NCT01754714|75665469|FG001|NOT COMPLETED|Overall Study||1||
59563274|NCT01754714|75665470|FG002|NOT COMPLETED|Overall Study||2||
59563275|NCT01754714|75665471|FG003|NOT COMPLETED|Overall Study||1||
59563276|NCT02370407|75665484|FG000|STARTED|Overall Study||20||
59563277|NCT02370407|75665485|FG001|STARTED|Overall Study||20||
59993976|NCT02234323|76109830|FG000|Immune Tolerance Induction (ITI)|All Treated|1/81 on episodic and 14/89 on prophylactic regimen had inhibitors and were switched directly to ITI.|15||
59993977|NCT02234323|76109830|FG000|COMPLETED|All Treated||85||
60098909|NCT00931996|76215865|FG000|STARTED|Overall Study||12||
60098910|NCT00931996|76215865|FG000|COMPLETED|Overall Study||5||
60098911|NCT00931996|76215865|FG000|NOT COMPLETED|Overall Study||7||
59993978|NCT02234323|76109830|FG000|NOT COMPLETED|All Treated||18||
59993979|NCT02414828|76109840|FG000|STARTED|Overall Study||11||
59993980|NCT02414828|76109841|FG001|STARTED|Overall Study||10||
59993981|NCT02414828|76109842|FG002|STARTED|Overall Study||20||
59993982|NCT02414828|76109843|FG003|STARTED|Overall Study||31||
59993983|NCT02414828|76109840|FG000|COMPLETED|Overall Study||11||
59993984|NCT02414828|76109841|FG001|COMPLETED|Overall Study||9||
59993985|NCT02414828|76109842|FG002|COMPLETED|Overall Study||19||
59993986|NCT02414828|76109843|FG003|COMPLETED|Overall Study||29||
60098912|NCT00928174|76215869|FG000|STARTED|Overall Study||27||
60098913|NCT00928174|76215869|FG000|COMPLETED|Overall Study|3 withdrawn before start of participation|22||
60098914|NCT00928174|76215869|FG000|NOT COMPLETED|Overall Study||5||
60098915|NCT01696214|76215877|FG000|STARTED|Overall Study||5||
60098916|NCT01696214|76215878|FG001|STARTED|Overall Study||5||
60098917|NCT01696214|76215879|FG002|STARTED|Overall Study||5||
60098918|NCT01696214|76215880|FG003|STARTED|Overall Study||5||
60098919|NCT01696214|76215877|FG000|COMPLETED|Overall Study||4||
60098920|NCT01696214|76215878|FG001|COMPLETED|Overall Study||5||
60098921|NCT01696214|76215879|FG002|COMPLETED|Overall Study||5||
60098922|NCT01696214|76215880|FG003|COMPLETED|Overall Study||5||
60098923|NCT01696214|76215877|FG000|NOT COMPLETED|Overall Study||1||
60098924|NCT01696214|76215878|FG001|NOT COMPLETED|Overall Study||0||
60098925|NCT01696214|76215879|FG002|NOT COMPLETED|Overall Study||0||
60098926|NCT01696214|76215880|FG003|NOT COMPLETED|Overall Study||0||
60098927|NCT02083263|76215900|FG000|STARTED|Overall Study||16||
60098928|NCT02083263|76215901|FG001|STARTED|Overall Study||16||
60098929|NCT02083263|76215900|FG000|COMPLETED|Overall Study||16||
60098930|NCT02083263|76215901|FG001|COMPLETED|Overall Study||16||
60098931|NCT02083263|76215900|FG000|NOT COMPLETED|Overall Study||0||
60098932|NCT02083263|76215901|FG001|NOT COMPLETED|Overall Study||0||
60098933|NCT01543087|76215913|FG000|STARTED|Stage 1 (48 Months)||70||
59563278|NCT02370407|75665484|FG000|COMPLETED|Overall Study||20||
59563279|NCT02370407|75665485|FG001|COMPLETED|Overall Study||20||
59563280|NCT02370407|75665484|FG000|NOT COMPLETED|Overall Study||0||
59993987|NCT02414828|76109840|FG000|NOT COMPLETED|Overall Study||0||
59993988|NCT02414828|76109841|FG001|NOT COMPLETED|Overall Study||1||
59993989|NCT02414828|76109842|FG002|NOT COMPLETED|Overall Study||1||
60098934|NCT01543087|76215914|FG001|STARTED|Stage 1 (48 Months)||103||
60098935|NCT01543087|76215915|FG002|STARTED|Stage 1 (48 Months)||277||
60098936|NCT01543087|76215916|FG003|STARTED|Stage 1 (48 Months)||116||
60098937|NCT01543087|76215917|FG004|STARTED|Stage 1 (48 Months)||86||
60098938|NCT01543087|76215918|FG005|STARTED|Stage 1 (48 Months)||46||
60098939|NCT01543087|76215913|FG000|Safety Population|Stage 1 (48 Months)||70|Participants who had at least 1 blood draw in this study.|
60098940|NCT01543087|76215914|FG001|Safety Population|Stage 1 (48 Months)||101|Participants who had at least 1 blood draw in this study.|
60098941|NCT01543087|76215915|FG002|Safety Population|Stage 1 (48 Months)||277|Participants who had at least 1 blood draw in this study.|
59563281|NCT02370407|75665485|FG001|NOT COMPLETED|Overall Study||0||
60098942|NCT01543087|76215916|FG003|Safety Population|Stage 1 (48 Months)||116|Participants who had at least 1 blood draw in this study.|
60098943|NCT01543087|76215917|FG004|Safety Population|Stage 1 (48 Months)||86|Participants who had at least 1 blood draw in this study.|
60098944|NCT01543087|76215918|FG005|Safety Population|Stage 1 (48 Months)||46|Participants who had at least 1 blood draw in this study.|
60098945|NCT01543087|76215913|FG000|COMPLETED|Stage 1 (48 Months)||56||
60098946|NCT01543087|76215914|FG001|COMPLETED|Stage 1 (48 Months)||93||
60098947|NCT01543087|76215915|FG002|COMPLETED|Stage 1 (48 Months)||237||
60098948|NCT01543087|76215916|FG003|COMPLETED|Stage 1 (48 Months)||108||
59563282|NCT01756976|75665497|FG000|STARTED|Overall Study||76||
60098949|NCT01543087|76215917|FG004|COMPLETED|Stage 1 (48 Months)||83||
60098950|NCT01543087|76215918|FG005|COMPLETED|Stage 1 (48 Months)||46||
60098951|NCT01543087|76215913|FG000|NOT COMPLETED|Stage 1 (48 Months)||14||
60098952|NCT01543087|76215914|FG001|NOT COMPLETED|Stage 1 (48 Months)||10||
60098953|NCT01543087|76215915|FG002|NOT COMPLETED|Stage 1 (48 Months)||40||
59563283|NCT01756976|75665498|FG001|STARTED|Overall Study||8||
59563284|NCT01756976|75665497|FG000|COMPLETED|Overall Study||73||
59563285|NCT01756976|75665498|FG001|COMPLETED|Overall Study||8||
59563286|NCT01756976|75665497|FG000|NOT COMPLETED|Overall Study||3||
59563287|NCT01756976|75665498|FG001|NOT COMPLETED|Overall Study||0||
59563288|NCT02371187|75665506|FG000|STARTED|Overall Study||18||
59708264|NCT01113801|75827085|FG003|Received at Least One Dose of Drug|Overall Study||105||
59708265|NCT01113801|75827082|FG000|COMPLETED|Overall Study||62||
59993990|NCT02414828|76109843|FG003|NOT COMPLETED|Overall Study||2||
59993991|NCT02413346|76109856|FG000|STARTED|Overall Study||236||
59993992|NCT02413346|76109857|FG001|STARTED|Overall Study||247||
59993993|NCT02413346|76109856|FG000|COMPLETED|Overall Study||177||
59993994|NCT02413346|76109857|FG001|COMPLETED|Overall Study||177||
59993995|NCT02413346|76109856|FG000|NOT COMPLETED|Overall Study||59||
59993996|NCT02413346|76109857|FG001|NOT COMPLETED|Overall Study||70||
60098954|NCT01543087|76215916|FG003|NOT COMPLETED|Stage 1 (48 Months)||8||
60098955|NCT01543087|76215917|FG004|NOT COMPLETED|Stage 1 (48 Months)||3||
60098956|NCT01543087|76215918|FG005|NOT COMPLETED|Stage 1 (48 Months)||0||
60098957|NCT01543087|76215913|FG000|STARTED|Booster Stage (26 Months)|Group1 participants (primary study B1971015)were not invited to participate in Booster stage (BS).|0||
59563289|NCT02371187|75665507|FG001|STARTED|Overall Study||19||
59563290|NCT02371187|75665506|FG000|COMPLETED|Overall Study||15||
59563291|NCT02371187|75665507|FG001|COMPLETED|Overall Study||15||
59563292|NCT02371187|75665506|FG000|NOT COMPLETED|Overall Study||3||
59563293|NCT02371187|75665507|FG001|NOT COMPLETED|Overall Study||4||
59563294|NCT02373137|75665515|FG000|STARTED|Overall Study||19||25
59563295|NCT02373137|75665516|FG001|STARTED|Overall Study||19||25
59708266|NCT01113801|75827083|FG001|COMPLETED|Overall Study||65||
59993997|NCT04048343|76109863|FG000|STARTED|Overall Study||65||
60098958|NCT01543087|76215914|FG001|STARTED|Booster Stage (26 Months)|BS was optional for eligible participants. Not all participants completing stage 1 continued to BS.|60||
59993998|NCT04048343|76109863|FG000|COMPLETED|Overall Study||65||
59993999|NCT04048343|76109863|FG000|NOT COMPLETED|Overall Study||0||
60098959|NCT01543087|76215915|FG002|STARTED|Booster Stage (26 Months)|BS was optional for eligible participants. Not all participants completing stage 1 continued to BS.|92||
60098960|NCT01543087|76215916|FG003|STARTED|Booster Stage (26 Months)|BS was optional for eligible participants. Not all participants completing stage 1 continued to BS.|64||
60098961|NCT01543087|76215917|FG004|STARTED|Booster Stage (26 Months)|BS was optional for eligible participants. Not all participants completing stage 1 continued to BS.|56||
60098962|NCT01543087|76215918|FG005|STARTED|Booster Stage (26 Months)|BS was optional for eligible participants. Not all participants completing stage 1 continued to BS.|32||
60098963|NCT01543087|76215913|FG000|Vaccinated|Booster Stage (26 Months)||0||
60098964|NCT01543087|76215914|FG001|Vaccinated|Booster Stage (26 Months)||59||
60098965|NCT01543087|76215915|FG002|Vaccinated|Booster Stage (26 Months)||92||
60098966|NCT01543087|76215916|FG003|Vaccinated|Booster Stage (26 Months)||64||
60098967|NCT01543087|76215917|FG004|Vaccinated|Booster Stage (26 Months)||54||
60098968|NCT01543087|76215918|FG005|Vaccinated|Booster Stage (26 Months)||32||
59708267|NCT01113801|75827084|FG002|COMPLETED|Overall Study||66||
59708268|NCT01113801|75827085|FG003|COMPLETED|Overall Study||65||
59708269|NCT01113801|75827082|FG000|NOT COMPLETED|Overall Study||41||
59708270|NCT01113801|75827083|FG001|NOT COMPLETED|Overall Study||40||
59708271|NCT01113801|75827084|FG002|NOT COMPLETED|Overall Study||37||
60098969|NCT01543087|76215913|FG000|COMPLETED|Booster Stage (26 Months)||0||
60098970|NCT01543087|76215914|FG001|COMPLETED|Booster Stage (26 Months)||59||
60098971|NCT01543087|76215915|FG002|COMPLETED|Booster Stage (26 Months)||91||
60098972|NCT01543087|76215916|FG003|COMPLETED|Booster Stage (26 Months)||64||
60098973|NCT01543087|76215917|FG004|COMPLETED|Booster Stage (26 Months)||54||
60098974|NCT01543087|76215918|FG005|COMPLETED|Booster Stage (26 Months)||32||
60098975|NCT01543087|76215913|FG000|NOT COMPLETED|Booster Stage (26 Months)||0||
60098976|NCT01543087|76215914|FG001|NOT COMPLETED|Booster Stage (26 Months)||1||
60098977|NCT01543087|76215915|FG002|NOT COMPLETED|Booster Stage (26 Months)||1||
60098978|NCT01543087|76215916|FG003|NOT COMPLETED|Booster Stage (26 Months)||0||
60098979|NCT01543087|76215917|FG004|NOT COMPLETED|Booster Stage (26 Months)||2||
60098980|NCT01543087|76215918|FG005|NOT COMPLETED|Booster Stage (26 Months)||0||
60098981|NCT01696058|76215956|FG000|STARTED|Overall Study||566||
60098982|NCT01696058|76215957|FG001|STARTED|Overall Study||569||
60098983|NCT01696058|76215956|FG000|COMPLETED|Overall Study||523||
60098984|NCT01696058|76215957|FG001|COMPLETED|Overall Study||538||
60098985|NCT01696058|76215956|FG000|NOT COMPLETED|Overall Study||43||
60098986|NCT01696058|76215957|FG001|NOT COMPLETED|Overall Study||31||
60098987|NCT01695746|76215963|FG000|STARTED|Overall Study||108||
60098988|NCT01695746|76215963|FG000|COMPLETED|Overall Study||96||
60098989|NCT01695746|76215963|FG000|NOT COMPLETED|Overall Study||12||
60098990|NCT03790137|76215968|FG000|STARTED|Overall Study||20||
60098991|NCT03790137|76215968|FG000|COMPLETED|Overall Study||19||
60098992|NCT03790137|76215968|FG000|NOT COMPLETED|Overall Study||1||
60098993|NCT01694420|76215974|FG000|STARTED|Overall Study||33||
60098994|NCT01694420|76215974|FG000|COMPLETED|Overall Study||30||
60098995|NCT01694420|76215974|FG000|NOT COMPLETED|Overall Study||3||
60098996|NCT00705081|76215980|FG000|STARTED|Overall Study||255||
60098997|NCT00705081|76215981|FG001|STARTED|Overall Study||198||
60098998|NCT00705081|76215980|FG000|COMPLETED|Overall Study||255||
60098999|NCT00705081|76215981|FG001|COMPLETED|Overall Study||198||
60099000|NCT00705081|76215980|FG000|NOT COMPLETED|Overall Study||0||
60099001|NCT00705081|76215981|FG001|NOT COMPLETED|Overall Study||0||
60099002|NCT00704769|76215987|FG000|STARTED|Overall Study||591||
59708272|NCT01113801|75827085|FG003|NOT COMPLETED|Overall Study||41||
59708273|NCT01256684|75827098|FG000|STARTED|Overall Study||81||
59708274|NCT01256684|75827099|FG001|STARTED|Overall Study||87||
59708275|NCT01256684|75827100|FG002|STARTED|Overall Study||87||
60099003|NCT00704769|76215987|FG000|COMPLETED|Overall Study||591||
60099004|NCT00704769|76215987|FG000|NOT COMPLETED|Overall Study||0||
60099005|NCT00938548|76215993|FG000|STARTED|Overall Study||35||
60099006|NCT00938548|76215994|FG001|STARTED|Overall Study||35||
60099007|NCT00938548|76215993|FG000|COMPLETED|Overall Study||35||
60099008|NCT00938548|76215994|FG001|COMPLETED|Overall Study||35||
60099009|NCT00938548|76215993|FG000|NOT COMPLETED|Overall Study||0||
60099010|NCT00938548|76215994|FG001|NOT COMPLETED|Overall Study||0||
60099011|NCT00932620|76216002|FG000|STARTED|Overall Study||50||
60099012|NCT00932620|76216003|FG001|STARTED|Overall Study||50||
60099013|NCT00932620|76216002|FG000|COMPLETED|Overall Study||50||
60099014|NCT00932620|76216003|FG001|COMPLETED|Overall Study||50||
60099015|NCT00932620|76216002|FG000|NOT COMPLETED|Overall Study||0||
60099016|NCT00932620|76216003|FG001|NOT COMPLETED|Overall Study||0||
60099017|NCT00003453|76216011|FG000|STARTED|Overall Study||6||
60099018|NCT00003453|76216011|FG000|COMPLETED|Overall Study|One patient was not evaluable|5||
60099019|NCT00003453|76216011|FG000|NOT COMPLETED|Overall Study||1||
60099020|NCT00938704|76216017|FG000|STARTED|Overall Study||33||
60099021|NCT00938704|76216018|FG001|STARTED|Overall Study||37||
60099022|NCT00938704|76216017|FG000|COMPLETED|Overall Study||33||
60099023|NCT00938704|76216018|FG001|COMPLETED|Overall Study||37||
60099024|NCT00938704|76216017|FG000|NOT COMPLETED|Overall Study||0||
60099025|NCT00938704|76216018|FG001|NOT COMPLETED|Overall Study||0||
60099026|NCT00938782|76216026|FG000|STARTED|Overall Study|Pre-induction of anesthesia|32||
60099027|NCT00938782|76216027|FG001|STARTED|Overall Study|Monitoring started pre-induction of anesthesia|35||
60099028|NCT00938782|76216026|FG000|COMPLETED|Overall Study|Upon discharge from PACU|32||
60099029|NCT00938782|76216027|FG001|COMPLETED|Overall Study|Upon discharge from PACU|35||
60099030|NCT00938782|76216026|FG000|NOT COMPLETED|Overall Study||0||
59563296|NCT02373137|75665515|FG000|3-Month Follow-Up|Overall Study||19||25
59563297|NCT02373137|75665516|FG001|3-Month Follow-Up|Overall Study||19||25
59563298|NCT02373137|75665515|FG000|6-Month Follow-Up|Overall Study||19||25
59565970|NCT02303574|75668410|FG005|STARTED|Part 1b (Fed State) - SAD||5||
60099031|NCT00938782|76216027|FG001|NOT COMPLETED|Overall Study||0||
60099032|NCT00928642|76216033|FG000|STARTED|Overall Study||8||
60099033|NCT00928642|76216033|FG000|COMPLETED|Overall Study|1 subject withdrew after 1st cycle but before disease assessment. 7 of 8 are evaluable for response|8||
60099034|NCT00928642|76216033|FG000|NOT COMPLETED|Overall Study||0||
60099035|NCT00928720|76216043|FG000|STARTED|Overall Study||19||
60099036|NCT00928720|76216044|FG001|STARTED|Overall Study||20||
60099037|NCT00928720|76216045|FG002|STARTED|Overall Study||18||
60099038|NCT00928720|76216043|FG000|COMPLETED|Overall Study||17||
60099039|NCT00928720|76216044|FG001|COMPLETED|Overall Study||14||
60099040|NCT00928720|76216045|FG002|COMPLETED|Overall Study||15||
60099041|NCT00928720|76216043|FG000|NOT COMPLETED|Overall Study||2||
60099042|NCT00928720|76216044|FG001|NOT COMPLETED|Overall Study||6||
60099043|NCT00928720|76216045|FG002|NOT COMPLETED|Overall Study||3||
60099044|NCT00934024|76216058|FG000|STARTED|Overall Study||10||
60099045|NCT00934024|76216059|FG001|STARTED|Overall Study||11||
60099046|NCT00934024|76216058|FG000|COMPLETED|Overall Study||10||
60099047|NCT00934024|76216059|FG001|COMPLETED|Overall Study||6||
59563299|NCT02373137|75665516|FG001|6-Month Follow-Up|Overall Study||18||24
59563300|NCT02373137|75665515|FG000|12-Month Follow-Up|Overall Study||19||25
59563301|NCT02373137|75665516|FG001|12-Month Follow-Up|Overall Study||19||25
60099048|NCT00934024|76216058|FG000|NOT COMPLETED|Overall Study||0||
60099049|NCT00934024|76216059|FG001|NOT COMPLETED|Overall Study||5||
60099050|NCT00928954|76216064|FG000|STARTED|Overall Study||4||
59563302|NCT02373137|75665515|FG000|COMPLETED|Overall Study||18||24
59708276|NCT01256684|75827098|FG000|Safety Population|Overall Study||80||
59708277|NCT01256684|75827099|FG001|Safety Population|Overall Study||86||
59994000|NCT03390101|76109870|FG000|STARTED|Weeks 0-12||85||
59994001|NCT03390101|76109871|FG001|STARTED|Weeks 0-12||84||
59994002|NCT03390101|76109872|FG002|STARTED|Weeks 0-12||44||
59994003|NCT03390101|76109870|FG000|COMPLETED|Weeks 0-12||85||
59994004|NCT03390101|76109871|FG001|COMPLETED|Weeks 0-12||82||
60099051|NCT00928954|76216065|FG001|STARTED|Overall Study||6||
60099052|NCT00928954|76216064|FG000|COMPLETED|Overall Study||4||
60099053|NCT00928954|76216065|FG001|COMPLETED|Overall Study||6||
60099054|NCT00928954|76216064|FG000|NOT COMPLETED|Overall Study||0||
60099055|NCT00928954|76216065|FG001|NOT COMPLETED|Overall Study||0||
60099056|NCT00939562|76216071|FG000|STARTED|Period 1||12||
60099057|NCT00939562|76216072|FG001|STARTED|Period 1||12||
60099058|NCT00939562|76216071|FG000|COMPLETED|Period 1||12||
60099059|NCT00939562|76216072|FG001|COMPLETED|Period 1||12||
60099060|NCT00939562|76216071|FG000|NOT COMPLETED|Period 1||0||
60099061|NCT00939562|76216072|FG001|NOT COMPLETED|Period 1||0||
59994005|NCT03390101|76109872|FG002|COMPLETED|Weeks 0-12||43||
59994006|NCT03390101|76109870|FG000|NOT COMPLETED|Weeks 0-12||0||
59994007|NCT03390101|76109871|FG001|NOT COMPLETED|Weeks 0-12||2||
59994008|NCT03390101|76109872|FG002|NOT COMPLETED|Weeks 0-12||1||
59994009|NCT03390101|76109870|FG000|STARTED|Weeks 12-54||85||
59994010|NCT03390101|76109871|FG001|STARTED|Weeks 12-54||82||
59994011|NCT03390101|76109872|FG002|STARTED|Weeks 12-54||43||
59994012|NCT03390101|76109870|FG000|COMPLETED|Weeks 12-54||82||
60099062|NCT00939562|76216071|FG000|STARTED|Period 2||12||
60099063|NCT00939562|76216072|FG001|STARTED|Period 2||12||
60099064|NCT00939562|76216071|FG000|COMPLETED|Period 2||12||
60099065|NCT00939562|76216072|FG001|COMPLETED|Period 2||12||
60099066|NCT00939562|76216071|FG000|NOT COMPLETED|Period 2||0||
60099067|NCT00939562|76216072|FG001|NOT COMPLETED|Period 2||0||
60099068|NCT00935428|76216078|FG000|STARTED|Overall Study||231||
60099069|NCT00935428|76216078|FG000|COMPLETED|Overall Study||231||
60099070|NCT00935428|76216078|FG000|NOT COMPLETED|Overall Study||0||
60099071|NCT02084511|76216092|FG000|STARTED|Overall Study||20||
60099072|NCT02084511|76216093|FG001|STARTED|Overall Study||20||
60099073|NCT02084511|76216094|FG002|STARTED|Overall Study||20||
60099074|NCT02084511|76216095|FG003|STARTED|Overall Study||20||
60099075|NCT02084511|76216092|FG000|COMPLETED|Overall Study||20||
60099076|NCT02084511|76216093|FG001|COMPLETED|Overall Study||20||
60099077|NCT02084511|76216094|FG002|COMPLETED|Overall Study||20||
59994013|NCT03390101|76109871|FG001|COMPLETED|Weeks 12-54||78||
60099078|NCT02084511|76216095|FG003|COMPLETED|Overall Study||20||
60099079|NCT02084511|76216092|FG000|NOT COMPLETED|Overall Study||0||
59563303|NCT02373137|75665516|FG001|COMPLETED|Overall Study||18||23
59563304|NCT02373137|75665515|FG000|NOT COMPLETED|Overall Study||1||1
59563305|NCT02373137|75665516|FG001|NOT COMPLETED|Overall Study||1||2
59563306|NCT01757678|75665523|FG000|STARTED|Overall Study||276||
59563307|NCT01757678|75665523|FG000|COMPLETED|Overall Study||276||
59563308|NCT01757678|75665523|FG000|NOT COMPLETED|Overall Study||0||
59563309|NCT02373371|75665533|FG000|STARTED|Overall Study||13||
59563310|NCT02373371|75665534|FG001|STARTED|Overall Study||13||
59563311|NCT02373371|75665533|FG000|COMPLETED|Overall Study||13||
59563312|NCT02373371|75665534|FG001|COMPLETED|Overall Study||13||
59563313|NCT02373371|75665533|FG000|NOT COMPLETED|Overall Study||0||
59563314|NCT02373371|75665534|FG001|NOT COMPLETED|Overall Study||0||
59563315|NCT01759160|75665542|FG000|STARTED|Overall Study||30||
59563316|NCT01759160|75665543|FG001|STARTED|Overall Study||30||
59563317|NCT01759160|75665542|FG000|COMPLETED|Overall Study||30||
59563318|NCT01759160|75665543|FG001|COMPLETED|Overall Study||30||
59994014|NCT03390101|76109872|FG002|COMPLETED|Weeks 12-54||41||
60099080|NCT02084511|76216093|FG001|NOT COMPLETED|Overall Study||0||
60099081|NCT02084511|76216094|FG002|NOT COMPLETED|Overall Study||0||
60099082|NCT02084511|76216095|FG003|NOT COMPLETED|Overall Study||0||
60099083|NCT00942448|76216109|FG000|STARTED|Overall Study||77||
60099084|NCT00942448|76216110|FG001|STARTED|Overall Study||76||
60099085|NCT00942448|76216111|FG002|STARTED|Overall Study||78||
60099086|NCT00942448|76216112|FG003|STARTED|Overall Study||75||
60099087|NCT00942448|76216109|FG000|COMPLETED|Overall Study||77||
60099088|NCT00942448|76216110|FG001|COMPLETED|Overall Study||76||
60099089|NCT00942448|76216111|FG002|COMPLETED|Overall Study||78||
59563319|NCT01759160|75665542|FG000|NOT COMPLETED|Overall Study||0||
59994015|NCT03390101|76109870|FG000|NOT COMPLETED|Weeks 12-54||3||
59994016|NCT03390101|76109871|FG001|NOT COMPLETED|Weeks 12-54||4||
59994017|NCT03390101|76109872|FG002|NOT COMPLETED|Weeks 12-54||2||
59994018|NCT02732639|76109880|FG000|STARTED|Overall Study||31||
59994019|NCT02732639|76109880|FG000|COMPLETED|Overall Study||30||
59994020|NCT02732639|76109880|FG000|NOT COMPLETED|Overall Study||1||
59994021|NCT02732561|76109886|FG000|STARTED|Overall Study||5||
59994022|NCT02732561|76109887|FG001|STARTED|Overall Study||5||
59994023|NCT02732561|76109886|FG000|COMPLETED|Overall Study||3||
60099090|NCT00942448|76216112|FG003|COMPLETED|Overall Study||75||
60099091|NCT00942448|76216109|FG000|NOT COMPLETED|Overall Study||0||
60099092|NCT00942448|76216110|FG001|NOT COMPLETED|Overall Study||0||
60099093|NCT00942448|76216111|FG002|NOT COMPLETED|Overall Study||0||
60099094|NCT00942448|76216112|FG003|NOT COMPLETED|Overall Study||0||
60099095|NCT00939796|76216126|FG000|STARTED|Overall Study||16||
60099096|NCT00939796|76216126|FG000|COMPLETED|Overall Study||16||
59563320|NCT01759160|75665543|FG001|NOT COMPLETED|Overall Study||0||
59563321|NCT02376179|75665549|FG000|STARTED|Overall Study||84||
59563322|NCT02376179|75665549|FG000|COMPLETED|Overall Study||84||
59563323|NCT02376179|75665549|FG000|NOT COMPLETED|Overall Study||0||
59563324|NCT01762904|75665553|FG000|STARTED|Overall Study|January, 2013|135||
59994024|NCT02732561|76109887|FG001|COMPLETED|Overall Study||4||
59994025|NCT02732561|76109886|FG000|NOT COMPLETED|Overall Study||2||
60099097|NCT00939796|76216126|FG000|NOT COMPLETED|Overall Study||0||
60099098|NCT00939874|76216130|FG000|STARTED|Overall Study||52||
60099099|NCT00939874|76216130|FG000|Completed Week 48|Overall Study||37||
60099100|NCT00939874|76216130|FG000|COMPLETED|Overall Study||32||
60099101|NCT00939874|76216130|FG000|NOT COMPLETED|Overall Study||20||
60099102|NCT01670565|76216136|FG000|STARTED|Overall Study||10||
60099103|NCT01670565|76216137|FG001|STARTED|Overall Study||10||
60099104|NCT01670565|76216136|FG000|COMPLETED|Overall Study||9||
60099105|NCT01670565|76216137|FG001|COMPLETED|Overall Study||9||
60099106|NCT01670565|76216136|FG000|NOT COMPLETED|Overall Study||1||
60099107|NCT01670565|76216137|FG001|NOT COMPLETED|Overall Study||1||
60099108|NCT01675479|76216145|FG000|STARTED|Overall Study||69||135
59563325|NCT01762904|75665553|FG000|COMPLETED|Overall Study|October, 2013|135||
59708278|NCT01256684|75827100|FG002|Safety Population|Overall Study||87||
60099109|NCT01675479|76216145|FG000|COMPLETED|Overall Study||58||112
60099110|NCT01675479|76216145|FG000|NOT COMPLETED|Overall Study||11||23
60099111|NCT00943150|76216151|FG000|STARTED|Overall Study||10||
60099112|NCT00943150|76216152|FG001|STARTED|Overall Study||10||
60099113|NCT00943150|76216151|FG000|COMPLETED|Overall Study||10||
60099114|NCT00943150|76216152|FG001|COMPLETED|Overall Study||10||
60099115|NCT00943150|76216151|FG000|NOT COMPLETED|Overall Study||0||
60099116|NCT00943150|76216152|FG001|NOT COMPLETED|Overall Study||0||
60099117|NCT04320940|76216164|FG000|STARTED|Overall Study||3||
60099118|NCT04320940|76216165|FG001|STARTED|Overall Study||1||
60099119|NCT04320940|76216164|FG000|COMPLETED|Overall Study||3||
60099120|NCT04320940|76216165|FG001|COMPLETED|Overall Study||1||
60099121|NCT04320940|76216164|FG000|NOT COMPLETED|Overall Study||0||
60099122|NCT04320940|76216165|FG001|NOT COMPLETED|Overall Study||0||
59708279|NCT01256684|75827098|FG000|ITT Population|Overall Study||77||
59563326|NCT01762904|75665553|FG000|NOT COMPLETED|Overall Study||0||
59708280|NCT01256684|75827099|FG001|ITT Population|Overall Study||79||
60099123|NCT00939952|76216171|FG000|STARTED|Overall Study||7||
60099124|NCT00939952|76216171|FG000|COMPLETED|Overall Study||7||
60099125|NCT00939952|76216171|FG000|NOT COMPLETED|Overall Study||0||
60099126|NCT00947752|76216177|FG000|STARTED|7-Day Run-in Treatment Period|All subjects started with a daily does of F1 for 7 days|147||
60099127|NCT00947752|76216178|FG001|STARTED|7-Day Run-in Treatment Period||0||
60099128|NCT00947752|76216177|FG000|COMPLETED|7-Day Run-in Treatment Period||147||
60099129|NCT00947752|76216178|FG001|COMPLETED|7-Day Run-in Treatment Period||0||
60099130|NCT00947752|76216177|FG000|NOT COMPLETED|7-Day Run-in Treatment Period||0||
60099131|NCT00947752|76216178|FG001|NOT COMPLETED|7-Day Run-in Treatment Period||0||
60099132|NCT00947752|76216177|FG000|STARTED|1st 14-day Treatment Period||76||
59563327|NCT02376257|75665563|FG000|STARTED|Overall Study||13||
59708281|NCT01256684|75827100|FG002|ITT Population|Overall Study||81||
59708282|NCT01256684|75827098|FG000|COMPLETED|Overall Study||72||
59708283|NCT01256684|75827099|FG001|COMPLETED|Overall Study||74||
59994026|NCT02732561|76109887|FG001|NOT COMPLETED|Overall Study||1||
59994027|NCT02412878|76109895|FG000|STARTED|Overall Study||238||
59994028|NCT02412878|76109896|FG001|STARTED|Overall Study||240||
59994029|NCT02412878|76109895|FG000|Received Carfilzomib|Overall Study||235||
59994030|NCT02412878|76109896|FG001|Received Carfilzomib|Overall Study||238||
60099133|NCT00947752|76216178|FG001|STARTED|1st 14-day Treatment Period||71||
60099134|NCT00947752|76216177|FG000|COMPLETED|1st 14-day Treatment Period||76||
60099135|NCT00947752|76216178|FG001|COMPLETED|1st 14-day Treatment Period||71||
60099136|NCT00947752|76216177|FG000|NOT COMPLETED|1st 14-day Treatment Period||0||
60099137|NCT00947752|76216178|FG001|NOT COMPLETED|1st 14-day Treatment Period||0||
60099138|NCT00947752|76216177|FG000|STARTED|Crossover to 2nd 14-day Treatment Period||71||
60099139|NCT00947752|76216178|FG001|STARTED|Crossover to 2nd 14-day Treatment Period||76||
60099140|NCT00947752|76216177|FG000|COMPLETED|Crossover to 2nd 14-day Treatment Period||71||
60099141|NCT00947752|76216178|FG001|COMPLETED|Crossover to 2nd 14-day Treatment Period||76||
60099142|NCT00947752|76216177|FG000|NOT COMPLETED|Crossover to 2nd 14-day Treatment Period||0||
60099143|NCT00947752|76216178|FG001|NOT COMPLETED|Crossover to 2nd 14-day Treatment Period||0||
60099144|NCT00948298|76216186|FG000|STARTED|Overall Study||65||
60099145|NCT00948298|76216187|FG001|STARTED|Overall Study||65||
60099146|NCT00948298|76216186|FG000|COMPLETED|Overall Study||55||
60099147|NCT00948298|76216187|FG001|COMPLETED|Overall Study||60||
60099148|NCT00948298|76216186|FG000|NOT COMPLETED|Overall Study||10||
60099149|NCT00948298|76216187|FG001|NOT COMPLETED|Overall Study||5||
60099150|NCT00948610|76216195|FG000|STARTED|Overall Study||10||
60099151|NCT00948610|76216196|FG001|STARTED|Overall Study||10||
60099152|NCT00948610|76216195|FG000|COMPLETED|Overall Study||9||
60099153|NCT00948610|76216196|FG001|COMPLETED|Overall Study||9||
60099154|NCT00948610|76216195|FG000|NOT COMPLETED|Overall Study||1||
60099155|NCT00948610|76216196|FG001|NOT COMPLETED|Overall Study||1||
60099156|NCT00944554|76216204|FG000|STARTED|Overall Study||50||
60099157|NCT00944554|76216205|FG001|STARTED|Overall Study||54||
60099158|NCT00944554|76216204|FG000|COMPLETED|Overall Study||22||
60099159|NCT00944554|76216205|FG001|COMPLETED|Overall Study||25||
60099160|NCT00944554|76216204|FG000|NOT COMPLETED|Overall Study||28||
60099161|NCT00944554|76216205|FG001|NOT COMPLETED|Overall Study||29||
60099162|NCT00944710|76216213|FG000|STARTED|10-week Primary Outcome||40||
60099163|NCT00944710|76216214|FG001|STARTED|10-week Primary Outcome||33||
59708284|NCT01256684|75827100|FG002|COMPLETED|Overall Study||76||
59994031|NCT02412878|76109895|FG000|COMPLETED|Overall Study||217|Defined as participants who discontinued due to death or study closure|
59994032|NCT02412878|76109896|FG001|COMPLETED|Overall Study||227|Defined as participants who discontinued due to death or study closure|
59994033|NCT02412878|76109895|FG000|NOT COMPLETED|Overall Study||21||
59994034|NCT02412878|76109896|FG001|NOT COMPLETED|Overall Study||13||
59994035|NCT02380742|76109904|FG000|STARTED|Overall Study||28||
59994036|NCT02380742|76109905|FG001|STARTED|Overall Study||26||
59994037|NCT02380742|76109904|FG000|COMPLETED|Overall Study||27||
60099164|NCT00944710|76216213|FG000|COMPLETED|10-week Primary Outcome||40||
60099165|NCT00944710|76216214|FG001|COMPLETED|10-week Primary Outcome||33||
60099166|NCT00944710|76216213|FG000|NOT COMPLETED|10-week Primary Outcome||0||
60099167|NCT00944710|76216214|FG001|NOT COMPLETED|10-week Primary Outcome||0||
60099168|NCT00944710|76216213|FG000|STARTED|12-week Visit (Off-treatment)||40||
60099169|NCT00944710|76216214|FG001|STARTED|12-week Visit (Off-treatment)||33||
60099170|NCT00944710|76216213|FG000|COMPLETED|12-week Visit (Off-treatment)||40||
60099171|NCT00944710|76216214|FG001|COMPLETED|12-week Visit (Off-treatment)||33||
60099172|NCT00944710|76216213|FG000|NOT COMPLETED|12-week Visit (Off-treatment)||0||
60099173|NCT00944710|76216214|FG001|NOT COMPLETED|12-week Visit (Off-treatment)||0||
60099174|NCT00944710|76216213|FG000|STARTED|Additional Post 10-week Primary Outcome||40||
60099175|NCT00944710|76216214|FG001|STARTED|Additional Post 10-week Primary Outcome||33||
60099176|NCT00944710|76216213|FG000|Eligible to Enter Post 10-week Phase|Additional Post 10-week Primary Outcome||24||
60099177|NCT00944710|76216214|FG001|Eligible to Enter Post 10-week Phase|Additional Post 10-week Primary Outcome||26||
60099178|NCT00944710|76216213|FG000|COMPLETED|Additional Post 10-week Primary Outcome||23||
60099179|NCT00944710|76216214|FG001|COMPLETED|Additional Post 10-week Primary Outcome||22||
60099180|NCT00944710|76216213|FG000|NOT COMPLETED|Additional Post 10-week Primary Outcome||17||
60099181|NCT00944710|76216214|FG001|NOT COMPLETED|Additional Post 10-week Primary Outcome||11||
60099182|NCT00945100|76216222|FG000|STARTED|10-week Primary Outcome||83||
60099183|NCT00945100|76216223|FG001|STARTED|10-week Primary Outcome||86||
59994038|NCT02380742|76109905|FG001|COMPLETED|Overall Study||26||
59994039|NCT02380742|76109904|FG000|NOT COMPLETED|Overall Study||1||
59994040|NCT02380742|76109905|FG001|NOT COMPLETED|Overall Study||0||
60099184|NCT00945100|76216222|FG000|Completed, Eligible|10-week Primary Outcome|Eligible for Post-10 week phase|55||
59563328|NCT02376257|75665564|FG001|STARTED|Overall Study||12||
59563329|NCT02376257|75665565|FG002|STARTED|Overall Study||11||
59563330|NCT02376257|75665563|FG000|COMPLETED|Overall Study||13||
60099185|NCT00945100|76216223|FG001|Completed, Eligible|10-week Primary Outcome|Eligible for Post-10 week phase|63||
60099186|NCT00945100|76216222|FG000|Completed, Not Eligible|10-week Primary Outcome|Not Eligible for Post-10 week phase|27||
60099187|NCT00945100|76216223|FG001|Completed, Not Eligible|10-week Primary Outcome|Not Eligible for Post-10 week phase|20||
60099188|NCT00945100|76216222|FG000|COMPLETED|10-week Primary Outcome||82||
60099189|NCT00945100|76216223|FG001|COMPLETED|10-week Primary Outcome||83||
60099190|NCT00945100|76216222|FG000|NOT COMPLETED|10-week Primary Outcome||1||
59563331|NCT02376257|75665564|FG001|COMPLETED|Overall Study||12||
59563332|NCT02376257|75665565|FG002|COMPLETED|Overall Study||11||
60099191|NCT00945100|76216223|FG001|NOT COMPLETED|10-week Primary Outcome||3||
60099192|NCT00945100|76216222|FG000|STARTED|Post-10 Week Primary Outcome|27 participants were not eligible for Post 10 week Primary Outcome phase|55||
60099193|NCT00945100|76216223|FG001|STARTED|Post-10 Week Primary Outcome|20 participants were not eligible for Post 10 week Primary Outcome phase|63||
60099194|NCT00945100|76216222|FG000|COMPLETED|Post-10 Week Primary Outcome||51||
60099195|NCT00945100|76216223|FG001|COMPLETED|Post-10 Week Primary Outcome||56||
59563333|NCT02376257|75665563|FG000|NOT COMPLETED|Overall Study||0||
59563334|NCT02376257|75665564|FG001|NOT COMPLETED|Overall Study||0||
60099196|NCT00945100|76216222|FG000|NOT COMPLETED|Post-10 Week Primary Outcome||4||
60099197|NCT00945100|76216223|FG001|NOT COMPLETED|Post-10 Week Primary Outcome||7||
60099198|NCT00949078|76216231|FG000|STARTED|Overall Study||5||
59563335|NCT02376257|75665565|FG002|NOT COMPLETED|Overall Study||0||
59563336|NCT01762982|75665573|FG000|STARTED|Overall Study||36||
59563337|NCT01762982|75665573|FG000|Received Saline Water|Overall Study||36||
59563338|NCT01762982|75665573|FG000|Received Benzalkonium Chloride|Overall Study||36||
59563339|NCT01762982|75665573|FG000|Received SLS|Overall Study||36||
60099199|NCT00949078|76216232|FG001|STARTED|Overall Study||9||
60099200|NCT00949078|76216231|FG000|COMPLETED|Overall Study||5||
60099201|NCT00949078|76216232|FG001|COMPLETED|Overall Study||9||
60099202|NCT00949078|76216231|FG000|NOT COMPLETED|Overall Study||0||
60099203|NCT00949078|76216232|FG001|NOT COMPLETED|Overall Study||0||
60099204|NCT00945256|76216243|FG000|STARTED|Overall Study||13||
60099205|NCT00945256|76216244|FG001|STARTED|Overall Study||10||
60099206|NCT00945256|76216245|FG002|STARTED|Overall Study||15||
60099207|NCT00945256|76216246|FG003|STARTED|Overall Study||16||
60099208|NCT00945256|76216247|FG004|STARTED|Overall Study||8||
60099209|NCT00945256|76216243|FG000|COMPLETED|Overall Study||9||
60099210|NCT00945256|76216244|FG001|COMPLETED|Overall Study||8||
60099211|NCT00945256|76216245|FG002|COMPLETED|Overall Study||7||
60099212|NCT00945256|76216246|FG003|COMPLETED|Overall Study||7||
60099213|NCT00945256|76216247|FG004|COMPLETED|Overall Study||7||
60099214|NCT00945256|76216243|FG000|NOT COMPLETED|Overall Study||4||
60099215|NCT00945256|76216244|FG001|NOT COMPLETED|Overall Study||2||
60099216|NCT00945256|76216245|FG002|NOT COMPLETED|Overall Study||8||
60099217|NCT00945256|76216246|FG003|NOT COMPLETED|Overall Study||9||
60099218|NCT00945256|76216247|FG004|NOT COMPLETED|Overall Study||1||
60099219|NCT00940576|76216259|FG000|STARTED|Overall Study||8||
60099220|NCT00940576|76216260|FG001|STARTED|Overall Study||9||
60099221|NCT00940576|76216259|FG000|COMPLETED|Overall Study||8||
60099222|NCT00940576|76216260|FG001|COMPLETED|Overall Study||9||
60099223|NCT00940576|76216259|FG000|NOT COMPLETED|Overall Study||0||
60099224|NCT00940576|76216260|FG001|NOT COMPLETED|Overall Study||0||
60099225|NCT00945334|76216269|FG000|STARTED|Overall Study||19||
60099226|NCT00945334|76216270|FG001|STARTED|Overall Study||18||
60099227|NCT00945334|76216269|FG000|COMPLETED|Overall Study||16||
60099228|NCT00945334|76216270|FG001|COMPLETED|Overall Study||15||
60099229|NCT00945334|76216269|FG000|NOT COMPLETED|Overall Study||3||
60099230|NCT00945334|76216270|FG001|NOT COMPLETED|Overall Study||3||
60099231|NCT00089973|76216276|FG000|STARTED|Overall Study||50||
60099232|NCT00089973|76216276|FG000|COMPLETED|Overall Study||0||
60099233|NCT00089973|76216276|FG000|NOT COMPLETED|Overall Study||50||
60099234|NCT00949234|76216280|FG000|STARTED|Overall Study||267||
60099235|NCT00949234|76216280|FG000|COMPLETED|Overall Study||225||
60099236|NCT00949234|76216280|FG000|NOT COMPLETED|Overall Study||42||
60099237|NCT00951808|76216284|FG000|STARTED|Overall Study||4||
60099238|NCT00951808|76216285|FG001|STARTED|Overall Study||6||
60099239|NCT00951808|76216286|FG002|STARTED|Overall Study||227||
60099240|NCT00951808|76216284|FG000|COMPLETED|Overall Study||4||
59563340|NCT01762982|75665573|FG000|Received Empty Finn Chamber|Overall Study||36||
59563341|NCT01762982|75665573|FG000|COMPLETED|Overall Study||36||
59563342|NCT01762982|75665573|FG000|NOT COMPLETED|Overall Study||0||
59563343|NCT01763606|75665583|FG000|STARTED|Overall Study||10||
59563344|NCT01763606|75665584|FG001|STARTED|Overall Study||10||
59563345|NCT01763606|75665583|FG000|COMPLETED|Overall Study||10||
59563346|NCT01763606|75665584|FG001|COMPLETED|Overall Study||10||
59563347|NCT01763606|75665583|FG000|NOT COMPLETED|Overall Study||0||
59563348|NCT01763606|75665584|FG001|NOT COMPLETED|Overall Study||0||
59563349|NCT01765712|75665593|FG000|STARTED|Overall Study||27||
59563350|NCT01765712|75665594|FG001|STARTED|Overall Study||23||
59563351|NCT01765712|75665593|FG000|COMPLETED|Overall Study||27||
59563352|NCT01765712|75665594|FG001|COMPLETED|Overall Study||23||
59563353|NCT01765712|75665593|FG000|NOT COMPLETED|Overall Study||0||
59563354|NCT01765712|75665594|FG001|NOT COMPLETED|Overall Study||0||
59563355|NCT02378207|75665604|FG000|STARTED|Overall Study||24||
59563356|NCT02378207|75665605|FG001|STARTED|Overall Study||24||
59563357|NCT02378207|75665606|FG002|STARTED|Overall Study||24||
59563358|NCT02378207|75665607|FG003|STARTED|Overall Study||12||
59563359|NCT02378207|75665604|FG000|COMPLETED|Overall Study||24||
59994041|NCT02922725|76109914|FG000|STARTED|Overall Study||12||
59994042|NCT02922725|76109915|FG001|STARTED|Overall Study||12||
59994043|NCT02922725|76109916|FG002|STARTED|Overall Study||8||
59994044|NCT02922725|76109914|FG000|COMPLETED|Overall Study||11||
59994045|NCT02922725|76109915|FG001|COMPLETED|Overall Study||12||
59994046|NCT02922725|76109916|FG002|COMPLETED|Overall Study||8||
59994047|NCT02922725|76109914|FG000|NOT COMPLETED|Overall Study||1||
59994048|NCT02922725|76109915|FG001|NOT COMPLETED|Overall Study||0||
59994049|NCT02922725|76109916|FG002|NOT COMPLETED|Overall Study||0||
59994050|NCT02805257|76109925|FG000|STARTED|Overall Study||60||
60099241|NCT00951808|76216285|FG001|COMPLETED|Overall Study||6||
60099242|NCT00951808|76216286|FG002|COMPLETED|Overall Study|Four subjects withdrew from the study.|223||
60099243|NCT00951808|76216284|FG000|NOT COMPLETED|Overall Study||0||
60099244|NCT00951808|76216285|FG001|NOT COMPLETED|Overall Study||0||
60099245|NCT00951808|76216286|FG002|NOT COMPLETED|Overall Study||4||
60099246|NCT00089661|76216294|FG000|STARTED|Overall Study||127||
60099247|NCT00089661|76216295|FG001|STARTED|Overall Study||125||
60099248|NCT00089661|76216294|FG000|COMPLETED|Overall Study||106||
60099249|NCT00089661|76216295|FG001|COMPLETED|Overall Study||99||
60099250|NCT00089661|76216294|FG000|NOT COMPLETED|Overall Study||21||
60099251|NCT00089661|76216295|FG001|NOT COMPLETED|Overall Study||26||
60099252|NCT00941668|76216303|FG000|STARTED|Overall Study||24||
60099253|NCT00941668|76216304|FG001|STARTED|Overall Study||25||
60099254|NCT00941668|76216303|FG000|COMPLETED|Overall Study||0||
60099255|NCT00941668|76216304|FG001|COMPLETED|Overall Study||0||
60099256|NCT00941668|76216303|FG000|NOT COMPLETED|Overall Study||24||
60099257|NCT00941668|76216304|FG001|NOT COMPLETED|Overall Study||25||
60099258|NCT00089583|76216312|FG000|STARTED|Overall Study||20||
60099259|NCT00089583|76216313|FG001|STARTED|Overall Study||89||
60099260|NCT00089583|76216312|FG000|COMPLETED|Overall Study||13||
60099261|NCT00089583|76216313|FG001|COMPLETED|Overall Study||51||
60099262|NCT00089583|76216312|FG000|NOT COMPLETED|Overall Study||7||
60099263|NCT00089583|76216313|FG001|NOT COMPLETED|Overall Study||38||
60099264|NCT00088881|76216325|FG000|STARTED|Step 1 - R-CHOP||62||
60099265|NCT00088881|76216325|FG000|Eligible and Treated|Step 1 - R-CHOP||53||
60099266|NCT00088881|76216325|FG000|COMPLETED|Step 1 - R-CHOP||48||
60099267|NCT00088881|76216325|FG000|NOT COMPLETED|Step 1 - R-CHOP||14||
59994051|NCT02805257|76109926|FG001|STARTED|Overall Study||59||
59994052|NCT02805257|76109925|FG000|COMPLETED|Overall Study||53||
59994053|NCT02805257|76109926|FG001|COMPLETED|Overall Study||52||
59994054|NCT02805257|76109925|FG000|NOT COMPLETED|Overall Study||7||
59994055|NCT02805257|76109926|FG001|NOT COMPLETED|Overall Study||7||
59994056|NCT01791595|76109939|FG000|STARTED|Part 1 AZD3965 Cohort 1 (5 mg OD)||3||
59994057|NCT01791595|76109940|FG001|STARTED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0||
59994058|NCT01791595|76109941|FG002|STARTED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0||
59994059|NCT01791595|76109942|FG003|STARTED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0||
59995206|NCT02648217|76111029|FG001|STARTED|Overall Study||132||
60099268|NCT00088881|76216325|FG000|STARTED|Step 2 - Zevalin™ Radioimmunotherapy|This includes all patients who received step 2 treatment regardless of eligibility.|56||
59994060|NCT01791595|76109943|FG004|STARTED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0||
59994061|NCT01791595|76109944|FG005|STARTED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0||
59994062|NCT01791595|76109945|FG006|STARTED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0||
59994063|NCT01791595|76109939|FG000|COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0||
59994064|NCT01791595|76109940|FG001|COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0||
59994065|NCT01791595|76109941|FG002|COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0||
59994066|NCT01791595|76109942|FG003|COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0||
59994067|NCT01791595|76109943|FG004|COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0||
59994068|NCT01791595|76109944|FG005|COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0||
59994069|NCT01791595|76109945|FG006|COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0||
59994070|NCT01791595|76109939|FG000|NOT COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||3||
59994071|NCT01791595|76109940|FG001|NOT COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0||
59994072|NCT01791595|76109941|FG002|NOT COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0||
59994073|NCT01791595|76109942|FG003|NOT COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0||
59994074|NCT01791595|76109943|FG004|NOT COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0||
59994075|NCT01791595|76109944|FG005|NOT COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0||
59994076|NCT01791595|76109945|FG006|NOT COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0||
59994077|NCT01791595|76109939|FG000|STARTED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0||
59994078|NCT01791595|76109940|FG001|STARTED|Part 1 AZD3965 Cohort 2 (10 mg OD)||5||
59994079|NCT01791595|76109941|FG002|STARTED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0||
59994080|NCT01791595|76109942|FG003|STARTED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0||
59994081|NCT01791595|76109943|FG004|STARTED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0||
59994082|NCT01791595|76109944|FG005|STARTED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0||
59994083|NCT01791595|76109945|FG006|STARTED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0||
59994084|NCT01791595|76109939|FG000|COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0||
59994085|NCT01791595|76109940|FG001|COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0||
59994086|NCT01791595|76109941|FG002|COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0||
59994087|NCT01791595|76109942|FG003|COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0||
59994088|NCT01791595|76109943|FG004|COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0||
59563360|NCT02378207|75665605|FG001|COMPLETED|Overall Study||21||
59563361|NCT02378207|75665606|FG002|COMPLETED|Overall Study||22||
59563362|NCT02378207|75665607|FG003|COMPLETED|Overall Study||11||
59563363|NCT02378207|75665604|FG000|NOT COMPLETED|Overall Study||0||
59563364|NCT02378207|75665605|FG001|NOT COMPLETED|Overall Study||3||
59563365|NCT02378207|75665606|FG002|NOT COMPLETED|Overall Study||2||
59563366|NCT02378207|75665607|FG003|NOT COMPLETED|Overall Study||1||
59563367|NCT01766024|75665619|FG000|STARTED|Overall Study||16||
59563368|NCT01766024|75665620|FG001|STARTED|Overall Study||16||
59563369|NCT01766024|75665619|FG000|COMPLETED|Overall Study||16||
59563370|NCT01766024|75665620|FG001|COMPLETED|Overall Study||16||
59563371|NCT01766024|75665619|FG000|NOT COMPLETED|Overall Study||0||
59563372|NCT01766024|75665620|FG001|NOT COMPLETED|Overall Study||0||
59563373|NCT01766102|75665630|FG000|STARTED|Overall Study||36||
59563374|NCT01766102|75665631|FG001|STARTED|Overall Study||36||
59563375|NCT01766102|75665630|FG000|COMPLETED|Overall Study||36||
59563376|NCT01766102|75665631|FG001|COMPLETED|Overall Study||36||
59563377|NCT01766102|75665630|FG000|NOT COMPLETED|Overall Study||0||
59994089|NCT01791595|76109944|FG005|COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0||
59994090|NCT01791595|76109945|FG006|COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0||
59994091|NCT01791595|76109939|FG000|NOT COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0||
59994092|NCT01791595|76109940|FG001|NOT COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||5||
59994093|NCT01791595|76109941|FG002|NOT COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0||
59994094|NCT01791595|76109942|FG003|NOT COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0||
59994095|NCT01791595|76109943|FG004|NOT COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0||
59994096|NCT01791595|76109944|FG005|NOT COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0||
59994097|NCT01791595|76109945|FG006|NOT COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0||
59994098|NCT01791595|76109939|FG000|STARTED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0||
59994099|NCT01791595|76109940|FG001|STARTED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0||
59994100|NCT01791595|76109941|FG002|STARTED|Part 1 AZD3965 Cohort 3 (20 mg OD)||8||
59994101|NCT01791595|76109942|FG003|STARTED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0||
59994102|NCT01791595|76109943|FG004|STARTED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0||
59994103|NCT01791595|76109944|FG005|STARTED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0||
59994104|NCT01791595|76109945|FG006|STARTED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0||
59994105|NCT01791595|76109939|FG000|COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0||
59994106|NCT01791595|76109940|FG001|COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0||
59994107|NCT01791595|76109941|FG002|COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0||
60099269|NCT00088881|76216325|FG000|Eligible and Treated|Step 2 - Zevalin™ Radioimmunotherapy||48||
60099270|NCT00088881|76216325|FG000|COMPLETED|Step 2 - Zevalin™ Radioimmunotherapy||45||
60099271|NCT00088881|76216325|FG000|NOT COMPLETED|Step 2 - Zevalin™ Radioimmunotherapy||11||
60099272|NCT00088881|76216325|FG000|STARTED|Step 3 - Radiation Therapy||1||
59994108|NCT01791595|76109942|FG003|COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0||
60099273|NCT00088881|76216325|FG000|COMPLETED|Step 3 - Radiation Therapy||1||
60099274|NCT00088881|76216325|FG000|NOT COMPLETED|Step 3 - Radiation Therapy||0||
60099275|NCT00952120|76216334|FG000|STARTED|Overall Study||52||
60099276|NCT00952120|76216335|FG001|STARTED|Overall Study||47||
60099277|NCT00952120|76216336|FG002|STARTED|Overall Study||5||
60099278|NCT00952120|76216334|FG000|COMPLETED|Overall Study||52||
60099279|NCT00952120|76216335|FG001|COMPLETED|Overall Study||47||
60099280|NCT00952120|76216336|FG002|COMPLETED|Overall Study||5||
60099281|NCT00952120|76216334|FG000|NOT COMPLETED|Overall Study||0||
60099282|NCT00952120|76216335|FG001|NOT COMPLETED|Overall Study||0||
60099283|NCT00952120|76216336|FG002|NOT COMPLETED|Overall Study||0||
60099284|NCT00953212|76216346|FG000|STARTED|Overall Study||76||
60099285|NCT00953212|76216347|FG001|STARTED|Overall Study||74||
60099286|NCT00953212|76216348|FG002|STARTED|Overall Study||78||
60099287|NCT00953212|76216349|FG003|STARTED|Overall Study||76||
60099288|NCT00953212|76216346|FG000|COMPLETED|Overall Study||76||
60099289|NCT00953212|76216347|FG001|COMPLETED|Overall Study||74||
60099290|NCT00953212|76216348|FG002|COMPLETED|Overall Study||78||
60099291|NCT00953212|76216349|FG003|COMPLETED|Overall Study||76||
60099292|NCT00953212|76216346|FG000|NOT COMPLETED|Overall Study||0||
60099293|NCT00953212|76216347|FG001|NOT COMPLETED|Overall Study||0||
60099294|NCT00953212|76216348|FG002|NOT COMPLETED|Overall Study||0||
60099295|NCT00953212|76216349|FG003|NOT COMPLETED|Overall Study||0||
59563378|NCT01766102|75665631|FG001|NOT COMPLETED|Overall Study||0||
59563379|NCT02378753|75665639|FG000|STARTED|Overall Study||4319||
59563380|NCT02378753|75665640|FG001|STARTED|Overall Study||4332||
59563381|NCT02378753|75665639|FG000|COMPLETED|Overall Study||4101||
59563382|NCT02378753|75665640|FG001|COMPLETED|Overall Study||3637||
59563383|NCT02378753|75665639|FG000|NOT COMPLETED|Overall Study||218||
59563384|NCT02378753|75665640|FG001|NOT COMPLETED|Overall Study||695||
59563385|NCT01767506|75665648|FG000|STARTED|Overall Study|"26 communities were randomized to intervention group~The study was conducted at the community level."|||26
59563386|NCT01767506|75665649|FG001|STARTED|Overall Study|"26 communities were randomized to control group~The study was conducted at the community level."|||26
59563387|NCT01767506|75665648|FG000|COMPLETED|Overall Study|The study was conducted at the community level.|||26
59563388|NCT01767506|75665649|FG001|COMPLETED|Overall Study|The study was conducted at the community level.|||26
59563389|NCT01767506|75665648|FG000|NOT COMPLETED|Overall Study||||0
59563390|NCT01767506|75665649|FG001|NOT COMPLETED|Overall Study||||0
59563391|NCT02381015|75665659|FG000|STARTED|Visit 1 - Enrollment||175||
60099296|NCT00953290|76216363|FG000|STARTED|Overall Study||4||
60099297|NCT00953290|76216363|FG000|COMPLETED|Overall Study||4||
60099298|NCT00953290|76216363|FG000|NOT COMPLETED|Overall Study||0||
59563392|NCT02381015|75665660|FG001|STARTED|Visit 1 - Enrollment||175||
59563393|NCT02381015|75665661|FG002|STARTED|Visit 1 - Enrollment||175||
59563394|NCT02381015|75665662|FG003|STARTED|Visit 1 - Enrollment||175||
59563395|NCT02381015|75665659|FG000|COMPLETED|Visit 1 - Enrollment||175||
59563396|NCT02381015|75665660|FG001|COMPLETED|Visit 1 - Enrollment||173||
59563397|NCT02381015|75665661|FG002|COMPLETED|Visit 1 - Enrollment||175||
59563398|NCT02381015|75665662|FG003|COMPLETED|Visit 1 - Enrollment||172||
59563399|NCT02381015|75665659|FG000|NOT COMPLETED|Visit 1 - Enrollment||0||
59563400|NCT02381015|75665660|FG001|NOT COMPLETED|Visit 1 - Enrollment||2||
60099299|NCT00087555|76216373|FG000|STARTED|Overall Study||66||
60099300|NCT00087555|76216374|FG001|STARTED|Overall Study||62||
59563401|NCT02381015|75665661|FG002|NOT COMPLETED|Visit 1 - Enrollment||0||
59563402|NCT02381015|75665662|FG003|NOT COMPLETED|Visit 1 - Enrollment||3||
59708285|NCT01256684|75827098|FG000|NOT COMPLETED|Overall Study||9||
59563403|NCT02381015|75665659|FG000|STARTED|Visit 2 - Results DIsclosure||175||
59563404|NCT02381015|75665660|FG001|STARTED|Visit 2 - Results DIsclosure||173||
60099301|NCT00087555|76216375|FG002|STARTED|Overall Study||67||
60099302|NCT00087555|76216373|FG000|Treated|Overall Study||65||
60099303|NCT00087555|76216374|FG001|Treated|Overall Study||60||
60099304|NCT00087555|76216375|FG002|Treated|Overall Study||67||
60099305|NCT00087555|76216373|FG000|COMPLETED|Overall Study||54||
60099306|NCT00087555|76216374|FG001|COMPLETED|Overall Study||51||
60099307|NCT00087555|76216375|FG002|COMPLETED|Overall Study||46||
59563405|NCT02381015|75665661|FG002|STARTED|Visit 2 - Results DIsclosure||175||
59563406|NCT02381015|75665662|FG003|STARTED|Visit 2 - Results DIsclosure||172||
59563407|NCT02381015|75665659|FG000|COMPLETED|Visit 2 - Results DIsclosure||172||
59563408|NCT02381015|75665660|FG001|COMPLETED|Visit 2 - Results DIsclosure||168||
59563409|NCT02381015|75665661|FG002|COMPLETED|Visit 2 - Results DIsclosure||173||
59563410|NCT02381015|75665662|FG003|COMPLETED|Visit 2 - Results DIsclosure||169||
59563411|NCT02381015|75665659|FG000|NOT COMPLETED|Visit 2 - Results DIsclosure||3||
59563412|NCT02381015|75665660|FG001|NOT COMPLETED|Visit 2 - Results DIsclosure||5||
59563413|NCT02381015|75665661|FG002|NOT COMPLETED|Visit 2 - Results DIsclosure||2||
59563414|NCT02381015|75665662|FG003|NOT COMPLETED|Visit 2 - Results DIsclosure||3||
60099308|NCT00087555|76216373|FG000|NOT COMPLETED|Overall Study||12||
60099309|NCT00087555|76216374|FG001|NOT COMPLETED|Overall Study||11||
60099310|NCT00087555|76216375|FG002|NOT COMPLETED|Overall Study||21||
60099311|NCT00956020|76216383|FG000|STARTED|Overall Study||4||
60099312|NCT00956020|76216383|FG000|COMPLETED|Overall Study||4||
60099313|NCT00956020|76216383|FG000|NOT COMPLETED|Overall Study||0||
59563415|NCT02381015|75665659|FG000|STARTED|Visit 3 - 3 Months Followup||172||
59563416|NCT02381015|75665660|FG001|STARTED|Visit 3 - 3 Months Followup||168||
59563417|NCT02381015|75665661|FG002|STARTED|Visit 3 - 3 Months Followup||173||
59563418|NCT02381015|75665662|FG003|STARTED|Visit 3 - 3 Months Followup||169||
59563419|NCT02381015|75665659|FG000|COMPLETED|Visit 3 - 3 Months Followup||172||
59563420|NCT02381015|75665660|FG001|COMPLETED|Visit 3 - 3 Months Followup||168||
59563421|NCT02381015|75665661|FG002|COMPLETED|Visit 3 - 3 Months Followup||173||
59563422|NCT02381015|75665662|FG003|COMPLETED|Visit 3 - 3 Months Followup||169||
59563423|NCT02381015|75665659|FG000|NOT COMPLETED|Visit 3 - 3 Months Followup||0||
59563424|NCT02381015|75665660|FG001|NOT COMPLETED|Visit 3 - 3 Months Followup||0||
59563425|NCT02381015|75665661|FG002|NOT COMPLETED|Visit 3 - 3 Months Followup||0||
59563426|NCT02381015|75665662|FG003|NOT COMPLETED|Visit 3 - 3 Months Followup||0||
59708286|NCT01256684|75827099|FG001|NOT COMPLETED|Overall Study||13||
59708287|NCT01256684|75827100|FG002|NOT COMPLETED|Overall Study||11||
60099314|NCT00086619|76216398|FG000|STARTED|Overall Study||40||
60099315|NCT00086619|76216399|FG001|STARTED|Overall Study||40||
60099316|NCT00086619|76216398|FG000|Completed Baseline Visit|Overall Study||34||
60099317|NCT00086619|76216399|FG001|Completed Baseline Visit|Overall Study||36||
60099318|NCT00086619|76216398|FG000|Completed 12 Month Visit|Overall Study||26||
60099319|NCT00086619|76216399|FG001|Completed 12 Month Visit|Overall Study||26||
60099320|NCT00086619|76216398|FG000|COMPLETED|Overall Study||25||
60099321|NCT00086619|76216399|FG001|COMPLETED|Overall Study||23||
60099322|NCT00086619|76216398|FG000|NOT COMPLETED|Overall Study||15||
60099323|NCT00086619|76216399|FG001|NOT COMPLETED|Overall Study||17||
60099324|NCT00945958|76216405|FG000|STARTED|Overall Study||161||
60099325|NCT00945958|76216405|FG000|COMPLETED|Overall Study||149||
60099326|NCT00945958|76216405|FG000|NOT COMPLETED|Overall Study||12||
60099327|NCT00085917|76216412|FG000|STARTED|Overall Study||15||
60099328|NCT00085917|76216413|FG001|STARTED|Overall Study||14||
60099329|NCT00085917|76216412|FG000|COMPLETED|Overall Study||11||
60099330|NCT00085917|76216413|FG001|COMPLETED|Overall Study||11||
60099331|NCT00085917|76216412|FG000|NOT COMPLETED|Overall Study||4||
60099332|NCT00085917|76216413|FG001|NOT COMPLETED|Overall Study||3||
60099333|NCT00084747|76216419|FG000|STARTED|Overall Study||30||
60099334|NCT00084747|76216419|FG000|COMPLETED|Overall Study||17||
60099335|NCT00084747|76216419|FG000|NOT COMPLETED|Overall Study||13||
60099336|NCT00946270|76216427|FG000|STARTED|Overall Study||21||
60099337|NCT00946270|76216428|FG001|STARTED|Overall Study||20||
60099338|NCT00946270|76216429|FG002|STARTED|Overall Study||29||
60099339|NCT00946270|76216427|FG000|COMPLETED|Overall Study||21||
60099340|NCT00946270|76216428|FG001|COMPLETED|Overall Study||20||
60099341|NCT00946270|76216429|FG002|COMPLETED|Overall Study||29||
60099342|NCT00946270|76216427|FG000|NOT COMPLETED|Overall Study||0||
60099343|NCT00946270|76216428|FG001|NOT COMPLETED|Overall Study||0||
60099344|NCT00946270|76216429|FG002|NOT COMPLETED|Overall Study||0||
60099345|NCT00956254|76216437|FG000|STARTED|Overall Study||18||
60099346|NCT00956254|76216437|FG000|COMPLETED|Overall Study||18||
60099347|NCT00956254|76216437|FG000|NOT COMPLETED|Overall Study||0||
60099348|NCT00946348|76216445|FG000|STARTED|Overall Study||6||
60099349|NCT00946348|76216446|FG001|STARTED|Overall Study||6||
60099350|NCT00946348|76216445|FG000|COMPLETED|Overall Study||6||
60099351|NCT00946348|76216446|FG001|COMPLETED|Overall Study||6||
60099352|NCT00946348|76216445|FG000|NOT COMPLETED|Overall Study||0||
60099353|NCT00946348|76216446|FG001|NOT COMPLETED|Overall Study||0||
60099354|NCT00081159|76216454|FG000|STARTED|Overall Study||39||
60099355|NCT00081159|76216455|FG001|STARTED|Overall Study||40||
60099356|NCT00081159|76216454|FG000|COMPLETED|Overall Study||37||
60099357|NCT00081159|76216455|FG001|COMPLETED|Overall Study||35||
60099358|NCT00081159|76216454|FG000|NOT COMPLETED|Overall Study||2||
60099359|NCT00081159|76216455|FG001|NOT COMPLETED|Overall Study||5||
60099360|NCT00958282|76216463|FG000|STARTED|Overall Study||22||
60099361|NCT00958282|76216464|FG001|STARTED|Overall Study||21||
60099362|NCT00958282|76216463|FG000|COMPLETED|Overall Study||12||
60099363|NCT00958282|76216464|FG001|COMPLETED|Overall Study||15||
60099364|NCT00958282|76216463|FG000|NOT COMPLETED|Overall Study||10||
60099365|NCT00958282|76216464|FG001|NOT COMPLETED|Overall Study||6||
60099366|NCT00080223|76216470|FG000|STARTED|Overall Study||83||
60099367|NCT00080223|76216470|FG000|COMPLETED|Overall Study||7||
60099368|NCT00080223|76216470|FG000|NOT COMPLETED|Overall Study||76||
60099369|NCT00959764|76216477|FG000|STARTED|Overall Study||271||
60099370|NCT00959764|76216478|FG001|STARTED|Overall Study||185||
60099371|NCT00959764|76216479|FG002|STARTED|Overall Study||109||
60099372|NCT00959764|76216477|FG000|COMPLETED|Overall Study||176||
60099373|NCT00959764|76216478|FG001|COMPLETED|Overall Study||128||
60099374|NCT00959764|76216479|FG002|COMPLETED|Overall Study||73||
60099375|NCT00959764|76216477|FG000|NOT COMPLETED|Overall Study||95||
60099376|NCT00959764|76216478|FG001|NOT COMPLETED|Overall Study||57||
60099377|NCT00959764|76216479|FG002|NOT COMPLETED|Overall Study||36||
60099378|NCT01005706|76216492|FG000|STARTED|Overall Study||23||
60099379|NCT01005706|76216493|FG001|STARTED|Overall Study||17||
59563427|NCT02381015|75665659|FG000|STARTED|Year 3 Chart Review||172||
59563428|NCT02381015|75665660|FG001|STARTED|Year 3 Chart Review||168||
59563429|NCT02381015|75665661|FG002|STARTED|Year 3 Chart Review||173||
59563430|NCT02381015|75665662|FG003|STARTED|Year 3 Chart Review||169||
59563431|NCT02381015|75665659|FG000|COMPLETED|Year 3 Chart Review||125||
59563432|NCT02381015|75665660|FG001|COMPLETED|Year 3 Chart Review||134||
59994109|NCT01791595|76109943|FG004|COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0||
59994110|NCT01791595|76109944|FG005|COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0||
59994111|NCT01791595|76109945|FG006|COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0||
59994112|NCT01791595|76109939|FG000|NOT COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0||
59994113|NCT01791595|76109940|FG001|NOT COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0||
59994114|NCT01791595|76109941|FG002|NOT COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||8||
59994115|NCT01791595|76109942|FG003|NOT COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0||
59994116|NCT01791595|76109943|FG004|NOT COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0||
59994117|NCT01791595|76109944|FG005|NOT COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0||
59994118|NCT01791595|76109945|FG006|NOT COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0||
59994119|NCT01791595|76109939|FG000|STARTED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0||
59994120|NCT01791595|76109940|FG001|STARTED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0||
59994121|NCT01791595|76109941|FG002|STARTED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0||
59994122|NCT01791595|76109942|FG003|STARTED|Part 1 AZD3965 Cohort 4 (30 mg OD)||5||
59994123|NCT01791595|76109943|FG004|STARTED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0||
59994124|NCT01791595|76109944|FG005|STARTED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0||
59994125|NCT01791595|76109945|FG006|STARTED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0||
59994126|NCT01791595|76109939|FG000|COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0||
59994127|NCT01791595|76109940|FG001|COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0||
59994128|NCT01791595|76109941|FG002|COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0||
59994129|NCT01791595|76109942|FG003|COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||1||
59994130|NCT01791595|76109943|FG004|COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0||
59995207|NCT02648217|76111028|FG000|Exposed|Overall Study||130||
60099380|NCT01005706|76216492|FG000|COMPLETED|Overall Study||23||
60099381|NCT01005706|76216493|FG001|COMPLETED|Overall Study||17||
60099382|NCT01005706|76216492|FG000|NOT COMPLETED|Overall Study||0||
60099383|NCT01005706|76216493|FG001|NOT COMPLETED|Overall Study||0||
60099384|NCT01006252|76216501|FG000|STARTED|Overall Study||168||
60099385|NCT01006252|76216502|FG001|STARTED|Overall Study||168||
60099386|NCT01006252|76216501|FG000|Received Treatment|Overall Study||164||
60099387|NCT01006252|76216502|FG001|Received Treatment|Overall Study||161||
60099388|NCT01006252|76216501|FG000|COMPLETED|Overall Study||168||
60099389|NCT01006252|76216502|FG001|COMPLETED|Overall Study||168||
60099390|NCT01006252|76216501|FG000|NOT COMPLETED|Overall Study||0||
60099391|NCT01006252|76216502|FG001|NOT COMPLETED|Overall Study||0||
60099392|NCT00959842|76216512|FG000|STARTED|Overall Study|17 were recruited and at baseline. 2 dropped out before starting the study drug. 15 finished|15||
60099393|NCT00959842|76216512|FG000|COMPLETED|Overall Study||15||
60099394|NCT00959842|76216512|FG000|NOT COMPLETED|Overall Study||0||
59563433|NCT02381015|75665661|FG002|COMPLETED|Year 3 Chart Review||115||
59563434|NCT02381015|75665662|FG003|COMPLETED|Year 3 Chart Review||118||
59563435|NCT02381015|75665659|FG000|NOT COMPLETED|Year 3 Chart Review||47||
59563436|NCT02381015|75665660|FG001|NOT COMPLETED|Year 3 Chart Review||34||
59563437|NCT02381015|75665661|FG002|NOT COMPLETED|Year 3 Chart Review||58||
59563438|NCT02381015|75665662|FG003|NOT COMPLETED|Year 3 Chart Review||51||
59563439|NCT02383043|75665680|FG000|STARTED|Overall Study||9||
59563440|NCT02383043|75665681|FG001|STARTED|Overall Study||5||
59563441|NCT02383043|75665682|FG002|STARTED|Overall Study||4||
59563442|NCT02383043|75665680|FG000|COMPLETED|Overall Study||7||
59563443|NCT02383043|75665681|FG001|COMPLETED|Overall Study||5||
60099395|NCT00959920|76216518|FG000|STARTED|Overall Study||72||
60099396|NCT00959920|76216519|FG001|STARTED|Overall Study||67||
60099397|NCT00959920|76216518|FG000|COMPLETED|Overall Study||72||
60099398|NCT00959920|76216519|FG001|COMPLETED|Overall Study||66||
60099399|NCT00959920|76216518|FG000|NOT COMPLETED|Overall Study||0||
60099400|NCT00959920|76216519|FG001|NOT COMPLETED|Overall Study||1||
60099401|NCT01007110|76216529|FG000|STARTED|Allocation||32||
60099402|NCT01007110|76216530|FG001|STARTED|Allocation||35||
60099403|NCT01007110|76216529|FG000|COMPLETED|Allocation||25||
60099404|NCT01007110|76216530|FG001|COMPLETED|Allocation||27||
60099405|NCT01007110|76216529|FG000|NOT COMPLETED|Allocation||7||
60099406|NCT01007110|76216530|FG001|NOT COMPLETED|Allocation||8||
60099407|NCT01007110|76216529|FG000|STARTED|Follow-Up at 24 Weeks||25||
60099408|NCT01007110|76216530|FG001|STARTED|Follow-Up at 24 Weeks||27||
60099409|NCT01007110|76216529|FG000|COMPLETED|Follow-Up at 24 Weeks||25||
60099410|NCT01007110|76216530|FG001|COMPLETED|Follow-Up at 24 Weeks||23||
60099411|NCT01007110|76216529|FG000|NOT COMPLETED|Follow-Up at 24 Weeks||0||
59563444|NCT02383043|75665682|FG002|COMPLETED|Overall Study||4||
59563445|NCT02383043|75665680|FG000|NOT COMPLETED|Overall Study||2||
59563446|NCT02383043|75665681|FG001|NOT COMPLETED|Overall Study||0||
59563447|NCT02383043|75665682|FG002|NOT COMPLETED|Overall Study||0||
59563448|NCT01768520|75665694|FG000|STARTED|Overall Study||152||
59563449|NCT01768520|75665695|FG001|STARTED|Overall Study||147||
59563450|NCT01768520|75665696|FG002|STARTED|Overall Study||39||
59563451|NCT01768520|75665694|FG000|COMPLETED|Overall Study||120||
59563452|NCT01768520|75665695|FG001|COMPLETED|Overall Study||121||
59563453|NCT01768520|75665696|FG002|COMPLETED|Overall Study||30||
59563454|NCT01768520|75665694|FG000|NOT COMPLETED|Overall Study||32||
59563455|NCT01768520|75665695|FG001|NOT COMPLETED|Overall Study||26||
59563456|NCT01768520|75665696|FG002|NOT COMPLETED|Overall Study||9||
59563457|NCT01768832|75665707|FG000|STARTED|Overall Study||41||
59563458|NCT01768832|75665708|FG001|STARTED|Overall Study||43||
59563459|NCT01768832|75665709|FG002|STARTED|Overall Study||35||
59563460|NCT01768832|75665707|FG000|COMPLETED|Overall Study||31||
59563461|NCT01768832|75665708|FG001|COMPLETED|Overall Study||39||
59563462|NCT01768832|75665709|FG002|COMPLETED|Overall Study||26||
59994131|NCT01791595|76109944|FG005|COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0||
59994132|NCT01791595|76109945|FG006|COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0||
59994133|NCT01791595|76109939|FG000|NOT COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0||
59994134|NCT01791595|76109940|FG001|NOT COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0||
59994135|NCT01791595|76109941|FG002|NOT COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0||
60099412|NCT01007110|76216530|FG001|NOT COMPLETED|Follow-Up at 24 Weeks||4||
60099413|NCT01007110|76216529|FG000|STARTED|Follow-Up at 32 Weeks||25||
60099414|NCT01007110|76216530|FG001|STARTED|Follow-Up at 32 Weeks||23||
59994136|NCT01791595|76109942|FG003|NOT COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||4||
59994137|NCT01791595|76109943|FG004|NOT COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0||
59994138|NCT01791595|76109944|FG005|NOT COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0||
59994139|NCT01791595|76109945|FG006|NOT COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0||
59994140|NCT01791595|76109939|FG000|STARTED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0||
60099415|NCT01007110|76216529|FG000|COMPLETED|Follow-Up at 32 Weeks||24||
60099416|NCT01007110|76216530|FG001|COMPLETED|Follow-Up at 32 Weeks||22||
60099417|NCT01007110|76216529|FG000|NOT COMPLETED|Follow-Up at 32 Weeks||1||
60099418|NCT01007110|76216530|FG001|NOT COMPLETED|Follow-Up at 32 Weeks||1||
60099419|NCT01007110|76216529|FG000|STARTED|Follow-Up at 36 Weeks||24||
60099420|NCT01007110|76216530|FG001|STARTED|Follow-Up at 36 Weeks||22||
60099421|NCT01007110|76216529|FG000|COMPLETED|Follow-Up at 36 Weeks||24||
60099422|NCT01007110|76216530|FG001|COMPLETED|Follow-Up at 36 Weeks||20||
60099423|NCT01007110|76216529|FG000|NOT COMPLETED|Follow-Up at 36 Weeks||0||
60099424|NCT01007110|76216530|FG001|NOT COMPLETED|Follow-Up at 36 Weeks||2||
60099425|NCT01007110|76216529|FG000|STARTED|Neonatal Behavioral Assessment Scale (NB||24||
60099426|NCT01007110|76216530|FG001|STARTED|Neonatal Behavioral Assessment Scale (NB||20||
60099427|NCT01007110|76216529|FG000|COMPLETED|Neonatal Behavioral Assessment Scale (NB||12||
60099428|NCT01007110|76216530|FG001|COMPLETED|Neonatal Behavioral Assessment Scale (NB||15||
60099429|NCT01007110|76216529|FG000|NOT COMPLETED|Neonatal Behavioral Assessment Scale (NB||12||
59563463|NCT01768832|75665707|FG000|NOT COMPLETED|Overall Study||10||
59563464|NCT01768832|75665708|FG001|NOT COMPLETED|Overall Study||4||
60099430|NCT01007110|76216530|FG001|NOT COMPLETED|Neonatal Behavioral Assessment Scale (NB||5||
60099431|NCT00960622|76216539|FG000|STARTED|Overall Study||10||
60099432|NCT00960622|76216540|FG001|STARTED|Overall Study||10||
60099433|NCT00960622|76216539|FG000|COMPLETED|Overall Study||10||
59563465|NCT01768832|75665709|FG002|NOT COMPLETED|Overall Study||9||
59563466|NCT02383667|75665717|FG000|STARTED|Overall Study||20||
59994141|NCT01791595|76109940|FG001|STARTED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0||
60099434|NCT00960622|76216540|FG001|COMPLETED|Overall Study||7||
60099435|NCT00960622|76216539|FG000|NOT COMPLETED|Overall Study||0||
60099436|NCT00960622|76216540|FG001|NOT COMPLETED|Overall Study||3||
60099437|NCT00960778|76216548|FG000|STARTED|Overall Study||17||
60099438|NCT00960778|76216549|FG001|STARTED|Overall Study||16||
60099439|NCT00960778|76216548|FG000|COMPLETED|Overall Study||8||
60099440|NCT00960778|76216549|FG001|COMPLETED|Overall Study||13||
59563467|NCT02383667|75665717|FG000|COMPLETED|Overall Study||20||
59563468|NCT02383667|75665717|FG000|NOT COMPLETED|Overall Study||0||
59563469|NCT02386319|75665723|FG000|STARTED|Overall Study||18||
59708288|NCT01204710|75827110|FG000|STARTED|Randomization Treatment||63||
59708289|NCT01204710|75827111|FG001|STARTED|Randomization Treatment||60||
60099441|NCT00960778|76216548|FG000|NOT COMPLETED|Overall Study||9||
60099442|NCT00960778|76216549|FG001|NOT COMPLETED|Overall Study||3||
60099443|NCT03392649|76216557|FG000|STARTED|Overall Study||40||
60099444|NCT03392649|76216558|FG001|STARTED|Overall Study||41||
60099445|NCT03392649|76216557|FG000|COMPLETED|Overall Study||40||
60099446|NCT03392649|76216558|FG001|COMPLETED|Overall Study||41||
60099447|NCT03392649|76216557|FG000|NOT COMPLETED|Overall Study||0||
60099448|NCT03392649|76216558|FG001|NOT COMPLETED|Overall Study||0||
60099449|NCT00961402|76216566|FG000|STARTED|Overall Study||64||
60099450|NCT00961402|76216567|FG001|STARTED|Overall Study||66||
60099451|NCT00961402|76216566|FG000|Randomized|Overall Study||64||
60099452|NCT00961402|76216567|FG001|Randomized|Overall Study||66||
60099453|NCT00961402|76216566|FG000|COMPLETED|Overall Study||63||
60099454|NCT00961402|76216567|FG001|COMPLETED|Overall Study||61||
60099455|NCT00961402|76216566|FG000|NOT COMPLETED|Overall Study||1||
60099456|NCT00961402|76216567|FG001|NOT COMPLETED|Overall Study||5||
60099457|NCT01007656|76216573|FG000|STARTED|Overall Study||31||
60099458|NCT01007656|76216573|FG000|COMPLETED|Overall Study||31||
60099459|NCT01007656|76216573|FG000|NOT COMPLETED|Overall Study||0||
60099460|NCT01008280|76216579|FG000|STARTED|Overall Study||88||
60099461|NCT01008280|76216580|FG001|STARTED|Overall Study||92||
60099462|NCT01008280|76216579|FG000|COMPLETED|Overall Study||67||
60099463|NCT01008280|76216580|FG001|COMPLETED|Overall Study||73||
60099464|NCT01008280|76216579|FG000|NOT COMPLETED|Overall Study||21||
60099465|NCT01008280|76216580|FG001|NOT COMPLETED|Overall Study||19||
60099466|NCT00963430|76216588|FG000|STARTED|Overall Study||60||
60099467|NCT00963430|76216589|FG001|STARTED|Overall Study||60||
60099468|NCT00963430|76216588|FG000|COMPLETED|Overall Study||59||
60099469|NCT00963430|76216589|FG001|COMPLETED|Overall Study||57||
60099470|NCT00963430|76216588|FG000|NOT COMPLETED|Overall Study||1||
60099471|NCT00963430|76216589|FG001|NOT COMPLETED|Overall Study||3||
60099472|NCT01009762|76216597|FG000|STARTED|Overall Study||1||
60099473|NCT01009762|76216598|FG001|STARTED|Overall Study||10||
60099474|NCT01009762|76216597|FG000|Primary Outcome|Overall Study|no Serious Adverse Events (SAE), no treatment related side effects DLT grade 3 or more|0||
60099475|NCT01009762|76216598|FG001|Primary Outcome|Overall Study|no SAE, no treatment related side effects DLT grade 3 or more|0||
60099476|NCT01009762|76216597|FG000|COMPLETED|Overall Study|according to randomization this one participant received placebo|1||
60099477|NCT01009762|76216598|FG001|COMPLETED|Overall Study|10 participants received vaccine|10||
60099478|NCT01009762|76216597|FG000|NOT COMPLETED|Overall Study||0||
60099479|NCT01009762|76216598|FG001|NOT COMPLETED|Overall Study||0||
60099480|NCT01009918|76216609|FG000|STARTED|Overall Study||158||
60099481|NCT01009918|76216610|FG001|STARTED|Overall Study||156||
60099482|NCT01009918|76216611|FG002|STARTED|Overall Study||154||
60099483|NCT01009918|76216609|FG000|COMPLETED|Overall Study||134||
60099484|NCT01009918|76216610|FG001|COMPLETED|Overall Study||132||
60099485|NCT01009918|76216611|FG002|COMPLETED|Overall Study||124||
60099486|NCT01009918|76216609|FG000|NOT COMPLETED|Overall Study||24||
60099487|NCT01009918|76216610|FG001|NOT COMPLETED|Overall Study||24||
60099488|NCT01009918|76216611|FG002|NOT COMPLETED|Overall Study||30||
60099489|NCT00963508|76216621|FG000|STARTED|Overall Study||206||
60099490|NCT00963508|76216622|FG001|STARTED|Overall Study||197||
60099491|NCT00963508|76216621|FG000|COMPLETED|Overall Study||196||
60099492|NCT00963508|76216622|FG001|COMPLETED|Overall Study||169||
60099493|NCT00963508|76216621|FG000|NOT COMPLETED|Overall Study||10||
60099494|NCT00963508|76216622|FG001|NOT COMPLETED|Overall Study||28||
60099495|NCT01010854|76216628|FG000|STARTED|Overall Study||6||
60099496|NCT01010854|76216628|FG000|COMPLETED|Overall Study||6||
60099497|NCT01010854|76216628|FG000|NOT COMPLETED|Overall Study||0||
60099498|NCT00964444|76216632|FG000|STARTED|Overall Study||10||
60099499|NCT00964444|76216632|FG000|COMPLETED|Overall Study||10||
60099500|NCT00964444|76216632|FG000|NOT COMPLETED|Overall Study||0||
60099501|NCT01010932|76216636|FG000|STARTED|Overall Study||222||
60099502|NCT01010932|76216636|FG000|COMPLETED|Overall Study||200||
60099503|NCT01010932|76216636|FG000|NOT COMPLETED|Overall Study||22||
60099504|NCT00966238|76216650|FG000|STARTED|Overall Study||20||
60099505|NCT00966238|76216651|FG001|STARTED|Overall Study||20||
60099506|NCT00966238|76216652|FG002|STARTED|Overall Study||20||
60099507|NCT00966238|76216653|FG003|STARTED|Overall Study||20||
60099508|NCT00966238|76216654|FG004|STARTED|Overall Study||20||
60099509|NCT00966238|76216655|FG005|STARTED|Overall Study||20||
60099510|NCT00966238|76216650|FG000|COMPLETED|Overall Study||20||
60099511|NCT00966238|76216651|FG001|COMPLETED|Overall Study||20||
60099512|NCT00966238|76216652|FG002|COMPLETED|Overall Study||20||
60099513|NCT00966238|76216653|FG003|COMPLETED|Overall Study||20||
60099514|NCT00966238|76216654|FG004|COMPLETED|Overall Study||20||
60099515|NCT00966238|76216655|FG005|COMPLETED|Overall Study||20||
60099516|NCT00966238|76216650|FG000|NOT COMPLETED|Overall Study||0||
60099517|NCT00966238|76216651|FG001|NOT COMPLETED|Overall Study||0||
59563470|NCT02386319|75665724|FG001|STARTED|Overall Study||18||
59563471|NCT02386319|75665723|FG000|COMPLETED|Overall Study||16||
59563472|NCT02386319|75665724|FG001|COMPLETED|Overall Study||17||
59563473|NCT02386319|75665723|FG000|NOT COMPLETED|Overall Study||2||
59563474|NCT02386319|75665724|FG001|NOT COMPLETED|Overall Study||1||
59563475|NCT01769612|75665730|FG000|STARTED|Overall Study||168||
60099518|NCT00966238|76216652|FG002|NOT COMPLETED|Overall Study||0||
60099519|NCT00966238|76216653|FG003|NOT COMPLETED|Overall Study||0||
60099520|NCT00966238|76216654|FG004|NOT COMPLETED|Overall Study||0||
60099521|NCT00966238|76216655|FG005|NOT COMPLETED|Overall Study||0||
60099522|NCT01012336|76216669|FG000|STARTED|Overall Study||85||
60099523|NCT01012336|76216669|FG000|COMPLETED|Overall Study||85||
60099524|NCT01012336|76216669|FG000|NOT COMPLETED|Overall Study||0||
60099525|NCT00966550|76216675|FG000|STARTED|Overall Study||13||
60099526|NCT00966550|76216676|FG001|STARTED|Overall Study||12||
60099527|NCT00966550|76216675|FG000|COMPLETED|Overall Study||13||
60099528|NCT00966550|76216676|FG001|COMPLETED|Overall Study||12||
60099529|NCT00966550|76216675|FG000|NOT COMPLETED|Overall Study||0||
59563476|NCT01769612|75665730|FG000|COMPLETED|Overall Study||168||
59563477|NCT01769612|75665730|FG000|NOT COMPLETED|Overall Study||0||
59563478|NCT02387801|75665738|FG000|STARTED|Induction Dosing Period||6||
59563479|NCT02387801|75665739|FG001|STARTED|Induction Dosing Period||6||
59563480|NCT02387801|75665738|FG000|COMPLETED|Induction Dosing Period||6||
60099530|NCT00966550|76216676|FG001|NOT COMPLETED|Overall Study||0||
60099531|NCT01012492|76216682|FG000|STARTED|Overall Study||10||
59563481|NCT02387801|75665739|FG001|COMPLETED|Induction Dosing Period||6||
60099532|NCT01012492|76216682|FG000|COMPLETED|Overall Study||10||
60099533|NCT01012492|76216682|FG000|NOT COMPLETED|Overall Study||0||
60099534|NCT00967486|76216688|FG000|STARTED|Overall Study||98||
60099535|NCT00967486|76216689|FG001|STARTED|Overall Study||102||
59563482|NCT02387801|75665738|FG000|NOT COMPLETED|Induction Dosing Period||0||
59563483|NCT02387801|75665739|FG001|NOT COMPLETED|Induction Dosing Period||0||
59563484|NCT02387801|75665738|FG000|STARTED|Maintenance Dosing Period|All participants from Induction Dosing Period went to ixe Q4W arm during Maintenance Dosing Period.|0||
59563485|NCT02387801|75665739|FG001|STARTED|Maintenance Dosing Period||12||
59563486|NCT02387801|75665738|FG000|COMPLETED|Maintenance Dosing Period||0||
59563487|NCT02387801|75665739|FG001|COMPLETED|Maintenance Dosing Period||12||
59563488|NCT02387801|75665738|FG000|NOT COMPLETED|Maintenance Dosing Period||0||
59563489|NCT02387801|75665739|FG001|NOT COMPLETED|Maintenance Dosing Period||0||
59563490|NCT02387801|75665738|FG000|STARTED|Post-Treatment Follow-up||0||
60099536|NCT00967486|76216688|FG000|COMPLETED|Overall Study||98||
59563491|NCT02387801|75665739|FG001|STARTED|Post-Treatment Follow-up||12||
59563492|NCT02387801|75665738|FG000|COMPLETED|Post-Treatment Follow-up||0||
59563493|NCT02387801|75665739|FG001|COMPLETED|Post-Treatment Follow-up||12||
59563494|NCT02387801|75665738|FG000|NOT COMPLETED|Post-Treatment Follow-up||0||
59563495|NCT02387801|75665739|FG001|NOT COMPLETED|Post-Treatment Follow-up||0||
59563496|NCT01770314|75665749|FG000|STARTED|Overall Study||86||
59563497|NCT01770314|75665750|FG001|STARTED|Overall Study||90||
59563498|NCT01770314|75665749|FG000|Contributed Data to Baseline|Overall Study||68||
59563499|NCT01770314|75665750|FG001|Contributed Data to Baseline|Overall Study||72||
59563500|NCT01770314|75665749|FG000|Contributed Data to Post-test|Overall Study||65||
59563501|NCT01770314|75665750|FG001|Contributed Data to Post-test|Overall Study||67||
59563502|NCT01770314|75665749|FG000|Contributed Data to One-month Follow-up|Overall Study||61||
59565971|NCT02303574|75668411|FG006|STARTED|Part 1b (Fed State) - SAD||0||
59994142|NCT01791595|76109941|FG002|STARTED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0||
59994143|NCT01791595|76109942|FG003|STARTED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0||
59994144|NCT01791595|76109943|FG004|STARTED|Part 1 AZD3965 Cohort 5 (15 mg BD)||11||
59994145|NCT01791595|76109944|FG005|STARTED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0||
59994146|NCT01791595|76109945|FG006|STARTED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0||
59994147|NCT01791595|76109939|FG000|COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0||
59994148|NCT01791595|76109940|FG001|COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0||
59994149|NCT01791595|76109941|FG002|COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0||
59994150|NCT01791595|76109942|FG003|COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0||
59994151|NCT01791595|76109943|FG004|COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0||
60099537|NCT00967486|76216689|FG001|COMPLETED|Overall Study||102||
60099538|NCT00967486|76216688|FG000|NOT COMPLETED|Overall Study||0||
60099539|NCT00967486|76216689|FG001|NOT COMPLETED|Overall Study||0||
60099540|NCT01013194|76216697|FG000|STARTED|Overall Study||9||
60099541|NCT01013194|76216698|FG001|STARTED|Overall Study||16||
60099542|NCT01013194|76216697|FG000|COMPLETED|Overall Study|Consecutive patients|9||
60099543|NCT01013194|76216698|FG001|COMPLETED|Overall Study|Retrospectively contemporary matched-pair group|16||
60099544|NCT01013194|76216697|FG000|NOT COMPLETED|Overall Study||0||
60099545|NCT01013194|76216698|FG001|NOT COMPLETED|Overall Study||0||
60099546|NCT00968032|76216708|FG000|STARTED|Overall Study||63||
60099547|NCT00968032|76216708|FG000|COMPLETED|Overall Study|"1 patient not receiving investigational device due to failure in usage~1 patient denied latest FU"|61||
60099548|NCT00968032|76216708|FG000|NOT COMPLETED|Overall Study||2||
60099549|NCT00968344|76216714|FG000|STARTED|Overall Study|Includes screen fails|20||
60099550|NCT00968344|76216715|FG001|STARTED|Overall Study|Includes screen fails|20||
60099551|NCT00968344|76216714|FG000|COMPLETED|Overall Study||10||
60099552|NCT00968344|76216715|FG001|COMPLETED|Overall Study||9||
60099553|NCT00968344|76216714|FG000|NOT COMPLETED|Overall Study||10||
60099554|NCT00968344|76216715|FG001|NOT COMPLETED|Overall Study||11||
60099555|NCT01015534|76216723|FG000|STARTED|Overall Study||28||
60099556|NCT01015534|76216724|FG001|STARTED|Overall Study||27||
60099557|NCT01015534|76216723|FG000|COMPLETED|Overall Study||27||
60099558|NCT01015534|76216724|FG001|COMPLETED|Overall Study||27||
60099559|NCT01015534|76216723|FG000|NOT COMPLETED|Overall Study||1||
60099560|NCT01015534|76216724|FG001|NOT COMPLETED|Overall Study||0||
60099561|NCT00968890|76216735|FG000|STARTED|Overall Study||84||
60099562|NCT00968890|76216736|FG001|STARTED|Overall Study||84||
60099563|NCT00968890|76216735|FG000|COMPLETED|Overall Study||84||
60099564|NCT00968890|76216736|FG001|COMPLETED|Overall Study||84||
60099565|NCT00968890|76216735|FG000|NOT COMPLETED|Overall Study||0||
60099566|NCT00968890|76216736|FG001|NOT COMPLETED|Overall Study||0||
60099567|NCT00970216|76216742|FG000|STARTED|Overall Study||160||
60099568|NCT00970216|76216742|FG000|COMPLETED|Overall Study||80||
60099569|NCT00970216|76216742|FG000|NOT COMPLETED|Overall Study||80||
60099570|NCT00971620|76216748|FG000|STARTED|Overall Study||9||
60099571|NCT00971620|76216749|FG001|STARTED|Overall Study||9||
60099572|NCT00971620|76216748|FG000|COMPLETED|Overall Study||9||
60099573|NCT00971620|76216749|FG001|COMPLETED|Overall Study||9||
60099574|NCT00971620|76216748|FG000|NOT COMPLETED|Overall Study||0||
60099575|NCT00971620|76216749|FG001|NOT COMPLETED|Overall Study||0||
60099576|NCT01016938|76216755|FG000|STARTED|Overall Study||16||
60099577|NCT01016938|76216755|FG000|COMPLETED|Overall Study||7||
60099578|NCT01016938|76216755|FG000|NOT COMPLETED|Overall Study||9||
60099579|NCT02162680|76216763|FG000|STARTED|Overall Study||33||
60099580|NCT02162680|76216764|FG001|STARTED|Overall Study||33||
60099581|NCT02162680|76216765|FG002|STARTED|Overall Study||32||
60099582|NCT02162680|76216763|FG000|COMPLETED|Overall Study||33||
60099583|NCT02162680|76216764|FG001|COMPLETED|Overall Study||33||
60099584|NCT02162680|76216765|FG002|COMPLETED|Overall Study||32||
60099585|NCT02162680|76216763|FG000|NOT COMPLETED|Overall Study||0||
60099586|NCT02162680|76216764|FG001|NOT COMPLETED|Overall Study||0||
60099587|NCT02162680|76216765|FG002|NOT COMPLETED|Overall Study||0||
60099588|NCT02162992|76216775|FG000|STARTED|Overall Study||51||
60099589|NCT02162992|76216776|FG001|STARTED|Overall Study||100||
60099590|NCT02162992|76216775|FG000|COMPLETED|Overall Study||46||
60099591|NCT02162992|76216776|FG001|COMPLETED|Overall Study||99||
60099592|NCT02162992|76216775|FG000|NOT COMPLETED|Overall Study||5||
60099593|NCT02162992|76216776|FG001|NOT COMPLETED|Overall Study||1||
60099594|NCT00972088|76216782|FG000|STARTED|Overall Study||26||
60099595|NCT00972088|76216782|FG000|COMPLETED|Overall Study||26||
60099596|NCT00972088|76216782|FG000|NOT COMPLETED|Overall Study||0||
60099597|NCT01017250|76216786|FG000|STARTED|Overall Study||15||
60099598|NCT01017250|76216786|FG000|2-month MRI|Overall Study|1 participant did not return for the 2 month MRI at treating facility. Resides out of state.|14||
60099599|NCT01017250|76216786|FG000|COMPLETED|Overall Study||15||
60099600|NCT01017250|76216786|FG000|NOT COMPLETED|Overall Study||0||
60099601|NCT02159872|76216791|FG000|STARTED|Overall Study||48||
60099602|NCT02159872|76216791|FG000|COMPLETED|Overall Study||48||
59563503|NCT01770314|75665750|FG001|Contributed Data to One-month Follow-up|Overall Study||66||
59563504|NCT01770314|75665749|FG000|COMPLETED|Overall Study||86||
59563505|NCT01770314|75665750|FG001|COMPLETED|Overall Study||90||
59563506|NCT01770314|75665749|FG000|NOT COMPLETED|Overall Study||0||
59563507|NCT01770314|75665750|FG001|NOT COMPLETED|Overall Study||0||
59563508|NCT02259608|75665756|FG000|STARTED|Overall Study||15||
59563509|NCT02259608|75665756|FG000|COMPLETED|Overall Study||15||
59563510|NCT02259608|75665756|FG000|NOT COMPLETED|Overall Study||0||
59563511|NCT02326844|75665760|FG000|STARTED|Overall Study||3||
59563512|NCT02326844|75665760|FG000|COMPLETED|Overall Study||3||
60099603|NCT02159872|76216791|FG000|NOT COMPLETED|Overall Study||0||
60099604|NCT01021306|76216799|FG000|STARTED|2 Month (Primary Outcome)||20||
60099605|NCT01021306|76216800|FG001|STARTED|2 Month (Primary Outcome)||20||
60099606|NCT01021306|76216801|FG002|STARTED|2 Month (Primary Outcome)||19||
60099607|NCT01021306|76216802|FG003|STARTED|2 Month (Primary Outcome)||21||
60099608|NCT01021306|76216799|FG000|COMPLETED|2 Month (Primary Outcome)||14||
60099609|NCT01021306|76216800|FG001|COMPLETED|2 Month (Primary Outcome)||14||
60099610|NCT01021306|76216801|FG002|COMPLETED|2 Month (Primary Outcome)||14||
60099611|NCT01021306|76216802|FG003|COMPLETED|2 Month (Primary Outcome)||17||
60099612|NCT01021306|76216799|FG000|NOT COMPLETED|2 Month (Primary Outcome)||6||
60099613|NCT01021306|76216800|FG001|NOT COMPLETED|2 Month (Primary Outcome)||6||
60099614|NCT01021306|76216801|FG002|NOT COMPLETED|2 Month (Primary Outcome)||5||
60099615|NCT01021306|76216802|FG003|NOT COMPLETED|2 Month (Primary Outcome)||4||
60099616|NCT01021306|76216799|FG000|STARTED|6 Month (Follow-up)||14||
60099617|NCT01021306|76216800|FG001|STARTED|6 Month (Follow-up)||14||
60099618|NCT01021306|76216801|FG002|STARTED|6 Month (Follow-up)||14||
60099619|NCT01021306|76216802|FG003|STARTED|6 Month (Follow-up)||17||
60099620|NCT01021306|76216799|FG000|COMPLETED|6 Month (Follow-up)||11||
60099621|NCT01021306|76216800|FG001|COMPLETED|6 Month (Follow-up)||13||
60099622|NCT01021306|76216801|FG002|COMPLETED|6 Month (Follow-up)||14||
60099623|NCT01021306|76216802|FG003|COMPLETED|6 Month (Follow-up)||14||
60099624|NCT01021306|76216799|FG000|NOT COMPLETED|6 Month (Follow-up)||3||
60099625|NCT01021306|76216800|FG001|NOT COMPLETED|6 Month (Follow-up)||1||
60099626|NCT01021306|76216801|FG002|NOT COMPLETED|6 Month (Follow-up)||0||
60099627|NCT01021306|76216802|FG003|NOT COMPLETED|6 Month (Follow-up)||3||
60099628|NCT01021618|76216814|FG000|STARTED|Overall Study||44||
60099629|NCT01021618|76216815|FG001|STARTED|Overall Study||96||
60099630|NCT01021618|76216814|FG000|COMPLETED|Overall Study||44||
60099631|NCT01021618|76216815|FG001|COMPLETED|Overall Study||96||
60099632|NCT01021618|76216814|FG000|NOT COMPLETED|Overall Study||0||
60099633|NCT01021618|76216815|FG001|NOT COMPLETED|Overall Study||0||
60099634|NCT01022242|76216823|FG000|STARTED|Overall Study|71 pat rand to placebo. 1 got incorrect mix of placebo. 70 patients treated with the correct mix.|70||
60099635|NCT01022242|76216824|FG001|STARTED|Overall Study|67 pat rand to PXL01. 2 got incorrect mix of PXL01. 65 patients treated with the correct PXL01 mix.|65||
60099636|NCT01022242|76216823|FG000|COMPLETED|Overall Study||49||
59563513|NCT02326844|75665760|FG000|NOT COMPLETED|Overall Study||0||
59563514|NCT02388815|75665764|FG000|STARTED|Overall Study||89||
59563515|NCT02388815|75665764|FG000|COMPLETED|Overall Study||85||
59563516|NCT02388815|75665764|FG000|NOT COMPLETED|Overall Study||4||
59708290|NCT01204710|75827110|FG000|Received ≥1 Dose of Study Drug|Randomization Treatment||62||
59708291|NCT01204710|75827111|FG001|Received ≥1 Dose of Study Drug|Randomization Treatment||59||
59708292|NCT01204710|75827110|FG000|COMPLETED|Randomization Treatment||49||
60099637|NCT01022242|76216824|FG001|COMPLETED|Overall Study||46||
60099638|NCT01022242|76216823|FG000|NOT COMPLETED|Overall Study||21||
60099639|NCT01022242|76216824|FG001|NOT COMPLETED|Overall Study||19||
60099640|NCT01018420|76216832|FG000|STARTED|Overall Study||15||
60099641|NCT01018420|76216833|FG001|STARTED|Overall Study||3||
60099642|NCT01018420|76216832|FG000|COMPLETED|Overall Study||15||
60099643|NCT01018420|76216833|FG001|COMPLETED|Overall Study||3||
60099644|NCT01018420|76216832|FG000|NOT COMPLETED|Overall Study||0||
60099645|NCT01018420|76216833|FG001|NOT COMPLETED|Overall Study||0||
60099646|NCT00974350|76216859|FG000|STARTED|Overall Study||45||
60099647|NCT00974350|76216860|FG001|STARTED|Overall Study||47||
60099648|NCT00974350|76216861|FG002|STARTED|Overall Study||32||
60099649|NCT00974350|76216859|FG000|COMPLETED|Overall Study||42||
60099650|NCT00974350|76216860|FG001|COMPLETED|Overall Study||47||
60099651|NCT00974350|76216861|FG002|COMPLETED|Overall Study||31||
60099652|NCT00974350|76216859|FG000|NOT COMPLETED|Overall Study||3||
60099653|NCT00974350|76216860|FG001|NOT COMPLETED|Overall Study||0||
60099654|NCT00974350|76216861|FG002|NOT COMPLETED|Overall Study||1||
60099655|NCT01023178|76216873|FG000|STARTED|Overall Study||5||
60099656|NCT01023178|76216874|FG001|STARTED|Overall Study||8||
60099657|NCT01023178|76216875|FG002|STARTED|Overall Study||7||
60099658|NCT01023178|76216873|FG000|COMPLETED|Overall Study||3||
60099659|NCT01023178|76216874|FG001|COMPLETED|Overall Study||6||
60099660|NCT01023178|76216875|FG002|COMPLETED|Overall Study||4||
60099661|NCT01023178|76216873|FG000|NOT COMPLETED|Overall Study||2||
60099662|NCT01023178|76216874|FG001|NOT COMPLETED|Overall Study||2||
60099663|NCT01023178|76216875|FG002|NOT COMPLETED|Overall Study||3||
60099664|NCT01023568|76216886|FG000|STARTED|Overall Study||45||
60099665|NCT01023568|76216887|FG001|STARTED|Overall Study||44||
60099666|NCT01023568|76216888|FG002|STARTED|Overall Study||45||
60099667|NCT01023568|76216886|FG000|COMPLETED|Overall Study||45||
60099668|NCT01023568|76216887|FG001|COMPLETED|Overall Study||44||
60099669|NCT01023568|76216888|FG002|COMPLETED|Overall Study||45||
60099670|NCT01023568|76216886|FG000|NOT COMPLETED|Overall Study||0||
60099671|NCT01023568|76216887|FG001|NOT COMPLETED|Overall Study||0||
60099672|NCT01023568|76216888|FG002|NOT COMPLETED|Overall Study||0||
60099673|NCT01023724|76216898|FG000|STARTED|Overall Study||25||
60099674|NCT01023724|76216899|FG001|STARTED|Overall Study||25||
60099675|NCT01023724|76216898|FG000|COMPLETED|Overall Study||21||
60099676|NCT01023724|76216899|FG001|COMPLETED|Overall Study||22||
60099677|NCT01023724|76216898|FG000|NOT COMPLETED|Overall Study||4||
59994152|NCT01791595|76109944|FG005|COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0||
60099678|NCT01023724|76216899|FG001|NOT COMPLETED|Overall Study||3||
59563517|NCT01771172|75665768|FG000|STARTED|Overall Study||48||
59563518|NCT01771172|75665768|FG000|COMPLETED|Overall Study||46||
59563519|NCT01771172|75665768|FG000|NOT COMPLETED|Overall Study||2||
59563520|NCT01771952|75665774|FG000|STARTED|Overall Study||45||
59563521|NCT01771952|75665775|FG001|STARTED|Overall Study||41||
59563522|NCT01771952|75665774|FG000|COMPLETED|Overall Study||42||
59563523|NCT01771952|75665775|FG001|COMPLETED|Overall Study||38||
59563524|NCT01771952|75665774|FG000|NOT COMPLETED|Overall Study||3||
59563525|NCT01771952|75665775|FG001|NOT COMPLETED|Overall Study||3||
59563526|NCT01772654|75665783|FG000|STARTED|Overall Study||2||
59563527|NCT01772654|75665784|FG001|STARTED|Overall Study||15||
59563528|NCT01772654|75665783|FG000|COMPLETED|Overall Study||2||
59563529|NCT01772654|75665784|FG001|COMPLETED|Overall Study||15||
59563530|NCT01772654|75665783|FG000|NOT COMPLETED|Overall Study||0||
59563531|NCT01772654|75665784|FG001|NOT COMPLETED|Overall Study||0||
59563532|NCT02389361|75665792|FG000|STARTED|Overall Study||24||
59563533|NCT02389361|75665793|FG001|STARTED|Overall Study||27||
59563534|NCT02389361|75665792|FG000|COMPLETED|Overall Study||24||
59563535|NCT02389361|75665793|FG001|COMPLETED|Overall Study||27||
59994153|NCT01791595|76109945|FG006|COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0||
59994154|NCT01791595|76109939|FG000|NOT COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0||
59994155|NCT01791595|76109940|FG001|NOT COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0||
59994156|NCT01791595|76109941|FG002|NOT COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0||
60099679|NCT00974818|76216907|FG000|STARTED|Overall Study||25||
60099680|NCT00974818|76216908|FG001|STARTED|Overall Study||25||
60099681|NCT00974818|76216907|FG000|COMPLETED|Overall Study||25||
60099682|NCT00974818|76216908|FG001|COMPLETED|Overall Study||25||
60099683|NCT00974818|76216907|FG000|NOT COMPLETED|Overall Study||0||
60099684|NCT00974818|76216908|FG001|NOT COMPLETED|Overall Study||0||
60099685|NCT00977704|76216914|FG000|STARTED|Overall Study||20||
60099686|NCT00977704|76216914|FG000|COMPLETED|Overall Study||20||
60099687|NCT00977704|76216914|FG000|NOT COMPLETED|Overall Study||0||
60099688|NCT01024738|76216921|FG000|STARTED|First Intervention:||7||
60099689|NCT01024738|76216922|FG001|STARTED|First Intervention:||7||
60099690|NCT01024738|76216923|FG002|STARTED|First Intervention:||8||
60099691|NCT01024738|76216921|FG000|COMPLETED|First Intervention:||7||
60099692|NCT01024738|76216922|FG001|COMPLETED|First Intervention:||7||
60099693|NCT01024738|76216923|FG002|COMPLETED|First Intervention:||8||
59994157|NCT01791595|76109942|FG003|NOT COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0||
59994158|NCT01791595|76109943|FG004|NOT COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||11||
59994159|NCT01791595|76109944|FG005|NOT COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0||
59994160|NCT01791595|76109945|FG006|NOT COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0||
60099694|NCT01024738|76216921|FG000|NOT COMPLETED|First Intervention:||0||
60099695|NCT01024738|76216922|FG001|NOT COMPLETED|First Intervention:||0||
60099696|NCT01024738|76216923|FG002|NOT COMPLETED|First Intervention:||0||
60099697|NCT01024738|76216921|FG000|STARTED|Washout After 1st Intervention||7||
59563536|NCT02389361|75665792|FG000|NOT COMPLETED|Overall Study||0||
59563537|NCT02389361|75665793|FG001|NOT COMPLETED|Overall Study||0||
59994161|NCT01791595|76109939|FG000|STARTED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0||
59563538|NCT02251496|75665801|FG000|STARTED|Overall Study||19||
59708293|NCT01204710|75827111|FG001|COMPLETED|Randomization Treatment||47||
59563539|NCT02251496|75665802|FG001|STARTED|Overall Study||15||
59563540|NCT02251496|75665801|FG000|COMPLETED|Overall Study||14||
59708294|NCT01204710|75827110|FG000|NOT COMPLETED|Randomization Treatment||14||
59563541|NCT02251496|75665802|FG001|COMPLETED|Overall Study||11||
59563542|NCT02251496|75665801|FG000|NOT COMPLETED|Overall Study||5||
60099698|NCT01024738|76216922|FG001|STARTED|Washout After 1st Intervention||7||
60099699|NCT01024738|76216923|FG002|STARTED|Washout After 1st Intervention||8||
60099700|NCT01024738|76216921|FG000|COMPLETED|Washout After 1st Intervention||7||
60099701|NCT01024738|76216922|FG001|COMPLETED|Washout After 1st Intervention||7||
60099702|NCT01024738|76216923|FG002|COMPLETED|Washout After 1st Intervention||8||
60099703|NCT01024738|76216921|FG000|NOT COMPLETED|Washout After 1st Intervention||0||
59563543|NCT02251496|75665802|FG001|NOT COMPLETED|Overall Study||4||
59563544|NCT02251886|75665812|FG000|STARTED|Overall Study||48||
59563545|NCT02251886|75665813|FG001|STARTED|Overall Study||54||
59563546|NCT02251886|75665814|FG002|STARTED|Overall Study||44||
60099704|NCT01024738|76216922|FG001|NOT COMPLETED|Washout After 1st Intervention||0||
60099705|NCT01024738|76216923|FG002|NOT COMPLETED|Washout After 1st Intervention||0||
60099706|NCT01024738|76216921|FG000|STARTED|Second Intervention:||7||
59563547|NCT02251886|75665815|FG003|STARTED|Overall Study||54||
60099707|NCT01024738|76216922|FG001|STARTED|Second Intervention:||7||
60099708|NCT01024738|76216923|FG002|STARTED|Second Intervention:||8||
60099709|NCT01024738|76216921|FG000|COMPLETED|Second Intervention:||7||
60099710|NCT01024738|76216922|FG001|COMPLETED|Second Intervention:||7||
60099711|NCT01024738|76216923|FG002|COMPLETED|Second Intervention:||8||
60099712|NCT01024738|76216921|FG000|NOT COMPLETED|Second Intervention:||0||
60099713|NCT01024738|76216922|FG001|NOT COMPLETED|Second Intervention:||0||
60099714|NCT01024738|76216923|FG002|NOT COMPLETED|Second Intervention:||0||
60099715|NCT01024738|76216921|FG000|STARTED|Washout After 2nd Intervention||7||
59563548|NCT02251886|75665812|FG000|COMPLETED|Overall Study||48||
59563549|NCT02251886|75665813|FG001|COMPLETED|Overall Study||54||
59563550|NCT02251886|75665814|FG002|COMPLETED|Overall Study||44||
59563551|NCT02251886|75665815|FG003|COMPLETED|Overall Study||54||
60099716|NCT01024738|76216922|FG001|STARTED|Washout After 2nd Intervention||7||
60099717|NCT01024738|76216923|FG002|STARTED|Washout After 2nd Intervention||8||
60099718|NCT01024738|76216921|FG000|COMPLETED|Washout After 2nd Intervention||7||
60099719|NCT01024738|76216922|FG001|COMPLETED|Washout After 2nd Intervention||7||
59563552|NCT02251886|75665812|FG000|NOT COMPLETED|Overall Study||0||
59563553|NCT02251886|75665813|FG001|NOT COMPLETED|Overall Study||0||
59563554|NCT02251886|75665814|FG002|NOT COMPLETED|Overall Study||0||
59563555|NCT02251886|75665815|FG003|NOT COMPLETED|Overall Study||0||
59563556|NCT02391701|75665827|FG000|STARTED|Overall Study||367||
59563557|NCT02391701|75665828|FG001|STARTED|Overall Study||353||
60099720|NCT01024738|76216923|FG002|COMPLETED|Washout After 2nd Intervention||8||
60099721|NCT01024738|76216921|FG000|NOT COMPLETED|Washout After 2nd Intervention||0||
59563558|NCT02391701|75665827|FG000|COMPLETED|Overall Study||346||
59563559|NCT02391701|75665828|FG001|COMPLETED|Overall Study||315||
60099722|NCT01024738|76216922|FG001|NOT COMPLETED|Washout After 2nd Intervention||0||
60099723|NCT01024738|76216923|FG002|NOT COMPLETED|Washout After 2nd Intervention||0||
60099724|NCT01024738|76216921|FG000|STARTED|Third Intervention:||7||
60099725|NCT01024738|76216922|FG001|STARTED|Third Intervention:||7||
59563560|NCT02391701|75665827|FG000|NOT COMPLETED|Overall Study||21||
59563561|NCT02391701|75665828|FG001|NOT COMPLETED|Overall Study||38||
59708295|NCT01204710|75827111|FG001|NOT COMPLETED|Randomization Treatment||13||
60099726|NCT01024738|76216923|FG002|STARTED|Third Intervention:||8||
60099727|NCT01024738|76216921|FG000|COMPLETED|Third Intervention:||7||
60099728|NCT01024738|76216922|FG001|COMPLETED|Third Intervention:||7||
60099729|NCT01024738|76216923|FG002|COMPLETED|Third Intervention:||8||
60099730|NCT01024738|76216921|FG000|NOT COMPLETED|Third Intervention:||0||
60099731|NCT01024738|76216922|FG001|NOT COMPLETED|Third Intervention:||0||
60099732|NCT01024738|76216923|FG002|NOT COMPLETED|Third Intervention:||0||
60099733|NCT01024972|76216933|FG000|STARTED|Overall Study||16||
60099734|NCT01024972|76216934|FG001|STARTED|Overall Study||15||
60099735|NCT01024972|76216933|FG000|COMPLETED|Overall Study||16||
60099736|NCT01024972|76216934|FG001|COMPLETED|Overall Study||15||
60099737|NCT01024972|76216933|FG000|NOT COMPLETED|Overall Study||0||
60099738|NCT01024972|76216934|FG001|NOT COMPLETED|Overall Study||0||
60099739|NCT01025830|76216941|FG000|STARTED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||8||
60099740|NCT01025830|76216942|FG001|STARTED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||12||
60099741|NCT01025830|76216941|FG000|COMPLETED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||8||
60099742|NCT01025830|76216942|FG001|COMPLETED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||12||
60099743|NCT01025830|76216941|FG000|NOT COMPLETED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||0||
60099744|NCT01025830|76216942|FG001|NOT COMPLETED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||0||
60099745|NCT01025830|76216941|FG000|STARTED|Washout Period of 30 Days||8||
60099746|NCT01025830|76216942|FG001|STARTED|Washout Period of 30 Days||12||
60099747|NCT01025830|76216941|FG000|COMPLETED|Washout Period of 30 Days||8||
60099748|NCT01025830|76216942|FG001|COMPLETED|Washout Period of 30 Days||12||
60099749|NCT01025830|76216941|FG000|NOT COMPLETED|Washout Period of 30 Days||0||
60099750|NCT01025830|76216942|FG001|NOT COMPLETED|Washout Period of 30 Days||0||
60099751|NCT01025830|76216941|FG000|STARTED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||8||
60099752|NCT01025830|76216942|FG001|STARTED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||12||
60099753|NCT01025830|76216941|FG000|COMPLETED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||8||
60099754|NCT01025830|76216942|FG001|COMPLETED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||12||
60099755|NCT01025830|76216941|FG000|NOT COMPLETED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||0||
60099756|NCT01025830|76216942|FG001|NOT COMPLETED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||0||
60099757|NCT01026844|76216955|FG000|STARTED|Overall Study||19||
60099758|NCT01026844|76216956|FG001|STARTED|Overall Study||8||
60099759|NCT01026844|76216955|FG000|COMPLETED|Overall Study||19||
60099760|NCT01026844|76216956|FG001|COMPLETED|Overall Study||8||
60099761|NCT01026844|76216955|FG000|NOT COMPLETED|Overall Study||0||
60099762|NCT01026844|76216956|FG001|NOT COMPLETED|Overall Study||0||
60099763|NCT00979732|76216964|FG000|STARTED|Overall Study||15||
60099764|NCT00979732|76216965|FG001|STARTED|Overall Study||18||
60099765|NCT00979732|76216964|FG000|COMPLETED|Overall Study||12||
60099766|NCT00979732|76216965|FG001|COMPLETED|Overall Study||17||
60099767|NCT00979732|76216964|FG000|NOT COMPLETED|Overall Study||3||
60099768|NCT00979732|76216965|FG001|NOT COMPLETED|Overall Study||1||
60099769|NCT03368781|76216971|FG000|STARTED|Overall Study||128||
60099770|NCT03368781|76216971|FG000|Treated Subjects|Overall Study|106 subjects underwent an ablation procedure|106||
60099771|NCT03368781|76216971|FG000|COMPLETED|Overall Study||103||
60099772|NCT03368781|76216971|FG000|NOT COMPLETED|Overall Study||25||
60099773|NCT01027468|76216979|FG000|STARTED|Overall Study||160||
60099774|NCT01027468|76216979|FG000|COMPLETED|Overall Study||160||
60099775|NCT01027468|76216979|FG000|NOT COMPLETED|Overall Study||0||
60099776|NCT01027780|76216985|FG000|STARTED|Overall Study||105||
60099777|NCT01027780|76216986|FG001|STARTED|Overall Study||103||
60099778|NCT01027780|76216985|FG000|COMPLETED|Overall Study||105||
60099779|NCT01027780|76216986|FG001|COMPLETED|Overall Study||102||
60099780|NCT01027780|76216985|FG000|NOT COMPLETED|Overall Study||0||
60099781|NCT01027780|76216986|FG001|NOT COMPLETED|Overall Study||1||
59563562|NCT02252354|75665836|FG000|STARTED|Overall Study||6||
59563563|NCT02252354|75665837|FG001|STARTED|Overall Study||6||
59563564|NCT02252354|75665836|FG000|COMPLETED|Overall Study||6||
59563565|NCT02252354|75665837|FG001|COMPLETED|Overall Study||6||
59563566|NCT02252354|75665836|FG000|NOT COMPLETED|Overall Study||0||
59563567|NCT02252354|75665837|FG001|NOT COMPLETED|Overall Study||0||
59563568|NCT02393339|75665845|FG000|STARTED|Overall Study||58||
59563569|NCT02393339|75665846|FG001|STARTED|Overall Study||56||
59563570|NCT02393339|75665845|FG000|COMPLETED|Overall Study||51||
59563571|NCT02393339|75665846|FG001|COMPLETED|Overall Study||51||
59563572|NCT02393339|75665845|FG000|NOT COMPLETED|Overall Study||7||
59994162|NCT01791595|76109940|FG001|STARTED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0||
59994163|NCT01791595|76109941|FG002|STARTED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0||
59994164|NCT01791595|76109942|FG003|STARTED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0||
59994165|NCT01791595|76109943|FG004|STARTED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0||
59994166|NCT01791595|76109944|FG005|STARTED|Part 1 AZD3965 Cohort 6 (10 mg BD)||8||
59994167|NCT01791595|76109945|FG006|STARTED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0||
59994168|NCT01791595|76109939|FG000|COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0||
59994169|NCT01791595|76109940|FG001|COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0||
59994170|NCT01791595|76109941|FG002|COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0||
59994171|NCT01791595|76109942|FG003|COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0||
59563573|NCT02393339|75665846|FG001|NOT COMPLETED|Overall Study||5||
59563574|NCT01774604|75665854|FG000|STARTED|Overall Study||223||
59563575|NCT01774604|75665855|FG001|STARTED|Overall Study||226||
60099782|NCT00980278|76216995|FG000|STARTED|Overall Study||13||
60099783|NCT00980278|76216996|FG001|STARTED|Overall Study||13||
60099784|NCT00980278|76216995|FG000|COMPLETED|Overall Study||11||
60099785|NCT00980278|76216996|FG001|COMPLETED|Overall Study||13||
60099786|NCT00980278|76216995|FG000|NOT COMPLETED|Overall Study||2||
60099787|NCT00980278|76216996|FG001|NOT COMPLETED|Overall Study||0||
60099788|NCT01029730|76217002|FG000|STARTED|Combination Therapy||55||
59563576|NCT01774604|75665854|FG000|COMPLETED|Overall Study||223||
59563577|NCT01774604|75665855|FG001|COMPLETED|Overall Study||226||
60099789|NCT01029730|76217002|FG000|COMPLETED|Combination Therapy|Patients remained on-study until completing 6 cycles or coming off-treatment for any other reason|39||
60099790|NCT01029730|76217002|FG000|NOT COMPLETED|Combination Therapy||16||
60099791|NCT01029730|76217002|FG000|STARTED|Maintenance Therapy|Two patients complete study treatment but declined subsequent maintenance therapy|37||
60099792|NCT01029730|76217002|FG000|COMPLETED|Maintenance Therapy||14||
60099793|NCT01029730|76217002|FG000|NOT COMPLETED|Maintenance Therapy||23||
59563578|NCT01774604|75665854|FG000|NOT COMPLETED|Overall Study||0||
59563579|NCT01774604|75665855|FG001|NOT COMPLETED|Overall Study||0||
59563580|NCT01774760|75665861|FG000|STARTED|Overall Study||10||
59563581|NCT01774760|75665861|FG000|COMPLETED|Overall Study||10||
59563582|NCT01774760|75665861|FG000|NOT COMPLETED|Overall Study||0||
59563583|NCT01775774|75665868|FG000|STARTED|Overall Study||3||
59563584|NCT01775774|75665869|FG001|STARTED|Overall Study||3||
59563585|NCT01775774|75665870|FG002|STARTED|Overall Study||3||
59563586|NCT01775774|75665868|FG000|COMPLETED|Overall Study||3||
59563587|NCT01775774|75665869|FG001|COMPLETED|Overall Study||3||
59817002|NCT02040857|75939413|FG000|Treatment Discontinuation Evaluable|Overall Study|Evaluable population excludes participants who discontinue early for reasons unrelated to treatment.|152||
59817003|NCT02040857|75939413|FG000|COMPLETED|Overall Study||102||
59817004|NCT02040857|75939413|FG000|NOT COMPLETED|Overall Study||60||
59817005|NCT01709435|75939426|FG000|STARTED|Overall Study||6||
59817006|NCT01709435|75939427|FG001|STARTED|Overall Study||9||
59817007|NCT01709435|75939428|FG002|STARTED|Overall Study||6||
59994172|NCT01791595|76109943|FG004|COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0||
59563588|NCT01775774|75665870|FG002|COMPLETED|Overall Study||3||
59563589|NCT01775774|75665868|FG000|NOT COMPLETED|Overall Study||0||
60099794|NCT00980746|76217012|FG000|STARTED|Overall Study||85||
60099795|NCT00980746|76217013|FG001|STARTED|Overall Study||89||
60099796|NCT00980746|76217014|FG002|STARTED|Overall Study||95||
60099797|NCT00980746|76217015|FG003|STARTED|Overall Study||100||
60099798|NCT00980746|76217016|FG004|STARTED|Overall Study||92||
60099799|NCT00980746|76217017|FG005|STARTED|Overall Study||96||
60099800|NCT00980746|76217012|FG000|Randomized|Overall Study||85||
60099801|NCT00980746|76217013|FG001|Randomized|Overall Study||89||
59563590|NCT01775774|75665869|FG001|NOT COMPLETED|Overall Study||0||
59563591|NCT01775774|75665870|FG002|NOT COMPLETED|Overall Study||0||
59563592|NCT02393417|75665882|FG000|STARTED|Overall Study||43|Subjects Randomized|
59563593|NCT02393417|75665883|FG001|STARTED|Overall Study||45|Subjects Randomized|
59563594|NCT02393417|75665884|FG002|STARTED|Overall Study||40|Subjects Randomized|
59563595|NCT02393417|75665885|FG003|STARTED|Overall Study||41|Subjects Randomized|
59563596|NCT02393417|75665882|FG000|Completed Treatment|Overall Study||30||
59563597|NCT02393417|75665883|FG001|Completed Treatment|Overall Study||34||
60099802|NCT00980746|76217014|FG002|Randomized|Overall Study||95||
60099803|NCT00980746|76217015|FG003|Randomized|Overall Study||100||
60099804|NCT00980746|76217016|FG004|Randomized|Overall Study||92||
60099805|NCT00980746|76217017|FG005|Randomized|Overall Study||96||
60099806|NCT00980746|76217012|FG000|Safety Population|Overall Study||85||
60099807|NCT00980746|76217013|FG001|Safety Population|Overall Study||89||
60099808|NCT00980746|76217014|FG002|Safety Population|Overall Study||95||
60099809|NCT00980746|76217015|FG003|Safety Population|Overall Study||100||
60099810|NCT00980746|76217016|FG004|Safety Population|Overall Study||92||
60099811|NCT00980746|76217017|FG005|Safety Population|Overall Study||96||
60099812|NCT00980746|76217012|FG000|Per-protocol|Overall Study||55||
60099813|NCT00980746|76217013|FG001|Per-protocol|Overall Study||66||
60099814|NCT00980746|76217014|FG002|Per-protocol|Overall Study||73||
60099815|NCT00980746|76217015|FG003|Per-protocol|Overall Study||62||
60099816|NCT00980746|76217016|FG004|Per-protocol|Overall Study||73||
60099817|NCT00980746|76217017|FG005|Per-protocol|Overall Study||74||
60099818|NCT00980746|76217012|FG000|COMPLETED|Overall Study||58||
60099819|NCT00980746|76217013|FG001|COMPLETED|Overall Study||67||
60099820|NCT00980746|76217014|FG002|COMPLETED|Overall Study||75||
60099821|NCT00980746|76217015|FG003|COMPLETED|Overall Study||64||
60099822|NCT00980746|76217016|FG004|COMPLETED|Overall Study||75||
60099823|NCT00980746|76217017|FG005|COMPLETED|Overall Study||78||
60099824|NCT00980746|76217012|FG000|NOT COMPLETED|Overall Study||27||
60099825|NCT00980746|76217013|FG001|NOT COMPLETED|Overall Study||22||
60099826|NCT00980746|76217014|FG002|NOT COMPLETED|Overall Study||20||
60099827|NCT00980746|76217015|FG003|NOT COMPLETED|Overall Study||36||
60099828|NCT00980746|76217016|FG004|NOT COMPLETED|Overall Study||17||
60099829|NCT00980746|76217017|FG005|NOT COMPLETED|Overall Study||18||
60099830|NCT00981214|76217031|FG000|STARTED|Overall Study||19||
60099831|NCT00981214|76217031|FG000|COMPLETED|Overall Study||19||
60099832|NCT00981214|76217031|FG000|NOT COMPLETED|Overall Study||0||
60099833|NCT01031134|76217037|FG000|STARTED|Overall Study||114||
60099834|NCT01031134|76217038|FG001|STARTED|Overall Study||88||
60099835|NCT01031134|76217037|FG000|COMPLETED|Overall Study||103||
60099836|NCT01031134|76217038|FG001|COMPLETED|Overall Study||78||
60099837|NCT01031134|76217037|FG000|NOT COMPLETED|Overall Study||11||
60099838|NCT01031134|76217038|FG001|NOT COMPLETED|Overall Study||10||
60099839|NCT01031914|76217044|FG000|STARTED|Overall Study||36||
60099840|NCT01031914|76217044|FG000|COMPLETED|Overall Study||36||
60099841|NCT01031914|76217044|FG000|NOT COMPLETED|Overall Study||0||
60099842|NCT02167204|76217048|FG000|STARTED|Overall Study||9||
60099843|NCT02167204|76217048|FG000|COMPLETED|Overall Study||9||
59563598|NCT02393417|75665884|FG002|Completed Treatment|Overall Study||32||
59563599|NCT02393417|75665885|FG003|Completed Treatment|Overall Study||30||
60099844|NCT02167204|76217048|FG000|NOT COMPLETED|Overall Study||0||
60099845|NCT00982072|76217060|FG000|STARTED|Overall Study||25||
60099846|NCT00982072|76217061|FG001|STARTED|Overall Study||27||
60099847|NCT00982072|76217060|FG000|COMPLETED|Overall Study||25||
60099848|NCT00982072|76217061|FG001|COMPLETED|Overall Study||25||
60099849|NCT00982072|76217060|FG000|NOT COMPLETED|Overall Study||0||
60099850|NCT00982072|76217061|FG001|NOT COMPLETED|Overall Study||2||
60099851|NCT01899053|76217081|FG000|STARTED|Overall Study||7||
60099852|NCT01899053|76217082|FG001|STARTED|Overall Study||3||
60099853|NCT01899053|76217083|FG002|STARTED|Overall Study||7||
60099854|NCT01899053|76217084|FG003|STARTED|Overall Study||3||
60099855|NCT01899053|76217085|FG004|STARTED|Overall Study||6||
60099856|NCT01899053|76217086|FG005|STARTED|Overall Study||3||
60099857|NCT01899053|76217087|FG006|STARTED|Overall Study||3||
60099858|NCT01899053|76217088|FG007|STARTED|Overall Study||3||
60099859|NCT01899053|76217089|FG008|STARTED|Overall Study||6||
60099860|NCT01899053|76217090|FG009|STARTED|Overall Study||3||
60099861|NCT01899053|76217091|FG010|STARTED|Overall Study||16||
60099862|NCT01899053|76217092|FG011|STARTED|Overall Study||7||
60099863|NCT01899053|76217093|FG012|STARTED|Overall Study||14||
60099864|NCT01899053|76217094|FG013|STARTED|Overall Study||20||
60099865|NCT01899053|76217081|FG000|COMPLETED|Overall Study||0|Completed=Participants who completed the study treatment.|
60099866|NCT01899053|76217082|FG001|COMPLETED|Overall Study||0|Completed=Participants who completed the study treatment.|
59563600|NCT02393417|75665882|FG000|COMPLETED|Overall Study||28|Completed Treatment and both follow up visits|
59563601|NCT02393417|75665883|FG001|COMPLETED|Overall Study||32|Completed Treatment and both follow up visits|
59563602|NCT02393417|75665884|FG002|COMPLETED|Overall Study||30|Completed Treatment and both follow up visits|
59563603|NCT02393417|75665885|FG003|COMPLETED|Overall Study||29|Completed Treatment and both follow up visits|
59563604|NCT02393417|75665882|FG000|NOT COMPLETED|Overall Study||15||
59563605|NCT02393417|75665883|FG001|NOT COMPLETED|Overall Study||13||
59563606|NCT02393417|75665884|FG002|NOT COMPLETED|Overall Study||10||
59563607|NCT02393417|75665885|FG003|NOT COMPLETED|Overall Study||12||
59563608|NCT01775852|75665898|FG000|STARTED|Overall Study||31||
59994173|NCT01791595|76109944|FG005|COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0||
59994174|NCT01791595|76109945|FG006|COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0||
59994175|NCT01791595|76109939|FG000|NOT COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0||
59994176|NCT01791595|76109940|FG001|NOT COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0||
59994177|NCT01791595|76109941|FG002|NOT COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0||
59994178|NCT01791595|76109942|FG003|NOT COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0||
59994179|NCT01791595|76109943|FG004|NOT COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0||
59994180|NCT01791595|76109944|FG005|NOT COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||8||
60099867|NCT01899053|76217083|FG002|COMPLETED|Overall Study||0|Completed=Participants who completed the study treatment.|
60099868|NCT01899053|76217084|FG003|COMPLETED|Overall Study||0|Completed=Participants who completed the study treatment.|
60099869|NCT01899053|76217085|FG004|COMPLETED|Overall Study||0|Completed=Participants who completed the study treatment.|
59563609|NCT01775852|75665899|FG001|STARTED|Overall Study||14||
59563610|NCT01775852|75665898|FG000|COMPLETED|Overall Study||31||
59563611|NCT01775852|75665899|FG001|COMPLETED|Overall Study||13||
59563612|NCT01775852|75665898|FG000|NOT COMPLETED|Overall Study||0||
59994181|NCT01791595|76109945|FG006|NOT COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0||
59994182|NCT01791595|76109939|FG000|STARTED|Part 2 AZD3965 Expansion (10 mg BD)||0||
59994183|NCT01791595|76109940|FG001|STARTED|Part 2 AZD3965 Expansion (10 mg BD)||0||
59994184|NCT01791595|76109941|FG002|STARTED|Part 2 AZD3965 Expansion (10 mg BD)||0||
60099870|NCT01899053|76217086|FG005|COMPLETED|Overall Study||0|Completed=Participants who completed the study treatment.|
59563613|NCT01775852|75665899|FG001|NOT COMPLETED|Overall Study||1||
59563614|NCT01776632|75665907|FG000|STARTED|Overall Study||217||
59563615|NCT01776632|75665908|FG001|STARTED|Overall Study||219||
59994185|NCT01791595|76109942|FG003|STARTED|Part 2 AZD3965 Expansion (10 mg BD)||0||
59994186|NCT01791595|76109943|FG004|STARTED|Part 2 AZD3965 Expansion (10 mg BD)||0||
60099871|NCT01899053|76217087|FG006|COMPLETED|Overall Study||0|Completed=Participants who completed the study treatment.|
60099872|NCT01899053|76217088|FG007|COMPLETED|Overall Study||0|Completed=Participants who completed the study treatment.|
60099873|NCT01899053|76217089|FG008|COMPLETED|Overall Study||0|Completed=Participants who completed the study treatment.|
60099874|NCT01899053|76217090|FG009|COMPLETED|Overall Study||0|Completed=Participants who completed the study treatment.|
60099875|NCT01899053|76217091|FG010|COMPLETED|Overall Study||0|Completed=Participants who completed the study treatment.|
60099876|NCT01899053|76217092|FG011|COMPLETED|Overall Study||0|Completed=Participants who completed the study treatment.|
60099877|NCT01899053|76217093|FG012|COMPLETED|Overall Study||0|Completed=Participants who completed the study treatment.|
60099878|NCT01899053|76217094|FG013|COMPLETED|Overall Study||0|Completed=Participants who completed the study treatment.|
60099879|NCT01899053|76217081|FG000|NOT COMPLETED|Overall Study||7||
60099880|NCT01899053|76217082|FG001|NOT COMPLETED|Overall Study||3||
60099881|NCT01899053|76217083|FG002|NOT COMPLETED|Overall Study||7||
60099882|NCT01899053|76217084|FG003|NOT COMPLETED|Overall Study||3||
60099883|NCT01899053|76217085|FG004|NOT COMPLETED|Overall Study||6||
59563616|NCT01776632|75665907|FG000|COMPLETED|Overall Study||190||
59563617|NCT01776632|75665908|FG001|COMPLETED|Overall Study||190||
60099884|NCT01899053|76217086|FG005|NOT COMPLETED|Overall Study||3||
60099885|NCT01899053|76217087|FG006|NOT COMPLETED|Overall Study||3||
60099886|NCT01899053|76217088|FG007|NOT COMPLETED|Overall Study||3||
59563618|NCT01776632|75665907|FG000|NOT COMPLETED|Overall Study||27||
59563619|NCT01776632|75665908|FG001|NOT COMPLETED|Overall Study||29||
59563620|NCT01777412|75665914|FG000|STARTED|Overall Study||10||
59563621|NCT01777412|75665914|FG000|COMPLETED|Overall Study||10||
59563622|NCT01777412|75665914|FG000|NOT COMPLETED|Overall Study||0||
59563623|NCT01777568|75665920|FG000|STARTED|Overall Study||2853||
59563624|NCT01777568|75665921|FG001|STARTED|Overall Study||2896||
59563625|NCT01777568|75665920|FG000|COMPLETED|Overall Study||2853||
60099887|NCT01899053|76217089|FG008|NOT COMPLETED|Overall Study||6||
60099888|NCT01899053|76217090|FG009|NOT COMPLETED|Overall Study||3||
60099889|NCT01899053|76217091|FG010|NOT COMPLETED|Overall Study||16||
60099890|NCT01899053|76217092|FG011|NOT COMPLETED|Overall Study||7||
60099891|NCT01899053|76217093|FG012|NOT COMPLETED|Overall Study||14||
60099892|NCT01899053|76217094|FG013|NOT COMPLETED|Overall Study||20||
60099893|NCT01032538|76217126|FG000|STARTED|Overall Study|Knees|99||
60099894|NCT01032538|76217126|FG000|COMPLETED|Overall Study|Knees|99||
60099895|NCT01032538|76217126|FG000|NOT COMPLETED|Overall Study||0||
60099896|NCT01032694|76217134|FG000|STARTED|Overall Study||20||
60099897|NCT01032694|76217135|FG001|STARTED|Overall Study||10||
60099898|NCT01032694|76217134|FG000|COMPLETED|Overall Study||20||
60099899|NCT01032694|76217135|FG001|COMPLETED|Overall Study||10||
59563626|NCT01777568|75665921|FG001|COMPLETED|Overall Study||2896||
59563627|NCT01777568|75665920|FG000|NOT COMPLETED|Overall Study||0||
59563628|NCT01777568|75665921|FG001|NOT COMPLETED|Overall Study||0||
59565972|NCT02303574|75668412|FG007|STARTED|Part 1b (Fed State) - SAD||0||
60099900|NCT01032694|76217134|FG000|NOT COMPLETED|Overall Study||0||
60099901|NCT01032694|76217135|FG001|NOT COMPLETED|Overall Study||0||
60099902|NCT01032850|76217141|FG000|STARTED|Overall Study||15||
59563629|NCT01778426|75665929|FG000|STARTED|Overall Study - Full Analysis Set (FAS)||264|Patients included in the study.|
59563630|NCT01778426|75665930|FG001|STARTED|Overall Study - Full Analysis Set (FAS)||138|Patients included in the study.|
59563631|NCT01778426|75665929|FG000|COMPLETED|Overall Study - Full Analysis Set (FAS)||208|Patients having completed the 2 year follow-up.|
59563632|NCT01778426|75665930|FG001|COMPLETED|Overall Study - Full Analysis Set (FAS)||113|Patients having completed the 2 year follow-up.|
59563633|NCT01778426|75665929|FG000|NOT COMPLETED|Overall Study - Full Analysis Set (FAS)||56||
59563634|NCT01778426|75665930|FG001|NOT COMPLETED|Overall Study - Full Analysis Set (FAS)||25||
59563635|NCT01778426|75665929|FG000|STARTED|Intention-To-Treat (ITT) - Completer||198|Primo-implanted patients with baseline and follow-up pain intensity data at 2 years completed.|
59563636|NCT01778426|75665930|FG001|STARTED|Intention-To-Treat (ITT) - Completer|Not applicable: ITT-completer contains only primo-implant subjects.|0|Primo-implanted patients with baseline and follow-up pain intensity data at 2 years completed.|
59563637|NCT01778426|75665929|FG000|COMPLETED|Intention-To-Treat (ITT) - Completer||198|Patients having completed the 2 year follow-up.|
59563638|NCT01778426|75665930|FG001|COMPLETED|Intention-To-Treat (ITT) - Completer|Not applicable: ITT-completer contains only primo-implant subjects.|0|Patients having completed the 2 year follow-up.|
59563639|NCT01778426|75665929|FG000|NOT COMPLETED|Intention-To-Treat (ITT) - Completer||0||
59563640|NCT01778426|75665930|FG001|NOT COMPLETED|Intention-To-Treat (ITT) - Completer||0||
59563641|NCT01780454|75665939|FG000|STARTED|Overall Study||2||
60099903|NCT01032850|76217141|FG000|COMPLETED|Overall Study||13||
60099904|NCT01032850|76217141|FG000|NOT COMPLETED|Overall Study||2||
60099905|NCT01032928|76217145|FG000|STARTED|Overall Study||30||
60099906|NCT01032928|76217145|FG000|COMPLETED|Overall Study||30||
60099907|NCT01032928|76217145|FG000|NOT COMPLETED|Overall Study||0||
60099908|NCT00983242|76217153|FG000|STARTED|Colchicine Alone||24||
59817008|NCT01709435|75939429|FG003|STARTED|Overall Study||4||
59817009|NCT01709435|75939430|FG004|STARTED|Overall Study||10||
59817010|NCT01709435|75939431|FG005|STARTED|Overall Study||6||
59708296|NCT01204710|75827110|FG000|STARTED|Optional Olaratumab Monotherapy|Olaratumab follow-on treatment was optional for participants in mitoxantrone group only who had PD.|0||
59708297|NCT01204710|75827111|FG001|STARTED|Optional Olaratumab Monotherapy|Among 43 participants who experienced PD, 19 received olaratumab monotherapy.|19||
59708298|NCT01204710|75827110|FG000|COMPLETED|Optional Olaratumab Monotherapy||0||
60099909|NCT00983242|76217153|FG000|COMPLETED|Colchicine Alone||24||
60099910|NCT00983242|76217153|FG000|NOT COMPLETED|Colchicine Alone||0||
60099911|NCT00983242|76217153|FG000|STARTED|14 Day Washout Period||24||
60099912|NCT00983242|76217153|FG000|COMPLETED|14 Day Washout Period||24||
60099913|NCT00983242|76217153|FG000|NOT COMPLETED|14 Day Washout Period||0||
60099914|NCT00983242|76217153|FG000|STARTED|Verapamil HCl ER Alone||24||
60099915|NCT00983242|76217153|FG000|COMPLETED|Verapamil HCl ER Alone||24||
59708299|NCT01204710|75827111|FG001|COMPLETED|Optional Olaratumab Monotherapy||16||
59708300|NCT01204710|75827110|FG000|NOT COMPLETED|Optional Olaratumab Monotherapy||0||
59708301|NCT01204710|75827111|FG001|NOT COMPLETED|Optional Olaratumab Monotherapy||3||
59817011|NCT01709435|75939426|FG000|COMPLETED|Overall Study||0||
59817012|NCT01709435|75939427|FG001|COMPLETED|Overall Study||0||
59817013|NCT01709435|75939428|FG002|COMPLETED|Overall Study||0||
59994187|NCT01791595|76109944|FG005|STARTED|Part 2 AZD3965 Expansion (10 mg BD)||0||
59994188|NCT01791595|76109945|FG006|STARTED|Part 2 AZD3965 Expansion (10 mg BD)||11||
59994189|NCT01791595|76109939|FG000|COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||0||
59994190|NCT01791595|76109940|FG001|COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||0||
59994191|NCT01791595|76109941|FG002|COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||0||
59994192|NCT01791595|76109942|FG003|COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||0||
59994193|NCT01791595|76109943|FG004|COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||0||
59994194|NCT01791595|76109944|FG005|COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||0||
59994195|NCT01791595|76109945|FG006|COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||1||
59817014|NCT01709435|75939429|FG003|COMPLETED|Overall Study||1||
59817015|NCT01709435|75939430|FG004|COMPLETED|Overall Study||0||
59817016|NCT01709435|75939431|FG005|COMPLETED|Overall Study||0||
59817017|NCT01709435|75939426|FG000|NOT COMPLETED|Overall Study||6||
59994196|NCT01791595|76109939|FG000|NOT COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||0||
59995208|NCT02648217|76111029|FG001|Exposed|Overall Study||132||
60099916|NCT00983242|76217153|FG000|NOT COMPLETED|Verapamil HCl ER Alone||0||
60099917|NCT00983242|76217153|FG000|STARTED|Colchicine With Verapamil HCl ER||24||
59563642|NCT01780454|75665939|FG000|COMPLETED|Overall Study||2||
59563643|NCT01780454|75665939|FG000|NOT COMPLETED|Overall Study||0||
59994197|NCT01791595|76109940|FG001|NOT COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||0||
59994198|NCT01791595|76109941|FG002|NOT COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||0||
59994199|NCT01791595|76109942|FG003|NOT COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||0||
60099918|NCT00983242|76217153|FG000|COMPLETED|Colchicine With Verapamil HCl ER||24||
60099919|NCT00983242|76217153|FG000|NOT COMPLETED|Colchicine With Verapamil HCl ER||0||
60099920|NCT00984334|76217165|FG000|STARTED|Overall Study||8||
60099921|NCT00984334|76217166|FG001|STARTED|Overall Study||8||
60099922|NCT00984334|76217167|FG002|STARTED|Overall Study||8||
60099923|NCT00984334|76217168|FG003|STARTED|Overall Study||8||
60099924|NCT00984334|76217169|FG004|STARTED|Overall Study||8||
60099925|NCT00984334|76217165|FG000|COMPLETED|Overall Study||7||
59994200|NCT01791595|76109943|FG004|NOT COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||0||
59994201|NCT01791595|76109944|FG005|NOT COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||0||
59994202|NCT01791595|76109945|FG006|NOT COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||10||
59994203|NCT02667067|76109967|FG000|STARTED|Overall Study||117||
59994204|NCT02667067|76109968|FG001|STARTED|Overall Study||150||
59994205|NCT02667067|76109967|FG000|COMPLETED|Overall Study||96||
59994206|NCT02667067|76109968|FG001|COMPLETED|Overall Study||139||
59994207|NCT02667067|76109967|FG000|NOT COMPLETED|Overall Study||21||
59994208|NCT02667067|76109968|FG001|NOT COMPLETED|Overall Study||11||
60099926|NCT00984334|76217166|FG001|COMPLETED|Overall Study||7||
60099927|NCT00984334|76217167|FG002|COMPLETED|Overall Study||8||
60099928|NCT00984334|76217168|FG003|COMPLETED|Overall Study||7||
59563644|NCT01780922|75665943|FG000|STARTED|First Intervention (1 Day)||2||
59994209|NCT04881175|76109975|FG000|STARTED|Overall Study||3||
59994210|NCT04881175|76109975|FG000|COMPLETED|Overall Study||3||
59994211|NCT04881175|76109975|FG000|NOT COMPLETED|Overall Study||0||
59994212|NCT03860311|76109981|FG000|STARTED|Overall Study||22||
59994213|NCT03860311|76109982|FG001|STARTED|Overall Study||23||
59994214|NCT03860311|76109981|FG000|COMPLETED|Overall Study||22||
59994215|NCT03860311|76109982|FG001|COMPLETED|Overall Study||23||
59994216|NCT03860311|76109981|FG000|NOT COMPLETED|Overall Study||0||
59994217|NCT03860311|76109982|FG001|NOT COMPLETED|Overall Study||0||
60099929|NCT00984334|76217169|FG004|COMPLETED|Overall Study||7||
60099930|NCT00984334|76217165|FG000|NOT COMPLETED|Overall Study||1||
60099931|NCT00984334|76217166|FG001|NOT COMPLETED|Overall Study||1||
60099932|NCT00984334|76217167|FG002|NOT COMPLETED|Overall Study||0||
60099933|NCT00984334|76217168|FG003|NOT COMPLETED|Overall Study||1||
60099934|NCT00984334|76217169|FG004|NOT COMPLETED|Overall Study||1||
59563645|NCT01780922|75665944|FG001|STARTED|First Intervention (1 Day)||2||
59563646|NCT01780922|75665945|FG002|STARTED|First Intervention (1 Day)||2||
59563647|NCT01780922|75665946|FG003|STARTED|First Intervention (1 Day)||2||
59563648|NCT01780922|75665947|FG004|STARTED|First Intervention (1 Day)||2||
59563649|NCT01780922|75665948|FG005|STARTED|First Intervention (1 Day)||2||
59563650|NCT01780922|75665943|FG000|COMPLETED|First Intervention (1 Day)||2||
59563651|NCT01780922|75665944|FG001|COMPLETED|First Intervention (1 Day)||2||
59563652|NCT01780922|75665945|FG002|COMPLETED|First Intervention (1 Day)||2||
59563653|NCT01780922|75665946|FG003|COMPLETED|First Intervention (1 Day)||2||
59708302|NCT01256450|75827126|FG000|STARTED|Open-label Titration||334||
59708303|NCT01256450|75827127|FG001|STARTED|Open-label Titration||0||
59708304|NCT01256450|75827128|FG002|STARTED|Open-label Titration||0||
59708305|NCT01256450|75827126|FG000|COMPLETED|Open-label Titration||235||
59708306|NCT01256450|75827127|FG001|COMPLETED|Open-label Titration||0||
59708307|NCT01256450|75827128|FG002|COMPLETED|Open-label Titration||0||
59708308|NCT01256450|75827126|FG000|NOT COMPLETED|Open-label Titration||99||
59708309|NCT01256450|75827127|FG001|NOT COMPLETED|Open-label Titration||0||
59817018|NCT01709435|75939427|FG001|NOT COMPLETED|Overall Study||9||
59817019|NCT01709435|75939428|FG002|NOT COMPLETED|Overall Study||6||
59817020|NCT01709435|75939429|FG003|NOT COMPLETED|Overall Study||3||
59994218|NCT04255381|76109988|FG000|STARTED|Overall Study||20||
59994219|NCT04255381|76109988|FG000|COMPLETED|Overall Study||20||
59994220|NCT04255381|76109988|FG000|NOT COMPLETED|Overall Study||0||
59994221|NCT01559363|76109998|FG000|STARTED|Phase 1b: Up to 36 Months||24||
59994222|NCT01559363|76109999|FG001|STARTED|Phase 1b: Up to 36 Months||8||
59994223|NCT01559363|76110000|FG002|STARTED|Phase 1b: Up to 36 Months||5||
59994224|NCT01559363|76110001|FG003|STARTED|Phase 1b: Up to 36 Months||0||
59994225|NCT01559363|76110002|FG004|STARTED|Phase 1b: Up to 36 Months||0||
59994226|NCT01559363|76110003|FG005|STARTED|Phase 1b: Up to 36 Months||0||
59994227|NCT01559363|76109998|FG000|COMPLETED|Phase 1b: Up to 36 Months||18||
59994228|NCT01559363|76109999|FG001|COMPLETED|Phase 1b: Up to 36 Months||5||
60099935|NCT02168062|76217184|FG000|STARTED|Overall Study||23||
60099936|NCT02168062|76217185|FG001|STARTED|Overall Study||26||
60099937|NCT02168062|76217186|FG002|STARTED|Overall Study||8||
60099938|NCT02168062|76217184|FG000|COMPLETED|Overall Study||23||
60099939|NCT02168062|76217185|FG001|COMPLETED|Overall Study||26||
60099940|NCT02168062|76217186|FG002|COMPLETED|Overall Study||8||
60099941|NCT02168062|76217184|FG000|NOT COMPLETED|Overall Study||0||
60099942|NCT02168062|76217185|FG001|NOT COMPLETED|Overall Study||0||
60099943|NCT02168062|76217186|FG002|NOT COMPLETED|Overall Study||0||
60099944|NCT01888367|76217199|FG000|STARTED|Overall Study||296||
60099945|NCT01888367|76217200|FG001|STARTED|Overall Study||71||
60099946|NCT01888367|76217201|FG002|STARTED|Overall Study||78||
60099947|NCT01888367|76217199|FG000|COMPLETED|Overall Study||288||
60099948|NCT01888367|76217200|FG001|COMPLETED|Overall Study||66||
60099949|NCT01888367|76217201|FG002|COMPLETED|Overall Study||73||
60099950|NCT01888367|76217199|FG000|NOT COMPLETED|Overall Study||8||
60099951|NCT01888367|76217200|FG001|NOT COMPLETED|Overall Study||5||
60099952|NCT01888367|76217201|FG002|NOT COMPLETED|Overall Study||5||
60099953|NCT00988000|76217212|FG000|STARTED|Overall Study||49||
60099954|NCT00988000|76217213|FG001|STARTED|Overall Study||51||
60099955|NCT00988000|76217214|FG002|STARTED|Overall Study||57||
60099956|NCT00988000|76217212|FG000|COMPLETED|Overall Study||49||
60099957|NCT00988000|76217213|FG001|COMPLETED|Overall Study||51||
60099958|NCT00988000|76217214|FG002|COMPLETED|Overall Study||57||
60099959|NCT00988000|76217212|FG000|NOT COMPLETED|Overall Study||0||
60099960|NCT00988000|76217213|FG001|NOT COMPLETED|Overall Study||0||
60099961|NCT00988000|76217214|FG002|NOT COMPLETED|Overall Study||0||
60099962|NCT01898195|76217227|FG000|STARTED|Varenicline Adherence||53||
60099963|NCT01898195|76217228|FG001|STARTED|Varenicline Adherence||54||
60099964|NCT01898195|76217229|FG002|STARTED|Varenicline Adherence||51||
60099965|NCT01898195|76217227|FG000|COMPLETED|Varenicline Adherence||18||
60099966|NCT01898195|76217228|FG001|COMPLETED|Varenicline Adherence||16||
60099967|NCT01898195|76217229|FG002|COMPLETED|Varenicline Adherence||15||
60099968|NCT01898195|76217227|FG000|NOT COMPLETED|Varenicline Adherence||35||
60099969|NCT01898195|76217228|FG001|NOT COMPLETED|Varenicline Adherence||38||
60099970|NCT01898195|76217229|FG002|NOT COMPLETED|Varenicline Adherence||36||
60099971|NCT01898195|76217227|FG000|STARTED|Smoking Abstinence||53||
60099972|NCT01898195|76217228|FG001|STARTED|Smoking Abstinence||54||
59563654|NCT01780922|75665947|FG004|COMPLETED|First Intervention (1 Day)||2||
59563655|NCT01780922|75665948|FG005|COMPLETED|First Intervention (1 Day)||2||
59563656|NCT01780922|75665943|FG000|NOT COMPLETED|First Intervention (1 Day)||0||
59563657|NCT01780922|75665944|FG001|NOT COMPLETED|First Intervention (1 Day)||0||
59563658|NCT01780922|75665945|FG002|NOT COMPLETED|First Intervention (1 Day)||0||
60099973|NCT01898195|76217229|FG002|STARTED|Smoking Abstinence||51||
60099974|NCT01898195|76217227|FG000|COMPLETED|Smoking Abstinence||18||
60099975|NCT01898195|76217228|FG001|COMPLETED|Smoking Abstinence||16||
60099976|NCT01898195|76217229|FG002|COMPLETED|Smoking Abstinence||15||
60099977|NCT01898195|76217227|FG000|NOT COMPLETED|Smoking Abstinence||35||
60099978|NCT01898195|76217228|FG001|NOT COMPLETED|Smoking Abstinence||38||
60099979|NCT01898195|76217229|FG002|NOT COMPLETED|Smoking Abstinence||36||
60099980|NCT03696927|76217237|FG000|STARTED|Overall Study||4||
60099981|NCT03696927|76217237|FG000|COMPLETED|Overall Study||4||
60099982|NCT03696927|76217237|FG000|NOT COMPLETED|Overall Study||0||
60099983|NCT01897727|76217243|FG000|STARTED|Overall Study||8||
60099984|NCT01897727|76217244|FG001|STARTED|Overall Study||9||
60099985|NCT01897727|76217243|FG000|COMPLETED|Overall Study||8||
60099986|NCT01897727|76217244|FG001|COMPLETED|Overall Study||8||
60099987|NCT01897727|76217243|FG000|NOT COMPLETED|Overall Study||0||
60099988|NCT01897727|76217244|FG001|NOT COMPLETED|Overall Study||1||
60099989|NCT01897493|76217250|FG000|STARTED|Period 1 (Day 1 Through Day 6 Predose)||16||
60099990|NCT01897493|76217250|FG000|Received at Least 1 Dose of Study Drug|Period 1 (Day 1 Through Day 6 Predose)||16||
60099991|NCT01897493|76217250|FG000|COMPLETED|Period 1 (Day 1 Through Day 6 Predose)||15||
60099992|NCT01897493|76217250|FG000|NOT COMPLETED|Period 1 (Day 1 Through Day 6 Predose)||1||
60099993|NCT01897493|76217250|FG000|STARTED|Period 2 (Day 6 Postdose Through Day 20)||15||
60099994|NCT01897493|76217250|FG000|Received at Least 1 Dose of Study Drug|Period 2 (Day 6 Postdose Through Day 20)||15||
60099995|NCT01897493|76217250|FG000|COMPLETED|Period 2 (Day 6 Postdose Through Day 20)||15||
60099996|NCT01897493|76217250|FG000|NOT COMPLETED|Period 2 (Day 6 Postdose Through Day 20)||0||
60099997|NCT01887353|76217259|FG000|STARTED|Overall Study||4||
60099998|NCT01887353|76217260|FG001|STARTED|Overall Study||4||
60099999|NCT01887353|76217259|FG000|COMPLETED|Overall Study|Study was stopped early because of difficulty recruiting.|0||
60100000|NCT01887353|76217260|FG001|COMPLETED|Overall Study|Study was stopped early because of difficulty recruiting.|1||
60100001|NCT01887353|76217259|FG000|NOT COMPLETED|Overall Study||4||
60100002|NCT01887353|76217260|FG001|NOT COMPLETED|Overall Study||3||
60100003|NCT00988156|76217268|FG000|STARTED|Overall Study||149||
60100004|NCT00988156|76217269|FG001|STARTED|Overall Study||155||
60100005|NCT00988156|76217268|FG000|Intention-to-Treat Set (ITT)|Overall Study||129||
60100006|NCT00988156|76217269|FG001|Intention-to-Treat Set (ITT)|Overall Study||134||
60100007|NCT00988156|76217268|FG000|Per Protocol Set (PP)|Overall Study||101||
60100008|NCT00988156|76217269|FG001|Per Protocol Set (PP)|Overall Study||97||
60100009|NCT00988156|76217268|FG000|Safety Set|Overall Study||129||
60100010|NCT00988156|76217269|FG001|Safety Set|Overall Study||134||
60100011|NCT00988156|76217268|FG000|COMPLETED|Overall Study||132||
60100012|NCT00988156|76217269|FG001|COMPLETED|Overall Study||135||
60100013|NCT00988156|76217268|FG000|NOT COMPLETED|Overall Study||17||
59563659|NCT01780922|75665946|FG003|NOT COMPLETED|First Intervention (1 Day)||0||
60100014|NCT00988156|76217269|FG001|NOT COMPLETED|Overall Study||20||
60100015|NCT02160730|76217275|FG000|STARTED|Overall Study||4||
60100016|NCT02160730|76217275|FG000|COMPLETED|Overall Study||4||
60100017|NCT02160730|76217275|FG000|NOT COMPLETED|Overall Study||0||
60100018|NCT01896869|76217282|FG000|STARTED|Overall Study||41||
60100019|NCT01896869|76217283|FG001|STARTED|Overall Study||42||
60100020|NCT01896869|76217282|FG000|COMPLETED|Overall Study||40||
59563660|NCT01780922|75665947|FG004|NOT COMPLETED|First Intervention (1 Day)||0||
59563661|NCT01780922|75665948|FG005|NOT COMPLETED|First Intervention (1 Day)||0||
59563662|NCT01780922|75665943|FG000|STARTED|Washout (7 Days)||2||
59563663|NCT01780922|75665944|FG001|STARTED|Washout (7 Days)||2||
60100021|NCT01896869|76217283|FG001|COMPLETED|Overall Study||36||
60100022|NCT01896869|76217282|FG000|NOT COMPLETED|Overall Study||1||
60100023|NCT01896869|76217283|FG001|NOT COMPLETED|Overall Study||6||
60100024|NCT01896557|76217293|FG000|STARTED|Clopidogrel Alone||44||
60100025|NCT01896557|76217294|FG001|STARTED|Clopidogrel Alone||48||
60100026|NCT01896557|76217293|FG000|COMPLETED|Clopidogrel Alone||43||
59563664|NCT01780922|75665945|FG002|STARTED|Washout (7 Days)||2||
59563665|NCT01780922|75665946|FG003|STARTED|Washout (7 Days)||2||
59563666|NCT01780922|75665947|FG004|STARTED|Washout (7 Days)||2||
59563667|NCT01780922|75665948|FG005|STARTED|Washout (7 Days)||2||
59563668|NCT01780922|75665943|FG000|COMPLETED|Washout (7 Days)||2||
59563669|NCT01780922|75665944|FG001|COMPLETED|Washout (7 Days)||2||
59563670|NCT01780922|75665945|FG002|COMPLETED|Washout (7 Days)||2||
59563671|NCT01780922|75665946|FG003|COMPLETED|Washout (7 Days)||2||
60100027|NCT01896557|76217294|FG001|COMPLETED|Clopidogrel Alone||48||
59563672|NCT01780922|75665947|FG004|COMPLETED|Washout (7 Days)||2||
59563673|NCT01780922|75665948|FG005|COMPLETED|Washout (7 Days)||2||
59817021|NCT01709435|75939430|FG004|NOT COMPLETED|Overall Study||10||
60100028|NCT01896557|76217293|FG000|NOT COMPLETED|Clopidogrel Alone||1||
60100029|NCT01896557|76217294|FG001|NOT COMPLETED|Clopidogrel Alone||0||
59563674|NCT01780922|75665943|FG000|NOT COMPLETED|Washout (7 Days)||0||
59563675|NCT01780922|75665944|FG001|NOT COMPLETED|Washout (7 Days)||0||
59563676|NCT01780922|75665945|FG002|NOT COMPLETED|Washout (7 Days)||0||
59563677|NCT01780922|75665946|FG003|NOT COMPLETED|Washout (7 Days)||0||
59563678|NCT01780922|75665947|FG004|NOT COMPLETED|Washout (7 Days)||0||
59563679|NCT01780922|75665948|FG005|NOT COMPLETED|Washout (7 Days)||0||
59563680|NCT01780922|75665943|FG000|STARTED|Second Intervention (1 Day)||2||
59563681|NCT01780922|75665944|FG001|STARTED|Second Intervention (1 Day)||2||
60100030|NCT01896557|76217293|FG000|STARTED|Clopidogrel + GI Protector||43||
60100031|NCT01896557|76217294|FG001|STARTED|Clopidogrel + GI Protector||48||
60100032|NCT01896557|76217293|FG000|COMPLETED|Clopidogrel + GI Protector||41||
60100033|NCT01896557|76217294|FG001|COMPLETED|Clopidogrel + GI Protector||44||
60100034|NCT01896557|76217293|FG000|NOT COMPLETED|Clopidogrel + GI Protector||2||
60100035|NCT01896557|76217294|FG001|NOT COMPLETED|Clopidogrel + GI Protector||4||
59563682|NCT01780922|75665945|FG002|STARTED|Second Intervention (1 Day)||2||
60100036|NCT02160808|76217302|FG000|STARTED|Overall Study||87||
60100037|NCT02160808|76217303|FG001|STARTED|Overall Study||83||
60100038|NCT02160808|76217302|FG000|COMPLETED|Overall Study||87||
60100039|NCT02160808|76217303|FG001|COMPLETED|Overall Study||83||
60100040|NCT02160808|76217302|FG000|NOT COMPLETED|Overall Study||0||
60100041|NCT02160808|76217303|FG001|NOT COMPLETED|Overall Study||0||
60100042|NCT01886105|76217309|FG000|STARTED|Overall Study||4||
60100043|NCT01886105|76217309|FG000|COMPLETED|Overall Study||1||
60100044|NCT01886105|76217309|FG000|NOT COMPLETED|Overall Study||3||
59563683|NCT01780922|75665946|FG003|STARTED|Second Intervention (1 Day)||2||
60100045|NCT00989014|76217318|FG000|STARTED|Overall Study||31||
60100046|NCT00989014|76217319|FG001|STARTED|Overall Study||31||
59563684|NCT01780922|75665947|FG004|STARTED|Second Intervention (1 Day)||2||
59563685|NCT01780922|75665948|FG005|STARTED|Second Intervention (1 Day)||2||
59563686|NCT01780922|75665943|FG000|COMPLETED|Second Intervention (1 Day)||2||
59563687|NCT01780922|75665944|FG001|COMPLETED|Second Intervention (1 Day)||2||
59563688|NCT01780922|75665945|FG002|COMPLETED|Second Intervention (1 Day)||2||
59563689|NCT01780922|75665946|FG003|COMPLETED|Second Intervention (1 Day)||2||
59563690|NCT01780922|75665947|FG004|COMPLETED|Second Intervention (1 Day)||2||
59563691|NCT01780922|75665948|FG005|COMPLETED|Second Intervention (1 Day)||2||
59563692|NCT01780922|75665943|FG000|NOT COMPLETED|Second Intervention (1 Day)||0||
59563693|NCT01780922|75665944|FG001|NOT COMPLETED|Second Intervention (1 Day)||0||
59563694|NCT01780922|75665945|FG002|NOT COMPLETED|Second Intervention (1 Day)||0||
59563695|NCT01780922|75665946|FG003|NOT COMPLETED|Second Intervention (1 Day)||0||
59563696|NCT01780922|75665947|FG004|NOT COMPLETED|Second Intervention (1 Day)||0||
59563697|NCT01780922|75665948|FG005|NOT COMPLETED|Second Intervention (1 Day)||0||
59563698|NCT01780922|75665943|FG000|STARTED|Washout (7 Days)||2||
59563699|NCT01780922|75665944|FG001|STARTED|Washout (7 Days)||2||
59563700|NCT01780922|75665945|FG002|STARTED|Washout (7 Days)||2||
59563701|NCT01780922|75665946|FG003|STARTED|Washout (7 Days)||2||
59563702|NCT01780922|75665947|FG004|STARTED|Washout (7 Days)||2||
59563703|NCT01780922|75665948|FG005|STARTED|Washout (7 Days)||2||
59563704|NCT01780922|75665943|FG000|COMPLETED|Washout (7 Days)||2||
59563705|NCT01780922|75665944|FG001|COMPLETED|Washout (7 Days)||2||
59563706|NCT01780922|75665945|FG002|COMPLETED|Washout (7 Days)||2||
59563707|NCT01780922|75665946|FG003|COMPLETED|Washout (7 Days)||2||
59563708|NCT01780922|75665947|FG004|COMPLETED|Washout (7 Days)||2||
59563709|NCT01780922|75665948|FG005|COMPLETED|Washout (7 Days)||2||
59563710|NCT01780922|75665943|FG000|NOT COMPLETED|Washout (7 Days)||0||
59563711|NCT01780922|75665944|FG001|NOT COMPLETED|Washout (7 Days)||0||
59563712|NCT01780922|75665945|FG002|NOT COMPLETED|Washout (7 Days)||0||
59563713|NCT01780922|75665946|FG003|NOT COMPLETED|Washout (7 Days)||0||
59563714|NCT01780922|75665947|FG004|NOT COMPLETED|Washout (7 Days)||0||
59563715|NCT01780922|75665948|FG005|NOT COMPLETED|Washout (7 Days)||0||
59563716|NCT01780922|75665943|FG000|STARTED|Third Intervention (1 Day)||2||
59563717|NCT01780922|75665944|FG001|STARTED|Third Intervention (1 Day)||2||
59563718|NCT01780922|75665945|FG002|STARTED|Third Intervention (1 Day)||2||
59563719|NCT01780922|75665946|FG003|STARTED|Third Intervention (1 Day)||2||
59563720|NCT01780922|75665947|FG004|STARTED|Third Intervention (1 Day)||2||
59563721|NCT01780922|75665948|FG005|STARTED|Third Intervention (1 Day)||2||
59563722|NCT01780922|75665943|FG000|COMPLETED|Third Intervention (1 Day)||2||
59563723|NCT01780922|75665944|FG001|COMPLETED|Third Intervention (1 Day)||2||
59563724|NCT01780922|75665945|FG002|COMPLETED|Third Intervention (1 Day)||2||
59563725|NCT01780922|75665946|FG003|COMPLETED|Third Intervention (1 Day)||2||
59563726|NCT01780922|75665947|FG004|COMPLETED|Third Intervention (1 Day)||2||
59563727|NCT01780922|75665948|FG005|COMPLETED|Third Intervention (1 Day)||2||
59563728|NCT01780922|75665943|FG000|NOT COMPLETED|Third Intervention (1 Day)||0||
59563729|NCT01780922|75665944|FG001|NOT COMPLETED|Third Intervention (1 Day)||0||
59563730|NCT01780922|75665945|FG002|NOT COMPLETED|Third Intervention (1 Day)||0||
59563731|NCT01780922|75665946|FG003|NOT COMPLETED|Third Intervention (1 Day)||0||
59563732|NCT01780922|75665947|FG004|NOT COMPLETED|Third Intervention (1 Day)||0||
59563733|NCT01780922|75665948|FG005|NOT COMPLETED|Third Intervention (1 Day)||0||
59708310|NCT01256450|75827128|FG002|NOT COMPLETED|Open-label Titration||0||
59708311|NCT01256450|75827126|FG000|STARTED|Double-blind Treatment|All subjects completing OL titration in the previous period were randomized to a DB treatment.|0||
59709834|NCT01072149|75828528|FG008|STARTED|Treatment Period 2 (28 Days)||3||
59563734|NCT01648764|75665970|FG000|STARTED|Overall Study||3||
59563735|NCT01648764|75665971|FG001|STARTED|Overall Study||3||
59563736|NCT01648764|75665972|FG002|STARTED|Overall Study||3||
59563737|NCT01648764|75665973|FG003|STARTED|Overall Study||3||
59563738|NCT01648764|75665974|FG004|STARTED|Overall Study||3||
59563739|NCT01648764|75665975|FG005|STARTED|Overall Study||5||
59563740|NCT01648764|75665976|FG006|STARTED|Overall Study||9||
59563741|NCT01648764|75665977|FG007|STARTED|Overall Study||3||
59563742|NCT01648764|75665978|FG008|STARTED|Overall Study||3||
59563743|NCT01648764|75665979|FG009|STARTED|Overall Study||7||
59563744|NCT01648764|75665980|FG010|STARTED|Overall Study||3||
59563745|NCT01648764|75665981|FG011|STARTED|Overall Study||9||
59563746|NCT01648764|75665982|FG012|STARTED|Overall Study||7||
59563747|NCT01648764|75665983|FG013|STARTED|Overall Study||12||
59708312|NCT01256450|75827127|FG001|STARTED|Double-blind Treatment|Subjects were randomized to DB treatment after completing OL titration in the previous period.|117||
59708313|NCT01256450|75827128|FG002|STARTED|Double-blind Treatment|Subjects were randomized to DB treatment after completing OL titration in the previous period.|118||
59708314|NCT01256450|75827126|FG000|COMPLETED|Double-blind Treatment||0||
59563748|NCT01648764|75665970|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3||
59563749|NCT01648764|75665971|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3||
59563750|NCT01648764|75665972|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3||
60100047|NCT00989014|76217320|FG002|STARTED|Overall Study||28||
60100048|NCT00989014|76217321|FG003|STARTED|Overall Study||32||
60100049|NCT00989014|76217318|FG000|COMPLETED|Overall Study||31||
60100050|NCT00989014|76217319|FG001|COMPLETED|Overall Study||31||
60100051|NCT00989014|76217320|FG002|COMPLETED|Overall Study||28||
60100052|NCT00989014|76217321|FG003|COMPLETED|Overall Study||32||
60100053|NCT00989014|76217318|FG000|NOT COMPLETED|Overall Study||0||
60100054|NCT00989014|76217319|FG001|NOT COMPLETED|Overall Study||0||
60100055|NCT00989014|76217320|FG002|NOT COMPLETED|Overall Study||0||
60100056|NCT00989014|76217321|FG003|NOT COMPLETED|Overall Study||0||
60100057|NCT00990964|76217331|FG000|STARTED|Overall Study|Total number of subjects enrolled|2014||
60100058|NCT00990964|76217331|FG000|Attain Family Study System Attempt|Overall Study|Total number of subjects with an Attain Family lead attempt after an Attain Family catheter attempt|1917||
60100059|NCT00990964|76217331|FG000|COMPLETED|Overall Study|Total number of subjects with successful Attain Family lead using Attain Family catheter|1802||
60100060|NCT00990964|76217331|FG000|NOT COMPLETED|Overall Study||212||
60100061|NCT01895777|76217338|FG000|STARTED|Overall Study||177||
60100062|NCT01895777|76217339|FG001|STARTED|Overall Study||90||
60100063|NCT01895777|76217338|FG000|Treated|Overall Study||176||
60100064|NCT01895777|76217339|FG001|Treated|Overall Study||90||
60100065|NCT01895777|76217338|FG000|COMPLETED|Overall Study||168||
60100066|NCT01895777|76217339|FG001|COMPLETED|Overall Study||85||
60100067|NCT01895777|76217338|FG000|NOT COMPLETED|Overall Study||9||
60100068|NCT01895777|76217339|FG001|NOT COMPLETED|Overall Study||5||
60100069|NCT00992602|76217348|FG000|STARTED|Overall Study||3||
60100070|NCT00992602|76217348|FG000|COMPLETED|Overall Study||0||
60100071|NCT00992602|76217348|FG000|NOT COMPLETED|Overall Study||3||
60100072|NCT00993226|76217355|FG000|STARTED|Overall Study||61||
60100073|NCT00993226|76217356|FG001|STARTED|Overall Study||27||
60100074|NCT00993226|76217357|FG002|STARTED|Overall Study||27||
59563751|NCT01648764|75665973|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3||
60100075|NCT00993226|76217355|FG000|COMPLETED|Overall Study||60||
60100076|NCT00993226|76217356|FG001|COMPLETED|Overall Study||26||
60100077|NCT00993226|76217357|FG002|COMPLETED|Overall Study||27||
60100078|NCT00993226|76217355|FG000|NOT COMPLETED|Overall Study||1||
60100079|NCT00993226|76217356|FG001|NOT COMPLETED|Overall Study||1||
60100080|NCT00993226|76217357|FG002|NOT COMPLETED|Overall Study||0||
60100081|NCT01885559|76217367|FG000|STARTED|Overall Study||242||
60100082|NCT01885559|76217368|FG001|STARTED|Overall Study||244||
60100083|NCT01885559|76217367|FG000|COMPLETED|Overall Study||218||
60100084|NCT01885559|76217368|FG001|COMPLETED|Overall Study||208||
60100085|NCT01885559|76217367|FG000|NOT COMPLETED|Overall Study||24||
60100086|NCT01885559|76217368|FG001|NOT COMPLETED|Overall Study||36||
60100087|NCT01884545|76217378|FG000|STARTED|Overall Study||50||
60100088|NCT01884545|76217379|FG001|STARTED|Overall Study||49||
59708315|NCT01256450|75827127|FG001|COMPLETED|Double-blind Treatment||89||
59563752|NCT01648764|75665974|FG004|Received at Least 1 Dose of Study Drug|Overall Study||3||
59565973|NCT02303574|75668413|FG008|STARTED|Part 1b (Fed State) - SAD||0||
60100089|NCT01884545|76217380|FG002|STARTED|Overall Study||49||
60100090|NCT01884545|76217381|FG003|STARTED|Overall Study||52||
60100091|NCT01884545|76217378|FG000|COMPLETED|Overall Study||37||
60100092|NCT01884545|76217379|FG001|COMPLETED|Overall Study||31||
60100093|NCT01884545|76217380|FG002|COMPLETED|Overall Study||35||
60100094|NCT01884545|76217381|FG003|COMPLETED|Overall Study||43||
60100095|NCT01884545|76217378|FG000|NOT COMPLETED|Overall Study||13||
60100096|NCT01884545|76217379|FG001|NOT COMPLETED|Overall Study||18||
60100097|NCT01884545|76217380|FG002|NOT COMPLETED|Overall Study||14||
60100098|NCT01884545|76217381|FG003|NOT COMPLETED|Overall Study||9||
60100099|NCT01895543|76217391|FG000|STARTED|Overall Study||411||
60100100|NCT01895543|76217391|FG000|Safety Analysis Set|Overall Study|Set included all enrolled patients who took at least one dose of Investigational Medicinal Product.|409||
60100101|NCT01895543|76217391|FG000|Per Protocol Analysis Set|Overall Study|Set included all enrolled patients who had no major protocol deviations.|380||
60100102|NCT01895543|76217391|FG000|COMPLETED|Overall Study||282||
60100103|NCT01895543|76217391|FG000|NOT COMPLETED|Overall Study||129||
60100104|NCT00994318|76217398|FG000|STARTED|Overall Study||155||
60100105|NCT00994318|76217399|FG001|STARTED|Overall Study||154||
60100106|NCT00994318|76217400|FG002|STARTED|Overall Study||317||
60100107|NCT00994318|76217398|FG000|COMPLETED|Overall Study||133||
60100108|NCT00994318|76217399|FG001|COMPLETED|Overall Study||136||
60100109|NCT00994318|76217400|FG002|COMPLETED|Overall Study||250||
60100110|NCT00994318|76217398|FG000|NOT COMPLETED|Overall Study||22||
60100111|NCT00994318|76217399|FG001|NOT COMPLETED|Overall Study||18||
60100112|NCT00994318|76217400|FG002|NOT COMPLETED|Overall Study||67||
60100113|NCT04525456|76217408|FG000|STARTED|Overall Study||20||
60100114|NCT04525456|76217408|FG000|COMPLETED|Overall Study||20||
60100115|NCT04525456|76217408|FG000|NOT COMPLETED|Overall Study||0||
60100116|NCT00995722|76217415|FG000|STARTED|Double Blinded: 16 Weeks||6||
60100117|NCT00995722|76217416|FG001|STARTED|Double Blinded: 16 Weeks||5||
60100118|NCT00995722|76217415|FG000|COMPLETED|Double Blinded: 16 Weeks||5||
60100119|NCT00995722|76217416|FG001|COMPLETED|Double Blinded: 16 Weeks||4||
60100120|NCT00995722|76217415|FG000|NOT COMPLETED|Double Blinded: 16 Weeks||1||
60100121|NCT00995722|76217416|FG001|NOT COMPLETED|Double Blinded: 16 Weeks||1||
60100122|NCT00995722|76217415|FG000|STARTED|Overall Study: 36 Weeks||5||
60100123|NCT00995722|76217416|FG001|STARTED|Overall Study: 36 Weeks||4||
60100124|NCT00995722|76217415|FG000|COMPLETED|Overall Study: 36 Weeks||3||
60100125|NCT00995722|76217416|FG001|COMPLETED|Overall Study: 36 Weeks||2||
60100126|NCT00995722|76217415|FG000|NOT COMPLETED|Overall Study: 36 Weeks||2||
60100127|NCT00995722|76217416|FG001|NOT COMPLETED|Overall Study: 36 Weeks||2||
60100128|NCT00996346|76217425|FG000|STARTED|Overall Study||6||
60100129|NCT00996346|76217426|FG001|STARTED|Overall Study||8||
60100130|NCT00996346|76217427|FG002|STARTED|Overall Study||3||
60100131|NCT00996346|76217425|FG000|COMPLETED|Overall Study||6||
60100132|NCT00996346|76217426|FG001|COMPLETED|Overall Study||8||
60100133|NCT00996346|76217427|FG002|COMPLETED|Overall Study||3||
60100134|NCT00996346|76217425|FG000|NOT COMPLETED|Overall Study||0||
60100135|NCT00996346|76217426|FG001|NOT COMPLETED|Overall Study||0||
60100136|NCT00996346|76217427|FG002|NOT COMPLETED|Overall Study||0||
60100137|NCT00997204|76217435|FG000|STARTED|Naive Treatment Phase||25||
60100138|NCT00997204|76217436|FG001|STARTED|Naive Treatment Phase|Non-naive patients participated in the study but they were not treated in the naive treatment phase|79||
60100139|NCT00997204|76217435|FG000|COMPLETED|Naive Treatment Phase||19||
60100140|NCT00997204|76217436|FG001|COMPLETED|Naive Treatment Phase||0||
60100141|NCT00997204|76217435|FG000|NOT COMPLETED|Naive Treatment Phase||6||
60100142|NCT00997204|76217436|FG001|NOT COMPLETED|Naive Treatment Phase||79||
60100143|NCT00997204|76217435|FG000|STARTED|Self-administration Phase||19||
60100144|NCT00997204|76217436|FG001|STARTED|Self-administration Phase|1 subject did not self-administered icatibant but had a HCP to perform. the data were not included.|78||
60100145|NCT00997204|76217435|FG000|COMPLETED|Self-administration Phase||19||
60100146|NCT00997204|76217436|FG001|COMPLETED|Self-administration Phase||77||
60100147|NCT00997204|76217435|FG000|NOT COMPLETED|Self-administration Phase||0||
60100148|NCT00997204|76217436|FG001|NOT COMPLETED|Self-administration Phase||1||
60100149|NCT00997516|76217448|FG000|STARTED|Short-term Follow-up (Post Operative)||37||
60100150|NCT00997516|76217449|FG001|STARTED|Short-term Follow-up (Post Operative)||38||
60100151|NCT00997516|76217448|FG000|COMPLETED|Short-term Follow-up (Post Operative)||37||
60100152|NCT00997516|76217449|FG001|COMPLETED|Short-term Follow-up (Post Operative)||38||
60100153|NCT00997516|76217448|FG000|NOT COMPLETED|Short-term Follow-up (Post Operative)||0||
60100154|NCT00997516|76217449|FG001|NOT COMPLETED|Short-term Follow-up (Post Operative)||0||
60100155|NCT00997516|76217448|FG000|STARTED|Long-term Follow-up (After 6 Months)||37||
60100156|NCT00997516|76217449|FG001|STARTED|Long-term Follow-up (After 6 Months)||38||
60100157|NCT00997516|76217448|FG000|COMPLETED|Long-term Follow-up (After 6 Months)||31||
60100158|NCT00997516|76217449|FG001|COMPLETED|Long-term Follow-up (After 6 Months)||36||
60100159|NCT00997516|76217448|FG000|NOT COMPLETED|Long-term Follow-up (After 6 Months)||6||
60100160|NCT00997516|76217449|FG001|NOT COMPLETED|Long-term Follow-up (After 6 Months)||2||
60100161|NCT00997594|76217457|FG000|STARTED|Overall Study||9||
60100162|NCT00997594|76217458|FG001|STARTED|Overall Study||9||
60100163|NCT00997594|76217457|FG000|Completion of Ablation Procedure|Overall Study||9||
60100164|NCT00997594|76217458|FG001|Completion of Ablation Procedure|Overall Study||9||
60100165|NCT00997594|76217457|FG000|COMPLETED|Overall Study||9||
59563753|NCT01648764|75665975|FG005|Received at Least 1 Dose of Study Drug|Overall Study||5||
59563754|NCT01648764|75665976|FG006|Received at Least 1 Dose of Study Drug|Overall Study||9||
59563755|NCT01648764|75665977|FG007|Received at Least 1 Dose of Study Drug|Overall Study||3||
59563756|NCT01648764|75665978|FG008|Received at Least 1 Dose of Study Drug|Overall Study||3||
60100166|NCT00997594|76217458|FG001|COMPLETED|Overall Study||9||
60100167|NCT00997594|76217457|FG000|NOT COMPLETED|Overall Study||0||
60100168|NCT00997594|76217458|FG001|NOT COMPLETED|Overall Study||0||
60100169|NCT00997672|76217466|FG000|STARTED|Overall Study||4||
60100170|NCT00997672|76217467|FG001|STARTED|Overall Study||5||
60100171|NCT00997672|76217466|FG000|COMPLETED|Overall Study||0||
60100172|NCT00997672|76217467|FG001|COMPLETED|Overall Study||1||
60100173|NCT00997672|76217466|FG000|NOT COMPLETED|Overall Study||4||
60100174|NCT00997672|76217467|FG001|NOT COMPLETED|Overall Study||4||
60100175|NCT00998374|76217475|FG000|STARTED|Overall Study||39||
60100176|NCT00998374|76217476|FG001|STARTED|Overall Study||23||
60100177|NCT00998374|76217475|FG000|COMPLETED|Overall Study||27||
60100178|NCT00998374|76217476|FG001|COMPLETED|Overall Study||12||
60100179|NCT00998374|76217475|FG000|NOT COMPLETED|Overall Study||12||
60100180|NCT00998374|76217476|FG001|NOT COMPLETED|Overall Study||11||
60100181|NCT04828161|76217488|FG000|STARTED|Overall Study||100|Randomized|
60100182|NCT04828161|76217489|FG001|STARTED|Overall Study||102|Randomized|
60100183|NCT04828161|76217490|FG002|STARTED|Overall Study||103|Randomized|
60100184|NCT04828161|76217491|FG003|STARTED|Overall Study||102|Randomized|
60100185|NCT04828161|76217488|FG000|COMPLETED|Overall Study||97||
60100186|NCT04828161|76217489|FG001|COMPLETED|Overall Study||95||
60100187|NCT04828161|76217490|FG002|COMPLETED|Overall Study||96||
60100188|NCT04828161|76217491|FG003|COMPLETED|Overall Study||94||
60100189|NCT04828161|76217488|FG000|NOT COMPLETED|Overall Study||3||
60100190|NCT04828161|76217489|FG001|NOT COMPLETED|Overall Study||7||
60100191|NCT04828161|76217490|FG002|NOT COMPLETED|Overall Study||7||
60100192|NCT04828161|76217491|FG003|NOT COMPLETED|Overall Study||8||
60100193|NCT01000324|76217504|FG000|STARTED|Year 16||40||
60100194|NCT01000324|76217504|FG000|COMPLETED|Year 16||40||
60100195|NCT01000324|76217504|FG000|NOT COMPLETED|Year 16||0||
60100196|NCT01000324|76217504|FG000|STARTED|Year 17||32||
60100197|NCT01000324|76217504|FG000|COMPLETED|Year 17||32||
60100198|NCT01000324|76217504|FG000|NOT COMPLETED|Year 17||0||
60100199|NCT01000324|76217504|FG000|STARTED|Year 18||29||
60100200|NCT01000324|76217504|FG000|COMPLETED|Year 18||29||
60100201|NCT01000324|76217504|FG000|NOT COMPLETED|Year 18||0||
60100202|NCT01000324|76217504|FG000|STARTED|Year 19||28||
60100203|NCT01000324|76217504|FG000|COMPLETED|Year 19||28||
60100204|NCT01000324|76217504|FG000|NOT COMPLETED|Year 19||0||
60100205|NCT01000324|76217504|FG000|STARTED|Year 20||28||
60100206|NCT01000324|76217504|FG000|COMPLETED|Year 20||28||
60100207|NCT01000324|76217504|FG000|NOT COMPLETED|Year 20||0||
60100208|NCT02164240|76217509|FG000|STARTED|Overall Study||4||
60100209|NCT02164240|76217510|FG001|STARTED|Overall Study||5||
60100210|NCT02164240|76217511|FG002|STARTED|Overall Study||4||
60100211|NCT02164240|76217509|FG000|COMPLETED|Overall Study||4||
60100212|NCT02164240|76217510|FG001|COMPLETED|Overall Study||5||
60100213|NCT02164240|76217511|FG002|COMPLETED|Overall Study||4||
60100214|NCT02164240|76217509|FG000|NOT COMPLETED|Overall Study||0||
60100215|NCT02164240|76217510|FG001|NOT COMPLETED|Overall Study||0||
60100216|NCT02164240|76217511|FG002|NOT COMPLETED|Overall Study||0||
60100217|NCT02164396|76217523|FG000|STARTED|Overall Study||10||
60100218|NCT02164396|76217524|FG001|STARTED|Overall Study||10||
60100219|NCT02164396|76217525|FG002|STARTED|Overall Study||10||
60100220|NCT02164396|76217523|FG000|COMPLETED|Overall Study||10||
60100221|NCT02164396|76217524|FG001|COMPLETED|Overall Study||10||
60100222|NCT02164396|76217525|FG002|COMPLETED|Overall Study||10||
60100223|NCT02164396|76217523|FG000|NOT COMPLETED|Overall Study||0||
60100224|NCT02164396|76217524|FG001|NOT COMPLETED|Overall Study||0||
60100225|NCT02164396|76217525|FG002|NOT COMPLETED|Overall Study||0||
60100226|NCT02169466|76217537|FG000|STARTED|Overall Study||6||
60100227|NCT02169466|76217538|FG001|STARTED|Overall Study||6||
60100228|NCT02169466|76217539|FG002|STARTED|Overall Study||5||
60100229|NCT02169466|76217540|FG003|STARTED|Overall Study||5||
60100230|NCT02169466|76217537|FG000|25 mg BIA 9-1067|Overall Study||6||
60100231|NCT02169466|76217538|FG001|25 mg BIA 9-1067|Overall Study||5||
60100232|NCT02169466|76217539|FG002|25 mg BIA 9-1067|Overall Study||5||
60100233|NCT02169466|76217540|FG003|25 mg BIA 9-1067|Overall Study||5||
60100234|NCT02169466|76217537|FG000|50 mg BIA 9-1067|Overall Study||6||
60100235|NCT02169466|76217538|FG001|50 mg BIA 9-1067|Overall Study||6||
60100236|NCT02169466|76217539|FG002|50 mg BIA 9-1067|Overall Study||5||
60100237|NCT02169466|76217540|FG003|50 mg BIA 9-1067|Overall Study||5||
60100238|NCT02169466|76217537|FG000|100 mg BIA 9-1067|Overall Study||6||
60100239|NCT02169466|76217538|FG001|100 mg BIA 9-1067|Overall Study||6||
60100240|NCT02169466|76217539|FG002|100 mg BIA 9-1067|Overall Study||5||
60100241|NCT02169466|76217540|FG003|100 mg BIA 9-1067|Overall Study||5||
60100242|NCT02169466|76217537|FG000|Placebo|Overall Study||5||
60100243|NCT02169466|76217538|FG001|Placebo|Overall Study||6||
60100244|NCT02169466|76217539|FG002|Placebo|Overall Study||5||
60100245|NCT02169466|76217540|FG003|Placebo|Overall Study||5||
60100246|NCT02169466|76217537|FG000|COMPLETED|Overall Study||5||
60100247|NCT02169466|76217538|FG001|COMPLETED|Overall Study||5||
60100248|NCT02169466|76217539|FG002|COMPLETED|Overall Study||5||
60100249|NCT02169466|76217540|FG003|COMPLETED|Overall Study||5||
59563757|NCT01648764|75665979|FG009|Received at Least 1 Dose of Study Drug|Overall Study||7||
59563758|NCT01648764|75665980|FG010|Received at Least 1 Dose of Study Drug|Overall Study||3||
59563759|NCT01648764|75665981|FG011|Received at Least 1 Dose of Study Drug|Overall Study||9||
59563760|NCT01648764|75665982|FG012|Received at Least 1 Dose of Study Drug|Overall Study||7||
59563761|NCT01648764|75665983|FG013|Received at Least 1 Dose of Study Drug|Overall Study||12||
59563762|NCT01648764|75665970|FG000|COMPLETED|Overall Study||3||
60100250|NCT02169466|76217537|FG000|NOT COMPLETED|Overall Study||1||
60100251|NCT02169466|76217538|FG001|NOT COMPLETED|Overall Study||1||
60100252|NCT02169466|76217539|FG002|NOT COMPLETED|Overall Study||0||
60100253|NCT02169466|76217540|FG003|NOT COMPLETED|Overall Study||0||
60100254|NCT01001806|76217557|FG000|STARTED|Overall Study||42||
60100255|NCT01001806|76217558|FG001|STARTED|Overall Study||42||
60100256|NCT01001806|76217559|FG002|STARTED|Overall Study||42||
60100257|NCT01001806|76217557|FG000|COMPLETED|Overall Study||42||
60100258|NCT01001806|76217558|FG001|COMPLETED|Overall Study||41||
60100259|NCT01001806|76217559|FG002|COMPLETED|Overall Study||38||
60100260|NCT01001806|76217557|FG000|NOT COMPLETED|Overall Study||0||
60100261|NCT01001806|76217558|FG001|NOT COMPLETED|Overall Study||1||
60100262|NCT01001806|76217559|FG002|NOT COMPLETED|Overall Study||4||
60100263|NCT01002118|76217567|FG000|STARTED|Overall Study||1||
60100264|NCT01002118|76217567|FG000|Randomized Only Patient|Overall Study||1||
60100265|NCT01002118|76217567|FG000|COMPLETED|Overall Study||1||
60100266|NCT01002118|76217567|FG000|NOT COMPLETED|Overall Study||0||
60100267|NCT01003288|76217573|FG000|STARTED|Overall Study||255||
60100268|NCT01003288|76217573|FG000|COMPLETED|Overall Study||255||
60100269|NCT01003288|76217573|FG000|NOT COMPLETED|Overall Study||0||
60100270|NCT02162446|76217578|FG000|STARTED|Overall Study||12||
60100271|NCT02162446|76217578|FG000|COMPLETED|Overall Study||12||
60100272|NCT02162446|76217578|FG000|NOT COMPLETED|Overall Study||0||
60100273|NCT01895309|76217589|FG000|STARTED|Overall Study||299||
60100274|NCT01895309|76217590|FG001|STARTED|Overall Study||297||
60100275|NCT01895309|76217589|FG000|COMPLETED|Overall Study||259||
60100276|NCT01895309|76217590|FG001|COMPLETED|Overall Study||246||
60100277|NCT01895309|76217589|FG000|NOT COMPLETED|Overall Study||40||
60100278|NCT01895309|76217590|FG001|NOT COMPLETED|Overall Study||51||
60100279|NCT01884311|76217600|FG000|STARTED|Overall Study||38||
60100280|NCT01884311|76217600|FG000|COMPLETED|Overall Study||33||
60100281|NCT01884311|76217600|FG000|NOT COMPLETED|Overall Study||5||
60100282|NCT01004770|76217612|FG000|STARTED|Overall Study||10||
60100283|NCT01004770|76217613|FG001|STARTED|Overall Study||10||
60100284|NCT01004770|76217614|FG002|STARTED|Overall Study||10||
60100285|NCT01004770|76217615|FG003|STARTED|Overall Study||10||
60100286|NCT01004770|76217616|FG004|STARTED|Overall Study||10||
60100287|NCT01004770|76217612|FG000|COMPLETED|Overall Study||10||
60100288|NCT01004770|76217613|FG001|COMPLETED|Overall Study||10||
60100289|NCT01004770|76217614|FG002|COMPLETED|Overall Study||10||
60100290|NCT01004770|76217615|FG003|COMPLETED|Overall Study||10||
60100291|NCT01004770|76217616|FG004|COMPLETED|Overall Study||10||
60100292|NCT01004770|76217612|FG000|NOT COMPLETED|Overall Study||0||
60100293|NCT01004770|76217613|FG001|NOT COMPLETED|Overall Study||0||
60100294|NCT01004770|76217614|FG002|NOT COMPLETED|Overall Study||0||
60100295|NCT01004770|76217615|FG003|NOT COMPLETED|Overall Study||0||
60100296|NCT01004770|76217616|FG004|NOT COMPLETED|Overall Study||0||
60100297|NCT03230877|76217628|FG000|STARTED|Visit 1||23||
60100298|NCT03230877|76217629|FG001|STARTED|Visit 1||15||
60100299|NCT03230877|76217628|FG000|COMPLETED|Visit 1||23||
60100300|NCT03230877|76217629|FG001|COMPLETED|Visit 1||15||
60100301|NCT03230877|76217628|FG000|NOT COMPLETED|Visit 1||0||
60100302|NCT03230877|76217629|FG001|NOT COMPLETED|Visit 1||0||
60100303|NCT03230877|76217628|FG000|STARTED|Visit 2||23||
60100304|NCT03230877|76217629|FG001|STARTED|Visit 2||15||
60100305|NCT03230877|76217628|FG000|COMPLETED|Visit 2||23||
60100306|NCT03230877|76217629|FG001|COMPLETED|Visit 2||15||
60100307|NCT03230877|76217628|FG000|NOT COMPLETED|Visit 2||0||
60100308|NCT03230877|76217629|FG001|NOT COMPLETED|Visit 2||0||
60100309|NCT01884077|76217640|FG000|STARTED|Overall Study||8||
60100310|NCT01884077|76217641|FG001|STARTED|Overall Study||11||
60100311|NCT01884077|76217640|FG000|COMPLETED|Overall Study||0||
60100312|NCT01884077|76217641|FG001|COMPLETED|Overall Study||1||
60100313|NCT01884077|76217640|FG000|NOT COMPLETED|Overall Study||8||
60100314|NCT01884077|76217641|FG001|NOT COMPLETED|Overall Study||10||
60100315|NCT01894919|76217660|FG000|STARTED|Overall Study||98||
60100316|NCT01894919|76217661|FG001|STARTED|Overall Study||47||
60100317|NCT01894919|76217662|FG002|STARTED|Overall Study||89||
60100318|NCT01894919|76217663|FG003|STARTED|Overall Study||43||
60100319|NCT01894919|76217664|FG004|STARTED|Overall Study||81||
60100320|NCT01894919|76217665|FG005|STARTED|Overall Study||39||
60100321|NCT01894919|76217666|FG006|STARTED|Overall Study||32||
60100322|NCT01894919|76217667|FG007|STARTED|Overall Study||36||
60100323|NCT01894919|76217668|FG008|STARTED|Overall Study||91||
60100324|NCT01894919|76217669|FG009|STARTED|Overall Study||90||
60100325|NCT01894919|76217670|FG010|STARTED|Overall Study||100||
60100326|NCT01894919|76217671|FG011|STARTED|Overall Study||55||
60100327|NCT01894919|76217672|FG012|STARTED|Overall Study||50||
60100328|NCT01894919|76217660|FG000|COMPLETED|Overall Study||96||
60100329|NCT01894919|76217661|FG001|COMPLETED|Overall Study||47||
60100330|NCT01894919|76217662|FG002|COMPLETED|Overall Study||89||
60100331|NCT01894919|76217663|FG003|COMPLETED|Overall Study||43||
60100332|NCT01894919|76217664|FG004|COMPLETED|Overall Study||78||
60100333|NCT01894919|76217665|FG005|COMPLETED|Overall Study||39||
60100334|NCT01894919|76217666|FG006|COMPLETED|Overall Study||32||
60100335|NCT01894919|76217667|FG007|COMPLETED|Overall Study||36||
60100336|NCT01894919|76217668|FG008|COMPLETED|Overall Study||91||
59563763|NCT01648764|75665971|FG001|COMPLETED|Overall Study||2||
59563764|NCT01648764|75665972|FG002|COMPLETED|Overall Study||3||
59563765|NCT01648764|75665973|FG003|COMPLETED|Overall Study||3||
59817022|NCT01709435|75939431|FG005|NOT COMPLETED|Overall Study||6||
59563766|NCT01648764|75665974|FG004|COMPLETED|Overall Study||3||
59563767|NCT01648764|75665975|FG005|COMPLETED|Overall Study||3||
59563768|NCT01648764|75665976|FG006|COMPLETED|Overall Study||4||
59563769|NCT01648764|75665977|FG007|COMPLETED|Overall Study||3||
59563770|NCT01648764|75665978|FG008|COMPLETED|Overall Study||3||
59563771|NCT01648764|75665979|FG009|COMPLETED|Overall Study||4||
59563772|NCT01648764|75665980|FG010|COMPLETED|Overall Study||3||
59563773|NCT01648764|75665981|FG011|COMPLETED|Overall Study||4||
59563774|NCT01648764|75665982|FG012|COMPLETED|Overall Study||3||
59563775|NCT01648764|75665983|FG013|COMPLETED|Overall Study||9||
59563776|NCT01648764|75665970|FG000|NOT COMPLETED|Overall Study||0||
59563777|NCT01648764|75665971|FG001|NOT COMPLETED|Overall Study||1||
59563778|NCT01648764|75665972|FG002|NOT COMPLETED|Overall Study||0||
59563779|NCT01648764|75665973|FG003|NOT COMPLETED|Overall Study||0||
59563780|NCT01648764|75665974|FG004|NOT COMPLETED|Overall Study||0||
59563781|NCT01648764|75665975|FG005|NOT COMPLETED|Overall Study||2||
59563782|NCT01648764|75665976|FG006|NOT COMPLETED|Overall Study||5||
59563783|NCT01648764|75665977|FG007|NOT COMPLETED|Overall Study||0||
59817023|NCT01358877|75939449|FG000|STARTED|Overall Study||2400||
59817024|NCT01358877|75939450|FG001|STARTED|Overall Study||2404||
59563784|NCT01648764|75665978|FG008|NOT COMPLETED|Overall Study||0||
59563785|NCT01648764|75665979|FG009|NOT COMPLETED|Overall Study||3||
59563786|NCT01648764|75665980|FG010|NOT COMPLETED|Overall Study||0||
59563787|NCT01648764|75665981|FG011|NOT COMPLETED|Overall Study||5||
59563788|NCT01648764|75665982|FG012|NOT COMPLETED|Overall Study||4||
59563789|NCT01648764|75665983|FG013|NOT COMPLETED|Overall Study||3||
59563790|NCT02364336|75666019|FG000|STARTED|Overall Study||1||
59563791|NCT02364336|75666020|FG001|STARTED|Overall Study||12||
59563792|NCT02364336|75666019|FG000|6 Hours Post First Peginterferon Inject|Overall Study||1||
59563793|NCT02364336|75666020|FG001|6 Hours Post First Peginterferon Inject|Overall Study||12||
59563794|NCT02364336|75666019|FG000|End of Peginterferon Treatment|Overall Study||1||
59563795|NCT02364336|75666020|FG001|End of Peginterferon Treatment|Overall Study||11||
59563796|NCT02364336|75666019|FG000|24 Weeks After End of Peginterferon|Overall Study||1||
59563797|NCT02364336|75666020|FG001|24 Weeks After End of Peginterferon|Overall Study||11||
59563798|NCT02364336|75666019|FG000|48 Weeks After End of Peginterferon|Overall Study||1||
60100337|NCT01894919|76217669|FG009|COMPLETED|Overall Study||89||
60100338|NCT01894919|76217670|FG010|COMPLETED|Overall Study||98||
60100339|NCT01894919|76217671|FG011|COMPLETED|Overall Study||55||
60100340|NCT01894919|76217672|FG012|COMPLETED|Overall Study||50||
60100341|NCT01894919|76217660|FG000|NOT COMPLETED|Overall Study||2||
60100342|NCT01894919|76217661|FG001|NOT COMPLETED|Overall Study||0||
60100343|NCT01894919|76217662|FG002|NOT COMPLETED|Overall Study||0||
59563799|NCT02364336|75666020|FG001|48 Weeks After End of Peginterferon|Overall Study||10||
59563800|NCT02364336|75666019|FG000|COMPLETED|Overall Study||1||
59563801|NCT02364336|75666020|FG001|COMPLETED|Overall Study||11||
59563802|NCT02364336|75666019|FG000|NOT COMPLETED|Overall Study||0||
59563803|NCT02364336|75666020|FG001|NOT COMPLETED|Overall Study||1||
59563804|NCT01781078|75666029|FG000|STARTED|Overall Study|Randomized post implantation|229||
59563805|NCT01781078|75666030|FG001|STARTED|Overall Study|Randomized post implantation|118||
59563806|NCT01781078|75666031|FG002|STARTED|Overall Study||16||
59563807|NCT01781078|75666029|FG000|COMPLETED|Overall Study|Patients having completed the MRI + 1 month (Primary endpoint assessment)|217||
59708316|NCT01256450|75827128|FG002|COMPLETED|Double-blind Treatment||81||
60100344|NCT01894919|76217663|FG003|NOT COMPLETED|Overall Study||0||
60100345|NCT01894919|76217664|FG004|NOT COMPLETED|Overall Study||3||
60100346|NCT01894919|76217665|FG005|NOT COMPLETED|Overall Study||0||
60100347|NCT01894919|76217666|FG006|NOT COMPLETED|Overall Study||0||
60100348|NCT01894919|76217667|FG007|NOT COMPLETED|Overall Study||0||
60100349|NCT01894919|76217668|FG008|NOT COMPLETED|Overall Study||0||
60100350|NCT01894919|76217669|FG009|NOT COMPLETED|Overall Study||1||
60100351|NCT01894919|76217670|FG010|NOT COMPLETED|Overall Study||2||
59708317|NCT01256450|75827126|FG000|NOT COMPLETED|Double-blind Treatment||0||
59708318|NCT01256450|75827127|FG001|NOT COMPLETED|Double-blind Treatment||28||
59708319|NCT01256450|75827128|FG002|NOT COMPLETED|Double-blind Treatment||37||
59563808|NCT01781078|75666030|FG001|COMPLETED|Overall Study|Patients having completed the MRI + 1 month (Primary endpoint assessment)|113||
59563809|NCT01781078|75666031|FG002|COMPLETED|Overall Study||0||
59563810|NCT01781078|75666029|FG000|NOT COMPLETED|Overall Study||12||
59563811|NCT01781078|75666030|FG001|NOT COMPLETED|Overall Study||5||
59563812|NCT01781078|75666031|FG002|NOT COMPLETED|Overall Study||16||
59563813|NCT01312922|75666043|FG000|STARTED|Overall Study||185||
59563814|NCT01312922|75666044|FG001|STARTED|Overall Study||185||
59563815|NCT01312922|75666045|FG002|STARTED|Overall Study||185||
59563816|NCT01312922|75666043|FG000|COMPLETED|Overall Study||117||
59708320|NCT01204398|75827135|FG000|STARTED|Overall Study|Entered and treated.|27||
59708321|NCT01204398|75827135|FG000|COMPLETED|Overall Study|Completed trial medication.|26||
59708322|NCT01204398|75827135|FG000|NOT COMPLETED|Overall Study||1||
60100352|NCT01894919|76217671|FG011|NOT COMPLETED|Overall Study||0||
60100353|NCT01894919|76217672|FG012|NOT COMPLETED|Overall Study||0||
60100354|NCT01894841|76217716|FG000|STARTED|Overall Study||52||
60100355|NCT01894841|76217717|FG001|STARTED|Overall Study||53||
60100356|NCT01894841|76217716|FG000|COMPLETED|Overall Study||34||
60100357|NCT01894841|76217717|FG001|COMPLETED|Overall Study||44||
60100358|NCT01894841|76217716|FG000|NOT COMPLETED|Overall Study||18||
60100359|NCT01894841|76217717|FG001|NOT COMPLETED|Overall Study||9||
59563817|NCT01312922|75666044|FG001|COMPLETED|Overall Study||131||
59563818|NCT01312922|75666045|FG002|COMPLETED|Overall Study||135||
59563819|NCT01312922|75666043|FG000|NOT COMPLETED|Overall Study||68||
59563820|NCT01312922|75666044|FG001|NOT COMPLETED|Overall Study||54||
59563821|NCT01312922|75666045|FG002|NOT COMPLETED|Overall Study||50||
60100360|NCT01894607|76217727|FG000|STARTED|Overall Study||11||
59563822|NCT01783574|75666055|FG000|STARTED|Overall Study||51||
59563823|NCT01783574|75666056|FG001|STARTED|Overall Study||50||
59563824|NCT01783574|75666055|FG000|COMPLETED|Overall Study||46||
59563825|NCT01783574|75666056|FG001|COMPLETED|Overall Study||41||
59563826|NCT01783574|75666055|FG000|NOT COMPLETED|Overall Study||5||
59563827|NCT01783574|75666056|FG001|NOT COMPLETED|Overall Study||9||
59563828|NCT03656783|75666062|FG000|STARTED|Overall Study||25||
59563829|NCT03656783|75666062|FG000|COMPLETED|Overall Study||25||
59563830|NCT03656783|75666062|FG000|NOT COMPLETED|Overall Study||0||
59563831|NCT01784588|75666068|FG000|STARTED|Overall Study||141||
59563832|NCT01784588|75666069|FG001|STARTED|Overall Study||140||
59563833|NCT01784588|75666068|FG000|COMPLETED|Overall Study||104||
59563834|NCT01784588|75666069|FG001|COMPLETED|Overall Study||108||
59563835|NCT01784588|75666068|FG000|NOT COMPLETED|Overall Study||37||
59563836|NCT01784588|75666069|FG001|NOT COMPLETED|Overall Study||32||
59563837|NCT01733186|75666077|FG000|STARTED|Overall Study||6||
59563838|NCT01733186|75666078|FG001|STARTED|Overall Study||6||
59708323|NCT01111851|75827141|FG000|STARTED|Overall Study||8||
59708324|NCT01111851|75827142|FG001|STARTED|Overall Study||8||
59708325|NCT01111851|75827141|FG000|COMPLETED|Overall Study||6||
59708326|NCT01111851|75827142|FG001|COMPLETED|Overall Study||8||
59708327|NCT01111851|75827141|FG000|NOT COMPLETED|Overall Study||2||
59708328|NCT01111851|75827142|FG001|NOT COMPLETED|Overall Study||0||
59708329|NCT01256294|75827148|FG000|STARTED|Overall Study||36||
59708330|NCT01256294|75827149|FG001|STARTED|Overall Study||35||
59708331|NCT01256294|75827148|FG000|COMPLETED|Overall Study||32||
60100361|NCT01894607|76217727|FG000|COMPLETED|Overall Study||10||
60100362|NCT01894607|76217727|FG000|NOT COMPLETED|Overall Study||1||
60100363|NCT01883453|76217733|FG000|STARTED|Overall Study||73||
60100364|NCT01883453|76217734|FG001|STARTED|Overall Study||73||
60100365|NCT01883453|76217733|FG000|COMPLETED|Overall Study||48||
60100366|NCT01883453|76217734|FG001|COMPLETED|Overall Study||50||
60100367|NCT01883453|76217733|FG000|NOT COMPLETED|Overall Study||25||
60100368|NCT01883453|76217734|FG001|NOT COMPLETED|Overall Study||23||
60100369|NCT02000596|76217743|FG000|STARTED|Cohort 1||2||
60100370|NCT02000596|76217744|FG001|STARTED|Cohort 1||0||
60100371|NCT02000596|76217745|FG002|STARTED|Cohort 1||0||
60100372|NCT02000596|76217743|FG000|COMPLETED|Cohort 1||2||
60100373|NCT02000596|76217744|FG001|COMPLETED|Cohort 1||0||
60100374|NCT02000596|76217745|FG002|COMPLETED|Cohort 1||0||
59563839|NCT01733186|75666077|FG000|COMPLETED|Overall Study||6||
59563840|NCT01733186|75666078|FG001|COMPLETED|Overall Study||6||
59563841|NCT01733186|75666077|FG000|NOT COMPLETED|Overall Study||0||
59563842|NCT01733186|75666078|FG001|NOT COMPLETED|Overall Study||0||
59563843|NCT01734746|75666084|FG000|STARTED|Overall Study||22||
59563844|NCT01734746|75666084|FG000|COMPLETED|Overall Study||21||
59563845|NCT01734746|75666084|FG000|NOT COMPLETED|Overall Study||1||
59563846|NCT01785134|75666091|FG000|STARTED|Overall Study||41||
59563847|NCT01785134|75666092|FG001|STARTED|Overall Study||40||
59563848|NCT01785134|75666091|FG000|COMPLETED|Overall Study||29||
59563849|NCT01785134|75666092|FG001|COMPLETED|Overall Study||33||
59563850|NCT01785134|75666091|FG000|NOT COMPLETED|Overall Study||12||
59708332|NCT01256294|75827149|FG001|COMPLETED|Overall Study||33||
59563851|NCT01785134|75666092|FG001|NOT COMPLETED|Overall Study||7||
59563852|NCT01785680|75666100|FG000|STARTED|Overall Study||1100||
59563853|NCT01785680|75666101|FG001|STARTED|Overall Study||857||
59563854|NCT01785680|75666100|FG000|COMPLETED|Overall Study||1100||
59563855|NCT01785680|75666101|FG001|COMPLETED|Overall Study||857||
59563856|NCT01785680|75666100|FG000|NOT COMPLETED|Overall Study||0||
59563857|NCT01785680|75666101|FG001|NOT COMPLETED|Overall Study||0||
59563858|NCT01784666|75666110|FG000|STARTED|Overall Study||1||
59563859|NCT01784666|75666111|FG001|STARTED|Overall Study||0||
59708333|NCT01256294|75827148|FG000|NOT COMPLETED|Overall Study||4||
59708334|NCT01256294|75827149|FG001|NOT COMPLETED|Overall Study||2||
59708335|NCT01256060|75827155|FG000|STARTED|Overall Study||3||
59708336|NCT01256060|75827156|FG001|STARTED|Overall Study||3||
59708337|NCT01256060|75827157|FG002|STARTED|Overall Study||3||
59563860|NCT01784666|75666112|FG002|STARTED|Overall Study||1||
59563861|NCT01784666|75666110|FG000|COMPLETED|Overall Study||1||
59563862|NCT01784666|75666111|FG001|COMPLETED|Overall Study||0||
59563863|NCT01784666|75666112|FG002|COMPLETED|Overall Study||1||
59563864|NCT01784666|75666110|FG000|NOT COMPLETED|Overall Study||0||
59563865|NCT01784666|75666111|FG001|NOT COMPLETED|Overall Study||0||
59563866|NCT01784666|75666112|FG002|NOT COMPLETED|Overall Study||0||
59563867|NCT01787006|75666122|FG000|STARTED|Overall Study||35||
59563868|NCT01787006|75666123|FG001|STARTED|Overall Study||39||
59563869|NCT01787006|75666122|FG000|COMPLETED|Overall Study||32||
59563870|NCT01787006|75666123|FG001|COMPLETED|Overall Study||36||
59563871|NCT01787006|75666122|FG000|NOT COMPLETED|Overall Study||3||
59563872|NCT01787006|75666123|FG001|NOT COMPLETED|Overall Study||3||
59563873|NCT02260622|75666131|FG000|STARTED|Overall Study||11||
59563874|NCT02260622|75666132|FG001|STARTED|Overall Study||9||
59563875|NCT02260622|75666131|FG000|COMPLETED|Overall Study||11||
59563876|NCT02260622|75666132|FG001|COMPLETED|Overall Study||9||
60100375|NCT02000596|76217743|FG000|NOT COMPLETED|Cohort 1||0||
60100376|NCT02000596|76217744|FG001|NOT COMPLETED|Cohort 1||0||
60100377|NCT02000596|76217745|FG002|NOT COMPLETED|Cohort 1||0||
60100378|NCT02000596|76217743|FG000|STARTED|Cohort 2||0||
60100379|NCT02000596|76217744|FG001|STARTED|Cohort 2||0||
60100380|NCT02000596|76217745|FG002|STARTED|Cohort 2||2||
60100381|NCT02000596|76217743|FG000|COMPLETED|Cohort 2||0||
60100382|NCT02000596|76217744|FG001|COMPLETED|Cohort 2||0||
59563877|NCT02260622|75666131|FG000|NOT COMPLETED|Overall Study||0||
60100383|NCT02000596|76217745|FG002|COMPLETED|Cohort 2||2||
60100384|NCT02000596|76217743|FG000|NOT COMPLETED|Cohort 2||0||
60100385|NCT02000596|76217744|FG001|NOT COMPLETED|Cohort 2||0||
60100386|NCT02000596|76217745|FG002|NOT COMPLETED|Cohort 2||0||
60100387|NCT02165722|76217755|FG000|STARTED|Overall Study||1971||9
60100388|NCT02165722|76217756|FG001|STARTED|Overall Study||2202||11
60100389|NCT02165722|76217755|FG000|COMPLETED|Overall Study|Started and completed participants reflect the longitudinal analytic data set of patients used|1971||9
60100390|NCT02165722|76217756|FG001|COMPLETED|Overall Study|Started and completed participants reflect the longitudinal analytic data set of patients used|2202||11
60100391|NCT02165722|76217755|FG000|NOT COMPLETED|Overall Study||0||0
60100392|NCT02165722|76217756|FG001|NOT COMPLETED|Overall Study||0||0
59563878|NCT02260622|75666132|FG001|NOT COMPLETED|Overall Study||0||
59563879|NCT02261714|75666138|FG000|STARTED|Overall Study||32||
59563880|NCT02261714|75666138|FG000|COMPLETED|Overall Study||4||
59563881|NCT02261714|75666138|FG000|NOT COMPLETED|Overall Study||28||
59563882|NCT02261948|75666145|FG000|STARTED|Overall Study||23||
59563883|NCT02261948|75666146|FG001|STARTED|Overall Study||19||
59563884|NCT02261948|75666145|FG000|COMPLETED|Overall Study||23||
59563885|NCT02261948|75666146|FG001|COMPLETED|Overall Study||19||
59563886|NCT02261948|75666145|FG000|NOT COMPLETED|Overall Study||0||
59563887|NCT02261948|75666146|FG001|NOT COMPLETED|Overall Study||0||
59817025|NCT01358877|75939449|FG000|Did Not Receive Study Drug|Overall Study||22||
59563888|NCT03278067|75666155|FG000|STARTED|Overall Study||16433||
59563889|NCT03278067|75666156|FG001|STARTED|Overall Study||3310||
59563890|NCT03278067|75666157|FG002|STARTED|Overall Study||4196||
59563891|NCT03278067|75666155|FG000|COMPLETED|Overall Study||16433||
59563892|NCT03278067|75666156|FG001|COMPLETED|Overall Study||3310||
59563893|NCT03278067|75666157|FG002|COMPLETED|Overall Study||4196||
59563894|NCT03278067|75666155|FG000|NOT COMPLETED|Overall Study||0||
60100393|NCT01882985|76217768|FG000|STARTED|Overall Study||14||
60100394|NCT01882985|76217768|FG000|COMPLETED|Overall Study||12||
60100395|NCT01882985|76217768|FG000|NOT COMPLETED|Overall Study||2||
59563895|NCT03278067|75666156|FG001|NOT COMPLETED|Overall Study||0||
59563896|NCT03278067|75666157|FG002|NOT COMPLETED|Overall Study||0||
59563897|NCT01787240|75666172|FG000|STARTED|Overall Study||15||
59563898|NCT01787240|75666173|FG001|STARTED|Overall Study||5||
59563899|NCT01787240|75666172|FG000|COMPLETED|Overall Study||10||
59563900|NCT01787240|75666173|FG001|COMPLETED|Overall Study||4||
60100396|NCT02166346|76217772|FG000|STARTED|Screening and Randomization||12||
60100397|NCT02166346|76217773|FG001|STARTED|Screening and Randomization||12||
60100398|NCT02166346|76217772|FG000|COMPLETED|Screening and Randomization||8||
60100399|NCT02166346|76217773|FG001|COMPLETED|Screening and Randomization||8||
60100400|NCT02166346|76217772|FG000|NOT COMPLETED|Screening and Randomization||4||
60100401|NCT02166346|76217773|FG001|NOT COMPLETED|Screening and Randomization||4||
60100402|NCT02166346|76217772|FG000|STARTED|Intervention - Phase 1||8||
60100403|NCT02166346|76217773|FG001|STARTED|Intervention - Phase 1||8||
60100404|NCT02166346|76217772|FG000|COMPLETED|Intervention - Phase 1||8||
60100405|NCT02166346|76217773|FG001|COMPLETED|Intervention - Phase 1||6||
60100406|NCT02166346|76217772|FG000|NOT COMPLETED|Intervention - Phase 1||0||
60100407|NCT02166346|76217773|FG001|NOT COMPLETED|Intervention - Phase 1||2||
60100408|NCT02166346|76217772|FG000|STARTED|Intervention - Phase 2 (After Crossover)||8||
60100409|NCT02166346|76217773|FG001|STARTED|Intervention - Phase 2 (After Crossover)||6||
60100410|NCT02166346|76217772|FG000|COMPLETED|Intervention - Phase 2 (After Crossover)||7||
60100411|NCT02166346|76217773|FG001|COMPLETED|Intervention - Phase 2 (After Crossover)||6||
60100412|NCT02166346|76217772|FG000|NOT COMPLETED|Intervention - Phase 2 (After Crossover)||1||
60100413|NCT02166346|76217773|FG001|NOT COMPLETED|Intervention - Phase 2 (After Crossover)||0||
60100414|NCT01893905|76217781|FG000|STARTED|Overall Study||80||
60100415|NCT01893905|76217782|FG001|STARTED|Overall Study||78||
60100416|NCT01893905|76217781|FG000|COMPLETED|Overall Study||55||
60100417|NCT01893905|76217782|FG001|COMPLETED|Overall Study||64||
60100418|NCT01893905|76217781|FG000|NOT COMPLETED|Overall Study||25||
60100419|NCT01893905|76217782|FG001|NOT COMPLETED|Overall Study||14||
60100420|NCT01050946|76217788|FG000|STARTED|Overall Study||1||
60100421|NCT01050946|76217788|FG000|COMPLETED|Overall Study|Patient signed consent 2/3/2011. Patient had their transplant 2/15/2011. Patient died 9/2/2011|1||
60100422|NCT01050946|76217788|FG000|NOT COMPLETED|Overall Study||0||
60100423|NCT01893827|76217795|FG000|STARTED|Overall Study||117||
60100424|NCT01893827|76217796|FG001|STARTED|Overall Study||120||
60100425|NCT01893827|76217795|FG000|COMPLETED|Overall Study||98||
60100426|NCT01893827|76217796|FG001|COMPLETED|Overall Study||94||
60100427|NCT01893827|76217795|FG000|NOT COMPLETED|Overall Study||19||
60100428|NCT01893827|76217796|FG001|NOT COMPLETED|Overall Study||26||
60100429|NCT01882907|76217804|FG000|STARTED|Overall Study||117|The patients who were screening failure and didn't taking investigational product are excluded.|
60100430|NCT01882907|76217805|FG001|STARTED|Overall Study||111|The patients who were screening failure and didn't taking investigational product are excluded.|
60100431|NCT01882907|76217804|FG000|COMPLETED|Overall Study||103||
60100432|NCT01882907|76217805|FG001|COMPLETED|Overall Study||83||
59563901|NCT01787240|75666172|FG000|NOT COMPLETED|Overall Study||5||
59563902|NCT01787240|75666173|FG001|NOT COMPLETED|Overall Study||1||
59563903|NCT01735214|75666182|FG000|STARTED|Overall Study||358||
60100433|NCT01882907|76217804|FG000|NOT COMPLETED|Overall Study||14||
60100434|NCT01882907|76217805|FG001|NOT COMPLETED|Overall Study||28||
60100435|NCT04073823|76217815|FG000|STARTED|Overall Study||1||
60100436|NCT04073823|76217816|FG001|STARTED|Overall Study||1||
59563904|NCT01735214|75666182|FG000|COMPLETED|Overall Study||358||
59563905|NCT01735214|75666182|FG000|NOT COMPLETED|Overall Study||0||
59563906|NCT01789814|75666188|FG000|STARTED|Overall Study||12||
59708338|NCT01256060|75827158|FG003|STARTED|Overall Study||6||
59563907|NCT01789814|75666189|FG001|STARTED|Overall Study||12||
59708339|NCT01256060|75827155|FG000|COMPLETED|Overall Study||3||
59708340|NCT01256060|75827156|FG001|COMPLETED|Overall Study||2||
60100437|NCT04073823|76217815|FG000|COMPLETED|Overall Study||1||
60100438|NCT04073823|76217816|FG001|COMPLETED|Overall Study||1||
60100439|NCT04073823|76217815|FG000|NOT COMPLETED|Overall Study||0||
60100440|NCT04073823|76217816|FG001|NOT COMPLETED|Overall Study||0||
60100441|NCT01051570|76217823|FG000|STARTED|Overall Study||26||
60100442|NCT01051570|76217823|FG000|COMPLETED|Overall Study||26||
59563908|NCT01789814|75666188|FG000|COMPLETED|Overall Study||12||
59563909|NCT01789814|75666189|FG001|COMPLETED|Overall Study||12||
59563910|NCT01789814|75666188|FG000|NOT COMPLETED|Overall Study||0||
59563911|NCT01789814|75666189|FG001|NOT COMPLETED|Overall Study||0||
59563912|NCT01736852|75666197|FG000|STARTED|Overall Study||65||
59563913|NCT01736852|75666198|FG001|STARTED|Overall Study||64||
59563914|NCT01736852|75666197|FG000|COMPLETED|Overall Study||63||
59563915|NCT01736852|75666198|FG001|COMPLETED|Overall Study||61||
59563916|NCT01736852|75666197|FG000|NOT COMPLETED|Overall Study||2||
59563917|NCT01736852|75666198|FG001|NOT COMPLETED|Overall Study||3||
59563918|NCT01790750|75666204|FG000|STARTED|Overall Study||50||
59563919|NCT01790750|75666204|FG000|COMPLETED|Overall Study||50||
59563920|NCT01790750|75666204|FG000|NOT COMPLETED|Overall Study||0||
59563921|NCT01809938|75666209|FG000|STARTED|First Intervention (170 Minutes)||5||
59563922|NCT01809938|75666210|FG001|STARTED|First Intervention (170 Minutes)||5||
59563923|NCT01809938|75666209|FG000|COMPLETED|First Intervention (170 Minutes)||5||
59563924|NCT01809938|75666210|FG001|COMPLETED|First Intervention (170 Minutes)||5||
59563925|NCT01809938|75666209|FG000|NOT COMPLETED|First Intervention (170 Minutes)||0||
59563926|NCT01809938|75666210|FG001|NOT COMPLETED|First Intervention (170 Minutes)||0||
59563927|NCT01809938|75666209|FG000|STARTED|Washout (Not Less Than 24 Hours)||5||
59563928|NCT01809938|75666210|FG001|STARTED|Washout (Not Less Than 24 Hours)||5||
59563929|NCT01809938|75666209|FG000|COMPLETED|Washout (Not Less Than 24 Hours)||5||
59563930|NCT01809938|75666210|FG001|COMPLETED|Washout (Not Less Than 24 Hours)||5||
59563931|NCT01809938|75666209|FG000|NOT COMPLETED|Washout (Not Less Than 24 Hours)||0||
59563932|NCT01809938|75666210|FG001|NOT COMPLETED|Washout (Not Less Than 24 Hours)||0||
59563933|NCT01809938|75666209|FG000|STARTED|Second Intervention (170 Minutes)||5||
59563934|NCT01809938|75666210|FG001|STARTED|Second Intervention (170 Minutes)||5||
59563935|NCT01809938|75666209|FG000|COMPLETED|Second Intervention (170 Minutes)||5||
59563936|NCT01809938|75666210|FG001|COMPLETED|Second Intervention (170 Minutes)||5||
59563937|NCT01809938|75666209|FG000|NOT COMPLETED|Second Intervention (170 Minutes)||0||
59563938|NCT01809938|75666210|FG001|NOT COMPLETED|Second Intervention (170 Minutes)||0||
59563939|NCT01810952|75666217|FG000|STARTED|Overall Study||20||
59563940|NCT01810952|75666218|FG001|STARTED|Overall Study||17||
59563941|NCT01810952|75666217|FG000|COMPLETED|Overall Study||20||
59563942|NCT01810952|75666218|FG001|COMPLETED|Overall Study||17||
59563943|NCT01810952|75666217|FG000|NOT COMPLETED|Overall Study||0||
59563944|NCT01810952|75666218|FG001|NOT COMPLETED|Overall Study||0||
59563945|NCT01877642|75666232|FG000|STARTED|Overall Study||4||
59563946|NCT01877642|75666233|FG001|STARTED|Overall Study||3||
59563947|NCT01877642|75666234|FG002|STARTED|Overall Study||3||
59563948|NCT01877642|75666235|FG003|STARTED|Overall Study||3||
59563949|NCT01877642|75666236|FG004|STARTED|Overall Study||3||
59563950|NCT01877642|75666237|FG005|STARTED|Overall Study||3||
59563951|NCT01877642|75666238|FG006|STARTED|Overall Study||3||
59563952|NCT01877642|75666232|FG000|COMPLETED|Overall Study||4||
59563953|NCT01877642|75666233|FG001|COMPLETED|Overall Study||3||
59563954|NCT01877642|75666234|FG002|COMPLETED|Overall Study||3||
59708341|NCT01256060|75827157|FG002|COMPLETED|Overall Study||3||
59563955|NCT01877642|75666235|FG003|COMPLETED|Overall Study||3||
59563956|NCT01877642|75666236|FG004|COMPLETED|Overall Study||3||
59563957|NCT01877642|75666237|FG005|COMPLETED|Overall Study||3||
59563958|NCT01877642|75666238|FG006|COMPLETED|Overall Study||3||
59563959|NCT01877642|75666232|FG000|NOT COMPLETED|Overall Study||0||
59563960|NCT01877642|75666233|FG001|NOT COMPLETED|Overall Study||0||
59563961|NCT01877642|75666234|FG002|NOT COMPLETED|Overall Study||0||
59563962|NCT01877642|75666235|FG003|NOT COMPLETED|Overall Study||0||
59563963|NCT01877642|75666236|FG004|NOT COMPLETED|Overall Study||0||
59563964|NCT01877642|75666237|FG005|NOT COMPLETED|Overall Study||0||
59563965|NCT01877642|75666238|FG006|NOT COMPLETED|Overall Study||0||
59563966|NCT01811030|75666247|FG000|STARTED|Overall Study||33||
59563967|NCT01811030|75666247|FG000|COMPLETED|Overall Study||20||
59563968|NCT01811030|75666247|FG000|NOT COMPLETED|Overall Study||13||
59563969|NCT02810951|75666251|FG000|STARTED|Overall Study||6||
59563970|NCT02810951|75666251|FG000|FCX-007 Injection|Overall Study||6||
59563971|NCT02810951|75666251|FG000|No FCX-007 Injection|Overall Study||6||
59563972|NCT02810951|75666251|FG000|COMPLETED|Overall Study||5||
59563973|NCT02810951|75666251|FG000|NOT COMPLETED|Overall Study||1||
59563974|NCT01878656|75666259|FG000|STARTED|Overall Study||72||
59708342|NCT01256060|75827158|FG003|COMPLETED|Overall Study||6||
59708343|NCT01256060|75827155|FG000|NOT COMPLETED|Overall Study||0||
59563975|NCT01878656|75666260|FG001|STARTED|Overall Study||72||
59563976|NCT01878656|75666259|FG000|COMPLETED|Overall Study||72||
59563977|NCT01878656|75666260|FG001|COMPLETED|Overall Study||72||
59563978|NCT01878656|75666259|FG000|NOT COMPLETED|Overall Study||0||
59563979|NCT01878656|75666260|FG001|NOT COMPLETED|Overall Study||0||
59563980|NCT01811654|75666268|FG000|STARTED|Overall Study||14||
59563981|NCT01811654|75666269|FG001|STARTED|Overall Study||16||
59563982|NCT01811654|75666268|FG000|COMPLETED|Overall Study||14||
59563983|NCT01811654|75666269|FG001|COMPLETED|Overall Study||16||
59563984|NCT01811654|75666268|FG000|NOT COMPLETED|Overall Study||0||
59563985|NCT01811654|75666269|FG001|NOT COMPLETED|Overall Study||0||
59563986|NCT01794806|75666277|FG000|STARTED|Overall Study||31||
59563987|NCT01794806|75666278|FG001|STARTED|Overall Study||28||
59563988|NCT01794806|75666277|FG000|1 Week|Overall Study||28||
59563989|NCT01794806|75666278|FG001|1 Week|Overall Study||28||
59563990|NCT01794806|75666277|FG000|4 Weeks|Overall Study||26||
59563991|NCT01794806|75666278|FG001|4 Weeks|Overall Study||27||
59563992|NCT01794806|75666277|FG000|COMPLETED|Overall Study||26||
59563993|NCT01794806|75666278|FG001|COMPLETED|Overall Study||27||
59563994|NCT01794806|75666277|FG000|NOT COMPLETED|Overall Study||5||
59563995|NCT01794806|75666278|FG001|NOT COMPLETED|Overall Study||1||
59563996|NCT03496701|75666284|FG000|STARTED|Overall Study||77||
59563997|NCT03496701|75666284|FG000|COMPLETED|Overall Study||77||
59563998|NCT03496701|75666284|FG000|NOT COMPLETED|Overall Study||0||
59563999|NCT02266472|75666292|FG000|STARTED|Period 1+ Washout||15||
59564000|NCT02266472|75666293|FG001|STARTED|Period 1+ Washout||15||
59564001|NCT02266472|75666292|FG000|COMPLETED|Period 1+ Washout||15||
59564002|NCT02266472|75666293|FG001|COMPLETED|Period 1+ Washout||15||
59564003|NCT02266472|75666292|FG000|NOT COMPLETED|Period 1+ Washout||0||
59564004|NCT02266472|75666293|FG001|NOT COMPLETED|Period 1+ Washout||0||
59564005|NCT02266472|75666292|FG000|STARTED|Period 2+ Washout||15||
59564006|NCT02266472|75666293|FG001|STARTED|Period 2+ Washout||15||
59564007|NCT02266472|75666292|FG000|COMPLETED|Period 2+ Washout||15||
59564008|NCT02266472|75666293|FG001|COMPLETED|Period 2+ Washout||15||
59564009|NCT02266472|75666292|FG000|NOT COMPLETED|Period 2+ Washout||0||
59564010|NCT02266472|75666293|FG001|NOT COMPLETED|Period 2+ Washout||0||
59564011|NCT03500289|75666301|FG000|STARTED|Overall Study||12||
59564012|NCT03500289|75666302|FG001|STARTED|Overall Study||6||
59564013|NCT03500289|75666301|FG000|COMPLETED|Overall Study||12||
59564014|NCT03500289|75666302|FG001|COMPLETED|Overall Study||6||
59564015|NCT03500289|75666301|FG000|NOT COMPLETED|Overall Study||0||
59564016|NCT03500289|75666302|FG001|NOT COMPLETED|Overall Study||0||
59564017|NCT01812044|75666311|FG000|STARTED|Overall Study||17||
59564018|NCT01812044|75666312|FG001|STARTED|Overall Study||17||
59564019|NCT01812044|75666313|FG002|STARTED|Overall Study||16||
59564020|NCT01812044|75666311|FG000|COMPLETED|Overall Study||17||
59564021|NCT01812044|75666312|FG001|COMPLETED|Overall Study||17||
59564022|NCT01812044|75666313|FG002|COMPLETED|Overall Study||16||
59564023|NCT01812044|75666311|FG000|NOT COMPLETED|Overall Study||0||
59564024|NCT01812044|75666312|FG001|NOT COMPLETED|Overall Study||0||
59564025|NCT01812044|75666313|FG002|NOT COMPLETED|Overall Study||0||
59564026|NCT03331185|75666323|FG000|STARTED|Overall Study||14||
59564027|NCT03331185|75666324|FG001|STARTED|Overall Study||12||
59564028|NCT03331185|75666323|FG000|COMPLETED|Overall Study||14||
59564029|NCT03331185|75666324|FG001|COMPLETED|Overall Study||12||
59564030|NCT03331185|75666323|FG000|NOT COMPLETED|Overall Study||0||
59564031|NCT03331185|75666324|FG001|NOT COMPLETED|Overall Study||0||
59564032|NCT01812668|75666330|FG000|STARTED|Overall Study||20||
59564033|NCT01812668|75666330|FG000|COMPLETED|Overall Study||20||
59564034|NCT01812668|75666330|FG000|NOT COMPLETED|Overall Study||0||
59564035|NCT01878812|75666336|FG000|STARTED|Overall Study||60||
59564036|NCT01878812|75666337|FG001|STARTED|Overall Study||57||
59564037|NCT01878812|75666336|FG000|COMPLETED|Overall Study||60||
59564038|NCT01878812|75666337|FG001|COMPLETED|Overall Study||57||
59564039|NCT01878812|75666336|FG000|NOT COMPLETED|Overall Study||0||
59564040|NCT01878812|75666337|FG001|NOT COMPLETED|Overall Study||0||
59708344|NCT01256060|75827156|FG001|NOT COMPLETED|Overall Study||1||
60100443|NCT01051570|76217823|FG000|NOT COMPLETED|Overall Study||0||
59564041|NCT02310906|75666347|FG000|STARTED|Part 1: Double Blind Phase (12 Weeks)||4||
59564042|NCT02310906|75666348|FG001|STARTED|Part 1: Double Blind Phase (12 Weeks)||8||
59564043|NCT02310906|75666349|FG002|STARTED|Part 1: Double Blind Phase (12 Weeks)||0||
59564044|NCT02310906|75666350|FG003|STARTED|Part 1: Double Blind Phase (12 Weeks)||0||
60100444|NCT01893281|76217827|FG000|STARTED|Overall Study||78||
60100445|NCT01893281|76217827|FG000|Received at Least 1 Dose of Study Drug|Overall Study||78||
60100446|NCT01893281|76217827|FG000|COMPLETED|Overall Study||75||
60100447|NCT01893281|76217827|FG000|NOT COMPLETED|Overall Study||3||
60100448|NCT01893203|76217831|FG000|STARTED|Overall Study||14||
60100449|NCT01893203|76217831|FG000|COMPLETED|Overall Study||13||
60100450|NCT01893203|76217831|FG000|NOT COMPLETED|Overall Study||1||
60100451|NCT01882829|76217835|FG000|STARTED|Overall Study||20||
60100452|NCT01882829|76217835|FG000|COMPLETED|Overall Study||14||
60100453|NCT01882829|76217835|FG000|NOT COMPLETED|Overall Study||6||
60100454|NCT02170870|76217845|FG000|STARTED|Overall Study||13||
60100455|NCT02170870|76217846|FG001|STARTED|Overall Study||11||
60100456|NCT02170870|76217847|FG002|STARTED|Overall Study||20||
60100457|NCT02170870|76217848|FG003|STARTED|Overall Study||20||
60100458|NCT02170870|76217849|FG004|STARTED|Overall Study||20||
60100459|NCT02170870|76217850|FG005|STARTED|Overall Study||20||
60100460|NCT02170870|76217845|FG000|COMPLETED|Overall Study||13||
60100461|NCT02170870|76217846|FG001|COMPLETED|Overall Study||11||
60100462|NCT02170870|76217847|FG002|COMPLETED|Overall Study||20||
60100463|NCT02170870|76217848|FG003|COMPLETED|Overall Study||20||
60100464|NCT02170870|76217849|FG004|COMPLETED|Overall Study||20||
60100465|NCT02170870|76217850|FG005|COMPLETED|Overall Study||20||
60100466|NCT02170870|76217845|FG000|NOT COMPLETED|Overall Study||0||
60100467|NCT02170870|76217846|FG001|NOT COMPLETED|Overall Study||0||
60100468|NCT02170870|76217847|FG002|NOT COMPLETED|Overall Study||0||
60100469|NCT02170870|76217848|FG003|NOT COMPLETED|Overall Study||0||
60100470|NCT02170870|76217849|FG004|NOT COMPLETED|Overall Study||0||
60100471|NCT02170870|76217850|FG005|NOT COMPLETED|Overall Study||0||
60100472|NCT01054768|76217869|FG000|STARTED|Overall Study||17||
60100473|NCT01054768|76217870|FG001|STARTED|Overall Study||20||
60100474|NCT01054768|76217869|FG000|COMPLETED|Overall Study||9||
60100475|NCT01054768|76217870|FG001|COMPLETED|Overall Study||17||
60100476|NCT01054768|76217869|FG000|NOT COMPLETED|Overall Study||8||
60100477|NCT01054768|76217870|FG001|NOT COMPLETED|Overall Study||3||
60100478|NCT04387617|76217878|FG000|STARTED|Overall Study||45||
60100479|NCT04387617|76217879|FG001|STARTED|Overall Study||45||
60100480|NCT04387617|76217878|FG000|COMPLETED|Overall Study||45||
60100481|NCT04387617|76217879|FG001|COMPLETED|Overall Study||45||
60100482|NCT04387617|76217878|FG000|NOT COMPLETED|Overall Study||0||
60100483|NCT04387617|76217879|FG001|NOT COMPLETED|Overall Study||0||
60100484|NCT04365465|76217888|FG000|STARTED|Overall Study||20||
60100485|NCT04365465|76217889|FG001|STARTED|Overall Study||20||
60100486|NCT04365465|76217890|FG002|STARTED|Overall Study||20||
60100487|NCT04365465|76217888|FG000|COMPLETED|Overall Study||20||
60100488|NCT04365465|76217889|FG001|COMPLETED|Overall Study||20||
60100489|NCT04365465|76217890|FG002|COMPLETED|Overall Study||20||
60100490|NCT04365465|76217888|FG000|NOT COMPLETED|Overall Study||0||
60100491|NCT04365465|76217889|FG001|NOT COMPLETED|Overall Study||0||
60100492|NCT04365465|76217890|FG002|NOT COMPLETED|Overall Study||0||
60100493|NCT01055704|76217902|FG000|STARTED|Overall Study||16||
59708345|NCT01256060|75827157|FG002|NOT COMPLETED|Overall Study||0||
59708346|NCT01256060|75827158|FG003|NOT COMPLETED|Overall Study||0||
59708347|NCT01255904|75827166|FG000|STARTED|Overall Study||45||
59708348|NCT01255904|75827167|FG001|STARTED|Overall Study||45||
59708349|NCT01255904|75827166|FG000|COMPLETED|Overall Study||44||
60100494|NCT01055704|76217903|FG001|STARTED|Overall Study||8||
60100495|NCT01055704|76217904|FG002|STARTED|Overall Study||16||
60100496|NCT01055704|76217905|FG003|STARTED|Overall Study||8||
60100497|NCT01055704|76217902|FG000|COMPLETED|Overall Study||16||
59708350|NCT01255904|75827167|FG001|COMPLETED|Overall Study||41||
60100498|NCT01055704|76217903|FG001|COMPLETED|Overall Study||8||
60100499|NCT01055704|76217904|FG002|COMPLETED|Overall Study||16||
60100500|NCT01055704|76217905|FG003|COMPLETED|Overall Study||8||
60100501|NCT01055704|76217902|FG000|NOT COMPLETED|Overall Study||0||
60100502|NCT01055704|76217903|FG001|NOT COMPLETED|Overall Study||0||
60100503|NCT01055704|76217904|FG002|NOT COMPLETED|Overall Study||0||
60100504|NCT01055704|76217905|FG003|NOT COMPLETED|Overall Study||0||
60100505|NCT01882439|76217919|FG000|STARTED|Overall Study|Received treatment|131||
60100506|NCT01882439|76217920|FG001|STARTED|Overall Study|Received treatment|132||
60100507|NCT01882439|76217921|FG002|STARTED|Overall Study|Received treatment|66||
60100508|NCT01882439|76217922|FG003|STARTED|Overall Study|Received treatment|65||
59708351|NCT01255904|75827166|FG000|NOT COMPLETED|Overall Study||1||
59708352|NCT01255904|75827167|FG001|NOT COMPLETED|Overall Study||4||
60100509|NCT01882439|76217919|FG000|COMPLETED|Overall Study||122||
60100510|NCT01882439|76217920|FG001|COMPLETED|Overall Study||111||
60100511|NCT01882439|76217921|FG002|COMPLETED|Overall Study||56||
60100512|NCT01882439|76217922|FG003|COMPLETED|Overall Study||56||
60100513|NCT01882439|76217919|FG000|NOT COMPLETED|Overall Study||9||
59708353|NCT01255670|75827175|FG000|STARTED|Overall Study||100||
59708354|NCT01255670|75827176|FG001|STARTED|Overall Study||100||
59708355|NCT01255670|75827175|FG000|COMPLETED|Overall Study||74||
59708356|NCT01255670|75827176|FG001|COMPLETED|Overall Study||80||
59708357|NCT01255670|75827175|FG000|NOT COMPLETED|Overall Study||26||
59708358|NCT01255670|75827176|FG001|NOT COMPLETED|Overall Study||20||
59708359|NCT01255592|75827184|FG000|STARTED|Overall Study||26||
59708360|NCT01255592|75827185|FG001|STARTED|Overall Study||26||
59708361|NCT01255592|75827184|FG000|COMPLETED|Overall Study||20||
59708362|NCT01255592|75827185|FG001|COMPLETED|Overall Study||25||
59564045|NCT02310906|75666347|FG000|Received 4 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0||
59564046|NCT02310906|75666348|FG001|Received 4 mg/kg|Part 1: Double Blind Phase (12 Weeks)||8||
59564047|NCT02310906|75666349|FG002|Received 4 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0||
59564048|NCT02310906|75666350|FG003|Received 4 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0||
59564049|NCT02310906|75666347|FG000|Received 10 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0||
59564050|NCT02310906|75666348|FG001|Received 10 mg/kg|Part 1: Double Blind Phase (12 Weeks)||8||
59564051|NCT02310906|75666349|FG002|Received 10 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0||
59564052|NCT02310906|75666350|FG003|Received 10 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0||
59564053|NCT02310906|75666347|FG000|Received 20 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0||
59564054|NCT02310906|75666348|FG001|Received 20 mg/kg|Part 1: Double Blind Phase (12 Weeks)||8||
60100514|NCT01882439|76217920|FG001|NOT COMPLETED|Overall Study||21||
60100515|NCT01882439|76217921|FG002|NOT COMPLETED|Overall Study||10||
60100516|NCT01882439|76217922|FG003|NOT COMPLETED|Overall Study||9||
60100517|NCT01055782|76217939|FG000|STARTED|Overall Study||555||
60100518|NCT01055782|76217940|FG001|STARTED|Overall Study||449||
60100519|NCT01055782|76217939|FG000|COMPLETED|Overall Study||555||
60100520|NCT01055782|76217940|FG001|COMPLETED|Overall Study||449||
60100521|NCT01055782|76217939|FG000|NOT COMPLETED|Overall Study||0||
60100522|NCT01055782|76217940|FG001|NOT COMPLETED|Overall Study||0||
60100523|NCT01056016|76217950|FG000|STARTED|Overall Study|22 pediatricians were at 4 practices; practices were unit of randomization|22||
60100524|NCT01056016|76217951|FG001|STARTED|Overall Study|27 pediatricians were at 4 practices; practices were unit of randomization|27||
60100525|NCT01056016|76217950|FG000|COMPLETED|Overall Study||20||
60100526|NCT01056016|76217951|FG001|COMPLETED|Overall Study||26||
60100527|NCT01056016|76217950|FG000|NOT COMPLETED|Overall Study||2||
60100528|NCT01056016|76217951|FG001|NOT COMPLETED|Overall Study||1||
60100529|NCT01056328|76217959|FG000|STARTED|Overall Study||164||
60100530|NCT01056328|76217960|FG001|STARTED|Overall Study||160||
60100531|NCT01056328|76217959|FG000|COMPLETED|Overall Study||147||
60100532|NCT01056328|76217960|FG001|COMPLETED|Overall Study||144||
60100533|NCT01056328|76217959|FG000|NOT COMPLETED|Overall Study||17||
60100534|NCT01056328|76217960|FG001|NOT COMPLETED|Overall Study||16||
59564055|NCT02310906|75666349|FG002|Received 20 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0||
59564056|NCT02310906|75666350|FG003|Received 20 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0||
59564057|NCT02310906|75666347|FG000|Received 30 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0||
60100535|NCT01892657|76217969|FG000|STARTED|Overall Study||128||
60100536|NCT01892657|76217969|FG000|COMPLETED|Overall Study||110||
60100537|NCT01892657|76217969|FG000|NOT COMPLETED|Overall Study||18||
60100538|NCT01057888|76217988|FG000|STARTED|Overall Study||2504||
60100539|NCT01057888|76217989|FG001|STARTED|Overall Study||2406||
59564058|NCT02310906|75666348|FG001|Received 30 mg/kg|Part 1: Double Blind Phase (12 Weeks)||8||
60100540|NCT01057888|76217990|FG002|STARTED|Overall Study||2494||
60100541|NCT01057888|76217988|FG000|COMPLETED|Overall Study||2504||
60100542|NCT01057888|76217989|FG001|COMPLETED|Overall Study||2406||
60100543|NCT01057888|76217990|FG002|COMPLETED|Overall Study||2494||
60100544|NCT01057888|76217988|FG000|NOT COMPLETED|Overall Study||0||
60100545|NCT01057888|76217989|FG001|NOT COMPLETED|Overall Study||0||
60100546|NCT01057888|76217990|FG002|NOT COMPLETED|Overall Study||0||
59564059|NCT02310906|75666349|FG002|Received 30 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0||
59564060|NCT02310906|75666350|FG003|Received 30 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0||
59564061|NCT02310906|75666347|FG000|COMPLETED|Part 1: Double Blind Phase (12 Weeks)||4||
59564062|NCT02310906|75666348|FG001|COMPLETED|Part 1: Double Blind Phase (12 Weeks)||8||
59564063|NCT02310906|75666349|FG002|COMPLETED|Part 1: Double Blind Phase (12 Weeks)||0||
59564064|NCT02310906|75666350|FG003|COMPLETED|Part 1: Double Blind Phase (12 Weeks)||0||
59564065|NCT02310906|75666347|FG000|NOT COMPLETED|Part 1: Double Blind Phase (12 Weeks)||0||
59564066|NCT02310906|75666348|FG001|NOT COMPLETED|Part 1: Double Blind Phase (12 Weeks)||0||
59564067|NCT02310906|75666349|FG002|NOT COMPLETED|Part 1: Double Blind Phase (12 Weeks)||0||
59564068|NCT02310906|75666350|FG003|NOT COMPLETED|Part 1: Double Blind Phase (12 Weeks)||0||
59564069|NCT02310906|75666347|FG000|STARTED|Part 2: Open Label Phase (168 Weeks)||0||
59564070|NCT02310906|75666348|FG001|STARTED|Part 2: Open Label Phase (168 Weeks)||0||
59564071|NCT02310906|75666349|FG002|STARTED|Part 2: Open Label Phase (168 Weeks)|4 participants from Part 1(Placebo) + 8 participants from Part 1(Golodirsen) +13 new participants|25||
59564072|NCT02310906|75666350|FG003|STARTED|Part 2: Open Label Phase (168 Weeks)||14||
59564073|NCT02310906|75666347|FG000|COMPLETED|Part 2: Open Label Phase (168 Weeks)||0||
59564074|NCT02310906|75666348|FG001|COMPLETED|Part 2: Open Label Phase (168 Weeks)||0||
59564075|NCT02310906|75666349|FG002|COMPLETED|Part 2: Open Label Phase (168 Weeks)||23||
59564076|NCT02310906|75666350|FG003|COMPLETED|Part 2: Open Label Phase (168 Weeks)||6||
59564077|NCT02310906|75666347|FG000|NOT COMPLETED|Part 2: Open Label Phase (168 Weeks)||0||
59564078|NCT02310906|75666348|FG001|NOT COMPLETED|Part 2: Open Label Phase (168 Weeks)||0||
59564079|NCT02310906|75666349|FG002|NOT COMPLETED|Part 2: Open Label Phase (168 Weeks)||2||
59564080|NCT02310906|75666350|FG003|NOT COMPLETED|Part 2: Open Label Phase (168 Weeks)||8||
59564081|NCT01796912|75666371|FG000|STARTED|First Intervention||10||
59564082|NCT01796912|75666372|FG001|STARTED|First Intervention||10||
59564083|NCT01796912|75666371|FG000|COMPLETED|First Intervention||10||
60100547|NCT01881737|76217996|FG000|STARTED|Overall Study|This is a pilot study|15||
60100548|NCT01881737|76217996|FG000|Number Screened|Overall Study||15||
60100549|NCT01881737|76217996|FG000|COMPLETED|Overall Study||10||
60100550|NCT01881737|76217996|FG000|NOT COMPLETED|Overall Study||5||
60100551|NCT01109056|76218004|FG000|STARTED|Overall Study||57||
59564084|NCT01796912|75666372|FG001|COMPLETED|First Intervention||10||
59564085|NCT01796912|75666371|FG000|NOT COMPLETED|First Intervention||0||
59708363|NCT01255592|75827184|FG000|NOT COMPLETED|Overall Study||6||
60100552|NCT01109056|76218005|FG001|STARTED|Overall Study||58||
60100553|NCT01109056|76218004|FG000|COMPLETED|Overall Study||50||
60100554|NCT01109056|76218005|FG001|COMPLETED|Overall Study||53||
60100555|NCT01109056|76218004|FG000|NOT COMPLETED|Overall Study||7||
60100556|NCT01109056|76218005|FG001|NOT COMPLETED|Overall Study||5||
60100557|NCT01109602|76218014|FG000|STARTED|Overall Study||14||
60100558|NCT01109602|76218015|FG001|STARTED|Overall Study||23||
59564086|NCT01796912|75666372|FG001|NOT COMPLETED|First Intervention||0||
59564087|NCT01796912|75666371|FG000|STARTED|Washout||10||
59564088|NCT01796912|75666372|FG001|STARTED|Washout||10||
59708364|NCT01255592|75827185|FG001|NOT COMPLETED|Overall Study||1||
59564089|NCT01796912|75666371|FG000|COMPLETED|Washout||10||
59564090|NCT01796912|75666372|FG001|COMPLETED|Washout||10||
59564091|NCT01796912|75666371|FG000|NOT COMPLETED|Washout||0||
59564092|NCT01796912|75666372|FG001|NOT COMPLETED|Washout||0||
59564093|NCT01796912|75666371|FG000|STARTED|Second Intervention||10||
59564094|NCT01796912|75666372|FG001|STARTED|Second Intervention||10||
59564095|NCT01796912|75666371|FG000|COMPLETED|Second Intervention||10||
59564096|NCT01796912|75666372|FG001|COMPLETED|Second Intervention||10||
59709835|NCT01072149|75828529|FG009|STARTED|Treatment Period 2 (28 Days)||3||
59994229|NCT01559363|76110000|FG002|COMPLETED|Phase 1b: Up to 36 Months||3||
60100559|NCT01109602|76218016|FG002|STARTED|Overall Study||10||
60100560|NCT01109602|76218014|FG000|COMPLETED|Overall Study||13||
60100561|NCT01109602|76218015|FG001|COMPLETED|Overall Study||21||
60100562|NCT01109602|76218016|FG002|COMPLETED|Overall Study||9||
60100563|NCT01109602|76218014|FG000|NOT COMPLETED|Overall Study||1||
60100564|NCT01109602|76218015|FG001|NOT COMPLETED|Overall Study||2||
60100565|NCT01109602|76218016|FG002|NOT COMPLETED|Overall Study||1||
60100566|NCT02175472|76218025|FG000|STARTED|Overall Study||45||
60100567|NCT02175472|76218026|FG001|STARTED|Overall Study||47||
60100568|NCT02175472|76218025|FG000|COMPLETED|Overall Study||38||
60100569|NCT02175472|76218026|FG001|COMPLETED|Overall Study||45||
60100570|NCT02175472|76218025|FG000|NOT COMPLETED|Overall Study||7||
60100571|NCT02175472|76218026|FG001|NOT COMPLETED|Overall Study||2||
60100572|NCT01892501|76218032|FG000|STARTED|Overall Study||75||
60100573|NCT01892501|76218032|FG000|Group A : Biopsy Surgically Possible|Overall Study||72|Eligible for surgical procedure : Patients with no major protocol violation or medical contraindication|
60100574|NCT01892501|76218032|FG000|Group B : Biopsy Not Surgically Possible|Overall Study||3|No eligible for surgical procedure : major protocol deviations or medical contraindication|
60100575|NCT01892501|76218032|FG000|COMPLETED|Overall Study||47||
60100576|NCT01892501|76218032|FG000|NOT COMPLETED|Overall Study||28||
60100577|NCT01059682|76218038|FG000|STARTED|Overall Study||474||
60100578|NCT01059682|76218039|FG001|STARTED|Overall Study||462||
60100579|NCT01059682|76218038|FG000|COMPLETED|Overall Study||464||
60100580|NCT01059682|76218039|FG001|COMPLETED|Overall Study||444||
60100581|NCT01059682|76218038|FG000|NOT COMPLETED|Overall Study||10||
59564097|NCT01796912|75666371|FG000|NOT COMPLETED|Second Intervention||0||
59564098|NCT01796912|75666372|FG001|NOT COMPLETED|Second Intervention||0||
59564099|NCT01798316|75666382|FG000|STARTED|Overall Study||52||
59994230|NCT01559363|76110001|FG003|COMPLETED|Phase 1b: Up to 36 Months||0||
59994231|NCT01559363|76110002|FG004|COMPLETED|Phase 1b: Up to 36 Months||0||
59994232|NCT01559363|76110003|FG005|COMPLETED|Phase 1b: Up to 36 Months||0||
59994233|NCT01559363|76109998|FG000|NOT COMPLETED|Phase 1b: Up to 36 Months||6||
59994234|NCT01559363|76109999|FG001|NOT COMPLETED|Phase 1b: Up to 36 Months||3||
60100582|NCT01059682|76218039|FG001|NOT COMPLETED|Overall Study||18||
60100583|NCT01892345|76218047|FG000|STARTED|Overall Study||96||
60100584|NCT01892345|76218048|FG001|STARTED|Overall Study||47||
60100585|NCT01892345|76218047|FG000|Received At Least 1 Dose Of Study Drug|Overall Study||96|Full Analysis Set (FAS)|
60100586|NCT01892345|76218048|FG001|Received At Least 1 Dose Of Study Drug|Overall Study||47|Full Analysis Set (FAS)|
60100587|NCT01892345|76218047|FG000|COMPLETED|Overall Study||80||
60100588|NCT01892345|76218048|FG001|COMPLETED|Overall Study||44||
59564100|NCT01798316|75666383|FG001|STARTED|Overall Study||53||
59564101|NCT01798316|75666382|FG000|COMPLETED|Overall Study||52||
59564102|NCT01798316|75666383|FG001|COMPLETED|Overall Study||53||
59994235|NCT01559363|76110000|FG002|NOT COMPLETED|Phase 1b: Up to 36 Months||2||
59994236|NCT01559363|76110001|FG003|NOT COMPLETED|Phase 1b: Up to 36 Months||0||
59994237|NCT01559363|76110002|FG004|NOT COMPLETED|Phase 1b: Up to 36 Months||0||
59994238|NCT01559363|76110003|FG005|NOT COMPLETED|Phase 1b: Up to 36 Months||0||
59994239|NCT01559363|76109998|FG000|STARTED|Phase 2a: Up to 28 Months||0||
59994240|NCT01559363|76109999|FG001|STARTED|Phase 2a: Up to 28 Months||0||
59994241|NCT01559363|76110000|FG002|STARTED|Phase 2a: Up to 28 Months||0||
59995209|NCT02648217|76111028|FG000|COMPLETED|Overall Study||121||
59564103|NCT01798316|75666382|FG000|NOT COMPLETED|Overall Study||0||
59564104|NCT01798316|75666383|FG001|NOT COMPLETED|Overall Study||0||
59564105|NCT01798394|75666393|FG000|STARTED|Overall Study||24||
59564106|NCT01798394|75666394|FG001|STARTED|Overall Study||22||
59564107|NCT01798394|75666393|FG000|COMPLETED|Overall Study||21||
59564108|NCT01798394|75666394|FG001|COMPLETED|Overall Study||19||
59564109|NCT01798394|75666393|FG000|NOT COMPLETED|Overall Study||3||
59564110|NCT01798394|75666394|FG001|NOT COMPLETED|Overall Study||3||
59564111|NCT02340078|75666400|FG000|STARTED|Overall Study||62||
59564112|NCT02340078|75666400|FG000|COMPLETED|Overall Study||61||
59564113|NCT02340078|75666400|FG000|NOT COMPLETED|Overall Study||1||
59564114|NCT01798550|75666407|FG000|STARTED|Overall Study||30||
59564115|NCT01798550|75666408|FG001|STARTED|Overall Study||32||
59564116|NCT01798550|75666407|FG000|COMPLETED|Overall Study||28||
59564117|NCT01798550|75666408|FG001|COMPLETED|Overall Study||26||
59564118|NCT01798550|75666407|FG000|NOT COMPLETED|Overall Study||2||
59564119|NCT01798550|75666408|FG001|NOT COMPLETED|Overall Study||6||
60100589|NCT01892345|76218047|FG000|NOT COMPLETED|Overall Study||16||
60100590|NCT01892345|76218048|FG001|NOT COMPLETED|Overall Study||3||
60100591|NCT01059760|76218056|FG000|STARTED|Overall Study||16||
60100592|NCT01059760|76218057|FG001|STARTED|Overall Study||14||
60100593|NCT01059760|76218056|FG000|COMPLETED|Overall Study||16||
60100594|NCT01059760|76218057|FG001|COMPLETED|Overall Study||14||
60100595|NCT01059760|76218056|FG000|NOT COMPLETED|Overall Study||0||
59564120|NCT02340000|75666416|FG000|STARTED|Time Period 1||90||
59564121|NCT02340000|75666417|FG001|STARTED|Time Period 1||89||
59564122|NCT02340000|75666416|FG000|COMPLETED|Time Period 1||78||
59564123|NCT02340000|75666417|FG001|COMPLETED|Time Period 1||74||
59564124|NCT02340000|75666416|FG000|NOT COMPLETED|Time Period 1||12||
59564125|NCT02340000|75666417|FG001|NOT COMPLETED|Time Period 1||15||
59564126|NCT02340000|75666416|FG000|STARTED|Time Period 2||69||
59564127|NCT02340000|75666417|FG001|STARTED|Time Period 2||67||
59564128|NCT02340000|75666416|FG000|COMPLETED|Time Period 2||50||
59564129|NCT02340000|75666417|FG001|COMPLETED|Time Period 2||52||
59564130|NCT02340000|75666416|FG000|NOT COMPLETED|Time Period 2||19||
59564131|NCT02340000|75666417|FG001|NOT COMPLETED|Time Period 2||15||
59564132|NCT01800890|75666430|FG000|STARTED|Test Period 1||3||
59564133|NCT01800890|75666431|FG001|STARTED|Test Period 1||3||
59564134|NCT01800890|75666432|FG002|STARTED|Test Period 1||3||
59564135|NCT01800890|75666433|FG003|STARTED|Test Period 1||3||
59564136|NCT01800890|75666434|FG004|STARTED|Test Period 1||4||
59564137|NCT01800890|75666435|FG005|STARTED|Test Period 1||4||
59564138|NCT01800890|75666436|FG006|STARTED|Test Period 1||3||
59564139|NCT01800890|75666437|FG007|STARTED|Test Period 1||3||
60100596|NCT01059760|76218057|FG001|NOT COMPLETED|Overall Study||0||
60100597|NCT01059994|76218068|FG000|STARTED|Overall Study||3||
60100598|NCT01059994|76218069|FG001|STARTED|Overall Study||2||
60100599|NCT01059994|76218070|FG002|STARTED|Overall Study||3||
59564140|NCT01800890|75666438|FG008|STARTED|Test Period 1||3||
59564141|NCT01800890|75666430|FG000|COMPLETED|Test Period 1||3||
59564142|NCT01800890|75666431|FG001|COMPLETED|Test Period 1||3||
59564143|NCT01800890|75666432|FG002|COMPLETED|Test Period 1||3||
59564144|NCT01800890|75666433|FG003|COMPLETED|Test Period 1||2||
59564145|NCT01800890|75666434|FG004|COMPLETED|Test Period 1||4||
59564146|NCT01800890|75666435|FG005|COMPLETED|Test Period 1||4||
59564147|NCT01800890|75666436|FG006|COMPLETED|Test Period 1||3||
59564148|NCT01800890|75666437|FG007|COMPLETED|Test Period 1||3||
60100600|NCT01059994|76218071|FG003|STARTED|Overall Study||4||
59564149|NCT01800890|75666438|FG008|COMPLETED|Test Period 1||3||
59564150|NCT01800890|75666430|FG000|NOT COMPLETED|Test Period 1||0||
59564151|NCT01800890|75666431|FG001|NOT COMPLETED|Test Period 1||0||
59564152|NCT01800890|75666432|FG002|NOT COMPLETED|Test Period 1||0||
59564153|NCT01800890|75666433|FG003|NOT COMPLETED|Test Period 1||1||
59564154|NCT01800890|75666434|FG004|NOT COMPLETED|Test Period 1||0||
59564155|NCT01800890|75666435|FG005|NOT COMPLETED|Test Period 1||0||
59564156|NCT01800890|75666436|FG006|NOT COMPLETED|Test Period 1||0||
59564157|NCT01800890|75666437|FG007|NOT COMPLETED|Test Period 1||0||
59564158|NCT01800890|75666438|FG008|NOT COMPLETED|Test Period 1||0||
59564159|NCT01800890|75666430|FG000|STARTED|Test Period 2||3||
59564160|NCT01800890|75666431|FG001|STARTED|Test Period 2||3||
59564161|NCT01800890|75666432|FG002|STARTED|Test Period 2||3||
59564162|NCT01800890|75666433|FG003|STARTED|Test Period 2||2||
59564163|NCT01800890|75666434|FG004|STARTED|Test Period 2||4||
59564164|NCT01800890|75666435|FG005|STARTED|Test Period 2||4||
59564165|NCT01800890|75666436|FG006|STARTED|Test Period 2||3||
59564166|NCT01800890|75666437|FG007|STARTED|Test Period 2||3||
59564167|NCT01800890|75666438|FG008|STARTED|Test Period 2||3||
59564168|NCT01800890|75666430|FG000|COMPLETED|Test Period 2||3||
59564169|NCT01800890|75666431|FG001|COMPLETED|Test Period 2||3||
59564170|NCT01800890|75666432|FG002|COMPLETED|Test Period 2||3||
59564171|NCT01800890|75666433|FG003|COMPLETED|Test Period 2||2||
59564172|NCT01800890|75666434|FG004|COMPLETED|Test Period 2||4||
59564173|NCT01800890|75666435|FG005|COMPLETED|Test Period 2||4||
60100601|NCT01059994|76218068|FG000|COMPLETED|Overall Study||3||
60100602|NCT01059994|76218069|FG001|COMPLETED|Overall Study||2||
60100603|NCT01059994|76218070|FG002|COMPLETED|Overall Study||3||
60100604|NCT01059994|76218071|FG003|COMPLETED|Overall Study||3||
60100605|NCT01059994|76218068|FG000|NOT COMPLETED|Overall Study||0||
60100606|NCT01059994|76218069|FG001|NOT COMPLETED|Overall Study||0||
60100607|NCT01059994|76218070|FG002|NOT COMPLETED|Overall Study||0||
60100608|NCT01059994|76218071|FG003|NOT COMPLETED|Overall Study||1||
60100609|NCT01061476|76218081|FG000|STARTED|Overall Study||12||
60100610|NCT01061476|76218081|FG000|COMPLETED|Overall Study||12||
60100611|NCT01061476|76218081|FG000|NOT COMPLETED|Overall Study||0||
60100612|NCT01111162|76218085|FG000|STARTED|Overall Study||120||
60100613|NCT01111162|76218085|FG000|COMPLETED|Overall Study||120||
60100614|NCT01111162|76218085|FG000|NOT COMPLETED|Overall Study||0||
60100615|NCT01111318|76218094|FG000|STARTED|Overall Study||12||
60100616|NCT01111318|76218095|FG001|STARTED|Overall Study||8||
60100617|NCT01111318|76218096|FG002|STARTED|Overall Study||8||
60100618|NCT01111318|76218097|FG003|STARTED|Overall Study||8||
60100619|NCT01111318|76218094|FG000|COMPLETED|Overall Study||12||
60100620|NCT01111318|76218095|FG001|COMPLETED|Overall Study||8||
60100621|NCT01111318|76218096|FG002|COMPLETED|Overall Study||8||
60100622|NCT01111318|76218097|FG003|COMPLETED|Overall Study||8||
60100623|NCT01111318|76218094|FG000|NOT COMPLETED|Overall Study||0||
60100624|NCT01111318|76218095|FG001|NOT COMPLETED|Overall Study||0||
60100625|NCT01111318|76218096|FG002|NOT COMPLETED|Overall Study||0||
60100626|NCT01111318|76218097|FG003|NOT COMPLETED|Overall Study||0||
60100627|NCT03571048|76218109|FG000|STARTED|Overall Study||40||
60100628|NCT03571048|76218110|FG001|STARTED|Overall Study||41||
60100629|NCT03571048|76218109|FG000|COMPLETED|Overall Study||31||
60100630|NCT03571048|76218110|FG001|COMPLETED|Overall Study||32||
60100631|NCT03571048|76218109|FG000|NOT COMPLETED|Overall Study||9||
60100632|NCT03571048|76218110|FG001|NOT COMPLETED|Overall Study||9||
59564174|NCT01800890|75666436|FG006|COMPLETED|Test Period 2||3||
59564175|NCT01800890|75666437|FG007|COMPLETED|Test Period 2||3||
59564176|NCT01800890|75666438|FG008|COMPLETED|Test Period 2||3||
59564177|NCT01800890|75666430|FG000|NOT COMPLETED|Test Period 2||0||
59564178|NCT01800890|75666431|FG001|NOT COMPLETED|Test Period 2||0||
59564179|NCT01800890|75666432|FG002|NOT COMPLETED|Test Period 2||0||
59564180|NCT01800890|75666433|FG003|NOT COMPLETED|Test Period 2||0||
59564181|NCT01800890|75666434|FG004|NOT COMPLETED|Test Period 2||0||
59564182|NCT01800890|75666435|FG005|NOT COMPLETED|Test Period 2||0||
59564183|NCT01800890|75666436|FG006|NOT COMPLETED|Test Period 2||0||
60100633|NCT01892189|76218125|FG000|STARTED|First Intervention Period (1 Day)||3||
60100634|NCT01892189|76218126|FG001|STARTED|First Intervention Period (1 Day)||3||
60100635|NCT01892189|76218127|FG002|STARTED|First Intervention Period (1 Day)||3||
60100636|NCT01892189|76218128|FG003|STARTED|First Intervention Period (1 Day)||3||
60100637|NCT01892189|76218129|FG004|STARTED|First Intervention Period (1 Day)||3||
60100638|NCT01892189|76218130|FG005|STARTED|First Intervention Period (1 Day)||3||
59564184|NCT01800890|75666437|FG007|NOT COMPLETED|Test Period 2||0||
59564185|NCT01800890|75666438|FG008|NOT COMPLETED|Test Period 2||0||
59564186|NCT01800890|75666430|FG000|STARTED|Test Period 3||3||
59564187|NCT01800890|75666431|FG001|STARTED|Test Period 3||3||
59564188|NCT01800890|75666432|FG002|STARTED|Test Period 3||3||
59564189|NCT01800890|75666433|FG003|STARTED|Test Period 3||2||
59564190|NCT01800890|75666434|FG004|STARTED|Test Period 3||4||
59564191|NCT01800890|75666435|FG005|STARTED|Test Period 3||4||
59564192|NCT01800890|75666436|FG006|STARTED|Test Period 3||3||
59564193|NCT01800890|75666437|FG007|STARTED|Test Period 3||3||
60100639|NCT01892189|76218131|FG006|STARTED|First Intervention Period (1 Day)||3||
60100640|NCT01892189|76218132|FG007|STARTED|First Intervention Period (1 Day)||3||
60100641|NCT01892189|76218133|FG008|STARTED|First Intervention Period (1 Day)||3||
60100642|NCT01892189|76218125|FG000|COMPLETED|First Intervention Period (1 Day)||3||
60100643|NCT01892189|76218126|FG001|COMPLETED|First Intervention Period (1 Day)||3||
59564194|NCT01800890|75666438|FG008|STARTED|Test Period 3||3||
59564195|NCT01800890|75666430|FG000|COMPLETED|Test Period 3||3||
59564196|NCT01800890|75666431|FG001|COMPLETED|Test Period 3||3||
59564197|NCT01800890|75666432|FG002|COMPLETED|Test Period 3||3||
59564198|NCT01800890|75666433|FG003|COMPLETED|Test Period 3||2||
59708365|NCT01255436|75827194|FG000|STARTED|Overall Study|350 patients enrolled but 17 excluded because of missing baseline data.|333||
60100644|NCT01892189|76218127|FG002|COMPLETED|First Intervention Period (1 Day)||3||
59564199|NCT01800890|75666434|FG004|COMPLETED|Test Period 3||4||
59564200|NCT01800890|75666435|FG005|COMPLETED|Test Period 3||4||
59564201|NCT01800890|75666436|FG006|COMPLETED|Test Period 3||3||
59564202|NCT01800890|75666437|FG007|COMPLETED|Test Period 3||3||
59564203|NCT01800890|75666438|FG008|COMPLETED|Test Period 3||3||
59564204|NCT01800890|75666430|FG000|NOT COMPLETED|Test Period 3||0||
59564205|NCT01800890|75666431|FG001|NOT COMPLETED|Test Period 3||0||
59564206|NCT01800890|75666432|FG002|NOT COMPLETED|Test Period 3||0||
59564207|NCT01800890|75666433|FG003|NOT COMPLETED|Test Period 3||0||
59564208|NCT01800890|75666434|FG004|NOT COMPLETED|Test Period 3||0||
59564209|NCT01800890|75666435|FG005|NOT COMPLETED|Test Period 3||0||
59564210|NCT01800890|75666436|FG006|NOT COMPLETED|Test Period 3||0||
59564211|NCT01800890|75666437|FG007|NOT COMPLETED|Test Period 3||0||
59564212|NCT01800890|75666438|FG008|NOT COMPLETED|Test Period 3||0||
59564213|NCT02364180|75666448|FG000|STARTED|Overall Study||11||
59564214|NCT02364180|75666448|FG000|COMPLETED|Overall Study||10||
59817026|NCT01358877|75939450|FG001|Did Not Receive Study Drug|Overall Study||13||
59564215|NCT02364180|75666448|FG000|NOT COMPLETED|Overall Study||1||
59564216|NCT01813214|75666454|FG000|STARTED|Overall Study||3||
59564217|NCT01813214|75666455|FG001|STARTED|Overall Study||2||
59564218|NCT01813214|75666454|FG000|COMPLETED|Overall Study||3||
59564219|NCT01813214|75666455|FG001|COMPLETED|Overall Study||2||
60100645|NCT01892189|76218128|FG003|COMPLETED|First Intervention Period (1 Day)||3||
60100646|NCT01892189|76218129|FG004|COMPLETED|First Intervention Period (1 Day)||3||
60100647|NCT01892189|76218130|FG005|COMPLETED|First Intervention Period (1 Day)||3||
60100648|NCT01892189|76218131|FG006|COMPLETED|First Intervention Period (1 Day)||3||
60100649|NCT01892189|76218132|FG007|COMPLETED|First Intervention Period (1 Day)||3||
60100650|NCT01892189|76218133|FG008|COMPLETED|First Intervention Period (1 Day)||3||
60100651|NCT01892189|76218125|FG000|NOT COMPLETED|First Intervention Period (1 Day)||0||
60100652|NCT01892189|76218126|FG001|NOT COMPLETED|First Intervention Period (1 Day)||0||
60100653|NCT01892189|76218127|FG002|NOT COMPLETED|First Intervention Period (1 Day)||0||
60100654|NCT01892189|76218128|FG003|NOT COMPLETED|First Intervention Period (1 Day)||0||
60100655|NCT01892189|76218129|FG004|NOT COMPLETED|First Intervention Period (1 Day)||0||
60100656|NCT01892189|76218130|FG005|NOT COMPLETED|First Intervention Period (1 Day)||0||
60100657|NCT01892189|76218131|FG006|NOT COMPLETED|First Intervention Period (1 Day)||0||
60100658|NCT01892189|76218132|FG007|NOT COMPLETED|First Intervention Period (1 Day)||0||
60100659|NCT01892189|76218133|FG008|NOT COMPLETED|First Intervention Period (1 Day)||0||
60100660|NCT01892189|76218125|FG000|STARTED|Washout Period 1 (7 Days)||3||
60100661|NCT01892189|76218126|FG001|STARTED|Washout Period 1 (7 Days)||3||
60100662|NCT01892189|76218127|FG002|STARTED|Washout Period 1 (7 Days)||3||
60100663|NCT01892189|76218128|FG003|STARTED|Washout Period 1 (7 Days)||3||
60100664|NCT01892189|76218129|FG004|STARTED|Washout Period 1 (7 Days)||3||
60100665|NCT01892189|76218130|FG005|STARTED|Washout Period 1 (7 Days)||3||
60100666|NCT01892189|76218131|FG006|STARTED|Washout Period 1 (7 Days)||3||
60100667|NCT01892189|76218132|FG007|STARTED|Washout Period 1 (7 Days)||3||
60100668|NCT01892189|76218133|FG008|STARTED|Washout Period 1 (7 Days)||3||
60100669|NCT01892189|76218125|FG000|COMPLETED|Washout Period 1 (7 Days)||3||
60100670|NCT01892189|76218126|FG001|COMPLETED|Washout Period 1 (7 Days)||3||
60100671|NCT01892189|76218127|FG002|COMPLETED|Washout Period 1 (7 Days)||1||
59564220|NCT01813214|75666454|FG000|NOT COMPLETED|Overall Study||0||
60100672|NCT01892189|76218128|FG003|COMPLETED|Washout Period 1 (7 Days)||2||
60100673|NCT01892189|76218129|FG004|COMPLETED|Washout Period 1 (7 Days)||3||
60100674|NCT01892189|76218130|FG005|COMPLETED|Washout Period 1 (7 Days)||2||
60100675|NCT01892189|76218131|FG006|COMPLETED|Washout Period 1 (7 Days)||2||
60100676|NCT01892189|76218132|FG007|COMPLETED|Washout Period 1 (7 Days)||3||
60100677|NCT01892189|76218133|FG008|COMPLETED|Washout Period 1 (7 Days)||1||
60100678|NCT01892189|76218125|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0||
60100679|NCT01892189|76218126|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0||
60100680|NCT01892189|76218127|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||2||
60100681|NCT01892189|76218128|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||1||
60100682|NCT01892189|76218129|FG004|NOT COMPLETED|Washout Period 1 (7 Days)||0||
60100683|NCT01892189|76218130|FG005|NOT COMPLETED|Washout Period 1 (7 Days)||1||
60100684|NCT01892189|76218131|FG006|NOT COMPLETED|Washout Period 1 (7 Days)||1||
60100685|NCT01892189|76218132|FG007|NOT COMPLETED|Washout Period 1 (7 Days)||0||
60100686|NCT01892189|76218133|FG008|NOT COMPLETED|Washout Period 1 (7 Days)||2||
60100687|NCT01892189|76218125|FG000|STARTED|Second Intervention Period (1 Day)||3||
60100688|NCT01892189|76218126|FG001|STARTED|Second Intervention Period (1 Day)||3||
60100689|NCT01892189|76218127|FG002|STARTED|Second Intervention Period (1 Day)||1||
60100690|NCT01892189|76218128|FG003|STARTED|Second Intervention Period (1 Day)||2||
60100691|NCT01892189|76218129|FG004|STARTED|Second Intervention Period (1 Day)||3||
60100692|NCT01892189|76218130|FG005|STARTED|Second Intervention Period (1 Day)||2||
60100693|NCT01892189|76218131|FG006|STARTED|Second Intervention Period (1 Day)||2||
60100694|NCT01892189|76218132|FG007|STARTED|Second Intervention Period (1 Day)||3||
60100695|NCT01892189|76218133|FG008|STARTED|Second Intervention Period (1 Day)||1||
60100696|NCT01892189|76218125|FG000|COMPLETED|Second Intervention Period (1 Day)||3||
60100697|NCT01892189|76218126|FG001|COMPLETED|Second Intervention Period (1 Day)||3||
60100698|NCT01892189|76218127|FG002|COMPLETED|Second Intervention Period (1 Day)||1||
60100699|NCT01892189|76218128|FG003|COMPLETED|Second Intervention Period (1 Day)||2||
60100700|NCT01892189|76218129|FG004|COMPLETED|Second Intervention Period (1 Day)||3||
60100701|NCT01892189|76218130|FG005|COMPLETED|Second Intervention Period (1 Day)||2||
60100702|NCT01892189|76218131|FG006|COMPLETED|Second Intervention Period (1 Day)||2||
60100703|NCT01892189|76218132|FG007|COMPLETED|Second Intervention Period (1 Day)||3||
60100704|NCT01892189|76218133|FG008|COMPLETED|Second Intervention Period (1 Day)||1||
60100705|NCT01892189|76218125|FG000|NOT COMPLETED|Second Intervention Period (1 Day)||0||
60100706|NCT01892189|76218126|FG001|NOT COMPLETED|Second Intervention Period (1 Day)||0||
60100707|NCT01892189|76218127|FG002|NOT COMPLETED|Second Intervention Period (1 Day)||0||
60100708|NCT01892189|76218128|FG003|NOT COMPLETED|Second Intervention Period (1 Day)||0||
60100709|NCT01892189|76218129|FG004|NOT COMPLETED|Second Intervention Period (1 Day)||0||
60100710|NCT01892189|76218130|FG005|NOT COMPLETED|Second Intervention Period (1 Day)||0||
60100711|NCT01892189|76218131|FG006|NOT COMPLETED|Second Intervention Period (1 Day)||0||
60100712|NCT01892189|76218132|FG007|NOT COMPLETED|Second Intervention Period (1 Day)||0||
60100713|NCT01892189|76218133|FG008|NOT COMPLETED|Second Intervention Period (1 Day)||0||
60100714|NCT01892189|76218125|FG000|STARTED|Washout Period 2 (7 Days)||3||
60100715|NCT01892189|76218126|FG001|STARTED|Washout Period 2 (7 Days)||3||
60100716|NCT01892189|76218127|FG002|STARTED|Washout Period 2 (7 Days)||1||
60100717|NCT01892189|76218128|FG003|STARTED|Washout Period 2 (7 Days)||2||
60100718|NCT01892189|76218129|FG004|STARTED|Washout Period 2 (7 Days)||3||
60100719|NCT01892189|76218130|FG005|STARTED|Washout Period 2 (7 Days)||2||
60100720|NCT01892189|76218131|FG006|STARTED|Washout Period 2 (7 Days)||2||
60100721|NCT01892189|76218132|FG007|STARTED|Washout Period 2 (7 Days)||3||
60100722|NCT01892189|76218133|FG008|STARTED|Washout Period 2 (7 Days)||1||
60100723|NCT01892189|76218125|FG000|COMPLETED|Washout Period 2 (7 Days)||3||
60100724|NCT01892189|76218126|FG001|COMPLETED|Washout Period 2 (7 Days)||3||
60100725|NCT01892189|76218127|FG002|COMPLETED|Washout Period 2 (7 Days)||1||
60100726|NCT01892189|76218128|FG003|COMPLETED|Washout Period 2 (7 Days)||2||
60100727|NCT01892189|76218129|FG004|COMPLETED|Washout Period 2 (7 Days)||3||
60100728|NCT01892189|76218130|FG005|COMPLETED|Washout Period 2 (7 Days)||2||
60100729|NCT01892189|76218131|FG006|COMPLETED|Washout Period 2 (7 Days)||2||
60100730|NCT01892189|76218132|FG007|COMPLETED|Washout Period 2 (7 Days)||3||
60100731|NCT01892189|76218133|FG008|COMPLETED|Washout Period 2 (7 Days)||1||
60100732|NCT01892189|76218125|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0||
60100733|NCT01892189|76218126|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0||
60100734|NCT01892189|76218127|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0||
60100735|NCT01892189|76218128|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0||
60100736|NCT01892189|76218129|FG004|NOT COMPLETED|Washout Period 2 (7 Days)||0||
60100737|NCT01892189|76218130|FG005|NOT COMPLETED|Washout Period 2 (7 Days)||0||
59564221|NCT01813214|75666455|FG001|NOT COMPLETED|Overall Study||0||
59564222|NCT01814774|75666461|FG000|STARTED|Overall Study||48||
59564223|NCT01814774|75666461|FG000|COMPLETED|Overall Study||48||
59564224|NCT01814774|75666461|FG000|NOT COMPLETED|Overall Study||0||
59564225|NCT01815008|75666467|FG000|STARTED|Overall Study|Had difficulty in completing enrollment|19||
60100738|NCT01892189|76218131|FG006|NOT COMPLETED|Washout Period 2 (7 Days)||0||
60100739|NCT01892189|76218132|FG007|NOT COMPLETED|Washout Period 2 (7 Days)||0||
60100740|NCT01892189|76218133|FG008|NOT COMPLETED|Washout Period 2 (7 Days)||0||
60100741|NCT01892189|76218125|FG000|STARTED|Third Intervention Period (1 Day)||3||
60100742|NCT01892189|76218126|FG001|STARTED|Third Intervention Period (1 Day)||3||
59564226|NCT01815008|75666467|FG000|COMPLETED|Overall Study|transcriptomic data was available on 9 participants only|15||
60100743|NCT01892189|76218127|FG002|STARTED|Third Intervention Period (1 Day)||1||
60100744|NCT01892189|76218128|FG003|STARTED|Third Intervention Period (1 Day)||2||
60100745|NCT01892189|76218129|FG004|STARTED|Third Intervention Period (1 Day)||3||
60100746|NCT01892189|76218130|FG005|STARTED|Third Intervention Period (1 Day)||2||
60100747|NCT01892189|76218131|FG006|STARTED|Third Intervention Period (1 Day)||2||
60100748|NCT01892189|76218132|FG007|STARTED|Third Intervention Period (1 Day)||3||
60100749|NCT01892189|76218133|FG008|STARTED|Third Intervention Period (1 Day)||1||
60100750|NCT01892189|76218125|FG000|COMPLETED|Third Intervention Period (1 Day)||3||
59564227|NCT01815008|75666467|FG000|NOT COMPLETED|Overall Study||4||
59564228|NCT01818518|75666479|FG000|STARTED|Overall Study||310||
59564229|NCT01818518|75666480|FG001|STARTED|Overall Study||263||
59564230|NCT01818518|75666481|FG002|STARTED|Overall Study||288||
59564231|NCT01818518|75666482|FG003|STARTED|Overall Study||59||
60100751|NCT01892189|76218126|FG001|COMPLETED|Third Intervention Period (1 Day)||3||
60100752|NCT01892189|76218127|FG002|COMPLETED|Third Intervention Period (1 Day)||1||
59564232|NCT01818518|75666483|FG004|STARTED|Overall Study||38||
60100753|NCT01892189|76218128|FG003|COMPLETED|Third Intervention Period (1 Day)||2||
60100754|NCT01892189|76218129|FG004|COMPLETED|Third Intervention Period (1 Day)||3||
60100755|NCT01892189|76218130|FG005|COMPLETED|Third Intervention Period (1 Day)||2||
60100756|NCT01892189|76218131|FG006|COMPLETED|Third Intervention Period (1 Day)||2||
60100757|NCT01892189|76218132|FG007|COMPLETED|Third Intervention Period (1 Day)||3||
60100758|NCT01892189|76218133|FG008|COMPLETED|Third Intervention Period (1 Day)||1||
60100759|NCT01892189|76218125|FG000|NOT COMPLETED|Third Intervention Period (1 Day)||0||
60100760|NCT01892189|76218126|FG001|NOT COMPLETED|Third Intervention Period (1 Day)||0||
60100761|NCT01892189|76218127|FG002|NOT COMPLETED|Third Intervention Period (1 Day)||0||
60100762|NCT01892189|76218128|FG003|NOT COMPLETED|Third Intervention Period (1 Day)||0||
60100763|NCT01892189|76218129|FG004|NOT COMPLETED|Third Intervention Period (1 Day)||0||
60100764|NCT01892189|76218130|FG005|NOT COMPLETED|Third Intervention Period (1 Day)||0||
60100765|NCT01892189|76218131|FG006|NOT COMPLETED|Third Intervention Period (1 Day)||0||
60100766|NCT01892189|76218132|FG007|NOT COMPLETED|Third Intervention Period (1 Day)||0||
60100767|NCT01892189|76218133|FG008|NOT COMPLETED|Third Intervention Period (1 Day)||0||
59564233|NCT01818518|75666484|FG005|STARTED|Overall Study||37||
59564234|NCT01818518|75666479|FG000|COMPLETED|Overall Study||310||
59564235|NCT01818518|75666480|FG001|COMPLETED|Overall Study||263||
59564236|NCT01818518|75666481|FG002|COMPLETED|Overall Study||288||
59564237|NCT01818518|75666482|FG003|COMPLETED|Overall Study||59||
59564238|NCT01818518|75666483|FG004|COMPLETED|Overall Study||38||
59564239|NCT01818518|75666484|FG005|COMPLETED|Overall Study||37||
59564240|NCT01818518|75666479|FG000|NOT COMPLETED|Overall Study||0||
59564241|NCT01818518|75666480|FG001|NOT COMPLETED|Overall Study||0||
59564242|NCT01818518|75666481|FG002|NOT COMPLETED|Overall Study||0||
59564243|NCT01818518|75666482|FG003|NOT COMPLETED|Overall Study||0||
59564244|NCT01818518|75666483|FG004|NOT COMPLETED|Overall Study||0||
59564245|NCT01818518|75666484|FG005|NOT COMPLETED|Overall Study||0||
59564246|NCT01801124|75666498|FG000|STARTED|Overall Study||13||
59564247|NCT01801124|75666498|FG000|COMPLETED|Overall Study||13||
59564248|NCT01801124|75666498|FG000|NOT COMPLETED|Overall Study||0||
59564249|NCT03501069|75666511|FG000|STARTED|Period A||2||
59708366|NCT01255436|75827195|FG001|STARTED|Overall Study|350 patients enrolled but 21 excluded because of missing baseline data|329||
60100768|NCT01062568|76218150|FG000|STARTED|Overall Study||10||
59564250|NCT03501069|75666512|FG001|STARTED|Period A||4||
59564251|NCT03501069|75666513|FG002|STARTED|Period A||2||
59564252|NCT03501069|75666514|FG003|STARTED|Period A||5||
59564253|NCT03501069|75666515|FG004|STARTED|Period A||1||
59564254|NCT03501069|75666516|FG005|STARTED|Period A||6||
59564255|NCT03501069|75666517|FG006|STARTED|Period A||6||
60100769|NCT01062568|76218151|FG001|STARTED|Overall Study||40||
60100770|NCT01062568|76218150|FG000|COMPLETED|Overall Study||10||
60100771|NCT01062568|76218151|FG001|COMPLETED|Overall Study||40||
60100772|NCT01062568|76218150|FG000|NOT COMPLETED|Overall Study||0||
59564256|NCT03501069|75666518|FG007|STARTED|Period A||3||
60100773|NCT01062568|76218151|FG001|NOT COMPLETED|Overall Study||0||
60100774|NCT01881425|76218164|FG000|STARTED|Overall Study||395||
60100775|NCT01881425|76218165|FG001|STARTED|Overall Study||132||
60100776|NCT01881425|76218164|FG000|COMPLETED|Overall Study||370||
59564257|NCT03501069|75666519|FG008|STARTED|Period A||3||
59564258|NCT03501069|75666511|FG000|COMPLETED|Period A||2||
59564259|NCT03501069|75666512|FG001|COMPLETED|Period A||4||
59564260|NCT03501069|75666513|FG002|COMPLETED|Period A||2||
59564261|NCT03501069|75666514|FG003|COMPLETED|Period A||5||
59564262|NCT03501069|75666515|FG004|COMPLETED|Period A||1||
59564263|NCT03501069|75666516|FG005|COMPLETED|Period A||6||
59564264|NCT03501069|75666517|FG006|COMPLETED|Period A||6||
59564265|NCT03501069|75666518|FG007|COMPLETED|Period A||3||
59564266|NCT03501069|75666519|FG008|COMPLETED|Period A||3||
59564267|NCT03501069|75666511|FG000|NOT COMPLETED|Period A||0||
59564268|NCT03501069|75666512|FG001|NOT COMPLETED|Period A||0||
59564269|NCT03501069|75666513|FG002|NOT COMPLETED|Period A||0||
59564270|NCT03501069|75666514|FG003|NOT COMPLETED|Period A||0||
59564271|NCT03501069|75666515|FG004|NOT COMPLETED|Period A||0||
59564272|NCT03501069|75666516|FG005|NOT COMPLETED|Period A||0||
59564273|NCT03501069|75666517|FG006|NOT COMPLETED|Period A||0||
59564274|NCT03501069|75666518|FG007|NOT COMPLETED|Period A||0||
59564275|NCT03501069|75666519|FG008|NOT COMPLETED|Period A||0||
59564276|NCT03501069|75666511|FG000|STARTED|Washout Period (at Least 14 Days)||2||
59564277|NCT03501069|75666512|FG001|STARTED|Washout Period (at Least 14 Days)||4||
59564278|NCT03501069|75666513|FG002|STARTED|Washout Period (at Least 14 Days)||2||
59564279|NCT03501069|75666514|FG003|STARTED|Washout Period (at Least 14 Days)|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0||
59564280|NCT03501069|75666515|FG004|STARTED|Washout Period (at Least 14 Days)|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0||
59708367|NCT01255436|75827194|FG000|COMPLETED|Overall Study||151||
59564281|NCT03501069|75666516|FG005|STARTED|Washout Period (at Least 14 Days)|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0||
59564282|NCT03501069|75666517|FG006|STARTED|Washout Period (at Least 14 Days)|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0||
59564283|NCT03501069|75666518|FG007|STARTED|Washout Period (at Least 14 Days)|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0||
59564284|NCT03501069|75666519|FG008|STARTED|Washout Period (at Least 14 Days)|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0||
59564285|NCT03501069|75666511|FG000|COMPLETED|Washout Period (at Least 14 Days)||2||
59564286|NCT03501069|75666512|FG001|COMPLETED|Washout Period (at Least 14 Days)||4||
59564287|NCT03501069|75666513|FG002|COMPLETED|Washout Period (at Least 14 Days)||2||
59564288|NCT03501069|75666514|FG003|COMPLETED|Washout Period (at Least 14 Days)||0||
59564289|NCT03501069|75666515|FG004|COMPLETED|Washout Period (at Least 14 Days)||0||
59564290|NCT03501069|75666516|FG005|COMPLETED|Washout Period (at Least 14 Days)||0||
59564291|NCT03501069|75666517|FG006|COMPLETED|Washout Period (at Least 14 Days)||0||
59564292|NCT03501069|75666518|FG007|COMPLETED|Washout Period (at Least 14 Days)||0||
59564293|NCT03501069|75666519|FG008|COMPLETED|Washout Period (at Least 14 Days)||0||
59708368|NCT01255436|75827195|FG001|COMPLETED|Overall Study||135||
59708369|NCT01255436|75827194|FG000|NOT COMPLETED|Overall Study||182||
59994242|NCT01559363|76110001|FG003|STARTED|Phase 2a: Up to 28 Months|Phase 2b and Phase 1b were separate populations.|10||
59994243|NCT01559363|76110002|FG004|STARTED|Phase 2a: Up to 28 Months|Phase 2b and Phase 1b were separate populations.|14||
59994244|NCT01559363|76110003|FG005|STARTED|Phase 2a: Up to 28 Months|Phase 2b and Phase 1b were separate populations.|8||
59994245|NCT01559363|76109998|FG000|COMPLETED|Phase 2a: Up to 28 Months||0||
59994246|NCT01559363|76109999|FG001|COMPLETED|Phase 2a: Up to 28 Months||0||
59994247|NCT01559363|76110000|FG002|COMPLETED|Phase 2a: Up to 28 Months||0||
59994248|NCT01559363|76110001|FG003|COMPLETED|Phase 2a: Up to 28 Months||8||
59994249|NCT01559363|76110002|FG004|COMPLETED|Phase 2a: Up to 28 Months||13||
59994250|NCT01559363|76110003|FG005|COMPLETED|Phase 2a: Up to 28 Months||8||
59564294|NCT03501069|75666511|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0||
59564295|NCT03501069|75666512|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0||
59564296|NCT03501069|75666513|FG002|NOT COMPLETED|Washout Period (at Least 14 Days)||0||
59564297|NCT03501069|75666514|FG003|NOT COMPLETED|Washout Period (at Least 14 Days)||0||
59564298|NCT03501069|75666515|FG004|NOT COMPLETED|Washout Period (at Least 14 Days)||0||
59564299|NCT03501069|75666516|FG005|NOT COMPLETED|Washout Period (at Least 14 Days)||0||
59564300|NCT03501069|75666517|FG006|NOT COMPLETED|Washout Period (at Least 14 Days)||0||
59564301|NCT03501069|75666518|FG007|NOT COMPLETED|Washout Period (at Least 14 Days)||0||
59564302|NCT03501069|75666519|FG008|NOT COMPLETED|Washout Period (at Least 14 Days)||0||
59564303|NCT03501069|75666511|FG000|STARTED|Period B||2||
59564304|NCT03501069|75666512|FG001|STARTED|Period B||4||
59564305|NCT03501069|75666513|FG002|STARTED|Period B||2||
59994251|NCT01559363|76109998|FG000|NOT COMPLETED|Phase 2a: Up to 28 Months||0||
59994252|NCT01559363|76109999|FG001|NOT COMPLETED|Phase 2a: Up to 28 Months||0||
59994253|NCT01559363|76110000|FG002|NOT COMPLETED|Phase 2a: Up to 28 Months||0||
59994254|NCT01559363|76110001|FG003|NOT COMPLETED|Phase 2a: Up to 28 Months||2||
59994255|NCT01559363|76110002|FG004|NOT COMPLETED|Phase 2a: Up to 28 Months||1||
59994256|NCT01559363|76110003|FG005|NOT COMPLETED|Phase 2a: Up to 28 Months||0||
59994257|NCT02732327|76110025|FG000|STARTED|Overall Study||0||
59994258|NCT02732327|76110026|FG001|STARTED|Overall Study||2||
59564306|NCT03501069|75666514|FG003|STARTED|Period B|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0||
59994259|NCT02732327|76110025|FG000|COMPLETED|Overall Study||0||
59994260|NCT02732327|76110026|FG001|COMPLETED|Overall Study||1||
59994261|NCT02732327|76110025|FG000|NOT COMPLETED|Overall Study||0||
59994262|NCT02732327|76110026|FG001|NOT COMPLETED|Overall Study||1||
59994263|NCT03179605|76110032|FG000|STARTED|Overall Study||22||
59994264|NCT03179605|76110032|FG000|COMPLETED|Overall Study||21||
60100777|NCT01881425|76218165|FG001|COMPLETED|Overall Study||123||
60100778|NCT01881425|76218164|FG000|NOT COMPLETED|Overall Study||25||
60100779|NCT01881425|76218165|FG001|NOT COMPLETED|Overall Study||9||
60100780|NCT01064284|76218173|FG000|STARTED|Overall Study|Taking into account the analyzed patients only|125||
60100781|NCT01064284|76218174|FG001|STARTED|Overall Study|Taking into account the analyzed patients only|126||
60100782|NCT01064284|76218173|FG000|COMPLETED|Overall Study||107||
59564307|NCT03501069|75666515|FG004|STARTED|Period B|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0||
59564308|NCT03501069|75666516|FG005|STARTED|Period B|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0||
59564309|NCT03501069|75666517|FG006|STARTED|Period B|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0||
60100783|NCT01064284|76218174|FG001|COMPLETED|Overall Study||109||
60100784|NCT01064284|76218173|FG000|NOT COMPLETED|Overall Study||18||
60100785|NCT01064284|76218174|FG001|NOT COMPLETED|Overall Study||17||
60100786|NCT01891721|76218184|FG000|STARTED|Overall Study||39||
60100787|NCT01891721|76218185|FG001|STARTED|Overall Study||40||
60100788|NCT01891721|76218186|FG002|STARTED|Overall Study||20||
60100789|NCT01891721|76218184|FG000|COMPLETED|Overall Study||29||
60100790|NCT01891721|76218185|FG001|COMPLETED|Overall Study||35||
60100791|NCT01891721|76218186|FG002|COMPLETED|Overall Study||19||
60100792|NCT01891721|76218184|FG000|NOT COMPLETED|Overall Study||10||
60100793|NCT01891721|76218185|FG001|NOT COMPLETED|Overall Study||5||
60100794|NCT01891721|76218186|FG002|NOT COMPLETED|Overall Study||1||
60100795|NCT01064362|76218196|FG000|STARTED|Overall Study||1559||
60100796|NCT01064362|76218197|FG001|STARTED|Overall Study||11883||
60100797|NCT01064362|76218196|FG000|COMPLETED|Overall Study||1559||
60100798|NCT01064362|76218197|FG001|COMPLETED|Overall Study||11883||
60100799|NCT01064362|76218196|FG000|NOT COMPLETED|Overall Study||0||
60100800|NCT01064362|76218197|FG001|NOT COMPLETED|Overall Study||0||
60100801|NCT01880957|76218205|FG000|STARTED|Overall Study||47||
60100802|NCT01880957|76218206|FG001|STARTED|Overall Study||29||
60100803|NCT01880957|76218205|FG000|COMPLETED|Overall Study||19||
60100804|NCT01880957|76218206|FG001|COMPLETED|Overall Study||29||
60100805|NCT01880957|76218205|FG000|NOT COMPLETED|Overall Study||28||
60100806|NCT01880957|76218206|FG001|NOT COMPLETED|Overall Study||0||
60100807|NCT04152837|76218221|FG000|STARTED|Baseline Period (No Treatment)||7||
60100808|NCT04152837|76218221|FG000|COMPLETED|Baseline Period (No Treatment)||6||
60100809|NCT04152837|76218221|FG000|NOT COMPLETED|Baseline Period (No Treatment)||1||
60100810|NCT04152837|76218221|FG000|STARTED|Titration Period||6||
60100811|NCT04152837|76218221|FG000|COMPLETED|Titration Period||6||
60100812|NCT04152837|76218221|FG000|NOT COMPLETED|Titration Period||0||
60100813|NCT04152837|76218221|FG000|STARTED|Maintenance Period||6||
60100814|NCT04152837|76218221|FG000|COMPLETED|Maintenance Period||2||
60100815|NCT04152837|76218221|FG000|NOT COMPLETED|Maintenance Period||4||
60100816|NCT04152837|76218221|FG000|STARTED|Follow-up Period|All participants who were treated with Lixivaptan completed the Follow-up Period, including those who did not complete the Maintenance Period.|6||
60100817|NCT04152837|76218221|FG000|COMPLETED|Follow-up Period||6||
60100818|NCT04152837|76218221|FG000|NOT COMPLETED|Follow-up Period||0||
60100819|NCT01064830|76218229|FG000|STARTED|Overall Study||10||
60100820|NCT01064830|76218230|FG001|STARTED|Overall Study||11||
60100821|NCT01064830|76218229|FG000|COMPLETED|Overall Study||8||
60100822|NCT01064830|76218230|FG001|COMPLETED|Overall Study||7||
60100823|NCT01064830|76218229|FG000|NOT COMPLETED|Overall Study||2||
60100824|NCT01064830|76218230|FG001|NOT COMPLETED|Overall Study||4||
60100825|NCT01879553|76218240|FG000|STARTED|Overall Study||63||
60100826|NCT01879553|76218241|FG001|STARTED|Overall Study||63||
60100827|NCT01879553|76218240|FG000|COMPLETED|Overall Study||62||
60100828|NCT01879553|76218241|FG001|COMPLETED|Overall Study||63||
60100829|NCT01879553|76218240|FG000|NOT COMPLETED|Overall Study||1||
60100830|NCT01879553|76218241|FG001|NOT COMPLETED|Overall Study||0||
60100831|NCT01115452|76218248|FG000|STARTED|Overall Study||32||
60100832|NCT01115452|76218248|FG000|COMPLETED|Overall Study||32||
60100833|NCT01115452|76218248|FG000|NOT COMPLETED|Overall Study||0||
60100834|NCT01890785|76218262|FG000|STARTED|First Intervention||5||
60100835|NCT01890785|76218263|FG001|STARTED|First Intervention||5||
60100836|NCT01890785|76218264|FG002|STARTED|First Intervention||5||
60100837|NCT01890785|76218265|FG003|STARTED|First Intervention||5||
60100838|NCT01890785|76218266|FG004|STARTED|First Intervention||5||
60100839|NCT01890785|76218267|FG005|STARTED|First Intervention||5||
60100840|NCT01890785|76218262|FG000|COMPLETED|First Intervention||5||
60100841|NCT01890785|76218263|FG001|COMPLETED|First Intervention||5||
60100842|NCT01890785|76218264|FG002|COMPLETED|First Intervention||5||
60100843|NCT01890785|76218265|FG003|COMPLETED|First Intervention||5||
60100844|NCT01890785|76218266|FG004|COMPLETED|First Intervention||5||
59564310|NCT03501069|75666518|FG007|STARTED|Period B|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0||
59564311|NCT03501069|75666519|FG008|STARTED|Period B|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0||
59564312|NCT03501069|75666511|FG000|COMPLETED|Period B||2||
59564313|NCT03501069|75666512|FG001|COMPLETED|Period B||4||
59564314|NCT03501069|75666513|FG002|COMPLETED|Period B||2||
59564315|NCT03501069|75666514|FG003|COMPLETED|Period B||0||
59564316|NCT03501069|75666515|FG004|COMPLETED|Period B||0||
59564317|NCT03501069|75666516|FG005|COMPLETED|Period B||0||
59564318|NCT03501069|75666517|FG006|COMPLETED|Period B||0||
59564319|NCT03501069|75666518|FG007|COMPLETED|Period B||0||
59708370|NCT01255436|75827195|FG001|NOT COMPLETED|Overall Study||194||
60100845|NCT01890785|76218267|FG005|COMPLETED|First Intervention||5||
60100846|NCT01890785|76218262|FG000|NOT COMPLETED|First Intervention||0||
60100847|NCT01890785|76218263|FG001|NOT COMPLETED|First Intervention||0||
60100848|NCT01890785|76218264|FG002|NOT COMPLETED|First Intervention||0||
60100849|NCT01890785|76218265|FG003|NOT COMPLETED|First Intervention||0||
60100850|NCT01890785|76218266|FG004|NOT COMPLETED|First Intervention||0||
60100851|NCT01890785|76218267|FG005|NOT COMPLETED|First Intervention||0||
60100852|NCT01890785|76218262|FG000|STARTED|Second Intervention||5||
60100853|NCT01890785|76218263|FG001|STARTED|Second Intervention||5||
60100854|NCT01890785|76218264|FG002|STARTED|Second Intervention||5||
60100855|NCT01890785|76218265|FG003|STARTED|Second Intervention||5||
60100856|NCT01890785|76218266|FG004|STARTED|Second Intervention||5||
60100857|NCT01890785|76218267|FG005|STARTED|Second Intervention||5||
59564320|NCT03501069|75666519|FG008|COMPLETED|Period B||0||
60100858|NCT01890785|76218262|FG000|COMPLETED|Second Intervention||5||
59708371|NCT01203930|75827203|FG000|STARTED|Overall Study||64||
60100859|NCT01890785|76218263|FG001|COMPLETED|Second Intervention||5||
60100860|NCT01890785|76218264|FG002|COMPLETED|Second Intervention||5||
59564321|NCT03501069|75666511|FG000|NOT COMPLETED|Period B||0||
60100861|NCT01890785|76218265|FG003|COMPLETED|Second Intervention||5||
60100862|NCT01890785|76218266|FG004|COMPLETED|Second Intervention||5||
60100863|NCT01890785|76218267|FG005|COMPLETED|Second Intervention||5||
60100864|NCT01890785|76218262|FG000|NOT COMPLETED|Second Intervention||0||
60100865|NCT01890785|76218263|FG001|NOT COMPLETED|Second Intervention||0||
60100866|NCT01890785|76218264|FG002|NOT COMPLETED|Second Intervention||0||
59564322|NCT03501069|75666512|FG001|NOT COMPLETED|Period B||0||
59564323|NCT03501069|75666513|FG002|NOT COMPLETED|Period B||0||
59564324|NCT03501069|75666514|FG003|NOT COMPLETED|Period B||0||
59564325|NCT03501069|75666515|FG004|NOT COMPLETED|Period B||0||
59564326|NCT03501069|75666516|FG005|NOT COMPLETED|Period B||0||
59564327|NCT03501069|75666517|FG006|NOT COMPLETED|Period B||0||
60100867|NCT01890785|76218265|FG003|NOT COMPLETED|Second Intervention||0||
60100868|NCT01890785|76218266|FG004|NOT COMPLETED|Second Intervention||0||
59564328|NCT03501069|75666518|FG007|NOT COMPLETED|Period B||0||
59564329|NCT03501069|75666519|FG008|NOT COMPLETED|Period B||0||
59564330|NCT01819844|75666547|FG000|STARTED|Overall Study||12||
59564331|NCT01819844|75666547|FG000|COMPLETED|Overall Study||12||
59564332|NCT01819844|75666547|FG000|NOT COMPLETED|Overall Study||0||
59564333|NCT01819922|75666552|FG000|STARTED|First Intervention Period (1 Day)||6||
59564334|NCT01819922|75666553|FG001|STARTED|First Intervention Period (1 Day)||6||
59564335|NCT01819922|75666552|FG000|COMPLETED|First Intervention Period (1 Day)||6||
59564336|NCT01819922|75666553|FG001|COMPLETED|First Intervention Period (1 Day)||6||
59564337|NCT01819922|75666552|FG000|NOT COMPLETED|First Intervention Period (1 Day)||0||
59564338|NCT01819922|75666553|FG001|NOT COMPLETED|First Intervention Period (1 Day)||0||
59564339|NCT01819922|75666552|FG000|STARTED|Washout Period (at Least 7-10 Days)||6||
59564340|NCT01819922|75666553|FG001|STARTED|Washout Period (at Least 7-10 Days)||6||
59564341|NCT01819922|75666552|FG000|COMPLETED|Washout Period (at Least 7-10 Days)||6||
59564342|NCT01819922|75666553|FG001|COMPLETED|Washout Period (at Least 7-10 Days)||6||
59564343|NCT01819922|75666552|FG000|NOT COMPLETED|Washout Period (at Least 7-10 Days)||0||
59564344|NCT01819922|75666553|FG001|NOT COMPLETED|Washout Period (at Least 7-10 Days)||0||
59564345|NCT01819922|75666552|FG000|STARTED|Second Intervention Period (1 Day)||6||
59564346|NCT01819922|75666553|FG001|STARTED|Second Intervention Period (1 Day)||6||
59564347|NCT01819922|75666552|FG000|COMPLETED|Second Intervention Period (1 Day)||6||
59564348|NCT01819922|75666553|FG001|COMPLETED|Second Intervention Period (1 Day)||6||
59564349|NCT01819922|75666552|FG000|NOT COMPLETED|Second Intervention Period (1 Day)||0||
59564350|NCT01819922|75666553|FG001|NOT COMPLETED|Second Intervention Period (1 Day)||0||
59564351|NCT03331965|75666561|FG000|STARTED|Overall Study||55||
59564352|NCT03331965|75666562|FG001|STARTED|Overall Study||55||
60100869|NCT01890785|76218267|FG005|NOT COMPLETED|Second Intervention||0||
59564353|NCT03331965|75666561|FG000|COMPLETED|Overall Study||45||
60100870|NCT01890785|76218262|FG000|STARTED|Third Intervention||5||
60100871|NCT01890785|76218263|FG001|STARTED|Third Intervention||5||
60100872|NCT01890785|76218264|FG002|STARTED|Third Intervention||5||
59564354|NCT03331965|75666562|FG001|COMPLETED|Overall Study||51||
59564355|NCT03331965|75666561|FG000|NOT COMPLETED|Overall Study||10||
59708372|NCT01203930|75827204|FG001|STARTED|Overall Study||41||
59708373|NCT01203930|75827203|FG000|COMPLETED|Overall Study|43 participants completed 12 cycles and were then eligible to enroll in the extension study (101-99)|43||
59564356|NCT03331965|75666562|FG001|NOT COMPLETED|Overall Study||4||
59564357|NCT03332979|75666568|FG000|STARTED|Overall Study||150||
59564358|NCT03332979|75666568|FG000|COMPLETED|Overall Study||150||
60100873|NCT01890785|76218265|FG003|STARTED|Third Intervention||5||
60100874|NCT01890785|76218266|FG004|STARTED|Third Intervention||5||
60100875|NCT01890785|76218267|FG005|STARTED|Third Intervention||5||
60100876|NCT01890785|76218262|FG000|COMPLETED|Third Intervention||5||
60100877|NCT01890785|76218263|FG001|COMPLETED|Third Intervention||4||
60100878|NCT01890785|76218264|FG002|COMPLETED|Third Intervention||5||
60100879|NCT01890785|76218265|FG003|COMPLETED|Third Intervention||5||
60100880|NCT01890785|76218266|FG004|COMPLETED|Third Intervention||5||
60100881|NCT01890785|76218267|FG005|COMPLETED|Third Intervention||5||
59564359|NCT03332979|75666568|FG000|NOT COMPLETED|Overall Study||0||
59564360|NCT03278223|75666574|FG000|STARTED|Overall Study||125||
59564361|NCT03278223|75666575|FG001|STARTED|Overall Study||69||
59564362|NCT03278223|75666574|FG000|COMPLETED|Overall Study||122||
59708374|NCT01203930|75827204|FG001|COMPLETED|Overall Study||0||
59708375|NCT01203930|75827203|FG000|NOT COMPLETED|Overall Study||21||
59708376|NCT01203930|75827204|FG001|NOT COMPLETED|Overall Study||41||
59708377|NCT01254890|75827214|FG000|STARTED|Overall Study||3||
59994265|NCT03179605|76110032|FG000|NOT COMPLETED|Overall Study||1||
59994266|NCT02412722|76110042|FG000|STARTED|Overall Study||11||
59994267|NCT02412722|76110043|FG001|STARTED|Overall Study||8||
59994268|NCT02412722|76110044|FG002|STARTED|Overall Study||7||
59994269|NCT02412722|76110045|FG003|STARTED|Overall Study||15||
59994270|NCT02412722|76110046|FG004|STARTED|Overall Study||7||
59994271|NCT02412722|76110047|FG005|STARTED|Overall Study||13||
60100882|NCT01890785|76218262|FG000|NOT COMPLETED|Third Intervention||0||
60100883|NCT01890785|76218263|FG001|NOT COMPLETED|Third Intervention||1||
60100884|NCT01890785|76218264|FG002|NOT COMPLETED|Third Intervention||0||
60100885|NCT01890785|76218265|FG003|NOT COMPLETED|Third Intervention||0||
60100886|NCT01890785|76218266|FG004|NOT COMPLETED|Third Intervention||0||
60100887|NCT01890785|76218267|FG005|NOT COMPLETED|Third Intervention||0||
60100888|NCT01066624|76218279|FG000|STARTED|Overall Study||38||
60100889|NCT01066624|76218280|FG001|STARTED|Overall Study||40||
59708378|NCT01254890|75827215|FG001|STARTED|Overall Study||57||
59708379|NCT01254890|75827214|FG000|COMPLETED|Overall Study||2||
59994272|NCT02412722|76110042|FG000|Safety Population|Overall Study||11||
59564363|NCT03278223|75666575|FG001|COMPLETED|Overall Study||65||
59564364|NCT03278223|75666574|FG000|NOT COMPLETED|Overall Study||3||
59564365|NCT03278223|75666575|FG001|NOT COMPLETED|Overall Study||4||
59994273|NCT02412722|76110043|FG001|Safety Population|Overall Study||6||
60100890|NCT01066624|76218281|FG002|STARTED|Overall Study||39||
60100891|NCT01066624|76218279|FG000|COMPLETED|Overall Study||38||
60100892|NCT01066624|76218280|FG001|COMPLETED|Overall Study||40||
60100893|NCT01066624|76218281|FG002|COMPLETED|Overall Study||39||
60100894|NCT01066624|76218279|FG000|NOT COMPLETED|Overall Study||0||
60100895|NCT01066624|76218280|FG001|NOT COMPLETED|Overall Study||0||
60100896|NCT01066624|76218281|FG002|NOT COMPLETED|Overall Study||0||
60100897|NCT01878383|76218291|FG000|STARTED|Overall Study||50||
60100898|NCT01878383|76218292|FG001|STARTED|Overall Study||12500||
60100899|NCT01878383|76218291|FG000|COMPLETED|Overall Study||50||
60100900|NCT01878383|76218292|FG001|COMPLETED|Overall Study||11001||
60100901|NCT01878383|76218291|FG000|NOT COMPLETED|Overall Study||0||
60100902|NCT01878383|76218292|FG001|NOT COMPLETED|Overall Study||1499||
60100903|NCT01878149|76218300|FG000|STARTED|Overall Study||21||
60100904|NCT01878149|76218301|FG001|STARTED|Overall Study||17||
60100905|NCT01878149|76218300|FG000|COMPLETED|Overall Study||19||
60100906|NCT01878149|76218301|FG001|COMPLETED|Overall Study||15||
60100907|NCT01878149|76218300|FG000|NOT COMPLETED|Overall Study||2||
60100908|NCT01878149|76218301|FG001|NOT COMPLETED|Overall Study||2||
60100909|NCT01067716|76218310|FG000|STARTED|Overall Study|110 eyes|57||
60100910|NCT01067716|76218311|FG001|STARTED|Overall Study|25 eyes|13||
60100911|NCT01067716|76218312|FG002|STARTED|Overall Study|15 eyes|9||
60100912|NCT01067716|76218310|FG000|COMPLETED|Overall Study|110 eyes|57||
60100913|NCT01067716|76218311|FG001|COMPLETED|Overall Study|25 eyes|13||
60100914|NCT01067716|76218312|FG002|COMPLETED|Overall Study|15 eyes|9||
60100915|NCT01067716|76218310|FG000|NOT COMPLETED|Overall Study||0||
60100916|NCT01067716|76218311|FG001|NOT COMPLETED|Overall Study||0||
60100917|NCT01067716|76218312|FG002|NOT COMPLETED|Overall Study||0||
60100918|NCT01863953|76218323|FG000|STARTED|Overall Study||38||
60100919|NCT01863953|76218324|FG001|STARTED|Overall Study||36||
60100920|NCT01863953|76218325|FG002|STARTED|Overall Study||38||
60100921|NCT01863953|76218323|FG000|COMPLETED|Overall Study||38||
60100922|NCT01863953|76218324|FG001|COMPLETED|Overall Study||36||
60100923|NCT01863953|76218325|FG002|COMPLETED|Overall Study||37||
60100924|NCT01863953|76218323|FG000|NOT COMPLETED|Overall Study||0||
60100925|NCT01863953|76218324|FG001|NOT COMPLETED|Overall Study||0||
60100926|NCT01863953|76218325|FG002|NOT COMPLETED|Overall Study||1||
60100927|NCT01068964|76218335|FG000|STARTED|Overall Study||121||
60100928|NCT01068964|76218336|FG001|STARTED|Overall Study||114||
60100929|NCT01068964|76218335|FG000|COMPLETED|Overall Study||113||
60100930|NCT01068964|76218336|FG001|COMPLETED|Overall Study||104||
60100931|NCT01068964|76218335|FG000|NOT COMPLETED|Overall Study||8||
60100932|NCT01068964|76218336|FG001|NOT COMPLETED|Overall Study||10||
60100933|NCT01116466|76218342|FG000|STARTED|Overall Study||5||
60100934|NCT01116466|76218342|FG000|COMPLETED|Overall Study||5||
60100935|NCT01116466|76218342|FG000|NOT COMPLETED|Overall Study||0||
60100936|NCT01116934|76218349|FG000|STARTED|Overall Study||8||
60100937|NCT01116934|76218350|FG001|STARTED|Overall Study||9||
60100938|NCT01116934|76218349|FG000|COMPLETED|Overall Study||8||
60100939|NCT01116934|76218350|FG001|COMPLETED|Overall Study||9||
60100940|NCT01116934|76218349|FG000|NOT COMPLETED|Overall Study||0||
60100941|NCT01116934|76218350|FG001|NOT COMPLETED|Overall Study||0||
60100942|NCT01069354|76218356|FG000|STARTED|Overall Study||102||
60100943|NCT01069354|76218356|FG000|COMPLETED|Overall Study|One subject's treatment fold not injected due to adverse event during control fold injection|101||
60100944|NCT01069354|76218356|FG000|NOT COMPLETED|Overall Study||1||
60100945|NCT01069510|76218366|FG000|STARTED|Overall Study||8||
60100946|NCT01069510|76218367|FG001|STARTED|Overall Study||7||
60100947|NCT01069510|76218366|FG000|COMPLETED|Overall Study||8||
60100948|NCT01069510|76218367|FG001|COMPLETED|Overall Study||7||
60100949|NCT01069510|76218366|FG000|NOT COMPLETED|Overall Study||0||
60100950|NCT01069510|76218367|FG001|NOT COMPLETED|Overall Study||0||
60100951|NCT01117090|76218373|FG000|STARTED|Overall Study||47||
60100952|NCT01117090|76218373|FG000|COMPLETED|Overall Study||47||
60100953|NCT01117090|76218373|FG000|NOT COMPLETED|Overall Study||0||
60100954|NCT01117948|76218386|FG000|STARTED|Double Blind||111||
60100955|NCT01117948|76218387|FG001|STARTED|Double Blind||108||
60100956|NCT01117948|76218386|FG000|COMPLETED|Double Blind||93||
60100957|NCT01117948|76218387|FG001|COMPLETED|Double Blind||98||
60100958|NCT01117948|76218386|FG000|NOT COMPLETED|Double Blind||18||
60100959|NCT01117948|76218387|FG001|NOT COMPLETED|Double Blind||10||
60100960|NCT01117948|76218386|FG000|STARTED|Open Label||93||
60100961|NCT01117948|76218387|FG001|STARTED|Open Label||98||
60100962|NCT01117948|76218386|FG000|COMPLETED|Open Label||41||
60100963|NCT01117948|76218387|FG001|COMPLETED|Open Label||51||
60100964|NCT01117948|76218386|FG000|NOT COMPLETED|Open Label||52||
60100965|NCT01117948|76218387|FG001|NOT COMPLETED|Open Label||47||
60100966|NCT02445027|76218393|FG000|STARTED|Overall Study||60||
60100967|NCT02445027|76218393|FG000|COMPLETED|Overall Study||45||
60100968|NCT02445027|76218393|FG000|NOT COMPLETED|Overall Study||15||
60100969|NCT01118338|76218399|FG000|STARTED|Overall Study||185||
60100970|NCT01118338|76218400|FG001|STARTED|Overall Study||183||
60100971|NCT01118338|76218399|FG000|COMPLETED|Overall Study||182||
59564366|NCT03279237|75666581|FG000|STARTED|Overall Study||25||
59564367|NCT03279237|75666581|FG000|Chemo-radiation|Overall Study||23||
59564368|NCT03279237|75666581|FG000|Surgical Resection|Overall Study||20||
60100972|NCT01118338|76218400|FG001|COMPLETED|Overall Study||174||
59564369|NCT03279237|75666581|FG000|COMPLETED|Overall Study||20||
59564370|NCT03279237|75666581|FG000|NOT COMPLETED|Overall Study||5||
60100973|NCT01118338|76218399|FG000|NOT COMPLETED|Overall Study||3||
60100974|NCT01118338|76218400|FG001|NOT COMPLETED|Overall Study||9||
60100975|NCT01071538|76218406|FG000|STARTED|Overall Study||15||
60100976|NCT01071538|76218406|FG000|COMPLETED|Overall Study||13||
60100977|NCT01071538|76218406|FG000|NOT COMPLETED|Overall Study||2||
60100978|NCT01072006|76218414|FG000|STARTED|Overall Study||14||
59564371|NCT03282591|75666587|FG000|STARTED|Overall Study||92||
59564372|NCT03282591|75666588|FG001|STARTED|Overall Study||93||
59708380|NCT01254890|75827215|FG001|COMPLETED|Overall Study||47||
60100979|NCT01072006|76218415|FG001|STARTED|Overall Study||5||
60100980|NCT01072006|76218416|FG002|STARTED|Overall Study||0||
60100981|NCT01072006|76218417|FG003|STARTED|Overall Study||11||
60100982|NCT01072006|76218414|FG000|COMPLETED|Overall Study||14||
60100983|NCT01072006|76218415|FG001|COMPLETED|Overall Study||5||
59564373|NCT03282591|75666587|FG000|COMPLETED|Overall Study||88||
59564374|NCT03282591|75666588|FG001|COMPLETED|Overall Study||89||
60100984|NCT01072006|76218416|FG002|COMPLETED|Overall Study||0||
59564375|NCT03282591|75666587|FG000|NOT COMPLETED|Overall Study||4||
59564376|NCT03282591|75666588|FG001|NOT COMPLETED|Overall Study||4||
59564377|NCT03502941|75666598|FG000|STARTED|Overall Study||3||
59564378|NCT03502941|75666599|FG001|STARTED|Overall Study||5||
59564379|NCT03502941|75666600|FG002|STARTED|Overall Study||8||
59564380|NCT03502941|75666598|FG000|COMPLETED|Overall Study||3||
59564381|NCT03502941|75666599|FG001|COMPLETED|Overall Study||5||
59564382|NCT03502941|75666600|FG002|COMPLETED|Overall Study||8||
59564383|NCT03502941|75666598|FG000|NOT COMPLETED|Overall Study||0||
59564384|NCT03502941|75666599|FG001|NOT COMPLETED|Overall Study||0||
59564385|NCT03502941|75666600|FG002|NOT COMPLETED|Overall Study||0||
59564386|NCT03503565|75666610|FG000|STARTED|Overall Study||59||
59564387|NCT03503565|75666611|FG001|STARTED|Overall Study||58||
59564388|NCT03503565|75666610|FG000|COMPLETED|Overall Study||59||
59564389|NCT03503565|75666611|FG001|COMPLETED|Overall Study||58||
59564390|NCT03503565|75666610|FG000|NOT COMPLETED|Overall Study||0||
59564391|NCT03503565|75666611|FG001|NOT COMPLETED|Overall Study||0||
59564392|NCT03506295|75666617|FG000|STARTED|Overall Study||10||40
59564393|NCT03506295|75666617|FG000|COMPLETED|Overall Study||10||40
59564394|NCT03506295|75666617|FG000|NOT COMPLETED|Overall Study||0||0
59564395|NCT03509883|75666625|FG000|STARTED|Initial Treatment||15||
59564396|NCT03509883|75666626|FG001|STARTED|Initial Treatment||15||
60100985|NCT01072006|76218417|FG003|COMPLETED|Overall Study||11||
60100986|NCT01072006|76218414|FG000|NOT COMPLETED|Overall Study||0||
60100987|NCT01072006|76218415|FG001|NOT COMPLETED|Overall Study||0||
60100988|NCT01072006|76218416|FG002|NOT COMPLETED|Overall Study||0||
60100989|NCT01072006|76218417|FG003|NOT COMPLETED|Overall Study||0||
60100990|NCT01119040|76218428|FG000|STARTED|Overall Study||1||
60100991|NCT01119040|76218428|FG000|COMPLETED|Overall Study||0||
60100992|NCT01119040|76218428|FG000|NOT COMPLETED|Overall Study||1||
60100993|NCT02172742|76218434|FG000|STARTED|Overall Study||7||
59564397|NCT03509883|75666625|FG000|COMPLETED|Initial Treatment||15||
59564398|NCT03509883|75666626|FG001|COMPLETED|Initial Treatment||15||
59564399|NCT03509883|75666625|FG000|NOT COMPLETED|Initial Treatment||0||
59564400|NCT03509883|75666626|FG001|NOT COMPLETED|Initial Treatment||0||
59564401|NCT03509883|75666625|FG000|STARTED|Initial Treatment Washout||15||
59564402|NCT03509883|75666626|FG001|STARTED|Initial Treatment Washout||15||
59564403|NCT03509883|75666625|FG000|COMPLETED|Initial Treatment Washout||15||
59564404|NCT03509883|75666626|FG001|COMPLETED|Initial Treatment Washout||15||
59564405|NCT03509883|75666625|FG000|NOT COMPLETED|Initial Treatment Washout||0||
59564406|NCT03509883|75666626|FG001|NOT COMPLETED|Initial Treatment Washout||0||
59564407|NCT03509883|75666625|FG000|STARTED|Cross-over and Treatment||15||
59564408|NCT03509883|75666626|FG001|STARTED|Cross-over and Treatment||15||
59564409|NCT03509883|75666625|FG000|COMPLETED|Cross-over and Treatment||15||
59564410|NCT03509883|75666626|FG001|COMPLETED|Cross-over and Treatment||15||
59564411|NCT03509883|75666625|FG000|NOT COMPLETED|Cross-over and Treatment||0||
59564412|NCT03509883|75666626|FG001|NOT COMPLETED|Cross-over and Treatment||0||
59564413|NCT03336645|75666633|FG000|STARTED|Overall Study||25||
59564414|NCT03336645|75666633|FG000|COMPLETED|Overall Study||25||
59564415|NCT03336645|75666633|FG000|NOT COMPLETED|Overall Study||0||
60100994|NCT02172742|76218435|FG001|STARTED|Overall Study||6||
60100995|NCT02172742|76218434|FG000|COMPLETED|Overall Study||6||
59564416|NCT03510195|75666637|FG000|STARTED|Overall Study||267||
59564417|NCT03510195|75666637|FG000|COMPLETED|Overall Study||101||
60100996|NCT02172742|76218435|FG001|COMPLETED|Overall Study||6||
59564418|NCT03510195|75666637|FG000|NOT COMPLETED|Overall Study||166||
60100997|NCT02172742|76218434|FG000|NOT COMPLETED|Overall Study||1||
60100998|NCT02172742|76218435|FG001|NOT COMPLETED|Overall Study||0||
60100999|NCT02172820|76218442|FG000|STARTED|Overall Study||65||
60101000|NCT02172820|76218443|FG001|STARTED|Overall Study||65||
60101001|NCT02172820|76218442|FG000|COMPLETED|Overall Study||65||
60101002|NCT02172820|76218443|FG001|COMPLETED|Overall Study||65||
60101003|NCT02172820|76218442|FG000|NOT COMPLETED|Overall Study||0||
60101004|NCT02172820|76218443|FG001|NOT COMPLETED|Overall Study||0||
60101005|NCT01074034|76218449|FG000|STARTED|Overall Study||211||
60101006|NCT01074034|76218449|FG000|COMPLETED|Overall Study||205||
60101007|NCT01074034|76218449|FG000|NOT COMPLETED|Overall Study||6||
60101008|NCT02173522|76218456|FG000|STARTED|Overall Study||4||
59564419|NCT03511521|75666653|FG000|STARTED|Overall Study||2||
59564420|NCT03511521|75666654|FG001|STARTED|Overall Study||1||
59564421|NCT03511521|75666653|FG000|COMPLETED|Overall Study||2||
59564422|NCT03511521|75666654|FG001|COMPLETED|Overall Study||1||
60101009|NCT02173522|76218457|FG001|STARTED|Overall Study||0||
60101010|NCT02173522|76218456|FG000|COMPLETED|Overall Study||4||
59564423|NCT03511521|75666653|FG000|NOT COMPLETED|Overall Study||0||
59708381|NCT01254890|75827214|FG000|NOT COMPLETED|Overall Study||1||
59564424|NCT03511521|75666654|FG001|NOT COMPLETED|Overall Study||0||
59708382|NCT01254890|75827215|FG001|NOT COMPLETED|Overall Study||10||
60101011|NCT02173522|76218457|FG001|COMPLETED|Overall Study||0||
60101012|NCT02173522|76218456|FG000|NOT COMPLETED|Overall Study||0||
60101013|NCT02173522|76218457|FG001|NOT COMPLETED|Overall Study||0||
60101014|NCT01075204|76218461|FG000|STARTED|Overall Study||335||
60101015|NCT01075204|76218461|FG000|COMPLETED|Overall Study||335||
59564425|NCT03512067|75666660|FG000|STARTED|Overall Study||1||
59564426|NCT03512067|75666660|FG000|COMPLETED|Overall Study||1||
59564427|NCT03512067|75666660|FG000|NOT COMPLETED|Overall Study||0||
59564428|NCT03512457|75666666|FG000|STARTED|Overall Study||195||
59564429|NCT03512457|75666667|FG001|STARTED|Overall Study||225||
59564430|NCT03512457|75666666|FG000|COMPLETED|Overall Study||161||
59564431|NCT03512457|75666667|FG001|COMPLETED|Overall Study||185||
59564432|NCT03512457|75666666|FG000|NOT COMPLETED|Overall Study||34||
59564433|NCT03512457|75666667|FG001|NOT COMPLETED|Overall Study||40||
59564434|NCT03519243|75666678|FG000|STARTED|Overall Study||25||
59564435|NCT03519243|75666679|FG001|STARTED|Overall Study||25||
59564436|NCT03519243|75666680|FG002|STARTED|Overall Study|The dose level was not studied due to the dose level l.7 µg/kg demonstrated the sufficient PD effect|0||
59564437|NCT03519243|75666681|FG003|STARTED|Overall Study||25||
59564438|NCT03519243|75666678|FG000|COMPLETED|Overall Study||20||
59564439|NCT03519243|75666679|FG001|COMPLETED|Overall Study||21||
59564440|NCT03519243|75666680|FG002|COMPLETED|Overall Study||0||
59564441|NCT03519243|75666681|FG003|COMPLETED|Overall Study||24||
60101016|NCT01075204|76218461|FG000|NOT COMPLETED|Overall Study||0||
60101017|NCT01120834|76218465|FG000|STARTED|Overall Study||18||
60101018|NCT01120834|76218465|FG000|COMPLETED|Overall Study||18||
60101019|NCT01120834|76218465|FG000|NOT COMPLETED|Overall Study||0||
60101020|NCT01120990|76218469|FG000|STARTED|Overall Study||51||
60101021|NCT01120990|76218469|FG000|COMPLETED|Overall Study||51||
60101022|NCT01120990|76218469|FG000|NOT COMPLETED|Overall Study||0||
60101023|NCT01122160|76218473|FG000|STARTED|First Intervention (7 Days)||6||
60101024|NCT01122160|76218474|FG001|STARTED|First Intervention (7 Days)||5||
60101025|NCT01122160|76218473|FG000|COMPLETED|First Intervention (7 Days)||6||
60101026|NCT01122160|76218474|FG001|COMPLETED|First Intervention (7 Days)||5||
60101027|NCT01122160|76218473|FG000|NOT COMPLETED|First Intervention (7 Days)||0||
60101028|NCT01122160|76218474|FG001|NOT COMPLETED|First Intervention (7 Days)||0||
59564442|NCT03519243|75666678|FG000|NOT COMPLETED|Overall Study||5||
59564443|NCT03519243|75666679|FG001|NOT COMPLETED|Overall Study||4||
59564444|NCT03519243|75666680|FG002|NOT COMPLETED|Overall Study||0||
59564445|NCT03519243|75666681|FG003|NOT COMPLETED|Overall Study||1||
59564446|NCT03577275|75666689|FG000|STARTED|Overall Study|All participants received all of the 4 interventions|32||
60101029|NCT01122160|76218473|FG000|STARTED|Washout (7-14 Days)||6||
60101030|NCT01122160|76218474|FG001|STARTED|Washout (7-14 Days)||5||
60101031|NCT01122160|76218473|FG000|COMPLETED|Washout (7-14 Days)||6||
60101032|NCT01122160|76218474|FG001|COMPLETED|Washout (7-14 Days)||5||
60101033|NCT01122160|76218473|FG000|NOT COMPLETED|Washout (7-14 Days)||0||
60101034|NCT01122160|76218474|FG001|NOT COMPLETED|Washout (7-14 Days)||0||
59564447|NCT03577275|75666689|FG000|Placebo|Overall Study||32||
59564448|NCT03577275|75666689|FG000|Moxifloxacin 400mg|Overall Study||32||
59564449|NCT03577275|75666689|FG000|NST-4016 600mg|Overall Study||32||
59564450|NCT03577275|75666689|FG000|NST-4016 2000mg|Overall Study||32||
59564451|NCT03577275|75666689|FG000|COMPLETED|Overall Study||32||
60101035|NCT01122160|76218473|FG000|STARTED|Second Intervention (7 Days)||6||
60101036|NCT01122160|76218474|FG001|STARTED|Second Intervention (7 Days)||5||
60101037|NCT01122160|76218473|FG000|COMPLETED|Second Intervention (7 Days)||6||
60101038|NCT01122160|76218474|FG001|COMPLETED|Second Intervention (7 Days)||5||
60101039|NCT01122160|76218473|FG000|NOT COMPLETED|Second Intervention (7 Days)||0||
60101040|NCT01122160|76218474|FG001|NOT COMPLETED|Second Intervention (7 Days)||0||
60101041|NCT02623816|76218482|FG000|STARTED|Overall Study||40||
60101042|NCT02623816|76218483|FG001|STARTED|Overall Study||24||
60101043|NCT02623816|76218482|FG000|COMPLETED|Overall Study|Two subjects discontinued participation.|38||
60101044|NCT02623816|76218483|FG001|COMPLETED|Overall Study||22||
60101045|NCT02623816|76218482|FG000|NOT COMPLETED|Overall Study||2||
60101046|NCT02623816|76218483|FG001|NOT COMPLETED|Overall Study||2||
60101047|NCT02180230|76218489|FG000|STARTED|Overall Study||38||
60101048|NCT02180230|76218489|FG000|COMPLETED|Overall Study||31||
60101049|NCT02180230|76218489|FG000|NOT COMPLETED|Overall Study||7||
60101050|NCT01122238|76218509|FG000|STARTED|Overall Study||30||
60101051|NCT01122238|76218510|FG001|STARTED|Overall Study||37||
60101052|NCT01122238|76218511|FG002|STARTED|Overall Study||33||
60101053|NCT01122238|76218512|FG003|STARTED|Overall Study||33||
60101054|NCT01122238|76218513|FG004|STARTED|Overall Study||33||
60101055|NCT01122238|76218514|FG005|STARTED|Overall Study||32||
59564452|NCT03577275|75666689|FG000|NOT COMPLETED|Overall Study||0||
59564453|NCT03581097|75666705|FG000|STARTED|Overall Study||46||
59564454|NCT03581097|75666706|FG001|STARTED|Overall Study||47||
59564455|NCT03581097|75666705|FG000|COMPLETED|Overall Study||46||
59564456|NCT03581097|75666706|FG001|COMPLETED|Overall Study||47||
59564457|NCT03581097|75666705|FG000|NOT COMPLETED|Overall Study||0||
60101056|NCT01122238|76218515|FG006|STARTED|Overall Study||35||
60101057|NCT01122238|76218516|FG007|STARTED|Overall Study||32||
60101058|NCT01122238|76218517|FG008|STARTED|Overall Study||32||
60101059|NCT01122238|76218518|FG009|STARTED|Overall Study||34||
60101060|NCT01122238|76218519|FG010|STARTED|Overall Study||32||
60101061|NCT01122238|76218520|FG011|STARTED|Overall Study||33||
60101062|NCT01122238|76218521|FG012|STARTED|Overall Study||30||
60101063|NCT01122238|76218522|FG013|STARTED|Overall Study||32||
60101064|NCT01122238|76218523|FG014|STARTED|Overall Study||28||
60101065|NCT01122238|76218524|FG015|STARTED|Overall Study||31||
60101066|NCT01122238|76218509|FG000|COMPLETED|Overall Study||28||
60101067|NCT01122238|76218510|FG001|COMPLETED|Overall Study||36||
60101068|NCT01122238|76218511|FG002|COMPLETED|Overall Study||28||
60101069|NCT01122238|76218512|FG003|COMPLETED|Overall Study||33||
60101070|NCT01122238|76218513|FG004|COMPLETED|Overall Study||33||
60101071|NCT01122238|76218514|FG005|COMPLETED|Overall Study||31||
60101072|NCT01122238|76218515|FG006|COMPLETED|Overall Study||34||
60101073|NCT01122238|76218516|FG007|COMPLETED|Overall Study||32||
60101074|NCT01122238|76218517|FG008|COMPLETED|Overall Study||31||
60101075|NCT01122238|76218518|FG009|COMPLETED|Overall Study||33||
60101076|NCT01122238|76218519|FG010|COMPLETED|Overall Study||32||
60101077|NCT01122238|76218520|FG011|COMPLETED|Overall Study||31||
60101078|NCT01122238|76218521|FG012|COMPLETED|Overall Study||28||
60101079|NCT01122238|76218522|FG013|COMPLETED|Overall Study||31||
60101080|NCT01122238|76218523|FG014|COMPLETED|Overall Study||28||
60101081|NCT01122238|76218524|FG015|COMPLETED|Overall Study||31||
60101082|NCT01122238|76218509|FG000|NOT COMPLETED|Overall Study||2||
60101083|NCT01122238|76218510|FG001|NOT COMPLETED|Overall Study||1||
60101084|NCT01122238|76218511|FG002|NOT COMPLETED|Overall Study||5||
60101085|NCT01122238|76218512|FG003|NOT COMPLETED|Overall Study||0||
60101086|NCT01122238|76218513|FG004|NOT COMPLETED|Overall Study||0||
60101087|NCT01122238|76218514|FG005|NOT COMPLETED|Overall Study||1||
60101088|NCT01122238|76218515|FG006|NOT COMPLETED|Overall Study||1||
60101089|NCT01122238|76218516|FG007|NOT COMPLETED|Overall Study||0||
60101090|NCT01122238|76218517|FG008|NOT COMPLETED|Overall Study||1||
60101091|NCT01122238|76218518|FG009|NOT COMPLETED|Overall Study||1||
60101092|NCT01122238|76218519|FG010|NOT COMPLETED|Overall Study||0||
60101093|NCT01122238|76218520|FG011|NOT COMPLETED|Overall Study||2||
60101094|NCT01122238|76218521|FG012|NOT COMPLETED|Overall Study||2||
60101095|NCT01122238|76218522|FG013|NOT COMPLETED|Overall Study||1||
60101096|NCT01122238|76218523|FG014|NOT COMPLETED|Overall Study||0||
60101097|NCT01122238|76218524|FG015|NOT COMPLETED|Overall Study||0||
60101098|NCT01122316|76218538|FG000|STARTED|Overall Study||10||
60101099|NCT01122316|76218538|FG000|COMPLETED|Overall Study||8||
60101100|NCT01122316|76218538|FG000|NOT COMPLETED|Overall Study||2||
60101101|NCT01076296|76218542|FG000|STARTED|Overall Study||54||
60101102|NCT01076296|76218543|FG001|STARTED|Overall Study||196||
60101103|NCT01076296|76218544|FG002|STARTED|Overall Study||51||
60101104|NCT01076296|76218545|FG003|STARTED|Overall Study||199||
60101105|NCT01076296|76218546|FG004|STARTED|Overall Study||59||
60101106|NCT01076296|76218547|FG005|STARTED|Overall Study||191||
60101107|NCT01076296|76218548|FG006|STARTED|Overall Study||51||
60101108|NCT01076296|76218549|FG007|STARTED|Overall Study||199||
60101109|NCT01076296|76218542|FG000|COMPLETED|Overall Study||54||
60101110|NCT01076296|76218543|FG001|COMPLETED|Overall Study||196||
60101111|NCT01076296|76218544|FG002|COMPLETED|Overall Study||51||
60101112|NCT01076296|76218545|FG003|COMPLETED|Overall Study||199||
60101113|NCT01076296|76218546|FG004|COMPLETED|Overall Study||59||
60101114|NCT01076296|76218547|FG005|COMPLETED|Overall Study||191||
60101115|NCT01076296|76218548|FG006|COMPLETED|Overall Study||51||
60101116|NCT01076296|76218549|FG007|COMPLETED|Overall Study||199||
60101117|NCT01076296|76218542|FG000|NOT COMPLETED|Overall Study||0||
60101118|NCT01076296|76218543|FG001|NOT COMPLETED|Overall Study||0||
60101119|NCT01076296|76218544|FG002|NOT COMPLETED|Overall Study||0||
60101120|NCT01076296|76218545|FG003|NOT COMPLETED|Overall Study||0||
60101121|NCT01076296|76218546|FG004|NOT COMPLETED|Overall Study||0||
60101122|NCT01076296|76218547|FG005|NOT COMPLETED|Overall Study||0||
60101123|NCT01076296|76218548|FG006|NOT COMPLETED|Overall Study||0||
60101124|NCT01076296|76218549|FG007|NOT COMPLETED|Overall Study||0||
60101125|NCT01076452|76218569|FG000|STARTED|Overall Study||147||
60101126|NCT01076452|76218570|FG001|STARTED|Overall Study||152||
60101127|NCT01076452|76218569|FG000|COMPLETED|Overall Study||123||
60101128|NCT01076452|76218570|FG001|COMPLETED|Overall Study||138||
60101129|NCT01076452|76218569|FG000|NOT COMPLETED|Overall Study||24||
60101130|NCT01076452|76218570|FG001|NOT COMPLETED|Overall Study||14||
60101131|NCT01076686|76218580|FG000|STARTED|Overall Study||17||
60101132|NCT01076686|76218581|FG001|STARTED|Overall Study||14||
60101133|NCT01076686|76218582|FG002|STARTED|Overall Study||32||
60101134|NCT01076686|76218583|FG003|STARTED|Overall Study||31||
60101135|NCT01076686|76218580|FG000|COMPLETED|Overall Study||17||
60101136|NCT01076686|76218581|FG001|COMPLETED|Overall Study||14||
60101137|NCT01076686|76218582|FG002|COMPLETED|Overall Study||32||
60101138|NCT01076686|76218583|FG003|COMPLETED|Overall Study||31||
60101139|NCT01076686|76218580|FG000|NOT COMPLETED|Overall Study||0||
60101140|NCT01076686|76218581|FG001|NOT COMPLETED|Overall Study||0||
60101141|NCT01076686|76218582|FG002|NOT COMPLETED|Overall Study||0||
60101142|NCT01076686|76218583|FG003|NOT COMPLETED|Overall Study||0||
60101143|NCT03049449|76218601|FG000|STARTED|Overall Study||0||
60101144|NCT03049449|76218602|FG001|STARTED|Overall Study||3||
60101145|NCT03049449|76218603|FG002|STARTED|Overall Study|One participant was enrolled and removed from study with no treatment and was later re-enrolled and treated.|4||
60101146|NCT03049449|76218604|FG003|STARTED|Overall Study|One participant was enrolled and removed from study with no treatment and was later re-enrolled and treated.|8||
60101147|NCT03049449|76218605|FG004|STARTED|Overall Study||5||
60101148|NCT03049449|76218606|FG005|STARTED|Overall Study||0||
60101149|NCT03049449|76218607|FG006|STARTED|Overall Study||3||
60101150|NCT03049449|76218608|FG007|STARTED|Overall Study||1||
60101151|NCT03049449|76218609|FG008|STARTED|Overall Study||1||
60101152|NCT03049449|76218610|FG009|STARTED|Overall Study||1||
60101153|NCT03049449|76218601|FG000|COMPLETED|Overall Study||0||
60101154|NCT03049449|76218602|FG001|COMPLETED|Overall Study||3||
60101155|NCT03049449|76218603|FG002|COMPLETED|Overall Study||3||
60101156|NCT03049449|76218604|FG003|COMPLETED|Overall Study||7||
60101157|NCT03049449|76218605|FG004|COMPLETED|Overall Study||5||
60101158|NCT03049449|76218606|FG005|COMPLETED|Overall Study||0||
60101159|NCT03049449|76218607|FG006|COMPLETED|Overall Study||3||
60101160|NCT03049449|76218608|FG007|COMPLETED|Overall Study||0||
60101161|NCT03049449|76218609|FG008|COMPLETED|Overall Study||0||
60101162|NCT03049449|76218610|FG009|COMPLETED|Overall Study||0||
60101163|NCT03049449|76218601|FG000|NOT COMPLETED|Overall Study||0||
60101164|NCT03049449|76218602|FG001|NOT COMPLETED|Overall Study||0||
60101165|NCT03049449|76218603|FG002|NOT COMPLETED|Overall Study||1||
60101166|NCT03049449|76218604|FG003|NOT COMPLETED|Overall Study||1||
60101167|NCT03049449|76218605|FG004|NOT COMPLETED|Overall Study||0||
60101168|NCT03049449|76218606|FG005|NOT COMPLETED|Overall Study||0||
60101169|NCT03049449|76218607|FG006|NOT COMPLETED|Overall Study||0||
60101170|NCT03049449|76218608|FG007|NOT COMPLETED|Overall Study||1||
60101171|NCT03049449|76218609|FG008|NOT COMPLETED|Overall Study||1||
60101172|NCT03049449|76218610|FG009|NOT COMPLETED|Overall Study||1||
60101173|NCT02176408|76218630|FG000|STARTED|Overall Study||15||
60101174|NCT02176408|76218631|FG001|STARTED|Overall Study||16||
60101175|NCT02176408|76218630|FG000|COMPLETED|Overall Study||9||
60101176|NCT02176408|76218631|FG001|COMPLETED|Overall Study||12||
60101177|NCT02176408|76218630|FG000|NOT COMPLETED|Overall Study||6||
60101178|NCT02176408|76218631|FG001|NOT COMPLETED|Overall Study||4||
60101179|NCT02176486|76218640|FG000|STARTED|Overall Study||3||
60101180|NCT02176486|76218641|FG001|STARTED|Overall Study||5||
60101181|NCT02176486|76218642|FG002|STARTED|Overall Study||4||
60101182|NCT02176486|76218640|FG000|COMPLETED|Overall Study||3||
60101183|NCT02176486|76218641|FG001|COMPLETED|Overall Study||5||
60101184|NCT02176486|76218642|FG002|COMPLETED|Overall Study||4||
60101185|NCT02176486|76218640|FG000|NOT COMPLETED|Overall Study||0||
60101186|NCT02176486|76218641|FG001|NOT COMPLETED|Overall Study||0||
60101187|NCT02176486|76218642|FG002|NOT COMPLETED|Overall Study||0||
60101188|NCT01124188|76218654|FG000|STARTED|Overall Study||68||
60101189|NCT01124188|76218655|FG001|STARTED|Overall Study||71||
60101190|NCT01124188|76218654|FG000|COMPLETED|Overall Study||60||
60101191|NCT01124188|76218655|FG001|COMPLETED|Overall Study||65||
60101192|NCT01124188|76218654|FG000|NOT COMPLETED|Overall Study||8||
60101193|NCT01124188|76218655|FG001|NOT COMPLETED|Overall Study||6||
60101194|NCT02220478|76218663|FG000|STARTED|Overall Study||14||
60101195|NCT02220478|76218664|FG001|STARTED|Overall Study||10||
60101196|NCT02220478|76218663|FG000|COMPLETED|Overall Study||11||
60101197|NCT02220478|76218664|FG001|COMPLETED|Overall Study||9||
60101198|NCT02220478|76218663|FG000|NOT COMPLETED|Overall Study||3||
60101199|NCT02220478|76218664|FG001|NOT COMPLETED|Overall Study||1||
60101200|NCT01125202|76218672|FG000|STARTED|Overall Study||93||
60101201|NCT01125202|76218673|FG001|STARTED|Overall Study||86||
60101202|NCT01125202|76218672|FG000|COMPLETED|Overall Study||81||
60101203|NCT01125202|76218673|FG001|COMPLETED|Overall Study||79||
60101204|NCT01125202|76218672|FG000|NOT COMPLETED|Overall Study||12||
60101205|NCT01125202|76218673|FG001|NOT COMPLETED|Overall Study||7||
60101206|NCT01077310|76218681|FG000|STARTED|Overall Study||67||
60101207|NCT01077310|76218682|FG001|STARTED|Overall Study||33||
60101208|NCT01077310|76218681|FG000|COMPLETED|Overall Study||67||
60101209|NCT01077310|76218682|FG001|COMPLETED|Overall Study||33||
60101210|NCT01077310|76218681|FG000|NOT COMPLETED|Overall Study||0||
60101211|NCT01077310|76218682|FG001|NOT COMPLETED|Overall Study||0||
60101212|NCT01078246|76218700|FG000|STARTED|Overall Study||1041||
60101213|NCT01078246|76218701|FG001|STARTED|Overall Study||405||
60101214|NCT01078246|76218702|FG002|STARTED|Overall Study||1963||
60101215|NCT01078246|76218703|FG003|STARTED|Overall Study||152||
60101216|NCT01078246|76218704|FG004|STARTED|Overall Study||3310||
60101217|NCT01078246|76218705|FG005|STARTED|Overall Study||231||
60101218|NCT01078246|76218706|FG006|STARTED|Overall Study||22||
60101219|NCT01078246|76218700|FG000|COMPLETED|Overall Study||1041||
60101220|NCT01078246|76218701|FG001|COMPLETED|Overall Study||405||
60101221|NCT01078246|76218702|FG002|COMPLETED|Overall Study||1963||
60101222|NCT01078246|76218703|FG003|COMPLETED|Overall Study||152||
60101223|NCT01078246|76218704|FG004|COMPLETED|Overall Study||3310||
60101224|NCT01078246|76218705|FG005|COMPLETED|Overall Study||231||
60101225|NCT01078246|76218706|FG006|COMPLETED|Overall Study||22||
60101226|NCT01078246|76218700|FG000|NOT COMPLETED|Overall Study||0||
60101227|NCT01078246|76218701|FG001|NOT COMPLETED|Overall Study||0||
60101228|NCT01078246|76218702|FG002|NOT COMPLETED|Overall Study||0||
60101229|NCT01078246|76218703|FG003|NOT COMPLETED|Overall Study||0||
60101230|NCT01078246|76218704|FG004|NOT COMPLETED|Overall Study||0||
60101231|NCT01078246|76218705|FG005|NOT COMPLETED|Overall Study||0||
60101232|NCT01078246|76218706|FG006|NOT COMPLETED|Overall Study||0||
60101233|NCT01078402|76218717|FG000|STARTED|Overall Study||431||
60101234|NCT01078402|76218718|FG001|STARTED|Overall Study||124||
60101235|NCT01078402|76218719|FG002|STARTED|Overall Study||234||
60101236|NCT01078402|76218717|FG000|COMPLETED|Overall Study||324||
60101237|NCT01078402|76218718|FG001|COMPLETED|Overall Study||95||
60101238|NCT01078402|76218719|FG002|COMPLETED|Overall Study||166||
60101239|NCT01078402|76218717|FG000|NOT COMPLETED|Overall Study||107||
60101240|NCT01078402|76218718|FG001|NOT COMPLETED|Overall Study||29||
60101241|NCT01078402|76218719|FG002|NOT COMPLETED|Overall Study||68||
60101242|NCT02989857|76218733|FG000|STARTED|Randomization Phase||126||
60101243|NCT02989857|76218734|FG001|STARTED|Randomization Phase||61||
60101244|NCT02989857|76218735|FG002|STARTED|Randomization Phase||0||
60101245|NCT02989857|76218733|FG000|COMPLETED|Randomization Phase|Completed = Participants who completed the protocol defined treatment.|123||
60101246|NCT02989857|76218734|FG001|COMPLETED|Randomization Phase|Completed = Participants who completed the protocol defined treatment.|59||
60101247|NCT02989857|76218735|FG002|COMPLETED|Randomization Phase||0||
60101248|NCT02989857|76218733|FG000|NOT COMPLETED|Randomization Phase||3||
60101249|NCT02989857|76218734|FG001|NOT COMPLETED|Randomization Phase||2||
59817027|NCT01358877|75939449|FG000|Received Study Drug (Safety Population)|Overall Study|24 placebo participants received at least 1 dose of pertuzumab and were included in pertuzumab arm.|2364||
59817028|NCT01358877|75939450|FG001|Received Study Drug (Safety Population)|Overall Study|38 pertuzumab participants did not receive pertuzumab and were included in placebo arm.|2405||
59817029|NCT01358877|75939449|FG000|COMPLETED|Overall Study||0||
60101250|NCT02989857|76218735|FG002|NOT COMPLETED|Randomization Phase||0||
60101251|NCT02989857|76218733|FG000|STARTED|Cross Over Phase||0||
60101252|NCT02989857|76218734|FG001|STARTED|Cross Over Phase||0||
60101253|NCT02989857|76218735|FG002|STARTED|Cross Over Phase|Participants who had experienced disease progression and received placebo were allowed to cross over to receive AG-120.|43||
60101254|NCT02989857|76218733|FG000|COMPLETED|Cross Over Phase||0||
60101255|NCT02989857|76218734|FG001|COMPLETED|Cross Over Phase||0||
60101256|NCT02989857|76218735|FG002|COMPLETED|Cross Over Phase|Completed = Participants who completed the protocol defined treatment.|43||
60101257|NCT02989857|76218733|FG000|NOT COMPLETED|Cross Over Phase||0||
60101258|NCT02989857|76218734|FG001|NOT COMPLETED|Cross Over Phase||0||
60101259|NCT02989857|76218735|FG002|NOT COMPLETED|Cross Over Phase||0||
60101260|NCT01877915|76218746|FG000|STARTED|Overall Study||2507||
60101261|NCT01877915|76218747|FG001|STARTED|Overall Study||2515||
60101262|NCT01877915|76218746|FG000|COMPLETED|Overall Study||2453||
60101263|NCT01877915|76218747|FG001|COMPLETED|Overall Study||2447||
60101264|NCT01877915|76218746|FG000|NOT COMPLETED|Overall Study||54||
60101265|NCT01877915|76218747|FG001|NOT COMPLETED|Overall Study||68||
60101266|NCT01876979|76218755|FG000|STARTED|Overall Study||2||
60101267|NCT01876979|76218756|FG001|STARTED|Overall Study||3||
60101268|NCT01876979|76218755|FG000|COMPLETED|Overall Study||0||
60101269|NCT01876979|76218756|FG001|COMPLETED|Overall Study||0||
60101270|NCT01876979|76218755|FG000|NOT COMPLETED|Overall Study||2||
60101271|NCT01876979|76218756|FG001|NOT COMPLETED|Overall Study||3||
60101272|NCT01860989|76218762|FG000|STARTED|Overall Study||11||
60101273|NCT01860989|76218762|FG000|COMPLETED|Overall Study||6||
60101274|NCT01860989|76218762|FG000|NOT COMPLETED|Overall Study||5||
60101275|NCT02906241|76218769|FG000|STARTED|Overall Study||25||
60101276|NCT02906241|76218770|FG001|STARTED|Overall Study||29||
60101277|NCT02906241|76218771|FG002|STARTED|Overall Study||27||
60101278|NCT02906241|76218772|FG003|STARTED|Overall Study|Total number of patients 289 minus the number qualified for randomization (54)|235||
60101279|NCT02906241|76218769|FG000|COMPLETED|Overall Study||25||
60101280|NCT02906241|76218770|FG001|COMPLETED|Overall Study||29||
60101281|NCT02906241|76218771|FG002|COMPLETED|Overall Study||19||
60101282|NCT02906241|76218772|FG003|COMPLETED|Overall Study||235||
60101283|NCT02906241|76218769|FG000|NOT COMPLETED|Overall Study||0||
59817030|NCT01358877|75939450|FG001|COMPLETED|Overall Study||0||
60101284|NCT02906241|76218770|FG001|NOT COMPLETED|Overall Study||0||
60101285|NCT02906241|76218771|FG002|NOT COMPLETED|Overall Study||8||
60101286|NCT02906241|76218772|FG003|NOT COMPLETED|Overall Study||0||
60101287|NCT01860677|76218778|FG000|STARTED|First Intervention (1 Day)||8||
60101288|NCT01860677|76218779|FG001|STARTED|First Intervention (1 Day)||0||
60101289|NCT01860677|76218778|FG000|COMPLETED|First Intervention (1 Day)||8||
60101290|NCT01860677|76218779|FG001|COMPLETED|First Intervention (1 Day)||0||
60101291|NCT01860677|76218778|FG000|NOT COMPLETED|First Intervention (1 Day)||0||
60101292|NCT01860677|76218779|FG001|NOT COMPLETED|First Intervention (1 Day)||0||
60101293|NCT01860677|76218778|FG000|STARTED|Second Intervention (1 Day)||8||
60101294|NCT01860677|76218779|FG001|STARTED|Second Intervention (1 Day)||0||
60101295|NCT01860677|76218778|FG000|COMPLETED|Second Intervention (1 Day)||1||
60101296|NCT01860677|76218779|FG001|COMPLETED|Second Intervention (1 Day)||0||
60101297|NCT01860677|76218778|FG000|NOT COMPLETED|Second Intervention (1 Day)||7||
60101298|NCT01860677|76218779|FG001|NOT COMPLETED|Second Intervention (1 Day)||0||
60101299|NCT02843529|76218788|FG000|STARTED|Overall Study||244||
60101300|NCT02843529|76218789|FG001|STARTED|Overall Study||304||
60101301|NCT02843529|76218788|FG000|COMPLETED|Overall Study||213||
60101302|NCT02843529|76218789|FG001|COMPLETED|Overall Study||283||
60101303|NCT02843529|76218788|FG000|NOT COMPLETED|Overall Study||31||
60101304|NCT02843529|76218789|FG001|NOT COMPLETED|Overall Study||21||
60101305|NCT01876901|76218797|FG000|STARTED|Overall Study||65||
60101306|NCT01876901|76218798|FG001|STARTED|Overall Study||59||
60101307|NCT01876901|76218797|FG000|COMPLETED|Overall Study||48||
60101308|NCT01876901|76218798|FG001|COMPLETED|Overall Study||52||
60101309|NCT01876901|76218797|FG000|NOT COMPLETED|Overall Study||17||
60101310|NCT01876901|76218798|FG001|NOT COMPLETED|Overall Study||7||
60101311|NCT01876823|76218805|FG000|STARTED|Overall Study||35||
60101312|NCT01876823|76218805|FG000|COMPLETED|Overall Study||26||
60101313|NCT01876823|76218805|FG000|NOT COMPLETED|Overall Study||9||
60101314|NCT01876511|76218812|FG000|STARTED|Overall Study||41||
60101315|NCT01876511|76218813|FG001|STARTED|Overall Study||25||
60101316|NCT01876511|76218814|FG002|STARTED|Overall Study||47||
60101317|NCT01876511|76218812|FG000|Stages 1 and 2|Overall Study||24||
60101318|NCT01876511|76218813|FG001|Stages 1 and 2|Overall Study||25||
60101319|NCT01876511|76218814|FG002|Stages 1 and 2|Overall Study||21||
60101320|NCT01876511|76218812|FG000|COMPLETED|Overall Study||18||
60101321|NCT01876511|76218813|FG001|COMPLETED|Overall Study||0||
60101322|NCT01876511|76218814|FG002|COMPLETED|Overall Study||16||
60101323|NCT01876511|76218812|FG000|NOT COMPLETED|Overall Study||23||
60101324|NCT01876511|76218813|FG001|NOT COMPLETED|Overall Study||25||
60101325|NCT01876511|76218814|FG002|NOT COMPLETED|Overall Study||31||
60101326|NCT01993719|76218829|FG000|STARTED|First Drug Administration||8||
60101327|NCT01993719|76218830|FG001|STARTED|First Drug Administration||11||
60101328|NCT01993719|76218831|FG002|STARTED|First Drug Administration||3||
60101329|NCT01993719|76218832|FG003|STARTED|First Drug Administration||9||
60101330|NCT01993719|76218833|FG004|STARTED|First Drug Administration||2||
60101331|NCT01993719|76218829|FG000|COMPLETED|First Drug Administration||7||
60101332|NCT01993719|76218830|FG001|COMPLETED|First Drug Administration||11||
60101333|NCT01993719|76218831|FG002|COMPLETED|First Drug Administration||3||
60101334|NCT01993719|76218832|FG003|COMPLETED|First Drug Administration||9||
60101335|NCT01993719|76218833|FG004|COMPLETED|First Drug Administration||2||
60101336|NCT01993719|76218829|FG000|NOT COMPLETED|First Drug Administration||1||
60101337|NCT01993719|76218830|FG001|NOT COMPLETED|First Drug Administration||0||
60101338|NCT01993719|76218831|FG002|NOT COMPLETED|First Drug Administration||0||
60101339|NCT01993719|76218832|FG003|NOT COMPLETED|First Drug Administration||0||
60101340|NCT01993719|76218833|FG004|NOT COMPLETED|First Drug Administration||0||
60101341|NCT01993719|76218829|FG000|STARTED|Retreatment After First Drug Administrat||0||
60101342|NCT01993719|76218830|FG001|STARTED|Retreatment After First Drug Administrat||0||
60101343|NCT01993719|76218831|FG002|STARTED|Retreatment After First Drug Administrat||3||
60101344|NCT01993719|76218832|FG003|STARTED|Retreatment After First Drug Administrat||0||
60101345|NCT01993719|76218833|FG004|STARTED|Retreatment After First Drug Administrat||2||
60101346|NCT01993719|76218829|FG000|COMPLETED|Retreatment After First Drug Administrat||0||
60101347|NCT01993719|76218830|FG001|COMPLETED|Retreatment After First Drug Administrat||0||
60101348|NCT01993719|76218831|FG002|COMPLETED|Retreatment After First Drug Administrat||3||
60101349|NCT01993719|76218832|FG003|COMPLETED|Retreatment After First Drug Administrat||0||
60101350|NCT01993719|76218833|FG004|COMPLETED|Retreatment After First Drug Administrat||2||
60101351|NCT01993719|76218829|FG000|NOT COMPLETED|Retreatment After First Drug Administrat||0||
60101352|NCT01993719|76218830|FG001|NOT COMPLETED|Retreatment After First Drug Administrat||0||
60101353|NCT01993719|76218831|FG002|NOT COMPLETED|Retreatment After First Drug Administrat||0||
60101354|NCT01993719|76218832|FG003|NOT COMPLETED|Retreatment After First Drug Administrat||0||
60101355|NCT01993719|76218833|FG004|NOT COMPLETED|Retreatment After First Drug Administrat||0||
60101356|NCT00638235|76218875|FG000|STARTED|Overall Study||141||
60101357|NCT00638235|76218876|FG001|STARTED|Overall Study||26||
60101358|NCT00638235|76218877|FG002|STARTED|Overall Study||81||
60101359|NCT00638235|76218878|FG003|STARTED|Overall Study||56||
60101360|NCT00638235|76218879|FG004|STARTED|Overall Study||55||
60101361|NCT00638235|76218880|FG005|STARTED|Overall Study||139||
60101362|NCT00638235|76218881|FG006|STARTED|Overall Study||23||
60101363|NCT00638235|76218882|FG007|STARTED|Overall Study||35||
60101364|NCT00638235|76218883|FG008|STARTED|Overall Study||142||
60101365|NCT00638235|76218875|FG000|COMPLETED|Overall Study||110||
60101366|NCT00638235|76218876|FG001|COMPLETED|Overall Study||23||
59564458|NCT03581097|75666706|FG001|NOT COMPLETED|Overall Study||0||
59564459|NCT03521505|75666716|FG000|STARTED|Overall Study||25||
60101367|NCT00638235|76218877|FG002|COMPLETED|Overall Study|Ph-II ended before all subjects had 24M b/c Perigee next generation was already under trial P-III/IV|63||
60101368|NCT00638235|76218878|FG003|COMPLETED|Overall Study||46||
60101369|NCT00638235|76218879|FG004|COMPLETED|Overall Study||42||
60101370|NCT00638235|76218880|FG005|COMPLETED|Overall Study||113||
60101371|NCT00638235|76218881|FG006|COMPLETED|Overall Study||23||
59817031|NCT01358877|75939449|FG000|NOT COMPLETED|Overall Study||2400||
59817032|NCT01358877|75939450|FG001|NOT COMPLETED|Overall Study||2404||
60101372|NCT00638235|76218882|FG007|COMPLETED|Overall Study|Ph-VI ended after 12M b/c next generation of Elevate Anterior was already under trial in Phase VII|34||
59564460|NCT03521505|75666717|FG001|STARTED|Overall Study||25||
60101373|NCT00638235|76218883|FG008|COMPLETED|Overall Study||124||
60101374|NCT00638235|76218875|FG000|NOT COMPLETED|Overall Study||31||
60101375|NCT00638235|76218876|FG001|NOT COMPLETED|Overall Study||3||
60101376|NCT00638235|76218877|FG002|NOT COMPLETED|Overall Study||18||
60101377|NCT00638235|76218878|FG003|NOT COMPLETED|Overall Study||10||
60101378|NCT00638235|76218879|FG004|NOT COMPLETED|Overall Study||13||
60101379|NCT00638235|76218880|FG005|NOT COMPLETED|Overall Study||26||
59564461|NCT03521505|75666716|FG000|COMPLETED|Overall Study||25||
59564462|NCT03521505|75666717|FG001|COMPLETED|Overall Study||25||
59564463|NCT03521505|75666716|FG000|NOT COMPLETED|Overall Study||0||
59564464|NCT03521505|75666717|FG001|NOT COMPLETED|Overall Study||0||
59564465|NCT03522441|75666726|FG000|STARTED|Overall Study||450||
59564466|NCT03522441|75666727|FG001|STARTED|Overall Study||450||
60101380|NCT00638235|76218881|FG006|NOT COMPLETED|Overall Study||0||
60101381|NCT00638235|76218882|FG007|NOT COMPLETED|Overall Study||1||
60101382|NCT00638235|76218883|FG008|NOT COMPLETED|Overall Study||18||
60101383|NCT00638157|76218912|FG000|STARTED|Overall Study||12||
60101384|NCT00638157|76218913|FG001|STARTED|Overall Study||12||
60101385|NCT00638157|76218912|FG000|Treated|Overall Study||10||
59564467|NCT03522441|75666728|FG002|STARTED|Overall Study||225||
59564468|NCT03522441|75666726|FG000|COMPLETED|Overall Study||424||
59564469|NCT03522441|75666727|FG001|COMPLETED|Overall Study||431||
59564470|NCT03522441|75666728|FG002|COMPLETED|Overall Study||214||
59564471|NCT03522441|75666726|FG000|NOT COMPLETED|Overall Study||26||
59564472|NCT03522441|75666727|FG001|NOT COMPLETED|Overall Study||19||
59564473|NCT03522441|75666728|FG002|NOT COMPLETED|Overall Study||11||
59564474|NCT03529461|75666738|FG000|STARTED|Overall Study||28||
59564475|NCT03529461|75666739|FG001|STARTED|Overall Study||28||
59564476|NCT03529461|75666738|FG000|COMPLETED|Overall Study||28||
59564477|NCT03529461|75666739|FG001|COMPLETED|Overall Study||28||
60101386|NCT00638157|76218913|FG001|Treated|Overall Study||12||
59564478|NCT03529461|75666738|FG000|NOT COMPLETED|Overall Study||0||
59564479|NCT03529461|75666739|FG001|NOT COMPLETED|Overall Study||0||
59564480|NCT03585543|75666746|FG000|STARTED|Overall Study||30||
59564481|NCT03585543|75666746|FG000|Mid-intervention Assessment (6-weeks)|Overall Study||25||
59564482|NCT03585543|75666746|FG000|End-of-intervention Assessment (12 Weeks|Overall Study||22||
59564483|NCT03585543|75666746|FG000|3-month Post-intervention Follow-up (6 m|Overall Study||15||
59564484|NCT03585543|75666746|FG000|COMPLETED|Overall Study||15||
59564485|NCT03585543|75666746|FG000|NOT COMPLETED|Overall Study||15||
59564486|NCT03346161|75666753|FG000|STARTED|Overall Study||60||
59564487|NCT03346161|75666754|FG001|STARTED|Overall Study||60||
59564488|NCT03346161|75666753|FG000|COMPLETED|Overall Study||60||
59564489|NCT03346161|75666754|FG001|COMPLETED|Overall Study||60||
59564490|NCT03346161|75666753|FG000|NOT COMPLETED|Overall Study||0||
59564491|NCT03346161|75666754|FG001|NOT COMPLETED|Overall Study||0||
59564492|NCT03530631|75666760|FG000|STARTED|Adderall/Truth||4||
59564493|NCT03530631|75666760|FG000|COMPLETED|Adderall/Truth||4||
59564494|NCT03530631|75666760|FG000|NOT COMPLETED|Adderall/Truth||0||
59564495|NCT03530631|75666760|FG000|STARTED|Placebo/Truth||4||
59564496|NCT03530631|75666760|FG000|COMPLETED|Placebo/Truth||4||
59564497|NCT03530631|75666760|FG000|NOT COMPLETED|Placebo/Truth||0||
59564498|NCT03530631|75666760|FG000|STARTED|Adderall/Deception||4||
59564499|NCT03530631|75666760|FG000|COMPLETED|Adderall/Deception||4||
59564500|NCT03530631|75666760|FG000|NOT COMPLETED|Adderall/Deception||0||
59564501|NCT03530631|75666760|FG000|STARTED|Placebo/Deception||4||
59564502|NCT03530631|75666760|FG000|COMPLETED|Placebo/Deception||4||
59564503|NCT03530631|75666760|FG000|NOT COMPLETED|Placebo/Deception||0||
59564504|NCT03533829|75666773|FG000|STARTED|Overall Study||10||
59564505|NCT03533829|75666774|FG001|STARTED|Overall Study||10||
59564506|NCT03533829|75666775|FG002|STARTED|Overall Study||10||
59564507|NCT03533829|75666773|FG000|COMPLETED|Overall Study||10||
59564508|NCT03533829|75666774|FG001|COMPLETED|Overall Study||10||
59564509|NCT03533829|75666775|FG002|COMPLETED|Overall Study||10||
59564510|NCT03533829|75666773|FG000|NOT COMPLETED|Overall Study||0||
59564511|NCT03533829|75666774|FG001|NOT COMPLETED|Overall Study||0||
59564512|NCT03533829|75666775|FG002|NOT COMPLETED|Overall Study||0||
60101387|NCT00638157|76218912|FG000|COMPLETED|Overall Study|4 subjects completed study drug in this arm|5||
60101388|NCT00638157|76218913|FG001|COMPLETED|Overall Study|4 subjects completed study drug in this arm|8||
60101389|NCT00638157|76218912|FG000|NOT COMPLETED|Overall Study||7||
60101390|NCT00638157|76218913|FG001|NOT COMPLETED|Overall Study||4||
60101391|NCT00637377|76218924|FG000|STARTED|Overall Study||303||
60101392|NCT00637377|76218925|FG001|STARTED|Overall Study||313||
60101393|NCT00637377|76218926|FG002|STARTED|Overall Study||311||
60101394|NCT00637377|76218927|FG003|STARTED|Overall Study||313||
60101395|NCT00637377|76218924|FG000|Participants Received Treatment|Overall Study|safety population|291||
60101396|NCT00637377|76218925|FG001|Participants Received Treatment|Overall Study|safety population|309||
60101397|NCT00637377|76218926|FG002|Participants Received Treatment|Overall Study|safety population|297||
60101398|NCT00637377|76218927|FG003|Participants Received Treatment|Overall Study|safety population|307||
60101399|NCT00637377|76218924|FG000|Participants Treated (FAS)|Overall Study||291||
60101400|NCT00637377|76218925|FG001|Participants Treated (FAS)|Overall Study||309||
60101401|NCT00637377|76218926|FG002|Participants Treated (FAS)|Overall Study||296||
60101402|NCT00637377|76218927|FG003|Participants Treated (FAS)|Overall Study||306||
60101403|NCT00637377|76218924|FG000|COMPLETED|Overall Study||276||
60101404|NCT00637377|76218925|FG001|COMPLETED|Overall Study||281||
60101405|NCT00637377|76218926|FG002|COMPLETED|Overall Study||274||
60101406|NCT00637377|76218927|FG003|COMPLETED|Overall Study||284||
60101407|NCT00637377|76218924|FG000|NOT COMPLETED|Overall Study||27||
59564513|NCT03350217|75666785|FG000|STARTED|Overall Study||79||
59564514|NCT03350217|75666786|FG001|STARTED|Overall Study||81||
59564515|NCT03350217|75666785|FG000|COMPLETED|Overall Study||77||
59564516|NCT03350217|75666786|FG001|COMPLETED|Overall Study||81||
59564517|NCT03350217|75666785|FG000|NOT COMPLETED|Overall Study||2||
59564518|NCT03350217|75666786|FG001|NOT COMPLETED|Overall Study||0||
60101408|NCT00637377|76218925|FG001|NOT COMPLETED|Overall Study||32||
60101409|NCT00637377|76218926|FG002|NOT COMPLETED|Overall Study||37||
60101410|NCT00637377|76218927|FG003|NOT COMPLETED|Overall Study||29||
60101411|NCT00636987|76218937|FG000|STARTED|Overall Study||297||
60101412|NCT00636987|76218937|FG000|COMPLETED|Overall Study||108||
59564519|NCT03350919|75666794|FG000|STARTED|Overall Study||25||
59564520|NCT03350919|75666795|FG001|STARTED|Overall Study||23||
59564521|NCT03350919|75666794|FG000|COMPLETED|Overall Study||23||
60101413|NCT00636987|76218937|FG000|NOT COMPLETED|Overall Study||189||
60101414|NCT01078558|76218948|FG000|STARTED|Overall Study||2836||
60101415|NCT01078558|76218949|FG001|STARTED|Overall Study||1127||
60101416|NCT01078558|76218950|FG002|STARTED|Overall Study||1957||
60101417|NCT01078558|76218948|FG000|Oligoarticular PsA|Overall Study||0||
60101418|NCT01078558|76218949|FG001|Oligoarticular PsA|Overall Study||197||
60101419|NCT01078558|76218950|FG002|Oligoarticular PsA|Overall Study||0||
60101420|NCT01078558|76218948|FG000|COMPLETED|Overall Study||818||
60101421|NCT01078558|76218949|FG001|COMPLETED|Overall Study||372||
60101422|NCT01078558|76218950|FG002|COMPLETED|Overall Study||596||
60101423|NCT01078558|76218948|FG000|NOT COMPLETED|Overall Study||2018||
60101424|NCT01078558|76218949|FG001|NOT COMPLETED|Overall Study||755||
60101425|NCT01078558|76218950|FG002|NOT COMPLETED|Overall Study||1361||
60101426|NCT01080118|76218960|FG000|STARTED|Overall Study||15||
60101427|NCT01080118|76218961|FG001|STARTED|Overall Study||15||
60101428|NCT01080118|76218962|FG002|STARTED|Overall Study||30||
60101429|NCT01080118|76218963|FG003|STARTED|Overall Study||30||
60101430|NCT01080118|76218960|FG000|COMPLETED|Overall Study||15||
60101431|NCT01080118|76218961|FG001|COMPLETED|Overall Study||15||
60101432|NCT01080118|76218962|FG002|COMPLETED|Overall Study||30||
60101433|NCT01080118|76218963|FG003|COMPLETED|Overall Study||30||
60101434|NCT01080118|76218960|FG000|NOT COMPLETED|Overall Study||0||
60101435|NCT01080118|76218961|FG001|NOT COMPLETED|Overall Study||0||
60101436|NCT01080118|76218962|FG002|NOT COMPLETED|Overall Study||0||
60101437|NCT01080118|76218963|FG003|NOT COMPLETED|Overall Study||0||
60101438|NCT01080976|76218971|FG000|STARTED|Overall Study||5||
60101439|NCT01080976|76218972|FG001|STARTED|Overall Study||5||
60101440|NCT01080976|76218971|FG000|COMPLETED|Overall Study||5||
60101441|NCT01080976|76218972|FG001|COMPLETED|Overall Study||5||
60101442|NCT01080976|76218971|FG000|NOT COMPLETED|Overall Study||0||
60101443|NCT01080976|76218972|FG001|NOT COMPLETED|Overall Study||0||
60101444|NCT01033864|76218980|FG000|STARTED|Overall Study||12||
60101445|NCT01033864|76218981|FG001|STARTED|Overall Study||11||
60101446|NCT01033864|76218980|FG000|COMPLETED|Overall Study||12||
59564522|NCT03350919|75666795|FG001|COMPLETED|Overall Study||23||
59564523|NCT03350919|75666794|FG000|NOT COMPLETED|Overall Study||2||
60101447|NCT01033864|76218981|FG001|COMPLETED|Overall Study||11||
60101448|NCT01033864|76218980|FG000|NOT COMPLETED|Overall Study||0||
60101449|NCT01033864|76218981|FG001|NOT COMPLETED|Overall Study||0||
60101450|NCT01082380|76218987|FG000|STARTED|Overall Study||6||
60101451|NCT01082380|76218987|FG000|COMPLETED|Overall Study||6||
60101452|NCT01082380|76218987|FG000|NOT COMPLETED|Overall Study||0||
60101453|NCT01083628|76218993|FG000|STARTED|Overall Study||45||
60101454|NCT01083628|76218994|FG001|STARTED|Overall Study||40||
60101455|NCT01083628|76218993|FG000|COMPLETED|Overall Study||45||
60101456|NCT01083628|76218994|FG001|COMPLETED|Overall Study||40||
60101457|NCT01083628|76218993|FG000|NOT COMPLETED|Overall Study||0||
59564524|NCT03350919|75666795|FG001|NOT COMPLETED|Overall Study||0||
59564525|NCT03351699|75666808|FG000|STARTED|Overall Study||6||
59564526|NCT03351699|75666809|FG001|STARTED|Overall Study||6||
59564527|NCT03351699|75666810|FG002|STARTED|Overall Study||6||
60101458|NCT01083628|76218994|FG001|NOT COMPLETED|Overall Study||0||
60101459|NCT01083706|76219000|FG000|STARTED|Overall Study||39||
60101460|NCT01083706|76219000|FG000|COMPLETED|Overall Study||39||
60101461|NCT01083706|76219000|FG000|NOT COMPLETED|Overall Study||0||
60101462|NCT01035346|76219006|FG000|STARTED|Overall Study||7||
60101463|NCT01035346|76219007|FG001|STARTED|Overall Study||9||
60101464|NCT01035346|76219006|FG000|COMPLETED|Overall Study||7||
60101465|NCT01035346|76219007|FG001|COMPLETED|Overall Study||9||
60101466|NCT01035346|76219006|FG000|NOT COMPLETED|Overall Study||0||
60101467|NCT01035346|76219007|FG001|NOT COMPLETED|Overall Study||0||
59564528|NCT03351699|75666811|FG003|STARTED|Overall Study||6||
60101468|NCT01085344|76219013|FG000|STARTED|Overall Study||56||
60101469|NCT01085344|76219013|FG000|COMPLETED|Overall Study||50||
60101470|NCT01085344|76219013|FG000|NOT COMPLETED|Overall Study||6||
60101471|NCT01085500|76219019|FG000|STARTED|Overall Study||26||
60101472|NCT01085500|76219020|FG001|STARTED|Overall Study||24||
60101473|NCT01085500|76219019|FG000|COMPLETED|Overall Study||26||
60101474|NCT01085500|76219020|FG001|COMPLETED|Overall Study||24||
60101475|NCT01085500|76219019|FG000|NOT COMPLETED|Overall Study||0||
60101476|NCT01085500|76219020|FG001|NOT COMPLETED|Overall Study||0||
60101477|NCT01035658|76219030|FG000|STARTED|Overall Study||5||
60101478|NCT01035658|76219031|FG001|STARTED|Overall Study||8||
59817033|NCT00670358|75939462|FG000|STARTED|Overall Study||3||
59817034|NCT00670358|75939463|FG001|STARTED|Overall Study||3||
59817035|NCT00670358|75939464|FG002|STARTED|Overall Study||6||
59708383|NCT01203852|75827220|FG000|STARTED|Metoprolol 8 Weeks|This is the total number of subjects for both groups.|839||
59708384|NCT01203852|75827220|FG000|COMPLETED|Metoprolol 8 Weeks||369||
59708385|NCT01203852|75827220|FG000|NOT COMPLETED|Metoprolol 8 Weeks||470||
59708386|NCT01203852|75827220|FG000|STARTED|Washout 2 Weeks|Some study subjects did not proceed to the washout phase after the first intervention.|328||
59708387|NCT01203852|75827220|FG000|COMPLETED|Washout 2 Weeks||282||
59708388|NCT01203852|75827220|FG000|NOT COMPLETED|Washout 2 Weeks||46||
59709836|NCT01072149|75828530|FG010|STARTED|Treatment Period 2 (28 Days)||2||
59817036|NCT00670358|75939465|FG003|STARTED|Overall Study||77||
59817037|NCT00670358|75939466|FG004|STARTED|Overall Study||39||
59817038|NCT00670358|75939467|FG005|STARTED|Overall Study||10||
59817039|NCT00670358|75939462|FG000|COMPLETED|Overall Study||3||
59817040|NCT00670358|75939463|FG001|COMPLETED|Overall Study||3||
59817041|NCT00670358|75939464|FG002|COMPLETED|Overall Study||5||
59817042|NCT00670358|75939465|FG003|COMPLETED|Overall Study||59||
59817043|NCT00670358|75939466|FG004|COMPLETED|Overall Study||33||
59817044|NCT00670358|75939467|FG005|COMPLETED|Overall Study||0||
60101479|NCT01035658|76219032|FG002|STARTED|Overall Study||3||
60101480|NCT01035658|76219033|FG003|STARTED|Overall Study||6||
60101481|NCT01035658|76219030|FG000|COMPLETED|Overall Study||5||
60101482|NCT01035658|76219031|FG001|COMPLETED|Overall Study||8||
60101483|NCT01035658|76219032|FG002|COMPLETED|Overall Study||3||
60101484|NCT01035658|76219033|FG003|COMPLETED|Overall Study||6||
60101485|NCT01035658|76219030|FG000|NOT COMPLETED|Overall Study||0||
60101486|NCT01035658|76219031|FG001|NOT COMPLETED|Overall Study||0||
60101487|NCT01035658|76219032|FG002|NOT COMPLETED|Overall Study||0||
60101488|NCT01035658|76219033|FG003|NOT COMPLETED|Overall Study||0||
60101489|NCT01037452|76219050|FG000|STARTED|Overall Study||30||
60101490|NCT01037452|76219051|FG001|STARTED|Overall Study||30||
60101491|NCT01037452|76219052|FG002|STARTED|Overall Study||30||
60101492|NCT01037452|76219053|FG003|STARTED|Overall Study||30||
60101493|NCT01037452|76219050|FG000|COMPLETED|Overall Study||30||
60101494|NCT01037452|76219051|FG001|COMPLETED|Overall Study||30||
60101495|NCT01037452|76219052|FG002|COMPLETED|Overall Study||30||
60101496|NCT01037452|76219053|FG003|COMPLETED|Overall Study||30||
60101497|NCT01037452|76219050|FG000|NOT COMPLETED|Overall Study||0||
60101498|NCT01037452|76219051|FG001|NOT COMPLETED|Overall Study||0||
60101499|NCT01037452|76219052|FG002|NOT COMPLETED|Overall Study||0||
60101500|NCT01037452|76219053|FG003|NOT COMPLETED|Overall Study||0||
60101501|NCT01085968|76219065|FG000|STARTED|Overall Study||29||
60101502|NCT01085968|76219066|FG001|STARTED|Overall Study||25||
59817045|NCT00670358|75939462|FG000|NOT COMPLETED|Overall Study||0||
59817046|NCT00670358|75939463|FG001|NOT COMPLETED|Overall Study||0||
59817047|NCT00670358|75939464|FG002|NOT COMPLETED|Overall Study||1||
60101503|NCT01085968|76219065|FG000|COMPLETED|Overall Study||19||
60101504|NCT01085968|76219066|FG001|COMPLETED|Overall Study||21||
59817048|NCT00670358|75939465|FG003|NOT COMPLETED|Overall Study||18||
59817049|NCT00670358|75939466|FG004|NOT COMPLETED|Overall Study||6||
59817050|NCT00670358|75939467|FG005|NOT COMPLETED|Overall Study||10||
60101505|NCT01085968|76219065|FG000|NOT COMPLETED|Overall Study||10||
60101506|NCT01085968|76219066|FG001|NOT COMPLETED|Overall Study||4||
60101507|NCT01087918|76219074|FG000|STARTED|Overall Study||5||
60101508|NCT01087918|76219075|FG001|STARTED|Overall Study||4||
60101509|NCT01087918|76219074|FG000|COMPLETED|Overall Study||5||
60101510|NCT01087918|76219075|FG001|COMPLETED|Overall Study||4||
60101511|NCT01087918|76219074|FG000|NOT COMPLETED|Overall Study||0||
60101512|NCT01087918|76219075|FG001|NOT COMPLETED|Overall Study||0||
59817051|NCT00643279|75939482|FG000|STARTED|Overall Study||134||
59817052|NCT00643279|75939483|FG001|STARTED|Overall Study||140||
59817053|NCT00643279|75939482|FG000|COMPLETED|Overall Study||118||
59817054|NCT00643279|75939483|FG001|COMPLETED|Overall Study||127||
59817055|NCT00643279|75939482|FG000|NOT COMPLETED|Overall Study||16||
59817056|NCT00643279|75939483|FG001|NOT COMPLETED|Overall Study||13||
59817057|NCT00633087|75939491|FG000|STARTED|Overall Study||12||
59817058|NCT00633087|75939491|FG000|COMPLETED|Overall Study||12||
59817059|NCT00633087|75939491|FG000|NOT COMPLETED|Overall Study||0||
59817060|NCT00182728|75939495|FG000|STARTED|Overall Study||71||
59817061|NCT00182728|75939495|FG000|COMPLETED|Overall Study||71||
59817062|NCT00182728|75939495|FG000|NOT COMPLETED|Overall Study||0||
59817063|NCT00176631|75939499|FG000|STARTED|Overall Study||10||
59817064|NCT00176631|75939499|FG000|COMPLETED|Overall Study||10||
59817065|NCT00176631|75939499|FG000|NOT COMPLETED|Overall Study||0||
59817066|NCT05607043|75939503|FG000|STARTED|Overall Study||11||
59817067|NCT05607043|75939503|FG000|COMPLETED|Overall Study||9||
59817068|NCT05607043|75939503|FG000|NOT COMPLETED|Overall Study||2||
59817069|NCT05216081|75939507|FG000|STARTED|Overall Study||102||
59817070|NCT05216081|75939507|FG000|COMPLETED|Overall Study||101||
59817071|NCT05216081|75939507|FG000|NOT COMPLETED|Overall Study||1||
59817072|NCT04949243|75939516|FG000|STARTED|Overall Study||338||
59817073|NCT04949243|75939516|FG000|COMPLETED|Overall Study||263||
59817074|NCT04949243|75939516|FG000|NOT COMPLETED|Overall Study||75||
59817075|NCT04894084|75939520|FG000|STARTED|Overall Study||25|Enrollment started April 29th 2021|
59817076|NCT04894084|75939520|FG000|COMPLETED|Overall Study||25|Study completed (Last patient out July 14th 2021)|
59817077|NCT04894084|75939520|FG000|NOT COMPLETED|Overall Study||0||
59817078|NCT04791514|75939524|FG000|STARTED|Overall Study||0||
59817079|NCT04791514|75939524|FG000|COMPLETED|Overall Study||0||
59817080|NCT04791514|75939524|FG000|NOT COMPLETED|Overall Study||0||
59817081|NCT04550221|75939530|FG000|STARTED|Overall Study||32||
59817082|NCT04550221|75939531|FG001|STARTED|Overall Study||31||
59817083|NCT04550221|75939530|FG000|Month 1 Visit|Overall Study||29||
59994274|NCT02412722|76110044|FG002|Safety Population|Overall Study||7||
59994275|NCT02412722|76110045|FG003|Safety Population|Overall Study||15||
59994276|NCT02412722|76110046|FG004|Safety Population|Overall Study||7||
59994277|NCT02412722|76110047|FG005|Safety Population|Overall Study||13||
59994278|NCT02412722|76110042|FG000|COMPLETED|Overall Study||0|Completed=Participants who completed study treatment.|
59994279|NCT02412722|76110043|FG001|COMPLETED|Overall Study||0|Completed=Participants who completed study treatment.|
59994280|NCT02412722|76110044|FG002|COMPLETED|Overall Study||0|Completed=Participants who completed study treatment.|
59994281|NCT02412722|76110045|FG003|COMPLETED|Overall Study||0|Completed=Participants who completed study treatment.|
59994282|NCT02412722|76110046|FG004|COMPLETED|Overall Study||0|Completed=Participants who completed study treatment.|
59817084|NCT04550221|75939531|FG001|Month 1 Visit|Overall Study||31||
59817085|NCT04550221|75939530|FG000|Month 3 Visit|Overall Study||29||
59817086|NCT04550221|75939531|FG001|Month 3 Visit|Overall Study||30||
60101513|NCT00636441|76219092|FG000|STARTED|Overall Study||6||
60101514|NCT00636441|76219093|FG001|STARTED|Overall Study||7||
60101515|NCT00636441|76219094|FG002|STARTED|Overall Study||6||
59817087|NCT04550221|75939530|FG000|Month 6 Visit|Overall Study||27||
59817088|NCT04550221|75939531|FG001|Month 6 Visit|Overall Study||27||
59817089|NCT04550221|75939530|FG000|Exit Interviews|Overall Study||28||
59817090|NCT04550221|75939531|FG001|Exit Interviews|Overall Study|Exit interviews were only conducted for intervention participants.|0||
59817091|NCT04550221|75939530|FG000|COMPLETED|Overall Study||27||
59817092|NCT04550221|75939531|FG001|COMPLETED|Overall Study||27||
59564529|NCT03351699|75666812|FG004|STARTED|Overall Study|Panel F did not enroll, following evaluation of earlier Panel data.|0||
59564530|NCT03351699|75666808|FG000|COMPLETED|Overall Study||6||
59564531|NCT03351699|75666809|FG001|COMPLETED|Overall Study||6||
60101516|NCT00636441|76219095|FG003|STARTED|Overall Study||6||
60101517|NCT00636441|76219096|FG004|STARTED|Overall Study||6||
60101518|NCT00636441|76219097|FG005|STARTED|Overall Study||7||
60101519|NCT00636441|76219098|FG006|STARTED|Overall Study||18||
60101520|NCT00636441|76219092|FG000|Assigned Treatment|Overall Study||6||
60101521|NCT00636441|76219093|FG001|Assigned Treatment|Overall Study||7||
60101522|NCT00636441|76219094|FG002|Assigned Treatment|Overall Study||6||
60101523|NCT00636441|76219095|FG003|Assigned Treatment|Overall Study||6||
60101524|NCT00636441|76219096|FG004|Assigned Treatment|Overall Study||6||
60101525|NCT00636441|76219097|FG005|Assigned Treatment|Overall Study||7||
60101526|NCT00636441|76219098|FG006|Assigned Treatment|Overall Study|This is a late determined ineligibility.|1||
60101527|NCT00636441|76219092|FG000|COMPLETED|Overall Study||6||
60101528|NCT00636441|76219093|FG001|COMPLETED|Overall Study||6||
60101529|NCT00636441|76219094|FG002|COMPLETED|Overall Study||5||
60101530|NCT00636441|76219095|FG003|COMPLETED|Overall Study||6||
59564532|NCT03351699|75666810|FG002|COMPLETED|Overall Study||6||
59564533|NCT03351699|75666811|FG003|COMPLETED|Overall Study||6||
59564534|NCT03351699|75666812|FG004|COMPLETED|Overall Study|Panel F did not enroll, following evaluation of earlier Panel data.|0||
59708389|NCT01203852|75827220|FG000|STARTED|Chlorthalidone 8 Weeks|Subjects were allowed to enter the study at Chlorthalidone without completing Metoprolol.|328||
60101531|NCT00636441|76219096|FG004|COMPLETED|Overall Study||6||
60101532|NCT00636441|76219097|FG005|COMPLETED|Overall Study||6||
60101533|NCT00636441|76219098|FG006|COMPLETED|Overall Study||0||
60101534|NCT00636441|76219092|FG000|NOT COMPLETED|Overall Study||0||
60101535|NCT00636441|76219093|FG001|NOT COMPLETED|Overall Study||1||
60101536|NCT00636441|76219094|FG002|NOT COMPLETED|Overall Study||1||
60101537|NCT00636441|76219095|FG003|NOT COMPLETED|Overall Study||0||
59564535|NCT03351699|75666808|FG000|NOT COMPLETED|Overall Study||0||
59564536|NCT03351699|75666809|FG001|NOT COMPLETED|Overall Study||0||
59564537|NCT03351699|75666810|FG002|NOT COMPLETED|Overall Study||0||
60101538|NCT00636441|76219096|FG004|NOT COMPLETED|Overall Study||0||
59564538|NCT03351699|75666811|FG003|NOT COMPLETED|Overall Study||0||
59564539|NCT03351699|75666812|FG004|NOT COMPLETED|Overall Study||0||
59564540|NCT03351933|75666830|FG000|STARTED|Overall Study||28||
59564541|NCT03351933|75666830|FG000|COMPLETED|Overall Study||26||
59564542|NCT03351933|75666830|FG000|NOT COMPLETED|Overall Study||2||
59564543|NCT03352245|75666836|FG000|STARTED|Overall Study||20||
59708390|NCT01203852|75827220|FG000|Continued From Metoprolol|Chlorthalidone 8 Weeks||282||
59817093|NCT04550221|75939530|FG000|NOT COMPLETED|Overall Study||5||
60101539|NCT00636441|76219097|FG005|NOT COMPLETED|Overall Study||1||
60101540|NCT00636441|76219098|FG006|NOT COMPLETED|Overall Study||18||
60101541|NCT01087996|76219111|FG000|STARTED|Overall Study||15||
60101542|NCT01087996|76219112|FG001|STARTED|Overall Study||15||
60101543|NCT01087996|76219111|FG000|COMPLETED|Overall Study||15||
60101544|NCT01087996|76219112|FG001|COMPLETED|Overall Study||15||
60101545|NCT01087996|76219111|FG000|NOT COMPLETED|Overall Study||0||
60101546|NCT01087996|76219112|FG001|NOT COMPLETED|Overall Study||0||
60101547|NCT00636363|76219121|FG000|STARTED|Overall Study||178||
59564544|NCT03352245|75666837|FG001|STARTED|Overall Study||20||
59564545|NCT03352245|75666836|FG000|COMPLETED|Overall Study||20||
59564546|NCT03352245|75666837|FG001|COMPLETED|Overall Study||19||
59564547|NCT03352245|75666836|FG000|NOT COMPLETED|Overall Study||0||
59564548|NCT03352245|75666837|FG001|NOT COMPLETED|Overall Study||1||
59564549|NCT03594045|75666845|FG000|STARTED|Overall Study||0||
59564550|NCT03594045|75666846|FG001|STARTED|Overall Study||5||
59564551|NCT03594045|75666845|FG000|COMPLETED|Overall Study||0||
59564552|NCT03594045|75666846|FG001|COMPLETED|Overall Study||5||
59564553|NCT03594045|75666845|FG000|NOT COMPLETED|Overall Study||0||
59564554|NCT03594045|75666846|FG001|NOT COMPLETED|Overall Study||0||
59564555|NCT03595215|75666852|FG000|STARTED|Overall Study||18||
59564556|NCT03595215|75666852|FG000|COMPLETED|Overall Study||10||
59564557|NCT03595215|75666852|FG000|NOT COMPLETED|Overall Study||8||
59564558|NCT03595449|75666858|FG000|STARTED|Overall Study||118||
59564559|NCT03595449|75666859|FG001|STARTED|Overall Study||115||
59564560|NCT03595449|75666858|FG000|COMPLETED|Overall Study||118||
59564561|NCT03595449|75666859|FG001|COMPLETED|Overall Study||115||
59564562|NCT03595449|75666858|FG000|NOT COMPLETED|Overall Study||0||
59564563|NCT03595449|75666859|FG001|NOT COMPLETED|Overall Study||0||
59564564|NCT03597009|75666865|FG000|STARTED|Overall Study||1||
59564565|NCT03597009|75666865|FG000|COMPLETED|Overall Study||1||
59564566|NCT03597009|75666865|FG000|NOT COMPLETED|Overall Study||0||
59564567|NCT03352323|75666869|FG000|STARTED|Overall Study||50||
59564568|NCT03352323|75666869|FG000|COMPLETED|Overall Study||49||
59564569|NCT03352323|75666869|FG000|NOT COMPLETED|Overall Study||1||
59564570|NCT03597789|75666873|FG000|STARTED|Overall Study||45||
59564571|NCT03597789|75666873|FG000|COMPLETED|Overall Study||10||
59564572|NCT03597789|75666873|FG000|NOT COMPLETED|Overall Study||35||
59708391|NCT01203852|75827220|FG000|COMPLETED|Chlorthalidone 8 Weeks||328||
59708392|NCT01203852|75827220|FG000|NOT COMPLETED|Chlorthalidone 8 Weeks||0||
59708393|NCT01105533|75827227|FG000|STARTED|Overall Study||1||
60101548|NCT00636363|76219122|FG001|STARTED|Overall Study||176||
60101549|NCT00636363|76219123|FG002|STARTED|Overall Study||181||
60101550|NCT00636363|76219121|FG000|COMPLETED|Overall Study||165||
60101551|NCT00636363|76219122|FG001|COMPLETED|Overall Study||156||
60101552|NCT00636363|76219123|FG002|COMPLETED|Overall Study||163||
60101553|NCT00636363|76219121|FG000|NOT COMPLETED|Overall Study||13||
60101554|NCT00636363|76219122|FG001|NOT COMPLETED|Overall Study||20||
60101555|NCT00636363|76219123|FG002|NOT COMPLETED|Overall Study||18||
60101556|NCT01600131|76219133|FG000|STARTED|Post-Test 1||86||
60101557|NCT01600131|76219134|FG001|STARTED|Post-Test 1||88||
60101558|NCT01600131|76219133|FG000|COMPLETED|Post-Test 1||43||
60101559|NCT01600131|76219134|FG001|COMPLETED|Post-Test 1||73||
59564573|NCT03598647|75666879|FG000|STARTED|Exercisers vs. Non-exercisers||30||
59708394|NCT01105533|75827228|FG001|STARTED|Overall Study||1||
60101560|NCT01600131|76219133|FG000|NOT COMPLETED|Post-Test 1||43||
60101561|NCT01600131|76219134|FG001|NOT COMPLETED|Post-Test 1||15||
60101562|NCT01600131|76219133|FG000|STARTED|Post-Test 2||43||
60101563|NCT01600131|76219134|FG001|STARTED|Post-Test 2||73||
60101564|NCT01600131|76219133|FG000|COMPLETED|Post-Test 2||43||
60101565|NCT01600131|76219134|FG001|COMPLETED|Post-Test 2||71||
60101566|NCT01600131|76219133|FG000|NOT COMPLETED|Post-Test 2||0||
60101567|NCT01600131|76219134|FG001|NOT COMPLETED|Post-Test 2||2||
60101568|NCT01088464|76219143|FG000|STARTED|Overall Study||3||
60101569|NCT01088464|76219144|FG001|STARTED|Overall Study||6||
59564574|NCT03598647|75666880|FG001|STARTED|Exercisers vs. Non-exercisers||30||
59708395|NCT01105533|75827229|FG002|STARTED|Overall Study||3||
60101570|NCT01088464|76219145|FG002|STARTED|Overall Study||6||
59708396|NCT01105533|75827230|FG003|STARTED|Overall Study||3||
59708397|NCT01105533|75827231|FG004|STARTED|Overall Study||7||
59708398|NCT01105533|75827232|FG005|STARTED|Overall Study||7||
59564575|NCT03598647|75666881|FG002|STARTED|Exercisers vs. Non-exercisers||0||
59564576|NCT03598647|75666882|FG003|STARTED|Exercisers vs. Non-exercisers||0||
59708399|NCT01105533|75827233|FG006|STARTED|Overall Study||8||
59708400|NCT01105533|75827234|FG007|STARTED|Overall Study||4||
59708401|NCT01105533|75827235|FG008|STARTED|Overall Study||12||
59708402|NCT01105533|75827227|FG000|COMPLETED|Overall Study||0||
59708403|NCT01105533|75827228|FG001|COMPLETED|Overall Study||0||
59708404|NCT01105533|75827229|FG002|COMPLETED|Overall Study||0||
59708405|NCT01105533|75827230|FG003|COMPLETED|Overall Study||0||
59708406|NCT01105533|75827231|FG004|COMPLETED|Overall Study||0||
59708407|NCT01105533|75827232|FG005|COMPLETED|Overall Study||0||
59708408|NCT01105533|75827233|FG006|COMPLETED|Overall Study||0||
59708409|NCT01105533|75827234|FG007|COMPLETED|Overall Study||0||
59817094|NCT04550221|75939531|FG001|NOT COMPLETED|Overall Study||4||
59817095|NCT04534738|75939539|FG000|STARTED|Overall Study||23||
59817096|NCT04534738|75939540|FG001|STARTED|Overall Study||10||
59817097|NCT04534738|75939539|FG000|COMPLETED|Overall Study||23||
59817098|NCT04534738|75939540|FG001|COMPLETED|Overall Study||10||
59817099|NCT04534738|75939539|FG000|NOT COMPLETED|Overall Study||0||
59817100|NCT04534738|75939540|FG001|NOT COMPLETED|Overall Study||0||
59817101|NCT04525157|75939546|FG000|STARTED|Overall Study||18||
59817102|NCT04525157|75939546|FG000|COMPLETED|Overall Study||15||
59817103|NCT04525157|75939546|FG000|NOT COMPLETED|Overall Study||3||
59817104|NCT04193176|75939552|FG000|STARTED|Overall Study||190||
59564577|NCT03598647|75666879|FG000|COMPLETED|Exercisers vs. Non-exercisers||29||
59564578|NCT03598647|75666880|FG001|COMPLETED|Exercisers vs. Non-exercisers||30||
59564579|NCT03598647|75666881|FG002|COMPLETED|Exercisers vs. Non-exercisers||0||
59564580|NCT03598647|75666882|FG003|COMPLETED|Exercisers vs. Non-exercisers||0||
59564581|NCT03598647|75666879|FG000|NOT COMPLETED|Exercisers vs. Non-exercisers||1||
59564582|NCT03598647|75666880|FG001|NOT COMPLETED|Exercisers vs. Non-exercisers||0||
59817105|NCT04193176|75939553|FG001|STARTED|Overall Study||186||
59817106|NCT04193176|75939552|FG000|Treated|Overall Study||190||
59817107|NCT04193176|75939553|FG001|Treated|Overall Study||185||
59817108|NCT04193176|75939552|FG000|COMPLETED|Overall Study||184||
59817109|NCT04193176|75939553|FG001|COMPLETED|Overall Study||176||
59994283|NCT02412722|76110047|FG005|COMPLETED|Overall Study||0|Completed=Participants who completed study treatment.|
59994284|NCT02412722|76110042|FG000|NOT COMPLETED|Overall Study||11||
59994285|NCT02412722|76110043|FG001|NOT COMPLETED|Overall Study||8||
59994286|NCT02412722|76110044|FG002|NOT COMPLETED|Overall Study||7||
59994287|NCT02412722|76110045|FG003|NOT COMPLETED|Overall Study||15||
59994288|NCT02412722|76110046|FG004|NOT COMPLETED|Overall Study||7||
59994289|NCT02412722|76110047|FG005|NOT COMPLETED|Overall Study||13||
59994290|NCT03074695|76110083|FG000|STARTED|Overall Study||70||
59994291|NCT03074695|76110084|FG001|STARTED|Overall Study||71||
59994292|NCT03074695|76110083|FG000|COMPLETED|Overall Study||66||
59994293|NCT03074695|76110084|FG001|COMPLETED|Overall Study||66||
60101571|NCT01088464|76219143|FG000|Received Any Quantity of Study Drug|Overall Study||3||
60101572|NCT01088464|76219144|FG001|Received Any Quantity of Study Drug|Overall Study||6||
60101573|NCT01088464|76219145|FG002|Received Any Quantity of Study Drug|Overall Study||6||
60101574|NCT01088464|76219143|FG000|COMPLETED|Overall Study||3||
60101575|NCT01088464|76219144|FG001|COMPLETED|Overall Study||6||
60101576|NCT01088464|76219145|FG002|COMPLETED|Overall Study||6||
60101577|NCT01088464|76219143|FG000|NOT COMPLETED|Overall Study||0||
60101578|NCT01088464|76219144|FG001|NOT COMPLETED|Overall Study||0||
59817110|NCT04193176|75939552|FG000|NOT COMPLETED|Overall Study||6||
59817111|NCT04193176|75939553|FG001|NOT COMPLETED|Overall Study||10||
59994294|NCT03074695|76110083|FG000|NOT COMPLETED|Overall Study||4||
59994295|NCT03074695|76110084|FG001|NOT COMPLETED|Overall Study||5||
60101579|NCT01088464|76219145|FG002|NOT COMPLETED|Overall Study||0||
60101580|NCT01090180|76219155|FG000|STARTED|Overall Study||33||
60101581|NCT01090180|76219156|FG001|STARTED|Overall Study||29||
60101582|NCT01090180|76219155|FG000|COMPLETED|Overall Study||22||
60101583|NCT01090180|76219156|FG001|COMPLETED|Overall Study||21||
60101584|NCT01090180|76219155|FG000|NOT COMPLETED|Overall Study||11||
60101585|NCT01090180|76219156|FG001|NOT COMPLETED|Overall Study||8||
60101586|NCT00636207|76219165|FG000|STARTED|Overall Study|One participant discontinued after completing Period 2. Doses in Periods 1 and 2 were Montelukast.|1||
60101587|NCT00636207|76219166|FG001|STARTED|Overall Study|One participant withdrew consent after completing all study doses.|8||
60101588|NCT00636207|76219167|FG002|STARTED|Overall Study||18||
60101589|NCT00636207|76219168|FG003|STARTED|Overall Study||6||
60101590|NCT00636207|76219169|FG004|STARTED|Overall Study|One participant withdrew consent after completing all study doses.|9||
60101591|NCT00636207|76219170|FG005|STARTED|Overall Study||1||
60101592|NCT00636207|76219171|FG006|STARTED|Overall Study||3||
60101593|NCT00636207|76219165|FG000|COMPLETED|Overall Study||0||
59994296|NCT03469999|76110090|FG000|STARTED|Overall Study||12||
60101594|NCT00636207|76219166|FG001|COMPLETED|Overall Study||7||
60101595|NCT00636207|76219167|FG002|COMPLETED|Overall Study||18||
60101596|NCT00636207|76219168|FG003|COMPLETED|Overall Study||6||
60101597|NCT00636207|76219169|FG004|COMPLETED|Overall Study||8||
59564583|NCT03598647|75666881|FG002|NOT COMPLETED|Exercisers vs. Non-exercisers||0||
59564584|NCT03598647|75666882|FG003|NOT COMPLETED|Exercisers vs. Non-exercisers||0||
59564585|NCT03598647|75666879|FG000|STARTED|Interventions for Non-exercisers||0||
59564586|NCT03598647|75666880|FG001|STARTED|Interventions for Non-exercisers||0||
59708410|NCT01105533|75827235|FG008|COMPLETED|Overall Study||0||
59994297|NCT03469999|76110090|FG000|COMPLETED|Overall Study||10||
59994298|NCT03469999|76110090|FG000|NOT COMPLETED|Overall Study||2||
59994299|NCT02379728|76110097|FG000|STARTED|Overall Study||84||
59994300|NCT02379728|76110098|FG001|STARTED|Overall Study||16||
59994301|NCT02379728|76110099|FG002|STARTED|Overall Study||84||
59994302|NCT02379728|76110100|FG003|STARTED|Overall Study||16||
59994303|NCT02379728|76110097|FG000|COMPLETED|Overall Study||78||
59994304|NCT02379728|76110098|FG001|COMPLETED|Overall Study||16||
59994305|NCT02379728|76110099|FG002|COMPLETED|Overall Study||74||
59994306|NCT02379728|76110100|FG003|COMPLETED|Overall Study||13||
59994307|NCT02379728|76110097|FG000|NOT COMPLETED|Overall Study||6||
59708411|NCT01105533|75827227|FG000|NOT COMPLETED|Overall Study||1||
60101598|NCT00636207|76219170|FG005|COMPLETED|Overall Study||1||
60101599|NCT00636207|76219171|FG006|COMPLETED|Overall Study||3||
60101600|NCT00636207|76219165|FG000|NOT COMPLETED|Overall Study||1||
60101601|NCT00636207|76219166|FG001|NOT COMPLETED|Overall Study||1||
60101602|NCT00636207|76219167|FG002|NOT COMPLETED|Overall Study||0||
59994308|NCT02379728|76110098|FG001|NOT COMPLETED|Overall Study||0||
59994309|NCT02379728|76110099|FG002|NOT COMPLETED|Overall Study||10||
59994310|NCT02379728|76110100|FG003|NOT COMPLETED|Overall Study||3||
60101603|NCT00636207|76219168|FG003|NOT COMPLETED|Overall Study||0||
60101604|NCT00636207|76219169|FG004|NOT COMPLETED|Overall Study||1||
59564587|NCT03598647|75666881|FG002|STARTED|Interventions for Non-exercisers||14||
59564588|NCT03598647|75666882|FG003|STARTED|Interventions for Non-exercisers||16||
59564589|NCT03598647|75666879|FG000|COMPLETED|Interventions for Non-exercisers||0||
59564590|NCT03598647|75666880|FG001|COMPLETED|Interventions for Non-exercisers||0||
59564591|NCT03598647|75666881|FG002|COMPLETED|Interventions for Non-exercisers||14||
59564592|NCT03598647|75666882|FG003|COMPLETED|Interventions for Non-exercisers||16||
59564593|NCT03598647|75666879|FG000|NOT COMPLETED|Interventions for Non-exercisers||0||
60101605|NCT00636207|76219170|FG005|NOT COMPLETED|Overall Study||0||
60101606|NCT00636207|76219171|FG006|NOT COMPLETED|Overall Study||0||
60101607|NCT00635661|76219192|FG000|STARTED|Overall Study||34||
60101608|NCT00635661|76219192|FG000|COMPLETED|Overall Study||30||
60101609|NCT00635661|76219192|FG000|NOT COMPLETED|Overall Study||4||
60101610|NCT01091116|76219201|FG000|STARTED|Overall Study||83||
59564594|NCT03598647|75666880|FG001|NOT COMPLETED|Interventions for Non-exercisers||0||
59564595|NCT03598647|75666881|FG002|NOT COMPLETED|Interventions for Non-exercisers||0||
59564596|NCT03598647|75666882|FG003|NOT COMPLETED|Interventions for Non-exercisers||0||
59564597|NCT03599271|75666894|FG000|STARTED|Overall Study||70||140
59564598|NCT03599271|75666895|FG001|STARTED|Overall Study||5||10
59564599|NCT03599271|75666894|FG000|Drug-Coated Device|Overall Study||70||70
60101611|NCT01091116|76219202|FG001|STARTED|Overall Study||88||
60101612|NCT01091116|76219203|FG002|STARTED|Overall Study||84||
59564600|NCT03599271|75666895|FG001|Drug-Coated Device|Overall Study||5||10
59564601|NCT03599271|75666894|FG000|Control Device|Overall Study||70||70
59708412|NCT01105533|75827228|FG001|NOT COMPLETED|Overall Study||1||
59564602|NCT03599271|75666895|FG001|Control Device|Overall Study||0||0
59564603|NCT03599271|75666894|FG000|COMPLETED|Overall Study||70||140
60101613|NCT01091116|76219204|FG003|STARTED|Overall Study||84||
60101614|NCT01091116|76219205|FG004|STARTED|Overall Study||84||
60101615|NCT01091116|76219201|FG000|COMPLETED|Overall Study||77||
60101616|NCT01091116|76219202|FG001|COMPLETED|Overall Study||80||
60101617|NCT01091116|76219203|FG002|COMPLETED|Overall Study||73||
60101618|NCT01091116|76219204|FG003|COMPLETED|Overall Study||80||
60101619|NCT01091116|76219205|FG004|COMPLETED|Overall Study||73||
60101620|NCT01091116|76219201|FG000|NOT COMPLETED|Overall Study||6||
60101621|NCT01091116|76219202|FG001|NOT COMPLETED|Overall Study||8||
60101622|NCT01091116|76219203|FG002|NOT COMPLETED|Overall Study||11||
60101623|NCT01091116|76219204|FG003|NOT COMPLETED|Overall Study||4||
60101624|NCT01091116|76219205|FG004|NOT COMPLETED|Overall Study||11||
59564604|NCT03599271|75666895|FG001|COMPLETED|Overall Study||5||10
59564605|NCT03599271|75666894|FG000|NOT COMPLETED|Overall Study||0||0
59564606|NCT03599271|75666895|FG001|NOT COMPLETED|Overall Study||0||0
59564607|NCT03357393|75666906|FG000|STARTED|Overall Study||50||
59564608|NCT03357393|75666907|FG001|STARTED|Overall Study||50||
59994311|NCT03463993|76110111|FG000|STARTED|Overall Study||253||
60101625|NCT01092364|76219220|FG000|STARTED|Overall Study||122||
60101626|NCT01092364|76219221|FG001|STARTED|Overall Study||120||
60101627|NCT01092364|76219222|FG002|STARTED|Overall Study||123||
60101628|NCT01092364|76219220|FG000|COMPLETED|Overall Study||104||
59564609|NCT03357393|75666908|FG002|STARTED|Overall Study||50||
59564610|NCT03357393|75666906|FG000|COMPLETED|Overall Study||50||
59564611|NCT03357393|75666907|FG001|COMPLETED|Overall Study||50||
59564612|NCT03357393|75666908|FG002|COMPLETED|Overall Study||50||
59708413|NCT01105533|75827229|FG002|NOT COMPLETED|Overall Study||3||
59994312|NCT03463993|76110112|FG001|STARTED|Overall Study||253||
59994313|NCT03463993|76110111|FG000|COMPLETED|Overall Study||224||
59994314|NCT03463993|76110112|FG001|COMPLETED|Overall Study||227||
59994315|NCT03463993|76110111|FG000|NOT COMPLETED|Overall Study||29||
59994316|NCT03463993|76110112|FG001|NOT COMPLETED|Overall Study||26||
59994317|NCT04899440|76110120|FG000|STARTED|Overall Study||15||
59994318|NCT04899440|76110121|FG001|STARTED|Overall Study||15||
59564613|NCT03357393|75666906|FG000|NOT COMPLETED|Overall Study||0||
59564614|NCT03357393|75666907|FG001|NOT COMPLETED|Overall Study||0||
59564615|NCT03357393|75666908|FG002|NOT COMPLETED|Overall Study||0||
59564616|NCT03539211|75666918|FG000|STARTED|Overall Study||16||
59564617|NCT03539211|75666919|FG001|STARTED|Overall Study||15||
59994319|NCT04899440|76110120|FG000|COMPLETED|Overall Study||15||
59564618|NCT03539211|75666918|FG000|COMPLETED|Overall Study||16||
59564619|NCT03539211|75666919|FG001|COMPLETED|Overall Study||15||
59994320|NCT04899440|76110121|FG001|COMPLETED|Overall Study||15||
59994321|NCT04899440|76110120|FG000|NOT COMPLETED|Overall Study||0||
59994322|NCT04899440|76110121|FG001|NOT COMPLETED|Overall Study||0||
60101629|NCT01092364|76219221|FG001|COMPLETED|Overall Study||104||
60101630|NCT01092364|76219222|FG002|COMPLETED|Overall Study||105||
59564620|NCT03539211|75666918|FG000|NOT COMPLETED|Overall Study||0||
59564621|NCT03539211|75666919|FG001|NOT COMPLETED|Overall Study||0||
59564622|NCT03358251|75666925|FG000|STARTED|Overall Study||34||
59564623|NCT03358251|75666925|FG000|COMPLETED|Overall Study||34||
59564624|NCT03358251|75666925|FG000|NOT COMPLETED|Overall Study||0||
59564625|NCT03604263|75666932|FG000|STARTED|Overall Study||17||
59564626|NCT03604263|75666932|FG000|COMPLETED|Overall Study||15||
59564627|NCT03604263|75666932|FG000|NOT COMPLETED|Overall Study||2||
59564628|NCT03540147|75666936|FG000|STARTED|Overall Study||20||
60101631|NCT01092364|76219220|FG000|NOT COMPLETED|Overall Study||18||
60101632|NCT01092364|76219221|FG001|NOT COMPLETED|Overall Study||16||
60101633|NCT01092364|76219222|FG002|NOT COMPLETED|Overall Study||18||
60101634|NCT01092442|76219232|FG000|STARTED|Overall Study||80||
60101635|NCT01092442|76219233|FG001|STARTED|Overall Study||60||
60101636|NCT01092442|76219232|FG000|COMPLETED|Overall Study||80||
60101637|NCT01092442|76219233|FG001|COMPLETED|Overall Study||60||
60101638|NCT01092442|76219232|FG000|NOT COMPLETED|Overall Study||0||
60101639|NCT01092442|76219233|FG001|NOT COMPLETED|Overall Study||0||
60101640|NCT01092676|76219246|FG000|STARTED|Overall Study||50||
60101641|NCT01092676|76219247|FG001|STARTED|Overall Study||49||
60101642|NCT01092676|76219246|FG000|COMPLETED|Overall Study||50||
60101643|NCT01092676|76219247|FG001|COMPLETED|Overall Study||49||
60101644|NCT01092676|76219246|FG000|NOT COMPLETED|Overall Study||0||
60101645|NCT01092676|76219247|FG001|NOT COMPLETED|Overall Study||0||
60101646|NCT01092910|76219253|FG000|STARTED|Overall Study||57||
60101647|NCT01092910|76219253|FG000|4 Month Follow-up|Overall Study||54||
60101648|NCT01092910|76219253|FG000|10 Month Follow-up|Overall Study||52||
60101649|NCT01092910|76219253|FG000|COMPLETED|Overall Study||52||
60101650|NCT01092910|76219253|FG000|NOT COMPLETED|Overall Study||5||
60101651|NCT01039792|76219260|FG000|STARTED|Overall Study||29||
60101652|NCT01039792|76219261|FG001|STARTED|Overall Study||28||
60101653|NCT01039792|76219260|FG000|COMPLETED|Overall Study||23||
60101654|NCT01039792|76219261|FG001|COMPLETED|Overall Study||27||
60101655|NCT01039792|76219260|FG000|NOT COMPLETED|Overall Study||6||
60101656|NCT01039792|76219261|FG001|NOT COMPLETED|Overall Study||1||
60101657|NCT01041274|76219269|FG000|STARTED|Overall Study||49|Total Randomized|
60101658|NCT01041274|76219270|FG001|STARTED|Overall Study||46|Total Randomized|
60101659|NCT01041274|76219269|FG000|COMPLETED|Overall Study||26|Week 52 Completers|
60101660|NCT01041274|76219270|FG001|COMPLETED|Overall Study||25|Week 52 Completers|
60101661|NCT01041274|76219269|FG000|NOT COMPLETED|Overall Study||23||
60101662|NCT01041274|76219270|FG001|NOT COMPLETED|Overall Study||21||
60101663|NCT00635427|76219281|FG000|STARTED|Overall Study|12 participants were considered ITT population as 1 participant did not have type 1 Gaucher disease|13||
60101664|NCT00635427|76219282|FG001|STARTED|Overall Study|11 participants were considered ITT population as 1 participant did not have type 1 Gaucher disease|12||
60101665|NCT00635427|76219283|FG002|STARTED|Overall Study||16||
60101666|NCT00635427|76219284|FG003|STARTED|Overall Study||16||
60101667|NCT00635427|76219285|FG004|STARTED|Overall Study||38||
60101668|NCT00635427|76219281|FG000|COMPLETED|Overall Study||1||
60101669|NCT00635427|76219282|FG001|COMPLETED|Overall Study||6||
60101670|NCT00635427|76219283|FG002|COMPLETED|Overall Study||5||
59564629|NCT03540147|75666936|FG000|COMPLETED|Overall Study||20||
59564630|NCT03540147|75666936|FG000|NOT COMPLETED|Overall Study||0||
59564631|NCT03541941|75666951|FG000|STARTED|Overall Study||57||
59564632|NCT03541941|75666952|FG001|STARTED|Overall Study||55||
59564633|NCT03541941|75666953|FG002|STARTED|Overall Study||52||
60101671|NCT00635427|76219284|FG003|COMPLETED|Overall Study||7||
60101672|NCT00635427|76219285|FG004|COMPLETED|Overall Study||30||
60101673|NCT00635427|76219281|FG000|NOT COMPLETED|Overall Study||12||
60101674|NCT00635427|76219282|FG001|NOT COMPLETED|Overall Study||6||
60101675|NCT00635427|76219283|FG002|NOT COMPLETED|Overall Study||11||
59564634|NCT03541941|75666951|FG000|COMPLETED|Overall Study||57||
59564635|NCT03541941|75666952|FG001|COMPLETED|Overall Study||55||
60101676|NCT00635427|76219284|FG003|NOT COMPLETED|Overall Study||9||
59708414|NCT01105533|75827230|FG003|NOT COMPLETED|Overall Study||3||
59564636|NCT03541941|75666953|FG002|COMPLETED|Overall Study||52||
59564637|NCT03541941|75666951|FG000|NOT COMPLETED|Overall Study||0||
59564638|NCT03541941|75666952|FG001|NOT COMPLETED|Overall Study||0||
59564639|NCT03541941|75666953|FG002|NOT COMPLETED|Overall Study||0||
59564640|NCT03542019|75666964|FG000|STARTED|Overall Study||20||
59564641|NCT03542019|75666965|FG001|STARTED|Overall Study||20||
59708415|NCT01105533|75827231|FG004|NOT COMPLETED|Overall Study||7||
59708416|NCT01105533|75827232|FG005|NOT COMPLETED|Overall Study||7||
60101677|NCT00635427|76219285|FG004|NOT COMPLETED|Overall Study||8||
60101678|NCT00635349|76219297|FG000|STARTED|Overall Study||73||
60101679|NCT00635349|76219298|FG001|STARTED|Overall Study||67||
60101680|NCT00635349|76219297|FG000|COMPLETED|Overall Study||29||
60101681|NCT00635349|76219298|FG001|COMPLETED|Overall Study||19||
60101682|NCT00635349|76219297|FG000|NOT COMPLETED|Overall Study||44||
60101683|NCT00635349|76219298|FG001|NOT COMPLETED|Overall Study||48||
60101684|NCT00634803|76219307|FG000|STARTED|Overall Study||30||
60101685|NCT00634803|76219308|FG001|STARTED|Overall Study||30||
60101686|NCT00634803|76219309|FG002|STARTED|Overall Study||30||
59564642|NCT03542019|75666966|FG002|STARTED|Overall Study||20||
59564643|NCT03542019|75666964|FG000|COMPLETED|Overall Study||19||
59564644|NCT03542019|75666965|FG001|COMPLETED|Overall Study||17||
59564645|NCT03542019|75666966|FG002|COMPLETED|Overall Study||19||
59564646|NCT03542019|75666964|FG000|NOT COMPLETED|Overall Study||1||
59564647|NCT03542019|75666965|FG001|NOT COMPLETED|Overall Study||3||
59564648|NCT03542019|75666966|FG002|NOT COMPLETED|Overall Study||1||
59564649|NCT03550989|75666978|FG000|STARTED|Overall Study||190||
59708417|NCT01105533|75827233|FG006|NOT COMPLETED|Overall Study||8||
59708418|NCT01105533|75827234|FG007|NOT COMPLETED|Overall Study||4||
59708419|NCT01105533|75827235|FG008|NOT COMPLETED|Overall Study||12||
60101687|NCT00634803|76219307|FG000|Month 1|Overall Study||29||
60101688|NCT00634803|76219308|FG001|Month 1|Overall Study||29||
60101689|NCT00634803|76219309|FG002|Month 1|Overall Study||29||
60101690|NCT00634803|76219307|FG000|Month 2|Overall Study||26||
60101691|NCT00634803|76219308|FG001|Month 2|Overall Study||26||
60101692|NCT00634803|76219309|FG002|Month 2|Overall Study||28||
60101693|NCT00634803|76219307|FG000|Month 3|Overall Study||25||
59564650|NCT03550989|75666979|FG001|STARTED|Overall Study||74||
59564651|NCT03550989|75666980|FG002|STARTED|Overall Study||77||
59564652|NCT03550989|75666981|FG003|STARTED|Overall Study||60||
59564653|NCT03550989|75666978|FG000|COMPLETED|Overall Study||188||
59564654|NCT03550989|75666979|FG001|COMPLETED|Overall Study||73||
59564655|NCT03550989|75666980|FG002|COMPLETED|Overall Study||76||
59564656|NCT03550989|75666981|FG003|COMPLETED|Overall Study||60||
59564657|NCT03550989|75666978|FG000|NOT COMPLETED|Overall Study||2||
59564658|NCT03550989|75666979|FG001|NOT COMPLETED|Overall Study||1||
59564659|NCT03550989|75666980|FG002|NOT COMPLETED|Overall Study||1||
59564660|NCT03550989|75666981|FG003|NOT COMPLETED|Overall Study||0||
59564661|NCT03611829|75666997|FG000|STARTED|Overall Study||43||
59564662|NCT03611829|75666998|FG001|STARTED|Overall Study||44||
59564663|NCT03611829|75666997|FG000|COMPLETED|Overall Study||21||
59564664|NCT03611829|75666998|FG001|COMPLETED|Overall Study||19||
59564665|NCT03611829|75666997|FG000|NOT COMPLETED|Overall Study||22||
59564666|NCT03611829|75666998|FG001|NOT COMPLETED|Overall Study||25||
59564667|NCT03556761|75667007|FG000|STARTED|Overall Study||192||
59564668|NCT03556761|75667008|FG001|STARTED|Overall Study||192||
59564669|NCT03556761|75667007|FG000|COMPLETED|Overall Study||168||
59564670|NCT03556761|75667008|FG001|COMPLETED|Overall Study||163||
59564671|NCT03556761|75667007|FG000|NOT COMPLETED|Overall Study||24||
59564672|NCT03556761|75667008|FG001|NOT COMPLETED|Overall Study||29||
59564673|NCT03361917|75667016|FG000|STARTED|Overall Study||99||
59564674|NCT03361917|75667017|FG001|STARTED|Overall Study||101||
59708420|NCT01203072|75827253|FG000|STARTED|Overall Study||105||
59708421|NCT01203072|75827254|FG001|STARTED|Overall Study||106||
59564675|NCT03361917|75667016|FG000|COMPLETED|Overall Study||99||
59564676|NCT03361917|75667017|FG001|COMPLETED|Overall Study||101||
59708422|NCT01203072|75827255|FG002|STARTED|Overall Study||104||
59708423|NCT01203072|75827256|FG003|STARTED|Overall Study||106||
59564677|NCT03361917|75667016|FG000|NOT COMPLETED|Overall Study||0||
59564678|NCT03361917|75667017|FG001|NOT COMPLETED|Overall Study||0||
59564679|NCT03559179|75667026|FG000|STARTED|Overall Study||8||
59564680|NCT03559179|75667027|FG001|STARTED|Overall Study||24||
59564681|NCT03559179|75667028|FG002|STARTED|Overall Study||23||
59564682|NCT03559179|75667026|FG000|COMPLETED|Overall Study||8||
59564683|NCT03559179|75667027|FG001|COMPLETED|Overall Study||23||
59564684|NCT03559179|75667028|FG002|COMPLETED|Overall Study||23||
59564685|NCT03559179|75667026|FG000|NOT COMPLETED|Overall Study||0||
59564686|NCT03559179|75667027|FG001|NOT COMPLETED|Overall Study||1||
59564687|NCT03559179|75667028|FG002|NOT COMPLETED|Overall Study||0||
59564688|NCT03366207|75667045|FG000|STARTED|Overall Study||250||
59708424|NCT01203072|75827257|FG004|STARTED|Overall Study||102||
59564689|NCT03366207|75667045|FG000|COMPLETED|Overall Study||242||
59708425|NCT01203072|75827253|FG000|COMPLETED|Overall Study||95||
59564690|NCT03366207|75667045|FG000|NOT COMPLETED|Overall Study||8||
59564691|NCT03368235|75667051|FG000|STARTED|Overall Study||11||
59564692|NCT03368235|75667052|FG001|STARTED|Overall Study||10||
59564693|NCT03368235|75667051|FG000|COMPLETED|Overall Study||11||
59564694|NCT03368235|75667052|FG001|COMPLETED|Overall Study||10||
59564695|NCT03368235|75667051|FG000|NOT COMPLETED|Overall Study||0||
59564696|NCT03368235|75667052|FG001|NOT COMPLETED|Overall Study||0||
59564697|NCT03615183|75667063|FG000|STARTED|Overall Study||6||
59564698|NCT03615183|75667064|FG001|STARTED|Overall Study||6||
59564699|NCT03615183|75667065|FG002|STARTED|Overall Study||5||
59564700|NCT03615183|75667066|FG003|STARTED|Overall Study|Panel D was not conducted as the scientific study objectives were met in the conducted panels.|0||
59564701|NCT03615183|75667067|FG004|STARTED|Overall Study|Panel E was not conducted as the scientific study objectives were met in the conducted panels.|0||
59564702|NCT03615183|75667063|FG000|COMPLETED|Overall Study||6||
59564703|NCT03615183|75667064|FG001|COMPLETED|Overall Study||6||
59564704|NCT03615183|75667065|FG002|COMPLETED|Overall Study||5||
59564705|NCT03615183|75667066|FG003|COMPLETED|Overall Study||0||
59564706|NCT03615183|75667067|FG004|COMPLETED|Overall Study||0||
59564707|NCT03615183|75667063|FG000|NOT COMPLETED|Overall Study||0||
59564708|NCT03615183|75667064|FG001|NOT COMPLETED|Overall Study||0||
59564709|NCT03615183|75667065|FG002|NOT COMPLETED|Overall Study||0||
59564710|NCT03615183|75667066|FG003|NOT COMPLETED|Overall Study||0||
59564711|NCT03615183|75667067|FG004|NOT COMPLETED|Overall Study||0||
59564712|NCT02310750|75667086|FG000|STARTED|HP Period 1||7||
59564713|NCT02310750|75667087|FG001|STARTED|HP Period 1||6||
59564714|NCT02310750|75667088|FG002|STARTED|HP Period 1||6||
59564715|NCT02310750|75667089|FG003|STARTED|HP Period 1||6||
59564716|NCT02310750|75667090|FG004|STARTED|HP Period 1||8||
59564717|NCT02310750|75667091|FG005|STARTED|HP Period 1||8||
59564718|NCT02310750|75667092|FG006|STARTED|HP Period 1||13||
59564719|NCT02310750|75667093|FG007|STARTED|HP Period 1||0||
59564720|NCT02310750|75667094|FG008|STARTED|HP Period 1||0||
59564721|NCT02310750|75667095|FG009|STARTED|HP Period 1||0||
59564722|NCT02310750|75667096|FG010|STARTED|HP Period 1||2||
59564723|NCT02310750|75667097|FG011|STARTED|HP Period 1||2||
59564724|NCT02310750|75667098|FG012|STARTED|HP Period 1||2||
59564725|NCT02310750|75667099|FG013|STARTED|HP Period 1||2||
59564726|NCT02310750|75667100|FG014|STARTED|HP Period 1||2||
59564727|NCT02310750|75667101|FG015|STARTED|HP Period 1||2||
59564728|NCT02310750|75667086|FG000|COMPLETED|HP Period 1||6||
59564729|NCT02310750|75667087|FG001|COMPLETED|HP Period 1||6||
59564730|NCT02310750|75667088|FG002|COMPLETED|HP Period 1||6||
59564731|NCT02310750|75667089|FG003|COMPLETED|HP Period 1||5||
59564732|NCT02310750|75667090|FG004|COMPLETED|HP Period 1||8||
59564733|NCT02310750|75667091|FG005|COMPLETED|HP Period 1||8||
59564734|NCT02310750|75667092|FG006|COMPLETED|HP Period 1||12||
59564735|NCT02310750|75667093|FG007|COMPLETED|HP Period 1||0||
59564736|NCT02310750|75667094|FG008|COMPLETED|HP Period 1||0||
59564737|NCT02310750|75667095|FG009|COMPLETED|HP Period 1||0||
59564738|NCT02310750|75667096|FG010|COMPLETED|HP Period 1||2||
59564739|NCT02310750|75667097|FG011|COMPLETED|HP Period 1||2||
59564740|NCT02310750|75667098|FG012|COMPLETED|HP Period 1||2||
59564741|NCT02310750|75667099|FG013|COMPLETED|HP Period 1||2||
59564742|NCT02310750|75667100|FG014|COMPLETED|HP Period 1||2||
59564743|NCT02310750|75667101|FG015|COMPLETED|HP Period 1||2||
59564744|NCT02310750|75667086|FG000|NOT COMPLETED|HP Period 1||1||
59564745|NCT02310750|75667087|FG001|NOT COMPLETED|HP Period 1||0||
59564746|NCT02310750|75667088|FG002|NOT COMPLETED|HP Period 1||0||
59564747|NCT02310750|75667089|FG003|NOT COMPLETED|HP Period 1||1||
59564748|NCT02310750|75667090|FG004|NOT COMPLETED|HP Period 1||0||
59564749|NCT02310750|75667091|FG005|NOT COMPLETED|HP Period 1||0||
59564750|NCT02310750|75667092|FG006|NOT COMPLETED|HP Period 1||1||
59564751|NCT02310750|75667093|FG007|NOT COMPLETED|HP Period 1||0||
59564752|NCT02310750|75667094|FG008|NOT COMPLETED|HP Period 1||0||
59564753|NCT02310750|75667095|FG009|NOT COMPLETED|HP Period 1||0||
59564754|NCT02310750|75667096|FG010|NOT COMPLETED|HP Period 1||0||
59564755|NCT02310750|75667097|FG011|NOT COMPLETED|HP Period 1||0||
59564756|NCT02310750|75667098|FG012|NOT COMPLETED|HP Period 1||0||
59564757|NCT02310750|75667099|FG013|NOT COMPLETED|HP Period 1||0||
59564758|NCT02310750|75667100|FG014|NOT COMPLETED|HP Period 1||0||
59564759|NCT02310750|75667101|FG015|NOT COMPLETED|HP Period 1||0||
59564760|NCT02310750|75667086|FG000|STARTED|HP Washout 1||0||
59564761|NCT02310750|75667087|FG001|STARTED|HP Washout 1||0||
59564762|NCT02310750|75667088|FG002|STARTED|HP Washout 1||6||
59564763|NCT02310750|75667089|FG003|STARTED|HP Washout 1||5||
59564764|NCT02310750|75667090|FG004|STARTED|HP Washout 1||8||
59564765|NCT02310750|75667091|FG005|STARTED|HP Washout 1||8||
59564766|NCT02310750|75667092|FG006|STARTED|HP Washout 1||12||
59817112|NCT05384834|75939559|FG000|STARTED|Overall Study||60||
59564767|NCT02310750|75667093|FG007|STARTED|HP Washout 1||0||
59564768|NCT02310750|75667094|FG008|STARTED|HP Washout 1||0||
59564769|NCT02310750|75667095|FG009|STARTED|HP Washout 1||0||
59564770|NCT02310750|75667096|FG010|STARTED|HP Washout 1||2||
59564771|NCT02310750|75667097|FG011|STARTED|HP Washout 1||2||
59564772|NCT02310750|75667098|FG012|STARTED|HP Washout 1||2||
59564773|NCT02310750|75667099|FG013|STARTED|HP Washout 1||2||
59817113|NCT05384834|75939559|FG000|COMPLETED|Overall Study||12||
59564774|NCT02310750|75667100|FG014|STARTED|HP Washout 1||2||
59564775|NCT02310750|75667101|FG015|STARTED|HP Washout 1||2||
59564776|NCT02310750|75667086|FG000|COMPLETED|HP Washout 1||0||
59564777|NCT02310750|75667087|FG001|COMPLETED|HP Washout 1||0||
59564778|NCT02310750|75667088|FG002|COMPLETED|HP Washout 1||5||
59564779|NCT02310750|75667089|FG003|COMPLETED|HP Washout 1||4||
59564780|NCT02310750|75667090|FG004|COMPLETED|HP Washout 1||6||
59564781|NCT02310750|75667091|FG005|COMPLETED|HP Washout 1||6||
59564782|NCT02310750|75667092|FG006|COMPLETED|HP Washout 1||9||
59564783|NCT02310750|75667093|FG007|COMPLETED|HP Washout 1||0||
59564784|NCT02310750|75667094|FG008|COMPLETED|HP Washout 1||0||
59564785|NCT02310750|75667095|FG009|COMPLETED|HP Washout 1||0||
59564786|NCT02310750|75667096|FG010|COMPLETED|HP Washout 1||2||
59564787|NCT02310750|75667097|FG011|COMPLETED|HP Washout 1||2||
59564788|NCT02310750|75667098|FG012|COMPLETED|HP Washout 1||2||
59564789|NCT02310750|75667099|FG013|COMPLETED|HP Washout 1||2||
59564790|NCT02310750|75667100|FG014|COMPLETED|HP Washout 1||2||
59564791|NCT02310750|75667101|FG015|COMPLETED|HP Washout 1||2||
59564792|NCT02310750|75667086|FG000|NOT COMPLETED|HP Washout 1||0||
59564793|NCT02310750|75667087|FG001|NOT COMPLETED|HP Washout 1||0||
59564794|NCT02310750|75667088|FG002|NOT COMPLETED|HP Washout 1||1||
59564795|NCT02310750|75667089|FG003|NOT COMPLETED|HP Washout 1||1||
59564796|NCT02310750|75667090|FG004|NOT COMPLETED|HP Washout 1||2||
59564797|NCT02310750|75667091|FG005|NOT COMPLETED|HP Washout 1||2||
59564798|NCT02310750|75667092|FG006|NOT COMPLETED|HP Washout 1||3||
59564799|NCT02310750|75667093|FG007|NOT COMPLETED|HP Washout 1||0||
59564800|NCT02310750|75667094|FG008|NOT COMPLETED|HP Washout 1||0||
59564801|NCT02310750|75667095|FG009|NOT COMPLETED|HP Washout 1||0||
59564802|NCT02310750|75667096|FG010|NOT COMPLETED|HP Washout 1||0||
59564803|NCT02310750|75667097|FG011|NOT COMPLETED|HP Washout 1||0||
59564804|NCT02310750|75667098|FG012|NOT COMPLETED|HP Washout 1||0||
59564805|NCT02310750|75667099|FG013|NOT COMPLETED|HP Washout 1||0||
59564806|NCT02310750|75667100|FG014|NOT COMPLETED|HP Washout 1||0||
59564807|NCT02310750|75667101|FG015|NOT COMPLETED|HP Washout 1||0||
59564808|NCT02310750|75667086|FG000|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||0||
59564809|NCT02310750|75667087|FG001|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||0||
59564810|NCT02310750|75667088|FG002|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||5||
59564811|NCT02310750|75667089|FG003|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||4||
59564812|NCT02310750|75667090|FG004|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||6||
59564813|NCT02310750|75667091|FG005|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||6||
59564814|NCT02310750|75667092|FG006|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||9||
59564815|NCT02310750|75667093|FG007|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||9||
59564816|NCT02310750|75667094|FG008|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||14||
59564817|NCT02310750|75667095|FG009|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||7||
59564818|NCT02310750|75667096|FG010|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2||
59564819|NCT02310750|75667097|FG011|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2||
59564820|NCT02310750|75667098|FG012|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2||
59564821|NCT02310750|75667099|FG013|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2||
59564822|NCT02310750|75667100|FG014|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2||
59564823|NCT02310750|75667101|FG015|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2||
59564824|NCT02310750|75667086|FG000|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0||
59564825|NCT02310750|75667087|FG001|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0||
59564826|NCT02310750|75667088|FG002|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||5||
59564827|NCT02310750|75667089|FG003|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||3||
59564828|NCT02310750|75667090|FG004|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||6||
59564829|NCT02310750|75667091|FG005|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||4||
59564830|NCT02310750|75667092|FG006|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||9||
59564831|NCT02310750|75667093|FG007|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||7||
59564832|NCT02310750|75667094|FG008|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||6||
59564833|NCT02310750|75667095|FG009|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||4||
60101694|NCT00634803|76219308|FG001|Month 3|Overall Study||23||
59564834|NCT02310750|75667096|FG010|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2||
59564835|NCT02310750|75667097|FG011|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2||
60101695|NCT00634803|76219309|FG002|Month 3|Overall Study||26||
60101696|NCT00634803|76219307|FG000|COMPLETED|Overall Study||24||
59564836|NCT02310750|75667098|FG012|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2||
59564837|NCT02310750|75667099|FG013|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2||
59564838|NCT02310750|75667100|FG014|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2||
59564839|NCT02310750|75667101|FG015|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2||
59564840|NCT02310750|75667086|FG000|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0||
59564841|NCT02310750|75667087|FG001|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0||
59564842|NCT02310750|75667088|FG002|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0||
59564843|NCT02310750|75667089|FG003|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||1||
59564844|NCT02310750|75667090|FG004|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0||
59564845|NCT02310750|75667091|FG005|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2||
59564846|NCT02310750|75667092|FG006|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0||
59564847|NCT02310750|75667093|FG007|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2||
59564848|NCT02310750|75667094|FG008|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||8||
59564849|NCT02310750|75667095|FG009|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||3||
59564850|NCT02310750|75667096|FG010|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0||
59564851|NCT02310750|75667097|FG011|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0||
59564852|NCT02310750|75667098|FG012|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0||
59564853|NCT02310750|75667099|FG013|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0||
59564854|NCT02310750|75667100|FG014|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0||
59564855|NCT02310750|75667101|FG015|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0||
59564856|NCT02310750|75667086|FG000|STARTED|HP Washout 2||0||
59564857|NCT02310750|75667087|FG001|STARTED|HP Washout 2||0||
59564858|NCT02310750|75667088|FG002|STARTED|HP Washout 2||0||
59564859|NCT02310750|75667089|FG003|STARTED|HP Washout 2||0||
59564860|NCT02310750|75667090|FG004|STARTED|HP Washout 2||6||
59564861|NCT02310750|75667091|FG005|STARTED|HP Washout 2||0||
59564862|NCT02310750|75667092|FG006|STARTED|HP Washout 2||9||
59564863|NCT02310750|75667093|FG007|STARTED|HP Washout 2||0||
59564864|NCT02310750|75667094|FG008|STARTED|HP Washout 2||0||
59564865|NCT02310750|75667095|FG009|STARTED|HP Washout 2||0||
59564866|NCT02310750|75667096|FG010|STARTED|HP Washout 2||2||
59564867|NCT02310750|75667097|FG011|STARTED|HP Washout 2||2||
59564868|NCT02310750|75667098|FG012|STARTED|HP Washout 2||2||
59564869|NCT02310750|75667099|FG013|STARTED|HP Washout 2||2||
59564870|NCT02310750|75667100|FG014|STARTED|HP Washout 2||2||
59564871|NCT02310750|75667101|FG015|STARTED|HP Washout 2||2||
59564872|NCT02310750|75667086|FG000|COMPLETED|HP Washout 2||0||
59564873|NCT02310750|75667087|FG001|COMPLETED|HP Washout 2||0||
59564874|NCT02310750|75667088|FG002|COMPLETED|HP Washout 2||0||
59564875|NCT02310750|75667089|FG003|COMPLETED|HP Washout 2||0||
59564876|NCT02310750|75667090|FG004|COMPLETED|HP Washout 2||5||
59564877|NCT02310750|75667091|FG005|COMPLETED|HP Washout 2||0||
59564878|NCT02310750|75667092|FG006|COMPLETED|HP Washout 2||2||
59564879|NCT02310750|75667093|FG007|COMPLETED|HP Washout 2||0||
59564880|NCT02310750|75667094|FG008|COMPLETED|HP Washout 2||0||
59564881|NCT02310750|75667095|FG009|COMPLETED|HP Washout 2||0||
59564882|NCT02310750|75667096|FG010|COMPLETED|HP Washout 2||2||
59564883|NCT02310750|75667097|FG011|COMPLETED|HP Washout 2||2||
59564884|NCT02310750|75667098|FG012|COMPLETED|HP Washout 2||2||
59564885|NCT02310750|75667099|FG013|COMPLETED|HP Washout 2||2||
59564886|NCT02310750|75667100|FG014|COMPLETED|HP Washout 2||2||
59564887|NCT02310750|75667101|FG015|COMPLETED|HP Washout 2||2||
59564888|NCT02310750|75667086|FG000|NOT COMPLETED|HP Washout 2||0||
59564889|NCT02310750|75667087|FG001|NOT COMPLETED|HP Washout 2||0||
59564890|NCT02310750|75667088|FG002|NOT COMPLETED|HP Washout 2||0||
59564891|NCT02310750|75667089|FG003|NOT COMPLETED|HP Washout 2||0||
59564892|NCT02310750|75667090|FG004|NOT COMPLETED|HP Washout 2||1||
59564893|NCT02310750|75667091|FG005|NOT COMPLETED|HP Washout 2||0||
59564894|NCT02310750|75667092|FG006|NOT COMPLETED|HP Washout 2||7||
59564895|NCT02310750|75667093|FG007|NOT COMPLETED|HP Washout 2||0||
59564896|NCT02310750|75667094|FG008|NOT COMPLETED|HP Washout 2||0||
59564897|NCT02310750|75667095|FG009|NOT COMPLETED|HP Washout 2||0||
59564898|NCT02310750|75667096|FG010|NOT COMPLETED|HP Washout 2||0||
59564899|NCT02310750|75667097|FG011|NOT COMPLETED|HP Washout 2||0||
59564900|NCT02310750|75667098|FG012|NOT COMPLETED|HP Washout 2||0||
59564901|NCT02310750|75667099|FG013|NOT COMPLETED|HP Washout 2||0||
59564902|NCT02310750|75667100|FG014|NOT COMPLETED|HP Washout 2||0||
59564903|NCT02310750|75667101|FG015|NOT COMPLETED|HP Washout 2||0||
59564904|NCT02310750|75667086|FG000|STARTED|HP MAD and Fasted/Fed||0||
59564905|NCT02310750|75667087|FG001|STARTED|HP MAD and Fasted/Fed||0||
59564906|NCT02310750|75667088|FG002|STARTED|HP MAD and Fasted/Fed||0||
59564907|NCT02310750|75667089|FG003|STARTED|HP MAD and Fasted/Fed||0||
59564908|NCT02310750|75667090|FG004|STARTED|HP MAD and Fasted/Fed||5||
59564909|NCT02310750|75667091|FG005|STARTED|HP MAD and Fasted/Fed||0||
59564910|NCT02310750|75667092|FG006|STARTED|HP MAD and Fasted/Fed||2||
59564911|NCT02310750|75667093|FG007|STARTED|HP MAD and Fasted/Fed||0||
59564912|NCT02310750|75667094|FG008|STARTED|HP MAD and Fasted/Fed||0||
59564913|NCT02310750|75667095|FG009|STARTED|HP MAD and Fasted/Fed||0||
59564914|NCT02310750|75667096|FG010|STARTED|HP MAD and Fasted/Fed||2||
59564915|NCT02310750|75667097|FG011|STARTED|HP MAD and Fasted/Fed||2||
59564916|NCT02310750|75667098|FG012|STARTED|HP MAD and Fasted/Fed||2||
59564917|NCT02310750|75667099|FG013|STARTED|HP MAD and Fasted/Fed||2||
59564918|NCT02310750|75667100|FG014|STARTED|HP MAD and Fasted/Fed||2||
59564919|NCT02310750|75667101|FG015|STARTED|HP MAD and Fasted/Fed||2||
59564920|NCT02310750|75667086|FG000|COMPLETED|HP MAD and Fasted/Fed||0||
59564921|NCT02310750|75667087|FG001|COMPLETED|HP MAD and Fasted/Fed||0||
59564922|NCT02310750|75667088|FG002|COMPLETED|HP MAD and Fasted/Fed||0||
59564923|NCT02310750|75667089|FG003|COMPLETED|HP MAD and Fasted/Fed||0||
59564924|NCT02310750|75667090|FG004|COMPLETED|HP MAD and Fasted/Fed||4||
59564925|NCT02310750|75667091|FG005|COMPLETED|HP MAD and Fasted/Fed||0||
59564926|NCT02310750|75667092|FG006|COMPLETED|HP MAD and Fasted/Fed||2||
59564927|NCT02310750|75667093|FG007|COMPLETED|HP MAD and Fasted/Fed||0||
59564928|NCT02310750|75667094|FG008|COMPLETED|HP MAD and Fasted/Fed||0||
59564929|NCT02310750|75667095|FG009|COMPLETED|HP MAD and Fasted/Fed||0||
59564930|NCT02310750|75667096|FG010|COMPLETED|HP MAD and Fasted/Fed||2||
59564931|NCT02310750|75667097|FG011|COMPLETED|HP MAD and Fasted/Fed||2||
59564932|NCT02310750|75667098|FG012|COMPLETED|HP MAD and Fasted/Fed||2||
59564933|NCT02310750|75667099|FG013|COMPLETED|HP MAD and Fasted/Fed||2||
59564934|NCT02310750|75667100|FG014|COMPLETED|HP MAD and Fasted/Fed||2||
59564935|NCT02310750|75667101|FG015|COMPLETED|HP MAD and Fasted/Fed||2||
59564936|NCT02310750|75667086|FG000|NOT COMPLETED|HP MAD and Fasted/Fed||0||
59564937|NCT02310750|75667087|FG001|NOT COMPLETED|HP MAD and Fasted/Fed||0||
59564938|NCT02310750|75667088|FG002|NOT COMPLETED|HP MAD and Fasted/Fed||0||
59564939|NCT02310750|75667089|FG003|NOT COMPLETED|HP MAD and Fasted/Fed||0||
59564940|NCT02310750|75667090|FG004|NOT COMPLETED|HP MAD and Fasted/Fed||1||
59564941|NCT02310750|75667091|FG005|NOT COMPLETED|HP MAD and Fasted/Fed||0||
59564942|NCT02310750|75667092|FG006|NOT COMPLETED|HP MAD and Fasted/Fed||0||
59564943|NCT02310750|75667093|FG007|NOT COMPLETED|HP MAD and Fasted/Fed||0||
59564944|NCT02310750|75667094|FG008|NOT COMPLETED|HP MAD and Fasted/Fed||0||
59564945|NCT02310750|75667095|FG009|NOT COMPLETED|HP MAD and Fasted/Fed||0||
59564946|NCT02310750|75667096|FG010|NOT COMPLETED|HP MAD and Fasted/Fed||0||
59564947|NCT02310750|75667097|FG011|NOT COMPLETED|HP MAD and Fasted/Fed||0||
59564948|NCT02310750|75667098|FG012|NOT COMPLETED|HP MAD and Fasted/Fed||0||
59564949|NCT02310750|75667099|FG013|NOT COMPLETED|HP MAD and Fasted/Fed||0||
59564950|NCT02310750|75667100|FG014|NOT COMPLETED|HP MAD and Fasted/Fed||0||
59564951|NCT02310750|75667101|FG015|NOT COMPLETED|HP MAD and Fasted/Fed||0||
59564952|NCT03615807|75667184|FG000|STARTED|Overall Study||91||
59564953|NCT03615807|75667185|FG001|STARTED|Overall Study||91||
59564954|NCT03615807|75667184|FG000|COMPLETED|Overall Study||79||
59564955|NCT03615807|75667185|FG001|COMPLETED|Overall Study||80||
59564956|NCT03615807|75667184|FG000|NOT COMPLETED|Overall Study||12||
59564957|NCT03615807|75667185|FG001|NOT COMPLETED|Overall Study||11||
59564958|NCT03563313|75667193|FG000|STARTED|Overall Study||112||
59564959|NCT03563313|75667194|FG001|STARTED|Overall Study||56||
59564960|NCT03563313|75667193|FG000|COMPLETED|Overall Study||112||
59564961|NCT03563313|75667194|FG001|COMPLETED|Overall Study||56||
59564962|NCT03563313|75667193|FG000|NOT COMPLETED|Overall Study||0||
59564963|NCT03563313|75667194|FG001|NOT COMPLETED|Overall Study||0||
59564964|NCT02310672|75667206|FG000|STARTED|Overall Study||87||
59564965|NCT02310672|75667206|FG000|COMPLETED|Overall Study||72||
59564966|NCT02310672|75667206|FG000|NOT COMPLETED|Overall Study||15||
59564967|NCT03616899|75667212|FG000|STARTED|Overall Study||447||
59564968|NCT03616899|75667213|FG001|STARTED|Overall Study||454||
59564969|NCT03616899|75667212|FG000|COMPLETED|Overall Study||437||
59564970|NCT03616899|75667213|FG001|COMPLETED|Overall Study||453||
59564971|NCT03616899|75667212|FG000|NOT COMPLETED|Overall Study||10||
59564972|NCT03616899|75667213|FG001|NOT COMPLETED|Overall Study||1||
59564973|NCT03618147|75667219|FG000|STARTED|Overall Study||314||
59564974|NCT03618147|75667219|FG000|COMPLETED|Overall Study||314||
59564975|NCT03618147|75667219|FG000|NOT COMPLETED|Overall Study||0||
59564976|NCT03568539|75667226|FG000|STARTED|Overall Study||3||
59564977|NCT03568539|75667227|FG001|STARTED|Overall Study||36||
59564978|NCT03568539|75667226|FG000|COMPLETED|Overall Study||3||
59564979|NCT03568539|75667227|FG001|COMPLETED|Overall Study||36||
59564980|NCT03568539|75667226|FG000|NOT COMPLETED|Overall Study||0||
59564981|NCT03568539|75667227|FG001|NOT COMPLETED|Overall Study||0||
59564982|NCT03569397|75667236|FG000|STARTED|Overall Study||29||
59564983|NCT03569397|75667237|FG001|STARTED|Overall Study||28||
59564984|NCT03569397|75667236|FG000|COMPLETED|Overall Study||29||
59564985|NCT03569397|75667237|FG001|COMPLETED|Overall Study||28||
59564986|NCT03569397|75667236|FG000|NOT COMPLETED|Overall Study||0||
59564987|NCT03569397|75667237|FG001|NOT COMPLETED|Overall Study||0||
59564988|NCT03570255|75667242|FG000|STARTED|Overall Study||28||
59564989|NCT03570255|75667242|FG000|COMPLETED|Overall Study||28||
59564990|NCT03570255|75667242|FG000|NOT COMPLETED|Overall Study||0||
59564991|NCT03576183|75667248|FG000|STARTED|Overall Study||17||
59564992|NCT03576183|75667249|FG001|STARTED|Overall Study||17||
59564993|NCT03576183|75667248|FG000|COMPLETED|Overall Study||15||
59564994|NCT03576183|75667249|FG001|COMPLETED|Overall Study||16||
59564995|NCT03576183|75667248|FG000|NOT COMPLETED|Overall Study||2||
59564996|NCT03576183|75667249|FG001|NOT COMPLETED|Overall Study||1||
59564997|NCT03377127|75667257|FG000|STARTED|Overall Study||42||
59564998|NCT03377127|75667258|FG001|STARTED|Overall Study||44||
59564999|NCT03377127|75667257|FG000|COMPLETED|Overall Study||42||
59565000|NCT03377127|75667258|FG001|COMPLETED|Overall Study||44||
59565001|NCT03377127|75667257|FG000|NOT COMPLETED|Overall Study||0||
59565002|NCT03377127|75667258|FG001|NOT COMPLETED|Overall Study||0||
59565003|NCT03378921|75667266|FG000|STARTED|Overall Study||13||
59565004|NCT03378921|75667267|FG001|STARTED|Overall Study||13||
59565005|NCT03378921|75667266|FG000|COMPLETED|Overall Study||13||
59565006|NCT03378921|75667267|FG001|COMPLETED|Overall Study||13||
59565007|NCT03378921|75667266|FG000|NOT COMPLETED|Overall Study||0||
59565008|NCT03378921|75667267|FG001|NOT COMPLETED|Overall Study||0||
59565009|NCT03626415|75667276|FG000|STARTED|Overall Study||8||
59565010|NCT03626415|75667277|FG001|STARTED|Overall Study||8||
59565011|NCT03626415|75667278|FG002|STARTED|Overall Study||8||
59565012|NCT03626415|75667276|FG000|COMPLETED|Overall Study||8||
59708426|NCT01203072|75827254|FG001|COMPLETED|Overall Study||100||
59708427|NCT01203072|75827255|FG002|COMPLETED|Overall Study||101||
59708428|NCT01203072|75827256|FG003|COMPLETED|Overall Study||100||
59565013|NCT03626415|75667277|FG001|COMPLETED|Overall Study||8||
59565014|NCT03626415|75667278|FG002|COMPLETED|Overall Study||8||
59708429|NCT01203072|75827257|FG004|COMPLETED|Overall Study||96||
59565015|NCT03626415|75667276|FG000|NOT COMPLETED|Overall Study||0||
59708430|NCT01203072|75827253|FG000|NOT COMPLETED|Overall Study||10||
59565016|NCT03626415|75667277|FG001|NOT COMPLETED|Overall Study||0||
59565017|NCT03626415|75667278|FG002|NOT COMPLETED|Overall Study||0||
59817114|NCT05384834|75939559|FG000|NOT COMPLETED|Overall Study||48||
59565018|NCT04373421|75667289|FG000|STARTED|Overall Study||30||
60101697|NCT00634803|76219308|FG001|COMPLETED|Overall Study||23||
59565019|NCT04373421|75667290|FG001|STARTED|Overall Study||30||
59565020|NCT04373421|75667291|FG002|STARTED|Overall Study||30||
59565021|NCT04373421|75667289|FG000|COMPLETED|Overall Study||26||
59565022|NCT04373421|75667290|FG001|COMPLETED|Overall Study||26||
59565023|NCT04373421|75667291|FG002|COMPLETED|Overall Study||29||
59565024|NCT04373421|75667289|FG000|NOT COMPLETED|Overall Study||4||
59565025|NCT04373421|75667290|FG001|NOT COMPLETED|Overall Study||4||
59565026|NCT04373421|75667291|FG002|NOT COMPLETED|Overall Study||1||
59565027|NCT03629535|75667302|FG000|STARTED|Overall Study||8||
59565028|NCT03629535|75667302|FG000|COMPLETED|Overall Study||8||
59565029|NCT03629535|75667302|FG000|NOT COMPLETED|Overall Study||0||
59565030|NCT03379545|75667306|FG000|STARTED|Overall Study||29||
59565031|NCT03379545|75667306|FG000|COMPLETED|Overall Study||29||
59565032|NCT03379545|75667306|FG000|NOT COMPLETED|Overall Study||0||
59565033|NCT04528017|75667313|FG000|STARTED|First Wear Period (8 -0/+3 Days)||27||54
59565034|NCT04528017|75667314|FG001|STARTED|First Wear Period (8 -0/+3 Days)||28||56
59565035|NCT04528017|75667313|FG000|COMPLETED|First Wear Period (8 -0/+3 Days)||27||54
59565036|NCT04528017|75667314|FG001|COMPLETED|First Wear Period (8 -0/+3 Days)||28||56
59565037|NCT04528017|75667313|FG000|NOT COMPLETED|First Wear Period (8 -0/+3 Days)||0||0
59565038|NCT04528017|75667314|FG001|NOT COMPLETED|First Wear Period (8 -0/+3 Days)||0||0
59565039|NCT04528017|75667313|FG000|STARTED|Second Wear Period (8 -0/+3 Days)||27||54
59565040|NCT04528017|75667314|FG001|STARTED|Second Wear Period (8 -0/+3 Days)||28||56
59565041|NCT04528017|75667313|FG000|COMPLETED|Second Wear Period (8 -0/+3 Days)||27||54
59565042|NCT04528017|75667314|FG001|COMPLETED|Second Wear Period (8 -0/+3 Days)||28||56
59565043|NCT04528017|75667313|FG000|NOT COMPLETED|Second Wear Period (8 -0/+3 Days)||0||0
59565044|NCT04528017|75667314|FG001|NOT COMPLETED|Second Wear Period (8 -0/+3 Days)||0||0
59565045|NCT03382509|75667325|FG000|STARTED|Overall Study||8|Started are treated|
59565046|NCT03382509|75667326|FG001|STARTED|Overall Study||8|Started are treated|
59565047|NCT03382509|75667325|FG000|COMPLETED|Overall Study||8||
59565048|NCT03382509|75667326|FG001|COMPLETED|Overall Study||8||
59565049|NCT03382509|75667325|FG000|NOT COMPLETED|Overall Study||0||
59565050|NCT03382509|75667326|FG001|NOT COMPLETED|Overall Study||0||
59565051|NCT03632109|75667333|FG000|STARTED|Overall Study||13||
59565052|NCT03632109|75667333|FG000|COMPLETED|Overall Study||13||
59565053|NCT03632109|75667333|FG000|NOT COMPLETED|Overall Study||0||
59565054|NCT02363946|75667352|FG000|STARTED|Overall Study||4||
59565055|NCT02363946|75667353|FG001|STARTED|Overall Study||4||
59565056|NCT02363946|75667354|FG002|STARTED|Overall Study||4||
59565057|NCT02363946|75667355|FG003|STARTED|Overall Study||4||
59565058|NCT02363946|75667356|FG004|STARTED|Overall Study||4||
59565059|NCT02363946|75667357|FG005|STARTED|Overall Study||4||
59565060|NCT02363946|75667358|FG006|STARTED|Overall Study||4||
59565061|NCT02363946|75667359|FG007|STARTED|Overall Study||4||
59565062|NCT02363946|75667360|FG008|STARTED|Overall Study||4||
59565063|NCT02363946|75667361|FG009|STARTED|Overall Study||18||
59565064|NCT02363946|75667362|FG010|STARTED|Overall Study||4||
59565065|NCT02363946|75667363|FG011|STARTED|Overall Study||3||
59565066|NCT02363946|75667364|FG012|STARTED|Overall Study||4||
59565067|NCT02363946|75667352|FG000|COMPLETED|Overall Study||4||
59817115|NCT05101486|75939566|FG000|STARTED|Overall Study||251||
59565068|NCT02363946|75667353|FG001|COMPLETED|Overall Study||4||
59565069|NCT02363946|75667354|FG002|COMPLETED|Overall Study||4||
59565070|NCT02363946|75667355|FG003|COMPLETED|Overall Study||4||
59565071|NCT02363946|75667356|FG004|COMPLETED|Overall Study||4||
59565072|NCT02363946|75667357|FG005|COMPLETED|Overall Study||4||
59565073|NCT02363946|75667358|FG006|COMPLETED|Overall Study||4||
59565074|NCT02363946|75667359|FG007|COMPLETED|Overall Study||3||
59565075|NCT02363946|75667360|FG008|COMPLETED|Overall Study||4||
59565076|NCT02363946|75667361|FG009|COMPLETED|Overall Study||18||
59565077|NCT02363946|75667362|FG010|COMPLETED|Overall Study||4||
59708431|NCT01203072|75827254|FG001|NOT COMPLETED|Overall Study||6||
60101698|NCT00634803|76219309|FG002|COMPLETED|Overall Study||23||
60101699|NCT00634803|76219307|FG000|NOT COMPLETED|Overall Study||6||
60101700|NCT00634803|76219308|FG001|NOT COMPLETED|Overall Study||7||
59708432|NCT01203072|75827255|FG002|NOT COMPLETED|Overall Study||3||
59565078|NCT02363946|75667363|FG011|COMPLETED|Overall Study||3||
59708433|NCT01203072|75827256|FG003|NOT COMPLETED|Overall Study||6||
59708434|NCT01203072|75827257|FG004|NOT COMPLETED|Overall Study||6||
60101701|NCT00634803|76219309|FG002|NOT COMPLETED|Overall Study||7||
60101702|NCT01401699|76219317|FG000|STARTED|Overall Study||109||
60101703|NCT01401699|76219317|FG000|COMPLETED|Overall Study||109||
60101704|NCT01401699|76219317|FG000|NOT COMPLETED|Overall Study||0||
60101705|NCT01042288|76219321|FG000|STARTED|Overall Study||69||
60101706|NCT01042288|76219321|FG000|Maintenance|Overall Study||27||
60103773|NCT04102098|76222035|FG000|NOT COMPLETED|Crossover: AS Who Crossed Over||81||
59565079|NCT02363946|75667364|FG012|COMPLETED|Overall Study||4||
59708435|NCT01105377|75827271|FG000|STARTED|Overall Study||24||
59708436|NCT01105377|75827272|FG001|STARTED|Overall Study||23||
59565080|NCT02363946|75667352|FG000|NOT COMPLETED|Overall Study||0||
59565081|NCT02363946|75667353|FG001|NOT COMPLETED|Overall Study||0||
59565082|NCT02363946|75667354|FG002|NOT COMPLETED|Overall Study||0||
59565083|NCT02363946|75667355|FG003|NOT COMPLETED|Overall Study||0||
59565084|NCT02363946|75667356|FG004|NOT COMPLETED|Overall Study||0||
59565085|NCT02363946|75667357|FG005|NOT COMPLETED|Overall Study||0||
59565086|NCT02363946|75667358|FG006|NOT COMPLETED|Overall Study||0||
59565087|NCT02363946|75667359|FG007|NOT COMPLETED|Overall Study||1||
59565088|NCT02363946|75667360|FG008|NOT COMPLETED|Overall Study||0||
59565089|NCT02363946|75667361|FG009|NOT COMPLETED|Overall Study||0||
59565090|NCT02363946|75667362|FG010|NOT COMPLETED|Overall Study||0||
59565091|NCT02363946|75667363|FG011|NOT COMPLETED|Overall Study||0||
59565092|NCT02363946|75667364|FG012|NOT COMPLETED|Overall Study||0||
59565093|NCT02363478|75667392|FG000|STARTED|Overall Study||30||
59565094|NCT02363478|75667392|FG000|COMPLETED|Overall Study||22||
59565095|NCT02363478|75667392|FG000|NOT COMPLETED|Overall Study||8||
59565096|NCT02310126|75667399|FG000|STARTED|Period 1 (15 Minutes)||94||
59565097|NCT02310126|75667400|FG001|STARTED|Period 1 (15 Minutes)||97||
59565098|NCT02310126|75667399|FG000|Hyperopes|Period 1 (15 Minutes)||38||
59565099|NCT02310126|75667400|FG001|Hyperopes|Period 1 (15 Minutes)||33||
59565100|NCT02310126|75667399|FG000|Myopes|Period 1 (15 Minutes)||56||
59565101|NCT02310126|75667400|FG001|Myopes|Period 1 (15 Minutes)||64||
59565102|NCT02310126|75667399|FG000|COMPLETED|Period 1 (15 Minutes)||94||
59565103|NCT02310126|75667400|FG001|COMPLETED|Period 1 (15 Minutes)||95||
59565104|NCT02310126|75667399|FG000|NOT COMPLETED|Period 1 (15 Minutes)||0||
59565105|NCT02310126|75667400|FG001|NOT COMPLETED|Period 1 (15 Minutes)||2||
59565106|NCT02310126|75667399|FG000|STARTED|Period 2 (15 Minutes)||94||
59565107|NCT02310126|75667400|FG001|STARTED|Period 2 (15 Minutes)||95||
59565108|NCT02310126|75667399|FG000|Hyperopes|Period 2 (15 Minutes)||38||
59565109|NCT02310126|75667400|FG001|Hyperopes|Period 2 (15 Minutes)||32||
59565110|NCT02310126|75667399|FG000|Myopes|Period 2 (15 Minutes)||56||
59565111|NCT02310126|75667400|FG001|Myopes|Period 2 (15 Minutes)||63||
59565112|NCT02310126|75667399|FG000|COMPLETED|Period 2 (15 Minutes)||94||
59565113|NCT02310126|75667400|FG001|COMPLETED|Period 2 (15 Minutes)||95||
59565114|NCT02310126|75667399|FG000|NOT COMPLETED|Period 2 (15 Minutes)||0||
59565115|NCT02310126|75667400|FG001|NOT COMPLETED|Period 2 (15 Minutes)||0||
59565116|NCT02338362|75667408|FG000|STARTED|Overall Study||11||
59565117|NCT02338362|75667409|FG001|STARTED|Overall Study||11||
59565118|NCT02338362|75667408|FG000|COMPLETED|Overall Study||10||
59565119|NCT02338362|75667409|FG001|COMPLETED|Overall Study||10||
59565120|NCT02338362|75667408|FG000|NOT COMPLETED|Overall Study||1||
59565121|NCT02338362|75667409|FG001|NOT COMPLETED|Overall Study||1||
59565122|NCT02363322|75667417|FG000|STARTED|Overall Study||36||
59565123|NCT02363322|75667418|FG001|STARTED|Overall Study||36||
59565124|NCT02363322|75667417|FG000|COMPLETED|Overall Study||35||
59565125|NCT02363322|75667418|FG001|COMPLETED|Overall Study||36||
59565126|NCT02363322|75667417|FG000|NOT COMPLETED|Overall Study||1||
59565127|NCT02363322|75667418|FG001|NOT COMPLETED|Overall Study||0||
59565128|NCT02361762|75667426|FG000|STARTED|Overall Study||35||
59565129|NCT02361762|75667427|FG001|STARTED|Overall Study||35||
59565130|NCT02361762|75667426|FG000|COMPLETED|Overall Study||35||
59565131|NCT02361762|75667427|FG001|COMPLETED|Overall Study||33||
59565132|NCT02361762|75667426|FG000|NOT COMPLETED|Overall Study||0||
59565133|NCT02361762|75667427|FG001|NOT COMPLETED|Overall Study||2||
59565134|NCT02337738|75667436|FG000|STARTED|Overall Study||141||
59565135|NCT02337738|75667437|FG001|STARTED|Overall Study||134||
59565136|NCT02337738|75667438|FG002|STARTED|Overall Study||129||
59565137|NCT02337738|75667436|FG000|COMPLETED|Overall Study||119||
59565138|NCT02337738|75667437|FG001|COMPLETED|Overall Study||104||
59565139|NCT02337738|75667438|FG002|COMPLETED|Overall Study||103||
59565140|NCT02337738|75667436|FG000|NOT COMPLETED|Overall Study||22||
59565141|NCT02337738|75667437|FG001|NOT COMPLETED|Overall Study||30||
59565142|NCT02337738|75667438|FG002|NOT COMPLETED|Overall Study||26||
59565143|NCT02309112|75667449|FG000|STARTED|Overall Study||5||
59565144|NCT02309112|75667450|FG001|STARTED|Overall Study||5||
59565145|NCT02309112|75667451|FG002|STARTED|Overall Study||5||
59565146|NCT02309112|75667449|FG000|Completed Yoga Intervention|Overall Study||4||
59565147|NCT02309112|75667450|FG001|Completed Yoga Intervention|Overall Study||5||
59565148|NCT02309112|75667451|FG002|Completed Yoga Intervention|Overall Study||4||
59565149|NCT02309112|75667449|FG000|COMPLETED|Overall Study||4||
59565150|NCT02309112|75667450|FG001|COMPLETED|Overall Study||4||
59565151|NCT02309112|75667451|FG002|COMPLETED|Overall Study||4||
59565152|NCT02309112|75667449|FG000|NOT COMPLETED|Overall Study||1||
59565153|NCT02309112|75667450|FG001|NOT COMPLETED|Overall Study||1||
59565154|NCT02309112|75667451|FG002|NOT COMPLETED|Overall Study||1||
59565155|NCT02361216|75667463|FG000|STARTED|3 Day Treatment and 8 Week Follow/up||552||
59565156|NCT02361216|75667464|FG001|STARTED|3 Day Treatment and 8 Week Follow/up||177||
59565157|NCT02361216|75667463|FG000|COMPLETED|3 Day Treatment and 8 Week Follow/up||541||
59565158|NCT02361216|75667464|FG001|COMPLETED|3 Day Treatment and 8 Week Follow/up||158||
59565159|NCT02361216|75667463|FG000|NOT COMPLETED|3 Day Treatment and 8 Week Follow/up||11||
59565160|NCT02361216|75667464|FG001|NOT COMPLETED|3 Day Treatment and 8 Week Follow/up||19||
59565161|NCT02361216|75667463|FG000|STARTED|12-month Follow-up||541||
59565162|NCT02361216|75667464|FG001|STARTED|12-month Follow-up|1 of the 158 subjects did not receive treatment and was also excluded from the 12-month follow-up.|157||
59565163|NCT02361216|75667463|FG000|COMPLETED|12-month Follow-up||489||
59565164|NCT02361216|75667464|FG001|COMPLETED|12-month Follow-up||130||
59565165|NCT02361216|75667463|FG000|NOT COMPLETED|12-month Follow-up||52||
59565166|NCT02361216|75667464|FG001|NOT COMPLETED|12-month Follow-up||27||
59565167|NCT01803074|75667487|FG000|STARTED|Period 1: Part A (HIV-1 Clade B)||8||
59565168|NCT01803074|75667488|FG001|STARTED|Period 1: Part A (HIV-1 Clade B)||8||
59565169|NCT01803074|75667489|FG002|STARTED|Period 1: Part A (HIV-1 Clade B)||8||
59565170|NCT01803074|75667490|FG003|STARTED|Period 1: Part A (HIV-1 Clade B)||8||
59565171|NCT01803074|75667491|FG004|STARTED|Period 1: Part A (HIV-1 Clade B)||8||
59565172|NCT01803074|75667492|FG005|STARTED|Period 1: Part A (HIV-1 Clade B)||8||
59565173|NCT01803074|75667493|FG006|STARTED|Period 1: Part A (HIV-1 Clade B)||12||
59565174|NCT01803074|75667494|FG007|STARTED|Period 1: Part A (HIV-1 Clade B)||0||
59565175|NCT01803074|75667495|FG008|STARTED|Period 1: Part A (HIV-1 Clade B)||0||
59565176|NCT01803074|75667496|FG009|STARTED|Period 1: Part A (HIV-1 Clade B)||0||
59565177|NCT01803074|75667497|FG010|STARTED|Period 1: Part A (HIV-1 Clade B)||0||
59565178|NCT01803074|75667498|FG011|STARTED|Period 1: Part A (HIV-1 Clade B)||0||
59565179|NCT01803074|75667499|FG012|STARTED|Period 1: Part A (HIV-1 Clade B)||0||
59565180|NCT01803074|75667500|FG013|STARTED|Period 1: Part A (HIV-1 Clade B)||0||
59565181|NCT01803074|75667487|FG000|COMPLETED|Period 1: Part A (HIV-1 Clade B)||8||
59565182|NCT01803074|75667488|FG001|COMPLETED|Period 1: Part A (HIV-1 Clade B)||8||
59565183|NCT01803074|75667489|FG002|COMPLETED|Period 1: Part A (HIV-1 Clade B)||8||
59565184|NCT01803074|75667490|FG003|COMPLETED|Period 1: Part A (HIV-1 Clade B)||8||
59565185|NCT01803074|75667491|FG004|COMPLETED|Period 1: Part A (HIV-1 Clade B)||8||
59565186|NCT01803074|75667492|FG005|COMPLETED|Period 1: Part A (HIV-1 Clade B)||8||
59565187|NCT01803074|75667493|FG006|COMPLETED|Period 1: Part A (HIV-1 Clade B)||12||
59565188|NCT01803074|75667494|FG007|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0||
59565189|NCT01803074|75667495|FG008|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0||
59565190|NCT01803074|75667496|FG009|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0||
59565191|NCT01803074|75667497|FG010|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0||
59565192|NCT01803074|75667498|FG011|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0||
59565193|NCT01803074|75667499|FG012|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0||
59565194|NCT01803074|75667500|FG013|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0||
59565195|NCT01803074|75667487|FG000|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0||
59565196|NCT01803074|75667488|FG001|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0||
59565197|NCT01803074|75667489|FG002|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0||
59565198|NCT01803074|75667490|FG003|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0||
59708437|NCT01105377|75827271|FG000|COMPLETED|Overall Study||24||
59708438|NCT01105377|75827272|FG001|COMPLETED|Overall Study||22||
59708439|NCT01105377|75827271|FG000|NOT COMPLETED|Overall Study||0||
59708440|NCT01105377|75827272|FG001|NOT COMPLETED|Overall Study||1||
59565199|NCT01803074|75667491|FG004|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0||
59565200|NCT01803074|75667492|FG005|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0||
59565201|NCT01803074|75667493|FG006|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0||
59565202|NCT01803074|75667494|FG007|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0||
59565203|NCT01803074|75667495|FG008|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0||
59565204|NCT01803074|75667496|FG009|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0||
59565205|NCT01803074|75667497|FG010|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0||
59565206|NCT01803074|75667498|FG011|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0||
59565207|NCT01803074|75667499|FG012|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0||
59565208|NCT01803074|75667500|FG013|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0||
59565209|NCT01803074|75667487|FG000|STARTED|Period 2: Part B (HIV-1 Clade B)||0||
59565210|NCT01803074|75667488|FG001|STARTED|Period 2: Part B (HIV-1 Clade B)||0||
59565211|NCT01803074|75667489|FG002|STARTED|Period 2: Part B (HIV-1 Clade B)||0||
59565212|NCT01803074|75667490|FG003|STARTED|Period 2: Part B (HIV-1 Clade B)||0||
59565213|NCT01803074|75667491|FG004|STARTED|Period 2: Part B (HIV-1 Clade B)||0||
59565214|NCT01803074|75667492|FG005|STARTED|Period 2: Part B (HIV-1 Clade B)||0||
59565215|NCT01803074|75667493|FG006|STARTED|Period 2: Part B (HIV-1 Clade B)||0||
59565216|NCT01803074|75667494|FG007|STARTED|Period 2: Part B (HIV-1 Clade B)||8||
59565217|NCT01803074|75667495|FG008|STARTED|Period 2: Part B (HIV-1 Clade B)||8||
59565218|NCT01803074|75667496|FG009|STARTED|Period 2: Part B (HIV-1 Clade B)||4||
59565219|NCT01803074|75667497|FG010|STARTED|Period 2: Part B (HIV-1 Clade B)||8||
59565220|NCT01803074|75667498|FG011|STARTED|Period 2: Part B (HIV-1 Clade B)||0||
59565221|NCT01803074|75667499|FG012|STARTED|Period 2: Part B (HIV-1 Clade B)||0||
59565222|NCT01803074|75667500|FG013|STARTED|Period 2: Part B (HIV-1 Clade B)||0||
59565223|NCT01803074|75667487|FG000|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0||
59565224|NCT01803074|75667488|FG001|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0||
59565225|NCT01803074|75667489|FG002|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0||
59565226|NCT01803074|75667490|FG003|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0||
59565227|NCT01803074|75667491|FG004|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0||
59565228|NCT01803074|75667492|FG005|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0||
59565229|NCT01803074|75667493|FG006|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0||
59565230|NCT01803074|75667494|FG007|COMPLETED|Period 2: Part B (HIV-1 Clade B)||8||
59565231|NCT01803074|75667495|FG008|COMPLETED|Period 2: Part B (HIV-1 Clade B)||8||
59565232|NCT01803074|75667496|FG009|COMPLETED|Period 2: Part B (HIV-1 Clade B)||4||
59565233|NCT01803074|75667497|FG010|COMPLETED|Period 2: Part B (HIV-1 Clade B)||8||
59565234|NCT01803074|75667498|FG011|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0||
59565235|NCT01803074|75667499|FG012|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0||
59565236|NCT01803074|75667500|FG013|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0||
59565237|NCT01803074|75667487|FG000|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0||
59565238|NCT01803074|75667488|FG001|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0||
59565239|NCT01803074|75667489|FG002|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0||
59565240|NCT01803074|75667490|FG003|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0||
59565241|NCT01803074|75667491|FG004|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0||
59565242|NCT01803074|75667492|FG005|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0||
59565243|NCT01803074|75667493|FG006|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0||
59565244|NCT01803074|75667494|FG007|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0||
59565245|NCT01803074|75667495|FG008|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0||
59565246|NCT01803074|75667496|FG009|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0||
59565247|NCT01803074|75667497|FG010|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0||
59565248|NCT01803074|75667498|FG011|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0||
59565249|NCT01803074|75667499|FG012|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0||
59565250|NCT01803074|75667500|FG013|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0||
59565251|NCT01803074|75667487|FG000|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0||
59565252|NCT01803074|75667488|FG001|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0||
59565253|NCT01803074|75667489|FG002|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0||
59565254|NCT01803074|75667490|FG003|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0||
59565255|NCT01803074|75667491|FG004|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0||
59565256|NCT01803074|75667492|FG005|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0||
59565257|NCT01803074|75667493|FG006|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0||
59565258|NCT01803074|75667494|FG007|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0||
59565259|NCT01803074|75667495|FG008|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0||
59565260|NCT01803074|75667496|FG009|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0||
59565261|NCT01803074|75667497|FG010|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0||
59565262|NCT01803074|75667498|FG011|STARTED|Period 3: Part C (HIV-1 Clade C Only)||8||
59565263|NCT01803074|75667499|FG012|STARTED|Period 3: Part C (HIV-1 Clade C Only)||7||
59565264|NCT01803074|75667500|FG013|STARTED|Period 3: Part C (HIV-1 Clade C Only)||4||
59565265|NCT01803074|75667487|FG000|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0||
59565266|NCT01803074|75667488|FG001|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0||
59565267|NCT01803074|75667489|FG002|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0||
59565268|NCT01803074|75667490|FG003|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0||
59565269|NCT01803074|75667491|FG004|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0||
59565270|NCT01803074|75667492|FG005|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0||
59565271|NCT01803074|75667493|FG006|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0||
59565272|NCT01803074|75667494|FG007|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0||
59565273|NCT01803074|75667495|FG008|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0||
59565274|NCT01803074|75667496|FG009|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0||
59565275|NCT01803074|75667497|FG010|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0||
59817116|NCT05101486|75939567|FG001|STARTED|Overall Study||252||
59565276|NCT01803074|75667498|FG011|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||8||
59565277|NCT01803074|75667499|FG012|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||7||
59565278|NCT01803074|75667500|FG013|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||4||
59565279|NCT01803074|75667487|FG000|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0||
59565280|NCT01803074|75667488|FG001|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0||
59817117|NCT05101486|75939568|FG002|STARTED|Overall Study||252||
59565281|NCT01803074|75667489|FG002|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0||
59565282|NCT01803074|75667490|FG003|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0||
59565283|NCT01803074|75667491|FG004|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0||
59565284|NCT01803074|75667492|FG005|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0||
59565285|NCT01803074|75667493|FG006|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0||
59565286|NCT01803074|75667494|FG007|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0||
59565287|NCT01803074|75667495|FG008|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0||
59565288|NCT01803074|75667496|FG009|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0||
59565289|NCT01803074|75667497|FG010|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0||
59565290|NCT01803074|75667498|FG011|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0||
59565291|NCT01803074|75667499|FG012|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0||
59565292|NCT01803074|75667500|FG013|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0||
59565293|NCT01805024|75667543|FG000|STARTED|Overall Study||4||
59565294|NCT01805024|75667544|FG001|STARTED|Overall Study||4||
59565295|NCT01805024|75667545|FG002|STARTED|Overall Study||4||
59565296|NCT01805024|75667546|FG003|STARTED|Overall Study||8||
59565297|NCT01805024|75667543|FG000|COMPLETED|Overall Study||4||
59565298|NCT01805024|75667544|FG001|COMPLETED|Overall Study||4||
59565299|NCT01805024|75667545|FG002|COMPLETED|Overall Study||4||
59565300|NCT01805024|75667546|FG003|COMPLETED|Overall Study||8||
59565301|NCT01805024|75667543|FG000|NOT COMPLETED|Overall Study||0||
59565302|NCT01805024|75667544|FG001|NOT COMPLETED|Overall Study||0||
59565303|NCT01805024|75667545|FG002|NOT COMPLETED|Overall Study||0||
59565304|NCT01805024|75667546|FG003|NOT COMPLETED|Overall Study||0||
59565305|NCT01821326|75667556|FG000|STARTED|Overall Study||339||
59565306|NCT01821326|75667556|FG000|COMPLETED|Overall Study||339||
59565307|NCT01821326|75667556|FG000|NOT COMPLETED|Overall Study||0||
59565308|NCT01822574|75667563|FG000|STARTED|Overall Study||30||
59565309|NCT01822574|75667564|FG001|STARTED|Overall Study||30||
59565310|NCT01822574|75667565|FG002|STARTED|Overall Study||30||
59565311|NCT01822574|75667563|FG000|COMPLETED|Overall Study||30||
59565312|NCT01822574|75667564|FG001|COMPLETED|Overall Study||30||
59565313|NCT01822574|75667565|FG002|COMPLETED|Overall Study||30||
59565314|NCT01822574|75667563|FG000|NOT COMPLETED|Overall Study||0||
59565315|NCT01822574|75667564|FG001|NOT COMPLETED|Overall Study||0||
59565316|NCT01822574|75667565|FG002|NOT COMPLETED|Overall Study||0||
59565317|NCT01822886|75667573|FG000|STARTED|Overall Study||20||
59565318|NCT01822886|75667573|FG000|COMPLETED|Overall Study||5||
59708441|NCT01105065|75827278|FG000|STARTED|Overall Study||23||
59708442|NCT01105065|75827278|FG000|COMPLETED|Overall Study||17||
59708443|NCT01105065|75827278|FG000|NOT COMPLETED|Overall Study||6||
59708444|NCT01111539|75827284|FG000|STARTED|Phase B (Day 1 to Week 8)||211||
59708445|NCT01111539|75827285|FG001|STARTED|Phase B (Day 1 to Week 8)||0||
59708446|NCT01111539|75827286|FG002|STARTED|Phase B (Day 1 to Week 8)||0||
59708447|NCT01111539|75827287|FG003|STARTED|Phase B (Day 1 to Week 8)||0||
59708448|NCT01111539|75827288|FG004|STARTED|Phase B (Day 1 to Week 8)||0||
59708449|NCT01111539|75827284|FG000|COMPLETED|Phase B (Day 1 to Week 8)||129||
59708450|NCT01111539|75827285|FG001|COMPLETED|Phase B (Day 1 to Week 8)||0||
59708451|NCT01111539|75827286|FG002|COMPLETED|Phase B (Day 1 to Week 8)||0||
59708452|NCT01111539|75827287|FG003|COMPLETED|Phase B (Day 1 to Week 8)||0||
59708453|NCT01111539|75827288|FG004|COMPLETED|Phase B (Day 1 to Week 8)||0||
59708454|NCT01111539|75827284|FG000|NOT COMPLETED|Phase B (Day 1 to Week 8)||82||
59708455|NCT01111539|75827285|FG001|NOT COMPLETED|Phase B (Day 1 to Week 8)||0||
60101707|NCT01042288|76219321|FG000|COMPLETED|Overall Study|Patients remained on maintenance until disease progression, toxicity or other reason to come off|0||
60101708|NCT01042288|76219321|FG000|NOT COMPLETED|Overall Study||69||
60101709|NCT01217385|76219325|FG000|STARTED|Overall Study||60||
60101710|NCT01217385|76219325|FG000|COMPLETED|Overall Study||34||
59565319|NCT01822886|75667573|FG000|NOT COMPLETED|Overall Study||15||
59565320|NCT01823510|75667577|FG000|STARTED|Days 1-7||10||
59565321|NCT01823510|75667578|FG001|STARTED|Days 1-7||10||
59565322|NCT01823510|75667577|FG000|COMPLETED|Days 1-7||10||
59565323|NCT01823510|75667578|FG001|COMPLETED|Days 1-7||10||
59565324|NCT01823510|75667577|FG000|NOT COMPLETED|Days 1-7||0||
59565325|NCT01823510|75667578|FG001|NOT COMPLETED|Days 1-7||0||
59565326|NCT01823510|75667577|FG000|STARTED|Days 8-21||10||
60101711|NCT01217385|76219325|FG000|NOT COMPLETED|Overall Study||26||
60101712|NCT01042366|76219338|FG000|STARTED|Overall Study||5||
60101713|NCT01042366|76219339|FG001|STARTED|Overall Study||6||
60101714|NCT01042366|76219340|FG002|STARTED|Overall Study||4||
59708456|NCT01111539|75827286|FG002|NOT COMPLETED|Phase B (Day 1 to Week 8)||0||
59708457|NCT01111539|75827287|FG003|NOT COMPLETED|Phase B (Day 1 to Week 8)||0||
59708458|NCT01111539|75827288|FG004|NOT COMPLETED|Phase B (Day 1 to Week 8)||0||
59708459|NCT01111539|75827284|FG000|STARTED|Phase B+ and Phase C (Weeks 9 to 14)||0||
60101715|NCT01042366|76219338|FG000|COMPLETED|Overall Study||5||
60101716|NCT01042366|76219339|FG001|COMPLETED|Overall Study||6||
60101717|NCT01042366|76219340|FG002|COMPLETED|Overall Study||4||
60101718|NCT01042366|76219338|FG000|NOT COMPLETED|Overall Study||0||
60101719|NCT01042366|76219339|FG001|NOT COMPLETED|Overall Study||0||
60101720|NCT01042366|76219340|FG002|NOT COMPLETED|Overall Study||0||
60101721|NCT01043146|76219352|FG000|STARTED|Overall Study||10||
60101722|NCT01043146|76219353|FG001|STARTED|Overall Study||8||
60101723|NCT01043146|76219354|FG002|STARTED|Overall Study||8||
60101724|NCT01043146|76219355|FG003|STARTED|Overall Study||8||
60101725|NCT01043146|76219356|FG004|STARTED|Overall Study||8||
60101726|NCT01043146|76219357|FG005|STARTED|Overall Study||8||
60101727|NCT01043146|76219352|FG000|COMPLETED|Overall Study||10||
59565327|NCT01823510|75667578|FG001|STARTED|Days 8-21||10||
59565328|NCT01823510|75667577|FG000|COMPLETED|Days 8-21||10||
59565329|NCT01823510|75667578|FG001|COMPLETED|Days 8-21||10||
59565330|NCT01823510|75667577|FG000|NOT COMPLETED|Days 8-21||0||
59565331|NCT01823510|75667578|FG001|NOT COMPLETED|Days 8-21||0||
59565332|NCT01823510|75667577|FG000|STARTED|Days 22-28||10||
59565333|NCT01823510|75667578|FG001|STARTED|Days 22-28||10||
59565334|NCT01823510|75667577|FG000|COMPLETED|Days 22-28||10||
59565335|NCT01823510|75667578|FG001|COMPLETED|Days 22-28||10||
59565336|NCT01823510|75667577|FG000|NOT COMPLETED|Days 22-28||0||
59565337|NCT01823510|75667578|FG001|NOT COMPLETED|Days 22-28||0||
59565338|NCT01824446|75667584|FG000|STARTED|Overall Study||6||
59565339|NCT01824446|75667584|FG000|COMPLETED|Overall Study||6||
59565340|NCT01824446|75667584|FG000|NOT COMPLETED|Overall Study||0||
60101728|NCT01043146|76219353|FG001|COMPLETED|Overall Study||8||
60101729|NCT01043146|76219354|FG002|COMPLETED|Overall Study||8||
60101730|NCT01043146|76219355|FG003|COMPLETED|Overall Study||8||
60101731|NCT01043146|76219356|FG004|COMPLETED|Overall Study||8||
60101732|NCT01043146|76219357|FG005|COMPLETED|Overall Study||8||
60101733|NCT01043146|76219352|FG000|NOT COMPLETED|Overall Study||0||
60101734|NCT01043146|76219353|FG001|NOT COMPLETED|Overall Study||0||
60101735|NCT01043146|76219354|FG002|NOT COMPLETED|Overall Study||0||
60101736|NCT01043146|76219355|FG003|NOT COMPLETED|Overall Study||0||
60101737|NCT01043146|76219356|FG004|NOT COMPLETED|Overall Study||0||
60101738|NCT01043146|76219357|FG005|NOT COMPLETED|Overall Study||0||
59565341|NCT02263040|75667590|FG000|STARTED|Overall Study||87||
59565342|NCT02263040|75667591|FG001|STARTED|Overall Study||83||
59565343|NCT02263040|75667590|FG000|COMPLETED|Overall Study||87||
59565344|NCT02263040|75667591|FG001|COMPLETED|Overall Study||83||
60101739|NCT01043926|76219373|FG000|STARTED|Overall Study||8||
60101740|NCT01043926|76219374|FG001|STARTED|Overall Study||8||
59565345|NCT02263040|75667590|FG000|NOT COMPLETED|Overall Study||0||
59565346|NCT02263040|75667591|FG001|NOT COMPLETED|Overall Study||0||
60101741|NCT01043926|76219375|FG002|STARTED|Overall Study||0||
60101742|NCT01043926|76219376|FG003|STARTED|Overall Study||0||
60101743|NCT01043926|76219373|FG000|COMPLETED|Overall Study||8||
60101744|NCT01043926|76219374|FG001|COMPLETED|Overall Study||8||
60101745|NCT01043926|76219375|FG002|COMPLETED|Overall Study||0||
60101746|NCT01043926|76219376|FG003|COMPLETED|Overall Study||0||
60101747|NCT01043926|76219373|FG000|NOT COMPLETED|Overall Study||0||
60101748|NCT01043926|76219374|FG001|NOT COMPLETED|Overall Study||0||
60101749|NCT01043926|76219375|FG002|NOT COMPLETED|Overall Study||0||
60101750|NCT01043926|76219376|FG003|NOT COMPLETED|Overall Study||0||
60101751|NCT01044706|76219386|FG000|STARTED|Overall Study||30||
60101752|NCT01044706|76219387|FG001|STARTED|Overall Study||30||
60101753|NCT01044706|76219386|FG000|COMPLETED|Overall Study||30||
60101754|NCT01044706|76219387|FG001|COMPLETED|Overall Study||30||
60101755|NCT01044706|76219386|FG000|NOT COMPLETED|Overall Study||0||
60101756|NCT01044706|76219387|FG001|NOT COMPLETED|Overall Study||0||
60101757|NCT01044862|76219396|FG000|STARTED|Overall Study||299||
60101758|NCT01044862|76219397|FG001|STARTED|Overall Study||300||
59708460|NCT01111539|75827285|FG001|STARTED|Phase B+ and Phase C (Weeks 9 to 14)||45||
59708461|NCT01111539|75827286|FG002|STARTED|Phase B+ and Phase C (Weeks 9 to 14)||28||
59708462|NCT01111539|75827287|FG003|STARTED|Phase B+ and Phase C (Weeks 9 to 14)||28||
59708463|NCT01111539|75827288|FG004|STARTED|Phase B+ and Phase C (Weeks 9 to 14)||28||
59708464|NCT01111539|75827284|FG000|Intent-to-treat (ITT) Sample|Phase B+ and Phase C (Weeks 9 to 14)||0|ITT Sample included all participants in the Randomized Sample who received at least one dose of double-blind study medication and had at least one post-randomization efficacy evaluation.|
59994323|NCT02412488|76110127|FG000|STARTED|Overall Study||192||
59994324|NCT02412488|76110127|FG000|Reveal LINQ Implanted|Overall Study||191||
59994325|NCT02412488|76110127|FG000|COMPLETED|Overall Study||174||
59994326|NCT02412488|76110127|FG000|NOT COMPLETED|Overall Study||18||
59994327|NCT02378480|76110133|FG000|STARTED|Overall Study||329||
59994328|NCT02378480|76110134|FG001|STARTED|Overall Study||326||
59994329|NCT02378480|76110133|FG000|COMPLETED|Overall Study||301||
59994330|NCT02378480|76110134|FG001|COMPLETED|Overall Study||294||
59994331|NCT02378480|76110133|FG000|NOT COMPLETED|Overall Study||28||
59994332|NCT02378480|76110134|FG001|NOT COMPLETED|Overall Study||32||
59994333|NCT02411396|76110140|FG000|STARTED|Overall Study||483|First participant enrolled on 4/30/2015 at Johns Hopkins|
59994334|NCT02411396|76110140|FG000|COMPLETED|Overall Study||442||
59994335|NCT02411396|76110140|FG000|NOT COMPLETED|Overall Study||41||
59994336|NCT01004029|76110151|FG000|STARTED|Overall Study||578|ITT Population - intent to treat|
59994337|NCT01004029|76110152|FG001|STARTED|Overall Study||1130|ITT Population - intent to treat|
59994338|NCT01004029|76110151|FG000|Safety Population|Overall Study||578|Two subjects in the vehicle group were randomized to 17P but did not receive treatment with study medication.|
59994339|NCT01004029|76110152|FG001|Safety Population|Overall Study||1128|Two subjects in the vehicle group were randomized to 17P but did not receive treatment with study medication.|
59994340|NCT01004029|76110151|FG000|COMPLETED|Overall Study||530|PP Population - per-protocol|
59994341|NCT01004029|76110152|FG001|COMPLETED|Overall Study||1057|PP Population - per-protocol|
59708465|NCT01111539|75827285|FG001|Intent-to-treat (ITT) Sample|Phase B+ and Phase C (Weeks 9 to 14)||45|ITT Sample included all participants in the Randomized Sample who received at least one dose of double-blind study medication and had at least one post-randomization efficacy evaluation.|
59708466|NCT01111539|75827286|FG002|Intent-to-treat (ITT) Sample|Phase B+ and Phase C (Weeks 9 to 14)||28|ITT Sample included all participants in the Randomized Sample who received at least one dose of double-blind study medication and had at least one post-randomization efficacy evaluation.|
59708467|NCT01111539|75827287|FG003|Intent-to-treat (ITT) Sample|Phase B+ and Phase C (Weeks 9 to 14)||27|ITT Sample included all participants in the Randomized Sample who received at least one dose of double-blind study medication and had at least one post-randomization efficacy evaluation.|
59708468|NCT01111539|75827288|FG004|Intent-to-treat (ITT) Sample|Phase B+ and Phase C (Weeks 9 to 14)||28|ITT Sample included all participants in the Randomized Sample who received at least one dose of double-blind study medication and had at least one post-randomization efficacy evaluation.|
59708469|NCT01111539|75827284|FG000|Safety Sample|Phase B+ and Phase C (Weeks 9 to 14)||0|Safety Sample included those randomized participants in Phase C who received at least one dose of double-blind study medication as indicated on the dosing record.|
59708470|NCT01111539|75827285|FG001|Safety Sample|Phase B+ and Phase C (Weeks 9 to 14)||45|Safety Sample included those randomized participants in Phase C who received at least one dose of double-blind study medication as indicated on the dosing record.|
60101759|NCT01044862|76219398|FG002|STARTED|Overall Study||301||
60101760|NCT01044862|76219396|FG000|COMPLETED|Overall Study||246||
60101761|NCT01044862|76219397|FG001|COMPLETED|Overall Study||251||
60101762|NCT01044862|76219398|FG002|COMPLETED|Overall Study||249||
60101763|NCT01044862|76219396|FG000|NOT COMPLETED|Overall Study||53||
60101764|NCT01044862|76219397|FG001|NOT COMPLETED|Overall Study||49||
60101765|NCT01044862|76219398|FG002|NOT COMPLETED|Overall Study||52||
60101766|NCT01045174|76219408|FG000|STARTED|Overall Study||90||
60101767|NCT01045174|76219409|FG001|STARTED|Overall Study||90||
60101768|NCT01045174|76219408|FG000|COMPLETED|Overall Study||90||
60101769|NCT01045174|76219409|FG001|COMPLETED|Overall Study||90||
60101770|NCT01045174|76219408|FG000|NOT COMPLETED|Overall Study||0||
60101771|NCT01045174|76219409|FG001|NOT COMPLETED|Overall Study||0||
60101772|NCT01047358|76219415|FG000|STARTED|Overall Study||206||
60101773|NCT01047358|76219415|FG000|COMPLETED|Overall Study|At least one safety assessment (Safety Population)|206||
60101774|NCT01047358|76219415|FG000|NOT COMPLETED|Overall Study||0||
60101775|NCT01048606|76219424|FG000|STARTED|Overall Study||28||
60101776|NCT01048606|76219425|FG001|STARTED|Overall Study||15||
60101777|NCT01048606|76219426|FG002|STARTED|Overall Study||26||
60101778|NCT01048606|76219427|FG003|STARTED|Overall Study||10||
60101779|NCT01048606|76219424|FG000|COMPLETED|Overall Study||16||
60101780|NCT01048606|76219425|FG001|COMPLETED|Overall Study||8||
60101781|NCT01048606|76219426|FG002|COMPLETED|Overall Study||16||
60101782|NCT01048606|76219427|FG003|COMPLETED|Overall Study||5||
60101783|NCT01048606|76219424|FG000|NOT COMPLETED|Overall Study||12||
60101784|NCT01048606|76219425|FG001|NOT COMPLETED|Overall Study||7||
60101785|NCT01048606|76219426|FG002|NOT COMPLETED|Overall Study||10||
60101786|NCT01048606|76219427|FG003|NOT COMPLETED|Overall Study||5||
60101787|NCT01049776|76219437|FG000|STARTED|Overall Study||32||
60101788|NCT01049776|76219437|FG000|COMPLETED|Overall Study||12||
60101789|NCT01049776|76219437|FG000|NOT COMPLETED|Overall Study||20||
60101790|NCT01772004|76219464|FG000|STARTED|Dose Escalation Phase||4||
60101791|NCT01772004|76219465|FG001|STARTED|Dose Escalation Phase||13||
60101792|NCT01772004|76219466|FG002|STARTED|Dose Escalation Phase||15||
60101793|NCT01772004|76219467|FG003|STARTED|Dose Escalation Phase||21||
60101794|NCT01772004|76219468|FG004|STARTED|Dose Escalation Phase||8||
60101795|NCT01772004|76219469|FG005|STARTED|Dose Escalation Phase||0||
60101796|NCT01772004|76219470|FG006|STARTED|Dose Escalation Phase||0||
60101797|NCT01772004|76219471|FG007|STARTED|Dose Escalation Phase||0||
60101798|NCT01772004|76219472|FG008|STARTED|Dose Escalation Phase||0||
60101799|NCT01772004|76219473|FG009|STARTED|Dose Escalation Phase||0||
60101800|NCT01772004|76219474|FG010|STARTED|Dose Escalation Phase||0||
60101801|NCT01772004|76219475|FG011|STARTED|Dose Escalation Phase||0||
60101802|NCT01772004|76219476|FG012|STARTED|Dose Escalation Phase||0||
60101803|NCT01772004|76219477|FG013|STARTED|Dose Escalation Phase||0||
60101804|NCT01772004|76219478|FG014|STARTED|Dose Escalation Phase||0||
60101805|NCT01772004|76219479|FG015|STARTED|Dose Escalation Phase||0||
60101806|NCT01772004|76219480|FG016|STARTED|Dose Escalation Phase||0||
59708471|NCT01111539|75827286|FG002|Safety Sample|Phase B+ and Phase C (Weeks 9 to 14)||28|Safety Sample included those randomized participants in Phase C who received at least one dose of double-blind study medication as indicated on the dosing record.|
60101807|NCT01772004|76219481|FG017|STARTED|Dose Escalation Phase||0||
60101808|NCT01772004|76219482|FG018|STARTED|Dose Escalation Phase||0||
60101809|NCT01772004|76219483|FG019|STARTED|Dose Escalation Phase||0||
60101810|NCT01772004|76219484|FG020|STARTED|Dose Escalation Phase||0||
60101811|NCT01772004|76219485|FG021|STARTED|Dose Escalation Phase||0||
60101812|NCT01772004|76219486|FG022|STARTED|Dose Escalation Phase||0||
60101813|NCT01772004|76219464|FG000|COMPLETED|Dose Escalation Phase||4||
60101814|NCT01772004|76219465|FG001|COMPLETED|Dose Escalation Phase||13||
59565347|NCT02271698|75667605|FG000|STARTED|Overall Study||11||
59565348|NCT02271698|75667606|FG001|STARTED|Overall Study||10||
59565349|NCT02271698|75667607|FG002|STARTED|Overall Study||10||
59565350|NCT02271698|75667608|FG003|STARTED|Overall Study||11||
59709837|NCT01072149|75828531|FG011|STARTED|Treatment Period 2 (28 Days)||3||
59709838|NCT01072149|75828532|FG012|STARTED|Treatment Period 2 (28 Days)||3||
60101815|NCT01772004|76219466|FG002|COMPLETED|Dose Escalation Phase||15||
60101816|NCT01772004|76219467|FG003|COMPLETED|Dose Escalation Phase||21||
60101817|NCT01772004|76219468|FG004|COMPLETED|Dose Escalation Phase||8||
59565351|NCT02271698|75667605|FG000|COMPLETED|Overall Study||11||
59565352|NCT02271698|75667606|FG001|COMPLETED|Overall Study||10||
59565353|NCT02271698|75667607|FG002|COMPLETED|Overall Study||10||
59565354|NCT02271698|75667608|FG003|COMPLETED|Overall Study||11||
59565355|NCT02271698|75667605|FG000|NOT COMPLETED|Overall Study||0||
59565356|NCT02271698|75667606|FG001|NOT COMPLETED|Overall Study||0||
59565357|NCT02271698|75667607|FG002|NOT COMPLETED|Overall Study||0||
59565358|NCT02271698|75667608|FG003|NOT COMPLETED|Overall Study||0||
59565359|NCT02272244|75667620|FG000|STARTED|Overall Study||203||
60101818|NCT01772004|76219469|FG005|COMPLETED|Dose Escalation Phase||0||
60101819|NCT01772004|76219470|FG006|COMPLETED|Dose Escalation Phase||0||
60101820|NCT01772004|76219471|FG007|COMPLETED|Dose Escalation Phase||0||
60101821|NCT01772004|76219472|FG008|COMPLETED|Dose Escalation Phase||0||
60101822|NCT01772004|76219473|FG009|COMPLETED|Dose Escalation Phase||0||
60101823|NCT01772004|76219474|FG010|COMPLETED|Dose Escalation Phase||0||
60101824|NCT01772004|76219475|FG011|COMPLETED|Dose Escalation Phase||0||
60101825|NCT01772004|76219476|FG012|COMPLETED|Dose Escalation Phase||0||
60101826|NCT01772004|76219477|FG013|COMPLETED|Dose Escalation Phase||0||
60101827|NCT01772004|76219478|FG014|COMPLETED|Dose Escalation Phase||0||
60101828|NCT01772004|76219479|FG015|COMPLETED|Dose Escalation Phase||0||
60101829|NCT01772004|76219480|FG016|COMPLETED|Dose Escalation Phase||0||
60101830|NCT01772004|76219481|FG017|COMPLETED|Dose Escalation Phase||0||
60101831|NCT01772004|76219482|FG018|COMPLETED|Dose Escalation Phase||0||
60101832|NCT01772004|76219483|FG019|COMPLETED|Dose Escalation Phase||0||
60101833|NCT01772004|76219484|FG020|COMPLETED|Dose Escalation Phase||0||
60101834|NCT01772004|76219485|FG021|COMPLETED|Dose Escalation Phase||0||
60101835|NCT01772004|76219486|FG022|COMPLETED|Dose Escalation Phase||0||
60101836|NCT01772004|76219464|FG000|NOT COMPLETED|Dose Escalation Phase||0||
60101837|NCT01772004|76219465|FG001|NOT COMPLETED|Dose Escalation Phase||0||
60101838|NCT01772004|76219466|FG002|NOT COMPLETED|Dose Escalation Phase||0||
60101839|NCT01772004|76219467|FG003|NOT COMPLETED|Dose Escalation Phase||0||
60101840|NCT01772004|76219468|FG004|NOT COMPLETED|Dose Escalation Phase||0||
60101841|NCT01772004|76219469|FG005|NOT COMPLETED|Dose Escalation Phase||0||
60101842|NCT01772004|76219470|FG006|NOT COMPLETED|Dose Escalation Phase||0||
60101843|NCT01772004|76219471|FG007|NOT COMPLETED|Dose Escalation Phase||0||
60101844|NCT01772004|76219472|FG008|NOT COMPLETED|Dose Escalation Phase||0||
60101845|NCT01772004|76219473|FG009|NOT COMPLETED|Dose Escalation Phase||0||
60101846|NCT01772004|76219474|FG010|NOT COMPLETED|Dose Escalation Phase||0||
60101847|NCT01772004|76219475|FG011|NOT COMPLETED|Dose Escalation Phase||0||
60101848|NCT01772004|76219476|FG012|NOT COMPLETED|Dose Escalation Phase||0||
60101849|NCT01772004|76219477|FG013|NOT COMPLETED|Dose Escalation Phase||0||
60101850|NCT01772004|76219478|FG014|NOT COMPLETED|Dose Escalation Phase||0||
60101851|NCT01772004|76219479|FG015|NOT COMPLETED|Dose Escalation Phase||0||
60101852|NCT01772004|76219480|FG016|NOT COMPLETED|Dose Escalation Phase||0||
60101853|NCT01772004|76219481|FG017|NOT COMPLETED|Dose Escalation Phase||0||
60101854|NCT01772004|76219482|FG018|NOT COMPLETED|Dose Escalation Phase||0||
60101855|NCT01772004|76219483|FG019|NOT COMPLETED|Dose Escalation Phase||0||
60101856|NCT01772004|76219484|FG020|NOT COMPLETED|Dose Escalation Phase||0||
60101857|NCT01772004|76219485|FG021|NOT COMPLETED|Dose Escalation Phase||0||
60101858|NCT01772004|76219486|FG022|NOT COMPLETED|Dose Escalation Phase||0||
60101859|NCT01772004|76219464|FG000|STARTED|Dose Expansion Phase||0||
60101860|NCT01772004|76219465|FG001|STARTED|Dose Expansion Phase||0||
60101861|NCT01772004|76219466|FG002|STARTED|Dose Expansion Phase||0||
60101862|NCT01772004|76219467|FG003|STARTED|Dose Expansion Phase||0||
60101863|NCT01772004|76219468|FG004|STARTED|Dose Expansion Phase||0||
59817118|NCT05101486|75939566|FG000|Vaccinated (Full Analysis Set [FAS])|Overall Study||250||
59817119|NCT05101486|75939567|FG001|Vaccinated (Full Analysis Set [FAS])|Overall Study||251||
59817120|NCT05101486|75939568|FG002|Vaccinated (Full Analysis Set [FAS])|Overall Study||251||
59817121|NCT05101486|75939566|FG000|COMPLETED|Overall Study||231||
59817122|NCT05101486|75939567|FG001|COMPLETED|Overall Study||241||
59817123|NCT05101486|75939568|FG002|COMPLETED|Overall Study||228||
59817124|NCT05101486|75939566|FG000|NOT COMPLETED|Overall Study||20||
60101864|NCT01772004|76219469|FG005|STARTED|Dose Expansion Phase||184||
60101865|NCT01772004|76219470|FG006|STARTED|Dose Expansion Phase||156||
60101866|NCT01772004|76219471|FG007|STARTED|Dose Expansion Phase||168||
60101867|NCT01772004|76219472|FG008|STARTED|Dose Expansion Phase||60||
60101868|NCT01772004|76219473|FG009|STARTED|Dose Expansion Phase||90||
60101869|NCT01772004|76219474|FG010|STARTED|Dose Expansion Phase||21||
60101870|NCT01772004|76219475|FG011|STARTED|Dose Expansion Phase||18||
60101871|NCT01772004|76219476|FG012|STARTED|Dose Expansion Phase||50||
60101872|NCT01772004|76219477|FG013|STARTED|Dose Expansion Phase||51||
60101873|NCT01772004|76219478|FG014|STARTED|Dose Expansion Phase||53||
60101874|NCT01772004|76219479|FG015|STARTED|Dose Expansion Phase||44||
59817125|NCT05101486|75939567|FG001|NOT COMPLETED|Overall Study||11||
59817126|NCT05101486|75939568|FG002|NOT COMPLETED|Overall Study||24||
59817127|NCT05083585|75939578|FG000|STARTED|Overall Study||125||
59817128|NCT05083585|75939579|FG001|STARTED|Overall Study||125||
60101875|NCT01772004|76219480|FG016|STARTED|Dose Expansion Phase||125||
60101876|NCT01772004|76219481|FG017|STARTED|Dose Expansion Phase||62||
60101877|NCT01772004|76219482|FG018|STARTED|Dose Expansion Phase||20||
60101878|NCT01772004|76219483|FG019|STARTED|Dose Expansion Phase||103||
60101879|NCT01772004|76219484|FG020|STARTED|Dose Expansion Phase||205||
60101880|NCT01772004|76219485|FG021|STARTED|Dose Expansion Phase||132||
60101881|NCT01772004|76219486|FG022|STARTED|Dose Expansion Phase||153||
60101882|NCT01772004|76219464|FG000|COMPLETED|Dose Expansion Phase||0||
60101883|NCT01772004|76219465|FG001|COMPLETED|Dose Expansion Phase||0||
60101884|NCT01772004|76219466|FG002|COMPLETED|Dose Expansion Phase||0||
60101885|NCT01772004|76219467|FG003|COMPLETED|Dose Expansion Phase||0||
59708472|NCT01111539|75827287|FG003|Safety Sample|Phase B+ and Phase C (Weeks 9 to 14)||27|Safety Sample included those randomized participants in Phase C who received at least one dose of double-blind study medication as indicated on the dosing record.|
59708473|NCT01111539|75827288|FG004|Safety Sample|Phase B+ and Phase C (Weeks 9 to 14)||28|Safety Sample included those randomized participants in Phase C who received at least one dose of double-blind study medication as indicated on the dosing record.|
59708474|NCT01111539|75827284|FG000|COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||0||
59708475|NCT01111539|75827285|FG001|COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||38||
59708476|NCT01111539|75827286|FG002|COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||22||
59708477|NCT01111539|75827287|FG003|COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||20||
59708478|NCT01111539|75827288|FG004|COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||18||
59708479|NCT01111539|75827284|FG000|NOT COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||0||
59708480|NCT01111539|75827285|FG001|NOT COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||7||
59708481|NCT01111539|75827286|FG002|NOT COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||6||
59994342|NCT01004029|76110151|FG000|NOT COMPLETED|Overall Study||48||
59565360|NCT02272244|75667621|FG001|STARTED|Overall Study||197||
59565361|NCT02272244|75667620|FG000|COMPLETED|Overall Study||203||
59708482|NCT01111539|75827287|FG003|NOT COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||8||
59708483|NCT01111539|75827288|FG004|NOT COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||10||
59708484|NCT01111149|75827301|FG000|STARTED|Overall Study||9||
59708485|NCT01111149|75827302|FG001|STARTED|Overall Study||6||
59708486|NCT01111149|75827303|FG002|STARTED|Overall Study||9||
59708487|NCT01111149|75827301|FG000|COMPLETED|Overall Study||7||
59708488|NCT01111149|75827302|FG001|COMPLETED|Overall Study||5||
59708489|NCT01111149|75827303|FG002|COMPLETED|Overall Study||5||
59708490|NCT01111149|75827301|FG000|NOT COMPLETED|Overall Study||2||
59708491|NCT01111149|75827302|FG001|NOT COMPLETED|Overall Study||1||
59708492|NCT01111149|75827303|FG002|NOT COMPLETED|Overall Study||4||
60101886|NCT01772004|76219468|FG004|COMPLETED|Dose Expansion Phase||0||
60101887|NCT01772004|76219469|FG005|COMPLETED|Dose Expansion Phase||184||
60101888|NCT01772004|76219470|FG006|COMPLETED|Dose Expansion Phase||156||
60101889|NCT01772004|76219471|FG007|COMPLETED|Dose Expansion Phase||168||
60101890|NCT01772004|76219472|FG008|COMPLETED|Dose Expansion Phase||60||
60101891|NCT01772004|76219473|FG009|COMPLETED|Dose Expansion Phase||90||
60101892|NCT01772004|76219474|FG010|COMPLETED|Dose Expansion Phase||21||
60101893|NCT01772004|76219475|FG011|COMPLETED|Dose Expansion Phase||18||
59708493|NCT01254656|75827314|FG000|STARTED|Overall Study||47||
59708494|NCT01254656|75827315|FG001|STARTED|Overall Study||43||
59708495|NCT01254656|75827316|FG002|STARTED|Overall Study||18||
59708496|NCT01254656|75827314|FG000|Treated|Overall Study||47||
59708497|NCT01254656|75827315|FG001|Treated|Overall Study||43||
59817129|NCT05083585|75939578|FG000|Vaccinated (Full Analysis Set [FAS])|Overall Study||123||
59817130|NCT05083585|75939579|FG001|Vaccinated (Full Analysis Set [FAS])|Overall Study||125||
59817131|NCT05083585|75939578|FG000|COMPLETED|Overall Study||119||
59817132|NCT05083585|75939579|FG001|COMPLETED|Overall Study||123||
59994343|NCT01004029|76110152|FG001|NOT COMPLETED|Overall Study||73||
59994344|NCT02345252|76110161|FG000|STARTED|Double-Blind Phase||316||
59994345|NCT02345252|76110162|FG001|STARTED|Double-Blind Phase||316||
59994346|NCT02345252|76110161|FG000|COMPLETED|Double-Blind Phase||276||
59994347|NCT02345252|76110162|FG001|COMPLETED|Double-Blind Phase||267||
59994348|NCT02345252|76110161|FG000|NOT COMPLETED|Double-Blind Phase||40||
59994349|NCT02345252|76110162|FG001|NOT COMPLETED|Double-Blind Phase||49||
59994350|NCT02345252|76110161|FG000|STARTED|Open-Label Extension Phase|257 participants completed the Double-Blind Phase, but did not enter Open-Label Extension Phase.|19||
60101894|NCT01772004|76219476|FG012|COMPLETED|Dose Expansion Phase||50||
60101895|NCT01772004|76219477|FG013|COMPLETED|Dose Expansion Phase||51||
60101896|NCT01772004|76219478|FG014|COMPLETED|Dose Expansion Phase||53||
60101897|NCT01772004|76219479|FG015|COMPLETED|Dose Expansion Phase||44||
60101898|NCT01772004|76219480|FG016|COMPLETED|Dose Expansion Phase||125||
60101899|NCT01772004|76219481|FG017|COMPLETED|Dose Expansion Phase||62||
60101900|NCT01772004|76219482|FG018|COMPLETED|Dose Expansion Phase||20||
60101901|NCT01772004|76219483|FG019|COMPLETED|Dose Expansion Phase||103||
60101902|NCT01772004|76219484|FG020|COMPLETED|Dose Expansion Phase||205||
60101903|NCT01772004|76219485|FG021|COMPLETED|Dose Expansion Phase||132||
60101904|NCT01772004|76219486|FG022|COMPLETED|Dose Expansion Phase||153||
60101905|NCT01772004|76219464|FG000|NOT COMPLETED|Dose Expansion Phase||0||
60101906|NCT01772004|76219465|FG001|NOT COMPLETED|Dose Expansion Phase||0||
60101907|NCT01772004|76219466|FG002|NOT COMPLETED|Dose Expansion Phase||0||
60101908|NCT01772004|76219467|FG003|NOT COMPLETED|Dose Expansion Phase||0||
60101909|NCT01772004|76219468|FG004|NOT COMPLETED|Dose Expansion Phase||0||
60101910|NCT01772004|76219469|FG005|NOT COMPLETED|Dose Expansion Phase||0||
60101911|NCT01772004|76219470|FG006|NOT COMPLETED|Dose Expansion Phase||0||
60101912|NCT01772004|76219471|FG007|NOT COMPLETED|Dose Expansion Phase||0||
60101913|NCT01772004|76219472|FG008|NOT COMPLETED|Dose Expansion Phase||0||
59817133|NCT05083585|75939578|FG000|NOT COMPLETED|Overall Study||6||
59817134|NCT05083585|75939579|FG001|NOT COMPLETED|Overall Study||2||
59817135|NCT05071313|75939587|FG000|STARTED|Overall Study||389||
59817136|NCT05071313|75939588|FG001|STARTED|Overall Study||388||
59817137|NCT05071313|75939587|FG000|Received Ad26/Protein preF RSV Vaccine With Fluzone in CoAd Group at Day 1|Overall Study||385||
59817138|NCT05071313|75939588|FG001|Received Ad26/Protein preF RSV Vaccine With Fluzone in CoAd Group at Day 1|Overall Study||0||
59994351|NCT02345252|76110162|FG001|STARTED|Open-Label Extension Phase|250 participants completed the Double-Blind Phase, but did not enter Open-Label Extension Phase.|17||
60101914|NCT01772004|76219473|FG009|NOT COMPLETED|Dose Expansion Phase||0||
60101915|NCT01772004|76219474|FG010|NOT COMPLETED|Dose Expansion Phase||0||
59565362|NCT02272244|75667621|FG001|COMPLETED|Overall Study||197||
59817139|NCT05071313|75939587|FG000|Received Placebo With Fluzone in Control Group at Day 1|Overall Study||0||
59817140|NCT05071313|75939588|FG001|Received Placebo With Fluzone in Control Group at Day 1|Overall Study||386||
59817141|NCT05071313|75939587|FG000|Received Placebo in CoAd Group at Day 29|Overall Study||357||
59817142|NCT05071313|75939588|FG001|Received Placebo in CoAd Group at Day 29|Overall Study||0||
59817143|NCT05071313|75939587|FG000|Received Ad26/Protein preF RSV Vaccine in Control Group at Day 29|Overall Study||0||
59817144|NCT05071313|75939588|FG001|Received Ad26/Protein preF RSV Vaccine in Control Group at Day 29|Overall Study||363||
59817145|NCT05071313|75939587|FG000|COMPLETED|Overall Study||355||
59817146|NCT05071313|75939588|FG001|COMPLETED|Overall Study||355||
59817147|NCT05071313|75939587|FG000|NOT COMPLETED|Overall Study||34||
59817148|NCT05071313|75939588|FG001|NOT COMPLETED|Overall Study||33||
60101916|NCT01772004|76219475|FG011|NOT COMPLETED|Dose Expansion Phase||0||
60101917|NCT01772004|76219476|FG012|NOT COMPLETED|Dose Expansion Phase||0||
60101918|NCT01772004|76219477|FG013|NOT COMPLETED|Dose Expansion Phase||0||
60101919|NCT01772004|76219478|FG014|NOT COMPLETED|Dose Expansion Phase||0||
60101920|NCT01772004|76219479|FG015|NOT COMPLETED|Dose Expansion Phase||0||
60101921|NCT01772004|76219480|FG016|NOT COMPLETED|Dose Expansion Phase||0||
60101922|NCT01772004|76219481|FG017|NOT COMPLETED|Dose Expansion Phase||0||
60101923|NCT01772004|76219482|FG018|NOT COMPLETED|Dose Expansion Phase||0||
60101924|NCT01772004|76219483|FG019|NOT COMPLETED|Dose Expansion Phase||0||
60101925|NCT01772004|76219484|FG020|NOT COMPLETED|Dose Expansion Phase||0||
60101926|NCT01772004|76219485|FG021|NOT COMPLETED|Dose Expansion Phase||0||
60101927|NCT01772004|76219486|FG022|NOT COMPLETED|Dose Expansion Phase||0||
60101928|NCT02181400|76219584|FG000|STARTED|Overall Study||7||
60101929|NCT02181400|76219585|FG001|STARTED|Overall Study||7||
60101930|NCT02181400|76219586|FG002|STARTED|Overall Study||7||
60101931|NCT02181400|76219584|FG000|COMPLETED|Overall Study||7||
60101932|NCT02181400|76219585|FG001|COMPLETED|Overall Study||7||
60101933|NCT02181400|76219586|FG002|COMPLETED|Overall Study||7||
60101934|NCT02181400|76219584|FG000|NOT COMPLETED|Overall Study||0||
60101935|NCT02181400|76219585|FG001|NOT COMPLETED|Overall Study||0||
60101936|NCT02181400|76219586|FG002|NOT COMPLETED|Overall Study||0||
60101937|NCT02182492|76219596|FG000|STARTED|Overall Study|CRSsNP: 28; Non-Eos CRSwNP: 34; Eos CRSwNP: 31|93||
60101938|NCT02182492|76219597|FG001|STARTED|Overall Study|CRSsNP: 30; Non-Eos CRSwNP: 32; Eos CRSwNP: 32|94||
60101939|NCT02182492|76219596|FG000|COMPLETED|Overall Study|CRSsNP: 27; Non-Eos CRSwNP: 31; Eos CRSwNP: 28|86||
60101940|NCT02182492|76219597|FG001|COMPLETED|Overall Study|CRSsNP: 29; Non-Eos CRSwNP: 28; Eos CRSwNP: 29|86||
60101941|NCT02182492|76219596|FG000|NOT COMPLETED|Overall Study||7||
60101942|NCT02182492|76219597|FG001|NOT COMPLETED|Overall Study||8||
60101943|NCT02182804|76219603|FG000|STARTED|Overall Study||44||
60101944|NCT02182804|76219603|FG000|COMPLETED|Overall Study||44||
60101945|NCT02182804|76219603|FG000|NOT COMPLETED|Overall Study||0||
60101946|NCT01163656|76219609|FG000|STARTED|Overall Study||33||
60101947|NCT01163656|76219610|FG001|STARTED|Overall Study||33||
60101948|NCT01163656|76219609|FG000|COMPLETED|Overall Study||30||
60101949|NCT01163656|76219610|FG001|COMPLETED|Overall Study||30||
60101950|NCT01163656|76219609|FG000|NOT COMPLETED|Overall Study||3||
60101951|NCT01163656|76219610|FG001|NOT COMPLETED|Overall Study||3||
59565363|NCT02272244|75667620|FG000|NOT COMPLETED|Overall Study||0||
59565364|NCT02272244|75667621|FG001|NOT COMPLETED|Overall Study||0||
59565365|NCT02328404|75667629|FG000|STARTED|Overall Study||30||
59565366|NCT02328404|75667630|FG001|STARTED|Overall Study||30||
59565367|NCT02328404|75667629|FG000|COMPLETED|Overall Study||29||
59565368|NCT02328404|75667630|FG001|COMPLETED|Overall Study||29||
59565369|NCT02328404|75667629|FG000|NOT COMPLETED|Overall Study||1||
60101952|NCT01129804|76219618|FG000|STARTED|Overall Study||96||
60101953|NCT01129804|76219619|FG001|STARTED|Overall Study||97||
60101954|NCT01129804|76219618|FG000|COMPLETED|Overall Study||64||
60101955|NCT01129804|76219619|FG001|COMPLETED|Overall Study||66||
60101956|NCT01129804|76219618|FG000|NOT COMPLETED|Overall Study||32||
60101957|NCT01129804|76219619|FG001|NOT COMPLETED|Overall Study||31||
60101958|NCT01165840|76219625|FG000|STARTED|Overall Study||36||
60101959|NCT01165840|76219625|FG000|COMPLETED|Overall Study||36||
60101960|NCT01165840|76219625|FG000|NOT COMPLETED|Overall Study||0||
60101961|NCT01166230|76219631|FG000|STARTED|Overall Study||280||
60101962|NCT01166230|76219632|FG001|STARTED|Overall Study||271||
59565370|NCT02328404|75667630|FG001|NOT COMPLETED|Overall Study||1||
59565371|NCT01829516|75667640|FG000|STARTED|First Intervention||18||
59565372|NCT01829516|75667641|FG001|STARTED|First Intervention||14||
60101963|NCT01166230|76219631|FG000|COMPLETED|Overall Study||261||
60101964|NCT01166230|76219632|FG001|COMPLETED|Overall Study||255||
60101965|NCT01166230|76219631|FG000|NOT COMPLETED|Overall Study||19||
59565373|NCT01829516|75667640|FG000|COMPLETED|First Intervention||18||
59565374|NCT01829516|75667641|FG001|COMPLETED|First Intervention||14||
59565375|NCT01829516|75667640|FG000|NOT COMPLETED|First Intervention||0||
59565376|NCT01829516|75667641|FG001|NOT COMPLETED|First Intervention||0||
59565377|NCT01829516|75667640|FG000|STARTED|Washout Period - 1 Week||18||
59565378|NCT01829516|75667641|FG001|STARTED|Washout Period - 1 Week||14||
60101966|NCT01166230|76219632|FG001|NOT COMPLETED|Overall Study||16||
60101967|NCT00952692|76219638|FG000|STARTED|Overall Study||12||
60101968|NCT00952692|76219638|FG000|COMPLETED|Overall Study||12||
60101969|NCT00952692|76219638|FG000|NOT COMPLETED|Overall Study||0||
60101970|NCT01168024|76219644|FG000|STARTED|Overall Study|13 tx/3 controls. Roll-ins occurred for product training, several more treatment cases than control.|13||
60101971|NCT01168024|76219645|FG001|STARTED|Overall Study||3||
60101972|NCT01168024|76219644|FG000|COMPLETED|Overall Study||13||
60101973|NCT01168024|76219645|FG001|COMPLETED|Overall Study||3||
60101974|NCT01168024|76219644|FG000|NOT COMPLETED|Overall Study||0||
60101975|NCT01168024|76219645|FG001|NOT COMPLETED|Overall Study||0||
60101976|NCT01168726|76219654|FG000|STARTED|Overall Study||111||
60101977|NCT01168726|76219655|FG001|STARTED|Overall Study||121||
59708498|NCT01254656|75827316|FG002|Treated|Overall Study||18||
60101978|NCT01168726|76219656|FG002|STARTED|Overall Study||133||
60101979|NCT01168726|76219654|FG000|COMPLETED|Overall Study||103||
59708499|NCT01254656|75827314|FG000|COMPLETED|Overall Study||0||
60101980|NCT01168726|76219655|FG001|COMPLETED|Overall Study||112||
60101981|NCT01168726|76219656|FG002|COMPLETED|Overall Study||128||
60101982|NCT01168726|76219654|FG000|NOT COMPLETED|Overall Study||8||
59565379|NCT01829516|75667640|FG000|COMPLETED|Washout Period - 1 Week||18||
60101983|NCT01168726|76219655|FG001|NOT COMPLETED|Overall Study||9||
60101984|NCT01168726|76219656|FG002|NOT COMPLETED|Overall Study||5||
60101985|NCT01170754|76219666|FG000|STARTED|Overall Study||66||
60101986|NCT01170754|76219667|FG001|STARTED|Overall Study||70||
60101987|NCT01170754|76219666|FG000|COMPLETED|Overall Study||66||
60101988|NCT01170754|76219667|FG001|COMPLETED|Overall Study||70||
60101989|NCT01170754|76219666|FG000|NOT COMPLETED|Overall Study||0||
60101990|NCT01170754|76219667|FG001|NOT COMPLETED|Overall Study||0||
60101991|NCT01378104|76219677|FG000|STARTED|Overall Study||92||
60101992|NCT01378104|76219678|FG001|STARTED|Overall Study||86||
60101993|NCT01378104|76219677|FG000|COMPLETED|Overall Study||65||
60101994|NCT01378104|76219678|FG001|COMPLETED|Overall Study||60||
60101995|NCT01378104|76219677|FG000|NOT COMPLETED|Overall Study||27||
60101996|NCT01378104|76219678|FG001|NOT COMPLETED|Overall Study||26||
60101997|NCT01130740|76219688|FG000|STARTED|Overall Study||149||
59565380|NCT01829516|75667641|FG001|COMPLETED|Washout Period - 1 Week||14||
59565381|NCT01829516|75667640|FG000|NOT COMPLETED|Washout Period - 1 Week||0||
59565382|NCT01829516|75667641|FG001|NOT COMPLETED|Washout Period - 1 Week||0||
59565383|NCT01829516|75667640|FG000|STARTED|2nd Intervention||18||
59565384|NCT01829516|75667641|FG001|STARTED|2nd Intervention||14||
59708500|NCT01254656|75827315|FG001|COMPLETED|Overall Study||0||
59708501|NCT01254656|75827316|FG002|COMPLETED|Overall Study||0||
59708502|NCT01254656|75827314|FG000|NOT COMPLETED|Overall Study||47||
59708503|NCT01254656|75827315|FG001|NOT COMPLETED|Overall Study||43||
59708504|NCT01254656|75827316|FG002|NOT COMPLETED|Overall Study||18||
59708505|NCT01110915|75827326|FG000|STARTED|Overall Study|Subjects being randomized to the MRI group.|177||
59708506|NCT01110915|75827327|FG001|STARTED|Overall Study|Subjects being randomized to the Control group.|86||
59708507|NCT01110915|75827326|FG000|COMPLETED|Overall Study|Subjects completing at least 4 months of follow-up.|167||
59708508|NCT01110915|75827327|FG001|COMPLETED|Overall Study|Subjects completing at least 4 months of follow-up.|84||
59708509|NCT01110915|75827326|FG000|NOT COMPLETED|Overall Study||10||
59708510|NCT01110915|75827327|FG001|NOT COMPLETED|Overall Study||2||
59708511|NCT01254344|75827336|FG000|STARTED|Overall Study||299||
59708512|NCT01254344|75827337|FG001|STARTED|Overall Study||300||
59565385|NCT01829516|75667640|FG000|COMPLETED|2nd Intervention||18||
59565386|NCT01829516|75667641|FG001|COMPLETED|2nd Intervention||14||
59565387|NCT01829516|75667640|FG000|NOT COMPLETED|2nd Intervention||0||
59565388|NCT01829516|75667641|FG001|NOT COMPLETED|2nd Intervention||0||
59708513|NCT01254344|75827336|FG000|Treated|Overall Study||290||
59708514|NCT01254344|75827337|FG001|Treated|Overall Study||297||
59708515|NCT01254344|75827336|FG000|COMPLETED|Overall Study||286||
59708516|NCT01254344|75827337|FG001|COMPLETED|Overall Study||281||
59708517|NCT01254344|75827336|FG000|NOT COMPLETED|Overall Study||13||
59708518|NCT01254344|75827337|FG001|NOT COMPLETED|Overall Study||19||
59708519|NCT01102803|75827345|FG000|STARTED|Baseline to Post-Treatment||14||
59708520|NCT01102803|75827346|FG001|STARTED|Baseline to Post-Treatment||15||
59708521|NCT01102803|75827345|FG000|COMPLETED|Baseline to Post-Treatment||11||
59708522|NCT01102803|75827346|FG001|COMPLETED|Baseline to Post-Treatment||15||
59708523|NCT01102803|75827345|FG000|NOT COMPLETED|Baseline to Post-Treatment||3||
59708524|NCT01102803|75827346|FG001|NOT COMPLETED|Baseline to Post-Treatment||0||
59708525|NCT01102803|75827345|FG000|STARTED|Post to Follow-Up||11||
59708526|NCT01102803|75827346|FG001|STARTED|Post to Follow-Up||15||
59708527|NCT01102803|75827345|FG000|COMPLETED|Post to Follow-Up||10||
59708528|NCT01102803|75827346|FG001|COMPLETED|Post to Follow-Up||12||
59708529|NCT01102803|75827345|FG000|NOT COMPLETED|Post to Follow-Up||1||
59708530|NCT01102803|75827346|FG001|NOT COMPLETED|Post to Follow-Up||3||
59708531|NCT01254188|75827354|FG000|STARTED|Overall Study||421||
59708532|NCT01254188|75827354|FG000|COMPLETED|Overall Study||328||
60101998|NCT01130740|76219689|FG001|STARTED|Overall Study||151||
60101999|NCT01130740|76219688|FG000|COMPLETED|Overall Study||137||
60102000|NCT01130740|76219689|FG001|COMPLETED|Overall Study||136||
60102001|NCT01130740|76219688|FG000|NOT COMPLETED|Overall Study||12||
60102002|NCT01130740|76219689|FG001|NOT COMPLETED|Overall Study||15||
60102003|NCT01130896|76219695|FG000|STARTED|Overall Study||1509||
60102004|NCT01130896|76219695|FG000|COMPLETED|Overall Study||1509||
60102005|NCT01130896|76219695|FG000|NOT COMPLETED|Overall Study||0||
60102006|NCT01131052|76219701|FG000|STARTED|Overall Study||75||
60102007|NCT01131052|76219702|FG001|STARTED|Overall Study||75||
60102008|NCT01131052|76219701|FG000|COMPLETED|Overall Study||75||
60102009|NCT01131052|76219702|FG001|COMPLETED|Overall Study||75||
60102010|NCT01131052|76219701|FG000|NOT COMPLETED|Overall Study||0||
60102011|NCT01131052|76219702|FG001|NOT COMPLETED|Overall Study||0||
60102012|NCT01132144|76219710|FG000|STARTED|Overall Study||79||
59708533|NCT01254188|75827354|FG000|NOT COMPLETED|Overall Study||93||
59708534|NCT01109979|75827360|FG000|STARTED|Overall Study||12||
59708535|NCT01109979|75827361|FG001|STARTED|Overall Study||12||
59708536|NCT01109979|75827360|FG000|COMPLETED|Overall Study||10||
59708537|NCT01109979|75827361|FG001|COMPLETED|Overall Study||11||
59708538|NCT01109979|75827360|FG000|NOT COMPLETED|Overall Study||2||
59708539|NCT01109979|75827361|FG001|NOT COMPLETED|Overall Study||1||
59708540|NCT01102491|75827369|FG000|STARTED|Overall Study||71||
59708541|NCT01102491|75827370|FG001|STARTED|Overall Study||71||
59708542|NCT01102491|75827369|FG000|COMPLETED|Overall Study|11 patient excluded|60||
59817149|NCT05019729|75939616|FG000|STARTED|Overall Study||5||
59817150|NCT05019729|75939617|FG001|STARTED|Overall Study||4||
59817151|NCT05019729|75939618|FG002|STARTED|Overall Study||5||
59708543|NCT01102491|75827370|FG001|COMPLETED|Overall Study|12 patients were excluded|59||
59708544|NCT01102491|75827369|FG000|NOT COMPLETED|Overall Study||11||
59708545|NCT01102491|75827370|FG001|NOT COMPLETED|Overall Study||12||
59708546|NCT01102257|75827378|FG000|STARTED|Overall Study||9||
59817152|NCT05019729|75939619|FG003|STARTED|Overall Study||4||
59708547|NCT01102257|75827379|FG001|STARTED|Overall Study||9||
59708548|NCT01102257|75827378|FG000|COMPLETED|Overall Study|2 withdrew from the study d/t adverse events. 1 had shortness of breath and the other had chest pain|7||
59817153|NCT05019729|75939620|FG004|STARTED|Overall Study||9||
59817154|NCT05019729|75939621|FG005|STARTED|Overall Study||5||
59817155|NCT05019729|75939616|FG000|Received Product Administration|Overall Study||5||
59817156|NCT05019729|75939617|FG001|Received Product Administration|Overall Study||4||
59817157|NCT05019729|75939618|FG002|Received Product Administration|Overall Study||5||
59817158|NCT05019729|75939619|FG003|Received Product Administration|Overall Study||4||
59817159|NCT05019729|75939620|FG004|Received Product Administration|Overall Study||0||
59708549|NCT01102257|75827379|FG001|COMPLETED|Overall Study||9||
59708550|NCT01102257|75827378|FG000|NOT COMPLETED|Overall Study||2||
59708551|NCT01102257|75827379|FG001|NOT COMPLETED|Overall Study||0||
59708552|NCT01253564|75827385|FG000|STARTED|Overall Study||24||
59817160|NCT05019729|75939621|FG005|Received Product Administration|Overall Study||5||
59995210|NCT02648217|76111029|FG001|COMPLETED|Overall Study||127||
59995211|NCT02648217|76111028|FG000|NOT COMPLETED|Overall Study||10||
59995212|NCT02648217|76111029|FG001|NOT COMPLETED|Overall Study||5||
59995213|NCT00709735|76111037|FG000|STARTED|Overall Study||11||
59995214|NCT00709735|76111038|FG001|STARTED|Overall Study||12||
59995215|NCT00709735|76111037|FG000|COMPLETED|Overall Study||8||
59995216|NCT00709735|76111038|FG001|COMPLETED|Overall Study||10||
59995217|NCT00709735|76111037|FG000|NOT COMPLETED|Overall Study||3||
59995218|NCT00709735|76111038|FG001|NOT COMPLETED|Overall Study||2||
59995219|NCT02647905|76111044|FG000|STARTED|Overall Study||90||
59995220|NCT02647905|76111044|FG000|COMPLETED|Overall Study||87||
59995221|NCT02647905|76111044|FG000|NOT COMPLETED|Overall Study||3||
59708553|NCT01253564|75827385|FG000|COMPLETED|Overall Study||0||
59708554|NCT01253564|75827385|FG000|NOT COMPLETED|Overall Study||24||
59708555|NCT01108809|75827389|FG000|STARTED|Overall Study||295||
59708556|NCT01108809|75827389|FG000|COMPLETED|Overall Study||291||
60102013|NCT01132144|76219711|FG001|STARTED|Overall Study||79||
60102014|NCT01132144|76219710|FG000|COMPLETED|Overall Study||79||
60102015|NCT01132144|76219711|FG001|COMPLETED|Overall Study||79||
60102016|NCT01132144|76219710|FG000|NOT COMPLETED|Overall Study||0||
60102017|NCT01132144|76219711|FG001|NOT COMPLETED|Overall Study||0||
60102018|NCT01379274|76219719|FG000|STARTED|Overall Study||2||
60102019|NCT01379274|76219719|FG000|COMPLETED|Overall Study||1||
60102020|NCT01379274|76219719|FG000|NOT COMPLETED|Overall Study||1||
60102021|NCT01171690|76219725|FG000|STARTED|Overall Study||5||
60102022|NCT01171690|76219726|FG001|STARTED|Overall Study||5||
60102023|NCT01171690|76219725|FG000|COMPLETED|Overall Study||5||
60102024|NCT01171690|76219726|FG001|COMPLETED|Overall Study||5||
60102025|NCT01171690|76219725|FG000|NOT COMPLETED|Overall Study||0||
60102026|NCT01171690|76219726|FG001|NOT COMPLETED|Overall Study||0||
60102027|NCT01171924|76219734|FG000|STARTED|Overall Study||23||
59708557|NCT01108809|75827389|FG000|NOT COMPLETED|Overall Study||4||
59708558|NCT01253408|75827397|FG000|STARTED|Overall Study||10||
59708559|NCT01253408|75827398|FG001|STARTED|Overall Study||13||
59708560|NCT01253408|75827399|FG002|STARTED|Overall Study||13||
60102028|NCT01171924|76219735|FG001|STARTED|Overall Study||23||
59708561|NCT01253408|75827397|FG000|COMPLETED|Overall Study||10||
60102029|NCT01171924|76219734|FG000|COMPLETED|Overall Study||0||
60102030|NCT01171924|76219735|FG001|COMPLETED|Overall Study||0||
60102031|NCT01171924|76219734|FG000|NOT COMPLETED|Overall Study||23||
59565389|NCT01830140|75667651|FG000|STARTED|Overall Study||233||
59565390|NCT01830140|75667652|FG001|STARTED|Overall Study||233||
59565391|NCT01830140|75667651|FG000|COMPLETED|Overall Study||226||
59817161|NCT05019729|75939616|FG000|Completed Controlled Human Malaria Infection (CHMI)|Overall Study||5||
60102032|NCT01171924|76219735|FG001|NOT COMPLETED|Overall Study||23||
60102033|NCT01132378|76219741|FG000|STARTED|Overall Study||40||
60102034|NCT01132378|76219741|FG000|COMPLETED|Overall Study||40||
60102035|NCT01132378|76219741|FG000|NOT COMPLETED|Overall Study||0||
60102036|NCT01132690|76219748|FG000|STARTED|Overall Study||6||
60102037|NCT01132690|76219749|FG001|STARTED|Overall Study||5||
60102038|NCT01132690|76219748|FG000|COMPLETED|Overall Study||6||
60102039|NCT01132690|76219749|FG001|COMPLETED|Overall Study||5||
60102040|NCT01132690|76219748|FG000|NOT COMPLETED|Overall Study||0||
60102041|NCT01132690|76219749|FG001|NOT COMPLETED|Overall Study||0||
60102042|NCT01132846|76219758|FG000|STARTED|Overall Study||122||
60102043|NCT01132846|76219759|FG001|STARTED|Overall Study||119||
60102044|NCT01132846|76219760|FG002|STARTED|Overall Study||119||
60102045|NCT01132846|76219758|FG000|COMPLETED|Overall Study||106||
60102046|NCT01132846|76219759|FG001|COMPLETED|Overall Study||101||
60102047|NCT01132846|76219760|FG002|COMPLETED|Overall Study||108||
60102048|NCT01132846|76219758|FG000|NOT COMPLETED|Overall Study||16||
60102049|NCT01132846|76219759|FG001|NOT COMPLETED|Overall Study||18||
60102050|NCT01132846|76219760|FG002|NOT COMPLETED|Overall Study||11||
60102051|NCT01173016|76219770|FG000|STARTED|Overall Study||11||
60102052|NCT01173016|76219770|FG000|COMPLETED|Overall Study||10||
60102053|NCT01173016|76219770|FG000|NOT COMPLETED|Overall Study||1||
60102054|NCT01133158|76219774|FG000|STARTED|Overall Study||60||
60102055|NCT01133158|76219774|FG000|COMPLETED|Overall Study||43||
60102056|NCT01133158|76219774|FG000|NOT COMPLETED|Overall Study||17||
60102057|NCT01133860|76219780|FG000|STARTED|Overall Study||12||
60102058|NCT01133860|76219780|FG000|COMPLETED|Overall Study||12||
60102059|NCT01133860|76219780|FG000|NOT COMPLETED|Overall Study||0||
60102060|NCT02184208|76219785|FG000|STARTED|Overall Study||278||
60102061|NCT02184208|76219785|FG000|COMPLETED|Overall Study||222||
60102062|NCT02184208|76219785|FG000|NOT COMPLETED|Overall Study||56||
60102063|NCT01134016|76219791|FG000|STARTED|Overall Study||13||
60102064|NCT01134016|76219791|FG000|COMPLETED|Overall Study||10||
59708562|NCT01253408|75827398|FG001|COMPLETED|Overall Study||12||
59708563|NCT01253408|75827399|FG002|COMPLETED|Overall Study||13||
59708564|NCT01253408|75827397|FG000|NOT COMPLETED|Overall Study||0||
59708565|NCT01253408|75827398|FG001|NOT COMPLETED|Overall Study||1||
59994352|NCT02345252|76110161|FG000|COMPLETED|Open-Label Extension Phase||19||
59994353|NCT02345252|76110162|FG001|COMPLETED|Open-Label Extension Phase||17||
60102065|NCT01134016|76219791|FG000|NOT COMPLETED|Overall Study||3||
59994354|NCT02345252|76110161|FG000|NOT COMPLETED|Open-Label Extension Phase||0||
59994355|NCT02345252|76110162|FG001|NOT COMPLETED|Open-Label Extension Phase||0||
59994356|NCT01239797|76110172|FG000|STARTED|Randomized Participants||321||
59994357|NCT01239797|76110173|FG001|STARTED|Randomized Participants||325||
59994358|NCT01239797|76110172|FG000|COMPLETED|Randomized Participants||319||
60102066|NCT01173874|76219826|FG000|STARTED|Overall Study||56||
60102067|NCT01173874|76219827|FG001|STARTED|Overall Study||64||
60102068|NCT01173874|76219826|FG000|COMPLETED|Overall Study||33||
60102069|NCT01173874|76219827|FG001|COMPLETED|Overall Study||41||
60102070|NCT01173874|76219826|FG000|NOT COMPLETED|Overall Study||23||
60102071|NCT01173874|76219827|FG001|NOT COMPLETED|Overall Study||23||
60102072|NCT01174030|76219838|FG000|STARTED|Overall Study||53||
60102073|NCT01174030|76219839|FG001|STARTED|Overall Study||54||
60102074|NCT01174030|76219840|FG002|STARTED|Overall Study||54||
60102075|NCT01174030|76219841|FG003|STARTED|Overall Study||55||
60102076|NCT01174030|76219842|FG004|STARTED|Overall Study||53||
60102077|NCT01174030|76219838|FG000|COMPLETED|Overall Study||51||
60102078|NCT01174030|76219839|FG001|COMPLETED|Overall Study||52||
60102079|NCT01174030|76219840|FG002|COMPLETED|Overall Study||52||
60102080|NCT01174030|76219841|FG003|COMPLETED|Overall Study||53||
60102081|NCT01174030|76219842|FG004|COMPLETED|Overall Study||52||
60102082|NCT01174030|76219838|FG000|NOT COMPLETED|Overall Study||2||
60102083|NCT01174030|76219839|FG001|NOT COMPLETED|Overall Study||2||
60102084|NCT01174030|76219840|FG002|NOT COMPLETED|Overall Study||2||
60102085|NCT01174030|76219841|FG003|NOT COMPLETED|Overall Study||2||
60102086|NCT01174030|76219842|FG004|NOT COMPLETED|Overall Study||1||
60102087|NCT01174576|76219854|FG000|STARTED|Overall Study|All participants received all interventions without exception.|16||
60102088|NCT01174576|76219854|FG000|COMPLETED|Overall Study||16||
60102089|NCT01174576|76219854|FG000|NOT COMPLETED|Overall Study||0||
60102090|NCT01134328|76219871|FG000|STARTED|Overall Study||21||
60102091|NCT01134328|76219872|FG001|STARTED|Overall Study||21||
60102092|NCT01134328|76219873|FG002|STARTED|Overall Study||20||
60102093|NCT01134328|76219874|FG003|STARTED|Overall Study||21||
59994359|NCT01239797|76110173|FG001|COMPLETED|Randomized Participants||316||
59994360|NCT01239797|76110172|FG000|NOT COMPLETED|Randomized Participants||2||
59994361|NCT01239797|76110173|FG001|NOT COMPLETED|Randomized Participants||9||
59994362|NCT01239797|76110172|FG000|STARTED|Treated Participants|1 participant was randomized to treatment E-Ld but received treatment Ld|318|Participants treated|
59994363|NCT01239797|76110173|FG001|STARTED|Treated Participants|1 participant was randomized to treatment E-Ld but received treatment Ld|317|Participants treated|
59994364|NCT01239797|76110172|FG000|COMPLETED|Treated Participants||0|Participants still on treatment|
59994365|NCT01239797|76110173|FG001|COMPLETED|Treated Participants||0|Participants still on treatment|
59994366|NCT01239797|76110172|FG000|NOT COMPLETED|Treated Participants||318||
59994367|NCT01239797|76110173|FG001|NOT COMPLETED|Treated Participants||317||
59994368|NCT01092143|76110184|FG000|STARTED|Overall Study||78||
59994369|NCT01092143|76110185|FG001|STARTED|Overall Study||77||
59994370|NCT01092143|76110186|FG002|STARTED|Overall Study||84||
59994371|NCT01092143|76110187|FG003|STARTED|Overall Study||79||
60102094|NCT01134328|76219871|FG000|COMPLETED|Overall Study||19||
60102095|NCT01134328|76219872|FG001|COMPLETED|Overall Study||18||
60102096|NCT01134328|76219873|FG002|COMPLETED|Overall Study||17||
60102097|NCT01134328|76219874|FG003|COMPLETED|Overall Study||17||
60102098|NCT01134328|76219871|FG000|NOT COMPLETED|Overall Study||2||
60102099|NCT01134328|76219872|FG001|NOT COMPLETED|Overall Study||3||
60102100|NCT01134328|76219873|FG002|NOT COMPLETED|Overall Study||3||
60102101|NCT01134328|76219874|FG003|NOT COMPLETED|Overall Study||4||
60102102|NCT01134952|76219884|FG000|STARTED|Overall Study||11||
60102103|NCT01134952|76219884|FG000|COMPLETED|Overall Study||11||
60102104|NCT01134952|76219884|FG000|NOT COMPLETED|Overall Study||0||
60102105|NCT01175434|76219894|FG000|STARTED|Overall Study||48||
60102106|NCT01175434|76219895|FG001|STARTED|Overall Study||51||
60102107|NCT01175434|76219894|FG000|COMPLETED|Overall Study||48||
60102108|NCT01175434|76219895|FG001|COMPLETED|Overall Study||51||
60102109|NCT01175434|76219894|FG000|NOT COMPLETED|Overall Study||0||
60102110|NCT01175434|76219895|FG001|NOT COMPLETED|Overall Study||0||
60102111|NCT01175902|76219903|FG000|STARTED|Overall Study||22||
60102112|NCT01175902|76219904|FG001|STARTED|Overall Study||22||
60102113|NCT01175902|76219903|FG000|COMPLETED|Overall Study||22||
60102114|NCT01175902|76219904|FG001|COMPLETED|Overall Study||22||
60102115|NCT01175902|76219903|FG000|NOT COMPLETED|Overall Study||0||
60102116|NCT01175902|76219904|FG001|NOT COMPLETED|Overall Study||0||
60102117|NCT01135186|76219912|FG000|STARTED|Overall Study||9||
60102118|NCT01135186|76219912|FG000|COMPLETED|Overall Study||9||
60102119|NCT01135186|76219912|FG000|NOT COMPLETED|Overall Study||0||
60102120|NCT00634569|76219920|FG000|STARTED|Overall Study||14||
60102121|NCT00634569|76219921|FG001|STARTED|Overall Study||10||
60102122|NCT00634569|76219920|FG000|COMPLETED|Overall Study||14||
60102123|NCT00634569|76219921|FG001|COMPLETED|Overall Study||5||
60102124|NCT00634569|76219920|FG000|NOT COMPLETED|Overall Study||0||
60102125|NCT00634569|76219921|FG001|NOT COMPLETED|Overall Study||5||
60102126|NCT01175980|76219927|FG000|STARTED|Overall Study||30||
60102127|NCT01175980|76219927|FG000|COMPLETED|Overall Study||30||
60102128|NCT01175980|76219927|FG000|NOT COMPLETED|Overall Study||0||
60102129|NCT04246554|76219933|FG000|STARTED|Overall Study||26||
60102130|NCT04246554|76219934|FG001|STARTED|Overall Study||23||
60102131|NCT04246554|76219933|FG000|COMPLETED|Overall Study||26||
60102132|NCT04246554|76219934|FG001|COMPLETED|Overall Study||22||
60102133|NCT04246554|76219933|FG000|NOT COMPLETED|Overall Study||0||
60102134|NCT04246554|76219934|FG001|NOT COMPLETED|Overall Study||1||
60102135|NCT01176448|76219940|FG000|STARTED|Overall Study||6||
60102136|NCT01176448|76219940|FG000|COMPLETED|Overall Study||6||
60102137|NCT01176448|76219940|FG000|NOT COMPLETED|Overall Study||0||
60102138|NCT01135420|76219950|FG000|STARTED|Overall Study||199||
60102139|NCT01135420|76219951|FG001|STARTED|Overall Study||207||
60102140|NCT01135420|76219950|FG000|COMPLETED|Overall Study||155||
60102141|NCT01135420|76219951|FG001|COMPLETED|Overall Study||175||
60102142|NCT01135420|76219950|FG000|NOT COMPLETED|Overall Study||44||
60102143|NCT01135420|76219951|FG001|NOT COMPLETED|Overall Study||32||
60102144|NCT01137370|76219959|FG000|STARTED|Overall Study||116||
60102145|NCT01137370|76219960|FG001|STARTED|Overall Study||87||
60102146|NCT01137370|76219959|FG000|COMPLETED|Overall Study||116||
60102147|NCT01137370|76219960|FG001|COMPLETED|Overall Study||87||
60102148|NCT01137370|76219959|FG000|NOT COMPLETED|Overall Study||0||
60102149|NCT01137370|76219960|FG001|NOT COMPLETED|Overall Study||0||
60102150|NCT00634179|76219966|FG000|STARTED|Phase I: Induction||19||
60102151|NCT00634179|76219966|FG000|COMPLETED|Phase I: Induction||19||
60102152|NCT00634179|76219966|FG000|NOT COMPLETED|Phase I: Induction||0||
60102153|NCT00634179|76219966|FG000|STARTED|Phase II: Maintenance||30||
60102154|NCT00634179|76219966|FG000|COMPLETED|Phase II: Maintenance||29||
60102155|NCT00634179|76219966|FG000|NOT COMPLETED|Phase II: Maintenance||1||
60102156|NCT01178944|76219973|FG000|STARTED|Overall Study||35||
60102157|NCT01178944|76219973|FG000|COMPLETED|Overall Study||35||
60102158|NCT01178944|76219973|FG000|NOT COMPLETED|Overall Study||0||
60102159|NCT01179490|76219977|FG000|STARTED|Overall Study||5||
60102160|NCT01179490|76219977|FG000|COMPLETED|Overall Study||5||
60102161|NCT01179490|76219977|FG000|NOT COMPLETED|Overall Study||0||
60102162|NCT01179568|76219985|FG000|STARTED|Overall Study||101||
60102163|NCT01179568|76219986|FG001|STARTED|Overall Study||99||
60102164|NCT01179568|76219987|FG002|STARTED|Overall Study||99||
60102165|NCT01179568|76219988|FG003|STARTED|Overall Study||96||
60102166|NCT01179568|76219985|FG000|Completed Week 12 Assessment|Overall Study||69||
60102167|NCT01179568|76219986|FG001|Completed Week 12 Assessment|Overall Study||69||
60102168|NCT01179568|76219987|FG002|Completed Week 12 Assessment|Overall Study||76||
60102169|NCT01179568|76219988|FG003|Completed Week 12 Assessment|Overall Study||75||
60102170|NCT01179568|76219985|FG000|COMPLETED|Overall Study||73|Week 20 assessment|
60102171|NCT01179568|76219986|FG001|COMPLETED|Overall Study||61|Week 20 assessment|
60102172|NCT01179568|76219987|FG002|COMPLETED|Overall Study||76|Week 20 assessment|
60102173|NCT01179568|76219988|FG003|COMPLETED|Overall Study||76|Week 20 assessment|
60102174|NCT01179568|76219985|FG000|NOT COMPLETED|Overall Study||28||
60102175|NCT01179568|76219986|FG001|NOT COMPLETED|Overall Study||38||
60102176|NCT01179568|76219987|FG002|NOT COMPLETED|Overall Study||23||
60102177|NCT01179568|76219988|FG003|NOT COMPLETED|Overall Study||20||
60102178|NCT01180036|76220003|FG000|STARTED|Overall Study||65||
60102179|NCT01180036|76220004|FG001|STARTED|Overall Study||65||
60102180|NCT01180036|76220003|FG000|COMPLETED|Overall Study||65||
60102181|NCT01180036|76220004|FG001|COMPLETED|Overall Study||65||
60102182|NCT01180036|76220003|FG000|NOT COMPLETED|Overall Study||0||
60102183|NCT01180036|76220004|FG001|NOT COMPLETED|Overall Study||0||
60102184|NCT01180894|76220014|FG000|STARTED|Overall Study||75||
60102185|NCT01180894|76220015|FG001|STARTED|Overall Study||75||
60102186|NCT01180894|76220014|FG000|COMPLETED|Overall Study||75||
60102187|NCT01180894|76220015|FG001|COMPLETED|Overall Study||75||
60102188|NCT01180894|76220014|FG000|NOT COMPLETED|Overall Study||0||
60102189|NCT01180894|76220015|FG001|NOT COMPLETED|Overall Study||0||
60102190|NCT01181050|76220025|FG000|STARTED|Overall Study||41||
60102191|NCT01181050|76220026|FG001|STARTED|Overall Study||22||
60102192|NCT01181050|76220025|FG000|COMPLETED|Overall Study||41||
59708566|NCT01253408|75827399|FG002|NOT COMPLETED|Overall Study||0||
59708567|NCT01253174|75827407|FG000|STARTED|Period 1||6||
59708568|NCT01253174|75827408|FG001|STARTED|Period 1||10||
59708569|NCT01253174|75827409|FG002|STARTED|Period 1||9||
59708570|NCT01253174|75827410|FG003|STARTED|Period 1||7||
59708571|NCT01253174|75827411|FG004|STARTED|Period 1||9||
59708572|NCT01253174|75827412|FG005|STARTED|Period 1||7||
60102193|NCT01181050|76220026|FG001|COMPLETED|Overall Study||22||
60102194|NCT01181050|76220025|FG000|NOT COMPLETED|Overall Study||0||
60102195|NCT01181050|76220026|FG001|NOT COMPLETED|Overall Study||0||
60102196|NCT01181596|76220032|FG000|STARTED|Overall Study||31||
60102197|NCT01181596|76220032|FG000|COMPLETED|Overall Study||31||
60102198|NCT01181596|76220032|FG000|NOT COMPLETED|Overall Study||0||
60102199|NCT03877926|76220041|FG000|STARTED|Overall Study||1103||
60102200|NCT03877926|76220042|FG001|STARTED|Overall Study||1103||
60102201|NCT03877926|76220043|FG002|STARTED|Overall Study||1098||
60102202|NCT03877926|76220044|FG003|STARTED|Overall Study||558||
60102203|NCT03877926|76220041|FG000|Received at Least One Study Vaccination|Overall Study||1100||
60102204|NCT03877926|76220042|FG001|Received at Least One Study Vaccination|Overall Study||1102||
60102205|NCT03877926|76220043|FG002|Received at Least One Study Vaccination|Overall Study||1097||
59708573|NCT01253174|75827407|FG000|COMPLETED|Period 1||6||
59708574|NCT01253174|75827408|FG001|COMPLETED|Period 1||9||
59708575|NCT01253174|75827409|FG002|COMPLETED|Period 1||8||
59708576|NCT01253174|75827410|FG003|COMPLETED|Period 1||7||
59708577|NCT01253174|75827411|FG004|COMPLETED|Period 1||8||
60102206|NCT03877926|76220044|FG003|Received at Least One Study Vaccination|Overall Study||558||
60102207|NCT03877926|76220041|FG000|Did Not Receive Any Study Vaccination|Overall Study||3||
60102208|NCT03877926|76220042|FG001|Did Not Receive Any Study Vaccination|Overall Study||1||
60102209|NCT03877926|76220043|FG002|Did Not Receive Any Study Vaccination|Overall Study||1||
60102210|NCT03877926|76220044|FG003|Did Not Receive Any Study Vaccination|Overall Study||0||
60102211|NCT03877926|76220041|FG000|COMPLETED|Overall Study||1032|Number of participants who completed 12-month follow-up after last study vaccination|
59708578|NCT01253174|75827412|FG005|COMPLETED|Period 1||7||
60102212|NCT03877926|76220042|FG001|COMPLETED|Overall Study||1026|Number of participants who completed 12-month follow-up after last study vaccination|
60102213|NCT03877926|76220043|FG002|COMPLETED|Overall Study||1035|Number of participants who completed 12-month follow-up after last study vaccination|
59708579|NCT01253174|75827407|FG000|NOT COMPLETED|Period 1||0||
59708580|NCT01253174|75827408|FG001|NOT COMPLETED|Period 1||1||
59708581|NCT01253174|75827409|FG002|NOT COMPLETED|Period 1||1||
59708582|NCT01253174|75827410|FG003|NOT COMPLETED|Period 1||0||
59708583|NCT01253174|75827411|FG004|NOT COMPLETED|Period 1||1||
60102214|NCT03877926|76220044|FG003|COMPLETED|Overall Study||537|Number of participants who completed 12-month follow-up after last study vaccination|
59708584|NCT01253174|75827412|FG005|NOT COMPLETED|Period 1||0||
59708585|NCT01253174|75827407|FG000|STARTED|Period 2||6||
59708586|NCT01253174|75827408|FG001|STARTED|Period 2||9||
60102215|NCT03877926|76220041|FG000|NOT COMPLETED|Overall Study||71||
60102216|NCT03877926|76220042|FG001|NOT COMPLETED|Overall Study||77||
60102217|NCT03877926|76220043|FG002|NOT COMPLETED|Overall Study||63||
60102218|NCT03877926|76220044|FG003|NOT COMPLETED|Overall Study||21||
60102219|NCT01181674|76220070|FG000|STARTED|Overall Study||28||
59708587|NCT01253174|75827409|FG002|STARTED|Period 2||8||
59708588|NCT01253174|75827410|FG003|STARTED|Period 2||7||
59708589|NCT01253174|75827411|FG004|STARTED|Period 2||8||
59565392|NCT01830140|75667652|FG001|COMPLETED|Overall Study||229||
59565393|NCT01830140|75667651|FG000|NOT COMPLETED|Overall Study||7||
59565394|NCT01830140|75667652|FG001|NOT COMPLETED|Overall Study||4||
59565395|NCT01830842|75667660|FG000|STARTED|Overall Study||30||
59565396|NCT01830842|75667661|FG001|STARTED|Overall Study||24||
59565397|NCT01830842|75667660|FG000|COMPLETED|Overall Study||25||
59565398|NCT01830842|75667661|FG001|COMPLETED|Overall Study||22||
59565399|NCT01830842|75667660|FG000|NOT COMPLETED|Overall Study||5||
59565400|NCT01830842|75667661|FG001|NOT COMPLETED|Overall Study||2||
59565401|NCT01831154|75667670|FG000|STARTED|Overall Study|Study Institutional Review Board (IRB) approval 11-11-2009, first subjects enrolled 6-7-2010|15||
59565402|NCT01831154|75667671|FG001|STARTED|Overall Study|Study IRB approval 11-11-2009, first subjects enrolled 6-7-2010|11||
59565403|NCT01831154|75667672|FG002|STARTED|Overall Study|Study IRB approval 11-11-2009, first subjects enrolled 6-7-2010|11||
59708590|NCT01253174|75827412|FG005|STARTED|Period 2||7||
60102220|NCT01181674|76220071|FG001|STARTED|Overall Study||27||
60102221|NCT01181674|76220072|FG002|STARTED|Overall Study||28||
59565404|NCT01831154|75667670|FG000|COMPLETED|Overall Study||15||
59708591|NCT01253174|75827407|FG000|COMPLETED|Period 2||6||
59708592|NCT01253174|75827408|FG001|COMPLETED|Period 2||9||
59708593|NCT01253174|75827409|FG002|COMPLETED|Period 2||7||
59708594|NCT01253174|75827410|FG003|COMPLETED|Period 2||7||
59708595|NCT01253174|75827411|FG004|COMPLETED|Period 2||8||
59708596|NCT01253174|75827412|FG005|COMPLETED|Period 2||7||
59708597|NCT01253174|75827407|FG000|NOT COMPLETED|Period 2||0||
59708598|NCT01253174|75827408|FG001|NOT COMPLETED|Period 2||0||
60102222|NCT01181674|76220070|FG000|COMPLETED|Overall Study||28||
60102223|NCT01181674|76220071|FG001|COMPLETED|Overall Study||27||
60102224|NCT01181674|76220072|FG002|COMPLETED|Overall Study|28 included in analyses|26||
60102225|NCT01181674|76220070|FG000|NOT COMPLETED|Overall Study||0||
60102226|NCT01181674|76220071|FG001|NOT COMPLETED|Overall Study||0||
60102227|NCT01181674|76220072|FG002|NOT COMPLETED|Overall Study||2||
60102228|NCT01182376|76220082|FG000|STARTED|Overall Study||15||
60102229|NCT01182376|76220083|FG001|STARTED|Overall Study||18||
60102230|NCT01182376|76220082|FG000|COMPLETED|Overall Study||4||
60102231|NCT01182376|76220083|FG001|COMPLETED|Overall Study||13||
60102232|NCT01182376|76220082|FG000|NOT COMPLETED|Overall Study||11||
60102233|NCT01182376|76220083|FG001|NOT COMPLETED|Overall Study||5||
60102234|NCT01183312|76220091|FG000|STARTED|First Intervention Day||5||
60102235|NCT01183312|76220092|FG001|STARTED|First Intervention Day||5||
60102236|NCT01183312|76220091|FG000|COMPLETED|First Intervention Day||5||
59565405|NCT01831154|75667671|FG001|COMPLETED|Overall Study||11||
59708599|NCT01253174|75827409|FG002|NOT COMPLETED|Period 2||1||
59708600|NCT01253174|75827410|FG003|NOT COMPLETED|Period 2||0||
59708601|NCT01253174|75827411|FG004|NOT COMPLETED|Period 2||0||
59708602|NCT01253174|75827412|FG005|NOT COMPLETED|Period 2||0||
59708603|NCT01253174|75827407|FG000|STARTED|Period 3||6||
59708604|NCT01253174|75827408|FG001|STARTED|Period 3||9||
59708605|NCT01253174|75827409|FG002|STARTED|Period 3||7||
59708606|NCT01253174|75827410|FG003|STARTED|Period 3||7||
59708607|NCT01253174|75827411|FG004|STARTED|Period 3||8||
59708608|NCT01253174|75827412|FG005|STARTED|Period 3||7||
59708609|NCT01253174|75827407|FG000|COMPLETED|Period 3||6||
59708610|NCT01253174|75827408|FG001|COMPLETED|Period 3||8||
59708611|NCT01253174|75827409|FG002|COMPLETED|Period 3||6||
59708612|NCT01253174|75827410|FG003|COMPLETED|Period 3||7||
59708613|NCT01253174|75827411|FG004|COMPLETED|Period 3||7||
59708614|NCT01253174|75827412|FG005|COMPLETED|Period 3||7||
59708615|NCT01253174|75827407|FG000|NOT COMPLETED|Period 3||0||
59708616|NCT01253174|75827408|FG001|NOT COMPLETED|Period 3||1||
59708617|NCT01253174|75827409|FG002|NOT COMPLETED|Period 3||1||
59708618|NCT01253174|75827410|FG003|NOT COMPLETED|Period 3||0||
59708619|NCT01253174|75827411|FG004|NOT COMPLETED|Period 3||1||
59708620|NCT01253174|75827412|FG005|NOT COMPLETED|Period 3||0||
59708621|NCT01108731|75827423|FG000|STARTED|Overall Study||17||
59708622|NCT01108731|75827424|FG001|STARTED|Overall Study||17||
59708623|NCT01108731|75827423|FG000|COMPLETED|Overall Study||13||
59708624|NCT01108731|75827424|FG001|COMPLETED|Overall Study||13||
59708625|NCT01108731|75827423|FG000|NOT COMPLETED|Overall Study||4||
59708626|NCT01108731|75827424|FG001|NOT COMPLETED|Overall Study||4||
59708627|NCT01253018|75827432|FG000|STARTED|Overall Study||22||
59708628|NCT01253018|75827433|FG001|STARTED|Overall Study||23||
59708629|NCT01253018|75827432|FG000|COMPLETED|Overall Study||18||
59708630|NCT01253018|75827433|FG001|COMPLETED|Overall Study||21||
59994372|NCT01092143|76110188|FG004|STARTED|Overall Study||71||
59994373|NCT01092143|76110184|FG000|Treated|Overall Study||78||
59994374|NCT01092143|76110185|FG001|Treated|Overall Study||77||
59994375|NCT01092143|76110186|FG002|Treated|Overall Study||83||
59994376|NCT01092143|76110187|FG003|Treated|Overall Study||79||
59994377|NCT01092143|76110188|FG004|Treated|Overall Study||71||
60102237|NCT01183312|76220092|FG001|COMPLETED|First Intervention Day||5||
60102238|NCT01183312|76220091|FG000|NOT COMPLETED|First Intervention Day||0||
60102239|NCT01183312|76220092|FG001|NOT COMPLETED|First Intervention Day||0||
60102240|NCT01183312|76220091|FG000|STARTED|Washout Period of at Least 1 Week||5||
60102241|NCT01183312|76220092|FG001|STARTED|Washout Period of at Least 1 Week||5||
59708631|NCT01253018|75827432|FG000|NOT COMPLETED|Overall Study||4||
59708632|NCT01253018|75827433|FG001|NOT COMPLETED|Overall Study||2||
59708633|NCT01108341|75827440|FG000|STARTED|Overall Study||50||
59708634|NCT01108341|75827440|FG000|Safety Set (Enrolled and Treated)|Overall Study||49||
59708635|NCT01108341|75827440|FG000|COMPLETED|Overall Study||45||
59708636|NCT01108341|75827440|FG000|NOT COMPLETED|Overall Study||5||
59708637|NCT01108263|75827446|FG000|STARTED|Overall Study||2||
59994378|NCT01092143|76110184|FG000|COMPLETED|Overall Study||63||
59994379|NCT01092143|76110185|FG001|COMPLETED|Overall Study||70||
59994380|NCT01092143|76110186|FG002|COMPLETED|Overall Study||80||
59994381|NCT01092143|76110187|FG003|COMPLETED|Overall Study||72||
59994382|NCT01092143|76110188|FG004|COMPLETED|Overall Study||63||
59994383|NCT01092143|76110184|FG000|NOT COMPLETED|Overall Study||15||
59994384|NCT01092143|76110185|FG001|NOT COMPLETED|Overall Study||7||
59994385|NCT01092143|76110186|FG002|NOT COMPLETED|Overall Study||4||
59994386|NCT01092143|76110187|FG003|NOT COMPLETED|Overall Study||7||
59994387|NCT01092143|76110188|FG004|NOT COMPLETED|Overall Study||8||
59994388|NCT02377466|76110202|FG000|STARTED|Overall Study||13||
59994389|NCT02377466|76110203|FG001|STARTED|Overall Study||12||
59994390|NCT02377466|76110202|FG000|Treated|Overall Study||13||
59994391|NCT02377466|76110203|FG001|Treated|Overall Study||10||
59994392|NCT02377466|76110202|FG000|COMPLETED|Overall Study||13||
59994393|NCT02377466|76110203|FG001|COMPLETED|Overall Study||10||
59994394|NCT02377466|76110202|FG000|NOT COMPLETED|Overall Study||0||
59708638|NCT01108263|75827447|FG001|STARTED|Overall Study||3||
60102242|NCT01183312|76220091|FG000|COMPLETED|Washout Period of at Least 1 Week||5||
60102243|NCT01183312|76220092|FG001|COMPLETED|Washout Period of at Least 1 Week||5||
60102244|NCT01183312|76220091|FG000|NOT COMPLETED|Washout Period of at Least 1 Week||0||
60102245|NCT01183312|76220092|FG001|NOT COMPLETED|Washout Period of at Least 1 Week||0||
60102246|NCT01183312|76220091|FG000|STARTED|Second Intervention Day||5||
60102247|NCT01183312|76220092|FG001|STARTED|Second Intervention Day||5||
60102248|NCT01183312|76220091|FG000|COMPLETED|Second Intervention Day||5||
60102249|NCT01183312|76220092|FG001|COMPLETED|Second Intervention Day||5||
60102250|NCT01183312|76220091|FG000|NOT COMPLETED|Second Intervention Day||0||
59565406|NCT01831154|75667672|FG002|COMPLETED|Overall Study||11||
59565407|NCT01831154|75667670|FG000|NOT COMPLETED|Overall Study||0||
59565408|NCT01831154|75667671|FG001|NOT COMPLETED|Overall Study||0||
59565409|NCT01831154|75667672|FG002|NOT COMPLETED|Overall Study||0||
59565410|NCT04544787|75667687|FG000|STARTED|Overall Study||50||
59565411|NCT04544787|75667688|FG001|STARTED|Overall Study||50||
59565412|NCT04544787|75667689|FG002|STARTED|Overall Study||50||
59565413|NCT04544787|75667690|FG003|STARTED|Overall Study||50||
59565414|NCT04544787|75667691|FG004|STARTED|Overall Study||17||
59565415|NCT04544787|75667692|FG005|STARTED|Overall Study||16||
59565416|NCT04544787|75667693|FG006|STARTED|Overall Study||17||
59565417|NCT04544787|75667687|FG000|Received First Dose of Vaccine|Overall Study||50||
59565418|NCT04544787|75667688|FG001|Received First Dose of Vaccine|Overall Study||50||
59565419|NCT04544787|75667689|FG002|Received First Dose of Vaccine|Overall Study||50||
59565420|NCT04544787|75667690|FG003|Received First Dose of Vaccine|Overall Study||50||
59565421|NCT04544787|75667691|FG004|Received First Dose of Vaccine|Overall Study||17||
59565422|NCT04544787|75667692|FG005|Received First Dose of Vaccine|Overall Study||16||
59708639|NCT01108263|75827446|FG000|COMPLETED|Overall Study||2||
59708640|NCT01108263|75827447|FG001|COMPLETED|Overall Study||2||
59708641|NCT01108263|75827446|FG000|NOT COMPLETED|Overall Study||0||
59994395|NCT02377466|76110203|FG001|NOT COMPLETED|Overall Study||2||
59994396|NCT00950989|76110220|FG000|STARTED|Overall Study||63||
59994397|NCT00950989|76110221|FG001|STARTED|Overall Study||63||
60102251|NCT01183312|76220092|FG001|NOT COMPLETED|Second Intervention Day||0||
60102252|NCT01183546|76220098|FG000|STARTED|Overall Study||53||
60102253|NCT01183546|76220098|FG000|COMPLETED|Overall Study||53||
60102254|NCT01183546|76220098|FG000|NOT COMPLETED|Overall Study||0||
59994398|NCT00950989|76110222|FG002|STARTED|Overall Study||63||
59994399|NCT00950989|76110223|FG003|STARTED|Overall Study||63||
59994400|NCT00950989|76110220|FG000|COMPLETED|Overall Study||59||
59994401|NCT00950989|76110221|FG001|COMPLETED|Overall Study||60||
59994402|NCT00950989|76110222|FG002|COMPLETED|Overall Study||60||
59994403|NCT00950989|76110223|FG003|COMPLETED|Overall Study||63||
60102255|NCT01184014|76220105|FG000|STARTED|Overall Study||35||
60102256|NCT01184014|76220106|FG001|STARTED|Overall Study||37||
60102257|NCT01184014|76220105|FG000|COMPLETED|Overall Study||30||
60102258|NCT01184014|76220106|FG001|COMPLETED|Overall Study||31||
60102259|NCT01184014|76220105|FG000|NOT COMPLETED|Overall Study||5||
60102260|NCT01184014|76220106|FG001|NOT COMPLETED|Overall Study||6||
60102261|NCT01185028|76220112|FG000|STARTED|Overall Study||8||
60102262|NCT01185028|76220112|FG000|COMPLETED|Overall Study||4||
60102263|NCT01185028|76220112|FG000|NOT COMPLETED|Overall Study||4||
60102264|NCT01143142|76220118|FG000|STARTED|Overall Study||36||
60102265|NCT01143142|76220119|FG001|STARTED|Overall Study||34||
60102266|NCT01143142|76220118|FG000|COMPLETED|Overall Study||36||
60102267|NCT01143142|76220119|FG001|COMPLETED|Overall Study||34||
60102268|NCT01143142|76220118|FG000|NOT COMPLETED|Overall Study||0||
60102269|NCT01143142|76220119|FG001|NOT COMPLETED|Overall Study||0||
60102270|NCT02186938|76220127|FG000|STARTED|Overall Study|2012|47||
60102271|NCT02186938|76220128|FG001|STARTED|Overall Study||47||
60102272|NCT02186938|76220127|FG000|COMPLETED|Overall Study||38||
60102273|NCT02186938|76220128|FG001|COMPLETED|Overall Study||44||
60102274|NCT02186938|76220127|FG000|NOT COMPLETED|Overall Study||9||
60102275|NCT02186938|76220128|FG001|NOT COMPLETED|Overall Study||3||
60102276|NCT02187016|76220138|FG000|STARTED|Overall Study||80||
60102277|NCT02187016|76220139|FG001|STARTED|Overall Study||80||
60102278|NCT02187016|76220140|FG002|STARTED|Overall Study||79||
60102279|NCT02187016|76220141|FG003|STARTED|Overall Study||51||
60102280|NCT02187016|76220138|FG000|COMPLETED|Overall Study||79||
60102281|NCT02187016|76220139|FG001|COMPLETED|Overall Study||78||
60102282|NCT02187016|76220140|FG002|COMPLETED|Overall Study||78||
60102283|NCT02187016|76220141|FG003|COMPLETED|Overall Study||51||
60102284|NCT02187016|76220138|FG000|NOT COMPLETED|Overall Study||1||
60102285|NCT02187016|76220139|FG001|NOT COMPLETED|Overall Study||2||
60102286|NCT02187016|76220140|FG002|NOT COMPLETED|Overall Study||1||
60102287|NCT02187016|76220141|FG003|NOT COMPLETED|Overall Study||0||
60102288|NCT02188576|76220153|FG000|STARTED|Overall Study||32||
60102289|NCT02188576|76220154|FG001|STARTED|Overall Study||34||
60102290|NCT02188576|76220153|FG000|COMPLETED|Overall Study||32||
60102291|NCT02188576|76220154|FG001|COMPLETED|Overall Study||34||
60102292|NCT02188576|76220153|FG000|NOT COMPLETED|Overall Study||0||
60102293|NCT02188576|76220154|FG001|NOT COMPLETED|Overall Study||0||
60102294|NCT02189122|76220162|FG000|STARTED|Overall Study||18||
60102295|NCT02189122|76220163|FG001|STARTED|Overall Study||18||
60102296|NCT02189122|76220162|FG000|COMPLETED|Overall Study||18||
60102297|NCT02189122|76220163|FG001|COMPLETED|Overall Study||18||
60102298|NCT02189122|76220162|FG000|NOT COMPLETED|Overall Study||0||
60102299|NCT02189122|76220163|FG001|NOT COMPLETED|Overall Study||0||
60102300|NCT01093690|76220173|FG000|STARTED|Overall Study||83||
60102301|NCT01093690|76220174|FG001|STARTED|Overall Study||79||
60102302|NCT01093690|76220173|FG000|COMPLETED|Overall Study||83||
60102303|NCT01093690|76220174|FG001|COMPLETED|Overall Study||79||
60102304|NCT01093690|76220173|FG000|NOT COMPLETED|Overall Study||0||
60102305|NCT01093690|76220174|FG001|NOT COMPLETED|Overall Study||0||
60102306|NCT01143610|76220182|FG000|STARTED|Overall Study||7||
60102307|NCT01143610|76220183|FG001|STARTED|Overall Study||8||
59708642|NCT01108263|75827447|FG001|NOT COMPLETED|Overall Study||1||
59708643|NCT01108185|75827453|FG000|STARTED|Overall Study||3181||
60102308|NCT01143610|76220182|FG000|COMPLETED|Overall Study||7||
60102309|NCT01143610|76220183|FG001|COMPLETED|Overall Study||8||
60102310|NCT01143610|76220182|FG000|NOT COMPLETED|Overall Study||0||
60102311|NCT01143610|76220183|FG001|NOT COMPLETED|Overall Study||0||
60102312|NCT01143688|76220189|FG000|STARTED|Overall Study||39||
60102313|NCT01143688|76220189|FG000|COMPLETED|Overall Study||39||
60102314|NCT01143688|76220189|FG000|NOT COMPLETED|Overall Study||0||
60102315|NCT01187914|76220199|FG000|STARTED|Overall Study||40||
60102316|NCT01187914|76220199|FG000|COMPLETED|Overall Study||40||
60102317|NCT01187914|76220199|FG000|NOT COMPLETED|Overall Study||0||
60102318|NCT01188460|76220205|FG000|STARTED|Overall Study||25||
60102319|NCT01188460|76220206|FG001|STARTED|Overall Study||23||
60102320|NCT01188460|76220205|FG000|COMPLETED|Overall Study||25||
60102321|NCT01188460|76220206|FG001|COMPLETED|Overall Study||23||
60102322|NCT01188460|76220205|FG000|NOT COMPLETED|Overall Study||0||
60102323|NCT01188460|76220206|FG001|NOT COMPLETED|Overall Study||0||
60102324|NCT01188694|76220215|FG000|STARTED|Overall Study||15||
60102325|NCT01188694|76220216|FG001|STARTED|Overall Study||16||
60102326|NCT01188694|76220217|FG002|STARTED|Overall Study||11||
60102327|NCT01188694|76220215|FG000|COMPLETED|Overall Study||10||
60102328|NCT01188694|76220216|FG001|COMPLETED|Overall Study||15||
60102329|NCT01188694|76220217|FG002|COMPLETED|Overall Study||10||
60102330|NCT01188694|76220215|FG000|NOT COMPLETED|Overall Study||5||
59994404|NCT00950989|76110220|FG000|NOT COMPLETED|Overall Study||4||
59994405|NCT00950989|76110221|FG001|NOT COMPLETED|Overall Study||3||
59994406|NCT00950989|76110222|FG002|NOT COMPLETED|Overall Study||3||
59994407|NCT00950989|76110223|FG003|NOT COMPLETED|Overall Study||0||
59994408|NCT00593567|76110238|FG000|STARTED|Overall Study||48||
59994409|NCT00593567|76110239|FG001|STARTED|Overall Study||22||
59994410|NCT00593567|76110238|FG000|COMPLETED|Overall Study||28||
59994411|NCT00593567|76110239|FG001|COMPLETED|Overall Study||12||
59994412|NCT00593567|76110238|FG000|NOT COMPLETED|Overall Study||20||
59994413|NCT00593567|76110239|FG001|NOT COMPLETED|Overall Study||10||
59994414|NCT02411084|76110247|FG000|STARTED|Overall Study||18||
59994415|NCT02411084|76110248|FG001|STARTED|Overall Study||18||
59994416|NCT02411084|76110247|FG000|COMPLETED|Overall Study||5||
59994417|NCT02411084|76110248|FG001|COMPLETED|Overall Study||5||
59994418|NCT02411084|76110247|FG000|NOT COMPLETED|Overall Study||13||
59994419|NCT02411084|76110248|FG001|NOT COMPLETED|Overall Study||13||
59994420|NCT01602315|76110261|FG000|STARTED|Overall Study||16||
59994421|NCT01602315|76110262|FG001|STARTED|Overall Study||5||
59994422|NCT01602315|76110263|FG002|STARTED|Overall Study||18||
59994423|NCT01602315|76110264|FG003|STARTED|Overall Study||6||
59994424|NCT01602315|76110265|FG004|STARTED|Overall Study||71||
59994425|NCT01602315|76110266|FG005|STARTED|Overall Study||35||
59994426|NCT01602315|76110267|FG006|STARTED|Overall Study||29||
59994427|NCT01602315|76110261|FG000|COMPLETED|Overall Study||0||
59994428|NCT01602315|76110262|FG001|COMPLETED|Overall Study||0||
59994429|NCT01602315|76110263|FG002|COMPLETED|Overall Study||0||
59994430|NCT01602315|76110264|FG003|COMPLETED|Overall Study||0||
59994431|NCT01602315|76110265|FG004|COMPLETED|Overall Study||0||
59994432|NCT01602315|76110266|FG005|COMPLETED|Overall Study||0||
59994433|NCT01602315|76110267|FG006|COMPLETED|Overall Study||0||
59994434|NCT01602315|76110261|FG000|NOT COMPLETED|Overall Study||16||
59994435|NCT01602315|76110262|FG001|NOT COMPLETED|Overall Study||5||
59994436|NCT01602315|76110263|FG002|NOT COMPLETED|Overall Study||18||
59994437|NCT01602315|76110264|FG003|NOT COMPLETED|Overall Study||6||
59994438|NCT01602315|76110265|FG004|NOT COMPLETED|Overall Study||71||
59994439|NCT01602315|76110266|FG005|NOT COMPLETED|Overall Study||35||
59994440|NCT01602315|76110267|FG006|NOT COMPLETED|Overall Study||29||
59994441|NCT03413605|76110305|FG000|STARTED|Overall Study Baseline||392||
59994442|NCT03413605|76110306|FG001|STARTED|Overall Study Baseline||409||
59994443|NCT03413605|76110305|FG000|COMPLETED|Overall Study Baseline||392||
59994444|NCT03413605|76110306|FG001|COMPLETED|Overall Study Baseline||409||
59994445|NCT03413605|76110305|FG000|NOT COMPLETED|Overall Study Baseline||0||
59994446|NCT03413605|76110306|FG001|NOT COMPLETED|Overall Study Baseline||0||
59994447|NCT03413605|76110305|FG000|STARTED|Post Intervention Assessment||392||
59994448|NCT03413605|76110306|FG001|STARTED|Post Intervention Assessment||409||
59994449|NCT03413605|76110305|FG000|COMPLETED|Post Intervention Assessment||392||
59994450|NCT03413605|76110306|FG001|COMPLETED|Post Intervention Assessment||409||
59994451|NCT03413605|76110305|FG000|NOT COMPLETED|Post Intervention Assessment||0||
59994452|NCT03413605|76110306|FG001|NOT COMPLETED|Post Intervention Assessment||0||
59994453|NCT03413605|76110305|FG000|STARTED|12-m Follow up||392||
59994454|NCT03413605|76110306|FG001|STARTED|12-m Follow up||409||
59994455|NCT03413605|76110305|FG000|COMPLETED|12-m Follow up||364||
59994456|NCT03413605|76110306|FG001|COMPLETED|12-m Follow up||382||
59994457|NCT03413605|76110305|FG000|NOT COMPLETED|12-m Follow up||28||
59994458|NCT03413605|76110306|FG001|NOT COMPLETED|12-m Follow up||27||
59994459|NCT02344004|76110314|FG000|STARTED|Overall Study||224||
59994460|NCT02344004|76110315|FG001|STARTED|Overall Study||112||
59994461|NCT02344004|76110314|FG000|COMPLETED|Overall Study||163||
59994462|NCT02344004|76110315|FG001|COMPLETED|Overall Study||98||
59994463|NCT02344004|76110314|FG000|NOT COMPLETED|Overall Study||61||
59994464|NCT02344004|76110315|FG001|NOT COMPLETED|Overall Study||14||
59994465|NCT01328093|76110324|FG000|STARTED|Double-Blind Phase||516||
59994466|NCT01328093|76110325|FG001|STARTED|Double-Blind Phase||162||
59994467|NCT01328093|76110324|FG000|Received at Least 1 Dose of Study Drug|Double-Blind Phase||514||
59994468|NCT01328093|76110325|FG001|Received at Least 1 Dose of Study Drug|Double-Blind Phase||161||
59994469|NCT01328093|76110324|FG000|Modified Intent-To-Treat (mITT)|Double-Blind Phase||511||
59994470|NCT01328093|76110325|FG001|Modified Intent-To-Treat (mITT)|Double-Blind Phase||161||
59994471|NCT01328093|76110324|FG000|COMPLETED|Double-Blind Phase|Not all participants entered Open-Label Treatment Phase.|231||
59994472|NCT01328093|76110325|FG001|COMPLETED|Double-Blind Phase|Not all participants entered Open-Label Treatment Phase.|84||
59994473|NCT01328093|76110324|FG000|NOT COMPLETED|Double-Blind Phase||285||
59994474|NCT01328093|76110325|FG001|NOT COMPLETED|Double-Blind Phase||78||
59994475|NCT01328093|76110324|FG000|STARTED|Open-Label Phase||200||
59994476|NCT01328093|76110325|FG001|STARTED|Open-Label Phase||73||
59994477|NCT01328093|76110324|FG000|Received at Least 1 Dose of Study Drug|Open-Label Phase||198||
59994478|NCT01328093|76110325|FG001|Received at Least 1 Dose of Study Drug|Open-Label Phase||73||
59994479|NCT01328093|76110324|FG000|Modified Intent-To-Treat (mITT)|Open-Label Phase||197||
59994480|NCT01328093|76110325|FG001|Modified Intent-To-Treat (mITT)|Open-Label Phase||73||
59994481|NCT01328093|76110324|FG000|COMPLETED|Open-Label Phase||60||
59994482|NCT01328093|76110325|FG001|COMPLETED|Open-Label Phase||23||
59994483|NCT01328093|76110324|FG000|NOT COMPLETED|Open-Label Phase||140||
60102331|NCT01188694|76220216|FG001|NOT COMPLETED|Overall Study||1||
60102332|NCT01188694|76220217|FG002|NOT COMPLETED|Overall Study||1||
59708644|NCT01108185|75827453|FG000|Per Protocol Population|Overall Study||3181||
59708645|NCT01108185|75827453|FG000|COMPLETED|Overall Study||3154||
59708646|NCT01108185|75827453|FG000|NOT COMPLETED|Overall Study||27||
59708647|NCT01252940|75827459|FG000|STARTED|Main Study Phase||321||
60102333|NCT01188928|76220229|FG000|STARTED|Overall Study||482||
60102334|NCT01188928|76220230|FG001|STARTED|Overall Study||479||
60102335|NCT01188928|76220231|FG002|STARTED|Overall Study||96||
60102336|NCT01188928|76220232|FG003|STARTED|Overall Study||95||
60102337|NCT01188928|76220229|FG000|COMPLETED|Overall Study||444||
60102338|NCT01188928|76220230|FG001|COMPLETED|Overall Study||417||
60102339|NCT01188928|76220231|FG002|COMPLETED|Overall Study||82||
60102340|NCT01188928|76220232|FG003|COMPLETED|Overall Study||77||
59708648|NCT01252940|75827460|FG001|STARTED|Main Study Phase||161||
59708649|NCT01252940|75827459|FG000|Completed 24 Weeks|Main Study Phase||0||
60102341|NCT01188928|76220229|FG000|NOT COMPLETED|Overall Study||38||
60102342|NCT01188928|76220230|FG001|NOT COMPLETED|Overall Study||62||
60102343|NCT01188928|76220231|FG002|NOT COMPLETED|Overall Study||14||
59708650|NCT01252940|75827460|FG001|Completed 24 Weeks|Main Study Phase|152 participants switched regimens at Week 24.|153||
59708651|NCT01252940|75827459|FG000|COMPLETED|Main Study Phase||295||
59565423|NCT04544787|75667693|FG006|Received First Dose of Vaccine|Overall Study||17||
59565424|NCT04544787|75667687|FG000|Received Second Dose of Vaccine|Overall Study||0||
59565425|NCT04544787|75667688|FG001|Received Second Dose of Vaccine|Overall Study||49||
59565426|NCT04544787|75667689|FG002|Received Second Dose of Vaccine|Overall Study||0||
59565427|NCT04544787|75667690|FG003|Received Second Dose of Vaccine|Overall Study||49||
59565428|NCT04544787|75667691|FG004|Received Second Dose of Vaccine|Overall Study||17||
59565429|NCT04544787|75667692|FG005|Received Second Dose of Vaccine|Overall Study||15||
59565430|NCT04544787|75667693|FG006|Received Second Dose of Vaccine|Overall Study||16||
59565431|NCT04544787|75667687|FG000|COMPLETED|Overall Study||50|defined as completing the last study visit (Day 70)|
59708652|NCT01252940|75827460|FG001|COMPLETED|Main Study Phase|Discontinuations after switch: withdrawal by subject, 2; adverse event, 1; protocol violation, 1.|149||
59994484|NCT01328093|76110325|FG001|NOT COMPLETED|Open-Label Phase||50||
59994485|NCT02654145|76110332|FG000|STARTED|Overall Study||145||
59565432|NCT04544787|75667688|FG001|COMPLETED|Overall Study||50|defined as completing the last study visit (Day 70)|
59565433|NCT04544787|75667689|FG002|COMPLETED|Overall Study||50|defined as completing the last study visit (Day 70)|
59565434|NCT04544787|75667690|FG003|COMPLETED|Overall Study||50|defined as completing the last study visit (Day 70)|
59708653|NCT01252940|75827459|FG000|NOT COMPLETED|Main Study Phase||26||
59708654|NCT01252940|75827460|FG001|NOT COMPLETED|Main Study Phase||12||
59708655|NCT01252940|75827459|FG000|STARTED|Extension Phase|FTC/RPV/TDF group: 110 participants completing the main study continued in extension phase.|110||
59708656|NCT01252940|75827460|FG001|STARTED|Extension Phase|SBR/Delayed Switch Group: 49 participants completing the main study continued in extension phase.|49||
59817162|NCT05019729|75939617|FG001|Completed Controlled Human Malaria Infection (CHMI)|Overall Study|One Group 2 participant declined to participate in the CHMI prior to the scheduled pre-CHMI visit and therefore was not enrolled in the CHMI group.|3||
59817163|NCT05019729|75939618|FG002|Completed Controlled Human Malaria Infection (CHMI)|Overall Study||5||
59994486|NCT02654145|76110332|FG000|COMPLETED|Overall Study||138||
59994487|NCT02654145|76110332|FG000|NOT COMPLETED|Overall Study||7||
59994488|NCT01111565|76110336|FG000|STARTED|Phase B (Weeks 0 to 8)||137||
59994489|NCT01111565|76110337|FG001|STARTED|Phase B (Weeks 0 to 8)||0||
59994490|NCT01111565|76110338|FG002|STARTED|Phase B (Weeks 0 to 8)||0||
59994491|NCT01111565|76110339|FG003|STARTED|Phase B (Weeks 0 to 8)||0||
59994492|NCT01111565|76110340|FG004|STARTED|Phase B (Weeks 0 to 8)||0||
59994493|NCT01111565|76110336|FG000|COMPLETED|Phase B (Weeks 0 to 8)||71||
59994494|NCT01111565|76110337|FG001|COMPLETED|Phase B (Weeks 0 to 8)||0||
59994495|NCT01111565|76110338|FG002|COMPLETED|Phase B (Weeks 0 to 8)||0||
59994496|NCT01111565|76110339|FG003|COMPLETED|Phase B (Weeks 0 to 8)||0||
59994497|NCT01111565|76110340|FG004|COMPLETED|Phase B (Weeks 0 to 8)||0||
59994498|NCT01111565|76110336|FG000|NOT COMPLETED|Phase B (Weeks 0 to 8)||66||
59708657|NCT01252940|75827459|FG000|COMPLETED|Extension Phase||100||
59708658|NCT01252940|75827460|FG001|COMPLETED|Extension Phase||46||
59708659|NCT01252940|75827459|FG000|NOT COMPLETED|Extension Phase||10||
59708660|NCT01252940|75827460|FG001|NOT COMPLETED|Extension Phase||3||
59708661|NCT01252238|75827470|FG000|STARTED|Overall Study||8||
59708662|NCT01252238|75827471|FG001|STARTED|Overall Study||8||
59708663|NCT01252238|75827472|FG002|STARTED|Overall Study||8||
60102344|NCT01188928|76220232|FG003|NOT COMPLETED|Overall Study||18||
60102345|NCT01189240|76220242|FG000|STARTED|Overall Study||4||
59565435|NCT04544787|75667691|FG004|COMPLETED|Overall Study||17|defined as completing the last study visit (Day 70)|
59565436|NCT04544787|75667692|FG005|COMPLETED|Overall Study||16|defined as completing the last study visit (Day 70)|
59565437|NCT04544787|75667693|FG006|COMPLETED|Overall Study||17|defined as completing the last study visit (Day 70)|
59565438|NCT04544787|75667687|FG000|NOT COMPLETED|Overall Study||0||
59565439|NCT04544787|75667688|FG001|NOT COMPLETED|Overall Study||0||
59565440|NCT04544787|75667689|FG002|NOT COMPLETED|Overall Study||0||
59565441|NCT04544787|75667690|FG003|NOT COMPLETED|Overall Study||0||
59708664|NCT01252238|75827470|FG000|COMPLETED|Overall Study|sponsor terminated study|4||
59708665|NCT01252238|75827471|FG001|COMPLETED|Overall Study|sponsor terminated study|4||
59708666|NCT01252238|75827472|FG002|COMPLETED|Overall Study|sponsor terminated study|4||
59817164|NCT05019729|75939619|FG003|Completed Controlled Human Malaria Infection (CHMI)|Overall Study||4||
59817165|NCT05019729|75939620|FG004|Completed Controlled Human Malaria Infection (CHMI)|Overall Study||6||
59817166|NCT05019729|75939621|FG005|Completed Controlled Human Malaria Infection (CHMI)|Overall Study|Group 6 participants did not participate in the CHMI.|0||
59817167|NCT05019729|75939616|FG000|COMPLETED|Overall Study||5||
59994499|NCT01111565|76110337|FG001|NOT COMPLETED|Phase B (Weeks 0 to 8)||0||
59565442|NCT04544787|75667691|FG004|NOT COMPLETED|Overall Study||0||
59565443|NCT04544787|75667692|FG005|NOT COMPLETED|Overall Study||0||
59565444|NCT04544787|75667693|FG006|NOT COMPLETED|Overall Study||0||
59565445|NCT01831232|75667732|FG000|STARTED|Overall Study||24||
59565446|NCT01831232|75667732|FG000|COMPLETED|Overall Study||24||
59565447|NCT01831232|75667732|FG000|NOT COMPLETED|Overall Study||0||
59708667|NCT01252238|75827470|FG000|NOT COMPLETED|Overall Study||4||
59994500|NCT01111565|76110338|FG002|NOT COMPLETED|Phase B (Weeks 0 to 8)||0||
59994501|NCT01111565|76110339|FG003|NOT COMPLETED|Phase B (Weeks 0 to 8)||0||
59994502|NCT01111565|76110340|FG004|NOT COMPLETED|Phase B (Weeks 0 to 8)||0||
59994503|NCT01111565|76110336|FG000|STARTED|Phase B + and Phase C (Weeks 9 to 14)||0||
59994504|NCT01111565|76110337|FG001|STARTED|Phase B + and Phase C (Weeks 9 to 14)||26||
59994505|NCT01111565|76110338|FG002|STARTED|Phase B + and Phase C (Weeks 9 to 14)||16||
59994506|NCT01111565|76110339|FG003|STARTED|Phase B + and Phase C (Weeks 9 to 14)||14||
59994507|NCT01111565|76110340|FG004|STARTED|Phase B + and Phase C (Weeks 9 to 14)||15||
59994508|NCT01111565|76110336|FG000|COMPLETED|Phase B + and Phase C (Weeks 9 to 14)||0||
59994509|NCT01111565|76110337|FG001|COMPLETED|Phase B + and Phase C (Weeks 9 to 14)||19||
59994510|NCT01111565|76110338|FG002|COMPLETED|Phase B + and Phase C (Weeks 9 to 14)||11||
59994511|NCT01111565|76110339|FG003|COMPLETED|Phase B + and Phase C (Weeks 9 to 14)||10||
59994512|NCT01111565|76110340|FG004|COMPLETED|Phase B + and Phase C (Weeks 9 to 14)||11||
59994513|NCT01111565|76110336|FG000|NOT COMPLETED|Phase B + and Phase C (Weeks 9 to 14)||0||
60102346|NCT01189240|76220243|FG001|STARTED|Overall Study||6||
60102347|NCT01189240|76220244|FG002|STARTED|Overall Study||3||
59817168|NCT05019729|75939617|FG001|COMPLETED|Overall Study||4||
59565448|NCT04470375|75667736|FG000|STARTED|Overall Study||20||
59565449|NCT04470375|75667736|FG000|COMPLETED|Overall Study||20||
59565450|NCT04470375|75667736|FG000|NOT COMPLETED|Overall Study||0||
59565451|NCT01831934|75667742|FG000|STARTED|Overall Study||12||
59565452|NCT01831934|75667743|FG001|STARTED|Overall Study||10||
59565453|NCT01831934|75667742|FG000|COMPLETED|Overall Study|Volunteer consented but not enrolled after reporting a prior bad reaction to influenza vaccine.|11||
59565454|NCT01831934|75667743|FG001|COMPLETED|Overall Study||10||
59817169|NCT05019729|75939618|FG002|COMPLETED|Overall Study||5||
59565455|NCT01831934|75667742|FG000|NOT COMPLETED|Overall Study||1||
59565456|NCT01831934|75667743|FG001|NOT COMPLETED|Overall Study||0||
59565457|NCT01832090|75667751|FG000|STARTED|Overall Study||89||
59708668|NCT01252238|75827471|FG001|NOT COMPLETED|Overall Study||4||
59708669|NCT01252238|75827472|FG002|NOT COMPLETED|Overall Study||4||
59708670|NCT01101477|75827486|FG000|STARTED|Overall Study||49||
59994514|NCT01111565|76110337|FG001|NOT COMPLETED|Phase B + and Phase C (Weeks 9 to 14)||7||
59994515|NCT01111565|76110338|FG002|NOT COMPLETED|Phase B + and Phase C (Weeks 9 to 14)||5||
59817170|NCT05019729|75939619|FG003|COMPLETED|Overall Study||4||
59817171|NCT05019729|75939620|FG004|COMPLETED|Overall Study||6||
59994516|NCT01111565|76110339|FG003|NOT COMPLETED|Phase B + and Phase C (Weeks 9 to 14)||4||
59994517|NCT01111565|76110340|FG004|NOT COMPLETED|Phase B + and Phase C (Weeks 9 to 14)||4||
59994518|NCT02343458|76110354|FG000|STARTED|Overall Study||555||
59994519|NCT02343458|76110355|FG001|STARTED|Overall Study||483||
59994520|NCT02343458|76110356|FG002|STARTED|Overall Study||480||
59994521|NCT02343458|76110357|FG003|STARTED|Overall Study||238||
59994522|NCT02343458|76110354|FG000|COMPLETED|Overall Study||494|1 subject has been captured in CSR who completed the study but had no follow up phone call.|
59994523|NCT02343458|76110355|FG001|COMPLETED|Overall Study||417|1 subject has been captured in CSR who completed the study but had no follow up phone call.|
59994524|NCT02343458|76110356|FG002|COMPLETED|Overall Study||417|1 subject has been captured in CSR who completed the study but had no follow up phone call.|
59994525|NCT02343458|76110357|FG003|COMPLETED|Overall Study||200|1 subject has been captured in CSR who completed the study but had no follow up phone call.|
59994526|NCT02343458|76110354|FG000|NOT COMPLETED|Overall Study||61||
59994527|NCT02343458|76110355|FG001|NOT COMPLETED|Overall Study||66||
59994528|NCT02343458|76110356|FG002|NOT COMPLETED|Overall Study||63||
59994529|NCT02343458|76110357|FG003|NOT COMPLETED|Overall Study||38||
59994530|NCT02964377|76110370|FG000|STARTED|Overall Study||5||
59994531|NCT02964377|76110371|FG001|STARTED|Overall Study||5||
59994532|NCT02964377|76110372|FG002|STARTED|Overall Study||5||
59994533|NCT02964377|76110370|FG000|COMPLETED|Overall Study||5||
59994534|NCT02964377|76110371|FG001|COMPLETED|Overall Study||5||
59994535|NCT02964377|76110372|FG002|COMPLETED|Overall Study||5||
59994536|NCT02964377|76110370|FG000|NOT COMPLETED|Overall Study||0||
59994537|NCT02964377|76110371|FG001|NOT COMPLETED|Overall Study||0||
59994538|NCT02964377|76110372|FG002|NOT COMPLETED|Overall Study||0||
59994539|NCT01328041|76110380|FG000|STARTED|Overall Study||183||
59994540|NCT01328041|76110380|FG000|COMPLETED|Overall Study||126||
59994541|NCT01328041|76110380|FG000|NOT COMPLETED|Overall Study||57||
59994542|NCT02410772|76110387|FG000|STARTED|Overall Study||829||
59994543|NCT02410772|76110388|FG001|STARTED|Overall Study||838||
59994544|NCT02410772|76110389|FG002|STARTED|Overall Study||849||
59708671|NCT01101477|75827487|FG001|STARTED|Overall Study||49||
59708672|NCT01101477|75827488|FG002|STARTED|Overall Study||46||
59708673|NCT01101477|75827486|FG000|COMPLETED|Overall Study||44||
59708674|NCT01101477|75827487|FG001|COMPLETED|Overall Study||46||
59708675|NCT01101477|75827488|FG002|COMPLETED|Overall Study||45||
59708676|NCT01101477|75827486|FG000|NOT COMPLETED|Overall Study||5||
60102348|NCT01189240|76220242|FG000|COMPLETED|Overall Study||4||
60102349|NCT01189240|76220243|FG001|COMPLETED|Overall Study||6||
60102350|NCT01189240|76220244|FG002|COMPLETED|Overall Study||3||
60102351|NCT01189240|76220242|FG000|NOT COMPLETED|Overall Study||0||
59708677|NCT01101477|75827487|FG001|NOT COMPLETED|Overall Study||3||
59708678|NCT01101477|75827488|FG002|NOT COMPLETED|Overall Study||1||
60102352|NCT01189240|76220243|FG001|NOT COMPLETED|Overall Study||0||
59708679|NCT01251770|75827498|FG000|STARTED|Overall Study||42||
59708680|NCT01251770|75827499|FG001|STARTED|Overall Study||36||
60102353|NCT01189240|76220244|FG002|NOT COMPLETED|Overall Study||0||
60102354|NCT02874144|76220256|FG000|STARTED|Overall Study||22||
60102355|NCT02874144|76220257|FG001|STARTED|Overall Study||21||
60102356|NCT02874144|76220256|FG000|COMPLETED|Overall Study||19||
60102357|NCT02874144|76220257|FG001|COMPLETED|Overall Study||16||
60102358|NCT02874144|76220256|FG000|NOT COMPLETED|Overall Study||3||
60102359|NCT02874144|76220257|FG001|NOT COMPLETED|Overall Study||5||
60102360|NCT01094548|76220265|FG000|STARTED|Overall Study||17||
60102361|NCT01094548|76220266|FG001|STARTED|Overall Study||17||
60102362|NCT01094548|76220265|FG000|COMPLETED|Overall Study||17||
60102363|NCT01094548|76220266|FG001|COMPLETED|Overall Study||17||
60102364|NCT01094548|76220265|FG000|NOT COMPLETED|Overall Study||0||
60102365|NCT01094548|76220266|FG001|NOT COMPLETED|Overall Study||0||
60102366|NCT01094704|76220276|FG000|STARTED|Overall Study||8||
60102367|NCT01094704|76220277|FG001|STARTED|Overall Study||8||
60102368|NCT01094704|76220276|FG000|COMPLETED|Overall Study||8||
60102369|NCT01094704|76220277|FG001|COMPLETED|Overall Study||8||
60102370|NCT01094704|76220276|FG000|NOT COMPLETED|Overall Study||0||
60102371|NCT01094704|76220277|FG001|NOT COMPLETED|Overall Study||0||
60102372|NCT02611830|76220287|FG000|STARTED|OL Induction Phase||383||
60102373|NCT02611830|76220288|FG001|STARTED|OL Induction Phase||0||
60102374|NCT02611830|76220289|FG002|STARTED|OL Induction Phase||0||
60102375|NCT02611830|76220290|FG003|STARTED|OL Induction Phase||0||
60102376|NCT02611830|76220287|FG000|COMPLETED|OL Induction Phase||353|Completers included randomized participants, or if not randomized, those who had Week 14 visit|
60102377|NCT02611830|76220288|FG001|COMPLETED|OL Induction Phase||0|Completers included randomized participants, or if not randomized, those who had Week 14 visit|
60102378|NCT02611830|76220289|FG002|COMPLETED|OL Induction Phase||0|Completers included randomized participants, or if not randomized, those who had Week 14 visit|
60102379|NCT02611830|76220290|FG003|COMPLETED|OL Induction Phase||0|Completers included randomized participants, or if not randomized, those who had Week 14 visit|
60102380|NCT02611830|76220287|FG000|NOT COMPLETED|OL Induction Phase||30||
60102381|NCT02611830|76220288|FG001|NOT COMPLETED|OL Induction Phase||0||
60102382|NCT02611830|76220289|FG002|NOT COMPLETED|OL Induction Phase||0||
60102383|NCT02611830|76220290|FG003|NOT COMPLETED|OL Induction Phase||0||
60102384|NCT02611830|76220287|FG000|STARTED|Maintenance Phase||0|Participants who achieved clinical response at Week 6 entered the maintenance phase.|
60102385|NCT02611830|76220288|FG001|STARTED|Maintenance Phase||56|Participants who achieved clinical response at Week 6 entered the maintenance phase.|
60102386|NCT02611830|76220289|FG002|STARTED|Maintenance Phase||106|Participants who achieved clinical response at Week 6 entered the maintenance phase.|
60102387|NCT02611830|76220290|FG003|STARTED|Maintenance Phase||54|Participants who achieved clinical response at Week 6 entered the maintenance phase.|
60102388|NCT02611830|76220287|FG000|COMPLETED|Maintenance Phase||0||
60102389|NCT02611830|76220288|FG001|COMPLETED|Maintenance Phase||20||
60102390|NCT02611830|76220289|FG002|COMPLETED|Maintenance Phase||75||
60102391|NCT02611830|76220290|FG003|COMPLETED|Maintenance Phase||39||
60102392|NCT02611830|76220287|FG000|NOT COMPLETED|Maintenance Phase||0||
60102393|NCT02611830|76220288|FG001|NOT COMPLETED|Maintenance Phase||36||
60102394|NCT02611830|76220289|FG002|NOT COMPLETED|Maintenance Phase||31||
60102395|NCT02611830|76220290|FG003|NOT COMPLETED|Maintenance Phase||15||
60102396|NCT01144624|76220302|FG000|STARTED|Overall Study||7||
60102397|NCT01144624|76220303|FG001|STARTED|Overall Study||7||
60102398|NCT01144624|76220304|FG002|STARTED|Overall Study||6||
60102399|NCT01144624|76220302|FG000|Received Treatment|Overall Study||7||
60102400|NCT01144624|76220303|FG001|Received Treatment|Overall Study||7||
60102401|NCT01144624|76220304|FG002|Received Treatment|Overall Study||6||
60102402|NCT01144624|76220302|FG000|Completed Treatment|Overall Study|One patient died after completing the full course of study treatment.|7||
60102403|NCT01144624|76220303|FG001|Completed Treatment|Overall Study||7||
60102404|NCT01144624|76220304|FG002|Completed Treatment|Overall Study|Two patients died during the dosing period. Death was not a reason for treatment discontinuation.|6||
60102405|NCT01144624|76220302|FG000|COMPLETED|Overall Study|One patient died during the study. Death was not a reason for treatment or study discontinuation.|7||
60102406|NCT01144624|76220303|FG001|COMPLETED|Overall Study||7||
60102407|NCT01144624|76220304|FG002|COMPLETED|Overall Study|Two patients died during the study. Death was not a reason for treatment or study discontinuation.|6||
60102408|NCT01144624|76220302|FG000|NOT COMPLETED|Overall Study||0||
60102409|NCT01144624|76220303|FG001|NOT COMPLETED|Overall Study||0||
60102410|NCT01144624|76220304|FG002|NOT COMPLETED|Overall Study||0||
60102411|NCT01096810|76220312|FG000|STARTED|Overall Study||20||
60102412|NCT01096810|76220312|FG000|COMPLETED|Overall Study||20||
60102413|NCT01096810|76220312|FG000|NOT COMPLETED|Overall Study||0||
60102414|NCT01145638|76220318|FG000|STARTED|Overall Study||231||
60102415|NCT01145638|76220319|FG001|STARTED|Overall Study||119||
59708681|NCT01251770|75827498|FG000|COMPLETED|Overall Study||29||
59708682|NCT01251770|75827499|FG001|COMPLETED|Overall Study||29||
59708683|NCT01251770|75827498|FG000|NOT COMPLETED|Overall Study||13||
59708684|NCT01251770|75827499|FG001|NOT COMPLETED|Overall Study||7||
59708685|NCT01101321|75827505|FG000|STARTED|Period 1||30||
59708686|NCT01101321|75827506|FG001|STARTED|Period 1||28||
59708687|NCT01101321|75827505|FG000|COMPLETED|Period 1||26||
59708688|NCT01101321|75827506|FG001|COMPLETED|Period 1||24||
60102416|NCT01145638|76220318|FG000|COMPLETED|Overall Study||141||
60102417|NCT01145638|76220319|FG001|COMPLETED|Overall Study||62||
60102418|NCT01145638|76220318|FG000|NOT COMPLETED|Overall Study||90||
60102419|NCT01145638|76220319|FG001|NOT COMPLETED|Overall Study||57||
60102420|NCT01190566|76220327|FG000|STARTED|Overall Study||6||
60102421|NCT01190566|76220328|FG001|STARTED|Overall Study||42||
59565458|NCT01832090|75667752|FG001|STARTED|Overall Study||29||
59565459|NCT01832090|75667751|FG000|COMPLETED|Overall Study||83||
59565460|NCT01832090|75667752|FG001|COMPLETED|Overall Study||28||
59565461|NCT01832090|75667751|FG000|NOT COMPLETED|Overall Study||6||
59565462|NCT01832090|75667752|FG001|NOT COMPLETED|Overall Study||1||
59565463|NCT01833026|75667780|FG000|STARTED|Overall Study||22||
59565464|NCT01833026|75667781|FG001|STARTED|Overall Study||34||
59565465|NCT01833026|75667780|FG000|COMPLETED|Overall Study||22||
59565466|NCT01833026|75667781|FG001|COMPLETED|Overall Study||34||
59565467|NCT01833026|75667780|FG000|NOT COMPLETED|Overall Study||0||
59565468|NCT01833026|75667781|FG001|NOT COMPLETED|Overall Study||0||
60102422|NCT01190566|76220327|FG000|COMPLETED|Overall Study||6||
59708689|NCT01101321|75827505|FG000|NOT COMPLETED|Period 1||4||
59708690|NCT01101321|75827506|FG001|NOT COMPLETED|Period 1||4||
59708691|NCT01101321|75827505|FG000|STARTED|Period 2||26||
59708692|NCT01101321|75827506|FG001|STARTED|Period 2||24||
59708693|NCT01101321|75827505|FG000|COMPLETED|Period 2||26||
59708694|NCT01101321|75827506|FG001|COMPLETED|Period 2||24||
59708695|NCT01101321|75827505|FG000|NOT COMPLETED|Period 2||0||
60102423|NCT01190566|76220328|FG001|COMPLETED|Overall Study||42||
59565469|NCT03383523|75667794|FG000|STARTED|Overall Study||11||
59565470|NCT03383523|75667795|FG001|STARTED|Overall Study||11||
59565471|NCT03383523|75667796|FG002|STARTED|Overall Study||10||
59708696|NCT01101321|75827506|FG001|NOT COMPLETED|Period 2||0||
59708697|NCT01101165|75827512|FG000|STARTED|Period 1||47||
60102424|NCT01190566|76220327|FG000|NOT COMPLETED|Overall Study||0||
60102425|NCT01190566|76220328|FG001|NOT COMPLETED|Overall Study||0||
60102426|NCT01190878|76220339|FG000|STARTED|Overall Study||40||
60102427|NCT01190878|76220340|FG001|STARTED|Overall Study||45||
60102428|NCT01190878|76220341|FG002|STARTED|Overall Study||42||
60102429|NCT01190878|76220342|FG003|STARTED|Overall Study||42||
60102430|NCT01190878|76220339|FG000|COMPLETED|Overall Study||37||
60102431|NCT01190878|76220340|FG001|COMPLETED|Overall Study||42||
60102432|NCT01190878|76220341|FG002|COMPLETED|Overall Study||37||
60102433|NCT01190878|76220342|FG003|COMPLETED|Overall Study||22||
60102434|NCT01190878|76220339|FG000|NOT COMPLETED|Overall Study||3||
60102435|NCT01190878|76220340|FG001|NOT COMPLETED|Overall Study||3||
60102436|NCT01190878|76220341|FG002|NOT COMPLETED|Overall Study||5||
60102437|NCT01190878|76220342|FG003|NOT COMPLETED|Overall Study||20||
60102438|NCT01146496|76220354|FG000|STARTED|Overall Study||114168||
60102439|NCT01146496|76220355|FG001|STARTED|Overall Study||109693||
60102440|NCT01146496|76220354|FG000|COMPLETED|Overall Study||114168||
60102441|NCT01146496|76220355|FG001|COMPLETED|Overall Study||109693||
60102442|NCT01146496|76220354|FG000|NOT COMPLETED|Overall Study||0||
60102443|NCT01146496|76220355|FG001|NOT COMPLETED|Overall Study||0||
60102444|NCT01146808|76220362|FG000|STARTED|Overall Study||16||
60102445|NCT01146808|76220362|FG000|COMPLETED|Overall Study||16||
60102446|NCT01146808|76220362|FG000|NOT COMPLETED|Overall Study||0||
60102447|NCT01148524|76220375|FG000|STARTED|Overall Study||49||
60102448|NCT01148524|76220376|FG001|STARTED|Overall Study||95||
60102449|NCT01148524|76220377|FG002|STARTED|Overall Study||53||
59565472|NCT03383523|75667797|FG003|STARTED|Overall Study||12||
59565473|NCT03383523|75667798|FG004|STARTED|Overall Study||11||
59565474|NCT03383523|75667799|FG005|STARTED|Overall Study||12||
59565475|NCT03383523|75667800|FG006|STARTED|Overall Study||10||
59708698|NCT01101165|75827513|FG001|STARTED|Period 1||45||
59708699|NCT01101165|75827512|FG000|COMPLETED|Period 1||45||
59708700|NCT01101165|75827513|FG001|COMPLETED|Period 1||40||
59708701|NCT01101165|75827512|FG000|NOT COMPLETED|Period 1||2||
59708702|NCT01101165|75827513|FG001|NOT COMPLETED|Period 1||5||
59708703|NCT01101165|75827512|FG000|STARTED|Period 2||45||
59817172|NCT05019729|75939621|FG005|COMPLETED|Overall Study||5||
59994545|NCT02410772|76110387|FG000|Microbiologically Eligible Analysis Population|Overall Study||768|Microbiologically Eligible Population included all enrolled participants that received a treatment assignment but excluded the participants with no evidence of cultures positive for M. tuberculosis, or with resistance to one or more of isoniazid, rifampin or fluoroquinolones, or are enrolled in violation of eligibility criteria|
59994546|NCT02410772|76110388|FG001|Microbiologically Eligible Analysis Population|Overall Study||784|Microbiologically Eligible Population included all enrolled participants that received a treatment assignment but excluded the participants with no evidence of cultures positive for M. tuberculosis, or with resistance to one or more of isoniazid, rifampin or fluoroquinolones, or are enrolled in violation of eligibility criteria|
59994547|NCT02410772|76110389|FG002|Microbiologically Eligible Analysis Population|Overall Study||791|Microbiologically Eligible Population included all enrolled participants that received a treatment assignment but excluded the participants with no evidence of cultures positive for M. tuberculosis, or with resistance to one or more of isoniazid, rifampin or fluoroquinolones, or are enrolled in violation of eligibility criteria|
60102450|NCT01148524|76220378|FG003|STARTED|Overall Study||102||
60102451|NCT01148524|76220379|FG004|STARTED|Overall Study||57||
60102452|NCT01148524|76220380|FG005|STARTED|Overall Study||106||
60102453|NCT01148524|76220381|FG006|STARTED|Overall Study||153||
60102454|NCT01148524|76220382|FG007|STARTED|Overall Study||51||
59565476|NCT03383523|75667794|FG000|COMPLETED|Overall Study||10||
59565477|NCT03383523|75667795|FG001|COMPLETED|Overall Study||11||
59708704|NCT01101165|75827513|FG001|STARTED|Period 2||40||
59708705|NCT01101165|75827512|FG000|COMPLETED|Period 2||41||
59708706|NCT01101165|75827513|FG001|COMPLETED|Period 2||39||
59708707|NCT01101165|75827512|FG000|NOT COMPLETED|Period 2||4||
59817173|NCT05019729|75939616|FG000|NOT COMPLETED|Overall Study||0||
60102455|NCT01148524|76220383|FG008|STARTED|Overall Study||151||
59817174|NCT05019729|75939617|FG001|NOT COMPLETED|Overall Study||0||
59565478|NCT03383523|75667796|FG002|COMPLETED|Overall Study||9||
59565479|NCT03383523|75667797|FG003|COMPLETED|Overall Study||12||
59708708|NCT01101165|75827513|FG001|NOT COMPLETED|Period 2||1||
60102456|NCT01148524|76220375|FG000|COMPLETED|Overall Study||49||
60102457|NCT01148524|76220376|FG001|COMPLETED|Overall Study||95||
60102458|NCT01148524|76220377|FG002|COMPLETED|Overall Study||53||
60102459|NCT01148524|76220378|FG003|COMPLETED|Overall Study||102||
60102460|NCT01148524|76220379|FG004|COMPLETED|Overall Study||57||
60102461|NCT01148524|76220380|FG005|COMPLETED|Overall Study||106||
60102462|NCT01148524|76220381|FG006|COMPLETED|Overall Study||153||
60102463|NCT01148524|76220382|FG007|COMPLETED|Overall Study||51||
60102464|NCT01148524|76220383|FG008|COMPLETED|Overall Study||151||
60102465|NCT01148524|76220375|FG000|NOT COMPLETED|Overall Study||0||
60102466|NCT01148524|76220376|FG001|NOT COMPLETED|Overall Study||0||
60102467|NCT01148524|76220377|FG002|NOT COMPLETED|Overall Study||0||
60102468|NCT01148524|76220378|FG003|NOT COMPLETED|Overall Study||0||
60102469|NCT01148524|76220379|FG004|NOT COMPLETED|Overall Study||0||
60102470|NCT01148524|76220380|FG005|NOT COMPLETED|Overall Study||0||
60102471|NCT01148524|76220381|FG006|NOT COMPLETED|Overall Study||0||
60102472|NCT01148524|76220382|FG007|NOT COMPLETED|Overall Study||0||
60102473|NCT01148524|76220383|FG008|NOT COMPLETED|Overall Study||0||
60102474|NCT01191736|76220410|FG000|STARTED|Overall Study||51||
60102475|NCT01191736|76220411|FG001|STARTED|Overall Study||47||
60102476|NCT01191736|76220412|FG002|STARTED|Overall Study||49||
60102477|NCT01191736|76220413|FG003|STARTED|Overall Study||46||
60102478|NCT01191736|76220414|FG004|STARTED|Overall Study||48||
60102479|NCT01191736|76220415|FG005|STARTED|Overall Study||50||
60102480|NCT01191736|76220416|FG006|STARTED|Overall Study||45||
60102481|NCT01191736|76220410|FG000|COMPLETED|Overall Study||51||
60102482|NCT01191736|76220411|FG001|COMPLETED|Overall Study||47||
60102483|NCT01191736|76220412|FG002|COMPLETED|Overall Study||49||
60102484|NCT01191736|76220413|FG003|COMPLETED|Overall Study||46||
59565480|NCT03383523|75667798|FG004|COMPLETED|Overall Study||11||
59565481|NCT03383523|75667799|FG005|COMPLETED|Overall Study||12||
59565482|NCT03383523|75667800|FG006|COMPLETED|Overall Study||10||
59565483|NCT03383523|75667794|FG000|NOT COMPLETED|Overall Study||1||
59708709|NCT01100853|75827521|FG000|STARTED|Overall Study||51||
59708710|NCT01100853|75827522|FG001|STARTED|Overall Study||49||
59708711|NCT01100853|75827521|FG000|COMPLETED|Overall Study||24||
59994548|NCT02410772|76110387|FG000|Assessable Population|Overall Study||726|Excluded the Microbiologically eligible participants without an assessable outcome (if they were not already classified as unfavorable and additionally did not attend12M visit but were culture negative when last seen, or had treatment changed due to pregnancy, or died during follow-up with cause unrelated to tuberculosis, or received additional treatment for tuberculosis following exogenous reinfection shown by whole genome sequencing, or died from a violent or accidental death during treatment|
59995222|NCT05584189|76111050|FG000|STARTED|Overall Study||53||
59708712|NCT01100853|75827522|FG001|COMPLETED|Overall Study||26||
59708713|NCT01100853|75827521|FG000|NOT COMPLETED|Overall Study||27||
59708714|NCT01100853|75827522|FG001|NOT COMPLETED|Overall Study||23||
59708715|NCT01100307|75827530|FG000|STARTED|Double Masked Phase (Up to Week 24)||123||
59708716|NCT01100307|75827531|FG001|STARTED|Double Masked Phase (Up to Week 24)||120||
59708717|NCT01100307|75827530|FG000|COMPLETED|Double Masked Phase (Up to Week 24)||117||
59817175|NCT05019729|75939618|FG002|NOT COMPLETED|Overall Study||0||
59995223|NCT05584189|76111051|FG001|STARTED|Overall Study||46||
59995224|NCT05584189|76111050|FG000|COMPLETED|Overall Study||53||
60102485|NCT01191736|76220414|FG004|COMPLETED|Overall Study||48||
60102486|NCT01191736|76220415|FG005|COMPLETED|Overall Study||50||
60102487|NCT01191736|76220416|FG006|COMPLETED|Overall Study||45||
60102488|NCT01191736|76220410|FG000|NOT COMPLETED|Overall Study||0||
60102489|NCT01191736|76220411|FG001|NOT COMPLETED|Overall Study||0||
60102490|NCT01191736|76220412|FG002|NOT COMPLETED|Overall Study||0||
60102491|NCT01191736|76220413|FG003|NOT COMPLETED|Overall Study||0||
60102492|NCT01191736|76220414|FG004|NOT COMPLETED|Overall Study||0||
60102493|NCT01191736|76220415|FG005|NOT COMPLETED|Overall Study||0||
60102494|NCT01191736|76220416|FG006|NOT COMPLETED|Overall Study||0||
60102495|NCT01192282|76220435|FG000|STARTED|Overall Study||156||
60102496|NCT01192282|76220435|FG000|COMPLETED|Overall Study||156||
60102497|NCT01192282|76220435|FG000|NOT COMPLETED|Overall Study||0||
60102498|NCT01192828|76220448|FG000|STARTED|Overall Study||14||
60102499|NCT01192828|76220448|FG000|COMPLETED|Overall Study||14||
60102500|NCT01192828|76220448|FG000|NOT COMPLETED|Overall Study||0||
60102501|NCT01099618|76220457|FG000|STARTED|Overall Study||17||
59708718|NCT01100307|75827531|FG001|COMPLETED|Double Masked Phase (Up to Week 24)||116||
59708719|NCT01100307|75827530|FG000|NOT COMPLETED|Double Masked Phase (Up to Week 24)||6||
59817176|NCT05019729|75939619|FG003|NOT COMPLETED|Overall Study||0||
59817177|NCT05019729|75939620|FG004|NOT COMPLETED|Overall Study||3||
60102502|NCT01099618|76220458|FG001|STARTED|Overall Study||16||
60102503|NCT01099618|76220459|FG002|STARTED|Overall Study||15||
60102504|NCT01099618|76220457|FG000|COMPLETED|Overall Study||17||
60102505|NCT01099618|76220458|FG001|COMPLETED|Overall Study||16||
60102506|NCT01099618|76220459|FG002|COMPLETED|Overall Study||15||
60102507|NCT01099618|76220457|FG000|NOT COMPLETED|Overall Study||0||
60102508|NCT01099618|76220458|FG001|NOT COMPLETED|Overall Study||0||
60102509|NCT01099618|76220459|FG002|NOT COMPLETED|Overall Study||0||
60102510|NCT01099774|76220469|FG000|STARTED|Overall Study||302||
60102511|NCT01099774|76220470|FG001|STARTED|Overall Study||295||
60102512|NCT01099774|76220469|FG000|COMPLETED|Overall Study||296||
60102513|NCT01099774|76220470|FG001|COMPLETED|Overall Study||289||
60102514|NCT01099774|76220469|FG000|NOT COMPLETED|Overall Study||6||
60102515|NCT01099774|76220470|FG001|NOT COMPLETED|Overall Study||6||
60102516|NCT01328574|76220476|FG000|STARTED|Overall Study||13||
60102517|NCT01328574|76220476|FG000|COMPLETED|Overall Study||12||
60102518|NCT01328574|76220476|FG000|NOT COMPLETED|Overall Study||1||
60102519|NCT01100242|76220485|FG000|STARTED|Overall Study||17||
60102520|NCT01100242|76220485|FG000|COMPLETED|Overall Study||17||
60102521|NCT01100242|76220485|FG000|NOT COMPLETED|Overall Study||0||
60102522|NCT01148836|76220491|FG000|STARTED|Overall Study|Enrollment completed|8||
60102523|NCT01148836|76220492|FG001|STARTED|Overall Study||10||
60102524|NCT01148836|76220491|FG000|COMPLETED|Overall Study|Enrollment completed|7||
60102525|NCT01148836|76220492|FG001|COMPLETED|Overall Study||8||
60102526|NCT01148836|76220491|FG000|NOT COMPLETED|Overall Study||1||
60102527|NCT01148836|76220492|FG001|NOT COMPLETED|Overall Study||2||
60102528|NCT01149616|76220500|FG000|STARTED|Overall Study||41||
60102529|NCT01149616|76220501|FG001|STARTED|Overall Study||41||
60102530|NCT01149616|76220500|FG000|COMPLETED|Overall Study||41||
60102531|NCT01149616|76220501|FG001|COMPLETED|Overall Study||41||
60102532|NCT01149616|76220500|FG000|NOT COMPLETED|Overall Study||0||
60102533|NCT01149616|76220501|FG001|NOT COMPLETED|Overall Study||0||
60102534|NCT01101100|76220509|FG000|STARTED|Overall Study||181||
60102535|NCT01101100|76220509|FG000|COMPLETED|Overall Study||126||
60102536|NCT01101100|76220509|FG000|NOT COMPLETED|Overall Study||55||
60102537|NCT01149772|76220516|FG000|STARTED|Overall Study||180||
60102538|NCT01149772|76220517|FG001|STARTED|Overall Study||122||
60102539|NCT01149772|76220516|FG000|COMPLETED|Overall Study||132||
60102540|NCT01149772|76220517|FG001|COMPLETED|Overall Study||101||
60102541|NCT01149772|76220516|FG000|NOT COMPLETED|Overall Study||48||
60102542|NCT01149772|76220517|FG001|NOT COMPLETED|Overall Study||21||
59565484|NCT03383523|75667795|FG001|NOT COMPLETED|Overall Study||0||
59565485|NCT03383523|75667796|FG002|NOT COMPLETED|Overall Study||1||
59565486|NCT03383523|75667797|FG003|NOT COMPLETED|Overall Study||0||
59565487|NCT03383523|75667798|FG004|NOT COMPLETED|Overall Study||0||
59565488|NCT03383523|75667799|FG005|NOT COMPLETED|Overall Study||0||
59565489|NCT03383523|75667800|FG006|NOT COMPLETED|Overall Study||0||
59565490|NCT03383757|75667816|FG000|STARTED|Overall Study||117||
59565491|NCT03383757|75667816|FG000|TruSignal AllFit Sensor Subjects|Overall Study||56||
59994549|NCT02410772|76110388|FG001|Assessable Population|Overall Study||752|Excluded the Microbiologically eligible participants without an assessable outcome (if they were not already classified as unfavorable and additionally did not attend12M visit but were culture negative when last seen, or had treatment changed due to pregnancy, or died during follow-up with cause unrelated to tuberculosis, or received additional treatment for tuberculosis following exogenous reinfection shown by whole genome sequencing, or died from a violent or accidental death during treatment|
59995225|NCT05584189|76111051|FG001|COMPLETED|Overall Study||46||
60102543|NCT01101880|76220525|FG000|STARTED|Overall Study||50||
59995226|NCT05584189|76111050|FG000|NOT COMPLETED|Overall Study||0||
60102544|NCT01101880|76220525|FG000|COMPLETED|Overall Study||50||
60102545|NCT01101880|76220525|FG000|NOT COMPLETED|Overall Study||0||
60102546|NCT01101958|76220531|FG000|STARTED|Overall Study||62||
60102547|NCT01101958|76220532|FG001|STARTED|Overall Study||34||
59565492|NCT03383757|75667816|FG000|TruSignal Sensitive Sensor Subjects|Overall Study||59||
59565493|NCT03383757|75667816|FG000|TruSignal AllFit Sensor Data Pairs|Overall Study||52||
59565494|NCT03383757|75667816|FG000|TruSignal Sensitive Sensor Data Pairs|Overall Study||51||
59565495|NCT03383757|75667816|FG000|COMPLETED|Overall Study||78||
59565496|NCT03383757|75667816|FG000|NOT COMPLETED|Overall Study||39||
59708720|NCT01100307|75827531|FG001|NOT COMPLETED|Double Masked Phase (Up to Week 24)||4||
59708721|NCT01100307|75827530|FG000|STARTED|Open Phase (Week 24 up to Week 54)|One participant discontinued from the study due to adverse event before study drug administration.|116||
59708722|NCT01100307|75827531|FG001|STARTED|Open Phase (Week 24 up to Week 54)|Four participants did not enter to the open phase after completing the double masked phase.|112||
59708723|NCT01100307|75827530|FG000|COMPLETED|Open Phase (Week 24 up to Week 54)||110||
59708724|NCT01100307|75827531|FG001|COMPLETED|Open Phase (Week 24 up to Week 54)||99||
59708725|NCT01100307|75827530|FG000|NOT COMPLETED|Open Phase (Week 24 up to Week 54)||6||
59708726|NCT01100307|75827531|FG001|NOT COMPLETED|Open Phase (Week 24 up to Week 54)||13||
59708727|NCT01100073|75827539|FG000|STARTED|Overall Study|Baseline (Visit 1)|1699||
59708728|NCT01100073|75827539|FG000|COMPLETED|Overall Study|End of study (Visit 3)|1599||
59708729|NCT01100073|75827539|FG000|NOT COMPLETED|Overall Study||100||
59708730|NCT01099917|75827543|FG000|STARTED|Overall Study||45||
59708731|NCT01099917|75827543|FG000|COMPLETED|Overall Study||18||
59708732|NCT01099917|75827543|FG000|NOT COMPLETED|Overall Study||27||
59708733|NCT01099215|75827549|FG000|STARTED|Overall Study||11||
59708734|NCT01099215|75827550|FG001|STARTED|Overall Study||10||
59708735|NCT01099215|75827549|FG000|COMPLETED|Overall Study||10||
59708736|NCT01099215|75827550|FG001|COMPLETED|Overall Study||9||
59708737|NCT01099215|75827549|FG000|NOT COMPLETED|Overall Study||1||
59565497|NCT03387033|75667820|FG000|STARTED|Overall Study||20||
59565498|NCT03387033|75667820|FG000|COMPLETED|Overall Study||20||
59565499|NCT03387033|75667820|FG000|NOT COMPLETED|Overall Study||0||
59565500|NCT03387267|75667824|FG000|STARTED|Overall Study||452||
59565501|NCT03387267|75667824|FG000|COMPLETED|Overall Study||438||
59708738|NCT01099215|75827550|FG001|NOT COMPLETED|Overall Study||1||
59708739|NCT01097655|75827556|FG000|STARTED|Overall Study||3049||
59708740|NCT01097655|75827556|FG000|COMPLETED|Overall Study|participants included for analysis|3039||
59708741|NCT01097655|75827556|FG000|NOT COMPLETED|Overall Study||10||
59708742|NCT01107405|75827565|FG000|STARTED|Overall Study||21||
59708743|NCT01107405|75827566|FG001|STARTED|Overall Study||20||
59708744|NCT01107405|75827567|FG002|STARTED|Overall Study||20||
59708745|NCT01107405|75827568|FG003|STARTED|Overall Study||20||
59708746|NCT01107405|75827569|FG004|STARTED|Overall Study||20||
59708747|NCT01107405|75827565|FG000|COMPLETED|Overall Study||19||
59708748|NCT01107405|75827566|FG001|COMPLETED|Overall Study||19||
59994550|NCT02410772|76110389|FG002|Assessable Population|Overall Study||756|Excluded the Microbiologically eligible participants without an assessable outcome (if they were not already classified as unfavorable and additionally did not attend12M visit but were culture negative when last seen, or had treatment changed due to pregnancy, or died during follow-up with cause unrelated to tuberculosis, or received additional treatment for tuberculosis following exogenous reinfection shown by whole genome sequencing, or died from a violent or accidental death during treatment|
59994551|NCT02410772|76110387|FG000|COMPLETED|Overall Study||726|Completed Population included all participants that are randomized and are microbiologically eligible with an Assessable outcome (Assessable Population)|
59994552|NCT02410772|76110388|FG001|COMPLETED|Overall Study||752|Completed Population included all participants that are randomized and are microbiologically eligible with an Assessable outcome (Assessable Population)|
60102548|NCT01101958|76220531|FG000|COMPLETED|Overall Study||51||
60102549|NCT01101958|76220532|FG001|COMPLETED|Overall Study||29||
60102550|NCT01101958|76220531|FG000|NOT COMPLETED|Overall Study||11||
60102551|NCT01101958|76220532|FG001|NOT COMPLETED|Overall Study||5||
60102552|NCT01194466|76220538|FG000|STARTED|Overall Study||14||
59995227|NCT05584189|76111051|FG001|NOT COMPLETED|Overall Study||0||
60102553|NCT01194466|76220539|FG001|STARTED|Overall Study||14||
60102554|NCT01194466|76220540|FG002|STARTED|Overall Study||13||
60102555|NCT01194466|76220538|FG000|COMPLETED|Overall Study||14||
60102556|NCT01194466|76220539|FG001|COMPLETED|Overall Study||14||
59565502|NCT03387267|75667824|FG000|NOT COMPLETED|Overall Study||14||
59565503|NCT01835756|75667831|FG000|STARTED|Overall Study||31||
60102557|NCT01194466|76220540|FG002|COMPLETED|Overall Study||13||
60102558|NCT01194466|76220538|FG000|NOT COMPLETED|Overall Study||0||
60102559|NCT01194466|76220539|FG001|NOT COMPLETED|Overall Study||0||
60102560|NCT01194466|76220540|FG002|NOT COMPLETED|Overall Study||0||
60102561|NCT01102270|76220548|FG000|STARTED|Overall Study||8||
60102562|NCT01102270|76220549|FG001|STARTED|Overall Study||9||
60102563|NCT01102270|76220548|FG000|COMPLETED|Overall Study||8||
60102564|NCT01102270|76220549|FG001|COMPLETED|Overall Study||9||
60102565|NCT01102270|76220548|FG000|NOT COMPLETED|Overall Study||0||
60102566|NCT01102270|76220549|FG001|NOT COMPLETED|Overall Study||0||
60102567|NCT01102738|76220555|FG000|STARTED|Overall Study||369||
60102568|NCT01102738|76220555|FG000|COMPLETED|Overall Study||369||
60102569|NCT01102738|76220555|FG000|NOT COMPLETED|Overall Study||0||
60102570|NCT01102894|76220559|FG000|STARTED|Overall Study||10||
60102571|NCT01102894|76220559|FG000|COMPLETED|Overall Study||10||
60102572|NCT01102894|76220559|FG000|NOT COMPLETED|Overall Study||0||
60102573|NCT01103440|76220567|FG000|STARTED|Overall Study||18||
60102574|NCT01103440|76220568|FG001|STARTED|Overall Study||18||
60102575|NCT01103440|76220567|FG000|COMPLETED|Overall Study||18||
60102576|NCT01103440|76220568|FG001|COMPLETED|Overall Study||18||
60102577|NCT01103440|76220567|FG000|NOT COMPLETED|Overall Study||0||
60102578|NCT01103440|76220568|FG001|NOT COMPLETED|Overall Study||0||
60102579|NCT01152112|76220576|FG000|STARTED|Overall Study||42||
59994553|NCT02410772|76110389|FG002|COMPLETED|Overall Study||756|Completed Population included all participants that are randomized and are microbiologically eligible with an Assessable outcome (Assessable Population)|
59994554|NCT02410772|76110387|FG000|NOT COMPLETED|Overall Study||103||
59994555|NCT02410772|76110388|FG001|NOT COMPLETED|Overall Study||86||
59994556|NCT02410772|76110389|FG002|NOT COMPLETED|Overall Study||93||
59994557|NCT03905811|76110399|FG000|STARTED|Overall Study||8||
59994558|NCT03905811|76110400|FG001|STARTED|Overall Study||5||
59994559|NCT03905811|76110399|FG000|COMPLETED|Overall Study||6||
59994560|NCT03905811|76110400|FG001|COMPLETED|Overall Study||5||
59994561|NCT03905811|76110399|FG000|NOT COMPLETED|Overall Study||2||
59994562|NCT03905811|76110400|FG001|NOT COMPLETED|Overall Study||0||
59994563|NCT01648790|76110406|FG000|STARTED|Treatment 1||4||
59994564|NCT01648790|76110407|FG001|STARTED|Treatment 1||4||
59994565|NCT01648790|76110408|FG002|STARTED|Treatment 1||4||
59994566|NCT01648790|76110409|FG003|STARTED|Treatment 1||4||
60102580|NCT01152112|76220577|FG001|STARTED|Overall Study||32||
60102581|NCT01152112|76220576|FG000|COMPLETED|Overall Study||42||
60102582|NCT01152112|76220577|FG001|COMPLETED|Overall Study||32||
60102583|NCT01152112|76220576|FG000|NOT COMPLETED|Overall Study||0||
60102584|NCT01152112|76220577|FG001|NOT COMPLETED|Overall Study||0||
60102585|NCT01105312|76220586|FG000|STARTED|Overall Study||16||
60102586|NCT01105312|76220587|FG001|STARTED|Overall Study||6||
60102587|NCT01105312|76220588|FG002|STARTED|Overall Study||6||
60102588|NCT01105312|76220586|FG000|COMPLETED|Overall Study||13||
60102589|NCT01105312|76220587|FG001|COMPLETED|Overall Study||6||
60102590|NCT01105312|76220588|FG002|COMPLETED|Overall Study||6||
60102591|NCT01105312|76220586|FG000|NOT COMPLETED|Overall Study||3||
60102592|NCT01105312|76220587|FG001|NOT COMPLETED|Overall Study||0||
60102593|NCT01105312|76220588|FG002|NOT COMPLETED|Overall Study||0||
60102594|NCT01328496|76220598|FG000|STARTED|Overall Study||10||
60102595|NCT01328496|76220599|FG001|STARTED|Overall Study||4||
60102596|NCT01328496|76220598|FG000|COMPLETED|Overall Study||9||
60102597|NCT01328496|76220599|FG001|COMPLETED|Overall Study||4||
60102598|NCT01328496|76220598|FG000|NOT COMPLETED|Overall Study||1||
60102599|NCT01328496|76220599|FG001|NOT COMPLETED|Overall Study||0||
60102600|NCT01105702|76220608|FG000|STARTED|Overall Study||28||
60102601|NCT01105702|76220608|FG000|COMPLETED|Overall Study||10||
60102602|NCT01105702|76220608|FG000|NOT COMPLETED|Overall Study||18||
60102603|NCT01197898|76220616|FG000|STARTED|Overall Study||5||
60102604|NCT01197898|76220617|FG001|STARTED|Overall Study||5||
60102605|NCT01197898|76220616|FG000|COMPLETED|Overall Study||5||
60102606|NCT01197898|76220617|FG001|COMPLETED|Overall Study||5||
60102607|NCT01197898|76220616|FG000|NOT COMPLETED|Overall Study||0||
60102608|NCT01197898|76220617|FG001|NOT COMPLETED|Overall Study||0||
60102609|NCT01198366|76220629|FG000|STARTED|Overall Study||52||
60102610|NCT01198366|76220630|FG001|STARTED|Overall Study||51||
60102611|NCT01198366|76220631|FG002|STARTED|Overall Study||51||
60102612|NCT01198366|76220632|FG003|STARTED|Overall Study||52||
60102613|NCT01198366|76220633|FG004|STARTED|Overall Study||140||
60102614|NCT01198366|76220634|FG005|STARTED|Overall Study||141||
60102615|NCT01198366|76220629|FG000|COMPLETED|Overall Study||40||
60102616|NCT01198366|76220630|FG001|COMPLETED|Overall Study||44||
60102617|NCT01198366|76220631|FG002|COMPLETED|Overall Study||43||
60102618|NCT01198366|76220632|FG003|COMPLETED|Overall Study||47||
60102619|NCT01198366|76220633|FG004|COMPLETED|Overall Study||125||
60102620|NCT01198366|76220634|FG005|COMPLETED|Overall Study||128||
60102621|NCT01198366|76220629|FG000|NOT COMPLETED|Overall Study||12||
60102622|NCT01198366|76220630|FG001|NOT COMPLETED|Overall Study||7||
60102623|NCT01198366|76220631|FG002|NOT COMPLETED|Overall Study||8||
60102624|NCT01198366|76220632|FG003|NOT COMPLETED|Overall Study||5||
60102625|NCT01198366|76220633|FG004|NOT COMPLETED|Overall Study||15||
60102626|NCT01198366|76220634|FG005|NOT COMPLETED|Overall Study||13||
59565504|NCT01835756|75667832|FG001|STARTED|Overall Study||31||
59708749|NCT01107405|75827567|FG002|COMPLETED|Overall Study||18||
59708750|NCT01107405|75827568|FG003|COMPLETED|Overall Study||17||
59708751|NCT01107405|75827569|FG004|COMPLETED|Overall Study||17||
59708752|NCT01107405|75827565|FG000|NOT COMPLETED|Overall Study||2||
59708753|NCT01107405|75827566|FG001|NOT COMPLETED|Overall Study||1||
59708754|NCT01107405|75827567|FG002|NOT COMPLETED|Overall Study||2||
59708755|NCT01107405|75827568|FG003|NOT COMPLETED|Overall Study||3||
59708756|NCT01107405|75827569|FG004|NOT COMPLETED|Overall Study||3||
59708757|NCT01097577|75827583|FG000|STARTED|Overall Study||67||
59817178|NCT05019729|75939621|FG005|NOT COMPLETED|Overall Study||0||
59994567|NCT01648790|76110410|FG004|STARTED|Treatment 1||4||
60102627|NCT01199146|76220648|FG000|STARTED|Overall Study||42||
60102628|NCT01199146|76220648|FG000|COMPLETED|Overall Study||39||
60102629|NCT01199146|76220648|FG000|NOT COMPLETED|Overall Study||3||
60102630|NCT01199848|76220652|FG000|STARTED|Placebo Arm||29||
60102631|NCT01199848|76220652|FG000|COMPLETED|Placebo Arm||21||
60102632|NCT01199848|76220652|FG000|NOT COMPLETED|Placebo Arm||8||
60102633|NCT01199848|76220652|FG000|STARTED|10g STR Arm||21||
60102634|NCT01199848|76220652|FG000|COMPLETED|10g STR Arm||21||
60102635|NCT01199848|76220652|FG000|NOT COMPLETED|10g STR Arm||0||
59708758|NCT01097577|75827584|FG001|STARTED|Overall Study||63||
59994568|NCT01648790|76110406|FG000|Received at Least 1 Dose of Study Drug|Treatment 1||4||
59994569|NCT01648790|76110407|FG001|Received at Least 1 Dose of Study Drug|Treatment 1||4||
59994570|NCT01648790|76110408|FG002|Received at Least 1 Dose of Study Drug|Treatment 1||4||
59994571|NCT01648790|76110409|FG003|Received at Least 1 Dose of Study Drug|Treatment 1||4||
59994572|NCT01648790|76110410|FG004|Received at Least 1 Dose of Study Drug|Treatment 1||4||
59994573|NCT01648790|76110406|FG000|COMPLETED|Treatment 1||4||
59994574|NCT01648790|76110407|FG001|COMPLETED|Treatment 1||4||
59994575|NCT01648790|76110408|FG002|COMPLETED|Treatment 1||4||
59994576|NCT01648790|76110409|FG003|COMPLETED|Treatment 1||4||
59994577|NCT01648790|76110410|FG004|COMPLETED|Treatment 1||4||
60102636|NCT01199848|76220652|FG000|STARTED|20G STRB Arm||21||
60102637|NCT01199848|76220652|FG000|COMPLETED|20G STRB Arm||21||
60102638|NCT01199848|76220652|FG000|NOT COMPLETED|20G STRB Arm||0||
60102639|NCT01199848|76220652|FG000|STARTED|40G STRB Arm||21||
60102640|NCT01199848|76220652|FG000|COMPLETED|40G STRB Arm||21||
60102641|NCT01199848|76220652|FG000|NOT COMPLETED|40G STRB Arm||0||
60102642|NCT01199926|76220664|FG000|STARTED|Overall Study||17||
60102643|NCT01199926|76220665|FG001|STARTED|Overall Study||17||
60102644|NCT01199926|76220664|FG000|COMPLETED|Overall Study||10||
60102645|NCT01199926|76220665|FG001|COMPLETED|Overall Study||13||
60102646|NCT01199926|76220664|FG000|NOT COMPLETED|Overall Study||7||
60102647|NCT01199926|76220665|FG001|NOT COMPLETED|Overall Study||4||
60102648|NCT01106326|76220671|FG000|STARTED|Overall Study||30||
60102649|NCT01106326|76220671|FG000|COMPLETED|Overall Study||28||
60102650|NCT01106326|76220671|FG000|NOT COMPLETED|Overall Study||2||
60102651|NCT01106950|76220677|FG000|STARTED|Overall Study||15||
60102652|NCT01106950|76220677|FG000|COMPLETED|Overall Study||15||
60102653|NCT01106950|76220677|FG000|NOT COMPLETED|Overall Study||0||
60102654|NCT01107730|76220686|FG000|STARTED|Overall Study||11||
60102655|NCT01107730|76220687|FG001|STARTED|Overall Study||11||
60102656|NCT01107730|76220688|FG002|STARTED|Overall Study||11||
60102657|NCT01107730|76220686|FG000|COMPLETED|Overall Study||11||
60102658|NCT01107730|76220687|FG001|COMPLETED|Overall Study||11||
59708759|NCT01097577|75827583|FG000|COMPLETED|Overall Study||67||
59708760|NCT01097577|75827584|FG001|COMPLETED|Overall Study||62||
59708761|NCT01097577|75827583|FG000|NOT COMPLETED|Overall Study||0||
59708762|NCT01097577|75827584|FG001|NOT COMPLETED|Overall Study||1||
59565505|NCT01835756|75667831|FG000|COMPLETED|Overall Study||31||
60102659|NCT01107730|76220688|FG002|COMPLETED|Overall Study||11||
60102660|NCT01107730|76220686|FG000|NOT COMPLETED|Overall Study||0||
60102661|NCT01107730|76220687|FG001|NOT COMPLETED|Overall Study||0||
60102662|NCT01107730|76220688|FG002|NOT COMPLETED|Overall Study||0||
60102663|NCT01107964|76220698|FG000|STARTED|Overall Study||13||
60102664|NCT01107964|76220699|FG001|STARTED|Overall Study||14||
60102665|NCT01107964|76220698|FG000|COMPLETED|Overall Study||12||
60102666|NCT01107964|76220699|FG001|COMPLETED|Overall Study||13||
60102667|NCT01107964|76220698|FG000|NOT COMPLETED|Overall Study||1||
60102668|NCT01107964|76220699|FG001|NOT COMPLETED|Overall Study||1||
60102669|NCT01200160|76220705|FG000|STARTED|Overall Study||128||
60102670|NCT01200160|76220705|FG000|COMPLETED|Overall Study||66||
60102671|NCT01200160|76220705|FG000|NOT COMPLETED|Overall Study||62||
60102672|NCT01201486|76220709|FG000|STARTED|Overall Study||6781||
60102673|NCT01201486|76220709|FG000|COMPLETED|Overall Study||6781||
60102674|NCT01201486|76220709|FG000|NOT COMPLETED|Overall Study||0||
60102675|NCT01153672|76220713|FG000|STARTED|Overall Study||8||
60102676|NCT01153672|76220713|FG000|COMPLETED|Overall Study||6||
60102677|NCT01153672|76220713|FG000|NOT COMPLETED|Overall Study||2||
60102678|NCT02734212|76220719|FG000|STARTED|Overall Study||29||
60102679|NCT02734212|76220720|FG001|STARTED|Overall Study||28||
60102680|NCT02734212|76220719|FG000|COMPLETED|Overall Study||24||
60102681|NCT02734212|76220720|FG001|COMPLETED|Overall Study||18||
60102682|NCT02734212|76220719|FG000|NOT COMPLETED|Overall Study||5||
60102683|NCT02734212|76220720|FG001|NOT COMPLETED|Overall Study||10||
60102684|NCT01202578|76220727|FG000|STARTED|Overall Study||53||
60102685|NCT01202578|76220727|FG000|COMPLETED|Overall Study||53||
60102686|NCT01202578|76220727|FG000|NOT COMPLETED|Overall Study||0||
59708763|NCT01097421|75827590|FG000|STARTED|Overall Study||328||
59708764|NCT01097421|75827590|FG000|COMPLETED|Overall Study||314||
59708765|NCT01097421|75827590|FG000|NOT COMPLETED|Overall Study||14||
59708766|NCT01251614|75827597|FG000|STARTED|Overall Study||37||
59708767|NCT01251614|75827598|FG001|STARTED|Overall Study||39||
59708768|NCT01251614|75827599|FG002|STARTED|Overall Study||38||
59708769|NCT01251614|75827597|FG000|Entered Period B|Overall Study|Only participants who were responders at Week 16 (Period A) entered the Treatment Withdrawal Phase|13||
59708770|NCT01251614|75827598|FG001|Entered Period B|Overall Study|Only participants who were responders at Week 16 (Period A) entered the Treatment Withdrawal Phase|18||
59708771|NCT01251614|75827599|FG002|Entered Period B|Overall Study|Only participants who were responders at Week 16 (Period A) entered the Treatment Withdrawal Phase|23||
59708772|NCT01251614|75827597|FG000|Entered Period C|Overall Study|Only participants who experienced loss of disease control in Period B entered the Re-Treatment Phase|8||
59708773|NCT01251614|75827598|FG001|Entered Period C|Overall Study|Only participants who experienced loss of disease control in Period B entered the Re-Treatment Phase|11||
59708774|NCT01251614|75827599|FG002|Entered Period C|Overall Study|Only participants who experienced loss of disease control in Period B entered the Re-Treatment Phase|19||
59708775|NCT01251614|75827597|FG000|Entered Period D|Overall Study|Long-Term Follow-Up Phase (52 Weeks)|36||
59708776|NCT01251614|75827598|FG001|Entered Period D|Overall Study|Long-Term Follow-Up Phase (52 Weeks)|36||
59708777|NCT01251614|75827599|FG002|Entered Period D|Overall Study|Long-Term Follow-Up Phase (52 Weeks)|36||
59708778|NCT01251614|75827597|FG000|COMPLETED|Overall Study||34||
59708779|NCT01251614|75827598|FG001|COMPLETED|Overall Study||26||
59708780|NCT01251614|75827599|FG002|COMPLETED|Overall Study||30||
59708781|NCT01251614|75827597|FG000|NOT COMPLETED|Overall Study||3||
59708782|NCT01251614|75827598|FG001|NOT COMPLETED|Overall Study||13||
59708783|NCT01251614|75827599|FG002|NOT COMPLETED|Overall Study||8||
59708784|NCT01106625|75827620|FG000|STARTED|Core Period: Baseline to Week 26||156||
59708785|NCT01106625|75827621|FG001|STARTED|Core Period: Baseline to Week 26||157||
59708786|NCT01106625|75827622|FG002|STARTED|Core Period: Baseline to Week 26||156||
59708787|NCT01106625|75827620|FG000|COMPLETED|Core Period: Baseline to Week 26||123||
59708788|NCT01106625|75827621|FG001|COMPLETED|Core Period: Baseline to Week 26||129||
59994578|NCT01648790|76110406|FG000|NOT COMPLETED|Treatment 1||0||
59994579|NCT01648790|76110407|FG001|NOT COMPLETED|Treatment 1||0||
59994580|NCT01648790|76110408|FG002|NOT COMPLETED|Treatment 1||0||
59994581|NCT01648790|76110409|FG003|NOT COMPLETED|Treatment 1||0||
59994582|NCT01648790|76110410|FG004|NOT COMPLETED|Treatment 1||0||
59994583|NCT01648790|76110406|FG000|STARTED|Treatment 2||4||
59994584|NCT01648790|76110407|FG001|STARTED|Treatment 2||4||
59994585|NCT01648790|76110408|FG002|STARTED|Treatment 2||4||
59994586|NCT01648790|76110409|FG003|STARTED|Treatment 2||4||
59994587|NCT01648790|76110410|FG004|STARTED|Treatment 2||4||
59994588|NCT01648790|76110406|FG000|COMPLETED|Treatment 2||4||
60102687|NCT01202656|76220733|FG000|STARTED|Cycle 1|Results reported In Barad et al 2014 are combined from both G-CSF studies|67||
60102688|NCT01202656|76220734|FG001|STARTED|Cycle 1|Results reported In Barad et al 2014 are combined from both G-CSF studies|62||
60102689|NCT01202656|76220733|FG000|COMPLETED|Cycle 1||67||
60102690|NCT01202656|76220734|FG001|COMPLETED|Cycle 1||62||
60102691|NCT01202656|76220733|FG000|NOT COMPLETED|Cycle 1||0||
60102692|NCT01202656|76220734|FG001|NOT COMPLETED|Cycle 1||0||
60102693|NCT01202656|76220733|FG000|STARTED|CrossoverCycle|16 ongoing pregnancies were not eligible for crossover, others chose to not have another IVF cycle|18||
60102694|NCT01202656|76220734|FG001|STARTED|CrossoverCycle|14 ongoing pregnancies were not eligible for crossover, others chose to not have another IVF cycle|14||
60102695|NCT01202656|76220733|FG000|COMPLETED|CrossoverCycle||18||
60102696|NCT01202656|76220734|FG001|COMPLETED|CrossoverCycle||14||
60102697|NCT01202656|76220733|FG000|NOT COMPLETED|CrossoverCycle||0||
60102698|NCT01202656|76220734|FG001|NOT COMPLETED|CrossoverCycle||0||
60102699|NCT01219738|76220740|FG000|STARTED|Overall Study||20||
60102700|NCT01219738|76220740|FG000|Budesonide 360|Overall Study||20||
60102701|NCT01219738|76220740|FG000|Budesonide 720|Overall Study||20||
60102702|NCT01219738|76220740|FG000|Budesonide 1440|Overall Study||20||
60102703|NCT01219738|76220740|FG000|Budesonide 720- 4 Times|Overall Study||20||
60102704|NCT01219738|76220740|FG000|COMPLETED|Overall Study||20||
60102705|NCT01219738|76220740|FG000|NOT COMPLETED|Overall Study||0||
60102706|NCT01155154|76220756|FG000|STARTED|Overall Study||25||
60102707|NCT01155154|76220757|FG001|STARTED|Overall Study||24||
60102708|NCT01155154|76220758|FG002|STARTED|Overall Study||24||
60102709|NCT01155154|76220756|FG000|COMPLETED|Overall Study||25||
60102710|NCT01155154|76220757|FG001|COMPLETED|Overall Study||24||
59565506|NCT01835756|75667832|FG001|COMPLETED|Overall Study||31||
59708789|NCT01106625|75827622|FG002|COMPLETED|Core Period: Baseline to Week 26||129||
59708790|NCT01106625|75827620|FG000|NOT COMPLETED|Core Period: Baseline to Week 26||33||
59708791|NCT01106625|75827621|FG001|NOT COMPLETED|Core Period: Baseline to Week 26||28||
59708792|NCT01106625|75827622|FG002|NOT COMPLETED|Core Period: Baseline to Week 26||27||
59708793|NCT01106625|75827620|FG000|STARTED|Extension Period: Week 26 to Week 52|4 pts discontinued last day of core: physician decision (1), noncompliance (1), not specified (2).|119||
59708794|NCT01106625|75827621|FG001|STARTED|Extension Period: Week 26 to Week 52|2 pts discontinued last day of core: adverse event (1), not specified (1).|127||
59708795|NCT01106625|75827622|FG002|STARTED|Extension Period: Week 26 to Week 52|1 pt discontinued last day of core: withdrawal by subject (1).|128||
59708796|NCT01106625|75827620|FG000|COMPLETED|Extension Period: Week 26 to Week 52||90||
59708797|NCT01106625|75827621|FG001|COMPLETED|Extension Period: Week 26 to Week 52||109||
59708798|NCT01106625|75827622|FG002|COMPLETED|Extension Period: Week 26 to Week 52||111||
59708799|NCT01106625|75827620|FG000|NOT COMPLETED|Extension Period: Week 26 to Week 52||29||
59708800|NCT01106625|75827621|FG001|NOT COMPLETED|Extension Period: Week 26 to Week 52||18||
59708801|NCT01106625|75827622|FG002|NOT COMPLETED|Extension Period: Week 26 to Week 52||17||
59708802|NCT01251380|75827633|FG000|STARTED|Overall Study|Safety population.|216||
59708803|NCT01251380|75827633|FG000|Cycle 1|Overall Study||207||
59708804|NCT01251380|75827633|FG000|Cycle 2|Overall Study||175||
59708805|NCT01251380|75827633|FG000|Cycle 3|Overall Study||86||
59708806|NCT01251380|75827633|FG000|Cycle 4|Overall Study||11||
59708807|NCT01251380|75827633|FG000|COMPLETED|Overall Study||194||
59708808|NCT01251380|75827633|FG000|NOT COMPLETED|Overall Study||22||
59708809|NCT01251146|75827644|FG000|STARTED|Overall Study||86||
59708810|NCT01251146|75827645|FG001|STARTED|Overall Study||91||
59708811|NCT01251146|75827644|FG000|COMPLETED|Overall Study||83||
59708812|NCT01251146|75827645|FG001|COMPLETED|Overall Study||81||
59708813|NCT01251146|75827644|FG000|NOT COMPLETED|Overall Study||3||
59708814|NCT01251146|75827645|FG001|NOT COMPLETED|Overall Study||10||
59708815|NCT01096017|75827651|FG000|STARTED|Treatment Period 1||12||
59708816|NCT01096017|75827652|FG001|STARTED|Treatment Period 1||12||
59708817|NCT01096017|75827651|FG000|COMPLETED|Treatment Period 1||12||
60102711|NCT01155154|76220758|FG002|COMPLETED|Overall Study||24||
60102712|NCT01155154|76220756|FG000|NOT COMPLETED|Overall Study||0||
60102713|NCT01155154|76220757|FG001|NOT COMPLETED|Overall Study||0||
60102714|NCT01155154|76220758|FG002|NOT COMPLETED|Overall Study||0||
60102715|NCT03786432|76220766|FG000|STARTED|Overall Study||13||
60102716|NCT03786432|76220766|FG000|Completed 12 Month Visit|Overall Study||8||
60102717|NCT03786432|76220766|FG000|Completed 12 Month CT Scan|Overall Study||7||
60102718|NCT03786432|76220766|FG000|COMPLETED|Overall Study||7||
60102719|NCT03786432|76220766|FG000|NOT COMPLETED|Overall Study||6||
59708818|NCT01096017|75827652|FG001|COMPLETED|Treatment Period 1||12||
59708819|NCT01096017|75827651|FG000|NOT COMPLETED|Treatment Period 1||0||
59708820|NCT01096017|75827652|FG001|NOT COMPLETED|Treatment Period 1||0||
59708821|NCT01096017|75827651|FG000|STARTED|Washout 1 - 14 Days||12||
59708822|NCT01096017|75827652|FG001|STARTED|Washout 1 - 14 Days||12||
59708823|NCT01096017|75827651|FG000|COMPLETED|Washout 1 - 14 Days||12||
59708824|NCT01096017|75827652|FG001|COMPLETED|Washout 1 - 14 Days||12||
59708825|NCT01096017|75827651|FG000|NOT COMPLETED|Washout 1 - 14 Days||0||
60102720|NCT01221298|76220771|FG000|STARTED|Overall Study||11||
60102721|NCT01221298|76220771|FG000|COMPLETED|Overall Study|The number of participants who completed study drug|11||
60102722|NCT01221298|76220771|FG000|NOT COMPLETED|Overall Study||0||
60102723|NCT01222234|76220778|FG000|STARTED|Overall Study||15||
60102724|NCT01222234|76220779|FG001|STARTED|Overall Study||17||
60102725|NCT01222234|76220780|FG002|STARTED|Overall Study||24||
59708826|NCT01096017|75827652|FG001|NOT COMPLETED|Washout 1 - 14 Days||0||
59708827|NCT01096017|75827651|FG000|STARTED|Treatment Period 2||12||
59994589|NCT01648790|76110407|FG001|COMPLETED|Treatment 2||4||
59994590|NCT01648790|76110408|FG002|COMPLETED|Treatment 2||4||
59994591|NCT01648790|76110409|FG003|COMPLETED|Treatment 2||4||
59994592|NCT01648790|76110410|FG004|COMPLETED|Treatment 2||4||
59994593|NCT01648790|76110406|FG000|NOT COMPLETED|Treatment 2||0||
59994594|NCT01648790|76110407|FG001|NOT COMPLETED|Treatment 2||0||
59994595|NCT01648790|76110408|FG002|NOT COMPLETED|Treatment 2||0||
59994596|NCT01648790|76110409|FG003|NOT COMPLETED|Treatment 2||0||
59994597|NCT01648790|76110410|FG004|NOT COMPLETED|Treatment 2||0||
59994598|NCT01648790|76110406|FG000|STARTED|Treatment 3||4||
59994599|NCT01648790|76110407|FG001|STARTED|Treatment 3||4||
59994600|NCT01648790|76110408|FG002|STARTED|Treatment 3||4||
59994601|NCT01648790|76110409|FG003|STARTED|Treatment 3|Withdrew consent prior to dosing on this treatment day.|4||
59994602|NCT01648790|76110410|FG004|STARTED|Treatment 3||4||
59994603|NCT01648790|76110406|FG000|COMPLETED|Treatment 3||4||
59994604|NCT01648790|76110407|FG001|COMPLETED|Treatment 3||4||
59994605|NCT01648790|76110408|FG002|COMPLETED|Treatment 3||4||
59994606|NCT01648790|76110409|FG003|COMPLETED|Treatment 3||3||
59994607|NCT01648790|76110410|FG004|COMPLETED|Treatment 3||4||
59994608|NCT01648790|76110406|FG000|NOT COMPLETED|Treatment 3||0||
59994609|NCT01648790|76110407|FG001|NOT COMPLETED|Treatment 3||0||
59994610|NCT01648790|76110408|FG002|NOT COMPLETED|Treatment 3||0||
59994611|NCT01648790|76110409|FG003|NOT COMPLETED|Treatment 3||1||
59994612|NCT01648790|76110410|FG004|NOT COMPLETED|Treatment 3||0||
59994613|NCT01648790|76110406|FG000|STARTED|Treatment 4||4||
59994614|NCT01648790|76110407|FG001|STARTED|Treatment 4||4||
59994615|NCT01648790|76110408|FG002|STARTED|Treatment 4||4||
59994616|NCT01648790|76110409|FG003|STARTED|Treatment 4||3||
59994617|NCT01648790|76110410|FG004|STARTED|Treatment 4||4||
59994618|NCT01648790|76110406|FG000|COMPLETED|Treatment 4||4||
59994619|NCT01648790|76110407|FG001|COMPLETED|Treatment 4||4||
59994620|NCT01648790|76110408|FG002|COMPLETED|Treatment 4||4||
59994621|NCT01648790|76110409|FG003|COMPLETED|Treatment 4||3||
59994622|NCT01648790|76110410|FG004|COMPLETED|Treatment 4||4||
59994623|NCT01648790|76110406|FG000|NOT COMPLETED|Treatment 4||0||
59994624|NCT01648790|76110407|FG001|NOT COMPLETED|Treatment 4||0||
59994625|NCT01648790|76110408|FG002|NOT COMPLETED|Treatment 4||0||
59994626|NCT01648790|76110409|FG003|NOT COMPLETED|Treatment 4||0||
59994627|NCT01648790|76110410|FG004|NOT COMPLETED|Treatment 4||0||
59994628|NCT01648790|76110406|FG000|STARTED|Treatment 5||4||
59994629|NCT01648790|76110407|FG001|STARTED|Treatment 5||4||
59994630|NCT01648790|76110408|FG002|STARTED|Treatment 5||4||
59994631|NCT01648790|76110409|FG003|STARTED|Treatment 5||3||
59994632|NCT01648790|76110410|FG004|STARTED|Treatment 5||4||
59994633|NCT01648790|76110406|FG000|COMPLETED|Treatment 5||4||
59994634|NCT01648790|76110407|FG001|COMPLETED|Treatment 5||4||
60102726|NCT01222234|76220778|FG000|COMPLETED|Overall Study||15||
60102727|NCT01222234|76220779|FG001|COMPLETED|Overall Study||15||
60102728|NCT01222234|76220780|FG002|COMPLETED|Overall Study||22||
60102729|NCT01222234|76220778|FG000|NOT COMPLETED|Overall Study||0||
60102730|NCT01222234|76220779|FG001|NOT COMPLETED|Overall Study||2||
60102731|NCT01222234|76220780|FG002|NOT COMPLETED|Overall Study||2||
60102732|NCT01203046|76220791|FG000|STARTED|Overall Study||28||
60102733|NCT01203046|76220792|FG001|STARTED|Overall Study||28||
60102734|NCT01203046|76220791|FG000|COMPLETED|Overall Study||28||
60102735|NCT01203046|76220792|FG001|COMPLETED|Overall Study||28||
60102736|NCT01203046|76220791|FG000|NOT COMPLETED|Overall Study||0||
60102737|NCT01203046|76220792|FG001|NOT COMPLETED|Overall Study||0||
60102738|NCT04604184|76220802|FG000|STARTED|Overall Study||67||
60102739|NCT04604184|76220803|FG001|STARTED|Overall Study||66||
59994635|NCT01648790|76110408|FG002|COMPLETED|Treatment 5||4||
59994636|NCT01648790|76110409|FG003|COMPLETED|Treatment 5||3||
59994637|NCT01648790|76110410|FG004|COMPLETED|Treatment 5||4||
59994638|NCT01648790|76110406|FG000|NOT COMPLETED|Treatment 5||0||
59994639|NCT01648790|76110407|FG001|NOT COMPLETED|Treatment 5||0||
60102740|NCT04604184|76220802|FG000|Treated|Overall Study||65||
60102741|NCT04604184|76220803|FG001|Treated|Overall Study||64||
59708828|NCT01096017|75827652|FG001|STARTED|Treatment Period 2||12||
59994640|NCT01648790|76110408|FG002|NOT COMPLETED|Treatment 5||0||
59994641|NCT01648790|76110409|FG003|NOT COMPLETED|Treatment 5||0||
59994642|NCT01648790|76110410|FG004|NOT COMPLETED|Treatment 5||0||
59994643|NCT02356575|76110424|FG000|STARTED|Overall Study||80||
59994644|NCT02356575|76110425|FG001|STARTED|Overall Study||80||
59994645|NCT02356575|76110424|FG000|COMPLETED|Overall Study||80||
59994646|NCT02356575|76110425|FG001|COMPLETED|Overall Study||80||
59994647|NCT02356575|76110424|FG000|NOT COMPLETED|Overall Study||0||
59994648|NCT02356575|76110425|FG001|NOT COMPLETED|Overall Study||0||
59994649|NCT01936857|76110433|FG000|STARTED|Overall Study||141||
60102742|NCT04604184|76220802|FG000|COMPLETED|Overall Study||47||
60102743|NCT04604184|76220803|FG001|COMPLETED|Overall Study||47||
60102744|NCT04604184|76220802|FG000|NOT COMPLETED|Overall Study||20||
60102745|NCT04604184|76220803|FG001|NOT COMPLETED|Overall Study||19||
60102746|NCT01155778|76220812|FG000|STARTED|Overall Study||4||
60102747|NCT01155778|76220813|FG001|STARTED|Overall Study||4||
60102748|NCT01155778|76220814|FG002|STARTED|Overall Study||4||
60102749|NCT01155778|76220812|FG000|COMPLETED|Overall Study||4||
60102750|NCT01155778|76220813|FG001|COMPLETED|Overall Study||4||
60102751|NCT01155778|76220814|FG002|COMPLETED|Overall Study||4||
60102752|NCT01155778|76220812|FG000|NOT COMPLETED|Overall Study||0||
60102753|NCT01155778|76220813|FG001|NOT COMPLETED|Overall Study||0||
60102754|NCT01155778|76220814|FG002|NOT COMPLETED|Overall Study||0||
60102755|NCT04155840|76220822|FG000|STARTED|Overall Study||1||
60102756|NCT04155840|76220822|FG000|COMPLETED|Overall Study||1||
60102757|NCT04155840|76220822|FG000|NOT COMPLETED|Overall Study||0||
60102758|NCT01203826|76220828|FG000|STARTED|Overall Study|Dose cohorts are per assigned dose in ENB-006-09. Results presented are for Study ENB-008-10 only.|6||
60102759|NCT01203826|76220829|FG001|STARTED|Overall Study|Dose cohorts are per assigned dose in ENB-006-09. Results presented are for Study ENB-008-10 only.|6||
60102760|NCT01203826|76220828|FG000|COMPLETED|Overall Study||6||
60102761|NCT01203826|76220829|FG001|COMPLETED|Overall Study||6||
60102762|NCT01203826|76220828|FG000|NOT COMPLETED|Overall Study||0||
60102763|NCT01203826|76220829|FG001|NOT COMPLETED|Overall Study||0||
60102764|NCT01157416|76220837|FG000|STARTED|Overall Study||17||
60102765|NCT01157416|76220838|FG001|STARTED|Overall Study||16||
60102766|NCT01157416|76220837|FG000|COMPLETED|Overall Study||15||
60102767|NCT01157416|76220838|FG001|COMPLETED|Overall Study||16||
60102768|NCT01157416|76220837|FG000|NOT COMPLETED|Overall Study||2||
60102769|NCT01157416|76220838|FG001|NOT COMPLETED|Overall Study||0||
60102770|NCT01206478|76220846|FG000|STARTED|Overall Study||9||
60102771|NCT01206478|76220847|FG001|STARTED|Overall Study||12||
60102772|NCT01206478|76220846|FG000|COMPLETED|Overall Study||7||
60102773|NCT01206478|76220847|FG001|COMPLETED|Overall Study||7||
60102774|NCT01206478|76220846|FG000|NOT COMPLETED|Overall Study||2||
60102775|NCT01206478|76220847|FG001|NOT COMPLETED|Overall Study||5||
60102776|NCT01158820|76220855|FG000|STARTED|Overall Study||25||
60102777|NCT01158820|76220856|FG001|STARTED|Overall Study||25||
60102778|NCT01158820|76220855|FG000|COMPLETED|Overall Study||25||
60102779|NCT01158820|76220856|FG001|COMPLETED|Overall Study||25||
60102780|NCT01158820|76220855|FG000|NOT COMPLETED|Overall Study||0||
60102781|NCT01158820|76220856|FG001|NOT COMPLETED|Overall Study||0||
60102782|NCT01207570|76220865|FG000|STARTED|The First Stage (Before Crossover)||23||
60102783|NCT01207570|76220866|FG001|STARTED|The First Stage (Before Crossover)||31||
60102784|NCT01207570|76220865|FG000|COMPLETED|The First Stage (Before Crossover)||23||
60102785|NCT01207570|76220866|FG001|COMPLETED|The First Stage (Before Crossover)||31||
60102786|NCT01207570|76220865|FG000|NOT COMPLETED|The First Stage (Before Crossover)||0||
60102787|NCT01207570|76220866|FG001|NOT COMPLETED|The First Stage (Before Crossover)||0||
60102788|NCT01207570|76220865|FG000|STARTED|The Second Stage (After Crossover)||31||
60102789|NCT01207570|76220866|FG001|STARTED|The Second Stage (After Crossover)||23||
60102790|NCT01207570|76220865|FG000|COMPLETED|The Second Stage (After Crossover)||31||
60102791|NCT01207570|76220866|FG001|COMPLETED|The Second Stage (After Crossover)||23||
60102792|NCT01207570|76220865|FG000|NOT COMPLETED|The Second Stage (After Crossover)||0||
60102793|NCT01207570|76220866|FG001|NOT COMPLETED|The Second Stage (After Crossover)||0||
60102794|NCT01207648|76220874|FG000|STARTED|Overall Study||307||
60102795|NCT01207648|76220874|FG000|COMPLETED|Overall Study||307||
60102796|NCT01207648|76220874|FG000|NOT COMPLETED|Overall Study||0||
60102797|NCT01225354|76220878|FG000|STARTED|Overall Study||20||
60102798|NCT01225354|76220878|FG000|COMPLETED|Overall Study||19||
60102799|NCT01225354|76220878|FG000|NOT COMPLETED|Overall Study||1||
60102800|NCT01226914|76220885|FG000|STARTED|Overall Study||28||
60102801|NCT01226914|76220886|FG001|STARTED|Overall Study||27||
60102802|NCT01226914|76220885|FG000|COMPLETED|Overall Study||28||
60102803|NCT01226914|76220886|FG001|COMPLETED|Overall Study||27||
60102804|NCT01226914|76220885|FG000|NOT COMPLETED|Overall Study||0||
60102805|NCT01226914|76220886|FG001|NOT COMPLETED|Overall Study||0||
60102806|NCT01158976|76220894|FG000|STARTED|Overall Study||43||
60102807|NCT01158976|76220895|FG001|STARTED|Overall Study||21||
60102808|NCT01158976|76220894|FG000|COMPLETED|Overall Study||34||
60102809|NCT01158976|76220895|FG001|COMPLETED|Overall Study||17||
60102810|NCT01158976|76220894|FG000|NOT COMPLETED|Overall Study||9||
60102811|NCT01158976|76220895|FG001|NOT COMPLETED|Overall Study||4||
60102812|NCT01227382|76220901|FG000|STARTED|Overall Study||26||
60102813|NCT01227382|76220901|FG000|COMPLETED|Overall Study||26||
60102814|NCT01227382|76220901|FG000|NOT COMPLETED|Overall Study||0||
60102815|NCT01159054|76220907|FG000|STARTED|Overall Study||22||
60102816|NCT01159054|76220907|FG000|COMPLETED|Overall Study||2||
60102817|NCT01159054|76220907|FG000|NOT COMPLETED|Overall Study||20||
60102818|NCT01209442|76220911|FG000|STARTED|Overall Study||30||
60102819|NCT01209442|76220911|FG000|COMPLETED|Overall Study||30||
60102820|NCT01209442|76220911|FG000|NOT COMPLETED|Overall Study||0||
60102821|NCT01160380|76220917|FG000|STARTED|Overall Study||25||
60102822|NCT01160380|76220918|FG001|STARTED|Overall Study||25||
60102823|NCT01160380|76220917|FG000|COMPLETED|Overall Study||17||
60102824|NCT01160380|76220918|FG001|COMPLETED|Overall Study||20||
60102825|NCT01160380|76220917|FG000|NOT COMPLETED|Overall Study||8||
60102826|NCT01160380|76220918|FG001|NOT COMPLETED|Overall Study||5||
60102827|NCT01228084|76220924|FG000|STARTED|Overall Study||20||
60102828|NCT01228084|76220924|FG000|COMPLETED|Overall Study||16||
60102829|NCT01228084|76220924|FG000|NOT COMPLETED|Overall Study||4||
60102830|NCT01229410|76220930|FG000|STARTED|Overall Study||12||
60102831|NCT01229410|76220931|FG001|STARTED|Overall Study||12||
60102832|NCT01229410|76220930|FG000|COMPLETED|Overall Study||7||
60102833|NCT01229410|76220931|FG001|COMPLETED|Overall Study||9||
60102834|NCT01229410|76220930|FG000|NOT COMPLETED|Overall Study||5||
60102835|NCT01229410|76220931|FG001|NOT COMPLETED|Overall Study||3||
60102836|NCT01212172|76220937|FG000|STARTED|Overall Study||10||
60102837|NCT01212172|76220938|FG001|STARTED|Overall Study||10||
60102838|NCT01212172|76220937|FG000|COMPLETED|Overall Study||9||
60102839|NCT01212172|76220938|FG001|COMPLETED|Overall Study||9||
60102840|NCT01212172|76220937|FG000|NOT COMPLETED|Overall Study||1||
60102841|NCT01212172|76220938|FG001|NOT COMPLETED|Overall Study||1||
60102842|NCT01160458|76220946|FG000|STARTED|Overall Study||20||
60102843|NCT01160458|76220946|FG000|COMPLETED|Overall Study||20||
60102844|NCT01160458|76220946|FG000|NOT COMPLETED|Overall Study||0||
60102845|NCT01212484|76220950|FG000|STARTED|Carbidopa Titration Period (4 Weeks)||6||
60102846|NCT01212484|76220951|FG001|STARTED|Carbidopa Titration Period (4 Weeks)||6||
60102847|NCT01212484|76220950|FG000|COMPLETED|Carbidopa Titration Period (4 Weeks)||5||
60102848|NCT01212484|76220951|FG001|COMPLETED|Carbidopa Titration Period (4 Weeks)||6||
60102849|NCT01212484|76220950|FG000|NOT COMPLETED|Carbidopa Titration Period (4 Weeks)||1||
60102850|NCT01212484|76220951|FG001|NOT COMPLETED|Carbidopa Titration Period (4 Weeks)||0||
60102851|NCT01212484|76220950|FG000|STARTED|First Intervention (4 Weeks)||5||
60102852|NCT01212484|76220951|FG001|STARTED|First Intervention (4 Weeks)||6||
60102853|NCT01212484|76220950|FG000|COMPLETED|First Intervention (4 Weeks)||5||
60102854|NCT01212484|76220951|FG001|COMPLETED|First Intervention (4 Weeks)||4||
60102855|NCT01212484|76220950|FG000|NOT COMPLETED|First Intervention (4 Weeks)||0||
60102856|NCT01212484|76220951|FG001|NOT COMPLETED|First Intervention (4 Weeks)||2||
60102857|NCT01212484|76220950|FG000|STARTED|Second Intervention (4 Weeks)||5||
60102858|NCT01212484|76220951|FG001|STARTED|Second Intervention (4 Weeks)||4||
60102859|NCT01212484|76220950|FG000|COMPLETED|Second Intervention (4 Weeks)||5||
60102860|NCT01212484|76220951|FG001|COMPLETED|Second Intervention (4 Weeks)||3||
60102861|NCT01212484|76220950|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0||
60102862|NCT01212484|76220951|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||1||
60102863|NCT01212874|76220959|FG000|STARTED|Overall Study||35||
60102864|NCT01212874|76220960|FG001|STARTED|Overall Study||35||
60102865|NCT01212874|76220959|FG000|Received Allocated Intervention|Overall Study||13||
60102866|NCT01212874|76220960|FG001|Received Allocated Intervention|Overall Study||12||
60102867|NCT01212874|76220959|FG000|COMPLETED|Overall Study||13||
60102868|NCT01212874|76220960|FG001|COMPLETED|Overall Study||12||
60102869|NCT01212874|76220959|FG000|NOT COMPLETED|Overall Study||22||
60102870|NCT01212874|76220960|FG001|NOT COMPLETED|Overall Study||23||
60102871|NCT01859741|76220974|FG000|STARTED|Overall Study||3||
60102872|NCT01859741|76220975|FG001|STARTED|Overall Study||3||
60102873|NCT01859741|76220976|FG002|STARTED|Overall Study||6||
60102874|NCT01859741|76220977|FG003|STARTED|Overall Study||3||
60102875|NCT01859741|76220978|FG004|STARTED|Overall Study||6||
60102876|NCT01859741|76220979|FG005|STARTED|Overall Study||6||
60102877|NCT01859741|76220980|FG006|STARTED|Overall Study||72||
60102878|NCT01859741|76220981|FG007|STARTED|Overall Study||73||
60102879|NCT01859741|76220974|FG000|COMPLETED|Overall Study||0||
60102880|NCT01859741|76220975|FG001|COMPLETED|Overall Study||0||
60102881|NCT01859741|76220976|FG002|COMPLETED|Overall Study||0||
60102882|NCT01859741|76220977|FG003|COMPLETED|Overall Study||0||
60102883|NCT01859741|76220978|FG004|COMPLETED|Overall Study||0||
60102884|NCT01859741|76220979|FG005|COMPLETED|Overall Study||0||
60102885|NCT01859741|76220980|FG006|COMPLETED|Overall Study||2||
60102886|NCT01859741|76220981|FG007|COMPLETED|Overall Study||3||
60102887|NCT01859741|76220974|FG000|NOT COMPLETED|Overall Study||3||
60102888|NCT01859741|76220975|FG001|NOT COMPLETED|Overall Study||3||
60102889|NCT01859741|76220976|FG002|NOT COMPLETED|Overall Study||6||
60102890|NCT01859741|76220977|FG003|NOT COMPLETED|Overall Study||3||
60102891|NCT01859741|76220978|FG004|NOT COMPLETED|Overall Study||6||
60102892|NCT01859741|76220979|FG005|NOT COMPLETED|Overall Study||6||
60102893|NCT01859741|76220980|FG006|NOT COMPLETED|Overall Study||70||
60102894|NCT01859741|76220981|FG007|NOT COMPLETED|Overall Study||70||
60102895|NCT01212952|76221002|FG000|STARTED|Overall Study||3||
60102896|NCT01212952|76221003|FG001|STARTED|Overall Study||6||
60102897|NCT01212952|76221004|FG002|STARTED|Overall Study||41||
60102898|NCT01212952|76221002|FG000|COMPLETED|Overall Study||3||
60102899|NCT01212952|76221003|FG001|COMPLETED|Overall Study||6||
60102900|NCT01212952|76221004|FG002|COMPLETED|Overall Study||41||
60102901|NCT01212952|76221002|FG000|NOT COMPLETED|Overall Study||0||
60102902|NCT01212952|76221003|FG001|NOT COMPLETED|Overall Study||0||
60102903|NCT01212952|76221004|FG002|NOT COMPLETED|Overall Study||0||
60102904|NCT01229722|76221016|FG000|STARTED|Overall Study||36||
60102905|NCT01229722|76221017|FG001|STARTED|Overall Study||34||
60102906|NCT01229722|76221016|FG000|COMPLETED|Overall Study||36||
60102907|NCT01229722|76221017|FG001|COMPLETED|Overall Study||30||
60102908|NCT01229722|76221016|FG000|NOT COMPLETED|Overall Study||0||
60102909|NCT01229722|76221017|FG001|NOT COMPLETED|Overall Study||4||
60102910|NCT01859507|76221027|FG000|STARTED|Overall Study||32||
60102911|NCT01859507|76221027|FG000|COMPLETED|Overall Study||28||
60102912|NCT01859507|76221027|FG000|NOT COMPLETED|Overall Study||4||
60102913|NCT01876043|76221032|FG000|STARTED|Overall Study||24||
60102914|NCT01876043|76221032|FG000|Interim Analysis Population|Overall Study||17|Following Simon's 2-stage design (see arm description), 17 patients included in the first stage.|
60102915|NCT01876043|76221032|FG000|COMPLETED|Overall Study||22|Received one complete cycle or two incomplete cycles of treatment (17 patients included in the first stage of Simon's design + 5 additionnal patients included)|
60102916|NCT01876043|76221032|FG000|NOT COMPLETED|Overall Study||2||
60102917|NCT01875731|76221038|FG000|STARTED|Overall Study||34||
60102918|NCT01875731|76221039|FG001|STARTED|Overall Study||32||
60102919|NCT01875731|76221038|FG000|COMPLETED|Overall Study||33||
60102920|NCT01875731|76221039|FG001|COMPLETED|Overall Study||32||
60102921|NCT01875731|76221038|FG000|NOT COMPLETED|Overall Study||1||
60102922|NCT01875731|76221039|FG001|NOT COMPLETED|Overall Study||0||
60102923|NCT01873859|76221047|FG000|STARTED|Overall Study||83||
60102924|NCT01873859|76221048|FG001|STARTED|Overall Study||83||
60102925|NCT01873859|76221047|FG000|COMPLETED|Overall Study||83||
60102926|NCT01873859|76221048|FG001|COMPLETED|Overall Study||79||
60102927|NCT01873859|76221047|FG000|NOT COMPLETED|Overall Study||0||
60102928|NCT01873859|76221048|FG001|NOT COMPLETED|Overall Study||4||
60102929|NCT01857869|76221065|FG000|STARTED|Primary/Challenge Phase||34||
60102930|NCT01857869|76221066|FG001|STARTED|Primary/Challenge Phase||17||
60102931|NCT01857869|76221067|FG002|STARTED|Primary/Challenge Phase||12||
60102932|NCT01857869|76221068|FG003|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0||
60102933|NCT01857869|76221069|FG004|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0||
60102934|NCT01857869|76221070|FG005|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0||
60102935|NCT01857869|76221071|FG006|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0||
60102936|NCT01857869|76221072|FG007|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0||
60102937|NCT01857869|76221073|FG008|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0||
60102938|NCT01857869|76221074|FG009|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0||
60102939|NCT01857869|76221065|FG000|COMPLETED|Primary/Challenge Phase||29||
60102940|NCT01857869|76221066|FG001|COMPLETED|Primary/Challenge Phase||16||
60102941|NCT01857869|76221067|FG002|COMPLETED|Primary/Challenge Phase||12||
60102942|NCT01857869|76221068|FG003|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0||
60102943|NCT01857869|76221069|FG004|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0||
60102944|NCT01857869|76221070|FG005|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0||
60102945|NCT01857869|76221071|FG006|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0||
60102946|NCT01857869|76221072|FG007|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0||
60102947|NCT01857869|76221073|FG008|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0||
59565507|NCT01835756|75667831|FG000|NOT COMPLETED|Overall Study||0||
60102948|NCT01857869|76221074|FG009|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0||
59565508|NCT01835756|75667832|FG001|NOT COMPLETED|Overall Study||0||
59565509|NCT04462731|75667842|FG000|STARTED|Overall Study||97||
60102949|NCT01857869|76221065|FG000|NOT COMPLETED|Primary/Challenge Phase||5||
60102950|NCT01857869|76221066|FG001|NOT COMPLETED|Primary/Challenge Phase||1||
60102951|NCT01857869|76221067|FG002|NOT COMPLETED|Primary/Challenge Phase||0||
60102952|NCT01857869|76221068|FG003|NOT COMPLETED|Primary/Challenge Phase||0||
60102953|NCT01857869|76221069|FG004|NOT COMPLETED|Primary/Challenge Phase||0||
60102954|NCT01857869|76221070|FG005|NOT COMPLETED|Primary/Challenge Phase||0||
59708829|NCT01096017|75827651|FG000|COMPLETED|Treatment Period 2||11||
59708830|NCT01096017|75827652|FG001|COMPLETED|Treatment Period 2||11||
60102955|NCT01857869|76221071|FG006|NOT COMPLETED|Primary/Challenge Phase||0||
59565510|NCT04462731|75667843|FG001|STARTED|Overall Study||97||
59565511|NCT04462731|75667842|FG000|COMPLETED|Overall Study||41||
59565512|NCT04462731|75667843|FG001|COMPLETED|Overall Study||51||
59565513|NCT04462731|75667842|FG000|NOT COMPLETED|Overall Study||56||
59565514|NCT04462731|75667843|FG001|NOT COMPLETED|Overall Study||46||
59565515|NCT01835912|75667849|FG000|STARTED|Overall Study||10||
59565516|NCT01835912|75667849|FG000|Acute|Overall Study||10||
59565517|NCT01835912|75667849|FG000|Acute Placebo|Overall Study||10||
59565518|NCT01835912|75667849|FG000|Chronic|Overall Study||10||
59565519|NCT01835912|75667849|FG000|Chronic Placebo|Overall Study||10||
59565520|NCT01835912|75667849|FG000|COMPLETED|Overall Study||10||
59565521|NCT01835912|75667849|FG000|NOT COMPLETED|Overall Study||0||
59708831|NCT01096017|75827651|FG000|NOT COMPLETED|Treatment Period 2||1||
60102956|NCT01857869|76221072|FG007|NOT COMPLETED|Primary/Challenge Phase||0||
60102957|NCT01857869|76221073|FG008|NOT COMPLETED|Primary/Challenge Phase||0||
60102958|NCT01857869|76221074|FG009|NOT COMPLETED|Primary/Challenge Phase||0||
60102959|NCT01857869|76221065|FG000|STARTED|Booster/Rechallenge Phase|GSK257049-0,1,7M, GSK257049-0,1,2M and Infectivity Control Groups were not included in Booster phase|0||
59565522|NCT01837550|75667861|FG000|STARTED|T0-T1, 5 Weeks||37||
59565523|NCT01837550|75667862|FG001|STARTED|T0-T1, 5 Weeks||37||
59565524|NCT01837550|75667861|FG000|COMPLETED|T0-T1, 5 Weeks||37||
59565525|NCT01837550|75667862|FG001|COMPLETED|T0-T1, 5 Weeks||37||
60102960|NCT01857869|76221066|FG001|STARTED|Booster/Rechallenge Phase|GSK257049-0,1,7M, GSK257049-0,1,2M and Infectivity Control Groups were not included in Booster phase|0||
60102961|NCT01857869|76221067|FG002|STARTED|Booster/Rechallenge Phase|GSK257049-0,1,7M, GSK257049-0,1,2M and Infectivity Control Groups were not included in Booster phase|0||
59565526|NCT01837550|75667861|FG000|NOT COMPLETED|T0-T1, 5 Weeks||0||
59708832|NCT01096017|75827652|FG001|NOT COMPLETED|Treatment Period 2||1||
59708833|NCT01106157|75827660|FG000|STARTED|Overall Study||17||
59565527|NCT01837550|75667862|FG001|NOT COMPLETED|T0-T1, 5 Weeks||0||
59565528|NCT01837550|75667861|FG000|STARTED|T0-T2, 6 Months Follow-up||37||
59817179|NCT04891406|75939643|FG000|STARTED|Overall Study||5||
59817180|NCT04891406|75939644|FG001|STARTED|Overall Study||5||
59817181|NCT04891406|75939645|FG002|STARTED|Overall Study||5||
59817182|NCT04891406|75939646|FG003|STARTED|Overall Study||5||
59817183|NCT04891406|75939647|FG004|STARTED|Overall Study||4||
59817184|NCT04891406|75939643|FG000|COMPLETED|Overall Study||5||
60102962|NCT01857869|76221068|FG003|STARTED|Booster/Rechallenge Phase||9||
60102963|NCT01857869|76221069|FG004|STARTED|Booster/Rechallenge Phase||10||
60102964|NCT01857869|76221070|FG005|STARTED|Booster/Rechallenge Phase||2||
60102965|NCT01857869|76221071|FG006|STARTED|Booster/Rechallenge Phase||5||
60102966|NCT01857869|76221072|FG007|STARTED|Booster/Rechallenge Phase||4||
60102967|NCT01857869|76221073|FG008|STARTED|Booster/Rechallenge Phase||3||
60102968|NCT01857869|76221074|FG009|STARTED|Booster/Rechallenge Phase||6||
60102969|NCT01857869|76221065|FG000|COMPLETED|Booster/Rechallenge Phase|GSK257049-0,1,7M, GSK257049-0,1,2M and Infectivity Control Groups were not included in Booster phase|0||
60102970|NCT01857869|76221066|FG001|COMPLETED|Booster/Rechallenge Phase|GSK257049-0,1,7M, GSK257049-0,1,2M and Infectivity Control Groups were not included in Booster phase|0||
59817185|NCT04891406|75939644|FG001|COMPLETED|Overall Study||4||
59817186|NCT04891406|75939645|FG002|COMPLETED|Overall Study||5||
59817187|NCT04891406|75939646|FG003|COMPLETED|Overall Study||5||
59817188|NCT04891406|75939647|FG004|COMPLETED|Overall Study||3||
59817189|NCT04891406|75939643|FG000|NOT COMPLETED|Overall Study||0||
59817190|NCT04891406|75939644|FG001|NOT COMPLETED|Overall Study||1||
59817191|NCT04891406|75939645|FG002|NOT COMPLETED|Overall Study||0||
59817192|NCT04891406|75939646|FG003|NOT COMPLETED|Overall Study||0||
59817193|NCT04891406|75939647|FG004|NOT COMPLETED|Overall Study||1||
60102971|NCT01857869|76221067|FG002|COMPLETED|Booster/Rechallenge Phase|GSK257049-0,1,7M, GSK257049-0,1,2M and Infectivity Control Groups were not included in Booster phase|0||
60102972|NCT01857869|76221068|FG003|COMPLETED|Booster/Rechallenge Phase||7||
60102973|NCT01857869|76221069|FG004|COMPLETED|Booster/Rechallenge Phase||10||
59817194|NCT04589663|75939659|FG000|STARTED|Overall Study||24||
59817195|NCT04589663|75939659|FG000|COMPLETED|Overall Study||24||
59817196|NCT04589663|75939659|FG000|NOT COMPLETED|Overall Study||0||
59817197|NCT04544475|75939669|FG000|STARTED|Overall Study||23||
59817198|NCT04544475|75939670|FG001|STARTED|Overall Study||26||
59817199|NCT04544475|75939669|FG000|COMPLETED|Overall Study||22||
60102974|NCT01857869|76221070|FG005|COMPLETED|Booster/Rechallenge Phase||2||
60102975|NCT01857869|76221071|FG006|COMPLETED|Booster/Rechallenge Phase||5||
60102976|NCT01857869|76221072|FG007|COMPLETED|Booster/Rechallenge Phase||4||
59817200|NCT04544475|75939670|FG001|COMPLETED|Overall Study||23||
59817201|NCT04544475|75939669|FG000|NOT COMPLETED|Overall Study||1||
59817202|NCT04544475|75939670|FG001|NOT COMPLETED|Overall Study||3||
59817203|NCT04457973|75939678|FG000|STARTED|Overall Study||20||
59817204|NCT04457973|75939679|FG001|STARTED|Overall Study||20||
59817205|NCT04457973|75939678|FG000|COMPLETED|Overall Study||20||
59817206|NCT04457973|75939679|FG001|COMPLETED|Overall Study||20||
59817207|NCT04457973|75939678|FG000|NOT COMPLETED|Overall Study||0||
59817208|NCT04457973|75939679|FG001|NOT COMPLETED|Overall Study||0||
60102977|NCT01857869|76221073|FG008|COMPLETED|Booster/Rechallenge Phase||3||
59817209|NCT04124939|75939687|FG000|STARTED|Overall Study||21||
59817210|NCT04124939|75939688|FG001|STARTED|Overall Study||20||
59817211|NCT04124939|75939687|FG000|COMPLETED|Overall Study||20||
59817212|NCT04124939|75939688|FG001|COMPLETED|Overall Study||17||
59817213|NCT04124939|75939687|FG000|NOT COMPLETED|Overall Study||1||
59817214|NCT04124939|75939688|FG001|NOT COMPLETED|Overall Study||3||
59817215|NCT04045613|75939701|FG000|STARTED|Overall Study||32||
59817216|NCT04045613|75939702|FG001|STARTED|Overall Study||14||
59817217|NCT04045613|75939703|FG002|STARTED|Overall Study||12||
59817218|NCT04045613|75939704|FG003|STARTED|Overall Study||2||
59817219|NCT04045613|75939705|FG004|STARTED|Overall Study||8||
59817220|NCT04045613|75939706|FG005|STARTED|Overall Study||10||
59708834|NCT01106157|75827661|FG001|STARTED|Overall Study||8||
59708835|NCT01106157|75827660|FG000|COMPLETED|Overall Study||16||
59708836|NCT01106157|75827661|FG001|COMPLETED|Overall Study||8||
59708837|NCT01106157|75827660|FG000|NOT COMPLETED|Overall Study||1||
59708838|NCT01106157|75827661|FG001|NOT COMPLETED|Overall Study||0||
59708839|NCT01094301|75827667|FG000|STARTED|Trial Stage||28||
59708840|NCT01094301|75827667|FG000|Subjects Who Received Smartpatch Lead|Trial Stage||28||
59708841|NCT01094301|75827667|FG000|COMPLETED|Trial Stage||27||
59708842|NCT01094301|75827667|FG000|NOT COMPLETED|Trial Stage||1||
59708843|NCT01094301|75827667|FG000|STARTED|Implant Stage||13|Trial Stage Subjects who were successful and considered for Implant Stage phase.|
59708844|NCT01094301|75827667|FG000|Met Criteria for Implant Stage|Implant Stage||7|(Trial stage success in original design, and a return of pain in the revised design)|
59708845|NCT01094301|75827667|FG000|Subjects Who Received SPR IPG|Implant Stage||5||
59708846|NCT01094301|75827667|FG000|COMPLETED|Implant Stage||5||
59708847|NCT01094301|75827667|FG000|NOT COMPLETED|Implant Stage||8||
59817221|NCT04045613|75939707|FG006|STARTED|Overall Study||17||
59817222|NCT04045613|75939701|FG000|COMPLETED|Overall Study||0||
59817223|NCT04045613|75939702|FG001|COMPLETED|Overall Study||0||
59817224|NCT04045613|75939703|FG002|COMPLETED|Overall Study||0||
59817225|NCT04045613|75939704|FG003|COMPLETED|Overall Study||0||
59817226|NCT04045613|75939705|FG004|COMPLETED|Overall Study||0||
59817227|NCT04045613|75939706|FG005|COMPLETED|Overall Study||0||
59817228|NCT04045613|75939707|FG006|COMPLETED|Overall Study||0||
59817229|NCT04045613|75939701|FG000|NOT COMPLETED|Overall Study||32||
59817230|NCT04045613|75939702|FG001|NOT COMPLETED|Overall Study||14||
59817231|NCT04045613|75939703|FG002|NOT COMPLETED|Overall Study||12||
60102978|NCT01857869|76221074|FG009|COMPLETED|Booster/Rechallenge Phase||6||
60102979|NCT01857869|76221065|FG000|NOT COMPLETED|Booster/Rechallenge Phase||0||
60102980|NCT01857869|76221066|FG001|NOT COMPLETED|Booster/Rechallenge Phase||0||
60102981|NCT01857869|76221067|FG002|NOT COMPLETED|Booster/Rechallenge Phase||0||
60102982|NCT01857869|76221068|FG003|NOT COMPLETED|Booster/Rechallenge Phase||2||
60102983|NCT01857869|76221069|FG004|NOT COMPLETED|Booster/Rechallenge Phase||0||
60102984|NCT01857869|76221070|FG005|NOT COMPLETED|Booster/Rechallenge Phase||0||
60102985|NCT01857869|76221071|FG006|NOT COMPLETED|Booster/Rechallenge Phase||0||
60102986|NCT01857869|76221072|FG007|NOT COMPLETED|Booster/Rechallenge Phase||0||
60102987|NCT01857869|76221073|FG008|NOT COMPLETED|Booster/Rechallenge Phase||0||
60102988|NCT01857869|76221074|FG009|NOT COMPLETED|Booster/Rechallenge Phase||0||
60102989|NCT01230424|76221099|FG000|STARTED|Overall Study||70||
60102990|NCT01230424|76221100|FG001|STARTED|Overall Study||70||
60102991|NCT01230424|76221099|FG000|COMPLETED|Overall Study||70||
60102992|NCT01230424|76221100|FG001|COMPLETED|Overall Study||70||
60102993|NCT01230424|76221099|FG000|NOT COMPLETED|Overall Study||0||
59708848|NCT01093755|75827675|FG000|STARTED|Overall Study||16||
59817232|NCT04045613|75939704|FG003|NOT COMPLETED|Overall Study||2||
59817233|NCT04045613|75939705|FG004|NOT COMPLETED|Overall Study||8||
59817234|NCT04045613|75939706|FG005|NOT COMPLETED|Overall Study||10||
59817235|NCT04045613|75939707|FG006|NOT COMPLETED|Overall Study||17||
59817236|NCT03964207|75939737|FG000|STARTED|First Treatment||37|Randomized|
59817237|NCT03964207|75939738|FG001|STARTED|First Treatment||35|Randomized|
59817238|NCT03964207|75939737|FG000|Treated|First Treatment||36||
59817239|NCT03964207|75939738|FG001|Treated|First Treatment||35||
59817240|NCT03964207|75939737|FG000|COMPLETED|First Treatment||34||
59817241|NCT03964207|75939738|FG001|COMPLETED|First Treatment||33||
59817242|NCT03964207|75939737|FG000|NOT COMPLETED|First Treatment||3||
59817243|NCT03964207|75939738|FG001|NOT COMPLETED|First Treatment||2||
59817244|NCT03964207|75939737|FG000|STARTED|Second Treatment||34||
60102994|NCT01230424|76221100|FG001|NOT COMPLETED|Overall Study||0||
60102995|NCT01230502|76221112|FG000|STARTED|Overall Study||9||
60102996|NCT01230502|76221113|FG001|STARTED|Overall Study||0||
60102997|NCT01230502|76221114|FG002|STARTED|Overall Study||0||
60102998|NCT01230502|76221112|FG000|COMPLETED|Overall Study||9||
60102999|NCT01230502|76221113|FG001|COMPLETED|Overall Study||0||
60103000|NCT01230502|76221114|FG002|COMPLETED|Overall Study||0||
60103001|NCT01230502|76221112|FG000|NOT COMPLETED|Overall Study||0||
60103002|NCT01230502|76221113|FG001|NOT COMPLETED|Overall Study||0||
60103003|NCT01230502|76221114|FG002|NOT COMPLETED|Overall Study||0||
60103004|NCT01160848|76221127|FG000|STARTED|Overall Study||12||
60103005|NCT01160848|76221128|FG001|STARTED|Overall Study||8||
60103006|NCT01160848|76221127|FG000|COMPLETED|Overall Study||12||
60103007|NCT01160848|76221128|FG001|COMPLETED|Overall Study||8||
60103008|NCT01160848|76221127|FG000|NOT COMPLETED|Overall Study||0||
60103009|NCT01160848|76221128|FG001|NOT COMPLETED|Overall Study||0||
60103010|NCT01213576|76221142|FG000|STARTED|Overall Study||18||
60103011|NCT01213576|76221143|FG001|STARTED|Overall Study||17||
60103012|NCT01213576|76221144|FG002|STARTED|Overall Study||18||
60103013|NCT01213576|76221145|FG003|STARTED|Overall Study||17||
60103014|NCT01213576|76221142|FG000|COMPLETED|Overall Study||15||
60103015|NCT01213576|76221143|FG001|COMPLETED|Overall Study||13||
60103016|NCT01213576|76221144|FG002|COMPLETED|Overall Study||13||
59565529|NCT01837550|75667862|FG001|STARTED|T0-T2, 6 Months Follow-up||37||
59708849|NCT01093755|75827676|FG001|STARTED|Overall Study||14||
59708850|NCT01093755|75827675|FG000|COMPLETED|Overall Study||13||
59708851|NCT01093755|75827676|FG001|COMPLETED|Overall Study||10||
59708852|NCT01093755|75827675|FG000|NOT COMPLETED|Overall Study||3||
59708853|NCT01093755|75827676|FG001|NOT COMPLETED|Overall Study||4||
59708854|NCT01093599|75827684|FG000|STARTED|Overall Study||91||
59708855|NCT01093599|75827685|FG001|STARTED|Overall Study||105||
59708856|NCT01093599|75827684|FG000|COMPLETED|Overall Study||59||
59708857|NCT01093599|75827685|FG001|COMPLETED|Overall Study||59||
59708858|NCT01093599|75827684|FG000|NOT COMPLETED|Overall Study||32||
59708859|NCT01093599|75827685|FG001|NOT COMPLETED|Overall Study||46||
59708860|NCT01092663|75827693|FG000|STARTED|Overall Study||31||
59708861|NCT01092663|75827694|FG001|STARTED|Overall Study||30||
59708862|NCT01092663|75827693|FG000|COMPLETED|Overall Study||24||
59708863|NCT01092663|75827694|FG001|COMPLETED|Overall Study||26||
59708864|NCT01092663|75827693|FG000|NOT COMPLETED|Overall Study||7||
59708865|NCT01092663|75827694|FG001|NOT COMPLETED|Overall Study||4||
59708866|NCT01078623|75827705|FG000|STARTED|Treatment Period 1||6||
59708867|NCT01078623|75827706|FG001|STARTED|Treatment Period 1||6||
59708868|NCT01078623|75827707|FG002|STARTED|Treatment Period 1||7||
59708869|NCT01078623|75827708|FG003|STARTED|Treatment Period 1||6||
59708870|NCT01078623|75827709|FG004|STARTED|Treatment Period 1||7||
59708871|NCT01078623|75827710|FG005|STARTED|Treatment Period 1||6||
59817245|NCT03964207|75939738|FG001|STARTED|Second Treatment||33||
59817246|NCT03964207|75939737|FG000|COMPLETED|Second Treatment||33||
60103017|NCT01213576|76221145|FG003|COMPLETED|Overall Study||13||
60103018|NCT01213576|76221142|FG000|NOT COMPLETED|Overall Study||3||
60103019|NCT01213576|76221143|FG001|NOT COMPLETED|Overall Study||4||
60103020|NCT01213576|76221144|FG002|NOT COMPLETED|Overall Study||5||
60103021|NCT01213576|76221145|FG003|NOT COMPLETED|Overall Study||4||
60103022|NCT04452318|76221162|FG000|STARTED|Overall Study||1430||
60103023|NCT04452318|76221163|FG001|STARTED|Overall Study||1441||
60103024|NCT04452318|76221164|FG002|STARTED|Overall Study||1||
60103025|NCT04452318|76221165|FG003|STARTED|Overall Study||173||
59708872|NCT01078623|75827711|FG006|STARTED|Treatment Period 1||7||
59708873|NCT01078623|75827712|FG007|STARTED|Treatment Period 1||7||
59708874|NCT01078623|75827713|FG008|STARTED|Treatment Period 1||6||
59708875|NCT01078623|75827714|FG009|STARTED|Treatment Period 1||7||
59708876|NCT01078623|75827715|FG010|STARTED|Treatment Period 1||7||
59708877|NCT01078623|75827716|FG011|STARTED|Treatment Period 1||7||
60103026|NCT04452318|76221166|FG004|STARTED|Overall Study||166||
60103027|NCT04452318|76221167|FG005|STARTED|Overall Study||53||
60103028|NCT04452318|76221168|FG006|STARTED|Overall Study||34||
60103029|NCT04452318|76221162|FG000|Randomized and Treated|Overall Study||1428||
60103030|NCT04452318|76221163|FG001|Randomized and Treated|Overall Study||1439||
60103031|NCT04452318|76221164|FG002|Randomized and Treated|Overall Study||1||
60103032|NCT04452318|76221165|FG003|Randomized and Treated|Overall Study||170||
60103033|NCT04452318|76221166|FG004|Randomized and Treated|Overall Study||165||
60103034|NCT04452318|76221167|FG005|Randomized and Treated|Overall Study||44||
60103035|NCT04452318|76221168|FG006|Randomized and Treated|Overall Study||23||
60103036|NCT04452318|76221162|FG000|COMPLETED|Overall Study||1343||
60103037|NCT04452318|76221163|FG001|COMPLETED|Overall Study||1368||
59565530|NCT01837550|75667861|FG000|COMPLETED|T0-T2, 6 Months Follow-up||37||
59565531|NCT01837550|75667862|FG001|COMPLETED|T0-T2, 6 Months Follow-up||37||
59565532|NCT01837550|75667861|FG000|NOT COMPLETED|T0-T2, 6 Months Follow-up||0||
59565533|NCT01837550|75667862|FG001|NOT COMPLETED|T0-T2, 6 Months Follow-up||0||
59565534|NCT04452435|75667870|FG000|STARTED|Screening||51||
59565535|NCT04452435|75667871|FG001|STARTED|Screening||55||
59708878|NCT01078623|75827717|FG012|STARTED|Treatment Period 1||7||
59708879|NCT01078623|75827718|FG013|STARTED|Treatment Period 1||7||
59708880|NCT01078623|75827719|FG014|STARTED|Treatment Period 1||7||
59708881|NCT01078623|75827720|FG015|STARTED|Treatment Period 1||7||
59708882|NCT01078623|75827721|FG016|STARTED|Treatment Period 1||7||
59708883|NCT01078623|75827722|FG017|STARTED|Treatment Period 1||7||
59817247|NCT03964207|75939738|FG001|COMPLETED|Second Treatment||30||
59565536|NCT04452435|75667870|FG000|COMPLETED|Screening||51||
59565537|NCT04452435|75667871|FG001|COMPLETED|Screening||55||
59565538|NCT04452435|75667870|FG000|NOT COMPLETED|Screening||0||
59708884|NCT01078623|75827723|FG018|STARTED|Treatment Period 1||7||
59708885|NCT01078623|75827724|FG019|STARTED|Treatment Period 1||7||
59708886|NCT01078623|75827705|FG000|COMPLETED|Treatment Period 1||5||
59817248|NCT03964207|75939737|FG000|NOT COMPLETED|Second Treatment||1||
59817249|NCT03964207|75939738|FG001|NOT COMPLETED|Second Treatment||3||
59817250|NCT03947255|75939747|FG000|STARTED|Overall Study||6||
59994650|NCT01936857|76110434|FG001|STARTED|Overall Study||140||
59994651|NCT01936857|76110433|FG000|COMPLETED|Overall Study||107||
59994652|NCT01936857|76110434|FG001|COMPLETED|Overall Study||115||
59565539|NCT04452435|75667871|FG001|NOT COMPLETED|Screening||0||
59994653|NCT01936857|76110433|FG000|NOT COMPLETED|Overall Study||34||
59565540|NCT04452435|75667870|FG000|STARTED|Treatment Period||51||
59565541|NCT04452435|75667871|FG001|STARTED|Treatment Period||55||
59565542|NCT04452435|75667870|FG000|COMPLETED|Treatment Period||45||
59708887|NCT01078623|75827706|FG001|COMPLETED|Treatment Period 1||5||
59708888|NCT01078623|75827707|FG002|COMPLETED|Treatment Period 1||6||
59994654|NCT01936857|76110434|FG001|NOT COMPLETED|Overall Study||25||
59994655|NCT01602224|76110443|FG000|STARTED|Overall Study||74||
59994656|NCT01602224|76110444|FG001|STARTED|Overall Study||74||
59994657|NCT01602224|76110445|FG002|STARTED|Overall Study||72||
59994658|NCT01602224|76110443|FG000|Received at Least 1 Dose of Study Drug|Overall Study||73||
59994659|NCT01602224|76110444|FG001|Received at Least 1 Dose of Study Drug|Overall Study||74||
59708889|NCT01078623|75827708|FG003|COMPLETED|Treatment Period 1||6||
59708890|NCT01078623|75827709|FG004|COMPLETED|Treatment Period 1||7||
59817251|NCT03947255|75939748|FG001|STARTED|Overall Study||6||
59994660|NCT01602224|76110445|FG002|Received at Least 1 Dose of Study Drug|Overall Study||72||
60103038|NCT04452318|76221164|FG002|COMPLETED|Overall Study||1||
60103039|NCT04452318|76221165|FG003|COMPLETED|Overall Study||150||
59565543|NCT04452435|75667871|FG001|COMPLETED|Treatment Period||43||
59565544|NCT04452435|75667870|FG000|NOT COMPLETED|Treatment Period||6||
59708891|NCT01078623|75827710|FG005|COMPLETED|Treatment Period 1||5||
59708892|NCT01078623|75827711|FG006|COMPLETED|Treatment Period 1||6||
59817252|NCT03947255|75939747|FG000|COMPLETED|Overall Study||0||
59817253|NCT03947255|75939748|FG001|COMPLETED|Overall Study||0||
59817254|NCT03947255|75939747|FG000|NOT COMPLETED|Overall Study||6||
59817255|NCT03947255|75939748|FG001|NOT COMPLETED|Overall Study||6||
59708893|NCT01078623|75827712|FG007|COMPLETED|Treatment Period 1||6||
59708894|NCT01078623|75827713|FG008|COMPLETED|Treatment Period 1||5||
59708895|NCT01078623|75827714|FG009|COMPLETED|Treatment Period 1||6||
59708896|NCT01078623|75827715|FG010|COMPLETED|Treatment Period 1||6||
59708897|NCT01078623|75827716|FG011|COMPLETED|Treatment Period 1||7||
59708898|NCT01078623|75827717|FG012|COMPLETED|Treatment Period 1||7||
59708899|NCT01078623|75827718|FG013|COMPLETED|Treatment Period 1||7||
59817256|NCT03929757|75939756|FG000|STARTED|Main Study: Up to Day 365||75||
59817257|NCT03929757|75939757|FG001|STARTED|Main Study: Up to Day 365||33||
60103040|NCT04452318|76221166|FG004|COMPLETED|Overall Study||157||
60103041|NCT04452318|76221167|FG005|COMPLETED|Overall Study||41||
60103042|NCT04452318|76221168|FG006|COMPLETED|Overall Study||22||
59565545|NCT04452435|75667871|FG001|NOT COMPLETED|Treatment Period||12||
59565546|NCT04452435|75667870|FG000|STARTED|Follow-up||45||
59817258|NCT03929757|75939758|FG002|STARTED|Main Study: Up to Day 365||0||
59817259|NCT03929757|75939756|FG000|COMPLETED|Main Study: Up to Day 365||72||
59817260|NCT03929757|75939757|FG001|COMPLETED|Main Study: Up to Day 365||33||
59994661|NCT01602224|76110443|FG000|COMPLETED|Overall Study||66||
59565547|NCT04452435|75667871|FG001|STARTED|Follow-up||43||
59565548|NCT04452435|75667870|FG000|COMPLETED|Follow-up||45||
59565549|NCT04452435|75667871|FG001|COMPLETED|Follow-up||42||
59565550|NCT04452435|75667870|FG000|NOT COMPLETED|Follow-up||0||
59565551|NCT04452435|75667871|FG001|NOT COMPLETED|Follow-up||1||
59565552|NCT04410159|75667882|FG000|STARTED|Overall Study||5||
59565553|NCT04410159|75667883|FG001|STARTED|Overall Study||5||
59565554|NCT04410159|75667884|FG002|STARTED|Overall Study||5||
59565555|NCT04410159|75667885|FG003|STARTED|Overall Study||5||
59565556|NCT04410159|75667882|FG000|COMPLETED|Overall Study||5||
59565557|NCT04410159|75667883|FG001|COMPLETED|Overall Study||5||
59565558|NCT04410159|75667884|FG002|COMPLETED|Overall Study||5||
59565559|NCT04410159|75667885|FG003|COMPLETED|Overall Study||5||
59565560|NCT04410159|75667882|FG000|NOT COMPLETED|Overall Study||0||
59565561|NCT04410159|75667883|FG001|NOT COMPLETED|Overall Study||0||
59565562|NCT04410159|75667884|FG002|NOT COMPLETED|Overall Study||0||
59565563|NCT04410159|75667885|FG003|NOT COMPLETED|Overall Study||0||
59565564|NCT00559988|75667897|FG000|STARTED|Overall Study||1357||
59565565|NCT00559988|75667898|FG001|STARTED|Overall Study||1361||
59565566|NCT00559988|75667897|FG000|COMPLETED|Overall Study||1006||
59565567|NCT00559988|75667898|FG001|COMPLETED|Overall Study||1009||
59565568|NCT00559988|75667897|FG000|NOT COMPLETED|Overall Study||351||
59565569|NCT00559988|75667898|FG001|NOT COMPLETED|Overall Study||352||
59565570|NCT03398265|75667906|FG000|STARTED|Overall Study||7||
59565571|NCT03398265|75667907|FG001|STARTED|Overall Study||8||
59708900|NCT01078623|75827719|FG014|COMPLETED|Treatment Period 1||7||
59708901|NCT01078623|75827720|FG015|COMPLETED|Treatment Period 1||7||
59565572|NCT03398265|75667906|FG000|COMPLETED|Overall Study||7||
59708902|NCT01078623|75827721|FG016|COMPLETED|Treatment Period 1||7||
59708903|NCT01078623|75827722|FG017|COMPLETED|Treatment Period 1||7||
59708904|NCT01078623|75827723|FG018|COMPLETED|Treatment Period 1||7||
59817261|NCT03929757|75939758|FG002|COMPLETED|Main Study: Up to Day 365||0||
59817262|NCT03929757|75939756|FG000|NOT COMPLETED|Main Study: Up to Day 365||3||
59817263|NCT03929757|75939757|FG001|NOT COMPLETED|Main Study: Up to Day 365||0||
59817264|NCT03929757|75939758|FG002|NOT COMPLETED|Main Study: Up to Day 365||0||
59817265|NCT03929757|75939756|FG000|STARTED|Extension Study: Up to Extension Day 85||0||
59994662|NCT01602224|76110444|FG001|COMPLETED|Overall Study||66||
59994663|NCT01602224|76110445|FG002|COMPLETED|Overall Study||66||
59994664|NCT01602224|76110443|FG000|NOT COMPLETED|Overall Study||8||
59994665|NCT01602224|76110444|FG001|NOT COMPLETED|Overall Study||8||
59994666|NCT01602224|76110445|FG002|NOT COMPLETED|Overall Study||6||
59994667|NCT04498247|76110463|FG000|STARTED|Overall Study||21||
59994668|NCT04498247|76110464|FG001|STARTED|Overall Study||80||
59994669|NCT04498247|76110465|FG002|STARTED|Overall Study||4||
59994670|NCT04498247|76110466|FG003|STARTED|Overall Study||81||
59994671|NCT04498247|76110467|FG004|STARTED|Overall Study||4||
59708905|NCT01078623|75827724|FG019|COMPLETED|Treatment Period 1||7||
59708906|NCT01078623|75827705|FG000|NOT COMPLETED|Treatment Period 1||1||
59708907|NCT01078623|75827706|FG001|NOT COMPLETED|Treatment Period 1||1||
59708908|NCT01078623|75827707|FG002|NOT COMPLETED|Treatment Period 1||1||
59708909|NCT01078623|75827708|FG003|NOT COMPLETED|Treatment Period 1||0||
59817266|NCT03929757|75939757|FG001|STARTED|Extension Study: Up to Extension Day 85||0||
59817267|NCT03929757|75939758|FG002|STARTED|Extension Study: Up to Extension Day 85|Only eligible participants entered extension study|26||
59817268|NCT03929757|75939756|FG000|COMPLETED|Extension Study: Up to Extension Day 85||0||
60103043|NCT04452318|76221162|FG000|NOT COMPLETED|Overall Study||87||
60103044|NCT04452318|76221163|FG001|NOT COMPLETED|Overall Study||73||
60103045|NCT04452318|76221164|FG002|NOT COMPLETED|Overall Study||0||
60103046|NCT04452318|76221165|FG003|NOT COMPLETED|Overall Study||23||
60103047|NCT04452318|76221166|FG004|NOT COMPLETED|Overall Study||9||
60103048|NCT04452318|76221167|FG005|NOT COMPLETED|Overall Study||12||
60103049|NCT04452318|76221168|FG006|NOT COMPLETED|Overall Study||12||
60103050|NCT01161160|76221192|FG000|STARTED|Overall Study||76||
60103051|NCT01161160|76221193|FG001|STARTED|Overall Study||75||
60103052|NCT01161160|76221194|FG002|STARTED|Overall Study||58||
60103053|NCT01161160|76221192|FG000|COMPLETED|Overall Study||76||
60103054|NCT01161160|76221193|FG001|COMPLETED|Overall Study||75||
60103055|NCT01161160|76221194|FG002|COMPLETED|Overall Study||58||
60103056|NCT01161160|76221192|FG000|NOT COMPLETED|Overall Study||0||
60103057|NCT01161160|76221193|FG001|NOT COMPLETED|Overall Study||0||
60103058|NCT01161160|76221194|FG002|NOT COMPLETED|Overall Study||0||
60103059|NCT01161862|76221204|FG000|STARTED|Overall Study||12||
60103060|NCT01161862|76221205|FG001|STARTED|Overall Study||12||
59565573|NCT03398265|75667907|FG001|COMPLETED|Overall Study||8||
59565574|NCT03398265|75667906|FG000|NOT COMPLETED|Overall Study||0||
59565575|NCT03398265|75667907|FG001|NOT COMPLETED|Overall Study||0||
59565576|NCT03398421|75667914|FG000|STARTED|Treatment Period 1 (Up to 6 Days)||20||
59565577|NCT03398421|75667915|FG001|STARTED|Treatment Period 1 (Up to 6 Days)||0||
59565578|NCT03398421|75667914|FG000|COMPLETED|Treatment Period 1 (Up to 6 Days)||20||
59565579|NCT03398421|75667915|FG001|COMPLETED|Treatment Period 1 (Up to 6 Days)||0||
59565580|NCT03398421|75667914|FG000|NOT COMPLETED|Treatment Period 1 (Up to 6 Days)||0||
59565581|NCT03398421|75667915|FG001|NOT COMPLETED|Treatment Period 1 (Up to 6 Days)||0||
59565582|NCT03398421|75667914|FG000|STARTED|Washout Period (Up to 14 Days)||20||
59565583|NCT03398421|75667915|FG001|STARTED|Washout Period (Up to 14 Days)||0||
59565584|NCT03398421|75667914|FG000|COMPLETED|Washout Period (Up to 14 Days)||20||
59565585|NCT03398421|75667915|FG001|COMPLETED|Washout Period (Up to 14 Days)||0||
59565586|NCT03398421|75667914|FG000|NOT COMPLETED|Washout Period (Up to 14 Days)||0||
59708910|NCT01078623|75827709|FG004|NOT COMPLETED|Treatment Period 1||0||
59565587|NCT03398421|75667915|FG001|NOT COMPLETED|Washout Period (Up to 14 Days)||0||
59565588|NCT03398421|75667914|FG000|STARTED|Treatment Period 2 (Up to 11 Days)||0||
59708911|NCT01078623|75827710|FG005|NOT COMPLETED|Treatment Period 1||1||
59708912|NCT01078623|75827711|FG006|NOT COMPLETED|Treatment Period 1||1||
59708913|NCT01078623|75827712|FG007|NOT COMPLETED|Treatment Period 1||1||
59708914|NCT01078623|75827713|FG008|NOT COMPLETED|Treatment Period 1||1||
59708915|NCT01078623|75827714|FG009|NOT COMPLETED|Treatment Period 1||1||
59708916|NCT01078623|75827715|FG010|NOT COMPLETED|Treatment Period 1||1||
59708917|NCT01078623|75827716|FG011|NOT COMPLETED|Treatment Period 1||0||
59708918|NCT01078623|75827717|FG012|NOT COMPLETED|Treatment Period 1||0||
59708919|NCT01078623|75827718|FG013|NOT COMPLETED|Treatment Period 1||0||
59817269|NCT03929757|75939757|FG001|COMPLETED|Extension Study: Up to Extension Day 85||0||
59708920|NCT01078623|75827719|FG014|NOT COMPLETED|Treatment Period 1||0||
59708921|NCT01078623|75827720|FG015|NOT COMPLETED|Treatment Period 1||0||
59708922|NCT01078623|75827721|FG016|NOT COMPLETED|Treatment Period 1||0||
59708923|NCT01078623|75827722|FG017|NOT COMPLETED|Treatment Period 1||0||
59708924|NCT01078623|75827723|FG018|NOT COMPLETED|Treatment Period 1||0||
59708925|NCT01078623|75827724|FG019|NOT COMPLETED|Treatment Period 1||0||
60103061|NCT01161862|76221204|FG000|COMPLETED|Overall Study||12||
60103062|NCT01161862|76221205|FG001|COMPLETED|Overall Study||12||
60103063|NCT01161862|76221204|FG000|NOT COMPLETED|Overall Study||0||
60103064|NCT01161862|76221205|FG001|NOT COMPLETED|Overall Study||0||
60103065|NCT01214356|76221216|FG000|STARTED|Overall Study||27||
60103066|NCT01214356|76221217|FG001|STARTED|Overall Study||27||
60103067|NCT01214356|76221216|FG000|COMPLETED|Overall Study||10||
60103068|NCT01214356|76221217|FG001|COMPLETED|Overall Study||13||
59708926|NCT01078623|75827705|FG000|STARTED|Treatment Period 2||5||
59817270|NCT03929757|75939758|FG002|COMPLETED|Extension Study: Up to Extension Day 85||25||
59817271|NCT03929757|75939756|FG000|NOT COMPLETED|Extension Study: Up to Extension Day 85||0||
59817272|NCT03929757|75939757|FG001|NOT COMPLETED|Extension Study: Up to Extension Day 85||0||
59817273|NCT03929757|75939758|FG002|NOT COMPLETED|Extension Study: Up to Extension Day 85||1||
59817274|NCT03748823|75939767|FG000|STARTED|Randomized Treatment Period||46||
59708927|NCT01078623|75827706|FG001|STARTED|Treatment Period 2||5||
59708928|NCT01078623|75827707|FG002|STARTED|Treatment Period 2||6||
59708929|NCT01078623|75827708|FG003|STARTED|Treatment Period 2||6||
59708930|NCT01078623|75827709|FG004|STARTED|Treatment Period 2||7||
59708931|NCT01078623|75827710|FG005|STARTED|Treatment Period 2||5||
59817275|NCT03748823|75939768|FG001|STARTED|Randomized Treatment Period||90||
59817276|NCT03748823|75939767|FG000|Received at Least 1 Dose of Study Drug|Randomized Treatment Period||46||
59817277|NCT03748823|75939768|FG001|Received at Least 1 Dose of Study Drug|Randomized Treatment Period||90||
59994672|NCT04498247|76110468|FG005|STARTED|Overall Study||20||
59994673|NCT04498247|76110469|FG006|STARTED|Overall Study||51||
59994674|NCT04498247|76110470|FG007|STARTED|Overall Study||2||
59994675|NCT04498247|76110463|FG000|Vaccination 1|Overall Study||20||
59994676|NCT04498247|76110464|FG001|Vaccination 1|Overall Study||80||
59994677|NCT04498247|76110465|FG002|Vaccination 1|Overall Study||4||
59994678|NCT04498247|76110466|FG003|Vaccination 1|Overall Study||81||
59994679|NCT04498247|76110467|FG004|Vaccination 1|Overall Study||4||
59994680|NCT04498247|76110468|FG005|Vaccination 1|Overall Study||20||
59994681|NCT04498247|76110469|FG006|Vaccination 1|Overall Study||51||
59994682|NCT04498247|76110470|FG007|Vaccination 1|Overall Study||2||
59994683|NCT04498247|76110463|FG000|Vaccination 2|Overall Study||0||
59994684|NCT04498247|76110464|FG001|Vaccination 2|Overall Study||0||
59994685|NCT04498247|76110465|FG002|Vaccination 2|Overall Study||4||
59994686|NCT04498247|76110466|FG003|Vaccination 2|Overall Study||0||
59994687|NCT04498247|76110467|FG004|Vaccination 2|Overall Study||4||
59994688|NCT04498247|76110468|FG005|Vaccination 2|Overall Study||0||
59994689|NCT04498247|76110469|FG006|Vaccination 2|Overall Study||0||
59994690|NCT04498247|76110470|FG007|Vaccination 2|Overall Study||2||
59994691|NCT04498247|76110463|FG000|COMPLETED|Overall Study||20||
59994692|NCT04498247|76110464|FG001|COMPLETED|Overall Study||68||
59994693|NCT04498247|76110465|FG002|COMPLETED|Overall Study||4||
59994694|NCT04498247|76110466|FG003|COMPLETED|Overall Study||70||
59994695|NCT04498247|76110467|FG004|COMPLETED|Overall Study||4||
60103069|NCT01214356|76221216|FG000|NOT COMPLETED|Overall Study||17||
60103070|NCT01214356|76221217|FG001|NOT COMPLETED|Overall Study||14||
59708932|NCT01078623|75827711|FG006|STARTED|Treatment Period 2||6||
59708933|NCT01078623|75827712|FG007|STARTED|Treatment Period 2||6||
59708934|NCT01078623|75827713|FG008|STARTED|Treatment Period 2||5||
59708935|NCT01078623|75827714|FG009|STARTED|Treatment Period 2||6||
59708936|NCT01078623|75827715|FG010|STARTED|Treatment Period 2||6||
59708937|NCT01078623|75827716|FG011|STARTED|Treatment Period 2||7||
59708938|NCT01078623|75827717|FG012|STARTED|Treatment Period 2||7||
59708939|NCT01078623|75827718|FG013|STARTED|Treatment Period 2||7||
59708940|NCT01078623|75827719|FG014|STARTED|Treatment Period 2||7||
59994696|NCT04498247|76110468|FG005|COMPLETED|Overall Study||20||
60103071|NCT01214824|76221223|FG000|STARTED|Overall Study||32||
59994697|NCT04498247|76110469|FG006|COMPLETED|Overall Study||43||
60103072|NCT01214824|76221223|FG000|COMPLETED|Overall Study||29||
59817278|NCT03748823|75939767|FG000|Treated and Not Included in Analysis|Randomized Treatment Period||1|Participants from 1 site with source documentation deviations and findings related to deficiencies in Investigator oversight.|
59817279|NCT03748823|75939768|FG001|Treated and Not Included in Analysis|Randomized Treatment Period||6|Participants from 1 site with source documentation deviations and findings related to deficiencies in Investigator oversight.|
59817280|NCT03748823|75939767|FG000|Full Analysis Set|Randomized Treatment Period||45|Participants who had signed informed consent, randomized, received at least 1 dose of ravulizumab (participants from one noncompliant site were excluded from analysis).|
59817281|NCT03748823|75939768|FG001|Full Analysis Set|Randomized Treatment Period||84|Participants who had signed informed consent, randomized, received at least 1 dose of ravulizumab (participants from one noncompliant site were excluded from analysis).|
59817282|NCT03748823|75939767|FG000|Safety Analysis Set|Randomized Treatment Period||45|All participants who received at least 1 dose of ravulizumab (participants from one noncompliant site were excluded from analysis).|
59817283|NCT03748823|75939768|FG001|Safety Analysis Set|Randomized Treatment Period||84|All participants who received at least 1 dose of ravulizumab (participants from one noncompliant site were excluded from analysis).|
59817284|NCT03748823|75939767|FG000|COMPLETED|Randomized Treatment Period||45||
59817285|NCT03748823|75939768|FG001|COMPLETED|Randomized Treatment Period||90||
59817286|NCT03748823|75939767|FG000|NOT COMPLETED|Randomized Treatment Period||1||
59817287|NCT03748823|75939768|FG001|NOT COMPLETED|Randomized Treatment Period||0||
59817288|NCT03748823|75939767|FG000|STARTED|Extension Period||45||
59817289|NCT03748823|75939768|FG001|STARTED|Extension Period|1 participant withdrew consent prior to entering the Extension Period|89||
59817290|NCT03748823|75939767|FG000|Received at Least 1 Dose of Study Drug|Extension Period||45||
59817291|NCT03748823|75939768|FG001|Received at Least 1 Dose of Study Drug|Extension Period||89||
59817292|NCT03748823|75939767|FG000|Treated But Not Included in the Analysis|Extension Period||1|Participants from 1 site with source documentation deviations and findings related to deficiencies in Investigator oversight.|
59817293|NCT03748823|75939768|FG001|Treated But Not Included in the Analysis|Extension Period||6|Participants from 1 site with source documentation deviations and findings related to deficiencies in Investigator oversight.|
59817294|NCT03748823|75939767|FG000|COMPLETED|Extension Period||2||
59817295|NCT03748823|75939768|FG001|COMPLETED|Extension Period||2||
59817296|NCT03748823|75939767|FG000|NOT COMPLETED|Extension Period||43||
59817297|NCT03748823|75939768|FG001|NOT COMPLETED|Extension Period||87||
59817298|NCT03598699|75939777|FG000|STARTED|Overall Study||54||
59817299|NCT03598699|75939778|FG001|STARTED|Overall Study||48||
59817300|NCT03598699|75939777|FG000|COMPLETED|Overall Study||45||
59817301|NCT03598699|75939778|FG001|COMPLETED|Overall Study||46||
59817302|NCT03598699|75939777|FG000|NOT COMPLETED|Overall Study||9||
59817303|NCT03598699|75939778|FG001|NOT COMPLETED|Overall Study||2||
59817304|NCT03548558|75939791|FG000|STARTED|Phase 1: 16 Total Fortnightly Sessions|173 households with 173 mothers, 173 children, and 70 fathers enrolled at baseline.|173||10
59817305|NCT03548558|75939792|FG001|STARTED|Phase 1: 16 Total Fortnightly Sessions|202 households with 202 mothers, 202 children, and 90 fathers enrolled at baseline.|202||10
59817306|NCT03548558|75939793|FG002|STARTED|Phase 1: 16 Total Fortnightly Sessions|201 households with 201 mothers, 201 children, and 87 fathers enrolled at baseline.|201||10
59817307|NCT03548558|75939794|FG003|STARTED|Phase 1: 16 Total Fortnightly Sessions|199 households with 199 mothers, 199 children, and 103 fathers enrolled at baseline.|199||10
60103073|NCT01214824|76221223|FG000|NOT COMPLETED|Overall Study||3||
60103074|NCT01214980|76221230|FG000|STARTED|Overall Study||16||
60103075|NCT01214980|76221231|FG001|STARTED|Overall Study||16||
60103076|NCT01214980|76221230|FG000|COMPLETED|Overall Study||13||
60103077|NCT01214980|76221231|FG001|COMPLETED|Overall Study||14||
59565589|NCT03398421|75667915|FG001|STARTED|Treatment Period 2 (Up to 11 Days)||20||
59565590|NCT03398421|75667914|FG000|COMPLETED|Treatment Period 2 (Up to 11 Days)||0||
60103078|NCT01214980|76221230|FG000|NOT COMPLETED|Overall Study||3||
60103079|NCT01214980|76221231|FG001|NOT COMPLETED|Overall Study||2||
60103080|NCT01232920|76221239|FG000|STARTED|Overall Study||41||
60103081|NCT01232920|76221240|FG001|STARTED|Overall Study||39||
60103082|NCT01232920|76221239|FG000|COMPLETED|Overall Study||35||
60103083|NCT01232920|76221240|FG001|COMPLETED|Overall Study||32||
59565591|NCT03398421|75667915|FG001|COMPLETED|Treatment Period 2 (Up to 11 Days)||20||
60103084|NCT01232920|76221239|FG000|NOT COMPLETED|Overall Study||6||
60103085|NCT01232920|76221240|FG001|NOT COMPLETED|Overall Study||7||
60103086|NCT01234714|76221246|FG000|STARTED|Overall Study||84||
59565592|NCT03398421|75667914|FG000|NOT COMPLETED|Treatment Period 2 (Up to 11 Days)||0||
59565593|NCT03398421|75667915|FG001|NOT COMPLETED|Treatment Period 2 (Up to 11 Days)||0||
59565594|NCT01839110|75667926|FG000|STARTED|Overall Study||7||
59565595|NCT01839110|75667927|FG001|STARTED|Overall Study||6||
59708941|NCT01078623|75827720|FG015|STARTED|Treatment Period 2||7||
59708942|NCT01078623|75827721|FG016|STARTED|Treatment Period 2||7||
59708943|NCT01078623|75827722|FG017|STARTED|Treatment Period 2||7||
59708944|NCT01078623|75827723|FG018|STARTED|Treatment Period 2||7||
59708945|NCT01078623|75827724|FG019|STARTED|Treatment Period 2||7||
59708946|NCT01078623|75827705|FG000|COMPLETED|Treatment Period 2||5||
59708947|NCT01078623|75827706|FG001|COMPLETED|Treatment Period 2||5||
59708948|NCT01078623|75827707|FG002|COMPLETED|Treatment Period 2||6||
59708949|NCT01078623|75827708|FG003|COMPLETED|Treatment Period 2||6||
59708950|NCT01078623|75827709|FG004|COMPLETED|Treatment Period 2||7||
59708951|NCT01078623|75827710|FG005|COMPLETED|Treatment Period 2||4||
59708952|NCT01078623|75827711|FG006|COMPLETED|Treatment Period 2||5||
59708953|NCT01078623|75827712|FG007|COMPLETED|Treatment Period 2||6||
59708954|NCT01078623|75827713|FG008|COMPLETED|Treatment Period 2||5||
60103087|NCT01234714|76221246|FG000|COMPLETED|Overall Study||84||
59708955|NCT01078623|75827714|FG009|COMPLETED|Treatment Period 2||6||
59708956|NCT01078623|75827715|FG010|COMPLETED|Treatment Period 2||6||
60103088|NCT01234714|76221246|FG000|NOT COMPLETED|Overall Study||0||
60103089|NCT01162096|76221253|FG000|STARTED|Overall Study||34||
59565596|NCT01839110|75667928|FG002|STARTED|Overall Study||9||
59565597|NCT01839110|75667926|FG000|COMPLETED|Overall Study||4||
59565598|NCT01839110|75667927|FG001|COMPLETED|Overall Study||4||
59565599|NCT01839110|75667928|FG002|COMPLETED|Overall Study||6||
59565600|NCT01839110|75667926|FG000|NOT COMPLETED|Overall Study||3||
59565601|NCT01839110|75667927|FG001|NOT COMPLETED|Overall Study||2||
59565602|NCT01839110|75667928|FG002|NOT COMPLETED|Overall Study||3||
59565603|NCT04396665|75667938|FG000|STARTED|Overall Study||134||
59565604|NCT04396665|75667939|FG001|STARTED|Overall Study||90||
59565605|NCT04396665|75667938|FG000|COMPLETED|Overall Study||99||
59708957|NCT01078623|75827716|FG011|COMPLETED|Treatment Period 2||7||
59708958|NCT01078623|75827717|FG012|COMPLETED|Treatment Period 2||7||
59565606|NCT04396665|75667939|FG001|COMPLETED|Overall Study||83||
59708959|NCT01078623|75827718|FG013|COMPLETED|Treatment Period 2||7||
59708960|NCT01078623|75827719|FG014|COMPLETED|Treatment Period 2||7||
59708961|NCT01078623|75827720|FG015|COMPLETED|Treatment Period 2||7||
59565607|NCT04396665|75667938|FG000|NOT COMPLETED|Overall Study||35||
59565608|NCT04396665|75667939|FG001|NOT COMPLETED|Overall Study||7||
59565609|NCT03400449|75667951|FG000|STARTED|Overall Study||121||
59565610|NCT03400449|75667952|FG001|STARTED|Overall Study||119||
59708962|NCT01078623|75827721|FG016|COMPLETED|Treatment Period 2||7||
59708963|NCT01078623|75827722|FG017|COMPLETED|Treatment Period 2||7||
59708964|NCT01078623|75827723|FG018|COMPLETED|Treatment Period 2||6||
59817308|NCT03548558|75939795|FG004|STARTED|Phase 1: 16 Total Fortnightly Sessions|377 households with 377 mothers, 377 children, and 162 fathers enrolled at baseline.|377||20
59817309|NCT03548558|75939796|FG005|STARTED|Phase 1: 16 Total Fortnightly Sessions|Booster village assignments were randomized after first phase to begin phase 2. Half of arm 1 and arm 2 villages were re-randomized into receiving boosters at this stage for a total of 20 villages, half from each of Arms 1 and 2.|0||0
59817310|NCT03548558|75939797|FG006|STARTED|Phase 1: 16 Total Fortnightly Sessions|Booster village assignments were randomized after first phase to begin phase 2. Half of arm 1 and arm 2 villages were re-randomized into receiving boosters at this stage for a total of 20 villages, the other 20 villages did not receive supplemental boosters.|0||0
59817311|NCT03548558|75939791|FG000|COMPLETED|Phase 1: 16 Total Fortnightly Sessions||161||10
59817312|NCT03548558|75939792|FG001|COMPLETED|Phase 1: 16 Total Fortnightly Sessions||185||10
59817313|NCT03548558|75939793|FG002|COMPLETED|Phase 1: 16 Total Fortnightly Sessions||191||10
59817314|NCT03548558|75939794|FG003|COMPLETED|Phase 1: 16 Total Fortnightly Sessions||182||10
59817315|NCT03548558|75939795|FG004|COMPLETED|Phase 1: 16 Total Fortnightly Sessions||351||20
59817316|NCT03548558|75939796|FG005|COMPLETED|Phase 1: 16 Total Fortnightly Sessions||0||0
59817317|NCT03548558|75939797|FG006|COMPLETED|Phase 1: 16 Total Fortnightly Sessions||0||0
60103090|NCT01162096|76221253|FG000|COMPLETED|Overall Study||34||
60103091|NCT01162096|76221253|FG000|NOT COMPLETED|Overall Study||0||
60103092|NCT01234870|76221258|FG000|STARTED|Overall Study||40||
60103093|NCT01234870|76221258|FG000|COMPLETED|Overall Study||40||
60103094|NCT01234870|76221258|FG000|NOT COMPLETED|Overall Study||0||
60103095|NCT01215292|76221268|FG000|STARTED|Overall Study||8||
60103096|NCT01215292|76221269|FG001|STARTED|Overall Study||8||
60103097|NCT01215292|76221270|FG002|STARTED|Overall Study||8||
59817318|NCT03548558|75939791|FG000|NOT COMPLETED|Phase 1: 16 Total Fortnightly Sessions||12||0
59817319|NCT03548558|75939792|FG001|NOT COMPLETED|Phase 1: 16 Total Fortnightly Sessions||17||0
59817320|NCT03548558|75939793|FG002|NOT COMPLETED|Phase 1: 16 Total Fortnightly Sessions||10||0
59817321|NCT03548558|75939794|FG003|NOT COMPLETED|Phase 1: 16 Total Fortnightly Sessions||17||0
59817322|NCT03548558|75939795|FG004|NOT COMPLETED|Phase 1: 16 Total Fortnightly Sessions||26||0
59817323|NCT03548558|75939796|FG005|NOT COMPLETED|Phase 1: 16 Total Fortnightly Sessions||0||0
59817324|NCT03548558|75939797|FG006|NOT COMPLETED|Phase 1: 16 Total Fortnightly Sessions||0||0
59817325|NCT03548558|75939791|FG000|STARTED|Phase 2: Booster Sessions Every 2 Months||0||0
59817326|NCT03548558|75939792|FG001|STARTED|Phase 2: Booster Sessions Every 2 Months||0||0
59565611|NCT03400449|75667951|FG000|COMPLETED|Overall Study||120||
59708965|NCT01078623|75827724|FG019|COMPLETED|Treatment Period 2||7||
59708966|NCT01078623|75827705|FG000|NOT COMPLETED|Treatment Period 2||0||
59708967|NCT01078623|75827706|FG001|NOT COMPLETED|Treatment Period 2||0||
59708968|NCT01078623|75827707|FG002|NOT COMPLETED|Treatment Period 2||0||
60103098|NCT01215292|76221271|FG003|STARTED|Overall Study||8||
60103099|NCT01215292|76221272|FG004|STARTED|Overall Study||8||
60103100|NCT01215292|76221268|FG000|COMPLETED|Overall Study||8||
60103101|NCT01215292|76221269|FG001|COMPLETED|Overall Study||8||
59708969|NCT01078623|75827708|FG003|NOT COMPLETED|Treatment Period 2||0||
59708970|NCT01078623|75827709|FG004|NOT COMPLETED|Treatment Period 2||0||
59708971|NCT01078623|75827710|FG005|NOT COMPLETED|Treatment Period 2||1||
60103102|NCT01215292|76221270|FG002|COMPLETED|Overall Study||8||
60103103|NCT01215292|76221271|FG003|COMPLETED|Overall Study||8||
60103104|NCT01215292|76221272|FG004|COMPLETED|Overall Study||8||
60103105|NCT01215292|76221268|FG000|NOT COMPLETED|Overall Study||0||
60103106|NCT01215292|76221269|FG001|NOT COMPLETED|Overall Study||0||
60103107|NCT01215292|76221270|FG002|NOT COMPLETED|Overall Study||0||
60103108|NCT01215292|76221271|FG003|NOT COMPLETED|Overall Study||0||
59565612|NCT03400449|75667952|FG001|COMPLETED|Overall Study||119||
59565613|NCT03400449|75667951|FG000|NOT COMPLETED|Overall Study||1||
59565614|NCT03400449|75667952|FG001|NOT COMPLETED|Overall Study||0||
59565615|NCT00559754|75667960|FG000|STARTED|Overall Study||72||
59565616|NCT00559754|75667960|FG000|COMPLETED|Overall Study||61||
59565617|NCT00559754|75667960|FG000|NOT COMPLETED|Overall Study||11||
59565618|NCT03402243|75667967|FG000|STARTED|Overall Study||16|Number of participants who were informed of their randomization and contributed to the analysis|
59565619|NCT03402243|75667968|FG001|STARTED|Overall Study||15|Number of participants who were informed of their randomization and contributed to the analysis|
59565620|NCT03402243|75667969|FG002|STARTED|Overall Study||16|Number of participants who were informed of their randomization and contributed to the analysis|
59565621|NCT03402243|75667967|FG000|COMPLETED|Overall Study||13||
59565622|NCT03402243|75667968|FG001|COMPLETED|Overall Study||12||
59565623|NCT03402243|75667969|FG002|COMPLETED|Overall Study||14||
59565624|NCT03402243|75667967|FG000|NOT COMPLETED|Overall Study||3||
59708972|NCT01078623|75827711|FG006|NOT COMPLETED|Treatment Period 2||1||
60103109|NCT01215292|76221272|FG004|NOT COMPLETED|Overall Study||0||
60103110|NCT02189668|76221294|FG000|STARTED|Overall Study||5||
59817327|NCT03548558|75939793|FG002|STARTED|Phase 2: Booster Sessions Every 2 Months||0||0
59817328|NCT03548558|75939794|FG003|STARTED|Phase 2: Booster Sessions Every 2 Months||0||0
59817329|NCT03548558|75939795|FG004|STARTED|Phase 2: Booster Sessions Every 2 Months|All originally enrolled households assigned to control villages remained eligible for inclusion in phase 2|377||20
59817330|NCT03548558|75939796|FG005|STARTED|Phase 2: Booster Sessions Every 2 Months|All originally enrolled households at baseline remained eligible for phase 2. Boosters were re-randomized across Arms 1 and 2 at conclusion of phase 1. The starting sample size of 394 for this phase subtracts 3 deaths that occurred between baseline and the first follow-up survey in these villages. Fathers not enrolled for phase 2.|394||20
59817331|NCT03548558|75939797|FG006|STARTED|Phase 2: Booster Sessions Every 2 Months|All originally enrolled households at baseline remained eligible for phase 2. Boosters were re-randomized across Arms 1 and 2 at conclusion of phase 1. The starting sample size for this phase subtracts 1 death that occurred between baseline and the first follow-up survey in these villages. Fathers not enrolled for phase 2.|378||20
60103111|NCT02189668|76221295|FG001|STARTED|Overall Study||9||
60103112|NCT02189668|76221294|FG000|COMPLETED|Overall Study||5||
60103113|NCT02189668|76221295|FG001|COMPLETED|Overall Study||9||
60103114|NCT02189668|76221294|FG000|NOT COMPLETED|Overall Study||0||
60103115|NCT02189668|76221295|FG001|NOT COMPLETED|Overall Study||0||
60103116|NCT01236196|76221303|FG000|STARTED|Overall Study||18||
60103117|NCT01236196|76221304|FG001|STARTED|Overall Study||21||
60103118|NCT01236196|76221303|FG000|COMPLETED|Overall Study||17||
60103119|NCT01236196|76221304|FG001|COMPLETED|Overall Study||13||
60103120|NCT01236196|76221303|FG000|NOT COMPLETED|Overall Study||1||
60103121|NCT01236196|76221304|FG001|NOT COMPLETED|Overall Study||8||
60103122|NCT01236742|76221313|FG000|STARTED|Overall Study||18||
60103123|NCT01236742|76221314|FG001|STARTED|Overall Study||19||
60103124|NCT01236742|76221315|FG002|STARTED|Overall Study||16||
60103125|NCT01236742|76221313|FG000|COMPLETED|Overall Study||15||
60103126|NCT01236742|76221314|FG001|COMPLETED|Overall Study||16||
60103127|NCT01236742|76221315|FG002|COMPLETED|Overall Study||13||
60103128|NCT01236742|76221313|FG000|NOT COMPLETED|Overall Study||3||
60103129|NCT01236742|76221314|FG001|NOT COMPLETED|Overall Study||3||
60103130|NCT01236742|76221315|FG002|NOT COMPLETED|Overall Study||3||
60103131|NCT01282138|76221325|FG000|STARTED|EEC||6||
60103132|NCT01282138|76221326|FG001|STARTED|EEC||7||
60103133|NCT01282138|76221325|FG000|COMPLETED|EEC||6||
60103134|NCT01282138|76221326|FG001|COMPLETED|EEC||7||
60103135|NCT01282138|76221325|FG000|NOT COMPLETED|EEC||0||
59565625|NCT03402243|75667968|FG001|NOT COMPLETED|Overall Study||3||
59565626|NCT03402243|75667969|FG002|NOT COMPLETED|Overall Study||2||
59565627|NCT03402555|75667977|FG000|STARTED|Overall Study||96||
59565628|NCT03402555|75667977|FG000|COMPLETED|Overall Study||91||
59708973|NCT01078623|75827712|FG007|NOT COMPLETED|Treatment Period 2||0||
59708974|NCT01078623|75827713|FG008|NOT COMPLETED|Treatment Period 2||0||
59708975|NCT01078623|75827714|FG009|NOT COMPLETED|Treatment Period 2||0||
59708976|NCT01078623|75827715|FG010|NOT COMPLETED|Treatment Period 2||0||
59708977|NCT01078623|75827716|FG011|NOT COMPLETED|Treatment Period 2||0||
59708978|NCT01078623|75827717|FG012|NOT COMPLETED|Treatment Period 2||0||
59708979|NCT01078623|75827718|FG013|NOT COMPLETED|Treatment Period 2||0||
59708980|NCT01078623|75827719|FG014|NOT COMPLETED|Treatment Period 2||0||
59708981|NCT01078623|75827720|FG015|NOT COMPLETED|Treatment Period 2||0||
59708982|NCT01078623|75827721|FG016|NOT COMPLETED|Treatment Period 2||0||
59708983|NCT01078623|75827722|FG017|NOT COMPLETED|Treatment Period 2||0||
59708984|NCT01078623|75827723|FG018|NOT COMPLETED|Treatment Period 2||1||
59708985|NCT01078623|75827724|FG019|NOT COMPLETED|Treatment Period 2||0||
59708986|NCT01078623|75827705|FG000|STARTED|Treatment Period 3||5||
59708987|NCT01078623|75827706|FG001|STARTED|Treatment Period 3||5||
59708988|NCT01078623|75827707|FG002|STARTED|Treatment Period 3||6||
59708989|NCT01078623|75827708|FG003|STARTED|Treatment Period 3||6||
59708990|NCT01078623|75827709|FG004|STARTED|Treatment Period 3||7||
59708991|NCT01078623|75827710|FG005|STARTED|Treatment Period 3||4||
59708992|NCT01078623|75827711|FG006|STARTED|Treatment Period 3||5||
59708993|NCT01078623|75827712|FG007|STARTED|Treatment Period 3||6||
60103136|NCT01282138|76221326|FG001|NOT COMPLETED|EEC||0||
60103137|NCT01282138|76221325|FG000|STARTED|CAPT||6||
60103138|NCT01282138|76221326|FG001|STARTED|CAPT||7||
60103139|NCT01282138|76221325|FG000|COMPLETED|CAPT||6||
59565629|NCT03402555|75667977|FG000|NOT COMPLETED|Overall Study||5||
59565630|NCT01841216|75667983|FG000|STARTED|Overall Study||15||
59565631|NCT01841216|75667984|FG001|STARTED|Overall Study||15||
59565632|NCT01841216|75667983|FG000|COMPLETED|Overall Study||15||
60103140|NCT01282138|76221326|FG001|COMPLETED|CAPT||7||
60103141|NCT01282138|76221325|FG000|NOT COMPLETED|CAPT||0||
60103142|NCT01282138|76221326|FG001|NOT COMPLETED|CAPT||0||
60103143|NCT01238536|76221334|FG000|STARTED|Overall Study||200||
60103144|NCT01238536|76221335|FG001|STARTED|Overall Study||200||
60103145|NCT01238536|76221334|FG000|COMPLETED|Overall Study||153||
60103146|NCT01238536|76221335|FG001|COMPLETED|Overall Study||150||
60103147|NCT01238536|76221334|FG000|NOT COMPLETED|Overall Study||47||
60103148|NCT01238536|76221335|FG001|NOT COMPLETED|Overall Study||50||
60103149|NCT00634101|76221345|FG000|STARTED|Overall Study||66||
60103150|NCT00634101|76221346|FG001|STARTED|Overall Study||59||
60103151|NCT00634101|76221345|FG000|COMPLETED|Overall Study||61||
59708994|NCT01078623|75827713|FG008|STARTED|Treatment Period 3||5||
59708995|NCT01078623|75827714|FG009|STARTED|Treatment Period 3||6||
59708996|NCT01078623|75827715|FG010|STARTED|Treatment Period 3||6||
59708997|NCT01078623|75827716|FG011|STARTED|Treatment Period 3||7||
60103152|NCT00634101|76221346|FG001|COMPLETED|Overall Study||56||
60103153|NCT00634101|76221345|FG000|NOT COMPLETED|Overall Study||5||
60103154|NCT00634101|76221346|FG001|NOT COMPLETED|Overall Study||3||
60103155|NCT01284244|76221354|FG000|STARTED|Overall Study||18||
60103156|NCT01284244|76221355|FG001|STARTED|Overall Study||18||
60103157|NCT01284244|76221354|FG000|COMPLETED|Overall Study||18||
59708998|NCT01078623|75827717|FG012|STARTED|Treatment Period 3||7||
60103158|NCT01284244|76221355|FG001|COMPLETED|Overall Study||18||
60103159|NCT01284244|76221354|FG000|NOT COMPLETED|Overall Study||0||
60103160|NCT01284244|76221355|FG001|NOT COMPLETED|Overall Study||0||
60103161|NCT00633477|76221363|FG000|STARTED|Overall Study|Seven subjects were randomized, however, one was not treated.|7||
60103162|NCT00633477|76221364|FG001|STARTED|Overall Study||11||
60103163|NCT00633477|76221363|FG000|Randomized But Not Treated|Overall Study||1||
60103164|NCT00633477|76221364|FG001|Randomized But Not Treated|Overall Study||0||
60103165|NCT00633477|76221363|FG000|Prematurely Discontinued Study Drug|Overall Study||1||
60103166|NCT00633477|76221364|FG001|Prematurely Discontinued Study Drug|Overall Study||0||
60103167|NCT00633477|76221363|FG000|Completed Study Through Day 28|Overall Study||4||
60103168|NCT00633477|76221364|FG001|Completed Study Through Day 28|Overall Study||8||
60103169|NCT00633477|76221363|FG000|COMPLETED|Overall Study|Include all subjects who could be evaluated for 28-d survival.|5||
60103170|NCT00633477|76221364|FG001|COMPLETED|Overall Study|Include all subjects who could be evaluated for 28-d survival.|11||
60103171|NCT00633477|76221363|FG000|NOT COMPLETED|Overall Study||2||
59817332|NCT03548558|75939791|FG000|COMPLETED|Phase 2: Booster Sessions Every 2 Months||0||0
59817333|NCT03548558|75939792|FG001|COMPLETED|Phase 2: Booster Sessions Every 2 Months||0||0
59817334|NCT03548558|75939793|FG002|COMPLETED|Phase 2: Booster Sessions Every 2 Months||0||0
59708999|NCT01078623|75827718|FG013|STARTED|Treatment Period 3||7||
59709000|NCT01078623|75827719|FG014|STARTED|Treatment Period 3||7||
59709001|NCT01078623|75827720|FG015|STARTED|Treatment Period 3||7||
59709002|NCT01078623|75827721|FG016|STARTED|Treatment Period 3||7||
59709003|NCT01078623|75827722|FG017|STARTED|Treatment Period 3||7||
59709004|NCT01078623|75827723|FG018|STARTED|Treatment Period 3||6||
59709005|NCT01078623|75827724|FG019|STARTED|Treatment Period 3||7||
59817335|NCT03548558|75939794|FG003|COMPLETED|Phase 2: Booster Sessions Every 2 Months||0||0
59817336|NCT03548558|75939795|FG004|COMPLETED|Phase 2: Booster Sessions Every 2 Months||308||20
59817337|NCT03548558|75939796|FG005|COMPLETED|Phase 2: Booster Sessions Every 2 Months|There was 1 additional death between follow-up surveys 1 and 2 for booster villages.|323||20
59817338|NCT03548558|75939797|FG006|COMPLETED|Phase 2: Booster Sessions Every 2 Months|There was 1 additional death between follow-up survey waves in non-booster villages.|313||20
59817339|NCT03548558|75939791|FG000|NOT COMPLETED|Phase 2: Booster Sessions Every 2 Months||0||0
59709006|NCT01078623|75827705|FG000|COMPLETED|Treatment Period 3||5||
59709007|NCT01078623|75827706|FG001|COMPLETED|Treatment Period 3||5||
59709008|NCT01078623|75827707|FG002|COMPLETED|Treatment Period 3||6||
59709009|NCT01078623|75827708|FG003|COMPLETED|Treatment Period 3||6||
59709010|NCT01078623|75827709|FG004|COMPLETED|Treatment Period 3||6||
59994698|NCT04498247|76110470|FG007|COMPLETED|Overall Study||2||
59994699|NCT04498247|76110463|FG000|NOT COMPLETED|Overall Study||1||
59994700|NCT04498247|76110464|FG001|NOT COMPLETED|Overall Study||12||
59994701|NCT04498247|76110465|FG002|NOT COMPLETED|Overall Study||0||
59994702|NCT04498247|76110466|FG003|NOT COMPLETED|Overall Study||11||
59994703|NCT04498247|76110467|FG004|NOT COMPLETED|Overall Study||0||
59994704|NCT04498247|76110468|FG005|NOT COMPLETED|Overall Study||0||
59994705|NCT04498247|76110469|FG006|NOT COMPLETED|Overall Study||8||
59994706|NCT04498247|76110470|FG007|NOT COMPLETED|Overall Study||0||
59994707|NCT04359797|76110487|FG000|STARTED|Overall Study||243||
59994708|NCT04359797|76110488|FG001|STARTED|Overall Study||258||
59994709|NCT04359797|76110487|FG000|COMPLETED|Overall Study||243||
59994710|NCT04359797|76110488|FG001|COMPLETED|Overall Study||258||
59994711|NCT04359797|76110487|FG000|NOT COMPLETED|Overall Study||0||
59994712|NCT04359797|76110488|FG001|NOT COMPLETED|Overall Study||0||
59994713|NCT03887117|76110498|FG000|STARTED|Overall Study||25||
59994714|NCT03887117|76110499|FG001|STARTED|Overall Study||15||
59994715|NCT03887117|76110500|FG002|STARTED|Overall Study||26||
59994716|NCT03887117|76110501|FG003|STARTED|Overall Study||27||
59994717|NCT03887117|76110498|FG000|COMPLETED|Overall Study||25||
59994718|NCT03887117|76110499|FG001|COMPLETED|Overall Study||14||
59994719|NCT03887117|76110500|FG002|COMPLETED|Overall Study||25||
59565633|NCT01841216|75667984|FG001|COMPLETED|Overall Study||15||
59565634|NCT01841216|75667983|FG000|NOT COMPLETED|Overall Study||0||
59565635|NCT01841216|75667984|FG001|NOT COMPLETED|Overall Study||0||
59565636|NCT01841606|75667992|FG000|STARTED|Overall Study||25||
59565637|NCT01841606|75667993|FG001|STARTED|Overall Study||27||
59565638|NCT01841606|75667992|FG000|COMPLETED|Overall Study||25||
59565639|NCT01841606|75667993|FG001|COMPLETED|Overall Study||27||
59709011|NCT01078623|75827710|FG005|COMPLETED|Treatment Period 3||4||
59817340|NCT03548558|75939792|FG001|NOT COMPLETED|Phase 2: Booster Sessions Every 2 Months||0||0
59709012|NCT01078623|75827711|FG006|COMPLETED|Treatment Period 3||5||
59709013|NCT01078623|75827712|FG007|COMPLETED|Treatment Period 3||6||
59709014|NCT01078623|75827713|FG008|COMPLETED|Treatment Period 3||5||
59709015|NCT01078623|75827714|FG009|COMPLETED|Treatment Period 3||6||
59709016|NCT01078623|75827715|FG010|COMPLETED|Treatment Period 3||6||
59709017|NCT01078623|75827716|FG011|COMPLETED|Treatment Period 3||7||
59817341|NCT03548558|75939793|FG002|NOT COMPLETED|Phase 2: Booster Sessions Every 2 Months||0||0
59817342|NCT03548558|75939794|FG003|NOT COMPLETED|Phase 2: Booster Sessions Every 2 Months||0||0
59817343|NCT03548558|75939795|FG004|NOT COMPLETED|Phase 2: Booster Sessions Every 2 Months||69||0
59817344|NCT03548558|75939796|FG005|NOT COMPLETED|Phase 2: Booster Sessions Every 2 Months||71||0
59817345|NCT03548558|75939797|FG006|NOT COMPLETED|Phase 2: Booster Sessions Every 2 Months||65||0
59817346|NCT03502993|75939815|FG000|STARTED|Overall Study||5957||
59817347|NCT03502993|75939816|FG001|STARTED|Overall Study||1290||
59817348|NCT03502993|75939815|FG000|COMPLETED|Overall Study||5957||
59817349|NCT03502993|75939816|FG001|COMPLETED|Overall Study||1290||
59817350|NCT03502993|75939815|FG000|NOT COMPLETED|Overall Study||0||
59817351|NCT03502993|75939816|FG001|NOT COMPLETED|Overall Study||0||
59817352|NCT03419832|75939824|FG000|STARTED|Overall Study||52||
59817353|NCT03419832|75939825|FG001|STARTED|Overall Study||49||
59817354|NCT03419832|75939824|FG000|COMPLETED|Overall Study||52||
60103172|NCT00633477|76221364|FG001|NOT COMPLETED|Overall Study||0||
60103173|NCT01218958|76221373|FG000|STARTED|Overall Study||210||
60103174|NCT01218958|76221374|FG001|STARTED|Overall Study||205||
59709018|NCT01078623|75827717|FG012|COMPLETED|Treatment Period 3||7||
59817355|NCT03419832|75939825|FG001|COMPLETED|Overall Study||49||
59817356|NCT03419832|75939824|FG000|NOT COMPLETED|Overall Study||0||
59817357|NCT03419832|75939825|FG001|NOT COMPLETED|Overall Study||0||
60103175|NCT01218958|76221375|FG002|STARTED|Overall Study||209||
60103176|NCT01218958|76221373|FG000|COMPLETED|Overall Study||126||
60103177|NCT01218958|76221374|FG001|COMPLETED|Overall Study||124||
60103178|NCT01218958|76221375|FG002|COMPLETED|Overall Study||128||
59817358|NCT03367247|75939839|FG000|STARTED|Overall Study||6||
59817359|NCT03367247|75939840|FG001|STARTED|Overall Study||6||
60103179|NCT01218958|76221373|FG000|NOT COMPLETED|Overall Study||84||
60103180|NCT01218958|76221374|FG001|NOT COMPLETED|Overall Study||81||
59565640|NCT01841606|75667992|FG000|NOT COMPLETED|Overall Study||0||
59565641|NCT01841606|75667993|FG001|NOT COMPLETED|Overall Study||0||
59565642|NCT04392141|75668001|FG000|STARTED|Overall Study||60||
59565643|NCT04392141|75668002|FG001|STARTED|Overall Study||60||
59565644|NCT04392141|75668001|FG000|COMPLETED|Overall Study||60||
59565645|NCT04392141|75668002|FG001|COMPLETED|Overall Study||60||
59565646|NCT04392141|75668001|FG000|NOT COMPLETED|Overall Study||0||
59565647|NCT04392141|75668002|FG001|NOT COMPLETED|Overall Study||0||
59565648|NCT01842464|75668008|FG000|STARTED|Overall Study||44||
59817360|NCT03367247|75939841|FG002|STARTED|Overall Study||5||
59817361|NCT03367247|75939842|FG003|STARTED|Overall Study||4||
59817362|NCT03367247|75939843|FG004|STARTED|Overall Study||29||
59709019|NCT01078623|75827718|FG013|COMPLETED|Treatment Period 3||6||
60103181|NCT01218958|76221375|FG002|NOT COMPLETED|Overall Study||81||
60103182|NCT01240330|76221383|FG000|STARTED|Overall Study||33||
60103183|NCT01240330|76221383|FG000|COMPLETED|Overall Study||33||
60103184|NCT01240330|76221383|FG000|NOT COMPLETED|Overall Study||0||
60103185|NCT00331773|76221389|FG000|STARTED|Overall Study||558||
60103186|NCT00331773|76221390|FG001|STARTED|Overall Study||557||
60103187|NCT00331773|76221389|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|542||
60103188|NCT00331773|76221390|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|550||
60103189|NCT00331773|76221389|FG000|NOT COMPLETED|Overall Study||16||
60103190|NCT00331773|76221390|FG001|NOT COMPLETED|Overall Study||7||
60103191|NCT04327518|76221397|FG000|STARTED|Overall Study||125||202
60103192|NCT04327518|76221397|FG000|COMPLETED|Overall Study||124||200
60103193|NCT04327518|76221397|FG000|NOT COMPLETED|Overall Study||1||2
59709020|NCT01078623|75827719|FG014|COMPLETED|Treatment Period 3||7||
59709021|NCT01078623|75827720|FG015|COMPLETED|Treatment Period 3||7||
59817363|NCT03367247|75939844|FG005|STARTED|Overall Study||17||
59817364|NCT03367247|75939845|FG006|STARTED|Overall Study||32||
59817365|NCT03367247|75939846|FG007|STARTED|Overall Study||22||
59817366|NCT03367247|75939839|FG000|COMPLETED|Overall Study||3||
59817367|NCT03367247|75939840|FG001|COMPLETED|Overall Study||3||
60103194|NCT00244101|76221404|FG000|STARTED|Overall Study||209||
60103195|NCT00244101|76221405|FG001|STARTED|Overall Study||223||
60103196|NCT00244101|76221406|FG002|STARTED|Overall Study||216||
60103197|NCT00244101|76221404|FG000|COMPLETED|Overall Study||209||
60103198|NCT00244101|76221405|FG001|COMPLETED|Overall Study||223||
59709022|NCT01078623|75827721|FG016|COMPLETED|Treatment Period 3||7||
59709023|NCT01078623|75827722|FG017|COMPLETED|Treatment Period 3||7||
59709024|NCT01078623|75827723|FG018|COMPLETED|Treatment Period 3||6||
59709025|NCT01078623|75827724|FG019|COMPLETED|Treatment Period 3||7||
59709026|NCT01078623|75827705|FG000|NOT COMPLETED|Treatment Period 3||0||
60103199|NCT00244101|76221406|FG002|COMPLETED|Overall Study||216||
60103200|NCT00244101|76221404|FG000|NOT COMPLETED|Overall Study||0||
59709027|NCT01078623|75827706|FG001|NOT COMPLETED|Treatment Period 3||0||
59817368|NCT03367247|75939841|FG002|COMPLETED|Overall Study||5||
59817369|NCT03367247|75939842|FG003|COMPLETED|Overall Study||4||
59817370|NCT03367247|75939843|FG004|COMPLETED|Overall Study||21||
59817371|NCT03367247|75939844|FG005|COMPLETED|Overall Study||11||
59817372|NCT03367247|75939845|FG006|COMPLETED|Overall Study||20||
59817373|NCT03367247|75939846|FG007|COMPLETED|Overall Study||15||
59994720|NCT03887117|76110501|FG003|COMPLETED|Overall Study||25||
59994721|NCT03887117|76110498|FG000|NOT COMPLETED|Overall Study||0||
59994722|NCT03887117|76110499|FG001|NOT COMPLETED|Overall Study||1||
59994723|NCT03887117|76110500|FG002|NOT COMPLETED|Overall Study||1||
59994724|NCT03887117|76110501|FG003|NOT COMPLETED|Overall Study||2||
59994725|NCT04038385|76110522|FG000|STARTED|Overall Study||160||
59994726|NCT04038385|76110523|FG001|STARTED|Overall Study||137||
59994727|NCT04038385|76110522|FG000|COMPLETED|Overall Study||143|143 (intervention) and 130 (control) provided self-report data; 137 (intervention) and 124 (control) provided biometric data. For biometric data,13 (intervention) and 10 (control) competed the baseline assessment only.|
59994728|NCT04038385|76110523|FG001|COMPLETED|Overall Study||130|143 (intervention) and 130 (control) provided self-report data; 137 (intervention) and 124 (control) provided biometric data. For biometric data,13 (intervention) and 10 (control) competed the baseline assessment only.|
60103201|NCT00244101|76221405|FG001|NOT COMPLETED|Overall Study||0||
60103202|NCT00244101|76221406|FG002|NOT COMPLETED|Overall Study||0||
60103203|NCT02337465|76221417|FG000|STARTED|Overall Study||30||
59817374|NCT03367247|75939839|FG000|NOT COMPLETED|Overall Study||3||
59817375|NCT03367247|75939840|FG001|NOT COMPLETED|Overall Study||3||
59817376|NCT03367247|75939841|FG002|NOT COMPLETED|Overall Study||0||
59817377|NCT03367247|75939842|FG003|NOT COMPLETED|Overall Study||0||
59817378|NCT03367247|75939843|FG004|NOT COMPLETED|Overall Study||8||
59817379|NCT03367247|75939844|FG005|NOT COMPLETED|Overall Study||6||
59817380|NCT03367247|75939845|FG006|NOT COMPLETED|Overall Study||12||
59817381|NCT03367247|75939846|FG007|NOT COMPLETED|Overall Study||7||
59817382|NCT03364673|75939859|FG000|STARTED|Overall Study||29||
59817383|NCT03364673|75939859|FG000|COMPLETED|Overall Study||24||
59817384|NCT03364673|75939859|FG000|NOT COMPLETED|Overall Study||5||
59709028|NCT01078623|75827707|FG002|NOT COMPLETED|Treatment Period 3||0||
59709029|NCT01078623|75827708|FG003|NOT COMPLETED|Treatment Period 3||0||
59565649|NCT01842464|75668008|FG000|COMPLETED|Overall Study||44||
59565650|NCT01842464|75668008|FG000|NOT COMPLETED|Overall Study||0||
59565651|NCT04838054|75668015|FG000|STARTED|Overall Study||29||
59709030|NCT01078623|75827709|FG004|NOT COMPLETED|Treatment Period 3||1||
59709031|NCT01078623|75827710|FG005|NOT COMPLETED|Treatment Period 3||0||
59709032|NCT01078623|75827711|FG006|NOT COMPLETED|Treatment Period 3||0||
59709033|NCT01078623|75827712|FG007|NOT COMPLETED|Treatment Period 3||0||
59709034|NCT01078623|75827713|FG008|NOT COMPLETED|Treatment Period 3||0||
59709035|NCT01078623|75827714|FG009|NOT COMPLETED|Treatment Period 3||0||
59817385|NCT03330405|75939874|FG000|STARTED|Overall Study||12||
59817386|NCT03330405|75939875|FG001|STARTED|Overall Study||42||
59817387|NCT03330405|75939876|FG002|STARTED|Overall Study||5||
59709036|NCT01078623|75827715|FG010|NOT COMPLETED|Treatment Period 3||0||
59709037|NCT01078623|75827716|FG011|NOT COMPLETED|Treatment Period 3||0||
59709038|NCT01078623|75827717|FG012|NOT COMPLETED|Treatment Period 3||0||
59709039|NCT01078623|75827718|FG013|NOT COMPLETED|Treatment Period 3||1||
59709040|NCT01078623|75827719|FG014|NOT COMPLETED|Treatment Period 3||0||
59709041|NCT01078623|75827720|FG015|NOT COMPLETED|Treatment Period 3||0||
59709042|NCT01078623|75827721|FG016|NOT COMPLETED|Treatment Period 3||0||
59817388|NCT03330405|75939877|FG003|STARTED|Overall Study||22||
59565652|NCT04838054|75668016|FG001|STARTED|Overall Study||28||
59709043|NCT01078623|75827722|FG017|NOT COMPLETED|Treatment Period 3||0||
59709044|NCT01078623|75827723|FG018|NOT COMPLETED|Treatment Period 3||0||
59817389|NCT03330405|75939878|FG004|STARTED|Overall Study||23||
59817390|NCT03330405|75939879|FG005|STARTED|Overall Study||20||
59817391|NCT03330405|75939880|FG006|STARTED|Overall Study||11||
59817392|NCT03330405|75939881|FG007|STARTED|Overall Study||40||
59817393|NCT03330405|75939882|FG008|STARTED|Overall Study||21||
59817394|NCT03330405|75939883|FG009|STARTED|Overall Study||18||
59817395|NCT03330405|75939884|FG010|STARTED|Overall Study||9||
59817396|NCT03330405|75939874|FG000|COMPLETED|Overall Study||0||
59565653|NCT04838054|75668015|FG000|COMPLETED|Overall Study||27||
59565654|NCT04838054|75668016|FG001|COMPLETED|Overall Study||28||
59817397|NCT03330405|75939875|FG001|COMPLETED|Overall Study||0||
59994729|NCT04038385|76110522|FG000|NOT COMPLETED|Overall Study||17||
59817398|NCT03330405|75939876|FG002|COMPLETED|Overall Study||0||
59994730|NCT04038385|76110523|FG001|NOT COMPLETED|Overall Study||7||
59994731|NCT00783263|76110533|FG000|STARTED|Overall Study||99||
59994732|NCT00783263|76110534|FG001|STARTED|Overall Study||98||
59994733|NCT00783263|76110535|FG002|STARTED|Overall Study||122||
59994734|NCT00783263|76110536|FG003|STARTED|Overall Study||121||
59994735|NCT00783263|76110533|FG000|COMPLETED|Overall Study||95||
59994736|NCT00783263|76110534|FG001|COMPLETED|Overall Study||96||
59994737|NCT00783263|76110535|FG002|COMPLETED|Overall Study||119||
59994738|NCT00783263|76110536|FG003|COMPLETED|Overall Study||118||
59994739|NCT00783263|76110533|FG000|NOT COMPLETED|Overall Study||4||
59994740|NCT00783263|76110534|FG001|NOT COMPLETED|Overall Study||2||
59994741|NCT00783263|76110535|FG002|NOT COMPLETED|Overall Study||3||
59994742|NCT00783263|76110536|FG003|NOT COMPLETED|Overall Study||3||
59709045|NCT01078623|75827724|FG019|NOT COMPLETED|Treatment Period 3||0||
59709046|NCT01078623|75827705|FG000|STARTED|Treatment Period 4||5||
59709047|NCT01078623|75827706|FG001|STARTED|Treatment Period 4||5||
59709048|NCT01078623|75827707|FG002|STARTED|Treatment Period 4||6||
59709049|NCT01078623|75827708|FG003|STARTED|Treatment Period 4||6||
59709050|NCT01078623|75827709|FG004|STARTED|Treatment Period 4||6||
59709051|NCT01078623|75827710|FG005|STARTED|Treatment Period 4||4||
59709052|NCT01078623|75827711|FG006|STARTED|Treatment Period 4||5||
59709053|NCT01078623|75827712|FG007|STARTED|Treatment Period 4||6||
59709054|NCT01078623|75827713|FG008|STARTED|Treatment Period 4||5||
59709055|NCT01078623|75827714|FG009|STARTED|Treatment Period 4||6||
59709056|NCT01078623|75827715|FG010|STARTED|Treatment Period 4||6||
59709057|NCT01078623|75827716|FG011|STARTED|Treatment Period 4||7||
59709058|NCT01078623|75827717|FG012|STARTED|Treatment Period 4||7||
59709059|NCT01078623|75827718|FG013|STARTED|Treatment Period 4||6||
59709060|NCT01078623|75827719|FG014|STARTED|Treatment Period 4||7||
59709061|NCT01078623|75827720|FG015|STARTED|Treatment Period 4||7||
59709062|NCT01078623|75827721|FG016|STARTED|Treatment Period 4||7||
59709063|NCT01078623|75827722|FG017|STARTED|Treatment Period 4||7||
59817399|NCT03330405|75939877|FG003|COMPLETED|Overall Study||0||
59817400|NCT03330405|75939878|FG004|COMPLETED|Overall Study||0||
59817401|NCT03330405|75939879|FG005|COMPLETED|Overall Study||0||
59709064|NCT01078623|75827723|FG018|STARTED|Treatment Period 4||6||
59709065|NCT01078623|75827724|FG019|STARTED|Treatment Period 4||7||
59709066|NCT01078623|75827705|FG000|COMPLETED|Treatment Period 4||5||
59817402|NCT03330405|75939880|FG006|COMPLETED|Overall Study||0||
59817403|NCT03330405|75939881|FG007|COMPLETED|Overall Study||0||
59817404|NCT03330405|75939882|FG008|COMPLETED|Overall Study||0||
59817405|NCT03330405|75939883|FG009|COMPLETED|Overall Study||0||
59817406|NCT03330405|75939884|FG010|COMPLETED|Overall Study||0||
59817407|NCT03330405|75939874|FG000|NOT COMPLETED|Overall Study||12||
59817408|NCT03330405|75939875|FG001|NOT COMPLETED|Overall Study||42||
59817409|NCT03330405|75939876|FG002|NOT COMPLETED|Overall Study||5||
59817410|NCT03330405|75939877|FG003|NOT COMPLETED|Overall Study||22||
59709067|NCT01078623|75827706|FG001|COMPLETED|Treatment Period 4||5||
59709068|NCT01078623|75827707|FG002|COMPLETED|Treatment Period 4||5||
59709069|NCT01078623|75827708|FG003|COMPLETED|Treatment Period 4||6||
59817411|NCT03330405|75939878|FG004|NOT COMPLETED|Overall Study||23||
59817412|NCT03330405|75939879|FG005|NOT COMPLETED|Overall Study||20||
59817413|NCT03330405|75939880|FG006|NOT COMPLETED|Overall Study||11||
59817414|NCT03330405|75939881|FG007|NOT COMPLETED|Overall Study||40||
59817415|NCT03330405|75939882|FG008|NOT COMPLETED|Overall Study||21||
59817416|NCT03330405|75939883|FG009|NOT COMPLETED|Overall Study||18||
59817417|NCT03330405|75939884|FG010|NOT COMPLETED|Overall Study||9||
59817418|NCT03150797|75939928|FG000|STARTED|Single-blind Placebo Run in Phase||0|In the single-blind phase, all participants started on placebo for 8 weeks. At the end of the 8 weeks, only those who had not dropped out and who met randomization criteria went on to the double-blind phase. Of the 59 who completed phase 1, only 44 met randomization criteria, of whom 42 were randomized (2 were not randomized due to error).|
59817419|NCT03150797|75939929|FG001|STARTED|Single-blind Placebo Run in Phase||0|In the single-blind phase, all participants started on placebo for 8 weeks. At the end of the 8 weeks, only those who had not dropped out and who met randomization criteria went on to the double-blind phase. Of the 59 who completed phase 1, only 44 met randomization criteria, of whom 42 were randomized (2 were not randomized due to error).|
60103204|NCT02337465|76221417|FG000|COMPLETED|Overall Study||30||
60103205|NCT02337465|76221417|FG000|NOT COMPLETED|Overall Study||0||
60103206|NCT00633243|76221423|FG000|STARTED|Overall Study||12||
60103207|NCT00633243|76221424|FG001|STARTED|Overall Study||9||
60103208|NCT00633243|76221423|FG000|COMPLETED|Overall Study||11||
60103209|NCT00633243|76221424|FG001|COMPLETED|Overall Study||2||
60103210|NCT00633243|76221423|FG000|NOT COMPLETED|Overall Study||1||
60103211|NCT00633243|76221424|FG001|NOT COMPLETED|Overall Study||7||
60103212|NCT01872689|76221434|FG000|STARTED|Double-Blind/Placebo-Controlled Period||76||
60103213|NCT01872689|76221435|FG001|STARTED|Double-Blind/Placebo-Controlled Period||78||
60103214|NCT01872689|76221436|FG002|STARTED|Double-Blind/Placebo-Controlled Period||177||
60103215|NCT01872689|76221437|FG003|STARTED|Double-Blind/Placebo-Controlled Period||174||
60103216|NCT01872689|76221434|FG000|COMPLETED|Double-Blind/Placebo-Controlled Period||56||
60103217|NCT01872689|76221435|FG001|COMPLETED|Double-Blind/Placebo-Controlled Period||58||
60103218|NCT01872689|76221436|FG002|COMPLETED|Double-Blind/Placebo-Controlled Period||129||
60103219|NCT01872689|76221437|FG003|COMPLETED|Double-Blind/Placebo-Controlled Period||136||
60103220|NCT01872689|76221434|FG000|NOT COMPLETED|Double-Blind/Placebo-Controlled Period||20||
60103221|NCT01872689|76221435|FG001|NOT COMPLETED|Double-Blind/Placebo-Controlled Period||20||
60103222|NCT01872689|76221436|FG002|NOT COMPLETED|Double-Blind/Placebo-Controlled Period||48||
59709070|NCT01078623|75827709|FG004|COMPLETED|Treatment Period 4||6||
59709071|NCT01078623|75827710|FG005|COMPLETED|Treatment Period 4||4||
59709072|NCT01078623|75827711|FG006|COMPLETED|Treatment Period 4||5||
59817420|NCT03150797|75939930|FG002|STARTED|Single-blind Placebo Run in Phase||72|In the single-blind phase, all participants started on placebo for 8 weeks. At the end of the 8 weeks, only those who had not dropped out and who met randomization criteria went on to the double-blind phase. Of the 59 who completed phase 1, only 44 met randomization criteria, of whom 42 were randomized (2 were not randomized due to error).|
59817421|NCT03150797|75939928|FG000|COMPLETED|Single-blind Placebo Run in Phase||0||
59817422|NCT03150797|75939929|FG001|COMPLETED|Single-blind Placebo Run in Phase||0||
59817423|NCT03150797|75939930|FG002|COMPLETED|Single-blind Placebo Run in Phase||59||
59817424|NCT03150797|75939928|FG000|NOT COMPLETED|Single-blind Placebo Run in Phase||0||
59817425|NCT03150797|75939929|FG001|NOT COMPLETED|Single-blind Placebo Run in Phase||0||
59817426|NCT03150797|75939930|FG002|NOT COMPLETED|Single-blind Placebo Run in Phase||13||
59817427|NCT03150797|75939928|FG000|STARTED|Double Blind Phase||14|The reason this number does not match the number above is that in the single blind phase ALL participants received placebo.|
59817428|NCT03150797|75939929|FG001|STARTED|Double Blind Phase||14|The reason this number does not match the number above is that in the single blind phase ALL participants received placebo.|
59817429|NCT03150797|75939930|FG002|STARTED|Double Blind Phase||14|The reason this number does not match the number above is that in the single blind phase ALL participants received placebo.|
59817430|NCT03150797|75939928|FG000|COMPLETED|Double Blind Phase||10|i.e., provided at least 21/28 headache diary days during final four weeks of double-blind treatment (weeks 13-16 overall).|
59565655|NCT04838054|75668015|FG000|NOT COMPLETED|Overall Study||2||
59565656|NCT04838054|75668016|FG001|NOT COMPLETED|Overall Study||0||
59565657|NCT02263118|75668026|FG000|STARTED|Overall Study||24||
59817431|NCT03150797|75939929|FG001|COMPLETED|Double Blind Phase||10|i.e., provided at least 21/28 headache diary days during final four weeks of double-blind treatment (weeks 13-16 overall).|
59817432|NCT03150797|75939930|FG002|COMPLETED|Double Blind Phase||7|i.e., provided at least 21/28 headache diary days during final four weeks of double-blind treatment (weeks 13-16 overall).|
59817433|NCT03150797|75939928|FG000|NOT COMPLETED|Double Blind Phase||4||
59817434|NCT03150797|75939929|FG001|NOT COMPLETED|Double Blind Phase||4||
59817435|NCT03150797|75939930|FG002|NOT COMPLETED|Double Blind Phase||7||
59817436|NCT03096418|75939938|FG000|STARTED|Overall Study||24||
59817437|NCT03096418|75939938|FG000|Paclitaxel Concentration Determine|Overall Study||15||
59817438|NCT03096418|75939938|FG000|Analyzed After First Dose|Overall Study||16||
59817439|NCT03096418|75939938|FG000|Analyzed After Third Dose|Overall Study||5||
59817440|NCT03096418|75939938|FG000|Analyzed After Twelfth Dose|Overall Study||1||
59817441|NCT03096418|75939938|FG000|COMPLETED|Overall Study||24||
59817442|NCT03096418|75939938|FG000|NOT COMPLETED|Overall Study||0||
59817443|NCT03054909|75939951|FG000|STARTED|Overall Study||3||
59817444|NCT03054909|75939952|FG001|STARTED|Overall Study||4||
59817445|NCT03054909|75939951|FG000|COMPLETED|Overall Study||3||
59817446|NCT03054909|75939952|FG001|COMPLETED|Overall Study||4||
59817447|NCT03054909|75939951|FG000|NOT COMPLETED|Overall Study||0||
59817448|NCT03054909|75939952|FG001|NOT COMPLETED|Overall Study||0||
59817449|NCT02835443|75939958|FG000|STARTED|Overall Study||12||
59817450|NCT02835443|75939958|FG000|COMPLETED|Overall Study||12||
59565658|NCT02263118|75668027|FG001|STARTED|Overall Study||32||
59565659|NCT02263118|75668028|FG002|STARTED|Overall Study||30||
59565660|NCT02263118|75668029|FG003|STARTED|Overall Study||14||
59565661|NCT02263118|75668026|FG000|COMPLETED|Overall Study||20||
59565662|NCT02263118|75668027|FG001|COMPLETED|Overall Study||24||
59565663|NCT02263118|75668028|FG002|COMPLETED|Overall Study||22||
59817451|NCT02835443|75939958|FG000|NOT COMPLETED|Overall Study||0||
59817452|NCT02758717|75939962|FG000|STARTED|Overall Study||46||
59817453|NCT02758717|75939962|FG000|COMPLETED|Overall Study||46||
59817454|NCT02758717|75939962|FG000|NOT COMPLETED|Overall Study||0||
59817455|NCT02754830|75939976|FG000|STARTED|Overall Study||17||
59817456|NCT02754830|75939977|FG001|STARTED|Overall Study||6||
59817457|NCT02754830|75939978|FG002|STARTED|Overall Study||6||
59709073|NCT01078623|75827712|FG007|COMPLETED|Treatment Period 4||6||
59709074|NCT01078623|75827713|FG008|COMPLETED|Treatment Period 4||5||
59709075|NCT01078623|75827714|FG009|COMPLETED|Treatment Period 4||6||
59709076|NCT01078623|75827715|FG010|COMPLETED|Treatment Period 4||6||
59709077|NCT01078623|75827716|FG011|COMPLETED|Treatment Period 4||7||
59709078|NCT01078623|75827717|FG012|COMPLETED|Treatment Period 4||7||
59709079|NCT01078623|75827718|FG013|COMPLETED|Treatment Period 4||6||
59709080|NCT01078623|75827719|FG014|COMPLETED|Treatment Period 4||7||
59709081|NCT01078623|75827720|FG015|COMPLETED|Treatment Period 4||6||
59709082|NCT01078623|75827721|FG016|COMPLETED|Treatment Period 4||7||
59709083|NCT01078623|75827722|FG017|COMPLETED|Treatment Period 4||7||
59709084|NCT01078623|75827723|FG018|COMPLETED|Treatment Period 4||6||
59709085|NCT01078623|75827724|FG019|COMPLETED|Treatment Period 4||7||
59709086|NCT01078623|75827705|FG000|NOT COMPLETED|Treatment Period 4||0||
59709087|NCT01078623|75827706|FG001|NOT COMPLETED|Treatment Period 4||0||
59565664|NCT02263118|75668029|FG003|COMPLETED|Overall Study||12||
59565665|NCT02263118|75668026|FG000|NOT COMPLETED|Overall Study||4||
59565666|NCT02263118|75668027|FG001|NOT COMPLETED|Overall Study||8||
59709088|NCT01078623|75827707|FG002|NOT COMPLETED|Treatment Period 4||1||
59709089|NCT01078623|75827708|FG003|NOT COMPLETED|Treatment Period 4||0||
59709090|NCT01078623|75827709|FG004|NOT COMPLETED|Treatment Period 4||0||
59709091|NCT01078623|75827710|FG005|NOT COMPLETED|Treatment Period 4||0||
59709092|NCT01078623|75827711|FG006|NOT COMPLETED|Treatment Period 4||0||
59709093|NCT01078623|75827712|FG007|NOT COMPLETED|Treatment Period 4||0||
59709094|NCT01078623|75827713|FG008|NOT COMPLETED|Treatment Period 4||0||
59709095|NCT01078623|75827714|FG009|NOT COMPLETED|Treatment Period 4||0||
59709096|NCT01078623|75827715|FG010|NOT COMPLETED|Treatment Period 4||0||
59709097|NCT01078623|75827716|FG011|NOT COMPLETED|Treatment Period 4||0||
59709098|NCT01078623|75827717|FG012|NOT COMPLETED|Treatment Period 4||0||
59709099|NCT01078623|75827718|FG013|NOT COMPLETED|Treatment Period 4||0||
59709100|NCT01078623|75827719|FG014|NOT COMPLETED|Treatment Period 4||0||
59709101|NCT01078623|75827720|FG015|NOT COMPLETED|Treatment Period 4||1||
59709102|NCT01078623|75827721|FG016|NOT COMPLETED|Treatment Period 4||0||
59709103|NCT01078623|75827722|FG017|NOT COMPLETED|Treatment Period 4||0||
59709104|NCT01078623|75827723|FG018|NOT COMPLETED|Treatment Period 4||0||
60103223|NCT01872689|76221437|FG003|NOT COMPLETED|Double-Blind/Placebo-Controlled Period||38||
59565667|NCT02263118|75668028|FG002|NOT COMPLETED|Overall Study||8||
59709105|NCT01078623|75827724|FG019|NOT COMPLETED|Treatment Period 4||0||
59709106|NCT01092507|75827738|FG000|STARTED|Overall Study||149||
59709107|NCT01092507|75827739|FG001|STARTED|Overall Study||150||
59709108|NCT01092507|75827738|FG000|COMPLETED|Overall Study||147||
59709109|NCT01092507|75827739|FG001|COMPLETED|Overall Study||150||
60103224|NCT01872689|76221434|FG000|STARTED|Open-Label Period (Only For Monotherapy)|Of the 56 participants who completed Period 1, only 52 started Period 2.|52||
60103225|NCT01872689|76221435|FG001|STARTED|Open-Label Period (Only For Monotherapy)|Of the 58 participants who completed Period 1, only 56 started Period 2.|56||
60103226|NCT01872689|76221436|FG002|STARTED|Open-Label Period (Only For Monotherapy)|As per study design, Period 2 was not intended for this arm.|0||
60103227|NCT01872689|76221437|FG003|STARTED|Open-Label Period (Only For Monotherapy)|As per study design, Period 2 was not intended for this arm.|0||
60103228|NCT01872689|76221434|FG000|COMPLETED|Open-Label Period (Only For Monotherapy)||31||
60103229|NCT01872689|76221435|FG001|COMPLETED|Open-Label Period (Only For Monotherapy)||33||
60103230|NCT01872689|76221436|FG002|COMPLETED|Open-Label Period (Only For Monotherapy)||0||
60103231|NCT01872689|76221437|FG003|COMPLETED|Open-Label Period (Only For Monotherapy)||0||
59565668|NCT02263118|75668029|FG003|NOT COMPLETED|Overall Study||2||
59565669|NCT01846988|75668044|FG000|STARTED|APAP Pressurize Comparison (4-8 Weeks)||15||
59565670|NCT01846988|75668045|FG001|STARTED|APAP Pressurize Comparison (4-8 Weeks)||0||
59565671|NCT01846988|75668046|FG002|STARTED|APAP Pressurize Comparison (4-8 Weeks)||0||
59565672|NCT01846988|75668044|FG000|COMPLETED|APAP Pressurize Comparison (4-8 Weeks)||15||
59565673|NCT01846988|75668045|FG001|COMPLETED|APAP Pressurize Comparison (4-8 Weeks)||0||
60103232|NCT01872689|76221434|FG000|NOT COMPLETED|Open-Label Period (Only For Monotherapy)||21||
59817458|NCT02754830|75939979|FG003|STARTED|Overall Study||6||
59817459|NCT02754830|75939980|FG004|STARTED|Overall Study||6||
59817460|NCT02754830|75939981|FG005|STARTED|Overall Study||6||
59817461|NCT02754830|75939982|FG006|STARTED|Overall Study||6||
59817462|NCT02754830|75939983|FG007|STARTED|Overall Study||6||
59817463|NCT02754830|75939984|FG008|STARTED|Overall Study||7||
59817464|NCT02754830|75939985|FG009|STARTED|Overall Study||6||
59817465|NCT02754830|75939976|FG000|COMPLETED|Overall Study||17||
59817466|NCT02754830|75939977|FG001|COMPLETED|Overall Study||6||
59817467|NCT02754830|75939978|FG002|COMPLETED|Overall Study||6||
59817468|NCT02754830|75939979|FG003|COMPLETED|Overall Study||6||
59817469|NCT02754830|75939980|FG004|COMPLETED|Overall Study||6||
59709110|NCT01092507|75827738|FG000|NOT COMPLETED|Overall Study||2||
60103233|NCT01872689|76221435|FG001|NOT COMPLETED|Open-Label Period (Only For Monotherapy)||23||
60103234|NCT01872689|76221436|FG002|NOT COMPLETED|Open-Label Period (Only For Monotherapy)||0||
60103235|NCT01872689|76221437|FG003|NOT COMPLETED|Open-Label Period (Only For Monotherapy)||0||
60103236|NCT00632931|76221450|FG000|STARTED|Part 1, Period 1||13||
60103237|NCT00632931|76221451|FG001|STARTED|Part 1, Period 1||12||
60103238|NCT00632931|76221452|FG002|STARTED|Part 1, Period 1||0||
60103239|NCT00632931|76221450|FG000|COMPLETED|Part 1, Period 1||11||
60103240|NCT00632931|76221451|FG001|COMPLETED|Part 1, Period 1||12||
59709111|NCT01092507|75827739|FG001|NOT COMPLETED|Overall Study||0||
59709112|NCT01078545|75827745|FG000|STARTED|Overall Study||729||
59709113|NCT01078545|75827745|FG000|Intent-to-treat Population|Overall Study||729||
59817470|NCT02754830|75939981|FG005|COMPLETED|Overall Study||6||
59817471|NCT02754830|75939982|FG006|COMPLETED|Overall Study||6||
59817472|NCT02754830|75939983|FG007|COMPLETED|Overall Study||6||
59817473|NCT02754830|75939984|FG008|COMPLETED|Overall Study||7||
59817474|NCT02754830|75939985|FG009|COMPLETED|Overall Study||6||
59817475|NCT02754830|75939976|FG000|NOT COMPLETED|Overall Study||0||
59817476|NCT02754830|75939977|FG001|NOT COMPLETED|Overall Study||0||
59817477|NCT02754830|75939978|FG002|NOT COMPLETED|Overall Study||0||
59817478|NCT02754830|75939979|FG003|NOT COMPLETED|Overall Study||0||
59817479|NCT02754830|75939980|FG004|NOT COMPLETED|Overall Study||0||
59817480|NCT02754830|75939981|FG005|NOT COMPLETED|Overall Study||0||
59817481|NCT02754830|75939982|FG006|NOT COMPLETED|Overall Study||0||
59817482|NCT02754830|75939983|FG007|NOT COMPLETED|Overall Study||0||
59817483|NCT02754830|75939984|FG008|NOT COMPLETED|Overall Study||0||
59817484|NCT02754830|75939985|FG009|NOT COMPLETED|Overall Study||0||
59817485|NCT02683239|75940029|FG000|STARTED|Overall Study||1260||
59817486|NCT02683239|75940030|FG001|STARTED|Overall Study||971||
60103241|NCT00632931|76221452|FG002|COMPLETED|Part 1, Period 1||0||
60103242|NCT00632931|76221450|FG000|NOT COMPLETED|Part 1, Period 1||2||
59709114|NCT01078545|75827745|FG000|Per Protocol Population|Overall Study||661||
59709115|NCT01078545|75827745|FG000|COMPLETED|Overall Study||703||
59709116|NCT01078545|75827745|FG000|NOT COMPLETED|Overall Study||26||
59709117|NCT01202760|75827752|FG000|STARTED|Overall Study||379||
59709118|NCT01202760|75827753|FG001|STARTED|Overall Study||374||
59709119|NCT01202760|75827754|FG002|STARTED|Overall Study||251||
59709120|NCT01202760|75827752|FG000|Received at Least One Dose of Study Drug|Overall Study||379||
59709121|NCT01202760|75827753|FG001|Received at Least One Dose of Study Drug|Overall Study||371||
59709122|NCT01202760|75827754|FG002|Received at Least One Dose of Study Drug|Overall Study||250||
59817487|NCT02683239|75940031|FG002|STARTED|Overall Study||975||
59817488|NCT02683239|75940032|FG003|STARTED|Overall Study||214||
59817489|NCT02683239|75940033|FG004|STARTED|Overall Study||1680||
60103243|NCT00632931|76221451|FG001|NOT COMPLETED|Part 1, Period 1||0||
60103244|NCT00632931|76221452|FG002|NOT COMPLETED|Part 1, Period 1||0||
60103245|NCT00632931|76221450|FG000|STARTED|Part 1, Washout||11||
60103246|NCT00632931|76221451|FG001|STARTED|Part 1, Washout||12||
60103247|NCT00632931|76221452|FG002|STARTED|Part 1, Washout||0||
59817490|NCT02683239|75940034|FG005|STARTED|Overall Study||116||
59817491|NCT02683239|75940035|FG006|STARTED|Overall Study||115||
59817492|NCT02683239|75940029|FG000|COMPLETED|Overall Study||800||
59817493|NCT02683239|75940030|FG001|COMPLETED|Overall Study||738||
59817494|NCT02683239|75940031|FG002|COMPLETED|Overall Study||756||
59817495|NCT02683239|75940032|FG003|COMPLETED|Overall Study||94||
59817496|NCT02683239|75940033|FG004|COMPLETED|Overall Study||935||
59817497|NCT02683239|75940034|FG005|COMPLETED|Overall Study||56||
59817498|NCT02683239|75940035|FG006|COMPLETED|Overall Study||44||
59817499|NCT02683239|75940029|FG000|NOT COMPLETED|Overall Study||460||
59817500|NCT02683239|75940030|FG001|NOT COMPLETED|Overall Study||233||
60103248|NCT00632931|76221450|FG000|COMPLETED|Part 1, Washout||11||
60103249|NCT00632931|76221451|FG001|COMPLETED|Part 1, Washout||12||
60103250|NCT00632931|76221452|FG002|COMPLETED|Part 1, Washout||0||
60103251|NCT00632931|76221450|FG000|NOT COMPLETED|Part 1, Washout||0||
59817501|NCT02683239|75940031|FG002|NOT COMPLETED|Overall Study||219||
59817502|NCT02683239|75940032|FG003|NOT COMPLETED|Overall Study||120||
59817503|NCT02683239|75940033|FG004|NOT COMPLETED|Overall Study||745||
59817504|NCT02683239|75940034|FG005|NOT COMPLETED|Overall Study||60||
59817505|NCT02683239|75940035|FG006|NOT COMPLETED|Overall Study||71||
59817506|NCT02097134|75940051|FG000|STARTED|Overall Study||14||
59817507|NCT02097134|75940051|FG000|COMPLETED|Overall Study||5||
59817508|NCT02097134|75940051|FG000|NOT COMPLETED|Overall Study||9||
59817509|NCT01859130|75940056|FG000|STARTED|Overall Study||299||
59817510|NCT01859130|75940056|FG000|COMPLETED|Overall Study||192||
60103252|NCT00632931|76221451|FG001|NOT COMPLETED|Part 1, Washout||0||
60103253|NCT00632931|76221452|FG002|NOT COMPLETED|Part 1, Washout||0||
60103254|NCT00632931|76221450|FG000|STARTED|Part 1, Period 2||11||
60103255|NCT00632931|76221451|FG001|STARTED|Part 1, Period 2||12||
60103256|NCT00632931|76221452|FG002|STARTED|Part 1, Period 2||0||
60103257|NCT00632931|76221450|FG000|COMPLETED|Part 1, Period 2||11||
60103258|NCT00632931|76221451|FG001|COMPLETED|Part 1, Period 2||12||
60103259|NCT00632931|76221452|FG002|COMPLETED|Part 1, Period 2||0||
60103260|NCT00632931|76221450|FG000|NOT COMPLETED|Part 1, Period 2||0||
60103261|NCT00632931|76221451|FG001|NOT COMPLETED|Part 1, Period 2||0||
60103262|NCT00632931|76221452|FG002|NOT COMPLETED|Part 1, Period 2||0||
60103263|NCT00632931|76221450|FG000|STARTED|Post-Part 1 Washout|1 patient who did not complete Period 1 was subsequently enrolled into Post Part 1|12||
60103264|NCT00632931|76221451|FG001|STARTED|Post-Part 1 Washout||12||
60103265|NCT00632931|76221452|FG002|STARTED|Post-Part 1 Washout||0||
60103266|NCT00632931|76221450|FG000|COMPLETED|Post-Part 1 Washout||12||
60103267|NCT00632931|76221451|FG001|COMPLETED|Post-Part 1 Washout||12||
60103268|NCT00632931|76221452|FG002|COMPLETED|Post-Part 1 Washout||0||
60103269|NCT00632931|76221450|FG000|NOT COMPLETED|Post-Part 1 Washout||0||
60103270|NCT00632931|76221451|FG001|NOT COMPLETED|Post-Part 1 Washout||0||
60103271|NCT00632931|76221452|FG002|NOT COMPLETED|Post-Part 1 Washout||0||
59817511|NCT01859130|75940056|FG000|NOT COMPLETED|Overall Study||107||
59817512|NCT01335308|75940063|FG000|STARTED|Overall Study||198||
59817513|NCT01335308|75940064|FG001|STARTED|Overall Study||212||
59817514|NCT01335308|75940065|FG002|STARTED|Overall Study||235||
59817515|NCT01335308|75940063|FG000|COMPLETED|Overall Study||158||
59817516|NCT01335308|75940064|FG001|COMPLETED|Overall Study||145||
59817517|NCT01335308|75940065|FG002|COMPLETED|Overall Study||154||
59817518|NCT01335308|75940063|FG000|NOT COMPLETED|Overall Study||40||
59817519|NCT01335308|75940064|FG001|NOT COMPLETED|Overall Study||67||
59817520|NCT01335308|75940065|FG002|NOT COMPLETED|Overall Study||81||
59817521|NCT01174043|75940073|FG000|STARTED|Overall Study||11||
59817522|NCT01174043|75940073|FG000|COMPLETED|Overall Study||0||
59817523|NCT01174043|75940073|FG000|NOT COMPLETED|Overall Study||11||
59817524|NCT04050982|75940079|FG000|STARTED|Overall Study||9||
59817525|NCT04050982|75940080|FG001|STARTED|Overall Study||2||
59817526|NCT04050982|75940081|FG002|STARTED|Overall Study||0||
59817527|NCT04050982|75940079|FG000|Interfaced With AF CARE Digital Platform|Overall Study||7||
59817528|NCT04050982|75940080|FG001|Interfaced With AF CARE Digital Platform|Overall Study||1||
59817529|NCT04050982|75940081|FG002|Interfaced With AF CARE Digital Platform|Overall Study||0||
59817530|NCT04050982|75940079|FG000|COMPLETED|Overall Study||7||
59817531|NCT04050982|75940080|FG001|COMPLETED|Overall Study||1||
59817532|NCT04050982|75940081|FG002|COMPLETED|Overall Study||0||
59817533|NCT04050982|75940079|FG000|NOT COMPLETED|Overall Study||2||
59817534|NCT04050982|75940080|FG001|NOT COMPLETED|Overall Study||1||
59817535|NCT04050982|75940081|FG002|NOT COMPLETED|Overall Study||0||
59817536|NCT03905265|75940091|FG000|STARTED|Overall Study||4||
59817537|NCT03905265|75940092|FG001|STARTED|Overall Study||4||
59817538|NCT03905265|75940093|FG002|STARTED|Overall Study||6||
59817539|NCT03905265|75940094|FG003|STARTED|Overall Study||8||
59817540|NCT03905265|75940091|FG000|COMPLETED|Overall Study|1 participant withdrew from study prematurely due to withdrawal of consent.|3||
59817541|NCT03905265|75940092|FG001|COMPLETED|Overall Study|1 participant withdrew from study prematurely due to withdrawal of consent.|3||
59817542|NCT03905265|75940093|FG002|COMPLETED|Overall Study||6||
59817543|NCT03905265|75940094|FG003|COMPLETED|Overall Study||8||
59817544|NCT03905265|75940091|FG000|NOT COMPLETED|Overall Study||1||
60103272|NCT00632931|76221450|FG000|STARTED|Part 2||0||
60103273|NCT00632931|76221451|FG001|STARTED|Part 2||0||
60103274|NCT00632931|76221452|FG002|STARTED|Part 2||24||
60103275|NCT00632931|76221450|FG000|COMPLETED|Part 2||0||
60103276|NCT00632931|76221451|FG001|COMPLETED|Part 2||0||
60103277|NCT00632931|76221452|FG002|COMPLETED|Part 2||0||
60103278|NCT00632931|76221450|FG000|NOT COMPLETED|Part 2||0||
60103279|NCT00632931|76221451|FG001|NOT COMPLETED|Part 2||0||
60103280|NCT00632931|76221452|FG002|NOT COMPLETED|Part 2||24||
60103281|NCT01857323|76221457|FG000|STARTED|Overall Study|36 day treatment cohort: 45 participants 50 day treatment cohort: 272 participants|317||
60103282|NCT01857323|76221457|FG000|Safety Population|Overall Study|One enrolled participant was lost to follow-up.|316||
59817545|NCT03905265|75940092|FG001|NOT COMPLETED|Overall Study||1||
59817546|NCT03905265|75940093|FG002|NOT COMPLETED|Overall Study||0||
59817547|NCT03905265|75940094|FG003|NOT COMPLETED|Overall Study||0||
60103283|NCT01857323|76221457|FG000|COMPLETED|Overall Study||253||
59817548|NCT03848845|75940107|FG000|STARTED|Overall Study||6||
59817549|NCT03848845|75940108|FG001|STARTED|Overall Study||7||
59817550|NCT03848845|75940109|FG002|STARTED|Overall Study||28||
59817551|NCT03848845|75940107|FG000|COMPLETED|Overall Study|1 participant completed follow-up and 2 participants died.|3|Participants who completed follow-up or who died were considered to have completed the study.|
59817552|NCT03848845|75940108|FG001|COMPLETED|Overall Study|3 participants died.|3|Participants who completed follow-up or who died were considered to have completed the study.|
59817553|NCT03848845|75940109|FG002|COMPLETED|Overall Study|5 participants died.|5|Participants who completed follow-up or who died were considered to have completed the study.|
59817554|NCT03848845|75940107|FG000|NOT COMPLETED|Overall Study||3||
59817555|NCT03848845|75940108|FG001|NOT COMPLETED|Overall Study||4||
59817556|NCT03848845|75940109|FG002|NOT COMPLETED|Overall Study||23||
59817557|NCT03742037|75940122|FG000|STARTED|Treatment Period 1 (1st Dose - Month 6)||85||
59817558|NCT03742037|75940123|FG001|STARTED|Treatment Period 1 (1st Dose - Month 6)||85||
59817559|NCT03742037|75940124|FG002|STARTED|Treatment Period 1 (1st Dose - Month 6)||86||
59817560|NCT03742037|75940125|FG003|STARTED|Treatment Period 1 (1st Dose - Month 6)||0||
59817561|NCT03742037|75940126|FG004|STARTED|Treatment Period 1 (1st Dose - Month 6)||0||
59817562|NCT03742037|75940127|FG005|STARTED|Treatment Period 1 (1st Dose - Month 6)||85||
59817563|NCT03742037|75940128|FG006|STARTED|Treatment Period 1 (1st Dose - Month 6)||86||
59817564|NCT03742037|75940122|FG000|COMPLETED|Treatment Period 1 (1st Dose - Month 6)||78||
59817565|NCT03742037|75940123|FG001|COMPLETED|Treatment Period 1 (1st Dose - Month 6)||78||
59817566|NCT03742037|75940124|FG002|COMPLETED|Treatment Period 1 (1st Dose - Month 6)||71||
60103284|NCT01857323|76221457|FG000|NOT COMPLETED|Overall Study||64||
60103285|NCT00632541|76221461|FG000|STARTED|Overall Study|18 subjects were accrued to the study|18||
60103286|NCT00632541|76221461|FG000|COMPLETED|Overall Study||11||
60103287|NCT00632541|76221461|FG000|NOT COMPLETED|Overall Study||7||
60103288|NCT01872611|76221467|FG000|STARTED|Overall Study||301||
60103289|NCT01872611|76221468|FG001|STARTED|Overall Study||304||
60103290|NCT01872611|76221467|FG000|Randomized|Overall Study||301||
60103291|NCT01872611|76221468|FG001|Randomized|Overall Study||304||
60103292|NCT01872611|76221467|FG000|Treated (Safety Analysis Set)|Overall Study||293||
60103293|NCT01872611|76221468|FG001|Treated (Safety Analysis Set)|Overall Study||295||
60103294|NCT01872611|76221467|FG000|Full Analysis Set|Overall Study||289||
60103295|NCT01872611|76221468|FG001|Full Analysis Set|Overall Study||293||
60103296|NCT01872611|76221467|FG000|COMPLETED|Overall Study||277||
60103297|NCT01872611|76221468|FG001|COMPLETED|Overall Study||292||
60103298|NCT01872611|76221467|FG000|NOT COMPLETED|Overall Study||24||
60103299|NCT01872611|76221468|FG001|NOT COMPLETED|Overall Study||12||
60103300|NCT03089853|76221478|FG000|STARTED|Overall Study||4||
59709123|NCT01202760|75827752|FG000|COMPLETED|Overall Study||332||
60103301|NCT03089853|76221479|FG001|STARTED|Overall Study||3||
60103302|NCT03089853|76221478|FG000|COMPLETED|Overall Study||2||
60103303|NCT03089853|76221479|FG001|COMPLETED|Overall Study||2||
59709124|NCT01202760|75827753|FG001|COMPLETED|Overall Study||322||
59709125|NCT01202760|75827754|FG002|COMPLETED|Overall Study||216||
59709126|NCT01202760|75827752|FG000|NOT COMPLETED|Overall Study||47||
59709127|NCT01202760|75827753|FG001|NOT COMPLETED|Overall Study||52||
60103304|NCT03089853|76221478|FG000|NOT COMPLETED|Overall Study||2||
60103305|NCT03089853|76221479|FG001|NOT COMPLETED|Overall Study||1||
59709128|NCT01202760|75827754|FG002|NOT COMPLETED|Overall Study||35||
59709129|NCT01091259|75827774|FG000|STARTED|Overall Study||29||
59709130|NCT01091259|75827774|FG000|COMPLETED|Overall Study|Number of patients who had at least 2 cycles of treatments|24||
59709131|NCT01091259|75827774|FG000|NOT COMPLETED|Overall Study||5||
59709132|NCT01091103|75827778|FG000|STARTED|Overall Study||60||
59709133|NCT01091103|75827778|FG000|COMPLETED|Overall Study|Patients on study drug and completed Week 9 visit assessments.|56||
59709134|NCT01091103|75827778|FG000|NOT COMPLETED|Overall Study||4||
59709135|NCT01078389|75827786|FG000|STARTED|Overall Study||157||
59709136|NCT01078389|75827787|FG001|STARTED|Overall Study||157||
59709137|NCT01078389|75827786|FG000|COMPLETED|Overall Study||93||
59709138|NCT01078389|75827787|FG001|COMPLETED|Overall Study||90||
59817567|NCT03742037|75940125|FG003|COMPLETED|Treatment Period 1 (1st Dose - Month 6)||0||
59817568|NCT03742037|75940126|FG004|COMPLETED|Treatment Period 1 (1st Dose - Month 6)||0||
59817569|NCT03742037|75940127|FG005|COMPLETED|Treatment Period 1 (1st Dose - Month 6)||70||
59817570|NCT03742037|75940128|FG006|COMPLETED|Treatment Period 1 (1st Dose - Month 6)||77||
59817571|NCT03742037|75940122|FG000|NOT COMPLETED|Treatment Period 1 (1st Dose - Month 6)||7||
59817572|NCT03742037|75940123|FG001|NOT COMPLETED|Treatment Period 1 (1st Dose - Month 6)||7||
59817573|NCT03742037|75940124|FG002|NOT COMPLETED|Treatment Period 1 (1st Dose - Month 6)||15||
59817574|NCT03742037|75940125|FG003|NOT COMPLETED|Treatment Period 1 (1st Dose - Month 6)||0||
59817575|NCT03742037|75940126|FG004|NOT COMPLETED|Treatment Period 1 (1st Dose - Month 6)||0||
59817576|NCT03742037|75940127|FG005|NOT COMPLETED|Treatment Period 1 (1st Dose - Month 6)||15||
59817577|NCT03742037|75940128|FG006|NOT COMPLETED|Treatment Period 1 (1st Dose - Month 6)||9||
59817578|NCT03742037|75940122|FG000|STARTED|Treatment Period 2 (Month 6 - Month 12)||78||
59817579|NCT03742037|75940123|FG001|STARTED|Treatment Period 2 (Month 6 - Month 12)||78||
59817580|NCT03742037|75940124|FG002|STARTED|Treatment Period 2 (Month 6 - Month 12)||72||
59817581|NCT03742037|75940125|FG003|STARTED|Treatment Period 2 (Month 6 - Month 12)||35||
59817582|NCT03742037|75940126|FG004|STARTED|Treatment Period 2 (Month 6 - Month 12)||35||
59817583|NCT03742037|75940127|FG005|STARTED|Treatment Period 2 (Month 6 - Month 12)||0||
59709139|NCT01078389|75827786|FG000|NOT COMPLETED|Overall Study||64||
59709140|NCT01078389|75827787|FG001|NOT COMPLETED|Overall Study||67||
59709141|NCT01090323|75827795|FG000|STARTED|Overall Study||132||
59709142|NCT01090323|75827796|FG001|STARTED|Overall Study||53||
59709143|NCT01090323|75827795|FG000|COMPLETED|Overall Study||43||
59709144|NCT01090323|75827796|FG001|COMPLETED|Overall Study||19||
59709145|NCT01090323|75827795|FG000|NOT COMPLETED|Overall Study||89||
59709146|NCT01090323|75827796|FG001|NOT COMPLETED|Overall Study||34||
59709147|NCT01078155|75827802|FG000|STARTED|Overall Study||131||
59709148|NCT01078155|75827802|FG000|COMPLETED|Overall Study||87||
59709149|NCT01078155|75827802|FG000|NOT COMPLETED|Overall Study||44||
59709150|NCT01201356|75827806|FG000|STARTED|Overall Study||4125|All enrolled patients|
59709151|NCT01201356|75827806|FG000|Safety Set|Overall Study||4083|At least one dose of fingolimod in any study and a post-baseline safety assessment|
59817584|NCT03742037|75940128|FG006|STARTED|Treatment Period 2 (Month 6 - Month 12)||77||
59817585|NCT03742037|75940122|FG000|COMPLETED|Treatment Period 2 (Month 6 - Month 12)||74||
60103306|NCT03086967|76221487|FG000|STARTED|Overall Study||103||
60103307|NCT03086967|76221488|FG001|STARTED|Overall Study||101||
60103308|NCT03086967|76221487|FG000|COMPLETED|Overall Study||101||
60103309|NCT03086967|76221488|FG001|COMPLETED|Overall Study||99||
60103310|NCT03086967|76221487|FG000|NOT COMPLETED|Overall Study||2||
60103311|NCT03086967|76221488|FG001|NOT COMPLETED|Overall Study||2||
60103312|NCT01856543|76221496|FG000|STARTED|Overall Study||73||
60103313|NCT01856543|76221497|FG001|STARTED|Overall Study||70||
59709152|NCT01201356|75827806|FG000|Fingolimod Full Analysis Set|Overall Study||4046||
59709153|NCT01201356|75827806|FG000|COMPLETED|Overall Study||3481||
60103314|NCT01856543|76221496|FG000|COMPLETED|Overall Study||60||
60103315|NCT01856543|76221497|FG001|COMPLETED|Overall Study||64||
59709154|NCT01201356|75827806|FG000|NOT COMPLETED|Overall Study||644||
59709155|NCT01200810|75827812|FG000|STARTED|Overall Study||5||
59709156|NCT01200810|75827813|FG001|STARTED|Overall Study||5||
59709157|NCT01200810|75827812|FG000|COMPLETED|Overall Study||0||
59709158|NCT01200810|75827813|FG001|COMPLETED|Overall Study||0||
59709159|NCT01200810|75827812|FG000|NOT COMPLETED|Overall Study||5||
59709160|NCT01200810|75827813|FG001|NOT COMPLETED|Overall Study||5||
59709161|NCT01200342|75827819|FG000|STARTED|Overall Study||7||
59709162|NCT01200342|75827819|FG000|COMPLETED|Overall Study||6||
59709163|NCT01200342|75827819|FG000|NOT COMPLETED|Overall Study||1||
59709164|NCT01199016|75827823|FG000|STARTED|Overall Study||239||
59709165|NCT01199016|75827823|FG000|Treated|Overall Study||236||
59709166|NCT01199016|75827823|FG000|COMPLETED|Overall Study||162||
59709167|NCT01199016|75827823|FG000|NOT COMPLETED|Overall Study||77||
59709168|NCT01198548|75827827|FG000|STARTED|Overall Study||10||
59709169|NCT01198548|75827827|FG000|COMPLETED|Overall Study||0||
59709170|NCT01198548|75827827|FG000|NOT COMPLETED|Overall Study||10||
59709171|NCT01198470|75827831|FG000|STARTED|Overall Study||20||
59817586|NCT03742037|75940123|FG001|COMPLETED|Treatment Period 2 (Month 6 - Month 12)||74||
59817587|NCT03742037|75940124|FG002|COMPLETED|Treatment Period 2 (Month 6 - Month 12)||59||
59817588|NCT03742037|75940125|FG003|COMPLETED|Treatment Period 2 (Month 6 - Month 12)||30||
59817589|NCT03742037|75940126|FG004|COMPLETED|Treatment Period 2 (Month 6 - Month 12)||35||
59817590|NCT03742037|75940127|FG005|COMPLETED|Treatment Period 2 (Month 6 - Month 12)||0||
59817591|NCT03742037|75940128|FG006|COMPLETED|Treatment Period 2 (Month 6 - Month 12)||68||
59817592|NCT03742037|75940122|FG000|NOT COMPLETED|Treatment Period 2 (Month 6 - Month 12)||4||
60103316|NCT01856543|76221496|FG000|NOT COMPLETED|Overall Study||13||
60103317|NCT01856543|76221497|FG001|NOT COMPLETED|Overall Study||6||
59709172|NCT01198470|75827831|FG000|COMPLETED|Overall Study||18||
59709173|NCT01198470|75827831|FG000|NOT COMPLETED|Overall Study||2||
59709174|NCT00977938|75827839|FG000|STARTED|Treatment (12-30 mo. Post Procedure)||5020||
59709175|NCT00977938|75827840|FG001|STARTED|Treatment (12-30 mo. Post Procedure)||4941||
59709176|NCT00977938|75827841|FG002|STARTED|Treatment (12-30 mo. Post Procedure)||842||
59709177|NCT00977938|75827842|FG003|STARTED|Treatment (12-30 mo. Post Procedure)||845||
59817593|NCT03742037|75940123|FG001|NOT COMPLETED|Treatment Period 2 (Month 6 - Month 12)||4||
59817594|NCT03742037|75940124|FG002|NOT COMPLETED|Treatment Period 2 (Month 6 - Month 12)||13||
59817595|NCT03742037|75940125|FG003|NOT COMPLETED|Treatment Period 2 (Month 6 - Month 12)||5||
59817596|NCT03742037|75940126|FG004|NOT COMPLETED|Treatment Period 2 (Month 6 - Month 12)||0||
59817597|NCT03742037|75940127|FG005|NOT COMPLETED|Treatment Period 2 (Month 6 - Month 12)||0||
60103318|NCT00632463|76221507|FG000|STARTED|Overall Study||7||
59709178|NCT00977938|75827839|FG000|COMPLETED|Treatment (12-30 mo. Post Procedure)||4783||
59817598|NCT03742037|75940128|FG006|NOT COMPLETED|Treatment Period 2 (Month 6 - Month 12)||9||
59817599|NCT03714815|75940145|FG000|STARTED|Overall Study||91||
60103319|NCT00632463|76221508|FG001|STARTED|Overall Study||7||
60103320|NCT00632463|76221509|FG002|STARTED|Overall Study||7||
60103321|NCT00632463|76221507|FG000|COMPLETED|Overall Study||7||
60103322|NCT00632463|76221508|FG001|COMPLETED|Overall Study||6||
60103323|NCT00632463|76221509|FG002|COMPLETED|Overall Study||7||
60103324|NCT00632463|76221507|FG000|NOT COMPLETED|Overall Study||0||
60103325|NCT00632463|76221508|FG001|NOT COMPLETED|Overall Study||1||
60103326|NCT00632463|76221509|FG002|NOT COMPLETED|Overall Study||0||
60103327|NCT00632229|76221519|FG000|STARTED|Overall Study||17||
60103328|NCT00632229|76221520|FG001|STARTED|Overall Study||17||
59709179|NCT00977938|75827840|FG001|COMPLETED|Treatment (12-30 mo. Post Procedure)||4716||
59709180|NCT00977938|75827841|FG002|COMPLETED|Treatment (12-30 mo. Post Procedure)||796||
59709181|NCT00977938|75827842|FG003|COMPLETED|Treatment (12-30 mo. Post Procedure)||784||
60103329|NCT00632229|76221519|FG000|COMPLETED|Overall Study||11||
60103330|NCT00632229|76221520|FG001|COMPLETED|Overall Study||11||
59709182|NCT00977938|75827839|FG000|NOT COMPLETED|Treatment (12-30 mo. Post Procedure)||237||
59709183|NCT00977938|75827840|FG001|NOT COMPLETED|Treatment (12-30 mo. Post Procedure)||225||
59709184|NCT00977938|75827841|FG002|NOT COMPLETED|Treatment (12-30 mo. Post Procedure)||46||
59709185|NCT00977938|75827842|FG003|NOT COMPLETED|Treatment (12-30 mo. Post Procedure)||61||
59709186|NCT00977938|75827839|FG000|STARTED|Observation (30-33 mo. Post Procedure)||4783||
59709187|NCT00977938|75827840|FG001|STARTED|Observation (30-33 mo. Post Procedure)||4716||
59709188|NCT00977938|75827841|FG002|STARTED|Observation (30-33 mo. Post Procedure)||796||
59709189|NCT00977938|75827842|FG003|STARTED|Observation (30-33 mo. Post Procedure)||784||
59709190|NCT00977938|75827839|FG000|COMPLETED|Observation (30-33 mo. Post Procedure)||4732||
59709191|NCT00977938|75827840|FG001|COMPLETED|Observation (30-33 mo. Post Procedure)||4658||
59709192|NCT00977938|75827841|FG002|COMPLETED|Observation (30-33 mo. Post Procedure)||784||
59817600|NCT03714815|75940145|FG000|COMPLETED|Overall Study||76||
59817601|NCT03714815|75940145|FG000|NOT COMPLETED|Overall Study||15||
59817602|NCT03686488|75940149|FG000|STARTED|Overall Study||23||
59817603|NCT03686488|75940149|FG000|COMPLETED|Overall Study||23||
59817604|NCT03686488|75940149|FG000|NOT COMPLETED|Overall Study||0||
59817605|NCT03640312|75940155|FG000|STARTED|Overall Study||32||
59817606|NCT03640312|75940156|FG001|STARTED|Overall Study||30||
59817607|NCT03640312|75940155|FG000|6 Week Follow Up|Overall Study||32||
59817608|NCT03640312|75940156|FG001|6 Week Follow Up|Overall Study||28||
59817609|NCT03640312|75940155|FG000|COMPLETED|Overall Study||29||
59817610|NCT03640312|75940156|FG001|COMPLETED|Overall Study||24||
59817611|NCT03640312|75940155|FG000|NOT COMPLETED|Overall Study||3||
59817612|NCT03640312|75940156|FG001|NOT COMPLETED|Overall Study||6||
59817613|NCT03272464|75940162|FG000|STARTED|Overall Study|Participant received starting dose (DL1) = 150mg DABRAFENIB twice daily by mouth + 2mg TRAMETINIB once daily by mouth + 200mg INCB039110 once daily|1||
59817614|NCT03272464|75940162|FG000|COMPLETED|Overall Study||0||
59817615|NCT03272464|75940162|FG000|NOT COMPLETED|Overall Study||1||
59817616|NCT03071406|75940168|FG000|STARTED|Overall Study||25||
59817617|NCT03071406|75940169|FG001|STARTED|Overall Study||25||
59817618|NCT03071406|75940168|FG000|COMPLETED|Overall Study||25||
59817619|NCT03071406|75940169|FG001|COMPLETED|Overall Study||24||
59817620|NCT03071406|75940168|FG000|NOT COMPLETED|Overall Study||0||
59817621|NCT03071406|75940169|FG001|NOT COMPLETED|Overall Study||1||
59817622|NCT02254278|75940177|FG000|STARTED|Overall Study||158||
59817623|NCT02254278|75940178|FG001|STARTED|Overall Study||150||
59817624|NCT02254278|75940177|FG000|Eligible|Overall Study||157||
59817625|NCT02254278|75940178|FG001|Eligible|Overall Study||149||
59817626|NCT02254278|75940177|FG000|Started Study Treatment|Overall Study||152|Randomized and eligible participants who started study treatment|
59817627|NCT02254278|75940178|FG001|Started Study Treatment|Overall Study||147|Randomized and eligible participants who started study treatment|
59817628|NCT02254278|75940177|FG000|Negative Post-treatment PET|Overall Study||58|Randomized and eligible with negative post-treatment positron emission tomography (PET) scan|
59817629|NCT02254278|75940178|FG001|Negative Post-treatment PET|Overall Study||57|Randomized and eligible with negative post-treatment positron emission tomography (PET) scan|
59817630|NCT02254278|75940177|FG000|COMPLETED|Overall Study||157|Participants contributing data to results are considered to have completed the study|
59817631|NCT02254278|75940178|FG001|COMPLETED|Overall Study||149|Participants contributing data to results are considered to have completed the study|
59817632|NCT02254278|75940177|FG000|NOT COMPLETED|Overall Study||1||
59817633|NCT02254278|75940178|FG001|NOT COMPLETED|Overall Study||1||
59817634|NCT01998841|75940190|FG000|STARTED|Study Period A||85||
59817635|NCT01998841|75940191|FG001|STARTED|Study Period A||84||
59817636|NCT01998841|75940192|FG002|STARTED|Study Period A||83||
59817637|NCT01998841|75940193|FG003|STARTED|Study Period A||0||
59817638|NCT01998841|75940194|FG004|STARTED|Study Period A||0||
59817639|NCT01998841|75940190|FG000|COMPLETED|Study Period A||79||
59817640|NCT01998841|75940191|FG001|COMPLETED|Study Period A||78||
59817641|NCT01998841|75940192|FG002|COMPLETED|Study Period A||80||
59817642|NCT01998841|75940193|FG003|COMPLETED|Study Period A||0||
59994743|NCT03987919|76110563|FG000|STARTED|Overall Study||471||
59817643|NCT01998841|75940194|FG004|COMPLETED|Study Period A||0||
59994744|NCT03987919|76110564|FG001|STARTED|Overall Study||469||
59994745|NCT03987919|76110565|FG002|STARTED|Overall Study||470||
59994746|NCT03987919|76110566|FG003|STARTED|Overall Study||469||
59994747|NCT03987919|76110563|FG000|Received at Least One Dose of Study Drug|Overall Study||470||
59994748|NCT03987919|76110564|FG001|Received at Least One Dose of Study Drug|Overall Study||469||
59817644|NCT01998841|75940190|FG000|NOT COMPLETED|Study Period A||6||
59994749|NCT03987919|76110565|FG002|Received at Least One Dose of Study Drug|Overall Study||470||
59817645|NCT01998841|75940191|FG001|NOT COMPLETED|Study Period A||6||
59817646|NCT01998841|75940192|FG002|NOT COMPLETED|Study Period A||3||
59817647|NCT01998841|75940193|FG003|NOT COMPLETED|Study Period A||0||
59817648|NCT01998841|75940194|FG004|NOT COMPLETED|Study Period A||0||
59994750|NCT03987919|76110566|FG003|Received at Least One Dose of Study Drug|Overall Study||469||
59994751|NCT03987919|76110563|FG000|COMPLETED|Overall Study||452||
59994752|NCT03987919|76110564|FG001|COMPLETED|Overall Study||442||
59994753|NCT03987919|76110565|FG002|COMPLETED|Overall Study||446||
59817649|NCT01998841|75940190|FG000|STARTED|Study Period B|Following the end of Period A, participants were given the option to continue receiving the study treatment in Period B until the results of the study are known or post-trial access to crenezumab is started or development of crenezumab is discontinued.|0||
59817650|NCT01998841|75940191|FG001|STARTED|Study Period B|Following the end of Period A participants were given the option to continue receiving the study treatment in Period B until the results of the study are known or post-trial access to crenezumab is started or development of crenezumab is discontinued.|0||
59817651|NCT01998841|75940192|FG002|STARTED|Study Period B|Following the end of Period A participants were given the option to continue receiving the study treatment in Period B until the results of the study are known or post-trial access to crenezumab is started or development of crenezumab is discontinued.|0||
59817652|NCT01998841|75940193|FG003|STARTED|Study Period B|Following the end of Period A participants were given the option to continue receiving the study treatment in Period B until the results of the study are known or post-trial access to crenezumab is started or development of crenezumab is discontinued.|147||
59817653|NCT01998841|75940194|FG004|STARTED|Study Period B|Following the end of Period A participants were given the option to continue receiving the study treatment in Period B until the results of the study are known or post-trial access to crenezumab is started or development of crenezumab is discontinued.|72||
59817654|NCT01998841|75940190|FG000|COMPLETED|Study Period B||0||
59817655|NCT01998841|75940191|FG001|COMPLETED|Study Period B||0||
59817656|NCT01998841|75940192|FG002|COMPLETED|Study Period B||0||
59817657|NCT01998841|75940193|FG003|COMPLETED|Study Period B||0||
59817658|NCT01998841|75940194|FG004|COMPLETED|Study Period B||0||
59817659|NCT01998841|75940190|FG000|NOT COMPLETED|Study Period B||0||
59709193|NCT00977938|75827842|FG003|COMPLETED|Observation (30-33 mo. Post Procedure)||781||
59709194|NCT00977938|75827839|FG000|NOT COMPLETED|Observation (30-33 mo. Post Procedure)||51||
59709195|NCT00977938|75827840|FG001|NOT COMPLETED|Observation (30-33 mo. Post Procedure)||58||
59709196|NCT00977938|75827841|FG002|NOT COMPLETED|Observation (30-33 mo. Post Procedure)||12||
59709197|NCT00977938|75827842|FG003|NOT COMPLETED|Observation (30-33 mo. Post Procedure)||3||
59709198|NCT02716675|75827857|FG000|STARTED|Overall Study||903|Enrollment is concurrent with receiving the first infusion (safety analyses)|
60103331|NCT00632229|76221519|FG000|NOT COMPLETED|Overall Study||6||
60103332|NCT00632229|76221520|FG001|NOT COMPLETED|Overall Study||6||
60103333|NCT00631137|76221528|FG000|STARTED|Overall Study||1||
60103334|NCT00631137|76221529|FG001|STARTED|Overall Study||0||
60103335|NCT00631137|76221528|FG000|COMPLETED|Overall Study||0||
59817660|NCT01998841|75940191|FG001|NOT COMPLETED|Study Period B||0||
59817661|NCT01998841|75940192|FG002|NOT COMPLETED|Study Period B||0||
59817662|NCT01998841|75940193|FG003|NOT COMPLETED|Study Period B||147||
59817663|NCT01998841|75940194|FG004|NOT COMPLETED|Study Period B||72||
59817664|NCT01607879|75940204|FG000|STARTED|Overall Study||24||
59817665|NCT01607879|75940205|FG001|STARTED|Overall Study||24||
59817666|NCT01607879|75940204|FG000|COMPLETED|Overall Study||23||
59709199|NCT02716675|75827858|FG001|STARTED|Overall Study||899|Enrollment is concurrent with receiving the first infusion (safety analyses)|
59709200|NCT02716675|75827859|FG002|STARTED|Overall Study||897|Enrollment is concurrent with receiving the first infusion (safety analyses)|
59709201|NCT02716675|75827857|FG000|Modified Intent-to-treat Population|Overall Study||898|Participants excluded from MITT if HIV positive at enrollment or randomized/enrolled more than once (efficacy analyses)|
59709202|NCT02716675|75827858|FG001|Modified Intent-to-treat Population|Overall Study||895|Participants excluded from MITT if HIV positive at enrollment or randomized/enrolled more than once (efficacy analyses)|
59709839|NCT01072149|75828533|FG013|STARTED|Treatment Period 2 (28 Days)||3||
59817667|NCT01607879|75940205|FG001|COMPLETED|Overall Study||24||
59817668|NCT01607879|75940204|FG000|NOT COMPLETED|Overall Study||1||
59817669|NCT01607879|75940205|FG001|NOT COMPLETED|Overall Study||0||
60103336|NCT00631137|76221529|FG001|COMPLETED|Overall Study||0||
60103337|NCT00631137|76221528|FG000|NOT COMPLETED|Overall Study||1||
60103338|NCT00631137|76221529|FG001|NOT COMPLETED|Overall Study||0||
60103339|NCT03085563|76221537|FG000|STARTED|Overall Study||19||
60103340|NCT03085563|76221538|FG001|STARTED|Overall Study||41||
60103341|NCT03085563|76221537|FG000|COMPLETED|Overall Study||19||
60103342|NCT03085563|76221538|FG001|COMPLETED|Overall Study||41||
60103343|NCT03085563|76221537|FG000|NOT COMPLETED|Overall Study||0||
60103344|NCT03085563|76221538|FG001|NOT COMPLETED|Overall Study||0||
60103345|NCT00630825|76221548|FG000|STARTED|Overall Study||65||
60103346|NCT00630825|76221549|FG001|STARTED|Overall Study||65||
60103347|NCT00630825|76221550|FG002|STARTED|Overall Study||66||
59817670|NCT01336933|75940211|FG000|STARTED|Overall Study||34||
59817671|NCT01336933|75940211|FG000|COMPLETED|Overall Study||33||
59817672|NCT01336933|75940211|FG000|NOT COMPLETED|Overall Study||1||
59817673|NCT00352027|75940216|FG000|STARTED|Overall Study||80||
59817674|NCT00352027|75940216|FG000|COMPLETED|Overall Study||77||
59817675|NCT00352027|75940216|FG000|NOT COMPLETED|Overall Study||3||
59817676|NCT00082641|75940248|FG000|STARTED|Overall Study||11||
59817677|NCT00082641|75940249|FG001|STARTED|Overall Study||12||
59817678|NCT00082641|75940248|FG000|COMPLETED|Overall Study||11||
59817679|NCT00082641|75940249|FG001|COMPLETED|Overall Study||12||
59817680|NCT00082641|75940248|FG000|NOT COMPLETED|Overall Study||0||
59817681|NCT00082641|75940249|FG001|NOT COMPLETED|Overall Study||0||
59817682|NCT00440271|75940258|FG000|STARTED|Overall Study||15||
59817683|NCT00440271|75940259|FG001|STARTED|Overall Study||18||
59817684|NCT00440271|75940258|FG000|COMPLETED|Overall Study||3||
59817685|NCT00440271|75940259|FG001|COMPLETED|Overall Study||3||
59817686|NCT00440271|75940258|FG000|NOT COMPLETED|Overall Study||12||
59817687|NCT00440271|75940259|FG001|NOT COMPLETED|Overall Study||15||
59817688|NCT00346216|75940268|FG000|STARTED|Overall Study||8072||
59817689|NCT00346216|75940269|FG001|STARTED|Overall Study||8040||
59817690|NCT00346216|75940270|FG002|STARTED|Overall Study||7969||
59817691|NCT00346216|75940268|FG000|COMPLETED|Overall Study||5664||
59817692|NCT00346216|75940269|FG001|COMPLETED|Overall Study||5580||
59817693|NCT00346216|75940270|FG002|COMPLETED|Overall Study||5621||
59817694|NCT00346216|75940268|FG000|NOT COMPLETED|Overall Study||2408||
59817695|NCT00346216|75940269|FG001|NOT COMPLETED|Overall Study||2460||
59817696|NCT00346216|75940270|FG002|NOT COMPLETED|Overall Study||2348||
59817697|NCT00417963|75940278|FG000|STARTED|Overall Study|79 participants were enrolled in the roll-in cohort and 407 in the pivotal cohort.|486||
59817698|NCT00417963|75940278|FG000|COMPLETED|Overall Study|79 subjects completed in the roll-in cohort and 371 in the pivotal cohort.|445||
59817699|NCT00417963|75940278|FG000|NOT COMPLETED|Overall Study||41||
59817700|NCT00429273|75940290|FG000|STARTED|Overall Study||68||
59817701|NCT00429273|75940291|FG001|STARTED|Overall Study||69||
59817702|NCT00429273|75940292|FG002|STARTED|Overall Study||70||
59817703|NCT00429273|75940290|FG000|COMPLETED|Overall Study||60||
59817704|NCT00429273|75940291|FG001|COMPLETED|Overall Study||61||
59817705|NCT00429273|75940292|FG002|COMPLETED|Overall Study||61||
59817706|NCT00429273|75940290|FG000|NOT COMPLETED|Overall Study||8||
59817707|NCT00429273|75940291|FG001|NOT COMPLETED|Overall Study||8||
59817708|NCT00429273|75940292|FG002|NOT COMPLETED|Overall Study||9||
59817709|NCT00359632|75940302|FG000|STARTED|Overall Study||24||
59817710|NCT00359632|75940303|FG001|STARTED|Overall Study||9||
59817711|NCT00359632|75940302|FG000|COMPLETED|Overall Study||20||
59817712|NCT00359632|75940303|FG001|COMPLETED|Overall Study||9||
59817713|NCT00359632|75940302|FG000|NOT COMPLETED|Overall Study||4||
59817714|NCT00359632|75940303|FG001|NOT COMPLETED|Overall Study||0||
59817715|NCT00417885|75940309|FG000|STARTED|Overall Study||6||
59817716|NCT00417885|75940309|FG000|COMPLETED|Overall Study||0||
59817717|NCT00417885|75940309|FG000|NOT COMPLETED|Overall Study||6||
59817718|NCT04488770|75940326|FG000|STARTED|Part 1-Cohort 1: Period 1 (Up to 5 Days)||2||
59817719|NCT04488770|75940327|FG001|STARTED|Part 1-Cohort 1: Period 1 (Up to 5 Days)||2||
59817720|NCT04488770|75940328|FG002|STARTED|Part 1-Cohort 1: Period 1 (Up to 5 Days)||2||
59817721|NCT04488770|75940329|FG003|STARTED|Part 1-Cohort 1: Period 1 (Up to 5 Days)||2||
59817722|NCT04488770|75940330|FG004|STARTED|Part 1-Cohort 1: Period 1 (Up to 5 Days)||0||
59817723|NCT04488770|75940331|FG005|STARTED|Part 1-Cohort 1: Period 1 (Up to 5 Days)||0||
60103348|NCT00630825|76221551|FG003|STARTED|Overall Study||66||
60103349|NCT00630825|76221548|FG000|Received at Least One Dose of Study Drug|Overall Study||65||
60103350|NCT00630825|76221549|FG001|Received at Least One Dose of Study Drug|Overall Study||65||
60103351|NCT00630825|76221550|FG002|Received at Least One Dose of Study Drug|Overall Study||66||
60103352|NCT00630825|76221551|FG003|Received at Least One Dose of Study Drug|Overall Study||66||
60103353|NCT00630825|76221548|FG000|COMPLETED|Overall Study||56||
60103354|NCT00630825|76221549|FG001|COMPLETED|Overall Study||58||
59817724|NCT04488770|75940332|FG006|STARTED|Part 1-Cohort 1: Period 1 (Up to 5 Days)||0||
59817725|NCT04488770|75940333|FG007|STARTED|Part 1-Cohort 1: Period 1 (Up to 5 Days)||0||
59817726|NCT04488770|75940334|FG008|STARTED|Part 1-Cohort 1: Period 1 (Up to 5 Days)||0||
59817727|NCT04488770|75940335|FG009|STARTED|Part 1-Cohort 1: Period 1 (Up to 5 Days)||0||
59817728|NCT04488770|75940336|FG010|STARTED|Part 1-Cohort 1: Period 1 (Up to 5 Days)||0||
59817729|NCT04488770|75940337|FG011|STARTED|Part 1-Cohort 1: Period 1 (Up to 5 Days)||0||
59817730|NCT04488770|75940338|FG012|STARTED|Part 1-Cohort 1: Period 1 (Up to 5 Days)||0||
59817731|NCT04488770|75940326|FG000|COMPLETED|Part 1-Cohort 1: Period 1 (Up to 5 Days)||2||
59817732|NCT04488770|75940327|FG001|COMPLETED|Part 1-Cohort 1: Period 1 (Up to 5 Days)||2||
59817733|NCT04488770|75940328|FG002|COMPLETED|Part 1-Cohort 1: Period 1 (Up to 5 Days)||2||
59817734|NCT04488770|75940329|FG003|COMPLETED|Part 1-Cohort 1: Period 1 (Up to 5 Days)||1||
59817735|NCT04488770|75940330|FG004|COMPLETED|Part 1-Cohort 1: Period 1 (Up to 5 Days)||0||
59817736|NCT04488770|75940331|FG005|COMPLETED|Part 1-Cohort 1: Period 1 (Up to 5 Days)||0||
59817737|NCT04488770|75940332|FG006|COMPLETED|Part 1-Cohort 1: Period 1 (Up to 5 Days)||0||
59817738|NCT04488770|75940333|FG007|COMPLETED|Part 1-Cohort 1: Period 1 (Up to 5 Days)||0||
59817739|NCT04488770|75940334|FG008|COMPLETED|Part 1-Cohort 1: Period 1 (Up to 5 Days)||0||
59817740|NCT04488770|75940335|FG009|COMPLETED|Part 1-Cohort 1: Period 1 (Up to 5 Days)||0||
59817741|NCT04488770|75940336|FG010|COMPLETED|Part 1-Cohort 1: Period 1 (Up to 5 Days)||0||
59817742|NCT04488770|75940337|FG011|COMPLETED|Part 1-Cohort 1: Period 1 (Up to 5 Days)||0||
59817743|NCT04488770|75940338|FG012|COMPLETED|Part 1-Cohort 1: Period 1 (Up to 5 Days)||0||
59817744|NCT04488770|75940326|FG000|NOT COMPLETED|Part 1-Cohort 1: Period 1 (Up to 5 Days)||0||
60103355|NCT00630825|76221550|FG002|COMPLETED|Overall Study||58||
60103356|NCT00630825|76221551|FG003|COMPLETED|Overall Study||60||
60103357|NCT00630825|76221548|FG000|NOT COMPLETED|Overall Study||9||
60103358|NCT00630825|76221549|FG001|NOT COMPLETED|Overall Study||7||
60103359|NCT00630825|76221550|FG002|NOT COMPLETED|Overall Study||8||
60103360|NCT00630825|76221551|FG003|NOT COMPLETED|Overall Study||6||
60103361|NCT01241344|76221565|FG000|STARTED|Overall Study||14||
60103362|NCT01241344|76221566|FG001|STARTED|Overall Study||16||
59817745|NCT04488770|75940327|FG001|NOT COMPLETED|Part 1-Cohort 1: Period 1 (Up to 5 Days)||0||
59817746|NCT04488770|75940328|FG002|NOT COMPLETED|Part 1-Cohort 1: Period 1 (Up to 5 Days)||0||
59817747|NCT04488770|75940329|FG003|NOT COMPLETED|Part 1-Cohort 1: Period 1 (Up to 5 Days)||1||
60103363|NCT01241344|76221567|FG002|STARTED|Overall Study||18||
60103364|NCT01241344|76221568|FG003|STARTED|Overall Study||4||
59817748|NCT04488770|75940330|FG004|NOT COMPLETED|Part 1-Cohort 1: Period 1 (Up to 5 Days)||0||
59709203|NCT02716675|75827859|FG002|Modified Intent-to-treat Population|Overall Study||894|Participants excluded from MITT if HIV positive at enrollment or randomized/enrolled more than once (efficacy analyses)|
59709204|NCT02716675|75827857|FG000|COMPLETED|Overall Study||703||
59709205|NCT02716675|75827858|FG001|COMPLETED|Overall Study||702||
59817749|NCT04488770|75940331|FG005|NOT COMPLETED|Part 1-Cohort 1: Period 1 (Up to 5 Days)||0||
59817750|NCT04488770|75940332|FG006|NOT COMPLETED|Part 1-Cohort 1: Period 1 (Up to 5 Days)||0||
59817751|NCT04488770|75940333|FG007|NOT COMPLETED|Part 1-Cohort 1: Period 1 (Up to 5 Days)||0||
59817752|NCT04488770|75940334|FG008|NOT COMPLETED|Part 1-Cohort 1: Period 1 (Up to 5 Days)||0||
59817753|NCT04488770|75940335|FG009|NOT COMPLETED|Part 1-Cohort 1: Period 1 (Up to 5 Days)||0||
59709206|NCT02716675|75827859|FG002|COMPLETED|Overall Study||686||
60103365|NCT01241344|76221565|FG000|Randomized to Open-label|Overall Study||3|The number of previously randomized subjects who were considered treatment failures were offered open-label BCV therapy.|
60103366|NCT01241344|76221566|FG001|Randomized to Open-label|Overall Study||4|The number of previously randomized subjects who were considered treatment failures were offered open-label BCV therapy.|
60103367|NCT01241344|76221567|FG002|Randomized to Open-label|Overall Study||5|The number of previously randomized subjects who were considered treatment failures were offered open-label BCV therapy.|
60103368|NCT01241344|76221568|FG003|Randomized to Open-label|Overall Study||0|The number of previously randomized subjects who were considered treatment failures were offered open-label BCV therapy.|
59817754|NCT04488770|75940336|FG010|NOT COMPLETED|Part 1-Cohort 1: Period 1 (Up to 5 Days)||0||
59817755|NCT04488770|75940337|FG011|NOT COMPLETED|Part 1-Cohort 1: Period 1 (Up to 5 Days)||0||
59817756|NCT04488770|75940338|FG012|NOT COMPLETED|Part 1-Cohort 1: Period 1 (Up to 5 Days)||0||
59817757|NCT04488770|75940326|FG000|STARTED|Part 1-Cohort 1: Period 2 (Up to 5 Days)||2||
59817758|NCT04488770|75940327|FG001|STARTED|Part 1-Cohort 1: Period 2 (Up to 5 Days)||2||
59817759|NCT04488770|75940328|FG002|STARTED|Part 1-Cohort 1: Period 2 (Up to 5 Days)||2||
59817760|NCT04488770|75940329|FG003|STARTED|Part 1-Cohort 1: Period 2 (Up to 5 Days)|New participant enrolled and dosed as a replacement of withdrawn participant|2||
59817761|NCT04488770|75940330|FG004|STARTED|Part 1-Cohort 1: Period 2 (Up to 5 Days)||0||
59817762|NCT04488770|75940331|FG005|STARTED|Part 1-Cohort 1: Period 2 (Up to 5 Days)||0||
59817763|NCT04488770|75940332|FG006|STARTED|Part 1-Cohort 1: Period 2 (Up to 5 Days)||0||
59817764|NCT04488770|75940333|FG007|STARTED|Part 1-Cohort 1: Period 2 (Up to 5 Days)||0||
59817765|NCT04488770|75940334|FG008|STARTED|Part 1-Cohort 1: Period 2 (Up to 5 Days)||0||
59817766|NCT04488770|75940335|FG009|STARTED|Part 1-Cohort 1: Period 2 (Up to 5 Days)||0||
59817767|NCT04488770|75940336|FG010|STARTED|Part 1-Cohort 1: Period 2 (Up to 5 Days)||0||
59817768|NCT04488770|75940337|FG011|STARTED|Part 1-Cohort 1: Period 2 (Up to 5 Days)||0||
59817769|NCT04488770|75940338|FG012|STARTED|Part 1-Cohort 1: Period 2 (Up to 5 Days)||0||
59817770|NCT04488770|75940326|FG000|COMPLETED|Part 1-Cohort 1: Period 2 (Up to 5 Days)||2||
59817771|NCT04488770|75940327|FG001|COMPLETED|Part 1-Cohort 1: Period 2 (Up to 5 Days)||2||
59817772|NCT04488770|75940328|FG002|COMPLETED|Part 1-Cohort 1: Period 2 (Up to 5 Days)||2||
59817773|NCT04488770|75940329|FG003|COMPLETED|Part 1-Cohort 1: Period 2 (Up to 5 Days)||2||
59817774|NCT04488770|75940330|FG004|COMPLETED|Part 1-Cohort 1: Period 2 (Up to 5 Days)||0||
59817775|NCT04488770|75940331|FG005|COMPLETED|Part 1-Cohort 1: Period 2 (Up to 5 Days)||0||
59817776|NCT04488770|75940332|FG006|COMPLETED|Part 1-Cohort 1: Period 2 (Up to 5 Days)||0||
59817777|NCT04488770|75940333|FG007|COMPLETED|Part 1-Cohort 1: Period 2 (Up to 5 Days)||0||
60103369|NCT01241344|76221565|FG000|COMPLETED|Overall Study||9||
60103370|NCT01241344|76221566|FG001|COMPLETED|Overall Study||7||
60103371|NCT01241344|76221567|FG002|COMPLETED|Overall Study||9||
59709207|NCT02716675|75827857|FG000|NOT COMPLETED|Overall Study||200||
59709208|NCT02716675|75827858|FG001|NOT COMPLETED|Overall Study||197||
59709209|NCT02716675|75827859|FG002|NOT COMPLETED|Overall Study||211||
59709210|NCT00977548|75827872|FG000|STARTED|Overall Study||39||
59709211|NCT00977548|75827872|FG000|COMPLETED|Overall Study||26||
59709212|NCT00977548|75827872|FG000|NOT COMPLETED|Overall Study||13||
59709213|NCT01090011|75827876|FG000|STARTED|Overall Study||171||
59709214|NCT01090011|75827876|FG000|COMPLETED|Overall Study||0||
59817778|NCT04488770|75940334|FG008|COMPLETED|Part 1-Cohort 1: Period 2 (Up to 5 Days)||0||
59817779|NCT04488770|75940335|FG009|COMPLETED|Part 1-Cohort 1: Period 2 (Up to 5 Days)||0||
59817780|NCT04488770|75940336|FG010|COMPLETED|Part 1-Cohort 1: Period 2 (Up to 5 Days)||0||
59817781|NCT04488770|75940337|FG011|COMPLETED|Part 1-Cohort 1: Period 2 (Up to 5 Days)||0||
59817782|NCT04488770|75940338|FG012|COMPLETED|Part 1-Cohort 1: Period 2 (Up to 5 Days)||0||
59817783|NCT04488770|75940326|FG000|NOT COMPLETED|Part 1-Cohort 1: Period 2 (Up to 5 Days)||0||
59817784|NCT04488770|75940327|FG001|NOT COMPLETED|Part 1-Cohort 1: Period 2 (Up to 5 Days)||0||
59817785|NCT04488770|75940328|FG002|NOT COMPLETED|Part 1-Cohort 1: Period 2 (Up to 5 Days)||0||
59817786|NCT04488770|75940329|FG003|NOT COMPLETED|Part 1-Cohort 1: Period 2 (Up to 5 Days)||0||
59817787|NCT04488770|75940330|FG004|NOT COMPLETED|Part 1-Cohort 1: Period 2 (Up to 5 Days)||0||
59817788|NCT04488770|75940331|FG005|NOT COMPLETED|Part 1-Cohort 1: Period 2 (Up to 5 Days)||0||
59817789|NCT04488770|75940332|FG006|NOT COMPLETED|Part 1-Cohort 1: Period 2 (Up to 5 Days)||0||
59817790|NCT04488770|75940333|FG007|NOT COMPLETED|Part 1-Cohort 1: Period 2 (Up to 5 Days)||0||
59817791|NCT04488770|75940334|FG008|NOT COMPLETED|Part 1-Cohort 1: Period 2 (Up to 5 Days)||0||
59817792|NCT04488770|75940335|FG009|NOT COMPLETED|Part 1-Cohort 1: Period 2 (Up to 5 Days)||0||
59817793|NCT04488770|75940336|FG010|NOT COMPLETED|Part 1-Cohort 1: Period 2 (Up to 5 Days)||0||
59817794|NCT04488770|75940337|FG011|NOT COMPLETED|Part 1-Cohort 1: Period 2 (Up to 5 Days)||0||
59817795|NCT04488770|75940338|FG012|NOT COMPLETED|Part 1-Cohort 1: Period 2 (Up to 5 Days)||0||
59817796|NCT04488770|75940326|FG000|STARTED|Part 1-Cohort 1: Period 3 (Up to 5 Days)||2||
59817797|NCT04488770|75940327|FG001|STARTED|Part 1-Cohort 1: Period 3 (Up to 5 Days)||2||
59817798|NCT04488770|75940328|FG002|STARTED|Part 1-Cohort 1: Period 3 (Up to 5 Days)||2||
59817799|NCT04488770|75940329|FG003|STARTED|Part 1-Cohort 1: Period 3 (Up to 5 Days)||2||
59817800|NCT04488770|75940330|FG004|STARTED|Part 1-Cohort 1: Period 3 (Up to 5 Days)||0||
59817801|NCT04488770|75940331|FG005|STARTED|Part 1-Cohort 1: Period 3 (Up to 5 Days)||0||
59709215|NCT01090011|75827876|FG000|NOT COMPLETED|Overall Study||171||
59709216|NCT01251653|75827897|FG000|STARTED|Overall Study||3||
59709217|NCT01251653|75827898|FG001|STARTED|Overall Study||8||
59709218|NCT01251653|75827899|FG002|STARTED|Overall Study||20||
59709219|NCT01251653|75827900|FG003|STARTED|Overall Study||6||
59817802|NCT04488770|75940332|FG006|STARTED|Part 1-Cohort 1: Period 3 (Up to 5 Days)||0||
59817803|NCT04488770|75940333|FG007|STARTED|Part 1-Cohort 1: Period 3 (Up to 5 Days)||0||
59817804|NCT04488770|75940334|FG008|STARTED|Part 1-Cohort 1: Period 3 (Up to 5 Days)||0||
59817805|NCT04488770|75940335|FG009|STARTED|Part 1-Cohort 1: Period 3 (Up to 5 Days)||0||
59817806|NCT04488770|75940336|FG010|STARTED|Part 1-Cohort 1: Period 3 (Up to 5 Days)||0||
59817807|NCT04488770|75940337|FG011|STARTED|Part 1-Cohort 1: Period 3 (Up to 5 Days)||0||
59817808|NCT04488770|75940338|FG012|STARTED|Part 1-Cohort 1: Period 3 (Up to 5 Days)||0||
59817809|NCT04488770|75940326|FG000|COMPLETED|Part 1-Cohort 1: Period 3 (Up to 5 Days)||1||
59817810|NCT04488770|75940327|FG001|COMPLETED|Part 1-Cohort 1: Period 3 (Up to 5 Days)||2||
59817811|NCT04488770|75940328|FG002|COMPLETED|Part 1-Cohort 1: Period 3 (Up to 5 Days)||2||
59817812|NCT04488770|75940329|FG003|COMPLETED|Part 1-Cohort 1: Period 3 (Up to 5 Days)||2||
59817813|NCT04488770|75940330|FG004|COMPLETED|Part 1-Cohort 1: Period 3 (Up to 5 Days)||0||
59817814|NCT04488770|75940331|FG005|COMPLETED|Part 1-Cohort 1: Period 3 (Up to 5 Days)||0||
59817815|NCT04488770|75940332|FG006|COMPLETED|Part 1-Cohort 1: Period 3 (Up to 5 Days)||0||
59817816|NCT04488770|75940333|FG007|COMPLETED|Part 1-Cohort 1: Period 3 (Up to 5 Days)||0||
59817817|NCT04488770|75940334|FG008|COMPLETED|Part 1-Cohort 1: Period 3 (Up to 5 Days)||0||
59817818|NCT04488770|75940335|FG009|COMPLETED|Part 1-Cohort 1: Period 3 (Up to 5 Days)||0||
59817819|NCT04488770|75940336|FG010|COMPLETED|Part 1-Cohort 1: Period 3 (Up to 5 Days)||0||
59817820|NCT04488770|75940337|FG011|COMPLETED|Part 1-Cohort 1: Period 3 (Up to 5 Days)||0||
59817821|NCT04488770|75940338|FG012|COMPLETED|Part 1-Cohort 1: Period 3 (Up to 5 Days)||0||
59565674|NCT01846988|75668046|FG002|COMPLETED|APAP Pressurize Comparison (4-8 Weeks)||0||
59565675|NCT01846988|75668044|FG000|NOT COMPLETED|APAP Pressurize Comparison (4-8 Weeks)||0||
59709220|NCT01251653|75827901|FG004|STARTED|Overall Study||2||
59709221|NCT01251653|75827902|FG005|STARTED|Overall Study||18||
59817822|NCT04488770|75940326|FG000|NOT COMPLETED|Part 1-Cohort 1: Period 3 (Up to 5 Days)||1||
59565676|NCT01846988|75668045|FG001|NOT COMPLETED|APAP Pressurize Comparison (4-8 Weeks)||0||
59565677|NCT01846988|75668046|FG002|NOT COMPLETED|APAP Pressurize Comparison (4-8 Weeks)||0||
59565678|NCT01846988|75668044|FG000|STARTED|Intervention #1 - 4 Weeks||0||
59565679|NCT01846988|75668045|FG001|STARTED|Intervention #1 - 4 Weeks|Only 10 of 15 participants completing Comparison period started periods 1 & 2|5||
59565680|NCT01846988|75668046|FG002|STARTED|Intervention #1 - 4 Weeks||5||
59565681|NCT01846988|75668044|FG000|COMPLETED|Intervention #1 - 4 Weeks||0||
59709222|NCT01251653|75827903|FG006|STARTED|Overall Study||18||
59709223|NCT01251653|75827904|FG007|STARTED|Overall Study||12||
59709224|NCT01251653|75827905|FG008|STARTED|Overall Study||6||
59709225|NCT01251653|75827897|FG000|COMPLETED|Overall Study||0||
59709226|NCT01251653|75827898|FG001|COMPLETED|Overall Study||0||
59709227|NCT01251653|75827899|FG002|COMPLETED|Overall Study||0||
59709228|NCT01251653|75827900|FG003|COMPLETED|Overall Study||0||
59709229|NCT01251653|75827901|FG004|COMPLETED|Overall Study||0||
59709230|NCT01251653|75827902|FG005|COMPLETED|Overall Study||0||
59709231|NCT01251653|75827903|FG006|COMPLETED|Overall Study||0||
59817823|NCT04488770|75940327|FG001|NOT COMPLETED|Part 1-Cohort 1: Period 3 (Up to 5 Days)||0||
59817824|NCT04488770|75940328|FG002|NOT COMPLETED|Part 1-Cohort 1: Period 3 (Up to 5 Days)||0||
59994754|NCT03987919|76110566|FG003|COMPLETED|Overall Study||443||
59994755|NCT03987919|76110563|FG000|NOT COMPLETED|Overall Study||19||
59994756|NCT03987919|76110564|FG001|NOT COMPLETED|Overall Study||27||
59994757|NCT03987919|76110565|FG002|NOT COMPLETED|Overall Study||24||
59994758|NCT03987919|76110566|FG003|NOT COMPLETED|Overall Study||26||
59709232|NCT01251653|75827904|FG007|COMPLETED|Overall Study||0||
59994759|NCT00535405|76110586|FG000|STARTED|Overall Study||257||
59994760|NCT00535405|76110587|FG001|STARTED|Overall Study||259||
59565682|NCT01846988|75668045|FG001|COMPLETED|Intervention #1 - 4 Weeks||5||
59709233|NCT01251653|75827905|FG008|COMPLETED|Overall Study||0||
59709234|NCT01251653|75827897|FG000|NOT COMPLETED|Overall Study||3||
59709235|NCT01251653|75827898|FG001|NOT COMPLETED|Overall Study||8||
60103372|NCT01241344|76221568|FG003|COMPLETED|Overall Study||2||
60103373|NCT01241344|76221565|FG000|NOT COMPLETED|Overall Study||5||
60103374|NCT01241344|76221566|FG001|NOT COMPLETED|Overall Study||9||
59565683|NCT01846988|75668046|FG002|COMPLETED|Intervention #1 - 4 Weeks||5||
59565684|NCT01846988|75668044|FG000|NOT COMPLETED|Intervention #1 - 4 Weeks||0||
60103375|NCT01241344|76221567|FG002|NOT COMPLETED|Overall Study||9||
60103376|NCT01241344|76221568|FG003|NOT COMPLETED|Overall Study||2||
59565685|NCT01846988|75668045|FG001|NOT COMPLETED|Intervention #1 - 4 Weeks||0||
59565686|NCT01846988|75668046|FG002|NOT COMPLETED|Intervention #1 - 4 Weeks||0||
59565687|NCT01846988|75668044|FG000|STARTED|Intervention #2 - 4 Weeks||0||
59565688|NCT01846988|75668045|FG001|STARTED|Intervention #2 - 4 Weeks||5||
59565689|NCT01846988|75668046|FG002|STARTED|Intervention #2 - 4 Weeks||5||
59709236|NCT01251653|75827899|FG002|NOT COMPLETED|Overall Study||20||
60103377|NCT01285024|76221579|FG000|STARTED|Overall Study||49||
60103378|NCT01285024|76221580|FG001|STARTED|Overall Study||60||
60103379|NCT01285024|76221579|FG000|COMPLETED|Overall Study||49||
60103380|NCT01285024|76221580|FG001|COMPLETED|Overall Study||60||
59565690|NCT01846988|75668044|FG000|COMPLETED|Intervention #2 - 4 Weeks||0||
60103381|NCT01285024|76221579|FG000|NOT COMPLETED|Overall Study||0||
60103382|NCT01285024|76221580|FG001|NOT COMPLETED|Overall Study||0||
60103383|NCT01286818|76221586|FG000|STARTED|Overall Study||6||
60103384|NCT01286818|76221586|FG000|Completed DLT Assessment Period|Overall Study||5||
60103385|NCT01286818|76221586|FG000|COMPLETED|Overall Study||6||
60103386|NCT01286818|76221586|FG000|NOT COMPLETED|Overall Study||0||
60103387|NCT01243294|76221590|FG000|STARTED|First Intervention (10 Days +/- 2 Days)||28||
60103388|NCT01243294|76221591|FG001|STARTED|First Intervention (10 Days +/- 2 Days)||26||
60103389|NCT01243294|76221590|FG000|COMPLETED|First Intervention (10 Days +/- 2 Days)||28||
60103390|NCT01243294|76221591|FG001|COMPLETED|First Intervention (10 Days +/- 2 Days)||26||
60103391|NCT01243294|76221590|FG000|NOT COMPLETED|First Intervention (10 Days +/- 2 Days)||0||
60103392|NCT01243294|76221591|FG001|NOT COMPLETED|First Intervention (10 Days +/- 2 Days)||0||
60103393|NCT01243294|76221590|FG000|STARTED|Second Intervention (10 Days +/- 2 Days)||28||
60103394|NCT01243294|76221591|FG001|STARTED|Second Intervention (10 Days +/- 2 Days)||26||
60103395|NCT01243294|76221590|FG000|COMPLETED|Second Intervention (10 Days +/- 2 Days)||28||
60103396|NCT01243294|76221591|FG001|COMPLETED|Second Intervention (10 Days +/- 2 Days)||26||
60103397|NCT01243294|76221590|FG000|NOT COMPLETED|Second Intervention (10 Days +/- 2 Days)||0||
60103398|NCT01243294|76221591|FG001|NOT COMPLETED|Second Intervention (10 Days +/- 2 Days)||0||
60103399|NCT01243450|76221600|FG000|STARTED|Overall Study||401||
60103400|NCT01243450|76221601|FG001|STARTED|Overall Study||135||
60103401|NCT01243450|76221602|FG002|STARTED|Overall Study||404||
60103402|NCT01243450|76221600|FG000|COMPLETED|Overall Study||318||
60103403|NCT01243450|76221601|FG001|COMPLETED|Overall Study||110||
60103404|NCT01243450|76221602|FG002|COMPLETED|Overall Study||337||
60103405|NCT01243450|76221600|FG000|NOT COMPLETED|Overall Study||83||
60103406|NCT01243450|76221601|FG001|NOT COMPLETED|Overall Study||25||
60103407|NCT01243450|76221602|FG002|NOT COMPLETED|Overall Study||67||
60103408|NCT02197078|76221622|FG000|STARTED|Overall Study||14688||
60103409|NCT02197078|76221623|FG001|STARTED|Overall Study||14688||
60103410|NCT02197078|76221624|FG002|STARTED|Overall Study||10614||
60103411|NCT02197078|76221625|FG003|STARTED|Overall Study||10614||
60103412|NCT02197078|76221626|FG004|STARTED|Overall Study||9538||
60103413|NCT02197078|76221627|FG005|STARTED|Overall Study||9538||
60103414|NCT02197078|76221628|FG006|STARTED|Overall Study||25135||
60103415|NCT02197078|76221629|FG007|STARTED|Overall Study||25135||
59565691|NCT01846988|75668045|FG001|COMPLETED|Intervention #2 - 4 Weeks||5||
59565692|NCT01846988|75668046|FG002|COMPLETED|Intervention #2 - 4 Weeks||5||
59565693|NCT01846988|75668044|FG000|NOT COMPLETED|Intervention #2 - 4 Weeks||0||
59565694|NCT01846988|75668045|FG001|NOT COMPLETED|Intervention #2 - 4 Weeks||0||
59565695|NCT01846988|75668046|FG002|NOT COMPLETED|Intervention #2 - 4 Weeks||0||
59709237|NCT01251653|75827900|FG003|NOT COMPLETED|Overall Study||6||
59709238|NCT01251653|75827901|FG004|NOT COMPLETED|Overall Study||2||
59565696|NCT02268500|75668065|FG000|STARTED|Overall Study||24||
59565697|NCT02268500|75668066|FG001|STARTED|Overall Study||24||
59565698|NCT02268500|75668065|FG000|COMPLETED|Overall Study||24||
59565699|NCT02268500|75668066|FG001|COMPLETED|Overall Study||24||
59565700|NCT02268500|75668065|FG000|NOT COMPLETED|Overall Study||0||
59565701|NCT02268500|75668066|FG001|NOT COMPLETED|Overall Study||0||
59565702|NCT00559364|75668074|FG000|STARTED|Overall Study||30||
59565703|NCT00559364|75668075|FG001|STARTED|Overall Study||20||
60103416|NCT02197078|76221630|FG008|STARTED|Overall Study||18996||
60103417|NCT02197078|76221631|FG009|STARTED|Overall Study||18996||
60103418|NCT02197078|76221632|FG010|STARTED|Overall Study||15742||
60103419|NCT02197078|76221633|FG011|STARTED|Overall Study||15742||
60103420|NCT02197078|76221622|FG000|COMPLETED|Overall Study||14688||
60103421|NCT02197078|76221623|FG001|COMPLETED|Overall Study||14688||
60103422|NCT02197078|76221624|FG002|COMPLETED|Overall Study||10614||
60103423|NCT02197078|76221625|FG003|COMPLETED|Overall Study||10614||
60103424|NCT02197078|76221626|FG004|COMPLETED|Overall Study||9538||
60103425|NCT02197078|76221627|FG005|COMPLETED|Overall Study||9538||
60103426|NCT02197078|76221628|FG006|COMPLETED|Overall Study||25135||
59709239|NCT01251653|75827902|FG005|NOT COMPLETED|Overall Study||18||
60103427|NCT02197078|76221629|FG007|COMPLETED|Overall Study||25135||
60103428|NCT02197078|76221630|FG008|COMPLETED|Overall Study||18996||
60103429|NCT02197078|76221631|FG009|COMPLETED|Overall Study||18996||
59709240|NCT01251653|75827903|FG006|NOT COMPLETED|Overall Study||18||
59565704|NCT00559364|75668074|FG000|COMPLETED|Overall Study||29||
59565705|NCT00559364|75668075|FG001|COMPLETED|Overall Study||20||
59565706|NCT00559364|75668074|FG000|NOT COMPLETED|Overall Study||1||
59565707|NCT00559364|75668075|FG001|NOT COMPLETED|Overall Study||0||
59565708|NCT01848158|75668083|FG000|STARTED|Overall Study||10||
59565709|NCT01848158|75668084|FG001|STARTED|Overall Study||7||
59565710|NCT01848158|75668083|FG000|COMPLETED|Overall Study||10||
59709241|NCT01251653|75827904|FG007|NOT COMPLETED|Overall Study||12||
59565711|NCT01848158|75668084|FG001|COMPLETED|Overall Study||7||
59565712|NCT01848158|75668083|FG000|NOT COMPLETED|Overall Study||0||
59565713|NCT01848158|75668084|FG001|NOT COMPLETED|Overall Study||0||
59709242|NCT01251653|75827905|FG008|NOT COMPLETED|Overall Study||6||
59709243|NCT00910663|75827943|FG000|STARTED|Period 1||30||
59565714|NCT01849172|75668092|FG000|STARTED|Overall Study||180||
60103430|NCT02197078|76221632|FG010|COMPLETED|Overall Study||15742||
60103431|NCT02197078|76221633|FG011|COMPLETED|Overall Study||15742||
60103432|NCT02197078|76221622|FG000|NOT COMPLETED|Overall Study||0||
60103433|NCT02197078|76221623|FG001|NOT COMPLETED|Overall Study||0||
59565715|NCT01849172|75668093|FG001|STARTED|Overall Study||180||
59565716|NCT01849172|75668092|FG000|COMPLETED|Overall Study||173||
59565717|NCT01849172|75668093|FG001|COMPLETED|Overall Study||174||
59565718|NCT01849172|75668092|FG000|NOT COMPLETED|Overall Study||7||
59565719|NCT01849172|75668093|FG001|NOT COMPLETED|Overall Study||6||
59565720|NCT01853774|75668101|FG000|STARTED|Overall Study||257||
59565721|NCT01853774|75668102|FG001|STARTED|Overall Study||162||
59709244|NCT00910663|75827944|FG001|STARTED|Period 1||30||
59994761|NCT00535405|76110588|FG002|STARTED|Overall Study||259||
59994762|NCT00535405|76110589|FG003|STARTED|Overall Study||257||
59994763|NCT00535405|76110590|FG004|STARTED|Overall Study||257||
59994764|NCT00535405|76110586|FG000|COMPLETED|Overall Study||240||
59994765|NCT00535405|76110587|FG001|COMPLETED|Overall Study||233||
59994766|NCT00535405|76110588|FG002|COMPLETED|Overall Study||241||
59994767|NCT00535405|76110589|FG003|COMPLETED|Overall Study||235||
59994768|NCT00535405|76110590|FG004|COMPLETED|Overall Study||241||
60103434|NCT02197078|76221624|FG002|NOT COMPLETED|Overall Study||0||
59565722|NCT01853774|75668101|FG000|COMPLETED|Overall Study||211||
59565723|NCT01853774|75668102|FG001|COMPLETED|Overall Study||134||
59565724|NCT01853774|75668101|FG000|NOT COMPLETED|Overall Study||46||
59565725|NCT01853774|75668102|FG001|NOT COMPLETED|Overall Study||28||
59994769|NCT00535405|76110586|FG000|NOT COMPLETED|Overall Study||17||
59994770|NCT00535405|76110587|FG001|NOT COMPLETED|Overall Study||26||
59994771|NCT00535405|76110588|FG002|NOT COMPLETED|Overall Study||18||
59994772|NCT00535405|76110589|FG003|NOT COMPLETED|Overall Study||22||
60103435|NCT02197078|76221625|FG003|NOT COMPLETED|Overall Study||0||
59709245|NCT00910663|75827943|FG000|COMPLETED|Period 1||30||
59565726|NCT01853930|75668112|FG000|STARTED|Overall Study||25||
59565727|NCT01853930|75668113|FG001|STARTED|Overall Study||8||
59565728|NCT01853930|75668112|FG000|COMPLETED|Overall Study||25||
59565729|NCT01853930|75668113|FG001|COMPLETED|Overall Study||8||
59565730|NCT01853930|75668112|FG000|NOT COMPLETED|Overall Study||0||
59994773|NCT00535405|76110590|FG004|NOT COMPLETED|Overall Study||16||
60103436|NCT02197078|76221626|FG004|NOT COMPLETED|Overall Study||0||
60103437|NCT02197078|76221627|FG005|NOT COMPLETED|Overall Study||0||
60103438|NCT02197078|76221628|FG006|NOT COMPLETED|Overall Study||0||
60103439|NCT02197078|76221629|FG007|NOT COMPLETED|Overall Study||0||
60103440|NCT02197078|76221630|FG008|NOT COMPLETED|Overall Study||0||
60103441|NCT02197078|76221631|FG009|NOT COMPLETED|Overall Study||0||
59565731|NCT01853930|75668113|FG001|NOT COMPLETED|Overall Study||0||
59565732|NCT01854242|75668119|FG000|STARTED|Overall Study||50||
59565733|NCT01854242|75668119|FG000|COMPLETED|Overall Study||50||
59565734|NCT01854242|75668119|FG000|NOT COMPLETED|Overall Study||0||
59565735|NCT01854632|75668125|FG000|STARTED|Overall Study||1174||
59565736|NCT01854632|75668126|FG001|STARTED|Overall Study||587||
59565737|NCT01854632|75668125|FG000|COMPLETED|Overall Study||1148||
59565738|NCT01854632|75668126|FG001|COMPLETED|Overall Study||574||
59565739|NCT01854632|75668125|FG000|NOT COMPLETED|Overall Study||26||
59565740|NCT01854632|75668126|FG001|NOT COMPLETED|Overall Study||13||
59565741|NCT02308020|75668138|FG000|STARTED|Overall Study||27||
59565742|NCT02308020|75668139|FG001|STARTED|Overall Study||58||
59565743|NCT02308020|75668140|FG002|STARTED|Overall Study||9||
59565744|NCT02308020|75668141|FG003|STARTED|Overall Study||28||
59565745|NCT02308020|75668142|FG004|STARTED|Overall Study||23||
59565746|NCT02308020|75668143|FG005|STARTED|Overall Study||17||
59565747|NCT02308020|75668138|FG000|Received at Least One Dose of Study Drug|Overall Study||27||
59565748|NCT02308020|75668139|FG001|Received at Least One Dose of Study Drug|Overall Study||58||
59565749|NCT02308020|75668140|FG002|Received at Least One Dose of Study Drug|Overall Study||9||
59565750|NCT02308020|75668141|FG003|Received at Least One Dose of Study Drug|Overall Study||28||
59565751|NCT02308020|75668142|FG004|Received at Least One Dose of Study Drug|Overall Study||23||
59565752|NCT02308020|75668143|FG005|Received at Least One Dose of Study Drug|Overall Study||17||
59565753|NCT02308020|75668138|FG000|COMPLETED|Overall Study||23||
59565754|NCT02308020|75668139|FG001|COMPLETED|Overall Study||38||
59565755|NCT02308020|75668140|FG002|COMPLETED|Overall Study||6||
59565756|NCT02308020|75668141|FG003|COMPLETED|Overall Study||24||
59565757|NCT02308020|75668142|FG004|COMPLETED|Overall Study||19||
59565758|NCT02308020|75668143|FG005|COMPLETED|Overall Study||12||
59565759|NCT02308020|75668138|FG000|NOT COMPLETED|Overall Study||4||
59565760|NCT02308020|75668139|FG001|NOT COMPLETED|Overall Study||20||
59565761|NCT02308020|75668140|FG002|NOT COMPLETED|Overall Study||3||
59565762|NCT02308020|75668141|FG003|NOT COMPLETED|Overall Study||4||
59565763|NCT02308020|75668142|FG004|NOT COMPLETED|Overall Study||4||
59565764|NCT02308020|75668143|FG005|NOT COMPLETED|Overall Study||5||
59994774|NCT00271817|76110605|FG000|STARTED|Part 1||272||
59994775|NCT00271817|76110606|FG001|STARTED|Part 1||272||
59994776|NCT00271817|76110607|FG002|STARTED|Part 1||676||
59994777|NCT00271817|76110605|FG000|COMPLETED|Part 1|6 patients who completed Part 1 did not continue to Part 2; 1 patient never received drug in Part 2|166||
59994778|NCT00271817|76110606|FG001|COMPLETED|Part 1|1 patient who completed Part 1 did not continue to Part 2|213||
60103442|NCT02197078|76221632|FG010|NOT COMPLETED|Overall Study||0||
60103443|NCT02197078|76221633|FG011|NOT COMPLETED|Overall Study||0||
60103444|NCT01287208|76221661|FG000|STARTED|Phase 1: Randomized Phase||52||
60103445|NCT01287208|76221662|FG001|STARTED|Phase 1: Randomized Phase||52||
60103446|NCT01287208|76221661|FG000|COMPLETED|Phase 1: Randomized Phase||50||
59565765|NCT02359890|75668163|FG000|STARTED|Overall Study|Patients who enrolled in the study are those who signed informed consent forms.|165||
59565766|NCT02359890|75668163|FG000|Safety Population|Overall Study|Enrolled subjects who had the study catheter inserted|159||
59565767|NCT02359890|75668163|FG000|mITT Population|Overall Study|Enrolled subjects who met the inclusion/exclusion criteria and had the study catheter inserted|155||
59565768|NCT02359890|75668163|FG000|Per-Protocol (PP) Population|Overall Study|Subjects part of mITT population who had undergone RF ablation.|155||
59565769|NCT02359890|75668163|FG000|COMPLETED|Overall Study||155||
59994779|NCT00271817|76110607|FG002|COMPLETED|Part 1|11 patients who completed Part 1 did not continue to Part 2|391||
59994780|NCT00271817|76110605|FG000|NOT COMPLETED|Part 1||106||
60103447|NCT01287208|76221662|FG001|COMPLETED|Phase 1: Randomized Phase||49||
59565770|NCT02359890|75668163|FG000|NOT COMPLETED|Overall Study||10||
59565771|NCT02306850|75668167|FG000|STARTED|Overall Study||10||
59709246|NCT00910663|75827944|FG001|COMPLETED|Period 1||29||
59709247|NCT00910663|75827943|FG000|NOT COMPLETED|Period 1||0||
59709248|NCT00910663|75827944|FG001|NOT COMPLETED|Period 1||1||
59709249|NCT00910663|75827943|FG000|STARTED|Period 2||30||
59709250|NCT00910663|75827944|FG001|STARTED|Period 2||29||
59709251|NCT00910663|75827943|FG000|COMPLETED|Period 2||30||
59709252|NCT00910663|75827944|FG001|COMPLETED|Period 2||29||
59817825|NCT04488770|75940329|FG003|NOT COMPLETED|Part 1-Cohort 1: Period 3 (Up to 5 Days)||0||
59817826|NCT04488770|75940330|FG004|NOT COMPLETED|Part 1-Cohort 1: Period 3 (Up to 5 Days)||0||
59817827|NCT04488770|75940331|FG005|NOT COMPLETED|Part 1-Cohort 1: Period 3 (Up to 5 Days)||0||
59817828|NCT04488770|75940332|FG006|NOT COMPLETED|Part 1-Cohort 1: Period 3 (Up to 5 Days)||0||
59565772|NCT02306850|75668167|FG000|COMPLETED|Overall Study||8||
60103448|NCT01287208|76221661|FG000|NOT COMPLETED|Phase 1: Randomized Phase||2||
60103449|NCT01287208|76221662|FG001|NOT COMPLETED|Phase 1: Randomized Phase||3||
60103450|NCT01287208|76221661|FG000|STARTED|Phase 2: Team Competition||50||
60103451|NCT01287208|76221662|FG001|STARTED|Phase 2: Team Competition||49||
60103452|NCT01287208|76221661|FG000|COMPLETED|Phase 2: Team Competition||50||
60103453|NCT01287208|76221662|FG001|COMPLETED|Phase 2: Team Competition||49||
60103454|NCT01287208|76221661|FG000|NOT COMPLETED|Phase 2: Team Competition||0||
59565773|NCT02306850|75668167|FG000|NOT COMPLETED|Overall Study||2||
59565774|NCT02306694|75668172|FG000|STARTED|Overall Study||16||
59565775|NCT02306694|75668172|FG000|COMPLETED|Overall Study||12||
59565776|NCT02306694|75668172|FG000|NOT COMPLETED|Overall Study||4||
59565777|NCT03647475|75668176|FG000|STARTED|Overall Study||752||
59565778|NCT03647475|75668176|FG000|NCT03647475 - Included in One Month Clear Analysis Population|Overall Study||601||
59709253|NCT00910663|75827943|FG000|NOT COMPLETED|Period 2||0||
59817829|NCT04488770|75940333|FG007|NOT COMPLETED|Part 1-Cohort 1: Period 3 (Up to 5 Days)||0||
59817830|NCT04488770|75940334|FG008|NOT COMPLETED|Part 1-Cohort 1: Period 3 (Up to 5 Days)||0||
59817831|NCT04488770|75940335|FG009|NOT COMPLETED|Part 1-Cohort 1: Period 3 (Up to 5 Days)||0||
59817832|NCT04488770|75940336|FG010|NOT COMPLETED|Part 1-Cohort 1: Period 3 (Up to 5 Days)||0||
59817833|NCT04488770|75940337|FG011|NOT COMPLETED|Part 1-Cohort 1: Period 3 (Up to 5 Days)||0||
59817834|NCT04488770|75940338|FG012|NOT COMPLETED|Part 1-Cohort 1: Period 3 (Up to 5 Days)||0||
59565779|NCT03647475|75668176|FG000|NCT03344653- Included in One Month Clear Analysis Population|Overall Study||905||
59565780|NCT03647475|75668176|FG000|COMPLETED|Overall Study||75||
59709254|NCT00910663|75827944|FG001|NOT COMPLETED|Period 2||0||
59709255|NCT01077375|75827952|FG000|STARTED|Overall Study||21||
59709256|NCT01077375|75827953|FG001|STARTED|Overall Study|One randomized patient not taking study drug was excluded from the Double-blind Safety Population.|86||
59709257|NCT01077375|75827952|FG000|COMPLETED|Overall Study||11||
59709258|NCT01077375|75827953|FG001|COMPLETED|Overall Study||51||
59709259|NCT01077375|75827952|FG000|NOT COMPLETED|Overall Study||10||
59709260|NCT01077375|75827953|FG001|NOT COMPLETED|Overall Study||35||
59565781|NCT03647475|75668176|FG000|NOT COMPLETED|Overall Study||677||
59817835|NCT04488770|75940326|FG000|STARTED|Part 1-Cohort 1: Period 4 (Up to 5 Days)|New participant enrolled and dosed as a replacement of withdrawn participant|2||
59994781|NCT00271817|76110606|FG001|NOT COMPLETED|Part 1||59||
59994782|NCT00271817|76110607|FG002|NOT COMPLETED|Part 1||285||
59994783|NCT00271817|76110605|FG000|STARTED|Part 2|Patients completing the niacin group in Part 1, were re-allocated to one of the two arms in Part 2|0||
59994784|NCT00271817|76110606|FG001|STARTED|Part 2|Includes 54 patients re-allocated from the niacin group in Part 1|266||
59994785|NCT00271817|76110607|FG002|STARTED|Part 2|Includes 105 patients re-allocated from the niacin group in Part 1|485||
59994786|NCT00271817|76110605|FG000|COMPLETED|Part 2||0||
59994787|NCT00271817|76110606|FG001|COMPLETED|Part 2||234||
59994788|NCT00271817|76110607|FG002|COMPLETED|Part 2||401||
59994789|NCT00271817|76110605|FG000|NOT COMPLETED|Part 2||0||
59994790|NCT00271817|76110606|FG001|NOT COMPLETED|Part 2||32||
59994791|NCT00271817|76110607|FG002|NOT COMPLETED|Part 2||84||
59994792|NCT02731157|76110619|FG000|STARTED|First Standard RCE||4||
59994793|NCT02731157|76110619|FG000|COMPLETED|First Standard RCE||4||
59994794|NCT02731157|76110619|FG000|NOT COMPLETED|First Standard RCE||0||
59709261|NCT01250873|75827961|FG000|STARTED|Period 1: LY2216684 (Days 1-3)||20||
59709262|NCT01250873|75827961|FG000|COMPLETED|Period 1: LY2216684 (Days 1-3)||18||
59709263|NCT01250873|75827961|FG000|NOT COMPLETED|Period 1: LY2216684 (Days 1-3)||2||
59709264|NCT01250873|75827961|FG000|STARTED|Period 2: Sertraline (Day 4, 5-10)||18||
59709265|NCT01250873|75827961|FG000|COMPLETED|Period 2: Sertraline (Day 4, 5-10)||18||
59709266|NCT01250873|75827961|FG000|NOT COMPLETED|Period 2: Sertraline (Day 4, 5-10)||0||
59709267|NCT01250873|75827961|FG000|STARTED|Period 3:LY2216684+Sertraline(Days11-13)||18||
59709268|NCT01250873|75827961|FG000|COMPLETED|Period 3:LY2216684+Sertraline(Days11-13)||17||
59709269|NCT01250873|75827961|FG000|NOT COMPLETED|Period 3:LY2216684+Sertraline(Days11-13)||1||
59709270|NCT01250171|75827970|FG000|STARTED|Overall Study||26||
59709271|NCT01250171|75827971|FG001|STARTED|Overall Study||22||
59709272|NCT01250171|75827972|FG002|STARTED|Overall Study||24||
59709273|NCT01250171|75827970|FG000|COMPLETED|Overall Study||25||
59709274|NCT01250171|75827971|FG001|COMPLETED|Overall Study||22||
59709275|NCT01250171|75827972|FG002|COMPLETED|Overall Study||24||
59709276|NCT01250171|75827970|FG000|NOT COMPLETED|Overall Study||1||
59709277|NCT01250171|75827971|FG001|NOT COMPLETED|Overall Study||0||
59709278|NCT01250171|75827972|FG002|NOT COMPLETED|Overall Study||0||
59709279|NCT01077063|75827982|FG000|STARTED|Overall Study||4||
59565782|NCT01648140|75668184|FG000|STARTED|Overall Study||41||
59709280|NCT01077063|75827983|FG001|STARTED|Overall Study||3||
59709281|NCT01077063|75827982|FG000|COMPLETED|Overall Study||0||
59709282|NCT01077063|75827983|FG001|COMPLETED|Overall Study||0||
59709283|NCT01077063|75827982|FG000|NOT COMPLETED|Overall Study||4||
59709284|NCT01077063|75827983|FG001|NOT COMPLETED|Overall Study||3||
59709285|NCT01248065|75827991|FG000|STARTED|Overall Study||207||
59709286|NCT01248065|75827992|FG001|STARTED|Overall Study||201||
59709287|NCT01248065|75827991|FG000|COMPLETED|Overall Study|All 207 participants were included in the primary time-to-event analysis.|181||
59709288|NCT01248065|75827992|FG001|COMPLETED|Overall Study|All 201 participants were included in the primary time-to-event analysis.|179||
59709289|NCT01248065|75827991|FG000|NOT COMPLETED|Overall Study||26||
59709290|NCT01248065|75827992|FG001|NOT COMPLETED|Overall Study||22||
59709291|NCT01250756|75828000|FG000|STARTED|Infant Series||161||
59709292|NCT01250756|75828001|FG001|STARTED|Infant Series||160||
59709293|NCT01250756|75828000|FG000|Vaccinated Dose 1|Infant Series||159||
59709294|NCT01250756|75828001|FG001|Vaccinated Dose 1|Infant Series||158||
59709295|NCT01250756|75828000|FG000|Vaccinated Dose 2|Infant Series||147||
59709296|NCT01250756|75828001|FG001|Vaccinated Dose 2|Infant Series||157||
59709297|NCT01250756|75828000|FG000|Vaccinated Dose 3|Infant Series||133||
59709298|NCT01250756|75828001|FG001|Vaccinated Dose 3|Infant Series||155||
59709299|NCT01250756|75828000|FG000|COMPLETED|Infant Series||133||
59709300|NCT01250756|75828001|FG001|COMPLETED|Infant Series||153||
59709301|NCT01250756|75828000|FG000|NOT COMPLETED|Infant Series||28||
59709302|NCT01250756|75828001|FG001|NOT COMPLETED|Infant Series||7||
59709303|NCT01250756|75828000|FG000|STARTED|After Infant Series||133||
59709304|NCT01250756|75828001|FG001|STARTED|After Infant Series||153||
59709305|NCT01250756|75828000|FG000|COMPLETED|After Infant Series||122||
59709306|NCT01250756|75828001|FG001|COMPLETED|After Infant Series||149||
59709307|NCT01250756|75828000|FG000|NOT COMPLETED|After Infant Series||11||
59709308|NCT01250756|75828001|FG001|NOT COMPLETED|After Infant Series||4||
59709309|NCT01250756|75828000|FG000|STARTED|Toddler Dose||122||
59709310|NCT01250756|75828001|FG001|STARTED|Toddler Dose||149||
59709311|NCT01250756|75828000|FG000|COMPLETED|Toddler Dose||122||
59709312|NCT01250756|75828001|FG001|COMPLETED|Toddler Dose||148||
59709313|NCT01250756|75828000|FG000|NOT COMPLETED|Toddler Dose||0||
59709314|NCT01250756|75828001|FG001|NOT COMPLETED|Toddler Dose||1||
59709315|NCT01250756|75828000|FG000|STARTED|After Toddler Dose||0||
59709316|NCT01250756|75828001|FG001|STARTED|After Toddler Dose||148||
59709317|NCT01250756|75828000|FG000|COMPLETED|After Toddler Dose||0||
59709318|NCT01250756|75828001|FG001|COMPLETED|After Toddler Dose||147||
59709319|NCT01250756|75828000|FG000|NOT COMPLETED|After Toddler Dose||0||
59709320|NCT01250756|75828001|FG001|NOT COMPLETED|After Toddler Dose||1||
59709321|NCT01250054|75828013|FG000|STARTED|Period 1, One Week of Wear||8||
59709322|NCT01250054|75828014|FG001|STARTED|Period 1, One Week of Wear|One subject did not wear Period 1 lenses due to power availability and proceeded to Period 2 lenses.|8||
59709323|NCT01250054|75828013|FG000|COMPLETED|Period 1, One Week of Wear|One subject discontinued between Period 1 and Period 2 due to power availability.|8||
59709324|NCT01250054|75828014|FG001|COMPLETED|Period 1, One Week of Wear|One subject discontinued between Period 1 and Period 2 due to noncompliance.|8||
59709325|NCT01250054|75828013|FG000|NOT COMPLETED|Period 1, One Week of Wear||0||
59709326|NCT01250054|75828014|FG001|NOT COMPLETED|Period 1, One Week of Wear||0||
59709327|NCT01250054|75828013|FG000|STARTED|Period 2, One Week of Wear||7||
59709328|NCT01250054|75828014|FG001|STARTED|Period 2, One Week of Wear||8||
59709329|NCT01250054|75828013|FG000|COMPLETED|Period 2, One Week of Wear||6||
59709330|NCT01250054|75828014|FG001|COMPLETED|Period 2, One Week of Wear||8||
59709331|NCT01250054|75828013|FG000|NOT COMPLETED|Period 2, One Week of Wear||1||
59709332|NCT01250054|75828014|FG001|NOT COMPLETED|Period 2, One Week of Wear||0||
59709333|NCT00977470|75828022|FG000|STARTED|Overall Study||38||
59709334|NCT00977470|75828023|FG001|STARTED|Overall Study||38||
59709335|NCT00977470|75828022|FG000|COMPLETED|Overall Study||0||
59709336|NCT00977470|75828023|FG001|COMPLETED|Overall Study||0||
59709337|NCT00977470|75828022|FG000|NOT COMPLETED|Overall Study||38||
59709338|NCT00977470|75828023|FG001|NOT COMPLETED|Overall Study||38||
59709339|NCT01245374|75828029|FG000|STARTED|Overall Study||103||
59709340|NCT01245374|75828029|FG000|COMPLETED|Overall Study||99||
59709341|NCT01245374|75828029|FG000|NOT COMPLETED|Overall Study||4||
59709342|NCT00977314|75828036|FG000|STARTED|Overall Study||30||
59709343|NCT00977314|75828037|FG001|STARTED|Overall Study|First 5 subjects enrolled were pilot subjects and not included in analysis.|5||
59709344|NCT00977314|75828036|FG000|COMPLETED|Overall Study||28||
59709345|NCT00977314|75828037|FG001|COMPLETED|Overall Study|First 5 subjects enrolled were pilot subjects and not included in analysis.|5||
59709346|NCT00977314|75828036|FG000|NOT COMPLETED|Overall Study||2||
59709347|NCT00977314|75828037|FG001|NOT COMPLETED|Overall Study||0||
59709348|NCT01087203|75828045|FG000|STARTED|Overall Study||35||
59709349|NCT01087203|75828046|FG001|STARTED|Overall Study||38||
59709350|NCT01087203|75828045|FG000|COMPLETED|Overall Study||3||
59709351|NCT01087203|75828046|FG001|COMPLETED|Overall Study||3||
59709352|NCT01087203|75828045|FG000|NOT COMPLETED|Overall Study||32||
59709353|NCT01087203|75828046|FG001|NOT COMPLETED|Overall Study||35||
59709354|NCT01246583|75828057|FG000|STARTED|Overall Study||23||
59709355|NCT01246583|75828058|FG001|STARTED|Overall Study||13||
59709356|NCT01246583|75828059|FG002|STARTED|Overall Study||25||
59709357|NCT01246583|75828060|FG003|STARTED|Overall Study||10||
59709358|NCT01246583|75828057|FG000|COMPLETED|Overall Study||22||
59709359|NCT01246583|75828058|FG001|COMPLETED|Overall Study||13||
59709360|NCT01246583|75828059|FG002|COMPLETED|Overall Study||24||
59709361|NCT01246583|75828060|FG003|COMPLETED|Overall Study||9||
59709362|NCT01246583|75828057|FG000|NOT COMPLETED|Overall Study||1||
59709363|NCT01246583|75828058|FG001|NOT COMPLETED|Overall Study||0||
59709364|NCT01246583|75828059|FG002|NOT COMPLETED|Overall Study||1||
59709365|NCT01246583|75828060|FG003|NOT COMPLETED|Overall Study||1||
59709366|NCT01084239|75828073|FG000|STARTED|Randomization - Index Hospitalization||501||
59709367|NCT01084239|75828074|FG001|STARTED|Randomization - Index Hospitalization||499||
59709368|NCT01084239|75828073|FG000|COMPLETED|Randomization - Index Hospitalization||501||
59709369|NCT01084239|75828074|FG001|COMPLETED|Randomization - Index Hospitalization||499||
59709370|NCT01084239|75828073|FG000|NOT COMPLETED|Randomization - Index Hospitalization||0||
59709371|NCT01084239|75828074|FG001|NOT COMPLETED|Randomization - Index Hospitalization||0||
60103455|NCT01287208|76221662|FG001|NOT COMPLETED|Phase 2: Team Competition||0||
60103456|NCT01288534|76221670|FG000|STARTED|Overall Study||68||
60103457|NCT01288534|76221670|FG000|COMPLETED|Overall Study||68||
60103458|NCT01288534|76221670|FG000|NOT COMPLETED|Overall Study||0||
60103459|NCT03122301|76221676|FG000|STARTED|Overall Study||1||
60103460|NCT03122301|76221677|FG001|STARTED|Overall Study||1||
60103461|NCT03122301|76221676|FG000|COMPLETED|Overall Study||1||
60103462|NCT03122301|76221677|FG001|COMPLETED|Overall Study||1||
60103463|NCT03122301|76221676|FG000|NOT COMPLETED|Overall Study||0||
60103464|NCT03122301|76221677|FG001|NOT COMPLETED|Overall Study||0||
60103465|NCT02199496|76221685|FG000|STARTED|Ustekinumab-Single Dose||3||
59709372|NCT01084239|75828073|FG000|STARTED|28-Day Follow-up|All 501 patients enrolled were evaluated for follow-up at 28 days.|501||
59709373|NCT01084239|75828074|FG001|STARTED|28-Day Follow-up||499||
59709374|NCT01084239|75828073|FG000|COMPLETED|28-Day Follow-up||497||
59709375|NCT01084239|75828074|FG001|COMPLETED|28-Day Follow-up||490||
59709376|NCT01084239|75828073|FG000|NOT COMPLETED|28-Day Follow-up||4||
59709377|NCT01084239|75828074|FG001|NOT COMPLETED|28-Day Follow-up||9||
59709378|NCT01244906|75828082|FG000|STARTED|Overall Study||26||
59709379|NCT01244906|75828082|FG000|COMPLETED|Overall Study||18||
59709380|NCT01244906|75828082|FG000|NOT COMPLETED|Overall Study||8||
59709381|NCT01080807|75828088|FG000|STARTED|Overall Study|Nine patients randomly assigned to the armodafinil treatment group did not receive study drug.|193||
59709382|NCT01080807|75828089|FG001|STARTED|Overall Study|Three patients randomly assigned to the placebo treatment group did not receive study drug.|190||
59709383|NCT01080807|75828088|FG000|COMPLETED|Overall Study||158||
59709384|NCT01080807|75828089|FG001|COMPLETED|Overall Study||167||
59709385|NCT01080807|75828088|FG000|NOT COMPLETED|Overall Study||35||
59709386|NCT01080807|75828089|FG001|NOT COMPLETED|Overall Study||23||
59709387|NCT01076361|75828095|FG000|STARTED|Overall Study|631 leads were implanted in 370 patients. 22 leads in 21 patients were excluded from analysis.|370||
59709388|NCT01076361|75828095|FG000|COMPLETED|Overall Study|Follow-up data was not available for 21 participants (22 leads)|349||
59709389|NCT01076361|75828095|FG000|NOT COMPLETED|Overall Study||21||
60103466|NCT02199496|76221686|FG001|STARTED|Ustekinumab-Single Dose||0||
60103467|NCT02199496|76221685|FG000|COMPLETED|Ustekinumab-Single Dose||3||
60103468|NCT02199496|76221686|FG001|COMPLETED|Ustekinumab-Single Dose||0||
60103469|NCT02199496|76221685|FG000|NOT COMPLETED|Ustekinumab-Single Dose||0||
60103470|NCT02199496|76221686|FG001|NOT COMPLETED|Ustekinumab-Single Dose||0||
60103471|NCT02199496|76221685|FG000|STARTED|Ustekinumab-Multi-dose||3||
59709390|NCT01079949|75828101|FG000|STARTED|Overall Study||46||
59709391|NCT01079949|75828102|FG001|STARTED|Overall Study||47||
59709392|NCT01079949|75828101|FG000|COMPLETED|Overall Study||31||
59709393|NCT01079949|75828102|FG001|COMPLETED|Overall Study||34||
59817836|NCT04488770|75940327|FG001|STARTED|Part 1-Cohort 1: Period 4 (Up to 5 Days)||2||
59709394|NCT01079949|75828101|FG000|NOT COMPLETED|Overall Study||15||
59709395|NCT01079949|75828102|FG001|NOT COMPLETED|Overall Study||13||
59709396|NCT00909727|75828110|FG000|STARTED|Overall Study|All subjects who received at least 1 dose of study drug (placebo)|26||
59709397|NCT00909727|75828111|FG001|STARTED|Overall Study|All subjects who received at least 1 dose of study drug (ivacaftor)|26||
59709398|NCT00909727|75828110|FG000|Completed Treatment Period, Week 24|Overall Study||23||
59709399|NCT00909727|75828111|FG001|Completed Treatment Period, Week 24|Overall Study||26||
59709400|NCT00909727|75828110|FG000|COMPLETED|Overall Study|Completed Treatment and Extension Periods (through Week 48)|22||
59709401|NCT00909727|75828111|FG001|COMPLETED|Overall Study|Completed Treatment and Extension Periods (through Week 48)|26||
59709402|NCT00909727|75828110|FG000|NOT COMPLETED|Overall Study||4||
59709403|NCT00909727|75828111|FG001|NOT COMPLETED|Overall Study||0||
59709404|NCT00977080|75828121|FG000|STARTED|Overall Study||62||
59709405|NCT00977080|75828122|FG001|STARTED|Overall Study||64||
59709406|NCT00977080|75828123|FG002|STARTED|Overall Study||72||
59709407|NCT00977080|75828124|FG003|STARTED|Overall Study||70||
59709408|NCT00977080|75828121|FG000|COMPLETED|Overall Study||50||
59709409|NCT00977080|75828122|FG001|COMPLETED|Overall Study||44||
59709410|NCT00977080|75828123|FG002|COMPLETED|Overall Study||56||
59709411|NCT00977080|75828124|FG003|COMPLETED|Overall Study||53||
59709412|NCT00977080|75828121|FG000|NOT COMPLETED|Overall Study||12||
59709413|NCT00977080|75828122|FG001|NOT COMPLETED|Overall Study||20||
59709414|NCT00977080|75828123|FG002|NOT COMPLETED|Overall Study||16||
59709415|NCT00977080|75828124|FG003|NOT COMPLETED|Overall Study||17||
59709416|NCT00975676|75828136|FG000|STARTED|Overall Study||32||
59709417|NCT00975676|75828137|FG001|STARTED|Overall Study||91||
59709418|NCT00975676|75828136|FG000|COMPLETED|Overall Study||26||
59709419|NCT00975676|75828137|FG001|COMPLETED|Overall Study||83||
59709420|NCT00975676|75828136|FG000|NOT COMPLETED|Overall Study||6||
59709421|NCT00975676|75828137|FG001|NOT COMPLETED|Overall Study||8||
59709422|NCT00975286|75828150|FG000|STARTED|Overall Study|Randomized.|223||
59709423|NCT00975286|75828151|FG001|STARTED|Overall Study||223||
59709424|NCT00975286|75828150|FG000|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|223||
59709425|NCT00975286|75828151|FG001|Safety Population|Overall Study||223||
59709426|NCT00975286|75828150|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|223||
59709427|NCT00975286|75828151|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||223||
59709428|NCT00975286|75828150|FG000|COMPLETED|Overall Study||211||
59709429|NCT00975286|75828151|FG001|COMPLETED|Overall Study||194||
59709430|NCT00975286|75828150|FG000|NOT COMPLETED|Overall Study||12||
59709431|NCT00975286|75828151|FG001|NOT COMPLETED|Overall Study||29||
59709432|NCT00907777|75828159|FG000|STARTED|Overall Study||25||
59709433|NCT00907777|75828160|FG001|STARTED|Overall Study||27||
59709434|NCT00907777|75828159|FG000|COMPLETED|Overall Study||25||
59709435|NCT00907777|75828160|FG001|COMPLETED|Overall Study||26||
59709436|NCT00907777|75828159|FG000|NOT COMPLETED|Overall Study||0||
59709437|NCT00907777|75828160|FG001|NOT COMPLETED|Overall Study||1||
59709438|NCT00908011|75828168|FG000|STARTED|Overall Study||23||
60103472|NCT02199496|76221686|FG001|STARTED|Ustekinumab-Multi-dose|Cohort 2 only participated in multi-dose phase 2|2||
60103473|NCT02199496|76221685|FG000|COMPLETED|Ustekinumab-Multi-dose||3||
60103474|NCT02199496|76221686|FG001|COMPLETED|Ustekinumab-Multi-dose||2||
60103475|NCT02199496|76221685|FG000|NOT COMPLETED|Ustekinumab-Multi-dose||0||
60103476|NCT02199496|76221686|FG001|NOT COMPLETED|Ustekinumab-Multi-dose||0||
60103477|NCT02199574|76221694|FG000|STARTED|Overall Study||12||
60103478|NCT02199574|76221694|FG000|COMPLETED|Overall Study||12||
60103479|NCT02199574|76221694|FG000|NOT COMPLETED|Overall Study||0||
60103480|NCT02199652|76221702|FG000|STARTED|Overall Study||10||
60103481|NCT02199652|76221703|FG001|STARTED|Overall Study||10||
59817837|NCT04488770|75940328|FG002|STARTED|Part 1-Cohort 1: Period 4 (Up to 5 Days)||2||
60103482|NCT02199652|76221702|FG000|COMPLETED|Overall Study||3||
59709439|NCT00908011|75828169|FG001|STARTED|Overall Study||20||
59709440|NCT00908011|75828168|FG000|COMPLETED|Overall Study||21||
59709441|NCT00908011|75828169|FG001|COMPLETED|Overall Study||18||
60103483|NCT02199652|76221703|FG001|COMPLETED|Overall Study||3||
59709442|NCT00908011|75828168|FG000|NOT COMPLETED|Overall Study||2||
59709443|NCT00908011|75828169|FG001|NOT COMPLETED|Overall Study||2||
59709444|NCT00976456|75828177|FG000|STARTED|Overall Study||135||
60103484|NCT02199652|76221702|FG000|NOT COMPLETED|Overall Study||7||
60103485|NCT02199652|76221703|FG001|NOT COMPLETED|Overall Study||7||
59709445|NCT00976456|75828178|FG001|STARTED|Overall Study||136||
59709446|NCT00976456|75828177|FG000|COMPLETED|Overall Study||92||
59709447|NCT00976456|75828178|FG001|COMPLETED|Overall Study||98||
59709448|NCT00976456|75828177|FG000|NOT COMPLETED|Overall Study||43||
60103486|NCT01289080|76221711|FG000|STARTED|Overall Study||9||
60103487|NCT01289080|76221712|FG001|STARTED|Overall Study||10||
59709449|NCT00976456|75828178|FG001|NOT COMPLETED|Overall Study||38||
59709450|NCT01243151|75828189|FG000|STARTED|Overall Study||12||
59709451|NCT01243151|75828190|FG001|STARTED|Overall Study||14||
59709452|NCT01243151|75828191|FG002|STARTED|Overall Study||14||
59709453|NCT01243151|75828192|FG003|STARTED|Overall Study||14||
59709454|NCT01243151|75828193|FG004|STARTED|Overall Study||14||
59565783|NCT01648140|75668185|FG001|STARTED|Overall Study||40||
59709455|NCT01243151|75828189|FG000|Treated|Overall Study||12||
59709456|NCT01243151|75828190|FG001|Treated|Overall Study||14||
59709457|NCT01243151|75828191|FG002|Treated|Overall Study||14||
59709458|NCT01243151|75828192|FG003|Treated|Overall Study||13||
59709459|NCT01243151|75828193|FG004|Treated|Overall Study||14||
59709460|NCT01243151|75828189|FG000|COMPLETED|Overall Study||12||
59709461|NCT01243151|75828190|FG001|COMPLETED|Overall Study||13||
59709462|NCT01243151|75828191|FG002|COMPLETED|Overall Study||13||
59709463|NCT01243151|75828192|FG003|COMPLETED|Overall Study||12||
59709464|NCT01243151|75828193|FG004|COMPLETED|Overall Study||14||
59709465|NCT01243151|75828189|FG000|NOT COMPLETED|Overall Study||0||
59709466|NCT01243151|75828190|FG001|NOT COMPLETED|Overall Study||1||
59709467|NCT01243151|75828191|FG002|NOT COMPLETED|Overall Study||1||
59709468|NCT01243151|75828192|FG003|NOT COMPLETED|Overall Study||2||
59709469|NCT01243151|75828193|FG004|NOT COMPLETED|Overall Study||0||
59709470|NCT01711021|75828209|FG000|STARTED|Open-Label Dose Optimization Period||110||
59565784|NCT01648140|75668186|FG002|STARTED|Overall Study||17||
59565785|NCT01648140|75668187|FG003|STARTED|Overall Study||13||
59565786|NCT01648140|75668184|FG000|COMPLETED|Overall Study||29||
59565787|NCT01648140|75668185|FG001|COMPLETED|Overall Study||28||
59565788|NCT01648140|75668186|FG002|COMPLETED|Overall Study||9||
59565789|NCT01648140|75668187|FG003|COMPLETED|Overall Study||11||
59565790|NCT01648140|75668184|FG000|NOT COMPLETED|Overall Study||12||
59565791|NCT01648140|75668185|FG001|NOT COMPLETED|Overall Study||12||
59565792|NCT01648140|75668186|FG002|NOT COMPLETED|Overall Study||8||
59565793|NCT01648140|75668187|FG003|NOT COMPLETED|Overall Study||2||
59565794|NCT02336178|75668206|FG000|STARTED|Overall Study||70||
59565795|NCT02336178|75668206|FG000|COMPLETED|Overall Study||66||
59565796|NCT02336178|75668206|FG000|NOT COMPLETED|Overall Study||4||
59565797|NCT02357940|75668220|FG000|STARTED|Overall Study||9||
59994795|NCT02731157|76110619|FG000|STARTED|First Rejuvenated RCE||4||
59994796|NCT02731157|76110619|FG000|COMPLETED|First Rejuvenated RCE||3||
59994797|NCT02731157|76110619|FG000|NOT COMPLETED|First Rejuvenated RCE||1||
59994798|NCT02731157|76110619|FG000|STARTED|Second Rejuvenated RCE||3||
59994799|NCT02731157|76110619|FG000|COMPLETED|Second Rejuvenated RCE||3||
59994800|NCT02731157|76110619|FG000|NOT COMPLETED|Second Rejuvenated RCE||0||
59994801|NCT02731157|76110619|FG000|STARTED|Third Rejuvenated RCE||3||
59994802|NCT02731157|76110619|FG000|COMPLETED|Third Rejuvenated RCE||3||
60103488|NCT01289080|76221711|FG000|COMPLETED|Overall Study||9||
60103489|NCT01289080|76221712|FG001|COMPLETED|Overall Study||10||
60103490|NCT01289080|76221711|FG000|NOT COMPLETED|Overall Study||0||
60103491|NCT01289080|76221712|FG001|NOT COMPLETED|Overall Study||0||
60103492|NCT01246258|76221719|FG000|STARTED|Overall Study||5||
59565798|NCT02357940|75668221|FG001|STARTED|Overall Study||32||
59709471|NCT01711021|75828210|FG001|STARTED|Open-Label Dose Optimization Period|No placebo arm for Period 1 Open-Label Dose Optimization Period.|0||
59709472|NCT01711021|75828209|FG000|COMPLETED|Open-Label Dose Optimization Period||106||
59709473|NCT01711021|75828210|FG001|COMPLETED|Open-Label Dose Optimization Period|No placebo arm for Period 1 Open-Label Dose Optimization Period.|0||
59709474|NCT01711021|75828209|FG000|NOT COMPLETED|Open-Label Dose Optimization Period||4||
59994803|NCT02731157|76110619|FG000|NOT COMPLETED|Third Rejuvenated RCE||0||
59994804|NCT02731157|76110619|FG000|STARTED|Second Standard RCE||3||
59994805|NCT02731157|76110619|FG000|COMPLETED|Second Standard RCE||3||
60103493|NCT01246258|76221719|FG000|COMPLETED|Overall Study||5||
60103494|NCT01246258|76221719|FG000|NOT COMPLETED|Overall Study||0||
59709475|NCT01711021|75828210|FG001|NOT COMPLETED|Open-Label Dose Optimization Period||0||
59709840|NCT01072149|75828534|FG014|STARTED|Treatment Period 2 (28 Days)||3||
59994806|NCT02731157|76110619|FG000|NOT COMPLETED|Second Standard RCE||0||
60103495|NCT01339858|76221726|FG000|STARTED|Overall Study||30||
60103496|NCT01339858|76221727|FG001|STARTED|Overall Study||30||
60103497|NCT01339858|76221726|FG000|COMPLETED|Overall Study||14||
60103498|NCT01339858|76221727|FG001|COMPLETED|Overall Study||18||
60103499|NCT01339858|76221726|FG000|NOT COMPLETED|Overall Study||16||
60103500|NCT01339858|76221727|FG001|NOT COMPLETED|Overall Study||12||
60103501|NCT01339936|76221735|FG000|STARTED|Overall Study|plus 2 screen failures|38||
60103502|NCT01339936|76221735|FG000|COMPLETED|Overall Study|plus 1 excluded from analysis set|36||
60103503|NCT01339936|76221735|FG000|NOT COMPLETED|Overall Study||2||
60103504|NCT01289392|76221742|FG000|STARTED|Overall Study||9||
60103505|NCT01289392|76221743|FG001|STARTED|Overall Study||9||
60103506|NCT01289392|76221744|FG002|STARTED|Overall Study||7||
60103507|NCT01289392|76221742|FG000|COMPLETED|Overall Study||9||
60103508|NCT01289392|76221743|FG001|COMPLETED|Overall Study||9||
59709476|NCT01711021|75828209|FG000|STARTED|Double-blind Cross-Over Treatment Period|The 106 subjects who completed Period 1 study (1 arm) were assigned to 2 arms in Period 2 study. Therefore, 53 subjects were assigned to the d-Amphetamine Transdermal Patch, then Placebo arm, another 53 subjects were assigned to the Placebo, then d-Amphetamine Transdermal Patch arm.|53||
59709477|NCT01711021|75828210|FG001|STARTED|Double-blind Cross-Over Treatment Period|The 106 subjects who completed Period 1 study (1 arm) were assigned to 2 arms in Period 2 study. Therefore, 53 subjects were assigned to the d-Amphetamine Transdermal Patch, then Placebo arm, another 53 subjects were assigned to the Placebo, then d-Amphetamine Transdermal Patch arm.|53||
59709478|NCT01711021|75828209|FG000|COMPLETED|Double-blind Cross-Over Treatment Period||46||
59709479|NCT01711021|75828210|FG001|COMPLETED|Double-blind Cross-Over Treatment Period||46||
59709480|NCT01711021|75828209|FG000|NOT COMPLETED|Double-blind Cross-Over Treatment Period||7||
59817838|NCT04488770|75940329|FG003|STARTED|Part 1-Cohort 1: Period 4 (Up to 5 Days)||2||
59817839|NCT04488770|75940330|FG004|STARTED|Part 1-Cohort 1: Period 4 (Up to 5 Days)||0||
59994807|NCT02731157|76110619|FG000|STARTED|Third Standard RCE||3||
59994808|NCT02731157|76110619|FG000|COMPLETED|Third Standard RCE||3||
59565799|NCT02357940|75668220|FG000|COMPLETED|Overall Study||9||
59709481|NCT01711021|75828210|FG001|NOT COMPLETED|Double-blind Cross-Over Treatment Period||7||
59709482|NCT00993148|75828217|FG000|STARTED|Overall Study||25||
59709483|NCT00993148|75828217|FG000|COMPLETED|Overall Study||22||
59994809|NCT02731157|76110619|FG000|NOT COMPLETED|Third Standard RCE||0||
59994810|NCT03268811|76110627|FG000|STARTED|Overall Study||7||
59994811|NCT03268811|76110628|FG001|STARTED|Overall Study||2||
59994812|NCT03268811|76110627|FG000|COMPLETED|Overall Study||7||
59709484|NCT00993148|75828217|FG000|NOT COMPLETED|Overall Study||3||
59709485|NCT00907621|75828223|FG000|STARTED|Overall Study||45||
60103509|NCT01289392|76221744|FG002|COMPLETED|Overall Study||7||
60103510|NCT01289392|76221742|FG000|NOT COMPLETED|Overall Study||0||
60103511|NCT01289392|76221743|FG001|NOT COMPLETED|Overall Study||0||
60103512|NCT01289392|76221744|FG002|NOT COMPLETED|Overall Study||0||
60103513|NCT01289548|76221755|FG000|STARTED|Overall Study|include both donors and recipients listed as milestones below|40||
60103514|NCT01289548|76221756|FG001|STARTED|Overall Study|include both donors and recipients listed as milestones below|40||
60103515|NCT01289548|76221757|FG002|STARTED|Overall Study|include both donors and recipients listed as milestones below|40||
60103516|NCT01289548|76221755|FG000|Donors|Overall Study||20||
59709486|NCT00907621|75828224|FG001|STARTED|Overall Study||45||
60103517|NCT01289548|76221756|FG001|Donors|Overall Study||20||
59709487|NCT00907621|75828223|FG000|COMPLETED|Overall Study||38||
59709488|NCT00907621|75828224|FG001|COMPLETED|Overall Study||41||
59709489|NCT00907621|75828223|FG000|NOT COMPLETED|Overall Study||7||
59709490|NCT00907621|75828224|FG001|NOT COMPLETED|Overall Study||4||
60103518|NCT01289548|76221757|FG002|Donors|Overall Study||20||
60103519|NCT01289548|76221755|FG000|Recipients|Overall Study||20||
60103520|NCT01289548|76221756|FG001|Recipients|Overall Study||20||
59709491|NCT03601117|75828232|FG000|STARTED|Overall Study||20||
59709492|NCT03601117|75828233|FG001|STARTED|Overall Study||2||
59709493|NCT03601117|75828232|FG000|COMPLETED|Overall Study||17||
59709494|NCT03601117|75828233|FG001|COMPLETED|Overall Study||1||
59565800|NCT02357940|75668221|FG001|COMPLETED|Overall Study||30||
60103521|NCT01289548|76221757|FG002|Recipients|Overall Study||20||
60103522|NCT01289548|76221755|FG000|COMPLETED|Overall Study||40||
60103523|NCT01289548|76221756|FG001|COMPLETED|Overall Study||40||
59565801|NCT02357940|75668220|FG000|NOT COMPLETED|Overall Study||0||
59565802|NCT02357940|75668221|FG001|NOT COMPLETED|Overall Study||2||
59565803|NCT02335242|75668229|FG000|STARTED|Randomized Phase (20 Weeks)||8||
59565804|NCT02335242|75668230|FG001|STARTED|Randomized Phase (20 Weeks)||11||
59565805|NCT02335242|75668229|FG000|COMPLETED|Randomized Phase (20 Weeks)||7||
59709495|NCT03601117|75828232|FG000|NOT COMPLETED|Overall Study||3||
60103524|NCT01289548|76221757|FG002|COMPLETED|Overall Study||40||
60103525|NCT01289548|76221755|FG000|NOT COMPLETED|Overall Study||0||
59565806|NCT02335242|75668230|FG001|COMPLETED|Randomized Phase (20 Weeks)||11||
60103526|NCT01289548|76221756|FG001|NOT COMPLETED|Overall Study||0||
60103527|NCT01289548|76221757|FG002|NOT COMPLETED|Overall Study||0||
60103528|NCT01341730|76221767|FG000|STARTED|Overall Study||20||
60103529|NCT01341730|76221768|FG001|STARTED|Overall Study||21||
60103530|NCT01341730|76221767|FG000|COMPLETED|Overall Study||16||
60103531|NCT01341730|76221768|FG001|COMPLETED|Overall Study||17||
60103532|NCT01341730|76221767|FG000|NOT COMPLETED|Overall Study||4||
60103533|NCT01341730|76221768|FG001|NOT COMPLETED|Overall Study||4||
60103534|NCT01247272|76221778|FG000|STARTED|First Intervention||13||
60103535|NCT01247272|76221779|FG001|STARTED|First Intervention||13||
60103536|NCT01247272|76221778|FG000|COMPLETED|First Intervention||13||
59565807|NCT02335242|75668229|FG000|NOT COMPLETED|Randomized Phase (20 Weeks)||1||
59565808|NCT02335242|75668230|FG001|NOT COMPLETED|Randomized Phase (20 Weeks)||0||
60103537|NCT01247272|76221779|FG001|COMPLETED|First Intervention||13||
60103538|NCT01247272|76221778|FG000|NOT COMPLETED|First Intervention||0||
60103539|NCT01247272|76221779|FG001|NOT COMPLETED|First Intervention||0||
59709496|NCT03601117|75828233|FG001|NOT COMPLETED|Overall Study||1||
60103540|NCT01247272|76221778|FG000|STARTED|Washout of 28 Days||13||
60103541|NCT01247272|76221779|FG001|STARTED|Washout of 28 Days||13||
60103542|NCT01247272|76221778|FG000|COMPLETED|Washout of 28 Days||13||
60103543|NCT01247272|76221779|FG001|COMPLETED|Washout of 28 Days||13||
60103544|NCT01247272|76221778|FG000|NOT COMPLETED|Washout of 28 Days||0||
59709843|NCT01072149|75828537|FG017|STARTED|Treatment Period 2 (28 Days)||2||
59709844|NCT01072149|75828520|FG000|COMPLETED|Treatment Period 2 (28 Days)||3||
59709845|NCT01072149|75828521|FG001|COMPLETED|Treatment Period 2 (28 Days)||2||
59709846|NCT01072149|75828522|FG002|COMPLETED|Treatment Period 2 (28 Days)||1||
59709847|NCT01072149|75828523|FG003|COMPLETED|Treatment Period 2 (28 Days)||3||
59817940|NCT04488770|75940327|FG001|NOT COMPLETED|Part 1-Cohort 2: Period 2 (Up to 5 Days)||0||
59995494|NCT01828112|76111340|FG001|Entered Post-treatment Follow-up Phase|Overall Study||5||
59995495|NCT01828112|76111339|FG000|Entered Survival Follow-up Phase|Overall Study||61||
59995496|NCT01828112|76111340|FG001|Entered Survival Follow-up Phase|Overall Study||19||
59995497|NCT01828112|76111339|FG000|Discontinued From Study|Overall Study||14||
59995498|NCT01828112|76111340|FG001|Discontinued From Study|Overall Study||10||
60103833|NCT03746522|76222153|FG001|STARTED|Period 2: Open-Label (38 Weeks)||0||
60103834|NCT03746522|76222154|FG002|STARTED|Period 2: Open-Label (38 Weeks)||50||
60103835|NCT03746522|76222152|FG000|COMPLETED|Period 2: Open-Label (38 Weeks)||0||
60103836|NCT03746522|76222153|FG001|COMPLETED|Period 2: Open-Label (38 Weeks)||0||
60103837|NCT03746522|76222154|FG002|COMPLETED|Period 2: Open-Label (38 Weeks)||41||
60103838|NCT03746522|76222152|FG000|NOT COMPLETED|Period 2: Open-Label (38 Weeks)||0||
60103839|NCT03746522|76222153|FG001|NOT COMPLETED|Period 2: Open-Label (38 Weeks)||0||
60103840|NCT03746522|76222154|FG002|NOT COMPLETED|Period 2: Open-Label (38 Weeks)||9||
60103841|NCT03746522|76222152|FG000|STARTED|Period 3: Open-Label (14 Weeks)||0||
60103842|NCT03746522|76222153|FG001|STARTED|Period 3: Open-Label (14 Weeks)||0||
60103843|NCT03746522|76222154|FG002|STARTED|Period 3: Open-Label (14 Weeks)||41||
60103844|NCT03746522|76222152|FG000|COMPLETED|Period 3: Open-Label (14 Weeks)||0||
60103845|NCT03746522|76222153|FG001|COMPLETED|Period 3: Open-Label (14 Weeks)||0||
60103846|NCT03746522|76222154|FG002|COMPLETED|Period 3: Open-Label (14 Weeks)||41||
60103847|NCT03746522|76222152|FG000|NOT COMPLETED|Period 3: Open-Label (14 Weeks)||0||
60103848|NCT03746522|76222153|FG001|NOT COMPLETED|Period 3: Open-Label (14 Weeks)||0||
60103849|NCT03746522|76222154|FG002|NOT COMPLETED|Period 3: Open-Label (14 Weeks)||0||
60103850|NCT03710161|76222162|FG000|STARTED|Overall Study||3||
60103851|NCT03710161|76222163|FG001|STARTED|Overall Study||2||
60103852|NCT03710161|76222162|FG000|COMPLETED|Overall Study|Study halted due to COVID pandemic|0||
60103853|NCT03710161|76222163|FG001|COMPLETED|Overall Study|Study halted due to COVID pandemic|0||
60103854|NCT03710161|76222162|FG000|NOT COMPLETED|Overall Study||3||
60103855|NCT03710161|76222163|FG001|NOT COMPLETED|Overall Study||2||
60103856|NCT03709277|76222171|FG000|STARTED|Overall Study||218||
60103857|NCT03709277|76222172|FG001|STARTED|Overall Study||220||
60103858|NCT03709277|76222171|FG000|COMPLETED|Overall Study||218||
60103859|NCT03709277|76222172|FG001|COMPLETED|Overall Study||220||
60103860|NCT03709277|76222171|FG000|NOT COMPLETED|Overall Study||0||
59995499|NCT01828112|76111339|FG000|Untreated Patients|Overall Study||0||
59995500|NCT01828112|76111340|FG001|Untreated Patients|Overall Study|untreated = did not receive study drug|3||
59995501|NCT01828112|76111339|FG000|Untreated|Overall Study||0||
59995502|NCT01828112|76111340|FG001|Untreated|Overall Study||3||
59995503|NCT01828112|76111339|FG000|Treated|Overall Study||115||
59995504|NCT01828112|76111340|FG001|Treated|Overall Study||113||
59995505|NCT01828112|76111339|FG000|COMPLETED|Overall Study|Completed = Ongoing at time of data cut-off of 26-Jan-2016|33||
59995506|NCT01828112|76111340|FG001|COMPLETED|Overall Study|Completed = Ongoing at time of data cut-off of 26-Jan-2016|8||
59995507|NCT01828112|76111339|FG000|NOT COMPLETED|Overall Study||82||
59995508|NCT01828112|76111340|FG001|NOT COMPLETED|Overall Study||108||
59995509|NCT01740427|76111348|FG000|STARTED|Overall Study||444||
59995510|NCT01740427|76111349|FG001|STARTED|Overall Study||222||
60103861|NCT03709277|76222172|FG001|NOT COMPLETED|Overall Study||0||
60103862|NCT03478956|76222181|FG000|STARTED|Overall Study||12|Enrolled in Randomized Treatment Phase|
60103863|NCT03478956|76222182|FG001|STARTED|Overall Study||12|Enrolled in Randomized Treatment Phase|
60103864|NCT03478956|76222181|FG000|Received at Least One Dose of Study Drug|Overall Study||12||
60103865|NCT03478956|76222182|FG001|Received at Least One Dose of Study Drug|Overall Study||12||
60103866|NCT03478956|76222181|FG000|Completed Randomized Treatment Phase|Overall Study||11||
60103867|NCT03478956|76222182|FG001|Completed Randomized Treatment Phase|Overall Study||10||
60103868|NCT03478956|76222181|FG000|Started OLE Treatment Phase|Overall Study||11||
60103869|NCT03478956|76222182|FG001|Started OLE Treatment Phase|Overall Study||10||
60103870|NCT03478956|76222181|FG000|Completed OLE Treatment Phase|Overall Study||0||
59709848|NCT01072149|75828524|FG004|COMPLETED|Treatment Period 2 (28 Days)||3||
59709849|NCT01072149|75828525|FG005|COMPLETED|Treatment Period 2 (28 Days)||3||
59709850|NCT01072149|75828526|FG006|COMPLETED|Treatment Period 2 (28 Days)||3||
59709851|NCT01072149|75828527|FG007|COMPLETED|Treatment Period 2 (28 Days)||2||
59709852|NCT01072149|75828528|FG008|COMPLETED|Treatment Period 2 (28 Days)||3||
59709853|NCT01072149|75828529|FG009|COMPLETED|Treatment Period 2 (28 Days)||3||
59995511|NCT01740427|76111348|FG000|COMPLETED|Overall Study||0||
59995512|NCT01740427|76111349|FG001|COMPLETED|Overall Study||0||
59995513|NCT01740427|76111348|FG000|NOT COMPLETED|Overall Study||444||
59709854|NCT01072149|75828530|FG010|COMPLETED|Treatment Period 2 (28 Days)||2||
59709855|NCT01072149|75828531|FG011|COMPLETED|Treatment Period 2 (28 Days)||3||
59709856|NCT01072149|75828532|FG012|COMPLETED|Treatment Period 2 (28 Days)||3||
59709857|NCT01072149|75828533|FG013|COMPLETED|Treatment Period 2 (28 Days)||3||
60103871|NCT03478956|76222182|FG001|Completed OLE Treatment Phase|Overall Study||0||
60103872|NCT03478956|76222181|FG000|Started PML Safety Monitoring Phase|Overall Study||1||
60103873|NCT03478956|76222182|FG001|Started PML Safety Monitoring Phase|Overall Study||2||
60103874|NCT03478956|76222181|FG000|COMPLETED|Overall Study||0||
60103875|NCT03478956|76222182|FG001|COMPLETED|Overall Study||0||
60103876|NCT03478956|76222181|FG000|NOT COMPLETED|Overall Study||12||
60103877|NCT03478956|76222182|FG001|NOT COMPLETED|Overall Study||12||
60103878|NCT03347110|76222188|FG000|STARTED|Overall Study||183||
60103879|NCT03347110|76222188|FG000|COMPLETED|Overall Study||161||
60103880|NCT03347110|76222188|FG000|NOT COMPLETED|Overall Study||22||
60103881|NCT02951052|76222196|FG000|STARTED|Overall Study||308||
60103882|NCT02951052|76222197|FG001|STARTED|Overall Study||308||
60103883|NCT02951052|76222196|FG000|COMPLETED|Overall Study||281||
60103884|NCT02951052|76222197|FG001|COMPLETED|Overall Study||290||
60103885|NCT02951052|76222196|FG000|NOT COMPLETED|Overall Study||27||
60103886|NCT02951052|76222197|FG001|NOT COMPLETED|Overall Study||18||
60103887|NCT02851992|76222207|FG000|STARTED|Overall Study||303||
60103888|NCT02851992|76222207|FG000|COMPLETED|Overall Study||41||
60103889|NCT02851992|76222207|FG000|NOT COMPLETED|Overall Study||262||
60103890|NCT02788773|76222213|FG000|STARTED|Overall Study||39||
60103891|NCT02788773|76222214|FG001|STARTED|Overall Study||13||
60103892|NCT02788773|76222213|FG000|COMPLETED|Overall Study||39||
60103893|NCT02788773|76222214|FG001|COMPLETED|Overall Study||13||
60103894|NCT02788773|76222213|FG000|NOT COMPLETED|Overall Study||0||
60103895|NCT02788773|76222214|FG001|NOT COMPLETED|Overall Study||0||
60103896|NCT02768792|76222220|FG000|STARTED|Overall Study||38||
60103897|NCT02768792|76222220|FG000|COMPLETED|Overall Study||37||
60103898|NCT02768792|76222220|FG000|NOT COMPLETED|Overall Study||1||
60103899|NCT02688400|76222226|FG000|STARTED|Overall Study||187||
60103900|NCT02688400|76222227|FG001|STARTED|Overall Study||193||
60103901|NCT02688400|76222226|FG000|COMPLETED|Overall Study||141||
60103902|NCT02688400|76222227|FG001|COMPLETED|Overall Study||149||
60103903|NCT02688400|76222226|FG000|NOT COMPLETED|Overall Study||46||
60103904|NCT02688400|76222227|FG001|NOT COMPLETED|Overall Study||44||
60103905|NCT02193347|76222234|FG000|STARTED|Overall Study||24||
60103906|NCT02193347|76222234|FG000|COMPLETED|Overall Study||24||
59995514|NCT01740427|76111349|FG001|NOT COMPLETED|Overall Study||222||
59995515|NCT01657682|76111358|FG000|STARTED|Overall Study||13||
59995516|NCT01657682|76111359|FG001|STARTED|Overall Study||30||
59995517|NCT01657682|76111360|FG002|STARTED|Overall Study||13||
59995518|NCT01657682|76111358|FG000|COMPLETED|Overall Study||12||
59995519|NCT01657682|76111359|FG001|COMPLETED|Overall Study||28||
59995520|NCT01657682|76111360|FG002|COMPLETED|Overall Study||12||
59995521|NCT01657682|76111358|FG000|NOT COMPLETED|Overall Study||1||
59995522|NCT01657682|76111359|FG001|NOT COMPLETED|Overall Study||2||
59995523|NCT01657682|76111360|FG002|NOT COMPLETED|Overall Study||1||
59995524|NCT01644292|76111376|FG000|STARTED|Overall Study||2||
59995525|NCT01644292|76111376|FG000|COMPLETED|Overall Study||2||
59995526|NCT01644292|76111376|FG000|NOT COMPLETED|Overall Study||0||
59995527|NCT01556243|76111380|FG000|STARTED|Overall Study||270||
59995528|NCT01556243|76111380|FG000|COMPLETED|Overall Study||204||
59995529|NCT01556243|76111380|FG000|NOT COMPLETED|Overall Study||66||
59995530|NCT01421771|76111387|FG000|STARTED|Overall Study||62||
59995531|NCT01421771|76111388|FG001|STARTED|Overall Study||64||
59995532|NCT01421771|76111387|FG000|COMPLETED|Overall Study||62||
59995533|NCT01421771|76111388|FG001|COMPLETED|Overall Study||64||
60103907|NCT02193347|76222234|FG000|NOT COMPLETED|Overall Study||0||
59995534|NCT01421771|76111387|FG000|NOT COMPLETED|Overall Study||0||
59995535|NCT01421771|76111388|FG001|NOT COMPLETED|Overall Study||0||
59995536|NCT01128218|76111400|FG000|STARTED|Overall Study||3||
59995537|NCT01128218|76111401|FG001|STARTED|Overall Study||3||
59995538|NCT01128218|76111402|FG002|STARTED|Overall Study||3||
59995539|NCT01128218|76111403|FG003|STARTED|Overall Study||4||
60103908|NCT02039843|76222240|FG000|STARTED|Randomization and Observation Period||113|Number of participants randomized to each arm.|
60103909|NCT02039843|76222241|FG001|STARTED|Randomization and Observation Period||114|Number of participants randomized to each arm.|
60103910|NCT02039843|76222240|FG000|COMPLETED|Randomization and Observation Period||84|Randomized participants paired with a study dog.|
60103911|NCT02039843|76222241|FG001|COMPLETED|Randomization and Observation Period||97|Randomized participants paired with a study dog.|
60103912|NCT02039843|76222240|FG000|NOT COMPLETED|Randomization and Observation Period||29||
60103913|NCT02039843|76222241|FG001|NOT COMPLETED|Randomization and Observation Period||17||
60103914|NCT02039843|76222240|FG000|STARTED|Pairing With a Study Dog||84||
60103915|NCT02039843|76222241|FG001|STARTED|Pairing With a Study Dog||97||
59565974|NCT02303574|75668414|FG009|STARTED|Part 1b (Fed State) - SAD|Participants received AZD7986 matching placebo on Day 1 in fed state.|3||
59565975|NCT02303574|75668405|FG000|COMPLETED|Part 1b (Fed State) - SAD||0||
59565976|NCT02303574|75668406|FG001|COMPLETED|Part 1b (Fed State) - SAD||0||
59995540|NCT01128218|76111404|FG004|STARTED|Overall Study||6||
59995541|NCT01128218|76111405|FG005|STARTED|Overall Study||14||
59995542|NCT01128218|76111400|FG000|COMPLETED|Overall Study||3||
59995543|NCT01128218|76111401|FG001|COMPLETED|Overall Study||3||
59995544|NCT01128218|76111402|FG002|COMPLETED|Overall Study||3||
59995545|NCT01128218|76111403|FG003|COMPLETED|Overall Study||4||
59995546|NCT01128218|76111404|FG004|COMPLETED|Overall Study||6||
59995547|NCT01128218|76111405|FG005|COMPLETED|Overall Study||14||
59995548|NCT01128218|76111400|FG000|NOT COMPLETED|Overall Study||0||
60103916|NCT02039843|76222240|FG000|COMPLETED|Pairing With a Study Dog||65||
59565977|NCT02303574|75668407|FG002|COMPLETED|Part 1b (Fed State) - SAD||0||
59565978|NCT02303574|75668408|FG003|COMPLETED|Part 1b (Fed State) - SAD||0||
59565979|NCT02303574|75668409|FG004|COMPLETED|Part 1b (Fed State) - SAD||0||
59565980|NCT02303574|75668410|FG005|COMPLETED|Part 1b (Fed State) - SAD||5||
59565981|NCT02303574|75668411|FG006|COMPLETED|Part 1b (Fed State) - SAD||0||
59565982|NCT02303574|75668412|FG007|COMPLETED|Part 1b (Fed State) - SAD||0||
59565983|NCT02303574|75668413|FG008|COMPLETED|Part 1b (Fed State) - SAD||0||
59565984|NCT02303574|75668414|FG009|COMPLETED|Part 1b (Fed State) - SAD||3||
59995549|NCT01128218|76111401|FG001|NOT COMPLETED|Overall Study||0||
59995550|NCT01128218|76111402|FG002|NOT COMPLETED|Overall Study||0||
59995551|NCT01128218|76111403|FG003|NOT COMPLETED|Overall Study||0||
60103917|NCT02039843|76222241|FG001|COMPLETED|Pairing With a Study Dog||88||
60103918|NCT02039843|76222240|FG000|NOT COMPLETED|Pairing With a Study Dog||19||
60103919|NCT02039843|76222241|FG001|NOT COMPLETED|Pairing With a Study Dog||9||
60103920|NCT02004275|76222255|FG000|STARTED|Phase 1||0||
60103921|NCT02004275|76222256|FG001|STARTED|Phase 1||0||
60103922|NCT02004275|76222257|FG002|STARTED|Phase 1||3||
60103923|NCT02004275|76222258|FG003|STARTED|Phase 1||5||
60103924|NCT02004275|76222259|FG004|STARTED|Phase 1||7||
60103925|NCT02004275|76222260|FG005|STARTED|Phase 1||11||
60103926|NCT02004275|76222255|FG000|COMPLETED|Phase 1||0||
60103927|NCT02004275|76222256|FG001|COMPLETED|Phase 1||0||
60103928|NCT02004275|76222257|FG002|COMPLETED|Phase 1||3||
60103929|NCT02004275|76222258|FG003|COMPLETED|Phase 1||3||
60103930|NCT02004275|76222259|FG004|COMPLETED|Phase 1||6||
60103931|NCT02004275|76222260|FG005|COMPLETED|Phase 1||6||
60103932|NCT02004275|76222255|FG000|NOT COMPLETED|Phase 1||0||
60103933|NCT02004275|76222256|FG001|NOT COMPLETED|Phase 1||0||
60103934|NCT02004275|76222257|FG002|NOT COMPLETED|Phase 1||0||
60103935|NCT02004275|76222258|FG003|NOT COMPLETED|Phase 1||2||
60103936|NCT02004275|76222259|FG004|NOT COMPLETED|Phase 1||1||
60103937|NCT02004275|76222260|FG005|NOT COMPLETED|Phase 1||5||
60103938|NCT02004275|76222255|FG000|STARTED|Phase 2 Part 1||45||
60103939|NCT02004275|76222256|FG001|STARTED|Phase 2 Part 1||47||
60103940|NCT02004275|76222257|FG002|STARTED|Phase 2 Part 1||0||
60103941|NCT02004275|76222258|FG003|STARTED|Phase 2 Part 1||0||
60103942|NCT02004275|76222259|FG004|STARTED|Phase 2 Part 1||0||
60103943|NCT02004275|76222260|FG005|STARTED|Phase 2 Part 1||0||
60103944|NCT02004275|76222255|FG000|COMPLETED|Phase 2 Part 1||39||
59995552|NCT01128218|76111404|FG004|NOT COMPLETED|Overall Study||0||
59995553|NCT01128218|76111405|FG005|NOT COMPLETED|Overall Study||0||
59995554|NCT00819156|76111425|FG000|STARTED|Overall Study||30||
59995555|NCT00819156|76111426|FG001|STARTED|Overall Study||33||
59995556|NCT00819156|76111427|FG002|STARTED|Overall Study||32||
59995557|NCT00819156|76111428|FG003|STARTED|Overall Study||30||
59995558|NCT00819156|76111429|FG004|STARTED|Overall Study||33||
59995559|NCT00819156|76111430|FG005|STARTED|Overall Study||31||
60103945|NCT02004275|76222256|FG001|COMPLETED|Phase 2 Part 1||38||
60103946|NCT02004275|76222257|FG002|COMPLETED|Phase 2 Part 1||0||
59995560|NCT00819156|76111425|FG000|Randomised and Treated (ITT Population)|Overall Study||30||
60103947|NCT02004275|76222258|FG003|COMPLETED|Phase 2 Part 1||0||
60103948|NCT02004275|76222259|FG004|COMPLETED|Phase 2 Part 1||0||
60103949|NCT02004275|76222260|FG005|COMPLETED|Phase 2 Part 1||0||
60103950|NCT02004275|76222255|FG000|NOT COMPLETED|Phase 2 Part 1||6||
60103951|NCT02004275|76222256|FG001|NOT COMPLETED|Phase 2 Part 1||9||
60103952|NCT02004275|76222257|FG002|NOT COMPLETED|Phase 2 Part 1||0||
59565985|NCT02303574|75668405|FG000|NOT COMPLETED|Part 1b (Fed State) - SAD||0||
59565986|NCT02303574|75668406|FG001|NOT COMPLETED|Part 1b (Fed State) - SAD||0||
59565987|NCT02303574|75668407|FG002|NOT COMPLETED|Part 1b (Fed State) - SAD||0||
59565988|NCT02303574|75668408|FG003|NOT COMPLETED|Part 1b (Fed State) - SAD||0||
59995561|NCT00819156|76111426|FG001|Randomised and Treated (ITT Population)|Overall Study||32||
59565989|NCT02303574|75668409|FG004|NOT COMPLETED|Part 1b (Fed State) - SAD||0||
59565990|NCT02303574|75668410|FG005|NOT COMPLETED|Part 1b (Fed State) - SAD||0||
59709858|NCT01072149|75828534|FG014|COMPLETED|Treatment Period 2 (28 Days)||3||
59995562|NCT00819156|76111427|FG002|Randomised and Treated (ITT Population)|Overall Study||32||
59995563|NCT00819156|76111428|FG003|Randomised and Treated (ITT Population)|Overall Study||30||
59995564|NCT00819156|76111429|FG004|Randomised and Treated (ITT Population)|Overall Study||33||
59995565|NCT00819156|76111430|FG005|Randomised and Treated (ITT Population)|Overall Study||30||
59995566|NCT00819156|76111425|FG000|COMPLETED|Overall Study||20||
59995567|NCT00819156|76111426|FG001|COMPLETED|Overall Study||23||
59995568|NCT00819156|76111427|FG002|COMPLETED|Overall Study||26||
59995569|NCT00819156|76111428|FG003|COMPLETED|Overall Study||28||
59995570|NCT00819156|76111429|FG004|COMPLETED|Overall Study||27||
59995571|NCT00819156|76111430|FG005|COMPLETED|Overall Study||23||
59995572|NCT00819156|76111425|FG000|NOT COMPLETED|Overall Study||10||
60103953|NCT02004275|76222258|FG003|NOT COMPLETED|Phase 2 Part 1||0||
60103954|NCT02004275|76222259|FG004|NOT COMPLETED|Phase 2 Part 1||0||
60103955|NCT02004275|76222260|FG005|NOT COMPLETED|Phase 2 Part 1||0||
60103956|NCT02004275|76222255|FG000|STARTED|Phase 2 Part 2||30||
60103957|NCT02004275|76222256|FG001|STARTED|Phase 2 Part 2||0||
60103958|NCT02004275|76222257|FG002|STARTED|Phase 2 Part 2||0||
60103959|NCT02004275|76222258|FG003|STARTED|Phase 2 Part 2||0||
60103960|NCT02004275|76222259|FG004|STARTED|Phase 2 Part 2||0||
60103961|NCT02004275|76222260|FG005|STARTED|Phase 2 Part 2||0||
60103962|NCT02004275|76222255|FG000|COMPLETED|Phase 2 Part 2||26||
60103963|NCT02004275|76222256|FG001|COMPLETED|Phase 2 Part 2||0||
60103964|NCT02004275|76222257|FG002|COMPLETED|Phase 2 Part 2||0||
60103965|NCT02004275|76222258|FG003|COMPLETED|Phase 2 Part 2||0||
60103966|NCT02004275|76222259|FG004|COMPLETED|Phase 2 Part 2||0||
60103967|NCT02004275|76222260|FG005|COMPLETED|Phase 2 Part 2||0||
60103968|NCT02004275|76222255|FG000|NOT COMPLETED|Phase 2 Part 2||4||
60103969|NCT02004275|76222256|FG001|NOT COMPLETED|Phase 2 Part 2||0||
60103970|NCT02004275|76222257|FG002|NOT COMPLETED|Phase 2 Part 2||0||
60103971|NCT02004275|76222258|FG003|NOT COMPLETED|Phase 2 Part 2||0||
60103972|NCT02004275|76222259|FG004|NOT COMPLETED|Phase 2 Part 2||0||
60103973|NCT02004275|76222260|FG005|NOT COMPLETED|Phase 2 Part 2||0||
60103974|NCT01559129|76222286|FG000|STARTED|Treatment Phase||12||
60103975|NCT01559129|76222287|FG001|STARTED|Treatment Phase||11||
60103976|NCT01559129|76222286|FG000|Received Treatment|Treatment Phase||12||
60103977|NCT01559129|76222287|FG001|Received Treatment|Treatment Phase||10||
60103978|NCT01559129|76222286|FG000|COMPLETED|Treatment Phase||7||
60103979|NCT01559129|76222287|FG001|COMPLETED|Treatment Phase||4||
60103980|NCT01559129|76222286|FG000|NOT COMPLETED|Treatment Phase||5||
60103981|NCT01559129|76222287|FG001|NOT COMPLETED|Treatment Phase||7||
60103982|NCT01559129|76222286|FG000|STARTED|Open-label Extension Period|One participant elected not to enter the Extension Phase.|6||
60103983|NCT01559129|76222287|FG001|STARTED|Open-label Extension Period|Two participants elected not to enter the Extension Phase.|2||
60103984|NCT01559129|76222286|FG000|COMPLETED|Open-label Extension Period||0||
60103985|NCT01559129|76222287|FG001|COMPLETED|Open-label Extension Period||0||
60103986|NCT01559129|76222286|FG000|NOT COMPLETED|Open-label Extension Period||6||
60103987|NCT01559129|76222287|FG001|NOT COMPLETED|Open-label Extension Period||2||
60103988|NCT01005303|76222301|FG000|STARTED|Overall Study||36||
60103989|NCT01005303|76222302|FG001|STARTED|Overall Study||38||
60103990|NCT01005303|76222301|FG000|COMPLETED|Overall Study||36||
60103991|NCT01005303|76222302|FG001|COMPLETED|Overall Study|3 patients did not complete the study protocol (2 developed illnesses during the first 3 months of follow-up, requiring withdrawal from the study, and 1 died approximately 6 months into the study).|35||
60103992|NCT01005303|76222301|FG000|NOT COMPLETED|Overall Study||0||
60103993|NCT01005303|76222302|FG001|NOT COMPLETED|Overall Study||3||
60103994|NCT00355238|76222312|FG000|STARTED|Overall Study||55||
60103995|NCT00355238|76222313|FG001|STARTED|Overall Study||46||
60103996|NCT00355238|76222314|FG002|STARTED|Overall Study||22||
60103997|NCT00355238|76222315|FG003|STARTED|Overall Study||14||
60103998|NCT00355238|76222312|FG000|Crossed Over From Doxorubicin to Recieve Brivanib Alaninate|Overall Study||0||
60103999|NCT00355238|76222313|FG001|Crossed Over From Doxorubicin to Recieve Brivanib Alaninate|Overall Study||0||
60104000|NCT00355238|76222314|FG002|Crossed Over From Doxorubicin to Recieve Brivanib Alaninate|Overall Study||0||
60104001|NCT00355238|76222315|FG003|Crossed Over From Doxorubicin to Recieve Brivanib Alaninate|Overall Study||6||
60104002|NCT00355238|76222312|FG000|COMPLETED|Overall Study||0||
60104003|NCT00355238|76222313|FG001|COMPLETED|Overall Study||0||
60104004|NCT00355238|76222314|FG002|COMPLETED|Overall Study||0||
60104005|NCT00355238|76222315|FG003|COMPLETED|Overall Study||0||
60104006|NCT00355238|76222312|FG000|NOT COMPLETED|Overall Study||55||
59565991|NCT02303574|75668411|FG006|NOT COMPLETED|Part 1b (Fed State) - SAD||0||
59565992|NCT02303574|75668412|FG007|NOT COMPLETED|Part 1b (Fed State) - SAD||0||
59565993|NCT02303574|75668413|FG008|NOT COMPLETED|Part 1b (Fed State) - SAD||0||
59565994|NCT02303574|75668414|FG009|NOT COMPLETED|Part 1b (Fed State) - SAD||0||
59709859|NCT01072149|75828535|FG015|COMPLETED|Treatment Period 2 (28 Days)||3||
59709860|NCT01072149|75828536|FG016|COMPLETED|Treatment Period 2 (28 Days)||3||
59709861|NCT01072149|75828537|FG017|COMPLETED|Treatment Period 2 (28 Days)||2||
59709862|NCT01072149|75828520|FG000|NOT COMPLETED|Treatment Period 2 (28 Days)||0||
60104007|NCT00355238|76222313|FG001|NOT COMPLETED|Overall Study||46||
60104008|NCT00355238|76222314|FG002|NOT COMPLETED|Overall Study||22||
60104009|NCT00355238|76222315|FG003|NOT COMPLETED|Overall Study||14||
60104010|NCT00303303|76222330|FG000|STARTED|Overall Study||5||
60104011|NCT00303303|76222331|FG001|STARTED|Overall Study||4||
60104012|NCT00303303|76222332|FG002|STARTED|Overall Study||4||
60104013|NCT00303303|76222330|FG000|COMPLETED|Overall Study||5||
60104014|NCT00303303|76222331|FG001|COMPLETED|Overall Study||4||
60104015|NCT00303303|76222332|FG002|COMPLETED|Overall Study||3||
60104016|NCT00303303|76222330|FG000|NOT COMPLETED|Overall Study||0||
60104017|NCT00303303|76222331|FG001|NOT COMPLETED|Overall Study||0||
60104018|NCT00303303|76222332|FG002|NOT COMPLETED|Overall Study||1||
60104019|NCT01253824|76222348|FG000|STARTED|Overall Study||7||
60104020|NCT01253824|76222349|FG001|STARTED|Overall Study||7||
60104021|NCT01253824|76222348|FG000|COMPLETED|Overall Study||7||
60104022|NCT01253824|76222349|FG001|COMPLETED|Overall Study||7||
60104023|NCT01253824|76222348|FG000|NOT COMPLETED|Overall Study||0||
60104024|NCT01253824|76222349|FG001|NOT COMPLETED|Overall Study||0||
60104025|NCT01253902|76222358|FG000|STARTED|Overall Study||56||
60104026|NCT01253902|76222359|FG001|STARTED|Overall Study||53||
60104027|NCT01253902|76222360|FG002|STARTED|Overall Study||55||
60104028|NCT01253902|76222358|FG000|COMPLETED|Overall Study||51||
60104029|NCT01253902|76222359|FG001|COMPLETED|Overall Study||51||
60104030|NCT01253902|76222360|FG002|COMPLETED|Overall Study||51||
60104031|NCT01253902|76222358|FG000|NOT COMPLETED|Overall Study||5||
60104032|NCT01253902|76222359|FG001|NOT COMPLETED|Overall Study||2||
60104033|NCT01253902|76222360|FG002|NOT COMPLETED|Overall Study||4||
60104034|NCT01253980|76222370|FG000|STARTED|Overall Study||35||
60104035|NCT01253980|76222371|FG001|STARTED|Overall Study||39||
60104036|NCT01253980|76222370|FG000|COMPLETED|Overall Study||35||
60104037|NCT01253980|76222371|FG001|COMPLETED|Overall Study||39||
60104038|NCT01253980|76222370|FG000|NOT COMPLETED|Overall Study||0||
60104039|NCT01253980|76222371|FG001|NOT COMPLETED|Overall Study||0||
60104040|NCT00988533|76222377|FG000|STARTED|Overall Study||30||
60104041|NCT00988533|76222377|FG000|COMPLETED|Overall Study||27||
60104042|NCT00988533|76222377|FG000|NOT COMPLETED|Overall Study||3||
60104043|NCT01254214|76222383|FG000|STARTED|Overall Study||27||
60104044|NCT01254214|76222384|FG001|STARTED|Overall Study||28||
60104045|NCT01254214|76222383|FG000|COMPLETED|Overall Study||24||
60104046|NCT01254214|76222384|FG001|COMPLETED|Overall Study||27||
60104047|NCT01254214|76222383|FG000|NOT COMPLETED|Overall Study||3||
60104048|NCT01254214|76222384|FG001|NOT COMPLETED|Overall Study||1||
60104049|NCT01254760|76222390|FG000|STARTED|First Period, 5 Days of Wear||34||
60104050|NCT01254760|76222391|FG001|STARTED|First Period, 5 Days of Wear||38||
60104051|NCT01254760|76222390|FG000|COMPLETED|First Period, 5 Days of Wear||34||
60104052|NCT01254760|76222391|FG001|COMPLETED|First Period, 5 Days of Wear||38||
60104053|NCT01254760|76222390|FG000|NOT COMPLETED|First Period, 5 Days of Wear||0||
60104054|NCT01254760|76222391|FG001|NOT COMPLETED|First Period, 5 Days of Wear||0||
60104055|NCT01254760|76222390|FG000|STARTED|Second Period, 5 Days of Wear||34||
60104056|NCT01254760|76222391|FG001|STARTED|Second Period, 5 Days of Wear||38||
60104057|NCT01254760|76222390|FG000|COMPLETED|Second Period, 5 Days of Wear||34||
60104058|NCT01254760|76222391|FG001|COMPLETED|Second Period, 5 Days of Wear||38||
60104059|NCT01254760|76222390|FG000|NOT COMPLETED|Second Period, 5 Days of Wear||0||
60104060|NCT01254760|76222391|FG001|NOT COMPLETED|Second Period, 5 Days of Wear||0||
60104061|NCT01350388|76222400|FG000|STARTED|Overall Study||40||
60104062|NCT01350388|76222401|FG001|STARTED|Overall Study||40||
60104063|NCT01350388|76222400|FG000|COMPLETED|Overall Study||37||
60104064|NCT01350388|76222401|FG001|COMPLETED|Overall Study||39||
60104065|NCT01350388|76222400|FG000|NOT COMPLETED|Overall Study||3||
60104066|NCT01350388|76222401|FG001|NOT COMPLETED|Overall Study||1||
60104067|NCT03633396|76222409|FG000|STARTED|Overall Study||29||
60104068|NCT03633396|76222410|FG001|STARTED|Overall Study||30||
60104069|NCT03633396|76222409|FG000|COMPLETED|Overall Study||23||
60104070|NCT03633396|76222410|FG001|COMPLETED|Overall Study||24||
60104071|NCT03633396|76222409|FG000|NOT COMPLETED|Overall Study||6||
60104072|NCT03633396|76222410|FG001|NOT COMPLETED|Overall Study||6||
60104073|NCT01294228|76222416|FG000|STARTED|Overall Study||1001||
60104074|NCT01294228|76222416|FG000|COMPLETED|Overall Study||1001||
60104075|NCT01294228|76222416|FG000|NOT COMPLETED|Overall Study||0||
60104076|NCT00988065|76222423|FG000|STARTED|Overall Study|Randomized to double-blind treatment|148||
60104077|NCT00988065|76222424|FG001|STARTED|Overall Study|Randomized to double-blind treatment|150||
60104078|NCT00988065|76222425|FG002|STARTED|Overall Study|Randomized to double-blind treatment|150||
60104079|NCT00988065|76222423|FG000|Received First Randomized Dose|Overall Study||148||
60104080|NCT00988065|76222424|FG001|Received First Randomized Dose|Overall Study||150||
59709863|NCT01072149|75828521|FG001|NOT COMPLETED|Treatment Period 2 (28 Days)||1||
59709864|NCT01072149|75828522|FG002|NOT COMPLETED|Treatment Period 2 (28 Days)||1||
59709865|NCT01072149|75828523|FG003|NOT COMPLETED|Treatment Period 2 (28 Days)||0||
60104081|NCT00988065|76222425|FG002|Received First Randomized Dose|Overall Study||150||
60104082|NCT00988065|76222423|FG000|Received Second Randomized Dose|Overall Study||139||
60104083|NCT00988065|76222424|FG001|Received Second Randomized Dose|Overall Study||135||
60104084|NCT00988065|76222425|FG002|Received Second Randomized Dose|Overall Study||145||
60104085|NCT00988065|76222423|FG000|Received Third Randomized Dose|Overall Study||135||
60104086|NCT00988065|76222424|FG001|Received Third Randomized Dose|Overall Study||127||
59709866|NCT01072149|75828524|FG004|NOT COMPLETED|Treatment Period 2 (28 Days)||0||
60104087|NCT00988065|76222425|FG002|Received Third Randomized Dose|Overall Study||135||
60104088|NCT00988065|76222423|FG000|COMPLETED|Overall Study||135||
60104089|NCT00988065|76222424|FG001|COMPLETED|Overall Study||127||
60104090|NCT00988065|76222425|FG002|COMPLETED|Overall Study||135||
60104091|NCT00988065|76222423|FG000|NOT COMPLETED|Overall Study||13||
60104092|NCT00988065|76222424|FG001|NOT COMPLETED|Overall Study||23||
60104093|NCT00988065|76222425|FG002|NOT COMPLETED|Overall Study||15||
60104094|NCT01351090|76222436|FG000|STARTED|Overall Study||43||
60104095|NCT01351090|76222437|FG001|STARTED|Overall Study||42||
60104096|NCT01351090|76222438|FG002|STARTED|Overall Study||42||
60104097|NCT01351090|76222436|FG000|COMPLETED|Overall Study||32||
60104098|NCT01351090|76222437|FG001|COMPLETED|Overall Study||31||
60104099|NCT01351090|76222438|FG002|COMPLETED|Overall Study||36||
59709867|NCT01072149|75828525|FG005|NOT COMPLETED|Treatment Period 2 (28 Days)||0||
59709868|NCT01072149|75828526|FG006|NOT COMPLETED|Treatment Period 2 (28 Days)||0||
59709869|NCT01072149|75828527|FG007|NOT COMPLETED|Treatment Period 2 (28 Days)||1||
59709870|NCT01072149|75828528|FG008|NOT COMPLETED|Treatment Period 2 (28 Days)||0||
59709871|NCT01072149|75828529|FG009|NOT COMPLETED|Treatment Period 2 (28 Days)||0||
59709872|NCT01072149|75828530|FG010|NOT COMPLETED|Treatment Period 2 (28 Days)||0||
59709873|NCT01072149|75828531|FG011|NOT COMPLETED|Treatment Period 2 (28 Days)||0||
59709874|NCT01072149|75828532|FG012|NOT COMPLETED|Treatment Period 2 (28 Days)||0||
59709875|NCT01072149|75828533|FG013|NOT COMPLETED|Treatment Period 2 (28 Days)||0||
59709876|NCT01072149|75828534|FG014|NOT COMPLETED|Treatment Period 2 (28 Days)||0||
59709877|NCT01072149|75828535|FG015|NOT COMPLETED|Treatment Period 2 (28 Days)||0||
59995573|NCT00819156|76111426|FG001|NOT COMPLETED|Overall Study||10||
59995574|NCT00819156|76111427|FG002|NOT COMPLETED|Overall Study||6||
59995575|NCT00819156|76111428|FG003|NOT COMPLETED|Overall Study||2||
59995576|NCT00819156|76111429|FG004|NOT COMPLETED|Overall Study||6||
59995577|NCT00819156|76111430|FG005|NOT COMPLETED|Overall Study||8||
59995578|NCT00818623|76111460|FG000|STARTED|Overall Study||26||
59995579|NCT00818623|76111461|FG001|STARTED|Overall Study||12||
59995580|NCT00818623|76111462|FG002|STARTED|Overall Study||13||
59995581|NCT00818623|76111463|FG003|STARTED|Overall Study||24||
59995582|NCT00818623|76111464|FG004|STARTED|Overall Study||27||
59995583|NCT00818623|76111465|FG005|STARTED|Overall Study||24||
59995584|NCT00818623|76111466|FG006|STARTED|Overall Study||27||
59995585|NCT00818623|76111467|FG007|STARTED|Overall Study||27||
59995586|NCT00818623|76111460|FG000|Intent-to-treat (ITT) Population|Overall Study|One participant in this group was randomized but never received any treatment.|25||
59995587|NCT00818623|76111461|FG001|Intent-to-treat (ITT) Population|Overall Study||12||
59995588|NCT00818623|76111462|FG002|Intent-to-treat (ITT) Population|Overall Study|One participant in this group was randomized but never received any treatment.|12||
60104100|NCT01351090|76222436|FG000|NOT COMPLETED|Overall Study||11||
60104101|NCT01351090|76222437|FG001|NOT COMPLETED|Overall Study||11||
60104102|NCT01351090|76222438|FG002|NOT COMPLETED|Overall Study||6||
60104103|NCT00987831|76222449|FG000|STARTED|Overall Study|41 patients improved after depomedrol, if not improved, treated and moved to Group B|41||
59709878|NCT01072149|75828536|FG016|NOT COMPLETED|Treatment Period 2 (28 Days)||0||
59709879|NCT01072149|75828537|FG017|NOT COMPLETED|Treatment Period 2 (28 Days)||0||
59817941|NCT04488770|75940328|FG002|NOT COMPLETED|Part 1-Cohort 2: Period 2 (Up to 5 Days)||0||
59817942|NCT04488770|75940329|FG003|NOT COMPLETED|Part 1-Cohort 2: Period 2 (Up to 5 Days)||0||
59995589|NCT00818623|76111463|FG003|Intent-to-treat (ITT) Population|Overall Study||24||
60000398|NCT02593305|76116131|FG002|STARTED|Post 2||0||
60104104|NCT00987831|76222450|FG001|STARTED|Overall Study|52 healthy controls donated biomarkers on two occasions in order to verify biomarkers ranges|55||
60104105|NCT00987831|76222451|FG002|STARTED|Overall Study|Anyone who entered this arm completed it the same day|62||
59709880|NCT01072149|75828520|FG000|STARTED|Washout Period 2 (14 Days)||3||
59565995|NCT02303574|75668405|FG000|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0||
59995590|NCT00818623|76111464|FG004|Intent-to-treat (ITT) Population|Overall Study|Three participants in this group were randomized but never received any treatment.|24||
60104106|NCT00987831|76222449|FG000|COMPLETED|Overall Study|40 patients completed in 6 months. 1 patient did not meet completion definition in 12 months.|40||
60104107|NCT00987831|76222450|FG001|COMPLETED|Overall Study|all controls returned for two visits|52||
60104108|NCT00987831|76222451|FG002|COMPLETED|Overall Study|Anyone who entered this arm completed it the same day|62||
60104109|NCT00987831|76222449|FG000|NOT COMPLETED|Overall Study||1||
60104110|NCT00987831|76222450|FG001|NOT COMPLETED|Overall Study||3||
60104111|NCT00987831|76222451|FG002|NOT COMPLETED|Overall Study||0||
60104112|NCT01256164|76222462|FG000|STARTED|Overall Study||47||
60104113|NCT01256164|76222463|FG001|STARTED|Overall Study||23||
60104114|NCT01256164|76222462|FG000|COMPLETED|Overall Study||47||
60104115|NCT01256164|76222463|FG001|COMPLETED|Overall Study||23||
60104116|NCT01256164|76222462|FG000|NOT COMPLETED|Overall Study||0||
60104117|NCT01256164|76222463|FG001|NOT COMPLETED|Overall Study||0||
60104118|NCT01256944|76222471|FG000|STARTED|Overall Study||70||
60104119|NCT01256944|76222472|FG001|STARTED|Overall Study||220||
60104120|NCT01256944|76222471|FG000|COMPLETED|Overall Study||70||
60104121|NCT01256944|76222472|FG001|COMPLETED|Overall Study||220||
60104122|NCT01256944|76222471|FG000|NOT COMPLETED|Overall Study||0||
60104123|NCT01256944|76222472|FG001|NOT COMPLETED|Overall Study||0||
60104124|NCT00986973|76222482|FG000|STARTED|Overall Study||6||
59709881|NCT01072149|75828521|FG001|STARTED|Washout Period 2 (14 Days)||2||
59709882|NCT01072149|75828522|FG002|STARTED|Washout Period 2 (14 Days)||1||
59709883|NCT01072149|75828523|FG003|STARTED|Washout Period 2 (14 Days)||3||
59709884|NCT01072149|75828524|FG004|STARTED|Washout Period 2 (14 Days)||3||
59995591|NCT00818623|76111465|FG005|Intent-to-treat (ITT) Population|Overall Study||24||
59995592|NCT00818623|76111466|FG006|Intent-to-treat (ITT) Population|Overall Study|Three participants in this group were randomized but never received any treatment.|24||
60104125|NCT00986973|76222482|FG000|COMPLETED|Overall Study|One subject was withdrawn from the study due to poor compliance with KUVAN therapy.|5||
60104126|NCT00986973|76222482|FG000|NOT COMPLETED|Overall Study||1||
60104127|NCT00986427|76222489|FG000|STARTED|Overall Study||12||
60104128|NCT00986427|76222490|FG001|STARTED|Overall Study||12||
60104129|NCT00986427|76222489|FG000|COMPLETED|Overall Study||8||
60104130|NCT00986427|76222490|FG001|COMPLETED|Overall Study||12||
60104131|NCT00986427|76222489|FG000|NOT COMPLETED|Overall Study||4||
60104132|NCT00986427|76222490|FG001|NOT COMPLETED|Overall Study||0||
60104133|NCT00986349|76222500|FG000|STARTED|Overall Study|attempted implant procedures|23||
60104134|NCT00986349|76222500|FG000|Successful Implant Procedure|Overall Study|successful device implant procedure|20|Three subjects had anatomy that could not accommodate the device implant|
60104135|NCT00986349|76222500|FG000|Early Explant|Overall Study||4||
60104136|NCT00986349|76222500|FG000|COMPLETED|Overall Study||16||
60104137|NCT00986349|76222500|FG000|NOT COMPLETED|Overall Study||7||
60104138|NCT02053584|76222513|FG000|STARTED|Overall Study||230||
59995593|NCT00818623|76111467|FG007|Intent-to-treat (ITT) Population|Overall Study||27||
59995594|NCT00818623|76111460|FG000|COMPLETED|Overall Study||24||
59995595|NCT00818623|76111461|FG001|COMPLETED|Overall Study||8||
59995596|NCT00818623|76111462|FG002|COMPLETED|Overall Study||9||
59995597|NCT00818623|76111463|FG003|COMPLETED|Overall Study||19||
59995598|NCT00818623|76111464|FG004|COMPLETED|Overall Study||23||
59995599|NCT00818623|76111465|FG005|COMPLETED|Overall Study||21||
59995600|NCT00818623|76111466|FG006|COMPLETED|Overall Study||23||
59995601|NCT00818623|76111467|FG007|COMPLETED|Overall Study||26||
59995602|NCT00818623|76111460|FG000|NOT COMPLETED|Overall Study||2||
60104139|NCT02053584|76222513|FG000|COMPLETED|Overall Study|68 subjects (day one participants) were excluded from the final analysis.|230||
60104140|NCT02053584|76222513|FG000|NOT COMPLETED|Overall Study||0||
60104141|NCT00985959|76222523|FG000|STARTED|Overall Study|Number of participants treated|6||
60104142|NCT00985959|76222524|FG001|STARTED|Overall Study|Number of participants treated|6||
60104143|NCT00985959|76222525|FG002|STARTED|Overall Study|Number of participants treated|87||
60104144|NCT00985959|76222523|FG000|COMPLETED|Overall Study|Completed all 9 cycles|3||
60104145|NCT00985959|76222524|FG001|COMPLETED|Overall Study|Completed all 9 cycles|3||
60104146|NCT00985959|76222525|FG002|COMPLETED|Overall Study||28||
60104147|NCT00985959|76222523|FG000|NOT COMPLETED|Overall Study||3||
60104148|NCT00985959|76222524|FG001|NOT COMPLETED|Overall Study||3||
60104149|NCT00985959|76222525|FG002|NOT COMPLETED|Overall Study||59||
60104150|NCT00985725|76222541|FG000|STARTED|Overall Study||71||
60104151|NCT00985725|76222542|FG001|STARTED|Overall Study||72||
60104152|NCT00985725|76222541|FG000|COMPLETED|Overall Study||60||
59709885|NCT01072149|75828525|FG005|STARTED|Washout Period 2 (14 Days)||3||
59709886|NCT01072149|75828526|FG006|STARTED|Washout Period 2 (14 Days)||3||
59709887|NCT01072149|75828527|FG007|STARTED|Washout Period 2 (14 Days)||2||
59709888|NCT01072149|75828528|FG008|STARTED|Washout Period 2 (14 Days)||3||
59709889|NCT01072149|75828529|FG009|STARTED|Washout Period 2 (14 Days)||3||
59709890|NCT01072149|75828530|FG010|STARTED|Washout Period 2 (14 Days)||2||
59995603|NCT00818623|76111461|FG001|NOT COMPLETED|Overall Study||4||
60104153|NCT00985725|76222542|FG001|COMPLETED|Overall Study||59||
60104154|NCT00985725|76222541|FG000|NOT COMPLETED|Overall Study||11||
60104155|NCT00985725|76222542|FG001|NOT COMPLETED|Overall Study||13||
60104156|NCT01294306|76222550|FG000|STARTED|Overall Study||45||
59709891|NCT01072149|75828531|FG011|STARTED|Washout Period 2 (14 Days)||3||
59995604|NCT00818623|76111462|FG002|NOT COMPLETED|Overall Study||4||
59995605|NCT00818623|76111463|FG003|NOT COMPLETED|Overall Study||5||
59995606|NCT00818623|76111464|FG004|NOT COMPLETED|Overall Study||4||
59995607|NCT00818623|76111465|FG005|NOT COMPLETED|Overall Study||3||
59995608|NCT00818623|76111466|FG006|NOT COMPLETED|Overall Study||4||
59995609|NCT00818623|76111467|FG007|NOT COMPLETED|Overall Study||1||
59995610|NCT00540995|76111487|FG000|STARTED|Overall Study||23||
59995611|NCT00540995|76111488|FG001|STARTED|Overall Study||2||
59995612|NCT00540995|76111487|FG000|COMPLETED|Overall Study||23||
59995613|NCT00540995|76111488|FG001|COMPLETED|Overall Study||2||
59995614|NCT00540995|76111487|FG000|NOT COMPLETED|Overall Study||0||
59995615|NCT00540995|76111488|FG001|NOT COMPLETED|Overall Study||0||
59995616|NCT01285557|76111495|FG000|STARTED|Overall Study||239||
59995617|NCT01285557|76111496|FG001|STARTED|Overall Study||122||
59995618|NCT01285557|76111495|FG000|Treated|Overall Study||238||
59995619|NCT01285557|76111496|FG001|Treated|Overall Study||121||
59995620|NCT01285557|76111495|FG000|As Treated (AT) Population|Overall Study||230|Participants started either of 2 treatment regimens assigned according to actual treatment received.|
59995621|NCT01285557|76111496|FG001|As Treated (AT) Population|Overall Study||118|Participants started either of 2 treatment regimens assigned according to actual treatment received.|
59995622|NCT01285557|76111495|FG000|COMPLETED|Overall Study||0||
59995623|NCT01285557|76111496|FG001|COMPLETED|Overall Study||0||
59995624|NCT01285557|76111495|FG000|NOT COMPLETED|Overall Study||239||
59995625|NCT01285557|76111496|FG001|NOT COMPLETED|Overall Study||122||
59995626|NCT01032603|76111504|FG000|STARTED|Overall Study||101||
59995627|NCT01032603|76111505|FG001|STARTED|Overall Study||96||
59995628|NCT01032603|76111504|FG000|COMPLETED|Overall Study||86||
59995629|NCT01032603|76111505|FG001|COMPLETED|Overall Study||77||
59995630|NCT01032603|76111504|FG000|NOT COMPLETED|Overall Study||15||
59995631|NCT01032603|76111505|FG001|NOT COMPLETED|Overall Study||19||
59995632|NCT03406975|76111514|FG000|STARTED|Level 1: Lifestyle Modification vs ESG||123||
59995633|NCT03406975|76111515|FG001|STARTED|Level 1: Lifestyle Modification vs ESG||85||
59995634|NCT03406975|76111516|FG002|STARTED|Level 1: Lifestyle Modification vs ESG||0||
59995635|NCT03406975|76111514|FG000|COMPLETED|Level 1: Lifestyle Modification vs ESG||75||
59995636|NCT03406975|76111515|FG001|COMPLETED|Level 1: Lifestyle Modification vs ESG||62||
59995637|NCT03406975|76111516|FG002|COMPLETED|Level 1: Lifestyle Modification vs ESG||0||
59995638|NCT03406975|76111514|FG000|NOT COMPLETED|Level 1: Lifestyle Modification vs ESG||48||
59995639|NCT03406975|76111515|FG001|NOT COMPLETED|Level 1: Lifestyle Modification vs ESG||23||
59995640|NCT03406975|76111516|FG002|NOT COMPLETED|Level 1: Lifestyle Modification vs ESG||0||
59995641|NCT03406975|76111514|FG000|STARTED|Level 2: Crossover Lifestyle to ESG||0||
59995642|NCT03406975|76111515|FG001|STARTED|Level 2: Crossover Lifestyle to ESG||0||
59995643|NCT03406975|76111516|FG002|STARTED|Level 2: Crossover Lifestyle to ESG||73||
59995644|NCT03406975|76111514|FG000|COMPLETED|Level 2: Crossover Lifestyle to ESG||0||
59995645|NCT03406975|76111515|FG001|COMPLETED|Level 2: Crossover Lifestyle to ESG||0||
59995646|NCT03406975|76111516|FG002|COMPLETED|Level 2: Crossover Lifestyle to ESG||72||
59995647|NCT03406975|76111514|FG000|NOT COMPLETED|Level 2: Crossover Lifestyle to ESG||0||
59995648|NCT03406975|76111515|FG001|NOT COMPLETED|Level 2: Crossover Lifestyle to ESG||0||
60104157|NCT01294306|76222551|FG001|STARTED|Overall Study||35||
60104158|NCT01294306|76222550|FG000|COMPLETED|Overall Study||45||
60104159|NCT01294306|76222551|FG001|COMPLETED|Overall Study||35||
60104160|NCT01294306|76222550|FG000|NOT COMPLETED|Overall Study||0||
60104161|NCT01294306|76222551|FG001|NOT COMPLETED|Overall Study||0||
60104162|NCT00985491|76222557|FG000|STARTED|Overall Study|46 subjects underwent an attempted implantation procedure|46||
60104163|NCT00985491|76222557|FG000|Received Device|Overall Study||43||
60104164|NCT00985491|76222557|FG000|COMPLETED|Overall Study|43 subjects received a device, 27 subjects completed 12 month implant period|27||
59709892|NCT01072149|75828532|FG012|STARTED|Washout Period 2 (14 Days)||3||
59709893|NCT01072149|75828533|FG013|STARTED|Washout Period 2 (14 Days)||3||
59709894|NCT01072149|75828534|FG014|STARTED|Washout Period 2 (14 Days)||3||
59995649|NCT03406975|76111516|FG002|NOT COMPLETED|Level 2: Crossover Lifestyle to ESG||1||
59995650|NCT02992119|76111532|FG000|STARTED|Overall Study||21||
59995651|NCT02992119|76111533|FG001|STARTED|Overall Study||21||
59995652|NCT02992119|76111534|FG002|STARTED|Overall Study||30||
59995653|NCT02992119|76111535|FG003|STARTED|Overall Study||30||
59995654|NCT02992119|76111536|FG004|STARTED|Overall Study||30||
59995655|NCT02992119|76111537|FG005|STARTED|Overall Study||30||
59995656|NCT02992119|76111538|FG006|STARTED|Overall Study||31||
59995657|NCT02992119|76111532|FG000|COMPLETED|Overall Study||19||
59995658|NCT02992119|76111533|FG001|COMPLETED|Overall Study||20||
59995659|NCT02992119|76111534|FG002|COMPLETED|Overall Study||29||
59995660|NCT02992119|76111535|FG003|COMPLETED|Overall Study||30||
59995661|NCT02992119|76111536|FG004|COMPLETED|Overall Study||30||
59995662|NCT02992119|76111537|FG005|COMPLETED|Overall Study||30||
59995663|NCT02992119|76111538|FG006|COMPLETED|Overall Study||28||
59995664|NCT02992119|76111532|FG000|NOT COMPLETED|Overall Study||2||
59995665|NCT02992119|76111533|FG001|NOT COMPLETED|Overall Study||1||
59995666|NCT02992119|76111534|FG002|NOT COMPLETED|Overall Study||1||
59995667|NCT02992119|76111535|FG003|NOT COMPLETED|Overall Study||0||
59995668|NCT02992119|76111536|FG004|NOT COMPLETED|Overall Study||0||
59709895|NCT01072149|75828535|FG015|STARTED|Washout Period 2 (14 Days)||3||
59995669|NCT02992119|76111537|FG005|NOT COMPLETED|Overall Study||0||
59995670|NCT02992119|76111538|FG006|NOT COMPLETED|Overall Study||3||
59995671|NCT01376167|76111558|FG000|STARTED|Overall Study||133||
59995672|NCT01376167|76111559|FG001|STARTED|Overall Study||260||
59995673|NCT01376167|76111560|FG002|STARTED|Overall Study||129||
59995674|NCT01376167|76111558|FG000|COMPLETED|Overall Study||129||
59995675|NCT01376167|76111559|FG001|COMPLETED|Overall Study||250||
59995676|NCT01376167|76111560|FG002|COMPLETED|Overall Study||123||
59995677|NCT01376167|76111558|FG000|NOT COMPLETED|Overall Study||4||
59995678|NCT01376167|76111559|FG001|NOT COMPLETED|Overall Study||10||
59995679|NCT01376167|76111560|FG002|NOT COMPLETED|Overall Study||6||
60104165|NCT00985491|76222557|FG000|NOT COMPLETED|Overall Study||19||
59709896|NCT01072149|75828536|FG016|STARTED|Washout Period 2 (14 Days)||3||
59709897|NCT01072149|75828537|FG017|STARTED|Washout Period 2 (14 Days)||2||
59709898|NCT01072149|75828520|FG000|COMPLETED|Washout Period 2 (14 Days)||2||
59709899|NCT01072149|75828521|FG001|COMPLETED|Washout Period 2 (14 Days)||2||
59709900|NCT01072149|75828522|FG002|COMPLETED|Washout Period 2 (14 Days)||1||
59709901|NCT01072149|75828523|FG003|COMPLETED|Washout Period 2 (14 Days)||3||
59709902|NCT01072149|75828524|FG004|COMPLETED|Washout Period 2 (14 Days)||3||
59709903|NCT01072149|75828525|FG005|COMPLETED|Washout Period 2 (14 Days)||3||
59709904|NCT01072149|75828526|FG006|COMPLETED|Washout Period 2 (14 Days)||3||
59709905|NCT01072149|75828527|FG007|COMPLETED|Washout Period 2 (14 Days)||2||
59709906|NCT01072149|75828528|FG008|COMPLETED|Washout Period 2 (14 Days)||3||
59709907|NCT01072149|75828529|FG009|COMPLETED|Washout Period 2 (14 Days)||3||
59709908|NCT01072149|75828530|FG010|COMPLETED|Washout Period 2 (14 Days)||2||
59709909|NCT01072149|75828531|FG011|COMPLETED|Washout Period 2 (14 Days)||3||
59709910|NCT01072149|75828532|FG012|COMPLETED|Washout Period 2 (14 Days)||2||
59709911|NCT01072149|75828533|FG013|COMPLETED|Washout Period 2 (14 Days)||3||
59709912|NCT01072149|75828534|FG014|COMPLETED|Washout Period 2 (14 Days)||3||
59709913|NCT01072149|75828535|FG015|COMPLETED|Washout Period 2 (14 Days)||1||
59709914|NCT01072149|75828536|FG016|COMPLETED|Washout Period 2 (14 Days)||3||
59709915|NCT01072149|75828537|FG017|COMPLETED|Washout Period 2 (14 Days)||2||
59709916|NCT01072149|75828520|FG000|NOT COMPLETED|Washout Period 2 (14 Days)||1||
59709917|NCT01072149|75828521|FG001|NOT COMPLETED|Washout Period 2 (14 Days)||0||
59709918|NCT01072149|75828522|FG002|NOT COMPLETED|Washout Period 2 (14 Days)||0||
59817943|NCT04488770|75940330|FG004|NOT COMPLETED|Part 1-Cohort 2: Period 2 (Up to 5 Days)||1||
59817944|NCT04488770|75940331|FG005|NOT COMPLETED|Part 1-Cohort 2: Period 2 (Up to 5 Days)||0||
59817945|NCT04488770|75940332|FG006|NOT COMPLETED|Part 1-Cohort 2: Period 2 (Up to 5 Days)||0||
60104166|NCT01351480|76222562|FG000|STARTED|Overall Study||34||
60104167|NCT01351480|76222562|FG000|COMPLETED|Overall Study||26||
60104168|NCT01351480|76222562|FG000|NOT COMPLETED|Overall Study||8||
60104169|NCT03416829|76222569|FG000|STARTED|Overall Study||10||
60104170|NCT03416829|76222570|FG001|STARTED|Overall Study||10||
59709919|NCT01072149|75828523|FG003|NOT COMPLETED|Washout Period 2 (14 Days)||0||
59709920|NCT01072149|75828524|FG004|NOT COMPLETED|Washout Period 2 (14 Days)||0||
59709921|NCT01072149|75828525|FG005|NOT COMPLETED|Washout Period 2 (14 Days)||0||
59709922|NCT01072149|75828526|FG006|NOT COMPLETED|Washout Period 2 (14 Days)||0||
59817946|NCT04488770|75940333|FG007|NOT COMPLETED|Part 1-Cohort 2: Period 2 (Up to 5 Days)||0||
59817947|NCT04488770|75940334|FG008|NOT COMPLETED|Part 1-Cohort 2: Period 2 (Up to 5 Days)||0||
59817948|NCT04488770|75940335|FG009|NOT COMPLETED|Part 1-Cohort 2: Period 2 (Up to 5 Days)||0||
59817949|NCT04488770|75940336|FG010|NOT COMPLETED|Part 1-Cohort 2: Period 2 (Up to 5 Days)||0||
59817950|NCT04488770|75940337|FG011|NOT COMPLETED|Part 1-Cohort 2: Period 2 (Up to 5 Days)||0||
59817951|NCT04488770|75940338|FG012|NOT COMPLETED|Part 1-Cohort 2: Period 2 (Up to 5 Days)||0||
59817952|NCT04488770|75940326|FG000|STARTED|Part 1-Cohort 2: Period 3 (Up to 5 Days)||0||
59817953|NCT04488770|75940327|FG001|STARTED|Part 1-Cohort 2: Period 3 (Up to 5 Days)||0||
59817954|NCT04488770|75940328|FG002|STARTED|Part 1-Cohort 2: Period 3 (Up to 5 Days)||0||
59817955|NCT04488770|75940329|FG003|STARTED|Part 1-Cohort 2: Period 3 (Up to 5 Days)||0||
59817956|NCT04488770|75940330|FG004|STARTED|Part 1-Cohort 2: Period 3 (Up to 5 Days)|New participant enrolled and dosed as a replacement of withdrawn participant|2||
59817957|NCT04488770|75940331|FG005|STARTED|Part 1-Cohort 2: Period 3 (Up to 5 Days)||2||
59817958|NCT04488770|75940332|FG006|STARTED|Part 1-Cohort 2: Period 3 (Up to 5 Days)||2||
59817959|NCT04488770|75940333|FG007|STARTED|Part 1-Cohort 2: Period 3 (Up to 5 Days)||2||
59817960|NCT04488770|75940334|FG008|STARTED|Part 1-Cohort 2: Period 3 (Up to 5 Days)||0||
59817961|NCT04488770|75940335|FG009|STARTED|Part 1-Cohort 2: Period 3 (Up to 5 Days)||0||
59817962|NCT04488770|75940336|FG010|STARTED|Part 1-Cohort 2: Period 3 (Up to 5 Days)||0||
59817963|NCT04488770|75940337|FG011|STARTED|Part 1-Cohort 2: Period 3 (Up to 5 Days)||0||
59817964|NCT04488770|75940338|FG012|STARTED|Part 1-Cohort 2: Period 3 (Up to 5 Days)||0||
59995680|NCT02647281|76111580|FG000|STARTED|Single-Ascending Dose(Part 1-62 Days)||8||
60104171|NCT03416829|76222571|FG002|STARTED|Overall Study||9||
59709923|NCT01072149|75828527|FG007|NOT COMPLETED|Washout Period 2 (14 Days)||0||
59709924|NCT01072149|75828528|FG008|NOT COMPLETED|Washout Period 2 (14 Days)||0||
59709925|NCT01072149|75828529|FG009|NOT COMPLETED|Washout Period 2 (14 Days)||0||
59709926|NCT01072149|75828530|FG010|NOT COMPLETED|Washout Period 2 (14 Days)||0||
60104172|NCT03416829|76222569|FG000|COMPLETED|Overall Study||10||
60104173|NCT03416829|76222570|FG001|COMPLETED|Overall Study||10||
60104174|NCT03416829|76222571|FG002|COMPLETED|Overall Study||9||
60104175|NCT03416829|76222569|FG000|NOT COMPLETED|Overall Study||0||
60104176|NCT03416829|76222570|FG001|NOT COMPLETED|Overall Study||0||
60104177|NCT03416829|76222571|FG002|NOT COMPLETED|Overall Study||0||
60104178|NCT01352182|76222581|FG000|STARTED|Overall Study||8||
60104179|NCT01352182|76222582|FG001|STARTED|Overall Study||4||
60104180|NCT01352182|76222581|FG000|COMPLETED|Overall Study||8||
60104181|NCT01352182|76222582|FG001|COMPLETED|Overall Study||4||
60104182|NCT01352182|76222581|FG000|NOT COMPLETED|Overall Study||0||
60104183|NCT01352182|76222582|FG001|NOT COMPLETED|Overall Study||0||
60104184|NCT00984867|76222592|FG000|STARTED|Overall Study|Of the 226 randomized and treated participants only 224 were included in the full analysis set.|226||
59995681|NCT02647281|76111581|FG001|STARTED|Single-Ascending Dose(Part 1-62 Days)||6||
59995682|NCT02647281|76111582|FG002|STARTED|Single-Ascending Dose(Part 1-62 Days)||6||
60104185|NCT00984867|76222593|FG001|STARTED|Overall Study|Of the 225 randomized and treated participants only 223 were included in the full analysis set.|225||
60104186|NCT00984867|76222592|FG000|COMPLETED|Overall Study||203||
60104187|NCT00984867|76222593|FG001|COMPLETED|Overall Study||208||
60104188|NCT00984867|76222592|FG000|NOT COMPLETED|Overall Study||23||
60104189|NCT00984867|76222593|FG001|NOT COMPLETED|Overall Study||17||
60104190|NCT01294384|76222604|FG000|STARTED|Overall Study||101||
60104191|NCT01294384|76222605|FG001|STARTED|Overall Study||100||
60104192|NCT01294384|76222606|FG002|STARTED|Overall Study||104||
60104193|NCT01294384|76222604|FG000|COMPLETED|Overall Study||97||
60104194|NCT01294384|76222605|FG001|COMPLETED|Overall Study||94||
60104195|NCT01294384|76222606|FG002|COMPLETED|Overall Study||95||
60104196|NCT01294384|76222604|FG000|NOT COMPLETED|Overall Study||4||
60104197|NCT01294384|76222605|FG001|NOT COMPLETED|Overall Study||6||
60104198|NCT01294384|76222606|FG002|NOT COMPLETED|Overall Study||9||
60104199|NCT01257802|76222616|FG000|STARTED|Overall Study||6||
60104200|NCT01257802|76222617|FG001|STARTED|Overall Study||8||
60104201|NCT01257802|76222616|FG000|6 Month / 24 Week Visit|Overall Study||5||
60104202|NCT01257802|76222617|FG001|6 Month / 24 Week Visit|Overall Study||2||
60104203|NCT01257802|76222616|FG000|COMPLETED|Overall Study||5||
60104204|NCT01257802|76222617|FG001|COMPLETED|Overall Study||2||
60104205|NCT01257802|76222616|FG000|NOT COMPLETED|Overall Study||1||
60104206|NCT01257802|76222617|FG001|NOT COMPLETED|Overall Study||6||
60104207|NCT01257880|76222626|FG000|STARTED|Overall Study||12||
60104208|NCT01257880|76222627|FG001|STARTED|Overall Study||19||
60104209|NCT01257880|76222626|FG000|COMPLETED|Overall Study||12||
60104210|NCT01257880|76222627|FG001|COMPLETED|Overall Study||19||
60104211|NCT01257880|76222626|FG000|NOT COMPLETED|Overall Study||0||
59817965|NCT04488770|75940326|FG000|COMPLETED|Part 1-Cohort 2: Period 3 (Up to 5 Days)||0||
59817966|NCT04488770|75940327|FG001|COMPLETED|Part 1-Cohort 2: Period 3 (Up to 5 Days)||0||
59817967|NCT04488770|75940328|FG002|COMPLETED|Part 1-Cohort 2: Period 3 (Up to 5 Days)||0||
59817968|NCT04488770|75940329|FG003|COMPLETED|Part 1-Cohort 2: Period 3 (Up to 5 Days)||0||
59817969|NCT04488770|75940330|FG004|COMPLETED|Part 1-Cohort 2: Period 3 (Up to 5 Days)||2||
59817970|NCT04488770|75940331|FG005|COMPLETED|Part 1-Cohort 2: Period 3 (Up to 5 Days)||2||
59817971|NCT04488770|75940332|FG006|COMPLETED|Part 1-Cohort 2: Period 3 (Up to 5 Days)||2||
59817972|NCT04488770|75940333|FG007|COMPLETED|Part 1-Cohort 2: Period 3 (Up to 5 Days)||2||
59817973|NCT04488770|75940334|FG008|COMPLETED|Part 1-Cohort 2: Period 3 (Up to 5 Days)||0||
59817974|NCT04488770|75940335|FG009|COMPLETED|Part 1-Cohort 2: Period 3 (Up to 5 Days)||0||
59817975|NCT04488770|75940336|FG010|COMPLETED|Part 1-Cohort 2: Period 3 (Up to 5 Days)||0||
59995683|NCT02647281|76111583|FG003|STARTED|Single-Ascending Dose(Part 1-62 Days)||6||
59995684|NCT02647281|76111584|FG004|STARTED|Single-Ascending Dose(Part 1-62 Days)||6||
59995685|NCT02647281|76111585|FG005|STARTED|Single-Ascending Dose(Part 1-62 Days)||0||
59995686|NCT02647281|76111586|FG006|STARTED|Single-Ascending Dose(Part 1-62 Days)||0||
59995687|NCT02647281|76111587|FG007|STARTED|Single-Ascending Dose(Part 1-62 Days)||0||
59995688|NCT02647281|76111588|FG008|STARTED|Single-Ascending Dose(Part 1-62 Days)||0||
59995689|NCT02647281|76111580|FG000|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||8||
59995690|NCT02647281|76111581|FG001|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||6||
59995691|NCT02647281|76111582|FG002|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||6||
59995692|NCT02647281|76111583|FG003|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||6||
59817976|NCT04488770|75940337|FG011|COMPLETED|Part 1-Cohort 2: Period 3 (Up to 5 Days)||0||
59995693|NCT02647281|76111584|FG004|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||6||
59995694|NCT02647281|76111585|FG005|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0||
59995695|NCT02647281|76111586|FG006|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0||
59995696|NCT02647281|76111587|FG007|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0||
60104212|NCT01257880|76222627|FG001|NOT COMPLETED|Overall Study||0||
60104213|NCT00984009|76222633|FG000|STARTED|Colchicine Alone||22||
60104214|NCT00984009|76222633|FG000|COMPLETED|Colchicine Alone||22||
60104215|NCT00984009|76222633|FG000|NOT COMPLETED|Colchicine Alone||0||
60104216|NCT00984009|76222633|FG000|STARTED|14 Day Washout Period||22||
59817977|NCT04488770|75940338|FG012|COMPLETED|Part 1-Cohort 2: Period 3 (Up to 5 Days)||0||
60104217|NCT00984009|76222633|FG000|COMPLETED|14 Day Washout Period||22||
60104218|NCT00984009|76222633|FG000|NOT COMPLETED|14 Day Washout Period||0||
59995697|NCT02647281|76111588|FG008|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0||
59995698|NCT02647281|76111580|FG000|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0||
59995699|NCT02647281|76111581|FG001|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0||
59995700|NCT02647281|76111582|FG002|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0||
59995701|NCT02647281|76111583|FG003|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0||
59995702|NCT02647281|76111584|FG004|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0||
60104219|NCT00984009|76222633|FG000|STARTED|Grapefruit Juice Alone||22||
60104220|NCT00984009|76222633|FG000|COMPLETED|Grapefruit Juice Alone|one subject dropped due to missed a.m. serving of grapefruit juice on Day 16|21||
60104221|NCT00984009|76222633|FG000|NOT COMPLETED|Grapefruit Juice Alone||1||
60104222|NCT00984009|76222633|FG000|STARTED|Colchicine With Grapefruit Juice||21||
60104223|NCT00984009|76222633|FG000|COMPLETED|Colchicine With Grapefruit Juice||21||
60104224|NCT00984009|76222633|FG000|NOT COMPLETED|Colchicine With Grapefruit Juice||0||
60104225|NCT00983931|76222640|FG000|STARTED|Colchicine Alone||24||
60104226|NCT00983931|76222640|FG000|COMPLETED|Colchicine Alone||24||
60104227|NCT00983931|76222640|FG000|NOT COMPLETED|Colchicine Alone||0||
60104228|NCT00983931|76222640|FG000|STARTED|14 Day Washout Period||24||
60104229|NCT00983931|76222640|FG000|COMPLETED|14 Day Washout Period|one subject withdrawn due to creatine kinase out of range|23||
60104230|NCT00983931|76222640|FG000|NOT COMPLETED|14 Day Washout Period||1||
59817978|NCT04488770|75940326|FG000|NOT COMPLETED|Part 1-Cohort 2: Period 3 (Up to 5 Days)||0||
60104231|NCT00983931|76222640|FG000|STARTED|Colchicine With Cyclosporine||23||
60104232|NCT00983931|76222640|FG000|COMPLETED|Colchicine With Cyclosporine||23||
60104233|NCT00983931|76222640|FG000|NOT COMPLETED|Colchicine With Cyclosporine||0||
60104234|NCT00983853|76222652|FG000|STARTED|Overall Study||7||
59995703|NCT02647281|76111585|FG005|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0||
59995704|NCT02647281|76111586|FG006|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0||
59995705|NCT02647281|76111587|FG007|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0||
59995706|NCT02647281|76111588|FG008|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0||
59995707|NCT02647281|76111580|FG000|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||0||
59995708|NCT02647281|76111581|FG001|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||0||
59995709|NCT02647281|76111582|FG002|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||0||
59995710|NCT02647281|76111583|FG003|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||0||
59995711|NCT02647281|76111584|FG004|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||0||
59995712|NCT02647281|76111585|FG005|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||6||
60104235|NCT00983853|76222653|FG001|STARTED|Overall Study|1 subject was randomized but not dosed|7||
60104236|NCT00983853|76222654|FG002|STARTED|Overall Study|1 subject was randomized but not dosed|17||
60104237|NCT00983853|76222655|FG003|STARTED|Overall Study||8||
60104238|NCT00983853|76222656|FG004|STARTED|Overall Study||15||
60104239|NCT00983853|76222657|FG005|STARTED|Overall Study||8||
59817979|NCT04488770|75940327|FG001|NOT COMPLETED|Part 1-Cohort 2: Period 3 (Up to 5 Days)||0||
59817980|NCT04488770|75940328|FG002|NOT COMPLETED|Part 1-Cohort 2: Period 3 (Up to 5 Days)||0||
60104240|NCT00983853|76222652|FG000|COMPLETED|Overall Study||6||
60104241|NCT00983853|76222653|FG001|COMPLETED|Overall Study||5||
59995713|NCT02647281|76111586|FG006|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||6||
59709927|NCT01072149|75828531|FG011|NOT COMPLETED|Washout Period 2 (14 Days)||0||
59709928|NCT01072149|75828532|FG012|NOT COMPLETED|Washout Period 2 (14 Days)||1||
59709929|NCT01072149|75828533|FG013|NOT COMPLETED|Washout Period 2 (14 Days)||0||
59709930|NCT01072149|75828534|FG014|NOT COMPLETED|Washout Period 2 (14 Days)||0||
59709931|NCT01072149|75828535|FG015|NOT COMPLETED|Washout Period 2 (14 Days)||2||
59709932|NCT01072149|75828536|FG016|NOT COMPLETED|Washout Period 2 (14 Days)||0||
59709933|NCT01072149|75828537|FG017|NOT COMPLETED|Washout Period 2 (14 Days)||0||
59709934|NCT01072149|75828520|FG000|STARTED|Treatment Period 3 (28 Days)||2||
59709935|NCT01072149|75828521|FG001|STARTED|Treatment Period 3 (28 Days)||2||
59709936|NCT01072149|75828522|FG002|STARTED|Treatment Period 3 (28 Days)||1||
59709937|NCT01072149|75828523|FG003|STARTED|Treatment Period 3 (28 Days)||3||
59709938|NCT01072149|75828524|FG004|STARTED|Treatment Period 3 (28 Days)||3||
59709939|NCT01072149|75828525|FG005|STARTED|Treatment Period 3 (28 Days)||3||
59709940|NCT01072149|75828526|FG006|STARTED|Treatment Period 3 (28 Days)||3||
59709941|NCT01072149|75828527|FG007|STARTED|Treatment Period 3 (28 Days)||2||
59709942|NCT01072149|75828528|FG008|STARTED|Treatment Period 3 (28 Days)||3||
59709943|NCT01072149|75828529|FG009|STARTED|Treatment Period 3 (28 Days)||3||
59709944|NCT01072149|75828530|FG010|STARTED|Treatment Period 3 (28 Days)||2||
59709945|NCT01072149|75828531|FG011|STARTED|Treatment Period 3 (28 Days)||3||
59709946|NCT01072149|75828532|FG012|STARTED|Treatment Period 3 (28 Days)||2||
59709947|NCT01072149|75828533|FG013|STARTED|Treatment Period 3 (28 Days)||3||
59709948|NCT01072149|75828534|FG014|STARTED|Treatment Period 3 (28 Days)||3||
59709949|NCT01072149|75828535|FG015|STARTED|Treatment Period 3 (28 Days)||1||
59709950|NCT01072149|75828536|FG016|STARTED|Treatment Period 3 (28 Days)||3||
59709951|NCT01072149|75828537|FG017|STARTED|Treatment Period 3 (28 Days)||2||
59709952|NCT01072149|75828520|FG000|COMPLETED|Treatment Period 3 (28 Days)||2||
59709953|NCT01072149|75828521|FG001|COMPLETED|Treatment Period 3 (28 Days)||2||
59709954|NCT01072149|75828522|FG002|COMPLETED|Treatment Period 3 (28 Days)||0||
59709955|NCT01072149|75828523|FG003|COMPLETED|Treatment Period 3 (28 Days)||3||
59709956|NCT01072149|75828524|FG004|COMPLETED|Treatment Period 3 (28 Days)||3||
59709957|NCT01072149|75828525|FG005|COMPLETED|Treatment Period 3 (28 Days)||3||
59709958|NCT01072149|75828526|FG006|COMPLETED|Treatment Period 3 (28 Days)||3||
59709959|NCT01072149|75828527|FG007|COMPLETED|Treatment Period 3 (28 Days)||2||
59709960|NCT01072149|75828528|FG008|COMPLETED|Treatment Period 3 (28 Days)||3||
59709961|NCT01072149|75828529|FG009|COMPLETED|Treatment Period 3 (28 Days)||3||
59709962|NCT01072149|75828530|FG010|COMPLETED|Treatment Period 3 (28 Days)||2||
59709963|NCT01072149|75828531|FG011|COMPLETED|Treatment Period 3 (28 Days)||3||
59709964|NCT01072149|75828532|FG012|COMPLETED|Treatment Period 3 (28 Days)||2||
59709965|NCT01072149|75828533|FG013|COMPLETED|Treatment Period 3 (28 Days)||2||
59709966|NCT01072149|75828534|FG014|COMPLETED|Treatment Period 3 (28 Days)||3||
59709967|NCT01072149|75828535|FG015|COMPLETED|Treatment Period 3 (28 Days)||1||
59709968|NCT01072149|75828536|FG016|COMPLETED|Treatment Period 3 (28 Days)||3||
59709969|NCT01072149|75828537|FG017|COMPLETED|Treatment Period 3 (28 Days)||2||
59709970|NCT01072149|75828520|FG000|NOT COMPLETED|Treatment Period 3 (28 Days)||0||
59817981|NCT04488770|75940329|FG003|NOT COMPLETED|Part 1-Cohort 2: Period 3 (Up to 5 Days)||0||
59709971|NCT01072149|75828521|FG001|NOT COMPLETED|Treatment Period 3 (28 Days)||0||
59709972|NCT01072149|75828522|FG002|NOT COMPLETED|Treatment Period 3 (28 Days)||1||
59709973|NCT01072149|75828523|FG003|NOT COMPLETED|Treatment Period 3 (28 Days)||0||
59709974|NCT01072149|75828524|FG004|NOT COMPLETED|Treatment Period 3 (28 Days)||0||
59709975|NCT01072149|75828525|FG005|NOT COMPLETED|Treatment Period 3 (28 Days)||0||
59709976|NCT01072149|75828526|FG006|NOT COMPLETED|Treatment Period 3 (28 Days)||0||
59709977|NCT01072149|75828527|FG007|NOT COMPLETED|Treatment Period 3 (28 Days)||0||
59817982|NCT04488770|75940330|FG004|NOT COMPLETED|Part 1-Cohort 2: Period 3 (Up to 5 Days)||0||
60104242|NCT00983853|76222654|FG002|COMPLETED|Overall Study||14||
60104243|NCT00983853|76222655|FG003|COMPLETED|Overall Study||6||
60104244|NCT00983853|76222656|FG004|COMPLETED|Overall Study||12||
60104245|NCT00983853|76222657|FG005|COMPLETED|Overall Study||7||
60104246|NCT00983853|76222652|FG000|NOT COMPLETED|Overall Study||1||
60104247|NCT00983853|76222653|FG001|NOT COMPLETED|Overall Study||2||
60104248|NCT00983853|76222654|FG002|NOT COMPLETED|Overall Study||3||
60104249|NCT00983853|76222655|FG003|NOT COMPLETED|Overall Study||2||
60104250|NCT00983853|76222656|FG004|NOT COMPLETED|Overall Study||3||
60104251|NCT00983853|76222657|FG005|NOT COMPLETED|Overall Study||1||
60104252|NCT00983073|76222673|FG000|STARTED|Observation Period||224||
59817983|NCT04488770|75940331|FG005|NOT COMPLETED|Part 1-Cohort 2: Period 3 (Up to 5 Days)||0||
59817984|NCT04488770|75940332|FG006|NOT COMPLETED|Part 1-Cohort 2: Period 3 (Up to 5 Days)||0||
59709978|NCT01072149|75828528|FG008|NOT COMPLETED|Treatment Period 3 (28 Days)||0||
59709979|NCT01072149|75828529|FG009|NOT COMPLETED|Treatment Period 3 (28 Days)||0||
59709980|NCT01072149|75828530|FG010|NOT COMPLETED|Treatment Period 3 (28 Days)||0||
59709981|NCT01072149|75828531|FG011|NOT COMPLETED|Treatment Period 3 (28 Days)||0||
59709982|NCT01072149|75828532|FG012|NOT COMPLETED|Treatment Period 3 (28 Days)||0||
59709983|NCT01072149|75828533|FG013|NOT COMPLETED|Treatment Period 3 (28 Days)||1||
59709984|NCT01072149|75828534|FG014|NOT COMPLETED|Treatment Period 3 (28 Days)||0||
59709985|NCT01072149|75828535|FG015|NOT COMPLETED|Treatment Period 3 (28 Days)||0||
59709986|NCT01072149|75828536|FG016|NOT COMPLETED|Treatment Period 3 (28 Days)||0||
60104253|NCT00983073|76222673|FG000|COMPLETED|Observation Period|24 participants not eligible to be dosed.|200||
60104254|NCT00983073|76222673|FG000|NOT COMPLETED|Observation Period||24||
60104255|NCT00983073|76222673|FG000|STARTED|Titration and Optimal Dose Period||200||
60104256|NCT00983073|76222673|FG000|COMPLETED|Titration and Optimal Dose Period||160||
60104257|NCT00983073|76222673|FG000|NOT COMPLETED|Titration and Optimal Dose Period||40||
59709987|NCT01072149|75828537|FG017|NOT COMPLETED|Treatment Period 3 (28 Days)||0||
59709988|NCT01071915|75828547|FG000|STARTED|Overall Study|Intention to Treat Analysis Set|157||
59709989|NCT01071915|75828547|FG000|Full Analysis Set (FAS)|Overall Study||155||
59709990|NCT01071915|75828547|FG000|Safety Analysis Set|Overall Study||156||
59709991|NCT01071915|75828547|FG000|COMPLETED|Overall Study||148||
59995714|NCT02647281|76111587|FG007|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||6||
59995715|NCT02647281|76111588|FG008|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||6||
59995716|NCT02647281|76111580|FG000|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0||
59995717|NCT02647281|76111581|FG001|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0||
59995718|NCT02647281|76111582|FG002|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0||
59995719|NCT02647281|76111583|FG003|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0||
59995720|NCT02647281|76111584|FG004|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0||
59995721|NCT02647281|76111585|FG005|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||6||
59995722|NCT02647281|76111586|FG006|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||6||
59995723|NCT02647281|76111587|FG007|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||6||
60000399|NCT02593305|76116129|FG000|COMPLETED|Post 2||7||
59709992|NCT01071915|75828547|FG000|NOT COMPLETED|Overall Study||9||
59709993|NCT00904969|75828551|FG000|STARTED|Overall Study|Number of patients with an attempted implant; 1 subject with procedure aborted|50||
59709994|NCT00904969|75828551|FG000|COMPLETED|Overall Study|# of Implanted Subjects Who Completed the Study|31||
59709995|NCT00904969|75828551|FG000|NOT COMPLETED|Overall Study||19||
59709996|NCT01070979|75828573|FG000|STARTED|Overall Study||79||
59709997|NCT01070979|75828574|FG001|STARTED|Overall Study||85||
59709998|NCT01070979|75828575|FG002|STARTED|Overall Study||85||
59709999|NCT01070979|75828573|FG000|COMPLETED|Overall Study||68||
59710000|NCT01070979|75828574|FG001|COMPLETED|Overall Study||73||
59710001|NCT01070979|75828575|FG002|COMPLETED|Overall Study||72||
59710002|NCT01070979|75828573|FG000|NOT COMPLETED|Overall Study||11||
59710003|NCT01070979|75828574|FG001|NOT COMPLETED|Overall Study||12||
59710004|NCT01070979|75828575|FG002|NOT COMPLETED|Overall Study||13||
59710005|NCT01234337|75828585|FG000|STARTED|Overall Study||266||
59710006|NCT01234337|75828586|FG001|STARTED|Overall Study||271||
59710007|NCT01234337|75828585|FG000|Participants Received Treatment|Overall Study||260||
59710008|NCT01234337|75828586|FG001|Participants Received Treatment|Overall Study||267||
59710009|NCT01234337|75828585|FG000|COMPLETED|Overall Study||0||
59710010|NCT01234337|75828586|FG001|COMPLETED|Overall Study||0||
59710011|NCT01234337|75828585|FG000|NOT COMPLETED|Overall Study||266||
59710012|NCT01234337|75828586|FG001|NOT COMPLETED|Overall Study||271||
59710013|NCT01070043|75828594|FG000|STARTED|Run-In Phase||60||
59710014|NCT01070043|75828595|FG001|STARTED|Run-In Phase|This combination therapy arm is used only for double-blind phase.|0||
59710015|NCT01070043|75828596|FG002|STARTED|Run-In Phase|This monotherapy (Valsartan 160 mg) treatment arm is used only for double-blind phase.|0||
59710016|NCT01070043|75828594|FG000|COMPLETED|Run-In Phase||42||
59710017|NCT01070043|75828595|FG001|COMPLETED|Run-In Phase||0||
59710018|NCT01070043|75828596|FG002|COMPLETED|Run-In Phase||0||
59710019|NCT01070043|75828594|FG000|NOT COMPLETED|Run-In Phase||18||
59710020|NCT01070043|75828595|FG001|NOT COMPLETED|Run-In Phase||0||
59710021|NCT01070043|75828596|FG002|NOT COMPLETED|Run-In Phase||0||
59995724|NCT02647281|76111588|FG008|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||5||
59995725|NCT02647281|76111580|FG000|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0||
59995726|NCT02647281|76111581|FG001|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0||
59995727|NCT02647281|76111582|FG002|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0||
59995728|NCT02647281|76111583|FG003|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0||
59995729|NCT02647281|76111584|FG004|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0||
59995730|NCT02647281|76111585|FG005|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0||
59995731|NCT02647281|76111586|FG006|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0||
59995732|NCT02647281|76111587|FG007|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0||
59995733|NCT02647281|76111588|FG008|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||1||
59995734|NCT02729545|76111619|FG000|STARTED|Overall Study||30||
59995735|NCT02729545|76111620|FG001|STARTED|Overall Study||30||
59995736|NCT02729545|76111619|FG000|COMPLETED|Overall Study||27||
59995737|NCT02729545|76111620|FG001|COMPLETED|Overall Study||25||
59995738|NCT02729545|76111619|FG000|NOT COMPLETED|Overall Study||3||
59995739|NCT02729545|76111620|FG001|NOT COMPLETED|Overall Study||5||
60104258|NCT00983073|76222673|FG000|STARTED|Maintenance Period||160||
60104259|NCT00983073|76222673|FG000|COMPLETED|Maintenance Period||144||
60104260|NCT00983073|76222673|FG000|NOT COMPLETED|Maintenance Period||16||
60104261|NCT00982137|76222682|FG000|STARTED|Overall Study||36||
60104262|NCT00982137|76222683|FG001|STARTED|Overall Study||36||
60104263|NCT00982137|76222684|FG002|STARTED|Overall Study||18||
60104264|NCT00982137|76222685|FG003|STARTED|Overall Study||18||
60104265|NCT00982137|76222682|FG000|COMPLETED|Overall Study||36||
60104266|NCT00982137|76222683|FG001|COMPLETED|Overall Study||35||
60104267|NCT00982137|76222684|FG002|COMPLETED|Overall Study||18||
60104268|NCT00982137|76222685|FG003|COMPLETED|Overall Study||17||
60104269|NCT00982137|76222682|FG000|NOT COMPLETED|Overall Study||0||
60104270|NCT00982137|76222683|FG001|NOT COMPLETED|Overall Study||1||
60104271|NCT00982137|76222684|FG002|NOT COMPLETED|Overall Study||0||
60104272|NCT00982137|76222685|FG003|NOT COMPLETED|Overall Study||1||
60104273|NCT00981747|76222702|FG000|STARTED|Losartan||12||
60104274|NCT00981747|76222702|FG000|Started Losartan|Losartan||12||
60104275|NCT00981747|76222702|FG000|Completed Losartan|Losartan|Only 9 were analyzed because only 9 completed all four interventions.|10||
60104276|NCT00981747|76222702|FG000|COMPLETED|Losartan|Only 9 were analyzed because only 9 completed all four interventions.|10||
60104277|NCT00981747|76222702|FG000|NOT COMPLETED|Losartan||2||
60104278|NCT00981747|76222702|FG000|STARTED|Placebo Oral Tablet||10||
59710022|NCT01070043|75828594|FG000|STARTED|Double-Blind Treatment||0||
59710023|NCT01070043|75828595|FG001|STARTED|Double-Blind Treatment||21||
59710024|NCT01070043|75828596|FG002|STARTED|Double-Blind Treatment||21||
59710025|NCT01070043|75828594|FG000|COMPLETED|Double-Blind Treatment||0||
59710026|NCT01070043|75828595|FG001|COMPLETED|Double-Blind Treatment||21||
59710027|NCT01070043|75828596|FG002|COMPLETED|Double-Blind Treatment||19||
59710028|NCT01070043|75828594|FG000|NOT COMPLETED|Double-Blind Treatment||0||
59710029|NCT01070043|75828595|FG001|NOT COMPLETED|Double-Blind Treatment||0||
59710030|NCT01070043|75828596|FG002|NOT COMPLETED|Double-Blind Treatment||2||
59710031|NCT01074255|75828602|FG000|STARTED|Overall Study||3141||
59565996|NCT02303574|75668406|FG001|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0||
59565997|NCT02303574|75668407|FG002|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0||
59565998|NCT02303574|75668408|FG003|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0||
59565999|NCT02303574|75668409|FG004|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0||
59566000|NCT02303574|75668410|FG005|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0||
59566001|NCT02303574|75668411|FG006|STARTED|Part 2 - Multiple Ascending Dose (MAD)||6||
59566002|NCT02303574|75668412|FG007|STARTED|Part 2 - Multiple Ascending Dose (MAD)||8||
59566003|NCT02303574|75668413|FG008|STARTED|Part 2 - Multiple Ascending Dose (MAD)||10||
59566004|NCT02303574|75668414|FG009|STARTED|Part 2 - Multiple Ascending Dose (MAD)|Participants took AZD7986 matching placebo for 28 days (fasted/fed state, based on part 1b results)|12||
59566005|NCT02303574|75668405|FG000|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0||
59566006|NCT02303574|75668406|FG001|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0||
59566007|NCT02303574|75668407|FG002|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0||
59566008|NCT02303574|75668408|FG003|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0||
59566009|NCT02303574|75668409|FG004|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0||
59566010|NCT02303574|75668410|FG005|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0||
59566011|NCT02303574|75668411|FG006|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||6||
59710032|NCT01074255|75828602|FG000|Treated|Overall Study||3139||
59566012|NCT02303574|75668412|FG007|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||7||
59566013|NCT02303574|75668413|FG008|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||10||
59566014|NCT02303574|75668414|FG009|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||12||
59566015|NCT02303574|75668405|FG000|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0||
59566016|NCT02303574|75668406|FG001|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0||
59566017|NCT02303574|75668407|FG002|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0||
59566018|NCT02303574|75668408|FG003|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0||
59566019|NCT02303574|75668409|FG004|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0||
59566020|NCT02303574|75668410|FG005|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0||
59566021|NCT02303574|75668411|FG006|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0||
59566022|NCT02303574|75668412|FG007|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||1||
59566023|NCT02303574|75668413|FG008|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0||
59566024|NCT02303574|75668414|FG009|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0||
59566025|NCT02354976|75668450|FG000|STARTED|Overall Study||25||
59566026|NCT02354976|75668451|FG001|STARTED|Overall Study||27||
59566027|NCT02354976|75668452|FG002|STARTED|Overall Study||26||
59566028|NCT02354976|75668450|FG000|COMPLETED|Overall Study||23||
59566029|NCT02354976|75668451|FG001|COMPLETED|Overall Study||26||
59566030|NCT02354976|75668452|FG002|COMPLETED|Overall Study||23||
59566031|NCT02354976|75668450|FG000|NOT COMPLETED|Overall Study||2||
59710033|NCT01074255|75828602|FG000|COMPLETED|Overall Study||3139||
59566032|NCT02354976|75668451|FG001|NOT COMPLETED|Overall Study||1||
59566033|NCT02354976|75668452|FG002|NOT COMPLETED|Overall Study||3||
59566034|NCT02303262|75668460|FG000|STARTED|Overall Study||20||
59566035|NCT02303262|75668460|FG000|COMPLETED|Overall Study||18||
59566036|NCT02303262|75668460|FG000|NOT COMPLETED|Overall Study||2||
59566037|NCT00558896|75668471|FG000|STARTED|Overall Study||60||
59566038|NCT00558896|75668472|FG001|STARTED|Overall Study||34||
59566039|NCT00558896|75668473|FG002|STARTED|Overall Study||35||
59566040|NCT00558896|75668474|FG003|STARTED|Overall Study||35||
59566041|NCT00558896|75668475|FG004|STARTED|Overall Study||60||
59710034|NCT01074255|75828602|FG000|NOT COMPLETED|Overall Study||2||
59710035|NCT01073943|75828608|FG000|STARTED|Overall Study||300||
59710036|NCT01073943|75828609|FG001|STARTED|Overall Study||303||
59710037|NCT01073943|75828608|FG000|Safety Population (Treated)|Overall Study||296||
59710038|NCT01073943|75828609|FG001|Safety Population (Treated)|Overall Study||302||
59710039|NCT01073943|75828608|FG000|Intent to Treat Population|Overall Study|Two treated participants did not have an efficacy assessment performed.|294||
59710040|NCT01073943|75828609|FG001|Intent to Treat Population|Overall Study|Two treated participants did not have an efficacy assessment performed.|300||
59710041|NCT01073943|75828608|FG000|COMPLETED|Overall Study||287||
59710042|NCT01073943|75828609|FG001|COMPLETED|Overall Study||295||
59710043|NCT01073943|75828608|FG000|NOT COMPLETED|Overall Study||13||
59710044|NCT01073943|75828609|FG001|NOT COMPLETED|Overall Study||8||
59710045|NCT01073865|75828617|FG000|STARTED|Overall Study|Number of patients randomised|109||
59710046|NCT01073865|75828618|FG001|STARTED|Overall Study|Number of patients randomised|113||
59710047|NCT01073865|75828617|FG000|Received Randomised Treatment|Overall Study|Number of patients received randomised treatment|108||
59817985|NCT04488770|75940333|FG007|NOT COMPLETED|Part 1-Cohort 2: Period 3 (Up to 5 Days)||0||
59995740|NCT01376089|76111628|FG000|STARTED|Overall Study||151||
59995741|NCT01376089|76111629|FG001|STARTED|Overall Study||148||
59995742|NCT01376089|76111628|FG000|COMPLETED|Overall Study||148||
59995743|NCT01376089|76111629|FG001|COMPLETED|Overall Study||144||
59995744|NCT01376089|76111628|FG000|NOT COMPLETED|Overall Study||3||
60104279|NCT00981747|76222702|FG000|Started Placebo Oral Tablet|Placebo Oral Tablet||10||
60104280|NCT00981747|76222702|FG000|Completed Placebo Oral Tablet|Placebo Oral Tablet||9||
60104281|NCT00981747|76222702|FG000|COMPLETED|Placebo Oral Tablet||9||
60104282|NCT00981747|76222702|FG000|NOT COMPLETED|Placebo Oral Tablet||1||
60104283|NCT00981747|76222702|FG000|STARTED|Sildenafil||9||
60104284|NCT00981747|76222702|FG000|Started Sildenafil|Sildenafil||9||
60104285|NCT00981747|76222702|FG000|Completed Sildenafil|Sildenafil||9||
60104286|NCT00981747|76222702|FG000|COMPLETED|Sildenafil||9||
60104287|NCT00981747|76222702|FG000|NOT COMPLETED|Sildenafil||0||
60104288|NCT00981747|76222702|FG000|STARTED|Sildenafil and Losartan||9||
60104289|NCT00981747|76222702|FG000|Started Sildenafil and Losartan|Sildenafil and Losartan||9||
60104290|NCT00981747|76222702|FG000|Completed Sildenafil and Losartan|Sildenafil and Losartan||9||
60104291|NCT00981747|76222702|FG000|COMPLETED|Sildenafil and Losartan||9||
60104292|NCT00981747|76222702|FG000|NOT COMPLETED|Sildenafil and Losartan||0||
60104293|NCT03030183|76222712|FG000|STARTED|Overall Study||3||
60104294|NCT03030183|76222712|FG000|COMPLETED|Overall Study||3||
60104295|NCT03030183|76222712|FG000|NOT COMPLETED|Overall Study||0||
60104296|NCT01295710|76222718|FG000|STARTED|Overall Study|Randomized and treated|126||
60104297|NCT01295710|76222719|FG001|STARTED|Overall Study|Randomized and treated|128||
60104298|NCT01295710|76222718|FG000|COMPLETED|Overall Study||48||
60104299|NCT01295710|76222719|FG001|COMPLETED|Overall Study||78||
60104300|NCT01295710|76222718|FG000|NOT COMPLETED|Overall Study||78||
60104301|NCT01295710|76222719|FG001|NOT COMPLETED|Overall Study||50||
60104302|NCT01258504|76222725|FG000|STARTED|Bosentan Single Dose||13||
60104303|NCT01258504|76222725|FG000|COMPLETED|Bosentan Single Dose||13||
60104304|NCT01258504|76222725|FG000|NOT COMPLETED|Bosentan Single Dose||0||
60104305|NCT01258504|76222725|FG000|STARTED|Bosentan Steady-state||13||
60104306|NCT01258504|76222725|FG000|COMPLETED|Bosentan Steady-state||13||
60104307|NCT01258504|76222725|FG000|NOT COMPLETED|Bosentan Steady-state||0||
60104308|NCT01258504|76222725|FG000|STARTED|Bosentan and SJW||13||
60104309|NCT01258504|76222725|FG000|COMPLETED|Bosentan and SJW||13||
60104310|NCT01258504|76222725|FG000|NOT COMPLETED|Bosentan and SJW||0||
60104311|NCT01258582|76222736|FG000|STARTED|Overall Study||830||
60104312|NCT01258582|76222737|FG001|STARTED|Overall Study||821||
60104313|NCT01258582|76222736|FG000|COMPLETED|Overall Study||548||
60104314|NCT01258582|76222737|FG001|COMPLETED|Overall Study||563||
60104315|NCT01258582|76222736|FG000|NOT COMPLETED|Overall Study||282||
60104316|NCT01258582|76222737|FG001|NOT COMPLETED|Overall Study||258||
60104317|NCT01259128|76222745|FG000|STARTED|Overall Study||15||
60104318|NCT01259128|76222746|FG001|STARTED|Overall Study||17||
59566042|NCT00558896|75668476|FG005|STARTED|Overall Study||120||
59710048|NCT01073865|75828618|FG001|Received Randomised Treatment|Overall Study|Number of patients received randomised treatment|113||
59710049|NCT01073865|75828617|FG000|COMPLETED|Overall Study|Number of patients completed the study|81||
59995745|NCT01376089|76111629|FG001|NOT COMPLETED|Overall Study||4||
59995746|NCT00706849|76111641|FG000|STARTED|Treatment Period||41||
59995747|NCT00706849|76111642|FG001|STARTED|Treatment Period||83||
59995748|NCT00706849|76111641|FG000|Full Analysis Set|Treatment Period|Treated patients with a valid baseline & post-baseline LDL-C measurement|41||
60000400|NCT02593305|76116130|FG001|COMPLETED|Post 2||6||
60104319|NCT01259128|76222745|FG000|COMPLETED|Overall Study||15||
60104320|NCT01259128|76222746|FG001|COMPLETED|Overall Study||15||
60104321|NCT01259128|76222745|FG000|NOT COMPLETED|Overall Study||0||
60104322|NCT01259128|76222746|FG001|NOT COMPLETED|Overall Study||2||
59566043|NCT00558896|75668477|FG006|STARTED|Overall Study||33||
59566044|NCT00558896|75668471|FG000|COMPLETED|Overall Study||39||
60104323|NCT01353196|76222754|FG000|STARTED|Overall Study||100||
60104324|NCT01353196|76222755|FG001|STARTED|Overall Study||70||
60104325|NCT01353196|76222754|FG000|COMPLETED|Overall Study||71||
60104326|NCT01353196|76222755|FG001|COMPLETED|Overall Study||59||
59710050|NCT01073865|75828618|FG001|COMPLETED|Overall Study|Number of patients completed the study|74||
59710051|NCT01073865|75828617|FG000|NOT COMPLETED|Overall Study||28||
60104327|NCT01353196|76222754|FG000|NOT COMPLETED|Overall Study||29||
60104328|NCT01353196|76222755|FG001|NOT COMPLETED|Overall Study||11||
60104329|NCT01353976|76222763|FG000|STARTED|Overall Study||130||
59710052|NCT01073865|75828618|FG001|NOT COMPLETED|Overall Study||39||
59710053|NCT04862065|75828627|FG000|STARTED|Screening||15581||
59710054|NCT04862065|75828628|FG001|STARTED|Screening||403||
59995749|NCT00706849|76111642|FG001|Full Analysis Set|Treatment Period|Treated patients with a valid baseline & post-baseline LDL-C measurement.|82||
59995750|NCT00706849|76111641|FG000|COMPLETED|Treatment Period|38 patients entered the open-label extension study (301012-CS6; NCT00694109).|41||
59995751|NCT00706849|76111642|FG001|COMPLETED|Treatment Period|55 patients entered the open-label extension study (301012-CS6; NCT00694109).|73||
59995752|NCT00706849|76111641|FG000|NOT COMPLETED|Treatment Period||0||
59995753|NCT00706849|76111642|FG001|NOT COMPLETED|Treatment Period||10||
59995754|NCT00706849|76111641|FG000|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|3||
59995755|NCT00706849|76111642|FG001|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|28||
59710055|NCT04862065|75828629|FG002|STARTED|Screening||404||
59710056|NCT04862065|75828627|FG000|COMPLETED|Screening||15526||
59710057|NCT04862065|75828628|FG001|COMPLETED|Screening||403||
59710058|NCT04862065|75828629|FG002|COMPLETED|Screening||404||
59710059|NCT04862065|75828627|FG000|NOT COMPLETED|Screening||55||
59710060|NCT04862065|75828628|FG001|NOT COMPLETED|Screening||0||
59710061|NCT04862065|75828629|FG002|NOT COMPLETED|Screening||0||
60104330|NCT01353976|76222764|FG001|STARTED|Overall Study||134||
60104331|NCT01353976|76222763|FG000|COMPLETED|Overall Study||82||
60104332|NCT01353976|76222764|FG001|COMPLETED|Overall Study||83||
60104333|NCT01353976|76222763|FG000|NOT COMPLETED|Overall Study||48||
60104334|NCT01353976|76222764|FG001|NOT COMPLETED|Overall Study||51||
60104335|NCT01354444|76222772|FG000|STARTED|Overall Study||14||
60104336|NCT01354444|76222773|FG001|STARTED|Overall Study||15||
60104337|NCT01354444|76222772|FG000|COMPLETED|Overall Study||6||
60104338|NCT01354444|76222773|FG001|COMPLETED|Overall Study||11||
60104339|NCT01354444|76222772|FG000|NOT COMPLETED|Overall Study||8||
60104340|NCT01354444|76222773|FG001|NOT COMPLETED|Overall Study||4||
60104341|NCT01259440|76222783|FG000|STARTED|Overall Study||13||
60104342|NCT01259440|76222784|FG001|STARTED|Overall Study||10||
60104343|NCT01259440|76222783|FG000|COMPLETED|Overall Study||13||
60104344|NCT01259440|76222784|FG001|COMPLETED|Overall Study||10||
60104345|NCT01259440|76222783|FG000|NOT COMPLETED|Overall Study||0||
60104346|NCT01259440|76222784|FG001|NOT COMPLETED|Overall Study||0||
60104347|NCT01259596|76222792|FG000|STARTED|Overall Study||70||
60104348|NCT01259596|76222793|FG001|STARTED|Overall Study||71||
60104349|NCT01259596|76222792|FG000|COMPLETED|Overall Study||66||
60104350|NCT01259596|76222793|FG001|COMPLETED|Overall Study||65||
60104351|NCT01259596|76222792|FG000|NOT COMPLETED|Overall Study||4||
60104352|NCT01259596|76222793|FG001|NOT COMPLETED|Overall Study||6||
60104353|NCT01354990|76222801|FG000|STARTED|Overall Study||2974||
60104354|NCT01354990|76222801|FG000|COMPLETED|Overall Study||2974||
60104355|NCT01354990|76222801|FG000|NOT COMPLETED|Overall Study||0||
60104356|NCT01355224|76222809|FG000|STARTED|Overall Study||198||
60104357|NCT01355224|76222810|FG001|STARTED|Overall Study||203||
60104358|NCT01355224|76222811|FG002|STARTED|Overall Study||196||
60104359|NCT01355224|76222812|FG003|STARTED|Overall Study||201||
60104360|NCT01355224|76222809|FG000|Competed Baseline|Overall Study||191||
60104361|NCT01355224|76222810|FG001|Competed Baseline|Overall Study||200||
60104362|NCT01355224|76222811|FG002|Competed Baseline|Overall Study||193||
60104363|NCT01355224|76222812|FG003|Competed Baseline|Overall Study||193||
60104364|NCT01355224|76222809|FG000|COMPLETED|Overall Study||167||
60104365|NCT01355224|76222810|FG001|COMPLETED|Overall Study||180||
60104366|NCT01355224|76222811|FG002|COMPLETED|Overall Study||177||
60104367|NCT01355224|76222812|FG003|COMPLETED|Overall Study||172||
60104368|NCT01355224|76222809|FG000|NOT COMPLETED|Overall Study||31||
60104369|NCT01355224|76222810|FG001|NOT COMPLETED|Overall Study||23||
60104370|NCT01355224|76222811|FG002|NOT COMPLETED|Overall Study||19||
59710062|NCT04862065|75828627|FG000|STARTED|Follow-Up||6||
59710063|NCT04862065|75828628|FG001|STARTED|Follow-Up||0||
59995756|NCT00706849|76111641|FG000|COMPLETED|Follow-up Period||3||
59995757|NCT00706849|76111642|FG001|COMPLETED|Follow-up Period||25||
59995758|NCT00706849|76111641|FG000|NOT COMPLETED|Follow-up Period||0||
59995759|NCT00706849|76111642|FG001|NOT COMPLETED|Follow-up Period||3||
59995760|NCT00707161|76111648|FG000|STARTED|Overall Study|3 deceased (1-Huntsman Cancer Institute, 2- LDS Hospital).|6||
59995761|NCT00707161|76111648|FG000|COMPLETED|Overall Study||0||
59995762|NCT00707161|76111648|FG000|NOT COMPLETED|Overall Study||6||
59995763|NCT02130466|76111666|FG000|STARTED|Overall Study||7||
59995764|NCT02130466|76111667|FG001|STARTED|Overall Study||3||
60104371|NCT01355224|76222812|FG003|NOT COMPLETED|Overall Study||29||
60104372|NCT01260454|76222830|FG000|STARTED|Overall Study||6||
59995765|NCT02130466|76111668|FG002|STARTED|Overall Study||2||
60104373|NCT01260454|76222830|FG000|COMPLETED|Overall Study||6||
60104374|NCT01260454|76222830|FG000|NOT COMPLETED|Overall Study||0||
59995766|NCT02130466|76111669|FG003|STARTED|Overall Study||8||
59817986|NCT04488770|75940334|FG008|NOT COMPLETED|Part 1-Cohort 2: Period 3 (Up to 5 Days)||0||
59995767|NCT02130466|76111670|FG004|STARTED|Overall Study||2||
60104375|NCT01296646|76222836|FG000|STARTED|Overall Study||40||
60104376|NCT01296646|76222837|FG001|STARTED|Overall Study||40||
60104377|NCT01296646|76222836|FG000|COMPLETED|Overall Study||29||
60104378|NCT01296646|76222837|FG001|COMPLETED|Overall Study||29||
60104379|NCT01296646|76222836|FG000|NOT COMPLETED|Overall Study||11||
60104380|NCT01296646|76222837|FG001|NOT COMPLETED|Overall Study||11||
60104381|NCT01297348|76222845|FG000|STARTED|Overall Study||12281||
60104382|NCT01297348|76222846|FG001|STARTED|Overall Study||586401||
60104383|NCT01297348|76222845|FG000|COMPLETED|Overall Study||12281||
60104384|NCT01297348|76222846|FG001|COMPLETED|Overall Study||586401||
60104385|NCT01297348|76222845|FG000|NOT COMPLETED|Overall Study||0||
60104386|NCT01297348|76222846|FG001|NOT COMPLETED|Overall Study||0||
59566045|NCT00558896|75668472|FG001|COMPLETED|Overall Study||27||
59566046|NCT00558896|75668473|FG002|COMPLETED|Overall Study||30||
59566047|NCT00558896|75668474|FG003|COMPLETED|Overall Study||23||
59995768|NCT02130466|76111671|FG005|STARTED|Overall Study||60||
59995769|NCT02130466|76111672|FG006|STARTED|Overall Study||60||
59995770|NCT02130466|76111673|FG007|STARTED|Overall Study||3||
60104387|NCT01856309|76222857|FG000|STARTED|Overall Study||305||
59995771|NCT02130466|76111674|FG008|STARTED|Overall Study||4||
59995772|NCT02130466|76111675|FG009|STARTED|Overall Study||5||
59995773|NCT02130466|76111676|FG010|STARTED|Overall Study||6||
59995774|NCT02130466|76111677|FG011|STARTED|Overall Study||3||
59995775|NCT02130466|76111678|FG012|STARTED|Overall Study||12||
59995776|NCT02130466|76111679|FG013|STARTED|Overall Study||9||
59995777|NCT02130466|76111666|FG000|Treated|Overall Study||7||
59995778|NCT02130466|76111667|FG001|Treated|Overall Study||3||
59995779|NCT02130466|76111668|FG002|Treated|Overall Study||2||
59995780|NCT02130466|76111669|FG003|Treated|Overall Study||8||
59995781|NCT02130466|76111670|FG004|Treated|Overall Study||2||
59995782|NCT02130466|76111671|FG005|Treated|Overall Study||60||
59995783|NCT02130466|76111672|FG006|Treated|Overall Study||60||
59995784|NCT02130466|76111673|FG007|Treated|Overall Study||3||
59995785|NCT02130466|76111674|FG008|Treated|Overall Study||4||
59995786|NCT02130466|76111675|FG009|Treated|Overall Study||5||
59995787|NCT02130466|76111676|FG010|Treated|Overall Study||6||
59995788|NCT02130466|76111677|FG011|Treated|Overall Study||3||
59995789|NCT02130466|76111678|FG012|Treated|Overall Study||12||
59995790|NCT02130466|76111679|FG013|Treated|Overall Study||9||
60104388|NCT01856309|76222858|FG001|STARTED|Overall Study||291||
60104389|NCT01856309|76222859|FG002|STARTED|Overall Study||606||
60104390|NCT01856309|76222860|FG003|STARTED|Overall Study||618||
60104391|NCT01856309|76222857|FG000|Participants From Study CNTO136ARA3002|Overall Study||197||
60104392|NCT01856309|76222858|FG001|Participants From Study CNTO136ARA3002|Overall Study||187||
60104393|NCT01856309|76222859|FG002|Participants From Study CNTO136ARA3002|Overall Study||405||
60104394|NCT01856309|76222860|FG003|Participants From Study CNTO136ARA3002|Overall Study||412||
60104395|NCT01856309|76222857|FG000|Participants From Study CNTO136ARA3003|Overall Study||108||
60104396|NCT01856309|76222858|FG001|Participants From Study CNTO136ARA3003|Overall Study||104||
60104397|NCT01856309|76222859|FG002|Participants From Study CNTO136ARA3003|Overall Study||201||
60104398|NCT01856309|76222860|FG003|Participants From Study CNTO136ARA3003|Overall Study||206||
60104399|NCT01856309|76222857|FG000|Treated Partcipants|Overall Study||305||
60104400|NCT01856309|76222858|FG001|Treated Partcipants|Overall Study||290||
60104401|NCT01856309|76222859|FG002|Treated Partcipants|Overall Study||605||
60104402|NCT01856309|76222860|FG003|Treated Partcipants|Overall Study||618||
60104403|NCT01856309|76222857|FG000|COMPLETED|Overall Study||6||
60104404|NCT01856309|76222858|FG001|COMPLETED|Overall Study||3||
60104405|NCT01856309|76222859|FG002|COMPLETED|Overall Study||11||
60104406|NCT01856309|76222860|FG003|COMPLETED|Overall Study||9||
60104407|NCT01856309|76222857|FG000|NOT COMPLETED|Overall Study||299||
60104408|NCT01856309|76222858|FG001|NOT COMPLETED|Overall Study||288||
60104409|NCT01856309|76222859|FG002|NOT COMPLETED|Overall Study||595||
60104410|NCT01856309|76222860|FG003|NOT COMPLETED|Overall Study||609||
60104411|NCT01260688|76222872|FG000|STARTED|Overall Study||11||
60104412|NCT01260688|76222873|FG001|STARTED|Overall Study||11||
60104413|NCT01260688|76222872|FG000|COMPLETED|Overall Study||11||
60104414|NCT01260688|76222873|FG001|COMPLETED|Overall Study||11||
59995791|NCT02130466|76111666|FG000|COMPLETED|Overall Study||0||
59995792|NCT02130466|76111667|FG001|COMPLETED|Overall Study||0||
59995793|NCT02130466|76111668|FG002|COMPLETED|Overall Study||0||
60104415|NCT01260688|76222872|FG000|NOT COMPLETED|Overall Study||0||
60104416|NCT01260688|76222873|FG001|NOT COMPLETED|Overall Study||0||
60104417|NCT01355458|76222884|FG000|STARTED|Overall Study||129||
60104418|NCT01355458|76222885|FG001|STARTED|Overall Study||131||
59566048|NCT00558896|75668475|FG004|COMPLETED|Overall Study||37||
59566049|NCT00558896|75668476|FG005|COMPLETED|Overall Study||68||
59566050|NCT00558896|75668477|FG006|COMPLETED|Overall Study||9||
59995794|NCT02130466|76111669|FG003|COMPLETED|Overall Study||0||
59995795|NCT02130466|76111670|FG004|COMPLETED|Overall Study||0||
59995796|NCT02130466|76111671|FG005|COMPLETED|Overall Study||0||
60104419|NCT01355458|76222884|FG000|COMPLETED|Overall Study||127||
60104420|NCT01355458|76222885|FG001|COMPLETED|Overall Study||127||
60104421|NCT01355458|76222884|FG000|NOT COMPLETED|Overall Study||2||
59710064|NCT04862065|75828629|FG002|STARTED|Follow-Up||0||
59710065|NCT04862065|75828627|FG000|COMPLETED|Follow-Up||3||
59995797|NCT02130466|76111672|FG006|COMPLETED|Overall Study||0||
59995798|NCT02130466|76111673|FG007|COMPLETED|Overall Study||0||
59995799|NCT02130466|76111674|FG008|COMPLETED|Overall Study||0||
59995800|NCT02130466|76111675|FG009|COMPLETED|Overall Study||0||
59995801|NCT02130466|76111676|FG010|COMPLETED|Overall Study||0||
59995802|NCT02130466|76111677|FG011|COMPLETED|Overall Study||0||
60104422|NCT01355458|76222885|FG001|NOT COMPLETED|Overall Study||4||
60104423|NCT01298128|76222893|FG000|STARTED|Overall Study||35||
60104424|NCT01298128|76222894|FG001|STARTED|Overall Study||35||
60104425|NCT01298128|76222893|FG000|COMPLETED|Overall Study||26||
59566051|NCT00558896|75668471|FG000|NOT COMPLETED|Overall Study||21||
59566052|NCT00558896|75668472|FG001|NOT COMPLETED|Overall Study||7||
59566053|NCT00558896|75668473|FG002|NOT COMPLETED|Overall Study||5||
59566054|NCT00558896|75668474|FG003|NOT COMPLETED|Overall Study||12||
59566055|NCT00558896|75668475|FG004|NOT COMPLETED|Overall Study||23||
59566056|NCT00558896|75668476|FG005|NOT COMPLETED|Overall Study||52||
59566057|NCT00558896|75668477|FG006|NOT COMPLETED|Overall Study||24||
59566058|NCT01857362|75668493|FG000|STARTED|Overall Study||6||
60104426|NCT01298128|76222894|FG001|COMPLETED|Overall Study||27||
60104427|NCT01298128|76222893|FG000|NOT COMPLETED|Overall Study||9||
60104428|NCT01298128|76222894|FG001|NOT COMPLETED|Overall Study||8||
59566059|NCT01857362|75668494|FG001|STARTED|Overall Study||6||
59566060|NCT01857362|75668493|FG000|COMPLETED|Overall Study||6||
59566061|NCT01857362|75668494|FG001|COMPLETED|Overall Study||6||
59566062|NCT01857362|75668493|FG000|NOT COMPLETED|Overall Study||0||
59566063|NCT01857362|75668494|FG001|NOT COMPLETED|Overall Study||0||
59710066|NCT04862065|75828628|FG001|COMPLETED|Follow-Up||0||
59710067|NCT04862065|75828629|FG002|COMPLETED|Follow-Up||0||
59710068|NCT04862065|75828627|FG000|NOT COMPLETED|Follow-Up||3||
59710069|NCT04862065|75828628|FG001|NOT COMPLETED|Follow-Up||0||
59566064|NCT01857986|75668502|FG000|STARTED|Overall Study||39||
59566065|NCT01857986|75668503|FG001|STARTED|Overall Study||37||
59566066|NCT01857986|75668502|FG000|COMPLETED|Overall Study||34||
59710070|NCT04862065|75828629|FG002|NOT COMPLETED|Follow-Up||0||
59710071|NCT01073631|75828635|FG000|STARTED|Overall Study||543||
59710072|NCT01073631|75828635|FG000|COMPLETED|Overall Study||374||
59995803|NCT02130466|76111678|FG012|COMPLETED|Overall Study||0||
59995804|NCT02130466|76111679|FG013|COMPLETED|Overall Study||0||
59995805|NCT02130466|76111666|FG000|NOT COMPLETED|Overall Study||7||
59995806|NCT02130466|76111667|FG001|NOT COMPLETED|Overall Study||3||
60104429|NCT01298752|76222902|FG000|STARTED|Overall Study||120||
60104430|NCT01298752|76222903|FG001|STARTED|Overall Study||57||
60104431|NCT01298752|76222902|FG000|COMPLETED|Overall Study||77||
60104432|NCT01298752|76222903|FG001|COMPLETED|Overall Study||31||
60104433|NCT01298752|76222902|FG000|NOT COMPLETED|Overall Study||43||
59995807|NCT02130466|76111668|FG002|NOT COMPLETED|Overall Study||2||
59995808|NCT02130466|76111669|FG003|NOT COMPLETED|Overall Study||8||
59995809|NCT02130466|76111670|FG004|NOT COMPLETED|Overall Study||2||
59995810|NCT02130466|76111671|FG005|NOT COMPLETED|Overall Study||60||
60104434|NCT01298752|76222903|FG001|NOT COMPLETED|Overall Study||26||
60104435|NCT02199964|76222911|FG000|STARTED|Overall Study||2||
60104436|NCT02199964|76222912|FG001|STARTED|Overall Study||2||
59995811|NCT02130466|76111672|FG006|NOT COMPLETED|Overall Study||60||
59995812|NCT02130466|76111673|FG007|NOT COMPLETED|Overall Study||3||
59995813|NCT02130466|76111674|FG008|NOT COMPLETED|Overall Study||4||
59995814|NCT02130466|76111675|FG009|NOT COMPLETED|Overall Study||5||
59995815|NCT02130466|76111676|FG010|NOT COMPLETED|Overall Study||6||
60104437|NCT02199964|76222911|FG000|COMPLETED|Overall Study||2||
60104438|NCT02199964|76222912|FG001|COMPLETED|Overall Study||2||
60104439|NCT02199964|76222911|FG000|NOT COMPLETED|Overall Study||0||
60104440|NCT02199964|76222912|FG001|NOT COMPLETED|Overall Study||0||
59995816|NCT02130466|76111677|FG011|NOT COMPLETED|Overall Study||3||
59995817|NCT02130466|76111678|FG012|NOT COMPLETED|Overall Study||12||
59995818|NCT02130466|76111679|FG013|NOT COMPLETED|Overall Study||9||
60104441|NCT01299454|76222922|FG000|STARTED|Overall Study||8||
60104442|NCT01299454|76222923|FG001|STARTED|Overall Study||8||
60104443|NCT01299454|76222924|FG002|STARTED|Overall Study||6||
60104444|NCT01299454|76222925|FG003|STARTED|Overall Study||23||
60104445|NCT01299454|76222922|FG000|COMPLETED|Overall Study||8||
60104446|NCT01299454|76222923|FG001|COMPLETED|Overall Study||8||
60104447|NCT01299454|76222924|FG002|COMPLETED|Overall Study||6||
60104448|NCT01299454|76222925|FG003|COMPLETED|Overall Study||23||
60104449|NCT01299454|76222922|FG000|NOT COMPLETED|Overall Study||0||
59710073|NCT01073631|75828635|FG000|NOT COMPLETED|Overall Study||169||
60104450|NCT01299454|76222923|FG001|NOT COMPLETED|Overall Study||0||
60104451|NCT01299454|76222924|FG002|NOT COMPLETED|Overall Study||0||
60104452|NCT01299454|76222925|FG003|NOT COMPLETED|Overall Study||0||
60104453|NCT02323048|76222966|FG000|STARTED|Overall Study||25||
60104454|NCT02323048|76222967|FG001|STARTED|Overall Study||26||
60104455|NCT02323048|76222968|FG002|STARTED|Overall Study||23||
60104456|NCT02323048|76222969|FG003|STARTED|Overall Study||7||
60104457|NCT02323048|76222970|FG004|STARTED|Overall Study||9||
59710074|NCT01073163|75828639|FG000|STARTED|Overall Study||54||
59710075|NCT01073163|75828639|FG000|Enrolled But Not Treated|Overall Study||1||
59710076|NCT01073163|75828639|FG000|Treated With <6 Cycles|Overall Study||4||
59710077|NCT01073163|75828639|FG000|Treated With >=6 Cycles|Overall Study||49||
59710078|NCT01073163|75828639|FG000|COMPLETED|Overall Study|Patients completed study|51||
59995819|NCT02163538|76111728|FG000|STARTED|Overall Study||71||
59995820|NCT02163538|76111729|FG001|STARTED|Overall Study||71||
60104458|NCT02323048|76222966|FG000|COMPLETED|Overall Study||24||
60104459|NCT02323048|76222967|FG001|COMPLETED|Overall Study||24||
60104460|NCT02323048|76222968|FG002|COMPLETED|Overall Study||23||
60104461|NCT02323048|76222969|FG003|COMPLETED|Overall Study||7||
59995821|NCT02163538|76111728|FG000|COMPLETED|Overall Study||70||
59995822|NCT02163538|76111729|FG001|COMPLETED|Overall Study||70||
59995823|NCT02163538|76111728|FG000|NOT COMPLETED|Overall Study||1||
59995824|NCT02163538|76111729|FG001|NOT COMPLETED|Overall Study||1||
60104462|NCT02323048|76222970|FG004|COMPLETED|Overall Study||9||
60104463|NCT02323048|76222966|FG000|NOT COMPLETED|Overall Study||1||
60104464|NCT02323048|76222967|FG001|NOT COMPLETED|Overall Study||2||
60104465|NCT02323048|76222968|FG002|NOT COMPLETED|Overall Study||0||
60104466|NCT02323048|76222969|FG003|NOT COMPLETED|Overall Study||0||
60104467|NCT02323048|76222970|FG004|NOT COMPLETED|Overall Study||0||
60104468|NCT01265446|76222984|FG000|STARTED|Overall Study||125||
59995825|NCT02163226|76111737|FG000|STARTED|Overall Study||79||
59995826|NCT02163226|76111738|FG001|STARTED|Overall Study||81||
59995827|NCT02163226|76111737|FG000|COMPLETED|Overall Study||63||
59995828|NCT02163226|76111738|FG001|COMPLETED|Overall Study||70||
59995829|NCT02163226|76111737|FG000|NOT COMPLETED|Overall Study||16||
59995830|NCT02163226|76111738|FG001|NOT COMPLETED|Overall Study||11||
59995831|NCT02193178|76111744|FG000|STARTED|Overall Study||15||
59995832|NCT02193178|76111744|FG000|COMPLETED|Overall Study||13||
59995833|NCT02193178|76111744|FG000|NOT COMPLETED|Overall Study||2||
59995834|NCT02129608|76111765|FG000|STARTED|Overall Study||15||
59995835|NCT02129608|76111766|FG001|STARTED|Overall Study||14||
59995836|NCT02129608|76111767|FG002|STARTED|Overall Study||15||
60104469|NCT01265446|76222985|FG001|STARTED|Overall Study||125||
60104470|NCT01265446|76222984|FG000|COMPLETED|Overall Study||124||
59995837|NCT02129608|76111765|FG000|End of Treatment|Overall Study||15||
59995838|NCT02129608|76111766|FG001|End of Treatment|Overall Study||13||
59995839|NCT02129608|76111767|FG002|End of Treatment|Overall Study||12||
59995840|NCT02129608|76111765|FG000|COMPLETED|Overall Study||15||
59995841|NCT02129608|76111766|FG001|COMPLETED|Overall Study||13||
59995842|NCT02129608|76111767|FG002|COMPLETED|Overall Study||12||
59995843|NCT02129608|76111765|FG000|NOT COMPLETED|Overall Study||0||
59995844|NCT02129608|76111766|FG001|NOT COMPLETED|Overall Study||1||
60104471|NCT01265446|76222985|FG001|COMPLETED|Overall Study||125||
60104472|NCT01265446|76222984|FG000|NOT COMPLETED|Overall Study||1||
59995845|NCT02129608|76111767|FG002|NOT COMPLETED|Overall Study||3||
59995846|NCT01631188|76111775|FG000|STARTED|Overall Study||100||
59995847|NCT01631188|76111775|FG000|COMPLETED|Overall Study||25||
60104473|NCT01265446|76222985|FG001|NOT COMPLETED|Overall Study||0||
59566067|NCT01857986|75668503|FG001|COMPLETED|Overall Study||30||
59566068|NCT01857986|75668502|FG000|NOT COMPLETED|Overall Study||5||
59995848|NCT01631188|76111775|FG000|NOT COMPLETED|Overall Study||75||
60104474|NCT01265524|76222993|FG000|STARTED|Overall Study||59||
59995849|NCT02129062|76111779|FG000|STARTED|Overall Study||3||
59566069|NCT01857986|75668503|FG001|NOT COMPLETED|Overall Study||7||
59566070|NCT02265224|75668509|FG000|STARTED|Overall Study||48||
59566071|NCT02265224|75668509|FG000|COMPLETED|Overall Study||48||
59566072|NCT02265224|75668509|FG000|NOT COMPLETED|Overall Study||0||
59566073|NCT02265848|75668518|FG000|STARTED|Overall Study|First subject for this study was randomized on October 1st 2014|11||
59566074|NCT02265848|75668519|FG001|STARTED|Overall Study||11||
59566075|NCT02265848|75668518|FG000|COMPLETED|Overall Study||11||
59710079|NCT01073163|75828639|FG000|NOT COMPLETED|Overall Study||3||
59710080|NCT01072929|75828650|FG000|STARTED|Overall Study||199||
59710081|NCT01072929|75828651|FG001|STARTED|Overall Study||201||
59710082|NCT01072929|75828652|FG002|STARTED|Overall Study||33||
59710083|NCT01072929|75828650|FG000|Safety Population|Overall Study|Treated participants|199||
59995850|NCT02129062|76111779|FG000|COMPLETED|Overall Study||0||
59995851|NCT02129062|76111779|FG000|NOT COMPLETED|Overall Study||3||
59995852|NCT02162758|76111785|FG000|STARTED|Overall Study||3||
59995853|NCT02162758|76111786|FG001|STARTED|Overall Study||3||
59995854|NCT02162758|76111785|FG000|COMPLETED|Overall Study||3||
59995855|NCT02162758|76111786|FG001|COMPLETED|Overall Study||2||
59995856|NCT02162758|76111785|FG000|NOT COMPLETED|Overall Study||0||
59995857|NCT02162758|76111786|FG001|NOT COMPLETED|Overall Study||1||
59995858|NCT02192164|76111792|FG000|STARTED|Overall Study||126||
59995859|NCT02192164|76111792|FG000|Etanercept Treated Population|Overall Study||112||
59995860|NCT02192164|76111792|FG000|COMPLETED|Overall Study||112||
59995861|NCT02192164|76111792|FG000|NOT COMPLETED|Overall Study||14||
59995862|NCT02191618|76111799|FG000|STARTED|Overall Study||150||
59995863|NCT02191618|76111799|FG000|COMPLETED|Overall Study||143||
59995864|NCT02191618|76111799|FG000|NOT COMPLETED|Overall Study||7||
59995865|NCT02646891|76111813|FG000|STARTED|Overall Study||6||
59995866|NCT02646891|76111814|FG001|STARTED|Overall Study||12||
59995867|NCT02646891|76111815|FG002|STARTED|Overall Study||12||
60104475|NCT01265524|76222994|FG001|STARTED|Overall Study||52||
60104476|NCT01265524|76222993|FG000|COMPLETED|Overall Study||41||
60104477|NCT01265524|76222994|FG001|COMPLETED|Overall Study||46||
60104478|NCT01265524|76222993|FG000|NOT COMPLETED|Overall Study||18||
59995868|NCT02646891|76111816|FG003|STARTED|Overall Study||6||
59995869|NCT02646891|76111817|FG004|STARTED|Overall Study||12||
60104479|NCT01265524|76222994|FG001|NOT COMPLETED|Overall Study||6||
60104480|NCT01299610|76223003|FG000|STARTED|Overall Study||10||
60104481|NCT01299610|76223004|FG001|STARTED|Overall Study||5||
60104482|NCT01299610|76223005|FG002|STARTED|Overall Study||10||
60104483|NCT01299610|76223003|FG000|COMPLETED|Overall Study||10||
60104484|NCT01299610|76223004|FG001|COMPLETED|Overall Study||5||
60104485|NCT01299610|76223005|FG002|COMPLETED|Overall Study||10||
60104486|NCT01299610|76223003|FG000|NOT COMPLETED|Overall Study||0||
60104487|NCT01299610|76223004|FG001|NOT COMPLETED|Overall Study||0||
60104488|NCT01299610|76223005|FG002|NOT COMPLETED|Overall Study||0||
60104489|NCT01300624|76223017|FG000|STARTED|Overall Study||11||
60104490|NCT01300624|76223017|FG000|COMPLETED|Overall Study||11||
59566076|NCT02265848|75668519|FG001|COMPLETED|Overall Study|Last subject for this study completed the visit on December 24, 2014|11||
59566077|NCT02265848|75668518|FG000|NOT COMPLETED|Overall Study||0||
59566078|NCT02265848|75668519|FG001|NOT COMPLETED|Overall Study||0||
60104491|NCT01300624|76223017|FG000|NOT COMPLETED|Overall Study||0||
60104492|NCT01302808|76223026|FG000|STARTED|Overall Study||3||
59566079|NCT03403725|75668536|FG000|STARTED|Overall Study||1||
59566080|NCT03403725|75668537|FG001|STARTED|Overall Study||1||
59566081|NCT03403725|75668538|FG002|STARTED|Overall Study||1||
59995870|NCT02646891|76111818|FG005|STARTED|Overall Study||12||
59995871|NCT02646891|76111819|FG006|STARTED|Overall Study||139||
59995872|NCT02646891|76111820|FG007|STARTED|Overall Study||140||
59995873|NCT02646891|76111821|FG008|STARTED|Overall Study||140||
60104493|NCT01302808|76223027|FG001|STARTED|Overall Study||7||
60104494|NCT01302808|76223028|FG002|STARTED|Overall Study||4||
60104495|NCT01302808|76223029|FG003|STARTED|Overall Study||3||
60104496|NCT01302808|76223026|FG000|COMPLETED|Overall Study||3||
59566082|NCT03403725|75668539|FG003|STARTED|Overall Study||1||
59566083|NCT03403725|75668540|FG004|STARTED|Overall Study||1||
59995874|NCT02646891|76111822|FG009|STARTED|Overall Study||139||
59995875|NCT02646891|76111813|FG000|Received at Least 1 Dose|Overall Study||6||
59995876|NCT02646891|76111814|FG001|Received at Least 1 Dose|Overall Study||12||
60104497|NCT01302808|76223027|FG001|COMPLETED|Overall Study||7||
60104498|NCT01302808|76223028|FG002|COMPLETED|Overall Study||4||
59710084|NCT01072929|75828651|FG001|Safety Population|Overall Study|Treated participants. Three participants were randomized but not treated.|198||
59710085|NCT01072929|75828652|FG002|Safety Population|Overall Study|Treated participants. One participant was randomized but not treated.|32||
59995877|NCT02646891|76111815|FG002|Received at Least 1 Dose|Overall Study||12||
59995878|NCT02646891|76111816|FG003|Received at Least 1 Dose|Overall Study||6||
59995879|NCT02646891|76111817|FG004|Received at Least 1 Dose|Overall Study||12||
59995880|NCT02646891|76111818|FG005|Received at Least 1 Dose|Overall Study||12||
59995881|NCT02646891|76111819|FG006|Received at Least 1 Dose|Overall Study||139||
59995882|NCT02646891|76111820|FG007|Received at Least 1 Dose|Overall Study|One participant was randomized but determined to be ineligible pre-vaccination.|139||
59995883|NCT02646891|76111821|FG008|Received at Least 1 Dose|Overall Study||140||
59995884|NCT02646891|76111822|FG009|Received at Least 1 Dose|Overall Study||139||
59995885|NCT02646891|76111813|FG000|COMPLETED|Overall Study||4||
59995886|NCT02646891|76111814|FG001|COMPLETED|Overall Study||11||
59995887|NCT02646891|76111815|FG002|COMPLETED|Overall Study||11||
59995888|NCT02646891|76111816|FG003|COMPLETED|Overall Study||6||
59995889|NCT02646891|76111817|FG004|COMPLETED|Overall Study||12||
60104499|NCT01302808|76223029|FG003|COMPLETED|Overall Study||3||
60104500|NCT01302808|76223026|FG000|NOT COMPLETED|Overall Study||0||
60104501|NCT01302808|76223027|FG001|NOT COMPLETED|Overall Study||0||
60104502|NCT01302808|76223028|FG002|NOT COMPLETED|Overall Study||0||
60104503|NCT01302808|76223029|FG003|NOT COMPLETED|Overall Study||0||
60104504|NCT01267240|76223041|FG000|STARTED|Overall Study||25||
60104505|NCT01267240|76223041|FG000|COMPLETED|Overall Study||25||
60104506|NCT01267240|76223041|FG000|NOT COMPLETED|Overall Study||0||
60104507|NCT01357564|76223047|FG000|STARTED|Short-term (4-month) Follow up||154||
60104508|NCT01357564|76223048|FG001|STARTED|Short-term (4-month) Follow up||168||
60104509|NCT01357564|76223047|FG000|COMPLETED|Short-term (4-month) Follow up||106||
60104510|NCT01357564|76223048|FG001|COMPLETED|Short-term (4-month) Follow up||118||
60104511|NCT01357564|76223047|FG000|NOT COMPLETED|Short-term (4-month) Follow up||48||
60104512|NCT01357564|76223048|FG001|NOT COMPLETED|Short-term (4-month) Follow up||50||
60104513|NCT01357564|76223047|FG000|STARTED|Long-term (8-month) Follow-up||106||
60104514|NCT01357564|76223048|FG001|STARTED|Long-term (8-month) Follow-up||118||
60104515|NCT01357564|76223047|FG000|COMPLETED|Long-term (8-month) Follow-up||104||
60104516|NCT01357564|76223048|FG001|COMPLETED|Long-term (8-month) Follow-up||102||
60104517|NCT01357564|76223047|FG000|NOT COMPLETED|Long-term (8-month) Follow-up||2||
60104518|NCT01357564|76223048|FG001|NOT COMPLETED|Long-term (8-month) Follow-up||16||
60104519|NCT01855919|76223058|FG000|STARTED|Overall Study||232||
60104520|NCT01855919|76223059|FG001|STARTED|Overall Study||226||
60104521|NCT01855919|76223058|FG000|Received at Least 1 Dose of Study Drug|Overall Study||232||
60104522|NCT01855919|76223059|FG001|Received at Least 1 Dose of Study Drug|Overall Study||226||
60104523|NCT01855919|76223058|FG000|COMPLETED|Overall Study||209||
60104524|NCT01855919|76223059|FG001|COMPLETED|Overall Study||200||
60104525|NCT01855919|76223058|FG000|NOT COMPLETED|Overall Study||23||
60104526|NCT01855919|76223059|FG001|NOT COMPLETED|Overall Study||26||
60104527|NCT01357720|76223068|FG000|STARTED|Overall Study||200||
60104528|NCT01357720|76223069|FG001|STARTED|Overall Study||200||
60104529|NCT01357720|76223068|FG000|COMPLETED|Overall Study||198||
60104530|NCT01357720|76223069|FG001|COMPLETED|Overall Study||195||
60104531|NCT01357720|76223068|FG000|NOT COMPLETED|Overall Study||2||
60104532|NCT01357720|76223069|FG001|NOT COMPLETED|Overall Study||5||
60104533|NCT01871519|76223075|FG000|STARTED|Overall Study||350||
60104534|NCT01871519|76223075|FG000|COMPLETED|Overall Study||260||
60104535|NCT01871519|76223075|FG000|NOT COMPLETED|Overall Study||90||
60104536|NCT01871285|76223082|FG000|STARTED|First Intervention (1 Day)||18||
60104537|NCT01871285|76223083|FG001|STARTED|First Intervention (1 Day)||15||
60104538|NCT01871285|76223084|FG002|STARTED|First Intervention (1 Day)||4||
60104539|NCT01871285|76223085|FG003|STARTED|First Intervention (1 Day)||2||
60104540|NCT01871285|76223082|FG000|COMPLETED|First Intervention (1 Day)||17||
60104541|NCT01871285|76223083|FG001|COMPLETED|First Intervention (1 Day)||14||
60104542|NCT01871285|76223084|FG002|COMPLETED|First Intervention (1 Day)||3||
60104543|NCT01871285|76223085|FG003|COMPLETED|First Intervention (1 Day)||2||
60104544|NCT01871285|76223082|FG000|NOT COMPLETED|First Intervention (1 Day)||1||
59566084|NCT03403725|75668541|FG005|STARTED|Overall Study||6||
59566085|NCT03403725|75668542|FG006|STARTED|Overall Study||6||
59566086|NCT03403725|75668543|FG007|STARTED|Overall Study||3||
59566087|NCT03403725|75668544|FG008|STARTED|Overall Study||3||
59995890|NCT02646891|76111818|FG005|COMPLETED|Overall Study||12||
59995891|NCT02646891|76111819|FG006|COMPLETED|Overall Study||130||
59995892|NCT02646891|76111820|FG007|COMPLETED|Overall Study||127||
60104545|NCT01871285|76223083|FG001|NOT COMPLETED|First Intervention (1 Day)||1||
60104546|NCT01871285|76223084|FG002|NOT COMPLETED|First Intervention (1 Day)||1||
60104547|NCT01871285|76223085|FG003|NOT COMPLETED|First Intervention (1 Day)||0||
60104548|NCT01871285|76223082|FG000|STARTED|Second Intervention (1 Day)||17||
60104549|NCT01871285|76223083|FG001|STARTED|Second Intervention (1 Day)||14||
59995893|NCT02646891|76111821|FG008|COMPLETED|Overall Study||130||
60104550|NCT01871285|76223084|FG002|STARTED|Second Intervention (1 Day)||3||
59566088|NCT03403725|75668545|FG009|STARTED|Overall Study||4||
59995894|NCT02646891|76111822|FG009|COMPLETED|Overall Study||134||
60104551|NCT01871285|76223085|FG003|STARTED|Second Intervention (1 Day)||2||
60104552|NCT01871285|76223082|FG000|COMPLETED|Second Intervention (1 Day)||17||
60104553|NCT01871285|76223083|FG001|COMPLETED|Second Intervention (1 Day)||14||
60104554|NCT01871285|76223084|FG002|COMPLETED|Second Intervention (1 Day)||3||
60104555|NCT01871285|76223085|FG003|COMPLETED|Second Intervention (1 Day)||2||
59817987|NCT04488770|75940335|FG009|NOT COMPLETED|Part 1-Cohort 2: Period 3 (Up to 5 Days)||0||
60104556|NCT01871285|76223082|FG000|NOT COMPLETED|Second Intervention (1 Day)||0||
60104557|NCT01871285|76223083|FG001|NOT COMPLETED|Second Intervention (1 Day)||0||
60104558|NCT01871285|76223084|FG002|NOT COMPLETED|Second Intervention (1 Day)||0||
60104559|NCT01871285|76223085|FG003|NOT COMPLETED|Second Intervention (1 Day)||0||
60104560|NCT01358266|76223098|FG000|STARTED|Double-Masked Period||208||
60104561|NCT01358266|76223099|FG001|STARTED|Double-Masked Period||208||
60104562|NCT01358266|76223100|FG002|STARTED|Double-Masked Period||176||
60104563|NCT01358266|76223098|FG000|COMPLETED|Double-Masked Period||175||
60104564|NCT01358266|76223099|FG001|COMPLETED|Double-Masked Period||162||
60104565|NCT01358266|76223100|FG002|COMPLETED|Double-Masked Period||137||
60104566|NCT01358266|76223098|FG000|NOT COMPLETED|Double-Masked Period||33||
60104567|NCT01358266|76223099|FG001|NOT COMPLETED|Double-Masked Period||46||
59817988|NCT04488770|75940336|FG010|NOT COMPLETED|Part 1-Cohort 2: Period 3 (Up to 5 Days)||0||
59817989|NCT04488770|75940337|FG011|NOT COMPLETED|Part 1-Cohort 2: Period 3 (Up to 5 Days)||0||
59817990|NCT04488770|75940338|FG012|NOT COMPLETED|Part 1-Cohort 2: Period 3 (Up to 5 Days)||0||
59817991|NCT04488770|75940326|FG000|STARTED|Part 2 (Up to 26 Days)||0||
59817992|NCT04488770|75940327|FG001|STARTED|Part 2 (Up to 26 Days)||0||
59817993|NCT04488770|75940328|FG002|STARTED|Part 2 (Up to 26 Days)||0||
59995895|NCT02646891|76111813|FG000|NOT COMPLETED|Overall Study||2||
59995896|NCT02646891|76111814|FG001|NOT COMPLETED|Overall Study||1||
59995897|NCT02646891|76111815|FG002|NOT COMPLETED|Overall Study||1||
59995898|NCT02646891|76111816|FG003|NOT COMPLETED|Overall Study||0||
59995899|NCT02646891|76111817|FG004|NOT COMPLETED|Overall Study||0||
59995900|NCT02646891|76111818|FG005|NOT COMPLETED|Overall Study||0||
59995901|NCT02646891|76111819|FG006|NOT COMPLETED|Overall Study||9||
59995902|NCT02646891|76111820|FG007|NOT COMPLETED|Overall Study||13||
59995903|NCT02646891|76111821|FG008|NOT COMPLETED|Overall Study||10||
59995904|NCT02646891|76111822|FG009|NOT COMPLETED|Overall Study||5||
59995905|NCT02646423|76111858|FG000|STARTED|Overall Study||742||
59995906|NCT02646423|76111859|FG001|STARTED|Overall Study||743||
59995907|NCT02646423|76111858|FG000|COMPLETED|Overall Study||735||
59995908|NCT02646423|76111859|FG001|COMPLETED|Overall Study||735||
59995909|NCT02646423|76111858|FG000|NOT COMPLETED|Overall Study||7||
59995910|NCT02646423|76111859|FG001|NOT COMPLETED|Overall Study||8||
59995911|NCT01876953|76111867|FG000|STARTED|Overall Study||17||
59995912|NCT01876953|76111868|FG001|STARTED|Overall Study||3||
59995913|NCT01876953|76111867|FG000|COMPLETED|Overall Study||17||
59995914|NCT01876953|76111868|FG001|COMPLETED|Overall Study||3||
59817994|NCT04488770|75940329|FG003|STARTED|Part 2 (Up to 26 Days)||0||
59817995|NCT04488770|75940330|FG004|STARTED|Part 2 (Up to 26 Days)||0||
59817996|NCT04488770|75940331|FG005|STARTED|Part 2 (Up to 26 Days)||0||
59817997|NCT04488770|75940332|FG006|STARTED|Part 2 (Up to 26 Days)||0||
59995915|NCT01876953|76111867|FG000|NOT COMPLETED|Overall Study||0||
59995916|NCT01876953|76111868|FG001|NOT COMPLETED|Overall Study||0||
59995917|NCT04493281|76111876|FG000|STARTED|Period 1||21||
59995918|NCT04493281|76111877|FG001|STARTED|Period 1||21||
59995919|NCT04493281|76111876|FG000|COMPLETED|Period 1||21||
59995920|NCT04493281|76111877|FG001|COMPLETED|Period 1||21||
60104568|NCT01358266|76223100|FG002|NOT COMPLETED|Double-Masked Period||39||
60104569|NCT01358266|76223098|FG000|STARTED|Open-Label Period||119||
60104570|NCT01358266|76223099|FG001|STARTED|Open-Label Period||102||
60104571|NCT01358266|76223100|FG002|STARTED|Open-Label Period||114||
60104572|NCT01358266|76223098|FG000|COMPLETED|Open-Label Period||63||
60104573|NCT01358266|76223099|FG001|COMPLETED|Open-Label Period||58||
60104574|NCT01358266|76223100|FG002|COMPLETED|Open-Label Period||44||
60104575|NCT01358266|76223098|FG000|NOT COMPLETED|Open-Label Period||56||
60104576|NCT01358266|76223099|FG001|NOT COMPLETED|Open-Label Period||44||
60104577|NCT01358266|76223100|FG002|NOT COMPLETED|Open-Label Period||70||
60104578|NCT01870973|76223111|FG000|STARTED|Overall Study||56||
59995921|NCT04493281|76111876|FG000|NOT COMPLETED|Period 1||0||
59995922|NCT04493281|76111877|FG001|NOT COMPLETED|Period 1||0||
59995923|NCT04493281|76111876|FG000|STARTED|Period 2||21||
59995924|NCT04493281|76111877|FG001|STARTED|Period 2||21||
60104579|NCT01870973|76223112|FG001|STARTED|Overall Study||52||
59995925|NCT04493281|76111876|FG000|COMPLETED|Period 2||21||
60104580|NCT01870973|76223111|FG000|COMPLETED|Overall Study||46||
60104581|NCT01870973|76223112|FG001|COMPLETED|Overall Study||49||
60104582|NCT01870973|76223111|FG000|NOT COMPLETED|Overall Study||10||
60104583|NCT01870973|76223112|FG001|NOT COMPLETED|Overall Study||3||
60104584|NCT01267864|76223121|FG000|STARTED|Overall Study||110||
60104585|NCT01267864|76223122|FG001|STARTED|Overall Study||110||
60104586|NCT01267864|76223123|FG002|STARTED|Overall Study||110||
60104587|NCT01267864|76223121|FG000|COMPLETED|Overall Study||110||
60104588|NCT01267864|76223122|FG001|COMPLETED|Overall Study||110||
60104589|NCT01267864|76223123|FG002|COMPLETED|Overall Study||110||
59710086|NCT01072929|75828650|FG000|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|196||
59710087|NCT01072929|75828651|FG001|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|197||
59710088|NCT01072929|75828652|FG002|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|31||
59710089|NCT01072929|75828650|FG000|COMPLETED|Overall Study||155||
59710090|NCT01072929|75828651|FG001|COMPLETED|Overall Study||150||
59710091|NCT01072929|75828652|FG002|COMPLETED|Overall Study||24||
59710092|NCT01072929|75828650|FG000|NOT COMPLETED|Overall Study||44||
59710093|NCT01072929|75828651|FG001|NOT COMPLETED|Overall Study||51||
59710094|NCT01072929|75828652|FG002|NOT COMPLETED|Overall Study||9||
59710095|NCT01231607|75828666|FG000|STARTED|Overall Study||185||
59995926|NCT04493281|76111877|FG001|COMPLETED|Period 2||21||
59995927|NCT04493281|76111876|FG000|NOT COMPLETED|Period 2||0||
59995928|NCT04493281|76111877|FG001|NOT COMPLETED|Period 2||0||
59995929|NCT01764711|76111886|FG000|STARTED|Overall Study||8||
59995930|NCT01764711|76111887|FG001|STARTED|Overall Study||5||
59995931|NCT01764711|76111886|FG000|COMPLETED|Overall Study||8||
59995932|NCT01764711|76111887|FG001|COMPLETED|Overall Study||5||
59995933|NCT01764711|76111886|FG000|NOT COMPLETED|Overall Study||0||
59995934|NCT01764711|76111887|FG001|NOT COMPLETED|Overall Study||0||
59995935|NCT02647359|76111895|FG000|STARTED|Stage 1: Double-Masked Period (48 Weeks)||26||
59995936|NCT02647359|76111896|FG001|STARTED|Stage 1: Double-Masked Period (48 Weeks)||13||
59995937|NCT02647359|76111895|FG000|Received at Least 1 Dose of Study Drug|Stage 1: Double-Masked Period (48 Weeks)||26||
59995938|NCT02647359|76111896|FG001|Received at Least 1 Dose of Study Drug|Stage 1: Double-Masked Period (48 Weeks)||13||
59995939|NCT02647359|76111895|FG000|COMPLETED|Stage 1: Double-Masked Period (48 Weeks)||22||
60104590|NCT01267864|76223121|FG000|NOT COMPLETED|Overall Study||0||
59995940|NCT02647359|76111896|FG001|COMPLETED|Stage 1: Double-Masked Period (48 Weeks)||12||
60104591|NCT01267864|76223122|FG001|NOT COMPLETED|Overall Study||0||
59566089|NCT03403725|75668546|FG010|STARTED|Overall Study||1||
59710096|NCT01231607|75828667|FG001|STARTED|Overall Study||188||
59710097|NCT01231607|75828668|FG002|STARTED|Overall Study||184||
59710098|NCT01231607|75828669|FG003|STARTED|Overall Study||179||
59710099|NCT01231607|75828670|FG004|STARTED|Overall Study||181||
59710100|NCT01231607|75828666|FG000|COMPLETED|Overall Study||156||
59710101|NCT01231607|75828667|FG001|COMPLETED|Overall Study||154||
59710102|NCT01231607|75828668|FG002|COMPLETED|Overall Study||153||
59710103|NCT01231607|75828669|FG003|COMPLETED|Overall Study||141||
59710104|NCT01231607|75828670|FG004|COMPLETED|Overall Study||157||
59710105|NCT01231607|75828666|FG000|NOT COMPLETED|Overall Study||29||
59710106|NCT01231607|75828667|FG001|NOT COMPLETED|Overall Study||34||
59710107|NCT01231607|75828668|FG002|NOT COMPLETED|Overall Study||31||
60104592|NCT01267864|76223123|FG002|NOT COMPLETED|Overall Study||0||
60104593|NCT01854827|76223131|FG000|STARTED|Overall Study||30||
60104594|NCT01854827|76223131|FG000|COMPLETED|Overall Study||29||
60104595|NCT01854827|76223131|FG000|NOT COMPLETED|Overall Study||1||
60104596|NCT02196688|76223137|FG000|STARTED|Overall Study||47||
60104597|NCT02196688|76223138|FG001|STARTED|Overall Study||24||
60104598|NCT02196688|76223137|FG000|COMPLETED|Overall Study||40||
60104599|NCT02196688|76223138|FG001|COMPLETED|Overall Study||23||
60104600|NCT02196688|76223137|FG000|NOT COMPLETED|Overall Study||7||
60104601|NCT02196688|76223138|FG001|NOT COMPLETED|Overall Study||1||
60104602|NCT01359748|76223148|FG000|STARTED|Overall Study||48||
60104603|NCT01359748|76223149|FG001|STARTED|Overall Study||20||
60104604|NCT01359748|76223150|FG002|STARTED|Overall Study||10||
60104605|NCT01359748|76223151|FG003|STARTED|Overall Study||11||
60104606|NCT01359748|76223148|FG000|COMPLETED|Overall Study||48||
60104607|NCT01359748|76223149|FG001|COMPLETED|Overall Study||20||
60104608|NCT01359748|76223150|FG002|COMPLETED|Overall Study||10||
60104609|NCT01359748|76223151|FG003|COMPLETED|Overall Study||11||
60104610|NCT01359748|76223148|FG000|NOT COMPLETED|Overall Study||0||
60104611|NCT01359748|76223149|FG001|NOT COMPLETED|Overall Study||0||
60104612|NCT01359748|76223150|FG002|NOT COMPLETED|Overall Study||0||
59710108|NCT01231607|75828669|FG003|NOT COMPLETED|Overall Study||38||
59710109|NCT01231607|75828670|FG004|NOT COMPLETED|Overall Study||24||
59710110|NCT01231373|75828689|FG000|STARTED|Overall Study||59||
59710111|NCT01231373|75828690|FG001|STARTED|Overall Study||58||
59710112|NCT01231373|75828691|FG002|STARTED|Overall Study||60||
59710113|NCT01231373|75828692|FG003|STARTED|Overall Study||58||
59710114|NCT01231373|75828689|FG000|Patients Receiving Blinded Treatment|Overall Study||57||
59710115|NCT01231373|75828690|FG001|Patients Receiving Blinded Treatment|Overall Study||57||
59710116|NCT01231373|75828691|FG002|Patients Receiving Blinded Treatment|Overall Study||60||
59710117|NCT01231373|75828692|FG003|Patients Receiving Blinded Treatment|Overall Study||58||
59710118|NCT01231373|75828689|FG000|COMPLETED|Overall Study||56||
59710119|NCT01231373|75828690|FG001|COMPLETED|Overall Study||57||
59710120|NCT01231373|75828691|FG002|COMPLETED|Overall Study||60||
59710121|NCT01231373|75828692|FG003|COMPLETED|Overall Study||57||
60104613|NCT01359748|76223151|FG003|NOT COMPLETED|Overall Study||0||
60104614|NCT01360450|76223161|FG000|STARTED|Overall Study||6||
60104615|NCT01360450|76223162|FG001|STARTED|Overall Study||6||
60104616|NCT01360450|76223161|FG000|Completed Treatment|Overall Study||6||
59710122|NCT01231373|75828689|FG000|NOT COMPLETED|Overall Study||3||
60104617|NCT01360450|76223162|FG001|Completed Treatment|Overall Study||6||
60104618|NCT01360450|76223161|FG000|COMPLETED|Overall Study||6||
60104619|NCT01360450|76223162|FG001|COMPLETED|Overall Study||6||
60104620|NCT01360450|76223161|FG000|NOT COMPLETED|Overall Study||0||
60104621|NCT01360450|76223162|FG001|NOT COMPLETED|Overall Study||0||
60104622|NCT01268644|76223169|FG000|STARTED|Baseline Period (Week 0)||8||
60104623|NCT01268644|76223169|FG000|COMPLETED|Baseline Period (Week 0)||8||
59710123|NCT01231373|75828690|FG001|NOT COMPLETED|Overall Study||1||
59710124|NCT01231373|75828691|FG002|NOT COMPLETED|Overall Study||0||
60104624|NCT01268644|76223169|FG000|NOT COMPLETED|Baseline Period (Week 0)||0||
60104625|NCT01268644|76223169|FG000|STARTED|Phase A (Weeks 0-12) Leptin Therapy||8||
60104626|NCT01268644|76223169|FG000|COMPLETED|Phase A (Weeks 0-12) Leptin Therapy||8||
60104627|NCT01268644|76223169|FG000|NOT COMPLETED|Phase A (Weeks 0-12) Leptin Therapy||0||
60104628|NCT01268644|76223169|FG000|STARTED|Phase B (Weeks 12-20) Leptin Therapy|One subject withdrew after 12 weeks .|7||
60104629|NCT01268644|76223169|FG000|COMPLETED|Phase B (Weeks 12-20) Leptin Therapy||7||
60104630|NCT01268644|76223169|FG000|NOT COMPLETED|Phase B (Weeks 12-20) Leptin Therapy||0||
60104631|NCT01268644|76223169|FG000|STARTED|Phase C (Weeks 20-24) Off Leptin Therapy||7||
60104632|NCT01268644|76223169|FG000|COMPLETED|Phase C (Weeks 20-24) Off Leptin Therapy||7||
60104633|NCT01268644|76223169|FG000|NOT COMPLETED|Phase C (Weeks 20-24) Off Leptin Therapy||0||
60104634|NCT01303744|76223180|FG000|STARTED|Overall Study||24||
60104635|NCT01303744|76223181|FG001|STARTED|Overall Study||24||
60104636|NCT01303744|76223182|FG002|STARTED|Overall Study||24||
60104637|NCT01303744|76223183|FG003|STARTED|Overall Study||24||
60104638|NCT01303744|76223180|FG000|COMPLETED|Overall Study||24||
60104639|NCT01303744|76223181|FG001|COMPLETED|Overall Study||24||
60104640|NCT01303744|76223182|FG002|COMPLETED|Overall Study||24||
60104641|NCT01303744|76223183|FG003|COMPLETED|Overall Study||24||
60104642|NCT01303744|76223180|FG000|NOT COMPLETED|Overall Study||0||
60104643|NCT01303744|76223181|FG001|NOT COMPLETED|Overall Study||0||
60104644|NCT01303744|76223182|FG002|NOT COMPLETED|Overall Study||0||
60104645|NCT01303744|76223183|FG003|NOT COMPLETED|Overall Study||0||
60104646|NCT01361620|76223193|FG000|STARTED|Overall Study||132||
60104647|NCT01361620|76223193|FG000|COMPLETED|Overall Study||132||
60104648|NCT01361620|76223193|FG000|NOT COMPLETED|Overall Study||0||
60104649|NCT01361854|76223197|FG000|STARTED|Day 1||51||
60104650|NCT01361854|76223198|FG001|STARTED|Day 1||51||
60104651|NCT01361854|76223197|FG000|COMPLETED|Day 1||47||
60104652|NCT01361854|76223198|FG001|COMPLETED|Day 1||48||
60104653|NCT01361854|76223197|FG000|NOT COMPLETED|Day 1||4||
60104654|NCT01361854|76223198|FG001|NOT COMPLETED|Day 1||3||
60104655|NCT01361854|76223197|FG000|STARTED|Wash-out, Maximum 2 Weeks||47||
60104656|NCT01361854|76223198|FG001|STARTED|Wash-out, Maximum 2 Weeks||48||
60104657|NCT01361854|76223197|FG000|COMPLETED|Wash-out, Maximum 2 Weeks||47||
60104658|NCT01361854|76223198|FG001|COMPLETED|Wash-out, Maximum 2 Weeks||48||
60104659|NCT01361854|76223197|FG000|NOT COMPLETED|Wash-out, Maximum 2 Weeks||0||
60104660|NCT01361854|76223198|FG001|NOT COMPLETED|Wash-out, Maximum 2 Weeks||0||
60104661|NCT01361854|76223197|FG000|STARTED|Second Intervention||47||
60104662|NCT01361854|76223198|FG001|STARTED|Second Intervention||48||
59566090|NCT03403725|75668536|FG000|COMPLETED|Overall Study||1||
59566091|NCT03403725|75668537|FG001|COMPLETED|Overall Study||1||
59566092|NCT03403725|75668538|FG002|COMPLETED|Overall Study||1||
59995941|NCT02647359|76111895|FG000|NOT COMPLETED|Stage 1: Double-Masked Period (48 Weeks)||4||
59995942|NCT02647359|76111896|FG001|NOT COMPLETED|Stage 1: Double-Masked Period (48 Weeks)||1||
59995943|NCT02647359|76111895|FG000|STARTED|Stage 2: Open-Label Extension (96 Weeks)||22||
59995944|NCT02647359|76111896|FG001|STARTED|Stage 2: Open-Label Extension (96 Weeks)|1 participant completed Stage 1 but did not enter open-label part|11||
59995945|NCT02647359|76111895|FG000|COMPLETED|Stage 2: Open-Label Extension (96 Weeks)||12||
59995946|NCT02647359|76111896|FG001|COMPLETED|Stage 2: Open-Label Extension (96 Weeks)||7||
59995947|NCT02647359|76111895|FG000|NOT COMPLETED|Stage 2: Open-Label Extension (96 Weeks)||10||
59995948|NCT02647359|76111896|FG001|NOT COMPLETED|Stage 2: Open-Label Extension (96 Weeks)||4||
59995949|NCT02647359|76111895|FG000|STARTED|Open-Label Sub-Study (96 Weeks)|2 participants completed open-label 144-weeks but did not enter open-label sub-study|10||
59995950|NCT02647359|76111896|FG001|STARTED|Open-Label Sub-Study (96 Weeks)||7||
60104663|NCT01361854|76223197|FG000|COMPLETED|Second Intervention||47||
60104664|NCT01361854|76223198|FG001|COMPLETED|Second Intervention||48||
60104665|NCT01361854|76223197|FG000|NOT COMPLETED|Second Intervention||0||
60104666|NCT01361854|76223198|FG001|NOT COMPLETED|Second Intervention||0||
60104667|NCT01269736|76223206|FG000|STARTED|Nurses' Knowledge Assessments|873 unique nurses were assessed at 9 hospitals at the initiation of the study.|1585||9
60104668|NCT01269736|76223207|FG001|STARTED|Nurses' Knowledge Assessments|866 unique nurses were assessed at 8 hospitals at the initiation of the study.|1428||8
60104669|NCT01269736|76223206|FG000|Baseline Assessment|Nurses' Knowledge Assessments|873 unique nurses, assessed at 9 hospitals.|873||9
60104670|NCT01269736|76223207|FG001|Baseline Assessment|Nurses' Knowledge Assessments|866 unique nurses, assessed at 8 hospitals.|866||8
60104671|NCT01269736|76223206|FG000|15 Months Assessment|Nurses' Knowledge Assessments|1108 unique nurses, assessed at 9 hospitals.|1108||9
60104672|NCT01269736|76223207|FG001|15 Months Assessment|Nurses' Knowledge Assessments|866 unique nurses, assessed at 8 hospitals.|782||8
60104673|NCT01269736|76223206|FG000|30 Months Assessment|Nurses' Knowledge Assessments|741 unique nurses, assessed at 8 hospitals.|741||8
60104674|NCT01269736|76223207|FG001|30 Months Assessment|Nurses' Knowledge Assessments|926 unique nurses, assessed at 8 hospitals.|926||8
60104675|NCT01269736|76223206|FG000|COMPLETED|Nurses' Knowledge Assessments|1585 unique nurses assessed overall (at any time point) by end of study.|1585||8
60104676|NCT01269736|76223207|FG001|COMPLETED|Nurses' Knowledge Assessments|1428 unique nurses assessed overall (at any time point) by end of study.|1428||8
60104677|NCT01269736|76223206|FG000|NOT COMPLETED|Nurses' Knowledge Assessments||0||1
60104678|NCT01269736|76223207|FG001|NOT COMPLETED|Nurses' Knowledge Assessments||0||0
60104679|NCT01269736|76223206|FG000|STARTED|Patient Quality of Care Assessments|915 unique patients were assessed at 9 hospitals at the initiation of the study.|2299||9
60104680|NCT01269736|76223207|FG001|STARTED|Patient Quality of Care Assessments|889 unique patients were assessed at 8 hospitals at the initiation of the study.|2288||8
60104681|NCT01269736|76223206|FG000|Baseline Assessment|Patient Quality of Care Assessments|915 unique patients, assessed at 9 hospitals.|915||9
60104682|NCT01269736|76223207|FG001|Baseline Assessment|Patient Quality of Care Assessments|889 unique patients, assessed at 8 hospitals.|889||8
60104683|NCT01269736|76223206|FG000|15 Months Assessment|Patient Quality of Care Assessments|687 unique patients, assessed at 8 hospitals.|687||8
60104684|NCT01269736|76223207|FG001|15 Months Assessment|Patient Quality of Care Assessments|773 unique patients, assessed at 8 hospitals.|773||8
60104685|NCT01269736|76223206|FG000|30 Months Assessment|Patient Quality of Care Assessments|697 unique patients, assessed at 8 hospitals.|697||8
60104686|NCT01269736|76223207|FG001|30 Months Assessment|Patient Quality of Care Assessments|626 unique patients, assessed at 7 hospitals.|626||7
60104687|NCT01269736|76223206|FG000|COMPLETED|Patient Quality of Care Assessments|2299 unique patients assessed overall (at any time point) by end of study.|2299||8
60104688|NCT01269736|76223207|FG001|COMPLETED|Patient Quality of Care Assessments|2288 unique patients assessed overall (at any time point) by end of study.|2288||7
60104689|NCT01269736|76223206|FG000|NOT COMPLETED|Patient Quality of Care Assessments||0||1
60104690|NCT01269736|76223207|FG001|NOT COMPLETED|Patient Quality of Care Assessments||0||1
60104691|NCT01269736|76223206|FG000|STARTED|Patient Outcomes (Hospital Admissions)|17352 unique patients were assessed at 7 hospitals at the initiation of the study.|52085||7
60104692|NCT01269736|76223207|FG001|STARTED|Patient Outcomes (Hospital Admissions)|16459 unique patients were assessed at 6 hospitals at the initiation of the study.|43799||6
60104693|NCT01269736|76223206|FG000|Baseline Assessment|Patient Outcomes (Hospital Admissions)|17352 unique patients, assessed at 7 hospitals.|17352||7
60104694|NCT01269736|76223207|FG001|Baseline Assessment|Patient Outcomes (Hospital Admissions)|16549 unique patients, assessed at 6 hospitals.|16549||6
60104695|NCT01269736|76223206|FG000|15 Months Assessment|Patient Outcomes (Hospital Admissions)|18031 unique patients, assessed at 7 hospitals.|18031||7
60104696|NCT01269736|76223207|FG001|15 Months Assessment|Patient Outcomes (Hospital Admissions)|14075 unique patients, assessed at 6 hospitals.|14075||6
60104697|NCT01269736|76223206|FG000|30 Months Assessment|Patient Outcomes (Hospital Admissions)|16702 unique patients, assessed at 7 hospitals.|16702||7
60104698|NCT01269736|76223207|FG001|30 Months Assessment|Patient Outcomes (Hospital Admissions)|13265 unique patients, assessed at 6 hospitals.|13265||6
60104699|NCT01269736|76223206|FG000|COMPLETED|Patient Outcomes (Hospital Admissions)|52085 unique patients assessed overall (at any time point) by end of study.|52085||7
60104700|NCT01269736|76223207|FG001|COMPLETED|Patient Outcomes (Hospital Admissions)|43799 unique patients assessed overall (at any time point) by end of study.|43799||6
60104701|NCT01269736|76223206|FG000|NOT COMPLETED|Patient Outcomes (Hospital Admissions)||0||0
60104702|NCT01269736|76223207|FG001|NOT COMPLETED|Patient Outcomes (Hospital Admissions)||0||0
60104703|NCT01305772|76223217|FG000|STARTED|Overall Study||5||
60104704|NCT01305772|76223218|FG001|STARTED|Overall Study||1||
60104705|NCT01305772|76223217|FG000|Genomic Screening + Biopsy #1|Overall Study||5||
60104706|NCT01305772|76223218|FG001|Genomic Screening + Biopsy #1|Overall Study||1||
60104707|NCT01305772|76223217|FG000|Research PET/CT #1|Overall Study||5||
60104708|NCT01305772|76223218|FG001|Research PET/CT #1|Overall Study||1||
60104709|NCT01305772|76223217|FG000|Panitumumab Dose #1|Overall Study||5||
60104710|NCT01305772|76223218|FG001|Panitumumab Dose #1|Overall Study||1||
60104711|NCT01305772|76223217|FG000|Research PET/CT #2|Overall Study||5||
60104712|NCT01305772|76223218|FG001|Research PET/CT #2|Overall Study||1||
60104713|NCT01305772|76223217|FG000|Surgery/Biopsy #2|Overall Study|2nd research tissue sample not collected for 4 patients due to safety risk to subject.|1||
60104714|NCT01305772|76223218|FG001|Surgery/Biopsy #2|Overall Study||1||
60104715|NCT01305772|76223217|FG000|RT + Panitumumab Dose #2 / #3|Overall Study|RT and doses #2 and #3 of panitumumab administered to patients regardless of 2nd biopsy status.|5||
60104716|NCT01305772|76223218|FG001|RT + Panitumumab Dose #2 / #3|Overall Study||1||
60104717|NCT01305772|76223217|FG000|COMPLETED|Overall Study||5||
60104718|NCT01305772|76223218|FG001|COMPLETED|Overall Study||1||
60104719|NCT01305772|76223217|FG000|NOT COMPLETED|Overall Study||0||
60104720|NCT01305772|76223218|FG001|NOT COMPLETED|Overall Study||0||
60104721|NCT01270126|76223225|FG000|STARTED|Overall Study||12||
60104722|NCT01270126|76223226|FG001|STARTED|Overall Study||10||
60104723|NCT01270126|76223225|FG000|COMPLETED|Overall Study||12||
60104724|NCT01270126|76223226|FG001|COMPLETED|Overall Study||10||
60104725|NCT01270126|76223225|FG000|NOT COMPLETED|Overall Study||0||
60104726|NCT01270126|76223226|FG001|NOT COMPLETED|Overall Study||0||
60104727|NCT01270516|76223236|FG000|STARTED|Overall Study||20||
60104728|NCT01270516|76223237|FG001|STARTED|Overall Study||17||
60104729|NCT01270516|76223238|FG002|STARTED|Overall Study||18||
60104730|NCT01270516|76223239|FG003|STARTED|Overall Study||18||
60104731|NCT01270516|76223236|FG000|COMPLETED|Overall Study||17||
60104732|NCT01270516|76223237|FG001|COMPLETED|Overall Study||13||
60104733|NCT01270516|76223238|FG002|COMPLETED|Overall Study||13||
60104734|NCT01270516|76223239|FG003|COMPLETED|Overall Study||13||
60104735|NCT01270516|76223236|FG000|NOT COMPLETED|Overall Study||3||
60104736|NCT01270516|76223237|FG001|NOT COMPLETED|Overall Study||4||
60104737|NCT01270516|76223238|FG002|NOT COMPLETED|Overall Study||5||
60104738|NCT01270516|76223239|FG003|NOT COMPLETED|Overall Study||5||
60104739|NCT01271452|76223251|FG000|STARTED|Overall Study||112||
60104740|NCT01271452|76223252|FG001|STARTED|Overall Study||112||
60104741|NCT01271452|76223251|FG000|COMPLETED|Overall Study||105||
60104742|NCT01271452|76223252|FG001|COMPLETED|Overall Study||104||
60104743|NCT01271452|76223251|FG000|NOT COMPLETED|Overall Study||7||
60104744|NCT01271452|76223252|FG001|NOT COMPLETED|Overall Study||8||
60104745|NCT01271686|76223258|FG000|STARTED|Overall Study||16||
60104746|NCT01271686|76223258|FG000|COMPLETED|Overall Study||16||
60104747|NCT01271686|76223258|FG000|NOT COMPLETED|Overall Study||0||
60104748|NCT01362946|76223262|FG000|STARTED|First Behavior Modification Block||24||
60104749|NCT01362946|76223263|FG001|STARTED|First Behavior Modification Block||24||
60104750|NCT01362946|76223262|FG000|COMPLETED|First Behavior Modification Block||24||
60104751|NCT01362946|76223263|FG001|COMPLETED|First Behavior Modification Block||24||
60104752|NCT01362946|76223262|FG000|NOT COMPLETED|First Behavior Modification Block||0||
60104753|NCT01362946|76223263|FG001|NOT COMPLETED|First Behavior Modification Block||0||
60104754|NCT01362946|76223262|FG000|STARTED|Second Behavior Modification Block|1 participant withdrew after last but before this treatment period - illness unrelated to study.|23||
60104755|NCT01362946|76223263|FG001|STARTED|Second Behavior Modification Block||24||
60104756|NCT01362946|76223262|FG000|COMPLETED|Second Behavior Modification Block||23||
60104757|NCT01362946|76223263|FG001|COMPLETED|Second Behavior Modification Block||24||
60104758|NCT01362946|76223262|FG000|NOT COMPLETED|Second Behavior Modification Block||0||
60104759|NCT01362946|76223263|FG001|NOT COMPLETED|Second Behavior Modification Block||0||
60104760|NCT01854047|76223274|FG000|STARTED|Overall Study||158|Started = Randomized|
60104761|NCT01854047|76223275|FG001|STARTED|Overall Study||157|Started = Randomized|
60104762|NCT01854047|76223276|FG002|STARTED|Overall Study||150|Started = Randomized|
60104763|NCT01854047|76223277|FG003|STARTED|Overall Study||157|Started = Randomized|
60104764|NCT01854047|76223278|FG004|STARTED|Overall Study||154|Started = Randomized|
60104765|NCT01854047|76223274|FG000|Treated|Overall Study||158||
60104766|NCT01854047|76223275|FG001|Treated|Overall Study||156||
60104767|NCT01854047|76223276|FG002|Treated|Overall Study||148||
60104768|NCT01854047|76223277|FG003|Treated|Overall Study||157||
60104769|NCT01854047|76223278|FG004|Treated|Overall Study||150||
60104770|NCT01854047|76223274|FG000|Completed 12-week Study Treatment|Overall Study||153||
60104771|NCT01854047|76223275|FG001|Completed 12-week Study Treatment|Overall Study||149||
60104772|NCT01854047|76223276|FG002|Completed 12-week Study Treatment|Overall Study||141||
60104773|NCT01854047|76223277|FG003|Completed 12-week Study Treatment|Overall Study||146||
60104774|NCT01854047|76223278|FG004|Completed 12-week Study Treatment|Overall Study||143||
60104775|NCT01854047|76223274|FG000|COMPLETED|Overall Study||146|Completed = Completed study treatment period.|
60104776|NCT01854047|76223275|FG001|COMPLETED|Overall Study||149|Completed = Completed study treatment period.|
60104777|NCT01854047|76223276|FG002|COMPLETED|Overall Study||137|Completed = Completed study treatment period.|
60104778|NCT01854047|76223277|FG003|COMPLETED|Overall Study||142|Completed = Completed study treatment period.|
60104779|NCT01854047|76223278|FG004|COMPLETED|Overall Study||135|Completed = Completed study treatment period.|
60104780|NCT01854047|76223274|FG000|NOT COMPLETED|Overall Study||12||
60104781|NCT01854047|76223275|FG001|NOT COMPLETED|Overall Study||8||
60104782|NCT01854047|76223276|FG002|NOT COMPLETED|Overall Study||13||
60104783|NCT01854047|76223277|FG003|NOT COMPLETED|Overall Study||15||
60104784|NCT01854047|76223278|FG004|NOT COMPLETED|Overall Study||19||
60104785|NCT01363258|76223292|FG000|STARTED|Overall Study||54||
60104786|NCT01363258|76223293|FG001|STARTED|Overall Study||46||
60104787|NCT01363258|76223292|FG000|COMPLETED|Overall Study||54||
60104788|NCT01363258|76223293|FG001|COMPLETED|Overall Study||46||
60104789|NCT01363258|76223292|FG000|NOT COMPLETED|Overall Study||0||
60104790|NCT01363258|76223293|FG001|NOT COMPLETED|Overall Study||0||
60104791|NCT01363492|76223299|FG000|STARTED|Overall Study||14||
60104792|NCT01363492|76223299|FG000|COMPLETED|Overall Study||14||
60104793|NCT01363492|76223299|FG000|NOT COMPLETED|Overall Study||0||
60104794|NCT01307098|76223308|FG000|STARTED|Overall Study||3||
60104795|NCT01307098|76223309|FG001|STARTED|Overall Study||3||
60104796|NCT01307098|76223310|FG002|STARTED|Overall Study||3||
60104797|NCT01307098|76223308|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3||
60104798|NCT01307098|76223309|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3||
60104799|NCT01307098|76223310|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3||
60104800|NCT01307098|76223308|FG000|COMPLETED|Overall Study||3||
60104801|NCT01307098|76223309|FG001|COMPLETED|Overall Study||3||
60104802|NCT01307098|76223310|FG002|COMPLETED|Overall Study||3||
60104803|NCT01307098|76223308|FG000|NOT COMPLETED|Overall Study||0||
60104804|NCT01307098|76223309|FG001|NOT COMPLETED|Overall Study||0||
60104805|NCT01307098|76223310|FG002|NOT COMPLETED|Overall Study||0||
60104806|NCT01272076|76223318|FG000|STARTED|Overall Study||52||
60104807|NCT01272076|76223318|FG000|COMPLETED|Overall Study||52||
60104808|NCT01272076|76223318|FG000|NOT COMPLETED|Overall Study||0||
60104809|NCT01870739|76223324|FG000|STARTED|Single Drug Treatment (12 Weeks)|"Start = Safety/Pharmacokinetic/Pharmacodynamic analysis set"|57||
60104810|NCT01870739|76223325|FG001|STARTED|Single Drug Treatment (12 Weeks)||57||
60104811|NCT01870739|76223324|FG000|Initiation Dose Completed|Single Drug Treatment (12 Weeks)||57||
60104812|NCT01870739|76223325|FG001|Initiation Dose Completed|Single Drug Treatment (12 Weeks)||56||
59710125|NCT01231373|75828692|FG003|NOT COMPLETED|Overall Study||1||
60104813|NCT01870739|76223324|FG000|Maintenance Dose Started|Single Drug Treatment (12 Weeks)||57||
60104814|NCT01870739|76223325|FG001|Maintenance Dose Started|Single Drug Treatment (12 Weeks)||56||
60104815|NCT01870739|76223324|FG000|COMPLETED|Single Drug Treatment (12 Weeks)|"Completed indicates maintenance dose complete"|54||
60104816|NCT01870739|76223325|FG001|COMPLETED|Single Drug Treatment (12 Weeks)||53||
60104817|NCT01870739|76223324|FG000|NOT COMPLETED|Single Drug Treatment (12 Weeks)||3||
60104818|NCT01870739|76223325|FG001|NOT COMPLETED|Single Drug Treatment (12 Weeks)||4||
60104819|NCT01870739|76223324|FG000|STARTED|Add-on Period (40 Weeks)||54||
59566093|NCT03403725|75668539|FG003|COMPLETED|Overall Study||1||
60104820|NCT01870739|76223325|FG001|STARTED|Add-on Period (40 Weeks)||53||
60104821|NCT01870739|76223324|FG000|COMPLETED|Add-on Period (40 Weeks)||51||
60104822|NCT01870739|76223325|FG001|COMPLETED|Add-on Period (40 Weeks)||51||
60104823|NCT01870739|76223324|FG000|NOT COMPLETED|Add-on Period (40 Weeks)||3||
60104824|NCT01870739|76223325|FG001|NOT COMPLETED|Add-on Period (40 Weeks)||2||
60104825|NCT01272388|76223343|FG000|STARTED|Overall Study||1||
60104826|NCT01272388|76223344|FG001|STARTED|Overall Study||0||
60104827|NCT01272388|76223343|FG000|COMPLETED|Overall Study||1||
60104828|NCT01272388|76223344|FG001|COMPLETED|Overall Study||0||
60104829|NCT01272388|76223343|FG000|NOT COMPLETED|Overall Study||0||
60104830|NCT01272388|76223344|FG001|NOT COMPLETED|Overall Study||0||
60104831|NCT01613417|76223352|FG000|STARTED|First Injection||113||
60104832|NCT01613417|76223353|FG001|STARTED|First Injection||116||
60104833|NCT01613417|76223352|FG000|COMPLETED|First Injection||113||
60104834|NCT01613417|76223353|FG001|COMPLETED|First Injection||116||
60104835|NCT01613417|76223352|FG000|NOT COMPLETED|First Injection||0||
60104836|NCT01613417|76223353|FG001|NOT COMPLETED|First Injection||0||
60104837|NCT01613417|76223352|FG000|STARTED|Washout (no Second Injection/MRI)||113||
60104838|NCT01613417|76223353|FG001|STARTED|Washout (no Second Injection/MRI)||116||
60104839|NCT01613417|76223352|FG000|COMPLETED|Washout (no Second Injection/MRI)||100||
60104840|NCT01613417|76223353|FG001|COMPLETED|Washout (no Second Injection/MRI)||109||
60104841|NCT01613417|76223352|FG000|NOT COMPLETED|Washout (no Second Injection/MRI)||13||
60104842|NCT01613417|76223353|FG001|NOT COMPLETED|Washout (no Second Injection/MRI)||7||
60104843|NCT01613417|76223352|FG000|STARTED|Second Injection||100||
60104844|NCT01613417|76223353|FG001|STARTED|Second Injection||109||
60104845|NCT01613417|76223352|FG000|COMPLETED|Second Injection||100||
60104846|NCT01613417|76223353|FG001|COMPLETED|Second Injection||109||
60104847|NCT01613417|76223352|FG000|NOT COMPLETED|Second Injection||0||
60104848|NCT01613417|76223353|FG001|NOT COMPLETED|Second Injection||0||
60104849|NCT01364740|76223369|FG000|STARTED|Overall Study||10||
60104850|NCT01364740|76223369|FG000|COMPLETED|Overall Study||10||
60104851|NCT01364740|76223369|FG000|NOT COMPLETED|Overall Study||0||
60104852|NCT01364896|76223374|FG000|STARTED|Overall Study||46||
60104853|NCT01364896|76223374|FG000|COMPLETED|Overall Study||46||
60104854|NCT01364896|76223374|FG000|NOT COMPLETED|Overall Study||0||
60104855|NCT01870583|76223381|FG000|STARTED|Overall Study||467||
60104856|NCT01870583|76223382|FG001|STARTED|Overall Study||474||
60104857|NCT01870583|76223383|FG002|STARTED|Overall Study||463||
60104858|NCT01870583|76223381|FG000|COMPLETED|Overall Study||456||
60104859|NCT01870583|76223382|FG001|COMPLETED|Overall Study||456||
60104860|NCT01870583|76223383|FG002|COMPLETED|Overall Study||455||
60104861|NCT01870583|76223381|FG000|NOT COMPLETED|Overall Study||11||
60104862|NCT01870583|76223382|FG001|NOT COMPLETED|Overall Study||18||
60104863|NCT01870583|76223383|FG002|NOT COMPLETED|Overall Study||8||
60104864|NCT01308814|76223393|FG000|STARTED|Overall Study||86||
60104865|NCT01308814|76223394|FG001|STARTED|Overall Study||86||
60104866|NCT01308814|76223393|FG000|COMPLETED|Overall Study||69||
60104867|NCT01308814|76223394|FG001|COMPLETED|Overall Study||63||
60104868|NCT01308814|76223393|FG000|NOT COMPLETED|Overall Study||17||
60104869|NCT01308814|76223394|FG001|NOT COMPLETED|Overall Study||23||
60104870|NCT01275586|76223400|FG000|STARTED|Overall Study||6||
59817998|NCT04488770|75940333|FG007|STARTED|Part 2 (Up to 26 Days)||0||
59817999|NCT04488770|75940334|FG008|STARTED|Part 2 (Up to 26 Days)||8||
59818000|NCT04488770|75940335|FG009|STARTED|Part 2 (Up to 26 Days)||8||
59818001|NCT04488770|75940336|FG010|STARTED|Part 2 (Up to 26 Days)||8||
59818002|NCT04488770|75940337|FG011|STARTED|Part 2 (Up to 26 Days)||8||
59818003|NCT04488770|75940338|FG012|STARTED|Part 2 (Up to 26 Days)||8||
59818004|NCT04488770|75940326|FG000|COMPLETED|Part 2 (Up to 26 Days)||0||
59818005|NCT04488770|75940327|FG001|COMPLETED|Part 2 (Up to 26 Days)||0||
59818006|NCT04488770|75940328|FG002|COMPLETED|Part 2 (Up to 26 Days)||0||
59818007|NCT04488770|75940329|FG003|COMPLETED|Part 2 (Up to 26 Days)||0||
59818008|NCT04488770|75940330|FG004|COMPLETED|Part 2 (Up to 26 Days)||0||
59818009|NCT04488770|75940331|FG005|COMPLETED|Part 2 (Up to 26 Days)||0||
59818010|NCT04488770|75940332|FG006|COMPLETED|Part 2 (Up to 26 Days)||0||
59818011|NCT04488770|75940333|FG007|COMPLETED|Part 2 (Up to 26 Days)||0||
59818012|NCT04488770|75940334|FG008|COMPLETED|Part 2 (Up to 26 Days)||8||
59818013|NCT04488770|75940335|FG009|COMPLETED|Part 2 (Up to 26 Days)||8||
59818014|NCT04488770|75940336|FG010|COMPLETED|Part 2 (Up to 26 Days)||8||
59818015|NCT04488770|75940337|FG011|COMPLETED|Part 2 (Up to 26 Days)||8||
59818016|NCT04488770|75940338|FG012|COMPLETED|Part 2 (Up to 26 Days)||8||
59818017|NCT04488770|75940326|FG000|NOT COMPLETED|Part 2 (Up to 26 Days)||0||
59818018|NCT04488770|75940327|FG001|NOT COMPLETED|Part 2 (Up to 26 Days)||0||
59818019|NCT04488770|75940328|FG002|NOT COMPLETED|Part 2 (Up to 26 Days)||0||
59818020|NCT04488770|75940329|FG003|NOT COMPLETED|Part 2 (Up to 26 Days)||0||
59818021|NCT04488770|75940330|FG004|NOT COMPLETED|Part 2 (Up to 26 Days)||0||
59818022|NCT04488770|75940331|FG005|NOT COMPLETED|Part 2 (Up to 26 Days)||0||
59818023|NCT04488770|75940332|FG006|NOT COMPLETED|Part 2 (Up to 26 Days)||0||
59818024|NCT04488770|75940333|FG007|NOT COMPLETED|Part 2 (Up to 26 Days)||0||
59818025|NCT04488770|75940334|FG008|NOT COMPLETED|Part 2 (Up to 26 Days)||0||
59818026|NCT04488770|75940335|FG009|NOT COMPLETED|Part 2 (Up to 26 Days)||0||
59818027|NCT04488770|75940336|FG010|NOT COMPLETED|Part 2 (Up to 26 Days)||0||
59995951|NCT02647359|76111895|FG000|COMPLETED|Open-Label Sub-Study (96 Weeks)||2||
59995952|NCT02647359|76111896|FG001|COMPLETED|Open-Label Sub-Study (96 Weeks)||3||
59995953|NCT02647359|76111895|FG000|NOT COMPLETED|Open-Label Sub-Study (96 Weeks)||8||
59995954|NCT02647359|76111896|FG001|NOT COMPLETED|Open-Label Sub-Study (96 Weeks)||4||
59995955|NCT02645409|76111908|FG000|STARTED|Overall Study||14||
59995956|NCT02645409|76111909|FG001|STARTED|Overall Study|It was decided to not continue with the Radical Nephrectomy arm of the study.|0||
59995957|NCT02645409|76111908|FG000|COMPLETED|Overall Study||10||
59995958|NCT02645409|76111909|FG001|COMPLETED|Overall Study||0||
59995959|NCT02645409|76111908|FG000|NOT COMPLETED|Overall Study||4||
59995960|NCT02645409|76111909|FG001|NOT COMPLETED|Overall Study||0||
59995961|NCT01597479|76111916|FG000|STARTED|Overall Study||26||
59995962|NCT01597479|76111917|FG001|STARTED|Overall Study||26||
59995963|NCT01597479|76111916|FG000|COMPLETED|Overall Study||24||
59995964|NCT01597479|76111917|FG001|COMPLETED|Overall Study||26||
59995965|NCT01597479|76111916|FG000|NOT COMPLETED|Overall Study||2||
59995966|NCT01597479|76111917|FG001|NOT COMPLETED|Overall Study||0||
59995967|NCT04248465|76111926|FG000|STARTED|Randomized-Controlled Period||255||
59995968|NCT04248465|76111927|FG001|STARTED|Randomized-Controlled Period||127||
59995969|NCT04248465|76111926|FG000|Received at Least 1 Dose of Study Drug|Randomized-Controlled Period||255||
59995970|NCT04248465|76111927|FG001|Received at Least 1 Dose of Study Drug|Randomized-Controlled Period||127||
59995971|NCT04248465|76111926|FG000|COMPLETED|Randomized-Controlled Period||15||
59995972|NCT04248465|76111927|FG001|COMPLETED|Randomized-Controlled Period||5||
59995973|NCT04248465|76111926|FG000|NOT COMPLETED|Randomized-Controlled Period||240||
59995974|NCT04248465|76111927|FG001|NOT COMPLETED|Randomized-Controlled Period||122||
59818028|NCT04488770|75940337|FG011|NOT COMPLETED|Part 2 (Up to 26 Days)||0||
59818029|NCT04488770|75940338|FG012|NOT COMPLETED|Part 2 (Up to 26 Days)||0||
59818030|NCT00525044|75940384|FG000|STARTED|Overall Study||124||
59818031|NCT00525044|75940385|FG001|STARTED|Overall Study||125||
59818032|NCT00525044|75940384|FG000|COMPLETED|Overall Study||124||
59818033|NCT00525044|75940385|FG001|COMPLETED|Overall Study||124||
59818034|NCT00525044|75940384|FG000|NOT COMPLETED|Overall Study||0||
59818035|NCT00525044|75940385|FG001|NOT COMPLETED|Overall Study||1||
59818036|NCT00355342|75940393|FG000|STARTED|Overall Study||94||
59818037|NCT00355342|75940394|FG001|STARTED|Overall Study||92||
59818038|NCT00355342|75940393|FG000|COMPLETED|Overall Study||55||
59818039|NCT00355342|75940394|FG001|COMPLETED|Overall Study||56||
59818040|NCT00355342|75940393|FG000|NOT COMPLETED|Overall Study||39||
59818041|NCT00355342|75940394|FG001|NOT COMPLETED|Overall Study||36||
59818042|NCT01573754|75940402|FG000|STARTED|Overall Study||16||
59818043|NCT01573754|75940403|FG001|STARTED|Overall Study||32||
59818044|NCT01573754|75940402|FG000|COMPLETED|Overall Study||13||
59818045|NCT01573754|75940403|FG001|COMPLETED|Overall Study||17||
59818046|NCT01573754|75940402|FG000|NOT COMPLETED|Overall Study||3||
59818047|NCT01573754|75940403|FG001|NOT COMPLETED|Overall Study||15||
59818048|NCT00355264|75940409|FG000|STARTED|Part 1 (2 Weeks)||12||
59818049|NCT00355264|75940409|FG000|COMPLETED|Part 1 (2 Weeks)||12||
59818050|NCT00355264|75940409|FG000|NOT COMPLETED|Part 1 (2 Weeks)||0||
59818051|NCT00355264|75940409|FG000|STARTED|Part 2 (8 Weeks)||12||
59818052|NCT00355264|75940409|FG000|COMPLETED|Part 2 (8 Weeks)||12||
60104871|NCT01275586|76223400|FG000|COMPLETED|Overall Study||3||
60104872|NCT01275586|76223400|FG000|NOT COMPLETED|Overall Study||3||
60104873|NCT01275664|76223404|FG000|STARTED|Overall Study||4||
60104874|NCT01275664|76223404|FG000|COMPLETED|Overall Study||4||
60104875|NCT01275664|76223404|FG000|NOT COMPLETED|Overall Study||0||
60104876|NCT02193490|76223410|FG000|STARTED|Overall Study||25||
60104877|NCT02193490|76223411|FG001|STARTED|Overall Study||22||
60104878|NCT02193490|76223410|FG000|COMPLETED|Overall Study||21||
60104879|NCT02193490|76223411|FG001|COMPLETED|Overall Study||20||
60104880|NCT02193490|76223410|FG000|NOT COMPLETED|Overall Study||4||
60104881|NCT02193490|76223411|FG001|NOT COMPLETED|Overall Study||2||
59566094|NCT03403725|75668540|FG004|COMPLETED|Overall Study||1||
59710126|NCT00975130|75828704|FG000|STARTED|Study Part 1||3366||
59710127|NCT00975130|75828705|FG001|STARTED|Study Part 1||0||
60104882|NCT01367080|76223419|FG000|STARTED|1st Administration||6||
60104883|NCT01367080|76223420|FG001|STARTED|1st Administration||6||
60104884|NCT01367080|76223419|FG000|COMPLETED|1st Administration||6||
60104885|NCT01367080|76223420|FG001|COMPLETED|1st Administration||6||
60104886|NCT01367080|76223419|FG000|NOT COMPLETED|1st Administration||0||
60104887|NCT01367080|76223420|FG001|NOT COMPLETED|1st Administration||0||
60104888|NCT01367080|76223419|FG000|STARTED|2nd Administration||6||
60104889|NCT01367080|76223420|FG001|STARTED|2nd Administration||6||
60104890|NCT01367080|76223419|FG000|COMPLETED|2nd Administration||6||
60104891|NCT01367080|76223420|FG001|COMPLETED|2nd Administration||6||
60104892|NCT01367080|76223419|FG000|NOT COMPLETED|2nd Administration||0||
60104893|NCT01367080|76223420|FG001|NOT COMPLETED|2nd Administration||0||
60104894|NCT01367860|76223430|FG000|STARTED|Overall Study||20||
60104895|NCT01367860|76223431|FG001|STARTED|Overall Study||20||
59710128|NCT00975130|75828706|FG002|STARTED|Study Part 1||0||
60104896|NCT01367860|76223430|FG000|COMPLETED|Overall Study||20||
60104897|NCT01367860|76223431|FG001|COMPLETED|Overall Study||20||
60104898|NCT01367860|76223430|FG000|NOT COMPLETED|Overall Study||0||
60104899|NCT01367860|76223431|FG001|NOT COMPLETED|Overall Study||0||
60104900|NCT01869959|76223441|FG000|STARTED|Randomization Period||0||
60104901|NCT01869959|76223442|FG001|STARTED|Randomization Period||0||
60104902|NCT01869959|76223443|FG002|STARTED|Randomization Period||0||
60104903|NCT01869959|76223444|FG003|STARTED|Randomization Period||0||
60104904|NCT01869959|76223445|FG004|STARTED|Randomization Period||47||
60104905|NCT01869959|76223441|FG000|COMPLETED|Randomization Period||0||
60104906|NCT01869959|76223442|FG001|COMPLETED|Randomization Period||0||
60104907|NCT01869959|76223443|FG002|COMPLETED|Randomization Period||0||
60104908|NCT01869959|76223444|FG003|COMPLETED|Randomization Period||0||
60104909|NCT01869959|76223445|FG004|COMPLETED|Randomization Period|One participant discontinued after randomization but did not receive study drug.|46||
60104910|NCT01869959|76223441|FG000|NOT COMPLETED|Randomization Period||0||
60104911|NCT01869959|76223442|FG001|NOT COMPLETED|Randomization Period||0||
60104912|NCT01869959|76223443|FG002|NOT COMPLETED|Randomization Period||0||
60104913|NCT01869959|76223444|FG003|NOT COMPLETED|Randomization Period||0||
59710129|NCT00975130|75828704|FG000|COMPLETED|Study Part 1||3086||
59710130|NCT00975130|75828705|FG001|COMPLETED|Study Part 1||0||
59710131|NCT00975130|75828706|FG002|COMPLETED|Study Part 1||0||
59710132|NCT00975130|75828704|FG000|NOT COMPLETED|Study Part 1||280||
59710133|NCT00975130|75828705|FG001|NOT COMPLETED|Study Part 1||0||
59710134|NCT00975130|75828706|FG002|NOT COMPLETED|Study Part 1||0||
59710135|NCT00975130|75828704|FG000|STARTED|Study Part 2||0||
59995975|NCT04248465|76111926|FG000|STARTED|Open-label Extension Period||14||
59995976|NCT04248465|76111927|FG001|STARTED|Open-label Extension Period||5||
59710136|NCT00975130|75828705|FG001|STARTED|Study Part 2|Good/moderate responders without remission at the end of Part 1 were invited to enroll in Part 2.|250||
59995977|NCT04248465|76111926|FG000|Received at Least 1 Dose of Study Drug|Open-label Extension Period||14||
59995978|NCT04248465|76111927|FG001|Received at Least 1 Dose of Study Drug|Open-label Extension Period||5||
59995979|NCT04248465|76111926|FG000|COMPLETED|Open-label Extension Period||0||
59995980|NCT04248465|76111927|FG001|COMPLETED|Open-label Extension Period||0||
59995981|NCT04248465|76111926|FG000|NOT COMPLETED|Open-label Extension Period||14||
59995982|NCT04248465|76111927|FG001|NOT COMPLETED|Open-label Extension Period||5||
59995983|NCT02643693|76111935|FG000|STARTED|Overall Study||4||
59995984|NCT02643693|76111936|FG001|STARTED|Overall Study||4||
59995985|NCT02643693|76111937|FG002|STARTED|Overall Study||4||
59995986|NCT02643693|76111938|FG003|STARTED|Overall Study||4||
59995987|NCT02643693|76111939|FG004|STARTED|Overall Study||4||
59995988|NCT02643693|76111940|FG005|STARTED|Overall Study||4||
59995989|NCT02643693|76111935|FG000|COMPLETED|Overall Study||2||
59995990|NCT02643693|76111936|FG001|COMPLETED|Overall Study||2||
59995991|NCT02643693|76111937|FG002|COMPLETED|Overall Study||3||
59995992|NCT02643693|76111938|FG003|COMPLETED|Overall Study||4||
59995993|NCT02643693|76111939|FG004|COMPLETED|Overall Study||4||
60104914|NCT01869959|76223445|FG004|NOT COMPLETED|Randomization Period||1||
60104915|NCT01869959|76223441|FG000|STARTED|Treatment Period||11||
60104916|NCT01869959|76223442|FG001|STARTED|Treatment Period||10||
60104917|NCT01869959|76223443|FG002|STARTED|Treatment Period||15||
60104918|NCT01869959|76223444|FG003|STARTED|Treatment Period||10||
60104919|NCT01869959|76223445|FG004|STARTED|Treatment Period|Participants were randomized to treatment groups for the Treatment Period.|0||
60104920|NCT01869959|76223441|FG000|Received at Least 1 Dose of Study Drug|Treatment Period||11||
60104921|NCT01869959|76223442|FG001|Received at Least 1 Dose of Study Drug|Treatment Period||10||
60104922|NCT01869959|76223443|FG002|Received at Least 1 Dose of Study Drug|Treatment Period||15||
60104923|NCT01869959|76223444|FG003|Received at Least 1 Dose of Study Drug|Treatment Period||10||
60104924|NCT01869959|76223445|FG004|Received at Least 1 Dose of Study Drug|Treatment Period||0||
60104925|NCT01869959|76223441|FG000|COMPLETED|Treatment Period||10||
60104926|NCT01869959|76223442|FG001|COMPLETED|Treatment Period||8||
60104927|NCT01869959|76223443|FG002|COMPLETED|Treatment Period||12||
60104928|NCT01869959|76223444|FG003|COMPLETED|Treatment Period||8||
60104929|NCT01869959|76223445|FG004|COMPLETED|Treatment Period||0||
60104930|NCT01869959|76223441|FG000|NOT COMPLETED|Treatment Period||1||
60104931|NCT01869959|76223442|FG001|NOT COMPLETED|Treatment Period||2||
60104932|NCT01869959|76223443|FG002|NOT COMPLETED|Treatment Period||3||
60104933|NCT01869959|76223444|FG003|NOT COMPLETED|Treatment Period||2||
60104934|NCT01869959|76223445|FG004|NOT COMPLETED|Treatment Period||0||
60104935|NCT01368874|76223458|FG000|STARTED|Overall Study||34||
60104936|NCT01368874|76223459|FG001|STARTED|Overall Study||5||
60104937|NCT01368874|76223460|FG002|STARTED|Overall Study||25||
60104938|NCT01368874|76223458|FG000|COMPLETED|Overall Study||31||
60104939|NCT01368874|76223459|FG001|COMPLETED|Overall Study||5||
60104940|NCT01368874|76223460|FG002|COMPLETED|Overall Study||24||
60104941|NCT01368874|76223458|FG000|NOT COMPLETED|Overall Study||3||
60104942|NCT01368874|76223459|FG001|NOT COMPLETED|Overall Study||0||
60104943|NCT01368874|76223460|FG002|NOT COMPLETED|Overall Study||1||
60104944|NCT01369030|76223502|FG000|STARTED|Overall Study||594||
60104945|NCT01369030|76223502|FG000|COMPLETED|Overall Study||554||
60104946|NCT01369030|76223502|FG000|NOT COMPLETED|Overall Study||40||
60104947|NCT01613027|76223506|FG000|STARTED|Overall Study||135||
60104948|NCT01613027|76223506|FG000|COMPLETED|Overall Study||127||
60104949|NCT01613027|76223506|FG000|NOT COMPLETED|Overall Study||8||
60104950|NCT01369108|76223510|FG000|STARTED|Overall Study|120 teeth|60||
60104951|NCT01369108|76223510|FG000|COMPLETED|Overall Study||49||
60104952|NCT01369108|76223510|FG000|NOT COMPLETED|Overall Study||11||
60104953|NCT01369732|76223517|FG000|STARTED|Overall Study||33||
60104954|NCT01369732|76223518|FG001|STARTED|Overall Study||33||
60104955|NCT01369732|76223517|FG000|COMPLETED|Overall Study||29||
60104956|NCT01369732|76223518|FG001|COMPLETED|Overall Study||31||
60104957|NCT01369732|76223517|FG000|NOT COMPLETED|Overall Study||4||
60104958|NCT01369732|76223518|FG001|NOT COMPLETED|Overall Study||2||
60104959|NCT01869725|76223524|FG000|STARTED|Overall Study||68||
60104960|NCT01869725|76223524|FG000|COMPLETED|Overall Study||64||
60104961|NCT01869725|76223524|FG000|NOT COMPLETED|Overall Study||4||
60104962|NCT01309360|76223531|FG000|STARTED|Overall Study||40||
60104963|NCT01309360|76223532|FG001|STARTED|Overall Study||40||
60104964|NCT01309360|76223533|FG002|STARTED|Overall Study||40||
60104965|NCT01309360|76223531|FG000|COMPLETED|Overall Study||40||
60104966|NCT01309360|76223532|FG001|COMPLETED|Overall Study||40||
60104967|NCT01309360|76223533|FG002|COMPLETED|Overall Study||40||
60104968|NCT01309360|76223531|FG000|NOT COMPLETED|Overall Study||0||
60104969|NCT01309360|76223532|FG001|NOT COMPLETED|Overall Study||0||
60104970|NCT01309360|76223533|FG002|NOT COMPLETED|Overall Study||0||
60104971|NCT01851863|76223545|FG000|STARTED|Overall Study||65||
60104972|NCT01851863|76223546|FG001|STARTED|Overall Study||66||
60104973|NCT01851863|76223547|FG002|STARTED|Overall Study||65||
60104974|NCT01851863|76223548|FG003|STARTED|Overall Study||66||
60104975|NCT01851863|76223545|FG000|COMPLETED|Overall Study||60||
60104976|NCT01851863|76223546|FG001|COMPLETED|Overall Study||57||
60104977|NCT01851863|76223547|FG002|COMPLETED|Overall Study||60||
60104978|NCT01851863|76223548|FG003|COMPLETED|Overall Study||63||
60104979|NCT01851863|76223545|FG000|NOT COMPLETED|Overall Study||5||
60104980|NCT01851863|76223546|FG001|NOT COMPLETED|Overall Study||9||
60104981|NCT01851863|76223547|FG002|NOT COMPLETED|Overall Study||5||
60104982|NCT01851863|76223548|FG003|NOT COMPLETED|Overall Study||3||
60104983|NCT01369888|76223565|FG000|STARTED|Overall Study||1||
60104984|NCT01369888|76223566|FG001|STARTED|Overall Study||2||
60104985|NCT01369888|76223567|FG002|STARTED|Overall Study||0||
60104986|NCT01369888|76223568|FG003|STARTED|Overall Study||0||
60104987|NCT01369888|76223565|FG000|COMPLETED|Overall Study||1||
60104988|NCT01369888|76223566|FG001|COMPLETED|Overall Study||2||
60104989|NCT01369888|76223567|FG002|COMPLETED|Overall Study||0||
60104990|NCT01369888|76223568|FG003|COMPLETED|Overall Study||0||
60104991|NCT01369888|76223565|FG000|NOT COMPLETED|Overall Study||0||
60104992|NCT01369888|76223566|FG001|NOT COMPLETED|Overall Study||0||
60104993|NCT01369888|76223567|FG002|NOT COMPLETED|Overall Study||0||
60104994|NCT01369888|76223568|FG003|NOT COMPLETED|Overall Study||0||
60104995|NCT01850615|76223576|FG000|STARTED|Overall Study||116||
60104996|NCT01850615|76223577|FG001|STARTED|Overall Study||120||
60104997|NCT01850615|76223576|FG000|Exposed|Overall Study||115||
60104998|NCT01850615|76223577|FG001|Exposed|Overall Study||120||
60104999|NCT01850615|76223576|FG000|COMPLETED|Overall Study||107||
60105000|NCT01850615|76223577|FG001|COMPLETED|Overall Study||115||
60105001|NCT01850615|76223576|FG000|NOT COMPLETED|Overall Study||9||
60105002|NCT01850615|76223577|FG001|NOT COMPLETED|Overall Study||5||
60105003|NCT02196766|76223583|FG000|STARTED|First Intervention (7 Days)||15||
60105004|NCT02196766|76223584|FG001|STARTED|First Intervention (7 Days)||15||
60105005|NCT02196766|76223583|FG000|COMPLETED|First Intervention (7 Days)||15||
60105006|NCT02196766|76223584|FG001|COMPLETED|First Intervention (7 Days)||15||
60105007|NCT02196766|76223583|FG000|NOT COMPLETED|First Intervention (7 Days)||0||
60105008|NCT02196766|76223584|FG001|NOT COMPLETED|First Intervention (7 Days)||0||
60105009|NCT02196766|76223583|FG000|STARTED|Second Intervention (7 Days)||15||
60105010|NCT02196766|76223584|FG001|STARTED|Second Intervention (7 Days)||15||
60105011|NCT02196766|76223583|FG000|COMPLETED|Second Intervention (7 Days)||15||
60105012|NCT02196766|76223584|FG001|COMPLETED|Second Intervention (7 Days)||15||
60105013|NCT02196766|76223583|FG000|NOT COMPLETED|Second Intervention (7 Days)||0||
60105014|NCT02196766|76223584|FG001|NOT COMPLETED|Second Intervention (7 Days)||0||
60105015|NCT01309906|76223590|FG000|STARTED|Overall Study||33||
60105016|NCT01309906|76223591|FG001|STARTED|Overall Study||33||
60105017|NCT01309906|76223590|FG000|COMPLETED|Overall Study||32||
60105018|NCT01309906|76223591|FG001|COMPLETED|Overall Study||32||
60105019|NCT01309906|76223590|FG000|NOT COMPLETED|Overall Study||1||
60105020|NCT01309906|76223591|FG001|NOT COMPLETED|Overall Study||1||
60105021|NCT01372462|76223597|FG000|STARTED|NIOV - Room Air||15||
60105022|NCT01372462|76223597|FG000|COMPLETED|NIOV - Room Air||15||
60105023|NCT01372462|76223597|FG000|NOT COMPLETED|NIOV - Room Air||0||
60105024|NCT01372462|76223597|FG000|STARTED|NIOV - Oxygen||15||
60105025|NCT01372462|76223597|FG000|COMPLETED|NIOV - Oxygen||15||
60105026|NCT01372462|76223597|FG000|NOT COMPLETED|NIOV - Oxygen||0||
60105027|NCT01372462|76223597|FG000|STARTED|Oxygen Nasal Cannula||15||
60105028|NCT01372462|76223597|FG000|COMPLETED|Oxygen Nasal Cannula||15||
60105029|NCT01372462|76223597|FG000|NOT COMPLETED|Oxygen Nasal Cannula||0||
60105030|NCT01372462|76223597|FG000|STARTED|No Treatment Control||15||
60105031|NCT01372462|76223597|FG000|COMPLETED|No Treatment Control||15||
60105032|NCT01372462|76223597|FG000|NOT COMPLETED|No Treatment Control||0||
60105033|NCT01373242|76223607|FG000|STARTED|Overall Study||54||
60105034|NCT01373242|76223607|FG000|COMPLETED|Overall Study||38||
60105035|NCT01373242|76223607|FG000|NOT COMPLETED|Overall Study||16||
60105036|NCT01279564|76223615|FG000|STARTED|Overall Study||40||
60105037|NCT01279564|76223616|FG001|STARTED|Overall Study||32||
60105038|NCT01279564|76223615|FG000|COMPLETED|Overall Study||40||
60105039|NCT01279564|76223616|FG001|COMPLETED|Overall Study||32||
60105040|NCT01279564|76223615|FG000|NOT COMPLETED|Overall Study||0||
60105041|NCT01279564|76223616|FG001|NOT COMPLETED|Overall Study||0||
60105042|NCT01280110|76223624|FG000|STARTED|Overall Study||22||
60105043|NCT01280110|76223625|FG001|STARTED|Overall Study||22||
60105044|NCT01280110|76223624|FG000|COMPLETED|Overall Study||22||
60105045|NCT01280110|76223625|FG001|COMPLETED|Overall Study||22||
60105046|NCT01280110|76223624|FG000|NOT COMPLETED|Overall Study||0||
60105047|NCT01280110|76223625|FG001|NOT COMPLETED|Overall Study||0||
60105048|NCT01403584|76223633|FG000|STARTED|First Intervention (1 Night)||11||
60105049|NCT01403584|76223634|FG001|STARTED|First Intervention (1 Night)||10||
60105050|NCT01403584|76223633|FG000|COMPLETED|First Intervention (1 Night)||11||
60105051|NCT01403584|76223634|FG001|COMPLETED|First Intervention (1 Night)||10||
60105052|NCT01403584|76223633|FG000|NOT COMPLETED|First Intervention (1 Night)||0||
60105053|NCT01403584|76223634|FG001|NOT COMPLETED|First Intervention (1 Night)||0||
60105054|NCT01403584|76223633|FG000|STARTED|Second Intervention(1 Night)||10||
60105055|NCT01403584|76223634|FG001|STARTED|Second Intervention(1 Night)||11||
60105056|NCT01403584|76223633|FG000|COMPLETED|Second Intervention(1 Night)||10||
60105057|NCT01403584|76223634|FG001|COMPLETED|Second Intervention(1 Night)||11||
60105058|NCT01403584|76223633|FG000|NOT COMPLETED|Second Intervention(1 Night)||0||
60105059|NCT01403584|76223634|FG001|NOT COMPLETED|Second Intervention(1 Night)||0||
60105060|NCT01374490|76223640|FG000|STARTED|Overall Study||250||
60105061|NCT01374490|76223640|FG000|COMPLETED|Overall Study||190||
60105062|NCT01374490|76223640|FG000|NOT COMPLETED|Overall Study||60||
60105063|NCT01374802|76223644|FG000|STARTED|Overall Study||14||
60105064|NCT01374802|76223644|FG000|COMPLETED|Overall Study||14||
60105065|NCT01374802|76223644|FG000|NOT COMPLETED|Overall Study||0||
60105066|NCT01375660|76223652|FG000|STARTED|Overall Study||102||
60105067|NCT01375660|76223653|FG001|STARTED|Overall Study||103||
60105068|NCT01375660|76223652|FG000|COMPLETED|Overall Study||86||
60105069|NCT01375660|76223653|FG001|COMPLETED|Overall Study||87||
60105070|NCT01375660|76223652|FG000|NOT COMPLETED|Overall Study||16||
60105071|NCT01375660|76223653|FG001|NOT COMPLETED|Overall Study||16||
60105072|NCT01868477|76223662|FG000|STARTED|Overall Study||12||
60105073|NCT01868477|76223663|FG001|STARTED|Overall Study||11||
60105074|NCT01868477|76223662|FG000|Switched to EPO+DFX|Overall Study||5|Non-responders who switched to combination therapy at 12 weeks|
60105075|NCT01868477|76223663|FG001|Switched to EPO+DFX|Overall Study||0|Non-responders who switched to combination therapy at 12 weeks|
60105076|NCT01868477|76223662|FG000|Not Switched to EPO+DFX|Overall Study||7|Responders who were not switched to combination therapy at 12 weeks|
60105077|NCT01868477|76223663|FG001|Not Switched to EPO+DFX|Overall Study||0|Responders who were not switched to combination therapy at 12 weeks|
60105078|NCT01868477|76223662|FG000|COMPLETED|Overall Study||8||
60105079|NCT01868477|76223663|FG001|COMPLETED|Overall Study||6||
60105080|NCT01868477|76223662|FG000|NOT COMPLETED|Overall Study||4||
60105081|NCT01868477|76223663|FG001|NOT COMPLETED|Overall Study||5||
60105082|NCT01849289|76223678|FG000|STARTED|Overall Study||555||
60105083|NCT01849289|76223679|FG001|STARTED|Overall Study||278||
60105084|NCT01849289|76223678|FG000|Exposed|Overall Study|2 subjects withdrew prior to exposure of trial products|553||
60105085|NCT01849289|76223679|FG001|Exposed|Overall Study||278||
60105086|NCT01849289|76223678|FG000|COMPLETED|Overall Study||523||
60105087|NCT01849289|76223679|FG001|COMPLETED|Overall Study||254||
60105088|NCT01849289|76223678|FG000|NOT COMPLETED|Overall Study||32||
60105089|NCT01849289|76223679|FG001|NOT COMPLETED|Overall Study||24||
60105090|NCT01868243|76223687|FG000|STARTED|Overall Study||15||
60105091|NCT01868243|76223688|FG001|STARTED|Overall Study||12||
60105092|NCT01868243|76223687|FG000|COMPLETED|Overall Study||15||
60105093|NCT01868243|76223688|FG001|COMPLETED|Overall Study||11||
60105094|NCT01868243|76223687|FG000|NOT COMPLETED|Overall Study||0||
60105095|NCT01868243|76223688|FG001|NOT COMPLETED|Overall Study||1||
60105096|NCT01611935|76223696|FG000|STARTED|Overall Study||50||
60105097|NCT01611935|76223697|FG001|STARTED|Overall Study||51||
60105098|NCT01611935|76223696|FG000|COMPLETED|Overall Study||49||
59710137|NCT00975130|75828706|FG002|STARTED|Study Part 2|Good/moderate responders without remission at the end of Part 1 were invited to enroll in Part 2.|255||
59710138|NCT00975130|75828704|FG000|COMPLETED|Study Part 2||0||
59710139|NCT00975130|75828705|FG001|COMPLETED|Study Part 2||212||
59710140|NCT00975130|75828706|FG002|COMPLETED|Study Part 2||238||
59710141|NCT00975130|75828704|FG000|NOT COMPLETED|Study Part 2||0||
59710142|NCT00975130|75828705|FG001|NOT COMPLETED|Study Part 2||38||
59710143|NCT00975130|75828706|FG002|NOT COMPLETED|Study Part 2||17||
59710144|NCT01230827|75828723|FG000|STARTED|Overall Study||19||
59710145|NCT01230827|75828724|FG001|STARTED|Overall Study||11||
59710146|NCT01230827|75828725|FG002|STARTED|Overall Study||65||
59710147|NCT01230827|75828726|FG003|STARTED|Overall Study||78||
59710148|NCT01230827|75828723|FG000|COMPLETED|Overall Study||0||
59710149|NCT01230827|75828724|FG001|COMPLETED|Overall Study||0||
59710150|NCT01230827|75828725|FG002|COMPLETED|Overall Study||0||
59710151|NCT01230827|75828726|FG003|COMPLETED|Overall Study||0||
59710152|NCT01230827|75828723|FG000|NOT COMPLETED|Overall Study||19||
59710153|NCT01230827|75828724|FG001|NOT COMPLETED|Overall Study||11||
59710154|NCT01230827|75828725|FG002|NOT COMPLETED|Overall Study||65||
59710155|NCT01230827|75828726|FG003|NOT COMPLETED|Overall Study||78||
59710156|NCT01230749|75828738|FG000|STARTED|Overall Study||22||
59710157|NCT01230749|75828739|FG001|STARTED|Overall Study||22||
59710158|NCT01230749|75828740|FG002|STARTED|Overall Study||23||
59710159|NCT01230749|75828741|FG003|STARTED|Overall Study||22||
59710160|NCT01230749|75828738|FG000|COMPLETED|Overall Study||22||
59710161|NCT01230749|75828739|FG001|COMPLETED|Overall Study||20||
59710162|NCT01230749|75828740|FG002|COMPLETED|Overall Study||21||
59710163|NCT01230749|75828741|FG003|COMPLETED|Overall Study||20||
59710164|NCT01230749|75828738|FG000|NOT COMPLETED|Overall Study||0||
60105099|NCT01611935|76223697|FG001|COMPLETED|Overall Study||51||
60105100|NCT01611935|76223696|FG000|NOT COMPLETED|Overall Study||1||
59710165|NCT01230749|75828739|FG001|NOT COMPLETED|Overall Study||2||
59710166|NCT01230749|75828740|FG002|NOT COMPLETED|Overall Study||2||
59710167|NCT01230749|75828741|FG003|NOT COMPLETED|Overall Study||2||
59710168|NCT00903175|75828756|FG000|STARTED|Period 1 - First Line||238||
59710169|NCT00903175|75828757|FG001|STARTED|Period 1 - First Line||231||
59710170|NCT00903175|75828756|FG000|COMPLETED|Period 1 - First Line|Completed = Disease progression (completed 1L)|161||
59710171|NCT00903175|75828757|FG001|COMPLETED|Period 1 - First Line|Completed = Disease progression (completed 1L)|142||
59710172|NCT00903175|75828756|FG000|NOT COMPLETED|Period 1 - First Line||77||
59710173|NCT00903175|75828757|FG001|NOT COMPLETED|Period 1 - First Line||89||
59710174|NCT00903175|75828756|FG000|STARTED|Period 2 - Second Line|139 from everolimus 1L planned to enter 2L period and cross over to sunitinib but only 128 did.|128||
59710175|NCT00903175|75828757|FG001|STARTED|Period 2 - Second Line|130 from Sunitinib 1L planned to enter 2L period and cross over to everolimus but only 116 did.|116||
59710176|NCT00903175|75828756|FG000|COMPLETED|Period 2 - Second Line|Completed = Disease progression - (completed 2L)|79||
59566095|NCT03403725|75668541|FG005|COMPLETED|Overall Study||6||
59710177|NCT00903175|75828757|FG001|COMPLETED|Period 2 - Second Line|Completed = Disease progression - (completed 2L)|80||
59710178|NCT00903175|75828756|FG000|NOT COMPLETED|Period 2 - Second Line||49||
59818053|NCT00355264|75940409|FG000|NOT COMPLETED|Part 2 (8 Weeks)||0||
59818054|NCT00355264|75940409|FG000|STARTED|Part 3 (7 Weeks of Extension)||2||
59818055|NCT00355264|75940409|FG000|COMPLETED|Part 3 (7 Weeks of Extension)||2||
59818056|NCT00355264|75940409|FG000|NOT COMPLETED|Part 3 (7 Weeks of Extension)||0||
59818057|NCT00355264|75940409|FG000|STARTED|Extension (Variable Duration)||12||
59818058|NCT00355264|75940409|FG000|COMPLETED|Extension (Variable Duration)||10||
59818059|NCT00355264|75940409|FG000|NOT COMPLETED|Extension (Variable Duration)||2||
59818060|NCT00355030|75940420|FG000|STARTED|Study Period 1 Treatment||46||
59818061|NCT00355030|75940421|FG001|STARTED|Study Period 1 Treatment||45||
59818062|NCT00355030|75940420|FG000|Received At Least One Dose of Study Drug|Study Period 1 Treatment|1 non-eligible participant received somatropin from previous control group|45||
59818063|NCT00355030|75940421|FG001|Received At Least One Dose of Study Drug|Study Period 1 Treatment|2 non-eligible participants received somatropin from previous control group|43||
59818064|NCT00355030|75940420|FG000|COMPLETED|Study Period 1 Treatment|Participants from the Netherlands exited the study after Study Period 1.|1||
59818065|NCT00355030|75940421|FG001|COMPLETED|Study Period 1 Treatment|Participants from the Netherlands exited the study after Study Period 1.|1||
59710179|NCT00903175|75828757|FG001|NOT COMPLETED|Period 2 - Second Line||36||
59710180|NCT01229735|75828765|FG000|STARTED|Overall Study||177||
59710181|NCT01229735|75828766|FG001|STARTED|Overall Study||166||
59710182|NCT01229735|75828765|FG000|COMPLETED|Overall Study||111||
59710183|NCT01229735|75828766|FG001|COMPLETED|Overall Study||100||
59566096|NCT03403725|75668542|FG006|COMPLETED|Overall Study||6||
59566097|NCT03403725|75668543|FG007|COMPLETED|Overall Study||3||
59566098|NCT03403725|75668544|FG008|COMPLETED|Overall Study||3||
59566099|NCT03403725|75668545|FG009|COMPLETED|Overall Study||4||
59566100|NCT03403725|75668546|FG010|COMPLETED|Overall Study||1||
59566101|NCT03403725|75668536|FG000|NOT COMPLETED|Overall Study||0||
59566102|NCT03403725|75668537|FG001|NOT COMPLETED|Overall Study||0||
59710184|NCT01229735|75828765|FG000|NOT COMPLETED|Overall Study||66||
59710185|NCT01229735|75828766|FG001|NOT COMPLETED|Overall Study||66||
59710186|NCT03866200|75828776|FG000|STARTED|First Intervention (90 Days)||5||
59710187|NCT03866200|75828777|FG001|STARTED|First Intervention (90 Days)||1||
59710188|NCT03866200|75828776|FG000|COMPLETED|First Intervention (90 Days)||5||
59710189|NCT03866200|75828777|FG001|COMPLETED|First Intervention (90 Days)||1||
59566103|NCT03403725|75668538|FG002|NOT COMPLETED|Overall Study||0||
59566104|NCT03403725|75668539|FG003|NOT COMPLETED|Overall Study||0||
59566105|NCT03403725|75668540|FG004|NOT COMPLETED|Overall Study||0||
59710190|NCT03866200|75828776|FG000|NOT COMPLETED|First Intervention (90 Days)||0||
59710191|NCT03866200|75828777|FG001|NOT COMPLETED|First Intervention (90 Days)||0||
59995994|NCT02643693|76111940|FG005|COMPLETED|Overall Study||3||
59566106|NCT03403725|75668541|FG005|NOT COMPLETED|Overall Study||0||
59995995|NCT02643693|76111935|FG000|NOT COMPLETED|Overall Study||2||
59995996|NCT02643693|76111936|FG001|NOT COMPLETED|Overall Study||2||
59995997|NCT02643693|76111937|FG002|NOT COMPLETED|Overall Study||1||
59995998|NCT02643693|76111938|FG003|NOT COMPLETED|Overall Study||0||
59995999|NCT02643693|76111939|FG004|NOT COMPLETED|Overall Study||0||
59996000|NCT02643693|76111940|FG005|NOT COMPLETED|Overall Study||1||
59996001|NCT02726113|76111950|FG000|STARTED|Total Enrollment||28||
59996002|NCT02726113|76111951|FG001|STARTED|Total Enrollment||22||
59710192|NCT03866200|75828776|FG000|STARTED|Washout (30 Days)||5||
59710193|NCT03866200|75828777|FG001|STARTED|Washout (30 Days)||1||
59710194|NCT03866200|75828776|FG000|COMPLETED|Washout (30 Days)||5||
59710195|NCT03866200|75828777|FG001|COMPLETED|Washout (30 Days)||1||
59996003|NCT02726113|76111950|FG000|COMPLETED|Total Enrollment||24||
60105101|NCT01611935|76223697|FG001|NOT COMPLETED|Overall Study||0||
60105102|NCT01868165|76223703|FG000|STARTED|Overall Study||337||
60105103|NCT01868165|76223703|FG000|COMPLETED|Overall Study||292||
60105104|NCT01868165|76223703|FG000|NOT COMPLETED|Overall Study||45||
60105105|NCT02201056|76223714|FG000|STARTED|Overall Study||12||
60105106|NCT02201056|76223715|FG001|STARTED|Overall Study||6||
60105107|NCT02201056|76223716|FG002|STARTED|Overall Study||6||
60105108|NCT02201056|76223717|FG003|STARTED|Overall Study||6||
60105109|NCT02201056|76223718|FG004|STARTED|Overall Study||6||
60105110|NCT02201056|76223719|FG005|STARTED|Overall Study||6||
60105111|NCT02201056|76223720|FG006|STARTED|Overall Study||6||
60105112|NCT02201056|76223714|FG000|COMPLETED|Overall Study||12||
60105113|NCT02201056|76223715|FG001|COMPLETED|Overall Study||6||
60105114|NCT02201056|76223716|FG002|COMPLETED|Overall Study||6||
60105115|NCT02201056|76223717|FG003|COMPLETED|Overall Study||6||
60105116|NCT02201056|76223718|FG004|COMPLETED|Overall Study||6||
60105117|NCT02201056|76223719|FG005|COMPLETED|Overall Study||6||
60105118|NCT02201056|76223720|FG006|COMPLETED|Overall Study||6||
60105119|NCT02201056|76223714|FG000|NOT COMPLETED|Overall Study||0||
60105120|NCT02201056|76223715|FG001|NOT COMPLETED|Overall Study||0||
60105121|NCT02201056|76223716|FG002|NOT COMPLETED|Overall Study||0||
60105122|NCT02201056|76223717|FG003|NOT COMPLETED|Overall Study||0||
60105123|NCT02201056|76223718|FG004|NOT COMPLETED|Overall Study||0||
60105124|NCT02201056|76223719|FG005|NOT COMPLETED|Overall Study||0||
60105125|NCT02201056|76223720|FG006|NOT COMPLETED|Overall Study||0||
60105126|NCT01868009|76223742|FG000|STARTED|Period 1 (5-9 Days)||143||
60105127|NCT01868009|76223743|FG001|STARTED|Period 1 (5-9 Days)||144||
60105128|NCT01868009|76223742|FG000|COMPLETED|Period 1 (5-9 Days)||143||
60105129|NCT01868009|76223743|FG001|COMPLETED|Period 1 (5-9 Days)||142||
59996004|NCT02726113|76111951|FG001|COMPLETED|Total Enrollment||19||
59996005|NCT02726113|76111950|FG000|NOT COMPLETED|Total Enrollment||4||
59996006|NCT02726113|76111951|FG001|NOT COMPLETED|Total Enrollment||3||
59996007|NCT02726113|76111950|FG000|STARTED|Genomic Analysis||19||
59996008|NCT02726113|76111951|FG001|STARTED|Genomic Analysis||14||
59996009|NCT02726113|76111950|FG000|COMPLETED|Genomic Analysis||15||
59996010|NCT02726113|76111951|FG001|COMPLETED|Genomic Analysis||12||
59996011|NCT02726113|76111950|FG000|NOT COMPLETED|Genomic Analysis||4||
59996012|NCT02726113|76111951|FG001|NOT COMPLETED|Genomic Analysis||2||
59996013|NCT03800979|76111958|FG000|STARTED|Overall Study||19||
59996014|NCT03800979|76111958|FG000|COMPLETED|Overall Study||19||
59996015|NCT03800979|76111958|FG000|NOT COMPLETED|Overall Study||0||
59996016|NCT03794661|76111962|FG000|STARTED|Overall Study||8||
59996017|NCT03794661|76111962|FG000|COMPLETED|Overall Study||8||
59996018|NCT03794661|76111962|FG000|NOT COMPLETED|Overall Study||0||
59996019|NCT01361919|76111969|FG000|STARTED|Overall Study||100||
60105130|NCT01868009|76223742|FG000|NOT COMPLETED|Period 1 (5-9 Days)||0||
60105131|NCT01868009|76223743|FG001|NOT COMPLETED|Period 1 (5-9 Days)||2||
60105132|NCT01868009|76223742|FG000|STARTED|Period 2 (5-9 Days)||143||
60105133|NCT01868009|76223743|FG001|STARTED|Period 2 (5-9 Days)||142||
60105134|NCT01868009|76223742|FG000|COMPLETED|Period 2 (5-9 Days)||141||
59566107|NCT03403725|75668542|FG006|NOT COMPLETED|Overall Study||0||
59566108|NCT03403725|75668543|FG007|NOT COMPLETED|Overall Study||0||
59566109|NCT03403725|75668544|FG008|NOT COMPLETED|Overall Study||0||
59566110|NCT03403725|75668545|FG009|NOT COMPLETED|Overall Study||0||
59566111|NCT03403725|75668546|FG010|NOT COMPLETED|Overall Study||0||
59566112|NCT04332081|75668574|FG000|STARTED|Overall Study||20||
59566113|NCT04332081|75668575|FG001|STARTED|Overall Study||60||
59566114|NCT04332081|75668574|FG000|COMPLETED|Overall Study||20||
59566115|NCT04332081|75668575|FG001|COMPLETED|Overall Study||60||
59566116|NCT04332081|75668574|FG000|NOT COMPLETED|Overall Study||0||
59996020|NCT01361919|76111970|FG001|STARTED|Overall Study||100||
59996021|NCT01361919|76111971|FG002|STARTED|Overall Study||98||
59566117|NCT04332081|75668575|FG001|NOT COMPLETED|Overall Study||0||
59566118|NCT01859078|75668581|FG000|STARTED|Overall Study||28||
59566119|NCT01859078|75668581|FG000|COMPLETED|Overall Study||28||
59566120|NCT01859078|75668581|FG000|NOT COMPLETED|Overall Study||0||
59566121|NCT03662139|75668589|FG000|STARTED|Overall Study||16||
59710196|NCT03866200|75828776|FG000|NOT COMPLETED|Washout (30 Days)||0||
59818066|NCT00355030|75940420|FG000|NOT COMPLETED|Study Period 1 Treatment||45||
59818067|NCT00355030|75940421|FG001|NOT COMPLETED|Study Period 1 Treatment||44||
59818068|NCT00355030|75940420|FG000|STARTED|Study Period 2 Long Term Follow-Up|Participants from France were given the option to re-consent for Study Period 2.|20||
59818069|NCT00355030|75940421|FG001|STARTED|Study Period 2 Long Term Follow-Up|Participants from France were given the option to re-consent for Study Period 2.|19||
59818070|NCT00355030|75940420|FG000|COMPLETED|Study Period 2 Long Term Follow-Up||19||
59818071|NCT00355030|75940421|FG001|COMPLETED|Study Period 2 Long Term Follow-Up||17||
59818072|NCT00355030|75940420|FG000|NOT COMPLETED|Study Period 2 Long Term Follow-Up||1||
59818073|NCT00355030|75940421|FG001|NOT COMPLETED|Study Period 2 Long Term Follow-Up||2||
59818074|NCT00354172|75940427|FG000|STARTED|Overall Study||16||
60105135|NCT01868009|76223743|FG001|COMPLETED|Period 2 (5-9 Days)||142||
59818075|NCT00354172|75940427|FG000|COMPLETED|Overall Study|1 patient did not reach umbilical cord blood transplant|15||
59818076|NCT00354172|75940427|FG000|NOT COMPLETED|Overall Study||1||
59818077|NCT00345592|75940433|FG000|STARTED|Overall Study||199||
59818078|NCT00345592|75940434|FG001|STARTED|Overall Study||197||
59818079|NCT00345592|75940433|FG000|COMPLETED|Overall Study||174||
59818080|NCT00345592|75940434|FG001|COMPLETED|Overall Study||173||
59818081|NCT00345592|75940433|FG000|NOT COMPLETED|Overall Study||25||
59818082|NCT00345592|75940434|FG001|NOT COMPLETED|Overall Study||24||
59818083|NCT00353704|75940442|FG000|STARTED|Overall Study||25||
59818084|NCT00353704|75940443|FG001|STARTED|Overall Study||25||
59818085|NCT00353704|75940442|FG000|COMPLETED|Overall Study||22||
59818086|NCT00353704|75940443|FG001|COMPLETED|Overall Study||24||
59818087|NCT00353704|75940442|FG000|NOT COMPLETED|Overall Study||3||
59818088|NCT00353704|75940443|FG001|NOT COMPLETED|Overall Study||1||
59818089|NCT00512252|75940452|FG000|STARTED|Overall Study||3||
59818090|NCT00512252|75940453|FG001|STARTED|Overall Study||3||
59818091|NCT00512252|75940454|FG002|STARTED|Overall Study||46||
59818092|NCT00512252|75940452|FG000|COMPLETED|Overall Study||3||
59818093|NCT00512252|75940453|FG001|COMPLETED|Overall Study||3||
59818094|NCT00512252|75940454|FG002|COMPLETED|Overall Study||43||
59818095|NCT00512252|75940452|FG000|NOT COMPLETED|Overall Study||0||
59818096|NCT00512252|75940453|FG001|NOT COMPLETED|Overall Study||0||
59818097|NCT00512252|75940454|FG002|NOT COMPLETED|Overall Study||3||
60105136|NCT01868009|76223742|FG000|NOT COMPLETED|Period 2 (5-9 Days)||2||
60105137|NCT01868009|76223743|FG001|NOT COMPLETED|Period 2 (5-9 Days)||0||
60105138|NCT02201212|76223749|FG000|STARTED|Overall Study||30||
60105139|NCT02201212|76223749|FG000|COMPLETED|Overall Study||30||
60105140|NCT02201212|76223749|FG000|NOT COMPLETED|Overall Study||0||
60105141|NCT01376050|76223755|FG000|STARTED|Overall Study||13||
60105142|NCT01376050|76223756|FG001|STARTED|Overall Study||11||
60105143|NCT01376050|76223755|FG000|COMPLETED|Overall Study||13||
60105144|NCT01376050|76223756|FG001|COMPLETED|Overall Study||11||
60105145|NCT01376050|76223755|FG000|NOT COMPLETED|Overall Study||0||
60105146|NCT01376050|76223756|FG001|NOT COMPLETED|Overall Study||0||
60105147|NCT01376362|76223762|FG000|STARTED|Overall Study||5||
60105148|NCT01376362|76223762|FG000|COMPLETED|Overall Study||5||
59710197|NCT03866200|75828777|FG001|NOT COMPLETED|Washout (30 Days)||0||
59710198|NCT03866200|75828776|FG000|STARTED|Second Intervention (90 Days)||5||
59710199|NCT03866200|75828777|FG001|STARTED|Second Intervention (90 Days)||1||
59710200|NCT03866200|75828776|FG000|COMPLETED|Second Intervention (90 Days)||5||
59710201|NCT03866200|75828777|FG001|COMPLETED|Second Intervention (90 Days)||1||
59710202|NCT03866200|75828776|FG000|NOT COMPLETED|Second Intervention (90 Days)||0||
59710203|NCT03866200|75828777|FG001|NOT COMPLETED|Second Intervention (90 Days)||0||
59710204|NCT00974974|75828785|FG000|STARTED|IR CD-LD Dose Adjustment||0||
59710205|NCT00974974|75828786|FG001|STARTED|IR CD-LD Dose Adjustment||471||
59710206|NCT00974974|75828785|FG000|COMPLETED|IR CD-LD Dose Adjustment||0||
59818098|NCT00516386|75940469|FG000|STARTED|Overall Study||16||
59818099|NCT00516386|75940469|FG000|COMPLETED|Overall Study||10||
59818100|NCT00516386|75940469|FG000|NOT COMPLETED|Overall Study||6||
59818101|NCT00524420|75940475|FG000|STARTED|Overall Study|One was incorrectly randomized;she did not have a BIRS of >7. Was excluded from efficacy analysis.|8||
59818102|NCT00524420|75940476|FG001|STARTED|Overall Study||11||
59818103|NCT00524420|75940475|FG000|COMPLETED|Overall Study|1 dropped out after treatment 10 because of poor response and was included in the efficacy analyses.|7||
59818104|NCT00524420|75940476|FG001|COMPLETED|Overall Study||11||
60105149|NCT01376362|76223762|FG000|NOT COMPLETED|Overall Study||0||
60105150|NCT01312948|76223766|FG000|STARTED|Overall Study||6||
60105151|NCT01312948|76223766|FG000|COMPLETED|Overall Study||6||
60105152|NCT01312948|76223766|FG000|NOT COMPLETED|Overall Study||0||
60105153|NCT01962792|76223777|FG000|STARTED|Overall Study||3||
60105154|NCT01962792|76223778|FG001|STARTED|Overall Study||5||
60105155|NCT01962792|76223779|FG002|STARTED|Overall Study||17||
60105156|NCT01962792|76223780|FG003|STARTED|Overall Study||59||
60105157|NCT01962792|76223777|FG000|COMPLETED|Overall Study||3||
59818105|NCT00524420|75940475|FG000|NOT COMPLETED|Overall Study||1||
60105158|NCT01962792|76223778|FG001|COMPLETED|Overall Study||5||
60105159|NCT01962792|76223779|FG002|COMPLETED|Overall Study||17||
60105160|NCT01962792|76223780|FG003|COMPLETED|Overall Study||59||
59818106|NCT00524420|75940476|FG001|NOT COMPLETED|Overall Study||0||
60105161|NCT01962792|76223777|FG000|NOT COMPLETED|Overall Study||0||
60105162|NCT01962792|76223778|FG001|NOT COMPLETED|Overall Study||0||
60105163|NCT01962792|76223779|FG002|NOT COMPLETED|Overall Study||0||
60105164|NCT01962792|76223780|FG003|NOT COMPLETED|Overall Study||0||
60105165|NCT01849055|76223797|FG000|STARTED|Overall Study||8||
60105166|NCT01849055|76223798|FG001|STARTED|Overall Study||8||
60105167|NCT01849055|76223799|FG002|STARTED|Overall Study||8||
60105168|NCT01849055|76223800|FG003|STARTED|Overall Study||8||
60105169|NCT01849055|76223801|FG004|STARTED|Overall Study||8||
60105170|NCT01849055|76223802|FG005|STARTED|Overall Study||8||
60105171|NCT01849055|76223797|FG000|COMPLETED|Overall Study||8||
60105172|NCT01849055|76223798|FG001|COMPLETED|Overall Study||8||
60105173|NCT01849055|76223799|FG002|COMPLETED|Overall Study||7||
60105174|NCT01849055|76223800|FG003|COMPLETED|Overall Study||8||
60105175|NCT01849055|76223801|FG004|COMPLETED|Overall Study||8||
60105176|NCT01849055|76223802|FG005|COMPLETED|Overall Study||8||
60105177|NCT01849055|76223797|FG000|NOT COMPLETED|Overall Study||0||
60105178|NCT01849055|76223798|FG001|NOT COMPLETED|Overall Study||0||
60105179|NCT01849055|76223799|FG002|NOT COMPLETED|Overall Study||1||
60105180|NCT01849055|76223800|FG003|NOT COMPLETED|Overall Study||0||
60105181|NCT01849055|76223801|FG004|NOT COMPLETED|Overall Study||0||
60105182|NCT01849055|76223802|FG005|NOT COMPLETED|Overall Study||0||
60105183|NCT01404832|76223820|FG000|STARTED|Overall Study||21||
60105184|NCT01404832|76223820|FG000|COMPLETED|Overall Study||21||
60105185|NCT01404832|76223820|FG000|NOT COMPLETED|Overall Study||0||
60105186|NCT01848353|76223828|FG000|STARTED|Phase 1||38||
60105187|NCT01848353|76223829|FG001|STARTED|Phase 1||43||
60105188|NCT01848353|76223830|FG002|STARTED|Phase 1||20||
60105189|NCT01848353|76223831|FG003|STARTED|Phase 1||19||
60105190|NCT01848353|76223828|FG000|COMPLETED|Phase 1||35||
60105191|NCT01848353|76223829|FG001|COMPLETED|Phase 1||42||
60105192|NCT01848353|76223830|FG002|COMPLETED|Phase 1||20||
60105193|NCT01848353|76223831|FG003|COMPLETED|Phase 1||19||
60105194|NCT01848353|76223828|FG000|NOT COMPLETED|Phase 1||3||
60105195|NCT01848353|76223829|FG001|NOT COMPLETED|Phase 1||1||
60105196|NCT01848353|76223830|FG002|NOT COMPLETED|Phase 1||0||
60105197|NCT01848353|76223831|FG003|NOT COMPLETED|Phase 1||0||
60105198|NCT01848353|76223828|FG000|STARTED|Phase 2|26 participants from Phase 1 intervention (both groups) withdrew and did not complete Phase 2|23||
60105199|NCT01848353|76223829|FG001|STARTED|Phase 2|26 participants from Phase 1 intervention (both groups) withdrew and did not complete Phase 2|28||
60105200|NCT01848353|76223830|FG002|STARTED|Phase 2|Normal weight participants only completed baseline testing in Phase 1.|0||
60105201|NCT01848353|76223831|FG003|STARTED|Phase 2|Normal weight participants only completed baseline testing in Phase 1.|0||
60105202|NCT01848353|76223828|FG000|COMPLETED|Phase 2||20||
60105203|NCT01848353|76223829|FG001|COMPLETED|Phase 2||26||
60105204|NCT01848353|76223830|FG002|COMPLETED|Phase 2||0||
60105205|NCT01848353|76223831|FG003|COMPLETED|Phase 2||0||
60105206|NCT01848353|76223828|FG000|NOT COMPLETED|Phase 2||3||
60105207|NCT01848353|76223829|FG001|NOT COMPLETED|Phase 2||2||
60105208|NCT01848353|76223830|FG002|NOT COMPLETED|Phase 2||0||
60105209|NCT01848353|76223831|FG003|NOT COMPLETED|Phase 2||0||
60105210|NCT01848353|76223828|FG000|STARTED|Phase 3|31 participants from Phase 2 intervention (both groups) withdrew and did not complete Phase 3|5||
60105211|NCT01848353|76223829|FG001|STARTED|Phase 3|31 participants from Phase 2 intervention (both groups) withdrew and did not complete Phase 3|10||
60105212|NCT01848353|76223830|FG002|STARTED|Phase 3|Normal weight participants only completed baseline testing in Phase 1.|0||
60105213|NCT01848353|76223831|FG003|STARTED|Phase 3|Normal weight participants only completed baseline testing in Phase 1.|0||
60105214|NCT01848353|76223828|FG000|COMPLETED|Phase 3||4||
60105215|NCT01848353|76223829|FG001|COMPLETED|Phase 3||9||
60105216|NCT01848353|76223830|FG002|COMPLETED|Phase 3||0||
60105217|NCT01848353|76223831|FG003|COMPLETED|Phase 3||0||
60105218|NCT01848353|76223828|FG000|NOT COMPLETED|Phase 3||1||
60105219|NCT01848353|76223829|FG001|NOT COMPLETED|Phase 3||1||
60105220|NCT01848353|76223830|FG002|NOT COMPLETED|Phase 3||0||
60105221|NCT01848353|76223831|FG003|NOT COMPLETED|Phase 3||0||
60105222|NCT01313494|76223851|FG000|STARTED|Overall Study||313||
60105223|NCT01313494|76223852|FG001|STARTED|Overall Study||313||
60105224|NCT01313494|76223851|FG000|Safety Set|Overall Study|2 patients in the placebo arm were misallocated and may have received roflumilast in error.|315||
60105225|NCT01313494|76223852|FG001|Safety Set|Overall Study|2 patients in the placebo arm were misallocated and may have received roflumilast in error.|311||
60105226|NCT01313494|76223851|FG000|COMPLETED|Overall Study||246||
60105227|NCT01313494|76223852|FG001|COMPLETED|Overall Study||263||
60105228|NCT01313494|76223851|FG000|NOT COMPLETED|Overall Study||67||
60105229|NCT01313494|76223852|FG001|NOT COMPLETED|Overall Study||50||
60105230|NCT01847885|76223860|FG000|STARTED|Initial Enrollment (Consented)||88||
60105231|NCT01847885|76223861|FG001|STARTED|Initial Enrollment (Consented)||0||
60105232|NCT01847885|76223862|FG002|STARTED|Initial Enrollment (Consented)||0||
60105233|NCT01847885|76223860|FG000|Randomized|Initial Enrollment (Consented)||46|Subjects who signed a consent form, met all eligibility criteria, and were randomized.|
60105234|NCT01847885|76223861|FG001|Randomized|Initial Enrollment (Consented)||0|Subjects who signed a consent form, met all eligibility criteria, and were randomized.|
60105235|NCT01847885|76223862|FG002|Randomized|Initial Enrollment (Consented)||0|Subjects who signed a consent form, met all eligibility criteria, and were randomized.|
60105236|NCT01847885|76223860|FG000|Full Analysis Set|Initial Enrollment (Consented)||43|Subjects who were consented, randomized, and met all eligibility criteria prior to lead placement|
60105237|NCT01847885|76223861|FG001|Full Analysis Set|Initial Enrollment (Consented)||0|Subjects who were consented, randomized, and met all eligibility criteria prior to lead placement|
59566122|NCT03662139|75668590|FG001|STARTED|Overall Study||16||
59566123|NCT03662139|75668589|FG000|COMPLETED|Overall Study||16||
59566124|NCT03662139|75668590|FG001|COMPLETED|Overall Study||16||
59566125|NCT03662139|75668589|FG000|NOT COMPLETED|Overall Study||0||
59710207|NCT00974974|75828786|FG001|COMPLETED|IR CD-LD Dose Adjustment||450||
59710208|NCT00974974|75828785|FG000|NOT COMPLETED|IR CD-LD Dose Adjustment||0||
59710209|NCT00974974|75828786|FG001|NOT COMPLETED|IR CD-LD Dose Adjustment||21||
59710210|NCT00974974|75828785|FG000|STARTED|IPX066 Dose Conversion|All subjects who completed IR Dose adjustment entered into IPX066 dose conversion.|450||
59710211|NCT00974974|75828786|FG001|STARTED|IPX066 Dose Conversion|IR is not applicable in IPX066 dose conversion.|0||
59710212|NCT00974974|75828785|FG000|COMPLETED|IPX066 Dose Conversion||393||
59710213|NCT00974974|75828786|FG001|COMPLETED|IPX066 Dose Conversion||0||
59710214|NCT00974974|75828785|FG000|NOT COMPLETED|IPX066 Dose Conversion||57||
59710215|NCT00974974|75828786|FG001|NOT COMPLETED|IPX066 Dose Conversion||0||
59710216|NCT00974974|75828785|FG000|STARTED|Maintenance - Double Blind Treatment|All subjects who completed IPX066 Dose Conversion were randomized to either IPX066 or IR.|201||
59710217|NCT00974974|75828786|FG001|STARTED|Maintenance - Double Blind Treatment|All subjects who completed IPX066 Dose Conversion were randomized to either IPX066 or IR.|192||
59710218|NCT00974974|75828785|FG000|COMPLETED|Maintenance - Double Blind Treatment||186||
59818107|NCT00512096|75940484|FG000|STARTED|Overall Study||30||
59818108|NCT00512096|75940484|FG000|COMPLETED|Overall Study||23||
59818109|NCT00512096|75940484|FG000|NOT COMPLETED|Overall Study||7||
59818110|NCT00524030|75940490|FG000|STARTED|Overall Study||32||
59818111|NCT00524030|75940491|FG001|STARTED|Overall Study||129||
59818112|NCT00524030|75940490|FG000|Completed Double-Blind Treatment Phase|Overall Study||15||
59818113|NCT00524030|75940491|FG001|Completed Double-Blind Treatment Phase|Overall Study||70||
59818114|NCT00524030|75940490|FG000|Completed Taper/Titration Phase|Overall Study||15||
59818115|NCT00524030|75940491|FG001|Completed Taper/Titration Phase|Overall Study||70||
59818116|NCT00524030|75940490|FG000|COMPLETED|Overall Study||15||
59818117|NCT00524030|75940491|FG001|COMPLETED|Overall Study||70||
59818118|NCT00524030|75940490|FG000|NOT COMPLETED|Overall Study||17||
59818119|NCT00524030|75940491|FG001|NOT COMPLETED|Overall Study||59||
59818120|NCT00523718|75940500|FG000|STARTED|Overall Study||20||
59818121|NCT00523718|75940501|FG001|STARTED|Overall Study||18||
59818122|NCT00523718|75940500|FG000|COMPLETED|Overall Study||17||
60105238|NCT01847885|76223862|FG002|Full Analysis Set|Initial Enrollment (Consented)||0|Subjects who were consented, randomized, and met all eligibility criteria prior to lead placement|
60105239|NCT01847885|76223860|FG000|Safety Set|Initial Enrollment (Consented)||41|Subjects who received a Lead.|
60105240|NCT01847885|76223861|FG001|Safety Set|Initial Enrollment (Consented)||0|Subjects who received a Lead.|
60105241|NCT01847885|76223862|FG002|Safety Set|Initial Enrollment (Consented)||0|Subjects who received a Lead.|
60105242|NCT01847885|76223860|FG000|Per Protocol Set|Initial Enrollment (Consented)||40|Subjects who received a Lead, had enough scores in the diary, and met eligibility through treatment.|
60105243|NCT01847885|76223861|FG001|Per Protocol Set|Initial Enrollment (Consented)||0|Subjects who received a Lead, had enough scores in the diary, and met eligibility through treatment.|
60105244|NCT01847885|76223862|FG002|Per Protocol Set|Initial Enrollment (Consented)||0|Subjects who received a Lead, had enough scores in the diary, and met eligibility through treatment.|
60105245|NCT01847885|76223860|FG000|COMPLETED|Initial Enrollment (Consented)||40||
60105246|NCT01847885|76223861|FG001|COMPLETED|Initial Enrollment (Consented)||0||
60105247|NCT01847885|76223862|FG002|COMPLETED|Initial Enrollment (Consented)||0||
60105248|NCT01847885|76223860|FG000|NOT COMPLETED|Initial Enrollment (Consented)||48||
60105249|NCT01847885|76223861|FG001|NOT COMPLETED|Initial Enrollment (Consented)||0||
60105250|NCT01847885|76223862|FG002|NOT COMPLETED|Initial Enrollment (Consented)||0||
60105251|NCT01847885|76223860|FG000|STARTED|Randomization||0||
60105252|NCT01847885|76223861|FG001|STARTED|Randomization||31||
60105253|NCT01847885|76223862|FG002|STARTED|Randomization||15||
60105254|NCT01847885|76223860|FG000|Full Analysis Set|Randomization||0||
60105255|NCT01847885|76223861|FG001|Full Analysis Set|Randomization||28||
60105256|NCT01847885|76223862|FG002|Full Analysis Set|Randomization||15||
59710219|NCT00974974|75828786|FG001|COMPLETED|Maintenance - Double Blind Treatment||182||
59710220|NCT00974974|75828785|FG000|NOT COMPLETED|Maintenance - Double Blind Treatment||15||
59710221|NCT00974974|75828786|FG001|NOT COMPLETED|Maintenance - Double Blind Treatment||10||
59710222|NCT01233869|75828796|FG000|STARTED|Initial Treatment Period (24 Months)||58||
59710223|NCT01233869|75828797|FG001|STARTED|Initial Treatment Period (24 Months)||31||
59710224|NCT01233869|75828798|FG002|STARTED|Initial Treatment Period (24 Months)||24||
59710225|NCT01233869|75828799|FG003|STARTED|Initial Treatment Period (24 Months)||56||
59710226|NCT01233869|75828796|FG000|COMPLETED|Initial Treatment Period (24 Months)||34||
59818123|NCT00523718|75940501|FG001|COMPLETED|Overall Study||18||
59818124|NCT00523718|75940500|FG000|NOT COMPLETED|Overall Study||3||
60105257|NCT01847885|76223860|FG000|Safety Set|Randomization||0||
60105258|NCT01847885|76223861|FG001|Safety Set|Randomization||28||
60105259|NCT01847885|76223862|FG002|Safety Set|Randomization||13||
60105260|NCT01847885|76223860|FG000|Per Protocol Set|Randomization||0||
60105261|NCT01847885|76223861|FG001|Per Protocol Set|Randomization||27||
60105262|NCT01847885|76223862|FG002|Per Protocol Set|Randomization||13||
60105263|NCT01847885|76223860|FG000|COMPLETED|Randomization||0||
60105264|NCT01847885|76223861|FG001|COMPLETED|Randomization||27||
60105265|NCT01847885|76223862|FG002|COMPLETED|Randomization||13||
60105266|NCT01847885|76223860|FG000|NOT COMPLETED|Randomization||0||
59566126|NCT03662139|75668590|FG001|NOT COMPLETED|Overall Study||0||
59710227|NCT01233869|75828797|FG001|COMPLETED|Initial Treatment Period (24 Months)||3||
59710228|NCT01233869|75828798|FG002|COMPLETED|Initial Treatment Period (24 Months)||22||
59710229|NCT01233869|75828799|FG003|COMPLETED|Initial Treatment Period (24 Months)||34||
59710230|NCT01233869|75828796|FG000|NOT COMPLETED|Initial Treatment Period (24 Months)||24||
59710231|NCT01233869|75828797|FG001|NOT COMPLETED|Initial Treatment Period (24 Months)||28||
59710232|NCT01233869|75828798|FG002|NOT COMPLETED|Initial Treatment Period (24 Months)||2||
59710233|NCT01233869|75828799|FG003|NOT COMPLETED|Initial Treatment Period (24 Months)||22||
59710234|NCT01233869|75828796|FG000|STARTED|Washout Period 30 Days||34||
59710235|NCT01233869|75828797|FG001|STARTED|Washout Period 30 Days||3||
59710236|NCT01233869|75828798|FG002|STARTED|Washout Period 30 Days||22||
59710237|NCT01233869|75828799|FG003|STARTED|Washout Period 30 Days||34||
59710238|NCT01233869|75828796|FG000|COMPLETED|Washout Period 30 Days||34||
59710239|NCT01233869|75828797|FG001|COMPLETED|Washout Period 30 Days||3||
60105267|NCT01847885|76223861|FG001|NOT COMPLETED|Randomization||4||
60105268|NCT01847885|76223862|FG002|NOT COMPLETED|Randomization||2||
60105269|NCT01314742|76223876|FG000|STARTED|Overall Study||20||
60105270|NCT01314742|76223877|FG001|STARTED|Overall Study||21||
59710240|NCT01233869|75828798|FG002|COMPLETED|Washout Period 30 Days||22||
59710241|NCT01233869|75828799|FG003|COMPLETED|Washout Period 30 Days||34||
59710242|NCT01233869|75828796|FG000|NOT COMPLETED|Washout Period 30 Days||0||
59710243|NCT01233869|75828797|FG001|NOT COMPLETED|Washout Period 30 Days||0||
59710244|NCT01233869|75828798|FG002|NOT COMPLETED|Washout Period 30 Days||0||
59710245|NCT01233869|75828799|FG003|NOT COMPLETED|Washout Period 30 Days||0||
59710246|NCT01233869|75828796|FG000|STARTED|Extended Treatment Period (46 Months)||34||
59710247|NCT01233869|75828797|FG001|STARTED|Extended Treatment Period (46 Months)||3||
59710248|NCT01233869|75828798|FG002|STARTED|Extended Treatment Period (46 Months)||22||
59710249|NCT01233869|75828799|FG003|STARTED|Extended Treatment Period (46 Months)||34||
59710250|NCT01233869|75828796|FG000|COMPLETED|Extended Treatment Period (46 Months)||20||
59710251|NCT01233869|75828797|FG001|COMPLETED|Extended Treatment Period (46 Months)||0||
59710252|NCT01233869|75828798|FG002|COMPLETED|Extended Treatment Period (46 Months)||17||
59710253|NCT01233869|75828799|FG003|COMPLETED|Extended Treatment Period (46 Months)||18||
59818125|NCT00523718|75940501|FG001|NOT COMPLETED|Overall Study||0||
59818126|NCT00523640|75940507|FG000|STARTED|Overall Study||30||
59818127|NCT00523640|75940507|FG000|COMPLETED|Overall Study|1 patient died before starting treatment|29||
59818128|NCT00523640|75940507|FG000|NOT COMPLETED|Overall Study||1||
59818129|NCT00345358|75940515|FG000|STARTED|Primary Vaccination Phase||150||
59818130|NCT00345358|75940516|FG001|STARTED|Primary Vaccination Phase||150||
59818131|NCT00345358|75940517|FG002|STARTED|Primary Vaccination Phase||150||
59818132|NCT00345358|75940518|FG003|STARTED|Primary Vaccination Phase||150||
59818133|NCT00345358|75940515|FG000|COMPLETED|Primary Vaccination Phase||145||
59818134|NCT00345358|75940516|FG001|COMPLETED|Primary Vaccination Phase||146||
59818135|NCT00345358|75940517|FG002|COMPLETED|Primary Vaccination Phase||142||
59818136|NCT00345358|75940518|FG003|COMPLETED|Primary Vaccination Phase||148||
59818137|NCT00345358|75940515|FG000|NOT COMPLETED|Primary Vaccination Phase||5||
59818138|NCT00345358|75940516|FG001|NOT COMPLETED|Primary Vaccination Phase||4||
59818139|NCT00345358|75940517|FG002|NOT COMPLETED|Primary Vaccination Phase||8||
59818140|NCT00345358|75940518|FG003|NOT COMPLETED|Primary Vaccination Phase||2||
59818141|NCT00345358|75940515|FG000|STARTED|Booster Vaccination Phase||145||
59818142|NCT00345358|75940516|FG001|STARTED|Booster Vaccination Phase||145||
59818143|NCT00345358|75940517|FG002|STARTED|Booster Vaccination Phase||0||
59818144|NCT00345358|75940518|FG003|STARTED|Booster Vaccination Phase||0||
59818145|NCT00345358|75940515|FG000|COMPLETED|Booster Vaccination Phase||141||
59818146|NCT00345358|75940516|FG001|COMPLETED|Booster Vaccination Phase||145||
59818147|NCT00345358|75940517|FG002|COMPLETED|Booster Vaccination Phase||0||
59818148|NCT00345358|75940518|FG003|COMPLETED|Booster Vaccination Phase||0||
59818149|NCT00345358|75940515|FG000|NOT COMPLETED|Booster Vaccination Phase||4||
59818150|NCT00345358|75940516|FG001|NOT COMPLETED|Booster Vaccination Phase||0||
59818151|NCT00345358|75940517|FG002|NOT COMPLETED|Booster Vaccination Phase||0||
60105271|NCT01314742|76223876|FG000|COMPLETED|Overall Study||20||
60105272|NCT01314742|76223877|FG001|COMPLETED|Overall Study||21||
60105273|NCT01314742|76223876|FG000|NOT COMPLETED|Overall Study||0||
60105274|NCT01314742|76223877|FG001|NOT COMPLETED|Overall Study||0||
60105275|NCT01407094|76223888|FG000|STARTED|Stage 1|Stage 1 Sertraline (SERT): 34 exited|146||
60105276|NCT01407094|76223889|FG001|STARTED|Stage 1|Stage 1 Placebo (PBO): 27 exited.|150||
60105277|NCT01407094|76223890|FG002|STARTED|Stage 1|Bupropion (BUP) was used only in Stage 2 for non-responders to SERT.|0||
60105278|NCT01407094|76223888|FG000|COMPLETED|Stage 1|One participant completed Stage 1 but did not continue to Stage 2.|112||
60105279|NCT01407094|76223889|FG001|COMPLETED|Stage 1|Four participants completed Stage 1 but did not continue to Stage 2.|123||
60105280|NCT01407094|76223890|FG002|COMPLETED|Stage 1||0||
60105281|NCT01407094|76223888|FG000|NOT COMPLETED|Stage 1||34||
60105282|NCT01407094|76223889|FG001|NOT COMPLETED|Stage 1||27||
60105283|NCT01407094|76223890|FG002|NOT COMPLETED|Stage 1||0||
60105284|NCT01407094|76223888|FG000|STARTED|Stage 2|Stage 2 SERT includes Stage 1 SERT responders (n=61) and Stage 1 PBO non-responders (n=73).|134||
60105285|NCT01407094|76223889|FG001|STARTED|Stage 2|Stage 2 PBO includes Stage 1 PBO responders (n=47); 1 early exit (n=46).|46||
60105286|NCT01407094|76223890|FG002|STARTED|Stage 2|Stage 2 BUP includes Stage 1 SERT non-responders (n=54); 1 early exit (n=53).|53||
60105287|NCT01407094|76223888|FG000|COMPLETED|Stage 2||113||
60105288|NCT01407094|76223889|FG001|COMPLETED|Stage 2||35||
60105289|NCT01407094|76223890|FG002|COMPLETED|Stage 2||38||
60105290|NCT01407094|76223888|FG000|NOT COMPLETED|Stage 2||21||
60105291|NCT01407094|76223889|FG001|NOT COMPLETED|Stage 2||11||
60105292|NCT01407094|76223890|FG002|NOT COMPLETED|Stage 2||15||
60105293|NCT01867307|76223900|FG000|STARTED|Overall Study|Started are the treated patients|18||
60105294|NCT01867307|76223901|FG001|STARTED|Overall Study|Started are the treated patients|19||
60105295|NCT01867307|76223900|FG000|COMPLETED|Overall Study||15||
60105296|NCT01867307|76223901|FG001|COMPLETED|Overall Study||16||
60105297|NCT01867307|76223900|FG000|NOT COMPLETED|Overall Study||3||
60105298|NCT01867307|76223901|FG001|NOT COMPLETED|Overall Study||3||
60105299|NCT01845077|76223910|FG000|STARTED|Treatment Period 1||12||
60105300|NCT01845077|76223911|FG001|STARTED|Treatment Period 1||12||
60105301|NCT01845077|76223912|FG002|STARTED|Treatment Period 1||12||
60105302|NCT01845077|76223913|FG003|STARTED|Treatment Period 1||12||
60105303|NCT01845077|76223914|FG004|STARTED|Treatment Period 1||12||
60105304|NCT01845077|76223915|FG005|STARTED|Treatment Period 1||12||
60105305|NCT01845077|76223910|FG000|COMPLETED|Treatment Period 1||12||
60105306|NCT01845077|76223911|FG001|COMPLETED|Treatment Period 1||12||
60105307|NCT01845077|76223912|FG002|COMPLETED|Treatment Period 1||12||
60105308|NCT01845077|76223913|FG003|COMPLETED|Treatment Period 1||12||
60105309|NCT01845077|76223914|FG004|COMPLETED|Treatment Period 1||12||
60105310|NCT01845077|76223915|FG005|COMPLETED|Treatment Period 1||12||
60105311|NCT01845077|76223910|FG000|NOT COMPLETED|Treatment Period 1||0||
60105312|NCT01845077|76223911|FG001|NOT COMPLETED|Treatment Period 1||0||
60105313|NCT01845077|76223912|FG002|NOT COMPLETED|Treatment Period 1||0||
60105314|NCT01845077|76223913|FG003|NOT COMPLETED|Treatment Period 1||0||
60105315|NCT01845077|76223914|FG004|NOT COMPLETED|Treatment Period 1||0||
60105316|NCT01845077|76223915|FG005|NOT COMPLETED|Treatment Period 1||0||
60105317|NCT01845077|76223910|FG000|STARTED|Washout Period||12||
60105318|NCT01845077|76223911|FG001|STARTED|Washout Period||12||
60105319|NCT01845077|76223912|FG002|STARTED|Washout Period||12||
60105320|NCT01845077|76223913|FG003|STARTED|Washout Period||12||
60105321|NCT01845077|76223914|FG004|STARTED|Washout Period||12||
60105322|NCT01845077|76223915|FG005|STARTED|Washout Period||12||
60105323|NCT01845077|76223910|FG000|COMPLETED|Washout Period||11||
60105324|NCT01845077|76223911|FG001|COMPLETED|Washout Period||11||
60105325|NCT01845077|76223912|FG002|COMPLETED|Washout Period||11||
60105326|NCT01845077|76223913|FG003|COMPLETED|Washout Period||10||
60105327|NCT01845077|76223914|FG004|COMPLETED|Washout Period||11||
60105328|NCT01845077|76223915|FG005|COMPLETED|Washout Period||11||
60105329|NCT01845077|76223910|FG000|NOT COMPLETED|Washout Period||1||
60105330|NCT01845077|76223911|FG001|NOT COMPLETED|Washout Period||1||
60105331|NCT01845077|76223912|FG002|NOT COMPLETED|Washout Period||1||
60105332|NCT01845077|76223913|FG003|NOT COMPLETED|Washout Period||2||
59566127|NCT03663231|75668600|FG000|STARTED|First Intervention||16||
59566128|NCT03663231|75668601|FG001|STARTED|First Intervention||13||
59566129|NCT03663231|75668600|FG000|COMPLETED|First Intervention||14||
59566130|NCT03663231|75668601|FG001|COMPLETED|First Intervention||12||
59566131|NCT03663231|75668600|FG000|NOT COMPLETED|First Intervention||2||
59566132|NCT03663231|75668601|FG001|NOT COMPLETED|First Intervention||1||
59566133|NCT03663231|75668600|FG000|STARTED|Washout||14||
59566134|NCT03663231|75668601|FG001|STARTED|Washout||12||
59566135|NCT03663231|75668600|FG000|COMPLETED|Washout||14||
60105333|NCT01845077|76223914|FG004|NOT COMPLETED|Washout Period||1||
60105334|NCT01845077|76223915|FG005|NOT COMPLETED|Washout Period||1||
60105335|NCT01845077|76223910|FG000|STARTED|Treatment Period 2||11||
60105336|NCT01845077|76223911|FG001|STARTED|Treatment Period 2||11||
60105337|NCT01845077|76223912|FG002|STARTED|Treatment Period 2||11||
60105338|NCT01845077|76223913|FG003|STARTED|Treatment Period 2||10||
60105339|NCT01845077|76223914|FG004|STARTED|Treatment Period 2||11||
60105340|NCT01845077|76223915|FG005|STARTED|Treatment Period 2||11||
60105341|NCT01845077|76223910|FG000|COMPLETED|Treatment Period 2||11||
60105342|NCT01845077|76223911|FG001|COMPLETED|Treatment Period 2||11||
60105343|NCT01845077|76223912|FG002|COMPLETED|Treatment Period 2||11||
60105344|NCT01845077|76223913|FG003|COMPLETED|Treatment Period 2||10||
60105345|NCT01845077|76223914|FG004|COMPLETED|Treatment Period 2||11||
59566136|NCT03663231|75668601|FG001|COMPLETED|Washout||12||
60105346|NCT01845077|76223915|FG005|COMPLETED|Treatment Period 2||11||
59566137|NCT03663231|75668600|FG000|NOT COMPLETED|Washout||0||
59566138|NCT03663231|75668601|FG001|NOT COMPLETED|Washout||0||
59566139|NCT03663231|75668600|FG000|STARTED|Second Intervention||14||
60105347|NCT01845077|76223910|FG000|NOT COMPLETED|Treatment Period 2||0||
60105348|NCT01845077|76223911|FG001|NOT COMPLETED|Treatment Period 2||0||
60105349|NCT01845077|76223912|FG002|NOT COMPLETED|Treatment Period 2||0||
59710254|NCT01233869|75828796|FG000|NOT COMPLETED|Extended Treatment Period (46 Months)||14||
59710255|NCT01233869|75828797|FG001|NOT COMPLETED|Extended Treatment Period (46 Months)||3||
60105350|NCT01845077|76223913|FG003|NOT COMPLETED|Treatment Period 2||0||
60105351|NCT01845077|76223914|FG004|NOT COMPLETED|Treatment Period 2||0||
60105352|NCT01845077|76223915|FG005|NOT COMPLETED|Treatment Period 2||0||
59710256|NCT01233869|75828798|FG002|NOT COMPLETED|Extended Treatment Period (46 Months)||5||
59710257|NCT01233869|75828799|FG003|NOT COMPLETED|Extended Treatment Period (46 Months)||16||
59710258|NCT00992992|75828809|FG000|STARTED|Overall Study||25||
59710259|NCT00992992|75828809|FG000|COMPLETED|Overall Study||0||
59710260|NCT00992992|75828809|FG000|NOT COMPLETED|Overall Study||25||
59710261|NCT00992836|75828813|FG000|STARTED|Overall Study||155||
60105353|NCT01866917|76223932|FG000|STARTED|Overall Study||17||
60105354|NCT01866917|76223933|FG001|STARTED|Overall Study||18||
60105355|NCT01866917|76223932|FG000|COMPLETED|Overall Study||13||
60105356|NCT01866917|76223933|FG001|COMPLETED|Overall Study||12||
60105357|NCT01866917|76223932|FG000|NOT COMPLETED|Overall Study||4||
60105358|NCT01866917|76223933|FG001|NOT COMPLETED|Overall Study||6||
60105359|NCT01407952|76223943|FG000|STARTED|Overall Study||297||
60105360|NCT01407952|76223944|FG001|STARTED|Overall Study||303||
60105361|NCT01407952|76223943|FG000|COMPLETED|Overall Study||251||
60105362|NCT01407952|76223944|FG001|COMPLETED|Overall Study||266||
60105363|NCT01407952|76223943|FG000|NOT COMPLETED|Overall Study||46||
60105364|NCT01407952|76223944|FG001|NOT COMPLETED|Overall Study||37||
60105365|NCT01316302|76223952|FG000|STARTED|Overall Study||30||
59710262|NCT00992836|75828813|FG000|Received Both Study Vaccinations|Overall Study||150||
60105366|NCT01316302|76223953|FG001|STARTED|Overall Study||33||
60105367|NCT01316302|76223952|FG000|COMPLETED|Overall Study||20||
60105368|NCT01316302|76223953|FG001|COMPLETED|Overall Study||22||
60105369|NCT01316302|76223952|FG000|NOT COMPLETED|Overall Study||10||
60105370|NCT01316302|76223953|FG001|NOT COMPLETED|Overall Study||11||
60105371|NCT01410058|76223963|FG000|STARTED|Washout Day 0||13||
60105372|NCT01410058|76223964|FG001|STARTED|Washout Day 0||6||
60105373|NCT01410058|76223963|FG000|COMPLETED|Washout Day 0||13||
60105374|NCT01410058|76223964|FG001|COMPLETED|Washout Day 0||6||
60105375|NCT01410058|76223963|FG000|NOT COMPLETED|Washout Day 0||0||
60105376|NCT01410058|76223964|FG001|NOT COMPLETED|Washout Day 0||0||
60105377|NCT01410058|76223963|FG000|STARTED|Baseline Day 22||13||
60105378|NCT01410058|76223964|FG001|STARTED|Baseline Day 22||6||
60105379|NCT01410058|76223963|FG000|COMPLETED|Baseline Day 22||13||
60105380|NCT01410058|76223964|FG001|COMPLETED|Baseline Day 22||6||
60105381|NCT01410058|76223963|FG000|NOT COMPLETED|Baseline Day 22||0||
60105382|NCT01410058|76223964|FG001|NOT COMPLETED|Baseline Day 22||0||
60105383|NCT01410058|76223963|FG000|STARTED|Day 35||13||
60105384|NCT01410058|76223964|FG001|STARTED|Day 35||6||
60105385|NCT01410058|76223963|FG000|COMPLETED|Day 35||13||
60105386|NCT01410058|76223964|FG001|COMPLETED|Day 35||6||
60105387|NCT01410058|76223963|FG000|NOT COMPLETED|Day 35||0||
60105388|NCT01410058|76223964|FG001|NOT COMPLETED|Day 35||0||
59710263|NCT00992836|75828813|FG000|COMPLETED|Overall Study||150||
59710264|NCT00992836|75828813|FG000|NOT COMPLETED|Overall Study||5||
60105389|NCT01380106|76223974|FG000|STARTED|Overall Study||16||
60105390|NCT01380106|76223975|FG001|STARTED|Overall Study||17||
60105391|NCT01380106|76223974|FG000|COMPLETED|Overall Study||16||
60105392|NCT01380106|76223975|FG001|COMPLETED|Overall Study||17||
60105393|NCT01380106|76223974|FG000|NOT COMPLETED|Overall Study||0||
60105394|NCT01380106|76223975|FG001|NOT COMPLETED|Overall Study||0||
60105395|NCT01381120|76223983|FG000|STARTED|Overall Study||50||
60105396|NCT01381120|76223984|FG001|STARTED|Overall Study||27||
60105397|NCT01381120|76223983|FG000|COMPLETED|Overall Study||39||
60105398|NCT01381120|76223984|FG001|COMPLETED|Overall Study||18||
60105399|NCT01381120|76223983|FG000|NOT COMPLETED|Overall Study||11||
60105400|NCT01381120|76223984|FG001|NOT COMPLETED|Overall Study||9||
59566140|NCT03663231|75668601|FG001|STARTED|Second Intervention||12||
59566141|NCT03663231|75668600|FG000|COMPLETED|Second Intervention||14||
59566142|NCT03663231|75668601|FG001|COMPLETED|Second Intervention||12||
59566143|NCT03663231|75668600|FG000|NOT COMPLETED|Second Intervention||0||
59566144|NCT03663231|75668601|FG001|NOT COMPLETED|Second Intervention||0||
59566145|NCT00558428|75668611|FG000|STARTED|Overall Study||267||
59566146|NCT00558428|75668612|FG001|STARTED|Overall Study||276||
59566147|NCT00558428|75668613|FG002|STARTED|Overall Study||277||
59566148|NCT00558428|75668614|FG003|STARTED|Overall Study||277||
59566149|NCT00558428|75668611|FG000|COMPLETED|Overall Study||255||
59566150|NCT00558428|75668612|FG001|COMPLETED|Overall Study||252||
59566151|NCT00558428|75668613|FG002|COMPLETED|Overall Study||273||
59566152|NCT00558428|75668614|FG003|COMPLETED|Overall Study||266||
59566153|NCT00558428|75668611|FG000|NOT COMPLETED|Overall Study||12||
59566154|NCT00558428|75668612|FG001|NOT COMPLETED|Overall Study||24||
59566155|NCT00558428|75668613|FG002|NOT COMPLETED|Overall Study||4||
59566156|NCT00558428|75668614|FG003|NOT COMPLETED|Overall Study||11||
59566157|NCT03405363|75668626|FG000|STARTED|Overall Study||14239||
59566158|NCT03405363|75668627|FG001|STARTED|Overall Study||51167||
59566159|NCT03405363|75668626|FG000|COMPLETED|Overall Study||14239||
59710265|NCT00992446|75828823|FG000|STARTED|Overall Study||27||
59710266|NCT00992446|75828823|FG000|COMPLETED|Overall Study||19||
59710267|NCT00992446|75828823|FG000|NOT COMPLETED|Overall Study||8||
59710268|NCT04344301|75828829|FG000|STARTED|Overall Study||45||
59710269|NCT04344301|75828830|FG001|STARTED|Overall Study||46||
59710270|NCT04344301|75828829|FG000|COMPLETED|Overall Study||44||
59710271|NCT04344301|75828830|FG001|COMPLETED|Overall Study||45||
59710272|NCT04344301|75828829|FG000|NOT COMPLETED|Overall Study||1||
59710273|NCT04344301|75828830|FG001|NOT COMPLETED|Overall Study||1||
59710274|NCT00970294|75828837|FG000|STARTED|Overall Study||11||
59996022|NCT01361919|76111969|FG000|COMPLETED|Overall Study||90||
59996023|NCT01361919|76111970|FG001|COMPLETED|Overall Study||88||
59996024|NCT01361919|76111971|FG002|COMPLETED|Overall Study||88||
59996025|NCT01361919|76111969|FG000|NOT COMPLETED|Overall Study||10||
59996026|NCT01361919|76111970|FG001|NOT COMPLETED|Overall Study||12||
59996027|NCT01361919|76111971|FG002|NOT COMPLETED|Overall Study||10||
59996028|NCT02642679|76111979|FG000|STARTED|Overall Study||19||
59996029|NCT02642679|76111979|FG000|COMPLETED|Overall Study||16|Three patients were withdrawn for personal reasons, and surgeon request.|
59996030|NCT02642679|76111979|FG000|NOT COMPLETED|Overall Study||3||
59996031|NCT00705523|76111985|FG000|STARTED|Overall Study||19||
59996032|NCT00705523|76111986|FG001|STARTED|Overall Study||21||
59996033|NCT00705523|76111985|FG000|COMPLETED|Overall Study||17||
59996034|NCT00705523|76111986|FG001|COMPLETED|Overall Study||18||
59996035|NCT00705523|76111985|FG000|NOT COMPLETED|Overall Study||2||
59996036|NCT00705523|76111986|FG001|NOT COMPLETED|Overall Study||3||
59996037|NCT02725411|76111995|FG000|STARTED|Treatment Period (56 Weeks)||92||
60105401|NCT01316770|76223990|FG000|STARTED|Overall Study|Each study participant received the dexamethasone parotid irrigation on one side of mouth.|9||9
60105402|NCT01316770|76223991|FG001|STARTED|Overall Study|Each study participant received the placebo parotid irrigation on the other side of mouth.|9||9
60105403|NCT01316770|76223990|FG000|COMPLETED|Overall Study||9||9
60105404|NCT01316770|76223991|FG001|COMPLETED|Overall Study||9||9
60105405|NCT01316770|76223990|FG000|NOT COMPLETED|Overall Study||0||0
60105406|NCT01316770|76223991|FG001|NOT COMPLETED|Overall Study||0||0
60105407|NCT01316926|76224001|FG000|STARTED|Period 1||30||
60105408|NCT01316926|76224002|FG001|STARTED|Period 1||30||
60105409|NCT01316926|76224001|FG000|COMPLETED|Period 1||30||
60105410|NCT01316926|76224002|FG001|COMPLETED|Period 1||30||
60105411|NCT01316926|76224001|FG000|NOT COMPLETED|Period 1||0||
60105412|NCT01316926|76224002|FG001|NOT COMPLETED|Period 1||0||
60105413|NCT01316926|76224001|FG000|STARTED|Period 2|One participant completed Period 1, but did not appear in Period 2|29||
60105414|NCT01316926|76224002|FG001|STARTED|Period 2||30||
60105415|NCT01316926|76224001|FG000|COMPLETED|Period 2||29||
60105416|NCT01316926|76224002|FG001|COMPLETED|Period 2||30||
60105417|NCT01316926|76224001|FG000|NOT COMPLETED|Period 2||0||
60105418|NCT01316926|76224002|FG001|NOT COMPLETED|Period 2||0||
60105419|NCT01318018|76224011|FG000|STARTED|Overall Study||10||
60105420|NCT01318018|76224012|FG001|STARTED|Overall Study||10||
60105421|NCT01318018|76224011|FG000|COMPLETED|Overall Study||10||
60105422|NCT01318018|76224012|FG001|COMPLETED|Overall Study||10||
60105423|NCT01318018|76224011|FG000|NOT COMPLETED|Overall Study||0||
60105424|NCT01318018|76224012|FG001|NOT COMPLETED|Overall Study||0||
60105425|NCT01318408|76224018|FG000|STARTED|Overall Study||24||
60105426|NCT01318408|76224018|FG000|COMPLETED|Overall Study||16||
59566160|NCT03405363|75668627|FG001|COMPLETED|Overall Study||51167||
59566161|NCT03405363|75668626|FG000|NOT COMPLETED|Overall Study||0||
59566162|NCT03405363|75668627|FG001|NOT COMPLETED|Overall Study||0||
59566163|NCT04310085|75668635|FG000|STARTED|Overall Study||8||
59566164|NCT04310085|75668636|FG001|STARTED|Overall Study||8||
60105427|NCT01318408|76224018|FG000|NOT COMPLETED|Overall Study||8||
60105428|NCT01319110|76224024|FG000|STARTED|Overall Study||5||
60105429|NCT01319110|76224025|FG001|STARTED|Overall Study||5||
60105430|NCT01319110|76224024|FG000|COMPLETED|Overall Study||5||
60105431|NCT01319110|76224025|FG001|COMPLETED|Overall Study||5||
60105432|NCT01319110|76224024|FG000|NOT COMPLETED|Overall Study||0||
60105433|NCT01319110|76224025|FG001|NOT COMPLETED|Overall Study||0||
60105434|NCT01383616|76224033|FG000|STARTED|Overall Study||40||
60105435|NCT01383616|76224034|FG001|STARTED|Overall Study||44||
60105436|NCT01383616|76224033|FG000|COMPLETED|Overall Study||23||
60105437|NCT01383616|76224034|FG001|COMPLETED|Overall Study||21||
60105438|NCT01383616|76224033|FG000|NOT COMPLETED|Overall Study||17||
60105439|NCT01383616|76224034|FG001|NOT COMPLETED|Overall Study||23||
60105440|NCT01411696|76224044|FG000|STARTED|Overall Study||289||
60105441|NCT01411696|76224044|FG000|COMPLETED|Overall Study||289||
60105442|NCT01411696|76224044|FG000|NOT COMPLETED|Overall Study||0||
60105443|NCT01319500|76224050|FG000|STARTED|Overall Study||1187||
60105444|NCT01319500|76224051|FG001|STARTED|Overall Study||2589||
59710275|NCT00970294|75828837|FG000|COMPLETED|Overall Study||6||
60105445|NCT01319500|76224050|FG000|COMPLETED|Overall Study||1187||
60105446|NCT01319500|76224051|FG001|COMPLETED|Overall Study||2589||
60105447|NCT01319500|76224050|FG000|NOT COMPLETED|Overall Study||0||
60105448|NCT01319500|76224051|FG001|NOT COMPLETED|Overall Study||0||
60105449|NCT01412086|76224062|FG000|STARTED|Overall Study||112||
60105450|NCT01412086|76224062|FG000|COMPLETED|Overall Study||112||
60105451|NCT01412086|76224062|FG000|NOT COMPLETED|Overall Study||0||
60105452|NCT01844765|76224068|FG000|STARTED|Overall Study||34||
60105453|NCT01844765|76224069|FG001|STARTED|Overall Study||25||
60105454|NCT01844765|76224068|FG000|Treated|Overall Study||33||
60105455|NCT01844765|76224069|FG001|Treated|Overall Study||25||
60105456|NCT01844765|76224068|FG000|Untreated|Overall Study|Did not receive study drug due to adverse event (AE).|1||
60105457|NCT01844765|76224069|FG001|Untreated|Overall Study||0||
60105458|NCT01844765|76224068|FG000|COMPLETED|Overall Study||19|Completed = Treatment duration is completed per protocol|
59566165|NCT04310085|75668635|FG000|COMPLETED|Overall Study||8||
59566166|NCT04310085|75668636|FG001|COMPLETED|Overall Study||8||
59566167|NCT04310085|75668635|FG000|NOT COMPLETED|Overall Study||0||
59566168|NCT04310085|75668636|FG001|NOT COMPLETED|Overall Study||0||
59710276|NCT00970294|75828837|FG000|NOT COMPLETED|Overall Study||5||
60105459|NCT01844765|76224069|FG001|COMPLETED|Overall Study||10|Completed = Treatment duration is completed per protocol|
60105460|NCT01844765|76224068|FG000|NOT COMPLETED|Overall Study||15||
60105461|NCT01844765|76224069|FG001|NOT COMPLETED|Overall Study||15||
60105462|NCT01412164|76224080|FG000|STARTED|Overall Study||730||
59566169|NCT03406377|75668644|FG000|STARTED|Overall Study||41||
59566170|NCT03406377|75668645|FG001|STARTED|Overall Study||72||
59566171|NCT03406377|75668644|FG000|COMPLETED|Overall Study||25||
59566172|NCT03406377|75668645|FG001|COMPLETED|Overall Study||51||
59566173|NCT03406377|75668644|FG000|NOT COMPLETED|Overall Study||16||
59566174|NCT03406377|75668645|FG001|NOT COMPLETED|Overall Study||21||
59566175|NCT00558272|75668653|FG000|STARTED|Overall Study|Randomised|69||
59566176|NCT00558272|75668654|FG001|STARTED|Overall Study|Randomised|70||
59566177|NCT00558272|75668653|FG000|30 Days Follow-up|Overall Study|30 days after last dose|41||
59566178|NCT00558272|75668654|FG001|30 Days Follow-up|Overall Study|30 days after last dose|67||
59566179|NCT00558272|75668653|FG000|COMPLETED|Overall Study|4-week treatment period|56||
59566180|NCT00558272|75668654|FG001|COMPLETED|Overall Study|4-week treatment period|68||
59566181|NCT00558272|75668653|FG000|NOT COMPLETED|Overall Study||13||
59566182|NCT00558272|75668654|FG001|NOT COMPLETED|Overall Study||2||
59566183|NCT03407313|75668660|FG000|STARTED|Overall Study||68||
59566184|NCT03407313|75668660|FG000|COMPLETED|Overall Study||66||
59566185|NCT03407313|75668660|FG000|NOT COMPLETED|Overall Study||2||
59566186|NCT01859312|75668664|FG000|STARTED|Overall Study||8||
59566187|NCT01859312|75668664|FG000|COMPLETED|Overall Study|Based on medication & supply accountability, one participant was found to be partially non-compliant|8||
59566188|NCT01859312|75668664|FG000|NOT COMPLETED|Overall Study||0||
59566189|NCT03407625|75668671|FG000|STARTED|Overall Study||1117||
59566190|NCT03407625|75668672|FG001|STARTED|Overall Study||1110||
59566191|NCT03407625|75668671|FG000|COMPLETED|Overall Study||1117||
59566192|NCT03407625|75668672|FG001|COMPLETED|Overall Study||1110||
59566193|NCT03407625|75668671|FG000|NOT COMPLETED|Overall Study||0||
59566194|NCT03407625|75668672|FG001|NOT COMPLETED|Overall Study||0||
59566195|NCT03408171|75668680|FG000|STARTED|Overall Study||20||
59566196|NCT03408171|75668681|FG001|STARTED|Overall Study||20||
59566197|NCT03408171|75668680|FG000|COMPLETED|Overall Study||20||
59566198|NCT03408171|75668681|FG001|COMPLETED|Overall Study||20||
59566199|NCT03408171|75668680|FG000|NOT COMPLETED|Overall Study||0||
59566200|NCT03408171|75668681|FG001|NOT COMPLETED|Overall Study||0||
59566201|NCT01860950|75668693|FG000|STARTED|Overall Study||14||
59566202|NCT01860950|75668694|FG001|STARTED|Overall Study||15||
59566203|NCT01860950|75668695|FG002|STARTED|Overall Study||10||
59566204|NCT01860950|75668696|FG003|STARTED|Overall Study||13||
59566205|NCT01860950|75668697|FG004|STARTED|Overall Study||14||
59566206|NCT01860950|75668698|FG005|STARTED|Overall Study||13||
59566207|NCT01860950|75668693|FG000|COMPLETED|Overall Study||14||
59566208|NCT01860950|75668694|FG001|COMPLETED|Overall Study||15||
59566209|NCT01860950|75668695|FG002|COMPLETED|Overall Study||10||
59566210|NCT01860950|75668696|FG003|COMPLETED|Overall Study||13||
59566211|NCT01860950|75668697|FG004|COMPLETED|Overall Study||14||
59566212|NCT01860950|75668698|FG005|COMPLETED|Overall Study||13||
59566213|NCT01860950|75668693|FG000|NOT COMPLETED|Overall Study||0||
59566214|NCT01860950|75668694|FG001|NOT COMPLETED|Overall Study||0||
59566215|NCT01860950|75668695|FG002|NOT COMPLETED|Overall Study||0||
59566216|NCT01860950|75668696|FG003|NOT COMPLETED|Overall Study||0||
59566217|NCT01860950|75668697|FG004|NOT COMPLETED|Overall Study||0||
59566218|NCT01860950|75668698|FG005|NOT COMPLETED|Overall Study||0||
59566219|NCT03666663|75668717|FG000|STARTED|Overall Study||3||
59566220|NCT03666663|75668718|FG001|STARTED|Overall Study||1||
59566221|NCT03666663|75668719|FG002|STARTED|Overall Study||3||
59566222|NCT03666663|75668720|FG003|STARTED|Overall Study||3||
59710277|NCT00969436|75828844|FG000|STARTED|Overall Study||180||
59710278|NCT00969436|75828845|FG001|STARTED|Overall Study||180||
59710279|NCT00969436|75828846|FG002|STARTED|Overall Study||90||
59566223|NCT03666663|75668717|FG000|COMPLETED|Overall Study||3||
59710280|NCT00969436|75828844|FG000|COMPLETED|Overall Study||155||
59566224|NCT03666663|75668718|FG001|COMPLETED|Overall Study||1||
59566225|NCT03666663|75668719|FG002|COMPLETED|Overall Study||1||
59566226|NCT03666663|75668720|FG003|COMPLETED|Overall Study||1||
59566227|NCT03666663|75668717|FG000|NOT COMPLETED|Overall Study||0||
59566228|NCT03666663|75668718|FG001|NOT COMPLETED|Overall Study||0||
59566229|NCT03666663|75668719|FG002|NOT COMPLETED|Overall Study||2||
59566230|NCT03666663|75668720|FG003|NOT COMPLETED|Overall Study||2||
59566231|NCT03670017|75668730|FG000|STARTED|Overall Study||68||
59566232|NCT03670017|75668730|FG000|COMPLETED|Overall Study||50||
59566233|NCT03670017|75668730|FG000|NOT COMPLETED|Overall Study||18||
59566234|NCT04309617|75668734|FG000|STARTED|Overall Study||618||
59566235|NCT04309617|75668734|FG000|Modified High Risk of Recurrence|Overall Study||136||
59566236|NCT04309617|75668734|FG000|COMPLETED|Overall Study||618||
59710281|NCT00969436|75828845|FG001|COMPLETED|Overall Study||159||
59710282|NCT00969436|75828846|FG002|COMPLETED|Overall Study||79||
59710283|NCT00969436|75828844|FG000|NOT COMPLETED|Overall Study||25||
59710284|NCT00969436|75828845|FG001|NOT COMPLETED|Overall Study||21||
59710285|NCT00969436|75828846|FG002|NOT COMPLETED|Overall Study||11||
59818152|NCT00345358|75940518|FG003|NOT COMPLETED|Booster Vaccination Phase||0||
59818153|NCT03869684|75940531|FG000|STARTED|Overall Study||3||
59818154|NCT03869684|75940532|FG001|STARTED|Overall Study||5||
59818155|NCT03869684|75940533|FG002|STARTED|Overall Study||5||
59818156|NCT03869684|75940531|FG000|COMPLETED|Overall Study||1||
59818157|NCT03869684|75940532|FG001|COMPLETED|Overall Study||2||
59818158|NCT03869684|75940533|FG002|COMPLETED|Overall Study||2||
59818159|NCT03869684|75940531|FG000|NOT COMPLETED|Overall Study||2||
59818160|NCT03869684|75940532|FG001|NOT COMPLETED|Overall Study||3||
59818161|NCT03869684|75940533|FG002|NOT COMPLETED|Overall Study||3||
59818162|NCT00516074|75940543|FG000|STARTED|Overall Study||28||
59818163|NCT00516074|75940544|FG001|STARTED|Overall Study||26||
59818164|NCT00516074|75940543|FG000|COMPLETED|Overall Study||22||
59818165|NCT00516074|75940544|FG001|COMPLETED|Overall Study||23||
59818166|NCT00516074|75940543|FG000|NOT COMPLETED|Overall Study||6||
59818167|NCT00516074|75940544|FG001|NOT COMPLETED|Overall Study||3||
59818168|NCT00515294|75940554|FG000|STARTED|Overall Study||38||
59818169|NCT00515294|75940555|FG001|STARTED|Overall Study||39||
59818170|NCT00515294|75940556|FG002|STARTED|Overall Study||38||
59818171|NCT00515294|75940557|FG003|STARTED|Overall Study||39||
59818172|NCT00515294|75940554|FG000|COMPLETED|Overall Study||29||
59818173|NCT00515294|75940555|FG001|COMPLETED|Overall Study||36||
59818174|NCT00515294|75940556|FG002|COMPLETED|Overall Study||27||
59818175|NCT00515294|75940557|FG003|COMPLETED|Overall Study||35||
59818176|NCT00515294|75940554|FG000|NOT COMPLETED|Overall Study||9||
59818177|NCT00515294|75940555|FG001|NOT COMPLETED|Overall Study||3||
59818178|NCT00515294|75940556|FG002|NOT COMPLETED|Overall Study||11||
59818179|NCT00515294|75940557|FG003|NOT COMPLETED|Overall Study||4||
59818180|NCT00345046|75940570|FG000|STARTED|Overall Study||18||
59818181|NCT00345046|75940571|FG001|STARTED|Overall Study||22||
59818182|NCT00345046|75940572|FG002|STARTED|Overall Study||16||
59818183|NCT00345046|75940570|FG000|COMPLETED|Overall Study||17||
59818184|NCT00345046|75940571|FG001|COMPLETED|Overall Study||21||
59818185|NCT00345046|75940572|FG002|COMPLETED|Overall Study||14||
59710286|NCT00900757|75828854|FG000|STARTED|Overall Study||57||
59710287|NCT00900757|75828854|FG000|COMPLETED|Overall Study||38||
59710288|NCT00900757|75828854|FG000|NOT COMPLETED|Overall Study||19||
59818186|NCT00345046|75940570|FG000|NOT COMPLETED|Overall Study||1||
59818187|NCT00345046|75940571|FG001|NOT COMPLETED|Overall Study||1||
59818188|NCT00345046|75940572|FG002|NOT COMPLETED|Overall Study||2||
59818189|NCT00515216|75940580|FG000|STARTED|Overall Study||26||
59818190|NCT00515216|75940580|FG000|COMPLETED|Overall Study||25||
59818191|NCT00515216|75940580|FG000|NOT COMPLETED|Overall Study||1||
59818192|NCT00522626|75940585|FG000|STARTED|Overall Study||19||
59818193|NCT00522626|75940585|FG000|COMPLETED|Overall Study||12||
59710289|NCT00969280|75828860|FG000|STARTED|Overall Study||21||
59818194|NCT00522626|75940585|FG000|NOT COMPLETED|Overall Study||7||
59818195|NCT00440193|75940591|FG000|STARTED|Treatment Period||1731||
59996038|NCT02725411|76111996|FG001|STARTED|Treatment Period (56 Weeks)||93||
59996039|NCT02725411|76111997|FG002|STARTED|Treatment Period (56 Weeks)||92||
59996040|NCT02725411|76111995|FG000|Treated|Treatment Period (56 Weeks)||92||
59996041|NCT02725411|76111996|FG001|Treated|Treatment Period (56 Weeks)||93||
59996042|NCT02725411|76111997|FG002|Treated|Treatment Period (56 Weeks)||92||
59996043|NCT02725411|76111995|FG000|COMPLETED|Treatment Period (56 Weeks)||62||
59996044|NCT02725411|76111996|FG001|COMPLETED|Treatment Period (56 Weeks)||43||
59996045|NCT02725411|76111997|FG002|COMPLETED|Treatment Period (56 Weeks)||43||
59566237|NCT04309617|75668734|FG000|NOT COMPLETED|Overall Study||0||
59710290|NCT00969280|75828861|FG001|STARTED|Overall Study||21||
59818196|NCT00440193|75940592|FG001|STARTED|Treatment Period||1718||
59818197|NCT00440193|75940591|FG000|Participants Received Treatment|Treatment Period||1718||
59996046|NCT02725411|76111995|FG000|NOT COMPLETED|Treatment Period (56 Weeks)||30||
59996047|NCT02725411|76111996|FG001|NOT COMPLETED|Treatment Period (56 Weeks)||50||
59996048|NCT02725411|76111997|FG002|NOT COMPLETED|Treatment Period (56 Weeks)||49||
59996049|NCT02725411|76111995|FG000|STARTED|Follow-up Period (24 Weeks)|All participants on either completion or discontinuation of treatment, entered follow up period.|92||
59996050|NCT02725411|76111996|FG001|STARTED|Follow-up Period (24 Weeks)|All participants on either completion or discontinuation of treatment, entered follow up period.|93||
59996051|NCT02725411|76111997|FG002|STARTED|Follow-up Period (24 Weeks)|All participants on either completion or discontinuation of treatment, entered follow up period.|92||
59996052|NCT02725411|76111995|FG000|COMPLETED|Follow-up Period (24 Weeks)||88||
59710291|NCT00969280|75828860|FG000|COMPLETED|Overall Study||19||
59710292|NCT00969280|75828861|FG001|COMPLETED|Overall Study||18||
59710293|NCT00969280|75828860|FG000|NOT COMPLETED|Overall Study||2||
60105463|NCT01412164|76224080|FG000|COMPLETED|Overall Study||683||
60105464|NCT01412164|76224080|FG000|NOT COMPLETED|Overall Study||47||
60105465|NCT01866293|76224084|FG000|STARTED|Overall Study||11||
60105466|NCT01866293|76224084|FG000|COMPLETED|Overall Study||9||
59710294|NCT00969280|75828861|FG001|NOT COMPLETED|Overall Study||3||
60105467|NCT01866293|76224084|FG000|NOT COMPLETED|Overall Study||2||
60105468|NCT01844687|76224088|FG000|STARTED|Visit 1||50||
60105469|NCT01844687|76224088|FG000|COMPLETED|Visit 1||42||
60105470|NCT01844687|76224088|FG000|NOT COMPLETED|Visit 1||8||
60105471|NCT01844687|76224088|FG000|STARTED|Visit 2||42||
60105472|NCT01844687|76224088|FG000|COMPLETED|Visit 2||40||
60105473|NCT01844687|76224088|FG000|NOT COMPLETED|Visit 2||2||
60105474|NCT01844687|76224088|FG000|STARTED|Visit 3||40||
60105475|NCT01844687|76224088|FG000|COMPLETED|Visit 3||35||
60105476|NCT01844687|76224088|FG000|NOT COMPLETED|Visit 3||5||
60105477|NCT01844687|76224088|FG000|STARTED|Visit 4||35||
60105478|NCT01844687|76224088|FG000|COMPLETED|Visit 4||31||
60105479|NCT01844687|76224088|FG000|NOT COMPLETED|Visit 4||4||
60105480|NCT01844687|76224088|FG000|STARTED|Visit 5||31||
60105481|NCT01844687|76224088|FG000|COMPLETED|Visit 5||31||
60105482|NCT01844687|76224088|FG000|NOT COMPLETED|Visit 5||0||
60105483|NCT01844687|76224088|FG000|STARTED|Visit 6||31||
60105484|NCT01844687|76224088|FG000|COMPLETED|Visit 6||31||
60105485|NCT01844687|76224088|FG000|NOT COMPLETED|Visit 6||0||
60105486|NCT01844687|76224088|FG000|STARTED|Visit 7||31||
60105487|NCT01844687|76224088|FG000|COMPLETED|Visit 7||31||
60105488|NCT01844687|76224088|FG000|NOT COMPLETED|Visit 7||0||
60105489|NCT01844687|76224088|FG000|STARTED|Visit 8||31||
59566238|NCT01861574|75668744|FG000|STARTED|Overall Study||28||
60105490|NCT01844687|76224088|FG000|COMPLETED|Visit 8||31||
60105491|NCT01844687|76224088|FG000|NOT COMPLETED|Visit 8||0||
60105492|NCT01844531|76224114|FG000|STARTED|Overall Study||6||
60105493|NCT01844531|76224115|FG001|STARTED|Overall Study||6||
60105494|NCT01844531|76224116|FG002|STARTED|Overall Study||6||
60105495|NCT01844531|76224117|FG003|STARTED|Overall Study||6||
60105496|NCT01844531|76224114|FG000|COMPLETED|Overall Study||6||
60105497|NCT01844531|76224115|FG001|COMPLETED|Overall Study||5||
60105498|NCT01844531|76224116|FG002|COMPLETED|Overall Study||6||
59710295|NCT00969124|75828867|FG000|STARTED|Overall Study||328||
59818198|NCT00440193|75940592|FG001|Participants Received Treatment|Treatment Period||1711||
59818199|NCT00440193|75940591|FG000|COMPLETED|Treatment Period||1426||
59818200|NCT00440193|75940592|FG001|COMPLETED|Treatment Period||1367||
59818201|NCT00440193|75940591|FG000|NOT COMPLETED|Treatment Period||305||
59818202|NCT00440193|75940592|FG001|NOT COMPLETED|Treatment Period||351||
60105499|NCT01844531|76224117|FG003|COMPLETED|Overall Study||6||
60105500|NCT01844531|76224114|FG000|NOT COMPLETED|Overall Study||0||
60105501|NCT01844531|76224115|FG001|NOT COMPLETED|Overall Study||1||
60105502|NCT01844531|76224116|FG002|NOT COMPLETED|Overall Study||0||
60105503|NCT01844531|76224117|FG003|NOT COMPLETED|Overall Study||0||
60105504|NCT01844375|76224129|FG000|STARTED|Overall Study||35||
60105505|NCT01844375|76224130|FG001|STARTED|Overall Study||35||
60105506|NCT01844375|76224129|FG000|COMPLETED|Overall Study||34||
60105507|NCT01844375|76224130|FG001|COMPLETED|Overall Study||34||
60105508|NCT01844375|76224129|FG000|NOT COMPLETED|Overall Study||1||
60105509|NCT01844375|76224130|FG001|NOT COMPLETED|Overall Study||1||
59566239|NCT01861574|75668745|FG001|STARTED|Overall Study||25||
59566240|NCT01861574|75668746|FG002|STARTED|Overall Study||27||
59566241|NCT01861574|75668747|FG003|STARTED|Overall Study||28||
59566242|NCT01861574|75668744|FG000|COMPLETED|Overall Study||28||
59710296|NCT00969124|75828867|FG000|COMPLETED|Overall Study||298||
59710297|NCT00969124|75828867|FG000|NOT COMPLETED|Overall Study||30||
59710298|NCT00900601|75828872|FG000|STARTED|Overall Study||9||
59710299|NCT00900601|75828872|FG000|COMPLETED|Overall Study||8||
59710300|NCT00900601|75828872|FG000|NOT COMPLETED|Overall Study||1||
59710301|NCT03671239|75828876|FG000|STARTED|First Intervention (4 Weeks)||35||
59710302|NCT03671239|75828877|FG001|STARTED|First Intervention (4 Weeks)||36||
59710303|NCT03671239|75828878|FG002|STARTED|First Intervention (4 Weeks)||37||
59710304|NCT03671239|75828879|FG003|STARTED|First Intervention (4 Weeks)||36||
59710305|NCT03671239|75828880|FG004|STARTED|First Intervention (4 Weeks)||37||
59710306|NCT03671239|75828881|FG005|STARTED|First Intervention (4 Weeks)||36||
59710307|NCT03671239|75828876|FG000|COMPLETED|First Intervention (4 Weeks)||33||
59710308|NCT03671239|75828877|FG001|COMPLETED|First Intervention (4 Weeks)||33||
59710309|NCT03671239|75828878|FG002|COMPLETED|First Intervention (4 Weeks)||35||
59710310|NCT03671239|75828879|FG003|COMPLETED|First Intervention (4 Weeks)||35||
59710311|NCT03671239|75828880|FG004|COMPLETED|First Intervention (4 Weeks)||35||
59818203|NCT00440193|75940591|FG000|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|1425||
59818204|NCT00440193|75940592|FG001|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|1407||
59818205|NCT00440193|75940591|FG000|COMPLETED|Observational Period||1380||
59996053|NCT02725411|76111996|FG001|COMPLETED|Follow-up Period (24 Weeks)||82||
59996054|NCT02725411|76111997|FG002|COMPLETED|Follow-up Period (24 Weeks)||87||
59996055|NCT02725411|76111995|FG000|NOT COMPLETED|Follow-up Period (24 Weeks)||4||
59996056|NCT02725411|76111996|FG001|NOT COMPLETED|Follow-up Period (24 Weeks)||11||
59996057|NCT02725411|76111997|FG002|NOT COMPLETED|Follow-up Period (24 Weeks)||5||
59996058|NCT02435511|76112007|FG000|STARTED|Overall Study|Defined as enrolled and completed baseline|202||
59818206|NCT00440193|75940592|FG001|COMPLETED|Observational Period||1369||
59996059|NCT02435511|76112008|FG001|STARTED|Overall Study|Defined as enrolled and completed baseline|209||
59996060|NCT02435511|76112007|FG000|COMPLETED|Overall Study|Defined as completing the 3 month follow-up, not necessarily all time points|158||
59996061|NCT02435511|76112008|FG001|COMPLETED|Overall Study|Defined as completing the 3 month follow-up; not necessarily all time points|174||
59996062|NCT02435511|76112007|FG000|NOT COMPLETED|Overall Study||44||
59996063|NCT02435511|76112008|FG001|NOT COMPLETED|Overall Study||35||
59996064|NCT02190604|76112033|FG000|STARTED|Part 1 and 2 (Healthy Volunteers)||6||
59996065|NCT02190604|76112034|FG001|STARTED|Part 1 and 2 (Healthy Volunteers)||6||
59996066|NCT02190604|76112035|FG002|STARTED|Part 1 and 2 (Healthy Volunteers)||6||
59996067|NCT02190604|76112036|FG003|STARTED|Part 1 and 2 (Healthy Volunteers)||6||
59996068|NCT02190604|76112037|FG004|STARTED|Part 1 and 2 (Healthy Volunteers)||6||
59996069|NCT02190604|76112038|FG005|STARTED|Part 1 and 2 (Healthy Volunteers)||6||
60105510|NCT02367456|76224139|FG000|STARTED|Overall Study||12||
60105511|NCT02367456|76224140|FG001|STARTED|Overall Study||30||
59710312|NCT03671239|75828881|FG005|COMPLETED|First Intervention (4 Weeks)||33||
59710313|NCT03671239|75828876|FG000|NOT COMPLETED|First Intervention (4 Weeks)||2||
59710314|NCT03671239|75828877|FG001|NOT COMPLETED|First Intervention (4 Weeks)||3||
59710315|NCT03671239|75828878|FG002|NOT COMPLETED|First Intervention (4 Weeks)||2||
59710316|NCT03671239|75828879|FG003|NOT COMPLETED|First Intervention (4 Weeks)||1||
59710317|NCT03671239|75828880|FG004|NOT COMPLETED|First Intervention (4 Weeks)||2||
59710318|NCT03671239|75828881|FG005|NOT COMPLETED|First Intervention (4 Weeks)||3||
59818207|NCT00440193|75940591|FG000|NOT COMPLETED|Observational Period||45||
59818208|NCT00440193|75940592|FG001|NOT COMPLETED|Observational Period||38||
59818209|NCT00511472|75940600|FG000|STARTED|Overall Study||47||
59566243|NCT01861574|75668745|FG001|COMPLETED|Overall Study||25||
59710319|NCT03671239|75828876|FG000|STARTED|Washout (1 Week)|Per the trial protocol, participants who discontinued the product in the first or second intervention for self-initiated reasons (except for HIV infection and pregnancy) were allowed to progress to the next study period if they were willing. The two participants who did not complete the first intervention in Product Sequence A were willing to go through the washout period and received the study product in the second intervention.|35||
59818210|NCT00511472|75940601|FG001|STARTED|Overall Study||23||
60105512|NCT02367456|76224141|FG002|STARTED|Overall Study||30||
60105513|NCT02367456|76224139|FG000|COMPLETED|Overall Study||0||
60105514|NCT02367456|76224140|FG001|COMPLETED|Overall Study||0||
60105515|NCT02367456|76224141|FG002|COMPLETED|Overall Study||0||
60105516|NCT02367456|76224139|FG000|NOT COMPLETED|Overall Study||12||
60105517|NCT02367456|76224140|FG001|NOT COMPLETED|Overall Study||30||
60105518|NCT02367456|76224141|FG002|NOT COMPLETED|Overall Study||30||
60105519|NCT01319812|76224156|FG000|STARTED|Overall Study||161||
60105520|NCT01319812|76224157|FG001|STARTED|Overall Study||302||
60105521|NCT01319812|76224156|FG000|COMPLETED|Overall Study||145||
60105522|NCT01319812|76224157|FG001|COMPLETED|Overall Study||280||
60105523|NCT01319812|76224156|FG000|NOT COMPLETED|Overall Study||16||
60105524|NCT01319812|76224157|FG001|NOT COMPLETED|Overall Study||22||
60105525|NCT01865747|76224172|FG000|STARTED|Overall Study (ITT)||330|Randomized|
60105526|NCT01865747|76224173|FG001|STARTED|Overall Study (ITT)||328|Randomized|
60105527|NCT01865747|76224172|FG000|COMPLETED|Overall Study (ITT)|One subject randomized to everolimus arm received cabozantinib discontd due to clin. deterioration|132|Continuing study treatment at the time of data cut-off|
60105528|NCT01865747|76224173|FG001|COMPLETED|Overall Study (ITT)|Five subjects were randomized but not treated|73|Continuing study treatment at the time of data cut-off|
60105529|NCT01865747|76224172|FG000|NOT COMPLETED|Overall Study (ITT)||198||
60105530|NCT01865747|76224173|FG001|NOT COMPLETED|Overall Study (ITT)||255||
60105531|NCT01865747|76224172|FG000|STARTED|Primary Intent to Treat (PITT)||187|PITT population consisted of the first 375 subjects randomized to received study treatment.|
60105532|NCT01865747|76224173|FG001|STARTED|Primary Intent to Treat (PITT)|Three subjects in the everolimus arm were randomized but not treated.|188|PITT population consisted of the first 375 subjects randomized to received study treatment.|
60105533|NCT01865747|76224172|FG000|COMPLETED|Primary Intent to Treat (PITT)||56|Continuing study treatment at the time of data cut-off|
60105534|NCT01865747|76224173|FG001|COMPLETED|Primary Intent to Treat (PITT)||36|Continuing study treatment at the time of data cut-off|
60105535|NCT01865747|76224172|FG000|NOT COMPLETED|Primary Intent to Treat (PITT)||131||
60105536|NCT01865747|76224173|FG001|NOT COMPLETED|Primary Intent to Treat (PITT)||152||
59566244|NCT01861574|75668746|FG002|COMPLETED|Overall Study||27||
59566245|NCT01861574|75668747|FG003|COMPLETED|Overall Study||28||
59566246|NCT01861574|75668744|FG000|NOT COMPLETED|Overall Study||0||
59818211|NCT00511472|75940600|FG000|COMPLETED|Overall Study||44||
59818212|NCT00511472|75940601|FG001|COMPLETED|Overall Study||17||
59566247|NCT01861574|75668745|FG001|NOT COMPLETED|Overall Study||0||
59566248|NCT01861574|75668746|FG002|NOT COMPLETED|Overall Study||0||
59566249|NCT01861574|75668747|FG003|NOT COMPLETED|Overall Study||0||
59566250|NCT01863134|75668762|FG000|STARTED|Overall Study||72||
59566251|NCT01863134|75668763|FG001|STARTED|Overall Study||68||
59566252|NCT01863134|75668762|FG000|COMPLETED|Overall Study||72||
59566253|NCT01863134|75668763|FG001|COMPLETED|Overall Study||68||
59566254|NCT01863134|75668762|FG000|NOT COMPLETED|Overall Study||0||
59566255|NCT01863134|75668763|FG001|NOT COMPLETED|Overall Study||0||
59566256|NCT03676803|75668771|FG000|STARTED|Overall Study||15||
59566257|NCT03676803|75668772|FG001|STARTED|Overall Study||16||
59566258|NCT03676803|75668771|FG000|COMPLETED|Overall Study||15||
59566259|NCT03676803|75668772|FG001|COMPLETED|Overall Study||16||
59566260|NCT03676803|75668771|FG000|NOT COMPLETED|Overall Study||0||
59566261|NCT03676803|75668772|FG001|NOT COMPLETED|Overall Study||0||
59566262|NCT01864538|75668780|FG000|STARTED|Overall Study||11||
59566263|NCT01864538|75668780|FG000|COMPLETED|Overall Study||0||
59566264|NCT01864538|75668780|FG000|NOT COMPLETED|Overall Study||11||
59566265|NCT04267575|75668784|FG000|STARTED|Overall Study||20||
59566266|NCT04267575|75668784|FG000|COMPLETED|Overall Study||20||
59566267|NCT04267575|75668784|FG000|NOT COMPLETED|Overall Study||0||
59566268|NCT03415581|75668790|FG000|STARTED|Overall Study||7|"Enrollment numbers are shown as a function of participants who were randomized to placebo (N=7) and active doxazosin (N=6) first. Prior to testing under active and placebo conditions participants completed stabilization on each medication Stabilization (Weeks 1-2 and 5-6), prior to testing under each medication Testing (Weeks 3-4 and 7-8). Thus, for the entire duration of the trial was 8 weeks for each participant (who completed)."|
59566269|NCT03415581|75668791|FG001|STARTED|Overall Study||6|"Enrollment numbers are shown as a function of participants who were randomized to placebo (N=7) and active doxazosin (N=6) first. Prior to testing under active and placebo conditions participants completed stabilization on each medication Stabilization (Weeks 1-2 and 5-6), prior to testing under each medication Testing (Weeks 3-4 and 7-8). Thus, for the entire duration of the trial was 8 weeks for each participant (who completed)."|
59566270|NCT03415581|75668790|FG000|COMPLETED|Overall Study||1||
59710320|NCT03671239|75828877|FG001|STARTED|Washout (1 Week)|Three participants who did not complete the first intervention in Product Sequence B were willing to go through the washout period and received the study product in the second intervention.|36||
59818213|NCT00511472|75940600|FG000|NOT COMPLETED|Overall Study||3||
59818214|NCT00511472|75940601|FG001|NOT COMPLETED|Overall Study||6||
59818215|NCT00514904|75940618|FG000|STARTED|Overall Study||1125||
59818216|NCT00514904|75940619|FG001|STARTED|Overall Study||376||
59818217|NCT00514904|75940618|FG000|COMPLETED|Overall Study||1101||
59818218|NCT00514904|75940619|FG001|COMPLETED|Overall Study||371||
59818219|NCT00514904|75940618|FG000|NOT COMPLETED|Overall Study||24||
59818220|NCT00514904|75940619|FG001|NOT COMPLETED|Overall Study||5||
59818221|NCT00440115|75940628|FG000|STARTED|Overall Study||251||
59818222|NCT00440115|75940629|FG001|STARTED|Overall Study||249||
59818223|NCT00440115|75940630|FG002|STARTED|Overall Study||250||
59710321|NCT03671239|75828878|FG002|STARTED|Washout (1 Week)|Two participants who did not complete the first intervention in Product Sequence C were willing to go through the washout period and received the study product in the second intervention.|37||
59710322|NCT03671239|75828879|FG003|STARTED|Washout (1 Week)|One participant who did not complete the first intervention in Product Sequence D was willing to go through the washout period and received the study product in the second intervention.|36||
59818224|NCT00440115|75940628|FG000|COMPLETED|Overall Study||244||
59818225|NCT00440115|75940629|FG001|COMPLETED|Overall Study||238||
59818226|NCT00440115|75940630|FG002|COMPLETED|Overall Study||244||
59818227|NCT00440115|75940628|FG000|NOT COMPLETED|Overall Study||7||
59818228|NCT00440115|75940629|FG001|NOT COMPLETED|Overall Study||11||
59818229|NCT00440115|75940630|FG002|NOT COMPLETED|Overall Study||6||
59818230|NCT00440037|75940638|FG000|STARTED|Overall Study||44||
59818231|NCT00440037|75940638|FG000|COMPLETED|Overall Study||35||
59818232|NCT00440037|75940638|FG000|NOT COMPLETED|Overall Study||9||
59818233|NCT00417027|75940645|FG000|STARTED|Overall Study||66||
59818234|NCT00417027|75940646|FG001|STARTED|Overall Study||65||
59566271|NCT03415581|75668791|FG001|COMPLETED|Overall Study||1||
59566272|NCT03415581|75668790|FG000|NOT COMPLETED|Overall Study||6||
59566273|NCT03415581|75668791|FG001|NOT COMPLETED|Overall Study||5||
59566274|NCT00557492|75668799|FG000|STARTED|Overall Study||59||
59566275|NCT00557492|75668799|FG000|COMPLETED|Overall Study|Evaluable for outcomes|58||
59566276|NCT00557492|75668799|FG000|NOT COMPLETED|Overall Study||1||
59818235|NCT00417027|75940647|FG002|STARTED|Overall Study||59||
60105537|NCT01385644|76224181|FG000|STARTED|Overall Study||4||
60105538|NCT01385644|76224182|FG001|STARTED|Overall Study||4||
59818236|NCT00417027|75940645|FG000|COMPLETED|Overall Study||66||
59818237|NCT00417027|75940646|FG001|COMPLETED|Overall Study||60||
59818238|NCT00417027|75940647|FG002|COMPLETED|Overall Study||54||
59818239|NCT00417027|75940645|FG000|NOT COMPLETED|Overall Study||0||
59818240|NCT00417027|75940646|FG001|NOT COMPLETED|Overall Study||5||
59818241|NCT00417027|75940647|FG002|NOT COMPLETED|Overall Study||5||
59818242|NCT00416949|75940655|FG000|STARTED|Overall Study||9||
59818243|NCT00416949|75940655|FG000|COMPLETED|Overall Study||4||
59818244|NCT00416949|75940655|FG000|NOT COMPLETED|Overall Study||5||
60105539|NCT01385644|76224181|FG000|COMPLETED|Overall Study||4||
60105540|NCT01385644|76224182|FG001|COMPLETED|Overall Study||4||
60105541|NCT01385644|76224181|FG000|NOT COMPLETED|Overall Study||0||
60105542|NCT01385644|76224182|FG001|NOT COMPLETED|Overall Study||0||
60105543|NCT01387672|76224194|FG000|STARTED|Overall Study||39||
60105544|NCT01387672|76224195|FG001|STARTED|Overall Study||38||
60105545|NCT01387672|76224196|FG002|STARTED|Overall Study||38||
60105546|NCT01387672|76224197|FG003|STARTED|Overall Study||39||
60105547|NCT01387672|76224198|FG004|STARTED|Overall Study||38||
60105548|NCT01387672|76224199|FG005|STARTED|Overall Study||37||
60105549|NCT01387672|76224194|FG000|COMPLETED|Overall Study||32||
60105550|NCT01387672|76224195|FG001|COMPLETED|Overall Study||31||
60105551|NCT01387672|76224196|FG002|COMPLETED|Overall Study||33||
60105552|NCT01387672|76224197|FG003|COMPLETED|Overall Study||35||
60105553|NCT01387672|76224198|FG004|COMPLETED|Overall Study||34||
59818245|NCT00416715|75940659|FG000|STARTED|Overall Study||100||
59818246|NCT00416715|75940659|FG000|COMPLETED|Overall Study||85||
59818247|NCT00416715|75940659|FG000|NOT COMPLETED|Overall Study||15||
59818248|NCT00406029|75940671|FG000|STARTED|Overall Study||49||
59818249|NCT00406029|75940672|FG001|STARTED|Overall Study||49||
59818250|NCT00406029|75940673|FG002|STARTED|Overall Study||49||
59566277|NCT03416985|75668806|FG000|STARTED|Overall Study||30||
59818251|NCT00406029|75940674|FG003|STARTED|Overall Study||57||
59818252|NCT00406029|75940675|FG004|STARTED|Overall Study||49||
59818253|NCT00406029|75940671|FG000|Treated|Overall Study||49||
59818254|NCT00406029|75940672|FG001|Treated|Overall Study||49||
60105554|NCT01387672|76224199|FG005|COMPLETED|Overall Study||37||
60105555|NCT01387672|76224194|FG000|NOT COMPLETED|Overall Study||7||
60105556|NCT01387672|76224195|FG001|NOT COMPLETED|Overall Study||7||
60105557|NCT01387672|76224196|FG002|NOT COMPLETED|Overall Study||5||
60105558|NCT01387672|76224197|FG003|NOT COMPLETED|Overall Study||4||
59710323|NCT03671239|75828880|FG004|STARTED|Washout (1 Week)|Two participants who did not complete the first intervention in Product Sequence E were willing to go through the washout period and received the study product in the second intervention.|37||
59710324|NCT03671239|75828881|FG005|STARTED|Washout (1 Week)|Three participants who did not complete the first intervention in Product Sequence F were willing to go through the washout period and received the study product in the second intervention.|36||
59996070|NCT02190604|76112039|FG006|STARTED|Part 1 and 2 (Healthy Volunteers)||6||
59996071|NCT02190604|76112040|FG007|STARTED|Part 1 and 2 (Healthy Volunteers)||6||
60105559|NCT01387672|76224198|FG004|NOT COMPLETED|Overall Study||4||
60105560|NCT01387672|76224199|FG005|NOT COMPLETED|Overall Study||0||
60105561|NCT01843673|76224214|FG000|STARTED|Overall Study||16||
60105562|NCT01843673|76224214|FG000|COMPLETED|Overall Study||10||
60105563|NCT01843673|76224214|FG000|NOT COMPLETED|Overall Study||6||
60105564|NCT01412554|76224220|FG000|STARTED|Overall Study|103 persons re-examined in 2012-13 out of 158 persons originally examined in 1991-96.|103||
60105565|NCT01412554|76224220|FG000|COMPLETED|Overall Study||103||
60105566|NCT01412554|76224220|FG000|NOT COMPLETED|Overall Study||0||
60105567|NCT01412710|76224226|FG000|STARTED|Overall Study||50||
60105568|NCT01412710|76224227|FG001|STARTED|Overall Study||27||
60105569|NCT01412710|76224226|FG000|COMPLETED|Overall Study||46||
60105570|NCT01412710|76224227|FG001|COMPLETED|Overall Study||22||
60105571|NCT01412710|76224226|FG000|NOT COMPLETED|Overall Study||4||
60105572|NCT01412710|76224227|FG001|NOT COMPLETED|Overall Study||5||
60105573|NCT01843205|76224233|FG000|STARTED|First Treatment (11 Days)||5||
60105574|NCT01843205|76224234|FG001|STARTED|First Treatment (11 Days)||4||
60105575|NCT01843205|76224233|FG000|COMPLETED|First Treatment (11 Days)|4 completing subjects switched to buspirone for Condition 2.|4||
60105576|NCT01843205|76224234|FG001|COMPLETED|First Treatment (11 Days)|4 completing subjects switched to placebo for Condition 2.|4||
60105577|NCT01843205|76224233|FG000|NOT COMPLETED|First Treatment (11 Days)||1||
60105578|NCT01843205|76224234|FG001|NOT COMPLETED|First Treatment (11 Days)||0||
60105579|NCT01843205|76224233|FG000|STARTED|Second Treatment (11 Days)||4||
60105580|NCT01843205|76224234|FG001|STARTED|Second Treatment (11 Days)||4||
59996072|NCT02190604|76112041|FG008|STARTED|Part 1 and 2 (Healthy Volunteers)||16||
59996073|NCT02190604|76112042|FG009|STARTED|Part 1 and 2 (Healthy Volunteers)||6||
60105581|NCT01843205|76224233|FG000|COMPLETED|Second Treatment (11 Days)||4||
60105582|NCT01843205|76224234|FG001|COMPLETED|Second Treatment (11 Days)||4||
60105583|NCT01843205|76224233|FG000|NOT COMPLETED|Second Treatment (11 Days)||0||
60105584|NCT01843205|76224234|FG001|NOT COMPLETED|Second Treatment (11 Days)||0||
60105585|NCT01412866|76224242|FG000|STARTED|Overall Study||58||
60105586|NCT01412866|76224243|FG001|STARTED|Overall Study||66||
59996074|NCT02190604|76112043|FG010|STARTED|Part 1 and 2 (Healthy Volunteers)||6||
59996075|NCT02190604|76112044|FG011|STARTED|Part 1 and 2 (Healthy Volunteers)||6||
59996076|NCT02190604|76112045|FG012|STARTED|Part 1 and 2 (Healthy Volunteers)||6||
59996077|NCT02190604|76112046|FG013|STARTED|Part 1 and 2 (Healthy Volunteers)||6||
59996078|NCT02190604|76112047|FG014|STARTED|Part 1 and 2 (Healthy Volunteers)||10||
59996079|NCT02190604|76112048|FG015|STARTED|Part 1 and 2 (Healthy Volunteers)||0||
59996080|NCT02190604|76112049|FG016|STARTED|Part 1 and 2 (Healthy Volunteers)||0||
59996081|NCT02190604|76112050|FG017|STARTED|Part 1 and 2 (Healthy Volunteers)||0||
59710325|NCT03671239|75828876|FG000|COMPLETED|Washout (1 Week)||35||
59710326|NCT03671239|75828877|FG001|COMPLETED|Washout (1 Week)||36||
59710327|NCT03671239|75828878|FG002|COMPLETED|Washout (1 Week)||37||
59710328|NCT03671239|75828879|FG003|COMPLETED|Washout (1 Week)||36||
59710329|NCT03671239|75828880|FG004|COMPLETED|Washout (1 Week)||37||
59710330|NCT03671239|75828881|FG005|COMPLETED|Washout (1 Week)||36||
59710331|NCT03671239|75828876|FG000|NOT COMPLETED|Washout (1 Week)||0||
59996082|NCT02190604|76112051|FG018|STARTED|Part 1 and 2 (Healthy Volunteers)||0||
59996083|NCT02190604|76112033|FG000|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6||
59566278|NCT03416985|75668807|FG001|STARTED|Overall Study||30||
59710332|NCT03671239|75828877|FG001|NOT COMPLETED|Washout (1 Week)||0||
59818255|NCT00406029|75940673|FG002|Treated|Overall Study||47||
59818256|NCT00406029|75940674|FG003|Treated|Overall Study||54||
59818257|NCT00406029|75940675|FG004|Treated|Overall Study||47||
59818258|NCT00406029|75940671|FG000|COMPLETED|Overall Study||33||
59818259|NCT00406029|75940672|FG001|COMPLETED|Overall Study||41||
59818260|NCT00406029|75940673|FG002|COMPLETED|Overall Study||39||
59818261|NCT00406029|75940674|FG003|COMPLETED|Overall Study||40||
59818262|NCT00406029|75940675|FG004|COMPLETED|Overall Study||41||
59818263|NCT00406029|75940671|FG000|NOT COMPLETED|Overall Study||16||
59818264|NCT00406029|75940672|FG001|NOT COMPLETED|Overall Study||8||
59818265|NCT00406029|75940673|FG002|NOT COMPLETED|Overall Study||10||
59818266|NCT00406029|75940674|FG003|NOT COMPLETED|Overall Study||17||
59818267|NCT00406029|75940675|FG004|NOT COMPLETED|Overall Study||8||
59818268|NCT00514514|75940690|FG000|STARTED|Pre-phase|All enrolled patients received standard regimen for 3 months|802||
59818269|NCT00514514|75940691|FG001|STARTED|Pre-phase||0||
59818270|NCT00514514|75940692|FG002|STARTED|Pre-phase||0||
59818271|NCT00514514|75940690|FG000|COMPLETED|Pre-phase||499||
59566279|NCT03416985|75668808|FG002|STARTED|Overall Study||30||
59566280|NCT03416985|75668806|FG000|COMPLETED|Overall Study||28||
59566281|NCT03416985|75668807|FG001|COMPLETED|Overall Study||30||
59566282|NCT03416985|75668808|FG002|COMPLETED|Overall Study||24||
59710333|NCT03671239|75828878|FG002|NOT COMPLETED|Washout (1 Week)||0||
59710334|NCT03671239|75828879|FG003|NOT COMPLETED|Washout (1 Week)||0||
59710335|NCT03671239|75828880|FG004|NOT COMPLETED|Washout (1 Week)||0||
59710336|NCT03671239|75828881|FG005|NOT COMPLETED|Washout (1 Week)||0||
59710337|NCT03671239|75828876|FG000|STARTED|Second Intervetion (4 Weeks)||35||
59710338|NCT03671239|75828877|FG001|STARTED|Second Intervetion (4 Weeks)||36||
59710339|NCT03671239|75828878|FG002|STARTED|Second Intervetion (4 Weeks)||37||
59710340|NCT03671239|75828879|FG003|STARTED|Second Intervetion (4 Weeks)||36||
59710341|NCT03671239|75828880|FG004|STARTED|Second Intervetion (4 Weeks)||37||
59710342|NCT03671239|75828881|FG005|STARTED|Second Intervetion (4 Weeks)||36||
59710343|NCT03671239|75828876|FG000|COMPLETED|Second Intervetion (4 Weeks)||33||
59710344|NCT03671239|75828877|FG001|COMPLETED|Second Intervetion (4 Weeks)||33||
59710345|NCT03671239|75828878|FG002|COMPLETED|Second Intervetion (4 Weeks)||37||
59710346|NCT03671239|75828879|FG003|COMPLETED|Second Intervetion (4 Weeks)||34||
59710347|NCT03671239|75828880|FG004|COMPLETED|Second Intervetion (4 Weeks)||34||
59710348|NCT03671239|75828881|FG005|COMPLETED|Second Intervetion (4 Weeks)||35||
59710349|NCT03671239|75828876|FG000|NOT COMPLETED|Second Intervetion (4 Weeks)||2||
59710350|NCT03671239|75828877|FG001|NOT COMPLETED|Second Intervetion (4 Weeks)||3||
59710351|NCT03671239|75828878|FG002|NOT COMPLETED|Second Intervetion (4 Weeks)||0||
59710352|NCT03671239|75828879|FG003|NOT COMPLETED|Second Intervetion (4 Weeks)||2||
59710353|NCT03671239|75828880|FG004|NOT COMPLETED|Second Intervetion (4 Weeks)||3||
59710354|NCT03671239|75828881|FG005|NOT COMPLETED|Second Intervetion (4 Weeks)||1||
59710355|NCT03671239|75828876|FG000|STARTED|Washout (1 Week)|Per the trial protocol, participants who discontinued the product in the first or second intervention for self-initiated reasons (except for HIV infection and pregnancy) were allowed to progress to the next study period if they were willing. The two participants who did not complete the second intervention in Product Sequence A were willing to go through the washout period and received the study product in the third intervention.|35||
59710356|NCT03671239|75828877|FG001|STARTED|Washout (1 Week)|Three participants who did not complete the second intervention in Product Sequence B were willing to go through the washout period and received the study product in the third intervention.|36||
59710357|NCT03671239|75828878|FG002|STARTED|Washout (1 Week)||37||
59710358|NCT03671239|75828879|FG003|STARTED|Washout (1 Week)|Two participants who did not complete the second intervention in Product Sequence D were willing to go through the washout period and received the study product in the third intervention.|36||
59710359|NCT03671239|75828880|FG004|STARTED|Washout (1 Week)|Three participants who did not complete the second intervention in Product Sequence E were willing to go through the washout period and received the study product in the third intervention.|37||
59710360|NCT03671239|75828881|FG005|STARTED|Washout (1 Week)|One participant who did not complete the second intervention in Product Sequence F was willing to go through the washout period and received the study product in the third intervention.|36||
59710361|NCT03671239|75828876|FG000|COMPLETED|Washout (1 Week)||35||
59566283|NCT03416985|75668806|FG000|NOT COMPLETED|Overall Study||2||
59566284|NCT03416985|75668807|FG001|NOT COMPLETED|Overall Study||0||
59566285|NCT03416985|75668808|FG002|NOT COMPLETED|Overall Study||6||
59566286|NCT03682809|75668821|FG000|STARTED|Overall Study||22||
59710362|NCT03671239|75828877|FG001|COMPLETED|Washout (1 Week)||36||
59710363|NCT03671239|75828878|FG002|COMPLETED|Washout (1 Week)||37||
59710364|NCT03671239|75828879|FG003|COMPLETED|Washout (1 Week)||36||
59710365|NCT03671239|75828880|FG004|COMPLETED|Washout (1 Week)||37||
59710366|NCT03671239|75828881|FG005|COMPLETED|Washout (1 Week)||36||
59710367|NCT03671239|75828876|FG000|NOT COMPLETED|Washout (1 Week)||0||
59710368|NCT03671239|75828877|FG001|NOT COMPLETED|Washout (1 Week)||0||
59710369|NCT03671239|75828878|FG002|NOT COMPLETED|Washout (1 Week)||0||
59710370|NCT03671239|75828879|FG003|NOT COMPLETED|Washout (1 Week)||0||
59710371|NCT03671239|75828880|FG004|NOT COMPLETED|Washout (1 Week)||0||
59710372|NCT03671239|75828881|FG005|NOT COMPLETED|Washout (1 Week)||0||
59710373|NCT03671239|75828876|FG000|STARTED|Third Intervention (4 Weeks)||35||
59710374|NCT03671239|75828877|FG001|STARTED|Third Intervention (4 Weeks)||36||
59710375|NCT03671239|75828878|FG002|STARTED|Third Intervention (4 Weeks)||37||
59710376|NCT03671239|75828879|FG003|STARTED|Third Intervention (4 Weeks)||36||
59710377|NCT03671239|75828880|FG004|STARTED|Third Intervention (4 Weeks)||37||
59710378|NCT03671239|75828881|FG005|STARTED|Third Intervention (4 Weeks)||36||
59710379|NCT03671239|75828876|FG000|COMPLETED|Third Intervention (4 Weeks)||33||
59710380|NCT03671239|75828877|FG001|COMPLETED|Third Intervention (4 Weeks)||35||
59566287|NCT03682809|75668822|FG001|STARTED|Overall Study||24||
59818272|NCT00514514|75940691|FG001|COMPLETED|Pre-phase||0||
59818273|NCT00514514|75940692|FG002|COMPLETED|Pre-phase||0||
59818274|NCT00514514|75940690|FG000|NOT COMPLETED|Pre-phase||303||
59818275|NCT00514514|75940691|FG001|NOT COMPLETED|Pre-phase||0||
59818276|NCT00514514|75940692|FG002|NOT COMPLETED|Pre-phase||0||
59818277|NCT00514514|75940690|FG000|STARTED|Randomized - 9 Month||166||
59818278|NCT00514514|75940691|FG001|STARTED|Randomized - 9 Month||171||
59818279|NCT00514514|75940692|FG002|STARTED|Randomized - 9 Month||162||
59818280|NCT00514514|75940690|FG000|Randomized - Received Treatment|Randomized - 9 Month||165||
59818281|NCT00514514|75940691|FG001|Randomized - Received Treatment|Randomized - 9 Month||171||
59818282|NCT00514514|75940692|FG002|Randomized - Received Treatment|Randomized - 9 Month||161||
59818283|NCT00514514|75940690|FG000|COMPLETED|Randomized - 9 Month||127||
59818284|NCT00514514|75940691|FG001|COMPLETED|Randomized - 9 Month||110||
59818285|NCT00514514|75940692|FG002|COMPLETED|Randomized - 9 Month||124||
59818286|NCT00514514|75940690|FG000|NOT COMPLETED|Randomized - 9 Month||39||
59818287|NCT00514514|75940691|FG001|NOT COMPLETED|Randomized - 9 Month||61||
59818288|NCT00514514|75940692|FG002|NOT COMPLETED|Randomized - 9 Month||38||
59818289|NCT00514514|75940690|FG000|STARTED|Extension - 4 Years||145||
59818290|NCT00514514|75940691|FG001|STARTED|Extension - 4 Years||139||
60105587|NCT01412866|76224242|FG000|COMPLETED|Overall Study||57||
60105588|NCT01412866|76224243|FG001|COMPLETED|Overall Study||64||
60105589|NCT01412866|76224242|FG000|NOT COMPLETED|Overall Study||1||
60105590|NCT01412866|76224243|FG001|NOT COMPLETED|Overall Study||2||
60105591|NCT01320826|76224249|FG000|STARTED|Overall Study||577||
60105592|NCT01320826|76224249|FG000|COMPLETED|Overall Study||577||
60105593|NCT01320826|76224249|FG000|NOT COMPLETED|Overall Study||0||
60105594|NCT01414036|76224266|FG000|STARTED|Received Allocated Intervention||23||
60105595|NCT01414036|76224267|FG001|STARTED|Received Allocated Intervention||24||
60105596|NCT01414036|76224266|FG000|COMPLETED|Received Allocated Intervention||23||
60105597|NCT01414036|76224267|FG001|COMPLETED|Received Allocated Intervention||11||
60105598|NCT01414036|76224266|FG000|NOT COMPLETED|Received Allocated Intervention||0||
60105599|NCT01414036|76224267|FG001|NOT COMPLETED|Received Allocated Intervention||13||
60105600|NCT01414036|76224266|FG000|STARTED|Completed 3 Month Survey||23||
60105601|NCT01414036|76224267|FG001|STARTED|Completed 3 Month Survey||24||
60105602|NCT01414036|76224266|FG000|COMPLETED|Completed 3 Month Survey||14||
60105603|NCT01414036|76224267|FG001|COMPLETED|Completed 3 Month Survey||19||
60105604|NCT01414036|76224266|FG000|NOT COMPLETED|Completed 3 Month Survey||9||
60105605|NCT01414036|76224267|FG001|NOT COMPLETED|Completed 3 Month Survey||5||
60105606|NCT01414426|76224275|FG000|STARTED|Overall Study||10||
60105607|NCT01414426|76224276|FG001|STARTED|Overall Study||10||
60105608|NCT01414426|76224275|FG000|COMPLETED|Overall Study||9||
60105609|NCT01414426|76224276|FG001|COMPLETED|Overall Study||8||
60105610|NCT01414426|76224275|FG000|NOT COMPLETED|Overall Study||1||
60105611|NCT01414426|76224276|FG001|NOT COMPLETED|Overall Study||2||
60105612|NCT01389076|76224282|FG000|STARTED|Overall Study||22||
60105613|NCT01389076|76224282|FG000|COMPLETED|Overall Study||22||
60105614|NCT01389076|76224282|FG000|NOT COMPLETED|Overall Study||0||
60105615|NCT01389856|76224288|FG000|STARTED|Overall Study|Randomized and treated. An additional 2 patients were randomized but not treated.|13||
60105616|NCT01389856|76224289|FG001|STARTED|Overall Study|Randomized and treated.|8||
60105617|NCT01389856|76224288|FG000|COMPLETED|Overall Study||13||
60105618|NCT01389856|76224289|FG001|COMPLETED|Overall Study||8||
60105619|NCT01389856|76224288|FG000|NOT COMPLETED|Overall Study||0||
60105620|NCT01389856|76224289|FG001|NOT COMPLETED|Overall Study||0||
60105621|NCT01323010|76224297|FG000|STARTED|Overall Study||60||
60105622|NCT01323010|76224298|FG001|STARTED|Overall Study||59||
60105623|NCT01323010|76224297|FG000|COMPLETED|Overall Study||60||
60105624|NCT01323010|76224298|FG001|COMPLETED|Overall Study||59||
60105625|NCT01323010|76224297|FG000|NOT COMPLETED|Overall Study||0||
60105626|NCT01323010|76224298|FG001|NOT COMPLETED|Overall Study||0||
59818291|NCT00514514|75940692|FG002|STARTED|Extension - 4 Years||134||
60105627|NCT01835015|76224321|FG000|STARTED|Overall Study||6||
60105628|NCT01835015|76224322|FG001|STARTED|Overall Study||6||
59818292|NCT00514514|75940690|FG000|Non-randomized (Followed)|Extension - 4 Years|Patients were not randomized but continued on standard regimen and entered follow up.|95||
60105629|NCT01835015|76224323|FG002|STARTED|Overall Study||7||
60105630|NCT01835015|76224324|FG003|STARTED|Overall Study||6||
60105631|NCT01835015|76224325|FG004|STARTED|Overall Study||6||
60105632|NCT01835015|76224321|FG000|COMPLETED|Overall Study||6||
60105633|NCT01835015|76224322|FG001|COMPLETED|Overall Study||6||
60105634|NCT01835015|76224323|FG002|COMPLETED|Overall Study||6||
59818293|NCT00514514|75940691|FG001|Non-randomized (Followed)|Extension - 4 Years||0||
60105635|NCT01835015|76224324|FG003|COMPLETED|Overall Study||6||
60105636|NCT01835015|76224325|FG004|COMPLETED|Overall Study||6||
60105637|NCT01835015|76224321|FG000|NOT COMPLETED|Overall Study||0||
60105638|NCT01835015|76224322|FG001|NOT COMPLETED|Overall Study||0||
60105639|NCT01835015|76224323|FG002|NOT COMPLETED|Overall Study||1||
60105640|NCT01835015|76224324|FG003|NOT COMPLETED|Overall Study||0||
60105641|NCT01835015|76224325|FG004|NOT COMPLETED|Overall Study||0||
60105642|NCT01390246|76224340|FG000|STARTED|Overall Study||30||
60105643|NCT01390246|76224341|FG001|STARTED|Overall Study||35||
60105644|NCT01390246|76224340|FG000|Visit 2: Quit Day|Overall Study||24||
60105645|NCT01390246|76224341|FG001|Visit 2: Quit Day|Overall Study||24||
60105646|NCT01390246|76224340|FG000|Visit 6: End of Treatment|Overall Study||15||
60105647|NCT01390246|76224341|FG001|Visit 6: End of Treatment|Overall Study||15||
60105648|NCT01390246|76224340|FG000|Visit 7: 36-38 Weeks Gestation|Overall Study||10||
60105649|NCT01390246|76224341|FG001|Visit 7: 36-38 Weeks Gestation|Overall Study||10||
59996084|NCT02190604|76112034|FG001|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6||
59996085|NCT02190604|76112035|FG002|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6||
59996086|NCT02190604|76112036|FG003|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6||
59996087|NCT02190604|76112037|FG004|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6||
59996088|NCT02190604|76112038|FG005|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6||
59996089|NCT02190604|76112039|FG006|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6||
59996090|NCT02190604|76112040|FG007|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6||
59996091|NCT02190604|76112041|FG008|COMPLETED|Part 1 and 2 (Healthy Volunteers)||16||
60105650|NCT01390246|76224340|FG000|COMPLETED|Overall Study||10||
60105651|NCT01390246|76224341|FG001|COMPLETED|Overall Study||10||
60105652|NCT01390246|76224340|FG000|NOT COMPLETED|Overall Study||20||
60105653|NCT01390246|76224341|FG001|NOT COMPLETED|Overall Study||25||
60105654|NCT01390870|76224347|FG000|STARTED|Overall Study||400||
60105655|NCT01390870|76224347|FG000|COMPLETED|Overall Study||400||
60105656|NCT01390870|76224347|FG000|NOT COMPLETED|Overall Study||0||
60105657|NCT01842581|76224353|FG000|STARTED|Overall Study||113||
60105658|NCT01842581|76224354|FG001|STARTED|Overall Study||109||
60105659|NCT01842581|76224353|FG000|Received at Least 1 Dose of Study Drug|Overall Study||113||
60105660|NCT01842581|76224354|FG001|Received at Least 1 Dose of Study Drug|Overall Study||108||
60105661|NCT01842581|76224353|FG000|COMPLETED|Overall Study||69||
60105662|NCT01842581|76224354|FG001|COMPLETED|Overall Study||79||
60105663|NCT01842581|76224353|FG000|NOT COMPLETED|Overall Study||44||
60105664|NCT01842581|76224354|FG001|NOT COMPLETED|Overall Study||30||
60105665|NCT01833533|76224362|FG000|STARTED|Overall Study||100||
59996092|NCT02190604|76112042|FG009|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6||
59996093|NCT02190604|76112043|FG010|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6||
60000401|NCT02593305|76116131|FG002|COMPLETED|Post 2||0||
60105666|NCT01833533|76224363|FG001|STARTED|Overall Study||205||
59710381|NCT03671239|75828878|FG002|COMPLETED|Third Intervention (4 Weeks)||35||
60105667|NCT01833533|76224362|FG000|COMPLETED|Overall Study||94||
60105668|NCT01833533|76224363|FG001|COMPLETED|Overall Study||184||
60105669|NCT01833533|76224362|FG000|NOT COMPLETED|Overall Study||6||
60105670|NCT01833533|76224363|FG001|NOT COMPLETED|Overall Study||21||
60105671|NCT01833455|76224371|FG000|STARTED|Overall Study||4||
60105672|NCT01833455|76224372|FG001|STARTED|Overall Study||4||
60105673|NCT01833455|76224371|FG000|Completed 1st Baseline|Overall Study||4||
60105674|NCT01833455|76224372|FG001|Completed 1st Baseline|Overall Study||4||
60105675|NCT01833455|76224371|FG000|Completed 1st Intervention|Overall Study||3||
60105676|NCT01833455|76224372|FG001|Completed 1st Intervention|Overall Study||4||
60105677|NCT01833455|76224371|FG000|Completed 2nd Baseline (Washout)|Overall Study||3||
60105678|NCT01833455|76224372|FG001|Completed 2nd Baseline (Washout)|Overall Study||4||
60105679|NCT01833455|76224371|FG000|COMPLETED|Overall Study||3||
60105680|NCT01833455|76224372|FG001|COMPLETED|Overall Study||4||
60105681|NCT01833455|76224371|FG000|NOT COMPLETED|Overall Study||1||
60105682|NCT01833455|76224372|FG001|NOT COMPLETED|Overall Study||0||
60105683|NCT01833143|76224390|FG000|STARTED|Overall Study||17||
60105684|NCT01833143|76224390|FG000|COMPLETED|Overall Study||16||
60105685|NCT01833143|76224390|FG000|NOT COMPLETED|Overall Study||1||
60105686|NCT01841567|76224394|FG000|STARTED|Overall Study||60||
60105687|NCT01841567|76224394|FG000|COMPLETED|Overall Study||57||
60105688|NCT01841567|76224394|FG000|NOT COMPLETED|Overall Study||3||
60105689|NCT01833065|76224401|FG000|STARTED|Overall Study|Randomized patients - As treated|65||
60105690|NCT01833065|76224402|FG001|STARTED|Overall Study|Randomized patients - As treated|53||
60105691|NCT01833065|76224403|FG002|STARTED|Overall Study|Randomized patients - As treated|35||
60105692|NCT01833065|76224404|FG003|STARTED|Overall Study|Randomized patients - As treated|50||
60105693|NCT01833065|76224405|FG004|STARTED|Overall Study|Randomized patients - As treated|110||
60105694|NCT01833065|76224401|FG000|Intention-to-treat Analysis Set|Overall Study|Randomized patients|50||
60105695|NCT01833065|76224402|FG001|Intention-to-treat Analysis Set|Overall Study|Randomized patients|53||
60105696|NCT01833065|76224403|FG002|Intention-to-treat Analysis Set|Overall Study|Randomized patients|50||
60105697|NCT01833065|76224404|FG003|Intention-to-treat Analysis Set|Overall Study|Randomized patients|50||
60105698|NCT01833065|76224405|FG004|Intention-to-treat Analysis Set|Overall Study|Randomized patients|111||
60105699|NCT01833065|76224401|FG000|COMPLETED|Overall Study||41||
60105700|NCT01833065|76224402|FG001|COMPLETED|Overall Study||40||
60105701|NCT01833065|76224403|FG002|COMPLETED|Overall Study||23||
60105702|NCT01833065|76224404|FG003|COMPLETED|Overall Study||41||
60105703|NCT01833065|76224405|FG004|COMPLETED|Overall Study||74||
60105704|NCT01833065|76224401|FG000|NOT COMPLETED|Overall Study||24||
60105705|NCT01833065|76224402|FG001|NOT COMPLETED|Overall Study||13||
60105706|NCT01833065|76224403|FG002|NOT COMPLETED|Overall Study||12||
60105707|NCT01833065|76224404|FG003|NOT COMPLETED|Overall Study||9||
60105708|NCT01833065|76224405|FG004|NOT COMPLETED|Overall Study||36||
60105709|NCT01831817|76224419|FG000|STARTED|Overall Study||35||
60105710|NCT01831817|76224420|FG001|STARTED|Overall Study||34||
60105711|NCT01831817|76224421|FG002|STARTED|Overall Study||35||
60105712|NCT01831817|76224422|FG003|STARTED|Overall Study||36||
60105713|NCT01831817|76224419|FG000|COMPLETED|Overall Study||31||
60105714|NCT01831817|76224420|FG001|COMPLETED|Overall Study||34||
60105715|NCT01831817|76224421|FG002|COMPLETED|Overall Study||35||
60105716|NCT01831817|76224422|FG003|COMPLETED|Overall Study||36||
60105717|NCT01831817|76224419|FG000|NOT COMPLETED|Overall Study||4||
59710382|NCT03671239|75828879|FG003|COMPLETED|Third Intervention (4 Weeks)||34||
59710383|NCT03671239|75828880|FG004|COMPLETED|Third Intervention (4 Weeks)||36||
59710384|NCT03671239|75828881|FG005|COMPLETED|Third Intervention (4 Weeks)||34||
59710385|NCT03671239|75828876|FG000|NOT COMPLETED|Third Intervention (4 Weeks)||2||
59710386|NCT03671239|75828877|FG001|NOT COMPLETED|Third Intervention (4 Weeks)||1||
59710387|NCT03671239|75828878|FG002|NOT COMPLETED|Third Intervention (4 Weeks)||2||
59710388|NCT03671239|75828879|FG003|NOT COMPLETED|Third Intervention (4 Weeks)||2||
59710389|NCT03671239|75828880|FG004|NOT COMPLETED|Third Intervention (4 Weeks)||1||
59710390|NCT03671239|75828881|FG005|NOT COMPLETED|Third Intervention (4 Weeks)||2||
59710391|NCT01481935|75828892|FG000|STARTED|Overall Study||97||
59710392|NCT01481935|75828893|FG001|STARTED|Overall Study||93||
59710393|NCT01481935|75828892|FG000|COMPLETED|Overall Study||97||
60105718|NCT01831817|76224420|FG001|NOT COMPLETED|Overall Study||0||
60105719|NCT01831817|76224421|FG002|NOT COMPLETED|Overall Study||0||
60105720|NCT01831817|76224422|FG003|NOT COMPLETED|Overall Study||0||
60105721|NCT01417780|76224435|FG000|STARTED|Overall Study||15|ITT Population|
60105722|NCT01417780|76224436|FG001|STARTED|Overall Study||17|ITT Population|
60105723|NCT01417780|76224437|FG002|STARTED|Overall Study||11|ITT Population|
60105724|NCT01417780|76224435|FG000|COMPLETED|Overall Study||14|ITT Population|
60105725|NCT01417780|76224436|FG001|COMPLETED|Overall Study||14|ITT Population|
60105726|NCT01417780|76224437|FG002|COMPLETED|Overall Study||9|ITT Population|
60105727|NCT01417780|76224435|FG000|NOT COMPLETED|Overall Study||1||
60105728|NCT01417780|76224436|FG001|NOT COMPLETED|Overall Study||3||
60105729|NCT01417780|76224437|FG002|NOT COMPLETED|Overall Study||2||
60105730|NCT01840943|76224447|FG000|STARTED|Overall Study||14||
60105731|NCT01840943|76224448|FG001|STARTED|Overall Study||12||
60105732|NCT01840943|76224447|FG000|COMPLETED|Overall Study||1||
60105733|NCT01840943|76224448|FG001|COMPLETED|Overall Study||0||
60105734|NCT01840943|76224447|FG000|NOT COMPLETED|Overall Study||13||
60105735|NCT01840943|76224448|FG001|NOT COMPLETED|Overall Study||12||
60105736|NCT01840163|76224456|FG000|STARTED|First Follow up -Primary Outcome||267||
60105737|NCT01840163|76224457|FG001|STARTED|First Follow up -Primary Outcome||270||
60105738|NCT01840163|76224456|FG000|COMPLETED|First Follow up -Primary Outcome||248|Participants that completed Locoregional first follow up (primary outcome)|
60105739|NCT01840163|76224457|FG001|COMPLETED|First Follow up -Primary Outcome||254|Participants that completed Locoregional first follow up (primary outcome)|
60105740|NCT01840163|76224456|FG000|NOT COMPLETED|First Follow up -Primary Outcome||19||
60105741|NCT01840163|76224457|FG001|NOT COMPLETED|First Follow up -Primary Outcome||16||
60105742|NCT01840163|76224456|FG000|STARTED|Systemic Follow Up-secondary Outcome|From primary outcome to secondary outcome prd 1 participant withdrew and 1 became deceased|265||
60105743|NCT01840163|76224457|FG001|STARTED|Systemic Follow Up-secondary Outcome|4 participants became unreachable and lost to follow up before sending 9 mo follow up|266||
60105744|NCT01840163|76224456|FG000|COMPLETED|Systemic Follow Up-secondary Outcome||174||
60105745|NCT01840163|76224457|FG001|COMPLETED|Systemic Follow Up-secondary Outcome||191||
60105746|NCT01840163|76224456|FG000|NOT COMPLETED|Systemic Follow Up-secondary Outcome||91||
60105747|NCT01840163|76224457|FG001|NOT COMPLETED|Systemic Follow Up-secondary Outcome||75||
60105748|NCT02203630|76224465|FG000|STARTED|Overall Study||8||
60105749|NCT02203630|76224466|FG001|STARTED|Overall Study||9||
60105750|NCT02203630|76224465|FG000|COMPLETED|Overall Study||8||
60105751|NCT02203630|76224466|FG001|COMPLETED|Overall Study||9||
60105752|NCT02203630|76224465|FG000|NOT COMPLETED|Overall Study||0||
60105753|NCT02203630|76224466|FG001|NOT COMPLETED|Overall Study||0||
60105754|NCT02196922|76224474|FG000|STARTED|Overall Study||58||
60105755|NCT02196922|76224475|FG001|STARTED|Overall Study||46||
60105756|NCT02196922|76224474|FG000|COMPLETED|Overall Study||58||
60105757|NCT02196922|76224475|FG001|COMPLETED|Overall Study||46||
60105758|NCT02196922|76224474|FG000|NOT COMPLETED|Overall Study||0||
60105759|NCT02196922|76224475|FG001|NOT COMPLETED|Overall Study||0||
60105760|NCT01417936|76224483|FG000|STARTED|Overall Study||26||
60105761|NCT01417936|76224483|FG000|COMPLETED|Overall Study||26||
60105762|NCT01417936|76224483|FG000|NOT COMPLETED|Overall Study||0||
60105763|NCT01418482|76224487|FG000|STARTED|Overall Study||15||
60105764|NCT01418482|76224487|FG000|COMPLETED|Overall Study||15||
60105765|NCT01418482|76224487|FG000|NOT COMPLETED|Overall Study||0||
60105766|NCT01419028|76224491|FG000|STARTED|Overall Study||48||
59566288|NCT03682809|75668821|FG000|COMPLETED|Overall Study||22||
59566289|NCT03682809|75668822|FG001|COMPLETED|Overall Study||24||
60105767|NCT01419028|76224491|FG000|COMPLETED|Overall Study||48||
60105768|NCT01419028|76224491|FG000|NOT COMPLETED|Overall Study||0||
60105769|NCT01393132|76224497|FG000|STARTED|Overall Study||6||
60105770|NCT01393132|76224498|FG001|STARTED|Overall Study||3||
60105771|NCT01393132|76224497|FG000|COMPLETED|Overall Study||6||
60105772|NCT01393132|76224498|FG001|COMPLETED|Overall Study||3||
60105773|NCT01393132|76224497|FG000|NOT COMPLETED|Overall Study||0||
60105774|NCT01393132|76224498|FG001|NOT COMPLETED|Overall Study||0||
60105775|NCT01324882|76224508|FG000|STARTED|Overall Study|27 patients were randomized to this arm.|27||
60105776|NCT01324882|76224509|FG001|STARTED|Overall Study|30 patients were randomized to this arm|30||
60105777|NCT01324882|76224508|FG000|COMPLETED|Overall Study|27 patients had the colonoscopy|27||
59566290|NCT03682809|75668821|FG000|NOT COMPLETED|Overall Study||0||
60105778|NCT01324882|76224509|FG001|COMPLETED|Overall Study|30 patients had the colonoscopy|30||
60105779|NCT01324882|76224508|FG000|NOT COMPLETED|Overall Study||0||
60105780|NCT01324882|76224509|FG001|NOT COMPLETED|Overall Study||0||
60105781|NCT02201446|76224519|FG000|STARTED|Overall Study||81||
60105782|NCT02201446|76224520|FG001|STARTED|Overall Study||58||
60105783|NCT02201446|76224519|FG000|COMPLETED|Overall Study||81||
60105784|NCT02201446|76224520|FG001|COMPLETED|Overall Study||58||
60105785|NCT02201446|76224519|FG000|NOT COMPLETED|Overall Study||0||
59566291|NCT03682809|75668822|FG001|NOT COMPLETED|Overall Study||0||
60105786|NCT02201446|76224520|FG001|NOT COMPLETED|Overall Study||0||
60105787|NCT01328158|76224526|FG000|STARTED|Overall Study||220||
60105788|NCT01328158|76224526|FG000|COMPLETED|Overall Study||220||
60105789|NCT01328158|76224526|FG000|NOT COMPLETED|Overall Study||0||
60105790|NCT01394614|76224535|FG000|STARTED|Overall Study||8||
60105791|NCT01394614|76224536|FG001|STARTED|Overall Study||16||
60105792|NCT01394614|76224535|FG000|COMPLETED|Overall Study||8||
60105793|NCT01394614|76224536|FG001|COMPLETED|Overall Study||16||
60105794|NCT01394614|76224535|FG000|NOT COMPLETED|Overall Study||0||
60105795|NCT01394614|76224536|FG001|NOT COMPLETED|Overall Study||0||
60105796|NCT01394692|76224544|FG000|STARTED|Overall Study||29||
60105797|NCT01394692|76224545|FG001|STARTED|Overall Study||29||
60105798|NCT01394692|76224544|FG000|COMPLETED|Overall Study||29||
60105799|NCT01394692|76224545|FG001|COMPLETED|Overall Study||29||
60105800|NCT01394692|76224544|FG000|NOT COMPLETED|Overall Study||0||
60105801|NCT01394692|76224545|FG001|NOT COMPLETED|Overall Study||0||
60105802|NCT01422070|76224553|FG000|STARTED|Overall Study|Number of patients admitted to 140 intensive care units|5031||
60105803|NCT01422070|76224554|FG001|STARTED|Overall Study|Number of patients admitted to 27 intensive care units.|803||
60105804|NCT01422070|76224553|FG000|COMPLETED|Overall Study||5031||
60105805|NCT01422070|76224554|FG001|COMPLETED|Overall Study||803||
60105806|NCT01422070|76224553|FG000|NOT COMPLETED|Overall Study||0||
60105807|NCT01422070|76224554|FG001|NOT COMPLETED|Overall Study||0||
60105808|NCT01422226|76224561|FG000|STARTED|Overall Study||1||
60105809|NCT01422226|76224562|FG001|STARTED|Overall Study||2||
60105810|NCT01422226|76224561|FG000|COMPLETED|Overall Study||1||
60105811|NCT01422226|76224562|FG001|COMPLETED|Overall Study||2||
60105812|NCT01422226|76224561|FG000|NOT COMPLETED|Overall Study||0||
60105813|NCT01422226|76224562|FG001|NOT COMPLETED|Overall Study||0||
60105814|NCT01423162|76224570|FG000|STARTED|Overall Study||11||
60105815|NCT01423162|76224571|FG001|STARTED|Overall Study||9||
60105816|NCT01423162|76224570|FG000|COMPLETED|Overall Study|Crossover design: All subjects (n=20) completed both arms|11||
60105817|NCT01423162|76224571|FG001|COMPLETED|Overall Study|Crossover design: All subjects (n=20) completed both arms|9||
60105818|NCT01423162|76224570|FG000|NOT COMPLETED|Overall Study||0||
59996094|NCT02190604|76112044|FG011|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6||
59996095|NCT02190604|76112045|FG012|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6||
59996096|NCT02190604|76112046|FG013|COMPLETED|Part 1 and 2 (Healthy Volunteers)||5||
59996097|NCT02190604|76112047|FG014|COMPLETED|Part 1 and 2 (Healthy Volunteers)||8||
59996098|NCT02190604|76112048|FG015|COMPLETED|Part 1 and 2 (Healthy Volunteers)||0||
59996099|NCT02190604|76112049|FG016|COMPLETED|Part 1 and 2 (Healthy Volunteers)||0||
59996100|NCT02190604|76112050|FG017|COMPLETED|Part 1 and 2 (Healthy Volunteers)||0||
59996101|NCT02190604|76112051|FG018|COMPLETED|Part 1 and 2 (Healthy Volunteers)||0||
59996102|NCT02190604|76112033|FG000|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0||
59996103|NCT02190604|76112034|FG001|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0||
59996104|NCT02190604|76112035|FG002|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0||
59996105|NCT02190604|76112036|FG003|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0||
59996106|NCT02190604|76112037|FG004|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0||
60105819|NCT01423162|76224571|FG001|NOT COMPLETED|Overall Study||0||
60105820|NCT01328782|76224580|FG000|STARTED|Overall Study||43||
60105821|NCT01328782|76224581|FG001|STARTED|Overall Study||42||
60105822|NCT01328782|76224582|FG002|STARTED|Overall Study||39||
60105823|NCT01328782|76224580|FG000|COMPLETED|Overall Study||43||
60105824|NCT01328782|76224581|FG001|COMPLETED|Overall Study||42||
60105825|NCT01328782|76224582|FG002|COMPLETED|Overall Study||39||
60105826|NCT01328782|76224580|FG000|NOT COMPLETED|Overall Study||0||
60105827|NCT01328782|76224581|FG001|NOT COMPLETED|Overall Study||0||
60105828|NCT01328782|76224582|FG002|NOT COMPLETED|Overall Study||0||
60105829|NCT01426360|76224592|FG000|STARTED|Overall Study||38||
60105830|NCT01426360|76224593|FG001|STARTED|Overall Study||41||
60105831|NCT01426360|76224592|FG000|COMPLETED|Overall Study||38||
60105832|NCT01426360|76224593|FG001|COMPLETED|Overall Study||41||
60105833|NCT01426360|76224592|FG000|NOT COMPLETED|Overall Study||0||
60105834|NCT01426360|76224593|FG001|NOT COMPLETED|Overall Study||0||
60105835|NCT01831427|76224610|FG000|STARTED|Overall Study||5||
60105836|NCT01831427|76224611|FG001|STARTED|Overall Study||5||
60105837|NCT01831427|76224612|FG002|STARTED|Overall Study||5||
60105838|NCT01831427|76224613|FG003|STARTED|Overall Study||5||
60105839|NCT01831427|76224614|FG004|STARTED|Overall Study||4||
60105840|NCT01831427|76224615|FG005|STARTED|Overall Study||8||
60105841|NCT01831427|76224616|FG006|STARTED|Overall Study||8||
60105842|NCT01831427|76224617|FG007|STARTED|Overall Study||8||
60105843|NCT01831427|76224618|FG008|STARTED|Overall Study||8||
60105844|NCT01831427|76224619|FG009|STARTED|Overall Study||10||
59710394|NCT01481935|75828893|FG001|COMPLETED|Overall Study||93||
60105845|NCT01831427|76224620|FG010|STARTED|Overall Study||8||
60105846|NCT01831427|76224610|FG000|COMPLETED|Overall Study||5||
60105847|NCT01831427|76224611|FG001|COMPLETED|Overall Study||4||
60105848|NCT01831427|76224612|FG002|COMPLETED|Overall Study||5||
60105849|NCT01831427|76224613|FG003|COMPLETED|Overall Study||4||
60105850|NCT01831427|76224614|FG004|COMPLETED|Overall Study||4||
60105851|NCT01831427|76224615|FG005|COMPLETED|Overall Study||7||
60105852|NCT01831427|76224616|FG006|COMPLETED|Overall Study||6||
60105853|NCT01831427|76224617|FG007|COMPLETED|Overall Study||7||
60105854|NCT01831427|76224618|FG008|COMPLETED|Overall Study||8||
60105855|NCT01831427|76224619|FG009|COMPLETED|Overall Study||9||
60105856|NCT01831427|76224620|FG010|COMPLETED|Overall Study||5||
60105857|NCT01831427|76224610|FG000|NOT COMPLETED|Overall Study||0||
59566292|NCT03682965|75668830|FG000|STARTED|Overall Study||11||
59566293|NCT03682965|75668831|FG001|STARTED|Overall Study||10||
59566294|NCT03682965|75668830|FG000|COMPLETED|Overall Study||11||
59566295|NCT03682965|75668831|FG001|COMPLETED|Overall Study||10||
59996107|NCT02190604|76112038|FG005|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0||
59996108|NCT02190604|76112039|FG006|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0||
59996109|NCT02190604|76112040|FG007|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0||
59996110|NCT02190604|76112041|FG008|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0||
59996111|NCT02190604|76112042|FG009|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0||
59996112|NCT02190604|76112043|FG010|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0||
59996113|NCT02190604|76112044|FG011|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0||
59996114|NCT02190604|76112045|FG012|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0||
60105858|NCT01831427|76224611|FG001|NOT COMPLETED|Overall Study||1||
60105859|NCT01831427|76224612|FG002|NOT COMPLETED|Overall Study||0||
60105860|NCT01831427|76224613|FG003|NOT COMPLETED|Overall Study||1||
60105861|NCT01831427|76224614|FG004|NOT COMPLETED|Overall Study||0||
60105862|NCT01831427|76224615|FG005|NOT COMPLETED|Overall Study||1||
60105863|NCT01831427|76224616|FG006|NOT COMPLETED|Overall Study||2||
60105864|NCT01831427|76224617|FG007|NOT COMPLETED|Overall Study||1||
60105865|NCT01831427|76224618|FG008|NOT COMPLETED|Overall Study||0||
60105866|NCT01831427|76224619|FG009|NOT COMPLETED|Overall Study||1||
60105867|NCT01831427|76224620|FG010|NOT COMPLETED|Overall Study||3||
60105868|NCT01426828|76224657|FG000|STARTED|Overall Study Evaluations||22||
60105869|NCT01426828|76224658|FG001|STARTED|Overall Study Evaluations||18||
60105870|NCT01426828|76224657|FG000|COMPLETED|Overall Study Evaluations||17||
60105871|NCT01426828|76224658|FG001|COMPLETED|Overall Study Evaluations||15||
60105872|NCT01426828|76224657|FG000|NOT COMPLETED|Overall Study Evaluations||5||
60105873|NCT01426828|76224658|FG001|NOT COMPLETED|Overall Study Evaluations||3||
60105874|NCT01426828|76224657|FG000|STARTED|Immune Response Analysis||17||
60105875|NCT01426828|76224658|FG001|STARTED|Immune Response Analysis||15||
60105876|NCT01426828|76224657|FG000|COMPLETED|Immune Response Analysis||8|Only those subjects that had sufficient PBMC samples from pre-vaccination (D0), and Day 30, Day 90 and Day 180 time points for NanoString gene expression analysis were included in the immune response analysis.|
60105877|NCT01426828|76224658|FG001|COMPLETED|Immune Response Analysis||8|Only those subjects that had sufficient PBMC samples from pre-vaccination (D0), and Day 30, Day 90 and Day 180 time points for NanoString gene expression analysis were included in the immune response analysis.|
60105878|NCT01426828|76224657|FG000|NOT COMPLETED|Immune Response Analysis||9||
60105879|NCT01426828|76224658|FG001|NOT COMPLETED|Immune Response Analysis||7||
60105880|NCT01830881|76224666|FG000|STARTED|Overall Study||62||
60105881|NCT01830881|76224667|FG001|STARTED|Overall Study||62||
60105882|NCT01830881|76224666|FG000|COMPLETED|Overall Study||62||
60105883|NCT01830881|76224667|FG001|COMPLETED|Overall Study||61||
60105884|NCT01830881|76224666|FG000|NOT COMPLETED|Overall Study||0||
60105885|NCT01830881|76224667|FG001|NOT COMPLETED|Overall Study||1||
60105886|NCT01396486|76224678|FG000|STARTED|Overall Study||20||
60105887|NCT01396486|76224679|FG001|STARTED|Overall Study||19||
59566296|NCT03682965|75668830|FG000|NOT COMPLETED|Overall Study||0||
60105888|NCT01396486|76224680|FG002|STARTED|Overall Study||22||
60105889|NCT01396486|76224678|FG000|Exposed|Overall Study||19||
60105890|NCT01396486|76224679|FG001|Exposed|Overall Study||16||
60105891|NCT01396486|76224680|FG002|Exposed|Overall Study||17||
60105892|NCT01396486|76224678|FG000|COMPLETED|Overall Study||10||
60105893|NCT01396486|76224679|FG001|COMPLETED|Overall Study||7||
60105894|NCT01396486|76224680|FG002|COMPLETED|Overall Study||10||
60105895|NCT01396486|76224678|FG000|NOT COMPLETED|Overall Study||10||
60105896|NCT01396486|76224679|FG001|NOT COMPLETED|Overall Study||12||
60105897|NCT01396486|76224680|FG002|NOT COMPLETED|Overall Study||12||
59710395|NCT01481935|75828892|FG000|NOT COMPLETED|Overall Study||0||
59996115|NCT02190604|76112046|FG013|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||1||
59996116|NCT02190604|76112047|FG014|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||2||
59996117|NCT02190604|76112048|FG015|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0||
59996118|NCT02190604|76112049|FG016|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0||
59996119|NCT02190604|76112050|FG017|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0||
59996120|NCT02190604|76112051|FG018|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0||
59996121|NCT02190604|76112033|FG000|STARTED|Part 3 (Patients)||0||
59996122|NCT02190604|76112034|FG001|STARTED|Part 3 (Patients)||0||
59996123|NCT02190604|76112035|FG002|STARTED|Part 3 (Patients)||0||
59996124|NCT02190604|76112036|FG003|STARTED|Part 3 (Patients)||0||
59996125|NCT02190604|76112037|FG004|STARTED|Part 3 (Patients)||0||
59996126|NCT02190604|76112038|FG005|STARTED|Part 3 (Patients)||0||
59996127|NCT02190604|76112039|FG006|STARTED|Part 3 (Patients)||0||
59996128|NCT02190604|76112040|FG007|STARTED|Part 3 (Patients)||0||
59996129|NCT02190604|76112041|FG008|STARTED|Part 3 (Patients)||0||
60105898|NCT01397656|76224690|FG000|STARTED|Overall Study||33||
60105899|NCT01397656|76224691|FG001|STARTED|Overall Study||30||
60105900|NCT01397656|76224690|FG000|COMPLETED|Overall Study||33||
60105901|NCT01397656|76224691|FG001|COMPLETED|Overall Study||30||
60105902|NCT01397656|76224690|FG000|NOT COMPLETED|Overall Study||0||
59996130|NCT02190604|76112042|FG009|STARTED|Part 3 (Patients)||0||
59996131|NCT02190604|76112043|FG010|STARTED|Part 3 (Patients)||0||
59996132|NCT02190604|76112044|FG011|STARTED|Part 3 (Patients)||0||
59996133|NCT02190604|76112045|FG012|STARTED|Part 3 (Patients)||0||
59996134|NCT02190604|76112046|FG013|STARTED|Part 3 (Patients)||0||
59996135|NCT02190604|76112047|FG014|STARTED|Part 3 (Patients)||0||
60105903|NCT01397656|76224691|FG001|NOT COMPLETED|Overall Study||0||
60105904|NCT01330420|76224699|FG000|STARTED|Overall Study||28||
60105905|NCT01330420|76224699|FG000|COMPLETED|Overall Study||24||
60105906|NCT01330420|76224699|FG000|NOT COMPLETED|Overall Study||4||
60105907|NCT01838681|76224703|FG000|STARTED|Period A||1986||
60105908|NCT01838681|76224704|FG001|STARTED|Period A||0||
60105909|NCT01838681|76224705|FG002|STARTED|Period A||0||
60105910|NCT01838681|76224706|FG003|STARTED|Period A||0||
60105911|NCT01838681|76224703|FG000|COMPLETED|Period A||1661||
60105912|NCT01838681|76224704|FG001|COMPLETED|Period A||0||
60105913|NCT01838681|76224705|FG002|COMPLETED|Period A||0||
60105914|NCT01838681|76224706|FG003|COMPLETED|Period A||0||
60105915|NCT01838681|76224703|FG000|NOT COMPLETED|Period A||325||
60105916|NCT01838681|76224704|FG001|NOT COMPLETED|Period A||0||
60105917|NCT01838681|76224705|FG002|NOT COMPLETED|Period A||0||
60105918|NCT01838681|76224706|FG003|NOT COMPLETED|Period A||0||
60105919|NCT01838681|76224703|FG000|STARTED|Period B/A+||0||
60105920|NCT01838681|76224704|FG001|STARTED|Period B/A+||442||
60105921|NCT01838681|76224705|FG002|STARTED|Period B/A+||444||
60105922|NCT01838681|76224706|FG003|STARTED|Period B/A+||770||
60105923|NCT01838681|76224703|FG000|COMPLETED|Period B/A+||0||
60105924|NCT01838681|76224704|FG001|COMPLETED|Period B/A+||380||
59566297|NCT03682965|75668831|FG001|NOT COMPLETED|Overall Study||0||
59996136|NCT02190604|76112048|FG015|STARTED|Part 3 (Patients)||6||
59996137|NCT02190604|76112049|FG016|STARTED|Part 3 (Patients)||12||
59996138|NCT02190604|76112050|FG017|STARTED|Part 3 (Patients)||19||
59996139|NCT02190604|76112051|FG018|STARTED|Part 3 (Patients)||12||
59996140|NCT02190604|76112033|FG000|COMPLETED|Part 3 (Patients)||0||
59996141|NCT02190604|76112034|FG001|COMPLETED|Part 3 (Patients)||0||
59996142|NCT02190604|76112035|FG002|COMPLETED|Part 3 (Patients)||0||
60105925|NCT01838681|76224705|FG002|COMPLETED|Period B/A+||349||
60105926|NCT01838681|76224706|FG003|COMPLETED|Period B/A+||653||
60105927|NCT01838681|76224703|FG000|NOT COMPLETED|Period B/A+||0||
60105928|NCT01838681|76224704|FG001|NOT COMPLETED|Period B/A+||62||
59566298|NCT03683901|75668837|FG000|STARTED|Overall Study||10||
60105929|NCT01838681|76224705|FG002|NOT COMPLETED|Period B/A+||95||
60105930|NCT01838681|76224706|FG003|NOT COMPLETED|Period B/A+||117||
59818294|NCT00514514|75940692|FG002|Non-randomized (Followed)|Extension - 4 Years||0||
59818295|NCT00514514|75940690|FG000|COMPLETED|Extension - 4 Years||108||
59818296|NCT00514514|75940691|FG001|COMPLETED|Extension - 4 Years||117||
59818297|NCT00514514|75940692|FG002|COMPLETED|Extension - 4 Years||113||
59818298|NCT00514514|75940690|FG000|NOT COMPLETED|Extension - 4 Years||37||
59818299|NCT00514514|75940691|FG001|NOT COMPLETED|Extension - 4 Years||22||
59818300|NCT00514514|75940692|FG002|NOT COMPLETED|Extension - 4 Years||21||
59818301|NCT00405639|75940702|FG000|STARTED|Overall Study||25||
59818302|NCT00405639|75940703|FG001|STARTED|Overall Study||12||
59818303|NCT00405639|75940702|FG000|COMPLETED|Overall Study||22||
59818304|NCT00405639|75940703|FG001|COMPLETED|Overall Study||12||
59818305|NCT00405639|75940702|FG000|NOT COMPLETED|Overall Study||3||
59818306|NCT00405639|75940703|FG001|NOT COMPLETED|Overall Study||0||
59818307|NCT00439725|75940711|FG000|STARTED|Treatment Period||602||
59818308|NCT00439725|75940712|FG001|STARTED|Treatment Period||595||
59818309|NCT00439725|75940711|FG000|Participants Received Treatment|Treatment Period|Safety population|598||
59566299|NCT03683901|75668837|FG000|COMPLETED|Overall Study||10||
59996143|NCT02190604|76112036|FG003|COMPLETED|Part 3 (Patients)||0||
59996144|NCT02190604|76112037|FG004|COMPLETED|Part 3 (Patients)||0||
59996145|NCT02190604|76112038|FG005|COMPLETED|Part 3 (Patients)||0||
59996146|NCT02190604|76112039|FG006|COMPLETED|Part 3 (Patients)||0||
59818310|NCT00439725|75940712|FG001|Participants Received Treatment|Treatment Period|Safety population|590||
59996147|NCT02190604|76112040|FG007|COMPLETED|Part 3 (Patients)||0||
59996148|NCT02190604|76112041|FG008|COMPLETED|Part 3 (Patients)||0||
59996149|NCT02190604|76112042|FG009|COMPLETED|Part 3 (Patients)||0||
59996150|NCT02190604|76112043|FG010|COMPLETED|Part 3 (Patients)||0||
60105931|NCT01398280|76224714|FG000|STARTED|Overall Study||11||
60105932|NCT01398280|76224715|FG001|STARTED|Overall Study||4||
60105933|NCT01398280|76224714|FG000|COMPLETED|Overall Study||7||
60105934|NCT01398280|76224715|FG001|COMPLETED|Overall Study||4||
60105935|NCT01398280|76224714|FG000|NOT COMPLETED|Overall Study||4||
60105936|NCT01398280|76224715|FG001|NOT COMPLETED|Overall Study||0||
59566300|NCT03683901|75668837|FG000|NOT COMPLETED|Overall Study||0||
60105937|NCT01398982|76224723|FG000|STARTED|Overall Study||44||
60105938|NCT01398982|76224724|FG001|STARTED|Overall Study||49||
60105939|NCT01398982|76224723|FG000|COMPLETED|Overall Study||38||
60105940|NCT01398982|76224724|FG001|COMPLETED|Overall Study||47||
59818311|NCT00439725|75940711|FG000|COMPLETED|Treatment Period||366||
59818312|NCT00439725|75940712|FG001|COMPLETED|Treatment Period||349||
59818313|NCT00439725|75940711|FG000|NOT COMPLETED|Treatment Period||236||
59818314|NCT00439725|75940712|FG001|NOT COMPLETED|Treatment Period||246||
59818315|NCT00439725|75940711|FG000|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|577||
59818316|NCT00439725|75940712|FG001|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|560||
59818317|NCT00439725|75940711|FG000|COMPLETED|Observational Period||569||
59818318|NCT00439725|75940712|FG001|COMPLETED|Observational Period||553||
59818319|NCT00439725|75940711|FG000|NOT COMPLETED|Observational Period||8||
59818320|NCT00439725|75940712|FG001|NOT COMPLETED|Observational Period||7||
59818321|NCT00521586|75940720|FG000|STARTED|Initial Vaccination (Year 0)||554||
59818322|NCT00521586|75940721|FG001|STARTED|Initial Vaccination (Year 0)||562||
59818323|NCT00521586|75940720|FG000|Vaccinated Dose 1|Initial Vaccination (Year 0)||551||
59818324|NCT00521586|75940721|FG001|Vaccinated Dose 1|Initial Vaccination (Year 0)||560||
59818325|NCT00521586|75940720|FG000|Vaccinated Dose 2|Initial Vaccination (Year 0)||538||
59818326|NCT00521586|75940721|FG001|Vaccinated Dose 2|Initial Vaccination (Year 0)||543||
59818327|NCT00521586|75940720|FG000|Initially Reported to Complete Year 0|Initial Vaccination (Year 0)|Initially 1060 participants were reported to complete follow-up(Year 0),but 1066 actually completed.|531||
59818328|NCT00521586|75940721|FG001|Initially Reported to Complete Year 0|Initial Vaccination (Year 0)|Initially 1060 participants were reported to complete follow-up(Year 0),but 1066 actually completed.|529||
59818329|NCT00521586|75940720|FG000|COMPLETED|Initial Vaccination (Year 0)|6 additional participants initially reported to have withdrawn, actually completed follow-up(Year 0)|533||
59818330|NCT00521586|75940721|FG001|COMPLETED|Initial Vaccination (Year 0)|6 additional participants initially reported to have withdrawn, actually completed follow-up(Year 0)|533||
59818331|NCT00521586|75940720|FG000|NOT COMPLETED|Initial Vaccination (Year 0)||21||
59818332|NCT00521586|75940721|FG001|NOT COMPLETED|Initial Vaccination (Year 0)||29||
59818333|NCT00521586|75940720|FG000|STARTED|Follow-up (From 6-month[Year 0]-Year 5)||533||
59818334|NCT00521586|75940721|FG001|STARTED|Follow-up (From 6-month[Year 0]-Year 5)||533||
59818335|NCT00521586|75940720|FG000|COMPLETED|Follow-up (From 6-month[Year 0]-Year 5)||364||
59818336|NCT00521586|75940721|FG001|COMPLETED|Follow-up (From 6-month[Year 0]-Year 5)||363||
59818337|NCT00521586|75940720|FG000|NOT COMPLETED|Follow-up (From 6-month[Year 0]-Year 5)||169||
59818338|NCT00521586|75940721|FG001|NOT COMPLETED|Follow-up (From 6-month[Year 0]-Year 5)||170||
59818339|NCT00521586|75940720|FG000|STARTED|Revaccination With 13vPnC (Year 5)||364||
59818340|NCT00521586|75940721|FG001|STARTED|Revaccination With 13vPnC (Year 5)||363||
59818341|NCT00521586|75940720|FG000|Vaccinated 13vPnC (Year 5)|Revaccination With 13vPnC (Year 5)||364||
59818342|NCT00521586|75940721|FG001|Vaccinated 13vPnC (Year 5)|Revaccination With 13vPnC (Year 5)||363||
59818343|NCT00521586|75940720|FG000|Completed 1 Month Follow-up|Revaccination With 13vPnC (Year 5)||363||
59818344|NCT00521586|75940721|FG001|Completed 1 Month Follow-up|Revaccination With 13vPnC (Year 5)||359||
59818345|NCT00521586|75940720|FG000|Completed 6 Month Follow-up|Revaccination With 13vPnC (Year 5)||361||
59818346|NCT00521586|75940721|FG001|Completed 6 Month Follow-up|Revaccination With 13vPnC (Year 5)||351||
59818347|NCT00521586|75940720|FG000|COMPLETED|Revaccination With 13vPnC (Year 5)||361||
59818348|NCT00521586|75940721|FG001|COMPLETED|Revaccination With 13vPnC (Year 5)||351||
59818349|NCT00521586|75940720|FG000|NOT COMPLETED|Revaccination With 13vPnC (Year 5)||3||
59818350|NCT00521586|75940721|FG001|NOT COMPLETED|Revaccination With 13vPnC (Year 5)||12||
59818351|NCT00515502|75940739|FG000|STARTED|Treatment Period 1||1||
59818352|NCT00515502|75940740|FG001|STARTED|Treatment Period 1||4||
59818353|NCT00515502|75940741|FG002|STARTED|Treatment Period 1||4||
59818354|NCT00515502|75940742|FG003|STARTED|Treatment Period 1||3||
59818355|NCT00515502|75940743|FG004|STARTED|Treatment Period 1||3||
59818356|NCT00515502|75940744|FG005|STARTED|Treatment Period 1||1||
59818357|NCT00515502|75940745|FG006|STARTED|Treatment Period 1||2||
59818358|NCT00515502|75940746|FG007|STARTED|Treatment Period 1||1||
59818359|NCT00515502|75940747|FG008|STARTED|Treatment Period 1||1||
59818360|NCT00515502|75940748|FG009|STARTED|Treatment Period 1||2||
59818361|NCT00515502|75940749|FG010|STARTED|Treatment Period 1||1||
59818362|NCT00515502|75940750|FG011|STARTED|Treatment Period 1||1||
59818363|NCT00515502|75940739|FG000|COMPLETED|Treatment Period 1||1||
59818364|NCT00515502|75940740|FG001|COMPLETED|Treatment Period 1||4||
60105941|NCT01398982|76224723|FG000|NOT COMPLETED|Overall Study||6||
60105942|NCT01398982|76224724|FG001|NOT COMPLETED|Overall Study||2||
60105943|NCT02203162|76224730|FG000|STARTED|Overall Study||30||
59710396|NCT01481935|75828893|FG001|NOT COMPLETED|Overall Study||0||
59710397|NCT00901927|75828899|FG000|STARTED|Overall Study||14||
60105944|NCT02203162|76224730|FG000|COMPLETED|Overall Study||30||
60105945|NCT02203162|76224730|FG000|NOT COMPLETED|Overall Study||0||
60105946|NCT01427296|76224736|FG000|STARTED|Overall Study||1041||
60105947|NCT01427296|76224737|FG001|STARTED|Overall Study||1051||
60105948|NCT01427296|76224736|FG000|COMPLETED|Overall Study||1041||
60105949|NCT01427296|76224737|FG001|COMPLETED|Overall Study||1051||
60105950|NCT01427296|76224736|FG000|NOT COMPLETED|Overall Study||0||
60105951|NCT01427296|76224737|FG001|NOT COMPLETED|Overall Study||0||
60105952|NCT02203786|76224747|FG000|STARTED|Overall Study||15||
60105953|NCT02203786|76224748|FG001|STARTED|Overall Study||15||
60105954|NCT02203786|76224749|FG002|STARTED|Overall Study||17||
60105955|NCT02203786|76224750|FG003|STARTED|Overall Study||15||
60105956|NCT02203786|76224747|FG000|COMPLETED|Overall Study||15||
60105957|NCT02203786|76224748|FG001|COMPLETED|Overall Study||15||
60105958|NCT02203786|76224749|FG002|COMPLETED|Overall Study||15||
60105959|NCT02203786|76224750|FG003|COMPLETED|Overall Study||15||
60105960|NCT02203786|76224747|FG000|NOT COMPLETED|Overall Study||0||
60105961|NCT02203786|76224748|FG001|NOT COMPLETED|Overall Study||0||
60105962|NCT02203786|76224749|FG002|NOT COMPLETED|Overall Study||2||
60105963|NCT02203786|76224750|FG003|NOT COMPLETED|Overall Study||0||
60105964|NCT01611857|76224764|FG000|STARTED|Overall Study|Three dose levels of tivantinib (120 mg, 240 mg, and 360 mg) were evaluated to determine the MTD.|15||
60105965|NCT01611857|76224765|FG001|STARTED|Overall Study||34||
60105966|NCT01611857|76224764|FG000|Tivantinib 120 mg|Overall Study||5||
60105967|NCT01611857|76224765|FG001|Tivantinib 120 mg|Overall Study||0||
60105968|NCT01611857|76224764|FG000|Tivantinib 240 mg|Overall Study||3||
60105969|NCT01611857|76224765|FG001|Tivantinib 240 mg|Overall Study||0||
60105970|NCT01611857|76224764|FG000|Tivantinib 360 mg|Overall Study||7||
60105971|NCT01611857|76224765|FG001|Tivantinib 360 mg|Overall Study|Two participants withdrew prior to receiving drug.|32||
60105972|NCT01611857|76224764|FG000|COMPLETED|Overall Study||15||
60105973|NCT01611857|76224765|FG001|COMPLETED|Overall Study||32||
60105974|NCT01611857|76224764|FG000|NOT COMPLETED|Overall Study||0||
60105975|NCT01611857|76224765|FG001|NOT COMPLETED|Overall Study||2||
60105976|NCT02204176|76224776|FG000|STARTED|Overall Study||74||
60105977|NCT02204176|76224777|FG001|STARTED|Overall Study||73||
60105978|NCT02204176|76224778|FG002|STARTED|Overall Study||74||
60105979|NCT02204176|76224776|FG000|COMPLETED|Overall Study||64||
60105980|NCT02204176|76224777|FG001|COMPLETED|Overall Study||61||
60105981|NCT02204176|76224778|FG002|COMPLETED|Overall Study||58||
60105982|NCT02204176|76224776|FG000|NOT COMPLETED|Overall Study||10||
60105983|NCT02204176|76224777|FG001|NOT COMPLETED|Overall Study||12||
60105984|NCT02204176|76224778|FG002|NOT COMPLETED|Overall Study||16||
60105985|NCT01829477|76224788|FG000|STARTED|Overall Study||17||
60105986|NCT01829477|76224789|FG001|STARTED|Overall Study||16||
60105987|NCT01829477|76224788|FG000|COMPLETED|Overall Study||1||
60105988|NCT01829477|76224789|FG001|COMPLETED|Overall Study||1||
60105989|NCT01829477|76224788|FG000|NOT COMPLETED|Overall Study||16||
60105990|NCT01829477|76224789|FG001|NOT COMPLETED|Overall Study||15||
60105991|NCT02204566|76224795|FG000|STARTED|Overall Study||5||
60105992|NCT02204566|76224795|FG000|COMPLETED|Overall Study||1||
60105993|NCT02204566|76224795|FG000|NOT COMPLETED|Overall Study||4||
60105994|NCT01334086|76224799|FG000|STARTED|Overall Study||41||
60105995|NCT01334086|76224799|FG000|COMPLETED|Overall Study||41||
60105996|NCT01334086|76224799|FG000|NOT COMPLETED|Overall Study||0||
60105997|NCT01611155|76224805|FG000|STARTED|Overall Study||25||
60105998|NCT01611155|76224806|FG001|STARTED|Overall Study||25||
60105999|NCT01611155|76224805|FG000|Received Treatment|Overall Study||25||
60106000|NCT01611155|76224806|FG001|Received Treatment|Overall Study||25||
60106001|NCT01611155|76224805|FG000|COMPLETED|Overall Study||16|Evaluable for primary endpoint|
60106002|NCT01611155|76224806|FG001|COMPLETED|Overall Study||18|Evaluable for primary endpoint|
60106003|NCT01611155|76224805|FG000|NOT COMPLETED|Overall Study||9||
59710398|NCT00901927|75828899|FG000|COMPLETED|Overall Study||8||
59818365|NCT00515502|75940741|FG002|COMPLETED|Treatment Period 1||4||
60106004|NCT01611155|76224806|FG001|NOT COMPLETED|Overall Study||7||
60106005|NCT01430182|76224814|FG000|STARTED|Overall Study||9||
60106006|NCT01430182|76224815|FG001|STARTED|Overall Study||8||
60106007|NCT01430182|76224814|FG000|COMPLETED|Overall Study||9||
60106008|NCT01430182|76224815|FG001|COMPLETED|Overall Study||8||
60106009|NCT01430182|76224814|FG000|NOT COMPLETED|Overall Study||0||
60106010|NCT01430182|76224815|FG001|NOT COMPLETED|Overall Study||0||
60106011|NCT01829243|76224821|FG000|STARTED|First Intervention||11||
60106012|NCT01829243|76224822|FG001|STARTED|First Intervention||15||
60106013|NCT01829243|76224821|FG000|COMPLETED|First Intervention||7||
59710399|NCT00901927|75828899|FG000|NOT COMPLETED|Overall Study||6||
59710400|NCT00968968|75828905|FG000|STARTED|Overall Study||20||
60106014|NCT01829243|76224822|FG001|COMPLETED|First Intervention||13||
60106015|NCT01829243|76224821|FG000|NOT COMPLETED|First Intervention||4||
60106016|NCT01829243|76224822|FG001|NOT COMPLETED|First Intervention||2||
59996151|NCT02190604|76112044|FG011|COMPLETED|Part 3 (Patients)||0||
59996152|NCT02190604|76112045|FG012|COMPLETED|Part 3 (Patients)||0||
59996153|NCT02190604|76112046|FG013|COMPLETED|Part 3 (Patients)||0||
59996154|NCT02190604|76112047|FG014|COMPLETED|Part 3 (Patients)||0||
59996155|NCT02190604|76112048|FG015|COMPLETED|Part 3 (Patients)||6||
59996156|NCT02190604|76112049|FG016|COMPLETED|Part 3 (Patients)||12||
59996157|NCT02190604|76112050|FG017|COMPLETED|Part 3 (Patients)||19||
59996158|NCT02190604|76112051|FG018|COMPLETED|Part 3 (Patients)||12||
59996159|NCT02190604|76112033|FG000|NOT COMPLETED|Part 3 (Patients)||0||
60106017|NCT01829243|76224821|FG000|STARTED|Washout Period of 1 Week||7||
60106018|NCT01829243|76224822|FG001|STARTED|Washout Period of 1 Week||13||
60106019|NCT01829243|76224821|FG000|COMPLETED|Washout Period of 1 Week||7||
60106020|NCT01829243|76224822|FG001|COMPLETED|Washout Period of 1 Week||13||
60106021|NCT01829243|76224821|FG000|NOT COMPLETED|Washout Period of 1 Week||0||
60106022|NCT01829243|76224822|FG001|NOT COMPLETED|Washout Period of 1 Week||0||
59996160|NCT02190604|76112034|FG001|NOT COMPLETED|Part 3 (Patients)||0||
59996161|NCT02190604|76112035|FG002|NOT COMPLETED|Part 3 (Patients)||0||
59996162|NCT02190604|76112036|FG003|NOT COMPLETED|Part 3 (Patients)||0||
59710401|NCT00968968|75828906|FG001|STARTED|Overall Study||17||
59710402|NCT00968968|75828905|FG000|COMPLETED|Overall Study||4||
60106023|NCT01829243|76224821|FG000|STARTED|Second Intervention||7||
60106024|NCT01829243|76224822|FG001|STARTED|Second Intervention||13||
60106025|NCT01829243|76224821|FG000|COMPLETED|Second Intervention||7||
60106026|NCT01829243|76224822|FG001|COMPLETED|Second Intervention||13||
60106027|NCT01829243|76224821|FG000|NOT COMPLETED|Second Intervention||0||
60106028|NCT01829243|76224822|FG001|NOT COMPLETED|Second Intervention||0||
60106029|NCT01838447|76224832|FG000|STARTED|Overall Study||22||
60106030|NCT01838447|76224833|FG001|STARTED|Overall Study||24||
60106031|NCT01838447|76224832|FG000|COMPLETED|Overall Study||20||
60106032|NCT01838447|76224833|FG001|COMPLETED|Overall Study||21||
60106033|NCT01838447|76224832|FG000|NOT COMPLETED|Overall Study||2||
60106034|NCT01838447|76224833|FG001|NOT COMPLETED|Overall Study||3||
60106035|NCT01829165|76224841|FG000|STARTED|Overall Study||20||
60106036|NCT01829165|76224842|FG001|STARTED|Overall Study||13||
60106037|NCT01829165|76224841|FG000|COMPLETED|Overall Study||18||
60106038|NCT01829165|76224842|FG001|COMPLETED|Overall Study||13||
60106039|NCT01829165|76224841|FG000|NOT COMPLETED|Overall Study||2||
60106040|NCT01829165|76224842|FG001|NOT COMPLETED|Overall Study||0||
60106041|NCT01838213|76224850|FG000|STARTED|Overall Study||247||
60106042|NCT01838213|76224851|FG001|STARTED|Overall Study||453||
60106043|NCT01838213|76224850|FG000|COMPLETED|Overall Study||81||
60106044|NCT01838213|76224851|FG001|COMPLETED|Overall Study||262||
60106045|NCT01838213|76224850|FG000|NOT COMPLETED|Overall Study||166||
60106046|NCT01838213|76224851|FG001|NOT COMPLETED|Overall Study||191||
60106047|NCT01837823|76224857|FG000|STARTED|Overall Study||91||
60106048|NCT01837823|76224857|FG000|COMPLETED|Overall Study||85||
60106049|NCT01837823|76224857|FG000|NOT COMPLETED|Overall Study||6||
60106050|NCT01828073|76224867|FG000|STARTED|Overall Study||22||
60106051|NCT01828073|76224868|FG001|STARTED|Overall Study||18||
60106052|NCT01828073|76224867|FG000|COMPLETED|Overall Study||21||
60106053|NCT01828073|76224868|FG001|COMPLETED|Overall Study||16||
60106054|NCT01828073|76224867|FG000|NOT COMPLETED|Overall Study||1||
60106055|NCT01828073|76224868|FG001|NOT COMPLETED|Overall Study||2||
60106056|NCT04697693|76224880|FG000|STARTED|Overall Study||1||
60106057|NCT04697693|76224880|FG000|COMPLETED|Overall Study||1||
60106058|NCT04697693|76224880|FG000|NOT COMPLETED|Overall Study||0||
60106059|NCT03819114|76224888|FG000|STARTED|Overall Study||17||
60106060|NCT03819114|76224889|FG001|STARTED|Overall Study||36||
60106061|NCT03819114|76224890|FG002|STARTED|Overall Study||35||
60106062|NCT03819114|76224891|FG003|STARTED|Overall Study||34||
60106063|NCT03819114|76224888|FG000|Received LNG Treatment|Overall Study||17||
60106064|NCT03819114|76224889|FG001|Received LNG Treatment|Overall Study||36||
60106065|NCT03819114|76224890|FG002|Received LNG Treatment|Overall Study||35||
60106066|NCT03819114|76224891|FG003|Received LNG Treatment|Overall Study||34||
60106067|NCT03819114|76224888|FG000|COMPLETED|Overall Study||17||
60106068|NCT03819114|76224889|FG001|COMPLETED|Overall Study||35||
60106069|NCT03819114|76224890|FG002|COMPLETED|Overall Study||33||
60106070|NCT03819114|76224891|FG003|COMPLETED|Overall Study||34||
60106071|NCT03819114|76224888|FG000|NOT COMPLETED|Overall Study||0||
60106072|NCT03819114|76224889|FG001|NOT COMPLETED|Overall Study||1||
60106073|NCT03819114|76224890|FG002|NOT COMPLETED|Overall Study||2||
60106074|NCT03819114|76224891|FG003|NOT COMPLETED|Overall Study||0||
60106075|NCT01827839|76224903|FG000|STARTED|Overall Study||96||
60106076|NCT01827839|76224903|FG000|COMPLETED|Overall Study||93||
60106077|NCT01827839|76224903|FG000|NOT COMPLETED|Overall Study||3||
60106078|NCT01827371|76224918|FG000|STARTED|Overall Study||115||
60106079|NCT01827371|76224919|FG001|STARTED|Overall Study||96||
60106080|NCT01827371|76224920|FG002|STARTED|Overall Study||104||
60106081|NCT01827371|76224921|FG003|STARTED|Overall Study||120||
60106082|NCT01827371|76224918|FG000|COMPLETED|Overall Study||102||
60106083|NCT01827371|76224919|FG001|COMPLETED|Overall Study||89||
60106084|NCT01827371|76224920|FG002|COMPLETED|Overall Study||93||
60106085|NCT01827371|76224921|FG003|COMPLETED|Overall Study||97||
60106086|NCT01827371|76224918|FG000|NOT COMPLETED|Overall Study||13||
60106087|NCT01827371|76224919|FG001|NOT COMPLETED|Overall Study||7||
60106088|NCT01827371|76224920|FG002|NOT COMPLETED|Overall Study||11||
60106089|NCT01827371|76224921|FG003|NOT COMPLETED|Overall Study||23||
59710403|NCT00968968|75828906|FG001|COMPLETED|Overall Study||3||
59710404|NCT00968968|75828905|FG000|NOT COMPLETED|Overall Study||16||
59710405|NCT00968968|75828906|FG001|NOT COMPLETED|Overall Study||14||
59710406|NCT00973102|75828915|FG000|STARTED|Overall Study||24||
59710407|NCT00973102|75828916|FG001|STARTED|Overall Study||26||
60106090|NCT01401166|76224933|FG000|STARTED|Crossover Treatment 1 (Cycles 1 to 4)|A total of 124 participants were randomized, but 2 did not receive any treatment.|122||
60106091|NCT01401166|76224934|FG001|STARTED|Crossover Treatment 1 (Cycles 1 to 4)|A total of 124 participants were randomized, but 2 did not receive any treatment.|122||
60106092|NCT01401166|76224935|FG002|STARTED|Crossover Treatment 1 (Cycles 1 to 4)|A total of 121 participants were randomized who all received study treatment.|121||
60106093|NCT01401166|76224936|FG003|STARTED|Crossover Treatment 1 (Cycles 1 to 4)|A total of 119 participants were randomized, but 1 did not receive any treatment.|118||
60106094|NCT01401166|76224933|FG000|COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||119||
59710408|NCT00973102|75828915|FG000|COMPLETED|Overall Study||23||
59566301|NCT01865708|75668843|FG000|STARTED|Overall Study||10||
59710409|NCT00973102|75828916|FG001|COMPLETED|Overall Study||25||
59710410|NCT00973102|75828915|FG000|NOT COMPLETED|Overall Study||1||
60106095|NCT01401166|76224934|FG001|COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||120||
60106096|NCT01401166|76224935|FG002|COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||119||
60106097|NCT01401166|76224936|FG003|COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||116||
60106098|NCT01401166|76224933|FG000|NOT COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||3||
60106099|NCT01401166|76224934|FG001|NOT COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||2||
60106100|NCT01401166|76224935|FG002|NOT COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||2||
60106101|NCT01401166|76224936|FG003|NOT COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||2||
60106102|NCT01401166|76224933|FG000|STARTED|Crossover Treatment 2 (Cycles 5 to 8)||119||
60106103|NCT01401166|76224934|FG001|STARTED|Crossover Treatment 2 (Cycles 5 to 8)||120||
60106104|NCT01401166|76224935|FG002|STARTED|Crossover Treatment 2 (Cycles 5 to 8)||119||
60106105|NCT01401166|76224936|FG003|STARTED|Crossover Treatment 2 (Cycles 5 to 8)||116||
60106106|NCT01401166|76224933|FG000|COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||113||
60106107|NCT01401166|76224934|FG001|COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||116||
60106108|NCT01401166|76224935|FG002|COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||107||
60106109|NCT01401166|76224936|FG003|COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||105||
60106110|NCT01401166|76224933|FG000|NOT COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||6||
60106111|NCT01401166|76224934|FG001|NOT COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||4||
60106112|NCT01401166|76224935|FG002|NOT COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||12||
60106113|NCT01401166|76224936|FG003|NOT COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||11||
60106114|NCT01401166|76224933|FG000|STARTED|Continuation Treatment (Cycles 9 to 18)||113||
60106115|NCT01401166|76224934|FG001|STARTED|Continuation Treatment (Cycles 9 to 18)||116||
60106116|NCT01401166|76224935|FG002|STARTED|Continuation Treatment (Cycles 9 to 18)||107||
60106117|NCT01401166|76224936|FG003|STARTED|Continuation Treatment (Cycles 9 to 18)||105||
60106118|NCT01401166|76224933|FG000|COMPLETED|Continuation Treatment (Cycles 9 to 18)||109||
60106119|NCT01401166|76224934|FG001|COMPLETED|Continuation Treatment (Cycles 9 to 18)||109||
60106120|NCT01401166|76224935|FG002|COMPLETED|Continuation Treatment (Cycles 9 to 18)||105||
60106121|NCT01401166|76224936|FG003|COMPLETED|Continuation Treatment (Cycles 9 to 18)||102||
60106122|NCT01401166|76224933|FG000|NOT COMPLETED|Continuation Treatment (Cycles 9 to 18)||4||
60106123|NCT01401166|76224934|FG001|NOT COMPLETED|Continuation Treatment (Cycles 9 to 18)||7||
60106124|NCT01401166|76224935|FG002|NOT COMPLETED|Continuation Treatment (Cycles 9 to 18)||2||
60106125|NCT01401166|76224936|FG003|NOT COMPLETED|Continuation Treatment (Cycles 9 to 18)||3||
60106126|NCT01401166|76224933|FG000|STARTED|Safety Follow-Up Period|All 124 randomized participants entered follow-up regardless of whether they received treatment.|124||
60106127|NCT01401166|76224934|FG001|STARTED|Safety Follow-Up Period|All 124 randomized participants entered follow-up regardless of whether they received treatment.|124||
60106128|NCT01401166|76224935|FG002|STARTED|Safety Follow-Up Period|All 121 randomized participants entered follow-up regardless of whether they received treatment.|121||
60106129|NCT01401166|76224936|FG003|STARTED|Safety Follow-Up Period|All 119 randomized participants entered follow-up regardless of whether they received treatment.|119||
60106130|NCT01401166|76224933|FG000|COMPLETED|Safety Follow-Up Period||99||
60106131|NCT01401166|76224934|FG001|COMPLETED|Safety Follow-Up Period||106||
60106132|NCT01401166|76224935|FG002|COMPLETED|Safety Follow-Up Period||104||
60106133|NCT01401166|76224936|FG003|COMPLETED|Safety Follow-Up Period||100||
60106134|NCT01401166|76224933|FG000|NOT COMPLETED|Safety Follow-Up Period||25||
60106135|NCT01401166|76224934|FG001|NOT COMPLETED|Safety Follow-Up Period||18||
60106136|NCT01401166|76224935|FG002|NOT COMPLETED|Safety Follow-Up Period||17||
60106137|NCT01401166|76224936|FG003|NOT COMPLETED|Safety Follow-Up Period||19||
60106138|NCT01473160|76224953|FG000|STARTED|Overall Study||9||
60106139|NCT01473160|76224953|FG000|COMPLETED|Overall Study||9||
60106140|NCT01473160|76224953|FG000|NOT COMPLETED|Overall Study||0||
60106141|NCT01335724|76224961|FG000|STARTED|Overall Study||36||
60106142|NCT01335724|76224962|FG001|STARTED|Overall Study||36||
60106143|NCT01335724|76224961|FG000|COMPLETED|Overall Study||36||
60106144|NCT01335724|76224962|FG001|COMPLETED|Overall Study||36||
60106145|NCT01335724|76224961|FG000|NOT COMPLETED|Overall Study||0||
60106146|NCT01335724|76224962|FG001|NOT COMPLETED|Overall Study||0||
60106147|NCT01476202|76224971|FG000|STARTED|Overall Study||40||
60106148|NCT01476202|76224972|FG001|STARTED|Overall Study||40||
60106149|NCT01476202|76224973|FG002|STARTED|Overall Study||40||
60106150|NCT01476202|76224971|FG000|COMPLETED|Overall Study||40||
60106151|NCT01476202|76224972|FG001|COMPLETED|Overall Study||40||
59710411|NCT00973102|75828916|FG001|NOT COMPLETED|Overall Study||1||
59710412|NCT00901459|75828922|FG000|STARTED|Overall Study||21||
59710413|NCT00901459|75828922|FG000|COMPLETED|Overall Study||15||
59710414|NCT00901459|75828922|FG000|NOT COMPLETED|Overall Study||6||
59710415|NCT00896233|75828933|FG000|STARTED|Overall Study||10||
59710416|NCT00896233|75828933|FG000|COMPLETED|Overall Study||9||
59566302|NCT01865708|75668843|FG000|COMPLETED|Overall Study||10||
60106152|NCT01476202|76224973|FG002|COMPLETED|Overall Study||40||
60106153|NCT01476202|76224971|FG000|NOT COMPLETED|Overall Study||0||
60106154|NCT01476202|76224972|FG001|NOT COMPLETED|Overall Study||0||
60106155|NCT01476202|76224973|FG002|NOT COMPLETED|Overall Study||0||
60106156|NCT01539694|76224984|FG000|STARTED|Overall Study||63||
60106157|NCT01539694|76224985|FG001|STARTED|Overall Study||63||
60106158|NCT01539694|76224984|FG000|COMPLETED|Overall Study||62||
59818366|NCT00515502|75940742|FG003|COMPLETED|Treatment Period 1||3||
59818367|NCT00515502|75940743|FG004|COMPLETED|Treatment Period 1||3||
59818368|NCT00515502|75940744|FG005|COMPLETED|Treatment Period 1||1||
59818369|NCT00515502|75940745|FG006|COMPLETED|Treatment Period 1||1||
59818370|NCT00515502|75940746|FG007|COMPLETED|Treatment Period 1||1||
59818371|NCT00515502|75940747|FG008|COMPLETED|Treatment Period 1||0||
59818372|NCT00515502|75940748|FG009|COMPLETED|Treatment Period 1||2||
60106159|NCT01539694|76224985|FG001|COMPLETED|Overall Study||62||
60106160|NCT01539694|76224984|FG000|NOT COMPLETED|Overall Study||1||
60106161|NCT01539694|76224985|FG001|NOT COMPLETED|Overall Study||1||
60106162|NCT01476748|76224994|FG000|STARTED|Overall Study||5||
60106163|NCT01476748|76224995|FG001|STARTED|Overall Study||5||
60106164|NCT01476748|76224996|FG002|STARTED|Overall Study||5||
59818373|NCT00515502|75940749|FG010|COMPLETED|Treatment Period 1||1||
59818374|NCT00515502|75940750|FG011|COMPLETED|Treatment Period 1||0||
59818375|NCT00515502|75940739|FG000|NOT COMPLETED|Treatment Period 1||0||
59818376|NCT00515502|75940740|FG001|NOT COMPLETED|Treatment Period 1||0||
59818377|NCT00515502|75940741|FG002|NOT COMPLETED|Treatment Period 1||0||
59818378|NCT00515502|75940742|FG003|NOT COMPLETED|Treatment Period 1||0||
59818379|NCT00515502|75940743|FG004|NOT COMPLETED|Treatment Period 1||0||
59818380|NCT00515502|75940744|FG005|NOT COMPLETED|Treatment Period 1||0||
59818381|NCT00515502|75940745|FG006|NOT COMPLETED|Treatment Period 1||1||
59818382|NCT00515502|75940746|FG007|NOT COMPLETED|Treatment Period 1||0||
59818383|NCT00515502|75940747|FG008|NOT COMPLETED|Treatment Period 1||1||
59818384|NCT00515502|75940748|FG009|NOT COMPLETED|Treatment Period 1||0||
60106165|NCT01476748|76224994|FG000|COMPLETED|Overall Study||5||
60106166|NCT01476748|76224995|FG001|COMPLETED|Overall Study||5||
60106167|NCT01476748|76224996|FG002|COMPLETED|Overall Study||5||
60106168|NCT01476748|76224994|FG000|NOT COMPLETED|Overall Study||0||
60106169|NCT01476748|76224995|FG001|NOT COMPLETED|Overall Study||0||
60106170|NCT01476748|76224996|FG002|NOT COMPLETED|Overall Study||0||
60106171|NCT01477450|76225007|FG000|STARTED|Overall Study||10||
60106172|NCT01477450|76225008|FG001|STARTED|Overall Study||10||
60106173|NCT01477450|76225009|FG002|STARTED|Overall Study||10||
60106174|NCT01477450|76225007|FG000|COMPLETED|Overall Study||10||
60106175|NCT01477450|76225008|FG001|COMPLETED|Overall Study||10||
60106176|NCT01477450|76225009|FG002|COMPLETED|Overall Study||10||
60106177|NCT01477450|76225007|FG000|NOT COMPLETED|Overall Study||0||
60106178|NCT01477450|76225008|FG001|NOT COMPLETED|Overall Study||0||
60106179|NCT01477450|76225009|FG002|NOT COMPLETED|Overall Study||0||
60106180|NCT01477762|76225021|FG000|STARTED|Overall Study||25||
60106181|NCT01477762|76225022|FG001|STARTED|Overall Study||33||
60106182|NCT01477762|76225023|FG002|STARTED|Overall Study||20||
60106183|NCT01477762|76225024|FG003|STARTED|Overall Study||13||
60106184|NCT01477762|76225021|FG000|COMPLETED|Overall Study||16||
60106185|NCT01477762|76225022|FG001|COMPLETED|Overall Study||20||
60106186|NCT01477762|76225023|FG002|COMPLETED|Overall Study||16||
60106187|NCT01477762|76225024|FG003|COMPLETED|Overall Study||11||
59710417|NCT00896233|75828933|FG000|NOT COMPLETED|Overall Study||1||
59710418|NCT03340207|75828940|FG000|STARTED|Overall Study||16||
59710419|NCT03340207|75828941|FG001|STARTED|Overall Study||16||
59996163|NCT02190604|76112037|FG004|NOT COMPLETED|Part 3 (Patients)||0||
59996164|NCT02190604|76112038|FG005|NOT COMPLETED|Part 3 (Patients)||0||
59996165|NCT02190604|76112039|FG006|NOT COMPLETED|Part 3 (Patients)||0||
59566303|NCT01865708|75668843|FG000|NOT COMPLETED|Overall Study||0||
59566304|NCT04203225|75668849|FG000|STARTED|Overall Study||21||
59566305|NCT04203225|75668850|FG001|STARTED|Overall Study||27||
59710420|NCT03340207|75828940|FG000|COMPLETED|Overall Study||16||
59710421|NCT03340207|75828941|FG001|COMPLETED|Overall Study||16||
59710422|NCT03340207|75828940|FG000|NOT COMPLETED|Overall Study||0||
59710423|NCT03340207|75828941|FG001|NOT COMPLETED|Overall Study||0||
59710424|NCT00899431|75828958|FG000|STARTED|Overall Study||22||
59710425|NCT00899431|75828959|FG001|STARTED|Overall Study||8||
59710426|NCT00899431|75828960|FG002|STARTED|Overall Study||9||
59710427|NCT00899431|75828958|FG000|COMPLETED|Overall Study||21||
59710428|NCT00899431|75828959|FG001|COMPLETED|Overall Study||8||
59710429|NCT00899431|75828960|FG002|COMPLETED|Overall Study||9||
60106188|NCT01477762|76225021|FG000|NOT COMPLETED|Overall Study||9||
60106189|NCT01477762|76225022|FG001|NOT COMPLETED|Overall Study||13||
60106190|NCT01477762|76225023|FG002|NOT COMPLETED|Overall Study||4||
60106191|NCT01477762|76225024|FG003|NOT COMPLETED|Overall Study||2||
60106192|NCT01478854|76225034|FG000|STARTED|Overall Study||30||
60106193|NCT01478854|76225034|FG000|COMPLETED|Overall Study||30||
60106194|NCT01478854|76225034|FG000|NOT COMPLETED|Overall Study||0||
60106195|NCT01434472|76225038|FG000|STARTED|Overall Study||20||
60106196|NCT01434472|76225038|FG000|COMPLETED|Overall Study||20||
60106197|NCT01434472|76225038|FG000|NOT COMPLETED|Overall Study||0||
60106198|NCT01435174|76225042|FG000|STARTED|Overall Study||17||
60106199|NCT01435174|76225042|FG000|COMPLETED|Overall Study||8||
60106200|NCT01435174|76225042|FG000|NOT COMPLETED|Overall Study||9||
59566306|NCT04203225|75668849|FG000|COMPLETED|Overall Study||21||
59566307|NCT04203225|75668850|FG001|COMPLETED|Overall Study||27||
59566308|NCT04203225|75668849|FG000|NOT COMPLETED|Overall Study||0||
59710430|NCT00899431|75828958|FG000|NOT COMPLETED|Overall Study||1||
59710431|NCT00899431|75828959|FG001|NOT COMPLETED|Overall Study||0||
59710432|NCT00899431|75828960|FG002|NOT COMPLETED|Overall Study||0||
59710433|NCT00899353|75828971|FG000|STARTED|Overall Study||16||
59710434|NCT00899353|75828971|FG000|COMPLETED|Overall Study||11||
59996166|NCT02190604|76112040|FG007|NOT COMPLETED|Part 3 (Patients)||0||
59996167|NCT02190604|76112041|FG008|NOT COMPLETED|Part 3 (Patients)||0||
59996168|NCT02190604|76112042|FG009|NOT COMPLETED|Part 3 (Patients)||0||
59996169|NCT02190604|76112043|FG010|NOT COMPLETED|Part 3 (Patients)||0||
59996170|NCT02190604|76112044|FG011|NOT COMPLETED|Part 3 (Patients)||0||
59996171|NCT02190604|76112045|FG012|NOT COMPLETED|Part 3 (Patients)||0||
59996172|NCT02190604|76112046|FG013|NOT COMPLETED|Part 3 (Patients)||0||
59996173|NCT02190604|76112047|FG014|NOT COMPLETED|Part 3 (Patients)||0||
60106201|NCT01540162|76225048|FG000|STARTED|Overall Study||30||
59566309|NCT04203225|75668850|FG001|NOT COMPLETED|Overall Study||0||
59710435|NCT00899353|75828971|FG000|NOT COMPLETED|Overall Study||5||
60106202|NCT01540162|76225049|FG001|STARTED|Overall Study||32||
60106203|NCT01540162|76225048|FG000|COMPLETED|Overall Study||30||
59710436|NCT00898807|75828994|FG000|STARTED|Overall Study||94||
59710437|NCT00898807|75828995|FG001|STARTED|Overall Study||92||
59710438|NCT00898807|75828994|FG000|COMPLETED|Overall Study||86||
59710439|NCT00898807|75828995|FG001|COMPLETED|Overall Study||83||
59710440|NCT00898807|75828994|FG000|NOT COMPLETED|Overall Study||8||
59710441|NCT00898807|75828995|FG001|NOT COMPLETED|Overall Study||9||
59710442|NCT01229267|75829006|FG000|STARTED|Overall Study||189||
59710443|NCT01229267|75829007|FG001|STARTED|Overall Study||184||
59710444|NCT01229267|75829008|FG002|STARTED|Overall Study||187||
59818385|NCT00515502|75940749|FG010|NOT COMPLETED|Treatment Period 1||0||
59566310|NCT03949335|75668858|FG000|STARTED|Overall Study||135||
59710445|NCT01229267|75829009|FG003|STARTED|Overall Study||106||
59710446|NCT01229267|75829010|FG004|STARTED|Overall Study||564||
59710447|NCT01229267|75829006|FG000|Received Vaccination 1|Overall Study||188||
60106204|NCT01540162|76225049|FG001|COMPLETED|Overall Study||32||
60106205|NCT01540162|76225048|FG000|NOT COMPLETED|Overall Study||0||
60106206|NCT01540162|76225049|FG001|NOT COMPLETED|Overall Study||0||
60106207|NCT01436266|76225057|FG000|STARTED|Overall Study||1||
60106208|NCT01436266|76225058|FG001|STARTED|Overall Study||1||
60106209|NCT01436266|76225057|FG000|COMPLETED|Overall Study||1||
60106210|NCT01436266|76225058|FG001|COMPLETED|Overall Study||1||
60106211|NCT01436266|76225057|FG000|NOT COMPLETED|Overall Study||0||
60106212|NCT01436266|76225058|FG001|NOT COMPLETED|Overall Study||0||
59566311|NCT03949335|75668859|FG001|STARTED|Overall Study||137||
59566312|NCT03949335|75668858|FG000|COMPLETED|Overall Study||132||
59566313|NCT03949335|75668859|FG001|COMPLETED|Overall Study||131||
59566314|NCT03949335|75668858|FG000|NOT COMPLETED|Overall Study||3||
59566315|NCT03949335|75668859|FG001|NOT COMPLETED|Overall Study||6||
59710448|NCT01229267|75829007|FG001|Received Vaccination 1|Overall Study||180||
59996174|NCT02190604|76112048|FG015|NOT COMPLETED|Part 3 (Patients)||0||
60106213|NCT01542502|76225064|FG000|STARTED|Overall Study||6||
60106214|NCT01542502|76225065|FG001|STARTED|Overall Study||6||
60106215|NCT01542502|76225064|FG000|COMPLETED|Overall Study||6||
60106216|NCT01542502|76225065|FG001|COMPLETED|Overall Study||6||
60106217|NCT01542502|76225064|FG000|NOT COMPLETED|Overall Study||0||
60106218|NCT01542502|76225065|FG001|NOT COMPLETED|Overall Study||0||
60106219|NCT01437124|76225072|FG000|STARTED|Overall Study||83||
60106220|NCT01437124|76225072|FG000|COMPLETED|Overall Study||83||
60106221|NCT01437124|76225072|FG000|NOT COMPLETED|Overall Study||0||
60106222|NCT01439620|76225076|FG000|STARTED|Overall Study||7||
60106223|NCT01439620|76225076|FG000|COMPLETED|Overall Study||7||
60106224|NCT01439620|76225076|FG000|NOT COMPLETED|Overall Study||0||
60106225|NCT01439854|76225082|FG000|STARTED|Overall Study||8||
60106226|NCT01439854|76225083|FG001|STARTED|Overall Study||10||
60106227|NCT01439854|76225082|FG000|COMPLETED|Overall Study||8||
60106228|NCT01439854|76225083|FG001|COMPLETED|Overall Study||10||
60106229|NCT01439854|76225082|FG000|NOT COMPLETED|Overall Study||0||
60106230|NCT01439854|76225083|FG001|NOT COMPLETED|Overall Study||0||
60106231|NCT01479478|76225091|FG000|STARTED|Overall Study||125||
60106232|NCT01479478|76225092|FG001|STARTED|Overall Study||126||
60106233|NCT01479478|76225091|FG000|COMPLETED|Overall Study||125||
60106234|NCT01479478|76225092|FG001|COMPLETED|Overall Study||126||
60106235|NCT01479478|76225091|FG000|NOT COMPLETED|Overall Study||0||
60106236|NCT01479478|76225092|FG001|NOT COMPLETED|Overall Study||0||
60106237|NCT04409262|76225100|FG000|STARTED|Overall Study||215||
60106238|NCT04409262|76225101|FG001|STARTED|Overall Study||434||
60106239|NCT04409262|76225100|FG000|COMPLETED|Overall Study||140||
60106240|NCT04409262|76225101|FG001|COMPLETED|Overall Study||300||
60106241|NCT04409262|76225100|FG000|NOT COMPLETED|Overall Study||75||
60106242|NCT04409262|76225101|FG001|NOT COMPLETED|Overall Study||134||
60106243|NCT01481740|76225112|FG000|STARTED|Overall Study||90||
60106244|NCT01481740|76225113|FG001|STARTED|Overall Study||88||
60106245|NCT01481740|76225112|FG000|COMPLETED|Overall Study||79||
60106246|NCT01481740|76225113|FG001|COMPLETED|Overall Study||81||
60106247|NCT01481740|76225112|FG000|NOT COMPLETED|Overall Study||11||
59566316|NCT03690375|75668869|FG000|STARTED|Overall Study||10|While 10 subjects were enrolled, only 5 subjects were analyzed for senile purpura while the other 5 subjects were used as controls in some secondary measures|10
59566317|NCT03690375|75668870|FG001|STARTED|Overall Study||10|While 10 subjects were enrolled, only 5 subjects were analyzed for senile purpura while the other 5 subjects were used as controls in some secondary measures|10
59566318|NCT03690375|75668869|FG000|COMPLETED|Overall Study||10||10
59566319|NCT03690375|75668870|FG001|COMPLETED|Overall Study||10||10
59710449|NCT01229267|75829008|FG002|Received Vaccination 1|Overall Study||186||
59710450|NCT01229267|75829009|FG003|Received Vaccination 1|Overall Study||104||
59710451|NCT01229267|75829010|FG004|Received Vaccination 1|Overall Study||556||
59996175|NCT02190604|76112049|FG016|NOT COMPLETED|Part 3 (Patients)||0||
59566320|NCT03690375|75668869|FG000|NOT COMPLETED|Overall Study||0||0
59566321|NCT03690375|75668870|FG001|NOT COMPLETED|Overall Study||0||0
59566322|NCT03695913|75668879|FG000|STARTED|Overall Study||15||
59710452|NCT01229267|75829006|FG000|Received Vaccination 2|Overall Study||171||
59818386|NCT00515502|75940750|FG011|NOT COMPLETED|Treatment Period 1||1||
59996176|NCT02190604|76112050|FG017|NOT COMPLETED|Part 3 (Patients)||0||
59996177|NCT02190604|76112051|FG018|NOT COMPLETED|Part 3 (Patients)||0||
59996178|NCT02127970|76112110|FG000|STARTED|Overall Study||349||
59996179|NCT02127970|76112111|FG001|STARTED|Overall Study||349||
59996180|NCT02127970|76112110|FG000|COMPLETED|Overall Study||323||
59996181|NCT02127970|76112111|FG001|COMPLETED|Overall Study||322||
60106248|NCT01481740|76225113|FG001|NOT COMPLETED|Overall Study||7||
60106249|NCT01544062|76225121|FG000|STARTED|Overall Study||33||
60106250|NCT01544062|76225122|FG001|STARTED|Overall Study||35||
60106251|NCT01544062|76225121|FG000|COMPLETED|Overall Study||33||
60106252|NCT01544062|76225122|FG001|COMPLETED|Overall Study||35||
60106253|NCT01544062|76225121|FG000|NOT COMPLETED|Overall Study||0||
60106254|NCT01544062|76225122|FG001|NOT COMPLETED|Overall Study||0||
60106255|NCT01483378|76225129|FG000|STARTED|Overall Study||100||
60106256|NCT01483378|76225130|FG001|STARTED|Overall Study||66||
60106257|NCT01483378|76225129|FG000|COMPLETED|Overall Study||100||
60106258|NCT01483378|76225130|FG001|COMPLETED|Overall Study||66||
60106259|NCT01483378|76225129|FG000|NOT COMPLETED|Overall Study||0||
60106260|NCT01483378|76225130|FG001|NOT COMPLETED|Overall Study||0||
60106261|NCT01440634|76225138|FG000|STARTED|Cross Sectional Phase||0||
60106262|NCT01440634|76225139|FG001|STARTED|Cross Sectional Phase||347||
60106263|NCT01440634|76225138|FG000|COMPLETED|Cross Sectional Phase||0||
60106264|NCT01440634|76225139|FG001|COMPLETED|Cross Sectional Phase||347||
59710453|NCT01229267|75829007|FG001|Received Vaccination 2|Overall Study||163||
60106265|NCT01440634|76225138|FG000|NOT COMPLETED|Cross Sectional Phase||0||
60106266|NCT01440634|76225139|FG001|NOT COMPLETED|Cross Sectional Phase||0||
60106267|NCT01440634|76225138|FG000|STARTED|Randomization Phase||30||
60106268|NCT01440634|76225139|FG001|STARTED|Randomization Phase||24||
60106269|NCT01440634|76225138|FG000|COMPLETED|Randomization Phase||24||
60106270|NCT01440634|76225139|FG001|COMPLETED|Randomization Phase||14||
60106271|NCT01440634|76225138|FG000|NOT COMPLETED|Randomization Phase||6||
60106272|NCT01440634|76225139|FG001|NOT COMPLETED|Randomization Phase||10||
60106273|NCT04305912|76225145|FG000|STARTED|First Intervention||26||
60106274|NCT04305912|76225146|FG001|STARTED|First Intervention||25||
60106275|NCT04305912|76225145|FG000|COMPLETED|First Intervention||24||
60106276|NCT04305912|76225146|FG001|COMPLETED|First Intervention||24||
60106277|NCT04305912|76225145|FG000|NOT COMPLETED|First Intervention||2||
59710454|NCT01229267|75829008|FG002|Received Vaccination 2|Overall Study||168||
60106278|NCT04305912|76225146|FG001|NOT COMPLETED|First Intervention||1||
60106279|NCT04305912|76225145|FG000|STARTED|Second Intervention||24||
60106280|NCT04305912|76225146|FG001|STARTED|Second Intervention||24||
60106281|NCT04305912|76225145|FG000|COMPLETED|Second Intervention||24||
60106282|NCT04305912|76225146|FG001|COMPLETED|Second Intervention||23||
59710455|NCT01229267|75829009|FG003|Received Vaccination 2|Overall Study||94||
59710456|NCT01229267|75829010|FG004|Received Vaccination 2|Overall Study||511||
59710457|NCT01229267|75829006|FG000|Received Vaccination 3|Overall Study||163||
60106283|NCT04305912|76225145|FG000|NOT COMPLETED|Second Intervention||0||
60106284|NCT04305912|76225146|FG001|NOT COMPLETED|Second Intervention||1||
60106285|NCT01544998|76225152|FG000|STARTED|First Intervention (3 Hours)||26||
60106286|NCT01544998|76225153|FG001|STARTED|First Intervention (3 Hours)||15||
60106287|NCT01544998|76225152|FG000|COMPLETED|First Intervention (3 Hours)||26||
60106288|NCT01544998|76225153|FG001|COMPLETED|First Intervention (3 Hours)||15||
60106289|NCT01544998|76225152|FG000|NOT COMPLETED|First Intervention (3 Hours)||0||
60106290|NCT01544998|76225153|FG001|NOT COMPLETED|First Intervention (3 Hours)||0||
60106291|NCT01544998|76225152|FG000|STARTED|Washout (1 Week)||26||
60106292|NCT01544998|76225153|FG001|STARTED|Washout (1 Week)||15||
60106293|NCT01544998|76225152|FG000|COMPLETED|Washout (1 Week)||26||
60106294|NCT01544998|76225153|FG001|COMPLETED|Washout (1 Week)||15||
59710458|NCT01229267|75829007|FG001|Received Vaccination 3|Overall Study||155||
59710459|NCT01229267|75829008|FG002|Received Vaccination 3|Overall Study||160||
60106295|NCT01544998|76225152|FG000|NOT COMPLETED|Washout (1 Week)||0||
60106296|NCT01544998|76225153|FG001|NOT COMPLETED|Washout (1 Week)||0||
60106297|NCT01544998|76225152|FG000|STARTED|Second Intervention (3 Hours)||26||
60106298|NCT01544998|76225153|FG001|STARTED|Second Intervention (3 Hours)||15||
60106299|NCT01544998|76225152|FG000|COMPLETED|Second Intervention (3 Hours)||26||
60106300|NCT01544998|76225153|FG001|COMPLETED|Second Intervention (3 Hours)||15||
60106301|NCT01544998|76225152|FG000|NOT COMPLETED|Second Intervention (3 Hours)||0||
59566323|NCT03695913|75668879|FG000|COMPLETED|Overall Study||15||
59566324|NCT03695913|75668879|FG000|NOT COMPLETED|Overall Study||0||
59566325|NCT04234425|75668883|FG000|STARTED|Overall Study||18||
59566326|NCT04234425|75668883|FG000|Midpoint-Week 4|Overall Study||18||
59566327|NCT04234425|75668883|FG000|COMPLETED|Overall Study||18||
59566328|NCT04234425|75668883|FG000|NOT COMPLETED|Overall Study||0||
59566329|NCT03697083|75668892|FG000|STARTED|Overall Study||262||
59566330|NCT03697083|75668893|FG001|STARTED|Overall Study||260||
59566331|NCT03697083|75668894|FG002|STARTED|Overall Study||255||
59566332|NCT03697083|75668892|FG000|COMPLETED|Overall Study||262||
59566333|NCT03697083|75668893|FG001|COMPLETED|Overall Study||250||
59566334|NCT03697083|75668894|FG002|COMPLETED|Overall Study||255||
59566335|NCT03697083|75668892|FG000|NOT COMPLETED|Overall Study||0||
59566336|NCT03697083|75668893|FG001|NOT COMPLETED|Overall Study||10||
59566337|NCT03697083|75668894|FG002|NOT COMPLETED|Overall Study||0||
59566338|NCT02354586|75668902|FG000|STARTED|Overall Study||463||
59566339|NCT02354586|75668902|FG000|COMPLETED|Overall Study||0||
59566340|NCT02354586|75668902|FG000|NOT COMPLETED|Overall Study||463||
59566341|NCT01866410|75668906|FG000|STARTED|Overall Study||37||
59566342|NCT01866410|75668906|FG000|COMPLETED|Overall Study||37||
59566343|NCT01866410|75668906|FG000|NOT COMPLETED|Overall Study||0||
59566344|NCT04224753|75668913|FG000|STARTED|Overall Study||51||
59566345|NCT04224753|75668913|FG000|COMPLETED|Overall Study||51||
59566346|NCT04224753|75668913|FG000|NOT COMPLETED|Overall Study||0||
59566347|NCT04196907|75668917|FG000|STARTED|Overall Study||20||
59566348|NCT04196907|75668917|FG000|COMPLETED|Overall Study||20||
59566349|NCT04196907|75668917|FG000|NOT COMPLETED|Overall Study||0||
59566350|NCT02332824|75668927|FG000|STARTED|Overall Study||67||
59566351|NCT02332824|75668928|FG001|STARTED|Overall Study||67||
59566352|NCT02332824|75668929|FG002|STARTED|Overall Study||74||
59566353|NCT02332824|75668930|FG003|STARTED|Overall Study||68||
59566354|NCT02332824|75668931|FG004|STARTED|Overall Study||69||
59566355|NCT02332824|75668932|FG005|STARTED|Overall Study||70||
59566356|NCT02332824|75668927|FG000|COMPLETED|Overall Study||61||
59566357|NCT02332824|75668928|FG001|COMPLETED|Overall Study||66||
59566358|NCT02332824|75668929|FG002|COMPLETED|Overall Study||72||
59566359|NCT02332824|75668930|FG003|COMPLETED|Overall Study||66||
59566360|NCT02332824|75668931|FG004|COMPLETED|Overall Study||65||
59566361|NCT02332824|75668932|FG005|COMPLETED|Overall Study||69||
59566362|NCT02332824|75668927|FG000|NOT COMPLETED|Overall Study||6||
59566363|NCT02332824|75668928|FG001|NOT COMPLETED|Overall Study||1||
59710460|NCT01229267|75829009|FG003|Received Vaccination 3|Overall Study||89||
59710461|NCT01229267|75829010|FG004|Received Vaccination 3|Overall Study||491||
59710462|NCT01229267|75829006|FG000|Received Vaccination 4|Overall Study||155||
59710463|NCT01229267|75829007|FG001|Received Vaccination 4|Overall Study||149||
59566364|NCT02332824|75668929|FG002|NOT COMPLETED|Overall Study||2||
59566365|NCT02332824|75668930|FG003|NOT COMPLETED|Overall Study||2||
59566366|NCT02332824|75668931|FG004|NOT COMPLETED|Overall Study||4||
59566367|NCT02332824|75668932|FG005|NOT COMPLETED|Overall Study||1||
59566368|NCT03701061|75668948|FG000|STARTED|Overall Study||9||
59566369|NCT03701061|75668949|FG001|STARTED|Overall Study||3||
59566370|NCT03701061|75668948|FG000|COMPLETED|Overall Study||9||
59566371|NCT03701061|75668949|FG001|COMPLETED|Overall Study||3||
59566372|NCT03701061|75668948|FG000|NOT COMPLETED|Overall Study||0||
59710464|NCT01229267|75829008|FG002|Received Vaccination 4|Overall Study||149||
59710465|NCT01229267|75829009|FG003|Received Vaccination 4|Overall Study||87||
59710466|NCT01229267|75829010|FG004|Received Vaccination 4|Overall Study||477||
59710467|NCT01229267|75829006|FG000|COMPLETED|Overall Study||108||
59710468|NCT01229267|75829007|FG001|COMPLETED|Overall Study||102||
60106302|NCT01544998|76225153|FG001|NOT COMPLETED|Second Intervention (3 Hours)||0||
60106303|NCT01441492|76225163|FG000|STARTED|Overall Study||197||
60106304|NCT01441492|76225164|FG001|STARTED|Overall Study||202||
60106305|NCT01441492|76225163|FG000|COMPLETED|Overall Study||170||
60106306|NCT01441492|76225164|FG001|COMPLETED|Overall Study||174||
60106307|NCT01441492|76225163|FG000|NOT COMPLETED|Overall Study||27||
60106308|NCT01441492|76225164|FG001|NOT COMPLETED|Overall Study||28||
60106309|NCT04030416|76225172|FG000|STARTED|Overall Study||120||
60106310|NCT04030416|76225172|FG000|COMPLETED|Overall Study||119||
60106311|NCT04030416|76225172|FG000|NOT COMPLETED|Overall Study||1||
60106312|NCT01441570|76225178|FG000|STARTED|Overall Study||6||
60106313|NCT01441570|76225179|FG001|STARTED|Overall Study||5||
60106314|NCT01441570|76225178|FG000|COMPLETED|Overall Study||6||
60106315|NCT01441570|76225179|FG001|COMPLETED|Overall Study||5||
60106316|NCT01441570|76225178|FG000|NOT COMPLETED|Overall Study||0||
60106317|NCT01441570|76225179|FG001|NOT COMPLETED|Overall Study||0||
60106318|NCT01441882|76225185|FG000|STARTED|Overall Study||19||
60106319|NCT01441882|76225185|FG000|COMPLETED|Overall Study||13||
60106320|NCT01441882|76225185|FG000|NOT COMPLETED|Overall Study||6||
59710469|NCT01229267|75829008|FG002|COMPLETED|Overall Study||101||
59710470|NCT01229267|75829009|FG003|COMPLETED|Overall Study||71||
59710471|NCT01229267|75829010|FG004|COMPLETED|Overall Study||344||
59710472|NCT01229267|75829006|FG000|NOT COMPLETED|Overall Study||81||
59710473|NCT01229267|75829007|FG001|NOT COMPLETED|Overall Study||82||
59710474|NCT01229267|75829008|FG002|NOT COMPLETED|Overall Study||86||
59710475|NCT01229267|75829009|FG003|NOT COMPLETED|Overall Study||35||
59710476|NCT01229267|75829010|FG004|NOT COMPLETED|Overall Study||220||
59710477|NCT00897715|75829019|FG000|STARTED|Overall Study||8||
59710478|NCT00897715|75829020|FG001|STARTED|Overall Study||7||
59710479|NCT00897715|75829019|FG000|COMPLETED|Overall Study||6||
59710480|NCT00897715|75829020|FG001|COMPLETED|Overall Study||6||
59710481|NCT00897715|75829019|FG000|NOT COMPLETED|Overall Study||2||
59710482|NCT00897715|75829020|FG001|NOT COMPLETED|Overall Study||1||
59818387|NCT00515502|75940739|FG000|STARTED|Washout Period 1||1||
59818388|NCT00515502|75940740|FG001|STARTED|Washout Period 1||4||
59818389|NCT00515502|75940741|FG002|STARTED|Washout Period 1||4||
59818390|NCT00515502|75940742|FG003|STARTED|Washout Period 1||3||
59818391|NCT00515502|75940743|FG004|STARTED|Washout Period 1||3||
59818392|NCT00515502|75940744|FG005|STARTED|Washout Period 1||1||
59818393|NCT00515502|75940745|FG006|STARTED|Washout Period 1||1||
59818394|NCT00515502|75940746|FG007|STARTED|Washout Period 1||1||
59818395|NCT00515502|75940747|FG008|STARTED|Washout Period 1||0||
59818396|NCT00515502|75940748|FG009|STARTED|Washout Period 1||2||
59818397|NCT00515502|75940749|FG010|STARTED|Washout Period 1||1||
59818398|NCT00515502|75940750|FG011|STARTED|Washout Period 1||0||
59818399|NCT00515502|75940739|FG000|COMPLETED|Washout Period 1||1||
59996182|NCT02127970|76112110|FG000|NOT COMPLETED|Overall Study||26||
59996183|NCT02127970|76112111|FG001|NOT COMPLETED|Overall Study||27||
59996184|NCT03549871|76112119|FG000|STARTED|Factor/BPA Prophylaxis: Day -168 to -1||30|Enrolled|
59996185|NCT03549871|76112120|FG001|STARTED|Factor/BPA Prophylaxis: Day -168 to -1||50|Enrolled|
59996186|NCT03549871|76112119|FG000|Started Directly With Fitusiran|Factor/BPA Prophylaxis: Day -168 to -1||2||
59996187|NCT03549871|76112120|FG001|Started Directly With Fitusiran|Factor/BPA Prophylaxis: Day -168 to -1||0||
59996188|NCT03549871|76112119|FG000|Started With Factor or BPA Prophylaxis|Factor/BPA Prophylaxis: Day -168 to -1||28||
60106321|NCT01484626|76225189|FG000|STARTED|Overall Study||3||
60106322|NCT01484626|76225189|FG000|COMPLETED|Overall Study||3||
60106323|NCT01484626|76225189|FG000|NOT COMPLETED|Overall Study||0||
60106324|NCT01545232|76225195|FG000|STARTED|Overall Study||338||
60106325|NCT01545232|76225196|FG001|STARTED|Overall Study||342||
60106326|NCT01545232|76225195|FG000|COMPLETED|Overall Study||338||
60106327|NCT01545232|76225196|FG001|COMPLETED|Overall Study||342||
60106328|NCT01545232|76225195|FG000|NOT COMPLETED|Overall Study||0||
60106329|NCT01545232|76225196|FG001|NOT COMPLETED|Overall Study||0||
60106330|NCT01545700|76225210|FG000|STARTED|Overall Study||34||
60106331|NCT01545700|76225211|FG001|STARTED|Overall Study||33||
60106332|NCT01545700|76225212|FG002|STARTED|Overall Study||33||
59710483|NCT01229111|75829026|FG000|STARTED|Overall Study||14||
59710484|NCT01229111|75829026|FG000|COMPLETED|Overall Study||13||
59818400|NCT00515502|75940740|FG001|COMPLETED|Washout Period 1||4||
59996189|NCT03549871|76112120|FG001|Started With Factor or BPA Prophylaxis|Factor/BPA Prophylaxis: Day -168 to -1||50||
59996190|NCT03549871|76112119|FG000|COMPLETED|Factor/BPA Prophylaxis: Day -168 to -1||23||
59996191|NCT03549871|76112120|FG001|COMPLETED|Factor/BPA Prophylaxis: Day -168 to -1||46||
59996192|NCT03549871|76112119|FG000|NOT COMPLETED|Factor/BPA Prophylaxis: Day -168 to -1||7||
60000402|NCT02593305|76116129|FG000|NOT COMPLETED|Post 2||0||
60106333|NCT01545700|76225213|FG003|STARTED|Overall Study||34||
60106334|NCT01545700|76225214|FG004|STARTED|Overall Study||33||
60106335|NCT01545700|76225215|FG005|STARTED|Overall Study||33||
60106336|NCT01545700|76225210|FG000|COMPLETED|Overall Study||33||
59710485|NCT01229111|75829026|FG000|NOT COMPLETED|Overall Study||1||
59818401|NCT00515502|75940741|FG002|COMPLETED|Washout Period 1||4||
59996193|NCT03549871|76112120|FG001|NOT COMPLETED|Factor/BPA Prophylaxis: Day -168 to -1||4||
59996194|NCT03549871|76112119|FG000|STARTED|Fitusiran Treatment: Day 1 to Day 190||23||
59996195|NCT03549871|76112120|FG001|STARTED|Fitusiran Treatment: Day 1 to Day 190||46||
59996196|NCT03549871|76112119|FG000|Received 80mg QM & Part of Safety Analysis Set 1 (SAS 1)|Fitusiran Treatment: Day 1 to Day 190||21||
59710486|NCT00894361|75829032|FG000|STARTED|Overall Study||200||
59710487|NCT00894361|75829033|FG001|STARTED|Overall Study||200||
59710488|NCT00894361|75829032|FG000|COMPLETED|Overall Study||176||
59710489|NCT00894361|75829033|FG001|COMPLETED|Overall Study||136||
59710490|NCT00894361|75829032|FG000|NOT COMPLETED|Overall Study||24||
59996197|NCT03549871|76112120|FG001|Received 80mg QM & Part of Safety Analysis Set 1 (SAS 1)|Fitusiran Treatment: Day 1 to Day 190||46||
60000261|NCT02594163|76116037|FG000|STARTED|Follow-up Period|All participants were to be followed after treatment|12||
60106337|NCT01545700|76225211|FG001|COMPLETED|Overall Study||32||
59818402|NCT00515502|75940742|FG003|COMPLETED|Washout Period 1||3||
60106338|NCT01545700|76225212|FG002|COMPLETED|Overall Study||31||
60106339|NCT01545700|76225213|FG003|COMPLETED|Overall Study||34||
60106340|NCT01545700|76225214|FG004|COMPLETED|Overall Study||32||
60106341|NCT01545700|76225215|FG005|COMPLETED|Overall Study||33||
60106342|NCT01545700|76225210|FG000|NOT COMPLETED|Overall Study||1||
60106343|NCT01545700|76225211|FG001|NOT COMPLETED|Overall Study||1||
60106344|NCT01545700|76225212|FG002|NOT COMPLETED|Overall Study||2||
60106345|NCT01545700|76225213|FG003|NOT COMPLETED|Overall Study||0||
60106346|NCT01545700|76225214|FG004|NOT COMPLETED|Overall Study||1||
59710491|NCT00894361|75829033|FG001|NOT COMPLETED|Overall Study||64||
59710492|NCT01228175|75829043|FG000|STARTED|Overall Study||119||
59710493|NCT01228175|75829044|FG001|STARTED|Overall Study||99||
59710494|NCT01228175|75829043|FG000|COMPLETED|Overall Study||53||
59710495|NCT01228175|75829044|FG001|COMPLETED|Overall Study||46||
59710496|NCT01228175|75829043|FG000|NOT COMPLETED|Overall Study||66||
59818403|NCT00515502|75940743|FG004|COMPLETED|Washout Period 1||3||
59818404|NCT00515502|75940744|FG005|COMPLETED|Washout Period 1||1||
59818405|NCT00515502|75940745|FG006|COMPLETED|Washout Period 1||1||
59818406|NCT00515502|75940746|FG007|COMPLETED|Washout Period 1||1||
59818407|NCT00515502|75940747|FG008|COMPLETED|Washout Period 1||0||
60000262|NCT02594163|76116038|FG001|STARTED|Follow-up Period|All participants were to be followed after treatment|13||
60106347|NCT01545700|76225215|FG005|NOT COMPLETED|Overall Study||0||
60106348|NCT01486810|76225249|FG000|STARTED|Overall Study||17||
60106349|NCT01486810|76225249|FG000|COMPLETED|Overall Study||9||
60106350|NCT01486810|76225249|FG000|NOT COMPLETED|Overall Study||8||
60106351|NCT01487668|76225255|FG000|STARTED|Overall Study||146||
60106352|NCT01487668|76225256|FG001|STARTED|Overall Study||141||
60106353|NCT01487668|76225255|FG000|COMPLETED|Overall Study||121||
59710497|NCT01228175|75829044|FG001|NOT COMPLETED|Overall Study||53||
59818408|NCT00515502|75940748|FG009|COMPLETED|Washout Period 1||2||
59710498|NCT01228019|75829050|FG000|STARTED|Overall Study||1166||
59710499|NCT01228019|75829050|FG000|COMPLETED|Overall Study||862||
59710500|NCT01228019|75829050|FG000|NOT COMPLETED|Overall Study||304||
59710501|NCT02987959|75829054|FG000|STARTED|Overall Study||6||
59710502|NCT02987959|75829054|FG000|COMPLETED|Overall Study||0||
59710503|NCT02987959|75829054|FG000|NOT COMPLETED|Overall Study||6||
59710504|NCT01227707|75829058|FG000|STARTED|Overall Study||43||
59710505|NCT01227707|75829058|FG000|COMPLETED|Overall Study||19||
59710506|NCT01227707|75829058|FG000|NOT COMPLETED|Overall Study||24||
59710507|NCT00895843|75829064|FG000|STARTED|Overall Study||60||
59710508|NCT00895843|75829065|FG001|STARTED|Overall Study||62||
59710509|NCT00895843|75829064|FG000|COMPLETED|Overall Study||48||
59710510|NCT00895843|75829065|FG001|COMPLETED|Overall Study||50||
60106354|NCT01487668|76225256|FG001|COMPLETED|Overall Study||124||
60106355|NCT01487668|76225255|FG000|NOT COMPLETED|Overall Study||25||
60106356|NCT01487668|76225256|FG001|NOT COMPLETED|Overall Study||17||
60106357|NCT01443442|76225266|FG000|STARTED|Overall Study||12||
60106358|NCT01443442|76225267|FG001|STARTED|Overall Study||11||
60106359|NCT01443442|76225266|FG000|COMPLETED|Overall Study||12||
59710511|NCT00895843|75829064|FG000|NOT COMPLETED|Overall Study||12||
59710512|NCT00895843|75829065|FG001|NOT COMPLETED|Overall Study||12||
59818409|NCT00515502|75940749|FG010|COMPLETED|Washout Period 1||1||
60106360|NCT01443442|76225267|FG001|COMPLETED|Overall Study||11||
60106361|NCT01443442|76225266|FG000|NOT COMPLETED|Overall Study||0||
60106362|NCT01443442|76225267|FG001|NOT COMPLETED|Overall Study||0||
60106363|NCT01444924|76225275|FG000|STARTED|Overall Study||31||
60106364|NCT01444924|76225276|FG001|STARTED|Overall Study||33||
60106365|NCT01444924|76225275|FG000|COMPLETED|Overall Study||31||
60106366|NCT01444924|76225276|FG001|COMPLETED|Overall Study||33||
60106367|NCT01444924|76225275|FG000|NOT COMPLETED|Overall Study||0||
60106368|NCT01444924|76225276|FG001|NOT COMPLETED|Overall Study||0||
60106369|NCT01546402|76225284|FG000|STARTED|Overall Study||10||
60106370|NCT01546402|76225285|FG001|STARTED|Overall Study||10||
60106371|NCT01546402|76225284|FG000|COMPLETED|Overall Study||10||
60106372|NCT01546402|76225285|FG001|COMPLETED|Overall Study||10||
60106373|NCT01546402|76225284|FG000|NOT COMPLETED|Overall Study||0||
60106374|NCT01546402|76225285|FG001|NOT COMPLETED|Overall Study||0||
60106375|NCT01546636|76225293|FG000|STARTED|Overall Study||36||
60106376|NCT01546636|76225294|FG001|STARTED|Overall Study||34||
60106377|NCT01546636|76225293|FG000|COMPLETED|Overall Study||36||
60106378|NCT01546636|76225294|FG001|COMPLETED|Overall Study||34||
60106379|NCT01546636|76225293|FG000|NOT COMPLETED|Overall Study||0||
60106380|NCT01546636|76225294|FG001|NOT COMPLETED|Overall Study||0||
60106381|NCT01547806|76225300|FG000|STARTED|Overall Study||49||
60106382|NCT01547806|76225300|FG000|COMPLETED|Overall Study||49||
60106383|NCT01547806|76225300|FG000|NOT COMPLETED|Overall Study||0||
60106384|NCT01445626|76225305|FG000|STARTED|Overall Study||87||
60106385|NCT01445626|76225305|FG000|COMPLETED|Overall Study||87||
59710513|NCT00895453|75829074|FG000|STARTED|Overall Study||48||
59710514|NCT00895453|75829075|FG001|STARTED|Overall Study||50||
59710515|NCT00895453|75829076|FG002|STARTED|Overall Study||46||
59710516|NCT00895453|75829074|FG000|COMPLETED|Overall Study||23||
59710517|NCT00895453|75829075|FG001|COMPLETED|Overall Study||25||
59710518|NCT00895453|75829076|FG002|COMPLETED|Overall Study||23||
60106386|NCT01445626|76225305|FG000|NOT COMPLETED|Overall Study||0||
60106387|NCT01548040|76225311|FG000|STARTED|Overall Study||56||
60106388|NCT01548040|76225312|FG001|STARTED|Overall Study||55||
59710519|NCT00895453|75829074|FG000|NOT COMPLETED|Overall Study||25||
59710520|NCT00895453|75829075|FG001|NOT COMPLETED|Overall Study||25||
59710521|NCT00895453|75829076|FG002|NOT COMPLETED|Overall Study||23||
59710522|NCT00893971|75829084|FG000|STARTED|Overall Study||16||
59710523|NCT00893971|75829084|FG000|Placebo + GP MDI (PT001)|Overall Study||15||
59710524|NCT00893971|75829084|FG000|Placebo + GFF MDI (PT003)|Overall Study||15||
59710525|NCT00893971|75829084|FG000|Placebo + FF MDI (PT005)|Overall Study||13||
59710526|NCT00893971|75829084|FG000|GP MDI (PT001) + FF MDI (PT005)|Overall Study||16||
59710527|NCT00893971|75829084|FG000|COMPLETED|Overall Study||13||
59710528|NCT00893971|75829084|FG000|NOT COMPLETED|Overall Study||3||
59710529|NCT00893737|75829097|FG000|STARTED|Overall Study||147||
59710530|NCT00893737|75829097|FG000|COMPLETED|Overall Study||135||
59710531|NCT00893737|75829097|FG000|NOT COMPLETED|Overall Study||12||
59710532|NCT00893113|75829103|FG000|STARTED|Overall Study||36||
59710533|NCT00893113|75829104|FG001|STARTED|Overall Study||38||
59710534|NCT00893113|75829103|FG000|COMPLETED|Overall Study||23||
59710535|NCT00893113|75829104|FG001|COMPLETED|Overall Study||22||
59710536|NCT00893113|75829103|FG000|NOT COMPLETED|Overall Study||13||
59710537|NCT00893113|75829104|FG001|NOT COMPLETED|Overall Study||16||
59710538|NCT00892957|75829112|FG000|STARTED|Intraoperative Day 0||70||
59710539|NCT00892957|75829113|FG001|STARTED|Intraoperative Day 0||70||
59710540|NCT00892957|75829112|FG000|COMPLETED|Intraoperative Day 0||70||
59710541|NCT00892957|75829113|FG001|COMPLETED|Intraoperative Day 0||70||
60106389|NCT01548040|76225311|FG000|COMPLETED|Overall Study||43||
60106390|NCT01548040|76225312|FG001|COMPLETED|Overall Study||45||
60106391|NCT01548040|76225311|FG000|NOT COMPLETED|Overall Study||13||
60106392|NCT01548040|76225312|FG001|NOT COMPLETED|Overall Study||10||
60106393|NCT01548742|76225320|FG000|STARTED|Overall Study||58||
60106394|NCT01548742|76225321|FG001|STARTED|Overall Study||58||
60106395|NCT01548742|76225320|FG000|COMPLETED|Overall Study||45||
60106396|NCT01548742|76225321|FG001|COMPLETED|Overall Study||54||
60106397|NCT01548742|76225320|FG000|NOT COMPLETED|Overall Study||13||
60106398|NCT01548742|76225321|FG001|NOT COMPLETED|Overall Study||4||
60106399|NCT01447888|76225331|FG000|STARTED|Overall Study||45||
60106400|NCT01447888|76225332|FG001|STARTED|Overall Study||55||
60106401|NCT01447888|76225331|FG000|COMPLETED|Overall Study||45||
59566373|NCT03701061|75668949|FG001|NOT COMPLETED|Overall Study||0||
59566374|NCT03705273|75668957|FG000|STARTED|Overall Study|Planned enrollment of 110 participants in the arm was not achieved due to lack of study personnel.|20||
59566375|NCT03705273|75668958|FG001|STARTED|Overall Study|Planned enrollment of 110 participants in the arm was not achieved due to lack of study personnel.|20||
59566376|NCT03705273|75668957|FG000|COMPLETED|Overall Study||20||
59566377|NCT03705273|75668958|FG001|COMPLETED|Overall Study||20||
59566378|NCT03705273|75668957|FG000|NOT COMPLETED|Overall Study||0||
59566379|NCT03705273|75668958|FG001|NOT COMPLETED|Overall Study||0||
59566380|NCT03708393|75668964|FG000|STARTED|Overall Study||155||
59566381|NCT03708393|75668964|FG000|COMPLETED|Overall Study||155||
59566382|NCT03708393|75668964|FG000|NOT COMPLETED|Overall Study||0||
59566383|NCT03946059|75668975|FG000|STARTED|Overall Study||13||
59566384|NCT03946059|75668976|FG001|STARTED|Overall Study||12||
59566385|NCT03946059|75668975|FG000|COMPLETED|Overall Study||13||
59710542|NCT00892957|75829112|FG000|NOT COMPLETED|Intraoperative Day 0||0||
60106402|NCT01447888|76225332|FG001|COMPLETED|Overall Study||55||
59710543|NCT00892957|75829113|FG001|NOT COMPLETED|Intraoperative Day 0||0||
60106403|NCT01447888|76225331|FG000|NOT COMPLETED|Overall Study||0||
60106404|NCT01447888|76225332|FG001|NOT COMPLETED|Overall Study||0||
60106405|NCT01490788|76225338|FG000|STARTED|Overall Study||5||
59710544|NCT00892957|75829112|FG000|STARTED|Postoperative Day 1 Assessment||70||
59710545|NCT00892957|75829113|FG001|STARTED|Postoperative Day 1 Assessment||70||
59710546|NCT00892957|75829112|FG000|COMPLETED|Postoperative Day 1 Assessment||70||
59710547|NCT00892957|75829113|FG001|COMPLETED|Postoperative Day 1 Assessment||70||
59710548|NCT00892957|75829112|FG000|NOT COMPLETED|Postoperative Day 1 Assessment||0||
59710549|NCT00892957|75829113|FG001|NOT COMPLETED|Postoperative Day 1 Assessment||0||
59710550|NCT00892957|75829112|FG000|STARTED|Between Postoperative Day 1 and Day 14||70||
59710551|NCT00892957|75829113|FG001|STARTED|Between Postoperative Day 1 and Day 14||70||
59710552|NCT00892957|75829112|FG000|COMPLETED|Between Postoperative Day 1 and Day 14||70||
60106406|NCT01490788|76225339|FG001|STARTED|Overall Study||5||
60106407|NCT01490788|76225340|FG002|STARTED|Overall Study||5||
60106408|NCT01490788|76225341|FG003|STARTED|Overall Study||5||
60106409|NCT01490788|76225342|FG004|STARTED|Overall Study||5||
60106410|NCT01490788|76225343|FG005|STARTED|Overall Study||5||
60106411|NCT01490788|76225338|FG000|COMPLETED|Overall Study||4||
60106412|NCT01490788|76225339|FG001|COMPLETED|Overall Study||5||
60106413|NCT01490788|76225340|FG002|COMPLETED|Overall Study||5||
60106414|NCT01490788|76225341|FG003|COMPLETED|Overall Study||5||
60106415|NCT01490788|76225342|FG004|COMPLETED|Overall Study||5||
59566386|NCT03946059|75668976|FG001|COMPLETED|Overall Study||11||
59818410|NCT00515502|75940750|FG011|COMPLETED|Washout Period 1||0||
60106416|NCT01490788|76225343|FG005|COMPLETED|Overall Study||5||
60106417|NCT01490788|76225338|FG000|NOT COMPLETED|Overall Study||1||
60106418|NCT01490788|76225339|FG001|NOT COMPLETED|Overall Study||0||
60106419|NCT01490788|76225340|FG002|NOT COMPLETED|Overall Study||0||
60106420|NCT01490788|76225341|FG003|NOT COMPLETED|Overall Study||0||
60106421|NCT01490788|76225342|FG004|NOT COMPLETED|Overall Study||0||
59710553|NCT00892957|75829113|FG001|COMPLETED|Between Postoperative Day 1 and Day 14||66||
59710554|NCT00892957|75829112|FG000|NOT COMPLETED|Between Postoperative Day 1 and Day 14||0||
59818411|NCT00515502|75940739|FG000|NOT COMPLETED|Washout Period 1||0||
60106422|NCT01490788|76225343|FG005|NOT COMPLETED|Overall Study||0||
60106423|NCT01550224|76225353|FG000|STARTED|Overall Study||3||
60106424|NCT01550224|76225354|FG001|STARTED|Overall Study||20||
59710555|NCT00892957|75829113|FG001|NOT COMPLETED|Between Postoperative Day 1 and Day 14||4||
59710556|NCT00892957|75829112|FG000|STARTED|Postoperative Day 14 Assessment|Two participants missed postoperative Day 14 assessment, both returned for Day 30 postop assessment|68||
59710557|NCT00892957|75829113|FG001|STARTED|Postoperative Day 14 Assessment||66||
59710558|NCT00892957|75829112|FG000|COMPLETED|Postoperative Day 14 Assessment||68||
59710559|NCT00892957|75829113|FG001|COMPLETED|Postoperative Day 14 Assessment||66||
59710560|NCT00892957|75829112|FG000|NOT COMPLETED|Postoperative Day 14 Assessment||0||
59710561|NCT00892957|75829113|FG001|NOT COMPLETED|Postoperative Day 14 Assessment||0||
59710562|NCT00892957|75829112|FG000|STARTED|Postoperative Day 30 Assessment|Two participants missed postoperative Day 14 assessment, both returned for Day 30 postop assessment|70||
59710563|NCT00892957|75829113|FG001|STARTED|Postoperative Day 30 Assessment||66||
60106425|NCT01550224|76225353|FG000|COMPLETED|Overall Study||3||
59710564|NCT00892957|75829112|FG000|COMPLETED|Postoperative Day 30 Assessment||70||
59710565|NCT00892957|75829113|FG001|COMPLETED|Postoperative Day 30 Assessment||66||
59710566|NCT00892957|75829112|FG000|NOT COMPLETED|Postoperative Day 30 Assessment||0||
59710567|NCT00892957|75829113|FG001|NOT COMPLETED|Postoperative Day 30 Assessment||0||
59710568|NCT00968812|75829136|FG000|STARTED|Overall Study||483||
59710569|NCT00968812|75829137|FG001|STARTED|Overall Study||485||
59710570|NCT00968812|75829138|FG002|STARTED|Overall Study||482||
59710571|NCT00968812|75829136|FG000|COMPLETED|Overall Study||343||
59710572|NCT00968812|75829137|FG001|COMPLETED|Overall Study||323||
59710573|NCT00968812|75829138|FG002|COMPLETED|Overall Study||314||
59710574|NCT00968812|75829136|FG000|NOT COMPLETED|Overall Study||140||
59710575|NCT00968812|75829137|FG001|NOT COMPLETED|Overall Study||162||
59710576|NCT00968812|75829138|FG002|NOT COMPLETED|Overall Study||168||
59710577|NCT00992056|75829151|FG000|STARTED|Treatment Period 1 (6 Weeks)||12||
59710578|NCT00992056|75829152|FG001|STARTED|Treatment Period 1 (6 Weeks)||12||
59710579|NCT00992056|75829151|FG000|COMPLETED|Treatment Period 1 (6 Weeks)|February 2012|11||
59710580|NCT00992056|75829152|FG001|COMPLETED|Treatment Period 1 (6 Weeks)||10||
59710581|NCT00992056|75829151|FG000|NOT COMPLETED|Treatment Period 1 (6 Weeks)||1||
59710582|NCT00992056|75829152|FG001|NOT COMPLETED|Treatment Period 1 (6 Weeks)||2||
59710583|NCT00992056|75829151|FG000|STARTED|Washout Period (2 Weeks)||11||
59710584|NCT00992056|75829152|FG001|STARTED|Washout Period (2 Weeks)||10||
59710585|NCT00992056|75829151|FG000|COMPLETED|Washout Period (2 Weeks)||10||
59710586|NCT00992056|75829152|FG001|COMPLETED|Washout Period (2 Weeks)||10||
59710587|NCT00992056|75829151|FG000|NOT COMPLETED|Washout Period (2 Weeks)||1||
59710588|NCT00992056|75829152|FG001|NOT COMPLETED|Washout Period (2 Weeks)||0||
59710589|NCT00992056|75829151|FG000|STARTED|Treatment Period 2 (6 Weeks)||10||
59710590|NCT00992056|75829152|FG001|STARTED|Treatment Period 2 (6 Weeks)||10||
59710591|NCT00992056|75829151|FG000|COMPLETED|Treatment Period 2 (6 Weeks)||10||
59710592|NCT00992056|75829152|FG001|COMPLETED|Treatment Period 2 (6 Weeks)||10||
59710593|NCT00992056|75829151|FG000|NOT COMPLETED|Treatment Period 2 (6 Weeks)||0||
59710594|NCT00992056|75829152|FG001|NOT COMPLETED|Treatment Period 2 (6 Weeks)||0||
59710595|NCT00972322|75829160|FG000|STARTED|Overall Study||28||
59710596|NCT00972322|75829161|FG001|STARTED|Overall Study||28||
59710597|NCT00972322|75829160|FG000|COMPLETED|Overall Study||25||
59710598|NCT00972322|75829161|FG001|COMPLETED|Overall Study||25||
59710599|NCT00972322|75829160|FG000|NOT COMPLETED|Overall Study||3||
59710600|NCT00972322|75829161|FG001|NOT COMPLETED|Overall Study||3||
59818412|NCT00515502|75940740|FG001|NOT COMPLETED|Washout Period 1||0||
59818413|NCT00515502|75940741|FG002|NOT COMPLETED|Washout Period 1||0||
59818414|NCT00515502|75940742|FG003|NOT COMPLETED|Washout Period 1||0||
59818415|NCT00515502|75940743|FG004|NOT COMPLETED|Washout Period 1||0||
59818416|NCT00515502|75940744|FG005|NOT COMPLETED|Washout Period 1||0||
59818417|NCT00515502|75940745|FG006|NOT COMPLETED|Washout Period 1||0||
59818418|NCT00515502|75940746|FG007|NOT COMPLETED|Washout Period 1||0||
59818419|NCT00515502|75940747|FG008|NOT COMPLETED|Washout Period 1||0||
59818420|NCT00515502|75940748|FG009|NOT COMPLETED|Washout Period 1||0||
59818421|NCT00515502|75940749|FG010|NOT COMPLETED|Washout Period 1||0||
59818422|NCT00515502|75940750|FG011|NOT COMPLETED|Washout Period 1||0||
59818423|NCT00515502|75940739|FG000|STARTED|Treatment Period 2||1||
59818424|NCT00515502|75940740|FG001|STARTED|Treatment Period 2||4||
59818425|NCT00515502|75940741|FG002|STARTED|Treatment Period 2||4||
59818426|NCT00515502|75940742|FG003|STARTED|Treatment Period 2||3||
59818427|NCT00515502|75940743|FG004|STARTED|Treatment Period 2||3||
59818428|NCT00515502|75940744|FG005|STARTED|Treatment Period 2||1||
59818429|NCT00515502|75940745|FG006|STARTED|Treatment Period 2||1||
59818430|NCT00515502|75940746|FG007|STARTED|Treatment Period 2||1||
59818431|NCT00515502|75940747|FG008|STARTED|Treatment Period 2||0||
59818432|NCT00515502|75940748|FG009|STARTED|Treatment Period 2||2||
59818433|NCT00515502|75940749|FG010|STARTED|Treatment Period 2||1||
59818434|NCT00515502|75940750|FG011|STARTED|Treatment Period 2||0||
59818435|NCT00515502|75940739|FG000|COMPLETED|Treatment Period 2||1||
59818436|NCT00515502|75940740|FG001|COMPLETED|Treatment Period 2||3||
59818437|NCT00515502|75940741|FG002|COMPLETED|Treatment Period 2||4||
60106426|NCT01550224|76225354|FG001|COMPLETED|Overall Study||20||
60106427|NCT01550224|76225353|FG000|NOT COMPLETED|Overall Study||0||
60106428|NCT01550224|76225354|FG001|NOT COMPLETED|Overall Study||0||
60106429|NCT01491022|76225362|FG000|STARTED|Intervention 1||10||
60106430|NCT01491022|76225363|FG001|STARTED|Intervention 1||12||
60106431|NCT01491022|76225362|FG000|COMPLETED|Intervention 1||9||
60106432|NCT01491022|76225363|FG001|COMPLETED|Intervention 1||11||
60106433|NCT01491022|76225362|FG000|NOT COMPLETED|Intervention 1||1||
59818438|NCT00515502|75940742|FG003|COMPLETED|Treatment Period 2||3||
59818439|NCT00515502|75940743|FG004|COMPLETED|Treatment Period 2||3||
59818440|NCT00515502|75940744|FG005|COMPLETED|Treatment Period 2||1||
59818441|NCT00515502|75940745|FG006|COMPLETED|Treatment Period 2||1||
59818442|NCT00515502|75940746|FG007|COMPLETED|Treatment Period 2||1||
59818443|NCT00515502|75940747|FG008|COMPLETED|Treatment Period 2||0||
59818444|NCT00515502|75940748|FG009|COMPLETED|Treatment Period 2||2||
59818445|NCT00515502|75940749|FG010|COMPLETED|Treatment Period 2||1||
59818446|NCT00515502|75940750|FG011|COMPLETED|Treatment Period 2||0||
60106434|NCT01491022|76225363|FG001|NOT COMPLETED|Intervention 1||1||
60106435|NCT01491022|76225362|FG000|STARTED|2 Week Washout||9||
60106436|NCT01491022|76225363|FG001|STARTED|2 Week Washout||11||
60106437|NCT01491022|76225362|FG000|COMPLETED|2 Week Washout||9||
60106438|NCT01491022|76225363|FG001|COMPLETED|2 Week Washout||11||
60106439|NCT01491022|76225362|FG000|NOT COMPLETED|2 Week Washout||0||
59566387|NCT03946059|75668975|FG000|NOT COMPLETED|Overall Study||0||
59566388|NCT03946059|75668976|FG001|NOT COMPLETED|Overall Study||1||
59566389|NCT04184271|75668984|FG000|STARTED|Overall Study||16||
59710601|NCT00967798|75829169|FG000|STARTED|Overall Study||17||
60106440|NCT01491022|76225363|FG001|NOT COMPLETED|2 Week Washout||0||
59566390|NCT04184271|75668984|FG000|COMPLETED|Overall Study||16||
59566391|NCT04184271|75668984|FG000|NOT COMPLETED|Overall Study||0||
59566392|NCT03938337|75668990|FG000|STARTED|Overall Study||1||
59566393|NCT03938337|75668991|FG001|STARTED|Overall Study||0||
59566394|NCT03938337|75668990|FG000|COMPLETED|Overall Study||1||
59566395|NCT03938337|75668991|FG001|COMPLETED|Overall Study||0||
59566396|NCT03938337|75668990|FG000|NOT COMPLETED|Overall Study||0||
59566397|NCT03938337|75668991|FG001|NOT COMPLETED|Overall Study||0||
59566398|NCT03937791|75668997|FG000|STARTED|Overall Study||1||
59566399|NCT03937791|75668997|FG000|COMPLETED|Overall Study||1||
59566400|NCT03937791|75668997|FG000|NOT COMPLETED|Overall Study||0||
59566401|NCT03936387|75669001|FG000|STARTED|Overall Study||10||
59710602|NCT00967798|75829170|FG001|STARTED|Overall Study||16||
59710603|NCT00967798|75829169|FG000|COMPLETED|Overall Study||8||
59710604|NCT00967798|75829170|FG001|COMPLETED|Overall Study||13||
59710605|NCT00967798|75829169|FG000|NOT COMPLETED|Overall Study||9||
59566402|NCT03936387|75669001|FG000|COMPLETED|Overall Study||10||
59710606|NCT00967798|75829170|FG001|NOT COMPLETED|Overall Study||3||
59710607|NCT00965458|75829178|FG000|STARTED|Overall Study||33||
59710608|NCT00965458|75829179|FG001|STARTED|Overall Study||16||
59710609|NCT00965458|75829178|FG000|COMPLETED|Overall Study||31||
59710610|NCT00965458|75829179|FG001|COMPLETED|Overall Study||12||
59710611|NCT00965458|75829178|FG000|NOT COMPLETED|Overall Study||2||
59710612|NCT00965458|75829179|FG001|NOT COMPLETED|Overall Study||4||
59710613|NCT00972244|75829192|FG000|STARTED|Overall Study||59||
60106441|NCT01491022|76225362|FG000|STARTED|Intervention 2||9||
59818447|NCT00515502|75940739|FG000|NOT COMPLETED|Treatment Period 2||0||
59818448|NCT00515502|75940740|FG001|NOT COMPLETED|Treatment Period 2||1||
59818449|NCT00515502|75940741|FG002|NOT COMPLETED|Treatment Period 2||0||
59818450|NCT00515502|75940742|FG003|NOT COMPLETED|Treatment Period 2||0||
60106442|NCT01491022|76225363|FG001|STARTED|Intervention 2||11||
60106443|NCT01491022|76225362|FG000|COMPLETED|Intervention 2||8||
60106444|NCT01491022|76225363|FG001|COMPLETED|Intervention 2||11||
60106445|NCT01491022|76225362|FG000|NOT COMPLETED|Intervention 2||1||
60106446|NCT01491022|76225363|FG001|NOT COMPLETED|Intervention 2||0||
60106447|NCT00782184|76225375|FG000|STARTED|Overall Study||120||
60106448|NCT00782184|76225376|FG001|STARTED|Overall Study||130||
60106449|NCT00782184|76225375|FG000|COMPLETED|Overall Study||116||
60106450|NCT00782184|76225376|FG001|COMPLETED|Overall Study||125||
60106451|NCT00782184|76225375|FG000|NOT COMPLETED|Overall Study||4||
60106452|NCT00782184|76225376|FG001|NOT COMPLETED|Overall Study||5||
60106453|NCT01448356|76225383|FG000|STARTED|Overall Study||10||
60106454|NCT01448356|76225383|FG000|COMPLETED|Overall Study|cross-over|10||
60106455|NCT01448356|76225383|FG000|NOT COMPLETED|Overall Study||0||
59818451|NCT00515502|75940743|FG004|NOT COMPLETED|Treatment Period 2||0||
59818452|NCT00515502|75940744|FG005|NOT COMPLETED|Treatment Period 2||0||
59818453|NCT00515502|75940745|FG006|NOT COMPLETED|Treatment Period 2||0||
59818454|NCT00515502|75940746|FG007|NOT COMPLETED|Treatment Period 2||0||
59818455|NCT00515502|75940747|FG008|NOT COMPLETED|Treatment Period 2||0||
59710614|NCT00972244|75829193|FG001|STARTED|Overall Study||56||
59710615|NCT00972244|75829194|FG002|STARTED|Overall Study||58||
59710616|NCT00972244|75829195|FG003|STARTED|Overall Study||52||
59710617|NCT00972244|75829196|FG004|STARTED|Overall Study||54||
59710618|NCT00972244|75829192|FG000|COMPLETED|Overall Study||54||
59710619|NCT00972244|75829193|FG001|COMPLETED|Overall Study||51||
60106456|NCT02214238|76225390|FG000|STARTED|Overall Study||26||
60106457|NCT02214238|76225391|FG001|STARTED|Overall Study||23||
60106458|NCT02214238|76225390|FG000|COMPLETED|Overall Study||20||
60106459|NCT02214238|76225391|FG001|COMPLETED|Overall Study||17||
60106460|NCT02214238|76225390|FG000|NOT COMPLETED|Overall Study||6||
60106461|NCT02214238|76225391|FG001|NOT COMPLETED|Overall Study||6||
60106462|NCT01450306|76225399|FG000|STARTED|Overall Study||10||
60106463|NCT01450306|76225400|FG001|STARTED|Overall Study||10||
60106464|NCT01450306|76225399|FG000|COMPLETED|Overall Study||10||
60106465|NCT01450306|76225400|FG001|COMPLETED|Overall Study||10||
60106466|NCT01450306|76225399|FG000|NOT COMPLETED|Overall Study||0||
60106467|NCT01450306|76225400|FG001|NOT COMPLETED|Overall Study||0||
60106468|NCT01856868|76225406|FG000|STARTED|Overall Study||7||
60106469|NCT01856868|76225406|FG000|COMPLETED|Overall Study||7||
59710620|NCT00972244|75829194|FG002|COMPLETED|Overall Study||56||
59710621|NCT00972244|75829195|FG003|COMPLETED|Overall Study||52||
59710622|NCT00972244|75829196|FG004|COMPLETED|Overall Study||45||
59710623|NCT00972244|75829192|FG000|NOT COMPLETED|Overall Study||5||
59710624|NCT00972244|75829193|FG001|NOT COMPLETED|Overall Study||5||
59710625|NCT00972244|75829194|FG002|NOT COMPLETED|Overall Study||2||
59710626|NCT00972244|75829195|FG003|NOT COMPLETED|Overall Study||0||
59710627|NCT00972244|75829196|FG004|NOT COMPLETED|Overall Study||9||
59710628|NCT00892723|75829211|FG000|STARTED|Overall Study||21||
59710629|NCT00892723|75829212|FG001|STARTED|Overall Study||19||
59710630|NCT00892723|75829213|FG002|STARTED|Overall Study||19||
59710631|NCT00892723|75829211|FG000|COMPLETED|Overall Study||19||
59710632|NCT00892723|75829212|FG001|COMPLETED|Overall Study||15||
59710633|NCT00892723|75829213|FG002|COMPLETED|Overall Study||17||
59710634|NCT00892723|75829211|FG000|NOT COMPLETED|Overall Study||2||
59710635|NCT00892723|75829212|FG001|NOT COMPLETED|Overall Study||4||
59710636|NCT00892723|75829213|FG002|NOT COMPLETED|Overall Study||2||
59710637|NCT03811912|75829256|FG000|STARTED|Overall Study||29||
59710638|NCT03811912|75829257|FG001|STARTED|Overall Study||28||
59710639|NCT03811912|75829256|FG000|Safety Population|Overall Study||29|Safety Population included all participants who received study drug. Participants in the safety population were analyzed according to the actual dosing regimen received during the study.|
59710640|NCT03811912|75829257|FG001|Safety Population|Overall Study||28|Safety Population included all participants who received study drug. Participants in the safety population were analyzed according to the actual dosing regimen received during the study.|
59710641|NCT03811912|75829256|FG000|COMPLETED|Overall Study||25||
59710642|NCT03811912|75829257|FG001|COMPLETED|Overall Study||26||
59710643|NCT03811912|75829256|FG000|NOT COMPLETED|Overall Study||4||
59710644|NCT03811912|75829257|FG001|NOT COMPLETED|Overall Study||2||
59710645|NCT00971932|75829263|FG000|STARTED|Overall Study|Number of participants treated.|33||
59710646|NCT00971932|75829263|FG000|COMPLETED|Overall Study||26||
59710647|NCT00971932|75829263|FG000|NOT COMPLETED|Overall Study||7||
59710648|NCT00970684|75829267|FG000|STARTED|Overall Study||13||
59710649|NCT00970684|75829267|FG000|COMPLETED|Overall Study||3||
59710650|NCT00970684|75829267|FG000|NOT COMPLETED|Overall Study||10||
59710651|NCT00967330|75829273|FG000|STARTED|Overall Study||122||
59710652|NCT00967330|75829274|FG001|STARTED|Overall Study||60||
59710653|NCT00967330|75829273|FG000|COMPLETED|Overall Study||0||
59710654|NCT00967330|75829274|FG001|COMPLETED|Overall Study||0||
59710655|NCT00967330|75829273|FG000|NOT COMPLETED|Overall Study||122||
59710656|NCT00967330|75829274|FG001|NOT COMPLETED|Overall Study||60||
59710657|NCT00967018|75829280|FG000|STARTED|Overall Study||77||
59710658|NCT00967018|75829280|FG000|COMPLETED|Overall Study||56||
59710659|NCT00967018|75829280|FG000|NOT COMPLETED|Overall Study||21||
59710660|NCT00965146|75829284|FG000|STARTED|Overall Study||210||
59710661|NCT00965146|75829284|FG000|COMPLETED|Overall Study|Study was terminated prior to reaching 15 year endpoint.|0||
59710662|NCT00965146|75829284|FG000|NOT COMPLETED|Overall Study||210||
59710663|NCT00966940|75829290|FG000|STARTED|Period 1, First 6 Weeks||28||
59710664|NCT00966940|75829291|FG001|STARTED|Period 1, First 6 Weeks||23||
59710665|NCT00966940|75829290|FG000|COMPLETED|Period 1, First 6 Weeks||25||
59710666|NCT00966940|75829291|FG001|COMPLETED|Period 1, First 6 Weeks||23||
59996198|NCT03549871|76112119|FG000|Received 50 mg Q2M & Part of Safety Analysis Set 2 (SAS 2)|Fitusiran Treatment: Day 1 to Day 190|Participants received fitusiran 50mg Q2M dosing regimen after dose pause and amended protocol 5, dated 25-Nov-2020. They were considered as safety analysis set 2 (SAS 2) and were subjected only to safety analysis and not to main efficacy analysis (Efficacy Set 1).|2||
59996199|NCT03549871|76112120|FG001|Received 50 mg Q2M & Part of Safety Analysis Set 2 (SAS 2)|Fitusiran Treatment: Day 1 to Day 190||0||
59996200|NCT03549871|76112119|FG000|Efficacy Analysis Set 1 (EAS 1)|Fitusiran Treatment: Day 1 to Day 190||19||
59996201|NCT03549871|76112120|FG001|Efficacy Analysis Set 1 (EAS 1)|Fitusiran Treatment: Day 1 to Day 190||46||
60000263|NCT02594163|76116037|FG000|COMPLETED|Follow-up Period||1||
60106470|NCT01856868|76225406|FG000|NOT COMPLETED|Overall Study||0||
60106471|NCT02731638|76225412|FG000|STARTED|Overall Study||35||
60106472|NCT02731638|76225413|FG001|STARTED|Overall Study||35||
60000264|NCT02594163|76116038|FG001|COMPLETED|Follow-up Period||1||
60000265|NCT02594163|76116037|FG000|NOT COMPLETED|Follow-up Period||11||
60000266|NCT02594163|76116038|FG001|NOT COMPLETED|Follow-up Period||12||
60000267|NCT02712983|76116053|FG000|STARTED|Treatment Phase||14|All randomized patients (Full Analysis Set and Safety Set)|
60000268|NCT02712983|76116054|FG001|STARTED|Treatment Phase||13|All randomized patients (Full Analysis Set and Safety Set)|
60000269|NCT02712983|76116055|FG002|STARTED|Treatment Phase||7|All randomized patients (Full Analysis Set and Safety Set)|
60106473|NCT02731638|76225412|FG000|COMPLETED|Overall Study||29||
60106474|NCT02731638|76225413|FG001|COMPLETED|Overall Study||26||
60106475|NCT02731638|76225412|FG000|NOT COMPLETED|Overall Study||6||
60106476|NCT02731638|76225413|FG001|NOT COMPLETED|Overall Study||9||
60106477|NCT01451632|76225421|FG000|STARTED|Overall Study||8||
60106478|NCT01451632|76225422|FG001|STARTED|Overall Study||4||
60106479|NCT01451632|76225423|FG002|STARTED|Overall Study||3||
60106480|NCT01451632|76225424|FG003|STARTED|Overall Study||3||
60106481|NCT01451632|76225425|FG004|STARTED|Overall Study||4||
60106482|NCT01451632|76225426|FG005|STARTED|Overall Study||4||
60106483|NCT01451632|76225427|FG006|STARTED|Overall Study||8||
60106484|NCT01451632|76225428|FG007|STARTED|Overall Study||6||
59710667|NCT00966940|75829290|FG000|NOT COMPLETED|Period 1, First 6 Weeks||3||
60106485|NCT01451632|76225429|FG008|STARTED|Overall Study||4||
60106486|NCT01451632|76225430|FG009|STARTED|Overall Study||4||
59710668|NCT00966940|75829291|FG001|NOT COMPLETED|Period 1, First 6 Weeks||0||
59710669|NCT00966940|75829290|FG000|STARTED|Period 2, Second 6 Weeks||25||
59710670|NCT00966940|75829291|FG001|STARTED|Period 2, Second 6 Weeks||23||
59710671|NCT00966940|75829290|FG000|COMPLETED|Period 2, Second 6 Weeks||25||
59710672|NCT00966940|75829291|FG001|COMPLETED|Period 2, Second 6 Weeks||23||
59710673|NCT00966940|75829290|FG000|NOT COMPLETED|Period 2, Second 6 Weeks||0||
59710674|NCT00966940|75829291|FG001|NOT COMPLETED|Period 2, Second 6 Weeks||0||
59710675|NCT00965848|75829297|FG000|STARTED|Overall Study||107||
59710676|NCT00965848|75829298|FG001|STARTED|Overall Study||34||
59710677|NCT00965848|75829299|FG002|STARTED|Overall Study||127||
59710678|NCT00965848|75829297|FG000|COMPLETED|Overall Study||78||
59710679|NCT00965848|75829298|FG001|COMPLETED|Overall Study||32||
59710680|NCT00965848|75829299|FG002|COMPLETED|Overall Study||117||
59710681|NCT00965848|75829297|FG000|NOT COMPLETED|Overall Study||29||
59710682|NCT00965848|75829298|FG001|NOT COMPLETED|Overall Study||2||
59710683|NCT00965848|75829299|FG002|NOT COMPLETED|Overall Study||10||
59710684|NCT00961636|75829310|FG000|STARTED|Overall Study||463||
59710685|NCT00961636|75829311|FG001|STARTED|Overall Study||456||
59710686|NCT00961636|75829312|FG002|STARTED|Overall Study||233||
59710687|NCT00961636|75829310|FG000|COMPLETED|Overall Study||356||
59710688|NCT00961636|75829311|FG001|COMPLETED|Overall Study||325||
59710689|NCT00961636|75829312|FG002|COMPLETED|Overall Study||201||
59710690|NCT00961636|75829310|FG000|NOT COMPLETED|Overall Study||107||
59710691|NCT00961636|75829311|FG001|NOT COMPLETED|Overall Study||131||
59710692|NCT00961636|75829312|FG002|NOT COMPLETED|Overall Study||32||
59710693|NCT00964678|75829320|FG000|STARTED|Overall Study||10||
59710694|NCT00964678|75829320|FG000|COMPLETED|Overall Study||6||
59710695|NCT00964678|75829320|FG000|NOT COMPLETED|Overall Study||4||
59710696|NCT00964366|75829327|FG000|STARTED|Overall Study|27 of the 28 enrolled were eligible after screening.|28||
59710697|NCT00964366|75829328|FG001|STARTED|Overall Study||25||
59710698|NCT00964366|75829327|FG000|COMPLETED|Overall Study||27||
59710699|NCT00964366|75829328|FG001|COMPLETED|Overall Study||24||
59710700|NCT00964366|75829327|FG000|NOT COMPLETED|Overall Study||1||
59710701|NCT00964366|75829328|FG001|NOT COMPLETED|Overall Study||1||
59710702|NCT00960154|75829336|FG000|STARTED|Overall Study||25||
59710703|NCT00960154|75829337|FG001|STARTED|Overall Study||25||
59710704|NCT00960154|75829336|FG000|COMPLETED|Overall Study||0||
59710705|NCT00960154|75829337|FG001|COMPLETED|Overall Study||0||
59710706|NCT00960154|75829336|FG000|NOT COMPLETED|Overall Study||25||
59710707|NCT00960154|75829337|FG001|NOT COMPLETED|Overall Study||25||
59710708|NCT00960076|75829345|FG000|STARTED|Overall Study|Randomized and treated|138||
59710709|NCT00960076|75829346|FG001|STARTED|Overall Study|Randomized and treated|144||
59710710|NCT00960076|75829345|FG000|COMPLETED|Overall Study|Completing 18 weeks of treatment|130||
59710711|NCT00960076|75829346|FG001|COMPLETED|Overall Study|Completing 18 weeks of treatment|119||
59710712|NCT00960076|75829345|FG000|NOT COMPLETED|Overall Study||8||
59710713|NCT00960076|75829346|FG001|NOT COMPLETED|Overall Study||25||
59710714|NCT01227629|75829362|FG000|STARTED|Overall Study|Started: Participant was randomised and took at least one dose of randomised study medication|58||
59710715|NCT01227629|75829363|FG001|STARTED|Overall Study||20||
59710716|NCT01227629|75829364|FG002|STARTED|Overall Study||27||
59710717|NCT01227629|75829365|FG003|STARTED|Overall Study||99||
59710718|NCT01227629|75829366|FG004|STARTED|Overall Study||34||
59710719|NCT01227629|75829367|FG005|STARTED|Overall Study||33||
59710720|NCT01227629|75829368|FG006|STARTED|Overall Study||98||
59818456|NCT00515502|75940748|FG009|NOT COMPLETED|Treatment Period 2||0||
59818457|NCT00515502|75940749|FG010|NOT COMPLETED|Treatment Period 2||0||
59818458|NCT00515502|75940750|FG011|NOT COMPLETED|Treatment Period 2||0||
59710721|NCT01227629|75829369|FG007|STARTED|Overall Study||33||
59818459|NCT00515502|75940739|FG000|STARTED|Washout Period 2||1||
59818460|NCT00515502|75940740|FG001|STARTED|Washout Period 2||3||
59996202|NCT03549871|76112119|FG000|Efficacy Analysis Set 2 (EAS 2)|Fitusiran Treatment: Day 1 to Day 190|Efficacy Analysis Set 2 (EAS 2) included all participants in the SAS 2 who received BPA prophylaxis and fitusiran 50 mg Q2M after dose pause, protocol amendment 5 (dated 25-Nov-2020) and dose resumption.|2||
59996203|NCT03549871|76112120|FG001|Efficacy Analysis Set 2 (EAS 2)|Fitusiran Treatment: Day 1 to Day 190||0||
59710722|NCT01227629|75829370|FG008|STARTED|Overall Study||30||
59710723|NCT01227629|75829371|FG009|STARTED|Overall Study||70||
59710724|NCT01227629|75829362|FG000|COMPLETED|Overall Study|Completed: Participant without premature discontinuation in the randomised treatment period|56||
59996204|NCT03549871|76112119|FG000|COMPLETED|Fitusiran Treatment: Day 1 to Day 190||17||
59996205|NCT03549871|76112120|FG001|COMPLETED|Fitusiran Treatment: Day 1 to Day 190||37||
59710725|NCT01227629|75829363|FG001|COMPLETED|Overall Study||18||
59710726|NCT01227629|75829364|FG002|COMPLETED|Overall Study||26||
59710727|NCT01227629|75829365|FG003|COMPLETED|Overall Study||91||
59710728|NCT01227629|75829366|FG004|COMPLETED|Overall Study||32||
59710729|NCT01227629|75829367|FG005|COMPLETED|Overall Study||32||
59996206|NCT03549871|76112119|FG000|NOT COMPLETED|Fitusiran Treatment: Day 1 to Day 190||6||
59996207|NCT03549871|76112120|FG001|NOT COMPLETED|Fitusiran Treatment: Day 1 to Day 190||9||
59996208|NCT00705367|76112143|FG000|STARTED|Short-term Period||6||
60106487|NCT01451632|76225421|FG000|COMPLETED|Overall Study||8||
60106488|NCT01451632|76225422|FG001|COMPLETED|Overall Study||4||
60106489|NCT01451632|76225423|FG002|COMPLETED|Overall Study||3||
60106490|NCT01451632|76225424|FG003|COMPLETED|Overall Study||3||
60106491|NCT01451632|76225425|FG004|COMPLETED|Overall Study||4||
60106492|NCT01451632|76225426|FG005|COMPLETED|Overall Study||4||
60106493|NCT01451632|76225427|FG006|COMPLETED|Overall Study||8||
60106494|NCT01451632|76225428|FG007|COMPLETED|Overall Study||6||
60106495|NCT01451632|76225429|FG008|COMPLETED|Overall Study||4||
60106496|NCT01451632|76225430|FG009|COMPLETED|Overall Study||4||
60106497|NCT01451632|76225421|FG000|NOT COMPLETED|Overall Study||0||
60106498|NCT01451632|76225422|FG001|NOT COMPLETED|Overall Study||0||
60106499|NCT01451632|76225423|FG002|NOT COMPLETED|Overall Study||0||
60106500|NCT01451632|76225424|FG003|NOT COMPLETED|Overall Study||0||
60106501|NCT01451632|76225425|FG004|NOT COMPLETED|Overall Study||0||
60106502|NCT01451632|76225426|FG005|NOT COMPLETED|Overall Study||0||
60106503|NCT01451632|76225427|FG006|NOT COMPLETED|Overall Study||0||
60106504|NCT01451632|76225428|FG007|NOT COMPLETED|Overall Study||0||
60106505|NCT01451632|76225429|FG008|NOT COMPLETED|Overall Study||0||
60106506|NCT01451632|76225430|FG009|NOT COMPLETED|Overall Study||0||
60106507|NCT01491490|76225457|FG000|STARTED|Overall Study||1||
60106508|NCT01491490|76225458|FG001|STARTED|Overall Study||1||
60106509|NCT01491490|76225457|FG000|COMPLETED|Overall Study||1||
60106510|NCT01491490|76225458|FG001|COMPLETED|Overall Study||1||
60106511|NCT01491490|76225457|FG000|NOT COMPLETED|Overall Study||0||
60106512|NCT01491490|76225458|FG001|NOT COMPLETED|Overall Study||0||
60106513|NCT01491958|76225466|FG000|STARTED|Overall Study||40||
60106514|NCT01491958|76225467|FG001|STARTED|Overall Study||40||
60106515|NCT01491958|76225466|FG000|COMPLETED|Overall Study||40||
60106516|NCT01491958|76225467|FG001|COMPLETED|Overall Study||40||
60106517|NCT01491958|76225466|FG000|NOT COMPLETED|Overall Study||0||
60106518|NCT01491958|76225467|FG001|NOT COMPLETED|Overall Study||0||
60106519|NCT01492582|76225474|FG000|STARTED|Overall Study|Consented to the vaccine arm (265 quadrivalent vaccine; 188 nonavalent vaccine)|453|Type of vaccine based on standard of care at time of enrollment|
60106520|NCT01492582|76225475|FG001|STARTED|Overall Study|Consented to the survey arm of the study|1046|Type of vaccine based on standard of care at time of enrollment|
60106521|NCT01492582|76225474|FG000|Received First Quadrivalent Vaccine Dose|Overall Study||254||
60106522|NCT01492582|76225475|FG001|Received First Quadrivalent Vaccine Dose|Overall Study|Does not apply|0||
60106523|NCT01492582|76225474|FG000|Received First Nonavalent Vaccine Dose|Overall Study||182||
60106524|NCT01492582|76225475|FG001|Received First Nonavalent Vaccine Dose|Overall Study||0||
60106525|NCT01492582|76225474|FG000|COMPLETED|Overall Study|Received 3 vaccine doses and completed Month 7 blood draw (224 quadrivalent; 160 nonavalent)|384||
60106526|NCT01492582|76225475|FG001|COMPLETED|Overall Study|Returned evaluable survey|982||
59818461|NCT00515502|75940741|FG002|STARTED|Washout Period 2||4||
59818462|NCT00515502|75940742|FG003|STARTED|Washout Period 2||3||
59818463|NCT00515502|75940743|FG004|STARTED|Washout Period 2||3||
59818464|NCT00515502|75940744|FG005|STARTED|Washout Period 2||1||
59818465|NCT00515502|75940745|FG006|STARTED|Washout Period 2||1||
59818466|NCT00515502|75940746|FG007|STARTED|Washout Period 2||1||
59818467|NCT00515502|75940747|FG008|STARTED|Washout Period 2||0||
59818468|NCT00515502|75940748|FG009|STARTED|Washout Period 2||2||
59818469|NCT00515502|75940749|FG010|STARTED|Washout Period 2||1||
59818470|NCT00515502|75940750|FG011|STARTED|Washout Period 2||0||
59818471|NCT00515502|75940739|FG000|COMPLETED|Washout Period 2||1||
59818472|NCT00515502|75940740|FG001|COMPLETED|Washout Period 2||3||
59818473|NCT00515502|75940741|FG002|COMPLETED|Washout Period 2||4||
59818474|NCT00515502|75940742|FG003|COMPLETED|Washout Period 2||3||
59818475|NCT00515502|75940743|FG004|COMPLETED|Washout Period 2||3||
59818476|NCT00515502|75940744|FG005|COMPLETED|Washout Period 2||1||
59818477|NCT00515502|75940745|FG006|COMPLETED|Washout Period 2||1||
59818478|NCT00515502|75940746|FG007|COMPLETED|Washout Period 2||1||
59818479|NCT00515502|75940747|FG008|COMPLETED|Washout Period 2||0||
59566403|NCT03936387|75669001|FG000|NOT COMPLETED|Overall Study||0||
59818480|NCT00515502|75940748|FG009|COMPLETED|Washout Period 2||2||
59818481|NCT00515502|75940749|FG010|COMPLETED|Washout Period 2||1||
59818482|NCT00515502|75940750|FG011|COMPLETED|Washout Period 2||0||
59818483|NCT00515502|75940739|FG000|NOT COMPLETED|Washout Period 2||0||
59818484|NCT00515502|75940740|FG001|NOT COMPLETED|Washout Period 2||0||
59818485|NCT00515502|75940741|FG002|NOT COMPLETED|Washout Period 2||0||
59818486|NCT00515502|75940742|FG003|NOT COMPLETED|Washout Period 2||0||
59566404|NCT04173429|75669007|FG000|STARTED|Overall Study||32||
59566405|NCT04173429|75669008|FG001|STARTED|Overall Study||32||
59566406|NCT04173429|75669007|FG000|Completed the Nadroparin Calcium Therapy and Received Warfarin|Overall Study||32||
59710730|NCT01227629|75829368|FG006|COMPLETED|Overall Study||90||
59710731|NCT01227629|75829369|FG007|COMPLETED|Overall Study||27||
59710732|NCT01227629|75829370|FG008|COMPLETED|Overall Study||24||
59710733|NCT01227629|75829371|FG009|COMPLETED|Overall Study||68||
59710734|NCT01227629|75829362|FG000|NOT COMPLETED|Overall Study||2||
59710735|NCT01227629|75829363|FG001|NOT COMPLETED|Overall Study||2||
59710736|NCT01227629|75829364|FG002|NOT COMPLETED|Overall Study||1||
59710737|NCT01227629|75829365|FG003|NOT COMPLETED|Overall Study||8||
59710738|NCT01227629|75829366|FG004|NOT COMPLETED|Overall Study||2||
59710739|NCT01227629|75829367|FG005|NOT COMPLETED|Overall Study||1||
59710740|NCT01227629|75829368|FG006|NOT COMPLETED|Overall Study||8||
59710741|NCT01227629|75829369|FG007|NOT COMPLETED|Overall Study||6||
59566407|NCT04173429|75669008|FG001|Completed the Nadroparin Calcium Therapy and Received Warfarin|Overall Study||0||
59566408|NCT04173429|75669007|FG000|COMPLETED|Overall Study||30||
59710742|NCT01227629|75829370|FG008|NOT COMPLETED|Overall Study||6||
59710743|NCT01227629|75829371|FG009|NOT COMPLETED|Overall Study||2||
59710744|NCT00963820|75829417|FG000|STARTED|Dose Escalation Phase||3||
59710745|NCT00963820|75829418|FG001|STARTED|Dose Escalation Phase||3||
59710746|NCT00963820|75829419|FG002|STARTED|Dose Escalation Phase||3||
59710747|NCT00963820|75829420|FG003|STARTED|Dose Escalation Phase||3||
59710748|NCT00963820|75829421|FG004|STARTED|Dose Escalation Phase||4||
59710749|NCT00963820|75829422|FG005|STARTED|Dose Escalation Phase||3||
59710750|NCT00963820|75829423|FG006|STARTED|Dose Escalation Phase||8||
59710751|NCT00963820|75829424|FG007|STARTED|Dose Escalation Phase||5||
59710752|NCT00963820|75829425|FG008|STARTED|Dose Escalation Phase|Expansion cohorts were not part of Dose Escalation except as noted in comments.|0||
59710753|NCT00963820|75829426|FG009|STARTED|Dose Escalation Phase||0||
59710754|NCT00963820|75829427|FG010|STARTED|Dose Escalation Phase||0||
59710755|NCT00963820|75829428|FG011|STARTED|Dose Escalation Phase||0||
59710756|NCT00963820|75829417|FG000|COMPLETED|Dose Escalation Phase||0||
59710757|NCT00963820|75829418|FG001|COMPLETED|Dose Escalation Phase||0||
59710758|NCT00963820|75829419|FG002|COMPLETED|Dose Escalation Phase||0||
59710759|NCT00963820|75829420|FG003|COMPLETED|Dose Escalation Phase||0||
59710760|NCT00963820|75829421|FG004|COMPLETED|Dose Escalation Phase||0||
60106527|NCT01492582|76225474|FG000|NOT COMPLETED|Overall Study||69||
60106528|NCT01492582|76225475|FG001|NOT COMPLETED|Overall Study||64||
60106529|NCT01493596|76225505|FG000|STARTED|Overall Study||8||
60106530|NCT01493596|76225506|FG001|STARTED|Overall Study||8||
60106531|NCT01493596|76225507|FG002|STARTED|Overall Study|Repeat of dose cohort because of incidences of hyperkalemia observed in cohort 2(a).|7||
59710761|NCT00963820|75829422|FG005|COMPLETED|Dose Escalation Phase||0||
59710762|NCT00963820|75829423|FG006|COMPLETED|Dose Escalation Phase||0||
59818487|NCT00515502|75940743|FG004|NOT COMPLETED|Washout Period 2||0||
60106532|NCT01493596|76225508|FG003|STARTED|Overall Study||8||
60106533|NCT01493596|76225509|FG004|STARTED|Overall Study||8||
60106534|NCT01493596|76225510|FG005|STARTED|Overall Study||8||
60106535|NCT01493596|76225511|FG006|STARTED|Overall Study||8||
60106536|NCT01493596|76225505|FG000|COMPLETED|Overall Study||8||
60106537|NCT01493596|76225506|FG001|COMPLETED|Overall Study||8||
60106538|NCT01493596|76225507|FG002|COMPLETED|Overall Study||7||
60106539|NCT01493596|76225508|FG003|COMPLETED|Overall Study||8||
60106540|NCT01493596|76225509|FG004|COMPLETED|Overall Study||8||
60106541|NCT01493596|76225510|FG005|COMPLETED|Overall Study||8||
60106542|NCT01493596|76225511|FG006|COMPLETED|Overall Study||8||
59566409|NCT04173429|75669008|FG001|COMPLETED|Overall Study||30||
59566410|NCT04173429|75669007|FG000|NOT COMPLETED|Overall Study||2||
59710763|NCT00963820|75829424|FG007|COMPLETED|Dose Escalation Phase||0||
60106543|NCT01493596|76225505|FG000|NOT COMPLETED|Overall Study||0||
60106544|NCT01493596|76225506|FG001|NOT COMPLETED|Overall Study||0||
60106545|NCT01493596|76225507|FG002|NOT COMPLETED|Overall Study||0||
60106546|NCT01493596|76225508|FG003|NOT COMPLETED|Overall Study||0||
59710764|NCT00963820|75829425|FG008|COMPLETED|Dose Escalation Phase||0||
59710765|NCT00963820|75829426|FG009|COMPLETED|Dose Escalation Phase||0||
59710766|NCT00963820|75829427|FG010|COMPLETED|Dose Escalation Phase||0||
59710767|NCT00963820|75829428|FG011|COMPLETED|Dose Escalation Phase||0||
59710768|NCT00963820|75829417|FG000|NOT COMPLETED|Dose Escalation Phase||3||
59710769|NCT00963820|75829418|FG001|NOT COMPLETED|Dose Escalation Phase||3||
59710770|NCT00963820|75829419|FG002|NOT COMPLETED|Dose Escalation Phase||3||
59710771|NCT00963820|75829420|FG003|NOT COMPLETED|Dose Escalation Phase||3||
59710772|NCT00963820|75829421|FG004|NOT COMPLETED|Dose Escalation Phase||4||
59710773|NCT00963820|75829422|FG005|NOT COMPLETED|Dose Escalation Phase||3||
59710774|NCT00963820|75829423|FG006|NOT COMPLETED|Dose Escalation Phase||8||
59710775|NCT00963820|75829424|FG007|NOT COMPLETED|Dose Escalation Phase||5||
59818488|NCT00515502|75940744|FG005|NOT COMPLETED|Washout Period 2||0||
60106547|NCT01493596|76225509|FG004|NOT COMPLETED|Overall Study||0||
60106548|NCT01493596|76225510|FG005|NOT COMPLETED|Overall Study||0||
59566411|NCT04173429|75669008|FG001|NOT COMPLETED|Overall Study||2||
59566412|NCT03710187|75669017|FG000|STARTED|Overall Study||41||
59566413|NCT03710187|75669018|FG001|STARTED|Overall Study||43||
59566414|NCT03710187|75669017|FG000|COMPLETED|Overall Study||41||
59818489|NCT00515502|75940745|FG006|NOT COMPLETED|Washout Period 2||0||
59566415|NCT03710187|75669018|FG001|COMPLETED|Overall Study||43||
59566416|NCT03710187|75669017|FG000|NOT COMPLETED|Overall Study||0||
59996209|NCT00705367|76112144|FG001|STARTED|Short-term Period||3||
59566417|NCT03710187|75669018|FG001|NOT COMPLETED|Overall Study||0||
59566418|NCT03710577|75669026|FG000|STARTED|First Intervention||8||
59566419|NCT03710577|75669027|FG001|STARTED|First Intervention||4||
59566420|NCT03710577|75669026|FG000|COMPLETED|First Intervention||8||
59566421|NCT03710577|75669027|FG001|COMPLETED|First Intervention||4||
59996210|NCT00705367|76112143|FG000|COMPLETED|Short-term Period||6||
59996211|NCT00705367|76112144|FG001|COMPLETED|Short-term Period||3||
59996212|NCT00705367|76112143|FG000|NOT COMPLETED|Short-term Period||0||
59996213|NCT00705367|76112144|FG001|NOT COMPLETED|Short-term Period||0||
59996214|NCT00705367|76112143|FG000|STARTED|Long-term Extension Period||9||
59996215|NCT00705367|76112144|FG001|STARTED|Long-term Extension Period||0||
59996216|NCT00705367|76112143|FG000|COMPLETED|Long-term Extension Period||0||
59996217|NCT00705367|76112144|FG001|COMPLETED|Long-term Extension Period||0||
59996218|NCT00705367|76112143|FG000|NOT COMPLETED|Long-term Extension Period||9||
59566422|NCT03710577|75669026|FG000|NOT COMPLETED|First Intervention||0||
59996219|NCT00705367|76112144|FG001|NOT COMPLETED|Long-term Extension Period||0||
59996220|NCT00705289|76112152|FG000|STARTED|Overall Study||728||
59996221|NCT00705289|76112152|FG000|COMPLETED|Overall Study||597||
59710776|NCT00963820|75829425|FG008|NOT COMPLETED|Dose Escalation Phase||0||
59710777|NCT00963820|75829426|FG009|NOT COMPLETED|Dose Escalation Phase||0||
59710778|NCT00963820|75829427|FG010|NOT COMPLETED|Dose Escalation Phase||0||
59710779|NCT00963820|75829428|FG011|NOT COMPLETED|Dose Escalation Phase||0||
59710780|NCT00963820|75829417|FG000|STARTED|Expansion Phase|Dose escalation cohorts were not part of the Expansion Phase except as noted in comments.|0||
59710781|NCT00963820|75829418|FG001|STARTED|Expansion Phase||0||
59710782|NCT00963820|75829419|FG002|STARTED|Expansion Phase||0||
59818490|NCT00515502|75940746|FG007|NOT COMPLETED|Washout Period 2||0||
60106549|NCT01493596|76225511|FG006|NOT COMPLETED|Overall Study||0||
60106550|NCT02214628|76225527|FG000|STARTED|Overall Study||63||
60106551|NCT02214628|76225528|FG001|STARTED|Overall Study||38||
60106552|NCT02214628|76225527|FG000|COMPLETED|Overall Study||36||
60106553|NCT02214628|76225528|FG001|COMPLETED|Overall Study||9||
60106554|NCT02214628|76225527|FG000|NOT COMPLETED|Overall Study||27||
60106555|NCT02214628|76225528|FG001|NOT COMPLETED|Overall Study||29||
60106556|NCT01552876|76225536|FG000|STARTED|Overall Study||20||
60106557|NCT01552876|76225537|FG001|STARTED|Overall Study||20||
60106558|NCT01552876|76225536|FG000|COMPLETED|Overall Study||20||
60106559|NCT01552876|76225537|FG001|COMPLETED|Overall Study||20||
60106560|NCT01552876|76225536|FG000|NOT COMPLETED|Overall Study||0||
59818491|NCT00515502|75940747|FG008|NOT COMPLETED|Washout Period 2||0||
60106561|NCT01552876|76225537|FG001|NOT COMPLETED|Overall Study||0||
60106562|NCT01495858|76225552|FG000|STARTED|Overall Study||107||
60106563|NCT01495858|76225553|FG001|STARTED|Overall Study||106||
60106564|NCT01495858|76225554|FG002|STARTED|Overall Study||54||
60106565|NCT01495858|76225552|FG000|COMPLETED|Overall Study||107||
60106566|NCT01495858|76225553|FG001|COMPLETED|Overall Study||106||
60106567|NCT01495858|76225554|FG002|COMPLETED|Overall Study||54||
60106568|NCT01495858|76225552|FG000|NOT COMPLETED|Overall Study||0||
60106569|NCT01495858|76225553|FG001|NOT COMPLETED|Overall Study||0||
60106570|NCT01495858|76225554|FG002|NOT COMPLETED|Overall Study||0||
60106571|NCT01496248|76225562|FG000|STARTED|Overall Study||35||
60106572|NCT01496248|76225562|FG000|COMPLETED|Overall Study||25||
59710783|NCT00963820|75829420|FG003|STARTED|Expansion Phase||0||
59710784|NCT00963820|75829421|FG004|STARTED|Expansion Phase||0||
59710785|NCT00963820|75829422|FG005|STARTED|Expansion Phase||0||
59710786|NCT00963820|75829423|FG006|STARTED|Expansion Phase||0||
60106573|NCT01496248|76225562|FG000|NOT COMPLETED|Overall Study||10||
60106574|NCT01497496|76225566|FG000|STARTED|Overall Study||29||
60106575|NCT01497496|76225566|FG000|COMPLETED|Overall Study||29||
59710787|NCT00963820|75829424|FG007|STARTED|Expansion Phase||0||
59818492|NCT00515502|75940748|FG009|NOT COMPLETED|Washout Period 2||0||
59818493|NCT00515502|75940749|FG010|NOT COMPLETED|Washout Period 2||0||
59710788|NCT00963820|75829425|FG008|STARTED|Expansion Phase|Includes 2 participants from the dose escalation cohort 2.97 mg/m^2.|11||
59710789|NCT00963820|75829426|FG009|STARTED|Expansion Phase|Includes 1 participant from the dose escalation cohort 2.97 mg/m^2.|10||
59710790|NCT00963820|75829427|FG010|STARTED|Expansion Phase|Includes only participants who are proteasome inhibitor (PI)-naïve.|6||
59710791|NCT00963820|75829428|FG011|STARTED|Expansion Phase|Includes participants with last dose of carfilzomib 21 to 60 days before 1st ixazomib citrate dose.|4||
59710792|NCT00963820|75829417|FG000|COMPLETED|Expansion Phase||0||
59710793|NCT00963820|75829418|FG001|COMPLETED|Expansion Phase||0||
59818494|NCT00515502|75940750|FG011|NOT COMPLETED|Washout Period 2||0||
59996222|NCT00705289|76112152|FG000|NOT COMPLETED|Overall Study||131||
59996223|NCT00703963|76112175|FG000|STARTED|Overall Study||100||
59566423|NCT03710577|75669027|FG001|NOT COMPLETED|First Intervention||0||
59566424|NCT03710577|75669026|FG000|STARTED|Time Between Sessions (2-5 Days)||8||
59996224|NCT00703963|76112176|FG001|STARTED|Overall Study||100||
59566425|NCT03710577|75669027|FG001|STARTED|Time Between Sessions (2-5 Days)||4||
59566426|NCT03710577|75669026|FG000|COMPLETED|Time Between Sessions (2-5 Days)||8||
59566427|NCT03710577|75669027|FG001|COMPLETED|Time Between Sessions (2-5 Days)||4||
59566428|NCT03710577|75669026|FG000|NOT COMPLETED|Time Between Sessions (2-5 Days)||0||
59566429|NCT03710577|75669027|FG001|NOT COMPLETED|Time Between Sessions (2-5 Days)||0||
59710794|NCT00963820|75829419|FG002|COMPLETED|Expansion Phase||0||
59710795|NCT00963820|75829420|FG003|COMPLETED|Expansion Phase||0||
59710796|NCT00963820|75829421|FG004|COMPLETED|Expansion Phase||0||
59710797|NCT00963820|75829422|FG005|COMPLETED|Expansion Phase||0||
59996225|NCT00703963|76112175|FG000|COMPLETED|Overall Study||93||
59710798|NCT00963820|75829423|FG006|COMPLETED|Expansion Phase||0||
59710799|NCT00963820|75829424|FG007|COMPLETED|Expansion Phase||0||
59710800|NCT00963820|75829425|FG008|COMPLETED|Expansion Phase|Participant was ongoing at the time of data cut off for analysis|1||
59710801|NCT00963820|75829426|FG009|COMPLETED|Expansion Phase|Participant was ongoing at the time of data cut off for analysis|1||
59710802|NCT00963820|75829427|FG010|COMPLETED|Expansion Phase|Participant was ongoing at the time of data cut off for analysis|1||
59710803|NCT00963820|75829428|FG011|COMPLETED|Expansion Phase||0||
59710804|NCT00963820|75829417|FG000|NOT COMPLETED|Expansion Phase||0||
59710805|NCT00963820|75829418|FG001|NOT COMPLETED|Expansion Phase||0||
59710806|NCT00963820|75829419|FG002|NOT COMPLETED|Expansion Phase||0||
59818495|NCT00515502|75940739|FG000|STARTED|Treatment Period 3||1||
59818496|NCT00515502|75940740|FG001|STARTED|Treatment Period 3||3||
59818497|NCT00515502|75940741|FG002|STARTED|Treatment Period 3||4||
59818498|NCT00515502|75940742|FG003|STARTED|Treatment Period 3||3||
59818499|NCT00515502|75940743|FG004|STARTED|Treatment Period 3||3||
59818500|NCT00515502|75940744|FG005|STARTED|Treatment Period 3||1||
59818501|NCT00515502|75940745|FG006|STARTED|Treatment Period 3||1||
59818502|NCT00515502|75940746|FG007|STARTED|Treatment Period 3||1||
59818503|NCT00515502|75940747|FG008|STARTED|Treatment Period 3||0||
59818504|NCT00515502|75940748|FG009|STARTED|Treatment Period 3||2||
59818505|NCT00515502|75940749|FG010|STARTED|Treatment Period 3||1||
59818506|NCT00515502|75940750|FG011|STARTED|Treatment Period 3||0||
59818507|NCT00515502|75940739|FG000|COMPLETED|Treatment Period 3||1||
59818508|NCT00515502|75940740|FG001|COMPLETED|Treatment Period 3||3||
59818509|NCT00515502|75940741|FG002|COMPLETED|Treatment Period 3||4||
59818510|NCT00515502|75940742|FG003|COMPLETED|Treatment Period 3||3||
59818511|NCT00515502|75940743|FG004|COMPLETED|Treatment Period 3||3||
59818512|NCT00515502|75940744|FG005|COMPLETED|Treatment Period 3||1||
59818513|NCT00515502|75940745|FG006|COMPLETED|Treatment Period 3||1||
59818514|NCT00515502|75940746|FG007|COMPLETED|Treatment Period 3||1||
59818515|NCT00515502|75940747|FG008|COMPLETED|Treatment Period 3||0||
60106576|NCT01497496|76225566|FG000|NOT COMPLETED|Overall Study||0||
60106577|NCT02208310|76225572|FG000|STARTED|Overall Study||6||
60106578|NCT02208310|76225573|FG001|STARTED|Overall Study||5||
60106579|NCT02208310|76225572|FG000|Day 180|Overall Study||0||
60106580|NCT02208310|76225573|FG001|Day 180|Overall Study||1||
60106581|NCT02208310|76225572|FG000|COMPLETED|Overall Study||0||
60106582|NCT02208310|76225573|FG001|COMPLETED|Overall Study||0||
60106583|NCT02208310|76225572|FG000|NOT COMPLETED|Overall Study||6||
60106584|NCT02208310|76225573|FG001|NOT COMPLETED|Overall Study||5||
60106585|NCT01453894|76225581|FG000|STARTED|Overall Study||225||
60106586|NCT01453894|76225582|FG001|STARTED|Overall Study||225||
60106587|NCT01453894|76225581|FG000|COMPLETED|Overall Study||225||
60106588|NCT01453894|76225582|FG001|COMPLETED|Overall Study||225||
60106589|NCT01453894|76225581|FG000|NOT COMPLETED|Overall Study||0||
60106590|NCT01453894|76225582|FG001|NOT COMPLETED|Overall Study||0||
60106591|NCT01454362|76225590|FG000|STARTED|Overall Study||28||
60106592|NCT01454362|76225591|FG001|STARTED|Overall Study||23||
60106593|NCT01454362|76225590|FG000|COMPLETED|Overall Study||28||
60106594|NCT01454362|76225591|FG001|COMPLETED|Overall Study||23||
60106595|NCT01454362|76225590|FG000|NOT COMPLETED|Overall Study||0||
60106596|NCT01454362|76225591|FG001|NOT COMPLETED|Overall Study||0||
60106597|NCT01455064|76225599|FG000|STARTED|Overall Study||31||
60106598|NCT01455064|76225599|FG000|COMPLETED|Overall Study||30||
60106599|NCT01455064|76225599|FG000|NOT COMPLETED|Overall Study||1||
60106600|NCT01456000|76225605|FG000|STARTED|Overall Study||178||
60106601|NCT01456000|76225606|FG001|STARTED|Overall Study||175||
60106602|NCT01456000|76225605|FG000|COMPLETED|Overall Study||170||
59710807|NCT00963820|75829420|FG003|NOT COMPLETED|Expansion Phase||0||
59710808|NCT00963820|75829421|FG004|NOT COMPLETED|Expansion Phase||0||
59818516|NCT00515502|75940748|FG009|COMPLETED|Treatment Period 3||2||
59818517|NCT00515502|75940749|FG010|COMPLETED|Treatment Period 3||1||
59818518|NCT00515502|75940750|FG011|COMPLETED|Treatment Period 3||0||
60106603|NCT01456000|76225606|FG001|COMPLETED|Overall Study||172||
60106604|NCT01456000|76225605|FG000|NOT COMPLETED|Overall Study||8||
60106605|NCT01456000|76225606|FG001|NOT COMPLETED|Overall Study||3||
60106606|NCT01554982|76225612|FG000|STARTED|Overall Study||168||
59710809|NCT00963820|75829422|FG005|NOT COMPLETED|Expansion Phase||0||
60106607|NCT01554982|76225612|FG000|Received Drug|Overall Study||166||
60106608|NCT01554982|76225612|FG000|COMPLETED|Overall Study||125||
60106609|NCT01554982|76225612|FG000|NOT COMPLETED|Overall Study||43||
60106610|NCT01497808|76225620|FG000|STARTED|Overall Study||6||
60106611|NCT01497808|76225621|FG001|STARTED|Overall Study||4||
60106612|NCT01497808|76225622|FG002|STARTED|Overall Study||6||
60106613|NCT01497808|76225623|FG003|STARTED|Overall Study||6||
60106614|NCT01497808|76225620|FG000|COMPLETED|Overall Study||6||
60106615|NCT01497808|76225621|FG001|COMPLETED|Overall Study||4||
60106616|NCT01497808|76225622|FG002|COMPLETED|Overall Study||6||
60106617|NCT01497808|76225623|FG003|COMPLETED|Overall Study||6||
60106618|NCT01497808|76225620|FG000|NOT COMPLETED|Overall Study||0||
60106619|NCT01497808|76225621|FG001|NOT COMPLETED|Overall Study||0||
60106620|NCT01497808|76225622|FG002|NOT COMPLETED|Overall Study||0||
60106621|NCT01497808|76225623|FG003|NOT COMPLETED|Overall Study||0||
60106622|NCT01498588|76225633|FG000|STARTED|Overall Study||7||
60106623|NCT01498588|76225633|FG000|COMPLETED|Overall Study||7||
60106624|NCT01498588|76225633|FG000|NOT COMPLETED|Overall Study||0||
60106625|NCT01498744|76225639|FG000|STARTED|Overall Study||22||
60106626|NCT01498744|76225640|FG001|STARTED|Overall Study||31||
60106627|NCT01498744|76225639|FG000|COMPLETED|Overall Study||22||
60106628|NCT01498744|76225640|FG001|COMPLETED|Overall Study||31||
60106629|NCT01498744|76225639|FG000|NOT COMPLETED|Overall Study||0||
60106630|NCT01498744|76225640|FG001|NOT COMPLETED|Overall Study||0||
60106631|NCT01498978|76225646|FG000|STARTED|Overall Study||10||
60106632|NCT01498978|76225646|FG000|COMPLETED|Overall Study||8||
60106633|NCT01498978|76225646|FG000|NOT COMPLETED|Overall Study||2||
60106634|NCT01458418|76225656|FG000|STARTED|Overall Study||0||
60106635|NCT01458418|76225657|FG001|STARTED|Overall Study||0||
60106636|NCT01458418|76225658|FG002|STARTED|Overall Study||0||
60106637|NCT01458418|76225659|FG003|STARTED|Overall Study||4||
60106638|NCT01458418|76225656|FG000|COMPLETED|Overall Study||0||
60106639|NCT01458418|76225657|FG001|COMPLETED|Overall Study||0||
60106640|NCT01458418|76225658|FG002|COMPLETED|Overall Study||0||
60106641|NCT01458418|76225659|FG003|COMPLETED|Overall Study||4||
60106642|NCT01458418|76225656|FG000|NOT COMPLETED|Overall Study||0||
60106643|NCT01458418|76225657|FG001|NOT COMPLETED|Overall Study||0||
60106644|NCT01458418|76225658|FG002|NOT COMPLETED|Overall Study||0||
60106645|NCT01458418|76225659|FG003|NOT COMPLETED|Overall Study||0||
60106646|NCT01557322|76225671|FG000|STARTED|Overall Study||211||
60106647|NCT01557322|76225672|FG001|STARTED|Overall Study||1543||
60106648|NCT01557322|76225671|FG000|COMPLETED|Overall Study||211||
60106649|NCT01557322|76225672|FG001|COMPLETED|Overall Study||1543||
60106650|NCT01557322|76225671|FG000|NOT COMPLETED|Overall Study||0||
60106651|NCT01557322|76225672|FG001|NOT COMPLETED|Overall Study||0||
60106652|NCT01459588|76225682|FG000|STARTED|Overall Study||105||
60106653|NCT01459588|76225683|FG001|STARTED|Overall Study||51||
60106654|NCT01459588|76225684|FG002|STARTED|Overall Study||103||
60106655|NCT01459588|76225685|FG003|STARTED|Overall Study||56||
60106656|NCT01459588|76225682|FG000|COMPLETED|Overall Study||104||
60106657|NCT01459588|76225683|FG001|COMPLETED|Overall Study||49||
60106658|NCT01459588|76225684|FG002|COMPLETED|Overall Study||102||
60106659|NCT01459588|76225685|FG003|COMPLETED|Overall Study||55||
60106660|NCT01459588|76225682|FG000|NOT COMPLETED|Overall Study||1||
60106661|NCT01459588|76225683|FG001|NOT COMPLETED|Overall Study||2||
60106662|NCT01459588|76225684|FG002|NOT COMPLETED|Overall Study||1||
60106663|NCT01459588|76225685|FG003|NOT COMPLETED|Overall Study||1||
60106664|NCT01501162|76225697|FG000|STARTED|Overall Study||65||
60106665|NCT01501162|76225698|FG001|STARTED|Overall Study||65||
60106666|NCT01501162|76225697|FG000|COMPLETED|Overall Study||57||
60106667|NCT01501162|76225698|FG001|COMPLETED|Overall Study||60||
60106668|NCT01501162|76225697|FG000|NOT COMPLETED|Overall Study||8||
60106669|NCT01501162|76225698|FG001|NOT COMPLETED|Overall Study||5||
60106670|NCT01502332|76225706|FG000|STARTED|Overall Study||157||
60106671|NCT01502332|76225707|FG001|STARTED|Overall Study||163||
60106672|NCT01502332|76225706|FG000|COMPLETED|Overall Study||157||
60106673|NCT01502332|76225707|FG001|COMPLETED|Overall Study||163||
60106674|NCT01502332|76225706|FG000|NOT COMPLETED|Overall Study||0||
59710810|NCT00963820|75829423|FG006|NOT COMPLETED|Expansion Phase||0||
59710811|NCT00963820|75829424|FG007|NOT COMPLETED|Expansion Phase||0||
60106675|NCT01502332|76225707|FG001|NOT COMPLETED|Overall Study||0||
60106676|NCT01504672|76225715|FG000|STARTED|Overall Study||230||
60106677|NCT01504672|76225716|FG001|STARTED|Overall Study||230||
60106678|NCT01504672|76225715|FG000|COMPLETED|Overall Study||212||
60106679|NCT01504672|76225716|FG001|COMPLETED|Overall Study||217||
60106680|NCT01504672|76225715|FG000|NOT COMPLETED|Overall Study||18||
60106681|NCT01504672|76225716|FG001|NOT COMPLETED|Overall Study||13||
60106682|NCT01557790|76225724|FG000|STARTED|Overall Study||5||
60106683|NCT01557790|76225724|FG000|COMPLETED|Overall Study||4||
60106684|NCT01557790|76225724|FG000|NOT COMPLETED|Overall Study||1||
60106685|NCT01557868|76225730|FG000|STARTED|Overall Study||103||
59710812|NCT00963820|75829425|FG008|NOT COMPLETED|Expansion Phase||10||
59710813|NCT00963820|75829426|FG009|NOT COMPLETED|Expansion Phase||9||
59710814|NCT00963820|75829427|FG010|NOT COMPLETED|Expansion Phase||5||
59710815|NCT00963820|75829428|FG011|NOT COMPLETED|Expansion Phase||4||
59710816|NCT01227395|75829447|FG000|STARTED|Overall Study||391||
59710817|NCT01227395|75829448|FG001|STARTED|Overall Study||85||
59818519|NCT00515502|75940739|FG000|NOT COMPLETED|Treatment Period 3||0||
59818520|NCT00515502|75940740|FG001|NOT COMPLETED|Treatment Period 3||0||
59818521|NCT00515502|75940741|FG002|NOT COMPLETED|Treatment Period 3||0||
59818522|NCT00515502|75940742|FG003|NOT COMPLETED|Treatment Period 3||0||
59818523|NCT00515502|75940743|FG004|NOT COMPLETED|Treatment Period 3||0||
59818524|NCT00515502|75940744|FG005|NOT COMPLETED|Treatment Period 3||0||
59818525|NCT00515502|75940745|FG006|NOT COMPLETED|Treatment Period 3||0||
59818526|NCT00515502|75940746|FG007|NOT COMPLETED|Treatment Period 3||0||
59818527|NCT00515502|75940747|FG008|NOT COMPLETED|Treatment Period 3||0||
59818528|NCT00515502|75940748|FG009|NOT COMPLETED|Treatment Period 3||0||
59566430|NCT03710577|75669026|FG000|STARTED|Second Intervention||8||
59566431|NCT03710577|75669027|FG001|STARTED|Second Intervention||4||
59566432|NCT03710577|75669026|FG000|COMPLETED|Second Intervention||8||
59566433|NCT03710577|75669027|FG001|COMPLETED|Second Intervention||4||
59566434|NCT03710577|75669026|FG000|NOT COMPLETED|Second Intervention||0||
59566435|NCT03710577|75669027|FG001|NOT COMPLETED|Second Intervention||0||
59566436|NCT04167189|75669033|FG000|STARTED|Overall Study||28||
59566437|NCT04167189|75669033|FG000|COMPLETED|Overall Study||28||
59566438|NCT04167189|75669033|FG000|NOT COMPLETED|Overall Study||0||
59566439|NCT03929367|75669037|FG000|STARTED|Overall Study||11||
59566440|NCT03929367|75669037|FG000|COMPLETED|Overall Study||11||
59566441|NCT03929367|75669037|FG000|NOT COMPLETED|Overall Study||0||
59566442|NCT03715803|75669043|FG000|STARTED|Overall Study||91||
59566443|NCT03715803|75669044|FG001|STARTED|Overall Study||126||
59566444|NCT03715803|75669043|FG000|COMPLETED|Overall Study||91||
59566445|NCT03715803|75669044|FG001|COMPLETED|Overall Study||126||
59566446|NCT03715803|75669043|FG000|NOT COMPLETED|Overall Study||0||
59566447|NCT03715803|75669044|FG001|NOT COMPLETED|Overall Study||0||
59710818|NCT01227395|75829447|FG000|COMPLETED|Overall Study||391||
59710819|NCT01227395|75829448|FG001|COMPLETED|Overall Study||84||
59710820|NCT01227395|75829447|FG000|NOT COMPLETED|Overall Study||0||
59710821|NCT01227395|75829448|FG001|NOT COMPLETED|Overall Study||1||
59710822|NCT01226459|75829475|FG000|STARTED|Overall Study||201||
59710823|NCT01226459|75829476|FG001|STARTED|Overall Study||203||
59710824|NCT01226459|75829475|FG000|COMPLETED|Overall Study||180||
59710825|NCT01226459|75829476|FG001|COMPLETED|Overall Study||171||
59710826|NCT01226459|75829475|FG000|NOT COMPLETED|Overall Study||21||
59710827|NCT01226459|75829476|FG001|NOT COMPLETED|Overall Study||32||
59710828|NCT01225991|75829482|FG000|STARTED|Overall Study||18||
59818529|NCT00515502|75940749|FG010|NOT COMPLETED|Treatment Period 3||0||
59566448|NCT04155567|75669050|FG000|STARTED|Overall Study||10||
59566449|NCT04155567|75669050|FG000|COMPLETED|Overall Study||10||
59566450|NCT04155567|75669050|FG000|NOT COMPLETED|Overall Study||0||
59710829|NCT01225991|75829482|FG000|COMPLETED|Overall Study||12||
59566451|NCT04149405|75669058|FG000|STARTED|Overall Study||12||
59566452|NCT04149405|75669059|FG001|STARTED|Overall Study||10||
59566453|NCT04149405|75669060|FG002|STARTED|Overall Study||11||
59566454|NCT04149405|75669061|FG003|STARTED|Overall Study||10||
59566455|NCT04149405|75669058|FG000|COMPLETED|Overall Study||12||
59566456|NCT04149405|75669059|FG001|COMPLETED|Overall Study||10||
59566457|NCT04149405|75669060|FG002|COMPLETED|Overall Study||11||
59566458|NCT04149405|75669061|FG003|COMPLETED|Overall Study||10||
59818530|NCT00515502|75940750|FG011|NOT COMPLETED|Treatment Period 3||0||
59566459|NCT04149405|75669058|FG000|NOT COMPLETED|Overall Study||0||
59566460|NCT04149405|75669059|FG001|NOT COMPLETED|Overall Study||0||
59566461|NCT04149405|75669060|FG002|NOT COMPLETED|Overall Study||0||
59710830|NCT01225991|75829482|FG000|NOT COMPLETED|Overall Study||6||
59710831|NCT00959374|75829486|FG000|STARTED|Overall Study|Of the 241 enrolled subjects, 229 were randomized and treated|241||
59710832|NCT00959374|75829486|FG000|COMPLETED|Overall Study||218||
59710833|NCT00959374|75829486|FG000|NOT COMPLETED|Overall Study||23||
59710834|NCT01225835|75829496|FG000|STARTED|Overall Study||62||
59710835|NCT01225835|75829497|FG001|STARTED|Overall Study||62||
59710836|NCT01225835|75829496|FG000|Per Protocol Population|Overall Study||48||
59710837|NCT01225835|75829497|FG001|Per Protocol Population|Overall Study||58||
59818531|NCT00515502|75940739|FG000|STARTED|Washout Period 3||1||
59818532|NCT00515502|75940740|FG001|STARTED|Washout Period 3||3||
59818533|NCT00515502|75940741|FG002|STARTED|Washout Period 3||4||
59818534|NCT00515502|75940742|FG003|STARTED|Washout Period 3||3||
59818535|NCT00515502|75940743|FG004|STARTED|Washout Period 3||3||
59996226|NCT00703963|76112176|FG001|COMPLETED|Overall Study||86||
59818536|NCT00515502|75940744|FG005|STARTED|Washout Period 3||1||
59818537|NCT00515502|75940745|FG006|STARTED|Washout Period 3||1||
59818538|NCT00515502|75940746|FG007|STARTED|Washout Period 3||1||
59818539|NCT00515502|75940747|FG008|STARTED|Washout Period 3||0||
59818540|NCT00515502|75940748|FG009|STARTED|Washout Period 3||2||
59818541|NCT00515502|75940749|FG010|STARTED|Washout Period 3||1||
59996227|NCT00703963|76112175|FG000|NOT COMPLETED|Overall Study||7||
59996228|NCT00703963|76112176|FG001|NOT COMPLETED|Overall Study||14||
59710838|NCT01225835|75829496|FG000|COMPLETED|Overall Study|hCG criterion met|55||
59566462|NCT04149405|75669061|FG003|NOT COMPLETED|Overall Study||0||
59710839|NCT01225835|75829497|FG001|COMPLETED|Overall Study|hCG criterion met|59||
59710840|NCT01225835|75829496|FG000|NOT COMPLETED|Overall Study||7||
59710841|NCT01225835|75829497|FG001|NOT COMPLETED|Overall Study||3||
59710842|NCT00962650|75829509|FG000|STARTED|Overall Study||10||
59818542|NCT00515502|75940750|FG011|STARTED|Washout Period 3||0||
59818543|NCT00515502|75940739|FG000|COMPLETED|Washout Period 3||1||
59818544|NCT00515502|75940740|FG001|COMPLETED|Washout Period 3||3||
59818545|NCT00515502|75940741|FG002|COMPLETED|Washout Period 3||4||
59818546|NCT00515502|75940742|FG003|COMPLETED|Washout Period 3||3||
59818547|NCT00515502|75940743|FG004|COMPLETED|Washout Period 3||3||
59818548|NCT00515502|75940744|FG005|COMPLETED|Washout Period 3||1||
59818549|NCT00515502|75940745|FG006|COMPLETED|Washout Period 3||1||
59818550|NCT00515502|75940746|FG007|COMPLETED|Washout Period 3||1||
59818551|NCT00515502|75940747|FG008|COMPLETED|Washout Period 3||0||
60106686|NCT01557868|76225731|FG001|STARTED|Overall Study||95||
60106687|NCT01557868|76225730|FG000|COMPLETED|Overall Study||76||
60106688|NCT01557868|76225731|FG001|COMPLETED|Overall Study||65||
60106689|NCT01557868|76225730|FG000|NOT COMPLETED|Overall Study||27||
60106690|NCT01557868|76225731|FG001|NOT COMPLETED|Overall Study||30||
60106691|NCT01559506|76225739|FG000|STARTED|Overall Study||20||
60106692|NCT01559506|76225740|FG001|STARTED|Overall Study||21||
60106693|NCT01559506|76225739|FG000|COMPLETED|Overall Study||20||
60106694|NCT01559506|76225740|FG001|COMPLETED|Overall Study||18||
60106695|NCT01559506|76225739|FG000|NOT COMPLETED|Overall Study||0||
60106696|NCT01559506|76225740|FG001|NOT COMPLETED|Overall Study||3||
60106697|NCT02208466|76225749|FG000|STARTED|Overall Study||9||
60106698|NCT02208466|76225750|FG001|STARTED|Overall Study||10||
60106699|NCT02208466|76225751|FG002|STARTED|Overall Study||8||
60106700|NCT02208466|76225749|FG000|COMPLETED|Overall Study||9||
60106701|NCT02208466|76225750|FG001|COMPLETED|Overall Study||10||
60106702|NCT02208466|76225751|FG002|COMPLETED|Overall Study||8||
60106703|NCT02208466|76225749|FG000|NOT COMPLETED|Overall Study||0||
59566463|NCT00556712|75669079|FG000|STARTED|Overall Study||451||
59710843|NCT00962650|75829509|FG000|COMPLETED|Overall Study||8||
59710844|NCT00962650|75829509|FG000|NOT COMPLETED|Overall Study||2||
59710845|NCT02899000|75829513|FG000|STARTED|Overall Study||186||
59710846|NCT02899000|75829513|FG000|COMPLETED|Overall Study||157||
59710847|NCT02899000|75829513|FG000|NOT COMPLETED|Overall Study||29||
59710848|NCT00958828|75829517|FG000|STARTED|Period 1, 1 Week of Wear||89||
59710849|NCT00958828|75829518|FG001|STARTED|Period 1, 1 Week of Wear||89||
59710850|NCT00958828|75829517|FG000|COMPLETED|Period 1, 1 Week of Wear||89||
60106704|NCT02208466|76225750|FG001|NOT COMPLETED|Overall Study||0||
60106705|NCT02208466|76225751|FG002|NOT COMPLETED|Overall Study||0||
59566464|NCT00556712|75669080|FG001|STARTED|Overall Study||438||
59566465|NCT00556712|75669079|FG000|COMPLETED|Overall Study|Data cutoff date: 17 May 2008|0||
59566466|NCT00556712|75669080|FG001|COMPLETED|Overall Study|Data cutoff date: 17 May 2008|0||
59710851|NCT00958828|75829518|FG001|COMPLETED|Period 1, 1 Week of Wear||88||
59566467|NCT00556712|75669079|FG000|NOT COMPLETED|Overall Study||451||
59566468|NCT00556712|75669080|FG001|NOT COMPLETED|Overall Study||438||
59566469|NCT04137783|75669089|FG000|STARTED|Overall Study||7||
59710852|NCT00958828|75829517|FG000|NOT COMPLETED|Period 1, 1 Week of Wear||0||
59710853|NCT00958828|75829518|FG001|NOT COMPLETED|Period 1, 1 Week of Wear||1||
59710854|NCT00958828|75829517|FG000|STARTED|Period 2, 1 Week of Wear||89||
59710855|NCT00958828|75829518|FG001|STARTED|Period 2, 1 Week of Wear||88||
59710856|NCT00958828|75829517|FG000|COMPLETED|Period 2, 1 Week of Wear||89||
59710857|NCT00958828|75829518|FG001|COMPLETED|Period 2, 1 Week of Wear||87||
59710858|NCT00958828|75829517|FG000|NOT COMPLETED|Period 2, 1 Week of Wear||0||
59710859|NCT00958828|75829518|FG001|NOT COMPLETED|Period 2, 1 Week of Wear||1||
59710860|NCT00960934|75829530|FG000|STARTED|Overall Study||64||
59710861|NCT00960934|75829531|FG001|STARTED|Overall Study||63||
59710862|NCT00960934|75829532|FG002|STARTED|Overall Study||64||
59710863|NCT00960934|75829533|FG003|STARTED|Overall Study||64||
59710864|NCT00960934|75829534|FG004|STARTED|Overall Study||64||
59710865|NCT00960934|75829535|FG005|STARTED|Overall Study||64||
59710866|NCT00960934|75829530|FG000|Number Treated|Overall Study||64||
59710867|NCT00960934|75829531|FG001|Number Treated|Overall Study|1 participant was randomized but not treated|62||
59710868|NCT00960934|75829532|FG002|Number Treated|Overall Study||64||
59710869|NCT00960934|75829533|FG003|Number Treated|Overall Study||64||
59710870|NCT00960934|75829534|FG004|Number Treated|Overall Study|1 participant was randomized but not treated|63||
59710871|NCT00960934|75829535|FG005|Number Treated|Overall Study|1 participant was randomized but not treated|63||
59710872|NCT00960934|75829530|FG000|COMPLETED|Overall Study||0||
59710873|NCT00960934|75829531|FG001|COMPLETED|Overall Study||0||
59710874|NCT00960934|75829532|FG002|COMPLETED|Overall Study||0||
59710875|NCT00960934|75829533|FG003|COMPLETED|Overall Study||0||
59710876|NCT00960934|75829534|FG004|COMPLETED|Overall Study||0||
59818552|NCT00515502|75940748|FG009|COMPLETED|Washout Period 3||2||
59818553|NCT00515502|75940749|FG010|COMPLETED|Washout Period 3||1||
59818554|NCT00515502|75940750|FG011|COMPLETED|Washout Period 3||0||
59566470|NCT04137783|75669090|FG001|STARTED|Overall Study||10||
59566471|NCT04137783|75669091|FG002|STARTED|Overall Study||22||
59566472|NCT04137783|75669089|FG000|COMPLETED|Overall Study||7||
59566473|NCT04137783|75669090|FG001|COMPLETED|Overall Study||10||
59710877|NCT00960934|75829535|FG005|COMPLETED|Overall Study||0||
59818555|NCT00515502|75940739|FG000|NOT COMPLETED|Washout Period 3||0||
59818556|NCT00515502|75940740|FG001|NOT COMPLETED|Washout Period 3||0||
59818557|NCT00515502|75940741|FG002|NOT COMPLETED|Washout Period 3||0||
59818558|NCT00515502|75940742|FG003|NOT COMPLETED|Washout Period 3||0||
59818559|NCT00515502|75940743|FG004|NOT COMPLETED|Washout Period 3||0||
59818560|NCT00515502|75940744|FG005|NOT COMPLETED|Washout Period 3||0||
59818561|NCT00515502|75940745|FG006|NOT COMPLETED|Washout Period 3||0||
59818562|NCT00515502|75940746|FG007|NOT COMPLETED|Washout Period 3||0||
59818563|NCT00515502|75940747|FG008|NOT COMPLETED|Washout Period 3||0||
59818564|NCT00515502|75940748|FG009|NOT COMPLETED|Washout Period 3||0||
59818565|NCT00515502|75940749|FG010|NOT COMPLETED|Washout Period 3||0||
59818566|NCT00515502|75940750|FG011|NOT COMPLETED|Washout Period 3||0||
59818567|NCT00515502|75940739|FG000|STARTED|Treatment Period 4||1||
59818568|NCT00515502|75940740|FG001|STARTED|Treatment Period 4||3||
59818569|NCT00515502|75940741|FG002|STARTED|Treatment Period 4||4||
59818570|NCT00515502|75940742|FG003|STARTED|Treatment Period 4||3||
59818571|NCT00515502|75940743|FG004|STARTED|Treatment Period 4||3||
59818572|NCT00515502|75940744|FG005|STARTED|Treatment Period 4||1||
59818573|NCT00515502|75940745|FG006|STARTED|Treatment Period 4||1||
59566474|NCT04137783|75669091|FG002|COMPLETED|Overall Study||22||
59566475|NCT04137783|75669089|FG000|NOT COMPLETED|Overall Study||0||
59818574|NCT00515502|75940746|FG007|STARTED|Treatment Period 4||1||
59818575|NCT00515502|75940747|FG008|STARTED|Treatment Period 4||0||
59566476|NCT04137783|75669090|FG001|NOT COMPLETED|Overall Study||0||
59566477|NCT04137783|75669091|FG002|NOT COMPLETED|Overall Study||0||
59710878|NCT00960934|75829530|FG000|NOT COMPLETED|Overall Study||64||
59710879|NCT00960934|75829531|FG001|NOT COMPLETED|Overall Study||63||
59710880|NCT00960934|75829532|FG002|NOT COMPLETED|Overall Study||64||
59710881|NCT00960934|75829533|FG003|NOT COMPLETED|Overall Study||64||
59710882|NCT00960934|75829534|FG004|NOT COMPLETED|Overall Study||64||
59710883|NCT00960934|75829535|FG005|NOT COMPLETED|Overall Study||64||
59710884|NCT00892177|75829552|FG000|STARTED|Phase I: Dose Level 0||3||
59818576|NCT00515502|75940748|FG009|STARTED|Treatment Period 4||2||
59818577|NCT00515502|75940749|FG010|STARTED|Treatment Period 4||1||
59818578|NCT00515502|75940750|FG011|STARTED|Treatment Period 4||0||
59818579|NCT00515502|75940739|FG000|COMPLETED|Treatment Period 4||1||
59818580|NCT00515502|75940740|FG001|COMPLETED|Treatment Period 4||3||
59818581|NCT00515502|75940741|FG002|COMPLETED|Treatment Period 4||4||
59710885|NCT00892177|75829553|FG001|STARTED|Phase I: Dose Level 0||0||
59710886|NCT00892177|75829554|FG002|STARTED|Phase I: Dose Level 0||0||
59710887|NCT00892177|75829555|FG003|STARTED|Phase I: Dose Level 0||0||
59566478|NCT03717051|75669101|FG000|STARTED|Overall Study||352||
59566479|NCT03717051|75669102|FG001|STARTED|Overall Study||482||
59566480|NCT03717051|75669101|FG000|COMPLETED|Overall Study||352||
59566481|NCT03717051|75669102|FG001|COMPLETED|Overall Study||482||
59566482|NCT03717051|75669101|FG000|NOT COMPLETED|Overall Study||0||
59566483|NCT03717051|75669102|FG001|NOT COMPLETED|Overall Study||0||
59566484|NCT04147455|75669110|FG000|STARTED|Overall Study||397||
59710888|NCT00892177|75829556|FG004|STARTED|Phase I: Dose Level 0||0||
59710889|NCT00892177|75829557|FG005|STARTED|Phase I: Dose Level 0||0||
59710890|NCT00892177|75829552|FG000|COMPLETED|Phase I: Dose Level 0||3||
59710891|NCT00892177|75829553|FG001|COMPLETED|Phase I: Dose Level 0||0||
59710892|NCT00892177|75829554|FG002|COMPLETED|Phase I: Dose Level 0||0||
59710893|NCT00892177|75829555|FG003|COMPLETED|Phase I: Dose Level 0||0||
59710894|NCT00892177|75829556|FG004|COMPLETED|Phase I: Dose Level 0||0||
59710895|NCT00892177|75829557|FG005|COMPLETED|Phase I: Dose Level 0||0||
59996229|NCT02721355|76112184|FG000|STARTED|Overall Study||42||
59996230|NCT02721355|76112185|FG001|STARTED|Overall Study||42||
59996231|NCT02721355|76112184|FG000|COMPLETED|Overall Study||36||
59996232|NCT02721355|76112185|FG001|COMPLETED|Overall Study||41||
59996233|NCT02721355|76112184|FG000|NOT COMPLETED|Overall Study||6||
59996234|NCT02721355|76112185|FG001|NOT COMPLETED|Overall Study||1||
59996235|NCT02733991|76112193|FG000|STARTED|Overall Study||76||
59996236|NCT02733991|76112194|FG001|STARTED|Overall Study||77||
59996237|NCT02733991|76112193|FG000|COMPLETED|Overall Study||75||
59996238|NCT02733991|76112194|FG001|COMPLETED|Overall Study||72||
59996239|NCT02733991|76112193|FG000|NOT COMPLETED|Overall Study||1||
60106706|NCT02209948|76225761|FG000|STARTED|Overall Study||80||
60106707|NCT02209948|76225762|FG001|STARTED|Overall Study||79||
60106708|NCT02209948|76225761|FG000|Recieved Alocated Intervention|Overall Study||80||
60106709|NCT02209948|76225762|FG001|Recieved Alocated Intervention|Overall Study||79||
60106710|NCT02209948|76225761|FG000|Lost to Follow up|Overall Study||0||
60106711|NCT02209948|76225762|FG001|Lost to Follow up|Overall Study||1||
60106712|NCT02209948|76225761|FG000|Discontinued Due to Progression|Overall Study||31||
60106713|NCT02209948|76225762|FG001|Discontinued Due to Progression|Overall Study||39||
60106714|NCT02209948|76225761|FG000|COMPLETED|Overall Study||80|Used for analysis|
60106715|NCT02209948|76225762|FG001|COMPLETED|Overall Study||79|Used for analysis|
60106716|NCT02209948|76225761|FG000|NOT COMPLETED|Overall Study||0||
60106717|NCT02209948|76225762|FG001|NOT COMPLETED|Overall Study||0||
60106718|NCT01560286|76225768|FG000|STARTED|Overall Study||24||
60106719|NCT01560286|76225768|FG000|COMPLETED|Overall Study||24||
60106720|NCT01560286|76225768|FG000|NOT COMPLETED|Overall Study||0||
60106721|NCT01505764|76225774|FG000|STARTED|Overall Study||6||
60106722|NCT01505764|76225775|FG001|STARTED|Overall Study||3||
60106723|NCT01505764|76225774|FG000|COMPLETED|Overall Study||3|not completed due to poor recruitment|
60106724|NCT01505764|76225775|FG001|COMPLETED|Overall Study||2|not completed due to poor recruitment|
60106725|NCT01505764|76225774|FG000|NOT COMPLETED|Overall Study||3||
60106726|NCT01505764|76225775|FG001|NOT COMPLETED|Overall Study||1||
59566485|NCT04147455|75669111|FG001|STARTED|Overall Study||396||
59566486|NCT04147455|75669110|FG000|COMPLETED|Overall Study||375||
59566487|NCT04147455|75669111|FG001|COMPLETED|Overall Study||364||
59566488|NCT04147455|75669110|FG000|NOT COMPLETED|Overall Study||22||
59566489|NCT04147455|75669111|FG001|NOT COMPLETED|Overall Study||32||
59566490|NCT04143945|75669117|FG000|STARTED|Treatment Period 1 (Day 1)||26||
59566491|NCT04143945|75669118|FG001|STARTED|Treatment Period 1 (Day 1)||26||
59566492|NCT04143945|75669119|FG002|STARTED|Treatment Period 1 (Day 1)||26||
59566493|NCT04143945|75669120|FG003|STARTED|Treatment Period 1 (Day 1)||26||
59566494|NCT04143945|75669117|FG000|Full Analysis Set (FAS)|Treatment Period 1 (Day 1)||26||
59566495|NCT04143945|75669118|FG001|Full Analysis Set (FAS)|Treatment Period 1 (Day 1)||26||
59710896|NCT00892177|75829552|FG000|NOT COMPLETED|Phase I: Dose Level 0||0||
59996240|NCT02733991|76112194|FG001|NOT COMPLETED|Overall Study||5||
59996241|NCT00702949|76112203|FG000|STARTED|Overall Study||63||
59996242|NCT00702949|76112204|FG001|STARTED|Overall Study||66||
59996243|NCT00702949|76112205|FG002|STARTED|Overall Study||62||
59996244|NCT00702949|76112203|FG000|Evaluable for Primary Endpoint|Overall Study||56||
59996245|NCT00702949|76112204|FG001|Evaluable for Primary Endpoint|Overall Study||56||
59996246|NCT00702949|76112205|FG002|Evaluable for Primary Endpoint|Overall Study||51||
59996247|NCT00702949|76112203|FG000|COMPLETED|Overall Study||58||
60106727|NCT01464190|76225784|FG000|STARTED|Overall Study||391||
60106728|NCT01464190|76225785|FG001|STARTED|Overall Study||268||
59710897|NCT00892177|75829553|FG001|NOT COMPLETED|Phase I: Dose Level 0||0||
59710898|NCT00892177|75829554|FG002|NOT COMPLETED|Phase I: Dose Level 0||0||
59710899|NCT00892177|75829555|FG003|NOT COMPLETED|Phase I: Dose Level 0||0||
59710900|NCT00892177|75829556|FG004|NOT COMPLETED|Phase I: Dose Level 0||0||
59818582|NCT00515502|75940742|FG003|COMPLETED|Treatment Period 4||3||
59818583|NCT00515502|75940743|FG004|COMPLETED|Treatment Period 4||3||
59710901|NCT00892177|75829557|FG005|NOT COMPLETED|Phase I: Dose Level 0||0||
59710902|NCT00892177|75829552|FG000|STARTED|Phase I: Dose Level 1||0||
59710903|NCT00892177|75829553|FG001|STARTED|Phase I: Dose Level 1||4||
59710904|NCT00892177|75829554|FG002|STARTED|Phase I: Dose Level 1||0||
59710905|NCT00892177|75829555|FG003|STARTED|Phase I: Dose Level 1||0||
59710906|NCT00892177|75829556|FG004|STARTED|Phase I: Dose Level 1||0||
59818584|NCT00515502|75940744|FG005|COMPLETED|Treatment Period 4||1||
59818585|NCT00515502|75940745|FG006|COMPLETED|Treatment Period 4||1||
59818586|NCT00515502|75940746|FG007|COMPLETED|Treatment Period 4||1||
59818587|NCT00515502|75940747|FG008|COMPLETED|Treatment Period 4||0||
59818588|NCT00515502|75940748|FG009|COMPLETED|Treatment Period 4||2||
59818589|NCT00515502|75940749|FG010|COMPLETED|Treatment Period 4||1||
59818590|NCT00515502|75940750|FG011|COMPLETED|Treatment Period 4||0||
59818591|NCT00515502|75940739|FG000|NOT COMPLETED|Treatment Period 4||0||
59818592|NCT00515502|75940740|FG001|NOT COMPLETED|Treatment Period 4||0||
59818593|NCT00515502|75940741|FG002|NOT COMPLETED|Treatment Period 4||0||
59818594|NCT00515502|75940742|FG003|NOT COMPLETED|Treatment Period 4||0||
59818595|NCT00515502|75940743|FG004|NOT COMPLETED|Treatment Period 4||0||
59818596|NCT00515502|75940744|FG005|NOT COMPLETED|Treatment Period 4||0||
59818597|NCT00515502|75940745|FG006|NOT COMPLETED|Treatment Period 4||0||
59818598|NCT00515502|75940746|FG007|NOT COMPLETED|Treatment Period 4||0||
59818599|NCT00515502|75940747|FG008|NOT COMPLETED|Treatment Period 4||0||
59818600|NCT00515502|75940748|FG009|NOT COMPLETED|Treatment Period 4||0||
59818601|NCT00515502|75940749|FG010|NOT COMPLETED|Treatment Period 4||0||
59818602|NCT00515502|75940750|FG011|NOT COMPLETED|Treatment Period 4||0||
59818603|NCT00439647|75940769|FG000|STARTED|Overall Study|"Started indicates intent to treat (ITT) and safety set."|588||
59818604|NCT00439647|75940770|FG001|STARTED|Overall Study||611||
59818605|NCT00439647|75940769|FG000|Modified Intent to Treat (mITT)|Overall Study||553||
59818606|NCT00439647|75940770|FG001|Modified Intent to Treat (mITT)|Overall Study||574||
59818607|NCT00439647|75940769|FG000|COMPLETED|Overall Study||530||
59818608|NCT00439647|75940770|FG001|COMPLETED|Overall Study||540||
59818609|NCT00439647|75940769|FG000|NOT COMPLETED|Overall Study||58||
59818610|NCT00439647|75940770|FG001|NOT COMPLETED|Overall Study||71||
60106729|NCT01464190|76225784|FG000|COMPLETED|Overall Study||322||
60106730|NCT01464190|76225785|FG001|COMPLETED|Overall Study||227||
60106731|NCT01464190|76225784|FG000|NOT COMPLETED|Overall Study||69||
60106732|NCT01464190|76225785|FG001|NOT COMPLETED|Overall Study||41||
60106733|NCT01466764|76225793|FG000|STARTED|Overall Study||5||
60106734|NCT01466764|76225794|FG001|STARTED|Overall Study||5||
60106735|NCT01466764|76225793|FG000|COMPLETED|Overall Study||5||
59566496|NCT04143945|75669119|FG002|Full Analysis Set (FAS)|Treatment Period 1 (Day 1)||26||
59566497|NCT04143945|75669120|FG003|Full Analysis Set (FAS)|Treatment Period 1 (Day 1)||26||
59566498|NCT04143945|75669117|FG000|Safety Analysis Set (SAS)|Treatment Period 1 (Day 1)||26||
59566499|NCT04143945|75669118|FG001|Safety Analysis Set (SAS)|Treatment Period 1 (Day 1)||26||
59566500|NCT04143945|75669119|FG002|Safety Analysis Set (SAS)|Treatment Period 1 (Day 1)||26||
59566501|NCT04143945|75669120|FG003|Safety Analysis Set (SAS)|Treatment Period 1 (Day 1)||26||
59566502|NCT04143945|75669117|FG000|Per Protocol Set|Treatment Period 1 (Day 1)||26||
59566503|NCT04143945|75669118|FG001|Per Protocol Set|Treatment Period 1 (Day 1)||26||
59566504|NCT04143945|75669119|FG002|Per Protocol Set|Treatment Period 1 (Day 1)||26||
59566505|NCT04143945|75669120|FG003|Per Protocol Set|Treatment Period 1 (Day 1)||26||
59566506|NCT04143945|75669117|FG000|COMPLETED|Treatment Period 1 (Day 1)||26||
59710907|NCT00892177|75829557|FG005|STARTED|Phase I: Dose Level 1||0||
59818611|NCT00515112|75940778|FG000|STARTED|Overall Study||3||
59818612|NCT00515112|75940779|FG001|STARTED|Overall Study||3||
59818613|NCT00515112|75940778|FG000|COMPLETED|Overall Study||0||
59818614|NCT00515112|75940779|FG001|COMPLETED|Overall Study||0||
59818615|NCT00515112|75940778|FG000|NOT COMPLETED|Overall Study||3||
59818616|NCT00515112|75940779|FG001|NOT COMPLETED|Overall Study||3||
59818617|NCT00404547|75940787|FG000|STARTED|Overall Study||762||
60106736|NCT01466764|76225794|FG001|COMPLETED|Overall Study||5||
59710908|NCT00892177|75829552|FG000|COMPLETED|Phase I: Dose Level 1||0||
59710909|NCT00892177|75829553|FG001|COMPLETED|Phase I: Dose Level 1||4||
59710910|NCT00892177|75829554|FG002|COMPLETED|Phase I: Dose Level 1||0||
59710911|NCT00892177|75829555|FG003|COMPLETED|Phase I: Dose Level 1||0||
59710912|NCT00892177|75829556|FG004|COMPLETED|Phase I: Dose Level 1||0||
59710913|NCT00892177|75829557|FG005|COMPLETED|Phase I: Dose Level 1||0||
59710914|NCT00892177|75829552|FG000|NOT COMPLETED|Phase I: Dose Level 1||0||
59818618|NCT00404547|75940788|FG001|STARTED|Overall Study||359||
59818619|NCT00404547|75940787|FG000|COMPLETED|Overall Study||672||
59818620|NCT00404547|75940788|FG001|COMPLETED|Overall Study||334||
59818621|NCT00404547|75940787|FG000|NOT COMPLETED|Overall Study||90||
60106737|NCT01466764|76225793|FG000|NOT COMPLETED|Overall Study||0||
60106738|NCT01466764|76225794|FG001|NOT COMPLETED|Overall Study||0||
59710915|NCT00892177|75829553|FG001|NOT COMPLETED|Phase I: Dose Level 1||0||
59710916|NCT00892177|75829554|FG002|NOT COMPLETED|Phase I: Dose Level 1||0||
59710917|NCT00892177|75829555|FG003|NOT COMPLETED|Phase I: Dose Level 1||0||
59710918|NCT00892177|75829556|FG004|NOT COMPLETED|Phase I: Dose Level 1||0||
59710919|NCT00892177|75829557|FG005|NOT COMPLETED|Phase I: Dose Level 1||0||
59710920|NCT00892177|75829552|FG000|STARTED|Phase I: Dose Level 2||0||
59710921|NCT00892177|75829553|FG001|STARTED|Phase I: Dose Level 2||0||
59710922|NCT00892177|75829554|FG002|STARTED|Phase I: Dose Level 2||3||
59710923|NCT00892177|75829555|FG003|STARTED|Phase I: Dose Level 2||0||
59710924|NCT00892177|75829556|FG004|STARTED|Phase I: Dose Level 2||0||
59710925|NCT00892177|75829557|FG005|STARTED|Phase I: Dose Level 2||0||
59710926|NCT00892177|75829552|FG000|COMPLETED|Phase I: Dose Level 2||0||
59710927|NCT00892177|75829553|FG001|COMPLETED|Phase I: Dose Level 2||0||
59710928|NCT00892177|75829554|FG002|COMPLETED|Phase I: Dose Level 2||3||
59710929|NCT00892177|75829555|FG003|COMPLETED|Phase I: Dose Level 2||0||
59710930|NCT00892177|75829556|FG004|COMPLETED|Phase I: Dose Level 2||0||
59710931|NCT00892177|75829557|FG005|COMPLETED|Phase I: Dose Level 2||0||
59710932|NCT00892177|75829552|FG000|NOT COMPLETED|Phase I: Dose Level 2||0||
59710933|NCT00892177|75829553|FG001|NOT COMPLETED|Phase I: Dose Level 2||0||
59710934|NCT00892177|75829554|FG002|NOT COMPLETED|Phase I: Dose Level 2||0||
59710935|NCT00892177|75829555|FG003|NOT COMPLETED|Phase I: Dose Level 2||0||
59710936|NCT00892177|75829556|FG004|NOT COMPLETED|Phase I: Dose Level 2||0||
59710937|NCT00892177|75829557|FG005|NOT COMPLETED|Phase I: Dose Level 2||0||
60106739|NCT01563406|76225804|FG000|STARTED|Overall Study|194 hubs|60||
59710938|NCT00892177|75829552|FG000|STARTED|Phase I: Dose Level 3||0||
59710939|NCT00892177|75829553|FG001|STARTED|Phase I: Dose Level 3||0||
59710940|NCT00892177|75829554|FG002|STARTED|Phase I: Dose Level 3||0||
59710941|NCT00892177|75829555|FG003|STARTED|Phase I: Dose Level 3||6||
60106740|NCT01563406|76225805|FG001|STARTED|Overall Study|102 hubs|30||
60106741|NCT01563406|76225806|FG002|STARTED|Overall Study|101 hubs|30||
59710942|NCT00892177|75829556|FG004|STARTED|Phase I: Dose Level 3||0||
60106742|NCT01563406|76225807|FG003|STARTED|Overall Study|112 hubs|29||
60106743|NCT01563406|76225804|FG000|COMPLETED|Overall Study|194 hubs|60||
60106744|NCT01563406|76225805|FG001|COMPLETED|Overall Study|102 hubs|30||
60106745|NCT01563406|76225806|FG002|COMPLETED|Overall Study|101 hubs|30||
60106746|NCT01563406|76225807|FG003|COMPLETED|Overall Study|112 hubs|29||
60106747|NCT01563406|76225804|FG000|NOT COMPLETED|Overall Study||0||
60106748|NCT01563406|76225805|FG001|NOT COMPLETED|Overall Study||0||
60106749|NCT01563406|76225806|FG002|NOT COMPLETED|Overall Study||0||
60106750|NCT01563406|76225807|FG003|NOT COMPLETED|Overall Study||0||
60106751|NCT01467934|76225824|FG000|STARTED|Overall Study||208||
60106752|NCT01467934|76225825|FG001|STARTED|Overall Study||212||
60106753|NCT01467934|76225826|FG002|STARTED|Overall Study||110||
60106754|NCT01467934|76225824|FG000|COMPLETED|Overall Study||208||
60106755|NCT01467934|76225825|FG001|COMPLETED|Overall Study||212||
59566507|NCT04143945|75669118|FG001|COMPLETED|Treatment Period 1 (Day 1)||26||
59566508|NCT04143945|75669119|FG002|COMPLETED|Treatment Period 1 (Day 1)||26||
59710943|NCT00892177|75829557|FG005|STARTED|Phase I: Dose Level 3||0||
59710944|NCT00892177|75829552|FG000|COMPLETED|Phase I: Dose Level 3||0||
59710945|NCT00892177|75829553|FG001|COMPLETED|Phase I: Dose Level 3||0||
59710946|NCT00892177|75829554|FG002|COMPLETED|Phase I: Dose Level 3||0||
59710947|NCT00892177|75829555|FG003|COMPLETED|Phase I: Dose Level 3||6||
59710948|NCT00892177|75829556|FG004|COMPLETED|Phase I: Dose Level 3||0||
59710949|NCT00892177|75829557|FG005|COMPLETED|Phase I: Dose Level 3||0||
59710950|NCT00892177|75829552|FG000|NOT COMPLETED|Phase I: Dose Level 3||0||
59710951|NCT00892177|75829553|FG001|NOT COMPLETED|Phase I: Dose Level 3||0||
59710952|NCT00892177|75829554|FG002|NOT COMPLETED|Phase I: Dose Level 3||0||
59710953|NCT00892177|75829555|FG003|NOT COMPLETED|Phase I: Dose Level 3||0||
60106756|NCT01467934|76225826|FG002|COMPLETED|Overall Study||110||
60106757|NCT01467934|76225824|FG000|NOT COMPLETED|Overall Study||0||
60106758|NCT01467934|76225825|FG001|NOT COMPLETED|Overall Study||0||
59710954|NCT00892177|75829556|FG004|NOT COMPLETED|Phase I: Dose Level 3||0||
59710955|NCT00892177|75829557|FG005|NOT COMPLETED|Phase I: Dose Level 3||0||
59710956|NCT00892177|75829552|FG000|STARTED|Phase II||0||
59710957|NCT00892177|75829553|FG001|STARTED|Phase II||0||
59710958|NCT00892177|75829554|FG002|STARTED|Phase II||0||
59710959|NCT00892177|75829555|FG003|STARTED|Phase II||0||
59710960|NCT00892177|75829556|FG004|STARTED|Phase II||88||
60106759|NCT01467934|76225826|FG002|NOT COMPLETED|Overall Study||0||
60106760|NCT01468012|76225837|FG000|STARTED|Overall Study||9||
60106761|NCT01468012|76225838|FG001|STARTED|Overall Study||10||
60106762|NCT01468012|76225839|FG002|STARTED|Overall Study||4||
60106763|NCT01468012|76225837|FG000|COMPLETED|Overall Study||7||
60106764|NCT01468012|76225838|FG001|COMPLETED|Overall Study||9||
60106765|NCT01468012|76225839|FG002|COMPLETED|Overall Study||0||
60106766|NCT01468012|76225837|FG000|NOT COMPLETED|Overall Study||2||
60106767|NCT01468012|76225838|FG001|NOT COMPLETED|Overall Study||1||
60106768|NCT01468012|76225839|FG002|NOT COMPLETED|Overall Study||4||
60106769|NCT01468558|76225848|FG000|STARTED|Overall Study||24||
60106770|NCT01468558|76225848|FG000|COMPLETED|Overall Study||22||
60106771|NCT01468558|76225848|FG000|NOT COMPLETED|Overall Study||2||
60106772|NCT03730662|76225860|FG000|STARTED|Treatment Period (52 Weeks)||329||
60106773|NCT03730662|76225861|FG001|STARTED|Treatment Period (52 Weeks)||330||
60106774|NCT03730662|76225862|FG002|STARTED|Treatment Period (52 Weeks)||338||
60106775|NCT03730662|76225863|FG003|STARTED|Treatment Period (52 Weeks)||1005||
60106776|NCT03730662|76225860|FG000|Received at Least One Dose of Study Drug|Treatment Period (52 Weeks)||329||
59710961|NCT00892177|75829557|FG005|STARTED|Phase II||40||
59710962|NCT00892177|75829552|FG000|COMPLETED|Phase II||0||
59710963|NCT00892177|75829553|FG001|COMPLETED|Phase II||0||
59710964|NCT00892177|75829554|FG002|COMPLETED|Phase II||0||
59710965|NCT00892177|75829555|FG003|COMPLETED|Phase II||0||
59710966|NCT00892177|75829556|FG004|COMPLETED|Phase II||83||
59710967|NCT00892177|75829557|FG005|COMPLETED|Phase II||38||
59710968|NCT00892177|75829552|FG000|NOT COMPLETED|Phase II||0||
59710969|NCT00892177|75829553|FG001|NOT COMPLETED|Phase II||0||
59710970|NCT00892177|75829554|FG002|NOT COMPLETED|Phase II||0||
59710971|NCT00892177|75829555|FG003|NOT COMPLETED|Phase II||0||
59710972|NCT00892177|75829556|FG004|NOT COMPLETED|Phase II||5||
60106777|NCT03730662|76225861|FG001|Received at Least One Dose of Study Drug|Treatment Period (52 Weeks)||328||
60106778|NCT03730662|76225862|FG002|Received at Least One Dose of Study Drug|Treatment Period (52 Weeks)||338||
60106779|NCT03730662|76225863|FG003|Received at Least One Dose of Study Drug|Treatment Period (52 Weeks)||1000||
60106780|NCT03730662|76225860|FG000|COMPLETED|Treatment Period (52 Weeks)||308||
60106781|NCT03730662|76225861|FG001|COMPLETED|Treatment Period (52 Weeks)||319||
60106782|NCT03730662|76225862|FG002|COMPLETED|Treatment Period (52 Weeks)||329||
59710973|NCT00892177|75829557|FG005|NOT COMPLETED|Phase II||2||
59710974|NCT00962104|75829574|FG000|STARTED|Overall Study||195||
59710975|NCT00962104|75829575|FG001|STARTED|Overall Study||196||
59710976|NCT00962104|75829574|FG000|Full Analysis Set|Overall Study|2 participants were excluded because they failed to take the assigned study medication.|193||
59710977|NCT00962104|75829575|FG001|Full Analysis Set|Overall Study|1 participant was excluded because that participant failed to take the assigned study medication.|195||
59710978|NCT00962104|75829574|FG000|COMPLETED|Overall Study||155||
59710979|NCT00962104|75829575|FG001|COMPLETED|Overall Study||171||
59818622|NCT00404547|75940788|FG001|NOT COMPLETED|Overall Study||25||
59818623|NCT00515034|75940798|FG000|STARTED|Overall Study||49||
59566509|NCT04143945|75669120|FG003|COMPLETED|Treatment Period 1 (Day 1)||26||
59566510|NCT04143945|75669117|FG000|NOT COMPLETED|Treatment Period 1 (Day 1)||0||
59566511|NCT04143945|75669118|FG001|NOT COMPLETED|Treatment Period 1 (Day 1)||0||
59566512|NCT04143945|75669119|FG002|NOT COMPLETED|Treatment Period 1 (Day 1)||0||
59566513|NCT04143945|75669120|FG003|NOT COMPLETED|Treatment Period 1 (Day 1)||0||
59566514|NCT04143945|75669117|FG000|STARTED|Treatment Period 2 (Day 1)||26||
59566515|NCT04143945|75669118|FG001|STARTED|Treatment Period 2 (Day 1)||26||
59566516|NCT04143945|75669119|FG002|STARTED|Treatment Period 2 (Day 1)||26||
59566517|NCT04143945|75669120|FG003|STARTED|Treatment Period 2 (Day 1)||26||
59566518|NCT04143945|75669117|FG000|COMPLETED|Treatment Period 2 (Day 1)||26||
59566519|NCT04143945|75669118|FG001|COMPLETED|Treatment Period 2 (Day 1)||26||
59566520|NCT04143945|75669119|FG002|COMPLETED|Treatment Period 2 (Day 1)||26||
59566521|NCT04143945|75669120|FG003|COMPLETED|Treatment Period 2 (Day 1)||26||
59566522|NCT04143945|75669117|FG000|NOT COMPLETED|Treatment Period 2 (Day 1)||0||
59566523|NCT04143945|75669118|FG001|NOT COMPLETED|Treatment Period 2 (Day 1)||0||
59566524|NCT04143945|75669119|FG002|NOT COMPLETED|Treatment Period 2 (Day 1)||0||
59566525|NCT04143945|75669120|FG003|NOT COMPLETED|Treatment Period 2 (Day 1)||0||
59566526|NCT04134429|75669125|FG000|STARTED|Overall Study||20||
59566527|NCT04134429|75669125|FG000|COMPLETED|Overall Study||19||
59566528|NCT04134429|75669125|FG000|NOT COMPLETED|Overall Study||1||
59566529|NCT03920865|75669132|FG000|STARTED|Overall Study||8||
59566530|NCT03920865|75669133|FG001|STARTED|Overall Study||8||
59710980|NCT00962104|75829574|FG000|NOT COMPLETED|Overall Study||40||
59710981|NCT00962104|75829575|FG001|NOT COMPLETED|Overall Study||25||
59710982|NCT02821000|75829581|FG000|STARTED|Overall Study||103||
60106783|NCT03730662|76225863|FG003|COMPLETED|Treatment Period (52 Weeks)||953||
60106784|NCT03730662|76225860|FG000|NOT COMPLETED|Treatment Period (52 Weeks)||21||
60106785|NCT03730662|76225861|FG001|NOT COMPLETED|Treatment Period (52 Weeks)||11||
60106786|NCT03730662|76225862|FG002|NOT COMPLETED|Treatment Period (52 Weeks)||9||
60106787|NCT03730662|76225863|FG003|NOT COMPLETED|Treatment Period (52 Weeks)||52||
60106788|NCT03730662|76225860|FG000|STARTED|Variable Treatment Period||308||
60106789|NCT03730662|76225861|FG001|STARTED|Variable Treatment Period||319||
60106790|NCT03730662|76225862|FG002|STARTED|Variable Treatment Period||329||
60106791|NCT03730662|76225863|FG003|STARTED|Variable Treatment Period||953||
60106792|NCT03730662|76225860|FG000|COMPLETED|Variable Treatment Period||294||
60106793|NCT03730662|76225861|FG001|COMPLETED|Variable Treatment Period||312||
60106794|NCT03730662|76225862|FG002|COMPLETED|Variable Treatment Period||313||
60106795|NCT03730662|76225863|FG003|COMPLETED|Variable Treatment Period||882||
60106796|NCT03730662|76225860|FG000|NOT COMPLETED|Variable Treatment Period||14||
60106797|NCT03730662|76225861|FG001|NOT COMPLETED|Variable Treatment Period||7||
60106798|NCT03730662|76225862|FG002|NOT COMPLETED|Variable Treatment Period||16||
60106799|NCT03730662|76225863|FG003|NOT COMPLETED|Variable Treatment Period||71||
60106800|NCT01509040|76225880|FG000|STARTED|Overall Study||0||
60106801|NCT01509040|76225881|FG001|STARTED|Overall Study||2||
60106802|NCT01509040|76225882|FG002|STARTED|Overall Study||0||
60106803|NCT01509040|76225880|FG000|COMPLETED|Overall Study||0||
60106804|NCT01509040|76225881|FG001|COMPLETED|Overall Study||1||
59566531|NCT03920865|75669134|FG002|STARTED|Overall Study||10||
59710983|NCT02821000|75829581|FG000|Treated|Overall Study||103||
59710984|NCT02821000|75829581|FG000|COMPLETED|Overall Study||0||
59710985|NCT02821000|75829581|FG000|NOT COMPLETED|Overall Study||103||
59710986|NCT00892099|75829588|FG000|STARTED|Overall Study||36||
59710987|NCT00892099|75829589|FG001|STARTED|Overall Study||33||
59710988|NCT00892099|75829590|FG002|STARTED|Overall Study||36||
59710989|NCT00892099|75829588|FG000|COMPLETED|Overall Study||31||
59710990|NCT00892099|75829589|FG001|COMPLETED|Overall Study||32||
59710991|NCT00892099|75829590|FG002|COMPLETED|Overall Study||29||
60106805|NCT01509040|76225882|FG002|COMPLETED|Overall Study||0||
60106806|NCT01509040|76225880|FG000|NOT COMPLETED|Overall Study||0||
60106807|NCT01509040|76225881|FG001|NOT COMPLETED|Overall Study||1||
60106808|NCT01509040|76225882|FG002|NOT COMPLETED|Overall Study||0||
60106809|NCT01470118|76225900|FG000|STARTED|Overall Study||43||
60106810|NCT01470118|76225901|FG001|STARTED|Overall Study||43||
60106811|NCT01470118|76225902|FG002|STARTED|Overall Study||41||
59566532|NCT03920865|75669132|FG000|COMPLETED|Overall Study||8||
59566533|NCT03920865|75669133|FG001|COMPLETED|Overall Study||8||
59566534|NCT03920865|75669134|FG002|COMPLETED|Overall Study||10||
59566535|NCT03920865|75669132|FG000|NOT COMPLETED|Overall Study||0||
59566536|NCT03920865|75669133|FG001|NOT COMPLETED|Overall Study||0||
59566537|NCT03920865|75669134|FG002|NOT COMPLETED|Overall Study||0||
59566538|NCT00556322|75669154|FG000|STARTED|Overall Study||221||
59566539|NCT00556322|75669155|FG001|STARTED|Overall Study||203||
59710992|NCT00892099|75829588|FG000|NOT COMPLETED|Overall Study||5||
59710993|NCT00892099|75829589|FG001|NOT COMPLETED|Overall Study||1||
59710994|NCT00892099|75829590|FG002|NOT COMPLETED|Overall Study||7||
59710995|NCT00960856|75829598|FG000|STARTED|Period I||10||
59710996|NCT00960856|75829599|FG001|STARTED|Period I||9||
59710997|NCT00960856|75829600|FG002|STARTED|Period I||9||
59710998|NCT00960856|75829601|FG003|STARTED|Period I||9||
59710999|NCT00960856|75829598|FG000|COMPLETED|Period I||10||
59711000|NCT00960856|75829599|FG001|COMPLETED|Period I||9||
59711001|NCT00960856|75829600|FG002|COMPLETED|Period I||9||
59711002|NCT00960856|75829601|FG003|COMPLETED|Period I||9||
59711003|NCT00960856|75829598|FG000|NOT COMPLETED|Period I||0||
59711004|NCT00960856|75829599|FG001|NOT COMPLETED|Period I||0||
59711005|NCT00960856|75829600|FG002|NOT COMPLETED|Period I||0||
59711006|NCT00960856|75829601|FG003|NOT COMPLETED|Period I||0||
60106812|NCT01470118|76225900|FG000|COMPLETED|Overall Study||38||
59566540|NCT00556322|75669154|FG000|COMPLETED|Overall Study|Data cutoff was 01 August 2010|0||
59566541|NCT00556322|75669155|FG001|COMPLETED|Overall Study|Data cutoff was 01 August 2010|0||
59566542|NCT00556322|75669154|FG000|NOT COMPLETED|Overall Study||221||
59566543|NCT00556322|75669155|FG001|NOT COMPLETED|Overall Study||203||
59566544|NCT04137627|75669166|FG000|STARTED|Overall Study||25||
59566545|NCT04137627|75669167|FG001|STARTED|Overall Study||25||
59566546|NCT04137627|75669166|FG000|COMPLETED|Overall Study||13||
59566547|NCT04137627|75669167|FG001|COMPLETED|Overall Study||12||
59566548|NCT04137627|75669166|FG000|NOT COMPLETED|Overall Study||12||
60106813|NCT01470118|76225901|FG001|COMPLETED|Overall Study||38||
60106814|NCT01470118|76225902|FG002|COMPLETED|Overall Study||39||
60106815|NCT01470118|76225900|FG000|NOT COMPLETED|Overall Study||5||
60106816|NCT01470118|76225901|FG001|NOT COMPLETED|Overall Study||5||
60106817|NCT01470118|76225902|FG002|NOT COMPLETED|Overall Study||2||
60106818|NCT01470196|76225910|FG000|STARTED|Overall Study||31||
60106819|NCT01470196|76225910|FG000|COMPLETED|Overall Study||31||
60106820|NCT01470196|76225910|FG000|NOT COMPLETED|Overall Study||0||
60106821|NCT01565356|76225914|FG000|STARTED|Overall Study||41||
60106822|NCT01565356|76225914|FG000|COMPLETED|Overall Study||41||
60106823|NCT01565356|76225914|FG000|NOT COMPLETED|Overall Study||0||
60106824|NCT01510834|76225918|FG000|STARTED|Overall Study||90||
60106825|NCT01510834|76225918|FG000|COMPLETED|Overall Study||57||
60106826|NCT01510834|76225918|FG000|NOT COMPLETED|Overall Study||33||
60106827|NCT01565902|76225929|FG000|STARTED|Overall Study||8||
60106828|NCT01565902|76225930|FG001|STARTED|Overall Study||8||
60106829|NCT01565902|76225931|FG002|STARTED|Overall Study||8||
60106830|NCT01565902|76225932|FG003|STARTED|Overall Study||16||
60106831|NCT01565902|76225929|FG000|COMPLETED|Overall Study||8||
60106832|NCT01565902|76225930|FG001|COMPLETED|Overall Study||8||
60106833|NCT01565902|76225931|FG002|COMPLETED|Overall Study||8||
60106834|NCT01565902|76225932|FG003|COMPLETED|Overall Study||16||
60106835|NCT01565902|76225929|FG000|NOT COMPLETED|Overall Study||0||
60106836|NCT01565902|76225930|FG001|NOT COMPLETED|Overall Study||0||
60106837|NCT01565902|76225931|FG002|NOT COMPLETED|Overall Study||0||
60106838|NCT01565902|76225932|FG003|NOT COMPLETED|Overall Study||0||
60106839|NCT01566448|76225945|FG000|STARTED|Overall Study||30||
60106840|NCT01566448|76225945|FG000|COMPLETED|Overall Study||30||
59566549|NCT04137627|75669167|FG001|NOT COMPLETED|Overall Study||13||
59566550|NCT00556166|75669173|FG000|STARTED|Overall Study||4||
59566551|NCT00556166|75669173|FG000|COMPLETED|Overall Study||3||
59711007|NCT00960856|75829598|FG000|STARTED|Washout Period of 7 Days||10||
59711008|NCT00960856|75829599|FG001|STARTED|Washout Period of 7 Days||9||
59711009|NCT00960856|75829600|FG002|STARTED|Washout Period of 7 Days||9||
59711010|NCT00960856|75829601|FG003|STARTED|Washout Period of 7 Days||9||
59711011|NCT00960856|75829598|FG000|COMPLETED|Washout Period of 7 Days||10||
59566552|NCT00556166|75669173|FG000|NOT COMPLETED|Overall Study||1||
59566553|NCT01869374|75669179|FG000|STARTED|Overall Study||9||
59566554|NCT01869374|75669180|FG001|STARTED|Overall Study||9||
59566555|NCT01869374|75669179|FG000|COMPLETED|Overall Study||9||
59566556|NCT01869374|75669180|FG001|COMPLETED|Overall Study||8||
60106841|NCT01566448|76225945|FG000|NOT COMPLETED|Overall Study||0||
59711012|NCT00960856|75829599|FG001|COMPLETED|Washout Period of 7 Days|personal reasons|7||
59711013|NCT00960856|75829600|FG002|COMPLETED|Washout Period of 7 Days||9||
59711014|NCT00960856|75829601|FG003|COMPLETED|Washout Period of 7 Days||9||
59711015|NCT00960856|75829598|FG000|NOT COMPLETED|Washout Period of 7 Days||0||
60106842|NCT01566526|76225949|FG000|STARTED|Overall Study||26||
59711016|NCT00960856|75829599|FG001|NOT COMPLETED|Washout Period of 7 Days||2||
60106843|NCT01566526|76225949|FG000|COMPLETED|Overall Study||26||
60106844|NCT01566526|76225949|FG000|NOT COMPLETED|Overall Study||0||
60106845|NCT01566682|76225953|FG000|STARTED|Overall Study||420||
60106846|NCT01566682|76225953|FG000|COMPLETED|Overall Study||374||
60106847|NCT01566682|76225953|FG000|NOT COMPLETED|Overall Study||46||
60106848|NCT03185832|76225961|FG000|STARTED|Overall Study||69||
60106849|NCT03185832|76225962|FG001|STARTED|Overall Study||102||
60106850|NCT03185832|76225963|FG002|STARTED|Overall Study||68||
60106851|NCT03185832|76225964|FG003|STARTED|Overall Study||115||
60106852|NCT03185832|76225961|FG000|COMPLETED|Overall Study||60||
60106853|NCT03185832|76225962|FG001|COMPLETED|Overall Study||87||
60106854|NCT03185832|76225963|FG002|COMPLETED|Overall Study||58||
60106855|NCT03185832|76225964|FG003|COMPLETED|Overall Study||104||
60106856|NCT03185832|76225961|FG000|NOT COMPLETED|Overall Study||9||
60106857|NCT03185832|76225962|FG001|NOT COMPLETED|Overall Study||15||
60106858|NCT03185832|76225963|FG002|NOT COMPLETED|Overall Study||10||
60106859|NCT03185832|76225964|FG003|NOT COMPLETED|Overall Study||11||
60106860|NCT01566838|76225974|FG000|STARTED|Overall Study||41||
60106861|NCT01566838|76225975|FG001|STARTED|Overall Study||42||
60106862|NCT01566838|76225974|FG000|COMPLETED|Overall Study||38||
60106863|NCT01566838|76225975|FG001|COMPLETED|Overall Study||42||
60106864|NCT01566838|76225974|FG000|NOT COMPLETED|Overall Study||3||
60106865|NCT01566838|76225975|FG001|NOT COMPLETED|Overall Study||0||
60106866|NCT01567150|76225983|FG000|STARTED|Overall Study||21||
60106867|NCT01567150|76225984|FG001|STARTED|Overall Study||18||
60106868|NCT01567150|76225983|FG000|COMPLETED|Overall Study||19||
60106869|NCT01567150|76225984|FG001|COMPLETED|Overall Study||16||
60106870|NCT01567150|76225983|FG000|NOT COMPLETED|Overall Study||2||
60106871|NCT01567150|76225984|FG001|NOT COMPLETED|Overall Study||2||
60106872|NCT01568008|76225990|FG000|STARTED|Overall Study||933||
60106873|NCT01568008|76225990|FG000|COMPLETED|Overall Study||699||
60106874|NCT01568008|76225990|FG000|NOT COMPLETED|Overall Study||234||
60106875|NCT01514734|76225994|FG000|STARTED|Overall Study||9||
60106876|NCT01514734|76225994|FG000|COMPLETED|Overall Study||9||
60106877|NCT01514734|76225994|FG000|NOT COMPLETED|Overall Study||0||
60106878|NCT01515046|76225998|FG000|STARTED|Overall Study||1||
60106879|NCT01515046|76225998|FG000|COMPLETED|Overall Study||1||
60106880|NCT01515046|76225998|FG000|NOT COMPLETED|Overall Study||0||
60106881|NCT01568944|76226004|FG000|STARTED|Overall Study||8||
60106882|NCT01568944|76226005|FG001|STARTED|Overall Study||10||
60106883|NCT01568944|76226004|FG000|COMPLETED|Overall Study||8||
60106884|NCT01568944|76226005|FG001|COMPLETED|Overall Study||10||
60106885|NCT01568944|76226004|FG000|NOT COMPLETED|Overall Study||0||
60106886|NCT01568944|76226005|FG001|NOT COMPLETED|Overall Study||0||
60106887|NCT04569786|76226016|FG000|STARTED|Overall Study||39||
60106888|NCT04569786|76226017|FG001|STARTED|Overall Study||39||
60106889|NCT04569786|76226018|FG002|STARTED|Overall Study||42||
60106890|NCT04569786|76226019|FG003|STARTED|Overall Study||56||
60106891|NCT04569786|76226020|FG004|STARTED|Overall Study||56||
60106892|NCT04569786|76226016|FG000|COMPLETED|Overall Study||38||
59711017|NCT00960856|75829600|FG002|NOT COMPLETED|Washout Period of 7 Days||0||
59818624|NCT00515034|75940799|FG001|STARTED|Overall Study||15||
60106893|NCT04569786|76226017|FG001|COMPLETED|Overall Study||39||
60106894|NCT04569786|76226018|FG002|COMPLETED|Overall Study||38||
60106895|NCT04569786|76226019|FG003|COMPLETED|Overall Study||49||
59711018|NCT00960856|75829601|FG003|NOT COMPLETED|Washout Period of 7 Days||0||
59818625|NCT00515034|75940800|FG002|STARTED|Overall Study||62||
59818626|NCT00515034|75940801|FG003|STARTED|Overall Study||20||
60106896|NCT04569786|76226020|FG004|COMPLETED|Overall Study||55||
60106897|NCT04569786|76226016|FG000|NOT COMPLETED|Overall Study||1||
60106898|NCT04569786|76226017|FG001|NOT COMPLETED|Overall Study||0||
60106899|NCT04569786|76226018|FG002|NOT COMPLETED|Overall Study||4||
60106900|NCT04569786|76226019|FG003|NOT COMPLETED|Overall Study||7||
60106901|NCT04569786|76226020|FG004|NOT COMPLETED|Overall Study||1||
60106902|NCT01570036|76226034|FG000|STARTED|Overall Study||136||
60106903|NCT01570036|76226035|FG001|STARTED|Overall Study||139||
60106904|NCT01570036|76226034|FG000|Primary Vaccine Series Completed|Overall Study||121||
60106905|NCT01570036|76226035|FG001|Primary Vaccine Series Completed|Overall Study||132||
60106906|NCT01570036|76226034|FG000|Booster Series Completed|Overall Study||40||
60106907|NCT01570036|76226035|FG001|Booster Series Completed|Overall Study||30||
60106908|NCT01570036|76226034|FG000|COMPLETED|Overall Study||18||
60106909|NCT01570036|76226035|FG001|COMPLETED|Overall Study||17||
60106910|NCT01570036|76226034|FG000|NOT COMPLETED|Overall Study||118||
60106911|NCT01570036|76226035|FG001|NOT COMPLETED|Overall Study||122||
60106912|NCT01516684|76226043|FG000|STARTED|Overall Study|"Overall number of units (trials) was used for measuring results with 170 trials.~Trials were randomized for each arm, not participants"|||85
60106913|NCT01516684|76226044|FG001|STARTED|Overall Study|"Overall number of units (trials) was used for measuring results with 170 trials.~Trials were randomized for each arm, not participants"|||85
60106914|NCT01516684|76226043|FG000|COMPLETED|Overall Study|Trials were randomized for each arm, not participants||Overall number of units (trials) completed was 152|75
60106915|NCT01516684|76226044|FG001|COMPLETED|Overall Study|"Overall number of units (trials) completed was 152~Trials were randomized for each arm, not participants"||Overall number of units (trials) completed was 152|77
60106916|NCT01516684|76226043|FG000|NOT COMPLETED|Overall Study||||10
60106917|NCT01516684|76226044|FG001|NOT COMPLETED|Overall Study||||8
60106918|NCT01517074|76226052|FG000|STARTED|Overall Study||5||
60106919|NCT01517074|76226052|FG000|COMPLETED|Overall Study||5||
60106920|NCT01517074|76226052|FG000|NOT COMPLETED|Overall Study||0||
60106921|NCT01570348|76226061|FG000|STARTED|Overall Study||2||
60106922|NCT01570348|76226061|FG000|COMPLETED|Overall Study||2||
60106923|NCT01570348|76226061|FG000|NOT COMPLETED|Overall Study||0||
60106924|NCT01572298|76226067|FG000|STARTED|Overall Study||14||
60106925|NCT01572298|76226068|FG001|STARTED|Overall Study||13||
60106926|NCT01572298|76226067|FG000|COMPLETED|Overall Study||12||
60106927|NCT01572298|76226068|FG001|COMPLETED|Overall Study||12||
60106928|NCT01572298|76226067|FG000|NOT COMPLETED|Overall Study||2||
60106929|NCT01572298|76226068|FG001|NOT COMPLETED|Overall Study||1||
60106930|NCT01518868|76226076|FG000|STARTED|Overall Study||63||
60106931|NCT01518868|76226077|FG001|STARTED|Overall Study||63||
60106932|NCT01518868|76226076|FG000|COMPLETED|Overall Study||59||
60106933|NCT01518868|76226077|FG001|COMPLETED|Overall Study||59||
60106934|NCT01518868|76226076|FG000|NOT COMPLETED|Overall Study||4||
60106935|NCT01518868|76226077|FG001|NOT COMPLETED|Overall Study||4||
60106936|NCT01573702|76226083|FG000|STARTED|Overall Study||25||
60106937|NCT01573702|76226083|FG000|COMPLETED|Overall Study||25||
60106938|NCT01573702|76226083|FG000|NOT COMPLETED|Overall Study||0||
60106939|NCT03093246|76226090|FG000|STARTED|Overall Study||19||
59711019|NCT00960856|75829598|FG000|STARTED|Period II||10||
60106940|NCT03093246|76226091|FG001|STARTED|Overall Study||19||
60106941|NCT03093246|76226090|FG000|COMPLETED|Overall Study||19||
60106942|NCT03093246|76226091|FG001|COMPLETED|Overall Study||19||
60106943|NCT03093246|76226090|FG000|NOT COMPLETED|Overall Study||0||
60106944|NCT03093246|76226091|FG001|NOT COMPLETED|Overall Study||0||
59818627|NCT00515034|75940798|FG000|TREATED|Overall Study||48||
60106945|NCT02969928|76226099|FG000|STARTED|Overall Study||23||
60106946|NCT02969928|76226100|FG001|STARTED|Overall Study||23||
60106947|NCT02969928|76226099|FG000|COMPLETED|Overall Study||23||
60106948|NCT02969928|76226100|FG001|COMPLETED|Overall Study||23||
60106949|NCT02969928|76226099|FG000|NOT COMPLETED|Overall Study||0||
60106950|NCT02969928|76226100|FG001|NOT COMPLETED|Overall Study||0||
60106951|NCT01519414|76226108|FG000|STARTED|Pre Cross-over||52||
60106952|NCT01519414|76226109|FG001|STARTED|Pre Cross-over||26||
60106953|NCT01519414|76226110|FG002|STARTED|Pre Cross-over||0||
60106954|NCT01519414|76226108|FG000|COMPLETED|Pre Cross-over||52||
60106955|NCT01519414|76226109|FG001|COMPLETED|Pre Cross-over||26||
60106956|NCT01519414|76226110|FG002|COMPLETED|Pre Cross-over||0||
60106957|NCT01519414|76226108|FG000|NOT COMPLETED|Pre Cross-over||0||
60106958|NCT01519414|76226109|FG001|NOT COMPLETED|Pre Cross-over||0||
59711020|NCT00960856|75829599|FG001|STARTED|Period II||7||
59711021|NCT00960856|75829600|FG002|STARTED|Period II||9||
59711022|NCT00960856|75829601|FG003|STARTED|Period II||9||
59711023|NCT00960856|75829598|FG000|COMPLETED|Period II||10||
59711024|NCT00960856|75829599|FG001|COMPLETED|Period II||7||
59711025|NCT00960856|75829600|FG002|COMPLETED|Period II||9||
59711026|NCT00960856|75829601|FG003|COMPLETED|Period II||9||
59711027|NCT00960856|75829598|FG000|NOT COMPLETED|Period II||0||
59711028|NCT00960856|75829599|FG001|NOT COMPLETED|Period II||0||
60106959|NCT01519414|76226110|FG002|NOT COMPLETED|Pre Cross-over||0||
60106960|NCT01519414|76226108|FG000|STARTED|Post Cross-over||52||
59711029|NCT00960856|75829600|FG002|NOT COMPLETED|Period II||0||
59711030|NCT00960856|75829601|FG003|NOT COMPLETED|Period II||0||
59711031|NCT00960856|75829598|FG000|STARTED|Washout Period of 7 Days||10||
59711032|NCT00960856|75829599|FG001|STARTED|Washout Period of 7 Days||7||
59711033|NCT00960856|75829600|FG002|STARTED|Washout Period of 7 Days||9||
59818628|NCT00515034|75940799|FG001|TREATED|Overall Study||15||
59818629|NCT00515034|75940800|FG002|TREATED|Overall Study||61||
59818630|NCT00515034|75940801|FG003|TREATED|Overall Study||19||
59818631|NCT00515034|75940798|FG000|COMPLETED|Overall Study||41||
59818632|NCT00515034|75940799|FG001|COMPLETED|Overall Study||13||
59818633|NCT00515034|75940800|FG002|COMPLETED|Overall Study||54||
59818634|NCT00515034|75940801|FG003|COMPLETED|Overall Study||15||
59818635|NCT00515034|75940798|FG000|NOT COMPLETED|Overall Study||8||
59818636|NCT00515034|75940799|FG001|NOT COMPLETED|Overall Study||2||
59818637|NCT00515034|75940800|FG002|NOT COMPLETED|Overall Study||8||
59818638|NCT00515034|75940801|FG003|NOT COMPLETED|Overall Study||5||
59818639|NCT00404235|75940813|FG000|STARTED|Overall Study||35||
59818640|NCT00404235|75940814|FG001|STARTED|Overall Study||41||
59818641|NCT00404235|75940813|FG000|COMPLETED|Overall Study||34||
59818642|NCT00404235|75940814|FG001|COMPLETED|Overall Study||39||
59818643|NCT00404235|75940813|FG000|NOT COMPLETED|Overall Study||1||
59818644|NCT00404235|75940814|FG001|NOT COMPLETED|Overall Study||2||
59818645|NCT00404079|75940822|FG000|STARTED|Overall Study||125||
59818646|NCT00404079|75940823|FG001|STARTED|Overall Study||125||
59818647|NCT00404079|75940822|FG000|COMPLETED|Overall Study||103||
60106961|NCT01519414|76226109|FG001|STARTED|Post Cross-over||14||
60106962|NCT01519414|76226110|FG002|STARTED|Post Cross-over||12||
60106963|NCT01519414|76226108|FG000|COMPLETED|Post Cross-over||52||
59711034|NCT00960856|75829601|FG003|STARTED|Washout Period of 7 Days||9||
59711035|NCT00960856|75829598|FG000|COMPLETED|Washout Period of 7 Days||10||
59818648|NCT00404079|75940823|FG001|COMPLETED|Overall Study||105||
59818649|NCT00404079|75940822|FG000|NOT COMPLETED|Overall Study||22||
59818650|NCT00404079|75940823|FG001|NOT COMPLETED|Overall Study||20||
59818651|NCT00403845|75940829|FG000|STARTED|Treatment Period 1||12||
59818652|NCT00403845|75940830|FG001|STARTED|Treatment Period 1||13||
59818653|NCT00403845|75940831|FG002|STARTED|Treatment Period 1||11||
59818654|NCT00403845|75940832|FG003|STARTED|Treatment Period 1||14||
59711036|NCT00960856|75829599|FG001|COMPLETED|Washout Period of 7 Days||7||
59818655|NCT00403845|75940829|FG000|COMPLETED|Treatment Period 1||11||
59818656|NCT00403845|75940830|FG001|COMPLETED|Treatment Period 1||13||
59818657|NCT00403845|75940831|FG002|COMPLETED|Treatment Period 1||11||
59818658|NCT00403845|75940832|FG003|COMPLETED|Treatment Period 1||13||
59818659|NCT00403845|75940829|FG000|NOT COMPLETED|Treatment Period 1||1||
59818660|NCT00403845|75940830|FG001|NOT COMPLETED|Treatment Period 1||0||
59818661|NCT00403845|75940831|FG002|NOT COMPLETED|Treatment Period 1||0||
59818662|NCT00403845|75940832|FG003|NOT COMPLETED|Treatment Period 1||1||
59818663|NCT00403845|75940829|FG000|STARTED|Treatment Period 2||11||
59818664|NCT00403845|75940830|FG001|STARTED|Treatment Period 2||13||
59818665|NCT00403845|75940831|FG002|STARTED|Treatment Period 2||11||
59818666|NCT00403845|75940832|FG003|STARTED|Treatment Period 2||13||
59711037|NCT00960856|75829600|FG002|COMPLETED|Washout Period of 7 Days||9||
59711038|NCT00960856|75829601|FG003|COMPLETED|Washout Period of 7 Days||9||
59818667|NCT00403845|75940829|FG000|COMPLETED|Treatment Period 2||10||
59818668|NCT00403845|75940830|FG001|COMPLETED|Treatment Period 2||13||
59818669|NCT00403845|75940831|FG002|COMPLETED|Treatment Period 2||11||
59818670|NCT00403845|75940832|FG003|COMPLETED|Treatment Period 2||13||
59818671|NCT00403845|75940829|FG000|NOT COMPLETED|Treatment Period 2||1||
59818672|NCT00403845|75940830|FG001|NOT COMPLETED|Treatment Period 2||0||
60106964|NCT01519414|76226109|FG001|COMPLETED|Post Cross-over||14||
60106965|NCT01519414|76226110|FG002|COMPLETED|Post Cross-over||12||
60106966|NCT01519414|76226108|FG000|NOT COMPLETED|Post Cross-over||0||
60106967|NCT01519414|76226109|FG001|NOT COMPLETED|Post Cross-over||0||
59566557|NCT01869374|75669179|FG000|NOT COMPLETED|Overall Study||0||
59566558|NCT01869374|75669180|FG001|NOT COMPLETED|Overall Study||1||
59711039|NCT00960856|75829598|FG000|NOT COMPLETED|Washout Period of 7 Days||0||
59711040|NCT00960856|75829599|FG001|NOT COMPLETED|Washout Period of 7 Days||0||
59711041|NCT00960856|75829600|FG002|NOT COMPLETED|Washout Period of 7 Days||0||
59711042|NCT00960856|75829601|FG003|NOT COMPLETED|Washout Period of 7 Days||0||
59711043|NCT00960856|75829598|FG000|STARTED|Period III||10||
59711044|NCT00960856|75829599|FG001|STARTED|Period III||7||
59711045|NCT00960856|75829600|FG002|STARTED|Period III||9||
59711046|NCT00960856|75829601|FG003|STARTED|Period III||9||
59818673|NCT00403845|75940831|FG002|NOT COMPLETED|Treatment Period 2||0||
59818674|NCT00403845|75940832|FG003|NOT COMPLETED|Treatment Period 2||0||
59818675|NCT00403845|75940829|FG000|STARTED|Treatment Period 3||10||
59818676|NCT00403845|75940830|FG001|STARTED|Treatment Period 3||13||
59818677|NCT00403845|75940831|FG002|STARTED|Treatment Period 3||11||
59818678|NCT00403845|75940832|FG003|STARTED|Treatment Period 3||13||
59818679|NCT00403845|75940829|FG000|COMPLETED|Treatment Period 3||10||
60106968|NCT01519414|76226110|FG002|NOT COMPLETED|Post Cross-over||0||
60106969|NCT01519570|76226123|FG000|STARTED|Overall Study||500||
60106970|NCT01519570|76226124|FG001|STARTED|Overall Study||2089||
60106971|NCT01519570|76226123|FG000|COMPLETED|Overall Study||500||
60106972|NCT01519570|76226124|FG001|COMPLETED|Overall Study||2089||
60106973|NCT01519570|76226123|FG000|NOT COMPLETED|Overall Study||0||
60106974|NCT01519570|76226124|FG001|NOT COMPLETED|Overall Study||0||
60106975|NCT01519648|76226132|FG000|STARTED|Overall Study||502||
60106976|NCT01519648|76226133|FG001|STARTED|Overall Study||306||
60106977|NCT01519648|76226132|FG000|COMPLETED|Overall Study||502||
60106978|NCT01519648|76226133|FG001|COMPLETED|Overall Study||306||
60106979|NCT01519648|76226132|FG000|NOT COMPLETED|Overall Study||0||
60106980|NCT01519648|76226133|FG001|NOT COMPLETED|Overall Study||0||
60106981|NCT01575106|76226139|FG000|STARTED|Overall Study||38||
60106982|NCT01575106|76226139|FG000|COMPLETED|Overall Study||24||
60106983|NCT01575106|76226139|FG000|NOT COMPLETED|Overall Study||14||
60106984|NCT01519882|76226146|FG000|STARTED|Overall Study||1||
59566559|NCT04136145|75669188|FG000|STARTED|Overall Study||12||
59566560|NCT04136145|75669189|FG001|STARTED|Overall Study||24||
59566561|NCT04136145|75669188|FG000|COMPLETED|Overall Study||12||
59566562|NCT04136145|75669189|FG001|COMPLETED|Overall Study||24||
59566563|NCT04136145|75669188|FG000|NOT COMPLETED|Overall Study||0||
59566564|NCT04136145|75669189|FG001|NOT COMPLETED|Overall Study||0||
59566565|NCT01869686|75669196|FG000|STARTED|Overall Study||12||
59711047|NCT00960856|75829598|FG000|COMPLETED|Period III||10||
59818680|NCT00403845|75940830|FG001|COMPLETED|Treatment Period 3||13||
59818681|NCT00403845|75940831|FG002|COMPLETED|Treatment Period 3||11||
59566566|NCT01869686|75669196|FG000|COMPLETED|Overall Study||12||
59566567|NCT01869686|75669196|FG000|NOT COMPLETED|Overall Study||0||
59818682|NCT00403845|75940832|FG003|COMPLETED|Treatment Period 3||11||
59818683|NCT00403845|75940829|FG000|NOT COMPLETED|Treatment Period 3||0||
60106985|NCT01519882|76226147|FG001|STARTED|Overall Study||0||
60106986|NCT01519882|76226146|FG000|COMPLETED|Overall Study||1||
59711048|NCT00960856|75829599|FG001|COMPLETED|Period III||7||
59711049|NCT00960856|75829600|FG002|COMPLETED|Period III||9||
59711050|NCT00960856|75829601|FG003|COMPLETED|Period III||9||
59711051|NCT00960856|75829598|FG000|NOT COMPLETED|Period III||0||
59711052|NCT00960856|75829599|FG001|NOT COMPLETED|Period III||0||
59711053|NCT00960856|75829600|FG002|NOT COMPLETED|Period III||0||
59818684|NCT00403845|75940830|FG001|NOT COMPLETED|Treatment Period 3||0||
59818685|NCT00403845|75940831|FG002|NOT COMPLETED|Treatment Period 3||0||
59818686|NCT00403845|75940832|FG003|NOT COMPLETED|Treatment Period 3||2||
59818687|NCT00403845|75940829|FG000|STARTED|Treatment Period 4||10||
59818688|NCT00403845|75940830|FG001|STARTED|Treatment Period 4||13||
59818689|NCT00403845|75940831|FG002|STARTED|Treatment Period 4||11||
59818690|NCT00403845|75940832|FG003|STARTED|Treatment Period 4||11||
59818691|NCT00403845|75940829|FG000|COMPLETED|Treatment Period 4||10||
59818692|NCT00403845|75940830|FG001|COMPLETED|Treatment Period 4||13||
59818693|NCT00403845|75940831|FG002|COMPLETED|Treatment Period 4||11||
59818694|NCT00403845|75940832|FG003|COMPLETED|Treatment Period 4||11||
59818695|NCT00403845|75940829|FG000|NOT COMPLETED|Treatment Period 4||0||
59818696|NCT00403845|75940830|FG001|NOT COMPLETED|Treatment Period 4||0||
59818697|NCT00403845|75940831|FG002|NOT COMPLETED|Treatment Period 4||0||
59818698|NCT00403845|75940832|FG003|NOT COMPLETED|Treatment Period 4||0||
59818699|NCT00509262|75940844|FG000|STARTED|Overall Study||211||
59818700|NCT00509262|75940845|FG001|STARTED|Overall Study||212||
59818701|NCT00509262|75940844|FG000|COMPLETED|Overall Study||164||
59818702|NCT00509262|75940845|FG001|COMPLETED|Overall Study||170||
59818703|NCT00509262|75940844|FG000|NOT COMPLETED|Overall Study||47||
59818704|NCT00509262|75940845|FG001|NOT COMPLETED|Overall Study||42||
59818705|NCT00607997|75940855|FG000|STARTED|Overall Study||29||
59818706|NCT00607997|75940856|FG001|STARTED|Overall Study||35||
59818707|NCT00607997|75940857|FG002|STARTED|Overall Study||29||
59818708|NCT00607997|75940858|FG003|STARTED|Overall Study||20||
59818709|NCT00607997|75940855|FG000|COMPLETED|Overall Study||2||
59818710|NCT00607997|75940856|FG001|COMPLETED|Overall Study||8||
59818711|NCT00607997|75940857|FG002|COMPLETED|Overall Study||5||
59818712|NCT00607997|75940858|FG003|COMPLETED|Overall Study||4||
59818713|NCT00607997|75940855|FG000|NOT COMPLETED|Overall Study||27||
59818714|NCT00607997|75940856|FG001|NOT COMPLETED|Overall Study||27||
59818715|NCT00607997|75940857|FG002|NOT COMPLETED|Overall Study||24||
59818716|NCT00607997|75940858|FG003|NOT COMPLETED|Overall Study||16||
59818717|NCT00509106|75940875|FG000|STARTED|Overall Study||315||
59818718|NCT00509106|75940876|FG001|STARTED|Overall Study||307||
59818719|NCT00509106|75940875|FG000|COMPLETED|Overall Study||284||
59818720|NCT00509106|75940876|FG001|COMPLETED|Overall Study||278||
59818721|NCT00509106|75940875|FG000|NOT COMPLETED|Overall Study||31||
59818722|NCT00509106|75940876|FG001|NOT COMPLETED|Overall Study||29||
59818723|NCT00607919|75940884|FG000|STARTED|Acute Phase||120||
59818724|NCT00607919|75940885|FG001|STARTED|Acute Phase||89||
59818725|NCT00607919|75940884|FG000|COMPLETED|Acute Phase|2 participants completed acute phase but did not continue into open-label.|86||
59818726|NCT00607919|75940885|FG001|COMPLETED|Acute Phase|2 participants completed acute phase but did not continue into open-label.|73||
59818727|NCT00607919|75940884|FG000|NOT COMPLETED|Acute Phase||34||
59818728|NCT00607919|75940885|FG001|NOT COMPLETED|Acute Phase||16||
59711054|NCT00960856|75829601|FG003|NOT COMPLETED|Period III||0||
59711055|NCT00960856|75829598|FG000|STARTED|Washout Period of 7 Days||10||
59711056|NCT00960856|75829599|FG001|STARTED|Washout Period of 7 Days||7||
59711057|NCT00960856|75829600|FG002|STARTED|Washout Period of 7 Days||9||
59711058|NCT00960856|75829601|FG003|STARTED|Washout Period of 7 Days||9||
59711059|NCT00960856|75829598|FG000|COMPLETED|Washout Period of 7 Days||10||
59711060|NCT00960856|75829599|FG001|COMPLETED|Washout Period of 7 Days||7||
59711061|NCT00960856|75829600|FG002|COMPLETED|Washout Period of 7 Days||8||
59711062|NCT00960856|75829601|FG003|COMPLETED|Washout Period of 7 Days||9||
59818729|NCT00607919|75940884|FG000|STARTED|Open-Label Phase||84||
59818730|NCT00607919|75940885|FG001|STARTED|Open-Label Phase||71||
59818731|NCT00607919|75940884|FG000|COMPLETED|Open-Label Phase||74||
60106987|NCT01519882|76226147|FG001|COMPLETED|Overall Study||0||
60106988|NCT01519882|76226146|FG000|NOT COMPLETED|Overall Study||0||
60106989|NCT01519882|76226147|FG001|NOT COMPLETED|Overall Study||0||
59711063|NCT00960856|75829598|FG000|NOT COMPLETED|Washout Period of 7 Days||0||
59711064|NCT00960856|75829599|FG001|NOT COMPLETED|Washout Period of 7 Days||0||
59711065|NCT00960856|75829600|FG002|NOT COMPLETED|Washout Period of 7 Days||1||
59818732|NCT00607919|75940885|FG001|COMPLETED|Open-Label Phase||59||
59818733|NCT00607919|75940884|FG000|NOT COMPLETED|Open-Label Phase||10||
59818734|NCT00607919|75940885|FG001|NOT COMPLETED|Open-Label Phase||12||
59818735|NCT00344968|75940896|FG000|STARTED|Overall Study||185||
59818736|NCT00344968|75940897|FG001|STARTED|Overall Study||376||
59818737|NCT00344968|75940898|FG002|STARTED|Overall Study||395||
59818738|NCT00344968|75940896|FG000|COMPLETED|Overall Study||126||
59818739|NCT00344968|75940897|FG001|COMPLETED|Overall Study||274||
59818740|NCT00344968|75940898|FG002|COMPLETED|Overall Study||279||
59818741|NCT00344968|75940896|FG000|NOT COMPLETED|Overall Study||59||
60106990|NCT01576120|76226155|FG000|STARTED|Overall Study||21||
60106991|NCT01576120|76226156|FG001|STARTED|Overall Study||19||
60106992|NCT01576120|76226155|FG000|COMPLETED|Overall Study||21||
60106993|NCT01576120|76226156|FG001|COMPLETED|Overall Study||19||
59711066|NCT00960856|75829601|FG003|NOT COMPLETED|Washout Period of 7 Days||0||
59711067|NCT00960856|75829598|FG000|STARTED|Period IV||10||
59711068|NCT00960856|75829599|FG001|STARTED|Period IV||7||
59711069|NCT00960856|75829600|FG002|STARTED|Period IV||8||
59711070|NCT00960856|75829601|FG003|STARTED|Period IV||9||
59711071|NCT00960856|75829598|FG000|COMPLETED|Period IV||10||
59711072|NCT00960856|75829599|FG001|COMPLETED|Period IV||7||
59711073|NCT00960856|75829600|FG002|COMPLETED|Period IV||8||
59711074|NCT00960856|75829601|FG003|COMPLETED|Period IV||9||
59818742|NCT00344968|75940897|FG001|NOT COMPLETED|Overall Study||102||
59818743|NCT00344968|75940898|FG002|NOT COMPLETED|Overall Study||116||
59818744|NCT00509028|75940909|FG000|STARTED|Overall Study||121||
59818745|NCT00509028|75940910|FG001|STARTED|Overall Study||120||
59818746|NCT00509028|75940909|FG000|COMPLETED|Overall Study||109||
59818747|NCT00509028|75940910|FG001|COMPLETED|Overall Study||113||
59818748|NCT00509028|75940909|FG000|NOT COMPLETED|Overall Study||12||
59818749|NCT00509028|75940910|FG001|NOT COMPLETED|Overall Study||7||
59818750|NCT00352846|75940918|FG000|STARTED|Overall Study||37||
59818751|NCT00352846|75940919|FG001|STARTED|Overall Study||37||
59818752|NCT00352846|75940918|FG000|COMPLETED|Overall Study||29||
59818753|NCT00352846|75940919|FG001|COMPLETED|Overall Study||24||
59818754|NCT00352846|75940918|FG000|NOT COMPLETED|Overall Study||8||
59818755|NCT00352846|75940919|FG001|NOT COMPLETED|Overall Study||13||
59818756|NCT00508872|75940925|FG000|STARTED|Overall Study||2||
59818757|NCT00508872|75940925|FG000|COMPLETED|Overall Study||0||
59818758|NCT00508872|75940925|FG000|NOT COMPLETED|Overall Study||2||
59818759|NCT00508482|75940932|FG000|STARTED|Over 4 Weeks of Treatment||237||
59818760|NCT00508482|75940933|FG001|STARTED|Over 4 Weeks of Treatment||119||
59818761|NCT00508482|75940934|FG002|STARTED|Over 4 Weeks of Treatment||119||
59818762|NCT00508482|75940932|FG000|COMPLETED|Over 4 Weeks of Treatment||216||
59818763|NCT00508482|75940933|FG001|COMPLETED|Over 4 Weeks of Treatment||102||
59818764|NCT00508482|75940934|FG002|COMPLETED|Over 4 Weeks of Treatment||99||
59818765|NCT00508482|75940932|FG000|NOT COMPLETED|Over 4 Weeks of Treatment||21||
59818766|NCT00508482|75940933|FG001|NOT COMPLETED|Over 4 Weeks of Treatment||17||
59818767|NCT00508482|75940934|FG002|NOT COMPLETED|Over 4 Weeks of Treatment||20||
59818768|NCT00508482|75940932|FG000|STARTED|at the 4th Week of Follow-up||216||
59818769|NCT00508482|75940933|FG001|STARTED|at the 4th Week of Follow-up||102||
59818770|NCT00508482|75940934|FG002|STARTED|at the 4th Week of Follow-up||99||
59818771|NCT00508482|75940932|FG000|COMPLETED|at the 4th Week of Follow-up||196||
59818772|NCT00508482|75940933|FG001|COMPLETED|at the 4th Week of Follow-up||96||
59818773|NCT00508482|75940934|FG002|COMPLETED|at the 4th Week of Follow-up||98||
59818774|NCT00508482|75940932|FG000|NOT COMPLETED|at the 4th Week of Follow-up||20||
59818775|NCT00508482|75940933|FG001|NOT COMPLETED|at the 4th Week of Follow-up||6||
59818776|NCT00508482|75940934|FG002|NOT COMPLETED|at the 4th Week of Follow-up||1||
59818777|NCT00508482|75940932|FG000|STARTED|at the 12th Week of Follow-up||196||
59818778|NCT00508482|75940933|FG001|STARTED|at the 12th Week of Follow-up||96||
59818779|NCT00508482|75940934|FG002|STARTED|at the 12th Week of Follow-up||98||
59818780|NCT00508482|75940932|FG000|COMPLETED|at the 12th Week of Follow-up||196||
59818781|NCT00508482|75940933|FG001|COMPLETED|at the 12th Week of Follow-up||96||
60106994|NCT01576120|76226155|FG000|NOT COMPLETED|Overall Study||0||
60106995|NCT01576120|76226156|FG001|NOT COMPLETED|Overall Study||0||
60106996|NCT01520038|76226162|FG000|STARTED|Overall Study||2||
60106997|NCT01520038|76226162|FG000|COMPLETED|Overall Study||1||
60106998|NCT01520038|76226162|FG000|NOT COMPLETED|Overall Study||1||
60106999|NCT01576276|76226168|FG000|STARTED|Overall Study||22||
60107000|NCT01576276|76226169|FG001|STARTED|Overall Study||29||
60107001|NCT01576276|76226168|FG000|COMPLETED|Overall Study||14||
59711075|NCT00960856|75829598|FG000|NOT COMPLETED|Period IV||0||
59818782|NCT00508482|75940934|FG002|COMPLETED|at the 12th Week of Follow-up||98||
59818783|NCT00508482|75940932|FG000|NOT COMPLETED|at the 12th Week of Follow-up||0||
59818784|NCT00508482|75940933|FG001|NOT COMPLETED|at the 12th Week of Follow-up||0||
59818785|NCT00508482|75940934|FG002|NOT COMPLETED|at the 12th Week of Follow-up||0||
60107002|NCT01576276|76226169|FG001|COMPLETED|Overall Study||18||
60107003|NCT01576276|76226168|FG000|NOT COMPLETED|Overall Study||8||
60107004|NCT01576276|76226169|FG001|NOT COMPLETED|Overall Study||11||
60107005|NCT01576588|76226176|FG000|STARTED|Overall Study||25||
59711076|NCT00960856|75829599|FG001|NOT COMPLETED|Period IV||0||
59711077|NCT00960856|75829600|FG002|NOT COMPLETED|Period IV||0||
59818786|NCT00344500|75940945|FG000|STARTED|Overall Study||48||
59818787|NCT00344500|75940946|FG001|STARTED|Overall Study||60||
59818788|NCT00344500|75940947|FG002|STARTED|Overall Study||14||
59818789|NCT00344500|75940945|FG000|COMPLETED|Overall Study||25||
60107006|NCT01576588|76226176|FG000|COMPLETED|Overall Study||23||
59711078|NCT00960856|75829601|FG003|NOT COMPLETED|Period IV||0||
59711079|NCT00958438|75829614|FG000|STARTED|Overall Study||82||
60107007|NCT01576588|76226176|FG000|NOT COMPLETED|Overall Study||2||
60107008|NCT01826981|76226196|FG000|STARTED|Overall Study||19||
60107009|NCT01826981|76226197|FG001|STARTED|Overall Study||10||
60107010|NCT01826981|76226198|FG002|STARTED|Overall Study||25||
59566568|NCT04109703|75669202|FG000|STARTED|Overall Study||49||
59566569|NCT04109703|75669203|FG001|STARTED|Overall Study||51||
59566570|NCT04109703|75669202|FG000|COMPLETED|Overall Study||49||
59566571|NCT04109703|75669203|FG001|COMPLETED|Overall Study||51||
59711080|NCT00958438|75829615|FG001|STARTED|Overall Study||82||
59711081|NCT00958438|75829616|FG002|STARTED|Overall Study||84||
59711082|NCT00958438|75829614|FG000|COMPLETED|Overall Study||72||
59711083|NCT00958438|75829615|FG001|COMPLETED|Overall Study||72||
59711084|NCT00958438|75829616|FG002|COMPLETED|Overall Study||78||
59711085|NCT00958438|75829614|FG000|NOT COMPLETED|Overall Study||10||
59711086|NCT00958438|75829615|FG001|NOT COMPLETED|Overall Study||10||
59566572|NCT04109703|75669202|FG000|NOT COMPLETED|Overall Study||0||
59566573|NCT04109703|75669203|FG001|NOT COMPLETED|Overall Study||0||
59566574|NCT01870388|75669213|FG000|STARTED|Overall Study||8||
59566575|NCT01870388|75669214|FG001|STARTED|Overall Study||8||
59566576|NCT01870388|75669213|FG000|Received 1 Dose of Study Drug|Overall Study||8||
59566577|NCT01870388|75669214|FG001|Received 1 Dose of Study Drug|Overall Study||8||
59711087|NCT00958438|75829616|FG002|NOT COMPLETED|Overall Study||6||
60107011|NCT01826981|76226199|FG003|STARTED|Overall Study||26||
60107012|NCT01826981|76226200|FG004|STARTED|Overall Study||25||
60107013|NCT01826981|76226201|FG005|STARTED|Overall Study||26||
60107014|NCT01826981|76226202|FG006|STARTED|Overall Study||25||
60107015|NCT01826981|76226203|FG007|STARTED|Overall Study||51||
60107016|NCT01826981|76226204|FG008|STARTED|Overall Study||20||
59711088|NCT00958360|75829626|FG000|STARTED|Overall Study||163||
59711089|NCT00958360|75829627|FG001|STARTED|Overall Study||160||
59711090|NCT00958360|75829626|FG000|COMPLETED|Overall Study||152||
59711091|NCT00958360|75829627|FG001|COMPLETED|Overall Study||150||
59711092|NCT00958360|75829626|FG000|NOT COMPLETED|Overall Study||11||
59711093|NCT00958360|75829627|FG001|NOT COMPLETED|Overall Study||10||
59711094|NCT00888433|75829635|FG000|STARTED|Overall Study||52||
59818790|NCT00344500|75940946|FG001|COMPLETED|Overall Study||25||
59818791|NCT00344500|75940947|FG002|COMPLETED|Overall Study||12||
60107017|NCT01826981|76226205|FG009|STARTED|Overall Study||27||
60107018|NCT01826981|76226206|FG010|STARTED|Overall Study||24||
60107019|NCT01826981|76226207|FG011|STARTED|Overall Study||27||
60107020|NCT01826981|76226208|FG012|STARTED|Overall Study||26||
60107021|NCT01826981|76226209|FG013|STARTED|Overall Study||20||
60107022|NCT01826981|76226210|FG014|STARTED|Overall Study||8||
60107023|NCT01826981|76226196|FG000|COMPLETED|Overall Study||19||
60107024|NCT01826981|76226197|FG001|COMPLETED|Overall Study||9||
60107025|NCT01826981|76226198|FG002|COMPLETED|Overall Study||25||
60107026|NCT01826981|76226199|FG003|COMPLETED|Overall Study||26||
60107027|NCT01826981|76226200|FG004|COMPLETED|Overall Study||18||
60107028|NCT01826981|76226201|FG005|COMPLETED|Overall Study||25||
60107029|NCT01826981|76226202|FG006|COMPLETED|Overall Study||24||
60107030|NCT01826981|76226203|FG007|COMPLETED|Overall Study||40||
60107031|NCT01826981|76226204|FG008|COMPLETED|Overall Study||13||
60107032|NCT01826981|76226205|FG009|COMPLETED|Overall Study||26||
60107033|NCT01826981|76226206|FG010|COMPLETED|Overall Study||22||
60107034|NCT01826981|76226207|FG011|COMPLETED|Overall Study||25||
60107035|NCT01826981|76226208|FG012|COMPLETED|Overall Study||25||
60107036|NCT01826981|76226209|FG013|COMPLETED|Overall Study||15||
60107037|NCT01826981|76226210|FG014|COMPLETED|Overall Study||8||
60107038|NCT01826981|76226196|FG000|NOT COMPLETED|Overall Study||0||
60107039|NCT01826981|76226197|FG001|NOT COMPLETED|Overall Study||1||
60107040|NCT01826981|76226198|FG002|NOT COMPLETED|Overall Study||0||
60107041|NCT01826981|76226199|FG003|NOT COMPLETED|Overall Study||0||
60107042|NCT01826981|76226200|FG004|NOT COMPLETED|Overall Study||7||
60107043|NCT01826981|76226201|FG005|NOT COMPLETED|Overall Study||1||
60107044|NCT01826981|76226202|FG006|NOT COMPLETED|Overall Study||1||
60107045|NCT01826981|76226203|FG007|NOT COMPLETED|Overall Study||11||
60107046|NCT01826981|76226204|FG008|NOT COMPLETED|Overall Study||7||
60107047|NCT01826981|76226205|FG009|NOT COMPLETED|Overall Study||1||
60107048|NCT01826981|76226206|FG010|NOT COMPLETED|Overall Study||2||
60107049|NCT01826981|76226207|FG011|NOT COMPLETED|Overall Study||2||
60107050|NCT01826981|76226208|FG012|NOT COMPLETED|Overall Study||1||
59711095|NCT00888433|75829636|FG001|STARTED|Overall Study||54||
59818792|NCT00344500|75940945|FG000|NOT COMPLETED|Overall Study||23||
60107051|NCT01826981|76226209|FG013|NOT COMPLETED|Overall Study||5||
60107052|NCT01826981|76226210|FG014|NOT COMPLETED|Overall Study||0||
60107053|NCT01522924|76226248|FG000|STARTED|Overall Study|There were 42 dental students in the intervention group.|42||
60107054|NCT01522924|76226249|FG001|STARTED|Overall Study|There were 52 dental students in the control group.|52||
60107055|NCT01522924|76226248|FG000|COMPLETED|Overall Study|There were 42 dental students who completed the second survey after the intervention.|42||
59818793|NCT00344500|75940946|FG001|NOT COMPLETED|Overall Study||35||
60107056|NCT01522924|76226249|FG001|COMPLETED|Overall Study|There were 52 dental students who completed the second survey after the lecture.|52||
60107057|NCT01522924|76226248|FG000|NOT COMPLETED|Overall Study||0||
60107058|NCT01522924|76226249|FG001|NOT COMPLETED|Overall Study||0||
60107059|NCT01523704|76226257|FG000|STARTED|Overall Study|January 2012|636||
60107060|NCT01523704|76226258|FG001|STARTED|Overall Study|January 2012|638||
60107061|NCT01523704|76226257|FG000|COMPLETED|Overall Study|February 2016 (Enrollment: as of October 2013)|558||
60107062|NCT01523704|76226258|FG001|COMPLETED|Overall Study|February 2016 (Enrollment: as of October 2013)|550||
60107063|NCT01523704|76226257|FG000|NOT COMPLETED|Overall Study||78||
60107064|NCT01523704|76226258|FG001|NOT COMPLETED|Overall Study||88||
59711096|NCT00888433|75829635|FG000|COMPLETED|Overall Study||49||
60107065|NCT02728752|76226267|FG000|STARTED|First Period||48||
60107066|NCT02728752|76226268|FG001|STARTED|First Period||47||
60107067|NCT02728752|76226267|FG000|COMPLETED|First Period||46||
60107068|NCT02728752|76226268|FG001|COMPLETED|First Period||45||
60107069|NCT02728752|76226267|FG000|NOT COMPLETED|First Period||2||
60107070|NCT02728752|76226268|FG001|NOT COMPLETED|First Period||2||
59566578|NCT01870388|75669213|FG000|COMPLETED|Overall Study||8||
59566579|NCT01870388|75669214|FG001|COMPLETED|Overall Study||8||
59566580|NCT01870388|75669213|FG000|NOT COMPLETED|Overall Study||0||
59566581|NCT01870388|75669214|FG001|NOT COMPLETED|Overall Study||0||
59566582|NCT03909009|75669224|FG000|STARTED|Overall Study||10||
60107071|NCT02728752|76226267|FG000|STARTED|Extension Period||46||
60107072|NCT02728752|76226268|FG001|STARTED|Extension Period||45||
60107073|NCT02728752|76226267|FG000|COMPLETED|Extension Period||35||
60107074|NCT02728752|76226268|FG001|COMPLETED|Extension Period||34||
60107075|NCT02728752|76226267|FG000|NOT COMPLETED|Extension Period||11||
60107076|NCT02728752|76226268|FG001|NOT COMPLETED|Extension Period||11||
60107077|NCT01578772|76226275|FG000|STARTED|Overall Study||17||
60107078|NCT01578772|76226275|FG000|COMPLETED|Overall Study||17||
60107079|NCT01578772|76226275|FG000|NOT COMPLETED|Overall Study||0||
60107080|NCT01804049|76226282|FG000|STARTED|Overall Study||43||
60107081|NCT01804049|76226283|FG001|STARTED|Overall Study||77||
60107082|NCT01804049|76226282|FG000|COMPLETED|Overall Study||32||
60107083|NCT01804049|76226283|FG001|COMPLETED|Overall Study||45||
60107084|NCT01804049|76226282|FG000|NOT COMPLETED|Overall Study||11||
60107085|NCT01804049|76226283|FG001|NOT COMPLETED|Overall Study||32||
60107086|NCT01826825|76226293|FG000|STARTED|Overall Study||100||
60107087|NCT01826825|76226294|FG001|STARTED|Overall Study||100||
60107088|NCT01826825|76226293|FG000|COMPLETED|Overall Study||100||
60107089|NCT01826825|76226294|FG001|COMPLETED|Overall Study||98||
60107090|NCT01826825|76226293|FG000|NOT COMPLETED|Overall Study||0||
60107091|NCT01826825|76226294|FG001|NOT COMPLETED|Overall Study||2||
60107092|NCT01803737|76226304|FG000|STARTED|Overall Study||13||
60107093|NCT01803737|76226305|FG001|STARTED|Overall Study||13||
60107094|NCT01803737|76226304|FG000|COMPLETED|Overall Study||12||
60107095|NCT01803737|76226305|FG001|COMPLETED|Overall Study||10||
60107096|NCT01803737|76226304|FG000|NOT COMPLETED|Overall Study||1||
60107097|NCT01803737|76226305|FG001|NOT COMPLETED|Overall Study||3||
60107098|NCT01826201|76226311|FG000|STARTED|Overall Study|Subjects in each arm are same|21||
60107099|NCT01826201|76226311|FG000|COMPLETED|Overall Study||17||
60107100|NCT01826201|76226311|FG000|NOT COMPLETED|Overall Study||4||
60107101|NCT01523782|76226320|FG000|STARTED|Overall Study||3||
60107102|NCT01523782|76226321|FG001|STARTED|Overall Study||13||
60107103|NCT01523782|76226322|FG002|STARTED|Overall Study||14||
60107104|NCT01523782|76226320|FG000|COMPLETED|Overall Study||2||
60107105|NCT01523782|76226321|FG001|COMPLETED|Overall Study||13||
60107106|NCT01523782|76226322|FG002|COMPLETED|Overall Study||9||
60107107|NCT01523782|76226320|FG000|NOT COMPLETED|Overall Study||1||
60107108|NCT01523782|76226321|FG001|NOT COMPLETED|Overall Study||0||
60107109|NCT01523782|76226322|FG002|NOT COMPLETED|Overall Study||5||
60107110|NCT01525420|76226332|FG000|STARTED|Overall Study||59||
60107111|NCT01525420|76226333|FG001|STARTED|Overall Study||62||
60107112|NCT01525420|76226332|FG000|COMPLETED|Overall Study||43||
59566583|NCT03909009|75669225|FG001|STARTED|Overall Study||10||
59566584|NCT03909009|75669224|FG000|COMPLETED|Overall Study||10||
59566585|NCT03909009|75669225|FG001|COMPLETED|Overall Study||10||
59566586|NCT03909009|75669224|FG000|NOT COMPLETED|Overall Study||0||
59566587|NCT03909009|75669225|FG001|NOT COMPLETED|Overall Study||0||
59566588|NCT01870856|75669233|FG000|STARTED|Overall Study||25||
59566589|NCT01870856|75669234|FG001|STARTED|Overall Study||27||
60107113|NCT01525420|76226333|FG001|COMPLETED|Overall Study||38||
60107114|NCT01525420|76226332|FG000|NOT COMPLETED|Overall Study||16||
60107115|NCT01525420|76226333|FG001|NOT COMPLETED|Overall Study||24||
60107116|NCT01803269|76226342|FG000|STARTED|Overall Study||7||
59566590|NCT01870856|75669233|FG000|COMPLETED|Overall Study||25||
59566591|NCT01870856|75669234|FG001|COMPLETED|Overall Study||27||
59566592|NCT01870856|75669233|FG000|NOT COMPLETED|Overall Study||0||
60107117|NCT01803269|76226343|FG001|STARTED|Overall Study||8||
60107118|NCT01803269|76226344|FG002|STARTED|Overall Study||14||
60107119|NCT01803269|76226342|FG000|COMPLETED|Overall Study||4||
60107120|NCT01803269|76226343|FG001|COMPLETED|Overall Study||8||
60107121|NCT01803269|76226344|FG002|COMPLETED|Overall Study||14||
60107122|NCT01803269|76226342|FG000|NOT COMPLETED|Overall Study||3||
60107123|NCT01803269|76226343|FG001|NOT COMPLETED|Overall Study||0||
60107124|NCT01803269|76226344|FG002|NOT COMPLETED|Overall Study||0||
60107125|NCT01802879|76226352|FG000|STARTED|Overall Study||8||
60107126|NCT01802879|76226352|FG000|COMPLETED|Overall Study||0||
60107127|NCT01802879|76226352|FG000|NOT COMPLETED|Overall Study||8||
60107128|NCT01825577|76226356|FG000|STARTED|Overall Study||14||
60107129|NCT01825577|76226356|FG000|COMPLETED|Overall Study||6||
59566593|NCT01870856|75669234|FG001|NOT COMPLETED|Overall Study||0||
59566594|NCT03739983|75669242|FG000|STARTED|Overall Study||2||
60107130|NCT01825577|76226356|FG000|NOT COMPLETED|Overall Study||8||
60107131|NCT01802411|76226362|FG000|STARTED|Overall Study||96||
59566595|NCT03739983|75669242|FG000|COMPLETED|Overall Study||2||
60107132|NCT01802411|76226363|FG001|STARTED|Overall Study||95||
60107133|NCT01802411|76226362|FG000|COMPLETED|Overall Study||82||
60107134|NCT01802411|76226363|FG001|COMPLETED|Overall Study||74||
60107135|NCT01802411|76226362|FG000|NOT COMPLETED|Overall Study||14||
60107136|NCT01802411|76226363|FG001|NOT COMPLETED|Overall Study||21||
60107137|NCT01579084|76226379|FG000|STARTED|Overall Study||8||
59818794|NCT00344500|75940947|FG002|NOT COMPLETED|Overall Study||2||
59818795|NCT00344032|75940956|FG000|STARTED|Overall Study||176||
59818796|NCT00344032|75940957|FG001|STARTED|Overall Study||178||
59818797|NCT00344032|75940956|FG000|COMPLETED|Overall Study||162||
59818798|NCT00344032|75940957|FG001|COMPLETED|Overall Study||168||
59818799|NCT00344032|75940956|FG000|NOT COMPLETED|Overall Study||14||
59818800|NCT00344032|75940957|FG001|NOT COMPLETED|Overall Study||10||
59818801|NCT00607373|75940965|FG000|STARTED|Treatment Period||17||
59818802|NCT00607373|75940966|FG001|STARTED|Treatment Period||34||
59818803|NCT00607373|75940965|FG000|COMPLETED|Treatment Period|16 enrolled in open-label extension study NCT00694109|17||
59818804|NCT00607373|75940966|FG001|COMPLETED|Treatment Period|23 enrolled in open-label extension study NCT00694109|28||
59818805|NCT00607373|75940965|FG000|NOT COMPLETED|Treatment Period||0||
59818806|NCT00607373|75940966|FG001|NOT COMPLETED|Treatment Period||6||
59818807|NCT00607373|75940965|FG000|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|1||
59818808|NCT00607373|75940966|FG001|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|11||
59818809|NCT00607373|75940965|FG000|COMPLETED|Follow-up Period||0||
59818810|NCT00607373|75940966|FG001|COMPLETED|Follow-up Period||6||
59818811|NCT00607373|75940965|FG000|NOT COMPLETED|Follow-up Period||1||
59818812|NCT00607373|75940966|FG001|NOT COMPLETED|Follow-up Period||5||
59818813|NCT00508404|75940972|FG000|STARTED|Overall Study||154||
59818814|NCT00508404|75940972|FG000|COMPLETED|Overall Study|Completion of safety follow-up visit conducted 8 weeks after last dose|112||
59818815|NCT00508404|75940972|FG000|NOT COMPLETED|Overall Study||42||
59818816|NCT00352690|75940979|FG000|STARTED|Overall Study||10||
59818817|NCT00352690|75940980|FG001|STARTED|Overall Study||0||
59818818|NCT00352690|75940979|FG000|COMPLETED|Overall Study||8||
59818819|NCT00352690|75940980|FG001|COMPLETED|Overall Study||0||
59818820|NCT00352690|75940979|FG000|NOT COMPLETED|Overall Study||2||
59818821|NCT00352690|75940980|FG001|NOT COMPLETED|Overall Study||0||
59818822|NCT00609245|75940986|FG000|STARTED|Overall Study||13||
59818823|NCT00609245|75940986|FG000|COMPLETED|Overall Study||12||
59818824|NCT00609245|75940986|FG000|NOT COMPLETED|Overall Study||1||
59818825|NCT00343642|75940995|FG000|STARTED|Overall Study||19||
59818826|NCT00343642|75940996|FG001|STARTED|Overall Study||19||
59818827|NCT00343642|75940997|FG002|STARTED|Overall Study||16||
59818828|NCT00343642|75940995|FG000|Upto 3 Months Complete or Flare|Overall Study||2||
59818829|NCT00343642|75940996|FG001|Upto 3 Months Complete or Flare|Overall Study||0||
59818830|NCT00343642|75940997|FG002|Upto 3 Months Complete or Flare|Overall Study||1||
59818831|NCT00343642|75940995|FG000|3-6 Months Complete or Flare|Overall Study||4||
59818832|NCT00343642|75940996|FG001|3-6 Months Complete or Flare|Overall Study||2||
59818833|NCT00343642|75940997|FG002|3-6 Months Complete or Flare|Overall Study||2||
59818834|NCT00343642|75940995|FG000|COMPLETED|Overall Study||10||
59818835|NCT00343642|75940996|FG001|COMPLETED|Overall Study||11||
59818836|NCT00343642|75940997|FG002|COMPLETED|Overall Study||9||
59818837|NCT00343642|75940995|FG000|NOT COMPLETED|Overall Study||9||
59818838|NCT00343642|75940996|FG001|NOT COMPLETED|Overall Study||8||
59818839|NCT00343642|75940997|FG002|NOT COMPLETED|Overall Study||7||
60107138|NCT01579084|76226380|FG001|STARTED|Overall Study||8||
60107139|NCT01579084|76226381|FG002|STARTED|Overall Study||8||
60107140|NCT01579084|76226382|FG003|STARTED|Overall Study||8||
60107141|NCT01579084|76226383|FG004|STARTED|Overall Study||8||
60107142|NCT01579084|76226384|FG005|STARTED|Overall Study||8||
60107143|NCT01579084|76226385|FG006|STARTED|Overall Study||4||
60107144|NCT01579084|76226386|FG007|STARTED|Overall Study||4||
60107145|NCT01579084|76226387|FG008|STARTED|Overall Study||4||
60107146|NCT01579084|76226388|FG009|STARTED|Overall Study||4||
60107147|NCT01579084|76226379|FG000|COMPLETED|Overall Study||8||
60107148|NCT01579084|76226380|FG001|COMPLETED|Overall Study||8||
60107149|NCT01579084|76226381|FG002|COMPLETED|Overall Study||8||
60107150|NCT01579084|76226382|FG003|COMPLETED|Overall Study||8||
60107151|NCT01579084|76226383|FG004|COMPLETED|Overall Study||8||
60107152|NCT01579084|76226384|FG005|COMPLETED|Overall Study||8||
60107153|NCT01579084|76226385|FG006|COMPLETED|Overall Study||4||
59818840|NCT00609167|75941010|FG000|STARTED|Overall Study||33||
59818841|NCT00609167|75941011|FG001|STARTED|Overall Study||30||
59818842|NCT00609167|75941010|FG000|COMPLETED|Overall Study||25||
59818843|NCT00609167|75941011|FG001|COMPLETED|Overall Study||23||
60107154|NCT01579084|76226386|FG007|COMPLETED|Overall Study||4||
60107155|NCT01579084|76226387|FG008|COMPLETED|Overall Study||4||
60107156|NCT01579084|76226388|FG009|COMPLETED|Overall Study||4||
60107157|NCT01579084|76226379|FG000|NOT COMPLETED|Overall Study||0||
60107158|NCT01579084|76226380|FG001|NOT COMPLETED|Overall Study||0||
60107159|NCT01579084|76226381|FG002|NOT COMPLETED|Overall Study||0||
60107160|NCT01579084|76226382|FG003|NOT COMPLETED|Overall Study||0||
59818844|NCT00609167|75941010|FG000|NOT COMPLETED|Overall Study||8||
59818845|NCT00609167|75941011|FG001|NOT COMPLETED|Overall Study||7||
59818846|NCT00606281|75941019|FG000|STARTED|Overall Study||128||
60107161|NCT01579084|76226383|FG004|NOT COMPLETED|Overall Study||0||
60107162|NCT01579084|76226384|FG005|NOT COMPLETED|Overall Study||0||
60107163|NCT01579084|76226385|FG006|NOT COMPLETED|Overall Study||0||
60107164|NCT01579084|76226386|FG007|NOT COMPLETED|Overall Study||0||
59711097|NCT00888433|75829636|FG001|COMPLETED|Overall Study||51||
59711098|NCT00888433|75829635|FG000|NOT COMPLETED|Overall Study||3||
59711099|NCT00888433|75829636|FG001|NOT COMPLETED|Overall Study||3||
59711100|NCT01243424|75829644|FG000|STARTED|Discontinuation From Study (Treated Set)||3028|Started are entered/ randomised|
59711101|NCT01243424|75829645|FG001|STARTED|Discontinuation From Study (Treated Set)||3014|Started are entered/ randomised|
59711102|NCT01243424|75829644|FG000|Patient Died (Other Cause Than CV Death)|Discontinuation From Study (Treated Set)||123||
59711103|NCT01243424|75829645|FG001|Patient Died (Other Cause Than CV Death)|Discontinuation From Study (Treated Set)||146||
59711104|NCT01243424|75829644|FG000|Treated|Discontinuation From Study (Treated Set)||3023||
59711105|NCT01243424|75829645|FG001|Treated|Discontinuation From Study (Treated Set)||3010||
59818847|NCT00606281|75941020|FG001|STARTED|Overall Study||130||
59818848|NCT00606281|75941019|FG000|COMPLETED|Overall Study||72||
59818849|NCT00606281|75941020|FG001|COMPLETED|Overall Study||64||
59818850|NCT00606281|75941019|FG000|NOT COMPLETED|Overall Study||56||
59818851|NCT00606281|75941020|FG001|NOT COMPLETED|Overall Study||66||
59818852|NCT00506142|75941028|FG000|STARTED|Overall Study||35||
59818853|NCT00506142|75941029|FG001|STARTED|Overall Study||19||
59818854|NCT00506142|75941028|FG000|COMPLETED|Overall Study||0||
59818855|NCT00506142|75941029|FG001|COMPLETED|Overall Study||0||
59818856|NCT00506142|75941028|FG000|NOT COMPLETED|Overall Study||35||
59818857|NCT00506142|75941029|FG001|NOT COMPLETED|Overall Study||19||
59818858|NCT00514020|75941035|FG000|STARTED|Overall Study|two patients withdrew before treatment; one withdrew after treatment|33||
59818859|NCT00514020|75941035|FG000|COMPLETED|Overall Study||5||
59818860|NCT00514020|75941035|FG000|NOT COMPLETED|Overall Study||28||
59818861|NCT00513708|75941042|FG000|STARTED|Overall Study||50||
59818862|NCT00513708|75941043|FG001|STARTED|Overall Study||50||
59818863|NCT00513708|75941044|FG002|STARTED|Overall Study||50||
59818864|NCT00513708|75941042|FG000|COMPLETED|Overall Study||46||
59818865|NCT00513708|75941043|FG001|COMPLETED|Overall Study||46||
59818866|NCT00513708|75941044|FG002|COMPLETED|Overall Study||46||
59818867|NCT00513708|75941042|FG000|NOT COMPLETED|Overall Study||4||
59818868|NCT00513708|75941043|FG001|NOT COMPLETED|Overall Study||4||
59818869|NCT00513708|75941044|FG002|NOT COMPLETED|Overall Study||4||
59818870|NCT00513474|75941054|FG000|STARTED|Overall Study||25||
59818871|NCT00513474|75941055|FG001|STARTED|Overall Study||21||
59818872|NCT00513474|75941054|FG000|Received Rasburicase Per Protocol|Overall Study||24||
59818873|NCT00513474|75941055|FG001|Received Rasburicase Per Protocol|Overall Study||0||
59818874|NCT00513474|75941054|FG000|COMPLETED|Overall Study||18||
59818875|NCT00513474|75941055|FG001|COMPLETED|Overall Study||12||
59818876|NCT00513474|75941054|FG000|NOT COMPLETED|Overall Study||7||
59818877|NCT00513474|75941055|FG001|NOT COMPLETED|Overall Study||9||
59818878|NCT00505752|75941065|FG000|STARTED|Overall Study||132||
59818879|NCT00505752|75941066|FG001|STARTED|Overall Study||128||
60107165|NCT01579084|76226387|FG008|NOT COMPLETED|Overall Study||0||
59818880|NCT00505752|75941067|FG002|STARTED|Overall Study||128||
60107166|NCT01579084|76226388|FG009|NOT COMPLETED|Overall Study||0||
60107167|NCT02963610|76226404|FG000|STARTED|Overall Study||3||
60107168|NCT02963610|76226404|FG000|COMPLETED|Overall Study||0||
60107169|NCT02963610|76226404|FG000|NOT COMPLETED|Overall Study||3||
60107170|NCT01579162|76226414|FG000|STARTED|Overall Study||16||
60107171|NCT01579162|76226415|FG001|STARTED|Overall Study||8||
60107172|NCT01579162|76226416|FG002|STARTED|Overall Study||8||
60107173|NCT01579162|76226417|FG003|STARTED|Overall Study||8||
60107174|NCT01579162|76226418|FG004|STARTED|Overall Study||8||
59818881|NCT00505752|75941068|FG003|STARTED|Overall Study||132||
60107175|NCT01579162|76226414|FG000|COMPLETED|Overall Study||16||
60107176|NCT01579162|76226415|FG001|COMPLETED|Overall Study||8||
60107177|NCT01579162|76226416|FG002|COMPLETED|Overall Study||8||
60107178|NCT01579162|76226417|FG003|COMPLETED|Overall Study||8||
60107179|NCT01579162|76226418|FG004|COMPLETED|Overall Study||8||
60107180|NCT01579162|76226414|FG000|NOT COMPLETED|Overall Study||0||
60107181|NCT01579162|76226415|FG001|NOT COMPLETED|Overall Study||0||
60107182|NCT01579162|76226416|FG002|NOT COMPLETED|Overall Study||0||
60107183|NCT01579162|76226417|FG003|NOT COMPLETED|Overall Study||0||
60107184|NCT01579162|76226418|FG004|NOT COMPLETED|Overall Study||0||
60107185|NCT01580098|76226433|FG000|STARTED|Overall Study||76||
59818882|NCT00505752|75941065|FG000|COMPLETED|Overall Study||126||
59818883|NCT00505752|75941066|FG001|COMPLETED|Overall Study||119||
60107186|NCT01580098|76226434|FG001|STARTED|Overall Study||114||
60107187|NCT01580098|76226435|FG002|STARTED|Overall Study||3||
60107188|NCT01580098|76226433|FG000|COMPLETED|Overall Study||61||
60107189|NCT01580098|76226434|FG001|COMPLETED|Overall Study||101||
59818884|NCT00505752|75941067|FG002|COMPLETED|Overall Study||120||
60107190|NCT01580098|76226435|FG002|COMPLETED|Overall Study|Due to high age and bad health conditions no patients finished (nursing)|0||
60107191|NCT01580098|76226433|FG000|NOT COMPLETED|Overall Study||15||
59711106|NCT01243424|75829644|FG000|COMPLETED|Discontinuation From Study (Treated Set)||2899|Completed regarding MACE status or died|
59711107|NCT01243424|75829645|FG001|COMPLETED|Discontinuation From Study (Treated Set)||2895|Completed regarding MACE status or died|
59711108|NCT01243424|75829644|FG000|NOT COMPLETED|Discontinuation From Study (Treated Set)||129||
59711109|NCT01243424|75829645|FG001|NOT COMPLETED|Discontinuation From Study (Treated Set)||119||
59711110|NCT01243424|75829644|FG000|STARTED|Discontinuation From Treatment||3028|Started are entered/ randomised|
59711111|NCT01243424|75829645|FG001|STARTED|Discontinuation From Treatment||3014|Started are entered/ randomised|
59711112|NCT01243424|75829644|FG000|Treated|Discontinuation From Treatment||3023||
59711113|NCT01243424|75829645|FG001|Treated|Discontinuation From Treatment||3010||
59711114|NCT01243424|75829644|FG000|COMPLETED|Discontinuation From Treatment||1896|Not prematurely discontinued from trial medication|
59711115|NCT01243424|75829645|FG001|COMPLETED|Discontinuation From Treatment||1832|Not prematurely discontinued from trial medication|
59711116|NCT01243424|75829644|FG000|NOT COMPLETED|Discontinuation From Treatment||1132||
59711117|NCT01243424|75829645|FG001|NOT COMPLETED|Discontinuation From Treatment||1182||
59711118|NCT00887809|75829654|FG000|STARTED|Overall Study||37||
59711119|NCT00887809|75829655|FG001|STARTED|Overall Study||10||
60107192|NCT01580098|76226434|FG001|NOT COMPLETED|Overall Study||13||
60107193|NCT01580098|76226435|FG002|NOT COMPLETED|Overall Study||3||
60107194|NCT01526356|76226445|FG000|STARTED|Overall Study||59||
60107195|NCT01526356|76226446|FG001|STARTED|Overall Study||63||
60107196|NCT01526356|76226447|FG002|STARTED|Overall Study||57||
59711120|NCT00887809|75829654|FG000|COMPLETED|Overall Study||33||
59711121|NCT00887809|75829655|FG001|COMPLETED|Overall Study||10||
60107197|NCT01526356|76226445|FG000|COMPLETED|Overall Study||51||
60107198|NCT01526356|76226446|FG001|COMPLETED|Overall Study||53||
60107199|NCT01526356|76226447|FG002|COMPLETED|Overall Study||45||
60107200|NCT01526356|76226445|FG000|NOT COMPLETED|Overall Study||8||
60107201|NCT01526356|76226446|FG001|NOT COMPLETED|Overall Study||10||
60107202|NCT01526356|76226447|FG002|NOT COMPLETED|Overall Study||12||
60107203|NCT01526902|76226457|FG000|STARTED|Overall Study||25||
60107204|NCT01526902|76226458|FG001|STARTED|Overall Study||24||
60107205|NCT01526902|76226457|FG000|COMPLETED|Overall Study||25||
60107206|NCT01526902|76226458|FG001|COMPLETED|Overall Study||24||
60107207|NCT01526902|76226457|FG000|NOT COMPLETED|Overall Study||0||
60107208|NCT01526902|76226458|FG001|NOT COMPLETED|Overall Study||0||
60107209|NCT01528150|76226464|FG000|STARTED|Overall Study||466||
60107210|NCT01528150|76226464|FG000|COMPLETED|Overall Study||422||
60107211|NCT01528150|76226464|FG000|NOT COMPLETED|Overall Study||44||
60107212|NCT01528228|76226470|FG000|STARTED|Overall Study||10||
60107213|NCT01528228|76226471|FG001|STARTED|Overall Study||10||
60107214|NCT01528228|76226470|FG000|COMPLETED|Overall Study||9||
59711122|NCT00887809|75829654|FG000|NOT COMPLETED|Overall Study||4||
59711123|NCT00887809|75829655|FG001|NOT COMPLETED|Overall Study||0||
59711124|NCT00958126|75829669|FG000|STARTED|Overall Study||49||
59711125|NCT00958126|75829670|FG001|STARTED|Overall Study||205||
59711126|NCT00958126|75829671|FG002|STARTED|Overall Study||201||
59711127|NCT00958126|75829672|FG003|STARTED|Overall Study||203||
59711128|NCT00958126|75829673|FG004|STARTED|Overall Study||50||
59711129|NCT00958126|75829674|FG005|STARTED|Overall Study||203||
59711130|NCT00958126|75829675|FG006|STARTED|Overall Study||200||
59711131|NCT00958126|75829676|FG007|STARTED|Overall Study||202||
59711132|NCT00958126|75829669|FG000|COMPLETED|Overall Study||48||
59711133|NCT00958126|75829670|FG001|COMPLETED|Overall Study||196||
59711134|NCT00958126|75829671|FG002|COMPLETED|Overall Study||191||
59711135|NCT00958126|75829672|FG003|COMPLETED|Overall Study||192||
59711136|NCT00958126|75829673|FG004|COMPLETED|Overall Study||50||
59711137|NCT00958126|75829674|FG005|COMPLETED|Overall Study||202||
59711138|NCT00958126|75829675|FG006|COMPLETED|Overall Study||199||
59711139|NCT00958126|75829676|FG007|COMPLETED|Overall Study||202||
59711140|NCT00958126|75829669|FG000|NOT COMPLETED|Overall Study||1||
59711141|NCT00958126|75829670|FG001|NOT COMPLETED|Overall Study||9||
59711142|NCT00958126|75829671|FG002|NOT COMPLETED|Overall Study||10||
59711143|NCT00958126|75829672|FG003|NOT COMPLETED|Overall Study||11||
59711144|NCT00958126|75829673|FG004|NOT COMPLETED|Overall Study||0||
59711145|NCT00958126|75829674|FG005|NOT COMPLETED|Overall Study||1||
59711146|NCT00958126|75829675|FG006|NOT COMPLETED|Overall Study||1||
59711147|NCT00958126|75829676|FG007|NOT COMPLETED|Overall Study||0||
59711148|NCT00887341|75829700|FG000|STARTED|Overall Study||37||
59711149|NCT00887341|75829701|FG001|STARTED|Overall Study||39||
59711150|NCT00887341|75829700|FG000|COMPLETED|Overall Study||35||
59711151|NCT00887341|75829701|FG001|COMPLETED|Overall Study||36||
59818885|NCT00505752|75941068|FG003|COMPLETED|Overall Study||126||
59818886|NCT00505752|75941065|FG000|NOT COMPLETED|Overall Study||6||
59818887|NCT00505752|75941066|FG001|NOT COMPLETED|Overall Study||9||
59818888|NCT00505752|75941067|FG002|NOT COMPLETED|Overall Study||8||
59818889|NCT00505752|75941068|FG003|NOT COMPLETED|Overall Study||6||
59818890|NCT03601637|75941080|FG000|STARTED|Overall Study||14||
59818891|NCT03601637|75941081|FG001|STARTED|Overall Study||46||
59818892|NCT03601637|75941080|FG000|COMPLETED|Overall Study||13||
59818893|NCT03601637|75941081|FG001|COMPLETED|Overall Study||43||
59818894|NCT03601637|75941080|FG000|NOT COMPLETED|Overall Study||1||
59818895|NCT03601637|75941081|FG001|NOT COMPLETED|Overall Study||3||
59818896|NCT00343252|75941096|FG000|STARTED|All Randomized Participants||361||
59818897|NCT00343252|75941097|FG001|STARTED|All Randomized Participants||351||
59818898|NCT00343252|75941096|FG000|COMPLETED|All Randomized Participants||259||
59818899|NCT00343252|75941097|FG001|COMPLETED|All Randomized Participants||269||
59818900|NCT00343252|75941096|FG000|NOT COMPLETED|All Randomized Participants||102||
59818901|NCT00343252|75941097|FG001|NOT COMPLETED|All Randomized Participants||82||
59818902|NCT00343252|75941096|FG000|STARTED|6 Months (All Treated Participants)|361 participants were randomized but 1 did not receive study drug and was not analyzed.|360||
59818903|NCT00343252|75941097|FG001|STARTED|6 Months (All Treated Participants)|351 participants were randomized but 1 did not receive study drug and was not analyzed.|350||
59818904|NCT00343252|75941096|FG000|COMPLETED|6 Months (All Treated Participants)||304||
60107215|NCT01528228|76226471|FG001|COMPLETED|Overall Study||9||
59818905|NCT00343252|75941097|FG001|COMPLETED|6 Months (All Treated Participants)||306||
59818906|NCT00343252|75941096|FG000|NOT COMPLETED|6 Months (All Treated Participants)||56||
59818907|NCT00343252|75941097|FG001|NOT COMPLETED|6 Months (All Treated Participants)||44||
59818908|NCT00343252|75941096|FG000|STARTED|12 Months (All Treated Participants)|361 participants were randomized but 1 did not receive study drug and was not analyzed.|360||
59818909|NCT00343252|75941097|FG001|STARTED|12 Months (All Treated Participants)|351 participants were randomized but 1 did not receive study drug and was not analyzed.|350||
59818910|NCT00343252|75941096|FG000|COMPLETED|12 Months (All Treated Participants)|Completed 12 Months.|274||
59818911|NCT00343252|75941097|FG001|COMPLETED|12 Months (All Treated Participants)|Completed 12 Months.|281||
59818912|NCT00343252|75941096|FG000|NOT COMPLETED|12 Months (All Treated Participants)||86||
59818913|NCT00343252|75941097|FG001|NOT COMPLETED|12 Months (All Treated Participants)||69||
59818914|NCT00343252|75941096|FG000|STARTED|18 Months (All Treated Participants)||360||
60107216|NCT01528228|76226470|FG000|NOT COMPLETED|Overall Study||1||
60107217|NCT01528228|76226471|FG001|NOT COMPLETED|Overall Study||1||
60107218|NCT01580410|76226479|FG000|STARTED|Overall Study||68||
60107219|NCT01580410|76226480|FG001|STARTED|Overall Study||68||
60107220|NCT01580410|76226479|FG000|COMPLETED|Overall Study||57||
59711152|NCT00887341|75829700|FG000|NOT COMPLETED|Overall Study||2||
59711153|NCT00887341|75829701|FG001|NOT COMPLETED|Overall Study||3||
59711154|NCT00886795|75829707|FG000|STARTED|Overall Study||4||
59711155|NCT00886795|75829707|FG000|COMPLETED|Overall Study||3||
59711156|NCT00886795|75829707|FG000|NOT COMPLETED|Overall Study||1||
59711157|NCT02783482|75829714|FG000|STARTED|Overall Study||29||
59711158|NCT02783482|75829715|FG001|STARTED|Overall Study||20||
59711159|NCT02783482|75829714|FG000|COMPLETED|Overall Study||24||
59711160|NCT02783482|75829715|FG001|COMPLETED|Overall Study||19||
59711161|NCT02783482|75829714|FG000|NOT COMPLETED|Overall Study||5||
59711162|NCT02783482|75829715|FG001|NOT COMPLETED|Overall Study||1||
59711163|NCT00889681|75829724|FG000|STARTED|Overall Study||81||
59711164|NCT00889681|75829724|FG000|Received Treatment|Overall Study||78||
59711165|NCT00889681|75829724|FG000|COMPLETED|Overall Study||78||
59711166|NCT00889681|75829724|FG000|NOT COMPLETED|Overall Study||3||
59711167|NCT00957658|75829728|FG000|STARTED|Overall Study||234||
59818915|NCT00343252|75941097|FG001|STARTED|18 Months (All Treated Participants)||350||
59566596|NCT03739983|75669242|FG000|NOT COMPLETED|Overall Study||0||
59566597|NCT02270060|75669249|FG000|STARTED|Overall Study||20||
59566598|NCT02270060|75669250|FG001|STARTED|Overall Study||20||
59566599|NCT02270060|75669251|FG002|STARTED|Overall Study||20||
59566600|NCT02270060|75669249|FG000|COMPLETED|Overall Study||20||
60107221|NCT01580410|76226480|FG001|COMPLETED|Overall Study||60||
60107222|NCT01580410|76226479|FG000|NOT COMPLETED|Overall Study||11||
60107223|NCT01580410|76226480|FG001|NOT COMPLETED|Overall Study||8||
60107224|NCT01581658|76226490|FG000|STARTED|Overall Study||8||
59566601|NCT02270060|75669250|FG001|COMPLETED|Overall Study||20||
59566602|NCT02270060|75669251|FG002|COMPLETED|Overall Study||20||
59566603|NCT02270060|75669249|FG000|NOT COMPLETED|Overall Study||0||
59566604|NCT02270060|75669250|FG001|NOT COMPLETED|Overall Study||0||
59566605|NCT02270060|75669251|FG002|NOT COMPLETED|Overall Study||0||
59566606|NCT03764007|75669259|FG000|STARTED|Overall Study||98||
59566607|NCT03764007|75669259|FG000|Imaging Completed|Overall Study||98||
59566608|NCT03764007|75669259|FG000|Underwent Parathyroidectomy Surgery|Overall Study||77||
59566609|NCT03764007|75669259|FG000|COMPLETED|Overall Study||77||
59566610|NCT03764007|75669259|FG000|NOT COMPLETED|Overall Study||21||
59711168|NCT00957658|75829728|FG000|COMPLETED|Overall Study|Completed/Not completed counts are based on participant status at the 2yr primary outcome interval.|169||
59711169|NCT00957658|75829728|FG000|NOT COMPLETED|Overall Study||65||
59711170|NCT00953680|75829734|FG000|STARTED|Period 1||38||
59711171|NCT00953680|75829735|FG001|STARTED|Period 1||39||
60107225|NCT01581658|76226491|FG001|STARTED|Overall Study||8||
60107226|NCT01581658|76226492|FG002|STARTED|Overall Study||8||
60107227|NCT01581658|76226493|FG003|STARTED|Overall Study||8||
59711172|NCT00953680|75829734|FG000|COMPLETED|Period 1||38||
59566611|NCT02271386|75669267|FG000|STARTED|Baseline Period- 8 Months||53||
59566612|NCT02271386|75669268|FG001|STARTED|Baseline Period- 8 Months||52||
59566613|NCT02271386|75669269|FG002|STARTED|Baseline Period- 8 Months||200||
59996248|NCT00702949|76112204|FG001|COMPLETED|Overall Study||57||
59996249|NCT00702949|76112205|FG002|COMPLETED|Overall Study||54||
59996250|NCT00702949|76112203|FG000|NOT COMPLETED|Overall Study||5||
59996251|NCT00702949|76112204|FG001|NOT COMPLETED|Overall Study||9||
59996252|NCT00702949|76112205|FG002|NOT COMPLETED|Overall Study||8||
59996253|NCT00702715|76112217|FG000|STARTED|Overall Study||35||
59996254|NCT00702715|76112218|FG001|STARTED|Overall Study|One subject was enrolled but did not start study|33||
59996255|NCT00702715|76112217|FG000|COMPLETED|Overall Study||34||
59996256|NCT00702715|76112218|FG001|COMPLETED|Overall Study||33||
59711173|NCT00953680|75829735|FG001|COMPLETED|Period 1||38||
59711174|NCT00953680|75829734|FG000|NOT COMPLETED|Period 1||0||
59711175|NCT00953680|75829735|FG001|NOT COMPLETED|Period 1||1||
59711176|NCT00953680|75829734|FG000|STARTED|Period 2||38||
59711177|NCT00953680|75829735|FG001|STARTED|Period 2||38||
59711178|NCT00953680|75829734|FG000|COMPLETED|Period 2||38||
59711179|NCT00953680|75829735|FG001|COMPLETED|Period 2||38||
59711180|NCT00953680|75829734|FG000|NOT COMPLETED|Period 2||0||
59711181|NCT00953680|75829735|FG001|NOT COMPLETED|Period 2||0||
59711182|NCT00890929|75829741|FG000|STARTED|Overall Study||45||
59711183|NCT00890929|75829741|FG000|Consented & Enrolled|Overall Study||45||
59711184|NCT00890929|75829741|FG000|Initiated Treatment|Overall Study||43||
60107228|NCT01581658|76226490|FG000|COMPLETED|Overall Study||8||
60107229|NCT01581658|76226491|FG001|COMPLETED|Overall Study||8||
60107230|NCT01581658|76226492|FG002|COMPLETED|Overall Study||8||
59711185|NCT00890929|75829741|FG000|COMPLETED|Overall Study||39||
59711186|NCT00890929|75829741|FG000|NOT COMPLETED|Overall Study||6||
59711187|NCT00886639|75829745|FG000|STARTED|Overall Study||127||
59711188|NCT00886639|75829745|FG000|COMPLETED|Overall Study||111||
59711189|NCT00886639|75829745|FG000|NOT COMPLETED|Overall Study||16||
59711190|NCT00889603|75829749|FG000|STARTED|Overall Study||370||
59711191|NCT00889603|75829749|FG000|COMPLETED|Overall Study||333||
59711192|NCT00889603|75829749|FG000|NOT COMPLETED|Overall Study||37||
59711193|NCT00886483|75829755|FG000|STARTED|Overall Study||26||
59711194|NCT00886483|75829756|FG001|STARTED|Overall Study||13||
59711195|NCT00886483|75829755|FG000|Completed 20 Treatments|Overall Study||25||
59711196|NCT00886483|75829756|FG001|Completed 20 Treatments|Overall Study||11||
59711197|NCT00886483|75829755|FG000|COMPLETED|Overall Study||24||
59711198|NCT00886483|75829756|FG001|COMPLETED|Overall Study||10||
59711199|NCT00886483|75829755|FG000|NOT COMPLETED|Overall Study||2||
59711200|NCT00886483|75829756|FG001|NOT COMPLETED|Overall Study||3||
59711201|NCT00886015|75829772|FG000|STARTED|Overall Study|1674 eyes; 960 participants|1674||
59711202|NCT00886015|75829773|FG001|STARTED|Overall Study|1671 eyes; 957 participants|1671||
60107231|NCT01581658|76226493|FG003|COMPLETED|Overall Study||8||
59711203|NCT00886015|75829772|FG000|COMPLETED|Overall Study|1674 eyes; 960 participants|1674||
59711204|NCT00886015|75829773|FG001|COMPLETED|Overall Study|1669 eyes; 956 participants|1669||
59711205|NCT00886015|75829772|FG000|NOT COMPLETED|Overall Study||0||
59711206|NCT00886015|75829773|FG001|NOT COMPLETED|Overall Study||2||
59711207|NCT00890695|75829781|FG000|STARTED|Overall Study||32||
59711208|NCT00890695|75829782|FG001|STARTED|Overall Study||33||
59711209|NCT00890695|75829781|FG000|COMPLETED|Overall Study||31||
59711210|NCT00890695|75829782|FG001|COMPLETED|Overall Study||33||
60107232|NCT01581658|76226490|FG000|NOT COMPLETED|Overall Study||0||
60107233|NCT01581658|76226491|FG001|NOT COMPLETED|Overall Study||0||
60107234|NCT01581658|76226492|FG002|NOT COMPLETED|Overall Study||0||
60107235|NCT01581658|76226493|FG003|NOT COMPLETED|Overall Study||0||
60107236|NCT01530178|76226505|FG000|STARTED|Overall Study||2||
60107237|NCT01530178|76226506|FG001|STARTED|Overall Study||6||
60107238|NCT01530178|76226505|FG000|COMPLETED|Overall Study||2||
60107239|NCT01530178|76226506|FG001|COMPLETED|Overall Study||6||
60107240|NCT01530178|76226505|FG000|NOT COMPLETED|Overall Study||0||
60107241|NCT01530178|76226506|FG001|NOT COMPLETED|Overall Study||0||
60107242|NCT01581970|76226516|FG000|STARTED|Overall Study||7||
60107243|NCT01581970|76226516|FG000|COMPLETED|Overall Study||7||
60107244|NCT01581970|76226516|FG000|NOT COMPLETED|Overall Study||0||
60107245|NCT01583452|76226522|FG000|STARTED|Overall Study||21||
60107246|NCT01583452|76226523|FG001|STARTED|Overall Study||20||
60107247|NCT01583452|76226522|FG000|COMPLETED|Overall Study||21||
60107248|NCT01583452|76226523|FG001|COMPLETED|Overall Study||20||
60107249|NCT01583452|76226522|FG000|NOT COMPLETED|Overall Study||0||
60107250|NCT01583452|76226523|FG001|NOT COMPLETED|Overall Study||0||
60107251|NCT01531738|76226534|FG000|STARTED|Overall Study||11||
60107252|NCT01531738|76226535|FG001|STARTED|Overall Study||11||
60107253|NCT01531738|76226534|FG000|COMPLETED|Overall Study||11||
59711211|NCT00890695|75829781|FG000|NOT COMPLETED|Overall Study||1||
59711212|NCT00890695|75829782|FG001|NOT COMPLETED|Overall Study||0||
59711213|NCT00957580|75829791|FG000|STARTED|Overall Study||33||
59711214|NCT00957580|75829792|FG001|STARTED|Overall Study||33||
59711215|NCT00957580|75829793|FG002|STARTED|Overall Study||15||
59711216|NCT00957580|75829791|FG000|Treated|Overall Study||33||
59711217|NCT00957580|75829792|FG001|Treated|Overall Study||32||
59711218|NCT00957580|75829793|FG002|Treated|Overall Study||15||
59711219|NCT00957580|75829791|FG000|COMPLETED|Overall Study||33||
59711220|NCT00957580|75829792|FG001|COMPLETED|Overall Study||31||
59711221|NCT00957580|75829793|FG002|COMPLETED|Overall Study||15||
59711222|NCT00957580|75829791|FG000|NOT COMPLETED|Overall Study||0||
59711223|NCT00957580|75829792|FG001|NOT COMPLETED|Overall Study||2||
59711224|NCT00957580|75829793|FG002|NOT COMPLETED|Overall Study||0||
59711225|NCT00957424|75829814|FG000|STARTED|Overall Study||67||
60107254|NCT01531738|76226535|FG001|COMPLETED|Overall Study||11||
59711226|NCT00957424|75829814|FG000|Follow-up #1|Overall Study||59||
59711227|NCT00957424|75829814|FG000|Follow-up #2|Overall Study||50||
60107255|NCT01531738|76226534|FG000|NOT COMPLETED|Overall Study||0||
60107256|NCT01531738|76226535|FG001|NOT COMPLETED|Overall Study||0||
60107257|NCT01583686|76226546|FG000|STARTED|Overall Study||3||
59711228|NCT00957424|75829814|FG000|COMPLETED|Overall Study||44||
59711229|NCT00957424|75829814|FG000|NOT COMPLETED|Overall Study||23||
59711230|NCT01061151|75829822|FG000|STARTED|Protocol Version 2.0: 04/2011-09/2012||855||
59711231|NCT01061151|75829823|FG001|STARTED|Protocol Version 2.0: 04/2011-09/2012||861||
59711232|NCT01061151|75829824|FG002|STARTED|Protocol Version 2.0: 04/2011-09/2012||25||
59711233|NCT01061151|75829825|FG003|STARTED|Protocol Version 2.0: 04/2011-09/2012||129||
59711234|NCT01061151|75829822|FG000|Mothers That Met All Inclusion Criteria|Protocol Version 2.0: 04/2011-09/2012||853||
59711235|NCT01061151|75829823|FG001|Mothers That Met All Inclusion Criteria|Protocol Version 2.0: 04/2011-09/2012||861||
59711236|NCT01061151|75829824|FG002|Mothers That Met All Inclusion Criteria|Protocol Version 2.0: 04/2011-09/2012||24||
59711237|NCT01061151|75829825|FG003|Mothers That Met All Inclusion Criteria|Protocol Version 2.0: 04/2011-09/2012||129||
59711238|NCT01061151|75829822|FG000|COMPLETED|Protocol Version 2.0: 04/2011-09/2012||623||
59711239|NCT01061151|75829823|FG001|COMPLETED|Protocol Version 2.0: 04/2011-09/2012||620||
59711240|NCT01061151|75829824|FG002|COMPLETED|Protocol Version 2.0: 04/2011-09/2012||16||
59711241|NCT01061151|75829825|FG003|COMPLETED|Protocol Version 2.0: 04/2011-09/2012||101||
59711242|NCT01061151|75829822|FG000|NOT COMPLETED|Protocol Version 2.0: 04/2011-09/2012||232||
59711243|NCT01061151|75829823|FG001|NOT COMPLETED|Protocol Version 2.0: 04/2011-09/2012||241||
59711244|NCT01061151|75829824|FG002|NOT COMPLETED|Protocol Version 2.0: 04/2011-09/2012||9||
59711245|NCT01061151|75829825|FG003|NOT COMPLETED|Protocol Version 2.0: 04/2011-09/2012||28||
59711246|NCT01061151|75829822|FG000|STARTED|Protocol Version 3.0: 10/2012-10/2014||694||
59818916|NCT00343252|75941096|FG000|COMPLETED|18 Months (All Treated Participants)||259||
59818917|NCT00343252|75941097|FG001|COMPLETED|18 Months (All Treated Participants)||269||
59818918|NCT00343252|75941096|FG000|NOT COMPLETED|18 Months (All Treated Participants)||101||
59818919|NCT00343252|75941097|FG001|NOT COMPLETED|18 Months (All Treated Participants)||81||
59818920|NCT00342628|75941106|FG000|STARTED|Overall Study||100||
60107258|NCT01583686|76226547|FG001|STARTED|Overall Study||3||
60107259|NCT01583686|76226548|FG002|STARTED|Overall Study||3||
60107260|NCT01583686|76226549|FG003|STARTED|Overall Study||3||
60107261|NCT01583686|76226550|FG004|STARTED|Overall Study||3||
60107262|NCT01583686|76226546|FG000|COMPLETED|Overall Study||3||
60107263|NCT01583686|76226547|FG001|COMPLETED|Overall Study||3||
60107264|NCT01583686|76226548|FG002|COMPLETED|Overall Study||3||
60107265|NCT01583686|76226549|FG003|COMPLETED|Overall Study||3||
60107266|NCT01583686|76226550|FG004|COMPLETED|Overall Study||3||
60107267|NCT01583686|76226546|FG000|NOT COMPLETED|Overall Study||0||
60107268|NCT01583686|76226547|FG001|NOT COMPLETED|Overall Study||0||
60107269|NCT01583686|76226548|FG002|NOT COMPLETED|Overall Study||0||
60107270|NCT01583686|76226549|FG003|NOT COMPLETED|Overall Study||0||
60107271|NCT01583686|76226550|FG004|NOT COMPLETED|Overall Study||0||
60107272|NCT01532128|76226568|FG000|STARTED|Overall Study||8||
60107273|NCT01532128|76226569|FG001|STARTED|Overall Study||8||
60107274|NCT01532128|76226570|FG002|STARTED|Overall Study||8||
60107275|NCT01532128|76226568|FG000|COMPLETED|Overall Study||8||
60107276|NCT01532128|76226569|FG001|COMPLETED|Overall Study||8||
60107277|NCT01532128|76226570|FG002|COMPLETED|Overall Study||8||
60107278|NCT01532128|76226568|FG000|NOT COMPLETED|Overall Study||0||
60107279|NCT01532128|76226569|FG001|NOT COMPLETED|Overall Study||0||
60107280|NCT01532128|76226570|FG002|NOT COMPLETED|Overall Study||0||
60107281|NCT01584388|76226579|FG000|STARTED|Overall Study||30||
60107282|NCT01584388|76226579|FG000|COMPLETED|Overall Study||30||
60107283|NCT01584388|76226579|FG000|NOT COMPLETED|Overall Study||0||
60107284|NCT01584544|76226602|FG000|STARTED|Overall Study||3||
60107285|NCT01584544|76226603|FG001|STARTED|Overall Study||6||
59566614|NCT02271386|75669270|FG003|STARTED|Baseline Period- 8 Months||191||
59711247|NCT01061151|75829823|FG001|STARTED|Protocol Version 3.0: 10/2012-10/2014||686||
59711248|NCT01061151|75829824|FG002|STARTED|Protocol Version 3.0: 10/2012-10/2014||422||
59711249|NCT01061151|75829825|FG003|STARTED|Protocol Version 3.0: 10/2012-10/2014||75||
59711250|NCT01061151|75829822|FG000|Mothers That Met All Inclusion Criteria|Protocol Version 3.0: 10/2012-10/2014||694||
59711251|NCT01061151|75829823|FG001|Mothers That Met All Inclusion Criteria|Protocol Version 3.0: 10/2012-10/2014||684||
59711252|NCT01061151|75829824|FG002|Mothers That Met All Inclusion Criteria|Protocol Version 3.0: 10/2012-10/2014||421||
59711253|NCT01061151|75829825|FG003|Mothers That Met All Inclusion Criteria|Protocol Version 3.0: 10/2012-10/2014||75||
59711254|NCT01061151|75829822|FG000|COMPLETED|Protocol Version 3.0: 10/2012-10/2014||542||
59711255|NCT01061151|75829823|FG001|COMPLETED|Protocol Version 3.0: 10/2012-10/2014||548||
59818921|NCT00342628|75941107|FG001|STARTED|Overall Study||101||
59818922|NCT00342628|75941108|FG002|STARTED|Overall Study||100||
60107286|NCT01584544|76226604|FG002|STARTED|Overall Study||6||
60107287|NCT01584544|76226605|FG003|STARTED|Overall Study||3||
60107288|NCT01584544|76226606|FG004|STARTED|Overall Study||6||
60107289|NCT01584544|76226602|FG000|COMPLETED|Overall Study||3||
60107290|NCT01584544|76226603|FG001|COMPLETED|Overall Study||6||
59711256|NCT01061151|75829824|FG002|COMPLETED|Protocol Version 3.0: 10/2012-10/2014||345||
59711257|NCT01061151|75829825|FG003|COMPLETED|Protocol Version 3.0: 10/2012-10/2014||55||
59711258|NCT01061151|75829822|FG000|NOT COMPLETED|Protocol Version 3.0: 10/2012-10/2014||152||
59711259|NCT01061151|75829823|FG001|NOT COMPLETED|Protocol Version 3.0: 10/2012-10/2014||138||
59711260|NCT01061151|75829824|FG002|NOT COMPLETED|Protocol Version 3.0: 10/2012-10/2014||77||
59711261|NCT01061151|75829825|FG003|NOT COMPLETED|Protocol Version 3.0: 10/2012-10/2014||20||
59711262|NCT01241552|75829849|FG000|STARTED|Overall Study||242||
59711263|NCT01241552|75829850|FG001|STARTED|Overall Study||403||
59711264|NCT01241552|75829851|FG002|STARTED|Overall Study||403||
59711265|NCT01241552|75829852|FG003|STARTED|Overall Study||404||
59711266|NCT01241552|75829849|FG000|Treated|Overall Study||235||
60107291|NCT01584544|76226604|FG002|COMPLETED|Overall Study||6||
60107292|NCT01584544|76226605|FG003|COMPLETED|Overall Study||3||
60107293|NCT01584544|76226606|FG004|COMPLETED|Overall Study||6||
59566615|NCT02271386|75669267|FG000|COMPLETED|Baseline Period- 8 Months||53||
59566616|NCT02271386|75669268|FG001|COMPLETED|Baseline Period- 8 Months||52||
59566617|NCT02271386|75669269|FG002|COMPLETED|Baseline Period- 8 Months||200||
59566618|NCT02271386|75669270|FG003|COMPLETED|Baseline Period- 8 Months||191||
59566619|NCT02271386|75669267|FG000|NOT COMPLETED|Baseline Period- 8 Months||0||
59711267|NCT01241552|75829850|FG001|Treated|Overall Study||392||
60107294|NCT01584544|76226602|FG000|NOT COMPLETED|Overall Study||0||
60107295|NCT01584544|76226603|FG001|NOT COMPLETED|Overall Study||0||
60107296|NCT01584544|76226604|FG002|NOT COMPLETED|Overall Study||0||
60107297|NCT01584544|76226605|FG003|NOT COMPLETED|Overall Study||0||
59711268|NCT01241552|75829851|FG002|Treated|Overall Study||388||
59711269|NCT01241552|75829852|FG003|Treated|Overall Study||397||
59711270|NCT01241552|75829849|FG000|COMPLETED|Overall Study||201||
59711271|NCT01241552|75829850|FG001|COMPLETED|Overall Study||340||
59711272|NCT01241552|75829851|FG002|COMPLETED|Overall Study||343||
59711273|NCT01241552|75829852|FG003|COMPLETED|Overall Study||340||
59711274|NCT01241552|75829849|FG000|NOT COMPLETED|Overall Study||41||
59711275|NCT01241552|75829850|FG001|NOT COMPLETED|Overall Study||63||
59711276|NCT01241552|75829851|FG002|NOT COMPLETED|Overall Study||60||
59711277|NCT01241552|75829852|FG003|NOT COMPLETED|Overall Study||64||
59818923|NCT00342628|75941106|FG000|COMPLETED|Overall Study|84 completed 4 injections, 4 were lost-to-followup after the 4th injection|80||
59818924|NCT00342628|75941107|FG001|COMPLETED|Overall Study|83 completed 4 injections, 3 were lost-to-followup after 4th injection|80||
60107298|NCT01584544|76226606|FG004|NOT COMPLETED|Overall Study||0||
60107299|NCT01532830|76226618|FG000|STARTED|Overall Study||30||
59711278|NCT00948922|75829865|FG000|STARTED|Overall Study||34||
59711279|NCT00948922|75829866|FG001|STARTED|Overall Study||51||
59711280|NCT00948922|75829867|FG002|STARTED|Overall Study||39||
59711281|NCT00948922|75829865|FG000|COMPLETED|Overall Study||26||
59711282|NCT00948922|75829866|FG001|COMPLETED|Overall Study||37||
59711283|NCT00948922|75829867|FG002|COMPLETED|Overall Study||38||
60107300|NCT01532830|76226618|FG000|COMPLETED|Overall Study||26||
59566620|NCT02271386|75669268|FG001|NOT COMPLETED|Baseline Period- 8 Months||0||
59711284|NCT00948922|75829865|FG000|NOT COMPLETED|Overall Study||8||
59711285|NCT00948922|75829866|FG001|NOT COMPLETED|Overall Study||14||
59711286|NCT00948922|75829867|FG002|NOT COMPLETED|Overall Study||1||
59711287|NCT01239992|75829879|FG000|STARTED|Overall Study||12||
60107301|NCT01532830|76226618|FG000|NOT COMPLETED|Overall Study||4||
60107302|NCT01802333|76226625|FG000|STARTED|Overall Study||263||
60107303|NCT01802333|76226626|FG001|STARTED|Overall Study||267||
60107304|NCT01802333|76226627|FG002|STARTED|Overall Study||224||
60107305|NCT01802333|76226625|FG000|High Risk Patients|Overall Study||60||
60107306|NCT01802333|76226626|FG001|High Risk Patients|Overall Study||61||
60107307|NCT01802333|76226627|FG002|High Risk Patients|Overall Study||38||
60107308|NCT01802333|76226625|FG000|High Risk Patients Achieved CR/CRi|Overall Study||38||
60107309|NCT01802333|76226626|FG001|High Risk Patients Achieved CR/CRi|Overall Study||40||
60107310|NCT01802333|76226627|FG002|High Risk Patients Achieved CR/CRi|Overall Study||29||
60107311|NCT01802333|76226625|FG000|Known NPM1 Status at Baseline|Overall Study||169||
60107312|NCT01802333|76226626|FG001|Known NPM1 Status at Baseline|Overall Study||156||
60107313|NCT01802333|76226627|FG002|Known NPM1 Status at Baseline|Overall Study||142||
60107314|NCT01802333|76226625|FG000|Known Cytogenetic Risk at Baseline|Overall Study||252||
60107315|NCT01802333|76226626|FG001|Known Cytogenetic Risk at Baseline|Overall Study||250||
60107316|NCT01802333|76226627|FG002|Known Cytogenetic Risk at Baseline|Overall Study||210||
60107317|NCT01802333|76226625|FG000|COMPLETED|Overall Study||214||
60107318|NCT01802333|76226626|FG001|COMPLETED|Overall Study||206||
60107319|NCT01802333|76226627|FG002|COMPLETED|Overall Study||161||
60107320|NCT01802333|76226625|FG000|NOT COMPLETED|Overall Study||49||
60107321|NCT01802333|76226626|FG001|NOT COMPLETED|Overall Study||61||
60107322|NCT01802333|76226627|FG002|NOT COMPLETED|Overall Study||63||
60107323|NCT01585324|76226641|FG000|STARTED|Overall Study||30||
60107324|NCT01585324|76226641|FG000|COMPLETED|Overall Study||30||
60107325|NCT01585324|76226641|FG000|NOT COMPLETED|Overall Study||0||
60107326|NCT01586026|76226647|FG000|STARTED|Overall Study||350||
60107327|NCT01586026|76226648|FG001|STARTED|Overall Study||414||
60107328|NCT01586026|76226649|FG002|STARTED|Overall Study||271||
60107329|NCT01586026|76226647|FG000|COMPLETED|Overall Study||350||
60107330|NCT01586026|76226648|FG001|COMPLETED|Overall Study||414||
60107331|NCT01586026|76226649|FG002|COMPLETED|Overall Study||271||
60107332|NCT01586026|76226647|FG000|NOT COMPLETED|Overall Study||0||
60107333|NCT01586026|76226648|FG001|NOT COMPLETED|Overall Study||0||
60107334|NCT01586026|76226649|FG002|NOT COMPLETED|Overall Study||0||
60107335|NCT01586962|76226657|FG000|STARTED|Overall Study||56||
60107336|NCT01586962|76226657|FG000|COMPLETED|Overall Study||56||
60107337|NCT01586962|76226657|FG000|NOT COMPLETED|Overall Study||0||
60107338|NCT01588444|76226663|FG000|STARTED|Overall Study||20||
60107339|NCT01588444|76226664|FG001|STARTED|Overall Study||20||
60107340|NCT01588444|76226663|FG000|COMPLETED|Overall Study||20||
60107341|NCT01588444|76226664|FG001|COMPLETED|Overall Study||20||
60107342|NCT01588444|76226663|FG000|NOT COMPLETED|Overall Study||0||
60107343|NCT01588444|76226664|FG001|NOT COMPLETED|Overall Study||0||
60107344|NCT00980655|76226672|FG000|STARTED|Overall Study||61||
60107345|NCT00980655|76226673|FG001|STARTED|Overall Study||190||
60107346|NCT00980655|76226672|FG000|Vaccinated 13vPnC Dose 1|Overall Study||59||
60107347|NCT00980655|76226673|FG001|Vaccinated 13vPnC Dose 1|Overall Study||188||
60107348|NCT00980655|76226672|FG000|Vaccinated 13vPnC Dose 2|Overall Study||55||
60107349|NCT00980655|76226673|FG001|Vaccinated 13vPnC Dose 2|Overall Study||176||
60107350|NCT00980655|76226672|FG000|Vaccinated 13vPnC Dose 3|Overall Study||54||
60107351|NCT00980655|76226673|FG001|Vaccinated 13vPnC Dose 3|Overall Study||167||
60107352|NCT00980655|76226672|FG000|Vaccinated 13vPnC Dose 4|Overall Study||46||
60107353|NCT00980655|76226673|FG001|Vaccinated 13vPnC Dose 4|Overall Study||146||
60107354|NCT00980655|76226672|FG000|Vaccinated 23vPS Dose|Overall Study||45||
60107355|NCT00980655|76226673|FG001|Vaccinated 23vPS Dose|Overall Study||140||
60107356|NCT00980655|76226672|FG000|COMPLETED|Overall Study||45||
60107357|NCT00980655|76226673|FG001|COMPLETED|Overall Study||139||
60107358|NCT00980655|76226672|FG000|NOT COMPLETED|Overall Study||16||
60107359|NCT00980655|76226673|FG001|NOT COMPLETED|Overall Study||51||
60107360|NCT01535014|76226688|FG000|STARTED|Overall Study||210||
60107361|NCT01535014|76226689|FG001|STARTED|Overall Study||200||
60107362|NCT01535014|76226690|FG002|STARTED|Overall Study||50||
60107363|NCT01535014|76226691|FG003|STARTED|Overall Study||33||
60107364|NCT01535014|76226688|FG000|COMPLETED|Overall Study||208||
60107365|NCT01535014|76226689|FG001|COMPLETED|Overall Study||194||
60107366|NCT01535014|76226690|FG002|COMPLETED|Overall Study||49||
60107367|NCT01535014|76226691|FG003|COMPLETED|Overall Study||33||
60107368|NCT01535014|76226688|FG000|NOT COMPLETED|Overall Study||2||
60107369|NCT01535014|76226689|FG001|NOT COMPLETED|Overall Study||6||
60107370|NCT01535014|76226690|FG002|NOT COMPLETED|Overall Study||1||
60107371|NCT01535014|76226691|FG003|NOT COMPLETED|Overall Study||0||
60107372|NCT01535326|76226702|FG000|STARTED|Overall Study||90||
60107373|NCT01535326|76226703|FG001|STARTED|Overall Study||90||
60107374|NCT01535326|76226704|FG002|STARTED|Overall Study||90||
60107375|NCT01535326|76226702|FG000|COMPLETED|Overall Study||90||
60107376|NCT01535326|76226703|FG001|COMPLETED|Overall Study||90||
60107377|NCT01535326|76226704|FG002|COMPLETED|Overall Study||90||
60107378|NCT01535326|76226702|FG000|NOT COMPLETED|Overall Study||0||
60107379|NCT01535326|76226703|FG001|NOT COMPLETED|Overall Study||0||
60107380|NCT01535326|76226704|FG002|NOT COMPLETED|Overall Study||0||
60107381|NCT01801865|76226715|FG000|STARTED|Overall Study||657||
60107382|NCT01801865|76226715|FG000|COMPLETED|Overall Study||615||
60107383|NCT01801865|76226715|FG000|NOT COMPLETED|Overall Study||42||
59818925|NCT00342628|75941108|FG002|COMPLETED|Overall Study|97 completed 3 injections of DTP alone, 16 were lost-to-followup for blood drawing at 12 months.|81||
60107384|NCT01590238|76226719|FG000|STARTED|Overall Study||15||
60107385|NCT01590238|76226719|FG000|COMPLETED|Overall Study||13||
60107386|NCT01590238|76226719|FG000|NOT COMPLETED|Overall Study||2||
60107387|NCT00980343|76226725|FG000|STARTED|Overall Study||21||
60107388|NCT00980343|76226726|FG001|STARTED|Overall Study||23||
60107389|NCT00980343|76226725|FG000|COMPLETED|Overall Study||20||
60107390|NCT00980343|76226726|FG001|COMPLETED|Overall Study||20||
60107391|NCT00980343|76226725|FG000|NOT COMPLETED|Overall Study||1||
60107392|NCT00980343|76226726|FG001|NOT COMPLETED|Overall Study||3||
60107393|NCT01801475|76226736|FG000|STARTED|Overall Study||10||
60107394|NCT01801475|76226737|FG001|STARTED|Overall Study||30||
60107395|NCT01801475|76226738|FG002|STARTED|Overall Study||10||
60107396|NCT01801475|76226739|FG003|STARTED|Overall Study||10||
60107397|NCT01801475|76226740|FG004|STARTED|Overall Study||40||
60107398|NCT01801475|76226736|FG000|COMPLETED|Overall Study||10||
60107399|NCT01801475|76226737|FG001|COMPLETED|Overall Study||30||
60107400|NCT01801475|76226738|FG002|COMPLETED|Overall Study||10||
60107401|NCT01801475|76226739|FG003|COMPLETED|Overall Study||10||
60107402|NCT01801475|76226740|FG004|COMPLETED|Overall Study||39||
60107403|NCT01801475|76226736|FG000|NOT COMPLETED|Overall Study||0||
60107404|NCT01801475|76226737|FG001|NOT COMPLETED|Overall Study||0||
60107405|NCT01801475|76226738|FG002|NOT COMPLETED|Overall Study||0||
60107406|NCT01801475|76226739|FG003|NOT COMPLETED|Overall Study||0||
60107407|NCT01801475|76226740|FG004|NOT COMPLETED|Overall Study||1||
60107408|NCT01536184|76226751|FG000|STARTED|Overall Study||8||
60107409|NCT01536184|76226752|FG001|STARTED|Overall Study||4||
60107410|NCT01536184|76226751|FG000|COMPLETED|Overall Study||8||
60107411|NCT01536184|76226752|FG001|COMPLETED|Overall Study||4||
60107412|NCT01536184|76226751|FG000|NOT COMPLETED|Overall Study||0||
60107413|NCT01536184|76226752|FG001|NOT COMPLETED|Overall Study||0||
60107414|NCT01536496|76226760|FG000|STARTED|Overall Study||57||
60107415|NCT01536496|76226761|FG001|STARTED|Overall Study||57||
60107416|NCT01536496|76226760|FG000|COMPLETED|Overall Study||55||
60107417|NCT01536496|76226761|FG001|COMPLETED|Overall Study||56||
60107418|NCT01536496|76226760|FG000|NOT COMPLETED|Overall Study||2||
60107419|NCT01536496|76226761|FG001|NOT COMPLETED|Overall Study||1||
60107420|NCT02337933|76226771|FG000|STARTED|Overall Study||12||
60107421|NCT02337933|76226772|FG001|STARTED|Overall Study||12||
60107422|NCT02337933|76226771|FG000|COMPLETED|Overall Study||12||
60107423|NCT02337933|76226772|FG001|COMPLETED|Overall Study||12||
60107424|NCT02337933|76226771|FG000|NOT COMPLETED|Overall Study||0||
60107425|NCT02337933|76226772|FG001|NOT COMPLETED|Overall Study||0||
60107426|NCT01536886|76226782|FG000|STARTED|Overall Study||141||
60107427|NCT01536886|76226783|FG001|STARTED|Overall Study||135||
60107428|NCT01536886|76226784|FG002|STARTED|Overall Study||49||
60107429|NCT01536886|76226785|FG003|STARTED|Overall Study||51||
60107430|NCT01536886|76226782|FG000|COMPLETED|Overall Study||136||
60107431|NCT01536886|76226783|FG001|COMPLETED|Overall Study||127||
60107432|NCT01536886|76226784|FG002|COMPLETED|Overall Study||47||
60107433|NCT01536886|76226785|FG003|COMPLETED|Overall Study||48||
60107434|NCT01536886|76226782|FG000|NOT COMPLETED|Overall Study||5||
60107435|NCT01536886|76226783|FG001|NOT COMPLETED|Overall Study||8||
60107436|NCT01536886|76226784|FG002|NOT COMPLETED|Overall Study||2||
60107437|NCT01536886|76226785|FG003|NOT COMPLETED|Overall Study||3||
60107438|NCT01822925|76226799|FG000|STARTED|Overall Study||32||
60107439|NCT01822925|76226800|FG001|STARTED|Overall Study||32||
60107440|NCT01822925|76226801|FG002|STARTED|Overall Study||32||
60107441|NCT01822925|76226802|FG003|STARTED|Overall Study||32||
60107442|NCT01822925|76226799|FG000|COMPLETED|Overall Study||26||
60107443|NCT01822925|76226800|FG001|COMPLETED|Overall Study||30||
60107444|NCT01822925|76226801|FG002|COMPLETED|Overall Study||29||
60107445|NCT01822925|76226802|FG003|COMPLETED|Overall Study||27||
60107446|NCT01822925|76226799|FG000|NOT COMPLETED|Overall Study||6||
60107447|NCT01822925|76226800|FG001|NOT COMPLETED|Overall Study||2||
60107448|NCT01822925|76226801|FG002|NOT COMPLETED|Overall Study||3||
60107449|NCT01822925|76226802|FG003|NOT COMPLETED|Overall Study||5||
60107450|NCT03041415|76226814|FG000|STARTED|Overall Study||140||5
60107451|NCT03041415|76226815|FG001|STARTED|Overall Study||160||5
60107452|NCT03041415|76226814|FG000|COMPLETED|Overall Study||123||5
60107453|NCT03041415|76226815|FG001|COMPLETED|Overall Study||145||5
60107454|NCT03041415|76226814|FG000|NOT COMPLETED|Overall Study||17||0
60107455|NCT03041415|76226815|FG001|NOT COMPLETED|Overall Study||15||0
60107456|NCT01590550|76226821|FG000|STARTED|Overall Study||18||
60107457|NCT01590550|76226821|FG000|COMPLETED|Overall Study||18||
60107458|NCT01590550|76226821|FG000|NOT COMPLETED|Overall Study||0||
60107459|NCT01591018|76226828|FG000|STARTED|Overall Study||60||
60107460|NCT01591018|76226829|FG001|STARTED|Overall Study||60||
60107461|NCT01591018|76226828|FG000|COMPLETED|Overall Study||60||
60107462|NCT01591018|76226829|FG001|COMPLETED|Overall Study||60||
60107463|NCT01591018|76226828|FG000|NOT COMPLETED|Overall Study||0||
60107464|NCT01591018|76226829|FG001|NOT COMPLETED|Overall Study||0||
60107465|NCT01801007|76226835|FG000|STARTED|Overall Study||145||
59818926|NCT00342628|75941106|FG000|NOT COMPLETED|Overall Study||20||
59818927|NCT00342628|75941107|FG001|NOT COMPLETED|Overall Study||21||
60107466|NCT01801007|76226835|FG000|COMPLETED|Overall Study||134||
60107467|NCT01801007|76226835|FG000|NOT COMPLETED|Overall Study||11||
59818928|NCT00342628|75941108|FG002|NOT COMPLETED|Overall Study||19||
59818929|NCT00505284|75941121|FG000|STARTED|Overall Study||73||
59818930|NCT00505284|75941122|FG001|STARTED|Overall Study||72||
59818931|NCT00505284|75941123|FG002|STARTED|Overall Study||69||
59818932|NCT00505284|75941124|FG003|STARTED|Overall Study||68||
60107468|NCT01822691|76226839|FG000|STARTED|Overall Study||15||
60107469|NCT01822691|76226839|FG000|COMPLETED|Overall Study||13||
60107470|NCT01822691|76226839|FG000|NOT COMPLETED|Overall Study||2||
60107471|NCT01822535|76226845|FG000|STARTED|Visit 1 - Tetraplegia and Able-Bodied||17||
60107472|NCT01822535|76226846|FG001|STARTED|Visit 1 - Tetraplegia and Able-Bodied||13||
59818933|NCT00505284|75941125|FG004|STARTED|Overall Study||70||
60107473|NCT01822535|76226845|FG000|COMPLETED|Visit 1 - Tetraplegia and Able-Bodied||11||
59818934|NCT00505284|75941121|FG000|COMPLETED|Overall Study||63||
60107474|NCT01822535|76226846|FG001|COMPLETED|Visit 1 - Tetraplegia and Able-Bodied||11||
60107475|NCT01822535|76226845|FG000|NOT COMPLETED|Visit 1 - Tetraplegia and Able-Bodied||6||
60107476|NCT01822535|76226846|FG001|NOT COMPLETED|Visit 1 - Tetraplegia and Able-Bodied||2||
60107477|NCT01822535|76226845|FG000|STARTED|Visit 2 - Tetraplegia Only - Drug|These subjects were individuals who completed Visit 1 of testing.|11||
60107478|NCT01822535|76226846|FG001|STARTED|Visit 2 - Tetraplegia Only - Drug|Able-bodied subjects were not enrolled for a second visit.|0||
60107479|NCT01822535|76226845|FG000|COMPLETED|Visit 2 - Tetraplegia Only - Drug||10||
60107480|NCT01822535|76226846|FG001|COMPLETED|Visit 2 - Tetraplegia Only - Drug||0||
60107481|NCT01822535|76226845|FG000|NOT COMPLETED|Visit 2 - Tetraplegia Only - Drug||1||
60107482|NCT01822535|76226846|FG001|NOT COMPLETED|Visit 2 - Tetraplegia Only - Drug||0||
60107483|NCT01537666|76226859|FG000|STARTED|Overall Study|2 of these 6 also received a single 250 mg IV dose of vancomycin at least 72 hours after AeroVanc.|6||
59566621|NCT02271386|75669269|FG002|NOT COMPLETED|Baseline Period- 8 Months||0||
59566622|NCT02271386|75669270|FG003|NOT COMPLETED|Baseline Period- 8 Months||0||
59566623|NCT02271386|75669267|FG000|STARTED|Intervention Period- 8 Months||53||
59566624|NCT02271386|75669268|FG001|STARTED|Intervention Period- 8 Months||52||
59566625|NCT02271386|75669269|FG002|STARTED|Intervention Period- 8 Months||202||
59566626|NCT02271386|75669270|FG003|STARTED|Intervention Period- 8 Months||197||
59566627|NCT02271386|75669267|FG000|COMPLETED|Intervention Period- 8 Months||53||
59566628|NCT02271386|75669268|FG001|COMPLETED|Intervention Period- 8 Months||52||
59566629|NCT02271386|75669269|FG002|COMPLETED|Intervention Period- 8 Months||202||
59566630|NCT02271386|75669270|FG003|COMPLETED|Intervention Period- 8 Months||197||
59566631|NCT02271386|75669267|FG000|NOT COMPLETED|Intervention Period- 8 Months||0||
59566632|NCT02271386|75669268|FG001|NOT COMPLETED|Intervention Period- 8 Months||0||
59566633|NCT02271386|75669269|FG002|NOT COMPLETED|Intervention Period- 8 Months||0||
59566634|NCT02271386|75669270|FG003|NOT COMPLETED|Intervention Period- 8 Months||0||
59566635|NCT04091061|75669288|FG000|STARTED|Overall Study||6||
59566636|NCT04091061|75669289|FG001|STARTED|Overall Study||6||
59566637|NCT04091061|75669290|FG002|STARTED|Overall Study||6||
59566638|NCT04091061|75669291|FG003|STARTED|Overall Study||6||
59566639|NCT04091061|75669288|FG000|COMPLETED|Overall Study||6||
59566640|NCT04091061|75669289|FG001|COMPLETED|Overall Study||6||
59566641|NCT04091061|75669290|FG002|COMPLETED|Overall Study||6||
59566642|NCT04091061|75669291|FG003|COMPLETED|Overall Study||6||
59566643|NCT04091061|75669288|FG000|NOT COMPLETED|Overall Study||0||
59566644|NCT04091061|75669289|FG001|NOT COMPLETED|Overall Study||0||
59566645|NCT04091061|75669290|FG002|NOT COMPLETED|Overall Study||0||
59566646|NCT04091061|75669291|FG003|NOT COMPLETED|Overall Study||0||
59566647|NCT01872338|75669303|FG000|STARTED|Overall Study||66||
59566648|NCT01872338|75669304|FG001|STARTED|Overall Study||69||
59566649|NCT01872338|75669303|FG000|COMPLETED|Overall Study||46||
60107484|NCT01537666|76226860|FG001|STARTED|Overall Study|2 of these 6 also received a single 250 mg IV dose of vancomycin at least 72 hours after AeroVanc.|6||
60107485|NCT01537666|76226861|FG002|STARTED|Overall Study|2 of these 6 also received a single 250 mg IV dose of vancomycin at least 72 hours after AeroVanc.|6||
60107486|NCT01537666|76226862|FG003|STARTED|Overall Study|5 of 7 patients received a 32 mg dose of AeroVanc followed by a dose of 80 mg at least 1 week later.|7||
60107487|NCT01537666|76226859|FG000|COMPLETED|Overall Study||6||
60107488|NCT01537666|76226860|FG001|COMPLETED|Overall Study||6||
60107489|NCT01537666|76226861|FG002|COMPLETED|Overall Study||6||
60107490|NCT01537666|76226862|FG003|COMPLETED|Overall Study|1 patient withdrew after a 32 mg dose and was replaced by a patient who only received an 80 mg dose.|7||
60107491|NCT01537666|76226859|FG000|NOT COMPLETED|Overall Study||0||
60107492|NCT01537666|76226860|FG001|NOT COMPLETED|Overall Study||0||
60107493|NCT01537666|76226861|FG002|NOT COMPLETED|Overall Study||0||
60107494|NCT01537666|76226862|FG003|NOT COMPLETED|Overall Study||0||
60107495|NCT01537900|76226882|FG000|STARTED|Overall Study||4||
60107496|NCT01537900|76226882|FG000|COMPLETED|Overall Study||4||
60107497|NCT01537900|76226882|FG000|NOT COMPLETED|Overall Study||0||
60107498|NCT01591408|76226888|FG000|STARTED|Overall Study||36||
60107499|NCT01591408|76226889|FG001|STARTED|Overall Study||32||
60107500|NCT01591408|76226888|FG000|COMPLETED|Overall Study||24||
59566650|NCT01872338|75669304|FG001|COMPLETED|Overall Study||69||
60107501|NCT01591408|76226889|FG001|COMPLETED|Overall Study||24||
59566651|NCT01872338|75669303|FG000|NOT COMPLETED|Overall Study||20||
59566652|NCT01872338|75669304|FG001|NOT COMPLETED|Overall Study||0||
59566653|NCT04079127|75669310|FG000|STARTED|Overall Study|hips (in 141 patients)|150||
59566654|NCT04079127|75669310|FG000|COMPLETED|Overall Study|89 hips have completed the study, and all 10 year data of 81 were available for analysis.|89||
59566655|NCT04079127|75669310|FG000|NOT COMPLETED|Overall Study||61||
59566656|NCT03862755|75669314|FG000|STARTED|Overall Study||581||
59566657|NCT03862755|75669314|FG000|COMPLETED|Overall Study||581||
59566658|NCT03862755|75669314|FG000|NOT COMPLETED|Overall Study||0||
59566659|NCT01874132|75669321|FG000|STARTED|Overall Study||22||
59566660|NCT01874132|75669322|FG001|STARTED|Overall Study||22||
59566661|NCT01874132|75669323|FG002|STARTED|Overall Study||22||
59566662|NCT01874132|75669321|FG000|COMPLETED|Overall Study||18||
59566663|NCT01874132|75669322|FG001|COMPLETED|Overall Study||18||
59566664|NCT01874132|75669323|FG002|COMPLETED|Overall Study||19||
59566665|NCT01874132|75669321|FG000|NOT COMPLETED|Overall Study||4||
59711288|NCT01239992|75829879|FG000|COMPLETED|Overall Study||10||
60107502|NCT01591408|76226888|FG000|NOT COMPLETED|Overall Study||12||
60107503|NCT01591408|76226889|FG001|NOT COMPLETED|Overall Study||8||
60107504|NCT01539070|76226897|FG000|STARTED|Overall Study||168||
60107505|NCT01539070|76226898|FG001|STARTED|Overall Study||138||
60107506|NCT01539070|76226897|FG000|COMPLETED|Overall Study||109||
60107507|NCT01539070|76226898|FG001|COMPLETED|Overall Study||99||
60107508|NCT01539070|76226897|FG000|NOT COMPLETED|Overall Study||59||
60107509|NCT01539070|76226898|FG001|NOT COMPLETED|Overall Study||39||
60107510|NCT01592500|76226908|FG000|STARTED|Overall Study|Randomized Participants|14||
59711289|NCT01239992|75829879|FG000|NOT COMPLETED|Overall Study||2||
59711290|NCT01239680|75829885|FG000|STARTED|Overall Study||3||
59711291|NCT01239680|75829886|FG001|STARTED|Overall Study||2||
59711292|NCT01239680|75829885|FG000|COMPLETED|Overall Study||1||
59711293|NCT01239680|75829886|FG001|COMPLETED|Overall Study||2||
59711294|NCT01239680|75829885|FG000|NOT COMPLETED|Overall Study||2||
59711295|NCT01239680|75829886|FG001|NOT COMPLETED|Overall Study||0||
59711296|NCT01238900|75829892|FG000|STARTED|6 Months Post Stent Placement||23||
59711297|NCT01238900|75829892|FG000|COMPLETED|6 Months Post Stent Placement||23||
59711298|NCT01238900|75829892|FG000|NOT COMPLETED|6 Months Post Stent Placement||0||
59711299|NCT01238900|75829892|FG000|STARTED|<12 Months Post Stent Removal||23||
59711300|NCT01238900|75829892|FG000|COMPLETED|<12 Months Post Stent Removal||18||
59711301|NCT01238900|75829892|FG000|NOT COMPLETED|<12 Months Post Stent Removal||5||
59711302|NCT01238822|75829897|FG000|STARTED|Overall Study||96||
59711303|NCT01238822|75829897|FG000|Received Placebo|Overall Study||93||
59711304|NCT01238822|75829897|FG000|Received Low Dosage|Overall Study||93||
59711305|NCT01238822|75829897|FG000|Received Medium Dosage|Overall Study||93||
59711306|NCT01238822|75829897|FG000|Received High Dosage|Overall Study||93||
59711307|NCT01238822|75829897|FG000|COMPLETED|Overall Study||93||
59711308|NCT01238822|75829897|FG000|NOT COMPLETED|Overall Study||3||
59711309|NCT01238588|75829907|FG000|STARTED|Overall Study||12||
59711310|NCT01238588|75829907|FG000|COMPLETED|Overall Study||9||
59711311|NCT01238588|75829907|FG000|NOT COMPLETED|Overall Study||3||
59711312|NCT01047501|75829914|FG000|STARTED|Overall Study||233||
59711313|NCT01047501|75829915|FG001|STARTED|Overall Study||236||
59711314|NCT01047501|75829916|FG002|STARTED|Overall Study||233||
60107511|NCT01592500|76226909|FG001|STARTED|Overall Study||15||
60107512|NCT01592500|76226910|FG002|STARTED|Overall Study||14||
59711315|NCT01047501|75829914|FG000|COMPLETED|Overall Study||217||
59711316|NCT01047501|75829915|FG001|COMPLETED|Overall Study||225||
59711317|NCT01047501|75829916|FG002|COMPLETED|Overall Study||221||
59711318|NCT01047501|75829914|FG000|NOT COMPLETED|Overall Study||16||
59711319|NCT01047501|75829915|FG001|NOT COMPLETED|Overall Study||11||
59711320|NCT01047501|75829916|FG002|NOT COMPLETED|Overall Study||12||
59711321|NCT01238120|75829928|FG000|STARTED|Overall Study||25|Randomized|
60107513|NCT01592500|76226911|FG003|STARTED|Overall Study|Randomized Participants|13||
59711322|NCT01238120|75829929|FG001|STARTED|Overall Study||23|Randomized|
60107514|NCT01592500|76226908|FG000|COMPLETED|Overall Study||13||
60107515|NCT01592500|76226909|FG001|COMPLETED|Overall Study||15||
60107516|NCT01592500|76226910|FG002|COMPLETED|Overall Study||14||
60107517|NCT01592500|76226911|FG003|COMPLETED|Overall Study||11||
60107518|NCT01592500|76226908|FG000|NOT COMPLETED|Overall Study||1||
60107519|NCT01592500|76226909|FG001|NOT COMPLETED|Overall Study||0||
59711323|NCT01238120|75829930|FG002|STARTED|Overall Study||25|Randomized|
59711324|NCT01238120|75829931|FG003|STARTED|Overall Study||24|Randomized|
59711325|NCT01238120|75829928|FG000|Received Intervention and Completed Baseline Assessments|Overall Study||21||
59711326|NCT01238120|75829929|FG001|Received Intervention and Completed Baseline Assessments|Overall Study||22||
59711327|NCT01238120|75829930|FG002|Received Intervention and Completed Baseline Assessments|Overall Study||22||
59711328|NCT01238120|75829931|FG003|Received Intervention and Completed Baseline Assessments|Overall Study||21||
60107520|NCT01592500|76226910|FG002|NOT COMPLETED|Overall Study||0||
59711329|NCT01238120|75829928|FG000|COMPLETED|Overall Study||17||
60107521|NCT01592500|76226911|FG003|NOT COMPLETED|Overall Study||2||
60107522|NCT02212834|76226923|FG000|STARTED|Overall Study||33938||33,938
60107523|NCT02212834|76226924|FG001|STARTED|Overall Study||2506||2,506
60107524|NCT02212834|76226923|FG000|COMPLETED|Overall Study||33938||33,938
60107525|NCT02212834|76226924|FG001|COMPLETED|Overall Study||2506||2,506
60107526|NCT02212834|76226923|FG000|NOT COMPLETED|Overall Study||0||NA
60107527|NCT02212834|76226924|FG001|NOT COMPLETED|Overall Study||0||NA
60107528|NCT01799993|76226932|FG000|STARTED|Overall Study||362||
60107529|NCT01799993|76226933|FG001|STARTED|Overall Study||363||
60107530|NCT01799993|76226932|FG000|ITT Population|Overall Study||354||
60107531|NCT01799993|76226933|FG001|ITT Population|Overall Study||358||
60107532|NCT01799993|76226932|FG000|mITT Population|Overall Study||255||
59711330|NCT01238120|75829929|FG001|COMPLETED|Overall Study||22||
59711331|NCT01238120|75829930|FG002|COMPLETED|Overall Study||21||
59711332|NCT01238120|75829931|FG003|COMPLETED|Overall Study||18||
59711333|NCT01238120|75829928|FG000|NOT COMPLETED|Overall Study||8||
59711334|NCT01238120|75829929|FG001|NOT COMPLETED|Overall Study||1||
59711335|NCT01238120|75829930|FG002|NOT COMPLETED|Overall Study||4||
59711336|NCT01238120|75829931|FG003|NOT COMPLETED|Overall Study||6||
59711337|NCT01237340|75829941|FG000|STARTED|Overall Study||59||
59711338|NCT01237340|75829941|FG000|COMPLETED|Overall Study||19||
59711339|NCT01237340|75829941|FG000|NOT COMPLETED|Overall Study||40||
59711340|NCT01045707|75829950|FG000|STARTED|Main: Week 0 to 26 (NN5401-3590)||266||
59711341|NCT01045707|75829951|FG001|STARTED|Main: Week 0 to 26 (NN5401-3590)||264||
59711342|NCT01045707|75829950|FG000|Exposed|Main: Week 0 to 26 (NN5401-3590)|One subject withdrew prior to exposure to trial drug|265||
59711343|NCT01045707|75829951|FG001|Exposed|Main: Week 0 to 26 (NN5401-3590)|Three subjects withdrew prior to exposure to trial drug|261||
59711344|NCT01045707|75829950|FG000|COMPLETED|Main: Week 0 to 26 (NN5401-3590)||219||
59711345|NCT01045707|75829951|FG001|COMPLETED|Main: Week 0 to 26 (NN5401-3590)||232||
59711346|NCT01045707|75829950|FG000|NOT COMPLETED|Main: Week 0 to 26 (NN5401-3590)||47||
59711347|NCT01045707|75829951|FG001|NOT COMPLETED|Main: Week 0 to 26 (NN5401-3590)||32||
59711348|NCT01045707|75829950|FG000|STARTED|Extension: Week 27 to 52 (NN5401-3726)|Twenty seven subjects from main trial did not continue into the extension|192||
59711349|NCT01045707|75829951|FG001|STARTED|Extension: Week 27 to 52 (NN5401-3726)|Eleven subjects from main trial did not continue into the extension|221||
59711350|NCT01045707|75829950|FG000|COMPLETED|Extension: Week 27 to 52 (NN5401-3726)||179||
59711351|NCT01045707|75829951|FG001|COMPLETED|Extension: Week 27 to 52 (NN5401-3726)||209||
59711352|NCT01045707|75829950|FG000|NOT COMPLETED|Extension: Week 27 to 52 (NN5401-3726)||13||
59711353|NCT01045707|75829951|FG001|NOT COMPLETED|Extension: Week 27 to 52 (NN5401-3726)||12||
59711354|NCT01054599|75829959|FG000|STARTED|Overall Study||13||
59711355|NCT01054599|75829960|FG001|STARTED|Overall Study||16||
59711356|NCT01054599|75829959|FG000|COMPLETED|Overall Study||9||
59711357|NCT01054599|75829960|FG001|COMPLETED|Overall Study||9||
59711358|NCT01054599|75829959|FG000|NOT COMPLETED|Overall Study||4||
59711359|NCT01054599|75829960|FG001|NOT COMPLETED|Overall Study||7||
59711360|NCT00948766|75829968|FG000|STARTED|Core Study||356||
59711361|NCT00948766|75829969|FG001|STARTED|Core Study||360||
59711362|NCT00948766|75829968|FG000|Exposed to Study Medication|Core Study||355||
59711363|NCT00948766|75829969|FG001|Exposed to Study Medication|Core Study||359||
59711364|NCT00948766|75829968|FG000|COMPLETED|Core Study||229||
59711365|NCT00948766|75829969|FG001|COMPLETED|Core Study||234||
59711366|NCT00948766|75829968|FG000|NOT COMPLETED|Core Study||127||
59711367|NCT00948766|75829969|FG001|NOT COMPLETED|Core Study||126||
59711368|NCT00948766|75829968|FG000|STARTED|Extension Study|397 of the 463 patients who completed the core study entered the extension study.|397||
59711369|NCT00948766|75829969|FG001|STARTED|Extension Study|No patients received this treatment in the extension study.|0||
59711370|NCT00948766|75829968|FG000|Exposed to Study Medication|Extension Study||396||
59818935|NCT00505284|75941122|FG001|COMPLETED|Overall Study||56||
59818936|NCT00505284|75941123|FG002|COMPLETED|Overall Study||57||
59818937|NCT00505284|75941124|FG003|COMPLETED|Overall Study||49||
59818938|NCT00505284|75941125|FG004|COMPLETED|Overall Study||37||
59818939|NCT00505284|75941121|FG000|NOT COMPLETED|Overall Study||10||
60107533|NCT01799993|76226933|FG001|mITT Population|Overall Study||253||
59711371|NCT00948766|75829969|FG001|Exposed to Study Medication|Extension Study||0||
59711372|NCT00948766|75829968|FG000|COMPLETED|Extension Study||306||
59711373|NCT00948766|75829969|FG001|COMPLETED|Extension Study||0||
59711374|NCT00948766|75829968|FG000|NOT COMPLETED|Extension Study||91||
59711375|NCT00948766|75829969|FG001|NOT COMPLETED|Extension Study||0||
59711376|NCT01053663|75829979|FG000|STARTED|Overall Study||9||
59711377|NCT01053663|75829979|FG000|COMPLETED|Overall Study||3||
59711378|NCT01053663|75829979|FG000|NOT COMPLETED|Overall Study||6||
59818940|NCT00505284|75941122|FG001|NOT COMPLETED|Overall Study||16||
59818941|NCT00505284|75941123|FG002|NOT COMPLETED|Overall Study||12||
59711379|NCT01235546|75829991|FG000|STARTED|Overall Study||994||
59711380|NCT01235546|75829992|FG001|STARTED|Overall Study||1019||
59711381|NCT01235546|75829991|FG000|COMPLETED|Overall Study||992||
59711382|NCT01235546|75829992|FG001|COMPLETED|Overall Study||1018||
59711383|NCT01235546|75829991|FG000|NOT COMPLETED|Overall Study||2||
59818942|NCT00505284|75941124|FG003|NOT COMPLETED|Overall Study||19||
59711384|NCT01235546|75829992|FG001|NOT COMPLETED|Overall Study||1||
59711385|NCT01053429|75830007|FG000|STARTED|Overall Study||3391||
59711386|NCT01053429|75830007|FG000|COMPLETED|Overall Study||3018||
59711387|NCT01053429|75830007|FG000|NOT COMPLETED|Overall Study||373||
59711388|NCT01233284|75830011|FG000|STARTED|Period 1 (4 Weeks)||37||
59711389|NCT01233284|75830012|FG001|STARTED|Period 1 (4 Weeks)||38||
59711390|NCT01233284|75830013|FG002|STARTED|Period 1 (4 Weeks)||38||
59711391|NCT01233284|75830014|FG003|STARTED|Period 1 (4 Weeks)||35||
59711392|NCT01233284|75830015|FG004|STARTED|Period 1 (4 Weeks)||1||
59711393|NCT01233284|75830011|FG000|COMPLETED|Period 1 (4 Weeks)||36||
59711394|NCT01233284|75830012|FG001|COMPLETED|Period 1 (4 Weeks)||37||
59711395|NCT01233284|75830013|FG002|COMPLETED|Period 1 (4 Weeks)||37||
59711396|NCT01233284|75830014|FG003|COMPLETED|Period 1 (4 Weeks)||35||
59711397|NCT01233284|75830015|FG004|COMPLETED|Period 1 (4 Weeks)||1||
59711398|NCT01233284|75830011|FG000|NOT COMPLETED|Period 1 (4 Weeks)||1||
59711399|NCT01233284|75830012|FG001|NOT COMPLETED|Period 1 (4 Weeks)||1||
59711400|NCT01233284|75830013|FG002|NOT COMPLETED|Period 1 (4 Weeks)||1||
59711401|NCT01233284|75830014|FG003|NOT COMPLETED|Period 1 (4 Weeks)||0||
59711402|NCT01233284|75830015|FG004|NOT COMPLETED|Period 1 (4 Weeks)||0||
59711403|NCT01233284|75830011|FG000|STARTED|Period 2 (4 Weeks)||36||
59711404|NCT01233284|75830012|FG001|STARTED|Period 2 (4 Weeks)||37||
59711405|NCT01233284|75830013|FG002|STARTED|Period 2 (4 Weeks)||37||
59711406|NCT01233284|75830014|FG003|STARTED|Period 2 (4 Weeks)||35||
59711407|NCT01233284|75830015|FG004|STARTED|Period 2 (4 Weeks)||1||
59711408|NCT01233284|75830011|FG000|COMPLETED|Period 2 (4 Weeks)||36||
59711409|NCT01233284|75830012|FG001|COMPLETED|Period 2 (4 Weeks)||37||
59711410|NCT01233284|75830013|FG002|COMPLETED|Period 2 (4 Weeks)||36||
59711411|NCT01233284|75830014|FG003|COMPLETED|Period 2 (4 Weeks)||35||
59711412|NCT01233284|75830015|FG004|COMPLETED|Period 2 (4 Weeks)||1||
60107534|NCT01799993|76226932|FG000|COMPLETED|Overall Study||229|Completed follow-up|
60107535|NCT01799993|76226933|FG001|COMPLETED|Overall Study||235|Completed follow-up|
60107536|NCT01799993|76226932|FG000|NOT COMPLETED|Overall Study||133||
60107537|NCT01799993|76226933|FG001|NOT COMPLETED|Overall Study||128||
60107538|NCT01593592|76226941|FG000|STARTED|Overall Study||35||
60107539|NCT01593592|76226942|FG001|STARTED|Overall Study||35||
60107540|NCT01593592|76226941|FG000|COMPLETED|Overall Study||35||
60107541|NCT01593592|76226942|FG001|COMPLETED|Overall Study||35||
60107542|NCT01593592|76226941|FG000|NOT COMPLETED|Overall Study||0||
60107543|NCT01593592|76226942|FG001|NOT COMPLETED|Overall Study||0||
60107544|NCT01822223|76226950|FG000|STARTED|Overall Study||10||
59711413|NCT01233284|75830011|FG000|NOT COMPLETED|Period 2 (4 Weeks)||0||
59711414|NCT01233284|75830012|FG001|NOT COMPLETED|Period 2 (4 Weeks)||0||
59711415|NCT01233284|75830013|FG002|NOT COMPLETED|Period 2 (4 Weeks)||1||
59711416|NCT01233284|75830014|FG003|NOT COMPLETED|Period 2 (4 Weeks)||0||
60107545|NCT01822223|76226951|FG001|STARTED|Overall Study||10||
60107546|NCT01822223|76226950|FG000|COMPLETED|Overall Study||10||
60107547|NCT01822223|76226951|FG001|COMPLETED|Overall Study||9||
60107548|NCT01822223|76226950|FG000|NOT COMPLETED|Overall Study||0||
60107549|NCT01822223|76226951|FG001|NOT COMPLETED|Overall Study||1||
60107550|NCT01593670|76226959|FG000|STARTED|Overall Study||9||
60107551|NCT01593670|76226959|FG000|COMPLETED|Overall Study||9||
60107552|NCT01593670|76226959|FG000|NOT COMPLETED|Overall Study||0||
60107553|NCT01593748|76226965|FG000|STARTED|Overall Study||45||
60107554|NCT01593748|76226966|FG001|STARTED|Overall Study||45||
60107555|NCT01593748|76226965|FG000|COMPLETED|Overall Study||45||
60107556|NCT01593748|76226966|FG001|COMPLETED|Overall Study||45||
60107557|NCT01593748|76226965|FG000|NOT COMPLETED|Overall Study||0||
60107558|NCT01593748|76226966|FG001|NOT COMPLETED|Overall Study||0||
60107559|NCT01594294|76226974|FG000|STARTED|Overall Study||39||
60107560|NCT01594294|76226975|FG001|STARTED|Overall Study||40||
59711417|NCT01233284|75830015|FG004|NOT COMPLETED|Period 2 (4 Weeks)||0||
59711418|NCT01233284|75830011|FG000|STARTED|Period 3 (4 Weeks)||36||
59711419|NCT01233284|75830012|FG001|STARTED|Period 3 (4 Weeks)||37||
59711420|NCT01233284|75830013|FG002|STARTED|Period 3 (4 Weeks)||36||
59711421|NCT01233284|75830014|FG003|STARTED|Period 3 (4 Weeks)||35||
59711422|NCT01233284|75830015|FG004|STARTED|Period 3 (4 Weeks)||1||
59711423|NCT01233284|75830011|FG000|COMPLETED|Period 3 (4 Weeks)||36||
59711424|NCT01233284|75830012|FG001|COMPLETED|Period 3 (4 Weeks)||37||
59711425|NCT01233284|75830013|FG002|COMPLETED|Period 3 (4 Weeks)||35||
59711426|NCT01233284|75830014|FG003|COMPLETED|Period 3 (4 Weeks)||34||
60107561|NCT01594294|76226974|FG000|COMPLETED|Overall Study||36||
60107562|NCT01594294|76226975|FG001|COMPLETED|Overall Study||36||
60107563|NCT01594294|76226974|FG000|NOT COMPLETED|Overall Study||3||
60107564|NCT01594294|76226975|FG001|NOT COMPLETED|Overall Study||4||
59711427|NCT01233284|75830015|FG004|COMPLETED|Period 3 (4 Weeks)||1||
59711428|NCT01233284|75830011|FG000|NOT COMPLETED|Period 3 (4 Weeks)||0||
59711429|NCT01233284|75830012|FG001|NOT COMPLETED|Period 3 (4 Weeks)||0||
60107565|NCT01594528|76226984|FG000|STARTED|Overall Study||16||
59711430|NCT01233284|75830013|FG002|NOT COMPLETED|Period 3 (4 Weeks)||1||
59711431|NCT01233284|75830014|FG003|NOT COMPLETED|Period 3 (4 Weeks)||1||
59711432|NCT01233284|75830015|FG004|NOT COMPLETED|Period 3 (4 Weeks)||0||
59711433|NCT01233284|75830011|FG000|STARTED|Period 4 (4 Weeks)||36||
59711434|NCT01233284|75830012|FG001|STARTED|Period 4 (4 Weeks)||37||
59711435|NCT01233284|75830013|FG002|STARTED|Period 4 (4 Weeks)||35||
59711436|NCT01233284|75830014|FG003|STARTED|Period 4 (4 Weeks)||34||
59711437|NCT01233284|75830015|FG004|STARTED|Period 4 (4 Weeks)||1||
59711438|NCT01233284|75830011|FG000|COMPLETED|Period 4 (4 Weeks)||36||
59711439|NCT01233284|75830012|FG001|COMPLETED|Period 4 (4 Weeks)||36||
59711440|NCT01233284|75830013|FG002|COMPLETED|Period 4 (4 Weeks)||35||
59711441|NCT01233284|75830014|FG003|COMPLETED|Period 4 (4 Weeks)||33||
59818943|NCT00505284|75941125|FG004|NOT COMPLETED|Overall Study||33||
59818944|NCT00337168|75941137|FG000|STARTED|Overall Study||37||
59711442|NCT01233284|75830015|FG004|COMPLETED|Period 4 (4 Weeks)||1||
59711443|NCT01233284|75830011|FG000|NOT COMPLETED|Period 4 (4 Weeks)||0||
59711444|NCT01233284|75830012|FG001|NOT COMPLETED|Period 4 (4 Weeks)||1||
59711445|NCT01233284|75830013|FG002|NOT COMPLETED|Period 4 (4 Weeks)||0||
59711446|NCT01233284|75830014|FG003|NOT COMPLETED|Period 4 (4 Weeks)||1||
59711447|NCT01233284|75830015|FG004|NOT COMPLETED|Period 4 (4 Weeks)||0||
59711448|NCT00948688|75830025|FG000|STARTED|Period 1: 200 mg Vorinostat||4||
59711449|NCT00948688|75830026|FG001|STARTED|Period 1: 200 mg Vorinostat||0||
59711450|NCT00948688|75830025|FG000|COMPLETED|Period 1: 200 mg Vorinostat||2||
59711451|NCT00948688|75830026|FG001|COMPLETED|Period 1: 200 mg Vorinostat||0||
59711452|NCT00948688|75830025|FG000|NOT COMPLETED|Period 1: 200 mg Vorinostat||2||
59711453|NCT00948688|75830026|FG001|NOT COMPLETED|Period 1: 200 mg Vorinostat||0||
59711454|NCT00948688|75830025|FG000|STARTED|Period 2: 100 mg Vorinostat||0||
59711455|NCT00948688|75830026|FG001|STARTED|Period 2: 100 mg Vorinostat||6||
59711456|NCT00948688|75830025|FG000|COMPLETED|Period 2: 100 mg Vorinostat||0||
59711457|NCT00948688|75830026|FG001|COMPLETED|Period 2: 100 mg Vorinostat||5||
59711458|NCT00948688|75830025|FG000|NOT COMPLETED|Period 2: 100 mg Vorinostat||0||
59711459|NCT00948688|75830026|FG001|NOT COMPLETED|Period 2: 100 mg Vorinostat||1||
59711460|NCT01233050|75830035|FG000|STARTED|Overall Study||400||
59711461|NCT01233050|75830036|FG001|STARTED|Overall Study||402||
59711462|NCT01233050|75830035|FG000|COMPLETED|Overall Study|8 participants were excluded after treatment administered due to inclusion/exclusion criteria|392||
59711463|NCT01233050|75830036|FG001|COMPLETED|Overall Study|6 participants were excluded after treatment administered due to inclusion/exclusion criteria|396||
59711464|NCT01233050|75830035|FG000|NOT COMPLETED|Overall Study||8||
59711465|NCT01233050|75830036|FG001|NOT COMPLETED|Overall Study||6||
59711466|NCT01232894|75830044|FG000|STARTED|Overall Study||60||
59711467|NCT01232894|75830045|FG001|STARTED|Overall Study||30||
59711468|NCT01232894|75830044|FG000|Received Study Drug|Overall Study||59||
59711469|NCT01232894|75830045|FG001|Received Study Drug|Overall Study||28||
59711470|NCT01232894|75830044|FG000|COMPLETED|Overall Study||48||
59818945|NCT00337168|75941137|FG000|Eligible|Overall Study||37||
59818946|NCT00337168|75941137|FG000|Eligible and Treated|Overall Study||36||
59818947|NCT00337168|75941137|FG000|COMPLETED|Overall Study||29||
60107566|NCT01594528|76226985|FG001|STARTED|Overall Study||17||
60107567|NCT01594528|76226986|FG002|STARTED|Overall Study||16||
60107568|NCT01594528|76226984|FG000|COMPLETED|Overall Study||16||
60107569|NCT01594528|76226985|FG001|COMPLETED|Overall Study||17||
60107570|NCT01594528|76226986|FG002|COMPLETED|Overall Study||16||
60107571|NCT01594528|76226984|FG000|NOT COMPLETED|Overall Study||0||
59566666|NCT01874132|75669322|FG001|NOT COMPLETED|Overall Study||4||
59711471|NCT01232894|75830045|FG001|COMPLETED|Overall Study||22||
59711472|NCT01232894|75830044|FG000|NOT COMPLETED|Overall Study||12||
59711473|NCT01232894|75830045|FG001|NOT COMPLETED|Overall Study||8||
59711474|NCT01049217|75830053|FG000|STARTED|Overall Study||183||
59566667|NCT01874132|75669323|FG002|NOT COMPLETED|Overall Study||3||
59711475|NCT01049217|75830054|FG001|STARTED|Overall Study||194||
59711476|NCT01049217|75830053|FG000|Treated|Overall Study||183||
59711477|NCT01049217|75830054|FG001|Treated|Overall Study||192||
59818948|NCT00337168|75941137|FG000|NOT COMPLETED|Overall Study||8||
59818949|NCT00606905|75941144|FG000|STARTED|Overall Study||38||
59818950|NCT00606905|75941145|FG001|STARTED|Overall Study||39||
59818951|NCT00606905|75941144|FG000|Pregnancy|Overall Study||29||
59818952|NCT00606905|75941145|FG001|Pregnancy|Overall Study||33||
59818953|NCT00606905|75941144|FG000|COMPLETED|Overall Study||23||
59818954|NCT00606905|75941145|FG001|COMPLETED|Overall Study||24||
59818955|NCT00606905|75941144|FG000|NOT COMPLETED|Overall Study||15||
59818956|NCT00606905|75941145|FG001|NOT COMPLETED|Overall Study||15||
59818957|NCT00606593|75941151|FG000|STARTED|Overall Study|Randomized participants|11||
59711478|NCT01049217|75830053|FG000|COMPLETED|Overall Study||127||
59711479|NCT01049217|75830054|FG001|COMPLETED|Overall Study||131||
59711480|NCT01049217|75830053|FG000|NOT COMPLETED|Overall Study||56||
59996257|NCT00702715|76112217|FG000|NOT COMPLETED|Overall Study||1||
59996258|NCT00702715|76112218|FG001|NOT COMPLETED|Overall Study||0||
59996259|NCT00702403|76112224|FG000|STARTED|From Consent to Engraftment|"57 agreed to participate and completed informed consent (= the 1st intention to treat population)"|57||
59996260|NCT00702403|76112224|FG000|Ineligible for Study Drug|From Consent to Engraftment||17||
59996261|NCT00702403|76112224|FG000|COMPLETED|From Consent to Engraftment|40 of 57 originally consented subjects remained eligible at engraftment (= the 2nd ITT population)|40||
59996262|NCT00702403|76112224|FG000|NOT COMPLETED|From Consent to Engraftment||17||
59566668|NCT02332590|75669333|FG000|STARTED|DB Period (up to 24 Weeks)||185||
59711481|NCT01049217|75830054|FG001|NOT COMPLETED|Overall Study||63||
59711482|NCT01232738|75830060|FG000|STARTED|Overall Study||36||
60107572|NCT01594528|76226985|FG001|NOT COMPLETED|Overall Study||0||
60107573|NCT01594528|76226986|FG002|NOT COMPLETED|Overall Study||0||
60107574|NCT01595386|76226994|FG000|STARTED|Overall Study||21||
60107575|NCT01595386|76226995|FG001|STARTED|Overall Study||19||
60107576|NCT01595386|76226994|FG000|COMPLETED|Overall Study||21||
60107577|NCT01595386|76226995|FG001|COMPLETED|Overall Study||19||
60107578|NCT01595386|76226994|FG000|NOT COMPLETED|Overall Study||0||
60107579|NCT01595386|76226995|FG001|NOT COMPLETED|Overall Study||0||
60107580|NCT01595854|76227006|FG000|STARTED|Overall Study||8||
60107581|NCT01595854|76227007|FG001|STARTED|Overall Study||4||
60107582|NCT01595854|76227008|FG002|STARTED|Overall Study||8||
60107583|NCT01595854|76227009|FG003|STARTED|Overall Study||4||
60107584|NCT01595854|76227010|FG004|STARTED|Overall Study||12||
60107585|NCT01595854|76227006|FG000|COMPLETED|Overall Study||8||
60107586|NCT01595854|76227007|FG001|COMPLETED|Overall Study||4||
60107587|NCT01595854|76227008|FG002|COMPLETED|Overall Study||8||
60107588|NCT01595854|76227009|FG003|COMPLETED|Overall Study||4||
60107589|NCT01595854|76227010|FG004|COMPLETED|Overall Study||12||
60107590|NCT01595854|76227006|FG000|NOT COMPLETED|Overall Study||0||
60107591|NCT01595854|76227007|FG001|NOT COMPLETED|Overall Study||0||
60107592|NCT01595854|76227008|FG002|NOT COMPLETED|Overall Study||0||
60107593|NCT01595854|76227009|FG003|NOT COMPLETED|Overall Study||0||
59566669|NCT02332590|75669334|FG001|STARTED|DB Period (up to 24 Weeks)||184||
59711483|NCT01232738|75830060|FG000|COMPLETED|Overall Study||23||
60107594|NCT01595854|76227010|FG004|NOT COMPLETED|Overall Study||0||
59566670|NCT02332590|75669333|FG000|Treated|DB Period (up to 24 Weeks)||184||
59711484|NCT01232738|75830060|FG000|NOT COMPLETED|Overall Study||13||
60107595|NCT01596088|76227028|FG000|STARTED|Overall Study||2||
60107596|NCT01596088|76227028|FG000|COMPLETED|Overall Study||2||
60107597|NCT01596088|76227028|FG000|NOT COMPLETED|Overall Study||0||
60107598|NCT02228382|76227037|FG000|STARTED|Overall Study||46||
60107599|NCT02228382|76227038|FG001|STARTED|Overall Study||61||
60107600|NCT02228382|76227039|FG002|STARTED|Overall Study||49||
60107601|NCT02228382|76227040|FG003|STARTED|Overall Study||4||
59711485|NCT00957268|75830073|FG000|STARTED|Overall Study||5||
59711486|NCT00957268|75830074|FG001|STARTED|Overall Study||4||
59711487|NCT00957268|75830075|FG002|STARTED|Overall Study||8||
59711488|NCT00957268|75830076|FG003|STARTED|Overall Study||7||
59711489|NCT00957268|75830077|FG004|STARTED|Overall Study||22||
59711490|NCT00957268|75830073|FG000|COMPLETED|Overall Study||5||
59711491|NCT00957268|75830074|FG001|COMPLETED|Overall Study||4||
59711492|NCT00957268|75830075|FG002|COMPLETED|Overall Study||7||
59711493|NCT00957268|75830076|FG003|COMPLETED|Overall Study||7||
59711494|NCT00957268|75830077|FG004|COMPLETED|Overall Study||22||
59818958|NCT00606593|75941152|FG001|STARTED|Overall Study|Randomized participants|11||
59818959|NCT00606593|75941153|FG002|STARTED|Overall Study|Randomized participants|11||
59818960|NCT00606593|75941154|FG003|STARTED|Overall Study|Randomized participants|11||
59818961|NCT00606593|75941155|FG004|STARTED|Overall Study|Randomized participants|12||
59818962|NCT00606593|75941156|FG005|STARTED|Overall Study|Randomized participants|11||
59818963|NCT00606593|75941157|FG006|STARTED|Overall Study|Randomized participants|11||
59818964|NCT00606593|75941158|FG007|STARTED|Overall Study|Randomized participants. One participant actually received the treatment sequence 200/P/100/ 50/25|11||
60107602|NCT02228382|76227041|FG004|STARTED|Overall Study||3||
60107603|NCT02228382|76227037|FG000|COMPLETED|Overall Study||36||
60107604|NCT02228382|76227038|FG001|COMPLETED|Overall Study||43||
60107605|NCT02228382|76227039|FG002|COMPLETED|Overall Study||28||
60107606|NCT02228382|76227040|FG003|COMPLETED|Overall Study||2||
60107607|NCT02228382|76227041|FG004|COMPLETED|Overall Study||1||
60107608|NCT02228382|76227037|FG000|NOT COMPLETED|Overall Study||10||
60107609|NCT02228382|76227038|FG001|NOT COMPLETED|Overall Study||18||
60107610|NCT02228382|76227039|FG002|NOT COMPLETED|Overall Study||21||
60107611|NCT02228382|76227040|FG003|NOT COMPLETED|Overall Study||2||
60107612|NCT02228382|76227041|FG004|NOT COMPLETED|Overall Study||2||
59566671|NCT02332590|75669334|FG001|Treated|DB Period (up to 24 Weeks)||184||
59566672|NCT02332590|75669333|FG000|COMPLETED|DB Period (up to 24 Weeks)|155 participants entered OLE period and 1 did not enroll.|156||
59566673|NCT02332590|75669334|FG001|COMPLETED|DB Period (up to 24 Weeks)||165||
59566674|NCT02332590|75669333|FG000|NOT COMPLETED|DB Period (up to 24 Weeks)||29||
59566675|NCT02332590|75669334|FG001|NOT COMPLETED|DB Period (up to 24 Weeks)||19||
59566676|NCT02332590|75669333|FG000|STARTED|OLE Period (Week 24 up to Week 300)||155||
59566677|NCT02332590|75669334|FG001|STARTED|OLE Period (Week 24 up to Week 300)||165||
59566678|NCT02332590|75669333|FG000|COMPLETED|OLE Period (Week 24 up to Week 300)||108||
59566679|NCT02332590|75669334|FG001|COMPLETED|OLE Period (Week 24 up to Week 300)||120||
59566680|NCT02332590|75669333|FG000|NOT COMPLETED|OLE Period (Week 24 up to Week 300)||47||
59566681|NCT02332590|75669334|FG001|NOT COMPLETED|OLE Period (Week 24 up to Week 300)||45||
59566682|NCT03869541|75669345|FG000|STARTED|Overall Study||40||
59566683|NCT03869541|75669346|FG001|STARTED|Overall Study||50||
59566684|NCT03869541|75669347|FG002|STARTED|Overall Study||10||
59566685|NCT03869541|75669345|FG000|COMPLETED|Overall Study||40||
59566686|NCT03869541|75669346|FG001|COMPLETED|Overall Study||50||
59566687|NCT03869541|75669347|FG002|COMPLETED|Overall Study||10||
59566688|NCT03869541|75669345|FG000|NOT COMPLETED|Overall Study||0||
59566689|NCT03869541|75669346|FG001|NOT COMPLETED|Overall Study||0||
59566690|NCT03869541|75669347|FG002|NOT COMPLETED|Overall Study||0||
59566691|NCT01874756|75669362|FG000|STARTED|Overall Study||29||
59566692|NCT01874756|75669363|FG001|STARTED|Overall Study||10||
59566693|NCT01874756|75669364|FG002|STARTED|Overall Study||29||
59566694|NCT01874756|75669365|FG003|STARTED|Overall Study||27||
59566695|NCT01874756|75669362|FG000|COMPLETED|Overall Study||28||
59566696|NCT01874756|75669363|FG001|COMPLETED|Overall Study||10||
59566697|NCT01874756|75669364|FG002|COMPLETED|Overall Study||27||
59566698|NCT01874756|75669365|FG003|COMPLETED|Overall Study||21||
59711495|NCT00957268|75830073|FG000|NOT COMPLETED|Overall Study||0||
59711496|NCT00957268|75830074|FG001|NOT COMPLETED|Overall Study||0||
59711497|NCT00957268|75830075|FG002|NOT COMPLETED|Overall Study||1||
59818965|NCT00606593|75941159|FG008|STARTED|Overall Study|Randomized participants|12||
60107613|NCT02216422|76227058|FG000|STARTED|Overall Study||36||
60107614|NCT02216422|76227058|FG000|COMPLETED|Overall Study||36||
60107615|NCT02216422|76227058|FG000|NOT COMPLETED|Overall Study||0||
60107616|NCT02217904|76227067|FG000|STARTED|Overall Study||6||
60107617|NCT02217904|76227068|FG001|STARTED|Overall Study||6||
60107618|NCT02217904|76227069|FG002|STARTED|Overall Study||6||
60107619|NCT02217904|76227070|FG003|STARTED|Overall Study||6||
60107620|NCT02217904|76227071|FG004|STARTED|Overall Study||6||
60107621|NCT02217904|76227072|FG005|STARTED|Overall Study||0||
60107622|NCT02217904|76227073|FG006|STARTED|Overall Study||0||
60107623|NCT02217904|76227067|FG000|COMPLETED|Overall Study||6||
60107624|NCT02217904|76227068|FG001|COMPLETED|Overall Study||6||
60107625|NCT02217904|76227069|FG002|COMPLETED|Overall Study||6||
60107626|NCT02217904|76227070|FG003|COMPLETED|Overall Study||6||
60107627|NCT02217904|76227071|FG004|COMPLETED|Overall Study||6||
60107628|NCT02217904|76227072|FG005|COMPLETED|Overall Study||0||
60107629|NCT02217904|76227073|FG006|COMPLETED|Overall Study||0||
60107630|NCT02217904|76227067|FG000|NOT COMPLETED|Overall Study||0||
60107631|NCT02217904|76227068|FG001|NOT COMPLETED|Overall Study||0||
60107632|NCT02217904|76227069|FG002|NOT COMPLETED|Overall Study||0||
60107633|NCT02217904|76227070|FG003|NOT COMPLETED|Overall Study||0||
60107634|NCT02217904|76227071|FG004|NOT COMPLETED|Overall Study||0||
60107635|NCT02217904|76227072|FG005|NOT COMPLETED|Overall Study||0||
60107636|NCT02217904|76227073|FG006|NOT COMPLETED|Overall Study||0||
60107637|NCT01900002|76227085|FG000|STARTED|Overall Study||40||
60107638|NCT01900002|76227085|FG000|COMPLETED|Overall Study||34||
60107639|NCT01900002|76227085|FG000|NOT COMPLETED|Overall Study||6||
60107640|NCT02224612|76227089|FG000|STARTED|Overall Study||48||
60107641|NCT02224612|76227090|FG001|STARTED|Overall Study||48||
60107642|NCT02224612|76227089|FG000|COMPLETED|Overall Study||48||
60107643|NCT02224612|76227090|FG001|COMPLETED|Overall Study||48||
60107644|NCT02224612|76227089|FG000|NOT COMPLETED|Overall Study||0||
60107645|NCT02224612|76227090|FG001|NOT COMPLETED|Overall Study||0||
60107646|NCT02225080|76227098|FG000|STARTED|Overall Study||100||
60107647|NCT02225080|76227098|FG000|COMPLETED|Overall Study||100||
60107648|NCT02225080|76227098|FG000|NOT COMPLETED|Overall Study||0||
60107649|NCT02225860|76227104|FG000|STARTED|Overall Study||17||
60107650|NCT02225860|76227105|FG001|STARTED|Overall Study||17||
60107651|NCT02225860|76227104|FG000|COMPLETED|Overall Study||16||
60107652|NCT02225860|76227105|FG001|COMPLETED|Overall Study||17||
60107653|NCT02225860|76227104|FG000|NOT COMPLETED|Overall Study||1||
60107654|NCT02225860|76227105|FG001|NOT COMPLETED|Overall Study||0||
60107655|NCT01377012|76227115|FG000|STARTED|Core Study||210||
60107656|NCT01377012|76227116|FG001|STARTED|Core Study||213||
60107657|NCT01377012|76227117|FG002|STARTED|Core Study||214||
60107658|NCT01377012|76227115|FG000|wk16 Re-randomized to AIN 75mg NR|Core Study||0||
60107659|NCT01377012|76227116|FG001|wk16 Re-randomized to AIN 75mg NR|Core Study||0||
60107660|NCT01377012|76227117|FG002|wk16 Re-randomized to AIN 75mg NR|Core Study|NR=Non-responder|56||
60107661|NCT01377012|76227115|FG000|wk16 Re-randomized to AIN 150mg NR|Core Study||0||
60107662|NCT01377012|76227116|FG001|wk16 Re-randomized to AIN 150mg NR|Core Study||0||
60107663|NCT01377012|76227117|FG002|wk16 Re-randomized to AIN 150mg NR|Core Study||53||
60107664|NCT01377012|76227115|FG000|wk 24 Re-randomized to AIN 75 mg Res|Core Study||0||
60107665|NCT01377012|76227116|FG001|wk 24 Re-randomized to AIN 75 mg Res|Core Study||0||
60107666|NCT01377012|76227117|FG002|wk 24 Re-randomized to AIN 75 mg Res|Core Study|Res= responder|38||
60107667|NCT01377012|76227115|FG000|wk 24 Re-randomized to AIN 150 mg Res|Core Study||0||
60107668|NCT01377012|76227116|FG001|wk 24 Re-randomized to AIN 150 mg Res|Core Study||0||
60107669|NCT01377012|76227117|FG002|wk 24 Re-randomized to AIN 150 mg Res|Core Study||34||
59818966|NCT00606593|75941160|FG009|STARTED|Overall Study|Randomized participants|11||
60107670|NCT01377012|76227115|FG000|COMPLETED|Core Study||76||
60107671|NCT01377012|76227116|FG001|COMPLETED|Core Study||81||
60107672|NCT01377012|76227117|FG002|COMPLETED|Core Study||80||
60107673|NCT01377012|76227115|FG000|NOT COMPLETED|Core Study||134||
60107674|NCT01377012|76227116|FG001|NOT COMPLETED|Core Study||132||
59818967|NCT00606593|75941151|FG000|1st Double-blind Treatment|Overall Study||11||
60107675|NCT01377012|76227117|FG002|NOT COMPLETED|Core Study||134||
60107676|NCT01377012|76227115|FG000|STARTED|Extension Study, Weeks 104-260||57||
60107677|NCT01377012|76227116|FG001|STARTED|Extension Study, Weeks 104-260||71||
60107678|NCT01377012|76227117|FG002|STARTED|Extension Study, Weeks 104-260||68||
60107679|NCT01377012|76227115|FG000|COMPLETED|Extension Study, Weeks 104-260||0||
60107680|NCT01377012|76227116|FG001|COMPLETED|Extension Study, Weeks 104-260||0||
60107681|NCT01377012|76227117|FG002|COMPLETED|Extension Study, Weeks 104-260||0||
60107682|NCT01377012|76227115|FG000|NOT COMPLETED|Extension Study, Weeks 104-260||57||
60107683|NCT01377012|76227116|FG001|NOT COMPLETED|Extension Study, Weeks 104-260||71||
60107684|NCT01377012|76227117|FG002|NOT COMPLETED|Extension Study, Weeks 104-260||68||
60107685|NCT02324920|76227127|FG000|STARTED|Overall Study||64||
60107686|NCT02324920|76227128|FG001|STARTED|Overall Study||64||
60107687|NCT02324920|76227127|FG000|COMPLETED|Overall Study||63||
60107688|NCT02324920|76227128|FG001|COMPLETED|Overall Study||64||
60107689|NCT02324920|76227127|FG000|NOT COMPLETED|Overall Study||1||
60107690|NCT02324920|76227128|FG001|NOT COMPLETED|Overall Study||0||
60107691|NCT04812184|76227136|FG000|STARTED|Overall Study||60||
60107692|NCT04812184|76227137|FG001|STARTED|Overall Study||63||
60107693|NCT04812184|76227136|FG000|COMPLETED|Overall Study||60||
59818968|NCT00606593|75941152|FG001|1st Double-blind Treatment|Overall Study||11||
59818969|NCT00606593|75941153|FG002|1st Double-blind Treatment|Overall Study||11||
60107694|NCT04812184|76227137|FG001|COMPLETED|Overall Study||63||
60107695|NCT04812184|76227136|FG000|NOT COMPLETED|Overall Study||0||
60107696|NCT04812184|76227137|FG001|NOT COMPLETED|Overall Study||0||
60107697|NCT04073056|76227145|FG000|STARTED|Overall Study||20||
60107698|NCT04073056|76227146|FG001|STARTED|Overall Study||20||
60107699|NCT04073056|76227145|FG000|COMPLETED|Overall Study||20||
60107700|NCT04073056|76227146|FG001|COMPLETED|Overall Study||20||
60107701|NCT04073056|76227145|FG000|NOT COMPLETED|Overall Study||0||
60107702|NCT04073056|76227146|FG001|NOT COMPLETED|Overall Study||0||
60107703|NCT02227810|76227156|FG000|STARTED|Overall Study||19||
60107704|NCT02227810|76227157|FG001|STARTED|Overall Study||34||
60107705|NCT02227810|76227156|FG000|COMPLETED|Overall Study||17||
60107706|NCT02227810|76227157|FG001|COMPLETED|Overall Study||29||
60107707|NCT02227810|76227156|FG000|NOT COMPLETED|Overall Study||2||
60107708|NCT02227810|76227157|FG001|NOT COMPLETED|Overall Study||5||
60107709|NCT01623466|76227167|FG000|STARTED|Overall Study||18||
60107710|NCT01623466|76227168|FG001|STARTED|Overall Study||18||
60107711|NCT01623466|76227167|FG000|COMPLETED|Overall Study||17||
60107712|NCT01623466|76227168|FG001|COMPLETED|Overall Study||18||
60107713|NCT01623466|76227167|FG000|NOT COMPLETED|Overall Study||1||
60107714|NCT01623466|76227168|FG001|NOT COMPLETED|Overall Study||0||
60107715|NCT01624168|76227177|FG000|STARTED|Overall Study||19||
60107716|NCT01624168|76227178|FG001|STARTED|Overall Study||28||
60107717|NCT01624168|76227179|FG002|STARTED|Overall Study||28||
60107718|NCT01624168|76227177|FG000|COMPLETED|Overall Study||15||
60107719|NCT01624168|76227178|FG001|COMPLETED|Overall Study||16||
60107720|NCT01624168|76227179|FG002|COMPLETED|Overall Study||22||
60107721|NCT01624168|76227177|FG000|NOT COMPLETED|Overall Study||4||
60107722|NCT01624168|76227178|FG001|NOT COMPLETED|Overall Study||12||
60107723|NCT01624168|76227179|FG002|NOT COMPLETED|Overall Study||6||
60107724|NCT01624948|76227189|FG000|STARTED|Overall Study||20||
60107725|NCT01624948|76227190|FG001|STARTED|Overall Study||20||
60107726|NCT01624948|76227189|FG000|COMPLETED|Overall Study||20||
60107727|NCT01624948|76227190|FG001|COMPLETED|Overall Study||20||
60107728|NCT01624948|76227189|FG000|NOT COMPLETED|Overall Study||0||
60107729|NCT01624948|76227190|FG001|NOT COMPLETED|Overall Study||0||
60107730|NCT01625104|76227202|FG000|STARTED|Overall Study||448||
60107731|NCT01625104|76227203|FG001|STARTED|Overall Study||434||
60107732|NCT01625104|76227202|FG000|COMPLETED|Overall Study||448||
60107733|NCT01625104|76227203|FG001|COMPLETED|Overall Study||434||
60107734|NCT01625104|76227202|FG000|NOT COMPLETED|Overall Study||0||
60107735|NCT01625104|76227203|FG001|NOT COMPLETED|Overall Study||0||
60107736|NCT01625416|76227211|FG000|STARTED|Overall Study||60||
60107737|NCT01625416|76227212|FG001|STARTED|Overall Study||61||
60107738|NCT01625416|76227211|FG000|COMPLETED|Overall Study||51||
60107739|NCT01625416|76227212|FG001|COMPLETED|Overall Study||54||
60107740|NCT01625416|76227211|FG000|NOT COMPLETED|Overall Study||9||
60107741|NCT01625416|76227212|FG001|NOT COMPLETED|Overall Study||7||
60107742|NCT01626664|76227221|FG000|STARTED|Randomization Period||47||
60107743|NCT01626664|76227222|FG001|STARTED|Randomization Period||24||
60107744|NCT01626664|76227223|FG002|STARTED|Randomization Period||0||
60107745|NCT01626664|76227221|FG000|COMPLETED|Randomization Period||47||
60107746|NCT01626664|76227222|FG001|COMPLETED|Randomization Period||24||
60107747|NCT01626664|76227223|FG002|COMPLETED|Randomization Period||0||
60107748|NCT01626664|76227221|FG000|NOT COMPLETED|Randomization Period||0||
60107749|NCT01626664|76227222|FG001|NOT COMPLETED|Randomization Period||0||
60107750|NCT01626664|76227223|FG002|NOT COMPLETED|Randomization Period||0||
60107751|NCT01626664|76227221|FG000|STARTED|Crossover Period||0||
60107752|NCT01626664|76227222|FG001|STARTED|Crossover Period||0||
59711498|NCT00957268|75830076|FG003|NOT COMPLETED|Overall Study||0||
59711499|NCT00957268|75830077|FG004|NOT COMPLETED|Overall Study||0||
59711500|NCT01230788|75830089|FG000|STARTED|Overall Study||1||
59711501|NCT01230788|75830089|FG000|COMPLETED|Overall Study||0||
59711502|NCT01230788|75830089|FG000|NOT COMPLETED|Overall Study||1||
59711503|NCT01230710|75830093|FG000|STARTED|Overall Study||51||
59711504|NCT01230710|75830093|FG000|COMPLETED|Overall Study||2||
59711505|NCT01230710|75830093|FG000|NOT COMPLETED|Overall Study||49||
59711506|NCT01230554|75830097|FG000|STARTED|Overall Study||212||
59711507|NCT01230554|75830097|FG000|COMPLETED|Overall Study||209||
59711508|NCT01230554|75830097|FG000|NOT COMPLETED|Overall Study||3||
59711509|NCT01040793|75830101|FG000|STARTED|Overall Study|Entered and treated|26||
59711510|NCT01040793|75830102|FG001|STARTED|Overall Study||26||
59711511|NCT01040793|75830103|FG002|STARTED|Overall Study||26||
59711512|NCT01040793|75830104|FG003|STARTED|Overall Study||26||
59711513|NCT01040793|75830105|FG004|STARTED|Overall Study||26||
59711514|NCT01040793|75830106|FG005|STARTED|Overall Study||27||
59711515|NCT01040793|75830101|FG000|COMPLETED|Overall Study||20||
59711516|NCT01040793|75830102|FG001|COMPLETED|Overall Study||21||
59711517|NCT01040793|75830103|FG002|COMPLETED|Overall Study||23||
59711518|NCT01040793|75830104|FG003|COMPLETED|Overall Study||22||
59711519|NCT01040793|75830105|FG004|COMPLETED|Overall Study||22||
59711520|NCT01040793|75830106|FG005|COMPLETED|Overall Study||26||
59711521|NCT01040793|75830101|FG000|NOT COMPLETED|Overall Study||6||
59711522|NCT01040793|75830102|FG001|NOT COMPLETED|Overall Study||5||
59711523|NCT01040793|75830103|FG002|NOT COMPLETED|Overall Study||3||
59711524|NCT01040793|75830104|FG003|NOT COMPLETED|Overall Study||4||
59711525|NCT01040793|75830105|FG004|NOT COMPLETED|Overall Study||4||
59711526|NCT01040793|75830106|FG005|NOT COMPLETED|Overall Study||1||
59711527|NCT00948064|75830119|FG000|STARTED|Phase I||31||
59711528|NCT00948064|75830120|FG001|STARTED|Phase I||0||
59711529|NCT00948064|75830121|FG002|STARTED|Phase I||0||
59711530|NCT00948064|75830119|FG000|COMPLETED|Phase I||30||
59711531|NCT00948064|75830120|FG001|COMPLETED|Phase I||0||
60107753|NCT01626664|76227223|FG002|STARTED|Crossover Period||18||
60107754|NCT01626664|76227221|FG000|COMPLETED|Crossover Period||0||
60107755|NCT01626664|76227222|FG001|COMPLETED|Crossover Period||0||
60107756|NCT01626664|76227223|FG002|COMPLETED|Crossover Period||18||
60107757|NCT01626664|76227221|FG000|NOT COMPLETED|Crossover Period||0||
59711532|NCT00948064|75830121|FG002|COMPLETED|Phase I||0||
59711533|NCT00948064|75830119|FG000|NOT COMPLETED|Phase I||1||
59711534|NCT00948064|75830120|FG001|NOT COMPLETED|Phase I||0||
59711535|NCT00948064|75830121|FG002|NOT COMPLETED|Phase I||0||
59711536|NCT00948064|75830119|FG000|STARTED|Phase II||0||
59711537|NCT00948064|75830120|FG001|STARTED|Phase II||52||
59711538|NCT00948064|75830121|FG002|STARTED|Phase II||27||
59711539|NCT00948064|75830119|FG000|COMPLETED|Phase II||0||
59711540|NCT00948064|75830120|FG001|COMPLETED|Phase II||51||
59711541|NCT00948064|75830121|FG002|COMPLETED|Phase II||26||
60107758|NCT01626664|76227222|FG001|NOT COMPLETED|Crossover Period||0||
60107759|NCT01626664|76227223|FG002|NOT COMPLETED|Crossover Period||0||
60107760|NCT01626820|76227232|FG000|STARTED|Overall Study||56||
60107761|NCT01626820|76227233|FG001|STARTED|Overall Study||57||
60107762|NCT01626820|76227232|FG000|COMPLETED|Overall Study||56||
60107763|NCT01626820|76227233|FG001|COMPLETED|Overall Study||57||
60107764|NCT01626820|76227232|FG000|NOT COMPLETED|Overall Study||0||
60107765|NCT01626820|76227233|FG001|NOT COMPLETED|Overall Study||0||
60107766|NCT01627288|76227244|FG000|STARTED|Overall Study||3||
60107767|NCT01627288|76227245|FG001|STARTED|Overall Study||3||
60107768|NCT01627288|76227246|FG002|STARTED|Overall Study||6||
60107769|NCT01627288|76227247|FG003|STARTED|Overall Study||0||
60107770|NCT01627288|76227244|FG000|COMPLETED|Overall Study||3||
60107771|NCT01627288|76227245|FG001|COMPLETED|Overall Study||3||
60107772|NCT01627288|76227246|FG002|COMPLETED|Overall Study||6||
60107773|NCT01627288|76227247|FG003|COMPLETED|Overall Study||0||
60107774|NCT01627288|76227244|FG000|NOT COMPLETED|Overall Study||0||
60107775|NCT01627288|76227245|FG001|NOT COMPLETED|Overall Study||0||
60107776|NCT01627288|76227246|FG002|NOT COMPLETED|Overall Study||0||
59711542|NCT00948064|75830119|FG000|NOT COMPLETED|Phase II||0||
59711543|NCT00948064|75830120|FG001|NOT COMPLETED|Phase II||1||
59711544|NCT00948064|75830121|FG002|NOT COMPLETED|Phase II||1||
59711545|NCT00953524|75830135|FG000|STARTED|Overall Study||249||
59711546|NCT00953524|75830136|FG001|STARTED|Overall Study||254||
59711547|NCT00953524|75830137|FG002|STARTED|Overall Study||247||
59711548|NCT00953524|75830138|FG003|STARTED|Overall Study||99||
59711549|NCT00953524|75830135|FG000|COMPLETED|Overall Study||227||
59711550|NCT00953524|75830136|FG001|COMPLETED|Overall Study||239||
59711551|NCT00953524|75830137|FG002|COMPLETED|Overall Study||233||
60107777|NCT01627288|76227247|FG003|NOT COMPLETED|Overall Study||0||
60107778|NCT01628614|76227259|FG000|STARTED|Overall Study||4812||
60107779|NCT01628614|76227259|FG000|COMPLETED|Overall Study||3037||
60107780|NCT01628614|76227259|FG000|NOT COMPLETED|Overall Study||1775||
60107781|NCT02528500|76227263|FG000|STARTED|Overall Study||10||
60107782|NCT02528500|76227263|FG000|COMPLETED|Overall Study||10||
60107783|NCT02528500|76227263|FG000|NOT COMPLETED|Overall Study||0||
59818970|NCT00606593|75941154|FG003|1st Double-blind Treatment|Overall Study||11||
59818971|NCT00606593|75941155|FG004|1st Double-blind Treatment|Overall Study||12||
59818972|NCT00606593|75941156|FG005|1st Double-blind Treatment|Overall Study||11||
59818973|NCT00606593|75941157|FG006|1st Double-blind Treatment|Overall Study||11||
60107784|NCT01629784|76227267|FG000|STARTED|Overall Study||31||
59818974|NCT00606593|75941158|FG007|1st Double-blind Treatment|Overall Study||11||
59818975|NCT00606593|75941159|FG008|1st Double-blind Treatment|Overall Study||12||
59818976|NCT00606593|75941160|FG009|1st Double-blind Treatment|Overall Study||11||
59818977|NCT00606593|75941151|FG000|2nd Double-blind Treatment|Overall Study||11||
59818978|NCT00606593|75941152|FG001|2nd Double-blind Treatment|Overall Study||11||
59818979|NCT00606593|75941153|FG002|2nd Double-blind Treatment|Overall Study||11||
59818980|NCT00606593|75941154|FG003|2nd Double-blind Treatment|Overall Study||10||
59818981|NCT00606593|75941155|FG004|2nd Double-blind Treatment|Overall Study||12||
59818982|NCT00606593|75941156|FG005|2nd Double-blind Treatment|Overall Study||11||
59818983|NCT00606593|75941157|FG006|2nd Double-blind Treatment|Overall Study||10||
59818984|NCT00606593|75941158|FG007|2nd Double-blind Treatment|Overall Study||9||
59818985|NCT00606593|75941159|FG008|2nd Double-blind Treatment|Overall Study||12||
59818986|NCT00606593|75941160|FG009|2nd Double-blind Treatment|Overall Study||11||
59818987|NCT00606593|75941151|FG000|3rd Double-blind Treatment|Overall Study||11||
60107785|NCT01629784|76227267|FG000|COMPLETED|Overall Study||25||
60107786|NCT01629784|76227267|FG000|NOT COMPLETED|Overall Study||6||
60107787|NCT02230696|76227277|FG000|STARTED|Overall Study||381||
60107788|NCT02230696|76227278|FG001|STARTED|Overall Study||376||
60107789|NCT02230696|76227279|FG002|STARTED|Overall Study||194||
60107790|NCT02230696|76227277|FG000|COMPLETED|Overall Study||366||
59818988|NCT00606593|75941152|FG001|3rd Double-blind Treatment|Overall Study||11||
59818989|NCT00606593|75941153|FG002|3rd Double-blind Treatment|Overall Study||10||
59818990|NCT00606593|75941154|FG003|3rd Double-blind Treatment|Overall Study||10||
59818991|NCT00606593|75941155|FG004|3rd Double-blind Treatment|Overall Study||11||
60107791|NCT02230696|76227278|FG001|COMPLETED|Overall Study||365||
60107792|NCT02230696|76227279|FG002|COMPLETED|Overall Study||190||
60107793|NCT02230696|76227277|FG000|NOT COMPLETED|Overall Study||15||
60107794|NCT02230696|76227278|FG001|NOT COMPLETED|Overall Study||11||
60107795|NCT02230696|76227279|FG002|NOT COMPLETED|Overall Study||4||
60107796|NCT02231086|76227289|FG000|STARTED|Overall Study||102||
60107797|NCT02231086|76227290|FG001|STARTED|Overall Study||102||
60107798|NCT02231086|76227289|FG000|COMPLETED|Overall Study||63||
59711552|NCT00953524|75830138|FG003|COMPLETED|Overall Study||91||
59711553|NCT00953524|75830135|FG000|NOT COMPLETED|Overall Study||22||
59711554|NCT00953524|75830136|FG001|NOT COMPLETED|Overall Study||15||
59711555|NCT00953524|75830137|FG002|NOT COMPLETED|Overall Study||14||
59711556|NCT00953524|75830138|FG003|NOT COMPLETED|Overall Study||8||
59711557|NCT04388683|75830150|FG000|STARTED|Overall Study||6||
59711558|NCT04388683|75830151|FG001|STARTED|Overall Study||3||
59711559|NCT04388683|75830150|FG000|COMPLETED|Overall Study||5||
59711560|NCT04388683|75830151|FG001|COMPLETED|Overall Study||3||
59711561|NCT04388683|75830150|FG000|NOT COMPLETED|Overall Study||1||
59711562|NCT04388683|75830151|FG001|NOT COMPLETED|Overall Study||0||
59711563|NCT01040403|75830157|FG000|STARTED|Overall Study||233||
59711564|NCT01040403|75830157|FG000|Completed Olo 5|Overall Study||106||
59711565|NCT01040403|75830157|FG000|Completed T+O 1.25/5|Overall Study||105||
59711566|NCT01040403|75830157|FG000|Completed T+O 2.5/5|Overall Study||111||
59711567|NCT01040403|75830157|FG000|Completed T+O 5/5|Overall Study||106||
59711568|NCT01040403|75830157|FG000|Completed Olo 10|Overall Study||109||
59711569|NCT01040403|75830157|FG000|Completed T+O 1.25/10|Overall Study||106||
59711570|NCT01040403|75830157|FG000|Completed T+O 2.5/10|Overall Study||110||
59711571|NCT01040403|75830157|FG000|Completed T+O 5/10|Overall Study||107||
59711572|NCT01040403|75830157|FG000|COMPLETED|Overall Study|All treatment periods|213||
59711573|NCT01040403|75830157|FG000|NOT COMPLETED|Overall Study||20||
59711574|NCT00957034|75830179|FG000|STARTED|Overall Study||6||
59711575|NCT00957034|75830180|FG001|STARTED|Overall Study||4||
59711576|NCT00957034|75830181|FG002|STARTED|Overall Study||7||
59711577|NCT00957034|75830179|FG000|COMPLETED|Overall Study||0||
59711578|NCT00957034|75830180|FG001|COMPLETED|Overall Study||0||
59711579|NCT00957034|75830181|FG002|COMPLETED|Overall Study||1||
59711580|NCT00957034|75830179|FG000|NOT COMPLETED|Overall Study||6||
60107799|NCT02231086|76227290|FG001|COMPLETED|Overall Study||65||
60107800|NCT02231086|76227289|FG000|NOT COMPLETED|Overall Study||39||
60107801|NCT02231086|76227290|FG001|NOT COMPLETED|Overall Study||37||
60107802|NCT01629862|76227298|FG000|STARTED|Overall Study||28||
59711581|NCT00957034|75830180|FG001|NOT COMPLETED|Overall Study||4||
59711582|NCT00957034|75830181|FG002|NOT COMPLETED|Overall Study||6||
59711583|NCT00953056|75830195|FG000|STARTED|Overall Study||24||
59711584|NCT00953056|75830196|FG001|STARTED|Overall Study||24||
59711585|NCT00953056|75830197|FG002|STARTED|Overall Study||24||
59711586|NCT00953056|75830198|FG003|STARTED|Overall Study||24||
59711587|NCT00953056|75830199|FG004|STARTED|Overall Study||24||
59711588|NCT00953056|75830200|FG005|STARTED|Overall Study||24||
59711589|NCT00953056|75830195|FG000|COMPLETED|Overall Study||24||
59711590|NCT00953056|75830196|FG001|COMPLETED|Overall Study||24||
59711591|NCT00953056|75830197|FG002|COMPLETED|Overall Study||24||
60107803|NCT01629862|76227299|FG001|STARTED|Overall Study||25||
60107804|NCT01629862|76227298|FG000|COMPLETED|Overall Study||26||
60107805|NCT01629862|76227299|FG001|COMPLETED|Overall Study||23||
60107806|NCT01629862|76227298|FG000|NOT COMPLETED|Overall Study||2||
59566699|NCT01874756|75669362|FG000|NOT COMPLETED|Overall Study||1||
60107807|NCT01629862|76227299|FG001|NOT COMPLETED|Overall Study||2||
60107808|NCT01631110|76227307|FG000|STARTED|Overall Study||55||
60107809|NCT01631110|76227308|FG001|STARTED|Overall Study||55||
60107810|NCT01631110|76227307|FG000|COMPLETED|Overall Study||55||
60107811|NCT01631110|76227308|FG001|COMPLETED|Overall Study||55||
59566700|NCT01874756|75669363|FG001|NOT COMPLETED|Overall Study||0||
59566701|NCT01874756|75669364|FG002|NOT COMPLETED|Overall Study||2||
59566702|NCT01874756|75669365|FG003|NOT COMPLETED|Overall Study||6||
59566703|NCT04076787|75669378|FG000|STARTED|Overall Study||318||
59566704|NCT04076787|75669379|FG001|STARTED|Overall Study||1031||
59566705|NCT04076787|75669380|FG002|STARTED|Overall Study||420||
59566706|NCT04076787|75669378|FG000|COMPLETED|Overall Study||318||
59566707|NCT04076787|75669379|FG001|COMPLETED|Overall Study||1031||
59566708|NCT04076787|75669380|FG002|COMPLETED|Overall Study||420||
59566709|NCT04076787|75669378|FG000|NOT COMPLETED|Overall Study||0||
59566710|NCT04076787|75669379|FG001|NOT COMPLETED|Overall Study||0||
59566711|NCT04076787|75669380|FG002|NOT COMPLETED|Overall Study||0||
59711592|NCT00953056|75830198|FG003|COMPLETED|Overall Study||24||
60107812|NCT01631110|76227307|FG000|NOT COMPLETED|Overall Study||0||
60107813|NCT01631110|76227308|FG001|NOT COMPLETED|Overall Study||0||
60107814|NCT01631656|76227316|FG000|STARTED|Overall Study||5||
60107815|NCT01631656|76227317|FG001|STARTED|Overall Study||5||
60107816|NCT01631656|76227316|FG000|COMPLETED|Overall Study||5||
60107817|NCT01631656|76227317|FG001|COMPLETED|Overall Study||5||
59711593|NCT00953056|75830199|FG004|COMPLETED|Overall Study|One participant received placebo at the second dose in error, but completed the study.|22||
59711594|NCT00953056|75830200|FG005|COMPLETED|Overall Study||20||
59711595|NCT00953056|75830195|FG000|NOT COMPLETED|Overall Study||0||
59711596|NCT00953056|75830196|FG001|NOT COMPLETED|Overall Study||0||
59711597|NCT00953056|75830197|FG002|NOT COMPLETED|Overall Study||0||
59711598|NCT00953056|75830198|FG003|NOT COMPLETED|Overall Study||0||
59711599|NCT00953056|75830199|FG004|NOT COMPLETED|Overall Study||2||
59711600|NCT00953056|75830200|FG005|NOT COMPLETED|Overall Study||4||
59711601|NCT02081248|75830218|FG000|STARTED|Overall Study||98||
59711602|NCT02081248|75830219|FG001|STARTED|Overall Study||100||
59711603|NCT02081248|75830218|FG000|COMPLETED|Overall Study||76||
59711604|NCT02081248|75830219|FG001|COMPLETED|Overall Study||87||
59711605|NCT02081248|75830218|FG000|NOT COMPLETED|Overall Study||22||
59711606|NCT02081248|75830219|FG001|NOT COMPLETED|Overall Study||13||
59711607|NCT00952822|75830225|FG000|STARTED|1st Pharmacokinetic Evaluation||9||
59711608|NCT00952822|75830226|FG001|STARTED|1st Pharmacokinetic Evaluation||18||
59711609|NCT00952822|75830227|FG002|STARTED|1st Pharmacokinetic Evaluation||11||
59711610|NCT00952822|75830228|FG003|STARTED|1st Pharmacokinetic Evaluation||4||
59711611|NCT00952822|75830225|FG000|COMPLETED|1st Pharmacokinetic Evaluation||9||
59711612|NCT00952822|75830226|FG001|COMPLETED|1st Pharmacokinetic Evaluation||17||
59711613|NCT00952822|75830227|FG002|COMPLETED|1st Pharmacokinetic Evaluation||11||
59711614|NCT00952822|75830228|FG003|COMPLETED|1st Pharmacokinetic Evaluation||4||
59711615|NCT00952822|75830225|FG000|NOT COMPLETED|1st Pharmacokinetic Evaluation||0||
59711616|NCT00952822|75830226|FG001|NOT COMPLETED|1st Pharmacokinetic Evaluation||1||
59711617|NCT00952822|75830227|FG002|NOT COMPLETED|1st Pharmacokinetic Evaluation||0||
59711618|NCT00952822|75830228|FG003|NOT COMPLETED|1st Pharmacokinetic Evaluation||0||
59711619|NCT00952822|75830225|FG000|STARTED|2nd Pharmacokinetic Evaluation||9||
59711620|NCT00952822|75830226|FG001|STARTED|2nd Pharmacokinetic Evaluation||17||
59711621|NCT00952822|75830227|FG002|STARTED|2nd Pharmacokinetic Evaluation||11||
60107818|NCT01631656|76227316|FG000|NOT COMPLETED|Overall Study||0||
59711622|NCT00952822|75830228|FG003|STARTED|2nd Pharmacokinetic Evaluation||4||
59711623|NCT00952822|75830225|FG000|COMPLETED|2nd Pharmacokinetic Evaluation||9||
59711624|NCT00952822|75830226|FG001|COMPLETED|2nd Pharmacokinetic Evaluation||17||
59711625|NCT00952822|75830227|FG002|COMPLETED|2nd Pharmacokinetic Evaluation||10||
59711626|NCT00952822|75830228|FG003|COMPLETED|2nd Pharmacokinetic Evaluation||4||
60107819|NCT01631656|76227317|FG001|NOT COMPLETED|Overall Study||0||
60107820|NCT01632202|76227325|FG000|STARTED|Overall Study||1||
60107821|NCT01632202|76227326|FG001|STARTED|Overall Study||7||
60107822|NCT01632202|76227325|FG000|COMPLETED|Overall Study||1||
60107823|NCT01632202|76227326|FG001|COMPLETED|Overall Study||7||
60107824|NCT01632202|76227325|FG000|NOT COMPLETED|Overall Study||0||
60107825|NCT01632202|76227326|FG001|NOT COMPLETED|Overall Study||0||
60107826|NCT01634620|76227332|FG000|STARTED|Overall Study||200||
60107827|NCT01634620|76227332|FG000|COMPLETED|Overall Study||200||
60107828|NCT01634620|76227332|FG000|NOT COMPLETED|Overall Study||0||
60107829|NCT01635244|76227344|FG000|STARTED|Overall Study||18||
60107830|NCT01635244|76227345|FG001|STARTED|Overall Study||22||
60107831|NCT01635244|76227346|FG002|STARTED|Overall Study||20||
60107832|NCT01635244|76227344|FG000|COMPLETED|Overall Study||17||
60107833|NCT01635244|76227345|FG001|COMPLETED|Overall Study||21||
60107834|NCT01635244|76227346|FG002|COMPLETED|Overall Study||18||
60107835|NCT01635244|76227344|FG000|NOT COMPLETED|Overall Study||1||
60107836|NCT01635244|76227345|FG001|NOT COMPLETED|Overall Study||1||
60107837|NCT01635244|76227346|FG002|NOT COMPLETED|Overall Study||2||
60107838|NCT01636102|76227356|FG000|STARTED|Overall Study||63||
60107839|NCT01636102|76227357|FG001|STARTED|Overall Study||63||
59566712|NCT04063371|75669391|FG000|STARTED|Overall Study||100||
60107840|NCT01636102|76227356|FG000|COMPLETED|Overall Study||63||
60107841|NCT01636102|76227357|FG001|COMPLETED|Overall Study||63||
60107842|NCT01636102|76227356|FG000|NOT COMPLETED|Overall Study||0||
60107843|NCT01636102|76227357|FG001|NOT COMPLETED|Overall Study||0||
60107844|NCT01376310|76227366|FG000|STARTED|Overall Study||126||
60107845|NCT01376310|76227367|FG001|STARTED|Overall Study||33||
59566713|NCT04063371|75669392|FG001|STARTED|Overall Study||100||
59566714|NCT04063371|75669393|FG002|STARTED|Overall Study||100||
59711627|NCT00952822|75830225|FG000|NOT COMPLETED|2nd Pharmacokinetic Evaluation||0||
59711628|NCT00952822|75830226|FG001|NOT COMPLETED|2nd Pharmacokinetic Evaluation||0||
59711629|NCT00952822|75830227|FG002|NOT COMPLETED|2nd Pharmacokinetic Evaluation||1||
59711630|NCT00952822|75830228|FG003|NOT COMPLETED|2nd Pharmacokinetic Evaluation||0||
59711631|NCT01038297|75830242|FG000|STARTED|Part A: Skin Testing Phase (50 Days)||10||
59711632|NCT01038297|75830243|FG001|STARTED|Part A: Skin Testing Phase (50 Days)||10||
59711633|NCT01038297|75830244|FG002|STARTED|Part A: Skin Testing Phase (50 Days)||10||
59818992|NCT00606593|75941156|FG005|3rd Double-blind Treatment|Overall Study||11||
59818993|NCT00606593|75941157|FG006|3rd Double-blind Treatment|Overall Study||10||
59818994|NCT00606593|75941158|FG007|3rd Double-blind Treatment|Overall Study||9||
59818995|NCT00606593|75941159|FG008|3rd Double-blind Treatment|Overall Study||12||
59818996|NCT00606593|75941160|FG009|3rd Double-blind Treatment|Overall Study||11||
59818997|NCT00606593|75941151|FG000|4th Double-blind Treatment|Overall Study||10||
59818998|NCT00606593|75941152|FG001|4th Double-blind Treatment|Overall Study||11||
59818999|NCT00606593|75941153|FG002|4th Double-blind Treatment|Overall Study||10||
59819000|NCT00606593|75941154|FG003|4th Double-blind Treatment|Overall Study||10||
59819001|NCT00606593|75941155|FG004|4th Double-blind Treatment|Overall Study||11||
59819002|NCT00606593|75941156|FG005|4th Double-blind Treatment|Overall Study||11||
59819003|NCT00606593|75941157|FG006|4th Double-blind Treatment|Overall Study||10||
59819004|NCT00606593|75941158|FG007|4th Double-blind Treatment|Overall Study||9||
59819005|NCT00606593|75941159|FG008|4th Double-blind Treatment|Overall Study||11||
59819006|NCT00606593|75941160|FG009|4th Double-blind Treatment|Overall Study||11||
59819007|NCT00606593|75941151|FG000|5th Double-blind Treatment|Overall Study||10||
59819008|NCT00606593|75941152|FG001|5th Double-blind Treatment|Overall Study||11||
59819009|NCT00606593|75941153|FG002|5th Double-blind Treatment|Overall Study||9||
59819010|NCT00606593|75941154|FG003|5th Double-blind Treatment|Overall Study||10||
59819011|NCT00606593|75941155|FG004|5th Double-blind Treatment|Overall Study||11||
59819012|NCT00606593|75941156|FG005|5th Double-blind Treatment|Overall Study||11||
59819013|NCT00606593|75941157|FG006|5th Double-blind Treatment|Overall Study||10||
59819014|NCT00606593|75941158|FG007|5th Double-blind Treatment|Overall Study||9||
59819015|NCT00606593|75941159|FG008|5th Double-blind Treatment|Overall Study||11||
59819016|NCT00606593|75941160|FG009|5th Double-blind Treatment|Overall Study||11||
59819017|NCT00606593|75941151|FG000|COMPLETED|Overall Study||10||
59819018|NCT00606593|75941152|FG001|COMPLETED|Overall Study||11||
59819019|NCT00606593|75941153|FG002|COMPLETED|Overall Study||9||
59819020|NCT00606593|75941154|FG003|COMPLETED|Overall Study||10||
59819021|NCT00606593|75941155|FG004|COMPLETED|Overall Study||11||
59819022|NCT00606593|75941156|FG005|COMPLETED|Overall Study||11||
59819023|NCT00606593|75941157|FG006|COMPLETED|Overall Study||10||
59819024|NCT00606593|75941158|FG007|COMPLETED|Overall Study||9||
59819025|NCT00606593|75941159|FG008|COMPLETED|Overall Study||11||
59819026|NCT00606593|75941160|FG009|COMPLETED|Overall Study||11||
59819027|NCT00606593|75941151|FG000|NOT COMPLETED|Overall Study||1||
60107846|NCT01376310|76227366|FG000|COMPLETED|Overall Study||90||
60107847|NCT01376310|76227367|FG001|COMPLETED|Overall Study||22||
60107848|NCT01376310|76227366|FG000|NOT COMPLETED|Overall Study||36||
60107849|NCT01376310|76227367|FG001|NOT COMPLETED|Overall Study||11||
60107850|NCT01949506|76227373|FG000|STARTED|Overall Study||9||
60107851|NCT01949506|76227373|FG000|COMPLETED|Overall Study||8||
60107852|NCT01949506|76227373|FG000|NOT COMPLETED|Overall Study||1||
59566715|NCT04063371|75669391|FG000|COMPLETED|Overall Study||100||
59566716|NCT04063371|75669392|FG001|COMPLETED|Overall Study||100||
60107853|NCT01585402|76227377|FG000|STARTED|Overall Study||7||
60107854|NCT01585402|76227377|FG000|COMPLETED|Overall Study||7||
60107855|NCT01585402|76227377|FG000|NOT COMPLETED|Overall Study||0||
60107856|NCT01636414|76227384|FG000|STARTED|Overall Study||64||
60107857|NCT01636414|76227385|FG001|STARTED|Overall Study||66||
60107858|NCT01636414|76227386|FG002|STARTED|Overall Study||74||
60107859|NCT01636414|76227384|FG000|COMPLETED|Overall Study||61||
60107860|NCT01636414|76227385|FG001|COMPLETED|Overall Study||60||
60107861|NCT01636414|76227386|FG002|COMPLETED|Overall Study||65||
60107862|NCT01636414|76227384|FG000|NOT COMPLETED|Overall Study||3||
60107863|NCT01636414|76227385|FG001|NOT COMPLETED|Overall Study||6||
60107864|NCT01636414|76227386|FG002|NOT COMPLETED|Overall Study||9||
59566717|NCT04063371|75669393|FG002|COMPLETED|Overall Study||100||
59566718|NCT04063371|75669391|FG000|NOT COMPLETED|Overall Study||0||
59711634|NCT01038297|75830242|FG000|COMPLETED|Part A: Skin Testing Phase (50 Days)||9||
59819028|NCT00606593|75941152|FG001|NOT COMPLETED|Overall Study||0||
59819029|NCT00606593|75941153|FG002|NOT COMPLETED|Overall Study||2||
59566719|NCT04063371|75669392|FG001|NOT COMPLETED|Overall Study||0||
59711635|NCT01038297|75830243|FG001|COMPLETED|Part A: Skin Testing Phase (50 Days)||10||
59711636|NCT01038297|75830244|FG002|COMPLETED|Part A: Skin Testing Phase (50 Days)||10||
59711637|NCT01038297|75830242|FG000|NOT COMPLETED|Part A: Skin Testing Phase (50 Days)||1||
59711638|NCT01038297|75830243|FG001|NOT COMPLETED|Part A: Skin Testing Phase (50 Days)||0||
59711639|NCT01038297|75830244|FG002|NOT COMPLETED|Part A: Skin Testing Phase (50 Days)||0||
59711640|NCT01038297|75830242|FG000|STARTED|Part B: Active Dosing Phase (13 Weeks)||9||
59711641|NCT01038297|75830243|FG001|STARTED|Part B: Active Dosing Phase (13 Weeks)||10||
59711642|NCT01038297|75830244|FG002|STARTED|Part B: Active Dosing Phase (13 Weeks)||10||
59711643|NCT01038297|75830242|FG000|COMPLETED|Part B: Active Dosing Phase (13 Weeks)||9||
59711644|NCT01038297|75830243|FG001|COMPLETED|Part B: Active Dosing Phase (13 Weeks)||10||
59711645|NCT01038297|75830244|FG002|COMPLETED|Part B: Active Dosing Phase (13 Weeks)||10||
59711646|NCT01038297|75830242|FG000|NOT COMPLETED|Part B: Active Dosing Phase (13 Weeks)||0||
59711647|NCT01038297|75830243|FG001|NOT COMPLETED|Part B: Active Dosing Phase (13 Weeks)||0||
59711648|NCT01038297|75830244|FG002|NOT COMPLETED|Part B: Active Dosing Phase (13 Weeks)||0||
59711649|NCT00955708|75830261|FG000|STARTED|Overall Study||1308||
59819030|NCT00606593|75941154|FG003|NOT COMPLETED|Overall Study||1||
59819031|NCT00606593|75941155|FG004|NOT COMPLETED|Overall Study||1||
59819032|NCT00606593|75941156|FG005|NOT COMPLETED|Overall Study||0||
60107865|NCT01636882|76227394|FG000|STARTED|Overall Study||16||
60107866|NCT01636882|76227394|FG000|COMPLETED|Overall Study||16||
60107867|NCT01636882|76227394|FG000|NOT COMPLETED|Overall Study||0||
60107868|NCT01638052|76227400|FG000|STARTED|Overall Study||28||
60107869|NCT01638052|76227401|FG001|STARTED|Overall Study||28||
60107870|NCT01638052|76227400|FG000|COMPLETED|Overall Study||28||
60107871|NCT01638052|76227401|FG001|COMPLETED|Overall Study||28||
60107872|NCT01638052|76227400|FG000|NOT COMPLETED|Overall Study||0||
60107873|NCT01638052|76227401|FG001|NOT COMPLETED|Overall Study||0||
60107874|NCT01639222|76227407|FG000|STARTED|Overall Study||55||
60107875|NCT01639222|76227407|FG000|COMPLETED|Overall Study||55||
60107876|NCT01639222|76227407|FG000|NOT COMPLETED|Overall Study||0||
60107877|NCT01640548|76227413|FG000|STARTED|Overall Study||309||
60107878|NCT01640548|76227413|FG000|COMPLETED|Overall Study||309||
60107879|NCT01640548|76227413|FG000|NOT COMPLETED|Overall Study||0||
60107880|NCT01598194|76227419|FG000|STARTED|Overall Study||30||
60107881|NCT01598194|76227420|FG001|STARTED|Overall Study||30||
60107882|NCT01598194|76227419|FG000|2 Passes With 25G for Cytology|Overall Study||30||
60107883|NCT01598194|76227420|FG001|2 Passes With 25G for Cytology|Overall Study||30||
60107884|NCT01598194|76227419|FG000|1 Pass With 22Gpc for Cytology|Overall Study|1 participant's pass could not be performed|29||
60107885|NCT01598194|76227420|FG001|1 Pass With 22Gpc for Cytology|Overall Study||30||
60107886|NCT01598194|76227419|FG000|1 Pass With 22Gpc for Histology|Overall Study|3 participants passes could not be performed|27||
60107887|NCT01598194|76227420|FG001|1 Pass With 22Gpc for Histology|Overall Study|1 participant's pass could not be performed|29||
59566720|NCT04063371|75669393|FG002|NOT COMPLETED|Overall Study||0||
59566721|NCT00554840|75669405|FG000|STARTED|Overall Study||4||
59566722|NCT00554840|75669406|FG001|STARTED|Overall Study||5||
59566723|NCT00554840|75669405|FG000|COMPLETED|Overall Study||4||
59566724|NCT00554840|75669406|FG001|COMPLETED|Overall Study||4||
59566725|NCT00554840|75669405|FG000|NOT COMPLETED|Overall Study||0||
59566726|NCT00554840|75669406|FG001|NOT COMPLETED|Overall Study||1||
59566727|NCT04069221|75669416|FG000|STARTED|Overall Study||8||
59566728|NCT04069221|75669417|FG001|STARTED|Overall Study||6||
59566729|NCT04069221|75669418|FG002|STARTED|Overall Study||6||
59566730|NCT04069221|75669419|FG003|STARTED|Overall Study||6||
59566731|NCT04069221|75669416|FG000|COMPLETED|Overall Study||8||
59566732|NCT04069221|75669417|FG001|COMPLETED|Overall Study||6||
59566733|NCT04069221|75669418|FG002|COMPLETED|Overall Study||6||
59566734|NCT04069221|75669419|FG003|COMPLETED|Overall Study||6||
59566735|NCT04069221|75669416|FG000|NOT COMPLETED|Overall Study||0||
59566736|NCT04069221|75669417|FG001|NOT COMPLETED|Overall Study||0||
59566737|NCT04069221|75669418|FG002|NOT COMPLETED|Overall Study||0||
59566738|NCT04069221|75669419|FG003|NOT COMPLETED|Overall Study||0||
59566739|NCT02302716|75669431|FG000|STARTED|Overall Study||249||
59566740|NCT02302716|75669432|FG001|STARTED|Overall Study||244||
59566741|NCT02302716|75669431|FG000|Received at Least 1 Dose of Study Drug|Overall Study||249||
59566742|NCT02302716|75669432|FG001|Received at Least 1 Dose of Study Drug|Overall Study||244||
59566743|NCT02302716|75669431|FG000|COMPLETED|Overall Study||230||
59566744|NCT02302716|75669432|FG001|COMPLETED|Overall Study||225||
59566745|NCT02302716|75669431|FG000|NOT COMPLETED|Overall Study||19||
59566746|NCT02302716|75669432|FG001|NOT COMPLETED|Overall Study||19||
59566747|NCT03881007|75669440|FG000|STARTED|First 3 Months||172||
59566748|NCT03881007|75669441|FG001|STARTED|First 3 Months||171||
59566749|NCT03881007|75669440|FG000|COMPLETED|First 3 Months||121||
59566750|NCT03881007|75669441|FG001|COMPLETED|First 3 Months||119||
59566751|NCT03881007|75669440|FG000|NOT COMPLETED|First 3 Months||51||
59566752|NCT03881007|75669441|FG001|NOT COMPLETED|First 3 Months||52||
59566753|NCT03881007|75669440|FG000|STARTED|Last 3 Months||121||
59566754|NCT03881007|75669441|FG001|STARTED|Last 3 Months||119||
59566755|NCT03881007|75669440|FG000|COMPLETED|Last 3 Months||77||
59566756|NCT03881007|75669441|FG001|COMPLETED|Last 3 Months||74||
59711650|NCT00955708|75830261|FG000|COMPLETED|Overall Study||250||
59711651|NCT00955708|75830261|FG000|NOT COMPLETED|Overall Study||1058||
59711652|NCT01037985|75830265|FG000|STARTED|Part A: Skin Testing (50 Days)||41||
59711653|NCT01037985|75830266|FG001|STARTED|Part A: Skin Testing (50 Days)||0||
59711654|NCT01037985|75830265|FG000|COMPLETED|Part A: Skin Testing (50 Days)||37||
59711655|NCT01037985|75830266|FG001|COMPLETED|Part A: Skin Testing (50 Days)||0||
59711656|NCT01037985|75830265|FG000|NOT COMPLETED|Part A: Skin Testing (50 Days)||4||
59711657|NCT01037985|75830266|FG001|NOT COMPLETED|Part A: Skin Testing (50 Days)||0||
59711658|NCT01037985|75830265|FG000|STARTED|Part B:Abdominoplasty Surgery (24 Weeks)|Participants who tested negative for skin sensitization proceeded to Part B of the study. .|0||
59711659|NCT01037985|75830266|FG001|STARTED|Part B:Abdominoplasty Surgery (24 Weeks)|Participants who completed Part A of the study and were negative for skin sensitization.|37||
59711660|NCT01037985|75830265|FG000|Treated|Part B:Abdominoplasty Surgery (24 Weeks)||0||
59711661|NCT01037985|75830266|FG001|Treated|Part B:Abdominoplasty Surgery (24 Weeks)||33||
59711662|NCT01037985|75830265|FG000|COMPLETED|Part B:Abdominoplasty Surgery (24 Weeks)||0||
59711663|NCT01037985|75830266|FG001|COMPLETED|Part B:Abdominoplasty Surgery (24 Weeks)||32||
59711664|NCT01037985|75830265|FG000|NOT COMPLETED|Part B:Abdominoplasty Surgery (24 Weeks)||0||
59711665|NCT01037985|75830266|FG001|NOT COMPLETED|Part B:Abdominoplasty Surgery (24 Weeks)||5||
59711666|NCT00955474|75830278|FG000|STARTED|Overall Study||12||
59819033|NCT00606593|75941157|FG006|NOT COMPLETED|Overall Study||1||
60107888|NCT01598194|76227419|FG000|COMPLETED|Overall Study||30||
60107889|NCT01598194|76227420|FG001|COMPLETED|Overall Study||30||
59566757|NCT03881007|75669440|FG000|NOT COMPLETED|Last 3 Months||44||
59566758|NCT03881007|75669441|FG001|NOT COMPLETED|Last 3 Months||45||
59566759|NCT03958071|75669450|FG000|STARTED|Overall Study||347||
59566760|NCT03958071|75669451|FG001|STARTED|Overall Study||423||
59566761|NCT03958071|75669452|FG002|STARTED|Overall Study||12494||
59566762|NCT03958071|75669450|FG000|COMPLETED|Overall Study||347||
59566763|NCT03958071|75669451|FG001|COMPLETED|Overall Study||423||
59566764|NCT03958071|75669452|FG002|COMPLETED|Overall Study||12494||
59566765|NCT03958071|75669450|FG000|NOT COMPLETED|Overall Study||0||
59566766|NCT03958071|75669451|FG001|NOT COMPLETED|Overall Study||0||
59566767|NCT03958071|75669452|FG002|NOT COMPLETED|Overall Study||0||
59566768|NCT00554606|75669461|FG000|STARTED|Overall Study||115||
60107890|NCT01598194|76227419|FG000|NOT COMPLETED|Overall Study||0||
60107891|NCT01598194|76227420|FG001|NOT COMPLETED|Overall Study||0||
60107892|NCT01598350|76227430|FG000|STARTED|Overall Study||6||
60107893|NCT01598350|76227430|FG000|COMPLETED|Overall Study||6||
60107894|NCT01598350|76227430|FG000|NOT COMPLETED|Overall Study||0||
60107895|NCT01598428|76227434|FG000|STARTED|Overall Study||20||
60107896|NCT01598428|76227434|FG000|COMPLETED|Overall Study||20||
60107897|NCT01598428|76227434|FG000|NOT COMPLETED|Overall Study||0||
60107898|NCT01598740|76227441|FG000|STARTED|Period 1||9||
60107899|NCT01598740|76227442|FG001|STARTED|Period 1||9||
60107900|NCT01598740|76227441|FG000|COMPLETED|Period 1||9||
60107901|NCT01598740|76227442|FG001|COMPLETED|Period 1||9||
60107902|NCT01598740|76227441|FG000|NOT COMPLETED|Period 1||0||
60107903|NCT01598740|76227442|FG001|NOT COMPLETED|Period 1||0||
60107904|NCT01598740|76227441|FG000|STARTED|Period 2|1 subject discontinued during the washout period prior to starting treatment period 2.|8||
60107905|NCT01598740|76227442|FG001|STARTED|Period 2||9||
60107906|NCT01598740|76227441|FG000|COMPLETED|Period 2||7||
60107907|NCT01598740|76227442|FG001|COMPLETED|Period 2||9||
60107908|NCT01598740|76227441|FG000|NOT COMPLETED|Period 2||1||
60107909|NCT01598740|76227442|FG001|NOT COMPLETED|Period 2||0||
60107910|NCT01599286|76227451|FG000|STARTED|Overall Study||24||54
60107911|NCT01599286|76227452|FG001|STARTED|Overall Study||23||52
60107912|NCT01599286|76227451|FG000|COMPLETED|Overall Study||24||54
60107913|NCT01599286|76227452|FG001|COMPLETED|Overall Study||23||52
59566769|NCT00554606|75669461|FG000|COMPLETED|Overall Study||30||
59566770|NCT00554606|75669461|FG000|NOT COMPLETED|Overall Study||85||
59566771|NCT04066647|75669467|FG000|STARTED|Overall Study||7||
59566772|NCT04066647|75669467|FG000|COMPLETED|Overall Study||7||
59566773|NCT04066647|75669467|FG000|NOT COMPLETED|Overall Study||0||
59566774|NCT04041453|75669475|FG000|STARTED|Overall Study||38||
59566775|NCT04041453|75669476|FG001|STARTED|Overall Study||57||
59566776|NCT04041453|75669477|FG002|STARTED|Overall Study||23||
59566777|NCT04041453|75669478|FG003|STARTED|Overall Study||58||
59566778|NCT04041453|75669475|FG000|Safety Population|Overall Study||38||
59566779|NCT04041453|75669476|FG001|Safety Population|Overall Study||56||
59566780|NCT04041453|75669477|FG002|Safety Population|Overall Study||23||
59566781|NCT04041453|75669478|FG003|Safety Population|Overall Study||58||
59711667|NCT00955474|75830279|FG001|STARTED|Overall Study||13||
59711668|NCT00955474|75830278|FG000|COMPLETED|Overall Study||5||
59711669|NCT00955474|75830279|FG001|COMPLETED|Overall Study||8||
59711670|NCT00955474|75830278|FG000|NOT COMPLETED|Overall Study||7||
59711671|NCT00955474|75830279|FG001|NOT COMPLETED|Overall Study||5||
59711672|NCT01229150|75830291|FG000|STARTED|Overall Study||30||
59711673|NCT01229150|75830292|FG001|STARTED|Overall Study||11||
59711674|NCT01229150|75830293|FG002|STARTED|Overall Study||19||
59711675|NCT01229150|75830294|FG003|STARTED|Overall Study||19||
59711676|NCT01229150|75830291|FG000|COMPLETED|Overall Study||28||
59711677|NCT01229150|75830292|FG001|COMPLETED|Overall Study||9||
59711678|NCT01229150|75830293|FG002|COMPLETED|Overall Study||19||
59711679|NCT01229150|75830294|FG003|COMPLETED|Overall Study||19||
59711680|NCT01229150|75830291|FG000|NOT COMPLETED|Overall Study||2||
59711681|NCT01229150|75830292|FG001|NOT COMPLETED|Overall Study||2||
59711682|NCT01229150|75830293|FG002|NOT COMPLETED|Overall Study||0||
59711683|NCT01229150|75830294|FG003|NOT COMPLETED|Overall Study||0||
59711684|NCT00952588|75830310|FG000|STARTED|Overall Study||48||
59711685|NCT00952588|75830311|FG001|STARTED|Overall Study||26||
59711686|NCT00952588|75830310|FG000|COMPLETED|Overall Study||12||
59711687|NCT00952588|75830311|FG001|COMPLETED|Overall Study||2||
59711688|NCT00952588|75830310|FG000|NOT COMPLETED|Overall Study||36||
59711689|NCT00952588|75830311|FG001|NOT COMPLETED|Overall Study||24||
59711690|NCT01227902|75830321|FG000|STARTED|Overall Study||56||
60107914|NCT01599286|76227451|FG000|NOT COMPLETED|Overall Study||0||0
60107915|NCT01599286|76227452|FG001|NOT COMPLETED|Overall Study||0||0
60107916|NCT01599832|76227458|FG000|STARTED|Overall Study||20||
60107917|NCT01599832|76227458|FG000|COMPLETED|Overall Study||20||
60107918|NCT01599832|76227458|FG000|NOT COMPLETED|Overall Study||0||
60107919|NCT01600222|76227462|FG000|STARTED|Overall Study||37||
59819034|NCT00606593|75941158|FG007|NOT COMPLETED|Overall Study||2||
59819035|NCT00606593|75941159|FG008|NOT COMPLETED|Overall Study||1||
59819036|NCT00606593|75941160|FG009|NOT COMPLETED|Overall Study||0||
60107920|NCT01600222|76227462|FG000|COMPLETED|Overall Study||35||
60107921|NCT01600222|76227462|FG000|NOT COMPLETED|Overall Study||2||
60107922|NCT00709098|76227470|FG000|STARTED|Double-blind Period||25||
60107923|NCT00709098|76227471|FG001|STARTED|Double-blind Period||24||
60107924|NCT00709098|76227472|FG002|STARTED|Double-blind Period||0||
60107925|NCT00709098|76227470|FG000|COMPLETED|Double-blind Period||19||
60107926|NCT00709098|76227471|FG001|COMPLETED|Double-blind Period||16||
60107927|NCT00709098|76227472|FG002|COMPLETED|Double-blind Period||0||
60107928|NCT00709098|76227470|FG000|NOT COMPLETED|Double-blind Period||6||
60107929|NCT00709098|76227471|FG001|NOT COMPLETED|Double-blind Period||8||
60107930|NCT00709098|76227472|FG002|NOT COMPLETED|Double-blind Period||0||
60107931|NCT00709098|76227470|FG000|STARTED|Open-label Period||0||
60107932|NCT00709098|76227471|FG001|STARTED|Open-label Period||0||
60107933|NCT00709098|76227472|FG002|STARTED|Open-label Period|The open-label period was only made available to patients in US centers|32||
60107934|NCT00709098|76227470|FG000|COMPLETED|Open-label Period||0||
60107935|NCT00709098|76227471|FG001|COMPLETED|Open-label Period||0||
60107936|NCT00709098|76227472|FG002|COMPLETED|Open-label Period||18||
60107937|NCT00709098|76227470|FG000|NOT COMPLETED|Open-label Period||0||
60107938|NCT00709098|76227471|FG001|NOT COMPLETED|Open-label Period||0||
60107939|NCT00709098|76227472|FG002|NOT COMPLETED|Open-label Period||14||
60107940|NCT01376700|76227481|FG000|STARTED|Overall Study||19||
60107941|NCT01376700|76227481|FG000|COMPLETED|Overall Study||3||
60107942|NCT01376700|76227481|FG000|NOT COMPLETED|Overall Study||16||
60107943|NCT01797965|76227492|FG000|STARTED|Overall Study||597||
60107944|NCT01797965|76227493|FG001|STARTED|Overall Study||607||
60107945|NCT01797965|76227494|FG002|STARTED|Overall Study||70||
60107946|NCT01797965|76227495|FG003|STARTED|Overall Study||227||
60107947|NCT01797965|76227492|FG000|COMPLETED|Overall Study||48||
60107948|NCT01797965|76227493|FG001|COMPLETED|Overall Study||38||
60107949|NCT01797965|76227494|FG002|COMPLETED|Overall Study||62||
60107950|NCT01797965|76227495|FG003|COMPLETED|Overall Study||154||
60107951|NCT01797965|76227492|FG000|NOT COMPLETED|Overall Study||549||
60107952|NCT01797965|76227493|FG001|NOT COMPLETED|Overall Study||569||
60107953|NCT01797965|76227494|FG002|NOT COMPLETED|Overall Study||8||
60107954|NCT01797965|76227495|FG003|NOT COMPLETED|Overall Study||73||
60107955|NCT01601236|76227512|FG000|STARTED|Overall Study||7||
60107956|NCT01601236|76227513|FG001|STARTED|Overall Study||3||
60107957|NCT01601236|76227514|FG002|STARTED|Overall Study||14||
60107958|NCT01601236|76227515|FG003|STARTED|Overall Study||6||
60107959|NCT01601236|76227516|FG004|STARTED|Overall Study||3||
60107960|NCT01601236|76227517|FG005|STARTED|Overall Study||1||
59711691|NCT01227902|75830322|FG001|STARTED|Overall Study||51||
59711692|NCT01227902|75830323|FG002|STARTED|Overall Study||44||
59711693|NCT01227902|75830324|FG003|STARTED|Overall Study||52||
59711694|NCT01227902|75830321|FG000|COMPLETED|Overall Study||38||
59711695|NCT01227902|75830322|FG001|COMPLETED|Overall Study||38||
59711696|NCT01227902|75830323|FG002|COMPLETED|Overall Study||25||
59711697|NCT01227902|75830324|FG003|COMPLETED|Overall Study||42||
59711698|NCT01227902|75830321|FG000|NOT COMPLETED|Overall Study||18||
59711699|NCT01227902|75830322|FG001|NOT COMPLETED|Overall Study||13||
59711700|NCT01227902|75830323|FG002|NOT COMPLETED|Overall Study||19||
59711701|NCT01227902|75830324|FG003|NOT COMPLETED|Overall Study||10||
59711702|NCT00946192|75830338|FG000|STARTED|Overall Study||43||
59711703|NCT00946192|75830339|FG001|STARTED|Overall Study||40||
59711704|NCT00946192|75830340|FG002|STARTED|Overall Study||38||
59711705|NCT00946192|75830338|FG000|COMPLETED|Overall Study||25||
59711706|NCT00946192|75830339|FG001|COMPLETED|Overall Study||22||
59711707|NCT00946192|75830340|FG002|COMPLETED|Overall Study||26||
59711708|NCT00946192|75830338|FG000|NOT COMPLETED|Overall Study||18||
59711709|NCT00946192|75830339|FG001|NOT COMPLETED|Overall Study||18||
59711710|NCT00946192|75830340|FG002|NOT COMPLETED|Overall Study||12||
59711711|NCT01037127|75830350|FG000|STARTED|Overall Study||40||
59711712|NCT01037127|75830351|FG001|STARTED|Overall Study||57||
59711713|NCT01037127|75830350|FG000|COMPLETED|Overall Study||35||
60107961|NCT01601236|76227512|FG000|COMPLETED|Overall Study||2||
60107962|NCT01601236|76227513|FG001|COMPLETED|Overall Study||2||
60107963|NCT01601236|76227514|FG002|COMPLETED|Overall Study||8||
60107964|NCT01601236|76227515|FG003|COMPLETED|Overall Study||4||
60107965|NCT01601236|76227516|FG004|COMPLETED|Overall Study||0||
60107966|NCT01601236|76227517|FG005|COMPLETED|Overall Study||0||
60107967|NCT01601236|76227512|FG000|NOT COMPLETED|Overall Study||5||
59819037|NCT00605267|75941175|FG000|STARTED|Overall Study||98||
60107968|NCT01601236|76227513|FG001|NOT COMPLETED|Overall Study||1||
60107969|NCT01601236|76227514|FG002|NOT COMPLETED|Overall Study||6||
60107970|NCT01601236|76227515|FG003|NOT COMPLETED|Overall Study||2||
59711714|NCT01037127|75830351|FG001|COMPLETED|Overall Study||36||
59711715|NCT01037127|75830350|FG000|NOT COMPLETED|Overall Study||5||
59711716|NCT01037127|75830351|FG001|NOT COMPLETED|Overall Study||21||
59711717|NCT00946114|75830369|FG000|STARTED|Overall Study||20||
60107971|NCT01601236|76227516|FG004|NOT COMPLETED|Overall Study||3||
60107972|NCT01601236|76227517|FG005|NOT COMPLETED|Overall Study||1||
60107973|NCT01601782|76227526|FG000|STARTED|Overall Study||16||
59711718|NCT00946114|75830370|FG001|STARTED|Overall Study||12||
59711719|NCT00946114|75830369|FG000|COMPLETED|Overall Study||12||
59711720|NCT00946114|75830370|FG001|COMPLETED|Overall Study||10||
59711721|NCT00946114|75830369|FG000|NOT COMPLETED|Overall Study||8||
59711722|NCT00946114|75830370|FG001|NOT COMPLETED|Overall Study||2||
59711723|NCT01038921|75830378|FG000|STARTED|Overall Study|19 subjects received melatonin first(10 weeks), washout (6 weeks), placebo second (10 weeks)|19||
59711724|NCT01038921|75830379|FG001|STARTED|Overall Study|20 subjects received placebo first (10 weeks), washout (6 weeks), melatonin second ( 10 weeks)|20||
59711725|NCT01038921|75830378|FG000|COMPLETED|Overall Study|2 subjects withdrew|17||
59711726|NCT01038921|75830379|FG001|COMPLETED|Overall Study||20||
59711727|NCT01038921|75830378|FG000|NOT COMPLETED|Overall Study||2||
59711728|NCT01038921|75830379|FG001|NOT COMPLETED|Overall Study||0||
59711729|NCT01038687|75830388|FG000|STARTED|Overall Study||12||
59711730|NCT01038687|75830389|FG001|STARTED|Overall Study||11||
59711731|NCT01038687|75830390|FG002|STARTED|Overall Study||13||
59711732|NCT01038687|75830388|FG000|COMPLETED|Overall Study||12||
59711733|NCT01038687|75830389|FG001|COMPLETED|Overall Study||9||
59711734|NCT01038687|75830390|FG002|COMPLETED|Overall Study||12||
59711735|NCT01038687|75830388|FG000|NOT COMPLETED|Overall Study||0||
59711736|NCT01038687|75830389|FG001|NOT COMPLETED|Overall Study||2||
59711737|NCT01038687|75830390|FG002|NOT COMPLETED|Overall Study||1||
59711738|NCT01081912|75830398|FG000|STARTED|Conversion/Titration||510||
59711739|NCT01081912|75830399|FG001|STARTED|Conversion/Titration||0||
59711740|NCT01081912|75830400|FG002|STARTED|Conversion/Titration||0||
59711741|NCT01081912|75830398|FG000|COMPLETED|Conversion/Titration||302||
59711742|NCT01081912|75830399|FG001|COMPLETED|Conversion/Titration||0||
59711743|NCT01081912|75830400|FG002|COMPLETED|Conversion/Titration||0||
59711744|NCT01081912|75830398|FG000|NOT COMPLETED|Conversion/Titration||208||
59711745|NCT01081912|75830399|FG001|NOT COMPLETED|Conversion/Titration||0||
59711746|NCT01081912|75830400|FG002|NOT COMPLETED|Conversion/Titration||0||
59711747|NCT01081912|75830398|FG000|STARTED|Maintenance Treatment||0||
59711748|NCT01081912|75830399|FG001|STARTED|Maintenance Treatment||151||
59711749|NCT01081912|75830400|FG002|STARTED|Maintenance Treatment||151||
59711750|NCT01081912|75830398|FG000|COMPLETED|Maintenance Treatment||0||
60107974|NCT01601782|76227526|FG000|COMPLETED|Overall Study||16||
60107975|NCT01601782|76227526|FG000|NOT COMPLETED|Overall Study||0||
60107976|NCT01601860|76227532|FG000|STARTED|Overall Study||40||
60107977|NCT01601860|76227533|FG001|STARTED|Overall Study||40||
60107978|NCT01601860|76227532|FG000|COMPLETED|Overall Study||19||
60107979|NCT01601860|76227533|FG001|COMPLETED|Overall Study||31||
60107980|NCT01601860|76227532|FG000|NOT COMPLETED|Overall Study||21||
59711751|NCT01081912|75830399|FG001|COMPLETED|Maintenance Treatment||124||
59711752|NCT01081912|75830400|FG002|COMPLETED|Maintenance Treatment||59||
60107981|NCT01601860|76227533|FG001|NOT COMPLETED|Overall Study||9||
60107982|NCT01376388|76227540|FG000|STARTED|Overall Study||130||
60107983|NCT01376388|76227540|FG000|COMPLETED|Overall Study||112||
60107984|NCT01376388|76227540|FG000|NOT COMPLETED|Overall Study||18||
60107985|NCT01643902|76227544|FG000|STARTED|Overall Study||20||
60107986|NCT01643902|76227544|FG000|COMPLETED|Overall Study||20||
60107987|NCT01643902|76227544|FG000|NOT COMPLETED|Overall Study||0||
60107988|NCT01644058|76227549|FG000|STARTED|Overall Study||18||
60107989|NCT01644058|76227549|FG000|COMPLETED|Overall Study||18||
60107990|NCT01644058|76227549|FG000|NOT COMPLETED|Overall Study||0||
60107991|NCT01821677|76227557|FG000|STARTED|Overall Study||117||141
60107992|NCT01821677|76227558|FG001|STARTED|Overall Study||117||142
60107993|NCT01821677|76227559|FG002|STARTED|Overall Study||120||142
60107994|NCT01821677|76227557|FG000|COMPLETED|Overall Study||94||114
60107995|NCT01821677|76227558|FG001|COMPLETED|Overall Study||102||126
59711753|NCT01081912|75830398|FG000|NOT COMPLETED|Maintenance Treatment||0||
59711754|NCT01081912|75830399|FG001|NOT COMPLETED|Maintenance Treatment||27||
59711755|NCT01081912|75830400|FG002|NOT COMPLETED|Maintenance Treatment||92||
59711756|NCT01038609|75830412|FG000|STARTED|Overall Study||50||
59711757|NCT01038609|75830413|FG001|STARTED|Overall Study||52||
59711758|NCT01038609|75830414|FG002|STARTED|Overall Study||49||
60107996|NCT01821677|76227559|FG002|COMPLETED|Overall Study||105||124
60107997|NCT01821677|76227557|FG000|NOT COMPLETED|Overall Study||23||27
60107998|NCT01821677|76227558|FG001|NOT COMPLETED|Overall Study||15||16
60107999|NCT01821677|76227559|FG002|NOT COMPLETED|Overall Study||15||18
60108000|NCT01797731|76227570|FG000|STARTED|Overall Study||50||
60108001|NCT01797731|76227571|FG001|STARTED|Overall Study||50||
59711759|NCT01038609|75830415|FG003|STARTED|Overall Study||48||
59711760|NCT01038609|75830416|FG004|STARTED|Overall Study||51||
59711761|NCT01038609|75830412|FG000|COMPLETED|Overall Study||49||
59711762|NCT01038609|75830413|FG001|COMPLETED|Overall Study||51||
59711763|NCT01038609|75830414|FG002|COMPLETED|Overall Study||48||
59711764|NCT01038609|75830415|FG003|COMPLETED|Overall Study||47||
59711765|NCT01038609|75830416|FG004|COMPLETED|Overall Study||50||
59711766|NCT01038609|75830412|FG000|NOT COMPLETED|Overall Study||1||
59711767|NCT01038609|75830413|FG001|NOT COMPLETED|Overall Study||1||
59711768|NCT01038609|75830414|FG002|NOT COMPLETED|Overall Study||1||
59819038|NCT00605267|75941176|FG001|STARTED|Overall Study||99||
59819039|NCT00605267|75941175|FG000|COMPLETED|Overall Study|Breast surgery performed|95||
60108002|NCT01797731|76227570|FG000|COMPLETED|Overall Study|3 were excluded due to not having proper radiographs for adequate follow up|47||
60108003|NCT01797731|76227571|FG001|COMPLETED|Overall Study|3 excluded due to not having proper radiographs for adequate follow up|47||
60108004|NCT01797731|76227570|FG000|NOT COMPLETED|Overall Study||3||
60108005|NCT01797731|76227571|FG001|NOT COMPLETED|Overall Study||3||
60108006|NCT00709722|76227577|FG000|STARTED|Overall Study||21||
60108007|NCT00709722|76227577|FG000|COMPLETED|Overall Study||20||
60108008|NCT00709722|76227577|FG000|NOT COMPLETED|Overall Study||1||
60108009|NCT01645306|76227584|FG000|STARTED|Overall Study||51||
60108010|NCT01645306|76227585|FG001|STARTED|Overall Study||54||
60108011|NCT01645306|76227586|FG002|STARTED|Overall Study||53||
60108012|NCT01645306|76227584|FG000|COMPLETED|Overall Study||49||
60108013|NCT01645306|76227585|FG001|COMPLETED|Overall Study||50||
60108014|NCT01645306|76227586|FG002|COMPLETED|Overall Study||48||
60108015|NCT01645306|76227584|FG000|NOT COMPLETED|Overall Study||2||
60108016|NCT01645306|76227585|FG001|NOT COMPLETED|Overall Study||4||
60108017|NCT01645306|76227586|FG002|NOT COMPLETED|Overall Study||5||
60108018|NCT01820585|76227598|FG000|STARTED|Overall Study||131||
60108019|NCT01820585|76227599|FG001|STARTED|Overall Study||130||
60108020|NCT01820585|76227600|FG002|STARTED|Overall Study||135||
60108021|NCT01820585|76227601|FG003|STARTED|Overall Study||132||
60108022|NCT01820585|76227598|FG000|Randomized and Treated|Overall Study||131||
60108023|NCT01820585|76227599|FG001|Randomized and Treated|Overall Study||130||
59566782|NCT04041453|75669475|FG000|COMPLETED|Overall Study||24||
59566783|NCT04041453|75669476|FG001|COMPLETED|Overall Study||35||
59566784|NCT04041453|75669477|FG002|COMPLETED|Overall Study||18||
60108024|NCT01820585|76227600|FG002|Randomized and Treated|Overall Study||135||
60108025|NCT01820585|76227601|FG003|Randomized and Treated|Overall Study||132||
60108026|NCT01820585|76227598|FG000|Full Analysis Set|Overall Study||131||
60108027|NCT01820585|76227599|FG001|Full Analysis Set|Overall Study||130||
60108028|NCT01820585|76227600|FG002|Full Analysis Set|Overall Study||135||
60108029|NCT01820585|76227601|FG003|Full Analysis Set|Overall Study||129||
60108030|NCT01820585|76227598|FG000|Completed Titration Period|Overall Study||128||
60108031|NCT01820585|76227599|FG001|Completed Titration Period|Overall Study||125||
60108032|NCT01820585|76227600|FG002|Completed Titration Period|Overall Study||131||
60108033|NCT01820585|76227601|FG003|Completed Titration Period|Overall Study||126||
60108034|NCT01820585|76227598|FG000|Entered Maintenance Period|Overall Study||128||
60108035|NCT01820585|76227599|FG001|Entered Maintenance Period|Overall Study||124||
60108036|NCT01820585|76227600|FG002|Entered Maintenance Period|Overall Study||131||
59566785|NCT04041453|75669478|FG003|COMPLETED|Overall Study||40||
59566786|NCT04041453|75669475|FG000|NOT COMPLETED|Overall Study||14||
59566787|NCT04041453|75669476|FG001|NOT COMPLETED|Overall Study||22||
59566788|NCT04041453|75669477|FG002|NOT COMPLETED|Overall Study||5||
59566789|NCT04041453|75669478|FG003|NOT COMPLETED|Overall Study||18||
59566790|NCT03998163|75669490|FG000|STARTED|Overall Study||222||
59566791|NCT03998163|75669490|FG000|COMPLETED|Overall Study||197||
59566792|NCT03998163|75669490|FG000|NOT COMPLETED|Overall Study||25||
59566793|NCT02354508|75669497|FG000|STARTED|Period 1: Core Phase||41||
59566794|NCT02354508|75669498|FG001|STARTED|Period 1: Core Phase||29||
59566795|NCT02354508|75669499|FG002|STARTED|Period 1: Core Phase||53||
59566796|NCT02354508|75669497|FG000|COMPLETED|Period 1: Core Phase||39|Completed 36 week (wk) Core phase|
59566797|NCT02354508|75669498|FG001|COMPLETED|Period 1: Core Phase||27|Completed 36 week (wk) Core phase|
59566798|NCT02354508|75669499|FG002|COMPLETED|Period 1: Core Phase||47|Completed 36 week (wk) Core phase|
59566799|NCT02354508|75669497|FG000|NOT COMPLETED|Period 1: Core Phase||2||
59566800|NCT02354508|75669498|FG001|NOT COMPLETED|Period 1: Core Phase||2||
59566801|NCT02354508|75669499|FG002|NOT COMPLETED|Period 1: Core Phase||6||
59566802|NCT02354508|75669497|FG000|STARTED|Period 2: Extension Phase|not all patients who completed the Core phase went into the Extension phase|26||
59566803|NCT02354508|75669498|FG001|STARTED|Period 2: Extension Phase|not all patients who completed the Core phase went into the Extension phase|23||
59566804|NCT02354508|75669499|FG002|STARTED|Period 2: Extension Phase|not all patients who completed the Core phase went into the Extension phase|39||
59566805|NCT02354508|75669497|FG000|COMPLETED|Period 2: Extension Phase||20|Completed 72 week extension phase|
59711769|NCT01038609|75830415|FG003|NOT COMPLETED|Overall Study||1||
59711770|NCT01038609|75830416|FG004|NOT COMPLETED|Overall Study||1||
59711771|NCT02357134|75830432|FG000|STARTED|Overall Study||11||
59711772|NCT02357134|75830433|FG001|STARTED|Overall Study||11||
60108037|NCT01820585|76227601|FG003|Entered Maintenance Period|Overall Study||123||
60108038|NCT01820585|76227598|FG000|Completed Maintenance Period|Overall Study||105||
59711773|NCT02357134|75830434|FG002|STARTED|Overall Study||12||
59711774|NCT02357134|75830435|FG003|STARTED|Overall Study||11||
59711775|NCT02357134|75830432|FG000|COMPLETED|Overall Study||10||
59711776|NCT02357134|75830433|FG001|COMPLETED|Overall Study||11||
59711777|NCT02357134|75830434|FG002|COMPLETED|Overall Study||12||
59711778|NCT02357134|75830435|FG003|COMPLETED|Overall Study||11||
60108039|NCT01820585|76227599|FG001|Completed Maintenance Period|Overall Study||98||
60108040|NCT01820585|76227600|FG002|Completed Maintenance Period|Overall Study||101||
60108041|NCT01820585|76227601|FG003|Completed Maintenance Period|Overall Study||84||
59711779|NCT02357134|75830432|FG000|NOT COMPLETED|Overall Study||1||
59711780|NCT02357134|75830433|FG001|NOT COMPLETED|Overall Study||0||
60000403|NCT02593305|76116130|FG001|NOT COMPLETED|Post 2||0||
60108042|NCT01820585|76227598|FG000|COMPLETED|Overall Study||104||
60108043|NCT01820585|76227599|FG001|COMPLETED|Overall Study||98||
60108044|NCT01820585|76227600|FG002|COMPLETED|Overall Study||101||
60108045|NCT01820585|76227601|FG003|COMPLETED|Overall Study||83||
60108046|NCT01820585|76227598|FG000|NOT COMPLETED|Overall Study||27||
60108047|NCT01820585|76227599|FG001|NOT COMPLETED|Overall Study||32||
60108048|NCT01820585|76227600|FG002|NOT COMPLETED|Overall Study||34||
60108049|NCT01820585|76227601|FG003|NOT COMPLETED|Overall Study||49||
60108050|NCT01797263|76227613|FG000|STARTED|Overall Study||129|Baseline|
60108051|NCT01797263|76227614|FG001|STARTED|Overall Study||127|Baseline|
60108052|NCT01797263|76227613|FG000|1 Month|Overall Study||96||
60108053|NCT01797263|76227614|FG001|1 Month|Overall Study||87||
60108054|NCT01797263|76227613|FG000|3 Month|Overall Study||87||
60108055|NCT01797263|76227614|FG001|3 Month|Overall Study||84||
60108056|NCT01797263|76227613|FG000|6 Month|Overall Study||90||
60108057|NCT01797263|76227614|FG001|6 Month|Overall Study||85||
60108058|NCT01797263|76227613|FG000|9 Month|Overall Study||92||
60108059|NCT01797263|76227614|FG001|9 Month|Overall Study||87||
60108060|NCT01797263|76227613|FG000|COMPLETED|Overall Study||92||
60108061|NCT01797263|76227614|FG001|COMPLETED|Overall Study||87||
60108062|NCT01797263|76227613|FG000|NOT COMPLETED|Overall Study||37||
60108063|NCT01797263|76227614|FG001|NOT COMPLETED|Overall Study||40||
60108064|NCT01602172|76227623|FG000|STARTED|Overall Study||37||
60108065|NCT01602172|76227624|FG001|STARTED|Overall Study||23||
60108066|NCT01602172|76227625|FG002|STARTED|Overall Study||22||
60108067|NCT01602172|76227623|FG000|COMPLETED|Overall Study||32||
60108068|NCT01602172|76227624|FG001|COMPLETED|Overall Study||17||
60108069|NCT01602172|76227625|FG002|COMPLETED|Overall Study||22||
60108070|NCT01602172|76227623|FG000|NOT COMPLETED|Overall Study||5||
60108071|NCT01602172|76227624|FG001|NOT COMPLETED|Overall Study||6||
60108072|NCT01602172|76227625|FG002|NOT COMPLETED|Overall Study||0||
60108073|NCT01603420|76227641|FG000|STARTED|Overall Study||1||
60108074|NCT01603420|76227642|FG001|STARTED|Overall Study||1||
60108075|NCT01603420|76227641|FG000|COMPLETED|Overall Study||1||
60108076|NCT01603420|76227642|FG001|COMPLETED|Overall Study||1||
60108077|NCT01603420|76227641|FG000|NOT COMPLETED|Overall Study||0||
60108078|NCT01603420|76227642|FG001|NOT COMPLETED|Overall Study||0||
60108079|NCT02232022|76227651|FG000|STARTED|Overall Study||53||
60108080|NCT02232022|76227651|FG000|COMPLETED|Overall Study||51||
60108081|NCT02232022|76227651|FG000|NOT COMPLETED|Overall Study||2||
60108082|NCT01605292|76227659|FG000|STARTED|Overall Study||351||
60108083|NCT01605292|76227660|FG001|STARTED|Overall Study||347||
60108084|NCT01605292|76227659|FG000|COMPLETED|Overall Study||351||
60108085|NCT01605292|76227660|FG001|COMPLETED|Overall Study||347||
60108086|NCT01605292|76227659|FG000|NOT COMPLETED|Overall Study||0||
60108087|NCT01605292|76227660|FG001|NOT COMPLETED|Overall Study||0||
60108088|NCT01797185|76227669|FG000|STARTED|Overall Study||162||
60108089|NCT01797185|76227670|FG001|STARTED|Overall Study||163||
60108090|NCT01797185|76227671|FG002|STARTED|Overall Study||50||
60108091|NCT01797185|76227669|FG000|COMPLETED|Overall Study||134||
60108092|NCT01797185|76227670|FG001|COMPLETED|Overall Study||125||
60108093|NCT01797185|76227671|FG002|COMPLETED|Overall Study||38||
60108094|NCT01797185|76227669|FG000|NOT COMPLETED|Overall Study||28||
60108095|NCT01797185|76227670|FG001|NOT COMPLETED|Overall Study||38||
60108096|NCT01797185|76227671|FG002|NOT COMPLETED|Overall Study||12||
60108097|NCT01691326|76227681|FG000|STARTED|Overall Study||30||
60108098|NCT01691326|76227682|FG001|STARTED|Overall Study||30||
60108099|NCT01691326|76227681|FG000|COMPLETED|Overall Study||30||
59711781|NCT02357134|75830434|FG002|NOT COMPLETED|Overall Study||0||
59711782|NCT02357134|75830435|FG003|NOT COMPLETED|Overall Study||0||
59711783|NCT00745420|75830445|FG000|STARTED|Overall Study||30||
59711784|NCT00745420|75830445|FG000|COMPLETED|Overall Study||29||
59711785|NCT00745420|75830445|FG000|NOT COMPLETED|Overall Study||1||
60000404|NCT02593305|76116131|FG002|NOT COMPLETED|Post 2||0||
60000405|NCT02593149|76116142|FG000|STARTED|Run-In||340||20
60000406|NCT02593149|76116143|FG001|STARTED|Run-In||361||20
60000407|NCT02593149|76116142|FG000|COMPLETED|Run-In||304||20
60000408|NCT02593149|76116143|FG001|COMPLETED|Run-In||323||20
60000409|NCT02593149|76116142|FG000|NOT COMPLETED|Run-In||36||0
60000410|NCT02593149|76116143|FG001|NOT COMPLETED|Run-In||38||0
60000411|NCT02593149|76116142|FG000|STARTED|Intervention||942||20
60000412|NCT02593149|76116143|FG001|STARTED|Intervention||960||20
60000413|NCT02593149|76116142|FG000|COMPLETED|Intervention||826||20
60108100|NCT01691326|76227682|FG001|COMPLETED|Overall Study||30||
60108101|NCT01691326|76227681|FG000|NOT COMPLETED|Overall Study||0||
60108102|NCT01691326|76227682|FG001|NOT COMPLETED|Overall Study||0||
60108103|NCT01606852|76227692|FG000|STARTED|Overall Study||7||
60108104|NCT01606852|76227693|FG001|STARTED|Overall Study||8||
60108105|NCT01606852|76227692|FG000|COMPLETED|Overall Study||7||
60108106|NCT01606852|76227693|FG001|COMPLETED|Overall Study||8||
60108107|NCT01606852|76227692|FG000|NOT COMPLETED|Overall Study||0||
60108108|NCT01606852|76227693|FG001|NOT COMPLETED|Overall Study||0||
60108109|NCT01691560|76227703|FG000|STARTED|Overall Study||34||
59566806|NCT02354508|75669498|FG001|COMPLETED|Period 2: Extension Phase||19|Completed 72 week extension phase|
59566807|NCT02354508|75669499|FG002|COMPLETED|Period 2: Extension Phase||36|Completed 72 week extension phase|
59566808|NCT02354508|75669497|FG000|NOT COMPLETED|Period 2: Extension Phase||6||
59711786|NCT02853370|75830449|FG000|STARTED|Overall Study||56||
59711787|NCT02853370|75830449|FG000|COMPLETED|Overall Study||45||
60108110|NCT01691560|76227704|FG001|STARTED|Overall Study||33||
60108111|NCT01691560|76227705|FG002|STARTED|Overall Study||34||
60108112|NCT01691560|76227706|FG003|STARTED|Overall Study||33||
60108113|NCT01691560|76227703|FG000|COMPLETED|Overall Study||34||
60108114|NCT01691560|76227704|FG001|COMPLETED|Overall Study||33||
60108115|NCT01691560|76227705|FG002|COMPLETED|Overall Study||34||
60108116|NCT01691560|76227706|FG003|COMPLETED|Overall Study||33||
60108117|NCT01691560|76227703|FG000|NOT COMPLETED|Overall Study||0||
60108118|NCT01691560|76227704|FG001|NOT COMPLETED|Overall Study||0||
60108119|NCT01691560|76227705|FG002|NOT COMPLETED|Overall Study||0||
60108120|NCT01691560|76227706|FG003|NOT COMPLETED|Overall Study||0||
60108121|NCT01691950|76227718|FG000|STARTED|Overall Study||20||
60108122|NCT01691950|76227719|FG001|STARTED|Overall Study||10||
60108123|NCT01691950|76227718|FG000|COMPLETED|Overall Study||10||
60108124|NCT01691950|76227719|FG001|COMPLETED|Overall Study||10||
60108125|NCT01691950|76227718|FG000|NOT COMPLETED|Overall Study||10||
60108126|NCT01691950|76227719|FG001|NOT COMPLETED|Overall Study||0||
60108127|NCT01819727|76227727|FG000|STARTED|Overall Study||131||
60108128|NCT01819727|76227728|FG001|STARTED|Overall Study||130||
60108129|NCT01819727|76227727|FG000|COMPLETED|Overall Study||111||
60108130|NCT01819727|76227728|FG001|COMPLETED|Overall Study||102||
60108131|NCT01819727|76227727|FG000|NOT COMPLETED|Overall Study||20||
60108132|NCT01819727|76227728|FG001|NOT COMPLETED|Overall Study||28||
60108133|NCT01649362|76227736|FG000|STARTED|Overall Study||47||
60108134|NCT01649362|76227737|FG001|STARTED|Overall Study||54||
59566809|NCT02354508|75669498|FG001|NOT COMPLETED|Period 2: Extension Phase||4||
59566810|NCT02354508|75669499|FG002|NOT COMPLETED|Period 2: Extension Phase||3||
59566811|NCT02354508|75669497|FG000|STARTED|Period 3: Post-treatment Follow up Phase||26|Entered post-treatment follow up|
59566812|NCT02354508|75669498|FG001|STARTED|Period 3: Post-treatment Follow up Phase||23|Entered post-treatment follow up|
59566813|NCT02354508|75669499|FG002|STARTED|Period 3: Post-treatment Follow up Phase||39|Entered post-treatment follow up|
59566814|NCT02354508|75669497|FG000|Entered Post-treatment f/up Discontinued|Period 3: Post-treatment Follow up Phase|Entered post-treatment follow-up, discontinued|4||
59711788|NCT02853370|75830449|FG000|NOT COMPLETED|Overall Study||11||
59711789|NCT01879072|75830454|FG000|STARTED|Overall Study||1860||
60108135|NCT01649362|76227736|FG000|COMPLETED|Overall Study||46||
60108136|NCT01649362|76227737|FG001|COMPLETED|Overall Study||40||
59711790|NCT01879072|75830454|FG000|COMPLETED|Overall Study||1709||
60108137|NCT01649362|76227736|FG000|NOT COMPLETED|Overall Study||1||
60108138|NCT01649362|76227737|FG001|NOT COMPLETED|Overall Study||14||
60108139|NCT01692340|76227746|FG000|STARTED|Overall Study||8||
60108140|NCT01692340|76227747|FG001|STARTED|Overall Study||4||
60108141|NCT01692340|76227748|FG002|STARTED|Overall Study||0||
60108142|NCT01692340|76227746|FG000|COMPLETED|Overall Study||8||
60108143|NCT01692340|76227747|FG001|COMPLETED|Overall Study||4||
60108144|NCT01692340|76227748|FG002|COMPLETED|Overall Study||0||
60108145|NCT01692340|76227746|FG000|NOT COMPLETED|Overall Study||0||
60108146|NCT01692340|76227747|FG001|NOT COMPLETED|Overall Study||0||
60108147|NCT01692340|76227748|FG002|NOT COMPLETED|Overall Study||0||
60108148|NCT01692496|76227757|FG000|STARTED|Overall Study||52||
60108149|NCT01692496|76227757|FG000|3 Weeks Pazopanib (Per Protocol PP)|Overall Study||50||
60108150|NCT01692496|76227757|FG000|COMPLETED|Overall Study||52||
60108151|NCT01692496|76227757|FG000|NOT COMPLETED|Overall Study||0||
60108152|NCT01692964|76227761|FG000|STARTED|Overall Study||237||
60108153|NCT01692964|76227761|FG000|COMPLETED|Overall Study||237||
60108154|NCT01692964|76227761|FG000|NOT COMPLETED|Overall Study||0||
60108155|NCT01649596|76227768|FG000|STARTED|Overall Study||46||
60108156|NCT01649596|76227769|FG001|STARTED|Overall Study||48||
60108157|NCT01649596|76227768|FG000|COMPLETED|Overall Study||46||
60108158|NCT01649596|76227769|FG001|COMPLETED|Overall Study||48||
60108159|NCT01649596|76227768|FG000|NOT COMPLETED|Overall Study||0||
60108160|NCT01649596|76227769|FG001|NOT COMPLETED|Overall Study||0||
60108161|NCT01650298|76227777|FG000|STARTED|Overall Study||16||
60108162|NCT01650298|76227778|FG001|STARTED|Overall Study||48||
60108163|NCT01650298|76227777|FG000|COMPLETED|Overall Study||11||
60108164|NCT01650298|76227778|FG001|COMPLETED|Overall Study||42||
60108165|NCT01650298|76227777|FG000|NOT COMPLETED|Overall Study||5||
60108166|NCT01650298|76227778|FG001|NOT COMPLETED|Overall Study||6||
60108167|NCT01795937|76227787|FG000|STARTED|Overall Study||18||
60108168|NCT01795937|76227788|FG001|STARTED|Overall Study||16||
60108169|NCT01795937|76227789|FG002|STARTED|Overall Study||17||
60108170|NCT01795937|76227787|FG000|COMPLETED|Overall Study||17||
60108171|NCT01795937|76227788|FG001|COMPLETED|Overall Study||15||
60108172|NCT01795937|76227789|FG002|COMPLETED|Overall Study||17||
60108173|NCT01795937|76227787|FG000|NOT COMPLETED|Overall Study||1||
60108174|NCT01795937|76227788|FG001|NOT COMPLETED|Overall Study||1||
60108175|NCT01795937|76227789|FG002|NOT COMPLETED|Overall Study||0||
60108176|NCT01608100|76227805|FG000|STARTED|Overall Study||1101||
60108177|NCT01608100|76227805|FG000|COMPLETED|Overall Study||1101||
60108178|NCT01608100|76227805|FG000|NOT COMPLETED|Overall Study||0||
60108179|NCT01817777|76227831|FG000|STARTED|Observational Phase (8 Weeks)||36||
60108180|NCT01817777|76227832|FG001|STARTED|Observational Phase (8 Weeks)||0||
60108181|NCT01817777|76227833|FG002|STARTED|Observational Phase (8 Weeks)||0||
60108182|NCT01817777|76227831|FG000|COMPLETED|Observational Phase (8 Weeks)||31||
60108183|NCT01817777|76227832|FG001|COMPLETED|Observational Phase (8 Weeks)||0||
60108184|NCT01817777|76227833|FG002|COMPLETED|Observational Phase (8 Weeks)||0||
60108185|NCT01817777|76227831|FG000|NOT COMPLETED|Observational Phase (8 Weeks)||5||
60108186|NCT01817777|76227832|FG001|NOT COMPLETED|Observational Phase (8 Weeks)||0||
60108187|NCT01817777|76227833|FG002|NOT COMPLETED|Observational Phase (8 Weeks)||0||
60108188|NCT01817777|76227831|FG000|STARTED|Interventional Phase (20 Weeks)||0||
60108189|NCT01817777|76227832|FG001|STARTED|Interventional Phase (20 Weeks)||16||
60108190|NCT01817777|76227833|FG002|STARTED|Interventional Phase (20 Weeks)||15||
60108191|NCT01817777|76227831|FG000|COMPLETED|Interventional Phase (20 Weeks)||0||
60108192|NCT01817777|76227832|FG001|COMPLETED|Interventional Phase (20 Weeks)||11||
60108193|NCT01817777|76227833|FG002|COMPLETED|Interventional Phase (20 Weeks)||10||
60108194|NCT01817777|76227831|FG000|NOT COMPLETED|Interventional Phase (20 Weeks)||0||
60108195|NCT01817777|76227832|FG001|NOT COMPLETED|Interventional Phase (20 Weeks)||5||
60108196|NCT01817777|76227833|FG002|NOT COMPLETED|Interventional Phase (20 Weeks)||5||
60108197|NCT01693900|76227841|FG000|STARTED|Overall Study||25||
60108198|NCT01693900|76227842|FG001|STARTED|Overall Study||25||
60108199|NCT01693900|76227841|FG000|COMPLETED|Overall Study||25||
60108200|NCT01693900|76227842|FG001|COMPLETED|Overall Study||25||
60108201|NCT01693900|76227841|FG000|NOT COMPLETED|Overall Study||0||
60108202|NCT01693900|76227842|FG001|NOT COMPLETED|Overall Study||0||
60108203|NCT01650844|76227850|FG000|STARTED|Overall Study||200||
60108204|NCT01650844|76227851|FG001|STARTED|Overall Study||200||
60108205|NCT01650844|76227850|FG000|COMPLETED|Overall Study||199|'Completed' indicates all participants who had data to include in the primary analysis.|
60108206|NCT01650844|76227851|FG001|COMPLETED|Overall Study||196|'Completed' indicates all participants who had data to include in the primary analysis.|
60108207|NCT01650844|76227850|FG000|NOT COMPLETED|Overall Study||1||
60108208|NCT01650844|76227851|FG001|NOT COMPLETED|Overall Study||4||
60108209|NCT01795547|76227859|FG000|STARTED|Overall Study||148||
60108210|NCT01795547|76227860|FG001|STARTED|Overall Study||147||
60108211|NCT01795547|76227859|FG000|COMPLETED|Overall Study||100||
60108212|NCT01795547|76227860|FG001|COMPLETED|Overall Study||83||
60108213|NCT01795547|76227859|FG000|NOT COMPLETED|Overall Study||48||
60108214|NCT01795547|76227860|FG001|NOT COMPLETED|Overall Study||64||
60108215|NCT01695304|76227870|FG000|STARTED|Overall Study||120||
60108216|NCT01695304|76227871|FG001|STARTED|Overall Study||120||
60108217|NCT01695304|76227870|FG000|COMPLETED|Overall Study|2 deaths & 1 drop out in the intervention group, contributed some information over the 26 weeks|120||
60108218|NCT01695304|76227871|FG001|COMPLETED|Overall Study|3 deaths & 2 drop out in the intervention group, contributed some information over the 26 weeks|120||
60108219|NCT01695304|76227870|FG000|NOT COMPLETED|Overall Study||0||
60108220|NCT01695304|76227871|FG001|NOT COMPLETED|Overall Study||0||
60108221|NCT01651078|76227879|FG000|STARTED|Overall Study|Two (2) out of 44 patients were enrolled but did not go on to have the NeuroBlate Procedure.|42||
60108222|NCT01651078|76227879|FG000|COMPLETED|Overall Study||16||
60108223|NCT01651078|76227879|FG000|NOT COMPLETED|Overall Study||26||
60108224|NCT01794923|76227886|FG000|STARTED|Overall Study||83||
60108225|NCT01794923|76227887|FG001|STARTED|Overall Study||60||
60108226|NCT01794923|76227888|FG002|STARTED|Overall Study||62||
59711791|NCT01879072|75830454|FG000|NOT COMPLETED|Overall Study||151||
59711792|NCT00954538|75830460|FG000|STARTED|Part I|These subjects did not participate in Part II or III|3||
59711793|NCT00954538|75830461|FG001|STARTED|Part I||0||
59711794|NCT00954538|75830462|FG002|STARTED|Part I||0||
59711795|NCT00954538|75830463|FG003|STARTED|Part I||0||
59711796|NCT00954538|75830464|FG004|STARTED|Part I||0||
59711797|NCT00954538|75830465|FG005|STARTED|Part I||0||
59711798|NCT00954538|75830460|FG000|COMPLETED|Part I||3||
59711799|NCT00954538|75830461|FG001|COMPLETED|Part I||0||
59711800|NCT00954538|75830462|FG002|COMPLETED|Part I||0||
59711801|NCT00954538|75830463|FG003|COMPLETED|Part I||0||
59711802|NCT00954538|75830464|FG004|COMPLETED|Part I||0||
59819040|NCT00605267|75941176|FG001|COMPLETED|Overall Study|Breast surgery performed|90||
59819041|NCT00605267|75941175|FG000|NOT COMPLETED|Overall Study||3||
59819042|NCT00605267|75941176|FG001|NOT COMPLETED|Overall Study||9||
59819043|NCT00605813|75941182|FG000|STARTED|Overall Study||542||
59819044|NCT00605813|75941182|FG000|COMPLETED|Overall Study||517||
59819045|NCT00605813|75941182|FG000|NOT COMPLETED|Overall Study||25||
59819046|NCT00604721|75941195|FG000|STARTED|Overall Study||19||
59819047|NCT00604721|75941195|FG000|COMPLETED|Overall Study|2 patients failed to complete a full cycle of therapy.|17||
59819048|NCT00604721|75941195|FG000|NOT COMPLETED|Overall Study||2||
59819049|NCT00605657|75941200|FG000|STARTED|Overall Study||5||
59819050|NCT00605657|75941200|FG000|COMPLETED|Overall Study||3||
59819051|NCT00605657|75941200|FG000|NOT COMPLETED|Overall Study||2||
59819052|NCT00604565|75941206|FG000|STARTED|Overall Study||4||
59819053|NCT00604565|75941207|FG001|STARTED|Overall Study||7||
59819054|NCT00604565|75941206|FG000|COMPLETED|Overall Study||4||
59819055|NCT00604565|75941207|FG001|COMPLETED|Overall Study||4||
59819056|NCT00604565|75941206|FG000|NOT COMPLETED|Overall Study||0||
59819057|NCT00604565|75941207|FG001|NOT COMPLETED|Overall Study||3||
59819058|NCT00605345|75941215|FG000|STARTED|Overall Study||46||
59819059|NCT00605345|75941216|FG001|STARTED|Overall Study||25||
59819060|NCT00605345|75941215|FG000|COMPLETED|Overall Study||45||
59819061|NCT00605345|75941216|FG001|COMPLETED|Overall Study||22||
59819062|NCT00605345|75941215|FG000|NOT COMPLETED|Overall Study||1||
59819063|NCT00605345|75941216|FG001|NOT COMPLETED|Overall Study||3||
60108227|NCT01794923|76227886|FG000|COMPLETED|Overall Study||83||
60108228|NCT01794923|76227887|FG001|COMPLETED|Overall Study||60||
59711803|NCT00954538|75830465|FG005|COMPLETED|Part I||0||
59711804|NCT00954538|75830460|FG000|NOT COMPLETED|Part I||0||
59819064|NCT00604175|75941225|FG000|STARTED|Entry Through Week 28||130||
59819065|NCT00604175|75941226|FG001|STARTED|Entry Through Week 28||95||
59819066|NCT00604175|75941227|FG002|STARTED|Entry Through Week 28||94||
59819067|NCT00604175|75941225|FG000|COMPLETED|Entry Through Week 28|Completed 28 weeks of the study (the primary endpoint time point).|120||
59819068|NCT00604175|75941226|FG001|COMPLETED|Entry Through Week 28|Completed 28 weeks of the study (the primary endpoint time point).|92||
60108229|NCT01794923|76227888|FG002|COMPLETED|Overall Study||61||
59819069|NCT00604175|75941227|FG002|COMPLETED|Entry Through Week 28|Completed 28 weeks of the study (the primary endpoint time point).|93||
59819070|NCT00604175|75941225|FG000|NOT COMPLETED|Entry Through Week 28||10||
59819071|NCT00604175|75941226|FG001|NOT COMPLETED|Entry Through Week 28||3||
59819072|NCT00604175|75941227|FG002|NOT COMPLETED|Entry Through Week 28||1||
59819073|NCT00604175|75941225|FG000|STARTED|Week 29 Through Week 72||120||
59819074|NCT00604175|75941226|FG001|STARTED|Week 29 Through Week 72||92||
59819075|NCT00604175|75941227|FG002|STARTED|Week 29 Through Week 72||93||
59819076|NCT00604175|75941225|FG000|COMPLETED|Week 29 Through Week 72||108||
60108230|NCT01794923|76227886|FG000|NOT COMPLETED|Overall Study||0||
59711805|NCT00954538|75830461|FG001|NOT COMPLETED|Part I||0||
59711806|NCT00954538|75830462|FG002|NOT COMPLETED|Part I||0||
59711807|NCT00954538|75830463|FG003|NOT COMPLETED|Part I||0||
59711808|NCT00954538|75830464|FG004|NOT COMPLETED|Part I||0||
59711809|NCT00954538|75830465|FG005|NOT COMPLETED|Part I||0||
59711810|NCT00954538|75830460|FG000|STARTED|Part II||0||
59711811|NCT00954538|75830461|FG001|STARTED|Part II|This subject did not participate in Part I or III|1||
59711812|NCT00954538|75830462|FG002|STARTED|Part II|These subjects did not participate in Part I or III|3||
59711813|NCT00954538|75830463|FG003|STARTED|Part II||0||
59711814|NCT00954538|75830464|FG004|STARTED|Part II||0||
59711815|NCT00954538|75830465|FG005|STARTED|Part II|These subjects did not participate in Part I and did participate in Part II and III|2||
59711816|NCT00954538|75830460|FG000|COMPLETED|Part II||0||
59711817|NCT00954538|75830461|FG001|COMPLETED|Part II||1||
59711818|NCT00954538|75830462|FG002|COMPLETED|Part II||3||
59711819|NCT00954538|75830463|FG003|COMPLETED|Part II||0||
59711820|NCT00954538|75830464|FG004|COMPLETED|Part II||0||
59711821|NCT00954538|75830465|FG005|COMPLETED|Part II||2||
59711822|NCT00954538|75830460|FG000|NOT COMPLETED|Part II||0||
59711823|NCT00954538|75830461|FG001|NOT COMPLETED|Part II||0||
59711824|NCT00954538|75830462|FG002|NOT COMPLETED|Part II||0||
59711825|NCT00954538|75830463|FG003|NOT COMPLETED|Part II||0||
59711826|NCT00954538|75830464|FG004|NOT COMPLETED|Part II||0||
59711827|NCT00954538|75830465|FG005|NOT COMPLETED|Part II||0||
59711828|NCT00954538|75830460|FG000|STARTED|Part III||0||
59711829|NCT00954538|75830461|FG001|STARTED|Part III||0||
59711830|NCT00954538|75830462|FG002|STARTED|Part III||0||
59711831|NCT00954538|75830463|FG003|STARTED|Part III|These subjects did not participate in Part I or II|4||
59711832|NCT00954538|75830464|FG004|STARTED|Part III|These subjects did not participate in Part I or II|6||
59711833|NCT00954538|75830465|FG005|STARTED|Part III|These subjects did not participate in Part I and did participate in Part II and III|2||
59711834|NCT00954538|75830460|FG000|COMPLETED|Part III||0||
59711835|NCT00954538|75830461|FG001|COMPLETED|Part III||0||
59711836|NCT00954538|75830462|FG002|COMPLETED|Part III||0||
59711837|NCT00954538|75830463|FG003|COMPLETED|Part III||4||
59711838|NCT00954538|75830464|FG004|COMPLETED|Part III|The subject who did not complete received 1 dose of study drug|5||
59711839|NCT00954538|75830465|FG005|COMPLETED|Part III||2||
59711840|NCT00954538|75830460|FG000|NOT COMPLETED|Part III||0||
59711841|NCT00954538|75830461|FG001|NOT COMPLETED|Part III||0||
59711842|NCT00954538|75830462|FG002|NOT COMPLETED|Part III||0||
59711843|NCT00954538|75830463|FG003|NOT COMPLETED|Part III||0||
59711844|NCT00954538|75830464|FG004|NOT COMPLETED|Part III||1||
60108231|NCT01794923|76227887|FG001|NOT COMPLETED|Overall Study||0||
59711845|NCT00954538|75830465|FG005|NOT COMPLETED|Part III||0||
59711846|NCT00943852|75830474|FG000|STARTED|First Period of Treatment Intervention||2||
59711847|NCT00943852|75830475|FG001|STARTED|First Period of Treatment Intervention||1||
59711848|NCT00943852|75830476|FG002|STARTED|First Period of Treatment Intervention||1||
59711849|NCT00943852|75830477|FG003|STARTED|First Period of Treatment Intervention||2||
59711850|NCT00943852|75830478|FG004|STARTED|First Period of Treatment Intervention||1||
59711851|NCT00943852|75830479|FG005|STARTED|First Period of Treatment Intervention||1||
59711852|NCT00943852|75830480|FG006|STARTED|First Period of Treatment Intervention||2||
59711853|NCT00943852|75830481|FG007|STARTED|First Period of Treatment Intervention||1||
59711854|NCT00943852|75830482|FG008|STARTED|First Period of Treatment Intervention||1||
59711855|NCT00943852|75830483|FG009|STARTED|First Period of Treatment Intervention||1||
59711856|NCT00943852|75830474|FG000|COMPLETED|First Period of Treatment Intervention||2||
59711857|NCT00943852|75830475|FG001|COMPLETED|First Period of Treatment Intervention||1||
59711858|NCT00943852|75830476|FG002|COMPLETED|First Period of Treatment Intervention||1||
60108232|NCT01794923|76227888|FG002|NOT COMPLETED|Overall Study||1||
60108233|NCT01794845|76227896|FG000|STARTED|Overall Study||5||
60108234|NCT01794845|76227896|FG000|COMPLETED|Overall Study||4||
60108235|NCT01794845|76227896|FG000|NOT COMPLETED|Overall Study||1||
60108236|NCT01794689|76227904|FG000|STARTED|Intervention 1 (2 Nights)||25||
60108237|NCT01794689|76227905|FG001|STARTED|Intervention 1 (2 Nights)||29||
60108238|NCT01794689|76227906|FG002|STARTED|Intervention 1 (2 Nights)||24||
59711859|NCT00943852|75830477|FG003|COMPLETED|First Period of Treatment Intervention||2||
59711860|NCT00943852|75830478|FG004|COMPLETED|First Period of Treatment Intervention||1||
59711861|NCT00943852|75830479|FG005|COMPLETED|First Period of Treatment Intervention||1||
59711862|NCT00943852|75830480|FG006|COMPLETED|First Period of Treatment Intervention||2||
59711863|NCT00943852|75830481|FG007|COMPLETED|First Period of Treatment Intervention||1||
59711864|NCT00943852|75830482|FG008|COMPLETED|First Period of Treatment Intervention||1||
59711865|NCT00943852|75830483|FG009|COMPLETED|First Period of Treatment Intervention||1||
59711866|NCT00943852|75830474|FG000|NOT COMPLETED|First Period of Treatment Intervention||0||
59711867|NCT00943852|75830475|FG001|NOT COMPLETED|First Period of Treatment Intervention||0||
59711868|NCT00943852|75830476|FG002|NOT COMPLETED|First Period of Treatment Intervention||0||
59711869|NCT00943852|75830477|FG003|NOT COMPLETED|First Period of Treatment Intervention||0||
59711870|NCT00943852|75830478|FG004|NOT COMPLETED|First Period of Treatment Intervention||0||
59711871|NCT00943852|75830479|FG005|NOT COMPLETED|First Period of Treatment Intervention||0||
59711872|NCT00943852|75830480|FG006|NOT COMPLETED|First Period of Treatment Intervention||0||
59711873|NCT00943852|75830481|FG007|NOT COMPLETED|First Period of Treatment Intervention||0||
59711874|NCT00943852|75830482|FG008|NOT COMPLETED|First Period of Treatment Intervention||0||
59711875|NCT00943852|75830483|FG009|NOT COMPLETED|First Period of Treatment Intervention||0||
59711876|NCT00943852|75830474|FG000|STARTED|Washout Period After Period 1 Treatment||2||
59711877|NCT00943852|75830475|FG001|STARTED|Washout Period After Period 1 Treatment||1||
59711878|NCT00943852|75830476|FG002|STARTED|Washout Period After Period 1 Treatment||1||
59711879|NCT00943852|75830477|FG003|STARTED|Washout Period After Period 1 Treatment||2||
59711880|NCT00943852|75830478|FG004|STARTED|Washout Period After Period 1 Treatment||1||
59711881|NCT00943852|75830479|FG005|STARTED|Washout Period After Period 1 Treatment||1||
59819077|NCT00604175|75941226|FG001|COMPLETED|Week 29 Through Week 72||85||
59819078|NCT00604175|75941227|FG002|COMPLETED|Week 29 Through Week 72||89||
59819079|NCT00604175|75941225|FG000|NOT COMPLETED|Week 29 Through Week 72||12||
59819080|NCT00604175|75941226|FG001|NOT COMPLETED|Week 29 Through Week 72||7||
59819081|NCT00604175|75941227|FG002|NOT COMPLETED|Week 29 Through Week 72||4||
59819082|NCT00605189|75941262|FG000|STARTED|Overall Study||20||
59819083|NCT00605189|75941263|FG001|STARTED|Overall Study||21||
59819084|NCT00605189|75941264|FG002|STARTED|Overall Study||9||
59819085|NCT00605189|75941262|FG000|COMPLETED|Overall Study||17||
59819086|NCT00605189|75941263|FG001|COMPLETED|Overall Study||19||
59819087|NCT00605189|75941264|FG002|COMPLETED|Overall Study||9||
59819088|NCT00605189|75941262|FG000|NOT COMPLETED|Overall Study||3||
59819089|NCT00605189|75941263|FG001|NOT COMPLETED|Overall Study||2||
59819090|NCT00605189|75941264|FG002|NOT COMPLETED|Overall Study||0||
59819091|NCT00340834|75941277|FG000|STARTED|Core Phase of Study||426||
59819092|NCT00340834|75941278|FG001|STARTED|Core Phase of Study||431||
59819093|NCT00340834|75941279|FG002|STARTED|Core Phase of Study||435||
59819094|NCT00340834|75941280|FG003|STARTED|Core Phase of Study|This group was formed at the beginning of the extension phase of the study.|0||
59819095|NCT00340834|75941281|FG004|STARTED|Core Phase of Study|This group was formed at the beginning of the extension phase of the study.|0||
59819096|NCT00340834|75941277|FG000|COMPLETED|Core Phase of Study|On study drug: 358, Off study drug: 11|369||
59819097|NCT00340834|75941278|FG001|COMPLETED|Core Phase of Study|On study drug: 385, Off study drug: 13|398||
59819098|NCT00340834|75941279|FG002|COMPLETED|Core Phase of Study|On study drug: 380, Off study drug: 6|386||
59819099|NCT00340834|75941280|FG003|COMPLETED|Core Phase of Study||0||
59819100|NCT00340834|75941281|FG004|COMPLETED|Core Phase of Study||0||
59819101|NCT00340834|75941277|FG000|NOT COMPLETED|Core Phase of Study||57||
59819102|NCT00340834|75941278|FG001|NOT COMPLETED|Core Phase of Study||33||
59819103|NCT00340834|75941279|FG002|NOT COMPLETED|Core Phase of Study||49||
59711882|NCT00943852|75830480|FG006|STARTED|Washout Period After Period 1 Treatment||2||
59711883|NCT00943852|75830481|FG007|STARTED|Washout Period After Period 1 Treatment||1||
59711884|NCT00943852|75830482|FG008|STARTED|Washout Period After Period 1 Treatment||1||
59711885|NCT00943852|75830483|FG009|STARTED|Washout Period After Period 1 Treatment||1||
59819104|NCT00340834|75941280|FG003|NOT COMPLETED|Core Phase of Study||0||
59819105|NCT00340834|75941281|FG004|NOT COMPLETED|Core Phase of Study||0||
59819106|NCT00340834|75941277|FG000|STARTED|Extension Phase of Study|Entry into the extension phase of the study was optional.|330||
59819107|NCT00340834|75941278|FG001|STARTED|Extension Phase of Study|Entry into the extension phase of the study was optional.|357||
59819108|NCT00340834|75941279|FG002|STARTED|Extension Phase of Study|This group did not exist in the extension phase of the study.|0||
59996263|NCT00702403|76112224|FG000|STARTED|From Engraftment to Study Completion||40||
59996264|NCT00702403|76112224|FG000|Patient Drop-outs|From Engraftment to Study Completion||27||
59996265|NCT00702403|76112224|FG000|COMPLETED|From Engraftment to Study Completion||13||
59996266|NCT00702403|76112224|FG000|NOT COMPLETED|From Engraftment to Study Completion||27||
59996267|NCT00702325|76112233|FG000|STARTED|Overall Study|Randomized|156||
59711886|NCT00943852|75830474|FG000|COMPLETED|Washout Period After Period 1 Treatment||2||
59711887|NCT00943852|75830475|FG001|COMPLETED|Washout Period After Period 1 Treatment||1||
59711888|NCT00943852|75830476|FG002|COMPLETED|Washout Period After Period 1 Treatment||1||
59711889|NCT00943852|75830477|FG003|COMPLETED|Washout Period After Period 1 Treatment||1||
59996268|NCT00702325|76112234|FG001|STARTED|Overall Study|Randomized|155||
59996269|NCT00702325|76112233|FG000|COMPLETED|Overall Study|Completed participants based on randomized population (156) minus discontinued participants (38).|118||
59996270|NCT00702325|76112234|FG001|COMPLETED|Overall Study|Completed participants based on randomized population (155) minus discontinued participants (53).|102||
59996271|NCT00702325|76112233|FG000|NOT COMPLETED|Overall Study||38||
59996272|NCT00702325|76112234|FG001|NOT COMPLETED|Overall Study||53||
59996273|NCT02719171|76112245|FG000|STARTED|Overall Study||42||
59996274|NCT02719171|76112246|FG001|STARTED|Overall Study||42||
59996275|NCT02719171|76112247|FG002|STARTED|Overall Study||42||
59996276|NCT02719171|76112248|FG003|STARTED|Overall Study||39||
59996277|NCT02719171|76112249|FG004|STARTED|Overall Study||20||
59996278|NCT02719171|76112245|FG000|COMPLETED|Overall Study||41||
59996279|NCT02719171|76112246|FG001|COMPLETED|Overall Study||38||
59996280|NCT02719171|76112247|FG002|COMPLETED|Overall Study||39||
59996281|NCT02719171|76112248|FG003|COMPLETED|Overall Study||37||
59996282|NCT02719171|76112249|FG004|COMPLETED|Overall Study||18||
59711890|NCT00943852|75830478|FG004|COMPLETED|Washout Period After Period 1 Treatment||1||
59711891|NCT00943852|75830479|FG005|COMPLETED|Washout Period After Period 1 Treatment||1||
59711892|NCT00943852|75830480|FG006|COMPLETED|Washout Period After Period 1 Treatment||2||
59711893|NCT00943852|75830481|FG007|COMPLETED|Washout Period After Period 1 Treatment||1||
59711894|NCT00943852|75830482|FG008|COMPLETED|Washout Period After Period 1 Treatment||1||
59711895|NCT00943852|75830483|FG009|COMPLETED|Washout Period After Period 1 Treatment||1||
59711896|NCT00943852|75830474|FG000|NOT COMPLETED|Washout Period After Period 1 Treatment||0||
59711897|NCT00943852|75830475|FG001|NOT COMPLETED|Washout Period After Period 1 Treatment||0||
59711898|NCT00943852|75830476|FG002|NOT COMPLETED|Washout Period After Period 1 Treatment||0||
59711899|NCT00943852|75830477|FG003|NOT COMPLETED|Washout Period After Period 1 Treatment||1||
59711900|NCT00943852|75830478|FG004|NOT COMPLETED|Washout Period After Period 1 Treatment||0||
59711901|NCT00943852|75830479|FG005|NOT COMPLETED|Washout Period After Period 1 Treatment||0||
59711902|NCT00943852|75830480|FG006|NOT COMPLETED|Washout Period After Period 1 Treatment||0||
59711903|NCT00943852|75830481|FG007|NOT COMPLETED|Washout Period After Period 1 Treatment||0||
59711904|NCT00943852|75830482|FG008|NOT COMPLETED|Washout Period After Period 1 Treatment||0||
59711905|NCT00943852|75830483|FG009|NOT COMPLETED|Washout Period After Period 1 Treatment||0||
59711906|NCT00943852|75830474|FG000|STARTED|Second Period of Treatment Intervention||2||
59711907|NCT00943852|75830475|FG001|STARTED|Second Period of Treatment Intervention||1||
59711908|NCT00943852|75830476|FG002|STARTED|Second Period of Treatment Intervention||1||
59711909|NCT00943852|75830477|FG003|STARTED|Second Period of Treatment Intervention||1||
59711910|NCT00943852|75830478|FG004|STARTED|Second Period of Treatment Intervention||1||
59711911|NCT00943852|75830479|FG005|STARTED|Second Period of Treatment Intervention||1||
59711912|NCT00943852|75830480|FG006|STARTED|Second Period of Treatment Intervention||2||
59711913|NCT00943852|75830481|FG007|STARTED|Second Period of Treatment Intervention||1||
59711914|NCT00943852|75830482|FG008|STARTED|Second Period of Treatment Intervention||1||
59711915|NCT00943852|75830483|FG009|STARTED|Second Period of Treatment Intervention||1||
59711916|NCT00943852|75830474|FG000|COMPLETED|Second Period of Treatment Intervention||2||
59711917|NCT00943852|75830475|FG001|COMPLETED|Second Period of Treatment Intervention||1||
59711918|NCT00943852|75830476|FG002|COMPLETED|Second Period of Treatment Intervention||1||
59711919|NCT00943852|75830477|FG003|COMPLETED|Second Period of Treatment Intervention||1||
59711920|NCT00943852|75830478|FG004|COMPLETED|Second Period of Treatment Intervention||1||
59711921|NCT00943852|75830479|FG005|COMPLETED|Second Period of Treatment Intervention||1||
59711922|NCT00943852|75830480|FG006|COMPLETED|Second Period of Treatment Intervention||2||
59711923|NCT00943852|75830481|FG007|COMPLETED|Second Period of Treatment Intervention||1||
59711924|NCT00943852|75830482|FG008|COMPLETED|Second Period of Treatment Intervention||1||
59819109|NCT00340834|75941280|FG003|STARTED|Extension Phase of Study|Entry into the extension phase of the study was optional.|176||
60108239|NCT01794689|76227907|FG003|STARTED|Intervention 1 (2 Nights)||22||
60108240|NCT01794689|76227904|FG000|COMPLETED|Intervention 1 (2 Nights)||20||
60108241|NCT01794689|76227905|FG001|COMPLETED|Intervention 1 (2 Nights)||27||
60108242|NCT01794689|76227906|FG002|COMPLETED|Intervention 1 (2 Nights)||21||
60108243|NCT01794689|76227907|FG003|COMPLETED|Intervention 1 (2 Nights)||18||
60108244|NCT01794689|76227904|FG000|NOT COMPLETED|Intervention 1 (2 Nights)||5||
60108245|NCT01794689|76227905|FG001|NOT COMPLETED|Intervention 1 (2 Nights)||2||
60108246|NCT01794689|76227906|FG002|NOT COMPLETED|Intervention 1 (2 Nights)||3||
60108247|NCT01794689|76227907|FG003|NOT COMPLETED|Intervention 1 (2 Nights)||4||
60108248|NCT01794689|76227904|FG000|STARTED|Washout (2 Weeks)||20||
60108249|NCT01794689|76227905|FG001|STARTED|Washout (2 Weeks)||27||
60108250|NCT01794689|76227906|FG002|STARTED|Washout (2 Weeks)||21||
60108251|NCT01794689|76227907|FG003|STARTED|Washout (2 Weeks)||18||
60108252|NCT01794689|76227904|FG000|COMPLETED|Washout (2 Weeks)||20||
60108253|NCT01794689|76227905|FG001|COMPLETED|Washout (2 Weeks)||27||
60108254|NCT01794689|76227906|FG002|COMPLETED|Washout (2 Weeks)||21||
60108255|NCT01794689|76227907|FG003|COMPLETED|Washout (2 Weeks)||18||
60108256|NCT01794689|76227904|FG000|NOT COMPLETED|Washout (2 Weeks)||0||
60108257|NCT01794689|76227905|FG001|NOT COMPLETED|Washout (2 Weeks)||0||
60108258|NCT01794689|76227906|FG002|NOT COMPLETED|Washout (2 Weeks)||0||
60108259|NCT01794689|76227907|FG003|NOT COMPLETED|Washout (2 Weeks)||0||
60108260|NCT01794689|76227904|FG000|STARTED|Intervention 2 (2 Nights)||20||
60108261|NCT01794689|76227905|FG001|STARTED|Intervention 2 (2 Nights)||27||
60108262|NCT01794689|76227906|FG002|STARTED|Intervention 2 (2 Nights)||21||
60108263|NCT01794689|76227907|FG003|STARTED|Intervention 2 (2 Nights)||18||
59711925|NCT00943852|75830483|FG009|COMPLETED|Second Period of Treatment Intervention||1||
59711926|NCT00943852|75830474|FG000|NOT COMPLETED|Second Period of Treatment Intervention||0||
60108264|NCT01794689|76227904|FG000|COMPLETED|Intervention 2 (2 Nights)||20||
59711927|NCT00943852|75830475|FG001|NOT COMPLETED|Second Period of Treatment Intervention||0||
59711928|NCT00943852|75830476|FG002|NOT COMPLETED|Second Period of Treatment Intervention||0||
59711929|NCT00943852|75830477|FG003|NOT COMPLETED|Second Period of Treatment Intervention||0||
59711930|NCT00943852|75830478|FG004|NOT COMPLETED|Second Period of Treatment Intervention||0||
59711931|NCT00943852|75830479|FG005|NOT COMPLETED|Second Period of Treatment Intervention||0||
59711932|NCT00943852|75830480|FG006|NOT COMPLETED|Second Period of Treatment Intervention||0||
59711933|NCT00943852|75830481|FG007|NOT COMPLETED|Second Period of Treatment Intervention||0||
59711934|NCT00943852|75830482|FG008|NOT COMPLETED|Second Period of Treatment Intervention||0||
59711935|NCT00943852|75830483|FG009|NOT COMPLETED|Second Period of Treatment Intervention||0||
59711936|NCT00943852|75830474|FG000|STARTED|Washout Period After Period 2 Treatment||2||
59711937|NCT00943852|75830475|FG001|STARTED|Washout Period After Period 2 Treatment||1||
59711938|NCT00943852|75830476|FG002|STARTED|Washout Period After Period 2 Treatment||1||
59711939|NCT00943852|75830477|FG003|STARTED|Washout Period After Period 2 Treatment||1||
59566815|NCT02354508|75669498|FG001|Entered Post-treatment f/up Discontinued|Period 3: Post-treatment Follow up Phase|Entered post-treatment follow-up, discontinued|3||
59566816|NCT02354508|75669499|FG002|Entered Post-treatment f/up Discontinued|Period 3: Post-treatment Follow up Phase|Entered post-treatment follow-up, discontinued|3||
59711940|NCT00943852|75830478|FG004|STARTED|Washout Period After Period 2 Treatment||1||
60108265|NCT01794689|76227905|FG001|COMPLETED|Intervention 2 (2 Nights)||27||
60108266|NCT01794689|76227906|FG002|COMPLETED|Intervention 2 (2 Nights)||21||
60108267|NCT01794689|76227907|FG003|COMPLETED|Intervention 2 (2 Nights)||18||
60108268|NCT01794689|76227904|FG000|NOT COMPLETED|Intervention 2 (2 Nights)||0||
60108269|NCT01794689|76227905|FG001|NOT COMPLETED|Intervention 2 (2 Nights)||0||
60108270|NCT01794689|76227906|FG002|NOT COMPLETED|Intervention 2 (2 Nights)||0||
60108271|NCT01794689|76227907|FG003|NOT COMPLETED|Intervention 2 (2 Nights)||0||
60108272|NCT01794299|76227923|FG000|STARTED|Overall Study||31||
60108273|NCT01794299|76227923|FG000|COMPLETED|Overall Study||9||
60108274|NCT01794299|76227923|FG000|NOT COMPLETED|Overall Study||22||
60108275|NCT01817075|76227929|FG000|STARTED|Overall Study||88||
60108276|NCT01817075|76227930|FG001|STARTED|Overall Study||89||
60108277|NCT01817075|76227929|FG000|COMPLETED|Overall Study||41||
60108278|NCT01817075|76227930|FG001|COMPLETED|Overall Study||54||
60108279|NCT01817075|76227929|FG000|NOT COMPLETED|Overall Study||47||
60108280|NCT01817075|76227930|FG001|NOT COMPLETED|Overall Study||35||
60108281|NCT01816763|76227939|FG000|STARTED|Overall Study||195||
60108282|NCT01816763|76227940|FG001|STARTED|Overall Study||194||
60108283|NCT01816763|76227941|FG002|STARTED|Overall Study||180||
60108284|NCT01816763|76227939|FG000|COMPLETED|Overall Study||191||
60108285|NCT01816763|76227940|FG001|COMPLETED|Overall Study||179||
60108286|NCT01816763|76227941|FG002|COMPLETED|Overall Study||169||
60108287|NCT01816763|76227939|FG000|NOT COMPLETED|Overall Study||4||
60108288|NCT01816763|76227940|FG001|NOT COMPLETED|Overall Study||15||
60108289|NCT01816763|76227941|FG002|NOT COMPLETED|Overall Study||11||
59566817|NCT02354508|75669497|FG000|COMPLETED|Period 3: Post-treatment Follow up Phase|Entered post-treatment follow-up, completed|22|Entered post-treatment follow-up, completed|
59566818|NCT02354508|75669498|FG001|COMPLETED|Period 3: Post-treatment Follow up Phase|Entered post-treatment follow-up, completed|20|Entered post-treatment follow-up, completed|
59566819|NCT02354508|75669499|FG002|COMPLETED|Period 3: Post-treatment Follow up Phase|Entered post-treatment follow-up, completed|36|Entered post-treatment follow-up, completed|
59566820|NCT02354508|75669497|FG000|NOT COMPLETED|Period 3: Post-treatment Follow up Phase||4||
59711941|NCT00943852|75830479|FG005|STARTED|Washout Period After Period 2 Treatment||1||
59711942|NCT00943852|75830480|FG006|STARTED|Washout Period After Period 2 Treatment||2||
59711943|NCT00943852|75830481|FG007|STARTED|Washout Period After Period 2 Treatment||1||
59711944|NCT00943852|75830482|FG008|STARTED|Washout Period After Period 2 Treatment||1||
59711945|NCT00943852|75830483|FG009|STARTED|Washout Period After Period 2 Treatment||1||
59711946|NCT00943852|75830474|FG000|COMPLETED|Washout Period After Period 2 Treatment||2||
59711947|NCT00943852|75830475|FG001|COMPLETED|Washout Period After Period 2 Treatment||1||
60108290|NCT01816685|76227954|FG000|STARTED|Overall Study||68||
60108291|NCT01816685|76227955|FG001|STARTED|Overall Study||67||
60108292|NCT01816685|76227954|FG000|COMPLETED|Overall Study||58||
60108293|NCT01816685|76227955|FG001|COMPLETED|Overall Study||56||
60108294|NCT01816685|76227954|FG000|NOT COMPLETED|Overall Study||10||
60108295|NCT01816685|76227955|FG001|NOT COMPLETED|Overall Study||11||
59711948|NCT00943852|75830476|FG002|COMPLETED|Washout Period After Period 2 Treatment||1||
59711949|NCT00943852|75830477|FG003|COMPLETED|Washout Period After Period 2 Treatment||1||
59711950|NCT00943852|75830478|FG004|COMPLETED|Washout Period After Period 2 Treatment||1||
59711951|NCT00943852|75830479|FG005|COMPLETED|Washout Period After Period 2 Treatment||0||
59711952|NCT00943852|75830480|FG006|COMPLETED|Washout Period After Period 2 Treatment||2||
59711953|NCT00943852|75830481|FG007|COMPLETED|Washout Period After Period 2 Treatment||1||
59711954|NCT00943852|75830482|FG008|COMPLETED|Washout Period After Period 2 Treatment||1||
59711955|NCT00943852|75830483|FG009|COMPLETED|Washout Period After Period 2 Treatment||1||
59711956|NCT00943852|75830474|FG000|NOT COMPLETED|Washout Period After Period 2 Treatment||0||
59711957|NCT00943852|75830475|FG001|NOT COMPLETED|Washout Period After Period 2 Treatment||0||
59711958|NCT00943852|75830476|FG002|NOT COMPLETED|Washout Period After Period 2 Treatment||0||
59711959|NCT00943852|75830477|FG003|NOT COMPLETED|Washout Period After Period 2 Treatment||0||
59711960|NCT00943852|75830478|FG004|NOT COMPLETED|Washout Period After Period 2 Treatment||0||
59711961|NCT00943852|75830479|FG005|NOT COMPLETED|Washout Period After Period 2 Treatment||1||
59711962|NCT00943852|75830480|FG006|NOT COMPLETED|Washout Period After Period 2 Treatment||0||
59711963|NCT00943852|75830481|FG007|NOT COMPLETED|Washout Period After Period 2 Treatment||0||
59711964|NCT00943852|75830482|FG008|NOT COMPLETED|Washout Period After Period 2 Treatment||0||
59711965|NCT00943852|75830483|FG009|NOT COMPLETED|Washout Period After Period 2 Treatment||0||
59711966|NCT00943852|75830474|FG000|STARTED|Third Period of Treatment Intervention||2||
59711967|NCT00943852|75830475|FG001|STARTED|Third Period of Treatment Intervention||1||
59819110|NCT00340834|75941281|FG004|STARTED|Extension Phase of Study|Entry into the extension phase of the study was optional.|167||
59819111|NCT00340834|75941277|FG000|Received Study Drug|Extension Phase of Study||330||
59819112|NCT00340834|75941278|FG001|Received Study Drug|Extension Phase of Study||356||
59819113|NCT00340834|75941279|FG002|Received Study Drug|Extension Phase of Study||0||
59819114|NCT00340834|75941280|FG003|Received Study Drug|Extension Phase of Study||174||
59819115|NCT00340834|75941281|FG004|Received Study Drug|Extension Phase of Study||167||
59819116|NCT00340834|75941277|FG000|COMPLETED|Extension Phase of Study||245||
59819117|NCT00340834|75941278|FG001|COMPLETED|Extension Phase of Study||281||
60108296|NCT01653028|76227966|FG000|STARTED|Overall Study||12||
60108297|NCT01653028|76227967|FG001|STARTED|Overall Study||10||
60108298|NCT01653028|76227968|FG002|STARTED|Overall Study||11||
60108299|NCT01653028|76227969|FG003|STARTED|Overall Study||10||
60108300|NCT01653028|76227970|FG004|STARTED|Overall Study||29||
60108301|NCT01653028|76227966|FG000|COMPLETED|Overall Study||12||
60108302|NCT01653028|76227967|FG001|COMPLETED|Overall Study||10||
60108303|NCT01653028|76227968|FG002|COMPLETED|Overall Study||11||
60108304|NCT01653028|76227969|FG003|COMPLETED|Overall Study||10||
60108305|NCT01653028|76227970|FG004|COMPLETED|Overall Study||29||
60108306|NCT01653028|76227966|FG000|NOT COMPLETED|Overall Study||0||
60108307|NCT01653028|76227967|FG001|NOT COMPLETED|Overall Study||0||
60108308|NCT01653028|76227968|FG002|NOT COMPLETED|Overall Study||0||
60108309|NCT01653028|76227969|FG003|NOT COMPLETED|Overall Study||0||
60108310|NCT01653028|76227970|FG004|NOT COMPLETED|Overall Study||0||
60108311|NCT00708552|76227986|FG000|STARTED|Overall Study||145||
60108312|NCT00708552|76227987|FG001|STARTED|Overall Study||145||
60108313|NCT00708552|76227988|FG002|STARTED|Overall Study||133||
60108314|NCT00708552|76227989|FG003|STARTED|Overall Study||151||
60108315|NCT00708552|76227986|FG000|COMPLETED|Overall Study||118||
60108316|NCT00708552|76227987|FG001|COMPLETED|Overall Study||127||
60108317|NCT00708552|76227988|FG002|COMPLETED|Overall Study||118||
60108318|NCT00708552|76227989|FG003|COMPLETED|Overall Study||130||
60108319|NCT00708552|76227986|FG000|NOT COMPLETED|Overall Study||27||
60108320|NCT00708552|76227987|FG001|NOT COMPLETED|Overall Study||18||
60108321|NCT00708552|76227988|FG002|NOT COMPLETED|Overall Study||15||
60108322|NCT00708552|76227989|FG003|NOT COMPLETED|Overall Study||21||
60108323|NCT01608490|76228005|FG000|STARTED|Overall Study||158||
60108324|NCT01608490|76228006|FG001|STARTED|Overall Study||157||
60108325|NCT01608490|76228005|FG000|COMPLETED|Overall Study||141||
59711968|NCT00943852|75830476|FG002|STARTED|Third Period of Treatment Intervention||1||
60108326|NCT01608490|76228006|FG001|COMPLETED|Overall Study||142||
60108327|NCT01608490|76228005|FG000|NOT COMPLETED|Overall Study||17||
60108328|NCT01608490|76228006|FG001|NOT COMPLETED|Overall Study||15||
60108329|NCT01609348|76228014|FG000|STARTED|Overall Study||3||
60108330|NCT01609348|76228015|FG001|STARTED|Overall Study||2||
60108331|NCT01609348|76228014|FG000|COMPLETED|Overall Study||3||
60108332|NCT01609348|76228015|FG001|COMPLETED|Overall Study||2||
60108333|NCT01609348|76228014|FG000|NOT COMPLETED|Overall Study||0||
60108334|NCT01609348|76228015|FG001|NOT COMPLETED|Overall Study||0||
60108335|NCT01696084|76228023|FG000|STARTED|Overall Study||153||
60108336|NCT01696084|76228024|FG001|STARTED|Overall Study||156||
59711969|NCT00943852|75830477|FG003|STARTED|Third Period of Treatment Intervention||1||
59711970|NCT00943852|75830478|FG004|STARTED|Third Period of Treatment Intervention||1||
59711971|NCT00943852|75830479|FG005|STARTED|Third Period of Treatment Intervention||0||
59711972|NCT00943852|75830480|FG006|STARTED|Third Period of Treatment Intervention||2||
59711973|NCT00943852|75830481|FG007|STARTED|Third Period of Treatment Intervention||1||
59711974|NCT00943852|75830482|FG008|STARTED|Third Period of Treatment Intervention||1||
59711975|NCT00943852|75830483|FG009|STARTED|Third Period of Treatment Intervention||1||
59711976|NCT00943852|75830474|FG000|COMPLETED|Third Period of Treatment Intervention||2||
59711977|NCT00943852|75830475|FG001|COMPLETED|Third Period of Treatment Intervention||1||
59711978|NCT00943852|75830476|FG002|COMPLETED|Third Period of Treatment Intervention||1||
59711979|NCT00943852|75830477|FG003|COMPLETED|Third Period of Treatment Intervention||1||
59711980|NCT00943852|75830478|FG004|COMPLETED|Third Period of Treatment Intervention||1||
59711981|NCT00943852|75830479|FG005|COMPLETED|Third Period of Treatment Intervention||0||
59711982|NCT00943852|75830480|FG006|COMPLETED|Third Period of Treatment Intervention||2||
59711983|NCT00943852|75830481|FG007|COMPLETED|Third Period of Treatment Intervention||1||
59711984|NCT00943852|75830482|FG008|COMPLETED|Third Period of Treatment Intervention||1||
59711985|NCT00943852|75830483|FG009|COMPLETED|Third Period of Treatment Intervention||1||
59711986|NCT00943852|75830474|FG000|NOT COMPLETED|Third Period of Treatment Intervention||0||
59711987|NCT00943852|75830475|FG001|NOT COMPLETED|Third Period of Treatment Intervention||0||
59711988|NCT00943852|75830476|FG002|NOT COMPLETED|Third Period of Treatment Intervention||0||
59711989|NCT00943852|75830477|FG003|NOT COMPLETED|Third Period of Treatment Intervention||0||
59711990|NCT00943852|75830478|FG004|NOT COMPLETED|Third Period of Treatment Intervention||0||
59711991|NCT00943852|75830479|FG005|NOT COMPLETED|Third Period of Treatment Intervention||0||
59711992|NCT00943852|75830480|FG006|NOT COMPLETED|Third Period of Treatment Intervention||0||
59711993|NCT00943852|75830481|FG007|NOT COMPLETED|Third Period of Treatment Intervention||0||
59711994|NCT00943852|75830482|FG008|NOT COMPLETED|Third Period of Treatment Intervention||0||
59711995|NCT00943852|75830483|FG009|NOT COMPLETED|Third Period of Treatment Intervention||0||
59711996|NCT00943852|75830474|FG000|STARTED|Washout Period After Period 3 Treatment||2||
59819118|NCT00340834|75941279|FG002|COMPLETED|Extension Phase of Study||0||
59819119|NCT00340834|75941280|FG003|COMPLETED|Extension Phase of Study||123||
60108337|NCT01696084|76228023|FG000|COMPLETED|Overall Study||22||
60108338|NCT01696084|76228024|FG001|COMPLETED|Overall Study||10||
60108339|NCT01696084|76228023|FG000|NOT COMPLETED|Overall Study||131||
60108340|NCT01696084|76228024|FG001|NOT COMPLETED|Overall Study||146||
60108341|NCT02228824|76228032|FG000|STARTED|Overall Study||118||
60108342|NCT02228824|76228033|FG001|STARTED|Overall Study||120||
60108343|NCT02228824|76228032|FG000|COMPLETED|Overall Study||89||
60108344|NCT02228824|76228033|FG001|COMPLETED|Overall Study||98||
60108345|NCT02228824|76228032|FG000|NOT COMPLETED|Overall Study||29||
60108346|NCT02228824|76228033|FG001|NOT COMPLETED|Overall Study||22||
60108347|NCT02230540|76228039|FG000|STARTED|Overall Study||8||
60108348|NCT02230540|76228040|FG001|STARTED|Overall Study|The study was terminated before initiation of sequence B. Sequence B was therefore not initiated.|0||
59711997|NCT00943852|75830475|FG001|STARTED|Washout Period After Period 3 Treatment||1||
59819120|NCT00340834|75941281|FG004|COMPLETED|Extension Phase of Study||123||
59819121|NCT00340834|75941277|FG000|NOT COMPLETED|Extension Phase of Study||85||
60108349|NCT02230540|76228039|FG000|COMPLETED|Overall Study||8||
60108350|NCT02230540|76228040|FG001|COMPLETED|Overall Study||0||
60108351|NCT02230540|76228039|FG000|NOT COMPLETED|Overall Study||0||
60108352|NCT02230540|76228040|FG001|NOT COMPLETED|Overall Study||0||
60108353|NCT01653418|76228044|FG000|STARTED|Overall Study||10||
60108354|NCT01653418|76228044|FG000|COMPLETED|Overall Study||10||
60108355|NCT01653418|76228044|FG000|NOT COMPLETED|Overall Study||0||
60108356|NCT01653964|76228048|FG000|STARTED|Overall Study||82||
60108357|NCT01653964|76228048|FG000|COMPLETED|Overall Study||82||
60108358|NCT01653964|76228048|FG000|NOT COMPLETED|Overall Study||0||
60108359|NCT02237950|76228054|FG000|STARTED|Overall Study||295||
60108360|NCT02237950|76228055|FG001|STARTED|Overall Study||291||
60108361|NCT02237950|76228054|FG000|COMPLETED|Overall Study||247||
60108362|NCT02237950|76228055|FG001|COMPLETED|Overall Study||243||
60108363|NCT02237950|76228054|FG000|NOT COMPLETED|Overall Study||48||
60108364|NCT02237950|76228055|FG001|NOT COMPLETED|Overall Study||48||
59711998|NCT00943852|75830476|FG002|STARTED|Washout Period After Period 3 Treatment||1||
59711999|NCT00943852|75830477|FG003|STARTED|Washout Period After Period 3 Treatment||1||
60108365|NCT02238028|76228061|FG000|STARTED|Overall Study||14||
59566821|NCT02354508|75669498|FG001|NOT COMPLETED|Period 3: Post-treatment Follow up Phase||3||
59712000|NCT00943852|75830478|FG004|STARTED|Washout Period After Period 3 Treatment||1||
59819122|NCT00340834|75941278|FG001|NOT COMPLETED|Extension Phase of Study||76||
59819123|NCT00340834|75941279|FG002|NOT COMPLETED|Extension Phase of Study||0||
59819124|NCT00340834|75941280|FG003|NOT COMPLETED|Extension Phase of Study||53||
59819125|NCT00340834|75941281|FG004|NOT COMPLETED|Extension Phase of Study||44||
59819126|NCT00603941|75941294|FG000|STARTED|Overall Study||7||
59819127|NCT00603941|75941295|FG001|STARTED|Overall Study||10||
59819128|NCT00603941|75941296|FG002|STARTED|Overall Study||2||
59819129|NCT00603941|75941294|FG000|COMPLETED|Overall Study||0||
59819130|NCT00603941|75941295|FG001|COMPLETED|Overall Study||0||
59819131|NCT00603941|75941296|FG002|COMPLETED|Overall Study||0||
59819132|NCT00603941|75941294|FG000|NOT COMPLETED|Overall Study||7||
59819133|NCT00603941|75941295|FG001|NOT COMPLETED|Overall Study||10||
59712001|NCT00943852|75830479|FG005|STARTED|Washout Period After Period 3 Treatment||0||
59566822|NCT02354508|75669499|FG002|NOT COMPLETED|Period 3: Post-treatment Follow up Phase||3||
59566823|NCT00554216|75669551|FG000|STARTED|Overall Study||514||
59566824|NCT00554216|75669552|FG001|STARTED|Overall Study||241||
59566825|NCT00554216|75669553|FG002|STARTED|Overall Study||512||
60108366|NCT02238028|76228062|FG001|STARTED|Overall Study||14||
60108367|NCT02238028|76228061|FG000|COMPLETED|Overall Study||12||
60108368|NCT02238028|76228062|FG001|COMPLETED|Overall Study||12||
60108369|NCT02238028|76228061|FG000|NOT COMPLETED|Overall Study||2||
59566826|NCT00554216|75669551|FG000|COMPLETED|Overall Study||272||
59566827|NCT00554216|75669552|FG001|COMPLETED|Overall Study||147||
59566828|NCT00554216|75669553|FG002|COMPLETED|Overall Study||340||
59566829|NCT00554216|75669551|FG000|NOT COMPLETED|Overall Study||242||
59566830|NCT00554216|75669552|FG001|NOT COMPLETED|Overall Study||94||
59566831|NCT00554216|75669553|FG002|NOT COMPLETED|Overall Study||172||
59566832|NCT04001517|75669564|FG000|STARTED|Overall Study||20||
59566833|NCT04001517|75669565|FG001|STARTED|Overall Study||26||
59566834|NCT04001517|75669566|FG002|STARTED|Overall Study||27||
59566835|NCT04001517|75669567|FG003|STARTED|Overall Study||18||
59566836|NCT04001517|75669564|FG000|COMPLETED|Overall Study||20||
59566837|NCT04001517|75669565|FG001|COMPLETED|Overall Study||20||
59566838|NCT04001517|75669566|FG002|COMPLETED|Overall Study||26||
59566839|NCT04001517|75669567|FG003|COMPLETED|Overall Study||15||
59566840|NCT04001517|75669564|FG000|NOT COMPLETED|Overall Study||0||
59566841|NCT04001517|75669565|FG001|NOT COMPLETED|Overall Study||6||
59566842|NCT04001517|75669566|FG002|NOT COMPLETED|Overall Study||1||
59566843|NCT04001517|75669567|FG003|NOT COMPLETED|Overall Study||3||
59566844|NCT02353572|75669578|FG000|STARTED|Overall Study||3||
59566845|NCT02353572|75669578|FG000|COMPLETED|Overall Study||0||
59566846|NCT02353572|75669578|FG000|NOT COMPLETED|Overall Study||3||
59566847|NCT03886701|75669582|FG000|STARTED|Period 1: Study Days 1-4||11|Healthy volunteers received oral DOR 100 mg twice daily alone|
59566848|NCT03886701|75669582|FG000|COMPLETED|Period 1: Study Days 1-4||11||
59566849|NCT03886701|75669582|FG000|NOT COMPLETED|Period 1: Study Days 1-4||0||
59712002|NCT00943852|75830480|FG006|STARTED|Washout Period After Period 3 Treatment||2||
59712003|NCT00943852|75830481|FG007|STARTED|Washout Period After Period 3 Treatment||1||
59712004|NCT00943852|75830482|FG008|STARTED|Washout Period After Period 3 Treatment||1||
59712005|NCT00943852|75830483|FG009|STARTED|Washout Period After Period 3 Treatment||1||
59712006|NCT00943852|75830474|FG000|COMPLETED|Washout Period After Period 3 Treatment||2||
59712007|NCT00943852|75830475|FG001|COMPLETED|Washout Period After Period 3 Treatment||1||
59712008|NCT00943852|75830476|FG002|COMPLETED|Washout Period After Period 3 Treatment||1||
60108370|NCT02238028|76228062|FG001|NOT COMPLETED|Overall Study||2||
59712009|NCT00943852|75830477|FG003|COMPLETED|Washout Period After Period 3 Treatment||1||
59712010|NCT00943852|75830478|FG004|COMPLETED|Washout Period After Period 3 Treatment||1||
59819134|NCT00603941|75941296|FG002|NOT COMPLETED|Overall Study||2||
59819135|NCT00340678|75941309|FG000|STARTED|Overall Study||46||
60108371|NCT01612546|76228073|FG000|STARTED|Overall Study||10||
59819136|NCT00340678|75941310|FG001|STARTED|Overall Study||46||
59819137|NCT00340678|75941311|FG002|STARTED|Overall Study||39||
59819138|NCT00340678|75941312|FG003|STARTED|Overall Study||39||
59819139|NCT00340678|75941309|FG000|COMPLETED|Overall Study||45||
59819140|NCT00340678|75941310|FG001|COMPLETED|Overall Study||46||
60108372|NCT01612546|76228073|FG000|COMPLETED|Overall Study||10||
60108373|NCT01612546|76228073|FG000|NOT COMPLETED|Overall Study||0||
60108374|NCT01698502|76228079|FG000|STARTED|Overall Study||11||
60108375|NCT01698502|76228080|FG001|STARTED|Overall Study||10||
59712011|NCT00943852|75830479|FG005|COMPLETED|Washout Period After Period 3 Treatment||0||
59712012|NCT00943852|75830480|FG006|COMPLETED|Washout Period After Period 3 Treatment||1||
59712013|NCT00943852|75830481|FG007|COMPLETED|Washout Period After Period 3 Treatment||1||
59712014|NCT00943852|75830482|FG008|COMPLETED|Washout Period After Period 3 Treatment||1||
59712015|NCT00943852|75830483|FG009|COMPLETED|Washout Period After Period 3 Treatment||1||
59712016|NCT00943852|75830474|FG000|NOT COMPLETED|Washout Period After Period 3 Treatment||0||
59712017|NCT00943852|75830475|FG001|NOT COMPLETED|Washout Period After Period 3 Treatment||0||
59712018|NCT00943852|75830476|FG002|NOT COMPLETED|Washout Period After Period 3 Treatment||0||
59712019|NCT00943852|75830477|FG003|NOT COMPLETED|Washout Period After Period 3 Treatment||0||
59712020|NCT00943852|75830478|FG004|NOT COMPLETED|Washout Period After Period 3 Treatment||0||
59712021|NCT00943852|75830479|FG005|NOT COMPLETED|Washout Period After Period 3 Treatment||0||
59712022|NCT00943852|75830480|FG006|NOT COMPLETED|Washout Period After Period 3 Treatment||1||
59712023|NCT00943852|75830481|FG007|NOT COMPLETED|Washout Period After Period 3 Treatment||0||
59712024|NCT00943852|75830482|FG008|NOT COMPLETED|Washout Period After Period 3 Treatment||0||
59712025|NCT00943852|75830483|FG009|NOT COMPLETED|Washout Period After Period 3 Treatment||0||
59712026|NCT00943852|75830474|FG000|STARTED|Fourth Period of Treatment Intervention||2||
59712027|NCT00943852|75830475|FG001|STARTED|Fourth Period of Treatment Intervention||1||
59712028|NCT00943852|75830476|FG002|STARTED|Fourth Period of Treatment Intervention||1||
59712029|NCT00943852|75830477|FG003|STARTED|Fourth Period of Treatment Intervention||1||
59712030|NCT00943852|75830478|FG004|STARTED|Fourth Period of Treatment Intervention||1||
59712031|NCT00943852|75830479|FG005|STARTED|Fourth Period of Treatment Intervention||0||
59712032|NCT00943852|75830480|FG006|STARTED|Fourth Period of Treatment Intervention||1||
59712033|NCT00943852|75830481|FG007|STARTED|Fourth Period of Treatment Intervention||1||
59712034|NCT00943852|75830482|FG008|STARTED|Fourth Period of Treatment Intervention||1||
59712035|NCT00943852|75830483|FG009|STARTED|Fourth Period of Treatment Intervention||1||
59712036|NCT00943852|75830474|FG000|COMPLETED|Fourth Period of Treatment Intervention||2||
59712037|NCT00943852|75830475|FG001|COMPLETED|Fourth Period of Treatment Intervention||1||
59712038|NCT00943852|75830476|FG002|COMPLETED|Fourth Period of Treatment Intervention||1||
59712039|NCT00943852|75830477|FG003|COMPLETED|Fourth Period of Treatment Intervention||1||
59712040|NCT00943852|75830478|FG004|COMPLETED|Fourth Period of Treatment Intervention||1||
59712041|NCT00943852|75830479|FG005|COMPLETED|Fourth Period of Treatment Intervention||0||
59712042|NCT00943852|75830480|FG006|COMPLETED|Fourth Period of Treatment Intervention||1||
59712043|NCT00943852|75830481|FG007|COMPLETED|Fourth Period of Treatment Intervention||1||
59712044|NCT00943852|75830482|FG008|COMPLETED|Fourth Period of Treatment Intervention||1||
59712045|NCT00943852|75830483|FG009|COMPLETED|Fourth Period of Treatment Intervention||1||
59566850|NCT03886701|75669582|FG000|STARTED|Period 2: Study Days 7-21||11|Healthy volunteers received oral DOR 100 mg twice daily together with once weekly RPT and INH|
59566851|NCT03886701|75669582|FG000|COMPLETED|Period 2: Study Days 7-21||11||
59566852|NCT03886701|75669582|FG000|NOT COMPLETED|Period 2: Study Days 7-21||0||
59566853|NCT00552578|75669590|FG000|STARTED|Overall Study||6||
59566854|NCT00552578|75669591|FG001|STARTED|Overall Study||6||
59566855|NCT00552578|75669590|FG000|COMPLETED|Overall Study||5||
59566856|NCT00552578|75669591|FG001|COMPLETED|Overall Study||5||
59566857|NCT00552578|75669590|FG000|NOT COMPLETED|Overall Study||1||
59566858|NCT00552578|75669591|FG001|NOT COMPLETED|Overall Study||1||
59566859|NCT02301936|75669599|FG000|STARTED|Overall Study||9||
59566860|NCT02301936|75669600|FG001|STARTED|Overall Study||1||
59566861|NCT02301936|75669599|FG000|COMPLETED|Overall Study||8||
59566862|NCT02301936|75669600|FG001|COMPLETED|Overall Study||1||
59566863|NCT02301936|75669599|FG000|NOT COMPLETED|Overall Study||1||
59566864|NCT02301936|75669600|FG001|NOT COMPLETED|Overall Study||0||
59566865|NCT03881163|75669606|FG000|STARTED|Overall Study||24||
59566866|NCT03881163|75669606|FG000|COMPLETED|Overall Study||24||
59566867|NCT03881163|75669606|FG000|NOT COMPLETED|Overall Study||0||
59566868|NCT03848871|75669612|FG000|STARTED|Overall Study||20||
59566869|NCT03848871|75669612|FG000|COMPLETED|Overall Study||20||
59566870|NCT03848871|75669612|FG000|NOT COMPLETED|Overall Study||0||
59566871|NCT04032327|75669618|FG000|STARTED|Overall Study||60||
59566872|NCT04032327|75669619|FG001|STARTED|Overall Study||60||
59566873|NCT04032327|75669618|FG000|COMPLETED|Overall Study||60||
59566874|NCT04032327|75669619|FG001|COMPLETED|Overall Study||60||
59566875|NCT04032327|75669618|FG000|NOT COMPLETED|Overall Study||0||
59712046|NCT00943852|75830474|FG000|NOT COMPLETED|Fourth Period of Treatment Intervention||0||
59712047|NCT00943852|75830475|FG001|NOT COMPLETED|Fourth Period of Treatment Intervention||0||
59712048|NCT00943852|75830476|FG002|NOT COMPLETED|Fourth Period of Treatment Intervention||0||
59712049|NCT00943852|75830477|FG003|NOT COMPLETED|Fourth Period of Treatment Intervention||0||
59712050|NCT00943852|75830478|FG004|NOT COMPLETED|Fourth Period of Treatment Intervention||0||
59712051|NCT00943852|75830479|FG005|NOT COMPLETED|Fourth Period of Treatment Intervention||0||
59712052|NCT00943852|75830480|FG006|NOT COMPLETED|Fourth Period of Treatment Intervention||0||
59712053|NCT00943852|75830481|FG007|NOT COMPLETED|Fourth Period of Treatment Intervention||0||
59712054|NCT00943852|75830482|FG008|NOT COMPLETED|Fourth Period of Treatment Intervention||0||
59712055|NCT00943852|75830483|FG009|NOT COMPLETED|Fourth Period of Treatment Intervention||0||
59712056|NCT00943852|75830474|FG000|STARTED|Washout Period After Period 4 Treatment||2||
59712057|NCT00943852|75830475|FG001|STARTED|Washout Period After Period 4 Treatment||1||
59712058|NCT00943852|75830476|FG002|STARTED|Washout Period After Period 4 Treatment||1||
59712059|NCT00943852|75830477|FG003|STARTED|Washout Period After Period 4 Treatment||1||
59712060|NCT00943852|75830478|FG004|STARTED|Washout Period After Period 4 Treatment||1||
59712061|NCT00943852|75830479|FG005|STARTED|Washout Period After Period 4 Treatment||0||
59712062|NCT00943852|75830480|FG006|STARTED|Washout Period After Period 4 Treatment||1||
59712063|NCT00943852|75830481|FG007|STARTED|Washout Period After Period 4 Treatment||1||
59712064|NCT00943852|75830482|FG008|STARTED|Washout Period After Period 4 Treatment||1||
59712065|NCT00943852|75830483|FG009|STARTED|Washout Period After Period 4 Treatment||1||
59712066|NCT00943852|75830474|FG000|COMPLETED|Washout Period After Period 4 Treatment||1||
59712067|NCT00943852|75830475|FG001|COMPLETED|Washout Period After Period 4 Treatment||1||
59712068|NCT00943852|75830476|FG002|COMPLETED|Washout Period After Period 4 Treatment||0||
59712069|NCT00943852|75830477|FG003|COMPLETED|Washout Period After Period 4 Treatment||0||
59712070|NCT00943852|75830478|FG004|COMPLETED|Washout Period After Period 4 Treatment||1||
59712071|NCT00943852|75830479|FG005|COMPLETED|Washout Period After Period 4 Treatment||0||
59712072|NCT00943852|75830480|FG006|COMPLETED|Washout Period After Period 4 Treatment||0||
59712073|NCT00943852|75830481|FG007|COMPLETED|Washout Period After Period 4 Treatment||0||
59712074|NCT00943852|75830482|FG008|COMPLETED|Washout Period After Period 4 Treatment||1||
59712075|NCT00943852|75830483|FG009|COMPLETED|Washout Period After Period 4 Treatment||1||
59712076|NCT00943852|75830474|FG000|NOT COMPLETED|Washout Period After Period 4 Treatment||1||
59712077|NCT00943852|75830475|FG001|NOT COMPLETED|Washout Period After Period 4 Treatment||0||
59712078|NCT00943852|75830476|FG002|NOT COMPLETED|Washout Period After Period 4 Treatment||1||
59712079|NCT00943852|75830477|FG003|NOT COMPLETED|Washout Period After Period 4 Treatment||1||
59712080|NCT00943852|75830478|FG004|NOT COMPLETED|Washout Period After Period 4 Treatment||0||
59712081|NCT00943852|75830479|FG005|NOT COMPLETED|Washout Period After Period 4 Treatment||0||
59712082|NCT00943852|75830480|FG006|NOT COMPLETED|Washout Period After Period 4 Treatment||1||
59712083|NCT00943852|75830481|FG007|NOT COMPLETED|Washout Period After Period 4 Treatment||1||
59712084|NCT00943852|75830482|FG008|NOT COMPLETED|Washout Period After Period 4 Treatment||0||
59712085|NCT00943852|75830483|FG009|NOT COMPLETED|Washout Period After Period 4 Treatment||0||
59712086|NCT00943852|75830474|FG000|STARTED|Fifth Period of Treatment Intervention||1||
59712087|NCT00943852|75830475|FG001|STARTED|Fifth Period of Treatment Intervention||1||
59712088|NCT00943852|75830476|FG002|STARTED|Fifth Period of Treatment Intervention||0||
59712089|NCT00943852|75830477|FG003|STARTED|Fifth Period of Treatment Intervention||0||
59712090|NCT00943852|75830478|FG004|STARTED|Fifth Period of Treatment Intervention||1||
59712091|NCT00943852|75830479|FG005|STARTED|Fifth Period of Treatment Intervention||0||
59712092|NCT00943852|75830480|FG006|STARTED|Fifth Period of Treatment Intervention||0||
59712093|NCT00943852|75830481|FG007|STARTED|Fifth Period of Treatment Intervention||0||
59712094|NCT00943852|75830482|FG008|STARTED|Fifth Period of Treatment Intervention||1||
59712095|NCT00943852|75830483|FG009|STARTED|Fifth Period of Treatment Intervention||1||
59712096|NCT00943852|75830474|FG000|COMPLETED|Fifth Period of Treatment Intervention||1||
59712097|NCT00943852|75830475|FG001|COMPLETED|Fifth Period of Treatment Intervention||1||
59712098|NCT00943852|75830476|FG002|COMPLETED|Fifth Period of Treatment Intervention||0||
59712099|NCT00943852|75830477|FG003|COMPLETED|Fifth Period of Treatment Intervention||0||
59712100|NCT00943852|75830478|FG004|COMPLETED|Fifth Period of Treatment Intervention||1||
59712101|NCT00943852|75830479|FG005|COMPLETED|Fifth Period of Treatment Intervention||0||
59712102|NCT00943852|75830480|FG006|COMPLETED|Fifth Period of Treatment Intervention||0||
59712103|NCT00943852|75830481|FG007|COMPLETED|Fifth Period of Treatment Intervention||0||
59712104|NCT00943852|75830482|FG008|COMPLETED|Fifth Period of Treatment Intervention||1||
59712105|NCT00943852|75830483|FG009|COMPLETED|Fifth Period of Treatment Intervention||1||
59712106|NCT00943852|75830474|FG000|NOT COMPLETED|Fifth Period of Treatment Intervention||0||
59712107|NCT00943852|75830475|FG001|NOT COMPLETED|Fifth Period of Treatment Intervention||0||
59712108|NCT00943852|75830476|FG002|NOT COMPLETED|Fifth Period of Treatment Intervention||0||
59712109|NCT00943852|75830477|FG003|NOT COMPLETED|Fifth Period of Treatment Intervention||0||
59712110|NCT00943852|75830478|FG004|NOT COMPLETED|Fifth Period of Treatment Intervention||0||
59712111|NCT00943852|75830479|FG005|NOT COMPLETED|Fifth Period of Treatment Intervention||0||
59712112|NCT00943852|75830480|FG006|NOT COMPLETED|Fifth Period of Treatment Intervention||0||
59712113|NCT00943852|75830481|FG007|NOT COMPLETED|Fifth Period of Treatment Intervention||0||
59712114|NCT00943852|75830482|FG008|NOT COMPLETED|Fifth Period of Treatment Intervention||0||
59712115|NCT00943852|75830483|FG009|NOT COMPLETED|Fifth Period of Treatment Intervention||0||
59712116|NCT00952276|75830498|FG000|STARTED|Overall Study||127||
59712117|NCT00952276|75830499|FG001|STARTED|Overall Study||115||
59712118|NCT00952276|75830500|FG002|STARTED|Overall Study||122||
59712119|NCT00952276|75830501|FG003|STARTED|Overall Study||121||
59712120|NCT00952276|75830502|FG004|STARTED|Overall Study||63||
59712121|NCT00952276|75830498|FG000|COMPLETED|Overall Study||126||
59712122|NCT00952276|75830499|FG001|COMPLETED|Overall Study||115||
59712123|NCT00952276|75830500|FG002|COMPLETED|Overall Study||122||
59712124|NCT00952276|75830501|FG003|COMPLETED|Overall Study||120||
59712125|NCT00952276|75830502|FG004|COMPLETED|Overall Study||63||
59712126|NCT00952276|75830498|FG000|NOT COMPLETED|Overall Study||1||
59712127|NCT00952276|75830499|FG001|NOT COMPLETED|Overall Study||0||
59712128|NCT00952276|75830500|FG002|NOT COMPLETED|Overall Study||0||
59712129|NCT00952276|75830501|FG003|NOT COMPLETED|Overall Study||1||
59712130|NCT00952276|75830502|FG004|NOT COMPLETED|Overall Study||0||
59712131|NCT00943384|75830514|FG000|STARTED|Overall Study|104 subjects consented and underwent additional screening to determine eligibility to participate|104||
59712132|NCT00943384|75830514|FG000|Treated|Overall Study|81 subjects were eligible and willing to participate in the study and were treated|81||
59712133|NCT00943384|75830514|FG000|Treated on Protocol|Overall Study|5 subjects were treated off protocol due to intraoperative decisions made by the surgeon|76||
59712134|NCT00943384|75830514|FG000|COMPLETED|Overall Study|evaluated at the Month 24 visit with complete or partial data|55||
59712135|NCT00943384|75830514|FG000|NOT COMPLETED|Overall Study||49||
59712136|NCT00943306|75830518|FG000|STARTED|Overall Study||19||
59712137|NCT00943306|75830518|FG000|COMPLETED|Overall Study||16||
59712138|NCT00943306|75830518|FG000|NOT COMPLETED|Overall Study||3||
59712139|NCT01198002|75830525|FG000|STARTED|Treatment Period 1 (Weeks 0-52)||345||
59712140|NCT01198002|75830526|FG001|STARTED|Treatment Period 1 (Weeks 0-52)||347||
59712141|NCT01198002|75830527|FG002|STARTED|Treatment Period 1 (Weeks 0-52)||349||
59712142|NCT01198002|75830525|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0-52)||345||
59712143|NCT01198002|75830526|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0-52)||345||
59712144|NCT01198002|75830527|FG002|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0-52)||348||
59712145|NCT01198002|75830525|FG000|Week 16 NR|Treatment Period 1 (Weeks 0-52)||58||
59712146|NCT01198002|75830526|FG001|Week 16 NR|Treatment Period 1 (Weeks 0-52)||62||
59712147|NCT01198002|75830527|FG002|Week 16 NR|Treatment Period 1 (Weeks 0-52)||90||
59712148|NCT01198002|75830525|FG000|Post-Treatment Follow-Up Population|Treatment Period 1 (Weeks 0-52)||293||
59712149|NCT01198002|75830526|FG001|Post-Treatment Follow-Up Population|Treatment Period 1 (Weeks 0-52)||303||
59819141|NCT00340678|75941311|FG002|COMPLETED|Overall Study||39||
59819142|NCT00340678|75941312|FG003|COMPLETED|Overall Study||39||
59819143|NCT00340678|75941309|FG000|NOT COMPLETED|Overall Study||1||
60108376|NCT01698502|76228079|FG000|COMPLETED|Overall Study||11||
59819144|NCT00340678|75941310|FG001|NOT COMPLETED|Overall Study||0||
59819145|NCT00340678|75941311|FG002|NOT COMPLETED|Overall Study||0||
60108377|NCT01698502|76228080|FG001|COMPLETED|Overall Study||10||
59566876|NCT04032327|75669619|FG001|NOT COMPLETED|Overall Study||0||
59712150|NCT01198002|75830527|FG002|Post-Treatment Follow-Up Population|Treatment Period 1 (Weeks 0-52)||307||
59712151|NCT01198002|75830525|FG000|COMPLETED|Treatment Period 1 (Weeks 0-52)|Those who completed 52-week Treatment Period 1 including both Week 16 responders and NR.|70||
59712152|NCT01198002|75830526|FG001|COMPLETED|Treatment Period 1 (Weeks 0-52)|Those who completed 52-week Treatment Period 1 including both Week 16 responders and NR.|73||
59712153|NCT01198002|75830527|FG002|COMPLETED|Treatment Period 1 (Weeks 0-52)|Those who completed 52-week Treatment Period 1 including both Week 16 responders and NR.|80||
59712154|NCT01198002|75830525|FG000|NOT COMPLETED|Treatment Period 1 (Weeks 0-52)||275||
59712155|NCT01198002|75830526|FG001|NOT COMPLETED|Treatment Period 1 (Weeks 0-52)||274||
59712156|NCT01198002|75830527|FG002|NOT COMPLETED|Treatment Period 1 (Weeks 0-52)||269||
59712157|NCT01198002|75830525|FG000|STARTED|Treatment Period 2 (Weeks 52-100)||70||
59712158|NCT01198002|75830526|FG001|STARTED|Treatment Period 2 (Weeks 52-100)||73||
59712159|NCT01198002|75830527|FG002|STARTED|Treatment Period 2 (Weeks 52-100)||80||
59712160|NCT01198002|75830525|FG000|COMPLETED|Treatment Period 2 (Weeks 52-100)||1||
59712161|NCT01198002|75830526|FG001|COMPLETED|Treatment Period 2 (Weeks 52-100)||0||
59712162|NCT01198002|75830527|FG002|COMPLETED|Treatment Period 2 (Weeks 52-100)||2||
59712163|NCT01198002|75830525|FG000|NOT COMPLETED|Treatment Period 2 (Weeks 52-100)||69||
59712164|NCT01198002|75830526|FG001|NOT COMPLETED|Treatment Period 2 (Weeks 52-100)||73||
59712165|NCT01198002|75830527|FG002|NOT COMPLETED|Treatment Period 2 (Weeks 52-100)||78||
59712166|NCT01197534|75830560|FG000|STARTED|Overall Study|Patients who received treatment|308||
59712167|NCT01197534|75830561|FG001|STARTED|Overall Study|Patients who received treatment|298||
59712168|NCT01197534|75830562|FG002|STARTED|Overall Study|Patients who received treatment|302||
59712169|NCT01197534|75830560|FG000|Randomised But Did Not Receive Treatment|Overall Study||0||
59712170|NCT01197534|75830561|FG001|Randomised But Did Not Receive Treatment|Overall Study|Adverse event / Other|2||
59712171|NCT01197534|75830562|FG002|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled / Severe non-compliance to protocol|3||
59712172|NCT01197534|75830560|FG000|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|174||
59712173|NCT01197534|75830561|FG001|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|168||
59712174|NCT01197534|75830562|FG002|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|129||
59712175|NCT01197534|75830560|FG000|NOT COMPLETED|Overall Study||134||
59712176|NCT01197534|75830561|FG001|NOT COMPLETED|Overall Study||130||
59712177|NCT01197534|75830562|FG002|NOT COMPLETED|Overall Study||173||
59712178|NCT01197378|75830573|FG000|STARTED|Overall Study||60||
59712179|NCT01197378|75830573|FG000|Received Treatment|Overall Study||59||
59712180|NCT01197378|75830573|FG000|COMPLETED|Overall Study||53||
59712181|NCT01197378|75830573|FG000|NOT COMPLETED|Overall Study||7||
59712182|NCT01197300|75830579|FG000|STARTED|Overall Study||10|All enrolled patients were included in the Full Analysis Set (FAS) and Safety Set|
59712183|NCT01197300|75830580|FG001|STARTED|Overall Study||15|All enrolled patients were included in the Full Analysis Set (FAS) and Safety Set|
59712184|NCT01197300|75830579|FG000|COMPLETED|Overall Study||10||
59712185|NCT01197300|75830580|FG001|COMPLETED|Overall Study||13||
59712186|NCT01197300|75830579|FG000|NOT COMPLETED|Overall Study||0||
59712187|NCT01197300|75830580|FG001|NOT COMPLETED|Overall Study||2||
59712188|NCT04010695|75830586|FG000|STARTED|Overall Study||250||
59712189|NCT04010695|75830586|FG000|COMPLETED|Overall Study||250||
59712190|NCT04010695|75830586|FG000|NOT COMPLETED|Overall Study||0||
59712191|NCT01196988|75830595|FG000|STARTED|Overall Study||915||
59712192|NCT01196988|75830596|FG001|STARTED|Overall Study||912||
59712193|NCT01196988|75830597|FG002|STARTED|Overall Study||911||
59712194|NCT01196988|75830598|FG003|STARTED|Overall Study||277||
59712195|NCT01196988|75830595|FG000|COMPLETED|Overall Study||891||
59712196|NCT01196988|75830596|FG001|COMPLETED|Overall Study||880||
59712197|NCT01196988|75830597|FG002|COMPLETED|Overall Study||886||
59712198|NCT01196988|75830598|FG003|COMPLETED|Overall Study||276||
59712199|NCT01196988|75830595|FG000|NOT COMPLETED|Overall Study||24||
59712200|NCT01196988|75830596|FG001|NOT COMPLETED|Overall Study||32||
59712201|NCT01196988|75830597|FG002|NOT COMPLETED|Overall Study||25||
59712202|NCT01196988|75830598|FG003|NOT COMPLETED|Overall Study||1||
59712203|NCT01196052|75830609|FG000|STARTED|Overall Study||153||
59712204|NCT01196052|75830609|FG000|Received Trastuzumab Emtansine|Overall Study||148||
59819146|NCT00340678|75941312|FG003|NOT COMPLETED|Overall Study||0||
59819147|NCT00336544|75941322|FG000|STARTED|Overall Study|All subjects who were randomized and dosed.|261||
59712205|NCT01196052|75830609|FG000|COMPLETED|Overall Study||130||
59712206|NCT01196052|75830609|FG000|NOT COMPLETED|Overall Study||23||
59712207|NCT01195662|75830616|FG000|STARTED|Double Blind Treatment Period||224||
59712208|NCT01195662|75830617|FG001|STARTED|Double Blind Treatment Period||225||
59712209|NCT01195662|75830618|FG002|STARTED|Double Blind Treatment Period||133||
59712210|NCT01195662|75830616|FG000|COMPLETED|Double Blind Treatment Period||202||
59712211|NCT01195662|75830617|FG001|COMPLETED|Double Blind Treatment Period||211||
59712212|NCT01195662|75830618|FG002|COMPLETED|Double Blind Treatment Period||119||
59712213|NCT01195662|75830616|FG000|NOT COMPLETED|Double Blind Treatment Period||22||
59712214|NCT01195662|75830617|FG001|NOT COMPLETED|Double Blind Treatment Period||14||
59712215|NCT01195662|75830618|FG002|NOT COMPLETED|Double Blind Treatment Period||14||
59819148|NCT00336544|75941323|FG001|STARTED|Overall Study|All subjects who were randomized and dosed.|260||
59712216|NCT01195662|75830616|FG000|STARTED|Follow-Up(Week 13/1 Week Post Last Dose)|1 participant discontinued drug but remained in study and entered Follow-Up.|203||
59712217|NCT01195662|75830617|FG001|STARTED|Follow-Up(Week 13/1 Week Post Last Dose)|2 participants completed treatment period but chose not to enter follow up period.|209||
59712218|NCT01195662|75830618|FG002|STARTED|Follow-Up(Week 13/1 Week Post Last Dose)|1 participant discontinued drug but remained in the study and entered the follow up period.|120||
59712219|NCT01195662|75830616|FG000|COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||200||
59712220|NCT01195662|75830617|FG001|COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||209||
59712221|NCT01195662|75830618|FG002|COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||119||
59712222|NCT01195662|75830616|FG000|NOT COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||3||
59712223|NCT01195662|75830617|FG001|NOT COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||0||
59712224|NCT01195662|75830618|FG002|NOT COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||1||
59712225|NCT01195272|75830627|FG000|STARTED|Overall Study||21||
59712226|NCT01195272|75830627|FG000|COMPLETED|Overall Study||17||
59712227|NCT01195272|75830627|FG000|NOT COMPLETED|Overall Study||4||
59712228|NCT01194804|75830631|FG000|STARTED|Overall Study||27||
59712229|NCT01194804|75830631|FG000|COMPLETED|Overall Study||26||
59712230|NCT01194804|75830631|FG000|NOT COMPLETED|Overall Study||1||
59712231|NCT02268175|75830637|FG000|STARTED|Overall Study||50||
59712232|NCT02268175|75830638|FG001|STARTED|Overall Study||25||
59712233|NCT02268175|75830637|FG000|COMPLETED|Overall Study||50||
59712234|NCT02268175|75830638|FG001|COMPLETED|Overall Study||25||
59712235|NCT02268175|75830637|FG000|NOT COMPLETED|Overall Study||0||
59712236|NCT02268175|75830638|FG001|NOT COMPLETED|Overall Study||0||
59712237|NCT01855867|75830644|FG000|STARTED|Overall Study||100||
59712238|NCT01855867|75830644|FG000|COMPLETED|Overall Study||100||
59712239|NCT01855867|75830644|FG000|NOT COMPLETED|Overall Study||0||
59712240|NCT04182217|75830649|FG000|STARTED|Overall Study||91||
59712241|NCT04182217|75830649|FG000|COMPLETED|Overall Study||91||
59712242|NCT04182217|75830649|FG000|NOT COMPLETED|Overall Study||0||
59712243|NCT01194414|75830655|FG000|STARTED|24 Weeks Double Blind Period||631||
59712244|NCT01194414|75830656|FG001|STARTED|24 Weeks Double Blind Period||631||
59712245|NCT01194414|75830657|FG002|STARTED|24 Weeks Double Blind Period||0||
59712246|NCT01194414|75830658|FG003|STARTED|24 Weeks Double Blind Period||0||
59712247|NCT01194414|75830655|FG000|Per Protocol Population|24 Weeks Double Blind Period||558||
59712248|NCT01194414|75830656|FG001|Per Protocol Population|24 Weeks Double Blind Period||537||
59712249|NCT01194414|75830657|FG002|Per Protocol Population|24 Weeks Double Blind Period||0||
59712250|NCT01194414|75830658|FG003|Per Protocol Population|24 Weeks Double Blind Period||0||
59712251|NCT01194414|75830655|FG000|COMPLETED|24 Weeks Double Blind Period||572||
59712252|NCT01194414|75830656|FG001|COMPLETED|24 Weeks Double Blind Period||564||
59712253|NCT01194414|75830657|FG002|COMPLETED|24 Weeks Double Blind Period||0||
59712254|NCT01194414|75830658|FG003|COMPLETED|24 Weeks Double Blind Period||0||
59712255|NCT01194414|75830655|FG000|NOT COMPLETED|24 Weeks Double Blind Period||59||
59712256|NCT01194414|75830656|FG001|NOT COMPLETED|24 Weeks Double Blind Period||67||
59712257|NCT01194414|75830657|FG002|NOT COMPLETED|24 Weeks Double Blind Period||0||
59712258|NCT01194414|75830658|FG003|NOT COMPLETED|24 Weeks Double Blind Period||0||
59712259|NCT01194414|75830655|FG000|STARTED|72 Weeks Open Label Extension||524||
59712260|NCT01194414|75830656|FG001|STARTED|72 Weeks Open Label Extension||377||
59712261|NCT01194414|75830657|FG002|STARTED|72 Weeks Open Label Extension||48||
59712262|NCT01194414|75830658|FG003|STARTED|72 Weeks Open Label Extension||186||
59712263|NCT01194414|75830655|FG000|COMPLETED|72 Weeks Open Label Extension||445||
59712264|NCT01194414|75830656|FG001|COMPLETED|72 Weeks Open Label Extension||311||
59712265|NCT01194414|75830657|FG002|COMPLETED|72 Weeks Open Label Extension||40||
59712266|NCT01194414|75830658|FG003|COMPLETED|72 Weeks Open Label Extension||160||
59712267|NCT01194414|75830655|FG000|NOT COMPLETED|72 Weeks Open Label Extension||79||
59712268|NCT01194414|75830656|FG001|NOT COMPLETED|72 Weeks Open Label Extension||66||
59712269|NCT01194414|75830657|FG002|NOT COMPLETED|72 Weeks Open Label Extension||8||
59712270|NCT01194414|75830658|FG003|NOT COMPLETED|72 Weeks Open Label Extension||26||
59712271|NCT01194258|75830670|FG000|STARTED|Titration Period||132||
59712272|NCT01194258|75830671|FG001|STARTED|Titration Period||0||
59712273|NCT01194258|75830672|FG002|STARTED|Titration Period||0||
59712274|NCT01194258|75830673|FG003|STARTED|Titration Period||0||
59712275|NCT01194258|75830674|FG004|STARTED|Titration Period||0||
59712276|NCT01194258|75830670|FG000|COMPLETED|Titration Period||121||
59712277|NCT01194258|75830671|FG001|COMPLETED|Titration Period||0||
59712278|NCT01194258|75830672|FG002|COMPLETED|Titration Period||0||
59712279|NCT01194258|75830673|FG003|COMPLETED|Titration Period||0||
59712280|NCT01194258|75830674|FG004|COMPLETED|Titration Period||0||
59712281|NCT01194258|75830670|FG000|NOT COMPLETED|Titration Period||11||
59712282|NCT01194258|75830671|FG001|NOT COMPLETED|Titration Period||0||
59712283|NCT01194258|75830672|FG002|NOT COMPLETED|Titration Period||0||
59819149|NCT00336544|75941322|FG000|COMPLETED|Overall Study|Number of subjects completing the test of cure (TOC) visit.|242||
59712284|NCT01194258|75830673|FG003|NOT COMPLETED|Titration Period||0||
59712285|NCT01194258|75830674|FG004|NOT COMPLETED|Titration Period||0||
59996283|NCT02719171|76112245|FG000|NOT COMPLETED|Overall Study||1||
59712286|NCT01194258|75830670|FG000|STARTED|Period 1 (12 Weeks)|Participants were randomized to the Insulin lispro or an Analog-PH20 group after titration.|0||
59712287|NCT01194258|75830671|FG001|STARTED|Period 1 (12 Weeks)|After the titration phase, 29 participants were randomized to the Insulin lispro/Lispro-PH20 group.|29||
59712288|NCT01194258|75830672|FG002|STARTED|Period 1 (12 Weeks)|After the titration phase, 30 participants were randomized to the Lispro-PH20/Insulin lispro group.|30||
59712289|NCT01194258|75830673|FG003|STARTED|Period 1 (12 Weeks)|After the titration phase, 29 participants were randomized to the Insulin lispro/Aspart-PH20 group.|29||
59712290|NCT01194258|75830674|FG004|STARTED|Period 1 (12 Weeks)|After the titration phase, 33 participants were randomized to the Aspart-PH20/Insulin lispro group.|33||
59712291|NCT01194258|75830670|FG000|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||0||
59712292|NCT01194258|75830671|FG001|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||29||
59712293|NCT01194258|75830672|FG002|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||30||
59712294|NCT01194258|75830673|FG003|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||29||
59712295|NCT01194258|75830674|FG004|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||33||
59712296|NCT01194258|75830670|FG000|COMPLETED|Period 1 (12 Weeks)||0||
59712297|NCT01194258|75830671|FG001|COMPLETED|Period 1 (12 Weeks)||29||
59712298|NCT01194258|75830672|FG002|COMPLETED|Period 1 (12 Weeks)||30||
59712299|NCT01194258|75830673|FG003|COMPLETED|Period 1 (12 Weeks)||29||
59712300|NCT01194258|75830674|FG004|COMPLETED|Period 1 (12 Weeks)||32||
59712301|NCT01194258|75830670|FG000|NOT COMPLETED|Period 1 (12 Weeks)||0||
59712302|NCT01194258|75830671|FG001|NOT COMPLETED|Period 1 (12 Weeks)||0||
59712303|NCT01194258|75830672|FG002|NOT COMPLETED|Period 1 (12 Weeks)||0||
59712304|NCT01194258|75830673|FG003|NOT COMPLETED|Period 1 (12 Weeks)||0||
59712305|NCT01194258|75830674|FG004|NOT COMPLETED|Period 1 (12 Weeks)||1||
59712306|NCT01194258|75830670|FG000|STARTED|Period 2 (12 Weeks)||0||
59712307|NCT01194258|75830671|FG001|STARTED|Period 2 (12 Weeks)||29||
59712308|NCT01194258|75830672|FG002|STARTED|Period 2 (12 Weeks)||30||
59712309|NCT01194258|75830673|FG003|STARTED|Period 2 (12 Weeks)||29||
59712310|NCT01194258|75830674|FG004|STARTED|Period 2 (12 Weeks)||32||
59712311|NCT01194258|75830670|FG000|COMPLETED|Period 2 (12 Weeks)||0||
59712312|NCT01194258|75830671|FG001|COMPLETED|Period 2 (12 Weeks)||27||
59712313|NCT01194258|75830672|FG002|COMPLETED|Period 2 (12 Weeks)||29||
59712314|NCT01194258|75830673|FG003|COMPLETED|Period 2 (12 Weeks)||29||
59712315|NCT01194258|75830674|FG004|COMPLETED|Period 2 (12 Weeks)||30||
59712316|NCT01194258|75830670|FG000|NOT COMPLETED|Period 2 (12 Weeks)||0||
59712317|NCT01194258|75830671|FG001|NOT COMPLETED|Period 2 (12 Weeks)||2||
59712318|NCT01194258|75830672|FG002|NOT COMPLETED|Period 2 (12 Weeks)||1||
59712319|NCT01194258|75830673|FG003|NOT COMPLETED|Period 2 (12 Weeks)||0||
59712320|NCT01194258|75830674|FG004|NOT COMPLETED|Period 2 (12 Weeks)||2||
59712321|NCT01193556|75830687|FG000|STARTED|Overall Study||26||
59712322|NCT01193556|75830688|FG001|STARTED|Overall Study||25||
59712323|NCT01193556|75830687|FG000|COMPLETED|Overall Study||0||
59712324|NCT01193556|75830688|FG001|COMPLETED|Overall Study||0||
59712325|NCT01193556|75830687|FG000|NOT COMPLETED|Overall Study||26||
59712326|NCT01193556|75830688|FG001|NOT COMPLETED|Overall Study||25||
59712327|NCT04875013|75830694|FG000|STARTED|Overall Study||13||
59712328|NCT04875013|75830694|FG000|Post-treatment Assessment|Overall Study||13||
59712329|NCT04875013|75830694|FG000|COMPLETED|Overall Study||9||
59712330|NCT04875013|75830694|FG000|NOT COMPLETED|Overall Study||4||
59712331|NCT00951496|75830701|FG000|STARTED|Overall Study||521||
59712332|NCT00951496|75830702|FG001|STARTED|Overall Study||518||
59712333|NCT00951496|75830703|FG002|STARTED|Overall Study||521||
59712334|NCT00951496|75830701|FG000|COMPLETED|Overall Study||511||
59712335|NCT00951496|75830702|FG001|COMPLETED|Overall Study||510||
59712336|NCT00951496|75830703|FG002|COMPLETED|Overall Study||508||
59712337|NCT00951496|75830701|FG000|NOT COMPLETED|Overall Study||10||
59712338|NCT00951496|75830702|FG001|NOT COMPLETED|Overall Study||8||
59712339|NCT00951496|75830703|FG002|NOT COMPLETED|Overall Study||13||
59712340|NCT01193244|75830716|FG000|STARTED|Overall Study||779||
59819150|NCT00336544|75941323|FG001|COMPLETED|Overall Study|Number of subjects completing the test of cure (TOC) visit.|238||
59819151|NCT00336544|75941322|FG000|NOT COMPLETED|Overall Study||19||
59712341|NCT01193244|75830717|FG001|STARTED|Overall Study||781||
59712342|NCT01193244|75830716|FG000|Treated|Overall Study|Participants who continued to receive Placebo after unblinding.|770||
59712343|NCT01193244|75830717|FG001|Treated|Overall Study|Participants randomized to receive Placebo but crossed-over to receive Orteronel after unblinding.|784||
59712344|NCT01193244|75830716|FG000|COMPLETED|Overall Study||391||
59712345|NCT01193244|75830717|FG001|COMPLETED|Overall Study||391||
59712346|NCT01193244|75830716|FG000|NOT COMPLETED|Overall Study||388||
59712347|NCT01193244|75830717|FG001|NOT COMPLETED|Overall Study||390||
59712348|NCT01192152|75830723|FG000|STARTED|Period 1||15||
59712349|NCT01192152|75830724|FG001|STARTED|Period 1||15||
59712350|NCT01192152|75830723|FG000|COMPLETED|Period 1||15||
59712351|NCT01192152|75830724|FG001|COMPLETED|Period 1||14||
59712352|NCT01192152|75830723|FG000|NOT COMPLETED|Period 1||0||
59712353|NCT01192152|75830724|FG001|NOT COMPLETED|Period 1||1||
59712354|NCT01192152|75830723|FG000|STARTED|Period 2||15||
59712355|NCT01192152|75830724|FG001|STARTED|Period 2||14||
59712356|NCT01192152|75830723|FG000|COMPLETED|Period 2||15||
59712357|NCT01192152|75830724|FG001|COMPLETED|Period 2||14||
59712358|NCT01192152|75830723|FG000|NOT COMPLETED|Period 2||0||
59712359|NCT01192152|75830724|FG001|NOT COMPLETED|Period 2||0||
59712360|NCT01192152|75830723|FG000|STARTED|Period 3||15||
59712361|NCT01192152|75830724|FG001|STARTED|Period 3||0||
59712362|NCT01192152|75830723|FG000|COMPLETED|Period 3||14||
59712363|NCT01192152|75830724|FG001|COMPLETED|Period 3||0||
59712364|NCT01192152|75830723|FG000|NOT COMPLETED|Period 3||1||
59712365|NCT01192152|75830724|FG001|NOT COMPLETED|Period 3||0||
59712366|NCT01191840|75830734|FG000|STARTED|Overall Study||254||
59712367|NCT01191840|75830735|FG001|STARTED|Overall Study||255||
59712368|NCT01191840|75830734|FG000|COMPLETED|Overall Study||240||
59712369|NCT01191840|75830735|FG001|COMPLETED|Overall Study||240||
59712370|NCT01191840|75830734|FG000|NOT COMPLETED|Overall Study||14||
59712371|NCT01191840|75830735|FG001|NOT COMPLETED|Overall Study||15||
59712372|NCT04529005|75830741|FG000|STARTED|Overall Study||20||
59712373|NCT04529005|75830741|FG000|COMPLETED|Overall Study||20||
59712374|NCT04529005|75830741|FG000|NOT COMPLETED|Overall Study||0||
59712375|NCT00943072|75830747|FG000|STARTED|Overall Study||115||
59712376|NCT00943072|75830748|FG001|STARTED|Overall Study||74||
59712377|NCT00943072|75830747|FG000|Participants Received Treatment|Overall Study|Safety population (SAF)|114||
59712378|NCT00943072|75830748|FG001|Participants Received Treatment|Overall Study||74||
59712379|NCT00943072|75830747|FG000|Full Analysis Set (FAS) Population|Overall Study|FAS population used for analysis of Primary and Secondary Outcome Measures|114||
59712380|NCT00943072|75830748|FG001|Full Analysis Set (FAS) Population|Overall Study||73||
59712381|NCT00943072|75830747|FG000|COMPLETED|Overall Study|110 Participants completed Week 24, From FAS; 102 Participants completed up to Week 100, From SAF|110||
59712382|NCT00943072|75830748|FG001|COMPLETED|Overall Study|60 Participants completed Week 24, From FAS; 50 Participants completed up to Week 100, From SAF|60||
59712383|NCT00943072|75830747|FG000|NOT COMPLETED|Overall Study||5||
59712384|NCT00943072|75830748|FG001|NOT COMPLETED|Overall Study||14||
59712385|NCT00942994|75830758|FG000|STARTED|Overall Study||203||
59712386|NCT00942994|75830759|FG001|STARTED|Overall Study||209||
59712387|NCT00942994|75830758|FG000|COMPLETED|Overall Study||187||
59712388|NCT00942994|75830759|FG001|COMPLETED|Overall Study||190||
59712389|NCT00942994|75830758|FG000|NOT COMPLETED|Overall Study||16||
59712390|NCT00942994|75830759|FG001|NOT COMPLETED|Overall Study||19||
59712391|NCT00942604|75830767|FG000|STARTED|Overall Study||100||
59712392|NCT00942604|75830768|FG001|STARTED|Overall Study||103||
59712393|NCT00942604|75830767|FG000|COMPLETED|Overall Study||98||
59712394|NCT00942604|75830768|FG001|COMPLETED|Overall Study||99||
59712395|NCT00942604|75830767|FG000|NOT COMPLETED|Overall Study||2||
59712396|NCT00942604|75830768|FG001|NOT COMPLETED|Overall Study||4||
59712397|NCT01188564|75830776|FG000|STARTED|Double-blind Phase||44||
59712398|NCT01188564|75830777|FG001|STARTED|Double-blind Phase||31||
59712399|NCT01188564|75830776|FG000|COMPLETED|Double-blind Phase||43||
59712400|NCT01188564|75830777|FG001|COMPLETED|Double-blind Phase||31||
59712401|NCT01188564|75830776|FG000|NOT COMPLETED|Double-blind Phase||1||
59712402|NCT01188564|75830777|FG001|NOT COMPLETED|Double-blind Phase||0||
59712403|NCT01188564|75830776|FG000|STARTED|Open Label Phase|Not all Double-Blind Phase participants went on to Open Label Phase|24||
59819152|NCT00336544|75941323|FG001|NOT COMPLETED|Overall Study||22||
59819153|NCT00605033|75941331|FG000|STARTED|Overall Study||143||
59819154|NCT00605033|75941332|FG001|STARTED|Overall Study|One participant was randomized but withdrew before taking any study medication (treated n=97).|98||
59819155|NCT00605033|75941331|FG000|COMPLETED|Overall Study||136||
59819156|NCT00605033|75941332|FG001|COMPLETED|Overall Study||90||
59819157|NCT00605033|75941331|FG000|NOT COMPLETED|Overall Study||7||
59819158|NCT00605033|75941332|FG001|NOT COMPLETED|Overall Study||8||
59819159|NCT00339040|75941340|FG000|STARTED|Stage I||96||
59819160|NCT00339040|75941341|FG001|STARTED|Stage I||30||
60108378|NCT01698502|76228079|FG000|NOT COMPLETED|Overall Study||0||
59819161|NCT00339040|75941340|FG000|Vaccination 1 at Week 0|Stage I||96||
59819162|NCT00339040|75941341|FG001|Vaccination 1 at Week 0|Stage I||30||
59819163|NCT00339040|75941340|FG000|Vaccination 2 at Week 8|Stage I||95||
59819164|NCT00339040|75941341|FG001|Vaccination 2 at Week 8|Stage I||30||
59819165|NCT00339040|75941340|FG000|Vaccination 3 at Week 24|Stage I||94||
59819166|NCT00339040|75941341|FG001|Vaccination 3 at Week 24|Stage I||30||
59819167|NCT00339040|75941340|FG000|COMPLETED|Stage I||94||
59819168|NCT00339040|75941341|FG001|COMPLETED|Stage I||29||
59819169|NCT00339040|75941340|FG000|NOT COMPLETED|Stage I||2||
59819170|NCT00339040|75941341|FG001|NOT COMPLETED|Stage I||1||
60108379|NCT01698502|76228080|FG001|NOT COMPLETED|Overall Study||0||
59712404|NCT01188564|75830777|FG001|STARTED|Open Label Phase|Not all Double Blind Phase participants went on to Open Label Phase|20||
59712405|NCT01188564|75830776|FG000|COMPLETED|Open Label Phase||24||
59712406|NCT01188564|75830777|FG001|COMPLETED|Open Label Phase||20||
59712407|NCT01188564|75830776|FG000|NOT COMPLETED|Open Label Phase||0||
59712408|NCT01188564|75830777|FG001|NOT COMPLETED|Open Label Phase||0||
59712409|NCT01187550|75830785|FG000|STARTED|Overall Study||183||
59712410|NCT01187550|75830786|FG001|STARTED|Overall Study||30||
59712411|NCT01187550|75830785|FG000|Treated|Overall Study||175||
59712412|NCT01187550|75830786|FG001|Treated|Overall Study||30||
59712413|NCT01187550|75830785|FG000|COMPLETED|Overall Study||169||
59712414|NCT01187550|75830786|FG001|COMPLETED|Overall Study||29||
59712415|NCT01187550|75830785|FG000|NOT COMPLETED|Overall Study||14||
59712416|NCT01187550|75830786|FG001|NOT COMPLETED|Overall Study||1||
59819171|NCT00339040|75941340|FG000|STARTED|Stage II||94||
59819172|NCT00339040|75941341|FG001|STARTED|Stage II||29||
59712417|NCT01186770|75830796|FG000|STARTED|Overall Study||201||
59712418|NCT01186770|75830797|FG001|STARTED|Overall Study||202||
59712419|NCT01186770|75830798|FG002|STARTED|Overall Study||200||
59712420|NCT01186770|75830799|FG003|STARTED|Overall Study||201||
59712421|NCT01186770|75830796|FG000|Intent-to-treat (ITT Population)|Overall Study||201|Received at least 1 dose of study drug|
59712422|NCT01186770|75830797|FG001|Intent-to-treat (ITT Population)|Overall Study||201|Received at least 1 dose of study drug|
59712423|NCT01186770|75830798|FG002|Intent-to-treat (ITT Population)|Overall Study||200|Received at least 1 dose of study drug|
59712424|NCT01186770|75830799|FG003|Intent-to-treat (ITT Population)|Overall Study||201|Received at least 1 dose of study drug|
59712425|NCT01186770|75830796|FG000|COMPLETED|Overall Study||160||
59712426|NCT01186770|75830797|FG001|COMPLETED|Overall Study||156||
59712427|NCT01186770|75830798|FG002|COMPLETED|Overall Study||148||
59712428|NCT01186770|75830799|FG003|COMPLETED|Overall Study||143||
59712429|NCT01186770|75830796|FG000|NOT COMPLETED|Overall Study||41||
59712430|NCT01186770|75830797|FG001|NOT COMPLETED|Overall Study||46||
59712431|NCT01186770|75830798|FG002|NOT COMPLETED|Overall Study||52||
59712432|NCT01186770|75830799|FG003|NOT COMPLETED|Overall Study||58||
59712433|NCT01186692|75830809|FG000|STARTED|Overall Study||131||
59712434|NCT01186692|75830809|FG000|COMPLETED|Overall Study||99||
59712435|NCT01186692|75830809|FG000|NOT COMPLETED|Overall Study||32||
59712436|NCT01186458|75830817|FG000|STARTED|Overall Study||4||
59712437|NCT01186458|75830817|FG000|COMPLETED|Overall Study||3||
59712438|NCT01186458|75830817|FG000|NOT COMPLETED|Overall Study||1||
59712439|NCT01185834|75830821|FG000|STARTED|Overall Study||118||
59712440|NCT01185834|75830821|FG000|COMPLETED|Overall Study||104||
59712441|NCT01185834|75830821|FG000|NOT COMPLETED|Overall Study||14||
59712442|NCT01185600|75830827|FG000|STARTED|Overall Study||73||
59819173|NCT00339040|75941340|FG000|Vaccination 4 at Week 96|Stage II||84||
59819174|NCT00339040|75941341|FG001|Vaccination 4 at Week 96|Stage II||29||
59819175|NCT00339040|75941340|FG000|Vaccination 5 at Week 104|Stage II||0||
59819176|NCT00339040|75941341|FG001|Vaccination 5 at Week 104|Stage II||28||
59819177|NCT00339040|75941340|FG000|Vaccination 6 at Week 120|Stage II||0||
59819178|NCT00339040|75941341|FG001|Vaccination 6 at Week 120|Stage II||27||
59819179|NCT00339040|75941340|FG000|COMPLETED|Stage II||84||
59819180|NCT00339040|75941341|FG001|COMPLETED|Stage II||27||
59819181|NCT00339040|75941340|FG000|NOT COMPLETED|Stage II||10||
59819182|NCT00339040|75941341|FG001|NOT COMPLETED|Stage II||2||
59819183|NCT00338962|75941351|FG000|STARTED|Overall Study||22||
59819184|NCT00338962|75941352|FG001|STARTED|Overall Study||20||
59819185|NCT00338962|75941353|FG002|STARTED|Overall Study||22||
59819186|NCT00338962|75941354|FG003|STARTED|Overall Study||24||
59819187|NCT00338962|75941351|FG000|COMPLETED|Overall Study||14||
59819188|NCT00338962|75941352|FG001|COMPLETED|Overall Study||16||
59819189|NCT00338962|75941353|FG002|COMPLETED|Overall Study||16||
59819190|NCT00338962|75941354|FG003|COMPLETED|Overall Study||21||
59819191|NCT00338962|75941351|FG000|NOT COMPLETED|Overall Study||8||
59819192|NCT00338962|75941352|FG001|NOT COMPLETED|Overall Study||4||
59819193|NCT00338962|75941353|FG002|NOT COMPLETED|Overall Study||6||
59819194|NCT00338962|75941354|FG003|NOT COMPLETED|Overall Study||3||
59819195|NCT00568061|75941366|FG000|STARTED|Overall Study||13||
59819196|NCT00568061|75941367|FG001|STARTED|Overall Study||16||
59819197|NCT00568061|75941366|FG000|COMPLETED|Overall Study||8||
59819198|NCT00568061|75941367|FG001|COMPLETED|Overall Study||14||
59819199|NCT00568061|75941366|FG000|NOT COMPLETED|Overall Study||5||
59819200|NCT00568061|75941367|FG001|NOT COMPLETED|Overall Study||2||
60108380|NCT01613014|76228088|FG000|STARTED|Overall Study||75||
59712443|NCT01185600|75830828|FG001|STARTED|Overall Study||104||
59712444|NCT01185600|75830827|FG000|COMPLETED|Overall Study||41||
59712445|NCT01185600|75830828|FG001|COMPLETED|Overall Study||59||
59712446|NCT01185600|75830827|FG000|NOT COMPLETED|Overall Study||32||
59712447|NCT01185600|75830828|FG001|NOT COMPLETED|Overall Study||45||
59712448|NCT01185522|75830837|FG000|STARTED|Overall Study||693||
59712449|NCT01185522|75830837|FG000|COMPLETED|Overall Study||585||
59712450|NCT01185522|75830837|FG000|NOT COMPLETED|Overall Study||108||
59712451|NCT01185366|75830844|FG000|STARTED|First Line Therapy||38||
59819201|NCT00338884|75941374|FG000|STARTED|Overall Study||120||
59819202|NCT00338884|75941374|FG000|Received Treatment|Overall Study||119||
59712452|NCT01185366|75830845|FG001|STARTED|First Line Therapy||34||
59712453|NCT01185366|75830844|FG000|Received 1st Drug|First Line Therapy||36||
59819203|NCT00338884|75941374|FG000|COMPLETED|Overall Study||42||
59819204|NCT00338884|75941374|FG000|NOT COMPLETED|Overall Study||78||
59819205|NCT00338806|75941380|FG000|STARTED|Acute Phase||2||
59819206|NCT00338806|75941381|FG001|STARTED|Acute Phase||5||
59819207|NCT00338806|75941380|FG000|COMPLETED|Acute Phase||2||
59712454|NCT01185366|75830845|FG001|Received 1st Drug|First Line Therapy||33||
59712455|NCT01185366|75830844|FG000|COMPLETED|First Line Therapy||35||
59712456|NCT01185366|75830845|FG001|COMPLETED|First Line Therapy||33||
59819208|NCT00338806|75941381|FG001|COMPLETED|Acute Phase||4||
59819209|NCT00338806|75941380|FG000|NOT COMPLETED|Acute Phase||0||
59819210|NCT00338806|75941381|FG001|NOT COMPLETED|Acute Phase||1||
59819211|NCT00338806|75941380|FG000|STARTED|Follow-up||2||
60108381|NCT01613014|76228089|FG001|STARTED|Overall Study||75||
59712457|NCT01185366|75830844|FG000|NOT COMPLETED|First Line Therapy||3||
59712458|NCT01185366|75830845|FG001|NOT COMPLETED|First Line Therapy||1||
59712459|NCT01185366|75830844|FG000|STARTED|Crossover to Second Line Therapy||35||
59712460|NCT01185366|75830845|FG001|STARTED|Crossover to Second Line Therapy||33||
59712461|NCT01185366|75830844|FG000|Received Crossover Drug|Crossover to Second Line Therapy||21||
59712462|NCT01185366|75830845|FG001|Received Crossover Drug|Crossover to Second Line Therapy||23||
59712463|NCT01185366|75830844|FG000|COMPLETED|Crossover to Second Line Therapy||21||
59712464|NCT01185366|75830845|FG001|COMPLETED|Crossover to Second Line Therapy||23||
59712465|NCT01185366|75830844|FG000|NOT COMPLETED|Crossover to Second Line Therapy||14||
59712466|NCT01185366|75830845|FG001|NOT COMPLETED|Crossover to Second Line Therapy||10||
59712467|NCT01185288|75830855|FG000|STARTED|Overall Study||154||
59712468|NCT01185288|75830856|FG001|STARTED|Overall Study||155||
59712469|NCT01185288|75830855|FG000|COMPLETED|Overall Study||135||
59712470|NCT01185288|75830856|FG001|COMPLETED|Overall Study||139||
59712471|NCT01185288|75830855|FG000|NOT COMPLETED|Overall Study||19||
59712472|NCT01185288|75830856|FG001|NOT COMPLETED|Overall Study||16||
59712473|NCT01184508|75830864|FG000|STARTED|Overall Study||45||
59712474|NCT01184508|75830865|FG001|STARTED|Overall Study||42||
59712475|NCT01184508|75830864|FG000|Received at Least 1 Dose of Study Drug|Overall Study||45||
59712476|NCT01184508|75830865|FG001|Received at Least 1 Dose of Study Drug|Overall Study||41||
59712477|NCT01184508|75830864|FG000|COMPLETED|Overall Study||29||
59712478|NCT01184508|75830865|FG001|COMPLETED|Overall Study||27||
59712479|NCT01184508|75830864|FG000|NOT COMPLETED|Overall Study||16||
59712480|NCT01184508|75830865|FG001|NOT COMPLETED|Overall Study||15||
59712481|NCT01184118|75830872|FG000|STARTED|Overall Study||36||
59712482|NCT01184118|75830872|FG000|FP MDI 1,760 mcg/Day (16 Weeks)|Overall Study||18||
59712483|NCT01184118|75830872|FG000|FP MDI 880 mcg/Day (2 Weeks)|Overall Study||18||
59712484|NCT01184118|75830872|FG000|FP MDI as Indicated (2 Weeks)|Overall Study||18||
59712485|NCT01184118|75830872|FG000|COMPLETED|Overall Study||18||
59712486|NCT01184118|75830872|FG000|NOT COMPLETED|Overall Study||18||
59712487|NCT01183884|75830876|FG000|STARTED|Overall Study||46||
59712488|NCT01183884|75830876|FG000|COMPLETED|Overall Study||8||
59712489|NCT01183884|75830876|FG000|NOT COMPLETED|Overall Study||38||
59712490|NCT01183260|75830882|FG000|STARTED|Overall Study||14||
59712491|NCT01183260|75830883|FG001|STARTED|Overall Study||11||
59712492|NCT01183260|75830882|FG000|COMPLETED|Overall Study||10||
59712493|NCT01183260|75830883|FG001|COMPLETED|Overall Study||9||
59712494|NCT01183260|75830882|FG000|NOT COMPLETED|Overall Study||4||
59712495|NCT01183260|75830883|FG001|NOT COMPLETED|Overall Study||2||
59712496|NCT01191762|75830891|FG000|STARTED|Overall Study||15||
59712497|NCT01191762|75830892|FG001|STARTED|Overall Study||15||
59712498|NCT01191762|75830891|FG000|COMPLETED|Overall Study|One subject dropped out on the 3rd treatment day because of gastrointestinal complaints.|14||
59566877|NCT04041219|75669625|FG000|STARTED|Overall Study||10||
59566878|NCT04041219|75669625|FG000|COMPLETED|Overall Study||10||
59566879|NCT04041219|75669625|FG000|NOT COMPLETED|Overall Study||0||
59566880|NCT04037865|75669629|FG000|STARTED|Overall Study||8||
59566881|NCT04037865|75669629|FG000|COMPLETED|Overall Study||8||
59566882|NCT04037865|75669629|FG000|NOT COMPLETED|Overall Study||0||
59566883|NCT03847233|75669634|FG000|STARTED|Index Procedure||31||
59566884|NCT03847233|75669634|FG000|COMPLETED|Index Procedure||31||
59566885|NCT03847233|75669634|FG000|NOT COMPLETED|Index Procedure||0||
59712499|NCT01191762|75830892|FG001|COMPLETED|Overall Study||15||
59712500|NCT01191762|75830891|FG000|NOT COMPLETED|Overall Study||1||
59712501|NCT01191762|75830892|FG001|NOT COMPLETED|Overall Study||0||
59712502|NCT01190514|75830898|FG000|STARTED|First Intervention (Period 1)||11||
59819212|NCT00338806|75941381|FG001|STARTED|Follow-up||4||
59819213|NCT00338806|75941380|FG000|COMPLETED|Follow-up||1||
59566886|NCT03847233|75669634|FG000|STARTED|6 Month After Index Procedure||31||
59712503|NCT01190514|75830899|FG001|STARTED|First Intervention (Period 1)||10||
59712504|NCT01190514|75830900|FG002|STARTED|First Intervention (Period 1)||10||
59712505|NCT01190514|75830901|FG003|STARTED|First Intervention (Period 1)||10||
59712506|NCT01190514|75830898|FG000|COMPLETED|First Intervention (Period 1)|Discontinued participant received treatment A of sequence ABCD.|10||
59712507|NCT01190514|75830899|FG001|COMPLETED|First Intervention (Period 1)||10||
59712508|NCT01190514|75830900|FG002|COMPLETED|First Intervention (Period 1)||10||
59712509|NCT01190514|75830901|FG003|COMPLETED|First Intervention (Period 1)||10||
59712510|NCT01190514|75830898|FG000|NOT COMPLETED|First Intervention (Period 1)||1||
59712511|NCT01190514|75830899|FG001|NOT COMPLETED|First Intervention (Period 1)||0||
59712512|NCT01190514|75830900|FG002|NOT COMPLETED|First Intervention (Period 1)||0||
59712513|NCT01190514|75830901|FG003|NOT COMPLETED|First Intervention (Period 1)||0||
59712514|NCT01190514|75830898|FG000|STARTED|Second Intervention (Period 2)|Period 2 received treatment B|10||
59712515|NCT01190514|75830899|FG001|STARTED|Second Intervention (Period 2)|Period 2 received treatment A|10||
59712516|NCT01190514|75830900|FG002|STARTED|Second Intervention (Period 2)|Period 2 received treatment D|10||
59712517|NCT01190514|75830901|FG003|STARTED|Second Intervention (Period 2)|Period 2 received treatment C|10||
59712518|NCT01190514|75830898|FG000|COMPLETED|Second Intervention (Period 2)||10||
59712519|NCT01190514|75830899|FG001|COMPLETED|Second Intervention (Period 2)||10||
59712520|NCT01190514|75830900|FG002|COMPLETED|Second Intervention (Period 2)||10||
59712521|NCT01190514|75830901|FG003|COMPLETED|Second Intervention (Period 2)||10||
59712522|NCT01190514|75830898|FG000|NOT COMPLETED|Second Intervention (Period 2)||0||
59712523|NCT01190514|75830899|FG001|NOT COMPLETED|Second Intervention (Period 2)||0||
59712524|NCT01190514|75830900|FG002|NOT COMPLETED|Second Intervention (Period 2)||0||
59712525|NCT01190514|75830901|FG003|NOT COMPLETED|Second Intervention (Period 2)||0||
59712526|NCT01190514|75830898|FG000|STARTED|Third Intervention (Period 3)|Period 3 received treatment C|10||
59712527|NCT01190514|75830899|FG001|STARTED|Third Intervention (Period 3)|Period 3 received treatment D|10||
59712528|NCT01190514|75830900|FG002|STARTED|Third Intervention (Period 3)|Period 3 received treatment A|10||
59712529|NCT01190514|75830901|FG003|STARTED|Third Intervention (Period 3)|Period 3 received treatment B|10||
59712530|NCT01190514|75830898|FG000|COMPLETED|Third Intervention (Period 3)|Discontinued participant received treatments ABC of sequence ABCD.|9||
59712531|NCT01190514|75830899|FG001|COMPLETED|Third Intervention (Period 3)||10||
59712532|NCT01190514|75830900|FG002|COMPLETED|Third Intervention (Period 3)||10||
59712533|NCT01190514|75830901|FG003|COMPLETED|Third Intervention (Period 3)||10||
59712534|NCT01190514|75830898|FG000|NOT COMPLETED|Third Intervention (Period 3)||1||
59712535|NCT01190514|75830899|FG001|NOT COMPLETED|Third Intervention (Period 3)||0||
59712536|NCT01190514|75830900|FG002|NOT COMPLETED|Third Intervention (Period 3)||0||
59712537|NCT01190514|75830901|FG003|NOT COMPLETED|Third Intervention (Period 3)||0||
59712538|NCT01190514|75830898|FG000|STARTED|Fourth Intervention (Period 4)|Period 4 received treatment D|9||
59712539|NCT01190514|75830899|FG001|STARTED|Fourth Intervention (Period 4)|Period 4 received treatment C|10||
59712540|NCT01190514|75830900|FG002|STARTED|Fourth Intervention (Period 4)|Period 4 received treatment B|10||
59712541|NCT01190514|75830901|FG003|STARTED|Fourth Intervention (Period 4)|Period 4 received treatment A|10||
59712542|NCT01190514|75830898|FG000|COMPLETED|Fourth Intervention (Period 4)||9||
59712543|NCT01190514|75830899|FG001|COMPLETED|Fourth Intervention (Period 4)||10||
59712544|NCT01190514|75830900|FG002|COMPLETED|Fourth Intervention (Period 4)||10||
59712545|NCT01190514|75830901|FG003|COMPLETED|Fourth Intervention (Period 4)||10||
59712546|NCT01190514|75830898|FG000|NOT COMPLETED|Fourth Intervention (Period 4)||0||
59712547|NCT01190514|75830899|FG001|NOT COMPLETED|Fourth Intervention (Period 4)||0||
59712548|NCT01190514|75830900|FG002|NOT COMPLETED|Fourth Intervention (Period 4)||0||
59712549|NCT01190514|75830901|FG003|NOT COMPLETED|Fourth Intervention (Period 4)||0||
59712550|NCT01190436|75830911|FG000|STARTED|Overall Study||125||
59712551|NCT01190436|75830911|FG000|COMPLETED|Overall Study||86||
59712552|NCT01190436|75830911|FG000|NOT COMPLETED|Overall Study||39||
59712553|NCT01035255|75830918|FG000|STARTED|Overall Study||4209||
59712554|NCT01035255|75830919|FG001|STARTED|Overall Study||4233||
59712555|NCT01035255|75830918|FG000|GCP Violations|Overall Study||18||
59712556|NCT01035255|75830919|FG001|GCP Violations|Overall Study||19||
59712557|NCT01035255|75830918|FG000|Mis-randomized|Overall Study||4||
59712558|NCT01035255|75830919|FG001|Mis-randomized|Overall Study||2||
59712559|NCT01035255|75830918|FG000|Full Analysis Set (FAS)|Overall Study|patents with GCP violation and mis-randomized are not included in FAS|4187||
59712560|NCT01035255|75830919|FG001|Full Analysis Set (FAS)|Overall Study|patents with GCP violation and mis-randomized are not included in FAS|4212||
59712561|NCT01035255|75830918|FG000|COMPLETED|Overall Study||3468||
59712562|NCT01035255|75830919|FG001|COMPLETED|Overall Study||3371||
59712563|NCT01035255|75830918|FG000|NOT COMPLETED|Overall Study||741||
59712564|NCT01035255|75830919|FG001|NOT COMPLETED|Overall Study||862||
59712565|NCT01190124|75830928|FG000|STARTED|Overall Study||107||
59712566|NCT01190124|75830929|FG001|STARTED|Overall Study||24||
59712567|NCT01190124|75830930|FG002|STARTED|Overall Study||20||
59712568|NCT01190124|75830928|FG000|COMPLETED|Overall Study||90||
59712569|NCT01190124|75830929|FG001|COMPLETED|Overall Study||24||
59712570|NCT01190124|75830930|FG002|COMPLETED|Overall Study||19||
60108382|NCT01613014|76228088|FG000|COMPLETED|Overall Study||57||
59712571|NCT01190124|75830928|FG000|NOT COMPLETED|Overall Study||17||
60108383|NCT01613014|76228089|FG001|COMPLETED|Overall Study||63||
60108384|NCT01613014|76228088|FG000|NOT COMPLETED|Overall Study||18||
59712572|NCT01190124|75830929|FG001|NOT COMPLETED|Overall Study||0||
59712573|NCT01190124|75830930|FG002|NOT COMPLETED|Overall Study||1||
59712574|NCT01189890|75830943|FG000|STARTED|Overall Study||241||
59712575|NCT01189890|75830944|FG001|STARTED|Overall Study|3 randomized glimepiride participants did not receive study drug.|239||
59712576|NCT01189890|75830943|FG000|COMPLETED|Overall Study||204||
59712577|NCT01189890|75830944|FG001|COMPLETED|Overall Study||200||
60108385|NCT01613014|76228089|FG001|NOT COMPLETED|Overall Study||12||
60108386|NCT01656460|76228095|FG000|STARTED|Overall Study||3||
59712578|NCT01189890|75830943|FG000|NOT COMPLETED|Overall Study||37||
59712579|NCT01189890|75830944|FG001|NOT COMPLETED|Overall Study||39||
59712580|NCT01189812|75830952|FG000|STARTED|Overall Study||40||
59712581|NCT01189812|75830953|FG001|STARTED|Overall Study||40||
59712582|NCT01189812|75830952|FG000|COMPLETED|Overall Study||32||
59712583|NCT01189812|75830953|FG001|COMPLETED|Overall Study||32||
59712584|NCT01189812|75830952|FG000|NOT COMPLETED|Overall Study||8||
59712585|NCT01189812|75830953|FG001|NOT COMPLETED|Overall Study||8||
59712586|NCT00950950|75830961|FG000|STARTED|Overall Study||12||
59712587|NCT00950950|75830962|FG001|STARTED|Overall Study||12||
59712588|NCT00950950|75830961|FG000|COMPLETED|Overall Study||11||
59712589|NCT00950950|75830962|FG001|COMPLETED|Overall Study||11||
59712590|NCT00950950|75830961|FG000|NOT COMPLETED|Overall Study||1||
59712591|NCT00950950|75830962|FG001|NOT COMPLETED|Overall Study||1||
59712592|NCT00950872|75830969|FG000|STARTED|Overall Study||29||
59712593|NCT00950872|75830969|FG000|COMPLETED|Overall Study||26||
59712594|NCT00950872|75830969|FG000|NOT COMPLETED|Overall Study||3||
59712595|NCT01189500|75830973|FG000|STARTED|Period 1: TAMOX Alone||30||
59712596|NCT01189500|75830973|FG000|COMPLETED|Period 1: TAMOX Alone||29||
59712597|NCT01189500|75830973|FG000|NOT COMPLETED|Period 1: TAMOX Alone||1||
59712598|NCT01189500|75830973|FG000|STARTED|Period 2: Coadministration TAMOX+DVS SR||29||
59712599|NCT01189500|75830973|FG000|COMPLETED|Period 2: Coadministration TAMOX+DVS SR||28||
59712600|NCT01189500|75830973|FG000|NOT COMPLETED|Period 2: Coadministration TAMOX+DVS SR||1||
59712601|NCT00938860|75830982|FG000|STARTED|Overall Study|Intent-to-Treat (ITT) population. ITT population consisted of all randomized patients|50||
59712602|NCT00938860|75830983|FG001|STARTED|Overall Study||42||
59712603|NCT00938860|75830982|FG000|Efficacy Population|Overall Study||40||
59712604|NCT00938860|75830983|FG001|Efficacy Population|Overall Study||41||
59712605|NCT00938860|75830982|FG000|COMPLETED|Overall Study||25||
59712606|NCT00938860|75830983|FG001|COMPLETED|Overall Study||25||
59712607|NCT00938860|75830982|FG000|NOT COMPLETED|Overall Study||25||
59712608|NCT00938860|75830983|FG001|NOT COMPLETED|Overall Study||17||
59712609|NCT00938470|75830991|FG000|STARTED|Overall Study||34||
59712610|NCT00938470|75830992|FG001|STARTED|Overall Study||28||
59712611|NCT00938470|75830991|FG000|COMPLETED|Overall Study||27||
59712612|NCT00938470|75830992|FG001|COMPLETED|Overall Study||25||
59712613|NCT00938470|75830991|FG000|NOT COMPLETED|Overall Study||7||
59712614|NCT00938470|75830992|FG001|NOT COMPLETED|Overall Study||3||
59712615|NCT00938392|75831000|FG000|STARTED|Overall Study||362||
59712616|NCT00938392|75831001|FG001|STARTED|Overall Study||362||
59712617|NCT00938392|75831000|FG000|COMPLETED|Overall Study||360||
59712618|NCT00938392|75831001|FG001|COMPLETED|Overall Study||358||
59712619|NCT00938392|75831000|FG000|NOT COMPLETED|Overall Study||2||
59712620|NCT00938392|75831001|FG001|NOT COMPLETED|Overall Study||4||
59712621|NCT01022853|75831012|FG000|STARTED|Overall Study|entered and treated|3||
59712622|NCT01022853|75831013|FG001|STARTED|Overall Study|entered and treated|4||
59712623|NCT01022853|75831014|FG002|STARTED|Overall Study|entered and treated|13||
59712624|NCT01022853|75831015|FG003|STARTED|Overall Study|entered and treated|8||
59712625|NCT01022853|75831016|FG004|STARTED|Overall Study|entered and treated|2||
59712626|NCT01022853|75831012|FG000|COMPLETED|Overall Study||0||
59819214|NCT00338806|75941381|FG001|COMPLETED|Follow-up||1||
59819215|NCT00338806|75941380|FG000|NOT COMPLETED|Follow-up||1||
59712627|NCT01022853|75831013|FG001|COMPLETED|Overall Study||0||
59712628|NCT01022853|75831014|FG002|COMPLETED|Overall Study||0||
59712629|NCT01022853|75831015|FG003|COMPLETED|Overall Study||0||
59712630|NCT01022853|75831016|FG004|COMPLETED|Overall Study||0||
59712631|NCT01022853|75831012|FG000|NOT COMPLETED|Overall Study||3||
59712632|NCT01022853|75831013|FG001|NOT COMPLETED|Overall Study||4||
59712633|NCT01022853|75831014|FG002|NOT COMPLETED|Overall Study||13||
59712634|NCT01022853|75831015|FG003|NOT COMPLETED|Overall Study||8||
59712635|NCT01022853|75831016|FG004|NOT COMPLETED|Overall Study||2||
59712636|NCT01034709|75831033|FG000|STARTED|Overall Study||53||
59712637|NCT01034709|75831034|FG001|STARTED|Overall Study||58||
59712638|NCT01034709|75831033|FG000|COMPLETED|Overall Study||44||
59712639|NCT01034709|75831034|FG001|COMPLETED|Overall Study||42||
59712640|NCT01034709|75831033|FG000|NOT COMPLETED|Overall Study||9||
59712641|NCT01034709|75831034|FG001|NOT COMPLETED|Overall Study||16||
59712642|NCT00937768|75831042|FG000|STARTED|Overall Study||8||
59712643|NCT00937768|75831043|FG001|STARTED|Overall Study||8||
59712644|NCT00937768|75831042|FG000|COMPLETED|Overall Study||0||
59819216|NCT00338806|75941381|FG001|NOT COMPLETED|Follow-up||3||
59819217|NCT03038100|75941391|FG000|STARTED|Overall Study||650||
59819218|NCT03038100|75941392|FG001|STARTED|Overall Study||651||
59819219|NCT03038100|75941391|FG000|COMPLETED|Overall Study||0||
59712645|NCT00937768|75831043|FG001|COMPLETED|Overall Study||0||
59712646|NCT00937768|75831042|FG000|NOT COMPLETED|Overall Study||8||
59712647|NCT00937768|75831043|FG001|NOT COMPLETED|Overall Study||8||
59712648|NCT00940888|75831049|FG000|STARTED|Overall Study|Total number of subjects consented|1701||
59712649|NCT00940888|75831049|FG000|COMPLETED|Overall Study|Subjects that completed the 60 month follow up visit|866||
59712650|NCT00940888|75831049|FG000|NOT COMPLETED|Overall Study||835||
59712651|NCT01189266|75831056|FG000|STARTED|Overall Study||6||
59712652|NCT01189266|75831057|FG001|STARTED|Overall Study||6||
59712653|NCT01189266|75831058|FG002|STARTED|Overall Study||67||
59712654|NCT01189266|75831056|FG000|COMPLETED|Overall Study||0||
59712655|NCT01189266|75831057|FG001|COMPLETED|Overall Study||0||
59712656|NCT01189266|75831058|FG002|COMPLETED|Overall Study||2||
59712657|NCT01189266|75831056|FG000|NOT COMPLETED|Overall Study||6||
59712658|NCT01189266|75831057|FG001|NOT COMPLETED|Overall Study||6||
59712659|NCT01189266|75831058|FG002|NOT COMPLETED|Overall Study||65||
59712660|NCT01189032|75831070|FG000|STARTED|Overall Study||94||
59712661|NCT01189032|75831071|FG001|STARTED|Overall Study||96||
59712662|NCT01189032|75831072|FG002|STARTED|Overall Study||96||
59712663|NCT01189032|75831070|FG000|COMPLETED|Overall Study||89||
59712664|NCT01189032|75831071|FG001|COMPLETED|Overall Study||89||
59712665|NCT01189032|75831072|FG002|COMPLETED|Overall Study||90||
59712666|NCT01189032|75831070|FG000|NOT COMPLETED|Overall Study||5||
59712667|NCT01189032|75831071|FG001|NOT COMPLETED|Overall Study||7||
59712668|NCT01189032|75831072|FG002|NOT COMPLETED|Overall Study||6||
59712669|NCT01188798|75831082|FG000|STARTED|Overall Study||2||
59712670|NCT01188798|75831083|FG001|STARTED|Overall Study||4||
59712671|NCT01188798|75831082|FG000|COMPLETED|Overall Study||0||
59712672|NCT01188798|75831083|FG001|COMPLETED|Overall Study||1||
59712673|NCT01188798|75831082|FG000|NOT COMPLETED|Overall Study||2||
59712674|NCT01188798|75831083|FG001|NOT COMPLETED|Overall Study||3||
59712675|NCT01183104|75831092|FG000|STARTED|Overall Study||153||
59712676|NCT01183104|75831093|FG001|STARTED|Overall Study||152||
59712677|NCT01183104|75831092|FG000|Received Study Drug|Overall Study||148|Analysis set of evaluation for safety|
59712678|NCT01183104|75831093|FG001|Received Study Drug|Overall Study||143|Analysis set of evaluation for safety|
59712679|NCT01183104|75831092|FG000|Continued Treatment for 12 Weeks|Overall Study||143|Analysis set of evaluation for efficacy; Per Protocol Set|
59712680|NCT01183104|75831093|FG001|Continued Treatment for 12 Weeks|Overall Study||129|Analysis set of evaluation for efficacy; Per Protocol Set|
59712681|NCT01183104|75831092|FG000|Completed 52-week Treatment|Overall Study||119||
59712682|NCT01183104|75831093|FG001|Completed 52-week Treatment|Overall Study||111||
59712683|NCT01183104|75831092|FG000|Enrolled in Extension Study|Overall Study||80||
59712684|NCT01183104|75831093|FG001|Enrolled in Extension Study|Overall Study||61||
59712685|NCT01183104|75831092|FG000|COMPLETED|Overall Study||76|104-week extension study|
59712686|NCT01183104|75831093|FG001|COMPLETED|Overall Study||60|104-week extension study|
59712687|NCT01183104|75831092|FG000|NOT COMPLETED|Overall Study||77||
59712688|NCT01183104|75831093|FG001|NOT COMPLETED|Overall Study||92||
59712689|NCT01163292|75831101|FG000|STARTED|Overall Study||106||
59712690|NCT01163292|75831102|FG001|STARTED|Overall Study||114||
59712691|NCT01163292|75831101|FG000|COMPLETED|Overall Study||65||
59712692|NCT01163292|75831102|FG001|COMPLETED|Overall Study||92||
59712693|NCT01163292|75831101|FG000|NOT COMPLETED|Overall Study||41||
59712694|NCT01163292|75831102|FG001|NOT COMPLETED|Overall Study||22||
59712695|NCT00950248|75831110|FG000|STARTED|Year 1: Baseline||85||
59712696|NCT00950248|75831111|FG001|STARTED|Year 1: Baseline||0||
59712697|NCT00950248|75831112|FG002|STARTED|Year 1: Baseline||0||
59712698|NCT00950248|75831110|FG000|COMPLETED|Year 1: Baseline||77||
59712699|NCT00950248|75831111|FG001|COMPLETED|Year 1: Baseline||0||
59712700|NCT00950248|75831112|FG002|COMPLETED|Year 1: Baseline||0||
59712701|NCT00950248|75831110|FG000|NOT COMPLETED|Year 1: Baseline||8||
59712702|NCT00950248|75831111|FG001|NOT COMPLETED|Year 1: Baseline||0||
59712703|NCT00950248|75831112|FG002|NOT COMPLETED|Year 1: Baseline||0||
59712704|NCT00950248|75831110|FG000|STARTED|Year 2&3 Treatment Randomization||0||
59712705|NCT00950248|75831111|FG001|STARTED|Year 2&3 Treatment Randomization||39||
59712706|NCT00950248|75831112|FG002|STARTED|Year 2&3 Treatment Randomization||38||
59712707|NCT00950248|75831110|FG000|COMPLETED|Year 2&3 Treatment Randomization||0||
59712708|NCT00950248|75831111|FG001|COMPLETED|Year 2&3 Treatment Randomization||33||
59712709|NCT00950248|75831112|FG002|COMPLETED|Year 2&3 Treatment Randomization||33||
59712710|NCT00950248|75831110|FG000|NOT COMPLETED|Year 2&3 Treatment Randomization||0||
59712711|NCT00950248|75831111|FG001|NOT COMPLETED|Year 2&3 Treatment Randomization||6||
59712712|NCT00950248|75831112|FG002|NOT COMPLETED|Year 2&3 Treatment Randomization||5||
59712713|NCT00950170|75831119|FG000|STARTED|Overall Study||23||
59712714|NCT00950170|75831119|FG000|COMPLETED|Overall Study||19||
59712715|NCT00950170|75831119|FG000|NOT COMPLETED|Overall Study||4||
59712716|NCT01227824|75831143|FG000|STARTED|Double-blind Phase: 96 Weeks Duration||411||
59712717|NCT01227824|75831144|FG001|STARTED|Double-blind Phase: 96 Weeks Duration||411||
59712718|NCT01227824|75831145|FG002|STARTED|Double-blind Phase: 96 Weeks Duration||0||
59712719|NCT01227824|75831143|FG000|COMPLETED|Double-blind Phase: 96 Weeks Duration||304||
59712720|NCT01227824|75831144|FG001|COMPLETED|Double-blind Phase: 96 Weeks Duration||332||
59712721|NCT01227824|75831145|FG002|COMPLETED|Double-blind Phase: 96 Weeks Duration||0||
59712722|NCT01227824|75831143|FG000|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||107||
59712723|NCT01227824|75831144|FG001|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||79||
59712724|NCT01227824|75831145|FG002|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||0||
59712725|NCT01227824|75831143|FG000|STARTED|Open-label Phase: Median of 1267 Days||0||
59712726|NCT01227824|75831144|FG001|STARTED|Open-label Phase: Median of 1267 Days||0||
59712727|NCT01227824|75831145|FG002|STARTED|Open-label Phase: Median of 1267 Days|338 participants continued into the Open-label phase on completing the Double-blind Phase|338||
59712728|NCT01227824|75831143|FG000|COMPLETED|Open-label Phase: Median of 1267 Days||0||
59712729|NCT01227824|75831144|FG001|COMPLETED|Open-label Phase: Median of 1267 Days||0||
59712730|NCT01227824|75831145|FG002|COMPLETED|Open-label Phase: Median of 1267 Days||294||
59712731|NCT01227824|75831143|FG000|NOT COMPLETED|Open-label Phase: Median of 1267 Days||0||
59712732|NCT01227824|75831144|FG001|NOT COMPLETED|Open-label Phase: Median of 1267 Days||0||
60108387|NCT01656460|76228096|FG001|STARTED|Overall Study||3||
60108388|NCT01656460|76228097|FG002|STARTED|Overall Study||3||
59712733|NCT01227824|75831145|FG002|NOT COMPLETED|Open-label Phase: Median of 1267 Days||44||
59712734|NCT00949702|75831152|FG000|STARTED|Overall Study||132||
59819220|NCT03038100|75941392|FG001|COMPLETED|Overall Study||0||
59819221|NCT03038100|75941391|FG000|NOT COMPLETED|Overall Study||650||
59819222|NCT03038100|75941392|FG001|NOT COMPLETED|Overall Study||651||
59819223|NCT00338728|75941399|FG000|STARTED|Overall Study||59||
59819224|NCT00338728|75941399|FG000|COMPLETED|Overall Study||45||
59819225|NCT00338728|75941399|FG000|NOT COMPLETED|Overall Study||14||
59819226|NCT00336856|75941403|FG000|STARTED|Overall Study|Number of patients consented and registered for the study|35||
59819227|NCT00336856|75941403|FG000|COMPLETED|Overall Study||31||
59819228|NCT00336856|75941403|FG000|NOT COMPLETED|Overall Study||4||
59819229|NCT00566501|75941409|FG000|STARTED|Overall Study||570||
59819230|NCT00566501|75941410|FG001|STARTED|Overall Study||332||
59819231|NCT00566501|75941409|FG000|COMPLETED|Overall Study||423||
59819232|NCT00566501|75941410|FG001|COMPLETED|Overall Study||210||
59819233|NCT00566501|75941409|FG000|NOT COMPLETED|Overall Study||147||
59819234|NCT00566501|75941410|FG001|NOT COMPLETED|Overall Study||122||
59819235|NCT00504894|75941419|FG000|STARTED|Overall Study||20||
59819236|NCT00504894|75941420|FG001|STARTED|Overall Study||21||
59819237|NCT00504894|75941421|FG002|STARTED|Overall Study||19||
59819238|NCT00504894|75941419|FG000|COMPLETED|Overall Study||17||
59819239|NCT00504894|75941420|FG001|COMPLETED|Overall Study||18||
59819240|NCT00504894|75941421|FG002|COMPLETED|Overall Study||19||
59819241|NCT00504894|75941419|FG000|NOT COMPLETED|Overall Study||3||
59819242|NCT00504894|75941420|FG001|NOT COMPLETED|Overall Study||3||
59819243|NCT00504894|75941421|FG002|NOT COMPLETED|Overall Study||0||
59819244|NCT00513240|75941431|FG000|STARTED|Overall Study|3 did not have intended surgery; 28 had all 3 doses; 4 had 1 dose but no more due to delayed surgery|35||
59819245|NCT00513240|75941432|FG001|STARTED|Overall Study|25 had 3 doses; 1 had 1 dose due to rash; 1 had 2 doses and 1 dose of EPO due to pharmacy error|27||
59819246|NCT00513240|75941431|FG000|Clinical Data Collection &Pre/Postop MRI|Overall Study|3 not having intended surgery are subtracted from original 35 subjects, leaving 32|32||
59819247|NCT00513240|75941432|FG001|Clinical Data Collection &Pre/Postop MRI|Overall Study||27||
59819248|NCT00513240|75941431|FG000|COMPLETED|Overall Study|Competed 12 month neurodevelopmental exam, which are the only results published at this time.|22||
59819249|NCT00513240|75941432|FG001|COMPLETED|Overall Study|Competed 12 month neurodevelopmental exam, which are the only results published at this time.|20||
59819250|NCT00513240|75941431|FG000|NOT COMPLETED|Overall Study||13||
59819251|NCT00513240|75941432|FG001|NOT COMPLETED|Overall Study||7||
59819252|NCT00504426|75941445|FG000|STARTED|Overall Study||32||
59819253|NCT00504426|75941446|FG001|STARTED|Overall Study||23||
59819254|NCT00504426|75941447|FG002|STARTED|Overall Study||22||
59819255|NCT00504426|75941448|FG003|STARTED|Overall Study||24||
59819256|NCT00504426|75941445|FG000|COMPLETED|Overall Study||29||
59819257|NCT00504426|75941446|FG001|COMPLETED|Overall Study||22||
59819258|NCT00504426|75941447|FG002|COMPLETED|Overall Study||18||
59819259|NCT00504426|75941448|FG003|COMPLETED|Overall Study||24||
59566887|NCT03847233|75669634|FG000|COMPLETED|6 Month After Index Procedure||30||
59712735|NCT00949702|75831152|FG000|COMPLETED|Overall Study||84||
59712736|NCT00949702|75831152|FG000|NOT COMPLETED|Overall Study||48||
59712737|NCT01034631|75831159|FG000|STARTED|Phase I||15||
59712738|NCT01034631|75831160|FG001|STARTED|Phase I|No Phase II Participants were enrolled during this time period|0||
59712739|NCT01034631|75831161|FG002|STARTED|Phase I|No Phase II Participants were enrolled during this time period|0||
59712740|NCT01034631|75831159|FG000|COMPLETED|Phase I||12||
59819260|NCT00504426|75941445|FG000|NOT COMPLETED|Overall Study||3||
59819261|NCT00504426|75941446|FG001|NOT COMPLETED|Overall Study||1||
59819262|NCT00504426|75941447|FG002|NOT COMPLETED|Overall Study||4||
59819263|NCT00504426|75941448|FG003|NOT COMPLETED|Overall Study||0||
59819264|NCT00504348|75941461|FG000|STARTED|Overall Study||25||
59819265|NCT00504348|75941461|FG000|COMPLETED|Overall Study||17||
59819266|NCT00504348|75941461|FG000|NOT COMPLETED|Overall Study||8||
60108389|NCT01656460|76228098|FG003|STARTED|Overall Study||3||
59712741|NCT01034631|75831160|FG001|COMPLETED|Phase I||0||
59712742|NCT01034631|75831161|FG002|COMPLETED|Phase I||0||
59712743|NCT01034631|75831159|FG000|NOT COMPLETED|Phase I||3||
59712744|NCT01034631|75831160|FG001|NOT COMPLETED|Phase I||0||
59712745|NCT01034631|75831161|FG002|NOT COMPLETED|Phase I||0||
59712746|NCT01034631|75831159|FG000|STARTED|Phase II|No Phase I Participants were enrolled during this time period.|0||
59712747|NCT01034631|75831160|FG001|STARTED|Phase II||70||
59712748|NCT01034631|75831161|FG002|STARTED|Phase II||69||
59712749|NCT01034631|75831159|FG000|COMPLETED|Phase II||0||
59712750|NCT01034631|75831160|FG001|COMPLETED|Phase II||69||
59712751|NCT01034631|75831161|FG002|COMPLETED|Phase II||67||
59712752|NCT01034631|75831159|FG000|NOT COMPLETED|Phase II||0||
59712753|NCT01034631|75831160|FG001|NOT COMPLETED|Phase II||1||
59712754|NCT01034631|75831161|FG002|NOT COMPLETED|Phase II||2||
59712755|NCT01227668|75831173|FG000|STARTED|Phase 1 (Stabilization Phase)|Randomized|157||
59712756|NCT01227668|75831174|FG001|STARTED|Phase 1 (Stabilization Phase)||0||
59712757|NCT01227668|75831173|FG000|Received Treatment|Phase 1 (Stabilization Phase)||155||
59712758|NCT01227668|75831174|FG001|Received Treatment|Phase 1 (Stabilization Phase)||0||
59712759|NCT01227668|75831173|FG000|COMPLETED|Phase 1 (Stabilization Phase)||85||
59712760|NCT01227668|75831174|FG001|COMPLETED|Phase 1 (Stabilization Phase)||0||
59712761|NCT01227668|75831173|FG000|NOT COMPLETED|Phase 1 (Stabilization Phase)||72||
59712762|NCT01227668|75831174|FG001|NOT COMPLETED|Phase 1 (Stabilization Phase)||0||
59712763|NCT01227668|75831173|FG000|STARTED|Phase 2 (Randomization Phase)|Randomized|41||
59712764|NCT01227668|75831174|FG001|STARTED|Phase 2 (Randomization Phase)|Randomized|44||
59712765|NCT01227668|75831173|FG000|Received Treatment|Phase 2 (Randomization Phase)||39||
59712766|NCT01227668|75831174|FG001|Received Treatment|Phase 2 (Randomization Phase)||43||
59712767|NCT01227668|75831173|FG000|COMPLETED|Phase 2 (Randomization Phase)||22||
59712768|NCT01227668|75831174|FG001|COMPLETED|Phase 2 (Randomization Phase)||19||
59712769|NCT01227668|75831173|FG000|NOT COMPLETED|Phase 2 (Randomization Phase)||19||
59712770|NCT01227668|75831174|FG001|NOT COMPLETED|Phase 2 (Randomization Phase)||25||
59712771|NCT01227512|75831186|FG000|STARTED|Overall Study||66||
59712772|NCT01227512|75831187|FG001|STARTED|Overall Study||58||
59712773|NCT01227512|75831186|FG000|COMPLETED|Overall Study||53||
59712774|NCT01227512|75831187|FG001|COMPLETED|Overall Study||48||
59712775|NCT01227512|75831186|FG000|NOT COMPLETED|Overall Study||13||
59712776|NCT01227512|75831187|FG001|NOT COMPLETED|Overall Study||10||
59712777|NCT01227278|75831197|FG000|STARTED|Overall Study||50||
59712778|NCT01227278|75831198|FG001|STARTED|Overall Study||51||
59712779|NCT01227278|75831197|FG000|COMPLETED|Overall Study||45||
59712780|NCT01227278|75831198|FG001|COMPLETED|Overall Study||43||
59712781|NCT01227278|75831197|FG000|NOT COMPLETED|Overall Study||5||
59712782|NCT01227278|75831198|FG001|NOT COMPLETED|Overall Study||8||
59712783|NCT01034397|75831206|FG000|STARTED|Overall Study||35||
59712784|NCT01034397|75831207|FG001|STARTED|Overall Study||19||
59712785|NCT01034397|75831206|FG000|COMPLETED|Overall Study||28||
59712786|NCT01034397|75831207|FG001|COMPLETED|Overall Study||17||
59712787|NCT01034397|75831206|FG000|NOT COMPLETED|Overall Study||7||
59712788|NCT01034397|75831207|FG001|NOT COMPLETED|Overall Study||2||
59712789|NCT01227044|75831224|FG000|STARTED|Overall Study||25||
59712790|NCT01227044|75831225|FG001|STARTED|Overall Study||26||
59712791|NCT01227044|75831224|FG000|COMPLETED|Overall Study||19||
59712792|NCT01227044|75831225|FG001|COMPLETED|Overall Study||17||
59712793|NCT01227044|75831224|FG000|NOT COMPLETED|Overall Study||6||
59712794|NCT01227044|75831225|FG001|NOT COMPLETED|Overall Study||9||
59712795|NCT01225952|75831234|FG000|STARTED|Overall Study||31||
59712796|NCT01225952|75831235|FG001|STARTED|Overall Study||31||
59712797|NCT01225952|75831236|FG002|STARTED|Overall Study||31||
59712798|NCT01225952|75831234|FG000|COMPLETED|Overall Study||25||
59712799|NCT01225952|75831235|FG001|COMPLETED|Overall Study||27||
59712800|NCT01225952|75831236|FG002|COMPLETED|Overall Study||25||
59712801|NCT01225952|75831234|FG000|NOT COMPLETED|Overall Study||6||
59712802|NCT01225952|75831235|FG001|NOT COMPLETED|Overall Study||4||
59712803|NCT01225952|75831236|FG002|NOT COMPLETED|Overall Study||6||
59712804|NCT01034163|75831246|FG000|STARTED|Overall Study||27||
59712805|NCT01034163|75831247|FG001|STARTED|Overall Study||14||
59712806|NCT01034163|75831246|FG000|Untreated (Not in Safety Set)|Overall Study||1||
59712807|NCT01034163|75831247|FG001|Untreated (Not in Safety Set)|Overall Study||2||
59712808|NCT01034163|75831246|FG000|Safety Set|Overall Study||26||
59712809|NCT01034163|75831247|FG001|Safety Set|Overall Study||12||
59712810|NCT01034163|75831246|FG000|In Open Label Phase After Unblinding|Overall Study||5||
59712811|NCT01034163|75831247|FG001|In Open Label Phase After Unblinding|Overall Study||0||
59712812|NCT01034163|75831246|FG000|COMPLETED|Overall Study||0||
59712813|NCT01034163|75831247|FG001|COMPLETED|Overall Study||0||
59712814|NCT01034163|75831246|FG000|NOT COMPLETED|Overall Study||27||
59712815|NCT01034163|75831247|FG001|NOT COMPLETED|Overall Study||14||
59712816|NCT01033851|75831255|FG000|STARTED|Overall Study||48||
59712817|NCT01033851|75831256|FG001|STARTED|Overall Study||41||
59712818|NCT01033851|75831255|FG000|COMPLETED|Overall Study||45||
59712819|NCT01033851|75831256|FG001|COMPLETED|Overall Study||34||
59712820|NCT01033851|75831255|FG000|NOT COMPLETED|Overall Study||3||
59712821|NCT01033851|75831256|FG001|NOT COMPLETED|Overall Study||7||
59712822|NCT01162122|75831264|FG000|STARTED|Overall Study||3552||
59712823|NCT01162122|75831265|FG001|STARTED|Overall Study||3552||
59712824|NCT01162122|75831264|FG000|Vaccinated|Overall Study||3541||
60108390|NCT01656460|76228095|FG000|COMPLETED|Overall Study||3||
60108391|NCT01656460|76228096|FG001|COMPLETED|Overall Study||3||
59712825|NCT01162122|75831265|FG001|Vaccinated|Overall Study||3541||
59712826|NCT01162122|75831264|FG000|COMPLETED|Overall Study||3361||
59712827|NCT01162122|75831265|FG001|COMPLETED|Overall Study||3356||
60108392|NCT01656460|76228097|FG002|COMPLETED|Overall Study||3||
59712828|NCT01162122|75831264|FG000|NOT COMPLETED|Overall Study||191||
59712829|NCT01162122|75831265|FG001|NOT COMPLETED|Overall Study||196||
59712830|NCT01033071|75831277|FG000|STARTED|Overall Study||355||
59712831|NCT01033071|75831278|FG001|STARTED|Overall Study||352||
59712832|NCT01033071|75831279|FG002|STARTED|Overall Study||364||
59712833|NCT01033071|75831277|FG000|COMPLETED|Overall Study||300||
59712834|NCT01033071|75831278|FG001|COMPLETED|Overall Study||275||
59712835|NCT01033071|75831279|FG002|COMPLETED|Overall Study||317||
59712836|NCT01033071|75831277|FG000|NOT COMPLETED|Overall Study||55||
59712837|NCT01033071|75831278|FG001|NOT COMPLETED|Overall Study||77||
59712838|NCT01033071|75831279|FG002|NOT COMPLETED|Overall Study||47||
59712839|NCT01032915|75831291|FG000|STARTED|Overall Study||29||
59712840|NCT01032915|75831292|FG001|STARTED|Overall Study||31||
59712841|NCT01032915|75831293|FG002|STARTED|Overall Study||31||
59712842|NCT01032915|75831294|FG003|STARTED|Overall Study||34||
59712843|NCT01032915|75831291|FG000|COMPLETED|Overall Study||21||
59712844|NCT01032915|75831292|FG001|COMPLETED|Overall Study||20||
59712845|NCT01032915|75831293|FG002|COMPLETED|Overall Study||24||
59712846|NCT01032915|75831294|FG003|COMPLETED|Overall Study||27||
59712847|NCT01032915|75831291|FG000|NOT COMPLETED|Overall Study||8||
59712848|NCT01032915|75831292|FG001|NOT COMPLETED|Overall Study||11||
59712849|NCT01032915|75831293|FG002|NOT COMPLETED|Overall Study||7||
59712850|NCT01032915|75831294|FG003|NOT COMPLETED|Overall Study||7||
59712851|NCT01161498|75831306|FG000|STARTED|Overall Study||3||
59712852|NCT01161498|75831307|FG001|STARTED|Overall Study||2||
59712853|NCT01161498|75831306|FG000|COMPLETED|Overall Study||3||
59712854|NCT01161498|75831307|FG001|COMPLETED|Overall Study||1||
59712855|NCT01161498|75831306|FG000|NOT COMPLETED|Overall Study||0||
59712856|NCT01161498|75831307|FG001|NOT COMPLETED|Overall Study||1||
59712857|NCT01180998|75831316|FG000|STARTED|Overall Study||67||
59712858|NCT01180998|75831317|FG001|STARTED|Overall Study||72||
59712859|NCT01180998|75831318|FG002|STARTED|Overall Study||61||
59712860|NCT01180998|75831316|FG000|COMPLETED|Overall Study||63||
59712861|NCT01180998|75831317|FG001|COMPLETED|Overall Study||68||
59712862|NCT01180998|75831318|FG002|COMPLETED|Overall Study||51||
59712863|NCT01180998|75831316|FG000|NOT COMPLETED|Overall Study||4||
59712864|NCT01180998|75831317|FG001|NOT COMPLETED|Overall Study||4||
59712865|NCT01180998|75831318|FG002|NOT COMPLETED|Overall Study||10||
59712866|NCT01029795|75831329|FG000|STARTED|Overall Study||16||
59712867|NCT01029795|75831330|FG001|STARTED|Overall Study||22||
59712868|NCT01029795|75831329|FG000|COMPLETED|Overall Study||0||
59712869|NCT01029795|75831330|FG001|COMPLETED|Overall Study||0||
59712870|NCT01029795|75831329|FG000|NOT COMPLETED|Overall Study||16||
59712871|NCT01029795|75831330|FG001|NOT COMPLETED|Overall Study||22||
59712872|NCT01032837|75831340|FG000|STARTED|Overall Study||26||
59712873|NCT01032837|75831341|FG001|STARTED|Overall Study||26||
59712874|NCT01032837|75831342|FG002|STARTED|Overall Study||25||
59712875|NCT01032837|75831343|FG003|STARTED|Overall Study||25||
59712876|NCT01032837|75831340|FG000|Intent-to-Treat|Overall Study|All patients randomized who received at least one dose of study medication.|26||
59712877|NCT01032837|75831341|FG001|Intent-to-Treat|Overall Study|All patients randomized who received at least one dose of study medication.|26||
59712878|NCT01032837|75831342|FG002|Intent-to-Treat|Overall Study|All patients randomized who received at least one dose of study medication.|25||
59712879|NCT01032837|75831343|FG003|Intent-to-Treat|Overall Study|All patients randomized who received at least one dose of study medication.|24||
59712880|NCT01032837|75831340|FG000|COMPLETED|Overall Study|Represents patients who completed treatment.|26||
59712881|NCT01032837|75831341|FG001|COMPLETED|Overall Study|Represents patients who completed treatment.|23||
60108393|NCT01656460|76228098|FG003|COMPLETED|Overall Study||3||
60108394|NCT01656460|76228095|FG000|NOT COMPLETED|Overall Study||0||
60108395|NCT01656460|76228096|FG001|NOT COMPLETED|Overall Study||0||
60108396|NCT01656460|76228097|FG002|NOT COMPLETED|Overall Study||0||
59566888|NCT03847233|75669634|FG000|NOT COMPLETED|6 Month After Index Procedure||1||
59566889|NCT00552344|75669639|FG000|STARTED|Overall Study||402||
59566890|NCT00552344|75669639|FG000|COMPLETED|Overall Study||87||
59712882|NCT01032837|75831342|FG002|COMPLETED|Overall Study|Represents patients who completed treatment.|24||
59819267|NCT00507546|75941467|FG000|STARTED|Overall Study||4||
59819268|NCT00507546|75941468|FG001|STARTED|Overall Study||4||
59819269|NCT00507546|75941467|FG000|COMPLETED|Overall Study||2||
60108397|NCT01656460|76228098|FG003|NOT COMPLETED|Overall Study||0||
59712883|NCT01032837|75831343|FG003|COMPLETED|Overall Study|Represents patients who completed treatment.|22||
59712884|NCT01032837|75831340|FG000|NOT COMPLETED|Overall Study||0||
59712885|NCT01032837|75831341|FG001|NOT COMPLETED|Overall Study||3||
59712886|NCT01032837|75831342|FG002|NOT COMPLETED|Overall Study||1||
59566891|NCT00552344|75669639|FG000|NOT COMPLETED|Overall Study||315||
59566892|NCT03879603|75669650|FG000|STARTED|Overall Study||5||
59566893|NCT03879603|75669651|FG001|STARTED|Overall Study||5||
59566894|NCT03879603|75669652|FG002|STARTED|Overall Study||5||
59566895|NCT03879603|75669653|FG003|STARTED|Overall Study||5||
59566896|NCT03879603|75669654|FG004|STARTED|Overall Study||5||
59566897|NCT03879603|75669655|FG005|STARTED|Overall Study||5||
59566898|NCT03879603|75669650|FG000|Received First Product Administration|Overall Study||5||
59712887|NCT01032837|75831343|FG003|NOT COMPLETED|Overall Study||3||
59712888|NCT01180296|75831355|FG000|STARTED|Overall Study||20||
59819270|NCT00507546|75941468|FG001|COMPLETED|Overall Study||3||
59819271|NCT00507546|75941467|FG000|NOT COMPLETED|Overall Study||2||
59819272|NCT00507546|75941468|FG001|NOT COMPLETED|Overall Study||1||
59819273|NCT00567593|75941476|FG000|STARTED|Overall Study||12||
59819274|NCT00567593|75941476|FG000|COMPLETED|Overall Study||10||
59819275|NCT00567593|75941476|FG000|NOT COMPLETED|Overall Study||2||
59819276|NCT00335764|75941485|FG000|STARTED|Overall Study||17||
59819277|NCT00335764|75941486|FG001|STARTED|Overall Study||13||
59819278|NCT00335764|75941487|FG002|STARTED|Overall Study||24||
59819279|NCT00335764|75941488|FG003|STARTED|Overall Study||19||
59819280|NCT00335764|75941489|FG004|STARTED|Overall Study||19||
59819281|NCT00335764|75941485|FG000|COMPLETED|Overall Study||16||
59819282|NCT00335764|75941486|FG001|COMPLETED|Overall Study||13||
59819283|NCT00335764|75941487|FG002|COMPLETED|Overall Study||24||
59819284|NCT00335764|75941488|FG003|COMPLETED|Overall Study||19||
59819285|NCT00335764|75941489|FG004|COMPLETED|Overall Study||18||
59819286|NCT00335764|75941485|FG000|NOT COMPLETED|Overall Study||1||
59819287|NCT00335764|75941486|FG001|NOT COMPLETED|Overall Study||0||
59819288|NCT00335764|75941487|FG002|NOT COMPLETED|Overall Study||0||
59819289|NCT00335764|75941488|FG003|NOT COMPLETED|Overall Study||0||
59819290|NCT00335764|75941489|FG004|NOT COMPLETED|Overall Study||1||
59819291|NCT00567359|75941525|FG000|STARTED|Overall Study||100||
59819292|NCT00567359|75941525|FG000|COMPLETED|Overall Study||99||
59819293|NCT00567359|75941525|FG000|NOT COMPLETED|Overall Study||1||
59819294|NCT00492726|75941531|FG000|STARTED|Overall Study||410||
59819295|NCT00492726|75941532|FG001|STARTED|Overall Study||394||
59819296|NCT00492726|75941531|FG000|End of Treatment (EOT, Day 5 to 14)|Overall Study||387||
59819297|NCT00492726|75941532|FG001|End of Treatment (EOT, Day 5 to 14)|Overall Study||377||
59819298|NCT00492726|75941531|FG000|End of Study|Overall Study||360||
59819299|NCT00492726|75941532|FG001|End of Study|Overall Study||358||
59819300|NCT00492726|75941531|FG000|COMPLETED|Overall Study||360||
59819301|NCT00492726|75941532|FG001|COMPLETED|Overall Study||358||
59819302|NCT00492726|75941531|FG000|NOT COMPLETED|Overall Study||50||
59819303|NCT00492726|75941532|FG001|NOT COMPLETED|Overall Study||36||
59819304|NCT00309946|75941538|FG000|STARTED|Overall Study||51||
59819305|NCT00309946|75941538|FG000|COMPLETED|Overall Study||50||
59819306|NCT00309946|75941538|FG000|NOT COMPLETED|Overall Study||1||
59819307|NCT00492648|75941544|FG000|STARTED|Month 30 (109671 Study)||4||
59819308|NCT00492648|75941545|FG001|STARTED|Month 30 (109671 Study)||30||
59819309|NCT00492648|75941544|FG000|COMPLETED|Month 30 (109671 Study)||4||
59819310|NCT00492648|75941545|FG001|COMPLETED|Month 30 (109671 Study)||29||
59712889|NCT01180296|75831356|FG001|STARTED|Overall Study||16||
59712890|NCT01180296|75831355|FG000|COMPLETED|Overall Study||19||
59712891|NCT01180296|75831356|FG001|COMPLETED|Overall Study||14||
59712892|NCT01180296|75831355|FG000|NOT COMPLETED|Overall Study||1||
59712893|NCT01180296|75831356|FG001|NOT COMPLETED|Overall Study||2||
59712894|NCT01160640|75831366|FG000|STARTED|Overall Study||117||
59712895|NCT01160640|75831367|FG001|STARTED|Overall Study||116||
59712896|NCT01160640|75831366|FG000|COMPLETED|Overall Study||113||
59819311|NCT00492648|75941544|FG000|NOT COMPLETED|Month 30 (109671 Study)||0||
59819312|NCT00492648|75941545|FG001|NOT COMPLETED|Month 30 (109671 Study)||1||
59819313|NCT00492648|75941544|FG000|STARTED|Month 42 (109674 Study)||3||
59819314|NCT00492648|75941545|FG001|STARTED|Month 42 (109674 Study)||20||
59819315|NCT00492648|75941544|FG000|COMPLETED|Month 42 (109674 Study)||3||
59712897|NCT01160640|75831367|FG001|COMPLETED|Overall Study||110||
59819316|NCT00492648|75941545|FG001|COMPLETED|Month 42 (109674 Study)||20||
60108398|NCT01656772|76228110|FG000|STARTED|Overall Study||43||
59712898|NCT01160640|75831366|FG000|NOT COMPLETED|Overall Study||4||
59819317|NCT00492648|75941544|FG000|NOT COMPLETED|Month 42 (109674 Study)||0||
59819318|NCT00492648|75941545|FG001|NOT COMPLETED|Month 42 (109674 Study)||0||
59819319|NCT00506922|75941556|FG000|STARTED|Overall Study||37||
59819320|NCT00506922|75941557|FG001|STARTED|Overall Study||10||
59819321|NCT00506922|75941558|FG002|STARTED|Overall Study||29||
59819322|NCT00506922|75941559|FG003|STARTED|Overall Study||63||
59819323|NCT00506922|75941560|FG004|STARTED|Overall Study||11||
59819324|NCT00506922|75941556|FG000|COMPLETED|Overall Study||37||
59819325|NCT00506922|75941557|FG001|COMPLETED|Overall Study||10||
59819326|NCT00506922|75941558|FG002|COMPLETED|Overall Study||29||
59819327|NCT00506922|75941559|FG003|COMPLETED|Overall Study||61||
59819328|NCT00506922|75941560|FG004|COMPLETED|Overall Study||10||
59566899|NCT03879603|75669651|FG001|Received First Product Administration|Overall Study||5||
59712899|NCT01160640|75831367|FG001|NOT COMPLETED|Overall Study||6||
59712900|NCT01160484|75831375|FG000|STARTED|Overall Study||40||
59712901|NCT01160484|75831375|FG000|COMPLETED|Overall Study||22||
59712902|NCT01160484|75831375|FG000|NOT COMPLETED|Overall Study||18||
59712903|NCT01032291|75831382|FG000|STARTED|Safety Lead-in||8||
59712904|NCT01032291|75831383|FG001|STARTED|Safety Lead-in||0||
59712905|NCT01032291|75831384|FG002|STARTED|Safety Lead-in||0||
59712906|NCT01032291|75831382|FG000|COMPLETED|Safety Lead-in|Participants with disease progression|6||
59712907|NCT01032291|75831383|FG001|COMPLETED|Safety Lead-in||0||
59712908|NCT01032291|75831384|FG002|COMPLETED|Safety Lead-in||0||
59712909|NCT01032291|75831382|FG000|NOT COMPLETED|Safety Lead-in||2||
59712910|NCT01032291|75831383|FG001|NOT COMPLETED|Safety Lead-in||0||
59712911|NCT01032291|75831384|FG002|NOT COMPLETED|Safety Lead-in||0||
59712912|NCT01032291|75831382|FG000|STARTED|Proof of Concept||0||
59819329|NCT00506922|75941556|FG000|NOT COMPLETED|Overall Study||0||
60108399|NCT01656772|76228111|FG001|STARTED|Overall Study||77||
59712913|NCT01032291|75831383|FG001|STARTED|Proof of Concept||22||
59712914|NCT01032291|75831384|FG002|STARTED|Proof of Concept||21||
59712915|NCT01032291|75831382|FG000|Intent to Treat and Safety Populations|Proof of Concept||0||
59712916|NCT01032291|75831383|FG001|Intent to Treat and Safety Populations|Proof of Concept|Participants who took at least one dose of study drug|21||
59712917|NCT01032291|75831384|FG002|Intent to Treat and Safety Populations|Proof of Concept|Participants who took at least one dose of study drug|21||
59712918|NCT01032291|75831382|FG000|COMPLETED|Proof of Concept||0||
59712919|NCT01032291|75831383|FG001|COMPLETED|Proof of Concept|Participants with disease progression|14||
59712920|NCT01032291|75831384|FG002|COMPLETED|Proof of Concept|Participants with disease progression|18||
59712921|NCT01032291|75831382|FG000|NOT COMPLETED|Proof of Concept||0||
59712922|NCT01032291|75831383|FG001|NOT COMPLETED|Proof of Concept||8||
59712923|NCT01032291|75831384|FG002|NOT COMPLETED|Proof of Concept||3||
59712924|NCT01159938|75831398|FG000|STARTED|First Study Period||26||
59712925|NCT01159938|75831399|FG001|STARTED|First Study Period||11||
59712926|NCT01159938|75831400|FG002|STARTED|First Study Period||11||
59712927|NCT01159938|75831401|FG003|STARTED|First Study Period||12||
59712928|NCT01159938|75831402|FG004|STARTED|First Study Period||12||
59712929|NCT01159938|75831398|FG000|Received at Least 1 Dose of Study Drug|First Study Period||0||
59712930|NCT01159938|75831399|FG001|Received at Least 1 Dose of Study Drug|First Study Period||11||
59712931|NCT01159938|75831400|FG002|Received at Least 1 Dose of Study Drug|First Study Period||11||
59712932|NCT01159938|75831401|FG003|Received at Least 1 Dose of Study Drug|First Study Period||12||
59712933|NCT01159938|75831402|FG004|Received at Least 1 Dose of Study Drug|First Study Period||12||
59712934|NCT01159938|75831398|FG000|Safety and Efficacy Analysis Population|First Study Period|One healthy participant completed study but was excluded from analyses (major protocol violation).|25||
59712935|NCT01159938|75831399|FG001|Safety and Efficacy Analysis Population|First Study Period||11||
59712936|NCT01159938|75831400|FG002|Safety and Efficacy Analysis Population|First Study Period|Microalbuminuria relaxed with protocol amendment. T2DM albuminuria participant included in analyses.|11||
59712937|NCT01159938|75831401|FG003|Safety and Efficacy Analysis Population|First Study Period||12||
59712938|NCT01159938|75831402|FG004|Safety and Efficacy Analysis Population|First Study Period||12||
59712939|NCT01159938|75831398|FG000|COMPLETED|First Study Period||26||
59712940|NCT01159938|75831399|FG001|COMPLETED|First Study Period||11||
59712941|NCT01159938|75831400|FG002|COMPLETED|First Study Period||10||
59712942|NCT01159938|75831401|FG003|COMPLETED|First Study Period||12||
59712943|NCT01159938|75831402|FG004|COMPLETED|First Study Period||12||
59712944|NCT01159938|75831398|FG000|NOT COMPLETED|First Study Period||0||
59712945|NCT01159938|75831399|FG001|NOT COMPLETED|First Study Period||0||
59712946|NCT01159938|75831400|FG002|NOT COMPLETED|First Study Period||1||
59712947|NCT01159938|75831401|FG003|NOT COMPLETED|First Study Period||0||
59712948|NCT01159938|75831402|FG004|NOT COMPLETED|First Study Period||0||
59712949|NCT01159938|75831398|FG000|STARTED|Second Study Period||0||
59712950|NCT01159938|75831399|FG001|STARTED|Second Study Period||11||
59712951|NCT01159938|75831400|FG002|STARTED|Second Study Period||10||
59712952|NCT01159938|75831401|FG003|STARTED|Second Study Period||12||
59712953|NCT01159938|75831402|FG004|STARTED|Second Study Period||12||
59712954|NCT01159938|75831398|FG000|COMPLETED|Second Study Period||0||
59712955|NCT01159938|75831399|FG001|COMPLETED|Second Study Period||11||
59712956|NCT01159938|75831400|FG002|COMPLETED|Second Study Period||10||
59712957|NCT01159938|75831401|FG003|COMPLETED|Second Study Period||12||
59712958|NCT01159938|75831402|FG004|COMPLETED|Second Study Period||12||
59712959|NCT01159938|75831398|FG000|NOT COMPLETED|Second Study Period||0||
59712960|NCT01159938|75831399|FG001|NOT COMPLETED|Second Study Period||0||
59712961|NCT01159938|75831400|FG002|NOT COMPLETED|Second Study Period||0||
59819330|NCT00506922|75941557|FG001|NOT COMPLETED|Overall Study||0||
60108400|NCT01656772|76228110|FG000|COMPLETED|Overall Study||43||
59819331|NCT00506922|75941558|FG002|NOT COMPLETED|Overall Study||0||
60108401|NCT01656772|76228111|FG001|COMPLETED|Overall Study||77||
59712962|NCT01159938|75831401|FG003|NOT COMPLETED|Second Study Period||0||
59712963|NCT01159938|75831402|FG004|NOT COMPLETED|Second Study Period||0||
59712964|NCT01029405|75831427|FG000|STARTED|Overall Study||36||
59712965|NCT01029405|75831428|FG001|STARTED|Overall Study||37||
59712966|NCT01029405|75831429|FG002|STARTED|Overall Study||35||
59712967|NCT01029405|75831430|FG003|STARTED|Overall Study||37||
59712968|NCT01029405|75831427|FG000|COMPLETED|Overall Study||34||
59712969|NCT01029405|75831428|FG001|COMPLETED|Overall Study||34||
59712970|NCT01029405|75831429|FG002|COMPLETED|Overall Study||31||
59712971|NCT01029405|75831430|FG003|COMPLETED|Overall Study||32||
59712972|NCT01029405|75831427|FG000|NOT COMPLETED|Overall Study||2||
59712973|NCT01029405|75831428|FG001|NOT COMPLETED|Overall Study||3||
59712974|NCT01029405|75831429|FG002|NOT COMPLETED|Overall Study||4||
59712975|NCT01029405|75831430|FG003|NOT COMPLETED|Overall Study||5||
59712976|NCT01021683|75831440|FG000|STARTED|Overall Study||203||
59712977|NCT01021683|75831440|FG000|COMPLETED|Overall Study||132||
59712978|NCT01021683|75831440|FG000|NOT COMPLETED|Overall Study||71||
59712979|NCT01021293|75831446|FG000|STARTED|Overall Study||550||
59712980|NCT01021293|75831447|FG001|STARTED|Overall Study||550||
59712981|NCT01021293|75831446|FG000|COMPLETED|Overall Study||538||
59712982|NCT01021293|75831447|FG001|COMPLETED|Overall Study||526||
59712983|NCT01021293|75831446|FG000|NOT COMPLETED|Overall Study||12||
59712984|NCT01021293|75831447|FG001|NOT COMPLETED|Overall Study||24||
59712985|NCT04625725|75831456|FG000|STARTED|Overall Study||3500|Randomized|
59712986|NCT04625725|75831457|FG001|STARTED|Overall Study||1754|Randomized|
59712987|NCT04625725|75831456|FG000|COMPLETED|Overall Study||0|Ongoing study|
59712988|NCT04625725|75831457|FG001|COMPLETED|Overall Study||0|Ongoing study|
59712989|NCT04625725|75831456|FG000|NOT COMPLETED|Overall Study||3500||
59712990|NCT04625725|75831457|FG001|NOT COMPLETED|Overall Study||1754||
59712991|NCT01021215|75831465|FG000|STARTED|Overall Study||60||
59712992|NCT01021215|75831466|FG001|STARTED|Overall Study||20||
59712993|NCT01021215|75831465|FG000|Received Allocated Intervention|Overall Study||60||
59712994|NCT01021215|75831466|FG001|Received Allocated Intervention|Overall Study||20||
59712995|NCT01021215|75831465|FG000|COMPLETED|Overall Study||57||
59712996|NCT01021215|75831466|FG001|COMPLETED|Overall Study||20||
59712997|NCT01021215|75831465|FG000|NOT COMPLETED|Overall Study||3||
59712998|NCT01021215|75831466|FG001|NOT COMPLETED|Overall Study||0||
59712999|NCT01021137|75831476|FG000|STARTED|Overall Study||62||
59713000|NCT01021137|75831477|FG001|STARTED|Overall Study||20||
59713001|NCT01021137|75831478|FG002|STARTED|Overall Study||11||
59713002|NCT01021137|75831479|FG003|STARTED|Overall Study||41||
59713003|NCT01021137|75831476|FG000|COMPLETED|Overall Study||52||
59713004|NCT01021137|75831477|FG001|COMPLETED|Overall Study||16||
59713005|NCT01021137|75831478|FG002|COMPLETED|Overall Study||9||
59713006|NCT01021137|75831479|FG003|COMPLETED|Overall Study||32||
59713007|NCT01021137|75831476|FG000|NOT COMPLETED|Overall Study||10||
59713008|NCT01021137|75831477|FG001|NOT COMPLETED|Overall Study||4||
59713009|NCT01021137|75831478|FG002|NOT COMPLETED|Overall Study||2||
59713010|NCT01021137|75831479|FG003|NOT COMPLETED|Overall Study||9||
59713011|NCT01020981|75831492|FG000|STARTED|Overall Study||150||
59713012|NCT01020981|75831493|FG001|STARTED|Overall Study||150||
59713013|NCT01020981|75831492|FG000|COMPLETED|Overall Study||66||
59713014|NCT01020981|75831493|FG001|COMPLETED|Overall Study||60||
59713015|NCT01020981|75831492|FG000|NOT COMPLETED|Overall Study||84||
59713016|NCT01020981|75831493|FG001|NOT COMPLETED|Overall Study||90||
59713017|NCT01020747|75831501|FG000|STARTED|Overall Study||20||
59713018|NCT01020747|75831501|FG000|COMPLETED|Overall Study||19||
59713019|NCT01020747|75831501|FG000|NOT COMPLETED|Overall Study||1||
59713020|NCT01020435|75831508|FG000|STARTED|Overall Study||24||
59713021|NCT01020435|75831509|FG001|STARTED|Overall Study||27||
59713022|NCT01020435|75831508|FG000|COMPLETED|Overall Study||24||
59819332|NCT00506922|75941559|FG003|NOT COMPLETED|Overall Study||2||
59819333|NCT00506922|75941560|FG004|NOT COMPLETED|Overall Study||1||
60108402|NCT01656772|76228110|FG000|NOT COMPLETED|Overall Study||0||
60108403|NCT01656772|76228111|FG001|NOT COMPLETED|Overall Study||0||
60108404|NCT01816295|76228119|FG000|STARTED|Double Blind Phase||357||
59566900|NCT03879603|75669652|FG002|Received First Product Administration|Overall Study||5||
59713023|NCT01020435|75831509|FG001|COMPLETED|Overall Study||26||
60108405|NCT01816295|76228120|FG001|STARTED|Double Blind Phase||358||
59713024|NCT01020435|75831508|FG000|NOT COMPLETED|Overall Study||0||
59713025|NCT01020435|75831509|FG001|NOT COMPLETED|Overall Study||1||
59713026|NCT01031979|75831518|FG000|STARTED|Overall Study|To meet eligibility requirements for randomization, subjects had to reach session 3 w/o dropping.|14||
59713027|NCT01031979|75831519|FG001|STARTED|Overall Study|To meet eligibility requirements for randomization, subjects had to reach session 3 w/o dropping.|12||
59713028|NCT01031979|75831518|FG000|Completed Primary Outcome Measure|Overall Study||12||
59713029|NCT01031979|75831519|FG001|Completed Primary Outcome Measure|Overall Study||12||
59713030|NCT01031979|75831518|FG000|COMPLETED|Overall Study|These are individuals who completed treatment in the study.|9||
59713031|NCT01031979|75831519|FG001|COMPLETED|Overall Study|These are individuals who completed treatment in the study.|8||
59713032|NCT01031979|75831518|FG000|NOT COMPLETED|Overall Study||5||
59819334|NCT00492024|75941570|FG000|STARTED|Treatment||251||
59819335|NCT00492024|75941571|FG001|STARTED|Treatment||123||
59713033|NCT01031979|75831519|FG001|NOT COMPLETED|Overall Study||4||
59713034|NCT01020123|75831532|FG000|STARTED|Main Period||93||
59713035|NCT01020123|75831533|FG001|STARTED|Main Period||91||
59713036|NCT01020123|75831534|FG002|STARTED|Main Period||52||
59713037|NCT01020123|75831535|FG003|STARTED|Main Period||40||
59713038|NCT01020123|75831536|FG004|STARTED|Main Period||88||
59713039|NCT01020123|75831537|FG005|STARTED|Main Period||94||
59819336|NCT00492024|75941570|FG000|COMPLETED|Treatment||222||
59819337|NCT00492024|75941571|FG001|COMPLETED|Treatment||101||
59819338|NCT00492024|75941570|FG000|NOT COMPLETED|Treatment||29||
59819339|NCT00492024|75941571|FG001|NOT COMPLETED|Treatment||22||
59819340|NCT00492024|75941570|FG000|STARTED|Follow up||222||
59819341|NCT00492024|75941571|FG001|STARTED|Follow up||101||
59819342|NCT00492024|75941570|FG000|COMPLETED|Follow up||221||
59819343|NCT00492024|75941571|FG001|COMPLETED|Follow up||99||
59819344|NCT00492024|75941570|FG000|NOT COMPLETED|Follow up||1||
59819345|NCT00492024|75941571|FG001|NOT COMPLETED|Follow up||2||
59819346|NCT00491556|75941579|FG000|STARTED|Entry-Week (WK) 48: EXP/Standard Care||75||
59819347|NCT00491556|75941580|FG001|STARTED|Entry-Week (WK) 48: EXP/Standard Care||27||
59819348|NCT00491556|75941579|FG000|Wk 24 VL Suppressed (EXP)/WK 24 (STAND)|Entry-Week (WK) 48: EXP/Standard Care||53||
59819349|NCT00491556|75941580|FG001|Wk 24 VL Suppressed (EXP)/WK 24 (STAND)|Entry-Week (WK) 48: EXP/Standard Care||27||
59819350|NCT00491556|75941579|FG000|COMPLETED|Entry-Week (WK) 48: EXP/Standard Care||49||
59819351|NCT00491556|75941580|FG001|COMPLETED|Entry-Week (WK) 48: EXP/Standard Care||27||
59819352|NCT00491556|75941579|FG000|NOT COMPLETED|Entry-Week (WK) 48: EXP/Standard Care||26||
59819353|NCT00491556|75941580|FG001|NOT COMPLETED|Entry-Week (WK) 48: EXP/Standard Care||0||
59819354|NCT00491556|75941579|FG000|STARTED|Wk 48-152: EXP (On De-Int)/Standard Care||49||
59819355|NCT00491556|75941580|FG001|STARTED|Wk 48-152: EXP (On De-Int)/Standard Care||27||
59819356|NCT00491556|75941579|FG000|COMPLETED|Wk 48-152: EXP (On De-Int)/Standard Care||25||
59819357|NCT00491556|75941580|FG001|COMPLETED|Wk 48-152: EXP (On De-Int)/Standard Care||22||
59819358|NCT00491556|75941579|FG000|NOT COMPLETED|Wk 48-152: EXP (On De-Int)/Standard Care||24||
59819359|NCT00491556|75941580|FG001|NOT COMPLETED|Wk 48-152: EXP (On De-Int)/Standard Care||5||
59819360|NCT00506454|75941588|FG000|STARTED|Overall Study||11||
59819361|NCT00506454|75941589|FG001|STARTED|Overall Study||11||
59819362|NCT00506454|75941588|FG000|COMPLETED|Overall Study||10||
59819363|NCT00506454|75941589|FG001|COMPLETED|Overall Study||10||
59819364|NCT00506454|75941588|FG000|NOT COMPLETED|Overall Study||1||
59819365|NCT00506454|75941589|FG001|NOT COMPLETED|Overall Study||1||
59819366|NCT00485472|75941597|FG000|STARTED|Overall Study||73||
59819367|NCT00485472|75941598|FG001|STARTED|Overall Study||76||
59819368|NCT00485472|75941597|FG000|Entered Maintenance Phase|Overall Study||65||
59819369|NCT00485472|75941598|FG001|Entered Maintenance Phase|Overall Study||67||
59819370|NCT00485472|75941597|FG000|COMPLETED|Overall Study||57||
59819371|NCT00485472|75941598|FG001|COMPLETED|Overall Study||64||
59819372|NCT00485472|75941597|FG000|NOT COMPLETED|Overall Study||16||
59819373|NCT00485472|75941598|FG001|NOT COMPLETED|Overall Study||12||
59819374|NCT00491400|75941606|FG000|STARTED|Overall Study||15||
59819375|NCT00491400|75941607|FG001|STARTED|Overall Study||13||
59819376|NCT00491400|75941606|FG000|Started First Treatment|Overall Study|1 withdrew prior to starting fenofibrate|14||
59819377|NCT00491400|75941607|FG001|Started First Treatment|Overall Study|None withdrew prior to starting atorvastatin|13||
59819378|NCT00491400|75941606|FG000|Completed First Treatment|Overall Study|None withdrew during fenofibrate treatment (first treatment)|14||
59819379|NCT00491400|75941607|FG001|Completed First Treatment|Overall Study|4 withdrew during atorvastatin treatment (first treatment)|9||
59819380|NCT00491400|75941606|FG000|Started Second Treatment|Overall Study|2 withdrew during washout period|12||
59819381|NCT00491400|75941607|FG001|Started Second Treatment|Overall Study|None withdrew during the washout period|9||
59819382|NCT00491400|75941606|FG000|Finished Second Treatment|Overall Study|2 withdrew during atorvastatin treatment (second treatment)|10||
59819383|NCT00491400|75941607|FG001|Finished Second Treatment|Overall Study|None withdrew during fenofibrate treatment (second treatment)|9||
59819384|NCT00491400|75941606|FG000|COMPLETED|Overall Study||10||
59819385|NCT00491400|75941607|FG001|COMPLETED|Overall Study||9||
59819386|NCT00491400|75941606|FG000|NOT COMPLETED|Overall Study||5||
59819387|NCT00491400|75941607|FG001|NOT COMPLETED|Overall Study||4||
59819388|NCT00491322|75941617|FG000|STARTED|Overall Study||41||
59819389|NCT00491322|75941618|FG001|STARTED|Overall Study||51||
59819390|NCT00491322|75941617|FG000|COMPLETED|Overall Study||40||
59819391|NCT00491322|75941618|FG001|COMPLETED|Overall Study||50||
59819392|NCT00491322|75941617|FG000|NOT COMPLETED|Overall Study||1||
59819393|NCT00491322|75941618|FG001|NOT COMPLETED|Overall Study||1||
59819394|NCT00502320|75941626|FG000|STARTED|Overall Study||25||
59819395|NCT00502320|75941627|FG001|STARTED|Overall Study||25||
60108406|NCT01816295|76228119|FG000|Received Study Drug|Double Blind Phase||356||
59819396|NCT00502320|75941626|FG000|Screening Visit|Overall Study||25||
59819397|NCT00502320|75941627|FG001|Screening Visit|Overall Study|Participant signed informed consent but was a screen failure because she was nursing at the time.|24||
59819398|NCT00502320|75941626|FG000|COMPLETED|Overall Study||19||
59819399|NCT00502320|75941627|FG001|COMPLETED|Overall Study||18||
59819400|NCT00502320|75941626|FG000|NOT COMPLETED|Overall Study||6||
59819401|NCT00502320|75941627|FG001|NOT COMPLETED|Overall Study||7||
59819402|NCT02567825|75941635|FG000|STARTED|Overall Study||129||
59819403|NCT02567825|75941636|FG001|STARTED|Overall Study||121||
59819404|NCT02567825|75941635|FG000|COMPLETED|Overall Study||108||
59819405|NCT02567825|75941636|FG001|COMPLETED|Overall Study||100||
60108407|NCT01816295|76228120|FG001|Received Study Drug|Double Blind Phase||354||
60108408|NCT01816295|76228119|FG000|COMPLETED|Double Blind Phase||294||
59819406|NCT02567825|75941635|FG000|NOT COMPLETED|Overall Study||21||
59819407|NCT02567825|75941636|FG001|NOT COMPLETED|Overall Study||21||
59819408|NCT00490776|75941642|FG000|STARTED|Overall Study||9||
59819409|NCT00490776|75941642|FG000|COMPLETED|Overall Study||0||
59819410|NCT00490776|75941642|FG000|NOT COMPLETED|Overall Study||9||
59819411|NCT00566735|75941648|FG000|STARTED|Overall Study||20||
59819412|NCT00566735|75941649|FG001|STARTED|Overall Study||19||
59819413|NCT00566735|75941648|FG000|Withdrew Before Baseline Measures|Overall Study||2||
59819414|NCT00566735|75941649|FG001|Withdrew Before Baseline Measures|Overall Study||7||
59819415|NCT00566735|75941648|FG000|COMPLETED|Overall Study|2 participants withdrew before baselines. Therefore, 18 participants will be included in baselines.|18||
59819416|NCT00566735|75941649|FG001|COMPLETED|Overall Study|7 participants withdrew before baselines. Therefore, 12 participants will be included in baselines.|12||
59819417|NCT00566735|75941648|FG000|NOT COMPLETED|Overall Study||2||
59819418|NCT00566735|75941649|FG001|NOT COMPLETED|Overall Study||7||
59819419|NCT00566111|75941657|FG000|STARTED|Overall Study||2||
59819420|NCT00566111|75941658|FG001|STARTED|Overall Study||3||
59819421|NCT00566111|75941657|FG000|COMPLETED|Overall Study||2||
59819422|NCT00566111|75941658|FG001|COMPLETED|Overall Study||1||
59819423|NCT00566111|75941657|FG000|NOT COMPLETED|Overall Study||0||
59819424|NCT00566111|75941658|FG001|NOT COMPLETED|Overall Study||2||
59819425|NCT00514046|75941673|FG000|STARTED|Overall Study||5||
59819426|NCT00514046|75941674|FG001|STARTED|Overall Study||1||
59819427|NCT00514046|75941675|FG002|STARTED|Overall Study||5||
59819428|NCT00514046|75941676|FG003|STARTED|Overall Study||1||
59819429|NCT00514046|75941677|FG004|STARTED|Overall Study||1||
59819430|NCT00514046|75941678|FG005|STARTED|Overall Study||1||
59819431|NCT00514046|75941679|FG006|STARTED|Overall Study||1||
59819432|NCT00514046|75941680|FG007|STARTED|Overall Study||1||
59819433|NCT00514046|75941681|FG008|STARTED|Overall Study||1||
59819434|NCT00514046|75941673|FG000|COMPLETED|Overall Study||2||
59819435|NCT00514046|75941674|FG001|COMPLETED|Overall Study||0||
59819436|NCT00514046|75941675|FG002|COMPLETED|Overall Study||0||
59819437|NCT00514046|75941676|FG003|COMPLETED|Overall Study||1||
59819438|NCT00514046|75941677|FG004|COMPLETED|Overall Study||0||
59819439|NCT00514046|75941678|FG005|COMPLETED|Overall Study||0||
59819440|NCT00514046|75941679|FG006|COMPLETED|Overall Study||1||
59819441|NCT00514046|75941680|FG007|COMPLETED|Overall Study||0||
59819442|NCT00514046|75941681|FG008|COMPLETED|Overall Study||0||
59819443|NCT00514046|75941673|FG000|NOT COMPLETED|Overall Study||3||
59819444|NCT00514046|75941674|FG001|NOT COMPLETED|Overall Study||1||
59819445|NCT00514046|75941675|FG002|NOT COMPLETED|Overall Study||5||
59819446|NCT00514046|75941676|FG003|NOT COMPLETED|Overall Study||0||
59819447|NCT00514046|75941677|FG004|NOT COMPLETED|Overall Study||1||
59819448|NCT00514046|75941678|FG005|NOT COMPLETED|Overall Study||1||
59819449|NCT00514046|75941679|FG006|NOT COMPLETED|Overall Study||0||
59819450|NCT00514046|75941680|FG007|NOT COMPLETED|Overall Study||1||
59819451|NCT00514046|75941681|FG008|NOT COMPLETED|Overall Study||1||
59819452|NCT00564629|75941705|FG000|STARTED|Overall Study||51||
59819453|NCT00564629|75941706|FG001|STARTED|Overall Study||54||
59819454|NCT00564629|75941705|FG000|COMPLETED|Overall Study||36||
59819455|NCT00564629|75941706|FG001|COMPLETED|Overall Study||45||
59819456|NCT00564629|75941705|FG000|NOT COMPLETED|Overall Study||15||
59819457|NCT00564629|75941706|FG001|NOT COMPLETED|Overall Study||9||
59713040|NCT01020123|75831538|FG006|STARTED|Main Period||72||
59713041|NCT01020123|75831532|FG000|COMPLETED|Main Period||76||
59713042|NCT01020123|75831533|FG001|COMPLETED|Main Period||77||
59819458|NCT00564395|75941712|FG000|STARTED|First Intervention (10 Days)||9||
59819459|NCT00564395|75941713|FG001|STARTED|First Intervention (10 Days)||9||
59819460|NCT00564395|75941712|FG000|Received Intervention|First Intervention (10 Days)||7||
59819461|NCT00564395|75941713|FG001|Received Intervention|First Intervention (10 Days)||7||
59819462|NCT00564395|75941712|FG000|COMPLETED|First Intervention (10 Days)||7||
59819463|NCT00564395|75941713|FG001|COMPLETED|First Intervention (10 Days)||7||
59819464|NCT00564395|75941712|FG000|NOT COMPLETED|First Intervention (10 Days)||2||
59819465|NCT00564395|75941713|FG001|NOT COMPLETED|First Intervention (10 Days)||2||
59819466|NCT00564395|75941712|FG000|STARTED|Second Intervention (10 Days)||7||
60108409|NCT01816295|76228120|FG001|COMPLETED|Double Blind Phase||302||
60108410|NCT01816295|76228119|FG000|NOT COMPLETED|Double Blind Phase||63||
59819467|NCT00564395|75941713|FG001|STARTED|Second Intervention (10 Days)||7||
60108411|NCT01816295|76228120|FG001|NOT COMPLETED|Double Blind Phase||56||
60108412|NCT01816295|76228119|FG000|STARTED|OLE Phase|Participants who completed the DBP and still met eligibility criteria had option to enroll in OLE.|275||
60108413|NCT01816295|76228120|FG001|STARTED|OLE Phase|Participants who completed the DBP and still met eligibility criteria had option to enroll in OLE.|283||
60108414|NCT01816295|76228119|FG000|COMPLETED|OLE Phase||222||
60108415|NCT01816295|76228120|FG001|COMPLETED|OLE Phase||227||
59713043|NCT01020123|75831534|FG002|COMPLETED|Main Period||44||
59819468|NCT00564395|75941712|FG000|COMPLETED|Second Intervention (10 Days)||7||
59713044|NCT01020123|75831535|FG003|COMPLETED|Main Period||33||
59713045|NCT01020123|75831536|FG004|COMPLETED|Main Period||77||
59713046|NCT01020123|75831537|FG005|COMPLETED|Main Period||83||
59819469|NCT00564395|75941713|FG001|COMPLETED|Second Intervention (10 Days)||7||
59713047|NCT01020123|75831538|FG006|COMPLETED|Main Period||61||
59713048|NCT01020123|75831532|FG000|NOT COMPLETED|Main Period||17||
59713049|NCT01020123|75831533|FG001|NOT COMPLETED|Main Period||14||
59819470|NCT00564395|75941712|FG000|NOT COMPLETED|Second Intervention (10 Days)||0||
59819471|NCT00564395|75941713|FG001|NOT COMPLETED|Second Intervention (10 Days)||0||
59819472|NCT00502242|75941721|FG000|STARTED|Overall Study||155||
59819473|NCT00502242|75941722|FG001|STARTED|Overall Study||140||
59819474|NCT00502242|75941721|FG000|COMPLETED|Overall Study||104||
59819475|NCT00502242|75941722|FG001|COMPLETED|Overall Study||84||
59819476|NCT00502242|75941721|FG000|NOT COMPLETED|Overall Study||51||
59819477|NCT00502242|75941722|FG001|NOT COMPLETED|Overall Study||56||
59819478|NCT03045653|75941728|FG000|STARTED|Overall Study||30||
59819479|NCT03045653|75941728|FG000|COMPLETED|Overall Study||30||
59819480|NCT03045653|75941728|FG000|NOT COMPLETED|Overall Study||0||
59819481|NCT03972137|75941732|FG000|STARTED|Overall Study||10||
59819482|NCT03972137|75941732|FG000|Enrolled|Overall Study||10||
59819483|NCT03972137|75941732|FG000|Treatment Completed|Overall Study||6||
59819484|NCT03972137|75941732|FG000|Follow-up Completed|Overall Study||4||
59819485|NCT03972137|75941732|FG000|COMPLETED|Overall Study||4||
59819486|NCT03972137|75941732|FG000|NOT COMPLETED|Overall Study||6||
59819487|NCT00490698|75941748|FG000|STARTED|Overall Study||11||
59819488|NCT00490698|75941748|FG000|COMPLETED|Overall Study||1||
59819489|NCT00490698|75941748|FG000|NOT COMPLETED|Overall Study||10||
59819490|NCT03855228|75941756|FG000|STARTED|Overall Study||169||
59819491|NCT03855228|75941757|FG001|STARTED|Overall Study||176||
59819492|NCT03855228|75941758|FG002|STARTED|Overall Study||182||
59819493|NCT03855228|75941759|FG003|STARTED|Overall Study||177||
59819494|NCT03855228|75941756|FG000|Treated|Overall Study||169||
59819495|NCT03855228|75941757|FG001|Treated|Overall Study||176||
59819496|NCT03855228|75941758|FG002|Treated|Overall Study|1 participant immediately dropped out prior to starting study intervention.|181||
59819497|NCT03855228|75941759|FG003|Treated|Overall Study|1 participant immediately dropped out prior to starting study intervention.|176||
59819498|NCT03855228|75941756|FG000|COMPLETED|Overall Study||166||
59819499|NCT03855228|75941757|FG001|COMPLETED|Overall Study||167||
59819500|NCT03855228|75941758|FG002|COMPLETED|Overall Study||174||
59819501|NCT03855228|75941759|FG003|COMPLETED|Overall Study||158||
59819502|NCT03855228|75941756|FG000|NOT COMPLETED|Overall Study||3||
59819503|NCT03855228|75941757|FG001|NOT COMPLETED|Overall Study||9||
59819504|NCT03855228|75941758|FG002|NOT COMPLETED|Overall Study||8||
59819505|NCT03855228|75941759|FG003|NOT COMPLETED|Overall Study||19||
59996284|NCT02719171|76112246|FG001|NOT COMPLETED|Overall Study||4||
59996285|NCT02719171|76112247|FG002|NOT COMPLETED|Overall Study||3||
59996286|NCT02719171|76112248|FG003|NOT COMPLETED|Overall Study||2||
59996287|NCT02719171|76112249|FG004|NOT COMPLETED|Overall Study||2||
59996288|NCT02718625|76112266|FG000|STARTED|Overall Study||1||
59996289|NCT02718625|76112267|FG001|STARTED|Overall Study||2||
59996290|NCT02718625|76112266|FG000|COMPLETED|Overall Study||1||
59996291|NCT02718625|76112267|FG001|COMPLETED|Overall Study||0||
60108416|NCT01816295|76228119|FG000|NOT COMPLETED|OLE Phase||53||
60108417|NCT01816295|76228120|FG001|NOT COMPLETED|OLE Phase||56||
60108418|NCT01659268|76228129|FG000|STARTED|Overall Study||9||
60108419|NCT01659268|76228130|FG001|STARTED|Overall Study||8||
60108420|NCT01659268|76228129|FG000|COMPLETED|Overall Study||9||
60108421|NCT01659268|76228130|FG001|COMPLETED|Overall Study||8||
59996292|NCT02718625|76112266|FG000|NOT COMPLETED|Overall Study||0||
59996293|NCT02718625|76112267|FG001|NOT COMPLETED|Overall Study||2||
59996294|NCT02716987|76112279|FG000|STARTED|Overall Study||4||
59996295|NCT02716987|76112280|FG001|STARTED|Overall Study||2||
59996296|NCT02716987|76112281|FG002|STARTED|Overall Study||5||
59996297|NCT02716987|76112282|FG003|STARTED|Overall Study||2||
59996298|NCT02716987|76112283|FG004|STARTED|Overall Study||6||
59996299|NCT02716987|76112284|FG005|STARTED|Overall Study||1||
59996300|NCT02716987|76112279|FG000|COMPLETED|Overall Study||4||
59996301|NCT02716987|76112280|FG001|COMPLETED|Overall Study||2||
59996302|NCT02716987|76112281|FG002|COMPLETED|Overall Study||4||
59996303|NCT02716987|76112282|FG003|COMPLETED|Overall Study||2||
59996304|NCT02716987|76112283|FG004|COMPLETED|Overall Study||5||
59996305|NCT02716987|76112284|FG005|COMPLETED|Overall Study||0||
59996306|NCT02716987|76112279|FG000|NOT COMPLETED|Overall Study||0||
59996307|NCT02716987|76112280|FG001|NOT COMPLETED|Overall Study||0||
59996308|NCT02716987|76112281|FG002|NOT COMPLETED|Overall Study||1||
59996309|NCT02716987|76112282|FG003|NOT COMPLETED|Overall Study||0||
59996310|NCT02716987|76112283|FG004|NOT COMPLETED|Overall Study||1||
59996311|NCT02716987|76112284|FG005|NOT COMPLETED|Overall Study||1||
59996312|NCT00701779|76112309|FG000|STARTED|Overall Study||63||
59996313|NCT00701779|76112309|FG000|3 Month|Overall Study||60||
59996314|NCT00701779|76112309|FG000|6 Month|Overall Study||58||
59996315|NCT00701779|76112309|FG000|9 Month|Overall Study||56||
59996316|NCT00701779|76112309|FG000|12 Month|Overall Study||54||
59996317|NCT00701779|76112309|FG000|COMPLETED|Overall Study||54||
59996318|NCT00701779|76112309|FG000|NOT COMPLETED|Overall Study||9||
59996319|NCT04150861|76112316|FG000|STARTED|Overall Study||8||
59996320|NCT04150861|76112317|FG001|STARTED|Overall Study||8||
59996321|NCT04150861|76112318|FG002|STARTED|Overall Study||8||
60108422|NCT01659268|76228129|FG000|NOT COMPLETED|Overall Study||0||
60108423|NCT01659268|76228130|FG001|NOT COMPLETED|Overall Study||0||
60108424|NCT01704196|76228138|FG000|STARTED|Overall Study||90||
59996322|NCT04150861|76112316|FG000|COMPLETED|Overall Study||8||
60108425|NCT01704196|76228139|FG001|STARTED|Overall Study||89||
60108426|NCT01704196|76228138|FG000|COMPLETED|Overall Study||71||
59566901|NCT03879603|75669653|FG003|Received First Product Administration|Overall Study||5||
59566902|NCT03879603|75669654|FG004|Received First Product Administration|Overall Study||5||
59566903|NCT03879603|75669655|FG005|Received First Product Administration|Overall Study||5||
59566904|NCT03879603|75669650|FG000|Received All Product Administrations|Overall Study|Second administration not completed due to a grade 3 neutropenia not related to study product.|4||
59566905|NCT03879603|75669651|FG001|Received All Product Administrations|Overall Study||5||
59566906|NCT03879603|75669652|FG002|Received All Product Administrations|Overall Study||5||
59566907|NCT03879603|75669653|FG003|Received All Product Administrations|Overall Study||5||
59566908|NCT03879603|75669654|FG004|Received All Product Administrations|Overall Study||5||
59566909|NCT03879603|75669655|FG005|Received All Product Administrations|Overall Study||5||
59566910|NCT03879603|75669650|FG000|COMPLETED|Overall Study||5||
59713050|NCT01020123|75831534|FG002|NOT COMPLETED|Main Period||8||
59713051|NCT01020123|75831535|FG003|NOT COMPLETED|Main Period||7||
59713052|NCT01020123|75831536|FG004|NOT COMPLETED|Main Period||11||
59713053|NCT01020123|75831537|FG005|NOT COMPLETED|Main Period||11||
59713054|NCT01020123|75831538|FG006|NOT COMPLETED|Main Period||11||
59713055|NCT01020123|75831532|FG000|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|40||
59713056|NCT01020123|75831533|FG001|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|35||
59713057|NCT01020123|75831534|FG002|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|19||
59713058|NCT01020123|75831535|FG003|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|13||
59713059|NCT01020123|75831536|FG004|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|31||
59713060|NCT01020123|75831537|FG005|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|38||
59713061|NCT01020123|75831538|FG006|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|19||
59713062|NCT01020123|75831532|FG000|COMPLETED|Extention Period||37||
59713063|NCT01020123|75831533|FG001|COMPLETED|Extention Period||33||
59713064|NCT01020123|75831534|FG002|COMPLETED|Extention Period||17||
59713065|NCT01020123|75831535|FG003|COMPLETED|Extention Period||12||
59713066|NCT01020123|75831536|FG004|COMPLETED|Extention Period||31||
59713067|NCT01020123|75831537|FG005|COMPLETED|Extention Period||36||
59713068|NCT01020123|75831538|FG006|COMPLETED|Extention Period||18||
59713069|NCT01020123|75831532|FG000|NOT COMPLETED|Extention Period||3||
59713070|NCT01020123|75831533|FG001|NOT COMPLETED|Extention Period||2||
59713071|NCT01020123|75831534|FG002|NOT COMPLETED|Extention Period||2||
59713072|NCT01020123|75831535|FG003|NOT COMPLETED|Extention Period||1||
59713073|NCT01020123|75831536|FG004|NOT COMPLETED|Extention Period||0||
59713074|NCT01020123|75831537|FG005|NOT COMPLETED|Extention Period||2||
59713075|NCT01020123|75831538|FG006|NOT COMPLETED|Extention Period||1||
59713076|NCT04603027|75831561|FG000|STARTED|Overall Study||56||
59713077|NCT04603027|75831562|FG001|STARTED|Overall Study||28||
59713078|NCT04603027|75831563|FG002|STARTED|Overall Study||55||
59713079|NCT04603027|75831564|FG003|STARTED|Overall Study||27||
59713080|NCT04603027|75831565|FG004|STARTED|Overall Study||55||
59713081|NCT04603027|75831566|FG005|STARTED|Overall Study||28||
59713082|NCT04603027|75831561|FG000|COMPLETED|Overall Study||40||
59713083|NCT04603027|75831562|FG001|COMPLETED|Overall Study||20||
59713084|NCT04603027|75831563|FG002|COMPLETED|Overall Study||48||
59713085|NCT04603027|75831564|FG003|COMPLETED|Overall Study||26||
59713086|NCT04603027|75831565|FG004|COMPLETED|Overall Study||42||
59713087|NCT04603027|75831566|FG005|COMPLETED|Overall Study||22||
59713088|NCT04603027|75831561|FG000|NOT COMPLETED|Overall Study||16||
59713089|NCT04603027|75831562|FG001|NOT COMPLETED|Overall Study||8||
59713090|NCT04603027|75831563|FG002|NOT COMPLETED|Overall Study||7||
59713091|NCT04603027|75831564|FG003|NOT COMPLETED|Overall Study||1||
59713092|NCT04603027|75831565|FG004|NOT COMPLETED|Overall Study||13||
60108427|NCT01704196|76228139|FG001|COMPLETED|Overall Study||65||
60108428|NCT01704196|76228138|FG000|NOT COMPLETED|Overall Study||19||
60108429|NCT01704196|76228139|FG001|NOT COMPLETED|Overall Study||24||
59713093|NCT04603027|75831566|FG005|NOT COMPLETED|Overall Study||6||
59713094|NCT01028391|75831579|FG000|STARTED|Overall Study||164||
59713095|NCT01028391|75831580|FG001|STARTED|Overall Study||153||
59713096|NCT01028391|75831579|FG000|COMPLETED|Overall Study||150||
59713097|NCT01028391|75831580|FG001|COMPLETED|Overall Study||142||
59713098|NCT01028391|75831579|FG000|NOT COMPLETED|Overall Study||14||
59713099|NCT01028391|75831580|FG001|NOT COMPLETED|Overall Study||11||
59713100|NCT01179672|75831588|FG000|STARTED|Overall Study||203||
59713101|NCT01179672|75831589|FG001|STARTED|Overall Study||202||
59713102|NCT01179672|75831588|FG000|Received at Least 1 Dose of Study Drug|Overall Study||202||
59713103|NCT01179672|75831589|FG001|Received at Least 1 Dose of Study Drug|Overall Study||202||
59713104|NCT01179672|75831588|FG000|Entered Taper|Overall Study||181||
59713105|NCT01179672|75831589|FG001|Entered Taper|Overall Study||177||
59819506|NCT00511238|75941771|FG000|STARTED|Overall Study||46||
60108430|NCT01610297|76228145|FG000|STARTED|Overall Study||27||
60108431|NCT01610297|76228145|FG000|COMPLETED|Overall Study||26||
60108432|NCT01610297|76228145|FG000|NOT COMPLETED|Overall Study||1||
59566911|NCT03879603|75669651|FG001|COMPLETED|Overall Study||5||
59566912|NCT03879603|75669652|FG002|COMPLETED|Overall Study||5||
59566913|NCT03879603|75669653|FG003|COMPLETED|Overall Study||5||
59566914|NCT03879603|75669654|FG004|COMPLETED|Overall Study||5||
59566915|NCT03879603|75669655|FG005|COMPLETED|Overall Study||5||
59566916|NCT03879603|75669650|FG000|NOT COMPLETED|Overall Study||0||
59566917|NCT03879603|75669651|FG001|NOT COMPLETED|Overall Study||0||
59566918|NCT03879603|75669652|FG002|NOT COMPLETED|Overall Study||0||
59566919|NCT03879603|75669653|FG003|NOT COMPLETED|Overall Study||0||
59566920|NCT03879603|75669654|FG004|NOT COMPLETED|Overall Study||0||
59713106|NCT01179672|75831588|FG000|COMPLETED|Overall Study||173||
59713107|NCT01179672|75831589|FG001|COMPLETED|Overall Study||176||
59713108|NCT01179672|75831588|FG000|NOT COMPLETED|Overall Study||30||
59713109|NCT01179672|75831589|FG001|NOT COMPLETED|Overall Study||26||
59713110|NCT01030965|75831603|FG000|STARTED|Overall Study||71||
59713111|NCT01030965|75831604|FG001|STARTED|Overall Study||71||
59713112|NCT01030965|75831605|FG002|STARTED|Overall Study||72||
59713113|NCT01030965|75831606|FG003|STARTED|Overall Study||71||
59713114|NCT01030965|75831603|FG000|COMPLETED|Overall Study||67||
59713115|NCT01030965|75831604|FG001|COMPLETED|Overall Study||65||
59713116|NCT01030965|75831605|FG002|COMPLETED|Overall Study||68||
59713117|NCT01030965|75831606|FG003|COMPLETED|Overall Study||64||
59713118|NCT01030965|75831603|FG000|NOT COMPLETED|Overall Study||4||
59713119|NCT01030965|75831604|FG001|NOT COMPLETED|Overall Study||6||
59713120|NCT01030965|75831605|FG002|NOT COMPLETED|Overall Study||4||
59713121|NCT01030965|75831606|FG003|NOT COMPLETED|Overall Study||7||
59713122|NCT01179516|75831619|FG000|STARTED|Overall Study||160||
59713123|NCT01179516|75831620|FG001|STARTED|Overall Study||157||
59713124|NCT01179516|75831621|FG002|STARTED|Overall Study||152||
59713125|NCT01179516|75831619|FG000|Treated|Overall Study||160||
59713126|NCT01179516|75831620|FG001|Treated|Overall Study||154||
59713127|NCT01179516|75831621|FG002|Treated|Overall Study||151||
59713128|NCT01179516|75831619|FG000|COMPLETED|Overall Study||133||
59713129|NCT01179516|75831620|FG001|COMPLETED|Overall Study||131||
59713130|NCT01179516|75831621|FG002|COMPLETED|Overall Study||121||
59713131|NCT01179516|75831619|FG000|NOT COMPLETED|Overall Study||27||
59713132|NCT01179516|75831620|FG001|NOT COMPLETED|Overall Study||26||
59713133|NCT01179516|75831621|FG002|NOT COMPLETED|Overall Study||31||
59713134|NCT01018953|75831629|FG000|STARTED|Overall Study||8||
59713135|NCT01018953|75831629|FG000|BIM 23A760 1 mg|Overall Study||3||
59713136|NCT01018953|75831629|FG000|BIM 23A760 2 mg|Overall Study||2||
59713137|NCT01018953|75831629|FG000|BIM 23A760 4 mg|Overall Study||3||
59713138|NCT01018953|75831629|FG000|COMPLETED|Overall Study||0||
59713139|NCT01018953|75831629|FG000|NOT COMPLETED|Overall Study||8||
59713140|NCT01158924|75831636|FG000|STARTED|Overall Study||14||
59713141|NCT01158924|75831637|FG001|STARTED|Overall Study||26||
59713142|NCT01158924|75831636|FG000|COMPLETED|Overall Study||13||
59713143|NCT01158924|75831637|FG001|COMPLETED|Overall Study||23||
59713144|NCT01158924|75831636|FG000|NOT COMPLETED|Overall Study||1||
59713145|NCT01158924|75831637|FG001|NOT COMPLETED|Overall Study||3||
59713146|NCT01027845|75831645|FG000|STARTED|Primary Vaccination Phase||237||
59713147|NCT01027845|75831646|FG001|STARTED|Primary Vaccination Phase||123||
59713148|NCT01027845|75831647|FG002|STARTED|Primary Vaccination Phase|Subjects were not yet assigned to this group at the time of the primary vaccination|0||
59713149|NCT01027845|75831648|FG003|STARTED|Primary Vaccination Phase|Subjects were not yet assigned to this group at the time of the primary vaccination|0||
59713150|NCT01027845|75831645|FG000|COMPLETED|Primary Vaccination Phase||233||
59713151|NCT01027845|75831646|FG001|COMPLETED|Primary Vaccination Phase||122||
59819507|NCT00511238|75941772|FG001|STARTED|Overall Study||266||
59819508|NCT00511238|75941771|FG000|COMPLETED|Overall Study|Number of patients who completed 12 cycles of treatment|4||
59819509|NCT00511238|75941772|FG001|COMPLETED|Overall Study|Number of patients who completed 12 cycles of treatment|40||
59819510|NCT00511238|75941771|FG000|NOT COMPLETED|Overall Study||42||
59819511|NCT00511238|75941772|FG001|NOT COMPLETED|Overall Study||226||
59819512|NCT00513500|75941790|FG000|STARTED|Overall Study||1017||
59819513|NCT00513500|75941791|FG001|STARTED|Overall Study||2108||
59819514|NCT00513500|75941790|FG000|COMPLETED|Overall Study||976||
59819515|NCT00513500|75941791|FG001|COMPLETED|Overall Study||2054||
59819516|NCT00513500|75941790|FG000|NOT COMPLETED|Overall Study||41||
59819517|NCT00513500|75941791|FG001|NOT COMPLETED|Overall Study||54||
59819518|NCT03969719|75941800|FG000|STARTED|Overall Study||54||
59819519|NCT03969719|75941801|FG001|STARTED|Overall Study||55||
59713152|NCT01027845|75831647|FG002|COMPLETED|Primary Vaccination Phase||0||
59713153|NCT01027845|75831648|FG003|COMPLETED|Primary Vaccination Phase||0||
59713154|NCT01027845|75831645|FG000|NOT COMPLETED|Primary Vaccination Phase||4||
59713155|NCT01027845|75831646|FG001|NOT COMPLETED|Primary Vaccination Phase||1||
59713156|NCT01027845|75831647|FG002|NOT COMPLETED|Primary Vaccination Phase||0||
59713157|NCT01027845|75831648|FG003|NOT COMPLETED|Primary Vaccination Phase||0||
59819520|NCT03969719|75941802|FG002|STARTED|Overall Study||55||
59819521|NCT03969719|75941800|FG000|COMPLETED|Overall Study||50||
59819522|NCT03969719|75941801|FG001|COMPLETED|Overall Study||46||
59819523|NCT03969719|75941802|FG002|COMPLETED|Overall Study||50||
59819524|NCT03969719|75941800|FG000|NOT COMPLETED|Overall Study||4||
59819525|NCT03969719|75941801|FG001|NOT COMPLETED|Overall Study||9||
59819526|NCT03969719|75941802|FG002|NOT COMPLETED|Overall Study||5||
59819527|NCT00511004|75941813|FG000|STARTED|Overall Study||13||
59819528|NCT00511004|75941814|FG001|STARTED|Overall Study||13||
59819529|NCT00511004|75941815|FG002|STARTED|Overall Study||14||
59819530|NCT00511004|75941813|FG000|COMPLETED|Overall Study||13||
59819531|NCT00511004|75941814|FG001|COMPLETED|Overall Study||13||
59819532|NCT00511004|75941815|FG002|COMPLETED|Overall Study||10||
59819533|NCT00511004|75941813|FG000|NOT COMPLETED|Overall Study||0||
59819534|NCT00511004|75941814|FG001|NOT COMPLETED|Overall Study||0||
59819535|NCT00511004|75941815|FG002|NOT COMPLETED|Overall Study||4||
59819536|NCT02550197|75941828|FG000|STARTED|Overall Study||200||
59819537|NCT02550197|75941829|FG001|STARTED|Overall Study||100||
59819538|NCT02550197|75941828|FG000|COMPLETED|Overall Study||200||
59819539|NCT02550197|75941829|FG001|COMPLETED|Overall Study||100||
59819540|NCT02550197|75941828|FG000|NOT COMPLETED|Overall Study||0||
59819541|NCT02550197|75941829|FG001|NOT COMPLETED|Overall Study||0||
59819542|NCT02877134|75941842|FG000|STARTED|Main Study (Parts I,II): Up to Week 38||72||
59819543|NCT02877134|75941843|FG001|STARTED|Main Study (Parts I,II): Up to Week 38||73||
59819544|NCT02877134|75941844|FG002|STARTED|Main Study (Parts I,II): Up to Week 38||48||
59819545|NCT02877134|75941845|FG003|STARTED|Main Study (Parts I,II): Up to Week 38||50||
59819546|NCT02877134|75941846|FG004|STARTED|Main Study (Parts I,II): Up to Week 38||49||
59819547|NCT02877134|75941847|FG005|STARTED|Main Study (Parts I,II): Up to Week 38||49||
59819548|NCT02877134|75941848|FG006|STARTED|Main Study (Parts I,II): Up to Week 38||47||
59819549|NCT02877134|75941849|FG007|STARTED|Main Study (Parts I,II): Up to Week 38||0||
59819550|NCT02877134|75941850|FG008|STARTED|Main Study (Parts I,II): Up to Week 38||0||
59819551|NCT02877134|75941851|FG009|STARTED|Main Study (Parts I,II): Up to Week 38||0||
59819552|NCT02877134|75941852|FG010|STARTED|Main Study (Parts I,II): Up to Week 38||0||
59819553|NCT02877134|75941853|FG011|STARTED|Main Study (Parts I,II): Up to Week 38||0||
59819554|NCT02877134|75941842|FG000|Placebo Non Responders at Week 12|Main Study (Parts I,II): Up to Week 38||44||
59819555|NCT02877134|75941843|FG001|Placebo Non Responders at Week 12|Main Study (Parts I,II): Up to Week 38||0||
59819556|NCT02877134|75941844|FG002|Placebo Non Responders at Week 12|Main Study (Parts I,II): Up to Week 38||31||
59819557|NCT02877134|75941845|FG003|Placebo Non Responders at Week 12|Main Study (Parts I,II): Up to Week 38||0||
59819558|NCT02877134|75941846|FG004|Placebo Non Responders at Week 12|Main Study (Parts I,II): Up to Week 38||0||
59819559|NCT02877134|75941847|FG005|Placebo Non Responders at Week 12|Main Study (Parts I,II): Up to Week 38||0||
59819560|NCT02877134|75941848|FG006|Placebo Non Responders at Week 12|Main Study (Parts I,II): Up to Week 38||0||
59819561|NCT02877134|75941849|FG007|Placebo Non Responders at Week 12|Main Study (Parts I,II): Up to Week 38||0||
59819562|NCT02877134|75941850|FG008|Placebo Non Responders at Week 12|Main Study (Parts I,II): Up to Week 38||0||
59819563|NCT02877134|75941851|FG009|Placebo Non Responders at Week 12|Main Study (Parts I,II): Up to Week 38||0||
59819564|NCT02877134|75941852|FG010|Placebo Non Responders at Week 12|Main Study (Parts I,II): Up to Week 38||0||
59819565|NCT02877134|75941853|FG011|Placebo Non Responders at Week 12|Main Study (Parts I,II): Up to Week 38||0||
59819566|NCT02877134|75941842|FG000|COMPLETED|Main Study (Parts I,II): Up to Week 38||58||
59819567|NCT02877134|75941843|FG001|COMPLETED|Main Study (Parts I,II): Up to Week 38||48||
59819568|NCT02877134|75941844|FG002|COMPLETED|Main Study (Parts I,II): Up to Week 38||40||
59819569|NCT02877134|75941845|FG003|COMPLETED|Main Study (Parts I,II): Up to Week 38||35||
59819570|NCT02877134|75941846|FG004|COMPLETED|Main Study (Parts I,II): Up to Week 38||42||
59819571|NCT02877134|75941847|FG005|COMPLETED|Main Study (Parts I,II): Up to Week 38||39||
59819572|NCT02877134|75941848|FG006|COMPLETED|Main Study (Parts I,II): Up to Week 38||42||
59819573|NCT02877134|75941849|FG007|COMPLETED|Main Study (Parts I,II): Up to Week 38||0||
59819574|NCT02877134|75941850|FG008|COMPLETED|Main Study (Parts I,II): Up to Week 38||0||
59819575|NCT02877134|75941851|FG009|COMPLETED|Main Study (Parts I,II): Up to Week 38||0||
59819576|NCT02877134|75941852|FG010|COMPLETED|Main Study (Parts I,II): Up to Week 38||0||
60108433|NCT01660672|76228149|FG000|STARTED|Overall Study||7||
59713158|NCT01027845|75831645|FG000|STARTED|Booster Vaccination Phase||228||
59713159|NCT01027845|75831646|FG001|STARTED|Booster Vaccination Phase|Subjects from this group were assigned to DTPa+Prevenar&DTPa-No Prevenar Groups in the booster phase|0||
59713160|NCT01027845|75831647|FG002|STARTED|Booster Vaccination Phase||119||
59713161|NCT01027845|75831648|FG003|STARTED|Booster Vaccination Phase||1||
59713162|NCT01027845|75831645|FG000|COMPLETED|Booster Vaccination Phase||226||
59713163|NCT01027845|75831646|FG001|COMPLETED|Booster Vaccination Phase||0||
59713164|NCT01027845|75831647|FG002|COMPLETED|Booster Vaccination Phase||119||
59713165|NCT01027845|75831648|FG003|COMPLETED|Booster Vaccination Phase||1||
59713166|NCT01027845|75831645|FG000|NOT COMPLETED|Booster Vaccination Phase||2||
59713167|NCT01027845|75831646|FG001|NOT COMPLETED|Booster Vaccination Phase||0||
59713168|NCT01027845|75831647|FG002|NOT COMPLETED|Booster Vaccination Phase||0||
59713169|NCT01027845|75831648|FG003|NOT COMPLETED|Booster Vaccination Phase||0||
59819577|NCT02877134|75941853|FG011|COMPLETED|Main Study (Parts I,II): Up to Week 38||0||
59819578|NCT02877134|75941842|FG000|NOT COMPLETED|Main Study (Parts I,II): Up to Week 38||14||
59819579|NCT02877134|75941843|FG001|NOT COMPLETED|Main Study (Parts I,II): Up to Week 38||25||
59819580|NCT02877134|75941844|FG002|NOT COMPLETED|Main Study (Parts I,II): Up to Week 38||8||
60108434|NCT01660672|76228149|FG000|COMPLETED|Overall Study||7||
59819581|NCT02877134|75941845|FG003|NOT COMPLETED|Main Study (Parts I,II): Up to Week 38||15||
59819582|NCT02877134|75941846|FG004|NOT COMPLETED|Main Study (Parts I,II): Up to Week 38||7||
59819583|NCT02877134|75941847|FG005|NOT COMPLETED|Main Study (Parts I,II): Up to Week 38||10||
59819584|NCT02877134|75941848|FG006|NOT COMPLETED|Main Study (Parts I,II): Up to Week 38||5||
59819585|NCT02877134|75941849|FG007|NOT COMPLETED|Main Study (Parts I,II): Up to Week 38||0||
59819586|NCT02877134|75941850|FG008|NOT COMPLETED|Main Study (Parts I,II): Up to Week 38||0||
59819587|NCT02877134|75941851|FG009|NOT COMPLETED|Main Study (Parts I,II): Up to Week 38||0||
59819588|NCT02877134|75941852|FG010|NOT COMPLETED|Main Study (Parts I,II): Up to Week 38||0||
59819589|NCT02877134|75941853|FG011|NOT COMPLETED|Main Study (Parts I,II): Up to Week 38||0||
59819590|NCT02877134|75941842|FG000|STARTED|Part II LTE Phase: From Week 24-88||0||
59819591|NCT02877134|75941843|FG001|STARTED|Part II LTE Phase: From Week 24-88||0||
59819592|NCT02877134|75941844|FG002|STARTED|Part II LTE Phase: From Week 24-88||0||
59819593|NCT02877134|75941845|FG003|STARTED|Part II LTE Phase: From Week 24-88||0||
59819594|NCT02877134|75941846|FG004|STARTED|Part II LTE Phase: From Week 24-88||0||
59819595|NCT02877134|75941847|FG005|STARTED|Part II LTE Phase: From Week 24-88||0||
59819596|NCT02877134|75941848|FG006|STARTED|Part II LTE Phase: From Week 24-88||0||
59819597|NCT02877134|75941849|FG007|STARTED|Part II LTE Phase: From Week 24-88|Only eligible participants from main study phase, entered into Part II LTE phase.|22||
59819598|NCT02877134|75941850|FG008|STARTED|Part II LTE Phase: From Week 24-88|Only eligible participants from main study phase, entered into Part II LTE phase.|21||
59819599|NCT02877134|75941851|FG009|STARTED|Part II LTE Phase: From Week 24-88|Only eligible participants from main study phase, entered into Part II LTE phase.|27||
59819600|NCT02877134|75941852|FG010|STARTED|Part II LTE Phase: From Week 24-88|Only eligible participants from main study phase, entered into Part II LTE phase.|24||
59819601|NCT02877134|75941853|FG011|STARTED|Part II LTE Phase: From Week 24-88|Only eligible participants from main study phase, entered into Part II LTE phase.|28||
59819602|NCT02877134|75941842|FG000|COMPLETED|Part II LTE Phase: From Week 24-88||0||
59819603|NCT02877134|75941843|FG001|COMPLETED|Part II LTE Phase: From Week 24-88||0||
59819604|NCT02877134|75941844|FG002|COMPLETED|Part II LTE Phase: From Week 24-88||0||
59819605|NCT02877134|75941845|FG003|COMPLETED|Part II LTE Phase: From Week 24-88||0||
59819606|NCT02877134|75941846|FG004|COMPLETED|Part II LTE Phase: From Week 24-88||0||
59819607|NCT02877134|75941847|FG005|COMPLETED|Part II LTE Phase: From Week 24-88||0||
59819608|NCT02877134|75941848|FG006|COMPLETED|Part II LTE Phase: From Week 24-88||0||
59819609|NCT02877134|75941849|FG007|COMPLETED|Part II LTE Phase: From Week 24-88||20||
59819610|NCT02877134|75941850|FG008|COMPLETED|Part II LTE Phase: From Week 24-88||17||
59819611|NCT02877134|75941851|FG009|COMPLETED|Part II LTE Phase: From Week 24-88||20||
59819612|NCT02877134|75941852|FG010|COMPLETED|Part II LTE Phase: From Week 24-88||14||
59819613|NCT02877134|75941853|FG011|COMPLETED|Part II LTE Phase: From Week 24-88||24||
59819614|NCT02877134|75941842|FG000|NOT COMPLETED|Part II LTE Phase: From Week 24-88||0||
59819615|NCT02877134|75941843|FG001|NOT COMPLETED|Part II LTE Phase: From Week 24-88||0||
59819616|NCT02877134|75941844|FG002|NOT COMPLETED|Part II LTE Phase: From Week 24-88||0||
59819617|NCT02877134|75941845|FG003|NOT COMPLETED|Part II LTE Phase: From Week 24-88||0||
59819618|NCT02877134|75941846|FG004|NOT COMPLETED|Part II LTE Phase: From Week 24-88||0||
59819619|NCT02877134|75941847|FG005|NOT COMPLETED|Part II LTE Phase: From Week 24-88||0||
59819620|NCT02877134|75941848|FG006|NOT COMPLETED|Part II LTE Phase: From Week 24-88||0||
59819621|NCT02877134|75941849|FG007|NOT COMPLETED|Part II LTE Phase: From Week 24-88||2||
59819622|NCT02877134|75941850|FG008|NOT COMPLETED|Part II LTE Phase: From Week 24-88||4||
59819623|NCT02877134|75941851|FG009|NOT COMPLETED|Part II LTE Phase: From Week 24-88||7||
59819624|NCT02877134|75941852|FG010|NOT COMPLETED|Part II LTE Phase: From Week 24-88||10||
59819625|NCT02877134|75941853|FG011|NOT COMPLETED|Part II LTE Phase: From Week 24-88||4||
59819626|NCT00563381|75941879|FG000|STARTED|Overall Study|Started treatment|3707||
59819627|NCT00563381|75941880|FG001|STARTED|Overall Study|Started treatment|3669||
59819628|NCT00563381|75941879|FG000|COMPLETED|Overall Study|Completed treatment|3122||
59819629|NCT00563381|75941880|FG001|COMPLETED|Overall Study|Completed treatment|3021||
59819630|NCT00563381|75941879|FG000|NOT COMPLETED|Overall Study||585||
59819631|NCT00563381|75941880|FG001|NOT COMPLETED|Overall Study||648||
59819632|NCT00512798|75941888|FG000|STARTED|Overall Study||19||
59819633|NCT00512798|75941889|FG001|STARTED|Overall Study||28||
59819634|NCT00512798|75941888|FG000|COMPLETED|Overall Study||0||
59819635|NCT00512798|75941889|FG001|COMPLETED|Overall Study||1||
59819636|NCT00512798|75941888|FG000|NOT COMPLETED|Overall Study||19||
59819637|NCT00512798|75941889|FG001|NOT COMPLETED|Overall Study||27||
59819638|NCT00565721|75941896|FG000|STARTED|Overall Study||33||
59819639|NCT00565721|75941896|FG000|COMPLETED|Overall Study||16||
59819640|NCT00565721|75941896|FG000|NOT COMPLETED|Overall Study||17||
59819641|NCT04012619|75941917|FG000|STARTED|Overall Study||4||
59819642|NCT04012619|75941918|FG001|STARTED|Overall Study||4||
59819643|NCT04012619|75941917|FG000|COMPLETED|Overall Study||4||
59819644|NCT04012619|75941918|FG001|COMPLETED|Overall Study||4||
59819645|NCT04012619|75941917|FG000|NOT COMPLETED|Overall Study||0||
59819646|NCT04012619|75941918|FG001|NOT COMPLETED|Overall Study||0||
59819647|NCT00561977|75941926|FG000|STARTED|Overall Study||12||
59819648|NCT00561977|75941927|FG001|STARTED|Overall Study||12||
59819649|NCT00561977|75941928|FG002|STARTED|Overall Study||12||
59819650|NCT00561977|75941926|FG000|COMPLETED|Overall Study||12||
59819651|NCT00561977|75941927|FG001|COMPLETED|Overall Study||9||
59819652|NCT00561977|75941928|FG002|COMPLETED|Overall Study||10||
59819653|NCT00561977|75941926|FG000|NOT COMPLETED|Overall Study||0||
59819654|NCT00561977|75941927|FG001|NOT COMPLETED|Overall Study||3||
59819655|NCT00561977|75941928|FG002|NOT COMPLETED|Overall Study||2||
59819656|NCT00561821|75941940|FG000|STARTED|Overall Study||132||
59819657|NCT00561821|75941941|FG001|STARTED|Overall Study||136||
59819658|NCT00561821|75941942|FG002|STARTED|Overall Study||134||
59819659|NCT00561821|75941943|FG003|STARTED|Overall Study||136||
59819660|NCT00561821|75941940|FG000|Treated|Overall Study||132||
59819661|NCT00561821|75941941|FG001|Treated|Overall Study||136||
59819662|NCT00561821|75941942|FG002|Treated|Overall Study||133||
59819663|NCT00561821|75941943|FG003|Treated|Overall Study||136||
59819664|NCT00561821|75941940|FG000|COMPLETED|Overall Study||127||
59819665|NCT00561821|75941941|FG001|COMPLETED|Overall Study||130||
59819666|NCT00561821|75941942|FG002|COMPLETED|Overall Study||132||
59819667|NCT00561821|75941943|FG003|COMPLETED|Overall Study||133||
59819668|NCT00561821|75941940|FG000|NOT COMPLETED|Overall Study||5||
59819669|NCT00561821|75941941|FG001|NOT COMPLETED|Overall Study||6||
59819670|NCT00561821|75941942|FG002|NOT COMPLETED|Overall Study||2||
59819671|NCT00561821|75941943|FG003|NOT COMPLETED|Overall Study||3||
59819672|NCT00558701|75941955|FG000|STARTED|Overall Study||15||
59819673|NCT00558701|75941956|FG001|STARTED|Overall Study||15||
59819674|NCT00558701|75941955|FG000|COMPLETED|Overall Study||14||
59819675|NCT00558701|75941956|FG001|COMPLETED|Overall Study||11||
59819676|NCT00558701|75941955|FG000|NOT COMPLETED|Overall Study||1||
59819677|NCT00558701|75941956|FG001|NOT COMPLETED|Overall Study||4||
59819678|NCT03684044|75941964|FG000|STARTED|Overall Study||239||
59819679|NCT03684044|75941965|FG001|STARTED|Overall Study||124||
59819680|NCT03684044|75941964|FG000|COMPLETED|Overall Study||217||
59819681|NCT03684044|75941965|FG001|COMPLETED|Overall Study||104||
59819682|NCT03684044|75941964|FG000|NOT COMPLETED|Overall Study||22||
59819683|NCT03684044|75941965|FG001|NOT COMPLETED|Overall Study||20||
59819684|NCT00510692|75941973|FG000|STARTED|Overall Study||29||
59819685|NCT00510692|75941974|FG001|STARTED|Overall Study||29||
59819686|NCT00510692|75941973|FG000|COMPLETED|Overall Study||27||
59819687|NCT00510692|75941974|FG001|COMPLETED|Overall Study||26||
59819688|NCT00510692|75941973|FG000|NOT COMPLETED|Overall Study||2||
59819689|NCT00510692|75941974|FG001|NOT COMPLETED|Overall Study||3||
59819690|NCT00335452|75941986|FG000|STARTED|Overall Study|Randomized|6312||
59819691|NCT00335452|75941987|FG001|STARTED|Overall Study|Randomized|6254||
59713170|NCT01017549|75831657|FG000|STARTED|Eligibility Through 6 Month Follow-up||44||
59713171|NCT01017549|75831657|FG000|COMPLETED|Eligibility Through 6 Month Follow-up|6 month follow-up complete Oct 2008; data through 6 months and 1 year are published.|43||
59713172|NCT01017549|75831657|FG000|NOT COMPLETED|Eligibility Through 6 Month Follow-up||1||
59713173|NCT01017549|75831657|FG000|STARTED|One-year Follow-up||43||
59713174|NCT01017549|75831657|FG000|COMPLETED|One-year Follow-up||36||
59713175|NCT01017549|75831657|FG000|NOT COMPLETED|One-year Follow-up||7||
59713176|NCT01017549|75831657|FG000|STARTED|5 Year Follow-up||36||
59713177|NCT01017549|75831657|FG000|COMPLETED|5 Year Follow-up||24||
59713178|NCT01017549|75831657|FG000|NOT COMPLETED|5 Year Follow-up||12||
59713179|NCT01030341|75831661|FG000|STARTED|Overall Study|45 participants met all enrollment criteria by completing the screening and run-in phases|45||
59713180|NCT01030341|75831661|FG000|COMPLETED|Overall Study|42 participants completed the study|42||
59713181|NCT01030341|75831661|FG000|NOT COMPLETED|Overall Study||3||
59713182|NCT01026831|75831667|FG000|STARTED|Overall Study|randomized|320||
59713183|NCT01026831|75831668|FG001|STARTED|Overall Study|randomized|323||
59713184|NCT01026831|75831667|FG000|COMPLETED|Overall Study||306||
59713185|NCT01026831|75831668|FG001|COMPLETED|Overall Study||312||
59713186|NCT01026831|75831667|FG000|NOT COMPLETED|Overall Study||14||
59713187|NCT01026831|75831668|FG001|NOT COMPLETED|Overall Study||11||
59713188|NCT01016067|75831676|FG000|STARTED|Overall Study||11||
59713189|NCT01016067|75831677|FG001|STARTED|Overall Study||12||
59713190|NCT01016067|75831676|FG000|COMPLETED|Overall Study||9||
59713191|NCT01016067|75831677|FG001|COMPLETED|Overall Study||8||
59713192|NCT01016067|75831676|FG000|NOT COMPLETED|Overall Study||2||
59819692|NCT00335452|75941988|FG002|STARTED|Overall Study|Randomized|6267||
59819693|NCT00335452|75941989|FG003|STARTED|Overall Study|Randomized|6253||
59819694|NCT00335452|75941986|FG000|TREATED WITH CLOPIDOGREL|Overall Study||6271||
59819695|NCT00335452|75941987|FG001|TREATED WITH CLOPIDOGREL|Overall Study||6218||
59819696|NCT00335452|75941988|FG002|TREATED WITH CLOPIDOGREL|Overall Study||6228||
59819697|NCT00335452|75941989|FG003|TREATED WITH CLOPIDOGREL|Overall Study||6217||
59819698|NCT00335452|75941986|FG000|TREATED WITH ASA|Overall Study||6302||
59819699|NCT00335452|75941987|FG001|TREATED WITH ASA|Overall Study||6251||
59819700|NCT00335452|75941988|FG002|TREATED WITH ASA|Overall Study||6261||
59819701|NCT00335452|75941989|FG003|TREATED WITH ASA|Overall Study||6247||
59819702|NCT00335452|75941986|FG000|COMPLETED|Overall Study|Completed 30 days follow-up period|6154||
59819703|NCT00335452|75941987|FG001|COMPLETED|Overall Study|Completed 30 days follow-up period|6107||
59819704|NCT00335452|75941988|FG002|COMPLETED|Overall Study|Completed 30 days follow-up period|6108||
59819705|NCT00335452|75941989|FG003|COMPLETED|Overall Study|Completed 30 days follow-up period|6122||
59819706|NCT00335452|75941986|FG000|NOT COMPLETED|Overall Study||158||
59819707|NCT00335452|75941987|FG001|NOT COMPLETED|Overall Study||147||
59819708|NCT00335452|75941988|FG002|NOT COMPLETED|Overall Study||159||
59819709|NCT00335452|75941989|FG003|NOT COMPLETED|Overall Study||131||
59819710|NCT00522548|75942006|FG000|STARTED|Overall Study||18||
59819711|NCT00522548|75942007|FG001|STARTED|Overall Study||19||
59819712|NCT00522548|75942006|FG000|Consented to Pharmacokinetic Study|Overall Study||11||
59819713|NCT00522548|75942007|FG001|Consented to Pharmacokinetic Study|Overall Study||10||
59819714|NCT00522548|75942006|FG000|Completed 0/2 PK Visits|Overall Study||3||
59819715|NCT00522548|75942007|FG001|Completed 0/2 PK Visits|Overall Study||4||
59819716|NCT00522548|75942006|FG000|Completed 1/2 PK Visits|Overall Study||1||
59819717|NCT00522548|75942007|FG001|Completed 1/2 PK Visits|Overall Study||1||
59819718|NCT00522548|75942006|FG000|Completed 2/2 PK Visits|Overall Study||7||
59819719|NCT00522548|75942007|FG001|Completed 2/2 PK Visits|Overall Study||5||
59819720|NCT00522548|75942006|FG000|COMPLETED|Overall Study||16||
59819721|NCT00522548|75942007|FG001|COMPLETED|Overall Study||15||
59819722|NCT00522548|75942006|FG000|NOT COMPLETED|Overall Study||2||
59819723|NCT00522548|75942007|FG001|NOT COMPLETED|Overall Study||4||
59819724|NCT00522392|75942015|FG000|STARTED|Overall Study||23||
59819725|NCT00522392|75942016|FG001|STARTED|Overall Study||25||
59819726|NCT00522392|75942015|FG000|Pts w/ Measurable Disease at Baseline|Overall Study||16||
59819727|NCT00522392|75942016|FG001|Pts w/ Measurable Disease at Baseline|Overall Study||16||
59819728|NCT00522392|75942015|FG000|Pts w/ QOL Assessments Complete|Overall Study||12||
59819729|NCT00522392|75942016|FG001|Pts w/ QOL Assessments Complete|Overall Study||8||
59819730|NCT00522392|75942015|FG000|COMPLETED|Overall Study||15||
59819731|NCT00522392|75942016|FG001|COMPLETED|Overall Study||12||
59819732|NCT00522392|75942015|FG000|NOT COMPLETED|Overall Study||8||
59819733|NCT00522392|75942016|FG001|NOT COMPLETED|Overall Study||13||
59819734|NCT00309244|75942024|FG000|STARTED|Overall Study||334||
59819735|NCT00309244|75942025|FG001|STARTED|Overall Study||343||
59819736|NCT00309244|75942024|FG000|COMPLETED|Overall Study||216||
59819737|NCT00309244|75942025|FG001|COMPLETED|Overall Study||246||
59819738|NCT00309244|75942024|FG000|NOT COMPLETED|Overall Study||118||
59819739|NCT00309244|75942025|FG001|NOT COMPLETED|Overall Study||97||
59819740|NCT00483756|75942034|FG000|STARTED|Overall Study||110||
59819741|NCT00483756|75942035|FG001|STARTED|Overall Study||110||
59819742|NCT00483756|75942036|FG002|STARTED|Overall Study||111||
59819743|NCT00483756|75942034|FG000|Treated|Overall Study||109||
59819744|NCT00483756|75942035|FG001|Treated|Overall Study||106||
59819745|NCT00483756|75942036|FG002|Treated|Overall Study||107||
59819746|NCT00483756|75942034|FG000|COMPLETED|Overall Study||77||
59819747|NCT00483756|75942035|FG001|COMPLETED|Overall Study||60||
59819748|NCT00483756|75942036|FG002|COMPLETED|Overall Study||59||
59819749|NCT00483756|75942034|FG000|NOT COMPLETED|Overall Study||33||
59819750|NCT00483756|75942035|FG001|NOT COMPLETED|Overall Study||50||
59819751|NCT00483756|75942036|FG002|NOT COMPLETED|Overall Study||52||
59819752|NCT00309166|75942046|FG000|STARTED|Overall Study||181||
59819753|NCT00309166|75942047|FG001|STARTED|Overall Study||89||
59819754|NCT00309166|75942046|FG000|COMPLETED|Overall Study||176||
59819755|NCT00309166|75942047|FG001|COMPLETED|Overall Study||86||
59819756|NCT00309166|75942046|FG000|NOT COMPLETED|Overall Study||5||
59819757|NCT00309166|75942047|FG001|NOT COMPLETED|Overall Study||3||
59819758|NCT00501852|75942053|FG000|STARTED|Overall Study||83||
59819759|NCT00501852|75942053|FG000|NVA237 12.5µg|Overall Study||55||
59819760|NCT00501852|75942053|FG000|NVA237 25µg|Overall Study||51||
59819761|NCT00501852|75942053|FG000|NVA237 50µg|Overall Study||53||
59819762|NCT00501852|75942053|FG000|NVA237 100µg|Overall Study||54||
59819763|NCT00501852|75942053|FG000|Placebo|Overall Study||55||
59819764|NCT00501852|75942053|FG000|Tiotropium|Overall Study||55||
59819765|NCT00501852|75942053|FG000|COMPLETED|Overall Study||78||
59819766|NCT00501852|75942053|FG000|NOT COMPLETED|Overall Study||5||
59819767|NCT00482274|75942067|FG000|STARTED|Overall Study||3||
59819768|NCT00482274|75942067|FG000|COMPLETED|Overall Study||2||
59819769|NCT00482274|75942067|FG000|NOT COMPLETED|Overall Study||1||
59819770|NCT00490542|75942073|FG000|STARTED|Overall Study||38||
59819771|NCT00490542|75942074|FG001|STARTED|Overall Study||35||
59819772|NCT00490542|75942073|FG000|COMPLETED|Overall Study||31||
59566921|NCT03879603|75669655|FG005|NOT COMPLETED|Overall Study||0||
59819773|NCT00490542|75942074|FG001|COMPLETED|Overall Study||31||
59819774|NCT00490542|75942073|FG000|NOT COMPLETED|Overall Study||7||
59819775|NCT00490542|75942074|FG001|NOT COMPLETED|Overall Study||4||
59819776|NCT00501540|75942080|FG000|STARTED|Overall Study||15||
59819777|NCT00501540|75942080|FG000|COMPLETED|Overall Study||10||
59819778|NCT00501540|75942080|FG000|NOT COMPLETED|Overall Study||5||
59819779|NCT00322348|75942086|FG000|STARTED|Overall Study||49||
59819780|NCT00322348|75942087|FG001|STARTED|Overall Study||49||
59819781|NCT00322348|75942086|FG000|Received Study Treatment|Overall Study||50||
59819782|NCT00322348|75942087|FG001|Received Study Treatment|Overall Study||48||
59819783|NCT00322348|75942086|FG000|COMPLETED|Overall Study|Number of participants completed up to Week 96|12||
59819784|NCT00322348|75942087|FG001|COMPLETED|Overall Study|Number of participants completed up to Week 96|16||
59819785|NCT00322348|75942086|FG000|NOT COMPLETED|Overall Study||37||
59819786|NCT00322348|75942087|FG001|NOT COMPLETED|Overall Study||33||
59819787|NCT00501228|75942093|FG000|STARTED|Overall Study||2||
59819788|NCT00501228|75942093|FG000|COMPLETED|Overall Study||1||
59819789|NCT00501228|75942093|FG000|NOT COMPLETED|Overall Study||1||
59819790|NCT00308620|75942100|FG000|STARTED|Overall Study||3||
59819791|NCT00308620|75942101|FG001|STARTED|Overall Study||4||
59819792|NCT00308620|75942102|FG002|STARTED|Overall Study||6||
59819793|NCT00308620|75942100|FG000|COMPLETED|Overall Study||2||
59819794|NCT00308620|75942101|FG001|COMPLETED|Overall Study||3||
59819795|NCT00308620|75942102|FG002|COMPLETED|Overall Study||5||
60108435|NCT01660672|76228149|FG000|NOT COMPLETED|Overall Study||0||
60108436|NCT01793051|76228156|FG000|STARTED|Overall Study||43||
60108437|NCT01793051|76228157|FG001|STARTED|Overall Study||44||
59566922|NCT00553514|75669676|FG000|STARTED|Overall Study||14||
59566923|NCT00553514|75669677|FG001|STARTED|Overall Study||14||
59566924|NCT00553514|75669678|FG002|STARTED|Overall Study||15||
59566925|NCT00553514|75669679|FG003|STARTED|Overall Study||13||
59566926|NCT00553514|75669680|FG004|STARTED|Overall Study||15||
59566927|NCT00553514|75669676|FG000|COMPLETED|Overall Study||6||
59566928|NCT00553514|75669677|FG001|COMPLETED|Overall Study||6||
59566929|NCT00553514|75669678|FG002|COMPLETED|Overall Study||9||
59566930|NCT00553514|75669679|FG003|COMPLETED|Overall Study||6||
59566931|NCT00553514|75669680|FG004|COMPLETED|Overall Study||8||
59566932|NCT00553514|75669676|FG000|NOT COMPLETED|Overall Study||8||
59566933|NCT00553514|75669677|FG001|NOT COMPLETED|Overall Study||8||
59566934|NCT00553514|75669678|FG002|NOT COMPLETED|Overall Study||6||
59566935|NCT00553514|75669679|FG003|NOT COMPLETED|Overall Study||7||
59566936|NCT00553514|75669680|FG004|NOT COMPLETED|Overall Study||7||
59713193|NCT01016067|75831677|FG001|NOT COMPLETED|Overall Study||4||
59713194|NCT01015833|75831685|FG000|STARTED|Overall Study||180||
59713195|NCT01015833|75831686|FG001|STARTED|Overall Study||176||
59713196|NCT01015833|75831685|FG000|COMPLETED|Overall Study||167||
59713197|NCT01015833|75831686|FG001|COMPLETED|Overall Study||171||
59713198|NCT01015833|75831685|FG000|NOT COMPLETED|Overall Study||13||
59713199|NCT01015833|75831686|FG001|NOT COMPLETED|Overall Study||5||
59713200|NCT03523273|75831694|FG000|STARTED|Overall Study||67||
59713201|NCT03523273|75831695|FG001|STARTED|Overall Study||69||
59713202|NCT03523273|75831694|FG000|COMPLETED|Overall Study||59||
59713203|NCT03523273|75831695|FG001|COMPLETED|Overall Study||65||
59713204|NCT03523273|75831694|FG000|NOT COMPLETED|Overall Study||8||
59713205|NCT03523273|75831695|FG001|NOT COMPLETED|Overall Study||4||
59713206|NCT01015677|75831704|FG000|STARTED|Overall Study||34||
59713207|NCT01015677|75831705|FG001|STARTED|Overall Study||32||
59713208|NCT01015677|75831706|FG002|STARTED|Overall Study||33||
59713209|NCT01015677|75831704|FG000|COMPLETED|Overall Study||33||
59713210|NCT01015677|75831705|FG001|COMPLETED|Overall Study||28||
59713211|NCT01015677|75831706|FG002|COMPLETED|Overall Study||33||
59713212|NCT01015677|75831704|FG000|NOT COMPLETED|Overall Study||1||
59713213|NCT01015677|75831705|FG001|NOT COMPLETED|Overall Study||4||
59713214|NCT01015677|75831706|FG002|NOT COMPLETED|Overall Study||0||
59713215|NCT04286581|75831716|FG000|STARTED|Overall Study||74||
59713216|NCT04286581|75831717|FG001|STARTED|Overall Study||74||
59713217|NCT04286581|75831716|FG000|COMPLETED|Overall Study||70||
59713218|NCT04286581|75831717|FG001|COMPLETED|Overall Study||70||
59713219|NCT04286581|75831716|FG000|NOT COMPLETED|Overall Study||4||
59713220|NCT04286581|75831717|FG001|NOT COMPLETED|Overall Study||4||
59713221|NCT03204643|75831725|FG000|STARTED|Overall Study||323|All those randomized to the intervention were included in the analysis|
59713222|NCT03204643|75831726|FG001|STARTED|Overall Study||314|All those randomized to the intervention were included in the analysis|
59713223|NCT03204643|75831725|FG000|COMPLETED|Overall Study||323||
59713224|NCT03204643|75831726|FG001|COMPLETED|Overall Study||314||
59713225|NCT03204643|75831725|FG000|NOT COMPLETED|Overall Study||0||
59713226|NCT03204643|75831726|FG001|NOT COMPLETED|Overall Study||0||
60108438|NCT01793051|76228156|FG000|COMPLETED|Overall Study||33||
60108439|NCT01793051|76228157|FG001|COMPLETED|Overall Study||36||
60108440|NCT01793051|76228156|FG000|NOT COMPLETED|Overall Study||10||
60108441|NCT01793051|76228157|FG001|NOT COMPLETED|Overall Study||8||
60108442|NCT01661764|76228169|FG000|STARTED|Overall Study||26||
60108443|NCT01661764|76228170|FG001|STARTED|Overall Study||25||
60108444|NCT01661764|76228171|FG002|STARTED|Overall Study||25||
60108445|NCT01661764|76228172|FG003|STARTED|Overall Study||26||
60108446|NCT01661764|76228173|FG004|STARTED|Overall Study||19||
60108447|NCT01661764|76228174|FG005|STARTED|Overall Study||20||
60108448|NCT01661764|76228169|FG000|COMPLETED|Overall Study||24||
59566937|NCT03878745|75669692|FG000|STARTED|Overall Study||55||
59713227|NCT02339233|75831732|FG000|STARTED|Overall Study||8||
59713228|NCT02339233|75831732|FG000|COMPLETED|Overall Study||8||
59819796|NCT00308620|75942100|FG000|NOT COMPLETED|Overall Study||1||
59566938|NCT03878745|75669692|FG000|COMPLETED|Overall Study||55||
59566939|NCT03878745|75669692|FG000|NOT COMPLETED|Overall Study||0||
59566940|NCT00553436|75669704|FG000|STARTED|Overall Study|20 August 2007|7||
59566941|NCT00553436|75669704|FG000|COMPLETED|Overall Study|09 April 2009|6||
59713229|NCT02339233|75831732|FG000|NOT COMPLETED|Overall Study||0||
59819797|NCT00308620|75942101|FG001|NOT COMPLETED|Overall Study||1||
60108449|NCT01661764|76228170|FG001|COMPLETED|Overall Study||20||
59819798|NCT00308620|75942102|FG002|NOT COMPLETED|Overall Study||1||
59819799|NCT00492752|75942112|FG000|STARTED|Double Blind Treatment||134||
59819800|NCT00492752|75942113|FG001|STARTED|Double Blind Treatment||16||
59819801|NCT00492752|75942114|FG002|STARTED|Double Blind Treatment||70||
59819802|NCT00492752|75942115|FG003|STARTED|Double Blind Treatment||6||
59819803|NCT00492752|75942112|FG000|Received Treatment|Double Blind Treatment|Safety Population. 1 participant never received treatment due to an Adverse Event.|133||
59819804|NCT00492752|75942113|FG001|Received Treatment|Double Blind Treatment|Safety Population|16||
59819805|NCT00492752|75942114|FG002|Received Treatment|Double Blind Treatment|Safety Population. 1 participant never received treatment due to protocol violation.|69||
59819806|NCT00492752|75942115|FG003|Received Treatment|Double Blind Treatment|Safety Population|6||
59819807|NCT00492752|75942112|FG000|COMPLETED|Double Blind Treatment||120||
59819808|NCT00492752|75942113|FG001|COMPLETED|Double Blind Treatment||16||
59819809|NCT00492752|75942114|FG002|COMPLETED|Double Blind Treatment||67||
59819810|NCT00492752|75942115|FG003|COMPLETED|Double Blind Treatment||6||
59819811|NCT00492752|75942112|FG000|NOT COMPLETED|Double Blind Treatment||14||
59819812|NCT00492752|75942113|FG001|NOT COMPLETED|Double Blind Treatment||0||
59819813|NCT00492752|75942114|FG002|NOT COMPLETED|Double Blind Treatment||3||
59819814|NCT00492752|75942115|FG003|NOT COMPLETED|Double Blind Treatment||0||
59819815|NCT00492752|75942112|FG000|STARTED|Follow-up and/or Open Label Sorafenib||120||
59819816|NCT00492752|75942113|FG001|STARTED|Follow-up and/or Open Label Sorafenib||16||
59819817|NCT00492752|75942114|FG002|STARTED|Follow-up and/or Open Label Sorafenib||67||
59819818|NCT00492752|75942115|FG003|STARTED|Follow-up and/or Open Label Sorafenib||6||
59819819|NCT00492752|75942112|FG000|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Sorafenib||120||
59819820|NCT00492752|75942113|FG001|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Sorafenib||0||
59819821|NCT00492752|75942114|FG002|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Sorafenib||67||
59819822|NCT00492752|75942115|FG003|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Sorafenib||0||
59819823|NCT00492752|75942112|FG000|Follow-up First, Then Open Label|Follow-up and/or Open Label Sorafenib||0||
59819824|NCT00492752|75942113|FG001|Follow-up First, Then Open Label|Follow-up and/or Open Label Sorafenib||16||
59819825|NCT00492752|75942114|FG002|Follow-up First, Then Open Label|Follow-up and/or Open Label Sorafenib||0||
59819826|NCT00492752|75942115|FG003|Follow-up First, Then Open Label|Follow-up and/or Open Label Sorafenib||6||
59819827|NCT00492752|75942112|FG000|COMPLETED|Follow-up and/or Open Label Sorafenib|1 participant completed all assessments, 33 were followed up until the end of this trial|34||
59819828|NCT00492752|75942113|FG001|COMPLETED|Follow-up and/or Open Label Sorafenib||0||
59819829|NCT00492752|75942114|FG002|COMPLETED|Follow-up and/or Open Label Sorafenib|20 participants were followed up until the end of this trial|20||
59819830|NCT00492752|75942115|FG003|COMPLETED|Follow-up and/or Open Label Sorafenib||0||
59819831|NCT00492752|75942112|FG000|NOT COMPLETED|Follow-up and/or Open Label Sorafenib||86||
59819832|NCT00492752|75942113|FG001|NOT COMPLETED|Follow-up and/or Open Label Sorafenib||16||
59819833|NCT00492752|75942114|FG002|NOT COMPLETED|Follow-up and/or Open Label Sorafenib||47||
59819834|NCT00492752|75942115|FG003|NOT COMPLETED|Follow-up and/or Open Label Sorafenib||6||
59819835|NCT00308308|75942124|FG000|STARTED|Overall Study||301||
59819836|NCT00308308|75942125|FG001|STARTED|Overall Study||288||
59819837|NCT00308308|75942124|FG000|COMPLETED|Overall Study||198||
59819838|NCT00308308|75942125|FG001|COMPLETED|Overall Study||220||
59819839|NCT00308308|75942124|FG000|NOT COMPLETED|Overall Study||103||
59819840|NCT00308308|75942125|FG001|NOT COMPLETED|Overall Study||68||
59819841|NCT00505934|75942131|FG000|STARTED|Overall Study|Of the 23 subjects screened, 19 were enrolled into the study and received levetiracetam IV (LEV IV).|19||
59819842|NCT00505934|75942131|FG000|COMPLETED|Overall Study||16||
59819843|NCT00505934|75942131|FG000|NOT COMPLETED|Overall Study||3||
59819844|NCT00505778|75942137|FG000|STARTED|Overall Study||514||
59819845|NCT00505778|75942138|FG001|STARTED|Overall Study||513||
59819846|NCT00505778|75942137|FG000|Intent to Treat (ITT) Population|Overall Study||512||
59819847|NCT00505778|75942138|FG001|Intent to Treat (ITT) Population|Overall Study||511||
59819848|NCT00505778|75942137|FG000|COMPLETED|Overall Study||380||
59996323|NCT04150861|76112317|FG001|COMPLETED|Overall Study||8||
59819849|NCT00505778|75942138|FG001|COMPLETED|Overall Study||378||
59819850|NCT00505778|75942137|FG000|NOT COMPLETED|Overall Study||134||
59819851|NCT00505778|75942138|FG001|NOT COMPLETED|Overall Study||135||
59819852|NCT00308074|75942144|FG000|STARTED|Overall Study||14||
59819853|NCT00308074|75942144|FG000|COMPLETED|Overall Study||13||
59819854|NCT00308074|75942144|FG000|NOT COMPLETED|Overall Study||1||
59819855|NCT00500760|75942150|FG000|STARTED|Overall Study||89||
59819856|NCT00500760|75942151|FG001|STARTED|Overall Study||64||
59819857|NCT00500760|75942150|FG000|Received Treatment|Overall Study||87||
59819858|NCT00500760|75942151|FG001|Received Treatment|Overall Study||63||
59819859|NCT00500760|75942150|FG000|COMPLETED|Overall Study||46||
59819860|NCT00500760|75942151|FG001|COMPLETED|Overall Study||40||
59819861|NCT00500760|75942150|FG000|NOT COMPLETED|Overall Study||43||
59819862|NCT00500760|75942151|FG001|NOT COMPLETED|Overall Study||24||
59819863|NCT00505622|75942160|FG000|STARTED|Overall Study||121||
59996324|NCT04150861|76112318|FG002|COMPLETED|Overall Study||8||
59996325|NCT04150861|76112316|FG000|NOT COMPLETED|Overall Study||0||
59819864|NCT00505622|75942161|FG001|STARTED|Overall Study||108||
59819865|NCT00505622|75942162|FG002|STARTED|Overall Study||96||
59819866|NCT00505622|75942160|FG000|COMPLETED|Overall Study||0||
59819867|NCT00505622|75942161|FG001|COMPLETED|Overall Study||0||
59819868|NCT00505622|75942162|FG002|COMPLETED|Overall Study||0||
59819869|NCT00505622|75942160|FG000|NOT COMPLETED|Overall Study||121||
59819870|NCT00505622|75942161|FG001|NOT COMPLETED|Overall Study||108||
59819871|NCT00505622|75942162|FG002|NOT COMPLETED|Overall Study||96||
59819872|NCT03851094|75942172|FG000|STARTED|Overall Study||111||
59819873|NCT03851094|75942173|FG001|STARTED|Overall Study||55||
59819874|NCT03851094|75942172|FG000|COMPLETED|Overall Study||111||
59819875|NCT03851094|75942173|FG001|COMPLETED|Overall Study||51||
59819876|NCT03851094|75942172|FG000|NOT COMPLETED|Overall Study||0||
59819877|NCT03851094|75942173|FG001|NOT COMPLETED|Overall Study||4||
59819878|NCT00505076|75942184|FG000|STARTED|Overall Study||22||
59819879|NCT00505076|75942185|FG001|STARTED|Overall Study||19||
59819880|NCT00505076|75942186|FG002|STARTED|Overall Study||22||
59819881|NCT00505076|75942184|FG000|COMPLETED|Overall Study||19||
59819882|NCT00505076|75942185|FG001|COMPLETED|Overall Study||17||
59819883|NCT00505076|75942186|FG002|COMPLETED|Overall Study||17||
59819884|NCT00505076|75942184|FG000|NOT COMPLETED|Overall Study||3||
59819885|NCT00505076|75942185|FG001|NOT COMPLETED|Overall Study||2||
59819886|NCT00505076|75942186|FG002|NOT COMPLETED|Overall Study||5||
59819887|NCT00307684|75942194|FG000|STARTED|Open Label Phase||0||
59819888|NCT00307684|75942195|FG001|STARTED|Open Label Phase||0||
59819889|NCT00307684|75942196|FG002|STARTED|Open Label Phase|1 screening failure|155||
59819890|NCT00307684|75942194|FG000|COMPLETED|Open Label Phase||0||
59819891|NCT00307684|75942195|FG001|COMPLETED|Open Label Phase||0||
59819892|NCT00307684|75942196|FG002|COMPLETED|Open Label Phase||99||
59819893|NCT00307684|75942194|FG000|NOT COMPLETED|Open Label Phase||0||
59819894|NCT00307684|75942195|FG001|NOT COMPLETED|Open Label Phase||0||
59819895|NCT00307684|75942196|FG002|NOT COMPLETED|Open Label Phase||56||
59819896|NCT00307684|75942194|FG000|STARTED|Double Blind Phase||23||
59713230|NCT01225211|75831746|FG000|STARTED|Overall Study||21||
59713231|NCT01225211|75831747|FG001|STARTED|Overall Study||20||
59713232|NCT01225211|75831748|FG002|STARTED|Overall Study||21||
59819897|NCT00307684|75942195|FG001|STARTED|Double Blind Phase||22||
59819898|NCT00307684|75942196|FG002|STARTED|Double Blind Phase||0||
59819899|NCT00307684|75942194|FG000|COMPLETED|Double Blind Phase||21||
59819900|NCT00307684|75942195|FG001|COMPLETED|Double Blind Phase||17||
59819901|NCT00307684|75942196|FG002|COMPLETED|Double Blind Phase||0||
59819902|NCT00307684|75942194|FG000|NOT COMPLETED|Double Blind Phase||2||
59819903|NCT00307684|75942195|FG001|NOT COMPLETED|Double Blind Phase||5||
59819904|NCT00307684|75942196|FG002|NOT COMPLETED|Double Blind Phase||0||
59819905|NCT00489918|75942209|FG000|STARTED|Overall Study||33||
59819906|NCT00489918|75942210|FG001|STARTED|Overall Study||34||
59819907|NCT00489918|75942211|FG002|STARTED|Overall Study||32||
59819908|NCT00489918|75942212|FG003|STARTED|Overall Study||33||
59819909|NCT00489918|75942213|FG004|STARTED|Overall Study||33||
59819910|NCT00489918|75942209|FG000|COMPLETED|Overall Study||31||
59819911|NCT00489918|75942210|FG001|COMPLETED|Overall Study||32||
59819912|NCT00489918|75942211|FG002|COMPLETED|Overall Study||28||
59713233|NCT01225211|75831749|FG003|STARTED|Overall Study||27||
59713234|NCT01225211|75831750|FG004|STARTED|Overall Study||23||
59713235|NCT01225211|75831751|FG005|STARTED|Overall Study||21||
59713236|NCT01225211|75831752|FG006|STARTED|Overall Study||42||
59713237|NCT01225211|75831753|FG007|STARTED|Overall Study||11||
59713238|NCT01225211|75831754|FG008|STARTED|Overall Study||63||
59713239|NCT01225211|75831755|FG009|STARTED|Overall Study||62||
59713240|NCT01225211|75831746|FG000|COMPLETED|Overall Study||21||
59713241|NCT01225211|75831747|FG001|COMPLETED|Overall Study||20||
59713242|NCT01225211|75831748|FG002|COMPLETED|Overall Study||20||
59713243|NCT01225211|75831749|FG003|COMPLETED|Overall Study||27||
59713244|NCT01225211|75831750|FG004|COMPLETED|Overall Study||23||
59819913|NCT00489918|75942212|FG003|COMPLETED|Overall Study||32||
59819914|NCT00489918|75942213|FG004|COMPLETED|Overall Study||32||
59819915|NCT00489918|75942209|FG000|NOT COMPLETED|Overall Study||2||
59819916|NCT00489918|75942210|FG001|NOT COMPLETED|Overall Study||2||
59819917|NCT00489918|75942211|FG002|NOT COMPLETED|Overall Study||4||
59819918|NCT00489918|75942212|FG003|NOT COMPLETED|Overall Study||1||
59819919|NCT00489918|75942213|FG004|NOT COMPLETED|Overall Study||1||
59819920|NCT00307294|75942225|FG000|STARTED|Overall Study||40||
59819921|NCT00307294|75942225|FG000|COMPLETED|Overall Study||39||
59819922|NCT00307294|75942225|FG000|NOT COMPLETED|Overall Study||1||
59819923|NCT03963401|75942236|FG000|STARTED|Initial Period (Day 1 - Week 16)||60||
59819924|NCT03963401|75942237|FG001|STARTED|Initial Period (Day 1 - Week 16)||61||
59819925|NCT03963401|75942238|FG002|STARTED|Initial Period (Day 1 - Week 16)||16||
59819926|NCT03963401|75942239|FG003|STARTED|Initial Period (Day 1 - Week 16)||15||
59819927|NCT03963401|75942240|FG004|STARTED|Initial Period (Day 1 - Week 16)||34||
59819928|NCT03963401|75942241|FG005|STARTED|Initial Period (Day 1 - Week 16)||33||
59819929|NCT03963401|75942236|FG000|Treated|Initial Period (Day 1 - Week 16)||60||
59819930|NCT03963401|75942237|FG001|Treated|Initial Period (Day 1 - Week 16)||60||
59819931|NCT03963401|75942238|FG002|Treated|Initial Period (Day 1 - Week 16)||16||
59819932|NCT03963401|75942239|FG003|Treated|Initial Period (Day 1 - Week 16)||15||
59819933|NCT03963401|75942240|FG004|Treated|Initial Period (Day 1 - Week 16)||34||
59819934|NCT03963401|75942241|FG005|Treated|Initial Period (Day 1 - Week 16)||33||
59819935|NCT03963401|75942236|FG000|COMPLETED|Initial Period (Day 1 - Week 16)||57||
59819936|NCT03963401|75942237|FG001|COMPLETED|Initial Period (Day 1 - Week 16)||57||
59819937|NCT03963401|75942238|FG002|COMPLETED|Initial Period (Day 1 - Week 16)||14||
59819938|NCT03963401|75942239|FG003|COMPLETED|Initial Period (Day 1 - Week 16)||13||
59819939|NCT03963401|75942240|FG004|COMPLETED|Initial Period (Day 1 - Week 16)||31||
59819940|NCT03963401|75942241|FG005|COMPLETED|Initial Period (Day 1 - Week 16)||31||
59819941|NCT03963401|75942236|FG000|NOT COMPLETED|Initial Period (Day 1 - Week 16)||3||
59713245|NCT01225211|75831751|FG005|COMPLETED|Overall Study||21||
59713246|NCT01225211|75831752|FG006|COMPLETED|Overall Study||41||
59713247|NCT01225211|75831753|FG007|COMPLETED|Overall Study||11||
59819942|NCT03963401|75942237|FG001|NOT COMPLETED|Initial Period (Day 1 - Week 16)||4||
59819943|NCT03963401|75942238|FG002|NOT COMPLETED|Initial Period (Day 1 - Week 16)||2||
59819944|NCT03963401|75942239|FG003|NOT COMPLETED|Initial Period (Day 1 - Week 16)||2||
59819945|NCT03963401|75942240|FG004|NOT COMPLETED|Initial Period (Day 1 - Week 16)||3||
59819946|NCT03963401|75942241|FG005|NOT COMPLETED|Initial Period (Day 1 - Week 16)||2||
59819947|NCT03963401|75942236|FG000|STARTED|Extension Period (Week 17 - Week 52)||57||
59819948|NCT03963401|75942237|FG001|STARTED|Extension Period (Week 17 - Week 52)||57||
59819949|NCT03963401|75942238|FG002|STARTED|Extension Period (Week 17 - Week 52)||14||
59819950|NCT03963401|75942239|FG003|STARTED|Extension Period (Week 17 - Week 52)||13||
59819951|NCT03963401|75942240|FG004|STARTED|Extension Period (Week 17 - Week 52)||31||
59819952|NCT03963401|75942241|FG005|STARTED|Extension Period (Week 17 - Week 52)||31||
59819953|NCT03963401|75942236|FG000|COMPLETED|Extension Period (Week 17 - Week 52)||43||
59819954|NCT03963401|75942237|FG001|COMPLETED|Extension Period (Week 17 - Week 52)||52||
59819955|NCT03963401|75942238|FG002|COMPLETED|Extension Period (Week 17 - Week 52)||10||
59819956|NCT03963401|75942239|FG003|COMPLETED|Extension Period (Week 17 - Week 52)||12||
59819957|NCT03963401|75942240|FG004|COMPLETED|Extension Period (Week 17 - Week 52)||25||
59819958|NCT03963401|75942241|FG005|COMPLETED|Extension Period (Week 17 - Week 52)||26||
59819959|NCT03963401|75942236|FG000|NOT COMPLETED|Extension Period (Week 17 - Week 52)||14||
59819960|NCT03963401|75942237|FG001|NOT COMPLETED|Extension Period (Week 17 - Week 52)||5||
59819961|NCT03963401|75942238|FG002|NOT COMPLETED|Extension Period (Week 17 - Week 52)||4||
60108450|NCT01661764|76228171|FG002|COMPLETED|Overall Study||22||
60108451|NCT01661764|76228172|FG003|COMPLETED|Overall Study||24||
59713248|NCT01225211|75831754|FG008|COMPLETED|Overall Study||62||
59713249|NCT01225211|75831755|FG009|COMPLETED|Overall Study||57||
59713250|NCT01225211|75831746|FG000|NOT COMPLETED|Overall Study||0||
59713251|NCT01225211|75831747|FG001|NOT COMPLETED|Overall Study||0||
59713252|NCT01225211|75831748|FG002|NOT COMPLETED|Overall Study||1||
59713253|NCT01225211|75831749|FG003|NOT COMPLETED|Overall Study||0||
59713254|NCT01225211|75831750|FG004|NOT COMPLETED|Overall Study||0||
59819962|NCT03963401|75942239|FG003|NOT COMPLETED|Extension Period (Week 17 - Week 52)||1||
59713255|NCT01225211|75831751|FG005|NOT COMPLETED|Overall Study||0||
59713256|NCT01225211|75831752|FG006|NOT COMPLETED|Overall Study||1||
59713257|NCT01225211|75831753|FG007|NOT COMPLETED|Overall Study||0||
60108452|NCT01661764|76228173|FG004|COMPLETED|Overall Study||16||
60108453|NCT01661764|76228174|FG005|COMPLETED|Overall Study||18||
60108454|NCT01661764|76228169|FG000|NOT COMPLETED|Overall Study||2||
60108455|NCT01661764|76228170|FG001|NOT COMPLETED|Overall Study||5||
60108456|NCT01661764|76228171|FG002|NOT COMPLETED|Overall Study||3||
60108457|NCT01661764|76228172|FG003|NOT COMPLETED|Overall Study||2||
60108458|NCT01661764|76228173|FG004|NOT COMPLETED|Overall Study||3||
60108459|NCT01661764|76228174|FG005|NOT COMPLETED|Overall Study||2||
60108460|NCT01816061|76228190|FG000|STARTED|Overall Study||40||
59713258|NCT01225211|75831754|FG008|NOT COMPLETED|Overall Study||1||
59713259|NCT01225211|75831755|FG009|NOT COMPLETED|Overall Study||5||
59713260|NCT02685709|75831816|FG000|STARTED|Run-in Phase||146||
59713261|NCT02685709|75831817|FG001|STARTED|Run-in Phase||0||
59713262|NCT02685709|75831818|FG002|STARTED|Run-in Phase||0||
59713263|NCT02685709|75831819|FG003|STARTED|Run-in Phase||0||
59713264|NCT02685709|75831816|FG000|COMPLETED|Run-in Phase|30 patients early terminated the Run-in phase and 24 patient were not randomized to RCT|116||
59713265|NCT02685709|75831817|FG001|COMPLETED|Run-in Phase||0||
59713266|NCT02685709|75831818|FG002|COMPLETED|Run-in Phase||0||
59713267|NCT02685709|75831819|FG003|COMPLETED|Run-in Phase||0||
59713268|NCT02685709|75831816|FG000|NOT COMPLETED|Run-in Phase||30||
59713269|NCT02685709|75831817|FG001|NOT COMPLETED|Run-in Phase||0||
59713270|NCT02685709|75831818|FG002|NOT COMPLETED|Run-in Phase||0||
59819963|NCT03963401|75942240|FG004|NOT COMPLETED|Extension Period (Week 17 - Week 52)||6||
59819964|NCT03963401|75942241|FG005|NOT COMPLETED|Extension Period (Week 17 - Week 52)||5||
59819965|NCT00334282|75942261|FG000|STARTED|Overall Study||290||
59819966|NCT00334282|75942262|FG001|STARTED|Overall Study||145||
59713271|NCT02685709|75831819|FG003|NOT COMPLETED|Run-in Phase||0||
59713272|NCT02685709|75831816|FG000|STARTED|RCT Phase|116 patients completed the Run-in phase, out of which 92 were randomized to the RCT phase, and 24 were not randomized to the RCT phase. Out of these 24, 11 patients eneterd the combination phase.|0||
59713273|NCT02685709|75831817|FG001|STARTED|RCT Phase||55||
59713274|NCT02685709|75831818|FG002|STARTED|RCT Phase||37||
59819967|NCT00334282|75942261|FG000|COMPLETED|Overall Study||68||
59819968|NCT00334282|75942262|FG001|COMPLETED|Overall Study||37||
59819969|NCT00334282|75942261|FG000|NOT COMPLETED|Overall Study||222||
59819970|NCT00334282|75942262|FG001|NOT COMPLETED|Overall Study||108||
59819971|NCT00306670|75942274|FG000|STARTED|Overall Study|no patients recruited; Genentech, the study sponsor, pulled funding and discontinued the protocol|0||
59819972|NCT00306670|75942275|FG001|STARTED|Overall Study|2 patients recruited; Genentech, the study sponsor, discontinued trial before treatment started|2||
59819973|NCT00306670|75942274|FG000|COMPLETED|Overall Study|no patients recruited; Genentech, the study sponsor, pulled funding and discontinued the protocol|0||
59819974|NCT00306670|75942275|FG001|COMPLETED|Overall Study|2 patients recruited; Genentech, the study sponsor, discontinued study before treatment initiated|0||
59819975|NCT00306670|75942274|FG000|NOT COMPLETED|Overall Study||0||
59819976|NCT00306670|75942275|FG001|NOT COMPLETED|Overall Study||2||
59819977|NCT00306592|75942281|FG000|STARTED|Overall Study||404||
59819978|NCT00306592|75942282|FG001|STARTED|Overall Study||690||
59566942|NCT00553436|75669704|FG000|NOT COMPLETED|Overall Study||1||
59566943|NCT04034121|75669708|FG000|STARTED|European Cohort|The European Cohort enrolled 30 patients|30||
59566944|NCT04034121|75669708|FG000|COMPLETED|European Cohort||30||
59566945|NCT04034121|75669708|FG000|NOT COMPLETED|European Cohort||0||
59566946|NCT04034121|75669708|FG000|STARTED|Brazil Cohort|The Brazil Cohort enrolled 20 patients|20|20 patients enrolled in Brazil continued follow-up through 3 years|
59566947|NCT04034121|75669708|FG000|COMPLETED|Brazil Cohort||20||
59566948|NCT04034121|75669708|FG000|NOT COMPLETED|Brazil Cohort||0||
59566949|NCT04026399|75669715|FG000|STARTED|Overall Study||6||
59566950|NCT04026399|75669716|FG001|STARTED|Overall Study||6||
59566951|NCT04026399|75669715|FG000|COMPLETED|Overall Study||1||
59566952|NCT04026399|75669716|FG001|COMPLETED|Overall Study||3||
59713275|NCT02685709|75831819|FG003|STARTED|RCT Phase||0||
59713276|NCT02685709|75831816|FG000|COMPLETED|RCT Phase||0||
59713277|NCT02685709|75831817|FG001|COMPLETED|RCT Phase||54||
59566953|NCT04026399|75669715|FG000|NOT COMPLETED|Overall Study||5||
59566954|NCT04026399|75669716|FG001|NOT COMPLETED|Overall Study||3||
59566955|NCT03852537|75669724|FG000|STARTED|Overall Study||23||
59566956|NCT03852537|75669725|FG001|STARTED|Overall Study||21||
59566957|NCT03852537|75669724|FG000|COMPLETED|Overall Study||23||
59566958|NCT03852537|75669725|FG001|COMPLETED|Overall Study||21||
59566959|NCT03852537|75669724|FG000|NOT COMPLETED|Overall Study||0||
59566960|NCT03852537|75669725|FG001|NOT COMPLETED|Overall Study||0||
59566961|NCT03875859|75669731|FG000|STARTED|Overall Study||4||
59566962|NCT03875859|75669731|FG000|COMPLETED|Overall Study||4||
59566963|NCT03875859|75669731|FG000|NOT COMPLETED|Overall Study||0||
59566964|NCT00553202|75669735|FG000|STARTED|Overall Study||158||
59566965|NCT00553202|75669735|FG000|COMPLETED|Overall Study||90||
59566966|NCT00553202|75669735|FG000|NOT COMPLETED|Overall Study||68||
59566967|NCT04133415|75669740|FG000|STARTED|Overall Study||20||
59566968|NCT04133415|75669740|FG000|COMPLETED|Overall Study||20||
59566969|NCT04133415|75669740|FG000|NOT COMPLETED|Overall Study||0||
59566970|NCT04016259|75669746|FG000|STARTED|Overall Study||15||
59566971|NCT04016259|75669747|FG001|STARTED|Overall Study||15||
59566972|NCT04016259|75669746|FG000|COMPLETED|Overall Study||15||
59566973|NCT04016259|75669747|FG001|COMPLETED|Overall Study||15||
59566974|NCT04016259|75669746|FG000|NOT COMPLETED|Overall Study||0||
59566975|NCT04016259|75669747|FG001|NOT COMPLETED|Overall Study||0||
59566976|NCT03874377|75669753|FG000|STARTED|Overall Study||11||
59566977|NCT03874377|75669753|FG000|COMPLETED|Overall Study||8||
59566978|NCT03874377|75669753|FG000|NOT COMPLETED|Overall Study||3||
59566979|NCT00552188|75669759|FG000|STARTED|Overall Study||26||
59566980|NCT00552188|75669760|FG001|STARTED|Overall Study||26||
59713278|NCT02685709|75831818|FG002|COMPLETED|RCT Phase||35||
59713279|NCT02685709|75831819|FG003|COMPLETED|RCT Phase||0||
59713280|NCT02685709|75831816|FG000|NOT COMPLETED|RCT Phase||0||
59713281|NCT02685709|75831817|FG001|NOT COMPLETED|RCT Phase||1||
59713282|NCT02685709|75831818|FG002|NOT COMPLETED|RCT Phase||2||
59713283|NCT02685709|75831819|FG003|NOT COMPLETED|RCT Phase||0||
59819979|NCT00306592|75942281|FG000|Completed at 24 Weeks|Overall Study||207||
59819980|NCT00306592|75942282|FG001|Completed at 24 Weeks|Overall Study||0||
59819981|NCT00306592|75942281|FG000|Completed Between 24 and 48 Weeks|Overall Study||85||
59819982|NCT00306592|75942282|FG001|Completed Between 24 and 48 Weeks|Overall Study||0||
59819983|NCT00306592|75942281|FG000|Completed at 48 Weeks|Overall Study||81||
59566981|NCT00552188|75669759|FG000|COMPLETED|Overall Study||24||
59566982|NCT00552188|75669760|FG001|COMPLETED|Overall Study||21||
59566983|NCT00552188|75669759|FG000|NOT COMPLETED|Overall Study||2||
59566984|NCT00552188|75669760|FG001|NOT COMPLETED|Overall Study||5||
59566985|NCT04027803|75669768|FG000|STARTED|Overall Study||39||
59566986|NCT04027803|75669769|FG001|STARTED|Overall Study||39||
59566987|NCT04027803|75669768|FG000|COMPLETED|Overall Study||39||
59713284|NCT02685709|75831816|FG000|STARTED|Combination Phase||0||
59713285|NCT02685709|75831817|FG001|STARTED|Combination Phase||0||
59819984|NCT00306592|75942282|FG001|Completed at 48 Weeks|Overall Study||632||
59819985|NCT00306592|75942281|FG000|Entered 101-MS-321 Extension Study|Overall Study||22||
59819986|NCT00306592|75942282|FG001|Entered 101-MS-321 Extension Study|Overall Study|pertains to participants transitioning from 101-MS-322 (NCT00306592) study only|0||
59819987|NCT00306592|75942281|FG000|COMPLETED|Overall Study||373||
59819988|NCT00306592|75942282|FG001|COMPLETED|Overall Study||632||
59819989|NCT00306592|75942281|FG000|NOT COMPLETED|Overall Study||31||
59819990|NCT00306592|75942282|FG001|NOT COMPLETED|Overall Study||58||
59819991|NCT00321646|75942286|FG000|STARTED|Neoadjuvant Chemotherapy||42||
59819992|NCT00321646|75942286|FG000|COMPLETED|Neoadjuvant Chemotherapy|1 pt withdrew before start of therapy, 38 completed 6 cycles neoadjuvant therapy.|38||
59819993|NCT00321646|75942286|FG000|NOT COMPLETED|Neoadjuvant Chemotherapy||4||
59819994|NCT00321646|75942286|FG000|STARTED|Prostatectomy||37||
59819995|NCT00321646|75942286|FG000|COMPLETED|Prostatectomy||37||
59819996|NCT00321646|75942286|FG000|NOT COMPLETED|Prostatectomy||0||
59819997|NCT00403767|75942292|FG000|STARTED|Overall Study||7111||
59819998|NCT00403767|75942293|FG001|STARTED|Overall Study||7125||
59819999|NCT00403767|75942292|FG000|COMPLETED|Overall Study||4591||
59820000|NCT00403767|75942293|FG001|COMPLETED|Overall Study||4657||
59820001|NCT00403767|75942292|FG000|NOT COMPLETED|Overall Study||2520||
59820002|NCT00403767|75942293|FG001|NOT COMPLETED|Overall Study||2468||
59820003|NCT00492284|75942303|FG000|STARTED|Overall Study||39||
59820004|NCT00492284|75942304|FG001|STARTED|Overall Study||39||
59820005|NCT00492284|75942305|FG002|STARTED|Overall Study||43||
59820006|NCT00492284|75942306|FG003|STARTED|Overall Study||41||
59820007|NCT00492284|75942303|FG000|COMPLETED|Overall Study||38||
59820008|NCT00492284|75942304|FG001|COMPLETED|Overall Study||35||
59820009|NCT00492284|75942305|FG002|COMPLETED|Overall Study||37||
59820010|NCT00492284|75942306|FG003|COMPLETED|Overall Study||31||
59820011|NCT00492284|75942303|FG000|NOT COMPLETED|Overall Study||1||
59820012|NCT00492284|75942304|FG001|NOT COMPLETED|Overall Study||4||
59820013|NCT00492284|75942305|FG002|NOT COMPLETED|Overall Study||6||
60108461|NCT01816061|76228191|FG001|STARTED|Overall Study||51||
60108462|NCT01816061|76228190|FG000|COMPLETED|Overall Study||27||
60108463|NCT01816061|76228191|FG001|COMPLETED|Overall Study||27||
60108464|NCT01816061|76228190|FG000|NOT COMPLETED|Overall Study||13||
60108465|NCT01816061|76228191|FG001|NOT COMPLETED|Overall Study||24||
60108466|NCT01662778|76228197|FG000|STARTED|Period 1||6||
60108467|NCT01662778|76228198|FG001|STARTED|Period 1||5||
60108468|NCT01662778|76228199|FG002|STARTED|Period 1||6||
60108469|NCT01662778|76228200|FG003|STARTED|Period 1||4||
60108470|NCT01662778|76228197|FG000|COMPLETED|Period 1||6||
59713286|NCT02685709|75831818|FG002|STARTED|Combination Phase||0||
59713287|NCT02685709|75831819|FG003|STARTED|Combination Phase|14 patients entered the combination phase (3 patients early discontinued the Run-in phase, and 11 patients completed Run-in and were not eligible to RCT phase).|14||
59713288|NCT02685709|75831816|FG000|COMPLETED|Combination Phase||0||
59713289|NCT02685709|75831817|FG001|COMPLETED|Combination Phase||0||
59713290|NCT02685709|75831818|FG002|COMPLETED|Combination Phase||0||
59713291|NCT02685709|75831819|FG003|COMPLETED|Combination Phase||8||
59713292|NCT02685709|75831816|FG000|NOT COMPLETED|Combination Phase||0||
59713293|NCT02685709|75831817|FG001|NOT COMPLETED|Combination Phase||0||
59713294|NCT02685709|75831818|FG002|NOT COMPLETED|Combination Phase||0||
59713295|NCT02685709|75831819|FG003|NOT COMPLETED|Combination Phase||6||
59713296|NCT02265367|75831831|FG000|STARTED|Overall Study||28||
59713297|NCT02265367|75831832|FG001|STARTED|Overall Study||28||
59713298|NCT02265367|75831831|FG000|Completed First 3-week Period|Overall Study||24||
59713299|NCT02265367|75831832|FG001|Completed First 3-week Period|Overall Study||26||
59820014|NCT00492284|75942306|FG003|NOT COMPLETED|Overall Study||10||
59820015|NCT00510458|75942316|FG000|STARTED|Overall Study||74||78
59820016|NCT00510458|75942316|FG000|COMPLETED|Overall Study||27||27
59820017|NCT00510458|75942316|FG000|NOT COMPLETED|Overall Study||47||51
59820018|NCT00414765|75942323|FG000|STARTED|Overall Study||7||
59820019|NCT00414765|75942324|FG001|STARTED|Overall Study||19||
59820020|NCT00414765|75942323|FG000|Completed Study|Overall Study||7|A participant was considered a completer when the participant did not die or have disease progression at the end of treatment.|
59820021|NCT00414765|75942324|FG001|Completed Study|Overall Study||18|A participant was considered a completer when the participant did not die or have disease progression at the end of treatment.|
59820022|NCT00414765|75942323|FG000|Completed Cycle 1|Overall Study||7|Completion of a cycle was defined as any participant who received at least seven IV infusions during the cycle.|
59820023|NCT00414765|75942324|FG001|Completed Cycle 1|Overall Study||19|Completion of a cycle was defined as any participant who received at least seven IV infusions during the cycle.|
59820024|NCT00414765|75942323|FG000|Completed Cycle 2|Overall Study||4|Completion of a cycle was defined as any participant who received at least seven IV infusions during the cycle.|
59820025|NCT00414765|75942324|FG001|Completed Cycle 2|Overall Study||16|Completion of a cycle was defined as any participant who received at least seven IV infusions during the cycle.|
59820026|NCT00414765|75942323|FG000|COMPLETED|Overall Study||1||
60108471|NCT01662778|76228198|FG001|COMPLETED|Period 1||5||
60108472|NCT01662778|76228199|FG002|COMPLETED|Period 1||6||
60108473|NCT01662778|76228200|FG003|COMPLETED|Period 1||4||
60108474|NCT01662778|76228197|FG000|NOT COMPLETED|Period 1||0||
60108475|NCT01662778|76228198|FG001|NOT COMPLETED|Period 1||0||
59820027|NCT00414765|75942324|FG001|COMPLETED|Overall Study||8||
59820028|NCT00414765|75942323|FG000|NOT COMPLETED|Overall Study||6||
59820029|NCT00414765|75942324|FG001|NOT COMPLETED|Overall Study||11||
59820030|NCT00500682|75942332|FG000|STARTED|Overall Study||510||
59820031|NCT00500682|75942333|FG001|STARTED|Overall Study||510||
59820032|NCT00500682|75942332|FG000|COMPLETED|Overall Study||204||
59820033|NCT00500682|75942333|FG001|COMPLETED|Overall Study||223||
59820034|NCT00500682|75942332|FG000|NOT COMPLETED|Overall Study||306||
59820035|NCT00500682|75942333|FG001|NOT COMPLETED|Overall Study||287||
59820036|NCT00500370|75942341|FG000|STARTED|Overall Study||80||
59820037|NCT00500370|75942342|FG001|STARTED|Overall Study||83||
59820038|NCT00500370|75942341|FG000|Treatment Start-Baseline (Week 0)|Overall Study||73||
59713300|NCT02265367|75831831|FG000|COMPLETED|Overall Study||18|Completer defined as participants who completed at least 2 of the 5 assessments occurring during the third week of each three-week period.|
59713301|NCT02265367|75831832|FG001|COMPLETED|Overall Study||22|Completer defined as participants who completed at least 2 of the 5 assessments occurring during the third week of each three-week period.|
59713302|NCT02265367|75831831|FG000|NOT COMPLETED|Overall Study||10||
59713303|NCT02265367|75831832|FG001|NOT COMPLETED|Overall Study||6||
59820039|NCT00500370|75942342|FG001|Treatment Start-Baseline (Week 0)|Overall Study||79||
59820040|NCT00500370|75942341|FG000|Treatment Complete (Week 24)|Overall Study||48||
59820041|NCT00500370|75942342|FG001|Treatment Complete (Week 24)|Overall Study||54||
59820042|NCT00500370|75942341|FG000|COMPLETED|Overall Study|COMPLETED = completion of treatment period (Week 24) plus follow-up visit 4 weeks later|47||
59820043|NCT00500370|75942342|FG001|COMPLETED|Overall Study|COMPLETED = completion of treatment period (Week 24) plus follow-up visit 4 weeks later|49||
59820044|NCT00500370|75942341|FG000|NOT COMPLETED|Overall Study||33||
59820045|NCT00500370|75942342|FG001|NOT COMPLETED|Overall Study||34||
59820046|NCT00320788|75942353|FG000|STARTED|Overall Study||32||
59820047|NCT00320788|75942354|FG001|STARTED|Overall Study||32||
59820048|NCT00320788|75942355|FG002|STARTED|Overall Study||32||
59820049|NCT00320788|75942356|FG003|STARTED|Overall Study|Participants Randomized|32||
59820050|NCT00320788|75942357|FG004|STARTED|Overall Study||31||
59820051|NCT00320788|75942353|FG000|Participants Received Treatment (SAF)|Overall Study||32||
59820052|NCT00320788|75942354|FG001|Participants Received Treatment (SAF)|Overall Study||32||
59820053|NCT00320788|75942355|FG002|Participants Received Treatment (SAF)|Overall Study|One participant in this group did not receive treatment and was not included in the SAF and FAS|31||
59820054|NCT00320788|75942356|FG003|Participants Received Treatment (SAF)|Overall Study|One participant in this group did not receive treatment and was not included in the SAF and FAS|31||
59820055|NCT00320788|75942357|FG004|Participants Received Treatment (SAF)|Overall Study||31||
59820056|NCT00320788|75942353|FG000|COMPLETED|Overall Study||26||
59820057|NCT00320788|75942354|FG001|COMPLETED|Overall Study||26||
59820058|NCT00320788|75942355|FG002|COMPLETED|Overall Study||29||
59713304|NCT01224821|75831838|FG000|STARTED|Dosimetric and Therapeutic Treatment||47||
59713305|NCT01224821|75831838|FG000|COMPLETED|Dosimetric and Therapeutic Treatment|This participant completed the study per Protocol Amendment 2.|1||
59713306|NCT01224821|75831838|FG000|NOT COMPLETED|Dosimetric and Therapeutic Treatment||46||
59713307|NCT01224821|75831838|FG000|STARTED|Long-Term Follow-Up|11/47 participants withdrawing from this study enrolled in the LTFU study for continued evaluation.|11||
59713308|NCT01224821|75831838|FG000|COMPLETED|Long-Term Follow-Up||0||
59713309|NCT01224821|75831838|FG000|NOT COMPLETED|Long-Term Follow-Up||11||
59713310|NCT02684851|75831844|FG000|STARTED|Overall Study||42||
59713311|NCT02684851|75831845|FG001|STARTED|Overall Study||45||
59713312|NCT02684851|75831844|FG000|COMPLETED|Overall Study||42||
59713313|NCT02684851|75831845|FG001|COMPLETED|Overall Study||45||
59713314|NCT02684851|75831844|FG000|NOT COMPLETED|Overall Study||0||
59713315|NCT02684851|75831845|FG001|NOT COMPLETED|Overall Study||0||
59713316|NCT01224431|75831855|FG000|STARTED|Overall Study||30||
59713317|NCT01224431|75831856|FG001|STARTED|Overall Study||30||
59713318|NCT01224431|75831855|FG000|COMPLETED|Overall Study||30||
59713319|NCT01224431|75831856|FG001|COMPLETED|Overall Study||25||
59713320|NCT01224431|75831855|FG000|NOT COMPLETED|Overall Study||0||
59713321|NCT01224431|75831856|FG001|NOT COMPLETED|Overall Study||5||
59713322|NCT01223183|75831866|FG000|STARTED|Imaging Day 1||10||
59713323|NCT01223183|75831867|FG001|STARTED|Imaging Day 1||10||
59713324|NCT01223183|75831866|FG000|COMPLETED|Imaging Day 1||10||
59713325|NCT01223183|75831867|FG001|COMPLETED|Imaging Day 1||9||
59713326|NCT01223183|75831866|FG000|NOT COMPLETED|Imaging Day 1||0||
59820059|NCT00320788|75942356|FG003|COMPLETED|Overall Study||27||
59820060|NCT00320788|75942357|FG004|COMPLETED|Overall Study||26||
59820061|NCT00320788|75942353|FG000|NOT COMPLETED|Overall Study||6||
59820062|NCT00320788|75942354|FG001|NOT COMPLETED|Overall Study||6||
59820063|NCT00320788|75942355|FG002|NOT COMPLETED|Overall Study||3||
59820064|NCT00320788|75942356|FG003|NOT COMPLETED|Overall Study||5||
59820065|NCT00320788|75942357|FG004|NOT COMPLETED|Overall Study||5||
59820066|NCT00503984|75942377|FG000|STARTED|Overall Study||3||
59820067|NCT00503984|75942378|FG001|STARTED|Overall Study||3||
59820068|NCT00503984|75942379|FG002|STARTED|Overall Study||3||
59820069|NCT00503984|75942380|FG003|STARTED|Overall Study||6||
59820070|NCT00503984|75942381|FG004|STARTED|Overall Study||6||
59820071|NCT00503984|75942382|FG005|STARTED|Overall Study||1||
59713327|NCT01223183|75831867|FG001|NOT COMPLETED|Imaging Day 1||1||
59713328|NCT01223183|75831866|FG000|STARTED|Washout Period (5-24 Days)||10||
59713329|NCT01223183|75831867|FG001|STARTED|Washout Period (5-24 Days)||9||
59713330|NCT01223183|75831866|FG000|COMPLETED|Washout Period (5-24 Days)||8||
59713331|NCT01223183|75831867|FG001|COMPLETED|Washout Period (5-24 Days)||9||
59713332|NCT01223183|75831866|FG000|NOT COMPLETED|Washout Period (5-24 Days)||2||
59713333|NCT01223183|75831867|FG001|NOT COMPLETED|Washout Period (5-24 Days)||0||
59713334|NCT01223183|75831866|FG000|STARTED|Imaging Day 2||8||
59713335|NCT01223183|75831867|FG001|STARTED|Imaging Day 2||9||
59713336|NCT01223183|75831866|FG000|COMPLETED|Imaging Day 2||8||
59713337|NCT01223183|75831867|FG001|COMPLETED|Imaging Day 2||9||
59713338|NCT01223183|75831866|FG000|NOT COMPLETED|Imaging Day 2||0||
59713339|NCT01223183|75831867|FG001|NOT COMPLETED|Imaging Day 2||0||
59713340|NCT01223027|75831876|FG000|STARTED|Overall Study||284||
59713341|NCT01223027|75831877|FG001|STARTED|Overall Study||286||
59713342|NCT01223027|75831876|FG000|COMPLETED|Overall Study|Completed = Ongoing at data cut-off of 25-Jan-2013|10||
59713343|NCT01223027|75831877|FG001|COMPLETED|Overall Study|Completed = Ongoing at data cut-off of 25-Jan-2013|9||
59713344|NCT01223027|75831876|FG000|NOT COMPLETED|Overall Study||274||
59713345|NCT01223027|75831877|FG001|NOT COMPLETED|Overall Study||277||
59713346|NCT01015287|75831885|FG000|STARTED|Overall Study||1996||
59713347|NCT01015287|75831886|FG001|STARTED|Overall Study||2037||
59713348|NCT01015287|75831885|FG000|Received at Least 1 Dose of Study Drug|Overall Study||1996||
59713349|NCT01015287|75831886|FG001|Received at Least 1 Dose of Study Drug|Overall Study||2037||
59820072|NCT00503984|75942377|FG000|COMPLETED|Overall Study||3||
59820073|NCT00503984|75942378|FG001|COMPLETED|Overall Study||1||
59820074|NCT00503984|75942379|FG002|COMPLETED|Overall Study||3||
59820075|NCT00503984|75942380|FG003|COMPLETED|Overall Study||6||
59820076|NCT00503984|75942381|FG004|COMPLETED|Overall Study||5||
59820077|NCT00503984|75942382|FG005|COMPLETED|Overall Study||1||
59820078|NCT00503984|75942377|FG000|NOT COMPLETED|Overall Study||0||
59820079|NCT00503984|75942378|FG001|NOT COMPLETED|Overall Study||2||
59820080|NCT00503984|75942379|FG002|NOT COMPLETED|Overall Study||0||
59820081|NCT00503984|75942380|FG003|NOT COMPLETED|Overall Study||0||
59820082|NCT00503984|75942381|FG004|NOT COMPLETED|Overall Study||1||
59820083|NCT00503984|75942382|FG005|NOT COMPLETED|Overall Study||0||
59820084|NCT00565409|75942406|FG000|STARTED|Period 1 Open Label||834||
59820085|NCT00565409|75942407|FG001|STARTED|Period 1 Open Label||0||
59820086|NCT00565409|75942408|FG002|STARTED|Period 1 Open Label||0||
59820087|NCT00565409|75942409|FG003|STARTED|Period 1 Open Label||0||
59820088|NCT00565409|75942406|FG000|COMPLETED|Period 1 Open Label||756||
59820089|NCT00565409|75942407|FG001|COMPLETED|Period 1 Open Label||0||
59820090|NCT00565409|75942408|FG002|COMPLETED|Period 1 Open Label||0||
59820091|NCT00565409|75942409|FG003|COMPLETED|Period 1 Open Label||0||
59820092|NCT00565409|75942406|FG000|NOT COMPLETED|Period 1 Open Label||78||
59820093|NCT00565409|75942407|FG001|NOT COMPLETED|Period 1 Open Label||0||
59820094|NCT00565409|75942408|FG002|NOT COMPLETED|Period 1 Open Label||0||
59820095|NCT00565409|75942409|FG003|NOT COMPLETED|Period 1 Open Label||0||
59820096|NCT00565409|75942406|FG000|STARTED|After Period 1, Prior to Period 2||756||
59820097|NCT00565409|75942407|FG001|STARTED|After Period 1, Prior to Period 2||0||
59820098|NCT00565409|75942408|FG002|STARTED|After Period 1, Prior to Period 2||0||
59820099|NCT00565409|75942409|FG003|STARTED|After Period 1, Prior to Period 2||0||
59713350|NCT01015287|75831885|FG000|COMPLETED|Overall Study||1924||
59713351|NCT01015287|75831886|FG001|COMPLETED|Overall Study||1958||
60108476|NCT01662778|76228199|FG002|NOT COMPLETED|Period 1||0||
59713352|NCT01015287|75831885|FG000|NOT COMPLETED|Overall Study||72||
59713353|NCT01015287|75831886|FG001|NOT COMPLETED|Overall Study||79||
59713354|NCT01015131|75831894|FG000|STARTED|Overall Study||44||
59713355|NCT01015131|75831894|FG000|COMPLETED|Overall Study||36||
59713356|NCT01015131|75831894|FG000|NOT COMPLETED|Overall Study||8||
59820100|NCT00565409|75942406|FG000|COMPLETED|After Period 1, Prior to Period 2||604||
59820101|NCT00565409|75942407|FG001|COMPLETED|After Period 1, Prior to Period 2||0||
59820102|NCT00565409|75942408|FG002|COMPLETED|After Period 1, Prior to Period 2||0||
59820103|NCT00565409|75942409|FG003|COMPLETED|After Period 1, Prior to Period 2||0||
59820104|NCT00565409|75942406|FG000|NOT COMPLETED|After Period 1, Prior to Period 2||152||
59820105|NCT00565409|75942407|FG001|NOT COMPLETED|After Period 1, Prior to Period 2||0||
59820106|NCT00565409|75942408|FG002|NOT COMPLETED|After Period 1, Prior to Period 2||0||
59820107|NCT00565409|75942409|FG003|NOT COMPLETED|After Period 1, Prior to Period 2||0||
59820108|NCT00565409|75942406|FG000|STARTED|Period 2 Double-Blind||0||
59820109|NCT00565409|75942407|FG001|STARTED|Period 2 Double-Blind||202||
60108477|NCT01662778|76228200|FG003|NOT COMPLETED|Period 1||0||
60108478|NCT01662778|76228197|FG000|STARTED|Period 2||6||
60108479|NCT01662778|76228198|FG001|STARTED|Period 2||5||
59713357|NCT01222715|75831900|FG000|STARTED|Overall Study||44||
59713358|NCT01222715|75831901|FG001|STARTED|Overall Study||43||
59713359|NCT01222715|75831900|FG000|COMPLETED|Overall Study||8||
59713360|NCT01222715|75831901|FG001|COMPLETED|Overall Study||16||
59820110|NCT00565409|75942408|FG002|STARTED|Period 2 Double-Blind||202||
59820111|NCT00565409|75942409|FG003|STARTED|Period 2 Double-Blind||200||
59820112|NCT00565409|75942406|FG000|COMPLETED|Period 2 Double-Blind||0||
59820113|NCT00565409|75942407|FG001|COMPLETED|Period 2 Double-Blind||181||
59820114|NCT00565409|75942408|FG002|COMPLETED|Period 2 Double-Blind||175||
59820115|NCT00565409|75942409|FG003|COMPLETED|Period 2 Double-Blind||141||
59820116|NCT00565409|75942406|FG000|NOT COMPLETED|Period 2 Double-Blind||0||
59820117|NCT00565409|75942407|FG001|NOT COMPLETED|Period 2 Double-Blind||21||
59820118|NCT00565409|75942408|FG002|NOT COMPLETED|Period 2 Double-Blind||27||
59820119|NCT00565409|75942409|FG003|NOT COMPLETED|Period 2 Double-Blind||59||
59820120|NCT00394251|75942421|FG000|STARTED|Overall Study||98||
59820121|NCT00394251|75942422|FG001|STARTED|Overall Study||99||
59820122|NCT00394251|75942421|FG000|At Least One Dose of Taxane|Overall Study||93||
59820123|NCT00394251|75942422|FG001|At Least One Dose of Taxane|Overall Study||93||
59713361|NCT01222715|75831900|FG000|NOT COMPLETED|Overall Study||36||
59713362|NCT01222715|75831901|FG001|NOT COMPLETED|Overall Study||27||
59820124|NCT00394251|75942421|FG000|COMPLETED|Overall Study||61||
59820125|NCT00394251|75942422|FG001|COMPLETED|Overall Study||61||
59820126|NCT00394251|75942421|FG000|NOT COMPLETED|Overall Study||37||
59820127|NCT00394251|75942422|FG001|NOT COMPLETED|Overall Study||38||
59820128|NCT00394095|75942434|FG000|STARTED|Overall Study||17||
59820129|NCT00394095|75942435|FG001|STARTED|Overall Study||14||
59820130|NCT00394095|75942434|FG000|Screened|Overall Study||17||
59820131|NCT00394095|75942435|FG001|Screened|Overall Study||14||
59820132|NCT00394095|75942434|FG000|COMPLETED|Overall Study||16||
59820133|NCT00394095|75942435|FG001|COMPLETED|Overall Study||14||
59820134|NCT00394095|75942434|FG000|NOT COMPLETED|Overall Study||1||
59820135|NCT00394095|75942435|FG001|NOT COMPLETED|Overall Study||0||
59820136|NCT00503906|75942442|FG000|STARTED|Overall Study||30||
59820137|NCT00503906|75942442|FG000|COMPLETED|Overall Study||29||
59820138|NCT00503906|75942442|FG000|NOT COMPLETED|Overall Study||1||
59820139|NCT00305110|75942447|FG000|STARTED|Overall Study||298||
59820140|NCT00305110|75942447|FG000|All Necessary Data Collected|Overall Study||269||
59820141|NCT00305110|75942447|FG000|COMPLETED|Overall Study||269||
59820142|NCT00305110|75942447|FG000|NOT COMPLETED|Overall Study||29||
59820143|NCT00491894|75942451|FG000|STARTED|Overall Study||137||
59820144|NCT00491894|75942451|FG000|COMPLETED|Overall Study||103||
60108480|NCT01662778|76228199|FG002|STARTED|Period 2||6||
60108481|NCT01662778|76228200|FG003|STARTED|Period 2||4||
59713363|NCT01222403|75831909|FG000|STARTED|Overall Study||386||
59713364|NCT01222403|75831910|FG001|STARTED|Overall Study||381||
59713365|NCT01222403|75831909|FG000|COMPLETED|Overall Study||386||
59713366|NCT01222403|75831910|FG001|COMPLETED|Overall Study||379||
59713367|NCT01222403|75831909|FG000|NOT COMPLETED|Overall Study||0||
59713368|NCT01222403|75831910|FG001|NOT COMPLETED|Overall Study||2||
59713369|NCT01222247|75831918|FG000|STARTED|Overall Study||1429||
59713370|NCT01222247|75831919|FG001|STARTED|Overall Study||1402||
59713371|NCT01222247|75831918|FG000|Received 2 Doses|Overall Study||860||
59713372|NCT01222247|75831919|FG001|Received 2 Doses|Overall Study||826||
59713373|NCT01222247|75831918|FG000|Received 1 Dose|Overall Study||568||
59713374|NCT01222247|75831919|FG001|Received 1 Dose|Overall Study||571||
59713375|NCT01222247|75831918|FG000|Did Not Receive Assigned Medication|Overall Study||1||
59713376|NCT01222247|75831919|FG001|Did Not Receive Assigned Medication|Overall Study||5||
59713377|NCT01222247|75831918|FG000|COMPLETED|Overall Study||1427||
59820145|NCT00491894|75942451|FG000|NOT COMPLETED|Overall Study||34||
59820146|NCT00491504|75942459|FG000|STARTED|Overall Study|All subjects who received MFNS only on Day 1|77||
59820147|NCT00491504|75942460|FG001|STARTED|Overall Study|All subjects who received placebo only on Day 1|78||
59820148|NCT00491504|75942461|FG002|STARTED|Overall Study|All subjects who received MFNS on Day 1 through Day 7|78||
59820149|NCT00491504|75942462|FG003|STARTED|Overall Study|All subjects who received placebo on Day 1 through Day 7|77||
59820150|NCT00491504|75942459|FG000|COMPLETED|Overall Study||77||
59820151|NCT00491504|75942460|FG001|COMPLETED|Overall Study||77||
59820152|NCT00491504|75942461|FG002|COMPLETED|Overall Study||74||
59820153|NCT00491504|75942462|FG003|COMPLETED|Overall Study||73||
59820154|NCT00491504|75942459|FG000|NOT COMPLETED|Overall Study||0||
59820155|NCT00491504|75942460|FG001|NOT COMPLETED|Overall Study||1||
59820156|NCT00491504|75942461|FG002|NOT COMPLETED|Overall Study||4||
59820157|NCT00491504|75942462|FG003|NOT COMPLETED|Overall Study||4||
59820158|NCT00500292|75942473|FG000|STARTED|Overall Study|randomised patients|32||
59820159|NCT00500292|75942474|FG001|STARTED|Overall Study|randomised patients|35||
59820160|NCT00500292|75942475|FG002|STARTED|Overall Study|randomised patients|37||
59820161|NCT00500292|75942473|FG000|COMPLETED|Overall Study|Ongoing study treatment at data cut-off date 8 March 2008.|7||
59820162|NCT00500292|75942474|FG001|COMPLETED|Overall Study|Ongoing study treatment at data cut-off date 8 March 2008.|4||
60108482|NCT01662778|76228197|FG000|COMPLETED|Period 2||6||
60108483|NCT01662778|76228198|FG001|COMPLETED|Period 2||5||
60108484|NCT01662778|76228199|FG002|COMPLETED|Period 2||6||
60108485|NCT01662778|76228200|FG003|COMPLETED|Period 2||4||
60108486|NCT01662778|76228197|FG000|NOT COMPLETED|Period 2||0||
59820163|NCT00500292|75942475|FG002|COMPLETED|Overall Study|Ongoing study treatment at data cut-off date 8 March 2008.|10||
59820164|NCT00500292|75942473|FG000|NOT COMPLETED|Overall Study||25||
59713378|NCT01222247|75831919|FG001|COMPLETED|Overall Study||1400||
59713379|NCT01222247|75831918|FG000|NOT COMPLETED|Overall Study||2||
59713380|NCT01222247|75831919|FG001|NOT COMPLETED|Overall Study||2||
59713381|NCT01014975|75831925|FG000|STARTED|Overall Study||8||
59713382|NCT01014975|75831926|FG001|STARTED|Overall Study||16||
59713383|NCT01014975|75831927|FG002|STARTED|Overall Study||16||
59713384|NCT01014975|75831925|FG000|COMPLETED|Overall Study||4||
59713385|NCT01014975|75831926|FG001|COMPLETED|Overall Study||13||
59713386|NCT01014975|75831927|FG002|COMPLETED|Overall Study||10||
59713387|NCT01014975|75831925|FG000|NOT COMPLETED|Overall Study||4||
59713388|NCT01014975|75831926|FG001|NOT COMPLETED|Overall Study||3||
59713389|NCT01014975|75831927|FG002|NOT COMPLETED|Overall Study||6||
59820165|NCT00500292|75942474|FG001|NOT COMPLETED|Overall Study||31||
59820166|NCT00500292|75942475|FG002|NOT COMPLETED|Overall Study||27||
59820167|NCT00499746|75942483|FG000|STARTED|Phase 1(6-9 One Day Sessions)||20||
59566988|NCT04027803|75669769|FG001|COMPLETED|Overall Study||39||
59566989|NCT04027803|75669768|FG000|NOT COMPLETED|Overall Study||0||
59566990|NCT04027803|75669769|FG001|NOT COMPLETED|Overall Study||0||
59566991|NCT00552110|75669780|FG000|STARTED|Overall Study|One subject was excluded from the intent to treat population because there was no record of dosing.|146||
59566992|NCT00552110|75669781|FG001|STARTED|Overall Study||139||
59566993|NCT00552110|75669782|FG002|STARTED|Overall Study||139||
59566994|NCT00552110|75669783|FG003|STARTED|Overall Study|One subject was excluded from the intent to treat population because there was no record of dosing.|141||
59566995|NCT00552110|75669784|FG004|STARTED|Overall Study||142||
59566996|NCT00552110|75669780|FG000|COMPLETED|Overall Study||142||
59566997|NCT00552110|75669781|FG001|COMPLETED|Overall Study||134||
59566998|NCT00552110|75669782|FG002|COMPLETED|Overall Study||137||
59566999|NCT00552110|75669783|FG003|COMPLETED|Overall Study||133||
59567000|NCT00552110|75669784|FG004|COMPLETED|Overall Study||133||
59567001|NCT00552110|75669780|FG000|NOT COMPLETED|Overall Study||4||
59567002|NCT00552110|75669781|FG001|NOT COMPLETED|Overall Study||5||
59567003|NCT00552110|75669782|FG002|NOT COMPLETED|Overall Study||2||
59713390|NCT01221623|75831937|FG000|STARTED|Overall Study||274||
59713391|NCT01221623|75831938|FG001|STARTED|Overall Study||141||
59713392|NCT01221623|75831937|FG000|COMPLETED|Overall Study||236||
59713393|NCT01221623|75831938|FG001|COMPLETED|Overall Study||127||
59713394|NCT01221623|75831937|FG000|NOT COMPLETED|Overall Study||38||
59713395|NCT01221623|75831938|FG001|NOT COMPLETED|Overall Study||14||
59713396|NCT01014585|75831948|FG000|STARTED|Overall Study||51||
59713397|NCT01014585|75831949|FG001|STARTED|Overall Study||100||
59713398|NCT01014585|75831950|FG002|STARTED|Overall Study||60||
59713399|NCT01014585|75831951|FG003|STARTED|Overall Study||129||
59713400|NCT01014585|75831948|FG000|COMPLETED|Overall Study||31||
59713401|NCT01014585|75831949|FG001|COMPLETED|Overall Study||75||
59713402|NCT01014585|75831950|FG002|COMPLETED|Overall Study||37||
59713403|NCT01014585|75831951|FG003|COMPLETED|Overall Study||99||
59713404|NCT01014585|75831948|FG000|NOT COMPLETED|Overall Study||20||
59713405|NCT01014585|75831949|FG001|NOT COMPLETED|Overall Study||25||
59713406|NCT01014585|75831950|FG002|NOT COMPLETED|Overall Study||23||
59713407|NCT01014585|75831951|FG003|NOT COMPLETED|Overall Study||30||
59713408|NCT01221233|75831963|FG000|STARTED|Overall Study||18||
59713409|NCT01221233|75831964|FG001|STARTED|Overall Study||20||
59713410|NCT01221233|75831963|FG000|COMPLETED|Overall Study||15||
59713411|NCT01221233|75831964|FG001|COMPLETED|Overall Study||19||
59820168|NCT00499746|75942483|FG000|COMPLETED|Phase 1(6-9 One Day Sessions)||8||
59820169|NCT00499746|75942483|FG000|NOT COMPLETED|Phase 1(6-9 One Day Sessions)||12||
59820170|NCT00499746|75942483|FG000|STARTED|Phase 2 (6-9 One Day Sessions)||8||
59820171|NCT00499746|75942483|FG000|COMPLETED|Phase 2 (6-9 One Day Sessions)||8||
59820172|NCT00499746|75942483|FG000|NOT COMPLETED|Phase 2 (6-9 One Day Sessions)||0||
59820173|NCT00499746|75942483|FG000|STARTED|Phase 3 (9-14 One Day Sessions)||8||
59820174|NCT00499746|75942483|FG000|COMPLETED|Phase 3 (9-14 One Day Sessions)||8||
60108487|NCT01662778|76228198|FG001|NOT COMPLETED|Period 2||0||
59567004|NCT00552110|75669783|FG003|NOT COMPLETED|Overall Study||8||
59567005|NCT00552110|75669784|FG004|NOT COMPLETED|Overall Study||9||
59567006|NCT03854253|75669798|FG000|STARTED|Overall Study||50||
59567007|NCT03854253|75669799|FG001|STARTED|Overall Study||50||
59567008|NCT03854253|75669798|FG000|COMPLETED|Overall Study||49||
59567009|NCT03854253|75669799|FG001|COMPLETED|Overall Study||50||
59567010|NCT03854253|75669798|FG000|NOT COMPLETED|Overall Study||1||
59713412|NCT01221233|75831963|FG000|NOT COMPLETED|Overall Study||3||
59713413|NCT01221233|75831964|FG001|NOT COMPLETED|Overall Study||1||
59713414|NCT01220609|75831970|FG000|STARTED|Overall Study||26||
59713415|NCT01220609|75831970|FG000|COMPLETED|Overall Study|Eligible and treated patients|23||
59713416|NCT01220609|75831970|FG000|NOT COMPLETED|Overall Study||3||
59713417|NCT01220297|75831982|FG000|STARTED|Overall Study||3||
59713418|NCT01220297|75831982|FG000|COMPLETED|Overall Study||0||
59713419|NCT01220297|75831982|FG000|NOT COMPLETED|Overall Study||3||
59820175|NCT00499746|75942483|FG000|NOT COMPLETED|Phase 3 (9-14 One Day Sessions)||0||
59820176|NCT00489216|75942497|FG000|STARTED|Overall Study||2||
59820177|NCT00489216|75942497|FG000|COMPLETED|Overall Study||1||
59820178|NCT00489216|75942497|FG000|NOT COMPLETED|Overall Study||1||
59820179|NCT00499590|75942504|FG000|STARTED|Overall Study||113||
59820180|NCT00499590|75942505|FG001|STARTED|Overall Study||112||
59820181|NCT00499590|75942506|FG002|STARTED|Overall Study||113||
59820182|NCT00499590|75942504|FG000|COMPLETED|Overall Study||0||
59820183|NCT00499590|75942505|FG001|COMPLETED|Overall Study||0||
59820184|NCT00499590|75942506|FG002|COMPLETED|Overall Study||0||
59820185|NCT00499590|75942504|FG000|NOT COMPLETED|Overall Study||113||
59820186|NCT00499590|75942505|FG001|NOT COMPLETED|Overall Study||112||
59820187|NCT00499590|75942506|FG002|NOT COMPLETED|Overall Study||113||
59820188|NCT00510146|75942517|FG000|STARTED|Double-Blind Treatment||343||
59820189|NCT00510146|75942518|FG001|STARTED|Double-Blind Treatment||171||
59820190|NCT00510146|75942517|FG000|COMPLETED|Double-Blind Treatment||267||
59820191|NCT00510146|75942518|FG001|COMPLETED|Double-Blind Treatment||122||
59820192|NCT00510146|75942517|FG000|NOT COMPLETED|Double-Blind Treatment||76||
59820193|NCT00510146|75942518|FG001|NOT COMPLETED|Double-Blind Treatment||49||
59820194|NCT00510146|75942517|FG000|STARTED|Open-Label Treatment||267||
59820195|NCT00510146|75942518|FG001|STARTED|Open-Label Treatment||122||
59820196|NCT00510146|75942517|FG000|COMPLETED|Open-Label Treatment||196||
59820197|NCT00510146|75942518|FG001|COMPLETED|Open-Label Treatment||96||
59820198|NCT00510146|75942517|FG000|NOT COMPLETED|Open-Label Treatment||71||
59820199|NCT00510146|75942518|FG001|NOT COMPLETED|Open-Label Treatment||26||
59820200|NCT00480636|75942526|FG000|STARTED|Overall Study||102||
59820201|NCT00480636|75942526|FG000|COMPLETED|Overall Study||83||
59820202|NCT00480636|75942526|FG000|NOT COMPLETED|Overall Study||19||
59820203|NCT00499122|75942530|FG000|STARTED|Overall Study||41||
59820204|NCT00499122|75942530|FG000|COMPLETED|Overall Study||39||
59820205|NCT00499122|75942530|FG000|NOT COMPLETED|Overall Study||2||
59820206|NCT00393939|75942537|FG000|STARTED|Overall Study||296||
59820207|NCT00393939|75942538|FG001|STARTED|Overall Study||297||
59820208|NCT00393939|75942537|FG000|Treated|Overall Study||295||
59820209|NCT00393939|75942538|FG001|Treated|Overall Study||293||
59820210|NCT00393939|75942537|FG000|COMPLETED|Overall Study||0||
59820211|NCT00393939|75942538|FG001|COMPLETED|Overall Study||0||
59820212|NCT00393939|75942537|FG000|NOT COMPLETED|Overall Study||296||
59820213|NCT00393939|75942538|FG001|NOT COMPLETED|Overall Study||297||
59820214|NCT00488982|75942544|FG000|STARTED|Induction Chemotherapy||125||
59820215|NCT00488982|75942545|FG001|STARTED|Induction Chemotherapy||0||
59820216|NCT00488982|75942546|FG002|STARTED|Induction Chemotherapy||0||
59820217|NCT00488982|75942544|FG000|6 Cycles Completed|Induction Chemotherapy||94||
59820218|NCT00488982|75942545|FG001|6 Cycles Completed|Induction Chemotherapy||0||
59820219|NCT00488982|75942546|FG002|6 Cycles Completed|Induction Chemotherapy||0||
59820220|NCT00488982|75942544|FG000|≥ 50% Prostate-specific Antigen Decline|Induction Chemotherapy||52||
59820221|NCT00488982|75942545|FG001|≥ 50% Prostate-specific Antigen Decline|Induction Chemotherapy||0||
59820222|NCT00488982|75942546|FG002|≥ 50% Prostate-specific Antigen Decline|Induction Chemotherapy||0||
59820223|NCT00488982|75942544|FG000|COMPLETED|Induction Chemotherapy||52||
59820224|NCT00488982|75942545|FG001|COMPLETED|Induction Chemotherapy||0||
59820225|NCT00488982|75942546|FG002|COMPLETED|Induction Chemotherapy||0||
59820226|NCT00488982|75942544|FG000|NOT COMPLETED|Induction Chemotherapy||73||
59820227|NCT00488982|75942545|FG001|NOT COMPLETED|Induction Chemotherapy||0||
59820228|NCT00488982|75942546|FG002|NOT COMPLETED|Induction Chemotherapy||0||
59820229|NCT00488982|75942544|FG000|STARTED|Course 1||0||
59820230|NCT00488982|75942545|FG001|STARTED|Course 1||25||
59820231|NCT00488982|75942546|FG002|STARTED|Course 1||27||
59820232|NCT00488982|75942544|FG000|COMPLETED|Course 1||0||
59820233|NCT00488982|75942545|FG001|COMPLETED|Course 1||13||
59820234|NCT00488982|75942546|FG002|COMPLETED|Course 1||13||
59820235|NCT00488982|75942544|FG000|NOT COMPLETED|Course 1||0||
59820236|NCT00488982|75942545|FG001|NOT COMPLETED|Course 1||12||
59820237|NCT00488982|75942546|FG002|NOT COMPLETED|Course 1||14||
59820238|NCT00488982|75942544|FG000|STARTED|Course 2||0||
59713420|NCT01219985|75831988|FG000|STARTED|Overall Study||50||
59713421|NCT01219985|75831988|FG000|COMPLETED|Overall Study||30||
59713422|NCT01219985|75831988|FG000|NOT COMPLETED|Overall Study||20||
59713423|NCT01218659|75831996|FG000|STARTED|18-Month Randomized Period||36||
59713424|NCT01218659|75831997|FG001|STARTED|18-Month Randomized Period||24||
59713425|NCT01218659|75831998|FG002|STARTED|18-Month Randomized Period|Zero participants are noted here because participants started in this group during the 12-month OLE.|0||
59713426|NCT01218659|75831996|FG000|Safety Population|18-Month Randomized Period||36|Safety: received at least 1 dose of migalastat or ERT.|
59713427|NCT01218659|75831997|FG001|Safety Population|18-Month Randomized Period||21|Safety: received at least 1 dose of migalastat or ERT.|
59820239|NCT00488982|75942545|FG001|STARTED|Course 2||13||
59820240|NCT00488982|75942546|FG002|STARTED|Course 2||13||
59820241|NCT00488982|75942544|FG000|COMPLETED|Course 2||0||
59820242|NCT00488982|75942545|FG001|COMPLETED|Course 2||4||
59820243|NCT00488982|75942546|FG002|COMPLETED|Course 2||8||
59820244|NCT00488982|75942544|FG000|NOT COMPLETED|Course 2||0||
59820245|NCT00488982|75942545|FG001|NOT COMPLETED|Course 2||9||
59820246|NCT00488982|75942546|FG002|NOT COMPLETED|Course 2||5||
59820247|NCT00488982|75942544|FG000|STARTED|Course 3||0||
59713428|NCT01218659|75831998|FG002|Safety Population|18-Month Randomized Period|Zero participants are noted here because participants started in this group during the 12-month OLE.|0|Safety: received at least 1 dose of migalastat or ERT.|
59713429|NCT01218659|75831996|FG000|COMPLETED|18-Month Randomized Period||34||
59713430|NCT01218659|75831997|FG001|COMPLETED|18-Month Randomized Period||18||
59713431|NCT01218659|75831998|FG002|COMPLETED|18-Month Randomized Period|Zero participants are noted here because participants started in this group during the 12-month OLE.|0||
59713432|NCT01218659|75831996|FG000|NOT COMPLETED|18-Month Randomized Period||2||
59713433|NCT01218659|75831997|FG001|NOT COMPLETED|18-Month Randomized Period||6||
59713434|NCT01218659|75831998|FG002|NOT COMPLETED|18-Month Randomized Period||0||
59713435|NCT01218659|75831996|FG000|STARTED|12-Month OLE|Zero participants are noted here because they were combined in the All Migalastat (0-30 mo.) group.|0||
59713436|NCT01218659|75831997|FG001|STARTED|12-Month OLE|Zero participants are noted here because they were combined in the All Migalastat (0-30 mo.) group.|0||
59713437|NCT01218659|75831998|FG002|STARTED|12-Month OLE|Fifty-two participants completed the 18-mo. randomized treatment period.|52||
59713438|NCT01218659|75831996|FG000|Safety Population|12-Month OLE||0|Safety: ITT pop. who received ≥1 dose of study drug during the 18-mo randomized treatment period.|
59713439|NCT01218659|75831997|FG001|Safety Population|12-Month OLE||0|Safety: ITT pop. who received ≥1 dose of study drug during the 18-mo randomized treatment period.|
59713440|NCT01218659|75831998|FG002|Safety Population|12-Month OLE||51|Safety: ITT pop. who received ≥1 dose of study drug during the 18-mo randomized treatment period.|
59713441|NCT01218659|75831996|FG000|Modified Intent-to-Treat (mITT)|12-Month OLE|Zero participants are noted here because they were combined in the All Migalastat (0-30 mo.) group.|0|mITT: Eligibility based on Good Laboratory Practice (GLP) human embryonic kidney cell (HEK) assay.|
59820248|NCT00488982|75942545|FG001|STARTED|Course 3||4||
59820249|NCT00488982|75942546|FG002|STARTED|Course 3||8||
59820250|NCT00488982|75942544|FG000|COMPLETED|Course 3||0||
59820251|NCT00488982|75942545|FG001|COMPLETED|Course 3||2||
59820252|NCT00488982|75942546|FG002|COMPLETED|Course 3||3||
59820253|NCT00488982|75942544|FG000|NOT COMPLETED|Course 3||0||
59713442|NCT01218659|75831997|FG001|Modified Intent-to-Treat (mITT)|12-Month OLE|Zero participants are noted here because they were combined in the All Migalastat (0-30 mo.) group.|0|mITT: Eligibility based on Good Laboratory Practice (GLP) human embryonic kidney cell (HEK) assay.|
59713443|NCT01218659|75831998|FG002|Modified Intent-to-Treat (mITT)|12-Month OLE||46|mITT: Eligibility based on Good Laboratory Practice (GLP) human embryonic kidney cell (HEK) assay.|
59713444|NCT01218659|75831996|FG000|COMPLETED|12-Month OLE|Zero participants are noted here because they were combined in the All Migalastat (0-30 mo.) group.|0||
59713445|NCT01218659|75831997|FG001|COMPLETED|12-Month OLE|Zero participants are noted here because they were combined in the All Migalastat (0-30 mo.) group.|0||
59713446|NCT01218659|75831998|FG002|COMPLETED|12-Month OLE||42||
59713447|NCT01218659|75831996|FG000|NOT COMPLETED|12-Month OLE||0||
59820254|NCT00488982|75942545|FG001|NOT COMPLETED|Course 3||2||
59820255|NCT00488982|75942546|FG002|NOT COMPLETED|Course 3||5||
59820256|NCT00488982|75942544|FG000|STARTED|Response to Course 3||0||
59820257|NCT00488982|75942545|FG001|STARTED|Response to Course 3||2||
59820258|NCT00488982|75942546|FG002|STARTED|Response to Course 3||3||
59820259|NCT00488982|75942544|FG000|COMPLETED|Response to Course 3||0||
59820260|NCT00488982|75942545|FG001|COMPLETED|Response to Course 3||1||
59820261|NCT00488982|75942546|FG002|COMPLETED|Response to Course 3||0||
59820262|NCT00488982|75942544|FG000|NOT COMPLETED|Response to Course 3||0||
59820263|NCT00488982|75942545|FG001|NOT COMPLETED|Response to Course 3||1||
59820264|NCT00488982|75942546|FG002|NOT COMPLETED|Response to Course 3||3||
59820265|NCT00488826|75942563|FG000|STARTED|Overall Study||300||
59820266|NCT00488826|75942564|FG001|STARTED|Overall Study||296||
59713448|NCT01218659|75831997|FG001|NOT COMPLETED|12-Month OLE||0||
59713449|NCT01218659|75831998|FG002|NOT COMPLETED|12-Month OLE||10||
59713450|NCT00940498|75832013|FG000|STARTED|Overall Study||4||
59713451|NCT00940498|75832014|FG001|STARTED|Overall Study||4||
59713452|NCT00940498|75832015|FG002|STARTED|Overall Study||4||
59713453|NCT00940498|75832016|FG003|STARTED|Overall Study||4||
59713454|NCT00940498|75832017|FG004|STARTED|Overall Study||43||
59713455|NCT00940498|75832018|FG005|STARTED|Overall Study||7||
59713456|NCT00940498|75832019|FG006|STARTED|Overall Study||8||
59713457|NCT00940498|75832020|FG007|STARTED|Overall Study||4||
59713458|NCT00940498|75832013|FG000|COMPLETED|Overall Study||1||
59713459|NCT00940498|75832014|FG001|COMPLETED|Overall Study||3||
59713460|NCT00940498|75832015|FG002|COMPLETED|Overall Study||1||
59713461|NCT00940498|75832016|FG003|COMPLETED|Overall Study||2||
59713462|NCT00940498|75832017|FG004|COMPLETED|Overall Study||34||
59713463|NCT00940498|75832018|FG005|COMPLETED|Overall Study||6||
59713464|NCT00940498|75832019|FG006|COMPLETED|Overall Study||7||
59713465|NCT00940498|75832020|FG007|COMPLETED|Overall Study||3||
59820267|NCT00488826|75942565|FG002|STARTED|Overall Study||204||
59820268|NCT00488826|75942563|FG000|COMPLETED|Overall Study||244||
59820269|NCT00488826|75942564|FG001|COMPLETED|Overall Study||244||
59820270|NCT00488826|75942565|FG002|COMPLETED|Overall Study||178||
59820271|NCT00488826|75942563|FG000|NOT COMPLETED|Overall Study||56||
59820272|NCT00488826|75942564|FG001|NOT COMPLETED|Overall Study||52||
59820273|NCT00488826|75942565|FG002|NOT COMPLETED|Overall Study||26||
59820274|NCT00393861|75942573|FG000|STARTED|Overall Study||29||
59820275|NCT00393861|75942573|FG000|COMPLETED|Overall Study||3||
59820276|NCT00393861|75942573|FG000|NOT COMPLETED|Overall Study||26||
59820277|NCT00480324|75942579|FG000|STARTED|Overall Study||508||
59820278|NCT00480324|75942580|FG001|STARTED|Overall Study||257||
59820279|NCT00480324|75942579|FG000|COMPLETED|Overall Study||476||
59820280|NCT00480324|75942580|FG001|COMPLETED|Overall Study||241||
59820281|NCT00480324|75942579|FG000|NOT COMPLETED|Overall Study||32||
59713466|NCT00940498|75832013|FG000|NOT COMPLETED|Overall Study||3||
59713467|NCT00940498|75832014|FG001|NOT COMPLETED|Overall Study||1||
59713468|NCT00940498|75832015|FG002|NOT COMPLETED|Overall Study||3||
59713469|NCT00940498|75832016|FG003|NOT COMPLETED|Overall Study||2||
59713470|NCT00940498|75832017|FG004|NOT COMPLETED|Overall Study||9||
59713471|NCT00940498|75832018|FG005|NOT COMPLETED|Overall Study||1||
59713472|NCT00940498|75832019|FG006|NOT COMPLETED|Overall Study||1||
59713473|NCT00940498|75832020|FG007|NOT COMPLETED|Overall Study||1||
59713474|NCT00940342|75832047|FG000|STARTED|Overall Study||50||
59713475|NCT00940342|75832048|FG001|STARTED|Overall Study||40||
59713476|NCT00940342|75832049|FG002|STARTED|Overall Study||40||
59713477|NCT00940342|75832047|FG000|COMPLETED|Overall Study||50||
59713478|NCT00940342|75832048|FG001|COMPLETED|Overall Study||38||
59713479|NCT00940342|75832049|FG002|COMPLETED|Overall Study||39||
59713480|NCT00940342|75832047|FG000|NOT COMPLETED|Overall Study||0||
59713481|NCT00940342|75832048|FG001|NOT COMPLETED|Overall Study||2||
59713482|NCT00940342|75832049|FG002|NOT COMPLETED|Overall Study||1||
59713483|NCT00936910|75832057|FG000|STARTED|Overall Study||13||
59820282|NCT00480324|75942580|FG001|NOT COMPLETED|Overall Study||16||
59820283|NCT00488592|75942586|FG000|STARTED|Overall Study|10 subjects were accrued|10||
59820284|NCT00488592|75942586|FG000|COMPLETED|Overall Study|7 completed the initial series of 6 vaccinations|7||
59820285|NCT00488592|75942586|FG000|NOT COMPLETED|Overall Study||3||
59820286|NCT00488514|75942590|FG000|STARTED|Overall Study||656||
59820287|NCT00488514|75942590|FG000|COMPLETED|Overall Study||363||
59820288|NCT00488514|75942590|FG000|NOT COMPLETED|Overall Study||293||
59820289|NCT00320710|75942614|FG000|STARTED|Overall Study||200||
59820290|NCT00320710|75942615|FG001|STARTED|Overall Study||203||
59820291|NCT00320710|75942616|FG002|STARTED|Overall Study||13||
59820292|NCT00320710|75942614|FG000|Treated (Safety Set)|Overall Study||198||
59820293|NCT00320710|75942615|FG001|Treated (Safety Set)|Overall Study||202||
59820294|NCT00320710|75942616|FG002|Treated (Safety Set)|Overall Study||13||
59820295|NCT00320710|75942614|FG000|COMPLETED|Overall Study||106||
59820296|NCT00320710|75942615|FG001|COMPLETED|Overall Study||127||
59820297|NCT00320710|75942616|FG002|COMPLETED|Overall Study||8||
59820298|NCT00320710|75942614|FG000|NOT COMPLETED|Overall Study||94||
59713484|NCT00936910|75832057|FG000|COMPLETED|Overall Study|The primary endpt. of 2 (-) cultures within 5 d of lock therapy was met for 10 patients|10||
59820299|NCT00320710|75942615|FG001|NOT COMPLETED|Overall Study||76||
59713485|NCT00936910|75832057|FG000|NOT COMPLETED|Overall Study||3||
59713486|NCT00940108|75832066|FG000|STARTED|Overall Study||82||
59713487|NCT00940108|75832067|FG001|STARTED|Overall Study||80||
59713488|NCT00940108|75832068|FG002|STARTED|Overall Study||103||
59713489|NCT00940108|75832069|FG003|STARTED|Overall Study||104||
59713490|NCT00940108|75832066|FG000|COMPLETED|Overall Study||77||
59713491|NCT00940108|75832067|FG001|COMPLETED|Overall Study||71||
59713492|NCT00940108|75832068|FG002|COMPLETED|Overall Study||100||
59713493|NCT00940108|75832069|FG003|COMPLETED|Overall Study||99||
59713494|NCT00940108|75832066|FG000|NOT COMPLETED|Overall Study||5||
59713495|NCT00940108|75832067|FG001|NOT COMPLETED|Overall Study||9||
59713496|NCT00940108|75832068|FG002|NOT COMPLETED|Overall Study||3||
59713497|NCT00940108|75832069|FG003|NOT COMPLETED|Overall Study||5||
59713498|NCT00936598|75832081|FG000|STARTED|Overall Study||4||
59713499|NCT00936598|75832082|FG001|STARTED|Overall Study||1||
59713500|NCT00936598|75832081|FG000|COMPLETED|Overall Study||2||
59713501|NCT00936598|75832082|FG001|COMPLETED|Overall Study||1||
59713502|NCT00936598|75832081|FG000|NOT COMPLETED|Overall Study||2||
60108488|NCT01662778|76228199|FG002|NOT COMPLETED|Period 2||0||
59713503|NCT00936598|75832082|FG001|NOT COMPLETED|Overall Study||0||
59820300|NCT00320710|75942616|FG002|NOT COMPLETED|Overall Study||5||
59820301|NCT00320398|75942625|FG000|STARTED|Overall Study||58||
59820302|NCT00320398|75942626|FG001|STARTED|Overall Study||56||
59820303|NCT00320398|75942625|FG000|COMPLETED|Overall Study||56||
59820304|NCT00320398|75942626|FG001|COMPLETED|Overall Study||52||
60108489|NCT01662778|76228200|FG003|NOT COMPLETED|Period 2||0||
60108490|NCT01662778|76228197|FG000|STARTED|Period 3||6||
59713504|NCT01025817|75832090|FG000|STARTED|Completed Study Medication||309||
59713505|NCT01025817|75832091|FG001|STARTED|Completed Study Medication||304||
59820305|NCT00320398|75942625|FG000|NOT COMPLETED|Overall Study||2||
60108491|NCT01662778|76228198|FG001|STARTED|Period 3||5||
60108492|NCT01662778|76228199|FG002|STARTED|Period 3||6||
60108493|NCT01662778|76228200|FG003|STARTED|Period 3||4||
59820306|NCT00320398|75942626|FG001|NOT COMPLETED|Overall Study||4||
60108494|NCT01662778|76228197|FG000|COMPLETED|Period 3||6||
60108495|NCT01662778|76228198|FG001|COMPLETED|Period 3||5||
60108496|NCT01662778|76228199|FG002|COMPLETED|Period 3||6||
59820307|NCT00498186|75942633|FG000|STARTED|Overall Study||295||
59820308|NCT00498186|75942633|FG000|COMPLETED|Overall Study||122||
59820309|NCT00498186|75942633|FG000|NOT COMPLETED|Overall Study||173||
59820310|NCT00333970|75942639|FG000|STARTED|Overall Study||50||
59820311|NCT00333970|75942640|FG001|STARTED|Overall Study||25||
59820312|NCT00333970|75942639|FG000|COMPLETED|Overall Study||37||
59820313|NCT00333970|75942640|FG001|COMPLETED|Overall Study||18||
59820314|NCT00333970|75942639|FG000|NOT COMPLETED|Overall Study||13||
59820315|NCT00333970|75942640|FG001|NOT COMPLETED|Overall Study||7||
59820316|NCT00477594|75942648|FG000|STARTED|Year 1 and Year 2||16||
59820317|NCT00477594|75942649|FG001|STARTED|Year 1 and Year 2||5||
59820318|NCT00477594|75942648|FG000|COMPLETED|Year 1 and Year 2||7||
59820319|NCT00477594|75942649|FG001|COMPLETED|Year 1 and Year 2||1||
59820320|NCT00477594|75942648|FG000|NOT COMPLETED|Year 1 and Year 2||9||
59820321|NCT00477594|75942649|FG001|NOT COMPLETED|Year 1 and Year 2||4||
59820322|NCT00477594|75942648|FG000|STARTED|Year 3||4||
59820323|NCT00477594|75942649|FG001|STARTED|Year 3||0||
59820324|NCT00477594|75942648|FG000|COMPLETED|Year 3||2||
59820325|NCT00477594|75942649|FG001|COMPLETED|Year 3||0||
59820326|NCT00477594|75942648|FG000|NOT COMPLETED|Year 3||2||
59820327|NCT00477594|75942649|FG001|NOT COMPLETED|Year 3||0||
59820328|NCT00477594|75942648|FG000|STARTED|Follow-up Period||16||
59820329|NCT00477594|75942649|FG001|STARTED|Follow-up Period||5||
59820330|NCT00477594|75942648|FG000|COMPLETED|Follow-up Period||13||
59820331|NCT00477594|75942649|FG001|COMPLETED|Follow-up Period||4||
59820332|NCT00477594|75942648|FG000|NOT COMPLETED|Follow-up Period||3||
59820333|NCT00477594|75942649|FG001|NOT COMPLETED|Follow-up Period||1||
59820334|NCT00475722|75942657|FG000|STARTED|Overall Study||61||
59820335|NCT00475722|75942658|FG001|STARTED|Overall Study||59||
59820336|NCT00475722|75942657|FG000|COMPLETED|Overall Study||46||
59820337|NCT00475722|75942658|FG001|COMPLETED|Overall Study||47||
59820338|NCT00475722|75942657|FG000|NOT COMPLETED|Overall Study||15||
59820339|NCT00475722|75942658|FG001|NOT COMPLETED|Overall Study||12||
59820340|NCT00304954|75942668|FG000|STARTED|Overall Study||4||
59820341|NCT00304954|75942669|FG001|STARTED|Overall Study||3||
59820342|NCT00304954|75942670|FG002|STARTED|Overall Study||3||
59820343|NCT00304954|75942671|FG003|STARTED|Overall Study||3||
59820344|NCT00304954|75942668|FG000|COMPLETED|Overall Study||3||
59820345|NCT00304954|75942669|FG001|COMPLETED|Overall Study||3||
59820346|NCT00304954|75942670|FG002|COMPLETED|Overall Study||2||
59820347|NCT00304954|75942671|FG003|COMPLETED|Overall Study||3||
59820348|NCT00304954|75942668|FG000|NOT COMPLETED|Overall Study||1||
59820349|NCT00304954|75942669|FG001|NOT COMPLETED|Overall Study||0||
59820350|NCT00304954|75942670|FG002|NOT COMPLETED|Overall Study||1||
59820351|NCT00304954|75942671|FG003|NOT COMPLETED|Overall Study||0||
59820352|NCT00475176|75942689|FG000|STARTED|Overall Study||24||
59820353|NCT00475176|75942689|FG000|COMPLETED|Overall Study||20||
59820354|NCT00475176|75942689|FG000|NOT COMPLETED|Overall Study||4||
59820355|NCT00414609|75942695|FG000|STARTED|Core Study||397||
59820356|NCT00414609|75942696|FG001|STARTED|Core Study||423||
59820357|NCT00414609|75942697|FG002|STARTED|Core Study||0||
59820358|NCT00414609|75942695|FG000|Received Study Drug|Core Study||397||
59820359|NCT00414609|75942696|FG001|Received Study Drug|Core Study||422||
59820360|NCT00414609|75942697|FG002|Received Study Drug|Core Study||0||
59713506|NCT01025817|75832090|FG000|COMPLETED|Completed Study Medication||204||
59713507|NCT01025817|75832091|FG001|COMPLETED|Completed Study Medication||232||
59820361|NCT00414609|75942695|FG000|Echocardiogram Evaluable Set|Core Study||330||
59820362|NCT00414609|75942696|FG001|Echocardiogram Evaluable Set|Core Study||343||
59820363|NCT00414609|75942697|FG002|Echocardiogram Evaluable Set|Core Study||0||
59713508|NCT01025817|75832090|FG000|NOT COMPLETED|Completed Study Medication||105||
59820364|NCT00414609|75942695|FG000|COMPLETED|Core Study||363||
59820365|NCT00414609|75942696|FG001|COMPLETED|Core Study||378||
59713509|NCT01025817|75832091|FG001|NOT COMPLETED|Completed Study Medication||72||
59713510|NCT01025817|75832090|FG000|STARTED|Completed Study||309||
59713511|NCT01025817|75832091|FG001|STARTED|Completed Study||304||
59713512|NCT01025817|75832090|FG000|COMPLETED|Completed Study|Completed study phase|293||
59713513|NCT01025817|75832091|FG001|COMPLETED|Completed Study|Completed study phase|282||
59713514|NCT01025817|75832090|FG000|NOT COMPLETED|Completed Study||16||
59713515|NCT01025817|75832091|FG001|NOT COMPLETED|Completed Study||22||
59713516|NCT00939640|75832097|FG000|STARTED|Overall Study||14||
59713517|NCT00939640|75832097|FG000|COMPLETED|Overall Study||13||
59713518|NCT00939640|75832097|FG000|NOT COMPLETED|Overall Study||1||
59820366|NCT00414609|75942697|FG002|COMPLETED|Core Study||0||
59820367|NCT00414609|75942695|FG000|NOT COMPLETED|Core Study||34||
59820368|NCT00414609|75942696|FG001|NOT COMPLETED|Core Study||45||
59820369|NCT00414609|75942697|FG002|NOT COMPLETED|Core Study||0||
59820370|NCT00414609|75942695|FG000|STARTED|Extension Study||0||
59820371|NCT00414609|75942696|FG001|STARTED|Extension Study||0||
59820372|NCT00414609|75942697|FG002|STARTED|Extension Study|Patients of both core arms who completed core study and signed informed consent form for extension.|422||
59996326|NCT04150861|76112317|FG001|NOT COMPLETED|Overall Study||0||
59820373|NCT00414609|75942695|FG000|Echocardiogram (ECHO) Analysis Set|Extension Study||0||
59820374|NCT00414609|75942696|FG001|Echocardiogram (ECHO) Analysis Set|Extension Study||0||
59820375|NCT00414609|75942697|FG002|Echocardiogram (ECHO) Analysis Set|Extension Study||400||
59820376|NCT00414609|75942695|FG000|COMPLETED|Extension Study||0||
59820377|NCT00414609|75942696|FG001|COMPLETED|Extension Study||0||
59820378|NCT00414609|75942697|FG002|COMPLETED|Extension Study||365||
59820379|NCT00414609|75942695|FG000|NOT COMPLETED|Extension Study||0||
59820380|NCT00414609|75942696|FG001|NOT COMPLETED|Extension Study||0||
59820381|NCT00414609|75942697|FG002|NOT COMPLETED|Extension Study||57||
59820382|NCT00393705|75942708|FG000|STARTED|Overall Study||151||
59820383|NCT00393705|75942709|FG001|STARTED|Overall Study||151||
59820384|NCT00393705|75942708|FG000|Received at Least One Dose of Study Drug|Overall Study||139||
59820385|NCT00393705|75942709|FG001|Received at Least One Dose of Study Drug|Overall Study||139||
59820386|NCT00393705|75942708|FG000|COMPLETED|Overall Study||128||
59820387|NCT00393705|75942709|FG001|COMPLETED|Overall Study||128||
59820388|NCT00393705|75942708|FG000|NOT COMPLETED|Overall Study||23||
59820389|NCT00393705|75942709|FG001|NOT COMPLETED|Overall Study||23||
59820390|NCT00303628|75942717|FG000|STARTED|Overall Study||176||
59820391|NCT00303628|75942718|FG001|STARTED|Overall Study||179||
59820392|NCT00303628|75942717|FG000|Eligible|Overall Study||171||
59820393|NCT00303628|75942718|FG001|Eligible|Overall Study||177||
59820394|NCT00303628|75942717|FG000|Treated|Overall Study||173||
59820395|NCT00303628|75942718|FG001|Treated|Overall Study||174||
59820396|NCT00303628|75942717|FG000|COMPLETED|Overall Study||126||
59820397|NCT00303628|75942718|FG001|COMPLETED|Overall Study||106||
59820398|NCT00303628|75942717|FG000|NOT COMPLETED|Overall Study||50||
59820399|NCT00303628|75942718|FG001|NOT COMPLETED|Overall Study||73||
59820400|NCT00414453|75942724|FG000|STARTED|Overall Study||19||
59820401|NCT00414453|75942724|FG000|COMPLETED|Overall Study||3||
59820402|NCT00414453|75942724|FG000|NOT COMPLETED|Overall Study||16||
59820403|NCT00332488|75942737|FG000|STARTED|Initial Treatment Phase (Weeks 0 - 12)||183||
59820404|NCT00332488|75942738|FG001|STARTED|Initial Treatment Phase (Weeks 0 - 12)||170||
60108497|NCT01662778|76228200|FG003|COMPLETED|Period 3||4||
60108498|NCT01662778|76228197|FG000|NOT COMPLETED|Period 3||0||
59713519|NCT01218113|75832109|FG000|STARTED|Overall Study||62||
59713520|NCT01218113|75832110|FG001|STARTED|Overall Study||64||
59713521|NCT01218113|75832111|FG002|STARTED|Overall Study||64||
59713522|NCT01218113|75832109|FG000|COMPLETED|Overall Study||57||
59820405|NCT00332488|75942739|FG002|STARTED|Initial Treatment Phase (Weeks 0 - 12)||175||
59820406|NCT00332488|75942737|FG000|COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||133||
59820407|NCT00332488|75942738|FG001|COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||152||
59820408|NCT00332488|75942739|FG002|COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||119||
59820409|NCT00332488|75942737|FG000|NOT COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||50||
59820410|NCT00332488|75942738|FG001|NOT COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||18||
59820411|NCT00332488|75942739|FG002|NOT COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||56||
59820412|NCT00332488|75942737|FG000|STARTED|Transfer Treatment Phase (Weeks 12 - 24)|Subjects on TI who achieved an HbA1c < 7.5% or had an HbA1c decrease from baseline >= 1.0%|29||
59713523|NCT01218113|75832110|FG001|COMPLETED|Overall Study||63||
59713524|NCT01218113|75832111|FG002|COMPLETED|Overall Study||58||
59713525|NCT01218113|75832109|FG000|NOT COMPLETED|Overall Study||5||
59713526|NCT01218113|75832110|FG001|NOT COMPLETED|Overall Study||1||
59713527|NCT01218113|75832111|FG002|NOT COMPLETED|Overall Study||6||
59713528|NCT03873493|75832126|FG000|STARTED|Overall Study||14||
59713529|NCT03873493|75832126|FG000|COMPLETED|Overall Study||0||
59713530|NCT03873493|75832126|FG000|NOT COMPLETED|Overall Study||14||
59713531|NCT03757819|75832132|FG000|STARTED|Overall Study||3||
59820413|NCT00332488|75942738|FG001|STARTED|Transfer Treatment Phase (Weeks 12 - 24)|Subjects on treatment who achieved an HbA1c < 7.5% or had an HbA1c decrease from baseline >= 1.0%|72||
59820414|NCT00332488|75942739|FG002|STARTED|Transfer Treatment Phase (Weeks 12 - 24)|Subjects in this arm who met HbA1c criteria + subjects from other arms who did not|254||
59820415|NCT00332488|75942737|FG000|COMPLETED|Transfer Treatment Phase (Weeks 12 - 24)||27||
59820416|NCT00332488|75942738|FG001|COMPLETED|Transfer Treatment Phase (Weeks 12 - 24)||70||
59820417|NCT00332488|75942739|FG002|COMPLETED|Transfer Treatment Phase (Weeks 12 - 24)||233||
59713532|NCT03757819|75832133|FG001|STARTED|Overall Study||3||
59713533|NCT03757819|75832134|FG002|STARTED|Overall Study||3||
59820418|NCT00332488|75942737|FG000|NOT COMPLETED|Transfer Treatment Phase (Weeks 12 - 24)||2||
59820419|NCT00332488|75942738|FG001|NOT COMPLETED|Transfer Treatment Phase (Weeks 12 - 24)||2||
59820420|NCT00332488|75942739|FG002|NOT COMPLETED|Transfer Treatment Phase (Weeks 12 - 24)||21||
59820421|NCT00332332|75942749|FG000|STARTED|Overall Study||246||
59820422|NCT00332332|75942749|FG000|Received Study Medication|Overall Study||230||
59820423|NCT00332332|75942749|FG000|COMPLETED|Overall Study||178||
60108499|NCT01662778|76228198|FG001|NOT COMPLETED|Period 3||0||
60108500|NCT01662778|76228199|FG002|NOT COMPLETED|Period 3||0||
60108501|NCT01662778|76228200|FG003|NOT COMPLETED|Period 3||0||
60108502|NCT01662778|76228197|FG000|STARTED|Period 4||6||
59713534|NCT03757819|75832135|FG003|STARTED|Overall Study||3||
60108503|NCT01662778|76228198|FG001|STARTED|Period 4||5||
60108504|NCT01662778|76228199|FG002|STARTED|Period 4||6||
60108505|NCT01662778|76228200|FG003|STARTED|Period 4||4||
59820424|NCT00332332|75942749|FG000|NOT COMPLETED|Overall Study||68||
59820425|NCT00392925|75942757|FG000|STARTED|4 Week Lead-In Period - Non-Randomized||177||
59820426|NCT00392925|75942758|FG001|STARTED|4 Week Lead-In Period - Non-Randomized||0||
59820427|NCT00392925|75942759|FG002|STARTED|4 Week Lead-In Period - Non-Randomized||0||
59820428|NCT00392925|75942760|FG003|STARTED|4 Week Lead-In Period - Non-Randomized||0||
59820429|NCT00392925|75942757|FG000|COMPLETED|4 Week Lead-In Period - Non-Randomized||139||
59820430|NCT00392925|75942758|FG001|COMPLETED|4 Week Lead-In Period - Non-Randomized||0||
59820431|NCT00392925|75942759|FG002|COMPLETED|4 Week Lead-In Period - Non-Randomized||0||
59820432|NCT00392925|75942760|FG003|COMPLETED|4 Week Lead-In Period - Non-Randomized||0||
59820433|NCT00392925|75942757|FG000|NOT COMPLETED|4 Week Lead-In Period - Non-Randomized||38||
59820434|NCT00392925|75942758|FG001|NOT COMPLETED|4 Week Lead-In Period - Non-Randomized||0||
59820435|NCT00392925|75942759|FG002|NOT COMPLETED|4 Week Lead-In Period - Non-Randomized||0||
59820436|NCT00392925|75942760|FG003|NOT COMPLETED|4 Week Lead-In Period - Non-Randomized||0||
59820437|NCT00392925|75942757|FG000|STARTED|Randomization to Treatment Group Period||0||
59820438|NCT00392925|75942758|FG001|STARTED|Randomization to Treatment Group Period||27||
59820439|NCT00392925|75942759|FG002|STARTED|Randomization to Treatment Group Period||56||
59820440|NCT00392925|75942760|FG003|STARTED|Randomization to Treatment Group Period||56||
59820441|NCT00392925|75942757|FG000|COMPLETED|Randomization to Treatment Group Period||0||
59820442|NCT00392925|75942758|FG001|COMPLETED|Randomization to Treatment Group Period|AT Week 20|19||
59820443|NCT00392925|75942759|FG002|COMPLETED|Randomization to Treatment Group Period|At Week 20|37||
59820444|NCT00392925|75942760|FG003|COMPLETED|Randomization to Treatment Group Period|At Week 20|38||
59820445|NCT00392925|75942757|FG000|NOT COMPLETED|Randomization to Treatment Group Period||0||
59820446|NCT00392925|75942758|FG001|NOT COMPLETED|Randomization to Treatment Group Period||8||
59820447|NCT00392925|75942759|FG002|NOT COMPLETED|Randomization to Treatment Group Period||19||
59820448|NCT00392925|75942760|FG003|NOT COMPLETED|Randomization to Treatment Group Period||18||
59820449|NCT00474786|75942778|FG000|STARTED|Overall Study||259||
59820450|NCT00474786|75942779|FG001|STARTED|Overall Study||253||
59820451|NCT00474786|75942778|FG000|COMPLETED|Overall Study||0||
59820452|NCT00474786|75942779|FG001|COMPLETED|Overall Study||0||
60108506|NCT01662778|76228197|FG000|COMPLETED|Period 4||6||
60108507|NCT01662778|76228198|FG001|COMPLETED|Period 4||5||
60108508|NCT01662778|76228199|FG002|COMPLETED|Period 4||6||
60108509|NCT01662778|76228200|FG003|COMPLETED|Period 4||4||
60108510|NCT01662778|76228197|FG000|NOT COMPLETED|Period 4||0||
60108511|NCT01662778|76228198|FG001|NOT COMPLETED|Period 4||0||
60108512|NCT01662778|76228199|FG002|NOT COMPLETED|Period 4||0||
60108513|NCT01662778|76228200|FG003|NOT COMPLETED|Period 4||0||
60108514|NCT01792115|76228217|FG000|STARTED|Overall Study||7||
60108515|NCT01792115|76228218|FG001|STARTED|Overall Study||7||
60108516|NCT01792115|76228219|FG002|STARTED|Overall Study||8||
60108517|NCT01792115|76228217|FG000|COMPLETED|Overall Study||7||
60108518|NCT01792115|76228218|FG001|COMPLETED|Overall Study||6||
60108519|NCT01792115|76228219|FG002|COMPLETED|Overall Study||8||
60108520|NCT01792115|76228217|FG000|NOT COMPLETED|Overall Study||0||
60108521|NCT01792115|76228218|FG001|NOT COMPLETED|Overall Study||1||
60108522|NCT01792115|76228219|FG002|NOT COMPLETED|Overall Study||0||
59820453|NCT00474786|75942778|FG000|NOT COMPLETED|Overall Study||259||
59820454|NCT00474786|75942779|FG001|NOT COMPLETED|Overall Study||253||
59820455|NCT00392769|75942785|FG000|STARTED|Overall Study||33||
59820456|NCT00392769|75942785|FG000|COMPLETED|Overall Study||23||
59820457|NCT00392769|75942785|FG000|NOT COMPLETED|Overall Study||10||
59820458|NCT00319696|75942789|FG000|STARTED|Overall Study||116||
59820459|NCT00319696|75942789|FG000|COMPLETED|Overall Study||56||
59820460|NCT00319696|75942789|FG000|NOT COMPLETED|Overall Study||60||
59820461|NCT00474630|75942801|FG000|STARTED|Overall Study||335||
59820462|NCT00474630|75942802|FG001|STARTED|Overall Study||170||
59820463|NCT00474630|75942801|FG000|COMPLETED|Overall Study||175||
59820464|NCT00474630|75942802|FG001|COMPLETED|Overall Study||100||
59820465|NCT00474630|75942801|FG000|NOT COMPLETED|Overall Study||160||
59820466|NCT00474630|75942802|FG001|NOT COMPLETED|Overall Study||70||
59820467|NCT00392379|75942811|FG000|STARTED|Overall Study|Medication period|136||
59820468|NCT00392379|75942812|FG001|STARTED|Overall Study|Medication period|134||
59820469|NCT00392379|75942811|FG000|COMPLETED|Overall Study|Medication period|114||
59820470|NCT00392379|75942812|FG001|COMPLETED|Overall Study|Medication period|96||
59820471|NCT00392379|75942811|FG000|NOT COMPLETED|Overall Study||22||
59820472|NCT00392379|75942812|FG001|NOT COMPLETED|Overall Study||38||
59820473|NCT00497874|75942820|FG000|STARTED|Overall Study||443||
59820474|NCT00497874|75942821|FG001|STARTED|Overall Study||459||
59820475|NCT00497874|75942820|FG000|COMPLETED|Overall Study||296||
60108523|NCT01791803|76228231|FG000|STARTED|Overall Study||41||
60108524|NCT01791803|76228232|FG001|STARTED|Overall Study||41||
60108525|NCT01791803|76228233|FG002|STARTED|Overall Study||40||
60108526|NCT01791803|76228234|FG003|STARTED|Overall Study||42||
60108527|NCT01791803|76228231|FG000|COMPLETED|Overall Study||41||
60108528|NCT01791803|76228232|FG001|COMPLETED|Overall Study||39||
60108529|NCT01791803|76228233|FG002|COMPLETED|Overall Study||38||
60108530|NCT01791803|76228234|FG003|COMPLETED|Overall Study||37||
60108531|NCT01791803|76228231|FG000|NOT COMPLETED|Overall Study||0||
60108532|NCT01791803|76228232|FG001|NOT COMPLETED|Overall Study||2||
59820476|NCT00497874|75942821|FG001|COMPLETED|Overall Study||343||
59820477|NCT00497874|75942820|FG000|NOT COMPLETED|Overall Study||147||
59820478|NCT00497874|75942821|FG001|NOT COMPLETED|Overall Study||116||
59820479|NCT00403455|75942829|FG000|STARTED|Overall Study||38||
59820480|NCT00403455|75942829|FG000|COMPLETED|Overall Study||37||
59820481|NCT00403455|75942829|FG000|NOT COMPLETED|Overall Study||1||
59820482|NCT00318370|75942833|FG000|STARTED|Period 1||28||
59820483|NCT00318370|75942834|FG001|STARTED|Period 1||0||
59820484|NCT00318370|75942835|FG002|STARTED|Period 1||0||
59820485|NCT00318370|75942833|FG000|COMPLETED|Period 1|21 participants proceeded from Far Only to Chemo Plus Far.|21||
59820486|NCT00318370|75942834|FG001|COMPLETED|Period 1||0||
59820487|NCT00318370|75942835|FG002|COMPLETED|Period 1||0||
59820488|NCT00318370|75942833|FG000|NOT COMPLETED|Period 1||7||
59820489|NCT00318370|75942834|FG001|NOT COMPLETED|Period 1||0||
59820490|NCT00318370|75942835|FG002|NOT COMPLETED|Period 1||0||
59820491|NCT00318370|75942833|FG000|STARTED|Period 2||0||
59820492|NCT00318370|75942834|FG001|STARTED|Period 2|26 participants enrolled directly into Chemo Plus Far plus 21 participants from Far Only.|47||
59820493|NCT00318370|75942835|FG002|STARTED|Period 2||0||
59820494|NCT00318370|75942833|FG000|COMPLETED|Period 2||0||
59820495|NCT00318370|75942834|FG001|COMPLETED|Period 2||36||
59820496|NCT00318370|75942835|FG002|COMPLETED|Period 2||0||
59820497|NCT00318370|75942833|FG000|NOT COMPLETED|Period 2||0||
59820498|NCT00318370|75942834|FG001|NOT COMPLETED|Period 2||11||
59820499|NCT00318370|75942835|FG002|NOT COMPLETED|Period 2||0||
59820500|NCT00318370|75942833|FG000|STARTED|Period 3||0||
59820501|NCT00318370|75942834|FG001|STARTED|Period 3||0||
59820502|NCT00318370|75942835|FG002|STARTED|Period 3||36||
59820503|NCT00318370|75942833|FG000|COMPLETED|Period 3||0||
59820504|NCT00318370|75942834|FG001|COMPLETED|Period 3||0||
59820505|NCT00318370|75942835|FG002|COMPLETED|Period 3||3||
59820506|NCT00318370|75942833|FG000|NOT COMPLETED|Period 3||0||
59820507|NCT00318370|75942834|FG001|NOT COMPLETED|Period 3||0||
59820508|NCT00318370|75942835|FG002|NOT COMPLETED|Period 3||33||
59820509|NCT00510068|75942843|FG000|STARTED|Double-blind Period||207||
59820510|NCT00510068|75942844|FG001|STARTED|Double-blind Period||203||
59820511|NCT00510068|75942843|FG000|Safety Population|Double-blind Period||204||
59820512|NCT00510068|75942844|FG001|Safety Population|Double-blind Period||203||
59820513|NCT00510068|75942843|FG000|COMPLETED|Double-blind Period||0||
59820514|NCT00510068|75942844|FG001|COMPLETED|Double-blind Period||0||
59820515|NCT00510068|75942843|FG000|NOT COMPLETED|Double-blind Period||207||
59820516|NCT00510068|75942844|FG001|NOT COMPLETED|Double-blind Period||203||
59820517|NCT00510068|75942843|FG000|STARTED|Open-label Period|172 patients switched over from placebo & 53 who were initially randomized to Everolimus arm.|225||
59820518|NCT00510068|75942844|FG001|STARTED|Open-label Period||0||
59820519|NCT00510068|75942843|FG000|COMPLETED|Open-label Period||0||
59820520|NCT00510068|75942844|FG001|COMPLETED|Open-label Period||0||
59820521|NCT00510068|75942843|FG000|NOT COMPLETED|Open-label Period||225||
59820522|NCT00510068|75942844|FG001|NOT COMPLETED|Open-label Period||0||
59820523|NCT00509600|75942852|FG000|STARTED|Overall Study||1||
59820524|NCT00509600|75942852|FG000|COMPLETED|Overall Study||0||
60108533|NCT01791803|76228233|FG002|NOT COMPLETED|Overall Study||2||
59713535|NCT03757819|75832132|FG000|COMPLETED|Overall Study||3||
59713536|NCT03757819|75832133|FG001|COMPLETED|Overall Study||3||
59713537|NCT03757819|75832134|FG002|COMPLETED|Overall Study||3||
59713538|NCT03757819|75832135|FG003|COMPLETED|Overall Study||3||
59713539|NCT03757819|75832132|FG000|NOT COMPLETED|Overall Study||0||
59713540|NCT03757819|75832133|FG001|NOT COMPLETED|Overall Study||0||
59713541|NCT03757819|75832134|FG002|NOT COMPLETED|Overall Study||0||
59713542|NCT03757819|75832135|FG003|NOT COMPLETED|Overall Study||0||
59713543|NCT00939484|75832146|FG000|STARTED|Overall Study||8||
59713544|NCT00939484|75832147|FG001|STARTED|Overall Study||20||
59820525|NCT00509600|75942852|FG000|NOT COMPLETED|Overall Study||1||
59820526|NCT00402987|75942860|FG000|STARTED|Overall Study||90||
59820527|NCT00402987|75942861|FG001|STARTED|Overall Study||45||
59820528|NCT00402987|75942862|FG002|STARTED|Overall Study||45||
59820529|NCT00402987|75942863|FG003|STARTED|Overall Study||89||
59820530|NCT00402987|75942860|FG000|COMPLETED|Overall Study||90||
59820531|NCT00402987|75942861|FG001|COMPLETED|Overall Study||45||
59820532|NCT00402987|75942862|FG002|COMPLETED|Overall Study||44||
59820533|NCT00402987|75942863|FG003|COMPLETED|Overall Study||89||
59820534|NCT00402987|75942860|FG000|NOT COMPLETED|Overall Study||0||
59820535|NCT00402987|75942861|FG001|NOT COMPLETED|Overall Study||0||
59713545|NCT00939484|75832148|FG002|STARTED|Overall Study||3||
59713546|NCT00939484|75832146|FG000|COMPLETED|Overall Study||0||
59820536|NCT00402987|75942862|FG002|NOT COMPLETED|Overall Study||1||
59820537|NCT00402987|75942863|FG003|NOT COMPLETED|Overall Study||0||
59820538|NCT00501644|75942887|FG000|STARTED|Overall Study||59||
59820539|NCT00501644|75942887|FG000|COMPLETED|Overall Study||54||
59820540|NCT00501644|75942887|FG000|NOT COMPLETED|Overall Study||5||
59820541|NCT00497796|75942893|FG000|STARTED|Overall Study||147||
59820542|NCT00497796|75942894|FG001|STARTED|Overall Study||160||
59820543|NCT00497796|75942893|FG000|COMPLETED|Overall Study||62||
59820544|NCT00497796|75942894|FG001|COMPLETED|Overall Study||101||
59820545|NCT00497796|75942893|FG000|NOT COMPLETED|Overall Study||85||
59713547|NCT00939484|75832147|FG001|COMPLETED|Overall Study||0||
59820546|NCT00497796|75942894|FG001|NOT COMPLETED|Overall Study||59||
59820547|NCT00496782|75942902|FG000|STARTED|Overall Study||9||
59820548|NCT00496782|75942903|FG001|STARTED|Overall Study||7||
59820549|NCT00496782|75942902|FG000|COMPLETED|Overall Study||8||
59820550|NCT00496782|75942903|FG001|COMPLETED|Overall Study||5||
59820551|NCT00496782|75942902|FG000|NOT COMPLETED|Overall Study||1||
59820552|NCT00496782|75942903|FG001|NOT COMPLETED|Overall Study||2||
59820553|NCT00402831|75942911|FG000|STARTED|Overall Study||202||
59820554|NCT00402831|75942912|FG001|STARTED|Overall Study||203||
59820555|NCT00402831|75942911|FG000|ProQuad® Dose 1 (Day 1)|Overall Study||202||
59820556|NCT00402831|75942912|FG001|ProQuad® Dose 1 (Day 1)|Overall Study||203||
59820557|NCT00402831|75942911|FG000|ProQuad® Dose 1 (Day 30)|Overall Study||202||
59820558|NCT00402831|75942912|FG001|ProQuad® Dose 1 (Day 30)|Overall Study||203||
59820559|NCT00402831|75942911|FG000|COMPLETED|Overall Study||201||
59820560|NCT00402831|75942912|FG001|COMPLETED|Overall Study||200||
59820561|NCT00402831|75942911|FG000|NOT COMPLETED|Overall Study||1||
59820562|NCT00402831|75942912|FG001|NOT COMPLETED|Overall Study||3||
59820563|NCT00496626|75942922|FG000|STARTED|Overall Study||302||
59820564|NCT00496626|75942923|FG001|STARTED|Overall Study||298||
59820565|NCT00496626|75942922|FG000|COMPLETED|Overall Study||296||
59820566|NCT00496626|75942923|FG001|COMPLETED|Overall Study||292||
59820567|NCT00496626|75942922|FG000|NOT COMPLETED|Overall Study||6||
59820568|NCT00496626|75942923|FG001|NOT COMPLETED|Overall Study||6||
59820569|NCT00471822|75942933|FG000|STARTED|Overall Study||9707||
59820570|NCT00471822|75942933|FG000|Treated|Overall Study||9705||
59820571|NCT00471822|75942933|FG000|COMPLETED|Overall Study||9705||
59820572|NCT00471822|75942933|FG000|NOT COMPLETED|Overall Study||2||
59820573|NCT00471276|75942937|FG000|STARTED|Overall Study||83||
59820574|NCT00471276|75942937|FG000|COMPLETED|Overall Study||0||
59820575|NCT00471276|75942937|FG000|NOT COMPLETED|Overall Study||83||
59820576|NCT00470262|75942943|FG000|STARTED|Overall Study||15||
59820577|NCT00470262|75942944|FG001|STARTED|Overall Study||12||
59820578|NCT00470262|75942943|FG000|COMPLETED|Overall Study||13||
59820579|NCT00470262|75942944|FG001|COMPLETED|Overall Study||12||
59820580|NCT00470262|75942943|FG000|NOT COMPLETED|Overall Study||2||
59820581|NCT00470262|75942944|FG001|NOT COMPLETED|Overall Study||0||
59820582|NCT00496470|75942953|FG000|STARTED|Overall Study||329||
59820583|NCT00496470|75942954|FG001|STARTED|Overall Study||331||
59820584|NCT00496470|75942953|FG000|Received Study Medication|Overall Study||329||
59820585|NCT00496470|75942954|FG001|Received Study Medication|Overall Study||330||
59820586|NCT00496470|75942953|FG000|COMPLETED|Overall Study||303||
59820587|NCT00496470|75942954|FG001|COMPLETED|Overall Study||302||
59820588|NCT00496470|75942953|FG000|NOT COMPLETED|Overall Study||26||
59820589|NCT00496470|75942954|FG001|NOT COMPLETED|Overall Study||29||
59820590|NCT00496080|75942960|FG000|STARTED|Overall Study||87||
59820591|NCT00496080|75942960|FG000|COMPLETED|Overall Study||60||
59820592|NCT00496080|75942960|FG000|NOT COMPLETED|Overall Study||27||
59820593|NCT00487578|75942967|FG000|STARTED|Overall Study||3||
59820594|NCT00487578|75942968|FG001|STARTED|Overall Study||9||
59820595|NCT00487578|75942967|FG000|COMPLETED|Overall Study||2||
59820596|NCT00487578|75942968|FG001|COMPLETED|Overall Study||5||
59820597|NCT00487578|75942967|FG000|NOT COMPLETED|Overall Study||1||
59820598|NCT00487578|75942968|FG001|NOT COMPLETED|Overall Study||4||
59820599|NCT00495612|75942976|FG000|STARTED|Overall Study||36||
59820600|NCT00495612|75942977|FG001|STARTED|Overall Study||33||
60108534|NCT01791803|76228234|FG003|NOT COMPLETED|Overall Study||5||
59820601|NCT00495612|75942976|FG000|COMPLETED|Overall Study||32||
59820602|NCT00495612|75942977|FG001|COMPLETED|Overall Study||33||
59820603|NCT00495612|75942976|FG000|NOT COMPLETED|Overall Study||4||
59820604|NCT00495612|75942977|FG001|NOT COMPLETED|Overall Study||0||
59820605|NCT00487188|75942985|FG000|STARTED|Induction Phase||31||
59820606|NCT00487188|75942986|FG001|STARTED|Induction Phase||16||
60108535|NCT01662856|76228249|FG000|STARTED|Part I + Part II (Overall Study)||168||
60108536|NCT01662856|76228250|FG001|STARTED|Part I + Part II (Overall Study)||57||
59820607|NCT00487188|75942987|FG002|STARTED|Induction Phase|Participants were only randomized to this treatment arm in the Maintenance Phase|0||
59820608|NCT00487188|75942985|FG000|Safety Population|Induction Phase||29||
59820609|NCT00487188|75942986|FG001|Safety Population|Induction Phase|2 patients randomized to ENF + HARRT only received treatment with HAART|18||
59820610|NCT00487188|75942987|FG002|Safety Population|Induction Phase||0||
59820611|NCT00487188|75942985|FG000|COMPLETED|Induction Phase||22||
59820612|NCT00487188|75942986|FG001|COMPLETED|Induction Phase||9||
59820613|NCT00487188|75942987|FG002|COMPLETED|Induction Phase||0||
59820614|NCT00487188|75942985|FG000|NOT COMPLETED|Induction Phase||9||
59820615|NCT00487188|75942986|FG001|NOT COMPLETED|Induction Phase||7||
59820616|NCT00487188|75942987|FG002|NOT COMPLETED|Induction Phase||0||
59820617|NCT00487188|75942985|FG000|STARTED|Maintenance Phase||10||
59820618|NCT00487188|75942986|FG001|STARTED|Maintenance Phase||8||
59820619|NCT00487188|75942987|FG002|STARTED|Maintenance Phase||9||
59820620|NCT00487188|75942985|FG000|COMPLETED|Maintenance Phase||7||
59820621|NCT00487188|75942986|FG001|COMPLETED|Maintenance Phase||8||
59820622|NCT00487188|75942987|FG002|COMPLETED|Maintenance Phase||8||
59820623|NCT00487188|75942985|FG000|NOT COMPLETED|Maintenance Phase||3||
59820624|NCT00487188|75942986|FG001|NOT COMPLETED|Maintenance Phase||0||
59820625|NCT00487188|75942987|FG002|NOT COMPLETED|Maintenance Phase||1||
59567011|NCT03854253|75669799|FG001|NOT COMPLETED|Overall Study||0||
59713548|NCT00939484|75832148|FG002|COMPLETED|Overall Study||0||
59713549|NCT00939484|75832146|FG000|NOT COMPLETED|Overall Study||8||
59713550|NCT00939484|75832147|FG001|NOT COMPLETED|Overall Study||20||
59713551|NCT00939484|75832148|FG002|NOT COMPLETED|Overall Study||3||
59713552|NCT01010217|75832163|FG000|STARTED|Overall Study||89||
59713553|NCT01010217|75832164|FG001|STARTED|Overall Study||56||
59713554|NCT01010217|75832165|FG002|STARTED|Overall Study||22||
59713555|NCT01010217|75832166|FG003|STARTED|Overall Study||6||
59713556|NCT01010217|75832167|FG004|STARTED|Overall Study||3||
59713557|NCT01010217|75832163|FG000|COMPLETED|Overall Study||84||
59713558|NCT01010217|75832164|FG001|COMPLETED|Overall Study||51||
59713559|NCT01010217|75832165|FG002|COMPLETED|Overall Study||21||
59713560|NCT01010217|75832166|FG003|COMPLETED|Overall Study||0||
59713561|NCT01010217|75832167|FG004|COMPLETED|Overall Study||0||
59713562|NCT01010217|75832163|FG000|NOT COMPLETED|Overall Study||5||
59713563|NCT01010217|75832164|FG001|NOT COMPLETED|Overall Study||5||
59713564|NCT01010217|75832165|FG002|NOT COMPLETED|Overall Study||1||
59713565|NCT01010217|75832166|FG003|NOT COMPLETED|Overall Study||6||
59713566|NCT01010217|75832167|FG004|NOT COMPLETED|Overall Study||3||
59713567|NCT01217957|75832184|FG000|STARTED|Phase 1||3||
59713568|NCT01217957|75832185|FG001|STARTED|Phase 1||3||
59713569|NCT01217957|75832186|FG002|STARTED|Phase 1||6||
59713570|NCT01217957|75832187|FG003|STARTED|Phase 1||3||
59713571|NCT01217957|75832188|FG004|STARTED|Phase 1||0||
59713572|NCT01217957|75832184|FG000|COMPLETED|Phase 1||2||
59713573|NCT01217957|75832185|FG001|COMPLETED|Phase 1||3||
59713574|NCT01217957|75832186|FG002|COMPLETED|Phase 1||5||
59713575|NCT01217957|75832187|FG003|COMPLETED|Phase 1||2||
59713576|NCT01217957|75832188|FG004|COMPLETED|Phase 1||0||
59713577|NCT01217957|75832184|FG000|NOT COMPLETED|Phase 1||1||
59713578|NCT01217957|75832185|FG001|NOT COMPLETED|Phase 1||0||
59713579|NCT01217957|75832186|FG002|NOT COMPLETED|Phase 1||1||
59713580|NCT01217957|75832187|FG003|NOT COMPLETED|Phase 1||1||
59713581|NCT01217957|75832188|FG004|NOT COMPLETED|Phase 1||0||
59713582|NCT01217957|75832184|FG000|STARTED|Phase 2||0||
59713583|NCT01217957|75832185|FG001|STARTED|Phase 2||0||
59713584|NCT01217957|75832186|FG002|STARTED|Phase 2||0||
59713585|NCT01217957|75832187|FG003|STARTED|Phase 2||0||
59713586|NCT01217957|75832188|FG004|STARTED|Phase 2||50||
59713587|NCT01217957|75832184|FG000|COMPLETED|Phase 2||0||
59713588|NCT01217957|75832185|FG001|COMPLETED|Phase 2||0||
59713589|NCT01217957|75832186|FG002|COMPLETED|Phase 2||0||
59713590|NCT01217957|75832187|FG003|COMPLETED|Phase 2||0||
59713591|NCT01217957|75832188|FG004|COMPLETED|Phase 2|Completed=Participants who are ongoing or who have died on study.|49||
59713592|NCT01217957|75832184|FG000|NOT COMPLETED|Phase 2||0||
59713593|NCT01217957|75832185|FG001|NOT COMPLETED|Phase 2||0||
59713594|NCT01217957|75832186|FG002|NOT COMPLETED|Phase 2||0||
59713595|NCT01217957|75832187|FG003|NOT COMPLETED|Phase 2||0||
59713596|NCT01217957|75832188|FG004|NOT COMPLETED|Phase 2||1||
59713597|NCT00939094|75832211|FG000|STARTED|Overall Study||42||
59713598|NCT00939094|75832212|FG001|STARTED|Overall Study||45||
59713599|NCT00939094|75832211|FG000|COMPLETED|Overall Study||28||
59713600|NCT00939094|75832212|FG001|COMPLETED|Overall Study||35||
59713601|NCT00939094|75832211|FG000|NOT COMPLETED|Overall Study||14||
59713602|NCT00939094|75832212|FG001|NOT COMPLETED|Overall Study||10||
59713603|NCT01217801|75832220|FG000|STARTED|Period 1||24||
59713604|NCT01217801|75832221|FG001|STARTED|Period 1||24||
59713605|NCT01217801|75832220|FG000|COMPLETED|Period 1||23||
59713606|NCT01217801|75832221|FG001|COMPLETED|Period 1||22||
59713607|NCT01217801|75832220|FG000|NOT COMPLETED|Period 1||1||
59713608|NCT01217801|75832221|FG001|NOT COMPLETED|Period 1||2||
59713609|NCT01217801|75832220|FG000|STARTED|Period 2||23||
59713610|NCT01217801|75832221|FG001|STARTED|Period 2||22||
59713611|NCT01217801|75832220|FG000|COMPLETED|Period 2||23||
59713612|NCT01217801|75832221|FG001|COMPLETED|Period 2||22||
59713613|NCT01217801|75832220|FG000|NOT COMPLETED|Period 2||0||
59713614|NCT01217801|75832221|FG001|NOT COMPLETED|Period 2||0||
59713615|NCT00935818|75832229|FG000|STARTED|Overall Study||249||
59713616|NCT00935818|75832230|FG001|STARTED|Overall Study||257||
59713617|NCT00935818|75832229|FG000|End of Medication Phase|Overall Study||182||
59713618|NCT00935818|75832230|FG001|End of Medication Phase|Overall Study||184||
59567012|NCT02301624|75669807|FG000|STARTED|Blind Induction Phase||56||
59567013|NCT02301624|75669808|FG001|STARTED|Blind Induction Phase||61||
59567014|NCT02301624|75669807|FG000|Received at Least 1 Dose of Study Drug|Blind Induction Phase||56||
59567015|NCT02301624|75669808|FG001|Received at Least 1 Dose of Study Drug|Blind Induction Phase||61||
59567016|NCT02301624|75669807|FG000|COMPLETED|Blind Induction Phase||55||
59567017|NCT02301624|75669808|FG001|COMPLETED|Blind Induction Phase||61||
59567018|NCT02301624|75669807|FG000|NOT COMPLETED|Blind Induction Phase||1||
59567019|NCT02301624|75669808|FG001|NOT COMPLETED|Blind Induction Phase||0||
59713619|NCT00935818|75832229|FG000|COMPLETED|Overall Study||158||
59713620|NCT00935818|75832230|FG001|COMPLETED|Overall Study||157||
59713621|NCT00935818|75832229|FG000|NOT COMPLETED|Overall Study||91||
59713622|NCT00935818|75832230|FG001|NOT COMPLETED|Overall Study||100||
59713623|NCT01216319|75832236|FG000|STARTED|Overall Study||50||
59713624|NCT01216319|75832236|FG000|COMPLETED|Overall Study||46||
59713625|NCT01216319|75832236|FG000|NOT COMPLETED|Overall Study||4||
59713626|NCT00936208|75832242|FG000|STARTED|Overall Study||1499||
59713627|NCT00936208|75832243|FG001|STARTED|Overall Study||1596||
59713628|NCT00936208|75832242|FG000|COMPLETED|Overall Study||1462||
59713629|NCT00936208|75832243|FG001|COMPLETED|Overall Study||1574||
59713630|NCT00936208|75832242|FG000|NOT COMPLETED|Overall Study||37||
59713631|NCT00936208|75832243|FG001|NOT COMPLETED|Overall Study||22||
59713632|NCT01216163|75832252|FG000|STARTED|Overall Study||45||
59713633|NCT01216163|75832253|FG001|STARTED|Overall Study||88||
59713634|NCT01216163|75832254|FG002|STARTED|Overall Study||85||
59713635|NCT01216163|75832252|FG000|COMPLETED|Overall Study||44||
59713636|NCT01216163|75832253|FG001|COMPLETED|Overall Study||87||
59713637|NCT01216163|75832254|FG002|COMPLETED|Overall Study||85||
59713638|NCT01216163|75832252|FG000|NOT COMPLETED|Overall Study||1||
59713639|NCT01216163|75832253|FG001|NOT COMPLETED|Overall Study||1||
59713640|NCT01216163|75832254|FG002|NOT COMPLETED|Overall Study||0||
59713641|NCT00933244|75832265|FG000|STARTED|Overall Study||79||
59713642|NCT00933244|75832266|FG001|STARTED|Overall Study||75||
59713643|NCT00933244|75832267|FG002|STARTED|Overall Study||76||
59713644|NCT00933244|75832265|FG000|COMPLETED|Overall Study||74||
59713645|NCT00933244|75832266|FG001|COMPLETED|Overall Study||74||
59713646|NCT00933244|75832267|FG002|COMPLETED|Overall Study||73||
59713647|NCT00933244|75832265|FG000|NOT COMPLETED|Overall Study||5||
59713648|NCT00933244|75832266|FG001|NOT COMPLETED|Overall Study||1||
59713649|NCT00933244|75832267|FG002|NOT COMPLETED|Overall Study||3||
59713650|NCT00930046|75832277|FG000|STARTED|Overall Study||8||
59713651|NCT00930046|75832278|FG001|STARTED|Overall Study||7||
59713652|NCT00930046|75832277|FG000|COMPLETED|Overall Study||7||
59713653|NCT00930046|75832278|FG001|COMPLETED|Overall Study||5||
59713654|NCT00930046|75832277|FG000|NOT COMPLETED|Overall Study||1||
59713655|NCT00930046|75832278|FG001|NOT COMPLETED|Overall Study||2||
59713656|NCT00935584|75832286|FG000|STARTED|Overall Study|Out of 128 participants consented, 2 patients had no data collected, as the clinic was cancelled.|126||
59713657|NCT00935584|75832287|FG001|STARTED|Overall Study||23||
59713658|NCT00935584|75832286|FG000|COMPLETED|Overall Study||77||
59713659|NCT00935584|75832287|FG001|COMPLETED|Overall Study||19||
59713660|NCT00935584|75832286|FG000|NOT COMPLETED|Overall Study||49||
59713661|NCT00935584|75832287|FG001|NOT COMPLETED|Overall Study||4||
59713662|NCT01215851|75832297|FG000|STARTED|Treatment Period||15||
59713663|NCT01215851|75832298|FG001|STARTED|Treatment Period||15||
59713664|NCT01215851|75832299|FG002|STARTED|Treatment Period||15||
59713665|NCT01215851|75832300|FG003|STARTED|Treatment Period||15||
59713666|NCT01215851|75832301|FG004|STARTED|Treatment Period||10||
59713667|NCT01215851|75832302|FG005|STARTED|Treatment Period||15||
59713668|NCT01215851|75832297|FG000|COMPLETED|Treatment Period||14||
59713669|NCT01215851|75832298|FG001|COMPLETED|Treatment Period||14||
59713670|NCT01215851|75832299|FG002|COMPLETED|Treatment Period||14||
59713671|NCT01215851|75832300|FG003|COMPLETED|Treatment Period||12||
59713672|NCT01215851|75832301|FG004|COMPLETED|Treatment Period||10||
59713673|NCT01215851|75832302|FG005|COMPLETED|Treatment Period||14||
59713674|NCT01215851|75832297|FG000|NOT COMPLETED|Treatment Period||1||
59713675|NCT01215851|75832298|FG001|NOT COMPLETED|Treatment Period||1||
59713676|NCT01215851|75832299|FG002|NOT COMPLETED|Treatment Period||1||
59713677|NCT01215851|75832300|FG003|NOT COMPLETED|Treatment Period||3||
59713678|NCT01215851|75832301|FG004|NOT COMPLETED|Treatment Period||0||
59713679|NCT01215851|75832302|FG005|NOT COMPLETED|Treatment Period||1||
59713680|NCT01215851|75832297|FG000|STARTED|Follow up Period||14||
59713681|NCT01215851|75832298|FG001|STARTED|Follow up Period||14||
59713682|NCT01215851|75832299|FG002|STARTED|Follow up Period||14||
59713683|NCT01215851|75832300|FG003|STARTED|Follow up Period||12||
59713684|NCT01215851|75832301|FG004|STARTED|Follow up Period||10||
59713685|NCT01215851|75832302|FG005|STARTED|Follow up Period||14||
59713686|NCT01215851|75832297|FG000|COMPLETED|Follow up Period||14||
59713687|NCT01215851|75832298|FG001|COMPLETED|Follow up Period||14||
59713688|NCT01215851|75832299|FG002|COMPLETED|Follow up Period||14||
60108537|NCT01662856|76228249|FG000|Completed Study up to Week 6|Part I + Part II (Overall Study)||164||
59713689|NCT01215851|75832300|FG003|COMPLETED|Follow up Period||12||
59713690|NCT01215851|75832301|FG004|COMPLETED|Follow up Period||10||
59713691|NCT01215851|75832302|FG005|COMPLETED|Follow up Period||13||
59713692|NCT01215851|75832297|FG000|NOT COMPLETED|Follow up Period||0||
59713693|NCT01215851|75832298|FG001|NOT COMPLETED|Follow up Period||0||
59713694|NCT01215851|75832299|FG002|NOT COMPLETED|Follow up Period||0||
59713695|NCT01215851|75832300|FG003|NOT COMPLETED|Follow up Period||0||
59713696|NCT01215851|75832301|FG004|NOT COMPLETED|Follow up Period||0||
59713697|NCT01215851|75832302|FG005|NOT COMPLETED|Follow up Period||1||
59713698|NCT00933166|75832317|FG000|STARTED|Overall Study||169||
59713699|NCT00933166|75832317|FG000|COMPLETED|Overall Study||151||
60108538|NCT01662856|76228250|FG001|Completed Study up to Week 6|Part I + Part II (Overall Study)||56||
59713700|NCT00933166|75832317|FG000|NOT COMPLETED|Overall Study||18||
59713701|NCT00935272|75832323|FG000|STARTED|Overall Study||135||
59713702|NCT00935272|75832324|FG001|STARTED|Overall Study||45||
59713703|NCT00935272|75832323|FG000|COMPLETED|Overall Study||116||
59713704|NCT00935272|75832324|FG001|COMPLETED|Overall Study||39||
59713705|NCT00935272|75832323|FG000|NOT COMPLETED|Overall Study||19||
59713706|NCT00935272|75832324|FG001|NOT COMPLETED|Overall Study||6||
59713707|NCT01010061|75832333|FG000|STARTED|Overall Study||238||
59713708|NCT01010061|75832334|FG001|STARTED|Overall Study||118||
59713709|NCT01010061|75832333|FG000|Received Study Drug|Overall Study||236||
59713710|NCT01010061|75832334|FG001|Received Study Drug|Overall Study||116||
59713711|NCT01010061|75832333|FG000|COMPLETED|Overall Study|Completed=Completed treatment.|190||
59713712|NCT01010061|75832334|FG001|COMPLETED|Overall Study||78||
59713713|NCT01010061|75832333|FG000|NOT COMPLETED|Overall Study||48||
59713714|NCT01010061|75832334|FG001|NOT COMPLETED|Overall Study||40||
59713715|NCT05143801|75832342|FG000|STARTED|Overall Study||10||
59713716|NCT05143801|75832342|FG000|COMPLETED|Overall Study||10||
59713717|NCT05143801|75832342|FG000|NOT COMPLETED|Overall Study||0||
59713718|NCT00929734|75832354|FG000|STARTED|Overall Study||49||
59713719|NCT00929734|75832355|FG001|STARTED|Overall Study||50||
59713720|NCT00929734|75832354|FG000|COMPLETED|Overall Study||47||
59713721|NCT00929734|75832355|FG001|COMPLETED|Overall Study||47||
59713722|NCT00929734|75832354|FG000|NOT COMPLETED|Overall Study||2||
59713723|NCT00929734|75832355|FG001|NOT COMPLETED|Overall Study||3||
59713724|NCT01013883|75832363|FG000|STARTED|Overall Study||270||
59713725|NCT01013883|75832364|FG001|STARTED|Overall Study||243||
59713726|NCT01013883|75832363|FG000|COMPLETED|Overall Study||268||
59713727|NCT01013883|75832364|FG001|COMPLETED|Overall Study||241||
59713728|NCT01013883|75832363|FG000|NOT COMPLETED|Overall Study||2||
59713729|NCT01013883|75832364|FG001|NOT COMPLETED|Overall Study||2||
59713730|NCT01009983|75832370|FG000|STARTED|Overall Study||14||
59713731|NCT01009983|75832370|FG000|COMPLETED|Overall Study||13||
59713732|NCT01009983|75832370|FG000|NOT COMPLETED|Overall Study||1||
59713733|NCT04474795|75832374|FG000|STARTED|Overall Study||85||
59713734|NCT04474795|75832374|FG000|Completed Pre-test|Overall Study||82||
59713735|NCT04474795|75832374|FG000|Accessed Training Module 1|Overall Study||65||
59713736|NCT04474795|75832374|FG000|Accessed Training Module 2|Overall Study||45||
59713737|NCT04474795|75832374|FG000|Accessed Training Module 3|Overall Study||41||
59713738|NCT04474795|75832374|FG000|Accessed Training Module 4|Overall Study||20||
59713739|NCT04474795|75832374|FG000|COMPLETED|Overall Study||20||
59713740|NCT04474795|75832374|FG000|NOT COMPLETED|Overall Study||65||
59713741|NCT01215227|75832384|FG000|STARTED|Overall Study||218||
59713742|NCT01215227|75832385|FG001|STARTED|Overall Study||215||
59713743|NCT01215227|75832386|FG002|STARTED|Overall Study||107||
59713744|NCT01215227|75832387|FG003|STARTED|Overall Study||97||
59713745|NCT01215227|75832388|FG004|STARTED|Overall Study||93||
59713746|NCT01215227|75832389|FG005|STARTED|Overall Study||109||
59713747|NCT01215227|75832384|FG000|Treated|Overall Study||218||
59713748|NCT01215227|75832385|FG001|Treated|Overall Study||215||
59713749|NCT01215227|75832386|FG002|Treated|Overall Study||106||
59713750|NCT01215227|75832387|FG003|Treated|Overall Study||96||
59713751|NCT01215227|75832388|FG004|Treated|Overall Study||93||
59713752|NCT01215227|75832389|FG005|Treated|Overall Study||108||
59713753|NCT01215227|75832384|FG000|COMPLETED|Overall Study||97||
59713754|NCT01215227|75832385|FG001|COMPLETED|Overall Study||96||
59713755|NCT01215227|75832386|FG002|COMPLETED|Overall Study||50||
59713756|NCT01215227|75832387|FG003|COMPLETED|Overall Study||48||
59713757|NCT01215227|75832388|FG004|COMPLETED|Overall Study||45||
59713758|NCT01215227|75832389|FG005|COMPLETED|Overall Study||51||
59713759|NCT01215227|75832384|FG000|NOT COMPLETED|Overall Study||121||
59713760|NCT01215227|75832385|FG001|NOT COMPLETED|Overall Study||119||
59713761|NCT01215227|75832386|FG002|NOT COMPLETED|Overall Study||57||
59713762|NCT01215227|75832387|FG003|NOT COMPLETED|Overall Study||49||
59713763|NCT01215227|75832388|FG004|NOT COMPLETED|Overall Study||48||
59713764|NCT01215227|75832389|FG005|NOT COMPLETED|Overall Study||58||
59713765|NCT01009515|75832403|FG000|STARTED|Overall Study||19||
59713766|NCT01009515|75832403|FG000|COMPLETED|Overall Study||16||
59567020|NCT02301624|75669807|FG000|STARTED|Open-label Maintenance Phase||55||
59567021|NCT02301624|75669808|FG001|STARTED|Open-label Maintenance Phase||61||
59567022|NCT02301624|75669807|FG000|Received at Least 1 Dose of Study Drug|Open-label Maintenance Phase||55||
59567023|NCT02301624|75669808|FG001|Received at Least 1 Dose of Study Drug|Open-label Maintenance Phase||61||
59567024|NCT02301624|75669807|FG000|COMPLETED|Open-label Maintenance Phase||43||
59567025|NCT02301624|75669808|FG001|COMPLETED|Open-label Maintenance Phase||44||
59567026|NCT02301624|75669807|FG000|NOT COMPLETED|Open-label Maintenance Phase||12||
59567027|NCT02301624|75669808|FG001|NOT COMPLETED|Open-label Maintenance Phase||17||
59567028|NCT03860181|75669819|FG000|STARTED|Overall Study||21||
59567029|NCT03860181|75669820|FG001|STARTED|Overall Study||22||
59567030|NCT03860181|75669821|FG002|STARTED|Overall Study||25||
59567031|NCT03860181|75669822|FG003|STARTED|Overall Study||21||
59567032|NCT03860181|75669819|FG000|COMPLETED|Overall Study||21||
59713767|NCT01009515|75832403|FG000|NOT COMPLETED|Overall Study||3||
59567033|NCT03860181|75669820|FG001|COMPLETED|Overall Study||22||
59713768|NCT01214915|75832407|FG000|STARTED|Overall Study||53||
59713769|NCT01214915|75832407|FG000|COMPLETED|Overall Study||42||
59713770|NCT01214915|75832407|FG000|NOT COMPLETED|Overall Study||11||
59713771|NCT01009281|75832411|FG000|STARTED|Overall Study||7||
59713772|NCT01009281|75832411|FG000|COMPLETED|Overall Study||0||
59713773|NCT01009281|75832411|FG000|NOT COMPLETED|Overall Study||7||
59820626|NCT00509366|75943008|FG000|STARTED|Overall Study|Registered patients who were assigned cisplatin/gemcitabine treatment.|18||
59820627|NCT00509366|75943009|FG001|STARTED|Overall Study|Registered patients who were assigned cisplatin/pemetrexed treatment.|8||
59820628|NCT00509366|75943010|FG002|STARTED|Overall Study|Registered patients who were assigned pemetrexed/gemcitabine treatment.|22||
59820629|NCT00509366|75943011|FG003|STARTED|Overall Study|Registered patients who were assigned docetaxel/gemcitabine treatment.|2||
59820630|NCT00509366|75943012|FG004|STARTED|Overall Study|Registered patients who were neither assigned nor treated with protocol-based therapy.|51||
59820631|NCT00509366|75943008|FG000|Assigned Treatment|Overall Study|Patients who were assigned to cisplatin/gemcitabine treatment arm.|18||
59820632|NCT00509366|75943009|FG001|Assigned Treatment|Overall Study|Patients who were assigned to cisplatin/pemetrexed treatment arm.|8||
59820633|NCT00509366|75943010|FG002|Assigned Treatment|Overall Study|Patients who were assigned to pemetrexed/gemcitabine treatment arm.|22||
59820634|NCT00509366|75943011|FG003|Assigned Treatment|Overall Study|Patients who were assigned to docetaxel/gemcitabine treatment arm.|2||
59820635|NCT00509366|75943012|FG004|Assigned Treatment|Overall Study||0||
59820636|NCT00509366|75943008|FG000|COMPLETED|Overall Study|Patients assigned to treatment and treated with cisplatin/gemcitabine treatment combination.|17||
59820637|NCT00509366|75943009|FG001|COMPLETED|Overall Study|Patients assigned to treatment and treated with cisplatin/pemetrexed treatment combination.|7||
59820638|NCT00509366|75943010|FG002|COMPLETED|Overall Study|Patients assigned to treatment and treated with pemetrexed/gemcitabine treatment combination.|21||
59820639|NCT00509366|75943011|FG003|COMPLETED|Overall Study|Patients assigned to treatment and treated with docetaxel/gemcitabine treatment combination.|2||
59820640|NCT00509366|75943012|FG004|COMPLETED|Overall Study|Patients who were neither assigned nor treated with protocol-based therapy.|51||
59820641|NCT00509366|75943008|FG000|NOT COMPLETED|Overall Study||1||
59820642|NCT00509366|75943009|FG001|NOT COMPLETED|Overall Study||1||
59820643|NCT00509366|75943010|FG002|NOT COMPLETED|Overall Study||1||
59820644|NCT00509366|75943011|FG003|NOT COMPLETED|Overall Study||0||
59820645|NCT00509366|75943012|FG004|NOT COMPLETED|Overall Study||0||
59820646|NCT00500318|75943024|FG000|STARTED|Overall Study||86||
59820647|NCT00500318|75943025|FG001|STARTED|Overall Study||95||
59820648|NCT00500318|75943024|FG000|COMPLETED|Overall Study||81||
59820649|NCT00500318|75943025|FG001|COMPLETED|Overall Study||78||
59820650|NCT00500318|75943024|FG000|NOT COMPLETED|Overall Study||5||
59820651|NCT00500318|75943025|FG001|NOT COMPLETED|Overall Study||17||
59820652|NCT00508820|75943033|FG000|STARTED|Overall Study||168||
59820653|NCT00508820|75943034|FG001|STARTED|Overall Study||239||
59820654|NCT00508820|75943033|FG000|COMPLETED|Overall Study||113||
59820655|NCT00508820|75943034|FG001|COMPLETED|Overall Study||175||
59820656|NCT00508820|75943033|FG000|NOT COMPLETED|Overall Study||55||
59820657|NCT00508820|75943034|FG001|NOT COMPLETED|Overall Study||64||
59820658|NCT00499694|75943040|FG000|STARTED|Overall Study||31||
59820659|NCT00499694|75943040|FG000|COMPLETED|Overall Study||30||
59820660|NCT00499694|75943040|FG000|NOT COMPLETED|Overall Study||1||
59820661|NCT00486954|75943049|FG000|STARTED|Pilot Part||6||
59820662|NCT00486954|75943050|FG001|STARTED|Pilot Part||0||
59820663|NCT00486954|75943051|FG002|STARTED|Pilot Part||6||
59820664|NCT00486954|75943052|FG003|STARTED|Pilot Part||0||
59820665|NCT00486954|75943053|FG004|STARTED|Pilot Part||0||
59820666|NCT00486954|75943049|FG000|COMPLETED|Pilot Part||0||
59820667|NCT00486954|75943050|FG001|COMPLETED|Pilot Part||0||
59820668|NCT00486954|75943051|FG002|COMPLETED|Pilot Part||0||
59820669|NCT00486954|75943052|FG003|COMPLETED|Pilot Part||0||
59820670|NCT00486954|75943053|FG004|COMPLETED|Pilot Part||0||
59820671|NCT00486954|75943049|FG000|NOT COMPLETED|Pilot Part||6||
59820672|NCT00486954|75943050|FG001|NOT COMPLETED|Pilot Part||0||
59820673|NCT00486954|75943051|FG002|NOT COMPLETED|Pilot Part||6||
59820674|NCT00486954|75943052|FG003|NOT COMPLETED|Pilot Part||0||
59820675|NCT00486954|75943053|FG004|NOT COMPLETED|Pilot Part||0||
59820676|NCT00486954|75943049|FG000|STARTED|Randomized Part||0||
59820677|NCT00486954|75943050|FG001|STARTED|Randomized Part||0||
59820678|NCT00486954|75943051|FG002|STARTED|Randomized Part||0||
59820679|NCT00486954|75943052|FG003|STARTED|Randomized Part||132||
59820680|NCT00486954|75943053|FG004|STARTED|Randomized Part||129||
59820681|NCT00486954|75943049|FG000|COMPLETED|Randomized Part||0||
59820682|NCT00486954|75943050|FG001|COMPLETED|Randomized Part||0||
59820683|NCT00486954|75943051|FG002|COMPLETED|Randomized Part||0||
59820684|NCT00486954|75943052|FG003|COMPLETED|Randomized Part||112||
59820685|NCT00486954|75943053|FG004|COMPLETED|Randomized Part||115||
59820686|NCT00486954|75943049|FG000|NOT COMPLETED|Randomized Part||0||
59820687|NCT00486954|75943050|FG001|NOT COMPLETED|Randomized Part||0||
59820688|NCT00486954|75943051|FG002|NOT COMPLETED|Randomized Part||0||
59820689|NCT00486954|75943052|FG003|NOT COMPLETED|Randomized Part||20||
59820690|NCT00486954|75943053|FG004|NOT COMPLETED|Randomized Part||14||
59820691|NCT00494676|75943063|FG000|STARTED|Allocation||37||
59820692|NCT00494676|75943064|FG001|STARTED|Allocation||36||
59820693|NCT00494676|75943063|FG000|COMPLETED|Allocation||35||
59820694|NCT00494676|75943064|FG001|COMPLETED|Allocation||32||
59820695|NCT00494676|75943063|FG000|NOT COMPLETED|Allocation||2||
59820696|NCT00494676|75943064|FG001|NOT COMPLETED|Allocation||4||
59820697|NCT00494676|75943063|FG000|STARTED|First Intervention||35||
59820698|NCT00494676|75943064|FG001|STARTED|First Intervention||32||
59820699|NCT00494676|75943063|FG000|COMPLETED|First Intervention||34||
59820700|NCT00494676|75943064|FG001|COMPLETED|First Intervention||29||
59820701|NCT00494676|75943063|FG000|NOT COMPLETED|First Intervention||1||
59820702|NCT00494676|75943064|FG001|NOT COMPLETED|First Intervention||3||
59820703|NCT00494676|75943063|FG000|STARTED|Second Intervention||34||
59820704|NCT00494676|75943064|FG001|STARTED|Second Intervention||29||
59820705|NCT00494676|75943063|FG000|COMPLETED|Second Intervention||33||
59820706|NCT00494676|75943064|FG001|COMPLETED|Second Intervention||28||
59820707|NCT00494676|75943063|FG000|NOT COMPLETED|Second Intervention||1||
59820708|NCT00494676|75943064|FG001|NOT COMPLETED|Second Intervention||1||
59820709|NCT00486720|75943072|FG000|STARTED|Overall Study|1 randomized patient was discontinued before receiving treatment due to a protocol violation|10||
59820710|NCT00486720|75943073|FG001|STARTED|Overall Study||12||
59820711|NCT00486720|75943072|FG000|COMPLETED|Overall Study||0||
59820712|NCT00486720|75943073|FG001|COMPLETED|Overall Study||0||
59820713|NCT00486720|75943072|FG000|NOT COMPLETED|Overall Study||10||
59820714|NCT00486720|75943073|FG001|NOT COMPLETED|Overall Study||12||
59820715|NCT00486330|75943079|FG000|STARTED|Overall Study|Twelve subjects met inclusion/exclusion criteria|12||
59820716|NCT00486330|75943079|FG000|COMPLETED|Overall Study|Of the 12 subjects treated, two developed adverse events leading to study drug discontinuation.|10||
59820717|NCT00486330|75943079|FG000|NOT COMPLETED|Overall Study||2||
59820718|NCT00486252|75943083|FG000|STARTED|Overall Study||996||
59820719|NCT00486252|75943083|FG000|COMPLETED|Overall Study||938||
59820720|NCT00486252|75943083|FG000|NOT COMPLETED|Overall Study||58||
59820721|NCT00494442|75943091|FG000|STARTED|Overall Study|Patients received treatment|24||
59820722|NCT00494442|75943092|FG001|STARTED|Overall Study|Patients received treatment|33||
59820723|NCT00494442|75943091|FG000|COMPLETED|Overall Study|Patients completed the full study schedule (168 days treatment)|7||
59820724|NCT00494442|75943092|FG001|COMPLETED|Overall Study|Patients completed the full study schedule (168 days treatment)|17||
59820725|NCT00494442|75943091|FG000|NOT COMPLETED|Overall Study||17||
59820726|NCT00494442|75943092|FG001|NOT COMPLETED|Overall Study||16||
59820727|NCT03851016|75943100|FG000|STARTED|First Intervention (3 Weeks)||12||
59820728|NCT03851016|75943101|FG001|STARTED|First Intervention (3 Weeks)||12||
59820729|NCT03851016|75943100|FG000|COMPLETED|First Intervention (3 Weeks)||11||
59820730|NCT03851016|75943101|FG001|COMPLETED|First Intervention (3 Weeks)||10||
59820731|NCT03851016|75943100|FG000|NOT COMPLETED|First Intervention (3 Weeks)||1||
59820732|NCT03851016|75943101|FG001|NOT COMPLETED|First Intervention (3 Weeks)||2||
59820733|NCT03851016|75943100|FG000|STARTED|Washout (1 Week)||11||
59820734|NCT03851016|75943101|FG001|STARTED|Washout (1 Week)||10||
59820735|NCT03851016|75943100|FG000|COMPLETED|Washout (1 Week)||11||
59820736|NCT03851016|75943101|FG001|COMPLETED|Washout (1 Week)||10||
59820737|NCT03851016|75943100|FG000|NOT COMPLETED|Washout (1 Week)||0||
59820738|NCT03851016|75943101|FG001|NOT COMPLETED|Washout (1 Week)||0||
59820739|NCT03851016|75943100|FG000|STARTED|Second Intervention (3 Weeks)||11||
59820740|NCT03851016|75943101|FG001|STARTED|Second Intervention (3 Weeks)||10||
59820741|NCT03851016|75943100|FG000|COMPLETED|Second Intervention (3 Weeks)||11||
59820742|NCT03851016|75943101|FG001|COMPLETED|Second Intervention (3 Weeks)||10||
59820743|NCT03851016|75943100|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||0||
59820744|NCT03851016|75943101|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0||
59820745|NCT00493974|75943109|FG000|STARTED|Overall Study||60||
59820746|NCT00493974|75943110|FG001|STARTED|Overall Study||59||
59820747|NCT00493974|75943109|FG000|COMPLETED|Overall Study||47||
59820748|NCT00493974|75943110|FG001|COMPLETED|Overall Study||45||
59820749|NCT00493974|75943109|FG000|NOT COMPLETED|Overall Study||13||
59820750|NCT00493974|75943110|FG001|NOT COMPLETED|Overall Study||14||
59820751|NCT00469092|75943118|FG000|STARTED|Overall Study||239||
59820752|NCT00469092|75943119|FG001|STARTED|Overall Study||241||
59820753|NCT00469092|75943118|FG000|Exposed to Study Drug|Overall Study||231||
59820754|NCT00469092|75943119|FG001|Exposed to Study Drug|Overall Study||238||
59820755|NCT00469092|75943118|FG000|COMPLETED|Overall Study||213||
59820756|NCT00469092|75943119|FG001|COMPLETED|Overall Study||220||
59820757|NCT00469092|75943118|FG000|NOT COMPLETED|Overall Study||26||
59820758|NCT00469092|75943119|FG001|NOT COMPLETED|Overall Study||21||
59820759|NCT00499616|75943129|FG000|STARTED|Overall Study||176||
59820760|NCT00499616|75943130|FG001|STARTED|Overall Study||142||
59820761|NCT00499616|75943131|FG002|STARTED|Overall Study||89||
59820762|NCT00499616|75943132|FG003|STARTED|Overall Study||57||
59820763|NCT00499616|75943129|FG000|COMPLETED|Overall Study||161||
59820764|NCT00499616|75943130|FG001|COMPLETED|Overall Study||114||
59820765|NCT00499616|75943131|FG002|COMPLETED|Overall Study||53||
59820766|NCT00499616|75943132|FG003|COMPLETED|Overall Study||0||
59820767|NCT00499616|75943129|FG000|NOT COMPLETED|Overall Study||15||
59820768|NCT00499616|75943130|FG001|NOT COMPLETED|Overall Study||28||
59820769|NCT00499616|75943131|FG002|NOT COMPLETED|Overall Study||36||
59820770|NCT00499616|75943132|FG003|NOT COMPLETED|Overall Study||57||
59820771|NCT00402597|75943150|FG000|STARTED|Overall Study||1153||
59820772|NCT00402597|75943151|FG001|STARTED|Overall Study||307||
59820773|NCT00402597|75943152|FG002|STARTED|Overall Study||1046||
59820774|NCT00402597|75943153|FG003|STARTED|Overall Study||353||
59820775|NCT00402597|75943154|FG004|STARTED|Overall Study||603||
59820776|NCT00402597|75943150|FG000|COMPLETED|Overall Study||962||
59820777|NCT00402597|75943151|FG001|COMPLETED|Overall Study||261||
59820778|NCT00402597|75943152|FG002|COMPLETED|Overall Study||834||
59820779|NCT00402597|75943153|FG003|COMPLETED|Overall Study||279||
59820780|NCT00402597|75943154|FG004|COMPLETED|Overall Study||479||
59820781|NCT00402597|75943150|FG000|NOT COMPLETED|Overall Study||191||
59820782|NCT00402597|75943151|FG001|NOT COMPLETED|Overall Study||46||
59820783|NCT00402597|75943152|FG002|NOT COMPLETED|Overall Study||212||
59820784|NCT00402597|75943153|FG003|NOT COMPLETED|Overall Study||74||
59820785|NCT00402597|75943154|FG004|NOT COMPLETED|Overall Study||124||
59820786|NCT00402363|75943170|FG000|STARTED|Overall Study||266||
59820787|NCT00402363|75943171|FG001|STARTED|Overall Study||276||
59820788|NCT00402363|75943172|FG002|STARTED|Overall Study||66||
59820789|NCT00402363|75943173|FG003|STARTED|Overall Study||55||
59820790|NCT00402363|75943170|FG000|COMPLETED|Overall Study||233||
59820791|NCT00402363|75943171|FG001|COMPLETED|Overall Study||246||
59820792|NCT00402363|75943172|FG002|COMPLETED|Overall Study||60||
59820793|NCT00402363|75943173|FG003|COMPLETED|Overall Study||45||
59820794|NCT00402363|75943170|FG000|NOT COMPLETED|Overall Study||33||
59820795|NCT00402363|75943171|FG001|NOT COMPLETED|Overall Study||30||
59820796|NCT00402363|75943172|FG002|NOT COMPLETED|Overall Study||6||
59820797|NCT00402363|75943173|FG003|NOT COMPLETED|Overall Study||10||
59820798|NCT00469014|75943193|FG000|STARTED|Initial Phase Randomization||5||
59820799|NCT00469014|75943194|FG001|STARTED|Initial Phase Randomization||4||
59820800|NCT00469014|75943195|FG002|STARTED|Initial Phase Randomization||5||
59820801|NCT00469014|75943196|FG003|STARTED|Initial Phase Randomization||6||
59820802|NCT00469014|75943193|FG000|COMPLETED|Initial Phase Randomization||4||
59820803|NCT00469014|75943194|FG001|COMPLETED|Initial Phase Randomization||3||
59820804|NCT00469014|75943195|FG002|COMPLETED|Initial Phase Randomization||4||
59820805|NCT00469014|75943196|FG003|COMPLETED|Initial Phase Randomization||5||
59820806|NCT00469014|75943193|FG000|NOT COMPLETED|Initial Phase Randomization||1||
59820807|NCT00469014|75943194|FG001|NOT COMPLETED|Initial Phase Randomization||1||
59820808|NCT00469014|75943195|FG002|NOT COMPLETED|Initial Phase Randomization||1||
59820809|NCT00469014|75943196|FG003|NOT COMPLETED|Initial Phase Randomization||1||
59820810|NCT00469014|75943193|FG000|STARTED|Adaptive Randomization||13||
59820811|NCT00469014|75943194|FG001|STARTED|Adaptive Randomization||3||
59820812|NCT00469014|75943195|FG002|STARTED|Adaptive Randomization||24||
59820813|NCT00469014|75943196|FG003|STARTED|Adaptive Randomization||11||
59820814|NCT00469014|75943193|FG000|COMPLETED|Adaptive Randomization||12||
59820815|NCT00469014|75943194|FG001|COMPLETED|Adaptive Randomization||2||
59713774|NCT01009203|75832415|FG000|STARTED|Overall Study||13||
59713775|NCT01009203|75832415|FG000|Received Treatment|Overall Study|One patient withdrew consent before treatment started.|12||
59713776|NCT01009203|75832415|FG000|COMPLETED|Overall Study||6||
59713777|NCT01009203|75832415|FG000|NOT COMPLETED|Overall Study||7||
59820816|NCT00469014|75943195|FG002|COMPLETED|Adaptive Randomization||23||
59820817|NCT00469014|75943196|FG003|COMPLETED|Adaptive Randomization||10||
59820818|NCT00469014|75943193|FG000|NOT COMPLETED|Adaptive Randomization||1||
59820819|NCT00469014|75943194|FG001|NOT COMPLETED|Adaptive Randomization||1||
59820820|NCT00469014|75943195|FG002|NOT COMPLETED|Adaptive Randomization||1||
59820821|NCT00469014|75943196|FG003|NOT COMPLETED|Adaptive Randomization||1||
59820822|NCT00493038|75943208|FG000|STARTED|Treatment||147||
59820823|NCT00493038|75943209|FG001|STARTED|Treatment||146||
59820824|NCT00493038|75943208|FG000|Randomization|Treatment||147||
59820825|NCT00493038|75943209|FG001|Randomization|Treatment||146||
60108539|NCT01662856|76228249|FG000|COMPLETED|Part I + Part II (Overall Study)|Completed Virology follow-up visit at Month 3 or Month 6|152||
60108540|NCT01662856|76228250|FG001|COMPLETED|Part I + Part II (Overall Study)|Completed Virology follow-up visit at Month 3 or Month 6|55||
60108541|NCT01662856|76228249|FG000|NOT COMPLETED|Part I + Part II (Overall Study)||16||
59820826|NCT00493038|75943208|FG000|Treated With Study Medication|Treatment||145||
59820827|NCT00493038|75943209|FG001|Treated With Study Medication|Treatment||142||
59820828|NCT00493038|75943208|FG000|Test-of-Cure Visit|Treatment||123||
59820829|NCT00493038|75943209|FG001|Test-of-Cure Visit|Treatment||126||
59820830|NCT00493038|75943208|FG000|COMPLETED|Treatment||123||
59820831|NCT00493038|75943209|FG001|COMPLETED|Treatment||126||
59820832|NCT00493038|75943208|FG000|NOT COMPLETED|Treatment||24||
59820833|NCT00493038|75943209|FG001|NOT COMPLETED|Treatment||20||
59820834|NCT00493038|75943208|FG000|STARTED|Follow-up||123||
59820835|NCT00493038|75943209|FG001|STARTED|Follow-up||126||
59820836|NCT00493038|75943208|FG000|COMPLETED|Follow-up||122||
59820837|NCT00493038|75943209|FG001|COMPLETED|Follow-up||126||
60108542|NCT01662856|76228250|FG001|NOT COMPLETED|Part I + Part II (Overall Study)||2||
60108543|NCT01662856|76228249|FG000|STARTED|Primary Part II||109||
60108544|NCT01662856|76228250|FG001|STARTED|Primary Part II||57||
59713778|NCT01009047|75832421|FG000|STARTED|Overall Study||113||
59713779|NCT01009047|75832422|FG001|STARTED|Overall Study||115||
59713780|NCT01009047|75832421|FG000|COMPLETED|Overall Study||85||
59713781|NCT01009047|75832422|FG001|COMPLETED|Overall Study||89||
59713782|NCT01009047|75832421|FG000|NOT COMPLETED|Overall Study||28||
59820838|NCT00493038|75943208|FG000|NOT COMPLETED|Follow-up||1||
59820839|NCT00493038|75943209|FG001|NOT COMPLETED|Follow-up||0||
59820840|NCT00392223|75943217|FG000|STARTED|Overall Study||58||
59820841|NCT00392223|75943218|FG001|STARTED|Overall Study||60||
59820842|NCT00392223|75943217|FG000|COMPLETED|Overall Study||49||
59820843|NCT00392223|75943218|FG001|COMPLETED|Overall Study||47||
59820844|NCT00392223|75943217|FG000|NOT COMPLETED|Overall Study||9||
59820845|NCT00392223|75943218|FG001|NOT COMPLETED|Overall Study||13||
59820846|NCT00402285|75943227|FG000|STARTED|Overall Study||29||
59820847|NCT00402285|75943228|FG001|STARTED|Overall Study||27||
59820848|NCT00402285|75943229|FG002|STARTED|Overall Study||28||
59820849|NCT00402285|75943227|FG000|COMPLETED|Overall Study||22||
59820850|NCT00402285|75943228|FG001|COMPLETED|Overall Study||21||
59820851|NCT00402285|75943229|FG002|COMPLETED|Overall Study||26||
59820852|NCT00402285|75943227|FG000|NOT COMPLETED|Overall Study||7||
59820853|NCT00402285|75943228|FG001|NOT COMPLETED|Overall Study||6||
59820854|NCT00402285|75943229|FG002|NOT COMPLETED|Overall Study||2||
59820855|NCT00413283|75943239|FG000|STARTED|Overall Study||12||
59820856|NCT00413283|75943240|FG001|STARTED|Overall Study||16||
59820857|NCT00413283|75943241|FG002|STARTED|Overall Study||18||
59820858|NCT00413283|75943242|FG003|STARTED|Overall Study||17||
59820859|NCT00413283|75943239|FG000|Received Study Drug|Overall Study||12||
59820860|NCT00413283|75943240|FG001|Received Study Drug|Overall Study||16||
59820861|NCT00413283|75943241|FG002|Received Study Drug|Overall Study||18||
59820862|NCT00413283|75943242|FG003|Received Study Drug|Overall Study||16||
59820863|NCT00413283|75943239|FG000|COMPLETED|Overall Study||11||
59820864|NCT00413283|75943240|FG001|COMPLETED|Overall Study||13||
59820865|NCT00413283|75943241|FG002|COMPLETED|Overall Study||16||
59820866|NCT00413283|75943242|FG003|COMPLETED|Overall Study||13||
59820867|NCT00413283|75943239|FG000|NOT COMPLETED|Overall Study||1||
59820868|NCT00413283|75943240|FG001|NOT COMPLETED|Overall Study||3||
59820869|NCT00413283|75943241|FG002|NOT COMPLETED|Overall Study||2||
59820870|NCT00413283|75943242|FG003|NOT COMPLETED|Overall Study||4||
59820871|NCT00402051|75943254|FG000|STARTED|Overall Study||66||
59820872|NCT00402051|75943255|FG001|STARTED|Overall Study||67||
59820873|NCT00402051|75943254|FG000|Received Treatment|Overall Study||65||
59820874|NCT00402051|75943255|FG001|Received Treatment|Overall Study||65||
59820875|NCT00402051|75943254|FG000|COMPLETED|Overall Study|Completed 6 treatment cycles and 30 days of follow-up after last dose of study drug|28||
59820876|NCT00402051|75943255|FG001|COMPLETED|Overall Study|Completed 6 treatment cycles and 30 days of follow-up after last dose of study drug|32||
59820877|NCT00402051|75943254|FG000|NOT COMPLETED|Overall Study||38||
60108545|NCT01662856|76228249|FG000|Completed Study up to Week 6|Primary Part II||106||
59567034|NCT03860181|75669821|FG002|COMPLETED|Overall Study||25||
60108546|NCT01662856|76228250|FG001|Completed Study up to Week 6|Primary Part II||56||
60108547|NCT01662856|76228249|FG000|COMPLETED|Primary Part II|Completed Virology follow-up visit at Month 3 or Month 6|99||
60108548|NCT01662856|76228250|FG001|COMPLETED|Primary Part II|Completed Virology follow-up visit at Month 3 or Month 6|55||
60108549|NCT01662856|76228249|FG000|NOT COMPLETED|Primary Part II||10||
60108550|NCT01662856|76228250|FG001|NOT COMPLETED|Primary Part II||2||
60108551|NCT01791725|76228259|FG000|STARTED|Overall Study||12||
60108552|NCT01791725|76228260|FG001|STARTED|Overall Study||5||
60108553|NCT01791725|76228261|FG002|STARTED|Overall Study||6||
60108554|NCT01791725|76228259|FG000|COMPLETED|Overall Study||12||
60108555|NCT01791725|76228260|FG001|COMPLETED|Overall Study||4||
60108556|NCT01791725|76228261|FG002|COMPLETED|Overall Study||6||
60108557|NCT01791725|76228259|FG000|NOT COMPLETED|Overall Study||0||
60108558|NCT01791725|76228260|FG001|NOT COMPLETED|Overall Study||1||
60108559|NCT01791725|76228261|FG002|NOT COMPLETED|Overall Study||0||
60108560|NCT01791413|76228271|FG000|STARTED|Overall Study||20||
60108561|NCT01791413|76228272|FG001|STARTED|Overall Study||20||
60108562|NCT01791413|76228271|FG000|COMPLETED|Overall Study||15||
60108563|NCT01791413|76228272|FG001|COMPLETED|Overall Study||19||
60108564|NCT01791413|76228271|FG000|NOT COMPLETED|Overall Study||5||
60108565|NCT01791413|76228272|FG001|NOT COMPLETED|Overall Study||1||
60108566|NCT01614574|76228279|FG000|STARTED|Overall Study||6||
60108567|NCT01614574|76228279|FG000|COMPLETED|Overall Study||6||
60108568|NCT01614574|76228279|FG000|NOT COMPLETED|Overall Study||0||
60108569|NCT01610063|76228285|FG000|STARTED|Overall Study||114||
60108570|NCT01610063|76228286|FG001|STARTED|Overall Study||113||
60108571|NCT01610063|76228285|FG000|Baseline|Overall Study||114||
60108572|NCT01610063|76228286|FG001|Baseline|Overall Study||113||
60108573|NCT01610063|76228285|FG000|Completed 2-week|Overall Study||97||
60108574|NCT01610063|76228286|FG001|Completed 2-week|Overall Study||105||
60108575|NCT01610063|76228285|FG000|Completed 4-week|Overall Study||86||
60108576|NCT01610063|76228286|FG001|Completed 4-week|Overall Study||98||
60108577|NCT01610063|76228285|FG000|Completed 8-week|Overall Study||72||
60108578|NCT01610063|76228286|FG001|Completed 8-week|Overall Study||93||
60108579|NCT01610063|76228285|FG000|COMPLETED|Overall Study||72||
60108580|NCT01610063|76228286|FG001|COMPLETED|Overall Study||93||
60108581|NCT01610063|76228285|FG000|NOT COMPLETED|Overall Study||42||
60108582|NCT01610063|76228286|FG001|NOT COMPLETED|Overall Study||20||
60108583|NCT01813721|76228292|FG000|STARTED|Overall Study|Indicates number of participants enrolled|1007||
60108584|NCT01813721|76228292|FG000|COMPLETED|Overall Study||943||
59713783|NCT01009047|75832422|FG001|NOT COMPLETED|Overall Study||26||
59713784|NCT01025193|75832428|FG000|STARTED|Overall Study||8||
59713785|NCT01025193|75832428|FG000|COMPLETED|Overall Study|one patient was transplanted 2 weeks after 8 month belimumab dose and did not receive further doses.|4||
59713786|NCT01025193|75832428|FG000|NOT COMPLETED|Overall Study||4||
59713787|NCT01025037|75832436|FG000|STARTED|Overall Study||61||
59713788|NCT01025037|75832436|FG000|COMPLETED|Overall Study||50||
59713789|NCT01025037|75832436|FG000|NOT COMPLETED|Overall Study||11||
59713790|NCT01214837|75832443|FG000|STARTED|Overall Study||249||
59713791|NCT01214837|75832444|FG001|STARTED|Overall Study||256||
59713792|NCT01214837|75832445|FG002|STARTED|Overall Study||246||
60108585|NCT01813721|76228292|FG000|NOT COMPLETED|Overall Study||64||
60108586|NCT01790633|76228316|FG000|STARTED|Overall Study||163||
60108587|NCT01790633|76228317|FG001|STARTED|Overall Study||164||
60108588|NCT01790633|76228316|FG000|COMPLETED|Overall Study||115||
60108589|NCT01790633|76228317|FG001|COMPLETED|Overall Study||159||
60108590|NCT01790633|76228316|FG000|NOT COMPLETED|Overall Study||48||
60108591|NCT01790633|76228317|FG001|NOT COMPLETED|Overall Study||5||
60108592|NCT01788215|76228326|FG000|STARTED|Overall Study||5||
60108593|NCT01788215|76228327|FG001|STARTED|Overall Study||5||
60108594|NCT01788215|76228326|FG000|12 Weeks of Doxycycline or Placebo|Overall Study||5||
60108595|NCT01788215|76228327|FG001|12 Weeks of Doxycycline or Placebo|Overall Study||5||
60108596|NCT01788215|76228326|FG000|COMPLETED|Overall Study||3||
60108597|NCT01788215|76228327|FG001|COMPLETED|Overall Study||4||
60108598|NCT01788215|76228326|FG000|NOT COMPLETED|Overall Study||2||
60108599|NCT01788215|76228327|FG001|NOT COMPLETED|Overall Study||1||
60108600|NCT01787825|76228333|FG000|STARTED|Overall Study||60||
60108601|NCT01787825|76228334|FG001|STARTED|Overall Study||61||
60108602|NCT01787825|76228333|FG000|COMPLETED|Overall Study||54|This was a paired study with crossover with randomization.|
60108603|NCT01787825|76228334|FG001|COMPLETED|Overall Study||60|This was a paired study with crossover with randomization.|
60108604|NCT01787825|76228333|FG000|NOT COMPLETED|Overall Study||6||
60108605|NCT01787825|76228334|FG001|NOT COMPLETED|Overall Study||1||
60108606|NCT01813019|76228343|FG000|STARTED|Overall Study||24||
60108607|NCT01813019|76228344|FG001|STARTED|Overall Study||26||
60108608|NCT01813019|76228343|FG000|COMPLETED|Overall Study||17||
60108609|NCT01813019|76228344|FG001|COMPLETED|Overall Study||20||
60108610|NCT01813019|76228343|FG000|NOT COMPLETED|Overall Study||7||
60108611|NCT01813019|76228344|FG001|NOT COMPLETED|Overall Study||6||
60108612|NCT01787591|76228352|FG000|STARTED|Period 1 (Cross-over Arm 1)||5||
60108613|NCT01787591|76228353|FG001|STARTED|Period 1 (Cross-over Arm 1)||5||
60108614|NCT01787591|76228354|FG002|STARTED|Period 1 (Cross-over Arm 1)||5||
60108615|NCT01787591|76228355|FG003|STARTED|Period 1 (Cross-over Arm 1)||6||
60108616|NCT01787591|76228352|FG000|COMPLETED|Period 1 (Cross-over Arm 1)||5||
60108617|NCT01787591|76228353|FG001|COMPLETED|Period 1 (Cross-over Arm 1)||5||
60108618|NCT01787591|76228354|FG002|COMPLETED|Period 1 (Cross-over Arm 1)||5||
60108619|NCT01787591|76228355|FG003|COMPLETED|Period 1 (Cross-over Arm 1)||5||
60108620|NCT01787591|76228352|FG000|NOT COMPLETED|Period 1 (Cross-over Arm 1)||0||
60108621|NCT01787591|76228353|FG001|NOT COMPLETED|Period 1 (Cross-over Arm 1)||0||
60108622|NCT01787591|76228354|FG002|NOT COMPLETED|Period 1 (Cross-over Arm 1)||0||
60108623|NCT01787591|76228355|FG003|NOT COMPLETED|Period 1 (Cross-over Arm 1)||1||
60108624|NCT01787591|76228352|FG000|STARTED|Period 2 (Cross-over Arm 2)||5||
60108625|NCT01787591|76228353|FG001|STARTED|Period 2 (Cross-over Arm 2)||5||
60108626|NCT01787591|76228354|FG002|STARTED|Period 2 (Cross-over Arm 2)||5||
60108627|NCT01787591|76228355|FG003|STARTED|Period 2 (Cross-over Arm 2)||5||
60108628|NCT01787591|76228352|FG000|COMPLETED|Period 2 (Cross-over Arm 2)||5||
60108629|NCT01787591|76228353|FG001|COMPLETED|Period 2 (Cross-over Arm 2)||5||
60108630|NCT01787591|76228354|FG002|COMPLETED|Period 2 (Cross-over Arm 2)||5||
60108631|NCT01787591|76228355|FG003|COMPLETED|Period 2 (Cross-over Arm 2)||5||
60108632|NCT01787591|76228352|FG000|NOT COMPLETED|Period 2 (Cross-over Arm 2)||0||
60108633|NCT01787591|76228353|FG001|NOT COMPLETED|Period 2 (Cross-over Arm 2)||0||
60108634|NCT01787591|76228354|FG002|NOT COMPLETED|Period 2 (Cross-over Arm 2)||0||
60108635|NCT01787591|76228355|FG003|NOT COMPLETED|Period 2 (Cross-over Arm 2)||0||
60108636|NCT01787591|76228352|FG000|STARTED|Period 3 (Cross-over Arm 3)||5||
60108637|NCT01787591|76228353|FG001|STARTED|Period 3 (Cross-over Arm 3)||5||
60108638|NCT01787591|76228354|FG002|STARTED|Period 3 (Cross-over Arm 3)||5||
60108639|NCT01787591|76228355|FG003|STARTED|Period 3 (Cross-over Arm 3)||5||
60108640|NCT01787591|76228352|FG000|COMPLETED|Period 3 (Cross-over Arm 3)||5||
60108641|NCT01787591|76228353|FG001|COMPLETED|Period 3 (Cross-over Arm 3)||5||
60108642|NCT01787591|76228354|FG002|COMPLETED|Period 3 (Cross-over Arm 3)||5||
60108643|NCT01787591|76228355|FG003|COMPLETED|Period 3 (Cross-over Arm 3)||5||
60108644|NCT01787591|76228352|FG000|NOT COMPLETED|Period 3 (Cross-over Arm 3)||0||
60108645|NCT01787591|76228353|FG001|NOT COMPLETED|Period 3 (Cross-over Arm 3)||0||
60108646|NCT01787591|76228354|FG002|NOT COMPLETED|Period 3 (Cross-over Arm 3)||0||
60108647|NCT01787591|76228355|FG003|NOT COMPLETED|Period 3 (Cross-over Arm 3)||0||
60108648|NCT01787591|76228352|FG000|STARTED|Period 4 (Cross-over Arm 4)||5||
60108649|NCT01787591|76228353|FG001|STARTED|Period 4 (Cross-over Arm 4)||5||
60108650|NCT01787591|76228354|FG002|STARTED|Period 4 (Cross-over Arm 4)||5||
59713793|NCT01214837|75832443|FG000|COMPLETED|Overall Study||195||
59713794|NCT01214837|75832444|FG001|COMPLETED|Overall Study||192||
59713795|NCT01214837|75832445|FG002|COMPLETED|Overall Study||184||
59713796|NCT01214837|75832443|FG000|NOT COMPLETED|Overall Study||54||
59713797|NCT01214837|75832444|FG001|NOT COMPLETED|Overall Study||64||
59713798|NCT01214837|75832445|FG002|NOT COMPLETED|Overall Study||62||
59713799|NCT01024959|75832454|FG000|STARTED|Overall Study||507||
59713800|NCT01024959|75832454|FG000|COMPLETED|Overall Study||466||
59713801|NCT01024959|75832454|FG000|NOT COMPLETED|Overall Study||41||
59713802|NCT01008423|75832465|FG000|STARTED|Overall Study||134||
59713803|NCT01008423|75832466|FG001|STARTED|Overall Study||147||
59713804|NCT01008423|75832465|FG000|Received at Least 1 Dose of Study Drug|Overall Study||134||
59713805|NCT01008423|75832466|FG001|Received at Least 1 Dose of Study Drug|Overall Study||147||
59713806|NCT01008423|75832465|FG000|COMPLETED|Overall Study||115||
59713807|NCT01008423|75832466|FG001|COMPLETED|Overall Study||125||
59713808|NCT01008423|75832465|FG000|NOT COMPLETED|Overall Study||19||
59713809|NCT01008423|75832466|FG001|NOT COMPLETED|Overall Study||22||
59713810|NCT01012947|75832477|FG000|STARTED|Overall Study||212||
59713811|NCT01012947|75832478|FG001|STARTED|Overall Study||215||
59713812|NCT01012947|75832479|FG002|STARTED|Overall Study||241||
59820878|NCT00402051|75943255|FG001|NOT COMPLETED|Overall Study||35||
59820879|NCT00468858|75943264|FG000|STARTED|Overall Study||211||
59820880|NCT00468858|75943265|FG001|STARTED|Overall Study||212||
59820881|NCT00468858|75943266|FG002|STARTED|Overall Study||213||
59820882|NCT00468858|75943264|FG000|COMPLETED|Overall Study||202||
59820883|NCT00468858|75943265|FG001|COMPLETED|Overall Study||202||
59820884|NCT00468858|75943266|FG002|COMPLETED|Overall Study||199||
59820885|NCT00468858|75943264|FG000|NOT COMPLETED|Overall Study||9||
59820886|NCT00468858|75943265|FG001|NOT COMPLETED|Overall Study||10||
59820887|NCT00468858|75943266|FG002|NOT COMPLETED|Overall Study||14||
59820888|NCT00401973|75943331|FG000|STARTED|Overall Study||50||
59820889|NCT00401973|75943332|FG001|STARTED|Overall Study||76||
59820890|NCT00401973|75943333|FG002|STARTED|Overall Study||73||
59820891|NCT00401973|75943331|FG000|COMPLETED|Overall Study||39||
59820892|NCT00401973|75943332|FG001|COMPLETED|Overall Study||50||
59820893|NCT00401973|75943333|FG002|COMPLETED|Overall Study||50||
59820894|NCT00401973|75943331|FG000|NOT COMPLETED|Overall Study||11||
59820895|NCT00401973|75943332|FG001|NOT COMPLETED|Overall Study||26||
59820896|NCT00401973|75943333|FG002|NOT COMPLETED|Overall Study||23||
59820897|NCT00401193|75943346|FG000|STARTED|Overall Study||118||
59820898|NCT00401193|75943347|FG001|STARTED|Overall Study||117||
59820899|NCT00401193|75943348|FG002|STARTED|Overall Study||69||
59820900|NCT00401193|75943346|FG000|Intent to Treat Population|Overall Study||115||
59820901|NCT00401193|75943347|FG001|Intent to Treat Population|Overall Study||115||
60108651|NCT01787591|76228355|FG003|STARTED|Period 4 (Cross-over Arm 4)||5||
60108652|NCT01787591|76228352|FG000|COMPLETED|Period 4 (Cross-over Arm 4)||5||
60108653|NCT01787591|76228353|FG001|COMPLETED|Period 4 (Cross-over Arm 4)||5||
60108654|NCT01787591|76228354|FG002|COMPLETED|Period 4 (Cross-over Arm 4)||5||
60108655|NCT01787591|76228355|FG003|COMPLETED|Period 4 (Cross-over Arm 4)||5||
60108656|NCT01787591|76228352|FG000|NOT COMPLETED|Period 4 (Cross-over Arm 4)||0||
60108657|NCT01787591|76228353|FG001|NOT COMPLETED|Period 4 (Cross-over Arm 4)||0||
60108658|NCT01787591|76228354|FG002|NOT COMPLETED|Period 4 (Cross-over Arm 4)||0||
60108659|NCT01787591|76228355|FG003|NOT COMPLETED|Period 4 (Cross-over Arm 4)||0||
60108660|NCT01812707|76228370|FG000|STARTED|Overall Study||25||
60108661|NCT01812707|76228371|FG001|STARTED|Overall Study||25||
60108662|NCT01812707|76228372|FG002|STARTED|Overall Study||25||
60108663|NCT01812707|76228373|FG003|STARTED|Overall Study||25||
60108664|NCT01812707|76228370|FG000|Treated|Overall Study||25||
60108665|NCT01812707|76228371|FG001|Treated|Overall Study||25||
60108666|NCT01812707|76228372|FG002|Treated|Overall Study||25||
60108667|NCT01812707|76228373|FG003|Treated|Overall Study||25||
60108668|NCT01812707|76228370|FG000|COMPLETED|Overall Study||23||
60108669|NCT01812707|76228371|FG001|COMPLETED|Overall Study||25||
60108670|NCT01812707|76228372|FG002|COMPLETED|Overall Study||25||
60108671|NCT01812707|76228373|FG003|COMPLETED|Overall Study||23||
60108672|NCT01812707|76228370|FG000|NOT COMPLETED|Overall Study||2||
60108673|NCT01812707|76228371|FG001|NOT COMPLETED|Overall Study||0||
60108674|NCT01812707|76228372|FG002|NOT COMPLETED|Overall Study||0||
60108675|NCT01812707|76228373|FG003|NOT COMPLETED|Overall Study||2||
60108676|NCT01787279|76228384|FG000|STARTED|Overall Study||59||
60108677|NCT01787279|76228384|FG000|COMPLETED|Overall Study||56||
60108678|NCT01787279|76228384|FG000|NOT COMPLETED|Overall Study||3||
60108679|NCT02728206|76228388|FG000|STARTED|Overall Study||9||
60108680|NCT02728206|76228388|FG000|COMPLETED|Overall Study||8||
60108681|NCT02728206|76228388|FG000|NOT COMPLETED|Overall Study||1||
60108682|NCT01811225|76228392|FG000|STARTED|Treatment Period 1||49||
60108683|NCT01811225|76228393|FG001|STARTED|Treatment Period 1||46||
60108684|NCT01811225|76228392|FG000|COMPLETED|Treatment Period 1|53 completed one arm of the cross-over and 43 completed two arms of the cross-over|24||
60108685|NCT01811225|76228393|FG001|COMPLETED|Treatment Period 1||29||
60108686|NCT01811225|76228392|FG000|NOT COMPLETED|Treatment Period 1||25||
60108687|NCT01811225|76228393|FG001|NOT COMPLETED|Treatment Period 1||17||
60108688|NCT01811225|76228392|FG000|STARTED|Treatment Period 2||24||
59820902|NCT00401193|75943348|FG002|Intent to Treat Population|Overall Study||67||
59820903|NCT00401193|75943346|FG000|Modified Intent to Treat Population|Overall Study||112||
59820904|NCT00401193|75943347|FG001|Modified Intent to Treat Population|Overall Study||115||
59820905|NCT00401193|75943348|FG002|Modified Intent to Treat Population|Overall Study||67||
59820906|NCT00401193|75943346|FG000|COMPLETED|Overall Study||103||
59820907|NCT00401193|75943347|FG001|COMPLETED|Overall Study||106||
59820908|NCT00401193|75943348|FG002|COMPLETED|Overall Study||63||
59820909|NCT00401193|75943346|FG000|NOT COMPLETED|Overall Study||15||
59820910|NCT00401193|75943347|FG001|NOT COMPLETED|Overall Study||11||
59820911|NCT00401193|75943348|FG002|NOT COMPLETED|Overall Study||6||
60108689|NCT01811225|76228393|FG001|STARTED|Treatment Period 2||29||
60108690|NCT01811225|76228392|FG000|COMPLETED|Treatment Period 2||20||
60108691|NCT01811225|76228393|FG001|COMPLETED|Treatment Period 2||23||
59713813|NCT01012947|75832480|FG003|STARTED|Overall Study||211||
59713814|NCT01012947|75832481|FG004|STARTED|Overall Study||236||
60108692|NCT01811225|76228392|FG000|NOT COMPLETED|Treatment Period 2||4||
59713815|NCT01012947|75832477|FG000|COMPLETED|Overall Study||81||
59713816|NCT01012947|75832478|FG001|COMPLETED|Overall Study||80||
59713817|NCT01012947|75832479|FG002|COMPLETED|Overall Study||111||
59713818|NCT01012947|75832480|FG003|COMPLETED|Overall Study||93||
59713819|NCT01012947|75832481|FG004|COMPLETED|Overall Study||94||
59713820|NCT01012947|75832477|FG000|NOT COMPLETED|Overall Study||131||
59713821|NCT01012947|75832478|FG001|NOT COMPLETED|Overall Study||135||
59713822|NCT01012947|75832479|FG002|NOT COMPLETED|Overall Study||130||
59713823|NCT01012947|75832480|FG003|NOT COMPLETED|Overall Study||118||
59713824|NCT01012947|75832481|FG004|NOT COMPLETED|Overall Study||142||
59713825|NCT03685747|75832493|FG000|STARTED|Overall Study||4||
59713826|NCT03685747|75832493|FG000|COMPLETED|Overall Study||4||
59713827|NCT03685747|75832493|FG000|NOT COMPLETED|Overall Study||0||
59713828|NCT03586687|75832500|FG000|STARTED|Overall Study||6||
59713829|NCT03586687|75832501|FG001|STARTED|Overall Study||9||
59713830|NCT03586687|75832502|FG002|STARTED|Overall Study||4||
59713831|NCT03586687|75832500|FG000|COMPLETED|Overall Study||6||
59713832|NCT03586687|75832501|FG001|COMPLETED|Overall Study||9||
59713833|NCT03586687|75832502|FG002|COMPLETED|Overall Study||4||
59713834|NCT03586687|75832500|FG000|NOT COMPLETED|Overall Study||0||
59713835|NCT03586687|75832501|FG001|NOT COMPLETED|Overall Study||0||
59713836|NCT03586687|75832502|FG002|NOT COMPLETED|Overall Study||0||
59713837|NCT01214603|75832513|FG000|STARTED|Overall Study||7||
59713838|NCT01214603|75832514|FG001|STARTED|Overall Study||6||
59713839|NCT01214603|75832515|FG002|STARTED|Overall Study||7||
59713840|NCT01214603|75832513|FG000|Received at Least 1 Dose of LY2090314|Overall Study||7||
59713841|NCT01214603|75832514|FG001|Received at Least 1 Dose of LY2090314|Overall Study||6||
59713842|NCT01214603|75832515|FG002|Received at Least 1 Dose of LY2090314|Overall Study||7||
59713843|NCT01214603|75832513|FG000|COMPLETED|Overall Study||2||
59713844|NCT01214603|75832514|FG001|COMPLETED|Overall Study||5||
59713845|NCT01214603|75832515|FG002|COMPLETED|Overall Study||3||
59713846|NCT01214603|75832513|FG000|NOT COMPLETED|Overall Study||5||
59713847|NCT01214603|75832514|FG001|NOT COMPLETED|Overall Study||1||
59713848|NCT01214603|75832515|FG002|NOT COMPLETED|Overall Study||4||
59713849|NCT01212185|75832526|FG000|STARTED|Overall Study||6||
59713850|NCT01212185|75832527|FG001|STARTED|Overall Study||8||
59713851|NCT01212185|75832526|FG000|COMPLETED|Overall Study||4||
59713852|NCT01212185|75832527|FG001|COMPLETED|Overall Study||7||
59713853|NCT01212185|75832526|FG000|NOT COMPLETED|Overall Study||2||
59713854|NCT01212185|75832527|FG001|NOT COMPLETED|Overall Study||1||
59713855|NCT01995175|75832533|FG000|STARTED|Period 1 - From 0 up to 2 Years of Age||2401||
59713856|NCT01995175|75832533|FG000|COMPLETED|Period 1 - From 0 up to 2 Years of Age||2148|Completed=Number of subjects that completed the primary study|
59713857|NCT01995175|75832533|FG000|NOT COMPLETED|Period 1 - From 0 up to 2 Years of Age||253||
59820912|NCT00400569|75943357|FG000|STARTED|Overall Study||48||
59820913|NCT00400569|75943357|FG000|COMPLETED|Overall Study||47||
59820914|NCT00400569|75943357|FG000|NOT COMPLETED|Overall Study||1||
60108693|NCT01811225|76228393|FG001|NOT COMPLETED|Treatment Period 2||6||
60108694|NCT01809197|76228401|FG000|STARTED|Overall Study||187||
59820915|NCT00413049|75943366|FG000|STARTED|Overall Study||349||
60108695|NCT01809197|76228402|FG001|STARTED|Overall Study||185||
60108696|NCT01809197|76228401|FG000|COMPLETED|Overall Study||177||
60108697|NCT01809197|76228402|FG001|COMPLETED|Overall Study||177||
60108698|NCT01809197|76228401|FG000|NOT COMPLETED|Overall Study||10||
60108699|NCT01809197|76228402|FG001|NOT COMPLETED|Overall Study||8||
59713858|NCT01995175|75832533|FG000|STARTED|Period 2 - From 2 up to 6 Years of Age|Out of 2148 subjects who completed the primary study, 10 subjects were excluded from the extension study due to invalid informed consent form (ICF) or fraudulent data, and 743 subjects were at a site that did not participate, or they did not consent to participate in the extension study.|1395||
59713859|NCT01995175|75832533|FG000|COMPLETED|Period 2 - From 2 up to 6 Years of Age||1338||
59713860|NCT01995175|75832533|FG000|NOT COMPLETED|Period 2 - From 2 up to 6 Years of Age||57||
59820916|NCT00413049|75943367|FG001|STARTED|Overall Study||349||
59820917|NCT00413049|75943366|FG000|COMPLETED|Overall Study||325||
59820918|NCT00413049|75943367|FG001|COMPLETED|Overall Study||331||
59820919|NCT00413049|75943366|FG000|NOT COMPLETED|Overall Study||24||
60108700|NCT01786109|76228411|FG000|STARTED|Overall Study||24||
59820920|NCT00413049|75943367|FG001|NOT COMPLETED|Overall Study||18||
59820921|NCT00454194|75943375|FG000|STARTED|Overall Study||47||
59820922|NCT00454194|75943376|FG001|STARTED|Overall Study||51||
59820923|NCT00454194|75943375|FG000|COMPLETED|Overall Study||25||
59820924|NCT00454194|75943376|FG001|COMPLETED|Overall Study||37||
59820925|NCT00454194|75943375|FG000|NOT COMPLETED|Overall Study||22||
59820926|NCT00454194|75943376|FG001|NOT COMPLETED|Overall Study||14||
59820927|NCT00412971|75943384|FG000|STARTED|Overall Study||115||
59820928|NCT00412971|75943385|FG001|STARTED|Overall Study||118||
59820929|NCT00412971|75943384|FG000|COMPLETED|Overall Study||85||
59820930|NCT00412971|75943385|FG001|COMPLETED|Overall Study||108||
59820931|NCT00412971|75943384|FG000|NOT COMPLETED|Overall Study||30||
59820932|NCT00412971|75943385|FG001|NOT COMPLETED|Overall Study||10||
59820933|NCT00303472|75943398|FG000|STARTED|Treatment Period||6||
59820934|NCT00303472|75943399|FG001|STARTED|Treatment Period||11||
59820935|NCT00303472|75943400|FG002|STARTED|Treatment Period||11||
59820936|NCT00303472|75943401|FG003|STARTED|Treatment Period||16||
59820937|NCT00303472|75943402|FG004|STARTED|Treatment Period||11||
59820938|NCT00303472|75943403|FG005|STARTED|Treatment Period||12||
59820939|NCT00303472|75943404|FG006|STARTED|Treatment Period||5||
59820940|NCT00303472|75943398|FG000|COMPLETED|Treatment Period||6||
59820941|NCT00303472|75943399|FG001|COMPLETED|Treatment Period||11||
59820942|NCT00303472|75943400|FG002|COMPLETED|Treatment Period||11||
59820943|NCT00303472|75943401|FG003|COMPLETED|Treatment Period||14||
59820944|NCT00303472|75943402|FG004|COMPLETED|Treatment Period||8||
59820945|NCT00303472|75943403|FG005|COMPLETED|Treatment Period||11||
59820946|NCT00303472|75943404|FG006|COMPLETED|Treatment Period||3||
59820947|NCT00303472|75943398|FG000|NOT COMPLETED|Treatment Period||0||
59820948|NCT00303472|75943399|FG001|NOT COMPLETED|Treatment Period||0||
59820949|NCT00303472|75943400|FG002|NOT COMPLETED|Treatment Period||0||
59820950|NCT00303472|75943401|FG003|NOT COMPLETED|Treatment Period||2||
59820951|NCT00303472|75943402|FG004|NOT COMPLETED|Treatment Period||3||
59820952|NCT00303472|75943403|FG005|NOT COMPLETED|Treatment Period||1||
59820953|NCT00303472|75943404|FG006|NOT COMPLETED|Treatment Period||2||
59820954|NCT00303472|75943398|FG000|STARTED|Treatment Extension (Optional)||6||
59820955|NCT00303472|75943399|FG001|STARTED|Treatment Extension (Optional)||11||
59820956|NCT00303472|75943400|FG002|STARTED|Treatment Extension (Optional)||11||
59820957|NCT00303472|75943401|FG003|STARTED|Treatment Extension (Optional)||13||
59820958|NCT00303472|75943402|FG004|STARTED|Treatment Extension (Optional)||5||
59820959|NCT00303472|75943403|FG005|STARTED|Treatment Extension (Optional)||5||
59820960|NCT00303472|75943404|FG006|STARTED|Treatment Extension (Optional)||1||
59820961|NCT00303472|75943398|FG000|COMPLETED|Treatment Extension (Optional)||1||
59820962|NCT00303472|75943399|FG001|COMPLETED|Treatment Extension (Optional)||5||
59820963|NCT00303472|75943400|FG002|COMPLETED|Treatment Extension (Optional)||2||
59820964|NCT00303472|75943401|FG003|COMPLETED|Treatment Extension (Optional)||5||
59820965|NCT00303472|75943402|FG004|COMPLETED|Treatment Extension (Optional)||1||
59820966|NCT00303472|75943403|FG005|COMPLETED|Treatment Extension (Optional)||4||
59820967|NCT00303472|75943404|FG006|COMPLETED|Treatment Extension (Optional)||1||
59820968|NCT00303472|75943398|FG000|NOT COMPLETED|Treatment Extension (Optional)||5||
59820969|NCT00303472|75943399|FG001|NOT COMPLETED|Treatment Extension (Optional)||6||
59820970|NCT00303472|75943400|FG002|NOT COMPLETED|Treatment Extension (Optional)||9||
59820971|NCT00303472|75943401|FG003|NOT COMPLETED|Treatment Extension (Optional)||8||
59820972|NCT00303472|75943402|FG004|NOT COMPLETED|Treatment Extension (Optional)||4||
59820973|NCT00303472|75943403|FG005|NOT COMPLETED|Treatment Extension (Optional)||1||
59820974|NCT00303472|75943404|FG006|NOT COMPLETED|Treatment Extension (Optional)||0||
59820975|NCT00468546|75943422|FG000|STARTED|Week 24 Analysis||208||
59820976|NCT00468546|75943423|FG001|STARTED|Week 24 Analysis||308||
59820977|NCT00468546|75943422|FG000|COMPLETED|Week 24 Analysis||111||
59820978|NCT00468546|75943423|FG001|COMPLETED|Week 24 Analysis||253||
59820979|NCT00468546|75943422|FG000|NOT COMPLETED|Week 24 Analysis||97||
59820980|NCT00468546|75943423|FG001|NOT COMPLETED|Week 24 Analysis||55||
60108701|NCT01786109|76228412|FG001|STARTED|Overall Study||24||
59820981|NCT00468546|75943422|FG000|STARTED|Week 24 to Week 104 Analysis|Participants who completed/not completed Week (W) 24 analysis were entered in W24 to W104 analysis.|208||
59820982|NCT00468546|75943423|FG001|STARTED|Week 24 to Week 104 Analysis|Participants who completed/not completed W24 analysis were entered in W24 to W104 analysis.|308||
59820983|NCT00468546|75943422|FG000|COMPLETED|Week 24 to Week 104 Analysis||103||
60108702|NCT01786109|76228413|FG002|STARTED|Overall Study||27||
59820984|NCT00468546|75943423|FG001|COMPLETED|Week 24 to Week 104 Analysis||83||
59820985|NCT00468546|75943422|FG000|NOT COMPLETED|Week 24 to Week 104 Analysis||105||
59820986|NCT00468546|75943423|FG001|NOT COMPLETED|Week 24 to Week 104 Analysis||225||
59820987|NCT00303316|75943431|FG000|STARTED|Overall Study||232||
59820988|NCT00303316|75943432|FG001|STARTED|Overall Study||226||
59820989|NCT00303316|75943431|FG000|COMPLETED|Overall Study||230||
59820990|NCT00303316|75943432|FG001|COMPLETED|Overall Study||223||
59820991|NCT00303316|75943431|FG000|NOT COMPLETED|Overall Study||2||
59820992|NCT00303316|75943432|FG001|NOT COMPLETED|Overall Study||3||
59820993|NCT00468312|75943440|FG000|STARTED|Overall Study||220||
59820994|NCT00468312|75943441|FG001|STARTED|Overall Study||209||
59820995|NCT00468312|75943440|FG000|COMPLETED|Overall Study||216||
60108703|NCT01786109|76228411|FG000|COMPLETED|Overall Study||23||
59820996|NCT00468312|75943441|FG001|COMPLETED|Overall Study||204||
59820997|NCT00468312|75943440|FG000|NOT COMPLETED|Overall Study||4||
59820998|NCT00468312|75943441|FG001|NOT COMPLETED|Overall Study||5||
59820999|NCT00331864|75943449|FG000|STARTED|Overall Study||513||
59821000|NCT00331864|75943450|FG001|STARTED|Overall Study||18||
59821001|NCT00331864|75943449|FG000|COMPLETED|Overall Study||455||
59821002|NCT00331864|75943450|FG001|COMPLETED|Overall Study||14||
59821003|NCT00331864|75943449|FG000|NOT COMPLETED|Overall Study||58||
59821004|NCT00331864|75943450|FG001|NOT COMPLETED|Overall Study||4||
59821005|NCT00331630|75943456|FG000|STARTED|Treatment on Study||30||
59821006|NCT00331630|75943456|FG000|Completed 1st Cycle|Treatment on Study||30||
59821007|NCT00331630|75943456|FG000|Completed 4 Cycles|Treatment on Study||30||
59821008|NCT00331630|75943456|FG000|COMPLETED|Treatment on Study||30||
59821009|NCT00331630|75943456|FG000|NOT COMPLETED|Treatment on Study||0||
59821010|NCT00331630|75943456|FG000|STARTED|Evaluated for and Completed SOC Surgery||30||
59821011|NCT00331630|75943456|FG000|COMPLETED|Evaluated for and Completed SOC Surgery||28||
59821012|NCT00331630|75943456|FG000|NOT COMPLETED|Evaluated for and Completed SOC Surgery||2||
59821013|NCT00331630|75943456|FG000|STARTED|Follow up for 5 Years|One patient did not enter follow up as was lost to follow up|29|All patients that are treated on the study go into follow up period.|
59821014|NCT00331630|75943456|FG000|COMPLETED|Follow up for 5 Years||0||
59821015|NCT00331630|75943456|FG000|NOT COMPLETED|Follow up for 5 Years||29||
59821016|NCT00331552|75943462|FG000|STARTED|Period 1: Doxil 30 mg/m^2 (Phase I)||3||
59821017|NCT00331552|75943463|FG001|STARTED|Period 1: Doxil 30 mg/m^2 (Phase I)||0||
59821018|NCT00331552|75943462|FG000|COMPLETED|Period 1: Doxil 30 mg/m^2 (Phase I)||3||
59821019|NCT00331552|75943463|FG001|COMPLETED|Period 1: Doxil 30 mg/m^2 (Phase I)||0||
59821020|NCT00331552|75943462|FG000|NOT COMPLETED|Period 1: Doxil 30 mg/m^2 (Phase I)||0||
59821021|NCT00331552|75943463|FG001|NOT COMPLETED|Period 1: Doxil 30 mg/m^2 (Phase I)||0||
59821022|NCT00331552|75943462|FG000|STARTED|Period 2: Doxil 35 mg/m^2 (Phase I)||0||
59821023|NCT00331552|75943463|FG001|STARTED|Period 2: Doxil 35 mg/m^2 (Phase I)||3||
59713861|NCT03611101|75832541|FG000|STARTED|Overall Study||32||
59713862|NCT03611101|75832542|FG001|STARTED|Overall Study||32||
59713863|NCT03611101|75832543|FG002|STARTED|Overall Study||30||
59713864|NCT03611101|75832544|FG003|STARTED|Overall Study||30||
59713865|NCT03611101|75832541|FG000|COMPLETED|Overall Study||25||
59713866|NCT03611101|75832542|FG001|COMPLETED|Overall Study||28||
59713867|NCT03611101|75832543|FG002|COMPLETED|Overall Study||27||
59713868|NCT03611101|75832544|FG003|COMPLETED|Overall Study||23||
59713869|NCT03611101|75832541|FG000|NOT COMPLETED|Overall Study||7||
59713870|NCT03611101|75832542|FG001|NOT COMPLETED|Overall Study||4||
60108704|NCT01786109|76228412|FG001|COMPLETED|Overall Study||24||
60108705|NCT01786109|76228413|FG002|COMPLETED|Overall Study||25||
60108706|NCT01786109|76228411|FG000|NOT COMPLETED|Overall Study||1||
59821024|NCT00331552|75943462|FG000|COMPLETED|Period 2: Doxil 35 mg/m^2 (Phase I)||0||
59821025|NCT00331552|75943463|FG001|COMPLETED|Period 2: Doxil 35 mg/m^2 (Phase I)||3||
59821026|NCT00331552|75943462|FG000|NOT COMPLETED|Period 2: Doxil 35 mg/m^2 (Phase I)||0||
59821027|NCT00331552|75943463|FG001|NOT COMPLETED|Period 2: Doxil 35 mg/m^2 (Phase I)||0||
59713871|NCT03611101|75832543|FG002|NOT COMPLETED|Overall Study||3||
59713872|NCT03611101|75832544|FG003|NOT COMPLETED|Overall Study||7||
59713873|NCT02430181|75832589|FG000|STARTED|Overall Study||3||
59713874|NCT02430181|75832590|FG001|STARTED|Overall Study||3||
59713875|NCT02430181|75832591|FG002|STARTED|Overall Study||3||
59713876|NCT02430181|75832592|FG003|STARTED|Overall Study||3||
59713877|NCT02430181|75832593|FG004|STARTED|Overall Study||3||
59713878|NCT02430181|75832594|FG005|STARTED|Overall Study||2||
59713879|NCT02430181|75832595|FG006|STARTED|Overall Study||3||
59713880|NCT02430181|75832589|FG000|COMPLETED|Overall Study||3||
59713881|NCT02430181|75832590|FG001|COMPLETED|Overall Study||3||
59713882|NCT02430181|75832591|FG002|COMPLETED|Overall Study||2||
59821028|NCT00331552|75943462|FG000|STARTED|Period 3: Phase II||24||
59821029|NCT00331552|75943463|FG001|STARTED|Period 3: Phase II||0||
59821030|NCT00331552|75943462|FG000|COMPLETED|Period 3: Phase II||22||
60108707|NCT01786109|76228412|FG001|NOT COMPLETED|Overall Study||0||
60108708|NCT01786109|76228413|FG002|NOT COMPLETED|Overall Study||2||
60108709|NCT01615120|76228423|FG000|STARTED|Overall Study||38||
60108710|NCT01615120|76228424|FG001|STARTED|Overall Study||39||
60108711|NCT01615120|76228423|FG000|COMPLETED|Overall Study||23||
60108712|NCT01615120|76228424|FG001|COMPLETED|Overall Study||19||
60108713|NCT01615120|76228423|FG000|NOT COMPLETED|Overall Study||15||
60108714|NCT01615120|76228424|FG001|NOT COMPLETED|Overall Study||20||
60108715|NCT01616056|76228430|FG000|STARTED|Overall Study||20||
59713883|NCT02430181|75832592|FG003|COMPLETED|Overall Study||3||
59713884|NCT02430181|75832593|FG004|COMPLETED|Overall Study||3||
59713885|NCT02430181|75832594|FG005|COMPLETED|Overall Study||0||
59713886|NCT02430181|75832595|FG006|COMPLETED|Overall Study||0||
59713887|NCT02430181|75832589|FG000|NOT COMPLETED|Overall Study||0||
59713888|NCT02430181|75832590|FG001|NOT COMPLETED|Overall Study||0||
59821031|NCT00331552|75943463|FG001|COMPLETED|Period 3: Phase II||0||
59821032|NCT00331552|75943462|FG000|NOT COMPLETED|Period 3: Phase II||2||
59821033|NCT00331552|75943463|FG001|NOT COMPLETED|Period 3: Phase II||0||
59821034|NCT00317356|75943478|FG000|STARTED|Overall Study||11||
60108716|NCT01616056|76228430|FG000|COMPLETED|Overall Study||19||
59713889|NCT02430181|75832591|FG002|NOT COMPLETED|Overall Study||1||
59713890|NCT02430181|75832592|FG003|NOT COMPLETED|Overall Study||0||
59713891|NCT02430181|75832593|FG004|NOT COMPLETED|Overall Study||0||
59713892|NCT02430181|75832594|FG005|NOT COMPLETED|Overall Study||2||
59713893|NCT02430181|75832595|FG006|NOT COMPLETED|Overall Study||3||
59713894|NCT02118727|75832613|FG000|STARTED|Overall Study||58||
59713895|NCT02118727|75832614|FG001|STARTED|Overall Study||31||
59713896|NCT02118727|75832613|FG000|COMPLETED|Overall Study||33||
59713897|NCT02118727|75832614|FG001|COMPLETED|Overall Study||20||
59713898|NCT02118727|75832613|FG000|NOT COMPLETED|Overall Study||25||
59713899|NCT02118727|75832614|FG001|NOT COMPLETED|Overall Study||11||
59713900|NCT01752907|75832622|FG000|STARTED|Overall Study||151||
59713901|NCT01752907|75832623|FG001|STARTED|Overall Study||153||
59713902|NCT01752907|75832622|FG000|Received Pegfilgrastim|Overall Study||149||
59713903|NCT01752907|75832623|FG001|Received Pegfilgrastim|Overall Study||151||
59713904|NCT01752907|75832622|FG000|COMPLETED|Overall Study||139||
59713905|NCT01752907|75832623|FG001|COMPLETED|Overall Study||133||
59713906|NCT01752907|75832622|FG000|NOT COMPLETED|Overall Study||12||
59713907|NCT01752907|75832623|FG001|NOT COMPLETED|Overall Study||20||
59713908|NCT03439189|75832629|FG000|STARTED|Overall Study|Subjects performed at least one Methacetin Breath Test (MBT)|343||
59713909|NCT03439189|75832629|FG000|COMPLETED|Overall Study||261||
59713910|NCT03439189|75832629|FG000|NOT COMPLETED|Overall Study||82||
59713911|NCT01211483|75832638|FG000|STARTED|Phase 1b||7||
59713912|NCT01211483|75832639|FG001|STARTED|Phase 1b||0||
59713913|NCT01211483|75832640|FG002|STARTED|Phase 1b||0||
59713914|NCT01211483|75832641|FG003|STARTED|Phase 1b||0||
59713915|NCT01211483|75832638|FG000|COMPLETED|Phase 1b||0||
59713916|NCT01211483|75832639|FG001|COMPLETED|Phase 1b||0||
59713917|NCT01211483|75832640|FG002|COMPLETED|Phase 1b||0||
59713918|NCT01211483|75832641|FG003|COMPLETED|Phase 1b||0||
59713919|NCT01211483|75832638|FG000|NOT COMPLETED|Phase 1b||7||
59713920|NCT01211483|75832639|FG001|NOT COMPLETED|Phase 1b||0||
59713921|NCT01211483|75832640|FG002|NOT COMPLETED|Phase 1b||0||
59713922|NCT01211483|75832641|FG003|NOT COMPLETED|Phase 1b||0||
59713923|NCT01211483|75832638|FG000|STARTED|Phase 2||0||
59713924|NCT01211483|75832639|FG001|STARTED|Phase 2|Participants entered only at Period 2.|72||
59713925|NCT01211483|75832640|FG002|STARTED|Phase 2|Participants entered only at Period 2.|72||
59713926|NCT01211483|75832641|FG003|STARTED|Phase 2|Participants entered only at Period 2.|71||
59713927|NCT01211483|75832638|FG000|COMPLETED|Phase 2||0||
59713928|NCT01211483|75832639|FG001|COMPLETED|Phase 2||0||
59713929|NCT01211483|75832640|FG002|COMPLETED|Phase 2||0||
59713930|NCT01211483|75832641|FG003|COMPLETED|Phase 2||0||
59713931|NCT01211483|75832638|FG000|NOT COMPLETED|Phase 2||0||
59713932|NCT01211483|75832639|FG001|NOT COMPLETED|Phase 2||72||
59713933|NCT01211483|75832640|FG002|NOT COMPLETED|Phase 2||72||
59713934|NCT01211483|75832641|FG003|NOT COMPLETED|Phase 2||71||
59713935|NCT01210001|75832658|FG000|STARTED|Overall Study||166||
59713936|NCT01210001|75832659|FG001|STARTED|Overall Study||165||
59713937|NCT01210001|75832660|FG002|STARTED|Overall Study||168||
59713938|NCT01210001|75832658|FG000|COMPLETED|Overall Study||147||
59713939|NCT01210001|75832659|FG001|COMPLETED|Overall Study||154||
59713940|NCT01210001|75832660|FG002|COMPLETED|Overall Study||156||
59713941|NCT01210001|75832658|FG000|NOT COMPLETED|Overall Study||19||
59713942|NCT01210001|75832659|FG001|NOT COMPLETED|Overall Study||11||
59713943|NCT01210001|75832660|FG002|NOT COMPLETED|Overall Study||12||
59713944|NCT01127659|75832674|FG000|STARTED|Overall Study||22||
59713945|NCT01127659|75832675|FG001|STARTED|Overall Study||22||
59713946|NCT01127659|75832676|FG002|STARTED|Overall Study||12||
59713947|NCT01127659|75832677|FG003|STARTED|Overall Study||10||
59713948|NCT01127659|75832678|FG004|STARTED|Overall Study||50||
59713949|NCT01127659|75832679|FG005|STARTED|Overall Study||21||
59713950|NCT01127659|75832674|FG000|COMPLETED|Overall Study||20||
59713951|NCT01127659|75832675|FG001|COMPLETED|Overall Study||14||
59713952|NCT01127659|75832676|FG002|COMPLETED|Overall Study||10||
59713953|NCT01127659|75832677|FG003|COMPLETED|Overall Study||6||
59713954|NCT01127659|75832678|FG004|COMPLETED|Overall Study||50||
59713955|NCT01127659|75832679|FG005|COMPLETED|Overall Study||21||
59713956|NCT01127659|75832674|FG000|NOT COMPLETED|Overall Study||2||
59713957|NCT01127659|75832675|FG001|NOT COMPLETED|Overall Study||8||
59713958|NCT01127659|75832676|FG002|NOT COMPLETED|Overall Study||2||
59713959|NCT01127659|75832677|FG003|NOT COMPLETED|Overall Study||4||
59713960|NCT01127659|75832678|FG004|NOT COMPLETED|Overall Study||0||
59713961|NCT01127659|75832679|FG005|NOT COMPLETED|Overall Study||0||
59713962|NCT01209689|75832701|FG000|STARTED|Overall Study||91||
59713963|NCT01209689|75832702|FG001|STARTED|Overall Study||22||
59713964|NCT01209689|75832701|FG000|COMPLETED|Overall Study||0||
59713965|NCT01209689|75832702|FG001|COMPLETED|Overall Study||0||
59713966|NCT01209689|75832701|FG000|NOT COMPLETED|Overall Study||91||
59821035|NCT00317356|75943479|FG001|STARTED|Overall Study||11||
59713967|NCT01209689|75832702|FG001|NOT COMPLETED|Overall Study||22||
59713968|NCT01209143|75832710|FG000|STARTED|Overall Study||24||
59713969|NCT01209143|75832711|FG001|STARTED|Overall Study||28||
59821036|NCT00317356|75943480|FG002|STARTED|Overall Study||10||
59821037|NCT00317356|75943481|FG003|STARTED|Overall Study||11||
59821038|NCT00317356|75943478|FG000|COMPLETED|Overall Study||10||
59821039|NCT00317356|75943479|FG001|COMPLETED|Overall Study||9||
59821040|NCT00317356|75943480|FG002|COMPLETED|Overall Study||9||
59821041|NCT00317356|75943481|FG003|COMPLETED|Overall Study||8||
59821042|NCT00317356|75943478|FG000|NOT COMPLETED|Overall Study||1||
59821043|NCT00317356|75943479|FG001|NOT COMPLETED|Overall Study||2||
59821044|NCT00317356|75943480|FG002|NOT COMPLETED|Overall Study||1||
59821045|NCT00317356|75943481|FG003|NOT COMPLETED|Overall Study||3||
59821046|NCT00331006|75943491|FG000|STARTED|Screening Phase||23||
59821047|NCT00331006|75943491|FG000|COMPLETED|Screening Phase|subjects eligible for the treatment phase if inhibitor titer following Factor VIII was at least 5 BU|16||
59821048|NCT00331006|75943491|FG000|NOT COMPLETED|Screening Phase||7||
59821049|NCT00331006|75943491|FG000|STARTED|Treatment Phase||16||
59821050|NCT00331006|75943491|FG000|COMPLETED|Treatment Phase||15||
59821051|NCT00331006|75943491|FG000|NOT COMPLETED|Treatment Phase||1||
59821052|NCT00331006|75943491|FG000|STARTED|Follow-Up Phase I||15||
59821053|NCT00331006|75943491|FG000|COMPLETED|Follow-Up Phase I||14||
59821054|NCT00331006|75943491|FG000|NOT COMPLETED|Follow-Up Phase I||1||
59821055|NCT00331006|75943491|FG000|STARTED|Follow-Up Phase II||14||
59821056|NCT00331006|75943491|FG000|COMPLETED|Follow-Up Phase II||11||
59821057|NCT00331006|75943491|FG000|NOT COMPLETED|Follow-Up Phase II||3||
59821058|NCT00302458|75943495|FG000|STARTED|Overall Study||29||
59821059|NCT00302458|75943495|FG000|COMPLETED|Overall Study||26||
59821060|NCT00302458|75943495|FG000|NOT COMPLETED|Overall Study||3||
59821061|NCT00391053|75943507|FG000|STARTED|Overall Study||857||
59821062|NCT00391053|75943508|FG001|STARTED|Overall Study||848||
59821063|NCT00391053|75943509|FG002|STARTED|Overall Study||870||
59821064|NCT00391053|75943510|FG003|STARTED|Overall Study||1262||
59821065|NCT00391053|75943507|FG000|COMPLETED|Overall Study||848||
59821066|NCT00391053|75943508|FG001|COMPLETED|Overall Study||847||
59821067|NCT00391053|75943509|FG002|COMPLETED|Overall Study||868||
59821068|NCT00391053|75943510|FG003|COMPLETED|Overall Study||1252||
59821069|NCT00391053|75943507|FG000|NOT COMPLETED|Overall Study||9||
59821070|NCT00391053|75943508|FG001|NOT COMPLETED|Overall Study||1||
59821071|NCT00391053|75943509|FG002|NOT COMPLETED|Overall Study||2||
59821072|NCT00391053|75943510|FG003|NOT COMPLETED|Overall Study||10||
59567035|NCT03860181|75669822|FG003|COMPLETED|Overall Study||21||
59567036|NCT03860181|75669819|FG000|NOT COMPLETED|Overall Study||0||
59567037|NCT03860181|75669820|FG001|NOT COMPLETED|Overall Study||0||
59567038|NCT03860181|75669821|FG002|NOT COMPLETED|Overall Study||0||
59821073|NCT00317044|75943523|FG000|STARTED|Overall Study||320||
59821074|NCT00317044|75943524|FG001|STARTED|Overall Study||313||
59821075|NCT00317044|75943525|FG002|STARTED|Overall Study||328||
59821076|NCT00317044|75943523|FG000|COMPLETED|Overall Study||272||
59821077|NCT00317044|75943524|FG001|COMPLETED|Overall Study||273||
59821078|NCT00317044|75943525|FG002|COMPLETED|Overall Study||283||
59821079|NCT00317044|75943523|FG000|NOT COMPLETED|Overall Study||48||
59567039|NCT03860181|75669822|FG003|NOT COMPLETED|Overall Study||0||
59567040|NCT03865329|75669843|FG000|STARTED|Overall Study||9||
59821080|NCT00317044|75943524|FG001|NOT COMPLETED|Overall Study||40||
59821081|NCT00317044|75943525|FG002|NOT COMPLETED|Overall Study||45||
59821082|NCT00301834|75943533|FG000|STARTED|Overall Study||35||
59821083|NCT00301834|75943533|FG000|COMPLETED|Overall Study||34||
59821084|NCT00301834|75943533|FG000|NOT COMPLETED|Overall Study||1||
59821085|NCT00301366|75943540|FG000|STARTED|Overall Study||38||
59821086|NCT00301366|75943540|FG000|COMPLETED|Overall Study||37||
59821087|NCT00301366|75943540|FG000|NOT COMPLETED|Overall Study||1||
59821088|NCT00330928|75943544|FG000|STARTED|Overall Study|Subjects that signed consent and were subject to research procedures.|106||
59821089|NCT00330928|75943544|FG000|7 Day Phone Contact|Overall Study||99||
59821090|NCT00330928|75943544|FG000|1 Year Phone Contact|Overall Study||89||
59821091|NCT00330928|75943544|FG000|COMPLETED|Overall Study||89||
59821092|NCT00330928|75943544|FG000|NOT COMPLETED|Overall Study||17||
59821093|NCT00330616|75943548|FG000|STARTED|Overall Study||35||
59821094|NCT00330616|75943548|FG000|COMPLETED|Overall Study||14||
59821095|NCT00330616|75943548|FG000|NOT COMPLETED|Overall Study||21||
59821096|NCT00466440|75943555|FG000|STARTED|Overall Study||14||
59821097|NCT00466440|75943556|FG001|STARTED|Overall Study||48||
59821098|NCT00466440|75943557|FG002|STARTED|Overall Study||46||
59567041|NCT03865329|75669843|FG000|COMPLETED|Overall Study||9||
59821099|NCT00466440|75943555|FG000|Received at Least One Dose of Study Drug|Overall Study||14||
59821100|NCT00466440|75943556|FG001|Received at Least One Dose of Study Drug|Overall Study||47||
59821101|NCT00466440|75943557|FG002|Received at Least One Dose of Study Drug|Overall Study||41||
59821102|NCT00466440|75943555|FG000|COMPLETED|Overall Study||0||
59821103|NCT00466440|75943556|FG001|COMPLETED|Overall Study|Completed = completed 4 cycles of treatment|36||
59821104|NCT00466440|75943557|FG002|COMPLETED|Overall Study|Completed = completed 4 cycles of treatment|34||
59821105|NCT00466440|75943555|FG000|NOT COMPLETED|Overall Study||14||
59821106|NCT00466440|75943556|FG001|NOT COMPLETED|Overall Study||12||
59821107|NCT00466440|75943557|FG002|NOT COMPLETED|Overall Study||12||
59821108|NCT00465972|75943576|FG000|STARTED|Overall Study||20||
59821109|NCT00465972|75943577|FG001|STARTED|Overall Study||24||
59821110|NCT00465972|75943576|FG000|COMPLETED|Overall Study||18||
59821111|NCT00465972|75943577|FG001|COMPLETED|Overall Study||23||
59821112|NCT00465972|75943576|FG000|NOT COMPLETED|Overall Study||2||
59821113|NCT00465972|75943577|FG001|NOT COMPLETED|Overall Study||1||
59821114|NCT00465894|75943587|FG000|STARTED|Treatment For 12 Weeks||30||
59821115|NCT00465894|75943588|FG001|STARTED|Treatment For 12 Weeks||28||
59821116|NCT00465894|75943587|FG000|COMPLETED|Treatment For 12 Weeks||25||
59821117|NCT00465894|75943588|FG001|COMPLETED|Treatment For 12 Weeks||25||
59821118|NCT00465894|75943587|FG000|NOT COMPLETED|Treatment For 12 Weeks||5||
59821119|NCT00465894|75943588|FG001|NOT COMPLETED|Treatment For 12 Weeks||3||
59821120|NCT00465894|75943587|FG000|STARTED|Treatment From 12 Weeks To 24 Weeks|We included data only from participants that had complete data sets.|14||
59821121|NCT00465894|75943588|FG001|STARTED|Treatment From 12 Weeks To 24 Weeks|We included data only from participants that had complete data sets.|14||
59821122|NCT00465894|75943587|FG000|COMPLETED|Treatment From 12 Weeks To 24 Weeks||14||
59821123|NCT00465894|75943588|FG001|COMPLETED|Treatment From 12 Weeks To 24 Weeks||14||
59821124|NCT00465894|75943587|FG000|NOT COMPLETED|Treatment From 12 Weeks To 24 Weeks||0||
59821125|NCT00465894|75943588|FG001|NOT COMPLETED|Treatment From 12 Weeks To 24 Weeks||0||
59821126|NCT00465894|75943587|FG000|STARTED|Treatment From 24 Weeks to 52 Weeks|We included data only from participants that had complete data sets.|11||
59821127|NCT00465894|75943588|FG001|STARTED|Treatment From 24 Weeks to 52 Weeks||14||
59821128|NCT00465894|75943587|FG000|COMPLETED|Treatment From 24 Weeks to 52 Weeks||11||
59821129|NCT00465894|75943588|FG001|COMPLETED|Treatment From 24 Weeks to 52 Weeks||14||
59821130|NCT00465894|75943587|FG000|NOT COMPLETED|Treatment From 24 Weeks to 52 Weeks||0||
59821131|NCT00465894|75943588|FG001|NOT COMPLETED|Treatment From 24 Weeks to 52 Weeks||0||
59821132|NCT00330460|75943612|FG000|STARTED|Overall Study||595||
59821133|NCT00330460|75943613|FG001|STARTED|Overall Study||594||
59821134|NCT00330460|75943612|FG000|COMPLETED|Overall Study||553||
59821135|NCT00330460|75943613|FG001|COMPLETED|Overall Study||561||
59821136|NCT00330460|75943612|FG000|NOT COMPLETED|Overall Study||42||
59821137|NCT00330460|75943613|FG001|NOT COMPLETED|Overall Study||33||
59821138|NCT00454116|75943622|FG000|STARTED|Overall Study|randomised patients|35||
59821139|NCT00454116|75943623|FG001|STARTED|Overall Study|randomised patients|36||
59821140|NCT00454116|75943624|FG002|STARTED|Overall Study|randomised patients|35||
59821141|NCT00454116|75943622|FG000|COMPLETED|Overall Study|ongoing study treatment at data cut-off|8||
59821142|NCT00454116|75943623|FG001|COMPLETED|Overall Study|ongoing study treatment at data cut-off|7||
59821143|NCT00454116|75943624|FG002|COMPLETED|Overall Study|ongoing study treatment at data cut-off|7||
59821144|NCT00454116|75943622|FG000|NOT COMPLETED|Overall Study||27||
59821145|NCT00454116|75943623|FG001|NOT COMPLETED|Overall Study||29||
59821146|NCT00454116|75943624|FG002|NOT COMPLETED|Overall Study||28||
59821147|NCT00465816|75943635|FG000|STARTED|Overall Study||367||
59567042|NCT03865329|75669843|FG000|NOT COMPLETED|Overall Study||0||
59567043|NCT02301546|75669849|FG000|STARTED|Short-term Effectiveness (~13 Weeks)||73||
59713970|NCT01209143|75832710|FG000|COMPLETED|Overall Study||5||
59713971|NCT01209143|75832711|FG001|COMPLETED|Overall Study||8||
59713972|NCT01209143|75832710|FG000|NOT COMPLETED|Overall Study||19||
59713973|NCT01209143|75832711|FG001|NOT COMPLETED|Overall Study||20||
59713974|NCT01023789|75832717|FG000|STARTED|30-day Follow-up Visit|Intent-to-treat population (ITT).|812||
59713975|NCT01023789|75832717|FG000|COMPLETED|30-day Follow-up Visit||812||
59713976|NCT01023789|75832717|FG000|NOT COMPLETED|30-day Follow-up Visit||0||
59713977|NCT01023789|75832717|FG000|STARTED|180-day Clinical Follow-up||812||
59713978|NCT01023789|75832717|FG000|COMPLETED|180-day Clinical Follow-up||812||
59713979|NCT01023789|75832717|FG000|NOT COMPLETED|180-day Clinical Follow-up||0||
59713980|NCT01023789|75832717|FG000|STARTED|1 - Year Visit||812||
59713981|NCT01023789|75832717|FG000|COMPLETED|1 - Year Visit||812||
59713982|NCT01023789|75832717|FG000|NOT COMPLETED|1 - Year Visit||0||
59821148|NCT00465816|75943636|FG001|STARTED|Overall Study||122||
59821149|NCT00465816|75943637|FG002|STARTED|Overall Study||122||
59821150|NCT00465816|75943635|FG000|COMPLETED|Overall Study||367||
59821151|NCT00465816|75943636|FG001|COMPLETED|Overall Study||122||
59821152|NCT00465816|75943637|FG002|COMPLETED|Overall Study||120||
59821153|NCT00465816|75943635|FG000|NOT COMPLETED|Overall Study||0||
59821154|NCT00465816|75943636|FG001|NOT COMPLETED|Overall Study||0||
59821155|NCT00465816|75943637|FG002|NOT COMPLETED|Overall Study||2||
59821156|NCT00465738|75943648|FG000|STARTED|Overall Study||97||
59821157|NCT00465738|75943649|FG001|STARTED|Overall Study||95||
59821158|NCT00465738|75943648|FG000|COMPLETED|Overall Study||91||
59713983|NCT01023789|75832717|FG000|STARTED|2 - Year Visit||812||
59713984|NCT01023789|75832717|FG000|COMPLETED|2 - Year Visit||812||
59713985|NCT01023789|75832717|FG000|NOT COMPLETED|2 - Year Visit||0||
59821159|NCT00465738|75943649|FG001|COMPLETED|Overall Study||89||
59821160|NCT00465738|75943648|FG000|NOT COMPLETED|Overall Study||6||
59821161|NCT00465738|75943649|FG001|NOT COMPLETED|Overall Study||6||
59713986|NCT01023789|75832717|FG000|STARTED|3 - Year Visit||812||
59713987|NCT01023789|75832717|FG000|COMPLETED|3 - Year Visit||769||
59713988|NCT01023789|75832717|FG000|NOT COMPLETED|3 - Year Visit||43||
59713989|NCT01208207|75832724|FG000|STARTED|Part I||702||
59713990|NCT01208207|75832725|FG001|STARTED|Part I||156||
59713991|NCT01208207|75832726|FG002|STARTED|Part I||157||
59713992|NCT01208207|75832727|FG003|STARTED|Part I||0||
59821162|NCT00400179|75943657|FG000|STARTED|Overall Study|Signed informed consent form and randomized|527||
59821163|NCT00400179|75943658|FG001|STARTED|Overall Study||526||
59821164|NCT00400179|75943657|FG000|COMPLETED|Overall Study|Received Treatment|521||
59821165|NCT00400179|75943658|FG001|COMPLETED|Overall Study||508||
59821166|NCT00400179|75943657|FG000|NOT COMPLETED|Overall Study||6||
59821167|NCT00400179|75943658|FG001|NOT COMPLETED|Overall Study||18||
59821168|NCT00465270|75943666|FG000|STARTED|Overall Study||499||
59821169|NCT00465270|75943667|FG001|STARTED|Overall Study||481||
59821170|NCT00465270|75943666|FG000|COMPLETED|Overall Study||395||
59821171|NCT00465270|75943667|FG001|COMPLETED|Overall Study||321||
59821172|NCT00465270|75943666|FG000|NOT COMPLETED|Overall Study||104||
59821173|NCT00465270|75943667|FG001|NOT COMPLETED|Overall Study||160||
59821174|NCT00464568|75943673|FG000|STARTED|Overall Study||32||
59713993|NCT01208207|75832728|FG004|STARTED|Part I||0||
59713994|NCT01208207|75832729|FG005|STARTED|Part I||0||
59713995|NCT01208207|75832730|FG006|STARTED|Part I||0||
59713996|NCT01208207|75832724|FG000|COMPLETED|Part I||632||
59713997|NCT01208207|75832725|FG001|COMPLETED|Part I||145||
59713998|NCT01208207|75832726|FG002|COMPLETED|Part I||142||
59713999|NCT01208207|75832727|FG003|COMPLETED|Part I||0||
59714000|NCT01208207|75832728|FG004|COMPLETED|Part I||0||
59714001|NCT01208207|75832729|FG005|COMPLETED|Part I||0||
59714002|NCT01208207|75832730|FG006|COMPLETED|Part I||0||
59714003|NCT01208207|75832724|FG000|NOT COMPLETED|Part I||70||
59714004|NCT01208207|75832725|FG001|NOT COMPLETED|Part I||11||
59714005|NCT01208207|75832726|FG002|NOT COMPLETED|Part I||15||
59714006|NCT01208207|75832727|FG003|NOT COMPLETED|Part I||0||
59714007|NCT01208207|75832728|FG004|NOT COMPLETED|Part I||0||
59714008|NCT01208207|75832729|FG005|NOT COMPLETED|Part I||0||
59714009|NCT01208207|75832730|FG006|NOT COMPLETED|Part I||0||
59714010|NCT01208207|75832724|FG000|STARTED|Part II||0||
59714011|NCT01208207|75832725|FG001|STARTED|Part II||0||
59714012|NCT01208207|75832726|FG002|STARTED|Part II||0||
59714013|NCT01208207|75832727|FG003|STARTED|Part II||314||
59714014|NCT01208207|75832728|FG004|STARTED|Part II||318||
59714015|NCT01208207|75832729|FG005|STARTED|Part II||145||
59714016|NCT01208207|75832730|FG006|STARTED|Part II||142||
59714017|NCT01208207|75832724|FG000|COMPLETED|Part II||0||
59714018|NCT01208207|75832725|FG001|COMPLETED|Part II||0||
59714019|NCT01208207|75832726|FG002|COMPLETED|Part II||0||
59714020|NCT01208207|75832727|FG003|COMPLETED|Part II||282||
59714021|NCT01208207|75832728|FG004|COMPLETED|Part II||295||
59714022|NCT01208207|75832729|FG005|COMPLETED|Part II||129||
59714023|NCT01208207|75832730|FG006|COMPLETED|Part II||131||
59714024|NCT01208207|75832724|FG000|NOT COMPLETED|Part II||0||
59714025|NCT01208207|75832725|FG001|NOT COMPLETED|Part II||0||
59714026|NCT01208207|75832726|FG002|NOT COMPLETED|Part II||0||
59714027|NCT01208207|75832727|FG003|NOT COMPLETED|Part II||32||
59714028|NCT01208207|75832728|FG004|NOT COMPLETED|Part II||23||
59714029|NCT01208207|75832729|FG005|NOT COMPLETED|Part II||16||
59714030|NCT01208207|75832730|FG006|NOT COMPLETED|Part II||11||
59714031|NCT03292471|75832754|FG000|STARTED|Overall Study||8||
59714032|NCT03292471|75832755|FG001|STARTED|Overall Study||8||
59714033|NCT03292471|75832754|FG000|COMPLETED|Overall Study||8||
59714034|NCT03292471|75832755|FG001|COMPLETED|Overall Study||8||
59714035|NCT03292471|75832754|FG000|NOT COMPLETED|Overall Study||0||
59714036|NCT03292471|75832755|FG001|NOT COMPLETED|Overall Study||0||
59714037|NCT01012713|75832761|FG000|STARTED|Overall Study||30||
59714038|NCT01012713|75832761|FG000|COMPLETED|Overall Study||27||
59714039|NCT01012713|75832761|FG000|NOT COMPLETED|Overall Study||3||
59714040|NCT01007253|75832766|FG000|STARTED|First Intervention||6||
59714041|NCT01007253|75832767|FG001|STARTED|First Intervention||5||
59714042|NCT01007253|75832768|FG002|STARTED|First Intervention||5||
59714043|NCT01007253|75832769|FG003|STARTED|First Intervention||5||
59714044|NCT01007253|75832766|FG000|COMPLETED|First Intervention||6||
59714045|NCT01007253|75832767|FG001|COMPLETED|First Intervention||5||
59714046|NCT01007253|75832768|FG002|COMPLETED|First Intervention||5||
59714047|NCT01007253|75832769|FG003|COMPLETED|First Intervention||5||
59714048|NCT01007253|75832766|FG000|NOT COMPLETED|First Intervention||0||
59714049|NCT01007253|75832767|FG001|NOT COMPLETED|First Intervention||0||
59714050|NCT01007253|75832768|FG002|NOT COMPLETED|First Intervention||0||
59714051|NCT01007253|75832769|FG003|NOT COMPLETED|First Intervention||0||
59714052|NCT01007253|75832766|FG000|STARTED|Washout Period (2 Weeks) # 1||6||
59714053|NCT01007253|75832767|FG001|STARTED|Washout Period (2 Weeks) # 1||5||
59714054|NCT01007253|75832768|FG002|STARTED|Washout Period (2 Weeks) # 1||5||
59714055|NCT01007253|75832769|FG003|STARTED|Washout Period (2 Weeks) # 1||5||
59714056|NCT01007253|75832766|FG000|COMPLETED|Washout Period (2 Weeks) # 1||6||
59714057|NCT01007253|75832767|FG001|COMPLETED|Washout Period (2 Weeks) # 1||5||
59714058|NCT01007253|75832768|FG002|COMPLETED|Washout Period (2 Weeks) # 1||5||
59714059|NCT01007253|75832769|FG003|COMPLETED|Washout Period (2 Weeks) # 1||5||
59714060|NCT01007253|75832766|FG000|NOT COMPLETED|Washout Period (2 Weeks) # 1||0||
59714061|NCT01007253|75832767|FG001|NOT COMPLETED|Washout Period (2 Weeks) # 1||0||
59714062|NCT01007253|75832768|FG002|NOT COMPLETED|Washout Period (2 Weeks) # 1||0||
59821175|NCT00464568|75943673|FG000|COMPLETED|Overall Study||30||
59821176|NCT00464568|75943673|FG000|NOT COMPLETED|Overall Study||2||
59567044|NCT02301546|75669850|FG001|STARTED|Short-term Effectiveness (~13 Weeks)||73||
59567045|NCT02301546|75669849|FG000|COMPLETED|Short-term Effectiveness (~13 Weeks)||55||
59567046|NCT02301546|75669850|FG001|COMPLETED|Short-term Effectiveness (~13 Weeks)||58||
59567047|NCT02301546|75669849|FG000|NOT COMPLETED|Short-term Effectiveness (~13 Weeks)||18||
59567048|NCT02301546|75669850|FG001|NOT COMPLETED|Short-term Effectiveness (~13 Weeks)||15||
59567049|NCT02301546|75669849|FG000|STARTED|Long Term Effectiveness (~1 Year)||55||
59821177|NCT00464490|75943692|FG000|STARTED|Overall Study||21||
59821178|NCT00464490|75943693|FG001|STARTED|Overall Study||21||
59821179|NCT00464490|75943692|FG000|COMPLETED|Overall Study||10||
59821180|NCT00464490|75943693|FG001|COMPLETED|Overall Study||10||
59821181|NCT00464490|75943692|FG000|NOT COMPLETED|Overall Study||11||
59821182|NCT00464490|75943693|FG001|NOT COMPLETED|Overall Study||11||
59821183|NCT03849300|75943703|FG000|STARTED|Overall Study||42||
59821184|NCT03849300|75943704|FG001|STARTED|Overall Study||42||
59821185|NCT03849300|75943705|FG002|STARTED|Overall Study||32||
59821186|NCT03849300|75943706|FG003|STARTED|Overall Study||31||
59821187|NCT03849300|75943703|FG000|COMPLETED|Overall Study||37||
59821188|NCT03849300|75943704|FG001|COMPLETED|Overall Study||35||
59821189|NCT03849300|75943705|FG002|COMPLETED|Overall Study||28||
59821190|NCT03849300|75943706|FG003|COMPLETED|Overall Study||25||
59821191|NCT03849300|75943703|FG000|NOT COMPLETED|Overall Study||5||
59821192|NCT03849300|75943704|FG001|NOT COMPLETED|Overall Study||7||
59821193|NCT03849300|75943705|FG002|NOT COMPLETED|Overall Study||4||
59821194|NCT03849300|75943706|FG003|NOT COMPLETED|Overall Study||6||
59821195|NCT00412893|75943720|FG000|STARTED|Overall Study||263||
59821196|NCT00412893|75943721|FG001|STARTED|Overall Study||264||
59821197|NCT00412893|75943720|FG000|Received Treatment|Overall Study|One participant randomized to this group received voriconazole treatment for the first 7 days|258||
59821198|NCT00412893|75943721|FG001|Received Treatment|Overall Study||258||
59821199|NCT00412893|75943720|FG000|COMPLETED|Overall Study|Defined as completed treatment|118||
59821200|NCT00412893|75943721|FG001|COMPLETED|Overall Study|Defined as completed treatment|120||
59821201|NCT00412893|75943720|FG000|NOT COMPLETED|Overall Study||145||
59821202|NCT00412893|75943721|FG001|NOT COMPLETED|Overall Study||144||
59821203|NCT00412737|75943729|FG000|STARTED|Overall Study||237||
59821204|NCT00412737|75943730|FG001|STARTED|Overall Study||238||
59821205|NCT00412737|75943729|FG000|COMPLETED|Overall Study||221||
59821206|NCT00412737|75943730|FG001|COMPLETED|Overall Study||232||
59821207|NCT00412737|75943729|FG000|NOT COMPLETED|Overall Study||16||
59821208|NCT00412737|75943730|FG001|NOT COMPLETED|Overall Study||6||
59821209|NCT00508742|75943738|FG000|STARTED|Period 1: Infant Series||932||
59821210|NCT00508742|75943739|FG001|STARTED|Period 1: Infant Series||934||
59821211|NCT00508742|75943738|FG000|Vaccinated Dose 1 (at 2 Months of Age)|Period 1: Infant Series||930||
59821212|NCT00508742|75943739|FG001|Vaccinated Dose 1 (at 2 Months of Age)|Period 1: Infant Series||933||
59821213|NCT00508742|75943738|FG000|Vaccinated Dose 2 (at 4 Months of Age)|Period 1: Infant Series||904||
59821214|NCT00508742|75943739|FG001|Vaccinated Dose 2 (at 4 Months of Age)|Period 1: Infant Series||902||
59821215|NCT00508742|75943738|FG000|Vaccinated Dose 3 (at 6 Months of Age)|Period 1: Infant Series||898||
59821216|NCT00508742|75943739|FG001|Vaccinated Dose 3 (at 6 Months of Age)|Period 1: Infant Series||892||
59567050|NCT02301546|75669850|FG001|STARTED|Long Term Effectiveness (~1 Year)||58||
59567051|NCT02301546|75669849|FG000|COMPLETED|Long Term Effectiveness (~1 Year)||43||
59567052|NCT02301546|75669850|FG001|COMPLETED|Long Term Effectiveness (~1 Year)||51||
59714063|NCT01007253|75832769|FG003|NOT COMPLETED|Washout Period (2 Weeks) # 1||0||
59714064|NCT01007253|75832766|FG000|STARTED|Second Intervention||6||
59714065|NCT01007253|75832767|FG001|STARTED|Second Intervention||5||
59714066|NCT01007253|75832768|FG002|STARTED|Second Intervention||5||
59714067|NCT01007253|75832769|FG003|STARTED|Second Intervention||5||
59714068|NCT01007253|75832766|FG000|COMPLETED|Second Intervention||6||
59714069|NCT01007253|75832767|FG001|COMPLETED|Second Intervention||5||
59714070|NCT01007253|75832768|FG002|COMPLETED|Second Intervention||5||
59714071|NCT01007253|75832769|FG003|COMPLETED|Second Intervention||5||
59821217|NCT00508742|75943738|FG000|COMPLETED|Period 1: Infant Series||890||
59821218|NCT00508742|75943739|FG001|COMPLETED|Period 1: Infant Series||889||
59821219|NCT00508742|75943738|FG000|NOT COMPLETED|Period 1: Infant Series||42||
59821220|NCT00508742|75943739|FG001|NOT COMPLETED|Period 1: Infant Series||45||
59821221|NCT00508742|75943738|FG000|STARTED|Period 2: After Infant Series||890||
59821222|NCT00508742|75943739|FG001|STARTED|Period 2: After Infant Series||889||
59821223|NCT00508742|75943738|FG000|COMPLETED|Period 2: After Infant Series||883||
59567053|NCT02301546|75669849|FG000|NOT COMPLETED|Long Term Effectiveness (~1 Year)||12||
59714072|NCT01007253|75832766|FG000|NOT COMPLETED|Second Intervention||0||
59714073|NCT01007253|75832767|FG001|NOT COMPLETED|Second Intervention||0||
59714074|NCT01007253|75832768|FG002|NOT COMPLETED|Second Intervention||0||
59714075|NCT01007253|75832769|FG003|NOT COMPLETED|Second Intervention||0||
59714076|NCT01007253|75832766|FG000|STARTED|Washout Period (2 Weeks) # 2||6||
59714077|NCT01007253|75832767|FG001|STARTED|Washout Period (2 Weeks) # 2||5||
59821224|NCT00508742|75943739|FG001|COMPLETED|Period 2: After Infant Series||878||
59821225|NCT00508742|75943738|FG000|NOT COMPLETED|Period 2: After Infant Series||7||
59821226|NCT00508742|75943739|FG001|NOT COMPLETED|Period 2: After Infant Series||11||
59821227|NCT00508742|75943738|FG000|STARTED|Period 3: Toddler Dose||883||
59821228|NCT00508742|75943739|FG001|STARTED|Period 3: Toddler Dose||878||
59821229|NCT00508742|75943738|FG000|COMPLETED|Period 3: Toddler Dose||858||
59821230|NCT00508742|75943739|FG001|COMPLETED|Period 3: Toddler Dose||863||
59821231|NCT00508742|75943738|FG000|NOT COMPLETED|Period 3: Toddler Dose||25||
59821232|NCT00508742|75943739|FG001|NOT COMPLETED|Period 3: Toddler Dose||15||
59821233|NCT00848757|75943753|FG000|STARTED|Overall Study||65||
59714078|NCT01007253|75832768|FG002|STARTED|Washout Period (2 Weeks) # 2||5||
59714079|NCT01007253|75832769|FG003|STARTED|Washout Period (2 Weeks) # 2||5||
59714080|NCT01007253|75832766|FG000|COMPLETED|Washout Period (2 Weeks) # 2||6||
59714081|NCT01007253|75832767|FG001|COMPLETED|Washout Period (2 Weeks) # 2||5||
59714082|NCT01007253|75832768|FG002|COMPLETED|Washout Period (2 Weeks) # 2||5||
59714083|NCT01007253|75832769|FG003|COMPLETED|Washout Period (2 Weeks) # 2||5||
59714084|NCT01007253|75832766|FG000|NOT COMPLETED|Washout Period (2 Weeks) # 2||0||
59714085|NCT01007253|75832767|FG001|NOT COMPLETED|Washout Period (2 Weeks) # 2||0||
59714086|NCT01007253|75832768|FG002|NOT COMPLETED|Washout Period (2 Weeks) # 2||0||
59714087|NCT01007253|75832769|FG003|NOT COMPLETED|Washout Period (2 Weeks) # 2||0||
59714088|NCT01007253|75832766|FG000|STARTED|Third Intervention||6||
59714089|NCT01007253|75832767|FG001|STARTED|Third Intervention||5||
59714090|NCT01007253|75832768|FG002|STARTED|Third Intervention||5||
59714091|NCT01007253|75832769|FG003|STARTED|Third Intervention||5||
59714092|NCT01007253|75832766|FG000|COMPLETED|Third Intervention||6||
59714093|NCT01007253|75832767|FG001|COMPLETED|Third Intervention||5||
59714094|NCT01007253|75832768|FG002|COMPLETED|Third Intervention||5||
59714095|NCT01007253|75832769|FG003|COMPLETED|Third Intervention||5||
59714096|NCT01007253|75832766|FG000|NOT COMPLETED|Third Intervention||0||
59714097|NCT01007253|75832767|FG001|NOT COMPLETED|Third Intervention||0||
59714098|NCT01007253|75832768|FG002|NOT COMPLETED|Third Intervention||0||
59714099|NCT01007253|75832769|FG003|NOT COMPLETED|Third Intervention||0||
59714100|NCT01007253|75832766|FG000|STARTED|Washout Period (2 Weeks) # 3||6||
59714101|NCT01007253|75832767|FG001|STARTED|Washout Period (2 Weeks) # 3||5||
59714102|NCT01007253|75832768|FG002|STARTED|Washout Period (2 Weeks) # 3||5||
59714103|NCT01007253|75832769|FG003|STARTED|Washout Period (2 Weeks) # 3||5||
59714104|NCT01007253|75832766|FG000|COMPLETED|Washout Period (2 Weeks) # 3||5||
59714105|NCT01007253|75832767|FG001|COMPLETED|Washout Period (2 Weeks) # 3||5||
59714106|NCT01007253|75832768|FG002|COMPLETED|Washout Period (2 Weeks) # 3||5||
59714107|NCT01007253|75832769|FG003|COMPLETED|Washout Period (2 Weeks) # 3||5||
59714108|NCT01007253|75832766|FG000|NOT COMPLETED|Washout Period (2 Weeks) # 3||1||
59714109|NCT01007253|75832767|FG001|NOT COMPLETED|Washout Period (2 Weeks) # 3||0||
59714110|NCT01007253|75832768|FG002|NOT COMPLETED|Washout Period (2 Weeks) # 3||0||
59714111|NCT01007253|75832769|FG003|NOT COMPLETED|Washout Period (2 Weeks) # 3||0||
59714112|NCT01007253|75832766|FG000|STARTED|Fourth Intervention||5||
59714113|NCT01007253|75832767|FG001|STARTED|Fourth Intervention||5||
59714114|NCT01007253|75832768|FG002|STARTED|Fourth Intervention||5||
59714115|NCT01007253|75832769|FG003|STARTED|Fourth Intervention||5||
59714116|NCT01007253|75832766|FG000|COMPLETED|Fourth Intervention||5||
59714117|NCT01007253|75832767|FG001|COMPLETED|Fourth Intervention||5||
59714118|NCT01007253|75832768|FG002|COMPLETED|Fourth Intervention||5||
59714119|NCT01007253|75832769|FG003|COMPLETED|Fourth Intervention||5||
59714120|NCT01007253|75832766|FG000|NOT COMPLETED|Fourth Intervention||0||
59714121|NCT01007253|75832767|FG001|NOT COMPLETED|Fourth Intervention||0||
59714122|NCT01007253|75832768|FG002|NOT COMPLETED|Fourth Intervention||0||
59714123|NCT01007253|75832769|FG003|NOT COMPLETED|Fourth Intervention||0||
59714124|NCT01006707|75832779|FG000|STARTED|Study Session 1||15||
59714125|NCT01006707|75832780|FG001|STARTED|Study Session 1||0||
59714126|NCT01006707|75832781|FG002|STARTED|Study Session 1||0||
59714127|NCT01006707|75832779|FG000|COMPLETED|Study Session 1||10|After run-in, participants were randomized to Ondansetron then Placebo, or Placebo then Ondansetron|
59714128|NCT01006707|75832780|FG001|COMPLETED|Study Session 1||0|After run-in, participants were randomized to Ondansetron then Placebo, or Placebo then Ondansetron|
59714129|NCT01006707|75832781|FG002|COMPLETED|Study Session 1||0|After run-in, participants were randomized to Ondansetron then Placebo, or Placebo then Ondansetron|
59714130|NCT01006707|75832779|FG000|NOT COMPLETED|Study Session 1||5||
59714131|NCT01006707|75832780|FG001|NOT COMPLETED|Study Session 1||0||
59821234|NCT00848757|75943754|FG001|STARTED|Overall Study||65||
59714132|NCT01006707|75832781|FG002|NOT COMPLETED|Study Session 1||0||
59714133|NCT01006707|75832779|FG000|STARTED|Study Session 2||0||
59714134|NCT01006707|75832780|FG001|STARTED|Study Session 2||4||
59714135|NCT01006707|75832781|FG002|STARTED|Study Session 2||6||
59714136|NCT01006707|75832779|FG000|COMPLETED|Study Session 2||0||
59714137|NCT01006707|75832780|FG001|COMPLETED|Study Session 2||4||
59714138|NCT01006707|75832781|FG002|COMPLETED|Study Session 2||6||
59714139|NCT01006707|75832779|FG000|NOT COMPLETED|Study Session 2||0||
59714140|NCT01006707|75832780|FG001|NOT COMPLETED|Study Session 2||0||
59714141|NCT01006707|75832781|FG002|NOT COMPLETED|Study Session 2||0||
59714142|NCT01006707|75832779|FG000|STARTED|Study Session 3||0||
59714143|NCT01006707|75832780|FG001|STARTED|Study Session 3||4||
59714144|NCT01006707|75832781|FG002|STARTED|Study Session 3||6||
59714145|NCT01006707|75832779|FG000|COMPLETED|Study Session 3||0||
59821235|NCT00848757|75943753|FG000|COMPLETED|Overall Study||61||
59821236|NCT00848757|75943754|FG001|COMPLETED|Overall Study||61||
59821237|NCT00848757|75943753|FG000|NOT COMPLETED|Overall Study||4||
59821238|NCT00848757|75943754|FG001|NOT COMPLETED|Overall Study||4||
59821239|NCT00508274|75943760|FG000|STARTED|Overall Study||52||
59821240|NCT00508274|75943760|FG000|COMPLETED|Overall Study||2||
59821241|NCT00508274|75943760|FG000|NOT COMPLETED|Overall Study||50||
59821242|NCT00499460|75943766|FG000|STARTED|Intervention 1 (30 Days)||8||
59821243|NCT00499460|75943767|FG001|STARTED|Intervention 1 (30 Days)||7||
59821244|NCT00499460|75943766|FG000|COMPLETED|Intervention 1 (30 Days)||6||
59821245|NCT00499460|75943767|FG001|COMPLETED|Intervention 1 (30 Days)||7||
59821246|NCT00499460|75943766|FG000|NOT COMPLETED|Intervention 1 (30 Days)||2||
59821247|NCT00499460|75943767|FG001|NOT COMPLETED|Intervention 1 (30 Days)||0||
59821248|NCT00499460|75943766|FG000|STARTED|Intervention 2 (30 Days)||6||
59821249|NCT00499460|75943767|FG001|STARTED|Intervention 2 (30 Days)||7||
59821250|NCT00499460|75943766|FG000|COMPLETED|Intervention 2 (30 Days)||6||
59821251|NCT00499460|75943767|FG001|COMPLETED|Intervention 2 (30 Days)||6||
59821252|NCT00499460|75943766|FG000|NOT COMPLETED|Intervention 2 (30 Days)||0||
59821253|NCT00499460|75943767|FG001|NOT COMPLETED|Intervention 2 (30 Days)||1||
59821254|NCT00412113|75943785|FG000|STARTED|Overall Study|15-January-2007|123||
59821255|NCT00412113|75943786|FG001|STARTED|Overall Study|15-January-2007|122||
59821256|NCT00412113|75943785|FG000|Received Treatment|Overall Study|One subject assigned to Norvasc and TLC did not receive treatment and was excluded from all analyses|122||
59821257|NCT00412113|75943786|FG001|Received Treatment|Overall Study||122||
60108717|NCT01616056|76228430|FG000|NOT COMPLETED|Overall Study||1||
60108718|NCT01617148|76228434|FG000|STARTED|Overall Study||26||
60108719|NCT01617148|76228434|FG000|COMPLETED|Overall Study||26||
60108720|NCT01617148|76228434|FG000|NOT COMPLETED|Overall Study||0||
60108721|NCT01618240|76228439|FG000|STARTED|Overall Study||30||
60108722|NCT01618240|76228439|FG000|COMPLETED|Overall Study||30||
60108723|NCT01618240|76228439|FG000|NOT COMPLETED|Overall Study||0||
60108724|NCT01618942|76228445|FG000|STARTED|Overall Study||50||
60108725|NCT01618942|76228446|FG001|STARTED|Overall Study||50||
60108726|NCT01618942|76228445|FG000|COMPLETED|Overall Study||50||
60108727|NCT01618942|76228446|FG001|COMPLETED|Overall Study||50||
60108728|NCT01618942|76228445|FG000|NOT COMPLETED|Overall Study||0||
60108729|NCT01618942|76228446|FG001|NOT COMPLETED|Overall Study||0||
60108730|NCT01620190|76228452|FG000|STARTED|Overall Study||26||
60108731|NCT01620190|76228452|FG000|COMPLETED|Overall Study||26||
60108732|NCT01620190|76228452|FG000|NOT COMPLETED|Overall Study||0||
60108733|NCT01621672|76228458|FG000|STARTED|Overall Study||25||
60108734|NCT01621672|76228459|FG001|STARTED|Overall Study||17||
59714146|NCT01006707|75832780|FG001|COMPLETED|Study Session 3||4||
59714147|NCT01006707|75832781|FG002|COMPLETED|Study Session 3||6||
59714148|NCT01006707|75832779|FG000|NOT COMPLETED|Study Session 3||0||
59714149|NCT01006707|75832780|FG001|NOT COMPLETED|Study Session 3||0||
59714150|NCT01006707|75832781|FG002|NOT COMPLETED|Study Session 3||0||
59714151|NCT01006629|75832789|FG000|STARTED|Overall Study||100||
59714152|NCT01006629|75832789|FG000|COMPLETED|Overall Study||94||
59714153|NCT01006629|75832789|FG000|NOT COMPLETED|Overall Study||6||
59714154|NCT01012323|75832793|FG000|STARTED|Overall Study||51||
59714155|NCT01012323|75832793|FG000|COMPLETED|Overall Study||50||
59714156|NCT01012323|75832793|FG000|NOT COMPLETED|Overall Study||1||
59821258|NCT00412113|75943785|FG000|COMPLETED|Overall Study|15-April-2008|111||
59821259|NCT00412113|75943786|FG001|COMPLETED|Overall Study|15-April-2008|107||
59821260|NCT00412113|75943785|FG000|NOT COMPLETED|Overall Study||12||
59821261|NCT00412113|75943786|FG001|NOT COMPLETED|Overall Study||15||
59821262|NCT00411645|75943794|FG000|STARTED|Overall Study||227||
59821263|NCT00411645|75943795|FG001|STARTED|Overall Study||454||
59821264|NCT00411645|75943794|FG000|COMPLETED|Overall Study||146||
59821265|NCT00411645|75943795|FG001|COMPLETED|Overall Study||290||
59821266|NCT00411645|75943794|FG000|NOT COMPLETED|Overall Study||81||
59821267|NCT00411645|75943795|FG001|NOT COMPLETED|Overall Study||164||
59821268|NCT00490724|75943805|FG000|STARTED|Period I||21||
59821269|NCT00490724|75943806|FG001|STARTED|Period I||20||
59821270|NCT00490724|75943807|FG002|STARTED|Period I||20||
59821271|NCT00490724|75943805|FG000|COMPLETED|Period I||21||
59821272|NCT00490724|75943806|FG001|COMPLETED|Period I||20||
59821273|NCT00490724|75943807|FG002|COMPLETED|Period I||19||
59821274|NCT00490724|75943805|FG000|NOT COMPLETED|Period I||0||
59821275|NCT00490724|75943806|FG001|NOT COMPLETED|Period I||0||
59821276|NCT00490724|75943807|FG002|NOT COMPLETED|Period I||1||
59821277|NCT00490724|75943805|FG000|STARTED|Period II||21||
59821278|NCT00490724|75943806|FG001|STARTED|Period II||20||
59821279|NCT00490724|75943807|FG002|STARTED|Period II||19||
59821280|NCT00490724|75943805|FG000|COMPLETED|Period II||18||
59821281|NCT00490724|75943806|FG001|COMPLETED|Period II||19||
59821282|NCT00490724|75943807|FG002|COMPLETED|Period II||16||
59821283|NCT00490724|75943805|FG000|NOT COMPLETED|Period II||3||
60108735|NCT01621672|76228458|FG000|COMPLETED|Overall Study||25||
60108736|NCT01621672|76228459|FG001|COMPLETED|Overall Study||17||
60108737|NCT01621672|76228458|FG000|NOT COMPLETED|Overall Study||0||
59714157|NCT01011933|75832797|FG000|STARTED|Overall Study|total enrolled|54||
59821284|NCT00490724|75943806|FG001|NOT COMPLETED|Period II||1||
59821285|NCT00490724|75943807|FG002|NOT COMPLETED|Period II||3||
59821286|NCT03835221|75943815|FG000|STARTED|Methafilcon A||43||
59821287|NCT03835221|75943815|FG000|COMPLETED|Methafilcon A||42||
59821288|NCT03835221|75943815|FG000|NOT COMPLETED|Methafilcon A||1||
59821289|NCT03835221|75943815|FG000|STARTED|Fanfilcon A||42||
59821290|NCT03835221|75943815|FG000|COMPLETED|Fanfilcon A||42||
59821291|NCT03835221|75943815|FG000|NOT COMPLETED|Fanfilcon A||0||
59821292|NCT00398073|75943823|FG000|STARTED|Overall Study||18||
59821293|NCT00398073|75943824|FG001|STARTED|Overall Study||17||
59821294|NCT00398073|75943823|FG000|COMPLETED|Overall Study||17||
59821295|NCT00398073|75943824|FG001|COMPLETED|Overall Study||17||
59821296|NCT00398073|75943823|FG000|NOT COMPLETED|Overall Study||1||
59821297|NCT00398073|75943824|FG001|NOT COMPLETED|Overall Study||0||
59821298|NCT00490646|75943832|FG000|STARTED|Overall Study||25||
59821299|NCT00490646|75943833|FG001|STARTED|Overall Study||25||
59821300|NCT00490646|75943832|FG000|Treated|Overall Study||24||
59821301|NCT00490646|75943833|FG001|Treated|Overall Study||24||
59821302|NCT00490646|75943832|FG000|COMPLETED|Overall Study|Completed=Off-treatment (Major reasons: Disease progression=14; study drug toxicity=4)|23||
59821303|NCT00490646|75943833|FG001|COMPLETED|Overall Study|Completed=Off-treatment (Major reasons: Disease progression=13; study drug toxicity=1)|23||
59821304|NCT00490646|75943832|FG000|NOT COMPLETED|Overall Study||2||
59821305|NCT00490646|75943833|FG001|NOT COMPLETED|Overall Study||2||
59821306|NCT00388947|75943839|FG000|STARTED|Overall Study||1590||
59821307|NCT00388947|75943839|FG000|COMPLETED|Overall Study|47 patients excluded because no AMS prolapse device was noted.|1543||
59821308|NCT00388947|75943839|FG000|NOT COMPLETED|Overall Study||47||
59821309|NCT00490568|75943843|FG000|STARTED|Overall Study||1461||
59821310|NCT00490568|75943843|FG000|COMPLETED|Overall Study||97||
59821311|NCT00490568|75943843|FG000|NOT COMPLETED|Overall Study||1364||
59821312|NCT00561353|75943858|FG000|STARTED|Overall Study||18||
59821313|NCT00561353|75943859|FG001|STARTED|Overall Study||19||
59821314|NCT00561353|75943860|FG002|STARTED|Overall Study||13||
59821315|NCT00561353|75943861|FG003|STARTED|Overall Study||18||
59821316|NCT00561353|75943862|FG004|STARTED|Overall Study||6||
59821317|NCT00561353|75943863|FG005|STARTED|Overall Study||9||
59821318|NCT00561353|75943864|FG006|STARTED|Overall Study||9||
59821319|NCT00561353|75943865|FG007|STARTED|Overall Study||10||
59821320|NCT00561353|75943866|FG008|STARTED|Overall Study||9||
59821321|NCT00561353|75943867|FG009|STARTED|Overall Study||5||
59821322|NCT00561353|75943858|FG000|COMPLETED|Overall Study||13||
59821323|NCT00561353|75943859|FG001|COMPLETED|Overall Study||16||
59821324|NCT00561353|75943860|FG002|COMPLETED|Overall Study||10||
59821325|NCT00561353|75943861|FG003|COMPLETED|Overall Study||12||
59821326|NCT00561353|75943862|FG004|COMPLETED|Overall Study||5||
59821327|NCT00561353|75943863|FG005|COMPLETED|Overall Study||3||
59821328|NCT00561353|75943864|FG006|COMPLETED|Overall Study||3||
59821329|NCT00561353|75943865|FG007|COMPLETED|Overall Study||6||
59821330|NCT00561353|75943866|FG008|COMPLETED|Overall Study||2||
59821331|NCT00561353|75943867|FG009|COMPLETED|Overall Study||3||
59821332|NCT00561353|75943858|FG000|NOT COMPLETED|Overall Study||5||
59821333|NCT00561353|75943859|FG001|NOT COMPLETED|Overall Study||3||
59821334|NCT00561353|75943860|FG002|NOT COMPLETED|Overall Study||3||
59821335|NCT00561353|75943861|FG003|NOT COMPLETED|Overall Study||6||
59821336|NCT00561353|75943862|FG004|NOT COMPLETED|Overall Study||1||
59821337|NCT00561353|75943863|FG005|NOT COMPLETED|Overall Study||6||
59821338|NCT00561353|75943864|FG006|NOT COMPLETED|Overall Study||6||
59821339|NCT00561353|75943865|FG007|NOT COMPLETED|Overall Study||4||
59821340|NCT00561353|75943866|FG008|NOT COMPLETED|Overall Study||7||
59821341|NCT00561353|75943867|FG009|NOT COMPLETED|Overall Study||2||
59821342|NCT04383587|75943929|FG000|STARTED|Overall Study||300||
59821343|NCT04383587|75943929|FG000|COMPLETED|Overall Study||292||
59821344|NCT04383587|75943929|FG000|NOT COMPLETED|Overall Study||8||
59821345|NCT00560885|75943934|FG000|STARTED|Overall Study||55||
59821346|NCT00560885|75943934|FG000|30 Day Follow-up|Overall Study|53 pts available for 30 day follow-up, 52 pts assessed|53||
59821347|NCT00560885|75943934|FG000|3 Month Follow-up|Overall Study|51 pts available for 3 month follow-up, 48 pts assessed.|51||
59821348|NCT00560885|75943934|FG000|6 Month Follow-up|Overall Study|50 pts available for 6 month follow-up, 50 pts assessed|50||
59821349|NCT00560885|75943934|FG000|12 Month Follow-up|Overall Study|48 pts available for 12 month follow-up, 46 pts assessed|48||
59821350|NCT00560885|75943934|FG000|2 Year Follow-up|Overall Study||47||
59821351|NCT00560885|75943934|FG000|COMPLETED|Overall Study||47||
59821352|NCT00560885|75943934|FG000|NOT COMPLETED|Overall Study||8||
59821353|NCT00397215|75943942|FG000|STARTED|Month 0 (Day 0)||165||
59821354|NCT00397215|75943943|FG001|STARTED|Month 0 (Day 0)||61||
59821355|NCT00397215|75943944|FG002|STARTED|Month 0 (Day 0)||159||
59821356|NCT00397215|75943945|FG003|STARTED|Month 0 (Day 0)||52||
59821357|NCT00397215|75943942|FG000|COMPLETED|Month 0 (Day 0)||158||
59821358|NCT00397215|75943943|FG001|COMPLETED|Month 0 (Day 0)||56||
59821359|NCT00397215|75943944|FG002|COMPLETED|Month 0 (Day 0)||153||
59821360|NCT00397215|75943945|FG003|COMPLETED|Month 0 (Day 0)||48||
59821361|NCT00397215|75943942|FG000|NOT COMPLETED|Month 0 (Day 0)||7||
59821362|NCT00397215|75943943|FG001|NOT COMPLETED|Month 0 (Day 0)||5||
59821363|NCT00397215|75943944|FG002|NOT COMPLETED|Month 0 (Day 0)||6||
59821364|NCT00397215|75943945|FG003|NOT COMPLETED|Month 0 (Day 0)||4||
59821365|NCT00397215|75943942|FG000|STARTED|Month 6 (Day 180)||164||
59821366|NCT00397215|75943943|FG001|STARTED|Month 6 (Day 180)||58||
59821367|NCT00397215|75943944|FG002|STARTED|Month 6 (Day 180)||158||
59821368|NCT00397215|75943945|FG003|STARTED|Month 6 (Day 180)||51||
59821369|NCT00397215|75943942|FG000|COMPLETED|Month 6 (Day 180)||162||
59821370|NCT00397215|75943943|FG001|COMPLETED|Month 6 (Day 180)||55||
59821371|NCT00397215|75943944|FG002|COMPLETED|Month 6 (Day 180)||153||
59821372|NCT00397215|75943945|FG003|COMPLETED|Month 6 (Day 180)||51||
59821373|NCT00397215|75943942|FG000|NOT COMPLETED|Month 6 (Day 180)||2||
59821374|NCT00397215|75943943|FG001|NOT COMPLETED|Month 6 (Day 180)||3||
59821375|NCT00397215|75943944|FG002|NOT COMPLETED|Month 6 (Day 180)||5||
59821376|NCT00397215|75943945|FG003|NOT COMPLETED|Month 6 (Day 180)||0||
59821377|NCT00397215|75943942|FG000|STARTED|Month 12 (Day 360)||130||
59821378|NCT00397215|75943943|FG001|STARTED|Month 12 (Day 360)||48||
59821379|NCT00397215|75943944|FG002|STARTED|Month 12 (Day 360)||125||
59821380|NCT00397215|75943945|FG003|STARTED|Month 12 (Day 360)||42||
59821381|NCT00397215|75943942|FG000|COMPLETED|Month 12 (Day 360)||130||
59821382|NCT00397215|75943943|FG001|COMPLETED|Month 12 (Day 360)||48||
59821383|NCT00397215|75943944|FG002|COMPLETED|Month 12 (Day 360)||125||
59821384|NCT00397215|75943945|FG003|COMPLETED|Month 12 (Day 360)||42||
59821385|NCT00397215|75943942|FG000|NOT COMPLETED|Month 12 (Day 360)||0||
59821386|NCT00397215|75943943|FG001|NOT COMPLETED|Month 12 (Day 360)||0||
59821387|NCT00397215|75943944|FG002|NOT COMPLETED|Month 12 (Day 360)||0||
59821388|NCT00397215|75943945|FG003|NOT COMPLETED|Month 12 (Day 360)||0||
59821389|NCT00397215|75943942|FG000|STARTED|Month 24 (Day 720)||122||
59821390|NCT00397215|75943943|FG001|STARTED|Month 24 (Day 720)||45||
59821391|NCT00397215|75943944|FG002|STARTED|Month 24 (Day 720)||117||
59821392|NCT00397215|75943945|FG003|STARTED|Month 24 (Day 720)||36||
59821393|NCT00397215|75943942|FG000|COMPLETED|Month 24 (Day 720)||122||
59821394|NCT00397215|75943943|FG001|COMPLETED|Month 24 (Day 720)||45||
59821395|NCT00397215|75943944|FG002|COMPLETED|Month 24 (Day 720)||117||
59821396|NCT00397215|75943945|FG003|COMPLETED|Month 24 (Day 720)||36||
59821397|NCT00397215|75943942|FG000|NOT COMPLETED|Month 24 (Day 720)||0||
59821398|NCT00397215|75943943|FG001|NOT COMPLETED|Month 24 (Day 720)||0||
59821399|NCT00397215|75943944|FG002|NOT COMPLETED|Month 24 (Day 720)||0||
59821400|NCT00397215|75943945|FG003|NOT COMPLETED|Month 24 (Day 720)||0||
59821401|NCT00556439|75943962|FG000|STARTED|Study Entry to Week 12|58 signed informed consent with 9 not being eligible. The remaining 49 received study drug.|49||
59821402|NCT00556439|75943963|FG001|STARTED|Study Entry to Week 12|No participants received placebo until the Week 12 Randomization|0||
59821403|NCT00556439|75943964|FG002|STARTED|Study Entry to Week 12|39 signed informed consent with 5 not being eligible. The remaining 34 received study drug.|34||
59821404|NCT00556439|75943965|FG003|STARTED|Study Entry to Week 12|No participants received placebo until the Week 12 Randomization|0||
59821405|NCT00556439|75943962|FG000|COMPLETED|Study Entry to Week 12||41||
59821406|NCT00556439|75943963|FG001|COMPLETED|Study Entry to Week 12||0||
59821407|NCT00556439|75943964|FG002|COMPLETED|Study Entry to Week 12||26||
59821408|NCT00556439|75943965|FG003|COMPLETED|Study Entry to Week 12||0||
59821409|NCT00556439|75943962|FG000|NOT COMPLETED|Study Entry to Week 12||8||
59821410|NCT00556439|75943963|FG001|NOT COMPLETED|Study Entry to Week 12||0||
59821411|NCT00556439|75943964|FG002|NOT COMPLETED|Study Entry to Week 12||8||
59821412|NCT00556439|75943965|FG003|NOT COMPLETED|Study Entry to Week 12||0||
59821413|NCT00556439|75943962|FG000|STARTED|After Week 12 (Randomized Study Period)||20||
59821414|NCT00556439|75943963|FG001|STARTED|After Week 12 (Randomized Study Period)||21||
59821415|NCT00556439|75943964|FG002|STARTED|After Week 12 (Randomized Study Period)||11||
59821416|NCT00556439|75943965|FG003|STARTED|After Week 12 (Randomized Study Period)||15||
60108738|NCT01621672|76228459|FG001|NOT COMPLETED|Overall Study||0||
59714158|NCT01011933|75832797|FG000|COMPLETED|Overall Study|total eligible and evaluable|50||
59714159|NCT01011933|75832797|FG000|NOT COMPLETED|Overall Study||4||
59714160|NCT02549209|75832807|FG000|STARTED|Overall Study||46||
59714161|NCT02549209|75832807|FG000|COMPLETED|Overall Study||46||
59714162|NCT02549209|75832807|FG000|NOT COMPLETED|Overall Study||0||
59714163|NCT01011465|75832819|FG000|STARTED|Overall Study||36||
59714164|NCT01011465|75832820|FG001|STARTED|Overall Study||20||
59714165|NCT01011465|75832821|FG002|STARTED|Overall Study||36||
59821417|NCT00556439|75943962|FG000|COMPLETED|After Week 12 (Randomized Study Period)||17||
59821418|NCT00556439|75943963|FG001|COMPLETED|After Week 12 (Randomized Study Period)||17||
59821419|NCT00556439|75943964|FG002|COMPLETED|After Week 12 (Randomized Study Period)||11||
59821420|NCT00556439|75943965|FG003|COMPLETED|After Week 12 (Randomized Study Period)||14||
59821421|NCT00556439|75943962|FG000|NOT COMPLETED|After Week 12 (Randomized Study Period)||3||
59821422|NCT00556439|75943963|FG001|NOT COMPLETED|After Week 12 (Randomized Study Period)||4||
59821423|NCT00556439|75943964|FG002|NOT COMPLETED|After Week 12 (Randomized Study Period)||0||
59821424|NCT00556439|75943965|FG003|NOT COMPLETED|After Week 12 (Randomized Study Period)||1||
59821425|NCT00387465|75943978|FG000|STARTED|Overall Study||3||
60108739|NCT01663012|76228465|FG000|STARTED|Overall Study||20||
60108740|NCT01663012|76228465|FG000|COMPLETED|Overall Study||20||
59821426|NCT00387465|75943979|FG001|STARTED|Overall Study||7||
59821427|NCT00387465|75943980|FG002|STARTED|Overall Study||35||
60108741|NCT01663012|76228465|FG000|NOT COMPLETED|Overall Study||0||
59714166|NCT01011465|75832822|FG003|STARTED|Overall Study||18||
59714167|NCT01011465|75832823|FG004|STARTED|Overall Study||47||
59714168|NCT01011465|75832824|FG005|STARTED|Overall Study||29||
59821428|NCT00387465|75943978|FG000|COMPLETED|Overall Study||3||
59821429|NCT00387465|75943979|FG001|COMPLETED|Overall Study||6||
59821430|NCT00387465|75943980|FG002|COMPLETED|Overall Study||35||
59821431|NCT00387465|75943978|FG000|NOT COMPLETED|Overall Study||0||
59821432|NCT00387465|75943979|FG001|NOT COMPLETED|Overall Study||1||
59821433|NCT00387465|75943980|FG002|NOT COMPLETED|Overall Study||0||
59821434|NCT00456261|75943990|FG000|STARTED|Combination Therapy||55||
59821435|NCT00456261|75943991|FG001|STARTED|Combination Therapy||55||
59821436|NCT00456261|75943990|FG000|COMPLETED|Combination Therapy||3||
59821437|NCT00456261|75943991|FG001|COMPLETED|Combination Therapy||29||
59821438|NCT00456261|75943990|FG000|NOT COMPLETED|Combination Therapy||52||
59821439|NCT00456261|75943991|FG001|NOT COMPLETED|Combination Therapy||26||
59821440|NCT00456261|75943990|FG000|STARTED|Maintenance Therapy||3||
59821441|NCT00456261|75943991|FG001|STARTED|Maintenance Therapy||29||
59821442|NCT00456261|75943990|FG000|COMPLETED|Maintenance Therapy||3||
59821443|NCT00456261|75943991|FG001|COMPLETED|Maintenance Therapy||29||
59821444|NCT00456261|75943990|FG000|NOT COMPLETED|Maintenance Therapy||0||
59821445|NCT00456261|75943991|FG001|NOT COMPLETED|Maintenance Therapy||0||
59821446|NCT00387153|75943997|FG000|STARTED|Overall Study||8||
59821447|NCT00387153|75943997|FG000|COMPLETED|Overall Study||0||
59821448|NCT00387153|75943997|FG000|NOT COMPLETED|Overall Study||8||
59821449|NCT00386607|75944001|FG000|STARTED|Core||601||
59821450|NCT00386607|75944002|FG001|STARTED|Core||0||
59821451|NCT00386607|75944001|FG000|COMPLETED|Core||486||
59821452|NCT00386607|75944002|FG001|COMPLETED|Core||0||
59821453|NCT00386607|75944001|FG000|NOT COMPLETED|Core||115||
59821454|NCT00386607|75944002|FG001|NOT COMPLETED|Core||0||
59714169|NCT01011465|75832825|FG006|STARTED|Overall Study||52||
59714170|NCT01011465|75832826|FG007|STARTED|Overall Study||32||
59714171|NCT01011465|75832819|FG000|COMPLETED|Overall Study||34||
59714172|NCT01011465|75832820|FG001|COMPLETED|Overall Study||19||
59714173|NCT01011465|75832821|FG002|COMPLETED|Overall Study||36||
59714174|NCT01011465|75832822|FG003|COMPLETED|Overall Study||18||
59714175|NCT01011465|75832823|FG004|COMPLETED|Overall Study||46||
59821455|NCT00386607|75944001|FG000|STARTED|Extension||0||
59821456|NCT00386607|75944002|FG001|STARTED|Extension||162||
59821457|NCT00386607|75944001|FG000|COMPLETED|Extension||0||
59821458|NCT00386607|75944002|FG001|COMPLETED|Extension||145||
59821459|NCT00386607|75944001|FG000|NOT COMPLETED|Extension||0||
59821460|NCT00386607|75944002|FG001|NOT COMPLETED|Extension||17||
59821461|NCT00410163|75944016|FG000|STARTED|Treatment and Follow-up Phase (2 Years)||31||
59821462|NCT00410163|75944017|FG001|STARTED|Treatment and Follow-up Phase (2 Years)||30||
59821463|NCT00410163|75944016|FG000|COMPLETED|Treatment and Follow-up Phase (2 Years)||19||
59821464|NCT00410163|75944017|FG001|COMPLETED|Treatment and Follow-up Phase (2 Years)||19||
59821465|NCT00410163|75944016|FG000|NOT COMPLETED|Treatment and Follow-up Phase (2 Years)||12||
59821466|NCT00410163|75944017|FG001|NOT COMPLETED|Treatment and Follow-up Phase (2 Years)||11||
59821467|NCT00410163|75944016|FG000|STARTED|Extended Follow-up (FU) Phase (2-5 Years|Participants who withdrew from the Treatment Phase were eligible to enter the Extended FU Phase.|20||
59567054|NCT02301546|75669850|FG001|NOT COMPLETED|Long Term Effectiveness (~1 Year)||7||
59714176|NCT01011465|75832824|FG005|COMPLETED|Overall Study||29||
59714177|NCT01011465|75832825|FG006|COMPLETED|Overall Study||51||
59714178|NCT01011465|75832826|FG007|COMPLETED|Overall Study||32||
59714179|NCT01011465|75832819|FG000|NOT COMPLETED|Overall Study||2||
59821468|NCT00410163|75944017|FG001|STARTED|Extended Follow-up (FU) Phase (2-5 Years|Participants who withdrew from the Treatment Phase were eligible to enter the Extended FU Phase.|21||
59821469|NCT00410163|75944016|FG000|COMPLETED|Extended Follow-up (FU) Phase (2-5 Years||10||
59821470|NCT00410163|75944017|FG001|COMPLETED|Extended Follow-up (FU) Phase (2-5 Years||11||
59821471|NCT00410163|75944016|FG000|NOT COMPLETED|Extended Follow-up (FU) Phase (2-5 Years||10||
59821472|NCT00410163|75944017|FG001|NOT COMPLETED|Extended Follow-up (FU) Phase (2-5 Years||10||
59821473|NCT03617523|75944032|FG000|STARTED|Overall Study||30||
59821474|NCT03617523|75944033|FG001|STARTED|Overall Study||30||
60108742|NCT01704976|76228471|FG000|STARTED|Overall Study||14||
60108743|NCT01704976|76228472|FG001|STARTED|Overall Study||13||
60108744|NCT01704976|76228471|FG000|COMPLETED|Overall Study|One participant completed < 11 SR-WBV sessions and was excluded from the statistical analysis|13||
60108745|NCT01704976|76228472|FG001|COMPLETED|Overall Study|2 participants completed < 11 SR-WBV sessions, they were excluded from statistical analysis|11||
60108746|NCT01704976|76228471|FG000|NOT COMPLETED|Overall Study||1||
60108747|NCT01704976|76228472|FG001|NOT COMPLETED|Overall Study||2||
60108748|NCT02234128|76228481|FG000|STARTED|Overall Study||35||
60108749|NCT02234128|76228482|FG001|STARTED|Overall Study||31||
60108750|NCT02234128|76228483|FG002|STARTED|Overall Study||52||
60108751|NCT02234128|76228481|FG000|COMPLETED|Overall Study||30||
60108752|NCT02234128|76228482|FG001|COMPLETED|Overall Study||29||
60108753|NCT02234128|76228483|FG002|COMPLETED|Overall Study||48||
59821475|NCT03617523|75944034|FG002|STARTED|Overall Study||61||
59821476|NCT03617523|75944035|FG003|STARTED|Overall Study||59||
59821477|NCT03617523|75944036|FG004|STARTED|Overall Study||60||
59821478|NCT03617523|75944032|FG000|COMPLETED|Overall Study||30||
59821479|NCT03617523|75944033|FG001|COMPLETED|Overall Study||30||
59821480|NCT03617523|75944034|FG002|COMPLETED|Overall Study||61||
59821481|NCT03617523|75944035|FG003|COMPLETED|Overall Study||59||
59821482|NCT03617523|75944036|FG004|COMPLETED|Overall Study||60||
59821483|NCT03617523|75944032|FG000|NOT COMPLETED|Overall Study||0||
59821484|NCT03617523|75944033|FG001|NOT COMPLETED|Overall Study||0||
59821485|NCT03617523|75944034|FG002|NOT COMPLETED|Overall Study||0||
59821486|NCT03617523|75944035|FG003|NOT COMPLETED|Overall Study||0||
59821487|NCT03617523|75944036|FG004|NOT COMPLETED|Overall Study||0||
59821488|NCT00409617|75944053|FG000|STARTED|Overall Study||945||
59821489|NCT00409617|75944053|FG000|COMPLETED|Overall Study||785||
59821490|NCT00409617|75944053|FG000|NOT COMPLETED|Overall Study||160||
59821491|NCT00300274|75944060|FG000|STARTED|Overall Study||282||
59821492|NCT00300274|75944061|FG001|STARTED|Overall Study||168||
59821493|NCT00300274|75944062|FG002|STARTED|Overall Study||271||
59821494|NCT00300274|75944060|FG000|Completed 12 Month|Overall Study||250||
59821495|NCT00300274|75944061|FG001|Completed 12 Month|Overall Study||149||
59821496|NCT00300274|75944062|FG002|Completed 12 Month|Overall Study||248||
59821497|NCT00300274|75944060|FG000|COMPLETED|Overall Study||236||
59821498|NCT00300274|75944061|FG001|COMPLETED|Overall Study||141||
59821499|NCT00300274|75944062|FG002|COMPLETED|Overall Study||226||
59821500|NCT00300274|75944060|FG000|NOT COMPLETED|Overall Study||46||
59821501|NCT00300274|75944061|FG001|NOT COMPLETED|Overall Study||27||
59821502|NCT00300274|75944062|FG002|NOT COMPLETED|Overall Study||45||
59821503|NCT00299728|75944072|FG000|STARTED|Overall Study||11||
59821504|NCT00299728|75944073|FG001|STARTED|Overall Study||11||
59821505|NCT00299728|75944072|FG000|COMPLETED|Overall Study||11||
59821506|NCT00299728|75944073|FG001|COMPLETED|Overall Study||8||
59821507|NCT00299728|75944072|FG000|NOT COMPLETED|Overall Study||0||
59821508|NCT00299728|75944073|FG001|NOT COMPLETED|Overall Study||3||
59821509|NCT00396591|75944079|FG000|STARTED|Overall Study||16||
59821510|NCT00396591|75944079|FG000|COMPLETED|Overall Study||0||
59821511|NCT00396591|75944079|FG000|NOT COMPLETED|Overall Study||16||
59821512|NCT00316264|75944086|FG000|STARTED|Overall Study||83||
59821513|NCT00316264|75944087|FG001|STARTED|Overall Study||84||
59821514|NCT00316264|75944088|FG002|STARTED|Overall Study||93||
59821515|NCT00316264|75944086|FG000|COMPLETED|Overall Study||77||
59821516|NCT00316264|75944087|FG001|COMPLETED|Overall Study||77||
59714180|NCT01011465|75832820|FG001|NOT COMPLETED|Overall Study||1||
59714181|NCT01011465|75832821|FG002|NOT COMPLETED|Overall Study||0||
59714182|NCT01011465|75832822|FG003|NOT COMPLETED|Overall Study||0||
59714183|NCT01011465|75832823|FG004|NOT COMPLETED|Overall Study||1||
59714184|NCT01011465|75832824|FG005|NOT COMPLETED|Overall Study||0||
59714185|NCT01011465|75832825|FG006|NOT COMPLETED|Overall Study||1||
59714186|NCT01011465|75832826|FG007|NOT COMPLETED|Overall Study||0||
59714187|NCT02494141|75832844|FG000|STARTED|Overall Study||34||
59821517|NCT00316264|75944088|FG002|COMPLETED|Overall Study||87||
59821518|NCT00316264|75944086|FG000|NOT COMPLETED|Overall Study||6||
59821519|NCT00316264|75944087|FG001|NOT COMPLETED|Overall Study||7||
59821520|NCT00316264|75944088|FG002|NOT COMPLETED|Overall Study||6||
59821521|NCT00385827|75944099|FG000|STARTED|Part 1||9||
59821522|NCT00385827|75944100|FG001|STARTED|Part 1||0||
59821523|NCT00385827|75944101|FG002|STARTED|Part 1||0||
59821524|NCT00385827|75944099|FG000|Treated|Part 1||9||
59821525|NCT00385827|75944100|FG001|Treated|Part 1||0||
59821526|NCT00385827|75944101|FG002|Treated|Part 1||0||
59821527|NCT00385827|75944099|FG000|COMPLETED|Part 1||0||
59821528|NCT00385827|75944100|FG001|COMPLETED|Part 1||0||
59821529|NCT00385827|75944101|FG002|COMPLETED|Part 1||0||
59821530|NCT00385827|75944099|FG000|NOT COMPLETED|Part 1||9||
59821531|NCT00385827|75944100|FG001|NOT COMPLETED|Part 1||0||
59821532|NCT00385827|75944101|FG002|NOT COMPLETED|Part 1||0||
59821533|NCT00385827|75944099|FG000|STARTED|Part 2||0||
59821534|NCT00385827|75944100|FG001|STARTED|Part 2||49||
59821535|NCT00385827|75944101|FG002|STARTED|Part 2||48||
59821536|NCT00385827|75944099|FG000|Treated|Part 2||0||
59821537|NCT00385827|75944100|FG001|Treated|Part 2||47||
59821538|NCT00385827|75944101|FG002|Treated|Part 2||46||
59821539|NCT00385827|75944099|FG000|COMPLETED|Part 2||0||
59714188|NCT02494141|75832845|FG001|STARTED|Overall Study||34||
59714189|NCT02494141|75832844|FG000|COMPLETED|Overall Study||28||
59821540|NCT00385827|75944100|FG001|COMPLETED|Part 2||16||
59821541|NCT00385827|75944101|FG002|COMPLETED|Part 2||0||
59821542|NCT00385827|75944099|FG000|NOT COMPLETED|Part 2||0||
59821543|NCT00385827|75944100|FG001|NOT COMPLETED|Part 2||33||
59821544|NCT00385827|75944101|FG002|NOT COMPLETED|Part 2||48||
59821545|NCT00498602|75944118|FG000|STARTED|Overall Study||36||
59821546|NCT00498602|75944119|FG001|STARTED|Overall Study||61||
59821547|NCT00498602|75944120|FG002|STARTED|Overall Study||40||
59821548|NCT00498602|75944121|FG003|STARTED|Overall Study||35||
59821549|NCT00498602|75944122|FG004|STARTED|Overall Study||12||
59821550|NCT00498602|75944123|FG005|STARTED|Overall Study||44||
59821551|NCT00498602|75944124|FG006|STARTED|Overall Study||17||
59821552|NCT00498602|75944118|FG000|Treated|Overall Study||36||
59821553|NCT00498602|75944119|FG001|Treated|Overall Study|One participant discontinued due to an AE, with an outcome of death.|60||
59821554|NCT00498602|75944120|FG002|Treated|Overall Study||40||
59821555|NCT00498602|75944121|FG003|Treated|Overall Study||35||
59821556|NCT00498602|75944122|FG004|Treated|Overall Study||12||
59821557|NCT00498602|75944123|FG005|Treated|Overall Study||44||
59821558|NCT00498602|75944124|FG006|Treated|Overall Study||17||
59821559|NCT00498602|75944118|FG000|COMPLETED|Overall Study||26||
59821560|NCT00498602|75944119|FG001|COMPLETED|Overall Study||51||
59821561|NCT00498602|75944120|FG002|COMPLETED|Overall Study||32||
59821562|NCT00498602|75944121|FG003|COMPLETED|Overall Study||30||
59821563|NCT00498602|75944122|FG004|COMPLETED|Overall Study||8||
59821564|NCT00498602|75944123|FG005|COMPLETED|Overall Study||31||
59821565|NCT00498602|75944124|FG006|COMPLETED|Overall Study||15||
59821566|NCT00498602|75944118|FG000|NOT COMPLETED|Overall Study||10||
59821567|NCT00498602|75944119|FG001|NOT COMPLETED|Overall Study||10||
59821568|NCT00498602|75944120|FG002|NOT COMPLETED|Overall Study||8||
59821569|NCT00498602|75944121|FG003|NOT COMPLETED|Overall Study||5||
59821570|NCT00498602|75944122|FG004|NOT COMPLETED|Overall Study||4||
59821571|NCT00498602|75944123|FG005|NOT COMPLETED|Overall Study||13||
59821572|NCT00498602|75944124|FG006|NOT COMPLETED|Overall Study||2||
59821573|NCT00507728|75944143|FG000|STARTED|Randomization to Month 3||75||
59821574|NCT00507728|75944144|FG001|STARTED|Randomization to Month 3||89||
59821575|NCT00507728|75944145|FG002|STARTED|Randomization to Month 3||90||
59821576|NCT00507728|75944143|FG000|COMPLETED|Randomization to Month 3||60||
59821577|NCT00507728|75944144|FG001|COMPLETED|Randomization to Month 3||75||
59821578|NCT00507728|75944145|FG002|COMPLETED|Randomization to Month 3||70||
59821579|NCT00507728|75944143|FG000|NOT COMPLETED|Randomization to Month 3||15||
59821580|NCT00507728|75944144|FG001|NOT COMPLETED|Randomization to Month 3||14||
59821581|NCT00507728|75944145|FG002|NOT COMPLETED|Randomization to Month 3||20||
59821582|NCT00507728|75944143|FG000|STARTED|From 3 Months to 6 Months||60||
59821583|NCT00507728|75944144|FG001|STARTED|From 3 Months to 6 Months||75||
59821584|NCT00507728|75944145|FG002|STARTED|From 3 Months to 6 Months||70||
59821585|NCT00507728|75944143|FG000|COMPLETED|From 3 Months to 6 Months||54||
59821586|NCT00507728|75944144|FG001|COMPLETED|From 3 Months to 6 Months||65||
59821587|NCT00507728|75944145|FG002|COMPLETED|From 3 Months to 6 Months||61||
59821588|NCT00507728|75944143|FG000|NOT COMPLETED|From 3 Months to 6 Months||6||
59821589|NCT00507728|75944144|FG001|NOT COMPLETED|From 3 Months to 6 Months||10||
59821590|NCT00507728|75944145|FG002|NOT COMPLETED|From 3 Months to 6 Months||9||
59821591|NCT00498368|75944161|FG000|STARTED|Overall Study||17||
59821592|NCT00498368|75944162|FG001|STARTED|Overall Study||17||
59821593|NCT00498368|75944161|FG000|COMPLETED|Overall Study||14||
59821594|NCT00498368|75944162|FG001|COMPLETED|Overall Study||15||
59821595|NCT00498368|75944161|FG000|NOT COMPLETED|Overall Study||3||
59821596|NCT00498368|75944162|FG001|NOT COMPLETED|Overall Study||2||
59821597|NCT00385671|75944171|FG000|STARTED|Overall Study||134||
59821598|NCT00385671|75944172|FG001|STARTED|Overall Study||138||
59821599|NCT00385671|75944173|FG002|STARTED|Overall Study||135||
60108754|NCT02234128|76228481|FG000|NOT COMPLETED|Overall Study||5||
60108755|NCT02234128|76228482|FG001|NOT COMPLETED|Overall Study||2||
60108756|NCT02234128|76228483|FG002|NOT COMPLETED|Overall Study||4||
60108757|NCT01622296|76228491|FG000|STARTED|First Intervention||10||
59821600|NCT00385671|75944171|FG000|COMPLETED|Overall Study||96||
59821601|NCT00385671|75944172|FG001|COMPLETED|Overall Study||87||
59821602|NCT00385671|75944173|FG002|COMPLETED|Overall Study||99||
59821603|NCT00385671|75944171|FG000|NOT COMPLETED|Overall Study||38||
59821604|NCT00385671|75944172|FG001|NOT COMPLETED|Overall Study||51||
59821605|NCT00385671|75944173|FG002|NOT COMPLETED|Overall Study||36||
59821606|NCT00497198|75944185|FG000|STARTED|Overall Study||92||
59821607|NCT00497198|75944186|FG001|STARTED|Overall Study||91||
59821608|NCT00497198|75944185|FG000|COMPLETED|Overall Study||87||
59821609|NCT00497198|75944186|FG001|COMPLETED|Overall Study||86||
59821610|NCT00497198|75944185|FG000|NOT COMPLETED|Overall Study||5||
59821611|NCT00497198|75944186|FG001|NOT COMPLETED|Overall Study||5||
59821612|NCT00496964|75944194|FG000|STARTED|Overall Study||1||
59821613|NCT00496964|75944195|FG001|STARTED|Overall Study||4||
59821614|NCT00496964|75944194|FG000|COMPLETED|Overall Study||1||
59821615|NCT00496964|75944195|FG001|COMPLETED|Overall Study||3||
59821616|NCT00496964|75944194|FG000|NOT COMPLETED|Overall Study||0||
59821617|NCT00496964|75944195|FG001|NOT COMPLETED|Overall Study||1||
59821618|NCT00490490|75944203|FG000|STARTED|Completed Assessment for CR||8||
59821619|NCT00490490|75944203|FG000|COMPLETED|Completed Assessment for CR||8||
59821620|NCT00490490|75944203|FG000|NOT COMPLETED|Completed Assessment for CR||0||
59821621|NCT00490490|75944203|FG000|STARTED|Completed Assessment for TTP||8||
59821622|NCT00490490|75944203|FG000|COMPLETED|Completed Assessment for TTP||5||
59821623|NCT00490490|75944203|FG000|NOT COMPLETED|Completed Assessment for TTP||3||
59821624|NCT00385593|75944209|FG000|STARTED|Overall Study||328||
59821625|NCT00385593|75944210|FG001|STARTED|Overall Study||326||
59821626|NCT00385593|75944209|FG000|COMPLETED|Overall Study||270||
59821627|NCT00385593|75944210|FG001|COMPLETED|Overall Study||289||
60108758|NCT01622296|76228492|FG001|STARTED|First Intervention||10||
59821628|NCT00385593|75944209|FG000|NOT COMPLETED|Overall Study||58||
59821629|NCT00385593|75944210|FG001|NOT COMPLETED|Overall Study||37||
59821630|NCT00495794|75944218|FG000|STARTED|Overall Study||2319||
59821631|NCT00495794|75944219|FG001|STARTED|Overall Study||2303||
59821632|NCT00495794|75944218|FG000|COMPLETED|Overall Study||1797||
59821633|NCT00495794|75944219|FG001|COMPLETED|Overall Study||2303||
59821634|NCT00495794|75944218|FG000|NOT COMPLETED|Overall Study||522||
59821635|NCT00495794|75944219|FG001|NOT COMPLETED|Overall Study||0||
59821636|NCT00495170|75944225|FG000|STARTED|Overall Study||84||
59821637|NCT00495170|75944225|FG000|COMPLETED|Overall Study||64||
59821638|NCT00495170|75944225|FG000|NOT COMPLETED|Overall Study||20||
59821639|NCT03853148|75944233|FG000|STARTED|Overall Study||10||
59821640|NCT03853148|75944234|FG001|STARTED|Overall Study||10||
59821641|NCT03853148|75944235|FG002|STARTED|Overall Study||10||
59821642|NCT03853148|75944236|FG003|STARTED|Overall Study||20||
59821643|NCT03853148|75944233|FG000|COMPLETED|Overall Study||5|"The participant completers varied throughout the study for each of the outcomes which ranged from 8 completers to as low as 2 completers, depending on the outcome. Reported in the Not Completed section here are the lowest numbers of completers in any one outcome."|
59821644|NCT03853148|75944234|FG001|COMPLETED|Overall Study||2|"The participant completers varied throughout the study for each of the outcomes which ranged from 8 completers to as low as 2 completers, depending on the outcome. Reported in the Not Completed section here are the lowest numbers of completers in any one outcome."|
59821645|NCT03853148|75944235|FG002|COMPLETED|Overall Study||2|"The participant completers varied throughout the study for each of the outcomes which ranged from 8 completers to as low as 2 completers, depending on the outcome. Reported in the Not Completed section here are the lowest numbers of completers in any one outcome."|
59821646|NCT03853148|75944236|FG003|COMPLETED|Overall Study||15|"The participant completers varied throughout the study for each of the outcomes which ranged from 8 completers to as low as 2 completers, depending on the outcome. Reported in the Not Completed section here are the lowest numbers of completers in any one outcome."|
59821647|NCT03853148|75944233|FG000|NOT COMPLETED|Overall Study||5||
60108759|NCT01622296|76228491|FG000|COMPLETED|First Intervention||10||
60108760|NCT01622296|76228492|FG001|COMPLETED|First Intervention||10||
60108761|NCT01622296|76228491|FG000|NOT COMPLETED|First Intervention||0||
60108762|NCT01622296|76228492|FG001|NOT COMPLETED|First Intervention||0||
60108763|NCT01622296|76228491|FG000|STARTED|Washout Period of at Least 1 Week||10||
60108764|NCT01622296|76228492|FG001|STARTED|Washout Period of at Least 1 Week||10||
60108765|NCT01622296|76228491|FG000|COMPLETED|Washout Period of at Least 1 Week||10||
60108766|NCT01622296|76228492|FG001|COMPLETED|Washout Period of at Least 1 Week||10||
60108767|NCT01622296|76228491|FG000|NOT COMPLETED|Washout Period of at Least 1 Week||0||
60108768|NCT01622296|76228492|FG001|NOT COMPLETED|Washout Period of at Least 1 Week||0||
60108769|NCT01622296|76228491|FG000|STARTED|Second Intervention||10||
60108770|NCT01622296|76228492|FG001|STARTED|Second Intervention||10||
60108771|NCT01622296|76228491|FG000|COMPLETED|Second Intervention||10||
60108772|NCT01622296|76228492|FG001|COMPLETED|Second Intervention||10||
60108773|NCT01622296|76228491|FG000|NOT COMPLETED|Second Intervention||0||
60108774|NCT01622296|76228492|FG001|NOT COMPLETED|Second Intervention||0||
60108775|NCT02728830|76228497|FG000|STARTED|Overall Study||39||
60108776|NCT02728830|76228497|FG000|COMPLETED|Overall Study||15||
60108777|NCT02728830|76228497|FG000|NOT COMPLETED|Overall Study||24||
60108778|NCT01705288|76228503|FG000|STARTED|Overall Study||52||
60108779|NCT01705288|76228504|FG001|STARTED|Overall Study||51||
60108780|NCT01705288|76228503|FG000|COMPLETED|Overall Study||52||
60108781|NCT01705288|76228504|FG001|COMPLETED|Overall Study||51||
60108782|NCT01705288|76228503|FG000|NOT COMPLETED|Overall Study||0||
60108783|NCT01705288|76228504|FG001|NOT COMPLETED|Overall Study||0||
60108784|NCT01707238|76228512|FG000|STARTED|Overall Study||48||
60108785|NCT01707238|76228513|FG001|STARTED|Overall Study||52||
59714190|NCT02494141|75832845|FG001|COMPLETED|Overall Study||29||
59714191|NCT02494141|75832844|FG000|NOT COMPLETED|Overall Study||6||
59714192|NCT02494141|75832845|FG001|NOT COMPLETED|Overall Study||5||
59714193|NCT01011387|75832851|FG000|STARTED|Overall Study||16||
59714194|NCT01011387|75832851|FG000|COMPLETED|Overall Study||10||
59714195|NCT01011387|75832851|FG000|NOT COMPLETED|Overall Study||6||
59714196|NCT01011309|75832858|FG000|STARTED|Overall Study||14||
60108786|NCT01707238|76228512|FG000|COMPLETED|Overall Study||48||
60108787|NCT01707238|76228513|FG001|COMPLETED|Overall Study||52||
60108788|NCT01707238|76228512|FG000|NOT COMPLETED|Overall Study||0||
60108789|NCT01707238|76228513|FG001|NOT COMPLETED|Overall Study||0||
60108790|NCT02234752|76228520|FG000|STARTED|Overall Study||3||
59714197|NCT01011309|75832859|FG001|STARTED|Overall Study||10||
59714198|NCT01011309|75832860|FG002|STARTED|Overall Study||21||
59821648|NCT03853148|75944234|FG001|NOT COMPLETED|Overall Study||8||
60108791|NCT02234752|76228520|FG000|COMPLETED|Overall Study||2||
60108792|NCT02234752|76228520|FG000|NOT COMPLETED|Overall Study||1||
60108793|NCT01664806|76228527|FG000|STARTED|Overall Study||20||
60108794|NCT01664806|76228528|FG001|STARTED|Overall Study||20||
60108795|NCT01664806|76228527|FG000|COMPLETED|Overall Study||20||
60108796|NCT01664806|76228528|FG001|COMPLETED|Overall Study||20||
59714199|NCT01011309|75832858|FG000|COMPLETED|Overall Study||12||
59714200|NCT01011309|75832859|FG001|COMPLETED|Overall Study||7||
59714201|NCT01011309|75832860|FG002|COMPLETED|Overall Study||16||
59714202|NCT01011309|75832858|FG000|NOT COMPLETED|Overall Study||2||
59821649|NCT03853148|75944235|FG002|NOT COMPLETED|Overall Study||8||
59821650|NCT03853148|75944236|FG003|NOT COMPLETED|Overall Study||5||
59821651|NCT00385203|75944248|FG000|STARTED|Overall Study||26||
59821652|NCT00385203|75944249|FG001|STARTED|Overall Study||10||
59821653|NCT00385203|75944248|FG000|COMPLETED|Overall Study||0||
59821654|NCT00385203|75944249|FG001|COMPLETED|Overall Study||3||
59821655|NCT00385203|75944248|FG000|NOT COMPLETED|Overall Study||26||
59821656|NCT00385203|75944249|FG001|NOT COMPLETED|Overall Study||7||
59821657|NCT00408993|75944258|FG000|STARTED|Overall Study||106||
59821658|NCT00408993|75944259|FG001|STARTED|Overall Study||109||
59821659|NCT00408993|75944258|FG000|COMPLETED|Overall Study||87||
59821660|NCT00408993|75944259|FG001|COMPLETED|Overall Study||92||
59821661|NCT00408993|75944258|FG000|NOT COMPLETED|Overall Study||19||
59821662|NCT00408993|75944259|FG001|NOT COMPLETED|Overall Study||17||
59821663|NCT00395967|75944269|FG000|STARTED|Treatment Period||5||
59821664|NCT00395967|75944269|FG000|COMPLETED|Treatment Period|Failed mobilization due to <2 fold yield after one day of plerixafor treatment|4||
59821665|NCT00395967|75944269|FG000|NOT COMPLETED|Treatment Period||1||
59821666|NCT00395967|75944269|FG000|STARTED|Follow-up Period|Participants who had transplants.|5||
59821667|NCT00395967|75944269|FG000|COMPLETED|Follow-up Period||3||
59821668|NCT00395967|75944269|FG000|NOT COMPLETED|Follow-up Period||2||
59821669|NCT00395733|75944275|FG000|STARTED|Period 1||41||
59821670|NCT00395733|75944276|FG001|STARTED|Period 1||42||
59821671|NCT00395733|75944275|FG000|COMPLETED|Period 1||41||
59821672|NCT00395733|75944276|FG001|COMPLETED|Period 1||42||
59821673|NCT00395733|75944275|FG000|NOT COMPLETED|Period 1||0||
59821674|NCT00395733|75944276|FG001|NOT COMPLETED|Period 1||0||
59821675|NCT00395733|75944275|FG000|STARTED|Period 2||41||
59821676|NCT00395733|75944276|FG001|STARTED|Period 2||42||
59821677|NCT00395733|75944275|FG000|COMPLETED|Period 2||39||
59821678|NCT00395733|75944276|FG001|COMPLETED|Period 2||37||
59821679|NCT00395733|75944275|FG000|NOT COMPLETED|Period 2||2||
59821680|NCT00395733|75944276|FG001|NOT COMPLETED|Period 2||5||
59821681|NCT00395343|75944284|FG000|STARTED|Overall Study||322||
59821682|NCT00395343|75944285|FG001|STARTED|Overall Study||319||
59821683|NCT00395343|75944284|FG000|COMPLETED|Overall Study||281||
59821684|NCT00395343|75944285|FG001|COMPLETED|Overall Study||283||
59821685|NCT00395343|75944284|FG000|NOT COMPLETED|Overall Study||41||
60108797|NCT01664806|76228527|FG000|NOT COMPLETED|Overall Study||0||
60108798|NCT01664806|76228528|FG001|NOT COMPLETED|Overall Study||0||
60108799|NCT01665040|76228534|FG000|STARTED|Overall Study||40||
59714203|NCT01011309|75832859|FG001|NOT COMPLETED|Overall Study||3||
59714204|NCT01011309|75832860|FG002|NOT COMPLETED|Overall Study||5||
59714205|NCT01011153|75832871|FG000|STARTED|Overall Study||54||
59714206|NCT01011153|75832872|FG001|STARTED|Overall Study||75||
59714207|NCT01011153|75832873|FG002|STARTED|Overall Study||54||
59714208|NCT01011153|75832871|FG000|COMPLETED|Overall Study||46||
59714209|NCT01011153|75832872|FG001|COMPLETED|Overall Study||64||
59714210|NCT01011153|75832873|FG002|COMPLETED|Overall Study||45||
59714211|NCT01011153|75832871|FG000|NOT COMPLETED|Overall Study||8||
59714212|NCT01011153|75832872|FG001|NOT COMPLETED|Overall Study||11||
59714213|NCT01011153|75832873|FG002|NOT COMPLETED|Overall Study||9||
59821686|NCT00395343|75944285|FG001|NOT COMPLETED|Overall Study||36||
59821687|NCT00560573|75944291|FG000|STARTED|Overall Study||6||
59821688|NCT00560573|75944292|FG001|STARTED|Overall Study||3||
59821689|NCT00560573|75944293|FG002|STARTED|Overall Study||6||
59821690|NCT00560573|75944294|FG003|STARTED|Overall Study||10||
59821691|NCT00560573|75944295|FG004|STARTED|Overall Study||8||
59821692|NCT00560573|75944296|FG005|STARTED|Overall Study||13||
59821693|NCT00560573|75944291|FG000|Treated|Overall Study||6||
59821694|NCT00560573|75944292|FG001|Treated|Overall Study||3||
59821695|NCT00560573|75944293|FG002|Treated|Overall Study||6||
59821696|NCT00560573|75944294|FG003|Treated|Overall Study||10||
59821697|NCT00560573|75944295|FG004|Treated|Overall Study||7||
59821698|NCT00560573|75944296|FG005|Treated|Overall Study||13||
59821699|NCT00560573|75944291|FG000|COMPLETED|Overall Study||0||
59821700|NCT00560573|75944292|FG001|COMPLETED|Overall Study||0||
59821701|NCT00560573|75944293|FG002|COMPLETED|Overall Study||0||
59821702|NCT00560573|75944294|FG003|COMPLETED|Overall Study||0||
59821703|NCT00560573|75944295|FG004|COMPLETED|Overall Study||1||
59821704|NCT00560573|75944296|FG005|COMPLETED|Overall Study||0||
59821705|NCT00560573|75944291|FG000|NOT COMPLETED|Overall Study||6||
59821706|NCT00560573|75944292|FG001|NOT COMPLETED|Overall Study||3||
59821707|NCT00560573|75944293|FG002|NOT COMPLETED|Overall Study||6||
59821708|NCT00560573|75944294|FG003|NOT COMPLETED|Overall Study||10||
59821709|NCT00560573|75944295|FG004|NOT COMPLETED|Overall Study||7||
59821710|NCT00560573|75944296|FG005|NOT COMPLETED|Overall Study||13||
59821711|NCT03961529|75944329|FG000|STARTED|Overall Study||166||
59821712|NCT03961529|75944330|FG001|STARTED|Overall Study||144||
59821713|NCT03961529|75944331|FG002|STARTED|Overall Study||56||
59821714|NCT03961529|75944329|FG000|COMPLETED|Overall Study||124||
59821715|NCT03961529|75944330|FG001|COMPLETED|Overall Study||127||
60108800|NCT01665040|76228534|FG000|COMPLETED|Overall Study||36||
60108801|NCT01665040|76228534|FG000|NOT COMPLETED|Overall Study||4||
59821716|NCT03961529|75944331|FG002|COMPLETED|Overall Study||51||
59821717|NCT03961529|75944329|FG000|NOT COMPLETED|Overall Study||42||
59821718|NCT03961529|75944330|FG001|NOT COMPLETED|Overall Study||17||
59821719|NCT03961529|75944331|FG002|NOT COMPLETED|Overall Study||5||
59821720|NCT00494780|75944341|FG000|STARTED|Overall Study||29||
59821721|NCT00494780|75944342|FG001|STARTED|Overall Study||30||
59821722|NCT00494780|75944341|FG000|COMPLETED|Overall Study||18||
59821723|NCT00494780|75944342|FG001|COMPLETED|Overall Study||17||
59821724|NCT00494780|75944341|FG000|NOT COMPLETED|Overall Study||11||
59821725|NCT00494780|75944342|FG001|NOT COMPLETED|Overall Study||13||
59821726|NCT00490022|75944352|FG000|STARTED|Overall Study||16||
59821727|NCT00490022|75944353|FG001|STARTED|Overall Study||15||
59821728|NCT00490022|75944352|FG000|COMPLETED|Overall Study||15||
59821729|NCT00490022|75944353|FG001|COMPLETED|Overall Study||12||
59821730|NCT00490022|75944352|FG000|NOT COMPLETED|Overall Study||1||
59821731|NCT00490022|75944353|FG001|NOT COMPLETED|Overall Study||3||
59821732|NCT00493454|75944359|FG000|STARTED|Overall Study||6||
59821733|NCT00493454|75944359|FG000|COMPLETED|Overall Study||5||
59821734|NCT00493454|75944359|FG000|NOT COMPLETED|Overall Study||1||
59821735|NCT00493220|75944369|FG000|STARTED|First Intervention||5||
59821736|NCT00493220|75944370|FG001|STARTED|First Intervention||5||
59821737|NCT00493220|75944371|FG002|STARTED|First Intervention||5||
59821738|NCT00493220|75944372|FG003|STARTED|First Intervention||5||
59821739|NCT00493220|75944373|FG004|STARTED|First Intervention||5||
59821740|NCT00493220|75944374|FG005|STARTED|First Intervention||5||
59821741|NCT00493220|75944369|FG000|COMPLETED|First Intervention||5||
59821742|NCT00493220|75944370|FG001|COMPLETED|First Intervention||5||
59821743|NCT00493220|75944371|FG002|COMPLETED|First Intervention||5||
59821744|NCT00493220|75944372|FG003|COMPLETED|First Intervention||5||
59821745|NCT00493220|75944373|FG004|COMPLETED|First Intervention||5||
59821746|NCT00493220|75944374|FG005|COMPLETED|First Intervention||5||
59821747|NCT00493220|75944369|FG000|NOT COMPLETED|First Intervention||0||
59821748|NCT00493220|75944370|FG001|NOT COMPLETED|First Intervention||0||
59821749|NCT00493220|75944371|FG002|NOT COMPLETED|First Intervention||0||
59821750|NCT00493220|75944372|FG003|NOT COMPLETED|First Intervention||0||
59821751|NCT00493220|75944373|FG004|NOT COMPLETED|First Intervention||0||
59821752|NCT00493220|75944374|FG005|NOT COMPLETED|First Intervention||0||
59821753|NCT00493220|75944369|FG000|STARTED|First 7-Day Washout & Safety Follow-up||5||
59821754|NCT00493220|75944370|FG001|STARTED|First 7-Day Washout & Safety Follow-up||5||
59714214|NCT03250507|75832892|FG000|STARTED|Overall Study||30||
59714215|NCT03250507|75832893|FG001|STARTED|Overall Study||30||
59821755|NCT00493220|75944371|FG002|STARTED|First 7-Day Washout & Safety Follow-up||5||
59821756|NCT00493220|75944372|FG003|STARTED|First 7-Day Washout & Safety Follow-up||5||
59821757|NCT00493220|75944373|FG004|STARTED|First 7-Day Washout & Safety Follow-up||5||
59821758|NCT00493220|75944374|FG005|STARTED|First 7-Day Washout & Safety Follow-up||5||
59821759|NCT00493220|75944369|FG000|COMPLETED|First 7-Day Washout & Safety Follow-up||5||
59821760|NCT00493220|75944370|FG001|COMPLETED|First 7-Day Washout & Safety Follow-up||5||
59821761|NCT00493220|75944371|FG002|COMPLETED|First 7-Day Washout & Safety Follow-up||5||
59821762|NCT00493220|75944372|FG003|COMPLETED|First 7-Day Washout & Safety Follow-up||5||
59821763|NCT00493220|75944373|FG004|COMPLETED|First 7-Day Washout & Safety Follow-up||5||
59821764|NCT00493220|75944374|FG005|COMPLETED|First 7-Day Washout & Safety Follow-up||5||
59821765|NCT00493220|75944369|FG000|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0||
59821766|NCT00493220|75944370|FG001|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0||
59821767|NCT00493220|75944371|FG002|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0||
60108802|NCT01665508|76228538|FG000|STARTED|Overall Study||12||
60108803|NCT01665508|76228538|FG000|COMPLETED|Overall Study||7||
59714216|NCT03250507|75832894|FG002|STARTED|Overall Study||30||
59714217|NCT03250507|75832892|FG000|COMPLETED|Overall Study||30||
59714218|NCT03250507|75832893|FG001|COMPLETED|Overall Study||30||
59714219|NCT03250507|75832894|FG002|COMPLETED|Overall Study||30||
59714220|NCT03250507|75832892|FG000|NOT COMPLETED|Overall Study||0||
59714221|NCT03250507|75832893|FG001|NOT COMPLETED|Overall Study||0||
59714222|NCT03250507|75832894|FG002|NOT COMPLETED|Overall Study||0||
59714223|NCT00997893|75832905|FG000|STARTED|Overall Study||14||
59714224|NCT00997893|75832906|FG001|STARTED|Overall Study||13||
59714225|NCT00997893|75832907|FG002|STARTED|Overall Study||13||
59714226|NCT00997893|75832905|FG000|COMPLETED|Overall Study||12||
59714227|NCT00997893|75832906|FG001|COMPLETED|Overall Study||12||
59821768|NCT00493220|75944372|FG003|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0||
59714228|NCT00997893|75832907|FG002|COMPLETED|Overall Study||13||
59821769|NCT00493220|75944373|FG004|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0||
59821770|NCT00493220|75944374|FG005|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0||
59821771|NCT00493220|75944369|FG000|STARTED|Second Intervention||5||
59821772|NCT00493220|75944370|FG001|STARTED|Second Intervention||5||
59821773|NCT00493220|75944371|FG002|STARTED|Second Intervention||5||
59821774|NCT00493220|75944372|FG003|STARTED|Second Intervention||5||
59821775|NCT00493220|75944373|FG004|STARTED|Second Intervention||5||
59821776|NCT00493220|75944374|FG005|STARTED|Second Intervention||5||
59821777|NCT00493220|75944369|FG000|COMPLETED|Second Intervention||5||
59821778|NCT00493220|75944370|FG001|COMPLETED|Second Intervention||5||
59821779|NCT00493220|75944371|FG002|COMPLETED|Second Intervention||5||
60108804|NCT01665508|76228538|FG000|NOT COMPLETED|Overall Study||5||
59821780|NCT00493220|75944372|FG003|COMPLETED|Second Intervention||5||
59821781|NCT00493220|75944373|FG004|COMPLETED|Second Intervention||5||
59821782|NCT00493220|75944374|FG005|COMPLETED|Second Intervention||5||
59821783|NCT00493220|75944369|FG000|NOT COMPLETED|Second Intervention||0||
59821784|NCT00493220|75944370|FG001|NOT COMPLETED|Second Intervention||0||
59821785|NCT00493220|75944371|FG002|NOT COMPLETED|Second Intervention||0||
59821786|NCT00493220|75944372|FG003|NOT COMPLETED|Second Intervention||0||
59821787|NCT00493220|75944373|FG004|NOT COMPLETED|Second Intervention||0||
59821788|NCT00493220|75944374|FG005|NOT COMPLETED|Second Intervention||0||
59821789|NCT00493220|75944369|FG000|STARTED|Second 7-Day Washout & Safety Follow-up||5||
59821790|NCT00493220|75944370|FG001|STARTED|Second 7-Day Washout & Safety Follow-up||5||
59821791|NCT00493220|75944371|FG002|STARTED|Second 7-Day Washout & Safety Follow-up||5||
59821792|NCT00493220|75944372|FG003|STARTED|Second 7-Day Washout & Safety Follow-up||5||
59821793|NCT00493220|75944373|FG004|STARTED|Second 7-Day Washout & Safety Follow-up||5||
59821794|NCT00493220|75944374|FG005|STARTED|Second 7-Day Washout & Safety Follow-up||5||
59821795|NCT00493220|75944369|FG000|COMPLETED|Second 7-Day Washout & Safety Follow-up||5||
59821796|NCT00493220|75944370|FG001|COMPLETED|Second 7-Day Washout & Safety Follow-up||5||
59821797|NCT00493220|75944371|FG002|COMPLETED|Second 7-Day Washout & Safety Follow-up||5||
59821798|NCT00493220|75944372|FG003|COMPLETED|Second 7-Day Washout & Safety Follow-up||5||
59821799|NCT00493220|75944373|FG004|COMPLETED|Second 7-Day Washout & Safety Follow-up||5||
59821800|NCT00493220|75944374|FG005|COMPLETED|Second 7-Day Washout & Safety Follow-up||5||
59821801|NCT00493220|75944369|FG000|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0||
59821802|NCT00493220|75944370|FG001|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0||
59821803|NCT00493220|75944371|FG002|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0||
59821804|NCT00493220|75944372|FG003|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0||
59821805|NCT00493220|75944373|FG004|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0||
59821806|NCT00493220|75944374|FG005|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0||
59821807|NCT00493220|75944369|FG000|STARTED|Third Intervention||5||
59821808|NCT00493220|75944370|FG001|STARTED|Third Intervention||5||
59821809|NCT00493220|75944371|FG002|STARTED|Third Intervention||5||
59821810|NCT00493220|75944372|FG003|STARTED|Third Intervention||5||
59821811|NCT00493220|75944373|FG004|STARTED|Third Intervention||5||
59821812|NCT00493220|75944374|FG005|STARTED|Third Intervention||5||
59821813|NCT00493220|75944369|FG000|COMPLETED|Third Intervention||4||
59821814|NCT00493220|75944370|FG001|COMPLETED|Third Intervention||5||
59821815|NCT00493220|75944371|FG002|COMPLETED|Third Intervention||5||
59821816|NCT00493220|75944372|FG003|COMPLETED|Third Intervention||5||
59821817|NCT00493220|75944373|FG004|COMPLETED|Third Intervention||5||
59821818|NCT00493220|75944374|FG005|COMPLETED|Third Intervention||5||
59821819|NCT00493220|75944369|FG000|NOT COMPLETED|Third Intervention||1||
59821820|NCT00493220|75944370|FG001|NOT COMPLETED|Third Intervention||0||
59821821|NCT00493220|75944371|FG002|NOT COMPLETED|Third Intervention||0||
59821822|NCT00493220|75944372|FG003|NOT COMPLETED|Third Intervention||0||
59821823|NCT00493220|75944373|FG004|NOT COMPLETED|Third Intervention||0||
59821824|NCT00493220|75944374|FG005|NOT COMPLETED|Third Intervention||0||
59821825|NCT00493220|75944369|FG000|STARTED|Final 7-Day Safety Follow-up||4||
59821826|NCT00493220|75944370|FG001|STARTED|Final 7-Day Safety Follow-up||5||
59821827|NCT00493220|75944371|FG002|STARTED|Final 7-Day Safety Follow-up||5||
59821828|NCT00493220|75944372|FG003|STARTED|Final 7-Day Safety Follow-up||5||
59821829|NCT00493220|75944373|FG004|STARTED|Final 7-Day Safety Follow-up||5||
59821830|NCT00493220|75944374|FG005|STARTED|Final 7-Day Safety Follow-up||5||
59821831|NCT00493220|75944369|FG000|COMPLETED|Final 7-Day Safety Follow-up||4||
59821832|NCT00493220|75944370|FG001|COMPLETED|Final 7-Day Safety Follow-up||5||
60108805|NCT02728596|76228551|FG000|STARTED|Overall Study||707||
60108806|NCT02728596|76228552|FG001|STARTED|Overall Study||644||
59821833|NCT00493220|75944371|FG002|COMPLETED|Final 7-Day Safety Follow-up||5||
59821834|NCT00493220|75944372|FG003|COMPLETED|Final 7-Day Safety Follow-up||5||
59821835|NCT00493220|75944373|FG004|COMPLETED|Final 7-Day Safety Follow-up||5||
59821836|NCT00493220|75944374|FG005|COMPLETED|Final 7-Day Safety Follow-up||5||
59821837|NCT00493220|75944369|FG000|NOT COMPLETED|Final 7-Day Safety Follow-up||0||
59821838|NCT00493220|75944370|FG001|NOT COMPLETED|Final 7-Day Safety Follow-up||0||
59821839|NCT00493220|75944371|FG002|NOT COMPLETED|Final 7-Day Safety Follow-up||0||
59821840|NCT00493220|75944372|FG003|NOT COMPLETED|Final 7-Day Safety Follow-up||0||
60108807|NCT02728596|76228553|FG002|STARTED|Overall Study||1281||
60108808|NCT02728596|76228554|FG003|STARTED|Overall Study||973||
60108809|NCT02728596|76228551|FG000|Treatment Completed|Overall Study||665||
60108810|NCT02728596|76228552|FG001|Treatment Completed|Overall Study||602||
60108811|NCT02728596|76228553|FG002|Treatment Completed|Overall Study||1158||
60108812|NCT02728596|76228554|FG003|Treatment Completed|Overall Study||905||
60108813|NCT02728596|76228551|FG000|COMPLETED|Overall Study||660||
60108814|NCT02728596|76228552|FG001|COMPLETED|Overall Study||596||
60108815|NCT02728596|76228553|FG002|COMPLETED|Overall Study||1151||
59821841|NCT00493220|75944373|FG004|NOT COMPLETED|Final 7-Day Safety Follow-up||0||
59821842|NCT00493220|75944374|FG005|NOT COMPLETED|Final 7-Day Safety Follow-up||0||
59821843|NCT00394953|75944386|FG000|STARTED|First Treatment Period||245||
60108816|NCT02728596|76228554|FG003|COMPLETED|Overall Study||898||
60108817|NCT02728596|76228551|FG000|NOT COMPLETED|Overall Study||47||
59821844|NCT00394953|75944387|FG001|STARTED|First Treatment Period||244||
59821845|NCT00394953|75944386|FG000|COMPLETED|First Treatment Period||216||
59821846|NCT00394953|75944387|FG001|COMPLETED|First Treatment Period||222||
59821847|NCT00394953|75944386|FG000|NOT COMPLETED|First Treatment Period||29||
59821848|NCT00394953|75944387|FG001|NOT COMPLETED|First Treatment Period||22||
59821849|NCT00394953|75944386|FG000|STARTED|Second Treatment Period||216||
59821850|NCT00394953|75944387|FG001|STARTED|Second Treatment Period||222||
59821851|NCT00394953|75944386|FG000|COMPLETED|Second Treatment Period||187||
59821852|NCT00394953|75944387|FG001|COMPLETED|Second Treatment Period||148||
59821853|NCT00394953|75944386|FG000|NOT COMPLETED|Second Treatment Period||29||
59821854|NCT00394953|75944387|FG001|NOT COMPLETED|Second Treatment Period||74||
59821855|NCT00485732|75944395|FG000|STARTED|Overall Study||149||
59821856|NCT00485732|75944396|FG001|STARTED|Overall Study||76||
59821857|NCT00485732|75944395|FG000|COMPLETED|Overall Study||141||
59821858|NCT00485732|75944396|FG001|COMPLETED|Overall Study||67||
59821859|NCT00485732|75944395|FG000|NOT COMPLETED|Overall Study||8||
59821860|NCT00485732|75944396|FG001|NOT COMPLETED|Overall Study||9||
59821861|NCT00489554|75944402|FG000|STARTED|Overall Study||230||
59821862|NCT00489554|75944402|FG000|COMPLETED|Overall Study||226||
59821863|NCT00489554|75944402|FG000|NOT COMPLETED|Overall Study||4||
59821864|NCT00408681|75944406|FG000|STARTED|Overall Study||20||
59821865|NCT00408681|75944406|FG000|COMPLETED|Overall Study|Completion was defined as administration of the study product for at least 28 days.|11||
59821866|NCT00408681|75944406|FG000|NOT COMPLETED|Overall Study||9||
59821867|NCT00560417|75944413|FG000|STARTED|Overall Study||171||
59821868|NCT00560417|75944414|FG001|STARTED|Overall Study||168||
59821869|NCT00560417|75944413|FG000|Intention to Treat (ITT) Population|Overall Study||170||
59821870|NCT00560417|75944414|FG001|Intention to Treat (ITT) Population|Overall Study||167||
59821871|NCT00560417|75944413|FG000|COMPLETED|Overall Study||154||
59821872|NCT00560417|75944414|FG001|COMPLETED|Overall Study||151||
59821873|NCT00560417|75944413|FG000|NOT COMPLETED|Overall Study||17||
59821874|NCT00560417|75944414|FG001|NOT COMPLETED|Overall Study||17||
59821875|NCT00345345|75944420|FG000|STARTED|Overall Study||29||
59821876|NCT00345345|75944420|FG000|COMPLETED|Overall Study||27||
59821877|NCT00345345|75944420|FG000|NOT COMPLETED|Overall Study||2||
59821878|NCT03968159|75944427|FG000|STARTED|Overall Study||148||
59821879|NCT03968159|75944428|FG001|STARTED|Overall Study||150||
59821880|NCT03968159|75944427|FG000|COMPLETED|Overall Study||135||
59821881|NCT03968159|75944428|FG001|COMPLETED|Overall Study||135||
59821882|NCT03968159|75944427|FG000|NOT COMPLETED|Overall Study||13||
59821883|NCT03968159|75944428|FG001|NOT COMPLETED|Overall Study||15||
59821884|NCT03966911|75944436|FG000|STARTED|Overall Study||169||
59821885|NCT03966911|75944437|FG001|STARTED|Overall Study||142||
59821886|NCT03966911|75944436|FG000|COMPLETED|Overall Study||160||
59821887|NCT03966911|75944437|FG001|COMPLETED|Overall Study||126||
59821888|NCT03966911|75944436|FG000|NOT COMPLETED|Overall Study||9||
59821889|NCT03966911|75944437|FG001|NOT COMPLETED|Overall Study||16||
60108818|NCT02728596|76228552|FG001|NOT COMPLETED|Overall Study||48||
60108819|NCT02728596|76228553|FG002|NOT COMPLETED|Overall Study||130||
60108820|NCT02728596|76228554|FG003|NOT COMPLETED|Overall Study||75||
59821890|NCT03966365|75944447|FG000|STARTED|Overall Study||12||
59821891|NCT03966365|75944448|FG001|STARTED|Overall Study||12||
59821892|NCT03966365|75944447|FG000|COMPLETED|Overall Study||11||
59821893|NCT03966365|75944448|FG001|COMPLETED|Overall Study||12||
59821894|NCT03966365|75944447|FG000|NOT COMPLETED|Overall Study||1||
59821895|NCT03966365|75944448|FG001|NOT COMPLETED|Overall Study||0||
59821896|NCT00375219|75944457|FG000|STARTED|Overall Study||62||
59821897|NCT00375219|75944458|FG001|STARTED|Overall Study||20||
59821898|NCT00375219|75944459|FG002|STARTED|Overall Study||21||
59821899|NCT00375219|75944457|FG000|COMPLETED|Overall Study||3||
59821900|NCT00375219|75944458|FG001|COMPLETED|Overall Study||0||
59821901|NCT00375219|75944459|FG002|COMPLETED|Overall Study||0||
59821902|NCT00375219|75944457|FG000|NOT COMPLETED|Overall Study||59||
59821903|NCT00375219|75944458|FG001|NOT COMPLETED|Overall Study||20||
59821904|NCT00375219|75944459|FG002|NOT COMPLETED|Overall Study||21||
59821905|NCT03965351|75944468|FG000|STARTED|First Intervention (4 Weeks)||3||
59821906|NCT03965351|75944469|FG001|STARTED|First Intervention (4 Weeks)||5||
59821907|NCT03965351|75944468|FG000|COMPLETED|First Intervention (4 Weeks)||3||
59821908|NCT03965351|75944469|FG001|COMPLETED|First Intervention (4 Weeks)||4||
60108821|NCT01707472|76228571|FG000|STARTED|Overall Study||4||
60108822|NCT01707472|76228572|FG001|STARTED|Overall Study||6||
60108823|NCT01707472|76228573|FG002|STARTED|Overall Study||8||
60108824|NCT01707472|76228571|FG000|COMPLETED|Overall Study||4||
59821909|NCT03965351|75944468|FG000|NOT COMPLETED|First Intervention (4 Weeks)||0||
59821910|NCT03965351|75944469|FG001|NOT COMPLETED|First Intervention (4 Weeks)||1||
59821911|NCT03965351|75944468|FG000|STARTED|Wash Out Period (4 Weeks)||3||
59821912|NCT03965351|75944469|FG001|STARTED|Wash Out Period (4 Weeks)||4||
59821913|NCT03965351|75944468|FG000|COMPLETED|Wash Out Period (4 Weeks)||3||
59821914|NCT03965351|75944469|FG001|COMPLETED|Wash Out Period (4 Weeks)||4||
59821915|NCT03965351|75944468|FG000|NOT COMPLETED|Wash Out Period (4 Weeks)||0||
59821916|NCT03965351|75944469|FG001|NOT COMPLETED|Wash Out Period (4 Weeks)||0||
59821917|NCT03965351|75944468|FG000|STARTED|Second Intervention (4 Weeks)||3||
60108825|NCT01707472|76228572|FG001|COMPLETED|Overall Study||6||
59821918|NCT03965351|75944469|FG001|STARTED|Second Intervention (4 Weeks)||4||
59821919|NCT03965351|75944468|FG000|COMPLETED|Second Intervention (4 Weeks)||3||
59821920|NCT03965351|75944469|FG001|COMPLETED|Second Intervention (4 Weeks)||3||
59821921|NCT03965351|75944468|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0||
59821922|NCT03965351|75944469|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||1||
59821923|NCT00554801|75944477|FG000|STARTED|Overall Study||55||
59821924|NCT00554801|75944478|FG001|STARTED|Overall Study||29||
59821925|NCT00554801|75944477|FG000|COMPLETED|Overall Study||36||
59821926|NCT00554801|75944478|FG001|COMPLETED|Overall Study||29||
59821927|NCT00554801|75944477|FG000|NOT COMPLETED|Overall Study||19||
59821928|NCT00554801|75944478|FG001|NOT COMPLETED|Overall Study||0||
59821929|NCT00374907|75944488|FG000|STARTED|12-Week Short-term Period||20||
59821930|NCT00374907|75944489|FG001|STARTED|12-Week Short-term Period||16||
59821931|NCT00374907|75944488|FG000|COMPLETED|12-Week Short-term Period||17||
59821932|NCT00374907|75944489|FG001|COMPLETED|12-Week Short-term Period||15||
59821933|NCT00374907|75944488|FG000|NOT COMPLETED|12-Week Short-term Period||3||
59821934|NCT00374907|75944489|FG001|NOT COMPLETED|12-Week Short-term Period||1||
59821935|NCT00374907|75944488|FG000|STARTED|116-Week Short-term + Long-term Period||20||
59821936|NCT00374907|75944489|FG001|STARTED|116-Week Short-term + Long-term Period||16||
59821937|NCT00374907|75944488|FG000|Completed 12-week Short Term Period|116-Week Short-term + Long-term Period||17||
59821938|NCT00374907|75944489|FG001|Completed 12-week Short Term Period|116-Week Short-term + Long-term Period||15||
59821939|NCT00374907|75944488|FG000|COMPLETED|116-Week Short-term + Long-term Period||7||
59821940|NCT00374907|75944489|FG001|COMPLETED|116-Week Short-term + Long-term Period||2||
59821941|NCT00374907|75944488|FG000|NOT COMPLETED|116-Week Short-term + Long-term Period||13||
59821942|NCT00374907|75944489|FG001|NOT COMPLETED|116-Week Short-term + Long-term Period||14||
59821943|NCT00374127|75944497|FG000|STARTED|Overall Study||35||
59821944|NCT00374127|75944497|FG000|COMPLETED|Overall Study||24||
59821945|NCT00374127|75944497|FG000|NOT COMPLETED|Overall Study||11||
59821946|NCT00553787|75944510|FG000|STARTED|Overall Study||994||
59821947|NCT00553787|75944511|FG001|STARTED|Overall Study||498||
59821948|NCT00553787|75944512|FG002|STARTED|Overall Study||995||
59821949|NCT00553787|75944510|FG000|COMPLETED|Overall Study||616||
59821950|NCT00553787|75944511|FG001|COMPLETED|Overall Study||374||
59821951|NCT00553787|75944512|FG002|COMPLETED|Overall Study||733||
59821952|NCT00553787|75944510|FG000|NOT COMPLETED|Overall Study||378||
59821953|NCT00553787|75944511|FG001|NOT COMPLETED|Overall Study||124||
59821954|NCT00553787|75944512|FG002|NOT COMPLETED|Overall Study||262||
59821955|NCT00407745|75944522|FG000|STARTED|Overall Study||112||
59821956|NCT00407745|75944523|FG001|STARTED|Overall Study||108||
59821957|NCT00407745|75944522|FG000|Treated|Overall Study||112||
60108826|NCT01707472|76228573|FG002|COMPLETED|Overall Study||8||
60108827|NCT01707472|76228571|FG000|NOT COMPLETED|Overall Study||0||
60108828|NCT01707472|76228572|FG001|NOT COMPLETED|Overall Study||0||
60108829|NCT01707472|76228573|FG002|NOT COMPLETED|Overall Study||0||
60108830|NCT01666210|76228583|FG000|STARTED|Overall Study||30||
60108831|NCT01666210|76228584|FG001|STARTED|Overall Study||30||
60108832|NCT01666210|76228583|FG000|COMPLETED|Overall Study||28||
60108833|NCT01666210|76228584|FG001|COMPLETED|Overall Study||29||
60108834|NCT01666210|76228583|FG000|NOT COMPLETED|Overall Study||2||
60108835|NCT01666210|76228584|FG001|NOT COMPLETED|Overall Study||1||
59821958|NCT00407745|75944523|FG001|Treated|Overall Study||107||
59821959|NCT00407745|75944522|FG000|COMPLETED|Overall Study||93||
59821960|NCT00407745|75944523|FG001|COMPLETED|Overall Study||91||
59821961|NCT00407745|75944522|FG000|NOT COMPLETED|Overall Study||19||
60108836|NCT01666912|76228592|FG000|STARTED|Overall Study||48||
59821962|NCT00407745|75944523|FG001|NOT COMPLETED|Overall Study||17||
59821963|NCT03958955|75944529|FG000|STARTED|Overall Study||27||
59821964|NCT03958955|75944529|FG000|Lesions Treated With Delgocitinib Cream|Overall Study||27|All subjects had one target lesion treated with delgocitinib cream|
59821965|NCT03958955|75944529|FG000|Lesions Treated With Delgocitinib Cream Vehicle|Overall Study||27|All subjects had one target lesion treated with delgocitinib cream vehicle|
59821966|NCT03958955|75944529|FG000|COMPLETED|Overall Study||26||
59821967|NCT03958955|75944529|FG000|NOT COMPLETED|Overall Study||1||
59821968|NCT00464334|75944546|FG000|STARTED|Overall Study||5||
59821969|NCT00464334|75944547|FG001|STARTED|Overall Study||13||
59821970|NCT00464334|75944548|FG002|STARTED|Overall Study||8||
59821971|NCT00464334|75944549|FG003|STARTED|Overall Study||8||
59821972|NCT00464334|75944550|FG004|STARTED|Overall Study||7||
59821973|NCT00464334|75944551|FG005|STARTED|Overall Study||7||
59821974|NCT00464334|75944552|FG006|STARTED|Overall Study||9||
59821975|NCT00464334|75944553|FG007|STARTED|Overall Study||8||
59821976|NCT00464334|75944554|FG008|STARTED|Overall Study||8||
59821977|NCT00464334|75944555|FG009|STARTED|Overall Study||5||
59821978|NCT00464334|75944556|FG010|STARTED|Overall Study||8||
59821979|NCT00464334|75944546|FG000|COMPLETED|Overall Study||4||
59821980|NCT00464334|75944547|FG001|COMPLETED|Overall Study||5||
59821981|NCT00464334|75944548|FG002|COMPLETED|Overall Study||3||
59821982|NCT00464334|75944549|FG003|COMPLETED|Overall Study||4||
59821983|NCT00464334|75944550|FG004|COMPLETED|Overall Study||3||
59821984|NCT00464334|75944551|FG005|COMPLETED|Overall Study||3||
59821985|NCT00464334|75944552|FG006|COMPLETED|Overall Study||6||
59821986|NCT00464334|75944553|FG007|COMPLETED|Overall Study||7||
59821987|NCT00464334|75944554|FG008|COMPLETED|Overall Study||2||
59821988|NCT00464334|75944555|FG009|COMPLETED|Overall Study||4||
59821989|NCT00464334|75944556|FG010|COMPLETED|Overall Study||4||
59821990|NCT00464334|75944546|FG000|NOT COMPLETED|Overall Study||1||
59821991|NCT00464334|75944547|FG001|NOT COMPLETED|Overall Study||8||
59821992|NCT00464334|75944548|FG002|NOT COMPLETED|Overall Study||5||
59821993|NCT00464334|75944549|FG003|NOT COMPLETED|Overall Study||4||
59821994|NCT00464334|75944550|FG004|NOT COMPLETED|Overall Study||4||
59821995|NCT00464334|75944551|FG005|NOT COMPLETED|Overall Study||4||
59821996|NCT00464334|75944552|FG006|NOT COMPLETED|Overall Study||3||
59821997|NCT00464334|75944553|FG007|NOT COMPLETED|Overall Study||1||
59821998|NCT00464334|75944554|FG008|NOT COMPLETED|Overall Study||6||
59821999|NCT00464334|75944555|FG009|NOT COMPLETED|Overall Study||1||
59822000|NCT00464334|75944556|FG010|NOT COMPLETED|Overall Study||4||
59822001|NCT00299494|75944597|FG000|STARTED|Overall Study||5||
59822002|NCT00299494|75944598|FG001|STARTED|Overall Study||3||
59822003|NCT00299494|75944599|FG002|STARTED|Overall Study||7||
59822004|NCT00299494|75944600|FG003|STARTED|Overall Study||34||
59822005|NCT00299494|75944601|FG004|STARTED|Overall Study|1 participant received rituximab only, and did not receive inotuzumab ozogamicin|40||
59822006|NCT00299494|75944602|FG005|STARTED|Overall Study||30||
59822007|NCT00299494|75944597|FG000|COMPLETED|Overall Study||2||
59822008|NCT00299494|75944598|FG001|COMPLETED|Overall Study||2||
59822009|NCT00299494|75944599|FG002|COMPLETED|Overall Study||3||
59822010|NCT00299494|75944600|FG003|COMPLETED|Overall Study||24||
59822011|NCT00299494|75944601|FG004|COMPLETED|Overall Study||13||
59822012|NCT00299494|75944602|FG005|COMPLETED|Overall Study||4||
59822013|NCT00299494|75944597|FG000|NOT COMPLETED|Overall Study||3||
60108837|NCT01666912|76228593|FG001|STARTED|Overall Study||48||
60108838|NCT01666912|76228592|FG000|COMPLETED|Overall Study||27||
59714229|NCT00997893|75832905|FG000|NOT COMPLETED|Overall Study||2||
59714230|NCT00997893|75832906|FG001|NOT COMPLETED|Overall Study||1||
59714231|NCT00997893|75832907|FG002|NOT COMPLETED|Overall Study||0||
59714232|NCT01032265|75832917|FG000|STARTED|Overall Study||126||
59714233|NCT01032265|75832918|FG001|STARTED|Overall Study||124||
59714234|NCT01032265|75832917|FG000|COMPLETED|Overall Study||113||
59714235|NCT01032265|75832918|FG001|COMPLETED|Overall Study||107||
59714236|NCT01032265|75832917|FG000|NOT COMPLETED|Overall Study||13||
59714237|NCT01032265|75832918|FG001|NOT COMPLETED|Overall Study||17||
59714238|NCT02905825|75832924|FG000|STARTED|Overall Study||53||
59714239|NCT02905825|75832924|FG000|COMPLETED|Overall Study||41||
59714240|NCT02905825|75832924|FG000|NOT COMPLETED|Overall Study||12||
59714241|NCT01208051|75832933|FG000|STARTED|Total Enrollment||4||
59714242|NCT01208051|75832934|FG001|STARTED|Total Enrollment||7||
59714243|NCT01208051|75832935|FG002|STARTED|Total Enrollment||6||
59714244|NCT01208051|75832936|FG003|STARTED|Total Enrollment||39||
59714245|NCT01208051|75832937|FG004|STARTED|Total Enrollment||71||
59714246|NCT01208051|75832933|FG000|COMPLETED|Total Enrollment||4||
59822014|NCT00299494|75944598|FG001|NOT COMPLETED|Overall Study||1||
59822015|NCT00299494|75944599|FG002|NOT COMPLETED|Overall Study||4||
59822016|NCT00299494|75944600|FG003|NOT COMPLETED|Overall Study||10||
59822017|NCT00299494|75944601|FG004|NOT COMPLETED|Overall Study||27||
59822018|NCT00299494|75944602|FG005|NOT COMPLETED|Overall Study||26||
59822019|NCT00453180|75944629|FG000|STARTED|Overall Study||16||
59822020|NCT00453180|75944630|FG001|STARTED|Overall Study||15||
59822021|NCT00453180|75944629|FG000|COMPLETED|Overall Study||13||
59822022|NCT00453180|75944630|FG001|COMPLETED|Overall Study||12||
59822023|NCT00453180|75944629|FG000|NOT COMPLETED|Overall Study||3||
60108839|NCT01666912|76228593|FG001|COMPLETED|Overall Study||37||
59714247|NCT01208051|75832934|FG001|COMPLETED|Total Enrollment||6||
59714248|NCT01208051|75832935|FG002|COMPLETED|Total Enrollment||5||
59714249|NCT01208051|75832936|FG003|COMPLETED|Total Enrollment||39||
59822024|NCT00453180|75944630|FG001|NOT COMPLETED|Overall Study||3||
59822025|NCT00464178|75944636|FG000|STARTED|Overall Study||6||
60108840|NCT01666912|76228592|FG000|NOT COMPLETED|Overall Study||21||
59822026|NCT00464178|75944636|FG000|COMPLETED|Overall Study||4||
59822027|NCT00464178|75944636|FG000|NOT COMPLETED|Overall Study||2||
59822028|NCT00560105|75944643|FG000|STARTED|Overall Study||20||
59822029|NCT00560105|75944644|FG001|STARTED|Overall Study||20||
59822030|NCT00560105|75944643|FG000|COMPLETED|Overall Study||19||
59822031|NCT00560105|75944644|FG001|COMPLETED|Overall Study||18||
59822032|NCT00560105|75944643|FG000|NOT COMPLETED|Overall Study||1||
59822033|NCT00560105|75944644|FG001|NOT COMPLETED|Overall Study||2||
59822034|NCT00467610|75944650|FG000|STARTED|Overall Study||6||
59822035|NCT00467610|75944650|FG000|COMPLETED|Overall Study||5||
59822036|NCT00467610|75944650|FG000|NOT COMPLETED|Overall Study||1||
59822037|NCT00316186|75944654|FG000|STARTED|Overall Study||33||
59822038|NCT00316186|75944654|FG000|COMPLETED|Overall Study||21||
59822039|NCT00316186|75944654|FG000|NOT COMPLETED|Overall Study||12||
59822040|NCT00453102|75944658|FG000|STARTED|Overall Study||18||
59822041|NCT00453102|75944658|FG000|COMPLETED|Overall Study||16||
59822042|NCT00453102|75944658|FG000|NOT COMPLETED|Overall Study||2||
59822043|NCT00299182|75944669|FG000|STARTED|Overall Study||6||
59822044|NCT00299182|75944670|FG001|STARTED|Overall Study||4||
59822045|NCT00299182|75944671|FG002|STARTED|Overall Study||6||
59822046|NCT00299182|75944672|FG003|STARTED|Overall Study||14||
59822047|NCT00299182|75944673|FG004|STARTED|Overall Study||8||
59822048|NCT00299182|75944674|FG005|STARTED|Overall Study||7||
59822049|NCT00299182|75944675|FG006|STARTED|Overall Study||5||
59822050|NCT00299182|75944669|FG000|COMPLETED|Overall Study||6||
59822051|NCT00299182|75944670|FG001|COMPLETED|Overall Study||4||
59822052|NCT00299182|75944671|FG002|COMPLETED|Overall Study||4||
59822053|NCT00299182|75944672|FG003|COMPLETED|Overall Study||14||
59822054|NCT00299182|75944673|FG004|COMPLETED|Overall Study||5||
59822055|NCT00299182|75944674|FG005|COMPLETED|Overall Study||4||
59822056|NCT00299182|75944675|FG006|COMPLETED|Overall Study||4||
59822057|NCT00299182|75944669|FG000|NOT COMPLETED|Overall Study||0||
59822058|NCT00299182|75944670|FG001|NOT COMPLETED|Overall Study||0||
59822059|NCT00299182|75944671|FG002|NOT COMPLETED|Overall Study||2||
59822060|NCT00299182|75944672|FG003|NOT COMPLETED|Overall Study||0||
59822061|NCT00299182|75944673|FG004|NOT COMPLETED|Overall Study||3||
59822062|NCT00299182|75944674|FG005|NOT COMPLETED|Overall Study||3||
59822063|NCT00299182|75944675|FG006|NOT COMPLETED|Overall Study||1||
59822064|NCT00467142|75944693|FG000|STARTED|Overall Study||62||
59822065|NCT00467142|75944693|FG000|COMPLETED|Overall Study||59||
59822066|NCT00467142|75944693|FG000|NOT COMPLETED|Overall Study||3||
59822067|NCT00553475|75944700|FG000|STARTED|Overall Study||135||
59822068|NCT00553475|75944701|FG001|STARTED|Overall Study||134||
59822069|NCT00553475|75944702|FG002|STARTED|Overall Study||45||
59822070|NCT00553475|75944700|FG000|COMPLETED|Overall Study||119||
59822071|NCT00553475|75944701|FG001|COMPLETED|Overall Study||114||
60108841|NCT01666912|76228593|FG001|NOT COMPLETED|Overall Study||11||
60108842|NCT01709032|76228599|FG000|STARTED|Overall Study||9||
59714250|NCT01208051|75832937|FG004|COMPLETED|Total Enrollment||69||
59714251|NCT01208051|75832933|FG000|NOT COMPLETED|Total Enrollment||0||
59714252|NCT01208051|75832934|FG001|NOT COMPLETED|Total Enrollment||1||
59714253|NCT01208051|75832935|FG002|NOT COMPLETED|Total Enrollment||1||
59714254|NCT01208051|75832936|FG003|NOT COMPLETED|Total Enrollment||0||
59714255|NCT01208051|75832937|FG004|NOT COMPLETED|Total Enrollment||2||
59714256|NCT01208051|75832933|FG000|STARTED|Interim Futility Analysis||0||
59714257|NCT01208051|75832934|FG001|STARTED|Interim Futility Analysis||0||
59714258|NCT01208051|75832935|FG002|STARTED|Interim Futility Analysis||0||
59714259|NCT01208051|75832936|FG003|STARTED|Interim Futility Analysis||39||
59714260|NCT01208051|75832937|FG004|STARTED|Interim Futility Analysis||68||
59714261|NCT01208051|75832933|FG000|COMPLETED|Interim Futility Analysis||0||
59714262|NCT01208051|75832934|FG001|COMPLETED|Interim Futility Analysis||0||
59714263|NCT01208051|75832935|FG002|COMPLETED|Interim Futility Analysis||0||
59714264|NCT01208051|75832936|FG003|COMPLETED|Interim Futility Analysis||39||
59714265|NCT01208051|75832937|FG004|COMPLETED|Interim Futility Analysis||68||
59714266|NCT01208051|75832933|FG000|NOT COMPLETED|Interim Futility Analysis||0||
59714267|NCT01208051|75832934|FG001|NOT COMPLETED|Interim Futility Analysis||0||
59714268|NCT01208051|75832935|FG002|NOT COMPLETED|Interim Futility Analysis||0||
59714269|NCT01208051|75832936|FG003|NOT COMPLETED|Interim Futility Analysis||0||
59714270|NCT01208051|75832937|FG004|NOT COMPLETED|Interim Futility Analysis||0||
59714271|NCT01208051|75832933|FG000|STARTED|After Crossover to Cediranib Only||0||
59714272|NCT01208051|75832934|FG001|STARTED|After Crossover to Cediranib Only||0||
59714273|NCT01208051|75832935|FG002|STARTED|After Crossover to Cediranib Only||0||
59714274|NCT01208051|75832936|FG003|STARTED|After Crossover to Cediranib Only||39||
59714275|NCT01208051|75832937|FG004|STARTED|After Crossover to Cediranib Only|One patient entered while futility analysis was ongoing.|69||
59714276|NCT01208051|75832933|FG000|COMPLETED|After Crossover to Cediranib Only||0||
59714277|NCT01208051|75832934|FG001|COMPLETED|After Crossover to Cediranib Only||0||
59822072|NCT00553475|75944702|FG002|COMPLETED|Overall Study||32||
59822073|NCT00553475|75944700|FG000|NOT COMPLETED|Overall Study||16||
59822074|NCT00553475|75944701|FG001|NOT COMPLETED|Overall Study||20||
59822075|NCT00553475|75944702|FG002|NOT COMPLETED|Overall Study||13||
59822076|NCT00329602|75944714|FG000|STARTED|26-Week Double-Blind Treatment Phase|"Numbers of participants in the Participant Flow section are based on the Safety Population."|207||
59822077|NCT00329602|75944715|FG001|STARTED|26-Week Double-Blind Treatment Phase||197||
59822078|NCT00329602|75944716|FG002|STARTED|26-Week Double-Blind Treatment Phase||0||
59822079|NCT00329602|75944714|FG000|COMPLETED|26-Week Double-Blind Treatment Phase||88||
59822080|NCT00329602|75944715|FG001|COMPLETED|26-Week Double-Blind Treatment Phase||98||
59822081|NCT00329602|75944716|FG002|COMPLETED|26-Week Double-Blind Treatment Phase||0||
59822082|NCT00329602|75944714|FG000|NOT COMPLETED|26-Week Double-Blind Treatment Phase||119||
59822083|NCT00329602|75944715|FG001|NOT COMPLETED|26-Week Double-Blind Treatment Phase||99||
59822084|NCT00329602|75944716|FG002|NOT COMPLETED|26-Week Double-Blind Treatment Phase||0||
59822085|NCT00329602|75944714|FG000|STARTED|40-Week Open-Label Treatment Phase||0||
59822086|NCT00329602|75944715|FG001|STARTED|40-Week Open-Label Treatment Phase||0||
59822087|NCT00329602|75944716|FG002|STARTED|40-Week Open-Label Treatment Phase|148 and 121 par. randomized to DB placebo and ropinirole IR, respectively, entered the OL phase.|269||
59822088|NCT00329602|75944714|FG000|COMPLETED|40-Week Open-Label Treatment Phase||0||
59822089|NCT00329602|75944715|FG001|COMPLETED|40-Week Open-Label Treatment Phase||0||
59822090|NCT00329602|75944716|FG002|COMPLETED|40-Week Open-Label Treatment Phase||233||
59822091|NCT00329602|75944714|FG000|NOT COMPLETED|40-Week Open-Label Treatment Phase||0||
59822092|NCT00329602|75944715|FG001|NOT COMPLETED|40-Week Open-Label Treatment Phase||0||
59822093|NCT00329602|75944716|FG002|NOT COMPLETED|40-Week Open-Label Treatment Phase||36||
59822094|NCT00463866|75944734|FG000|STARTED|Overall Study|4203 participants randomised. Out of these, 195 had no efficacy data after randomisation.|4008||
59822095|NCT00463866|75944735|FG001|STARTED|Overall Study|4221 participants randomised. Out of these, 176 had no efficacy data after randomisation.|4045||
59822096|NCT00463866|75944734|FG000|COMPLETED|Overall Study||3699||
59822097|NCT00463866|75944735|FG001|COMPLETED|Overall Study||3705||
59822098|NCT00463866|75944734|FG000|NOT COMPLETED|Overall Study||309||
59822099|NCT00463866|75944735|FG001|NOT COMPLETED|Overall Study||340||
59822100|NCT00313846|75944743|FG000|STARTED|Overall Study||162||
59822101|NCT00313846|75944744|FG001|STARTED|Overall Study|327 subjects were randomized: 1 subject was lost to follow-up (N = 326).|164||
59822102|NCT00313846|75944743|FG000|COMPLETED|Overall Study||157||
59822103|NCT00313846|75944744|FG001|COMPLETED|Overall Study||153||
59822104|NCT00313846|75944743|FG000|NOT COMPLETED|Overall Study||5||
59822105|NCT00313846|75944744|FG001|NOT COMPLETED|Overall Study||11||
59822106|NCT00551135|75944755|FG000|STARTED|Overall Study||108||
59822107|NCT00551135|75944756|FG001|STARTED|Overall Study||106||
59822108|NCT00551135|75944757|FG002|STARTED|Overall Study||103||
59822109|NCT00551135|75944758|FG003|STARTED|Overall Study||108||
59822110|NCT00551135|75944755|FG000|COMPLETED|Overall Study||103||
59822111|NCT00551135|75944756|FG001|COMPLETED|Overall Study||104||
59822112|NCT00551135|75944757|FG002|COMPLETED|Overall Study||98||
59822113|NCT00551135|75944758|FG003|COMPLETED|Overall Study||103||
59822114|NCT00551135|75944755|FG000|NOT COMPLETED|Overall Study||5||
59822115|NCT00551135|75944756|FG001|NOT COMPLETED|Overall Study||2||
59822116|NCT00551135|75944757|FG002|NOT COMPLETED|Overall Study||5||
59822117|NCT00551135|75944758|FG003|NOT COMPLETED|Overall Study||5||
59822118|NCT00299104|75944771|FG000|STARTED|Treatment Period||251||
59822119|NCT00299104|75944772|FG001|STARTED|Treatment Period||252||
59822120|NCT00299104|75944773|FG002|STARTED|Treatment Period||252||
59822121|NCT00299104|75944771|FG000|Safety/ITT: Received Study Drug|Treatment Period||249||
59822122|NCT00299104|75944772|FG001|Safety/ITT: Received Study Drug|Treatment Period||249||
59822123|NCT00299104|75944773|FG002|Safety/ITT: Received Study Drug|Treatment Period||250||
59822124|NCT00299104|75944771|FG000|Completed Week 24|Treatment Period||227||
59822125|NCT00299104|75944772|FG001|Completed Week 24|Treatment Period||240||
59822126|NCT00299104|75944773|FG002|Completed Week 24|Treatment Period||241||
59822127|NCT00299104|75944771|FG000|Completed Week 52|Treatment Period||213||
59822128|NCT00299104|75944772|FG001|Completed Week 52|Treatment Period||227||
59822129|NCT00299104|75944773|FG002|Completed Week 52|Treatment Period||232||
59822130|NCT00299104|75944771|FG000|Completed Week 104|Treatment Period||178||
59822131|NCT00299104|75944772|FG001|Completed Week 104|Treatment Period||213||
59822132|NCT00299104|75944773|FG002|Completed Week 104|Treatment Period||216||
59822133|NCT00299104|75944771|FG000|COMPLETED|Treatment Period|Completed Week 152|62||
59822134|NCT00299104|75944772|FG001|COMPLETED|Treatment Period||77||
59822135|NCT00299104|75944773|FG002|COMPLETED|Treatment Period||80||
59822136|NCT00299104|75944771|FG000|NOT COMPLETED|Treatment Period||189||
59822137|NCT00299104|75944772|FG001|NOT COMPLETED|Treatment Period||175||
59822138|NCT00299104|75944773|FG002|NOT COMPLETED|Treatment Period||172||
59822139|NCT00299104|75944771|FG000|STARTED|Safety Follow-Up (SFU) Period|All participants who received treatment were to enter SFU even if withdrawn during treatment period.|184||
59822140|NCT00299104|75944772|FG001|STARTED|Safety Follow-Up (SFU) Period|All participants who received treatment were to enter SFU even if withdrawn during treatment period.|212||
60108843|NCT01709032|76228599|FG000|COMPLETED|Overall Study||6||
59822141|NCT00299104|75944773|FG002|STARTED|Safety Follow-Up (SFU) Period|All participants who received treatment were to enter SFU even if withdrawn during treatment period.|213||
59822142|NCT00299104|75944771|FG000|COMPLETED|Safety Follow-Up (SFU) Period||129||
59822143|NCT00299104|75944772|FG001|COMPLETED|Safety Follow-Up (SFU) Period||171||
59822144|NCT00299104|75944773|FG002|COMPLETED|Safety Follow-Up (SFU) Period||176||
59822145|NCT00299104|75944771|FG000|NOT COMPLETED|Safety Follow-Up (SFU) Period||55||
59822146|NCT00299104|75944772|FG001|NOT COMPLETED|Safety Follow-Up (SFU) Period||41||
59822147|NCT00299104|75944773|FG002|NOT COMPLETED|Safety Follow-Up (SFU) Period||37||
59822148|NCT00299104|75944771|FG000|STARTED|Extended Safety Follow-Up (ESFU) Period|Only participants with CD19+ B-cell counts below baseline level or less than 80 cells/microliter.|34||
59822149|NCT00299104|75944772|FG001|STARTED|Extended Safety Follow-Up (ESFU) Period|Only participants with CD19+ B-cell counts below baseline level or less than 80 cells/microliter.|40||
59822150|NCT00299104|75944773|FG002|STARTED|Extended Safety Follow-Up (ESFU) Period|Only participants with CD19+ B-cell counts below baseline level or less than 80 cells/microliter.|51||
59822151|NCT00299104|75944771|FG000|COMPLETED|Extended Safety Follow-Up (ESFU) Period||29||
59822152|NCT00299104|75944772|FG001|COMPLETED|Extended Safety Follow-Up (ESFU) Period||31||
59822153|NCT00299104|75944773|FG002|COMPLETED|Extended Safety Follow-Up (ESFU) Period||39||
59822154|NCT00299104|75944771|FG000|NOT COMPLETED|Extended Safety Follow-Up (ESFU) Period||5||
59822155|NCT00299104|75944772|FG001|NOT COMPLETED|Extended Safety Follow-Up (ESFU) Period||9||
59822156|NCT00299104|75944773|FG002|NOT COMPLETED|Extended Safety Follow-Up (ESFU) Period||12||
59822157|NCT00313612|75944783|FG000|STARTED|Overall Study||19||
59822158|NCT00313612|75944784|FG001|STARTED|Overall Study||20||
59822159|NCT00313612|75944783|FG000|COMPLETED|Overall Study||19||
59822160|NCT00313612|75944784|FG001|COMPLETED|Overall Study||19||
59822161|NCT00313612|75944783|FG000|NOT COMPLETED|Overall Study||0||
59822162|NCT00313612|75944784|FG001|NOT COMPLETED|Overall Study||1||
59822163|NCT00507416|75944793|FG000|STARTED|Overall Study||168||
59822164|NCT00507416|75944794|FG001|STARTED|Overall Study||167||
59822165|NCT00507416|75944795|FG002|STARTED|Overall Study||167||
59822166|NCT00507416|75944793|FG000|Treated (Safety Population)|Overall Study||165||
59822167|NCT00507416|75944794|FG001|Treated (Safety Population)|Overall Study||158||
59822168|NCT00507416|75944795|FG002|Treated (Safety Population)|Overall Study||163||
60108844|NCT01709032|76228599|FG000|NOT COMPLETED|Overall Study||3||
60108845|NCT01667536|76228604|FG000|STARTED|Overall Study||105||
59714278|NCT01208051|75832935|FG002|COMPLETED|After Crossover to Cediranib Only||0||
59714279|NCT01208051|75832936|FG003|COMPLETED|After Crossover to Cediranib Only||39||
59714280|NCT01208051|75832937|FG004|COMPLETED|After Crossover to Cediranib Only||69||
60108846|NCT01667536|76228604|FG000|COMPLETED|Overall Study|105 subjects comprised the safety popn, defined as all subjects who received an MIP-1404 injection.|105||
59822169|NCT00507416|75944793|FG000|Completed 8 Treatment Cycles|Overall Study||82||
59822170|NCT00507416|75944794|FG001|Completed 8 Treatment Cycles|Overall Study||60||
59822171|NCT00507416|75944795|FG002|Completed 8 Treatment Cycles|Overall Study||69||
59822172|NCT00507416|75944793|FG000|COMPLETED|Overall Study|Completed is defined as having completed 13 treatment cycles.|50||
59822173|NCT00507416|75944794|FG001|COMPLETED|Overall Study|Completed is defined as having completed 13 treatment cycles.|42||
59822174|NCT00507416|75944795|FG002|COMPLETED|Overall Study|Completed is defined as having completed 13 treatment cycles.|53||
59822175|NCT00507416|75944793|FG000|NOT COMPLETED|Overall Study||118||
59822176|NCT00507416|75944794|FG001|NOT COMPLETED|Overall Study||125||
59822177|NCT00507416|75944795|FG002|NOT COMPLETED|Overall Study||114||
59822178|NCT00489476|75944807|FG000|STARTED|Overall Study||39||
59822179|NCT00489476|75944808|FG001|STARTED|Overall Study||43||
59822180|NCT00489476|75944809|FG002|STARTED|Overall Study||43||
59822181|NCT00489476|75944810|FG003|STARTED|Overall Study||43||
59822182|NCT00489476|75944807|FG000|COMPLETED|Overall Study||39||
59822183|NCT00489476|75944808|FG001|COMPLETED|Overall Study||42||
59822184|NCT00489476|75944809|FG002|COMPLETED|Overall Study||43||
59822185|NCT00489476|75944810|FG003|COMPLETED|Overall Study||43||
59822186|NCT00489476|75944807|FG000|NOT COMPLETED|Overall Study||0||
59822187|NCT00489476|75944808|FG001|NOT COMPLETED|Overall Study||1||
60108847|NCT01667536|76228604|FG000|NOT COMPLETED|Overall Study||0||
60108848|NCT01667848|76228613|FG000|STARTED|Overall Study||67||
59714281|NCT01208051|75832933|FG000|NOT COMPLETED|After Crossover to Cediranib Only||0||
59714282|NCT01208051|75832934|FG001|NOT COMPLETED|After Crossover to Cediranib Only||0||
59822188|NCT00489476|75944809|FG002|NOT COMPLETED|Overall Study||0||
59822189|NCT00489476|75944810|FG003|NOT COMPLETED|Overall Study||0||
59822190|NCT00550745|75944822|FG000|STARTED|Overall Study||6000||
59822191|NCT00550745|75944823|FG001|STARTED|Overall Study||5999||
60108849|NCT01667848|76228614|FG001|STARTED|Overall Study||81||
60108850|NCT01667848|76228613|FG000|COMPLETED|Overall Study||67||
59714283|NCT01208051|75832935|FG002|NOT COMPLETED|After Crossover to Cediranib Only||0||
59822192|NCT00550745|75944822|FG000|COMPLETED|Overall Study||5913||
59822193|NCT00550745|75944823|FG001|COMPLETED|Overall Study||5939||
59822194|NCT00550745|75944822|FG000|NOT COMPLETED|Overall Study||87||
59822195|NCT00550745|75944823|FG001|NOT COMPLETED|Overall Study||60||
59822196|NCT00452790|75944831|FG000|STARTED|Infant Series||354||
59822197|NCT00452790|75944832|FG001|STARTED|Infant Series||355||
59822198|NCT00452790|75944831|FG000|Vaccinated Dose 1|Infant Series||353||
59822199|NCT00452790|75944832|FG001|Vaccinated Dose 1|Infant Series||353||
59822200|NCT00452790|75944831|FG000|Vaccinated Dose 2|Infant Series||300||
59822201|NCT00452790|75944832|FG001|Vaccinated Dose 2|Infant Series||300||
60108851|NCT01667848|76228614|FG001|COMPLETED|Overall Study||81||
59714284|NCT01208051|75832936|FG003|NOT COMPLETED|After Crossover to Cediranib Only||0||
59714285|NCT01208051|75832937|FG004|NOT COMPLETED|After Crossover to Cediranib Only||0||
59822202|NCT00452790|75944831|FG000|Vaccinated Dose 3|Infant Series||221||
59822203|NCT00452790|75944832|FG001|Vaccinated Dose 3|Infant Series||218||
59822204|NCT00452790|75944831|FG000|COMPLETED|Infant Series||219||
59822205|NCT00452790|75944832|FG001|COMPLETED|Infant Series||214||
59822206|NCT00452790|75944831|FG000|NOT COMPLETED|Infant Series||135||
59822207|NCT00452790|75944832|FG001|NOT COMPLETED|Infant Series||141||
59822208|NCT00452790|75944831|FG000|STARTED|After Infant Series||219||
59822209|NCT00452790|75944832|FG001|STARTED|After Infant Series||214||
59822210|NCT00452790|75944831|FG000|COMPLETED|After Infant Series||198||
59822211|NCT00452790|75944832|FG001|COMPLETED|After Infant Series||200||
59822212|NCT00452790|75944831|FG000|NOT COMPLETED|After Infant Series||21||
59822213|NCT00452790|75944832|FG001|NOT COMPLETED|After Infant Series||14||
59822214|NCT00452790|75944831|FG000|STARTED|Toddler Dose||198||
59822215|NCT00452790|75944832|FG001|STARTED|Toddler Dose||200||
59822216|NCT00452790|75944831|FG000|COMPLETED|Toddler Dose||198||
59822217|NCT00452790|75944832|FG001|COMPLETED|Toddler Dose||198||
59822218|NCT00452790|75944831|FG000|NOT COMPLETED|Toddler Dose||0||
59822219|NCT00452790|75944832|FG001|NOT COMPLETED|Toddler Dose||2||
59714286|NCT01207583|75832956|FG000|STARTED|Overall Study||14||
59714287|NCT01207583|75832957|FG001|STARTED|Overall Study||31||
59714288|NCT01207583|75832958|FG002|STARTED|Overall Study||55||
59714289|NCT01207583|75832956|FG000|Dose 1|Overall Study||14||
59714290|NCT01207583|75832957|FG001|Dose 1|Overall Study||31||
59714291|NCT01207583|75832958|FG002|Dose 1|Overall Study||55||
59714292|NCT01207583|75832956|FG000|Dose 2|Overall Study||13||
59714293|NCT01207583|75832957|FG001|Dose 2|Overall Study||29||
59714294|NCT01207583|75832958|FG002|Dose 2|Overall Study||54||
59714295|NCT01207583|75832956|FG000|Dose 3|Overall Study||13||
59714296|NCT01207583|75832957|FG001|Dose 3|Overall Study||27||
59714297|NCT01207583|75832958|FG002|Dose 3|Overall Study||0||
59714298|NCT01207583|75832956|FG000|Dose 4|Overall Study||7||
59714299|NCT01207583|75832957|FG001|Dose 4|Overall Study||0||
59714300|NCT01207583|75832958|FG002|Dose 4|Overall Study||0||
59714301|NCT01207583|75832956|FG000|COMPLETED|Overall Study||13||
59714302|NCT01207583|75832957|FG001|COMPLETED|Overall Study||26||
59714303|NCT01207583|75832958|FG002|COMPLETED|Overall Study||54||
59714304|NCT01207583|75832956|FG000|NOT COMPLETED|Overall Study||1||
59714305|NCT01207583|75832957|FG001|NOT COMPLETED|Overall Study||5||
59714306|NCT01207583|75832958|FG002|NOT COMPLETED|Overall Study||1||
59714307|NCT01207427|75832982|FG000|STARTED|Run-in Placebo Period||43||
59714308|NCT01207427|75832983|FG001|STARTED|Run-in Placebo Period||45||
59714309|NCT01207427|75832984|FG002|STARTED|Run-in Placebo Period||43||
59714310|NCT01207427|75832982|FG000|COMPLETED|Run-in Placebo Period||43||
59714311|NCT01207427|75832983|FG001|COMPLETED|Run-in Placebo Period||45||
59714312|NCT01207427|75832984|FG002|COMPLETED|Run-in Placebo Period||43||
59714313|NCT01207427|75832982|FG000|NOT COMPLETED|Run-in Placebo Period||0||
59714314|NCT01207427|75832983|FG001|NOT COMPLETED|Run-in Placebo Period||0||
59714315|NCT01207427|75832984|FG002|NOT COMPLETED|Run-in Placebo Period||0||
59714316|NCT01207427|75832982|FG000|STARTED|Double-blind Treatment Period||43||
59714317|NCT01207427|75832983|FG001|STARTED|Double-blind Treatment Period||45||
59714318|NCT01207427|75832984|FG002|STARTED|Double-blind Treatment Period||43||
59714319|NCT01207427|75832982|FG000|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||43||
59714320|NCT01207427|75832983|FG001|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||45||
59714321|NCT01207427|75832984|FG002|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||43||
59714322|NCT01207427|75832982|FG000|COMPLETED|Double-blind Treatment Period||40||
59714323|NCT01207427|75832983|FG001|COMPLETED|Double-blind Treatment Period||43||
59714324|NCT01207427|75832984|FG002|COMPLETED|Double-blind Treatment Period||41||
59714325|NCT01207427|75832982|FG000|NOT COMPLETED|Double-blind Treatment Period||3||
59714326|NCT01207427|75832983|FG001|NOT COMPLETED|Double-blind Treatment Period||2||
59714327|NCT01207427|75832984|FG002|NOT COMPLETED|Double-blind Treatment Period||2||
59714328|NCT01207427|75832982|FG000|STARTED|Run-out Placebo Period||40||
59567055|NCT03847389|75669859|FG000|STARTED|Overall Study||8||
59822220|NCT00463788|75944844|FG000|STARTED|Overall Study||115||
59822221|NCT00463788|75944845|FG001|STARTED|Overall Study||58||
60108852|NCT01667848|76228613|FG000|NOT COMPLETED|Overall Study||0||
59714329|NCT01207427|75832983|FG001|STARTED|Run-out Placebo Period||43||
59714330|NCT01207427|75832984|FG002|STARTED|Run-out Placebo Period||41||
59714331|NCT01207427|75832982|FG000|COMPLETED|Run-out Placebo Period||40||
59714332|NCT01207427|75832983|FG001|COMPLETED|Run-out Placebo Period||43||
59714333|NCT01207427|75832984|FG002|COMPLETED|Run-out Placebo Period||41||
59714334|NCT01207427|75832982|FG000|NOT COMPLETED|Run-out Placebo Period||0||
59714335|NCT01207427|75832983|FG001|NOT COMPLETED|Run-out Placebo Period||0||
59714336|NCT01207427|75832984|FG002|NOT COMPLETED|Run-out Placebo Period||0||
59822222|NCT00463788|75944844|FG000|Treated|Overall Study||114||
59714337|NCT04713553|75832997|FG000|STARTED|Primary Study (2 Months)||351||
59822223|NCT00463788|75944845|FG001|Treated|Overall Study||57||
59822224|NCT00463788|75944844|FG000|COMPLETED|Overall Study||6||
59822225|NCT00463788|75944845|FG001|COMPLETED|Overall Study||4||
59822226|NCT00463788|75944844|FG000|NOT COMPLETED|Overall Study||109||
59822227|NCT00463788|75944845|FG001|NOT COMPLETED|Overall Study||54||
59822228|NCT00548249|75944857|FG000|STARTED|Overall Study||26||
59822229|NCT00548249|75944858|FG001|STARTED|Overall Study||26||
59822230|NCT00548249|75944859|FG002|STARTED|Overall Study||29||
59822231|NCT00548249|75944860|FG003|STARTED|Overall Study||22||
59822232|NCT00548249|75944861|FG004|STARTED|Overall Study||28||
59822233|NCT00548249|75944857|FG000|COMPLETED|Overall Study||10||
59822234|NCT00548249|75944858|FG001|COMPLETED|Overall Study||13||
59822235|NCT00548249|75944859|FG002|COMPLETED|Overall Study||9||
59822236|NCT00548249|75944860|FG003|COMPLETED|Overall Study||9||
59822237|NCT00548249|75944861|FG004|COMPLETED|Overall Study||7||
59822238|NCT00548249|75944857|FG000|NOT COMPLETED|Overall Study||16||
59822239|NCT00548249|75944858|FG001|NOT COMPLETED|Overall Study||13||
59822240|NCT00548249|75944859|FG002|NOT COMPLETED|Overall Study||20||
59822241|NCT00548249|75944860|FG003|NOT COMPLETED|Overall Study||13||
59822242|NCT00548249|75944861|FG004|NOT COMPLETED|Overall Study||21||
59822243|NCT00463476|75944875|FG000|STARTED|Overall Study||151||
59822244|NCT00463476|75944876|FG001|STARTED|Overall Study||154||
59822245|NCT00463476|75944875|FG000|COMPLETED|Overall Study||149||
59822246|NCT00463476|75944876|FG001|COMPLETED|Overall Study||151||
59822247|NCT00463476|75944875|FG000|NOT COMPLETED|Overall Study||2||
59822248|NCT00463476|75944876|FG001|NOT COMPLETED|Overall Study||3||
59822249|NCT03839940|75944884|FG000|STARTED|Overall Study||20||
59822250|NCT03839940|75944885|FG001|STARTED|Overall Study||19||
59822251|NCT03839940|75944884|FG000|COMPLETED|Overall Study||16||
59822252|NCT03839940|75944885|FG001|COMPLETED|Overall Study||17||
59822253|NCT03839940|75944884|FG000|NOT COMPLETED|Overall Study||4||
59822254|NCT03839940|75944885|FG001|NOT COMPLETED|Overall Study||2||
59822255|NCT03839628|75944893|FG000|STARTED|Overall Study||9||
59822256|NCT03839628|75944893|FG000|COMPLETED|Overall Study||8||
59822257|NCT03839628|75944893|FG000|NOT COMPLETED|Overall Study||1||
59822258|NCT00462462|75944899|FG000|STARTED|Overall Study||17||
59822259|NCT00462462|75944900|FG001|STARTED|Overall Study||14||
59822260|NCT00462462|75944899|FG000|COMPLETED|Overall Study||17||
59822261|NCT00462462|75944900|FG001|COMPLETED|Overall Study||13||
59822262|NCT00462462|75944899|FG000|NOT COMPLETED|Overall Study||0||
59822263|NCT00462462|75944900|FG001|NOT COMPLETED|Overall Study||1||
59822264|NCT00462384|75944908|FG000|STARTED|Overall Study||39||
59822265|NCT00462384|75944908|FG000|COMPLETED|Overall Study||30||
59822266|NCT00462384|75944908|FG000|NOT COMPLETED|Overall Study||9||
59822267|NCT00452400|75944917|FG000|STARTED|Overall Study||79||
59822268|NCT00452400|75944918|FG001|STARTED|Overall Study||81||
59822269|NCT00452400|75944919|FG002|STARTED|Overall Study||80||
59822270|NCT00452400|75944920|FG003|STARTED|Overall Study||86||
59822271|NCT00452400|75944921|FG004|STARTED|Overall Study||79||
59822272|NCT00452400|75944917|FG000|COMPLETED|Overall Study||74||
59822273|NCT00452400|75944918|FG001|COMPLETED|Overall Study||80||
59822274|NCT00452400|75944919|FG002|COMPLETED|Overall Study||73||
59822275|NCT00452400|75944920|FG003|COMPLETED|Overall Study||85||
59822276|NCT00452400|75944921|FG004|COMPLETED|Overall Study||76||
59822277|NCT00452400|75944917|FG000|NOT COMPLETED|Overall Study||5||
59822278|NCT00452400|75944918|FG001|NOT COMPLETED|Overall Study||1||
59822279|NCT00452400|75944919|FG002|NOT COMPLETED|Overall Study||7||
59822280|NCT00452400|75944920|FG003|NOT COMPLETED|Overall Study||1||
59822281|NCT00452400|75944921|FG004|NOT COMPLETED|Overall Study||3||
59822282|NCT00462306|75944935|FG000|STARTED|Overall Study||4074||
59822283|NCT00462306|75944936|FG001|STARTED|Overall Study||503||
59822284|NCT00462306|75944935|FG000|COMPLETED|Overall Study||4074||
59822285|NCT00462306|75944936|FG001|COMPLETED|Overall Study||490||
60108853|NCT01667848|76228614|FG001|NOT COMPLETED|Overall Study||0||
60108854|NCT01668628|76228623|FG000|STARTED|Overall Study|5 subjects had been excluded due to protocol violation and then data of the rest were anlayzed.|349||
60108855|NCT01668628|76228624|FG001|STARTED|Overall Study||359||
60108856|NCT01668628|76228625|FG002|STARTED|Overall Study|2 subjects had been excluded due to protocol violation and then data of the rest were anlayzed.|367||
60108857|NCT01668628|76228623|FG000|COMPLETED|Overall Study||347||
59714338|NCT04713553|75832998|FG001|STARTED|Primary Study (2 Months)||352||
59714339|NCT04713553|75832999|FG002|STARTED|Primary Study (2 Months)||347||
59714340|NCT04713553|75833000|FG003|STARTED|Primary Study (2 Months)||173||
59714341|NCT04713553|75833001|FG004|STARTED|Primary Study (2 Months)||351||
59714342|NCT04713553|75833002|FG005|STARTED|Primary Study (2 Months)|No participants were enrolled in this arm during the primary study.|0||
59714343|NCT04713553|75833003|FG006|STARTED|Primary Study (2 Months)|No participants were enrolled in this arm during the primary study.|0||
59714344|NCT04713553|75832997|FG000|Treated|Primary Study (2 Months)||351||
59714345|NCT04713553|75832998|FG001|Treated|Primary Study (2 Months)||352||
59714346|NCT04713553|75832999|FG002|Treated|Primary Study (2 Months)||346||
59714347|NCT04713553|75833000|FG003|Treated|Primary Study (2 Months)||173||
59714348|NCT04713553|75833001|FG004|Treated|Primary Study (2 Months)||351||
59714349|NCT04713553|75833002|FG005|Treated|Primary Study (2 Months)||0||
59714350|NCT04713553|75833003|FG006|Treated|Primary Study (2 Months)||0||
59714351|NCT04713553|75832997|FG000|COMPLETED|Primary Study (2 Months)||347||
59714352|NCT04713553|75832998|FG001|COMPLETED|Primary Study (2 Months)||346||
59714353|NCT04713553|75832999|FG002|COMPLETED|Primary Study (2 Months)||344||
59714354|NCT04713553|75833000|FG003|COMPLETED|Primary Study (2 Months)||171||
59714355|NCT04713553|75833001|FG004|COMPLETED|Primary Study (2 Months)||349||
60108858|NCT01668628|76228624|FG001|COMPLETED|Overall Study||359||
60108859|NCT01668628|76228625|FG002|COMPLETED|Overall Study||367||
60108860|NCT01668628|76228623|FG000|NOT COMPLETED|Overall Study||2||
60108861|NCT01668628|76228624|FG001|NOT COMPLETED|Overall Study||0||
60108862|NCT01668628|76228625|FG002|NOT COMPLETED|Overall Study||0||
60108863|NCT01669096|76228637|FG000|STARTED|Overall Study||20||
60108864|NCT01669096|76228637|FG000|COMPLETED|Overall Study||20||
60108865|NCT01669096|76228637|FG000|NOT COMPLETED|Overall Study||0||
60108866|NCT01709422|76228643|FG000|STARTED|Overall Study||70||
60108867|NCT01709422|76228644|FG001|STARTED|Overall Study||70||
60108868|NCT01709422|76228643|FG000|COMPLETED|Overall Study||70||
60108869|NCT01709422|76228644|FG001|COMPLETED|Overall Study||70||
60108870|NCT01709422|76228643|FG000|NOT COMPLETED|Overall Study||0||
60108871|NCT01709422|76228644|FG001|NOT COMPLETED|Overall Study||0||
60108872|NCT01669642|76228657|FG000|STARTED|Overall Study||20||
60108873|NCT01669642|76228658|FG001|STARTED|Overall Study||20||
60108874|NCT01669642|76228659|FG002|STARTED|Overall Study||20||
60108875|NCT01669642|76228660|FG003|STARTED|Overall Study||21||
60108876|NCT01669642|76228661|FG004|STARTED|Overall Study||20||
60108877|NCT01669642|76228662|FG005|STARTED|Overall Study||10||
60108878|NCT01669642|76228657|FG000|COMPLETED|Overall Study||20||
60108879|NCT01669642|76228658|FG001|COMPLETED|Overall Study||20||
60108880|NCT01669642|76228659|FG002|COMPLETED|Overall Study||20||
60108881|NCT01669642|76228660|FG003|COMPLETED|Overall Study||20||
60108882|NCT01669642|76228661|FG004|COMPLETED|Overall Study||20||
60108883|NCT01669642|76228662|FG005|COMPLETED|Overall Study||0||
60108884|NCT01669642|76228657|FG000|NOT COMPLETED|Overall Study||0||
60108885|NCT01669642|76228658|FG001|NOT COMPLETED|Overall Study||0||
60108886|NCT01669642|76228659|FG002|NOT COMPLETED|Overall Study||0||
60108887|NCT01669642|76228660|FG003|NOT COMPLETED|Overall Study||1||
60108888|NCT01669642|76228661|FG004|NOT COMPLETED|Overall Study||0||
60108889|NCT01669642|76228662|FG005|NOT COMPLETED|Overall Study||10||
60108890|NCT01669720|76228681|FG000|STARTED|Overall Study||7||
60108891|NCT01669720|76228682|FG001|STARTED|Overall Study||3||
60108892|NCT01669720|76228681|FG000|COMPLETED|Overall Study||7||
60108893|NCT01669720|76228682|FG001|COMPLETED|Overall Study||3||
60108894|NCT01669720|76228681|FG000|NOT COMPLETED|Overall Study||0||
60108895|NCT01669720|76228682|FG001|NOT COMPLETED|Overall Study||0||
60108896|NCT01670110|76228690|FG000|STARTED|Overall Study||33||
60108897|NCT01670110|76228691|FG001|STARTED|Overall Study||15||
60108898|NCT01670110|76228690|FG000|COMPLETED|Overall Study||29||
60108899|NCT01670110|76228691|FG001|COMPLETED|Overall Study||12||
60108900|NCT01670110|76228690|FG000|NOT COMPLETED|Overall Study||4||
60108901|NCT01670110|76228691|FG001|NOT COMPLETED|Overall Study||3||
60108902|NCT01672996|76228704|FG000|STARTED|Overall Study||30||
60108903|NCT01672996|76228705|FG001|STARTED|Overall Study||30||
60108904|NCT01672996|76228706|FG002|STARTED|Overall Study||6||
60108905|NCT01672996|76228704|FG000|COMPLETED|Overall Study||30||
60108906|NCT01672996|76228705|FG001|COMPLETED|Overall Study||30||
60108907|NCT01672996|76228706|FG002|COMPLETED|Overall Study||6||
60108908|NCT01672996|76228704|FG000|NOT COMPLETED|Overall Study||0||
60108909|NCT01672996|76228705|FG001|NOT COMPLETED|Overall Study||0||
60108910|NCT01672996|76228706|FG002|NOT COMPLETED|Overall Study||0||
60108911|NCT01674478|76228724|FG000|STARTED|Overall Study||9||
59714356|NCT04713553|75833002|FG005|COMPLETED|Primary Study (2 Months)||0||
59714357|NCT04713553|75833003|FG006|COMPLETED|Primary Study (2 Months)||0||
59714358|NCT04713553|75832997|FG000|NOT COMPLETED|Primary Study (2 Months)||4||
59714359|NCT04713553|75832998|FG001|NOT COMPLETED|Primary Study (2 Months)||6||
59714360|NCT04713553|75832999|FG002|NOT COMPLETED|Primary Study (2 Months)||3||
59714361|NCT04713553|75833000|FG003|NOT COMPLETED|Primary Study (2 Months)||2||
60108912|NCT01674478|76228725|FG001|STARTED|Overall Study||9||
60108913|NCT01674478|76228724|FG000|COMPLETED|Overall Study||9||
60108914|NCT01674478|76228725|FG001|COMPLETED|Overall Study||9||
60108915|NCT01674478|76228724|FG000|NOT COMPLETED|Overall Study||0||
59714362|NCT04713553|75833001|FG004|NOT COMPLETED|Primary Study (2 Months)||2||
59714363|NCT04713553|75833002|FG005|NOT COMPLETED|Primary Study (2 Months)||0||
59714364|NCT04713553|75833003|FG006|NOT COMPLETED|Primary Study (2 Months)||0||
59714365|NCT04713553|75832997|FG000|STARTED|Booster Study (1 Month)||0||
59714366|NCT04713553|75832998|FG001|STARTED|Booster Study (1 Month)||0||
59714367|NCT04713553|75832999|FG002|STARTED|Booster Study (1 Month)||0||
59714368|NCT04713553|75833000|FG003|STARTED|Booster Study (1 Month)||0||
59714369|NCT04713553|75833001|FG004|STARTED|Booster Study (1 Month)||0||
60108916|NCT01674478|76228725|FG001|NOT COMPLETED|Overall Study||0||
60108917|NCT02245360|76228733|FG000|STARTED|Overall Study||53||
60108918|NCT02245360|76228734|FG001|STARTED|Overall Study||54||
60108919|NCT02245360|76228733|FG000|COMPLETED|Overall Study||48||
60108920|NCT02245360|76228734|FG001|COMPLETED|Overall Study||52||
60108921|NCT02245360|76228733|FG000|NOT COMPLETED|Overall Study||5||
60108922|NCT02245360|76228734|FG001|NOT COMPLETED|Overall Study||2||
60108923|NCT02245516|76228742|FG000|STARTED|Overall Study||9||
60108924|NCT02245516|76228743|FG001|STARTED|Overall Study||7||
60108925|NCT02245516|76228742|FG000|COMPLETED|Overall Study||9||
60108926|NCT02245516|76228743|FG001|COMPLETED|Overall Study||4||
60108927|NCT02245516|76228742|FG000|NOT COMPLETED|Overall Study||0||
59822286|NCT00462306|75944935|FG000|NOT COMPLETED|Overall Study||0||
59822287|NCT00462306|75944936|FG001|NOT COMPLETED|Overall Study||13||
59822288|NCT00461682|75944944|FG000|STARTED|Overall Study||1||
59822289|NCT00461682|75944944|FG000|COMPLETED|Overall Study||0||
59822290|NCT00461682|75944944|FG000|NOT COMPLETED|Overall Study||1||
59822291|NCT00443430|75944952|FG000|STARTED|Overall Study||43||
59822292|NCT00443430|75944953|FG001|STARTED|Overall Study||42||
59822293|NCT00443430|75944952|FG000|COMPLETED|Overall Study||39||
59822294|NCT00443430|75944953|FG001|COMPLETED|Overall Study||38||
59822295|NCT00443430|75944952|FG000|NOT COMPLETED|Overall Study||4||
59822296|NCT00443430|75944953|FG001|NOT COMPLETED|Overall Study||4||
59822297|NCT00460746|75944959|FG000|STARTED|Overall Study||10||
59822298|NCT00460746|75944959|FG000|COMPLETED|Overall Study||8||
59822299|NCT00460746|75944959|FG000|NOT COMPLETED|Overall Study||2||
59822300|NCT00443118|75944966|FG000|STARTED|Overall Study||515||
59822301|NCT00443118|75944967|FG001|STARTED|Overall Study||291||
59822302|NCT00443118|75944968|FG002|STARTED|Overall Study||226||
59822303|NCT00443118|75944966|FG000|COMPLETED|Overall Study||511||
59822304|NCT00443118|75944967|FG001|COMPLETED|Overall Study||290||
59822305|NCT00443118|75944968|FG002|COMPLETED|Overall Study||226||
59822306|NCT00443118|75944966|FG000|NOT COMPLETED|Overall Study||4||
59822307|NCT00443118|75944967|FG001|NOT COMPLETED|Overall Study||1||
59822308|NCT00443118|75944968|FG002|NOT COMPLETED|Overall Study||0||
59822309|NCT00460434|75944996|FG000|STARTED|Overall Study||165||
59822310|NCT00460434|75944997|FG001|STARTED|Overall Study||172||
59822311|NCT00460434|75944996|FG000|3 Months|Overall Study||163||
59822312|NCT00460434|75944997|FG001|3 Months|Overall Study||171||
59822313|NCT00460434|75944996|FG000|12 Months|Overall Study||162||
59822314|NCT00460434|75944997|FG001|12 Months|Overall Study||165||
59822315|NCT00460434|75944996|FG000|COMPLETED|Overall Study||162||
59822316|NCT00460434|75944997|FG001|COMPLETED|Overall Study||165||
59822317|NCT00460434|75944996|FG000|NOT COMPLETED|Overall Study||3||
59714370|NCT04713553|75833002|FG005|STARTED|Booster Study (1 Month)||31||
59714371|NCT04713553|75833003|FG006|STARTED|Booster Study (1 Month)||31||
59714372|NCT04713553|75832997|FG000|COMPLETED|Booster Study (1 Month)||0||
59714373|NCT04713553|75832998|FG001|COMPLETED|Booster Study (1 Month)||0||
59714374|NCT04713553|75832999|FG002|COMPLETED|Booster Study (1 Month)||0||
59714375|NCT04713553|75833000|FG003|COMPLETED|Booster Study (1 Month)||0||
59714376|NCT04713553|75833001|FG004|COMPLETED|Booster Study (1 Month)||0||
59714377|NCT04713553|75833002|FG005|COMPLETED|Booster Study (1 Month)||31||
59714378|NCT04713553|75833003|FG006|COMPLETED|Booster Study (1 Month)||31||
59714379|NCT04713553|75832997|FG000|NOT COMPLETED|Booster Study (1 Month)||0||
59714380|NCT04713553|75832998|FG001|NOT COMPLETED|Booster Study (1 Month)||0||
59714381|NCT04713553|75832999|FG002|NOT COMPLETED|Booster Study (1 Month)||0||
59714382|NCT04713553|75833000|FG003|NOT COMPLETED|Booster Study (1 Month)||0||
59714383|NCT04713553|75833001|FG004|NOT COMPLETED|Booster Study (1 Month)||0||
59714384|NCT04713553|75833002|FG005|NOT COMPLETED|Booster Study (1 Month)||0||
59714385|NCT04713553|75833003|FG006|NOT COMPLETED|Booster Study (1 Month)||0||
59714386|NCT01206101|75833026|FG000|STARTED|Overall Study||2||
59714387|NCT01206101|75833027|FG001|STARTED|Overall Study||1||
59714388|NCT01206101|75833026|FG000|COMPLETED|Overall Study||0||
59714389|NCT01206101|75833027|FG001|COMPLETED|Overall Study||0||
59714390|NCT01206101|75833026|FG000|NOT COMPLETED|Overall Study||2||
59714391|NCT01206101|75833027|FG001|NOT COMPLETED|Overall Study||1||
59714392|NCT01205165|75833033|FG000|STARTED|Overall Study||104||
59714393|NCT01205165|75833033|FG000|COMPLETED|Overall Study||102||
59714394|NCT01205165|75833033|FG000|NOT COMPLETED|Overall Study||2||
59714395|NCT00997503|75833038|FG000|STARTED|Overall Study||4199||
59714396|NCT00997503|75833038|FG000|12 Months|Overall Study|4059 subjects evaluable at 12-months (cardiac death/MI within 365 days or completed follow-up)|4059||
59714397|NCT00997503|75833038|FG000|COMPLETED|Overall Study||3926||
59714398|NCT00997503|75833038|FG000|NOT COMPLETED|Overall Study||273||
59822318|NCT00460434|75944997|FG001|NOT COMPLETED|Overall Study||7||
59822319|NCT00373425|75945008|FG000|STARTED|Overall Study||623||
59822320|NCT00373425|75945009|FG001|STARTED|Overall Study||350||
59822321|NCT00373425|75945010|FG002|STARTED|Overall Study||134||
59822322|NCT00373425|75945011|FG003|STARTED|Overall Study||11||
59822323|NCT00373425|75945012|FG004|STARTED|Overall Study||132||
59822324|NCT00373425|75945008|FG000|Received Treatment|Overall Study||612||
59822325|NCT00373425|75945009|FG001|Received Treatment|Overall Study||342||
59822326|NCT00373425|75945010|FG002|Received Treatment|Overall Study||134||
59822327|NCT00373425|75945011|FG003|Received Treatment|Overall Study||7||
59822328|NCT00373425|75945012|FG004|Received Treatment|Overall Study||132||
59822329|NCT00373425|75945008|FG000|COMPLETED|Overall Study|Completed 2 years of study treatment|253||
59822330|NCT00373425|75945009|FG001|COMPLETED|Overall Study|Completed 2 years of study treatment|197||
59822331|NCT00373425|75945010|FG002|COMPLETED|Overall Study|Completed 2 years of study treatment|0||
59822332|NCT00373425|75945011|FG003|COMPLETED|Overall Study|Completed 2 years of study treatment|0||
59822333|NCT00373425|75945012|FG004|COMPLETED|Overall Study|Completed 2 years of study treatment|60||
59822334|NCT00373425|75945008|FG000|NOT COMPLETED|Overall Study||370||
59714399|NCT01204775|75833047|FG000|STARTED|Overall Study||4||
59714400|NCT01204775|75833048|FG001|STARTED|Overall Study||4||
59822335|NCT00373425|75945009|FG001|NOT COMPLETED|Overall Study||153||
59822336|NCT00373425|75945010|FG002|NOT COMPLETED|Overall Study||134||
59822337|NCT00373425|75945011|FG003|NOT COMPLETED|Overall Study||11||
59822338|NCT00373425|75945012|FG004|NOT COMPLETED|Overall Study||72||
59822339|NCT00459342|75945021|FG000|STARTED|Overall Study||35||
59822340|NCT00459342|75945021|FG000|COMPLETED|Overall Study||34||
59822341|NCT00459342|75945021|FG000|NOT COMPLETED|Overall Study||1||
59822342|NCT00443040|75945028|FG000|STARTED|Overall Study||14||
59822343|NCT00443040|75945029|FG001|STARTED|Overall Study||11||
59822344|NCT00443040|75945030|FG002|STARTED|Overall Study||10||
59822345|NCT00443040|75945028|FG000|COMPLETED|Overall Study||10||
59822346|NCT00443040|75945029|FG001|COMPLETED|Overall Study||11||
59822347|NCT00443040|75945030|FG002|COMPLETED|Overall Study||9||
59822348|NCT00443040|75945028|FG000|NOT COMPLETED|Overall Study||4||
59822349|NCT00443040|75945029|FG001|NOT COMPLETED|Overall Study||0||
59822350|NCT00443040|75945030|FG002|NOT COMPLETED|Overall Study||1||
59822351|NCT00442962|75945038|FG000|STARTED|Overall Study||54||
59822352|NCT00442962|75945038|FG000|Primary Outcome Evaluation|Overall Study|Primary outcome evaluation at week 24.|52||
59822353|NCT00442962|75945038|FG000|COMPLETED|Overall Study|Completed 48 weeks of follow-up.|46||
59822354|NCT00442962|75945038|FG000|NOT COMPLETED|Overall Study||8||
59822355|NCT00313300|75945047|FG000|STARTED|Randomized in Phase A (26 Weeks)||184||
59822356|NCT00313300|75945048|FG001|STARTED|Randomized in Phase A (26 Weeks)||179||
59822357|NCT00313300|75945049|FG002|STARTED|Randomized in Phase A (26 Weeks)||184||
59822358|NCT00313300|75945050|FG003|STARTED|Randomized in Phase A (26 Weeks)||0||
59822359|NCT00313300|75945051|FG004|STARTED|Randomized in Phase A (26 Weeks)||0||
59822360|NCT00313300|75945047|FG000|COMPLETED|Randomized in Phase A (26 Weeks)||130||
59822361|NCT00313300|75945048|FG001|COMPLETED|Randomized in Phase A (26 Weeks)||140||
59822362|NCT00313300|75945049|FG002|COMPLETED|Randomized in Phase A (26 Weeks)||149||
59822363|NCT00313300|75945050|FG003|COMPLETED|Randomized in Phase A (26 Weeks)||0||
59822364|NCT00313300|75945051|FG004|COMPLETED|Randomized in Phase A (26 Weeks)||0||
59822365|NCT00313300|75945047|FG000|NOT COMPLETED|Randomized in Phase A (26 Weeks)||54||
59822366|NCT00313300|75945048|FG001|NOT COMPLETED|Randomized in Phase A (26 Weeks)||39||
59822367|NCT00313300|75945049|FG002|NOT COMPLETED|Randomized in Phase A (26 Weeks)||35||
59822368|NCT00313300|75945050|FG003|NOT COMPLETED|Randomized in Phase A (26 Weeks)||0||
59822369|NCT00313300|75945051|FG004|NOT COMPLETED|Randomized in Phase A (26 Weeks)||0||
59822370|NCT00313300|75945047|FG000|STARTED|Randomized in Phase B (26 Weeks)||427||
59822371|NCT00313300|75945048|FG001|STARTED|Randomized in Phase B (26 Weeks)||138||
59822372|NCT00313300|75945049|FG002|STARTED|Randomized in Phase B (26 Weeks)||134||
59822373|NCT00313300|75945050|FG003|STARTED|Randomized in Phase B (26 Weeks)||248||
59822374|NCT00313300|75945051|FG004|STARTED|Randomized in Phase B (26 Weeks)||221||
59822375|NCT00313300|75945047|FG000|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||368||
59822376|NCT00313300|75945048|FG001|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||120||
59822377|NCT00313300|75945049|FG002|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||110||
59822378|NCT00313300|75945050|FG003|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||248||
59822379|NCT00313300|75945051|FG004|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||221||
59822380|NCT00313300|75945047|FG000|COMPLETED|Randomized in Phase B (26 Weeks)||333||
59822381|NCT00313300|75945048|FG001|COMPLETED|Randomized in Phase B (26 Weeks)||105||
59822382|NCT00313300|75945049|FG002|COMPLETED|Randomized in Phase B (26 Weeks)||94||
59822383|NCT00313300|75945050|FG003|COMPLETED|Randomized in Phase B (26 Weeks)||15||
59822384|NCT00313300|75945051|FG004|COMPLETED|Randomized in Phase B (26 Weeks)||13||
59822385|NCT00313300|75945047|FG000|NOT COMPLETED|Randomized in Phase B (26 Weeks)||94||
59822386|NCT00313300|75945048|FG001|NOT COMPLETED|Randomized in Phase B (26 Weeks)||33||
59822387|NCT00313300|75945049|FG002|NOT COMPLETED|Randomized in Phase B (26 Weeks)||40||
59822388|NCT00313300|75945050|FG003|NOT COMPLETED|Randomized in Phase B (26 Weeks)||233||
59822389|NCT00313300|75945051|FG004|NOT COMPLETED|Randomized in Phase B (26 Weeks)||208||
59822390|NCT00313300|75945047|FG000|STARTED|Follow-Up(30days)-Randomized Phase A||163||
59822391|NCT00313300|75945048|FG001|STARTED|Follow-Up(30days)-Randomized Phase A||162||
59822392|NCT00313300|75945049|FG002|STARTED|Follow-Up(30days)-Randomized Phase A||174||
59822393|NCT00313300|75945050|FG003|STARTED|Follow-Up(30days)-Randomized Phase A||0||
59822394|NCT00313300|75945051|FG004|STARTED|Follow-Up(30days)-Randomized Phase A||0||
59822395|NCT00313300|75945047|FG000|COMPLETED|Follow-Up(30days)-Randomized Phase A||158||
59822396|NCT00313300|75945048|FG001|COMPLETED|Follow-Up(30days)-Randomized Phase A||156||
59822397|NCT00313300|75945049|FG002|COMPLETED|Follow-Up(30days)-Randomized Phase A||172||
59822398|NCT00313300|75945050|FG003|COMPLETED|Follow-Up(30days)-Randomized Phase A||0||
59822399|NCT00313300|75945051|FG004|COMPLETED|Follow-Up(30days)-Randomized Phase A||0||
59822400|NCT00313300|75945047|FG000|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||5||
59996327|NCT04150861|76112318|FG002|NOT COMPLETED|Overall Study||0||
59996328|NCT04150705|76112326|FG000|STARTED|Overall Study||14||
59996329|NCT04150705|76112326|FG000|COMPLETED|Overall Study||14||
59996330|NCT04150705|76112326|FG000|NOT COMPLETED|Overall Study||0||
59996331|NCT03707977|76112332|FG000|STARTED|PK Step||6||
59996332|NCT03707977|76112333|FG001|STARTED|PK Step||6||
59996333|NCT03707977|76112334|FG002|STARTED|PK Step||0||
59996334|NCT03707977|76112332|FG000|COMPLETED|PK Step||6||
59996335|NCT03707977|76112333|FG001|COMPLETED|PK Step||6||
59822401|NCT00313300|75945048|FG001|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||6||
59822402|NCT00313300|75945049|FG002|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||2||
59822403|NCT00313300|75945050|FG003|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||0||
59822404|NCT00313300|75945051|FG004|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||0||
59822405|NCT00313300|75945047|FG000|STARTED|Follow-Up(30days)-Randomized Phase B||383||
59822406|NCT00313300|75945048|FG001|STARTED|Follow-Up(30days)-Randomized Phase B||123||
59822407|NCT00313300|75945049|FG002|STARTED|Follow-Up(30days)-Randomized Phase B||119||
59822408|NCT00313300|75945050|FG003|STARTED|Follow-Up(30days)-Randomized Phase B||222||
59822409|NCT00313300|75945051|FG004|STARTED|Follow-Up(30days)-Randomized Phase B||201||
59822410|NCT00313300|75945047|FG000|COMPLETED|Follow-Up(30days)-Randomized Phase B||380||
59822411|NCT00313300|75945048|FG001|COMPLETED|Follow-Up(30days)-Randomized Phase B||123||
59822412|NCT00313300|75945049|FG002|COMPLETED|Follow-Up(30days)-Randomized Phase B||117||
59822413|NCT00313300|75945050|FG003|COMPLETED|Follow-Up(30days)-Randomized Phase B||217||
59822414|NCT00313300|75945051|FG004|COMPLETED|Follow-Up(30days)-Randomized Phase B||199||
59822415|NCT00313300|75945047|FG000|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||3||
59822416|NCT00313300|75945048|FG001|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||0||
59822417|NCT00313300|75945049|FG002|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||2||
59822418|NCT00313300|75945050|FG003|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||5||
59822419|NCT00313300|75945051|FG004|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||2||
59822420|NCT00459186|75945069|FG000|STARTED|Single Agent RAD001||19||
59822421|NCT00459186|75945069|FG000|COMPLETED|Single Agent RAD001||18||
59822422|NCT00459186|75945069|FG000|NOT COMPLETED|Single Agent RAD001||1||
59822423|NCT00459186|75945069|FG000|STARTED|PET Imaging and Assessment||18||
59822424|NCT00459186|75945069|FG000|COMPLETED|PET Imaging and Assessment||15||
59822425|NCT00459186|75945069|FG000|NOT COMPLETED|PET Imaging and Assessment||3||
59822426|NCT00459186|75945069|FG000|STARTED|Combination RAD001 + Docetaxel||15||
59822427|NCT00459186|75945069|FG000|COMPLETED|Combination RAD001 + Docetaxel||15||
59822428|NCT00459186|75945069|FG000|NOT COMPLETED|Combination RAD001 + Docetaxel||0||
59822429|NCT00328510|75945075|FG000|STARTED|Overall Study||42||
59822430|NCT00328510|75945076|FG001|STARTED|Overall Study||41||
59822431|NCT00328510|75945075|FG000|COMPLETED|Overall Study||32||
59822432|NCT00328510|75945076|FG001|COMPLETED|Overall Study||37||
59822433|NCT00328510|75945075|FG000|NOT COMPLETED|Overall Study||10||
59822434|NCT00328510|75945076|FG001|NOT COMPLETED|Overall Study||4||
59822435|NCT00313144|75945082|FG000|STARTED|Overall Study||127||
59822436|NCT00313144|75945082|FG000|COMPLETED|Overall Study||17||
59822437|NCT00313144|75945082|FG000|NOT COMPLETED|Overall Study||110||
59822438|NCT00459108|75945095|FG000|STARTED|Overall Study||25||
59822439|NCT00459108|75945095|FG000|COMPLETED|Overall Study||14||
59822440|NCT00459108|75945095|FG000|NOT COMPLETED|Overall Study||11||
59822441|NCT00458484|75945107|FG000|STARTED|Overall Study||4||
59822442|NCT00458484|75945108|FG001|STARTED|Overall Study||6||
59822443|NCT00458484|75945109|FG002|STARTED|Overall Study||3||
60108928|NCT02245516|76228743|FG001|NOT COMPLETED|Overall Study||3||
60108929|NCT01677286|76228749|FG000|STARTED|Overall Study||25||
60108930|NCT01677286|76228749|FG000|COMPLETED|Overall Study||14||
60108931|NCT01677286|76228749|FG000|NOT COMPLETED|Overall Study||11||
60108932|NCT02246062|76228759|FG000|STARTED|Overall Study||21||
60108933|NCT02246062|76228760|FG001|STARTED|Overall Study||21||
60108934|NCT02246062|76228761|FG002|STARTED|Overall Study||21||
60108935|NCT02246062|76228762|FG003|STARTED|Overall Study||21||
60108936|NCT02246062|76228759|FG000|COMPLETED|Overall Study||21||
60108937|NCT02246062|76228760|FG001|COMPLETED|Overall Study||21||
60108938|NCT02246062|76228761|FG002|COMPLETED|Overall Study||21||
60108939|NCT02246062|76228762|FG003|COMPLETED|Overall Study||21||
59822444|NCT00458484|75945110|FG003|STARTED|Overall Study||6||
60108940|NCT02246062|76228759|FG000|NOT COMPLETED|Overall Study||0||
60108941|NCT02246062|76228760|FG001|NOT COMPLETED|Overall Study||0||
60108942|NCT02246062|76228761|FG002|NOT COMPLETED|Overall Study||0||
60108943|NCT02246062|76228762|FG003|NOT COMPLETED|Overall Study||0||
60108944|NCT01678846|76228774|FG000|STARTED|Overall Study|Whole school implementation. Started and completed shows number of students in the end-line survey.|1921||
60108945|NCT01678846|76228775|FG001|STARTED|Overall Study||1899||
60108946|NCT01678846|76228774|FG000|COMPLETED|Overall Study||1921||
60108947|NCT01678846|76228775|FG001|COMPLETED|Overall Study||1899||
60108948|NCT01678846|76228774|FG000|NOT COMPLETED|Overall Study||0||
60108949|NCT01678846|76228775|FG001|NOT COMPLETED|Overall Study||0||
59822445|NCT00458484|75945111|FG004|STARTED|Overall Study||4||
59822446|NCT00458484|75945112|FG005|STARTED|Overall Study||5||
59822447|NCT00458484|75945113|FG006|STARTED|Overall Study||3||
60108950|NCT01679314|76228783|FG000|STARTED|Overall Study||26||
60108951|NCT01679314|76228784|FG001|STARTED|Overall Study||28||
60108952|NCT01679314|76228783|FG000|COMPLETED|Overall Study||24||
60108953|NCT01679314|76228784|FG001|COMPLETED|Overall Study||28||
60108954|NCT01679314|76228783|FG000|NOT COMPLETED|Overall Study||2||
60108955|NCT01679314|76228784|FG001|NOT COMPLETED|Overall Study||0||
60108956|NCT01680172|76228796|FG000|STARTED|Overall Study||3||
60108957|NCT01680172|76228797|FG001|STARTED|Overall Study||2||
59822448|NCT00458484|75945107|FG000|COMPLETED|Overall Study||4||
60108958|NCT01680172|76228796|FG000|COMPLETED|Overall Study||3||
59822449|NCT00458484|75945108|FG001|COMPLETED|Overall Study||6||
59822450|NCT00458484|75945109|FG002|COMPLETED|Overall Study||3||
59822451|NCT00458484|75945110|FG003|COMPLETED|Overall Study||6||
59822452|NCT00458484|75945111|FG004|COMPLETED|Overall Study||4||
59822453|NCT00458484|75945112|FG005|COMPLETED|Overall Study||4||
59822454|NCT00458484|75945113|FG006|COMPLETED|Overall Study||3||
59822455|NCT00458484|75945107|FG000|NOT COMPLETED|Overall Study||0||
59822456|NCT00458484|75945108|FG001|NOT COMPLETED|Overall Study||0||
59822457|NCT00458484|75945109|FG002|NOT COMPLETED|Overall Study||0||
59822458|NCT00458484|75945110|FG003|NOT COMPLETED|Overall Study||0||
59822459|NCT00458484|75945111|FG004|NOT COMPLETED|Overall Study||0||
59822460|NCT00458484|75945112|FG005|NOT COMPLETED|Overall Study||1||
59822461|NCT00458484|75945113|FG006|NOT COMPLETED|Overall Study||0||
59822462|NCT00328198|75945138|FG000|STARTED|Treatment|16 participants escalated the dose. 70 participants started at the 30 mg target dose.|86||
59822463|NCT00328198|75945138|FG000|COMPLETED|Treatment|Depending upon protocol version, completed treatment was either 12 or 18 weeks in duration.|48||
59822464|NCT00328198|75945138|FG000|NOT COMPLETED|Treatment||38||
59822465|NCT00328198|75945138|FG000|STARTED|Follow-up|Eight participants did not enter Follow-up|78||
59822466|NCT00328198|75945138|FG000|COMPLETED|Follow-up||43||
59822467|NCT00328198|75945138|FG000|NOT COMPLETED|Follow-up||35||
59822468|NCT00450450|75945144|FG000|STARTED|Overall Study||13||
59822469|NCT00450450|75945145|FG001|STARTED|Overall Study||14||
59822470|NCT00450450|75945144|FG000|COMPLETED|Overall Study||8||
59822471|NCT00450450|75945145|FG001|COMPLETED|Overall Study||11||
59822472|NCT00450450|75945144|FG000|NOT COMPLETED|Overall Study||5||
59822473|NCT00450450|75945145|FG001|NOT COMPLETED|Overall Study||3||
59822474|NCT00442572|75945153|FG000|STARTED|Overall Study||17||
59822475|NCT00442572|75945154|FG001|STARTED|Overall Study||4||
59822476|NCT00442572|75945153|FG000|COMPLETED|Overall Study||9||
59822477|NCT00442572|75945154|FG001|COMPLETED|Overall Study||1||
59822478|NCT00442572|75945153|FG000|NOT COMPLETED|Overall Study||8||
59822479|NCT00442572|75945154|FG001|NOT COMPLETED|Overall Study||3||
59822480|NCT00442416|75945163|FG000|STARTED|Overall Study||39||
59822481|NCT00442416|75945164|FG001|STARTED|Overall Study||41||
59822482|NCT00442416|75945163|FG000|COMPLETED|Overall Study||2||
59822483|NCT00442416|75945164|FG001|COMPLETED|Overall Study||2||
59822484|NCT00442416|75945163|FG000|NOT COMPLETED|Overall Study||37||
59822485|NCT00442416|75945164|FG001|NOT COMPLETED|Overall Study||39||
59822486|NCT00441792|75945172|FG000|STARTED|Overall Study||59||
59822487|NCT00441792|75945173|FG001|STARTED|Overall Study||63||
59822488|NCT00441792|75945172|FG000|COMPLETED|Overall Study||59||
59822489|NCT00441792|75945173|FG001|COMPLETED|Overall Study|2 patients lost to follow up in Etomidate arm due to transfer to outside hospital.|61||
59822490|NCT00441792|75945172|FG000|NOT COMPLETED|Overall Study||0||
59822491|NCT00441792|75945173|FG001|NOT COMPLETED|Overall Study||2||
59822492|NCT00312208|75945181|FG000|STARTED|Overall Study|1649 patients randomized, 1634 patients treated|1649||
59822493|NCT00312208|75945182|FG001|STARTED|Overall Study|1649 patients randomized 1635 patients treated|1649||
59822494|NCT00312208|75945181|FG000|COMPLETED|Overall Study||1477||
59822495|NCT00312208|75945182|FG001|COMPLETED|Overall Study||1526||
59822496|NCT00312208|75945181|FG000|NOT COMPLETED|Overall Study||172||
59822497|NCT00312208|75945182|FG001|NOT COMPLETED|Overall Study||123||
59822498|NCT00297778|75945190|FG000|STARTED|Overall Study||152||
59822499|NCT00297778|75945191|FG001|STARTED|Overall Study||144||
59822500|NCT00297778|75945190|FG000|COMPLETED|Overall Study||133||
59822501|NCT00297778|75945191|FG001|COMPLETED|Overall Study||124||
59822502|NCT00297778|75945190|FG000|NOT COMPLETED|Overall Study||19||
59822503|NCT00297778|75945191|FG001|NOT COMPLETED|Overall Study||20||
59822504|NCT03848832|75945200|FG000|STARTED|Overall Study||10||
59822505|NCT03848832|75945201|FG001|STARTED|Overall Study||9||
59822506|NCT03848832|75945202|FG002|STARTED|Overall Study||10||
59822507|NCT03848832|75945200|FG000|COMPLETED|Overall Study||7||
59822508|NCT03848832|75945201|FG001|COMPLETED|Overall Study||6||
59822509|NCT03848832|75945202|FG002|COMPLETED|Overall Study||4||
59822510|NCT03848832|75945200|FG000|NOT COMPLETED|Overall Study||3||
59822511|NCT03848832|75945201|FG001|NOT COMPLETED|Overall Study||3||
59822512|NCT03848832|75945202|FG002|NOT COMPLETED|Overall Study||6||
59822513|NCT00450372|75945212|FG000|STARTED|Overall Study||38||
59822514|NCT00450372|75945212|FG000|COMPLETED|Overall Study||37||
59822515|NCT00450372|75945212|FG000|NOT COMPLETED|Overall Study||1||
59822516|NCT00327340|75945221|FG000|STARTED|Overall Study||23||
59822517|NCT00327340|75945222|FG001|STARTED|Overall Study||46||
59822518|NCT00327340|75945221|FG000|COMPLETED|Overall Study||8||
59822519|NCT00327340|75945222|FG001|COMPLETED|Overall Study||16||
59822520|NCT00327340|75945221|FG000|NOT COMPLETED|Overall Study||15||
59822521|NCT00327340|75945222|FG001|NOT COMPLETED|Overall Study||30||
59822522|NCT00548093|75945232|FG000|STARTED|Overall Study||50||
59822523|NCT00548093|75945233|FG001|STARTED|Overall Study||16||
59822524|NCT00548093|75945232|FG000|COMPLETED|Overall Study||0||
59822525|NCT00548093|75945233|FG001|COMPLETED|Overall Study||0||
59822526|NCT00548093|75945232|FG000|NOT COMPLETED|Overall Study||50||
59822527|NCT00548093|75945233|FG001|NOT COMPLETED|Overall Study||16||
59822528|NCT00450216|75945244|FG000|STARTED|Overall Study||607||
59822529|NCT00450216|75945245|FG001|STARTED|Overall Study||299||
59822530|NCT00450216|75945244|FG000|COMPLETED|Overall Study||433||
59822531|NCT00450216|75945245|FG001|COMPLETED|Overall Study||170||
59822532|NCT00450216|75945244|FG000|NOT COMPLETED|Overall Study||174||
59822533|NCT00450216|75945245|FG001|NOT COMPLETED|Overall Study||129||
59822534|NCT00441480|75945253|FG000|STARTED|Overall Study||46||
59822535|NCT00441480|75945254|FG001|STARTED|Overall Study||45||
59822536|NCT00441480|75945253|FG000|COMPLETED|Overall Study||43||
59822537|NCT00441480|75945254|FG001|COMPLETED|Overall Study||41||
59822538|NCT00441480|75945253|FG000|NOT COMPLETED|Overall Study||3||
59822539|NCT00441480|75945254|FG001|NOT COMPLETED|Overall Study||4||
59822540|NCT00547703|75945262|FG000|STARTED|Overall Study||4||
59822541|NCT00547703|75945263|FG001|STARTED|Overall Study||1||
59822542|NCT00547703|75945262|FG000|COMPLETED|Overall Study||3||
59822543|NCT00547703|75945263|FG001|COMPLETED|Overall Study||1||
59822544|NCT00547703|75945262|FG000|NOT COMPLETED|Overall Study||1||
59822545|NCT00547703|75945263|FG001|NOT COMPLETED|Overall Study||0||
59822546|NCT00297232|75945269|FG000|STARTED|Overall Study||1094||
59822547|NCT00297232|75945269|FG000|COMPLETED|Overall Study||489||
59822548|NCT00297232|75945269|FG000|NOT COMPLETED|Overall Study||605||
59822549|NCT03867383|75945275|FG000|STARTED|Overall Study||20||
59822550|NCT03867383|75945276|FG001|STARTED|Overall Study||20||
59822551|NCT03867383|75945275|FG000|COMPLETED|Overall Study||20||
59822552|NCT03867383|75945276|FG001|COMPLETED|Overall Study||20||
59822553|NCT03867383|75945275|FG000|NOT COMPLETED|Overall Study||0||
59822554|NCT03867383|75945276|FG001|NOT COMPLETED|Overall Study||0||
59822555|NCT00449670|75945285|FG000|STARTED|Primary Phase (Study no.109630)||961||
59822556|NCT00449670|75945286|FG001|STARTED|Primary Phase (Study no.109630)||245||
59822557|NCT00449670|75945285|FG000|COMPLETED|Primary Phase (Study no.109630)||947||
59822558|NCT00449670|75945286|FG001|COMPLETED|Primary Phase (Study no.109630)||243||
59822559|NCT00449670|75945285|FG000|NOT COMPLETED|Primary Phase (Study no.109630)||14||
59822560|NCT00449670|75945286|FG001|NOT COMPLETED|Primary Phase (Study no.109630)||2||
59822561|NCT00449670|75945285|FG000|STARTED|Booster Phase (Study no.109873)||265||
59822562|NCT00449670|75945286|FG001|STARTED|Booster Phase (Study no.109873)||236||
59822563|NCT00449670|75945285|FG000|COMPLETED|Booster Phase (Study no.109873)||265||
59822564|NCT00449670|75945286|FG001|COMPLETED|Booster Phase (Study no.109873)||233||
59822565|NCT00449670|75945285|FG000|NOT COMPLETED|Booster Phase (Study no.109873)||0||
59822566|NCT00449670|75945286|FG001|NOT COMPLETED|Booster Phase (Study no.109873)||3||
59822567|NCT00296374|75945302|FG000|STARTED|Overall Study||118||
59822568|NCT00296374|75945303|FG001|STARTED|Overall Study||124||
59822569|NCT00296374|75945304|FG002|STARTED|Overall Study||111||
59822570|NCT00296374|75945302|FG000|COMPLETED|Overall Study||93||
59822571|NCT00296374|75945303|FG001|COMPLETED|Overall Study||101||
59822572|NCT00296374|75945304|FG002|COMPLETED|Overall Study||82||
59822573|NCT00296374|75945302|FG000|NOT COMPLETED|Overall Study||25||
59822574|NCT00296374|75945303|FG001|NOT COMPLETED|Overall Study||23||
59822575|NCT00296374|75945304|FG002|NOT COMPLETED|Overall Study||29||
59822576|NCT03839082|75945320|FG000|STARTED|Initial Randomization||33||
59822577|NCT03839082|75945321|FG001|STARTED|Initial Randomization||37||
59822578|NCT03839082|75945320|FG000|COMPLETED|Initial Randomization||7|completing visit 2|
59822579|NCT03839082|75945321|FG001|COMPLETED|Initial Randomization||12|completing visit 2|
59822580|NCT03839082|75945320|FG000|NOT COMPLETED|Initial Randomization||26||
59822581|NCT03839082|75945321|FG001|NOT COMPLETED|Initial Randomization||25||
59822582|NCT03839082|75945320|FG000|STARTED|Crossover to Other Arm||7||
59822583|NCT03839082|75945321|FG001|STARTED|Crossover to Other Arm||12||
59822584|NCT03839082|75945320|FG000|COMPLETED|Crossover to Other Arm||0||
59822585|NCT03839082|75945321|FG001|COMPLETED|Crossover to Other Arm||0||
59822586|NCT03839082|75945320|FG000|NOT COMPLETED|Crossover to Other Arm||7||
59822587|NCT03839082|75945321|FG001|NOT COMPLETED|Crossover to Other Arm||12||
59822588|NCT00326950|75945327|FG000|STARTED|Overall Study||15||
59822589|NCT00326950|75945327|FG000|COMPLETED|Overall Study||14||
59822590|NCT00326950|75945327|FG000|NOT COMPLETED|Overall Study||1||
59822591|NCT00548717|75945333|FG000|STARTED|Overall Study||13||
59822592|NCT00548717|75945334|FG001|STARTED|Overall Study||2||
59822593|NCT00548717|75945333|FG000|COMPLETED|Overall Study||4||
59822594|NCT00548717|75945334|FG001|COMPLETED|Overall Study||0||
59822595|NCT00548717|75945333|FG000|NOT COMPLETED|Overall Study||9||
60108959|NCT01680172|76228797|FG001|COMPLETED|Overall Study||2||
59822596|NCT00548717|75945334|FG001|NOT COMPLETED|Overall Study||2||
59822597|NCT00441168|75945345|FG000|STARTED|Treatment Period||17||
59822598|NCT00441168|75945346|FG001|STARTED|Treatment Period||13||
59822599|NCT00441168|75945345|FG000|TREATED|Treatment Period||16||
59822600|NCT00441168|75945346|FG001|TREATED|Treatment Period||13||
59822601|NCT00441168|75945345|FG000|COMPLETED|Treatment Period||6||
59822602|NCT00441168|75945346|FG001|COMPLETED|Treatment Period||7||
59822603|NCT00441168|75945345|FG000|NOT COMPLETED|Treatment Period||11||
59822604|NCT00441168|75945346|FG001|NOT COMPLETED|Treatment Period||6||
59822605|NCT00441168|75945345|FG000|STARTED|Follow-up Period|Subjects who did not complete the treatment period could be entered into the follow-up period|17||
60108960|NCT01680172|76228796|FG000|NOT COMPLETED|Overall Study||0||
60108961|NCT01680172|76228797|FG001|NOT COMPLETED|Overall Study||0||
60108962|NCT01680328|76228803|FG000|STARTED|Overall Study||82||
60108963|NCT01680328|76228803|FG000|Subjects Missing Injections|Overall Study|One missed the [1600 μL, 450 μL/s; thighs]; one missed the [400 μL, 300 μL/s; abdomen]|2||
59714401|NCT01204775|75833047|FG000|Double-blind Treatment Period|Overall Study||4||
59714402|NCT01204775|75833048|FG001|Double-blind Treatment Period|Overall Study||4||
59714403|NCT01204775|75833047|FG000|COMPLETED|Overall Study||3||
59714404|NCT01204775|75833048|FG001|COMPLETED|Overall Study||3||
59714405|NCT01204775|75833047|FG000|NOT COMPLETED|Overall Study||1||
59714406|NCT01204775|75833048|FG001|NOT COMPLETED|Overall Study||1||
59714407|NCT00997035|75833056|FG000|STARTED|3-week Followup Visit||121||
59822606|NCT00441168|75945346|FG001|STARTED|Follow-up Period|Subjects who did not complete the treatment period could be entered into the follow-up period|13||
59822607|NCT00441168|75945345|FG000|COMPLETED|Follow-up Period||5||
59822608|NCT00441168|75945346|FG001|COMPLETED|Follow-up Period||4||
59822609|NCT00441168|75945345|FG000|NOT COMPLETED|Follow-up Period||12||
59822610|NCT00441168|75945346|FG001|NOT COMPLETED|Follow-up Period||9||
59822611|NCT00296140|75945354|FG000|STARTED|Overall Study||33||
59822612|NCT00296140|75945355|FG001|STARTED|Overall Study||33||
59822613|NCT00296140|75945354|FG000|COMPLETED|Overall Study||30||
59822614|NCT00296140|75945355|FG001|COMPLETED|Overall Study||33||
59822615|NCT00296140|75945354|FG000|NOT COMPLETED|Overall Study||3||
59822616|NCT00296140|75945355|FG001|NOT COMPLETED|Overall Study||0||
59822617|NCT03958331|75945364|FG000|STARTED|Overall Study||21||
59822618|NCT03958331|75945365|FG001|STARTED|Overall Study||19||
59822619|NCT03958331|75945366|FG002|STARTED|Overall Study||64||
59822620|NCT03958331|75945364|FG000|COMPLETED|Overall Study||14||
59822621|NCT03958331|75945365|FG001|COMPLETED|Overall Study||17||
59822622|NCT03958331|75945366|FG002|COMPLETED|Overall Study||47||
59822623|NCT03958331|75945364|FG000|NOT COMPLETED|Overall Study||7||
59822624|NCT03958331|75945365|FG001|NOT COMPLETED|Overall Study||2||
59822625|NCT03958331|75945366|FG002|NOT COMPLETED|Overall Study||17||
60108964|NCT01680328|76228803|FG000|COMPLETED|Overall Study||80||
60108965|NCT01680328|76228803|FG000|NOT COMPLETED|Overall Study||2||
60108966|NCT02235064|76228840|FG000|STARTED|Overall Study||1||
60108967|NCT02235064|76228841|FG001|STARTED|Overall Study||1||
60108968|NCT02235064|76228840|FG000|COMPLETED|Overall Study||1||
60108969|NCT02235064|76228841|FG001|COMPLETED|Overall Study||1||
60108970|NCT02235064|76228840|FG000|NOT COMPLETED|Overall Study||0||
60108971|NCT02235064|76228841|FG001|NOT COMPLETED|Overall Study||0||
60108972|NCT01680640|76228851|FG000|STARTED|Overall Study||55||
60108973|NCT01680640|76228852|FG001|STARTED|Overall Study||49||
60108974|NCT01680640|76228851|FG000|COMPLETED|Overall Study||45||
60108975|NCT01680640|76228852|FG001|COMPLETED|Overall Study||44||
60108976|NCT01680640|76228851|FG000|NOT COMPLETED|Overall Study||10||
60108977|NCT01680640|76228852|FG001|NOT COMPLETED|Overall Study||5||
60108978|NCT02246608|76228860|FG000|STARTED|Overall Study||22||
60108979|NCT02246608|76228861|FG001|STARTED|Overall Study||21||
60108980|NCT02246608|76228860|FG000|COMPLETED|Overall Study||10||
60108981|NCT02246608|76228861|FG001|COMPLETED|Overall Study||11||
60108982|NCT02246608|76228860|FG000|NOT COMPLETED|Overall Study||12||
60108983|NCT02246608|76228861|FG001|NOT COMPLETED|Overall Study||10||
60108984|NCT02237092|76228867|FG000|STARTED|Overall Study||196||
60108985|NCT02237092|76228867|FG000|COMPLETED|Overall Study||196||
60108986|NCT02237092|76228867|FG000|NOT COMPLETED|Overall Study||0||
60108987|NCT01681030|76228885|FG000|STARTED|Overall Study||13||
60108988|NCT01681030|76228886|FG001|STARTED|Overall Study||18||
60108989|NCT01681030|76228887|FG002|STARTED|Overall Study||11||
60108990|NCT01681030|76228885|FG000|COMPLETED|Overall Study||13||
59714408|NCT00997035|75833057|FG001|STARTED|3-week Followup Visit||119||
59714409|NCT00997035|75833056|FG000|COMPLETED|3-week Followup Visit||112||
59822626|NCT03956615|75945372|FG000|STARTED|Overall Study||10||
59822627|NCT03956615|75945372|FG000|COMPLETED|Overall Study||3||
59822628|NCT03956615|75945372|FG000|NOT COMPLETED|Overall Study||7||
59822629|NCT03956225|75945378|FG000|STARTED|Overall Study||119||238
59822630|NCT03956225|75945379|FG001|STARTED|Overall Study||117||234
59822631|NCT03956225|75945378|FG000|COMPLETED|Overall Study||114||228
59822632|NCT03956225|75945379|FG001|COMPLETED|Overall Study||113||226
59822633|NCT03956225|75945378|FG000|NOT COMPLETED|Overall Study||5||10
60108991|NCT01681030|76228886|FG001|COMPLETED|Overall Study||18||
60108992|NCT01681030|76228887|FG002|COMPLETED|Overall Study||11||
60108993|NCT01681030|76228885|FG000|NOT COMPLETED|Overall Study||0||
60108994|NCT01681030|76228886|FG001|NOT COMPLETED|Overall Study||0||
60108995|NCT01681030|76228887|FG002|NOT COMPLETED|Overall Study||0||
60108996|NCT01681810|76228895|FG000|STARTED|Overall Study||20||
60108997|NCT01681810|76228895|FG000|COMPLETED|Overall Study||20||
60108998|NCT01681810|76228895|FG000|NOT COMPLETED|Overall Study||0||
60108999|NCT01683526|76228901|FG000|STARTED|Overall Study||60||
60109000|NCT01683526|76228902|FG001|STARTED|Overall Study||57||
60109001|NCT01683526|76228901|FG000|COMPLETED|Overall Study||60||
59714410|NCT00997035|75833057|FG001|COMPLETED|3-week Followup Visit||113||
59714411|NCT00997035|75833056|FG000|NOT COMPLETED|3-week Followup Visit||9||
59822634|NCT03956225|75945379|FG001|NOT COMPLETED|Overall Study||4||8
59822635|NCT00457626|75945388|FG000|STARTED|Overall Study||66||
59822636|NCT00457626|75945388|FG000|COMPLETED|Overall Study||60||
60109002|NCT01683526|76228902|FG001|COMPLETED|Overall Study||57||
60109003|NCT01683526|76228901|FG000|NOT COMPLETED|Overall Study||0||
60109004|NCT01683526|76228902|FG001|NOT COMPLETED|Overall Study||0||
60109005|NCT01685242|76228910|FG000|STARTED|Overall Study||50||
60109006|NCT01685242|76228911|FG001|STARTED|Overall Study||50||
60109007|NCT01685242|76228910|FG000|COMPLETED|Overall Study||49||
60109008|NCT01685242|76228911|FG001|COMPLETED|Overall Study||47||
60109009|NCT01685242|76228910|FG000|NOT COMPLETED|Overall Study||1||
60109010|NCT01685242|76228911|FG001|NOT COMPLETED|Overall Study||3||
60109011|NCT01685320|76228919|FG000|STARTED|Overall Study||15||
60109012|NCT01685320|76228920|FG001|STARTED|Overall Study||15||
60109013|NCT01685320|76228919|FG000|COMPLETED|Overall Study||15||
60109014|NCT01685320|76228920|FG001|COMPLETED|Overall Study||15||
60109015|NCT01685320|76228919|FG000|NOT COMPLETED|Overall Study||0||
60109016|NCT01685320|76228920|FG001|NOT COMPLETED|Overall Study||0||
60109017|NCT00708162|76228928|FG000|STARTED|Randomized Phase||361||
60109018|NCT00708162|76228929|FG001|STARTED|Randomized Phase||363||
60109019|NCT00708162|76228928|FG000|Randomized and Treated|Randomized Phase||354||
60109020|NCT00708162|76228929|FG001|Randomized and Treated|Randomized Phase||358||
60109021|NCT00708162|76228928|FG000|COMPLETED|Randomized Phase||205||
60109022|NCT00708162|76228929|FG001|COMPLETED|Randomized Phase||209||
60109023|NCT00708162|76228928|FG000|NOT COMPLETED|Randomized Phase||156||
60109024|NCT00708162|76228929|FG001|NOT COMPLETED|Randomized Phase||154||
60109025|NCT00708162|76228928|FG000|STARTED|Open-Label Phase|9 participants completing the Randomized Phase did not continue to the Open-Label Phase.|196||
60109026|NCT00708162|76228929|FG001|STARTED|Open-Label Phase|58 participants completing the Randomized Phase did not continue to the Open-Label Phase.|151||
60109027|NCT00708162|76228928|FG000|COMPLETED|Open-Label Phase||152||
60109028|NCT00708162|76228929|FG001|COMPLETED|Open-Label Phase||121||
60109029|NCT00708162|76228928|FG000|NOT COMPLETED|Open-Label Phase||44||
60109030|NCT00708162|76228929|FG001|NOT COMPLETED|Open-Label Phase||30||
60109031|NCT01686646|76228940|FG000|STARTED|Overall Study||45||
60109032|NCT01686646|76228941|FG001|STARTED|Overall Study||45||
60109033|NCT01686646|76228942|FG002|STARTED|Overall Study||75||
60109034|NCT01686646|76228943|FG003|STARTED|Overall Study||75||
60109035|NCT01686646|76228940|FG000|Intent to Treat Population|Overall Study||45||
60109036|NCT01686646|76228941|FG001|Intent to Treat Population|Overall Study||45||
60109037|NCT01686646|76228942|FG002|Intent to Treat Population|Overall Study||75||
60109038|NCT01686646|76228943|FG003|Intent to Treat Population|Overall Study||75||
60109039|NCT01686646|76228940|FG000|Safety Population|Overall Study|One subject randomized to Paracetamol+Caffeine (500/65) group but received 1000/130 combination.|46||
60109040|NCT01686646|76228941|FG001|Safety Population|Overall Study||45||
60109041|NCT01686646|76228942|FG002|Safety Population|Overall Study||74||
60109042|NCT01686646|76228943|FG003|Safety Population|Overall Study||75||
60109043|NCT01686646|76228940|FG000|COMPLETED|Overall Study||45||
60109044|NCT01686646|76228941|FG001|COMPLETED|Overall Study||45||
60109045|NCT01686646|76228942|FG002|COMPLETED|Overall Study||75||
60109046|NCT01686646|76228943|FG003|COMPLETED|Overall Study||75||
60109047|NCT01686646|76228940|FG000|NOT COMPLETED|Overall Study||0||
60109048|NCT01686646|76228941|FG001|NOT COMPLETED|Overall Study||0||
60109049|NCT01686646|76228942|FG002|NOT COMPLETED|Overall Study||0||
60109050|NCT01686646|76228943|FG003|NOT COMPLETED|Overall Study||0||
60109051|NCT01687036|76228953|FG000|STARTED|Overall Study||10||
60109052|NCT01687036|76228953|FG000|COMPLETED|Overall Study||10||
60109053|NCT01687036|76228953|FG000|NOT COMPLETED|Overall Study||0||
60109054|NCT02325856|76228959|FG000|STARTED|Overall Study||148||
60109055|NCT02325856|76228960|FG001|STARTED|Overall Study||150||
60109056|NCT02325856|76228959|FG000|COMPLETED|Overall Study||128||
60109057|NCT02325856|76228960|FG001|COMPLETED|Overall Study||123||
60109058|NCT02325856|76228959|FG000|NOT COMPLETED|Overall Study||20||
60109059|NCT02325856|76228960|FG001|NOT COMPLETED|Overall Study||27||
60109060|NCT01687114|76228966|FG000|STARTED|Overall Study||5||
60109061|NCT01687114|76228966|FG000|COMPLETED|Overall Study||5||
60109062|NCT01687114|76228966|FG000|NOT COMPLETED|Overall Study||0||
60109063|NCT01687972|76228972|FG000|STARTED|Overall Study||44||
60109064|NCT01687972|76228973|FG001|STARTED|Overall Study||44||
60109065|NCT01687972|76228972|FG000|COMPLETED|Overall Study||44||
60109066|NCT01687972|76228973|FG001|COMPLETED|Overall Study||44||
60109067|NCT01687972|76228972|FG000|NOT COMPLETED|Overall Study||0||
60109068|NCT01687972|76228973|FG001|NOT COMPLETED|Overall Study||0||
60109069|NCT01688596|76228981|FG000|STARTED|Overall Study||67||
60109070|NCT01688596|76228982|FG001|STARTED|Overall Study||68||
60109071|NCT01688596|76228981|FG000|COMPLETED|Overall Study||59||
60109072|NCT01688596|76228982|FG001|COMPLETED|Overall Study||59||
60109073|NCT01688596|76228981|FG000|NOT COMPLETED|Overall Study||8||
60109074|NCT01688596|76228982|FG001|NOT COMPLETED|Overall Study||9||
60109075|NCT01690000|76228990|FG000|STARTED|Overall Study||40||
60109076|NCT01690000|76228991|FG001|STARTED|Overall Study||41||
60109077|NCT01690000|76228990|FG000|COMPLETED|Overall Study||37||
60109078|NCT01690000|76228991|FG001|COMPLETED|Overall Study||35||
60109079|NCT01690000|76228990|FG000|NOT COMPLETED|Overall Study||3||
60109080|NCT01690000|76228991|FG001|NOT COMPLETED|Overall Study||6||
60109081|NCT01690546|76228997|FG000|STARTED|Overall Study||35||
60109082|NCT01690546|76228997|FG000|Extended Release Injectable NTX|Overall Study||27||
60109083|NCT01690546|76228997|FG000|COMPLETED|Overall Study||26||
60109084|NCT01690546|76228997|FG000|NOT COMPLETED|Overall Study||9||
60109085|NCT02239744|76229003|FG000|STARTED|Period 1||17||
60109086|NCT02239744|76229004|FG001|STARTED|Period 1||18||
60109087|NCT02239744|76229003|FG000|COMPLETED|Period 1||17||
60109088|NCT02239744|76229004|FG001|COMPLETED|Period 1||18||
60109089|NCT02239744|76229003|FG000|NOT COMPLETED|Period 1||0||
60109090|NCT02239744|76229004|FG001|NOT COMPLETED|Period 1||0||
60109091|NCT02239744|76229003|FG000|STARTED|Period 2||17||
60109092|NCT02239744|76229004|FG001|STARTED|Period 2||18||
60109093|NCT02239744|76229003|FG000|COMPLETED|Period 2||17||
60109094|NCT02239744|76229004|FG001|COMPLETED|Period 2||18||
60109095|NCT02239744|76229003|FG000|NOT COMPLETED|Period 2||0||
60109096|NCT02239744|76229004|FG001|NOT COMPLETED|Period 2||0||
60109097|NCT02245672|76229014|FG000|STARTED|Overall Study||512||
60109098|NCT02245672|76229015|FG001|STARTED|Overall Study||513||
60109099|NCT02245672|76229016|FG002|STARTED|Overall Study||103||
60109100|NCT02245672|76229014|FG000|COMPLETED|Overall Study||499||
60109101|NCT02245672|76229015|FG001|COMPLETED|Overall Study||500||
60109102|NCT02245672|76229016|FG002|COMPLETED|Overall Study||98||
60109103|NCT02245672|76229014|FG000|NOT COMPLETED|Overall Study||13||
60109104|NCT02245672|76229015|FG001|NOT COMPLETED|Overall Study||13||
60109105|NCT02245672|76229016|FG002|NOT COMPLETED|Overall Study||5||
60109106|NCT01711294|76229027|FG000|STARTED|Overall Study||121||
60109107|NCT01711294|76229028|FG001|STARTED|Overall Study||65||
60109108|NCT01711294|76229029|FG002|STARTED|Overall Study||64||
60109109|NCT01711294|76229027|FG000|COMPLETED|Overall Study||121||
60109110|NCT01711294|76229028|FG001|COMPLETED|Overall Study||65||
60109111|NCT01711294|76229029|FG002|COMPLETED|Overall Study||64||
60109112|NCT01711294|76229027|FG000|NOT COMPLETED|Overall Study||0||
60109113|NCT01711294|76229028|FG001|NOT COMPLETED|Overall Study||0||
60109114|NCT01711294|76229029|FG002|NOT COMPLETED|Overall Study||0||
60109115|NCT01711372|76229039|FG000|STARTED|Overall Study||66||
60109116|NCT01711372|76229040|FG001|STARTED|Overall Study||47||
60109117|NCT01711372|76229039|FG000|COMPLETED|Overall Study||66||
60109118|NCT01711372|76229040|FG001|COMPLETED|Overall Study||47||
60109119|NCT01711372|76229039|FG000|NOT COMPLETED|Overall Study||0||
60109120|NCT01711372|76229040|FG001|NOT COMPLETED|Overall Study||0||
60109121|NCT01711918|76229045|FG000|STARTED|Overall Study||9||
60109122|NCT01711918|76229045|FG000|COMPLETED|Overall Study||7||
60109123|NCT01711918|76229045|FG000|NOT COMPLETED|Overall Study||2||
60109124|NCT01712230|76229052|FG000|STARTED|Overall Study||11||
60109125|NCT01712230|76229053|FG001|STARTED|Overall Study||18||
60109126|NCT01712230|76229054|FG002|STARTED|Overall Study||18||
60109127|NCT01712230|76229052|FG000|COMPLETED|Overall Study||9||
60109128|NCT01712230|76229053|FG001|COMPLETED|Overall Study||14||
60109129|NCT01712230|76229054|FG002|COMPLETED|Overall Study||11||
60109130|NCT01712230|76229052|FG000|NOT COMPLETED|Overall Study||2||
60109131|NCT01712230|76229053|FG001|NOT COMPLETED|Overall Study||4||
60109132|NCT01712230|76229054|FG002|NOT COMPLETED|Overall Study||7||
60109133|NCT01712776|76229064|FG000|STARTED|Overall Study||50||
60109134|NCT01712776|76229065|FG001|STARTED|Overall Study||50||
60109135|NCT01712776|76229064|FG000|COMPLETED|Overall Study|trial to enroll 50 in each group for total of 100|50||
60109136|NCT01712776|76229065|FG001|COMPLETED|Overall Study||50||
60109137|NCT01712776|76229064|FG000|NOT COMPLETED|Overall Study||0||
60109138|NCT01712776|76229065|FG001|NOT COMPLETED|Overall Study||0||
60109139|NCT01713400|76229073|FG000|STARTED|Overall Study||15||
60109140|NCT01713400|76229074|FG001|STARTED|Overall Study||15||
60109141|NCT01713400|76229073|FG000|COMPLETED|Overall Study||15||
60109142|NCT01713400|76229074|FG001|COMPLETED|Overall Study||15||
60109143|NCT01713400|76229073|FG000|NOT COMPLETED|Overall Study||0||
60109144|NCT01713400|76229074|FG001|NOT COMPLETED|Overall Study||0||
60109145|NCT02248246|76229080|FG000|STARTED|Overall Study||40||
60109146|NCT02248246|76229080|FG000|COMPLETED|Overall Study||40||
60109147|NCT02248246|76229080|FG000|NOT COMPLETED|Overall Study||0||
60109148|NCT01713868|76229088|FG000|STARTED|Overall Study||400||
60109149|NCT01713868|76229089|FG001|STARTED|Overall Study||400||
60109150|NCT01713868|76229090|FG002|STARTED|Overall Study||400||
60109151|NCT01713868|76229091|FG003|STARTED|Overall Study||400||
60109152|NCT01713868|76229088|FG000|COMPLETED|Overall Study||303||
60109153|NCT01713868|76229089|FG001|COMPLETED|Overall Study||335||
60109154|NCT01713868|76229090|FG002|COMPLETED|Overall Study||320||
60109155|NCT01713868|76229091|FG003|COMPLETED|Overall Study||305||
60109156|NCT01713868|76229088|FG000|NOT COMPLETED|Overall Study||97||
60109157|NCT01713868|76229089|FG001|NOT COMPLETED|Overall Study||65||
60109158|NCT01713868|76229090|FG002|NOT COMPLETED|Overall Study||80||
60109159|NCT01713868|76229091|FG003|NOT COMPLETED|Overall Study||95||
60109160|NCT01714024|76229106|FG000|STARTED|Overall Study||13||
60109161|NCT01714024|76229107|FG001|STARTED|Overall Study||18||
60109162|NCT01714024|76229108|FG002|STARTED|Overall Study||11||
60109163|NCT01714024|76229106|FG000|COMPLETED|Overall Study||12||
60109164|NCT01714024|76229107|FG001|COMPLETED|Overall Study||12||
60109165|NCT01714024|76229108|FG002|COMPLETED|Overall Study||8||
60109166|NCT01714024|76229106|FG000|NOT COMPLETED|Overall Study||1||
60109167|NCT01714024|76229107|FG001|NOT COMPLETED|Overall Study||6||
60109168|NCT01714024|76229108|FG002|NOT COMPLETED|Overall Study||3||
60109169|NCT01714336|76229127|FG000|STARTED|Overall Study||69||
60109170|NCT01714336|76229128|FG001|STARTED|Overall Study||69||
60109171|NCT01714336|76229127|FG000|COMPLETED|Overall Study||69||
60109172|NCT01714336|76229128|FG001|COMPLETED|Overall Study||69||
60109173|NCT01714336|76229127|FG000|NOT COMPLETED|Overall Study||0||
60109174|NCT01714336|76229128|FG001|NOT COMPLETED|Overall Study||0||
60109175|NCT01714492|76229134|FG000|STARTED|Overall Study||8||
60109176|NCT01714492|76229134|FG000|COMPLETED|Overall Study||8||
60109177|NCT01714492|76229134|FG000|NOT COMPLETED|Overall Study||0||
60109178|NCT01714804|76229141|FG000|STARTED|Overall Study||30||
60109179|NCT01714804|76229142|FG001|STARTED|Overall Study||30||
60109180|NCT01714804|76229141|FG000|COMPLETED|Overall Study||29||
60109181|NCT01714804|76229142|FG001|COMPLETED|Overall Study||30||
60109182|NCT01714804|76229141|FG000|NOT COMPLETED|Overall Study||1||
60109183|NCT01714804|76229142|FG001|NOT COMPLETED|Overall Study||0||
60109184|NCT01716208|76229150|FG000|STARTED|Overall Study||12||
60109185|NCT01716208|76229150|FG000|COMPLETED|Overall Study||12||
60109186|NCT01716208|76229150|FG000|NOT COMPLETED|Overall Study||0||
60109187|NCT00706992|76229161|FG000|STARTED|Overall Study||8||
60109188|NCT00706992|76229162|FG001|STARTED|Overall Study||8||
60109189|NCT00706992|76229163|FG002|STARTED|Overall Study||9||
60109190|NCT00706992|76229164|FG003|STARTED|Overall Study||8||
60109191|NCT00706992|76229165|FG004|STARTED|Overall Study||6||
60109192|NCT00706992|76229166|FG005|STARTED|Overall Study||5||
60109193|NCT00706992|76229167|FG006|STARTED|Overall Study||6||
60109194|NCT00706992|76229161|FG000|COMPLETED|Overall Study||3||
60109195|NCT00706992|76229162|FG001|COMPLETED|Overall Study||3||
59714412|NCT00997035|75833057|FG001|NOT COMPLETED|3-week Followup Visit||6||
59714413|NCT00997035|75833056|FG000|STARTED|3-month Follow-up Visit||112||
59714414|NCT00997035|75833057|FG001|STARTED|3-month Follow-up Visit||113||
59714415|NCT00997035|75833056|FG000|COMPLETED|3-month Follow-up Visit||100||
59714416|NCT00997035|75833057|FG001|COMPLETED|3-month Follow-up Visit||107||
59714417|NCT00997035|75833056|FG000|NOT COMPLETED|3-month Follow-up Visit||12||
59714418|NCT00997035|75833057|FG001|NOT COMPLETED|3-month Follow-up Visit||6||
59714419|NCT01204697|75833075|FG000|STARTED|Overall Study||36||
59714420|NCT01204697|75833076|FG001|STARTED|Overall Study||38||
59714421|NCT01204697|75833075|FG000|Treated|Overall Study||36||
59714422|NCT01204697|75833076|FG001|Treated|Overall Study||37||
59714423|NCT01204697|75833075|FG000|COMPLETED|Overall Study||5||
59714424|NCT01204697|75833076|FG001|COMPLETED|Overall Study||2||
59714425|NCT01204697|75833075|FG000|NOT COMPLETED|Overall Study||31||
59714426|NCT01204697|75833076|FG001|NOT COMPLETED|Overall Study||36||
59714427|NCT01001325|75833084|FG000|STARTED|Overall Study||234||
59714428|NCT01001325|75833085|FG001|STARTED|Overall Study||234||
59714429|NCT01001325|75833084|FG000|COMPLETED|Overall Study||216||
59714430|NCT01001325|75833085|FG001|COMPLETED|Overall Study||224||
59714431|NCT01001325|75833084|FG000|NOT COMPLETED|Overall Study||18||
59714432|NCT01001325|75833085|FG001|NOT COMPLETED|Overall Study||10||
59714433|NCT01203917|75833091|FG000|STARTED|Overall Study|106 patients were EGFR M+ patients and 1 patient was EGFR M+I|107||
59714434|NCT01203917|75833091|FG000|COMPLETED|Overall Study|Patients on-going study at data cut-off(of which 49 were still on study treatment).|71||
59714435|NCT01203917|75833091|FG000|NOT COMPLETED|Overall Study||36||
59714436|NCT01202903|75833097|FG000|STARTED|Overall Study||308||
59714437|NCT01202903|75833098|FG001|STARTED|Overall Study||308||
59714438|NCT01202903|75833097|FG000|Full Analysis Set|Overall Study||306||
59714439|NCT01202903|75833098|FG001|Full Analysis Set|Overall Study||302||
59714440|NCT01202903|75833097|FG000|Safety Set*|Overall Study||310||
59714441|NCT01202903|75833098|FG001|Safety Set*|Overall Study||299||
59714442|NCT01202903|75833097|FG000|COMPLETED|Overall Study||297||
59714443|NCT01202903|75833098|FG001|COMPLETED|Overall Study||292||
59714444|NCT01202903|75833097|FG000|NOT COMPLETED|Overall Study||11||
59714445|NCT01202903|75833098|FG001|NOT COMPLETED|Overall Study||16||
59714446|NCT01001169|75833106|FG000|STARTED|Overall Study||30||
59714447|NCT01001169|75833107|FG001|STARTED|Overall Study||30||
59714448|NCT01001169|75833106|FG000|COMPLETED|Overall Study||28||
59714449|NCT01001169|75833107|FG001|COMPLETED|Overall Study||29||
59714450|NCT01001169|75833106|FG000|NOT COMPLETED|Overall Study||2||
59714451|NCT01001169|75833107|FG001|NOT COMPLETED|Overall Study||1||
59714452|NCT01202747|75833121|FG000|STARTED|Overall Study||50||
59714453|NCT01202747|75833121|FG000|COMPLETED|Overall Study|One subject did not return for the 4 Week visit due to inconvenience.|49||
59714454|NCT01202747|75833121|FG000|NOT COMPLETED|Overall Study||1||
59714455|NCT00996801|75833131|FG000|STARTED|Overall Study||88||
59714456|NCT00996801|75833132|FG001|STARTED|Overall Study||88||
59714457|NCT00996801|75833133|FG002|STARTED|Overall Study||88||
59714458|NCT00996801|75833134|FG003|STARTED|Overall Study||87||
59714459|NCT00996801|75833135|FG004|STARTED|Overall Study|15-mg arm was discontinued as a result of Protocol Amendment 1.|88||
60109196|NCT00706992|76229163|FG002|COMPLETED|Overall Study||3||
60109197|NCT00706992|76229164|FG003|COMPLETED|Overall Study||6||
60109198|NCT00706992|76229165|FG004|COMPLETED|Overall Study||2||
60109199|NCT00706992|76229166|FG005|COMPLETED|Overall Study||3||
60109200|NCT00706992|76229167|FG006|COMPLETED|Overall Study||3||
60109201|NCT00706992|76229161|FG000|NOT COMPLETED|Overall Study||5||
60109202|NCT00706992|76229162|FG001|NOT COMPLETED|Overall Study||5||
60109203|NCT00706992|76229163|FG002|NOT COMPLETED|Overall Study||6||
60109204|NCT00706992|76229164|FG003|NOT COMPLETED|Overall Study||2||
59822637|NCT00457626|75945388|FG000|NOT COMPLETED|Overall Study||6||
59822638|NCT00373113|75945394|FG000|STARTED|Overall Study||238||
59822639|NCT00373113|75945395|FG001|STARTED|Overall Study||244||
59822640|NCT00373113|75945394|FG000|Received Treatment|Overall Study||238||
59822641|NCT00373113|75945395|FG001|Received Treatment|Overall Study||240||
59822642|NCT00373113|75945394|FG000|COMPLETED|Overall Study||0||
59822643|NCT00373113|75945395|FG001|COMPLETED|Overall Study||0||
59822644|NCT00373113|75945394|FG000|NOT COMPLETED|Overall Study||238||
59822645|NCT00373113|75945395|FG001|NOT COMPLETED|Overall Study||244||
59822646|NCT00407511|75945401|FG000|STARTED|Overall Study||121||
59822647|NCT00407511|75945401|FG000|COMPLETED|Overall Study||99||
59822648|NCT00407511|75945401|FG000|NOT COMPLETED|Overall Study||22||
59822649|NCT00384189|75945409|FG000|STARTED|Overall Study||305||
59822650|NCT00384189|75945410|FG001|STARTED|Overall Study||312||
59822651|NCT00384189|75945411|FG002|STARTED|Overall Study||313||
59822652|NCT00384189|75945412|FG003|STARTED|Overall Study||150||
59822653|NCT00384189|75945409|FG000|Randomized, Not Treated|Overall Study||1||
59822654|NCT00384189|75945410|FG001|Randomized, Not Treated|Overall Study||0||
59822655|NCT00384189|75945411|FG002|Randomized, Not Treated|Overall Study||2||
59822656|NCT00384189|75945412|FG003|Randomized, Not Treated|Overall Study||4||
59822657|NCT00384189|75945409|FG000|Actual Treatment Received|Overall Study|1 participant randomized to 160 μg who actually received 40 μg is included.|305||
59822658|NCT00384189|75945410|FG001|Actual Treatment Received|Overall Study||312||
59822659|NCT00384189|75945411|FG002|Actual Treatment Received|Overall Study|1 participants in the 160 μg arm actually received 40 μg and is moved to that arm.|310||
59822660|NCT00384189|75945412|FG003|Actual Treatment Received|Overall Study||146||
59822661|NCT00384189|75945409|FG000|COMPLETED|Overall Study||255||
59822662|NCT00384189|75945410|FG001|COMPLETED|Overall Study||255||
59822663|NCT00384189|75945411|FG002|COMPLETED|Overall Study||255||
59822664|NCT00384189|75945412|FG003|COMPLETED|Overall Study||110||
59822665|NCT00384189|75945409|FG000|NOT COMPLETED|Overall Study||50||
59822666|NCT00384189|75945410|FG001|NOT COMPLETED|Overall Study||57||
59822667|NCT00384189|75945411|FG002|NOT COMPLETED|Overall Study||58||
59822668|NCT00384189|75945412|FG003|NOT COMPLETED|Overall Study||40||
59822669|NCT00326716|75945424|FG000|STARTED|Pre-Natal Mothers||20||
59822670|NCT00326716|75945425|FG001|STARTED|Pre-Natal Mothers||21||
59822671|NCT00326716|75945426|FG002|STARTED|Pre-Natal Mothers||0||
59822672|NCT00326716|75945427|FG003|STARTED|Pre-Natal Mothers||0||
59822673|NCT00326716|75945424|FG000|COMPLETED|Pre-Natal Mothers|Completion was defined as completing the study.|19||
59822674|NCT00326716|75945425|FG001|COMPLETED|Pre-Natal Mothers|Completion was defined as completing the study.|19||
59822675|NCT00326716|75945426|FG002|COMPLETED|Pre-Natal Mothers|Completion was defined as completing all follow up visits through 6 months.|0||
59822676|NCT00326716|75945427|FG003|COMPLETED|Pre-Natal Mothers|Completion was defined as completing all follow up visits through 6 months.|0||
59822677|NCT00326716|75945424|FG000|NOT COMPLETED|Pre-Natal Mothers||1||
59822678|NCT00326716|75945425|FG001|NOT COMPLETED|Pre-Natal Mothers||2||
59822679|NCT00326716|75945426|FG002|NOT COMPLETED|Pre-Natal Mothers||0||
59822680|NCT00326716|75945427|FG003|NOT COMPLETED|Pre-Natal Mothers||0||
59822681|NCT00326716|75945424|FG000|STARTED|Infants||0||
59822682|NCT00326716|75945425|FG001|STARTED|Infants||0||
59822683|NCT00326716|75945426|FG002|STARTED|Infants|All infants were followed.|20||
59822684|NCT00326716|75945427|FG003|STARTED|Infants|All infants were followed. One mother withdrew consent pre-delivery and her infant was not followed.|20||
59822685|NCT00326716|75945424|FG000|COMPLETED|Infants||0||
59822686|NCT00326716|75945425|FG001|COMPLETED|Infants||0||
59822687|NCT00326716|75945426|FG002|COMPLETED|Infants||20||
59822688|NCT00326716|75945427|FG003|COMPLETED|Infants||20||
59822689|NCT00326716|75945424|FG000|NOT COMPLETED|Infants||0||
59822690|NCT00326716|75945425|FG001|NOT COMPLETED|Infants||0||
59822691|NCT00326716|75945426|FG002|NOT COMPLETED|Infants||0||
59822692|NCT00326716|75945427|FG003|NOT COMPLETED|Infants||0||
59822693|NCT00548405|75945460|FG000|STARTED|Overall Study|Randomized.|231||
59822694|NCT00548405|75945461|FG001|STARTED|Overall Study|Randomized.|436||
59822695|NCT00548405|75945462|FG002|STARTED|Overall Study|Randomized.|173||
59822696|NCT00548405|75945460|FG000|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug as per initial randomization.|202||
59822697|NCT00548405|75945461|FG001|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug as per initial randomization.|426||
59822698|NCT00548405|75945462|FG002|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug as per initial randomization.|170||
59822699|NCT00548405|75945460|FG000|COMPLETED|Overall Study||175||
59822700|NCT00548405|75945461|FG001|COMPLETED|Overall Study||416||
59822701|NCT00548405|75945462|FG002|COMPLETED|Overall Study||164||
59822702|NCT00548405|75945460|FG000|NOT COMPLETED|Overall Study||56||
59822703|NCT00548405|75945461|FG001|NOT COMPLETED|Overall Study||20||
60109205|NCT00706992|76229165|FG004|NOT COMPLETED|Overall Study||4||
60109206|NCT00706992|76229166|FG005|NOT COMPLETED|Overall Study||2||
60109207|NCT00706992|76229167|FG006|NOT COMPLETED|Overall Study||3||
60109208|NCT02249728|76229184|FG000|STARTED|Part One (4 Days)||6||
60109209|NCT02249728|76229184|FG000|COMPLETED|Part One (4 Days)||6||
60109210|NCT02249728|76229184|FG000|NOT COMPLETED|Part One (4 Days)||0||
60109211|NCT02249728|76229184|FG000|STARTED|Part Two (up to 6 Days)||6||
59822704|NCT00548405|75945462|FG002|NOT COMPLETED|Overall Study||9||
59822705|NCT00295750|75945474|FG000|STARTED|Overall Study|randomized|206||
59822706|NCT00295750|75945475|FG001|STARTED|Overall Study|randomized|210||
59822707|NCT00295750|75945476|FG002|STARTED|Overall Study|randomized|204||
59822708|NCT00295750|75945474|FG000|Intent-to-treat (ITT) Population|Overall Study|randomized and exposed patients|202||
59822709|NCT00295750|75945475|FG001|Intent-to-treat (ITT) Population|Overall Study|randomized and exposed patients|207||
59822710|NCT00295750|75945476|FG002|Intent-to-treat (ITT) Population|Overall Study|randomized and exposed patients|201||
59822711|NCT00295750|75945474|FG000|COMPLETED|Overall Study||163||
59822712|NCT00295750|75945475|FG001|COMPLETED|Overall Study||169||
59822713|NCT00295750|75945476|FG002|COMPLETED|Overall Study||172||
59822714|NCT00295750|75945474|FG000|NOT COMPLETED|Overall Study||43||
59822715|NCT00295750|75945475|FG001|NOT COMPLETED|Overall Study||41||
59822716|NCT00295750|75945476|FG002|NOT COMPLETED|Overall Study||32||
59822717|NCT03948581|75945486|FG000|STARTED|Overall Study||51||
59822718|NCT03948581|75945487|FG001|STARTED|Overall Study||51||
59822719|NCT03948581|75945486|FG000|COMPLETED|Overall Study||51||
59822720|NCT03948581|75945487|FG001|COMPLETED|Overall Study||50||
59822721|NCT03948581|75945486|FG000|NOT COMPLETED|Overall Study||0||
59822722|NCT03948581|75945487|FG001|NOT COMPLETED|Overall Study||1||
59822723|NCT00548327|75945495|FG000|STARTED|Overall Study||6||
59822724|NCT00548327|75945496|FG001|STARTED|Overall Study||5||
59822725|NCT00548327|75945495|FG000|COMPLETED|Overall Study||6||
59822726|NCT00548327|75945496|FG001|COMPLETED|Overall Study|Patient randomized to receive placebo first. While on placebo, Adverse Event lead to discontinuation|4||
59822727|NCT00548327|75945495|FG000|NOT COMPLETED|Overall Study||0||
59822728|NCT00548327|75945496|FG001|NOT COMPLETED|Overall Study||1||
59822729|NCT04720547|75945509|FG000|STARTED|Overall Study||6||
59822730|NCT04720547|75945510|FG001|STARTED|Overall Study||8||
59822731|NCT04720547|75945509|FG000|COMPLETED|Overall Study||6||
59822732|NCT04720547|75945510|FG001|COMPLETED|Overall Study||5||
59822733|NCT04720547|75945509|FG000|NOT COMPLETED|Overall Study||0||
59822734|NCT04720547|75945510|FG001|NOT COMPLETED|Overall Study||3||
59822735|NCT03953183|75945518|FG000|STARTED|Overall Study||30||
59822736|NCT03953183|75945519|FG001|STARTED|Overall Study||30||
59822737|NCT03953183|75945518|FG000|COMPLETED|Overall Study||30||
59822738|NCT03953183|75945519|FG001|COMPLETED|Overall Study||28||
59822739|NCT03953183|75945518|FG000|NOT COMPLETED|Overall Study||0||
59822740|NCT03953183|75945519|FG001|NOT COMPLETED|Overall Study||2||
59822741|NCT00406653|75945529|FG000|STARTED|Induction Period||65||
59822742|NCT00406653|75945530|FG001|STARTED|Induction Period||128||
59822743|NCT00406653|75945531|FG002|STARTED|Induction Period||130||
59822744|NCT00406653|75945532|FG003|STARTED|Induction Period||128||
59822745|NCT00406653|75945533|FG004|STARTED|Induction Period||0||
59822746|NCT00406653|75945534|FG005|STARTED|Induction Period||0||
59822747|NCT00406653|75945535|FG006|STARTED|Induction Period||0||
59822748|NCT00406653|75945529|FG000|COMPLETED|Induction Period||50||
60109212|NCT02249728|76229184|FG000|COMPLETED|Part Two (up to 6 Days)||6||
60109213|NCT02249728|76229184|FG000|NOT COMPLETED|Part Two (up to 6 Days)||0||
60109214|NCT02248558|76229193|FG000|STARTED|Overall Study||369||
60109215|NCT02248558|76229194|FG001|STARTED|Overall Study||352||
60109216|NCT02248558|76229193|FG000|COMPLETED|Overall Study||317||
60109217|NCT02248558|76229194|FG001|COMPLETED|Overall Study||307||
60109218|NCT02248558|76229193|FG000|NOT COMPLETED|Overall Study||52||
60109219|NCT02248558|76229194|FG001|NOT COMPLETED|Overall Study||45||
60109220|NCT02248636|76229204|FG000|STARTED|Overall Study||26||
60109221|NCT02248636|76229205|FG001|STARTED|Overall Study||35||
60109222|NCT02248636|76229204|FG000|COMPLETED|Overall Study||20||
60109223|NCT02248636|76229205|FG001|COMPLETED|Overall Study||32||
59714460|NCT00996801|75833136|FG005|STARTED|Overall Study||87||
59714461|NCT00996801|75833131|FG000|COMPLETED|Overall Study||68||
59714462|NCT00996801|75833132|FG001|COMPLETED|Overall Study||72||
59714463|NCT00996801|75833133|FG002|COMPLETED|Overall Study||65||
59714464|NCT00996801|75833134|FG003|COMPLETED|Overall Study||56||
59714465|NCT00996801|75833135|FG004|COMPLETED|Overall Study||0||
59714466|NCT00996801|75833136|FG005|COMPLETED|Overall Study||68||
59714467|NCT00996801|75833131|FG000|NOT COMPLETED|Overall Study||20||
59714468|NCT00996801|75833132|FG001|NOT COMPLETED|Overall Study||16||
59714469|NCT00996801|75833133|FG002|NOT COMPLETED|Overall Study||23||
59714470|NCT00996801|75833134|FG003|NOT COMPLETED|Overall Study||31||
59822749|NCT00406653|75945530|FG001|COMPLETED|Induction Period||94||
59822750|NCT00406653|75945531|FG002|COMPLETED|Induction Period||112||
59822751|NCT00406653|75945532|FG003|COMPLETED|Induction Period||102||
59822752|NCT00406653|75945533|FG004|COMPLETED|Induction Period||0||
59822753|NCT00406653|75945534|FG005|COMPLETED|Induction Period||0||
59822754|NCT00406653|75945535|FG006|COMPLETED|Induction Period||0||
60109224|NCT02248636|76229204|FG000|NOT COMPLETED|Overall Study||6||
59714471|NCT00996801|75833135|FG004|NOT COMPLETED|Overall Study||88||
59714472|NCT00996801|75833136|FG005|NOT COMPLETED|Overall Study||19||
59714473|NCT00996489|75833152|FG000|STARTED|Overall Study||459||
59714474|NCT00996489|75833152|FG000|COMPLETED|Overall Study||298||
59714475|NCT00996489|75833152|FG000|NOT COMPLETED|Overall Study||161||
59822755|NCT00406653|75945529|FG000|NOT COMPLETED|Induction Period||15||
59822756|NCT00406653|75945530|FG001|NOT COMPLETED|Induction Period||34||
59822757|NCT00406653|75945531|FG002|NOT COMPLETED|Induction Period||18||
60109225|NCT02248636|76229205|FG001|NOT COMPLETED|Overall Study||3||
60109226|NCT02248714|76229213|FG000|STARTED|Overall Study||66||
60109227|NCT02248714|76229214|FG001|STARTED|Overall Study||65||
60109228|NCT02248714|76229213|FG000|COMPLETED|Overall Study||62||
60109229|NCT02248714|76229214|FG001|COMPLETED|Overall Study||61||
60109230|NCT02248714|76229213|FG000|NOT COMPLETED|Overall Study||4||
60109231|NCT02248714|76229214|FG001|NOT COMPLETED|Overall Study||4||
60109232|NCT01785875|76229220|FG000|STARTED|Overall Study||384||
60109233|NCT01785875|76229221|FG001|STARTED|Overall Study||384||
60109234|NCT01785875|76229222|FG002|STARTED|Overall Study||123||
60109235|NCT01785875|76229220|FG000|Received Etelcalcetide|Overall Study||383||
60109236|NCT01785875|76229221|FG001|Received Etelcalcetide|Overall Study||384||
60109237|NCT01785875|76229222|FG002|Received Etelcalcetide|Overall Study||123||
60109238|NCT01785875|76229220|FG000|COMPLETED|Overall Study|Completed etelcalcetide and the 30-day safety follow-up period|90||
60109239|NCT01785875|76229221|FG001|COMPLETED|Overall Study|Completed etelcalcetide and the 30-day safety follow-up period|95||
60109240|NCT01785875|76229222|FG002|COMPLETED|Overall Study|Completed etelcalcetide and the 30-day safety follow-up period|16||
60109241|NCT01785875|76229220|FG000|NOT COMPLETED|Overall Study||294||
60109242|NCT01785875|76229221|FG001|NOT COMPLETED|Overall Study||289||
60109243|NCT01785875|76229222|FG002|NOT COMPLETED|Overall Study||107||
60109244|NCT05567393|76229251|FG000|STARTED|Overall Study||24||
60109245|NCT05567393|76229252|FG001|STARTED|Overall Study||6||
60109246|NCT05567393|76229253|FG002|STARTED|Overall Study||6||
60109247|NCT05567393|76229254|FG003|STARTED|Overall Study||6||
60109248|NCT05567393|76229255|FG004|STARTED|Overall Study||6||
60109249|NCT05567393|76229256|FG005|STARTED|Overall Study||6||
60109250|NCT05567393|76229257|FG006|STARTED|Overall Study||6||
60109251|NCT05567393|76229258|FG007|STARTED|Overall Study||6||
60109252|NCT05567393|76229259|FG008|STARTED|Overall Study||6||
60109253|NCT05567393|76229260|FG009|STARTED|Overall Study||6||
60109254|NCT05567393|76229261|FG010|STARTED|Overall Study||6||
59714476|NCT01000311|75833158|FG000|STARTED|Overall Study||258||
59714477|NCT01000311|75833159|FG001|STARTED|Overall Study||271||
59714478|NCT01000311|75833158|FG000|COMPLETED|Overall Study||213||
59714479|NCT01000311|75833159|FG001|COMPLETED|Overall Study||201||
59714480|NCT01000311|75833158|FG000|NOT COMPLETED|Overall Study||45||
59714481|NCT01000311|75833159|FG001|NOT COMPLETED|Overall Study||70||
59714482|NCT01003899|75833165|FG000|STARTED|Overall Study|enrolled|47||
59714483|NCT01003899|75833165|FG000|COMPLETED|Overall Study||0||
59714484|NCT01003899|75833165|FG000|NOT COMPLETED|Overall Study||47||
59714485|NCT01000155|75833169|FG000|STARTED|Overall Study||5||
59714486|NCT01000155|75833169|FG000|COMPLETED|Overall Study||3||
59714487|NCT01000155|75833169|FG000|NOT COMPLETED|Overall Study||2||
59714488|NCT00999921|75833175|FG000|STARTED|Overall Study||127||
59714489|NCT00999921|75833176|FG001|STARTED|Overall Study||129||
59714490|NCT00999921|75833175|FG000|COMPLETED|Overall Study||117||
59714491|NCT00999921|75833176|FG001|COMPLETED|Overall Study||110||
59714492|NCT00999921|75833175|FG000|NOT COMPLETED|Overall Study||10||
59714493|NCT00999921|75833176|FG001|NOT COMPLETED|Overall Study||19||
59714494|NCT01002573|75833187|FG000|STARTED|Overall Study||58||
59822758|NCT00406653|75945532|FG003|NOT COMPLETED|Induction Period||26||
60109255|NCT05567393|76229262|FG011|STARTED|Overall Study||6||
59714495|NCT01002573|75833188|FG001|STARTED|Overall Study||60||
59714496|NCT01002573|75833187|FG000|COMPLETED|Overall Study||47||
59714497|NCT01002573|75833188|FG001|COMPLETED|Overall Study||53||
59714498|NCT01002573|75833187|FG000|NOT COMPLETED|Overall Study||11||
59714499|NCT01002573|75833188|FG001|NOT COMPLETED|Overall Study||7||
59714500|NCT00999687|75833194|FG000|STARTED|First Intervention|16 used the INOE on the right hand,15 used the INOE on the left hand.|31||
59714501|NCT00999687|75833194|FG000|COMPLETED|First Intervention||30||
59714502|NCT00999687|75833194|FG000|NOT COMPLETED|First Intervention||1||
59714503|NCT00999687|75833194|FG000|STARTED|Second Intervention|From week 13 to 24, all participants applied INOE to both hands twice daily.|30||
59714504|NCT00999687|75833194|FG000|COMPLETED|Second Intervention||27||
59714505|NCT00999687|75833194|FG000|NOT COMPLETED|Second Intervention||3||
59714506|NCT00996333|75833200|FG000|STARTED|Overall Study||46||
60109256|NCT05567393|76229263|FG012|STARTED|Overall Study||6||
60109257|NCT05567393|76229264|FG013|STARTED|Overall Study||8||
60109258|NCT05567393|76229265|FG014|STARTED|Overall Study||6||
59714507|NCT00996333|75833200|FG000|COMPLETED|Overall Study||33||
59714508|NCT00996333|75833200|FG000|NOT COMPLETED|Overall Study||13||
59714509|NCT00995865|75833207|FG000|STARTED|Overall Study||24||
59714510|NCT00995865|75833208|FG001|STARTED|Overall Study||24||
59714511|NCT00995865|75833209|FG002|STARTED|Overall Study||12||
59714512|NCT00995865|75833207|FG000|COMPLETED|Overall Study||22||
59822759|NCT00406653|75945533|FG004|NOT COMPLETED|Induction Period||0||
60109259|NCT05567393|76229266|FG015|STARTED|Overall Study||6||
60109260|NCT05567393|76229267|FG016|STARTED|Overall Study||6||
60109261|NCT05567393|76229268|FG017|STARTED|Overall Study||6||
60109262|NCT05567393|76229251|FG000|COMPLETED|Overall Study||24||
60109263|NCT05567393|76229252|FG001|COMPLETED|Overall Study||6||
60109264|NCT05567393|76229253|FG002|COMPLETED|Overall Study||6||
60109265|NCT05567393|76229254|FG003|COMPLETED|Overall Study||6||
60109266|NCT05567393|76229255|FG004|COMPLETED|Overall Study||6||
60109267|NCT05567393|76229256|FG005|COMPLETED|Overall Study||6||
60109268|NCT05567393|76229257|FG006|COMPLETED|Overall Study||6||
60109269|NCT05567393|76229258|FG007|COMPLETED|Overall Study||6||
60109270|NCT05567393|76229259|FG008|COMPLETED|Overall Study||6||
60109271|NCT05567393|76229260|FG009|COMPLETED|Overall Study||6||
60109272|NCT05567393|76229261|FG010|COMPLETED|Overall Study||6||
60109273|NCT05567393|76229262|FG011|COMPLETED|Overall Study||6||
60109274|NCT05567393|76229263|FG012|COMPLETED|Overall Study||6||
60109275|NCT05567393|76229264|FG013|COMPLETED|Overall Study||7||
60109276|NCT05567393|76229265|FG014|COMPLETED|Overall Study||6||
60109277|NCT05567393|76229266|FG015|COMPLETED|Overall Study||6||
60109278|NCT05567393|76229267|FG016|COMPLETED|Overall Study||6||
60109279|NCT05567393|76229268|FG017|COMPLETED|Overall Study||6||
60109280|NCT05567393|76229251|FG000|NOT COMPLETED|Overall Study||0||
60109281|NCT05567393|76229252|FG001|NOT COMPLETED|Overall Study||0||
60109282|NCT05567393|76229253|FG002|NOT COMPLETED|Overall Study||0||
60109283|NCT05567393|76229254|FG003|NOT COMPLETED|Overall Study||0||
60109284|NCT05567393|76229255|FG004|NOT COMPLETED|Overall Study||0||
60109285|NCT05567393|76229256|FG005|NOT COMPLETED|Overall Study||0||
60109286|NCT05567393|76229257|FG006|NOT COMPLETED|Overall Study||0||
60109287|NCT05567393|76229258|FG007|NOT COMPLETED|Overall Study||0||
60109288|NCT05567393|76229259|FG008|NOT COMPLETED|Overall Study||0||
60109289|NCT05567393|76229260|FG009|NOT COMPLETED|Overall Study||0||
60109290|NCT05567393|76229261|FG010|NOT COMPLETED|Overall Study||0||
60109291|NCT05567393|76229262|FG011|NOT COMPLETED|Overall Study||0||
60109292|NCT05567393|76229263|FG012|NOT COMPLETED|Overall Study||0||
60109293|NCT05567393|76229264|FG013|NOT COMPLETED|Overall Study||1||
60109294|NCT05567393|76229265|FG014|NOT COMPLETED|Overall Study||0||
60109295|NCT05567393|76229266|FG015|NOT COMPLETED|Overall Study||0||
60109296|NCT05567393|76229267|FG016|NOT COMPLETED|Overall Study||0||
60109297|NCT05567393|76229268|FG017|NOT COMPLETED|Overall Study||0||
60109298|NCT05426902|76229325|FG000|STARTED|Overall Study||16||
60109299|NCT05426902|76229326|FG001|STARTED|Overall Study||49||
60109300|NCT05426902|76229327|FG002|STARTED|Overall Study||115||
60109301|NCT05426902|76229325|FG000|COMPLETED|Overall Study||16||
60109302|NCT05426902|76229326|FG001|COMPLETED|Overall Study||49||
60109303|NCT05426902|76229327|FG002|COMPLETED|Overall Study||115||
60109304|NCT05426902|76229325|FG000|NOT COMPLETED|Overall Study||0||
60109305|NCT05426902|76229326|FG001|NOT COMPLETED|Overall Study||0||
60109306|NCT05426902|76229327|FG002|NOT COMPLETED|Overall Study||0||
60109307|NCT05315479|76229335|FG000|STARTED|Overall Study||19||
60109308|NCT05315479|76229335|FG000|COMPLETED|Overall Study||19||
60109309|NCT05315479|76229335|FG000|NOT COMPLETED|Overall Study||0||
60109310|NCT04973085|76229341|FG000|STARTED|First Intervention||10||
60109311|NCT04973085|76229342|FG001|STARTED|First Intervention||12||
60109312|NCT04973085|76229341|FG000|COMPLETED|First Intervention||9||
60109313|NCT04973085|76229342|FG001|COMPLETED|First Intervention||12||
60109314|NCT04973085|76229341|FG000|NOT COMPLETED|First Intervention||1||
60109315|NCT04973085|76229342|FG001|NOT COMPLETED|First Intervention||0||
60109316|NCT04973085|76229341|FG000|STARTED|Second Intervention||9||
60109317|NCT04973085|76229342|FG001|STARTED|Second Intervention||12||
60109318|NCT04973085|76229341|FG000|MRI Adjusted Protocol|Second Intervention||7|The data from the first 5 subjects was used to modify the MRI protocol to improve the accuracy of the results. All subjects who were scanned using the modified MRI protocol were analyzed.|
60109319|NCT04973085|76229342|FG001|MRI Adjusted Protocol|Second Intervention||9|The data from the first 5 subjects was used to modify the MRI protocol to improve the accuracy of the results. All subjects who were scanned using the modified MRI protocol were analyzed.|
60109320|NCT04973085|76229341|FG000|COMPLETED|Second Intervention||7||
60109321|NCT04973085|76229342|FG001|COMPLETED|Second Intervention||9||
60109322|NCT04973085|76229341|FG000|NOT COMPLETED|Second Intervention||2||
60109323|NCT04973085|76229342|FG001|NOT COMPLETED|Second Intervention||3||
60109324|NCT04962009|76229348|FG000|STARTED|Overall Study||12||
60109325|NCT04962009|76229348|FG000|COMPLETED|Overall Study||10||
60109326|NCT04962009|76229348|FG000|NOT COMPLETED|Overall Study||2||
60109327|NCT04677374|76229357|FG000|STARTED|Overall Study||514|Healthcare Workers at the participating site who could participate in one or both of the interviews and/or surveys.|
60109328|NCT04677374|76229358|FG001|STARTED|Overall Study||731|Healthcare Workers at the participating site who could participate in one or both of the interviews and/or surveys.|
60109329|NCT04677374|76229359|FG002|STARTED|Overall Study||508|Healthcare Workers at the participating site who could participate in one or both of the interviews and/or surveys.|
60109330|NCT04677374|76229360|FG003|STARTED|Overall Study||477|Healthcare Workers at the participating site who could participate in one or both of the interviews and/or surveys.|
60109331|NCT04677374|76229361|FG004|STARTED|Overall Study||12|Healthcare Workers at the participating site who could participate in one or both of the interviews and/or surveys.|
59714513|NCT00995865|75833208|FG001|COMPLETED|Overall Study||24||
60109332|NCT04677374|76229357|FG000|COMPLETED|Overall Study||514||
60109333|NCT04677374|76229358|FG001|COMPLETED|Overall Study||731||
60109334|NCT04677374|76229359|FG002|COMPLETED|Overall Study||508||
60109335|NCT04677374|76229360|FG003|COMPLETED|Overall Study||477||
60109336|NCT04677374|76229361|FG004|COMPLETED|Overall Study||12||
60109337|NCT04677374|76229357|FG000|NOT COMPLETED|Overall Study||0||
60109338|NCT04677374|76229358|FG001|NOT COMPLETED|Overall Study||0||
60109339|NCT04677374|76229359|FG002|NOT COMPLETED|Overall Study||0||
60109340|NCT04677374|76229360|FG003|NOT COMPLETED|Overall Study||0||
60109341|NCT04677374|76229361|FG004|NOT COMPLETED|Overall Study||0||
60109342|NCT04542070|76229392|FG000|STARTED|Overall Study||175|Intent-to-Treat-Exposed (ITT-E)|
60109343|NCT04542070|76229393|FG001|STARTED|Overall Study||279|Intent-to-Treat-Exposed (ITT-E)|
60109344|NCT04542070|76229394|FG002|STARTED|Overall Study||227|Intent-to-Treat-Exposed (ITT-E)|
60109345|NCT04542070|76229392|FG000|COMPLETED|Overall Study||152||
60109346|NCT04542070|76229393|FG001|COMPLETED|Overall Study||255||
60109347|NCT04542070|76229394|FG002|COMPLETED|Overall Study||213||
60109348|NCT04542070|76229392|FG000|NOT COMPLETED|Overall Study||23||
60109349|NCT04542070|76229393|FG001|NOT COMPLETED|Overall Study||24||
60109350|NCT04542070|76229394|FG002|NOT COMPLETED|Overall Study||14||
60109351|NCT04538950|76229403|FG000|STARTED|Overall Study||6||
60109352|NCT04538950|76229403|FG000|COMPLETED|Overall Study||2||
60109353|NCT04538950|76229403|FG000|NOT COMPLETED|Overall Study||4||
60109354|NCT04499235|76229409|FG000|STARTED|Overall Study||5||
60109355|NCT04499235|76229410|FG001|STARTED|Overall Study||1||
60109356|NCT04499235|76229409|FG000|COMPLETED|Overall Study||5||
60109357|NCT04499235|76229410|FG001|COMPLETED|Overall Study||1||
60109358|NCT04499235|76229409|FG000|NOT COMPLETED|Overall Study||0||
60109359|NCT04499235|76229410|FG001|NOT COMPLETED|Overall Study||0||
60109360|NCT04445688|76229416|FG000|STARTED|First Intervention||62||
60109361|NCT04445688|76229416|FG000|Treatment A|First Intervention||21||
60109362|NCT04445688|76229416|FG000|Treatment B|First Intervention||21||
60109363|NCT04445688|76229416|FG000|Treatment C|First Intervention||20||
60109364|NCT04445688|76229416|FG000|COMPLETED|First Intervention||62||
60109365|NCT04445688|76229416|FG000|NOT COMPLETED|First Intervention||0||
60109366|NCT04445688|76229416|FG000|STARTED|Washout (One Week)||62||
60109367|NCT04445688|76229416|FG000|COMPLETED|Washout (One Week)||59||
60109368|NCT04445688|76229416|FG000|NOT COMPLETED|Washout (One Week)||3||
60109369|NCT04445688|76229416|FG000|STARTED|Second Intervention||59||
60109370|NCT04445688|76229416|FG000|Treatment A|Second Intervention||18||
60109371|NCT04445688|76229416|FG000|Treatment B|Second Intervention||21||
60109372|NCT04445688|76229416|FG000|Treatment C|Second Intervention||20||
60109373|NCT04445688|76229416|FG000|COMPLETED|Second Intervention||59||
60109374|NCT04445688|76229416|FG000|NOT COMPLETED|Second Intervention||0||
60109375|NCT04445688|76229416|FG000|STARTED|Washout (One Week)||59||
60109376|NCT04445688|76229416|FG000|COMPLETED|Washout (One Week)||59||
60109377|NCT04445688|76229416|FG000|NOT COMPLETED|Washout (One Week)||0||
60109378|NCT04445688|76229416|FG000|STARTED|Third Intervention||59||
60109379|NCT04445688|76229416|FG000|Treatment A|Third Intervention||20||
60109380|NCT04445688|76229416|FG000|Treatment B|Third Intervention||20||
60109381|NCT04445688|76229416|FG000|Treatment C|Third Intervention||19||
60109382|NCT04445688|76229416|FG000|COMPLETED|Third Intervention||59||
60109383|NCT04445688|76229416|FG000|NOT COMPLETED|Third Intervention||0||
60109384|NCT04382755|76229426|FG000|STARTED|Overall Study||55|randomized patients|
60109385|NCT04382755|76229427|FG001|STARTED|Overall Study||26|randomized patients|
60109386|NCT04382755|76229426|FG000|Treated|Overall Study||54|patients that received at least 1 intervention|
60109387|NCT04382755|76229427|FG001|Treated|Overall Study||24|patients that received at least 1 intervention|
60109388|NCT04382755|76229426|FG000|COMPLETED|Overall Study||54|included in safety and primary analysis|
60109389|NCT04382755|76229427|FG001|COMPLETED|Overall Study||24|included in safety and primary analysis|
60109390|NCT04382755|76229426|FG000|NOT COMPLETED|Overall Study||1||
60109391|NCT04382755|76229427|FG001|NOT COMPLETED|Overall Study||2||
60109392|NCT04322539|76229436|FG000|STARTED|Overall Study||461||
60109393|NCT04322539|76229437|FG001|STARTED|Overall Study||230||
60109394|NCT04322539|76229436|FG000|Safety Population (SP)|Overall Study||456|The Safety population (SP) included all randomized participants who received at least 1 dose of study drug.|
60109395|NCT04322539|76229437|FG001|Safety Population (SP)|Overall Study||230|The Safety population (SP) included all randomized participants who received at least 1 dose of study drug.|
60109396|NCT04322539|76229436|FG000|Pharmacokinetic (PK) Population|Overall Study||329|The Pharmacokinetic (PK) population included all participants who received at least 1 dose of study drug and had at least 1 post dose PK sample collected and analyzed.|
60109397|NCT04322539|76229437|FG001|Pharmacokinetic (PK) Population|Overall Study||2|The Pharmacokinetic (PK) population included all participants who received at least 1 dose of study drug and had at least 1 post dose PK sample collected and analyzed.|
60109398|NCT04322539|76229436|FG000|COMPLETED|Overall Study||0||
60109399|NCT04322539|76229437|FG001|COMPLETED|Overall Study||0||
60109400|NCT04322539|76229436|FG000|NOT COMPLETED|Overall Study||461||
60109401|NCT04322539|76229437|FG001|NOT COMPLETED|Overall Study||230||
60109402|NCT04249882|76229446|FG000|STARTED|Overall Study||19||
60109403|NCT04249882|76229447|FG001|STARTED|Overall Study||19||
60109404|NCT04249882|76229448|FG002|STARTED|Overall Study||15||
60109405|NCT04249882|76229446|FG000|COMPLETED|Overall Study||17||
60109406|NCT04249882|76229447|FG001|COMPLETED|Overall Study||17||
60109407|NCT04249882|76229448|FG002|COMPLETED|Overall Study||14||
60109408|NCT04249882|76229446|FG000|NOT COMPLETED|Overall Study||2||
60109409|NCT04249882|76229447|FG001|NOT COMPLETED|Overall Study||2||
60109410|NCT04249882|76229448|FG002|NOT COMPLETED|Overall Study||1||
60109411|NCT04002115|76229456|FG000|STARTED|Overall Study||2||
60109412|NCT04002115|76229456|FG000|COMPLETED|Overall Study||2||
60109413|NCT04002115|76229456|FG000|NOT COMPLETED|Overall Study||0||
60109414|NCT03960866|76229462|FG000|STARTED|Overall Study||19||
60109415|NCT03960866|76229463|FG001|STARTED|Overall Study||20||
60109416|NCT03960866|76229462|FG000|COMPLETED|Overall Study||19||
60109417|NCT03960866|76229463|FG001|COMPLETED|Overall Study||20||
60109418|NCT03960866|76229462|FG000|NOT COMPLETED|Overall Study||0||
60109419|NCT03960866|76229463|FG001|NOT COMPLETED|Overall Study||0||
60109420|NCT03928418|76229472|FG000|STARTED|Overall Study||91||
60109421|NCT03928418|76229473|FG001|STARTED|Overall Study||91||
60109422|NCT03928418|76229474|FG002|STARTED|Overall Study||90||
60109423|NCT03928418|76229472|FG000|Pilot Participant|Overall Study||1|The first 3 participants enrolled in the study were pilot participants - they are included in the total number started, but were excluded from all analyses.|
60109424|NCT03928418|76229473|FG001|Pilot Participant|Overall Study||1|The first 3 participants enrolled in the study were pilot participants - they are included in the total number started, but were excluded from all analyses.|
60109425|NCT03928418|76229474|FG002|Pilot Participant|Overall Study||1|The first 3 participants enrolled in the study were pilot participants - they are included in the total number started, but were excluded from all analyses.|
60109426|NCT03928418|76229472|FG000|6-month Visit|Overall Study||83|(excluding pilot participants)|
60109427|NCT03928418|76229473|FG001|6-month Visit|Overall Study||86|(excluding pilot participants)|
60109428|NCT03928418|76229474|FG002|6-month Visit|Overall Study||85|(excluding pilot participants)|
60109429|NCT03928418|76229472|FG000|COMPLETED|Overall Study||85|(excluding pilot participants)|
60109430|NCT03928418|76229473|FG001|COMPLETED|Overall Study||87|(excluding pilot participants)|
60109431|NCT03928418|76229474|FG002|COMPLETED|Overall Study||84|(excluding pilot participants)|
60109432|NCT03928418|76229472|FG000|NOT COMPLETED|Overall Study||6||
60109433|NCT03928418|76229473|FG001|NOT COMPLETED|Overall Study||4||
60109434|NCT03928418|76229474|FG002|NOT COMPLETED|Overall Study||6||
60109435|NCT04208516|76229489|FG000|STARTED|Overall Study||7||
60109436|NCT04208516|76229490|FG001|STARTED|Overall Study||7||
60109437|NCT04208516|76229489|FG000|COMPLETED|Overall Study||7||
60109438|NCT04208516|76229490|FG001|COMPLETED|Overall Study||7||
60109439|NCT04208516|76229489|FG000|NOT COMPLETED|Overall Study||0||
60109440|NCT04208516|76229490|FG001|NOT COMPLETED|Overall Study||0||
60109441|NCT03860207|76229502|FG000|STARTED|Overall Study||1||
60109442|NCT03860207|76229503|FG001|STARTED|Overall Study||1||
60109443|NCT03860207|76229504|FG002|STARTED|Overall Study||1||
60109444|NCT03860207|76229505|FG003|STARTED|Overall Study||3||
60109445|NCT03860207|76229506|FG004|STARTED|Overall Study||2||
60109446|NCT03860207|76229507|FG005|STARTED|Overall Study||3||
60109447|NCT03860207|76229502|FG000|Safety Analysis Set|Overall Study||1||
60109448|NCT03860207|76229503|FG001|Safety Analysis Set|Overall Study||1||
60109449|NCT03860207|76229504|FG002|Safety Analysis Set|Overall Study||1||
60109450|NCT03860207|76229505|FG003|Safety Analysis Set|Overall Study||3||
60109451|NCT03860207|76229506|FG004|Safety Analysis Set|Overall Study||2||
60109452|NCT03860207|76229507|FG005|Safety Analysis Set|Overall Study||3||
60109453|NCT03860207|76229502|FG000|Discontinued the Treatment|Overall Study||1||
60109454|NCT03860207|76229503|FG001|Discontinued the Treatment|Overall Study||1||
60109455|NCT03860207|76229504|FG002|Discontinued the Treatment|Overall Study||1||
60109456|NCT03860207|76229505|FG003|Discontinued the Treatment|Overall Study||3||
60109457|NCT03860207|76229506|FG004|Discontinued the Treatment|Overall Study||2||
60109458|NCT03860207|76229507|FG005|Discontinued the Treatment|Overall Study||3||
60109459|NCT03860207|76229502|FG000|Discontinued Treatment - Adverse Events|Overall Study||0||
60109460|NCT03860207|76229503|FG001|Discontinued Treatment - Adverse Events|Overall Study||0||
60109461|NCT03860207|76229504|FG002|Discontinued Treatment - Adverse Events|Overall Study||0||
60109462|NCT03860207|76229505|FG003|Discontinued Treatment - Adverse Events|Overall Study||0||
60109463|NCT03860207|76229506|FG004|Discontinued Treatment - Adverse Events|Overall Study||0||
60109464|NCT03860207|76229507|FG005|Discontinued Treatment - Adverse Events|Overall Study||2||
60109465|NCT03860207|76229502|FG000|Discontinued Treatment - Progressive Disease|Overall Study||1||
60109466|NCT03860207|76229503|FG001|Discontinued Treatment - Progressive Disease|Overall Study||1||
60109467|NCT03860207|76229504|FG002|Discontinued Treatment - Progressive Disease|Overall Study||1||
60109468|NCT03860207|76229505|FG003|Discontinued Treatment - Progressive Disease|Overall Study||3||
60109469|NCT03860207|76229506|FG004|Discontinued Treatment - Progressive Disease|Overall Study||2||
60109470|NCT03860207|76229507|FG005|Discontinued Treatment - Progressive Disease|Overall Study||1||
60109471|NCT03860207|76229502|FG000|COMPLETED|Overall Study||1|Completed minimum 30 days of follow-up from end of treatment.|
60109472|NCT03860207|76229503|FG001|COMPLETED|Overall Study||1|Completed minimum 30 days of follow-up from end of treatment.|
60109473|NCT03860207|76229504|FG002|COMPLETED|Overall Study||1|Completed minimum 30 days of follow-up from end of treatment.|
60109474|NCT03860207|76229505|FG003|COMPLETED|Overall Study||2|Completed minimum 30 days of follow-up from end of treatment.|
60109475|NCT03860207|76229506|FG004|COMPLETED|Overall Study||2|Completed minimum 30 days of follow-up from end of treatment.|
60109476|NCT03860207|76229507|FG005|COMPLETED|Overall Study||3|Completed minimum 30 days of follow-up from end of treatment.|
60109477|NCT03860207|76229502|FG000|NOT COMPLETED|Overall Study||0||
60109478|NCT03860207|76229503|FG001|NOT COMPLETED|Overall Study||0||
60109479|NCT03860207|76229504|FG002|NOT COMPLETED|Overall Study||0||
60109480|NCT03860207|76229505|FG003|NOT COMPLETED|Overall Study||1||
60109481|NCT03860207|76229506|FG004|NOT COMPLETED|Overall Study||0||
60109482|NCT03860207|76229507|FG005|NOT COMPLETED|Overall Study||0||
60109483|NCT03782545|76229521|FG000|STARTED|Overall Study||34||
60109484|NCT03782545|76229521|FG000|COMPLETED|Overall Study||30||
60109485|NCT03782545|76229521|FG000|NOT COMPLETED|Overall Study||4||
60109486|NCT03782376|76229527|FG000|STARTED|Overall Study||108||
60109487|NCT03782376|76229528|FG001|STARTED|Overall Study||107||
60109488|NCT03782376|76229527|FG000|COMPLETED|Overall Study||82||
60109489|NCT03782376|76229528|FG001|COMPLETED|Overall Study||77||
60109490|NCT03782376|76229527|FG000|NOT COMPLETED|Overall Study||26||
60109491|NCT03782376|76229528|FG001|NOT COMPLETED|Overall Study||30||
60109492|NCT03757130|76229542|FG000|STARTED|Overall Study||6||
60109493|NCT03757130|76229543|FG001|STARTED|Overall Study||6||
60109494|NCT03757130|76229544|FG002|STARTED|Overall Study||6||
60109495|NCT03757130|76229545|FG003|STARTED|Overall Study||8||
60109496|NCT03757130|76229546|FG004|STARTED|Overall Study||6||
60109497|NCT03757130|76229547|FG005|STARTED|Overall Study||6||
60109498|NCT03757130|76229548|FG006|STARTED|Overall Study||6||
60109499|NCT03757130|76229549|FG007|STARTED|Overall Study||6||
60109500|NCT03757130|76229542|FG000|COMPLETED|Overall Study||6||
60109501|NCT03757130|76229543|FG001|COMPLETED|Overall Study||6||
60109502|NCT03757130|76229544|FG002|COMPLETED|Overall Study||6||
60109503|NCT03757130|76229545|FG003|COMPLETED|Overall Study||7||
60109504|NCT03757130|76229546|FG004|COMPLETED|Overall Study||6||
60109505|NCT03757130|76229547|FG005|COMPLETED|Overall Study||6||
60109506|NCT03757130|76229548|FG006|COMPLETED|Overall Study||5||
60109507|NCT03757130|76229549|FG007|COMPLETED|Overall Study||5||
60109508|NCT03757130|76229542|FG000|NOT COMPLETED|Overall Study||0||
60109509|NCT03757130|76229543|FG001|NOT COMPLETED|Overall Study||0||
60109510|NCT03757130|76229544|FG002|NOT COMPLETED|Overall Study||0||
60109511|NCT03757130|76229545|FG003|NOT COMPLETED|Overall Study||1||
59714514|NCT00995865|75833209|FG002|COMPLETED|Overall Study||11||
59714515|NCT00995865|75833207|FG000|NOT COMPLETED|Overall Study||2||
59714516|NCT00995865|75833208|FG001|NOT COMPLETED|Overall Study||0||
59714517|NCT00995865|75833209|FG002|NOT COMPLETED|Overall Study||1||
59714518|NCT00995709|75833225|FG000|STARTED|Overall Study||39||
60109512|NCT03757130|76229546|FG004|NOT COMPLETED|Overall Study||0||
60109513|NCT03757130|76229547|FG005|NOT COMPLETED|Overall Study||0||
60109514|NCT03757130|76229548|FG006|NOT COMPLETED|Overall Study||1||
60109515|NCT03757130|76229549|FG007|NOT COMPLETED|Overall Study||1||
60109516|NCT03667573|76229577|FG000|STARTED|Overall Study||6||
60109517|NCT03667573|76229578|FG001|STARTED|Overall Study||5||
60109518|NCT03667573|76229579|FG002|STARTED|Overall Study||5||
60109519|NCT03667573|76229580|FG003|STARTED|Overall Study||7||
60109520|NCT03667573|76229577|FG000|COMPLETED|Overall Study||6||
60109521|NCT03667573|76229578|FG001|COMPLETED|Overall Study||5||
60109522|NCT03667573|76229579|FG002|COMPLETED|Overall Study||5||
60109523|NCT03667573|76229580|FG003|COMPLETED|Overall Study||7||
60109524|NCT03667573|76229577|FG000|NOT COMPLETED|Overall Study||0||
60109525|NCT03667573|76229578|FG001|NOT COMPLETED|Overall Study||0||
60109526|NCT03667573|76229579|FG002|NOT COMPLETED|Overall Study||0||
60109527|NCT03667573|76229580|FG003|NOT COMPLETED|Overall Study||0||
60109528|NCT03555565|76229590|FG000|STARTED|Overall Study||1026||
60109529|NCT03555565|76229590|FG000|COMPLETED|Overall Study||1011||
60109530|NCT03555565|76229590|FG000|NOT COMPLETED|Overall Study||15||
60109531|NCT03553836|76229596|FG000|STARTED|Overall Study||487||
59714519|NCT00995709|75833226|FG001|STARTED|Overall Study||40||
60109532|NCT03553836|76229597|FG001|STARTED|Overall Study||489||
60109533|NCT03553836|76229596|FG000|Treated|Overall Study||483||
60109534|NCT03553836|76229597|FG001|Treated|Overall Study||486||
60109535|NCT03553836|76229596|FG000|Re-challenged or Switched-over to Pembrolizumab|Overall Study||1||
60109536|NCT03553836|76229597|FG001|Re-challenged or Switched-over to Pembrolizumab|Overall Study||45||
60109537|NCT03553836|76229596|FG000|COMPLETED|Overall Study||0||
60109538|NCT03553836|76229597|FG001|COMPLETED|Overall Study||0||
60109539|NCT03553836|76229596|FG000|NOT COMPLETED|Overall Study||487||
60109540|NCT03553836|76229597|FG001|NOT COMPLETED|Overall Study||489||
60109541|NCT03519386|76229607|FG000|STARTED|Overall Study||200||
60109542|NCT03519386|76229608|FG001|STARTED|Overall Study||197||
60109543|NCT03519386|76229609|FG002|STARTED|Overall Study||193||
60109544|NCT03519386|76229607|FG000|Month 3|Overall Study||196||
60109545|NCT03519386|76229608|FG001|Month 3|Overall Study||195||
60109546|NCT03519386|76229609|FG002|Month 3|Overall Study||189||
60109547|NCT03519386|76229607|FG000|Month 12|Overall Study||190||
60109548|NCT03519386|76229608|FG001|Month 12|Overall Study||192||
60109549|NCT03519386|76229609|FG002|Month 12|Overall Study||183||
60109550|NCT03519386|76229607|FG000|COMPLETED|Overall Study||0||
60109551|NCT03519386|76229608|FG001|COMPLETED|Overall Study||0||
60109552|NCT03519386|76229609|FG002|COMPLETED|Overall Study||0||
60109553|NCT03519386|76229607|FG000|NOT COMPLETED|Overall Study||200||
60109554|NCT03519386|76229608|FG001|NOT COMPLETED|Overall Study||197||
60109555|NCT03519386|76229609|FG002|NOT COMPLETED|Overall Study||193||
60109556|NCT03424148|76229617|FG000|STARTED|Overall Study||10||
60109557|NCT03424148|76229617|FG000|COMPLETED|Overall Study||8||
60109558|NCT03424148|76229617|FG000|NOT COMPLETED|Overall Study||2||
60109559|NCT03411642|76229621|FG000|STARTED|Overall Study||494||
60109560|NCT03411642|76229621|FG000|Participants Who Received TTE|Overall Study||492||
60109561|NCT03411642|76229621|FG000|Participants Who Received TEE|Overall Study||454||
60109562|NCT03411642|76229621|FG000|COMPLETED|Overall Study|454 patients received both TEE and TTE|454||
60109563|NCT03411642|76229621|FG000|NOT COMPLETED|Overall Study||40||
60109564|NCT03369665|76229626|FG000|STARTED|Overall Study||482||
60109565|NCT03369665|76229626|FG000|Full Analysis Set (FAS)|Overall Study||482|Full Analysis Set (FAS) consisted of all participants from the Intent-to-treat (ITT [ITT population included all participants classified as eligible]) set treated with at least one dose of study medication.|
60109566|NCT03369665|76229626|FG000|Safety Analysis Set (SAS)|Overall Study||482|SAF consisted of all participants treated with at least one dose of study medication.|
60109567|NCT03369665|76229626|FG000|COMPLETED|Overall Study||452||
60109568|NCT03369665|76229626|FG000|NOT COMPLETED|Overall Study||30||
60109569|NCT03333590|76229632|FG000|STARTED|Overall Study||1||
60109570|NCT03333590|76229633|FG001|STARTED|Overall Study||1||
60109571|NCT03333590|76229632|FG000|COMPLETED|Overall Study||1||
60109572|NCT03333590|76229633|FG001|COMPLETED|Overall Study||1||
60109573|NCT03333590|76229632|FG000|NOT COMPLETED|Overall Study||0||
60109574|NCT03333590|76229633|FG001|NOT COMPLETED|Overall Study||0||
60109575|NCT03317405|76229644|FG000|STARTED|Overall Study||16||
60109576|NCT03317405|76229645|FG001|STARTED|Overall Study||8||
60109577|NCT03317405|76229646|FG002|STARTED|Overall Study||8||
60109578|NCT03317405|76229644|FG000|COMPLETED|Overall Study||15||
60109579|NCT03317405|76229645|FG001|COMPLETED|Overall Study||7||
60109580|NCT03317405|76229646|FG002|COMPLETED|Overall Study||7||
60109581|NCT03317405|76229644|FG000|NOT COMPLETED|Overall Study||1||
60109582|NCT03317405|76229645|FG001|NOT COMPLETED|Overall Study||1||
60109583|NCT03317405|76229646|FG002|NOT COMPLETED|Overall Study||1||
60109584|NCT03304249|76229660|FG000|STARTED|Overall Study|64 pediatric participants and 64 adult participants from 9 schools|128|0 months|9
60109585|NCT03304249|76229661|FG001|STARTED|Overall Study|84 pediatric participants and 84 adult participants from 9 schools|168|0 months|9
60109586|NCT03304249|76229660|FG000|8 Months|Overall Study|59 pediatric participants and 59 adult participants from 9 schools|118||9
60109587|NCT03304249|76229661|FG001|8 Months|Overall Study|83 pediatric participants and 83 adult participants from 9 schools|166||9
60109588|NCT03304249|76229660|FG000|COMPLETED|Overall Study|52 pediatric participants and 52 adult participants from 9 schools|104|20 months|9
60109589|NCT03304249|76229661|FG001|COMPLETED|Overall Study|77 pediatric participants and 77 adult participants from 9 schools|154|20 months|9
60109590|NCT03304249|76229660|FG000|NOT COMPLETED|Overall Study||24||0
60109591|NCT03304249|76229661|FG001|NOT COMPLETED|Overall Study||14||0
60109592|NCT03278847|76229671|FG000|STARTED|Overall Study||1618||
60109593|NCT03278847|76229672|FG001|STARTED|Overall Study||1618||
60109594|NCT03278847|76229673|FG002|STARTED|Overall Study||1240||
60109595|NCT03278847|76229674|FG003|STARTED|Overall Study||1240||
60109596|NCT03278847|76229671|FG000|COMPLETED|Overall Study||1618||
60109597|NCT03278847|76229672|FG001|COMPLETED|Overall Study||1618||
60109598|NCT03278847|76229673|FG002|COMPLETED|Overall Study||1240||
60109599|NCT03278847|76229674|FG003|COMPLETED|Overall Study||1240||
60109600|NCT03278847|76229671|FG000|NOT COMPLETED|Overall Study||0||
60109601|NCT03278847|76229672|FG001|NOT COMPLETED|Overall Study||0||
60109602|NCT03278847|76229673|FG002|NOT COMPLETED|Overall Study||0||
60109603|NCT03278847|76229674|FG003|NOT COMPLETED|Overall Study||0||
60109604|NCT03259620|76229686|FG000|STARTED|Overall Study||245||
60109605|NCT03259620|76229687|FG001|STARTED|Overall Study||246||
60109606|NCT03259620|76229686|FG000|Subjects Who Had 1 Wart|Overall Study||112||
60109607|NCT03259620|76229687|FG001|Subjects Who Had 1 Wart|Overall Study||118||
60109608|NCT03259620|76229686|FG000|Subjects Who Had 2 Warts|Overall Study||48||
60109609|NCT03259620|76229687|FG001|Subjects Who Had 2 Warts|Overall Study||40||
60109610|NCT03259620|76229686|FG000|Subjects Who Had 3 Warts|Overall Study||25||
60109611|NCT03259620|76229687|FG001|Subjects Who Had 3 Warts|Overall Study||31||
60109612|NCT03259620|76229686|FG000|Subjects Who Had 4 Warts|Overall Study||13||
60109613|NCT03259620|76229687|FG001|Subjects Who Had 4 Warts|Overall Study||18||
60109614|NCT03259620|76229686|FG000|Subjects Who Had 5 Warts|Overall Study||20||
60109615|NCT03259620|76229687|FG001|Subjects Who Had 5 Warts|Overall Study||20||
60109616|NCT03259620|76229686|FG000|Subjects Who Had 6 Warts|Overall Study||27||
60109617|NCT03259620|76229687|FG001|Subjects Who Had 6 Warts|Overall Study||19||
60109618|NCT03259620|76229686|FG000|COMPLETED|Overall Study||226||
60109619|NCT03259620|76229687|FG001|COMPLETED|Overall Study||217||
60109620|NCT03259620|76229686|FG000|NOT COMPLETED|Overall Study||19||
60109621|NCT03259620|76229687|FG001|NOT COMPLETED|Overall Study||29||
60109622|NCT03226522|76229696|FG000|STARTED|Overall Study||159||
60109623|NCT03226522|76229697|FG001|STARTED|Overall Study||49||
60109624|NCT03226522|76229698|FG002|STARTED|Overall Study||158||
60109625|NCT03226522|76229696|FG000|Safety Population|Overall Study||159||
60109626|NCT03226522|76229697|FG001|Safety Population|Overall Study||49||
60109627|NCT03226522|76229698|FG002|Safety Population|Overall Study||158||
60109628|NCT03226522|76229696|FG000|mITT Population|Overall Study||152||
60109629|NCT03226522|76229697|FG001|mITT Population|Overall Study||49||
60109630|NCT03226522|76229698|FG002|mITT Population|Overall Study||156||
60109631|NCT03226522|76229696|FG000|COMPLETED|Overall Study||137||
60109632|NCT03226522|76229697|FG001|COMPLETED|Overall Study||48||
60109633|NCT03226522|76229698|FG002|COMPLETED|Overall Study||136||
60109634|NCT03226522|76229696|FG000|NOT COMPLETED|Overall Study||22||
60109635|NCT03226522|76229697|FG001|NOT COMPLETED|Overall Study||1||
60109636|NCT03226522|76229698|FG002|NOT COMPLETED|Overall Study||22||
60109637|NCT03181893|76229717|FG000|STARTED|Baseline to Week 12 (All Stages)||10||
60109638|NCT03181893|76229718|FG001|STARTED|Baseline to Week 12 (All Stages)||22||
60109639|NCT03181893|76229719|FG002|STARTED|Baseline to Week 12 (All Stages)||1||
60109640|NCT03181893|76229720|FG003|STARTED|Baseline to Week 12 (All Stages)||5||
60109641|NCT03181893|76229721|FG004|STARTED|Baseline to Week 12 (All Stages)||3||
60109642|NCT03181893|76229722|FG005|STARTED|Baseline to Week 12 (All Stages)||2||
60109643|NCT03181893|76229723|FG006|STARTED|Baseline to Week 12 (All Stages)||1||
60109644|NCT03181893|76229724|FG007|STARTED|Baseline to Week 12 (All Stages)||10||
60109645|NCT03181893|76229725|FG008|STARTED|Baseline to Week 12 (All Stages)||3||
60109646|NCT03181893|76229726|FG009|STARTED|Baseline to Week 12 (All Stages)||9||
60109647|NCT03181893|76229727|FG010|STARTED|Baseline to Week 12 (All Stages)||9||
60109648|NCT03181893|76229717|FG000|COMPLETED|Baseline to Week 12 (All Stages)||9||
60109649|NCT03181893|76229718|FG001|COMPLETED|Baseline to Week 12 (All Stages)||20||
60109650|NCT03181893|76229719|FG002|COMPLETED|Baseline to Week 12 (All Stages)||1||
60109651|NCT03181893|76229720|FG003|COMPLETED|Baseline to Week 12 (All Stages)||5||
60109652|NCT03181893|76229721|FG004|COMPLETED|Baseline to Week 12 (All Stages)||3||
60109653|NCT03181893|76229722|FG005|COMPLETED|Baseline to Week 12 (All Stages)||2||
60109654|NCT03181893|76229723|FG006|COMPLETED|Baseline to Week 12 (All Stages)||1||
60109655|NCT03181893|76229724|FG007|COMPLETED|Baseline to Week 12 (All Stages)||10||
60109656|NCT03181893|76229725|FG008|COMPLETED|Baseline to Week 12 (All Stages)||3||
60109657|NCT03181893|76229726|FG009|COMPLETED|Baseline to Week 12 (All Stages)||9||
60109658|NCT03181893|76229727|FG010|COMPLETED|Baseline to Week 12 (All Stages)||9||
60109659|NCT03181893|76229717|FG000|NOT COMPLETED|Baseline to Week 12 (All Stages)||1||
60109660|NCT03181893|76229718|FG001|NOT COMPLETED|Baseline to Week 12 (All Stages)||2||
60109661|NCT03181893|76229719|FG002|NOT COMPLETED|Baseline to Week 12 (All Stages)||0||
60109662|NCT03181893|76229720|FG003|NOT COMPLETED|Baseline to Week 12 (All Stages)||0||
60109663|NCT03181893|76229721|FG004|NOT COMPLETED|Baseline to Week 12 (All Stages)||0||
59822760|NCT00406653|75945534|FG005|NOT COMPLETED|Induction Period||0||
59822761|NCT00406653|75945535|FG006|NOT COMPLETED|Induction Period||0||
60109664|NCT03181893|76229722|FG005|NOT COMPLETED|Baseline to Week 12 (All Stages)||0||
60109665|NCT03181893|76229723|FG006|NOT COMPLETED|Baseline to Week 12 (All Stages)||0||
60109666|NCT03181893|76229724|FG007|NOT COMPLETED|Baseline to Week 12 (All Stages)||0||
60109667|NCT03181893|76229725|FG008|NOT COMPLETED|Baseline to Week 12 (All Stages)||0||
60109668|NCT03181893|76229726|FG009|NOT COMPLETED|Baseline to Week 12 (All Stages)||0||
60109669|NCT03181893|76229727|FG010|NOT COMPLETED|Baseline to Week 12 (All Stages)||0||
60109670|NCT03181893|76229717|FG000|STARTED|Weeks 12-24 (Amended Stage 2, Stage 3)|Not applicable for this period.|0|Participants from Stage 1 or Stage 2 did not participate in the treatment switch from Week 12 to 24. Therefore, not applicable for this period.|
60109671|NCT03181893|76229718|FG001|STARTED|Weeks 12-24 (Amended Stage 2, Stage 3)|Not applicable for this period.|0|Participants from Stage 1 or Stage 2 did not participate in the treatment switch from Week 12 to 24. Therefore, not applicable for this period.|
60109672|NCT03181893|76229719|FG002|STARTED|Weeks 12-24 (Amended Stage 2, Stage 3)|Not applicable for this period.|0|Participants from Stage 1 or Stage 2 did not participate in the treatment switch from Week 12 to 24. Therefore, not applicable for this period.|
60109673|NCT03181893|76229720|FG003|STARTED|Weeks 12-24 (Amended Stage 2, Stage 3)|Not applicable for this period.|0|Participants from Stage 1 or Stage 2 did not participate in the treatment switch from Week 12 to 24. Therefore, not applicable for this period.|
60109674|NCT03181893|76229721|FG004|STARTED|Weeks 12-24 (Amended Stage 2, Stage 3)|Not applicable for this period.|0|Participants from Stage 1 or Stage 2 did not participate in the treatment switch from Week 12 to 24. Therefore, not applicable for this period.|
60109675|NCT03181893|76229722|FG005|STARTED|Weeks 12-24 (Amended Stage 2, Stage 3)||2|Participants from Stage 1 or Stage 2 did not participate in the treatment switch from Week 12 to 24. Therefore, not applicable for this period.|
60109676|NCT03181893|76229723|FG006|STARTED|Weeks 12-24 (Amended Stage 2, Stage 3)||1|Participants from Stage 1 or Stage 2 did not participate in the treatment switch from Week 12 to 24. Therefore, not applicable for this period.|
60109677|NCT03181893|76229724|FG007|STARTED|Weeks 12-24 (Amended Stage 2, Stage 3)||10|Participants from Stage 1 or Stage 2 did not participate in the treatment switch from Week 12 to 24. Therefore, not applicable for this period.|
60109678|NCT03181893|76229725|FG008|STARTED|Weeks 12-24 (Amended Stage 2, Stage 3)||3|Participants from Stage 1 or Stage 2 did not participate in the treatment switch from Week 12 to 24. Therefore, not applicable for this period.|
60109679|NCT03181893|76229726|FG009|STARTED|Weeks 12-24 (Amended Stage 2, Stage 3)||9|Participants from Stage 1 or Stage 2 did not participate in the treatment switch from Week 12 to 24. Therefore, not applicable for this period.|
60109680|NCT03181893|76229727|FG010|STARTED|Weeks 12-24 (Amended Stage 2, Stage 3)||9|Participants from Stage 1 or Stage 2 did not participate in the treatment switch from Week 12 to 24. Therefore, not applicable for this period.|
60109681|NCT03181893|76229717|FG000|COMPLETED|Weeks 12-24 (Amended Stage 2, Stage 3)||0||
60109682|NCT03181893|76229718|FG001|COMPLETED|Weeks 12-24 (Amended Stage 2, Stage 3)||0||
60109683|NCT03181893|76229719|FG002|COMPLETED|Weeks 12-24 (Amended Stage 2, Stage 3)||0||
60109684|NCT03181893|76229720|FG003|COMPLETED|Weeks 12-24 (Amended Stage 2, Stage 3)||0||
60109685|NCT03181893|76229721|FG004|COMPLETED|Weeks 12-24 (Amended Stage 2, Stage 3)||0||
60109686|NCT03181893|76229722|FG005|COMPLETED|Weeks 12-24 (Amended Stage 2, Stage 3)||2||
60109687|NCT03181893|76229723|FG006|COMPLETED|Weeks 12-24 (Amended Stage 2, Stage 3)||1||
60109688|NCT03181893|76229724|FG007|COMPLETED|Weeks 12-24 (Amended Stage 2, Stage 3)||9||
60109689|NCT03181893|76229725|FG008|COMPLETED|Weeks 12-24 (Amended Stage 2, Stage 3)||2||
60109690|NCT03181893|76229726|FG009|COMPLETED|Weeks 12-24 (Amended Stage 2, Stage 3)||8||
60109691|NCT03181893|76229727|FG010|COMPLETED|Weeks 12-24 (Amended Stage 2, Stage 3)||8||
60109692|NCT03181893|76229717|FG000|NOT COMPLETED|Weeks 12-24 (Amended Stage 2, Stage 3)||0||
60109693|NCT03181893|76229718|FG001|NOT COMPLETED|Weeks 12-24 (Amended Stage 2, Stage 3)||0||
60109694|NCT03181893|76229719|FG002|NOT COMPLETED|Weeks 12-24 (Amended Stage 2, Stage 3)||0||
60109695|NCT03181893|76229720|FG003|NOT COMPLETED|Weeks 12-24 (Amended Stage 2, Stage 3)||0||
60109696|NCT03181893|76229721|FG004|NOT COMPLETED|Weeks 12-24 (Amended Stage 2, Stage 3)||0||
60109697|NCT03181893|76229722|FG005|NOT COMPLETED|Weeks 12-24 (Amended Stage 2, Stage 3)||0||
60109698|NCT03181893|76229723|FG006|NOT COMPLETED|Weeks 12-24 (Amended Stage 2, Stage 3)||0||
60109699|NCT03181893|76229724|FG007|NOT COMPLETED|Weeks 12-24 (Amended Stage 2, Stage 3)||1||
60109700|NCT03181893|76229725|FG008|NOT COMPLETED|Weeks 12-24 (Amended Stage 2, Stage 3)||1||
60109701|NCT03181893|76229726|FG009|NOT COMPLETED|Weeks 12-24 (Amended Stage 2, Stage 3)||1||
60109702|NCT03181893|76229727|FG010|NOT COMPLETED|Weeks 12-24 (Amended Stage 2, Stage 3)||1||
60109703|NCT03180840|76229752|FG000|STARTED|Overall Study||30||
60109704|NCT03180840|76229752|FG000|COMPLETED|Overall Study||29|Of the 30 patients who were enrolled in the study and treated,1 patient withdrew consent after receiving the first infusion of PRX-102 2.0 mg/kg and 29 patients completed the study. The PRX-102 dosing regimen was changed to 1.0 mg/kg E2W for 1 patient during the study. A further patient was treated for more than 52 weeks due to the COVID-19 pandemic restrictions.|
59714520|NCT00995709|75833227|FG002|STARTED|Overall Study||39||
59714521|NCT00995709|75833225|FG000|COMPLETED|Overall Study||32||
59714522|NCT00995709|75833226|FG001|COMPLETED|Overall Study|patient in the 300 mg monthly group was randomized,was not eligible,never received study medication|31||
59714523|NCT00995709|75833227|FG002|COMPLETED|Overall Study||34||
60109705|NCT03180840|76229752|FG000|NOT COMPLETED|Overall Study||1||
59714524|NCT00995709|75833225|FG000|NOT COMPLETED|Overall Study||7||
59714525|NCT00995709|75833226|FG001|NOT COMPLETED|Overall Study||9||
59714526|NCT00995709|75833227|FG002|NOT COMPLETED|Overall Study||5||
59714527|NCT00998985|75833249|FG000|STARTED|Overall Study||5||
59714528|NCT00998985|75833250|FG001|STARTED|Overall Study||5||
59714529|NCT00998985|75833251|FG002|STARTED|Overall Study||15||
60109706|NCT03064035|76229763|FG000|STARTED|Overall Study|Randomized to fixed dosing|39||
60109707|NCT03064035|76229764|FG001|STARTED|Overall Study|Randomized to variable dosing|40||
60109708|NCT03064035|76229763|FG000|COMPLETED|Overall Study|Fixed dosing subjects used in analysis|34||
60109709|NCT03064035|76229764|FG001|COMPLETED|Overall Study|Variable dosing subjects used in analysis|37||
60109710|NCT03064035|76229763|FG000|NOT COMPLETED|Overall Study||5||
60109711|NCT03064035|76229764|FG001|NOT COMPLETED|Overall Study||3||
60109712|NCT03018730|76229770|FG000|STARTED|Overall Study||22||
60109713|NCT03018730|76229770|FG000|COMPLETED|Overall Study||20||
60109714|NCT03018730|76229770|FG000|NOT COMPLETED|Overall Study||2||
60109715|NCT03014206|76229777|FG000|STARTED|Overall Study||696||
60109716|NCT03014206|76229777|FG000|COMPLETED|Overall Study||684||
60109717|NCT03014206|76229777|FG000|NOT COMPLETED|Overall Study||12||
60109718|NCT02971891|76229783|FG000|STARTED|Overall Study||246||
60109719|NCT02971891|76229784|FG001|STARTED|Overall Study||238||
60109720|NCT02971891|76229783|FG000|Subjects Who Had 1 Wart|Overall Study||118||
60109721|NCT02971891|76229784|FG001|Subjects Who Had 1 Wart|Overall Study||117||
60109722|NCT02971891|76229783|FG000|Subjects Who Had 2 Warts|Overall Study||56||
60109723|NCT02971891|76229784|FG001|Subjects Who Had 2 Warts|Overall Study||53||
60109724|NCT02971891|76229783|FG000|Subjects Who Had 3 Warts|Overall Study||24||
60109725|NCT02971891|76229784|FG001|Subjects Who Had 3 Warts|Overall Study||24||
60109726|NCT02971891|76229783|FG000|Subjects Who Had 4 Warts|Overall Study||21||
60109727|NCT02971891|76229784|FG001|Subjects Who Had 4 Warts|Overall Study||12||
60109728|NCT02971891|76229783|FG000|Subjects Who Had 5 Warts|Overall Study||12||
60109729|NCT02971891|76229784|FG001|Subjects Who Had 5 Warts|Overall Study||11||
60109730|NCT02971891|76229783|FG000|Subjects Who Had 6 Warts|Overall Study||15||
60109731|NCT02971891|76229784|FG001|Subjects Who Had 6 Warts|Overall Study||21||
60109732|NCT02971891|76229783|FG000|COMPLETED|Overall Study||229||
60109733|NCT02971891|76229784|FG001|COMPLETED|Overall Study||214||
60109734|NCT02971891|76229783|FG000|NOT COMPLETED|Overall Study||17||
60109735|NCT02971891|76229784|FG001|NOT COMPLETED|Overall Study||24||
60109736|NCT02822573|76229792|FG000|STARTED|Overall Study||140||
60109737|NCT02822573|76229793|FG001|STARTED|Overall Study||136||
60109738|NCT02822573|76229792|FG000|COMPLETED|Overall Study||110||
60109739|NCT02822573|76229793|FG001|COMPLETED|Overall Study||117||
60109740|NCT02822573|76229792|FG000|NOT COMPLETED|Overall Study||30||
60109741|NCT02822573|76229793|FG001|NOT COMPLETED|Overall Study||19||
60109742|NCT02795676|76229801|FG000|STARTED|Overall Study||53||
60109743|NCT02795676|76229802|FG001|STARTED|Overall Study||25||
60109744|NCT02795676|76229801|FG000|Treated|Overall Study||52|One patient from PRX-102 arm withdrew consent before receiving the study product|
60109745|NCT02795676|76229802|FG001|Treated|Overall Study||25|One patient from PRX-102 arm withdrew consent before receiving the study product|
60109746|NCT02795676|76229801|FG000|COMPLETED|Overall Study||48||
60109747|NCT02795676|76229802|FG001|COMPLETED|Overall Study||24||
60109748|NCT02795676|76229801|FG000|NOT COMPLETED|Overall Study||5||
60109749|NCT02795676|76229802|FG001|NOT COMPLETED|Overall Study||1||
60109750|NCT02784535|76229808|FG000|STARTED|Overall Study||20||
60109751|NCT02784535|76229809|FG001|STARTED|Overall Study||20||
60109752|NCT02784535|76229808|FG000|COMPLETED|Overall Study|Randomized ,placebo controlled, crossover phase (days 0-64)|19||
60109753|NCT02784535|76229809|FG001|COMPLETED|Overall Study||18||
60109754|NCT02784535|76229808|FG000|NOT COMPLETED|Overall Study||1||
60109755|NCT02784535|76229809|FG001|NOT COMPLETED|Overall Study||2||
60109756|NCT02617511|76229820|FG000|STARTED|Overall Study||12||
60109757|NCT02617511|76229821|FG001|STARTED|Overall Study||12||
60109758|NCT02617511|76229820|FG000|COMPLETED|Overall Study||11||
60109759|NCT02617511|76229821|FG001|COMPLETED|Overall Study||12||
60109760|NCT02617511|76229820|FG000|NOT COMPLETED|Overall Study||1||
60109761|NCT02617511|76229821|FG001|NOT COMPLETED|Overall Study||0||
60109762|NCT02587234|76229829|FG000|STARTED|Overall Study||11||
60109763|NCT02587234|76229830|FG001|STARTED|Overall Study||10||
60109764|NCT02587234|76229829|FG000|COMPLETED|Overall Study||10||
60109765|NCT02587234|76229830|FG001|COMPLETED|Overall Study||7||
60109766|NCT02587234|76229829|FG000|NOT COMPLETED|Overall Study||1||
60109767|NCT02587234|76229830|FG001|NOT COMPLETED|Overall Study||3||
60109768|NCT02184195|76229838|FG000|STARTED|Overall Study||92||
60109769|NCT02184195|76229839|FG001|STARTED|Overall Study||62||
60109770|NCT02184195|76229838|FG000|COMPLETED|Overall Study||19||
60109771|NCT02184195|76229839|FG001|COMPLETED|Overall Study||7||
60109772|NCT02184195|76229838|FG000|NOT COMPLETED|Overall Study||73||
60109773|NCT02184195|76229839|FG001|NOT COMPLETED|Overall Study||55||
60109774|NCT02181413|76229847|FG000|STARTED|Overall Study||261||
60109775|NCT02181413|76229848|FG001|STARTED|Overall Study||395||
60109776|NCT02181413|76229847|FG000|Intent-to-Treat (ITT) Population|Overall Study||261||
60109777|NCT02181413|76229848|FG001|Intent-to-Treat (ITT) Population|Overall Study||395||
60109778|NCT02181413|76229847|FG000|Safety Population|Overall Study||259||
60109779|NCT02181413|76229848|FG001|Safety Population|Overall Study||394||
60109780|NCT02181413|76229847|FG000|Per Protocol (PP) Population|Overall Study||256||
60109781|NCT02181413|76229848|FG001|Per Protocol (PP) Population|Overall Study||387||
60109782|NCT02181413|76229847|FG000|COMPLETED|Overall Study||109|Completed indicates participants who completed maximum number of cycles per protocol|
60109783|NCT02181413|76229848|FG001|COMPLETED|Overall Study||198|Completed indicates participants who completed maximum number of cycles per protocol|
60109784|NCT02181413|76229847|FG000|NOT COMPLETED|Overall Study||152||
60109785|NCT02181413|76229848|FG001|NOT COMPLETED|Overall Study||197||
60109786|NCT02152631|76229856|FG000|STARTED|Overall Study||270||
60109787|NCT02152631|76229857|FG001|STARTED|Overall Study||183||
60109788|NCT02152631|76229856|FG000|Received at Least One Dose of Study Drug|Overall Study||265||
60109789|NCT02152631|76229857|FG001|Received at Least One Dose of Study Drug|Overall Study||175||
60109790|NCT02152631|76229856|FG000|Off Treatment|Overall Study||246||
60109791|NCT02152631|76229857|FG001|Off Treatment|Overall Study||172||
60109792|NCT02152631|76229856|FG000|Death Due to Any Cause|Overall Study||30||
60109793|NCT02152631|76229857|FG001|Death Due to Any Cause|Overall Study||20||
60109794|NCT02152631|76229856|FG000|Progressive Disease|Overall Study||174||
60109795|NCT02152631|76229857|FG001|Progressive Disease|Overall Study||137||
60109796|NCT02152631|76229856|FG000|COMPLETED|Overall Study||204||
60109797|NCT02152631|76229857|FG001|COMPLETED|Overall Study||157||
60109798|NCT02152631|76229856|FG000|NOT COMPLETED|Overall Study||66||
60109799|NCT02152631|76229857|FG001|NOT COMPLETED|Overall Study||26||
60109800|NCT02151981|76229865|FG000|STARTED|Overall Study||279||
60109801|NCT02151981|76229866|FG001|STARTED|Overall Study||140||
60109802|NCT02151981|76229865|FG000|Received Randomised Treatment Only|Overall Study||279||
60109803|NCT02151981|76229866|FG001|Received Randomised Treatment Only|Overall Study||136||
60109804|NCT02151981|76229865|FG000|Did Not Receive Treatment|Overall Study||0||
60109805|NCT02151981|76229866|FG001|Did Not Receive Treatment|Overall Study||4||
60109806|NCT02151981|76229865|FG000|Crossed Over Osimertinib|Overall Study||0||
60109807|NCT02151981|76229866|FG001|Crossed Over Osimertinib|Overall Study|Patients randomised to chemotherapy were allowed to crossover to Osimertinib after progression|99||
60109808|NCT02151981|76229865|FG000|COMPLETED|Overall Study||0||
60109809|NCT02151981|76229866|FG001|COMPLETED|Overall Study||0||
60109810|NCT02151981|76229865|FG000|NOT COMPLETED|Overall Study||279||
60109811|NCT02151981|76229866|FG001|NOT COMPLETED|Overall Study||140||
60109812|NCT01996605|76229875|FG000|STARTED|Overall Study||8||
60109813|NCT01996605|76229876|FG001|STARTED|Overall Study||5||
60109814|NCT01996605|76229877|FG002|STARTED|Overall Study||7||
60109815|NCT01996605|76229875|FG000|COMPLETED|Overall Study||8||
60109816|NCT01996605|76229876|FG001|COMPLETED|Overall Study||5||
60109817|NCT01996605|76229877|FG002|COMPLETED|Overall Study||7||
60109818|NCT01996605|76229875|FG000|NOT COMPLETED|Overall Study||0||
60109819|NCT01996605|76229876|FG001|NOT COMPLETED|Overall Study||0||
60109820|NCT01996605|76229877|FG002|NOT COMPLETED|Overall Study||0||
60109821|NCT01981720|76229885|FG000|STARTED|Overall Study||15||
60109822|NCT01981720|76229885|FG000|COMPLETED|Overall Study||10||
60109823|NCT01981720|76229885|FG000|NOT COMPLETED|Overall Study||5||
60109824|NCT01974440|76229895|FG000|STARTED|Overall Study||201||
60109825|NCT01974440|76229896|FG001|STARTED|Overall Study||202||
60109826|NCT01974440|76229895|FG000|Safety Analysis Set|Overall Study||199|Safety analysis set included all randomized participants who received at least 1 dose of study drug, and were analyzed according to the actual treatment received.|
60109827|NCT01974440|76229896|FG001|Safety Analysis Set|Overall Study||201|Safety analysis set included all randomized participants who received at least 1 dose of study drug, and were analyzed according to the actual treatment received.|
60109828|NCT01974440|76229895|FG000|Participants With Marginal Zone Lymphoma (MZL)|Overall Study||28||
60109829|NCT01974440|76229896|FG001|Participants With Marginal Zone Lymphoma (MZL)|Overall Study||28||
60109830|NCT01974440|76229895|FG000|COMPLETED|Overall Study||61||
59714530|NCT00998985|75833252|FG003|STARTED|Overall Study||5||
59822762|NCT00406653|75945529|FG000|STARTED|Maintenance Period||0||
60109831|NCT01974440|76229896|FG001|COMPLETED|Overall Study||60||
60109832|NCT01974440|76229895|FG000|NOT COMPLETED|Overall Study||140||
60109833|NCT01974440|76229896|FG001|NOT COMPLETED|Overall Study||142||
60109834|NCT01921166|76229904|FG000|STARTED|Overall Study||8||
60109835|NCT01921166|76229905|FG001|STARTED|Overall Study||15||
60109836|NCT01921166|76229904|FG000|COMPLETED|Overall Study||8||
60109837|NCT01921166|76229905|FG001|COMPLETED|Overall Study||15||
60109838|NCT01921166|76229904|FG000|NOT COMPLETED|Overall Study||0||
60109839|NCT01921166|76229905|FG001|NOT COMPLETED|Overall Study||0||
60109840|NCT01802281|76229913|FG000|STARTED|Overall Study||93|Started indicates randomized into the SUPeR study|
60109841|NCT01802281|76229914|FG001|STARTED|Overall Study||90|Started indicates randomized into the SUPeR study|
60109842|NCT01802281|76229913|FG000|Eligible and Received Randomized Treatment|Overall Study||88|A small number of randomized participants received the randomized treatment but were found to be ineligible for the intervention|
60109843|NCT01802281|76229914|FG001|Eligible and Received Randomized Treatment|Overall Study||87|A small number of randomized participants received the randomized treatment but were found to be ineligible for the intervention|
60109844|NCT01802281|76229913|FG000|Completed Year 1 Follow-up|Overall Study||88||
60109845|NCT01802281|76229914|FG001|Completed Year 1 Follow-up|Overall Study||86||
60109846|NCT01802281|76229913|FG000|Completed Year 2 Follow-up|Overall Study||87||
60109847|NCT01802281|76229914|FG001|Completed Year 2 Follow-up|Overall Study||84||
60109848|NCT01802281|76229913|FG000|COMPLETED|Overall Study||85|Completed Year 3 Follow-up|
60109849|NCT01802281|76229914|FG001|COMPLETED|Overall Study||84|Completed Year 3 Follow-up|
59822763|NCT00406653|75945530|FG001|STARTED|Maintenance Period||0||
59714531|NCT00998985|75833253|FG004|STARTED|Overall Study||5||
59714532|NCT00998985|75833254|FG005|STARTED|Overall Study||5||
60109850|NCT01802281|76229913|FG000|NOT COMPLETED|Overall Study||8||
60109851|NCT01802281|76229914|FG001|NOT COMPLETED|Overall Study||6||
59714533|NCT00998985|75833255|FG006|STARTED|Overall Study||5||
59714534|NCT00998985|75833256|FG007|STARTED|Overall Study||5||
60109852|NCT01696461|76229923|FG000|STARTED|Overall Study|First donor-recipient pair was enrolled in July, 2013.|64||
60109853|NCT01696461|76229924|FG001|STARTED|Overall Study||33||
60109854|NCT01696461|76229925|FG002|STARTED|Overall Study||30||
60109855|NCT01696461|76229923|FG000|COMPLETED|Overall Study|Last donor-recipient pair was enrolled in December, 2014|64||
60109856|NCT01696461|76229924|FG001|COMPLETED|Overall Study||33||
60109857|NCT01696461|76229925|FG002|COMPLETED|Overall Study||30||
60109858|NCT01696461|76229923|FG000|NOT COMPLETED|Overall Study||0||
59714535|NCT00998985|75833257|FG008|STARTED|Overall Study||6||
59714536|NCT00998985|75833258|FG009|STARTED|Overall Study||5||
59714537|NCT00998985|75833259|FG010|STARTED|Overall Study||5||
60109859|NCT01696461|76229924|FG001|NOT COMPLETED|Overall Study||0||
60109860|NCT01696461|76229925|FG002|NOT COMPLETED|Overall Study||0||
60109861|NCT01678898|76229937|FG000|STARTED|PB-102-F01||6||
60109862|NCT01678898|76229938|FG001|STARTED|PB-102-F01||8||
60109863|NCT01678898|76229939|FG002|STARTED|PB-102-F01||4||
60109864|NCT01678898|76229937|FG000|COMPLETED|PB-102-F01||6||
60109865|NCT01678898|76229938|FG001|COMPLETED|PB-102-F01||6||
60109866|NCT01678898|76229939|FG002|COMPLETED|PB-102-F01||4||
59714538|NCT00998985|75833260|FG011|STARTED|Overall Study||5||
60109867|NCT01678898|76229937|FG000|NOT COMPLETED|PB-102-F01||0||
60109868|NCT01678898|76229938|FG001|NOT COMPLETED|PB-102-F01||2||
60109869|NCT01678898|76229939|FG002|NOT COMPLETED|PB-102-F01||0||
60109870|NCT01678898|76229937|FG000|STARTED|PB-102-F02||6||
60109871|NCT01678898|76229938|FG001|STARTED|PB-102-F02||6||
60109872|NCT01678898|76229939|FG002|STARTED|PB-102-F02||4||
60109873|NCT01678898|76229937|FG000|COMPLETED|PB-102-F02||6||
60109874|NCT01678898|76229938|FG001|COMPLETED|PB-102-F02||6||
60109875|NCT01678898|76229939|FG002|COMPLETED|PB-102-F02||4||
59714539|NCT00998985|75833261|FG012|STARTED|Overall Study||5||
59714540|NCT00998985|75833262|FG013|STARTED|Overall Study||15||
60109876|NCT01678898|76229937|FG000|NOT COMPLETED|PB-102-F02||0||
60109877|NCT01678898|76229938|FG001|NOT COMPLETED|PB-102-F02||0||
60109878|NCT01678898|76229939|FG002|NOT COMPLETED|PB-102-F02||0||
60109879|NCT01508221|76229956|FG000|STARTED|Overall Study||31||
60109880|NCT01508221|76229956|FG000|COMPLETED|Overall Study||31||
60109881|NCT01508221|76229956|FG000|NOT COMPLETED|Overall Study||0||
60109882|NCT01485861|76229966|FG000|STARTED|Phase Ib||14|Intent-To-Treat (ITT) population based on randomization|
60109883|NCT01485861|76229967|FG001|STARTED|Phase Ib||6|Intent-To-Treat (ITT) population based on randomization|
60109884|NCT01485861|76229968|FG002|STARTED|Phase Ib||0|Intent-To-Treat (ITT) population based on randomization|
60109885|NCT01485861|76229969|FG003|STARTED|Phase Ib||0|Intent-To-Treat (ITT) population based on randomization|
60109886|NCT01485861|76229970|FG004|STARTED|Phase Ib||0|Intent-To-Treat (ITT) population based on randomization|
60109887|NCT01485861|76229971|FG005|STARTED|Phase Ib||0|Intent-To-Treat (ITT) population based on randomization|
60109888|NCT01485861|76229966|FG000|Safety Population|Phase Ib||14|Based on treatment received|
60109889|NCT01485861|76229967|FG001|Safety Population|Phase Ib||6|Based on treatment received|
60109890|NCT01485861|76229968|FG002|Safety Population|Phase Ib||0|Based on treatment received|
60109891|NCT01485861|76229969|FG003|Safety Population|Phase Ib||0|Based on treatment received|
60109892|NCT01485861|76229970|FG004|Safety Population|Phase Ib||0|Based on treatment received|
60109893|NCT01485861|76229971|FG005|Safety Population|Phase Ib||0|Based on treatment received|
60109894|NCT01485861|76229966|FG000|COMPLETED|Phase Ib||0||
60109895|NCT01485861|76229967|FG001|COMPLETED|Phase Ib||0||
60109896|NCT01485861|76229968|FG002|COMPLETED|Phase Ib||0||
60109897|NCT01485861|76229969|FG003|COMPLETED|Phase Ib||0||
60109898|NCT01485861|76229970|FG004|COMPLETED|Phase Ib||0||
60109899|NCT01485861|76229971|FG005|COMPLETED|Phase Ib||0||
60109900|NCT01485861|76229966|FG000|NOT COMPLETED|Phase Ib||14||
60109901|NCT01485861|76229967|FG001|NOT COMPLETED|Phase Ib||6||
60109902|NCT01485861|76229968|FG002|NOT COMPLETED|Phase Ib||0||
60109903|NCT01485861|76229969|FG003|NOT COMPLETED|Phase Ib||0||
60109904|NCT01485861|76229970|FG004|NOT COMPLETED|Phase Ib||0||
60109905|NCT01485861|76229971|FG005|NOT COMPLETED|Phase Ib||0||
60109906|NCT01485861|76229966|FG000|STARTED|Phase II||0||
60109907|NCT01485861|76229967|FG001|STARTED|Phase II||0||
60109908|NCT01485861|76229968|FG002|STARTED|Phase II||84||
60109909|NCT01485861|76229969|FG003|STARTED|Phase II||86||
60109910|NCT01485861|76229970|FG004|STARTED|Phase II||83||
60109911|NCT01485861|76229971|FG005|STARTED|Phase II||0||
60109912|NCT01485861|76229966|FG000|Safety Population|Phase II||0||
60109913|NCT01485861|76229967|FG001|Safety Population|Phase II||0||
60109914|NCT01485861|76229968|FG002|Safety Population|Phase II||84||
60109915|NCT01485861|76229969|FG003|Safety Population|Phase II||88||
60109916|NCT01485861|76229970|FG004|Safety Population|Phase II||81||
60109917|NCT01485861|76229971|FG005|Safety Population|Phase II||0||
60109918|NCT01485861|76229966|FG000|COMPLETED|Phase II||0||
60109919|NCT01485861|76229967|FG001|COMPLETED|Phase II||0||
60109920|NCT01485861|76229968|FG002|COMPLETED|Phase II||1||
60109921|NCT01485861|76229969|FG003|COMPLETED|Phase II||0||
60109922|NCT01485861|76229970|FG004|COMPLETED|Phase II||0||
60109923|NCT01485861|76229971|FG005|COMPLETED|Phase II||0||
60109924|NCT01485861|76229966|FG000|NOT COMPLETED|Phase II||0||
60109925|NCT01485861|76229967|FG001|NOT COMPLETED|Phase II||0||
60109926|NCT01485861|76229968|FG002|NOT COMPLETED|Phase II||83||
60109927|NCT01485861|76229969|FG003|NOT COMPLETED|Phase II||86||
60109928|NCT01485861|76229970|FG004|NOT COMPLETED|Phase II||83||
60109929|NCT01485861|76229971|FG005|NOT COMPLETED|Phase II||0||
60109930|NCT01485861|76229966|FG000|STARTED|Safety Phase||0||
60109931|NCT01485861|76229967|FG001|STARTED|Safety Phase||0||
60109932|NCT01485861|76229968|FG002|STARTED|Safety Phase||0||
60109933|NCT01485861|76229969|FG003|STARTED|Safety Phase||0||
60109934|NCT01485861|76229970|FG004|STARTED|Safety Phase||0||
60109935|NCT01485861|76229971|FG005|STARTED|Safety Phase||25||
60109936|NCT01485861|76229966|FG000|COMPLETED|Safety Phase||0||
60109937|NCT01485861|76229967|FG001|COMPLETED|Safety Phase||0||
60109938|NCT01485861|76229968|FG002|COMPLETED|Safety Phase||0||
60109939|NCT01485861|76229969|FG003|COMPLETED|Safety Phase||0||
60109940|NCT01485861|76229970|FG004|COMPLETED|Safety Phase||0||
60109941|NCT01485861|76229971|FG005|COMPLETED|Safety Phase||0||
60109942|NCT01485861|76229966|FG000|NOT COMPLETED|Safety Phase||0||
60109943|NCT01485861|76229967|FG001|NOT COMPLETED|Safety Phase||0||
60109944|NCT01485861|76229968|FG002|NOT COMPLETED|Safety Phase||0||
60109945|NCT01485861|76229969|FG003|NOT COMPLETED|Safety Phase||0||
60109946|NCT01485861|76229970|FG004|NOT COMPLETED|Safety Phase||0||
60109947|NCT01485861|76229971|FG005|NOT COMPLETED|Safety Phase||25||
60109948|NCT01241734|76229990|FG000|STARTED|Overall Study||3||
60109949|NCT01241734|76229991|FG001|STARTED|Overall Study||4||
60109950|NCT01241734|76229992|FG002|STARTED|Overall Study||3||
60109951|NCT01241734|76229993|FG003|STARTED|Overall Study||3||
60109952|NCT01241734|76229994|FG004|STARTED|Overall Study||5||
60109953|NCT01241734|76229990|FG000|COMPLETED|Overall Study||1||
60109954|NCT01241734|76229991|FG001|COMPLETED|Overall Study||2||
60109955|NCT01241734|76229992|FG002|COMPLETED|Overall Study||2||
60109956|NCT01241734|76229993|FG003|COMPLETED|Overall Study||1||
60109957|NCT01241734|76229994|FG004|COMPLETED|Overall Study||2||
60109958|NCT01241734|76229990|FG000|NOT COMPLETED|Overall Study||2||
60109959|NCT01241734|76229991|FG001|NOT COMPLETED|Overall Study||2||
60109960|NCT01241734|76229992|FG002|NOT COMPLETED|Overall Study||1||
60109961|NCT01241734|76229993|FG003|NOT COMPLETED|Overall Study||2||
60109962|NCT01241734|76229994|FG004|NOT COMPLETED|Overall Study||3||
60109963|NCT01101438|76230005|FG000|STARTED|Overall Study||1824||
60109964|NCT01101438|76230006|FG001|STARTED|Overall Study||1825||
60109965|NCT01101438|76230005|FG000|COMPLETED|Overall Study||1816||
60109966|NCT01101438|76230006|FG001|COMPLETED|Overall Study||1816||
60109967|NCT01101438|76230005|FG000|NOT COMPLETED|Overall Study||8||
60109968|NCT01101438|76230006|FG001|NOT COMPLETED|Overall Study||9||
60109969|NCT00966979|76230016|FG000|STARTED|Overall Study||111||112
60109970|NCT00966979|76230016|FG000|COMPLETED|Overall Study||13||13
60109971|NCT00966979|76230016|FG000|NOT COMPLETED|Overall Study||98||99
60109972|NCT00936663|76230023|FG000|STARTED|Overall Study||1||
60109973|NCT00936663|76230024|FG001|STARTED|Overall Study||2||
60109974|NCT00936663|76230023|FG000|COMPLETED|Overall Study||1||
60109975|NCT00936663|76230024|FG001|COMPLETED|Overall Study||2||
60109976|NCT00936663|76230023|FG000|NOT COMPLETED|Overall Study||0||
60109977|NCT00936663|76230024|FG001|NOT COMPLETED|Overall Study||0||
60109978|NCT00931606|76230034|FG000|STARTED|Overall Study||8||
60109979|NCT00931606|76230035|FG001|STARTED|Overall Study||10||
60109980|NCT00931606|76230036|FG002|STARTED|Overall Study||7||
60109981|NCT00931606|76230037|FG003|STARTED|Overall Study||5||
60109982|NCT00931606|76230034|FG000|COMPLETED|Overall Study||3||
60109983|NCT00931606|76230035|FG001|COMPLETED|Overall Study||1||
60109984|NCT00931606|76230036|FG002|COMPLETED|Overall Study||1||
60109985|NCT00931606|76230037|FG003|COMPLETED|Overall Study||2||
60109986|NCT00931606|76230034|FG000|NOT COMPLETED|Overall Study||5||
60109987|NCT00931606|76230035|FG001|NOT COMPLETED|Overall Study||9||
60109988|NCT00931606|76230036|FG002|NOT COMPLETED|Overall Study||6||
60109989|NCT00931606|76230037|FG003|NOT COMPLETED|Overall Study||3||
60109990|NCT00665457|76230049|FG000|STARTED|Overall Study||3||
60109991|NCT00665457|76230049|FG000|COMPLETED|Overall Study||3|All three subjects completed chemotherapy treatment and went on to surgery.|
59714541|NCT00998985|75833249|FG000|COMPLETED|Overall Study||5||
59714542|NCT00998985|75833250|FG001|COMPLETED|Overall Study||5||
59714543|NCT00998985|75833251|FG002|COMPLETED|Overall Study||15||
60109992|NCT00665457|76230049|FG000|NOT COMPLETED|Overall Study||0||
60109993|NCT00597870|76230053|FG000|STARTED|Overall Study||304||
60109994|NCT00597870|76230053|FG000|COMPLETED|Overall Study||304||
60109995|NCT00597870|76230053|FG000|NOT COMPLETED|Overall Study||0||
60109996|NCT00496756|76230058|FG000|STARTED|Overall Study||14||
60109997|NCT00496756|76230058|FG000|COMPLETED|Overall Study||11||
60109998|NCT00496756|76230058|FG000|NOT COMPLETED|Overall Study||3||
60109999|NCT00483561|76230062|FG000|STARTED|Overall Study||26||
60110000|NCT00483561|76230062|FG000|COMPLETED|Overall Study||15||
60110001|NCT00483561|76230062|FG000|NOT COMPLETED|Overall Study||11||
60110002|NCT01722292|76230069|FG000|STARTED|Overall Study||6||
60110003|NCT01722292|76230070|FG001|STARTED|Overall Study||6||
60110004|NCT01722292|76230071|FG002|STARTED|Overall Study||14||
60110005|NCT01722292|76230069|FG000|Received at Least One Dose of Study Drug|Overall Study||6||
60110006|NCT01722292|76230070|FG001|Received at Least One Dose of Study Drug|Overall Study||6||
60110007|NCT01722292|76230071|FG002|Received at Least One Dose of Study Drug|Overall Study||14||
60110008|NCT01722292|76230069|FG000|COMPLETED|Overall Study||6||
60110009|NCT01722292|76230070|FG001|COMPLETED|Overall Study||6||
60110010|NCT01722292|76230071|FG002|COMPLETED|Overall Study||14||
59714544|NCT00998985|75833252|FG003|COMPLETED|Overall Study||5||
59714545|NCT00998985|75833253|FG004|COMPLETED|Overall Study||5||
59714546|NCT00998985|75833254|FG005|COMPLETED|Overall Study||4||
60110011|NCT01722292|76230069|FG000|NOT COMPLETED|Overall Study||0||
60110012|NCT01722292|76230070|FG001|NOT COMPLETED|Overall Study||0||
60110013|NCT01722292|76230071|FG002|NOT COMPLETED|Overall Study||0||
60110014|NCT01723384|76230098|FG000|STARTED|Overall Study||15||
60110015|NCT01723384|76230099|FG001|STARTED|Overall Study||15||
60110016|NCT01723384|76230098|FG000|COMPLETED|Overall Study||15||
60110017|NCT01723384|76230099|FG001|COMPLETED|Overall Study||15||
60110018|NCT01723384|76230098|FG000|NOT COMPLETED|Overall Study||0||
60110019|NCT01723384|76230099|FG001|NOT COMPLETED|Overall Study||0||
60110020|NCT00706914|76230108|FG000|STARTED|Overall Study||63||
60110021|NCT00706914|76230109|FG001|STARTED|Overall Study||62||
60110022|NCT00706914|76230110|FG002|STARTED|Overall Study||31||
60110023|NCT00706914|76230108|FG000|COMPLETED|Overall Study||57||
60110024|NCT00706914|76230109|FG001|COMPLETED|Overall Study||58||
60110025|NCT00706914|76230110|FG002|COMPLETED|Overall Study||30||
60110026|NCT00706914|76230108|FG000|NOT COMPLETED|Overall Study||6||
60110027|NCT00706914|76230109|FG001|NOT COMPLETED|Overall Study||4||
60110028|NCT00706914|76230110|FG002|NOT COMPLETED|Overall Study||1||
60110029|NCT01723696|76230120|FG000|STARTED|Overall Study||126||
60110030|NCT01723696|76230121|FG001|STARTED|Overall Study||126||
60110031|NCT01723696|76230120|FG000|COMPLETED|Overall Study||109|Number of participants who completed the primary outcome.|
60110032|NCT01723696|76230121|FG001|COMPLETED|Overall Study||113|Number of participants who completed the primary outcome.|
60110033|NCT01723696|76230120|FG000|NOT COMPLETED|Overall Study||17||
60110034|NCT01723696|76230121|FG001|NOT COMPLETED|Overall Study||13||
60110035|NCT01726036|76230131|FG000|STARTED|Overall Study||137||
60110036|NCT01726036|76230132|FG001|STARTED|Overall Study||137||
60110037|NCT01726036|76230131|FG000|COMPLETED|Overall Study||121||
60110038|NCT01726036|76230132|FG001|COMPLETED|Overall Study||130||
60110039|NCT01726036|76230131|FG000|NOT COMPLETED|Overall Study||16||
60110040|NCT01726036|76230132|FG001|NOT COMPLETED|Overall Study||7||
60110041|NCT01726504|76230140|FG000|STARTED|Overall Study||536||
60110042|NCT01726504|76230141|FG001|STARTED|Overall Study||539||
60110043|NCT01726504|76230140|FG000|COMPLETED|Overall Study||524||
60110044|NCT01726504|76230141|FG001|COMPLETED|Overall Study||511||
60110045|NCT01726504|76230140|FG000|NOT COMPLETED|Overall Study||12||
59714547|NCT00998985|75833255|FG006|COMPLETED|Overall Study||5||
59714548|NCT00998985|75833256|FG007|COMPLETED|Overall Study||5||
59714549|NCT00998985|75833257|FG008|COMPLETED|Overall Study||5||
59714550|NCT00998985|75833258|FG009|COMPLETED|Overall Study||5||
59714551|NCT00998985|75833259|FG010|COMPLETED|Overall Study||5||
60110046|NCT01726504|76230141|FG001|NOT COMPLETED|Overall Study||28||
60110047|NCT02242630|76230151|FG000|STARTED|Overall Study||15||
60110048|NCT02242630|76230152|FG001|STARTED|Overall Study||15||
60110049|NCT02242630|76230153|FG002|STARTED|Overall Study||15||
60110050|NCT02242630|76230154|FG003|STARTED|Overall Study||16||
60110051|NCT02242630|76230151|FG000|COMPLETED|Overall Study||15||
60110052|NCT02242630|76230152|FG001|COMPLETED|Overall Study||15||
60110053|NCT02242630|76230153|FG002|COMPLETED|Overall Study||15||
60110054|NCT02242630|76230154|FG003|COMPLETED|Overall Study||16||
60110055|NCT02242630|76230151|FG000|NOT COMPLETED|Overall Study||0||
60110056|NCT02242630|76230152|FG001|NOT COMPLETED|Overall Study||0||
60110057|NCT02242630|76230153|FG002|NOT COMPLETED|Overall Study||0||
60110058|NCT02242630|76230154|FG003|NOT COMPLETED|Overall Study||0||
60110059|NCT01726738|76230164|FG000|STARTED|Overall Study||17||
60110060|NCT01726738|76230164|FG000|COMPLETED|Overall Study||17||
60110061|NCT01726738|76230164|FG000|NOT COMPLETED|Overall Study||0||
60110062|NCT03699280|76230170|FG000|STARTED|Overall Study||20||
60110063|NCT03699280|76230171|FG001|STARTED|Overall Study||20||
59822764|NCT00406653|75945531|FG002|STARTED|Maintenance Period||0||
59822765|NCT00406653|75945532|FG003|STARTED|Maintenance Period||0||
59822766|NCT00406653|75945533|FG004|STARTED|Maintenance Period|At end of IP, 44 participants met response criteria and were randomly assigned to abatacept in MP.|44||
60110064|NCT03699280|76230170|FG000|COMPLETED|Overall Study||20||
60110065|NCT03699280|76230171|FG001|COMPLETED|Overall Study||20||
60110066|NCT03699280|76230170|FG000|NOT COMPLETED|Overall Study||0||
60110067|NCT03699280|76230171|FG001|NOT COMPLETED|Overall Study||0||
60110068|NCT01728844|76230181|FG000|STARTED|Overall Study||22||
60110069|NCT01728844|76230182|FG001|STARTED|Overall Study||21||
60110070|NCT01728844|76230183|FG002|STARTED|Overall Study||22||
60110071|NCT01728844|76230184|FG003|STARTED|Overall Study||23||
60110072|NCT01728844|76230181|FG000|COMPLETED|Overall Study||21||
60110073|NCT01728844|76230182|FG001|COMPLETED|Overall Study||21||
60110074|NCT01728844|76230183|FG002|COMPLETED|Overall Study||22||
60110075|NCT01728844|76230184|FG003|COMPLETED|Overall Study||21||
60110076|NCT01728844|76230181|FG000|NOT COMPLETED|Overall Study||1||
60110077|NCT01728844|76230182|FG001|NOT COMPLETED|Overall Study||0||
60110078|NCT01728844|76230183|FG002|NOT COMPLETED|Overall Study||0||
60110079|NCT01728844|76230184|FG003|NOT COMPLETED|Overall Study||2||
60110080|NCT01730872|76230197|FG000|STARTED|Overall Study||8||
60110081|NCT01730872|76230198|FG001|STARTED|Overall Study||5||
60110082|NCT01730872|76230199|FG002|STARTED|Overall Study||3||
60110083|NCT01730872|76230197|FG000|Full Analysis Set|Overall Study||8||
60110084|NCT01730872|76230198|FG001|Full Analysis Set|Overall Study|1 subject did not complete the last post-CAE measurement on Day 6 and was excluded from the FAS|4||
60110085|NCT01730872|76230199|FG002|Full Analysis Set|Overall Study||0||
60110086|NCT01730872|76230197|FG000|COMPLETED|Overall Study||8||
60110087|NCT01730872|76230198|FG001|COMPLETED|Overall Study||5||
60110088|NCT01730872|76230199|FG002|COMPLETED|Overall Study||3||
60110089|NCT01730872|76230197|FG000|NOT COMPLETED|Overall Study||0||
60110090|NCT01730872|76230198|FG001|NOT COMPLETED|Overall Study||0||
60110091|NCT01730872|76230199|FG002|NOT COMPLETED|Overall Study||0||
60110092|NCT03469492|76230206|FG000|STARTED|Overall Study||8||
60110093|NCT03469492|76230206|FG000|COMPLETED|Overall Study||8||
60110094|NCT03469492|76230206|FG000|NOT COMPLETED|Overall Study||0||
60110095|NCT01738672|76230210|FG000|STARTED|Overall Study||16||
60110096|NCT01738672|76230210|FG000|COMPLETED|Overall Study||11||
60110097|NCT01738672|76230210|FG000|NOT COMPLETED|Overall Study||5||
60110098|NCT01808651|76230217|FG000|STARTED|Study Period 1||99||
60110099|NCT01808651|76230218|FG001|STARTED|Study Period 1||65||
60110100|NCT01808651|76230219|FG002|STARTED|Study Period 1||36||
60110101|NCT01808651|76230217|FG000|Received at Least One Dose of Study Drug|Study Period 1||98||
60110102|NCT01808651|76230218|FG001|Received at Least One Dose of Study Drug|Study Period 1||65||
60110103|NCT01808651|76230219|FG002|Received at Least One Dose of Study Drug|Study Period 1||36||
60110104|NCT01808651|76230217|FG000|COMPLETED|Study Period 1||73||
60110105|NCT01808651|76230218|FG001|COMPLETED|Study Period 1||48||
60110106|NCT01808651|76230219|FG002|COMPLETED|Study Period 1||31||
60110107|NCT01808651|76230217|FG000|NOT COMPLETED|Study Period 1||26||
60110108|NCT01808651|76230218|FG001|NOT COMPLETED|Study Period 1||17||
59996336|NCT03707977|76112334|FG002|COMPLETED|PK Step||0||
59996337|NCT03707977|76112332|FG000|NOT COMPLETED|PK Step||0||
59996338|NCT03707977|76112333|FG001|NOT COMPLETED|PK Step||0||
59996339|NCT03707977|76112334|FG002|NOT COMPLETED|PK Step||0||
59996340|NCT03707977|76112332|FG000|STARTED|Steps 1 (ART+bNAbs)||0||
59996341|NCT03707977|76112333|FG001|STARTED|Steps 1 (ART+bNAbs)||0||
59996342|NCT03707977|76112334|FG002|STARTED|Steps 1 (ART+bNAbs)||28||
59996343|NCT03707977|76112332|FG000|COMPLETED|Steps 1 (ART+bNAbs)||0||
59996344|NCT03707977|76112333|FG001|COMPLETED|Steps 1 (ART+bNAbs)||0||
59996345|NCT03707977|76112334|FG002|COMPLETED|Steps 1 (ART+bNAbs)||25||
59996346|NCT03707977|76112332|FG000|NOT COMPLETED|Steps 1 (ART+bNAbs)||0||
59996347|NCT03707977|76112333|FG001|NOT COMPLETED|Steps 1 (ART+bNAbs)||0||
59996348|NCT03707977|76112334|FG002|NOT COMPLETED|Steps 1 (ART+bNAbs)||3||
59996349|NCT03707977|76112332|FG000|STARTED|Step 2 (bNAbs Only)||0||
59996350|NCT03707977|76112333|FG001|STARTED|Step 2 (bNAbs Only)||0||
59996351|NCT03707977|76112334|FG002|STARTED|Step 2 (bNAbs Only)||25||
59996352|NCT03707977|76112332|FG000|COMPLETED|Step 2 (bNAbs Only)||0||
59996353|NCT03707977|76112333|FG001|COMPLETED|Step 2 (bNAbs Only)||0||
59996354|NCT03707977|76112334|FG002|COMPLETED|Step 2 (bNAbs Only)||11||
59996355|NCT03707977|76112332|FG000|NOT COMPLETED|Step 2 (bNAbs Only)||0||
59996356|NCT03707977|76112333|FG001|NOT COMPLETED|Step 2 (bNAbs Only)||0||
59996357|NCT03707977|76112334|FG002|NOT COMPLETED|Step 2 (bNAbs Only)||14||
59996358|NCT03707977|76112332|FG000|STARTED|Step 3 (Stop bNABs, Resume ART)||0||
59996359|NCT03707977|76112333|FG001|STARTED|Step 3 (Stop bNABs, Resume ART)||0||
59996360|NCT03707977|76112334|FG002|STARTED|Step 3 (Stop bNABs, Resume ART)||28||
59996361|NCT03707977|76112332|FG000|COMPLETED|Step 3 (Stop bNABs, Resume ART)||0||
59996362|NCT03707977|76112333|FG001|COMPLETED|Step 3 (Stop bNABs, Resume ART)||0||
59996363|NCT03707977|76112334|FG002|COMPLETED|Step 3 (Stop bNABs, Resume ART)||28||
59996364|NCT03707977|76112332|FG000|NOT COMPLETED|Step 3 (Stop bNABs, Resume ART)||0||
59996365|NCT03707977|76112333|FG001|NOT COMPLETED|Step 3 (Stop bNABs, Resume ART)||0||
60110109|NCT01808651|76230219|FG002|NOT COMPLETED|Study Period 1||5||
60110110|NCT01808651|76230217|FG000|STARTED|Study Period 2||77||
60110111|NCT01808651|76230218|FG001|STARTED|Study Period 2||52||
60110112|NCT01808651|76230219|FG002|STARTED|Study Period 2||33||
60110113|NCT01808651|76230217|FG000|COMPLETED|Study Period 2|9 Pts who DC'd from Study Period 1 and 68 Pts who completed Study Period 1 entered Study Period 2.|77||
60110114|NCT01808651|76230218|FG001|COMPLETED|Study Period 2|5 Pts who DC'd from Study Period 1 and 47 Pts who completed Study Period 1 entered Study Period 2.|52||
60110115|NCT01808651|76230219|FG002|COMPLETED|Study Period 2|3 Pts who DC'd from Study Period 1 and 30 pts who completed Study Period 1 entered Study Period 2.|33||
60110116|NCT01808651|76230217|FG000|NOT COMPLETED|Study Period 2||0||
60110117|NCT01808651|76230218|FG001|NOT COMPLETED|Study Period 2||0||
60110118|NCT01808651|76230219|FG002|NOT COMPLETED|Study Period 2||0||
60110119|NCT01738750|76230232|FG000|STARTED|Overall Study||49||
60110120|NCT01738750|76230233|FG001|STARTED|Overall Study||51||
60110121|NCT01738750|76230232|FG000|COMPLETED|Overall Study||49||
60110122|NCT01738750|76230233|FG001|COMPLETED|Overall Study||51||
60110123|NCT01738750|76230232|FG000|NOT COMPLETED|Overall Study||0||
60110124|NCT01738750|76230233|FG001|NOT COMPLETED|Overall Study||0||
60110125|NCT01743976|76230243|FG000|STARTED|Overall Study||2||
60110126|NCT01743976|76230244|FG001|STARTED|Overall Study||3||
60110127|NCT01743976|76230243|FG000|COMPLETED|Overall Study||2||
60110128|NCT01743976|76230244|FG001|COMPLETED|Overall Study||3||
60110129|NCT01743976|76230243|FG000|NOT COMPLETED|Overall Study||0||
60110130|NCT01743976|76230244|FG001|NOT COMPLETED|Overall Study||0||
60110131|NCT01746784|76230255|FG000|STARTED|Overall Study||19||
60110132|NCT01746784|76230256|FG001|STARTED|Overall Study||10||
60110133|NCT01746784|76230257|FG002|STARTED|Overall Study||9||
60110134|NCT01746784|76230258|FG003|STARTED|Overall Study||9||
60110135|NCT01746784|76230259|FG004|STARTED|Overall Study||19||
60110136|NCT01746784|76230255|FG000|Enrolled|Overall Study||19||
60110137|NCT01746784|76230256|FG001|Enrolled|Overall Study||10||
60110138|NCT01746784|76230257|FG002|Enrolled|Overall Study||9||
60110139|NCT01746784|76230258|FG003|Enrolled|Overall Study||9||
60110140|NCT01746784|76230259|FG004|Enrolled|Overall Study||19||
60110141|NCT01746784|76230255|FG000|COMPLETED|Overall Study||19||
60110142|NCT01746784|76230256|FG001|COMPLETED|Overall Study||10||
60110143|NCT01746784|76230257|FG002|COMPLETED|Overall Study||9||
60110144|NCT01746784|76230258|FG003|COMPLETED|Overall Study||9||
60110145|NCT01746784|76230259|FG004|COMPLETED|Overall Study||19||
60110146|NCT01746784|76230255|FG000|NOT COMPLETED|Overall Study||0||
60110147|NCT01746784|76230256|FG001|NOT COMPLETED|Overall Study||0||
60110148|NCT01746784|76230257|FG002|NOT COMPLETED|Overall Study||0||
60110149|NCT01746784|76230258|FG003|NOT COMPLETED|Overall Study||0||
60110150|NCT01746784|76230259|FG004|NOT COMPLETED|Overall Study||0||
60110151|NCT00706134|76230284|FG000|STARTED|Overall Study||189||
60110152|NCT00706134|76230285|FG001|STARTED|Overall Study||192||
60110153|NCT00706134|76230286|FG002|STARTED|Overall Study||189||
60110154|NCT00706134|76230287|FG003|STARTED|Overall Study||186||
60110155|NCT00706134|76230284|FG000|Entered Double-blind Period|Overall Study||187||
60110156|NCT00706134|76230285|FG001|Entered Double-blind Period|Overall Study||192||
60110157|NCT00706134|76230286|FG002|Entered Double-blind Period|Overall Study||189||
60110158|NCT00706134|76230287|FG003|Entered Double-blind Period|Overall Study||186||
60110159|NCT00706134|76230284|FG000|COMPLETED|Overall Study||169||
60110160|NCT00706134|76230285|FG001|COMPLETED|Overall Study||173||
60110161|NCT00706134|76230286|FG002|COMPLETED|Overall Study||183||
60110162|NCT00706134|76230287|FG003|COMPLETED|Overall Study||175||
60110163|NCT00706134|76230284|FG000|NOT COMPLETED|Overall Study||20||
60110164|NCT00706134|76230285|FG001|NOT COMPLETED|Overall Study||19||
60110165|NCT00706134|76230286|FG002|NOT COMPLETED|Overall Study||6||
60110166|NCT00706134|76230287|FG003|NOT COMPLETED|Overall Study||11||
60110167|NCT01808573|76230299|FG000|STARTED|Overall Study||307||
60110168|NCT01808573|76230300|FG001|STARTED|Overall Study||314||
60110169|NCT01808573|76230299|FG000|Received Treatment|Overall Study||303||
60110170|NCT01808573|76230300|FG001|Received Treatment|Overall Study||311||
60110171|NCT01808573|76230299|FG000|COMPLETED|Overall Study||0||
60110172|NCT01808573|76230300|FG001|COMPLETED|Overall Study||0||
59714552|NCT00998985|75833260|FG011|COMPLETED|Overall Study||5||
59714553|NCT00998985|75833261|FG012|COMPLETED|Overall Study||5||
59714554|NCT00998985|75833262|FG013|COMPLETED|Overall Study||15||
60110173|NCT01808573|76230299|FG000|NOT COMPLETED|Overall Study||307||
60110174|NCT01808573|76230300|FG001|NOT COMPLETED|Overall Study||314||
60110175|NCT01746940|76230310|FG000|STARTED|Safety and Efficacy First Phase||39||
60110176|NCT01746940|76230311|FG001|STARTED|Safety and Efficacy First Phase||41||
60110177|NCT01746940|76230312|FG002|STARTED|Safety and Efficacy First Phase||40||
60110178|NCT01746940|76230313|FG003|STARTED|Safety and Efficacy First Phase||3||
60110179|NCT01746940|76230310|FG000|COMPLETED|Safety and Efficacy First Phase||39||
60110180|NCT01746940|76230311|FG001|COMPLETED|Safety and Efficacy First Phase||41||
60110181|NCT01746940|76230312|FG002|COMPLETED|Safety and Efficacy First Phase||40||
60110182|NCT01746940|76230313|FG003|COMPLETED|Safety and Efficacy First Phase||0||
60110183|NCT01746940|76230310|FG000|NOT COMPLETED|Safety and Efficacy First Phase||0||
60110184|NCT01746940|76230311|FG001|NOT COMPLETED|Safety and Efficacy First Phase||0||
60110185|NCT01746940|76230312|FG002|NOT COMPLETED|Safety and Efficacy First Phase||0||
60110186|NCT01746940|76230313|FG003|NOT COMPLETED|Safety and Efficacy First Phase||3||
60110187|NCT01746940|76230310|FG000|STARTED|Safety Second Phase||18||
60110188|NCT01746940|76230311|FG001|STARTED|Safety Second Phase||18||
60110189|NCT01746940|76230312|FG002|STARTED|Safety Second Phase||0||
60110190|NCT01746940|76230313|FG003|STARTED|Safety Second Phase||0||
60110191|NCT01746940|76230310|FG000|COMPLETED|Safety Second Phase||18||
60110192|NCT01746940|76230311|FG001|COMPLETED|Safety Second Phase||18||
60110193|NCT01746940|76230312|FG002|COMPLETED|Safety Second Phase||0||
60110194|NCT01746940|76230313|FG003|COMPLETED|Safety Second Phase||0||
60110195|NCT01746940|76230310|FG000|NOT COMPLETED|Safety Second Phase||0||
60110196|NCT01746940|76230311|FG001|NOT COMPLETED|Safety Second Phase||0||
60110197|NCT01746940|76230312|FG002|NOT COMPLETED|Safety Second Phase||0||
60110198|NCT01746940|76230313|FG003|NOT COMPLETED|Safety Second Phase||0||
60110199|NCT01747330|76230321|FG000|STARTED|Overall Study||40||
60110200|NCT01747330|76230321|FG000|COMPLETED|Overall Study||40||
60110201|NCT01747330|76230321|FG000|NOT COMPLETED|Overall Study||0||
60110202|NCT02246530|76230327|FG000|STARTED|Overall Study||9||
60110203|NCT02246530|76230328|FG001|STARTED|Overall Study||2||
60110204|NCT02246530|76230327|FG000|COMPLETED|Overall Study||5||
60110205|NCT02246530|76230328|FG001|COMPLETED|Overall Study||2||
60110206|NCT02246530|76230327|FG000|NOT COMPLETED|Overall Study||4||
60110207|NCT02246530|76230328|FG001|NOT COMPLETED|Overall Study||0||
60110208|NCT01808339|76230334|FG000|STARTED|Treatment Period 1 (14 Days)||4||
60110209|NCT01808339|76230335|FG001|STARTED|Treatment Period 1 (14 Days)||4||
60110210|NCT01808339|76230336|FG002|STARTED|Treatment Period 1 (14 Days)||4||
60110211|NCT01808339|76230337|FG003|STARTED|Treatment Period 1 (14 Days)||4||
59822767|NCT00406653|75945534|FG005|STARTED|Maintenance Period|At end of IP, 46 participants met response criteria and were randomly assigned to placebo in MP.|46||
60110212|NCT01808339|76230338|FG004|STARTED|Treatment Period 1 (14 Days)||6||
60110213|NCT01808339|76230339|FG005|STARTED|Treatment Period 1 (14 Days)||6||
60110214|NCT01808339|76230334|FG000|COMPLETED|Treatment Period 1 (14 Days)||4||
60110215|NCT01808339|76230335|FG001|COMPLETED|Treatment Period 1 (14 Days)||3||
60110216|NCT01808339|76230336|FG002|COMPLETED|Treatment Period 1 (14 Days)||4||
60110217|NCT01808339|76230337|FG003|COMPLETED|Treatment Period 1 (14 Days)||2||
60110218|NCT01808339|76230338|FG004|COMPLETED|Treatment Period 1 (14 Days)||4||
60110219|NCT01808339|76230339|FG005|COMPLETED|Treatment Period 1 (14 Days)||5||
60110220|NCT01808339|76230334|FG000|NOT COMPLETED|Treatment Period 1 (14 Days)||0||
60110221|NCT01808339|76230335|FG001|NOT COMPLETED|Treatment Period 1 (14 Days)||1||
60110222|NCT01808339|76230336|FG002|NOT COMPLETED|Treatment Period 1 (14 Days)||0||
60110223|NCT01808339|76230337|FG003|NOT COMPLETED|Treatment Period 1 (14 Days)||2||
60110224|NCT01808339|76230338|FG004|NOT COMPLETED|Treatment Period 1 (14 Days)||2||
60110225|NCT01808339|76230339|FG005|NOT COMPLETED|Treatment Period 1 (14 Days)||1||
60110226|NCT01808339|76230334|FG000|STARTED|Washout Period 1 (14-21 Days)||4||
60110227|NCT01808339|76230335|FG001|STARTED|Washout Period 1 (14-21 Days)||3||
60110228|NCT01808339|76230336|FG002|STARTED|Washout Period 1 (14-21 Days)||4||
60110229|NCT01808339|76230337|FG003|STARTED|Washout Period 1 (14-21 Days)||2||
60110230|NCT01808339|76230338|FG004|STARTED|Washout Period 1 (14-21 Days)||4||
60110231|NCT01808339|76230339|FG005|STARTED|Washout Period 1 (14-21 Days)||5||
60110232|NCT01808339|76230334|FG000|COMPLETED|Washout Period 1 (14-21 Days)||4||
60110233|NCT01808339|76230335|FG001|COMPLETED|Washout Period 1 (14-21 Days)||3||
60110234|NCT01808339|76230336|FG002|COMPLETED|Washout Period 1 (14-21 Days)||4||
60110235|NCT01808339|76230337|FG003|COMPLETED|Washout Period 1 (14-21 Days)||2||
60110236|NCT01808339|76230338|FG004|COMPLETED|Washout Period 1 (14-21 Days)||4||
60110237|NCT01808339|76230339|FG005|COMPLETED|Washout Period 1 (14-21 Days)||5||
60110238|NCT01808339|76230334|FG000|NOT COMPLETED|Washout Period 1 (14-21 Days)||0||
60110239|NCT01808339|76230335|FG001|NOT COMPLETED|Washout Period 1 (14-21 Days)||0||
60110240|NCT01808339|76230336|FG002|NOT COMPLETED|Washout Period 1 (14-21 Days)||0||
60110241|NCT01808339|76230337|FG003|NOT COMPLETED|Washout Period 1 (14-21 Days)||0||
60110242|NCT01808339|76230338|FG004|NOT COMPLETED|Washout Period 1 (14-21 Days)||0||
60110243|NCT01808339|76230339|FG005|NOT COMPLETED|Washout Period 1 (14-21 Days)||0||
60110244|NCT01808339|76230334|FG000|STARTED|Treatment Period 2 (14 Days)||4||
60110245|NCT01808339|76230335|FG001|STARTED|Treatment Period 2 (14 Days)||3||
60110246|NCT01808339|76230336|FG002|STARTED|Treatment Period 2 (14 Days)||4||
60110247|NCT01808339|76230337|FG003|STARTED|Treatment Period 2 (14 Days)||2||
60110248|NCT01808339|76230338|FG004|STARTED|Treatment Period 2 (14 Days)||4||
60110249|NCT01808339|76230339|FG005|STARTED|Treatment Period 2 (14 Days)||5||
60110250|NCT01808339|76230334|FG000|COMPLETED|Treatment Period 2 (14 Days)||4||
60110251|NCT01808339|76230335|FG001|COMPLETED|Treatment Period 2 (14 Days)||3||
60110252|NCT01808339|76230336|FG002|COMPLETED|Treatment Period 2 (14 Days)||4||
60110253|NCT01808339|76230337|FG003|COMPLETED|Treatment Period 2 (14 Days)||2||
60110254|NCT01808339|76230338|FG004|COMPLETED|Treatment Period 2 (14 Days)||4||
60110255|NCT01808339|76230339|FG005|COMPLETED|Treatment Period 2 (14 Days)||5||
60110256|NCT01808339|76230334|FG000|NOT COMPLETED|Treatment Period 2 (14 Days)||0||
60110257|NCT01808339|76230335|FG001|NOT COMPLETED|Treatment Period 2 (14 Days)||0||
60110258|NCT01808339|76230336|FG002|NOT COMPLETED|Treatment Period 2 (14 Days)||0||
60110259|NCT01808339|76230337|FG003|NOT COMPLETED|Treatment Period 2 (14 Days)||0||
60110260|NCT01808339|76230338|FG004|NOT COMPLETED|Treatment Period 2 (14 Days)||0||
60110261|NCT01808339|76230339|FG005|NOT COMPLETED|Treatment Period 2 (14 Days)||0||
60110262|NCT01808339|76230334|FG000|STARTED|Washout Period 2 (14-21 Days)||4||
60110263|NCT01808339|76230335|FG001|STARTED|Washout Period 2 (14-21 Days)||3||
60110264|NCT01808339|76230336|FG002|STARTED|Washout Period 2 (14-21 Days)||4||
60110265|NCT01808339|76230337|FG003|STARTED|Washout Period 2 (14-21 Days)||2||
60110266|NCT01808339|76230338|FG004|STARTED|Washout Period 2 (14-21 Days)||4||
60110267|NCT01808339|76230339|FG005|STARTED|Washout Period 2 (14-21 Days)||5||
60110268|NCT01808339|76230334|FG000|COMPLETED|Washout Period 2 (14-21 Days)||4||
60110269|NCT01808339|76230335|FG001|COMPLETED|Washout Period 2 (14-21 Days)||3||
60110270|NCT01808339|76230336|FG002|COMPLETED|Washout Period 2 (14-21 Days)||4||
60110271|NCT01808339|76230337|FG003|COMPLETED|Washout Period 2 (14-21 Days)||2||
60110272|NCT01808339|76230338|FG004|COMPLETED|Washout Period 2 (14-21 Days)||4||
60110273|NCT01808339|76230339|FG005|COMPLETED|Washout Period 2 (14-21 Days)||5||
60110274|NCT01808339|76230334|FG000|NOT COMPLETED|Washout Period 2 (14-21 Days)||0||
60110275|NCT01808339|76230335|FG001|NOT COMPLETED|Washout Period 2 (14-21 Days)||0||
60110276|NCT01808339|76230336|FG002|NOT COMPLETED|Washout Period 2 (14-21 Days)||0||
60110277|NCT01808339|76230337|FG003|NOT COMPLETED|Washout Period 2 (14-21 Days)||0||
60110278|NCT01808339|76230338|FG004|NOT COMPLETED|Washout Period 2 (14-21 Days)||0||
60110279|NCT01808339|76230339|FG005|NOT COMPLETED|Washout Period 2 (14-21 Days)||0||
60110280|NCT01808339|76230334|FG000|STARTED|Treatment Period 3 (14 Days)||4||
60110281|NCT01808339|76230335|FG001|STARTED|Treatment Period 3 (14 Days)||3||
60110282|NCT01808339|76230336|FG002|STARTED|Treatment Period 3 (14 Days)||4||
60110283|NCT01808339|76230337|FG003|STARTED|Treatment Period 3 (14 Days)||2||
60110284|NCT01808339|76230338|FG004|STARTED|Treatment Period 3 (14 Days)||4||
60110285|NCT01808339|76230339|FG005|STARTED|Treatment Period 3 (14 Days)||5||
60110286|NCT01808339|76230334|FG000|COMPLETED|Treatment Period 3 (14 Days)||4||
60110287|NCT01808339|76230335|FG001|COMPLETED|Treatment Period 3 (14 Days)||3||
60110288|NCT01808339|76230336|FG002|COMPLETED|Treatment Period 3 (14 Days)||3||
60110289|NCT01808339|76230337|FG003|COMPLETED|Treatment Period 3 (14 Days)||2||
60110290|NCT01808339|76230338|FG004|COMPLETED|Treatment Period 3 (14 Days)||4||
60110291|NCT01808339|76230339|FG005|COMPLETED|Treatment Period 3 (14 Days)||5||
60110292|NCT01808339|76230334|FG000|NOT COMPLETED|Treatment Period 3 (14 Days)||0||
60110293|NCT01808339|76230335|FG001|NOT COMPLETED|Treatment Period 3 (14 Days)||0||
60110294|NCT01808339|76230336|FG002|NOT COMPLETED|Treatment Period 3 (14 Days)||1||
60110295|NCT01808339|76230337|FG003|NOT COMPLETED|Treatment Period 3 (14 Days)||0||
60110296|NCT01808339|76230338|FG004|NOT COMPLETED|Treatment Period 3 (14 Days)||0||
60110297|NCT01808339|76230339|FG005|NOT COMPLETED|Treatment Period 3 (14 Days)||0||
60110298|NCT01749904|76230349|FG000|STARTED|Overall Study|randomized population|286||
60110299|NCT01749904|76230350|FG001|STARTED|Overall Study|randomized population|134||
60110300|NCT01749904|76230349|FG000|COMPLETED|Overall Study|randomized population|264||
60110301|NCT01749904|76230350|FG001|COMPLETED|Overall Study|randomized population|123||
60110302|NCT01749904|76230349|FG000|NOT COMPLETED|Overall Study||22||
60110303|NCT01749904|76230350|FG001|NOT COMPLETED|Overall Study||11||
60110304|NCT02240134|76230363|FG000|STARTED|Overall Study||176||118
60110305|NCT02240134|76230364|FG001|STARTED|Overall Study||176||115
60110306|NCT02240134|76230365|FG002|STARTED|Overall Study||171||114
60110307|NCT02240134|76230363|FG000|COMPLETED|Overall Study||126||81
60110308|NCT02240134|76230364|FG001|COMPLETED|Overall Study||123||79
60110309|NCT02240134|76230365|FG002|COMPLETED|Overall Study||118||78
60110310|NCT02240134|76230363|FG000|NOT COMPLETED|Overall Study||50||37
60110311|NCT02240134|76230364|FG001|NOT COMPLETED|Overall Study||53||36
60110312|NCT02240134|76230365|FG002|NOT COMPLETED|Overall Study||53||36
60110313|NCT01751230|76230375|FG000|STARTED|Overall Study||20||
60110314|NCT01751230|76230376|FG001|STARTED|Overall Study||20||
60110315|NCT01751230|76230375|FG000|COMPLETED|Overall Study||19||
60110316|NCT01751230|76230376|FG001|COMPLETED|Overall Study||16||
60110317|NCT01751230|76230375|FG000|NOT COMPLETED|Overall Study||1||
60110318|NCT01751230|76230376|FG001|NOT COMPLETED|Overall Study||4||
60110319|NCT02727660|76230389|FG000|STARTED|Overall Study||619|mITT Population|
60110320|NCT02727660|76230390|FG001|STARTED|Overall Study||617|mITT Population|
59714555|NCT00998985|75833249|FG000|NOT COMPLETED|Overall Study||0||
60110321|NCT02727660|76230391|FG002|STARTED|Overall Study||607|mITT Population|
60110322|NCT02727660|76230389|FG000|COMPLETED|Overall Study||503|Completed Study Treatment|
60110323|NCT02727660|76230390|FG001|COMPLETED|Overall Study||501|Completed Study Treatment|
60110324|NCT02727660|76230391|FG002|COMPLETED|Overall Study||442|Completed Study Treatment|
60110325|NCT02727660|76230389|FG000|NOT COMPLETED|Overall Study||116||
60110326|NCT02727660|76230390|FG001|NOT COMPLETED|Overall Study||116||
60110327|NCT02727660|76230391|FG002|NOT COMPLETED|Overall Study||165||
60110328|NCT01784861|76230405|FG000|STARTED|Overall Study||3||
60110329|NCT01784861|76230406|FG001|STARTED|Overall Study||3||
60110330|NCT01784861|76230407|FG002|STARTED|Overall Study||4||
60110331|NCT01784861|76230408|FG003|STARTED|Overall Study||8||
60110332|NCT01784861|76230409|FG004|STARTED|Overall Study||3||
60110333|NCT01784861|76230410|FG005|STARTED|Overall Study||2||
60110334|NCT01784861|76230405|FG000|COMPLETED|Overall Study||3||
60110335|NCT01784861|76230406|FG001|COMPLETED|Overall Study||3||
60110336|NCT01784861|76230407|FG002|COMPLETED|Overall Study||3||
60110337|NCT01784861|76230408|FG003|COMPLETED|Overall Study||3||
59714556|NCT00998985|75833250|FG001|NOT COMPLETED|Overall Study||0||
59714557|NCT00998985|75833251|FG002|NOT COMPLETED|Overall Study||0||
59714558|NCT00998985|75833252|FG003|NOT COMPLETED|Overall Study||0||
59714559|NCT00998985|75833253|FG004|NOT COMPLETED|Overall Study||0||
59714560|NCT00998985|75833254|FG005|NOT COMPLETED|Overall Study||1||
59714561|NCT00998985|75833255|FG006|NOT COMPLETED|Overall Study||0||
59714562|NCT00998985|75833256|FG007|NOT COMPLETED|Overall Study||0||
59714563|NCT00998985|75833257|FG008|NOT COMPLETED|Overall Study||1||
59714564|NCT00998985|75833258|FG009|NOT COMPLETED|Overall Study||0||
59714565|NCT00998985|75833259|FG010|NOT COMPLETED|Overall Study||0||
59714566|NCT00998985|75833260|FG011|NOT COMPLETED|Overall Study||0||
59714567|NCT00998985|75833261|FG012|NOT COMPLETED|Overall Study||0||
59714568|NCT00998985|75833262|FG013|NOT COMPLETED|Overall Study||0||
59714569|NCT00995553|75833309|FG000|STARTED|Overall Study||40||
59714570|NCT00995553|75833310|FG001|STARTED|Overall Study||41||
59714571|NCT00995553|75833309|FG000|COMPLETED|Overall Study||38||
59714572|NCT00995553|75833310|FG001|COMPLETED|Overall Study||35||
59714573|NCT00995553|75833309|FG000|NOT COMPLETED|Overall Study||2||
59714574|NCT00995553|75833310|FG001|NOT COMPLETED|Overall Study||6||
59714575|NCT00991887|75833318|FG000|STARTED|Overall Study||26||
59714576|NCT00991887|75833319|FG001|STARTED|Overall Study||22||
59714577|NCT00991887|75833318|FG000|COMPLETED|Overall Study||24||
59714578|NCT00991887|75833319|FG001|COMPLETED|Overall Study||21||
59714579|NCT00991887|75833318|FG000|NOT COMPLETED|Overall Study||2||
60110338|NCT01784861|76230409|FG004|COMPLETED|Overall Study||2||
59714580|NCT00991887|75833319|FG001|NOT COMPLETED|Overall Study||1||
59714581|NCT01002339|75833328|FG000|STARTED|Overall Study||44||
59714582|NCT01002339|75833329|FG001|STARTED|Overall Study||43||
59714583|NCT01002339|75833330|FG002|STARTED|Overall Study||47||
60110339|NCT01784861|76230410|FG005|COMPLETED|Overall Study||1||
59714584|NCT01002339|75833328|FG000|COMPLETED|Overall Study||44||
59714585|NCT01002339|75833329|FG001|COMPLETED|Overall Study||42||
60110340|NCT01784861|76230405|FG000|NOT COMPLETED|Overall Study||0||
60110341|NCT01784861|76230406|FG001|NOT COMPLETED|Overall Study||0||
60110342|NCT01784861|76230407|FG002|NOT COMPLETED|Overall Study||1||
60110343|NCT01784861|76230408|FG003|NOT COMPLETED|Overall Study||5||
60110344|NCT01784861|76230409|FG004|NOT COMPLETED|Overall Study||1||
60110345|NCT01784861|76230410|FG005|NOT COMPLETED|Overall Study||1||
60110346|NCT01751308|76230431|FG000|STARTED|Phase 1||6||
60110347|NCT01751308|76230432|FG001|STARTED|Phase 1||3||
60110348|NCT01751308|76230433|FG002|STARTED|Phase 1||7||
60110349|NCT01751308|76230434|FG003|STARTED|Phase 1||7||
60110350|NCT01751308|76230435|FG004|STARTED|Phase 1|Phase 1 and Phase 2 were separate populations.|0||
60110351|NCT01751308|76230431|FG000|COMPLETED|Phase 1|DP, AE and death were considered as completed (defined in protocol)|6||
60110352|NCT01751308|76230432|FG001|COMPLETED|Phase 1|DP, AE and death were considered as completed (defined in protocol)|3||
60110353|NCT01751308|76230433|FG002|COMPLETED|Phase 1|DP, AE and death were considered as completed (defined in protocol)|7||
60110354|NCT01751308|76230434|FG003|COMPLETED|Phase 1|DP, AE and death were considered as completed (defined in protocol)|7||
60110355|NCT01751308|76230435|FG004|COMPLETED|Phase 1||0||
60110356|NCT01751308|76230431|FG000|NOT COMPLETED|Phase 1||0||
60110357|NCT01751308|76230432|FG001|NOT COMPLETED|Phase 1||0||
60110358|NCT01751308|76230433|FG002|NOT COMPLETED|Phase 1||0||
60110359|NCT01751308|76230434|FG003|NOT COMPLETED|Phase 1||0||
60110360|NCT01751308|76230435|FG004|NOT COMPLETED|Phase 1||0||
60110361|NCT01751308|76230431|FG000|STARTED|Phase 2||0||
60110362|NCT01751308|76230432|FG001|STARTED|Phase 2||0||
60110363|NCT01751308|76230433|FG002|STARTED|Phase 2||0||
60110364|NCT01751308|76230434|FG003|STARTED|Phase 2||0||
60110365|NCT01751308|76230435|FG004|STARTED|Phase 2|Phase 1 and Phase 2 were separate populations.|16||
60110366|NCT01751308|76230431|FG000|COMPLETED|Phase 2||0||
60110367|NCT01751308|76230432|FG001|COMPLETED|Phase 2||0||
60110368|NCT01751308|76230433|FG002|COMPLETED|Phase 2||0||
60110369|NCT01751308|76230434|FG003|COMPLETED|Phase 2||0||
60110370|NCT01751308|76230435|FG004|COMPLETED|Phase 2|DP, AE and death were considered as completed (defined in protocol)|16||
60110371|NCT01751308|76230431|FG000|NOT COMPLETED|Phase 2||0||
60110372|NCT01751308|76230432|FG001|NOT COMPLETED|Phase 2||0||
60110373|NCT01751308|76230433|FG002|NOT COMPLETED|Phase 2||0||
60110374|NCT01751308|76230434|FG003|NOT COMPLETED|Phase 2||0||
60110375|NCT01751308|76230435|FG004|NOT COMPLETED|Phase 2||0||
60110376|NCT01751386|76230453|FG000|STARTED|Overall Study||20||
60110377|NCT01751386|76230454|FG001|STARTED|Overall Study||19||
60110378|NCT01751386|76230453|FG000|COMPLETED|Overall Study||18||
60110379|NCT01751386|76230454|FG001|COMPLETED|Overall Study||16||
60110380|NCT01751386|76230453|FG000|NOT COMPLETED|Overall Study||2||
60110381|NCT01751386|76230454|FG001|NOT COMPLETED|Overall Study||3||
60110382|NCT01752400|76230460|FG000|STARTED|Overall Study||6||
60110383|NCT01752400|76230460|FG000|COMPLETED|Overall Study||6||
60110384|NCT01752400|76230460|FG000|NOT COMPLETED|Overall Study||0||
60110385|NCT01752712|76230466|FG000|STARTED|Overall Study||31||
60110386|NCT01752712|76230467|FG001|STARTED|Overall Study||31||
60110387|NCT01752712|76230466|FG000|COMPLETED|Overall Study||22||
60110388|NCT01752712|76230467|FG001|COMPLETED|Overall Study||21||
60110389|NCT01752712|76230466|FG000|NOT COMPLETED|Overall Study||9||
60110390|NCT01752712|76230467|FG001|NOT COMPLETED|Overall Study||10||
60110391|NCT01754350|76230475|FG000|STARTED|Overall Study||25||
60110392|NCT01754350|76230476|FG001|STARTED|Overall Study||25||
60110393|NCT01754350|76230475|FG000|COMPLETED|Overall Study||20||
60110394|NCT01754350|76230476|FG001|COMPLETED|Overall Study||22||
60110395|NCT01754350|76230475|FG000|NOT COMPLETED|Overall Study||5||
60110396|NCT01754350|76230476|FG001|NOT COMPLETED|Overall Study||3||
60110397|NCT02727192|76230484|FG000|STARTED|Overall Study||54||
60110398|NCT02727192|76230485|FG001|STARTED|Overall Study||54||
60110399|NCT02727192|76230486|FG002|STARTED|Overall Study||1||
60110400|NCT02727192|76230484|FG000|COMPLETED|Overall Study||53||
60110401|NCT02727192|76230485|FG001|COMPLETED|Overall Study||54||
60110402|NCT02727192|76230486|FG002|COMPLETED|Overall Study||1||
60110403|NCT02727192|76230484|FG000|NOT COMPLETED|Overall Study||1||
60110404|NCT02727192|76230485|FG001|NOT COMPLETED|Overall Study||0||
60110405|NCT02727192|76230486|FG002|NOT COMPLETED|Overall Study||0||
60110406|NCT02252068|76230496|FG000|STARTED|Overall Study||5||
60110407|NCT02252068|76230497|FG001|STARTED|Overall Study||13||
60110408|NCT02252068|76230498|FG002|STARTED|Overall Study||13||
60110409|NCT02252068|76230496|FG000|COMPLETED|Overall Study||3||
60110410|NCT02252068|76230497|FG001|COMPLETED|Overall Study||13||
60110411|NCT02252068|76230498|FG002|COMPLETED|Overall Study||13||
60110412|NCT02252068|76230496|FG000|NOT COMPLETED|Overall Study||2||
60110413|NCT02252068|76230497|FG001|NOT COMPLETED|Overall Study||0||
60110414|NCT02252068|76230498|FG002|NOT COMPLETED|Overall Study||0||
60110415|NCT00705666|76230506|FG000|STARTED|Overall Study||789||
60110416|NCT00705666|76230506|FG000|COMPLETED|Overall Study||450||
60110417|NCT00705666|76230506|FG000|NOT COMPLETED|Overall Study||339||
60110418|NCT02253160|76230513|FG000|STARTED|Overall Study||1||
60110419|NCT02253160|76230514|FG001|STARTED|Overall Study||12||
60110420|NCT02253160|76230515|FG002|STARTED|Overall Study||10||
60110421|NCT02253160|76230513|FG000|COMPLETED|Overall Study||1||
60110422|NCT02253160|76230514|FG001|COMPLETED|Overall Study||12||
60110423|NCT02253160|76230515|FG002|COMPLETED|Overall Study||10||
60110424|NCT02253160|76230513|FG000|NOT COMPLETED|Overall Study||0||
60110425|NCT02253160|76230514|FG001|NOT COMPLETED|Overall Study||0||
60110426|NCT02253160|76230515|FG002|NOT COMPLETED|Overall Study||0||
60110427|NCT02254252|76230527|FG000|STARTED|Overall Study||27||
60110428|NCT02254252|76230528|FG001|STARTED|Overall Study||27||
60110429|NCT02254252|76230527|FG000|COMPLETED|Overall Study||24||
60110430|NCT02254252|76230528|FG001|COMPLETED|Overall Study||25||
60110431|NCT02254252|76230527|FG000|NOT COMPLETED|Overall Study||3||
60110432|NCT02254252|76230528|FG001|NOT COMPLETED|Overall Study||2||
59822768|NCT00406653|75945535|FG006|STARTED|Maintenance Period||0||
59822769|NCT00406653|75945529|FG000|COMPLETED|Maintenance Period||0||
59822770|NCT00406653|75945530|FG001|COMPLETED|Maintenance Period||0||
59822771|NCT00406653|75945531|FG002|COMPLETED|Maintenance Period||0||
60110433|NCT02255032|76230536|FG000|STARTED|Overall Study||17||
60110434|NCT02255032|76230537|FG001|STARTED|Overall Study||5||
60110435|NCT02255032|76230536|FG000|COMPLETED|Overall Study||17||
60110436|NCT02255032|76230537|FG001|COMPLETED|Overall Study||5||
60110437|NCT02255032|76230536|FG000|NOT COMPLETED|Overall Study||0||
60110438|NCT02255032|76230537|FG001|NOT COMPLETED|Overall Study||0||
60110439|NCT02255110|76230543|FG000|STARTED|Overall Study||6||
60110440|NCT02255110|76230543|FG000|COMPLETED|Overall Study||6||
60110441|NCT02255110|76230543|FG000|NOT COMPLETED|Overall Study||0||
60110442|NCT01807624|76230547|FG000|STARTED|Overall Study||24||
60110443|NCT01807624|76230547|FG000|COMPLETED|Overall Study||24||
60110444|NCT01807624|76230547|FG000|NOT COMPLETED|Overall Study||0||
60110445|NCT01808326|76230551|FG000|STARTED|Overall Study||5||
60110446|NCT01808326|76230551|FG000|COMPLETED|Overall Study||5||
60110447|NCT01808326|76230551|FG000|NOT COMPLETED|Overall Study||0||
60110448|NCT01808560|76230558|FG000|STARTED|Randomization and Treatment Allocation||18||
60110449|NCT01808560|76230559|FG001|STARTED|Randomization and Treatment Allocation||16||
60110450|NCT01808560|76230560|FG002|STARTED|Randomization and Treatment Allocation||0||
60110451|NCT01808560|76230558|FG000|COMPLETED|Randomization and Treatment Allocation||18||
60110452|NCT01808560|76230559|FG001|COMPLETED|Randomization and Treatment Allocation||16||
60110453|NCT01808560|76230560|FG002|COMPLETED|Randomization and Treatment Allocation||0||
60110454|NCT01808560|76230558|FG000|NOT COMPLETED|Randomization and Treatment Allocation||0||
60110455|NCT01808560|76230559|FG001|NOT COMPLETED|Randomization and Treatment Allocation||0||
60110456|NCT01808560|76230560|FG002|NOT COMPLETED|Randomization and Treatment Allocation||0||
59822772|NCT00406653|75945532|FG003|COMPLETED|Maintenance Period||0||
59822773|NCT00406653|75945533|FG004|COMPLETED|Maintenance Period||14||
59822774|NCT00406653|75945534|FG005|COMPLETED|Maintenance Period||10||
59822775|NCT00406653|75945535|FG006|COMPLETED|Maintenance Period||0||
59822776|NCT00406653|75945529|FG000|NOT COMPLETED|Maintenance Period||0||
59822777|NCT00406653|75945530|FG001|NOT COMPLETED|Maintenance Period||0||
59822778|NCT00406653|75945531|FG002|NOT COMPLETED|Maintenance Period||0||
60110457|NCT01808560|76230558|FG000|STARTED|1-Month After Cataract Surgery|ITT: 2 subjects withdrew b/c they were unable to complete cataract surgery scheduled for both eyes|16||
60110458|NCT01808560|76230559|FG001|STARTED|1-Month After Cataract Surgery|ITT: 3 subjects withdrew b/c they were unable to complete cataract surgery scheduled for both eyes|13||
60110459|NCT01808560|76230560|FG002|STARTED|1-Month After Cataract Surgery||0||
60110460|NCT01808560|76230558|FG000|COMPLETED|1-Month After Cataract Surgery||16||
60110461|NCT01808560|76230559|FG001|COMPLETED|1-Month After Cataract Surgery||13||
60110462|NCT01808560|76230560|FG002|COMPLETED|1-Month After Cataract Surgery||0||
60110463|NCT01808560|76230558|FG000|NOT COMPLETED|1-Month After Cataract Surgery||0||
60110464|NCT01808560|76230559|FG001|NOT COMPLETED|1-Month After Cataract Surgery||0||
60110465|NCT01808560|76230560|FG002|NOT COMPLETED|1-Month After Cataract Surgery||0||
60110466|NCT01808560|76230558|FG000|STARTED|3-Month After Cataract Surgery||17||
60110467|NCT01808560|76230559|FG001|STARTED|3-Month After Cataract Surgery||13||
60110468|NCT01808560|76230560|FG002|STARTED|3-Month After Cataract Surgery||0||
60110469|NCT01808560|76230558|FG000|COMPLETED|3-Month After Cataract Surgery||17||
60110470|NCT01808560|76230559|FG001|COMPLETED|3-Month After Cataract Surgery||13||
60110471|NCT01808560|76230560|FG002|COMPLETED|3-Month After Cataract Surgery||0||
60110472|NCT01808560|76230558|FG000|NOT COMPLETED|3-Month After Cataract Surgery||0||
60110473|NCT01808560|76230559|FG001|NOT COMPLETED|3-Month After Cataract Surgery||0||
60110474|NCT01808560|76230560|FG002|NOT COMPLETED|3-Month After Cataract Surgery||0||
60110475|NCT01808560|76230558|FG000|STARTED|Crossover Treatment||0||
60110476|NCT01808560|76230559|FG001|STARTED|Crossover Treatment||0||
59714586|NCT01002339|75833330|FG002|COMPLETED|Overall Study||42||
59714587|NCT01002339|75833328|FG000|NOT COMPLETED|Overall Study||0||
59714588|NCT01002339|75833329|FG001|NOT COMPLETED|Overall Study||1||
59714589|NCT01002339|75833330|FG002|NOT COMPLETED|Overall Study||5||
60110477|NCT01808560|76230560|FG002|STARTED|Crossover Treatment|Post-Treatment Group Received Crossover LipiFlow treatment 3 Months after cataract surgery|13||
60110478|NCT01808560|76230558|FG000|COMPLETED|Crossover Treatment||0||
60110479|NCT01808560|76230559|FG001|COMPLETED|Crossover Treatment||0||
60110480|NCT01808560|76230560|FG002|COMPLETED|Crossover Treatment||13||
60110481|NCT01808560|76230558|FG000|NOT COMPLETED|Crossover Treatment||0||
59714590|NCT01002105|75833340|FG000|STARTED|Overall Study||32||
60110482|NCT01808560|76230559|FG001|NOT COMPLETED|Crossover Treatment||0||
60110483|NCT01808560|76230560|FG002|NOT COMPLETED|Crossover Treatment||0||
60110484|NCT01808560|76230558|FG000|STARTED|4-Month After Cataract Surgery||0||
60110485|NCT01808560|76230559|FG001|STARTED|4-Month After Cataract Surgery||0||
60110486|NCT01808560|76230560|FG002|STARTED|4-Month After Cataract Surgery||13||
60110487|NCT01808560|76230558|FG000|COMPLETED|4-Month After Cataract Surgery||0||
60110488|NCT01808560|76230559|FG001|COMPLETED|4-Month After Cataract Surgery||0||
60110489|NCT01808560|76230560|FG002|COMPLETED|4-Month After Cataract Surgery||13||
60110490|NCT01808560|76230558|FG000|NOT COMPLETED|4-Month After Cataract Surgery||0||
60110491|NCT01808560|76230559|FG001|NOT COMPLETED|4-Month After Cataract Surgery||0||
60110492|NCT01808560|76230560|FG002|NOT COMPLETED|4-Month After Cataract Surgery||0||
60110493|NCT01809106|76230572|FG000|STARTED|Overall Study||130||
60110494|NCT01809106|76230573|FG001|STARTED|Overall Study||130||
60110495|NCT01809106|76230574|FG002|STARTED|Overall Study||130||
60110496|NCT01809106|76230575|FG003|STARTED|Overall Study||128||
60110497|NCT01809106|76230572|FG000|COMPLETED|Overall Study||122||
60110498|NCT01809106|76230573|FG001|COMPLETED|Overall Study||125||
60110499|NCT01809106|76230574|FG002|COMPLETED|Overall Study||127||
60110500|NCT01809106|76230575|FG003|COMPLETED|Overall Study||124||
60110501|NCT01809106|76230572|FG000|NOT COMPLETED|Overall Study||8||
60110502|NCT01809106|76230573|FG001|NOT COMPLETED|Overall Study||5||
60110503|NCT01809106|76230574|FG002|NOT COMPLETED|Overall Study||3||
60110504|NCT01809106|76230575|FG003|NOT COMPLETED|Overall Study||4||
60110505|NCT01765972|76230585|FG000|STARTED|Overall Study||6||
60110506|NCT01765972|76230586|FG001|STARTED|Overall Study||6||
59714591|NCT01002105|75833341|FG001|STARTED|Overall Study||32||
59714592|NCT01002105|75833340|FG000|COMPLETED|Overall Study||13||
59714593|NCT01002105|75833341|FG001|COMPLETED|Overall Study||11||
60110507|NCT01765972|76230587|FG002|STARTED|Overall Study||6||
60110508|NCT01765972|76230588|FG003|STARTED|Overall Study||6||
60110509|NCT01765972|76230585|FG000|COMPLETED|Overall Study||6||
60110510|NCT01765972|76230586|FG001|COMPLETED|Overall Study||6||
60110511|NCT01765972|76230587|FG002|COMPLETED|Overall Study||6||
60110512|NCT01765972|76230588|FG003|COMPLETED|Overall Study||6||
60110513|NCT01765972|76230585|FG000|NOT COMPLETED|Overall Study||0||
60110514|NCT01765972|76230586|FG001|NOT COMPLETED|Overall Study||0||
60110515|NCT01765972|76230587|FG002|NOT COMPLETED|Overall Study||0||
60110516|NCT01765972|76230588|FG003|NOT COMPLETED|Overall Study||0||
60110517|NCT01810666|76230598|FG000|STARTED|Overall Study||30||
60110518|NCT01810666|76230598|FG000|COMPLETED|Overall Study||30||
60110519|NCT01810666|76230598|FG000|NOT COMPLETED|Overall Study||0||
60110520|NCT01766440|76230602|FG000|STARTED|Overall Study||18||
60110521|NCT01766440|76230602|FG000|COMPLETED|Overall Study||17||
60110522|NCT01766440|76230602|FG000|NOT COMPLETED|Overall Study||1||
60110523|NCT01811212|76230606|FG000|STARTED|Overall Study||25||
60110524|NCT01811212|76230606|FG000|COMPLETED|Overall Study||25||
60110525|NCT01811212|76230606|FG000|NOT COMPLETED|Overall Study||0||
60110526|NCT01766986|76230613|FG000|STARTED|Overall Study||41||
60110527|NCT01766986|76230614|FG001|STARTED|Overall Study||51||
60110528|NCT01766986|76230615|FG002|STARTED|Overall Study||38||
60110529|NCT01766986|76230613|FG000|COMPLETED|Overall Study||41||
60110530|NCT01766986|76230614|FG001|COMPLETED|Overall Study||51||
60110531|NCT01766986|76230615|FG002|COMPLETED|Overall Study||38||
60110532|NCT01766986|76230613|FG000|NOT COMPLETED|Overall Study||0||
59714594|NCT01002105|75833340|FG000|NOT COMPLETED|Overall Study||19||
59714595|NCT01002105|75833341|FG001|NOT COMPLETED|Overall Study||21||
59714596|NCT02605993|75833354|FG000|STARTED|Treatment Period||6||
59822779|NCT00406653|75945532|FG003|NOT COMPLETED|Maintenance Period||0||
59822780|NCT00406653|75945533|FG004|NOT COMPLETED|Maintenance Period||30||
60110533|NCT01766986|76230614|FG001|NOT COMPLETED|Overall Study||0||
60110534|NCT01766986|76230615|FG002|NOT COMPLETED|Overall Study||0||
60110535|NCT01767064|76230625|FG000|STARTED|Overall Study||7||
60110536|NCT01767064|76230626|FG001|STARTED|Overall Study||7||
60110537|NCT01767064|76230625|FG000|COMPLETED|Overall Study||7||
60110538|NCT01767064|76230626|FG001|COMPLETED|Overall Study||7||
60110539|NCT01767064|76230625|FG000|NOT COMPLETED|Overall Study||0||
59714597|NCT02605993|75833355|FG001|STARTED|Treatment Period||6||
59714598|NCT02605993|75833356|FG002|STARTED|Treatment Period||7||
59822781|NCT00406653|75945534|FG005|NOT COMPLETED|Maintenance Period||36||
60110540|NCT01767064|76230626|FG001|NOT COMPLETED|Overall Study||0||
60110541|NCT01811680|76230632|FG000|STARTED|Overall Study||10||
60110542|NCT01811680|76230632|FG000|COMPLETED|Overall Study||10||
60110543|NCT01811680|76230632|FG000|NOT COMPLETED|Overall Study||0||
60110544|NCT01767688|76230639|FG000|STARTED|Overall Study||8||
60110545|NCT01767688|76230640|FG001|STARTED|Overall Study||8||
60110546|NCT01767688|76230639|FG000|COMPLETED|Overall Study||8||
59822782|NCT00406653|75945535|FG006|NOT COMPLETED|Maintenance Period||0||
59822783|NCT00406653|75945529|FG000|STARTED|Open-Label Period||0||
59822784|NCT00406653|75945530|FG001|STARTED|Open-Label Period||0||
59822785|NCT00406653|75945531|FG002|STARTED|Open-Label Period||0||
59822786|NCT00406653|75945532|FG003|STARTED|Open-Label Period||0||
59822787|NCT00406653|75945533|FG004|STARTED|Open-Label Period||0||
60110547|NCT01767688|76230640|FG001|COMPLETED|Overall Study||8||
60110548|NCT01767688|76230639|FG000|NOT COMPLETED|Overall Study||0||
60110549|NCT01767688|76230640|FG001|NOT COMPLETED|Overall Study||0||
60110550|NCT01768000|76230650|FG000|STARTED|Overall Study||10||
60110551|NCT01768000|76230651|FG001|STARTED|Overall Study||10||
60110552|NCT01768000|76230652|FG002|STARTED|Overall Study||10||
60110553|NCT01768000|76230653|FG003|STARTED|Overall Study||10||
60110554|NCT01768000|76230650|FG000|COMPLETED|Overall Study||9||
60110555|NCT01768000|76230651|FG001|COMPLETED|Overall Study||8||
60110556|NCT01768000|76230652|FG002|COMPLETED|Overall Study||9||
60110557|NCT01768000|76230653|FG003|COMPLETED|Overall Study||8||
60110558|NCT01768000|76230650|FG000|NOT COMPLETED|Overall Study||1||
60110559|NCT01768000|76230651|FG001|NOT COMPLETED|Overall Study||2||
60110560|NCT01768000|76230652|FG002|NOT COMPLETED|Overall Study||1||
60110561|NCT01768000|76230653|FG003|NOT COMPLETED|Overall Study||2||
60110562|NCT02725866|76230665|FG000|STARTED|Overall Study||216||
60110563|NCT02725866|76230665|FG000|COMPLETED|Overall Study||202||
60110564|NCT02725866|76230665|FG000|NOT COMPLETED|Overall Study||14||
60110565|NCT01769170|76230671|FG000|STARTED|Overall Study||303||
60110566|NCT01769170|76230672|FG001|STARTED|Overall Study||149||
60110567|NCT01769170|76230671|FG000|COMPLETED|Overall Study||232||
60110568|NCT01769170|76230672|FG001|COMPLETED|Overall Study||122||
60110569|NCT01769170|76230671|FG000|NOT COMPLETED|Overall Study||71||
60110570|NCT01769170|76230672|FG001|NOT COMPLETED|Overall Study||27||
60110571|NCT01815502|76230680|FG000|STARTED|Overall Study||10||
60110572|NCT01815502|76230681|FG001|STARTED|Overall Study||10||
60110573|NCT01815502|76230680|FG000|COMPLETED|Overall Study||10||
60110574|NCT01815502|76230681|FG001|COMPLETED|Overall Study||10||
60110575|NCT01815502|76230680|FG000|NOT COMPLETED|Overall Study||0||
60110576|NCT01815502|76230681|FG001|NOT COMPLETED|Overall Study||0||
60110577|NCT01769248|76230692|FG000|STARTED|Overall Study||70||
60110578|NCT01769248|76230693|FG001|STARTED|Overall Study||70||
60110579|NCT01769248|76230692|FG000|Participants Who Crossed-over|Overall Study||28||
60110580|NCT01769248|76230693|FG001|Participants Who Crossed-over|Overall Study||12||
60110581|NCT01769248|76230692|FG000|COMPLETED|Overall Study||42||
60110582|NCT01769248|76230693|FG001|COMPLETED|Overall Study||58||
60110583|NCT01769248|76230692|FG000|NOT COMPLETED|Overall Study||28||
60110584|NCT01769248|76230693|FG001|NOT COMPLETED|Overall Study||12||
60110585|NCT02726022|76230701|FG000|STARTED|Overall Study||114||
60110586|NCT02726022|76230701|FG000|COMPLETED|Overall Study||78||
60110587|NCT02726022|76230701|FG000|NOT COMPLETED|Overall Study||36||
60110588|NCT02258152|76230707|FG000|STARTED|Overall Study||44||
60110589|NCT02258152|76230708|FG001|STARTED|Overall Study||38||
60110590|NCT02258152|76230707|FG000|COMPLETED|Overall Study||38||
60110591|NCT02258152|76230708|FG001|COMPLETED|Overall Study||34||
60110592|NCT02258152|76230707|FG000|NOT COMPLETED|Overall Study||6||
60110593|NCT02258152|76230708|FG001|NOT COMPLETED|Overall Study||4||
60110594|NCT02725788|76230716|FG000|STARTED|Overall Study||123||
60110595|NCT02725788|76230717|FG001|STARTED|Overall Study||124||
60110596|NCT02725788|76230716|FG000|COMPLETED|Overall Study||122||
60110597|NCT02725788|76230717|FG001|COMPLETED|Overall Study||122||
60110598|NCT02725788|76230716|FG000|NOT COMPLETED|Overall Study||1||
59714599|NCT02605993|75833357|FG003|STARTED|Treatment Period||7||
60110599|NCT02725788|76230717|FG001|NOT COMPLETED|Overall Study||2||
60110600|NCT01817374|76230723|FG000|STARTED|Overall Study||6||
60110601|NCT01817374|76230723|FG000|COMPLETED|Overall Study||6||
60110602|NCT01817374|76230723|FG000|NOT COMPLETED|Overall Study||0||
60110603|NCT01770652|76230733|FG000|STARTED|Overall Study||8||
60110604|NCT01770652|76230734|FG001|STARTED|Overall Study||8||
60110605|NCT01770652|76230735|FG002|STARTED|Overall Study||8||
60110606|NCT01770652|76230736|FG003|STARTED|Overall Study||8||
60110607|NCT01770652|76230733|FG000|COMPLETED|Overall Study||8||
60110608|NCT01770652|76230734|FG001|COMPLETED|Overall Study||8||
60110609|NCT01770652|76230735|FG002|COMPLETED|Overall Study||8||
59822788|NCT00406653|75945534|FG005|STARTED|Open-Label Period||0||
59822789|NCT00406653|75945535|FG006|STARTED|Open-Label Period|All completing IP but failing response criteria and those completing or relapsing on MP entered OL.|324||
59822790|NCT00406653|75945529|FG000|COMPLETED|Open-Label Period||0||
59822791|NCT00406653|75945530|FG001|COMPLETED|Open-Label Period||0||
59822792|NCT00406653|75945531|FG002|COMPLETED|Open-Label Period||0||
60110610|NCT01770652|76230736|FG003|COMPLETED|Overall Study||8||
60110611|NCT01770652|76230733|FG000|NOT COMPLETED|Overall Study||0||
60110612|NCT01770652|76230734|FG001|NOT COMPLETED|Overall Study||0||
60110613|NCT01770652|76230735|FG002|NOT COMPLETED|Overall Study||0||
60110614|NCT01770652|76230736|FG003|NOT COMPLETED|Overall Study||0||
60110615|NCT01820416|76230753|FG000|STARTED|Overall Study||12||
60110616|NCT01820416|76230754|FG001|STARTED|Overall Study||12||
60110617|NCT01820416|76230755|FG002|STARTED|Overall Study||11||
60110618|NCT01820416|76230753|FG000|COMPLETED|Overall Study||9||
60110619|NCT01820416|76230754|FG001|COMPLETED|Overall Study||10||
60110620|NCT01820416|76230755|FG002|COMPLETED|Overall Study||11||
60110621|NCT01820416|76230753|FG000|NOT COMPLETED|Overall Study||3||
59822793|NCT00406653|75945532|FG003|COMPLETED|Open-Label Period||0||
59822794|NCT00406653|75945533|FG004|COMPLETED|Open-Label Period||0||
59822795|NCT00406653|75945534|FG005|COMPLETED|Open-Label Period||0||
59822796|NCT00406653|75945535|FG006|COMPLETED|Open-Label Period||0||
59822797|NCT00406653|75945529|FG000|NOT COMPLETED|Open-Label Period||0||
59822798|NCT00406653|75945530|FG001|NOT COMPLETED|Open-Label Period||0||
59822799|NCT00406653|75945531|FG002|NOT COMPLETED|Open-Label Period||0||
59822800|NCT00406653|75945532|FG003|NOT COMPLETED|Open-Label Period||0||
59822801|NCT00406653|75945533|FG004|NOT COMPLETED|Open-Label Period||0||
59822802|NCT00406653|75945534|FG005|NOT COMPLETED|Open-Label Period||0||
59822803|NCT00406653|75945535|FG006|NOT COMPLETED|Open-Label Period||324||
59822804|NCT00547157|75945557|FG000|STARTED|Overall Study||90||
59822805|NCT00547157|75945558|FG001|STARTED|Overall Study||62||
59822806|NCT00547157|75945557|FG000|COMPLETED|Overall Study||41||
59822807|NCT00547157|75945558|FG001|COMPLETED|Overall Study||39||
59822808|NCT00547157|75945557|FG000|NOT COMPLETED|Overall Study||49||
59822809|NCT00547157|75945558|FG001|NOT COMPLETED|Overall Study||23||
59822810|NCT00384033|75945568|FG000|STARTED|Overall Study||164||
60110622|NCT01820416|76230754|FG001|NOT COMPLETED|Overall Study||2||
60110623|NCT01820416|76230755|FG002|NOT COMPLETED|Overall Study||0||
60110624|NCT03143218|76230766|FG000|STARTED|Overall Study||1965||
60110625|NCT03143218|76230767|FG001|STARTED|Overall Study||1988||
60110626|NCT03143218|76230768|FG002|STARTED|Overall Study||1967||
60110627|NCT03143218|76230766|FG000|COMPLETED|Overall Study||1716||
60110628|NCT03143218|76230767|FG001|COMPLETED|Overall Study||1734||
60110629|NCT03143218|76230768|FG002|COMPLETED|Overall Study||1740||
60110630|NCT03143218|76230766|FG000|NOT COMPLETED|Overall Study||249||
60110631|NCT03143218|76230767|FG001|NOT COMPLETED|Overall Study||254||
60110632|NCT03143218|76230768|FG002|NOT COMPLETED|Overall Study||227||
60110633|NCT01771666|76230776|FG000|STARTED|Overall Study||23||
60110634|NCT01771666|76230776|FG000|COMPLETED|Overall Study||23||
60110635|NCT01771666|76230776|FG000|NOT COMPLETED|Overall Study||0||
60110636|NCT01821352|76230782|FG000|STARTED|Overall Study||28||
60110637|NCT01821352|76230783|FG001|STARTED|Overall Study||25||
60110638|NCT01821352|76230782|FG000|COMPLETED|Overall Study||28||
60110639|NCT01821352|76230783|FG001|COMPLETED|Overall Study||25||
60110640|NCT01821352|76230782|FG000|NOT COMPLETED|Overall Study||0||
60110641|NCT01821352|76230783|FG001|NOT COMPLETED|Overall Study||0||
60110642|NCT01772758|76230793|FG000|STARTED|Overall Study||18||
60110643|NCT01772758|76230794|FG001|STARTED|Overall Study||17||
60110644|NCT01772758|76230795|FG002|STARTED|Overall Study||12||
60110645|NCT01772758|76230796|FG003|STARTED|Overall Study||17||
60110646|NCT01772758|76230793|FG000|COMPLETED|Overall Study||18||
60110647|NCT01772758|76230794|FG001|COMPLETED|Overall Study||17||
60110648|NCT01772758|76230795|FG002|COMPLETED|Overall Study||12||
60110649|NCT01772758|76230796|FG003|COMPLETED|Overall Study||17||
60110650|NCT01772758|76230793|FG000|NOT COMPLETED|Overall Study||0||
60110651|NCT01772758|76230794|FG001|NOT COMPLETED|Overall Study||0||
60110652|NCT01772758|76230795|FG002|NOT COMPLETED|Overall Study||0||
60110653|NCT01772758|76230796|FG003|NOT COMPLETED|Overall Study||0||
60110654|NCT01775410|76230806|FG000|STARTED|Overall Study||4||
60110655|NCT01775410|76230806|FG000|COMPLETED|Overall Study||4||
60110656|NCT01775410|76230806|FG000|NOT COMPLETED|Overall Study||0||
60110657|NCT01823614|76230816|FG000|STARTED|Overall Study||179||
60110658|NCT01823614|76230817|FG001|STARTED|Overall Study||140||
60110659|NCT01823614|76230818|FG002|STARTED|Overall Study||176||
60110660|NCT01823614|76230819|FG003|STARTED|Overall Study||122||
60110661|NCT01823614|76230820|FG004|STARTED|Overall Study||172||
60110662|NCT01823614|76230821|FG005|STARTED|Overall Study||154||
60110663|NCT01823614|76230816|FG000|COMPLETED|Overall Study||179||
60110664|NCT01823614|76230817|FG001|COMPLETED|Overall Study||140||
60110665|NCT01823614|76230818|FG002|COMPLETED|Overall Study||176||
60110666|NCT01823614|76230819|FG003|COMPLETED|Overall Study||122||
60110667|NCT01823614|76230820|FG004|COMPLETED|Overall Study||172||
59822811|NCT00384033|75945569|FG001|STARTED|Overall Study||155||
59822812|NCT00384033|75945570|FG002|STARTED|Overall Study||160||
59822813|NCT00384033|75945571|FG003|STARTED|Overall Study||159||
59822814|NCT00384033|75945568|FG000|Treated|Overall Study||161||
59822815|NCT00384033|75945569|FG001|Treated|Overall Study||148||
59822816|NCT00384033|75945570|FG002|Treated|Overall Study||150||
59822817|NCT00384033|75945571|FG003|Treated|Overall Study||157||
59822818|NCT00384033|75945568|FG000|COMPLETED|Overall Study||123||
59822819|NCT00384033|75945569|FG001|COMPLETED|Overall Study||120||
60110668|NCT01823614|76230821|FG005|COMPLETED|Overall Study||154||
60110669|NCT01823614|76230816|FG000|NOT COMPLETED|Overall Study||0||
60110670|NCT01823614|76230817|FG001|NOT COMPLETED|Overall Study||0||
60110671|NCT01823614|76230818|FG002|NOT COMPLETED|Overall Study||0||
60110672|NCT01823614|76230819|FG003|NOT COMPLETED|Overall Study||0||
60110673|NCT01823614|76230820|FG004|NOT COMPLETED|Overall Study||0||
60110674|NCT01823614|76230821|FG005|NOT COMPLETED|Overall Study||0||
60110675|NCT01824082|76230843|FG000|STARTED|Initial Treatment||71||
60110676|NCT01824082|76230844|FG001|STARTED|Initial Treatment||73||
60110677|NCT01824082|76230843|FG000|COMPLETED|Initial Treatment||71||
60110678|NCT01824082|76230844|FG001|COMPLETED|Initial Treatment||73||
60110679|NCT01824082|76230843|FG000|NOT COMPLETED|Initial Treatment||0||
59822820|NCT00384033|75945570|FG002|COMPLETED|Overall Study||117||
59822821|NCT00384033|75945571|FG003|COMPLETED|Overall Study||119||
59822822|NCT00384033|75945568|FG000|NOT COMPLETED|Overall Study||41||
59822823|NCT00384033|75945569|FG001|NOT COMPLETED|Overall Study||35||
59822824|NCT00384033|75945570|FG002|NOT COMPLETED|Overall Study||43||
59822825|NCT00384033|75945571|FG003|NOT COMPLETED|Overall Study||40||
59822826|NCT00546377|75945581|FG000|STARTED|Overall Study||50||
59822827|NCT00546377|75945581|FG000|COMPLETED|Overall Study||43||
59822828|NCT00546377|75945581|FG000|NOT COMPLETED|Overall Study||7||
59822829|NCT00545753|75945588|FG000|STARTED|Overall Study||243||
59822830|NCT00545753|75945589|FG001|STARTED|Overall Study||59||
59822831|NCT00545753|75945590|FG002|STARTED|Overall Study||256||
59822832|NCT00545753|75945588|FG000|COMPLETED|Overall Study||227||
59822833|NCT00545753|75945589|FG001|COMPLETED|Overall Study||54||
59822834|NCT00545753|75945590|FG002|COMPLETED|Overall Study||230||
59822835|NCT00545753|75945588|FG000|NOT COMPLETED|Overall Study||16||
59822836|NCT00545753|75945589|FG001|NOT COMPLETED|Overall Study||5||
59822837|NCT00545753|75945590|FG002|NOT COMPLETED|Overall Study||26||
59822838|NCT00406419|75945602|FG000|STARTED|Overall Study||324||
59822839|NCT00406419|75945603|FG001|STARTED|Overall Study||344||
59822840|NCT00406419|75945604|FG002|STARTED|Overall Study||347||
59822841|NCT00406419|75945602|FG000|COMPLETED|Overall Study||0||
59822842|NCT00406419|75945603|FG001|COMPLETED|Overall Study||0||
59822843|NCT00406419|75945604|FG002|COMPLETED|Overall Study||0||
59822844|NCT00406419|75945602|FG000|NOT COMPLETED|Overall Study||324||
59822845|NCT00406419|75945603|FG001|NOT COMPLETED|Overall Study||344||
59822846|NCT00406419|75945604|FG002|NOT COMPLETED|Overall Study||347||
59822847|NCT00325468|75945617|FG000|STARTED|Overall Study||23||
59822848|NCT00325468|75945618|FG001|STARTED|Overall Study||17||
59822849|NCT00325468|75945619|FG002|STARTED|Overall Study||14||
59822850|NCT00325468|75945620|FG003|STARTED|Overall Study||124||
59822851|NCT00325468|75945621|FG004|STARTED|Overall Study||22||
59822852|NCT00325468|75945617|FG000|COMPLETED|Overall Study||12||
59822853|NCT00325468|75945618|FG001|COMPLETED|Overall Study||12||
59822854|NCT00325468|75945619|FG002|COMPLETED|Overall Study||10||
59822855|NCT00325468|75945620|FG003|COMPLETED|Overall Study||90||
59822856|NCT00325468|75945621|FG004|COMPLETED|Overall Study||14||
59822857|NCT00325468|75945617|FG000|NOT COMPLETED|Overall Study||11||
60110680|NCT01824082|76230844|FG001|NOT COMPLETED|Initial Treatment||0||
60110681|NCT01824082|76230843|FG000|STARTED|Optional Crossover Treatment||40||
60110682|NCT01824082|76230844|FG001|STARTED|Optional Crossover Treatment||25||
60110683|NCT01824082|76230843|FG000|COMPLETED|Optional Crossover Treatment||40||
60110684|NCT01824082|76230844|FG001|COMPLETED|Optional Crossover Treatment||25||
60110685|NCT01824082|76230843|FG000|NOT COMPLETED|Optional Crossover Treatment||0||
60110686|NCT01824082|76230844|FG001|NOT COMPLETED|Optional Crossover Treatment||0||
60110687|NCT02725710|76230856|FG000|STARTED|Overall Study||48||
60110688|NCT02725710|76230857|FG001|STARTED|Overall Study||47||
60110689|NCT02725710|76230856|FG000|COMPLETED|Overall Study||47||
60110690|NCT02725710|76230857|FG001|COMPLETED|Overall Study||47||
60110691|NCT02725710|76230856|FG000|NOT COMPLETED|Overall Study||1||
60110692|NCT02725710|76230857|FG001|NOT COMPLETED|Overall Study||0||
60110693|NCT02256358|76230865|FG000|STARTED|Overall Study||34||
60110694|NCT02256358|76230866|FG001|STARTED|Overall Study||34||
60110695|NCT02256358|76230865|FG000|COMPLETED|Overall Study||34||
59714600|NCT02605993|75833354|FG000|Received at Least 1 Dose of Study Drug|Treatment Period||6||
59714601|NCT02605993|75833355|FG001|Received at Least 1 Dose of Study Drug|Treatment Period||6||
59714602|NCT02605993|75833356|FG002|Received at Least 1 Dose of Study Drug|Treatment Period||7||
59714603|NCT02605993|75833357|FG003|Received at Least 1 Dose of Study Drug|Treatment Period||7||
59714604|NCT02605993|75833354|FG000|COMPLETED|Treatment Period||6||
59714605|NCT02605993|75833355|FG001|COMPLETED|Treatment Period||6||
59714606|NCT02605993|75833356|FG002|COMPLETED|Treatment Period||7||
59714607|NCT02605993|75833357|FG003|COMPLETED|Treatment Period||7||
59714608|NCT02605993|75833354|FG000|NOT COMPLETED|Treatment Period||0||
59714609|NCT02605993|75833355|FG001|NOT COMPLETED|Treatment Period||0||
59714610|NCT02605993|75833356|FG002|NOT COMPLETED|Treatment Period||0||
59714611|NCT02605993|75833357|FG003|NOT COMPLETED|Treatment Period||0||
59714612|NCT02605993|75833354|FG000|STARTED|Extension Period||6||
59714613|NCT02605993|75833355|FG001|STARTED|Extension Period||6||
59714614|NCT02605993|75833356|FG002|STARTED|Extension Period||7||
59714615|NCT02605993|75833357|FG003|STARTED|Extension Period||7||
59714616|NCT02605993|75833354|FG000|Received at Least 1 Dose of Study Drug|Extension Period||6||
59714617|NCT02605993|75833355|FG001|Received at Least 1 Dose of Study Drug|Extension Period||6||
59714618|NCT02605993|75833356|FG002|Received at Least 1 Dose of Study Drug|Extension Period||7||
60110696|NCT02256358|76230866|FG001|COMPLETED|Overall Study||33||
60110697|NCT02256358|76230865|FG000|NOT COMPLETED|Overall Study||0||
60110698|NCT02256358|76230866|FG001|NOT COMPLETED|Overall Study||1||
60110699|NCT01824160|76230872|FG000|STARTED|Overall Study||50||
60110700|NCT01824160|76230872|FG000|COMPLETED|Overall Study||50||
60110701|NCT01824160|76230872|FG000|NOT COMPLETED|Overall Study||0||
60110702|NCT01775800|76230878|FG000|STARTED|Overall Study||8||
60110703|NCT01775800|76230879|FG001|STARTED|Overall Study||8||
60110704|NCT01775800|76230878|FG000|COMPLETED|Overall Study||8||
60110705|NCT01775800|76230879|FG001|COMPLETED|Overall Study||8||
60110706|NCT01775800|76230878|FG000|NOT COMPLETED|Overall Study||0||
60110707|NCT01775800|76230879|FG001|NOT COMPLETED|Overall Study||0||
60110708|NCT02724462|76230888|FG000|STARTED|3 Month Follow-up Survey||1254||
60110709|NCT02724462|76230889|FG001|STARTED|3 Month Follow-up Survey||1249||
60110710|NCT02724462|76230888|FG000|COMPLETED|3 Month Follow-up Survey||1043||
60110711|NCT02724462|76230889|FG001|COMPLETED|3 Month Follow-up Survey||1050||
60110712|NCT02724462|76230888|FG000|NOT COMPLETED|3 Month Follow-up Survey||211||
60110713|NCT02724462|76230889|FG001|NOT COMPLETED|3 Month Follow-up Survey||199||
60110714|NCT02724462|76230888|FG000|STARTED|6 Month Follow-up Survey||1254||
60110715|NCT02724462|76230889|FG001|STARTED|6 Month Follow-up Survey||1249||
60110716|NCT02724462|76230888|FG000|COMPLETED|6 Month Follow-up Survey||1058||
60110717|NCT02724462|76230889|FG001|COMPLETED|6 Month Follow-up Survey||1078||
60110718|NCT02724462|76230888|FG000|NOT COMPLETED|6 Month Follow-up Survey||196||
59567056|NCT03847389|75669860|FG001|STARTED|Overall Study|Start of Cohort 2 can only happen if less than or equal to 40% of subjects in Cohort 1 had HPA axis suppression.|0||
60110719|NCT02724462|76230889|FG001|NOT COMPLETED|6 Month Follow-up Survey||171||
60110720|NCT02724462|76230888|FG000|STARTED|12 Month Follow-up Survey||1254||
60110721|NCT02724462|76230889|FG001|STARTED|12 Month Follow-up Survey||1249||
60110722|NCT02724462|76230888|FG000|COMPLETED|12 Month Follow-up Survey||1040||
60110723|NCT02724462|76230889|FG001|COMPLETED|12 Month Follow-up Survey||1067||
60110724|NCT02724462|76230888|FG000|NOT COMPLETED|12 Month Follow-up Survey||214||
60110725|NCT02724462|76230889|FG001|NOT COMPLETED|12 Month Follow-up Survey||182||
60110726|NCT01825408|76230899|FG000|STARTED|Overall Study||7||
60110727|NCT01825408|76230900|FG001|STARTED|Overall Study||7||
60110728|NCT01825408|76230901|FG002|STARTED|Overall Study||14||
60110729|NCT01825408|76230902|FG003|STARTED|Overall Study||12||
60110730|NCT01825408|76230899|FG000|COMPLETED|Overall Study||7||
60110731|NCT01825408|76230900|FG001|COMPLETED|Overall Study||7||
60110732|NCT01825408|76230901|FG002|COMPLETED|Overall Study||14||
60110733|NCT01825408|76230902|FG003|COMPLETED|Overall Study||12||
60110734|NCT01825408|76230899|FG000|NOT COMPLETED|Overall Study||0||
60110735|NCT01825408|76230900|FG001|NOT COMPLETED|Overall Study||0||
60110736|NCT01825408|76230901|FG002|NOT COMPLETED|Overall Study||0||
60110737|NCT01825408|76230902|FG003|NOT COMPLETED|Overall Study||0||
60110738|NCT01776268|76230914|FG000|STARTED|Overall Study||48||
60110739|NCT01776268|76230915|FG001|STARTED|Overall Study||51||
60110740|NCT01776268|76230914|FG000|COMPLETED|Overall Study||48||
60110741|NCT01776268|76230915|FG001|COMPLETED|Overall Study||51||
60110742|NCT01776268|76230914|FG000|NOT COMPLETED|Overall Study||0||
60110743|NCT01776268|76230915|FG001|NOT COMPLETED|Overall Study||0||
60110744|NCT01777126|76230924|FG000|STARTED|Overall Study||48||
60110745|NCT01777126|76230925|FG001|STARTED|Overall Study||46||
60110746|NCT01777126|76230924|FG000|COMPLETED|Overall Study||48||
60110747|NCT01777126|76230925|FG001|COMPLETED|Overall Study||46||
60110748|NCT01777126|76230924|FG000|NOT COMPLETED|Overall Study||0||
60110749|NCT01777126|76230925|FG001|NOT COMPLETED|Overall Study||0||
60110750|NCT01826812|76230935|FG000|STARTED|Overall Study||167||
60110751|NCT01826812|76230936|FG001|STARTED|Overall Study||33||
60110752|NCT01826812|76230935|FG000|COMPLETED|Overall Study||167||
60110753|NCT01826812|76230936|FG001|COMPLETED|Overall Study||32||
60110754|NCT01826812|76230935|FG000|NOT COMPLETED|Overall Study||0||
60110755|NCT01826812|76230936|FG001|NOT COMPLETED|Overall Study||1||
60110756|NCT02725476|76230946|FG000|STARTED|Overall Study||15||
60110757|NCT02725476|76230947|FG001|STARTED|Overall Study||5||
60110758|NCT02725476|76230946|FG000|COMPLETED|Overall Study||12||
60110759|NCT02725476|76230947|FG001|COMPLETED|Overall Study||4||
60110760|NCT02725476|76230946|FG000|NOT COMPLETED|Overall Study||3||
60110761|NCT02725476|76230947|FG001|NOT COMPLETED|Overall Study||1||
60110762|NCT02262130|76230953|FG000|STARTED|Overall Study||10||
60110763|NCT02262130|76230953|FG000|COMPLETED|Overall Study||10||
60110764|NCT02262130|76230953|FG000|NOT COMPLETED|Overall Study||0||
60110765|NCT01777438|76230959|FG000|STARTED|Overall Study||352||
60110766|NCT01777438|76230960|FG001|STARTED|Overall Study||82||
60110767|NCT01777438|76230959|FG000|COMPLETED|Overall Study||352||
60110768|NCT01777438|76230960|FG001|COMPLETED|Overall Study||82||
60110769|NCT01777438|76230959|FG000|NOT COMPLETED|Overall Study||0||
60110770|NCT01777438|76230960|FG001|NOT COMPLETED|Overall Study||0||
60110771|NCT01778296|76230966|FG000|STARTED|Overall Study|There were 12 patients included in the study in the initial stage.|12||
60110772|NCT01778296|76230966|FG000|COMPLETED|Overall Study|No patient was lost to follow-up.|12||
60110773|NCT01778296|76230966|FG000|NOT COMPLETED|Overall Study||0||
60110774|NCT01827358|76230972|FG000|STARTED|Overall Study||80||
60110775|NCT01827358|76230973|FG001|STARTED|Overall Study||75||
60110776|NCT01827358|76230972|FG000|COMPLETED|Overall Study||45||
60110777|NCT01827358|76230973|FG001|COMPLETED|Overall Study||44||
60110778|NCT01827358|76230972|FG000|NOT COMPLETED|Overall Study||35||
60110779|NCT01827358|76230973|FG001|NOT COMPLETED|Overall Study||31||
60110780|NCT01828216|76230981|FG000|STARTED|Overall Study||159||
60110781|NCT01828216|76230982|FG001|STARTED|Overall Study||157||
60110782|NCT01828216|76230981|FG000|COMPLETED|Overall Study||159||
60110783|NCT01828216|76230982|FG001|COMPLETED|Overall Study||157||
60110784|NCT01828216|76230981|FG000|NOT COMPLETED|Overall Study||0||
60110785|NCT01828216|76230982|FG001|NOT COMPLETED|Overall Study||0||
60110786|NCT01780324|76230992|FG000|STARTED|Overall Study||41||
60110787|NCT01780324|76230993|FG001|STARTED|Overall Study||39||
60110788|NCT01780324|76230992|FG000|COMPLETED|Overall Study||40||
60110789|NCT01780324|76230993|FG001|COMPLETED|Overall Study||33||
60110790|NCT01780324|76230992|FG000|NOT COMPLETED|Overall Study||1||
60110791|NCT01780324|76230993|FG001|NOT COMPLETED|Overall Study||6||
60110792|NCT01780870|76231001|FG000|STARTED|Overall Study||0||
60110793|NCT01780870|76231002|FG001|STARTED|Overall Study||5||
60110794|NCT01780870|76231001|FG000|COMPLETED|Overall Study||0||
60110795|NCT01780870|76231002|FG001|COMPLETED|Overall Study||5||
60110796|NCT01780870|76231001|FG000|NOT COMPLETED|Overall Study||0||
60110797|NCT01780870|76231002|FG001|NOT COMPLETED|Overall Study||0||
60110798|NCT01781806|76231010|FG000|STARTED|Overall Study||297||
60110799|NCT01781806|76231011|FG001|STARTED|Overall Study||4||
60110800|NCT01781806|76231010|FG000|Week 0|Overall Study||297||
60110801|NCT01781806|76231011|FG001|Week 0|Overall Study||4||
60110802|NCT01781806|76231010|FG000|Week 4|Overall Study||284||
60110803|NCT01781806|76231011|FG001|Week 4|Overall Study||4||
60110804|NCT01781806|76231010|FG000|Week 8|Overall Study||278||
60110805|NCT01781806|76231011|FG001|Week 8|Overall Study||4||
60110806|NCT01781806|76231010|FG000|Week 12|Overall Study||272||
60110807|NCT01781806|76231011|FG001|Week 12|Overall Study||2||
60110808|NCT01781806|76231010|FG000|Week 24|Overall Study||260||
60110809|NCT01781806|76231011|FG001|Week 24|Overall Study||1||
60110810|NCT01781806|76231010|FG000|Week 36|Overall Study||247||
60110811|NCT01781806|76231011|FG001|Week 36|Overall Study||1||
60110812|NCT01781806|76231010|FG000|Week 48|Overall Study||222||
60110813|NCT01781806|76231011|FG001|Week 48|Overall Study||1||
60110814|NCT01781806|76231010|FG000|COMPLETED|Overall Study||218||
60110815|NCT01781806|76231011|FG001|COMPLETED|Overall Study||1||
60110816|NCT01781806|76231010|FG000|NOT COMPLETED|Overall Study||79||
60110817|NCT01781806|76231011|FG001|NOT COMPLETED|Overall Study||3||
60110818|NCT01784848|76231020|FG000|STARTED|Overall Study||50||
60110819|NCT01784848|76231021|FG001|STARTED|Overall Study||50||
60110820|NCT01784848|76231020|FG000|COMPLETED|Overall Study||49||
60110821|NCT01784848|76231021|FG001|COMPLETED|Overall Study||47||
60110822|NCT01784848|76231020|FG000|NOT COMPLETED|Overall Study||1||
60110823|NCT01784848|76231021|FG001|NOT COMPLETED|Overall Study||3||
60110824|NCT01782898|76231029|FG000|STARTED|Overall Study||35||
60110825|NCT01782898|76231030|FG001|STARTED|Overall Study||35||
60110826|NCT01782898|76231029|FG000|COMPLETED|Overall Study||29||
60110827|NCT01782898|76231030|FG001|COMPLETED|Overall Study||29||
60110828|NCT01782898|76231029|FG000|NOT COMPLETED|Overall Study||6||
60110829|NCT01782898|76231030|FG001|NOT COMPLETED|Overall Study||6||
60110830|NCT01831960|76231038|FG000|STARTED|Overall Study||20||
60110831|NCT01831960|76231039|FG001|STARTED|Overall Study||22||
60110832|NCT01831960|76231038|FG000|COMPLETED|Overall Study||20||
60110833|NCT01831960|76231039|FG001|COMPLETED|Overall Study||22||
60110834|NCT01831960|76231038|FG000|NOT COMPLETED|Overall Study||0||
60110835|NCT01831960|76231039|FG001|NOT COMPLETED|Overall Study||0||
60110836|NCT01783054|76231046|FG000|STARTED|Overall Study||2||
60110837|NCT01783054|76231046|FG000|COMPLETED|Overall Study||2||
60110838|NCT01783054|76231046|FG000|NOT COMPLETED|Overall Study||0||
60110839|NCT02725008|76231052|FG000|STARTED|Overall Study||46||
60110840|NCT02725008|76231053|FG001|STARTED|Overall Study||51||
60110841|NCT02725008|76231052|FG000|COMPLETED|Overall Study||37||
60110842|NCT02725008|76231053|FG001|COMPLETED|Overall Study||39||
60110843|NCT02725008|76231052|FG000|NOT COMPLETED|Overall Study||9||
60110844|NCT02725008|76231053|FG001|NOT COMPLETED|Overall Study||12||
60110845|NCT01832506|76231062|FG000|STARTED|Overall Study||3||
60110846|NCT01832506|76231063|FG001|STARTED|Overall Study||3||
60110847|NCT01832506|76231064|FG002|STARTED|Overall Study||6||
60110848|NCT01832506|76231062|FG000|COMPLETED|Overall Study||3||
59822858|NCT00325468|75945618|FG001|NOT COMPLETED|Overall Study||5||
59822859|NCT00325468|75945619|FG002|NOT COMPLETED|Overall Study||4||
59822860|NCT00325468|75945620|FG003|NOT COMPLETED|Overall Study||34||
59822861|NCT00325468|75945621|FG004|NOT COMPLETED|Overall Study||8||
59822862|NCT00311584|75945636|FG000|STARTED|Overall Study||29||
59822863|NCT00311584|75945637|FG001|STARTED|Overall Study||30||
59822864|NCT00311584|75945636|FG000|COMPLETED|Overall Study||9||
59822865|NCT00311584|75945637|FG001|COMPLETED|Overall Study||7||
60110849|NCT01832506|76231063|FG001|COMPLETED|Overall Study||3||
60110850|NCT01832506|76231064|FG002|COMPLETED|Overall Study||6||
60110851|NCT01832506|76231062|FG000|NOT COMPLETED|Overall Study||0||
60110852|NCT01832506|76231063|FG001|NOT COMPLETED|Overall Study||0||
60110853|NCT01832506|76231064|FG002|NOT COMPLETED|Overall Study||0||
60110854|NCT01783522|76231079|FG000|STARTED|Overall Study||4||
60110855|NCT01783522|76231080|FG001|STARTED|Overall Study||5||
59822866|NCT00311584|75945636|FG000|NOT COMPLETED|Overall Study||20||
59822867|NCT00311584|75945637|FG001|NOT COMPLETED|Overall Study||23||
59822868|NCT00383331|75945645|FG000|STARTED|Overall Study||10||
59822869|NCT00383331|75945646|FG001|STARTED|Overall Study||9||
59822870|NCT00383331|75945645|FG000|COMPLETED|Overall Study||10||
59822871|NCT00383331|75945646|FG001|COMPLETED|Overall Study||8||
59822872|NCT00383331|75945645|FG000|NOT COMPLETED|Overall Study||0||
59822873|NCT00383331|75945646|FG001|NOT COMPLETED|Overall Study||1||
59822874|NCT03934541|75945656|FG000|STARTED|Overall Study||5||
59822875|NCT03934541|75945657|FG001|STARTED|Overall Study||15||
59822876|NCT03934541|75945658|FG002|STARTED|Overall Study||1||
59822877|NCT03934541|75945659|FG003|STARTED|Overall Study||3||
59822878|NCT03934541|75945656|FG000|COMPLETED|Overall Study||5||
59822879|NCT03934541|75945657|FG001|COMPLETED|Overall Study||14||
59822880|NCT03934541|75945658|FG002|COMPLETED|Overall Study||1||
59822881|NCT03934541|75945659|FG003|COMPLETED|Overall Study||3||
59822882|NCT03934541|75945656|FG000|NOT COMPLETED|Overall Study||0||
59822883|NCT03934541|75945657|FG001|NOT COMPLETED|Overall Study||1||
60110856|NCT01783522|76231079|FG000|COMPLETED|Overall Study||4||
59714619|NCT02605993|75833357|FG003|Received at Least 1 Dose of Study Drug|Extension Period||7||
59714620|NCT02605993|75833354|FG000|COMPLETED|Extension Period||6|Extension Period ongoing|
59714621|NCT02605993|75833355|FG001|COMPLETED|Extension Period||6|Extension Period ongoing|
59714622|NCT02605993|75833356|FG002|COMPLETED|Extension Period||6|Extension Period ongoing|
59714623|NCT02605993|75833357|FG003|COMPLETED|Extension Period||7|Extension Period ongoing|
59714624|NCT02605993|75833354|FG000|NOT COMPLETED|Extension Period||0||
59714625|NCT02605993|75833355|FG001|NOT COMPLETED|Extension Period||0||
59714626|NCT02605993|75833356|FG002|NOT COMPLETED|Extension Period||1||
59714627|NCT02605993|75833357|FG003|NOT COMPLETED|Extension Period||0||
59714628|NCT00995085|75833367|FG000|STARTED|Overall Study||43||
59714629|NCT00995085|75833367|FG000|COMPLETED|Overall Study||38||
59822884|NCT03934541|75945658|FG002|NOT COMPLETED|Overall Study||0||
59822885|NCT03934541|75945659|FG003|NOT COMPLETED|Overall Study||0||
60110857|NCT01783522|76231080|FG001|COMPLETED|Overall Study||5||
60110858|NCT01783522|76231079|FG000|NOT COMPLETED|Overall Study||0||
60110859|NCT01783522|76231080|FG001|NOT COMPLETED|Overall Study||0||
60110860|NCT01833130|76231088|FG000|STARTED|Overall Study||25||
60110861|NCT01833130|76231089|FG001|STARTED|Overall Study||27||
60110862|NCT01833130|76231088|FG000|COMPLETED|Overall Study||15||
60110863|NCT01833130|76231089|FG001|COMPLETED|Overall Study||8||
60110864|NCT01833130|76231088|FG000|NOT COMPLETED|Overall Study||10||
60110865|NCT01833130|76231089|FG001|NOT COMPLETED|Overall Study||19||
60110866|NCT01783912|76231098|FG000|STARTED|Overall Study||118||
60110867|NCT01783912|76231099|FG001|STARTED|Overall Study||104||
60110868|NCT01783912|76231100|FG002|STARTED|Overall Study||48||
60110869|NCT01783912|76231098|FG000|COMPLETED|Overall Study||88||
59714630|NCT00995085|75833367|FG000|NOT COMPLETED|Overall Study||5||
59714631|NCT00603733|75833373|FG000|STARTED|Active Phase ITT|Note: a total of 190 new participants were enrolled and randomized in the Active Phase|95||
59714632|NCT00603733|75833374|FG001|STARTED|Active Phase ITT||95||
59822886|NCT00325234|75945671|FG000|STARTED|Overall Study||69||
59822887|NCT00325234|75945672|FG001|STARTED|Overall Study||66||
59822888|NCT00325234|75945671|FG000|Received At Least 1 Dose of Study Drug|Overall Study||65||
59822889|NCT00325234|75945672|FG001|Received At Least 1 Dose of Study Drug|Overall Study||66||
59822890|NCT00325234|75945671|FG000|COMPLETED|Overall Study||0||
59822891|NCT00325234|75945672|FG001|COMPLETED|Overall Study||0||
59822892|NCT00325234|75945671|FG000|NOT COMPLETED|Overall Study||69||
59822893|NCT00325234|75945672|FG001|NOT COMPLETED|Overall Study||66||
59822894|NCT00366249|75945682|FG000|STARTED|Overall Study||553||
59822895|NCT00366249|75945683|FG001|STARTED|Overall Study||508||
59822896|NCT00366249|75945682|FG000|COMPLETED|Overall Study||422||
59822897|NCT00366249|75945683|FG001|COMPLETED|Overall Study||430||
59822898|NCT00366249|75945682|FG000|NOT COMPLETED|Overall Study||131||
59822899|NCT00366249|75945683|FG001|NOT COMPLETED|Overall Study||78||
59822900|NCT00325156|75945689|FG000|STARTED|Overall Study||2590||
59822901|NCT00325156|75945689|FG000|COMPLETED|Overall Study||2478||
60110870|NCT01783912|76231099|FG001|COMPLETED|Overall Study||58||
60110871|NCT01783912|76231100|FG002|COMPLETED|Overall Study||25||
60110872|NCT01783912|76231098|FG000|NOT COMPLETED|Overall Study||30||
60110873|NCT01783912|76231099|FG001|NOT COMPLETED|Overall Study||46||
60110874|NCT01783912|76231100|FG002|NOT COMPLETED|Overall Study||23||
60110875|NCT01783990|76231110|FG000|STARTED|Overall Study||130||
60110876|NCT01783990|76231111|FG001|STARTED|Overall Study||20||
60110877|NCT01783990|76231110|FG000|COMPLETED|Overall Study||125||
60110878|NCT01783990|76231111|FG001|COMPLETED|Overall Study||18||
60110879|NCT01783990|76231110|FG000|NOT COMPLETED|Overall Study||5||
60110880|NCT01783990|76231111|FG001|NOT COMPLETED|Overall Study||2||
60110881|NCT01733056|76231122|FG000|STARTED|Overall Study||21||
60110882|NCT01733056|76231123|FG001|STARTED|Overall Study||10||
60110883|NCT01733056|76231124|FG002|STARTED|Overall Study||12||
60110884|NCT01733056|76231122|FG000|COMPLETED|Overall Study||21||
60110885|NCT01733056|76231123|FG001|COMPLETED|Overall Study||10||
59822902|NCT00325156|75945689|FG000|NOT COMPLETED|Overall Study||112||
60110886|NCT01733056|76231124|FG002|COMPLETED|Overall Study||12||
60110887|NCT01733056|76231122|FG000|NOT COMPLETED|Overall Study||0||
60110888|NCT01733056|76231123|FG001|NOT COMPLETED|Overall Study||0||
59714633|NCT00603733|75833373|FG000|COMPLETED|Active Phase ITT||84||
59822903|NCT03927911|75945699|FG000|STARTED|Overall Study||0||
60110889|NCT01733056|76231124|FG002|NOT COMPLETED|Overall Study||0||
60110890|NCT01833988|76231135|FG000|STARTED|Overall Study||16||
60110891|NCT01833988|76231136|FG001|STARTED|Overall Study||16||
60110892|NCT01833988|76231135|FG000|COMPLETED|Overall Study||16||
60110893|NCT01833988|76231136|FG001|COMPLETED|Overall Study||16||
59822904|NCT03927911|75945700|FG001|STARTED|Overall Study||17||
59822905|NCT03927911|75945701|FG002|STARTED|Overall Study||0||
59822906|NCT03927911|75945702|FG003|STARTED|Overall Study||3||
59822907|NCT03927911|75945703|FG004|STARTED|Overall Study||13||
59822908|NCT03927911|75945704|FG005|STARTED|Overall Study||32||
60110894|NCT01833988|76231135|FG000|NOT COMPLETED|Overall Study||0||
60110895|NCT01833988|76231136|FG001|NOT COMPLETED|Overall Study||0||
60110896|NCT01784614|76231147|FG000|STARTED|Period 1||3||
60110897|NCT01784614|76231148|FG001|STARTED|Period 1||3||
60110898|NCT01784614|76231149|FG002|STARTED|Period 1||3||
60110899|NCT01784614|76231150|FG003|STARTED|Period 1||3||
60110900|NCT01784614|76231151|FG004|STARTED|Period 1||3||
60110901|NCT01784614|76231152|FG005|STARTED|Period 1||3||
60110902|NCT01784614|76231153|FG006|STARTED|Period 1||3||
60110903|NCT01784614|76231154|FG007|STARTED|Period 1||3||
60110904|NCT01784614|76231147|FG000|Received at Least 1 Dose of Study Drug|Period 1||3||
60110905|NCT01784614|76231148|FG001|Received at Least 1 Dose of Study Drug|Period 1||3||
60110906|NCT01784614|76231149|FG002|Received at Least 1 Dose of Study Drug|Period 1||3||
60110907|NCT01784614|76231150|FG003|Received at Least 1 Dose of Study Drug|Period 1||3||
60110908|NCT01784614|76231151|FG004|Received at Least 1 Dose of Study Drug|Period 1||3||
60110909|NCT01784614|76231152|FG005|Received at Least 1 Dose of Study Drug|Period 1||3||
60110910|NCT01784614|76231153|FG006|Received at Least 1 Dose of Study Drug|Period 1||3||
60110911|NCT01784614|76231154|FG007|Received at Least 1 Dose of Study Drug|Period 1||3||
60110912|NCT01784614|76231147|FG000|COMPLETED|Period 1||3||
60110913|NCT01784614|76231148|FG001|COMPLETED|Period 1||3||
60110914|NCT01784614|76231149|FG002|COMPLETED|Period 1||3||
60110915|NCT01784614|76231150|FG003|COMPLETED|Period 1||3||
60110916|NCT01784614|76231151|FG004|COMPLETED|Period 1||3||
60110917|NCT01784614|76231152|FG005|COMPLETED|Period 1||3||
60110918|NCT01784614|76231153|FG006|COMPLETED|Period 1||3||
60110919|NCT01784614|76231154|FG007|COMPLETED|Period 1|One participant withdrew consent after completed Period 1 and did not enter Period 2.|3||
60110920|NCT01784614|76231147|FG000|NOT COMPLETED|Period 1||0||
60110921|NCT01784614|76231148|FG001|NOT COMPLETED|Period 1||0||
60110922|NCT01784614|76231149|FG002|NOT COMPLETED|Period 1||0||
60110923|NCT01784614|76231150|FG003|NOT COMPLETED|Period 1||0||
60110924|NCT01784614|76231151|FG004|NOT COMPLETED|Period 1||0||
60110925|NCT01784614|76231152|FG005|NOT COMPLETED|Period 1||0||
59567057|NCT03847389|75669861|FG002|STARTED|Overall Study|Start of Cohort 3 can only happen if less than or equal to 40% of subjects in Cohort 2 had HPA axis suppression.|0||
59567058|NCT03847389|75669859|FG000|COMPLETED|Overall Study||8||
60110926|NCT01784614|76231153|FG006|NOT COMPLETED|Period 1||0||
60110927|NCT01784614|76231154|FG007|NOT COMPLETED|Period 1||0||
60110928|NCT01784614|76231147|FG000|STARTED|Period 2||3||
60110929|NCT01784614|76231148|FG001|STARTED|Period 2||3||
60110930|NCT01784614|76231149|FG002|STARTED|Period 2||3||
60110931|NCT01784614|76231150|FG003|STARTED|Period 2||3||
60110932|NCT01784614|76231151|FG004|STARTED|Period 2||3||
60110933|NCT01784614|76231152|FG005|STARTED|Period 2||3||
60110934|NCT01784614|76231153|FG006|STARTED|Period 2||3||
60110935|NCT01784614|76231154|FG007|STARTED|Period 2||2||
60110936|NCT01784614|76231147|FG000|COMPLETED|Period 2||3||
60110937|NCT01784614|76231148|FG001|COMPLETED|Period 2|One participant withdrew consent after completed Period 2 and did not enter Period 3.|3||
60110938|NCT01784614|76231149|FG002|COMPLETED|Period 2||3||
60110939|NCT01784614|76231150|FG003|COMPLETED|Period 2||3||
60110940|NCT01784614|76231151|FG004|COMPLETED|Period 2||3||
60110941|NCT01784614|76231152|FG005|COMPLETED|Period 2||3||
60110942|NCT01784614|76231153|FG006|COMPLETED|Period 2||3||
60110943|NCT01784614|76231154|FG007|COMPLETED|Period 2||2||
60110944|NCT01784614|76231147|FG000|NOT COMPLETED|Period 2||0||
60110945|NCT01784614|76231148|FG001|NOT COMPLETED|Period 2||0||
60110946|NCT01784614|76231149|FG002|NOT COMPLETED|Period 2||0||
60110947|NCT01784614|76231150|FG003|NOT COMPLETED|Period 2||0||
59567059|NCT03847389|75669860|FG001|COMPLETED|Overall Study||0||
60110948|NCT01784614|76231151|FG004|NOT COMPLETED|Period 2||0||
60110949|NCT01784614|76231152|FG005|NOT COMPLETED|Period 2||0||
60110950|NCT01784614|76231153|FG006|NOT COMPLETED|Period 2||0||
60110951|NCT01784614|76231154|FG007|NOT COMPLETED|Period 2||0||
60110952|NCT01784614|76231147|FG000|STARTED|Period 3||3||
60110953|NCT01784614|76231148|FG001|STARTED|Period 3||2||
60110954|NCT01784614|76231149|FG002|STARTED|Period 3||3||
60110955|NCT01784614|76231150|FG003|STARTED|Period 3||3||
60110956|NCT01784614|76231151|FG004|STARTED|Period 3||3||
60110957|NCT01784614|76231152|FG005|STARTED|Period 3||3||
60110958|NCT01784614|76231153|FG006|STARTED|Period 3||3||
60110959|NCT01784614|76231154|FG007|STARTED|Period 3||2||
60110960|NCT01784614|76231147|FG000|COMPLETED|Period 3||3||
60110961|NCT01784614|76231148|FG001|COMPLETED|Period 3||2||
60110962|NCT01784614|76231149|FG002|COMPLETED|Period 3||3||
60110963|NCT01784614|76231150|FG003|COMPLETED|Period 3||3||
60110964|NCT01784614|76231151|FG004|COMPLETED|Period 3||3||
60110965|NCT01784614|76231152|FG005|COMPLETED|Period 3||3||
60110966|NCT01784614|76231153|FG006|COMPLETED|Period 3||3||
60110967|NCT01784614|76231154|FG007|COMPLETED|Period 3||2||
60110968|NCT01784614|76231147|FG000|NOT COMPLETED|Period 3||0||
60110969|NCT01784614|76231148|FG001|NOT COMPLETED|Period 3||0||
60110970|NCT01784614|76231149|FG002|NOT COMPLETED|Period 3||0||
60110971|NCT01784614|76231150|FG003|NOT COMPLETED|Period 3||0||
60110972|NCT01784614|76231151|FG004|NOT COMPLETED|Period 3||0||
60110973|NCT01784614|76231152|FG005|NOT COMPLETED|Period 3||0||
60110974|NCT01784614|76231153|FG006|NOT COMPLETED|Period 3||0||
60110975|NCT01784614|76231154|FG007|NOT COMPLETED|Period 3||0||
60110976|NCT01784614|76231147|FG000|STARTED|Period 4||3||
60110977|NCT01784614|76231148|FG001|STARTED|Period 4||2||
60110978|NCT01784614|76231149|FG002|STARTED|Period 4||3||
60110979|NCT01784614|76231150|FG003|STARTED|Period 4||3||
60110980|NCT01784614|76231151|FG004|STARTED|Period 4||3||
60110981|NCT01784614|76231152|FG005|STARTED|Period 4||3||
59714634|NCT00603733|75833374|FG001|COMPLETED|Active Phase ITT||78||
59714635|NCT00603733|75833373|FG000|NOT COMPLETED|Active Phase ITT||11||
59714636|NCT00603733|75833374|FG001|NOT COMPLETED|Active Phase ITT||17||
59714637|NCT00603733|75833373|FG000|STARTED|Run-In Phase - 4 Weeks|Note: Of the 98 subjects randomized at Run-In, 71 progressed into the maintenance phase.|49||
60110982|NCT01784614|76231153|FG006|STARTED|Period 4||3||
60110983|NCT01784614|76231154|FG007|STARTED|Period 4||2||
60110984|NCT01784614|76231147|FG000|COMPLETED|Period 4||3||
60110985|NCT01784614|76231148|FG001|COMPLETED|Period 4||2||
60110986|NCT01784614|76231149|FG002|COMPLETED|Period 4||3||
60110987|NCT01784614|76231150|FG003|COMPLETED|Period 4||3||
60110988|NCT01784614|76231151|FG004|COMPLETED|Period 4||3||
60110989|NCT01784614|76231152|FG005|COMPLETED|Period 4||3||
60110990|NCT01784614|76231153|FG006|COMPLETED|Period 4||3||
60110991|NCT01784614|76231154|FG007|COMPLETED|Period 4||2||
60110992|NCT01784614|76231147|FG000|NOT COMPLETED|Period 4||0||
60110993|NCT01784614|76231148|FG001|NOT COMPLETED|Period 4||0||
60110994|NCT01784614|76231149|FG002|NOT COMPLETED|Period 4||0||
60110995|NCT01784614|76231150|FG003|NOT COMPLETED|Period 4||0||
60110996|NCT01784614|76231151|FG004|NOT COMPLETED|Period 4||0||
60110997|NCT01784614|76231152|FG005|NOT COMPLETED|Period 4||0||
60110998|NCT01784614|76231153|FG006|NOT COMPLETED|Period 4||0||
60110999|NCT01784614|76231154|FG007|NOT COMPLETED|Period 4||0||
60111000|NCT01733212|76231176|FG000|STARTED|Overall Study||116||
60111001|NCT01733212|76231177|FG001|STARTED|Overall Study||123||
60111002|NCT01733212|76231176|FG000|COMPLETED|Overall Study||116||
60111003|NCT01733212|76231177|FG001|COMPLETED|Overall Study||123||
60111004|NCT01733212|76231176|FG000|NOT COMPLETED|Overall Study||0||
60111005|NCT01733212|76231177|FG001|NOT COMPLETED|Overall Study||0||
60111006|NCT01733368|76231183|FG000|STARTED|Overall Study||198||
60111007|NCT01733368|76231183|FG000|COMPLETED|Overall Study||167||
60111008|NCT01733368|76231183|FG000|NOT COMPLETED|Overall Study||31||
60111009|NCT01784770|76231189|FG000|STARTED|Overall Study||21||
60111010|NCT01784770|76231189|FG000|COMPLETED|Overall Study||21||
60111011|NCT01784770|76231189|FG000|NOT COMPLETED|Overall Study||0||
59714638|NCT00603733|75833374|FG001|STARTED|Run-In Phase - 4 Weeks||49||
59714639|NCT00603733|75833373|FG000|COMPLETED|Run-In Phase - 4 Weeks||35||
59714640|NCT00603733|75833374|FG001|COMPLETED|Run-In Phase - 4 Weeks||36||
59714641|NCT00603733|75833373|FG000|NOT COMPLETED|Run-In Phase - 4 Weeks||14||
59714642|NCT00603733|75833374|FG001|NOT COMPLETED|Run-In Phase - 4 Weeks||13||
60111012|NCT01784926|76231195|FG000|STARTED|Overall Study||54||
60111013|NCT01784926|76231196|FG001|STARTED|Overall Study||50||
60111014|NCT01784926|76231195|FG000|COMPLETED|Overall Study||43||
59714643|NCT00603733|75833373|FG000|STARTED|Maintenance Phase ITT|Note:82 subjects randomized at Active phase & 71 at Run-In phase progressed to the maintenance phase|71||
60111015|NCT01784926|76231196|FG001|COMPLETED|Overall Study||42||
60111016|NCT01784926|76231195|FG000|NOT COMPLETED|Overall Study||11||
60111017|NCT01784926|76231196|FG001|NOT COMPLETED|Overall Study||8||
60111018|NCT01835626|76231202|FG000|STARTED|Overall Study||24||
60111019|NCT01835626|76231202|FG000|COMPLETED|Overall Study||17||
60111020|NCT01835626|76231202|FG000|NOT COMPLETED|Overall Study||7||
60111021|NCT01786252|76231208|FG000|STARTED|Overall Study||7||
60111022|NCT01786252|76231209|FG001|STARTED|Overall Study||8||
60111023|NCT01786252|76231208|FG000|COMPLETED|Overall Study||7||
60111024|NCT01786252|76231209|FG001|COMPLETED|Overall Study||8||
60111025|NCT01786252|76231208|FG000|NOT COMPLETED|Overall Study||0||
60111026|NCT01786252|76231209|FG001|NOT COMPLETED|Overall Study||0||
60111027|NCT01786876|76231215|FG000|STARTED|Overall Study||6||
60111028|NCT01786876|76231215|FG000|COMPLETED|Overall Study||6||
60111029|NCT01786876|76231215|FG000|NOT COMPLETED|Overall Study||0||
60111030|NCT01786954|76231219|FG000|STARTED|Overall Study||34||
60111031|NCT01786954|76231220|FG001|STARTED|Overall Study||34||
60111032|NCT01786954|76231219|FG000|COMPLETED|Overall Study||34||
60111033|NCT01786954|76231220|FG001|COMPLETED|Overall Study||34||
60111034|NCT01786954|76231219|FG000|NOT COMPLETED|Overall Study||0||
60111035|NCT01786954|76231220|FG001|NOT COMPLETED|Overall Study||0||
60111036|NCT01837654|76231232|FG000|STARTED|Overall Study||11||
60111037|NCT01837654|76231233|FG001|STARTED|Overall Study||11||
60111038|NCT01837654|76231232|FG000|COMPLETED|Overall Study||11||
60111039|NCT01837654|76231233|FG001|COMPLETED|Overall Study||11||
60111040|NCT01837654|76231232|FG000|NOT COMPLETED|Overall Study||0||
60111041|NCT01837654|76231233|FG001|NOT COMPLETED|Overall Study||0||
60111042|NCT02261428|76231241|FG000|STARTED|Overall Study|Washout (30 minutes)|10||
60111043|NCT02261428|76231242|FG001|STARTED|Overall Study|Washout (30 minutes)|10||
60111044|NCT02261428|76231241|FG000|COMPLETED|Overall Study||10||
60111045|NCT02261428|76231242|FG001|COMPLETED|Overall Study||10||
60111046|NCT02261428|76231241|FG000|NOT COMPLETED|Overall Study||0||
60111047|NCT02261428|76231242|FG001|NOT COMPLETED|Overall Study||0||
60111048|NCT01838980|76231260|FG000|STARTED|Overall Study||15||
60111049|NCT01838980|76231260|FG000|COMPLETED|Overall Study||15||
60111050|NCT01838980|76231260|FG000|NOT COMPLETED|Overall Study||0||
60111051|NCT01839058|76231266|FG000|STARTED|Overall Study||21||
60111052|NCT01839058|76231267|FG001|STARTED|Overall Study||19||
60111053|NCT01839058|76231266|FG000|COMPLETED|Overall Study||17||
60111054|NCT01839058|76231267|FG001|COMPLETED|Overall Study||16||
60111055|NCT01839058|76231266|FG000|NOT COMPLETED|Overall Study||4||
60111056|NCT01839058|76231267|FG001|NOT COMPLETED|Overall Study||3||
60111057|NCT01839604|76231278|FG000|STARTED|Overall Study||6||
60111058|NCT01839604|76231279|FG001|STARTED|Overall Study||6||
60111059|NCT01839604|76231280|FG002|STARTED|Overall Study||7||
60111060|NCT01839604|76231281|FG003|STARTED|Overall Study||5||
60111061|NCT01839604|76231282|FG004|STARTED|Overall Study||15||
60111062|NCT01839604|76231278|FG000|COMPLETED|Overall Study||6||
60111063|NCT01839604|76231279|FG001|COMPLETED|Overall Study||6||
60111064|NCT01839604|76231280|FG002|COMPLETED|Overall Study||7||
60111065|NCT01839604|76231281|FG003|COMPLETED|Overall Study||5||
60111066|NCT01839604|76231282|FG004|COMPLETED|Overall Study||15||
60111067|NCT01839604|76231278|FG000|NOT COMPLETED|Overall Study||0||
60111068|NCT01839604|76231279|FG001|NOT COMPLETED|Overall Study||0||
60111069|NCT01839604|76231280|FG002|NOT COMPLETED|Overall Study||0||
60111070|NCT01839604|76231281|FG003|NOT COMPLETED|Overall Study||0||
60111071|NCT01839604|76231282|FG004|NOT COMPLETED|Overall Study||0||
60111072|NCT02261818|76231294|FG000|STARTED|Overall Study||30||
60111073|NCT02261818|76231294|FG000|COMPLETED|Overall Study||27||
60111074|NCT02261818|76231294|FG000|NOT COMPLETED|Overall Study||3||
60111075|NCT01840072|76231300|FG000|STARTED|Overall Study||2038||
60111076|NCT01840072|76231301|FG001|STARTED|Overall Study||2033||
60111077|NCT01840072|76231300|FG000|COMPLETED|Overall Study||2031||
60111078|NCT01840072|76231301|FG001|COMPLETED|Overall Study||1986||
60111079|NCT01840072|76231300|FG000|NOT COMPLETED|Overall Study||7||
60111080|NCT01840072|76231301|FG001|NOT COMPLETED|Overall Study||47||
60111081|NCT01789138|76231311|FG000|STARTED|Overall Study||254||
60111082|NCT01789138|76231312|FG001|STARTED|Overall Study||258||
60111083|NCT01789138|76231311|FG000|COMPLETED|Overall Study||213||
60111084|NCT01789138|76231312|FG001|COMPLETED|Overall Study||206||
60111085|NCT01789138|76231311|FG000|NOT COMPLETED|Overall Study||41||
60111086|NCT01789138|76231312|FG001|NOT COMPLETED|Overall Study||52||
60111087|NCT01841632|76231318|FG000|STARTED|Overall Study||3||
60111088|NCT01841632|76231318|FG000|COMPLETED|Overall Study||3||
60111089|NCT01841632|76231318|FG000|NOT COMPLETED|Overall Study||0||
60111090|NCT01807949|76231325|FG000|STARTED|Overall Study||187||
60111091|NCT01807949|76231326|FG001|STARTED|Overall Study||187||
60111092|NCT01807949|76231327|FG002|STARTED|Overall Study||189||
60111093|NCT01807949|76231325|FG000|COMPLETED|Overall Study||185||
60111094|NCT01807949|76231326|FG001|COMPLETED|Overall Study||180||
60111095|NCT01807949|76231327|FG002|COMPLETED|Overall Study||180||
60111096|NCT01807949|76231325|FG000|NOT COMPLETED|Overall Study||2||
60111097|NCT01807949|76231326|FG001|NOT COMPLETED|Overall Study||7||
60111098|NCT01807949|76231327|FG002|NOT COMPLETED|Overall Study||9||
60111099|NCT01806779|76231339|FG000|STARTED|Overall Study||90||
60111100|NCT01806779|76231340|FG001|STARTED|Overall Study||84||
60111101|NCT01806779|76231341|FG002|STARTED|Overall Study|All 197 subjects received nicotine patches but 23 dropped before receiving other study drugs.|23||
60111102|NCT01806779|76231339|FG000|Completed SE Quest. After Using Patches|Overall Study|SE quest. = Side Effects Questionnaire|90||
60111103|NCT01806779|76231340|FG001|Completed SE Quest. After Using Patches|Overall Study|SE quest. = Side Effects Questionnaire|84||
60111104|NCT01806779|76231341|FG002|Completed SE Quest. After Using Patches|Overall Study|SE quest. = Side Effects Questionnaire|2||
60111105|NCT01806779|76231339|FG000|Randomized at Visit 2|Overall Study||90||
60111106|NCT01806779|76231340|FG001|Randomized at Visit 2|Overall Study||84||
60111107|NCT01806779|76231341|FG002|Randomized at Visit 2|Overall Study||0||
60111108|NCT01806779|76231339|FG000|Completed SE Quest. After Randomization|Overall Study|SE quest. = Side Effects Questionnaire|87||
60111109|NCT01806779|76231340|FG001|Completed SE Quest. After Randomization|Overall Study|SE quest. = Side Effects Questionnaire|83||
60111110|NCT01806779|76231341|FG002|Completed SE Quest. After Randomization|Overall Study|SE quest. = Side Effects Questionnaire|0||
60111111|NCT01806779|76231339|FG000|COMPLETED|Overall Study||48||
60111112|NCT01806779|76231340|FG001|COMPLETED|Overall Study||40||
60111113|NCT01806779|76231341|FG002|COMPLETED|Overall Study||0||
60111114|NCT01806779|76231339|FG000|NOT COMPLETED|Overall Study||42||
60111115|NCT01806779|76231340|FG001|NOT COMPLETED|Overall Study||44||
60111116|NCT01806779|76231341|FG002|NOT COMPLETED|Overall Study||23||
60111117|NCT01789840|76231350|FG000|STARTED|Overall Study||52||
60111118|NCT01789840|76231351|FG001|STARTED|Overall Study||7||
60111119|NCT01789840|76231350|FG000|COMPLETED|Overall Study||52||
60111120|NCT01789840|76231351|FG001|COMPLETED|Overall Study||6||
60111121|NCT01789840|76231350|FG000|NOT COMPLETED|Overall Study||0||
60111122|NCT01789840|76231351|FG001|NOT COMPLETED|Overall Study||1||
60111123|NCT01878526|76231361|FG000|STARTED|Overall Study||40||
60111124|NCT01878526|76231362|FG001|STARTED|Overall Study||40||
60111125|NCT01878526|76231361|FG000|COMPLETED|Overall Study||37||
60111126|NCT01878526|76231362|FG001|COMPLETED|Overall Study||38||
60111127|NCT01878526|76231361|FG000|NOT COMPLETED|Overall Study||3||
60111128|NCT01878526|76231362|FG001|NOT COMPLETED|Overall Study||2||
60111129|NCT01878604|76231369|FG000|STARTED|Overall Study||5||
60111130|NCT01878604|76231369|FG000|COMPLETED|Overall Study||5||
60111131|NCT01878604|76231369|FG000|NOT COMPLETED|Overall Study||0||
60111132|NCT01792024|76231374|FG000|STARTED|Overall Study||27||
60111133|NCT01792024|76231374|FG000|COMPLETED|Overall Study||27||
60111134|NCT01792024|76231374|FG000|NOT COMPLETED|Overall Study||0||
60111135|NCT02266576|76231380|FG000|STARTED|Overall Study||102||
60111136|NCT02266576|76231381|FG001|STARTED|Overall Study||105||
60111137|NCT02266576|76231380|FG000|COMPLETED|Overall Study||85||
60111138|NCT02266576|76231381|FG001|COMPLETED|Overall Study||90||
60111139|NCT02266576|76231380|FG000|NOT COMPLETED|Overall Study||17||
60111140|NCT02266576|76231381|FG001|NOT COMPLETED|Overall Study||15||
60111141|NCT02266810|76231389|FG000|STARTED|Overall Study|sinus sides|80||160
60111142|NCT02266810|76231390|FG001|STARTED|Overall Study|sinus sides|80||160
60111143|NCT02266810|76231389|FG000|COMPLETED|Overall Study|sinus sides|79||158
60111144|NCT02266810|76231390|FG001|COMPLETED|Overall Study|sinus sides|79||158
60111145|NCT02266810|76231389|FG000|NOT COMPLETED|Overall Study||1||2
60111146|NCT02266810|76231390|FG001|NOT COMPLETED|Overall Study||1||2
60111147|NCT01879540|76231405|FG000|STARTED|Overall Study||63||
60111148|NCT01879540|76231405|FG000|COMPLETED|Overall Study||63||
60111149|NCT01879540|76231405|FG000|NOT COMPLETED|Overall Study||0||
60111150|NCT01842646|76231409|FG000|STARTED|Overall Study||35||
60111151|NCT01842646|76231409|FG000|COMPLETED|Overall Study||35||
60111152|NCT01842646|76231409|FG000|NOT COMPLETED|Overall Study||0||
60111153|NCT01607957|76231415|FG000|STARTED|Overall Study||534||
60111154|NCT01607957|76231416|FG001|STARTED|Overall Study||266||
60111155|NCT01607957|76231415|FG000|Treated|Overall Study||533||
60111156|NCT01607957|76231416|FG001|Treated|Overall Study||265||
60111157|NCT01607957|76231415|FG000|COMPLETED|Overall Study||162||
60111158|NCT01607957|76231416|FG001|COMPLETED|Overall Study||51||
60111159|NCT01607957|76231415|FG000|NOT COMPLETED|Overall Study||372||
60111160|NCT01607957|76231416|FG001|NOT COMPLETED|Overall Study||215||
60111161|NCT01845220|76231422|FG000|STARTED|Overall Study||30||30
60111162|NCT01845220|76231423|FG001|STARTED|Overall Study||30||30
60111163|NCT01845220|76231422|FG000|COMPLETED|Overall Study||30||30
60111164|NCT01845220|76231423|FG001|COMPLETED|Overall Study||30||30
60111165|NCT01845220|76231422|FG000|NOT COMPLETED|Overall Study||0||0
60111166|NCT01845220|76231423|FG001|NOT COMPLETED|Overall Study||0||0
60111167|NCT01795534|76231429|FG000|STARTED|First Intervention (First Shot)||5||
60111168|NCT01795534|76231430|FG001|STARTED|First Intervention (First Shot)||5||
60111169|NCT01795534|76231429|FG000|COMPLETED|First Intervention (First Shot)||5||
60111170|NCT01795534|76231430|FG001|COMPLETED|First Intervention (First Shot)||5||
60111171|NCT01795534|76231429|FG000|NOT COMPLETED|First Intervention (First Shot)||0||
60111172|NCT01795534|76231430|FG001|NOT COMPLETED|First Intervention (First Shot)||0||
60111173|NCT01795534|76231429|FG000|STARTED|Wash Out Period (4 Days)||5||
60111174|NCT01795534|76231430|FG001|STARTED|Wash Out Period (4 Days)||5||
60111175|NCT01795534|76231429|FG000|COMPLETED|Wash Out Period (4 Days)||5||
60111176|NCT01795534|76231430|FG001|COMPLETED|Wash Out Period (4 Days)||5||
60111177|NCT01795534|76231429|FG000|NOT COMPLETED|Wash Out Period (4 Days)||0||
60111178|NCT01795534|76231430|FG001|NOT COMPLETED|Wash Out Period (4 Days)||0||
60111179|NCT01795534|76231429|FG000|STARTED|Second Intervention (Second Shot)||5||
60111180|NCT01795534|76231430|FG001|STARTED|Second Intervention (Second Shot)||5||
60111181|NCT01795534|76231429|FG000|COMPLETED|Second Intervention (Second Shot)||5||
60111182|NCT01795534|76231430|FG001|COMPLETED|Second Intervention (Second Shot)||5||
60111183|NCT01795534|76231429|FG000|NOT COMPLETED|Second Intervention (Second Shot)||0||
60111184|NCT01795534|76231430|FG001|NOT COMPLETED|Second Intervention (Second Shot)||0||
60111185|NCT01806623|76231436|FG000|STARTED|Overall Study||157||
60111186|NCT01806623|76231436|FG000|COMPLETED|Overall Study||99||
60111187|NCT01806623|76231436|FG000|NOT COMPLETED|Overall Study||58||
60111188|NCT01806545|76231442|FG000|STARTED|Overall Study||29||
60111189|NCT01806545|76231443|FG001|STARTED|Overall Study||35||
60111190|NCT01806545|76231442|FG000|COMPLETED|Overall Study||23||
60111191|NCT01806545|76231443|FG001|COMPLETED|Overall Study||30||
60111192|NCT01806545|76231442|FG000|NOT COMPLETED|Overall Study||6||
60111193|NCT01806545|76231443|FG001|NOT COMPLETED|Overall Study||5||
60111194|NCT01806389|76231449|FG000|STARTED|Overall Study||14||
60111195|NCT01806389|76231449|FG000|COMPLETED|Overall Study||10||
60111196|NCT01806389|76231449|FG000|NOT COMPLETED|Overall Study||4||
60111197|NCT01846702|76231470|FG000|STARTED|Overall Study||6||
60111198|NCT01846702|76231471|FG001|STARTED|Overall Study||6||
60111199|NCT01846702|76231472|FG002|STARTED|Overall Study||7||
60111200|NCT01846702|76231473|FG003|STARTED|Overall Study||6||
60111201|NCT01846702|76231474|FG004|STARTED|Overall Study||6||
60111202|NCT01846702|76231475|FG005|STARTED|Overall Study||6||
60111203|NCT01846702|76231476|FG006|STARTED|Overall Study||6||
60111204|NCT01846702|76231470|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6||
60111205|NCT01846702|76231471|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6||
60111206|NCT01846702|76231472|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6||
60111207|NCT01846702|76231473|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6||
60111208|NCT01846702|76231474|FG004|Received at Least 1 Dose of Study Drug|Overall Study||6||
60111209|NCT01846702|76231475|FG005|Received at Least 1 Dose of Study Drug|Overall Study||6||
60111210|NCT01846702|76231476|FG006|Received at Least 1 Dose of Study Drug|Overall Study||6||
60111211|NCT01846702|76231470|FG000|COMPLETED|Overall Study||6||
60111212|NCT01846702|76231471|FG001|COMPLETED|Overall Study||6||
60111213|NCT01846702|76231472|FG002|COMPLETED|Overall Study||6||
60111214|NCT01846702|76231473|FG003|COMPLETED|Overall Study||6||
60111215|NCT01846702|76231474|FG004|COMPLETED|Overall Study||6||
60111216|NCT01846702|76231475|FG005|COMPLETED|Overall Study||6||
60111217|NCT01846702|76231476|FG006|COMPLETED|Overall Study||6||
60111218|NCT01846702|76231470|FG000|NOT COMPLETED|Overall Study||0||
60111219|NCT01846702|76231471|FG001|NOT COMPLETED|Overall Study||0||
60111220|NCT01846702|76231472|FG002|NOT COMPLETED|Overall Study||1||
60111221|NCT01846702|76231473|FG003|NOT COMPLETED|Overall Study||0||
60111222|NCT01846702|76231474|FG004|NOT COMPLETED|Overall Study||0||
60111223|NCT01846702|76231475|FG005|NOT COMPLETED|Overall Study||0||
60111224|NCT01846702|76231476|FG006|NOT COMPLETED|Overall Study||0||
60111225|NCT01847014|76231500|FG000|STARTED|Baseline Extension Visit||4||
60111226|NCT01847014|76231500|FG000|COMPLETED|Baseline Extension Visit||4||
60111227|NCT01847014|76231500|FG000|NOT COMPLETED|Baseline Extension Visit||0||
60111228|NCT01847014|76231500|FG000|STARTED|Completion of Extension Study||4||
60111229|NCT01847014|76231500|FG000|COMPLETED|Completion of Extension Study||0||
60111230|NCT01847014|76231500|FG000|NOT COMPLETED|Completion of Extension Study||4||
60111231|NCT01847560|76231514|FG000|STARTED|Overall Study||13464||
59714644|NCT00603733|75833374|FG001|STARTED|Maintenance Phase ITT||82||
59714645|NCT00603733|75833373|FG000|COMPLETED|Maintenance Phase ITT||61||
60111232|NCT01847560|76231515|FG001|STARTED|Overall Study||19955||
60111233|NCT01847560|76231516|FG002|STARTED|Overall Study||9731||
60111234|NCT01847560|76231517|FG003|STARTED|Overall Study||56655||
60111235|NCT01847560|76231518|FG004|STARTED|Overall Study||27731||
60111236|NCT01847560|76231519|FG005|STARTED|Overall Study||28343||
60111237|NCT01847560|76231520|FG006|STARTED|Overall Study||40971||
60111238|NCT01847560|76231521|FG007|STARTED|Overall Study||19829||
60111239|NCT01847560|76231522|FG008|STARTED|Overall Study||77547||
60111240|NCT01847560|76231523|FG009|STARTED|Overall Study||39438||
60111241|NCT01847560|76231514|FG000|COMPLETED|Overall Study||13464||
60111242|NCT01847560|76231515|FG001|COMPLETED|Overall Study||19955||
60111243|NCT01847560|76231516|FG002|COMPLETED|Overall Study||9731||
60111244|NCT01847560|76231517|FG003|COMPLETED|Overall Study||56655||
60111245|NCT01847560|76231518|FG004|COMPLETED|Overall Study||27731||
60111246|NCT01847560|76231519|FG005|COMPLETED|Overall Study||28343||
60111247|NCT01847560|76231520|FG006|COMPLETED|Overall Study||40971||
60111248|NCT01847560|76231521|FG007|COMPLETED|Overall Study||19829||
60111249|NCT01847560|76231522|FG008|COMPLETED|Overall Study||77547||
60111250|NCT01847560|76231523|FG009|COMPLETED|Overall Study||39438||
60111251|NCT01847560|76231514|FG000|NOT COMPLETED|Overall Study||0||
60111252|NCT01847560|76231515|FG001|NOT COMPLETED|Overall Study||0||
60111253|NCT01847560|76231516|FG002|NOT COMPLETED|Overall Study||0||
60111254|NCT01847560|76231517|FG003|NOT COMPLETED|Overall Study||0||
60111255|NCT01847560|76231518|FG004|NOT COMPLETED|Overall Study||0||
60111256|NCT01847560|76231519|FG005|NOT COMPLETED|Overall Study||0||
60111257|NCT01847560|76231520|FG006|NOT COMPLETED|Overall Study||0||
60111258|NCT01847560|76231521|FG007|NOT COMPLETED|Overall Study||0||
60111259|NCT01847560|76231522|FG008|NOT COMPLETED|Overall Study||0||
60111260|NCT01847560|76231523|FG009|NOT COMPLETED|Overall Study||0||
60111261|NCT01847638|76231567|FG000|STARTED|Overall Study||25||
60111262|NCT01847638|76231568|FG001|STARTED|Overall Study||25||
60111263|NCT01847638|76231567|FG000|COMPLETED|Overall Study||25||
60111264|NCT01847638|76231568|FG001|COMPLETED|Overall Study||25||
60111265|NCT01847638|76231567|FG000|NOT COMPLETED|Overall Study||0||
60111266|NCT01847638|76231568|FG001|NOT COMPLETED|Overall Study||0||
60111267|NCT01796236|76231576|FG000|STARTED|Overall Study||51||
60111268|NCT01796236|76231577|FG001|STARTED|Overall Study||52||
60111269|NCT01796236|76231576|FG000|COMPLETED|Overall Study||49||
60111270|NCT01796236|76231577|FG001|COMPLETED|Overall Study||50||
59714646|NCT00603733|75833374|FG001|COMPLETED|Maintenance Phase ITT||66||
59714647|NCT00603733|75833373|FG000|NOT COMPLETED|Maintenance Phase ITT||10||
59714648|NCT00603733|75833374|FG001|NOT COMPLETED|Maintenance Phase ITT||16||
59714649|NCT04631107|75833380|FG000|STARTED|First Intervention (1 Night)||32||
59714650|NCT04631107|75833380|FG000|Treatment A|First Intervention (1 Night)||11||
59714651|NCT04631107|75833380|FG000|Treatment B|First Intervention (1 Night)||9||
59714652|NCT04631107|75833380|FG000|Treatment C|First Intervention (1 Night)||11||
59714653|NCT04631107|75833380|FG000|COMPLETED|First Intervention (1 Night)||31||
59714654|NCT04631107|75833380|FG000|NOT COMPLETED|First Intervention (1 Night)||1||
59714655|NCT04631107|75833380|FG000|STARTED|Washout 1 Week||31||
59714656|NCT04631107|75833380|FG000|COMPLETED|Washout 1 Week||31||
59714657|NCT04631107|75833380|FG000|NOT COMPLETED|Washout 1 Week||0||
59714658|NCT04631107|75833380|FG000|STARTED|Second Intervention (1 Night)||31||
59714659|NCT04631107|75833380|FG000|Treatment A|Second Intervention (1 Night)||11||
59714660|NCT04631107|75833380|FG000|Treatment B|Second Intervention (1 Night)||9||
59714661|NCT04631107|75833380|FG000|Treatment C|Second Intervention (1 Night)||9||
59714662|NCT04631107|75833380|FG000|COMPLETED|Second Intervention (1 Night)||29||
59714663|NCT04631107|75833380|FG000|NOT COMPLETED|Second Intervention (1 Night)||2||
59714664|NCT04631107|75833380|FG000|STARTED|Washout-1 Week||29||
59714665|NCT04631107|75833380|FG000|COMPLETED|Washout-1 Week||29||
59714666|NCT04631107|75833380|FG000|NOT COMPLETED|Washout-1 Week||0||
60111271|NCT01796236|76231576|FG000|NOT COMPLETED|Overall Study||2||
60111272|NCT01796236|76231577|FG001|NOT COMPLETED|Overall Study||2||
60111273|NCT01848184|76231584|FG000|STARTED|Overall Study||126||
60111274|NCT01848184|76231584|FG000|COMPLETED|Overall Study||100||
60111275|NCT01848184|76231584|FG000|NOT COMPLETED|Overall Study||26||
60111276|NCT01797328|76231596|FG000|STARTED|Overall Study||16||
60111277|NCT01797328|76231597|FG001|STARTED|Overall Study||12||
60111278|NCT01797328|76231596|FG000|COMPLETED|Overall Study||14||
60111279|NCT01797328|76231597|FG001|COMPLETED|Overall Study||12||
60111280|NCT01797328|76231596|FG000|NOT COMPLETED|Overall Study||2||
60111281|NCT01797328|76231597|FG001|NOT COMPLETED|Overall Study||0||
60111282|NCT01849822|76231603|FG000|STARTED|Overall Study||1||
60111283|NCT01849822|76231603|FG000|COMPLETED|Overall Study||1||
60111284|NCT01849822|76231603|FG000|NOT COMPLETED|Overall Study||0||
60111285|NCT01797484|76231609|FG000|STARTED|Overall Study||10||
60111286|NCT01797484|76231610|FG001|STARTED|Overall Study||10||
60111287|NCT01797484|76231609|FG000|COMPLETED|Overall Study||10||
60111288|NCT01797484|76231610|FG001|COMPLETED|Overall Study||10||
60111289|NCT01797484|76231609|FG000|NOT COMPLETED|Overall Study||0||
60111290|NCT01797484|76231610|FG001|NOT COMPLETED|Overall Study||0||
60111291|NCT01798186|76231620|FG000|STARTED|Overall Study||6||
60111292|NCT01798186|76231621|FG001|STARTED|Overall Study||6||
60111293|NCT01798186|76231622|FG002|STARTED|Overall Study||6||
60111294|NCT01798186|76231623|FG003|STARTED|Overall Study||8||
60111295|NCT01798186|76231620|FG000|COMPLETED|Overall Study||6||
60111296|NCT01798186|76231621|FG001|COMPLETED|Overall Study||6||
60111297|NCT01798186|76231622|FG002|COMPLETED|Overall Study||6||
60111298|NCT01798186|76231623|FG003|COMPLETED|Overall Study||8||
60111299|NCT01798186|76231620|FG000|NOT COMPLETED|Overall Study||0||
60111300|NCT01798186|76231621|FG001|NOT COMPLETED|Overall Study||0||
60111301|NCT01798186|76231622|FG002|NOT COMPLETED|Overall Study||0||
60111302|NCT01798186|76231623|FG003|NOT COMPLETED|Overall Study||0||
59822909|NCT03927911|75945699|FG000|COMPLETED|Overall Study||0||
59822910|NCT03927911|75945700|FG001|COMPLETED|Overall Study||15||
59822911|NCT03927911|75945701|FG002|COMPLETED|Overall Study||0||
59822912|NCT03927911|75945702|FG003|COMPLETED|Overall Study||1||
59822913|NCT03927911|75945703|FG004|COMPLETED|Overall Study||13||
59822914|NCT03927911|75945704|FG005|COMPLETED|Overall Study||25||
59822915|NCT03927911|75945699|FG000|NOT COMPLETED|Overall Study||0||
59822916|NCT03927911|75945700|FG001|NOT COMPLETED|Overall Study||2||
59822917|NCT03927911|75945701|FG002|NOT COMPLETED|Overall Study||0||
59822918|NCT03927911|75945702|FG003|NOT COMPLETED|Overall Study||2||
59822919|NCT03927911|75945703|FG004|NOT COMPLETED|Overall Study||0||
59822920|NCT03927911|75945704|FG005|NOT COMPLETED|Overall Study||7||
59822921|NCT00383019|75945720|FG000|STARTED|Overall Study||144||
59822922|NCT00383019|75945721|FG001|STARTED|Overall Study||145||
59822923|NCT00383019|75945720|FG000|COMPLETED|Overall Study||139||
59822924|NCT00383019|75945721|FG001|COMPLETED|Overall Study||143||
59822925|NCT00383019|75945720|FG000|NOT COMPLETED|Overall Study||5||
59822926|NCT00383019|75945721|FG001|NOT COMPLETED|Overall Study||2||
59822927|NCT00310804|75945729|FG000|STARTED|Overall Study||1029||
59822928|NCT00310804|75945730|FG001|STARTED|Overall Study||171||
59822929|NCT00310804|75945729|FG000|COMPLETED|Overall Study||1024||
59822930|NCT00310804|75945730|FG001|COMPLETED|Overall Study||171||
59822931|NCT00310804|75945729|FG000|NOT COMPLETED|Overall Study||5||
59822932|NCT00310804|75945730|FG001|NOT COMPLETED|Overall Study||0||
59822933|NCT03826186|75945752|FG000|STARTED|Overall Study||60||
59822934|NCT03826186|75945753|FG001|STARTED|Overall Study||60||
59822935|NCT03826186|75945752|FG000|COMPLETED|Overall Study||57||
59822936|NCT03826186|75945753|FG001|COMPLETED|Overall Study||60||
59822937|NCT03826186|75945752|FG000|NOT COMPLETED|Overall Study||3||
59822938|NCT03826186|75945753|FG001|NOT COMPLETED|Overall Study||0||
59822939|NCT00382863|75945761|FG000|STARTED|Overall Study||96||
59822940|NCT00382863|75945762|FG001|STARTED|Overall Study||114||
59822941|NCT00382863|75945761|FG000|COMPLETED|Overall Study||81||
59822942|NCT00382863|75945762|FG001|COMPLETED|Overall Study||78||
59822943|NCT00382863|75945761|FG000|NOT COMPLETED|Overall Study||15||
59822944|NCT00382863|75945762|FG001|NOT COMPLETED|Overall Study||36||
59822945|NCT03933449|75945770|FG000|STARTED|Overall Study||62||
59822946|NCT03933449|75945771|FG001|STARTED|Overall Study||61||
59822947|NCT03933449|75945770|FG000|Treated|Overall Study||62||
59822948|NCT03933449|75945771|FG001|Treated|Overall Study||59||
59822949|NCT03933449|75945770|FG000|Received Second Course|Overall Study||1||
59822950|NCT03933449|75945771|FG001|Received Second Course|Overall Study||0||
59822951|NCT03933449|75945770|FG000|Discontinued|Overall Study||62||
59822952|NCT03933449|75945771|FG001|Discontinued|Overall Study||61||
60111303|NCT01851772|76231636|FG000|STARTED|Overall Study||3||
60111304|NCT01851772|76231636|FG000|COMPLETED|Overall Study||3||
59714667|NCT04631107|75833380|FG000|STARTED|Third Intervention (1 Night)||29||
59714668|NCT04631107|75833380|FG000|Treatment A|Third Intervention (1 Night)||8||
59714669|NCT04631107|75833380|FG000|Treatment B|Third Intervention (1 Night)||10||
59714670|NCT04631107|75833380|FG000|Treatment C|Third Intervention (1 Night)||9||
59714671|NCT04631107|75833380|FG000|COMPLETED|Third Intervention (1 Night)||27||
59714672|NCT04631107|75833380|FG000|NOT COMPLETED|Third Intervention (1 Night)||2||
59714673|NCT00995007|75833390|FG000|STARTED|Overall Study||56||
59714674|NCT00995007|75833391|FG001|STARTED|Overall Study||56||
59714675|NCT00995007|75833390|FG000|Crossover to Vandetanib|Overall Study||42||
59714676|NCT00995007|75833391|FG001|Crossover to Vandetanib|Overall Study||0||
59714677|NCT00995007|75833390|FG000|COMPLETED|Overall Study||39||
59714678|NCT00995007|75833391|FG001|COMPLETED|Overall Study||54||
59714679|NCT00995007|75833390|FG000|NOT COMPLETED|Overall Study||17||
59714680|NCT00995007|75833391|FG001|NOT COMPLETED|Overall Study||2||
59714681|NCT00994461|75833409|FG000|STARTED|Overall Study||76||
59822953|NCT03933449|75945770|FG000|COMPLETED|Overall Study||0||
59822954|NCT03933449|75945771|FG001|COMPLETED|Overall Study||0||
59822955|NCT03933449|75945770|FG000|NOT COMPLETED|Overall Study||62||
59714682|NCT00994461|75833410|FG001|STARTED|Overall Study||76||
59714683|NCT00994461|75833411|FG002|STARTED|Overall Study|One subject was randomized but did not receive study drug.|37||
59714684|NCT00994461|75833409|FG000|COMPLETED|Overall Study||74||
59822956|NCT03933449|75945771|FG001|NOT COMPLETED|Overall Study||61||
59822957|NCT02908269|75945781|FG000|STARTED|Overall Study||60||
59822958|NCT02908269|75945782|FG001|STARTED|Overall Study||60||
59822959|NCT02908269|75945783|FG002|STARTED|Overall Study||60||
59822960|NCT02908269|75945781|FG000|COMPLETED|Overall Study||60||
59822961|NCT02908269|75945782|FG001|COMPLETED|Overall Study||60||
59822962|NCT02908269|75945783|FG002|COMPLETED|Overall Study||60||
59822963|NCT02908269|75945781|FG000|NOT COMPLETED|Overall Study||0||
59822964|NCT02908269|75945782|FG001|NOT COMPLETED|Overall Study||0||
59822965|NCT02908269|75945783|FG002|NOT COMPLETED|Overall Study||0||
59822966|NCT00290758|75945794|FG000|STARTED|Pre-Intervention rFNA Through Follow-Up||62||
59822967|NCT00290758|75945795|FG001|STARTED|Pre-Intervention rFNA Through Follow-Up||64||
59822968|NCT00290758|75945794|FG000|First rFNA Tissue Collection|Pre-Intervention rFNA Through Follow-Up||62||
59714685|NCT00994461|75833410|FG001|COMPLETED|Overall Study||75||
59714686|NCT00994461|75833411|FG002|COMPLETED|Overall Study||37||
59714687|NCT00994461|75833409|FG000|NOT COMPLETED|Overall Study||2||
59714688|NCT00994461|75833410|FG001|NOT COMPLETED|Overall Study||1||
59714689|NCT00994461|75833411|FG002|NOT COMPLETED|Overall Study||0||
59714690|NCT00993915|75833419|FG000|STARTED|Overall Study||687||
59714691|NCT00993915|75833419|FG000|COMPLETED|Overall Study||678||
59714692|NCT00993915|75833419|FG000|NOT COMPLETED|Overall Study||9||
59714693|NCT01202591|75833429|FG000|STARTED|Overall Study||5||
59714694|NCT01202591|75833430|FG001|STARTED|Overall Study||5||
59714695|NCT01202591|75833431|FG002|STARTED|Overall Study||12||
59714696|NCT01202591|75833432|FG003|STARTED|Overall Study||9||
59714697|NCT01202591|75833433|FG004|STARTED|Overall Study||5||
59714698|NCT01202591|75833434|FG005|STARTED|Overall Study||4||
59714699|NCT01202591|75833429|FG000|COMPLETED|Overall Study||0||
59714700|NCT01202591|75833430|FG001|COMPLETED|Overall Study||0||
60111305|NCT01851772|76231636|FG000|NOT COMPLETED|Overall Study||0||
60111306|NCT01852084|76231644|FG000|STARTED|Overall Study||79||
60111307|NCT01852084|76231645|FG001|STARTED|Overall Study||80||
60111308|NCT01852084|76231646|FG002|STARTED|Overall Study||20||
60111309|NCT01852084|76231647|FG003|STARTED|Overall Study||12||
60111310|NCT01852084|76231644|FG000|COMPLETED|Overall Study||79||
60111311|NCT01852084|76231645|FG001|COMPLETED|Overall Study||80||
60111312|NCT01852084|76231646|FG002|COMPLETED|Overall Study||18||
60111313|NCT01852084|76231647|FG003|COMPLETED|Overall Study||12||
60111314|NCT01852084|76231644|FG000|NOT COMPLETED|Overall Study||0||
60111315|NCT01852084|76231645|FG001|NOT COMPLETED|Overall Study||0||
60111316|NCT01852084|76231646|FG002|NOT COMPLETED|Overall Study||2||
60111317|NCT01852084|76231647|FG003|NOT COMPLETED|Overall Study||0||
60111318|NCT01798264|76231661|FG000|STARTED|Overall Study||12||
60111319|NCT01798264|76231662|FG001|STARTED|Overall Study||11||
60111320|NCT01798264|76231663|FG002|STARTED|Overall Study||10||
60111321|NCT01798264|76231664|FG003|STARTED|Overall Study||11||
60111322|NCT01798264|76231661|FG000|COMPLETED|Overall Study||11||
60111323|NCT01798264|76231662|FG001|COMPLETED|Overall Study||11||
60111324|NCT01798264|76231663|FG002|COMPLETED|Overall Study||10||
60111325|NCT01798264|76231664|FG003|COMPLETED|Overall Study||7||
60111326|NCT01798264|76231661|FG000|NOT COMPLETED|Overall Study||1||
60111327|NCT01798264|76231662|FG001|NOT COMPLETED|Overall Study||0||
60111328|NCT01798264|76231663|FG002|NOT COMPLETED|Overall Study||0||
60111329|NCT01798264|76231664|FG003|NOT COMPLETED|Overall Study||4||
60111330|NCT01798966|76231674|FG000|STARTED|Overall Study||10||
60111331|NCT01798966|76231674|FG000|COMPLETED|Overall Study||10||
60111332|NCT01798966|76231674|FG000|NOT COMPLETED|Overall Study||0||
60111333|NCT01799278|76231679|FG000|STARTED|Overall Study||60||
60111334|NCT01799278|76231679|FG000|COMPLETED|Overall Study||60||
60111335|NCT01799278|76231679|FG000|NOT COMPLETED|Overall Study||0||
60111336|NCT01853332|76231687|FG000|STARTED|Overall Study||210||
60111337|NCT01853332|76231687|FG000|COMPLETED|Overall Study||151||
60111338|NCT01853332|76231687|FG000|NOT COMPLETED|Overall Study||59||
60111339|NCT01800838|76231696|FG000|STARTED|Overall Study||1||
60111340|NCT01800838|76231697|FG001|STARTED|Overall Study||1||
60111341|NCT01800838|76231698|FG002|STARTED|Overall Study||7||
60111342|NCT01800838|76231699|FG003|STARTED|Overall Study||2||
60111343|NCT01800838|76231696|FG000|COMPLETED|Overall Study||1||
60111344|NCT01800838|76231697|FG001|COMPLETED|Overall Study||1||
60111345|NCT01800838|76231698|FG002|COMPLETED|Overall Study||7||
60111346|NCT01800838|76231699|FG003|COMPLETED|Overall Study||2||
60111347|NCT01800838|76231696|FG000|NOT COMPLETED|Overall Study||0||
60111348|NCT01800838|76231697|FG001|NOT COMPLETED|Overall Study||0||
60111349|NCT01800838|76231698|FG002|NOT COMPLETED|Overall Study||0||
60111350|NCT01800838|76231699|FG003|NOT COMPLETED|Overall Study||0||
59714701|NCT01202591|75833431|FG002|COMPLETED|Overall Study||1||
59714702|NCT01202591|75833432|FG003|COMPLETED|Overall Study||2||
59822969|NCT00290758|75945795|FG001|First rFNA Tissue Collection|Pre-Intervention rFNA Through Follow-Up||64||
59822970|NCT00290758|75945794|FG000|Randomization|Pre-Intervention rFNA Through Follow-Up||62||
59822971|NCT00290758|75945795|FG001|Randomization|Pre-Intervention rFNA Through Follow-Up||62||
60111351|NCT01854034|76231703|FG000|STARTED|Overall Study||29||
60111352|NCT01854034|76231703|FG000|COMPLETED|Overall Study||29||
59822972|NCT00290758|75945794|FG000|Treatment|Pre-Intervention rFNA Through Follow-Up||61||
60111353|NCT01854034|76231703|FG000|NOT COMPLETED|Overall Study||0||
60111354|NCT01802554|76231709|FG000|STARTED|Overall Study||51||
60111355|NCT01802554|76231710|FG001|STARTED|Overall Study||49||
60111356|NCT01802554|76231709|FG000|COMPLETED|Overall Study||43||
59714703|NCT01202591|75833433|FG004|COMPLETED|Overall Study||0||
59714704|NCT01202591|75833434|FG005|COMPLETED|Overall Study||0||
60111357|NCT01802554|76231710|FG001|COMPLETED|Overall Study||43||
60111358|NCT01802554|76231709|FG000|NOT COMPLETED|Overall Study||8||
60111359|NCT01802554|76231710|FG001|NOT COMPLETED|Overall Study||6||
60111360|NCT01781975|76231718|FG000|STARTED|Overall Study||45||
60111361|NCT01781975|76231719|FG001|STARTED|Overall Study||22||
60111362|NCT01781975|76231718|FG000|Treatment Period|Overall Study||44||
60111363|NCT01781975|76231719|FG001|Treatment Period|Overall Study||22||
60111364|NCT01781975|76231718|FG000|Follow-Up Period|Overall Study||43||
60111365|NCT01781975|76231719|FG001|Follow-Up Period|Overall Study||21||
60111366|NCT01781975|76231718|FG000|COMPLETED|Overall Study||43||
60111367|NCT01781975|76231719|FG001|COMPLETED|Overall Study||21||
60111368|NCT01781975|76231718|FG000|NOT COMPLETED|Overall Study||2||
60111369|NCT01781975|76231719|FG001|NOT COMPLETED|Overall Study||1||
60111370|NCT01855360|76231725|FG000|STARTED|Overall Study||40||
60111371|NCT01855360|76231725|FG000|COMPLETED|Overall Study||30||
60111372|NCT01855360|76231725|FG000|NOT COMPLETED|Overall Study||10||
60111373|NCT01802710|76231731|FG000|STARTED|From T0 to T1||76||
60111374|NCT01802710|76231732|FG001|STARTED|From T0 to T1||82||
60111375|NCT01802710|76231731|FG000|COMPLETED|From T0 to T1||60||
60111376|NCT01802710|76231732|FG001|COMPLETED|From T0 to T1||72||
60111377|NCT01802710|76231731|FG000|NOT COMPLETED|From T0 to T1||16||
60111378|NCT01802710|76231732|FG001|NOT COMPLETED|From T0 to T1||10||
60111379|NCT01802710|76231731|FG000|STARTED|From T1 to T2||60||
60111380|NCT01802710|76231732|FG001|STARTED|From T1 to T2||72||
60111381|NCT01802710|76231731|FG000|COMPLETED|From T1 to T2||58||
60111382|NCT01802710|76231732|FG001|COMPLETED|From T1 to T2||70||
60111383|NCT01802710|76231731|FG000|NOT COMPLETED|From T1 to T2||2||
60111384|NCT01802710|76231732|FG001|NOT COMPLETED|From T1 to T2||2||
60111385|NCT01804673|76231740|FG000|STARTED|Overall Study||174||
60111386|NCT01804673|76231740|FG000|Completed Hour 24|Overall Study||170||
60111387|NCT01804673|76231740|FG000|Completed Hour 48|Overall Study||79||
60111388|NCT01804673|76231740|FG000|Completed Hour 72|Overall Study||36||
60111389|NCT01804673|76231740|FG000|COMPLETED|Overall Study||34||
60111390|NCT01804673|76231740|FG000|NOT COMPLETED|Overall Study||140||
60111391|NCT01856218|76231744|FG000|STARTED|First Phase||3||
60111392|NCT01856218|76231744|FG000|COMPLETED|First Phase||3||
60111393|NCT01856218|76231744|FG000|NOT COMPLETED|First Phase||0||
60111394|NCT01856218|76231744|FG000|STARTED|Long-Term Extension Phase||3||
60111395|NCT01856218|76231744|FG000|COMPLETED|Long-Term Extension Phase||3||
60111396|NCT01856218|76231744|FG000|NOT COMPLETED|Long-Term Extension Phase||0||
60111397|NCT01774097|76231750|FG000|STARTED|Overall Study||40||
60111398|NCT01774097|76231751|FG001|STARTED|Overall Study||42||
60111399|NCT01774097|76231750|FG000|COMPLETED|Overall Study||38||
60111400|NCT01774097|76231751|FG001|COMPLETED|Overall Study||40||
60111401|NCT01774097|76231750|FG000|NOT COMPLETED|Overall Study||2||
60111402|NCT01774097|76231751|FG001|NOT COMPLETED|Overall Study||2||
60111403|NCT01856530|76231761|FG000|STARTED|Overall Study||27||
60111404|NCT01856530|76231762|FG001|STARTED|Overall Study||27||
60111405|NCT01856530|76231761|FG000|COMPLETED|Overall Study||27||
60111406|NCT01856530|76231762|FG001|COMPLETED|Overall Study||27||
60111407|NCT01856530|76231761|FG000|NOT COMPLETED|Overall Study||0||
60111408|NCT01856530|76231762|FG001|NOT COMPLETED|Overall Study||0||
60111409|NCT01804036|76231770|FG000|STARTED|Overall Study||31||
60111410|NCT01804036|76231771|FG001|STARTED|Overall Study||41||
60111411|NCT01804036|76231770|FG000|COMPLETED|Overall Study||18||
60111412|NCT01804036|76231771|FG001|COMPLETED|Overall Study||21||
60111413|NCT01804036|76231770|FG000|NOT COMPLETED|Overall Study||13||
60111414|NCT01804036|76231771|FG001|NOT COMPLETED|Overall Study||20||
59714705|NCT01202591|75833429|FG000|NOT COMPLETED|Overall Study||5||
59714706|NCT01202591|75833430|FG001|NOT COMPLETED|Overall Study||5||
59714707|NCT01202591|75833431|FG002|NOT COMPLETED|Overall Study||11||
59714708|NCT01202591|75833432|FG003|NOT COMPLETED|Overall Study||7||
59714709|NCT01202591|75833433|FG004|NOT COMPLETED|Overall Study||5||
59714710|NCT01202591|75833434|FG005|NOT COMPLETED|Overall Study||4||
59714711|NCT01202279|75833450|FG000|STARTED|Overall Study||591||
59822973|NCT00290758|75945795|FG001|Treatment|Pre-Intervention rFNA Through Follow-Up||64||
59714712|NCT01202279|75833451|FG001|STARTED|Overall Study||588||
59714713|NCT01202279|75833450|FG000|COMPLETED|Overall Study||554||
59996366|NCT03707977|76112334|FG002|NOT COMPLETED|Step 3 (Stop bNABs, Resume ART)||0||
60111415|NCT01856764|76231780|FG000|STARTED|Overall Study||20||
60111416|NCT01856764|76231781|FG001|STARTED|Overall Study||20||
60111417|NCT01856764|76231780|FG000|COMPLETED|Overall Study||20||
60111418|NCT01856764|76231781|FG001|COMPLETED|Overall Study||20||
60111419|NCT01856764|76231780|FG000|NOT COMPLETED|Overall Study||0||
59996367|NCT03332095|76112350|FG000|STARTED|Overall Study||10||
59996368|NCT03332095|76112351|FG001|STARTED|Overall Study||45||
59996369|NCT03332095|76112350|FG000|Received at Least One Dose of Study Treatment|Overall Study||9||
59996370|NCT03332095|76112351|FG001|Received at Least One Dose of Study Treatment|Overall Study||45||
59996371|NCT03332095|76112350|FG000|COMPLETED|Overall Study||9||
59996372|NCT03332095|76112351|FG001|COMPLETED|Overall Study||44||
59996373|NCT03332095|76112350|FG000|NOT COMPLETED|Overall Study||1||
59996374|NCT03332095|76112351|FG001|NOT COMPLETED|Overall Study||1||
59996375|NCT02764489|76112358|FG000|STARTED|Part 1: Day 1 up to Day 16||17||
59996376|NCT02764489|76112359|FG001|STARTED|Part 1: Day 1 up to Day 16||16||
59996377|NCT02764489|76112358|FG000|COMPLETED|Part 1: Day 1 up to Day 16||14||
59996378|NCT02764489|76112359|FG001|COMPLETED|Part 1: Day 1 up to Day 16||16||
59567060|NCT03847389|75669861|FG002|COMPLETED|Overall Study||0||
59567061|NCT03847389|75669859|FG000|NOT COMPLETED|Overall Study||0||
59567062|NCT03847389|75669860|FG001|NOT COMPLETED|Overall Study||0||
59567063|NCT03847389|75669861|FG002|NOT COMPLETED|Overall Study||0||
59822974|NCT00290758|75945794|FG000|Post Intervention Follow-Up|Pre-Intervention rFNA Through Follow-Up||55||
59822975|NCT00290758|75945795|FG001|Post Intervention Follow-Up|Pre-Intervention rFNA Through Follow-Up||54||
59567064|NCT02351934|75669874|FG000|STARTED|Allocation||62||
59567065|NCT02351934|75669875|FG001|STARTED|Allocation||61||
59567066|NCT02351934|75669874|FG000|Received Allocation|Allocation||56||
59567067|NCT02351934|75669875|FG001|Received Allocation|Allocation||61||
60111420|NCT01856764|76231781|FG001|NOT COMPLETED|Overall Study||0||
60111421|NCT01857232|76231792|FG000|STARTED|Overall Study||69||
60111422|NCT01857232|76231793|FG001|STARTED|Overall Study||67||
60111423|NCT01857232|76231794|FG002|STARTED|Overall Study||67||
60111424|NCT01857232|76231795|FG003|STARTED|Overall Study||70||
60111425|NCT01857232|76231796|FG004|STARTED|Overall Study||69||
60111426|NCT01857232|76231792|FG000|Evaluable ITT|Overall Study||66||
60111427|NCT01857232|76231793|FG001|Evaluable ITT|Overall Study||66||
60111428|NCT01857232|76231794|FG002|Evaluable ITT|Overall Study||63||
60111429|NCT01857232|76231795|FG003|Evaluable ITT|Overall Study||68||
60111430|NCT01857232|76231796|FG004|Evaluable ITT|Overall Study||65||
60111431|NCT01857232|76231792|FG000|COMPLETED|Overall Study||61||
60111432|NCT01857232|76231793|FG001|COMPLETED|Overall Study||65||
60111433|NCT01857232|76231794|FG002|COMPLETED|Overall Study||63||
60111434|NCT01857232|76231795|FG003|COMPLETED|Overall Study||68||
60111435|NCT01857232|76231796|FG004|COMPLETED|Overall Study||63||
60111436|NCT01857232|76231792|FG000|NOT COMPLETED|Overall Study||8||
60111437|NCT01857232|76231793|FG001|NOT COMPLETED|Overall Study||2||
60111438|NCT01857232|76231794|FG002|NOT COMPLETED|Overall Study||4||
60111439|NCT01857232|76231795|FG003|NOT COMPLETED|Overall Study||2||
60111440|NCT01857232|76231796|FG004|NOT COMPLETED|Overall Study||6||
60111441|NCT01804114|76231813|FG000|STARTED|Overall Study||17||
60111442|NCT01804114|76231814|FG001|STARTED|Overall Study||12||
60111443|NCT01804114|76231813|FG000|COMPLETED|Overall Study||17||
60111444|NCT01804114|76231814|FG001|COMPLETED|Overall Study||12||
60111445|NCT01804114|76231813|FG000|NOT COMPLETED|Overall Study||0||
60111446|NCT01804114|76231814|FG001|NOT COMPLETED|Overall Study||0||
60111447|NCT02859558|76231825|FG000|STARTED|Step 1||49||
60111448|NCT02859558|76231826|FG001|STARTED|Step 1||79||
60111449|NCT02859558|76231827|FG002|STARTED|Step 1||60||
60111450|NCT02859558|76231828|FG003|STARTED|Step 1||4||
60111451|NCT02859558|76231829|FG004|STARTED|Step 1||3||
60111452|NCT02859558|76231825|FG000|Completed Week 48|Step 1||41||
60111453|NCT02859558|76231826|FG001|Completed Week 48|Step 1||68||
60111454|NCT02859558|76231827|FG002|Completed Week 48|Step 1||50||
60111455|NCT02859558|76231828|FG003|Completed Week 48|Step 1||0||
60111456|NCT02859558|76231829|FG004|Completed Week 48|Step 1||0||
60111457|NCT02859558|76231825|FG000|COMPLETED|Step 1||37||
60111458|NCT02859558|76231826|FG001|COMPLETED|Step 1||67||
60111459|NCT02859558|76231827|FG002|COMPLETED|Step 1||49||
60111460|NCT02859558|76231828|FG003|COMPLETED|Step 1||4||
60111461|NCT02859558|76231829|FG004|COMPLETED|Step 1||0||
60111462|NCT02859558|76231825|FG000|NOT COMPLETED|Step 1||12||
60111463|NCT02859558|76231826|FG001|NOT COMPLETED|Step 1||12||
60111464|NCT02859558|76231827|FG002|NOT COMPLETED|Step 1||11||
60111465|NCT02859558|76231828|FG003|NOT COMPLETED|Step 1||0||
60111466|NCT02859558|76231829|FG004|NOT COMPLETED|Step 1||3||
60111467|NCT02859558|76231825|FG000|STARTED|Step 2||25|Some participants who completed Step 1 will not or have not yet enrolled to Step 2. Step 2 follow-up is ongoing. Participant Flow Overview will be updated upon study completion. Summary tables are based on data through database freeze date (January 13, 2022) for this primary results submission.|
60111468|NCT02859558|76231826|FG001|STARTED|Step 2||39|Some participants who completed Step 1 will not or have not yet enrolled to Step 2. Step 2 follow-up is ongoing. Participant Flow Overview will be updated upon study completion. Summary tables are based on data through database freeze date (January 13, 2022) for this primary results submission.|
60111469|NCT02859558|76231827|FG002|STARTED|Step 2||21|Some participants who completed Step 1 will not or have not yet enrolled to Step 2. Step 2 follow-up is ongoing. Participant Flow Overview will be updated upon study completion. Summary tables are based on data through database freeze date (January 13, 2022) for this primary results submission.|
60111470|NCT02859558|76231828|FG003|STARTED|Step 2||0|Some participants who completed Step 1 will not or have not yet enrolled to Step 2. Step 2 follow-up is ongoing. Participant Flow Overview will be updated upon study completion. Summary tables are based on data through database freeze date (January 13, 2022) for this primary results submission.|
60111471|NCT02859558|76231829|FG004|STARTED|Step 2||0|Some participants who completed Step 1 will not or have not yet enrolled to Step 2. Step 2 follow-up is ongoing. Participant Flow Overview will be updated upon study completion. Summary tables are based on data through database freeze date (January 13, 2022) for this primary results submission.|
60111472|NCT02859558|76231825|FG000|COMPLETED|Step 2||0||
60111473|NCT02859558|76231826|FG001|COMPLETED|Step 2||0||
60111474|NCT02859558|76231827|FG002|COMPLETED|Step 2||0||
60111475|NCT02859558|76231828|FG003|COMPLETED|Step 2||0||
60111476|NCT02859558|76231829|FG004|COMPLETED|Step 2||0||
59567068|NCT02351934|75669874|FG000|COMPLETED|Allocation||56||
59567069|NCT02351934|75669875|FG001|COMPLETED|Allocation||61||
60111477|NCT02859558|76231825|FG000|NOT COMPLETED|Step 2||25||
60111478|NCT02859558|76231826|FG001|NOT COMPLETED|Step 2||39||
60111479|NCT02859558|76231827|FG002|NOT COMPLETED|Step 2||21||
60111480|NCT02859558|76231828|FG003|NOT COMPLETED|Step 2||0||
60111481|NCT02859558|76231829|FG004|NOT COMPLETED|Step 2||0||
60111482|NCT02267356|76231844|FG000|STARTED|Initial Study||53||
60111483|NCT02267356|76231845|FG001|STARTED|Initial Study||53||
60111484|NCT02267356|76231846|FG002|STARTED|Initial Study||52||
60111485|NCT02267356|76231847|FG003|STARTED|Initial Study||54||
60111486|NCT02267356|76231848|FG004|STARTED|Initial Study||47||
60111487|NCT02267356|76231844|FG000|COMPLETED|Initial Study||47||
60111488|NCT02267356|76231845|FG001|COMPLETED|Initial Study||48||
60111489|NCT02267356|76231846|FG002|COMPLETED|Initial Study||42||
60111490|NCT02267356|76231847|FG003|COMPLETED|Initial Study||43||
60111491|NCT02267356|76231848|FG004|COMPLETED|Initial Study||42||
60111492|NCT02267356|76231844|FG000|NOT COMPLETED|Initial Study||6||
60111493|NCT02267356|76231845|FG001|NOT COMPLETED|Initial Study||5||
60111494|NCT02267356|76231846|FG002|NOT COMPLETED|Initial Study||10||
60111495|NCT02267356|76231847|FG003|NOT COMPLETED|Initial Study||11||
60111496|NCT02267356|76231848|FG004|NOT COMPLETED|Initial Study||5||
60111497|NCT02267356|76231844|FG000|STARTED|Study Extension||33|Not all subjects completing initial study continued in study extension. Continuation was optional.|
60111498|NCT02267356|76231845|FG001|STARTED|Study Extension||37|Not all subjects completing initial study continued in study extension. Continuation was optional.|
60111499|NCT02267356|76231846|FG002|STARTED|Study Extension||30|Not all subjects completing initial study continued in study extension. Continuation was optional.|
60111500|NCT02267356|76231847|FG003|STARTED|Study Extension||32|Not all subjects completing initial study continued in study extension. Continuation was optional.|
60111501|NCT02267356|76231848|FG004|STARTED|Study Extension||26|Not all subjects completing initial study continued in study extension. Continuation was optional.|
60111502|NCT02267356|76231844|FG000|COMPLETED|Study Extension||32||
60111503|NCT02267356|76231845|FG001|COMPLETED|Study Extension||37||
60111504|NCT02267356|76231846|FG002|COMPLETED|Study Extension||29||
60111505|NCT02267356|76231847|FG003|COMPLETED|Study Extension||30||
60111506|NCT02267356|76231848|FG004|COMPLETED|Study Extension||26||
60111507|NCT02267356|76231844|FG000|NOT COMPLETED|Study Extension||1||
60111508|NCT02267356|76231845|FG001|NOT COMPLETED|Study Extension||0||
60111509|NCT02267356|76231846|FG002|NOT COMPLETED|Study Extension||1||
60111510|NCT02267356|76231847|FG003|NOT COMPLETED|Study Extension||2||
60111511|NCT02267356|76231848|FG004|NOT COMPLETED|Study Extension||0||
60111512|NCT01860586|76231860|FG000|STARTED|Overall Study||20||
60111513|NCT01860586|76231860|FG000|COMPLETED|Overall Study||20||
60111514|NCT01860586|76231860|FG000|NOT COMPLETED|Overall Study||0||
60111515|NCT02273206|76231867|FG000|STARTED|Overall Study||378||
60111516|NCT02273206|76231868|FG001|STARTED|Overall Study||379||
60111517|NCT02273206|76231867|FG000|COMPLETED|Overall Study||353||
60111518|NCT02273206|76231868|FG001|COMPLETED|Overall Study||337||
60111519|NCT02273206|76231867|FG000|NOT COMPLETED|Overall Study||25||
60111520|NCT02273206|76231868|FG001|NOT COMPLETED|Overall Study||42||
60111521|NCT00705432|76231880|FG000|STARTED|Treatment Period||311||
60111522|NCT00705432|76231881|FG001|STARTED|Treatment Period||316||
60111523|NCT00705432|76231882|FG002|STARTED|Treatment Period||311||
60111524|NCT00705432|76231883|FG003|STARTED|Treatment Period||52||
60111525|NCT00705432|76231884|FG004|STARTED|Treatment Period||52||
60111526|NCT00705432|76231885|FG005|STARTED|Treatment Period||55||
60111527|NCT00705432|76231880|FG000|STARTED BOCEPREVIR/PLACEBO|Treatment Period||297||
60111528|NCT00705432|76231881|FG001|STARTED BOCEPREVIR/PLACEBO|Treatment Period||303||
60111529|NCT00705432|76231882|FG002|STARTED BOCEPREVIR/PLACEBO|Treatment Period||299||
60111530|NCT00705432|76231883|FG003|STARTED BOCEPREVIR/PLACEBO|Treatment Period||47||
60111531|NCT00705432|76231884|FG004|STARTED BOCEPREVIR/PLACEBO|Treatment Period||47||
60111532|NCT00705432|76231885|FG005|STARTED BOCEPREVIR/PLACEBO|Treatment Period||55||
60111533|NCT00705432|76231880|FG000|COMPLETED|Treatment Period||148||
60111534|NCT00705432|76231881|FG001|COMPLETED|Treatment Period||205||
60111535|NCT00705432|76231882|FG002|COMPLETED|Treatment Period||190||
60111536|NCT00705432|76231883|FG003|COMPLETED|Treatment Period||11||
60111537|NCT00705432|76231884|FG004|COMPLETED|Treatment Period||24||
60111538|NCT00705432|76231885|FG005|COMPLETED|Treatment Period||25||
60111539|NCT00705432|76231880|FG000|NOT COMPLETED|Treatment Period||163||
60111540|NCT00705432|76231881|FG001|NOT COMPLETED|Treatment Period||111||
60111541|NCT00705432|76231882|FG002|NOT COMPLETED|Treatment Period||121||
60111542|NCT00705432|76231883|FG003|NOT COMPLETED|Treatment Period||41||
59822976|NCT00290758|75945794|FG000|COMPLETED|Pre-Intervention rFNA Through Follow-Up||55||
60111543|NCT00705432|76231884|FG004|NOT COMPLETED|Treatment Period||28||
60111544|NCT00705432|76231885|FG005|NOT COMPLETED|Treatment Period||30||
60111545|NCT00705432|76231880|FG000|STARTED|Follow-up Period (Upto Week 72)||278||
60111546|NCT00705432|76231881|FG001|STARTED|Follow-up Period (Upto Week 72)||295||
60111547|NCT00705432|76231882|FG002|STARTED|Follow-up Period (Upto Week 72)||291||
60111548|NCT00705432|76231883|FG003|STARTED|Follow-up Period (Upto Week 72)||42||
60111549|NCT00705432|76231884|FG004|STARTED|Follow-up Period (Upto Week 72)||44||
60111550|NCT00705432|76231885|FG005|STARTED|Follow-up Period (Upto Week 72)||53||
60111551|NCT00705432|76231880|FG000|COMPLETED|Follow-up Period (Upto Week 72)||207||
60111552|NCT00705432|76231881|FG001|COMPLETED|Follow-up Period (Upto Week 72)||252||
60111553|NCT00705432|76231882|FG002|COMPLETED|Follow-up Period (Upto Week 72)||266||
60111554|NCT00705432|76231883|FG003|COMPLETED|Follow-up Period (Upto Week 72)||28||
60111555|NCT00705432|76231884|FG004|COMPLETED|Follow-up Period (Upto Week 72)||38||
60111556|NCT00705432|76231885|FG005|COMPLETED|Follow-up Period (Upto Week 72)||46||
60111557|NCT00705432|76231880|FG000|NOT COMPLETED|Follow-up Period (Upto Week 72)||71||
60111558|NCT00705432|76231881|FG001|NOT COMPLETED|Follow-up Period (Upto Week 72)||43||
60111559|NCT00705432|76231882|FG002|NOT COMPLETED|Follow-up Period (Upto Week 72)||25||
60111560|NCT00705432|76231883|FG003|NOT COMPLETED|Follow-up Period (Upto Week 72)||14||
60111561|NCT00705432|76231884|FG004|NOT COMPLETED|Follow-up Period (Upto Week 72)||6||
60111562|NCT00705432|76231885|FG005|NOT COMPLETED|Follow-up Period (Upto Week 72)||7||
60111563|NCT00704964|76231896|FG000|STARTED|Overall Study|Number of participants who took at least one dose of study medication.|746||
60111564|NCT00704964|76231896|FG000|COMPLETED|Overall Study|Number of participants who completed therapy as scheduled.|418||
60111565|NCT00704964|76231896|FG000|NOT COMPLETED|Overall Study||328||
60111566|NCT01861054|76231902|FG000|STARTED|Overall Study||18||
60111567|NCT01861054|76231903|FG001|STARTED|Overall Study||2||
60111568|NCT01861054|76231902|FG000|Safety Population|Overall Study||18||
60111569|NCT01861054|76231903|FG001|Safety Population|Overall Study||2||
60111570|NCT01861054|76231902|FG000|PK Population|Overall Study||4||
60111571|NCT01861054|76231903|FG001|PK Population|Overall Study||2||
60111572|NCT01861054|76231902|FG000|COMPLETED|Overall Study||18||
60111573|NCT01861054|76231903|FG001|COMPLETED|Overall Study||2||
60111574|NCT01861054|76231902|FG000|NOT COMPLETED|Overall Study||0||
60111575|NCT01861054|76231903|FG001|NOT COMPLETED|Overall Study||0||
60111576|NCT00704808|76231912|FG000|STARTED|Overall Study||180||
60111577|NCT00704808|76231912|FG000|COMPLETED|Overall Study||49||
60111578|NCT00704808|76231912|FG000|NOT COMPLETED|Overall Study||131||
60111579|NCT01861756|76231918|FG000|STARTED|Overall Study||101||
60111580|NCT01861756|76231919|FG001|STARTED|Overall Study||103||
60111581|NCT01861756|76231918|FG000|COMPLETED|Overall Study||88||
60111582|NCT01861756|76231919|FG001|COMPLETED|Overall Study||85||
60111583|NCT01861756|76231918|FG000|NOT COMPLETED|Overall Study||13||
60111584|NCT01861756|76231919|FG001|NOT COMPLETED|Overall Study||18||
60111585|NCT01862536|76231927|FG000|STARTED|Overall Study||13||
60111586|NCT01862536|76231928|FG001|STARTED|Overall Study||23||
60111587|NCT01862536|76231927|FG000|COMPLETED|Overall Study||10||
60111588|NCT01862536|76231928|FG001|COMPLETED|Overall Study||16||
60111589|NCT01862536|76231927|FG000|NOT COMPLETED|Overall Study||3||
60111590|NCT01862536|76231928|FG001|NOT COMPLETED|Overall Study||7||
59567070|NCT02351934|75669874|FG000|NOT COMPLETED|Allocation||6||
60111591|NCT01862614|76231936|FG000|STARTED|First Appointment.|Received articaine injection at first appointment.|40||
60111592|NCT01862614|76231937|FG001|STARTED|First Appointment.|Received buffered articaine at first appointment.|40||
60111593|NCT01862614|76231936|FG000|COMPLETED|First Appointment.||40||
60111594|NCT01862614|76231937|FG001|COMPLETED|First Appointment.||40||
60111595|NCT01862614|76231936|FG000|NOT COMPLETED|First Appointment.||0||
60111596|NCT01862614|76231937|FG001|NOT COMPLETED|First Appointment.||0||
60111597|NCT01862614|76231936|FG000|STARTED|2 Week Washout Period.||40||
60111598|NCT01862614|76231937|FG001|STARTED|2 Week Washout Period.||40||
60111599|NCT01862614|76231936|FG000|COMPLETED|2 Week Washout Period.||40||
60111600|NCT01862614|76231937|FG001|COMPLETED|2 Week Washout Period.||40||
60111601|NCT01862614|76231936|FG000|NOT COMPLETED|2 Week Washout Period.||0||
60111602|NCT01862614|76231937|FG001|NOT COMPLETED|2 Week Washout Period.||0||
60111603|NCT01862614|76231936|FG000|STARTED|Second Appointment.|Received buffered articaine at second appointment.|40|Received buffered articaine at second appointment.|
60111604|NCT01862614|76231937|FG001|STARTED|Second Appointment.|Received articaine at second appointment.|40|Received buffered articaine at second appointment.|
60111605|NCT01862614|76231936|FG000|COMPLETED|Second Appointment.||40||
60111606|NCT01862614|76231937|FG001|COMPLETED|Second Appointment.||40||
60111607|NCT01862614|76231936|FG000|NOT COMPLETED|Second Appointment.||0||
60111608|NCT01862614|76231937|FG001|NOT COMPLETED|Second Appointment.||0||
60111609|NCT01866592|76231943|FG000|STARTED|Overall Study||81||
60111610|NCT01866592|76231943|FG000|COMPLETED|Overall Study||58||
60111611|NCT01866592|76231943|FG000|NOT COMPLETED|Overall Study||23||
60111612|NCT01375608|76231947|FG000|STARTED|Overall Study||10||
60111613|NCT01375608|76231947|FG000|COMPLETED|Overall Study||8||
60111614|NCT01375608|76231947|FG000|NOT COMPLETED|Overall Study||2||
60111615|NCT01868776|76231953|FG000|STARTED|Overall Study||50||
60111616|NCT01868776|76231954|FG001|STARTED|Overall Study||50||
60111617|NCT01868776|76231953|FG000|COMPLETED|Overall Study||50||
60111618|NCT01868776|76231954|FG001|COMPLETED|Overall Study||50||
60111619|NCT01868776|76231953|FG000|NOT COMPLETED|Overall Study||0||
60111620|NCT01868776|76231954|FG001|NOT COMPLETED|Overall Study||0||
60111621|NCT00704418|76231962|FG000|STARTED|Overall Study||78||
60111622|NCT00704418|76231963|FG001|STARTED|Overall Study||78||
60111623|NCT00704418|76231962|FG000|COMPLETED|Overall Study||73||
60111624|NCT00704418|76231963|FG001|COMPLETED|Overall Study||72||
60111625|NCT00704418|76231962|FG000|NOT COMPLETED|Overall Study||5||
60111626|NCT00704418|76231963|FG001|NOT COMPLETED|Overall Study||6||
60111627|NCT01869634|76231971|FG000|STARTED|Overall Study||20||
60111628|NCT01869634|76231972|FG001|STARTED|Overall Study||17||
60111629|NCT01869634|76231971|FG000|COMPLETED|Overall Study||18||
60111630|NCT01869634|76231972|FG001|COMPLETED|Overall Study||17||
60111631|NCT01869634|76231971|FG000|NOT COMPLETED|Overall Study||2||
60111632|NCT01869634|76231972|FG001|NOT COMPLETED|Overall Study||0||
60111633|NCT02266108|76231980|FG000|STARTED|Overall Study||80||
60111634|NCT02266108|76231981|FG001|STARTED|Overall Study||71||
60111635|NCT02266108|76231980|FG000|COMPLETED|Overall Study||80||
59567071|NCT02351934|75669875|FG001|NOT COMPLETED|Allocation||0||
59822977|NCT00290758|75945795|FG001|COMPLETED|Pre-Intervention rFNA Through Follow-Up||54||
59822978|NCT00290758|75945794|FG000|NOT COMPLETED|Pre-Intervention rFNA Through Follow-Up||7||
59822979|NCT00290758|75945795|FG001|NOT COMPLETED|Pre-Intervention rFNA Through Follow-Up||10||
60111636|NCT02266108|76231981|FG001|COMPLETED|Overall Study||71||
60111637|NCT02266108|76231980|FG000|NOT COMPLETED|Overall Study||0||
60111638|NCT02266108|76231981|FG001|NOT COMPLETED|Overall Study||0||
60111639|NCT01871506|76231989|FG000|STARTED|Overall Study||150||
60111640|NCT01871506|76231990|FG001|STARTED|Overall Study||153||
60111641|NCT01871506|76231989|FG000|COMPLETED|Overall Study||150||
60111642|NCT01871506|76231990|FG001|COMPLETED|Overall Study||153||
60111643|NCT01871506|76231989|FG000|NOT COMPLETED|Overall Study||0||
60111644|NCT01871506|76231990|FG001|NOT COMPLETED|Overall Study||0||
60111645|NCT01873846|76232009|FG000|STARTED|Overall Study||400||
60111646|NCT01873846|76232009|FG000|Eligble Participants Dispensed Lenses|Overall Study||396||
60111647|NCT01873846|76232009|FG000|COMPLETED|Overall Study||388||
60111648|NCT01873846|76232009|FG000|NOT COMPLETED|Overall Study||12||
60111649|NCT01874392|76232013|FG000|STARTED|Overall Study||9||
60111650|NCT01874392|76232013|FG000|COMPLETED|Overall Study||9||
60111651|NCT01874392|76232013|FG000|NOT COMPLETED|Overall Study||0||
60111652|NCT04064346|76232017|FG000|STARTED|Pre-randomization Single-blind Period||12||
60111653|NCT04064346|76232018|FG001|STARTED|Pre-randomization Single-blind Period|This arm was not applicable for the Pre-randomization Single-blind Period.|0||
59822980|NCT00290758|75945794|FG000|STARTED|Post Intervention rFNA||55||
60111654|NCT04064346|76232019|FG002|STARTED|Pre-randomization Single-blind Period|This arm was not applicable for the Pre-randomization Single-blind Period.|0||
60111655|NCT04064346|76232017|FG000|Treated in Placebo Run-in|Pre-randomization Single-blind Period||12||
60111656|NCT04064346|76232018|FG001|Treated in Placebo Run-in|Pre-randomization Single-blind Period||0||
60111657|NCT04064346|76232019|FG002|Treated in Placebo Run-in|Pre-randomization Single-blind Period||0||
60111658|NCT04064346|76232017|FG000|Treated in Lixivaptan Titration Period|Pre-randomization Single-blind Period||8||
60111659|NCT04064346|76232018|FG001|Treated in Lixivaptan Titration Period|Pre-randomization Single-blind Period||0||
60111660|NCT04064346|76232019|FG002|Treated in Lixivaptan Titration Period|Pre-randomization Single-blind Period||0||
60111661|NCT04064346|76232017|FG000|COMPLETED|Pre-randomization Single-blind Period||5||
60111662|NCT04064346|76232018|FG001|COMPLETED|Pre-randomization Single-blind Period||0||
60111663|NCT04064346|76232019|FG002|COMPLETED|Pre-randomization Single-blind Period||0||
60111664|NCT04064346|76232017|FG000|NOT COMPLETED|Pre-randomization Single-blind Period||7||
60111665|NCT04064346|76232018|FG001|NOT COMPLETED|Pre-randomization Single-blind Period||0||
60111666|NCT04064346|76232019|FG002|NOT COMPLETED|Pre-randomization Single-blind Period||0||
60111667|NCT04064346|76232017|FG000|STARTED|Randomized Double-blind Period|This arm was not applicable for the Randomized Double-blind Period.|0||
60111668|NCT04064346|76232018|FG001|STARTED|Randomized Double-blind Period||4||
60111669|NCT04064346|76232019|FG002|STARTED|Randomized Double-blind Period||1||
60111670|NCT04064346|76232017|FG000|Randomized|Randomized Double-blind Period||0||
60111671|NCT04064346|76232018|FG001|Randomized|Randomized Double-blind Period||4||
60111672|NCT04064346|76232019|FG002|Randomized|Randomized Double-blind Period||1||
60111673|NCT04064346|76232017|FG000|COMPLETED|Randomized Double-blind Period||0||
60111674|NCT04064346|76232018|FG001|COMPLETED|Randomized Double-blind Period|1 participant withdrew consent before entering Follow-up Period I.|4||
60111675|NCT04064346|76232019|FG002|COMPLETED|Randomized Double-blind Period||1||
60111676|NCT04064346|76232017|FG000|NOT COMPLETED|Randomized Double-blind Period||0||
60111677|NCT04064346|76232018|FG001|NOT COMPLETED|Randomized Double-blind Period||0||
60111678|NCT04064346|76232019|FG002|NOT COMPLETED|Randomized Double-blind Period||0||
60111679|NCT04064346|76232017|FG000|STARTED|Follow-up Period I|This arm was not applicable for Follow-up Period I.|0||
60111680|NCT04064346|76232018|FG001|STARTED|Follow-up Period I|1 participant who completed the Randomized Double-blind Period withdrew consent before entering Follow-up Period I.|3||
60111681|NCT04064346|76232019|FG002|STARTED|Follow-up Period I||1||
60111682|NCT04064346|76232017|FG000|COMPLETED|Follow-up Period I||0||
60111683|NCT04064346|76232018|FG001|COMPLETED|Follow-up Period I|The study was terminated prematurely before any participants proceeded to the Re-titration Period.|3||
60111684|NCT04064346|76232019|FG002|COMPLETED|Follow-up Period I|The study was terminated prematurely before any participants proceeded to the Re-titration Period.|1||
60111685|NCT04064346|76232017|FG000|NOT COMPLETED|Follow-up Period I||0||
60111686|NCT04064346|76232018|FG001|NOT COMPLETED|Follow-up Period I||0||
60111687|NCT04064346|76232019|FG002|NOT COMPLETED|Follow-up Period I||0||
60111688|NCT04064346|76232017|FG000|STARTED|Re-titration Period|This arm was not applicable for the Re-titration Period.|0||
60111689|NCT04064346|76232018|FG001|STARTED|Re-titration Period||0||
60111690|NCT04064346|76232019|FG002|STARTED|Re-titration Period||0||
60111691|NCT04064346|76232017|FG000|COMPLETED|Re-titration Period||0||
60111692|NCT04064346|76232018|FG001|COMPLETED|Re-titration Period||0||
60111693|NCT04064346|76232019|FG002|COMPLETED|Re-titration Period||0||
60111694|NCT04064346|76232017|FG000|NOT COMPLETED|Re-titration Period||0||
60111695|NCT04064346|76232018|FG001|NOT COMPLETED|Re-titration Period||0||
60111696|NCT04064346|76232019|FG002|NOT COMPLETED|Re-titration Period||0||
60111697|NCT04064346|76232017|FG000|STARTED|Maintenance Treatment Period|This arm was not applicable for the Maintenance Treatment Period.|0||
60111698|NCT04064346|76232018|FG001|STARTED|Maintenance Treatment Period||0||
60111699|NCT04064346|76232019|FG002|STARTED|Maintenance Treatment Period||0||
60111700|NCT04064346|76232017|FG000|COMPLETED|Maintenance Treatment Period||0||
60111701|NCT04064346|76232018|FG001|COMPLETED|Maintenance Treatment Period||0||
60111702|NCT04064346|76232019|FG002|COMPLETED|Maintenance Treatment Period||0||
60111703|NCT04064346|76232017|FG000|NOT COMPLETED|Maintenance Treatment Period||0||
60111704|NCT04064346|76232018|FG001|NOT COMPLETED|Maintenance Treatment Period||0||
60111705|NCT04064346|76232019|FG002|NOT COMPLETED|Maintenance Treatment Period||0||
60111706|NCT04064346|76232017|FG000|STARTED|Follow-up Period II|This arm was not applicable for Follow-up Period II.|0||
60111707|NCT04064346|76232018|FG001|STARTED|Follow-up Period II||0||
60111708|NCT04064346|76232019|FG002|STARTED|Follow-up Period II||0||
60111709|NCT04064346|76232017|FG000|COMPLETED|Follow-up Period II||0||
60111710|NCT04064346|76232018|FG001|COMPLETED|Follow-up Period II||0||
60111711|NCT04064346|76232019|FG002|COMPLETED|Follow-up Period II||0||
60111712|NCT04064346|76232017|FG000|NOT COMPLETED|Follow-up Period II||0||
60111713|NCT04064346|76232018|FG001|NOT COMPLETED|Follow-up Period II||0||
60111714|NCT04064346|76232019|FG002|NOT COMPLETED|Follow-up Period II||0||
60111715|NCT00704340|76232032|FG000|STARTED|Overall Study||120||
60111716|NCT00704340|76232033|FG001|STARTED|Overall Study||117||
60111717|NCT00704340|76232032|FG000|COMPLETED|Overall Study||118||
60111718|NCT00704340|76232033|FG001|COMPLETED|Overall Study||115||
60111719|NCT00704340|76232032|FG000|NOT COMPLETED|Overall Study||2||
60111720|NCT00704340|76232033|FG001|NOT COMPLETED|Overall Study||2||
60111721|NCT00552058|76232041|FG000|STARTED|Overall Study||223||
60111722|NCT00552058|76232042|FG001|STARTED|Overall Study||216||
60111723|NCT00552058|76232041|FG000|COMPLETED|Overall Study||207||
60111724|NCT00552058|76232042|FG001|COMPLETED|Overall Study||192||
60111725|NCT00552058|76232041|FG000|NOT COMPLETED|Overall Study||16||
60111726|NCT00552058|76232042|FG001|NOT COMPLETED|Overall Study||24||
60111727|NCT02274688|76232050|FG000|STARTED|Overall Study||86||
60111728|NCT02274688|76232051|FG001|STARTED|Overall Study||85||
60111729|NCT02274688|76232050|FG000|COMPLETED|Overall Study||72||
60111730|NCT02274688|76232051|FG001|COMPLETED|Overall Study||72||
60111731|NCT02274688|76232050|FG000|NOT COMPLETED|Overall Study||14||
60111732|NCT02274688|76232051|FG001|NOT COMPLETED|Overall Study||13||
60111733|NCT02276638|76232061|FG000|STARTED|Overall Study||28||
60111734|NCT02276638|76232062|FG001|STARTED|Overall Study||28||
60111735|NCT02276638|76232063|FG002|STARTED|Overall Study||23||
60111736|NCT02276638|76232061|FG000|COMPLETED|Overall Study||28||
60111737|NCT02276638|76232062|FG001|COMPLETED|Overall Study||28||
60111738|NCT02276638|76232063|FG002|COMPLETED|Overall Study||23||
60111739|NCT02276638|76232061|FG000|NOT COMPLETED|Overall Study||0||
60111740|NCT02276638|76232062|FG001|NOT COMPLETED|Overall Study||0||
60111741|NCT02276638|76232063|FG002|NOT COMPLETED|Overall Study||0||
60111742|NCT00550732|76232071|FG000|STARTED|Overall Study||40||
60111743|NCT00550732|76232071|FG000|COMPLETED|Overall Study||29||
60111744|NCT00550732|76232071|FG000|NOT COMPLETED|Overall Study||11||
60111745|NCT02274844|76232078|FG000|STARTED|Overall Study||203||
60111746|NCT02274844|76232079|FG001|STARTED|Overall Study||270||
60111747|NCT02274844|76232078|FG000|COMPLETED|Overall Study||165||
60111748|NCT02274844|76232079|FG001|COMPLETED|Overall Study||238||
60111749|NCT02274844|76232078|FG000|NOT COMPLETED|Overall Study||38||
60111750|NCT02274844|76232079|FG001|NOT COMPLETED|Overall Study||32||
60111751|NCT00550420|76232085|FG000|STARTED|Overall Study||331||
60111752|NCT00550420|76232085|FG000|COMPLETED|Overall Study||26||
60111753|NCT00550420|76232085|FG000|NOT COMPLETED|Overall Study||305||
60111754|NCT00559936|76232091|FG000|STARTED|Overall Study||24||
60111755|NCT00559936|76232091|FG000|COMPLETED|Overall Study||20||
60111756|NCT00559936|76232091|FG000|NOT COMPLETED|Overall Study||4||
60111757|NCT00558064|76232097|FG000|STARTED|Overall Study||269||
60111758|NCT00558064|76232098|FG001|STARTED|Overall Study||262||
60111759|NCT00558064|76232097|FG000|COMPLETED|Overall Study||264||
60111760|NCT00558064|76232098|FG001|COMPLETED|Overall Study||257||
60111761|NCT00558064|76232097|FG000|NOT COMPLETED|Overall Study||5||
60111762|NCT00558064|76232098|FG001|NOT COMPLETED|Overall Study||5||
60111763|NCT00557830|76232107|FG000|STARTED|Screening Treatment Phase||12||
60111764|NCT00557830|76232108|FG001|STARTED|Screening Treatment Phase||0||
60111765|NCT00557830|76232109|FG002|STARTED|Screening Treatment Phase||0||
60111766|NCT00557830|76232107|FG000|COMPLETED|Screening Treatment Phase||6||
60111767|NCT00557830|76232108|FG001|COMPLETED|Screening Treatment Phase||0||
60111768|NCT00557830|76232109|FG002|COMPLETED|Screening Treatment Phase||0||
60111769|NCT00557830|76232107|FG000|NOT COMPLETED|Screening Treatment Phase||6||
60111770|NCT00557830|76232108|FG001|NOT COMPLETED|Screening Treatment Phase||0||
60111771|NCT00557830|76232109|FG002|NOT COMPLETED|Screening Treatment Phase||0||
60111772|NCT00557830|76232107|FG000|STARTED|Treatment Phase||0||
60111773|NCT00557830|76232108|FG001|STARTED|Treatment Phase||4||
60111774|NCT00557830|76232109|FG002|STARTED|Treatment Phase||2||
60111775|NCT00557830|76232107|FG000|COMPLETED|Treatment Phase||0||
60111776|NCT00557830|76232108|FG001|COMPLETED|Treatment Phase||4||
60111777|NCT00557830|76232109|FG002|COMPLETED|Treatment Phase||2||
60111778|NCT00557830|76232107|FG000|NOT COMPLETED|Treatment Phase||0||
60111779|NCT00557830|76232108|FG001|NOT COMPLETED|Treatment Phase||0||
60111780|NCT00557830|76232109|FG002|NOT COMPLETED|Treatment Phase||0||
60111781|NCT00557440|76232120|FG000|STARTED|Treatment Period 1||12||
60111782|NCT00557440|76232121|FG001|STARTED|Treatment Period 1||12||
60111783|NCT00557440|76232122|FG002|STARTED|Treatment Period 1||13||
60111784|NCT00557440|76232120|FG000|COMPLETED|Treatment Period 1||12||
60111785|NCT00557440|76232121|FG001|COMPLETED|Treatment Period 1||12||
60111786|NCT00557440|76232122|FG002|COMPLETED|Treatment Period 1||12||
60111787|NCT00557440|76232120|FG000|NOT COMPLETED|Treatment Period 1||0||
60111788|NCT00557440|76232121|FG001|NOT COMPLETED|Treatment Period 1||0||
60111789|NCT00557440|76232122|FG002|NOT COMPLETED|Treatment Period 1||1||
60111790|NCT00557440|76232120|FG000|STARTED|Treatment Period 2||12||
60111791|NCT00557440|76232121|FG001|STARTED|Treatment Period 2||12||
60111792|NCT00557440|76232122|FG002|STARTED|Treatment Period 2||12||
60111793|NCT00557440|76232120|FG000|COMPLETED|Treatment Period 2||12||
60111794|NCT00557440|76232121|FG001|COMPLETED|Treatment Period 2||12||
60111795|NCT00557440|76232122|FG002|COMPLETED|Treatment Period 2||12||
60111796|NCT00557440|76232120|FG000|NOT COMPLETED|Treatment Period 2||0||
60111797|NCT00557440|76232121|FG001|NOT COMPLETED|Treatment Period 2||0||
60111798|NCT00557440|76232122|FG002|NOT COMPLETED|Treatment Period 2||0||
60111799|NCT00557440|76232120|FG000|STARTED|Treatment Period 3||12||
60111800|NCT00557440|76232121|FG001|STARTED|Treatment Period 3||12||
60111801|NCT00557440|76232122|FG002|STARTED|Treatment Period 3||12||
60111802|NCT00557440|76232120|FG000|COMPLETED|Treatment Period 3||12||
60111803|NCT00557440|76232121|FG001|COMPLETED|Treatment Period 3||12||
60111804|NCT00557440|76232122|FG002|COMPLETED|Treatment Period 3||12||
60111805|NCT00557440|76232120|FG000|NOT COMPLETED|Treatment Period 3||0||
60111806|NCT00557440|76232121|FG001|NOT COMPLETED|Treatment Period 3||0||
60111807|NCT00557440|76232122|FG002|NOT COMPLETED|Treatment Period 3||0||
60111808|NCT00556894|76232133|FG000|STARTED|Overall Study||82||
59822981|NCT00290758|75945795|FG001|STARTED|Post Intervention rFNA||54||
60111809|NCT00556894|76232134|FG001|STARTED|Overall Study||87||
60111810|NCT00556894|76232135|FG002|STARTED|Overall Study||84||
60111811|NCT00556894|76232133|FG000|COMPLETED|Overall Study||66||
60111812|NCT00556894|76232134|FG001|COMPLETED|Overall Study||68||
60111813|NCT00556894|76232135|FG002|COMPLETED|Overall Study||65||
60111814|NCT00556894|76232133|FG000|NOT COMPLETED|Overall Study||16||
60111815|NCT00556894|76232134|FG001|NOT COMPLETED|Overall Study||19||
60111816|NCT00556894|76232135|FG002|NOT COMPLETED|Overall Study||19||
60111817|NCT02722044|76232143|FG000|STARTED|Overall Study||33||
60111818|NCT02722044|76232143|FG000|COMPLETED|Overall Study||28||
60111819|NCT02722044|76232143|FG000|NOT COMPLETED|Overall Study||5||
60111820|NCT00556426|76232148|FG000|STARTED|Overall Study||100||
59714714|NCT01202279|75833451|FG001|COMPLETED|Overall Study||561||
59714715|NCT01202279|75833450|FG000|NOT COMPLETED|Overall Study||37||
59714716|NCT01202279|75833451|FG001|NOT COMPLETED|Overall Study||27||
59822982|NCT00290758|75945794|FG000|COMPLETED|Post Intervention rFNA||49||
59822983|NCT00290758|75945795|FG001|COMPLETED|Post Intervention rFNA||49||
59822984|NCT00290758|75945794|FG000|NOT COMPLETED|Post Intervention rFNA||6||
59567072|NCT02351934|75669874|FG000|STARTED|Follow-Up||56||
59567073|NCT02351934|75669875|FG001|STARTED|Follow-Up||61||
59567074|NCT02351934|75669874|FG000|COMPLETED|Follow-Up||44||
59567075|NCT02351934|75669875|FG001|COMPLETED|Follow-Up||51||
59567076|NCT02351934|75669874|FG000|NOT COMPLETED|Follow-Up||12||
59567077|NCT02351934|75669875|FG001|NOT COMPLETED|Follow-Up||10||
59567078|NCT04280445|75669881|FG000|STARTED|Overall Study||3||
59567079|NCT04280445|75669881|FG000|COMPLETED|Overall Study||3||
59567080|NCT04280445|75669881|FG000|NOT COMPLETED|Overall Study||0||
59567081|NCT04321239|75669887|FG000|STARTED|Overall Study||25||
59567082|NCT04321239|75669888|FG001|STARTED|Overall Study||26||
59567083|NCT04321239|75669887|FG000|COMPLETED|Overall Study||22||
59822985|NCT00290758|75945795|FG001|NOT COMPLETED|Post Intervention rFNA||5||
59822986|NCT00372567|75945808|FG000|STARTED|Phase 1 Sub-study||0||
60111821|NCT00556426|76232148|FG000|COMPLETED|Overall Study||91||
60111822|NCT00556426|76232148|FG000|NOT COMPLETED|Overall Study||9||
60111823|NCT00555568|76232156|FG000|STARTED|Overall Study||100||
60111824|NCT00555568|76232157|FG001|STARTED|Overall Study||98||
60111825|NCT00555568|76232158|FG002|STARTED|Overall Study||100||
60111826|NCT00555568|76232156|FG000|COMPLETED|Overall Study||74||
60111827|NCT00555568|76232157|FG001|COMPLETED|Overall Study||82||
60111828|NCT00555568|76232158|FG002|COMPLETED|Overall Study||84||
60111829|NCT00555568|76232156|FG000|NOT COMPLETED|Overall Study||26||
60111830|NCT00555568|76232157|FG001|NOT COMPLETED|Overall Study||16||
60111831|NCT00555568|76232158|FG002|NOT COMPLETED|Overall Study||16||
60111832|NCT00702702|76232169|FG000|STARTED|Overall Study||56||
60111833|NCT00702702|76232169|FG000|COMPLETED|Overall Study||0||
60111834|NCT00702702|76232169|FG000|NOT COMPLETED|Overall Study||56||
60111835|NCT02721966|76232180|FG000|STARTED|Overall Study||167|Randomized|
60111836|NCT02721966|76232181|FG001|STARTED|Overall Study||165|Randomized|
60111837|NCT02721966|76232182|FG002|STARTED|Overall Study||81|Randomized|
60111838|NCT02721966|76232183|FG003|STARTED|Overall Study||80|Randomized|
60111839|NCT02721966|76232184|FG004|STARTED|Overall Study||5|Randomized|
60111840|NCT02721966|76232180|FG000|Completed Period 1 & Went to Period 2|Overall Study||162||
60111841|NCT02721966|76232181|FG001|Completed Period 1 & Went to Period 2|Overall Study||153||
60111842|NCT02721966|76232182|FG002|Completed Period 1 & Went to Period 2|Overall Study||81||
60111843|NCT02721966|76232183|FG003|Completed Period 1 & Went to Period 2|Overall Study||80||
60111844|NCT02721966|76232184|FG004|Completed Period 1 & Went to Period 2|Overall Study||0||
60111845|NCT02721966|76232180|FG000|COMPLETED|Overall Study||138|Completed treatment period 2|
60111846|NCT02721966|76232181|FG001|COMPLETED|Overall Study||142|Completed treatment period 2|
60111847|NCT02721966|76232182|FG002|COMPLETED|Overall Study||72|Completed treatment period 2|
60111848|NCT02721966|76232183|FG003|COMPLETED|Overall Study||73|Completed treatment period 2|
59567084|NCT04321239|75669888|FG001|COMPLETED|Overall Study||24||
59567085|NCT04321239|75669887|FG000|NOT COMPLETED|Overall Study||3||
59567086|NCT04321239|75669888|FG001|NOT COMPLETED|Overall Study||2||
59567087|NCT03218163|75669894|FG000|STARTED|Overall Study||0||
59714717|NCT01201967|75833459|FG000|STARTED|Overall Study||92||
59714718|NCT01201967|75833460|FG001|STARTED|Overall Study||91||
59714719|NCT01201967|75833459|FG000|COMPLETED|Overall Study||86||
59714720|NCT01201967|75833460|FG001|COMPLETED|Overall Study||86||
59714721|NCT01201967|75833459|FG000|NOT COMPLETED|Overall Study||6||
59714722|NCT01201967|75833460|FG001|NOT COMPLETED|Overall Study||5||
59714723|NCT03758755|75833469|FG000|STARTED|Overall Study||25||
59714724|NCT03758755|75833470|FG001|STARTED|Overall Study||20||
59714725|NCT03758755|75833469|FG000|COMPLETED|Overall Study||25||
59714726|NCT03758755|75833470|FG001|COMPLETED|Overall Study||20||
59714727|NCT03758755|75833469|FG000|NOT COMPLETED|Overall Study||0||
59714728|NCT03758755|75833470|FG001|NOT COMPLETED|Overall Study||0||
59822987|NCT00372567|75945809|FG001|STARTED|Phase 1 Sub-study||0||
60111849|NCT02721966|76232184|FG004|COMPLETED|Overall Study||0|Completed treatment period 2|
59714729|NCT01201811|75833476|FG000|STARTED|Overall Study||44||
59714730|NCT01201811|75833476|FG000|COMPLETED|Overall Study||25||
59822988|NCT00372567|75945810|FG002|STARTED|Phase 1 Sub-study||12||
60111850|NCT02721966|76232180|FG000|NOT COMPLETED|Overall Study||29||
60111851|NCT02721966|76232181|FG001|NOT COMPLETED|Overall Study||23||
60111852|NCT02721966|76232182|FG002|NOT COMPLETED|Overall Study||9||
59714731|NCT01201811|75833476|FG000|NOT COMPLETED|Overall Study||19||
59714732|NCT01201343|75833480|FG000|STARTED|Overall Study||79||
60111853|NCT02721966|76232183|FG003|NOT COMPLETED|Overall Study||7||
60111854|NCT02721966|76232184|FG004|NOT COMPLETED|Overall Study||5||
60111855|NCT00553462|76232192|FG000|STARTED|Overall Study||75||
60111856|NCT00553462|76232192|FG000|COMPLETED|Overall Study||61||
60111857|NCT00553462|76232192|FG000|NOT COMPLETED|Overall Study||14||
60111858|NCT00553150|76232198|FG000|STARTED|Overall Study||6||
60111859|NCT00553150|76232199|FG001|STARTED|Overall Study||6||
60111860|NCT00553150|76232200|FG002|STARTED|Overall Study||6||
59714733|NCT01201343|75833480|FG000|Treated|Overall Study||76||
59714734|NCT01201343|75833480|FG000|COMPLETED|Overall Study||60||
59714735|NCT01201343|75833480|FG000|NOT COMPLETED|Overall Study||19||
59714736|NCT01201265|75833484|FG000|STARTED|Overall Study||40||
59714737|NCT01201265|75833484|FG000|COMPLETED|Overall Study||2||
59714738|NCT01201265|75833484|FG000|NOT COMPLETED|Overall Study||38||
59714739|NCT04246801|75833490|FG000|STARTED|Overall Study||140||
59714740|NCT04246801|75833491|FG001|STARTED|Overall Study||71||
59714741|NCT04246801|75833490|FG000|COMPLETED|Overall Study||135||
59822989|NCT00372567|75945808|FG000|COMPLETED|Phase 1 Sub-study||0||
59822990|NCT00372567|75945809|FG001|COMPLETED|Phase 1 Sub-study||0||
59822991|NCT00372567|75945810|FG002|COMPLETED|Phase 1 Sub-study||12||
60111861|NCT00553150|76232201|FG003|STARTED|Overall Study||104||
60111862|NCT00553150|76232198|FG000|COMPLETED|Overall Study||6||
60111863|NCT00553150|76232199|FG001|COMPLETED|Overall Study||6||
60111864|NCT00553150|76232200|FG002|COMPLETED|Overall Study||6||
60111865|NCT00553150|76232201|FG003|COMPLETED|Overall Study||100||
60111866|NCT00553150|76232198|FG000|NOT COMPLETED|Overall Study||0||
60111867|NCT00553150|76232199|FG001|NOT COMPLETED|Overall Study||0||
60111868|NCT00553150|76232200|FG002|NOT COMPLETED|Overall Study||0||
60111869|NCT00553150|76232201|FG003|NOT COMPLETED|Overall Study||4||
60111870|NCT03301350|76232209|FG000|STARTED|Overall Study||29||
60111871|NCT03301350|76232209|FG000|COMPLETED|Overall Study||21||
60111872|NCT03301350|76232209|FG000|NOT COMPLETED|Overall Study||8||
60111873|NCT04735432|76232216|FG000|STARTED|Overall Study||55||
60111874|NCT04735432|76232217|FG001|STARTED|Overall Study||55||
60111875|NCT04735432|76232216|FG000|COMPLETED|Overall Study||52||
60111876|NCT04735432|76232217|FG001|COMPLETED|Overall Study||55||
60111877|NCT04735432|76232216|FG000|NOT COMPLETED|Overall Study||3||
60111878|NCT04735432|76232217|FG001|NOT COMPLETED|Overall Study||0||
60111879|NCT02722278|76232226|FG000|STARTED|Overall Study||166||
59567088|NCT03218163|75669894|FG000|COMPLETED|Overall Study||0||
59567089|NCT03218163|75669894|FG000|NOT COMPLETED|Overall Study||0||
59714742|NCT04246801|75833491|FG001|COMPLETED|Overall Study||65||
59714743|NCT04246801|75833490|FG000|NOT COMPLETED|Overall Study||5||
59714744|NCT04246801|75833491|FG001|NOT COMPLETED|Overall Study||6||
59714745|NCT01200797|75833497|FG000|STARTED|Overall Study||19||
59714746|NCT01200797|75833497|FG000|COMPLETED|Overall Study||0||
59714747|NCT01200797|75833497|FG000|NOT COMPLETED|Overall Study||19||
59714748|NCT01200485|75833502|FG000|STARTED|Cycle 1: Rasburicase Alone Delivery|Of 55 participants screened, only 52 treated.|55||
59714749|NCT01200485|75833503|FG001|STARTED|Cycle 1: Rasburicase Alone Delivery||0||
59714750|NCT01200485|75833504|FG002|STARTED|Cycle 1: Rasburicase Alone Delivery||0||
59714751|NCT01200485|75833502|FG000|COMPLETED|Cycle 1: Rasburicase Alone Delivery||52||
59714752|NCT01200485|75833503|FG001|COMPLETED|Cycle 1: Rasburicase Alone Delivery||0||
59714753|NCT01200485|75833504|FG002|COMPLETED|Cycle 1: Rasburicase Alone Delivery||0||
59714754|NCT01200485|75833502|FG000|NOT COMPLETED|Cycle 1: Rasburicase Alone Delivery||3||
59714755|NCT01200485|75833503|FG001|NOT COMPLETED|Cycle 1: Rasburicase Alone Delivery||0||
59714756|NCT01200485|75833504|FG002|NOT COMPLETED|Cycle 1: Rasburicase Alone Delivery||0||
59714757|NCT01200485|75833502|FG000|STARTED|Cycle 2: Randomization|Of 55 enrolled on study, 52 participants were treated in Cycle 1, only 46 randomized to Cycle 2|0||
59714758|NCT01200485|75833503|FG001|STARTED|Cycle 2: Randomization|Six not randomized: Methemoglobinemia-1, Kidney failure-2, Chemotherapy changed-2, Not evaluable-1|21||
59714759|NCT01200485|75833504|FG002|STARTED|Cycle 2: Randomization||25||
59714760|NCT01200485|75833502|FG000|COMPLETED|Cycle 2: Randomization||0||
59714761|NCT01200485|75833503|FG001|COMPLETED|Cycle 2: Randomization||21||
59714762|NCT01200485|75833504|FG002|COMPLETED|Cycle 2: Randomization||25||
59714763|NCT01200485|75833502|FG000|NOT COMPLETED|Cycle 2: Randomization||0||
59714764|NCT01200485|75833503|FG001|NOT COMPLETED|Cycle 2: Randomization||0||
59822992|NCT00372567|75945808|FG000|NOT COMPLETED|Phase 1 Sub-study||0||
60111880|NCT02722278|76232227|FG001|STARTED|Overall Study||56||
60111881|NCT02722278|76232226|FG000|COMPLETED|Overall Study||154||
60111882|NCT02722278|76232227|FG001|COMPLETED|Overall Study||49||
60111883|NCT02722278|76232226|FG000|NOT COMPLETED|Overall Study||12||
60111884|NCT02722278|76232227|FG001|NOT COMPLETED|Overall Study||7||
60111885|NCT00703092|76232235|FG000|STARTED|Overall Study||2||
60111886|NCT00703092|76232235|FG000|COMPLETED|Overall Study||0||
60111887|NCT00703092|76232235|FG000|NOT COMPLETED|Overall Study||2||
60111888|NCT02720484|76232239|FG000|STARTED|Treatment on Study||10||
60111889|NCT02720484|76232239|FG000|Reached 1st Response/2 Cycles|Treatment on Study||7||
60111890|NCT02720484|76232239|FG000|Treated Cycle 3|Treatment on Study||4||
60111891|NCT02720484|76232239|FG000|COMPLETED|Treatment on Study||4||
60111892|NCT02720484|76232239|FG000|NOT COMPLETED|Treatment on Study||6||
60111893|NCT02720484|76232239|FG000|STARTED|Follow Up for 2 Years|All patients that receive at least one treatment on study go into follow up.|7|2 patients died before entering follow up period and 1 patient withdrew consent.|
60111894|NCT02720484|76232239|FG000|COMPLETED|Follow Up for 2 Years||1||
60111895|NCT02720484|76232239|FG000|NOT COMPLETED|Follow Up for 2 Years||6||
60111896|NCT02715804|76232245|FG000|STARTED|Overall Study||327||
60111897|NCT02715804|76232246|FG001|STARTED|Overall Study||165||
60111898|NCT02715804|76232245|FG000|Received at Least 1 Dose of Study Drug|Overall Study||323||
60111899|NCT02715804|76232246|FG001|Received at Least 1 Dose of Study Drug|Overall Study||158||
60111900|NCT02715804|76232245|FG000|Safety Population|Overall Study|3 participants randomized to AG but received PAG|325|Received at least 1 dose of study medication, and analyzed according to the treatment they received.|
60111901|NCT02715804|76232246|FG001|Safety Population|Overall Study|1 participant randomized to PAG but received AG|156|Received at least 1 dose of study medication, and analyzed according to the treatment they received.|
60111902|NCT02715804|76232245|FG000|COMPLETED|Overall Study||98||
60111903|NCT02715804|76232246|FG001|COMPLETED|Overall Study||52||
60111904|NCT02715804|76232245|FG000|NOT COMPLETED|Overall Study||229||
60111905|NCT02715804|76232246|FG001|NOT COMPLETED|Overall Study||113||
60111906|NCT02717832|76232252|FG000|STARTED|Overall Study||20||
60111907|NCT02717832|76232252|FG000|COMPLETED|Overall Study||17||
60111908|NCT02717832|76232252|FG000|NOT COMPLETED|Overall Study||3||
60111909|NCT02717754|76232263|FG000|STARTED|Overall Study||10||
60111910|NCT02717754|76232264|FG001|STARTED|Overall Study||19||
60111911|NCT02717754|76232265|FG002|STARTED|Overall Study||20||
60111912|NCT02717754|76232266|FG003|STARTED|Overall Study||10||
60111913|NCT02717754|76232267|FG004|STARTED|Overall Study||20||
60111914|NCT02717754|76232268|FG005|STARTED|Overall Study||20||
60111915|NCT02717754|76232263|FG000|COMPLETED|Overall Study||10||
60111916|NCT02717754|76232264|FG001|COMPLETED|Overall Study||19||
60111917|NCT02717754|76232265|FG002|COMPLETED|Overall Study||20||
60111918|NCT02717754|76232266|FG003|COMPLETED|Overall Study||0||
60111919|NCT02717754|76232267|FG004|COMPLETED|Overall Study||0||
60111920|NCT02717754|76232268|FG005|COMPLETED|Overall Study||0||
60111921|NCT02717754|76232263|FG000|NOT COMPLETED|Overall Study||0||
60111922|NCT02717754|76232264|FG001|NOT COMPLETED|Overall Study||0||
60111923|NCT02717754|76232265|FG002|NOT COMPLETED|Overall Study||0||
60111924|NCT02717754|76232266|FG003|NOT COMPLETED|Overall Study||10||
60111925|NCT02717754|76232267|FG004|NOT COMPLETED|Overall Study||20||
60111926|NCT02717754|76232268|FG005|NOT COMPLETED|Overall Study||20||
60111927|NCT02717130|76232278|FG000|STARTED|Overall Study|Of the nine enrolled subjects, eight received study drug.|8||
60111928|NCT02717130|76232278|FG000|COMPLETED|Overall Study||1||
60111929|NCT02717130|76232278|FG000|NOT COMPLETED|Overall Study||7||
60111930|NCT02256696|76232285|FG000|STARTED|Overall Study||56||
60111931|NCT02256696|76232286|FG001|STARTED|Overall Study||53||
60111932|NCT02256696|76232287|FG002|STARTED|Overall Study||48||
60111933|NCT02256696|76232285|FG000|COMPLETED|Overall Study||53||
60111934|NCT02256696|76232286|FG001|COMPLETED|Overall Study||50||
60111935|NCT02256696|76232287|FG002|COMPLETED|Overall Study||47||
60111936|NCT02256696|76232285|FG000|NOT COMPLETED|Overall Study||3||
60111937|NCT02256696|76232286|FG001|NOT COMPLETED|Overall Study||3||
60111938|NCT02256696|76232287|FG002|NOT COMPLETED|Overall Study||1||
60111939|NCT02192502|76232298|FG000|STARTED|Overall Study||76||
60111940|NCT02192502|76232299|FG001|STARTED|Overall Study||73||
60111941|NCT02192502|76232298|FG000|COMPLETED|Overall Study||69||
60111942|NCT02192502|76232299|FG001|COMPLETED|Overall Study||72||
60111943|NCT02192502|76232298|FG000|NOT COMPLETED|Overall Study||7||
60111944|NCT02192502|76232299|FG001|NOT COMPLETED|Overall Study||1||
60111945|NCT01781429|76232320|FG000|STARTED|Overall Study||1||
60111946|NCT01781429|76232321|FG001|STARTED|Overall Study||1||
60111947|NCT01781429|76232322|FG002|STARTED|Overall Study||1||
60111948|NCT01781429|76232323|FG003|STARTED|Overall Study||1||
60111949|NCT01781429|76232324|FG004|STARTED|Overall Study||1||
60111950|NCT01781429|76232325|FG005|STARTED|Overall Study||4||
60111951|NCT01781429|76232326|FG006|STARTED|Overall Study||7||
60111952|NCT01781429|76232327|FG007|STARTED|Overall Study||4||
60111953|NCT01781429|76232328|FG008|STARTED|Overall Study||7||
60111954|NCT01781429|76232329|FG009|STARTED|Overall Study||24||
60111955|NCT01781429|76232330|FG010|STARTED|Overall Study||18||
60111956|NCT01781429|76232331|FG011|STARTED|Overall Study||21||
60111957|NCT01781429|76232332|FG012|STARTED|Overall Study||22||
60111958|NCT01781429|76232333|FG013|STARTED|Overall Study||8||
60111959|NCT01781429|76232334|FG014|STARTED|Overall Study||16||
60111960|NCT01781429|76232335|FG015|STARTED|Overall Study||0||
60111961|NCT01781429|76232320|FG000|COMPLETED|Overall Study||0||
60111962|NCT01781429|76232321|FG001|COMPLETED|Overall Study||0||
60111963|NCT01781429|76232322|FG002|COMPLETED|Overall Study||0||
60111964|NCT01781429|76232323|FG003|COMPLETED|Overall Study||0||
60111965|NCT01781429|76232324|FG004|COMPLETED|Overall Study||0||
60111966|NCT01781429|76232325|FG005|COMPLETED|Overall Study||0||
60111967|NCT01781429|76232326|FG006|COMPLETED|Overall Study||0||
60111968|NCT01781429|76232327|FG007|COMPLETED|Overall Study||0||
60111969|NCT01781429|76232328|FG008|COMPLETED|Overall Study||0||
60111970|NCT01781429|76232329|FG009|COMPLETED|Overall Study||0||
60111971|NCT01781429|76232330|FG010|COMPLETED|Overall Study||0||
60111972|NCT01781429|76232331|FG011|COMPLETED|Overall Study||0||
60111973|NCT01781429|76232332|FG012|COMPLETED|Overall Study||0||
60111974|NCT01781429|76232333|FG013|COMPLETED|Overall Study||0||
60111975|NCT01781429|76232334|FG014|COMPLETED|Overall Study||0||
60111976|NCT01781429|76232335|FG015|COMPLETED|Overall Study||0||
60111977|NCT01781429|76232320|FG000|NOT COMPLETED|Overall Study||1||
60111978|NCT01781429|76232321|FG001|NOT COMPLETED|Overall Study||1||
60111979|NCT01781429|76232322|FG002|NOT COMPLETED|Overall Study||1||
60111980|NCT01781429|76232323|FG003|NOT COMPLETED|Overall Study||1||
60111981|NCT01781429|76232324|FG004|NOT COMPLETED|Overall Study||1||
60111982|NCT01781429|76232325|FG005|NOT COMPLETED|Overall Study||4||
60111983|NCT01781429|76232326|FG006|NOT COMPLETED|Overall Study||7||
60111984|NCT01781429|76232327|FG007|NOT COMPLETED|Overall Study||4||
60111985|NCT01781429|76232328|FG008|NOT COMPLETED|Overall Study||7||
60111986|NCT01781429|76232329|FG009|NOT COMPLETED|Overall Study||24||
60111987|NCT01781429|76232330|FG010|NOT COMPLETED|Overall Study||18||
60111988|NCT01781429|76232331|FG011|NOT COMPLETED|Overall Study||21||
60111989|NCT01781429|76232332|FG012|NOT COMPLETED|Overall Study||22||
60111990|NCT01781429|76232333|FG013|NOT COMPLETED|Overall Study||8||
60111991|NCT01781429|76232334|FG014|NOT COMPLETED|Overall Study||16||
60111992|NCT01781429|76232335|FG015|NOT COMPLETED|Overall Study||0||
60111993|NCT01773473|76232370|FG000|STARTED|Overall Study||207||
60111994|NCT01773473|76232371|FG001|STARTED|Overall Study||196||
60111995|NCT01773473|76232370|FG000|Received at Least 1 Dose of Study Drug|Overall Study||207||
60111996|NCT01773473|76232371|FG001|Received at Least 1 Dose of Study Drug|Overall Study||196||
60111997|NCT01773473|76232370|FG000|COMPLETED|Overall Study||191||
60111998|NCT01773473|76232371|FG001|COMPLETED|Overall Study||177||
60111999|NCT01773473|76232370|FG000|NOT COMPLETED|Overall Study||16||
60112000|NCT01773473|76232371|FG001|NOT COMPLETED|Overall Study||19||
60112001|NCT01772693|76232379|FG000|STARTED|Overall Study||20||
60112002|NCT01772693|76232380|FG001|STARTED|Overall Study||7||
60112003|NCT01772693|76232379|FG000|COMPLETED|Overall Study||14||
60112004|NCT01772693|76232380|FG001|COMPLETED|Overall Study||6||
60112005|NCT01772693|76232379|FG000|NOT COMPLETED|Overall Study||6||
60112006|NCT01772693|76232380|FG001|NOT COMPLETED|Overall Study||1||
60112007|NCT01779869|76232386|FG000|STARTED|Overall Study||16||
60112008|NCT01779869|76232386|FG000|COMPLETED|Overall Study||14||
60112009|NCT01779869|76232386|FG000|NOT COMPLETED|Overall Study||2||
60112010|NCT01772537|76232393|FG000|STARTED|Overall Study||5||
60112011|NCT01772537|76232394|FG001|STARTED|Overall Study||3||
60112012|NCT01772537|76232395|FG002|STARTED|Overall Study||6||
60112013|NCT01772537|76232393|FG000|COMPLETED|Overall Study||4||
60112014|NCT01772537|76232394|FG001|COMPLETED|Overall Study||3||
60112015|NCT01772537|76232395|FG002|COMPLETED|Overall Study||6||
60112016|NCT01772537|76232393|FG000|NOT COMPLETED|Overall Study||1||
60112017|NCT01772537|76232394|FG001|NOT COMPLETED|Overall Study||0||
60112018|NCT01772537|76232395|FG002|NOT COMPLETED|Overall Study||0||
60112019|NCT01772147|76232408|FG000|STARTED|Overall Study||201||
60112020|NCT01772147|76232409|FG001|STARTED|Overall Study||203||
60112021|NCT01772147|76232410|FG002|STARTED|Overall Study||202||
60112022|NCT01772147|76232408|FG000|COMPLETED|Overall Study||170||
60112023|NCT01772147|76232409|FG001|COMPLETED|Overall Study||178||
60112024|NCT01772147|76232410|FG002|COMPLETED|Overall Study||184||
60112025|NCT01772147|76232408|FG000|NOT COMPLETED|Overall Study||31||
60112026|NCT01772147|76232409|FG001|NOT COMPLETED|Overall Study||25||
60112027|NCT01772147|76232410|FG002|NOT COMPLETED|Overall Study||18||
60112028|NCT01771913|76232420|FG000|STARTED|Overall Study||9||
60112029|NCT01771913|76232421|FG001|STARTED|Overall Study||11||
60112030|NCT01771913|76232420|FG000|COMPLETED|Overall Study||8||
60112031|NCT01771913|76232421|FG001|COMPLETED|Overall Study||11||
60112032|NCT01771913|76232420|FG000|NOT COMPLETED|Overall Study||1||
60112033|NCT01771913|76232421|FG001|NOT COMPLETED|Overall Study||0||
60112034|NCT01606787|76232429|FG000|STARTED|Overall Study||105||
60112035|NCT01606787|76232430|FG001|STARTED|Overall Study||105||
60112036|NCT01606787|76232429|FG000|COMPLETED|Overall Study||101||
60112037|NCT01606787|76232430|FG001|COMPLETED|Overall Study||98||
60112038|NCT01606787|76232429|FG000|NOT COMPLETED|Overall Study||4||
60112039|NCT01606787|76232430|FG001|NOT COMPLETED|Overall Study||7||
60112040|NCT01778855|76232438|FG000|STARTED|Overall Study||2||
60112041|NCT01778855|76232439|FG001|STARTED|Overall Study||4||
60112042|NCT01778855|76232438|FG000|COMPLETED|Overall Study||2||
60112043|NCT01778855|76232439|FG001|COMPLETED|Overall Study||3||
60112044|NCT01778855|76232438|FG000|NOT COMPLETED|Overall Study||0||
60112045|NCT01778855|76232439|FG001|NOT COMPLETED|Overall Study||1||
60112046|NCT01777997|76232445|FG000|STARTED|12 Week lead-in of no ART||38||
60112047|NCT01777997|76232445|FG000|COMPLETED|12 Week lead-in of no ART||36||
60112048|NCT01777997|76232445|FG000|NOT COMPLETED|12 Week lead-in of no ART||2||
60112049|NCT01777997|76232445|FG000|STARTED|Weeks 0 to 24/48 on ART||36||
60112050|NCT01777997|76232445|FG000|COMPLETED|Weeks 0 to 24/48 on ART|7 of these participants opted not to continue ART into next period|35||
60112051|NCT01777997|76232445|FG000|NOT COMPLETED|Weeks 0 to 24/48 on ART||1||
60112052|NCT01777997|76232445|FG000|STARTED|Weeks 48 to 72/96 on ART||28||
60112053|NCT01777997|76232445|FG000|COMPLETED|Weeks 48 to 72/96 on ART||26||
60112054|NCT01777997|76232445|FG000|NOT COMPLETED|Weeks 48 to 72/96 on ART||2||
60112055|NCT01770509|76232451|FG000|STARTED|Overall Study||12||
60112056|NCT01770509|76232452|FG001|STARTED|Overall Study||17||
60112057|NCT01770509|76232451|FG000|COMPLETED|Overall Study||11||
60112058|NCT01770509|76232452|FG001|COMPLETED|Overall Study||14||
60112059|NCT01770509|76232451|FG000|NOT COMPLETED|Overall Study||1||
60112060|NCT01770509|76232452|FG001|NOT COMPLETED|Overall Study||3||
60112061|NCT01770353|76232460|FG000|STARTED|Overall Study||15||
60112062|NCT01770353|76232461|FG001|STARTED|Overall Study||30||
60112063|NCT01770353|76232460|FG000|Received FMX|Overall Study|2 subjects excluded from MM-398 safety population.|15|2 subjects in Pilot + 1 in Expansion died due to progressive disease before MM-398 treatment|
60112064|NCT01770353|76232461|FG001|Received FMX|Overall Study|1 subject excluded from MM-398 safety population.|30|2 subjects in Pilot + 1 in Expansion died due to progressive disease before MM-398 treatment|
60112065|NCT01770353|76232460|FG000|Received FMX and MM-398|Overall Study||13|MM-398 safety population.|
60112066|NCT01770353|76232461|FG001|Received FMX and MM-398|Overall Study||29|MM-398 safety population.|
60112067|NCT01770353|76232460|FG000|COMPLETED|Overall Study||9|Received MM-398 treatment up to disease progression.|
60112068|NCT01770353|76232461|FG001|COMPLETED|Overall Study||18|Received MM-398 treatment up to disease progression.|
60112069|NCT01770353|76232460|FG000|NOT COMPLETED|Overall Study||6||
60112070|NCT01770353|76232461|FG001|NOT COMPLETED|Overall Study||12||
60112071|NCT01777763|76232477|FG000|STARTED|Overall Study||20||
60112072|NCT01777763|76232478|FG001|STARTED|Overall Study||210||
60112073|NCT01777763|76232477|FG000|COMPLETED|Overall Study||16||
60112074|NCT01777763|76232478|FG001|COMPLETED|Overall Study||163||
60112075|NCT01777763|76232477|FG000|NOT COMPLETED|Overall Study||4||
60112076|NCT01777763|76232478|FG001|NOT COMPLETED|Overall Study||47||
60112077|NCT01769339|76232484|FG000|STARTED|Overall Study||115||
60112078|NCT01769339|76232484|FG000|COMPLETED|Overall Study||72||
60112079|NCT01769339|76232484|FG000|NOT COMPLETED|Overall Study||43||
60112080|NCT01769105|76232490|FG000|STARTED|First Intervention||16||
60112081|NCT01769105|76232491|FG001|STARTED|First Intervention||19||
60112082|NCT01769105|76232490|FG000|COMPLETED|First Intervention||14||
60112083|NCT01769105|76232491|FG001|COMPLETED|First Intervention||17||
60112084|NCT01769105|76232490|FG000|NOT COMPLETED|First Intervention||2||
60112085|NCT01769105|76232491|FG001|NOT COMPLETED|First Intervention||2||
60112086|NCT01769105|76232490|FG000|STARTED|Cross-over||14||
60112087|NCT01769105|76232491|FG001|STARTED|Cross-over|Cross-over was only intended for the Lid margin hygiene group|0||
60112088|NCT01769105|76232490|FG000|COMPLETED|Cross-over||9||
60112089|NCT01769105|76232491|FG001|COMPLETED|Cross-over|Was not intended by the study protocol|0||
60112090|NCT01769105|76232490|FG000|NOT COMPLETED|Cross-over||5||
60112091|NCT01769105|76232491|FG001|NOT COMPLETED|Cross-over||0||
60112092|NCT01777139|76232499|FG000|STARTED|Primary Reporting Phase (Up to 4 Years)||30||
60112093|NCT01777139|76232500|FG001|STARTED|Primary Reporting Phase (Up to 4 Years)||0||
60112094|NCT01777139|76232499|FG000|COMPLETED|Primary Reporting Phase (Up to 4 Years)||0||
60112095|NCT01777139|76232500|FG001|COMPLETED|Primary Reporting Phase (Up to 4 Years)||0||
60112096|NCT01777139|76232499|FG000|NOT COMPLETED|Primary Reporting Phase (Up to 4 Years)||30||
60112097|NCT01777139|76232500|FG001|NOT COMPLETED|Primary Reporting Phase (Up to 4 Years)||0||
60112098|NCT01777139|76232499|FG000|STARTED|SFUCP (Up to 1.4 Years)||0||
60112099|NCT01777139|76232500|FG001|STARTED|SFUCP (Up to 1.4 Years)||4||
60112100|NCT01777139|76232499|FG000|COMPLETED|SFUCP (Up to 1.4 Years)||0||
60112101|NCT01777139|76232500|FG001|COMPLETED|SFUCP (Up to 1.4 Years)||0||
59567090|NCT03195465|75669898|FG000|STARTED|Overall Study||0||
59567091|NCT03195465|75669898|FG000|COMPLETED|Overall Study||0||
59567092|NCT03195465|75669898|FG000|NOT COMPLETED|Overall Study||0||
59714765|NCT01200485|75833504|FG002|NOT COMPLETED|Cycle 2: Randomization||0||
59714766|NCT01200407|75833511|FG000|STARTED|Overall Study||615||
60112102|NCT01777139|76232499|FG000|NOT COMPLETED|SFUCP (Up to 1.4 Years)||0||
60112103|NCT01777139|76232500|FG001|NOT COMPLETED|SFUCP (Up to 1.4 Years)||4||
60112104|NCT01768637|76232509|FG000|STARTED|Overall Study||29|Signed consent|
60112105|NCT01768637|76232510|FG001|STARTED|Overall Study||19|Signed consent|
60112106|NCT01768637|76232509|FG000|Completed Visit 1|Overall Study||28||
60112107|NCT01768637|76232510|FG001|Completed Visit 1|Overall Study||16||
60112108|NCT01768637|76232509|FG000|Completed Visit 2|Overall Study||26||
60112109|NCT01768637|76232510|FG001|Completed Visit 2|Overall Study||13||
60112110|NCT01768637|76232509|FG000|COMPLETED|Overall Study||26|completed visit 3|
60112111|NCT01768637|76232510|FG001|COMPLETED|Overall Study||12|completed visit 3|
60112112|NCT01768637|76232509|FG000|NOT COMPLETED|Overall Study||3||
60112113|NCT01768637|76232510|FG001|NOT COMPLETED|Overall Study||7||
60112114|NCT01768559|76232519|FG000|STARTED|Overall Study||298||
59567093|NCT03165747|75669904|FG000|STARTED|Overall Study||0||
59714767|NCT01200407|75833511|FG000|COMPLETED|Overall Study||533||
60112115|NCT01768559|76232520|FG001|STARTED|Overall Study||298||
60112116|NCT01768559|76232521|FG002|STARTED|Overall Study||298||
60112117|NCT01768559|76232519|FG000|Treated|Overall Study||298||
60112118|NCT01768559|76232520|FG001|Treated|Overall Study|1 participant received Insulin Glulisine TID (for more than 50%)|298||
60112119|NCT01768559|76232521|FG002|Treated|Overall Study|4 participants received Insulin Glulisine QD (for more than 50%)|297||
60112120|NCT01768559|76232519|FG000|COMPLETED|Overall Study||268||
60112121|NCT01768559|76232520|FG001|COMPLETED|Overall Study||281||
60112122|NCT01768559|76232521|FG002|COMPLETED|Overall Study||285||
60112123|NCT01768559|76232519|FG000|NOT COMPLETED|Overall Study||30||
60112124|NCT01768559|76232520|FG001|NOT COMPLETED|Overall Study||17||
60112125|NCT01768559|76232521|FG002|NOT COMPLETED|Overall Study||13||
60112126|NCT00983619|76232545|FG000|STARTED|Overall Study||3||
60112127|NCT00983619|76232546|FG001|STARTED|Overall Study||4||
60112128|NCT00983619|76232547|FG002|STARTED|Overall Study||3||
60112129|NCT00983619|76232548|FG003|STARTED|Overall Study||6||
60112130|NCT00983619|76232549|FG004|STARTED|Overall Study||3||
60112131|NCT00983619|76232550|FG005|STARTED|Overall Study||76||
60112132|NCT00983619|76232551|FG006|STARTED|Overall Study||3||
60112133|NCT00983619|76232552|FG007|STARTED|Overall Study||3||
60112134|NCT00983619|76232553|FG008|STARTED|Overall Study||1||
60112135|NCT00983619|76232554|FG009|STARTED|Overall Study||3||
60112136|NCT00983619|76232555|FG010|STARTED|Overall Study||17||
60112137|NCT00983619|76232556|FG011|STARTED|Overall Study||14||
60112138|NCT00983619|76232545|FG000|COMPLETED|Overall Study||0||
60112139|NCT00983619|76232546|FG001|COMPLETED|Overall Study||0||
60112140|NCT00983619|76232547|FG002|COMPLETED|Overall Study||0||
60112141|NCT00983619|76232548|FG003|COMPLETED|Overall Study||1||
60112142|NCT00983619|76232549|FG004|COMPLETED|Overall Study||0||
60112143|NCT00983619|76232550|FG005|COMPLETED|Overall Study||9||
60112144|NCT00983619|76232551|FG006|COMPLETED|Overall Study||0||
60112145|NCT00983619|76232552|FG007|COMPLETED|Overall Study||1||
60112146|NCT00983619|76232553|FG008|COMPLETED|Overall Study||0||
60112147|NCT00983619|76232554|FG009|COMPLETED|Overall Study||0||
60112148|NCT00983619|76232555|FG010|COMPLETED|Overall Study||6||
60112149|NCT00983619|76232556|FG011|COMPLETED|Overall Study||3||
60112150|NCT00983619|76232545|FG000|NOT COMPLETED|Overall Study||3||
60112151|NCT00983619|76232546|FG001|NOT COMPLETED|Overall Study||4||
60112152|NCT00983619|76232547|FG002|NOT COMPLETED|Overall Study||3||
60112153|NCT00983619|76232548|FG003|NOT COMPLETED|Overall Study||5||
60112154|NCT00983619|76232549|FG004|NOT COMPLETED|Overall Study||3||
60112155|NCT00983619|76232550|FG005|NOT COMPLETED|Overall Study||67||
60112156|NCT00983619|76232551|FG006|NOT COMPLETED|Overall Study||3||
60112157|NCT00983619|76232552|FG007|NOT COMPLETED|Overall Study||2||
60112158|NCT00983619|76232553|FG008|NOT COMPLETED|Overall Study||1||
60112159|NCT00983619|76232554|FG009|NOT COMPLETED|Overall Study||3||
60112160|NCT00983619|76232555|FG010|NOT COMPLETED|Overall Study||11||
60112161|NCT00983619|76232556|FG011|NOT COMPLETED|Overall Study||11||
60112162|NCT01767857|76232604|FG000|STARTED|Overall Study||430||
60112163|NCT01767857|76232605|FG001|STARTED|Overall Study||213||
60112164|NCT01767857|76232604|FG000|Treated|Overall Study||411||
60112165|NCT01767857|76232605|FG001|Treated|Overall Study||200||
60112166|NCT01767857|76232604|FG000|COMPLETED|Overall Study||0||
60112167|NCT01767857|76232605|FG001|COMPLETED|Overall Study||0||
60112168|NCT01767857|76232604|FG000|NOT COMPLETED|Overall Study||430||
60112169|NCT01767857|76232605|FG001|NOT COMPLETED|Overall Study||213||
60112170|NCT01775501|76232612|FG000|STARTED|Overall Study||40||
60112171|NCT01775501|76232612|FG000|COMPLETED|Overall Study||39||
60112172|NCT01775501|76232612|FG000|NOT COMPLETED|Overall Study||1||
60112173|NCT01880320|76232619|FG000|STARTED|Overall Study||217||
60112174|NCT01880320|76232620|FG001|STARTED|Overall Study||217||
60112175|NCT01880320|76232621|FG002|STARTED|Overall Study||69||
60112176|NCT01880320|76232619|FG000|COMPLETED|Overall Study||197||
60112177|NCT01880320|76232620|FG001|COMPLETED|Overall Study||192||
60112178|NCT01880320|76232621|FG002|COMPLETED|Overall Study||61||
60112179|NCT01880320|76232619|FG000|NOT COMPLETED|Overall Study||20||
60112180|NCT01880320|76232620|FG001|NOT COMPLETED|Overall Study||25||
60112181|NCT01880320|76232621|FG002|NOT COMPLETED|Overall Study||8||
60112182|NCT02268994|76232631|FG000|STARTED|Overall Study||117||
60112183|NCT02268994|76232632|FG001|STARTED|Overall Study||116||
60112184|NCT02268994|76232631|FG000|COMPLETED|Overall Study||86||
60112185|NCT02268994|76232632|FG001|COMPLETED|Overall Study||81||
60112186|NCT02268994|76232631|FG000|NOT COMPLETED|Overall Study||31||
60112187|NCT02268994|76232632|FG001|NOT COMPLETED|Overall Study||35||
60112188|NCT01775189|76232641|FG000|STARTED|Naloxone Challenge Phase||45||
60112189|NCT01775189|76232642|FG001|STARTED|Naloxone Challenge Phase||0||
60112190|NCT01775189|76232643|FG002|STARTED|Naloxone Challenge Phase||0||
60112191|NCT01775189|76232644|FG003|STARTED|Naloxone Challenge Phase||0||
60112192|NCT01775189|76232645|FG004|STARTED|Naloxone Challenge Phase||0||
60112193|NCT01775189|76232646|FG005|STARTED|Naloxone Challenge Phase||0||
60112194|NCT01775189|76232647|FG006|STARTED|Naloxone Challenge Phase||0||
60112195|NCT01775189|76232641|FG000|COMPLETED|Naloxone Challenge Phase||45||
60112196|NCT01775189|76232642|FG001|COMPLETED|Naloxone Challenge Phase||0||
60112197|NCT01775189|76232643|FG002|COMPLETED|Naloxone Challenge Phase||0||
60112198|NCT01775189|76232644|FG003|COMPLETED|Naloxone Challenge Phase||0||
60112199|NCT01775189|76232645|FG004|COMPLETED|Naloxone Challenge Phase||0||
60112200|NCT01775189|76232646|FG005|COMPLETED|Naloxone Challenge Phase||0||
60112201|NCT01775189|76232647|FG006|COMPLETED|Naloxone Challenge Phase||0||
60112202|NCT01775189|76232641|FG000|NOT COMPLETED|Naloxone Challenge Phase||0||
60112203|NCT01775189|76232642|FG001|NOT COMPLETED|Naloxone Challenge Phase||0||
60112204|NCT01775189|76232643|FG002|NOT COMPLETED|Naloxone Challenge Phase||0||
60112205|NCT01775189|76232644|FG003|NOT COMPLETED|Naloxone Challenge Phase||0||
60112206|NCT01775189|76232645|FG004|NOT COMPLETED|Naloxone Challenge Phase||0||
60112207|NCT01775189|76232646|FG005|NOT COMPLETED|Naloxone Challenge Phase||0||
60112208|NCT01775189|76232647|FG006|NOT COMPLETED|Naloxone Challenge Phase||0||
60112209|NCT01775189|76232641|FG000|STARTED|Drug Discrimination Phase: Day 1||0||
60112210|NCT01775189|76232642|FG001|STARTED|Drug Discrimination Phase: Day 1||22||
60112211|NCT01775189|76232643|FG002|STARTED|Drug Discrimination Phase: Day 1||23||
60112212|NCT01775189|76232644|FG003|STARTED|Drug Discrimination Phase: Day 1||0||
60112213|NCT01775189|76232645|FG004|STARTED|Drug Discrimination Phase: Day 1||0||
60112214|NCT01775189|76232646|FG005|STARTED|Drug Discrimination Phase: Day 1||0||
60112215|NCT01775189|76232647|FG006|STARTED|Drug Discrimination Phase: Day 1||0||
60112216|NCT01775189|76232641|FG000|COMPLETED|Drug Discrimination Phase: Day 1||0||
60112217|NCT01775189|76232642|FG001|COMPLETED|Drug Discrimination Phase: Day 1||19||
60112218|NCT01775189|76232643|FG002|COMPLETED|Drug Discrimination Phase: Day 1||23||
60112219|NCT01775189|76232644|FG003|COMPLETED|Drug Discrimination Phase: Day 1||0||
60112220|NCT01775189|76232645|FG004|COMPLETED|Drug Discrimination Phase: Day 1||0||
60112221|NCT01775189|76232646|FG005|COMPLETED|Drug Discrimination Phase: Day 1||0||
60112222|NCT01775189|76232647|FG006|COMPLETED|Drug Discrimination Phase: Day 1||0||
60112223|NCT01775189|76232641|FG000|NOT COMPLETED|Drug Discrimination Phase: Day 1||0||
60112224|NCT01775189|76232642|FG001|NOT COMPLETED|Drug Discrimination Phase: Day 1||3||
60112225|NCT01775189|76232643|FG002|NOT COMPLETED|Drug Discrimination Phase: Day 1||0||
60112226|NCT01775189|76232644|FG003|NOT COMPLETED|Drug Discrimination Phase: Day 1||0||
60112227|NCT01775189|76232645|FG004|NOT COMPLETED|Drug Discrimination Phase: Day 1||0||
60112228|NCT01775189|76232646|FG005|NOT COMPLETED|Drug Discrimination Phase: Day 1||0||
60112229|NCT01775189|76232647|FG006|NOT COMPLETED|Drug Discrimination Phase: Day 1||0||
60112230|NCT01775189|76232641|FG000|STARTED|Drug Discrimination Phase: Day 2||0||
60112231|NCT01775189|76232642|FG001|STARTED|Drug Discrimination Phase: Day 2||19||
60112232|NCT01775189|76232643|FG002|STARTED|Drug Discrimination Phase: Day 2||23||
60112233|NCT01775189|76232644|FG003|STARTED|Drug Discrimination Phase: Day 2||0||
60112234|NCT01775189|76232645|FG004|STARTED|Drug Discrimination Phase: Day 2||0||
60112235|NCT01775189|76232646|FG005|STARTED|Drug Discrimination Phase: Day 2||0||
60112236|NCT01775189|76232647|FG006|STARTED|Drug Discrimination Phase: Day 2||0||
60112237|NCT01775189|76232641|FG000|COMPLETED|Drug Discrimination Phase: Day 2||0||
60112238|NCT01775189|76232642|FG001|COMPLETED|Drug Discrimination Phase: Day 2||16||
60112239|NCT01775189|76232643|FG002|COMPLETED|Drug Discrimination Phase: Day 2||16||
60112240|NCT01775189|76232644|FG003|COMPLETED|Drug Discrimination Phase: Day 2||0||
60112241|NCT01775189|76232645|FG004|COMPLETED|Drug Discrimination Phase: Day 2||0||
60112242|NCT01775189|76232646|FG005|COMPLETED|Drug Discrimination Phase: Day 2||0||
59567094|NCT03165747|75669905|FG001|STARTED|Overall Study||0||
60112243|NCT01775189|76232647|FG006|COMPLETED|Drug Discrimination Phase: Day 2||0||
60112244|NCT01775189|76232641|FG000|NOT COMPLETED|Drug Discrimination Phase: Day 2||0||
60112245|NCT01775189|76232642|FG001|NOT COMPLETED|Drug Discrimination Phase: Day 2||3||
60112246|NCT01775189|76232643|FG002|NOT COMPLETED|Drug Discrimination Phase: Day 2||7||
60112247|NCT01775189|76232644|FG003|NOT COMPLETED|Drug Discrimination Phase: Day 2||0||
60112248|NCT01775189|76232645|FG004|NOT COMPLETED|Drug Discrimination Phase: Day 2||0||
60112249|NCT01775189|76232646|FG005|NOT COMPLETED|Drug Discrimination Phase: Day 2||0||
60112250|NCT01775189|76232647|FG006|NOT COMPLETED|Drug Discrimination Phase: Day 2||0||
60112251|NCT01775189|76232641|FG000|STARTED|Treatment Phase: First Intervention||0||
60112252|NCT01775189|76232642|FG001|STARTED|Treatment Phase: First Intervention||0||
60112253|NCT01775189|76232643|FG002|STARTED|Treatment Phase: First Intervention||0||
60112254|NCT01775189|76232644|FG003|STARTED|Treatment Phase: First Intervention||8||
60112255|NCT01775189|76232645|FG004|STARTED|Treatment Phase: First Intervention||8||
60112256|NCT01775189|76232646|FG005|STARTED|Treatment Phase: First Intervention||8||
60112257|NCT01775189|76232647|FG006|STARTED|Treatment Phase: First Intervention||8||
60112258|NCT01775189|76232641|FG000|COMPLETED|Treatment Phase: First Intervention||0||
60112259|NCT01775189|76232642|FG001|COMPLETED|Treatment Phase: First Intervention||0||
60112260|NCT01775189|76232643|FG002|COMPLETED|Treatment Phase: First Intervention||0||
60112261|NCT01775189|76232644|FG003|COMPLETED|Treatment Phase: First Intervention||8||
60112262|NCT01775189|76232645|FG004|COMPLETED|Treatment Phase: First Intervention||8||
60112263|NCT01775189|76232646|FG005|COMPLETED|Treatment Phase: First Intervention||8||
60112264|NCT01775189|76232647|FG006|COMPLETED|Treatment Phase: First Intervention||8||
60112265|NCT01775189|76232641|FG000|NOT COMPLETED|Treatment Phase: First Intervention||0||
60112266|NCT01775189|76232642|FG001|NOT COMPLETED|Treatment Phase: First Intervention||0||
60112267|NCT01775189|76232643|FG002|NOT COMPLETED|Treatment Phase: First Intervention||0||
60112268|NCT01775189|76232644|FG003|NOT COMPLETED|Treatment Phase: First Intervention||0||
60112269|NCT01775189|76232645|FG004|NOT COMPLETED|Treatment Phase: First Intervention||0||
60112270|NCT01775189|76232646|FG005|NOT COMPLETED|Treatment Phase: First Intervention||0||
60112271|NCT01775189|76232647|FG006|NOT COMPLETED|Treatment Phase: First Intervention||0||
60112272|NCT01775189|76232641|FG000|STARTED|Treatment Phase: Washout Period 1||0||
60112273|NCT01775189|76232642|FG001|STARTED|Treatment Phase: Washout Period 1||0||
60112274|NCT01775189|76232643|FG002|STARTED|Treatment Phase: Washout Period 1||0||
60112275|NCT01775189|76232644|FG003|STARTED|Treatment Phase: Washout Period 1||8||
60112276|NCT01775189|76232645|FG004|STARTED|Treatment Phase: Washout Period 1||8||
60112277|NCT01775189|76232646|FG005|STARTED|Treatment Phase: Washout Period 1||8||
60112278|NCT01775189|76232647|FG006|STARTED|Treatment Phase: Washout Period 1||8||
60112279|NCT01775189|76232641|FG000|COMPLETED|Treatment Phase: Washout Period 1||0||
60112280|NCT01775189|76232642|FG001|COMPLETED|Treatment Phase: Washout Period 1||0||
60112281|NCT01775189|76232643|FG002|COMPLETED|Treatment Phase: Washout Period 1||0||
60112282|NCT01775189|76232644|FG003|COMPLETED|Treatment Phase: Washout Period 1||8||
60112283|NCT01775189|76232645|FG004|COMPLETED|Treatment Phase: Washout Period 1||8||
60112284|NCT01775189|76232646|FG005|COMPLETED|Treatment Phase: Washout Period 1||7||
60112285|NCT01775189|76232647|FG006|COMPLETED|Treatment Phase: Washout Period 1||8||
60112286|NCT01775189|76232641|FG000|NOT COMPLETED|Treatment Phase: Washout Period 1||0||
60112287|NCT01775189|76232642|FG001|NOT COMPLETED|Treatment Phase: Washout Period 1||0||
60112288|NCT01775189|76232643|FG002|NOT COMPLETED|Treatment Phase: Washout Period 1||0||
60112289|NCT01775189|76232644|FG003|NOT COMPLETED|Treatment Phase: Washout Period 1||0||
60112290|NCT01775189|76232645|FG004|NOT COMPLETED|Treatment Phase: Washout Period 1||0||
60112291|NCT01775189|76232646|FG005|NOT COMPLETED|Treatment Phase: Washout Period 1||1||
60112292|NCT01775189|76232647|FG006|NOT COMPLETED|Treatment Phase: Washout Period 1||0||
60112293|NCT01775189|76232641|FG000|STARTED|Treatment Phase: Second Intervention||0||
60112294|NCT01775189|76232642|FG001|STARTED|Treatment Phase: Second Intervention||0||
60112295|NCT01775189|76232643|FG002|STARTED|Treatment Phase: Second Intervention||0||
60112296|NCT01775189|76232644|FG003|STARTED|Treatment Phase: Second Intervention||8||
60112297|NCT01775189|76232645|FG004|STARTED|Treatment Phase: Second Intervention||8||
60112298|NCT01775189|76232646|FG005|STARTED|Treatment Phase: Second Intervention||7||
60112299|NCT01775189|76232647|FG006|STARTED|Treatment Phase: Second Intervention||8||
60112300|NCT01775189|76232641|FG000|COMPLETED|Treatment Phase: Second Intervention||0||
60112301|NCT01775189|76232642|FG001|COMPLETED|Treatment Phase: Second Intervention||0||
60112302|NCT01775189|76232643|FG002|COMPLETED|Treatment Phase: Second Intervention||0||
60112303|NCT01775189|76232644|FG003|COMPLETED|Treatment Phase: Second Intervention||8||
60112304|NCT01775189|76232645|FG004|COMPLETED|Treatment Phase: Second Intervention||8||
60112305|NCT01775189|76232646|FG005|COMPLETED|Treatment Phase: Second Intervention||7||
60112306|NCT01775189|76232647|FG006|COMPLETED|Treatment Phase: Second Intervention||8||
60112307|NCT01775189|76232641|FG000|NOT COMPLETED|Treatment Phase: Second Intervention||0||
60112308|NCT01775189|76232642|FG001|NOT COMPLETED|Treatment Phase: Second Intervention||0||
60112309|NCT01775189|76232643|FG002|NOT COMPLETED|Treatment Phase: Second Intervention||0||
60112310|NCT01775189|76232644|FG003|NOT COMPLETED|Treatment Phase: Second Intervention||0||
60112311|NCT01775189|76232645|FG004|NOT COMPLETED|Treatment Phase: Second Intervention||0||
60112312|NCT01775189|76232646|FG005|NOT COMPLETED|Treatment Phase: Second Intervention||0||
60112313|NCT01775189|76232647|FG006|NOT COMPLETED|Treatment Phase: Second Intervention||0||
60112314|NCT01775189|76232641|FG000|STARTED|Treatment Phase: Washout Period 2||0||
60112315|NCT01775189|76232642|FG001|STARTED|Treatment Phase: Washout Period 2||0||
60112316|NCT01775189|76232643|FG002|STARTED|Treatment Phase: Washout Period 2||0||
60112317|NCT01775189|76232644|FG003|STARTED|Treatment Phase: Washout Period 2||8||
60112318|NCT01775189|76232645|FG004|STARTED|Treatment Phase: Washout Period 2||8||
60112319|NCT01775189|76232646|FG005|STARTED|Treatment Phase: Washout Period 2||7||
60112320|NCT01775189|76232647|FG006|STARTED|Treatment Phase: Washout Period 2||8||
60112321|NCT01775189|76232641|FG000|COMPLETED|Treatment Phase: Washout Period 2||0||
60112322|NCT01775189|76232642|FG001|COMPLETED|Treatment Phase: Washout Period 2||0||
60112323|NCT01775189|76232643|FG002|COMPLETED|Treatment Phase: Washout Period 2||0||
60112324|NCT01775189|76232644|FG003|COMPLETED|Treatment Phase: Washout Period 2||7||
60112325|NCT01775189|76232645|FG004|COMPLETED|Treatment Phase: Washout Period 2||8||
60112326|NCT01775189|76232646|FG005|COMPLETED|Treatment Phase: Washout Period 2||7||
60112327|NCT01775189|76232647|FG006|COMPLETED|Treatment Phase: Washout Period 2||8||
60112328|NCT01775189|76232641|FG000|NOT COMPLETED|Treatment Phase: Washout Period 2||0||
60112329|NCT01775189|76232642|FG001|NOT COMPLETED|Treatment Phase: Washout Period 2||0||
60112330|NCT01775189|76232643|FG002|NOT COMPLETED|Treatment Phase: Washout Period 2||0||
60112331|NCT01775189|76232644|FG003|NOT COMPLETED|Treatment Phase: Washout Period 2||1||
60112332|NCT01775189|76232645|FG004|NOT COMPLETED|Treatment Phase: Washout Period 2||0||
60112333|NCT01775189|76232646|FG005|NOT COMPLETED|Treatment Phase: Washout Period 2||0||
60112334|NCT01775189|76232647|FG006|NOT COMPLETED|Treatment Phase: Washout Period 2||0||
60112335|NCT01775189|76232641|FG000|STARTED|Treatment Phase: Third Intervention||0||
60112336|NCT01775189|76232642|FG001|STARTED|Treatment Phase: Third Intervention||0||
60112337|NCT01775189|76232643|FG002|STARTED|Treatment Phase: Third Intervention||0||
60112338|NCT01775189|76232644|FG003|STARTED|Treatment Phase: Third Intervention||7||
60112339|NCT01775189|76232645|FG004|STARTED|Treatment Phase: Third Intervention||8||
60112340|NCT01775189|76232646|FG005|STARTED|Treatment Phase: Third Intervention||7||
60112341|NCT01775189|76232647|FG006|STARTED|Treatment Phase: Third Intervention||8||
60112342|NCT01775189|76232641|FG000|COMPLETED|Treatment Phase: Third Intervention||0||
60112343|NCT01775189|76232642|FG001|COMPLETED|Treatment Phase: Third Intervention||0||
60112344|NCT01775189|76232643|FG002|COMPLETED|Treatment Phase: Third Intervention||0||
60112345|NCT01775189|76232644|FG003|COMPLETED|Treatment Phase: Third Intervention||7||
60112346|NCT01775189|76232645|FG004|COMPLETED|Treatment Phase: Third Intervention||8||
60112347|NCT01775189|76232646|FG005|COMPLETED|Treatment Phase: Third Intervention||7||
60112348|NCT01775189|76232647|FG006|COMPLETED|Treatment Phase: Third Intervention||8||
60112349|NCT01775189|76232641|FG000|NOT COMPLETED|Treatment Phase: Third Intervention||0||
60112350|NCT01775189|76232642|FG001|NOT COMPLETED|Treatment Phase: Third Intervention||0||
60112351|NCT01775189|76232643|FG002|NOT COMPLETED|Treatment Phase: Third Intervention||0||
60112352|NCT01775189|76232644|FG003|NOT COMPLETED|Treatment Phase: Third Intervention||0||
60112353|NCT01775189|76232645|FG004|NOT COMPLETED|Treatment Phase: Third Intervention||0||
60112354|NCT01775189|76232646|FG005|NOT COMPLETED|Treatment Phase: Third Intervention||0||
60112355|NCT01775189|76232647|FG006|NOT COMPLETED|Treatment Phase: Third Intervention||0||
60112356|NCT01775189|76232641|FG000|STARTED|Treatment Phase: Washout Period 3||0||
60112357|NCT01775189|76232642|FG001|STARTED|Treatment Phase: Washout Period 3||0||
60112358|NCT01775189|76232643|FG002|STARTED|Treatment Phase: Washout Period 3||0||
60112359|NCT01775189|76232644|FG003|STARTED|Treatment Phase: Washout Period 3||7||
60112360|NCT01775189|76232645|FG004|STARTED|Treatment Phase: Washout Period 3||8||
60112361|NCT01775189|76232646|FG005|STARTED|Treatment Phase: Washout Period 3||7||
60112362|NCT01775189|76232647|FG006|STARTED|Treatment Phase: Washout Period 3||8||
60112363|NCT01775189|76232641|FG000|COMPLETED|Treatment Phase: Washout Period 3||0||
60112364|NCT01775189|76232642|FG001|COMPLETED|Treatment Phase: Washout Period 3||0||
60112365|NCT01775189|76232643|FG002|COMPLETED|Treatment Phase: Washout Period 3||0||
60112366|NCT01775189|76232644|FG003|COMPLETED|Treatment Phase: Washout Period 3||6||
60112367|NCT01775189|76232645|FG004|COMPLETED|Treatment Phase: Washout Period 3||8||
60112368|NCT01775189|76232646|FG005|COMPLETED|Treatment Phase: Washout Period 3||7||
60112369|NCT01775189|76232647|FG006|COMPLETED|Treatment Phase: Washout Period 3||7||
60112370|NCT01775189|76232641|FG000|NOT COMPLETED|Treatment Phase: Washout Period 3||0||
60112371|NCT01775189|76232642|FG001|NOT COMPLETED|Treatment Phase: Washout Period 3||0||
60112372|NCT01775189|76232643|FG002|NOT COMPLETED|Treatment Phase: Washout Period 3||0||
60112373|NCT01775189|76232644|FG003|NOT COMPLETED|Treatment Phase: Washout Period 3||1||
60112374|NCT01775189|76232645|FG004|NOT COMPLETED|Treatment Phase: Washout Period 3||0||
60112375|NCT01775189|76232646|FG005|NOT COMPLETED|Treatment Phase: Washout Period 3||0||
60112376|NCT01775189|76232647|FG006|NOT COMPLETED|Treatment Phase: Washout Period 3||1||
60112377|NCT01775189|76232641|FG000|STARTED|Treatment Phase: Fourth Intervention||0||
60112378|NCT01775189|76232642|FG001|STARTED|Treatment Phase: Fourth Intervention||0||
60112379|NCT01775189|76232643|FG002|STARTED|Treatment Phase: Fourth Intervention||0||
60112380|NCT01775189|76232644|FG003|STARTED|Treatment Phase: Fourth Intervention||6||
60112381|NCT01775189|76232645|FG004|STARTED|Treatment Phase: Fourth Intervention||8||
60112382|NCT01775189|76232646|FG005|STARTED|Treatment Phase: Fourth Intervention||7||
60112383|NCT01775189|76232647|FG006|STARTED|Treatment Phase: Fourth Intervention||7||
60112384|NCT01775189|76232641|FG000|COMPLETED|Treatment Phase: Fourth Intervention||0||
60112385|NCT01775189|76232642|FG001|COMPLETED|Treatment Phase: Fourth Intervention||0||
60112386|NCT01775189|76232643|FG002|COMPLETED|Treatment Phase: Fourth Intervention||0||
60112387|NCT01775189|76232644|FG003|COMPLETED|Treatment Phase: Fourth Intervention||6||
60112388|NCT01775189|76232645|FG004|COMPLETED|Treatment Phase: Fourth Intervention||8||
60112389|NCT01775189|76232646|FG005|COMPLETED|Treatment Phase: Fourth Intervention||7||
60112390|NCT01775189|76232647|FG006|COMPLETED|Treatment Phase: Fourth Intervention||7||
60112391|NCT01775189|76232641|FG000|NOT COMPLETED|Treatment Phase: Fourth Intervention||0||
60112392|NCT01775189|76232642|FG001|NOT COMPLETED|Treatment Phase: Fourth Intervention||0||
59714768|NCT01200407|75833511|FG000|NOT COMPLETED|Overall Study||82||
59714769|NCT01200329|75833515|FG000|STARTED|Overall Study||81||
60112393|NCT01775189|76232643|FG002|NOT COMPLETED|Treatment Phase: Fourth Intervention||0||
60112394|NCT01775189|76232644|FG003|NOT COMPLETED|Treatment Phase: Fourth Intervention||0||
60112395|NCT01775189|76232645|FG004|NOT COMPLETED|Treatment Phase: Fourth Intervention||0||
60112396|NCT01775189|76232646|FG005|NOT COMPLETED|Treatment Phase: Fourth Intervention||0||
60112397|NCT01775189|76232647|FG006|NOT COMPLETED|Treatment Phase: Fourth Intervention||0||
60112398|NCT01881412|76232677|FG000|STARTED|Overall Study||59||
60112399|NCT01881412|76232678|FG001|STARTED|Overall Study||59||
60112400|NCT01881412|76232677|FG000|COMPLETED|Overall Study||49||
60112401|NCT01881412|76232678|FG001|COMPLETED|Overall Study||57||
60112402|NCT01881412|76232677|FG000|NOT COMPLETED|Overall Study||10||
60112403|NCT01881412|76232678|FG001|NOT COMPLETED|Overall Study||2||
60112404|NCT04551105|76232686|FG000|STARTED|The 1st Study Sessions|Each reader of the same groups(8) tudy with the same number of cases (314).|8||314
60112405|NCT04551105|76232687|FG001|STARTED|The 1st Study Sessions|Each reader of the same groups(8) tudy with the same number of cases (314).|8||314
60112406|NCT04551105|76232686|FG000|COMPLETED|The 1st Study Sessions||8||314
60112407|NCT04551105|76232687|FG001|COMPLETED|The 1st Study Sessions||8||314
60112408|NCT04551105|76232686|FG000|NOT COMPLETED|The 1st Study Sessions||0||0
60112409|NCT04551105|76232687|FG001|NOT COMPLETED|The 1st Study Sessions||0||0
60112410|NCT04551105|76232686|FG000|STARTED|The 2st Study Sessions (5 Weeks Later)|Each reader of the same groups(8) tudy with the same number of cases (314).|8||314
60112411|NCT04551105|76232687|FG001|STARTED|The 2st Study Sessions (5 Weeks Later)|Each reader of the same groups(8) tudy with the same number of cases (314).|8||314
60112412|NCT04551105|76232686|FG000|COMPLETED|The 2st Study Sessions (5 Weeks Later)||8||314
60112413|NCT04551105|76232687|FG001|COMPLETED|The 2st Study Sessions (5 Weeks Later)||8||314
60112414|NCT04551105|76232686|FG000|NOT COMPLETED|The 2st Study Sessions (5 Weeks Later)||0||0
60112415|NCT04551105|76232687|FG001|NOT COMPLETED|The 2st Study Sessions (5 Weeks Later)||0||0
60112416|NCT01883440|76232700|FG000|STARTED|Overall Study||45||
60112417|NCT01883440|76232701|FG001|STARTED|Overall Study||45||
59567095|NCT03165747|75669904|FG000|COMPLETED|Overall Study||0||
59567096|NCT03165747|75669905|FG001|COMPLETED|Overall Study||0||
59567097|NCT03165747|75669904|FG000|NOT COMPLETED|Overall Study||0||
59567098|NCT03165747|75669905|FG001|NOT COMPLETED|Overall Study||0||
59567099|NCT03100617|75669911|FG000|STARTED|Overall Study||6||
59567100|NCT03100617|75669911|FG000|COMPLETED|Overall Study||6||
59567101|NCT03100617|75669911|FG000|NOT COMPLETED|Overall Study||0||
59567102|NCT02351856|75669915|FG000|STARTED|Overall Study||8||
59567103|NCT02351856|75669915|FG000|COMPLETED|Overall Study||0||
59567104|NCT02351856|75669915|FG000|NOT COMPLETED|Overall Study||8||
59567105|NCT03850275|75669925|FG000|STARTED|Overall Study||5||
59567106|NCT03850275|75669926|FG001|STARTED|Overall Study||5||
59567107|NCT03850275|75669927|FG002|STARTED|Overall Study||5||
59567108|NCT03850275|75669928|FG003|STARTED|Overall Study||5||
59567109|NCT03850275|75669929|FG004|STARTED|Overall Study||5||
59567110|NCT03850275|75669930|FG005|STARTED|Overall Study||5||
59567111|NCT03850275|75669925|FG000|COMPLETED|Overall Study||5||
59567112|NCT03850275|75669926|FG001|COMPLETED|Overall Study||5||
59567113|NCT03850275|75669927|FG002|COMPLETED|Overall Study||5||
59567114|NCT03850275|75669928|FG003|COMPLETED|Overall Study||5||
60112418|NCT01883440|76232700|FG000|COMPLETED|Overall Study||42||
60112419|NCT01883440|76232701|FG001|COMPLETED|Overall Study||45||
60112420|NCT01883440|76232700|FG000|NOT COMPLETED|Overall Study||3||
60112421|NCT01883440|76232701|FG001|NOT COMPLETED|Overall Study||0||
60112422|NCT01770743|76232713|FG000|STARTED|Overall Study||44||
60112423|NCT01770743|76232714|FG001|STARTED|Overall Study||34||
60112424|NCT01770743|76232715|FG002|STARTED|Overall Study||23||
60112425|NCT01770743|76232716|FG003|STARTED|Overall Study||44||
60112426|NCT01770743|76232717|FG004|STARTED|Overall Study||23||
60112427|NCT01770743|76232713|FG000|Treated|Overall Study||44||
60112428|NCT01770743|76232714|FG001|Treated|Overall Study||34||
60112429|NCT01770743|76232715|FG002|Treated|Overall Study||23||
60112430|NCT01770743|76232716|FG003|Treated|Overall Study||44||
60112431|NCT01770743|76232717|FG004|Treated|Overall Study||23||
60112432|NCT01770743|76232713|FG000|COMPLETED|Overall Study||42||
60112433|NCT01770743|76232714|FG001|COMPLETED|Overall Study||31||
60112434|NCT01770743|76232715|FG002|COMPLETED|Overall Study||22||
60112435|NCT01770743|76232716|FG003|COMPLETED|Overall Study||42||
60112436|NCT01770743|76232717|FG004|COMPLETED|Overall Study||21||
60112437|NCT01770743|76232713|FG000|NOT COMPLETED|Overall Study||2||
60112438|NCT01770743|76232714|FG001|NOT COMPLETED|Overall Study||3||
60112439|NCT01770743|76232715|FG002|NOT COMPLETED|Overall Study||1||
60112440|NCT01770743|76232716|FG003|NOT COMPLETED|Overall Study||2||
60112441|NCT01770743|76232717|FG004|NOT COMPLETED|Overall Study||2||
60112442|NCT01883986|76232731|FG000|STARTED|Overall Study|Allocated to intervention arm|20||
60112443|NCT01883986|76232732|FG001|STARTED|Overall Study|Allocated to usual care arm|20||
60112444|NCT01883986|76232731|FG000|Did Not Complete Study|Overall Study||3||
59567115|NCT03850275|75669929|FG004|COMPLETED|Overall Study||5||
59567116|NCT03850275|75669930|FG005|COMPLETED|Overall Study||5||
59567117|NCT03850275|75669925|FG000|NOT COMPLETED|Overall Study||0||
59567118|NCT03850275|75669926|FG001|NOT COMPLETED|Overall Study||0||
59567119|NCT03850275|75669927|FG002|NOT COMPLETED|Overall Study||0||
59567120|NCT03850275|75669928|FG003|NOT COMPLETED|Overall Study||0||
59567121|NCT03850275|75669929|FG004|NOT COMPLETED|Overall Study||0||
59567122|NCT03850275|75669930|FG005|NOT COMPLETED|Overall Study||0||
60112445|NCT01883986|76232732|FG001|Did Not Complete Study|Overall Study|Did not completed study|1||
60112446|NCT01883986|76232731|FG000|COMPLETED|Overall Study|Received allocated intervention|17||
60112447|NCT01883986|76232732|FG001|COMPLETED|Overall Study|Completed study|19||
60112448|NCT01883986|76232731|FG000|NOT COMPLETED|Overall Study||3||
60112449|NCT01883986|76232732|FG001|NOT COMPLETED|Overall Study||1||
60112450|NCT01884064|76232740|FG000|STARTED|Overall Study||12||
60112451|NCT01884064|76232741|FG001|STARTED|Overall Study||5||
60112452|NCT01884064|76232740|FG000|COMPLETED|Overall Study||12||
60112453|NCT01884064|76232741|FG001|COMPLETED|Overall Study||5||
60112454|NCT01884064|76232740|FG000|NOT COMPLETED|Overall Study||0||
60112455|NCT01884064|76232741|FG001|NOT COMPLETED|Overall Study||0||
60112456|NCT01884844|76232749|FG000|STARTED|Overall Study||16||
60112457|NCT01884844|76232750|FG001|STARTED|Overall Study||17||
60112458|NCT01884844|76232749|FG000|COMPLETED|Overall Study||13||
60112459|NCT01884844|76232750|FG001|COMPLETED|Overall Study||12||
60112460|NCT01884844|76232749|FG000|NOT COMPLETED|Overall Study||3||
60112461|NCT01884844|76232750|FG001|NOT COMPLETED|Overall Study||5||
60112462|NCT01890226|76232758|FG000|STARTED|Overall Study||155||
60112463|NCT01890226|76232759|FG001|STARTED|Overall Study||156||
60112464|NCT01890226|76232758|FG000|COMPLETED|Overall Study||155||
60112465|NCT01890226|76232759|FG001|COMPLETED|Overall Study||156||
60112466|NCT01890226|76232758|FG000|NOT COMPLETED|Overall Study||0||
60112467|NCT01890226|76232759|FG001|NOT COMPLETED|Overall Study||0||
60112468|NCT01894906|76232767|FG000|STARTED|Overall Study||6||
60112469|NCT01894906|76232768|FG001|STARTED|Overall Study||6||
60112470|NCT01894906|76232767|FG000|Treatment A|Overall Study||6||
60112471|NCT01894906|76232768|FG001|Treatment A|Overall Study||6||
60112472|NCT01894906|76232767|FG000|Treatment B|Overall Study||6||
60112473|NCT01894906|76232768|FG001|Treatment B|Overall Study||6||
60112474|NCT01894906|76232767|FG000|Treatment C|Overall Study||6||
60112475|NCT01894906|76232768|FG001|Treatment C|Overall Study||6||
60112476|NCT01894906|76232767|FG000|Treatment D|Overall Study||6||
60112477|NCT01894906|76232768|FG001|Treatment D|Overall Study||6||
60112478|NCT01894906|76232767|FG000|Treatment E|Overall Study||6||
60112479|NCT01894906|76232768|FG001|Treatment E|Overall Study||6||
60112480|NCT01894906|76232767|FG000|Treatment F|Overall Study||6||
60112481|NCT01894906|76232768|FG001|Treatment F|Overall Study||6||
60112482|NCT01894906|76232767|FG000|COMPLETED|Overall Study||6||
60112483|NCT01894906|76232768|FG001|COMPLETED|Overall Study||6||
60112484|NCT01894906|76232767|FG000|NOT COMPLETED|Overall Study||0||
60112485|NCT01894906|76232768|FG001|NOT COMPLETED|Overall Study||0||
60112486|NCT01895062|76232788|FG000|STARTED|Overall Study||30||
60112487|NCT01895062|76232789|FG001|STARTED|Overall Study||24||
60112488|NCT01895062|76232788|FG000|COMPLETED|Overall Study||30||
60112489|NCT01895062|76232789|FG001|COMPLETED|Overall Study||24||
60112490|NCT01895062|76232788|FG000|NOT COMPLETED|Overall Study||0||
60112491|NCT01895062|76232789|FG001|NOT COMPLETED|Overall Study||0||
60112492|NCT01896544|76232798|FG000|STARTED|Overall Study||10||
60112493|NCT01896544|76232799|FG001|STARTED|Overall Study||10||
60112494|NCT01896544|76232800|FG002|STARTED|Overall Study||10||
60112495|NCT01896544|76232798|FG000|COMPLETED|Overall Study||10||
60112496|NCT01896544|76232799|FG001|COMPLETED|Overall Study||10||
60112497|NCT01896544|76232800|FG002|COMPLETED|Overall Study||10||
60112498|NCT01896544|76232798|FG000|NOT COMPLETED|Overall Study||0||
60112499|NCT01896544|76232799|FG001|NOT COMPLETED|Overall Study||0||
60112500|NCT01896544|76232800|FG002|NOT COMPLETED|Overall Study||0||
60112501|NCT01767467|76232813|FG000|STARTED|Vaccination Phase (up to Month 2)||283||
60112502|NCT01767467|76232814|FG001|STARTED|Vaccination Phase (up to Month 2)||279||
60112503|NCT01767467|76232813|FG000|COMPLETED|Vaccination Phase (up to Month 2)||266||
60112504|NCT01767467|76232814|FG001|COMPLETED|Vaccination Phase (up to Month 2)||259||
60112505|NCT01767467|76232813|FG000|NOT COMPLETED|Vaccination Phase (up to Month 2)||17||
60112506|NCT01767467|76232814|FG001|NOT COMPLETED|Vaccination Phase (up to Month 2)||20||
60112507|NCT01767467|76232813|FG000|STARTED|End of Study Phase (up to Month 13)||283||
60112508|NCT01767467|76232814|FG001|STARTED|End of Study Phase (up to Month 13)||279||
60112509|NCT01767467|76232813|FG000|COMPLETED|End of Study Phase (up to Month 13)||236||
60112510|NCT01767467|76232814|FG001|COMPLETED|End of Study Phase (up to Month 13)||216||
60112511|NCT01767467|76232813|FG000|NOT COMPLETED|End of Study Phase (up to Month 13)||47||
60112512|NCT01767467|76232814|FG001|NOT COMPLETED|End of Study Phase (up to Month 13)||63||
60112513|NCT01931878|76232827|FG000|STARTED|First Intervention||10||
60112514|NCT01931878|76232828|FG001|STARTED|First Intervention||14||
60112515|NCT01931878|76232827|FG000|COMPLETED|First Intervention||9||
60112516|NCT01931878|76232828|FG001|COMPLETED|First Intervention||14||
60112517|NCT01931878|76232827|FG000|NOT COMPLETED|First Intervention||1||
60112518|NCT01931878|76232828|FG001|NOT COMPLETED|First Intervention||0||
60112519|NCT01931878|76232827|FG000|STARTED|Second Intervention (After 3 Months)||9||
60112520|NCT01931878|76232828|FG001|STARTED|Second Intervention (After 3 Months)||14||
60112521|NCT01931878|76232827|FG000|COMPLETED|Second Intervention (After 3 Months)||9||
60112522|NCT01931878|76232828|FG001|COMPLETED|Second Intervention (After 3 Months)||12||
60112523|NCT01931878|76232827|FG000|NOT COMPLETED|Second Intervention (After 3 Months)||0||
60112524|NCT01931878|76232828|FG001|NOT COMPLETED|Second Intervention (After 3 Months)||2||
60112525|NCT01932112|76232838|FG000|STARTED|Overall Study||378||
60112526|NCT01932112|76232838|FG000|COMPLETED|Overall Study||378||
60112527|NCT01932112|76232838|FG000|NOT COMPLETED|Overall Study||0||
60112528|NCT01897402|76232844|FG000|STARTED|Overall Study||265||
60112529|NCT01897402|76232845|FG001|STARTED|Overall Study||260||
60112530|NCT01897402|76232844|FG000|COMPLETED|Overall Study||246||
60112531|NCT01897402|76232845|FG001|COMPLETED|Overall Study||244||
60112532|NCT01897402|76232844|FG000|NOT COMPLETED|Overall Study||19||
60112533|NCT01897402|76232845|FG001|NOT COMPLETED|Overall Study||16||
60112534|NCT02280226|76232857|FG000|STARTED|Overall Study||17||
60112535|NCT02280226|76232857|FG000|COMPLETED|Overall Study||17||
60112536|NCT02280226|76232857|FG000|NOT COMPLETED|Overall Study||0||
60112537|NCT01897792|76232863|FG000|STARTED|Overall Study||6||
60112538|NCT01897792|76232864|FG001|STARTED|Overall Study||5||
60112539|NCT01897792|76232863|FG000|COMPLETED|Overall Study||6||
60112540|NCT01897792|76232864|FG001|COMPLETED|Overall Study||5||
60112541|NCT01897792|76232863|FG000|NOT COMPLETED|Overall Study||0||
60112542|NCT01897792|76232864|FG001|NOT COMPLETED|Overall Study||0||
60112543|NCT01933984|76232876|FG000|STARTED|Overall Study||26||
60112544|NCT01933984|76232877|FG001|STARTED|Overall Study||25||
60112545|NCT01933984|76232876|FG000|COMPLETED|Overall Study||26||
60112546|NCT01933984|76232877|FG001|COMPLETED|Overall Study||25||
60112547|NCT01933984|76232876|FG000|NOT COMPLETED|Overall Study||0||
59567123|NCT02349360|75669955|FG000|STARTED|Overall Study||21||
59567124|NCT02349360|75669956|FG001|STARTED|Overall Study||21||
59714770|NCT01200329|75833515|FG000|COMPLETED|Overall Study||78||
60112548|NCT01933984|76232877|FG001|NOT COMPLETED|Overall Study||0||
60112549|NCT04126083|76232887|FG000|STARTED|Overall Study||6||
60112550|NCT04126083|76232887|FG000|COMPLETED|Overall Study||5||
60112551|NCT04126083|76232887|FG000|NOT COMPLETED|Overall Study||1||
60112552|NCT02282722|76232893|FG000|STARTED|Overall Study||94||
60112553|NCT02282722|76232894|FG001|STARTED|Overall Study||92||
60112554|NCT02282722|76232893|FG000|2-week Assessment|Overall Study||79||
60112555|NCT02282722|76232894|FG001|2-week Assessment|Overall Study||75||
60112556|NCT02282722|76232893|FG000|3-month Assessment|Overall Study||71||
60112557|NCT02282722|76232894|FG001|3-month Assessment|Overall Study||73||
60112558|NCT02282722|76232893|FG000|COMPLETED|Overall Study||71||
59822993|NCT00372567|75945809|FG001|NOT COMPLETED|Phase 1 Sub-study||0||
59822994|NCT00372567|75945810|FG002|NOT COMPLETED|Phase 1 Sub-study||0||
59822995|NCT00372567|75945808|FG000|STARTED|Phase 3 Study||31||
59822996|NCT00372567|75945809|FG001|STARTED|Phase 3 Study||26||
60112559|NCT02282722|76232894|FG001|COMPLETED|Overall Study||73||
60112560|NCT02282722|76232893|FG000|NOT COMPLETED|Overall Study||23||
60112561|NCT02282722|76232894|FG001|NOT COMPLETED|Overall Study||19||
60112562|NCT01935622|76232903|FG000|STARTED|Overall Study||3||
60112563|NCT01935622|76232904|FG001|STARTED|Overall Study||3||
60112564|NCT01935622|76232905|FG002|STARTED|Overall Study||4||
60112565|NCT01935622|76232903|FG000|COMPLETED|Overall Study||1||
60112566|NCT01935622|76232904|FG001|COMPLETED|Overall Study||1||
60112567|NCT01935622|76232905|FG002|COMPLETED|Overall Study||4||
60112568|NCT01935622|76232903|FG000|NOT COMPLETED|Overall Study||2||
60112569|NCT01935622|76232904|FG001|NOT COMPLETED|Overall Study||2||
60112570|NCT01935622|76232905|FG002|NOT COMPLETED|Overall Study||0||
60112571|NCT01936324|76232916|FG000|STARTED|Overall Study||6||
60112572|NCT01936324|76232917|FG001|STARTED|Overall Study||53||
60112573|NCT01936324|76232918|FG002|STARTED|Overall Study||55||
60112574|NCT01936324|76232916|FG000|COMPLETED|Overall Study||6||
60112575|NCT01936324|76232917|FG001|COMPLETED|Overall Study||47||
60112576|NCT01936324|76232918|FG002|COMPLETED|Overall Study||50||
60112577|NCT01936324|76232916|FG000|NOT COMPLETED|Overall Study||0||
60112578|NCT01936324|76232917|FG001|NOT COMPLETED|Overall Study||6||
60112579|NCT01936324|76232918|FG002|NOT COMPLETED|Overall Study||5||
60112580|NCT01766921|76232927|FG000|STARTED|Overall Study||700||
60112581|NCT01766921|76232928|FG001|STARTED|Overall Study||693||
60112582|NCT01766921|76232927|FG000|COMPLETED|Overall Study||676||
60112583|NCT01766921|76232928|FG001|COMPLETED|Overall Study||676||
60112584|NCT01766921|76232927|FG000|NOT COMPLETED|Overall Study||24||
60112585|NCT01766921|76232928|FG001|NOT COMPLETED|Overall Study||17||
60112586|NCT01937026|76232935|FG000|STARTED|Period 1 (Day 1 Through Predose Day 3)||18||
60112587|NCT01937026|76232935|FG000|Received Baricitinib|Period 1 (Day 1 Through Predose Day 3)||18||
59567125|NCT02349360|75669955|FG000|COMPLETED|Overall Study||21||
59822997|NCT00372567|75945810|FG002|STARTED|Phase 3 Study||12||
59822998|NCT00372567|75945808|FG000|Received Treatment|Phase 3 Study||31||
59822999|NCT00372567|75945809|FG001|Received Treatment|Phase 3 Study||25||
59823000|NCT00372567|75945810|FG002|Received Treatment|Phase 3 Study||12||
59823001|NCT00372567|75945808|FG000|COMPLETED|Phase 3 Study||0||
59823002|NCT00372567|75945809|FG001|COMPLETED|Phase 3 Study||0||
59823003|NCT00372567|75945810|FG002|COMPLETED|Phase 3 Study||0||
59823004|NCT00372567|75945808|FG000|NOT COMPLETED|Phase 3 Study||31||
59823005|NCT00372567|75945809|FG001|NOT COMPLETED|Phase 3 Study||26||
59823006|NCT00372567|75945810|FG002|NOT COMPLETED|Phase 3 Study||12||
59823007|NCT00365547|75945818|FG000|STARTED|Overall Study||46||
59823008|NCT00365547|75945818|FG000|COMPLETED|Overall Study||43||
59823009|NCT00365547|75945818|FG000|NOT COMPLETED|Overall Study||3||
59823010|NCT00545441|75945827|FG000|STARTED|Overall Study||44||
60112588|NCT01937026|76232935|FG000|COMPLETED|Period 1 (Day 1 Through Predose Day 3)||18||
60112589|NCT01937026|76232935|FG000|NOT COMPLETED|Period 1 (Day 1 Through Predose Day 3)||0||
60112590|NCT01937026|76232935|FG000|STARTED|Period 2 (At Dosing Day 3 Through Day 8)||18||
59823011|NCT00545441|75945828|FG001|STARTED|Overall Study||42||
59823012|NCT00545441|75945827|FG000|COMPLETED|Overall Study||26||
59823013|NCT00545441|75945828|FG001|COMPLETED|Overall Study||26||
59823014|NCT00545441|75945827|FG000|NOT COMPLETED|Overall Study||18||
59823015|NCT00545441|75945828|FG001|NOT COMPLETED|Overall Study||16||
59823016|NCT00294658|75945836|FG000|STARTED|Overall Study||66||
59823017|NCT00294658|75945837|FG001|STARTED|Overall Study||60||
59823018|NCT00294658|75945836|FG000|COMPLETED|Overall Study||60||
59823019|NCT00294658|75945837|FG001|COMPLETED|Overall Study||51||
60112591|NCT01937026|76232935|FG000|Received Baricitinib|Period 2 (At Dosing Day 3 Through Day 8)||18||
60112592|NCT01937026|76232935|FG000|Received Probenecid on Days 3 Through 7|Period 2 (At Dosing Day 3 Through Day 8)||18||
60112593|NCT01937026|76232935|FG000|COMPLETED|Period 2 (At Dosing Day 3 Through Day 8)||18||
60112594|NCT01937026|76232935|FG000|NOT COMPLETED|Period 2 (At Dosing Day 3 Through Day 8)||0||
60112595|NCT01774799|76232946|FG000|STARTED|Overall Study||212||
59567126|NCT02349360|75669956|FG001|COMPLETED|Overall Study||20||
59567127|NCT02349360|75669955|FG000|NOT COMPLETED|Overall Study||0||
59823020|NCT00294658|75945836|FG000|NOT COMPLETED|Overall Study||6||
59823021|NCT00294658|75945837|FG001|NOT COMPLETED|Overall Study||9||
59823022|NCT03923933|75945845|FG000|STARTED|Overall Study||17||
59823023|NCT03923933|75945846|FG001|STARTED|Overall Study||17||
59823024|NCT03923933|75945845|FG000|COMPLETED|Overall Study||16||
59823025|NCT03923933|75945846|FG001|COMPLETED|Overall Study||16||
60112596|NCT01774799|76232947|FG001|STARTED|Overall Study||190||
60112597|NCT01774799|76232948|FG002|STARTED|Overall Study||212||
60112598|NCT01774799|76232949|FG003|STARTED|Overall Study||190||
60112599|NCT01774799|76232946|FG000|COMPLETED|Overall Study||211||
60112600|NCT01774799|76232947|FG001|COMPLETED|Overall Study||189||
60112601|NCT01774799|76232948|FG002|COMPLETED|Overall Study||212||
60112602|NCT01774799|76232949|FG003|COMPLETED|Overall Study||190||
60112603|NCT01774799|76232946|FG000|NOT COMPLETED|Overall Study||1||
60112604|NCT01774799|76232947|FG001|NOT COMPLETED|Overall Study||1||
60112605|NCT01774799|76232948|FG002|NOT COMPLETED|Overall Study||0||
59714771|NCT01200329|75833515|FG000|NOT COMPLETED|Overall Study||3||
60112606|NCT01774799|76232949|FG003|NOT COMPLETED|Overall Study||0||
60112607|NCT01937260|76232957|FG000|STARTED|Overall Study||21||
60112608|NCT01937260|76232958|FG001|STARTED|Overall Study||10||
60112609|NCT01937260|76232957|FG000|COMPLETED|Overall Study||20||
60112610|NCT01937260|76232958|FG001|COMPLETED|Overall Study||10||
60112611|NCT01937260|76232957|FG000|NOT COMPLETED|Overall Study||1||
60112612|NCT01937260|76232958|FG001|NOT COMPLETED|Overall Study||0||
60112613|NCT01902004|76232966|FG000|STARTED|Overall Study||48||
60112614|NCT01902004|76232967|FG001|STARTED|Overall Study||47||
60112615|NCT01902004|76232966|FG000|COMPLETED|Overall Study||33||
60112616|NCT01902004|76232967|FG001|COMPLETED|Overall Study||29||
60112617|NCT01902004|76232966|FG000|NOT COMPLETED|Overall Study||15||
60112618|NCT01902004|76232967|FG001|NOT COMPLETED|Overall Study||18||
60112619|NCT01938040|76232975|FG000|STARTED|Overall Study||28||
60112620|NCT01938040|76232976|FG001|STARTED|Overall Study||27||
60112621|NCT01938040|76232975|FG000|Plasma Analysis|Overall Study|complete set of blood samples could not be obtained|24||
60112622|NCT01938040|76232976|FG001|Plasma Analysis|Overall Study|complete set of blood samples could not be obtained|25||
60112623|NCT01938040|76232975|FG000|Behavior Metrics|Overall Study||28||
60112624|NCT01938040|76232976|FG001|Behavior Metrics|Overall Study||27||
60112625|NCT01938040|76232975|FG000|COMPLETED|Overall Study||28||
60112626|NCT01938040|76232976|FG001|COMPLETED|Overall Study||27||
60112627|NCT01938040|76232975|FG000|NOT COMPLETED|Overall Study||0||
60112628|NCT01938040|76232976|FG001|NOT COMPLETED|Overall Study||0||
60112629|NCT01765751|76232991|FG000|STARTED|Overall Study||16||
60112630|NCT01765751|76232992|FG001|STARTED|Overall Study||16||
60112631|NCT01765751|76232993|FG002|STARTED|Overall Study||16||
60112632|NCT01765751|76232991|FG000|COMPLETED|Overall Study||16||
60112633|NCT01765751|76232992|FG001|COMPLETED|Overall Study||14||
60112634|NCT01765751|76232993|FG002|COMPLETED|Overall Study||15||
60112635|NCT01765751|76232991|FG000|NOT COMPLETED|Overall Study||0||
60112636|NCT01765751|76232992|FG001|NOT COMPLETED|Overall Study||2||
60112637|NCT01765751|76232993|FG002|NOT COMPLETED|Overall Study||1||
60112638|NCT01938664|76233006|FG000|STARTED|Overall Study||20||
60112639|NCT01938664|76233007|FG001|STARTED|Overall Study||10||
60112640|NCT01938664|76233006|FG000|COMPLETED|Overall Study||5|This only includes subjects that completed 4 weeks of study treatment until the efficacy analysis.|
60112641|NCT01938664|76233007|FG001|COMPLETED|Overall Study||0|This only includes subjects that completed 4 weeks of study treatment until the efficacy analysis.|
60112642|NCT01938664|76233006|FG000|NOT COMPLETED|Overall Study||15||
60112643|NCT01938664|76233007|FG001|NOT COMPLETED|Overall Study||10||
60112644|NCT01736657|76233013|FG000|STARTED|Overall Study||73||
60112645|NCT01736657|76233013|FG000|COMPLETED|Overall Study||72||
60112646|NCT01736657|76233013|FG000|NOT COMPLETED|Overall Study||1||
60112647|NCT02284126|76233019|FG000|STARTED|Overall Study||552||
60112648|NCT02284126|76233020|FG001|STARTED|Overall Study||551||
60112649|NCT02284126|76233019|FG000|COMPLETED|Overall Study||484||
60112650|NCT02284126|76233020|FG001|COMPLETED|Overall Study||489||
60112651|NCT02284126|76233019|FG000|NOT COMPLETED|Overall Study||68||
60112652|NCT02284126|76233020|FG001|NOT COMPLETED|Overall Study||62||
60112653|NCT01736579|76233028|FG000|STARTED|Overall Study||2||
60112654|NCT01736579|76233029|FG001|STARTED|Overall Study||2||
60112655|NCT01736579|76233028|FG000|COMPLETED|Overall Study||0||
60112656|NCT01736579|76233029|FG001|COMPLETED|Overall Study||0||
60112657|NCT01736579|76233028|FG000|NOT COMPLETED|Overall Study||2||
60112658|NCT01736579|76233029|FG001|NOT COMPLETED|Overall Study||2||
60112659|NCT01939288|76233037|FG000|STARTED|Overall Study||5||
59714772|NCT01199939|75833519|FG000|STARTED|Overall Study|Number of enrolled participants|54||
60112660|NCT01939288|76233038|FG001|STARTED|Overall Study||5||
60112661|NCT01939288|76233037|FG000|COMPLETED|Overall Study||5||
60112662|NCT01939288|76233038|FG001|COMPLETED|Overall Study||5||
60112663|NCT01939288|76233037|FG000|NOT COMPLETED|Overall Study||0||
60112664|NCT01939288|76233038|FG001|NOT COMPLETED|Overall Study||0||
60112665|NCT01940146|76233047|FG000|STARTED|Overall Study||56||
60112666|NCT01940146|76233048|FG001|STARTED|Overall Study||55||
60112667|NCT01940146|76233049|FG002|STARTED|Overall Study||56||
60112668|NCT01940146|76233050|FG003|STARTED|Overall Study||55||
60112669|NCT01940146|76233047|FG000|COMPLETED|Overall Study||55||
60112670|NCT01940146|76233048|FG001|COMPLETED|Overall Study||55||
60112671|NCT01940146|76233049|FG002|COMPLETED|Overall Study||55||
60112672|NCT01940146|76233050|FG003|COMPLETED|Overall Study||53||
60112673|NCT01940146|76233047|FG000|NOT COMPLETED|Overall Study||1||
60112674|NCT01940146|76233048|FG001|NOT COMPLETED|Overall Study||0||
60112675|NCT01940146|76233049|FG002|NOT COMPLETED|Overall Study||1||
60112676|NCT01940146|76233050|FG003|NOT COMPLETED|Overall Study||2||
60112677|NCT01765673|76233060|FG000|STARTED|Overall Study||12||
60112678|NCT01765673|76233060|FG000|COMPLETED|Overall Study||11||
60112679|NCT01765673|76233060|FG000|NOT COMPLETED|Overall Study||1||
60112680|NCT01764659|76233067|FG000|STARTED|Overall Study||14||
60112681|NCT01764659|76233067|FG000|COMPLETED|Overall Study||12||
60112682|NCT01764659|76233067|FG000|NOT COMPLETED|Overall Study||2||
60112683|NCT01736189|76233073|FG000|STARTED|Overall Study||346||
59823026|NCT03923933|75945845|FG000|NOT COMPLETED|Overall Study||1||
60112684|NCT01736189|76233073|FG000|COMPLETED|Overall Study||300||
60112685|NCT01736189|76233073|FG000|NOT COMPLETED|Overall Study||46||
60112686|NCT01903564|76233079|FG000|STARTED|Overall Study||10||
60112687|NCT01903564|76233080|FG001|STARTED|Overall Study||29||
60112688|NCT01903564|76233079|FG000|COMPLETED|Overall Study||10||
59823027|NCT03923933|75945846|FG001|NOT COMPLETED|Overall Study||1||
59823028|NCT00372489|75945852|FG000|STARTED|Overall Study||81||
59823029|NCT00372489|75945852|FG000|COMPLETED|Overall Study||2||
59823030|NCT00372489|75945852|FG000|NOT COMPLETED|Overall Study||79||
59823031|NCT00372411|75945859|FG000|STARTED|Overall Study||49||
59823032|NCT00372411|75945860|FG001|STARTED|Overall Study||50||
59823033|NCT00372411|75945861|FG002|STARTED|Overall Study||28||
59823034|NCT00372411|75945859|FG000|COMPLETED|Overall Study||44||
59823035|NCT00372411|75945860|FG001|COMPLETED|Overall Study||42||
59823036|NCT00372411|75945861|FG002|COMPLETED|Overall Study||25||
59823037|NCT00372411|75945859|FG000|NOT COMPLETED|Overall Study||5||
59823038|NCT00372411|75945860|FG001|NOT COMPLETED|Overall Study||8||
59823039|NCT00372411|75945861|FG002|NOT COMPLETED|Overall Study||3||
59823040|NCT00372255|75945871|FG000|STARTED|Overall Study||110||
59823041|NCT00372255|75945872|FG001|STARTED|Overall Study||114||
59823042|NCT00372255|75945871|FG000|COMPLETED|Overall Study||108||
59823043|NCT00372255|75945872|FG001|COMPLETED|Overall Study||113||
59823044|NCT00372255|75945871|FG000|NOT COMPLETED|Overall Study||2||
59823045|NCT00372255|75945872|FG001|NOT COMPLETED|Overall Study||1||
60112689|NCT01903564|76233080|FG001|COMPLETED|Overall Study||29||
60112690|NCT01903564|76233079|FG000|NOT COMPLETED|Overall Study||0||
60112691|NCT01903564|76233080|FG001|NOT COMPLETED|Overall Study||0||
60112692|NCT02970981|76233086|FG000|STARTED|Overall Study||16||
60112693|NCT02970981|76233086|FG000|COMPLETED|Overall Study||16||
60112694|NCT02970981|76233086|FG000|NOT COMPLETED|Overall Study||0||
60112695|NCT01941472|76233090|FG000|STARTED|Overall Study||40||
60112696|NCT01941472|76233090|FG000|COMPLETED|Overall Study||40||
60112697|NCT01941472|76233090|FG000|NOT COMPLETED|Overall Study||0||
60112698|NCT01941628|76233096|FG000|STARTED|Overall Study||46||
60112699|NCT01941628|76233097|FG001|STARTED|Overall Study||45||
60112700|NCT01941628|76233096|FG000|COMPLETED|Overall Study||45||
60112701|NCT01941628|76233097|FG001|COMPLETED|Overall Study||45||
59714773|NCT01199939|75833519|FG000|COMPLETED|Overall Study||41||
59714774|NCT01199939|75833519|FG000|NOT COMPLETED|Overall Study||13||
59714775|NCT01199861|75833525|FG000|STARTED|Overall Study||95||
59714776|NCT01199861|75833526|FG001|STARTED|Overall Study||43||
60112702|NCT01941628|76233096|FG000|NOT COMPLETED|Overall Study||1||
60112703|NCT01941628|76233097|FG001|NOT COMPLETED|Overall Study||0||
60112704|NCT01735175|76233105|FG000|STARTED|Overall Study||159|Allocated|
60112705|NCT01735175|76233106|FG001|STARTED|Overall Study||157|Allocated|
60112706|NCT01735175|76233105|FG000|Completed All Cycles|Overall Study||141||
60112707|NCT01735175|76233106|FG001|Completed All Cycles|Overall Study||150||
60112708|NCT01735175|76233105|FG000|Completed All Treatments as Planned|Overall Study||140||
60112709|NCT01735175|76233106|FG001|Completed All Treatments as Planned|Overall Study||150||
59567128|NCT02349360|75669956|FG001|NOT COMPLETED|Overall Study||1||
59714777|NCT01199861|75833525|FG000|COMPLETED|Overall Study||93||
59714778|NCT01199861|75833526|FG001|COMPLETED|Overall Study||43||
59714779|NCT01199861|75833525|FG000|NOT COMPLETED|Overall Study||2||
59567129|NCT03825939|75669965|FG000|STARTED|Overall Study||18||
59567130|NCT03825939|75669966|FG001|STARTED|Overall Study||20||
59567131|NCT03825939|75669967|FG002|STARTED|Overall Study||14||
59567132|NCT03825939|75669965|FG000|COMPLETED|Overall Study||18||
59567133|NCT03825939|75669966|FG001|COMPLETED|Overall Study||20||
59567134|NCT03825939|75669967|FG002|COMPLETED|Overall Study||14||
59567135|NCT03825939|75669965|FG000|NOT COMPLETED|Overall Study||0||
59567136|NCT03825939|75669966|FG001|NOT COMPLETED|Overall Study||0||
59714780|NCT01199861|75833526|FG001|NOT COMPLETED|Overall Study||0||
59823046|NCT00274456|75945883|FG000|STARTED|Overall Study||76||
59823047|NCT00274456|75945884|FG001|STARTED|Overall Study||76||
59823048|NCT00274456|75945885|FG002|STARTED|Overall Study||74||
59823049|NCT00274456|75945886|FG003|STARTED|Overall Study||74||
59823050|NCT00274456|75945883|FG000|At Least One Response Assessment|Overall Study||73||
59823051|NCT00274456|75945884|FG001|At Least One Response Assessment|Overall Study||76||
60112710|NCT01735175|76233105|FG000|Completed the 6-month SFU Visit|Overall Study||120|1 more patient, LA-EP06 arm died due to disease progression, not included in participant flow-death|
60112711|NCT01735175|76233106|FG001|Completed the 6-month SFU Visit|Overall Study||138|1 more patient, LA-EP06 arm died due to disease progression, not included in participant flow-death|
60112712|NCT01735175|76233105|FG000|COMPLETED|Overall Study||130|Completed the study as planned (prior to Safety follow-up)|
60112713|NCT01735175|76233106|FG001|COMPLETED|Overall Study||144|Completed the study as planned (prior to Safety follow-up)|
60112714|NCT01735175|76233105|FG000|NOT COMPLETED|Overall Study||29||
60112715|NCT01735175|76233106|FG001|NOT COMPLETED|Overall Study||13||
60112716|NCT01942720|76233112|FG000|STARTED|Overall Study||74||
60112717|NCT01942720|76233112|FG000|COMPLETED|Overall Study||53||
60112718|NCT01942720|76233112|FG000|NOT COMPLETED|Overall Study||21||
60112719|NCT01762943|76233118|FG000|STARTED|Overall Study||19||
60112720|NCT01762943|76233119|FG001|STARTED|Overall Study||17||
60112721|NCT01762943|76233118|FG000|Hypogonadism|Overall Study||18||
60112722|NCT01762943|76233119|FG001|Hypogonadism|Overall Study||15||
60112723|NCT01762943|76233118|FG000|Addback|Overall Study||16||
60112724|NCT01762943|76233119|FG001|Addback|Overall Study||15||
60112725|NCT01762943|76233118|FG000|Withdrawal|Overall Study||15||
60112726|NCT01762943|76233119|FG001|Withdrawal|Overall Study||15||
59567137|NCT03825939|75669967|FG002|NOT COMPLETED|Overall Study||0||
59714781|NCT03196219|75833535|FG000|STARTED|Overall Study||8||
59714782|NCT03196219|75833536|FG001|STARTED|Overall Study||6||
59714783|NCT03196219|75833537|FG002|STARTED|Overall Study||6||
59714784|NCT03196219|75833538|FG003|STARTED|Overall Study||0||
59714785|NCT03196219|75833535|FG000|COMPLETED|Overall Study||8||
59714786|NCT03196219|75833536|FG001|COMPLETED|Overall Study||6||
59714787|NCT03196219|75833537|FG002|COMPLETED|Overall Study||6||
59714788|NCT03196219|75833538|FG003|COMPLETED|Overall Study||0||
59714789|NCT03196219|75833535|FG000|NOT COMPLETED|Overall Study||0||
59823052|NCT00274456|75945885|FG002|At Least One Response Assessment|Overall Study||73||
59823053|NCT00274456|75945886|FG003|At Least One Response Assessment|Overall Study||70||
59823054|NCT00274456|75945883|FG000|COMPLETED|Overall Study|Treatment completed upon progressive disease|39||
59823055|NCT00274456|75945884|FG001|COMPLETED|Overall Study|Treatment completed upon progressive disease|49||
60112727|NCT01762943|76233118|FG000|COMPLETED|Overall Study||15||
60000414|NCT02593149|76116143|FG001|COMPLETED|Intervention||845||20
60112728|NCT01762943|76233119|FG001|COMPLETED|Overall Study||15||
60112729|NCT01762943|76233118|FG000|NOT COMPLETED|Overall Study||4||
60112730|NCT01762943|76233119|FG001|NOT COMPLETED|Overall Study||2||
60112731|NCT01943110|76233125|FG000|STARTED|Overall Study||30||
60112732|NCT01943110|76233125|FG000|COMPLETED|Overall Study||30||
60112733|NCT01943110|76233125|FG000|NOT COMPLETED|Overall Study||0||
60112734|NCT01943344|76233141|FG000|STARTED|Overall Study||12||
60112735|NCT01943344|76233141|FG000|COMPLETED|Overall Study||9||
60112736|NCT01943344|76233141|FG000|NOT COMPLETED|Overall Study||3||
60112737|NCT01903798|76233151|FG000|STARTED|Overall Study||2||
60112738|NCT01903798|76233152|FG001|STARTED|Overall Study||0||
60112739|NCT01903798|76233153|FG002|STARTED|Overall Study||1||
60112740|NCT01903798|76233154|FG003|STARTED|Overall Study||1||
60112741|NCT01903798|76233151|FG000|COMPLETED|Overall Study||2||
60112742|NCT01903798|76233152|FG001|COMPLETED|Overall Study||0||
60112743|NCT01903798|76233153|FG002|COMPLETED|Overall Study||1||
60112744|NCT01903798|76233154|FG003|COMPLETED|Overall Study||1||
60112745|NCT01903798|76233151|FG000|NOT COMPLETED|Overall Study||0||
60112746|NCT01903798|76233152|FG001|NOT COMPLETED|Overall Study||0||
60112747|NCT01903798|76233153|FG002|NOT COMPLETED|Overall Study||0||
60112748|NCT01903798|76233154|FG003|NOT COMPLETED|Overall Study||0||
60112749|NCT01909180|76233164|FG000|STARTED|Overall Study||49||
60112750|NCT01909180|76233164|FG000|COMPLETED|Overall Study||49||
60112751|NCT01909180|76233164|FG000|NOT COMPLETED|Overall Study||0||
60112752|NCT01945138|76233172|FG000|STARTED|Overall Study||7||
60112753|NCT01945138|76233173|FG001|STARTED|Overall Study||7||
60112754|NCT01945138|76233172|FG000|COMPLETED|Overall Study||7||
60112755|NCT01945138|76233173|FG001|COMPLETED|Overall Study||7||
60112756|NCT01945138|76233172|FG000|NOT COMPLETED|Overall Study||0||
60112757|NCT01945138|76233173|FG001|NOT COMPLETED|Overall Study||0||
60112758|NCT01734785|76233182|FG000|STARTED|Open-Label Period||0||
60112759|NCT01734785|76233183|FG001|STARTED|Open-Label Period||0||
60112760|NCT01734785|76233184|FG002|STARTED|Open-Label Period||0||
60112761|NCT01734785|76233185|FG003|STARTED|Open-Label Period||606||
60112762|NCT01734785|76233182|FG000|COMPLETED|Open-Label Period||0||
60112763|NCT01734785|76233183|FG001|COMPLETED|Open-Label Period||0||
60112764|NCT01734785|76233184|FG002|COMPLETED|Open-Label Period||0||
60112765|NCT01734785|76233185|FG003|COMPLETED|Open-Label Period||333||
59714790|NCT03196219|75833536|FG001|NOT COMPLETED|Overall Study||0||
59714791|NCT03196219|75833537|FG002|NOT COMPLETED|Overall Study||0||
59714792|NCT03196219|75833538|FG003|NOT COMPLETED|Overall Study||0||
59714793|NCT01199705|75833546|FG000|STARTED|IVIG Treatment||25||
60000415|NCT02593149|76116142|FG000|NOT COMPLETED|Intervention||116||0
60000416|NCT02593149|76116143|FG001|NOT COMPLETED|Intervention||115||0
60112766|NCT01734785|76233182|FG000|NOT COMPLETED|Open-Label Period||0||
59567138|NCT03988647|75669975|FG000|STARTED|Overall Study||1||
59567139|NCT03988647|75669975|FG000|COMPLETED|Overall Study||1||
59567140|NCT03988647|75669975|FG000|NOT COMPLETED|Overall Study||0||
59567141|NCT00551642|75669981|FG000|STARTED|Treatment Period||399||
59996379|NCT02764489|76112358|FG000|NOT COMPLETED|Part 1: Day 1 up to Day 16||3||
59567142|NCT00551642|75669982|FG001|STARTED|Treatment Period||401||
59714794|NCT01199705|75833546|FG000|COMPLETED|IVIG Treatment||25||
59714795|NCT01199705|75833546|FG000|NOT COMPLETED|IVIG Treatment||0||
59714796|NCT01199705|75833546|FG000|STARTED|SCIG Treatment (Wash-in/Wash-out)||25||
59567143|NCT00551642|75669981|FG000|Safety Population|Treatment Period||395||
59714797|NCT01199705|75833546|FG000|COMPLETED|SCIG Treatment (Wash-in/Wash-out)||24||
59996380|NCT02764489|76112359|FG001|NOT COMPLETED|Part 1: Day 1 up to Day 16||0||
59996381|NCT02764489|76112358|FG000|STARTED|Part 2: Day 19 up to Day 41||14|Participants who completed Part 1 of the study entered Part 2 of the study:|
59996382|NCT02764489|76112359|FG001|STARTED|Part 2: Day 19 up to Day 41||16|Participants who completed Part 1 of the study entered Part 2 of the study:|
59996383|NCT02764489|76112358|FG000|Part 2: FEIBA 85±15U/kg 50% Reduced Volume at 4U/kg/Min Rate|Part 2: Day 19 up to Day 41||14|Participants who completed Part 1 of the study received up to 3 infusions of FEIBA 85 ± 15 U/kg IV reconstituted in 50% reduced volume SWFI at an increased infusion rate of 4 U/kg/min, every 48 hours (infusions 7, 8, and 9).|
59996384|NCT02764489|76112359|FG001|Part 2: FEIBA 85±15U/kg 50% Reduced Volume at 4U/kg/Min Rate|Part 2: Day 19 up to Day 41||16|Participants who completed Part 1 of the study received up to 3 infusions of FEIBA 85 ± 15 U/kg IV reconstituted in 50% reduced volume SWFI at an increased infusion rate of 4 U/kg/min, every 48 hours (infusions 7, 8, and 9).|
59996385|NCT02764489|76112358|FG000|Part 2: FEIBA 85±15U/kg 50% Reduced Volume at 10U/kg/Min Rate|Part 2: Day 19 up to Day 41||12|Participants who completed Part 1 of the study and received up to 3 infusions (infusions 7, 8, and 9) at the rate of 4 U/kg/min in Part 2 received up to 3 infusions (10, 11, and 12) of FEIBA 85 ± 15 U/kg IV reconstituted in 50% reduced volume SWFI at an increased infusion rate of 10 U/kg/min, every 48 hours.|
59996386|NCT02764489|76112359|FG001|Part 2: FEIBA 85±15U/kg 50% Reduced Volume at 10U/kg/Min Rate|Part 2: Day 19 up to Day 41||16|Participants who completed Part 1 of the study and received up to 3 infusions (infusions 7, 8, and 9) at the rate of 4 U/kg/min in Part 2 received up to 3 infusions (10, 11, and 12) of FEIBA 85 ± 15 U/kg IV reconstituted in 50% reduced volume SWFI at an increased infusion rate of 10 U/kg/min, every 48 hours.|
59996387|NCT02764489|76112358|FG000|COMPLETED|Part 2: Day 19 up to Day 41||12||
59996388|NCT02764489|76112359|FG001|COMPLETED|Part 2: Day 19 up to Day 41||16||
59996389|NCT02764489|76112358|FG000|NOT COMPLETED|Part 2: Day 19 up to Day 41||2||
59996390|NCT02764489|76112359|FG001|NOT COMPLETED|Part 2: Day 19 up to Day 41||0||
59996391|NCT02001623|76112384|FG000|STARTED|Overall Study||3||
59996392|NCT02001623|76112385|FG001|STARTED|Overall Study||3||
59996393|NCT02001623|76112386|FG002|STARTED|Overall Study||3||
59996394|NCT02001623|76112387|FG003|STARTED|Overall Study||3||
59996395|NCT02001623|76112388|FG004|STARTED|Overall Study||3||
59996396|NCT02001623|76112389|FG005|STARTED|Overall Study||3||
59996397|NCT02001623|76112390|FG006|STARTED|Overall Study||3||
59996398|NCT02001623|76112391|FG007|STARTED|Overall Study||6||
59996399|NCT02001623|76112392|FG008|STARTED|Overall Study||15||
59996400|NCT02001623|76112393|FG009|STARTED|Overall Study||55||
59996401|NCT02001623|76112394|FG010|STARTED|Overall Study||14||
59996402|NCT02001623|76112395|FG011|STARTED|Overall Study||15||
59996403|NCT02001623|76112396|FG012|STARTED|Overall Study||15||
59996404|NCT02001623|76112397|FG013|STARTED|Overall Study||36||
59996405|NCT02001623|76112398|FG014|STARTED|Overall Study||18||
59996406|NCT02001623|76112384|FG000|Completed 4 Cycles of Treatment|Overall Study||0||
59996407|NCT02001623|76112385|FG001|Completed 4 Cycles of Treatment|Overall Study||1||
59996408|NCT02001623|76112386|FG002|Completed 4 Cycles of Treatment|Overall Study||1||
59996409|NCT02001623|76112387|FG003|Completed 4 Cycles of Treatment|Overall Study||2||
59996410|NCT02001623|76112388|FG004|Completed 4 Cycles of Treatment|Overall Study||0||
59996411|NCT02001623|76112389|FG005|Completed 4 Cycles of Treatment|Overall Study||2||
59996412|NCT02001623|76112390|FG006|Completed 4 Cycles of Treatment|Overall Study||2||
59996413|NCT02001623|76112391|FG007|Completed 4 Cycles of Treatment|Overall Study||1||
59996414|NCT02001623|76112392|FG008|Completed 4 Cycles of Treatment|Overall Study||5||
59996415|NCT02001623|76112393|FG009|Completed 4 Cycles of Treatment|Overall Study||31||
59996416|NCT02001623|76112394|FG010|Completed 4 Cycles of Treatment|Overall Study||6||
59996417|NCT02001623|76112395|FG011|Completed 4 Cycles of Treatment|Overall Study||4||
59996418|NCT02001623|76112396|FG012|Completed 4 Cycles of Treatment|Overall Study||6||
59996419|NCT02001623|76112397|FG013|Completed 4 Cycles of Treatment|Overall Study||22||
59996420|NCT02001623|76112398|FG014|Completed 4 Cycles of Treatment|Overall Study||7||
59996421|NCT02001623|76112384|FG000|Completed 12 Cycles of Treatment|Overall Study||0||
59996422|NCT02001623|76112385|FG001|Completed 12 Cycles of Treatment|Overall Study||1||
59996423|NCT02001623|76112386|FG002|Completed 12 Cycles of Treatment|Overall Study||0||
59996424|NCT02001623|76112387|FG003|Completed 12 Cycles of Treatment|Overall Study||1||
59996425|NCT02001623|76112388|FG004|Completed 12 Cycles of Treatment|Overall Study||0||
59996426|NCT02001623|76112389|FG005|Completed 12 Cycles of Treatment|Overall Study||0||
59996427|NCT02001623|76112390|FG006|Completed 12 Cycles of Treatment|Overall Study||0||
59996428|NCT02001623|76112391|FG007|Completed 12 Cycles of Treatment|Overall Study||0||
59996429|NCT02001623|76112392|FG008|Completed 12 Cycles of Treatment|Overall Study||0||
60112767|NCT01734785|76233183|FG001|NOT COMPLETED|Open-Label Period||0||
60112768|NCT01734785|76233184|FG002|NOT COMPLETED|Open-Label Period||0||
60112769|NCT01734785|76233185|FG003|NOT COMPLETED|Open-Label Period||273||
60112770|NCT01734785|76233182|FG000|STARTED|Double-Blind Period||111||
60112771|NCT01734785|76233183|FG001|STARTED|Double-Blind Period||112||
60112772|NCT01734785|76233184|FG002|STARTED|Double-Blind Period||110||
60112773|NCT01734785|76233185|FG003|STARTED|Double-Blind Period||0||
60112774|NCT01734785|76233182|FG000|COMPLETED|Double-Blind Period||106||
60112775|NCT01734785|76233183|FG001|COMPLETED|Double-Blind Period||103||
60112776|NCT01734785|76233184|FG002|COMPLETED|Double-Blind Period||105||
60112777|NCT01734785|76233185|FG003|COMPLETED|Double-Blind Period||0||
60112778|NCT01734785|76233182|FG000|NOT COMPLETED|Double-Blind Period||5||
60112779|NCT01734785|76233183|FG001|NOT COMPLETED|Double-Blind Period||9||
60112780|NCT01734785|76233184|FG002|NOT COMPLETED|Double-Blind Period||5||
60112781|NCT01734785|76233185|FG003|NOT COMPLETED|Double-Blind Period||0||
60112782|NCT01734395|76233194|FG000|STARTED|Overall Study||1882||
60112783|NCT01734395|76233194|FG000|COMPLETED|Overall Study||1472||
60112784|NCT01734395|76233194|FG000|NOT COMPLETED|Overall Study||410||
60112785|NCT01945294|76233201|FG000|STARTED|Period 1: 12-Week PR + BOC Lead-In||257||
60112786|NCT01945294|76233202|FG001|STARTED|Period 1: 12-Week PR + BOC Lead-In||0||
60112787|NCT01945294|76233203|FG002|STARTED|Period 1: 12-Week PR + BOC Lead-In||0||
60112788|NCT01945294|76233204|FG003|STARTED|Period 1: 12-Week PR + BOC Lead-In||0||
60112789|NCT01945294|76233201|FG000|COMPLETED|Period 1: 12-Week PR + BOC Lead-In||236||
60112790|NCT01945294|76233202|FG001|COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0||
60112791|NCT01945294|76233203|FG002|COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0||
60112792|NCT01945294|76233204|FG003|COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0||
60112793|NCT01945294|76233201|FG000|NOT COMPLETED|Period 1: 12-Week PR + BOC Lead-In||21||
60112794|NCT01945294|76233202|FG001|NOT COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0||
60112795|NCT01945294|76233203|FG002|NOT COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0||
60112796|NCT01945294|76233204|FG003|NOT COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0||
60112797|NCT01945294|76233201|FG000|STARTED|Period 2: BOC+ PR Treatment & Follow-up|Participants were assigned to 1 of the 3 arms after upon the 12-week BOC + PR lead-in.|0||
60112798|NCT01945294|76233202|FG001|STARTED|Period 2: BOC+ PR Treatment & Follow-up||102||
60112799|NCT01945294|76233203|FG002|STARTED|Period 2: BOC+ PR Treatment & Follow-up||105||
60112800|NCT01945294|76233204|FG003|STARTED|Period 2: BOC+ PR Treatment & Follow-up||29||
60112801|NCT01945294|76233201|FG000|COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||0||
60112802|NCT01945294|76233202|FG001|COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||97||
60112803|NCT01945294|76233203|FG002|COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||97||
60112804|NCT01945294|76233204|FG003|COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||23||
60112805|NCT01945294|76233201|FG000|NOT COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||0||
60112806|NCT01945294|76233202|FG001|NOT COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||5||
60112807|NCT01945294|76233203|FG002|NOT COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||8||
60112808|NCT01945294|76233204|FG003|NOT COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||6||
60112809|NCT01947946|76233216|FG000|STARTED|Overall Study||3||
60112810|NCT01947946|76233217|FG001|STARTED|Overall Study||5||
60112811|NCT01947946|76233218|FG002|STARTED|Overall Study||5||
60112812|NCT01947946|76233216|FG000|COMPLETED|Overall Study|Study Stopped|0||
60112813|NCT01947946|76233217|FG001|COMPLETED|Overall Study||0||
60112814|NCT01947946|76233218|FG002|COMPLETED|Overall Study||0||
60112815|NCT01947946|76233216|FG000|NOT COMPLETED|Overall Study||3||
60112816|NCT01947946|76233217|FG001|NOT COMPLETED|Overall Study||5||
60112817|NCT01947946|76233218|FG002|NOT COMPLETED|Overall Study||5||
60112818|NCT01597505|76233228|FG000|STARTED|Overall Study|Randomized participants|308||
60112819|NCT01597505|76233229|FG001|STARTED|Overall Study|Randomized participants|298||
60112820|NCT01597505|76233228|FG000|Treated|Overall Study|One participant was instead randomized to vancomycin|305||
60112821|NCT01597505|76233229|FG001|Treated|Overall Study||286||
60112822|NCT01597505|76233228|FG000|COMPLETED|Overall Study||264||
60112823|NCT01597505|76233229|FG001|COMPLETED|Overall Study||265||
60112824|NCT01597505|76233228|FG000|NOT COMPLETED|Overall Study||44||
60112825|NCT01597505|76233229|FG001|NOT COMPLETED|Overall Study||33||
60112826|NCT01911910|76233238|FG000|STARTED|Overall Study||197||
60112827|NCT01911910|76233239|FG001|STARTED|Overall Study||205||
60112828|NCT01911910|76233238|FG000|COMPLETED|Overall Study||184||
60112829|NCT01911910|76233239|FG001|COMPLETED|Overall Study||194||
60112830|NCT01911910|76233238|FG000|NOT COMPLETED|Overall Study||13||
60112831|NCT01911910|76233239|FG001|NOT COMPLETED|Overall Study||11||
60112832|NCT01951066|76233245|FG000|STARTED|First Intervention (Baseline to Week 16)||10||
60112833|NCT01951066|76233246|FG001|STARTED|First Intervention (Baseline to Week 16)||10||
60112834|NCT01951066|76233245|FG000|COMPLETED|First Intervention (Baseline to Week 16)||10||
60112835|NCT01951066|76233246|FG001|COMPLETED|First Intervention (Baseline to Week 16)||10||
60112836|NCT01951066|76233245|FG000|NOT COMPLETED|First Intervention (Baseline to Week 16)||0||
60112837|NCT01951066|76233246|FG001|NOT COMPLETED|First Intervention (Baseline to Week 16)||0||
60112838|NCT01951066|76233245|FG000|STARTED|Second Intervention (Week 16 to Week 32)||10||
60112839|NCT01951066|76233246|FG001|STARTED|Second Intervention (Week 16 to Week 32)||10||
60112840|NCT01951066|76233245|FG000|COMPLETED|Second Intervention (Week 16 to Week 32)||10||
60112841|NCT01951066|76233246|FG001|COMPLETED|Second Intervention (Week 16 to Week 32)||10||
60112842|NCT01951066|76233245|FG000|NOT COMPLETED|Second Intervention (Week 16 to Week 32)||0||
60112843|NCT01951066|76233246|FG001|NOT COMPLETED|Second Intervention (Week 16 to Week 32)||0||
60112844|NCT01913314|76233251|FG000|STARTED|Overall Study||6||
60112845|NCT01913314|76233251|FG000|Received Study Drug|Overall Study||6||
60112846|NCT01913314|76233251|FG000|COMPLETED|Overall Study||6||
60112847|NCT01913314|76233251|FG000|NOT COMPLETED|Overall Study||0||
60112848|NCT01951768|76233257|FG000|STARTED|Overall Study||43||
60112849|NCT01951768|76233258|FG001|STARTED|Overall Study||45||
60112850|NCT01951768|76233257|FG000|COMPLETED|Overall Study|43 patients|43||
60112851|NCT01951768|76233258|FG001|COMPLETED|Overall Study|45 patients|45||
60112852|NCT01951768|76233257|FG000|NOT COMPLETED|Overall Study||0||
60112853|NCT01951768|76233258|FG001|NOT COMPLETED|Overall Study||0||
60112854|NCT01760447|76233268|FG000|STARTED|Weeks 0-20|The first randomization for the participant who withdrew and re-randomized is not counted in the 62.|62||
60112855|NCT01760447|76233269|FG001|STARTED|Weeks 0-20||62||
60112856|NCT01760447|76233270|FG002|STARTED|Weeks 0-20||47||
60112857|NCT01760447|76233271|FG003|STARTED|Weeks 0-20||51||
60112858|NCT01760447|76233268|FG000|Treated|Weeks 0-20||62||
59823056|NCT00274456|75945885|FG002|COMPLETED|Overall Study|Treatment completed upon progressive disease|39||
59823057|NCT00274456|75945886|FG003|COMPLETED|Overall Study|Treatment completed upon progressive disease|29||
59823058|NCT00274456|75945883|FG000|NOT COMPLETED|Overall Study||37||
59823059|NCT00274456|75945884|FG001|NOT COMPLETED|Overall Study||27||
59823060|NCT00274456|75945885|FG002|NOT COMPLETED|Overall Study||35||
59823061|NCT00274456|75945886|FG003|NOT COMPLETED|Overall Study||45||
59823062|NCT00364923|75945896|FG000|STARTED|Treatment With Pralatrexate|Received at least one dose of pralatrexate.|111||
59823063|NCT00364923|75945896|FG000|COMPLETED|Treatment With Pralatrexate|Treatment duration not limited. After treatment ends, patients attend survival follow-up visits.|107||
59823064|NCT00364923|75945896|FG000|NOT COMPLETED|Treatment With Pralatrexate||4||
59823065|NCT00364923|75945896|FG000|STARTED|Survival Follow-up, After Pralatrexate|Patients (pts) who stop treatment with pralatrexate are followed for survival|107||
59823066|NCT00364923|75945896|FG000|COMPLETED|Survival Follow-up, After Pralatrexate|Pts who completed follow-up either died, were followed for 24 months, or withdrew|83||
59823067|NCT00364923|75945896|FG000|NOT COMPLETED|Survival Follow-up, After Pralatrexate||24||
59823068|NCT00381849|75945902|FG000|STARTED|First Intervention||10||
59823069|NCT00381849|75945903|FG001|STARTED|First Intervention||10||
59823070|NCT00381849|75945902|FG000|COMPLETED|First Intervention||10||
59823071|NCT00381849|75945903|FG001|COMPLETED|First Intervention||10||
59823072|NCT00381849|75945902|FG000|NOT COMPLETED|First Intervention||0||
59823073|NCT00381849|75945903|FG001|NOT COMPLETED|First Intervention||0||
59823074|NCT00381849|75945902|FG000|STARTED|Wash Out||10||
59823075|NCT00381849|75945903|FG001|STARTED|Wash Out||10||
59823076|NCT00381849|75945902|FG000|COMPLETED|Wash Out||10||
59823077|NCT00381849|75945903|FG001|COMPLETED|Wash Out||9||
59823078|NCT00381849|75945902|FG000|NOT COMPLETED|Wash Out||0||
59823079|NCT00381849|75945903|FG001|NOT COMPLETED|Wash Out||1||
59823080|NCT00381849|75945902|FG000|STARTED|Second Intervention||10||
59823081|NCT00381849|75945903|FG001|STARTED|Second Intervention||9||
59823082|NCT00381849|75945902|FG000|COMPLETED|Second Intervention||10||
59823083|NCT00381849|75945903|FG001|COMPLETED|Second Intervention||9||
59823084|NCT00381849|75945902|FG000|NOT COMPLETED|Second Intervention||0||
59823085|NCT00381849|75945903|FG001|NOT COMPLETED|Second Intervention||0||
59823086|NCT00381849|75945902|FG000|STARTED|Open-label||10||
59823087|NCT00381849|75945903|FG001|STARTED|Open-label||9||
59823088|NCT00381849|75945902|FG000|COMPLETED|Open-label||10||
59823089|NCT00381849|75945903|FG001|COMPLETED|Open-label||9||
59823090|NCT00381849|75945902|FG000|NOT COMPLETED|Open-label||0||
59823091|NCT00381849|75945903|FG001|NOT COMPLETED|Open-label||0||
59823092|NCT00273052|75945911|FG000|STARTED|Overall Study||290||
59823093|NCT00273052|75945912|FG001|STARTED|Overall Study||278||
59823094|NCT00273052|75945911|FG000|COMPLETED|Overall Study||221||
60112859|NCT01760447|76233269|FG001|Treated|Weeks 0-20||62||
60112860|NCT01760447|76233270|FG002|Treated|Weeks 0-20||45||
60112861|NCT01760447|76233271|FG003|Treated|Weeks 0-20||51||
60112862|NCT01760447|76233268|FG000|COMPLETED|Weeks 0-20||59||
60112863|NCT01760447|76233269|FG001|COMPLETED|Weeks 0-20||62||
60112864|NCT01760447|76233270|FG002|COMPLETED|Weeks 0-20||42||
60112865|NCT01760447|76233271|FG003|COMPLETED|Weeks 0-20||47||
60112866|NCT01760447|76233268|FG000|NOT COMPLETED|Weeks 0-20||3||
60112867|NCT01760447|76233269|FG001|NOT COMPLETED|Weeks 0-20||0||
60112868|NCT01760447|76233270|FG002|NOT COMPLETED|Weeks 0-20||5||
60112869|NCT01760447|76233271|FG003|NOT COMPLETED|Weeks 0-20||4||
60112870|NCT01760447|76233268|FG000|STARTED|Weeks 20-54|MK-0431A-170 added Weeks 20-54 via amendment, but not all participants were eligible for this period|28||
60112871|NCT01760447|76233269|FG001|STARTED|Weeks 20-54|MK-0431A-170 added Weeks 20-54 via amendment, but not all participants were eligible for this period|30||
60112872|NCT01760447|76233270|FG002|STARTED|Weeks 20-54||42||
60112873|NCT01760447|76233271|FG003|STARTED|Weeks 20-54||47||
60112874|NCT01760447|76233268|FG000|COMPLETED|Weeks 20-54||25||
60112875|NCT01760447|76233269|FG001|COMPLETED|Weeks 20-54||28||
60112876|NCT01760447|76233270|FG002|COMPLETED|Weeks 20-54||39||
60112877|NCT01760447|76233271|FG003|COMPLETED|Weeks 20-54||43||
60112878|NCT01760447|76233268|FG000|NOT COMPLETED|Weeks 20-54||3||
60112879|NCT01760447|76233269|FG001|NOT COMPLETED|Weeks 20-54||2||
60112880|NCT01760447|76233270|FG002|NOT COMPLETED|Weeks 20-54||3||
60112881|NCT01760447|76233271|FG003|NOT COMPLETED|Weeks 20-54||4||
60112882|NCT01952470|76233289|FG000|STARTED|Overall Study||16||
60112883|NCT01952470|76233290|FG001|STARTED|Overall Study||16||
60112884|NCT01952470|76233289|FG000|ITT Analysis|Overall Study||16||
60112885|NCT01952470|76233290|FG001|ITT Analysis|Overall Study||16||
60112886|NCT01952470|76233289|FG000|Discontinued Intervention|Overall Study||2||
60112887|NCT01952470|76233290|FG001|Discontinued Intervention|Overall Study||1||
60112888|NCT01952470|76233289|FG000|Death|Overall Study||1||
60112889|NCT01952470|76233290|FG001|Death|Overall Study||1||
60112890|NCT01952470|76233289|FG000|Missing Baseline LCI 2% Data.|Overall Study||0||
60112891|NCT01952470|76233290|FG001|Missing Baseline LCI 2% Data.|Overall Study||2||
60112892|NCT01952470|76233289|FG000|Missing 1+3 Month LCI 2% Data.|Overall Study||2||
60112893|NCT01952470|76233290|FG001|Missing 1+3 Month LCI 2% Data.|Overall Study||1||
60112894|NCT01952470|76233289|FG000|Missing 3 Month LCI 2% Data.|Overall Study||1||
60112895|NCT01952470|76233290|FG001|Missing 3 Month LCI 2% Data.|Overall Study||0||
60112896|NCT01952470|76233289|FG000|COMPLETED|Overall Study||13|Complete data for primary outcome.|
60112897|NCT01952470|76233290|FG001|COMPLETED|Overall Study||13|Complete data for primary outcome.|
60112898|NCT01952470|76233289|FG000|NOT COMPLETED|Overall Study||3||
60112899|NCT01952470|76233290|FG001|NOT COMPLETED|Overall Study||3||
60112900|NCT01915108|76233300|FG000|STARTED|Overall Study||32||
60112901|NCT01915108|76233301|FG001|STARTED|Overall Study||32||
60112902|NCT01915108|76233302|FG002|STARTED|Overall Study||32||
60112903|NCT01915108|76233303|FG003|STARTED|Overall Study||32||
60112904|NCT01915108|76233300|FG000|COMPLETED|Overall Study|two patients were excluded from the study|30||
60112905|NCT01915108|76233301|FG001|COMPLETED|Overall Study|three patients were excluded from the study|29||
60112906|NCT01915108|76233302|FG002|COMPLETED|Overall Study|one patients were excluded from the study|31||
60112907|NCT01915108|76233303|FG003|COMPLETED|Overall Study|two patients were excluded from the study|30||
60112908|NCT01915108|76233300|FG000|NOT COMPLETED|Overall Study||2||
60112909|NCT01915108|76233301|FG001|NOT COMPLETED|Overall Study||3||
60112910|NCT01915108|76233302|FG002|NOT COMPLETED|Overall Study||1||
60112911|NCT01915108|76233303|FG003|NOT COMPLETED|Overall Study||2||
60112912|NCT01917136|76233313|FG000|STARTED|Overall Study||21||
60112913|NCT01917136|76233313|FG000|COMPLETED|Overall Study||21||
60112914|NCT01917136|76233313|FG000|NOT COMPLETED|Overall Study||0||
60112915|NCT01953874|76233319|FG000|STARTED|Overall Study||65||
59714798|NCT01199705|75833546|FG000|NOT COMPLETED|SCIG Treatment (Wash-in/Wash-out)||1||
59714799|NCT01199705|75833546|FG000|STARTED|SCIG Treatment (Efficacy)||24||
59714800|NCT01199705|75833546|FG000|COMPLETED|SCIG Treatment (Efficacy)||24||
59714801|NCT01199705|75833546|FG000|NOT COMPLETED|SCIG Treatment (Efficacy)||0||
59714802|NCT01199471|75833561|FG000|STARTED|Overall Study|3 patients who did not meet ASA Physical Status Class 1 - 3 were excluded from all analyses.|4000||
59823095|NCT00273052|75945912|FG001|COMPLETED|Overall Study||190||
59823096|NCT00273052|75945911|FG000|NOT COMPLETED|Overall Study||69||
59823097|NCT00273052|75945912|FG001|NOT COMPLETED|Overall Study||88||
59823098|NCT00290290|75945920|FG000|STARTED|Overall Study||440||
59823099|NCT00290290|75945921|FG001|STARTED|Overall Study||409||
59823100|NCT00290290|75945920|FG000|COMPLETED|Overall Study||422||
59823101|NCT00290290|75945921|FG001|COMPLETED|Overall Study||391||
59823102|NCT00290290|75945920|FG000|NOT COMPLETED|Overall Study||18||
59823103|NCT00290290|75945921|FG001|NOT COMPLETED|Overall Study||18||
59823104|NCT00272038|75945927|FG000|STARTED|Overall Study||29||
59823105|NCT00272038|75945927|FG000|COMPLETED|Overall Study||22||
60112916|NCT01953874|76233320|FG001|STARTED|Overall Study||61||
60112917|NCT01953874|76233319|FG000|COMPLETED|Overall Study||65||
60112918|NCT01953874|76233320|FG001|COMPLETED|Overall Study||61||
60112919|NCT01953874|76233319|FG000|NOT COMPLETED|Overall Study||0||
59714803|NCT01199471|75833561|FG000|COMPLETED|Overall Study||3994||
59714804|NCT01199471|75833561|FG000|NOT COMPLETED|Overall Study||6||
59714805|NCT01198145|75833568|FG000|STARTED|Overall Study||44||
59714806|NCT01198145|75833569|FG001|STARTED|Overall Study||43||
59714807|NCT01198145|75833568|FG000|COMPLETED|Overall Study||43||
59714808|NCT01198145|75833569|FG001|COMPLETED|Overall Study||42||
59823106|NCT00272038|75945927|FG000|NOT COMPLETED|Overall Study||7||
59823107|NCT00271024|75945936|FG000|STARTED|Overall Study||80||
60112920|NCT01953874|76233320|FG001|NOT COMPLETED|Overall Study||0||
60112921|NCT01954264|76233327|FG000|STARTED|Overall Study||2421||
60112922|NCT01954264|76233327|FG000|COMPLETED|Overall Study||2421||
60112923|NCT01954264|76233327|FG000|NOT COMPLETED|Overall Study||0||
60112924|NCT01917214|76233344|FG000|STARTED|Overall Study||212||
60112925|NCT01917214|76233344|FG000|COMPLETED|Overall Study||212||
60112926|NCT01917214|76233344|FG000|NOT COMPLETED|Overall Study||0||
60112927|NCT01955434|76233349|FG000|STARTED|Overall Study||25||
60112928|NCT01955434|76233349|FG000|COMPLETED|Overall Study||25||
60112929|NCT01955434|76233349|FG000|NOT COMPLETED|Overall Study||0||
60112930|NCT01917682|76233353|FG000|STARTED|Overall Study||754||
60112931|NCT01917682|76233353|FG000|COMPLETED|Overall Study||754||
60112932|NCT01917682|76233353|FG000|NOT COMPLETED|Overall Study||0||
60112933|NCT01732913|76233360|FG000|STARTED|Overall Study||198||
59823108|NCT00271024|75945937|FG001|STARTED|Overall Study||77||
59823109|NCT00271024|75945938|FG002|STARTED|Overall Study||88||
59823110|NCT00271024|75945939|FG003|STARTED|Overall Study||88||
59823111|NCT00271024|75945936|FG000|Received Study Treatment|Overall Study|n=4 did not start treatment (3 lost interest, 1 unknown)|76||
59823112|NCT00271024|75945937|FG001|Received Study Treatment|Overall Study|n=6 did not start treatment (1 diff treat. desired, 3 lost interest, 1 began psych meds, 1 unknown)|71||
59823113|NCT00271024|75945938|FG002|Received Study Treatment|Overall Study|n=3 did not start treatment (2 lost interest, 1 unknown)|85||
59823114|NCT00271024|75945939|FG003|Received Study Treatment|Overall Study|n=5 did not start treatment (2 health problems, 1 wanted diff. treatment method, 2 lost interest)|83||
59823115|NCT00271024|75945936|FG000|COMPLETED|Overall Study|Discontinued: 1 smoking related, 1 reaction to tablet, 6 time commitment, 2 other, 8 unspecified|58||
59823116|NCT00271024|75945937|FG001|COMPLETED|Overall Study|Discontinued: 5 smoking related, 3 reaction to tablet, 2 time commitment, 1 other, 9 unspecified|51||
59823117|NCT00271024|75945938|FG002|COMPLETED|Overall Study|Discontinued: 5 smoking related, 4 reaction to tablet, 4 time commitment, 3 other, 4 unspecified|65||
59823118|NCT00271024|75945939|FG003|COMPLETED|Overall Study|Discontinued: 9 smoking related, 2 reaction to tablet, 4 time commitment, 1 other, 3 unspecified|64||
59823119|NCT00271024|75945936|FG000|NOT COMPLETED|Overall Study||22||
59823120|NCT00271024|75945937|FG001|NOT COMPLETED|Overall Study||26||
59823121|NCT00271024|75945938|FG002|NOT COMPLETED|Overall Study||23||
59823122|NCT00271024|75945939|FG003|NOT COMPLETED|Overall Study||24||
59823123|NCT00381693|75945949|FG000|STARTED|Overall Study||10||
59823124|NCT00381693|75945949|FG000|COMPLETED|Overall Study||2||
59823125|NCT00381693|75945949|FG000|NOT COMPLETED|Overall Study||8||
59823126|NCT00545363|75945955|FG000|STARTED|Overall Study||358||
59823127|NCT00545363|75945956|FG001|STARTED|Overall Study||358||
59823128|NCT00545363|75945955|FG000|Treated|Overall Study||354||
59823129|NCT00545363|75945956|FG001|Treated|Overall Study||357||
59823130|NCT00545363|75945955|FG000|COMPLETED|Overall Study||339||
59823131|NCT00545363|75945956|FG001|COMPLETED|Overall Study||343||
59823132|NCT00545363|75945955|FG000|NOT COMPLETED|Overall Study||19||
59823133|NCT00545363|75945956|FG001|NOT COMPLETED|Overall Study||15||
59823134|NCT00457392|75945964|FG000|STARTED|Overall Study||480||
59823135|NCT00457392|75945965|FG001|STARTED|Overall Study||480||
59823136|NCT00457392|75945964|FG000|Treated|Overall Study||473||
59823137|NCT00457392|75945965|FG001|Treated|Overall Study||477||
59823138|NCT00457392|75945964|FG000|COMPLETED|Overall Study||0||
59823139|NCT00457392|75945965|FG001|COMPLETED|Overall Study||0||
59823140|NCT00457392|75945964|FG000|NOT COMPLETED|Overall Study||480||
59823141|NCT00457392|75945965|FG001|NOT COMPLETED|Overall Study||480||
59823142|NCT00545051|75945973|FG000|STARTED|Overall Study||68||
59823143|NCT00545051|75945974|FG001|STARTED|Overall Study||72||
60112934|NCT01732913|76233361|FG001|STARTED|Overall Study||97||
60112935|NCT01732913|76233360|FG000|COMPLETED|Overall Study||42|Completed = reached primary efficacy endpoint of progressive disease or death|
60112936|NCT01732913|76233361|FG001|COMPLETED|Overall Study||28|Completed = reached primary efficacy endpoint of progressive disease or death|
60112937|NCT01732913|76233360|FG000|NOT COMPLETED|Overall Study||156||
60112938|NCT01732913|76233361|FG001|NOT COMPLETED|Overall Study||69||
60112939|NCT01918072|76233367|FG000|STARTED|Controlled Trial Step One - Six Months||11||
60112940|NCT01918072|76233368|FG001|STARTED|Controlled Trial Step One - Six Months||0||
59714809|NCT01198145|75833568|FG000|NOT COMPLETED|Overall Study||1||
59714810|NCT01198145|75833569|FG001|NOT COMPLETED|Overall Study||1||
59714811|NCT01197911|75833579|FG000|STARTED|Overall Study||18||
59714812|NCT01197911|75833580|FG001|STARTED|Overall Study||10||
59714813|NCT01197911|75833581|FG002|STARTED|Overall Study||10||
59714814|NCT01197911|75833579|FG000|COMPLETED|Overall Study||18||
59714815|NCT01197911|75833580|FG001|COMPLETED|Overall Study||10||
59714816|NCT01197911|75833581|FG002|COMPLETED|Overall Study||9||
59714817|NCT01197911|75833579|FG000|NOT COMPLETED|Overall Study||0||
59714818|NCT01197911|75833580|FG001|NOT COMPLETED|Overall Study||0||
59714819|NCT01197911|75833581|FG002|NOT COMPLETED|Overall Study||1||
59714820|NCT01197755|75833593|FG000|STARTED|Overall Study|Patients who received treatment|105||
59714821|NCT01197755|75833594|FG001|STARTED|Overall Study|Patients who received treatment|108||
59714822|NCT01197755|75833595|FG002|STARTED|Overall Study|Patients who received treatment|109||
59823144|NCT00545051|75945973|FG000|COMPLETED|Overall Study||59||
59823145|NCT00545051|75945974|FG001|COMPLETED|Overall Study||65||
59823146|NCT00545051|75945973|FG000|NOT COMPLETED|Overall Study||9||
59823147|NCT00545051|75945974|FG001|NOT COMPLETED|Overall Study||7||
60112941|NCT01918072|76233369|FG002|STARTED|Controlled Trial Step One - Six Months||0||
60112942|NCT01918072|76233367|FG000|Intervention|Controlled Trial Step One - Six Months||1|First primary care provider group steps into intervention|
59714823|NCT01197755|75833593|FG000|Randomised But Did Not Receive Treatment|Overall Study||0||
59714824|NCT01197755|75833594|FG001|Randomised But Did Not Receive Treatment|Overall Study||0||
59714825|NCT01197755|75833595|FG002|Randomised But Did Not Receive Treatment|Overall Study|Severe non-compliance to the protocol|1||
59823148|NCT00381615|75945984|FG000|STARTED|Overall Study||48||
59823149|NCT00381615|75945985|FG001|STARTED|Overall Study||50||
59823150|NCT00381615|75945986|FG002|STARTED|Overall Study||25||
59823151|NCT00381615|75945987|FG003|STARTED|Overall Study||24||
60112943|NCT01918072|76233368|FG001|Intervention|Controlled Trial Step One - Six Months||0|First primary care provider group steps into intervention|
60112944|NCT01918072|76233369|FG002|Intervention|Controlled Trial Step One - Six Months||0|First primary care provider group steps into intervention|
60112945|NCT01918072|76233367|FG000|Control|Controlled Trial Step One - Six Months||10||
60112946|NCT01918072|76233368|FG001|Control|Controlled Trial Step One - Six Months||0||
60112947|NCT01918072|76233369|FG002|Control|Controlled Trial Step One - Six Months||0||
60112948|NCT01918072|76233367|FG000|COMPLETED|Controlled Trial Step One - Six Months||11||
60112949|NCT01918072|76233368|FG001|COMPLETED|Controlled Trial Step One - Six Months||0||
60112950|NCT01918072|76233369|FG002|COMPLETED|Controlled Trial Step One - Six Months||0||
60112951|NCT01918072|76233367|FG000|NOT COMPLETED|Controlled Trial Step One - Six Months||0||
60112952|NCT01918072|76233368|FG001|NOT COMPLETED|Controlled Trial Step One - Six Months||0||
60112953|NCT01918072|76233369|FG002|NOT COMPLETED|Controlled Trial Step One - Six Months||0||
60112954|NCT01918072|76233367|FG000|STARTED|Controlled Trial Step Two - Six Months||11||
60112955|NCT01918072|76233368|FG001|STARTED|Controlled Trial Step Two - Six Months||0||
60112956|NCT01918072|76233369|FG002|STARTED|Controlled Trial Step Two - Six Months||0||
60112957|NCT01918072|76233367|FG000|Intervention|Controlled Trial Step Two - Six Months||7|Second primary care provider group steps into intervention|
60112958|NCT01918072|76233368|FG001|Intervention|Controlled Trial Step Two - Six Months||0|Second primary care provider group steps into intervention|
60112959|NCT01918072|76233369|FG002|Intervention|Controlled Trial Step Two - Six Months||0|Second primary care provider group steps into intervention|
60112960|NCT01918072|76233367|FG000|Control|Controlled Trial Step Two - Six Months||4||
60112961|NCT01918072|76233368|FG001|Control|Controlled Trial Step Two - Six Months||0||
60112962|NCT01918072|76233369|FG002|Control|Controlled Trial Step Two - Six Months||0||
60112963|NCT01918072|76233367|FG000|COMPLETED|Controlled Trial Step Two - Six Months||11||
60112964|NCT01918072|76233368|FG001|COMPLETED|Controlled Trial Step Two - Six Months||0||
60112965|NCT01918072|76233369|FG002|COMPLETED|Controlled Trial Step Two - Six Months||0||
60112966|NCT01918072|76233367|FG000|NOT COMPLETED|Controlled Trial Step Two - Six Months||0||
60112967|NCT01918072|76233368|FG001|NOT COMPLETED|Controlled Trial Step Two - Six Months||0||
60112968|NCT01918072|76233369|FG002|NOT COMPLETED|Controlled Trial Step Two - Six Months||0||
60112969|NCT01918072|76233367|FG000|STARTED|Controlled Trial Step Three - Six Months||11||
60112970|NCT01918072|76233368|FG001|STARTED|Controlled Trial Step Three - Six Months||0||
60112971|NCT01918072|76233369|FG002|STARTED|Controlled Trial Step Three - Six Months||0||
60112972|NCT01918072|76233367|FG000|Intervention|Controlled Trial Step Three - Six Months||9|Third primary care provider group steps into intervention|
60112973|NCT01918072|76233368|FG001|Intervention|Controlled Trial Step Three - Six Months||0|Third primary care provider group steps into intervention|
60112974|NCT01918072|76233369|FG002|Intervention|Controlled Trial Step Three - Six Months||0|Third primary care provider group steps into intervention|
60112975|NCT01918072|76233367|FG000|Control|Controlled Trial Step Three - Six Months||2||
60112976|NCT01918072|76233368|FG001|Control|Controlled Trial Step Three - Six Months||0||
60112977|NCT01918072|76233369|FG002|Control|Controlled Trial Step Three - Six Months||0||
60112978|NCT01918072|76233367|FG000|COMPLETED|Controlled Trial Step Three - Six Months||11||
60112979|NCT01918072|76233368|FG001|COMPLETED|Controlled Trial Step Three - Six Months||0||
60112980|NCT01918072|76233369|FG002|COMPLETED|Controlled Trial Step Three - Six Months||0||
60112981|NCT01918072|76233367|FG000|NOT COMPLETED|Controlled Trial Step Three - Six Months||0||
60112982|NCT01918072|76233368|FG001|NOT COMPLETED|Controlled Trial Step Three - Six Months||0||
60112983|NCT01918072|76233369|FG002|NOT COMPLETED|Controlled Trial Step Three - Six Months||0||
60112984|NCT01918072|76233367|FG000|STARTED|Controlled Trial Step Four - Six Months||11||
60112985|NCT01918072|76233368|FG001|STARTED|Controlled Trial Step Four - Six Months||0||
60112986|NCT01918072|76233369|FG002|STARTED|Controlled Trial Step Four - Six Months||0||
60112987|NCT01918072|76233367|FG000|Intervention|Controlled Trial Step Four - Six Months||11|Fourth primary care provider group steps into intervention|
60112988|NCT01918072|76233368|FG001|Intervention|Controlled Trial Step Four - Six Months||0|Fourth primary care provider group steps into intervention|
60112989|NCT01918072|76233369|FG002|Intervention|Controlled Trial Step Four - Six Months||0|Fourth primary care provider group steps into intervention|
60112990|NCT01918072|76233367|FG000|Control|Controlled Trial Step Four - Six Months||0||
60112991|NCT01918072|76233368|FG001|Control|Controlled Trial Step Four - Six Months||0||
60112992|NCT01918072|76233369|FG002|Control|Controlled Trial Step Four - Six Months||0||
60112993|NCT01918072|76233367|FG000|COMPLETED|Controlled Trial Step Four - Six Months||11||
60112994|NCT01918072|76233368|FG001|COMPLETED|Controlled Trial Step Four - Six Months||0||
60112995|NCT01918072|76233369|FG002|COMPLETED|Controlled Trial Step Four - Six Months||0||
59823152|NCT00381615|75945984|FG000|COMPLETED|Overall Study||44||
59823153|NCT00381615|75945985|FG001|COMPLETED|Overall Study||45||
59823154|NCT00381615|75945986|FG002|COMPLETED|Overall Study||24||
59567144|NCT00551642|75669982|FG001|Safety Population|Treatment Period||397||
59567145|NCT00551642|75669981|FG000|COMPLETED|Treatment Period||338||
59823155|NCT00381615|75945987|FG003|COMPLETED|Overall Study||22||
59823156|NCT00381615|75945984|FG000|NOT COMPLETED|Overall Study||4||
59823157|NCT00381615|75945985|FG001|NOT COMPLETED|Overall Study||5||
59823158|NCT00381615|75945986|FG002|NOT COMPLETED|Overall Study||1||
60112996|NCT01918072|76233367|FG000|NOT COMPLETED|Controlled Trial Step Four - Six Months||0||
60112997|NCT01918072|76233368|FG001|NOT COMPLETED|Controlled Trial Step Four - Six Months||0||
60112998|NCT01918072|76233369|FG002|NOT COMPLETED|Controlled Trial Step Four - Six Months||0||
60112999|NCT01918072|76233367|FG000|STARTED|Controlled Trial Step Five - Four Months||11||
60113000|NCT01918072|76233368|FG001|STARTED|Controlled Trial Step Five - Four Months||0||
60113001|NCT01918072|76233369|FG002|STARTED|Controlled Trial Step Five - Four Months||0||
60113002|NCT01918072|76233367|FG000|Intervention|Controlled Trial Step Five - Four Months||11|All primary care provider groups fully in intervention|
60113003|NCT01918072|76233368|FG001|Intervention|Controlled Trial Step Five - Four Months||0|All primary care provider groups fully in intervention|
60113004|NCT01918072|76233369|FG002|Intervention|Controlled Trial Step Five - Four Months||0|All primary care provider groups fully in intervention|
60113005|NCT01918072|76233367|FG000|Control|Controlled Trial Step Five - Four Months||0||
60113006|NCT01918072|76233368|FG001|Control|Controlled Trial Step Five - Four Months||0||
60113007|NCT01918072|76233369|FG002|Control|Controlled Trial Step Five - Four Months||0||
60113008|NCT01918072|76233367|FG000|COMPLETED|Controlled Trial Step Five - Four Months||11||
60113009|NCT01918072|76233368|FG001|COMPLETED|Controlled Trial Step Five - Four Months||0||
60113010|NCT01918072|76233369|FG002|COMPLETED|Controlled Trial Step Five - Four Months||0||
60113011|NCT01918072|76233367|FG000|NOT COMPLETED|Controlled Trial Step Five - Four Months||0||
60113012|NCT01918072|76233368|FG001|NOT COMPLETED|Controlled Trial Step Five - Four Months||0||
60113013|NCT01918072|76233369|FG002|NOT COMPLETED|Controlled Trial Step Five - Four Months||0||
60113014|NCT01918072|76233367|FG000|STARTED|E-consult Assessment Period||0||
60113015|NCT01918072|76233368|FG001|STARTED|E-consult Assessment Period||42||
60113016|NCT01918072|76233369|FG002|STARTED|E-consult Assessment Period||0||
60113017|NCT01918072|76233367|FG000|COMPLETED|E-consult Assessment Period||0||
60113018|NCT01918072|76233368|FG001|COMPLETED|E-consult Assessment Period||42||
60113019|NCT01918072|76233369|FG002|COMPLETED|E-consult Assessment Period||0||
60113020|NCT01918072|76233367|FG000|NOT COMPLETED|E-consult Assessment Period||0||
60113021|NCT01918072|76233368|FG001|NOT COMPLETED|E-consult Assessment Period||0||
60113022|NCT01918072|76233369|FG002|NOT COMPLETED|E-consult Assessment Period||0||
60113023|NCT01918072|76233367|FG000|STARTED|Quality Assessment Period||0||
60113024|NCT01918072|76233368|FG001|STARTED|Quality Assessment Period||0||
60113025|NCT01918072|76233369|FG002|STARTED|Quality Assessment Period||202||
60113026|NCT01918072|76233367|FG000|COMPLETED|Quality Assessment Period||0||
60113027|NCT01918072|76233368|FG001|COMPLETED|Quality Assessment Period||0||
60113028|NCT01918072|76233369|FG002|COMPLETED|Quality Assessment Period||202||
60113029|NCT01918072|76233367|FG000|NOT COMPLETED|Quality Assessment Period||0||
60113030|NCT01918072|76233368|FG001|NOT COMPLETED|Quality Assessment Period||0||
60113031|NCT01918072|76233369|FG002|NOT COMPLETED|Quality Assessment Period||0||
59567146|NCT00551642|75669982|FG001|COMPLETED|Treatment Period||338||
59567147|NCT00551642|75669981|FG000|NOT COMPLETED|Treatment Period||61||
59823159|NCT00381615|75945987|FG003|NOT COMPLETED|Overall Study||2||
60113032|NCT01920802|76233382|FG000|STARTED|Overall Study||11||
60113033|NCT01920802|76233383|FG001|STARTED|Overall Study||9||
60113034|NCT01920802|76233384|FG002|STARTED|Overall Study||11||
60113035|NCT01920802|76233382|FG000|COMPLETED|Overall Study||7||
59567148|NCT00551642|75669982|FG001|NOT COMPLETED|Treatment Period||63||
59567149|NCT00551642|75669981|FG000|STARTED|7-Year Follow-up||152|Participants with data available at 7-year Follow-up|
59567150|NCT00551642|75669982|FG001|STARTED|7-Year Follow-up||153|Participants with data available at 7-year Follow-up|
60113036|NCT01920802|76233383|FG001|COMPLETED|Overall Study||7||
60113037|NCT01920802|76233384|FG002|COMPLETED|Overall Study||10||
60113038|NCT01920802|76233382|FG000|NOT COMPLETED|Overall Study||4||
60113039|NCT01920802|76233383|FG001|NOT COMPLETED|Overall Study||2||
60113040|NCT01920802|76233384|FG002|NOT COMPLETED|Overall Study||1||
60113041|NCT01732835|76233392|FG000|STARTED|6-month Primary Endpoint||68||
60113042|NCT01732835|76233392|FG000|COMPLETED|6-month Primary Endpoint||44||
60113043|NCT01732835|76233392|FG000|NOT COMPLETED|6-month Primary Endpoint||24||
60113044|NCT01732835|76233392|FG000|STARTED|2-year Extended Follow-up||44||
60113045|NCT01732835|76233392|FG000|COMPLETED|2-year Extended Follow-up||39||
60113046|NCT01732835|76233392|FG000|NOT COMPLETED|2-year Extended Follow-up||5||
60113047|NCT01957384|76233396|FG000|STARTED|Test Period 1 (14 Days)||4||
60113048|NCT01957384|76233397|FG001|STARTED|Test Period 1 (14 Days)||4||
60113049|NCT01957384|76233398|FG002|STARTED|Test Period 1 (14 Days)||4||
60113050|NCT01957384|76233399|FG003|STARTED|Test Period 1 (14 Days)||4||
60113051|NCT01957384|76233400|FG004|STARTED|Test Period 1 (14 Days)||3||
60113052|NCT01957384|76233401|FG005|STARTED|Test Period 1 (14 Days)||3||
60113053|NCT01957384|76233396|FG000|COMPLETED|Test Period 1 (14 Days)||4||
60113054|NCT01957384|76233397|FG001|COMPLETED|Test Period 1 (14 Days)||4||
60113055|NCT01957384|76233398|FG002|COMPLETED|Test Period 1 (14 Days)||4||
60113056|NCT01957384|76233399|FG003|COMPLETED|Test Period 1 (14 Days)||4||
60113057|NCT01957384|76233400|FG004|COMPLETED|Test Period 1 (14 Days)||3||
60113058|NCT01957384|76233401|FG005|COMPLETED|Test Period 1 (14 Days)||3||
60113059|NCT01957384|76233396|FG000|NOT COMPLETED|Test Period 1 (14 Days)||0||
60113060|NCT01957384|76233397|FG001|NOT COMPLETED|Test Period 1 (14 Days)||0||
60113061|NCT01957384|76233398|FG002|NOT COMPLETED|Test Period 1 (14 Days)||0||
60113062|NCT01957384|76233399|FG003|NOT COMPLETED|Test Period 1 (14 Days)||0||
60113063|NCT01957384|76233400|FG004|NOT COMPLETED|Test Period 1 (14 Days)||0||
60113064|NCT01957384|76233401|FG005|NOT COMPLETED|Test Period 1 (14 Days)||0||
60113065|NCT01957384|76233396|FG000|STARTED|Test Period 2 (14 Days)||4||
60113066|NCT01957384|76233397|FG001|STARTED|Test Period 2 (14 Days)||4||
60113067|NCT01957384|76233398|FG002|STARTED|Test Period 2 (14 Days)||4||
60113068|NCT01957384|76233399|FG003|STARTED|Test Period 2 (14 Days)||4||
60113069|NCT01957384|76233400|FG004|STARTED|Test Period 2 (14 Days)||3||
60113070|NCT01957384|76233401|FG005|STARTED|Test Period 2 (14 Days)||3||
60113071|NCT01957384|76233396|FG000|COMPLETED|Test Period 2 (14 Days)||4||
60113072|NCT01957384|76233397|FG001|COMPLETED|Test Period 2 (14 Days)||4||
60113073|NCT01957384|76233398|FG002|COMPLETED|Test Period 2 (14 Days)||4||
60113074|NCT01957384|76233399|FG003|COMPLETED|Test Period 2 (14 Days)||4||
60113075|NCT01957384|76233400|FG004|COMPLETED|Test Period 2 (14 Days)||3||
60113076|NCT01957384|76233401|FG005|COMPLETED|Test Period 2 (14 Days)||3||
60113077|NCT01957384|76233396|FG000|NOT COMPLETED|Test Period 2 (14 Days)||0||
60113078|NCT01957384|76233397|FG001|NOT COMPLETED|Test Period 2 (14 Days)||0||
60113079|NCT01957384|76233398|FG002|NOT COMPLETED|Test Period 2 (14 Days)||0||
60113080|NCT01957384|76233399|FG003|NOT COMPLETED|Test Period 2 (14 Days)||0||
60113081|NCT01957384|76233400|FG004|NOT COMPLETED|Test Period 2 (14 Days)||0||
60113082|NCT01957384|76233401|FG005|NOT COMPLETED|Test Period 2 (14 Days)||0||
60113083|NCT01957384|76233396|FG000|STARTED|Test Period 3 (14 Days)||4||
60113084|NCT01957384|76233397|FG001|STARTED|Test Period 3 (14 Days)||4||
60113085|NCT01957384|76233398|FG002|STARTED|Test Period 3 (14 Days)||4||
60113086|NCT01957384|76233399|FG003|STARTED|Test Period 3 (14 Days)||4||
60113087|NCT01957384|76233400|FG004|STARTED|Test Period 3 (14 Days)||3||
60113088|NCT01957384|76233401|FG005|STARTED|Test Period 3 (14 Days)||3||
60113089|NCT01957384|76233396|FG000|COMPLETED|Test Period 3 (14 Days)||4||
60113090|NCT01957384|76233397|FG001|COMPLETED|Test Period 3 (14 Days)||4||
60113091|NCT01957384|76233398|FG002|COMPLETED|Test Period 3 (14 Days)||4||
60113092|NCT01957384|76233399|FG003|COMPLETED|Test Period 3 (14 Days)||4||
59714826|NCT01197755|75833593|FG000|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|67||
59714827|NCT01197755|75833594|FG001|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|65||
59714828|NCT01197755|75833595|FG002|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|55||
59823160|NCT00371865|75946001|FG000|STARTED|Overall Study||57||
59823161|NCT00371865|75946002|FG001|STARTED|Overall Study||57||
59823162|NCT00371865|75946001|FG000|COMPLETED|Overall Study|7 withdrew before starting the intervention. 8 withdrew after starting the intervention.|42||
59823163|NCT00371865|75946002|FG001|COMPLETED|Overall Study|8 withdrew before starting the intervention. 6 withdrew after starting the intervention.|43||
59823164|NCT00371865|75946001|FG000|NOT COMPLETED|Overall Study||15||
59823165|NCT00371865|75946002|FG001|NOT COMPLETED|Overall Study||14||
59823166|NCT00364845|75946010|FG000|STARTED|Overall Study||28||
59823167|NCT00364845|75946011|FG001|STARTED|Overall Study||23||
59823168|NCT00364845|75946010|FG000|COMPLETED|Overall Study|Completed 36-week titration/treatment phase|17||
59823169|NCT00364845|75946011|FG001|COMPLETED|Overall Study|Completed 36-week titration/treatment phase|12||
60113093|NCT01957384|76233400|FG004|COMPLETED|Test Period 3 (14 Days)||3||
60113094|NCT01957384|76233401|FG005|COMPLETED|Test Period 3 (14 Days)||3||
60113095|NCT01957384|76233396|FG000|NOT COMPLETED|Test Period 3 (14 Days)||0||
60113096|NCT01957384|76233397|FG001|NOT COMPLETED|Test Period 3 (14 Days)||0||
60113097|NCT01957384|76233398|FG002|NOT COMPLETED|Test Period 3 (14 Days)||0||
60113098|NCT01957384|76233399|FG003|NOT COMPLETED|Test Period 3 (14 Days)||0||
60113099|NCT01957384|76233400|FG004|NOT COMPLETED|Test Period 3 (14 Days)||0||
60113100|NCT01957384|76233401|FG005|NOT COMPLETED|Test Period 3 (14 Days)||0||
60113101|NCT01921894|76233412|FG000|STARTED|Overall Study||8||
60113102|NCT01921894|76233413|FG001|STARTED|Overall Study||8||
60113103|NCT01921894|76233414|FG002|STARTED|Overall Study||8||
60113104|NCT01921894|76233412|FG000|COMPLETED|Overall Study||8||
59714829|NCT01197755|75833593|FG000|NOT COMPLETED|Overall Study||38||
59714830|NCT01197755|75833594|FG001|NOT COMPLETED|Overall Study||43||
59714831|NCT01197755|75833595|FG002|NOT COMPLETED|Overall Study||54||
59714832|NCT01179048|75833607|FG000|STARTED|Overall Study||4668||
60113105|NCT01921894|76233413|FG001|COMPLETED|Overall Study||8||
60113106|NCT01921894|76233414|FG002|COMPLETED|Overall Study||8||
60113107|NCT01921894|76233412|FG000|NOT COMPLETED|Overall Study||0||
60113108|NCT01921894|76233413|FG001|NOT COMPLETED|Overall Study||0||
60113109|NCT01921894|76233414|FG002|NOT COMPLETED|Overall Study||0||
60113110|NCT01957930|76233437|FG000|STARTED|Overall Study||35||
60113111|NCT01957930|76233438|FG001|STARTED|Overall Study||37||
60113112|NCT01957930|76233439|FG002|STARTED|Overall Study||19||
60113113|NCT01957930|76233437|FG000|COMPLETED|Overall Study||35||
60113114|NCT01957930|76233438|FG001|COMPLETED|Overall Study||37||
60113115|NCT01957930|76233439|FG002|COMPLETED|Overall Study||19||
60113116|NCT01957930|76233437|FG000|NOT COMPLETED|Overall Study||0||
59823170|NCT00364845|75946010|FG000|NOT COMPLETED|Overall Study||11||
59823171|NCT00364845|75946011|FG001|NOT COMPLETED|Overall Study||11||
59823172|NCT00293722|75946017|FG000|STARTED|Overall Study||1291||
59823173|NCT00293722|75946017|FG000|COMPLETED|Overall Study||864||
59823174|NCT00293722|75946017|FG000|NOT COMPLETED|Overall Study||427||
59823175|NCT00381303|75946023|FG000|STARTED|Overall Study||287||
59823176|NCT00381303|75946024|FG001|STARTED|Overall Study||142||
59823177|NCT00381303|75946023|FG000|COMPLETED|Overall Study||193||
59823178|NCT00381303|75946024|FG001|COMPLETED|Overall Study||109||
59823179|NCT00381303|75946023|FG000|NOT COMPLETED|Overall Study||94||
59823180|NCT00381303|75946024|FG001|NOT COMPLETED|Overall Study||33||
59823181|NCT00448812|75946044|FG000|STARTED|Year 1||45||
59823182|NCT00448812|75946045|FG001|STARTED|Year 1||24||
59823183|NCT00448812|75946044|FG000|COMPLETED|Year 1||45||
59823184|NCT00448812|75946045|FG001|COMPLETED|Year 1||24||
59823185|NCT00448812|75946044|FG000|NOT COMPLETED|Year 1||0||
59823186|NCT00448812|75946045|FG001|NOT COMPLETED|Year 1||0||
59823187|NCT00448812|75946044|FG000|STARTED|Year 2||45||
59823188|NCT00448812|75946045|FG001|STARTED|Year 2||24||
59823189|NCT00448812|75946044|FG000|COMPLETED|Year 2||41||
59823190|NCT00448812|75946045|FG001|COMPLETED|Year 2||23||
59823191|NCT00448812|75946044|FG000|NOT COMPLETED|Year 2||4||
59823192|NCT00448812|75946045|FG001|NOT COMPLETED|Year 2||1||
59823193|NCT00448812|75946044|FG000|STARTED|Year 3||45||
59823194|NCT00448812|75946045|FG001|STARTED|Year 3||24||
59823195|NCT00448812|75946044|FG000|COMPLETED|Year 3||41||
59823196|NCT00448812|75946045|FG001|COMPLETED|Year 3||21||
59823197|NCT00448812|75946044|FG000|NOT COMPLETED|Year 3||4||
59823198|NCT00448812|75946045|FG001|NOT COMPLETED|Year 3||3||
59823199|NCT00448812|75946044|FG000|STARTED|Year 4||43||
59823200|NCT00448812|75946045|FG001|STARTED|Year 4|Control group subjects exited from study after completing Year 3 evaluation.|0||
59823201|NCT00448812|75946044|FG000|COMPLETED|Year 4||43||
59823202|NCT00448812|75946045|FG001|COMPLETED|Year 4|Control group subjects exited from study after completing Year 3 evaluation.|0||
59823203|NCT00448812|75946044|FG000|NOT COMPLETED|Year 4||0||
59823204|NCT00448812|75946045|FG001|NOT COMPLETED|Year 4||0||
59823205|NCT00448812|75946044|FG000|STARTED|Year 5||43||
59823206|NCT00448812|75946045|FG001|STARTED|Year 5|Control group subjects exited from study after completing Year 3 evaluation.|0||
59823207|NCT00448812|75946044|FG000|COMPLETED|Year 5||42||
59823208|NCT00448812|75946045|FG001|COMPLETED|Year 5|Control group subjects exited from study after completing Year 3 evaluation.|0||
59823209|NCT00448812|75946044|FG000|NOT COMPLETED|Year 5||1||
59823210|NCT00448812|75946045|FG001|NOT COMPLETED|Year 5||0||
59823211|NCT00364689|75946066|FG000|STARTED|Overall Study||13||
59823212|NCT00364689|75946066|FG000|COMPLETED|Overall Study||12||
59823213|NCT00364689|75946066|FG000|NOT COMPLETED|Overall Study||1||
59823214|NCT00545129|75946074|FG000|STARTED|Overall Study||29||
59823215|NCT00545129|75946075|FG001|STARTED|Overall Study||30||
59823216|NCT00545129|75946074|FG000|COMPLETED|Overall Study||12||
59823217|NCT00545129|75946075|FG001|COMPLETED|Overall Study||6||
59823218|NCT00545129|75946074|FG000|NOT COMPLETED|Overall Study||17||
59823219|NCT00545129|75946075|FG001|NOT COMPLETED|Overall Study||24||
59823220|NCT00364611|75946083|FG000|STARTED|Overall Study||52||
59823221|NCT00364611|75946084|FG001|STARTED|Overall Study||21||
59823222|NCT00364611|75946083|FG000|TREATED (SAFTEY POPULATION)|Overall Study|Received at least one dose of study medication|52||
59823223|NCT00364611|75946084|FG001|TREATED (SAFTEY POPULATION)|Overall Study|Received at least one dose of study medication|20||
59823224|NCT00364611|75946083|FG000|COMPLETED|Overall Study|Ongoing treatment (June 2011-initial analysis). Continued treatment till March 2012 (study closed).|1||
59823225|NCT00364611|75946084|FG001|COMPLETED|Overall Study||0||
59823226|NCT00364611|75946083|FG000|NOT COMPLETED|Overall Study||51||
59823227|NCT00364611|75946084|FG001|NOT COMPLETED|Overall Study||21||
59823228|NCT00364533|75946095|FG000|STARTED|Overall Study||77||
59823229|NCT00364533|75946096|FG001|STARTED|Overall Study||71||
59823230|NCT00364533|75946097|FG002|STARTED|Overall Study||75||
59823231|NCT00364533|75946098|FG003|STARTED|Overall Study||67||
59823232|NCT00364533|75946099|FG004|STARTED|Overall Study||75||
59823233|NCT00364533|75946095|FG000|COMPLETED|Overall Study||35||
59823234|NCT00364533|75946096|FG001|COMPLETED|Overall Study||31||
59823235|NCT00364533|75946097|FG002|COMPLETED|Overall Study||30||
59823236|NCT00364533|75946098|FG003|COMPLETED|Overall Study||36||
59823237|NCT00364533|75946099|FG004|COMPLETED|Overall Study||24||
59823238|NCT00364533|75946095|FG000|NOT COMPLETED|Overall Study||42||
59823239|NCT00364533|75946096|FG001|NOT COMPLETED|Overall Study||40||
59823240|NCT00364533|75946097|FG002|NOT COMPLETED|Overall Study||45||
59823241|NCT00364533|75946098|FG003|NOT COMPLETED|Overall Study||31||
59823242|NCT00364533|75946099|FG004|NOT COMPLETED|Overall Study||51||
59823243|NCT04006847|75946111|FG000|STARTED|Overall Study||1||
59823244|NCT04006847|75946111|FG000|COMPLETED|Overall Study||0||
59823245|NCT04006847|75946111|FG000|NOT COMPLETED|Overall Study||1||
59823246|NCT00544817|75946115|FG000|STARTED|Combined Modality||47||
59823247|NCT00544817|75946115|FG000|COMPLETED|Combined Modality||40||
59823248|NCT00544817|75946115|FG000|NOT COMPLETED|Combined Modality||7||
59823249|NCT00544817|75946115|FG000|STARTED|No Treatment Interval||40||
59823250|NCT00544817|75946115|FG000|COMPLETED|No Treatment Interval||28||
59823251|NCT00544817|75946115|FG000|NOT COMPLETED|No Treatment Interval||12||
59823252|NCT00544817|75946115|FG000|STARTED|Follow-up Systemic Therapy||28||
59823253|NCT00544817|75946115|FG000|COMPLETED|Follow-up Systemic Therapy||9||
59823254|NCT00544817|75946115|FG000|NOT COMPLETED|Follow-up Systemic Therapy||19||
59823255|NCT00289978|75946122|FG000|STARTED|Overall Study||429||
59823256|NCT00289978|75946123|FG001|STARTED|Overall Study||425||
59823257|NCT00289978|75946124|FG002|STARTED|Overall Study||418||
59823258|NCT00289978|75946122|FG000|COMPLETED|Overall Study|296 completed on study drug, 35 completed off study drug.|332||
59823259|NCT00289978|75946123|FG001|COMPLETED|Overall Study|345 completed on study drug, 24 completed off study drug.|369||
59823260|NCT00289978|75946124|FG002|COMPLETED|Overall Study|303 completed on study drug, 29 completed off study drug.|332||
59823261|NCT00289978|75946122|FG000|NOT COMPLETED|Overall Study||97||
59823262|NCT00289978|75946123|FG001|NOT COMPLETED|Overall Study||56||
59823263|NCT00289978|75946124|FG002|NOT COMPLETED|Overall Study||86||
59823264|NCT00543803|75946132|FG000|STARTED|Overall Study||334||
59823265|NCT00543803|75946132|FG000|COMPLETED|Overall Study||192||
59823266|NCT00543803|75946132|FG000|NOT COMPLETED|Overall Study||142||
59823267|NCT00542321|75946140|FG000|STARTED|Overall Study||8||
59823268|NCT00542321|75946141|FG001|STARTED|Overall Study||8||
59823269|NCT00542321|75946140|FG000|COMPLETED|Overall Study||8||
59823270|NCT00542321|75946141|FG001|COMPLETED|Overall Study||7||
59823271|NCT00542321|75946140|FG000|NOT COMPLETED|Overall Study||0||
59823272|NCT00542321|75946141|FG001|NOT COMPLETED|Overall Study||1||
59823273|NCT00289900|75946153|FG000|STARTED|Overall Study||297||
59823274|NCT00289900|75946154|FG001|STARTED|Overall Study||436||
59823275|NCT00289900|75946155|FG002|STARTED|Overall Study||298||
59823276|NCT00289900|75946156|FG003|STARTED|Overall Study||439||
59823277|NCT00289900|75946157|FG004|STARTED|Overall Study||437||
59823278|NCT00289900|75946158|FG005|STARTED|Overall Study||433||
59823279|NCT00289900|75946153|FG000|Treated|Overall Study||297||
59823280|NCT00289900|75946154|FG001|Treated|Overall Study||435||
59823281|NCT00289900|75946155|FG002|Treated|Overall Study||298||
59823282|NCT00289900|75946156|FG003|Treated|Overall Study||439||
59823283|NCT00289900|75946157|FG004|Treated|Overall Study||437||
59823284|NCT00289900|75946158|FG005|Treated|Overall Study||433||
59823285|NCT00289900|75946153|FG000|COMPLETED|Overall Study||229||
59823286|NCT00289900|75946154|FG001|COMPLETED|Overall Study||316||
59823287|NCT00289900|75946155|FG002|COMPLETED|Overall Study||265||
59823288|NCT00289900|75946156|FG003|COMPLETED|Overall Study||380||
59823289|NCT00289900|75946157|FG004|COMPLETED|Overall Study||392||
59823290|NCT00289900|75946158|FG005|COMPLETED|Overall Study||372||
59823291|NCT00289900|75946153|FG000|NOT COMPLETED|Overall Study||68||
59823292|NCT00289900|75946154|FG001|NOT COMPLETED|Overall Study||120||
59823293|NCT00289900|75946155|FG002|NOT COMPLETED|Overall Study||33||
59823294|NCT00289900|75946156|FG003|NOT COMPLETED|Overall Study||59||
59823295|NCT00289900|75946157|FG004|NOT COMPLETED|Overall Study||45||
59823296|NCT00289900|75946158|FG005|NOT COMPLETED|Overall Study||61||
59823297|NCT00543725|75946177|FG000|STARTED|Overall Study||340||
59823298|NCT00543725|75946178|FG001|STARTED|Overall Study||338||
59823299|NCT00543725|75946177|FG000|COMPLETED|Overall Study||272||
59823300|NCT00543725|75946178|FG001|COMPLETED|Overall Study||264||
59823301|NCT00543725|75946177|FG000|NOT COMPLETED|Overall Study||68||
59823302|NCT00543725|75946178|FG001|NOT COMPLETED|Overall Study||74||
59823303|NCT00269152|75946186|FG000|STARTED|Overall Study|One participant in Pemetrexed+Carboplatin actually received Pemetrexed+Cisplatin|63||
59823304|NCT00269152|75946187|FG001|STARTED|Overall Study|4 were randomized without receiving any study drug.|59||
59823305|NCT00269152|75946186|FG000|COMPLETED|Overall Study||45||
59823306|NCT00269152|75946187|FG001|COMPLETED|Overall Study||49||
59823307|NCT00269152|75946186|FG000|NOT COMPLETED|Overall Study||18||
59823308|NCT00269152|75946187|FG001|NOT COMPLETED|Overall Study||10||
59823309|NCT00379899|75946195|FG000|STARTED|Overall Study||180||
59823310|NCT00379899|75946196|FG001|STARTED|Overall Study||180||
59823311|NCT00379899|75946195|FG000|COMPLETED|Overall Study||140||
59823312|NCT00379899|75946196|FG001|COMPLETED|Overall Study||140||
59823313|NCT00379899|75946195|FG000|NOT COMPLETED|Overall Study||40||
59823314|NCT00379899|75946196|FG001|NOT COMPLETED|Overall Study||40||
59823315|NCT00371787|75946204|FG000|STARTED|Overall Study||26||
59823316|NCT00371787|75946205|FG001|STARTED|Overall Study||12||
59823317|NCT00371787|75946204|FG000|COMPLETED|Overall Study||23||
59823318|NCT00371787|75946205|FG001|COMPLETED|Overall Study||11||
60113117|NCT01957930|76233438|FG001|NOT COMPLETED|Overall Study||0||
59823319|NCT00371787|75946204|FG000|NOT COMPLETED|Overall Study||3||
60113118|NCT01957930|76233439|FG002|NOT COMPLETED|Overall Study||0||
60113119|NCT01759511|76233446|FG000|STARTED|Overall Study||34||
59823320|NCT00371787|75946205|FG001|NOT COMPLETED|Overall Study||1||
59823321|NCT00363129|75946213|FG000|STARTED|Overall Study||96||
59823322|NCT00363129|75946214|FG001|STARTED|Overall Study||93||
59823323|NCT00363129|75946213|FG000|COMPLETED|Overall Study||67||
59823324|NCT00363129|75946214|FG001|COMPLETED|Overall Study||60||
59823325|NCT00363129|75946213|FG000|NOT COMPLETED|Overall Study||29||
59823326|NCT00363129|75946214|FG001|NOT COMPLETED|Overall Study||33||
59823327|NCT00268996|75946222|FG000|STARTED|Overall Study||151||
59823328|NCT00268996|75946223|FG001|STARTED|Overall Study||172||
60113120|NCT01759511|76233446|FG000|COMPLETED|Overall Study||0||
60113121|NCT01759511|76233446|FG000|NOT COMPLETED|Overall Study||34||
59823329|NCT00268996|75946222|FG000|COMPLETED|Overall Study||130||
59823330|NCT00268996|75946223|FG001|COMPLETED|Overall Study||152||
59823331|NCT00268996|75946222|FG000|NOT COMPLETED|Overall Study||21||
59823332|NCT00268996|75946223|FG001|NOT COMPLETED|Overall Study||20||
59823333|NCT00371397|75946231|FG000|STARTED|Session 1||5||
59823334|NCT00371397|75946232|FG001|STARTED|Session 1||7||
59823335|NCT00371397|75946233|FG002|STARTED|Session 1||5||
59823336|NCT00371397|75946234|FG003|STARTED|Session 1||2||
59823337|NCT00371397|75946235|FG004|STARTED|Session 1||3||
59823338|NCT00371397|75946236|FG005|STARTED|Session 1||4||
59823339|NCT00371397|75946237|FG006|STARTED|Session 1||4||
59823340|NCT00371397|75946238|FG007|STARTED|Session 1||5||
59823341|NCT00371397|75946239|FG008|STARTED|Session 1||6||
59823342|NCT00371397|75946240|FG009|STARTED|Session 1||5||
59823343|NCT00371397|75946241|FG010|STARTED|Session 1||4||
59823344|NCT00371397|75946242|FG011|STARTED|Session 1||2||
59823345|NCT00371397|75946231|FG000|COMPLETED|Session 1||4||
59823346|NCT00371397|75946232|FG001|COMPLETED|Session 1||7||
59823347|NCT00371397|75946233|FG002|COMPLETED|Session 1||5||
59823348|NCT00371397|75946234|FG003|COMPLETED|Session 1||2||
59823349|NCT00371397|75946235|FG004|COMPLETED|Session 1||3||
59823350|NCT00371397|75946236|FG005|COMPLETED|Session 1||4||
59823351|NCT00371397|75946237|FG006|COMPLETED|Session 1||4||
59823352|NCT00371397|75946238|FG007|COMPLETED|Session 1||4||
59823353|NCT00371397|75946239|FG008|COMPLETED|Session 1||6||
59823354|NCT00371397|75946240|FG009|COMPLETED|Session 1||5||
59823355|NCT00371397|75946241|FG010|COMPLETED|Session 1||4||
59823356|NCT00371397|75946242|FG011|COMPLETED|Session 1||2||
59823357|NCT00371397|75946231|FG000|NOT COMPLETED|Session 1||1||
59823358|NCT00371397|75946232|FG001|NOT COMPLETED|Session 1||0||
59823359|NCT00371397|75946233|FG002|NOT COMPLETED|Session 1||0||
59823360|NCT00371397|75946234|FG003|NOT COMPLETED|Session 1||0||
59823361|NCT00371397|75946235|FG004|NOT COMPLETED|Session 1||0||
59823362|NCT00371397|75946236|FG005|NOT COMPLETED|Session 1||0||
59823363|NCT00371397|75946237|FG006|NOT COMPLETED|Session 1||0||
59823364|NCT00371397|75946238|FG007|NOT COMPLETED|Session 1||1||
59823365|NCT00371397|75946239|FG008|NOT COMPLETED|Session 1||0||
59823366|NCT00371397|75946240|FG009|NOT COMPLETED|Session 1||0||
59823367|NCT00371397|75946241|FG010|NOT COMPLETED|Session 1||0||
59823368|NCT00371397|75946242|FG011|NOT COMPLETED|Session 1||0||
59823369|NCT00371397|75946231|FG000|STARTED|Session 2||4||
59823370|NCT00371397|75946232|FG001|STARTED|Session 2||7||
59823371|NCT00371397|75946233|FG002|STARTED|Session 2||5||
59823372|NCT00371397|75946234|FG003|STARTED|Session 2||2||
59823373|NCT00371397|75946235|FG004|STARTED|Session 2||3||
59823374|NCT00371397|75946236|FG005|STARTED|Session 2||4||
59823375|NCT00371397|75946237|FG006|STARTED|Session 2||4||
59823376|NCT00371397|75946238|FG007|STARTED|Session 2||4||
59823377|NCT00371397|75946239|FG008|STARTED|Session 2||6||
59823378|NCT00371397|75946240|FG009|STARTED|Session 2||5||
59823379|NCT00371397|75946241|FG010|STARTED|Session 2||4||
59823380|NCT00371397|75946242|FG011|STARTED|Session 2||2||
59823381|NCT00371397|75946231|FG000|COMPLETED|Session 2||4||
59823382|NCT00371397|75946232|FG001|COMPLETED|Session 2||7||
59823383|NCT00371397|75946233|FG002|COMPLETED|Session 2||5||
59823384|NCT00371397|75946234|FG003|COMPLETED|Session 2||2||
59823385|NCT00371397|75946235|FG004|COMPLETED|Session 2||3||
59823386|NCT00371397|75946236|FG005|COMPLETED|Session 2||4||
59823387|NCT00371397|75946237|FG006|COMPLETED|Session 2||4||
59823388|NCT00371397|75946238|FG007|COMPLETED|Session 2||4||
59823389|NCT00371397|75946239|FG008|COMPLETED|Session 2||6||
59823390|NCT00371397|75946240|FG009|COMPLETED|Session 2||5||
59823391|NCT00371397|75946241|FG010|COMPLETED|Session 2||4||
59823392|NCT00371397|75946242|FG011|COMPLETED|Session 2||2||
59823393|NCT00371397|75946231|FG000|NOT COMPLETED|Session 2||0||
60113122|NCT01958320|76233452|FG000|STARTED|Overall Study||104||
60113123|NCT01958320|76233453|FG001|STARTED|Overall Study||98||
59823394|NCT00371397|75946232|FG001|NOT COMPLETED|Session 2||0||
59823395|NCT00371397|75946233|FG002|NOT COMPLETED|Session 2||0||
59823396|NCT00371397|75946234|FG003|NOT COMPLETED|Session 2||0||
59823397|NCT00371397|75946235|FG004|NOT COMPLETED|Session 2||0||
59823398|NCT00371397|75946236|FG005|NOT COMPLETED|Session 2||0||
59823399|NCT00371397|75946237|FG006|NOT COMPLETED|Session 2||0||
59823400|NCT00371397|75946238|FG007|NOT COMPLETED|Session 2||0||
60113124|NCT01958320|76233452|FG000|COMPLETED|Overall Study||104||
59823401|NCT00371397|75946239|FG008|NOT COMPLETED|Session 2||0||
59823402|NCT00371397|75946240|FG009|NOT COMPLETED|Session 2||0||
59823403|NCT00371397|75946241|FG010|NOT COMPLETED|Session 2||0||
59823404|NCT00371397|75946242|FG011|NOT COMPLETED|Session 2||0||
59823405|NCT00371397|75946231|FG000|STARTED|Session 3||4||
59823406|NCT00371397|75946232|FG001|STARTED|Session 3||7||
59823407|NCT00371397|75946233|FG002|STARTED|Session 3||5||
59823408|NCT00371397|75946234|FG003|STARTED|Session 3||2||
59823409|NCT00371397|75946235|FG004|STARTED|Session 3||3||
59823410|NCT00371397|75946236|FG005|STARTED|Session 3||4||
59823411|NCT00371397|75946237|FG006|STARTED|Session 3||4||
59823412|NCT00371397|75946238|FG007|STARTED|Session 3||4||
59823413|NCT00371397|75946239|FG008|STARTED|Session 3||6||
59823414|NCT00371397|75946240|FG009|STARTED|Session 3||5||
60113125|NCT01958320|76233453|FG001|COMPLETED|Overall Study||98||
60113126|NCT01958320|76233452|FG000|NOT COMPLETED|Overall Study||0||
59823415|NCT00371397|75946241|FG010|STARTED|Session 3||4||
59823416|NCT00371397|75946242|FG011|STARTED|Session 3||2||
59823417|NCT00371397|75946231|FG000|COMPLETED|Session 3||4||
59823418|NCT00371397|75946232|FG001|COMPLETED|Session 3||7||
59823419|NCT00371397|75946233|FG002|COMPLETED|Session 3||5||
59823420|NCT00371397|75946234|FG003|COMPLETED|Session 3||2||
59823421|NCT00371397|75946235|FG004|COMPLETED|Session 3||3||
59823422|NCT00371397|75946236|FG005|COMPLETED|Session 3||4||
59823423|NCT00371397|75946237|FG006|COMPLETED|Session 3||4||
59823424|NCT00371397|75946238|FG007|COMPLETED|Session 3||4||
59823425|NCT00371397|75946239|FG008|COMPLETED|Session 3||6||
59823426|NCT00371397|75946240|FG009|COMPLETED|Session 3||5||
59823427|NCT00371397|75946241|FG010|COMPLETED|Session 3||4||
59823428|NCT00371397|75946242|FG011|COMPLETED|Session 3||2||
59823429|NCT00371397|75946231|FG000|NOT COMPLETED|Session 3||0||
59823430|NCT00371397|75946232|FG001|NOT COMPLETED|Session 3||0||
59823431|NCT00371397|75946233|FG002|NOT COMPLETED|Session 3||0||
59823432|NCT00371397|75946234|FG003|NOT COMPLETED|Session 3||0||
59823433|NCT00371397|75946235|FG004|NOT COMPLETED|Session 3||0||
59823434|NCT00371397|75946236|FG005|NOT COMPLETED|Session 3||0||
59823435|NCT00371397|75946237|FG006|NOT COMPLETED|Session 3||0||
59823436|NCT00371397|75946238|FG007|NOT COMPLETED|Session 3||0||
59823437|NCT00371397|75946239|FG008|NOT COMPLETED|Session 3||0||
59823438|NCT00371397|75946240|FG009|NOT COMPLETED|Session 3||0||
59823439|NCT00371397|75946241|FG010|NOT COMPLETED|Session 3||0||
59823440|NCT00371397|75946242|FG011|NOT COMPLETED|Session 3||0||
59823441|NCT00379587|75946248|FG000|STARTED|Overall Study||65||
59823442|NCT00379587|75946248|FG000|COMPLETED|Overall Study||63||
59823443|NCT00379587|75946248|FG000|NOT COMPLETED|Overall Study||2||
59823444|NCT00289276|75946254|FG000|STARTED|First Part of FAST Study (Pivotal)|11 patients were re-consented under version 7 of the CIP, but are included in Pivotal results only|47||
59823445|NCT00289276|75946255|FG001|STARTED|First Part of FAST Study (Pivotal)||0||
59823446|NCT00289276|75946254|FG000|COMPLETED|First Part of FAST Study (Pivotal)||47||
59823447|NCT00289276|75946255|FG001|COMPLETED|First Part of FAST Study (Pivotal)||0||
59823448|NCT00289276|75946254|FG000|NOT COMPLETED|First Part of FAST Study (Pivotal)||0||
59823449|NCT00289276|75946255|FG001|NOT COMPLETED|First Part of FAST Study (Pivotal)||0||
59823450|NCT00289276|75946254|FG000|STARTED|Second Part of FAST Study (Expansion)||0||
59823451|NCT00289276|75946255|FG001|STARTED|Second Part of FAST Study (Expansion)||109||
59823452|NCT00289276|75946254|FG000|COMPLETED|Second Part of FAST Study (Expansion)||0||
59823453|NCT00289276|75946255|FG001|COMPLETED|Second Part of FAST Study (Expansion)||106||
59823454|NCT00289276|75946254|FG000|NOT COMPLETED|Second Part of FAST Study (Expansion)||0||
59823455|NCT00289276|75946255|FG001|NOT COMPLETED|Second Part of FAST Study (Expansion)||3||
59823456|NCT00289198|75946263|FG000|STARTED|Overall Study||151||
59823457|NCT00289198|75946264|FG001|STARTED|Overall Study||151||
59823458|NCT00289198|75946263|FG000|COMPLETED|Overall Study||120||
59823459|NCT00289198|75946264|FG001|COMPLETED|Overall Study||121||
59823460|NCT00289198|75946263|FG000|NOT COMPLETED|Overall Study||31||
59823461|NCT00289198|75946264|FG001|NOT COMPLETED|Overall Study||30||
59823462|NCT00363051|75946273|FG000|STARTED|Overall Study||115||
59823463|NCT00363051|75946274|FG001|STARTED|Overall Study||45||
59823464|NCT00363051|75946273|FG000|COMPLETED|Overall Study|Patients with documented disease progression per RECIST criteria|77||
60113127|NCT01958320|76233453|FG001|NOT COMPLETED|Overall Study||0||
59823465|NCT00363051|75946274|FG001|COMPLETED|Overall Study||23||
59823466|NCT00363051|75946273|FG000|NOT COMPLETED|Overall Study||38||
59823467|NCT00363051|75946274|FG001|NOT COMPLETED|Overall Study||22||
59823468|NCT00379353|75946284|FG000|STARTED|Overall Study||16||
59823469|NCT00379353|75946285|FG001|STARTED|Overall Study||15||
59823470|NCT00379353|75946284|FG000|COMPLETED|Overall Study||5||
59823471|NCT00379353|75946285|FG001|COMPLETED|Overall Study||9||
59823472|NCT00379353|75946284|FG000|NOT COMPLETED|Overall Study||11||
59823473|NCT00379353|75946285|FG001|NOT COMPLETED|Overall Study||6||
59823474|NCT00378573|75946301|FG000|STARTED|Treatment Period||17||
60113128|NCT01732757|76233464|FG000|STARTED|Overall Study||53||
60113129|NCT01732757|76233465|FG001|STARTED|Overall Study||52||
60113130|NCT01732757|76233466|FG002|STARTED|Overall Study||52||
60113131|NCT01732757|76233464|FG000|COMPLETED|Overall Study||52||
60113132|NCT01732757|76233465|FG001|COMPLETED|Overall Study||52||
59823475|NCT00378573|75946301|FG000|COMPLETED|Treatment Period|Patients who did not complete treatment moved directly to the follow-up phase of the study.|0||
59823476|NCT00378573|75946301|FG000|NOT COMPLETED|Treatment Period||17||
59823477|NCT00378573|75946301|FG000|STARTED|Follow-up||17||
59823478|NCT00378573|75946301|FG000|COMPLETED|Follow-up||3||
59823479|NCT00378573|75946301|FG000|NOT COMPLETED|Follow-up||14||
59823480|NCT03831945|75946307|FG000|STARTED|Overall Study||10||
59823481|NCT03831945|75946308|FG001|STARTED|Overall Study||10||
59823482|NCT03831945|75946307|FG000|COMPLETED|Overall Study||3||
59823483|NCT03831945|75946308|FG001|COMPLETED|Overall Study||4||
59823484|NCT03831945|75946307|FG000|NOT COMPLETED|Overall Study||7||
59823485|NCT03831945|75946308|FG001|NOT COMPLETED|Overall Study||6||
59823486|NCT00457002|75946316|FG000|STARTED|Overall Study||3255||
59823487|NCT00457002|75946317|FG001|STARTED|Overall Study||3273||
59823488|NCT00457002|75946316|FG000|COMPLETED|Overall Study||2442||
60113133|NCT01732757|76233466|FG002|COMPLETED|Overall Study||52||
59823489|NCT00457002|75946317|FG001|COMPLETED|Overall Study||2516||
59823490|NCT00457002|75946316|FG000|NOT COMPLETED|Overall Study||813||
59823491|NCT00457002|75946317|FG001|NOT COMPLETED|Overall Study||757||
59823492|NCT00362115|75946330|FG000|STARTED|Overall Study||65||
59823493|NCT00362115|75946331|FG001|STARTED|Overall Study|1 participant failed to receive double-blind medication.|65||
59823494|NCT00362115|75946332|FG002|STARTED|Overall Study||64||
59823495|NCT00362115|75946333|FG003|STARTED|Overall Study|1 participant failed to receive double-blind medication.|63||
59823496|NCT00362115|75946334|FG004|STARTED|Overall Study||64||
60113134|NCT01732757|76233464|FG000|NOT COMPLETED|Overall Study||1||
60113135|NCT01732757|76233465|FG001|NOT COMPLETED|Overall Study||0||
60113136|NCT01732757|76233466|FG002|NOT COMPLETED|Overall Study||0||
60113137|NCT01758731|76233474|FG000|STARTED|Overall Study||17||
60113138|NCT01758731|76233474|FG000|COMPLETED|Overall Study||16||
59567151|NCT00551642|75669981|FG000|COMPLETED|7-Year Follow-up||152||
59567152|NCT00551642|75669982|FG001|COMPLETED|7-Year Follow-up||153||
59567153|NCT00551642|75669981|FG000|NOT COMPLETED|7-Year Follow-up||0||
59823497|NCT00362115|75946335|FG005|STARTED|Overall Study|1 participant failed to receive double-blind medication.|64||
59567154|NCT00551642|75669982|FG001|NOT COMPLETED|7-Year Follow-up||0||
59567155|NCT03040323|75669990|FG000|STARTED|Overall Study|No information available regarding how many participants Started and Completed the study in each arm|0||
59823498|NCT00362115|75946336|FG006|STARTED|Overall Study|1 participant failed to receive double-blind medication.|64||
60113139|NCT01758731|76233474|FG000|NOT COMPLETED|Overall Study||1||
60113140|NCT04168775|76233478|FG000|STARTED|Overall Study||80||
60113141|NCT04168775|76233478|FG000|COMPLETED|Overall Study||75||
60113142|NCT04168775|76233478|FG000|NOT COMPLETED|Overall Study||5||
60113143|NCT01606319|76233484|FG000|STARTED|Overall Study||150||
60113144|NCT01606319|76233485|FG001|STARTED|Overall Study||150||
60113145|NCT01606319|76233484|FG000|COMPLETED|Overall Study||116||
60113146|NCT01606319|76233485|FG001|COMPLETED|Overall Study||110||
60113147|NCT01606319|76233484|FG000|NOT COMPLETED|Overall Study||34||
60113148|NCT01606319|76233485|FG001|NOT COMPLETED|Overall Study||40||
60113149|NCT01757405|76233493|FG000|STARTED|Overall Study||18||
60113150|NCT01757405|76233494|FG001|STARTED|Overall Study||20||
60113151|NCT01757405|76233493|FG000|COMPLETED|Overall Study||17||
60113152|NCT01757405|76233494|FG001|COMPLETED|Overall Study||18||
60113153|NCT01757405|76233493|FG000|NOT COMPLETED|Overall Study||1||
60113154|NCT01757405|76233494|FG001|NOT COMPLETED|Overall Study||2||
60113155|NCT01455597|76233500|FG000|STARTED|Overall Study||101||
60113156|NCT01455597|76233501|FG001|STARTED|Overall Study||56||
60113157|NCT01455597|76233502|FG002|STARTED|Overall Study||100||
60113158|NCT01455597|76233503|FG003|STARTED|Overall Study||52||
60113159|NCT01455597|76233500|FG000|All-Participants-Treated Population|Overall Study||101|All enrolled participants who received at least 1 dose of study drug in Study PR-04509.|
60113160|NCT01455597|76233501|FG001|All-Participants-Treated Population|Overall Study||56|All enrolled participants who received at least 1 dose of study drug in Study PR-04509.|
60113161|NCT01455597|76233502|FG002|All-Participants-Treated Population|Overall Study||99|All enrolled participants who received at least 1 dose of study drug in Study PR-04509.|
60113162|NCT01455597|76233503|FG003|All-Participants-Treated Population|Overall Study||52|All enrolled participants who received at least 1 dose of study drug in Study PR-04509.|
60113163|NCT01455597|76233500|FG000|COMPLETED|Overall Study||84||
60113164|NCT01455597|76233501|FG001|COMPLETED|Overall Study||48||
60113165|NCT01455597|76233502|FG002|COMPLETED|Overall Study||80||
60113166|NCT01455597|76233503|FG003|COMPLETED|Overall Study||42||
60113167|NCT01455597|76233500|FG000|NOT COMPLETED|Overall Study||17||
60113168|NCT01455597|76233501|FG001|NOT COMPLETED|Overall Study||8||
60113169|NCT01455597|76233502|FG002|NOT COMPLETED|Overall Study||20||
60113170|NCT01455597|76233503|FG003|NOT COMPLETED|Overall Study||10||
60113171|NCT01453101|76233515|FG000|STARTED|Overall Study||54||
60113172|NCT01453101|76233515|FG000|COMPLETED|Overall Study||54||
60113173|NCT01453101|76233515|FG000|NOT COMPLETED|Overall Study||0||
60113174|NCT02085447|76233519|FG000|STARTED|Overall Study||30||
60113175|NCT02085447|76233519|FG000|COMPLETED|Overall Study||26||
60113176|NCT02085447|76233519|FG000|NOT COMPLETED|Overall Study||4||
60113177|NCT01757171|76233526|FG000|STARTED|Overall Study||61||
60113178|NCT01757171|76233527|FG001|STARTED|Overall Study||24||
60113179|NCT01757171|76233526|FG000|COMPLETED|Overall Study||53||
60113180|NCT01757171|76233527|FG001|COMPLETED|Overall Study||23||
60113181|NCT01757171|76233526|FG000|NOT COMPLETED|Overall Study||8||
60113182|NCT01757171|76233527|FG001|NOT COMPLETED|Overall Study||1||
60113183|NCT01756235|76233533|FG000|STARTED|Overall Study||462||
60113184|NCT01756235|76233533|FG000|COMPLETED|Overall Study||460||
60113185|NCT01756235|76233533|FG000|NOT COMPLETED|Overall Study||2||
60113186|NCT01730729|76233537|FG000|STARTED|Overall Study||20||
60113187|NCT01730729|76233537|FG000|Completed 2 Cycles/Reached 1st Response|Overall Study||18||
60113188|NCT01730729|76233537|FG000|Treated Cycle 3 and Beyond|Overall Study||6||
60113189|NCT01730729|76233537|FG000|COMPLETED|Overall Study||6|Patients treated until progressive disease, unacceptable toxicity, or withdrawal from study|
60113190|NCT01730729|76233537|FG000|NOT COMPLETED|Overall Study||14||
60113191|NCT01756157|76233541|FG000|STARTED|First Intervention Period||23||
60113192|NCT01756157|76233542|FG001|STARTED|First Intervention Period||24||
59714833|NCT01179048|75833608|FG001|STARTED|Overall Study||4672||
60113193|NCT01756157|76233541|FG000|COMPLETED|First Intervention Period||22||
60113194|NCT01756157|76233542|FG001|COMPLETED|First Intervention Period||22||
60113195|NCT01756157|76233541|FG000|NOT COMPLETED|First Intervention Period||1||
60113196|NCT01756157|76233542|FG001|NOT COMPLETED|First Intervention Period||2||
60113197|NCT01756157|76233541|FG000|STARTED|Washout Period (at Least 7 Days)||22||
60113198|NCT01756157|76233542|FG001|STARTED|Washout Period (at Least 7 Days)||22||
60113199|NCT01756157|76233541|FG000|COMPLETED|Washout Period (at Least 7 Days)||22||
60113200|NCT01756157|76233542|FG001|COMPLETED|Washout Period (at Least 7 Days)||22||
60113201|NCT01756157|76233541|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||0||
60113202|NCT01756157|76233542|FG001|NOT COMPLETED|Washout Period (at Least 7 Days)||0||
60113203|NCT01756157|76233541|FG000|STARTED|Second Intervention Period||22||
60113204|NCT01756157|76233542|FG001|STARTED|Second Intervention Period||22||
60113205|NCT01756157|76233541|FG000|COMPLETED|Second Intervention Period||22||
60113206|NCT01756157|76233542|FG001|COMPLETED|Second Intervention Period||22||
60113207|NCT01756157|76233541|FG000|NOT COMPLETED|Second Intervention Period||0||
60113208|NCT01756157|76233542|FG001|NOT COMPLETED|Second Intervention Period||0||
60113209|NCT01756079|76233548|FG000|STARTED|Lead-in: Day 0 to Week 4||58||
60113210|NCT01756079|76233548|FG000|COMPLETED|Lead-in: Day 0 to Week 4||58||
60113211|NCT01756079|76233548|FG000|NOT COMPLETED|Lead-in: Day 0 to Week 4||0||
60113212|NCT01756079|76233548|FG000|STARTED|Treatment / Follow-up: Week 4 to Week 72||58||
60113213|NCT01756079|76233548|FG000|Treated in Treatment Period|Treatment / Follow-up: Week 4 to Week 72||54||
60113214|NCT01756079|76233548|FG000|COMPLETED|Treatment / Follow-up: Week 4 to Week 72||23||
60113215|NCT01756079|76233548|FG000|NOT COMPLETED|Treatment / Follow-up: Week 4 to Week 72||35||
60113216|NCT04967885|76233555|FG000|STARTED|Week 1 Follow-Up||39||
60113217|NCT04967885|76233556|FG001|STARTED|Week 1 Follow-Up||41||
60113218|NCT04967885|76233555|FG000|COMPLETED|Week 1 Follow-Up||32||
60113219|NCT04967885|76233556|FG001|COMPLETED|Week 1 Follow-Up||37||
60113220|NCT04967885|76233555|FG000|NOT COMPLETED|Week 1 Follow-Up||7||
60113221|NCT04967885|76233556|FG001|NOT COMPLETED|Week 1 Follow-Up||4||
60113222|NCT04967885|76233555|FG000|STARTED|Week 2 Follow-Up||39|If participants missed a follow-up, they were able to complete subsequent follow-ups.|
60113223|NCT04967885|76233556|FG001|STARTED|Week 2 Follow-Up||41|If participants missed a follow-up, they were able to complete subsequent follow-ups.|
60113224|NCT04967885|76233555|FG000|COMPLETED|Week 2 Follow-Up||25||
60113225|NCT04967885|76233556|FG001|COMPLETED|Week 2 Follow-Up||35||
60113226|NCT04967885|76233555|FG000|NOT COMPLETED|Week 2 Follow-Up||14||
60113227|NCT04967885|76233556|FG001|NOT COMPLETED|Week 2 Follow-Up||6||
59714834|NCT01179048|75833607|FG000|COMPLETED|Overall Study||4529||
59823499|NCT00362115|75946330|FG000|COMPLETED|Overall Study||63||
60113228|NCT04967885|76233555|FG000|STARTED|Week 3 Follow-Up||39||
60113229|NCT04967885|76233556|FG001|STARTED|Week 3 Follow-Up||41||
59714835|NCT01179048|75833608|FG001|COMPLETED|Overall Study||4513||
59714836|NCT01179048|75833607|FG000|NOT COMPLETED|Overall Study||139||
60113230|NCT04967885|76233555|FG000|COMPLETED|Week 3 Follow-Up||23||
60113231|NCT04967885|76233556|FG001|COMPLETED|Week 3 Follow-Up||30||
60113232|NCT04967885|76233555|FG000|NOT COMPLETED|Week 3 Follow-Up||16||
60113233|NCT04967885|76233556|FG001|NOT COMPLETED|Week 3 Follow-Up||11||
60113234|NCT04967885|76233555|FG000|STARTED|Week 4 Follow-Up||39||
60113235|NCT04967885|76233556|FG001|STARTED|Week 4 Follow-Up||41||
60113236|NCT04967885|76233555|FG000|COMPLETED|Week 4 Follow-Up||23||
60113237|NCT04967885|76233556|FG001|COMPLETED|Week 4 Follow-Up||31||
60113238|NCT04967885|76233555|FG000|NOT COMPLETED|Week 4 Follow-Up||16||
60113239|NCT04967885|76233556|FG001|NOT COMPLETED|Week 4 Follow-Up||10||
60113240|NCT04967885|76233555|FG000|STARTED|EMI-II Intervention||39||
60113241|NCT04967885|76233556|FG001|STARTED|EMI-II Intervention||41||
60113242|NCT04967885|76233555|FG000|COMPLETED|EMI-II Intervention||25||
60113243|NCT04967885|76233556|FG001|COMPLETED|EMI-II Intervention||31||
60113244|NCT04967885|76233555|FG000|NOT COMPLETED|EMI-II Intervention||14||
60113245|NCT04967885|76233556|FG001|NOT COMPLETED|EMI-II Intervention||10||
60113246|NCT04831047|76233564|FG000|STARTED|Overall Study||57||
60113247|NCT04831047|76233565|FG001|STARTED|Overall Study||57||
60113248|NCT04831047|76233564|FG000|COMPLETED|Overall Study||57||
60113249|NCT04831047|76233565|FG001|COMPLETED|Overall Study||57||
60113250|NCT04831047|76233564|FG000|NOT COMPLETED|Overall Study||0||
60113251|NCT04831047|76233565|FG001|NOT COMPLETED|Overall Study||0||
60113252|NCT04571060|76233573|FG000|STARTED|Overall Study||703|Randomized|
60113253|NCT04571060|76233574|FG001|STARTED|Overall Study||702|Randomized|
60113254|NCT04571060|76233573|FG000|Treated|Overall Study||629||
60113255|NCT04571060|76233574|FG001|Treated|Overall Study||653||
60113256|NCT04571060|76233573|FG000|Efficacy Analysis Set Participants|Overall Study||623|Treated participants who were randomized only once, had a migraine of moderate or severe pain intensity at the time of dosing, were treated with study drug, and had post-dose efficacy data|
60113257|NCT04571060|76233574|FG001|Efficacy Analysis Set Participants|Overall Study||646|Treated participants who were randomized only once, had a migraine of moderate or severe pain intensity at the time of dosing, were treated with study drug, and had post-dose efficacy data|
60113258|NCT04571060|76233573|FG000|COMPLETED|Overall Study|Participants who were randomized, received the study drug and completed the study.|622||
60113259|NCT04571060|76233574|FG001|COMPLETED|Overall Study|Participants who were randomized, received the study drug and completed the study.|653||
60113260|NCT04571060|76233573|FG000|NOT COMPLETED|Overall Study||81||
60113261|NCT04571060|76233574|FG001|NOT COMPLETED|Overall Study||49||
60113262|NCT04512066|76233584|FG000|STARTED|Double-blind Treatment Period||73||
60113263|NCT04512066|76233585|FG001|STARTED|Double-blind Treatment Period||71||
60113264|NCT04512066|76233586|FG002|STARTED|Double-blind Treatment Period||69||
60113265|NCT04512066|76233587|FG003|STARTED|Double-blind Treatment Period||74||
60113266|NCT04512066|76233588|FG004|STARTED|Double-blind Treatment Period||0||
60113267|NCT04512066|76233589|FG005|STARTED|Double-blind Treatment Period||0||
60113268|NCT04512066|76233584|FG000|COMPLETED|Double-blind Treatment Period||56||
60113269|NCT04512066|76233585|FG001|COMPLETED|Double-blind Treatment Period||55||
59567156|NCT03040323|75669991|FG001|STARTED|Overall Study|No information available regarding how many participants Started and Completed the study in each arm|0||
59567157|NCT03040323|75669990|FG000|COMPLETED|Overall Study||0||
60113270|NCT04512066|76233586|FG002|COMPLETED|Double-blind Treatment Period||53||
60113271|NCT04512066|76233587|FG003|COMPLETED|Double-blind Treatment Period||60||
60113272|NCT04512066|76233588|FG004|COMPLETED|Double-blind Treatment Period||0||
60113273|NCT04512066|76233589|FG005|COMPLETED|Double-blind Treatment Period||0||
60113274|NCT04512066|76233584|FG000|NOT COMPLETED|Double-blind Treatment Period||17||
60113275|NCT04512066|76233585|FG001|NOT COMPLETED|Double-blind Treatment Period||16||
60113276|NCT04512066|76233586|FG002|NOT COMPLETED|Double-blind Treatment Period||16||
60113277|NCT04512066|76233587|FG003|NOT COMPLETED|Double-blind Treatment Period||14||
60113278|NCT04512066|76233588|FG004|NOT COMPLETED|Double-blind Treatment Period||0||
60113279|NCT04512066|76233589|FG005|NOT COMPLETED|Double-blind Treatment Period||0||
60113280|NCT04512066|76233584|FG000|STARTED|Extension Period||0||
60113281|NCT04512066|76233585|FG001|STARTED|Extension Period||44||
60113282|NCT04512066|76233586|FG002|STARTED|Extension Period||46||
60113283|NCT04512066|76233587|FG003|STARTED|Extension Period||56||
60113284|NCT04512066|76233588|FG004|STARTED|Extension Period||25||
60113285|NCT04512066|76233589|FG005|STARTED|Extension Period||26||
60113286|NCT04512066|76233584|FG000|COMPLETED|Extension Period||0||
60113287|NCT04512066|76233585|FG001|COMPLETED|Extension Period||30||
60113288|NCT04512066|76233586|FG002|COMPLETED|Extension Period||26||
60113289|NCT04512066|76233587|FG003|COMPLETED|Extension Period||38||
60113290|NCT04512066|76233588|FG004|COMPLETED|Extension Period||9||
60113291|NCT04512066|76233589|FG005|COMPLETED|Extension Period||12||
60113292|NCT04512066|76233584|FG000|NOT COMPLETED|Extension Period||0||
60113293|NCT04512066|76233585|FG001|NOT COMPLETED|Extension Period||14||
60113294|NCT04512066|76233586|FG002|NOT COMPLETED|Extension Period||20||
60113295|NCT04512066|76233587|FG003|NOT COMPLETED|Extension Period||18||
60113296|NCT04512066|76233588|FG004|NOT COMPLETED|Extension Period||16||
60113297|NCT04512066|76233589|FG005|NOT COMPLETED|Extension Period||14||
60113298|NCT04426318|76233611|FG000|STARTED|Overall Study||346||
60113299|NCT04426318|76233612|FG001|STARTED|Overall Study||320||
60113300|NCT04426318|76233611|FG000|Failed Attention Checks|Overall Study||4||
60113301|NCT04426318|76233612|FG001|Failed Attention Checks|Overall Study||6||
60113302|NCT04426318|76233611|FG000|Downloaded HMP App|Overall Study||329||
60113303|NCT04426318|76233612|FG001|Downloaded HMP App|Overall Study||0||
60113304|NCT04426318|76233611|FG000|Completed T2 Assessment|Overall Study||281||
60113305|NCT04426318|76233612|FG001|Completed T2 Assessment|Overall Study||280||
60113306|NCT04426318|76233611|FG000|Completed T3 Assessment|Overall Study||261||
60113307|NCT04426318|76233612|FG001|Completed T3 Assessment|Overall Study||274||
60113308|NCT04426318|76233611|FG000|Completed T4 Assessment|Overall Study||261||
60113309|NCT04426318|76233612|FG001|Completed T4 Assessment|Overall Study||275||
60113310|NCT04426318|76233611|FG000|Completed T5 Assessment|Overall Study||284||
60113311|NCT04426318|76233612|FG001|Completed T5 Assessment|Overall Study||293||
60113312|NCT04426318|76233611|FG000|Completed T6 Assessment|Overall Study||286||
60113313|NCT04426318|76233612|FG001|Completed T6 Assessment|Overall Study||293||
60113314|NCT04426318|76233611|FG000|Final Intent to Treat Sample|Overall Study||344||
60113315|NCT04426318|76233612|FG001|Final Intent to Treat Sample|Overall Study||318||
60113316|NCT04426318|76233611|FG000|COMPLETED|Overall Study||344||
60113317|NCT04426318|76233612|FG001|COMPLETED|Overall Study||318||
60113318|NCT04426318|76233611|FG000|NOT COMPLETED|Overall Study||2||
60113319|NCT04426318|76233612|FG001|NOT COMPLETED|Overall Study||2||
60113320|NCT04397614|76233620|FG000|STARTED|Overall Study||121||
60113321|NCT04397614|76233621|FG001|STARTED|Overall Study||7||
60113322|NCT04397614|76233620|FG000|COMPLETED|Overall Study||57||
60113323|NCT04397614|76233621|FG001|COMPLETED|Overall Study||4||
60113324|NCT04397614|76233620|FG000|NOT COMPLETED|Overall Study||64||
60113325|NCT04397614|76233621|FG001|NOT COMPLETED|Overall Study||3||
60113326|NCT04356963|76233627|FG000|STARTED|First Session||60||
60113327|NCT04356963|76233627|FG000|Completed VR Blu|First Session||21||
60113328|NCT04356963|76233627|FG000|Completed Tablet Blu|First Session||19||
60113329|NCT04356963|76233627|FG000|Completed VR Blank|First Session||19||
60113330|NCT04356963|76233627|FG000|COMPLETED|First Session||59||
60113331|NCT04356963|76233627|FG000|NOT COMPLETED|First Session||1||
60113332|NCT04356963|76233627|FG000|STARTED|Second Session||59||
60113333|NCT04356963|76233627|FG000|Completed VR Blu|Second Session||17||
60113334|NCT04356963|76233627|FG000|Completed Tablet Blu|Second Session||23||
60113335|NCT04356963|76233627|FG000|Completed VR Blank|Second Session||15||
60113336|NCT04356963|76233627|FG000|COMPLETED|Second Session||55||
60113337|NCT04356963|76233627|FG000|NOT COMPLETED|Second Session||4||
60113338|NCT04356963|76233627|FG000|STARTED|Third Session||55||
60113339|NCT04356963|76233627|FG000|Completed VR Blu|Third Session||14||
60113340|NCT04356963|76233627|FG000|Completed Tablet Blu|Third Session||12||
60113341|NCT04356963|76233627|FG000|Completed VR Blank|Third Session||22||
60113342|NCT04356963|76233627|FG000|COMPLETED|Third Session||48||
60113343|NCT04356963|76233627|FG000|NOT COMPLETED|Third Session||7||
60113344|NCT04231097|76233633|FG000|STARTED|Overall Study||8||
60113345|NCT04231097|76233633|FG000|COMPLETED|Overall Study||4||
60113346|NCT04231097|76233633|FG000|NOT COMPLETED|Overall Study||4||
60113347|NCT03941483|76233640|FG000|STARTED|Overall Study||70||
60113348|NCT03941483|76233641|FG001|STARTED|Overall Study||81||
60113349|NCT03941483|76233642|FG002|STARTED|Overall Study||200||
60113350|NCT03941483|76233640|FG000|Treated|Overall Study||69||
60113351|NCT03941483|76233641|FG001|Treated|Overall Study||81||
60113352|NCT03941483|76233642|FG002|Treated|Overall Study||0||
60113353|NCT03941483|76233640|FG000|COMPLETED|Overall Study||61||
60113354|NCT03941483|76233641|FG001|COMPLETED|Overall Study||71||
59823500|NCT00362115|75946331|FG001|COMPLETED|Overall Study||59||
60113355|NCT03941483|76233642|FG002|COMPLETED|Overall Study||185||
60113356|NCT03941483|76233640|FG000|NOT COMPLETED|Overall Study||9||
60113357|NCT03941483|76233641|FG001|NOT COMPLETED|Overall Study||10||
60113358|NCT03941483|76233642|FG002|NOT COMPLETED|Overall Study||15||
60113359|NCT03889756|76233649|FG000|STARTED|Overall Study||1||
60113360|NCT03889756|76233650|FG001|STARTED|Overall Study||2||
60113361|NCT03889756|76233649|FG000|COMPLETED|Overall Study||1||
60113362|NCT03889756|76233650|FG001|COMPLETED|Overall Study||2||
60113363|NCT03889756|76233649|FG000|NOT COMPLETED|Overall Study||0||
60113364|NCT03889756|76233650|FG001|NOT COMPLETED|Overall Study||0||
60113365|NCT03856177|76233658|FG000|STARTED|Overall Study||50||
60113366|NCT03856177|76233659|FG001|STARTED|Overall Study||50||
60113367|NCT03856177|76233658|FG000|COMPLETED|Overall Study||50||
60113368|NCT03856177|76233659|FG001|COMPLETED|Overall Study||50||
59823501|NCT00362115|75946332|FG002|COMPLETED|Overall Study||57||
60113369|NCT03856177|76233658|FG000|NOT COMPLETED|Overall Study||0||
60113370|NCT03856177|76233659|FG001|NOT COMPLETED|Overall Study||0||
60113371|NCT03775200|76233668|FG000|STARTED|Overall Study||79||
60113372|NCT03775200|76233669|FG001|STARTED|Overall Study||75||
60113373|NCT03775200|76233670|FG002|STARTED|Overall Study||79||
60113374|NCT03775200|76233668|FG000|COMPLETED|Overall Study||74||
60113375|NCT03775200|76233669|FG001|COMPLETED|Overall Study||66||
60113376|NCT03775200|76233670|FG002|COMPLETED|Overall Study||69||
60113377|NCT03775200|76233668|FG000|NOT COMPLETED|Overall Study||5||
60113378|NCT03775200|76233669|FG001|NOT COMPLETED|Overall Study||9||
60113379|NCT03775200|76233670|FG002|NOT COMPLETED|Overall Study||10||
60113380|NCT03689855|76233678|FG000|STARTED|Overall Study||21||
60113381|NCT03689855|76233678|FG000|COMPLETED|Overall Study||17||
60113382|NCT03689855|76233678|FG000|NOT COMPLETED|Overall Study||4||
60113383|NCT03635996|76233682|FG000|STARTED|Overall Study||169||
60113384|NCT03635996|76233682|FG000|Patients Not Treated With Etripamil|Overall Study||64||
60113385|NCT03635996|76233682|FG000|Safety Population|Overall Study||105||
60113386|NCT03635996|76233682|FG000|Efficacy Population|Overall Study|92 patients (from safety population) treated with etripamil for a positively adjudicated episode of PSVT|92||
60113387|NCT03635996|76233682|FG000|COMPLETED|Overall Study|Early study termination = 167 patients|2||
60113388|NCT03635996|76233682|FG000|NOT COMPLETED|Overall Study||167||
60113389|NCT03595878|76233689|FG000|STARTED|Overall Study||29||
60113390|NCT03595878|76233690|FG001|STARTED|Overall Study||27||
60113391|NCT03595878|76233691|FG002|STARTED|Overall Study||4||
60113392|NCT03595878|76233689|FG000|COMPLETED|Overall Study||25||
60113393|NCT03595878|76233690|FG001|COMPLETED|Overall Study||25||
60113394|NCT03595878|76233691|FG002|COMPLETED|Overall Study||2||
60113395|NCT03595878|76233689|FG000|NOT COMPLETED|Overall Study||4||
60113396|NCT03595878|76233690|FG001|NOT COMPLETED|Overall Study||2||
60113397|NCT03595878|76233691|FG002|NOT COMPLETED|Overall Study||2||
60113398|NCT03468478|76233707|FG000|STARTED|Overall Study||403||
60113399|NCT03468478|76233708|FG001|STARTED|Overall Study||403||
60113400|NCT03468478|76233709|FG002|STARTED|Overall Study||403||
60113401|NCT03468478|76233707|FG000|COMPLETED|Overall Study||86||
60113402|NCT03468478|76233708|FG001|COMPLETED|Overall Study||90||
60113403|NCT03468478|76233709|FG002|COMPLETED|Overall Study||90||
60113404|NCT03468478|76233707|FG000|NOT COMPLETED|Overall Study||317||
60113405|NCT03468478|76233708|FG001|NOT COMPLETED|Overall Study||313||
60113406|NCT03468478|76233709|FG002|NOT COMPLETED|Overall Study||313||
60113407|NCT03381729|76233721|FG000|STARTED|Overall Study||3||
60113408|NCT03381729|76233722|FG001|STARTED|Overall Study||13||
60113409|NCT03381729|76233723|FG002|STARTED|Overall Study||12||
60113410|NCT03381729|76233724|FG003|STARTED|Overall Study||4||
60113411|NCT03381729|76233725|FG004|STARTED|Overall Study||0||
60113412|NCT03381729|76233721|FG000|Received AVXS-101|Overall Study||3||
60113413|NCT03381729|76233722|FG001|Received AVXS-101|Overall Study||13||
60113414|NCT03381729|76233723|FG002|Received AVXS-101|Overall Study||12||
60113415|NCT03381729|76233724|FG003|Received AVXS-101|Overall Study||4||
60113416|NCT03381729|76233725|FG004|Received AVXS-101|Overall Study||0||
60113417|NCT03381729|76233721|FG000|COMPLETED|Overall Study||3||
60113418|NCT03381729|76233722|FG001|COMPLETED|Overall Study||13||
59823502|NCT00362115|75946333|FG003|COMPLETED|Overall Study||59||
59823503|NCT00362115|75946334|FG004|COMPLETED|Overall Study||57||
60113419|NCT03381729|76233723|FG002|COMPLETED|Overall Study||12||
60113420|NCT03381729|76233724|FG003|COMPLETED|Overall Study||4||
60113421|NCT03381729|76233725|FG004|COMPLETED|Overall Study||0||
60113422|NCT03381729|76233721|FG000|NOT COMPLETED|Overall Study||0||
60113423|NCT03381729|76233722|FG001|NOT COMPLETED|Overall Study||0||
60113424|NCT03381729|76233723|FG002|NOT COMPLETED|Overall Study||0||
60113425|NCT03381729|76233724|FG003|NOT COMPLETED|Overall Study||0||
60113426|NCT03381729|76233725|FG004|NOT COMPLETED|Overall Study||0||
60113427|NCT03168464|76233737|FG000|STARTED|Overall Study||15||
60113428|NCT03168464|76233737|FG000|COMPLETED|Overall Study||0||
60113429|NCT03168464|76233737|FG000|NOT COMPLETED|Overall Study||15||
60113430|NCT02818920|76233741|FG000|STARTED|Overall Study||30||
60113431|NCT02818920|76233741|FG000|Completed Surgery|Overall Study||25||
59823504|NCT00362115|75946335|FG005|COMPLETED|Overall Study||57||
59823505|NCT00362115|75946336|FG006|COMPLETED|Overall Study||52||
59823506|NCT00362115|75946330|FG000|NOT COMPLETED|Overall Study||2||
59823507|NCT00362115|75946331|FG001|NOT COMPLETED|Overall Study||6||
59823508|NCT00362115|75946332|FG002|NOT COMPLETED|Overall Study||7||
59823509|NCT00362115|75946333|FG003|NOT COMPLETED|Overall Study||4||
59823510|NCT00362115|75946334|FG004|NOT COMPLETED|Overall Study||7||
59823511|NCT00362115|75946335|FG005|NOT COMPLETED|Overall Study||7||
59823512|NCT00362115|75946336|FG006|NOT COMPLETED|Overall Study||12||
59823513|NCT00485264|75946358|FG000|STARTED|Overall Study||71||
59823514|NCT00485264|75946359|FG001|STARTED|Overall Study||16||
59823515|NCT00485264|75946360|FG002|STARTED|Overall Study||18||
59823516|NCT00485264|75946361|FG003|STARTED|Overall Study||21||
59823517|NCT00485264|75946362|FG004|STARTED|Overall Study||15||
59823518|NCT00485264|75946363|FG005|STARTED|Overall Study||12||
59823519|NCT00485264|75946358|FG000|Completed Week 24|Overall Study||67||
59823520|NCT00485264|75946359|FG001|Completed Week 24|Overall Study||16||
59823521|NCT00485264|75946360|FG002|Completed Week 24|Overall Study||18||
59823522|NCT00485264|75946361|FG003|Completed Week 24|Overall Study||21||
59823523|NCT00485264|75946362|FG004|Completed Week 24|Overall Study||14||
59823524|NCT00485264|75946363|FG005|Completed Week 24|Overall Study||11||
59823525|NCT00485264|75946358|FG000|COMPLETED|Overall Study||35||
59823526|NCT00485264|75946359|FG001|COMPLETED|Overall Study||9||
59823527|NCT00485264|75946360|FG002|COMPLETED|Overall Study||12||
59823528|NCT00485264|75946361|FG003|COMPLETED|Overall Study||17||
59823529|NCT00485264|75946362|FG004|COMPLETED|Overall Study||9||
59823530|NCT00485264|75946363|FG005|COMPLETED|Overall Study||5||
59823531|NCT00485264|75946358|FG000|NOT COMPLETED|Overall Study||36||
59823532|NCT00485264|75946359|FG001|NOT COMPLETED|Overall Study||7||
59823533|NCT00485264|75946360|FG002|NOT COMPLETED|Overall Study||6||
59823534|NCT00485264|75946361|FG003|NOT COMPLETED|Overall Study||4||
59823535|NCT00485264|75946362|FG004|NOT COMPLETED|Overall Study||6||
59823536|NCT00485264|75946363|FG005|NOT COMPLETED|Overall Study||7||
59823537|NCT00293254|75946384|FG000|STARTED|Primary Study - Double-Blind Week 0-48||232||
59823538|NCT00293254|75946385|FG001|STARTED|Primary Study - Double-Blind Week 0-48||119||
59823539|NCT00293254|75946384|FG000|Treated|Primary Study - Double-Blind Week 0-48||230||
59823540|NCT00293254|75946385|FG001|Treated|Primary Study - Double-Blind Week 0-48||119||
59823541|NCT00293254|75946384|FG000|Continuing in Double-Blind|Primary Study - Double-Blind Week 0-48|Excludes participants who entered the Open-Label Post-Virologic Failure (OLPVF) Phase|177||
59823542|NCT00293254|75946385|FG001|Continuing in Double-Blind|Primary Study - Double-Blind Week 0-48|Excludes participants who entered the OLPVF phase|55||
59823543|NCT00293254|75946384|FG000|COMPLETED|Primary Study - Double-Blind Week 0-48||177||
59823544|NCT00293254|75946385|FG001|COMPLETED|Primary Study - Double-Blind Week 0-48||55||
59823545|NCT00293254|75946384|FG000|NOT COMPLETED|Primary Study - Double-Blind Week 0-48||55||
59823546|NCT00293254|75946385|FG001|NOT COMPLETED|Primary Study - Double-Blind Week 0-48||64||
60113432|NCT02818920|76233741|FG000|Received Adjuvant Therapy|Overall Study||17||
60113433|NCT02818920|76233741|FG000|COMPLETED|Overall Study||12||
60113434|NCT02818920|76233741|FG000|NOT COMPLETED|Overall Study||18||
60113435|NCT02786264|76233747|FG000|STARTED|Overall Study||39||
60113436|NCT02786264|76233748|FG001|STARTED|Overall Study||34||
60113437|NCT02786264|76233747|FG000|COMPLETED|Overall Study||39||
60113438|NCT02786264|76233748|FG001|COMPLETED|Overall Study||34||
60113439|NCT02786264|76233747|FG000|NOT COMPLETED|Overall Study||0||
60113440|NCT02786264|76233748|FG001|NOT COMPLETED|Overall Study||0||
60113441|NCT01948505|76233756|FG000|STARTED|Overall Study||105||
60113442|NCT01948505|76233757|FG001|STARTED|Overall Study||105||
59823547|NCT00293254|75946384|FG000|STARTED|Extension - Double-Blind Week 49-156||177||
59823548|NCT00293254|75946385|FG001|STARTED|Extension - Double-Blind Week 49-156|1 of 55 participants who completed Week 48 did not enter the extension study.|54||
59823549|NCT00293254|75946384|FG000|COMPLETED|Extension - Double-Blind Week 49-156||120||
59823550|NCT00293254|75946385|FG001|COMPLETED|Extension - Double-Blind Week 49-156||25||
60113443|NCT01948505|76233756|FG000|COMPLETED|Overall Study||105||
60113444|NCT01948505|76233757|FG001|COMPLETED|Overall Study||105||
60113445|NCT01948505|76233756|FG000|NOT COMPLETED|Overall Study||0||
60113446|NCT01948505|76233757|FG001|NOT COMPLETED|Overall Study||0||
60113447|NCT01934296|76233763|FG000|STARTED|Overall Study||9||
60113448|NCT01934296|76233763|FG000|COMPLETED|Overall Study||9||
60113449|NCT01934296|76233763|FG000|NOT COMPLETED|Overall Study||0||
59567158|NCT03040323|75669991|FG001|COMPLETED|Overall Study||0||
60113450|NCT01454401|76233767|FG000|STARTED|Overall Study|ITT|44||
60113451|NCT01454401|76233767|FG000|COMPLETED|Overall Study|Per Protocol (PP)|39||
60113452|NCT01454401|76233767|FG000|NOT COMPLETED|Overall Study||5||
60113453|NCT01344018|76233773|FG000|STARTED|Overall Study||133||
59823551|NCT00293254|75946384|FG000|NOT COMPLETED|Extension - Double-Blind Week 49-156||57||
59823552|NCT00293254|75946385|FG001|NOT COMPLETED|Extension - Double-Blind Week 49-156||29||
59823553|NCT00293254|75946384|FG000|STARTED|Extension - Open-Label Week 157-240||120||
59823554|NCT00293254|75946385|FG001|STARTED|Extension - Open-Label Week 157-240|6 of 25 participants who completed the double-blind phase did not enter this open-label phase.|19||
60113454|NCT01344018|76233774|FG001|STARTED|Overall Study||133||
60113455|NCT01344018|76233773|FG000|COMPLETED|Overall Study||107||
60113456|NCT01344018|76233774|FG001|COMPLETED|Overall Study||101||
60113457|NCT01344018|76233773|FG000|NOT COMPLETED|Overall Study||26||
60113458|NCT01344018|76233774|FG001|NOT COMPLETED|Overall Study||32||
60113459|NCT01126957|76233780|FG000|STARTED|Overall Study||103||
60113460|NCT01126957|76233780|FG000|COMPLETED|Overall Study||103||
60113461|NCT01126957|76233780|FG000|NOT COMPLETED|Overall Study||0||
60113462|NCT00247377|76233787|FG000|STARTED|Overall Study||111||
60113463|NCT00247377|76233788|FG001|STARTED|Overall Study||86||
60113464|NCT00247377|76233787|FG000|COMPLETED|Overall Study||111||
60113465|NCT00247377|76233788|FG001|COMPLETED|Overall Study||86||
60113466|NCT00247377|76233787|FG000|NOT COMPLETED|Overall Study||0||
60113467|NCT00247377|76233788|FG001|NOT COMPLETED|Overall Study||0||
60113468|NCT02826681|76233796|FG000|STARTED|Overall Study||35||
60113469|NCT02826681|76233797|FG001|STARTED|Overall Study||35||
60113470|NCT02826681|76233796|FG000|COMPLETED|Overall Study||12||
60113471|NCT02826681|76233797|FG001|COMPLETED|Overall Study||13||
59823555|NCT00293254|75946384|FG000|COMPLETED|Extension - Open-Label Week 157-240||110||
60113472|NCT02826681|76233796|FG000|NOT COMPLETED|Overall Study||23||
60113473|NCT02826681|76233797|FG001|NOT COMPLETED|Overall Study||22||
60113474|NCT01755767|76233807|FG000|STARTED|Overall Study||28||
60113475|NCT01755767|76233808|FG001|STARTED|Overall Study||15||
60113476|NCT01755767|76233809|FG002|STARTED|Overall Study||226||
60113477|NCT01755767|76233810|FG003|STARTED|Overall Study||114||
60113478|NCT01755767|76233807|FG000|COMPLETED|Overall Study||0||
60113479|NCT01755767|76233808|FG001|COMPLETED|Overall Study||0||
60113480|NCT01755767|76233809|FG002|COMPLETED|Overall Study||0||
60113481|NCT01755767|76233810|FG003|COMPLETED|Overall Study||0||
60113482|NCT01755767|76233807|FG000|NOT COMPLETED|Overall Study||28||
60113483|NCT01755767|76233808|FG001|NOT COMPLETED|Overall Study||15||
60113484|NCT01755767|76233809|FG002|NOT COMPLETED|Overall Study||226||
60113485|NCT01755767|76233810|FG003|NOT COMPLETED|Overall Study||114||
60113486|NCT02327403|76233820|FG000|STARTED|Overall Study||15||
60113487|NCT02327403|76233820|FG000|COMPLETED|Overall Study||13||
60113488|NCT02327403|76233820|FG000|NOT COMPLETED|Overall Study||2||
60113489|NCT02372877|76233825|FG000|STARTED|Overall Study||83||
60113490|NCT02372877|76233825|FG000|COMPLETED|Overall Study||59||
60113491|NCT02372877|76233825|FG000|NOT COMPLETED|Overall Study||24||
60113492|NCT01922050|76233843|FG000|STARTED|Part 1 Open-label, Dose-escalation Phase||3||
60113493|NCT01922050|76233844|FG001|STARTED|Part 1 Open-label, Dose-escalation Phase||3||
60113494|NCT01922050|76233845|FG002|STARTED|Part 1 Open-label, Dose-escalation Phase||6||
60113495|NCT01922050|76233846|FG003|STARTED|Part 1 Open-label, Dose-escalation Phase||6||
60113496|NCT01922050|76233847|FG004|STARTED|Part 1 Open-label, Dose-escalation Phase||17||
60113497|NCT01922050|76233848|FG005|STARTED|Part 1 Open-label, Dose-escalation Phase||18||
60113498|NCT01922050|76233849|FG006|STARTED|Part 1 Open-label, Dose-escalation Phase||3||
59714837|NCT01179048|75833608|FG001|NOT COMPLETED|Overall Study||159||
59714838|NCT00603265|75833617|FG000|STARTED|Overall Study|1 participant was randomized in error and did not receive study medication|76||
59714839|NCT00603265|75833618|FG001|STARTED|Overall Study||78||
59714840|NCT00603265|75833619|FG002|STARTED|Overall Study||72||
59714841|NCT00603265|75833617|FG000|Received at Least 1 Dose of Study Drug|Overall Study||75||
60113499|NCT01922050|76233850|FG007|STARTED|Part 1 Open-label, Dose-escalation Phase||3||
60113500|NCT01922050|76233851|FG008|STARTED|Part 1 Open-label, Dose-escalation Phase||6||
59567159|NCT03040323|75669990|FG000|NOT COMPLETED|Overall Study||0||
59567160|NCT03040323|75669991|FG001|NOT COMPLETED|Overall Study||0||
59714842|NCT00603265|75833618|FG001|Received at Least 1 Dose of Study Drug|Overall Study||78||
59714843|NCT00603265|75833619|FG002|Received at Least 1 Dose of Study Drug|Overall Study||72||
59714844|NCT00603265|75833617|FG000|COMPLETED|Overall Study||69||
59714845|NCT00603265|75833618|FG001|COMPLETED|Overall Study||62||
59714846|NCT00603265|75833619|FG002|COMPLETED|Overall Study||67||
59714847|NCT00603265|75833617|FG000|NOT COMPLETED|Overall Study||7||
59714848|NCT00603265|75833618|FG001|NOT COMPLETED|Overall Study||16||
59714849|NCT00603265|75833619|FG002|NOT COMPLETED|Overall Study||5||
59714850|NCT04010227|75833629|FG000|STARTED|Overall Study||40||
59714851|NCT04010227|75833630|FG001|STARTED|Overall Study||40||
59714852|NCT04010227|75833629|FG000|Patients Started|Overall Study||20||
59714853|NCT04010227|75833630|FG001|Patients Started|Overall Study||20||
59714854|NCT04010227|75833629|FG000|Caregivers Started|Overall Study||20||
59714855|NCT04010227|75833630|FG001|Caregivers Started|Overall Study||20||
59714856|NCT04010227|75833629|FG000|COMPLETED|Overall Study||28||
59714857|NCT04010227|75833630|FG001|COMPLETED|Overall Study||30||
59714858|NCT04010227|75833629|FG000|NOT COMPLETED|Overall Study||12||
59714859|NCT04010227|75833630|FG001|NOT COMPLETED|Overall Study||10||
59714860|NCT01158534|75833637|FG000|STARTED|Overall Study||17||
59714861|NCT01158534|75833637|FG000|COMPLETED|Overall Study|All three pts that did not complete study had some treatment|14||
59714862|NCT01158534|75833637|FG000|NOT COMPLETED|Overall Study||3||
59714863|NCT01158378|75833643|FG000|STARTED|Overall Study||124||
59714864|NCT01158378|75833644|FG001|STARTED|Overall Study||126||
59714865|NCT01158378|75833643|FG000|COMPLETED|Overall Study||114||
59714866|NCT01158378|75833644|FG001|COMPLETED|Overall Study||117||
59714867|NCT01158378|75833643|FG000|NOT COMPLETED|Overall Study||10||
59714868|NCT01158378|75833644|FG001|NOT COMPLETED|Overall Study||9||
59714869|NCT01158222|75833651|FG000|STARTED|Overall Study||37||
59714870|NCT01158222|75833651|FG000|COMPLETED|Overall Study||20||
60113501|NCT01922050|76233852|FG009|STARTED|Part 1 Open-label, Dose-escalation Phase||12||
60113502|NCT01922050|76233853|FG010|STARTED|Part 1 Open-label, Dose-escalation Phase||0||
60113503|NCT01922050|76233854|FG011|STARTED|Part 1 Open-label, Dose-escalation Phase||0||
60113504|NCT01922050|76233855|FG012|STARTED|Part 1 Open-label, Dose-escalation Phase||0||
60113505|NCT01922050|76233856|FG013|STARTED|Part 1 Open-label, Dose-escalation Phase||0||
60113506|NCT01922050|76233843|FG000|COMPLETED|Part 1 Open-label, Dose-escalation Phase||3||
60113507|NCT01922050|76233844|FG001|COMPLETED|Part 1 Open-label, Dose-escalation Phase||3||
60113508|NCT01922050|76233845|FG002|COMPLETED|Part 1 Open-label, Dose-escalation Phase||6||
60113509|NCT01922050|76233846|FG003|COMPLETED|Part 1 Open-label, Dose-escalation Phase||6||
60113510|NCT01922050|76233847|FG004|COMPLETED|Part 1 Open-label, Dose-escalation Phase||17||
60113511|NCT01922050|76233848|FG005|COMPLETED|Part 1 Open-label, Dose-escalation Phase||18||
60113512|NCT01922050|76233849|FG006|COMPLETED|Part 1 Open-label, Dose-escalation Phase||3||
60113513|NCT01922050|76233850|FG007|COMPLETED|Part 1 Open-label, Dose-escalation Phase||3||
60113514|NCT01922050|76233851|FG008|COMPLETED|Part 1 Open-label, Dose-escalation Phase||6||
60113515|NCT01922050|76233852|FG009|COMPLETED|Part 1 Open-label, Dose-escalation Phase||12||
60113516|NCT01922050|76233853|FG010|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0||
60113517|NCT01922050|76233854|FG011|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0||
60113518|NCT01922050|76233855|FG012|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0||
60113519|NCT01922050|76233856|FG013|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0||
60113520|NCT01922050|76233843|FG000|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0||
60113521|NCT01922050|76233844|FG001|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0||
60113522|NCT01922050|76233845|FG002|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0||
60113523|NCT01922050|76233846|FG003|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0||
60113524|NCT01922050|76233847|FG004|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0||
60113525|NCT01922050|76233848|FG005|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0||
60113526|NCT01922050|76233849|FG006|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0||
60113527|NCT01922050|76233850|FG007|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0||
60113528|NCT01922050|76233851|FG008|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0||
60113529|NCT01922050|76233852|FG009|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0||
60113530|NCT01922050|76233853|FG010|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0||
60113531|NCT01922050|76233854|FG011|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0||
60113532|NCT01922050|76233855|FG012|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0||
60113533|NCT01922050|76233856|FG013|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0||
60113534|NCT01922050|76233843|FG000|STARTED|Part 2 Double-blind Phase||0||
60113535|NCT01922050|76233844|FG001|STARTED|Part 2 Double-blind Phase||0||
60113536|NCT01922050|76233845|FG002|STARTED|Part 2 Double-blind Phase||0||
60113537|NCT01922050|76233846|FG003|STARTED|Part 2 Double-blind Phase||0||
60113538|NCT01922050|76233847|FG004|STARTED|Part 2 Double-blind Phase||0||
60113539|NCT01922050|76233848|FG005|STARTED|Part 2 Double-blind Phase||0||
60113540|NCT01922050|76233849|FG006|STARTED|Part 2 Double-blind Phase||0||
60113541|NCT01922050|76233850|FG007|STARTED|Part 2 Double-blind Phase||0||
60113542|NCT01922050|76233851|FG008|STARTED|Part 2 Double-blind Phase||0||
60113543|NCT01922050|76233852|FG009|STARTED|Part 2 Double-blind Phase||0||
60113544|NCT01922050|76233853|FG010|STARTED|Part 2 Double-blind Phase||62||
59567161|NCT03036735|75669997|FG000|STARTED|Overall Study||10||
59714871|NCT01158222|75833651|FG000|NOT COMPLETED|Overall Study||17||
59714872|NCT01197521|75833658|FG000|STARTED|Overall Study|Patients who received treatment|310||
60113545|NCT01922050|76233854|FG011|STARTED|Part 2 Double-blind Phase||60||
59714873|NCT01197521|75833659|FG001|STARTED|Overall Study|Patients who received treatment|304||
60113546|NCT01922050|76233855|FG012|STARTED|Part 2 Double-blind Phase||62||
60113547|NCT01922050|76233856|FG013|STARTED|Part 2 Double-blind Phase||59||
60113548|NCT01922050|76233843|FG000|COMPLETED|Part 2 Double-blind Phase||0||
60113549|NCT01922050|76233844|FG001|COMPLETED|Part 2 Double-blind Phase||0||
60113550|NCT01922050|76233845|FG002|COMPLETED|Part 2 Double-blind Phase||0||
60113551|NCT01922050|76233846|FG003|COMPLETED|Part 2 Double-blind Phase||0||
60113552|NCT01922050|76233847|FG004|COMPLETED|Part 2 Double-blind Phase||0||
60113553|NCT01922050|76233848|FG005|COMPLETED|Part 2 Double-blind Phase||0||
60113554|NCT01922050|76233849|FG006|COMPLETED|Part 2 Double-blind Phase||0||
60113555|NCT01922050|76233850|FG007|COMPLETED|Part 2 Double-blind Phase||0||
60113556|NCT01922050|76233851|FG008|COMPLETED|Part 2 Double-blind Phase||0||
60113557|NCT01922050|76233852|FG009|COMPLETED|Part 2 Double-blind Phase||0||
60113558|NCT01922050|76233853|FG010|COMPLETED|Part 2 Double-blind Phase||61||
60113559|NCT01922050|76233854|FG011|COMPLETED|Part 2 Double-blind Phase||58||
60113560|NCT01922050|76233855|FG012|COMPLETED|Part 2 Double-blind Phase||62||
60113561|NCT01922050|76233856|FG013|COMPLETED|Part 2 Double-blind Phase||56||
60113562|NCT01922050|76233843|FG000|NOT COMPLETED|Part 2 Double-blind Phase||0||
60113563|NCT01922050|76233844|FG001|NOT COMPLETED|Part 2 Double-blind Phase||0||
60113564|NCT01922050|76233845|FG002|NOT COMPLETED|Part 2 Double-blind Phase||0||
60113565|NCT01922050|76233846|FG003|NOT COMPLETED|Part 2 Double-blind Phase||0||
60113566|NCT01922050|76233847|FG004|NOT COMPLETED|Part 2 Double-blind Phase||0||
60113567|NCT01922050|76233848|FG005|NOT COMPLETED|Part 2 Double-blind Phase||0||
60113568|NCT01922050|76233849|FG006|NOT COMPLETED|Part 2 Double-blind Phase||0||
60113569|NCT01922050|76233850|FG007|NOT COMPLETED|Part 2 Double-blind Phase||0||
60113570|NCT01922050|76233851|FG008|NOT COMPLETED|Part 2 Double-blind Phase||0||
60113571|NCT01922050|76233852|FG009|NOT COMPLETED|Part 2 Double-blind Phase||0||
60113572|NCT01922050|76233853|FG010|NOT COMPLETED|Part 2 Double-blind Phase||1||
60113573|NCT01922050|76233854|FG011|NOT COMPLETED|Part 2 Double-blind Phase||2||
60113574|NCT01922050|76233855|FG012|NOT COMPLETED|Part 2 Double-blind Phase||0||
60113575|NCT01922050|76233856|FG013|NOT COMPLETED|Part 2 Double-blind Phase||3||
60113576|NCT01922986|76233888|FG000|STARTED|Overall Study||2||
60113577|NCT01922986|76233889|FG001|STARTED|Overall Study||2||
60113578|NCT01922986|76233888|FG000|COMPLETED|Overall Study||2||
60113579|NCT01922986|76233889|FG001|COMPLETED|Overall Study||2||
60113580|NCT01922986|76233888|FG000|NOT COMPLETED|Overall Study||0||
60113581|NCT01922986|76233889|FG001|NOT COMPLETED|Overall Study||0||
60113582|NCT01924390|76233897|FG000|STARTED|Overall Study||22||
60113583|NCT01924390|76233898|FG001|STARTED|Overall Study||22||
60113584|NCT01924390|76233897|FG000|COMPLETED|Overall Study||21||
60113585|NCT01924390|76233898|FG001|COMPLETED|Overall Study||21||
60113586|NCT01924390|76233897|FG000|NOT COMPLETED|Overall Study||1||
60113587|NCT01924390|76233898|FG001|NOT COMPLETED|Overall Study||1||
60113588|NCT01730339|76233906|FG000|STARTED|Overall Study||45||
60113589|NCT01730339|76233907|FG001|STARTED|Overall Study||55||
60113590|NCT01730339|76233906|FG000|COMPLETED|Overall Study||40||
60113591|NCT01730339|76233907|FG001|COMPLETED|Overall Study||52||
60113592|NCT01730339|76233906|FG000|NOT COMPLETED|Overall Study||5||
60113593|NCT01730339|76233907|FG001|NOT COMPLETED|Overall Study||3||
60113594|NCT01925404|76233927|FG000|STARTED|Overall Study|"The primary outcome of this study is at the level of a park.~The park is the unit of analysis. We did not recruit participants, but had measure of park use by counting observed users"||The numbers reported are the number of parks assigned to the study arm|12
60113595|NCT01925404|76233928|FG001|STARTED|Overall Study|The park is the unit of analysis. We did not recruit participants, but had measure of park use by counting observed users||The numbers reported are the number of parks assigned to the study arm|12
60113596|NCT01925404|76233929|FG002|STARTED|Overall Study|The park is the unit of analysis. We did not recruit participants, but had measure of park use by counting observed users||The numbers reported are the number of parks assigned to the study arm|12
60113597|NCT01925404|76233930|FG003|STARTED|Overall Study|The park is the unit of analysis. We did not recruit participants, but had measure of park use by counting observed users||The numbers reported are the number of parks assigned to the study arm|12
60113598|NCT01925404|76233927|FG000|COMPLETED|Overall Study|We did not recruit participants or follow the same park users over time. The follow up numbers of users are greater than at baseline, and this generates an error message.|||12
60113599|NCT01925404|76233928|FG001|COMPLETED|Overall Study|We did not recruit participants or follow the same park users over time. The follow up numbers of users are greater than at baseline, and this generates an error message.|||12
60113600|NCT01925404|76233929|FG002|COMPLETED|Overall Study|We did not recruit participants or follow the same park users over time. The follow up numbers of users are greater than at baseline, and this generates an error message.|||12
60113601|NCT01925404|76233930|FG003|COMPLETED|Overall Study|We did not recruit participants or follow the same park users over time. The follow up numbers of users are greater than at baseline, and this generates an error message.|||12
60113602|NCT01925404|76233927|FG000|NOT COMPLETED|Overall Study||||0
60113603|NCT01925404|76233928|FG001|NOT COMPLETED|Overall Study||||0
60113604|NCT01925404|76233929|FG002|NOT COMPLETED|Overall Study||||0
60113605|NCT01925404|76233930|FG003|NOT COMPLETED|Overall Study||||0
60113606|NCT02329600|76233943|FG000|STARTED|Overall Study||10||
60113607|NCT02329600|76233944|FG001|STARTED|Overall Study||15||
60113608|NCT02329600|76233945|FG002|STARTED|Overall Study||15||
60113609|NCT02329600|76233943|FG000|COMPLETED|Overall Study||10||
60113610|NCT02329600|76233944|FG001|COMPLETED|Overall Study||15||
60113611|NCT02329600|76233945|FG002|COMPLETED|Overall Study||15||
60113612|NCT02329600|76233943|FG000|NOT COMPLETED|Overall Study||0||
60113613|NCT02329600|76233944|FG001|NOT COMPLETED|Overall Study||0||
60113614|NCT02329600|76233945|FG002|NOT COMPLETED|Overall Study||0||
60113615|NCT02620761|76233955|FG000|STARTED|Overall Study||1||
60113616|NCT02620761|76233956|FG001|STARTED|Overall Study||0||
60113617|NCT02620761|76233955|FG000|COMPLETED|Overall Study||1||
60113618|NCT02620761|76233956|FG001|COMPLETED|Overall Study||0||
60113619|NCT02620761|76233955|FG000|NOT COMPLETED|Overall Study||0||
60113620|NCT02620761|76233956|FG001|NOT COMPLETED|Overall Study||0||
60113621|NCT01754753|76233964|FG000|STARTED|Overall Study||78||
60113622|NCT01754753|76233965|FG001|STARTED|Overall Study||79||
60113623|NCT01754753|76233964|FG000|COMPLETED|Overall Study||26||
60113624|NCT01754753|76233965|FG001|COMPLETED|Overall Study||30||
60113625|NCT01754753|76233964|FG000|NOT COMPLETED|Overall Study||52||
60113626|NCT01754753|76233965|FG001|NOT COMPLETED|Overall Study||49||
60113627|NCT01729871|76233973|FG000|STARTED|Overall Study||124||
60113628|NCT01729871|76233974|FG001|STARTED|Overall Study||124||
60113629|NCT01729871|76233973|FG000|COMPLETED|Overall Study||112||
60113630|NCT01729871|76233974|FG001|COMPLETED|Overall Study||101||
60113631|NCT01729871|76233973|FG000|NOT COMPLETED|Overall Study||12||
60113632|NCT01729871|76233974|FG001|NOT COMPLETED|Overall Study||23||
60113633|NCT02611323|76233991|FG000|STARTED|Overall Study||7||
60113634|NCT02611323|76233992|FG001|STARTED|Overall Study||3||
60113635|NCT02611323|76233993|FG002|STARTED|Overall Study||3||
60113636|NCT02611323|76233994|FG003|STARTED|Overall Study||3||
60113637|NCT02611323|76233995|FG004|STARTED|Overall Study||9||
60113638|NCT02611323|76233996|FG005|STARTED|Overall Study||8||
60113639|NCT02611323|76233997|FG006|STARTED|Overall Study||41||
60113640|NCT02611323|76233998|FG007|STARTED|Overall Study||3||
60113641|NCT02611323|76233999|FG008|STARTED|Overall Study||6||
60113642|NCT02611323|76234000|FG009|STARTED|Overall Study||8||
60113643|NCT02611323|76234001|FG010|STARTED|Overall Study||40||
60113644|NCT02611323|76233991|FG000|COMPLETED|Overall Study||2||
60113645|NCT02611323|76233992|FG001|COMPLETED|Overall Study||2||
60113646|NCT02611323|76233993|FG002|COMPLETED|Overall Study||3||
60113647|NCT02611323|76233994|FG003|COMPLETED|Overall Study||3||
60113648|NCT02611323|76233995|FG004|COMPLETED|Overall Study||8||
60113649|NCT02611323|76233996|FG005|COMPLETED|Overall Study||7||
60113650|NCT02611323|76233997|FG006|COMPLETED|Overall Study||30||
60113651|NCT02611323|76233998|FG007|COMPLETED|Overall Study||2||
60113652|NCT02611323|76233999|FG008|COMPLETED|Overall Study||2||
60113653|NCT02611323|76234000|FG009|COMPLETED|Overall Study||0||
60113654|NCT02611323|76234001|FG010|COMPLETED|Overall Study||11||
60113655|NCT02611323|76233991|FG000|NOT COMPLETED|Overall Study||5||
60113656|NCT02611323|76233992|FG001|NOT COMPLETED|Overall Study||1||
60113657|NCT02611323|76233993|FG002|NOT COMPLETED|Overall Study||0||
60113658|NCT02611323|76233994|FG003|NOT COMPLETED|Overall Study||0||
60113659|NCT02611323|76233995|FG004|NOT COMPLETED|Overall Study||1||
60113660|NCT02611323|76233996|FG005|NOT COMPLETED|Overall Study||1||
60113661|NCT02611323|76233997|FG006|NOT COMPLETED|Overall Study||11||
60113662|NCT02611323|76233998|FG007|NOT COMPLETED|Overall Study||1||
60113663|NCT02611323|76233999|FG008|NOT COMPLETED|Overall Study||4||
60113664|NCT02611323|76234000|FG009|NOT COMPLETED|Overall Study||8||
60113665|NCT02611323|76234001|FG010|NOT COMPLETED|Overall Study||29||
60113666|NCT01729559|76234040|FG000|STARTED|Overall Study||251||
60113667|NCT01729559|76234041|FG001|STARTED|Overall Study||244||
60113668|NCT01729559|76234040|FG000|COMPLETED|Overall Study||220||
60113669|NCT01729559|76234041|FG001|COMPLETED|Overall Study||216||
60113670|NCT01729559|76234040|FG000|NOT COMPLETED|Overall Study||31||
60113671|NCT01729559|76234041|FG001|NOT COMPLETED|Overall Study||28||
60113672|NCT01926496|76234049|FG000|STARTED|Overall Study||240||
60113673|NCT01926496|76234050|FG001|STARTED|Overall Study||245||
60113674|NCT01926496|76234049|FG000|COMPLETED|Overall Study||203||
60113675|NCT01926496|76234050|FG001|COMPLETED|Overall Study||197||
60113676|NCT01926496|76234049|FG000|NOT COMPLETED|Overall Study||37||
60113677|NCT01926496|76234050|FG001|NOT COMPLETED|Overall Study||48||
60113678|NCT01728779|76234060|FG000|STARTED|Overall Study||38||
60113679|NCT01728779|76234060|FG000|COMPLETED|Overall Study||37||
60113680|NCT01728779|76234060|FG000|NOT COMPLETED|Overall Study||1||
60113681|NCT01927120|76234064|FG000|STARTED|Overall Study||20||
60113682|NCT01927120|76234064|FG000|COMPLETED|Overall Study||10||
60113683|NCT01927120|76234064|FG000|NOT COMPLETED|Overall Study||10||
60113684|NCT01728623|76234071|FG000|STARTED|Overall Study||51||
60113685|NCT01728623|76234071|FG000|DTC|Overall Study||25||
60113686|NCT01728623|76234071|FG000|MTC|Overall Study||9||
60113687|NCT01728623|76234071|FG000|ATC|Overall Study||17||
60113688|NCT01728623|76234071|FG000|COMPLETED|Overall Study||23||
60113689|NCT01728623|76234071|FG000|NOT COMPLETED|Overall Study||28||
60113690|NCT01754129|76234078|FG000|STARTED|Overall Study||148||
60113691|NCT01754129|76234078|FG000|Visit 1 (Enrollment Day)|Overall Study||145||
60113692|NCT01754129|76234078|FG000|Visit 2 (Year 1)|Overall Study||129||
60113693|NCT01754129|76234078|FG000|Visit 3 (Year 2)|Overall Study||115||
60113694|NCT01754129|76234078|FG000|COMPLETED|Overall Study||115||
60113695|NCT01754129|76234078|FG000|NOT COMPLETED|Overall Study||33||
60113696|NCT01728077|76234091|FG000|STARTED|Overall Study||19||
60113697|NCT01728077|76234092|FG001|STARTED|Overall Study||7||
60113698|NCT01728077|76234091|FG000|COMPLETED|Overall Study||11||
60113699|NCT01728077|76234092|FG001|COMPLETED|Overall Study||2||
60113700|NCT01728077|76234091|FG000|NOT COMPLETED|Overall Study||8||
60113701|NCT01728077|76234092|FG001|NOT COMPLETED|Overall Study||5||
60113702|NCT02307279|76234101|FG000|STARTED|Overall Study||223||
60113703|NCT02307279|76234102|FG001|STARTED|Overall Study||213||
60113704|NCT02307279|76234101|FG000|COMPLETED|Overall Study||172||
60113705|NCT02307279|76234102|FG001|COMPLETED|Overall Study||152||
60113706|NCT02307279|76234101|FG000|NOT COMPLETED|Overall Study||51||
60113707|NCT02307279|76234102|FG001|NOT COMPLETED|Overall Study||61||
60113708|NCT01606007|76234111|FG000|STARTED|Overall Study||176||
60113709|NCT01606007|76234112|FG001|STARTED|Overall Study||179||
60113710|NCT01606007|76234113|FG002|STARTED|Overall Study||179||
59567162|NCT03036735|75669997|FG000|COMPLETED|Overall Study||0||
59714874|NCT01197521|75833660|FG002|STARTED|Overall Study|Patients who received treatment|304||
59714875|NCT01197521|75833658|FG000|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled|1||
59714876|NCT01197521|75833659|FG001|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/other|2||
59714877|NCT01197521|75833660|FG002|Randomised But Did Not Receive Treatment|Overall Study|Adverse event/eligibility criteria not fulfilled|2||
59714878|NCT01197521|75833658|FG000|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|207||
59714879|NCT01197521|75833659|FG001|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|191||
59714880|NCT01197521|75833660|FG002|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|161||
59714881|NCT01197521|75833658|FG000|NOT COMPLETED|Overall Study||103||
59714882|NCT01197521|75833659|FG001|NOT COMPLETED|Overall Study||113||
59714883|NCT01197521|75833660|FG002|NOT COMPLETED|Overall Study||143||
59714884|NCT01157676|75833673|FG000|STARTED|Enrollment||174||
59714885|NCT01157676|75833674|FG001|STARTED|Enrollment||176||
59714886|NCT01157676|75833673|FG000|COMPLETED|Enrollment||174||
59714887|NCT01157676|75833674|FG001|COMPLETED|Enrollment||176||
59714888|NCT01157676|75833673|FG000|NOT COMPLETED|Enrollment||0||
59714889|NCT01157676|75833674|FG001|NOT COMPLETED|Enrollment||0||
59714890|NCT01157676|75833673|FG000|STARTED|Randomization||174||
59714891|NCT01157676|75833674|FG001|STARTED|Randomization||176||
59714892|NCT01157676|75833673|FG000|COMPLETED|Randomization||153||
59714893|NCT01157676|75833674|FG001|COMPLETED|Randomization||159||
59714894|NCT01157676|75833673|FG000|NOT COMPLETED|Randomization||21||
59714895|NCT01157676|75833674|FG001|NOT COMPLETED|Randomization||17||
59714896|NCT01157676|75833673|FG000|STARTED|Surgery||153||
59714897|NCT01157676|75833674|FG001|STARTED|Surgery||159||
59714898|NCT01157676|75833673|FG000|COMPLETED|Surgery||152|wrong procedure due to screen failure (n=2), failure to notify surgeon of randomization (n=2).|
59714899|NCT01157676|75833674|FG001|COMPLETED|Surgery|advanced disease=2, inadequate visualization=1, inability to tolerate position=1, colonic mass=1.|150|wrong procedure due to screen failure (n=2), failure to notify surgeon of randomization (n=2).|
59714900|NCT01157676|75833673|FG000|NOT COMPLETED|Surgery||1||
59714901|NCT01157676|75833674|FG001|NOT COMPLETED|Surgery||9||
59714902|NCT00991341|75833688|FG000|STARTED|Overall Study||742||
59714903|NCT00991341|75833689|FG001|STARTED|Overall Study||739||
59714904|NCT00991341|75833688|FG000|COMPLETED|Overall Study||538||
59714905|NCT00991341|75833689|FG001|COMPLETED|Overall Study||560||
59714906|NCT00991341|75833688|FG000|NOT COMPLETED|Overall Study||204||
59714907|NCT00991341|75833689|FG001|NOT COMPLETED|Overall Study||179||
59714908|NCT00990249|75833695|FG000|STARTED|Overall Study||120||
59714909|NCT00990249|75833695|FG000|COMPLETED|Overall Study||107||
59714910|NCT00990249|75833695|FG000|NOT COMPLETED|Overall Study||13||
59714911|NCT02846545|75833701|FG000|STARTED|Active Treatment Period: Week 0-52||28||
59714912|NCT02846545|75833702|FG001|STARTED|Active Treatment Period: Week 0-52||56||
60113711|NCT01606007|76234111|FG000|COMPLETED|Overall Study||161||
60113712|NCT01606007|76234112|FG001|COMPLETED|Overall Study||160||
60113713|NCT01606007|76234113|FG002|COMPLETED|Overall Study||169||
60113714|NCT01606007|76234111|FG000|NOT COMPLETED|Overall Study||15||
60113715|NCT01606007|76234112|FG001|NOT COMPLETED|Overall Study||19||
60113716|NCT01606007|76234113|FG002|NOT COMPLETED|Overall Study||10||
60113717|NCT01928290|76234123|FG000|STARTED|Overall Study||41||
60113718|NCT01928290|76234124|FG001|STARTED|Overall Study||26||
60113719|NCT01928290|76234123|FG000|COMPLETED|Overall Study||41||
60113720|NCT01928290|76234124|FG001|COMPLETED|Overall Study||26||
60113721|NCT01928290|76234123|FG000|NOT COMPLETED|Overall Study||0||
60113722|NCT01928290|76234124|FG001|NOT COMPLETED|Overall Study||0||
60113723|NCT01928446|76234132|FG000|STARTED|Overall Study||255||
59714913|NCT02846545|75833701|FG000|COMPLETED|Active Treatment Period: Week 0-52||25||
60113724|NCT01928446|76234133|FG001|STARTED|Overall Study||264||
60113725|NCT01928446|76234132|FG000|COMPLETED|Overall Study|39 subjects stopped study drug but continued with followup|144||
60113726|NCT01928446|76234133|FG001|COMPLETED|Overall Study|23 subjects stopped study drug but continued with followup|125||
60113727|NCT01928446|76234132|FG000|NOT COMPLETED|Overall Study||111||
60113728|NCT01928446|76234133|FG001|NOT COMPLETED|Overall Study||139||
60113729|NCT01928524|76234148|FG000|STARTED|Overall Study||3||
59823556|NCT00293254|75946385|FG001|COMPLETED|Extension - Open-Label Week 157-240||18||
59823557|NCT00293254|75946384|FG000|NOT COMPLETED|Extension - Open-Label Week 157-240||10||
59823558|NCT00293254|75946385|FG001|NOT COMPLETED|Extension - Open-Label Week 157-240||1||
59823559|NCT00293254|75946384|FG000|STARTED|Open-Label Post Virologic Failure Phase|Number of participants who failed treatment and consented to enter the OLPVF phase|50||
59823560|NCT00293254|75946385|FG001|STARTED|Open-Label Post Virologic Failure Phase|Number of participants who failed treatment and consented to enter the OLPVF phase|64||
59823561|NCT00293254|75946384|FG000|COMPLETED|Open-Label Post Virologic Failure Phase||19||
59823562|NCT00293254|75946385|FG001|COMPLETED|Open-Label Post Virologic Failure Phase||37||
59823563|NCT00293254|75946384|FG000|NOT COMPLETED|Open-Label Post Virologic Failure Phase||31||
59823564|NCT00293254|75946385|FG001|NOT COMPLETED|Open-Label Post Virologic Failure Phase||27||
59823565|NCT04170608|75946393|FG000|STARTED|Overall Study||10||
59823566|NCT04170608|75946393|FG000|COMPLETED|Overall Study||10||
60113730|NCT01928524|76234149|FG001|STARTED|Overall Study||3||
60113731|NCT01928524|76234150|FG002|STARTED|Overall Study||6||
60113732|NCT01928524|76234151|FG003|STARTED|Overall Study||6||
60113733|NCT01928524|76234152|FG004|STARTED|Overall Study||3||
60113734|NCT01928524|76234153|FG005|STARTED|Overall Study||8||
60113735|NCT01928524|76234154|FG006|STARTED|Overall Study||5||
60113736|NCT01928524|76234148|FG000|COMPLETED|Overall Study||3||
60113737|NCT01928524|76234149|FG001|COMPLETED|Overall Study||3||
60113738|NCT01928524|76234150|FG002|COMPLETED|Overall Study||6||
60113739|NCT01928524|76234151|FG003|COMPLETED|Overall Study||6||
60113740|NCT01928524|76234152|FG004|COMPLETED|Overall Study||3||
60113741|NCT01928524|76234153|FG005|COMPLETED|Overall Study||8||
60113742|NCT01928524|76234154|FG006|COMPLETED|Overall Study||5||
60113743|NCT01928524|76234148|FG000|NOT COMPLETED|Overall Study||0||
60113744|NCT01928524|76234149|FG001|NOT COMPLETED|Overall Study||0||
60113745|NCT01928524|76234150|FG002|NOT COMPLETED|Overall Study||0||
60113746|NCT01928524|76234151|FG003|NOT COMPLETED|Overall Study||0||
60113747|NCT01928524|76234152|FG004|NOT COMPLETED|Overall Study||0||
60113748|NCT01928524|76234153|FG005|NOT COMPLETED|Overall Study||0||
60113749|NCT01928524|76234154|FG006|NOT COMPLETED|Overall Study||0||
60113750|NCT01928680|76234170|FG000|STARTED|Overall Study||33||
60113751|NCT01928680|76234170|FG000|COMPLETED|Overall Study||33||
60113752|NCT01928680|76234170|FG000|NOT COMPLETED|Overall Study||0||
60113753|NCT02488785|76234176|FG000|STARTED|Overall Study||47||
59714914|NCT02846545|75833702|FG001|COMPLETED|Active Treatment Period: Week 0-52||50||
59714915|NCT02846545|75833701|FG000|NOT COMPLETED|Active Treatment Period: Week 0-52||3||
59714916|NCT02846545|75833702|FG001|NOT COMPLETED|Active Treatment Period: Week 0-52||6||
59714917|NCT02846545|75833701|FG000|STARTED|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60||25||
59714918|NCT02846545|75833702|FG001|STARTED|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|1 participant from the golimumab treatment group terminated study participation on the day of the Week 52 visit.|49||
59714919|NCT02846545|75833701|FG000|Participants Who Entered OLE Period|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60||0||
59714920|NCT02846545|75833702|FG001|Participants Who Entered OLE Period|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60||5||
59823567|NCT04170608|75946393|FG000|NOT COMPLETED|Overall Study||0||
59823568|NCT00456846|75946399|FG000|STARTED|Overall Study||47||
59823569|NCT00456846|75946400|FG001|STARTED|Overall Study||76||
60113754|NCT02488785|76234177|FG001|STARTED|Overall Study||49||
60113755|NCT02488785|76234176|FG000|COMPLETED|Overall Study||41||
60113756|NCT02488785|76234177|FG001|COMPLETED|Overall Study||38||
60113757|NCT02488785|76234176|FG000|NOT COMPLETED|Overall Study||6||
60113758|NCT02488785|76234177|FG001|NOT COMPLETED|Overall Study||11||
60113759|NCT01929460|76234185|FG000|STARTED|Overall Study||13||
60113760|NCT01929460|76234186|FG001|STARTED|Overall Study||13||
60113761|NCT01929460|76234185|FG000|COMPLETED|Overall Study||13||
60113762|NCT01929460|76234186|FG001|COMPLETED|Overall Study||13||
60113763|NCT01929460|76234185|FG000|NOT COMPLETED|Overall Study||0||
60113764|NCT01929460|76234186|FG001|NOT COMPLETED|Overall Study||0||
60113765|NCT01753193|76234192|FG000|STARTED|Overall Study||218||
59567163|NCT03036735|75669997|FG000|NOT COMPLETED|Overall Study||10||
59714921|NCT02846545|75833701|FG000|Participants Who Completed OLE Period|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60||0||
59714922|NCT02846545|75833702|FG001|Participants Who Completed OLE Period|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60||1||
59714923|NCT02846545|75833701|FG000|COMPLETED|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60||23||
59714924|NCT02846545|75833702|FG001|COMPLETED|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60||47||
59714925|NCT02846545|75833701|FG000|NOT COMPLETED|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60||2||
59714926|NCT02846545|75833702|FG001|NOT COMPLETED|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60||2||
60113766|NCT01753193|76234192|FG000|COMPLETED|Overall Study||172||
60113767|NCT01753193|76234192|FG000|NOT COMPLETED|Overall Study||46||
60113768|NCT02470377|76234199|FG000|STARTED|Overall Study||10||
60113769|NCT02470377|76234200|FG001|STARTED|Overall Study||9||
60113770|NCT02470377|76234201|FG002|STARTED|Overall Study||5||
60113771|NCT02470377|76234199|FG000|COMPLETED|Overall Study||10||
60113772|NCT02470377|76234200|FG001|COMPLETED|Overall Study||9||
60113773|NCT02470377|76234201|FG002|COMPLETED|Overall Study||5||
60113774|NCT02470377|76234199|FG000|NOT COMPLETED|Overall Study||0||
60113775|NCT02470377|76234200|FG001|NOT COMPLETED|Overall Study||0||
60113776|NCT02470377|76234201|FG002|NOT COMPLETED|Overall Study||0||
60113777|NCT02283814|76234211|FG000|STARTED|Overall Study||16||
60113778|NCT02283814|76234212|FG001|STARTED|Overall Study||16||
60113779|NCT02283814|76234211|FG000|COMPLETED|Overall Study||13||
60113780|NCT02283814|76234212|FG001|COMPLETED|Overall Study||14||
60113781|NCT02283814|76234211|FG000|NOT COMPLETED|Overall Study||3||
60113782|NCT02283814|76234212|FG001|NOT COMPLETED|Overall Study||2||
60113783|NCT02466009|76234218|FG000|STARTED|Overall Study||27||
60113784|NCT02466009|76234218|FG000|COMPLETED|Overall Study||27||
60113785|NCT02466009|76234218|FG000|NOT COMPLETED|Overall Study||0||
60113786|NCT02462421|76234226|FG000|STARTED|Overall Study||13||
60113787|NCT02462421|76234227|FG001|STARTED|Overall Study||4||
60113788|NCT02462421|76234228|FG002|STARTED|Overall Study||6||
60113789|NCT02462421|76234229|FG003|STARTED|Overall Study||7||
60113790|NCT02462421|76234226|FG000|COMPLETED|Overall Study||13||
60113791|NCT02462421|76234227|FG001|COMPLETED|Overall Study||4||
60113792|NCT02462421|76234228|FG002|COMPLETED|Overall Study||6||
60113793|NCT02462421|76234229|FG003|COMPLETED|Overall Study||7||
60113794|NCT02462421|76234226|FG000|NOT COMPLETED|Overall Study||0||
60113795|NCT02462421|76234227|FG001|NOT COMPLETED|Overall Study||0||
60113796|NCT02462421|76234228|FG002|NOT COMPLETED|Overall Study||0||
60113797|NCT02462421|76234229|FG003|NOT COMPLETED|Overall Study||0||
60113798|NCT01727297|76234239|FG000|STARTED|Overall Study||395||
60113799|NCT01727297|76234240|FG001|STARTED|Overall Study||51||
60113800|NCT01727297|76234239|FG000|COMPLETED|Overall Study||293||
60113801|NCT01727297|76234240|FG001|COMPLETED|Overall Study||0||
60113802|NCT01727297|76234239|FG000|NOT COMPLETED|Overall Study||102||
59823570|NCT00456846|75946399|FG000|COMPLETED|Overall Study|Treatment considered completed upon disease progression|31||
59996430|NCT02001623|76112393|FG009|Completed 12 Cycles of Treatment|Overall Study||3||
60113803|NCT01727297|76234240|FG001|NOT COMPLETED|Overall Study||51||
60113804|NCT01753115|76234256|FG000|STARTED|Overall Study||44||
60113805|NCT01753115|76234257|FG001|STARTED|Overall Study||40||
60113806|NCT01753115|76234258|FG002|STARTED|Overall Study||70||
60113807|NCT01753115|76234256|FG000|Treated|Overall Study||38||
60113808|NCT01753115|76234257|FG001|Treated|Overall Study||39||
60113809|NCT01753115|76234258|FG002|Treated|Overall Study||67||
60113810|NCT01753115|76234256|FG000|COMPLETED|Overall Study||32||
60113811|NCT01753115|76234257|FG001|COMPLETED|Overall Study||25||
60113812|NCT01753115|76234258|FG002|COMPLETED|Overall Study||56||
60113813|NCT01753115|76234256|FG000|NOT COMPLETED|Overall Study||12||
60113814|NCT01753115|76234257|FG001|NOT COMPLETED|Overall Study||15||
59996431|NCT02001623|76112394|FG010|Completed 12 Cycles of Treatment|Overall Study||0||
59996432|NCT02001623|76112395|FG011|Completed 12 Cycles of Treatment|Overall Study||0||
59996433|NCT02001623|76112396|FG012|Completed 12 Cycles of Treatment|Overall Study||1||
59996434|NCT02001623|76112397|FG013|Completed 12 Cycles of Treatment|Overall Study||1||
59996435|NCT02001623|76112398|FG014|Completed 12 Cycles of Treatment|Overall Study||0||
59996436|NCT02001623|76112384|FG000|COMPLETED|Overall Study||0||
59996437|NCT02001623|76112385|FG001|COMPLETED|Overall Study||0||
59996438|NCT02001623|76112386|FG002|COMPLETED|Overall Study||0||
59996439|NCT02001623|76112387|FG003|COMPLETED|Overall Study||1||
59996440|NCT02001623|76112388|FG004|COMPLETED|Overall Study||0||
59996441|NCT02001623|76112389|FG005|COMPLETED|Overall Study||0||
60113815|NCT01753115|76234258|FG002|NOT COMPLETED|Overall Study||14||
60113816|NCT02284516|76234268|FG000|STARTED|Overall Study||356||
60113817|NCT02284516|76234269|FG001|STARTED|Overall Study||355||
60113818|NCT02284516|76234268|FG000|Safety Population|Overall Study|Two placebo participants were considered for Lifitegrast arm; Placebo safety analysis set (N= 354).|354||
60113819|NCT02284516|76234269|FG001|Safety Population|Overall Study|Two placebo participants were included in Lifitegrast arm for safety analysis set (N=357).|357||
60113820|NCT02284516|76234268|FG000|COMPLETED|Overall Study||318||
60113821|NCT02284516|76234269|FG001|COMPLETED|Overall Study||319||
60113822|NCT02284516|76234268|FG000|NOT COMPLETED|Overall Study||38||
60113823|NCT02284516|76234269|FG001|NOT COMPLETED|Overall Study||36||
60113824|NCT01727141|76234279|FG000|STARTED|Overall Study||260||
60113825|NCT01727141|76234280|FG001|STARTED|Overall Study||260||
60113826|NCT01727141|76234281|FG002|STARTED|Overall Study||261||
60113827|NCT01727141|76234282|FG003|STARTED|Overall Study||261||
60113828|NCT01727141|76234279|FG000|Safety Set|Overall Study||258||
60113829|NCT01727141|76234280|FG001|Safety Set|Overall Study||260||
60113830|NCT01727141|76234281|FG002|Safety Set|Overall Study||262||
60113831|NCT01727141|76234282|FG003|Safety Set|Overall Study||260||
60113832|NCT01727141|76234279|FG000|Full Analysis Set|Overall Study||258||
60113833|NCT01727141|76234280|FG001|Full Analysis Set|Overall Study||260||
60113834|NCT01727141|76234281|FG002|Full Analysis Set|Overall Study||261||
60113835|NCT01727141|76234282|FG003|Full Analysis Set|Overall Study||261||
60113836|NCT01727141|76234279|FG000|COMPLETED|Overall Study||255||
60113837|NCT01727141|76234280|FG001|COMPLETED|Overall Study||251||
60113838|NCT01727141|76234281|FG002|COMPLETED|Overall Study||258||
60113839|NCT01727141|76234282|FG003|COMPLETED|Overall Study||246||
60113840|NCT01727141|76234279|FG000|NOT COMPLETED|Overall Study||5||
60113841|NCT01727141|76234280|FG001|NOT COMPLETED|Overall Study||9||
60113842|NCT01727141|76234281|FG002|NOT COMPLETED|Overall Study||3||
59714927|NCT00990093|75833712|FG000|STARTED|Test Period 1 (1-14 Days)||19||
59714928|NCT00990093|75833713|FG001|STARTED|Test Period 1 (1-14 Days)||17||
60113843|NCT01727141|76234282|FG003|NOT COMPLETED|Overall Study||15||
60113844|NCT02290444|76234294|FG000|STARTED|Overall Study||30||
60113845|NCT02290444|76234295|FG001|STARTED|Overall Study||34||
60113846|NCT02290444|76234294|FG000|COMPLETED|Overall Study||29||
60113847|NCT02290444|76234295|FG001|COMPLETED|Overall Study||32||
60113848|NCT02290444|76234294|FG000|NOT COMPLETED|Overall Study||1||
60113849|NCT02290444|76234295|FG001|NOT COMPLETED|Overall Study||2||
60113850|NCT01726517|76234306|FG000|STARTED|Overall Study||20||
60113851|NCT01726517|76234307|FG001|STARTED|Overall Study||21||
60113852|NCT01726517|76234308|FG002|STARTED|Overall Study||19||
60113853|NCT01726517|76234309|FG003|STARTED|Overall Study||19||
60113854|NCT01726517|76234310|FG004|STARTED|Overall Study||21||
60113855|NCT01726517|76234306|FG000|COMPLETED|Overall Study||20||
60113856|NCT01726517|76234307|FG001|COMPLETED|Overall Study||21||
60113857|NCT01726517|76234308|FG002|COMPLETED|Overall Study||18||
60113858|NCT01726517|76234309|FG003|COMPLETED|Overall Study||19||
59714929|NCT00990093|75833712|FG000|COMPLETED|Test Period 1 (1-14 Days)||15||
59714930|NCT00990093|75833713|FG001|COMPLETED|Test Period 1 (1-14 Days)||15||
59714931|NCT00990093|75833712|FG000|NOT COMPLETED|Test Period 1 (1-14 Days)||4||
59823571|NCT00456846|75946400|FG001|COMPLETED|Overall Study|Treatment considered completed upon disease progression|48||
59823572|NCT00456846|75946399|FG000|NOT COMPLETED|Overall Study||16||
59823573|NCT00456846|75946400|FG001|NOT COMPLETED|Overall Study||28||
59823574|NCT00448344|75946408|FG000|STARTED|Overall Study||235||
59823575|NCT00448344|75946409|FG001|STARTED|Overall Study||236||
59823576|NCT00448344|75946408|FG000|COMPLETED|Overall Study||205||
59823577|NCT00448344|75946409|FG001|COMPLETED|Overall Study||200||
59823578|NCT00448344|75946408|FG000|NOT COMPLETED|Overall Study||30||
59823579|NCT00448344|75946409|FG001|NOT COMPLETED|Overall Study||36||
59823580|NCT00484094|75946415|FG000|STARTED|Overall Study||209||
59823581|NCT00484094|75946415|FG000|COMPLETED|Overall Study||167||
59567164|NCT02648282|75670001|FG000|STARTED|Overall Study||58||
59567165|NCT02648282|75670001|FG000|COMPLETED|Overall Study||58||
59714932|NCT00990093|75833713|FG001|NOT COMPLETED|Test Period 1 (1-14 Days)||2||
59714933|NCT00990093|75833712|FG000|STARTED|Test Period 2 (15-28 Days)||15||
59714934|NCT00990093|75833713|FG001|STARTED|Test Period 2 (15-28 Days)||15||
59714935|NCT00990093|75833712|FG000|COMPLETED|Test Period 2 (15-28 Days)||13||
59714936|NCT00990093|75833713|FG001|COMPLETED|Test Period 2 (15-28 Days)||14||
60113859|NCT01726517|76234310|FG004|COMPLETED|Overall Study||21||
60113860|NCT01726517|76234306|FG000|NOT COMPLETED|Overall Study||0||
60113861|NCT01726517|76234307|FG001|NOT COMPLETED|Overall Study||0||
59714937|NCT00990093|75833712|FG000|NOT COMPLETED|Test Period 2 (15-28 Days)||2||
59823582|NCT00484094|75946415|FG000|NOT COMPLETED|Overall Study||42||
60113862|NCT01726517|76234308|FG002|NOT COMPLETED|Overall Study||1||
60113863|NCT01726517|76234309|FG003|NOT COMPLETED|Overall Study||0||
60113864|NCT01726517|76234310|FG004|NOT COMPLETED|Overall Study||0||
60113865|NCT01752023|76234324|FG000|STARTED|Overall Study||2||
60113866|NCT01752023|76234325|FG001|STARTED|Overall Study||1||
60113867|NCT01752023|76234324|FG000|COMPLETED|Overall Study||0||
60113868|NCT01752023|76234325|FG001|COMPLETED|Overall Study||0||
60113869|NCT01752023|76234324|FG000|NOT COMPLETED|Overall Study||2||
60113870|NCT01752023|76234325|FG001|NOT COMPLETED|Overall Study||1||
59823583|NCT00447876|75946421|FG000|STARTED|Overall Study||20||
59823584|NCT00447876|75946422|FG001|STARTED|Overall Study||20||
59823585|NCT00447876|75946421|FG000|COMPLETED|Overall Study||17||
60113871|NCT01726049|76234337|FG000|STARTED|Overall Study||26||
60113872|NCT01726049|76234338|FG001|STARTED|Overall Study||26||
60113873|NCT01726049|76234337|FG000|COMPLETED|Overall Study||21||
60113874|NCT01726049|76234338|FG001|COMPLETED|Overall Study||22||
60113875|NCT01726049|76234337|FG000|NOT COMPLETED|Overall Study||5||
60113876|NCT01726049|76234338|FG001|NOT COMPLETED|Overall Study||4||
60113877|NCT02162667|76234346|FG000|STARTED|Neoadjuvant Period||278||
60113878|NCT02162667|76234347|FG001|STARTED|Neoadjuvant Period||284||
60113879|NCT02162667|76234346|FG000|COMPLETED|Neoadjuvant Period||264|the number of patients who completed 8 cycles of the Neoadjuvant Period and underwent surgery.|
60113880|NCT02162667|76234347|FG001|COMPLETED|Neoadjuvant Period||267|the number of patients who completed 8 cycles of the Neoadjuvant Period and underwent surgery.|
60113881|NCT02162667|76234346|FG000|NOT COMPLETED|Neoadjuvant Period||14||
60113882|NCT02162667|76234347|FG001|NOT COMPLETED|Neoadjuvant Period||17||
60113883|NCT02162667|76234346|FG000|STARTED|Adjuvant Period||260||
60113884|NCT02162667|76234347|FG001|STARTED|Adjuvant Period||268||
60113885|NCT02162667|76234346|FG000|COMPLETED|Adjuvant Period||248||
60113886|NCT02162667|76234347|FG001|COMPLETED|Adjuvant Period||255||
60113887|NCT02162667|76234346|FG000|NOT COMPLETED|Adjuvant Period||12||
60113888|NCT02162667|76234347|FG001|NOT COMPLETED|Adjuvant Period||13||
60113889|NCT01605617|76234359|FG000|STARTED|First Intervention||2||
60113890|NCT01605617|76234360|FG001|STARTED|First Intervention||2||
60113891|NCT01605617|76234359|FG000|COMPLETED|First Intervention||2||
60113892|NCT01605617|76234360|FG001|COMPLETED|First Intervention||1||
60113893|NCT01605617|76234359|FG000|NOT COMPLETED|First Intervention||0||
60113894|NCT01605617|76234360|FG001|NOT COMPLETED|First Intervention||1||
60113895|NCT01605617|76234359|FG000|STARTED|Washout Period of 4 Weeks||2||
60113896|NCT01605617|76234360|FG001|STARTED|Washout Period of 4 Weeks||1||
60113897|NCT01605617|76234359|FG000|COMPLETED|Washout Period of 4 Weeks||0||
60113898|NCT01605617|76234360|FG001|COMPLETED|Washout Period of 4 Weeks||0||
60113899|NCT01605617|76234359|FG000|NOT COMPLETED|Washout Period of 4 Weeks||2||
60113900|NCT01605617|76234360|FG001|NOT COMPLETED|Washout Period of 4 Weeks||1||
60113901|NCT01605617|76234359|FG000|STARTED|Second Intervention||0||
60113902|NCT01605617|76234360|FG001|STARTED|Second Intervention||0||
60113903|NCT01605617|76234359|FG000|COMPLETED|Second Intervention||0||
60113904|NCT01605617|76234360|FG001|COMPLETED|Second Intervention||0||
60113905|NCT01605617|76234359|FG000|NOT COMPLETED|Second Intervention||0||
60113906|NCT01605617|76234360|FG001|NOT COMPLETED|Second Intervention||0||
59823586|NCT00447876|75946422|FG001|COMPLETED|Overall Study||16||
59823587|NCT00447876|75946421|FG000|NOT COMPLETED|Overall Study||3||
59823588|NCT00447876|75946422|FG001|NOT COMPLETED|Overall Study||4||
59823589|NCT00456612|75946428|FG000|STARTED|Overall Study||4||
59823590|NCT00456612|75946428|FG000|COMPLETED|Overall Study||1||
59823591|NCT00456612|75946428|FG000|NOT COMPLETED|Overall Study||3||
60113907|NCT02284828|76234368|FG000|STARTED|Overall Study||26||
60113908|NCT02284828|76234368|FG000|COMPLETED|Overall Study||22||
60113909|NCT02284828|76234368|FG000|NOT COMPLETED|Overall Study||4||
59823592|NCT00456300|75946433|FG000|STARTED|Overall Study||5|"Started means recruited, not enrolled."|
59823593|NCT00456300|75946434|FG001|STARTED|Overall Study||4|"Started means recruited, not enrolled."|
59823594|NCT00456300|75946433|FG000|COMPLETED|Overall Study||4||
59823595|NCT00456300|75946434|FG001|COMPLETED|Overall Study||4||
59823596|NCT00456300|75946433|FG000|NOT COMPLETED|Overall Study||1||
59823597|NCT00456300|75946434|FG001|NOT COMPLETED|Overall Study||0||
60113910|NCT01751867|76234377|FG000|STARTED|Overall Study||36||
60113911|NCT01751867|76234378|FG001|STARTED|Overall Study||99||
60113912|NCT01751867|76234377|FG000|Treated|Overall Study||34||
60113913|NCT01751867|76234378|FG001|Treated|Overall Study||98||
59823598|NCT00267748|75946445|FG000|STARTED|Non-randomized Period||25||
59823599|NCT00267748|75946446|FG001|STARTED|Non-randomized Period||0||
59823600|NCT00267748|75946447|FG002|STARTED|Non-randomized Period||0||
60113914|NCT01751867|76234377|FG000|COMPLETED|Overall Study||0||
60113915|NCT01751867|76234378|FG001|COMPLETED|Overall Study||0||
60113916|NCT01751867|76234377|FG000|NOT COMPLETED|Overall Study||36||
59567166|NCT02648282|75670001|FG000|NOT COMPLETED|Overall Study||0||
60113917|NCT01751867|76234378|FG001|NOT COMPLETED|Overall Study||99||
60113918|NCT02418195|76234388|FG000|STARTED|Overall Study|Number subjects screened in this group.|62||
60113919|NCT02418195|76234389|FG001|STARTED|Overall Study|Number subjects screened in this group.|63||
60113920|NCT02418195|76234390|FG002|STARTED|Overall Study|Number subjects screened in this group.|61||
60113921|NCT02418195|76234391|FG003|STARTED|Overall Study|Number subjects screened in this group.|61||
60113922|NCT02418195|76234388|FG000|COMPLETED|Overall Study|Number subjects screened in this group.|62||
59567167|NCT04004481|75670005|FG000|STARTED|Overall Study||50||
59823601|NCT00267748|75946445|FG000|COMPLETED|Non-randomized Period||2||
59823602|NCT00267748|75946446|FG001|COMPLETED|Non-randomized Period||0||
59823603|NCT00267748|75946447|FG002|COMPLETED|Non-randomized Period||0||
60113923|NCT02418195|76234389|FG001|COMPLETED|Overall Study|Number subjects screened in this group.|63||
59823604|NCT00267748|75946445|FG000|NOT COMPLETED|Non-randomized Period||23||
59823605|NCT00267748|75946446|FG001|NOT COMPLETED|Non-randomized Period||0||
59823606|NCT00267748|75946447|FG002|NOT COMPLETED|Non-randomized Period||0||
59823607|NCT00267748|75946445|FG000|STARTED|Randomized Period||0||
59823608|NCT00267748|75946446|FG001|STARTED|Randomized Period||146||
59823609|NCT00267748|75946447|FG002|STARTED|Randomized Period||146||
59823610|NCT00267748|75946445|FG000|Treated|Randomized Period||0||
59823611|NCT00267748|75946446|FG001|Treated|Randomized Period||146||
59823612|NCT00267748|75946447|FG002|Treated|Randomized Period||143||
59823613|NCT00267748|75946445|FG000|COMPLETED|Randomized Period||0||
59823614|NCT00267748|75946446|FG001|COMPLETED|Randomized Period||19||
59823615|NCT00267748|75946447|FG002|COMPLETED|Randomized Period||14||
59823616|NCT00267748|75946445|FG000|NOT COMPLETED|Randomized Period||0||
59823617|NCT00267748|75946446|FG001|NOT COMPLETED|Randomized Period||127||
59823618|NCT00267748|75946447|FG002|NOT COMPLETED|Randomized Period||132||
59823619|NCT00267202|75946456|FG000|STARTED|Overall Study||136||
59823620|NCT00267202|75946457|FG001|STARTED|Overall Study||139||
59823621|NCT00267202|75946456|FG000|COMPLETED|Overall Study||83||
59823622|NCT00267202|75946457|FG001|COMPLETED|Overall Study||105||
59823623|NCT00267202|75946456|FG000|NOT COMPLETED|Overall Study||53||
59823624|NCT00267202|75946457|FG001|NOT COMPLETED|Overall Study||34||
59823625|NCT00267046|75946466|FG000|STARTED|Overall Study||32||
59823626|NCT00267046|75946467|FG001|STARTED|Overall Study||16||
59823627|NCT00267046|75946466|FG000|COMPLETED|Overall Study||20||
59823628|NCT00267046|75946467|FG001|COMPLETED|Overall Study||5||
59823629|NCT00267046|75946466|FG000|NOT COMPLETED|Overall Study||12||
59823630|NCT00267046|75946467|FG001|NOT COMPLETED|Overall Study||11||
59823631|NCT00441090|75946478|FG000|STARTED|Overall Study||15||
59823632|NCT00441090|75946479|FG001|STARTED|Overall Study||15||
59823633|NCT00441090|75946480|FG002|STARTED|Overall Study||14||
59823634|NCT00441090|75946481|FG003|STARTED|Overall Study||15||
59823635|NCT00441090|75946482|FG004|STARTED|Overall Study||5||
59823636|NCT00441090|75946478|FG000|COMPLETED|Overall Study||13||
59823637|NCT00441090|75946479|FG001|COMPLETED|Overall Study||14||
59823638|NCT00441090|75946480|FG002|COMPLETED|Overall Study||12||
59823639|NCT00441090|75946481|FG003|COMPLETED|Overall Study||13||
59823640|NCT00441090|75946482|FG004|COMPLETED|Overall Study||5||
59823641|NCT00441090|75946478|FG000|NOT COMPLETED|Overall Study||2||
59823642|NCT00441090|75946479|FG001|NOT COMPLETED|Overall Study||1||
59823643|NCT00441090|75946480|FG002|NOT COMPLETED|Overall Study||2||
59823644|NCT00441090|75946481|FG003|NOT COMPLETED|Overall Study||2||
59823645|NCT00441090|75946482|FG004|NOT COMPLETED|Overall Study||0||
59823646|NCT00441012|75946496|FG000|STARTED|Overall Study||270||
59823647|NCT00441012|75946497|FG001|STARTED|Overall Study||276||
59823648|NCT00441012|75946496|FG000|Vaccination Visit 1|Overall Study|1 participant was randomized but not vaccinated in the Modified Process Vaccine group|269||
59823649|NCT00441012|75946497|FG001|Vaccination Visit 1|Overall Study|3 participants were vaccinated but were never randomized in the COMVAX™ group|276||
59823650|NCT00441012|75946496|FG000|Vaccination Visit 2|Overall Study||267||
59823651|NCT00441012|75946497|FG001|Vaccination Visit 2|Overall Study||272||
59823652|NCT00441012|75946496|FG000|Vaccination Visit 3|Overall Study||265||
59823653|NCT00441012|75946497|FG001|Vaccination Visit 3|Overall Study||269||
59823654|NCT00441012|75946496|FG000|COMPLETED|Overall Study||252||
59823655|NCT00441012|75946497|FG001|COMPLETED|Overall Study||263||
59823656|NCT00441012|75946496|FG000|NOT COMPLETED|Overall Study||18||
59823657|NCT00441012|75946497|FG001|NOT COMPLETED|Overall Study||13||
59823658|NCT00286468|75946506|FG000|STARTED|Overall Study||99||
59823659|NCT00286468|75946507|FG001|STARTED|Overall Study||203||
59823660|NCT00286468|75946508|FG002|STARTED|Overall Study||198||
60113924|NCT02418195|76234390|FG002|COMPLETED|Overall Study|Number subjects screened in this group.|61||
60113925|NCT02418195|76234391|FG003|COMPLETED|Overall Study|Number subjects screened in this group.|61||
59823661|NCT00286468|75946506|FG000|COMPLETED|Overall Study||62||
59823662|NCT00286468|75946507|FG001|COMPLETED|Overall Study||153||
59823663|NCT00286468|75946508|FG002|COMPLETED|Overall Study||148||
59823664|NCT00286468|75946506|FG000|NOT COMPLETED|Overall Study||37||
59823665|NCT00286468|75946507|FG001|NOT COMPLETED|Overall Study||50||
59823666|NCT00286468|75946508|FG002|NOT COMPLETED|Overall Study||50||
60113926|NCT02418195|76234388|FG000|NOT COMPLETED|Overall Study||0||
60113927|NCT02418195|76234389|FG001|NOT COMPLETED|Overall Study||0||
60113928|NCT02418195|76234390|FG002|NOT COMPLETED|Overall Study||0||
59823667|NCT00507026|75946519|FG000|STARTED|Overall Study||145||
59823668|NCT00507026|75946520|FG001|STARTED|Overall Study||60||
59823669|NCT00507026|75946521|FG002|STARTED|Overall Study||72||
59823670|NCT00507026|75946519|FG000|COMPLETED|Overall Study||132||
59823671|NCT00507026|75946520|FG001|COMPLETED|Overall Study||56||
59823672|NCT00507026|75946521|FG002|COMPLETED|Overall Study||51||
59823673|NCT00507026|75946519|FG000|NOT COMPLETED|Overall Study||13||
59823674|NCT00507026|75946520|FG001|NOT COMPLETED|Overall Study||4||
59823675|NCT00507026|75946521|FG002|NOT COMPLETED|Overall Study||21||
59823676|NCT00446550|75946531|FG000|STARTED|Overall Study||11||
59823677|NCT00446550|75946532|FG001|STARTED|Overall Study||8||
59823678|NCT00446550|75946531|FG000|Safety Population|Overall Study||11|All participants who received at least 1 dose of study drug.|
59823679|NCT00446550|75946532|FG001|Safety Population|Overall Study||8|All participants who received at least 1 dose of study drug.|
59823680|NCT00446550|75946531|FG000|PD Population|Overall Study||11|Participants in the Safety Population with a baseline and at least 1 post-baseline PD measurement.|
59823681|NCT00446550|75946532|FG001|PD Population|Overall Study||8|Participants in the Safety Population with a baseline and at least 1 post-baseline PD measurement.|
59823682|NCT00446550|75946531|FG000|COMPLETED|Overall Study||10||
59823683|NCT00446550|75946532|FG001|COMPLETED|Overall Study||8||
59823684|NCT00446550|75946531|FG000|NOT COMPLETED|Overall Study||1||
59823685|NCT00446550|75946532|FG001|NOT COMPLETED|Overall Study||0||
60113929|NCT02418195|76234391|FG003|NOT COMPLETED|Overall Study||0||
60113930|NCT01751165|76234404|FG000|STARTED|Overall Study||119||
60113931|NCT01751165|76234405|FG001|STARTED|Overall Study||119||
60113932|NCT01751165|76234406|FG002|STARTED|Overall Study||116||
60113933|NCT01751165|76234404|FG000|COMPLETED|Overall Study||117||
59823686|NCT03847974|75946539|FG000|STARTED|Overall Study||32||
59823687|NCT03847974|75946539|FG000|COMPLETED|Overall Study||26||
59823688|NCT03847974|75946539|FG000|NOT COMPLETED|Overall Study||6||
59823689|NCT03976102|75946545|FG000|STARTED|Overall Study||162||
59823690|NCT03976102|75946546|FG001|STARTED|Overall Study||155||
59823691|NCT03976102|75946545|FG000|COMPLETED|Overall Study||143||
59823692|NCT03976102|75946546|FG001|COMPLETED|Overall Study||129||
59823693|NCT03976102|75946545|FG000|NOT COMPLETED|Overall Study||19||
59823694|NCT03976102|75946546|FG001|NOT COMPLETED|Overall Study||26||
59823695|NCT00506948|75946555|FG000|STARTED|Overall Study||10||
59823696|NCT00506948|75946555|FG000|COMPLETED|Overall Study||0||
59823697|NCT00506948|75946555|FG000|NOT COMPLETED|Overall Study||10||
59823698|NCT00286234|75946563|FG000|STARTED|Overall Study||17||
59823699|NCT00286234|75946564|FG001|STARTED|Overall Study||17||
59823700|NCT00286234|75946565|FG002|STARTED|Overall Study||17||
59823701|NCT00286234|75946566|FG003|STARTED|Overall Study||17||
59823702|NCT00286234|75946563|FG000|COMPLETED|Overall Study||15||
59823703|NCT00286234|75946564|FG001|COMPLETED|Overall Study||15||
59823704|NCT00286234|75946565|FG002|COMPLETED|Overall Study||17||
59823705|NCT00286234|75946566|FG003|COMPLETED|Overall Study||13||
59823706|NCT00286234|75946563|FG000|NOT COMPLETED|Overall Study||2||
59823707|NCT00286234|75946564|FG001|NOT COMPLETED|Overall Study||2||
59823708|NCT00286234|75946565|FG002|NOT COMPLETED|Overall Study||0||
59823709|NCT00286234|75946566|FG003|NOT COMPLETED|Overall Study||4||
59823710|NCT00445848|75946576|FG000|STARTED|Overall Study||85||
59823711|NCT00445848|75946576|FG000|COMPLETED|Overall Study||0||
59823712|NCT00445848|75946576|FG000|NOT COMPLETED|Overall Study||85||
59823713|NCT00286156|75946583|FG000|STARTED|Overall Study||10||
59823714|NCT00286156|75946584|FG001|STARTED|Overall Study||10||
59823715|NCT00286156|75946585|FG002|STARTED|Overall Study||10||
59823716|NCT00286156|75946583|FG000|COMPLETED|Overall Study||8||
59823717|NCT00286156|75946584|FG001|COMPLETED|Overall Study||9||
59823718|NCT00286156|75946585|FG002|COMPLETED|Overall Study||9||
59823719|NCT00286156|75946583|FG000|NOT COMPLETED|Overall Study||2||
59823720|NCT00286156|75946584|FG001|NOT COMPLETED|Overall Study||1||
59823721|NCT00286156|75946585|FG002|NOT COMPLETED|Overall Study||1||
59823722|NCT00455520|75946595|FG000|STARTED|Open Label Tapentadol Extended Release||591||
59823723|NCT00455520|75946596|FG001|STARTED|Open Label Tapentadol Extended Release||0||
59823724|NCT00455520|75946595|FG000|COMPLETED|Open Label Tapentadol Extended Release||395||
59823725|NCT00455520|75946596|FG001|COMPLETED|Open Label Tapentadol Extended Release||0||
59823726|NCT00455520|75946595|FG000|NOT COMPLETED|Open Label Tapentadol Extended Release||196||
59823727|NCT00455520|75946596|FG001|NOT COMPLETED|Open Label Tapentadol Extended Release||0||
59823728|NCT00455520|75946595|FG000|STARTED|Double Blind Tapentadol ER vs Placebo|2 subjects enrolled two separate times in this study, 1 subject did not receive study medication|196||
59823729|NCT00455520|75946596|FG001|STARTED|Double Blind Tapentadol ER vs Placebo|1 subject enrolled two separate times in this study, 2 subjects did not receive study medication|193||
59823730|NCT00455520|75946595|FG000|COMPLETED|Double Blind Tapentadol ER vs Placebo||133||
59823731|NCT00455520|75946596|FG001|COMPLETED|Double Blind Tapentadol ER vs Placebo||131||
59823732|NCT00455520|75946595|FG000|NOT COMPLETED|Double Blind Tapentadol ER vs Placebo||63||
59823733|NCT00455520|75946596|FG001|NOT COMPLETED|Double Blind Tapentadol ER vs Placebo||62||
59823734|NCT00440700|75946605|FG000|STARTED|Overall Study||122||
59823735|NCT00440700|75946606|FG001|STARTED|Overall Study||118||
59823736|NCT00440700|75946607|FG002|STARTED|Overall Study||124||
60113934|NCT01751165|76234405|FG001|COMPLETED|Overall Study||116||
60113935|NCT01751165|76234406|FG002|COMPLETED|Overall Study||113||
60113936|NCT01751165|76234404|FG000|NOT COMPLETED|Overall Study||2||
60113937|NCT01751165|76234405|FG001|NOT COMPLETED|Overall Study||3||
60113938|NCT01751165|76234406|FG002|NOT COMPLETED|Overall Study||3||
60113939|NCT02145351|76234418|FG000|STARTED|Pacemaker Implantation (4 Weeks)||0||
59567168|NCT04004481|75670005|FG000|COMPLETED|Overall Study||47||
59567169|NCT04004481|75670005|FG000|NOT COMPLETED|Overall Study||3||
59823737|NCT00440700|75946605|FG000|COMPLETED|Overall Study||114||
59823738|NCT00440700|75946606|FG001|COMPLETED|Overall Study||110||
59823739|NCT00440700|75946607|FG002|COMPLETED|Overall Study||120||
59823740|NCT00440700|75946605|FG000|NOT COMPLETED|Overall Study||8||
59823741|NCT00440700|75946606|FG001|NOT COMPLETED|Overall Study||8||
60113940|NCT02145351|76234419|FG001|STARTED|Pacemaker Implantation (4 Weeks)||0||
59823742|NCT00440700|75946607|FG002|NOT COMPLETED|Overall Study||4||
59823743|NCT00284050|75946618|FG000|STARTED|Overall Study||51||
59823744|NCT00284050|75946619|FG001|STARTED|Overall Study||51||
59823745|NCT00284050|75946620|FG002|STARTED|Overall Study||49||
59823746|NCT00284050|75946618|FG000|COMPLETED|Overall Study||46||
59823747|NCT00284050|75946619|FG001|COMPLETED|Overall Study||46||
59823748|NCT00284050|75946620|FG002|COMPLETED|Overall Study||40||
59823749|NCT00284050|75946618|FG000|NOT COMPLETED|Overall Study||5||
59823750|NCT00284050|75946619|FG001|NOT COMPLETED|Overall Study||5||
59823751|NCT00284050|75946620|FG002|NOT COMPLETED|Overall Study||9||
59823752|NCT00293020|75946628|FG000|STARTED|Overall Study||244||
59823753|NCT00293020|75946628|FG000|COMPLETED|Overall Study||82||
59823754|NCT00293020|75946628|FG000|NOT COMPLETED|Overall Study||162||
59823755|NCT00377637|75946636|FG000|STARTED|Induction Phase|Intent-To-Treat|185||
59823756|NCT00377637|75946637|FG001|STARTED|Induction Phase|Intent-To-Treat|185||
59823757|NCT00377637|75946638|FG002|STARTED|Induction Phase||0||
59823758|NCT00377637|75946639|FG003|STARTED|Induction Phase||0||
59823759|NCT00377637|75946636|FG000|Safety Population|Induction Phase||180||
59823760|NCT00377637|75946637|FG001|Safety Population|Induction Phase||184||
59823761|NCT00377637|75946638|FG002|Safety Population|Induction Phase||0||
59823762|NCT00377637|75946639|FG003|Safety Population|Induction Phase||0||
59823763|NCT00377637|75946636|FG000|COMPLETED|Induction Phase||156||
59823764|NCT00377637|75946637|FG001|COMPLETED|Induction Phase||150||
59823765|NCT00377637|75946638|FG002|COMPLETED|Induction Phase||0||
59823766|NCT00377637|75946639|FG003|COMPLETED|Induction Phase||0||
59823767|NCT00377637|75946636|FG000|NOT COMPLETED|Induction Phase||29||
59823768|NCT00377637|75946637|FG001|NOT COMPLETED|Induction Phase||35||
59823769|NCT00377637|75946638|FG002|NOT COMPLETED|Induction Phase||0||
60113941|NCT02145351|76234420|FG002|STARTED|Pacemaker Implantation (4 Weeks)||32||
60113942|NCT02145351|76234418|FG000|COMPLETED|Pacemaker Implantation (4 Weeks)||0||
60113943|NCT02145351|76234419|FG001|COMPLETED|Pacemaker Implantation (4 Weeks)||0||
60113944|NCT02145351|76234420|FG002|COMPLETED|Pacemaker Implantation (4 Weeks)||32||
60113945|NCT02145351|76234418|FG000|NOT COMPLETED|Pacemaker Implantation (4 Weeks)||0||
60113946|NCT02145351|76234419|FG001|NOT COMPLETED|Pacemaker Implantation (4 Weeks)||0||
60113947|NCT02145351|76234420|FG002|NOT COMPLETED|Pacemaker Implantation (4 Weeks)||0||
60113948|NCT02145351|76234418|FG000|STARTED|First Intervention (4 Weeks)||15||
60113949|NCT02145351|76234419|FG001|STARTED|First Intervention (4 Weeks)||14||
60113950|NCT02145351|76234420|FG002|STARTED|First Intervention (4 Weeks)||0||
60113951|NCT02145351|76234418|FG000|COMPLETED|First Intervention (4 Weeks)||15||
60113952|NCT02145351|76234419|FG001|COMPLETED|First Intervention (4 Weeks)||14||
60113953|NCT02145351|76234420|FG002|COMPLETED|First Intervention (4 Weeks)||0||
60113954|NCT02145351|76234418|FG000|NOT COMPLETED|First Intervention (4 Weeks)||0||
60113955|NCT02145351|76234419|FG001|NOT COMPLETED|First Intervention (4 Weeks)||0||
59714938|NCT00990093|75833713|FG001|NOT COMPLETED|Test Period 2 (15-28 Days)||1||
59714939|NCT00984165|75833723|FG000|STARTED|Overall Study||9||
59714940|NCT00984165|75833724|FG001|STARTED|Overall Study||1||
59714941|NCT00984165|75833725|FG002|STARTED|Overall Study||4||
59714942|NCT00984165|75833726|FG003|STARTED|Overall Study||4||
59714943|NCT00984165|75833723|FG000|COMPLETED|Overall Study||2||
59714944|NCT00984165|75833724|FG001|COMPLETED|Overall Study||0||
59714945|NCT00984165|75833725|FG002|COMPLETED|Overall Study||4||
59714946|NCT00984165|75833726|FG003|COMPLETED|Overall Study||0||
59714947|NCT00984165|75833723|FG000|NOT COMPLETED|Overall Study||7||
59714948|NCT00984165|75833724|FG001|NOT COMPLETED|Overall Study||1||
59714949|NCT00984165|75833725|FG002|NOT COMPLETED|Overall Study||0||
60113956|NCT02145351|76234420|FG002|NOT COMPLETED|First Intervention (4 Weeks)||0||
59567170|NCT03997851|75670027|FG000|STARTED|Overall Study||17||136
59567171|NCT03997851|75670027|FG000|COMPLETED|Overall Study||17||136
59714950|NCT00984165|75833726|FG003|NOT COMPLETED|Overall Study||4||
59714951|NCT00993291|75833737|FG000|STARTED|Overall Study||20||
59714952|NCT00993291|75833737|FG000|COMPLETED|Overall Study||19||
59714953|NCT00993291|75833737|FG000|NOT COMPLETED|Overall Study||1||
59714954|NCT01196975|75833746|FG000|STARTED|Overall Study||423||
59823770|NCT00377637|75946639|FG003|NOT COMPLETED|Induction Phase||0||
59823771|NCT00377637|75946636|FG000|STARTED|Maintenance Phase||0||
59823772|NCT00377637|75946637|FG001|STARTED|Maintenance Phase||0||
59823773|NCT00377637|75946638|FG002|STARTED|Maintenance Phase||116||
59823774|NCT00377637|75946639|FG003|STARTED|Maintenance Phase||111||
59823775|NCT00377637|75946636|FG000|COMPLETED|Maintenance Phase||0||
59823776|NCT00377637|75946637|FG001|COMPLETED|Maintenance Phase||0||
59823777|NCT00377637|75946638|FG002|COMPLETED|Maintenance Phase||73||
59823778|NCT00377637|75946639|FG003|COMPLETED|Maintenance Phase||54||
59823779|NCT00377637|75946636|FG000|NOT COMPLETED|Maintenance Phase||0||
59823780|NCT00377637|75946637|FG001|NOT COMPLETED|Maintenance Phase||0||
60113957|NCT02145351|76234418|FG000|STARTED|Washout (4 Weeks)||15||
60113958|NCT02145351|76234419|FG001|STARTED|Washout (4 Weeks)||14||
60113959|NCT02145351|76234420|FG002|STARTED|Washout (4 Weeks)||0||
60113960|NCT02145351|76234418|FG000|COMPLETED|Washout (4 Weeks)||15||
60113961|NCT02145351|76234419|FG001|COMPLETED|Washout (4 Weeks)||14||
60113962|NCT02145351|76234420|FG002|COMPLETED|Washout (4 Weeks)||0||
60113963|NCT02145351|76234418|FG000|NOT COMPLETED|Washout (4 Weeks)||0||
60113964|NCT02145351|76234419|FG001|NOT COMPLETED|Washout (4 Weeks)||0||
59823781|NCT00377637|75946638|FG002|NOT COMPLETED|Maintenance Phase||43||
60113965|NCT02145351|76234420|FG002|NOT COMPLETED|Washout (4 Weeks)||0||
60113966|NCT02145351|76234418|FG000|STARTED|Second Intervention (4 Weeks)||15||
60113967|NCT02145351|76234419|FG001|STARTED|Second Intervention (4 Weeks)||14||
60113968|NCT02145351|76234420|FG002|STARTED|Second Intervention (4 Weeks)||0||
60113969|NCT02145351|76234418|FG000|COMPLETED|Second Intervention (4 Weeks)||15||
60113970|NCT02145351|76234419|FG001|COMPLETED|Second Intervention (4 Weeks)||14||
60113971|NCT02145351|76234420|FG002|COMPLETED|Second Intervention (4 Weeks)||0||
60113972|NCT02145351|76234418|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0||
60113973|NCT02145351|76234419|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||0||
60113974|NCT02145351|76234420|FG002|NOT COMPLETED|Second Intervention (4 Weeks)||0||
60113975|NCT01751087|76234431|FG000|STARTED|Overall Study||100||
60113976|NCT01751087|76234432|FG001|STARTED|Overall Study||100||
60113977|NCT01751087|76234433|FG002|STARTED|Overall Study||100||
60113978|NCT01751087|76234431|FG000|COMPLETED|Overall Study||99||
60113979|NCT01751087|76234432|FG001|COMPLETED|Overall Study||100||
60113980|NCT01751087|76234433|FG002|COMPLETED|Overall Study||99||
60113981|NCT01751087|76234431|FG000|NOT COMPLETED|Overall Study||1||
60113982|NCT01751087|76234432|FG001|NOT COMPLETED|Overall Study||0||
60113983|NCT01751087|76234433|FG002|NOT COMPLETED|Overall Study||1||
60113984|NCT01750697|76234441|FG000|STARTED|Overall Study||25|Remission Induction Phase (Day 1 to Month 6)|
60113985|NCT01750697|76234441|FG000|Completed|Overall Study||25|Remission Induction Phase (Day 1 to Month 6)|
60113986|NCT01750697|76234441|FG000|Follow-up Phase|Overall Study|Completed required follow-up|24|(Month 6 to Month 18)|
60113987|NCT01750697|76234441|FG000|COMPLETED|Overall Study|Completed to CCO. 6 participants entered Extended Safety Follow-up, 10 participants completed Study.|16|Completed until CCO (Month 18 up to 4.5 years)|
60113988|NCT01750697|76234441|FG000|NOT COMPLETED|Overall Study||9||
60113989|NCT02127723|76234448|FG000|STARTED|Overall Study||20||
60113990|NCT02127723|76234448|FG000|COMPLETED|Overall Study||19||
60113991|NCT02127723|76234448|FG000|NOT COMPLETED|Overall Study||1||
60113992|NCT01750229|76234452|FG000|STARTED|Randomized Crossover Phase||30||
60113993|NCT01750229|76234452|FG000|Subject Received Sham|Randomized Crossover Phase||24||
60113994|NCT01750229|76234452|FG000|Subjects Received 1200 Hz|Randomized Crossover Phase||24||
60113995|NCT01750229|76234452|FG000|Subjects Received 3030 Hz|Randomized Crossover Phase||24||
60113996|NCT01750229|76234452|FG000|Subjects Received 5882 Hz|Randomized Crossover Phase||24||
60113997|NCT01750229|76234452|FG000|Protocol Violation|Randomized Crossover Phase||4||
60113998|NCT01750229|76234452|FG000|COMPLETED|Randomized Crossover Phase||28||
60113999|NCT01750229|76234452|FG000|NOT COMPLETED|Randomized Crossover Phase||2||
60114000|NCT01750229|76234452|FG000|STARTED|Long-term Follow-up Phase|Four subjects who had protocol violations continued to be followed in long-term follow-up phase.|28||
59823782|NCT00377637|75946639|FG003|NOT COMPLETED|Maintenance Phase||57||
59823783|NCT00377403|75946655|FG000|STARTED|Overall Study||85||
59823784|NCT00377403|75946656|FG001|STARTED|Overall Study||81||
59823785|NCT00377403|75946655|FG000|Day -3 Assessment|Overall Study||81||
60114001|NCT01750229|76234452|FG000|COMPLETED|Long-term Follow-up Phase||25||
60114002|NCT01750229|76234452|FG000|NOT COMPLETED|Long-term Follow-up Phase||3||
60114003|NCT01724489|76234464|FG000|STARTED|Overall Study||39||
60114004|NCT01724489|76234465|FG001|STARTED|Overall Study||38||
60114005|NCT01724489|76234464|FG000|COMPLETED|Overall Study||23||
60114006|NCT01724489|76234465|FG001|COMPLETED|Overall Study||26||
60114007|NCT01724489|76234464|FG000|NOT COMPLETED|Overall Study||16||
60114008|NCT01724489|76234465|FG001|NOT COMPLETED|Overall Study||12||
60114009|NCT01992393|76234473|FG000|STARTED|Baseline||22||
60114010|NCT01992393|76234474|FG001|STARTED|Baseline||22||
60114011|NCT01992393|76234473|FG000|COMPLETED|Baseline||21||
60114012|NCT01992393|76234474|FG001|COMPLETED|Baseline||22||
60114013|NCT01992393|76234473|FG000|NOT COMPLETED|Baseline||1||
60114014|NCT01992393|76234474|FG001|NOT COMPLETED|Baseline||0||
60114015|NCT01992393|76234473|FG000|STARTED|Week 12 (3 Months)||21||
60114016|NCT01992393|76234474|FG001|STARTED|Week 12 (3 Months)||22||
60114017|NCT01992393|76234473|FG000|COMPLETED|Week 12 (3 Months)||19||
60114018|NCT01992393|76234474|FG001|COMPLETED|Week 12 (3 Months)||18||
60114019|NCT01992393|76234473|FG000|NOT COMPLETED|Week 12 (3 Months)||2||
60114020|NCT01992393|76234474|FG001|NOT COMPLETED|Week 12 (3 Months)||4||
60114021|NCT01992393|76234473|FG000|STARTED|Week 16 (4 Months)||19||
60114022|NCT01992393|76234474|FG001|STARTED|Week 16 (4 Months)||18||
60114023|NCT01992393|76234473|FG000|COMPLETED|Week 16 (4 Months)||19||
60114024|NCT01992393|76234474|FG001|COMPLETED|Week 16 (4 Months)||16||
60114025|NCT01992393|76234473|FG000|NOT COMPLETED|Week 16 (4 Months)||0||
60114026|NCT01992393|76234474|FG001|NOT COMPLETED|Week 16 (4 Months)||2||
60114027|NCT01724177|76234480|FG000|STARTED|Overall Study||26||
60114028|NCT01724177|76234480|FG000|Safety Population|Overall Study|Safety Population includes participants who received at least one dose of lenalidomide|26||
60114029|NCT01724177|76234480|FG000|COMPLETED|Overall Study||0||
60114030|NCT01724177|76234480|FG000|NOT COMPLETED|Overall Study||26||
59823786|NCT00377403|75946656|FG001|Day -3 Assessment|Overall Study||74||
59823787|NCT00377403|75946655|FG000|Day 7 Assessment|Overall Study||80||
59823788|NCT00377403|75946656|FG001|Day 7 Assessment|Overall Study||75||
60114031|NCT02292940|76234487|FG000|STARTED|Overall Study||165477||
60114032|NCT02292940|76234488|FG001|STARTED|Overall Study||3000||
60114033|NCT02292940|76234487|FG000|COMPLETED|Overall Study||165477||
60114034|NCT02292940|76234488|FG001|COMPLETED|Overall Study||1824||
60114035|NCT02292940|76234487|FG000|NOT COMPLETED|Overall Study||0||
60114036|NCT02292940|76234488|FG001|NOT COMPLETED|Overall Study||1176||
60114037|NCT04378270|76234495|FG000|STARTED|Overall Study||20||
60114038|NCT04378270|76234495|FG000|COMPLETED|Overall Study||15||
60114039|NCT04378270|76234495|FG000|NOT COMPLETED|Overall Study||5||
60114040|NCT01724021|76234501|FG000|STARTED|Overall Study||371||
60114041|NCT01724021|76234502|FG001|STARTED|Overall Study||369||
60114042|NCT01724021|76234501|FG000|COMPLETED|Overall Study||244||
60114043|NCT01724021|76234502|FG001|COMPLETED|Overall Study||236||
60114044|NCT01724021|76234501|FG000|NOT COMPLETED|Overall Study||127||
60114045|NCT01724021|76234502|FG001|NOT COMPLETED|Overall Study||133||
60114046|NCT02293096|76234510|FG000|STARTED|Overall Study||140||
60114047|NCT02293096|76234510|FG000|COMPLETED|Overall Study||140||
60114048|NCT02293096|76234510|FG000|NOT COMPLETED|Overall Study||0||
60114049|NCT01723397|76234516|FG000|STARTED|Study Period 1||7||
60114050|NCT01723397|76234517|FG001|STARTED|Study Period 1||7||
60114051|NCT01723397|76234516|FG000|COMPLETED|Study Period 1||7||
60114052|NCT01723397|76234517|FG001|COMPLETED|Study Period 1||6||
60114053|NCT01723397|76234516|FG000|NOT COMPLETED|Study Period 1||0||
60114054|NCT01723397|76234517|FG001|NOT COMPLETED|Study Period 1||1||
60114055|NCT01723397|76234516|FG000|STARTED|Washout||7||
60114056|NCT01723397|76234517|FG001|STARTED|Washout||6||
60114057|NCT01723397|76234516|FG000|COMPLETED|Washout||7||
60114058|NCT01723397|76234517|FG001|COMPLETED|Washout||6||
60114059|NCT01723397|76234516|FG000|NOT COMPLETED|Washout||0||
60114060|NCT01723397|76234517|FG001|NOT COMPLETED|Washout||0||
60114061|NCT01723397|76234516|FG000|STARTED|Study Period 2||7||
60114062|NCT01723397|76234517|FG001|STARTED|Study Period 2||6||
60114063|NCT01723397|76234516|FG000|COMPLETED|Study Period 2||7||
60114064|NCT01723397|76234517|FG001|COMPLETED|Study Period 2||5||
60114065|NCT01723397|76234516|FG000|NOT COMPLETED|Study Period 2||0||
60114066|NCT01723397|76234517|FG001|NOT COMPLETED|Study Period 2||1||
60114067|NCT01723163|76234525|FG000|STARTED|Baseline||156||
60114068|NCT01723163|76234526|FG001|STARTED|Baseline||154||
60114069|NCT01723163|76234525|FG000|COMPLETED|Baseline||156||
60114070|NCT01723163|76234526|FG001|COMPLETED|Baseline||154||
60114071|NCT01723163|76234525|FG000|NOT COMPLETED|Baseline||0||
60114072|NCT01723163|76234526|FG001|NOT COMPLETED|Baseline||0||
60114073|NCT01723163|76234525|FG000|STARTED|Treatment Phase||156||
60114074|NCT01723163|76234526|FG001|STARTED|Treatment Phase||154||
60114075|NCT01723163|76234525|FG000|COMPLETED|Treatment Phase||137||
59567172|NCT03997851|75670027|FG000|NOT COMPLETED|Overall Study||0||0
59567173|NCT03989427|75670039|FG000|STARTED|First Intervention (2 Weeks)||15||
59567174|NCT03989427|75670040|FG001|STARTED|First Intervention (2 Weeks)||15||
60114076|NCT01723163|76234526|FG001|COMPLETED|Treatment Phase||147||
60114077|NCT01723163|76234525|FG000|NOT COMPLETED|Treatment Phase||19||
60114078|NCT01723163|76234526|FG001|NOT COMPLETED|Treatment Phase||7||
60114079|NCT01723163|76234525|FG000|STARTED|3-Month Follow-up||137||
60114080|NCT01723163|76234526|FG001|STARTED|3-Month Follow-up||147||
60114081|NCT01723163|76234525|FG000|COMPLETED|3-Month Follow-up||124||
60114082|NCT01723163|76234526|FG001|COMPLETED|3-Month Follow-up||128||
60114083|NCT01723163|76234525|FG000|NOT COMPLETED|3-Month Follow-up||13||
60114084|NCT01723163|76234526|FG001|NOT COMPLETED|3-Month Follow-up||19||
60114085|NCT01723163|76234525|FG000|STARTED|6-Month Follow-up||136||
60114086|NCT01723163|76234526|FG001|STARTED|6-Month Follow-up||147||
60114087|NCT01723163|76234525|FG000|COMPLETED|6-Month Follow-up||118||
60114088|NCT01723163|76234526|FG001|COMPLETED|6-Month Follow-up||132||
60114089|NCT01723163|76234525|FG000|NOT COMPLETED|6-Month Follow-up||18||
60114090|NCT01723163|76234526|FG001|NOT COMPLETED|6-Month Follow-up||15||
60114091|NCT01723163|76234525|FG000|STARTED|12-Month Follow-up||135||
60114092|NCT01723163|76234526|FG001|STARTED|12-Month Follow-up||147||
60114093|NCT01723163|76234525|FG000|COMPLETED|12-Month Follow-up||111||
60114094|NCT01723163|76234526|FG001|COMPLETED|12-Month Follow-up||119||
60114095|NCT01723163|76234525|FG000|NOT COMPLETED|12-Month Follow-up||24||
60114096|NCT01723163|76234526|FG001|NOT COMPLETED|12-Month Follow-up||28||
60114097|NCT02293798|76234532|FG000|STARTED|Overall Study|2 units of SERI Mesh placed in each patient|13||26
60114098|NCT02293798|76234532|FG000|COMPLETED|Overall Study|2 units of SERI Mesh placed in each patient|13||26
60114099|NCT02293798|76234532|FG000|NOT COMPLETED|Overall Study||0||0
59567175|NCT03989427|75670039|FG000|COMPLETED|First Intervention (2 Weeks)||15||
59714955|NCT01196975|75833747|FG001|STARTED|Overall Study||424||
60114100|NCT01722071|76234536|FG000|STARTED|Overall Study||10||
60114101|NCT01722071|76234537|FG001|STARTED|Overall Study||10||
60114102|NCT01722071|76234536|FG000|COMPLETED|Overall Study||9||
60114103|NCT01722071|76234537|FG001|COMPLETED|Overall Study||10||
60114104|NCT01722071|76234536|FG000|NOT COMPLETED|Overall Study||1||
60114105|NCT01722071|76234537|FG001|NOT COMPLETED|Overall Study||0||
60114106|NCT01721759|76234543|FG000|STARTED|Treatment Period||117|= Starting Treatment|
60114107|NCT01721759|76234543|FG000|COMPLETED|Treatment Period||0|= Continuing in the treatment period|
60114108|NCT01721759|76234543|FG000|NOT COMPLETED|Treatment Period||117||
60114109|NCT01721759|76234543|FG000|STARTED|End of Study Period||117||
60114110|NCT01721759|76234543|FG000|COMPLETED|End of Study Period||0|= continuing in the study|
60114111|NCT01721759|76234543|FG000|NOT COMPLETED|End of Study Period||117||
60114112|NCT02297308|76234547|FG000|STARTED|Overall Study||90||
60114113|NCT02297308|76234547|FG000|COMPLETED|Overall Study||90||
60114114|NCT02297308|76234547|FG000|NOT COMPLETED|Overall Study||0||
60114115|NCT01721369|76234552|FG000|STARTED|Overall Study||581||
60114116|NCT01721369|76234552|FG000|COMPLETED|Overall Study||569||
60114117|NCT01721369|76234552|FG000|NOT COMPLETED|Overall Study||12||
60114118|NCT02298322|76234556|FG000|STARTED|Overall Study||60||
60114119|NCT02298322|76234556|FG000|COMPLETED|Overall Study||60||
60114120|NCT02298322|76234556|FG000|NOT COMPLETED|Overall Study||0||
60114121|NCT02331940|76234565|FG000|STARTED|Overall Study||100||
60114122|NCT02331940|76234566|FG001|STARTED|Overall Study||100||
60114123|NCT02331940|76234565|FG000|COMPLETED|Overall Study||93||
60114124|NCT02331940|76234566|FG001|COMPLETED|Overall Study||95||
60114125|NCT02331940|76234565|FG000|NOT COMPLETED|Overall Study||7||
60114126|NCT02331940|76234566|FG001|NOT COMPLETED|Overall Study||5||
60114127|NCT02291302|76234576|FG000|STARTED|Overall Study||59||
60114128|NCT02291302|76234577|FG001|STARTED|Overall Study||59||
60114129|NCT02291302|76234578|FG002|STARTED|Overall Study||59||
60114130|NCT02291302|76234579|FG003|STARTED|Overall Study||59||
60114131|NCT02291302|76234576|FG000|COMPLETED|Overall Study||59||
60114132|NCT02291302|76234577|FG001|COMPLETED|Overall Study||59||
60114133|NCT02291302|76234578|FG002|COMPLETED|Overall Study||59||
60114134|NCT02291302|76234579|FG003|COMPLETED|Overall Study||59||
60114135|NCT02291302|76234576|FG000|NOT COMPLETED|Overall Study||0||
60114136|NCT02291302|76234577|FG001|NOT COMPLETED|Overall Study||0||
60114137|NCT02291302|76234578|FG002|NOT COMPLETED|Overall Study||0||
60114138|NCT02291302|76234579|FG003|NOT COMPLETED|Overall Study||0||
60114139|NCT02292082|76234591|FG000|STARTED|Overall Study||56||
60114140|NCT02292082|76234592|FG001|STARTED|Overall Study||55||
60114141|NCT02292082|76234591|FG000|COMPLETED|Overall Study||56||
60114142|NCT02292082|76234592|FG001|COMPLETED|Overall Study||55||
60114143|NCT02292082|76234591|FG000|NOT COMPLETED|Overall Study||0||
60114144|NCT02292082|76234592|FG001|NOT COMPLETED|Overall Study||0||
60114145|NCT02296606|76234598|FG000|STARTED|Overall Study||127||
60114146|NCT02296606|76234598|FG000|COMPLETED|Overall Study||127||
60114147|NCT02296606|76234598|FG000|NOT COMPLETED|Overall Study||0||
60114148|NCT02299258|76234604|FG000|STARTED|Overall Study||32||
60114149|NCT02299258|76234605|FG001|STARTED|Overall Study||31||
60114150|NCT02299258|76234604|FG000|COMPLETED|Overall Study||31||
60114151|NCT02299258|76234605|FG001|COMPLETED|Overall Study||30||
60114152|NCT02299258|76234604|FG000|NOT COMPLETED|Overall Study||1||
60114153|NCT02299258|76234605|FG001|NOT COMPLETED|Overall Study||1||
60114154|NCT01721057|76234614|FG000|STARTED|Treatment Period||228||
60114155|NCT01721057|76234615|FG001|STARTED|Treatment Period||229||
60114156|NCT01721057|76234616|FG002|STARTED|Treatment Period||227||
60114157|NCT01721057|76234617|FG003|STARTED|Treatment Period||0||
60114158|NCT01721057|76234618|FG004|STARTED|Treatment Period||0||
60114159|NCT01721057|76234619|FG005|STARTED|Treatment Period||0||
60114160|NCT01721057|76234620|FG006|STARTED|Treatment Period||0||
60114161|NCT01721057|76234614|FG000|Received at Least 1 Dose of Study Drug|Treatment Period||228||
60114162|NCT01721057|76234615|FG001|Received at Least 1 Dose of Study Drug|Treatment Period||229||
60114163|NCT01721057|76234616|FG002|Received at Least 1 Dose of Study Drug|Treatment Period||227||
60114164|NCT01721057|76234617|FG003|Received at Least 1 Dose of Study Drug|Treatment Period||0||
60114165|NCT01721057|76234618|FG004|Received at Least 1 Dose of Study Drug|Treatment Period||0||
60114166|NCT01721057|76234619|FG005|Received at Least 1 Dose of Study Drug|Treatment Period||0||
60114167|NCT01721057|76234620|FG006|Received at Least 1 Dose of Study Drug|Treatment Period||0||
60114168|NCT01721057|76234614|FG000|Rescued|Treatment Period||55||
60114169|NCT01721057|76234615|FG001|Rescued|Treatment Period||21||
60114170|NCT01721057|76234616|FG002|Rescued|Treatment Period||15||
60114171|NCT01721057|76234617|FG003|Rescued|Treatment Period||0||
60114172|NCT01721057|76234618|FG004|Rescued|Treatment Period||0||
60114173|NCT01721057|76234619|FG005|Rescued|Treatment Period||0||
60114174|NCT01721057|76234620|FG006|Rescued|Treatment Period||0||
60114175|NCT01721057|76234614|FG000|COMPLETED|Treatment Period|"Completers include rescued participants."|200||
60114176|NCT01721057|76234615|FG001|COMPLETED|Treatment Period|"Completers include rescued participants."|210||
60114177|NCT01721057|76234616|FG002|COMPLETED|Treatment Period|"Completers include rescued participants."|204||
60114178|NCT01721057|76234617|FG003|COMPLETED|Treatment Period||0||
60114179|NCT01721057|76234618|FG004|COMPLETED|Treatment Period||0||
60114180|NCT01721057|76234619|FG005|COMPLETED|Treatment Period||0||
60114181|NCT01721057|76234620|FG006|COMPLETED|Treatment Period||0||
60114182|NCT01721057|76234614|FG000|NOT COMPLETED|Treatment Period||28||
60114183|NCT01721057|76234615|FG001|NOT COMPLETED|Treatment Period||19||
60114184|NCT01721057|76234616|FG002|NOT COMPLETED|Treatment Period||23||
60114185|NCT01721057|76234617|FG003|NOT COMPLETED|Treatment Period||0||
59823789|NCT00377403|75946655|FG000|Day 10 Assessment|Overall Study||81||
59823790|NCT00377403|75946656|FG001|Day 10 Assessment|Overall Study||71||
59823791|NCT00377403|75946655|FG000|Day 28 Assessment|Overall Study||82||
59823792|NCT00377403|75946656|FG001|Day 28 Assessment|Overall Study||77||
59823793|NCT00377403|75946655|FG000|COMPLETED|Overall Study|The number varied by day of follow-up from 80 to 82 in the intervention group.|81||
59823794|NCT00377403|75946656|FG001|COMPLETED|Overall Study|The number varied by day of follow-up from 71 to 77 in the symptomatic treatment only group.|74||
59823795|NCT00377403|75946655|FG000|NOT COMPLETED|Overall Study||4||
59823796|NCT00377403|75946656|FG001|NOT COMPLETED|Overall Study||7||
59823797|NCT00370149|75946664|FG000|STARTED|Overall Study||165||
59823798|NCT00370149|75946665|FG001|STARTED|Overall Study||161||
59823799|NCT00370149|75946664|FG000|COMPLETED|Overall Study||146||
59823800|NCT00370149|75946665|FG001|COMPLETED|Overall Study||142||
59823801|NCT00370149|75946664|FG000|NOT COMPLETED|Overall Study||19||
59823802|NCT00370149|75946665|FG001|NOT COMPLETED|Overall Study||19||
59823803|NCT00292942|75946678|FG000|STARTED|Overall Study||6||
59823804|NCT00292942|75946679|FG001|STARTED|Overall Study||6||
59823805|NCT00292942|75946680|FG002|STARTED|Overall Study||7||
59823806|NCT00292942|75946681|FG003|STARTED|Overall Study||7||
59823807|NCT00292942|75946678|FG000|COMPLETED|Overall Study||6||
59823808|NCT00292942|75946679|FG001|COMPLETED|Overall Study||6||
59823809|NCT00292942|75946680|FG002|COMPLETED|Overall Study||6||
59823810|NCT00292942|75946681|FG003|COMPLETED|Overall Study||6||
59823811|NCT00292942|75946678|FG000|NOT COMPLETED|Overall Study||0||
60114186|NCT01721057|76234618|FG004|NOT COMPLETED|Treatment Period||0||
60114187|NCT01721057|76234619|FG005|NOT COMPLETED|Treatment Period||0||
60114188|NCT01721057|76234620|FG006|NOT COMPLETED|Treatment Period||0||
60114189|NCT01721057|76234614|FG000|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0||
60114190|NCT01721057|76234615|FG001|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0||
60114191|NCT01721057|76234616|FG002|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0||
60114192|NCT01721057|76234617|FG003|STARTED|Rescue Period|Participants who were determined to be nonresponders based on tender/swollen joint count.|91||
60114193|NCT01721057|76234618|FG004|STARTED|Rescue Period||0||
60114194|NCT01721057|76234619|FG005|STARTED|Rescue Period||0||
60114195|NCT01721057|76234620|FG006|STARTED|Rescue Period||0||
60114196|NCT01721057|76234614|FG000|COMPLETED|Rescue Period||0||
60114197|NCT01721057|76234615|FG001|COMPLETED|Rescue Period||0||
60114198|NCT01721057|76234616|FG002|COMPLETED|Rescue Period||0||
60114199|NCT01721057|76234617|FG003|COMPLETED|Rescue Period||88||
60114200|NCT01721057|76234618|FG004|COMPLETED|Rescue Period||0||
60114201|NCT01721057|76234619|FG005|COMPLETED|Rescue Period||0||
60114202|NCT01721057|76234620|FG006|COMPLETED|Rescue Period||0||
60114203|NCT01721057|76234614|FG000|NOT COMPLETED|Rescue Period||0||
59567176|NCT03989427|75670040|FG001|COMPLETED|First Intervention (2 Weeks)||15||
60114204|NCT01721057|76234615|FG001|NOT COMPLETED|Rescue Period||0||
60114205|NCT01721057|76234616|FG002|NOT COMPLETED|Rescue Period||0||
60114206|NCT01721057|76234617|FG003|NOT COMPLETED|Rescue Period||3||
60114207|NCT01721057|76234618|FG004|NOT COMPLETED|Rescue Period||0||
60114208|NCT01721057|76234619|FG005|NOT COMPLETED|Rescue Period||0||
60114209|NCT01721057|76234620|FG006|NOT COMPLETED|Rescue Period||0||
60114210|NCT01721057|76234614|FG000|STARTED|Follow Up||0||
60114211|NCT01721057|76234615|FG001|STARTED|Follow Up||0||
60114212|NCT01721057|76234616|FG002|STARTED|Follow Up||0||
60114213|NCT01721057|76234617|FG003|STARTED|Follow Up|Rescued participants who entered post-treatment follow-up are included in Baricitinib 4 mg FollowUp|0||
60114214|NCT01721057|76234618|FG004|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|17||
60114215|NCT01721057|76234619|FG005|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|19||
60114216|NCT01721057|76234620|FG006|STARTED|Follow Up|Participants from treatment and rescue who entered the post-treatment follow-up period.|22||
60114217|NCT01721057|76234614|FG000|COMPLETED|Follow Up||0||
60114218|NCT01721057|76234615|FG001|COMPLETED|Follow Up||0||
60114219|NCT01721057|76234616|FG002|COMPLETED|Follow Up||0||
60114220|NCT01721057|76234617|FG003|COMPLETED|Follow Up||0||
60114221|NCT01721057|76234618|FG004|COMPLETED|Follow Up||17||
60114222|NCT01721057|76234619|FG005|COMPLETED|Follow Up||19||
59823812|NCT00292942|75946679|FG001|NOT COMPLETED|Overall Study||0||
59823813|NCT00292942|75946680|FG002|NOT COMPLETED|Overall Study||1||
59823814|NCT00292942|75946681|FG003|NOT COMPLETED|Overall Study||1||
59823815|NCT00483938|75946701|FG000|STARTED|Overall Study||41||
59823816|NCT00483938|75946702|FG001|STARTED|Overall Study||43||
59823817|NCT00483938|75946703|FG002|STARTED|Overall Study||30||
59823818|NCT00483938|75946704|FG003|STARTED|Overall Study||31||
60114223|NCT01721057|76234620|FG006|COMPLETED|Follow Up||22||
60114224|NCT01721057|76234614|FG000|NOT COMPLETED|Follow Up||0||
60114225|NCT01721057|76234615|FG001|NOT COMPLETED|Follow Up||0||
60114226|NCT01721057|76234616|FG002|NOT COMPLETED|Follow Up||0||
60114227|NCT01721057|76234617|FG003|NOT COMPLETED|Follow Up||0||
60114228|NCT01721057|76234618|FG004|NOT COMPLETED|Follow Up||0||
60114229|NCT01721057|76234619|FG005|NOT COMPLETED|Follow Up||0||
60114230|NCT01721057|76234620|FG006|NOT COMPLETED|Follow Up||0||
60114231|NCT04570384|76234649|FG000|STARTED|Overall Study||33||
60114232|NCT04570384|76234650|FG001|STARTED|Overall Study||32||
60114233|NCT04570384|76234649|FG000|COMPLETED|Overall Study||22||
60114234|NCT04570384|76234650|FG001|COMPLETED|Overall Study||23||
60114235|NCT04570384|76234649|FG000|NOT COMPLETED|Overall Study||11||
60114236|NCT04570384|76234650|FG001|NOT COMPLETED|Overall Study||9||
60114237|NCT02299570|76234659|FG000|STARTED|Overall Study||45||
60114238|NCT02299570|76234660|FG001|STARTED|Overall Study||44||
60114239|NCT02299570|76234661|FG002|STARTED|Overall Study||44||
60114240|NCT02299570|76234659|FG000|COMPLETED|Overall Study||31||
60114241|NCT02299570|76234660|FG001|COMPLETED|Overall Study||35||
60114242|NCT02299570|76234661|FG002|COMPLETED|Overall Study||25||
60114243|NCT02299570|76234659|FG000|NOT COMPLETED|Overall Study||14||
60114244|NCT02299570|76234660|FG001|NOT COMPLETED|Overall Study||9||
60114245|NCT02299570|76234661|FG002|NOT COMPLETED|Overall Study||19||
60114246|NCT02301364|76234674|FG000|STARTED|Overall Study||4||
60114247|NCT02301364|76234674|FG000|COMPLETED|Overall Study||4||
60114248|NCT02301364|76234674|FG000|NOT COMPLETED|Overall Study||0||
60114249|NCT03664726|76234682|FG000|STARTED|Overall Study||21||
60114250|NCT03664726|76234683|FG001|STARTED|Overall Study||20||
60114251|NCT03664726|76234684|FG002|STARTED|Overall Study||18||
60114252|NCT03664726|76234685|FG003|STARTED|Overall Study||19||
60114253|NCT03664726|76234682|FG000|COMPLETED|Overall Study||21||
60114254|NCT03664726|76234683|FG001|COMPLETED|Overall Study||20||
60114255|NCT03664726|76234684|FG002|COMPLETED|Overall Study||18||
60114256|NCT03664726|76234685|FG003|COMPLETED|Overall Study||19||
60114257|NCT03664726|76234682|FG000|NOT COMPLETED|Overall Study||0||
60114258|NCT03664726|76234683|FG001|NOT COMPLETED|Overall Study||0||
60114259|NCT03664726|76234684|FG002|NOT COMPLETED|Overall Study||0||
60114260|NCT03664726|76234685|FG003|NOT COMPLETED|Overall Study||0||
60114261|NCT02563522|76234703|FG000|STARTED|Overall Study||27||
60114262|NCT02563522|76234704|FG001|STARTED|Overall Study||17||
60114263|NCT02563522|76234703|FG000|COMPLETED|Overall Study||23||
59714956|NCT01196975|75833748|FG002|STARTED|Overall Study||425||
59714957|NCT01196975|75833749|FG003|STARTED|Overall Study||213||
59714958|NCT01196975|75833750|FG004|STARTED|Overall Study||218||
59714959|NCT01196975|75833746|FG000|COMPLETED|Overall Study||408||
59714960|NCT01196975|75833747|FG001|COMPLETED|Overall Study||415||
59714961|NCT01196975|75833748|FG002|COMPLETED|Overall Study||420||
59714962|NCT01196975|75833749|FG003|COMPLETED|Overall Study||207||
59714963|NCT01196975|75833750|FG004|COMPLETED|Overall Study||205||
59714964|NCT01196975|75833746|FG000|NOT COMPLETED|Overall Study||15||
59714965|NCT01196975|75833747|FG001|NOT COMPLETED|Overall Study||9||
59823819|NCT00483938|75946705|FG004|STARTED|Overall Study||25||
60114264|NCT02563522|76234704|FG001|COMPLETED|Overall Study||12||
60114265|NCT02563522|76234703|FG000|NOT COMPLETED|Overall Study||4||
60114266|NCT02563522|76234704|FG001|NOT COMPLETED|Overall Study||5||
60114267|NCT03578146|76234716|FG000|STARTED|Overall Study||16||
60114268|NCT03578146|76234717|FG001|STARTED|Overall Study||6||
60114269|NCT03578146|76234718|FG002|STARTED|Overall Study||6||
60114270|NCT03578146|76234719|FG003|STARTED|Overall Study||6||
59714966|NCT01196975|75833748|FG002|NOT COMPLETED|Overall Study||5||
59714967|NCT01196975|75833749|FG003|NOT COMPLETED|Overall Study||6||
59714968|NCT01196975|75833750|FG004|NOT COMPLETED|Overall Study||13||
59823820|NCT00483938|75946706|FG005|STARTED|Overall Study||26||
59823821|NCT00483938|75946707|FG006|STARTED|Overall Study||40||
59823822|NCT00483938|75946701|FG000|COMPLETED|Overall Study||36||
59823823|NCT00483938|75946702|FG001|COMPLETED|Overall Study||24||
59823824|NCT00483938|75946703|FG002|COMPLETED|Overall Study||30||
59823825|NCT00483938|75946704|FG003|COMPLETED|Overall Study||25||
59823826|NCT00483938|75946705|FG004|COMPLETED|Overall Study||23||
59823827|NCT00483938|75946706|FG005|COMPLETED|Overall Study||18||
59823828|NCT00483938|75946707|FG006|COMPLETED|Overall Study||0||
59823829|NCT00483938|75946701|FG000|NOT COMPLETED|Overall Study||5||
59823830|NCT00483938|75946702|FG001|NOT COMPLETED|Overall Study||19||
59823831|NCT00483938|75946703|FG002|NOT COMPLETED|Overall Study||0||
59823832|NCT00483938|75946704|FG003|NOT COMPLETED|Overall Study||6||
59823833|NCT00483938|75946705|FG004|NOT COMPLETED|Overall Study||2||
59823834|NCT00483938|75946706|FG005|NOT COMPLETED|Overall Study||8||
59823835|NCT00483938|75946707|FG006|NOT COMPLETED|Overall Study||40||
59823836|NCT00370071|75946726|FG000|STARTED|Overall Study||39||
59823837|NCT00370071|75946726|FG000|COMPLETED|Overall Study||37||
59996442|NCT02001623|76112390|FG006|COMPLETED|Overall Study||0||
59996443|NCT02001623|76112391|FG007|COMPLETED|Overall Study||0||
59996444|NCT02001623|76112392|FG008|COMPLETED|Overall Study||0||
59996445|NCT02001623|76112393|FG009|COMPLETED|Overall Study||2||
59996446|NCT02001623|76112394|FG010|COMPLETED|Overall Study||0||
59996447|NCT02001623|76112395|FG011|COMPLETED|Overall Study||0||
59996448|NCT02001623|76112396|FG012|COMPLETED|Overall Study||1||
60114271|NCT03578146|76234720|FG004|STARTED|Overall Study||6||
59823838|NCT00370071|75946726|FG000|NOT COMPLETED|Overall Study||2||
59823839|NCT00369915|75946732|FG000|STARTED|Overall Study||10||
59823840|NCT00369915|75946733|FG001|STARTED|Overall Study||7||
59996449|NCT02001623|76112397|FG013|COMPLETED|Overall Study||1||
59996450|NCT02001623|76112398|FG014|COMPLETED|Overall Study||0||
59996451|NCT02001623|76112384|FG000|NOT COMPLETED|Overall Study||3||
60114272|NCT03578146|76234721|FG005|STARTED|Overall Study||8||
60114273|NCT03578146|76234716|FG000|COMPLETED|Overall Study||15||
60114274|NCT03578146|76234717|FG001|COMPLETED|Overall Study||5||
60114275|NCT03578146|76234718|FG002|COMPLETED|Overall Study||5||
60114276|NCT03578146|76234719|FG003|COMPLETED|Overall Study||6||
60114277|NCT03578146|76234720|FG004|COMPLETED|Overall Study||6||
60114278|NCT03578146|76234721|FG005|COMPLETED|Overall Study||5||
60114279|NCT03578146|76234716|FG000|NOT COMPLETED|Overall Study||1||
60114280|NCT03578146|76234717|FG001|NOT COMPLETED|Overall Study||1||
60114281|NCT03578146|76234718|FG002|NOT COMPLETED|Overall Study||1||
60114282|NCT03578146|76234719|FG003|NOT COMPLETED|Overall Study||0||
60114283|NCT03578146|76234720|FG004|NOT COMPLETED|Overall Study||0||
60114284|NCT03578146|76234721|FG005|NOT COMPLETED|Overall Study||3||
60114285|NCT02716896|76234737|FG000|STARTED|Overall Study||1||
60114286|NCT02716896|76234738|FG001|STARTED|Overall Study||1||
60114287|NCT02716896|76234737|FG000|COMPLETED|Overall Study||1||
60114288|NCT02716896|76234738|FG001|COMPLETED|Overall Study||0||
60114289|NCT02716896|76234737|FG000|NOT COMPLETED|Overall Study||0||
60114290|NCT02716896|76234738|FG001|NOT COMPLETED|Overall Study||1||
60114291|NCT03510988|76234744|FG000|STARTED|Overall Study||14||
60114292|NCT03510988|76234744|FG000|COMPLETED|Overall Study||14||
60114293|NCT03510988|76234744|FG000|NOT COMPLETED|Overall Study||0||
60114294|NCT01986946|76234750|FG000|STARTED|Overall Study||5||
60114295|NCT01986946|76234751|FG001|STARTED|Overall Study||9||
60114296|NCT01986946|76234750|FG000|COMPLETED|Overall Study||5||
60114297|NCT01986946|76234751|FG001|COMPLETED|Overall Study||9||
60114298|NCT01986946|76234750|FG000|NOT COMPLETED|Overall Study||0||
60114299|NCT01986946|76234751|FG001|NOT COMPLETED|Overall Study||0||
60114300|NCT01987414|76234759|FG000|STARTED|Overall Study||10||
60114301|NCT01987414|76234760|FG001|STARTED|Overall Study||8||
60114302|NCT01987414|76234759|FG000|COMPLETED|Overall Study||8||
60114303|NCT01987414|76234760|FG001|COMPLETED|Overall Study||6||
60114304|NCT01987414|76234759|FG000|NOT COMPLETED|Overall Study||2||
60114305|NCT01987414|76234760|FG001|NOT COMPLETED|Overall Study||2||
60114306|NCT01909713|76234766|FG000|STARTED|Overall Study||35||
60114307|NCT01909713|76234766|FG000|COMPLETED|Overall Study||35||
60114308|NCT01909713|76234766|FG000|NOT COMPLETED|Overall Study||0||
60114309|NCT02715726|76234793|FG000|STARTED|Overall Study|Randomized|208||
60114310|NCT02715726|76234794|FG001|STARTED|Overall Study|Randomized|407||
60114311|NCT02715726|76234793|FG000|Treated|Overall Study||207||
60114312|NCT02715726|76234794|FG001|Treated|Overall Study||405||
60114313|NCT02715726|76234793|FG000|Safety Population|Overall Study||206|1 participant of ezetimibe arm received alirocumab: counted in alirocumab arm for safety analysis.|
60114314|NCT02715726|76234794|FG001|Safety Population|Overall Study||406|1 participant of ezetimibe arm received alirocumab: counted in alirocumab arm for safety analysis.|
60114315|NCT02715726|76234793|FG000|COMPLETED|Overall Study||190||
60114316|NCT02715726|76234794|FG001|COMPLETED|Overall Study||380||
60114317|NCT02715726|76234793|FG000|NOT COMPLETED|Overall Study||18||
60114318|NCT02715726|76234794|FG001|NOT COMPLETED|Overall Study||27||
60114319|NCT01893567|76234800|FG000|STARTED|Overall Study||28||
60114320|NCT01893567|76234800|FG000|COMPLETED|Overall Study||28||
60114321|NCT01893567|76234800|FG000|NOT COMPLETED|Overall Study||0||
60114322|NCT04248816|76234807|FG000|STARTED|Overall Study||123||
60114323|NCT04248816|76234808|FG001|STARTED|Overall Study||245||
60114324|NCT04248816|76234809|FG002|STARTED|Overall Study||247||
60114325|NCT04248816|76234807|FG000|COMPLETED|Overall Study||116||
60114326|NCT04248816|76234808|FG001|COMPLETED|Overall Study||224||
60114327|NCT04248816|76234809|FG002|COMPLETED|Overall Study||222||
60114328|NCT04248816|76234807|FG000|NOT COMPLETED|Overall Study||7||
60114329|NCT04248816|76234808|FG001|NOT COMPLETED|Overall Study||21||
60114330|NCT04248816|76234809|FG002|NOT COMPLETED|Overall Study||25||
60114331|NCT03426124|76234819|FG000|STARTED|Overall Study||991||
60114332|NCT03426124|76234820|FG001|STARTED|Overall Study||489||
60114333|NCT03426124|76234819|FG000|COMPLETED|Overall Study||941||
60114334|NCT03426124|76234820|FG001|COMPLETED|Overall Study||251||
60114335|NCT03426124|76234819|FG000|NOT COMPLETED|Overall Study||50||
60114336|NCT03426124|76234820|FG001|NOT COMPLETED|Overall Study||238||
60114337|NCT01989130|76234828|FG000|STARTED|Overall Study||43||
60114338|NCT01989130|76234829|FG001|STARTED|Overall Study||27||
60114339|NCT01989130|76234828|FG000|COMPLETED|Overall Study||43||
60114340|NCT01989130|76234829|FG001|COMPLETED|Overall Study||27||
60114341|NCT01989130|76234828|FG000|NOT COMPLETED|Overall Study||0||
60114342|NCT01989130|76234829|FG001|NOT COMPLETED|Overall Study||0||
60114343|NCT01989910|76234837|FG000|STARTED|Overall Study||53||
60114344|NCT01989910|76234838|FG001|STARTED|Overall Study||54||
60114345|NCT01989910|76234837|FG000|COMPLETED|Overall Study||51||
60114346|NCT01989910|76234838|FG001|COMPLETED|Overall Study||54||
60114347|NCT01989910|76234837|FG000|NOT COMPLETED|Overall Study||2||
60114348|NCT01989910|76234838|FG001|NOT COMPLETED|Overall Study||0||
60114349|NCT02314156|76234846|FG000|STARTED|Overall Study||33||
60114350|NCT02314156|76234847|FG001|STARTED|Overall Study||34||
60114351|NCT02314156|76234846|FG000|COMPLETED|Overall Study||31||
60114352|NCT02314156|76234847|FG001|COMPLETED|Overall Study||34||
60114353|NCT02314156|76234846|FG000|NOT COMPLETED|Overall Study||2||
60114354|NCT02314156|76234847|FG001|NOT COMPLETED|Overall Study||0||
60114355|NCT01991548|76234853|FG000|STARTED|Overall Study||40||
60114356|NCT01991548|76234853|FG000|COMPLETED|Overall Study||39||
60114357|NCT01991548|76234853|FG000|NOT COMPLETED|Overall Study||1||
60114358|NCT01991860|76234859|FG000|STARTED|Overall Study||176||
60114359|NCT01991860|76234860|FG001|STARTED|Overall Study||166||
60114360|NCT01991860|76234859|FG000|COMPLETED|Overall Study||172||
60114361|NCT01991860|76234860|FG001|COMPLETED|Overall Study||164||
60114362|NCT01991860|76234859|FG000|NOT COMPLETED|Overall Study||4||
60114363|NCT01991860|76234860|FG001|NOT COMPLETED|Overall Study||2||
60114364|NCT01986790|76234869|FG000|STARTED|Overall Study||91||
60114365|NCT01986790|76234870|FG001|STARTED|Overall Study||154||
60114366|NCT01986790|76234871|FG002|STARTED|Overall Study||98||
60114367|NCT01986790|76234869|FG000|COMPLETED|Overall Study||91||
60114368|NCT01986790|76234870|FG001|COMPLETED|Overall Study||154||
60114369|NCT01986790|76234871|FG002|COMPLETED|Overall Study||98||
60114370|NCT01986790|76234869|FG000|NOT COMPLETED|Overall Study||0||
60114371|NCT01986790|76234870|FG001|NOT COMPLETED|Overall Study||0||
60114372|NCT01986790|76234871|FG002|NOT COMPLETED|Overall Study||0||
60114373|NCT01992016|76234881|FG000|STARTED|Overall Study||4||
60114374|NCT01992016|76234882|FG001|STARTED|Overall Study||7||
60114375|NCT01992016|76234881|FG000|COMPLETED|Overall Study||4||
60114376|NCT01992016|76234882|FG001|COMPLETED|Overall Study||7||
60114377|NCT01992016|76234881|FG000|NOT COMPLETED|Overall Study||0||
60114378|NCT01992016|76234882|FG001|NOT COMPLETED|Overall Study||0||
60114379|NCT01992172|76234890|FG000|STARTED|Overall Study||7||
60114380|NCT01992172|76234891|FG001|STARTED|Overall Study||0||
60114381|NCT01992172|76234890|FG000|COMPLETED|Overall Study||7||
60114382|NCT01992172|76234891|FG001|COMPLETED|Overall Study||0||
60114383|NCT01992172|76234890|FG000|NOT COMPLETED|Overall Study||0||
60114384|NCT01992172|76234891|FG001|NOT COMPLETED|Overall Study||0||
60114385|NCT01853163|76234901|FG000|STARTED|Overall Study||45||
60114386|NCT01853163|76234902|FG001|STARTED|Overall Study||29||
60114387|NCT01853163|76234903|FG002|STARTED|Overall Study||7||
60114388|NCT01853163|76234904|FG003|STARTED|Overall Study||11||
60114389|NCT01853163|76234901|FG000|COMPLETED|Overall Study||45||
60114390|NCT01853163|76234902|FG001|COMPLETED|Overall Study||29||
60114391|NCT01853163|76234903|FG002|COMPLETED|Overall Study||7||
60114392|NCT01853163|76234904|FG003|COMPLETED|Overall Study||11||
60114393|NCT01853163|76234901|FG000|NOT COMPLETED|Overall Study||0||
60114394|NCT01853163|76234902|FG001|NOT COMPLETED|Overall Study||0||
60114395|NCT01853163|76234903|FG002|NOT COMPLETED|Overall Study||0||
60114396|NCT01853163|76234904|FG003|NOT COMPLETED|Overall Study||0||
60114397|NCT01852071|76234918|FG000|STARTED|Overall Study||20||
60114398|NCT01852071|76234919|FG001|STARTED|Overall Study||26||
60114399|NCT01852071|76234918|FG000|COMPLETED|Overall Study||20||
60114400|NCT01852071|76234919|FG001|COMPLETED|Overall Study||26||
60114401|NCT01852071|76234918|FG000|NOT COMPLETED|Overall Study||0||
60114402|NCT01852071|76234919|FG001|NOT COMPLETED|Overall Study||0||
60114403|NCT02059642|76234933|FG000|STARTED|Overall Study||148||
60114404|NCT02059642|76234934|FG001|STARTED|Overall Study||152||
60114405|NCT02059642|76234933|FG000|COMPLETED|Overall Study||121||
60114406|NCT02059642|76234934|FG001|COMPLETED|Overall Study||128||
60114407|NCT02059642|76234933|FG000|NOT COMPLETED|Overall Study||27||
60114408|NCT02059642|76234934|FG001|NOT COMPLETED|Overall Study||24||
60114409|NCT02087163|76234940|FG000|STARTED|Overall Study||90||
60114410|NCT02087163|76234940|FG000|COMPLETED|Overall Study||73||
60114411|NCT02087163|76234940|FG000|NOT COMPLETED|Overall Study||17||
60114412|NCT02318979|76234946|FG000|STARTED|Overall Study||15||
60114413|NCT02318979|76234947|FG001|STARTED|Overall Study||15||
60114414|NCT02318979|76234946|FG000|COMPLETED|Overall Study||15||
60114415|NCT02318979|76234947|FG001|COMPLETED|Overall Study||15||
60114416|NCT02318979|76234946|FG000|NOT COMPLETED|Overall Study||0||
60114417|NCT02318979|76234947|FG001|NOT COMPLETED|Overall Study||0||
60114418|NCT01992874|76234957|FG000|STARTED|Part A||21||
60114419|NCT01992874|76234958|FG001|STARTED|Part A||17||
60114420|NCT01992874|76234959|FG002|STARTED|Part A||0||
60114421|NCT01992874|76234957|FG000|COMPLETED|Part A||21||
60114422|NCT01992874|76234958|FG001|COMPLETED|Part A||17||
60114423|NCT01992874|76234959|FG002|COMPLETED|Part A||0||
60114424|NCT01992874|76234957|FG000|NOT COMPLETED|Part A||0||
60114425|NCT01992874|76234958|FG001|NOT COMPLETED|Part A||0||
60114426|NCT01992874|76234959|FG002|NOT COMPLETED|Part A||0||
60114427|NCT01992874|76234957|FG000|STARTED|Part B||0||
60114428|NCT01992874|76234958|FG001|STARTED|Part B||0||
60114429|NCT01992874|76234959|FG002|STARTED|Part B||38||
60114430|NCT01992874|76234957|FG000|COMPLETED|Part B||0||
60114431|NCT01992874|76234958|FG001|COMPLETED|Part B||0||
60114432|NCT01992874|76234959|FG002|COMPLETED|Part B||38||
59567177|NCT03989427|75670039|FG000|NOT COMPLETED|First Intervention (2 Weeks)||0||
59567178|NCT03989427|75670040|FG001|NOT COMPLETED|First Intervention (2 Weeks)||0||
60114433|NCT01992874|76234957|FG000|NOT COMPLETED|Part B||0||
60114434|NCT01992874|76234958|FG001|NOT COMPLETED|Part B||0||
60114435|NCT01992874|76234959|FG002|NOT COMPLETED|Part B||0||
60114436|NCT01993108|76234971|FG000|STARTED|Overall Study||11||
60114437|NCT01993108|76234972|FG001|STARTED|Overall Study||12||
60114438|NCT01993108|76234971|FG000|COMPLETED|Overall Study||11||
60114439|NCT01993108|76234972|FG001|COMPLETED|Overall Study||12||
60114440|NCT01993108|76234971|FG000|NOT COMPLETED|Overall Study||0||
60114441|NCT01993108|76234972|FG001|NOT COMPLETED|Overall Study||0||
60114442|NCT02307526|76234990|FG000|STARTED|Day 1 - No Drug||10||
60114443|NCT02307526|76234990|FG000|COMPLETED|Day 1 - No Drug||10||
60114444|NCT02307526|76234990|FG000|NOT COMPLETED|Day 1 - No Drug||0||
60114445|NCT02307526|76234990|FG000|STARTED|Day 2 - 60 mg of Pyridostigmine||10||
59567179|NCT03989427|75670039|FG000|STARTED|Washout (1 Week)||15||
59567180|NCT03989427|75670040|FG001|STARTED|Washout (1 Week)||15||
59714969|NCT00992589|75833785|FG000|STARTED|Open-Label Phase||344||
59714970|NCT00992589|75833786|FG001|STARTED|Open-Label Phase||0||
59714971|NCT00992589|75833787|FG002|STARTED|Open-Label Phase||0||
59714972|NCT00992589|75833788|FG003|STARTED|Open-Label Phase||0||
59714973|NCT00992589|75833785|FG000|COMPLETED|Open-Label Phase||267||
59714974|NCT00992589|75833786|FG001|COMPLETED|Open-Label Phase||0||
60114446|NCT02307526|76234990|FG000|COMPLETED|Day 2 - 60 mg of Pyridostigmine||10||
60114447|NCT02307526|76234990|FG000|NOT COMPLETED|Day 2 - 60 mg of Pyridostigmine||0||
60114448|NCT02307838|76234999|FG000|STARTED|Overall Study||56||
60114449|NCT02307838|76235000|FG001|STARTED|Overall Study||64||
60114450|NCT02307838|76235001|FG002|STARTED|Overall Study||55||
60114451|NCT02307838|76234999|FG000|COMPLETED|Overall Study||56||
60114452|NCT02307838|76235000|FG001|COMPLETED|Overall Study||64||
60114453|NCT02307838|76235001|FG002|COMPLETED|Overall Study||55||
60114454|NCT02307838|76234999|FG000|NOT COMPLETED|Overall Study||0||
60114455|NCT02307838|76235000|FG001|NOT COMPLETED|Overall Study||0||
60114456|NCT02307838|76235001|FG002|NOT COMPLETED|Overall Study||0||
60114457|NCT02307916|76235012|FG000|STARTED|Overall Study||42||
60114458|NCT02307916|76235013|FG001|STARTED|Overall Study||15||
60114459|NCT02307916|76235012|FG000|COMPLETED|Overall Study||40||
60114460|NCT02307916|76235013|FG001|COMPLETED|Overall Study||14||
60114461|NCT02307916|76235012|FG000|NOT COMPLETED|Overall Study||2||
60114462|NCT02307916|76235013|FG001|NOT COMPLETED|Overall Study||1||
60114463|NCT01994746|76235019|FG000|STARTED|First Visit||39||
60114464|NCT01994746|76235020|FG001|STARTED|First Visit||38||
60114465|NCT01994746|76235019|FG000|Received At Least 1 Dose|First Visit||39||
60114466|NCT01994746|76235020|FG001|Received At Least 1 Dose|First Visit||38||
60114467|NCT01994746|76235019|FG000|COMPLETED|First Visit||39||
60114468|NCT01994746|76235020|FG001|COMPLETED|First Visit||38||
60114469|NCT01994746|76235019|FG000|NOT COMPLETED|First Visit||0||
60114470|NCT01994746|76235020|FG001|NOT COMPLETED|First Visit||0||
60114471|NCT01994746|76235019|FG000|STARTED|Second Visit|One participant requested to withdraw after completing the first dosing visit.|38||
60114472|NCT01994746|76235020|FG001|STARTED|Second Visit||38||
60114473|NCT01994746|76235019|FG000|Completed Both Dosing Visits|Second Visit||38||
60114474|NCT01994746|76235020|FG001|Completed Both Dosing Visits|Second Visit||38||
60114475|NCT01994746|76235019|FG000|COMPLETED|Second Visit||38||
60114476|NCT01994746|76235020|FG001|COMPLETED|Second Visit||38||
60114477|NCT01994746|76235019|FG000|NOT COMPLETED|Second Visit||0||
60114478|NCT01994746|76235020|FG001|NOT COMPLETED|Second Visit||0||
60114479|NCT05333601|76235026|FG000|STARTED|Overall Study||44||
60114480|NCT05333601|76235026|FG000|COMPLETED|Overall Study||31||
60114481|NCT05333601|76235026|FG000|NOT COMPLETED|Overall Study||13||
60114482|NCT01997398|76235030|FG000|STARTED|Overall Study||35||
60114483|NCT01997398|76235030|FG000|COMPLETED|Overall Study|One patient took PD meds 3 hours prior to 6 mo. UPDRS testing and was excluded from the analysis.|34||
60114484|NCT01997398|76235030|FG000|NOT COMPLETED|Overall Study||1||
60114485|NCT01999192|76235043|FG000|STARTED|Main Phase I||83||
60114486|NCT01999192|76235044|FG001|STARTED|Main Phase I||80||
60114487|NCT01999192|76235045|FG002|STARTED|Main Phase I||78||
60114488|NCT01999192|76235046|FG003|STARTED|Main Phase I||80||
60114489|NCT01999192|76235043|FG000|COMPLETED|Main Phase I||72||
60114490|NCT01999192|76235044|FG001|COMPLETED|Main Phase I||70||
60114491|NCT01999192|76235045|FG002|COMPLETED|Main Phase I||70||
60114492|NCT01999192|76235046|FG003|COMPLETED|Main Phase I||72||
60114493|NCT01999192|76235043|FG000|NOT COMPLETED|Main Phase I||11||
60114494|NCT01999192|76235044|FG001|NOT COMPLETED|Main Phase I||10||
60114495|NCT01999192|76235045|FG002|NOT COMPLETED|Main Phase I||8||
60114496|NCT01999192|76235046|FG003|NOT COMPLETED|Main Phase I||8||
60114497|NCT01999192|76235043|FG000|STARTED|Main Phase II|Non-responders were switched to higher dose Level after Main Phase 1, started = completed -switched.|64||
60114498|NCT01999192|76235044|FG001|STARTED|Main Phase II|started Patient = completed patients + switched patients (non-responder) from other arms.|75||
60114499|NCT01999192|76235045|FG002|STARTED|Main Phase II|started Patient = completed patients + switched patients (non-responder) from other arms.|98||
60114500|NCT01999192|76235046|FG003|STARTED|Main Phase II|non-responders were switched to higher dose Level after Main Phase 1, started = completed -switched|44||
60114501|NCT01999192|76235043|FG000|COMPLETED|Main Phase II||55||
60114502|NCT01999192|76235044|FG001|COMPLETED|Main Phase II||66||
60114503|NCT01999192|76235045|FG002|COMPLETED|Main Phase II||76||
60114504|NCT01999192|76235046|FG003|COMPLETED|Main Phase II||43||
60114505|NCT01999192|76235043|FG000|NOT COMPLETED|Main Phase II||9||
60114506|NCT01999192|76235044|FG001|NOT COMPLETED|Main Phase II||9||
59567181|NCT03989427|75670039|FG000|COMPLETED|Washout (1 Week)||15||
59567182|NCT03989427|75670040|FG001|COMPLETED|Washout (1 Week)||15||
59567183|NCT03989427|75670039|FG000|NOT COMPLETED|Washout (1 Week)||0||
59567184|NCT03989427|75670040|FG001|NOT COMPLETED|Washout (1 Week)||0||
59567185|NCT03989427|75670039|FG000|STARTED|Second Intervention (2 Weeks)||15||
59567186|NCT03989427|75670040|FG001|STARTED|Second Intervention (2 Weeks)||15||
60114507|NCT01999192|76235045|FG002|NOT COMPLETED|Main Phase II||22||
60114508|NCT01999192|76235046|FG003|NOT COMPLETED|Main Phase II||1||
60114509|NCT01999192|76235043|FG000|STARTED|Extension Phase|Some patients terminated or were switched to higher dose Level after Main Phase 2.|54||
60114510|NCT01999192|76235044|FG001|STARTED|Extension Phase|Some patients terminated or were switched to higher dose Level after Main Phase 2.|56||
59567187|NCT03989427|75670039|FG000|COMPLETED|Second Intervention (2 Weeks)||15||
59567188|NCT03989427|75670040|FG001|COMPLETED|Second Intervention (2 Weeks)||15||
59567189|NCT03989427|75670039|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||0||
59714975|NCT00992589|75833787|FG002|COMPLETED|Open-Label Phase||0||
60114511|NCT01999192|76235045|FG002|STARTED|Extension Phase|Some patients terminated after Main Phase 2.|68||
60114512|NCT01999192|76235046|FG003|STARTED|Extension Phase|No Placebo arm for Extension Phase, all patients terminated or were switched to tregalizumab Groups.|0||
60114513|NCT01999192|76235043|FG000|COMPLETED|Extension Phase||41||
60114514|NCT01999192|76235044|FG001|COMPLETED|Extension Phase||38||
60114515|NCT01999192|76235045|FG002|COMPLETED|Extension Phase||44||
60114516|NCT01999192|76235046|FG003|COMPLETED|Extension Phase||0||
60114517|NCT01999192|76235043|FG000|NOT COMPLETED|Extension Phase||13||
60114518|NCT01999192|76235044|FG001|NOT COMPLETED|Extension Phase||18||
60114519|NCT01999192|76235045|FG002|NOT COMPLETED|Extension Phase||24||
60114520|NCT01999192|76235046|FG003|NOT COMPLETED|Extension Phase||0||
60114521|NCT01999348|76235056|FG000|STARTED|Overall Study||1553||
60114522|NCT01999348|76235056|FG000|COMPLETED|Overall Study||1433||
60114523|NCT01999348|76235056|FG000|NOT COMPLETED|Overall Study||120||
60114524|NCT02716584|76235062|FG000|STARTED|Overall Study||35||
60114525|NCT02716584|76235063|FG001|STARTED|Overall Study||18||
60114526|NCT02716584|76235062|FG000|COMPLETED|Overall Study||27||
60114527|NCT02716584|76235063|FG001|COMPLETED|Overall Study||13||
60114528|NCT02716584|76235062|FG000|NOT COMPLETED|Overall Study||8||
60114529|NCT02716584|76235063|FG001|NOT COMPLETED|Overall Study||5||
60114530|NCT02061748|76235071|FG000|STARTED|Overall Study||7646||
60114531|NCT02061748|76235072|FG001|STARTED|Overall Study||30853||
60114532|NCT02061748|76235071|FG000|COMPLETED|Overall Study||7646||
60114533|NCT02061748|76235072|FG001|COMPLETED|Overall Study||30853||
60114534|NCT02061748|76235071|FG000|NOT COMPLETED|Overall Study||0||
60114535|NCT02061748|76235072|FG001|NOT COMPLETED|Overall Study||0||
60114536|NCT02062294|76235078|FG000|STARTED|Overall Study||14||
60114537|NCT02062294|76235078|FG000|COMPLETED|Overall Study||14||
60114538|NCT02062294|76235078|FG000|NOT COMPLETED|Overall Study||0||
60114539|NCT02062606|76235082|FG000|STARTED|Overall Study||188||
60114540|NCT02062606|76235082|FG000|COMPLETED|Overall Study||99||
60114541|NCT02062606|76235082|FG000|NOT COMPLETED|Overall Study||89||
60114542|NCT02063230|76235119|FG000|STARTED|Overall Study||8||
60114543|NCT02063230|76235120|FG001|STARTED|Overall Study||8||
60114544|NCT02063230|76235121|FG002|STARTED|Overall Study||8||
60114545|NCT02063230|76235122|FG003|STARTED|Overall Study||8||
60114546|NCT02063230|76235119|FG000|Received Treatment|Overall Study||8||
60114547|NCT02063230|76235120|FG001|Received Treatment|Overall Study||8||
60114548|NCT02063230|76235121|FG002|Received Treatment|Overall Study||8||
60114549|NCT02063230|76235122|FG003|Received Treatment|Overall Study||8||
60114550|NCT02063230|76235119|FG000|COMPLETED|Overall Study||8||
60114551|NCT02063230|76235120|FG001|COMPLETED|Overall Study||8||
60114552|NCT02063230|76235121|FG002|COMPLETED|Overall Study||8||
60114553|NCT02063230|76235122|FG003|COMPLETED|Overall Study||8||
60114554|NCT02063230|76235119|FG000|NOT COMPLETED|Overall Study||0||
60114555|NCT02063230|76235120|FG001|NOT COMPLETED|Overall Study||0||
60114556|NCT02063230|76235121|FG002|NOT COMPLETED|Overall Study||0||
60114557|NCT02063230|76235122|FG003|NOT COMPLETED|Overall Study||0||
60114558|NCT02000908|76235134|FG000|STARTED|Overall Study||30||
60114559|NCT02000908|76235135|FG001|STARTED|Overall Study||40||
60114560|NCT02000908|76235134|FG000|COMPLETED|Overall Study||28||
60114561|NCT02000908|76235135|FG001|COMPLETED|Overall Study||36||
60114562|NCT02000908|76235134|FG000|NOT COMPLETED|Overall Study||2||
60114563|NCT02000908|76235135|FG001|NOT COMPLETED|Overall Study||4||
60114564|NCT02716194|76235144|FG000|STARTED|Period 1 - ADVATE||11||
60114565|NCT02716194|76235145|FG001|STARTED|Period 1 - ADVATE||16||
60114566|NCT02716194|76235146|FG002|STARTED|Period 1 - ADVATE||13||
60114567|NCT02716194|76235144|FG000|COMPLETED|Period 1 - ADVATE||10||
60114568|NCT02716194|76235145|FG001|COMPLETED|Period 1 - ADVATE||15||
60114569|NCT02716194|76235146|FG002|COMPLETED|Period 1 - ADVATE||13||
60114570|NCT02716194|76235144|FG000|NOT COMPLETED|Period 1 - ADVATE||1||
60114571|NCT02716194|76235145|FG001|NOT COMPLETED|Period 1 - ADVATE||1||
60114572|NCT02716194|76235146|FG002|NOT COMPLETED|Period 1 - ADVATE||0||
60114573|NCT02716194|76235144|FG000|STARTED|Period 2 - BAX 826||10||
60114574|NCT02716194|76235145|FG001|STARTED|Period 2 - BAX 826||15||
60114575|NCT02716194|76235146|FG002|STARTED|Period 2 - BAX 826||13||
59567190|NCT03989427|75670040|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||0||
59714976|NCT00992589|75833788|FG003|COMPLETED|Open-Label Phase||0||
59714977|NCT00992589|75833785|FG000|NOT COMPLETED|Open-Label Phase||77||
60114576|NCT02716194|76235144|FG000|COMPLETED|Period 2 - BAX 826||10||
60114577|NCT02716194|76235145|FG001|COMPLETED|Period 2 - BAX 826||15||
60114578|NCT02716194|76235146|FG002|COMPLETED|Period 2 - BAX 826||13||
60114579|NCT02716194|76235144|FG000|NOT COMPLETED|Period 2 - BAX 826||0||
60114580|NCT02716194|76235145|FG001|NOT COMPLETED|Period 2 - BAX 826||0||
60114581|NCT02716194|76235146|FG002|NOT COMPLETED|Period 2 - BAX 826||0||
60114582|NCT02002702|76235170|FG000|STARTED|Overall Study||16||
60114583|NCT02002702|76235171|FG001|STARTED|Overall Study||15||
60114584|NCT02002702|76235172|FG002|STARTED|Overall Study||15||
59567191|NCT03007719|75670049|FG000|STARTED|Overall Study||0||
59567192|NCT03007719|75670050|FG001|STARTED|Overall Study||4||
60114585|NCT02002702|76235170|FG000|COMPLETED|Overall Study||16||
60114586|NCT02002702|76235171|FG001|COMPLETED|Overall Study||15||
60114587|NCT02002702|76235172|FG002|COMPLETED|Overall Study||15||
60114588|NCT02002702|76235170|FG000|NOT COMPLETED|Overall Study||0||
60114589|NCT02002702|76235171|FG001|NOT COMPLETED|Overall Study||0||
60114590|NCT02002702|76235172|FG002|NOT COMPLETED|Overall Study||0||
60114591|NCT02002936|76235180|FG000|STARTED|Overall Study||1||
60114592|NCT02002936|76235180|FG000|COMPLETED|Overall Study||1||
60114593|NCT02002936|76235180|FG000|NOT COMPLETED|Overall Study||0||
60114594|NCT02003404|76235184|FG000|STARTED|Overall Study||17||
60114595|NCT02003404|76235184|FG000|COMPLETED|Overall Study||17||
60114596|NCT02003404|76235184|FG000|NOT COMPLETED|Overall Study||0||
60114597|NCT00003270|76235190|FG000|STARTED|Overall Study||20||
60114598|NCT00003270|76235190|FG000|COMPLETED|Overall Study||20||
60114599|NCT00003270|76235190|FG000|NOT COMPLETED|Overall Study||0||
60114600|NCT02005354|76235196|FG000|STARTED|Overall Study||35||
60114601|NCT02005354|76235197|FG001|STARTED|Overall Study||35||
60114602|NCT02005354|76235196|FG000|COMPLETED|Overall Study||35||
60114603|NCT02005354|76235197|FG001|COMPLETED|Overall Study||35||
59567193|NCT03007719|75670049|FG000|COMPLETED|Overall Study||0||
59714978|NCT00992589|75833786|FG001|NOT COMPLETED|Open-Label Phase||0||
59714979|NCT00992589|75833787|FG002|NOT COMPLETED|Open-Label Phase||0||
59714980|NCT00992589|75833788|FG003|NOT COMPLETED|Open-Label Phase||0||
60114604|NCT02005354|76235196|FG000|NOT COMPLETED|Overall Study||0||
60114605|NCT02005354|76235197|FG001|NOT COMPLETED|Overall Study||0||
60114606|NCT02066740|76235203|FG000|STARTED|Overall Study||34||
60114607|NCT02066740|76235203|FG000|COMPLETED|Overall Study||32||
60114608|NCT02066740|76235203|FG000|NOT COMPLETED|Overall Study||2||
60114609|NCT02066896|76235209|FG000|STARTED|Overall Study||33||
60114610|NCT02066896|76235210|FG001|STARTED|Overall Study||33||
60114611|NCT02066896|76235209|FG000|COMPLETED|Overall Study||33||
60114612|NCT02066896|76235210|FG001|COMPLETED|Overall Study||33||
60114613|NCT02066896|76235209|FG000|NOT COMPLETED|Overall Study||0||
60114614|NCT02066896|76235210|FG001|NOT COMPLETED|Overall Study||0||
60114615|NCT03773484|76235216|FG000|STARTED|Pre-intervention||41||
60114616|NCT03773484|76235216|FG000|COMPLETED|Pre-intervention||41||
60114617|NCT03773484|76235216|FG000|NOT COMPLETED|Pre-intervention||0||
60114618|NCT03773484|76235216|FG000|STARTED|Post-intervention||41||
60114619|NCT03773484|76235216|FG000|COMPLETED|Post-intervention||36||
60114620|NCT03773484|76235216|FG000|NOT COMPLETED|Post-intervention||5||
60114621|NCT02334358|76235220|FG000|STARTED|Overall Study||503||
60114622|NCT02334358|76235220|FG000|COMPLETED|Overall Study||494||
60114623|NCT02334358|76235220|FG000|NOT COMPLETED|Overall Study||9||
60114624|NCT02005510|76235226|FG000|STARTED|Randomized (Round 1)|Excludes 163 determined to be ineligible post-randomization due to delays in data warehouse update.|8120||
60114625|NCT02005510|76235227|FG001|STARTED|Randomized (Round 1)|Excludes 196 determined to be ineligible post-randomization due to delays in data warehouse update.|8111||
60114626|NCT02005510|76235226|FG000|COMPLETED|Randomized (Round 1)||8120||
60114627|NCT02005510|76235227|FG001|COMPLETED|Randomized (Round 1)||8111||
60114628|NCT02005510|76235226|FG000|NOT COMPLETED|Randomized (Round 1)||0||
60114629|NCT02005510|76235227|FG001|NOT COMPLETED|Randomized (Round 1)||0||
60114630|NCT02005510|76235226|FG000|STARTED|Rerandomized (Round 2)|Excludes 10 determined to be ineligible post-randomization due to delays in data warehouse update.|1631||
60114631|NCT02005510|76235227|FG001|STARTED|Rerandomized (Round 2)|Excludes 5 determined to be ineligible post-randomization due to delays in data warehouse update.|1585||
60114632|NCT02005510|76235226|FG000|COMPLETED|Rerandomized (Round 2)||1631||
60114633|NCT02005510|76235227|FG001|COMPLETED|Rerandomized (Round 2)||1585||
60114634|NCT02005510|76235226|FG000|NOT COMPLETED|Rerandomized (Round 2)||0||
60114635|NCT02005510|76235227|FG001|NOT COMPLETED|Rerandomized (Round 2)||0||
60114636|NCT02005510|76235226|FG000|STARTED|Rerandomized (Round 3)|Excludes 5 determined to be ineligible post-randomization due to delays in data warehouse update.|209||
60114637|NCT02005510|76235227|FG001|STARTED|Rerandomized (Round 3)||195||
60114638|NCT02005510|76235226|FG000|COMPLETED|Rerandomized (Round 3)||209||
60114639|NCT02005510|76235227|FG001|COMPLETED|Rerandomized (Round 3)||195||
60114640|NCT02005510|76235226|FG000|NOT COMPLETED|Rerandomized (Round 3)||0||
60114641|NCT02005510|76235227|FG001|NOT COMPLETED|Rerandomized (Round 3)||0||
60114642|NCT02005666|76235236|FG000|STARTED|Overall Study||338||
60114643|NCT02005666|76235237|FG001|STARTED|Overall Study||343||
60114644|NCT02005666|76235238|FG002|STARTED|Overall Study||169||
59823841|NCT00369915|75946732|FG000|COMPLETED|Overall Study||4||
59823842|NCT00369915|75946733|FG001|COMPLETED|Overall Study||4||
60114645|NCT02005666|76235236|FG000|COMPLETED|Overall Study||311||
60114646|NCT02005666|76235237|FG001|COMPLETED|Overall Study||299||
60114647|NCT02005666|76235238|FG002|COMPLETED|Overall Study||160||
60114648|NCT02005666|76235236|FG000|NOT COMPLETED|Overall Study||27||
60114649|NCT02005666|76235237|FG001|NOT COMPLETED|Overall Study||44||
60114650|NCT02005666|76235238|FG002|NOT COMPLETED|Overall Study||9||
60114651|NCT02006056|76235248|FG000|STARTED|Overall Study||26||
60114652|NCT02006056|76235249|FG001|STARTED|Overall Study||4||
60114653|NCT02006056|76235248|FG000|COMPLETED|Overall Study||26||
60114654|NCT02006056|76235249|FG001|COMPLETED|Overall Study||4||
60114655|NCT02006056|76235248|FG000|NOT COMPLETED|Overall Study||0||
60114656|NCT02006056|76235249|FG001|NOT COMPLETED|Overall Study||0||
60114657|NCT02006836|76235258|FG000|STARTED|Case-control Period: Month 1- Month 6||20||
60114658|NCT02006836|76235259|FG001|STARTED|Case-control Period: Month 1- Month 6||20||
60114659|NCT02006836|76235260|FG002|STARTED|Case-control Period: Month 1- Month 6||0||
60114660|NCT02006836|76235258|FG000|COMPLETED|Case-control Period: Month 1- Month 6||20||
60114661|NCT02006836|76235259|FG001|COMPLETED|Case-control Period: Month 1- Month 6||20||
60114662|NCT02006836|76235260|FG002|COMPLETED|Case-control Period: Month 1- Month 6||0||
60114663|NCT02006836|76235258|FG000|NOT COMPLETED|Case-control Period: Month 1- Month 6||0||
60114664|NCT02006836|76235259|FG001|NOT COMPLETED|Case-control Period: Month 1- Month 6||0||
60114665|NCT02006836|76235260|FG002|NOT COMPLETED|Case-control Period: Month 1- Month 6||0||
60114666|NCT02006836|76235258|FG000|STARTED|Self-control Period: Month 7-month 12||0||
60114667|NCT02006836|76235259|FG001|STARTED|Self-control Period: Month 7-month 12||0||
60114668|NCT02006836|76235260|FG002|STARTED|Self-control Period: Month 7-month 12||19||
60114669|NCT02006836|76235258|FG000|COMPLETED|Self-control Period: Month 7-month 12||0||
60114670|NCT02006836|76235259|FG001|COMPLETED|Self-control Period: Month 7-month 12||0||
60114671|NCT02006836|76235260|FG002|COMPLETED|Self-control Period: Month 7-month 12||19||
60114672|NCT02006836|76235258|FG000|NOT COMPLETED|Self-control Period: Month 7-month 12||0||
60114673|NCT02006836|76235259|FG001|NOT COMPLETED|Self-control Period: Month 7-month 12||0||
60114674|NCT02006836|76235260|FG002|NOT COMPLETED|Self-control Period: Month 7-month 12||0||
60114675|NCT02068846|76235272|FG000|STARTED|Overall Study||9||
60114676|NCT02068846|76235273|FG001|STARTED|Overall Study||8||
60114677|NCT02068846|76235272|FG000|COMPLETED|Overall Study||8||
60114678|NCT02068846|76235273|FG001|COMPLETED|Overall Study||7||
60114679|NCT02068846|76235272|FG000|NOT COMPLETED|Overall Study||1||
60114680|NCT02068846|76235273|FG001|NOT COMPLETED|Overall Study||1||
60114681|NCT02069704|76235281|FG000|STARTED|Overall Study|Two patients were randomized but they did not received study treatment|69||
60114682|NCT02069704|76235282|FG001|STARTED|Overall Study||71||
60114683|NCT02069704|76235281|FG000|COMPLETED|Overall Study||69||
60114684|NCT02069704|76235282|FG001|COMPLETED|Overall Study||71||
60114685|NCT02069704|76235281|FG000|NOT COMPLETED|Overall Study||0||
59823843|NCT00369915|75946732|FG000|NOT COMPLETED|Overall Study||6||
59823844|NCT00369915|75946733|FG001|NOT COMPLETED|Overall Study||3||
59823845|NCT00369681|75946739|FG000|STARTED|Overall Study||50||
59823846|NCT00369681|75946739|FG000|COMPLETED|Overall Study||49||
59823847|NCT00369681|75946739|FG000|NOT COMPLETED|Overall Study||1||
59823848|NCT00266812|75946745|FG000|STARTED|Overall Study||22||
60114686|NCT02069704|76235282|FG001|NOT COMPLETED|Overall Study||0||
60114687|NCT02314546|76235298|FG000|STARTED|Overall Study||5||
60114688|NCT02314546|76235299|FG001|STARTED|Overall Study||5||
60114689|NCT02314546|76235300|FG002|STARTED|Overall Study||5||
60114690|NCT02314546|76235298|FG000|COMPLETED|Overall Study||5||
60114691|NCT02314546|76235299|FG001|COMPLETED|Overall Study||5||
60114692|NCT02314546|76235300|FG002|COMPLETED|Overall Study||5||
60114693|NCT02314546|76235298|FG000|NOT COMPLETED|Overall Study||0||
60114694|NCT02314546|76235299|FG001|NOT COMPLETED|Overall Study||0||
60114695|NCT02314546|76235300|FG002|NOT COMPLETED|Overall Study||0||
60114696|NCT02314936|76235313|FG000|STARTED|Overall Study||48||
60114697|NCT02314936|76235314|FG001|STARTED|Overall Study||48||
60114698|NCT02314936|76235315|FG002|STARTED|Overall Study||48||
60114699|NCT02314936|76235316|FG003|STARTED|Overall Study||48||
60114700|NCT02314936|76235313|FG000|COMPLETED|Overall Study||48||
60114701|NCT02314936|76235314|FG001|COMPLETED|Overall Study||48||
60114702|NCT02314936|76235315|FG002|COMPLETED|Overall Study||46||
60114703|NCT02314936|76235316|FG003|COMPLETED|Overall Study||48||
60114704|NCT02314936|76235313|FG000|NOT COMPLETED|Overall Study||0||
60114705|NCT02314936|76235314|FG001|NOT COMPLETED|Overall Study||0||
60114706|NCT02314936|76235315|FG002|NOT COMPLETED|Overall Study||2||
60114707|NCT02314936|76235316|FG003|NOT COMPLETED|Overall Study||0||
60114708|NCT02334436|76235328|FG000|STARTED|Overall Study||246||
60114709|NCT02334436|76235329|FG001|STARTED|Overall Study||78||
60114710|NCT02334436|76235328|FG000|COMPLETED|Overall Study||237||
60114711|NCT02334436|76235329|FG001|COMPLETED|Overall Study||77||
60114712|NCT02334436|76235328|FG000|NOT COMPLETED|Overall Study||9||
60114713|NCT02334436|76235329|FG001|NOT COMPLETED|Overall Study||1||
60114714|NCT01958788|76235335|FG000|STARTED|Overall Study||7||
60114715|NCT01958788|76235335|FG000|COMPLETED|Overall Study||7||
60114716|NCT01958788|76235335|FG000|NOT COMPLETED|Overall Study||0||
60114717|NCT02070640|76235341|FG000|STARTED|Overall Study||93||
60114718|NCT02070640|76235342|FG001|STARTED|Overall Study||6||
60114719|NCT02070640|76235341|FG000|COMPLETED|Overall Study||82||
60114720|NCT02070640|76235342|FG001|COMPLETED|Overall Study||6||
60114721|NCT02070640|76235341|FG000|NOT COMPLETED|Overall Study||11||
60114722|NCT02070640|76235342|FG001|NOT COMPLETED|Overall Study||0||
60114723|NCT02071108|76235349|FG000|STARTED|Overall Study||35||
60114724|NCT02071108|76235349|FG000|COMPLETED|Overall Study||35||
60114725|NCT02071108|76235349|FG000|NOT COMPLETED|Overall Study||0||
60114726|NCT02008942|76235353|FG000|STARTED|First Intervention||27||
60114727|NCT02008942|76235354|FG001|STARTED|First Intervention||30||
60114728|NCT02008942|76235353|FG000|COMPLETED|First Intervention||27||
60114729|NCT02008942|76235354|FG001|COMPLETED|First Intervention||30||
60114730|NCT02008942|76235353|FG000|NOT COMPLETED|First Intervention||0||
60114731|NCT02008942|76235354|FG001|NOT COMPLETED|First Intervention||0||
60114732|NCT02008942|76235353|FG000|STARTED|Second Intervention||26||
60114733|NCT02008942|76235354|FG001|STARTED|Second Intervention||30||
60114734|NCT02008942|76235353|FG000|COMPLETED|Second Intervention||25||
60114735|NCT02008942|76235354|FG001|COMPLETED|Second Intervention||30||
60114736|NCT02008942|76235353|FG000|NOT COMPLETED|Second Intervention||1||
60114737|NCT02008942|76235354|FG001|NOT COMPLETED|Second Intervention||0||
60114738|NCT02071420|76235362|FG000|STARTED|Overall Study||30||
60114739|NCT02071420|76235363|FG001|STARTED|Overall Study||30||
60114740|NCT02071420|76235362|FG000|COMPLETED|Overall Study||27||
60114741|NCT02071420|76235363|FG001|COMPLETED|Overall Study||27||
60114742|NCT02071420|76235362|FG000|NOT COMPLETED|Overall Study||3||
60114743|NCT02071420|76235363|FG001|NOT COMPLETED|Overall Study||3||
60114744|NCT01959178|76235369|FG000|STARTED|Overall Study||73||
60114745|NCT01959178|76235370|FG001|STARTED|Overall Study||73||
60114746|NCT01959178|76235369|FG000|COMPLETED|Overall Study||71||
60114747|NCT01959178|76235370|FG001|COMPLETED|Overall Study||71||
59567194|NCT03007719|75670050|FG001|COMPLETED|Overall Study||4||
60114748|NCT01959178|76235369|FG000|NOT COMPLETED|Overall Study||2||
60114749|NCT01959178|76235370|FG001|NOT COMPLETED|Overall Study||2||
60114750|NCT02071810|76235381|FG000|STARTED|Overall Study||6||
60114751|NCT02071810|76235382|FG001|STARTED|Overall Study||6||
60114752|NCT02071810|76235383|FG002|STARTED|Overall Study||6||
60114753|NCT02071810|76235384|FG003|STARTED|Overall Study||7||
59567195|NCT03007719|75670049|FG000|NOT COMPLETED|Overall Study||0||
59567196|NCT03007719|75670050|FG001|NOT COMPLETED|Overall Study||0||
60114754|NCT02071810|76235385|FG004|STARTED|Overall Study||9||
60114755|NCT02071810|76235381|FG000|COMPLETED|Overall Study||6||
60114756|NCT02071810|76235382|FG001|COMPLETED|Overall Study||6||
60114757|NCT02071810|76235383|FG002|COMPLETED|Overall Study||6||
60114758|NCT02071810|76235384|FG003|COMPLETED|Overall Study||6||
60114759|NCT02071810|76235385|FG004|COMPLETED|Overall Study||8||
60114760|NCT02071810|76235381|FG000|NOT COMPLETED|Overall Study||0||
60114761|NCT02071810|76235382|FG001|NOT COMPLETED|Overall Study||0||
60114762|NCT02071810|76235383|FG002|NOT COMPLETED|Overall Study||0||
60114763|NCT02071810|76235384|FG003|NOT COMPLETED|Overall Study||1||
60114764|NCT02071810|76235385|FG004|NOT COMPLETED|Overall Study||1||
60114765|NCT02715258|76235399|FG000|STARTED|Overall Study||140||
60114766|NCT02715258|76235400|FG001|STARTED|Overall Study||70||
60114767|NCT02715258|76235399|FG000|Intent to Treat/Safety Analysis|Overall Study||138|Three randomized subject numbers were excluded in the ITT and the safety populations due to GCP violation.|
60114768|NCT02715258|76235400|FG001|Intent to Treat/Safety Analysis|Overall Study||69|Three randomized subject numbers were excluded in the ITT and the safety populations due to GCP violation.|
60114769|NCT02715258|76235399|FG000|COMPLETED|Overall Study||124||
60114770|NCT02715258|76235400|FG001|COMPLETED|Overall Study||64||
60114771|NCT02715258|76235399|FG000|NOT COMPLETED|Overall Study||16||
60114772|NCT02715258|76235400|FG001|NOT COMPLETED|Overall Study||6||
59714981|NCT00992589|75833785|FG000|STARTED|Double-Blind Phase||0||
59714982|NCT00992589|75833786|FG001|STARTED|Double-Blind Phase||89||
59714983|NCT00992589|75833787|FG002|STARTED|Double-Blind Phase||90||
59714984|NCT00992589|75833788|FG003|STARTED|Double-Blind Phase||88||
60114773|NCT01959490|76235409|FG000|STARTED|Overall Study||5||
59714985|NCT00992589|75833785|FG000|COMPLETED|Double-Blind Phase||0||
60114774|NCT01959490|76235410|FG001|STARTED|Overall Study||6||
60114775|NCT01959490|76235411|FG002|STARTED|Overall Study||5||
60114776|NCT01959490|76235409|FG000|COMPLETED|Overall Study||5||
60114777|NCT01959490|76235410|FG001|COMPLETED|Overall Study||6||
59714986|NCT00992589|75833786|FG001|COMPLETED|Double-Blind Phase||76||
60114778|NCT01959490|76235411|FG002|COMPLETED|Overall Study||5||
60114779|NCT01959490|76235409|FG000|NOT COMPLETED|Overall Study||0||
60114780|NCT01959490|76235410|FG001|NOT COMPLETED|Overall Study||0||
60114781|NCT01959490|76235411|FG002|NOT COMPLETED|Overall Study||0||
60114782|NCT02304406|76235419|FG000|STARTED|Overall Study||449||
60114783|NCT02304406|76235419|FG000|COMPLETED|Overall Study||449||
60114784|NCT02304406|76235419|FG000|NOT COMPLETED|Overall Study||0||
60114785|NCT02714868|76235425|FG000|STARTED|Overall Study||47||
60114786|NCT02714868|76235426|FG001|STARTED|Overall Study||35||
60114787|NCT02714868|76235425|FG000|COMPLETED|Overall Study||42||
60114788|NCT02714868|76235426|FG001|COMPLETED|Overall Study||35||
60114789|NCT02714868|76235425|FG000|NOT COMPLETED|Overall Study||5||
60114790|NCT02714868|76235426|FG001|NOT COMPLETED|Overall Study||0||
60114791|NCT02011516|76235435|FG000|STARTED|Overall Study||8||
60114792|NCT02011516|76235436|FG001|STARTED|Overall Study||8||
60114793|NCT02011516|76235435|FG000|COMPLETED|Overall Study||4||
60114794|NCT02011516|76235436|FG001|COMPLETED|Overall Study||6||
60114795|NCT02011516|76235435|FG000|NOT COMPLETED|Overall Study||4||
60114796|NCT02011516|76235436|FG001|NOT COMPLETED|Overall Study||2||
60114797|NCT01961362|76235442|FG000|STARTED|Overall Study||19||
60114798|NCT01961362|76235442|FG000|COMPLETED|Overall Study||19||
60114799|NCT01961362|76235442|FG000|NOT COMPLETED|Overall Study||0||
60114800|NCT01776723|76235451|FG000|STARTED|Overall Study||6||
60114801|NCT01776723|76235452|FG001|STARTED|Overall Study||4||
60114802|NCT01776723|76235453|FG002|STARTED|Overall Study||5||
60114803|NCT01776723|76235454|FG003|STARTED|Overall Study||5||
60114804|NCT01776723|76235455|FG004|STARTED|Overall Study||30||
60114805|NCT01776723|76235451|FG000|COMPLETED|Overall Study||6||
60114806|NCT01776723|76235452|FG001|COMPLETED|Overall Study||4||
60114807|NCT01776723|76235453|FG002|COMPLETED|Overall Study||5||
60114808|NCT01776723|76235454|FG003|COMPLETED|Overall Study||5||
60114809|NCT01776723|76235455|FG004|COMPLETED|Overall Study||30||
60114810|NCT01776723|76235451|FG000|NOT COMPLETED|Overall Study||0||
60114811|NCT01776723|76235452|FG001|NOT COMPLETED|Overall Study||0||
60114812|NCT01776723|76235453|FG002|NOT COMPLETED|Overall Study||0||
60114813|NCT01776723|76235454|FG003|NOT COMPLETED|Overall Study||0||
60114814|NCT01776723|76235455|FG004|NOT COMPLETED|Overall Study||0||
59714987|NCT00992589|75833787|FG002|COMPLETED|Double-Blind Phase||77||
60114815|NCT04046328|76235471|FG000|STARTED|First Intervention (14 Days)||6||
60114816|NCT04046328|76235472|FG001|STARTED|First Intervention (14 Days)||7||
60114817|NCT04046328|76235471|FG000|COMPLETED|First Intervention (14 Days)||6||
60114818|NCT04046328|76235472|FG001|COMPLETED|First Intervention (14 Days)||7||
60114819|NCT04046328|76235471|FG000|NOT COMPLETED|First Intervention (14 Days)||0||
60114820|NCT04046328|76235472|FG001|NOT COMPLETED|First Intervention (14 Days)||0||
60114821|NCT04046328|76235471|FG000|STARTED|Washout (14 Days)||6||
60114822|NCT04046328|76235472|FG001|STARTED|Washout (14 Days)||7||
60114823|NCT04046328|76235471|FG000|COMPLETED|Washout (14 Days)||6||
60114824|NCT04046328|76235472|FG001|COMPLETED|Washout (14 Days)||7||
60114825|NCT04046328|76235471|FG000|NOT COMPLETED|Washout (14 Days)||0||
60114826|NCT04046328|76235472|FG001|NOT COMPLETED|Washout (14 Days)||0||
60114827|NCT04046328|76235471|FG000|STARTED|Second Intervention (14 Days)||6||
60114828|NCT04046328|76235472|FG001|STARTED|Second Intervention (14 Days)||7||
60114829|NCT04046328|76235471|FG000|COMPLETED|Second Intervention (14 Days)||6||
60114830|NCT04046328|76235472|FG001|COMPLETED|Second Intervention (14 Days)||7||
60114831|NCT04046328|76235471|FG000|NOT COMPLETED|Second Intervention (14 Days)||0||
60114832|NCT04046328|76235472|FG001|NOT COMPLETED|Second Intervention (14 Days)||0||
60114833|NCT00136695|76235480|FG000|STARTED|Overall Study||45||
60114834|NCT00136695|76235481|FG001|STARTED|Overall Study||43||
60114835|NCT00136695|76235480|FG000|COMPLETED|Overall Study||34||
59714988|NCT00992589|75833788|FG003|COMPLETED|Double-Blind Phase||78||
60114836|NCT00136695|76235481|FG001|COMPLETED|Overall Study||35||
60114837|NCT00136695|76235480|FG000|NOT COMPLETED|Overall Study||11||
60114838|NCT00136695|76235481|FG001|NOT COMPLETED|Overall Study||8||
60114839|NCT01252719|76235489|FG000|STARTED|Overall Study|Participants Randomized|483||
60114840|NCT01252719|76235490|FG001|STARTED|Overall Study|Participants Randomized|485||
60114841|NCT01252719|76235489|FG000|Modified Intent to Treat Population|Overall Study||475||
60114842|NCT01252719|76235490|FG001|Modified Intent to Treat Population|Overall Study||479||
60114843|NCT01252719|76235489|FG000|COMPLETED|Overall Study||433||
60114844|NCT01252719|76235490|FG001|COMPLETED|Overall Study||423||
60114845|NCT01252719|76235489|FG000|NOT COMPLETED|Overall Study||50||
60114846|NCT01252719|76235490|FG001|NOT COMPLETED|Overall Study||62||
60114847|NCT02342314|76235498|FG000|STARTED|Part A||6||
60114848|NCT02342314|76235499|FG001|STARTED|Part A||3||
60114849|NCT02342314|76235500|FG002|STARTED|Part A||3||
60114850|NCT02342314|76235501|FG003|STARTED|Part A||3||
60114851|NCT02342314|76235502|FG004|STARTED|Part A||6||
60114852|NCT02342314|76235503|FG005|STARTED|Part A||3||
60114853|NCT02342314|76235504|FG006|STARTED|Part A||0||
60114854|NCT02342314|76235505|FG007|STARTED|Part A||0||
60114855|NCT02342314|76235506|FG008|STARTED|Part A||0||
60114856|NCT02342314|76235507|FG009|STARTED|Part A||0||
60114857|NCT02342314|76235508|FG010|STARTED|Part A||0||
60114858|NCT02342314|76235509|FG011|STARTED|Part A||0||
60114859|NCT02342314|76235510|FG012|STARTED|Part A||0||
60114860|NCT02342314|76235511|FG013|STARTED|Part A||0||
60114861|NCT02342314|76235512|FG014|STARTED|Part A||0||
60114862|NCT02342314|76235513|FG015|STARTED|Part A||0||
60114863|NCT02342314|76235514|FG016|STARTED|Part A||0||
60114864|NCT02342314|76235498|FG000|COMPLETED|Part A||6||
60114865|NCT02342314|76235499|FG001|COMPLETED|Part A||3||
60114866|NCT02342314|76235500|FG002|COMPLETED|Part A||3||
60114867|NCT02342314|76235501|FG003|COMPLETED|Part A||3||
60114868|NCT02342314|76235502|FG004|COMPLETED|Part A||6||
60114869|NCT02342314|76235503|FG005|COMPLETED|Part A||3||
60114870|NCT02342314|76235504|FG006|COMPLETED|Part A||0||
60114871|NCT02342314|76235505|FG007|COMPLETED|Part A||0||
60114872|NCT02342314|76235506|FG008|COMPLETED|Part A||0||
60114873|NCT02342314|76235507|FG009|COMPLETED|Part A||0||
60114874|NCT02342314|76235508|FG010|COMPLETED|Part A||0||
60114875|NCT02342314|76235509|FG011|COMPLETED|Part A||0||
60114876|NCT02342314|76235510|FG012|COMPLETED|Part A||0||
60114877|NCT02342314|76235511|FG013|COMPLETED|Part A||0||
60114878|NCT02342314|76235512|FG014|COMPLETED|Part A||0||
60114879|NCT02342314|76235513|FG015|COMPLETED|Part A||0||
60114880|NCT02342314|76235514|FG016|COMPLETED|Part A||0||
60114881|NCT02342314|76235498|FG000|NOT COMPLETED|Part A||0||
60114882|NCT02342314|76235499|FG001|NOT COMPLETED|Part A||0||
60114883|NCT02342314|76235500|FG002|NOT COMPLETED|Part A||0||
60114884|NCT02342314|76235501|FG003|NOT COMPLETED|Part A||0||
60114885|NCT02342314|76235502|FG004|NOT COMPLETED|Part A||0||
60114886|NCT02342314|76235503|FG005|NOT COMPLETED|Part A||0||
60114887|NCT02342314|76235504|FG006|NOT COMPLETED|Part A||0||
60114888|NCT02342314|76235505|FG007|NOT COMPLETED|Part A||0||
60114889|NCT02342314|76235506|FG008|NOT COMPLETED|Part A||0||
60114890|NCT02342314|76235507|FG009|NOT COMPLETED|Part A||0||
60114891|NCT02342314|76235508|FG010|NOT COMPLETED|Part A||0||
60114892|NCT02342314|76235509|FG011|NOT COMPLETED|Part A||0||
60114893|NCT02342314|76235510|FG012|NOT COMPLETED|Part A||0||
60114894|NCT02342314|76235511|FG013|NOT COMPLETED|Part A||0||
60114895|NCT02342314|76235512|FG014|NOT COMPLETED|Part A||0||
60114896|NCT02342314|76235513|FG015|NOT COMPLETED|Part A||0||
60114897|NCT02342314|76235514|FG016|NOT COMPLETED|Part A||0||
60114898|NCT02342314|76235498|FG000|STARTED|Part B|Participants received placebo in Part A.|0||
60114899|NCT02342314|76235499|FG001|STARTED|Part B|Participants received LY3143753 in Part A.|0||
60114900|NCT02342314|76235500|FG002|STARTED|Part B|Participants received LY3143753 in Part A.|0||
60114901|NCT02342314|76235501|FG003|STARTED|Part B|Participants received LY3143753 in Part A.|0||
60114902|NCT02342314|76235502|FG004|STARTED|Part B|Participants received LY3143753 in Part A.|0||
60114903|NCT02342314|76235503|FG005|STARTED|Part B|Participants received LY3143753 in Part A.|0||
60114904|NCT02342314|76235504|FG006|STARTED|Part B|Participants received placebo in Part B.|11||
60114905|NCT02342314|76235505|FG007|STARTED|Part B|Participants received LY3185643 in Part B.|3||
60114906|NCT02342314|76235506|FG008|STARTED|Part B|Participants received LY3185643 in Part B.|3||
60114907|NCT02342314|76235507|FG009|STARTED|Part B|Participants received LY3185643 in Part B.|3||
60114908|NCT02342314|76235508|FG010|STARTED|Part B|Participants received LY3185643 in Part B.|3||
60114909|NCT02342314|76235509|FG011|STARTED|Part B|Participants received LY3185643 in Part B.|3||
60114910|NCT02342314|76235510|FG012|STARTED|Part B|Participants received LY3185643 in Part B.|3||
60114911|NCT02342314|76235511|FG013|STARTED|Part B|Participants received LY3185643 in Part B.|3||
60114912|NCT02342314|76235512|FG014|STARTED|Part B|Participants received LY3185643 in Part B.|3||
60114913|NCT02342314|76235513|FG015|STARTED|Part B|Participants received LY3185643 in Part B.|3||
60114914|NCT02342314|76235514|FG016|STARTED|Part B|Participants received rGlucagon in Part B.|6||
60114915|NCT02342314|76235498|FG000|COMPLETED|Part B||0||
60114916|NCT02342314|76235499|FG001|COMPLETED|Part B||0||
59714989|NCT00992589|75833785|FG000|NOT COMPLETED|Double-Blind Phase||0||
59823849|NCT00266812|75946746|FG001|STARTED|Overall Study||13||
59823850|NCT00266812|75946745|FG000|COMPLETED|Overall Study||1||
59823851|NCT00266812|75946746|FG001|COMPLETED|Overall Study||2||
59823852|NCT00266812|75946745|FG000|NOT COMPLETED|Overall Study||21||
59823853|NCT00266812|75946746|FG001|NOT COMPLETED|Overall Study||11||
59823854|NCT00488774|75946756|FG000|STARTED|Overall Study||77||
59823855|NCT00488774|75946757|FG001|STARTED|Overall Study||62||
59823856|NCT00488774|75946758|FG002|STARTED|Overall Study||75||
59823857|NCT00488774|75946759|FG003|STARTED|Overall Study||77||
59823858|NCT00488774|75946756|FG000|COMPLETED|Overall Study||69||
59823859|NCT00488774|75946757|FG001|COMPLETED|Overall Study||57||
59823860|NCT00488774|75946758|FG002|COMPLETED|Overall Study||70||
59823861|NCT00488774|75946759|FG003|COMPLETED|Overall Study||74||
59823862|NCT00488774|75946756|FG000|NOT COMPLETED|Overall Study||8||
59823863|NCT00488774|75946757|FG001|NOT COMPLETED|Overall Study||5||
59823864|NCT00488774|75946758|FG002|NOT COMPLETED|Overall Study||5||
59823865|NCT00488774|75946759|FG003|NOT COMPLETED|Overall Study||3||
59823866|NCT00361569|75946774|FG000|STARTED|Overall Study||150||
59823867|NCT00361569|75946775|FG001|STARTED|Overall Study||161||
59823868|NCT00361569|75946776|FG002|STARTED|Overall Study||155||
59823869|NCT00361569|75946777|FG003|STARTED|Overall Study||156||
59823870|NCT00361569|75946774|FG000|COMPLETED|Overall Study||138||
59823871|NCT00361569|75946775|FG001|COMPLETED|Overall Study||150||
59823872|NCT00361569|75946776|FG002|COMPLETED|Overall Study||137||
59823873|NCT00361569|75946777|FG003|COMPLETED|Overall Study||135||
59823874|NCT00361569|75946774|FG000|NOT COMPLETED|Overall Study||12||
59823875|NCT00361569|75946775|FG001|NOT COMPLETED|Overall Study||11||
59823876|NCT00361569|75946776|FG002|NOT COMPLETED|Overall Study||18||
59823877|NCT00361569|75946777|FG003|NOT COMPLETED|Overall Study||21||
59823878|NCT00488618|75946789|FG000|STARTED|Overall Study||120||
59823879|NCT00488618|75946790|FG001|STARTED|Overall Study||118||
59823880|NCT00488618|75946789|FG000|Safety Population: Received Study Drug|Overall Study||118||
59714990|NCT00992589|75833786|FG001|NOT COMPLETED|Double-Blind Phase||13||
59714991|NCT00992589|75833787|FG002|NOT COMPLETED|Double-Blind Phase||13||
59714992|NCT00992589|75833788|FG003|NOT COMPLETED|Double-Blind Phase||10||
59714993|NCT01196741|75833808|FG000|STARTED|Overall Study||71||
59714994|NCT01196741|75833809|FG001|STARTED|Overall Study||36||
59714995|NCT01196741|75833808|FG000|COMPLETED|Overall Study||11||
59714996|NCT01196741|75833809|FG001|COMPLETED|Overall Study||8||
59714997|NCT01196741|75833808|FG000|NOT COMPLETED|Overall Study||60||
59714998|NCT01196741|75833809|FG001|NOT COMPLETED|Overall Study||28||
59714999|NCT00983385|75833815|FG000|STARTED|Observation Period||208||
60114917|NCT02342314|76235500|FG002|COMPLETED|Part B||0||
60114918|NCT02342314|76235501|FG003|COMPLETED|Part B||0||
60114919|NCT02342314|76235502|FG004|COMPLETED|Part B||0||
60114920|NCT02342314|76235503|FG005|COMPLETED|Part B||0||
60114921|NCT02342314|76235504|FG006|COMPLETED|Part B||11||
60114922|NCT02342314|76235505|FG007|COMPLETED|Part B||3||
60114923|NCT02342314|76235506|FG008|COMPLETED|Part B||3||
59715000|NCT00983385|75833815|FG000|COMPLETED|Observation Period||176||
59715001|NCT00983385|75833815|FG000|NOT COMPLETED|Observation Period||32||
59715002|NCT00983385|75833815|FG000|STARTED|Titration and Optimal Dose Period||176||
59823881|NCT00488618|75946790|FG001|Safety Population: Received Study Drug|Overall Study||118||
59823882|NCT00488618|75946789|FG000|COMPLETED|Overall Study||73||
60114924|NCT02342314|76235507|FG009|COMPLETED|Part B||3||
59823883|NCT00488618|75946790|FG001|COMPLETED|Overall Study||75||
59823884|NCT00488618|75946789|FG000|NOT COMPLETED|Overall Study||47||
59823885|NCT00488618|75946790|FG001|NOT COMPLETED|Overall Study||43||
60114925|NCT02342314|76235508|FG010|COMPLETED|Part B||3||
60114926|NCT02342314|76235509|FG011|COMPLETED|Part B||3||
60114927|NCT02342314|76235510|FG012|COMPLETED|Part B||3||
60114928|NCT02342314|76235511|FG013|COMPLETED|Part B||3||
60114929|NCT02342314|76235512|FG014|COMPLETED|Part B||3||
60114930|NCT02342314|76235513|FG015|COMPLETED|Part B||3||
60114931|NCT02342314|76235514|FG016|COMPLETED|Part B||6||
60114932|NCT02342314|76235498|FG000|NOT COMPLETED|Part B||0||
60114933|NCT02342314|76235499|FG001|NOT COMPLETED|Part B||0||
60114934|NCT02342314|76235500|FG002|NOT COMPLETED|Part B||0||
60114935|NCT02342314|76235501|FG003|NOT COMPLETED|Part B||0||
60114936|NCT02342314|76235502|FG004|NOT COMPLETED|Part B||0||
60114937|NCT02342314|76235503|FG005|NOT COMPLETED|Part B||0||
60114938|NCT02342314|76235504|FG006|NOT COMPLETED|Part B||0||
60114939|NCT02342314|76235505|FG007|NOT COMPLETED|Part B||0||
60114940|NCT02342314|76235506|FG008|NOT COMPLETED|Part B||0||
60114941|NCT02342314|76235507|FG009|NOT COMPLETED|Part B||0||
60114942|NCT02342314|76235508|FG010|NOT COMPLETED|Part B||0||
60114943|NCT02342314|76235509|FG011|NOT COMPLETED|Part B||0||
60114944|NCT02342314|76235510|FG012|NOT COMPLETED|Part B||0||
60114945|NCT02342314|76235511|FG013|NOT COMPLETED|Part B||0||
60114946|NCT02342314|76235512|FG014|NOT COMPLETED|Part B||0||
60114947|NCT02342314|76235513|FG015|NOT COMPLETED|Part B||0||
59715003|NCT00983385|75833815|FG000|COMPLETED|Titration and Optimal Dose Period||140||
59715004|NCT00983385|75833815|FG000|NOT COMPLETED|Titration and Optimal Dose Period||36||
59715005|NCT00983385|75833815|FG000|STARTED|Maintenance Period||140||
59823886|NCT00266656|75946798|FG000|STARTED|Overall Study||36||
59823887|NCT00266656|75946799|FG001|STARTED|Overall Study||33||
59823888|NCT00266656|75946798|FG000|COMPLETED|Overall Study||22||
59715006|NCT00983385|75833815|FG000|COMPLETED|Maintenance Period||117||
59715007|NCT00983385|75833815|FG000|NOT COMPLETED|Maintenance Period||23||
59715008|NCT00992511|75833838|FG000|STARTED|Overall Study||76||
59715009|NCT00992511|75833839|FG001|STARTED|Overall Study||73||
59715010|NCT00992511|75833840|FG002|STARTED|Overall Study||76||
59823889|NCT00266656|75946799|FG001|COMPLETED|Overall Study||20||
59823890|NCT00266656|75946798|FG000|NOT COMPLETED|Overall Study||14||
59823891|NCT00266656|75946799|FG001|NOT COMPLETED|Overall Study||13||
59823892|NCT00483704|75946808|FG000|STARTED|Randomization||644||
59823893|NCT00483704|75946809|FG001|STARTED|Randomization||645||
59823894|NCT00483704|75946810|FG002|STARTED|Randomization||646||
59823895|NCT00483704|75946808|FG000|COMPLETED|Randomization||573||
59823896|NCT00483704|75946809|FG001|COMPLETED|Randomization||549||
59823897|NCT00483704|75946810|FG002|COMPLETED|Randomization||555||
59823898|NCT00483704|75946808|FG000|NOT COMPLETED|Randomization||71||
59823899|NCT00483704|75946809|FG001|NOT COMPLETED|Randomization||96||
59823900|NCT00483704|75946810|FG002|NOT COMPLETED|Randomization||91||
59823901|NCT00483704|75946808|FG000|STARTED|Treatment||573||
59823902|NCT00483704|75946809|FG001|STARTED|Treatment||549||
59823903|NCT00483704|75946810|FG002|STARTED|Treatment||555||
59823904|NCT00483704|75946808|FG000|COMPLETED|Treatment||444||
59567197|NCT02985801|75670058|FG000|STARTED|Overall Study||8||
59567198|NCT02985801|75670059|FG001|STARTED|Overall Study||8||
59567199|NCT02985801|75670058|FG000|COMPLETED|Overall Study||8||
59567200|NCT02985801|75670059|FG001|COMPLETED|Overall Study||8||
59567201|NCT02985801|75670058|FG000|NOT COMPLETED|Overall Study||0||
59567202|NCT02985801|75670059|FG001|NOT COMPLETED|Overall Study||0||
59567203|NCT00550550|75670067|FG000|STARTED|Overall Study||176||
59567204|NCT00550550|75670068|FG001|STARTED|Overall Study||169||
59567205|NCT00550550|75670067|FG000|Number Treated|Overall Study||175||
59567206|NCT00550550|75670068|FG001|Number Treated|Overall Study||169||
59567207|NCT00550550|75670067|FG000|COMPLETED|Overall Study||142||
60114948|NCT02342314|76235514|FG016|NOT COMPLETED|Part B||0||
60114949|NCT01230411|76235587|FG000|STARTED|Overall Study||21||
59567208|NCT00550550|75670068|FG001|COMPLETED|Overall Study||140||
59567209|NCT00550550|75670067|FG000|NOT COMPLETED|Overall Study||34||
59715011|NCT00992511|75833841|FG003|STARTED|Overall Study||75||
59715012|NCT00992511|75833838|FG000|COMPLETED|Overall Study||74||
59823905|NCT00483704|75946809|FG001|COMPLETED|Treatment||420||
59823906|NCT00483704|75946810|FG002|COMPLETED|Treatment||399||
59823907|NCT00483704|75946808|FG000|NOT COMPLETED|Treatment||129||
59823908|NCT00483704|75946809|FG001|NOT COMPLETED|Treatment||129||
59823909|NCT00483704|75946810|FG002|NOT COMPLETED|Treatment||156||
59823910|NCT00483548|75946823|FG000|STARTED|Overall Study||148||
59823911|NCT00483548|75946824|FG001|STARTED|Overall Study||150||
59823912|NCT00483548|75946823|FG000|Received Study Treatment|Overall Study|1 subject randomized but lost to follow up; no treatment data.|147||
59823913|NCT00483548|75946824|FG001|Received Study Treatment|Overall Study|3 subjects randomized but not treated.|147||
59823914|NCT00483548|75946823|FG000|COMPLETED|Overall Study||88||
59823915|NCT00483548|75946824|FG001|COMPLETED|Overall Study||104||
59823916|NCT00483548|75946823|FG000|NOT COMPLETED|Overall Study||60||
59823917|NCT00483548|75946824|FG001|NOT COMPLETED|Overall Study||46||
59823918|NCT00445770|75946833|FG000|STARTED|Overall Study||176||
59823919|NCT00445770|75946834|FG001|STARTED|Overall Study||192||
59823920|NCT00445770|75946835|FG002|STARTED|Overall Study||182||
60114950|NCT01230411|76235588|FG001|STARTED|Overall Study||23||
60114951|NCT01230411|76235587|FG000|COMPLETED|Overall Study||21||
60114952|NCT01230411|76235588|FG001|COMPLETED|Overall Study||23||
60114953|NCT01230411|76235587|FG000|NOT COMPLETED|Overall Study||0||
60114954|NCT01230411|76235588|FG001|NOT COMPLETED|Overall Study||0||
60114955|NCT01962688|76235596|FG000|STARTED|Overall Study||19||
60114956|NCT01962688|76235597|FG001|STARTED|Overall Study||18||
60114957|NCT01962688|76235596|FG000|COMPLETED|Overall Study||19||
60114958|NCT01962688|76235597|FG001|COMPLETED|Overall Study||18||
60114959|NCT01962688|76235596|FG000|NOT COMPLETED|Overall Study||0||
60114960|NCT01962688|76235597|FG001|NOT COMPLETED|Overall Study||0||
60114961|NCT02309944|76235605|FG000|STARTED|Overall Study||38||
60114962|NCT02309944|76235606|FG001|STARTED|Overall Study||43||
60114963|NCT02309944|76235605|FG000|COMPLETED|Overall Study||38||
60114964|NCT02309944|76235606|FG001|COMPLETED|Overall Study||43||
60114965|NCT02309944|76235605|FG000|NOT COMPLETED|Overall Study||0||
60114966|NCT02309944|76235606|FG001|NOT COMPLETED|Overall Study||0||
60114967|NCT02311972|76235614|FG000|STARTED|Overall Study||12||
60114968|NCT02311972|76235615|FG001|STARTED|Overall Study||8||
60114969|NCT02311972|76235614|FG000|COMPLETED|Overall Study||12||
60114970|NCT02311972|76235615|FG001|COMPLETED|Overall Study||8||
60114971|NCT02311972|76235614|FG000|NOT COMPLETED|Overall Study||0||
60114972|NCT02311972|76235615|FG001|NOT COMPLETED|Overall Study||0||
60114973|NCT01963078|76235626|FG000|STARTED|Overall Study||9||
60114974|NCT01963078|76235627|FG001|STARTED|Overall Study||10||
60114975|NCT01963078|76235628|FG002|STARTED|Overall Study||10||
59823921|NCT00445770|75946833|FG000|COMPLETED|Overall Study||123||
59567210|NCT00550550|75670068|FG001|NOT COMPLETED|Overall Study||29||
59567211|NCT02971839|75670079|FG000|STARTED|Overall Study||2||
60114976|NCT01963078|76235629|FG003|STARTED|Overall Study||9||
60114977|NCT01963078|76235626|FG000|COMPLETED|Overall Study||8||
60114978|NCT01963078|76235627|FG001|COMPLETED|Overall Study||9||
60114979|NCT01963078|76235628|FG002|COMPLETED|Overall Study||9||
60114980|NCT01963078|76235629|FG003|COMPLETED|Overall Study||7||
59567212|NCT02971839|75670080|FG001|STARTED|Overall Study||2||
59567213|NCT02971839|75670081|FG002|STARTED|Overall Study||2||
59567214|NCT02971839|75670082|FG003|STARTED|Overall Study||2||
59715013|NCT00992511|75833839|FG001|COMPLETED|Overall Study||73||
59823922|NCT00445770|75946834|FG001|COMPLETED|Overall Study||157||
59823923|NCT00445770|75946835|FG002|COMPLETED|Overall Study||151||
60114981|NCT01963078|76235626|FG000|NOT COMPLETED|Overall Study||1||
60114982|NCT01963078|76235627|FG001|NOT COMPLETED|Overall Study||1||
60114983|NCT01963078|76235628|FG002|NOT COMPLETED|Overall Study||1||
60114984|NCT01963078|76235629|FG003|NOT COMPLETED|Overall Study||2||
60114985|NCT01963234|76235642|FG000|STARTED|Overall Study||268||
60114986|NCT01963234|76235643|FG001|STARTED|Overall Study||171||
60114987|NCT01963234|76235642|FG000|COMPLETED|Overall Study||207||
60114988|NCT01963234|76235643|FG001|COMPLETED|Overall Study||171||
60114989|NCT01963234|76235642|FG000|NOT COMPLETED|Overall Study||61||
60114990|NCT01963234|76235643|FG001|NOT COMPLETED|Overall Study||0||
60114991|NCT02346916|76235655|FG000|STARTED|Overall Study||20||
60114992|NCT02346916|76235655|FG000|COMPLETED|Overall Study||20||
60114993|NCT02346916|76235655|FG000|NOT COMPLETED|Overall Study||0||
60114994|NCT01964092|76235661|FG000|STARTED|Overall Study||229||
60114995|NCT01964092|76235662|FG001|STARTED|Overall Study||181||
60114996|NCT01964092|76235661|FG000|COMPLETED|Overall Study||227||
60114997|NCT01964092|76235662|FG001|COMPLETED|Overall Study||181||
60114998|NCT01964092|76235661|FG000|NOT COMPLETED|Overall Study||2||
59567215|NCT02971839|75670083|FG004|STARTED|Overall Study||3||
59567216|NCT02971839|75670079|FG000|COMPLETED|Overall Study||2||
59567217|NCT02971839|75670080|FG001|COMPLETED|Overall Study||2||
59567218|NCT02971839|75670081|FG002|COMPLETED|Overall Study||2||
59567219|NCT02971839|75670082|FG003|COMPLETED|Overall Study||2||
60114999|NCT01964092|76235662|FG001|NOT COMPLETED|Overall Study||0||
60115000|NCT01966354|76235671|FG000|STARTED|Overall Study||75||
60115001|NCT01966354|76235672|FG001|STARTED|Overall Study||73||
60115002|NCT01966354|76235673|FG002|STARTED|Overall Study||72||
60115003|NCT01966354|76235671|FG000|COMPLETED|Overall Study||75||
60115004|NCT01966354|76235672|FG001|COMPLETED|Overall Study||73||
60115005|NCT01966354|76235673|FG002|COMPLETED|Overall Study||72||
60115006|NCT01966354|76235671|FG000|NOT COMPLETED|Overall Study||0||
60115007|NCT01966354|76235672|FG001|NOT COMPLETED|Overall Study||0||
60115008|NCT01966354|76235673|FG002|NOT COMPLETED|Overall Study||0||
60115009|NCT02017210|76235684|FG000|STARTED|Overall Study||17|Individuals who participated in 2 previous studies performed at the Garvan Institute|
60115010|NCT02017210|76235685|FG001|STARTED|Overall Study||20|Individuals who participated in 2 previous studies performed at the Garvan Institute|
60115011|NCT02017210|76235686|FG002|STARTED|Overall Study||20|Individuals who participated in 2 previous studies performed at the Garvan Institute|
60115012|NCT02017210|76235684|FG000|COMPLETED|Overall Study||17||
60115013|NCT02017210|76235685|FG001|COMPLETED|Overall Study||20||
60115014|NCT02017210|76235686|FG002|COMPLETED|Overall Study||20||
60115015|NCT02017210|76235684|FG000|NOT COMPLETED|Overall Study||0||
59715014|NCT00992511|75833840|FG002|COMPLETED|Overall Study||74||
59715015|NCT00992511|75833841|FG003|COMPLETED|Overall Study||70||
59715016|NCT00992511|75833838|FG000|NOT COMPLETED|Overall Study||2||
59715017|NCT00992511|75833839|FG001|NOT COMPLETED|Overall Study||0||
59715018|NCT00992511|75833840|FG002|NOT COMPLETED|Overall Study||2||
59715019|NCT00992511|75833841|FG003|NOT COMPLETED|Overall Study||5||
59715020|NCT01196429|75833853|FG000|STARTED|Overall Study||45||
59715021|NCT01196429|75833854|FG001|STARTED|Overall Study||45||
59715022|NCT01196429|75833853|FG000|COMPLETED|Overall Study||42||
59715023|NCT01196429|75833854|FG001|COMPLETED|Overall Study||45||
59715024|NCT01196429|75833853|FG000|NOT COMPLETED|Overall Study||3||
59715025|NCT01196429|75833854|FG001|NOT COMPLETED|Overall Study||0||
59715026|NCT01157364|75833868|FG000|STARTED|Overall Study||15||
59715027|NCT01157364|75833869|FG001|STARTED|Overall Study||21||
59715028|NCT01157364|75833870|FG002|STARTED|Overall Study||21||
59715029|NCT01157364|75833871|FG003|STARTED|Overall Study||18||
59715030|NCT01157364|75833872|FG004|STARTED|Overall Study||11||
59715031|NCT01157364|75833873|FG005|STARTED|Overall Study||23||
59715032|NCT01157364|75833868|FG000|COMPLETED|Overall Study||13||
59715033|NCT01157364|75833869|FG001|COMPLETED|Overall Study||17||
59715034|NCT01157364|75833870|FG002|COMPLETED|Overall Study||17||
59715035|NCT01157364|75833871|FG003|COMPLETED|Overall Study||16||
59715036|NCT01157364|75833872|FG004|COMPLETED|Overall Study||9||
59715037|NCT01157364|75833873|FG005|COMPLETED|Overall Study||22||
59715038|NCT01157364|75833868|FG000|NOT COMPLETED|Overall Study||2||
59715039|NCT01157364|75833869|FG001|NOT COMPLETED|Overall Study||4||
59715040|NCT01157364|75833870|FG002|NOT COMPLETED|Overall Study||4||
59715041|NCT01157364|75833871|FG003|NOT COMPLETED|Overall Study||2||
60115016|NCT02017210|76235685|FG001|NOT COMPLETED|Overall Study||0||
60115017|NCT02017210|76235686|FG002|NOT COMPLETED|Overall Study||0||
60115018|NCT02348632|76235697|FG000|STARTED|Open-label Period||643||
60115019|NCT02348632|76235698|FG001|STARTED|Open-label Period||0||
60115020|NCT02348632|76235697|FG000|COMPLETED|Open-label Period||458||
60115021|NCT02348632|76235698|FG001|COMPLETED|Open-label Period||0||
60115022|NCT02348632|76235697|FG000|NOT COMPLETED|Open-label Period||185||
60115023|NCT02348632|76235698|FG001|NOT COMPLETED|Open-label Period||0||
60115024|NCT02348632|76235697|FG000|STARTED|Randomized Withdrawal Period||140||
60115025|NCT02348632|76235698|FG001|STARTED|Randomized Withdrawal Period||142||
60115026|NCT02348632|76235697|FG000|COMPLETED|Randomized Withdrawal Period||137||
60115027|NCT02348632|76235698|FG001|COMPLETED|Randomized Withdrawal Period||141||
60115028|NCT02348632|76235697|FG000|NOT COMPLETED|Randomized Withdrawal Period||3||
60115029|NCT02348632|76235698|FG001|NOT COMPLETED|Randomized Withdrawal Period||1||
60115030|NCT02349178|76235704|FG000|STARTED|Overall Study||6||
60115031|NCT02349178|76235704|FG000|COMPLETED|Overall Study||6||
60115032|NCT02349178|76235704|FG000|NOT COMPLETED|Overall Study||0||
59715042|NCT01157364|75833872|FG004|NOT COMPLETED|Overall Study||2||
59715043|NCT01157364|75833873|FG005|NOT COMPLETED|Overall Study||1||
59715044|NCT01195415|75833887|FG000|STARTED|Overall Study||25||
60115033|NCT01966900|76235710|FG000|STARTED|Overall Study||8||
60115034|NCT01966900|76235711|FG001|STARTED|Overall Study||6||
60115035|NCT01966900|76235710|FG000|COMPLETED|Overall Study||6||
60115036|NCT01966900|76235711|FG001|COMPLETED|Overall Study||6||
60115037|NCT01966900|76235710|FG000|NOT COMPLETED|Overall Study||2||
60115038|NCT01966900|76235711|FG001|NOT COMPLETED|Overall Study||0||
60115039|NCT02349646|76235717|FG000|STARTED|Overall Study||33||
60115040|NCT02349646|76235717|FG000|Received Trial System|Overall Study||24||
60115041|NCT02349646|76235717|FG000|Receive Permanent System|Overall Study||27||
60115042|NCT02349646|76235717|FG000|COMPLETED|Overall Study||16||
60115043|NCT02349646|76235717|FG000|NOT COMPLETED|Overall Study||17||
60115044|NCT01966978|76235723|FG000|STARTED|Overall Study||61||
60115045|NCT01966978|76235724|FG001|STARTED|Overall Study||59||
60115046|NCT01966978|76235723|FG000|COMPLETED|Overall Study||44||
60115047|NCT01966978|76235724|FG001|COMPLETED|Overall Study||46||
60115048|NCT01966978|76235723|FG000|NOT COMPLETED|Overall Study||17||
60115049|NCT01966978|76235724|FG001|NOT COMPLETED|Overall Study||13||
60115050|NCT02350660|76235732|FG000|STARTED|Overall Study||7||
60115051|NCT02350660|76235733|FG001|STARTED|Overall Study||17||
60115052|NCT02350660|76235732|FG000|COMPLETED|Overall Study||7||
60115053|NCT02350660|76235733|FG001|COMPLETED|Overall Study||17||
60115054|NCT02350660|76235732|FG000|NOT COMPLETED|Overall Study||0||
60115055|NCT02350660|76235733|FG001|NOT COMPLETED|Overall Study||0||
60115056|NCT02713542|76235741|FG000|STARTED|Overall Study||60||
60115057|NCT02713542|76235742|FG001|STARTED|Overall Study||30||
60115058|NCT02713542|76235741|FG000|COMPLETED|Overall Study||42||
60115059|NCT02713542|76235742|FG001|COMPLETED|Overall Study||24||
60115060|NCT02713542|76235741|FG000|NOT COMPLETED|Overall Study||18||
60115061|NCT02713542|76235742|FG001|NOT COMPLETED|Overall Study||6||
60115062|NCT02350816|76235752|FG000|STARTED|Overall Study||7||
60115063|NCT02350816|76235753|FG001|STARTED|Overall Study||6||
60115064|NCT02350816|76235754|FG002|STARTED|Overall Study||2||
60115065|NCT02350816|76235755|FG003|STARTED|Overall Study||2||
60115066|NCT02350816|76235752|FG000|COMPLETED|Overall Study||7|Participants who completed treatment period.|
60115067|NCT02350816|76235753|FG001|COMPLETED|Overall Study||6|Participants who completed treatment period.|
60115068|NCT02350816|76235754|FG002|COMPLETED|Overall Study||2|Participants who completed treatment period.|
60115069|NCT02350816|76235755|FG003|COMPLETED|Overall Study||2|Participants who completed treatment period.|
60115070|NCT02350816|76235752|FG000|NOT COMPLETED|Overall Study||0||
60115071|NCT02350816|76235753|FG001|NOT COMPLETED|Overall Study||0||
60115072|NCT02350816|76235754|FG002|NOT COMPLETED|Overall Study||0||
60115073|NCT02350816|76235755|FG003|NOT COMPLETED|Overall Study||0||
60115074|NCT02019940|76235765|FG000|STARTED|Overall Study||18||
60115075|NCT02019940|76235765|FG000|COMPLETED|Overall Study||8||
60115076|NCT02019940|76235765|FG000|NOT COMPLETED|Overall Study||10||
60115077|NCT01967836|76235769|FG000|STARTED|Overall Study||20||
60115078|NCT01967836|76235769|FG000|COMPLETED|Overall Study||11||
60115079|NCT01967836|76235769|FG000|NOT COMPLETED|Overall Study||9||
60115080|NCT01229943|76235776|FG000|STARTED|Overall Study||75||
60115081|NCT01229943|76235777|FG001|STARTED|Overall Study||75||
60115082|NCT01229943|76235776|FG000|COMPLETED|Overall Study||57||
60115083|NCT01229943|76235777|FG001|COMPLETED|Overall Study||58||
60115084|NCT01229943|76235776|FG000|NOT COMPLETED|Overall Study||18||
60115085|NCT01229943|76235777|FG001|NOT COMPLETED|Overall Study||17||
60115086|NCT02020018|76235787|FG000|STARTED|Overall Study||272||
60115087|NCT02020018|76235788|FG001|STARTED|Overall Study||1597||
60115088|NCT02020018|76235787|FG000|COMPLETED|Overall Study||272||
60115089|NCT02020018|76235788|FG001|COMPLETED|Overall Study||1597||
60115090|NCT02020018|76235787|FG000|NOT COMPLETED|Overall Study||0||
60115091|NCT02020018|76235788|FG001|NOT COMPLETED|Overall Study||0||
60115092|NCT02020252|76235794|FG000|STARTED|Overall Study||120||
60115093|NCT02020252|76235794|FG000|COMPLETED|Overall Study||120||
60115094|NCT02020252|76235794|FG000|NOT COMPLETED|Overall Study||0||
60115095|NCT02020408|76235798|FG000|STARTED|Overall Study||88||
60115096|NCT02020408|76235798|FG000|COMPLETED|Overall Study||85||
60115097|NCT02020408|76235798|FG000|NOT COMPLETED|Overall Study||3||
60115098|NCT02352298|76235808|FG000|STARTED|Overall Study||52||
60115099|NCT02352298|76235808|FG000|COMPLETED|Overall Study||52||
59715045|NCT01195415|75833887|FG000|COMPLETED|Overall Study||23||
59715046|NCT01195415|75833887|FG000|NOT COMPLETED|Overall Study||2||
59715047|NCT01195103|75833894|FG000|STARTED|Overall Study||6||
60115100|NCT02352298|76235808|FG000|NOT COMPLETED|Overall Study||0||
60115101|NCT01615887|76235815|FG000|STARTED|Overall Study||41||
60115102|NCT01615887|76235816|FG001|STARTED|Overall Study||22||
60115103|NCT01615887|76235815|FG000|COMPLETED|Overall Study||29||
60115104|NCT01615887|76235816|FG001|COMPLETED|Overall Study||19||
60115105|NCT01615887|76235815|FG000|NOT COMPLETED|Overall Study||12||
60115106|NCT01615887|76235816|FG001|NOT COMPLETED|Overall Study||3||
60115107|NCT03548220|76235826|FG000|STARTED|Overall Study||40||
60115108|NCT03548220|76235827|FG001|STARTED|Overall Study||2||
60115109|NCT03548220|76235828|FG002|STARTED|Overall Study||3||
60115110|NCT03548220|76235829|FG003|STARTED|Overall Study||35||
60115111|NCT03548220|76235826|FG000|COMPLETED|Overall Study||39||
60115112|NCT03548220|76235827|FG001|COMPLETED|Overall Study||2||
60115113|NCT03548220|76235828|FG002|COMPLETED|Overall Study||3||
60115114|NCT03548220|76235829|FG003|COMPLETED|Overall Study||35||
60115115|NCT03548220|76235826|FG000|NOT COMPLETED|Overall Study||1||
60115116|NCT03548220|76235827|FG001|NOT COMPLETED|Overall Study||0||
60115117|NCT03548220|76235828|FG002|NOT COMPLETED|Overall Study||0||
60115118|NCT03548220|76235829|FG003|NOT COMPLETED|Overall Study||0||
60115119|NCT01110681|76235849|FG000|STARTED|Overall Study||115||
60115120|NCT01110681|76235849|FG000|COMPLETED|Overall Study||83||
60115121|NCT01110681|76235849|FG000|NOT COMPLETED|Overall Study||32||
60115122|NCT02089113|76235855|FG000|STARTED|Overall Study||161||
60115123|NCT02089113|76235856|FG001|STARTED|Overall Study||80||
60115124|NCT02089113|76235855|FG000|COMPLETED|Overall Study||160||
60115125|NCT02089113|76235856|FG001|COMPLETED|Overall Study||80||
60115126|NCT02089113|76235855|FG000|NOT COMPLETED|Overall Study||1||
60115127|NCT02089113|76235856|FG001|NOT COMPLETED|Overall Study||0||
60115128|NCT02712996|76235864|FG000|STARTED|First Intervention (Study Days 1-42)||8||
60115129|NCT02712996|76235865|FG001|STARTED|First Intervention (Study Days 1-42)||9||
59715048|NCT01195103|75833895|FG001|STARTED|Overall Study||2||
60115130|NCT02712996|76235864|FG000|COMPLETED|First Intervention (Study Days 1-42)||8||
60115131|NCT02712996|76235865|FG001|COMPLETED|First Intervention (Study Days 1-42)||9||
60115132|NCT02712996|76235864|FG000|NOT COMPLETED|First Intervention (Study Days 1-42)||0||
60115133|NCT02712996|76235865|FG001|NOT COMPLETED|First Intervention (Study Days 1-42)||0||
60115134|NCT02712996|76235864|FG000|STARTED|Second Intervention (Study Days 43-84)||8||
60115135|NCT02712996|76235865|FG001|STARTED|Second Intervention (Study Days 43-84)||9||
60115136|NCT02712996|76235864|FG000|COMPLETED|Second Intervention (Study Days 43-84)||8||
60115137|NCT02712996|76235865|FG001|COMPLETED|Second Intervention (Study Days 43-84)||8||
60115138|NCT02712996|76235864|FG000|NOT COMPLETED|Second Intervention (Study Days 43-84)||0||
60115139|NCT02712996|76235865|FG001|NOT COMPLETED|Second Intervention (Study Days 43-84)||1||
60115140|NCT02089191|76235873|FG000|STARTED|Period 1, First 12 Hours||16||
60115141|NCT02089191|76235874|FG001|STARTED|Period 1, First 12 Hours||15||
60115142|NCT02089191|76235873|FG000|COMPLETED|Period 1, First 12 Hours||16||
60115143|NCT02089191|76235874|FG001|COMPLETED|Period 1, First 12 Hours||15||
60115144|NCT02089191|76235873|FG000|NOT COMPLETED|Period 1, First 12 Hours||0||
60115145|NCT02089191|76235874|FG001|NOT COMPLETED|Period 1, First 12 Hours||0||
60115146|NCT02089191|76235873|FG000|STARTED|Period 2, Second 12 Hours|One participant discontinued between Period 1 and Period 2 due to availability|15||
60115147|NCT02089191|76235874|FG001|STARTED|Period 2, Second 12 Hours||15||
60115148|NCT02089191|76235873|FG000|COMPLETED|Period 2, Second 12 Hours||15||
60115149|NCT02089191|76235874|FG001|COMPLETED|Period 2, Second 12 Hours||15||
60115150|NCT02089191|76235873|FG000|NOT COMPLETED|Period 2, Second 12 Hours||0||
60115151|NCT02089191|76235874|FG001|NOT COMPLETED|Period 2, Second 12 Hours||0||
60115152|NCT04776135|76235882|FG000|STARTED|Period 1||18||
60115153|NCT04776135|76235883|FG001|STARTED|Period 1||18||
60115154|NCT04776135|76235882|FG000|COMPLETED|Period 1||18||
60115155|NCT04776135|76235883|FG001|COMPLETED|Period 1||18||
60115156|NCT04776135|76235882|FG000|NOT COMPLETED|Period 1||0||
60115157|NCT04776135|76235883|FG001|NOT COMPLETED|Period 1||0||
60115158|NCT04776135|76235882|FG000|STARTED|Period 2||18||
60115159|NCT04776135|76235883|FG001|STARTED|Period 2||18||
60115160|NCT04776135|76235882|FG000|COMPLETED|Period 2||18||
60115161|NCT04776135|76235883|FG001|COMPLETED|Period 2||18||
60115162|NCT04776135|76235882|FG000|NOT COMPLETED|Period 2||0||
60115163|NCT04776135|76235883|FG001|NOT COMPLETED|Period 2||0||
60115164|NCT01968382|76235892|FG000|STARTED|Overall Study||18||
60115165|NCT01968382|76235893|FG001|STARTED|Overall Study||19||
60115166|NCT01968382|76235894|FG002|STARTED|Overall Study||20||
60115167|NCT01968382|76235892|FG000|COMPLETED|Overall Study||18||
60115168|NCT01968382|76235893|FG001|COMPLETED|Overall Study||19||
60115169|NCT01968382|76235894|FG002|COMPLETED|Overall Study||20||
60115170|NCT01968382|76235892|FG000|NOT COMPLETED|Overall Study||0||
60115171|NCT01968382|76235893|FG001|NOT COMPLETED|Overall Study||0||
60115172|NCT01968382|76235894|FG002|NOT COMPLETED|Overall Study||0||
60115173|NCT02352844|76235902|FG000|STARTED|Overall Study||12||
60115174|NCT02352844|76235902|FG000|COMPLETED|Overall Study||12||
60115175|NCT02352844|76235902|FG000|NOT COMPLETED|Overall Study||0||
60115176|NCT03562377|76235908|FG000|STARTED|Treatment Period|Number of participants assigned to treatment|107||
60115177|NCT03562377|76235909|FG001|STARTED|Treatment Period|Number of participants assigned to treatment|108||
60115178|NCT03562377|76235908|FG000|Safety Analysis Set|Treatment Period||107|Defined as all participants randomised to treatment who were exposed to IMP (tralokinumab/placebo).|
60115179|NCT03562377|76235909|FG001|Safety Analysis Set|Treatment Period||107|Defined as all participants randomised to treatment who were exposed to IMP (tralokinumab/placebo).|
60115180|NCT03562377|76235908|FG000|Per Protocol Anaysis Set|Treatment Period||88|Excluding participants who did not receive vaccines, violated selected eligiblity criteria, etc.|
60115181|NCT03562377|76235909|FG001|Per Protocol Anaysis Set|Treatment Period||78|Excluding participants who did not receive vaccines, violated selected eligiblity criteria, etc.|
60115182|NCT03562377|76235908|FG000|Full Analysis Set|Treatment Period||106|Defined as all participants randomised to treatment who were exposed to IMP (tralokinumab/placebo)|
60115183|NCT03562377|76235909|FG001|Full Analysis Set|Treatment Period||108|Defined as all participants randomised to treatment who were exposed to IMP (tralokinumab/placebo)|
60115184|NCT03562377|76235908|FG000|COMPLETED|Treatment Period|Number of participants attending the Week 16 visit (end of treatment visit)|100||
60115185|NCT03562377|76235909|FG001|COMPLETED|Treatment Period|Number of participants attending the Week 16 visit (end of treatment visit)|89||
60115186|NCT03562377|76235908|FG000|NOT COMPLETED|Treatment Period||7||
60115187|NCT03562377|76235909|FG001|NOT COMPLETED|Treatment Period||19||
60115188|NCT03562377|76235908|FG000|STARTED|Safety Follow-up Period|Last contact after exposure end. Main reason for not entering follow-up: transfer to extension trial|75||
60115189|NCT03562377|76235909|FG001|STARTED|Safety Follow-up Period|Last contact after exposure end. Main reason for not entering follow-up: transfer to extension trial|75||
60115190|NCT03562377|76235908|FG000|COMPLETED|Safety Follow-up Period|Attended Week 30 visit. Main reason for not attending was transfer to long-term extension trial.|16||
60115191|NCT03562377|76235909|FG001|COMPLETED|Safety Follow-up Period|Attended Week 30 visit. Main reason for not attending was transfer to long-term extension trial.|18||
60115192|NCT03562377|76235908|FG000|NOT COMPLETED|Safety Follow-up Period||59||
60115193|NCT03562377|76235909|FG001|NOT COMPLETED|Safety Follow-up Period||57||
60115194|NCT02352922|76235917|FG000|STARTED|Overall Study||32||
60115195|NCT02352922|76235918|FG001|STARTED|Overall Study||32||
60115196|NCT02352922|76235917|FG000|COMPLETED|Overall Study|completed POD14 Survey|28||
60115197|NCT02352922|76235918|FG001|COMPLETED|Overall Study|Completed POD14 survey|28||
60115198|NCT02352922|76235917|FG000|NOT COMPLETED|Overall Study||4||
60115199|NCT02352922|76235918|FG001|NOT COMPLETED|Overall Study||4||
60115200|NCT01969162|76235924|FG000|STARTED|Overall Study||35||
60115201|NCT01969162|76235924|FG000|COMPLETED|Overall Study||35||
59823924|NCT00445770|75946833|FG000|NOT COMPLETED|Overall Study||53||
59823925|NCT00445770|75946834|FG001|NOT COMPLETED|Overall Study||35||
59823926|NCT00445770|75946835|FG002|NOT COMPLETED|Overall Study||31||
59823927|NCT00266032|75946848|FG000|STARTED|Treatment|all randomized subjects, baseline data for full analysis set (FAS) only|691||
59823928|NCT00266032|75946849|FG001|STARTED|Treatment|all randomized subjects, baseline data for full analysis set (FAS) only|236||
59823929|NCT00266032|75946850|FG002|STARTED|Treatment|all randomized subjects, baseline data for full analysis set (FAS) only|239||
59823930|NCT00266032|75946848|FG000|Patients Treated|Treatment||684||
59823931|NCT00266032|75946849|FG001|Patients Treated|Treatment||221||
59823932|NCT00266032|75946850|FG002|Patients Treated|Treatment||229||
59823933|NCT00266032|75946848|FG000|Patients Treated and in FAS|Treatment|FAS|642||
60115202|NCT01969162|76235924|FG000|NOT COMPLETED|Overall Study||0||
60115203|NCT02089659|76235930|FG000|STARTED|Overall Study||8||
59715049|NCT01195103|75833896|FG002|STARTED|Overall Study||5||
59715050|NCT01195103|75833894|FG000|COMPLETED|Overall Study|One patient withdrew after randomization but before received study drug.|5||
59715051|NCT01195103|75833895|FG001|COMPLETED|Overall Study||2||
59715052|NCT01195103|75833896|FG002|COMPLETED|Overall Study||5||
59715053|NCT01195103|75833894|FG000|NOT COMPLETED|Overall Study||1||
59715054|NCT01195103|75833895|FG001|NOT COMPLETED|Overall Study||0||
59715055|NCT01195103|75833896|FG002|NOT COMPLETED|Overall Study||0||
59715056|NCT01194869|75833904|FG000|STARTED|Overall Study||25||
59715057|NCT01194869|75833904|FG000|COMPLETED|Overall Study||21||
59715058|NCT01194869|75833904|FG000|NOT COMPLETED|Overall Study||4||
59715059|NCT01177800|75833910|FG000|STARTED|Overall Study||84||
59823934|NCT00266032|75946849|FG001|Patients Treated and in FAS|Treatment|FAS|209||
59823935|NCT00266032|75946850|FG002|Patients Treated and in FAS|Treatment|FAS|216||
59823936|NCT00266032|75946848|FG000|COMPLETED|Treatment|not all entered period 2 (open-label safety extension)|580||
59823937|NCT00266032|75946849|FG001|COMPLETED|Treatment|not all entered period 2 (open-label safety extension)|172||
59823938|NCT00266032|75946850|FG002|COMPLETED|Treatment|not all entered period 2 (open-label safety extension)|192||
59823939|NCT00266032|75946848|FG000|NOT COMPLETED|Treatment||111||
59823940|NCT00266032|75946849|FG001|NOT COMPLETED|Treatment||64||
59823941|NCT00266032|75946850|FG002|NOT COMPLETED|Treatment||47||
59823942|NCT00266032|75946848|FG000|STARTED|Open-label Safety Extension|treatment for subjects of all 3 treatment groups in 2nd period, except for 28 in subgroups|489||
59823943|NCT00266032|75946849|FG001|STARTED|Open-label Safety Extension|7 subjects continued their treatment in second period (safety extension)|129||
59823944|NCT00266032|75946850|FG002|STARTED|Open-label Safety Extension|21 subjects continued their treatment in second period (safety extension)|165||
59823945|NCT00266032|75946848|FG000|COMPLETED|Open-label Safety Extension||448||
59823946|NCT00266032|75946849|FG001|COMPLETED|Open-label Safety Extension||115||
59823947|NCT00266032|75946850|FG002|COMPLETED|Open-label Safety Extension||140||
59823948|NCT00266032|75946848|FG000|NOT COMPLETED|Open-label Safety Extension||41||
59823949|NCT00266032|75946849|FG001|NOT COMPLETED|Open-label Safety Extension||14||
59823950|NCT00266032|75946850|FG002|NOT COMPLETED|Open-label Safety Extension||25||
59823951|NCT00483002|75946858|FG000|STARTED|Overall Study||3719||
59823952|NCT00483002|75946858|FG000|COMPLETED|Overall Study||1165||
59823953|NCT00483002|75946858|FG000|NOT COMPLETED|Overall Study||2554||
59823954|NCT00482612|75946866|FG000|STARTED|In-treatment Period||137||
59823955|NCT00482612|75946867|FG001|STARTED|In-treatment Period||125||
59823956|NCT00482612|75946868|FG002|STARTED|In-treatment Period||129||
59823957|NCT00482612|75946869|FG003|STARTED|In-treatment Period||135||
59823958|NCT00482612|75946866|FG000|Treated|In-treatment Period||137||
59823959|NCT00482612|75946867|FG001|Treated|In-treatment Period||125||
59823960|NCT00482612|75946868|FG002|Treated|In-treatment Period||128||
59823961|NCT00482612|75946869|FG003|Treated|In-treatment Period||135||
60115204|NCT02089659|76235931|FG001|STARTED|Overall Study||8||
60115205|NCT02089659|76235932|FG002|STARTED|Overall Study||0||
59823962|NCT00482612|75946866|FG000|COMPLETED|In-treatment Period||137||
59823963|NCT00482612|75946867|FG001|COMPLETED|In-treatment Period||125||
59823964|NCT00482612|75946868|FG002|COMPLETED|In-treatment Period||128||
59823965|NCT00482612|75946869|FG003|COMPLETED|In-treatment Period||135||
59823966|NCT00482612|75946866|FG000|NOT COMPLETED|In-treatment Period||0||
59823967|NCT00482612|75946867|FG001|NOT COMPLETED|In-treatment Period||0||
59823968|NCT00482612|75946868|FG002|NOT COMPLETED|In-treatment Period||1||
60115206|NCT02089659|76235930|FG000|COMPLETED|Overall Study||8||
60115207|NCT02089659|76235931|FG001|COMPLETED|Overall Study||8||
60115208|NCT02089659|76235932|FG002|COMPLETED|Overall Study||0||
60115209|NCT02089659|76235930|FG000|NOT COMPLETED|Overall Study||0||
60115210|NCT02089659|76235931|FG001|NOT COMPLETED|Overall Study||0||
60115211|NCT02089659|76235932|FG002|NOT COMPLETED|Overall Study||0||
60115212|NCT02353780|76235941|FG000|STARTED|Overall Study||3||
60115213|NCT02353780|76235942|FG001|STARTED|Overall Study||3||
60115214|NCT02353780|76235943|FG002|STARTED|Overall Study||3||
60115215|NCT02353780|76235941|FG000|COMPLETED|Overall Study||3||
60115216|NCT02353780|76235942|FG001|COMPLETED|Overall Study||3||
60115217|NCT02353780|76235943|FG002|COMPLETED|Overall Study||3||
59823969|NCT00482612|75946869|FG003|NOT COMPLETED|In-treatment Period||0||
59823970|NCT00482612|75946866|FG000|STARTED|Follow-up Period||137||
59823971|NCT00482612|75946867|FG001|STARTED|Follow-up Period||125||
59823972|NCT00482612|75946868|FG002|STARTED|Follow-up Period||128||
59823973|NCT00482612|75946869|FG003|STARTED|Follow-up Period||135||
59823974|NCT00482612|75946866|FG000|COMPLETED|Follow-up Period||123||
59823975|NCT00482612|75946867|FG001|COMPLETED|Follow-up Period||107||
59823976|NCT00482612|75946868|FG002|COMPLETED|Follow-up Period||106||
59823977|NCT00482612|75946869|FG003|COMPLETED|Follow-up Period||127||
59823978|NCT00482612|75946866|FG000|NOT COMPLETED|Follow-up Period||14||
59823979|NCT00482612|75946867|FG001|NOT COMPLETED|Follow-up Period||18||
59823980|NCT00482612|75946868|FG002|NOT COMPLETED|Follow-up Period||22||
59823981|NCT00482612|75946869|FG003|NOT COMPLETED|Follow-up Period||8||
59823982|NCT00282568|75946883|FG000|STARTED|Pharmacokinetic Treatment Period||70||
60115218|NCT02353780|76235941|FG000|NOT COMPLETED|Overall Study||0||
60115219|NCT02353780|76235942|FG001|NOT COMPLETED|Overall Study||0||
60115220|NCT02353780|76235943|FG002|NOT COMPLETED|Overall Study||0||
60115221|NCT02022826|76235951|FG000|STARTED|Overall Study||167||
60115222|NCT02022826|76235951|FG000|COMPLETED|Overall Study||139||
60115223|NCT02022826|76235951|FG000|NOT COMPLETED|Overall Study||28||
60115224|NCT01969240|76235957|FG000|STARTED|Overall Study||451||
60115225|NCT01969240|76235958|FG001|STARTED|Overall Study||447||
60115226|NCT01969240|76235957|FG000|COMPLETED|Overall Study||451||
60115227|NCT01969240|76235958|FG001|COMPLETED|Overall Study||447||
60115228|NCT01969240|76235957|FG000|NOT COMPLETED|Overall Study||0||
60115229|NCT01969240|76235958|FG001|NOT COMPLETED|Overall Study||0||
60115230|NCT02354092|76235968|FG000|STARTED|Overall Study||7||
60115231|NCT02354092|76235969|FG001|STARTED|Overall Study||7||
60115232|NCT02354092|76235968|FG000|COMPLETED|Overall Study||7||
60115233|NCT02354092|76235969|FG001|COMPLETED|Overall Study||7||
60115234|NCT02354092|76235968|FG000|NOT COMPLETED|Overall Study||0||
60115235|NCT02354092|76235969|FG001|NOT COMPLETED|Overall Study||0||
60115236|NCT00907101|76235975|FG000|STARTED|Overall Study||30||
60115237|NCT00907101|76235975|FG000|COMPLETED|Overall Study||30||
60115238|NCT00907101|76235975|FG000|NOT COMPLETED|Overall Study||0||
60115239|NCT00701064|76235981|FG000|STARTED|Overall Study||35||
60115240|NCT00701064|76235982|FG001|STARTED|Overall Study||36||
59715060|NCT01177800|75833911|FG001|STARTED|Overall Study||45||
59715061|NCT01177800|75833910|FG000|COMPLETED|Overall Study||74||
59715062|NCT01177800|75833911|FG001|COMPLETED|Overall Study||40||
59715063|NCT01177800|75833910|FG000|NOT COMPLETED|Overall Study||10||
59715064|NCT01177800|75833911|FG001|NOT COMPLETED|Overall Study||5||
59715065|NCT01177722|75833921|FG000|STARTED|Overall Study|A Batch B participant got Batch A vaccine data analyses was according to actual vaccine administered|344||
59715066|NCT01177722|75833922|FG001|STARTED|Overall Study|A randomized participant got Batch A vaccine, analyses was according to actual vaccine administered.|344||
59715067|NCT01177722|75833923|FG002|STARTED|Overall Study||342||
59715068|NCT01177722|75833924|FG003|STARTED|Overall Study||345||
59715069|NCT01177722|75833921|FG000|COMPLETED|Overall Study||331||
59715070|NCT01177722|75833922|FG001|COMPLETED|Overall Study||334||
59715071|NCT01177722|75833923|FG002|COMPLETED|Overall Study||333||
59715072|NCT01177722|75833924|FG003|COMPLETED|Overall Study||338||
59715073|NCT01177722|75833921|FG000|NOT COMPLETED|Overall Study||13||
59715074|NCT01177722|75833922|FG001|NOT COMPLETED|Overall Study||10||
59715075|NCT01177722|75833923|FG002|NOT COMPLETED|Overall Study||9||
59715076|NCT01177722|75833924|FG003|NOT COMPLETED|Overall Study||7||
59715077|NCT01177410|75833938|FG000|STARTED|Overall Study||51||
59715078|NCT01177410|75833939|FG001|STARTED|Overall Study||47||
59715079|NCT01177410|75833940|FG002|STARTED|Overall Study||50||
59715080|NCT01177410|75833938|FG000|COMPLETED|Overall Study||50||
59715081|NCT01177410|75833939|FG001|COMPLETED|Overall Study||40||
59823983|NCT00282568|75946883|FG000|Received Tacrolimus|Pharmacokinetic Treatment Period||68||
59823984|NCT00282568|75946883|FG000|Received Tacrolimus MR|Pharmacokinetic Treatment Period||67||
59823985|NCT00282568|75946883|FG000|COMPLETED|Pharmacokinetic Treatment Period||67||
59823986|NCT00282568|75946883|FG000|NOT COMPLETED|Pharmacokinetic Treatment Period||3||
59996452|NCT02001623|76112385|FG001|NOT COMPLETED|Overall Study||3||
59996453|NCT02001623|76112386|FG002|NOT COMPLETED|Overall Study||3||
59996454|NCT02001623|76112387|FG003|NOT COMPLETED|Overall Study||2||
59996455|NCT02001623|76112388|FG004|NOT COMPLETED|Overall Study||3||
59996456|NCT02001623|76112389|FG005|NOT COMPLETED|Overall Study||3||
59996457|NCT02001623|76112390|FG006|NOT COMPLETED|Overall Study||3||
59996458|NCT02001623|76112391|FG007|NOT COMPLETED|Overall Study||6||
59996459|NCT02001623|76112392|FG008|NOT COMPLETED|Overall Study||15||
59996460|NCT02001623|76112393|FG009|NOT COMPLETED|Overall Study||53||
59996461|NCT02001623|76112394|FG010|NOT COMPLETED|Overall Study||14||
59996462|NCT02001623|76112395|FG011|NOT COMPLETED|Overall Study||15||
59996463|NCT02001623|76112396|FG012|NOT COMPLETED|Overall Study||14||
59996464|NCT02001623|76112397|FG013|NOT COMPLETED|Overall Study||35||
59996465|NCT02001623|76112398|FG014|NOT COMPLETED|Overall Study||18||
59996466|NCT02713867|76112449|FG000|STARTED|Randomization||180|= Participants Randomized|
59996467|NCT02713867|76112450|FG001|STARTED|Randomization||183|= Participants Randomized|
59996468|NCT02713867|76112449|FG000|COMPLETED|Randomization||178|= Participants Treated|
59823987|NCT00282568|75946883|FG000|STARTED|Extended Treatment Period|One patient who completed the PK period did not enter the extended treatment period.|66||
59823988|NCT00282568|75946883|FG000|COMPLETED|Extended Treatment Period||42||
59823989|NCT00282568|75946883|FG000|NOT COMPLETED|Extended Treatment Period||24||
59823990|NCT00265564|75946889|FG000|STARTED|Overall Study||59||
59823991|NCT00265564|75946890|FG001|STARTED|Overall Study||58||
59823992|NCT00265564|75946889|FG000|COMPLETED|Overall Study||49||
59823993|NCT00265564|75946890|FG001|COMPLETED|Overall Study||49||
59823994|NCT00265564|75946889|FG000|NOT COMPLETED|Overall Study||10||
59823995|NCT00265564|75946890|FG001|NOT COMPLETED|Overall Study||9||
59823996|NCT00376623|75946899|FG000|STARTED|Overall Study||49|Entered|
59823997|NCT00376623|75946900|FG001|STARTED|Overall Study||26|Entered|
59823998|NCT00376623|75946901|FG002|STARTED|Overall Study||21|Entered|
59823999|NCT00376623|75946899|FG000|Treated With BI 2536|Overall Study||48||
59715082|NCT01177410|75833940|FG002|COMPLETED|Overall Study||45||
59715083|NCT01177410|75833938|FG000|NOT COMPLETED|Overall Study||1||
59715084|NCT01177410|75833939|FG001|NOT COMPLETED|Overall Study||7||
59715085|NCT01177410|75833940|FG002|NOT COMPLETED|Overall Study||5||
59715086|NCT01156116|75833950|FG000|STARTED|Overall Study||26||
59715087|NCT01156116|75833951|FG001|STARTED|Overall Study||13||
59715088|NCT01156116|75833950|FG000|COMPLETED|Overall Study||21||
59715089|NCT01156116|75833951|FG001|COMPLETED|Overall Study||12||
59715090|NCT01156116|75833950|FG000|NOT COMPLETED|Overall Study||5||
59715091|NCT01156116|75833951|FG001|NOT COMPLETED|Overall Study||1||
59715092|NCT01155726|75833957|FG000|STARTED|Period 1, 3 Days (Masked)||24||
59715093|NCT01155726|75833958|FG001|STARTED|Period 1, 3 Days (Masked)||20||
59715094|NCT01155726|75833959|FG002|STARTED|Period 1, 3 Days (Masked)||30||
59715095|NCT01155726|75833960|FG003|STARTED|Period 1, 3 Days (Masked)||25||
59715096|NCT01155726|75833957|FG000|COMPLETED|Period 1, 3 Days (Masked)||23||
59715097|NCT01155726|75833958|FG001|COMPLETED|Period 1, 3 Days (Masked)||20||
59715098|NCT01155726|75833959|FG002|COMPLETED|Period 1, 3 Days (Masked)||28||
59715099|NCT01155726|75833960|FG003|COMPLETED|Period 1, 3 Days (Masked)||25||
59715100|NCT01155726|75833957|FG000|NOT COMPLETED|Period 1, 3 Days (Masked)||1||
59715101|NCT01155726|75833958|FG001|NOT COMPLETED|Period 1, 3 Days (Masked)||0||
59715102|NCT01155726|75833959|FG002|NOT COMPLETED|Period 1, 3 Days (Masked)||2||
59715103|NCT01155726|75833960|FG003|NOT COMPLETED|Period 1, 3 Days (Masked)||0||
59715104|NCT01155726|75833957|FG000|STARTED|Period 2, 3 Days (Unmask) or (Partial)||23||
59715105|NCT01155726|75833958|FG001|STARTED|Period 2, 3 Days (Unmask) or (Partial)||20||
59715106|NCT01155726|75833959|FG002|STARTED|Period 2, 3 Days (Unmask) or (Partial)||28||
59715107|NCT01155726|75833960|FG003|STARTED|Period 2, 3 Days (Unmask) or (Partial)||25||
59715108|NCT01155726|75833957|FG000|COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||23||
59715109|NCT01155726|75833958|FG001|COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||20||
59715110|NCT01155726|75833959|FG002|COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||28||
59824000|NCT00376623|75946900|FG001|Treated With BI 2536|Overall Study||26||
59824001|NCT00376623|75946901|FG002|Treated With BI 2536|Overall Study||21||
59824002|NCT00376623|75946899|FG000|COMPLETED|Overall Study||0||
59824003|NCT00376623|75946900|FG001|COMPLETED|Overall Study||0||
59824004|NCT00376623|75946901|FG002|COMPLETED|Overall Study||0||
59824005|NCT00376623|75946899|FG000|NOT COMPLETED|Overall Study||49||
59824006|NCT00376623|75946900|FG001|NOT COMPLETED|Overall Study||26||
59715111|NCT01155726|75833960|FG003|COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||25||
59715112|NCT01155726|75833957|FG000|NOT COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||0||
59715113|NCT01155726|75833958|FG001|NOT COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||0||
59715114|NCT01155726|75833959|FG002|NOT COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||0||
59715115|NCT01155726|75833960|FG003|NOT COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||0||
59715116|NCT01155570|75833982|FG000|STARTED|Overall Study|Safety Analysis Population|734||
59715117|NCT01155570|75833982|FG000|Efficacy Analysis Population|Overall Study|5 received Humira off-label, 21 did not receive Humira after the first administration|708||
59715118|NCT01155570|75833982|FG000|COMPLETED|Overall Study||592||
59715119|NCT01155570|75833982|FG000|NOT COMPLETED|Overall Study||142||
59824007|NCT00376623|75946901|FG002|NOT COMPLETED|Overall Study||21||
59715120|NCT01155024|75833988|FG000|STARTED|First Socket Intervention Fitting||5||
59715121|NCT01155024|75833989|FG001|STARTED|First Socket Intervention Fitting||5||
59715122|NCT01155024|75833988|FG000|COMPLETED|First Socket Intervention Fitting||5||
59715123|NCT01155024|75833989|FG001|COMPLETED|First Socket Intervention Fitting||5||
59715124|NCT01155024|75833988|FG000|NOT COMPLETED|First Socket Intervention Fitting||0||
59715125|NCT01155024|75833989|FG001|NOT COMPLETED|First Socket Intervention Fitting||0||
59715126|NCT01155024|75833988|FG000|STARTED|Second Socket Intervention Fitting||5||
59715127|NCT01155024|75833989|FG001|STARTED|Second Socket Intervention Fitting||5||
59824008|NCT00445692|75946915|FG000|STARTED|Overall Study||31||
59824009|NCT00445692|75946915|FG000|COMPLETED|Overall Study||15||
59824010|NCT00445692|75946915|FG000|NOT COMPLETED|Overall Study||16||
59824011|NCT03824236|75946924|FG000|STARTED|Overall Study||25||
59824012|NCT03824236|75946925|FG001|STARTED|Overall Study||24||
59824013|NCT03824236|75946926|FG002|STARTED|Overall Study||12||
59824014|NCT03824236|75946924|FG000|COMPLETED|Overall Study||25||
59824015|NCT03824236|75946925|FG001|COMPLETED|Overall Study||24||
59824016|NCT03824236|75946926|FG002|COMPLETED|Overall Study||11||
59824017|NCT03824236|75946924|FG000|NOT COMPLETED|Overall Study||0||
59824018|NCT03824236|75946925|FG001|NOT COMPLETED|Overall Study||0||
59824019|NCT03824236|75946926|FG002|NOT COMPLETED|Overall Study||1||
59824020|NCT00282412|75946934|FG000|STARTED|Overall Study||4||
59824021|NCT00282412|75946934|FG000|COMPLETED|Overall Study|Two late deaths non-treatment related. One from pulmonary embolism and one from late leukemia.|2||
59824022|NCT00282412|75946934|FG000|NOT COMPLETED|Overall Study||2||
59824023|NCT00282334|75946940|FG000|STARTED|Overall Study||113||
59824024|NCT00282334|75946941|FG001|STARTED|Overall Study||123||
59824025|NCT00282334|75946940|FG000|COMPLETED|Overall Study||105||
59824026|NCT00282334|75946941|FG001|COMPLETED|Overall Study||118||
59824027|NCT00282334|75946940|FG000|NOT COMPLETED|Overall Study||8||
59824028|NCT00282334|75946941|FG001|NOT COMPLETED|Overall Study||5||
59824029|NCT00282256|75946947|FG000|STARTED|Pharmacokinetic Treatment Period||19||
59824030|NCT00282256|75946947|FG000|Received Tacrolimus|Pharmacokinetic Treatment Period||19||
59824031|NCT00282256|75946947|FG000|Received Tacrolimus MR|Pharmacokinetic Treatment Period||18||
59824032|NCT00282256|75946947|FG000|COMPLETED|Pharmacokinetic Treatment Period||18||
60115241|NCT00701064|76235981|FG000|COMPLETED|Overall Study||31||
60115242|NCT00701064|76235982|FG001|COMPLETED|Overall Study||32||
60115243|NCT00701064|76235981|FG000|NOT COMPLETED|Overall Study||4||
59715128|NCT01155024|75833988|FG000|COMPLETED|Second Socket Intervention Fitting||5||
59715129|NCT01155024|75833989|FG001|COMPLETED|Second Socket Intervention Fitting||5||
59715130|NCT01155024|75833988|FG000|NOT COMPLETED|Second Socket Intervention Fitting||0||
59715131|NCT01155024|75833989|FG001|NOT COMPLETED|Second Socket Intervention Fitting||0||
59715132|NCT01155024|75833988|FG000|STARTED|Direct Manufactured Socket 3 Month Trial||0||
59715133|NCT01155024|75833989|FG001|STARTED|Direct Manufactured Socket 3 Month Trial||10||
59715134|NCT01155024|75833988|FG000|COMPLETED|Direct Manufactured Socket 3 Month Trial||0||
59715135|NCT01155024|75833989|FG001|COMPLETED|Direct Manufactured Socket 3 Month Trial||4||
60115244|NCT00701064|76235982|FG001|NOT COMPLETED|Overall Study||4||
60115245|NCT05779072|76235990|FG000|STARTED|Overall Study||40||80
60115246|NCT05779072|76235991|FG001|STARTED|Overall Study||43||86
60115247|NCT05779072|76235990|FG000|COMPLETED|Overall Study||39||78
60115248|NCT05779072|76235991|FG001|COMPLETED|Overall Study||37||74
60115249|NCT05779072|76235990|FG000|NOT COMPLETED|Overall Study||1||2
60115250|NCT05779072|76235991|FG001|NOT COMPLETED|Overall Study||6||12
60115251|NCT05196776|76235999|FG000|STARTED|Overall Study||54||
60115252|NCT05196776|76236000|FG001|STARTED|Overall Study||56||
60115253|NCT05196776|76235999|FG000|COMPLETED|Overall Study||53||
60115254|NCT05196776|76236000|FG001|COMPLETED|Overall Study||56||
60115255|NCT05196776|76235999|FG000|NOT COMPLETED|Overall Study||1||
60115256|NCT05196776|76236000|FG001|NOT COMPLETED|Overall Study||0||
60115257|NCT05089682|76236006|FG000|STARTED|Overall Study||4||
60115258|NCT05089682|76236006|FG000|COMPLETED|Overall Study||2||
60115259|NCT05089682|76236006|FG000|NOT COMPLETED|Overall Study||2||
60115260|NCT05055128|76236015|FG000|STARTED|Overall Study||51||
60115261|NCT05055128|76236016|FG001|STARTED|Overall Study||48||
60115262|NCT05055128|76236017|FG002|STARTED|Overall Study||52||
60115263|NCT05055128|76236018|FG003|STARTED|Overall Study||47||
60115264|NCT05055128|76236019|FG004|STARTED|Overall Study||50||
60115265|NCT05055128|76236015|FG000|COMPLETED|Overall Study||45||
60115266|NCT05055128|76236016|FG001|COMPLETED|Overall Study||45||
60115267|NCT05055128|76236017|FG002|COMPLETED|Overall Study||50||
60115268|NCT05055128|76236018|FG003|COMPLETED|Overall Study||41||
60115269|NCT05055128|76236019|FG004|COMPLETED|Overall Study||47||
60115270|NCT05055128|76236015|FG000|NOT COMPLETED|Overall Study||6||
60115271|NCT05055128|76236016|FG001|NOT COMPLETED|Overall Study||3||
60115272|NCT05055128|76236017|FG002|NOT COMPLETED|Overall Study||2||
59567220|NCT02971839|75670083|FG004|COMPLETED|Overall Study||3||
59715136|NCT01155024|75833988|FG000|NOT COMPLETED|Direct Manufactured Socket 3 Month Trial||0||
59715137|NCT01155024|75833989|FG001|NOT COMPLETED|Direct Manufactured Socket 3 Month Trial||6||
59715138|NCT01176240|75834000|FG000|STARTED|Study 306A||24||
59715139|NCT01176240|75834001|FG001|STARTED|Study 306A||27||
59715140|NCT01176240|75834000|FG000|COMPLETED|Study 306A||21||
59715141|NCT01176240|75834001|FG001|COMPLETED|Study 306A||24||
59715142|NCT01176240|75834000|FG000|NOT COMPLETED|Study 306A||3||
59715143|NCT01176240|75834001|FG001|NOT COMPLETED|Study 306A||3||
59715144|NCT01176240|75834000|FG000|STARTED|Study 306B||89||
59715145|NCT01176240|75834001|FG001|STARTED|Study 306B||85||
59715146|NCT01176240|75834000|FG000|Took at Least 1 Dose of Study Drug|Study 306B|Two randomized patients discontinued before receiving study drug.|87||
59824033|NCT00282256|75946947|FG000|NOT COMPLETED|Pharmacokinetic Treatment Period||1||
59824034|NCT00282256|75946947|FG000|STARTED|Extension Treatment Period||18||
59824035|NCT00282256|75946947|FG000|COMPLETED|Extension Treatment Period||16||
59824036|NCT00282256|75946947|FG000|NOT COMPLETED|Extension Treatment Period||2||
60115273|NCT05055128|76236018|FG003|NOT COMPLETED|Overall Study||6||
60115274|NCT05055128|76236019|FG004|NOT COMPLETED|Overall Study||3||
60115275|NCT05038020|76236035|FG000|STARTED|Overall Study||3||
60115276|NCT05038020|76236036|FG001|STARTED|Overall Study||0||
60115277|NCT05038020|76236035|FG000|COMPLETED|Overall Study||0||
60115278|NCT05038020|76236036|FG001|COMPLETED|Overall Study||0||
60115279|NCT05038020|76236035|FG000|NOT COMPLETED|Overall Study||3||
60115280|NCT05038020|76236036|FG001|NOT COMPLETED|Overall Study||0||
60115281|NCT04831788|76236042|FG000|STARTED|Overall Study||521||1042
60115282|NCT04831788|76236042|FG000|COMPLETED|Overall Study||521||1042
60115283|NCT04831788|76236042|FG000|NOT COMPLETED|Overall Study||0||0
60115284|NCT04796610|76236051|FG000|STARTED|Overall Study||30||
60115285|NCT04796610|76236052|FG001|STARTED|Overall Study||30||
60115286|NCT04796610|76236053|FG002|STARTED|Overall Study||17||
60115287|NCT04796610|76236054|FG003|STARTED|Overall Study||28||
60115288|NCT04796610|76236051|FG000|COMPLETED|Overall Study||27||
60115289|NCT04796610|76236052|FG001|COMPLETED|Overall Study||30||
60115290|NCT04796610|76236053|FG002|COMPLETED|Overall Study||16||
60115291|NCT04796610|76236054|FG003|COMPLETED|Overall Study||27||
60115292|NCT04796610|76236051|FG000|NOT COMPLETED|Overall Study||3||
60115293|NCT04796610|76236052|FG001|NOT COMPLETED|Overall Study||0||
60115294|NCT04796610|76236053|FG002|NOT COMPLETED|Overall Study||1||
60115295|NCT04796610|76236054|FG003|NOT COMPLETED|Overall Study||1||
60115296|NCT04702997|76236064|FG000|STARTED|Overall Study||39||
60115297|NCT04702997|76236065|FG001|STARTED|Overall Study||42||
60115298|NCT04702997|76236064|FG000|COMPLETED|Overall Study||38||
60115299|NCT04702997|76236065|FG001|COMPLETED|Overall Study||41||
60115300|NCT04702997|76236064|FG000|NOT COMPLETED|Overall Study||1||
60115301|NCT04702997|76236065|FG001|NOT COMPLETED|Overall Study||1||
60115302|NCT04306952|76236074|FG000|STARTED|Overall Study||20||
60115303|NCT04306952|76236075|FG001|STARTED|Overall Study||20||
60115304|NCT04306952|76236076|FG002|STARTED|Overall Study||20||
60115305|NCT04306952|76236074|FG000|COMPLETED|Overall Study||20||
60115306|NCT04306952|76236075|FG001|COMPLETED|Overall Study||16||
60115307|NCT04306952|76236076|FG002|COMPLETED|Overall Study||19||
60115308|NCT04306952|76236074|FG000|NOT COMPLETED|Overall Study||0||
60115309|NCT04306952|76236075|FG001|NOT COMPLETED|Overall Study||4||
60115310|NCT04306952|76236076|FG002|NOT COMPLETED|Overall Study||1||
60115311|NCT04173494|76236086|FG000|STARTED|Randomized DB TP (Up to Week 24)||130||
60115312|NCT04173494|76236087|FG001|STARTED|Randomized DB TP (Up to Week 24)||65||
60115313|NCT04173494|76236086|FG000|COMPLETED|Randomized DB TP (Up to Week 24)||94||
60115314|NCT04173494|76236087|FG001|COMPLETED|Randomized DB TP (Up to Week 24)||38||
60115315|NCT04173494|76236086|FG000|NOT COMPLETED|Randomized DB TP (Up to Week 24)||36||
60115316|NCT04173494|76236087|FG001|NOT COMPLETED|Randomized DB TP (Up to Week 24)||27||
60115317|NCT04173494|76236086|FG000|STARTED|Open-Label Extended TP(Weeks 24 to 151)|93 participants from Randomized Treatment Phase entered in Open-label Phase|93||
60115318|NCT04173494|76236087|FG001|STARTED|Open-Label Extended TP(Weeks 24 to 151)|Total 41 participants entered in Open-label Phase (36 out of 38 participants who completed Randomized Phase and 5 out of 27 who withdrew from Randomized Phase) as per Protocol defined criteria.|41||
60115319|NCT04173494|76236086|FG000|COMPLETED|Open-Label Extended TP(Weeks 24 to 151)||0||
60115320|NCT04173494|76236087|FG001|COMPLETED|Open-Label Extended TP(Weeks 24 to 151)||0||
60115321|NCT04173494|76236086|FG000|NOT COMPLETED|Open-Label Extended TP(Weeks 24 to 151)||93||
60115322|NCT04173494|76236087|FG001|NOT COMPLETED|Open-Label Extended TP(Weeks 24 to 151)||41||
60115323|NCT03973697|76236101|FG000|STARTED|Overall Study||5||
60115324|NCT03973697|76236102|FG001|STARTED|Overall Study||4||
60115325|NCT03973697|76236101|FG000|COMPLETED|Overall Study||5||
60115326|NCT03973697|76236102|FG001|COMPLETED|Overall Study||4||
60115327|NCT03973697|76236101|FG000|NOT COMPLETED|Overall Study||0||
60115328|NCT03973697|76236102|FG001|NOT COMPLETED|Overall Study||0||
60115329|NCT03920215|76236112|FG000|STARTED|Overall Study||26||
60115330|NCT03920215|76236113|FG001|STARTED|Overall Study||29||
60115331|NCT03920215|76236114|FG002|STARTED|Overall Study||23||
60115332|NCT03920215|76236115|FG003|STARTED|Overall Study||23||
60115333|NCT03920215|76236112|FG000|COMPLETED|Overall Study||25||
60115334|NCT03920215|76236113|FG001|COMPLETED|Overall Study||27||
60115335|NCT03920215|76236114|FG002|COMPLETED|Overall Study||23||
60115336|NCT03920215|76236115|FG003|COMPLETED|Overall Study||22||
60115337|NCT03920215|76236112|FG000|NOT COMPLETED|Overall Study||1||
60115338|NCT03920215|76236113|FG001|NOT COMPLETED|Overall Study||2||
60115339|NCT03920215|76236114|FG002|NOT COMPLETED|Overall Study||0||
60115340|NCT03920215|76236115|FG003|NOT COMPLETED|Overall Study||1||
60115341|NCT03878134|76236125|FG000|STARTED|Overall Study||67||
60115342|NCT03878134|76236125|FG000|COMPLETED|Overall Study||56||
60115343|NCT03878134|76236125|FG000|NOT COMPLETED|Overall Study||11||
60115344|NCT03874429|76236131|FG000|STARTED|Overall Study||50||
60115345|NCT03874429|76236132|FG001|STARTED|Overall Study||51||
60115346|NCT03874429|76236131|FG000|COMPLETED|Overall Study||44||
60115347|NCT03874429|76236132|FG001|COMPLETED|Overall Study||46||
60115348|NCT03874429|76236131|FG000|NOT COMPLETED|Overall Study||6||
60115349|NCT03874429|76236132|FG001|NOT COMPLETED|Overall Study||5||
60115350|NCT03871153|76236138|FG000|STARTED|Overall Study||6||
60115351|NCT03871153|76236138|FG000|COMPLETED|Overall Study||6||
60115352|NCT03871153|76236138|FG000|NOT COMPLETED|Overall Study||0||
60115353|NCT03786094|76236144|FG000|STARTED|Overall Study||219||
60115354|NCT03786094|76236145|FG001|STARTED|Overall Study||213||
60115355|NCT03786094|76236144|FG000|Overall Population (2nd Line+)|Overall Study||219||
60115356|NCT03786094|76236145|FG001|Overall Population (2nd Line+)|Overall Study||213||
60115357|NCT03786094|76236144|FG000|3rd Line+ Population|Overall Study||175||
60115358|NCT03786094|76236145|FG001|3rd Line+ Population|Overall Study||173||
60115359|NCT03786094|76236144|FG000|COMPLETED|Overall Study||10||
60115360|NCT03786094|76236145|FG001|COMPLETED|Overall Study||11||
60115361|NCT03786094|76236144|FG000|NOT COMPLETED|Overall Study||209||
60115362|NCT03786094|76236145|FG001|NOT COMPLETED|Overall Study||202||
60115363|NCT03776747|76236153|FG000|STARTED|Overall Study||0||
60115364|NCT03776747|76236154|FG001|STARTED|Overall Study||18||
60115365|NCT03776747|76236153|FG000|COMPLETED|Overall Study||0||
60115366|NCT03776747|76236154|FG001|COMPLETED|Overall Study||18||
60115367|NCT03776747|76236153|FG000|NOT COMPLETED|Overall Study||0||
60115368|NCT03776747|76236154|FG001|NOT COMPLETED|Overall Study||0||
60115369|NCT03733730|76236162|FG000|STARTED|Overall Study||453|All subjects/eyes with attempted implantation|706
60115370|NCT03733730|76236163|FG001|STARTED|Overall Study||1827|All subjects/eyes with attempted implantation|3417
60115371|NCT03733730|76236162|FG000|First Eye Attempted Implantation|Overall Study||453||453
60115372|NCT03733730|76236163|FG001|First Eye Attempted Implantation|Overall Study||1827||1827
60115373|NCT03733730|76236162|FG000|First Eye Successful Implantation|Overall Study||453||453
60115374|NCT03733730|76236163|FG001|First Eye Successful Implantation|Overall Study||1827||1827
60115375|NCT03733730|76236162|FG000|Second Eye Attempted Implantation|Overall Study||453||253
60115376|NCT03733730|76236163|FG001|Second Eye Attempted Implantation|Overall Study||1827||1590
60115377|NCT03733730|76236162|FG000|Second Eye Successful Implantation|Overall Study||453||253
60115378|NCT03733730|76236163|FG001|Second Eye Successful Implantation|Overall Study||1827||1589
60115379|NCT03733730|76236162|FG000|Safety Analysis Set|Overall Study||453||706
60115380|NCT03733730|76236163|FG001|Safety Analysis Set|Overall Study||1827||3417
60115381|NCT03733730|76236162|FG000|COMPLETED|Overall Study||451||703
60115382|NCT03733730|76236163|FG001|COMPLETED|Overall Study||1778||3334
60115383|NCT03733730|76236162|FG000|NOT COMPLETED|Overall Study||2||3
60115384|NCT03733730|76236163|FG001|NOT COMPLETED|Overall Study||49||83
60115385|NCT03713632|76236180|FG000|STARTED|Treatment Period 1 (Until Week 16)|1 patient was mis randomized and excluded from the full analysis set.|181||
60115386|NCT03713632|76236181|FG001|STARTED|Treatment Period 1 (Until Week 16)||180||
60115387|NCT03713632|76236182|FG002|STARTED|Treatment Period 1 (Until Week 16)||183||
60115388|NCT03713632|76236183|FG003|STARTED|Treatment Period 1 (Until Week 16)||0||
60115389|NCT03713632|76236184|FG004|STARTED|Treatment Period 1 (Until Week 16)||0||
60115390|NCT03713632|76236180|FG000|Full Analysis Set|Treatment Period 1 (Until Week 16)||180||
60115391|NCT03713632|76236181|FG001|Full Analysis Set|Treatment Period 1 (Until Week 16)||180||
60115392|NCT03713632|76236182|FG002|Full Analysis Set|Treatment Period 1 (Until Week 16)||183||
60115393|NCT03713632|76236183|FG003|Full Analysis Set|Treatment Period 1 (Until Week 16)||0||
60115394|NCT03713632|76236184|FG004|Full Analysis Set|Treatment Period 1 (Until Week 16)||0||
60115395|NCT03713632|76236180|FG000|COMPLETED|Treatment Period 1 (Until Week 16)||170||
60115396|NCT03713632|76236181|FG001|COMPLETED|Treatment Period 1 (Until Week 16)||169||
60115397|NCT03713632|76236182|FG002|COMPLETED|Treatment Period 1 (Until Week 16)||167||
60115398|NCT03713632|76236183|FG003|COMPLETED|Treatment Period 1 (Until Week 16)||0||
60115399|NCT03713632|76236184|FG004|COMPLETED|Treatment Period 1 (Until Week 16)||0||
60115400|NCT03713632|76236180|FG000|NOT COMPLETED|Treatment Period 1 (Until Week 16)||11||
60115401|NCT03713632|76236181|FG001|NOT COMPLETED|Treatment Period 1 (Until Week 16)||11||
60115402|NCT03713632|76236182|FG002|NOT COMPLETED|Treatment Period 1 (Until Week 16)||16||
60115403|NCT03713632|76236183|FG003|NOT COMPLETED|Treatment Period 1 (Until Week 16)||0||
60115404|NCT03713632|76236184|FG004|NOT COMPLETED|Treatment Period 1 (Until Week 16)||0||
59715147|NCT01176240|75834001|FG001|Took at Least 1 Dose of Study Drug|Study 306B|One randomized patient discontinued before receiving study drug.|84||
59824037|NCT00265330|75946951|FG000|STARTED|Overall Study||162||
60115405|NCT03713632|76236180|FG000|STARTED|Treatment Period 2 (After Week 16)||170||
60115406|NCT03713632|76236181|FG001|STARTED|Treatment Period 2 (After Week 16)||169||
60115407|NCT03713632|76236182|FG002|STARTED|Treatment Period 2 (After Week 16)||0||
60115408|NCT03713632|76236183|FG003|STARTED|Treatment Period 2 (After Week 16)||81||
60115409|NCT03713632|76236184|FG004|STARTED|Treatment Period 2 (After Week 16)||86||
60115410|NCT03713632|76236180|FG000|COMPLETED|Treatment Period 2 (After Week 16)||149||
60115411|NCT03713632|76236181|FG001|COMPLETED|Treatment Period 2 (After Week 16)||133||
60115412|NCT03713632|76236182|FG002|COMPLETED|Treatment Period 2 (After Week 16)||0||
60115413|NCT03713632|76236183|FG003|COMPLETED|Treatment Period 2 (After Week 16)||68||
60115414|NCT03713632|76236184|FG004|COMPLETED|Treatment Period 2 (After Week 16)||69||
60115415|NCT03713632|76236180|FG000|NOT COMPLETED|Treatment Period 2 (After Week 16)||21||
60115416|NCT03713632|76236181|FG001|NOT COMPLETED|Treatment Period 2 (After Week 16)||36||
60115417|NCT03713632|76236182|FG002|NOT COMPLETED|Treatment Period 2 (After Week 16)||0||
60115418|NCT03713632|76236183|FG003|NOT COMPLETED|Treatment Period 2 (After Week 16)||13||
60115419|NCT03713632|76236184|FG004|NOT COMPLETED|Treatment Period 2 (After Week 16)||17||
60115420|NCT03682900|76236197|FG000|STARTED|Overall Study||1346||22
60115421|NCT03682900|76236198|FG001|STARTED|Overall Study||1327||21
60115422|NCT03682900|76236197|FG000|COMPLETED|Overall Study|Students completed either the baseline assessment or the follow-up assessment to be considered enrolled in the study and in the final sample.|1346||22
60115423|NCT03682900|76236198|FG001|COMPLETED|Overall Study||1327||21
60115424|NCT03682900|76236197|FG000|NOT COMPLETED|Overall Study||0||0
60115425|NCT03682900|76236198|FG001|NOT COMPLETED|Overall Study||0||0
60115426|NCT03517436|76236206|FG000|STARTED|Overall Study||101||
60115427|NCT03517436|76236206|FG000|COMPLETED|Overall Study||93||
60115428|NCT03517436|76236206|FG000|NOT COMPLETED|Overall Study||8||
60115429|NCT03237286|76236213|FG000|STARTED|Overall Study||53||
60115430|NCT03237286|76236214|FG001|STARTED|Overall Study||50||
60115431|NCT03237286|76236215|FG002|STARTED|Overall Study||51||
60115432|NCT03237286|76236213|FG000|COMPLETED|Overall Study||52||
60115433|NCT03237286|76236214|FG001|COMPLETED|Overall Study||50||
60115434|NCT03237286|76236215|FG002|COMPLETED|Overall Study||48||
60115435|NCT03237286|76236213|FG000|NOT COMPLETED|Overall Study||1||
60115436|NCT03237286|76236214|FG001|NOT COMPLETED|Overall Study||0||
60115437|NCT03237286|76236215|FG002|NOT COMPLETED|Overall Study||3||
60115438|NCT03170349|76236222|FG000|STARTED|At 30 Days Follow-up||124||
60115439|NCT03170349|76236222|FG000|COMPLETED|At 30 Days Follow-up||123||
60115440|NCT03170349|76236222|FG000|NOT COMPLETED|At 30 Days Follow-up||1||
60115441|NCT03170349|76236222|FG000|STARTED|At 6 Months Follow-up||123||
60115442|NCT03170349|76236222|FG000|COMPLETED|At 6 Months Follow-up||114||
60115443|NCT03170349|76236222|FG000|NOT COMPLETED|At 6 Months Follow-up||9||
60115444|NCT03170349|76236222|FG000|STARTED|At 1 Year Follow-up||114||
60115445|NCT03170349|76236222|FG000|COMPLETED|At 1 Year Follow-up||106||
60115446|NCT03170349|76236222|FG000|NOT COMPLETED|At 1 Year Follow-up||8||
60115447|NCT03170349|76236222|FG000|STARTED|At 2 Year Follow-up||106||
60115448|NCT03170349|76236222|FG000|COMPLETED|At 2 Year Follow-up||88||
60115449|NCT03170349|76236222|FG000|NOT COMPLETED|At 2 Year Follow-up||18||
60115450|NCT03051256|76236229|FG000|STARTED|Overall Study||19||
60115451|NCT03051256|76236230|FG001|STARTED|Overall Study||21||
60115452|NCT03051256|76236231|FG002|STARTED|Overall Study||22||
60115453|NCT03051256|76236229|FG000|COMPLETED|Overall Study||19|Day 7|
60115454|NCT03051256|76236230|FG001|COMPLETED|Overall Study||21|Day 7|
60115455|NCT03051256|76236231|FG002|COMPLETED|Overall Study||21|Day 7|
60115456|NCT03051256|76236229|FG000|NOT COMPLETED|Overall Study||0||
60115457|NCT03051256|76236230|FG001|NOT COMPLETED|Overall Study||0||
60115458|NCT03051256|76236231|FG002|NOT COMPLETED|Overall Study||1||
60115459|NCT02836236|76236242|FG000|STARTED|Overall Study||105||
60115460|NCT02836236|76236243|FG001|STARTED|Overall Study||50||
60115461|NCT02836236|76236242|FG000|COMPLETED|Overall Study||0||
60115462|NCT02836236|76236243|FG001|COMPLETED|Overall Study||0||
60115463|NCT02836236|76236242|FG000|NOT COMPLETED|Overall Study||105||
60115464|NCT02836236|76236243|FG001|NOT COMPLETED|Overall Study||50||
60115465|NCT02670525|76236251|FG000|STARTED|Overall Study||236||
60115466|NCT02670525|76236252|FG001|STARTED|Overall Study||102||
60115467|NCT02670525|76236251|FG000|Matched Targeted Therapy (MTT) Data Available|Overall Study||157||
60115468|NCT02670525|76236252|FG001|Matched Targeted Therapy (MTT) Data Available|Overall Study||74||
60115469|NCT02670525|76236251|FG000|Evaluable for Primary Endpoint|Overall Study||101||
60115470|NCT02670525|76236252|FG001|Evaluable for Primary Endpoint|Overall Study|Only Cohort 1 is meant to address the primary outcome. Cohort 2 will be reported for secondary outcomes.|0||
60115471|NCT02670525|76236251|FG000|COMPLETED|Overall Study||14|A patient is completed if they completed the required follow-up and came off study.|
60115472|NCT02670525|76236252|FG001|COMPLETED|Overall Study||9|A patient is completed if they completed the required follow-up and came off study.|
60115473|NCT02670525|76236251|FG000|NOT COMPLETED|Overall Study||222||
60115474|NCT02670525|76236252|FG001|NOT COMPLETED|Overall Study||93||
60115475|NCT02394795|76236260|FG000|STARTED|Overall Study||404||
60115476|NCT02394795|76236261|FG001|STARTED|Overall Study||407||
60115477|NCT02394795|76236260|FG000|COMPLETED|Overall Study||1||
59567221|NCT02971839|75670079|FG000|NOT COMPLETED|Overall Study||0||
60115478|NCT02394795|76236261|FG001|COMPLETED|Overall Study||1||
60115479|NCT02394795|76236260|FG000|NOT COMPLETED|Overall Study||403||
60115480|NCT02394795|76236261|FG001|NOT COMPLETED|Overall Study||406||
60115481|NCT02255422|76236274|FG000|STARTED|Overall Study||13||
60115482|NCT02255422|76236275|FG001|STARTED|Overall Study||6||
60115483|NCT02255422|76236276|FG002|STARTED|Overall Study||6||
60115484|NCT02255422|76236277|FG003|STARTED|Overall Study||6||
60115485|NCT02255422|76236278|FG004|STARTED|Overall Study||6||
60115486|NCT02255422|76236279|FG005|STARTED|Overall Study||6||
59567222|NCT02971839|75670080|FG001|NOT COMPLETED|Overall Study||0||
60115487|NCT02255422|76236280|FG006|STARTED|Overall Study||10||
60115488|NCT02255422|76236274|FG000|COMPLETED|Overall Study||13||
59567223|NCT02971839|75670081|FG002|NOT COMPLETED|Overall Study||0||
60115489|NCT02255422|76236275|FG001|COMPLETED|Overall Study||6||
60115490|NCT02255422|76236276|FG002|COMPLETED|Overall Study||5||
60115491|NCT02255422|76236277|FG003|COMPLETED|Overall Study||6||
60115492|NCT02255422|76236278|FG004|COMPLETED|Overall Study||6||
60115493|NCT02255422|76236279|FG005|COMPLETED|Overall Study||6||
60115494|NCT02255422|76236280|FG006|COMPLETED|Overall Study||8||
60115495|NCT02255422|76236274|FG000|NOT COMPLETED|Overall Study||0||
60115496|NCT02255422|76236275|FG001|NOT COMPLETED|Overall Study||0||
60115497|NCT02255422|76236276|FG002|NOT COMPLETED|Overall Study||1||
60115498|NCT02255422|76236277|FG003|NOT COMPLETED|Overall Study||0||
60115499|NCT02255422|76236278|FG004|NOT COMPLETED|Overall Study||0||
60115500|NCT02255422|76236279|FG005|NOT COMPLETED|Overall Study||0||
60115501|NCT02255422|76236280|FG006|NOT COMPLETED|Overall Study||2||
60115502|NCT02142959|76236299|FG000|STARTED|Overall Study||64||
60115503|NCT02142959|76236300|FG001|STARTED|Overall Study||62||
60115504|NCT02142959|76236301|FG002|STARTED|Overall Study||61||
60115505|NCT02142959|76236299|FG000|COMPLETED|Overall Study||59||
60115506|NCT02142959|76236300|FG001|COMPLETED|Overall Study||59||
60115507|NCT02142959|76236301|FG002|COMPLETED|Overall Study||55||
60115508|NCT02142959|76236299|FG000|NOT COMPLETED|Overall Study||5||
60115509|NCT02142959|76236300|FG001|NOT COMPLETED|Overall Study||3||
60115510|NCT02142959|76236301|FG002|NOT COMPLETED|Overall Study||6||
60115511|NCT02128113|76236312|FG000|STARTED|Overall Study||103||
60115512|NCT02128113|76236313|FG001|STARTED|Overall Study||102||
60115513|NCT02128113|76236314|FG002|STARTED|Overall Study||102||
60115514|NCT02128113|76236312|FG000|COMPLETED|Overall Study||100||
60115515|NCT02128113|76236313|FG001|COMPLETED|Overall Study||99||
60115516|NCT02128113|76236314|FG002|COMPLETED|Overall Study||101||
60115517|NCT02128113|76236312|FG000|NOT COMPLETED|Overall Study||3||
60115518|NCT02128113|76236313|FG001|NOT COMPLETED|Overall Study||3||
60115519|NCT02128113|76236314|FG002|NOT COMPLETED|Overall Study||1||
60115520|NCT02065375|76236325|FG000|STARTED|Overall Study||37||
60115521|NCT02065375|76236326|FG001|STARTED|Overall Study||33||
60115522|NCT02065375|76236327|FG002|STARTED|Overall Study||39||
60115523|NCT02065375|76236325|FG000|Completed Treatment|Overall Study||19||
60115524|NCT02065375|76236326|FG001|Completed Treatment|Overall Study||15||
60115525|NCT02065375|76236327|FG002|Completed Treatment|Overall Study||25||
60115526|NCT02065375|76236325|FG000|COMPLETED|Overall Study||37||
60115527|NCT02065375|76236326|FG001|COMPLETED|Overall Study||33||
60115528|NCT02065375|76236327|FG002|COMPLETED|Overall Study||39||
60115529|NCT02065375|76236325|FG000|NOT COMPLETED|Overall Study||0||
60115530|NCT02065375|76236326|FG001|NOT COMPLETED|Overall Study||0||
60115531|NCT02065375|76236327|FG002|NOT COMPLETED|Overall Study||0||
60115532|NCT02036970|76236351|FG000|STARTED|Part 1: Day 1 Through Week 16||6||
60115533|NCT02036970|76236352|FG001|STARTED|Part 1: Day 1 Through Week 16||12||
60115534|NCT02036970|76236353|FG002|STARTED|Part 1: Day 1 Through Week 16||11||
60115535|NCT02036970|76236354|FG003|STARTED|Part 1: Day 1 Through Week 16||12||
60115536|NCT02036970|76236355|FG004|STARTED|Part 1: Day 1 Through Week 16||2||
60115537|NCT02036970|76236356|FG005|STARTED|Part 1: Day 1 Through Week 16||4||
60115538|NCT02036970|76236357|FG006|STARTED|Part 1: Day 1 Through Week 16||3||
60115539|NCT02036970|76236358|FG007|STARTED|Part 1: Day 1 Through Week 16||4||
60115540|NCT02036970|76236359|FG008|STARTED|Part 1: Day 1 Through Week 16||74||
60115541|NCT02036970|76236360|FG009|STARTED|Part 1: Day 1 Through Week 16||38||
60115542|NCT02036970|76236351|FG000|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||6||
60115543|NCT02036970|76236352|FG001|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||6||
60115544|NCT02036970|76236353|FG002|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||11||
60115545|NCT02036970|76236354|FG003|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||6||
60115546|NCT02036970|76236355|FG004|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||2||
60115547|NCT02036970|76236356|FG005|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||2||
60115548|NCT02036970|76236357|FG006|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||3||
60115549|NCT02036970|76236358|FG007|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||2||
60115550|NCT02036970|76236359|FG008|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||0||
60115551|NCT02036970|76236360|FG009|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||0||
60115552|NCT02036970|76236351|FG000|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||0||
60115553|NCT02036970|76236352|FG001|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||6||
60115554|NCT02036970|76236353|FG002|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||0||
60115555|NCT02036970|76236354|FG003|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||6||
60115556|NCT02036970|76236355|FG004|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||0||
60115557|NCT02036970|76236356|FG005|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||2||
60115558|NCT02036970|76236357|FG006|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||0||
60115559|NCT02036970|76236358|FG007|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||2||
60115560|NCT02036970|76236359|FG008|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||0||
60115561|NCT02036970|76236360|FG009|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||0||
60115562|NCT02036970|76236351|FG000|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||0||
60115563|NCT02036970|76236352|FG001|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||0||
60115564|NCT02036970|76236353|FG002|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||0||
60115565|NCT02036970|76236354|FG003|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||0||
60115566|NCT02036970|76236355|FG004|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||0||
60115567|NCT02036970|76236356|FG005|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||0||
60115568|NCT02036970|76236357|FG006|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||0||
60115569|NCT02036970|76236358|FG007|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||0||
60115570|NCT02036970|76236359|FG008|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||14||
60115571|NCT02036970|76236360|FG009|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||8||
60115572|NCT02036970|76236351|FG000|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||0||
60115573|NCT02036970|76236352|FG001|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||0||
60115574|NCT02036970|76236353|FG002|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||0||
60115575|NCT02036970|76236354|FG003|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||0||
60115576|NCT02036970|76236355|FG004|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||0||
60115577|NCT02036970|76236356|FG005|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||0||
60115578|NCT02036970|76236357|FG006|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||0||
60115579|NCT02036970|76236358|FG007|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||0||
60115580|NCT02036970|76236359|FG008|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||16||
60115581|NCT02036970|76236360|FG009|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||9||
60115582|NCT02036970|76236351|FG000|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||0||
60115583|NCT02036970|76236352|FG001|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||0||
60115584|NCT02036970|76236353|FG002|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||0||
60115585|NCT02036970|76236354|FG003|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||0||
60115586|NCT02036970|76236355|FG004|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||0||
60115587|NCT02036970|76236356|FG005|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||0||
60115588|NCT02036970|76236357|FG006|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||0||
60115589|NCT02036970|76236358|FG007|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||0||
60115590|NCT02036970|76236359|FG008|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||17||
60115591|NCT02036970|76236360|FG009|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||8||
60115592|NCT02036970|76236351|FG000|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||0||
60115593|NCT02036970|76236352|FG001|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||0||
60115594|NCT02036970|76236353|FG002|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||0||
60115595|NCT02036970|76236354|FG003|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||0||
60115596|NCT02036970|76236355|FG004|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||0||
60115597|NCT02036970|76236356|FG005|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||0||
60115598|NCT02036970|76236357|FG006|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||0||
60115599|NCT02036970|76236358|FG007|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||0||
60115600|NCT02036970|76236359|FG008|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||6||
60115601|NCT02036970|76236360|FG009|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||2||
60115602|NCT02036970|76236351|FG000|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||0||
60115603|NCT02036970|76236352|FG001|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||0||
60115604|NCT02036970|76236353|FG002|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||0||
60115605|NCT02036970|76236354|FG003|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||0||
60115606|NCT02036970|76236355|FG004|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||0||
60115607|NCT02036970|76236356|FG005|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||0||
60115608|NCT02036970|76236357|FG006|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||0||
60115609|NCT02036970|76236358|FG007|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||0||
60115610|NCT02036970|76236359|FG008|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||4||
60115611|NCT02036970|76236360|FG009|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||1||
60115612|NCT02036970|76236351|FG000|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||0||
60115613|NCT02036970|76236352|FG001|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||0||
60115614|NCT02036970|76236353|FG002|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||0||
60115615|NCT02036970|76236354|FG003|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||0||
60115616|NCT02036970|76236355|FG004|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||0||
60115617|NCT02036970|76236356|FG005|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||0||
60115618|NCT02036970|76236357|FG006|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||0||
60115619|NCT02036970|76236358|FG007|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||0||
60115620|NCT02036970|76236359|FG008|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||17||
60115621|NCT02036970|76236360|FG009|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||1||
60115622|NCT02036970|76236351|FG000|COMPLETED|Part 1: Day 1 Through Week 16||5||
60115623|NCT02036970|76236352|FG001|COMPLETED|Part 1: Day 1 Through Week 16||12||
60115624|NCT02036970|76236353|FG002|COMPLETED|Part 1: Day 1 Through Week 16||7||
60115625|NCT02036970|76236354|FG003|COMPLETED|Part 1: Day 1 Through Week 16||9||
60115626|NCT02036970|76236355|FG004|COMPLETED|Part 1: Day 1 Through Week 16||1||
60115627|NCT02036970|76236356|FG005|COMPLETED|Part 1: Day 1 Through Week 16||3||
60115628|NCT02036970|76236357|FG006|COMPLETED|Part 1: Day 1 Through Week 16||3||
60115629|NCT02036970|76236358|FG007|COMPLETED|Part 1: Day 1 Through Week 16||3||
60115630|NCT02036970|76236359|FG008|COMPLETED|Part 1: Day 1 Through Week 16||66||
60115631|NCT02036970|76236360|FG009|COMPLETED|Part 1: Day 1 Through Week 16||33||
60115632|NCT02036970|76236351|FG000|NOT COMPLETED|Part 1: Day 1 Through Week 16||1||
60115633|NCT02036970|76236352|FG001|NOT COMPLETED|Part 1: Day 1 Through Week 16||0||
60115634|NCT02036970|76236353|FG002|NOT COMPLETED|Part 1: Day 1 Through Week 16||4||
60115635|NCT02036970|76236354|FG003|NOT COMPLETED|Part 1: Day 1 Through Week 16||3||
60115636|NCT02036970|76236355|FG004|NOT COMPLETED|Part 1: Day 1 Through Week 16||1||
60115637|NCT02036970|76236356|FG005|NOT COMPLETED|Part 1: Day 1 Through Week 16||1||
60115638|NCT02036970|76236357|FG006|NOT COMPLETED|Part 1: Day 1 Through Week 16||0||
60115639|NCT02036970|76236358|FG007|NOT COMPLETED|Part 1: Day 1 Through Week 16||1||
60115640|NCT02036970|76236359|FG008|NOT COMPLETED|Part 1: Day 1 Through Week 16||8||
59715148|NCT01176240|75834000|FG000|1 wk of Stable Dosing and Visit 4|Study 306B||69||
59715149|NCT01176240|75834001|FG001|1 wk of Stable Dosing and Visit 4|Study 306B||78||
59715150|NCT01176240|75834000|FG000|2 wk of Stable Dosing and Visit 5|Study 306B||68||
60115641|NCT02036970|76236360|FG009|NOT COMPLETED|Part 1: Day 1 Through Week 16||5||
60115642|NCT02036970|76236351|FG000|STARTED|Part 2: Week 16 Onwards||5||
60115643|NCT02036970|76236352|FG001|STARTED|Part 2: Week 16 Onwards|One patient who completed Part 1 elected not to continue to Part 2.|11||
60115644|NCT02036970|76236353|FG002|STARTED|Part 2: Week 16 Onwards|One patient who completed Part 1 elected not to continue to Part 2.|6||
60115645|NCT02036970|76236354|FG003|STARTED|Part 2: Week 16 Onwards||9||
60115646|NCT02036970|76236355|FG004|STARTED|Part 2: Week 16 Onwards||1||
60115647|NCT02036970|76236356|FG005|STARTED|Part 2: Week 16 Onwards||3||
60115648|NCT02036970|76236357|FG006|STARTED|Part 2: Week 16 Onwards||3||
60115649|NCT02036970|76236358|FG007|STARTED|Part 2: Week 16 Onwards||3||
60115650|NCT02036970|76236359|FG008|STARTED|Part 2: Week 16 Onwards|Three patients who completed Part 1 elected not to continue to Part 2.|63||
60115651|NCT02036970|76236360|FG009|STARTED|Part 2: Week 16 Onwards||33||
60115652|NCT02036970|76236351|FG000|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||5||
60115653|NCT02036970|76236352|FG001|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||5||
60115654|NCT02036970|76236353|FG002|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||6||
60115655|NCT02036970|76236354|FG003|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||5||
60115656|NCT02036970|76236355|FG004|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||1||
60115657|NCT02036970|76236356|FG005|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||1||
60115658|NCT02036970|76236357|FG006|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||3||
60115659|NCT02036970|76236358|FG007|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||2||
60115660|NCT02036970|76236359|FG008|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||0||
60115661|NCT02036970|76236360|FG009|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||0||
60115662|NCT02036970|76236351|FG000|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||0||
60115663|NCT02036970|76236352|FG001|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||6||
60115664|NCT02036970|76236353|FG002|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||0||
60115665|NCT02036970|76236354|FG003|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||4||
60115666|NCT02036970|76236355|FG004|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||0||
60115667|NCT02036970|76236356|FG005|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||2||
60115668|NCT02036970|76236357|FG006|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||0||
60115669|NCT02036970|76236358|FG007|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||1||
60115670|NCT02036970|76236359|FG008|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||0||
60115671|NCT02036970|76236360|FG009|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||0||
60115672|NCT02036970|76236351|FG000|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||0||
60115673|NCT02036970|76236352|FG001|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||0||
60115674|NCT02036970|76236353|FG002|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||0||
60115675|NCT02036970|76236354|FG003|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||0||
60115676|NCT02036970|76236355|FG004|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||0||
59715151|NCT01176240|75834001|FG001|2 wk of Stable Dosing and Visit 5|Study 306B||75||
59715152|NCT01176240|75834000|FG000|4 wk of Stable Dosing and Visit 6|Study 306B||67||
59715153|NCT01176240|75834001|FG001|4 wk of Stable Dosing and Visit 6|Study 306B||73||
59715154|NCT01176240|75834000|FG000|COMPLETED|Study 306B||63||
59824038|NCT00265330|75946951|FG000|COMPLETED|Overall Study||67||
60115677|NCT02036970|76236356|FG005|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||0||
60115678|NCT02036970|76236357|FG006|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||0||
60115679|NCT02036970|76236358|FG007|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||0||
60115680|NCT02036970|76236359|FG008|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||12||
60115681|NCT02036970|76236360|FG009|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||8||
60115682|NCT02036970|76236351|FG000|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||0||
60115683|NCT02036970|76236352|FG001|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||0||
60115684|NCT02036970|76236353|FG002|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||0||
60115685|NCT02036970|76236354|FG003|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||0||
60115686|NCT02036970|76236355|FG004|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||0||
60115687|NCT02036970|76236356|FG005|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||0||
59824039|NCT00265330|75946951|FG000|NOT COMPLETED|Overall Study||95||
59824040|NCT00292318|75946957|FG000|STARTED|Overall Study||4||
59824041|NCT00292318|75946958|FG001|STARTED|Overall Study||3||
59824042|NCT00292318|75946957|FG000|COMPLETED|Overall Study||2||
59824043|NCT00292318|75946958|FG001|COMPLETED|Overall Study||2||
59824044|NCT00292318|75946957|FG000|NOT COMPLETED|Overall Study||2||
59824045|NCT00292318|75946958|FG001|NOT COMPLETED|Overall Study||1||
59824046|NCT00281632|75946964|FG000|STARTED|Overall Study||36||
59824047|NCT00281632|75946964|FG000|COMPLETED|Overall Study|Three participants were ongoing in the study at the time of the data cut-off (30 Apr 2008).|0||
59824048|NCT00281632|75946964|FG000|NOT COMPLETED|Overall Study||36||
59824049|NCT00543569|75946980|FG000|STARTED|Overall Study||82||
59824050|NCT00543569|75946981|FG001|STARTED|Overall Study||80||
59824051|NCT00543569|75946982|FG002|STARTED|Overall Study||80||
59824052|NCT00543569|75946983|FG003|STARTED|Overall Study||81||
59824053|NCT00543569|75946980|FG000|Received Treatment|Overall Study||79||
59824054|NCT00543569|75946981|FG001|Received Treatment|Overall Study||77||
59824055|NCT00543569|75946982|FG002|Received Treatment|Overall Study||75||
59824056|NCT00543569|75946983|FG003|Received Treatment|Overall Study||78||
59824057|NCT00543569|75946980|FG000|COMPLETED|Overall Study||70||
59824058|NCT00543569|75946981|FG001|COMPLETED|Overall Study||72||
59824059|NCT00543569|75946982|FG002|COMPLETED|Overall Study||60||
59824060|NCT00543569|75946983|FG003|COMPLETED|Overall Study||72||
59824061|NCT00543569|75946980|FG000|NOT COMPLETED|Overall Study||12||
59824062|NCT00543569|75946981|FG001|NOT COMPLETED|Overall Study||8||
59824063|NCT00543569|75946982|FG002|NOT COMPLETED|Overall Study||20||
59824064|NCT00543569|75946983|FG003|NOT COMPLETED|Overall Study||9||
59824065|NCT00445458|75946997|FG000|STARTED|Overall Study||3||
59824066|NCT00445458|75946998|FG001|STARTED|Overall Study||5||
59824067|NCT00445458|75946999|FG002|STARTED|Overall Study||71||
59824068|NCT00445458|75947000|FG003|STARTED|Overall Study||31||
59824069|NCT00445458|75946997|FG000|COMPLETED|Overall Study||0||
59824070|NCT00445458|75946998|FG001|COMPLETED|Overall Study||0||
59824071|NCT00445458|75946999|FG002|COMPLETED|Overall Study||3||
59824072|NCT00445458|75947000|FG003|COMPLETED|Overall Study||3||
59824073|NCT00445458|75946997|FG000|NOT COMPLETED|Overall Study||3||
59824074|NCT00445458|75946998|FG001|NOT COMPLETED|Overall Study||5||
59824075|NCT00445458|75946999|FG002|NOT COMPLETED|Overall Study||68||
59824076|NCT00445458|75947000|FG003|NOT COMPLETED|Overall Study||28||
59824077|NCT03914417|75947013|FG000|STARTED|Overall Study||21||
59824078|NCT03914417|75947013|FG000|COMPLETED|Overall Study||19||
59824079|NCT03914417|75947013|FG000|NOT COMPLETED|Overall Study||2||
59824080|NCT00541385|75947019|FG000|STARTED|Overall Study||355||
59824081|NCT00541385|75947020|FG001|STARTED|Overall Study||180||
59824082|NCT00541385|75947019|FG000|COMPLETED|Overall Study||274||
60115688|NCT02036970|76236357|FG006|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||0||
60115689|NCT02036970|76236358|FG007|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||0||
60115690|NCT02036970|76236359|FG008|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||12||
60115691|NCT02036970|76236360|FG009|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||7||
60115692|NCT02036970|76236351|FG000|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||0||
60115693|NCT02036970|76236352|FG001|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||0||
60115694|NCT02036970|76236353|FG002|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||0||
60115695|NCT02036970|76236354|FG003|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||0||
60115696|NCT02036970|76236355|FG004|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||0||
60115697|NCT02036970|76236356|FG005|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||0||
60115698|NCT02036970|76236357|FG006|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||0||
60115699|NCT02036970|76236358|FG007|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||0||
60115700|NCT02036970|76236359|FG008|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||16||
60115701|NCT02036970|76236360|FG009|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||7||
60115702|NCT02036970|76236351|FG000|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||0||
60115703|NCT02036970|76236352|FG001|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||0||
60115704|NCT02036970|76236353|FG002|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||0||
60115705|NCT02036970|76236354|FG003|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||0||
60115706|NCT02036970|76236355|FG004|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||0||
59824083|NCT00541385|75947020|FG001|COMPLETED|Overall Study||142||
59824084|NCT00541385|75947019|FG000|NOT COMPLETED|Overall Study||81||
59824085|NCT00541385|75947020|FG001|NOT COMPLETED|Overall Study||38||
59824086|NCT00265096|75947029|FG000|STARTED|Overall Study||113||
59824087|NCT00265096|75947030|FG001|STARTED|Overall Study||146||
59824088|NCT00265096|75947031|FG002|STARTED|Overall Study||146||
59824089|NCT00265096|75947029|FG000|COMPLETED|Overall Study|Indicates number of patients that were continuing SC study agent at Wk 24|77||
59824090|NCT00265096|75947030|FG001|COMPLETED|Overall Study|Indicates number of patients that were continuing SC study agent at Wk 24|95||
59824091|NCT00265096|75947031|FG002|COMPLETED|Overall Study|Indicates number of patients that were continuing SC study agent at Wk 24|107||
59715155|NCT01176240|75834001|FG001|COMPLETED|Study 306B||68||
59715156|NCT01176240|75834000|FG000|NOT COMPLETED|Study 306B||26||
59824092|NCT00265096|75947029|FG000|NOT COMPLETED|Overall Study||36||
59824093|NCT00265096|75947030|FG001|NOT COMPLETED|Overall Study||51||
59824094|NCT00265096|75947031|FG002|NOT COMPLETED|Overall Study||39||
59824095|NCT00281320|75947043|FG000|STARTED|Overall Study||61||
59824096|NCT00281320|75947044|FG001|STARTED|Overall Study||61||
59824097|NCT00281320|75947043|FG000|COMPLETED|Overall Study||36||
59824098|NCT00281320|75947044|FG001|COMPLETED|Overall Study||40||
59824099|NCT00281320|75947043|FG000|NOT COMPLETED|Overall Study||25||
59824100|NCT00281320|75947044|FG001|NOT COMPLETED|Overall Study||21||
59824101|NCT00541307|75947056|FG000|STARTED|Overall Study||119||
59824102|NCT00541307|75947056|FG000|COMPLETED|Overall Study||95||
59824103|NCT00541307|75947056|FG000|NOT COMPLETED|Overall Study||24||
59824104|NCT00541229|75947066|FG000|STARTED|Treatment Period I (Week 1)||17||
59824105|NCT00541229|75947067|FG001|STARTED|Treatment Period I (Week 1)||16||
59824106|NCT00541229|75947068|FG002|STARTED|Treatment Period I (Week 1)||20||
59824107|NCT00541229|75947069|FG003|STARTED|Treatment Period I (Week 1)||18||
59824108|NCT00541229|75947070|FG004|STARTED|Treatment Period I (Week 1)||14||
59824109|NCT00541229|75947071|FG005|STARTED|Treatment Period I (Week 1)||18||
59824110|NCT00541229|75947066|FG000|COMPLETED|Treatment Period I (Week 1)||17||
59824111|NCT00541229|75947067|FG001|COMPLETED|Treatment Period I (Week 1)||15||
59824112|NCT00541229|75947068|FG002|COMPLETED|Treatment Period I (Week 1)||17||
59824113|NCT00541229|75947069|FG003|COMPLETED|Treatment Period I (Week 1)||17||
59824114|NCT00541229|75947070|FG004|COMPLETED|Treatment Period I (Week 1)||14||
59824115|NCT00541229|75947071|FG005|COMPLETED|Treatment Period I (Week 1)||16||
59824116|NCT00541229|75947066|FG000|NOT COMPLETED|Treatment Period I (Week 1)||0||
59824117|NCT00541229|75947067|FG001|NOT COMPLETED|Treatment Period I (Week 1)||1||
59824118|NCT00541229|75947068|FG002|NOT COMPLETED|Treatment Period I (Week 1)||3||
59824119|NCT00541229|75947069|FG003|NOT COMPLETED|Treatment Period I (Week 1)||1||
59824120|NCT00541229|75947070|FG004|NOT COMPLETED|Treatment Period I (Week 1)||0||
59824121|NCT00541229|75947071|FG005|NOT COMPLETED|Treatment Period I (Week 1)||2||
60115707|NCT02036970|76236356|FG005|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||0||
60115708|NCT02036970|76236357|FG006|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||0||
60115709|NCT02036970|76236358|FG007|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||0||
60115710|NCT02036970|76236359|FG008|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||5||
60115711|NCT02036970|76236360|FG009|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||2||
60115712|NCT02036970|76236351|FG000|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||0||
60115713|NCT02036970|76236352|FG001|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||0||
60115714|NCT02036970|76236353|FG002|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||0||
60115715|NCT02036970|76236354|FG003|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||0||
59715157|NCT01176240|75834001|FG001|NOT COMPLETED|Study 306B||17||
59715158|NCT00988221|75834010|FG000|STARTED|Part I||35||
59715159|NCT00988221|75834011|FG001|STARTED|Part I||34||
59715160|NCT00988221|75834012|FG002|STARTED|Part I||119||
59715161|NCT00988221|75834013|FG003|STARTED|Part I|No patients received placebo in Part I of this study.|0||
59715162|NCT00988221|75834010|FG000|COMPLETED|Part I||31||
59824122|NCT00541229|75947066|FG000|STARTED|Washout Period I (Week 2-5)||17||
59824123|NCT00541229|75947067|FG001|STARTED|Washout Period I (Week 2-5)||15||
59824124|NCT00541229|75947068|FG002|STARTED|Washout Period I (Week 2-5)||17||
59824125|NCT00541229|75947069|FG003|STARTED|Washout Period I (Week 2-5)||17||
59824126|NCT00541229|75947070|FG004|STARTED|Washout Period I (Week 2-5)||14||
60115716|NCT02036970|76236355|FG004|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||0||
59824127|NCT00541229|75947071|FG005|STARTED|Washout Period I (Week 2-5)||16||
59824128|NCT00541229|75947066|FG000|COMPLETED|Washout Period I (Week 2-5)||13||
59824129|NCT00541229|75947067|FG001|COMPLETED|Washout Period I (Week 2-5)||13||
59824130|NCT00541229|75947068|FG002|COMPLETED|Washout Period I (Week 2-5)||13||
59715163|NCT00988221|75834011|FG001|COMPLETED|Part I||24||
59715164|NCT00988221|75834012|FG002|COMPLETED|Part I||111||
59715165|NCT00988221|75834013|FG003|COMPLETED|Part I||0||
59715166|NCT00988221|75834010|FG000|NOT COMPLETED|Part I||4||
59715167|NCT00988221|75834011|FG001|NOT COMPLETED|Part I||10||
59715168|NCT00988221|75834012|FG002|NOT COMPLETED|Part I||8||
59715169|NCT00988221|75834013|FG003|NOT COMPLETED|Part I||0||
59715170|NCT00988221|75834010|FG000|STARTED|Part II|Some of the patients in this group in Part I were randomized to receive placebo in Part II.|16||
59824131|NCT00541229|75947069|FG003|COMPLETED|Washout Period I (Week 2-5)||13||
59567224|NCT02971839|75670082|FG003|NOT COMPLETED|Overall Study||0||
59715171|NCT00988221|75834011|FG001|STARTED|Part II|Some of the patients in this group in Part I were randomized to receive placebo in Part II.|11||
59715172|NCT00988221|75834012|FG002|STARTED|Part II|Some of the patients in this group in Part I were randomized to receive placebo in Part II.|55||
59715173|NCT00988221|75834013|FG003|STARTED|Part II||84||
59824132|NCT00541229|75947070|FG004|COMPLETED|Washout Period I (Week 2-5)||13||
59824133|NCT00541229|75947071|FG005|COMPLETED|Washout Period I (Week 2-5)||11||
59824134|NCT00541229|75947066|FG000|NOT COMPLETED|Washout Period I (Week 2-5)||4||
59824135|NCT00541229|75947067|FG001|NOT COMPLETED|Washout Period I (Week 2-5)||2||
59824136|NCT00541229|75947068|FG002|NOT COMPLETED|Washout Period I (Week 2-5)||4||
59824137|NCT00541229|75947069|FG003|NOT COMPLETED|Washout Period I (Week 2-5)||4||
59824138|NCT00541229|75947070|FG004|NOT COMPLETED|Washout Period I (Week 2-5)||1||
59824139|NCT00541229|75947071|FG005|NOT COMPLETED|Washout Period I (Week 2-5)||5||
59824140|NCT00541229|75947066|FG000|STARTED|Treatment Period II (Week 6)||13||
59824141|NCT00541229|75947067|FG001|STARTED|Treatment Period II (Week 6)||13||
59824142|NCT00541229|75947068|FG002|STARTED|Treatment Period II (Week 6)||13||
59824143|NCT00541229|75947069|FG003|STARTED|Treatment Period II (Week 6)||13||
59824144|NCT00541229|75947070|FG004|STARTED|Treatment Period II (Week 6)||13||
59824145|NCT00541229|75947071|FG005|STARTED|Treatment Period II (Week 6)||11||
59824146|NCT00541229|75947066|FG000|COMPLETED|Treatment Period II (Week 6)||11||
59824147|NCT00541229|75947067|FG001|COMPLETED|Treatment Period II (Week 6)||12||
59824148|NCT00541229|75947068|FG002|COMPLETED|Treatment Period II (Week 6)||12||
59824149|NCT00541229|75947069|FG003|COMPLETED|Treatment Period II (Week 6)||12||
59824150|NCT00541229|75947070|FG004|COMPLETED|Treatment Period II (Week 6)||11||
59824151|NCT00541229|75947071|FG005|COMPLETED|Treatment Period II (Week 6)||8||
59824152|NCT00541229|75947066|FG000|NOT COMPLETED|Treatment Period II (Week 6)||2||
59824153|NCT00541229|75947067|FG001|NOT COMPLETED|Treatment Period II (Week 6)||1||
59824154|NCT00541229|75947068|FG002|NOT COMPLETED|Treatment Period II (Week 6)||1||
59824155|NCT00541229|75947069|FG003|NOT COMPLETED|Treatment Period II (Week 6)||1||
59824156|NCT00541229|75947070|FG004|NOT COMPLETED|Treatment Period II (Week 6)||2||
59824157|NCT00541229|75947071|FG005|NOT COMPLETED|Treatment Period II (Week 6)||3||
59824158|NCT00541229|75947066|FG000|STARTED|Washout Period II (Week 7-10)||11||
59824159|NCT00541229|75947067|FG001|STARTED|Washout Period II (Week 7-10)||12||
59824160|NCT00541229|75947068|FG002|STARTED|Washout Period II (Week 7-10)||12||
59824161|NCT00541229|75947069|FG003|STARTED|Washout Period II (Week 7-10)||12||
59824162|NCT00541229|75947070|FG004|STARTED|Washout Period II (Week 7-10)||11||
59824163|NCT00541229|75947071|FG005|STARTED|Washout Period II (Week 7-10)||8||
59824164|NCT00541229|75947066|FG000|COMPLETED|Washout Period II (Week 7-10)||7||
59824165|NCT00541229|75947067|FG001|COMPLETED|Washout Period II (Week 7-10)||8||
59824166|NCT00541229|75947068|FG002|COMPLETED|Washout Period II (Week 7-10)||10||
59824167|NCT00541229|75947069|FG003|COMPLETED|Washout Period II (Week 7-10)||8||
59824168|NCT00541229|75947070|FG004|COMPLETED|Washout Period II (Week 7-10)||7||
59824169|NCT00541229|75947071|FG005|COMPLETED|Washout Period II (Week 7-10)||5||
59824170|NCT00541229|75947066|FG000|NOT COMPLETED|Washout Period II (Week 7-10)||4||
59824171|NCT00541229|75947067|FG001|NOT COMPLETED|Washout Period II (Week 7-10)||4||
59824172|NCT00541229|75947068|FG002|NOT COMPLETED|Washout Period II (Week 7-10)||2||
59824173|NCT00541229|75947069|FG003|NOT COMPLETED|Washout Period II (Week 7-10)||4||
59824174|NCT00541229|75947070|FG004|NOT COMPLETED|Washout Period II (Week 7-10)||4||
59824175|NCT00541229|75947071|FG005|NOT COMPLETED|Washout Period II (Week 7-10)||3||
59824176|NCT00541229|75947066|FG000|STARTED|Treatment Period III (Week 11)||7||
59824177|NCT00541229|75947067|FG001|STARTED|Treatment Period III (Week 11)||8||
59715174|NCT00988221|75834010|FG000|COMPLETED|Part II||15||
60115717|NCT02036970|76236356|FG005|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||0||
60115718|NCT02036970|76236357|FG006|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||0||
60115719|NCT02036970|76236358|FG007|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||0||
60115720|NCT02036970|76236359|FG008|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||3||
60115721|NCT02036970|76236360|FG009|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||1||
60115722|NCT02036970|76236351|FG000|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||0||
60115723|NCT02036970|76236352|FG001|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||0||
60115724|NCT02036970|76236353|FG002|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||0||
59715175|NCT00988221|75834011|FG001|COMPLETED|Part II||11||
59715176|NCT00988221|75834012|FG002|COMPLETED|Part II|One participant who did not complete Part II was available to continue in the study and did.|52||
59715177|NCT00988221|75834013|FG003|COMPLETED|Part II||81||
59715178|NCT00988221|75834010|FG000|NOT COMPLETED|Part II||1||
59715179|NCT00988221|75834011|FG001|NOT COMPLETED|Part II||0||
59715180|NCT00988221|75834012|FG002|NOT COMPLETED|Part II||3||
59715181|NCT00988221|75834013|FG003|NOT COMPLETED|Part II||3||
59715182|NCT00988221|75834010|FG000|STARTED|Part III||30||
59715183|NCT00988221|75834011|FG001|STARTED|Part III||24||
59715184|NCT00988221|75834012|FG002|STARTED|Part III||106||
59715185|NCT00988221|75834013|FG003|STARTED|Part III|No patients received placebo in Part III of this study.|0||
59715186|NCT00988221|75834010|FG000|COMPLETED|Part III||29||
59715187|NCT00988221|75834011|FG001|COMPLETED|Part III||23||
59715188|NCT00988221|75834012|FG002|COMPLETED|Part III||103||
59715189|NCT00988221|75834013|FG003|COMPLETED|Part III||0||
59715190|NCT00988221|75834010|FG000|NOT COMPLETED|Part III||1||
59715191|NCT00988221|75834011|FG001|NOT COMPLETED|Part III||1||
59824178|NCT00541229|75947068|FG002|STARTED|Treatment Period III (Week 11)||10||
59824179|NCT00541229|75947069|FG003|STARTED|Treatment Period III (Week 11)||8||
59824180|NCT00541229|75947070|FG004|STARTED|Treatment Period III (Week 11)||7||
59824181|NCT00541229|75947071|FG005|STARTED|Treatment Period III (Week 11)||5||
59824182|NCT00541229|75947066|FG000|COMPLETED|Treatment Period III (Week 11)||7||
59824183|NCT00541229|75947067|FG001|COMPLETED|Treatment Period III (Week 11)||8||
59824184|NCT00541229|75947068|FG002|COMPLETED|Treatment Period III (Week 11)||9||
59824185|NCT00541229|75947069|FG003|COMPLETED|Treatment Period III (Week 11)||8||
59824186|NCT00541229|75947070|FG004|COMPLETED|Treatment Period III (Week 11)||6||
59824187|NCT00541229|75947071|FG005|COMPLETED|Treatment Period III (Week 11)||4||
59824188|NCT00541229|75947066|FG000|NOT COMPLETED|Treatment Period III (Week 11)||0||
59824189|NCT00541229|75947067|FG001|NOT COMPLETED|Treatment Period III (Week 11)||0||
59824190|NCT00541229|75947068|FG002|NOT COMPLETED|Treatment Period III (Week 11)||1||
59824191|NCT00541229|75947069|FG003|NOT COMPLETED|Treatment Period III (Week 11)||0||
59824192|NCT00541229|75947070|FG004|NOT COMPLETED|Treatment Period III (Week 11)||1||
59824193|NCT00541229|75947071|FG005|NOT COMPLETED|Treatment Period III (Week 11)||1||
59824194|NCT00481988|75947081|FG000|STARTED|Overall Study||12||
59824195|NCT00481988|75947082|FG001|STARTED|Overall Study|one patient was dropped from the study before randomization|9||
59824196|NCT00481988|75947081|FG000|Crossover|Overall Study|patient dropped out of study after 5 sessions to pursue other treatment options|11||
59824197|NCT00481988|75947082|FG001|Crossover|Overall Study|patient dropped out of study after 5 sessions to illness unrelated to study|8||
59824198|NCT00481988|75947081|FG000|COMPLETED|Overall Study||11||
60115725|NCT02036970|76236354|FG003|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||0||
60115726|NCT02036970|76236355|FG004|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||0||
60115727|NCT02036970|76236356|FG005|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||0||
60115728|NCT02036970|76236357|FG006|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||0||
60115729|NCT02036970|76236358|FG007|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||0||
60115730|NCT02036970|76236359|FG008|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||15||
60115731|NCT02036970|76236360|FG009|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||8||
60115732|NCT02036970|76236351|FG000|COMPLETED|Part 2: Week 16 Onwards||5||
60115733|NCT02036970|76236352|FG001|COMPLETED|Part 2: Week 16 Onwards||6||
60115734|NCT02036970|76236353|FG002|COMPLETED|Part 2: Week 16 Onwards||3||
60115735|NCT02036970|76236354|FG003|COMPLETED|Part 2: Week 16 Onwards||7||
60115736|NCT02036970|76236355|FG004|COMPLETED|Part 2: Week 16 Onwards||0||
60115737|NCT02036970|76236356|FG005|COMPLETED|Part 2: Week 16 Onwards||3||
60115738|NCT02036970|76236357|FG006|COMPLETED|Part 2: Week 16 Onwards||2||
60115739|NCT02036970|76236358|FG007|COMPLETED|Part 2: Week 16 Onwards||2||
60115740|NCT02036970|76236359|FG008|COMPLETED|Part 2: Week 16 Onwards||54||
60115741|NCT02036970|76236360|FG009|COMPLETED|Part 2: Week 16 Onwards||28||
60115742|NCT02036970|76236351|FG000|NOT COMPLETED|Part 2: Week 16 Onwards||0||
60115743|NCT02036970|76236352|FG001|NOT COMPLETED|Part 2: Week 16 Onwards||5||
60115744|NCT02036970|76236353|FG002|NOT COMPLETED|Part 2: Week 16 Onwards||3||
60115745|NCT02036970|76236354|FG003|NOT COMPLETED|Part 2: Week 16 Onwards||2||
60115746|NCT02036970|76236355|FG004|NOT COMPLETED|Part 2: Week 16 Onwards||1||
59715192|NCT00988221|75834012|FG002|NOT COMPLETED|Part III||3||
59715193|NCT00988221|75834013|FG003|NOT COMPLETED|Part III||0||
59715194|NCT01149096|75834034|FG000|STARTED|Overall Study||6||
59715195|NCT01149096|75834035|FG001|STARTED|Overall Study||7||
59715196|NCT01149096|75834034|FG000|COMPLETED|Overall Study||6||
59715197|NCT01149096|75834035|FG001|COMPLETED|Overall Study||6||
59715198|NCT01149096|75834034|FG000|NOT COMPLETED|Overall Study||0||
59715199|NCT01149096|75834035|FG001|NOT COMPLETED|Overall Study||1||
59715200|NCT01175382|75834045|FG000|STARTED|Overall Study||71||
60115747|NCT02036970|76236356|FG005|NOT COMPLETED|Part 2: Week 16 Onwards||0||
59824199|NCT00481988|75947082|FG001|COMPLETED|Overall Study||8||
59824200|NCT00481988|75947081|FG000|NOT COMPLETED|Overall Study||1||
59824201|NCT00481988|75947082|FG001|NOT COMPLETED|Overall Study||1||
59824202|NCT04118270|75947090|FG000|STARTED|Overall Study||37||
59824203|NCT04118270|75947091|FG001|STARTED|Overall Study||13||
59824204|NCT04118270|75947090|FG000|Completed Provider Accuracy Assessment|Overall Study|Only the Providers were eligible for completing the Provider Accuracy Assessment.|0||
59824205|NCT04118270|75947091|FG001|Completed Provider Accuracy Assessment|Overall Study||10||
59824206|NCT04118270|75947090|FG000|COMPLETED|Overall Study||37||
59824207|NCT04118270|75947091|FG001|COMPLETED|Overall Study||13||
59824208|NCT04118270|75947090|FG000|NOT COMPLETED|Overall Study||0||
59824209|NCT04118270|75947091|FG001|NOT COMPLETED|Overall Study||0||
59824210|NCT00481832|75947099|FG000|STARTED|Enrollment||50||
59824211|NCT00481832|75947099|FG000|COMPLETED|Enrollment||40||
59824212|NCT00481832|75947099|FG000|NOT COMPLETED|Enrollment||10||
59824213|NCT00481832|75947099|FG000|STARTED|Autologous Hematopoietic Cell Transplant||40||
59824214|NCT00481832|75947099|FG000|COMPLETED|Autologous Hematopoietic Cell Transplant||40||
59824215|NCT00481832|75947099|FG000|NOT COMPLETED|Autologous Hematopoietic Cell Transplant||0||
59824216|NCT00481832|75947099|FG000|STARTED|Inter-transplant Period||40||
59824217|NCT00481832|75947099|FG000|COMPLETED|Inter-transplant Period||13||
59824218|NCT00481832|75947099|FG000|NOT COMPLETED|Inter-transplant Period||27||
59824219|NCT00481832|75947099|FG000|STARTED|Allogenic Hematopoietic Cell Transplant||13||
59824220|NCT00481832|75947099|FG000|COMPLETED|Allogenic Hematopoietic Cell Transplant||13||
59824221|NCT00481832|75947099|FG000|NOT COMPLETED|Allogenic Hematopoietic Cell Transplant||0||
59824222|NCT00481676|75947105|FG000|STARTED|Overall Study||27||
59824223|NCT00481676|75947106|FG001|STARTED|Overall Study||22||
59824224|NCT00481676|75947105|FG000|COMPLETED|Overall Study||25||
59824225|NCT00481676|75947106|FG001|COMPLETED|Overall Study||17||
59824226|NCT00481676|75947105|FG000|NOT COMPLETED|Overall Study||2||
59824227|NCT00481676|75947106|FG001|NOT COMPLETED|Overall Study||5||
59824228|NCT00542789|75947114|FG000|STARTED|Overall Study|Randomised|175||
59824229|NCT00542789|75947115|FG001|STARTED|Overall Study|Randomised|168||
59824230|NCT00542789|75947114|FG000|COMPLETED|Overall Study||134||
59824231|NCT00542789|75947115|FG001|COMPLETED|Overall Study||90||
59824232|NCT00542789|75947114|FG000|NOT COMPLETED|Overall Study||41||
59824233|NCT00542789|75947115|FG001|NOT COMPLETED|Overall Study||78||
59824234|NCT00464672|75947123|FG000|STARTED|Overall Study||460||
59824235|NCT00464672|75947124|FG001|STARTED|Overall Study||232||
59824236|NCT00464672|75947125|FG002|STARTED|Overall Study||400||
59824237|NCT00464672|75947126|FG003|STARTED|Overall Study||200||
59824238|NCT00464672|75947127|FG004|STARTED|Overall Study||402||
59824239|NCT00464672|75947128|FG005|STARTED|Overall Study||199||
59824240|NCT00464672|75947123|FG000|COMPLETED|Overall Study||435||
59824241|NCT00464672|75947124|FG001|COMPLETED|Overall Study||222||
59824242|NCT00464672|75947125|FG002|COMPLETED|Overall Study||400||
59824243|NCT00464672|75947126|FG003|COMPLETED|Overall Study||199||
59824244|NCT00464672|75947127|FG004|COMPLETED|Overall Study||392||
59824245|NCT00464672|75947128|FG005|COMPLETED|Overall Study||195||
59824246|NCT00464672|75947123|FG000|NOT COMPLETED|Overall Study||25||
59824247|NCT00464672|75947124|FG001|NOT COMPLETED|Overall Study||10||
59824248|NCT00464672|75947125|FG002|NOT COMPLETED|Overall Study||0||
59824249|NCT00464672|75947126|FG003|NOT COMPLETED|Overall Study||1||
59824250|NCT00464672|75947127|FG004|NOT COMPLETED|Overall Study||10||
59824251|NCT00464672|75947128|FG005|NOT COMPLETED|Overall Study||4||
59824252|NCT00473876|75947158|FG000|STARTED|Overall Study||39||
59824253|NCT00473876|75947159|FG001|STARTED|Overall Study||23||
59824254|NCT00473876|75947158|FG000|COMPLETED|Overall Study||36||
59824255|NCT00473876|75947159|FG001|COMPLETED|Overall Study||22||
59824256|NCT00473876|75947158|FG000|NOT COMPLETED|Overall Study||3||
59824257|NCT00473876|75947159|FG001|NOT COMPLETED|Overall Study||1||
59824258|NCT00463580|75947169|FG000|STARTED|Overall Study||30||
59824259|NCT00463580|75947170|FG001|STARTED|Overall Study||30||
59824260|NCT00463580|75947169|FG000|COMPLETED|Overall Study||27||
59824261|NCT00463580|75947170|FG001|COMPLETED|Overall Study||28||
59824262|NCT00463580|75947169|FG000|NOT COMPLETED|Overall Study||3||
59824263|NCT00463580|75947170|FG001|NOT COMPLETED|Overall Study||2||
59824264|NCT00540449|75947184|FG000|STARTED|Overall Study||346||
60115748|NCT02036970|76236357|FG006|NOT COMPLETED|Part 2: Week 16 Onwards||1||
60115749|NCT02036970|76236358|FG007|NOT COMPLETED|Part 2: Week 16 Onwards||1||
59824265|NCT00540449|75947185|FG001|STARTED|Overall Study||344||
59824266|NCT00540449|75947184|FG000|COMPLETED|Overall Study||262||
59824267|NCT00540449|75947185|FG001|COMPLETED|Overall Study||266||
59824268|NCT00540449|75947184|FG000|NOT COMPLETED|Overall Study||84||
59824269|NCT00540449|75947185|FG001|NOT COMPLETED|Overall Study||78||
59824270|NCT03911843|75947193|FG000|STARTED|Overall Study||26||
59824271|NCT03911843|75947194|FG001|STARTED|Overall Study||38||
59824272|NCT03911843|75947193|FG000|COMPLETED|Overall Study||22||
59824273|NCT03911843|75947194|FG001|COMPLETED|Overall Study||37||
59824274|NCT03911843|75947193|FG000|NOT COMPLETED|Overall Study||4||
59824275|NCT03911843|75947194|FG001|NOT COMPLETED|Overall Study||1||
59824276|NCT00361335|75947205|FG000|STARTED|IV Period: Baseline to E0||129||
59824277|NCT00361335|75947206|FG001|STARTED|IV Period: Baseline to E0||128||
59824278|NCT00361335|75947207|FG002|STARTED|IV Period: Baseline to E0||128||
59824279|NCT00361335|75947208|FG003|STARTED|IV Period: Baseline to E0||129||
59824280|NCT00361335|75947209|FG004|STARTED|IV Period: Baseline to E0||129||
59824281|NCT00361335|75947210|FG005|STARTED|IV Period: Baseline to E0|"0 in column indicates this reporting group is not relevant to the IV Period."|0||
59824282|NCT00361335|75947211|FG006|STARTED|IV Period: Baseline to E0|"0 in column indicates this reporting group is not relevant to the IV Period."|0||
59824283|NCT00361335|75947205|FG000|COMPLETED|IV Period: Baseline to E0||109||
59824284|NCT00361335|75947206|FG001|COMPLETED|IV Period: Baseline to E0||99||
59824285|NCT00361335|75947207|FG002|COMPLETED|IV Period: Baseline to E0||107||
59824286|NCT00361335|75947208|FG003|COMPLETED|IV Period: Baseline to E0||102||
59824287|NCT00361335|75947209|FG004|COMPLETED|IV Period: Baseline to E0||105||
59824288|NCT00361335|75947210|FG005|COMPLETED|IV Period: Baseline to E0||0||
59824289|NCT00361335|75947211|FG006|COMPLETED|IV Period: Baseline to E0||0||
59824290|NCT00361335|75947205|FG000|NOT COMPLETED|IV Period: Baseline to E0||20||
59824291|NCT00361335|75947206|FG001|NOT COMPLETED|IV Period: Baseline to E0||29||
59824292|NCT00361335|75947207|FG002|NOT COMPLETED|IV Period: Baseline to E0||21||
60115750|NCT02036970|76236359|FG008|NOT COMPLETED|Part 2: Week 16 Onwards||9||
60115751|NCT02036970|76236360|FG009|NOT COMPLETED|Part 2: Week 16 Onwards||5||
60115752|NCT01827787|76236394|FG000|STARTED|Overall Study||45||
59824293|NCT00361335|75947208|FG003|NOT COMPLETED|IV Period: Baseline to E0||27||
59824294|NCT00361335|75947209|FG004|NOT COMPLETED|IV Period: Baseline to E0||24||
59824295|NCT00361335|75947210|FG005|NOT COMPLETED|IV Period: Baseline to E0||0||
59824296|NCT00361335|75947211|FG006|NOT COMPLETED|IV Period: Baseline to E0||0||
59824297|NCT00361335|75947205|FG000|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|82||
59824298|NCT00361335|75947206|FG001|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|59||
59824299|NCT00361335|75947207|FG002|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|104||
59824300|NCT00361335|75947208|FG003|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|63||
59824301|NCT00361335|75947209|FG004|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|3||
59824302|NCT00361335|75947210|FG005|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|24||
59824303|NCT00361335|75947211|FG006|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|173||
59824304|NCT00361335|75947205|FG000|COMPLETED|SC Period: Week E0 to Week E24||80||
59824305|NCT00361335|75947206|FG001|COMPLETED|SC Period: Week E0 to Week E24||56||
59824306|NCT00361335|75947207|FG002|COMPLETED|SC Period: Week E0 to Week E24||99||
59824307|NCT00361335|75947208|FG003|COMPLETED|SC Period: Week E0 to Week E24||59||
59824308|NCT00361335|75947209|FG004|COMPLETED|SC Period: Week E0 to Week E24||3||
59824309|NCT00361335|75947210|FG005|COMPLETED|SC Period: Week E0 to Week E24||23||
59824310|NCT00361335|75947211|FG006|COMPLETED|SC Period: Week E0 to Week E24||164||
59824311|NCT00361335|75947205|FG000|NOT COMPLETED|SC Period: Week E0 to Week E24||2||
59824312|NCT00361335|75947206|FG001|NOT COMPLETED|SC Period: Week E0 to Week E24||3||
59824313|NCT00361335|75947207|FG002|NOT COMPLETED|SC Period: Week E0 to Week E24||5||
59824314|NCT00361335|75947208|FG003|NOT COMPLETED|SC Period: Week E0 to Week E24||4||
59824315|NCT00361335|75947209|FG004|NOT COMPLETED|SC Period: Week E0 to Week E24||0||
59824316|NCT00361335|75947210|FG005|NOT COMPLETED|SC Period: Week E0 to Week E24||1||
59824317|NCT00361335|75947211|FG006|NOT COMPLETED|SC Period: Week E0 to Week E24||9||
59824318|NCT00264550|75947231|FG000|STARTED|Overall Study||133||
59824319|NCT00264550|75947232|FG001|STARTED|Overall Study||133||
59824320|NCT00264550|75947233|FG002|STARTED|Overall Study||89||
59824321|NCT00264550|75947234|FG003|STARTED|Overall Study||89||
59824322|NCT00264550|75947231|FG000|COMPLETED|Overall Study||90||
59824323|NCT00264550|75947232|FG001|COMPLETED|Overall Study||92||
59824324|NCT00264550|75947233|FG002|COMPLETED|Overall Study||72||
59824325|NCT00264550|75947234|FG003|COMPLETED|Overall Study||59||
59824326|NCT00264550|75947231|FG000|NOT COMPLETED|Overall Study||43||
59824327|NCT00264550|75947232|FG001|NOT COMPLETED|Overall Study||41||
59824328|NCT00264550|75947233|FG002|NOT COMPLETED|Overall Study||17||
59824329|NCT00264550|75947234|FG003|NOT COMPLETED|Overall Study||30||
59824330|NCT00541931|75947246|FG000|STARTED|Overall Study||22||
59824331|NCT00541931|75947247|FG001|STARTED|Overall Study||15||
59824332|NCT00541931|75947246|FG000|COMPLETED|Overall Study||17||
60115753|NCT01827787|76236395|FG001|STARTED|Overall Study||38||
60115754|NCT01827787|76236394|FG000|COMPLETED|Overall Study||45||
60115755|NCT01827787|76236395|FG001|COMPLETED|Overall Study||38||
60115756|NCT01827787|76236394|FG000|NOT COMPLETED|Overall Study||0||
60115757|NCT01827787|76236395|FG001|NOT COMPLETED|Overall Study||0||
59824333|NCT00541931|75947247|FG001|COMPLETED|Overall Study||11||
59824334|NCT00541931|75947246|FG000|NOT COMPLETED|Overall Study||5||
59824335|NCT00541931|75947247|FG001|NOT COMPLETED|Overall Study||4||
59824336|NCT00368979|75947257|FG000|STARTED|Overall Study||185||
59824337|NCT00368979|75947258|FG001|STARTED|Overall Study||193||
59824338|NCT00368979|75947257|FG000|COMPLETED|Overall Study||160||
59824339|NCT00368979|75947258|FG001|COMPLETED|Overall Study||163||
59824340|NCT00368979|75947257|FG000|NOT COMPLETED|Overall Study||25||
59824341|NCT00368979|75947258|FG001|NOT COMPLETED|Overall Study||30||
59824342|NCT00264238|75947264|FG000|STARTED|Overall Study||15||
59824343|NCT00264238|75947264|FG000|COMPLETED|Overall Study||14||
59824344|NCT00264238|75947264|FG000|NOT COMPLETED|Overall Study||1||
59824345|NCT00540293|75947270|FG000|STARTED|Overall Study||425||
59824346|NCT00540293|75947270|FG000|COMPLETED|Overall Study||390||
59824347|NCT00540293|75947270|FG000|NOT COMPLETED|Overall Study||35||
59824348|NCT04971941|75947284|FG000|STARTED|Overall Study||15||
59824349|NCT04971941|75947285|FG001|STARTED|Overall Study||15||
59824350|NCT04971941|75947286|FG002|STARTED|Overall Study||15||
59824351|NCT04971941|75947287|FG003|STARTED|Overall Study||15||
59824352|NCT04971941|75947284|FG000|COMPLETED|Overall Study||15||
59824353|NCT04971941|75947285|FG001|COMPLETED|Overall Study||15||
59824354|NCT04971941|75947286|FG002|COMPLETED|Overall Study||15||
59824355|NCT04971941|75947287|FG003|COMPLETED|Overall Study||15||
59824356|NCT04971941|75947284|FG000|NOT COMPLETED|Overall Study||0||
59824357|NCT04971941|75947285|FG001|NOT COMPLETED|Overall Study||0||
59824358|NCT04971941|75947286|FG002|NOT COMPLETED|Overall Study||0||
59824359|NCT04971941|75947287|FG003|NOT COMPLETED|Overall Study||0||
59824360|NCT00359073|75947311|FG000|STARTED|Overall Study||12||
59824361|NCT00359073|75947312|FG001|STARTED|Overall Study||13||
59824362|NCT00359073|75947311|FG000|COMPLETED|Overall Study||8||
59824363|NCT00359073|75947312|FG001|COMPLETED|Overall Study||11||
59824364|NCT00359073|75947311|FG000|NOT COMPLETED|Overall Study||4||
59824365|NCT00359073|75947312|FG001|NOT COMPLETED|Overall Study||2||
59824366|NCT03918239|75947322|FG000|STARTED|Overall Study||94||
59824367|NCT03918239|75947323|FG001|STARTED|Overall Study||96||
59824368|NCT03918239|75947322|FG000|COMPLETED|Overall Study||84||
59824369|NCT03918239|75947323|FG001|COMPLETED|Overall Study||89||
59824370|NCT03918239|75947322|FG000|NOT COMPLETED|Overall Study||10||
59824371|NCT03918239|75947323|FG001|NOT COMPLETED|Overall Study||7||
59824372|NCT00368745|75947331|FG000|STARTED|Randomized to Double-blind Treatment||57||
59824373|NCT00368745|75947332|FG001|STARTED|Randomized to Double-blind Treatment||51||
59824374|NCT00368745|75947331|FG000|COMPLETED|Randomized to Double-blind Treatment|One subject did not return following randomization; study drug not dispensed.|56||
59824375|NCT00368745|75947332|FG001|COMPLETED|Randomized to Double-blind Treatment|One subject did not want to participate in study.|50||
59824376|NCT00368745|75947331|FG000|NOT COMPLETED|Randomized to Double-blind Treatment||1||
59824377|NCT00368745|75947332|FG001|NOT COMPLETED|Randomized to Double-blind Treatment||1||
59824378|NCT00368745|75947331|FG000|STARTED|Double-blind Treatment Period||56||
59824379|NCT00368745|75947332|FG001|STARTED|Double-blind Treatment Period||50||
59824380|NCT00368745|75947331|FG000|COMPLETED|Double-blind Treatment Period||30||
59824381|NCT00368745|75947332|FG001|COMPLETED|Double-blind Treatment Period||19||
59824382|NCT00368745|75947331|FG000|NOT COMPLETED|Double-blind Treatment Period||26||
59824383|NCT00368745|75947332|FG001|NOT COMPLETED|Double-blind Treatment Period||31||
59824384|NCT00454818|75947346|FG000|STARTED|Phase I: Open-label Dose-escalation||3||
59824385|NCT00454818|75947347|FG001|STARTED|Phase I: Open-label Dose-escalation||3||
59824386|NCT00454818|75947348|FG002|STARTED|Phase I: Open-label Dose-escalation||3||
59824387|NCT00454818|75947349|FG003|STARTED|Phase I: Open-label Dose-escalation||3||
59824388|NCT00454818|75947350|FG004|STARTED|Phase I: Open-label Dose-escalation||0||
59824389|NCT00454818|75947346|FG000|COMPLETED|Phase I: Open-label Dose-escalation||2||
59824390|NCT00454818|75947347|FG001|COMPLETED|Phase I: Open-label Dose-escalation||2||
59824391|NCT00454818|75947348|FG002|COMPLETED|Phase I: Open-label Dose-escalation||2||
59824392|NCT00454818|75947349|FG003|COMPLETED|Phase I: Open-label Dose-escalation||2||
59824393|NCT00454818|75947350|FG004|COMPLETED|Phase I: Open-label Dose-escalation||0||
59824394|NCT00454818|75947346|FG000|NOT COMPLETED|Phase I: Open-label Dose-escalation||1||
59824395|NCT00454818|75947347|FG001|NOT COMPLETED|Phase I: Open-label Dose-escalation||1||
59824396|NCT00454818|75947348|FG002|NOT COMPLETED|Phase I: Open-label Dose-escalation||1||
59824397|NCT00454818|75947349|FG003|NOT COMPLETED|Phase I: Open-label Dose-escalation||1||
59567225|NCT02971839|75670083|FG004|NOT COMPLETED|Overall Study||0||
59824398|NCT00454818|75947350|FG004|NOT COMPLETED|Phase I: Open-label Dose-escalation||0||
59824399|NCT00454818|75947346|FG000|STARTED|Phase 2: Randomized Double-blind||0||
59824400|NCT00454818|75947347|FG001|STARTED|Phase 2: Randomized Double-blind||8||
60115758|NCT01522768|76236404|FG000|STARTED|Overall Study||42||
60115759|NCT01522768|76236404|FG000|COMPLETED|Overall Study||42||
60115760|NCT01522768|76236404|FG000|NOT COMPLETED|Overall Study||0||
60115761|NCT00230100|76236410|FG000|STARTED|Overall Study||29||
60115762|NCT00230100|76236411|FG001|STARTED|Overall Study||17||
60115763|NCT00230100|76236410|FG000|COMPLETED|Overall Study||29||
60115764|NCT00230100|76236411|FG001|COMPLETED|Overall Study||17||
60115765|NCT00230100|76236410|FG000|NOT COMPLETED|Overall Study||0||
60115766|NCT00230100|76236411|FG001|NOT COMPLETED|Overall Study||0||
60115767|NCT01969708|76236419|FG000|STARTED|Overall Study||180||
60115768|NCT01969708|76236420|FG001|STARTED|Overall Study||182||
60115769|NCT01969708|76236419|FG000|COMPLETED|Overall Study||175||
60115770|NCT01969708|76236420|FG001|COMPLETED|Overall Study||173||
60115771|NCT01969708|76236419|FG000|NOT COMPLETED|Overall Study||5||
60115772|NCT01969708|76236420|FG001|NOT COMPLETED|Overall Study||9||
60115773|NCT02354482|76236426|FG000|STARTED|Patient Communication and Care||2158||
60115774|NCT02354482|76236426|FG000|COMPLETED|Patient Communication and Care||2158||
60115775|NCT02354482|76236426|FG000|NOT COMPLETED|Patient Communication and Care||0||
59567226|NCT03821259|75670095|FG000|STARTED|Overall Study||88||
59567227|NCT03821259|75670095|FG000|COMPLETED|Overall Study||88||
59567228|NCT03821259|75670095|FG000|NOT COMPLETED|Overall Study||0||
59567229|NCT03803085|75670101|FG000|STARTED|Overall Study||30||
59567230|NCT03803085|75670102|FG001|STARTED|Overall Study||30||
59567231|NCT03803085|75670101|FG000|COMPLETED|Overall Study||28||
59567232|NCT03803085|75670102|FG001|COMPLETED|Overall Study||28||
59567233|NCT03803085|75670101|FG000|NOT COMPLETED|Overall Study||2||
59567234|NCT03803085|75670102|FG001|NOT COMPLETED|Overall Study||2||
59567235|NCT02974803|75670109|FG000|STARTED|Overall Study||6||
59567236|NCT02974803|75670109|FG000|COMPLETED|Overall Study||6||
59715201|NCT01175382|75834046|FG001|STARTED|Overall Study||68||
59715202|NCT01175382|75834047|FG002|STARTED|Overall Study||65||
59715203|NCT01175382|75834045|FG000|COMPLETED|Overall Study||63||
59715204|NCT01175382|75834046|FG001|COMPLETED|Overall Study||61||
59715205|NCT01175382|75834047|FG002|COMPLETED|Overall Study||59||
59715206|NCT01175382|75834045|FG000|NOT COMPLETED|Overall Study||8||
59715207|NCT01175382|75834046|FG001|NOT COMPLETED|Overall Study||7||
59715208|NCT01175382|75834047|FG002|NOT COMPLETED|Overall Study||6||
59715209|NCT01194245|75834060|FG000|STARTED|Titration Period (4 to 6 Weeks)||135||
59824401|NCT00454818|75947348|FG002|STARTED|Phase 2: Randomized Double-blind||8||
59824402|NCT00454818|75947349|FG003|STARTED|Phase 2: Randomized Double-blind||9||
59567237|NCT02974803|75670109|FG000|NOT COMPLETED|Overall Study||0||
59567238|NCT02281136|75670113|FG000|STARTED|Overall Study||29||
59567239|NCT02281136|75670113|FG000|COMPLETED|Overall Study||29||
59567240|NCT02281136|75670113|FG000|NOT COMPLETED|Overall Study||0||
59567241|NCT02301156|75670119|FG000|STARTED|Overall Study||64||
59567242|NCT02301156|75670120|FG001|STARTED|Overall Study||62||
59567243|NCT02301156|75670119|FG000|Intent to Treat (ITT) Population|Overall Study||64|Intent-to-treat (ITT) Population included all randomized participants.|
59567244|NCT02301156|75670120|FG001|Intent to Treat (ITT) Population|Overall Study||62|Intent-to-treat (ITT) Population included all randomized participants.|
59567245|NCT02301156|75670119|FG000|Safety Population|Overall Study||59|Safety Population included all participants who received at least one dose of study medication (ublituximab + ibrutinib or ibrutinib alone).|
59715210|NCT01194245|75834061|FG001|STARTED|Titration Period (4 to 6 Weeks)||0||
59715211|NCT01194245|75834062|FG002|STARTED|Titration Period (4 to 6 Weeks)||0||
59715212|NCT01194245|75834063|FG003|STARTED|Titration Period (4 to 6 Weeks)||0||
59715213|NCT01194245|75834064|FG004|STARTED|Titration Period (4 to 6 Weeks)||0||
59824403|NCT00454818|75947350|FG004|STARTED|Phase 2: Randomized Double-blind||14||
60115776|NCT02354482|76236426|FG000|STARTED|Home-Based Trust and Plain Language||1979||
59567246|NCT02301156|75670120|FG001|Safety Population|Overall Study||58|Safety Population included all participants who received at least one dose of study medication (ublituximab + ibrutinib or ibrutinib alone).|
59567247|NCT02301156|75670119|FG000|COMPLETED|Overall Study||11||
59567248|NCT02301156|75670120|FG001|COMPLETED|Overall Study||10||
60115777|NCT02354482|76236426|FG000|COMPLETED|Home-Based Trust and Plain Language||1979||
60115778|NCT02354482|76236426|FG000|NOT COMPLETED|Home-Based Trust and Plain Language||0||
60115779|NCT02354482|76236426|FG000|STARTED|Hospital-Based Trust and Plain Language||2090||
60115780|NCT02354482|76236426|FG000|COMPLETED|Hospital-Based Trust and Plain Language||2090||
60115781|NCT02354482|76236426|FG000|NOT COMPLETED|Hospital-Based Trust and Plain Language||0||
60115782|NCT02354482|76236426|FG000|STARTED|Patient/Family Caregiver Assessment||3093||
60115783|NCT02354482|76236426|FG000|COMPLETED|Patient/Family Caregiver Assessment||3093||
60115784|NCT02354482|76236426|FG000|NOT COMPLETED|Patient/Family Caregiver Assessment||0||
60115785|NCT02354482|76236426|FG000|STARTED|Assessment and Teach Back||508||
60115786|NCT02354482|76236426|FG000|COMPLETED|Assessment and Teach Back||508||
60115787|NCT02354482|76236426|FG000|NOT COMPLETED|Assessment and Teach Back||0||
60115788|NCT02354482|76236426|FG000|STARTED|Reference||2042||
60115789|NCT02354482|76236426|FG000|COMPLETED|Reference||2042||
60115790|NCT02354482|76236426|FG000|NOT COMPLETED|Reference||0||
60115791|NCT01970176|76236442|FG000|STARTED|Overall Study||14||
60115792|NCT01970176|76236443|FG001|STARTED|Overall Study||6||
60115793|NCT01970176|76236442|FG000|COMPLETED|Overall Study||14||
60115794|NCT01970176|76236443|FG001|COMPLETED|Overall Study||6||
60115795|NCT01970176|76236442|FG000|NOT COMPLETED|Overall Study||0||
60115796|NCT01970176|76236443|FG001|NOT COMPLETED|Overall Study||0||
60115797|NCT02023918|76236449|FG000|STARTED|Overall Study||6||
60115798|NCT02023918|76236449|FG000|COMPLETED|Overall Study||6||
60115799|NCT02023918|76236449|FG000|NOT COMPLETED|Overall Study||0||
60115800|NCT02024386|76236456|FG000|STARTED|Overall Study||6||
60115801|NCT02024386|76236457|FG001|STARTED|Overall Study||11||
60115802|NCT02024386|76236458|FG002|STARTED|Overall Study||5||
60115803|NCT02024386|76236456|FG000|COMPLETED|Overall Study||6||
60115804|NCT02024386|76236457|FG001|COMPLETED|Overall Study||11||
60115805|NCT02024386|76236458|FG002|COMPLETED|Overall Study||5||
60115806|NCT02024386|76236456|FG000|NOT COMPLETED|Overall Study||0||
60115807|NCT02024386|76236457|FG001|NOT COMPLETED|Overall Study||0||
60115808|NCT02024386|76236458|FG002|NOT COMPLETED|Overall Study||0||
60115809|NCT01971580|76236469|FG000|STARTED|Overall Study||14||
60115810|NCT01971580|76236470|FG001|STARTED|Overall Study||14||
60115811|NCT01971580|76236469|FG000|COMPLETED|Overall Study||10||
60115812|NCT01971580|76236470|FG001|COMPLETED|Overall Study||9||
60115813|NCT01971580|76236469|FG000|NOT COMPLETED|Overall Study||4||
60115814|NCT01971580|76236470|FG001|NOT COMPLETED|Overall Study||5||
60115815|NCT00838383|76236481|FG000|STARTED|Overall Study||9||
60115816|NCT00838383|76236482|FG001|STARTED|Overall Study||10||
60115817|NCT00838383|76236483|FG002|STARTED|Overall Study||10||
60115818|NCT00838383|76236481|FG000|COMPLETED|Overall Study||9||
60115819|NCT00838383|76236482|FG001|COMPLETED|Overall Study||10||
60115820|NCT00838383|76236483|FG002|COMPLETED|Overall Study||10||
60115821|NCT00838383|76236481|FG000|NOT COMPLETED|Overall Study||0||
60115822|NCT00838383|76236482|FG001|NOT COMPLETED|Overall Study||0||
60115823|NCT00838383|76236483|FG002|NOT COMPLETED|Overall Study||0||
60115824|NCT01972204|76236493|FG000|STARTED|Overall Study||62||
60115825|NCT01972204|76236494|FG001|STARTED|Overall Study||63||
60115826|NCT01972204|76236493|FG000|COMPLETED|Overall Study||58||
60115827|NCT01972204|76236494|FG001|COMPLETED|Overall Study||59||
60115828|NCT01972204|76236493|FG000|NOT COMPLETED|Overall Study||4||
60115829|NCT01972204|76236494|FG001|NOT COMPLETED|Overall Study||4||
60115830|NCT02355886|76236502|FG000|STARTED|Overall Study||13||
60115831|NCT02355886|76236503|FG001|STARTED|Overall Study||12||
60115832|NCT02355886|76236502|FG000|COMPLETED|Overall Study||13||
60115833|NCT02355886|76236503|FG001|COMPLETED|Overall Study||12||
60115834|NCT02355886|76236502|FG000|NOT COMPLETED|Overall Study||0||
60115835|NCT02355886|76236503|FG001|NOT COMPLETED|Overall Study||0||
60115836|NCT02356198|76236511|FG000|STARTED|Overall Study||104||
60115837|NCT02356198|76236512|FG001|STARTED|Overall Study||105||
60115838|NCT02356198|76236511|FG000|COMPLETED|Overall Study||102||
60115839|NCT02356198|76236512|FG001|COMPLETED|Overall Study||98||
60115840|NCT02356198|76236511|FG000|NOT COMPLETED|Overall Study||2||
60115841|NCT02356198|76236512|FG001|NOT COMPLETED|Overall Study||7||
60115842|NCT02025634|76236520|FG000|STARTED|Overall Study||65||
60115843|NCT02025634|76236521|FG001|STARTED|Overall Study||54||
60115844|NCT02025634|76236520|FG000|COMPLETED|Overall Study||65||
60115845|NCT02025634|76236521|FG001|COMPLETED|Overall Study||54||
60115846|NCT02025634|76236520|FG000|NOT COMPLETED|Overall Study||0||
60115847|NCT02025634|76236521|FG001|NOT COMPLETED|Overall Study||0||
60115848|NCT01972282|76236527|FG000|STARTED|Overall Study||1020||
60115849|NCT01972282|76236527|FG000|COMPLETED|Overall Study||1005||
60115850|NCT01972282|76236527|FG000|NOT COMPLETED|Overall Study||15||
60115851|NCT01972516|76236533|FG000|STARTED|Overall Study||3||
60115852|NCT01972516|76236534|FG001|STARTED|Overall Study||1||
59567249|NCT02301156|75670119|FG000|NOT COMPLETED|Overall Study||53||
60115853|NCT01972516|76236533|FG000|COMPLETED|Overall Study||3||
60115854|NCT01972516|76236534|FG001|COMPLETED|Overall Study||1||
60115855|NCT01972516|76236533|FG000|NOT COMPLETED|Overall Study||0||
60115856|NCT01972516|76236534|FG001|NOT COMPLETED|Overall Study||0||
60115857|NCT01748825|76236550|FG000|STARTED|Dose Escalation||6||
60115858|NCT01748825|76236551|FG001|STARTED|Dose Escalation||4||
60115859|NCT01748825|76236552|FG002|STARTED|Dose Escalation||6||
60115860|NCT01748825|76236553|FG003|STARTED|Dose Escalation||3||
60115861|NCT01748825|76236554|FG004|STARTED|Dose Escalation||3||
60115862|NCT01748825|76236555|FG005|STARTED|Dose Escalation||6||
60115863|NCT01748825|76236556|FG006|STARTED|Dose Escalation||3||
60115864|NCT01748825|76236557|FG007|STARTED|Dose Escalation||3||
60115865|NCT01748825|76236558|FG008|STARTED|Dose Escalation||0||
60115866|NCT01748825|76236559|FG009|STARTED|Dose Escalation||0||
60115867|NCT01748825|76236550|FG000|COMPLETED|Dose Escalation||4||
60115868|NCT01748825|76236551|FG001|COMPLETED|Dose Escalation||2||
60115869|NCT01748825|76236552|FG002|COMPLETED|Dose Escalation||6||
60115870|NCT01748825|76236553|FG003|COMPLETED|Dose Escalation||2||
60115871|NCT01748825|76236554|FG004|COMPLETED|Dose Escalation||2||
60115872|NCT01748825|76236555|FG005|COMPLETED|Dose Escalation||4||
60115873|NCT01748825|76236556|FG006|COMPLETED|Dose Escalation||2||
60115874|NCT01748825|76236557|FG007|COMPLETED|Dose Escalation||3||
60115875|NCT01748825|76236558|FG008|COMPLETED|Dose Escalation||0||
60115876|NCT01748825|76236559|FG009|COMPLETED|Dose Escalation||0||
60115877|NCT01748825|76236550|FG000|NOT COMPLETED|Dose Escalation||2||
60115878|NCT01748825|76236551|FG001|NOT COMPLETED|Dose Escalation||2||
60115879|NCT01748825|76236552|FG002|NOT COMPLETED|Dose Escalation||0||
60115880|NCT01748825|76236553|FG003|NOT COMPLETED|Dose Escalation||1||
60115881|NCT01748825|76236554|FG004|NOT COMPLETED|Dose Escalation||1||
60115882|NCT01748825|76236555|FG005|NOT COMPLETED|Dose Escalation||2||
60115883|NCT01748825|76236556|FG006|NOT COMPLETED|Dose Escalation||1||
60115884|NCT01748825|76236557|FG007|NOT COMPLETED|Dose Escalation||0||
60115885|NCT01748825|76236558|FG008|NOT COMPLETED|Dose Escalation||0||
60115886|NCT01748825|76236559|FG009|NOT COMPLETED|Dose Escalation||0||
60115887|NCT01748825|76236550|FG000|STARTED|Dose Expansion||0||
60115888|NCT01748825|76236551|FG001|STARTED|Dose Expansion||0||
60115889|NCT01748825|76236552|FG002|STARTED|Dose Expansion||0||
60115890|NCT01748825|76236553|FG003|STARTED|Dose Expansion||0||
60115891|NCT01748825|76236554|FG004|STARTED|Dose Expansion||0||
60115892|NCT01748825|76236555|FG005|STARTED|Dose Expansion||0||
60115893|NCT01748825|76236556|FG006|STARTED|Dose Expansion||0||
60115894|NCT01748825|76236557|FG007|STARTED|Dose Expansion||0||
60115895|NCT01748825|76236558|FG008|STARTED|Dose Expansion||13||
60115896|NCT01748825|76236559|FG009|STARTED|Dose Expansion||20||
60115897|NCT01748825|76236550|FG000|COMPLETED|Dose Expansion||0||
60115898|NCT01748825|76236551|FG001|COMPLETED|Dose Expansion||0||
60115899|NCT01748825|76236552|FG002|COMPLETED|Dose Expansion||0||
60115900|NCT01748825|76236553|FG003|COMPLETED|Dose Expansion||0||
60115901|NCT01748825|76236554|FG004|COMPLETED|Dose Expansion||0||
60115902|NCT01748825|76236555|FG005|COMPLETED|Dose Expansion||0||
60115903|NCT01748825|76236556|FG006|COMPLETED|Dose Expansion||0||
60115904|NCT01748825|76236557|FG007|COMPLETED|Dose Expansion||0||
60115905|NCT01748825|76236558|FG008|COMPLETED|Dose Expansion||11||
60115906|NCT01748825|76236559|FG009|COMPLETED|Dose Expansion||15||
60115907|NCT01748825|76236550|FG000|NOT COMPLETED|Dose Expansion||0||
60115908|NCT01748825|76236551|FG001|NOT COMPLETED|Dose Expansion||0||
60115909|NCT01748825|76236552|FG002|NOT COMPLETED|Dose Expansion||0||
60115910|NCT01748825|76236553|FG003|NOT COMPLETED|Dose Expansion||0||
60115911|NCT01748825|76236554|FG004|NOT COMPLETED|Dose Expansion||0||
60115912|NCT01748825|76236555|FG005|NOT COMPLETED|Dose Expansion||0||
60115913|NCT01748825|76236556|FG006|NOT COMPLETED|Dose Expansion||0||
60115914|NCT01748825|76236557|FG007|NOT COMPLETED|Dose Expansion||0||
60115915|NCT01748825|76236558|FG008|NOT COMPLETED|Dose Expansion||2||
60115916|NCT01748825|76236559|FG009|NOT COMPLETED|Dose Expansion||5||
60115917|NCT02028208|76236591|FG000|STARTED|Overall Study||21||
60115918|NCT02028208|76236592|FG001|STARTED|Overall Study||13||
60115919|NCT02028208|76236593|FG002|STARTED|Overall Study||22||
60115920|NCT02028208|76236591|FG000|COMPLETED|Overall Study||21||
60115921|NCT02028208|76236592|FG001|COMPLETED|Overall Study||13||
60115922|NCT02028208|76236593|FG002|COMPLETED|Overall Study||21||
60115923|NCT02028208|76236591|FG000|NOT COMPLETED|Overall Study||0||
60115924|NCT02028208|76236592|FG001|NOT COMPLETED|Overall Study||0||
60115925|NCT02028208|76236593|FG002|NOT COMPLETED|Overall Study||1||
60115926|NCT02356900|76236603|FG000|STARTED|Overall Study||11||
60115927|NCT02356900|76236604|FG001|STARTED|Overall Study||10||
60115928|NCT02356900|76236603|FG000|COMPLETED|Overall Study||11||
60115929|NCT02356900|76236604|FG001|COMPLETED|Overall Study||10||
60115930|NCT02356900|76236603|FG000|NOT COMPLETED|Overall Study||0||
60115931|NCT02356900|76236604|FG001|NOT COMPLETED|Overall Study||0||
60115932|NCT00789399|76236612|FG000|STARTED|Overall Study||41||
60115933|NCT00789399|76236613|FG001|STARTED|Overall Study||37||
60115934|NCT00789399|76236612|FG000|COMPLETED|Overall Study||39||
60115935|NCT00789399|76236613|FG001|COMPLETED|Overall Study||37||
60115936|NCT00789399|76236612|FG000|NOT COMPLETED|Overall Study||2||
60115937|NCT00789399|76236613|FG001|NOT COMPLETED|Overall Study||0||
60115938|NCT01720667|76236621|FG000|STARTED|Overall Study||64||
60115939|NCT01720667|76236622|FG001|STARTED|Overall Study||42||
60115940|NCT01720667|76236621|FG000|Recieved Second Infusion of Same Drug|Overall Study||50||
60115941|NCT01720667|76236622|FG001|Recieved Second Infusion of Same Drug|Overall Study||20||
60115942|NCT01720667|76236621|FG000|Recieved Alternate Intervention|Overall Study||45||
60115943|NCT01720667|76236622|FG001|Recieved Alternate Intervention|Overall Study||10||
60115944|NCT01720667|76236621|FG000|Received 2nd Infusion of Alternate Drug|Overall Study||27||
60115945|NCT01720667|76236622|FG001|Received 2nd Infusion of Alternate Drug|Overall Study||6||
60115946|NCT01720667|76236621|FG000|Modified ITT|Overall Study||53||
60115947|NCT01720667|76236622|FG001|Modified ITT|Overall Study||30||
60115948|NCT01720667|76236621|FG000|COMPLETED|Overall Study||60||
60115949|NCT01720667|76236622|FG001|COMPLETED|Overall Study||41||
60115950|NCT01720667|76236621|FG000|NOT COMPLETED|Overall Study||4||
60115951|NCT01720667|76236622|FG001|NOT COMPLETED|Overall Study||1||
60115952|NCT01720043|76236630|FG000|STARTED|Overall Study||8||
60115953|NCT01720043|76236630|FG000|COMPLETED|Overall Study||7||
60115954|NCT01720043|76236630|FG000|NOT COMPLETED|Overall Study||1||
60115955|NCT00700752|76236634|FG000|STARTED|First Intervention||20||
60115956|NCT00700752|76236635|FG001|STARTED|First Intervention||20||
60115957|NCT00700752|76236634|FG000|COMPLETED|First Intervention||20||
60115958|NCT00700752|76236635|FG001|COMPLETED|First Intervention||18||
60115959|NCT00700752|76236634|FG000|NOT COMPLETED|First Intervention||0||
60115960|NCT00700752|76236635|FG001|NOT COMPLETED|First Intervention||2||
60115961|NCT00700752|76236634|FG000|STARTED|Second Intervention||20||
60115962|NCT00700752|76236635|FG001|STARTED|Second Intervention||18||
60115963|NCT00700752|76236634|FG000|COMPLETED|Second Intervention||20||
60115964|NCT00700752|76236635|FG001|COMPLETED|Second Intervention||18||
60115965|NCT00700752|76236634|FG000|NOT COMPLETED|Second Intervention||0||
60115966|NCT00700752|76236635|FG001|NOT COMPLETED|Second Intervention||0||
60115967|NCT03246789|76236643|FG000|STARTED|Overall Study||24||
60115968|NCT03246789|76236644|FG001|STARTED|Overall Study||15||
60115969|NCT03246789|76236643|FG000|COMPLETED|Overall Study||24||
60115970|NCT03246789|76236644|FG001|COMPLETED|Overall Study||15||
60115971|NCT03246789|76236643|FG000|NOT COMPLETED|Overall Study||0||
60115972|NCT03246789|76236644|FG001|NOT COMPLETED|Overall Study||0||
60115973|NCT01747811|76236652|FG000|STARTED|Overall Study||16||
60115974|NCT01747811|76236653|FG001|STARTED|Overall Study||16||
60115975|NCT01747811|76236652|FG000|COMPLETED|Overall Study||14||
60115976|NCT01747811|76236653|FG001|COMPLETED|Overall Study||12||
60115977|NCT01747811|76236652|FG000|NOT COMPLETED|Overall Study||2||
60115978|NCT01747811|76236653|FG001|NOT COMPLETED|Overall Study||4||
60115979|NCT01747655|76236661|FG000|STARTED|Temporary Naso-jejunal Tube Period|Main Analysis Set (MAS): participants with baseline and 1 further visit and ≥ 1 Duodopa treatment|64||
60115980|NCT01747655|76236662|FG001|STARTED|Temporary Naso-jejunal Tube Period||0||
59567250|NCT02301156|75670120|FG001|NOT COMPLETED|Overall Study||52||
59824404|NCT00454818|75947346|FG000|COMPLETED|Phase 2: Randomized Double-blind||0||
59824405|NCT00454818|75947347|FG001|COMPLETED|Phase 2: Randomized Double-blind||6||
59824406|NCT00454818|75947348|FG002|COMPLETED|Phase 2: Randomized Double-blind||5||
59824407|NCT00454818|75947349|FG003|COMPLETED|Phase 2: Randomized Double-blind||8||
59824408|NCT00454818|75947350|FG004|COMPLETED|Phase 2: Randomized Double-blind||10||
59824409|NCT00454818|75947346|FG000|NOT COMPLETED|Phase 2: Randomized Double-blind||0||
59824410|NCT00454818|75947347|FG001|NOT COMPLETED|Phase 2: Randomized Double-blind||2||
59824411|NCT00454818|75947348|FG002|NOT COMPLETED|Phase 2: Randomized Double-blind||3||
59824412|NCT00454818|75947349|FG003|NOT COMPLETED|Phase 2: Randomized Double-blind||1||
60115981|NCT01747655|76236661|FG000|COMPLETED|Temporary Naso-jejunal Tube Period||64||
60115982|NCT01747655|76236662|FG001|COMPLETED|Temporary Naso-jejunal Tube Period||0||
60115983|NCT01747655|76236661|FG000|NOT COMPLETED|Temporary Naso-jejunal Tube Period||0||
60115984|NCT01747655|76236662|FG001|NOT COMPLETED|Temporary Naso-jejunal Tube Period||0||
60115985|NCT01747655|76236661|FG000|STARTED|PEG-J Period (Duodopa Treatment)|Dudopa MAS: Participants in the MAS that received Duodopa via PEG-J.|58||
59824413|NCT00454818|75947350|FG004|NOT COMPLETED|Phase 2: Randomized Double-blind||4||
59824414|NCT00445224|75947369|FG000|STARTED|Specific Exercises||17||
59996469|NCT02713867|76112450|FG001|COMPLETED|Randomization||180|= Participants Treated|
59996470|NCT02713867|76112449|FG000|NOT COMPLETED|Randomization||2||
59996471|NCT02713867|76112450|FG001|NOT COMPLETED|Randomization||3||
59996472|NCT02713867|76112449|FG000|STARTED|Treatment Period||178|= Started Treatment|
59996473|NCT02713867|76112450|FG001|STARTED|Treatment Period||180|= Started Treatment|
59996474|NCT02713867|76112449|FG000|COMPLETED|Treatment Period||0|= Continuing Treatment Period|
59996475|NCT02713867|76112450|FG001|COMPLETED|Treatment Period||0|= Continuing Treatment Period|
59996476|NCT02713867|76112449|FG000|NOT COMPLETED|Treatment Period||178||
59996477|NCT02713867|76112450|FG001|NOT COMPLETED|Treatment Period||180||
59996478|NCT02730455|76112459|FG000|STARTED|Overall Study||94||
59996479|NCT02730455|76112460|FG001|STARTED|Overall Study||91||
59996480|NCT02730455|76112461|FG002|STARTED|Overall Study||92||
59996481|NCT02730455|76112459|FG000|Safety Population|Overall Study||91|Participants who had received any study treatment (including complete or incomplete infusion)|
59996482|NCT02730455|76112460|FG001|Safety Population|Overall Study||90|Participants who had received any study treatment (including complete or incomplete infusion)|
59996483|NCT02730455|76112461|FG002|Safety Population|Overall Study||89|Participants who had received any study treatment (including complete or incomplete infusion)|
59996484|NCT02730455|76112459|FG000|Participants Dosed|Overall Study||91||
59996485|NCT02730455|76112460|FG001|Participants Dosed|Overall Study||88||
59996486|NCT02730455|76112461|FG002|Participants Dosed|Overall Study||91||
59996487|NCT02730455|76112459|FG000|Who Received Total Volume of Study Drug|Overall Study||90||
59996488|NCT02730455|76112460|FG001|Who Received Total Volume of Study Drug|Overall Study||88||
59996489|NCT02730455|76112461|FG002|Who Received Total Volume of Study Drug|Overall Study||89||
59996490|NCT02730455|76112459|FG000|COMPLETED|Overall Study||81||
59996491|NCT02730455|76112460|FG001|COMPLETED|Overall Study||77||
59996492|NCT02730455|76112461|FG002|COMPLETED|Overall Study||81||
59996493|NCT02730455|76112459|FG000|NOT COMPLETED|Overall Study||13||
59996494|NCT02730455|76112460|FG001|NOT COMPLETED|Overall Study||14||
59996495|NCT02730455|76112461|FG002|NOT COMPLETED|Overall Study||11||
59996496|NCT04440449|76112471|FG000|STARTED|Overall Study||20||
59996497|NCT04440449|76112472|FG001|STARTED|Overall Study||0||
59996498|NCT04440449|76112471|FG000|COMPLETED|Overall Study||18||
59996499|NCT04440449|76112472|FG001|COMPLETED|Overall Study||0||
59996500|NCT04440449|76112471|FG000|NOT COMPLETED|Overall Study||2||
59996501|NCT04440449|76112472|FG001|NOT COMPLETED|Overall Study||0||
59996502|NCT00701311|76112479|FG000|STARTED|Overall Study||17||
59824415|NCT00445224|75947370|FG001|STARTED|Specific Exercises||16||
59824416|NCT00445224|75947369|FG000|Baseline|Specific Exercises||17||
59824417|NCT00445224|75947370|FG001|Baseline|Specific Exercises||16||
59567251|NCT03981939|75670129|FG000|STARTED|Overall Study||549||
59824418|NCT00445224|75947369|FG000|4 Weeks|Specific Exercises|Participants withdrew due to time conflicts|14||
59824419|NCT00445224|75947370|FG001|4 Weeks|Specific Exercises|Participants withdrew due to time conflicts|13||
59824420|NCT00445224|75947369|FG000|COMPLETED|Specific Exercises|No adverse event occurred|13||
59824421|NCT00445224|75947370|FG001|COMPLETED|Specific Exercises|No adverse event occurred|13||
59824422|NCT00445224|75947369|FG000|NOT COMPLETED|Specific Exercises||4||
59824423|NCT00445224|75947370|FG001|NOT COMPLETED|Specific Exercises||3||
59824424|NCT00445224|75947369|FG000|STARTED|Combined Exercises||13||
59824425|NCT00445224|75947370|FG001|STARTED|Combined Exercises||13||
59824426|NCT00445224|75947369|FG000|COMPLETED|Combined Exercises||13||
59824427|NCT00445224|75947370|FG001|COMPLETED|Combined Exercises||13||
59824428|NCT00445224|75947369|FG000|NOT COMPLETED|Combined Exercises||0||
59824429|NCT00445224|75947370|FG001|NOT COMPLETED|Combined Exercises||0||
60115986|NCT01747655|76236662|FG001|STARTED|PEG-J Period (Duodopa Treatment)|Participants in the MAS that returned to SoC (no PEG-J introduced; did not meet selection criteria)|6||
60115987|NCT01747655|76236661|FG000|COMPLETED|PEG-J Period (Duodopa Treatment)||44||
60115988|NCT01747655|76236662|FG001|COMPLETED|PEG-J Period (Duodopa Treatment)||6||
60115989|NCT01747655|76236661|FG000|NOT COMPLETED|PEG-J Period (Duodopa Treatment)||14||
60115990|NCT01747655|76236662|FG001|NOT COMPLETED|PEG-J Period (Duodopa Treatment)||0||
60115991|NCT01747655|76236661|FG000|STARTED|PEG-J Period (Continued Treatment)||41||
60115992|NCT01747655|76236662|FG001|STARTED|PEG-J Period (Continued Treatment)|SoC MAS: 6 SoC participants plus 9 participants who received Duodopa via PEG-J then returned to SoC|15||
60115993|NCT01747655|76236661|FG000|COMPLETED|PEG-J Period (Continued Treatment)||41||
60115994|NCT01747655|76236662|FG001|COMPLETED|PEG-J Period (Continued Treatment)||15||
60115995|NCT01747655|76236661|FG000|NOT COMPLETED|PEG-J Period (Continued Treatment)||0||
60115996|NCT01747655|76236662|FG001|NOT COMPLETED|PEG-J Period (Continued Treatment)||0||
60115997|NCT01718483|76236670|FG000|STARTED|Overall Study||191||
60115998|NCT01718483|76236671|FG001|STARTED|Overall Study||192||
60115999|NCT01718483|76236670|FG000|Treated|Overall Study||187||
59567252|NCT03981939|75670130|FG001|STARTED|Overall Study||1902||
59567253|NCT03981939|75670131|FG002|STARTED|Overall Study||581||
59567254|NCT03981939|75670129|FG000|COMPLETED|Overall Study||549||
59567255|NCT03981939|75670130|FG001|COMPLETED|Overall Study||1902||
59567256|NCT03981939|75670131|FG002|COMPLETED|Overall Study||581||
59567257|NCT03981939|75670129|FG000|NOT COMPLETED|Overall Study||0||
59567258|NCT03981939|75670130|FG001|NOT COMPLETED|Overall Study||0||
59567259|NCT03981939|75670131|FG002|NOT COMPLETED|Overall Study||0||
59567260|NCT03830307|75670142|FG000|STARTED|Overall Study||5||
59567261|NCT03830307|75670142|FG000|COMPLETED|Overall Study||5||
59567262|NCT03830307|75670142|FG000|NOT COMPLETED|Overall Study||0||
59567263|NCT03973905|75670148|FG000|STARTED|Overall Study||107||
59567264|NCT03973905|75670149|FG001|STARTED|Overall Study||183||
59567265|NCT03973905|75670148|FG000|COMPLETED|Overall Study||107||
59567266|NCT03973905|75670149|FG001|COMPLETED|Overall Study||183||
59567267|NCT03973905|75670148|FG000|NOT COMPLETED|Overall Study||0||
59567268|NCT03973905|75670149|FG001|NOT COMPLETED|Overall Study||0||
59567269|NCT02278484|75670155|FG000|STARTED|Overall Study||50||
59567270|NCT02278484|75670155|FG000|COMPLETED|Overall Study||50||
59567271|NCT02278484|75670155|FG000|NOT COMPLETED|Overall Study||0||
59567272|NCT02900781|75670162|FG000|STARTED|Overall Study||4|Study terminated due to device not working at our facility .|
59567273|NCT02900781|75670163|FG001|STARTED|Overall Study||5|Study terminated due to device not working at our facility .|
59567274|NCT02900781|75670162|FG000|COMPLETED|Overall Study||0|Participants were unable to use the device as required in the protocol. No data collected|
59567275|NCT02900781|75670163|FG001|COMPLETED|Overall Study||0|Participants were unable to use the device as required in the protocol. No data collected|
59567276|NCT02900781|75670162|FG000|NOT COMPLETED|Overall Study||4||
59567277|NCT02900781|75670163|FG001|NOT COMPLETED|Overall Study||5||
59567278|NCT03971721|75670169|FG000|STARTED|Overall Study||3||
59567279|NCT03971721|75670169|FG000|COMPLETED|Overall Study||3||
59567280|NCT03971721|75670169|FG000|NOT COMPLETED|Overall Study||0||
59567281|NCT03979677|75670173|FG000|STARTED|Overall Study|Participants enrolled|41||
59567282|NCT03979677|75670173|FG000|COMPLETED|Overall Study|participants completed|28||
59567283|NCT03979677|75670173|FG000|NOT COMPLETED|Overall Study||13||
59567284|NCT01507233|75670179|FG000|STARTED|Overall Study||5||
59824430|NCT02408315|75947378|FG000|STARTED|Overall Study||148||
59824431|NCT02408315|75947379|FG001|STARTED|Overall Study||152||
59824432|NCT02408315|75947378|FG000|COMPLETED|Overall Study||148||
59824433|NCT02408315|75947379|FG001|COMPLETED|Overall Study||152||
59824434|NCT02408315|75947378|FG000|NOT COMPLETED|Overall Study||0||
59824435|NCT02408315|75947379|FG001|NOT COMPLETED|Overall Study||0||
59824436|NCT00358917|75947387|FG000|STARTED|Overall Study||300||
59824437|NCT00358917|75947388|FG001|STARTED|Overall Study||299||
59824438|NCT00358917|75947387|FG000|COMPLETED|Overall Study||234||
59824439|NCT00358917|75947388|FG001|COMPLETED|Overall Study||230||
59824440|NCT00358917|75947387|FG000|NOT COMPLETED|Overall Study||66||
59824441|NCT00358917|75947388|FG001|NOT COMPLETED|Overall Study||69||
59824442|NCT00264004|75947400|FG000|STARTED|Overall Study|Randomised|30||
59824443|NCT00264004|75947401|FG001|STARTED|Overall Study|Randomised|32||
59824444|NCT00264004|75947402|FG002|STARTED|Overall Study|Randomised|30||
59824445|NCT00264004|75947403|FG003|STARTED|Overall Study|Randomised|34||
59824446|NCT00264004|75947400|FG000|COMPLETED|Overall Study|Completed 12 weeks treatment|13||
59824447|NCT00264004|75947401|FG001|COMPLETED|Overall Study|Completed 12 weeks treatment|21||
59824448|NCT00264004|75947402|FG002|COMPLETED|Overall Study|Completed 12 weeks treatment|16||
59824449|NCT00264004|75947403|FG003|COMPLETED|Overall Study|Completed 12 weeks treatment|19||
59824450|NCT00264004|75947400|FG000|NOT COMPLETED|Overall Study||17||
59824451|NCT00264004|75947401|FG001|NOT COMPLETED|Overall Study||11||
59824452|NCT00264004|75947402|FG002|NOT COMPLETED|Overall Study||14||
59824453|NCT00264004|75947403|FG003|NOT COMPLETED|Overall Study||15||
59824454|NCT00368355|75947415|FG000|STARTED|Overall Study||18||
59824455|NCT00368355|75947416|FG001|STARTED|Overall Study||28||
59824456|NCT00368355|75947415|FG000|COMPLETED|Overall Study||7||
59824457|NCT00368355|75947416|FG001|COMPLETED|Overall Study||11||
59824458|NCT00368355|75947415|FG000|NOT COMPLETED|Overall Study||11||
59824459|NCT00368355|75947416|FG001|NOT COMPLETED|Overall Study||17||
59824460|NCT00445146|75947422|FG000|STARTED|Overall Study||192||
59824461|NCT00445146|75947422|FG000|COMPLETED|Overall Study||73||
59824462|NCT00445146|75947422|FG000|NOT COMPLETED|Overall Study||119||
59824463|NCT00368277|75947428|FG000|STARTED|Overall Study||457||
59824464|NCT00368277|75947429|FG001|STARTED|Overall Study||444||
59824465|NCT00368277|75947428|FG000|COMPLETED|Overall Study||344||
59824466|NCT00368277|75947429|FG001|COMPLETED|Overall Study||336||
59824467|NCT00368277|75947428|FG000|NOT COMPLETED|Overall Study||113||
59824468|NCT00368277|75947429|FG001|NOT COMPLETED|Overall Study||108||
59824469|NCT00280150|75947439|FG000|STARTED|Overall Study||5||
59824470|NCT00280150|75947440|FG001|STARTED|Overall Study||5||
59824471|NCT00280150|75947441|FG002|STARTED|Overall Study||6||
59824472|NCT00280150|75947442|FG003|STARTED|Overall Study||30||
59824473|NCT00280150|75947439|FG000|Cohort Induction|Overall Study||5||
59824474|NCT00280150|75947440|FG001|Cohort Induction|Overall Study||5||
59824475|NCT00280150|75947441|FG002|Cohort Induction|Overall Study||6||
59824476|NCT00280150|75947442|FG003|Cohort Induction|Overall Study||30||
59824477|NCT00280150|75947439|FG000|Consolidation Therapy|Overall Study||2||
59824478|NCT00280150|75947440|FG001|Consolidation Therapy|Overall Study||5||
59824479|NCT00280150|75947441|FG002|Consolidation Therapy|Overall Study||3||
59824480|NCT00280150|75947442|FG003|Consolidation Therapy|Overall Study|Phase II participants did not receive consolidation therapy.|0||
59824481|NCT00280150|75947439|FG000|COMPLETED|Overall Study||2||
59824482|NCT00280150|75947440|FG001|COMPLETED|Overall Study||4||
59824483|NCT00280150|75947441|FG002|COMPLETED|Overall Study||1||
59824484|NCT00280150|75947442|FG003|COMPLETED|Overall Study||20||
59824485|NCT00280150|75947439|FG000|NOT COMPLETED|Overall Study||3||
59824486|NCT00280150|75947440|FG001|NOT COMPLETED|Overall Study||1||
59824487|NCT00280150|75947441|FG002|NOT COMPLETED|Overall Study||5||
59824488|NCT00280150|75947442|FG003|NOT COMPLETED|Overall Study||10||
59824489|NCT00279916|75947455|FG000|STARTED|Overall Study||45||
59824490|NCT00279916|75947456|FG001|STARTED|Overall Study||46||
59824491|NCT00279916|75947455|FG000|COMPLETED|Overall Study||38||
59824492|NCT00279916|75947456|FG001|COMPLETED|Overall Study||41||
60116000|NCT01718483|76236671|FG001|Treated|Overall Study||192||
60116001|NCT01718483|76236670|FG000|COMPLETED|Overall Study||157||
60116002|NCT01718483|76236671|FG001|COMPLETED|Overall Study||158||
60116003|NCT01718483|76236670|FG000|NOT COMPLETED|Overall Study||34||
59824493|NCT00279916|75947455|FG000|NOT COMPLETED|Overall Study||7||
59824494|NCT00279916|75947456|FG001|NOT COMPLETED|Overall Study||5||
59824495|NCT00358527|75947464|FG000|STARTED|Overall Study||267||
59824496|NCT00358527|75947465|FG001|STARTED|Overall Study||134||
59824497|NCT00358527|75947464|FG000|COMPLETED|Overall Study||254||
59824498|NCT00358527|75947465|FG001|COMPLETED|Overall Study||131||
59824499|NCT00358527|75947464|FG000|NOT COMPLETED|Overall Study||13||
59824500|NCT00358527|75947465|FG001|NOT COMPLETED|Overall Study||3||
59824501|NCT00251758|75947474|FG000|STARTED|Overall Study||292||
59824502|NCT00251758|75947475|FG001|STARTED|Overall Study||312||
59824503|NCT00251758|75947476|FG002|STARTED|Overall Study||304||
59824504|NCT00251758|75947474|FG000|COMPLETED|Overall Study||264||
59824505|NCT00251758|75947475|FG001|COMPLETED|Overall Study||285||
59824506|NCT00251758|75947476|FG002|COMPLETED|Overall Study||277||
59824507|NCT00251758|75947474|FG000|NOT COMPLETED|Overall Study||28||
59824508|NCT00251758|75947475|FG001|NOT COMPLETED|Overall Study||27||
60116004|NCT01718483|76236671|FG001|NOT COMPLETED|Overall Study||34||
60116005|NCT01717859|76236677|FG000|STARTED|Overall Study||54||
60116006|NCT01717859|76236677|FG000|3 Month|Overall Study||50||
60116007|NCT01717859|76236677|FG000|COMPLETED|Overall Study||44||
60116008|NCT01717859|76236677|FG000|NOT COMPLETED|Overall Study||10||
60116009|NCT01973608|76236692|FG000|STARTED|Overall Study||2||
60116010|NCT01973608|76236693|FG001|STARTED|Overall Study||2||
59824509|NCT00251758|75947476|FG002|NOT COMPLETED|Overall Study||27||
59824510|NCT00279214|75947486|FG000|STARTED|Overall Study||22||
59824511|NCT00279214|75947487|FG001|STARTED|Overall Study||21||
59824512|NCT00279214|75947486|FG000|COMPLETED|Overall Study|Completed means the number of per-protocol patients in the study|19||
59824513|NCT00279214|75947487|FG001|COMPLETED|Overall Study|Completed means the number of per-protocol patients in the study|19||
59824514|NCT00279214|75947486|FG000|NOT COMPLETED|Overall Study||3||
59824515|NCT00279214|75947487|FG001|NOT COMPLETED|Overall Study||2||
59824516|NCT00262834|75947495|FG000|STARTED|Overall Study||25||
59824517|NCT00262834|75947496|FG001|STARTED|Overall Study||29||
59824518|NCT00262834|75947495|FG000|COMPLETED|Overall Study||24||
59824519|NCT00262834|75947496|FG001|COMPLETED|Overall Study||25||
59824520|NCT00262834|75947495|FG000|NOT COMPLETED|Overall Study||1||
59824521|NCT00262834|75947496|FG001|NOT COMPLETED|Overall Study||4||
59824522|NCT00541775|75947505|FG000|STARTED|Overall Study||94||
59824523|NCT00541775|75947506|FG001|STARTED|Overall Study||87||
59824524|NCT00541775|75947507|FG002|STARTED|Overall Study||92||
59824525|NCT00541775|75947505|FG000|COMPLETED|Overall Study||85||
59824526|NCT00541775|75947506|FG001|COMPLETED|Overall Study||85||
59824527|NCT00541775|75947507|FG002|COMPLETED|Overall Study||84||
59824528|NCT00541775|75947505|FG000|NOT COMPLETED|Overall Study||9||
59824529|NCT00541775|75947506|FG001|NOT COMPLETED|Overall Study||2||
59824530|NCT00541775|75947507|FG002|NOT COMPLETED|Overall Study||8||
59824531|NCT00539513|75947517|FG000|STARTED|Overall Study||5||
59824532|NCT00539513|75947518|FG001|STARTED|Overall Study||5||
59824533|NCT00539513|75947517|FG000|Received Allocated Intervention|Overall Study||3||
59824534|NCT00539513|75947518|FG001|Received Allocated Intervention|Overall Study||4||
59824535|NCT00539513|75947517|FG000|COMPLETED|Overall Study||3||
59824536|NCT00539513|75947518|FG001|COMPLETED|Overall Study||3||
59824537|NCT00539513|75947517|FG000|NOT COMPLETED|Overall Study||2||
59824538|NCT00539513|75947518|FG001|NOT COMPLETED|Overall Study||2||
59824539|NCT00454584|75947527|FG000|STARTED|Controlled Period||347||
59824540|NCT00454584|75947528|FG001|STARTED|Controlled Period||209||
59824541|NCT00454584|75947529|FG002|STARTED|Controlled Period||347||
59824542|NCT00454584|75947530|FG003|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0||
59824543|NCT00454584|75947531|FG004|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0||
59824544|NCT00454584|75947532|FG005|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0||
60116011|NCT01973608|76236694|FG002|STARTED|Overall Study||6||
60116012|NCT01973608|76236695|FG003|STARTED|Overall Study||2||
60116013|NCT01973608|76236692|FG000|COMPLETED|Overall Study||2||
60116014|NCT01973608|76236693|FG001|COMPLETED|Overall Study||2||
60116015|NCT01973608|76236694|FG002|COMPLETED|Overall Study||6||
60116016|NCT01973608|76236695|FG003|COMPLETED|Overall Study||2||
60116017|NCT01973608|76236692|FG000|NOT COMPLETED|Overall Study||0||
59824545|NCT00454584|75947527|FG000|COMPLETED|Controlled Period||336||
59824546|NCT00454584|75947528|FG001|COMPLETED|Controlled Period||201||
59824547|NCT00454584|75947529|FG002|COMPLETED|Controlled Period||342||
59824548|NCT00454584|75947530|FG003|COMPLETED|Controlled Period||0||
59824549|NCT00454584|75947531|FG004|COMPLETED|Controlled Period||0||
59824550|NCT00454584|75947532|FG005|COMPLETED|Controlled Period||0||
59824551|NCT00454584|75947527|FG000|NOT COMPLETED|Controlled Period||11||
59824552|NCT00454584|75947528|FG001|NOT COMPLETED|Controlled Period||8||
60116018|NCT01973608|76236693|FG001|NOT COMPLETED|Overall Study||0||
60116019|NCT01973608|76236694|FG002|NOT COMPLETED|Overall Study||0||
60116020|NCT01973608|76236695|FG003|NOT COMPLETED|Overall Study||0||
60116021|NCT02357290|76236709|FG000|STARTED|Overall Study||40||
59824553|NCT00454584|75947529|FG002|NOT COMPLETED|Controlled Period||5||
59824554|NCT00454584|75947530|FG003|NOT COMPLETED|Controlled Period||0||
59824555|NCT00454584|75947531|FG004|NOT COMPLETED|Controlled Period||0||
59824556|NCT00454584|75947532|FG005|NOT COMPLETED|Controlled Period||0||
59824557|NCT00454584|75947527|FG000|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0||
59824558|NCT00454584|75947528|FG001|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0||
59824559|NCT00454584|75947529|FG002|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0||
59824560|NCT00454584|75947530|FG003|STARTED|After Controlled Period||336||
59824561|NCT00454584|75947531|FG004|STARTED|After Controlled Period||201||
59824562|NCT00454584|75947532|FG005|STARTED|After Controlled Period||342||
59824563|NCT00454584|75947527|FG000|COMPLETED|After Controlled Period||0||
59824564|NCT00454584|75947528|FG001|COMPLETED|After Controlled Period||0||
60116022|NCT02357290|76236709|FG000|Exposed|Overall Study||26||
60116023|NCT02357290|76236709|FG000|COMPLETED|Overall Study||14||
59824565|NCT00454584|75947529|FG002|COMPLETED|After Controlled Period||0||
59824566|NCT00454584|75947530|FG003|COMPLETED|After Controlled Period||310||
60116024|NCT02357290|76236709|FG000|NOT COMPLETED|Overall Study||26||
60116025|NCT00725049|76236715|FG000|STARTED|Overall Study||17||
60116026|NCT00725049|76236716|FG001|STARTED|Overall Study||20||
60116027|NCT00725049|76236715|FG000|COMPLETED|Overall Study||17||
60116028|NCT00725049|76236716|FG001|COMPLETED|Overall Study||20||
60116029|NCT00725049|76236715|FG000|NOT COMPLETED|Overall Study||0||
60116030|NCT00725049|76236716|FG001|NOT COMPLETED|Overall Study||0||
60116031|NCT00057681|76236725|FG000|STARTED|Overall Study||137||
60116032|NCT00057681|76236726|FG001|STARTED|Overall Study||139||
60116033|NCT00057681|76236727|FG002|STARTED|Overall Study||103||
60116034|NCT00057681|76236725|FG000|COMPLETED|Overall Study||72||
60116035|NCT00057681|76236726|FG001|COMPLETED|Overall Study||67||
60116036|NCT00057681|76236727|FG002|COMPLETED|Overall Study||69||
60116037|NCT00057681|76236725|FG000|NOT COMPLETED|Overall Study||65||
60116038|NCT00057681|76236726|FG001|NOT COMPLETED|Overall Study||72||
60116039|NCT00057681|76236727|FG002|NOT COMPLETED|Overall Study||34||
60116040|NCT00059475|76236743|FG000|STARTED|Overall Study||33||
60116041|NCT00059475|76236744|FG001|STARTED|Overall Study||2||
60116042|NCT00059475|76236745|FG002|STARTED|Overall Study||24||
60116043|NCT00059475|76236746|FG003|STARTED|Overall Study||3||
60116044|NCT00059475|76236747|FG004|STARTED|Overall Study||33||
60116045|NCT00059475|76236748|FG005|STARTED|Overall Study||2||
60116046|NCT00059475|76236749|FG006|STARTED|Overall Study||34||
60116047|NCT00059475|76236750|FG007|STARTED|Overall Study||7||
60116048|NCT00059475|76236743|FG000|COMPLETED|Overall Study||33||
60116049|NCT00059475|76236744|FG001|COMPLETED|Overall Study||2||
60116050|NCT00059475|76236745|FG002|COMPLETED|Overall Study||24||
60116051|NCT00059475|76236746|FG003|COMPLETED|Overall Study||3||
60116052|NCT00059475|76236747|FG004|COMPLETED|Overall Study||33||
60116053|NCT00059475|76236748|FG005|COMPLETED|Overall Study||2||
60116054|NCT00059475|76236749|FG006|COMPLETED|Overall Study||34||
60116055|NCT00059475|76236750|FG007|COMPLETED|Overall Study||7||
60116056|NCT00059475|76236743|FG000|NOT COMPLETED|Overall Study||0||
60116057|NCT00059475|76236744|FG001|NOT COMPLETED|Overall Study||0||
60116058|NCT00059475|76236745|FG002|NOT COMPLETED|Overall Study||0||
60116059|NCT00059475|76236746|FG003|NOT COMPLETED|Overall Study||0||
60116060|NCT00059475|76236747|FG004|NOT COMPLETED|Overall Study||0||
60116061|NCT00059475|76236748|FG005|NOT COMPLETED|Overall Study||0||
60116062|NCT00059475|76236749|FG006|NOT COMPLETED|Overall Study||0||
60116063|NCT00059475|76236750|FG007|NOT COMPLETED|Overall Study||0||
60116064|NCT00060333|76236775|FG000|STARTED|Overall Study||20||
60116065|NCT00060333|76236775|FG000|COMPLETED|Overall Study||20||
60116066|NCT00060333|76236775|FG000|NOT COMPLETED|Overall Study||0||
60116067|NCT02028676|76236791|FG000|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|606||
60116068|NCT02028676|76236792|FG001|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|600||
60116069|NCT02028676|76236793|FG002|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|0||
60116070|NCT02028676|76236794|FG003|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|0||
60116071|NCT02028676|76236795|FG004|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|0||
60116072|NCT02028676|76236796|FG005|STARTED|Initial Enrolment: CDM vs LCM|Secondary partial factorial randomization: Only a subset of ARROW children were eligible|0||
60116073|NCT02028676|76236797|FG006|STARTED|Initial Enrolment: CDM vs LCM|Secondary partial factorial randomization: Only a subset of ARROW children were eligible|0||
60116074|NCT02028676|76236798|FG007|STARTED|Initial Enrolment: CDM vs LCM|Secondary partial factorial randomization: Only a subset of ARROW children were eligible|0||
60116075|NCT02028676|76236799|FG008|STARTED|Initial Enrolment: CDM vs LCM|Secondary partial factorial randomization: Only a subset of ARROW children were eligible|0||
60116076|NCT02028676|76236791|FG000|COMPLETED|Initial Enrolment: CDM vs LCM||606||
60116077|NCT02028676|76236792|FG001|COMPLETED|Initial Enrolment: CDM vs LCM||600||
60116078|NCT02028676|76236793|FG002|COMPLETED|Initial Enrolment: CDM vs LCM||0||
60116079|NCT02028676|76236794|FG003|COMPLETED|Initial Enrolment: CDM vs LCM||0||
60116080|NCT02028676|76236795|FG004|COMPLETED|Initial Enrolment: CDM vs LCM||0||
60116081|NCT02028676|76236796|FG005|COMPLETED|Initial Enrolment: CDM vs LCM||0||
60116082|NCT02028676|76236797|FG006|COMPLETED|Initial Enrolment: CDM vs LCM||0||
60116083|NCT02028676|76236798|FG007|COMPLETED|Initial Enrolment: CDM vs LCM||0||
60116084|NCT02028676|76236799|FG008|COMPLETED|Initial Enrolment: CDM vs LCM||0||
60116085|NCT02028676|76236791|FG000|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0||
60116086|NCT02028676|76236792|FG001|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0||
60116087|NCT02028676|76236793|FG002|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0||
60116088|NCT02028676|76236794|FG003|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0||
60116089|NCT02028676|76236795|FG004|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0||
60116090|NCT02028676|76236796|FG005|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0||
60116091|NCT02028676|76236797|FG006|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0||
59567285|NCT01507233|75670180|FG001|STARTED|Overall Study||0||
60116092|NCT02028676|76236798|FG007|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0||
60116093|NCT02028676|76236799|FG008|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0||
60116094|NCT02028676|76236791|FG000|STARTED|Initial Enrolment: Induction ART||0||
60116095|NCT02028676|76236792|FG001|STARTED|Initial Enrolment: Induction ART||0||
60116096|NCT02028676|76236793|FG002|STARTED|Initial Enrolment: Induction ART||397||
60116097|NCT02028676|76236794|FG003|STARTED|Initial Enrolment: Induction ART||404||
60116098|NCT02028676|76236795|FG004|STARTED|Initial Enrolment: Induction ART||405||
60116099|NCT02028676|76236796|FG005|STARTED|Initial Enrolment: Induction ART||0||
60116100|NCT02028676|76236797|FG006|STARTED|Initial Enrolment: Induction ART||0||
60116101|NCT02028676|76236798|FG007|STARTED|Initial Enrolment: Induction ART||0||
60116102|NCT02028676|76236799|FG008|STARTED|Initial Enrolment: Induction ART||0||
60116103|NCT02028676|76236791|FG000|COMPLETED|Initial Enrolment: Induction ART||0||
60116104|NCT02028676|76236792|FG001|COMPLETED|Initial Enrolment: Induction ART||0||
60116105|NCT02028676|76236793|FG002|COMPLETED|Initial Enrolment: Induction ART||397||
60116106|NCT02028676|76236794|FG003|COMPLETED|Initial Enrolment: Induction ART||404||
60116107|NCT02028676|76236795|FG004|COMPLETED|Initial Enrolment: Induction ART||405||
59824567|NCT00454584|75947531|FG004|COMPLETED|After Controlled Period||189||
59824568|NCT00454584|75947532|FG005|COMPLETED|After Controlled Period||310||
59824569|NCT00454584|75947527|FG000|NOT COMPLETED|After Controlled Period||0||
59824570|NCT00454584|75947528|FG001|NOT COMPLETED|After Controlled Period||0||
59824571|NCT00454584|75947529|FG002|NOT COMPLETED|After Controlled Period||0||
59824572|NCT00454584|75947530|FG003|NOT COMPLETED|After Controlled Period||26||
59824573|NCT00454584|75947531|FG004|NOT COMPLETED|After Controlled Period||12||
59824574|NCT00454584|75947532|FG005|NOT COMPLETED|After Controlled Period||32||
59824575|NCT00445068|75947546|FG000|STARTED|Overall Study||38||
59824576|NCT00445068|75947546|FG000|COMPLETED|Overall Study||2||
59824577|NCT00445068|75947546|FG000|NOT COMPLETED|Overall Study||36||
59824578|NCT00539279|75947552|FG000|STARTED|Treatment||41||
59824579|NCT00539279|75947553|FG001|STARTED|Treatment||46||
59824580|NCT00539279|75947552|FG000|COMPLETED|Treatment||30||
59824581|NCT00539279|75947553|FG001|COMPLETED|Treatment||38||
59824582|NCT00539279|75947552|FG000|NOT COMPLETED|Treatment||11||
59824583|NCT00539279|75947553|FG001|NOT COMPLETED|Treatment||8||
59824584|NCT00539279|75947552|FG000|STARTED|Post-Treatment Assessment|Individuals eligible for post-treatment assessment (includes all individuals randomized to PE)|30||
59824585|NCT00539279|75947553|FG001|STARTED|Post-Treatment Assessment|Individuals eligible for post-treatment assessment (includes all individuals randomized to RT)|38||
59824586|NCT00539279|75947552|FG000|COMPLETED|Post-Treatment Assessment||18||
59824587|NCT00539279|75947553|FG001|COMPLETED|Post-Treatment Assessment||29||
59824588|NCT00539279|75947552|FG000|NOT COMPLETED|Post-Treatment Assessment||12||
59824589|NCT00539279|75947553|FG001|NOT COMPLETED|Post-Treatment Assessment||9||
59824590|NCT00539279|75947552|FG000|STARTED|6-Month Follow-Up Assessment|Individuals eligible for 6-month assessment (includes all individuals randomized to PE)|18||
59824591|NCT00539279|75947553|FG001|STARTED|6-Month Follow-Up Assessment|Individuals eligible for 6-month assessment (includes all individuals randomized to RT)|29||
59824592|NCT00539279|75947552|FG000|COMPLETED|6-Month Follow-Up Assessment||17||
59824593|NCT00539279|75947553|FG001|COMPLETED|6-Month Follow-Up Assessment||22||
59824594|NCT00539279|75947552|FG000|NOT COMPLETED|6-Month Follow-Up Assessment||1||
60116108|NCT02028676|76236796|FG005|COMPLETED|Initial Enrolment: Induction ART||0||
60116109|NCT02028676|76236797|FG006|COMPLETED|Initial Enrolment: Induction ART||0||
60116110|NCT02028676|76236798|FG007|COMPLETED|Initial Enrolment: Induction ART||0||
60116111|NCT02028676|76236799|FG008|COMPLETED|Initial Enrolment: Induction ART||0||
60116112|NCT02028676|76236791|FG000|NOT COMPLETED|Initial Enrolment: Induction ART||0||
60116113|NCT02028676|76236792|FG001|NOT COMPLETED|Initial Enrolment: Induction ART||0||
60116114|NCT02028676|76236793|FG002|NOT COMPLETED|Initial Enrolment: Induction ART||0||
60116115|NCT02028676|76236794|FG003|NOT COMPLETED|Initial Enrolment: Induction ART||0||
60116116|NCT02028676|76236795|FG004|NOT COMPLETED|Initial Enrolment: Induction ART||0||
60116117|NCT02028676|76236796|FG005|NOT COMPLETED|Initial Enrolment: Induction ART||0||
60116118|NCT02028676|76236797|FG006|NOT COMPLETED|Initial Enrolment: Induction ART||0||
60116119|NCT02028676|76236798|FG007|NOT COMPLETED|Initial Enrolment: Induction ART||0||
60116120|NCT02028676|76236799|FG008|NOT COMPLETED|Initial Enrolment: Induction ART||0||
60116121|NCT02028676|76236791|FG000|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0||
60116122|NCT02028676|76236792|FG001|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0||
59567286|NCT01507233|75670179|FG000|COMPLETED|Overall Study||5||
59824595|NCT00539279|75947553|FG001|NOT COMPLETED|6-Month Follow-Up Assessment||7||
59824596|NCT00444912|75947561|FG000|STARTED|Overall Study||15||
59824597|NCT00444912|75947562|FG001|STARTED|Overall Study||15||
59824598|NCT00444912|75947561|FG000|Received Plerixafor|Overall Study||15||
59824599|NCT00444912|75947562|FG001|Received Plerixafor|Overall Study||15||
59824600|NCT00444912|75947561|FG000|Received Transplant|Overall Study||14||
59824601|NCT00444912|75947562|FG001|Received Transplant|Overall Study||14||
59824602|NCT00444912|75947561|FG000|COMPLETED|Overall Study||12||
59824603|NCT00444912|75947562|FG001|COMPLETED|Overall Study||13||
59824604|NCT00444912|75947561|FG000|NOT COMPLETED|Overall Study||3||
59824605|NCT00444912|75947562|FG001|NOT COMPLETED|Overall Study||2||
60116123|NCT02028676|76236793|FG002|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0||
60116124|NCT02028676|76236794|FG003|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0||
60116125|NCT02028676|76236795|FG004|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0||
60116126|NCT02028676|76236796|FG005|STARTED|Subsequent Once vs Twice Daily ABC+3TC||336||
60116127|NCT02028676|76236797|FG006|STARTED|Subsequent Once vs Twice Daily ABC+3TC||333||
60116128|NCT02028676|76236798|FG007|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0||
60116129|NCT02028676|76236799|FG008|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0||
60116130|NCT02028676|76236791|FG000|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0||
60116131|NCT02028676|76236792|FG001|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0||
60116132|NCT02028676|76236793|FG002|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0||
60116133|NCT02028676|76236794|FG003|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0||
60116134|NCT02028676|76236795|FG004|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0||
60116135|NCT02028676|76236796|FG005|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||336||
60116136|NCT02028676|76236797|FG006|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||333||
60116137|NCT02028676|76236798|FG007|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0||
60116138|NCT02028676|76236799|FG008|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0||
60116139|NCT02028676|76236791|FG000|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0||
60116140|NCT02028676|76236792|FG001|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0||
60116141|NCT02028676|76236793|FG002|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0||
60116142|NCT02028676|76236794|FG003|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0||
60116143|NCT02028676|76236795|FG004|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0||
60116144|NCT02028676|76236796|FG005|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0||
60116145|NCT02028676|76236797|FG006|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0||
60116146|NCT02028676|76236798|FG007|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0||
60116147|NCT02028676|76236799|FG008|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0||
60116148|NCT02028676|76236791|FG000|STARTED|Subsequent Cotrimoxazole Randomization||0||
60116149|NCT02028676|76236792|FG001|STARTED|Subsequent Cotrimoxazole Randomization||0||
60116150|NCT02028676|76236793|FG002|STARTED|Subsequent Cotrimoxazole Randomization||0||
60116151|NCT02028676|76236794|FG003|STARTED|Subsequent Cotrimoxazole Randomization||0||
60116152|NCT02028676|76236795|FG004|STARTED|Subsequent Cotrimoxazole Randomization||0||
60116153|NCT02028676|76236796|FG005|STARTED|Subsequent Cotrimoxazole Randomization||0||
60116154|NCT02028676|76236797|FG006|STARTED|Subsequent Cotrimoxazole Randomization||0||
60116155|NCT02028676|76236798|FG007|STARTED|Subsequent Cotrimoxazole Randomization||376||
60116156|NCT02028676|76236799|FG008|STARTED|Subsequent Cotrimoxazole Randomization||382||
60116157|NCT02028676|76236791|FG000|COMPLETED|Subsequent Cotrimoxazole Randomization||0||
60116158|NCT02028676|76236792|FG001|COMPLETED|Subsequent Cotrimoxazole Randomization||0||
60116159|NCT02028676|76236793|FG002|COMPLETED|Subsequent Cotrimoxazole Randomization||0||
60116160|NCT02028676|76236794|FG003|COMPLETED|Subsequent Cotrimoxazole Randomization||0||
60116161|NCT02028676|76236795|FG004|COMPLETED|Subsequent Cotrimoxazole Randomization||0||
60116162|NCT02028676|76236796|FG005|COMPLETED|Subsequent Cotrimoxazole Randomization||0||
60116163|NCT02028676|76236797|FG006|COMPLETED|Subsequent Cotrimoxazole Randomization||0||
60116164|NCT02028676|76236798|FG007|COMPLETED|Subsequent Cotrimoxazole Randomization||376||
60116165|NCT02028676|76236799|FG008|COMPLETED|Subsequent Cotrimoxazole Randomization||382||
60116166|NCT02028676|76236791|FG000|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0||
60116167|NCT02028676|76236792|FG001|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0||
60116168|NCT02028676|76236793|FG002|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0||
60116169|NCT02028676|76236794|FG003|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0||
60116170|NCT02028676|76236795|FG004|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0||
60116171|NCT02028676|76236796|FG005|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0||
60116172|NCT02028676|76236797|FG006|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0||
60116173|NCT02028676|76236798|FG007|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0||
60116174|NCT02028676|76236799|FG008|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0||
60116175|NCT00061893|76236823|FG000|STARTED|Overall Study||38||
60116176|NCT00061893|76236823|FG000|COMPLETED|Overall Study||20||
60116177|NCT00061893|76236823|FG000|NOT COMPLETED|Overall Study||18||
60116178|NCT02028754|76236829|FG000|STARTED|Overall Study||90||
60116179|NCT02028754|76236830|FG001|STARTED|Overall Study||90||
60116180|NCT02028754|76236829|FG000|COMPLETED|Overall Study||83||
60116181|NCT02028754|76236830|FG001|COMPLETED|Overall Study||82||
60116182|NCT02028754|76236829|FG000|NOT COMPLETED|Overall Study||7||
60116183|NCT02028754|76236830|FG001|NOT COMPLETED|Overall Study||8||
59824606|NCT00538733|75947568|FG000|STARTED|Overall Study||26||
60116184|NCT01974700|76236838|FG000|STARTED|Overall Study||5||
60116185|NCT01974700|76236839|FG001|STARTED|Overall Study||3||
60116186|NCT01974700|76236838|FG000|COMPLETED|Overall Study||5||
60116187|NCT01974700|76236839|FG001|COMPLETED|Overall Study||3||
60116188|NCT01974700|76236838|FG000|NOT COMPLETED|Overall Study||0||
60116189|NCT01974700|76236839|FG001|NOT COMPLETED|Overall Study||0||
60116190|NCT02030080|76236849|FG000|STARTED|Overall Study|25 teams|100||
60116191|NCT02030080|76236850|FG001|STARTED|Overall Study|16 teams|64||
60116192|NCT02030080|76236851|FG002|STARTED|Overall Study|20 teams|80||
60116193|NCT02030080|76236852|FG003|STARTED|Overall Study|11 teams|44||
60116194|NCT02030080|76236849|FG000|COMPLETED|Overall Study||100||
60116195|NCT02030080|76236850|FG001|COMPLETED|Overall Study||64||
60116196|NCT02030080|76236851|FG002|COMPLETED|Overall Study||80||
60116197|NCT02030080|76236852|FG003|COMPLETED|Overall Study||42||
60116198|NCT02030080|76236849|FG000|NOT COMPLETED|Overall Study||0||
60116199|NCT02030080|76236850|FG001|NOT COMPLETED|Overall Study||0||
60116200|NCT02030080|76236851|FG002|NOT COMPLETED|Overall Study||0||
60116201|NCT02030080|76236852|FG003|NOT COMPLETED|Overall Study||2||
60116202|NCT02357758|76236865|FG000|STARTED|Overall Study||25||
60116203|NCT02357758|76236866|FG001|STARTED|Overall Study||20||
60116204|NCT02357758|76236867|FG002|STARTED|Overall Study||12||
60116205|NCT02357758|76236865|FG000|COMPLETED|Overall Study||9||
59715214|NCT01194245|75834060|FG000|COMPLETED|Titration Period (4 to 6 Weeks)|Participants that completed the Titration Period were randomized to Treatment Period 1.|117||
59715215|NCT01194245|75834061|FG001|COMPLETED|Titration Period (4 to 6 Weeks)||0||
59715216|NCT01194245|75834062|FG002|COMPLETED|Titration Period (4 to 6 Weeks)||0||
59715217|NCT01194245|75834063|FG003|COMPLETED|Titration Period (4 to 6 Weeks)||0||
59715218|NCT01194245|75834064|FG004|COMPLETED|Titration Period (4 to 6 Weeks)||0||
59715219|NCT01194245|75834060|FG000|NOT COMPLETED|Titration Period (4 to 6 Weeks)||18||
59715220|NCT01194245|75834061|FG001|NOT COMPLETED|Titration Period (4 to 6 Weeks)||0||
59715221|NCT01194245|75834062|FG002|NOT COMPLETED|Titration Period (4 to 6 Weeks)||0||
59715222|NCT01194245|75834063|FG003|NOT COMPLETED|Titration Period (4 to 6 Weeks)||0||
59715223|NCT01194245|75834064|FG004|NOT COMPLETED|Titration Period (4 to 6 Weeks)||0||
59715224|NCT01194245|75834060|FG000|STARTED|Treatment Period 1 (Weeks 0 to 12)||0||
59715225|NCT01194245|75834061|FG001|STARTED|Treatment Period 1 (Weeks 0 to 12)||29||
59715226|NCT01194245|75834062|FG002|STARTED|Treatment Period 1 (Weeks 0 to 12)||28||
59715227|NCT01194245|75834063|FG003|STARTED|Treatment Period 1 (Weeks 0 to 12)||30||
59715228|NCT01194245|75834064|FG004|STARTED|Treatment Period 1 (Weeks 0 to 12)||30||
59715229|NCT01194245|75834060|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||0||
59715230|NCT01194245|75834061|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||29||
59715231|NCT01194245|75834062|FG002|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||28||
59715232|NCT01194245|75834063|FG003|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||30||
59715233|NCT01194245|75834064|FG004|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||30||
59715234|NCT01194245|75834060|FG000|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||0||
59715235|NCT01194245|75834061|FG001|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||29||
59715236|NCT01194245|75834062|FG002|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||27||
59715237|NCT01194245|75834063|FG003|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||29||
59715238|NCT01194245|75834064|FG004|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||28||
59715239|NCT01194245|75834060|FG000|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||0||
59715240|NCT01194245|75834061|FG001|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||0||
59715241|NCT01194245|75834062|FG002|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||1||
59715242|NCT01194245|75834063|FG003|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||1||
59715243|NCT01194245|75834064|FG004|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||2||
59715244|NCT01194245|75834060|FG000|STARTED|Treatment Period 2 (Weeks 12 to 24)||0||
59715245|NCT01194245|75834061|FG001|STARTED|Treatment Period 2 (Weeks 12 to 24)||29||
59715246|NCT01194245|75834062|FG002|STARTED|Treatment Period 2 (Weeks 12 to 24)||27||
59715247|NCT01194245|75834063|FG003|STARTED|Treatment Period 2 (Weeks 12 to 24)||29||
59715248|NCT01194245|75834064|FG004|STARTED|Treatment Period 2 (Weeks 12 to 24)||28||
59715249|NCT01194245|75834060|FG000|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0||
59715250|NCT01194245|75834061|FG001|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||29||
59715251|NCT01194245|75834062|FG002|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||27||
59715252|NCT01194245|75834063|FG003|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||29||
59715253|NCT01194245|75834064|FG004|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||28||
59824607|NCT00538733|75947568|FG000|Removed Due to Progression of Disease|Overall Study||1||
60116206|NCT02357758|76236866|FG001|COMPLETED|Overall Study||20||
59715254|NCT01194245|75834060|FG000|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0||
59715255|NCT01194245|75834061|FG001|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0||
59715256|NCT01194245|75834062|FG002|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0||
59715257|NCT01194245|75834063|FG003|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0||
60116207|NCT02357758|76236867|FG002|COMPLETED|Overall Study||5||
60116208|NCT02357758|76236865|FG000|NOT COMPLETED|Overall Study||16||
60116209|NCT02357758|76236866|FG001|NOT COMPLETED|Overall Study||0||
59715258|NCT01194245|75834064|FG004|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0||
59715259|NCT00979407|75834075|FG000|STARTED|Overall Study||167||
59715260|NCT00979407|75834076|FG001|STARTED|Overall Study||167||
59715261|NCT00979407|75834075|FG000|COMPLETED|Overall Study||161||
59715262|NCT00979407|75834076|FG001|COMPLETED|Overall Study||160||
60116210|NCT02357758|76236867|FG002|NOT COMPLETED|Overall Study||7||
60116211|NCT02357836|76236875|FG000|STARTED|Overall Study||13||
60116212|NCT02357836|76236875|FG000|COMPLETED|Overall Study||13||
59824608|NCT00538733|75947568|FG000|Removed to Pursue a Stem Cell Transplant|Overall Study||11||
59824609|NCT00538733|75947568|FG000|Removed to Pursue Alternative Theray|Overall Study||2||
59824610|NCT00538733|75947568|FG000|COMPLETED|Overall Study||14||
59824611|NCT00538733|75947568|FG000|NOT COMPLETED|Overall Study||12||
59824612|NCT00444678|75947575|FG000|STARTED|Overall Study||36||
59824613|NCT00444678|75947575|FG000|COMPLETED|Overall Study||5||
59824614|NCT00444678|75947575|FG000|NOT COMPLETED|Overall Study||31||
59824615|NCT00358449|75947582|FG000|STARTED|Overall Study||19||
59824616|NCT00358449|75947583|FG001|STARTED|Overall Study||20||
59824617|NCT00358449|75947584|FG002|STARTED|Overall Study||20||
59824618|NCT00358449|75947582|FG000|COMPLETED|Overall Study||15||
59824619|NCT00358449|75947583|FG001|COMPLETED|Overall Study||19||
59824620|NCT00358449|75947584|FG002|COMPLETED|Overall Study||18||
59824621|NCT00358449|75947582|FG000|NOT COMPLETED|Overall Study||4||
59824622|NCT00358449|75947583|FG001|NOT COMPLETED|Overall Study||1||
59824623|NCT00358449|75947584|FG002|NOT COMPLETED|Overall Study||2||
59824624|NCT00539981|75947596|FG000|STARTED|Overall Study||2344||
59824625|NCT00539981|75947597|FG001|STARTED|Overall Study||2304||
60116213|NCT02357836|76236875|FG000|NOT COMPLETED|Overall Study||0||
60116214|NCT02359006|76236882|FG000|STARTED|Overall Study||14||
60116215|NCT02359006|76236883|FG001|STARTED|Overall Study||13||
60116216|NCT02359006|76236882|FG000|COMPLETED|Overall Study||10||
60116217|NCT02359006|76236883|FG001|COMPLETED|Overall Study||10||
60116218|NCT02359006|76236882|FG000|NOT COMPLETED|Overall Study||4||
60116219|NCT02359006|76236883|FG001|NOT COMPLETED|Overall Study||3||
60116220|NCT00068367|76236891|FG000|STARTED|Overall Study||20||
60116221|NCT00068367|76236891|FG000|COMPLETED|Overall Study||20||
60116222|NCT00068367|76236891|FG000|NOT COMPLETED|Overall Study||0||
60116223|NCT01975090|76236895|FG000|STARTED|Overall Study||129||
60116224|NCT01975090|76236895|FG000|6-month Follow-up|Overall Study||117||
60116225|NCT01975090|76236895|FG000|COMPLETED|Overall Study||117||
60116226|NCT01975090|76236895|FG000|NOT COMPLETED|Overall Study||12||
60116227|NCT01976416|76236907|FG000|STARTED|Overall Study||104||
60116228|NCT01976416|76236908|FG001|STARTED|Overall Study||104||
60116229|NCT01976416|76236907|FG000|COMPLETED|Overall Study||102||
60116230|NCT01976416|76236908|FG001|COMPLETED|Overall Study||102||
60116231|NCT01976416|76236907|FG000|NOT COMPLETED|Overall Study||2||
60116232|NCT01976416|76236908|FG001|NOT COMPLETED|Overall Study||2||
60116233|NCT02032420|76236916|FG000|STARTED|Overall Study||18||
60116234|NCT02032420|76236917|FG001|STARTED|Overall Study||17||
60116235|NCT02032420|76236916|FG000|COMPLETED|Overall Study||18||
60116236|NCT02032420|76236917|FG001|COMPLETED|Overall Study||17||
60116237|NCT02032420|76236916|FG000|NOT COMPLETED|Overall Study||0||
60116238|NCT02032420|76236917|FG001|NOT COMPLETED|Overall Study||0||
60116239|NCT01976572|76236923|FG000|STARTED|Overall Study||6||
60116240|NCT01976572|76236924|FG001|STARTED|Overall Study||6||
60116241|NCT01976572|76236925|FG002|STARTED|Overall Study||6||
60116242|NCT01976572|76236923|FG000|COMPLETED|Overall Study||6||
60116243|NCT01976572|76236924|FG001|COMPLETED|Overall Study||6||
60116244|NCT01976572|76236925|FG002|COMPLETED|Overall Study||6||
60116245|NCT01976572|76236923|FG000|NOT COMPLETED|Overall Study||0||
60116246|NCT01976572|76236924|FG001|NOT COMPLETED|Overall Study||0||
60116247|NCT01976572|76236925|FG002|NOT COMPLETED|Overall Study||0||
60116248|NCT02360488|76236936|FG000|STARTED|Overall Study||62||
60116249|NCT02360488|76236937|FG001|STARTED|Overall Study||62||
60116250|NCT02360488|76236936|FG000|COMPLETED|Overall Study||59||
59824626|NCT00539981|75947596|FG000|COMPLETED|Overall Study||2049||
59824627|NCT00539981|75947597|FG001|COMPLETED|Overall Study||2022||
59824628|NCT00539981|75947596|FG000|NOT COMPLETED|Overall Study||295||
59824629|NCT00539981|75947597|FG001|NOT COMPLETED|Overall Study||282||
59824630|NCT00367341|75947608|FG000|STARTED|Overall Study||42||
59824631|NCT00367341|75947609|FG001|STARTED|Overall Study||40||
60116251|NCT02360488|76236937|FG001|COMPLETED|Overall Study||55||
60116252|NCT02360488|76236936|FG000|NOT COMPLETED|Overall Study||3||
60116253|NCT02360488|76236937|FG001|NOT COMPLETED|Overall Study||7||
60116254|NCT01976650|76236943|FG000|STARTED|Overall Study||724||
60116255|NCT01976650|76236943|FG000|COMPLETED|Overall Study||718||
59824632|NCT00367341|75947608|FG000|COMPLETED|Overall Study||40||
59824633|NCT00367341|75947609|FG001|COMPLETED|Overall Study||40||
59824634|NCT00367341|75947608|FG000|NOT COMPLETED|Overall Study||2||
59824635|NCT00367341|75947609|FG001|NOT COMPLETED|Overall Study||0||
59824636|NCT00440466|75947618|FG000|STARTED|Overall Study||108||
59824637|NCT00440466|75947619|FG001|STARTED|Overall Study||107||
59824638|NCT00440466|75947620|FG002|STARTED|Overall Study||215||
59824639|NCT00440466|75947618|FG000|COMPLETED|Overall Study||95||
60116256|NCT01976650|76236943|FG000|NOT COMPLETED|Overall Study||6||
60116257|NCT02361736|76236949|FG000|STARTED|Overall Study||60||
60116258|NCT02361736|76236950|FG001|STARTED|Overall Study||60||
60116259|NCT02361736|76236949|FG000|COMPLETED|Overall Study||59||
60116260|NCT02361736|76236950|FG001|COMPLETED|Overall Study||59||
60116261|NCT02361736|76236949|FG000|NOT COMPLETED|Overall Study||1||
60116262|NCT02361736|76236950|FG001|NOT COMPLETED|Overall Study||1||
60116263|NCT01978600|76236958|FG000|STARTED|Overall Study||44||
60116264|NCT01978600|76236959|FG001|STARTED|Overall Study||42||
60116265|NCT01978600|76236958|FG000|COMPLETED|Overall Study||44||
60116266|NCT01978600|76236959|FG001|COMPLETED|Overall Study||42||
60116267|NCT01978600|76236958|FG000|NOT COMPLETED|Overall Study||0||
60116268|NCT01978600|76236959|FG001|NOT COMPLETED|Overall Study||0||
60116269|NCT01747499|76236970|FG000|STARTED|Overall Study||3||
60116270|NCT01747499|76236971|FG001|STARTED|Overall Study||3||
60116271|NCT01747499|76236972|FG002|STARTED|Overall Study||3||
60116272|NCT01747499|76236973|FG003|STARTED|Overall Study||6||
60116273|NCT01747499|76236974|FG004|STARTED|Overall Study||39||
60116274|NCT01747499|76236970|FG000|COMPLETED|Overall Study||2||
60116275|NCT01747499|76236971|FG001|COMPLETED|Overall Study||2||
60116276|NCT01747499|76236972|FG002|COMPLETED|Overall Study||3||
60116277|NCT01747499|76236973|FG003|COMPLETED|Overall Study||4||
60116278|NCT01747499|76236974|FG004|COMPLETED|Overall Study||24||
60116279|NCT01747499|76236970|FG000|NOT COMPLETED|Overall Study||1||
60116280|NCT01747499|76236971|FG001|NOT COMPLETED|Overall Study||1||
60116281|NCT01747499|76236972|FG002|NOT COMPLETED|Overall Study||0||
60116282|NCT01747499|76236973|FG003|NOT COMPLETED|Overall Study||2||
60116283|NCT01747499|76236974|FG004|NOT COMPLETED|Overall Study||15||
60116284|NCT00071721|76236990|FG000|STARTED|Overall Study||153||
60116285|NCT00071721|76236991|FG001|STARTED|Overall Study||160||
60116286|NCT00071721|76236990|FG000|COMPLETED|Overall Study||81||
60116287|NCT00071721|76236991|FG001|COMPLETED|Overall Study||69||
60116288|NCT00071721|76236990|FG000|NOT COMPLETED|Overall Study||72||
60116289|NCT00071721|76236991|FG001|NOT COMPLETED|Overall Study||91||
60116290|NCT03107208|76236999|FG000|STARTED|Overall Study||30||
60116291|NCT03107208|76237000|FG001|STARTED|Overall Study||27||
60116292|NCT03107208|76236999|FG000|Received Intervention|Overall Study||26||
60116293|NCT03107208|76237000|FG001|Received Intervention|Overall Study||24||
60116294|NCT03107208|76236999|FG000|COMPLETED|Overall Study||26||
60116295|NCT03107208|76237000|FG001|COMPLETED|Overall Study||24||
60116296|NCT03107208|76236999|FG000|NOT COMPLETED|Overall Study||4||
60116297|NCT03107208|76237000|FG001|NOT COMPLETED|Overall Study||3||
60116298|NCT01717391|76237006|FG000|STARTED|Overall Study||36||
60116299|NCT01717391|76237006|FG000|COMPLETED|Overall Study||27||
60116300|NCT01717391|76237006|FG000|NOT COMPLETED|Overall Study||9||
60116301|NCT02362048|76237014|FG000|STARTED|Overall Study|37 enrolled but only 35 received study medication.|37||
60116302|NCT02362048|76237015|FG001|STARTED|Overall Study|40 enrolled but only 38 received study medication.|40||
60116303|NCT02362048|76237014|FG000|Enrolled|Overall Study||37||
60116304|NCT02362048|76237015|FG001|Enrolled|Overall Study||40||
60116305|NCT02362048|76237014|FG000|Received Study Medication|Overall Study||35||
60116306|NCT02362048|76237015|FG001|Received Study Medication|Overall Study||38||
60116307|NCT02362048|76237014|FG000|Discontinued Study|Overall Study||37||
60116308|NCT02362048|76237015|FG001|Discontinued Study|Overall Study||40||
60116309|NCT02362048|76237014|FG000|COMPLETED|Overall Study||0||
60116310|NCT02362048|76237015|FG001|COMPLETED|Overall Study||0||
60116311|NCT02362048|76237014|FG000|NOT COMPLETED|Overall Study||37||
60116312|NCT02362048|76237015|FG001|NOT COMPLETED|Overall Study||40||
60116313|NCT00158223|76237023|FG000|STARTED|Overall Study||28||
60116314|NCT00158223|76237024|FG001|STARTED|Overall Study||25||
60116315|NCT00158223|76237023|FG000|COMPLETED|Overall Study||23||
60116316|NCT00158223|76237024|FG001|COMPLETED|Overall Study||22||
60116317|NCT00158223|76237023|FG000|NOT COMPLETED|Overall Study||5||
60116318|NCT00158223|76237024|FG001|NOT COMPLETED|Overall Study||3||
60116319|NCT00158379|76237030|FG000|STARTED|Overall Study||105||
60116320|NCT00158379|76237030|FG000|COMPLETED|Overall Study||105||
60116321|NCT00158379|76237030|FG000|NOT COMPLETED|Overall Study||0||
60116322|NCT02362672|76237036|FG000|STARTED|Titration Phase||1189||
60116323|NCT02362672|76237037|FG001|STARTED|Titration Phase||0||
60116324|NCT02362672|76237038|FG002|STARTED|Titration Phase||0||
60116325|NCT02362672|76237036|FG000|COMPLETED|Titration Phase||610||
60116326|NCT02362672|76237037|FG001|COMPLETED|Titration Phase||0||
60116327|NCT02362672|76237038|FG002|COMPLETED|Titration Phase||0||
60116328|NCT02362672|76237036|FG000|NOT COMPLETED|Titration Phase||579||
60116329|NCT02362672|76237037|FG001|NOT COMPLETED|Titration Phase||0||
60116330|NCT02362672|76237038|FG002|NOT COMPLETED|Titration Phase||0||
60116331|NCT02362672|76237036|FG000|STARTED|Double-blind Maintenance Phase||0||
60116332|NCT02362672|76237037|FG001|STARTED|Double-blind Maintenance Phase||309||
60116333|NCT02362672|76237038|FG002|STARTED|Double-blind Maintenance Phase||301||
59715263|NCT00979407|75834075|FG000|NOT COMPLETED|Overall Study||6||
60116334|NCT02362672|76237036|FG000|COMPLETED|Double-blind Maintenance Phase||0||
60116335|NCT02362672|76237037|FG001|COMPLETED|Double-blind Maintenance Phase||249||
60116336|NCT02362672|76237038|FG002|COMPLETED|Double-blind Maintenance Phase||242||
60116337|NCT02362672|76237036|FG000|NOT COMPLETED|Double-blind Maintenance Phase||0||
60116338|NCT02362672|76237037|FG001|NOT COMPLETED|Double-blind Maintenance Phase||60||
60116339|NCT02362672|76237038|FG002|NOT COMPLETED|Double-blind Maintenance Phase||59||
60116340|NCT00158925|76237047|FG000|STARTED|Overall Study|96 subjects were implanted or attempted with the study lead|96||
60116341|NCT00158925|76237047|FG000|COMPLETED|Overall Study||84||
60116342|NCT00158925|76237047|FG000|NOT COMPLETED|Overall Study||12||
60116343|NCT02364076|76237051|FG000|STARTED|Overall Study||45||
60116344|NCT02364076|76237051|FG000|COMPLETED|Overall Study||40||
60116345|NCT02364076|76237051|FG000|NOT COMPLETED|Overall Study||5||
60116346|NCT02364700|76237055|FG000|STARTED|Overall Study||12||
60116347|NCT02364700|76237055|FG000|COMPLETED|Overall Study||12||
60116348|NCT02364700|76237055|FG000|NOT COMPLETED|Overall Study||0||
60116349|NCT02364778|76237061|FG000|STARTED|Overall Study||30||
60116350|NCT02364778|76237061|FG000|COMPLETED|Overall Study||30||
60116351|NCT02364778|76237061|FG000|NOT COMPLETED|Overall Study||0||
60116352|NCT02365714|76237067|FG000|STARTED|Overall Study||2||
60116353|NCT02365714|76237067|FG000|COMPLETED|Overall Study||2||
60116354|NCT02365714|76237067|FG000|NOT COMPLETED|Overall Study||0||
60116355|NCT00163293|76237074|FG000|STARTED|Overall Study||79||
60116356|NCT00163293|76237075|FG001|STARTED|Overall Study||76||
60116357|NCT00163293|76237076|FG002|STARTED|Overall Study||85||
60116358|NCT00163293|76237074|FG000|COMPLETED|Overall Study||66||
59824640|NCT00440466|75947619|FG001|COMPLETED|Overall Study||92||
59824641|NCT00440466|75947620|FG002|COMPLETED|Overall Study||174||
59824642|NCT00440466|75947618|FG000|NOT COMPLETED|Overall Study||13||
59824643|NCT00440466|75947619|FG001|NOT COMPLETED|Overall Study||15||
59824644|NCT00440466|75947620|FG002|NOT COMPLETED|Overall Study||41||
59824645|NCT00537485|75947630|FG000|STARTED|Overall Study||90||
59824646|NCT00537485|75947631|FG001|STARTED|Overall Study||90||
59824647|NCT00537485|75947630|FG000|COMPLETED|Overall Study||75||
59824648|NCT00537485|75947631|FG001|COMPLETED|Overall Study||80||
59824649|NCT00537485|75947630|FG000|NOT COMPLETED|Overall Study||15||
59824650|NCT00537485|75947631|FG001|NOT COMPLETED|Overall Study||10||
59824651|NCT00616967|75947639|FG000|STARTED|Overall Study||6||
59824652|NCT00616967|75947640|FG001|STARTED|Overall Study||31||
60116359|NCT00163293|76237075|FG001|COMPLETED|Overall Study||69||
60116360|NCT00163293|76237076|FG002|COMPLETED|Overall Study||66||
60116361|NCT00163293|76237074|FG000|NOT COMPLETED|Overall Study||13||
60116362|NCT00163293|76237075|FG001|NOT COMPLETED|Overall Study||7||
60116363|NCT00163293|76237076|FG002|NOT COMPLETED|Overall Study||19||
60116364|NCT02033200|76237086|FG000|STARTED|Overall Study||40||
60116365|NCT02033200|76237087|FG001|STARTED|Overall Study||40||
60116366|NCT02033200|76237086|FG000|COMPLETED|Overall Study||40||
60116367|NCT02033200|76237087|FG001|COMPLETED|Overall Study||40||
60116368|NCT02033200|76237086|FG000|NOT COMPLETED|Overall Study||0||
60116369|NCT02033200|76237087|FG001|NOT COMPLETED|Overall Study||0||
60116370|NCT00076245|76237097|FG000|STARTED|Overall Study||16||
60116371|NCT00076245|76237098|FG001|STARTED|Overall Study||15||
60116372|NCT00076245|76237099|FG002|STARTED|Overall Study||15||
60116373|NCT00076245|76237100|FG003|STARTED|Overall Study||15||
60116374|NCT00076245|76237097|FG000|COMPLETED|Overall Study||16||
60116375|NCT00076245|76237098|FG001|COMPLETED|Overall Study||15||
60116376|NCT00076245|76237099|FG002|COMPLETED|Overall Study||15||
60116377|NCT00076245|76237100|FG003|COMPLETED|Overall Study||14||
60116378|NCT00076245|76237097|FG000|NOT COMPLETED|Overall Study||0||
60116379|NCT00076245|76237098|FG001|NOT COMPLETED|Overall Study||0||
60116380|NCT00076245|76237099|FG002|NOT COMPLETED|Overall Study||0||
60116381|NCT00076245|76237100|FG003|NOT COMPLETED|Overall Study||1||
60116382|NCT02365870|76237112|FG000|STARTED|Overall Study||1||
60116383|NCT02365870|76237113|FG001|STARTED|Overall Study||3||
60116384|NCT02365870|76237112|FG000|COMPLETED|Overall Study||1||
60116385|NCT02365870|76237113|FG001|COMPLETED|Overall Study||3||
59567287|NCT01507233|75670180|FG001|COMPLETED|Overall Study||0||
59715264|NCT00979407|75834076|FG001|NOT COMPLETED|Overall Study||7||
59715265|NCT01148862|75834084|FG000|STARTED|First Intervention||25||
59715266|NCT01148862|75834085|FG001|STARTED|First Intervention||25||
59715267|NCT01148862|75834084|FG000|COMPLETED|First Intervention||25||
59715268|NCT01148862|75834085|FG001|COMPLETED|First Intervention||25||
59715269|NCT01148862|75834084|FG000|NOT COMPLETED|First Intervention||0||
59715270|NCT01148862|75834085|FG001|NOT COMPLETED|First Intervention||0||
59715271|NCT01148862|75834084|FG000|STARTED|Washout Period of 2 Weeks||25||
59715272|NCT01148862|75834085|FG001|STARTED|Washout Period of 2 Weeks||25||
59715273|NCT01148862|75834084|FG000|COMPLETED|Washout Period of 2 Weeks||25||
59715274|NCT01148862|75834085|FG001|COMPLETED|Washout Period of 2 Weeks||25||
59715275|NCT01148862|75834084|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0||
59824653|NCT00616967|75947641|FG002|STARTED|Overall Study||31||
59824654|NCT00616967|75947639|FG000|COMPLETED|Overall Study||6||
59824655|NCT00616967|75947640|FG001|COMPLETED|Overall Study||31||
59824656|NCT00616967|75947641|FG002|COMPLETED|Overall Study||30||
59824657|NCT00616967|75947639|FG000|NOT COMPLETED|Overall Study||0||
59824658|NCT00616967|75947640|FG001|NOT COMPLETED|Overall Study||0||
59824659|NCT00616967|75947641|FG002|NOT COMPLETED|Overall Study||1||
59824660|NCT00537329|75947659|FG000|STARTED|Overall Study||43||
59824661|NCT00537329|75947659|FG000|COMPLETED|Overall Study||17||
60116386|NCT02365870|76237112|FG000|NOT COMPLETED|Overall Study||0||
60116387|NCT02365870|76237113|FG001|NOT COMPLETED|Overall Study||0||
60116388|NCT01981564|76237121|FG000|STARTED|Overall Study||107||
60116389|NCT01981564|76237122|FG001|STARTED|Overall Study||115||
60116390|NCT01981564|76237121|FG000|COMPLETED|Overall Study||98||
60116391|NCT01981564|76237122|FG001|COMPLETED|Overall Study||106||
60116392|NCT01981564|76237121|FG000|NOT COMPLETED|Overall Study||9||
60116393|NCT01981564|76237122|FG001|NOT COMPLETED|Overall Study||9||
60116394|NCT00078897|76237131|FG000|STARTED|Overall Study||809||
60116395|NCT00078897|76237132|FG001|STARTED|Overall Study||812||
60116396|NCT00078897|76237131|FG000|COMPLETED|Overall Study||685||
60116397|NCT00078897|76237132|FG001|COMPLETED|Overall Study||689||
60116398|NCT00078897|76237131|FG000|NOT COMPLETED|Overall Study||124||
60116399|NCT00078897|76237132|FG001|NOT COMPLETED|Overall Study||123||
60116400|NCT01746017|76237149|FG000|STARTED|Period 1||2||
60116401|NCT01746017|76237150|FG001|STARTED|Period 1||2||
60116402|NCT01746017|76237151|FG002|STARTED|Period 1||2||
60116403|NCT01746017|76237152|FG003|STARTED|Period 1||2||
60116404|NCT01746017|76237153|FG004|STARTED|Period 1||2||
60116405|NCT01746017|76237154|FG005|STARTED|Period 1||2||
60116406|NCT01746017|76237155|FG006|STARTED|Period 1||3||
60116407|NCT01746017|76237156|FG007|STARTED|Period 1||2||
60116408|NCT01746017|76237157|FG008|STARTED|Period 1||3||
60116409|NCT01746017|76237158|FG009|STARTED|Period 1||3||
60116410|NCT01746017|76237159|FG010|STARTED|Period 1||3||
60116411|NCT01746017|76237149|FG000|Received at Least 1 Dose of Study Drug|Period 1||2||
60116412|NCT01746017|76237150|FG001|Received at Least 1 Dose of Study Drug|Period 1||2||
60116413|NCT01746017|76237151|FG002|Received at Least 1 Dose of Study Drug|Period 1||2||
60116414|NCT01746017|76237152|FG003|Received at Least 1 Dose of Study Drug|Period 1||2||
60116415|NCT01746017|76237153|FG004|Received at Least 1 Dose of Study Drug|Period 1||2||
60116416|NCT01746017|76237154|FG005|Received at Least 1 Dose of Study Drug|Period 1||2||
60116417|NCT01746017|76237155|FG006|Received at Least 1 Dose of Study Drug|Period 1||3||
60116418|NCT01746017|76237156|FG007|Received at Least 1 Dose of Study Drug|Period 1||2||
60116419|NCT01746017|76237157|FG008|Received at Least 1 Dose of Study Drug|Period 1||3||
60116420|NCT01746017|76237158|FG009|Received at Least 1 Dose of Study Drug|Period 1||3||
60116421|NCT01746017|76237159|FG010|Received at Least 1 Dose of Study Drug|Period 1||3||
60116422|NCT01746017|76237149|FG000|COMPLETED|Period 1||2||
60116423|NCT01746017|76237150|FG001|COMPLETED|Period 1||2||
60116424|NCT01746017|76237151|FG002|COMPLETED|Period 1||2||
60116425|NCT01746017|76237152|FG003|COMPLETED|Period 1||2||
60116426|NCT01746017|76237153|FG004|COMPLETED|Period 1||2||
60116427|NCT01746017|76237154|FG005|COMPLETED|Period 1||2||
60116428|NCT01746017|76237155|FG006|COMPLETED|Period 1||2||
60116429|NCT01746017|76237156|FG007|COMPLETED|Period 1||2||
60116430|NCT01746017|76237157|FG008|COMPLETED|Period 1||3||
60116431|NCT01746017|76237158|FG009|COMPLETED|Period 1||3||
60116432|NCT01746017|76237159|FG010|COMPLETED|Period 1||3||
60116433|NCT01746017|76237149|FG000|NOT COMPLETED|Period 1||0||
60116434|NCT01746017|76237150|FG001|NOT COMPLETED|Period 1||0||
60116435|NCT01746017|76237151|FG002|NOT COMPLETED|Period 1||0||
60116436|NCT01746017|76237152|FG003|NOT COMPLETED|Period 1||0||
60116437|NCT01746017|76237153|FG004|NOT COMPLETED|Period 1||0||
60116438|NCT01746017|76237154|FG005|NOT COMPLETED|Period 1||0||
60116439|NCT01746017|76237155|FG006|NOT COMPLETED|Period 1||1||
60116440|NCT01746017|76237156|FG007|NOT COMPLETED|Period 1||0||
60116441|NCT01746017|76237157|FG008|NOT COMPLETED|Period 1||0||
60116442|NCT01746017|76237158|FG009|NOT COMPLETED|Period 1||0||
60116443|NCT01746017|76237159|FG010|NOT COMPLETED|Period 1||0||
60116444|NCT01746017|76237149|FG000|STARTED|Period 2||2||
60116445|NCT01746017|76237150|FG001|STARTED|Period 2||2||
60116446|NCT01746017|76237151|FG002|STARTED|Period 2||2||
60116447|NCT01746017|76237152|FG003|STARTED|Period 2||2||
60116448|NCT01746017|76237153|FG004|STARTED|Period 2||2||
60116449|NCT01746017|76237154|FG005|STARTED|Period 2||2||
60116450|NCT01746017|76237155|FG006|STARTED|Period 2||2||
60116451|NCT01746017|76237156|FG007|STARTED|Period 2||2||
60116452|NCT01746017|76237157|FG008|STARTED|Period 2||3||
60116453|NCT01746017|76237158|FG009|STARTED|Period 2||3||
60116454|NCT01746017|76237159|FG010|STARTED|Period 2||3||
60116455|NCT01746017|76237149|FG000|COMPLETED|Period 2||2||
60116456|NCT01746017|76237150|FG001|COMPLETED|Period 2||2||
60116457|NCT01746017|76237151|FG002|COMPLETED|Period 2||2||
60116458|NCT01746017|76237152|FG003|COMPLETED|Period 2||2||
60116459|NCT01746017|76237153|FG004|COMPLETED|Period 2||2||
60116460|NCT01746017|76237154|FG005|COMPLETED|Period 2||2||
60116461|NCT01746017|76237155|FG006|COMPLETED|Period 2||2||
60116462|NCT01746017|76237156|FG007|COMPLETED|Period 2||2||
60116463|NCT01746017|76237157|FG008|COMPLETED|Period 2||3||
60116464|NCT01746017|76237158|FG009|COMPLETED|Period 2||3||
60116465|NCT01746017|76237159|FG010|COMPLETED|Period 2||3||
60116466|NCT01746017|76237149|FG000|NOT COMPLETED|Period 2||0||
60116467|NCT01746017|76237150|FG001|NOT COMPLETED|Period 2||0||
60116468|NCT01746017|76237151|FG002|NOT COMPLETED|Period 2||0||
60116469|NCT01746017|76237152|FG003|NOT COMPLETED|Period 2||0||
60116470|NCT01746017|76237153|FG004|NOT COMPLETED|Period 2||0||
60116471|NCT01746017|76237154|FG005|NOT COMPLETED|Period 2||0||
60116472|NCT01746017|76237155|FG006|NOT COMPLETED|Period 2||0||
60116473|NCT01746017|76237156|FG007|NOT COMPLETED|Period 2||0||
60116474|NCT01746017|76237157|FG008|NOT COMPLETED|Period 2||0||
60116475|NCT01746017|76237158|FG009|NOT COMPLETED|Period 2||0||
60116476|NCT01746017|76237159|FG010|NOT COMPLETED|Period 2||0||
60116477|NCT01746017|76237149|FG000|STARTED|Period 3||2||
60116478|NCT01746017|76237150|FG001|STARTED|Period 3||2||
60116479|NCT01746017|76237151|FG002|STARTED|Period 3||2||
60116480|NCT01746017|76237152|FG003|STARTED|Period 3||2||
60116481|NCT01746017|76237153|FG004|STARTED|Period 3||2||
60116482|NCT01746017|76237154|FG005|STARTED|Period 3||2||
60116483|NCT01746017|76237155|FG006|STARTED|Period 3||2||
60116484|NCT01746017|76237156|FG007|STARTED|Period 3||2||
59567288|NCT01507233|75670179|FG000|NOT COMPLETED|Overall Study||0||
59824662|NCT00537329|75947659|FG000|NOT COMPLETED|Overall Study||26||
59824663|NCT03897179|75947663|FG000|STARTED|Overall Study||27||
59824664|NCT03897179|75947663|FG000|COMPLETED|Overall Study||26||
60116485|NCT01746017|76237157|FG008|STARTED|Period 3||3||
60116486|NCT01746017|76237158|FG009|STARTED|Period 3||3||
60116487|NCT01746017|76237159|FG010|STARTED|Period 3||3||
59567289|NCT01507233|75670180|FG001|NOT COMPLETED|Overall Study||0||
59824665|NCT03897179|75947663|FG000|NOT COMPLETED|Overall Study||1||
59824666|NCT03905135|75947669|FG000|STARTED|Dose Escalation||6||
60116488|NCT01746017|76237149|FG000|COMPLETED|Period 3||2||
60116489|NCT01746017|76237150|FG001|COMPLETED|Period 3||2||
60116490|NCT01746017|76237151|FG002|COMPLETED|Period 3||2||
60116491|NCT01746017|76237152|FG003|COMPLETED|Period 3||2||
60116492|NCT01746017|76237153|FG004|COMPLETED|Period 3||2||
60116493|NCT01746017|76237154|FG005|COMPLETED|Period 3||1||
60116494|NCT01746017|76237155|FG006|COMPLETED|Period 3||2||
60116495|NCT01746017|76237156|FG007|COMPLETED|Period 3||2||
60116496|NCT01746017|76237157|FG008|COMPLETED|Period 3||3||
60116497|NCT01746017|76237158|FG009|COMPLETED|Period 3||3||
60116498|NCT01746017|76237159|FG010|COMPLETED|Period 3||3||
60116499|NCT01746017|76237149|FG000|NOT COMPLETED|Period 3||0||
60116500|NCT01746017|76237150|FG001|NOT COMPLETED|Period 3||0||
59824667|NCT03905135|75947670|FG001|STARTED|Dose Escalation||2||
59824668|NCT03905135|75947669|FG000|COMPLETED|Dose Escalation||1||
59824669|NCT03905135|75947670|FG001|COMPLETED|Dose Escalation||0||
59824670|NCT03905135|75947669|FG000|NOT COMPLETED|Dose Escalation||5||
59824671|NCT03905135|75947670|FG001|NOT COMPLETED|Dose Escalation||2||
59824672|NCT03905135|75947669|FG000|STARTED|Dose Expansion||0||
59824673|NCT03905135|75947670|FG001|STARTED|Dose Expansion||0||
59824674|NCT03905135|75947669|FG000|COMPLETED|Dose Expansion||0||
59824675|NCT03905135|75947670|FG001|COMPLETED|Dose Expansion||0||
60116501|NCT01746017|76237151|FG002|NOT COMPLETED|Period 3||0||
60116502|NCT01746017|76237152|FG003|NOT COMPLETED|Period 3||0||
60116503|NCT01746017|76237153|FG004|NOT COMPLETED|Period 3||0||
60116504|NCT01746017|76237154|FG005|NOT COMPLETED|Period 3||1||
60116505|NCT01746017|76237155|FG006|NOT COMPLETED|Period 3||0||
60116506|NCT01746017|76237156|FG007|NOT COMPLETED|Period 3||0||
60116507|NCT01746017|76237157|FG008|NOT COMPLETED|Period 3||0||
60116508|NCT01746017|76237158|FG009|NOT COMPLETED|Period 3||0||
60116509|NCT01746017|76237159|FG010|NOT COMPLETED|Period 3||0||
60116510|NCT01746017|76237149|FG000|STARTED|Period 4||2||
60116511|NCT01746017|76237150|FG001|STARTED|Period 4||2||
60116512|NCT01746017|76237151|FG002|STARTED|Period 4||2||
60116513|NCT01746017|76237152|FG003|STARTED|Period 4||2||
60116514|NCT01746017|76237153|FG004|STARTED|Period 4||2||
60116515|NCT01746017|76237154|FG005|STARTED|Period 4||1||
60116516|NCT01746017|76237155|FG006|STARTED|Period 4||2||
60116517|NCT01746017|76237156|FG007|STARTED|Period 4||2||
60116518|NCT01746017|76237157|FG008|STARTED|Period 4|Part B occurred only for 3 periods.|0||
60116519|NCT01746017|76237158|FG009|STARTED|Period 4|Part B occurred only for 3 periods.|0||
60116520|NCT01746017|76237159|FG010|STARTED|Period 4|Part B occurred only for 3 periods.|0||
59824676|NCT03905135|75947669|FG000|NOT COMPLETED|Dose Expansion||0||
59824677|NCT03905135|75947670|FG001|NOT COMPLETED|Dose Expansion||0||
59824678|NCT00357903|75947680|FG000|STARTED|Overall Study||581||
59824679|NCT00357903|75947681|FG001|STARTED|Overall Study||58||
59824680|NCT00357903|75947680|FG000|COMPLETED|Overall Study||218||
59824681|NCT00357903|75947681|FG001|COMPLETED|Overall Study||15||
59824682|NCT00357903|75947680|FG000|NOT COMPLETED|Overall Study||363||
59824683|NCT00357903|75947681|FG001|NOT COMPLETED|Overall Study||43||
59824684|NCT00348933|75947688|FG000|STARTED|Overall Study||90||
59824685|NCT00348933|75947688|FG000|COMPLETED|Overall Study||65||
59824686|NCT00348933|75947688|FG000|NOT COMPLETED|Overall Study||25||
59824687|NCT03896477|75947696|FG000|STARTED|Overall Study||220||
59824688|NCT03896477|75947697|FG001|STARTED|Overall Study||220||
60116521|NCT01746017|76237149|FG000|COMPLETED|Period 4||2||
60116522|NCT01746017|76237150|FG001|COMPLETED|Period 4||2||
60116523|NCT01746017|76237151|FG002|COMPLETED|Period 4||2||
60116524|NCT01746017|76237152|FG003|COMPLETED|Period 4||2||
60116525|NCT01746017|76237153|FG004|COMPLETED|Period 4||2||
60116526|NCT01746017|76237154|FG005|COMPLETED|Period 4||1||
60116527|NCT01746017|76237155|FG006|COMPLETED|Period 4||2||
60116528|NCT01746017|76237156|FG007|COMPLETED|Period 4||2||
60116529|NCT01746017|76237157|FG008|COMPLETED|Period 4||0||
60116530|NCT01746017|76237158|FG009|COMPLETED|Period 4||0||
60116531|NCT01746017|76237159|FG010|COMPLETED|Period 4||0||
60116532|NCT01746017|76237149|FG000|NOT COMPLETED|Period 4||0||
60116533|NCT01746017|76237150|FG001|NOT COMPLETED|Period 4||0||
60116534|NCT01746017|76237151|FG002|NOT COMPLETED|Period 4||0||
60116535|NCT01746017|76237152|FG003|NOT COMPLETED|Period 4||0||
60116536|NCT01746017|76237153|FG004|NOT COMPLETED|Period 4||0||
60116537|NCT01746017|76237154|FG005|NOT COMPLETED|Period 4||0||
60116538|NCT01746017|76237155|FG006|NOT COMPLETED|Period 4||0||
60116539|NCT01746017|76237156|FG007|NOT COMPLETED|Period 4||0||
60116540|NCT01746017|76237157|FG008|NOT COMPLETED|Period 4||0||
60116541|NCT01746017|76237158|FG009|NOT COMPLETED|Period 4||0||
60116542|NCT01746017|76237159|FG010|NOT COMPLETED|Period 4||0||
60116543|NCT02366338|76237201|FG000|STARTED|Overall Study||73||
60116544|NCT02366338|76237202|FG001|STARTED|Overall Study||39||
60116545|NCT02366338|76237203|FG002|STARTED|Overall Study||36||
60116546|NCT02366338|76237201|FG000|COMPLETED|Overall Study||73||
60116547|NCT02366338|76237202|FG001|COMPLETED|Overall Study||39||
60116548|NCT02366338|76237203|FG002|COMPLETED|Overall Study||36||
60116549|NCT02366338|76237201|FG000|NOT COMPLETED|Overall Study||0||
60116550|NCT02366338|76237202|FG001|NOT COMPLETED|Overall Study||0||
60116551|NCT02366338|76237203|FG002|NOT COMPLETED|Overall Study||0||
60116552|NCT02091531|76237211|FG000|STARTED|Overall Study||9||
60116553|NCT02091531|76237211|FG000|COMPLETED|Overall Study||9||
60116554|NCT02091531|76237211|FG000|NOT COMPLETED|Overall Study||0||
60116555|NCT02367430|76237215|FG000|STARTED|Overall Study||14||
60116556|NCT02367430|76237215|FG000|COMPLETED|Overall Study||11||
60116557|NCT02367430|76237215|FG000|NOT COMPLETED|Overall Study||3||
60116558|NCT01717313|76237221|FG000|STARTED|Phase A (Weeks 0 to 24)||165||
59824689|NCT03896477|75947698|FG002|STARTED|Overall Study||220||
59824690|NCT03896477|75947696|FG000|Received First Vaccination|Overall Study||220||
59824691|NCT03896477|75947697|FG001|Received First Vaccination|Overall Study||220||
59824692|NCT03896477|75947698|FG002|Received First Vaccination|Overall Study||220||
59824693|NCT03896477|75947696|FG000|Received Second Vaccination|Overall Study||217||
59824694|NCT03896477|75947697|FG001|Received Second Vaccination|Overall Study||213||
59824695|NCT03896477|75947698|FG002|Received Second Vaccination|Overall Study||213||
59824696|NCT03896477|75947696|FG000|Received Booster Vaccination|Overall Study||208||
59824697|NCT03896477|75947697|FG001|Received Booster Vaccination|Overall Study||206||
59824698|NCT03896477|75947698|FG002|Received Booster Vaccination|Overall Study||206||
59824699|NCT03896477|75947696|FG000|COMPLETED|Overall Study||203||
59824700|NCT03896477|75947697|FG001|COMPLETED|Overall Study||200||
59824701|NCT03896477|75947698|FG002|COMPLETED|Overall Study||200||
59824702|NCT03896477|75947696|FG000|NOT COMPLETED|Overall Study||17||
59824703|NCT03896477|75947697|FG001|NOT COMPLETED|Overall Study||20||
59824704|NCT03896477|75947698|FG002|NOT COMPLETED|Overall Study||20||
59824705|NCT00444600|75947713|FG000|STARTED|Overall Study|Number of eyes|293||
59824706|NCT00444600|75947714|FG001|STARTED|Overall Study|Number of eyes|187||
59824707|NCT00444600|75947715|FG002|STARTED|Overall Study|Number of eyes|188||
59824708|NCT00444600|75947716|FG003|STARTED|Overall Study|Number of eyes|186||
59824709|NCT00444600|75947713|FG000|COMPLETED|Overall Study|Number of eyes|274||
59824710|NCT00444600|75947714|FG001|COMPLETED|Overall Study|Number of eyes|171||
59824711|NCT00444600|75947715|FG002|COMPLETED|Overall Study|Number of eyes|178||
59824712|NCT00444600|75947716|FG003|COMPLETED|Overall Study|Number of eyes|176||
59824713|NCT00444600|75947713|FG000|NOT COMPLETED|Overall Study||19||
59824714|NCT00444600|75947714|FG001|NOT COMPLETED|Overall Study||16||
59824715|NCT00444600|75947715|FG002|NOT COMPLETED|Overall Study||10||
59824716|NCT00444600|75947716|FG003|NOT COMPLETED|Overall Study||10||
59824717|NCT00537095|75947734|FG000|STARTED|Overall Study||72||
59824718|NCT00537095|75947735|FG001|STARTED|Overall Study||73||
59824719|NCT00537095|75947734|FG000|COMPLETED|Overall Study||21||
59824720|NCT00537095|75947735|FG001|COMPLETED|Overall Study||16||
59824721|NCT00537095|75947734|FG000|NOT COMPLETED|Overall Study||51||
59824722|NCT00537095|75947735|FG001|NOT COMPLETED|Overall Study||57||
59824723|NCT00443898|75947745|FG000|STARTED|Overall Study||126||
59824724|NCT00443898|75947746|FG001|STARTED|Overall Study||128||
59824725|NCT00443898|75947747|FG002|STARTED|Overall Study||136||
59824726|NCT00443898|75947748|FG003|STARTED|Overall Study||128||
59824727|NCT00443898|75947745|FG000|COMPLETED|Overall Study||102||
59824728|NCT00443898|75947746|FG001|COMPLETED|Overall Study||103||
59824729|NCT00443898|75947747|FG002|COMPLETED|Overall Study||107||
59824730|NCT00443898|75947748|FG003|COMPLETED|Overall Study||110||
59824731|NCT00443898|75947745|FG000|NOT COMPLETED|Overall Study||24||
59824732|NCT00443898|75947746|FG001|NOT COMPLETED|Overall Study||25||
59824733|NCT00443898|75947747|FG002|NOT COMPLETED|Overall Study||29||
59824734|NCT00443898|75947748|FG003|NOT COMPLETED|Overall Study||18||
59824735|NCT00537017|75947758|FG000|STARTED|Treatment Phase||140||
59824736|NCT00537017|75947758|FG000|COMPLETED|Treatment Phase||106||
59824737|NCT00537017|75947758|FG000|NOT COMPLETED|Treatment Phase||34||
59824738|NCT00537017|75947758|FG000|STARTED|Follow-up Phase|All TP participants were eligible for FUP entry. 5 participants completing TP did not enter FUP.|135||
59824739|NCT00537017|75947758|FG000|COMPLETED|Follow-up Phase||126||
59824740|NCT00537017|75947758|FG000|NOT COMPLETED|Follow-up Phase||9||
59824741|NCT00348309|75947765|FG000|STARTED|Overall Study||496||
59824742|NCT00348309|75947766|FG001|STARTED|Overall Study||494||
59824743|NCT00348309|75947767|FG002|STARTED|Overall Study||489||
59824744|NCT00348309|75947765|FG000|COMPLETED|Overall Study||362||
59824745|NCT00348309|75947766|FG001|COMPLETED|Overall Study||396||
59567290|NCT01517763|75670189|FG000|STARTED|Overall Study||0||
59567291|NCT01517763|75670190|FG001|STARTED|Overall Study||0||
59824746|NCT00348309|75947767|FG002|COMPLETED|Overall Study||346||
59824747|NCT00348309|75947765|FG000|NOT COMPLETED|Overall Study||134||
59824748|NCT00348309|75947766|FG001|NOT COMPLETED|Overall Study||98||
59824749|NCT00348309|75947767|FG002|NOT COMPLETED|Overall Study||143||
59824750|NCT00440310|75947778|FG000|STARTED|Overall Study||244||
59824751|NCT00440310|75947779|FG001|STARTED|Overall Study||239||
59824752|NCT00440310|75947778|FG000|Treated|Overall Study||222||
60116559|NCT01717313|76237222|FG001|STARTED|Phase A (Weeks 0 to 24)||164||
60116560|NCT01717313|76237221|FG000|COMPLETED|Phase A (Weeks 0 to 24)||147||
59567292|NCT01517763|75670191|FG002|STARTED|Overall Study||0||
59567293|NCT01517763|75670189|FG000|COMPLETED|Overall Study||0||
59824753|NCT00440310|75947779|FG001|Treated|Overall Study||232||
59824754|NCT00440310|75947778|FG000|COMPLETED|Overall Study||216||
59824755|NCT00440310|75947779|FG001|COMPLETED|Overall Study||209||
59824756|NCT00440310|75947778|FG000|NOT COMPLETED|Overall Study||28||
59824757|NCT00440310|75947779|FG001|NOT COMPLETED|Overall Study||30||
59824758|NCT00440232|75947787|FG000|STARTED|Overall Study||36||
59824759|NCT00440232|75947788|FG001|STARTED|Overall Study||38||
59824760|NCT00440232|75947787|FG000|COMPLETED|Overall Study||33||
60116561|NCT01717313|76237222|FG001|COMPLETED|Phase A (Weeks 0 to 24)||151||
60116562|NCT01717313|76237221|FG000|NOT COMPLETED|Phase A (Weeks 0 to 24)||18||
60116563|NCT01717313|76237222|FG001|NOT COMPLETED|Phase A (Weeks 0 to 24)||13||
60116564|NCT01717313|76237221|FG000|STARTED|Interphase||147||
60116565|NCT01717313|76237222|FG001|STARTED|Interphase||151||
60116566|NCT01717313|76237221|FG000|COMPLETED|Interphase||146||
60116567|NCT01717313|76237222|FG001|COMPLETED|Interphase||151||
60116568|NCT01717313|76237221|FG000|NOT COMPLETED|Interphase||1||
60116569|NCT01717313|76237222|FG001|NOT COMPLETED|Interphase||0||
60116570|NCT01717313|76237221|FG000|STARTED|Phase B (Weeks 24 to 54)||146||
60116571|NCT01717313|76237222|FG001|STARTED|Phase B (Weeks 24 to 54)||151||
60116572|NCT01717313|76237221|FG000|COMPLETED|Phase B (Weeks 24 to 54)||134||
60116573|NCT01717313|76237222|FG001|COMPLETED|Phase B (Weeks 24 to 54)||135||
60116574|NCT01717313|76237221|FG000|NOT COMPLETED|Phase B (Weeks 24 to 54)||12||
60116575|NCT01717313|76237222|FG001|NOT COMPLETED|Phase B (Weeks 24 to 54)||16||
60116576|NCT00080535|76237228|FG000|STARTED|Overall Study||10||
60116577|NCT00080535|76237228|FG000|COMPLETED|Overall Study||10||
60116578|NCT00080535|76237228|FG000|NOT COMPLETED|Overall Study||0||
60116579|NCT01745393|76237234|FG000|STARTED|Treatment to End-of-treatment Assessment||163||
60116580|NCT01745393|76237235|FG001|STARTED|Treatment to End-of-treatment Assessment||164||
60116581|NCT01745393|76237234|FG000|Received Treatment|Treatment to End-of-treatment Assessment|Behavioral counseling = TSE-reduction and cessation counseling via telephone|147||
60116582|NCT01745393|76237235|FG001|Received Treatment|Treatment to End-of-treatment Assessment|Attention control = nutrition education via telephone|144||
60116583|NCT01745393|76237234|FG000|COMPLETED|Treatment to End-of-treatment Assessment||142|completed end-of-treatment assessments|
60116584|NCT01745393|76237235|FG001|COMPLETED|Treatment to End-of-treatment Assessment||156|completed end-of-treatment assessments|
60116585|NCT01745393|76237234|FG000|NOT COMPLETED|Treatment to End-of-treatment Assessment||21||
60116586|NCT01745393|76237235|FG001|NOT COMPLETED|Treatment to End-of-treatment Assessment||8||
60116587|NCT01745393|76237234|FG000|STARTED|12-month Follow-up||142||
60116588|NCT01745393|76237235|FG001|STARTED|12-month Follow-up||156||
60116589|NCT01745393|76237234|FG000|COMPLETED|12-month Follow-up||136||
60116590|NCT01745393|76237235|FG001|COMPLETED|12-month Follow-up||151||
60116591|NCT01745393|76237234|FG000|NOT COMPLETED|12-month Follow-up||6||
60116592|NCT01745393|76237235|FG001|NOT COMPLETED|12-month Follow-up||5||
60116593|NCT00081861|76237241|FG000|STARTED|Overall Study||13||
60116594|NCT00081861|76237241|FG000|COMPLETED|Overall Study||13||
60116595|NCT00081861|76237241|FG000|NOT COMPLETED|Overall Study||0||
60116596|NCT02367820|76237249|FG000|STARTED|Overall Study||638||
60116597|NCT02367820|76237249|FG000|COMPLETED|Overall Study||402||
60116598|NCT02367820|76237249|FG000|NOT COMPLETED|Overall Study||236||
60116599|NCT02036320|76237259|FG000|STARTED|Period 1||95||
60116600|NCT02036320|76237260|FG001|STARTED|Period 1||95||
60116601|NCT02036320|76237259|FG000|COMPLETED|Period 1||95||
60116602|NCT02036320|76237260|FG001|COMPLETED|Period 1||95||
60116603|NCT02036320|76237259|FG000|NOT COMPLETED|Period 1||0||
60116604|NCT02036320|76237260|FG001|NOT COMPLETED|Period 1||0||
60116605|NCT02036320|76237259|FG000|STARTED|Period 2||95||
60116606|NCT02036320|76237260|FG001|STARTED|Period 2||95||
60116607|NCT02036320|76237259|FG000|COMPLETED|Period 2||95||
60116608|NCT02036320|76237260|FG001|COMPLETED|Period 2||95||
60116609|NCT02036320|76237259|FG000|NOT COMPLETED|Period 2||0||
60116610|NCT02036320|76237260|FG001|NOT COMPLETED|Period 2||0||
60116611|NCT01744691|76237266|FG000|STARTED|Overall Study|Participants who received study treatment|144||
60116612|NCT01744691|76237266|FG000|COMPLETED|Overall Study|Participants who were on study treatment at the time of the primary analysis|101||
60116613|NCT01744691|76237266|FG000|NOT COMPLETED|Overall Study||43||
60116614|NCT01982968|76237273|FG000|STARTED|Overall Study||29||
60116615|NCT01982968|76237274|FG001|STARTED|Overall Study||29||
60116616|NCT01982968|76237273|FG000|COMPLETED|Overall Study||21||
60116617|NCT01982968|76237274|FG001|COMPLETED|Overall Study||27||
60116618|NCT01982968|76237273|FG000|NOT COMPLETED|Overall Study||8||
60116619|NCT01982968|76237274|FG001|NOT COMPLETED|Overall Study||2||
60116620|NCT02038894|76237283|FG000|STARTED|Overall Study||60||
60116621|NCT02038894|76237284|FG001|STARTED|Overall Study||58||
60116622|NCT02038894|76237285|FG002|STARTED|Overall Study||61||
60116623|NCT02038894|76237283|FG000|COMPLETED|Overall Study||60||
60116624|NCT02038894|76237284|FG001|COMPLETED|Overall Study||58||
60116625|NCT02038894|76237285|FG002|COMPLETED|Overall Study||61||
60116626|NCT02038894|76237283|FG000|NOT COMPLETED|Overall Study||0||
60116627|NCT02038894|76237284|FG001|NOT COMPLETED|Overall Study||0||
60116628|NCT02038894|76237285|FG002|NOT COMPLETED|Overall Study||0||
60116629|NCT01716533|76237301|FG000|STARTED|Overall Study||7||
60116630|NCT01716533|76237302|FG001|STARTED|Overall Study||25||
60116631|NCT01716533|76237303|FG002|STARTED|Overall Study||5||
60116632|NCT01716533|76237304|FG003|STARTED|Overall Study||9||
60116633|NCT01716533|76237301|FG000|COMPLETED|Overall Study||7||
60116634|NCT01716533|76237302|FG001|COMPLETED|Overall Study||25||
60116635|NCT01716533|76237303|FG002|COMPLETED|Overall Study||0||
60116636|NCT01716533|76237304|FG003|COMPLETED|Overall Study||1||
60116637|NCT01716533|76237301|FG000|NOT COMPLETED|Overall Study||0||
60116638|NCT01716533|76237302|FG001|NOT COMPLETED|Overall Study||0||
60116639|NCT01716533|76237303|FG002|NOT COMPLETED|Overall Study||5||
60116640|NCT01716533|76237304|FG003|NOT COMPLETED|Overall Study||8||
60116641|NCT01375374|76237318|FG000|STARTED|Overall Study||11||
60116642|NCT01375374|76237318|FG000|COMPLETED|Overall Study||10||
60116643|NCT01375374|76237318|FG000|NOT COMPLETED|Overall Study||1||
60116644|NCT02369068|76237324|FG000|STARTED|1 Month||10||
60116645|NCT02369068|76237325|FG001|STARTED|1 Month||11||
60116646|NCT02369068|76237324|FG000|COMPLETED|1 Month||9||
60116647|NCT02369068|76237325|FG001|COMPLETED|1 Month||10||
60116648|NCT02369068|76237324|FG000|NOT COMPLETED|1 Month||1||
60116649|NCT02369068|76237325|FG001|NOT COMPLETED|1 Month||1||
60116650|NCT02369068|76237324|FG000|STARTED|3 Months||9||
60116651|NCT02369068|76237325|FG001|STARTED|3 Months||10||
60116652|NCT02369068|76237324|FG000|COMPLETED|3 Months||9||
60116653|NCT02369068|76237325|FG001|COMPLETED|3 Months||8||
60116654|NCT02369068|76237324|FG000|NOT COMPLETED|3 Months||0||
60116655|NCT02369068|76237325|FG001|NOT COMPLETED|3 Months||2||
60116656|NCT02369068|76237324|FG000|STARTED|6 Months||9||
59824761|NCT00440232|75947788|FG001|COMPLETED|Overall Study||34||
59824762|NCT00440232|75947787|FG000|NOT COMPLETED|Overall Study||3||
59824763|NCT00440232|75947788|FG001|NOT COMPLETED|Overall Study||4||
59824764|NCT00356889|75947794|FG000|STARTED|Overall Study||56||
59824765|NCT00356889|75947794|FG000|COMPLETED|Overall Study||53||
59824766|NCT00356889|75947794|FG000|NOT COMPLETED|Overall Study||3||
59824767|NCT00356811|75947799|FG000|STARTED|Overall Study||57||
60116657|NCT02369068|76237325|FG001|STARTED|6 Months||8||
60116658|NCT02369068|76237324|FG000|COMPLETED|6 Months||9||
60116659|NCT02369068|76237325|FG001|COMPLETED|6 Months||7||
60116660|NCT02369068|76237324|FG000|NOT COMPLETED|6 Months||0||
60116661|NCT02369068|76237325|FG001|NOT COMPLETED|6 Months||1||
60116662|NCT02370004|76237331|FG000|STARTED|Overall Study||11||
60116663|NCT02370004|76237331|FG000|COMPLETED|Overall Study||10||
59824768|NCT00356811|75947799|FG000|COMPLETED|Overall Study||8||
60116664|NCT02370004|76237331|FG000|NOT COMPLETED|Overall Study||1||
60116665|NCT01983826|76237342|FG000|STARTED|Overall Study||13||
60116666|NCT01983826|76237343|FG001|STARTED|Overall Study||8||
60116667|NCT01983826|76237342|FG000|COMPLETED|Overall Study||13||
60116668|NCT01983826|76237343|FG001|COMPLETED|Overall Study||8||
60116669|NCT01983826|76237342|FG000|NOT COMPLETED|Overall Study||0||
60116670|NCT01983826|76237343|FG001|NOT COMPLETED|Overall Study||0||
60116671|NCT02371252|76237355|FG000|STARTED|Overall Study||70||
60116672|NCT02371252|76237356|FG001|STARTED|Overall Study||70||
59567294|NCT01517763|75670190|FG001|COMPLETED|Overall Study||0||
59567295|NCT01517763|75670191|FG002|COMPLETED|Overall Study||0||
60116673|NCT02371252|76237355|FG000|COMPLETED|Overall Study||70||
60116674|NCT02371252|76237356|FG001|COMPLETED|Overall Study||70||
60116675|NCT02371252|76237355|FG000|NOT COMPLETED|Overall Study||0||
60116676|NCT02371252|76237356|FG001|NOT COMPLETED|Overall Study||0||
60116677|NCT02305732|76237362|FG000|STARTED|Overall Study||90||
60116678|NCT02305732|76237362|FG000|COMPLETED|Overall Study||72||
60116679|NCT02305732|76237362|FG000|NOT COMPLETED|Overall Study||18||
60116680|NCT02040298|76237369|FG000|STARTED|First Intervention (3 Months)||25||
60116681|NCT02040298|76237370|FG001|STARTED|First Intervention (3 Months)||25||
60116682|NCT02040298|76237369|FG000|COMPLETED|First Intervention (3 Months)||25||
60116683|NCT02040298|76237370|FG001|COMPLETED|First Intervention (3 Months)||25||
60116684|NCT02040298|76237369|FG000|NOT COMPLETED|First Intervention (3 Months)||0||
60116685|NCT02040298|76237370|FG001|NOT COMPLETED|First Intervention (3 Months)||0||
60116686|NCT02040298|76237369|FG000|STARTED|Second Intervention (2 Months)||25||
60116687|NCT02040298|76237370|FG001|STARTED|Second Intervention (2 Months)||25||
60116688|NCT02040298|76237369|FG000|COMPLETED|Second Intervention (2 Months)||25||
60116689|NCT02040298|76237370|FG001|COMPLETED|Second Intervention (2 Months)||25||
60116690|NCT02040298|76237369|FG000|NOT COMPLETED|Second Intervention (2 Months)||0||
60116691|NCT02040298|76237370|FG001|NOT COMPLETED|Second Intervention (2 Months)||0||
60116692|NCT01985542|76237384|FG000|STARTED|Overall Study||7||
60116693|NCT01985542|76237385|FG001|STARTED|Overall Study||9||
60116694|NCT01985542|76237384|FG000|COMPLETED|Overall Study||3||
60116695|NCT01985542|76237385|FG001|COMPLETED|Overall Study||3||
60116696|NCT01985542|76237384|FG000|NOT COMPLETED|Overall Study||4||
60116697|NCT01985542|76237385|FG001|NOT COMPLETED|Overall Study||6||
60116698|NCT02371876|76237392|FG000|STARTED|Overall Study||134||
60116699|NCT02371876|76237392|FG000|COMPLETED|Overall Study||134||
60116700|NCT02371876|76237392|FG000|NOT COMPLETED|Overall Study||0||
60116701|NCT02372344|76237400|FG000|STARTED|Period 1 (Visit 2)||14||
60116702|NCT02372344|76237401|FG001|STARTED|Period 1 (Visit 2)||14||
60116703|NCT02372344|76237402|FG002|STARTED|Period 1 (Visit 2)||14||
60116704|NCT02372344|76237400|FG000|COMPLETED|Period 1 (Visit 2)||14||
60116705|NCT02372344|76237401|FG001|COMPLETED|Period 1 (Visit 2)||14||
60116706|NCT02372344|76237402|FG002|COMPLETED|Period 1 (Visit 2)||14||
60116707|NCT02372344|76237400|FG000|NOT COMPLETED|Period 1 (Visit 2)||0||
60116708|NCT02372344|76237401|FG001|NOT COMPLETED|Period 1 (Visit 2)||0||
60116709|NCT02372344|76237402|FG002|NOT COMPLETED|Period 1 (Visit 2)||0||
60116710|NCT02372344|76237400|FG000|STARTED|Period 2 (Visit 3)||14||
60116711|NCT02372344|76237401|FG001|STARTED|Period 2 (Visit 3)||14||
60116712|NCT02372344|76237402|FG002|STARTED|Period 2 (Visit 3)||14||
60116713|NCT02372344|76237400|FG000|COMPLETED|Period 2 (Visit 3)||14||
60116714|NCT02372344|76237401|FG001|COMPLETED|Period 2 (Visit 3)||14||
60116715|NCT02372344|76237402|FG002|COMPLETED|Period 2 (Visit 3)||14||
60116716|NCT02372344|76237400|FG000|NOT COMPLETED|Period 2 (Visit 3)||0||
60116717|NCT02372344|76237401|FG001|NOT COMPLETED|Period 2 (Visit 3)||0||
60116718|NCT02372344|76237402|FG002|NOT COMPLETED|Period 2 (Visit 3)||0||
60116719|NCT02372344|76237400|FG000|STARTED|Period 3 (Visit 4)||14||
60116720|NCT02372344|76237401|FG001|STARTED|Period 3 (Visit 4)||14||
60116721|NCT02372344|76237402|FG002|STARTED|Period 3 (Visit 4)||14||
60116722|NCT02372344|76237400|FG000|COMPLETED|Period 3 (Visit 4)||14||
60116723|NCT02372344|76237401|FG001|COMPLETED|Period 3 (Visit 4)||14||
60116724|NCT02372344|76237402|FG002|COMPLETED|Period 3 (Visit 4)||14||
60116725|NCT02372344|76237400|FG000|NOT COMPLETED|Period 3 (Visit 4)||0||
60116726|NCT02372344|76237401|FG001|NOT COMPLETED|Period 3 (Visit 4)||0||
60116727|NCT02372344|76237402|FG002|NOT COMPLETED|Period 3 (Visit 4)||0||
60116728|NCT00081939|76237410|FG000|STARTED|Overall Study||303||
60116729|NCT00081939|76237410|FG000|COMPLETED|Overall Study||303||
60116730|NCT00081939|76237410|FG000|NOT COMPLETED|Overall Study||0||
60116731|NCT02373124|76237414|FG000|STARTED|Overall Study||4||
60116732|NCT02373124|76237414|FG000|COMPLETED|Overall Study||3||
60116733|NCT02373124|76237414|FG000|NOT COMPLETED|Overall Study||1||
60116734|NCT02374060|76237421|FG000|STARTED|Overall Study||65||
60116735|NCT02374060|76237422|FG001|STARTED|Overall Study||63||
60116736|NCT02374060|76237423|FG002|STARTED|Overall Study||64||
60116737|NCT02374060|76237421|FG000|COMPLETED|Overall Study||63||
60116738|NCT02374060|76237422|FG001|COMPLETED|Overall Study||62||
60116739|NCT02374060|76237423|FG002|COMPLETED|Overall Study||61||
60116740|NCT02374060|76237421|FG000|NOT COMPLETED|Overall Study||2||
60116741|NCT02374060|76237422|FG001|NOT COMPLETED|Overall Study||1||
60116742|NCT02374060|76237423|FG002|NOT COMPLETED|Overall Study||3||
60116743|NCT01985932|76237431|FG000|STARTED|Overall Study||15||
60116744|NCT01985932|76237431|FG000|COMPLETED|Overall Study||15||
60116745|NCT01985932|76237431|FG000|NOT COMPLETED|Overall Study||0||
60116746|NCT02042872|76237437|FG000|STARTED|Overall Study||8||
60116747|NCT02042872|76237438|FG001|STARTED|Overall Study||13||
60116748|NCT02042872|76237437|FG000|COMPLETED|Overall Study||8||
60116749|NCT02042872|76237438|FG001|COMPLETED|Overall Study||8||
60116750|NCT02042872|76237437|FG000|NOT COMPLETED|Overall Study||0||
60116751|NCT02042872|76237438|FG001|NOT COMPLETED|Overall Study||5||
60116752|NCT00082017|76237444|FG000|STARTED|Overall Study||11||
60116753|NCT00082017|76237445|FG001|STARTED|Overall Study||9||
59824769|NCT00356811|75947799|FG000|NOT COMPLETED|Overall Study||49||
59824770|NCT00439218|75947804|FG000|STARTED|Cohort 1 (500 mg/kg/Day)||4||
59824771|NCT00439218|75947804|FG000|COMPLETED|Cohort 1 (500 mg/kg/Day)|3 subjects completed the study in Cohort 1. Cohort 2 was then opened for new enrollments.|3||
59824772|NCT00439218|75947804|FG000|NOT COMPLETED|Cohort 1 (500 mg/kg/Day)||1||
59824773|NCT00439218|75947804|FG000|STARTED|Cohort 2 (500 mg/kg/Day)|One new subject was enrolled into the study after Cohort 1 completed the study.|1||
59824774|NCT00439218|75947804|FG000|COMPLETED|Cohort 2 (500 mg/kg/Day)||1||
59824775|NCT00439218|75947804|FG000|NOT COMPLETED|Cohort 2 (500 mg/kg/Day)||0||
59824776|NCT03138252|75947810|FG000|STARTED|Overall Study||90||
59824777|NCT03138252|75947811|FG001|STARTED|Overall Study||90||
59824778|NCT03138252|75947810|FG000|COMPLETED|Overall Study||90||
59824779|NCT03138252|75947811|FG001|COMPLETED|Overall Study||90||
59824780|NCT03138252|75947810|FG000|NOT COMPLETED|Overall Study||0||
59824781|NCT03138252|75947811|FG001|NOT COMPLETED|Overall Study||0||
59824782|NCT04941443|75947817|FG000|STARTED|Overall Study||4||
59824783|NCT04941443|75947817|FG000|COMPLETED|Overall Study||0||
59824784|NCT04941443|75947817|FG000|NOT COMPLETED|Overall Study||4||
59824785|NCT00535223|75947823|FG000|STARTED|Overall Study|Patients were randomized in cohorts of ten.|41||
59824786|NCT00535223|75947824|FG001|STARTED|Overall Study|Patients were randomized in cohorts of ten.|40||
59824787|NCT00535223|75947823|FG000|COMPLETED|Overall Study||37||
59824788|NCT00535223|75947824|FG001|COMPLETED|Overall Study||39||
59824789|NCT00535223|75947823|FG000|NOT COMPLETED|Overall Study||4||
59824790|NCT00535223|75947824|FG001|NOT COMPLETED|Overall Study||1||
59824791|NCT00536939|75947830|FG000|STARTED|Overall Study||2||
59824792|NCT00536939|75947831|FG001|STARTED|Overall Study||0||
59824793|NCT00536939|75947830|FG000|Entered Safety lead-in|Overall Study||2||
59824794|NCT00536939|75947831|FG001|Entered Safety lead-in|Overall Study||0||
59824795|NCT00536939|75947830|FG000|Randomized|Overall Study||0||
59824796|NCT00536939|75947831|FG001|Randomized|Overall Study||0||
59824797|NCT00536939|75947830|FG000|COMPLETED|Overall Study||0||
59824798|NCT00536939|75947831|FG001|COMPLETED|Overall Study||0||
59824799|NCT00536939|75947830|FG000|NOT COMPLETED|Overall Study||2||
59824800|NCT00536939|75947831|FG001|NOT COMPLETED|Overall Study||0||
59824801|NCT00347919|75947839|FG000|STARTED|Overall Study|Safety Population|73||
59824802|NCT00347919|75947840|FG001|STARTED|Overall Study|Safety Population|76||
59824803|NCT00347919|75947841|FG002|STARTED|Overall Study|Safety Population|40||
59824804|NCT00347919|75947839|FG000|COMPLETED|Overall Study||2||
59824805|NCT00347919|75947840|FG001|COMPLETED|Overall Study||0||
59824806|NCT00347919|75947841|FG002|COMPLETED|Overall Study||2||
59824807|NCT00347919|75947839|FG000|NOT COMPLETED|Overall Study||71||
59824808|NCT00347919|75947840|FG001|NOT COMPLETED|Overall Study||76||
59824809|NCT00347919|75947841|FG002|NOT COMPLETED|Overall Study||38||
59824810|NCT00439140|75947854|FG000|STARTED|Treatment Cycle 1||15||
59824811|NCT00439140|75947855|FG001|STARTED|Treatment Cycle 1||14||
59824812|NCT00439140|75947856|FG002|STARTED|Treatment Cycle 1||12||
59824813|NCT00439140|75947854|FG000|COMPLETED|Treatment Cycle 1||14||
59824814|NCT00439140|75947855|FG001|COMPLETED|Treatment Cycle 1||10||
59824815|NCT00439140|75947856|FG002|COMPLETED|Treatment Cycle 1|5 patients did not enter Cycle 2. 6 patients received botulinum toxin Type A in Cycle 2.|11||
59824816|NCT00439140|75947854|FG000|NOT COMPLETED|Treatment Cycle 1||1||
59824817|NCT00439140|75947855|FG001|NOT COMPLETED|Treatment Cycle 1||4||
59824818|NCT00439140|75947856|FG002|NOT COMPLETED|Treatment Cycle 1||1||
59824819|NCT00439140|75947854|FG000|STARTED|Treatment Cycle 2|8 patients from the 200U arm plus 5 patients from the placebo arm in Cycle 1 entered Cycle 2.|13||
59824820|NCT00439140|75947855|FG001|STARTED|Treatment Cycle 2|6 patients from the 300U arm plus 1 patient from the placebo arm in Cycle 1 entered Cycle 2.|7||
59824821|NCT00439140|75947856|FG002|STARTED|Treatment Cycle 2|No patients received placebo in Cycle 2.|0||
59824822|NCT00439140|75947854|FG000|COMPLETED|Treatment Cycle 2||11||
59824823|NCT00439140|75947855|FG001|COMPLETED|Treatment Cycle 2||6||
59824824|NCT00439140|75947856|FG002|COMPLETED|Treatment Cycle 2||0||
59824825|NCT00439140|75947854|FG000|NOT COMPLETED|Treatment Cycle 2||2||
59824826|NCT00439140|75947855|FG001|NOT COMPLETED|Treatment Cycle 2||1||
59824827|NCT00439140|75947856|FG002|NOT COMPLETED|Treatment Cycle 2||0||
60116754|NCT00082017|76237444|FG000|COMPLETED|Overall Study||11||
59824828|NCT00356421|75947866|FG000|STARTED|Overall Study||38||
59824829|NCT00356421|75947867|FG001|STARTED|Overall Study||20||
59824830|NCT00356421|75947866|FG000|COMPLETED|Overall Study||6||
60116755|NCT00082017|76237445|FG001|COMPLETED|Overall Study||9||
59824831|NCT00356421|75947867|FG001|COMPLETED|Overall Study||3||
59824832|NCT00356421|75947866|FG000|NOT COMPLETED|Overall Study||32||
59824833|NCT00356421|75947867|FG001|NOT COMPLETED|Overall Study||17||
59824834|NCT00443820|75947877|FG000|STARTED|Overall Study||133||
59824835|NCT00443820|75947878|FG001|STARTED|Overall Study||130||
59824836|NCT00443820|75947879|FG002|STARTED|Overall Study||135||
60116756|NCT00082017|76237444|FG000|NOT COMPLETED|Overall Study||0||
60116757|NCT00082017|76237445|FG001|NOT COMPLETED|Overall Study||0||
60116758|NCT02374138|76237453|FG000|STARTED|Six Month Follow Up||110||
59824837|NCT00443820|75947880|FG003|STARTED|Overall Study||128||
59824838|NCT00443820|75947877|FG000|Safety Population|Overall Study|Participants who received study drug and had at least one post-baseline safety assessment.|131||
60116759|NCT02374138|76237454|FG001|STARTED|Six Month Follow Up||107||
59824839|NCT00443820|75947878|FG001|Safety Population|Overall Study||129||
59824840|NCT00443820|75947879|FG002|Safety Population|Overall Study||134||
59824841|NCT00443820|75947880|FG003|Safety Population|Overall Study||126||
59824842|NCT00443820|75947877|FG000|COMPLETED|Overall Study||112||
59824843|NCT00443820|75947878|FG001|COMPLETED|Overall Study|A participant from this gr. discont'ed due to renal failure, was counted as an AE and also as a SAE.|111||
59824844|NCT00443820|75947879|FG002|COMPLETED|Overall Study||117||
59824845|NCT00443820|75947880|FG003|COMPLETED|Overall Study||111||
59824846|NCT00443820|75947877|FG000|NOT COMPLETED|Overall Study||21||
59824847|NCT00443820|75947878|FG001|NOT COMPLETED|Overall Study||19||
59824848|NCT00443820|75947879|FG002|NOT COMPLETED|Overall Study||18||
59824849|NCT00443820|75947880|FG003|NOT COMPLETED|Overall Study||17||
59824850|NCT00438672|75947892|FG000|STARTED|Overall Study||31||
59824851|NCT00438672|75947893|FG001|STARTED|Overall Study||33||
59824852|NCT00438672|75947892|FG000|COMPLETED|Overall Study||24||
59824853|NCT00438672|75947893|FG001|COMPLETED|Overall Study||24||
59824854|NCT00438672|75947892|FG000|NOT COMPLETED|Overall Study||7||
59824855|NCT00438672|75947893|FG001|NOT COMPLETED|Overall Study||9||
59824856|NCT00438360|75947901|FG000|STARTED|Overall Study|"Started indicates randomized patients."|162||
59824857|NCT00438360|75947902|FG001|STARTED|Overall Study||81||
59824858|NCT00438360|75947901|FG000|Intention to Treat (ITT) Population|Overall Study|These numbers are different from those started (randomized) as 2 pts from each arm never took drug.|160||
59824859|NCT00438360|75947902|FG001|Intention to Treat (ITT) Population|Overall Study||79||
59824860|NCT00438360|75947901|FG000|COMPLETED|Overall Study||90||
59824861|NCT00438360|75947902|FG001|COMPLETED|Overall Study||38||
59824862|NCT00438360|75947901|FG000|NOT COMPLETED|Overall Study||72||
59824863|NCT00438360|75947902|FG001|NOT COMPLETED|Overall Study||43||
59824864|NCT00536471|75947912|FG000|STARTED|Overall Study||257||
59824865|NCT00536471|75947913|FG001|STARTED|Overall Study||127||
59824866|NCT00536471|75947914|FG002|STARTED|Overall Study||261||
59824867|NCT00536471|75947915|FG003|STARTED|Overall Study||131||
59824868|NCT00536471|75947912|FG000|COMPLETED|Overall Study||101||
59824869|NCT00536471|75947913|FG001|COMPLETED|Overall Study||43||
59824870|NCT00536471|75947914|FG002|COMPLETED|Overall Study||122||
59824871|NCT00536471|75947915|FG003|COMPLETED|Overall Study||57||
59824872|NCT00536471|75947912|FG000|NOT COMPLETED|Overall Study||156||
59824873|NCT00536471|75947913|FG001|NOT COMPLETED|Overall Study||84||
59824874|NCT00536471|75947914|FG002|NOT COMPLETED|Overall Study||139||
59824875|NCT00536471|75947915|FG003|NOT COMPLETED|Overall Study||74||
59824876|NCT00359619|75947939|FG000|STARTED|Overall Study||88||
59824877|NCT00359619|75947940|FG001|STARTED|Overall Study||50||
60116760|NCT02374138|76237453|FG000|COMPLETED|Six Month Follow Up|6 Month Follow Up|102||
60116761|NCT02374138|76237454|FG001|COMPLETED|Six Month Follow Up|6 Month Follow Up|93||
59715276|NCT01148862|75834085|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0||
59715277|NCT01148862|75834084|FG000|STARTED|Second Intervention||25||
59715278|NCT01148862|75834085|FG001|STARTED|Second Intervention||25||
60116762|NCT02374138|76237453|FG000|NOT COMPLETED|Six Month Follow Up||8||
59567296|NCT01517763|75670189|FG000|NOT COMPLETED|Overall Study||0||
59567297|NCT01517763|75670190|FG001|NOT COMPLETED|Overall Study||0||
59567298|NCT01517763|75670191|FG002|NOT COMPLETED|Overall Study||0||
59567299|NCT02301390|75670201|FG000|STARTED|Overall Study||27||
59567300|NCT02301390|75670202|FG001|STARTED|Overall Study||26||
59715279|NCT01148862|75834084|FG000|COMPLETED|Second Intervention||25||
59715280|NCT01148862|75834085|FG001|COMPLETED|Second Intervention||23||
59715281|NCT01148862|75834084|FG000|NOT COMPLETED|Second Intervention||0||
59715282|NCT01148862|75834085|FG001|NOT COMPLETED|Second Intervention||2||
59715283|NCT00975975|75834091|FG000|STARTED|Overall Study||17||
59715284|NCT00975975|75834091|FG000|COMPLETED|Overall Study||11||
59715285|NCT00975975|75834091|FG000|NOT COMPLETED|Overall Study||6||
59715286|NCT01193153|75834095|FG000|STARTED|Open-label Lead in Period||667||
59715287|NCT01193153|75834096|FG001|STARTED|Open-label Lead in Period||0||
59715288|NCT01193153|75834095|FG000|COMPLETED|Open-label Lead in Period||432||
59715289|NCT01193153|75834096|FG001|COMPLETED|Open-label Lead in Period||0||
59715290|NCT01193153|75834095|FG000|NOT COMPLETED|Open-label Lead in Period||235||
59715291|NCT01193153|75834096|FG001|NOT COMPLETED|Open-label Lead in Period||0||
59715292|NCT01193153|75834095|FG000|STARTED|Open-label Stabilization Period||432||
59715293|NCT01193153|75834096|FG001|STARTED|Open-label Stabilization Period||0||
59715294|NCT01193153|75834095|FG000|COMPLETED|Open-label Stabilization Period||334||
59715295|NCT01193153|75834096|FG001|COMPLETED|Open-label Stabilization Period||0||
59715296|NCT01193153|75834095|FG000|NOT COMPLETED|Open-label Stabilization Period||98||
59715297|NCT01193153|75834096|FG001|NOT COMPLETED|Open-label Stabilization Period||0||
59824878|NCT00359619|75947941|FG002|STARTED|Overall Study||49||
59824879|NCT00359619|75947942|FG003|STARTED|Overall Study||48||
59824880|NCT00359619|75947943|FG004|STARTED|Overall Study||48||
59824881|NCT00359619|75947944|FG005|STARTED|Overall Study||50||
59824882|NCT00359619|75947945|FG006|STARTED|Overall Study||50||
59824883|NCT00359619|75947939|FG000|COMPLETED|Overall Study||80||
59567301|NCT02301390|75670201|FG000|COMPLETED|Overall Study||17||
59567302|NCT02301390|75670202|FG001|COMPLETED|Overall Study||13||
59567303|NCT02301390|75670201|FG000|NOT COMPLETED|Overall Study||10||
59567304|NCT02301390|75670202|FG001|NOT COMPLETED|Overall Study||13||
59567305|NCT02278562|75670211|FG000|STARTED|Overall Study||9||
59715298|NCT01193153|75834095|FG000|STARTED|Double Blind Relapse Prevention Period||164||
59824884|NCT00359619|75947940|FG001|COMPLETED|Overall Study||45||
59824885|NCT00359619|75947941|FG002|COMPLETED|Overall Study||42||
59824886|NCT00359619|75947942|FG003|COMPLETED|Overall Study||45||
59824887|NCT00359619|75947943|FG004|COMPLETED|Overall Study||45||
59824888|NCT00359619|75947944|FG005|COMPLETED|Overall Study||45||
59824889|NCT00359619|75947945|FG006|COMPLETED|Overall Study||46||
59824890|NCT00359619|75947939|FG000|NOT COMPLETED|Overall Study||8||
59824891|NCT00359619|75947940|FG001|NOT COMPLETED|Overall Study||5||
59824892|NCT00359619|75947941|FG002|NOT COMPLETED|Overall Study||7||
59824893|NCT00359619|75947942|FG003|NOT COMPLETED|Overall Study||3||
59824894|NCT00359619|75947943|FG004|NOT COMPLETED|Overall Study||3||
59824895|NCT00359619|75947944|FG005|NOT COMPLETED|Overall Study||5||
59824896|NCT00359619|75947945|FG006|NOT COMPLETED|Overall Study||4||
59824897|NCT00437658|75947964|FG000|STARTED|Treatment Period (24 Weeks)||84||
59824898|NCT00437658|75947965|FG001|STARTED|Treatment Period (24 Weeks)||84||
59824899|NCT00437658|75947966|FG002|STARTED|Treatment Period (24 Weeks)||84||
59824900|NCT00437658|75947964|FG000|Received Study Drug|Treatment Period (24 Weeks)||84||
59824901|NCT00437658|75947965|FG001|Received Study Drug|Treatment Period (24 Weeks)||84||
59824902|NCT00437658|75947966|FG002|Received Study Drug|Treatment Period (24 Weeks)||84||
59824903|NCT00437658|75947964|FG000|COMPLETED|Treatment Period (24 Weeks)||56||
59824904|NCT00437658|75947965|FG001|COMPLETED|Treatment Period (24 Weeks)||62||
59824905|NCT00437658|75947966|FG002|COMPLETED|Treatment Period (24 Weeks)||51||
59824906|NCT00437658|75947964|FG000|NOT COMPLETED|Treatment Period (24 Weeks)||28||
59824907|NCT00437658|75947965|FG001|NOT COMPLETED|Treatment Period (24 Weeks)||22||
59824908|NCT00437658|75947966|FG002|NOT COMPLETED|Treatment Period (24 Weeks)||33||
59824909|NCT00437658|75947964|FG000|STARTED|Post-treatment Period (24 Weeks)||56||
59824910|NCT00437658|75947965|FG001|STARTED|Post-treatment Period (24 Weeks)||62||
59824911|NCT00437658|75947966|FG002|STARTED|Post-treatment Period (24 Weeks)||51||
59824912|NCT00437658|75947964|FG000|COMPLETED|Post-treatment Period (24 Weeks)||32||
59824913|NCT00437658|75947965|FG001|COMPLETED|Post-treatment Period (24 Weeks)||54||
59824914|NCT00437658|75947966|FG002|COMPLETED|Post-treatment Period (24 Weeks)||37||
59824915|NCT00437658|75947964|FG000|NOT COMPLETED|Post-treatment Period (24 Weeks)||24||
59824916|NCT00437658|75947965|FG001|NOT COMPLETED|Post-treatment Period (24 Weeks)||8||
59824917|NCT00437658|75947966|FG002|NOT COMPLETED|Post-treatment Period (24 Weeks)||14||
59824918|NCT00356265|75947977|FG000|STARTED|Overall Study||7||
59824919|NCT00356265|75947978|FG001|STARTED|Overall Study||2||
59824920|NCT00356265|75947979|FG002|STARTED|Overall Study||6||
59824921|NCT00356265|75947977|FG000|COMPLETED|Overall Study||7||
59824922|NCT00356265|75947978|FG001|COMPLETED|Overall Study||2||
59824923|NCT00356265|75947979|FG002|COMPLETED|Overall Study||5||
59824924|NCT00356265|75947977|FG000|NOT COMPLETED|Overall Study||0||
59824925|NCT00356265|75947978|FG001|NOT COMPLETED|Overall Study||0||
59824926|NCT00356265|75947979|FG002|NOT COMPLETED|Overall Study||1||
59824927|NCT00535145|75947988|FG000|STARTED|Phase I||114||
59824928|NCT00535145|75947988|FG000|COMPLETED|Phase I||85||
59824929|NCT00535145|75947988|FG000|NOT COMPLETED|Phase I||29||
59824930|NCT00535145|75947988|FG000|STARTED|Phase II|Of the 85 participants who completed Phase 1, 84 met the criteria to enroll into Phase 2|84||
59824931|NCT00535145|75947988|FG000|COMPLETED|Phase II||69||
59824932|NCT00535145|75947988|FG000|NOT COMPLETED|Phase II||15||
60116763|NCT02374138|76237454|FG001|NOT COMPLETED|Six Month Follow Up||14||
60116764|NCT02374138|76237453|FG000|STARTED|Twelve Month FollowUp||110|All participants were contacted at 12m, regardless of whether they completed the 6m interview.|
60116765|NCT02374138|76237454|FG001|STARTED|Twelve Month FollowUp||107|All participants were contacted at 12m, regardless of whether they completed the 6m interview.|
60116766|NCT02374138|76237453|FG000|COMPLETED|Twelve Month FollowUp||101||
60116767|NCT02374138|76237454|FG001|COMPLETED|Twelve Month FollowUp||95||
60116768|NCT02374138|76237453|FG000|NOT COMPLETED|Twelve Month FollowUp||9||
59715299|NCT01193153|75834096|FG001|STARTED|Double Blind Relapse Prevention Period||170||
59715300|NCT01193153|75834095|FG000|COMPLETED|Double Blind Relapse Prevention Period||100||
59715301|NCT01193153|75834096|FG001|COMPLETED|Double Blind Relapse Prevention Period||65||
59715302|NCT01193153|75834095|FG000|NOT COMPLETED|Double Blind Relapse Prevention Period||64||
59715303|NCT01193153|75834096|FG001|NOT COMPLETED|Double Blind Relapse Prevention Period||105||
59715304|NCT01192295|75834107|FG000|STARTED|Overall Study||27||
59715305|NCT01192295|75834108|FG001|STARTED|Overall Study||128||
59715306|NCT01192295|75834107|FG000|COMPLETED|Overall Study||17||
59715307|NCT01192295|75834108|FG001|COMPLETED|Overall Study||105||
59715308|NCT01192295|75834107|FG000|NOT COMPLETED|Overall Study||10||
59715309|NCT01192295|75834108|FG001|NOT COMPLETED|Overall Study||23||
59824933|NCT00437268|75947998|FG000|STARTED|Overall Study||13||
59824934|NCT00437268|75947999|FG001|STARTED|Overall Study||13||
59824935|NCT00437268|75947998|FG000|Received at Least 1 Dose of Study Drug|Overall Study||13||
59824936|NCT00437268|75947999|FG001|Received at Least 1 Dose of Study Drug|Overall Study||13||
59824937|NCT00437268|75947998|FG000|Protocol Qualified (PQ) Participant|Overall Study|PQ population: randomized participants without an immune reaction to cetuximab after the first dose|13||
59824938|NCT00437268|75947999|FG001|Protocol Qualified (PQ) Participant|Overall Study|PQ population: randomized participants without an immune reaction to cetuximab after the first dose|12||
59715310|NCT01154166|75834118|FG000|STARTED|Overall Study||169||
59824939|NCT00437268|75947998|FG000|COMPLETED|Overall Study||0||
59824940|NCT00437268|75947999|FG001|COMPLETED|Overall Study||0||
59824941|NCT00437268|75947998|FG000|NOT COMPLETED|Overall Study||13||
59824942|NCT00437268|75947999|FG001|NOT COMPLETED|Overall Study||13||
59824943|NCT00437034|75948007|FG000|STARTED|Overall Study||6||
59824944|NCT00437034|75948007|FG000|COMPLETED|Overall Study||0||
59824945|NCT00437034|75948007|FG000|NOT COMPLETED|Overall Study||6||
59824946|NCT00337467|75948011|FG000|STARTED|Overall Study||61||
59824947|NCT00337467|75948011|FG000|Discontinued Prior to Week 96|Overall Study|5 of these participants discontinued prior to Week 48|10||
59824948|NCT00337467|75948011|FG000|COMPLETED|Overall Study||51||
59824949|NCT00337467|75948011|FG000|NOT COMPLETED|Overall Study||10||
59824950|NCT00337077|75948021|FG000|STARTED|Overall Study||43||
59824951|NCT00337077|75948022|FG001|STARTED|Overall Study||53||
59824952|NCT00337077|75948023|FG002|STARTED|Overall Study||25||
59824953|NCT00337077|75948021|FG000|Treated|Overall Study||42||
59824954|NCT00337077|75948022|FG001|Treated|Overall Study||52||
59824955|NCT00337077|75948023|FG002|Treated|Overall Study||25||
59824956|NCT00337077|75948021|FG000|Toxicity Assessed|Overall Study||42||
59824957|NCT00337077|75948022|FG001|Toxicity Assessed|Overall Study||51||
59824958|NCT00337077|75948023|FG002|Toxicity Assessed|Overall Study||25||
59824959|NCT00337077|75948021|FG000|Eligible and Treated|Overall Study||41||
59824960|NCT00337077|75948022|FG001|Eligible and Treated|Overall Study||51||
59824961|NCT00337077|75948023|FG002|Eligible and Treated|Overall Study||24||
59824962|NCT00337077|75948021|FG000|Patients With Measurable Disease|Overall Study||26||
59824963|NCT00337077|75948022|FG001|Patients With Measurable Disease|Overall Study||38||
59824964|NCT00337077|75948023|FG002|Patients With Measurable Disease|Overall Study||13||
59567306|NCT02278562|75670212|FG001|STARTED|Overall Study||7||
59824965|NCT00337077|75948021|FG000|COMPLETED|Overall Study|No completion of treatment because treatment was given until PD or unacceptable toxicity.|0||
59824966|NCT00337077|75948022|FG001|COMPLETED|Overall Study|No completion of treatment because treatment was given until PD or unacceptable toxicity.|0||
59824967|NCT00337077|75948023|FG002|COMPLETED|Overall Study|No completion of treatment because treatment was given until PD or unacceptable toxicity.|0||
59824968|NCT00337077|75948021|FG000|NOT COMPLETED|Overall Study||43||
59567307|NCT02278562|75670213|FG002|STARTED|Overall Study||8||
59824969|NCT00337077|75948022|FG001|NOT COMPLETED|Overall Study||53||
59824970|NCT00337077|75948023|FG002|NOT COMPLETED|Overall Study||25||
59824971|NCT00428220|75948029|FG000|STARTED|Overall Study||223||
59824972|NCT00428220|75948029|FG000|COMPLETED|Overall Study||0||
60116769|NCT02374138|76237454|FG001|NOT COMPLETED|Twelve Month FollowUp||12||
60116770|NCT00082329|76237461|FG000|STARTED|Overall Study||9||
60116771|NCT00082329|76237461|FG000|COMPLETED|Overall Study||9||
59715311|NCT01154166|75834119|FG001|STARTED|Overall Study||175||
59824973|NCT00428220|75948029|FG000|NOT COMPLETED|Overall Study||223||
59824974|NCT02873975|75948047|FG000|STARTED|Overall Study||8||
59824975|NCT02873975|75948048|FG001|STARTED|Overall Study||10||
59824976|NCT02873975|75948049|FG002|STARTED|Overall Study||9||
59824977|NCT02873975|75948047|FG000|COMPLETED|Overall Study||8||
59824978|NCT02873975|75948048|FG001|COMPLETED|Overall Study||10||
59824979|NCT02873975|75948049|FG002|COMPLETED|Overall Study||9||
59824980|NCT02873975|75948047|FG000|NOT COMPLETED|Overall Study||0||
60116772|NCT00082329|76237461|FG000|NOT COMPLETED|Overall Study||0||
59715312|NCT01154166|75834118|FG000|COMPLETED|Overall Study||135||
59715313|NCT01154166|75834119|FG001|COMPLETED|Overall Study||163||
59715314|NCT01154166|75834118|FG000|NOT COMPLETED|Overall Study||34||
59715315|NCT01154166|75834119|FG001|NOT COMPLETED|Overall Study||12||
59824981|NCT02873975|75948048|FG001|NOT COMPLETED|Overall Study||0||
59824982|NCT02873975|75948049|FG002|NOT COMPLETED|Overall Study||0||
60116773|NCT02092311|76237467|FG000|STARTED|Overall Study||285||
60116774|NCT02092311|76237468|FG001|STARTED|Overall Study||285||
60116775|NCT02092311|76237467|FG000|COMPLETED|Overall Study||285||
60116776|NCT02092311|76237468|FG001|COMPLETED|Overall Study||285||
59715316|NCT00975585|75834127|FG000|STARTED|Overall Study||184||
59715317|NCT00975585|75834128|FG001|STARTED|Overall Study||195||
59715318|NCT00975585|75834127|FG000|COMPLETED|Overall Study||177||
59715319|NCT00975585|75834128|FG001|COMPLETED|Overall Study||183||
59824983|NCT00345579|75948059|FG000|STARTED|Overall Study||3278||
59824984|NCT00345579|75948060|FG001|STARTED|Overall Study||1113||
60116777|NCT02092311|76237467|FG000|NOT COMPLETED|Overall Study||0||
60116778|NCT02092311|76237468|FG001|NOT COMPLETED|Overall Study||0||
59715320|NCT00975585|75834127|FG000|NOT COMPLETED|Overall Study||7||
59715321|NCT00975585|75834128|FG001|NOT COMPLETED|Overall Study||12||
59824985|NCT00345579|75948059|FG000|COMPLETED|Overall Study||3114||
60116779|NCT02092857|76237477|FG000|STARTED|Overall Study||30||
60116780|NCT02092857|76237478|FG001|STARTED|Overall Study||30||
59715322|NCT01181921|75834136|FG000|STARTED|Overall Study||1||
59824986|NCT00345579|75948060|FG001|COMPLETED|Overall Study||1048||
59567308|NCT02278562|75670211|FG000|COMPLETED|Overall Study||9||
59715323|NCT01181921|75834136|FG000|COMPLETED|Overall Study||0||
59715324|NCT01181921|75834136|FG000|NOT COMPLETED|Overall Study||1||
59715325|NCT01174446|75834140|FG000|STARTED|Part 1 -Pharmacokinetic Crossover||14||
59715326|NCT01174446|75834141|FG001|STARTED|Part 1 -Pharmacokinetic Crossover||14||
59824987|NCT00345579|75948059|FG000|NOT COMPLETED|Overall Study||164||
59824988|NCT00345579|75948060|FG001|NOT COMPLETED|Overall Study||65||
59824989|NCT00335829|75948067|FG000|STARTED|Overall Study||26||
60116781|NCT02092857|76237479|FG002|STARTED|Overall Study||29||
60116782|NCT02092857|76237477|FG000|COMPLETED|Overall Study||20||
60116783|NCT02092857|76237478|FG001|COMPLETED|Overall Study||18||
60116784|NCT02092857|76237479|FG002|COMPLETED|Overall Study||16||
60116785|NCT02092857|76237477|FG000|NOT COMPLETED|Overall Study||10||
60116786|NCT02092857|76237478|FG001|NOT COMPLETED|Overall Study||12||
60116787|NCT02092857|76237479|FG002|NOT COMPLETED|Overall Study||13||
60116788|NCT00167661|76237487|FG000|STARTED|Overall Study||33||
60116789|NCT00167661|76237487|FG000|COMPLETED|Overall Study||33||
60116790|NCT00167661|76237487|FG000|NOT COMPLETED|Overall Study||0||
60116791|NCT02395978|76237496|FG000|STARTED|Overall Study||6||
59715327|NCT01174446|75834142|FG002|STARTED|Part 1 -Pharmacokinetic Crossover||0||
60116792|NCT02395978|76237497|FG001|STARTED|Overall Study||6||
60116793|NCT02395978|76237498|FG002|STARTED|Overall Study||21||
60116794|NCT02395978|76237499|FG003|STARTED|Overall Study||19||
60116795|NCT02395978|76237500|FG004|STARTED|Overall Study||20||
60116796|NCT02395978|76237496|FG000|COMPLETED|Overall Study||6||
60116797|NCT02395978|76237497|FG001|COMPLETED|Overall Study||6||
60116798|NCT02395978|76237498|FG002|COMPLETED|Overall Study||19||
60116799|NCT02395978|76237499|FG003|COMPLETED|Overall Study||14||
60116800|NCT02395978|76237500|FG004|COMPLETED|Overall Study||15||
60116801|NCT02395978|76237496|FG000|NOT COMPLETED|Overall Study||0||
60116802|NCT02395978|76237497|FG001|NOT COMPLETED|Overall Study||0||
60116803|NCT02395978|76237498|FG002|NOT COMPLETED|Overall Study||2||
60116804|NCT02395978|76237499|FG003|NOT COMPLETED|Overall Study||5||
60116805|NCT02395978|76237500|FG004|NOT COMPLETED|Overall Study||5||
60116806|NCT00170157|76237513|FG000|STARTED|Treatment Period 1 Initial Randomization||54||
60116807|NCT00170157|76237514|FG001|STARTED|Treatment Period 1 Initial Randomization||58||
60116808|NCT00170157|76237513|FG000|COMPLETED|Treatment Period 1 Initial Randomization||54||
60116809|NCT00170157|76237514|FG001|COMPLETED|Treatment Period 1 Initial Randomization||58||
60116810|NCT00170157|76237513|FG000|NOT COMPLETED|Treatment Period 1 Initial Randomization||0||
60116811|NCT00170157|76237514|FG001|NOT COMPLETED|Treatment Period 1 Initial Randomization||0||
60116812|NCT00170157|76237513|FG000|STARTED|Washout Period of 14 Days|Participants initially randomized to this arm were not eligible for crossover.|0||
60116813|NCT00170157|76237514|FG001|STARTED|Washout Period of 14 Days||58||
60116814|NCT00170157|76237513|FG000|COMPLETED|Washout Period of 14 Days||0||
60116815|NCT00170157|76237514|FG001|COMPLETED|Washout Period of 14 Days||41||
60116816|NCT00170157|76237513|FG000|NOT COMPLETED|Washout Period of 14 Days||0||
60116817|NCT00170157|76237514|FG001|NOT COMPLETED|Washout Period of 14 Days||17||
60116818|NCT00170157|76237513|FG000|STARTED|Treatment Period 2 Crossover|Participants initially randomized to this arm were not eligible for crossover.|0||
60116819|NCT00170157|76237514|FG001|STARTED|Treatment Period 2 Crossover||41||
60116820|NCT00170157|76237513|FG000|COMPLETED|Treatment Period 2 Crossover||0||
60116821|NCT00170157|76237514|FG001|COMPLETED|Treatment Period 2 Crossover||41||
60116822|NCT00170157|76237513|FG000|NOT COMPLETED|Treatment Period 2 Crossover||0||
59715328|NCT01174446|75834143|FG003|STARTED|Part 1 -Pharmacokinetic Crossover||0||
59715329|NCT01174446|75834140|FG000|COMPLETED|Part 1 -Pharmacokinetic Crossover|BAX326 was mistakenly infused for second PK infusion (ie should have been BeneFIX) for 1 participant|14||
59715330|NCT01174446|75834141|FG001|COMPLETED|Part 1 -Pharmacokinetic Crossover||14||
59715331|NCT01174446|75834142|FG002|COMPLETED|Part 1 -Pharmacokinetic Crossover||0||
59715332|NCT01174446|75834143|FG003|COMPLETED|Part 1 -Pharmacokinetic Crossover||0||
60116823|NCT00170157|76237514|FG001|NOT COMPLETED|Treatment Period 2 Crossover||0||
60116824|NCT02043574|76237522|FG000|STARTED|Overall Study||25||
60116825|NCT02043574|76237523|FG001|STARTED|Overall Study||26||
60116826|NCT02043574|76237522|FG000|COMPLETED|Overall Study||19||
60116827|NCT02043574|76237523|FG001|COMPLETED|Overall Study||20||
60116828|NCT02043574|76237522|FG000|NOT COMPLETED|Overall Study||6||
60116829|NCT02043574|76237523|FG001|NOT COMPLETED|Overall Study||6||
60116830|NCT00170625|76237530|FG000|STARTED|Overall Study||26||
60116831|NCT00170625|76237530|FG000|COMPLETED|Overall Study||26||
60116832|NCT00170625|76237530|FG000|NOT COMPLETED|Overall Study||0||
60116833|NCT02043652|76237534|FG000|STARTED|Overall Study||119|We corrected the information in the patient flow section.|
60116834|NCT02043652|76237534|FG000|COMPLETED|Overall Study||93||
60116835|NCT02043652|76237534|FG000|NOT COMPLETED|Overall Study||26||
60116836|NCT02043808|76237540|FG000|STARTED|Overall Study||12793||
60116837|NCT02043808|76237541|FG001|STARTED|Overall Study||12793||
60116838|NCT02043808|76237540|FG000|COMPLETED|Overall Study||12793||
59567309|NCT02278562|75670212|FG001|COMPLETED|Overall Study||7||
59567310|NCT02278562|75670213|FG002|COMPLETED|Overall Study||8||
60116839|NCT02043808|76237541|FG001|COMPLETED|Overall Study||12793||
60116840|NCT02043808|76237540|FG000|NOT COMPLETED|Overall Study||0||
60116841|NCT02043808|76237541|FG001|NOT COMPLETED|Overall Study||0||
59567311|NCT02278562|75670211|FG000|NOT COMPLETED|Overall Study||0||
60116842|NCT00176865|76237550|FG000|STARTED|Overall Study||3||
60116843|NCT00176865|76237551|FG001|STARTED|Overall Study||10||
60116844|NCT00176865|76237552|FG002|STARTED|Overall Study||6||
60116845|NCT00176865|76237550|FG000|COMPLETED|Overall Study||3||
60116846|NCT00176865|76237551|FG001|COMPLETED|Overall Study||10||
60116847|NCT00176865|76237552|FG002|COMPLETED|Overall Study||6||
59715333|NCT01174446|75834140|FG000|NOT COMPLETED|Part 1 -Pharmacokinetic Crossover||0||
59715334|NCT01174446|75834141|FG001|NOT COMPLETED|Part 1 -Pharmacokinetic Crossover||0||
60116848|NCT00176865|76237550|FG000|NOT COMPLETED|Overall Study||0||
60116849|NCT00176865|76237551|FG001|NOT COMPLETED|Overall Study||0||
60116850|NCT00176865|76237552|FG002|NOT COMPLETED|Overall Study||0||
60116851|NCT00177255|76237560|FG000|STARTED|Overall Study||39||
60116852|NCT00177255|76237560|FG000|COMPLETED|Overall Study||39||
60116853|NCT00177255|76237560|FG000|NOT COMPLETED|Overall Study||0||
60116854|NCT02401048|76237566|FG000|STARTED|Overall Study||27||
60116855|NCT02401048|76237567|FG001|STARTED|Overall Study||34||
60116856|NCT02401048|76237566|FG000|COMPLETED|Overall Study||5||
60116857|NCT02401048|76237567|FG001|COMPLETED|Overall Study||4||
60116858|NCT02401048|76237566|FG000|NOT COMPLETED|Overall Study||22||
60116859|NCT02401048|76237567|FG001|NOT COMPLETED|Overall Study||30||
60116860|NCT00178191|76237581|FG000|STARTED|Overall Study||11||
60116861|NCT00178191|76237582|FG001|STARTED|Overall Study||10||
59715335|NCT01174446|75834142|FG002|NOT COMPLETED|Part 1 -Pharmacokinetic Crossover||0||
59715336|NCT01174446|75834143|FG003|NOT COMPLETED|Part 1 -Pharmacokinetic Crossover||0||
59715337|NCT01174446|75834140|FG000|STARTED|Part 2 -BAX326 Prophylaxis and On-demand|In Study Part 2 all 14 participants received Prophylaxis|14||
59715338|NCT01174446|75834141|FG001|STARTED|Part 2 -BAX326 Prophylaxis and On-demand|In Study Part 2 all 14 participants received Prophylaxis|14||
60116862|NCT00178191|76237583|FG002|STARTED|Overall Study||7||
60116863|NCT00178191|76237581|FG000|COMPLETED|Overall Study||11||
60116864|NCT00178191|76237582|FG001|COMPLETED|Overall Study||10||
60116865|NCT00178191|76237583|FG002|COMPLETED|Overall Study||7||
60116866|NCT00178191|76237581|FG000|NOT COMPLETED|Overall Study||0||
60116867|NCT00178191|76237582|FG001|NOT COMPLETED|Overall Study||0||
60116868|NCT00178191|76237583|FG002|NOT COMPLETED|Overall Study||0||
60116869|NCT02046382|76237593|FG000|STARTED|Overall Study||65||
60116870|NCT02046382|76237594|FG001|STARTED|Overall Study||67||
60116871|NCT02046382|76237593|FG000|COMPLETED|Overall Study||57||
60116872|NCT02046382|76237594|FG001|COMPLETED|Overall Study||47||
60116873|NCT02046382|76237593|FG000|NOT COMPLETED|Overall Study||8||
60116874|NCT02046382|76237594|FG001|NOT COMPLETED|Overall Study||20||
60116875|NCT02046772|76237602|FG000|STARTED|Overall Study||30||
60116876|NCT02046772|76237603|FG001|STARTED|Overall Study||33||
60116877|NCT02046772|76237602|FG000|COMPLETED|Overall Study||30||
60116878|NCT02046772|76237603|FG001|COMPLETED|Overall Study||33||
60116879|NCT02046772|76237602|FG000|NOT COMPLETED|Overall Study||0||
60116880|NCT02046772|76237603|FG001|NOT COMPLETED|Overall Study||0||
60116881|NCT00178503|76237609|FG000|STARTED|MPH Trial: Placebo||24||
60116882|NCT00178503|76237609|FG000|COMPLETED|MPH Trial: Placebo||24||
59715339|NCT01174446|75834142|FG002|STARTED|Part 2 -BAX326 Prophylaxis and On-demand|This group only participated in Study Part 2|31||
60116883|NCT00178503|76237609|FG000|NOT COMPLETED|MPH Trial: Placebo||0||
60116884|NCT00178503|76237609|FG000|STARTED|MPH Trial: Low Dose||24||
60116885|NCT00178503|76237609|FG000|COMPLETED|MPH Trial: Low Dose||24||
60116886|NCT00178503|76237609|FG000|NOT COMPLETED|MPH Trial: Low Dose||0||
60116887|NCT00178503|76237609|FG000|STARTED|MPH Trial: Med Dose||24||
60116888|NCT00178503|76237609|FG000|COMPLETED|MPH Trial: Med Dose||24||
60116889|NCT00178503|76237609|FG000|NOT COMPLETED|MPH Trial: Med Dose||0||
60116890|NCT00178503|76237609|FG000|STARTED|MPH Trial: High Dose||24||
60116891|NCT00178503|76237609|FG000|COMPLETED|MPH Trial: High Dose||24||
60116892|NCT00178503|76237609|FG000|NOT COMPLETED|MPH Trial: High Dose||0||
60116893|NCT02376010|76237626|FG000|STARTED|Overall Study||55||
60116894|NCT02376010|76237627|FG001|STARTED|Overall Study||55||
60116895|NCT02376010|76237626|FG000|COMPLETED|Overall Study||46||
59567312|NCT02278562|75670212|FG001|NOT COMPLETED|Overall Study||0||
60116896|NCT02376010|76237627|FG001|COMPLETED|Overall Study||51||
60116897|NCT02376010|76237626|FG000|NOT COMPLETED|Overall Study||9||
60116898|NCT02376010|76237627|FG001|NOT COMPLETED|Overall Study||4||
60116899|NCT00085293|76237633|FG000|STARTED|Overall Study||12||
60116900|NCT00085293|76237633|FG000|COMPLETED|Overall Study||12||
60116901|NCT00085293|76237633|FG000|NOT COMPLETED|Overall Study||0||
60116902|NCT02402062|76237637|FG000|STARTED|Overall Study||17||
60116903|NCT02402062|76237637|FG000|COMPLETED|Overall Study||17||
60116904|NCT02402062|76237637|FG000|NOT COMPLETED|Overall Study||0||
60116905|NCT02379442|76237641|FG000|STARTED|Overall Study||1||
60116906|NCT02379442|76237641|FG000|COMPLETED|Overall Study||1||
60116907|NCT02379442|76237641|FG000|NOT COMPLETED|Overall Study||0||
60116908|NCT02450760|76237647|FG000|STARTED|Overall Study||15||
60116909|NCT02450760|76237648|FG001|STARTED|Overall Study||18||
60116910|NCT02450760|76237647|FG000|COMPLETED|Overall Study||15||
60116911|NCT02450760|76237648|FG001|COMPLETED|Overall Study||18||
60116912|NCT02450760|76237647|FG000|NOT COMPLETED|Overall Study||0||
60116913|NCT02450760|76237648|FG001|NOT COMPLETED|Overall Study||0||
60116914|NCT02048878|76237661|FG000|STARTED|Overall Study||13||
60116915|NCT02048878|76237662|FG001|STARTED|Overall Study||15||
60116916|NCT02048878|76237661|FG000|COMPLETED|Overall Study||12||
60116917|NCT02048878|76237662|FG001|COMPLETED|Overall Study||12||
60116918|NCT02048878|76237661|FG000|NOT COMPLETED|Overall Study||1||
60116919|NCT02048878|76237662|FG001|NOT COMPLETED|Overall Study||3||
60116920|NCT02402296|76237670|FG000|STARTED|Overall Study||15||
60116921|NCT02402296|76237671|FG001|STARTED|Overall Study||15||
60116922|NCT02402296|76237670|FG000|COMPLETED|Overall Study||15||
60116923|NCT02402296|76237671|FG001|COMPLETED|Overall Study||15||
60116924|NCT02402296|76237670|FG000|NOT COMPLETED|Overall Study||0||
60116925|NCT02402296|76237671|FG001|NOT COMPLETED|Overall Study||0||
60116926|NCT00085839|76237679|FG000|STARTED|Overall Study||52||
60116927|NCT00085839|76237680|FG001|STARTED|Overall Study||51||
60116928|NCT00085839|76237679|FG000|COMPLETED|Overall Study||52||
60116929|NCT00085839|76237680|FG001|COMPLETED|Overall Study||51||
60116930|NCT00085839|76237679|FG000|NOT COMPLETED|Overall Study||0||
60116931|NCT00085839|76237680|FG001|NOT COMPLETED|Overall Study||0||
60116932|NCT02402452|76237688|FG000|STARTED|Overall Study||10||
60116933|NCT02402452|76237689|FG001|STARTED|Overall Study||10||
60116934|NCT02402452|76237688|FG000|COMPLETED|Overall Study||10||
60116935|NCT02402452|76237689|FG001|COMPLETED|Overall Study||10||
60116936|NCT02402452|76237688|FG000|NOT COMPLETED|Overall Study||0||
60116937|NCT02402452|76237689|FG001|NOT COMPLETED|Overall Study||0||
60116938|NCT02049502|76237695|FG000|STARTED|Overall Study||8||
60116939|NCT02049502|76237695|FG000|COMPLETED|Overall Study||8||
60116940|NCT02049502|76237695|FG000|NOT COMPLETED|Overall Study||0||
60116941|NCT02260869|76237701|FG000|STARTED|Overall Study||38||
60116942|NCT02260869|76237702|FG001|STARTED|Overall Study||37||
60116943|NCT02260869|76237701|FG000|COMPLETED|Overall Study||31||
60116944|NCT02260869|76237702|FG001|COMPLETED|Overall Study||29||
60116945|NCT02260869|76237701|FG000|NOT COMPLETED|Overall Study||7||
60116946|NCT02260869|76237702|FG001|NOT COMPLETED|Overall Study||8||
60116947|NCT02402764|76237708|FG000|STARTED|Overall Study||10||
60116948|NCT02402764|76237708|FG000|COMPLETED|Overall Study||10||
60116949|NCT02402764|76237708|FG000|NOT COMPLETED|Overall Study||0||
60116950|NCT02380612|76237712|FG000|STARTED|Overall Study||30||
60116951|NCT02380612|76237712|FG000|COMPLETED|Overall Study||27||
60116952|NCT02380612|76237712|FG000|NOT COMPLETED|Overall Study||3||
59567313|NCT02278562|75670213|FG002|NOT COMPLETED|Overall Study||0||
59567314|NCT01497171|75670223|FG000|STARTED|Overall Study||2||
60116953|NCT02403622|76237719|FG000|STARTED|Overall Study||15||
60116954|NCT02403622|76237719|FG000|COMPLETED|Overall Study||13||
60116955|NCT02403622|76237719|FG000|NOT COMPLETED|Overall Study||2||
60116956|NCT02381392|76237725|FG000|STARTED|Overall Study||11||
60116957|NCT02381392|76237726|FG001|STARTED|Overall Study||12||
60116958|NCT02381392|76237725|FG000|COMPLETED|Overall Study||11||
60116959|NCT02381392|76237726|FG001|COMPLETED|Overall Study||12||
60116960|NCT02381392|76237725|FG000|NOT COMPLETED|Overall Study||0||
60116961|NCT02381392|76237726|FG001|NOT COMPLETED|Overall Study||0||
60116962|NCT00180297|76237734|FG000|STARTED|Overall Study||107||
60116963|NCT00180297|76237735|FG001|STARTED|Overall Study||108||
60116964|NCT00180297|76237734|FG000|COMPLETED|Overall Study||61|Until 5 years follow-up|
60116965|NCT00180297|76237735|FG001|COMPLETED|Overall Study||67|Until 5 years follow-up|
60116966|NCT00180297|76237734|FG000|NOT COMPLETED|Overall Study||46||
60116967|NCT00180297|76237735|FG001|NOT COMPLETED|Overall Study||41||
60116968|NCT02312986|76237741|FG000|STARTED|Overall Study||1||
60116969|NCT02312986|76237741|FG000|COMPLETED|Overall Study||1||
60116970|NCT02312986|76237741|FG000|NOT COMPLETED|Overall Study||0||
60116971|NCT02404168|76237745|FG000|STARTED|Overall Study||4||
60116972|NCT02404168|76237745|FG000|COMPLETED|Overall Study||4||
60116973|NCT02404168|76237745|FG000|NOT COMPLETED|Overall Study||0||
60116974|NCT02051452|76237753|FG000|STARTED|Overall Study||16||
60116975|NCT02051452|76237754|FG001|STARTED|Overall Study||16||
60116976|NCT02051452|76237753|FG000|COMPLETED|Overall Study||16||
60116977|NCT02051452|76237754|FG001|COMPLETED|Overall Study||16||
60116978|NCT02051452|76237753|FG000|NOT COMPLETED|Overall Study||0||
60116979|NCT02051452|76237754|FG001|NOT COMPLETED|Overall Study||0||
60116980|NCT00180687|76237764|FG000|STARTED|Overall Study||20||
60116981|NCT00180687|76237765|FG001|STARTED|Overall Study||20||
60116982|NCT00180687|76237766|FG002|STARTED|Overall Study||20||
60116983|NCT00180687|76237767|FG003|STARTED|Overall Study||20||
60116984|NCT00180687|76237764|FG000|COMPLETED|Overall Study||20||
60116985|NCT00180687|76237765|FG001|COMPLETED|Overall Study||20||
60116986|NCT00180687|76237766|FG002|COMPLETED|Overall Study||20||
60116987|NCT00180687|76237767|FG003|COMPLETED|Overall Study||20||
60116988|NCT00180687|76237764|FG000|NOT COMPLETED|Overall Study||0||
60116989|NCT00180687|76237765|FG001|NOT COMPLETED|Overall Study||0||
60116990|NCT00180687|76237766|FG002|NOT COMPLETED|Overall Study||0||
60116991|NCT00180687|76237767|FG003|NOT COMPLETED|Overall Study||0||
60116992|NCT02313454|76237777|FG000|STARTED|Treatment 1||9||
60116993|NCT02313454|76237778|FG001|STARTED|Treatment 1||11||
60116994|NCT02313454|76237777|FG000|COMPLETED|Treatment 1||9||
60116995|NCT02313454|76237778|FG001|COMPLETED|Treatment 1||11||
60116996|NCT02313454|76237777|FG000|NOT COMPLETED|Treatment 1||0||
60116997|NCT02313454|76237778|FG001|NOT COMPLETED|Treatment 1||0||
60116998|NCT02313454|76237777|FG000|STARTED|Treatment 2|1 participant did not receive the second application.|8||
60116999|NCT02313454|76237778|FG001|STARTED|Treatment 2|1 participant did not receive the second application.|10||
60117000|NCT02313454|76237777|FG000|COMPLETED|Treatment 2||8||
59824990|NCT00335829|75948067|FG000|Received Bevacizumab|Overall Study||26|Patients reaching this milestone were evaluated for safety and toxicity outcomes|
60117001|NCT02313454|76237778|FG001|COMPLETED|Treatment 2||10||
60117002|NCT02313454|76237777|FG000|NOT COMPLETED|Treatment 2||0||
60117003|NCT02313454|76237778|FG001|NOT COMPLETED|Treatment 2||0||
60117004|NCT00181623|76237784|FG000|STARTED|Overall Study||6||
60117005|NCT00181623|76237784|FG000|COMPLETED|Overall Study||5||
60117006|NCT00181623|76237784|FG000|NOT COMPLETED|Overall Study||1||
60117007|NCT02404792|76237791|FG000|STARTED|Overall Study||32||
60117008|NCT02404792|76237792|FG001|STARTED|Overall Study||37||
60117009|NCT02404792|76237791|FG000|COMPLETED|Overall Study||27||
60117010|NCT02404792|76237792|FG001|COMPLETED|Overall Study||29||
60117011|NCT02404792|76237791|FG000|NOT COMPLETED|Overall Study||5||
60117012|NCT02404792|76237792|FG001|NOT COMPLETED|Overall Study||8||
60117013|NCT02383420|76237803|FG000|STARTED|Overall Study||10||
60117014|NCT02383420|76237804|FG001|STARTED|Overall Study||10||
60117015|NCT02383420|76237805|FG002|STARTED|Overall Study||3||
60117016|NCT02383420|76237803|FG000|COMPLETED|Overall Study||8||
60117017|NCT02383420|76237804|FG001|COMPLETED|Overall Study||10||
60117018|NCT02383420|76237805|FG002|COMPLETED|Overall Study||3||
60117019|NCT02383420|76237803|FG000|NOT COMPLETED|Overall Study||2||
60117020|NCT02383420|76237804|FG001|NOT COMPLETED|Overall Study||0||
60117021|NCT02383420|76237805|FG002|NOT COMPLETED|Overall Study||0||
60117022|NCT00087633|76237815|FG000|STARTED|Overall Study|Randomized|55||
60117023|NCT00087633|76237816|FG001|STARTED|Overall Study|Randomized|60||
60117024|NCT00087633|76237815|FG000|COMPLETED|Overall Study|Completed 48 weeks of treatment/observation|31||
60117025|NCT00087633|76237816|FG001|COMPLETED|Overall Study|Completed 48 weeks of treatment/observation|43||
60117026|NCT00087633|76237815|FG000|NOT COMPLETED|Overall Study||24||
60117027|NCT00087633|76237816|FG001|NOT COMPLETED|Overall Study||17||
60117028|NCT02384044|76237824|FG000|STARTED|Overall Study||15||
60117029|NCT02384044|76237825|FG001|STARTED|Overall Study||15||
60117030|NCT02384044|76237824|FG000|COMPLETED|Overall Study||15||
60117031|NCT02384044|76237825|FG001|COMPLETED|Overall Study||15||
60117032|NCT02384044|76237824|FG000|NOT COMPLETED|Overall Study||0||
60117033|NCT02384044|76237825|FG001|NOT COMPLETED|Overall Study||0||
60117034|NCT02384200|76237833|FG000|STARTED|Overall Study||43||
60117035|NCT02384200|76237834|FG001|STARTED|Overall Study||43||
60117036|NCT02384200|76237833|FG000|COMPLETED|Overall Study||43||
60117037|NCT02384200|76237834|FG001|COMPLETED|Overall Study||43||
59567315|NCT01497171|75670224|FG001|STARTED|Overall Study||3||
59567316|NCT01497171|75670223|FG000|COMPLETED|Overall Study||2||
60117038|NCT02384200|76237833|FG000|NOT COMPLETED|Overall Study||0||
60117039|NCT02384200|76237834|FG001|NOT COMPLETED|Overall Study||0||
60117040|NCT02314000|76237842|FG000|STARTED|Overall Study||75||
60117041|NCT02314000|76237843|FG001|STARTED|Overall Study||65||
60117042|NCT02314000|76237842|FG000|COMPLETED|Overall Study||62||
60117043|NCT02314000|76237843|FG001|COMPLETED|Overall Study||57||
60117044|NCT02314000|76237842|FG000|NOT COMPLETED|Overall Study||13||
59567317|NCT01497171|75670224|FG001|COMPLETED|Overall Study||3||
59715340|NCT01174446|75834143|FG003|STARTED|Part 2 -BAX326 Prophylaxis and On-demand|This group only participated in Study Part 2|14||
59715341|NCT01174446|75834140|FG000|COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||14||
59715342|NCT01174446|75834141|FG001|COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||14||
59715343|NCT01174446|75834142|FG002|COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||29||
59715344|NCT01174446|75834143|FG003|COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||14||
59715345|NCT01174446|75834140|FG000|NOT COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||0||
59715346|NCT01174446|75834141|FG001|NOT COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||0||
59824991|NCT00335829|75948067|FG000|Received First TACE|Overall Study|1 patient left after receiving bevacizumab but prior to first TACE|25||
59824992|NCT00335829|75948067|FG000|COMPLETED|Overall Study||23|Patients who were evaluable for tumor response for imaging outcomes|
59824993|NCT00335829|75948067|FG000|NOT COMPLETED|Overall Study||3||
59824994|NCT00344019|75948074|FG000|STARTED|Overall Study||12||
59824995|NCT00344019|75948075|FG001|STARTED|Overall Study||11||
59824996|NCT00344019|75948076|FG002|STARTED|Overall Study||74||
59824997|NCT00344019|75948074|FG000|COMPLETED|Overall Study||12||
59824998|NCT00344019|75948075|FG001|COMPLETED|Overall Study||11||
59824999|NCT00344019|75948076|FG002|COMPLETED|Overall Study||0||
59825000|NCT00344019|75948074|FG000|NOT COMPLETED|Overall Study||0||
59825001|NCT00344019|75948075|FG001|NOT COMPLETED|Overall Study||0||
59825002|NCT00344019|75948076|FG002|NOT COMPLETED|Overall Study||74||
59825003|NCT00535847|75948090|FG000|STARTED|Overall Study||81||
59825004|NCT00535847|75948091|FG001|STARTED|Overall Study||34||
59825005|NCT00535847|75948092|FG002|STARTED|Overall Study||2||
59825006|NCT00535847|75948090|FG000|COMPLETED|Overall Study||59||
59825007|NCT00535847|75948091|FG001|COMPLETED|Overall Study||20||
59825008|NCT00535847|75948092|FG002|COMPLETED|Overall Study||0||
59825009|NCT00535847|75948090|FG000|NOT COMPLETED|Overall Study||22||
59825010|NCT00535847|75948091|FG001|NOT COMPLETED|Overall Study||14||
60117045|NCT02314000|76237843|FG001|NOT COMPLETED|Overall Study||8||
60117046|NCT02051686|76237852|FG000|STARTED|Overall Study||42||
60117047|NCT02051686|76237853|FG001|STARTED|Overall Study||46||
60117048|NCT02051686|76237852|FG000|COMPLETED|Overall Study||42||
60117049|NCT02051686|76237853|FG001|COMPLETED|Overall Study||46||
60117050|NCT02051686|76237852|FG000|NOT COMPLETED|Overall Study||0||
60117051|NCT02051686|76237853|FG001|NOT COMPLETED|Overall Study||0||
60117052|NCT02407132|76237861|FG000|STARTED|Immediate Post-intervention||110||
60117053|NCT02407132|76237862|FG001|STARTED|Immediate Post-intervention||111||
60117054|NCT02407132|76237861|FG000|COMPLETED|Immediate Post-intervention||107||
60117055|NCT02407132|76237862|FG001|COMPLETED|Immediate Post-intervention||101||
60117056|NCT02407132|76237861|FG000|NOT COMPLETED|Immediate Post-intervention||3||
60117057|NCT02407132|76237862|FG001|NOT COMPLETED|Immediate Post-intervention||10||
60117058|NCT02407132|76237861|FG000|STARTED|6 Months Post-intervention||107|All participants were recontacted whether or not they completed post-intervention data collection.|
60117059|NCT02407132|76237862|FG001|STARTED|6 Months Post-intervention||101|All participants were recontacted whether or not they completed post-intervention data collection.|
60117060|NCT02407132|76237861|FG000|COMPLETED|6 Months Post-intervention||96||
60117061|NCT02407132|76237862|FG001|COMPLETED|6 Months Post-intervention||92||
60117062|NCT02407132|76237861|FG000|NOT COMPLETED|6 Months Post-intervention||11||
60117063|NCT02407132|76237862|FG001|NOT COMPLETED|6 Months Post-intervention||9||
59567318|NCT01497171|75670223|FG000|NOT COMPLETED|Overall Study||0||
59715347|NCT01174446|75834142|FG002|NOT COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||2||
59715348|NCT01174446|75834143|FG003|NOT COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||0||
59825011|NCT00535847|75948092|FG002|NOT COMPLETED|Overall Study||2||
59825012|NCT00334893|75948106|FG000|STARTED|Overall Study||37||
59825013|NCT00334893|75948107|FG001|STARTED|Overall Study||37||
59825014|NCT00334893|75948106|FG000|COMPLETED|Overall Study||36||
59825015|NCT00334893|75948107|FG001|COMPLETED|Overall Study||37||
59825016|NCT00334893|75948106|FG000|NOT COMPLETED|Overall Study||1||
59825017|NCT00334893|75948107|FG001|NOT COMPLETED|Overall Study||0||
59825018|NCT00334737|75948118|FG000|STARTED|Hospital Phase||34||
59825019|NCT00334737|75948119|FG001|STARTED|Hospital Phase||34||
59825020|NCT00334737|75948120|FG002|STARTED|Hospital Phase||34||
59825021|NCT00334737|75948118|FG000|COMPLETED|Hospital Phase||32||
59715349|NCT01174446|75834140|FG000|STARTED|Part 3 -Pharmacokinetic BAX326 Only|Includes all participants who completed Part 1|14||
59715350|NCT01174446|75834141|FG001|STARTED|Part 3 -Pharmacokinetic BAX326 Only|Includes all participants who completed Part 1|14||
59715351|NCT01174446|75834142|FG002|STARTED|Part 3 -Pharmacokinetic BAX326 Only||0||
59715352|NCT01174446|75834143|FG003|STARTED|Part 3 -Pharmacokinetic BAX326 Only||0||
59715353|NCT01174446|75834140|FG000|COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||13||
59715354|NCT01174446|75834141|FG001|COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||13||
59715355|NCT01174446|75834142|FG002|COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||0||
59715356|NCT01174446|75834143|FG003|COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||0||
59825022|NCT00334737|75948119|FG001|COMPLETED|Hospital Phase||32||
59825023|NCT00334737|75948120|FG002|COMPLETED|Hospital Phase||30||
59825024|NCT00334737|75948118|FG000|NOT COMPLETED|Hospital Phase||2||
59825025|NCT00334737|75948119|FG001|NOT COMPLETED|Hospital Phase||2||
59825026|NCT00334737|75948120|FG002|NOT COMPLETED|Hospital Phase||4||
59825027|NCT00334737|75948118|FG000|STARTED|Follow up Phase||32||
59825028|NCT00334737|75948119|FG001|STARTED|Follow up Phase||32||
59825029|NCT00334737|75948120|FG002|STARTED|Follow up Phase||30||
59825030|NCT00334737|75948118|FG000|COMPLETED|Follow up Phase||27||
59825031|NCT00334737|75948119|FG001|COMPLETED|Follow up Phase||29||
59825032|NCT00334737|75948120|FG002|COMPLETED|Follow up Phase||24||
59825033|NCT00334737|75948118|FG000|NOT COMPLETED|Follow up Phase||5||
60117064|NCT02407132|76237861|FG000|STARTED|12 Months Post-intervention||96|All participants were recontacted whether or not they completed previous data collection events.|
60117065|NCT02407132|76237862|FG001|STARTED|12 Months Post-intervention||92|All participants were recontacted whether or not they completed previous data collection events.|
60117066|NCT02407132|76237861|FG000|COMPLETED|12 Months Post-intervention||83||
60117067|NCT02407132|76237862|FG001|COMPLETED|12 Months Post-intervention||90||
60117068|NCT02407132|76237861|FG000|NOT COMPLETED|12 Months Post-intervention||13||
60117069|NCT02407132|76237862|FG001|NOT COMPLETED|12 Months Post-intervention||2||
60117070|NCT02052544|76237868|FG000|STARTED|Overall Study|First Subject In|123||
60117071|NCT02052544|76237868|FG000|COMPLETED|Overall Study|Last Subject Out|123||
60117072|NCT02052544|76237868|FG000|NOT COMPLETED|Overall Study||0||
60117073|NCT02387008|76237876|FG000|STARTED|Overall Study||2||
60117074|NCT02387008|76237877|FG001|STARTED|Overall Study||0||
60117075|NCT02387008|76237878|FG002|STARTED|Overall Study||4||
60117076|NCT02387008|76237876|FG000|COMPLETED|Overall Study||2||
60117077|NCT02387008|76237877|FG001|COMPLETED|Overall Study||0||
60117078|NCT02387008|76237878|FG002|COMPLETED|Overall Study||4||
60117079|NCT02387008|76237876|FG000|NOT COMPLETED|Overall Study||0||
59715357|NCT01174446|75834140|FG000|NOT COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||1||
59715358|NCT01174446|75834141|FG001|NOT COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||1||
59715359|NCT01174446|75834142|FG002|NOT COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||0||
59825034|NCT00334737|75948119|FG001|NOT COMPLETED|Follow up Phase||3||
59825035|NCT00334737|75948120|FG002|NOT COMPLETED|Follow up Phase||6||
59825036|NCT00427908|75948132|FG000|STARTED|Primary Phase||229||
59825037|NCT00427908|75948133|FG001|STARTED|Primary Phase||231||
59825038|NCT00427908|75948134|FG002|STARTED|Primary Phase||75||
59825039|NCT00427908|75948135|FG003|STARTED|Primary Phase||78||
59825040|NCT00427908|75948132|FG000|COMPLETED|Primary Phase||224||
59825041|NCT00427908|75948133|FG001|COMPLETED|Primary Phase||228||
59825042|NCT00427908|75948134|FG002|COMPLETED|Primary Phase||72||
59825043|NCT00427908|75948135|FG003|COMPLETED|Primary Phase||78||
59825044|NCT00427908|75948132|FG000|NOT COMPLETED|Primary Phase||5||
59825045|NCT00427908|75948133|FG001|NOT COMPLETED|Primary Phase||3||
59825046|NCT00427908|75948134|FG002|NOT COMPLETED|Primary Phase||3||
59825047|NCT00427908|75948135|FG003|NOT COMPLETED|Primary Phase||0||
59825048|NCT00427908|75948132|FG000|STARTED|Persistence Phase Year 1||222||
59825049|NCT00427908|75948133|FG001|STARTED|Persistence Phase Year 1||221||
59825050|NCT00427908|75948134|FG002|STARTED|Persistence Phase Year 1||71||
59825051|NCT00427908|75948135|FG003|STARTED|Persistence Phase Year 1||78||
59825052|NCT00427908|75948132|FG000|COMPLETED|Persistence Phase Year 1||222||
59825053|NCT00427908|75948133|FG001|COMPLETED|Persistence Phase Year 1||221||
59825054|NCT00427908|75948134|FG002|COMPLETED|Persistence Phase Year 1||71||
60117080|NCT02387008|76237877|FG001|NOT COMPLETED|Overall Study||0||
60117081|NCT02387008|76237878|FG002|NOT COMPLETED|Overall Study||0||
60117082|NCT02387476|76237888|FG000|STARTED|Overall Study||25||
60117083|NCT02387476|76237889|FG001|STARTED|Overall Study||22||
60117084|NCT02387476|76237888|FG000|COMPLETED|Overall Study||19||
60117085|NCT02387476|76237889|FG001|COMPLETED|Overall Study||17||
60117086|NCT02387476|76237888|FG000|NOT COMPLETED|Overall Study||6||
60117087|NCT02387476|76237889|FG001|NOT COMPLETED|Overall Study||5||
59567319|NCT01497171|75670224|FG001|NOT COMPLETED|Overall Study||0||
59567320|NCT01487499|75670230|FG000|STARTED|Overall Study||4||
59715360|NCT01174446|75834143|FG003|NOT COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||0||
59715361|NCT00932698|75834201|FG000|STARTED|Part 1 (Dose Escalation)||3||
59715362|NCT00932698|75834202|FG001|STARTED|Part 1 (Dose Escalation)||3||
59715363|NCT00932698|75834203|FG002|STARTED|Part 1 (Dose Escalation)||3||
59715364|NCT00932698|75834204|FG003|STARTED|Part 1 (Dose Escalation)||3||
59715365|NCT00932698|75834205|FG004|STARTED|Part 1 (Dose Escalation)||3||
59715366|NCT00932698|75834206|FG005|STARTED|Part 1 (Dose Escalation)||7||
59715367|NCT00932698|75834207|FG006|STARTED|Part 1 (Dose Escalation)||4||
59715368|NCT00932698|75834208|FG007|STARTED|Part 1 (Dose Escalation)||0||
59715369|NCT00932698|75834209|FG008|STARTED|Part 1 (Dose Escalation)||0||
59715370|NCT00932698|75834210|FG009|STARTED|Part 1 (Dose Escalation)||0||
60117088|NCT00182793|76237897|FG000|STARTED|Overall Study||32||
60117089|NCT00182793|76237897|FG000|COMPLETED|Overall Study||32||
59715371|NCT00932698|75834211|FG010|STARTED|Part 1 (Dose Escalation)||0||
59715372|NCT00932698|75834201|FG000|COMPLETED|Part 1 (Dose Escalation)||0||
59715373|NCT00932698|75834202|FG001|COMPLETED|Part 1 (Dose Escalation)||0||
59715374|NCT00932698|75834203|FG002|COMPLETED|Part 1 (Dose Escalation)||0||
59715375|NCT00932698|75834204|FG003|COMPLETED|Part 1 (Dose Escalation)||0||
60117090|NCT00182793|76237897|FG000|NOT COMPLETED|Overall Study||0||
60117091|NCT00183339|76237903|FG000|STARTED|Overall Study||10||
60117092|NCT00183339|76237904|FG001|STARTED|Overall Study||8||
60117093|NCT00183339|76237903|FG000|COMPLETED|Overall Study||4||
60117094|NCT00183339|76237904|FG001|COMPLETED|Overall Study||4||
60117095|NCT00183339|76237903|FG000|NOT COMPLETED|Overall Study||6||
60117096|NCT00183339|76237904|FG001|NOT COMPLETED|Overall Study||4||
60117097|NCT01743989|76237916|FG000|STARTED|Treatment Phase||120||
60117098|NCT01743989|76237917|FG001|STARTED|Treatment Phase||119||
60117099|NCT01743989|76237918|FG002|STARTED|Treatment Phase||381||
59715376|NCT00932698|75834205|FG004|COMPLETED|Part 1 (Dose Escalation)||0||
59825055|NCT00427908|75948135|FG003|COMPLETED|Persistence Phase Year 1||78||
59825056|NCT00427908|75948132|FG000|NOT COMPLETED|Persistence Phase Year 1||0||
59825057|NCT00427908|75948133|FG001|NOT COMPLETED|Persistence Phase Year 1||0||
59825058|NCT00427908|75948134|FG002|NOT COMPLETED|Persistence Phase Year 1||0||
59825059|NCT00427908|75948135|FG003|NOT COMPLETED|Persistence Phase Year 1||0||
59825060|NCT00427908|75948132|FG000|STARTED|Persistence Phase Year 2||208||
59825061|NCT00427908|75948133|FG001|STARTED|Persistence Phase Year 2||215||
60117100|NCT01743989|76237916|FG000|Participants Who Signed Informed Consent|Treatment Phase||120|Participants for whom informed consent was obtained prior to any study specific procedure|
60117101|NCT01743989|76237917|FG001|Participants Who Signed Informed Consent|Treatment Phase||118|Participants for whom informed consent was obtained prior to any study specific procedure|
60117102|NCT01743989|76237918|FG002|Participants Who Signed Informed Consent|Treatment Phase||381|Participants for whom informed consent was obtained prior to any study specific procedure|
60117103|NCT01743989|76237916|FG000|COMPLETED|Treatment Phase||119||
59567321|NCT01487499|75670230|FG000|COMPLETED|Overall Study||4||
59825062|NCT00427908|75948134|FG002|STARTED|Persistence Phase Year 2||53||
59825063|NCT00427908|75948135|FG003|STARTED|Persistence Phase Year 2||61||
59825064|NCT00427908|75948132|FG000|COMPLETED|Persistence Phase Year 2||208||
59825065|NCT00427908|75948133|FG001|COMPLETED|Persistence Phase Year 2||215||
60117104|NCT01743989|76237917|FG001|COMPLETED|Treatment Phase||104||
60117105|NCT01743989|76237918|FG002|COMPLETED|Treatment Phase||0||
60117106|NCT01743989|76237916|FG000|NOT COMPLETED|Treatment Phase||1||
60117107|NCT01743989|76237917|FG001|NOT COMPLETED|Treatment Phase||15||
60117108|NCT01743989|76237918|FG002|NOT COMPLETED|Treatment Phase||381||
60117109|NCT01743989|76237916|FG000|STARTED|TFR Phase||119||
60117110|NCT01743989|76237917|FG001|STARTED|TFR Phase||104||
60117111|NCT01743989|76237918|FG002|STARTED|TFR Phase||0||
60117112|NCT01743989|76237916|FG000|COMPLETED|TFR Phase||37||
60117113|NCT01743989|76237917|FG001|COMPLETED|TFR Phase||36||
60117114|NCT01743989|76237918|FG002|COMPLETED|TFR Phase||0||
60117115|NCT01743989|76237916|FG000|NOT COMPLETED|TFR Phase||82||
60117116|NCT01743989|76237917|FG001|NOT COMPLETED|TFR Phase||68||
60117117|NCT01743989|76237918|FG002|NOT COMPLETED|TFR Phase||0||
60117118|NCT01743989|76237916|FG000|STARTED|Re-treatment Phase||74||
60117119|NCT01743989|76237917|FG001|STARTED|Re-treatment Phase||55||
60117120|NCT01743989|76237918|FG002|STARTED|Re-treatment Phase||0||
60117121|NCT01743989|76237916|FG000|COMPLETED|Re-treatment Phase||58||
60117122|NCT01743989|76237917|FG001|COMPLETED|Re-treatment Phase||46||
60117123|NCT01743989|76237918|FG002|COMPLETED|Re-treatment Phase||0||
60117124|NCT01743989|76237916|FG000|NOT COMPLETED|Re-treatment Phase||16||
59715377|NCT00932698|75834206|FG005|COMPLETED|Part 1 (Dose Escalation)|6 participants from 2.0 mg/m^2 dose cohort transitioned to dose expansion cohort: 5 in RR, 1 in VR.|0||
59715378|NCT00932698|75834207|FG006|COMPLETED|Part 1 (Dose Escalation)||0||
59715379|NCT00932698|75834208|FG007|COMPLETED|Part 1 (Dose Escalation)||0||
59715380|NCT00932698|75834209|FG008|COMPLETED|Part 1 (Dose Escalation)||0||
59715381|NCT00932698|75834210|FG009|COMPLETED|Part 1 (Dose Escalation)||0||
60117125|NCT01743989|76237917|FG001|NOT COMPLETED|Re-treatment Phase||9||
60117126|NCT01743989|76237918|FG002|NOT COMPLETED|Re-treatment Phase||0||
60117127|NCT00183729|76237931|FG000|STARTED|Overall Study||17||
60117128|NCT00183729|76237932|FG001|STARTED|Overall Study||18||
60117129|NCT00183729|76237931|FG000|COMPLETED|Overall Study||14||
60117130|NCT00183729|76237932|FG001|COMPLETED|Overall Study||13||
60117131|NCT00183729|76237931|FG000|NOT COMPLETED|Overall Study||3||
60117132|NCT00183729|76237932|FG001|NOT COMPLETED|Overall Study||5||
60117133|NCT00185679|76237938|FG000|STARTED|Overall Study||13||
60117134|NCT00185679|76237938|FG000|COMPLETED|Overall Study||13||
60117135|NCT00185679|76237938|FG000|NOT COMPLETED|Overall Study||0||
60117136|NCT00186069|76237944|FG000|STARTED|Overall Study|Enrollment goal was not reached due to the introduction of magnesium sulfate for neuroprotection|15||
60117137|NCT00186069|76237945|FG001|STARTED|Overall Study|Enrollment goal was not reached due to the introduction of magnesium sulfate for neuroprotection|15||
60117138|NCT00186069|76237944|FG000|COMPLETED|Overall Study||15||
60117139|NCT00186069|76237945|FG001|COMPLETED|Overall Study||15||
60117140|NCT00186069|76237944|FG000|NOT COMPLETED|Overall Study||0||
60117141|NCT00186069|76237945|FG001|NOT COMPLETED|Overall Study||0||
60117142|NCT01605461|76237951|FG000|STARTED|Overall Study||12||
60117143|NCT01605461|76237951|FG000|COMPLETED|Overall Study||8||
60117144|NCT01605461|76237951|FG000|NOT COMPLETED|Overall Study||4||
60117145|NCT01742897|76237955|FG000|STARTED|Overall Study||35||
60117146|NCT01742897|76237955|FG000|Treated|Overall Study||33||
60117147|NCT01742897|76237955|FG000|COMPLETED|Overall Study||30||
60117148|NCT01742897|76237955|FG000|NOT COMPLETED|Overall Study||5||
60117149|NCT01715831|76237959|FG000|STARTED|Overall Study||26||
60117150|NCT01715831|76237959|FG000|COMPLETED|Overall Study||25||
60117151|NCT01715831|76237959|FG000|NOT COMPLETED|Overall Study||1||
60117152|NCT01741259|76237965|FG000|STARTED|Overall Study||133||
60117153|NCT01741259|76237966|FG001|STARTED|Overall Study||135||
60117154|NCT01741259|76237965|FG000|COMPLETED|Overall Study||127||
60117155|NCT01741259|76237966|FG001|COMPLETED|Overall Study||129||
60117156|NCT01741259|76237965|FG000|NOT COMPLETED|Overall Study||6||
59715382|NCT00932698|75834211|FG010|COMPLETED|Part 1 (Dose Escalation)||0||
59715383|NCT00932698|75834201|FG000|NOT COMPLETED|Part 1 (Dose Escalation)||3||
59715384|NCT00932698|75834202|FG001|NOT COMPLETED|Part 1 (Dose Escalation)||3||
59715385|NCT00932698|75834203|FG002|NOT COMPLETED|Part 1 (Dose Escalation)||3||
59715386|NCT00932698|75834204|FG003|NOT COMPLETED|Part 1 (Dose Escalation)||3||
60117157|NCT01741259|76237966|FG001|NOT COMPLETED|Overall Study||6||
60117158|NCT01715129|76237972|FG000|STARTED|Overall Study||126||
60117159|NCT01715129|76237972|FG000|COMPLETED|Overall Study||117||
60117160|NCT01715129|76237972|FG000|NOT COMPLETED|Overall Study||9||
60117161|NCT02407756|76237980|FG000|STARTED|Overall Study||20||
60117162|NCT02407756|76237981|FG001|STARTED|Overall Study||18||
60117163|NCT02407756|76237982|FG002|STARTED|Overall Study||20||
60117164|NCT02407756|76237983|FG003|STARTED|Overall Study||19||
60117165|NCT02407756|76237980|FG000|Treated|Overall Study||20||
60117166|NCT02407756|76237981|FG001|Treated|Overall Study||18||
60117167|NCT02407756|76237982|FG002|Treated|Overall Study||20||
60117168|NCT02407756|76237983|FG003|Treated|Overall Study||19||
60117169|NCT02407756|76237980|FG000|COMPLETED|Overall Study||20||
59567322|NCT01487499|75670230|FG000|NOT COMPLETED|Overall Study||0||
59567323|NCT01483209|75670234|FG000|STARTED|Overall Study||2||
59567324|NCT01483209|75670234|FG000|COMPLETED|Overall Study||1||
59567325|NCT01483209|75670234|FG000|NOT COMPLETED|Overall Study||1||
59567326|NCT02281448|75670240|FG000|STARTED|Overall Study||10||
59567327|NCT02281448|75670241|FG001|STARTED|Overall Study||10||
59715387|NCT00932698|75834205|FG004|NOT COMPLETED|Part 1 (Dose Escalation)||3||
60117170|NCT02407756|76237981|FG001|COMPLETED|Overall Study||18||
60117171|NCT02407756|76237982|FG002|COMPLETED|Overall Study||20||
60117172|NCT02407756|76237983|FG003|COMPLETED|Overall Study||19||
60117173|NCT02407756|76237980|FG000|NOT COMPLETED|Overall Study||0||
60117174|NCT02407756|76237981|FG001|NOT COMPLETED|Overall Study||0||
59567328|NCT02281448|75670240|FG000|COMPLETED|Overall Study||8||
59825066|NCT00427908|75948134|FG002|COMPLETED|Persistence Phase Year 2||53||
59825067|NCT00427908|75948135|FG003|COMPLETED|Persistence Phase Year 2||61||
59825068|NCT00427908|75948132|FG000|NOT COMPLETED|Persistence Phase Year 2||0||
60117175|NCT02407756|76237982|FG002|NOT COMPLETED|Overall Study||0||
60117176|NCT02407756|76237983|FG003|NOT COMPLETED|Overall Study||0||
60117177|NCT02387554|76237997|FG000|STARTED|Overall Study|A,C,ALC: intervention (8 days), L: intervention (4 days), Each period washout (14days)|10||
60117178|NCT02387554|76237998|FG001|STARTED|Overall Study|A,C,ALC: intervention (8 days), L: intervention (4 days), Each period washout (14days)|7||
60117179|NCT02387554|76237999|FG002|STARTED|Overall Study|A,C,ALC: intervention (8 days), L: intervention (4 days), Each period washout (14days)|8||
60117180|NCT02387554|76238000|FG003|STARTED|Overall Study|A,C,ALC: intervention (8 days), L: intervention (4 days), Each period washout (14days)|8||
60117181|NCT02387554|76237997|FG000|COMPLETED|Overall Study||7||
60117182|NCT02387554|76237998|FG001|COMPLETED|Overall Study||7||
60117183|NCT02387554|76237999|FG002|COMPLETED|Overall Study||6||
60117184|NCT02387554|76238000|FG003|COMPLETED|Overall Study||6||
60117185|NCT02387554|76237997|FG000|NOT COMPLETED|Overall Study||3||
60117186|NCT02387554|76237998|FG001|NOT COMPLETED|Overall Study||0||
60117187|NCT02387554|76237999|FG002|NOT COMPLETED|Overall Study||2||
60117188|NCT02387554|76238000|FG003|NOT COMPLETED|Overall Study||2||
60117189|NCT02408692|76238013|FG000|STARTED|Overall Study||5||
60117190|NCT02408692|76238014|FG001|STARTED|Overall Study||5||
60117191|NCT02408692|76238015|FG002|STARTED|Overall Study||5||
60117192|NCT02408692|76238013|FG000|COMPLETED|Overall Study||5||
60117193|NCT02408692|76238014|FG001|COMPLETED|Overall Study||5||
60117194|NCT02408692|76238015|FG002|COMPLETED|Overall Study||5||
60117195|NCT02408692|76238013|FG000|NOT COMPLETED|Overall Study||0||
60117196|NCT02408692|76238014|FG001|NOT COMPLETED|Overall Study||0||
60117197|NCT02408692|76238015|FG002|NOT COMPLETED|Overall Study||0||
60117198|NCT02387710|76238023|FG000|STARTED|First Study Night||9||
60117199|NCT02387710|76238024|FG001|STARTED|First Study Night||9||
60117200|NCT02387710|76238023|FG000|COMPLETED|First Study Night||9||
59825069|NCT00427908|75948133|FG001|NOT COMPLETED|Persistence Phase Year 2||0||
59825070|NCT00427908|75948134|FG002|NOT COMPLETED|Persistence Phase Year 2||0||
59825071|NCT00427908|75948135|FG003|NOT COMPLETED|Persistence Phase Year 2||0||
59825072|NCT00427908|75948132|FG000|STARTED|Persistence Phase Year 3||185||
59825073|NCT00427908|75948133|FG001|STARTED|Persistence Phase Year 3||201||
59825074|NCT00427908|75948134|FG002|STARTED|Persistence Phase Year 3||38||
59825075|NCT00427908|75948135|FG003|STARTED|Persistence Phase Year 3||38||
59825076|NCT00427908|75948132|FG000|COMPLETED|Persistence Phase Year 3||185||
59825077|NCT00427908|75948133|FG001|COMPLETED|Persistence Phase Year 3||201||
59825078|NCT00427908|75948134|FG002|COMPLETED|Persistence Phase Year 3||38||
59825079|NCT00427908|75948135|FG003|COMPLETED|Persistence Phase Year 3||38||
59825080|NCT00427908|75948132|FG000|NOT COMPLETED|Persistence Phase Year 3||0||
59825081|NCT00427908|75948133|FG001|NOT COMPLETED|Persistence Phase Year 3||0||
59825082|NCT00427908|75948134|FG002|NOT COMPLETED|Persistence Phase Year 3||0||
59825083|NCT00427908|75948135|FG003|NOT COMPLETED|Persistence Phase Year 3||0||
59825084|NCT00427908|75948132|FG000|STARTED|Persistence Phase Year 4||165||
59825085|NCT00427908|75948133|FG001|STARTED|Persistence Phase Year 4||192||
59825086|NCT00427908|75948134|FG002|STARTED|Persistence Phase Year 4||34||
59825087|NCT00427908|75948135|FG003|STARTED|Persistence Phase Year 4||32||
59825088|NCT00427908|75948132|FG000|COMPLETED|Persistence Phase Year 4||165||
59825089|NCT00427908|75948133|FG001|COMPLETED|Persistence Phase Year 4||192||
59825090|NCT00427908|75948134|FG002|COMPLETED|Persistence Phase Year 4||34||
59825091|NCT00427908|75948135|FG003|COMPLETED|Persistence Phase Year 4||32||
59825092|NCT00427908|75948132|FG000|NOT COMPLETED|Persistence Phase Year 4||0||
60117201|NCT02387710|76238024|FG001|COMPLETED|First Study Night||9||
60117202|NCT02387710|76238023|FG000|NOT COMPLETED|First Study Night||0||
60117203|NCT02387710|76238024|FG001|NOT COMPLETED|First Study Night||0||
60117204|NCT02387710|76238023|FG000|STARTED|Second Study Night||9||
60117205|NCT02387710|76238024|FG001|STARTED|Second Study Night|2 patients did not come back for excessive sleep disruption due to the equipment|7||
60117206|NCT02387710|76238023|FG000|COMPLETED|Second Study Night||9||
60117207|NCT02387710|76238024|FG001|COMPLETED|Second Study Night||7||
60117208|NCT02387710|76238023|FG000|NOT COMPLETED|Second Study Night||0||
60117209|NCT02387710|76238024|FG001|NOT COMPLETED|Second Study Night||0||
60117210|NCT02409784|76238032|FG000|STARTED|Overall Study||10||
60117211|NCT02409784|76238032|FG000|COMPLETED|Overall Study||10||
60117212|NCT02409784|76238032|FG000|NOT COMPLETED|Overall Study||0||
60117213|NCT02388568|76238039|FG000|STARTED|Overall Study||69||
60117214|NCT02388568|76238040|FG001|STARTED|Overall Study||68||
60117215|NCT02388568|76238039|FG000|COMPLETED|Overall Study||59||
60117216|NCT02388568|76238040|FG001|COMPLETED|Overall Study||53||
60117217|NCT02388568|76238039|FG000|NOT COMPLETED|Overall Study||10||
59825093|NCT00427908|75948133|FG001|NOT COMPLETED|Persistence Phase Year 4||0||
60117218|NCT02388568|76238040|FG001|NOT COMPLETED|Overall Study||15||
60117219|NCT02388646|76238049|FG000|STARTED|Overall Study||20||
60117220|NCT02388646|76238050|FG001|STARTED|Overall Study||20||
60117221|NCT02388646|76238051|FG002|STARTED|Overall Study||20||
60117222|NCT02388646|76238049|FG000|COMPLETED|Overall Study||16||
60117223|NCT02388646|76238050|FG001|COMPLETED|Overall Study||19||
59825094|NCT00427908|75948134|FG002|NOT COMPLETED|Persistence Phase Year 4||0||
59825095|NCT00427908|75948135|FG003|NOT COMPLETED|Persistence Phase Year 4||0||
59825096|NCT00427908|75948132|FG000|STARTED|Persistence Phase Year 5||52||
59825097|NCT00427908|75948133|FG001|STARTED|Persistence Phase Year 5||99||
59825098|NCT00427908|75948134|FG002|STARTED|Persistence Phase Year 5||12||
59825099|NCT00427908|75948135|FG003|STARTED|Persistence Phase Year 5||13||
59825100|NCT00427908|75948132|FG000|COMPLETED|Persistence Phase Year 5||52||
59825101|NCT00427908|75948133|FG001|COMPLETED|Persistence Phase Year 5||99||
59825102|NCT00427908|75948134|FG002|COMPLETED|Persistence Phase Year 5||12||
59825103|NCT00427908|75948135|FG003|COMPLETED|Persistence Phase Year 5||13||
59825104|NCT00427908|75948132|FG000|NOT COMPLETED|Persistence Phase Year 5||0||
59825105|NCT00427908|75948133|FG001|NOT COMPLETED|Persistence Phase Year 5||0||
59825106|NCT00427908|75948134|FG002|NOT COMPLETED|Persistence Phase Year 5||0||
59825107|NCT00427908|75948135|FG003|NOT COMPLETED|Persistence Phase Year 5||0||
59825108|NCT00334113|75948172|FG000|STARTED|Overall Study||32||
59825109|NCT00334113|75948173|FG001|STARTED|Overall Study||34||
59825110|NCT00334113|75948172|FG000|COMPLETED|Overall Study||30||
59825111|NCT00334113|75948173|FG001|COMPLETED|Overall Study||31||
59825112|NCT00334113|75948172|FG000|NOT COMPLETED|Overall Study||2||
59825113|NCT00334113|75948173|FG001|NOT COMPLETED|Overall Study||3||
59825114|NCT00416598|75948179|FG000|STARTED|Induction & Intensification||546||
59825115|NCT00416598|75948179|FG000|COMPLETED|Induction & Intensification||134||
59825116|NCT00416598|75948179|FG000|NOT COMPLETED|Induction & Intensification||412||
59825117|NCT00416598|75948179|FG000|STARTED|Decitabine Maintenance||134||
59825118|NCT00416598|75948179|FG000|COMPLETED|Decitabine Maintenance||62||
59825119|NCT00416598|75948179|FG000|NOT COMPLETED|Decitabine Maintenance||72||
59825120|NCT00534599|75948185|FG000|STARTED|Overall Study|Randomized|209||
59825121|NCT00534599|75948186|FG001|STARTED|Overall Study|Randomized|200||
59825122|NCT00534599|75948185|FG000|COMPLETED|Overall Study||152||
59825123|NCT00534599|75948186|FG001|COMPLETED|Overall Study||168||
59825124|NCT00534599|75948185|FG000|NOT COMPLETED|Overall Study||57||
59825125|NCT00534599|75948186|FG001|NOT COMPLETED|Overall Study||32||
59825126|NCT01913795|75948196|FG000|STARTED|Overall Study||4||
59715388|NCT00932698|75834206|FG005|NOT COMPLETED|Part 1 (Dose Escalation)||7||
59715389|NCT00932698|75834207|FG006|NOT COMPLETED|Part 1 (Dose Escalation)||4||
59715390|NCT00932698|75834208|FG007|NOT COMPLETED|Part 1 (Dose Escalation)||0||
59715391|NCT00932698|75834209|FG008|NOT COMPLETED|Part 1 (Dose Escalation)||0||
59715392|NCT00932698|75834210|FG009|NOT COMPLETED|Part 1 (Dose Escalation)||0||
59715393|NCT00932698|75834211|FG010|NOT COMPLETED|Part 1 (Dose Escalation)||0||
59715394|NCT00932698|75834201|FG000|STARTED|Part 2 (Dose Expansion)||0||
59715395|NCT00932698|75834202|FG001|STARTED|Part 2 (Dose Expansion)||0||
59715396|NCT00932698|75834203|FG002|STARTED|Part 2 (Dose Expansion)||0||
59715397|NCT00932698|75834204|FG003|STARTED|Part 2 (Dose Expansion)||0||
59715398|NCT00932698|75834205|FG004|STARTED|Part 2 (Dose Expansion)||0||
59715399|NCT00932698|75834206|FG005|STARTED|Part 2 (Dose Expansion)||0||
59715400|NCT00932698|75834207|FG006|STARTED|Part 2 (Dose Expansion)||0||
59715401|NCT00932698|75834208|FG007|STARTED|Part 2 (Dose Expansion)||20||
59715402|NCT00932698|75834209|FG008|STARTED|Part 2 (Dose Expansion)||12||
59715403|NCT00932698|75834210|FG009|STARTED|Part 2 (Dose Expansion)||6||
59715404|NCT00932698|75834211|FG010|STARTED|Part 2 (Dose Expansion)||2||
59715405|NCT00932698|75834201|FG000|COMPLETED|Part 2 (Dose Expansion)||0||
59715406|NCT00932698|75834202|FG001|COMPLETED|Part 2 (Dose Expansion)||0||
59715407|NCT00932698|75834203|FG002|COMPLETED|Part 2 (Dose Expansion)||0||
59715408|NCT00932698|75834204|FG003|COMPLETED|Part 2 (Dose Expansion)||0||
59715409|NCT00932698|75834205|FG004|COMPLETED|Part 2 (Dose Expansion)||0||
59715410|NCT00932698|75834206|FG005|COMPLETED|Part 2 (Dose Expansion)||0||
59715411|NCT00932698|75834207|FG006|COMPLETED|Part 2 (Dose Expansion)||0||
59715412|NCT00932698|75834208|FG007|COMPLETED|Part 2 (Dose Expansion)||0||
59825127|NCT01913795|75948197|FG001|STARTED|Overall Study||10||
59825128|NCT01913795|75948198|FG002|STARTED|Overall Study||9||
59825129|NCT01913795|75948199|FG003|STARTED|Overall Study||6||
59825130|NCT01913795|75948196|FG000|COMPLETED|Overall Study||4||
59825131|NCT01913795|75948197|FG001|COMPLETED|Overall Study||7||
59825132|NCT01913795|75948198|FG002|COMPLETED|Overall Study||9||
59825133|NCT01913795|75948199|FG003|COMPLETED|Overall Study||5||
59825134|NCT01913795|75948196|FG000|NOT COMPLETED|Overall Study||0||
59825135|NCT01913795|75948197|FG001|NOT COMPLETED|Overall Study||3||
59825136|NCT01913795|75948198|FG002|NOT COMPLETED|Overall Study||0||
59825137|NCT01913795|75948199|FG003|NOT COMPLETED|Overall Study||1||
59825138|NCT03892889|75948209|FG000|STARTED|Overall Study||277||
59825139|NCT03892889|75948209|FG000|COMPLETED|Overall Study||73||
59825140|NCT03892889|75948209|FG000|NOT COMPLETED|Overall Study||204||
59825141|NCT00473330|75948216|FG000|STARTED|Core Study||125||
59825142|NCT00473330|75948217|FG001|STARTED|Core Study||125||
59825143|NCT00473330|75948218|FG002|STARTED|Core Study||127||
59825144|NCT00473330|75948216|FG000|COMPLETED|Core Study||98||
59825145|NCT00473330|75948217|FG001|COMPLETED|Core Study||100||
59825146|NCT00473330|75948218|FG002|COMPLETED|Core Study||86||
59715413|NCT00932698|75834209|FG008|COMPLETED|Part 2 (Dose Expansion)||0||
59715414|NCT00932698|75834210|FG009|COMPLETED|Part 2 (Dose Expansion)||0||
59715415|NCT00932698|75834211|FG010|COMPLETED|Part 2 (Dose Expansion)||0||
60117224|NCT02388646|76238051|FG002|COMPLETED|Overall Study||14||
60117225|NCT02388646|76238049|FG000|NOT COMPLETED|Overall Study||4||
60117226|NCT02388646|76238050|FG001|NOT COMPLETED|Overall Study||1||
60117227|NCT02388646|76238051|FG002|NOT COMPLETED|Overall Study||6||
59715416|NCT00932698|75834201|FG000|NOT COMPLETED|Part 2 (Dose Expansion)||0||
59715417|NCT00932698|75834202|FG001|NOT COMPLETED|Part 2 (Dose Expansion)||0||
59825147|NCT00473330|75948216|FG000|NOT COMPLETED|Core Study||27||
59825148|NCT00473330|75948217|FG001|NOT COMPLETED|Core Study||25||
59825149|NCT00473330|75948218|FG002|NOT COMPLETED|Core Study||41||
59825150|NCT00473330|75948216|FG000|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|89||
59825151|NCT00473330|75948217|FG001|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|79||
59825152|NCT00473330|75948218|FG002|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|77||
59567329|NCT02281448|75670241|FG001|COMPLETED|Overall Study||9||
59567330|NCT02281448|75670240|FG000|NOT COMPLETED|Overall Study||2||
59567331|NCT02281448|75670241|FG001|NOT COMPLETED|Overall Study||1||
59715418|NCT00932698|75834203|FG002|NOT COMPLETED|Part 2 (Dose Expansion)||0||
59715419|NCT00932698|75834204|FG003|NOT COMPLETED|Part 2 (Dose Expansion)||0||
59715420|NCT00932698|75834205|FG004|NOT COMPLETED|Part 2 (Dose Expansion)||0||
59825153|NCT00473330|75948216|FG000|COMPLETED|Open-label Extension Through Month 48||63||
59825154|NCT00473330|75948217|FG001|COMPLETED|Open-label Extension Through Month 48||59||
59825155|NCT00473330|75948218|FG002|COMPLETED|Open-label Extension Through Month 48||50||
59825156|NCT00473330|75948216|FG000|NOT COMPLETED|Open-label Extension Through Month 48||26||
59825157|NCT00473330|75948217|FG001|NOT COMPLETED|Open-label Extension Through Month 48||20||
59715421|NCT00932698|75834206|FG005|NOT COMPLETED|Part 2 (Dose Expansion)||0||
59715422|NCT00932698|75834207|FG006|NOT COMPLETED|Part 2 (Dose Expansion)||0||
59715423|NCT00932698|75834208|FG007|NOT COMPLETED|Part 2 (Dose Expansion)||20||
59715424|NCT00932698|75834209|FG008|NOT COMPLETED|Part 2 (Dose Expansion)||12||
59715425|NCT00932698|75834210|FG009|NOT COMPLETED|Part 2 (Dose Expansion)||6||
59715426|NCT00932698|75834211|FG010|NOT COMPLETED|Part 2 (Dose Expansion)||2||
59715427|NCT00978627|75834239|FG000|STARTED|Main: Week 0 to 26 (NN5401-3594)||366||
59715428|NCT00978627|75834240|FG001|STARTED|Main: Week 0 to 26 (NN5401-3594)||182||
59715429|NCT00978627|75834239|FG000|Exposed|Main: Week 0 to 26 (NN5401-3594)|Four subjects withdrew prior to exposure to trial products|362||
59715430|NCT00978627|75834240|FG001|Exposed|Main: Week 0 to 26 (NN5401-3594)|Two subjects withdrew prior to exposure to trial products|180||
59715431|NCT00978627|75834239|FG000|COMPLETED|Main: Week 0 to 26 (NN5401-3594)||320||
59715432|NCT00978627|75834240|FG001|COMPLETED|Main: Week 0 to 26 (NN5401-3594)||156||
59715433|NCT00978627|75834239|FG000|NOT COMPLETED|Main: Week 0 to 26 (NN5401-3594)||46||
59825158|NCT00473330|75948218|FG002|NOT COMPLETED|Open-label Extension Through Month 48||27||
60000270|NCT02712983|76116056|FG003|STARTED|Treatment Phase||15|All randomized patients (Full Analysis Set and Safety Set)|
60000271|NCT02712983|76116057|FG004|STARTED|Treatment Phase||14|All randomized patients (Full Analysis Set and Safety Set)|
60000272|NCT02712983|76116058|FG005|STARTED|Treatment Phase||7|All randomized patients (Full Analysis Set and Safety Set)|
60000273|NCT02712983|76116059|FG006|STARTED|Treatment Phase||15|All randomized patients (Full Analysis Set and Safety Set)|
59567332|NCT02281526|75670249|FG000|STARTED|Overall Study||9||
60000274|NCT02712983|76116060|FG007|STARTED|Treatment Phase||15|All randomized patients (Full Analysis Set and Safety Set)|
60000275|NCT02712983|76116061|FG008|STARTED|Treatment Phase||7|All randomized patients (Full Analysis Set and Safety Set)|
60000276|NCT02712983|76116053|FG000|Pharmacokinetic Analysis Set|Treatment Phase||14||
60000277|NCT02712983|76116054|FG001|Pharmacokinetic Analysis Set|Treatment Phase||13||
60000278|NCT02712983|76116055|FG002|Pharmacokinetic Analysis Set|Treatment Phase||0||
60000279|NCT02712983|76116056|FG003|Pharmacokinetic Analysis Set|Treatment Phase||15||
60000280|NCT02712983|76116057|FG004|Pharmacokinetic Analysis Set|Treatment Phase||14||
60000281|NCT02712983|76116058|FG005|Pharmacokinetic Analysis Set|Treatment Phase||0||
60000282|NCT02712983|76116059|FG006|Pharmacokinetic Analysis Set|Treatment Phase||15||
60000283|NCT02712983|76116060|FG007|Pharmacokinetic Analysis Set|Treatment Phase||14||
60000284|NCT02712983|76116061|FG008|Pharmacokinetic Analysis Set|Treatment Phase||0||
60000285|NCT02712983|76116053|FG000|COMPLETED|Treatment Phase||9||
60000286|NCT02712983|76116054|FG001|COMPLETED|Treatment Phase||12||
60000287|NCT02712983|76116055|FG002|COMPLETED|Treatment Phase||6||
60000288|NCT02712983|76116056|FG003|COMPLETED|Treatment Phase||7||
60000289|NCT02712983|76116057|FG004|COMPLETED|Treatment Phase||10||
60000290|NCT02712983|76116058|FG005|COMPLETED|Treatment Phase||7||
60000291|NCT02712983|76116059|FG006|COMPLETED|Treatment Phase||6||
60000292|NCT02712983|76116060|FG007|COMPLETED|Treatment Phase||6||
60000293|NCT02712983|76116061|FG008|COMPLETED|Treatment Phase||5||
60000294|NCT02712983|76116053|FG000|NOT COMPLETED|Treatment Phase||5||
60000295|NCT02712983|76116054|FG001|NOT COMPLETED|Treatment Phase||1||
60000296|NCT02712983|76116055|FG002|NOT COMPLETED|Treatment Phase||1||
60000297|NCT02712983|76116056|FG003|NOT COMPLETED|Treatment Phase||8||
60000298|NCT02712983|76116057|FG004|NOT COMPLETED|Treatment Phase||4||
60000299|NCT02712983|76116058|FG005|NOT COMPLETED|Treatment Phase||0||
60000300|NCT02712983|76116059|FG006|NOT COMPLETED|Treatment Phase||9||
59825159|NCT00473330|75948216|FG000|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|89||
60117228|NCT01740791|76238065|FG000|STARTED|Overall Study||22||
60117229|NCT01740791|76238066|FG001|STARTED|Overall Study||7||
59715434|NCT00978627|75834240|FG001|NOT COMPLETED|Main: Week 0 to 26 (NN5401-3594)||26||
59715435|NCT00978627|75834239|FG000|STARTED|Extension: Week 27 to 52 (NN5401-3645)|Sixty six subjects from main trial did not continue into extension trial|254||
59825160|NCT00473330|75948217|FG001|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|79||
59825161|NCT00473330|75948218|FG002|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|77||
59825162|NCT00473330|75948216|FG000|COMPLETED|Open-label Extension Through Month 60||1||
59825163|NCT00473330|75948217|FG001|COMPLETED|Open-label Extension Through Month 60||1||
59825164|NCT00473330|75948218|FG002|COMPLETED|Open-label Extension Through Month 60||0||
59825165|NCT00473330|75948216|FG000|NOT COMPLETED|Open-label Extension Through Month 60||88||
59825166|NCT00473330|75948217|FG001|NOT COMPLETED|Open-label Extension Through Month 60||78||
59825167|NCT00473330|75948218|FG002|NOT COMPLETED|Open-label Extension Through Month 60||77||
59825168|NCT00416520|75948248|FG000|STARTED|Open-label Period||165||
59825169|NCT00416520|75948249|FG001|STARTED|Open-label Period||171||
59825170|NCT00416520|75948250|FG002|STARTED|Open-label Period||0||
59825171|NCT00416520|75948251|FG003|STARTED|Open-label Period||0||
59825172|NCT00416520|75948248|FG000|COMPLETED|Open-label Period||105||
59825173|NCT00416520|75948249|FG001|COMPLETED|Open-label Period||139||
59825174|NCT00416520|75948250|FG002|COMPLETED|Open-label Period||0||
59825175|NCT00416520|75948251|FG003|COMPLETED|Open-label Period||0||
59825176|NCT00416520|75948248|FG000|NOT COMPLETED|Open-label Period||60||
59825177|NCT00416520|75948249|FG001|NOT COMPLETED|Open-label Period||32||
59825178|NCT00416520|75948250|FG002|NOT COMPLETED|Open-label Period||0||
59825179|NCT00416520|75948251|FG003|NOT COMPLETED|Open-label Period||0||
59825180|NCT00416520|75948248|FG000|STARTED|Placebo-controlled Withdrawal Period||0||
59825181|NCT00416520|75948249|FG001|STARTED|Placebo-controlled Withdrawal Period||0||
59825182|NCT00416520|75948250|FG002|STARTED|Placebo-controlled Withdrawal Period||50||
59825183|NCT00416520|75948251|FG003|STARTED|Placebo-controlled Withdrawal Period||54||
59825184|NCT00416520|75948248|FG000|COMPLETED|Placebo-controlled Withdrawal Period||0||
59825185|NCT00416520|75948249|FG001|COMPLETED|Placebo-controlled Withdrawal Period||0||
59825186|NCT00416520|75948250|FG002|COMPLETED|Placebo-controlled Withdrawal Period||49||
59825187|NCT00416520|75948251|FG003|COMPLETED|Placebo-controlled Withdrawal Period||49||
59825188|NCT00416520|75948248|FG000|NOT COMPLETED|Placebo-controlled Withdrawal Period||0||
59825189|NCT00416520|75948249|FG001|NOT COMPLETED|Placebo-controlled Withdrawal Period||0||
59825190|NCT00416520|75948250|FG002|NOT COMPLETED|Placebo-controlled Withdrawal Period||1||
59825191|NCT00416520|75948251|FG003|NOT COMPLETED|Placebo-controlled Withdrawal Period||5||
59825192|NCT00533429|75948263|FG000|STARTED|Overall Study||20||
59825193|NCT00533429|75948264|FG001|STARTED|Overall Study||20||
59825194|NCT00533429|75948263|FG000|Received at Least 1 Dose of Study Drug|Overall Study||20||
59825195|NCT00533429|75948264|FG001|Received at Least 1 Dose of Study Drug|Overall Study||20||
59825196|NCT00533429|75948263|FG000|Entered Maintenance|Overall Study||8||
59825197|NCT00533429|75948264|FG001|Entered Maintenance|Overall Study||10||
59825198|NCT00533429|75948263|FG000|COMPLETED|Overall Study||1||
59825199|NCT00533429|75948264|FG001|COMPLETED|Overall Study||4||
60117230|NCT01740791|76238067|FG002|STARTED|Overall Study||17||
60117231|NCT01740791|76238068|FG003|STARTED|Overall Study||14||
60117232|NCT01740791|76238069|FG004|STARTED|Overall Study||9||
60117233|NCT01740791|76238070|FG005|STARTED|Overall Study||34||
60117234|NCT01740791|76238065|FG000|COMPLETED|Overall Study||10||
60117235|NCT01740791|76238066|FG001|COMPLETED|Overall Study||4||
59715436|NCT00978627|75834240|FG001|STARTED|Extension: Week 27 to 52 (NN5401-3645)|Thirty four subjects from main trial did not continue into extension trial|122||
59715437|NCT00978627|75834239|FG000|COMPLETED|Extension: Week 27 to 52 (NN5401-3645)||233||
59715438|NCT00978627|75834240|FG001|COMPLETED|Extension: Week 27 to 52 (NN5401-3645)||113||
59715439|NCT00978627|75834239|FG000|NOT COMPLETED|Extension: Week 27 to 52 (NN5401-3645)||21||
59825200|NCT00533429|75948263|FG000|NOT COMPLETED|Overall Study||19||
59825201|NCT00533429|75948264|FG001|NOT COMPLETED|Overall Study||16||
59825202|NCT00533273|75948274|FG000|STARTED|Double-blind||45||
59825203|NCT00533273|75948275|FG001|STARTED|Double-blind||21||
59825204|NCT00533273|75948274|FG000|COMPLETED|Double-blind||45||
59825205|NCT00533273|75948275|FG001|COMPLETED|Double-blind||19||
59825206|NCT00533273|75948274|FG000|NOT COMPLETED|Double-blind||0||
59825207|NCT00533273|75948275|FG001|NOT COMPLETED|Double-blind||2||
60117236|NCT01740791|76238067|FG002|COMPLETED|Overall Study||11||
60117237|NCT01740791|76238068|FG003|COMPLETED|Overall Study||7||
60117238|NCT01740791|76238069|FG004|COMPLETED|Overall Study||6||
60117239|NCT01740791|76238070|FG005|COMPLETED|Overall Study||23||
60117240|NCT01740791|76238065|FG000|NOT COMPLETED|Overall Study||12||
60117241|NCT01740791|76238066|FG001|NOT COMPLETED|Overall Study||3||
59715440|NCT00978627|75834240|FG001|NOT COMPLETED|Extension: Week 27 to 52 (NN5401-3645)||9||
59715441|NCT01181609|75834246|FG000|STARTED|Overall Study||54||
59715442|NCT01181609|75834246|FG000|COMPLETED|Overall Study||1||
60117242|NCT01740791|76238067|FG002|NOT COMPLETED|Overall Study||6||
59715443|NCT01181609|75834246|FG000|NOT COMPLETED|Overall Study||53||
59715444|NCT01154010|75834252|FG000|STARTED|Overall Study||9||
59715445|NCT01154010|75834253|FG001|STARTED|Overall Study||9||
59715446|NCT01154010|75834252|FG000|COMPLETED|Overall Study||9||
59715447|NCT01154010|75834253|FG001|COMPLETED|Overall Study||8||
59715448|NCT01154010|75834252|FG000|NOT COMPLETED|Overall Study||0||
59715449|NCT01154010|75834253|FG001|NOT COMPLETED|Overall Study||1||
59715450|NCT01174368|75834259|FG000|STARTED|Overall Study||1||
59715451|NCT01174368|75834259|FG000|COMPLETED|Overall Study||0||
59715452|NCT01174368|75834259|FG000|NOT COMPLETED|Overall Study||1||
59715453|NCT01147926|75834265|FG000|STARTED|Overall Study||187||
59715454|NCT01147926|75834266|FG001|STARTED|Overall Study||187||
59715455|NCT01147926|75834265|FG000|COMPLETED|Overall Study||160||
59715456|NCT01147926|75834266|FG001|COMPLETED|Overall Study||158||
59715457|NCT01147926|75834265|FG000|NOT COMPLETED|Overall Study||27||
59715458|NCT01147926|75834266|FG001|NOT COMPLETED|Overall Study||29||
59715459|NCT00975507|75834274|FG000|STARTED|Overall Study||323||
59715460|NCT00975507|75834275|FG001|STARTED|Overall Study||157||
59715461|NCT00975507|75834274|FG000|Vaccinated at Visit 1|Overall Study||323||
59715462|NCT00975507|75834275|FG001|Vaccinated at Visit 1|Overall Study||157||
59715463|NCT00975507|75834274|FG000|Vaccinated at Visit 2|Overall Study||310||
59715464|NCT00975507|75834275|FG001|Vaccinated at Visit 2|Overall Study|Per-protocol, subjects receiving M-M-R™ II + VARIVAX™ at Visit 1 were not vaccinated at Visit 2|0||
59715465|NCT00975507|75834274|FG000|COMPLETED|Overall Study||303||
59715466|NCT00975507|75834275|FG001|COMPLETED|Overall Study||153||
59715467|NCT00975507|75834274|FG000|NOT COMPLETED|Overall Study||20||
60117243|NCT01740791|76238068|FG003|NOT COMPLETED|Overall Study||7||
60117244|NCT01740791|76238069|FG004|NOT COMPLETED|Overall Study||3||
60117245|NCT01740791|76238070|FG005|NOT COMPLETED|Overall Study||11||
60117246|NCT01740323|76238127|FG000|STARTED|Overall Study||15||
60117247|NCT01740323|76238128|FG001|STARTED|Overall Study||15||
60117248|NCT01740323|76238127|FG000|COMPLETED|Overall Study||13||
60117249|NCT01740323|76238128|FG001|COMPLETED|Overall Study||15||
60117250|NCT01740323|76238127|FG000|NOT COMPLETED|Overall Study||2||
60117251|NCT01740323|76238128|FG001|NOT COMPLETED|Overall Study||0||
60117252|NCT00090051|76238136|FG000|STARTED|Overall Study||276||
60117253|NCT00090051|76238137|FG001|STARTED|Overall Study||276||
60117254|NCT00090051|76238136|FG000|Safety Population; Received Study Drug|Overall Study||272||
60117255|NCT00090051|76238137|FG001|Safety Population; Received Study Drug|Overall Study||274||
60117256|NCT00090051|76238136|FG000|COMPLETED|Overall Study|Completed 6 Cycles of Treatment|167||
60117257|NCT00090051|76238137|FG001|COMPLETED|Overall Study|Completed 6 Cycles of Treatment|181||
60117258|NCT00090051|76238136|FG000|NOT COMPLETED|Overall Study||109||
60117259|NCT00090051|76238137|FG001|NOT COMPLETED|Overall Study||95||
60117260|NCT01740089|76238146|FG000|STARTED|First 12 Weeks of Treatment||50||
60117261|NCT01740089|76238147|FG001|STARTED|First 12 Weeks of Treatment||50||
60117262|NCT01740089|76238148|FG002|STARTED|First 12 Weeks of Treatment||50||
60117263|NCT01740089|76238146|FG000|COMPLETED|First 12 Weeks of Treatment||50||
60117264|NCT01740089|76238147|FG001|COMPLETED|First 12 Weeks of Treatment|"Withdrawn due to:~AE before W12 (n=1) Withdrew consent before W12 (n=1)"|48||
60117265|NCT01740089|76238148|FG002|COMPLETED|First 12 Weeks of Treatment|"Withdrawn due to:~AE before W12 (n=2)"|48||
60117266|NCT01740089|76238146|FG000|NOT COMPLETED|First 12 Weeks of Treatment||0||
60117267|NCT01740089|76238147|FG001|NOT COMPLETED|First 12 Weeks of Treatment||2||
60117268|NCT01740089|76238148|FG002|NOT COMPLETED|First 12 Weeks of Treatment||2||
60117269|NCT01740089|76238146|FG000|STARTED|After 12 Weeks||50||
60117270|NCT01740089|76238147|FG001|STARTED|After 12 Weeks||48||
60117271|NCT01740089|76238148|FG002|STARTED|After 12 Weeks||48||
60117272|NCT01740089|76238146|FG000|COMPLETED|After 12 Weeks|"Withdrawn due to:~No EVR (n=3) AE (n=2) No EOT (n=1) Non-compliance (n=1)"|43||
60117273|NCT01740089|76238147|FG001|COMPLETED|After 12 Weeks|"Withdrawn due to:~Withdrawn consent (n=1) No EVR (n=1) Non-compliance (n=1)"|45||
60117274|NCT01740089|76238148|FG002|COMPLETED|After 12 Weeks|"Withdrawn due to:~No EVR (n=4) AE (n=5) Non-attendance of visit (n=1) Withdrawn consent (n=1)"|37||
60117275|NCT01740089|76238146|FG000|NOT COMPLETED|After 12 Weeks||7||
60117276|NCT01740089|76238147|FG001|NOT COMPLETED|After 12 Weeks||3||
60117277|NCT01740089|76238148|FG002|NOT COMPLETED|After 12 Weeks||11||
59715468|NCT00975507|75834275|FG001|NOT COMPLETED|Overall Study||4||
59715469|NCT01147848|75834285|FG000|STARTED|Run-in Period||1564||
59715470|NCT01147848|75834286|FG001|STARTED|Run-in Period||0||
59715471|NCT01147848|75834287|FG002|STARTED|Run-in Period||0||
59715472|NCT01147848|75834285|FG000|COMPLETED|Run-in Period||806||
59715473|NCT01147848|75834286|FG001|COMPLETED|Run-in Period||0||
59715474|NCT01147848|75834287|FG002|COMPLETED|Run-in Period||0||
59715475|NCT01147848|75834285|FG000|NOT COMPLETED|Run-in Period||758||
59715476|NCT01147848|75834286|FG001|NOT COMPLETED|Run-in Period||0||
59715477|NCT01147848|75834287|FG002|NOT COMPLETED|Run-in Period||0||
59715478|NCT01147848|75834285|FG000|STARTED|Randomized Phase||0||
59715479|NCT01147848|75834286|FG001|STARTED|Randomized Phase||403||
59715480|NCT01147848|75834287|FG002|STARTED|Randomized Phase||403||
59715481|NCT01147848|75834285|FG000|COMPLETED|Randomized Phase||0||
59715482|NCT01147848|75834286|FG001|COMPLETED|Randomized Phase||358||
59715483|NCT01147848|75834287|FG002|COMPLETED|Randomized Phase||357||
60117278|NCT01739933|76238159|FG000|STARTED|Overall Study|Underwent randomization and received study drug|214||
60117279|NCT01739933|76238160|FG001|STARTED|Overall Study|Underwent randomization and received study drug|208||
60117280|NCT01739933|76238159|FG000|Discharged From Hospital and Eligible for Follow-up|Overall Study||140||
60117281|NCT01739933|76238160|FG001|Discharged From Hospital and Eligible for Follow-up|Overall Study||147||
60117282|NCT01739933|76238159|FG000|COMPLETED|Overall Study|97% of those eligible (alive and who did not withdraw)|108|Alive and completed 6 mos follow-up|
60117283|NCT01739933|76238160|FG001|COMPLETED|Overall Study|91% of those eligible (alive and who did not withdraw)|101|Alive and completed 6 mos follow-up|
60117284|NCT01739933|76238159|FG000|NOT COMPLETED|Overall Study||106||
60117285|NCT01739933|76238160|FG001|NOT COMPLETED|Overall Study||107||
60117286|NCT00094497|76238168|FG000|STARTED|Overall Study||151||
60117287|NCT00094497|76238169|FG001|STARTED|Overall Study||153||
60117288|NCT00094497|76238168|FG000|Treated|Overall Study||148||
60117289|NCT00094497|76238169|FG001|Treated|Overall Study||149||
60117290|NCT00094497|76238168|FG000|Received Second Line Therapy|Overall Study||84||
60117291|NCT00094497|76238169|FG001|Received Second Line Therapy|Overall Study||101||
60117292|NCT00094497|76238168|FG000|COMPLETED|Overall Study||151||
60117293|NCT00094497|76238169|FG001|COMPLETED|Overall Study||153||
60117294|NCT00094497|76238168|FG000|NOT COMPLETED|Overall Study||0||
60117295|NCT00094497|76238169|FG001|NOT COMPLETED|Overall Study||0||
60117296|NCT01738919|76238177|FG000|STARTED|Overall Study||15||
60117297|NCT01738919|76238178|FG001|STARTED|Overall Study||17||
60117298|NCT01738919|76238177|FG000|COMPLETED|Overall Study||14||
60117299|NCT01738919|76238178|FG001|COMPLETED|Overall Study||14||
60117300|NCT01738919|76238177|FG000|NOT COMPLETED|Overall Study||1||
60117301|NCT01738919|76238178|FG001|NOT COMPLETED|Overall Study||3||
60117302|NCT00094887|76238188|FG000|STARTED|Overall Study||75||
60117303|NCT00094887|76238189|FG001|STARTED|Overall Study||75||
60117304|NCT00094887|76238188|FG000|Safety Population|Overall Study||75||
60117305|NCT00094887|76238189|FG001|Safety Population|Overall Study||75||
60117306|NCT00094887|76238188|FG000|Intent to Treat Population|Overall Study||75||
60117307|NCT00094887|76238189|FG001|Intent to Treat Population|Overall Study||75||
60117308|NCT00094887|76238188|FG000|Per Protocol Analysis Set|Overall Study||71||
60117309|NCT00094887|76238189|FG001|Per Protocol Analysis Set|Overall Study||71||
60117310|NCT00094887|76238188|FG000|Primary Efficacy Population|Overall Study||65||
60117311|NCT00094887|76238189|FG001|Primary Efficacy Population|Overall Study||64||
60117312|NCT00094887|76238188|FG000|COMPLETED|Overall Study||71||
60117313|NCT00094887|76238189|FG001|COMPLETED|Overall Study||71||
60117314|NCT00094887|76238188|FG000|NOT COMPLETED|Overall Study||4||
60117315|NCT00094887|76238189|FG001|NOT COMPLETED|Overall Study||4||
60117316|NCT00096681|76238195|FG000|STARTED|Overall Study||762||
60117317|NCT00096681|76238195|FG000|COMPLETED|Overall Study||762||
60117318|NCT00096681|76238195|FG000|NOT COMPLETED|Overall Study||0||
60117319|NCT01712399|76238199|FG000|STARTED|Overall Study||397||
60117320|NCT01712399|76238199|FG000|COMPLETED|Overall Study||0||
60117321|NCT01712399|76238199|FG000|NOT COMPLETED|Overall Study||397||
60117322|NCT00097695|76238207|FG000|STARTED|The Controlled Phase||27||
60117323|NCT00097695|76238208|FG001|STARTED|The Controlled Phase||29||
60117324|NCT00097695|76238209|FG002|STARTED|The Controlled Phase||8||
60117325|NCT00097695|76238210|FG003|STARTED|The Controlled Phase||20||
60117326|NCT00097695|76238207|FG000|COMPLETED|The Controlled Phase||23||
60117327|NCT00097695|76238208|FG001|COMPLETED|The Controlled Phase||26||
60117328|NCT00097695|76238209|FG002|COMPLETED|The Controlled Phase||3||
60117329|NCT00097695|76238210|FG003|COMPLETED|The Controlled Phase|Patients screened and found eligible but did not have HAE attack or attack was not severe enough|0||
60117330|NCT00097695|76238207|FG000|NOT COMPLETED|The Controlled Phase||4||
60117331|NCT00097695|76238208|FG001|NOT COMPLETED|The Controlled Phase||3||
60117332|NCT00097695|76238209|FG002|NOT COMPLETED|The Controlled Phase||5||
60117333|NCT00097695|76238210|FG003|NOT COMPLETED|The Controlled Phase||20||
60117334|NCT00097695|76238207|FG000|STARTED|The Open Label Extension (OLE) Phase||23||
60117335|NCT00097695|76238208|FG001|STARTED|The Open Label Extension (OLE) Phase||26||
60117336|NCT00097695|76238209|FG002|STARTED|The Open Label Extension (OLE) Phase||3||
60117337|NCT00097695|76238210|FG003|STARTED|The Open Label Extension (OLE) Phase||20||
60117338|NCT00097695|76238207|FG000|COMPLETED|The Open Label Extension (OLE) Phase||10||
60117339|NCT00097695|76238208|FG001|COMPLETED|The Open Label Extension (OLE) Phase||11||
60117340|NCT00097695|76238209|FG002|COMPLETED|The Open Label Extension (OLE) Phase||1||
60117341|NCT00097695|76238210|FG003|COMPLETED|The Open Label Extension (OLE) Phase||15||
60117342|NCT00097695|76238207|FG000|NOT COMPLETED|The Open Label Extension (OLE) Phase||13||
60117343|NCT00097695|76238208|FG001|NOT COMPLETED|The Open Label Extension (OLE) Phase||15||
60117344|NCT00097695|76238209|FG002|NOT COMPLETED|The Open Label Extension (OLE) Phase||2||
60117345|NCT00097695|76238210|FG003|NOT COMPLETED|The Open Label Extension (OLE) Phase||5||
60117346|NCT02096679|76238222|FG000|STARTED|Overall Study||8||
60117347|NCT02096679|76238222|FG000|COMPLETED|Overall Study||8||
60117348|NCT02096679|76238222|FG000|NOT COMPLETED|Overall Study||0||
59567333|NCT02281526|75670250|FG001|STARTED|Overall Study||8||
60117349|NCT00195039|76238226|FG000|STARTED|Overall Study||47||
60117350|NCT00195039|76238226|FG000|COMPLETED|Overall Study||47||
60117351|NCT00195039|76238226|FG000|NOT COMPLETED|Overall Study||0||
60117352|NCT02054338|76238232|FG000|STARTED|Overall Study||503||
60117353|NCT02054338|76238233|FG001|STARTED|Overall Study||501||
60117354|NCT02054338|76238232|FG000|COMPLETED|Overall Study||0||
60117355|NCT02054338|76238233|FG001|COMPLETED|Overall Study||0||
60117356|NCT02054338|76238232|FG000|NOT COMPLETED|Overall Study||503||
60117357|NCT02054338|76238233|FG001|NOT COMPLETED|Overall Study||501||
60117358|NCT00198081|76238241|FG000|STARTED|Overall Study|Eight (8) persons consented to participate but 3 withdrew prior to beginning protocol treatment.|5||
60117359|NCT00198081|76238242|FG001|STARTED|Overall Study|No enrollment on this arm.|0||
60117360|NCT00198081|76238241|FG000|COMPLETED|Overall Study||4||
60117361|NCT00198081|76238242|FG001|COMPLETED|Overall Study|No enrollment on this arm.|0||
60117362|NCT00198081|76238241|FG000|NOT COMPLETED|Overall Study||1||
60117363|NCT00198081|76238242|FG001|NOT COMPLETED|Overall Study||0||
60117364|NCT02054572|76238253|FG000|STARTED|Overall Study||6||
60117365|NCT02054572|76238253|FG000|COMPLETED|Overall Study||6||
60117366|NCT02054572|76238253|FG000|NOT COMPLETED|Overall Study||0||
60117367|NCT00100659|76238259|FG000|STARTED|Overall Study||55||
60117368|NCT00100659|76238260|FG001|STARTED|Overall Study||59||
60117369|NCT00100659|76238259|FG000|COMPLETED|Overall Study||52||
60117370|NCT00100659|76238260|FG001|COMPLETED|Overall Study||57||
60117371|NCT00100659|76238259|FG000|NOT COMPLETED|Overall Study||3||
60117372|NCT00100659|76238260|FG001|NOT COMPLETED|Overall Study||2||
60117373|NCT02055430|76238270|FG000|STARTED|Overall Study||45||
60117374|NCT02055430|76238271|FG001|STARTED|Overall Study||45||
60117375|NCT02055430|76238270|FG000|COMPLETED|Overall Study||45||
60117376|NCT02055430|76238271|FG001|COMPLETED|Overall Study||45||
60117377|NCT02055430|76238270|FG000|NOT COMPLETED|Overall Study||0||
60117378|NCT02055430|76238271|FG001|NOT COMPLETED|Overall Study||0||
60117379|NCT02388880|76238277|FG000|STARTED|Overall Study||3||
60117380|NCT02388880|76238277|FG000|COMPLETED|Overall Study||3||
60117381|NCT02388880|76238277|FG000|NOT COMPLETED|Overall Study||0||
60117382|NCT00101361|76238283|FG000|STARTED|Overall Study||108||
60117383|NCT00101361|76238284|FG001|STARTED|Overall Study||104||
60117384|NCT00101361|76238283|FG000|COMPLETED|Overall Study||108||
60117385|NCT00101361|76238284|FG001|COMPLETED|Overall Study||104||
60117386|NCT00101361|76238283|FG000|NOT COMPLETED|Overall Study||0||
60117387|NCT00101361|76238284|FG001|NOT COMPLETED|Overall Study||0||
60117388|NCT02410018|76238292|FG000|STARTED|Overall Study||2||
60117389|NCT02410018|76238293|FG001|STARTED|Overall Study||1||
60117390|NCT02410018|76238292|FG000|COMPLETED|Overall Study||2||
60117391|NCT02410018|76238293|FG001|COMPLETED|Overall Study||1||
60117392|NCT02410018|76238292|FG000|NOT COMPLETED|Overall Study||0||
60117393|NCT02410018|76238293|FG001|NOT COMPLETED|Overall Study||0||
60117394|NCT03225846|76238306|FG000|STARTED|Overall Study||22||
60117395|NCT03225846|76238307|FG001|STARTED|Overall Study||9||
60117396|NCT03225846|76238308|FG002|STARTED|Overall Study||12||
60117397|NCT03225846|76238309|FG003|STARTED|Overall Study||15||
60117398|NCT03225846|76238310|FG004|STARTED|Overall Study||8||
60117399|NCT03225846|76238311|FG005|STARTED|Overall Study||9||
60117400|NCT03225846|76238312|FG006|STARTED|Overall Study||13||
60117401|NCT03225846|76238306|FG000|Single Dose Period Only|Overall Study||6||
60117402|NCT03225846|76238307|FG001|Single Dose Period Only|Overall Study||3||
60117403|NCT03225846|76238308|FG002|Single Dose Period Only|Overall Study||4||
60117404|NCT03225846|76238309|FG003|Single Dose Period Only|Overall Study||7||
60117405|NCT03225846|76238310|FG004|Single Dose Period Only|Overall Study||8||
60117406|NCT03225846|76238311|FG005|Single Dose Period Only|Overall Study||0||
60117407|NCT03225846|76238312|FG006|Single Dose Period Only|Overall Study||4||
60117408|NCT03225846|76238306|FG000|Multiple Dose Period Only|Overall Study||3||
60117409|NCT03225846|76238307|FG001|Multiple Dose Period Only|Overall Study||0||
60117410|NCT03225846|76238308|FG002|Multiple Dose Period Only|Overall Study||3||
60117411|NCT03225846|76238309|FG003|Multiple Dose Period Only|Overall Study||6||
60117412|NCT03225846|76238310|FG004|Multiple Dose Period Only|Overall Study||0||
60117413|NCT03225846|76238311|FG005|Multiple Dose Period Only|Overall Study||0||
60117414|NCT03225846|76238312|FG006|Multiple Dose Period Only|Overall Study||4||
60117415|NCT03225846|76238306|FG000|Single Dose and Multiple Dose|Overall Study||13||
60117416|NCT03225846|76238307|FG001|Single Dose and Multiple Dose|Overall Study||6||
60117417|NCT03225846|76238308|FG002|Single Dose and Multiple Dose|Overall Study||5||
60117418|NCT03225846|76238309|FG003|Single Dose and Multiple Dose|Overall Study||2||
60117419|NCT03225846|76238310|FG004|Single Dose and Multiple Dose|Overall Study||0||
60117420|NCT03225846|76238311|FG005|Single Dose and Multiple Dose|Overall Study||9||
59567334|NCT02281526|75670249|FG000|COMPLETED|Overall Study||8||
59567335|NCT02281526|75670250|FG001|COMPLETED|Overall Study||8||
60117421|NCT03225846|76238312|FG006|Single Dose and Multiple Dose|Overall Study||5||
60117422|NCT03225846|76238306|FG000|COMPLETED|Overall Study||22||
60117423|NCT03225846|76238307|FG001|COMPLETED|Overall Study||7||
60117424|NCT03225846|76238308|FG002|COMPLETED|Overall Study||11||
60117425|NCT03225846|76238309|FG003|COMPLETED|Overall Study||15||
60117426|NCT03225846|76238310|FG004|COMPLETED|Overall Study||8||
60117427|NCT03225846|76238311|FG005|COMPLETED|Overall Study||9||
60117428|NCT03225846|76238312|FG006|COMPLETED|Overall Study||6||
60117429|NCT03225846|76238306|FG000|NOT COMPLETED|Overall Study||0||
60117430|NCT03225846|76238307|FG001|NOT COMPLETED|Overall Study||2||
60117431|NCT03225846|76238308|FG002|NOT COMPLETED|Overall Study||1||
60117432|NCT03225846|76238309|FG003|NOT COMPLETED|Overall Study||0||
60117433|NCT03225846|76238310|FG004|NOT COMPLETED|Overall Study||0||
60117434|NCT03225846|76238311|FG005|NOT COMPLETED|Overall Study||0||
59567336|NCT02281526|75670249|FG000|NOT COMPLETED|Overall Study||1||
59715484|NCT01147848|75834285|FG000|NOT COMPLETED|Randomized Phase||0||
59715485|NCT01147848|75834286|FG001|NOT COMPLETED|Randomized Phase||45||
59715486|NCT01147848|75834287|FG002|NOT COMPLETED|Randomized Phase||46||
59715487|NCT00929656|75834296|FG000|STARTED|Overall Study||13||
60117435|NCT03225846|76238312|FG006|NOT COMPLETED|Overall Study||7||
60117436|NCT02410798|76238335|FG000|STARTED|Overall Study||12||
60117437|NCT02410798|76238335|FG000|COMPLETED|Overall Study||12||
60117438|NCT02410798|76238335|FG000|NOT COMPLETED|Overall Study||0||
59825208|NCT00533273|75948274|FG000|STARTED|Open-label|open-label was extension of double-blind; 64 of 66 patients continued into open-label|64||
59825209|NCT00533273|75948275|FG001|STARTED|Open-label|no placebo - this phase was open label|0||
59825210|NCT00533273|75948274|FG000|COMPLETED|Open-label||58||
59825211|NCT00533273|75948275|FG001|COMPLETED|Open-label||0||
59825212|NCT00533273|75948274|FG000|NOT COMPLETED|Open-label||6||
59825213|NCT00533273|75948275|FG001|NOT COMPLETED|Open-label||0||
59825214|NCT03891641|75948283|FG000|STARTED|Overall Study||10||
59825215|NCT03891641|75948284|FG001|STARTED|Overall Study||7||
59825216|NCT03891641|75948283|FG000|COMPLETED|Overall Study||8||
59825217|NCT03891641|75948284|FG001|COMPLETED|Overall Study||5||
59825218|NCT03891641|75948283|FG000|NOT COMPLETED|Overall Study||2||
59825219|NCT03891641|75948284|FG001|NOT COMPLETED|Overall Study||2||
59825220|NCT00339183|75948292|FG000|STARTED|Overall Study||591||
59825221|NCT00339183|75948293|FG001|STARTED|Overall Study||595||
59825222|NCT00339183|75948292|FG000|Received Study Drug|Overall Study|Includes one participant who received FOLFIRI Alone|588||
59825223|NCT00339183|75948293|FG001|Received Study Drug|Overall Study||593||
59825224|NCT00339183|75948292|FG000|COMPLETED|Overall Study|Indicates participants who had completed the safety visit 30 days after last dose or had died|470||
59825225|NCT00339183|75948293|FG001|COMPLETED|Overall Study|Indicates participants who had completed the safety visit 30 days after last dose or had died|490||
59825226|NCT00339183|75948292|FG000|NOT COMPLETED|Overall Study||121||
59825227|NCT00339183|75948293|FG001|NOT COMPLETED|Overall Study||105||
59825228|NCT00333801|75948305|FG000|STARTED|Overall Study||43||
59825229|NCT00333801|75948306|FG001|STARTED|Overall Study||42||
59825230|NCT00333801|75948305|FG000|COMPLETED|Overall Study||35||
59825231|NCT00333801|75948306|FG001|COMPLETED|Overall Study||36||
59825232|NCT00333801|75948305|FG000|NOT COMPLETED|Overall Study||8||
59825233|NCT00333801|75948306|FG001|NOT COMPLETED|Overall Study||6||
60117439|NCT02389738|76238340|FG000|STARTED|Overall Study||6||
60117440|NCT02389738|76238340|FG000|COMPLETED|Overall Study||5||
60117441|NCT02389738|76238340|FG000|NOT COMPLETED|Overall Study||1||
59715488|NCT00929656|75834297|FG001|STARTED|Overall Study||9||
59715489|NCT00929656|75834296|FG000|COMPLETED|Overall Study||13||
59715490|NCT00929656|75834297|FG001|COMPLETED|Overall Study||8||
59715491|NCT00929656|75834296|FG000|NOT COMPLETED|Overall Study||0||
59715492|NCT00929656|75834297|FG001|NOT COMPLETED|Overall Study||1||
59715493|NCT00977613|75834303|FG000|STARTED|Overall Study||50||
59715494|NCT00977613|75834303|FG000|COMPLETED|Overall Study||34||
59715495|NCT00977613|75834303|FG000|NOT COMPLETED|Overall Study||16||
59715496|NCT01152996|75834307|FG000|STARTED|Overall Study||1075||
59715497|NCT01152996|75834307|FG000|Treated|Overall Study||1073||
59715498|NCT01152996|75834307|FG000|COMPLETED|Overall Study||538||
59825234|NCT00532883|75948316|FG000|STARTED|Overall Study||11||
59825235|NCT00532883|75948317|FG001|STARTED|Overall Study||12||
59825236|NCT00532883|75948318|FG002|STARTED|Overall Study||10||
59825237|NCT00532883|75948319|FG003|STARTED|Overall Study||11||
59825238|NCT00532883|75948316|FG000|COMPLETED|Overall Study|Study terminated early.|5||
59825239|NCT00532883|75948317|FG001|COMPLETED|Overall Study|Study terminated early.|5||
59825240|NCT00532883|75948318|FG002|COMPLETED|Overall Study|Study terminated early.|6||
59825241|NCT00532883|75948319|FG003|COMPLETED|Overall Study|Study terminated early.|6||
59825242|NCT00532883|75948316|FG000|NOT COMPLETED|Overall Study||6||
59825243|NCT00532883|75948317|FG001|NOT COMPLETED|Overall Study||7||
59825244|NCT00532883|75948318|FG002|NOT COMPLETED|Overall Study||4||
59825245|NCT00532883|75948319|FG003|NOT COMPLETED|Overall Study||5||
59825246|NCT00354159|75948331|FG000|STARTED|Randomized Study Period||202||
60117442|NCT00200343|76238347|FG000|STARTED|Overall Study||199||
59825247|NCT00354159|75948332|FG001|STARTED|Randomized Study Period||198||
59825248|NCT00354159|75948331|FG000|COMPLETED|Randomized Study Period||180||
60117443|NCT00200343|76238348|FG001|STARTED|Overall Study||200||
60117444|NCT00200343|76238349|FG002|STARTED|Overall Study||197||
60117445|NCT00200343|76238347|FG000|COMPLETED|Overall Study||183||
60117446|NCT00200343|76238348|FG001|COMPLETED|Overall Study||192||
60117447|NCT00200343|76238349|FG002|COMPLETED|Overall Study||184||
59715499|NCT01152996|75834307|FG000|NOT COMPLETED|Overall Study||537||
59715500|NCT00979953|75834315|FG000|STARTED|Overall Study||101||
59715501|NCT00979953|75834316|FG001|STARTED|Overall Study||99||
59715502|NCT00979953|75834317|FG002|STARTED|Overall Study||104||
59715503|NCT00979953|75834318|FG003|STARTED|Overall Study||104||
59715504|NCT00979953|75834315|FG000|Received at Least 1 Dose of Study Drug|Overall Study||101||
59715505|NCT00979953|75834316|FG001|Received at Least 1 Dose of Study Drug|Overall Study||99||
59715506|NCT00979953|75834317|FG002|Received at Least 1 Dose of Study Drug|Overall Study||104||
59715507|NCT00979953|75834318|FG003|Received at Least 1 Dose of Study Drug|Overall Study||104||
59825249|NCT00354159|75948332|FG001|COMPLETED|Randomized Study Period||176||
59825250|NCT00354159|75948331|FG000|NOT COMPLETED|Randomized Study Period||22||
59825251|NCT00354159|75948332|FG001|NOT COMPLETED|Randomized Study Period||22||
59825252|NCT00354159|75948331|FG000|STARTED|Long-term Follow-up|Number entering post 12-month non-randomized long-term follow-up period|180||
59825253|NCT00354159|75948332|FG001|STARTED|Long-term Follow-up|Number entering post 12-month non-randomized long-term follow-up period|176||
59825254|NCT00354159|75948331|FG000|COMPLETED|Long-term Follow-up|All subjects were exited at the time of study closure|0||
59825255|NCT00354159|75948332|FG001|COMPLETED|Long-term Follow-up|All subjects were exited at the time of study closure|0||
59825256|NCT00354159|75948331|FG000|NOT COMPLETED|Long-term Follow-up||180||
59825257|NCT00354159|75948332|FG001|NOT COMPLETED|Long-term Follow-up||176||
60117448|NCT00200343|76238347|FG000|NOT COMPLETED|Overall Study||16||
60117449|NCT00200343|76238348|FG001|NOT COMPLETED|Overall Study||8||
59825258|NCT00338949|75948347|FG000|STARTED|Subject Screening||36||
59825259|NCT00338949|75948348|FG001|STARTED|Subject Screening||41||
59825260|NCT00338949|75948347|FG000|COMPLETED|Subject Screening||25||
59825261|NCT00338949|75948348|FG001|COMPLETED|Subject Screening||30||
59825262|NCT00338949|75948347|FG000|NOT COMPLETED|Subject Screening||11||
59825263|NCT00338949|75948348|FG001|NOT COMPLETED|Subject Screening||11||
59825264|NCT00338949|75948347|FG000|STARTED|Randomization||25||
59825265|NCT00338949|75948348|FG001|STARTED|Randomization||30||
59825266|NCT00338949|75948347|FG000|COMPLETED|Randomization|1 subject withdrew after relapse and hospitalization|24||
59825267|NCT00338949|75948348|FG001|COMPLETED|Randomization|"Reasons for drop out:~2- insomnia 2- symptom exacerbation~1- akathisia"|25||
59825268|NCT00338949|75948347|FG000|NOT COMPLETED|Randomization||1||
59825269|NCT00338949|75948348|FG001|NOT COMPLETED|Randomization||5||
59825270|NCT00332709|75948356|FG000|STARTED|Overall Study||40||
59825271|NCT00332709|75948357|FG001|STARTED|Overall Study||41||
59825272|NCT00332709|75948356|FG000|COMPLETED|Overall Study||24||
59825273|NCT00332709|75948357|FG001|COMPLETED|Overall Study||21||
59825274|NCT00332709|75948356|FG000|NOT COMPLETED|Overall Study||16||
59825275|NCT00332709|75948357|FG001|NOT COMPLETED|Overall Study||20||
59825276|NCT00332241|75948365|FG000|STARTED|Overall Study||51||
59825277|NCT00332241|75948366|FG001|STARTED|Overall Study||47||
59825278|NCT00332241|75948365|FG000|COMPLETED|Overall Study||36||
59825279|NCT00332241|75948366|FG001|COMPLETED|Overall Study||39||
59825280|NCT00332241|75948365|FG000|NOT COMPLETED|Overall Study||15||
59825281|NCT00332241|75948366|FG001|NOT COMPLETED|Overall Study||8||
59825282|NCT00337935|75948374|FG000|STARTED|Overall Study||39||
59825283|NCT00337935|75948375|FG001|STARTED|Overall Study||118||
59825284|NCT00337935|75948374|FG000|COMPLETED|Overall Study||29||
59825285|NCT00337935|75948375|FG001|COMPLETED|Overall Study||91||
59825286|NCT00337935|75948374|FG000|NOT COMPLETED|Overall Study||10||
59825287|NCT00337935|75948375|FG001|NOT COMPLETED|Overall Study||27||
59825288|NCT00337779|75948384|FG000|STARTED|Overall Study||586||
59825289|NCT00337779|75948385|FG001|STARTED|Overall Study||569||
59825290|NCT00337779|75948384|FG000|COMPLETED|Overall Study||534||
59825291|NCT00337779|75948385|FG001|COMPLETED|Overall Study||490||
59825292|NCT00337779|75948384|FG000|NOT COMPLETED|Overall Study||52||
59825293|NCT00337779|75948385|FG001|NOT COMPLETED|Overall Study||79||
59825294|NCT00352755|75948391|FG000|STARTED|Overall Study||18||
59825295|NCT00352755|75948391|FG000|COMPLETED|Overall Study||16||
59825296|NCT00352755|75948391|FG000|NOT COMPLETED|Overall Study||2||
59825297|NCT00533897|75948398|FG000|STARTED|Lead-in (LI) Period 1||167||
59825298|NCT00533897|75948399|FG001|STARTED|Lead-in (LI) Period 1||0||
59825299|NCT00533897|75948400|FG002|STARTED|Lead-in (LI) Period 1||0||
59825300|NCT00533897|75948401|FG003|STARTED|Lead-in (LI) Period 1||0||
59825301|NCT00533897|75948402|FG004|STARTED|Lead-in (LI) Period 1||0||
59825302|NCT00533897|75948403|FG005|STARTED|Lead-in (LI) Period 1||0||
59825303|NCT00533897|75948404|FG006|STARTED|Lead-in (LI) Period 1||0||
59825304|NCT00533897|75948405|FG007|STARTED|Lead-in (LI) Period 1||0||
60000301|NCT02712983|76116060|FG007|NOT COMPLETED|Treatment Phase||9||
60000302|NCT02712983|76116061|FG008|NOT COMPLETED|Treatment Phase||2||
60000303|NCT02712983|76116053|FG000|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|0|All patients who discontinued treatment and entered Post-Treatment Efficacy Follow-Up Phase|
60000304|NCT02712983|76116054|FG001|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|1|All patients who discontinued treatment and entered Post-Treatment Efficacy Follow-Up Phase|
60000305|NCT02712983|76116055|FG002|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|0|All patients who discontinued treatment and entered Post-Treatment Efficacy Follow-Up Phase|
60000306|NCT02712983|76116056|FG003|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|1|All patients who discontinued treatment and entered Post-Treatment Efficacy Follow-Up Phase|
59825305|NCT00533897|75948398|FG000|COMPLETED|Lead-in (LI) Period 1|37 participants entered the LTE directly and did not enter the DBW Period nor receive DBW treatment.|157||
59825306|NCT00533897|75948399|FG001|COMPLETED|Lead-in (LI) Period 1||0||
59825307|NCT00533897|75948400|FG002|COMPLETED|Lead-in (LI) Period 1||0||
59825308|NCT00533897|75948401|FG003|COMPLETED|Lead-in (LI) Period 1||0||
59825309|NCT00533897|75948402|FG004|COMPLETED|Lead-in (LI) Period 1||0||
59825310|NCT00533897|75948403|FG005|COMPLETED|Lead-in (LI) Period 1||0||
59825311|NCT00533897|75948404|FG006|COMPLETED|Lead-in (LI) Period 1||0||
59825312|NCT00533897|75948405|FG007|COMPLETED|Lead-in (LI) Period 1||0||
59825313|NCT00533897|75948398|FG000|NOT COMPLETED|Lead-in (LI) Period 1||10||
59825314|NCT00533897|75948399|FG001|NOT COMPLETED|Lead-in (LI) Period 1||0||
59825315|NCT00533897|75948400|FG002|NOT COMPLETED|Lead-in (LI) Period 1||0||
59825316|NCT00533897|75948401|FG003|NOT COMPLETED|Lead-in (LI) Period 1||0||
59825317|NCT00533897|75948402|FG004|NOT COMPLETED|Lead-in (LI) Period 1||0||
59825318|NCT00533897|75948403|FG005|NOT COMPLETED|Lead-in (LI) Period 1||0||
59825319|NCT00533897|75948404|FG006|NOT COMPLETED|Lead-in (LI) Period 1||0||
59825320|NCT00533897|75948405|FG007|NOT COMPLETED|Lead-in (LI) Period 1||0||
59825321|NCT00533897|75948398|FG000|STARTED|Double-blind Withdrawal (DBW) Period 2||0||
60117450|NCT00200343|76238349|FG002|NOT COMPLETED|Overall Study||13||
59715508|NCT00979953|75834315|FG000|COMPLETED|Overall Study||93||
59715509|NCT00979953|75834316|FG001|COMPLETED|Overall Study||94||
59715510|NCT00979953|75834317|FG002|COMPLETED|Overall Study||82||
59715511|NCT00979953|75834318|FG003|COMPLETED|Overall Study||97||
59715512|NCT00979953|75834315|FG000|NOT COMPLETED|Overall Study||8||
59715513|NCT00979953|75834316|FG001|NOT COMPLETED|Overall Study||5||
59715514|NCT00979953|75834317|FG002|NOT COMPLETED|Overall Study||22||
59715515|NCT00979953|75834318|FG003|NOT COMPLETED|Overall Study||7||
59715516|NCT01181531|75834330|FG000|STARTED|Overall Study|Subjects are randomized after washout.|157||
59715517|NCT01181531|75834331|FG001|STARTED|Overall Study|Subjects are randomized after washout.|155||
59715518|NCT01181531|75834330|FG000|Received Investigational Product|Overall Study||155||
59715519|NCT01181531|75834331|FG001|Received Investigational Product|Overall Study||153||
59715520|NCT01181531|75834330|FG000|COMPLETED|Overall Study||96||
59715521|NCT01181531|75834331|FG001|COMPLETED|Overall Study||102||
59715522|NCT01181531|75834330|FG000|NOT COMPLETED|Overall Study||61||
59715523|NCT01181531|75834331|FG001|NOT COMPLETED|Overall Study||53||
59715524|NCT01152450|75834337|FG000|STARTED|Period 1 (4 Weeks)||15||
59715525|NCT01152450|75834338|FG001|STARTED|Period 1 (4 Weeks)||16||
59715526|NCT01152450|75834339|FG002|STARTED|Period 1 (4 Weeks)||17||
59715527|NCT01152450|75834340|FG003|STARTED|Period 1 (4 Weeks)||15||
59715528|NCT01152450|75834341|FG004|STARTED|Period 1 (4 Weeks)||18||
59715529|NCT01152450|75834342|FG005|STARTED|Period 1 (4 Weeks)||13||
59715530|NCT01152450|75834337|FG000|COMPLETED|Period 1 (4 Weeks)||15||
59715531|NCT01152450|75834338|FG001|COMPLETED|Period 1 (4 Weeks)||15||
59715532|NCT01152450|75834339|FG002|COMPLETED|Period 1 (4 Weeks)||16||
59715533|NCT01152450|75834340|FG003|COMPLETED|Period 1 (4 Weeks)||15||
59715534|NCT01152450|75834341|FG004|COMPLETED|Period 1 (4 Weeks)||16||
59715535|NCT01152450|75834342|FG005|COMPLETED|Period 1 (4 Weeks)||12||
59715536|NCT01152450|75834337|FG000|NOT COMPLETED|Period 1 (4 Weeks)||0||
59715537|NCT01152450|75834338|FG001|NOT COMPLETED|Period 1 (4 Weeks)||1||
59715538|NCT01152450|75834339|FG002|NOT COMPLETED|Period 1 (4 Weeks)||1||
59715539|NCT01152450|75834340|FG003|NOT COMPLETED|Period 1 (4 Weeks)||0||
59715540|NCT01152450|75834341|FG004|NOT COMPLETED|Period 1 (4 Weeks)||2||
59715541|NCT01152450|75834342|FG005|NOT COMPLETED|Period 1 (4 Weeks)||1||
59715542|NCT01152450|75834337|FG000|STARTED|Period 2 (4 Weeks)||15||
59715543|NCT01152450|75834338|FG001|STARTED|Period 2 (4 Weeks)||15||
59715544|NCT01152450|75834339|FG002|STARTED|Period 2 (4 Weeks)||16||
59715545|NCT01152450|75834340|FG003|STARTED|Period 2 (4 Weeks)||15||
59715546|NCT01152450|75834341|FG004|STARTED|Period 2 (4 Weeks)||16||
59715547|NCT01152450|75834342|FG005|STARTED|Period 2 (4 Weeks)||12||
59715548|NCT01152450|75834337|FG000|COMPLETED|Period 2 (4 Weeks)||15||
59715549|NCT01152450|75834338|FG001|COMPLETED|Period 2 (4 Weeks)||15||
59715550|NCT01152450|75834339|FG002|COMPLETED|Period 2 (4 Weeks)||16||
59715551|NCT01152450|75834340|FG003|COMPLETED|Period 2 (4 Weeks)||15||
59715552|NCT01152450|75834341|FG004|COMPLETED|Period 2 (4 Weeks)||16||
59715553|NCT01152450|75834342|FG005|COMPLETED|Period 2 (4 Weeks)||12||
59715554|NCT01152450|75834337|FG000|NOT COMPLETED|Period 2 (4 Weeks)||0||
59715555|NCT01152450|75834338|FG001|NOT COMPLETED|Period 2 (4 Weeks)||0||
59715556|NCT01152450|75834339|FG002|NOT COMPLETED|Period 2 (4 Weeks)||0||
59715557|NCT01152450|75834340|FG003|NOT COMPLETED|Period 2 (4 Weeks)||0||
59715558|NCT01152450|75834341|FG004|NOT COMPLETED|Period 2 (4 Weeks)||0||
59715559|NCT01152450|75834342|FG005|NOT COMPLETED|Period 2 (4 Weeks)||0||
59825322|NCT00533897|75948399|FG001|STARTED|Double-blind Withdrawal (DBW) Period 2||40||
59825323|NCT00533897|75948400|FG002|STARTED|Double-blind Withdrawal (DBW) Period 2||80||
59715560|NCT01152450|75834337|FG000|STARTED|Period 3 (4 Weeks)||15||
59825324|NCT00533897|75948401|FG003|STARTED|Double-blind Withdrawal (DBW) Period 2||0||
59715561|NCT01152450|75834338|FG001|STARTED|Period 3 (4 Weeks)||15||
59715562|NCT01152450|75834339|FG002|STARTED|Period 3 (4 Weeks)||16||
59715563|NCT01152450|75834340|FG003|STARTED|Period 3 (4 Weeks)||15||
59715564|NCT01152450|75834341|FG004|STARTED|Period 3 (4 Weeks)||16||
59825325|NCT00533897|75948402|FG004|STARTED|Double-blind Withdrawal (DBW) Period 2||0||
59825326|NCT00533897|75948403|FG005|STARTED|Double-blind Withdrawal (DBW) Period 2||0||
59825327|NCT00533897|75948404|FG006|STARTED|Double-blind Withdrawal (DBW) Period 2||0||
59825328|NCT00533897|75948405|FG007|STARTED|Double-blind Withdrawal (DBW) Period 2||0||
59825329|NCT00533897|75948398|FG000|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0||
59825330|NCT00533897|75948399|FG001|COMPLETED|Double-blind Withdrawal (DBW) Period 2|One participant discontinued the DBW Period due to Lack of Efficacy to enter the RI Period early|39||
59825331|NCT00533897|75948400|FG002|COMPLETED|Double-blind Withdrawal (DBW) Period 2|Two participants discontinued the DBW Period due to Lack of Efficacy to enter the RI Period early|77||
59825332|NCT00533897|75948401|FG003|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0||
59825333|NCT00533897|75948402|FG004|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0||
59825334|NCT00533897|75948403|FG005|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0||
59825335|NCT00533897|75948404|FG006|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0||
59825336|NCT00533897|75948405|FG007|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0||
59825337|NCT00533897|75948398|FG000|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0||
59825338|NCT00533897|75948399|FG001|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||1||
59825339|NCT00533897|75948400|FG002|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||3||
59825340|NCT00533897|75948401|FG003|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0||
59825341|NCT00533897|75948402|FG004|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0||
59825342|NCT00533897|75948403|FG005|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0||
59825343|NCT00533897|75948404|FG006|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0||
59825344|NCT00533897|75948405|FG007|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0||
59825345|NCT00533897|75948398|FG000|STARTED|Re-introduction (RI) Period 3||0||
59825346|NCT00533897|75948399|FG001|STARTED|Re-introduction (RI) Period 3||0||
59825347|NCT00533897|75948400|FG002|STARTED|Re-introduction (RI) Period 3||0||
59825348|NCT00533897|75948401|FG003|STARTED|Re-introduction (RI) Period 3|1 participant discontinued the DBW Period due to Lack of Efficacy to enter RI Period early|40||
59825349|NCT00533897|75948402|FG004|STARTED|Re-introduction (RI) Period 3|1 participant discontinued the DBW Period due to Lack of Efficacy to enter RI Period early|35||
59825350|NCT00533897|75948403|FG005|STARTED|Re-introduction (RI) Period 3|1 participant discontinued the DBW Period due to Lack of Efficacy to enter RI Period early|44||
59825351|NCT00533897|75948404|FG006|STARTED|Re-introduction (RI) Period 3||0||
59825352|NCT00533897|75948405|FG007|STARTED|Re-introduction (RI) Period 3||0||
59825353|NCT00533897|75948398|FG000|COMPLETED|Re-introduction (RI) Period 3||0||
59825354|NCT00533897|75948399|FG001|COMPLETED|Re-introduction (RI) Period 3||0||
59825355|NCT00533897|75948400|FG002|COMPLETED|Re-introduction (RI) Period 3||0||
59825356|NCT00533897|75948401|FG003|COMPLETED|Re-introduction (RI) Period 3||40||
59825357|NCT00533897|75948402|FG004|COMPLETED|Re-introduction (RI) Period 3||35||
59825358|NCT00533897|75948403|FG005|COMPLETED|Re-introduction (RI) Period 3||42||
59825359|NCT00533897|75948404|FG006|COMPLETED|Re-introduction (RI) Period 3||0||
59825360|NCT00533897|75948405|FG007|COMPLETED|Re-introduction (RI) Period 3||0||
59825361|NCT00533897|75948398|FG000|NOT COMPLETED|Re-introduction (RI) Period 3||0||
59825362|NCT00533897|75948399|FG001|NOT COMPLETED|Re-introduction (RI) Period 3||0||
59825363|NCT00533897|75948400|FG002|NOT COMPLETED|Re-introduction (RI) Period 3||0||
59825364|NCT00533897|75948401|FG003|NOT COMPLETED|Re-introduction (RI) Period 3||0||
59825365|NCT00533897|75948402|FG004|NOT COMPLETED|Re-introduction (RI) Period 3||0||
60117451|NCT00201123|76238360|FG000|STARTED|Overall Study||32||
59715565|NCT01152450|75834342|FG005|STARTED|Period 3 (4 Weeks)||12||
59715566|NCT01152450|75834337|FG000|COMPLETED|Period 3 (4 Weeks)||15||
59715567|NCT01152450|75834338|FG001|COMPLETED|Period 3 (4 Weeks)||15||
59715568|NCT01152450|75834339|FG002|COMPLETED|Period 3 (4 Weeks)||16||
59715569|NCT01152450|75834340|FG003|COMPLETED|Period 3 (4 Weeks)||15||
59715570|NCT01152450|75834341|FG004|COMPLETED|Period 3 (4 Weeks)||16||
59715571|NCT01152450|75834342|FG005|COMPLETED|Period 3 (4 Weeks)||12||
59715572|NCT01152450|75834337|FG000|NOT COMPLETED|Period 3 (4 Weeks)||0||
59715573|NCT01152450|75834338|FG001|NOT COMPLETED|Period 3 (4 Weeks)||0||
59715574|NCT01152450|75834339|FG002|NOT COMPLETED|Period 3 (4 Weeks)||0||
59715575|NCT01152450|75834340|FG003|NOT COMPLETED|Period 3 (4 Weeks)||0||
59825366|NCT00533897|75948403|FG005|NOT COMPLETED|Re-introduction (RI) Period 3||2||
59825367|NCT00533897|75948404|FG006|NOT COMPLETED|Re-introduction (RI) Period 3||0||
59825368|NCT00533897|75948405|FG007|NOT COMPLETED|Re-introduction (RI) Period 3||0||
59825369|NCT00533897|75948398|FG000|STARTED|Long Term Extension (LTE)||0||
60117452|NCT00201123|76238361|FG001|STARTED|Overall Study||32||
60117453|NCT00201123|76238362|FG002|STARTED|Overall Study||32||
59715576|NCT01152450|75834341|FG004|NOT COMPLETED|Period 3 (4 Weeks)||0||
59715577|NCT01152450|75834342|FG005|NOT COMPLETED|Period 3 (4 Weeks)||0||
59715578|NCT01181141|75834352|FG000|STARTED|Overall Study||62||
59715579|NCT01181141|75834353|FG001|STARTED|Overall Study||30||
59715580|NCT01181141|75834352|FG000|Safety Analysis Population|Overall Study||59||
59715581|NCT01181141|75834353|FG001|Safety Analysis Population|Overall Study||29||
59715582|NCT01181141|75834352|FG000|COMPLETED|Overall Study||50||
59715583|NCT01181141|75834353|FG001|COMPLETED|Overall Study||26||
59825370|NCT00533897|75948399|FG001|STARTED|Long Term Extension (LTE)||0||
59825371|NCT00533897|75948400|FG002|STARTED|Long Term Extension (LTE)||0||
59825372|NCT00533897|75948401|FG003|STARTED|Long Term Extension (LTE)||0||
59825373|NCT00533897|75948402|FG004|STARTED|Long Term Extension (LTE)||0||
59825374|NCT00533897|75948403|FG005|STARTED|Long Term Extension (LTE)||0||
59825375|NCT00533897|75948404|FG006|STARTED|Long Term Extension (LTE)|37 non-responders in Lead-In entered the LTE directly and didn't participate in DBW or RI Periods.|37||
59825376|NCT00533897|75948405|FG007|STARTED|Long Term Extension (LTE)|117 completed RI but 4 did not enter LTE: 1 lack of efficacy and 3 had their site closed.|113||
59825377|NCT00533897|75948398|FG000|COMPLETED|Long Term Extension (LTE)||0||
59825378|NCT00533897|75948399|FG001|COMPLETED|Long Term Extension (LTE)||0||
59825379|NCT00533897|75948400|FG002|COMPLETED|Long Term Extension (LTE)||0||
59825380|NCT00533897|75948401|FG003|COMPLETED|Long Term Extension (LTE)||0||
59825381|NCT00533897|75948402|FG004|COMPLETED|Long Term Extension (LTE)||0||
59825382|NCT00533897|75948403|FG005|COMPLETED|Long Term Extension (LTE)||0||
59825383|NCT00533897|75948404|FG006|COMPLETED|Long Term Extension (LTE)|Participant continued until SC ABA was available in respective country or Sponsor ended study.|24||
59825384|NCT00533897|75948405|FG007|COMPLETED|Long Term Extension (LTE)|Participant continued until SC ABA was available in respective country or Sponsor ended study.|88||
59825385|NCT00533897|75948398|FG000|NOT COMPLETED|Long Term Extension (LTE)||0||
59825386|NCT00533897|75948399|FG001|NOT COMPLETED|Long Term Extension (LTE)||0||
59825387|NCT00533897|75948400|FG002|NOT COMPLETED|Long Term Extension (LTE)||0||
59825388|NCT00533897|75948401|FG003|NOT COMPLETED|Long Term Extension (LTE)||0||
59825389|NCT00533897|75948402|FG004|NOT COMPLETED|Long Term Extension (LTE)||0||
59825390|NCT00533897|75948403|FG005|NOT COMPLETED|Long Term Extension (LTE)||0||
59825391|NCT00533897|75948404|FG006|NOT COMPLETED|Long Term Extension (LTE)||13||
59825392|NCT00533897|75948405|FG007|NOT COMPLETED|Long Term Extension (LTE)||25||
59825393|NCT00426660|75948436|FG000|STARTED|Overall Study||1047||
59825394|NCT00426660|75948436|FG000|Treated|Overall Study||1032||
59825395|NCT00426660|75948436|FG000|Safety Analysis Set|Overall Study||1032||
59825396|NCT00426660|75948436|FG000|COMPLETED|Overall Study||916||
59825397|NCT00426660|75948436|FG000|NOT COMPLETED|Overall Study||131||
59825398|NCT00426270|75948440|FG000|STARTED|Overall Study||116||
60117454|NCT00201123|76238360|FG000|Did Not Meet Continuation Criteria|Overall Study||2||
60117455|NCT00201123|76238361|FG001|Did Not Meet Continuation Criteria|Overall Study||0||
60117456|NCT00201123|76238362|FG002|Did Not Meet Continuation Criteria|Overall Study||5||
60117457|NCT00201123|76238360|FG000|COMPLETED|Overall Study||26||
60117458|NCT00201123|76238361|FG001|COMPLETED|Overall Study||28||
60117459|NCT00201123|76238362|FG002|COMPLETED|Overall Study||23||
60117460|NCT00201123|76238360|FG000|NOT COMPLETED|Overall Study||6||
60117461|NCT00201123|76238361|FG001|NOT COMPLETED|Overall Study||4||
60117462|NCT00201123|76238362|FG002|NOT COMPLETED|Overall Study||9||
59715584|NCT01181141|75834352|FG000|NOT COMPLETED|Overall Study||12||
59715585|NCT01181141|75834353|FG001|NOT COMPLETED|Overall Study||4||
59715586|NCT01173120|75834359|FG000|STARTED|Overall Study||62||
59715587|NCT01173120|75834359|FG000|Switched Back to Main Study|Overall Study||57||
59715588|NCT01173120|75834359|FG000|Discontinued ACP Substudy and Main Study|Overall Study||5||
59715589|NCT01173120|75834359|FG000|COMPLETED|Overall Study||0||
59715590|NCT01173120|75834359|FG000|NOT COMPLETED|Overall Study||62||
59715591|NCT00977379|75834367|FG000|STARTED|Overall Study|Randomized|12||
59715592|NCT00977379|75834368|FG001|STARTED|Overall Study|Randomized|12||
59715593|NCT00977379|75834367|FG000|Treated|Overall Study||12||
59715594|NCT00977379|75834368|FG001|Treated|Overall Study||11||
59715595|NCT00977379|75834367|FG000|COMPLETED|Overall Study||0||
59715596|NCT00977379|75834368|FG001|COMPLETED|Overall Study||0||
59715597|NCT00977379|75834367|FG000|NOT COMPLETED|Overall Study||12||
59715598|NCT00977379|75834368|FG001|NOT COMPLETED|Overall Study||12||
59715599|NCT01180985|75834374|FG000|STARTED|Period 1 (7 +/- Days)||27||
59715600|NCT01180985|75834375|FG001|STARTED|Period 1 (7 +/- Days)||26||
59825399|NCT00426270|75948440|FG000|COMPLETED|Overall Study||110||
59825400|NCT00426270|75948440|FG000|NOT COMPLETED|Overall Study||6||
59825401|NCT00330681|75948446|FG000|STARTED|Overall Study||102||
59825402|NCT00330681|75948447|FG001|STARTED|Overall Study||104||
60117463|NCT01712009|76238377|FG000|STARTED|Overall Study||198||
60117464|NCT01712009|76238378|FG001|STARTED|Overall Study||200||
60117465|NCT01712009|76238379|FG002|STARTED|Overall Study||202||
60117466|NCT01712009|76238377|FG000|Received Pegfilgrastim|Overall Study||191||
60117467|NCT01712009|76238378|FG001|Received Pegfilgrastim|Overall Study||196||
59825403|NCT00330681|75948446|FG000|COMPLETED|Overall Study||93||
59825404|NCT00330681|75948447|FG001|COMPLETED|Overall Study||90||
60117468|NCT01712009|76238379|FG002|Received Pegfilgrastim|Overall Study||200||
60117469|NCT01712009|76238377|FG000|Received Naproxen / Loratadine|Overall Study||0||
60117470|NCT01712009|76238378|FG001|Received Naproxen / Loratadine|Overall Study||193||
59715601|NCT01180985|75834374|FG000|COMPLETED|Period 1 (7 +/- Days)||27||
59715602|NCT01180985|75834375|FG001|COMPLETED|Period 1 (7 +/- Days)||26||
59825405|NCT00330681|75948446|FG000|NOT COMPLETED|Overall Study||9||
59825406|NCT00330681|75948447|FG001|NOT COMPLETED|Overall Study||14||
59715603|NCT01180985|75834374|FG000|NOT COMPLETED|Period 1 (7 +/- Days)||0||
59715604|NCT01180985|75834375|FG001|NOT COMPLETED|Period 1 (7 +/- Days)||0||
59715605|NCT01180985|75834374|FG000|STARTED|Period 2 (7 +/- 1 Days)||27||
59825407|NCT00329901|75948456|FG000|STARTED|Overall Study||361||
59825408|NCT00329901|75948457|FG001|STARTED|Overall Study||354||
59825409|NCT00329901|75948458|FG002|STARTED|Overall Study||357||
59825410|NCT00329901|75948456|FG000|COMPLETED|Overall Study||352||
59825411|NCT00329901|75948457|FG001|COMPLETED|Overall Study||349||
59825412|NCT00329901|75948458|FG002|COMPLETED|Overall Study||353||
59825413|NCT00329901|75948456|FG000|NOT COMPLETED|Overall Study||9||
59825414|NCT00329901|75948457|FG001|NOT COMPLETED|Overall Study||5||
59825415|NCT00329901|75948458|FG002|NOT COMPLETED|Overall Study||4||
59825416|NCT00436956|75948470|FG000|STARTED|Overall Study||36||
59825417|NCT00436956|75948471|FG001|STARTED|Overall Study||23||
59825418|NCT00436956|75948470|FG000|COMPLETED|Overall Study|One pt was not evaluable due to a cord compression on day 2 of therapy; was removed from the trial.|35||
59825419|NCT00436956|75948471|FG001|COMPLETED|Overall Study||23||
59825420|NCT00436956|75948470|FG000|NOT COMPLETED|Overall Study||1||
59825421|NCT00436956|75948471|FG001|NOT COMPLETED|Overall Study||0||
59825422|NCT00329745|75948480|FG000|STARTED|Overall Study||4359||
59825423|NCT00329745|75948481|FG001|STARTED|Overall Study||4328||
59825424|NCT00329745|75948480|FG000|COMPLETED|Overall Study||4272||
59825425|NCT00329745|75948481|FG001|COMPLETED|Overall Study||4226||
59825426|NCT00329745|75948480|FG000|NOT COMPLETED|Overall Study||87||
59825427|NCT00329745|75948481|FG001|NOT COMPLETED|Overall Study||102||
59825428|NCT00436644|75948487|FG000|STARTED|Overall Study||18||
59825429|NCT00436644|75948487|FG000|COMPLETED|Overall Study||15||
59825430|NCT00436644|75948487|FG000|NOT COMPLETED|Overall Study||3||
59825431|NCT00324987|75948493|FG000|STARTED|Overall Study||6||
59825432|NCT00324987|75948494|FG001|STARTED|Overall Study||6||
59825433|NCT00324987|75948493|FG000|COMPLETED|Overall Study|Patients were to be treated until progression|0||
59825434|NCT00324987|75948494|FG001|COMPLETED|Overall Study|Patients were to be treated until progression|0||
59825435|NCT00324987|75948493|FG000|NOT COMPLETED|Overall Study||6||
59825436|NCT00324987|75948494|FG001|NOT COMPLETED|Overall Study||6||
59825437|NCT00324675|75948502|FG000|STARTED|Overall Study||14||
59825438|NCT00324675|75948503|FG001|STARTED|Overall Study||14||
59825439|NCT00324675|75948502|FG000|COMPLETED|Overall Study||13||
60117471|NCT01712009|76238379|FG002|Received Naproxen / Loratadine|Overall Study||198||
60117472|NCT01712009|76238377|FG000|COMPLETED|Overall Study||160||
59825440|NCT00324675|75948503|FG001|COMPLETED|Overall Study||14||
59825441|NCT00324675|75948502|FG000|NOT COMPLETED|Overall Study||1||
60117473|NCT01712009|76238378|FG001|COMPLETED|Overall Study||171||
60117474|NCT01712009|76238379|FG002|COMPLETED|Overall Study||181||
60117475|NCT01712009|76238377|FG000|NOT COMPLETED|Overall Study||38||
60117476|NCT01712009|76238378|FG001|NOT COMPLETED|Overall Study||29||
60117477|NCT01712009|76238379|FG002|NOT COMPLETED|Overall Study||21||
60117478|NCT00201825|76238387|FG000|STARTED|Overall Study||29||
60117479|NCT00201825|76238387|FG000|COMPLETED|Overall Study||29||
60117480|NCT00201825|76238387|FG000|NOT COMPLETED|Overall Study||0||
60117481|NCT02390050|76238395|FG000|STARTED|Overall Study||72||
60117482|NCT02390050|76238396|FG001|STARTED|Overall Study||72||
60117483|NCT02390050|76238397|FG002|STARTED|Overall Study||72||
60117484|NCT02390050|76238398|FG003|STARTED|Overall Study||76||
60117485|NCT02390050|76238395|FG000|COMPLETED|Overall Study||65||
60117486|NCT02390050|76238396|FG001|COMPLETED|Overall Study||67||
60117487|NCT02390050|76238397|FG002|COMPLETED|Overall Study||68||
60117488|NCT02390050|76238398|FG003|COMPLETED|Overall Study||69||
60117489|NCT02390050|76238395|FG000|NOT COMPLETED|Overall Study||7||
60117490|NCT02390050|76238396|FG001|NOT COMPLETED|Overall Study||5||
60117491|NCT02390050|76238397|FG002|NOT COMPLETED|Overall Study||4||
60117492|NCT02390050|76238398|FG003|NOT COMPLETED|Overall Study||7||
60117493|NCT01711853|76238408|FG000|STARTED|Overall Study||19||
60117494|NCT01711853|76238408|FG000|COMPLETED|Overall Study||16||
60117495|NCT01711853|76238408|FG000|NOT COMPLETED|Overall Study||3||
60117496|NCT01708187|76238414|FG000|STARTED|Overall Study||1||
60117497|NCT01708187|76238415|FG001|STARTED|Overall Study||1||
60117498|NCT01708187|76238414|FG000|COMPLETED|Overall Study||1||
60117499|NCT01708187|76238415|FG001|COMPLETED|Overall Study||0||
60117500|NCT01708187|76238414|FG000|NOT COMPLETED|Overall Study||0||
60117501|NCT01708187|76238415|FG001|NOT COMPLETED|Overall Study||1||
60117502|NCT00202449|76238424|FG000|STARTED|Overall Study||18||
60117503|NCT00202449|76238425|FG001|STARTED|Overall Study||20||
60117504|NCT00202449|76238426|FG002|STARTED|Overall Study||21||
60117505|NCT00202449|76238424|FG000|COMPLETED|Overall Study||7||
59825442|NCT00324675|75948503|FG001|NOT COMPLETED|Overall Study||0||
59825443|NCT00436566|75948509|FG000|STARTED|Overall Study||112||
59825444|NCT00436566|75948509|FG000|COMPLETED|Overall Study||109||
59825445|NCT00436566|75948509|FG000|NOT COMPLETED|Overall Study||3||
59825446|NCT00352365|75948513|FG000|STARTED|Induction Therapy||41||
59825447|NCT00352365|75948513|FG000|Eligible|Induction Therapy||38||
59825448|NCT00352365|75948513|FG000|Eligible and Began Protocol Therapy|Induction Therapy||37||
59825449|NCT00352365|75948513|FG000|COMPLETED|Induction Therapy||14||
59825450|NCT00352365|75948513|FG000|NOT COMPLETED|Induction Therapy||27||
59825451|NCT00352365|75948513|FG000|STARTED|Maintenance Therapy||12||
59825452|NCT00352365|75948513|FG000|Eligible and Began Protocol Therapy|Maintenance Therapy||8||
59825453|NCT00352365|75948513|FG000|COMPLETED|Maintenance Therapy||0||
59825454|NCT00352365|75948513|FG000|NOT COMPLETED|Maintenance Therapy||12||
59825455|NCT00532493|75948523|FG000|STARTED|Overall Study||152||
59825456|NCT00532493|75948524|FG001|STARTED|Overall Study||152||
59825457|NCT00532493|75948523|FG000|COMPLETED|Overall Study||122||
59825458|NCT00532493|75948524|FG001|COMPLETED|Overall Study||123||
59825459|NCT00532493|75948523|FG000|NOT COMPLETED|Overall Study||30||
59825460|NCT00532493|75948524|FG001|NOT COMPLETED|Overall Study||29||
59825461|NCT00533507|75948532|FG000|STARTED|Overall Study||230||
59825462|NCT00533507|75948532|FG000|COMPLETED|Overall Study||229||
59825463|NCT00533507|75948532|FG000|NOT COMPLETED|Overall Study||1||
59825464|NCT03886493|75948536|FG000|STARTED|Overall Study||7||
59825465|NCT03886493|75948536|FG000|COMPLETED|Overall Study||6||
59825466|NCT03886493|75948536|FG000|NOT COMPLETED|Overall Study||1||
59825467|NCT00352053|75948542|FG000|STARTED|Double-Blind Phase (Through Week 48)||45||
59825468|NCT00352053|75948543|FG001|STARTED|Double-Blind Phase (Through Week 48)||42||
60117506|NCT00202449|76238425|FG001|COMPLETED|Overall Study||9||
60117507|NCT00202449|76238426|FG002|COMPLETED|Overall Study||9||
60117508|NCT00202449|76238424|FG000|NOT COMPLETED|Overall Study||11||
60117509|NCT00202449|76238425|FG001|NOT COMPLETED|Overall Study||11||
60117510|NCT00202449|76238426|FG002|NOT COMPLETED|Overall Study||12||
60117511|NCT00203229|76238436|FG000|STARTED|Overall Study||10||
60117512|NCT00203229|76238437|FG001|STARTED|Overall Study||10||
60117513|NCT00203229|76238436|FG000|COMPLETED|Overall Study||7||
60117514|NCT00203229|76238437|FG001|COMPLETED|Overall Study||7||
59825469|NCT00352053|75948542|FG000|COMPLETED|Double-Blind Phase (Through Week 48)||27||
59825470|NCT00352053|75948543|FG001|COMPLETED|Double-Blind Phase (Through Week 48)|The 10 participants discontinued for virologic failure enrolled early in the open-label extension.|29||
59825471|NCT00352053|75948542|FG000|NOT COMPLETED|Double-Blind Phase (Through Week 48)||18||
59825472|NCT00352053|75948543|FG001|NOT COMPLETED|Double-Blind Phase (Through Week 48)||13||
59825473|NCT00352053|75948542|FG000|STARTED|First Extension Phase (Weeks 48-144)|3 participants completed the double-blind phase but did not enroll in the 1st extension phase.|24||
59825474|NCT00352053|75948543|FG001|STARTED|First Extension Phase (Weeks 48-144)|3 participants completed the double-blind phase but did not enroll in the 1st extension phase.|36||
59825475|NCT00352053|75948542|FG000|COMPLETED|First Extension Phase (Weeks 48-144)||12||
59825476|NCT00352053|75948543|FG001|COMPLETED|First Extension Phase (Weeks 48-144)||19||
59825477|NCT00352053|75948542|FG000|NOT COMPLETED|First Extension Phase (Weeks 48-144)||12||
59825478|NCT00352053|75948543|FG001|NOT COMPLETED|First Extension Phase (Weeks 48-144)||17||
59825479|NCT00352053|75948542|FG000|STARTED|Second Extension Phase (Weeks 144-240)|3 participants completed the 1st extension phase but did not enroll in the 2nd extension phase.|9||
59825480|NCT00352053|75948543|FG001|STARTED|Second Extension Phase (Weeks 144-240)|5 participants completed the 1st extension phase but did not enroll in the 2nd extension phase.|14||
59825481|NCT00352053|75948542|FG000|COMPLETED|Second Extension Phase (Weeks 144-240)||4||
59825482|NCT00352053|75948543|FG001|COMPLETED|Second Extension Phase (Weeks 144-240)||9||
59825483|NCT00352053|75948542|FG000|NOT COMPLETED|Second Extension Phase (Weeks 144-240)||5||
59825484|NCT00352053|75948543|FG001|NOT COMPLETED|Second Extension Phase (Weeks 144-240)||5||
59825485|NCT00352053|75948542|FG000|STARTED|Third Extension Phase (Weeks 240-294)|3 participants completed the 2nd extension phase but did not enroll in the 3rd extension phase.|1||
59825486|NCT00352053|75948543|FG001|STARTED|Third Extension Phase (Weeks 240-294)|5 participants completed the 2nd extension phase but did not enroll in the 3rd extension phase.|4||
59825487|NCT00352053|75948542|FG000|COMPLETED|Third Extension Phase (Weeks 240-294)||0||
59825488|NCT00352053|75948543|FG001|COMPLETED|Third Extension Phase (Weeks 240-294)||2||
59825489|NCT00352053|75948542|FG000|NOT COMPLETED|Third Extension Phase (Weeks 240-294)||1||
59825490|NCT00352053|75948543|FG001|NOT COMPLETED|Third Extension Phase (Weeks 240-294)||2||
59825491|NCT00351819|75948559|FG000|STARTED|Overall Study||43||
59825492|NCT00351819|75948560|FG001|STARTED|Overall Study||41||
59825493|NCT00351819|75948559|FG000|COMPLETED|Overall Study||36||
59825494|NCT00351819|75948560|FG001|COMPLETED|Overall Study||29||
59825495|NCT00351819|75948559|FG000|NOT COMPLETED|Overall Study||7||
59825496|NCT00351819|75948560|FG001|NOT COMPLETED|Overall Study||12||
59825497|NCT00351351|75948568|FG000|STARTED|Overall Study||34||
59825498|NCT00351351|75948569|FG001|STARTED|Overall Study||36||
59825499|NCT00351351|75948568|FG000|COMPLETED|Overall Study||25||
59825500|NCT00351351|75948569|FG001|COMPLETED|Overall Study||32||
59825501|NCT00351351|75948568|FG000|NOT COMPLETED|Overall Study||9||
59825502|NCT00351351|75948569|FG001|NOT COMPLETED|Overall Study||4||
59825503|NCT00323115|75948575|FG000|STARTED|Vaccine Administration||11||
59825504|NCT00323115|75948575|FG000|COMPLETED|Vaccine Administration||10||
59825505|NCT00323115|75948575|FG000|NOT COMPLETED|Vaccine Administration||1||
59825506|NCT00323115|75948575|FG000|STARTED|Adjuvant Therapy & Survival Follow-Up||10||
60117515|NCT00203229|76238436|FG000|NOT COMPLETED|Overall Study||3||
60117516|NCT00203229|76238437|FG001|NOT COMPLETED|Overall Study||3||
60117517|NCT00203931|76238445|FG000|STARTED|Overall Study||27||
60117518|NCT00203931|76238446|FG001|STARTED|Overall Study||28||
60117519|NCT00203931|76238445|FG000|COMPLETED|Overall Study|These are the evaluable patients who received at least 3 doses of cetuximab.|20||
60117520|NCT00203931|76238446|FG001|COMPLETED|Overall Study|These are the evaluable patients who received at least 3 doses of cetuximab.|23||
60117521|NCT00203931|76238445|FG000|NOT COMPLETED|Overall Study||7||
60117522|NCT00203931|76238446|FG001|NOT COMPLETED|Overall Study||5||
59825507|NCT00323115|75948575|FG000|COMPLETED|Adjuvant Therapy & Survival Follow-Up||2||
59825508|NCT00323115|75948575|FG000|NOT COMPLETED|Adjuvant Therapy & Survival Follow-Up||8||
59825509|NCT00322881|75948584|FG000|STARTED|Overall Study||12||
59825510|NCT00322881|75948584|FG000|COMPLETED|Overall Study||7||
59825511|NCT00322881|75948584|FG000|NOT COMPLETED|Overall Study||5||
59825512|NCT00415194|75948590|FG000|STARTED|Overall Study||398||
59825513|NCT00415194|75948591|FG001|STARTED|Overall Study||397||
60117523|NCT02412982|76238458|FG000|STARTED|Primary Endpoint||51||
60117524|NCT02412982|76238459|FG001|STARTED|Primary Endpoint||52||
60117525|NCT02412982|76238458|FG000|COMPLETED|Primary Endpoint||47||
60117526|NCT02412982|76238459|FG001|COMPLETED|Primary Endpoint||49||
60117527|NCT02412982|76238458|FG000|NOT COMPLETED|Primary Endpoint||4||
60117528|NCT02412982|76238459|FG001|NOT COMPLETED|Primary Endpoint||3||
60117529|NCT02412982|76238458|FG000|STARTED|Intervention Group: Randomization|Control group patients did not undergo randomization (see study protocol section)|0||
60117530|NCT02412982|76238459|FG001|STARTED|Intervention Group: Randomization|52 patients in the intervention group underwent 1:1 randomization to the two intervention study arms: 26 patients in 40 mg every 12 hours with escalation to 50 mg every 12 hours and 26 patients in 30 mg every 8 hours.|52||
60117531|NCT02412982|76238458|FG000|COMPLETED|Intervention Group: Randomization||0||
59567337|NCT02281526|75670250|FG001|NOT COMPLETED|Overall Study||0||
59567338|NCT03802227|75670258|FG000|STARTED|Overall Study||4||
59715606|NCT01180985|75834375|FG001|STARTED|Period 2 (7 +/- 1 Days)||26||
60117532|NCT02412982|76238459|FG001|COMPLETED|Intervention Group: Randomization||51||
60117533|NCT02412982|76238458|FG000|NOT COMPLETED|Intervention Group: Randomization||0||
60117534|NCT02412982|76238459|FG001|NOT COMPLETED|Intervention Group: Randomization||1||
60117535|NCT02390908|76238470|FG000|STARTED|Overall Study||40||
59567339|NCT03802227|75670259|FG001|STARTED|Overall Study||4||
59567340|NCT03802227|75670258|FG000|COMPLETED|Overall Study||4||
59567341|NCT03802227|75670259|FG001|COMPLETED|Overall Study||4||
59567342|NCT03802227|75670258|FG000|NOT COMPLETED|Overall Study||0||
59567343|NCT03802227|75670259|FG001|NOT COMPLETED|Overall Study||0||
59567344|NCT01879826|75670269|FG000|STARTED|Overall Study||41||
59567345|NCT01879826|75670270|FG001|STARTED|Overall Study||40||
59715607|NCT01180985|75834374|FG000|COMPLETED|Period 2 (7 +/- 1 Days)||26||
59715608|NCT01180985|75834375|FG001|COMPLETED|Period 2 (7 +/- 1 Days)||26||
59715609|NCT01180985|75834374|FG000|NOT COMPLETED|Period 2 (7 +/- 1 Days)||1||
59715610|NCT01180985|75834375|FG001|NOT COMPLETED|Period 2 (7 +/- 1 Days)||0||
59715611|NCT01147536|75834382|FG000|STARTED|Overall Study||12||
59715612|NCT01147536|75834382|FG000|Received at Least 1 Dose of Study Drug|Overall Study||12||
59715613|NCT01147536|75834382|FG000|COMPLETED|Overall Study||9||
59715614|NCT01147536|75834382|FG000|NOT COMPLETED|Overall Study||3||
59715615|NCT01154088|75834389|FG000|STARTED|Overall Study||390||
59715616|NCT01154088|75834390|FG001|STARTED|Overall Study||390||
59715617|NCT01154088|75834391|FG002|STARTED|Overall Study||390||
59567346|NCT01879826|75670269|FG000|COMPLETED|Overall Study||41||
59567347|NCT01879826|75670270|FG001|COMPLETED|Overall Study||40||
59567348|NCT01879826|75670269|FG000|NOT COMPLETED|Overall Study||0||
59567349|NCT01879826|75670270|FG001|NOT COMPLETED|Overall Study||0||
59715618|NCT01154088|75834389|FG000|COMPLETED|Overall Study||386||
59715619|NCT01154088|75834390|FG001|COMPLETED|Overall Study||384||
59715620|NCT01154088|75834391|FG002|COMPLETED|Overall Study||383||
59715621|NCT01154088|75834389|FG000|NOT COMPLETED|Overall Study||4||
59715622|NCT01154088|75834390|FG001|NOT COMPLETED|Overall Study||6||
59715623|NCT01154088|75834391|FG002|NOT COMPLETED|Overall Study||7||
59715624|NCT01180049|75834402|FG000|STARTED|Overall Study||53||
59715625|NCT01180049|75834403|FG001|STARTED|Overall Study||48||
59715626|NCT01180049|75834402|FG000|COMPLETED|Overall Study||0||
59715627|NCT01180049|75834403|FG001|COMPLETED|Overall Study||0||
59715628|NCT01180049|75834402|FG000|NOT COMPLETED|Overall Study||53||
59715629|NCT01180049|75834403|FG001|NOT COMPLETED|Overall Study||48||
59825514|NCT00415194|75948590|FG000|Received at Least 1 Dose of Study Drug|Overall Study||392||
60117536|NCT02390908|76238471|FG001|STARTED|Overall Study||22||
60117537|NCT02390908|76238472|FG002|STARTED|Overall Study||22||
60117538|NCT02390908|76238473|FG003|STARTED|Overall Study||90||
60117539|NCT02390908|76238474|FG004|STARTED|Overall Study||120||
60117540|NCT02390908|76238470|FG000|COMPLETED|Overall Study||40||
60117541|NCT02390908|76238471|FG001|COMPLETED|Overall Study||22||
60117542|NCT02390908|76238472|FG002|COMPLETED|Overall Study||22||
60117543|NCT02390908|76238473|FG003|COMPLETED|Overall Study||90||
60117544|NCT02390908|76238474|FG004|COMPLETED|Overall Study||120||
60117545|NCT02390908|76238470|FG000|NOT COMPLETED|Overall Study||0||
59567350|NCT01383681|75670276|FG000|STARTED|Overall Study||235||
59715630|NCT01147458|75834409|FG000|STARTED|First Intervention||48||
59825515|NCT00415194|75948591|FG001|Received at Least 1 Dose of Study Drug|Overall Study||385||
59825516|NCT00415194|75948590|FG000|COMPLETED|Overall Study||70||
59825517|NCT00415194|75948591|FG001|COMPLETED|Overall Study||55||
59825518|NCT00415194|75948590|FG000|NOT COMPLETED|Overall Study||328||
59825519|NCT00415194|75948591|FG001|NOT COMPLETED|Overall Study||342||
59825520|NCT00436332|75948597|FG000|STARTED|Overall Study||84||
59825521|NCT00436332|75948597|FG000|Eligible|Overall Study||82||
59825522|NCT00436332|75948597|FG000|Eligible and Began Protocol Therapy|Overall Study||79||
59825523|NCT00436332|75948597|FG000|COMPLETED|Overall Study||1||
59825524|NCT00436332|75948597|FG000|NOT COMPLETED|Overall Study||83||
59825525|NCT00532259|75948601|FG000|STARTED|Overall Study||72||
59825526|NCT00532259|75948601|FG000|COMPLETED|Overall Study||40||
59825527|NCT00532259|75948601|FG000|NOT COMPLETED|Overall Study||32||
59825528|NCT00322491|75948608|FG000|STARTED|Overall Study||23||
59825529|NCT00322491|75948609|FG001|STARTED|Overall Study||26||
59825530|NCT00322491|75948608|FG000|COMPLETED|Overall Study||21||
59825531|NCT00322491|75948609|FG001|COMPLETED|Overall Study||24||
59825532|NCT00322491|75948608|FG000|NOT COMPLETED|Overall Study||2||
59825533|NCT00322491|75948609|FG001|NOT COMPLETED|Overall Study||2||
59825534|NCT00322023|75948619|FG000|STARTED|Overall Study||12||
59825535|NCT00322023|75948620|FG001|STARTED|Overall Study||21||
59825536|NCT00322023|75948621|FG002|STARTED|Overall Study||22||
59825537|NCT00322023|75948619|FG000|COMPLETED|Overall Study||12||
59825538|NCT00322023|75948620|FG001|COMPLETED|Overall Study||19||
59825539|NCT00322023|75948621|FG002|COMPLETED|Overall Study||16||
59825540|NCT00322023|75948619|FG000|NOT COMPLETED|Overall Study||0||
59825541|NCT00322023|75948620|FG001|NOT COMPLETED|Overall Study||2||
59825542|NCT00322023|75948621|FG002|NOT COMPLETED|Overall Study||6||
59825543|NCT00414960|75948631|FG000|STARTED|Overall Study||25||
59825544|NCT00414960|75948632|FG001|STARTED|Overall Study||15||
59825545|NCT00414960|75948631|FG000|Received at Least One Dose of Study Drug|Overall Study||24||
59825546|NCT00414960|75948632|FG001|Received at Least One Dose of Study Drug|Overall Study||15||
59825547|NCT00414960|75948631|FG000|COMPLETED|Overall Study||18||
59825548|NCT00414960|75948632|FG001|COMPLETED|Overall Study||14||
59825549|NCT00414960|75948631|FG000|NOT COMPLETED|Overall Study||7||
59825550|NCT00414960|75948632|FG001|NOT COMPLETED|Overall Study||1||
60117546|NCT02390908|76238471|FG001|NOT COMPLETED|Overall Study||0||
60117547|NCT02390908|76238472|FG002|NOT COMPLETED|Overall Study||0||
59715631|NCT01147458|75834410|FG001|STARTED|First Intervention||47||
59715632|NCT01147458|75834411|FG002|STARTED|First Intervention||47||
59715633|NCT01147458|75834412|FG003|STARTED|First Intervention||48||
59715634|NCT01147458|75834409|FG000|COMPLETED|First Intervention||34||
59715635|NCT01147458|75834410|FG001|COMPLETED|First Intervention||31||
59715636|NCT01147458|75834411|FG002|COMPLETED|First Intervention||35||
59715637|NCT01147458|75834412|FG003|COMPLETED|First Intervention||34||
59715638|NCT01147458|75834409|FG000|NOT COMPLETED|First Intervention||14||
59715639|NCT01147458|75834410|FG001|NOT COMPLETED|First Intervention||16||
59715640|NCT01147458|75834411|FG002|NOT COMPLETED|First Intervention||12||
59715641|NCT01147458|75834412|FG003|NOT COMPLETED|First Intervention||14||
59715642|NCT01147458|75834409|FG000|STARTED|Washout Period of 2 Weeks||34||
59715643|NCT01147458|75834410|FG001|STARTED|Washout Period of 2 Weeks||31||
59715644|NCT01147458|75834411|FG002|STARTED|Washout Period of 2 Weeks||35||
59715645|NCT01147458|75834412|FG003|STARTED|Washout Period of 2 Weeks||34||
59715646|NCT01147458|75834409|FG000|COMPLETED|Washout Period of 2 Weeks||34||
59715647|NCT01147458|75834410|FG001|COMPLETED|Washout Period of 2 Weeks||31||
59715648|NCT01147458|75834411|FG002|COMPLETED|Washout Period of 2 Weeks||35||
59715649|NCT01147458|75834412|FG003|COMPLETED|Washout Period of 2 Weeks||34||
59715650|NCT01147458|75834409|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0||
59715651|NCT01147458|75834410|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0||
59715652|NCT01147458|75834411|FG002|NOT COMPLETED|Washout Period of 2 Weeks||0||
59715653|NCT01147458|75834412|FG003|NOT COMPLETED|Washout Period of 2 Weeks||0||
59715654|NCT01147458|75834409|FG000|STARTED|Second Intervention||34||
60117548|NCT02390908|76238473|FG003|NOT COMPLETED|Overall Study||0||
59715655|NCT01147458|75834410|FG001|STARTED|Second Intervention||31||
59715656|NCT01147458|75834411|FG002|STARTED|Second Intervention||35||
59715657|NCT01147458|75834412|FG003|STARTED|Second Intervention||34||
59715658|NCT01147458|75834409|FG000|COMPLETED|Second Intervention||25||
59715659|NCT01147458|75834410|FG001|COMPLETED|Second Intervention||24||
59715660|NCT01147458|75834411|FG002|COMPLETED|Second Intervention||27||
59715661|NCT01147458|75834412|FG003|COMPLETED|Second Intervention||30||
59715662|NCT01147458|75834409|FG000|NOT COMPLETED|Second Intervention||9||
59715663|NCT01147458|75834410|FG001|NOT COMPLETED|Second Intervention||7||
59715664|NCT01147458|75834411|FG002|NOT COMPLETED|Second Intervention||8||
59715665|NCT01147458|75834412|FG003|NOT COMPLETED|Second Intervention||4||
59715666|NCT01172808|75834428|FG000|STARTED|Overall Study|Entered and Treated|269||
59825551|NCT00321789|75948640|FG000|STARTED|Overall Study||127||
59825552|NCT00321789|75948641|FG001|STARTED|Overall Study||128||
59825553|NCT00321789|75948640|FG000|COMPLETED|Overall Study||112||
59825554|NCT00321789|75948641|FG001|COMPLETED|Overall Study||112||
59825555|NCT00321789|75948640|FG000|NOT COMPLETED|Overall Study||15||
59825556|NCT00321789|75948641|FG001|NOT COMPLETED|Overall Study||16||
59825557|NCT00414726|75948649|FG000|STARTED|Overall Study||43||
59825558|NCT00414726|75948650|FG001|STARTED|Overall Study||42||
59825559|NCT00414726|75948649|FG000|COMPLETED|Overall Study||43||
59825560|NCT00414726|75948650|FG001|COMPLETED|Overall Study||41||
59825561|NCT00414726|75948649|FG000|NOT COMPLETED|Overall Study||0||
59825562|NCT00414726|75948650|FG001|NOT COMPLETED|Overall Study||1||
59825563|NCT00531947|75948658|FG000|STARTED|Overall Study|all randomized subjects who received at least one dose of placebo study medication|156||
59825564|NCT00531947|75948659|FG001|STARTED|Overall Study|all randomized subjects who received at least one dose of EMSAM study medication|152||
59825565|NCT00531947|75948658|FG000|COMPLETED|Overall Study||114||
59825566|NCT00531947|75948659|FG001|COMPLETED|Overall Study||101||
59825567|NCT00531947|75948658|FG000|NOT COMPLETED|Overall Study||42||
59825568|NCT00531947|75948659|FG001|NOT COMPLETED|Overall Study||51||
59825569|NCT00530855|75948665|FG000|STARTED|Overall Study||322||
59825570|NCT00530855|75948665|FG000|COMPLETED|Overall Study||210||
59567351|NCT01383681|75670276|FG000|COMPLETED|Overall Study||189||
59567352|NCT01383681|75670276|FG000|NOT COMPLETED|Overall Study||46||
59715667|NCT01172808|75834429|FG001|STARTED|Overall Study|Entered and Treated|262||
59825571|NCT00530855|75948665|FG000|NOT COMPLETED|Overall Study||112||
59825572|NCT00530777|75948671|FG000|STARTED|Overall Study||74||
59825573|NCT00530777|75948672|FG001|STARTED|Overall Study||74||
59825574|NCT00530777|75948671|FG000|COMPLETED|Overall Study||67||
59825575|NCT00530777|75948672|FG001|COMPLETED|Overall Study||69||
59825576|NCT00530777|75948671|FG000|NOT COMPLETED|Overall Study||7||
59825577|NCT00530777|75948672|FG001|NOT COMPLETED|Overall Study||5||
59825578|NCT03882047|75948681|FG000|STARTED|Overall Study||104||
59825579|NCT03882047|75948682|FG001|STARTED|Overall Study||105||
59825580|NCT03882047|75948683|FG002|STARTED|Overall Study||104||
59715668|NCT01172808|75834430|FG002|STARTED|Overall Study|Entered and Treated|264||
59715669|NCT01172808|75834431|FG003|STARTED|Overall Study|Entered and Treated|275||
59825581|NCT03882047|75948681|FG000|Treated|Overall Study||104||
59825582|NCT03882047|75948682|FG001|Treated|Overall Study||104||
59825583|NCT03882047|75948683|FG002|Treated|Overall Study||103||
59825584|NCT03882047|75948681|FG000|COMPLETED|Overall Study||98||
59825585|NCT03882047|75948682|FG001|COMPLETED|Overall Study||95||
59825586|NCT03882047|75948683|FG002|COMPLETED|Overall Study||88||
59825587|NCT03882047|75948681|FG000|NOT COMPLETED|Overall Study||6||
59825588|NCT03882047|75948682|FG001|NOT COMPLETED|Overall Study||10||
59825589|NCT03882047|75948683|FG002|NOT COMPLETED|Overall Study||16||
59825590|NCT00530621|75948693|FG000|STARTED|Overall Study||80||
59825591|NCT00530621|75948694|FG001|STARTED|Overall Study||80||
59825592|NCT00530621|75948693|FG000|Received at Least 1 Dose of Study Drug|Overall Study||79||
59825593|NCT00530621|75948694|FG001|Received at Least 1 Dose of Study Drug|Overall Study||80||
59825594|NCT00530621|75948693|FG000|COMPLETED|Overall Study||0||
59715670|NCT01172808|75834428|FG000|COMPLETED|Overall Study||248||
59715671|NCT01172808|75834429|FG001|COMPLETED|Overall Study||249||
59715672|NCT01172808|75834430|FG002|COMPLETED|Overall Study||241||
59715673|NCT01172808|75834431|FG003|COMPLETED|Overall Study||260||
59715674|NCT01172808|75834428|FG000|NOT COMPLETED|Overall Study||21||
59825595|NCT00530621|75948694|FG001|COMPLETED|Overall Study||0||
59825596|NCT00530621|75948693|FG000|NOT COMPLETED|Overall Study||80||
59825597|NCT00530621|75948694|FG001|NOT COMPLETED|Overall Study||80||
59825598|NCT00531479|75948706|FG000|STARTED|Overall Study||230||
59825599|NCT00531479|75948707|FG001|STARTED|Overall Study||229||
59825600|NCT00531479|75948706|FG000|Treated|Overall Study||228||
59825601|NCT00531479|75948707|FG001|Treated|Overall Study||226||
59825602|NCT00531479|75948706|FG000|COMPLETED|Overall Study||154||
59825603|NCT00531479|75948707|FG001|COMPLETED|Overall Study||146||
59825604|NCT00531479|75948706|FG000|NOT COMPLETED|Overall Study||76||
59825605|NCT00531479|75948707|FG001|NOT COMPLETED|Overall Study||83||
59825606|NCT00530075|75948713|FG000|STARTED|Overall Study||45||
59825607|NCT00530075|75948713|FG000|COMPLETED|Overall Study||38||
59825608|NCT00530075|75948713|FG000|NOT COMPLETED|Overall Study||7||
59825609|NCT00531011|75948719|FG000|STARTED|Overall Study||103||
59825610|NCT00531011|75948720|FG001|STARTED|Overall Study||97||
59825611|NCT00531011|75948719|FG000|COMPLETED|Overall Study||99||
59825612|NCT00531011|75948720|FG001|COMPLETED|Overall Study||90||
59825613|NCT00531011|75948719|FG000|NOT COMPLETED|Overall Study||4||
59715675|NCT01172808|75834429|FG001|NOT COMPLETED|Overall Study||13||
59715676|NCT01172808|75834430|FG002|NOT COMPLETED|Overall Study||23||
59715677|NCT01172808|75834431|FG003|NOT COMPLETED|Overall Study||15||
59715678|NCT01151280|75834441|FG000|STARTED|Overall Study||10||
59825614|NCT00531011|75948720|FG001|NOT COMPLETED|Overall Study||7||
59825615|NCT00529217|75948726|FG000|STARTED|Overall Study||12||
59825616|NCT00529217|75948726|FG000|COMPLETED|Overall Study||8||
59825617|NCT00529217|75948726|FG000|NOT COMPLETED|Overall Study||4||
59825618|NCT00471146|75948733|FG000|STARTED|Overall Study||314||
59825619|NCT00471146|75948734|FG001|STARTED|Overall Study||316||
59825620|NCT00471146|75948733|FG000|Treated|Overall Study||305||
59825621|NCT00471146|75948734|FG001|Treated|Overall Study||308||
59825622|NCT00471146|75948733|FG000|COMPLETED|Overall Study||142||
59825623|NCT00471146|75948734|FG001|COMPLETED|Overall Study||142||
59825624|NCT00471146|75948733|FG000|NOT COMPLETED|Overall Study||172||
59825625|NCT00471146|75948734|FG001|NOT COMPLETED|Overall Study||174||
59825626|NCT00469898|75948740|FG000|STARTED|Overall Study||50||
59825627|NCT00469898|75948740|FG000|COMPLETED|Overall Study||25||
59825628|NCT00469898|75948740|FG000|NOT COMPLETED|Overall Study||25||
59825629|NCT00529763|75948747|FG000|STARTED|Overall Study||25||
59567353|NCT02749617|75670280|FG000|STARTED|Overall Study||2||
59825630|NCT00529763|75948748|FG001|STARTED|Overall Study||37||
59825631|NCT00529763|75948749|FG002|STARTED|Overall Study||59||
59825632|NCT00529763|75948747|FG000|COMPLETED|Overall Study||4|All participants who completed treatment were transitioned to the patient support program of Sprycel.|
59825633|NCT00529763|75948748|FG001|COMPLETED|Overall Study||0|All participants who completed treatment were transitioned to the patient support program of Sprycel.|
59825634|NCT00529763|75948749|FG002|COMPLETED|Overall Study||27|All participants who completed treatment were transitioned to the patient support program of Sprycel.|
59825635|NCT00529763|75948747|FG000|NOT COMPLETED|Overall Study||21||
59825636|NCT00529763|75948748|FG001|NOT COMPLETED|Overall Study||37||
59825637|NCT00529763|75948749|FG002|NOT COMPLETED|Overall Study||32||
59825638|NCT00486902|75948764|FG000|STARTED|Overall Study||94||
59825639|NCT00486902|75948765|FG001|STARTED|Overall Study||94||
59825640|NCT00486902|75948764|FG000|COMPLETED|Overall Study||85||
59825641|NCT00486902|75948765|FG001|COMPLETED|Overall Study||89||
59825642|NCT00486902|75948764|FG000|NOT COMPLETED|Overall Study||9||
59825643|NCT00486902|75948765|FG001|NOT COMPLETED|Overall Study||5||
59825644|NCT03687827|75948771|FG000|STARTED|Treatment Period 1||249||
59825645|NCT03687827|75948772|FG001|STARTED|Treatment Period 1||249||
59825646|NCT03687827|75948771|FG000|Full Analysis Set (FAS)|Treatment Period 1||249||
59825647|NCT03687827|75948772|FG001|Full Analysis Set (FAS)|Treatment Period 1||249||
59825648|NCT03687827|75948771|FG000|Safety Analysis Set (SAS)|Treatment Period 1||249||
59825649|NCT03687827|75948772|FG001|Safety Analysis Set (SAS)|Treatment Period 1||249||
59825650|NCT03687827|75948771|FG000|Per Protocol Set|Treatment Period 1||219||
60117549|NCT02390908|76238474|FG004|NOT COMPLETED|Overall Study||0||
60117550|NCT01740401|76238491|FG000|STARTED|Overall Study||10||
60117551|NCT01740401|76238491|FG000|COMPLETED|Overall Study||0||
60117552|NCT01740401|76238491|FG000|NOT COMPLETED|Overall Study||10||
60117553|NCT02413684|76238495|FG000|STARTED|Overall Study||53||
60117554|NCT02413684|76238495|FG000|COMPLETED|Overall Study||40||
60117555|NCT02413684|76238495|FG000|NOT COMPLETED|Overall Study||13||
60117556|NCT02413918|76238499|FG000|STARTED|Overall Study||41||
60117557|NCT02413918|76238499|FG000|COMPLETED|Overall Study||16||
60117558|NCT02413918|76238499|FG000|NOT COMPLETED|Overall Study||25||
60117559|NCT00099021|76238506|FG000|STARTED|Overall Study||21||
60117560|NCT00099021|76238506|FG000|COMPLETED|Overall Study||21||
60117561|NCT00099021|76238506|FG000|NOT COMPLETED|Overall Study||0||
60117562|NCT01711619|76238512|FG000|STARTED|Overall Study||56||
60117563|NCT01711619|76238513|FG001|STARTED|Overall Study||60||
60117564|NCT01711619|76238512|FG000|COMPLETED|Overall Study||38||
60117565|NCT01711619|76238513|FG001|COMPLETED|Overall Study||36||
60117566|NCT01711619|76238512|FG000|NOT COMPLETED|Overall Study||18||
60117567|NCT01711619|76238513|FG001|NOT COMPLETED|Overall Study||24||
60117568|NCT02415244|76238521|FG000|STARTED|Overall Study||50||
60117569|NCT02415244|76238522|FG001|STARTED|Overall Study||25||
60117570|NCT02415244|76238521|FG000|COMPLETED|Overall Study||50||
59825651|NCT03687827|75948772|FG001|Per Protocol Set|Treatment Period 1||229||
59825652|NCT03687827|75948771|FG000|COMPLETED|Treatment Period 1||235||
59825653|NCT03687827|75948772|FG001|COMPLETED|Treatment Period 1||241||
60117571|NCT02415244|76238522|FG001|COMPLETED|Overall Study||25||
59567354|NCT02749617|75670280|FG000|COMPLETED|Overall Study||2||
60117572|NCT02415244|76238521|FG000|NOT COMPLETED|Overall Study||0||
60117573|NCT02415244|76238522|FG001|NOT COMPLETED|Overall Study||0||
59825654|NCT03687827|75948771|FG000|NOT COMPLETED|Treatment Period 1||14||
59825655|NCT03687827|75948772|FG001|NOT COMPLETED|Treatment Period 1||8||
59825656|NCT03687827|75948771|FG000|STARTED|Treatment Period 2||235||
59825657|NCT03687827|75948772|FG001|STARTED|Treatment Period 2||241||
59825658|NCT03687827|75948771|FG000|COMPLETED|Treatment Period 2||230||
59825659|NCT03687827|75948772|FG001|COMPLETED|Treatment Period 2||238||
59825660|NCT03687827|75948771|FG000|NOT COMPLETED|Treatment Period 2||5||
59825661|NCT03687827|75948772|FG001|NOT COMPLETED|Treatment Period 2||3||
59825662|NCT00529529|75948781|FG000|STARTED|Overall Study||268||
59825663|NCT00529529|75948782|FG001|STARTED|Overall Study||268||
59825664|NCT00529529|75948783|FG002|STARTED|Overall Study||269||
59825665|NCT00529529|75948781|FG000|COMPLETED|Overall Study||225||
59825666|NCT00529529|75948782|FG001|COMPLETED|Overall Study||225||
59825667|NCT00529529|75948783|FG002|COMPLETED|Overall Study||238||
59825668|NCT00529529|75948781|FG000|NOT COMPLETED|Overall Study||43||
59825669|NCT00529529|75948782|FG001|NOT COMPLETED|Overall Study||43||
59825670|NCT00529529|75948783|FG002|NOT COMPLETED|Overall Study||31||
59825671|NCT05655377|75948791|FG000|STARTED|Overall Study||9||
59825672|NCT05655377|75948791|FG000|COMPLETED|Overall Study||7||
59825673|NCT05655377|75948791|FG000|NOT COMPLETED|Overall Study||2||
59825674|NCT00486434|75948797|FG000|STARTED|Overall Study||588||
59825675|NCT00486434|75948798|FG001|STARTED|Overall Study||588||
59825676|NCT00486434|75948797|FG000|COMPLETED|Overall Study||394||
59825677|NCT00486434|75948798|FG001|COMPLETED|Overall Study||454||
59825678|NCT00486434|75948797|FG000|NOT COMPLETED|Overall Study||194||
59825679|NCT00486434|75948798|FG001|NOT COMPLETED|Overall Study||134||
59825680|NCT00424632|75948807|FG000|STARTED|Overall Study||1||
59825681|NCT00424632|75948808|FG001|STARTED|Overall Study||1||
59825682|NCT00424632|75948809|FG002|STARTED|Overall Study||1||
59825683|NCT00424632|75948810|FG003|STARTED|Overall Study||4||
59825684|NCT00424632|75948811|FG004|STARTED|Overall Study||3||
59825685|NCT00424632|75948812|FG005|STARTED|Overall Study||15||
59825686|NCT00424632|75948813|FG006|STARTED|Overall Study||7||
59825687|NCT00424632|75948814|FG007|STARTED|Overall Study||3||
59825688|NCT00424632|75948815|FG008|STARTED|Overall Study||16||
59825689|NCT00424632|75948816|FG009|STARTED|Overall Study||6||
59825690|NCT00424632|75948807|FG000|COMPLETED|Overall Study||0||
59825691|NCT00424632|75948808|FG001|COMPLETED|Overall Study||0||
59825692|NCT00424632|75948809|FG002|COMPLETED|Overall Study||0||
59825693|NCT00424632|75948810|FG003|COMPLETED|Overall Study||0||
59825694|NCT00424632|75948811|FG004|COMPLETED|Overall Study||0||
59825695|NCT00424632|75948812|FG005|COMPLETED|Overall Study||0||
59825696|NCT00424632|75948813|FG006|COMPLETED|Overall Study||0||
59825697|NCT00424632|75948814|FG007|COMPLETED|Overall Study||0||
60117574|NCT01710527|76238528|FG000|STARTED|Period 1: Intervention Period 1||16||
60117575|NCT01710527|76238529|FG001|STARTED|Period 1: Intervention Period 1||16||
60117576|NCT01710527|76238528|FG000|COMPLETED|Period 1: Intervention Period 1||16||
59567355|NCT02749617|75670280|FG000|NOT COMPLETED|Overall Study||0||
59567356|NCT02749227|75670284|FG000|STARTED|Overall Study||4||
59825698|NCT00424632|75948815|FG008|COMPLETED|Overall Study||0||
59825699|NCT00424632|75948816|FG009|COMPLETED|Overall Study||0||
59825700|NCT00424632|75948807|FG000|NOT COMPLETED|Overall Study||1||
59825701|NCT00424632|75948808|FG001|NOT COMPLETED|Overall Study||1||
59825702|NCT00424632|75948809|FG002|NOT COMPLETED|Overall Study||1||
59825703|NCT00424632|75948810|FG003|NOT COMPLETED|Overall Study||4||
59825704|NCT00424632|75948811|FG004|NOT COMPLETED|Overall Study||3||
59825705|NCT00424632|75948812|FG005|NOT COMPLETED|Overall Study||15||
59825706|NCT00424632|75948813|FG006|NOT COMPLETED|Overall Study||7||
59825707|NCT00424632|75948814|FG007|NOT COMPLETED|Overall Study||3||
59825708|NCT00424632|75948815|FG008|NOT COMPLETED|Overall Study||16||
59825709|NCT00424632|75948816|FG009|NOT COMPLETED|Overall Study||6||
59825710|NCT00529451|75948851|FG000|STARTED|Overall Study||331||
59825711|NCT00529451|75948852|FG001|STARTED|Overall Study||323||
59825712|NCT00529451|75948853|FG002|STARTED|Overall Study||332||
59825713|NCT00529451|75948854|FG003|STARTED|Overall Study||330||
59825714|NCT00529451|75948851|FG000|COMPLETED|Overall Study||294||
59825715|NCT00529451|75948852|FG001|COMPLETED|Overall Study||275||
59825716|NCT00529451|75948853|FG002|COMPLETED|Overall Study||292||
59825717|NCT00529451|75948854|FG003|COMPLETED|Overall Study||299||
59825718|NCT00529451|75948851|FG000|NOT COMPLETED|Overall Study||37||
59825719|NCT00529451|75948852|FG001|NOT COMPLETED|Overall Study||48||
59825720|NCT00529451|75948853|FG002|NOT COMPLETED|Overall Study||40||
59825721|NCT00529451|75948854|FG003|NOT COMPLETED|Overall Study||31||
60117577|NCT01710527|76238529|FG001|COMPLETED|Period 1: Intervention Period 1||16||
60117578|NCT01710527|76238528|FG000|NOT COMPLETED|Period 1: Intervention Period 1||0||
60117579|NCT01710527|76238529|FG001|NOT COMPLETED|Period 1: Intervention Period 1||0||
60117580|NCT01710527|76238528|FG000|STARTED|Period 2: Washout Period (7 Days)||16||
59825722|NCT03876743|75948871|FG000|STARTED|Overall Study||54||
59825723|NCT03876743|75948872|FG001|STARTED|Overall Study||51||
59825724|NCT03876743|75948873|FG002|STARTED|Overall Study||46||
59825725|NCT03876743|75948874|FG003|STARTED|Overall Study||50||
59825726|NCT03876743|75948871|FG000|COMPLETED|Overall Study||48||
59825727|NCT03876743|75948872|FG001|COMPLETED|Overall Study||47||
59825728|NCT03876743|75948873|FG002|COMPLETED|Overall Study||42||
59825729|NCT03876743|75948874|FG003|COMPLETED|Overall Study||43||
59825730|NCT03876743|75948871|FG000|NOT COMPLETED|Overall Study||6||
59825731|NCT03876743|75948872|FG001|NOT COMPLETED|Overall Study||4||
59825732|NCT03876743|75948873|FG002|NOT COMPLETED|Overall Study||4||
59825733|NCT03876743|75948874|FG003|NOT COMPLETED|Overall Study||7||
59825734|NCT00486278|75948888|FG000|STARTED|Overall Study|96 bleeds by 51 subjects, 77 were treated with vatreptacog alfa and 19 with rFVIIa|51||
59825735|NCT00486278|75948888|FG000|COMPLETED|Overall Study||42||
59825736|NCT00486278|75948888|FG000|NOT COMPLETED|Overall Study||9||
59825737|NCT00321711|75948907|FG000|STARTED|Part A||13||
59825738|NCT00321711|75948908|FG001|STARTED|Part A||13||
59825739|NCT00321711|75948909|FG002|STARTED|Part A||14||
59825740|NCT00321711|75948910|FG003|STARTED|Part A||0||
59825741|NCT00321711|75948911|FG004|STARTED|Part A||0||
59825742|NCT00321711|75948907|FG000|COMPLETED|Part A|Participants in Part A were not eligible for enrollment in Part B|8||
59825743|NCT00321711|75948908|FG001|COMPLETED|Part A|Participants in Part A were not eligible for enrollment in Part B|3||
59825744|NCT00321711|75948909|FG002|COMPLETED|Part A|Participants in Part A were not eligible for enrollment in Part B|3||
59825745|NCT00321711|75948910|FG003|COMPLETED|Part A||0||
59825746|NCT00321711|75948911|FG004|COMPLETED|Part A||0||
59825747|NCT00321711|75948907|FG000|NOT COMPLETED|Part A||5||
59825748|NCT00321711|75948908|FG001|NOT COMPLETED|Part A||10||
59825749|NCT00321711|75948909|FG002|NOT COMPLETED|Part A||11||
59825750|NCT00321711|75948910|FG003|NOT COMPLETED|Part A||0||
59825751|NCT00321711|75948911|FG004|NOT COMPLETED|Part A||0||
59825752|NCT00321711|75948907|FG000|STARTED|Part B|Participants in Part A were not eligible for enrollment in Part B|0||
59825753|NCT00321711|75948908|FG001|STARTED|Part B|Participants in Part A were not eligible for enrollment in Part B|0||
59825754|NCT00321711|75948909|FG002|STARTED|Part B|Participants in Part A were not eligible for enrollment in Part B|0||
59825755|NCT00321711|75948910|FG003|STARTED|Part B||14||
59825756|NCT00321711|75948911|FG004|STARTED|Part B||15||
59825757|NCT00321711|75948907|FG000|COMPLETED|Part B||0||
59825758|NCT00321711|75948908|FG001|COMPLETED|Part B||0||
59825759|NCT00321711|75948909|FG002|COMPLETED|Part B||0||
59825760|NCT00321711|75948910|FG003|COMPLETED|Part B||8||
59825761|NCT00321711|75948911|FG004|COMPLETED|Part B||10||
59825762|NCT00321711|75948907|FG000|NOT COMPLETED|Part B||0||
59825763|NCT00321711|75948908|FG001|NOT COMPLETED|Part B||0||
59825764|NCT00321711|75948909|FG002|NOT COMPLETED|Part B||0||
59825765|NCT00321711|75948910|FG003|NOT COMPLETED|Part B||6||
59715679|NCT01151280|75834441|FG000|COMPLETED|Overall Study||6||
59715680|NCT01151280|75834441|FG000|NOT COMPLETED|Overall Study||4||
59715681|NCT01149486|75834447|FG000|STARTED|First Intervention||10||
59715682|NCT01149486|75834448|FG001|STARTED|First Intervention||10||
59715683|NCT01149486|75834447|FG000|COMPLETED|First Intervention||10||
59715684|NCT01149486|75834448|FG001|COMPLETED|First Intervention||9||
59715685|NCT01149486|75834447|FG000|NOT COMPLETED|First Intervention||0||
59715686|NCT01149486|75834448|FG001|NOT COMPLETED|First Intervention||1||
59715687|NCT01149486|75834447|FG000|STARTED|Washout of 7 Days||10||
59715688|NCT01149486|75834448|FG001|STARTED|Washout of 7 Days||9||
59715689|NCT01149486|75834447|FG000|COMPLETED|Washout of 7 Days||10||
59715690|NCT01149486|75834448|FG001|COMPLETED|Washout of 7 Days||9||
59715691|NCT01149486|75834447|FG000|NOT COMPLETED|Washout of 7 Days||0||
59715692|NCT01149486|75834448|FG001|NOT COMPLETED|Washout of 7 Days||0||
59715693|NCT01149486|75834447|FG000|STARTED|Second Intervention||10||
59715694|NCT01149486|75834448|FG001|STARTED|Second Intervention||9||
59715695|NCT01149486|75834447|FG000|COMPLETED|Second Intervention||10||
59715696|NCT01149486|75834448|FG001|COMPLETED|Second Intervention||9||
59715697|NCT01149486|75834447|FG000|NOT COMPLETED|Second Intervention||0||
59825766|NCT00321711|75948911|FG004|NOT COMPLETED|Part B||5||
59825767|NCT00486044|75948925|FG000|STARTED|Overall Study|50 received assigned intervention (1 withdrew during baseline) 27 in MRI sub-study|51||
59825768|NCT00486044|75948926|FG001|STARTED|Overall Study|23 in MRI sub-study|49||
59825769|NCT00486044|75948925|FG000|COMPLETED|Overall Study|27 completed MRI sub-study|49||
59825770|NCT00486044|75948926|FG001|COMPLETED|Overall Study|21 completed MRI sub-study|46||
59825771|NCT00486044|75948925|FG000|NOT COMPLETED|Overall Study||2||
59825772|NCT00486044|75948926|FG001|NOT COMPLETED|Overall Study||3||
59825773|NCT00351273|75948935|FG000|STARTED|Overall Study||15||
59825774|NCT00351273|75948936|FG001|STARTED|Overall Study||12||
59825775|NCT00351273|75948937|FG002|STARTED|Overall Study||15||
59825776|NCT00351273|75948935|FG000|COMPLETED|Overall Study||14||
59825777|NCT00351273|75948936|FG001|COMPLETED|Overall Study||10||
59825778|NCT00351273|75948937|FG002|COMPLETED|Overall Study||10||
59825779|NCT00351273|75948935|FG000|NOT COMPLETED|Overall Study||1||
59825780|NCT00351273|75948936|FG001|NOT COMPLETED|Overall Study||2||
59825781|NCT00351273|75948937|FG002|NOT COMPLETED|Overall Study||5||
59825782|NCT00327717|75948952|FG000|STARTED|Overall Study||120||
59825783|NCT00327717|75948953|FG001|STARTED|Overall Study||120||
59715698|NCT01149486|75834448|FG001|NOT COMPLETED|Second Intervention||0||
59715699|NCT00601705|75834454|FG000|STARTED|Overall Study||61||
59715700|NCT00601705|75834454|FG000|COMPLETED|Overall Study||60||
59715701|NCT00601705|75834454|FG000|NOT COMPLETED|Overall Study||1||
59825784|NCT00327717|75948952|FG000|COMPLETED|Overall Study||111||
59825785|NCT00327717|75948953|FG001|COMPLETED|Overall Study||106||
59825786|NCT00327717|75948952|FG000|NOT COMPLETED|Overall Study||9||
59825787|NCT00327717|75948953|FG001|NOT COMPLETED|Overall Study||14||
59825788|NCT00463346|75948961|FG000|STARTED|Overall Study||12||
59825789|NCT00463346|75948962|FG001|STARTED|Overall Study||11||
59825790|NCT00463346|75948961|FG000|COMPLETED|Overall Study||9||
59825791|NCT00463346|75948962|FG001|COMPLETED|Overall Study||8||
59825792|NCT00463346|75948961|FG000|NOT COMPLETED|Overall Study||3||
59825793|NCT00463346|75948962|FG001|NOT COMPLETED|Overall Study||3||
59825794|NCT00462488|75948972|FG000|STARTED|Overall Study||23||
59825795|NCT00462488|75948973|FG001|STARTED|Overall Study||23||
59825796|NCT00462488|75948972|FG000|Completed Induction Phase|Overall Study||22||
59825797|NCT00462488|75948973|FG001|Completed Induction Phase|Overall Study||23||
59825798|NCT00462488|75948972|FG000|Completed Induction 2/Maintenance 1|Overall Study||18||
59825799|NCT00462488|75948973|FG001|Completed Induction 2/Maintenance 1|Overall Study||9||
59825800|NCT00462488|75948972|FG000|Completed Maintenance 2|Overall Study||7||
59825801|NCT00462488|75948973|FG001|Completed Maintenance 2|Overall Study||6||
59825802|NCT00462488|75948972|FG000|COMPLETED|Overall Study||3|Completed the full 51/57 weeks of study|
59825803|NCT00462488|75948973|FG001|COMPLETED|Overall Study||6|Completed the full 51/57 weeks of study|
59825804|NCT00462488|75948972|FG000|NOT COMPLETED|Overall Study||20||
59825805|NCT00462488|75948973|FG001|NOT COMPLETED|Overall Study||17||
59825806|NCT00454142|75948979|FG000|STARTED|Overall Study||33||
59825807|NCT00454142|75948979|FG000|COMPLETED|Overall Study||32||
59825808|NCT00454142|75948979|FG000|NOT COMPLETED|Overall Study||1||
59825809|NCT00424476|75948988|FG000|STARTED|Overall Study||287||
59825810|NCT00424476|75948989|FG001|STARTED|Overall Study||288||
59825811|NCT00424476|75948990|FG002|STARTED|Overall Study||290||
59567357|NCT02749227|75670284|FG000|COMPLETED|Overall Study||4||
59567358|NCT02749227|75670284|FG000|NOT COMPLETED|Overall Study||0||
59567359|NCT02746263|75670290|FG000|STARTED|Overall Study||0||
59825812|NCT00424476|75948988|FG000|COMPLETED|Overall Study||226||
59825813|NCT00424476|75948989|FG001|COMPLETED|Overall Study||240||
59825814|NCT00424476|75948990|FG002|COMPLETED|Overall Study||241||
59825815|NCT00424476|75948988|FG000|NOT COMPLETED|Overall Study||61||
59825816|NCT00424476|75948989|FG001|NOT COMPLETED|Overall Study||48||
59825817|NCT00424476|75948990|FG002|NOT COMPLETED|Overall Study||49||
59825818|NCT00453986|75949003|FG000|STARTED|Overall Study||311||
59825819|NCT00453986|75949004|FG001|STARTED|Overall Study||311||
59825820|NCT00453986|75949005|FG002|STARTED|Overall Study||313||
59825821|NCT00453986|75949006|FG003|STARTED|Overall Study||312||
59825822|NCT00453986|75949007|FG004|STARTED|Overall Study||105||
59825823|NCT00453986|75949003|FG000|COMPLETED|Overall Study||305||
59825824|NCT00453986|75949004|FG001|COMPLETED|Overall Study||306||
59825825|NCT00453986|75949005|FG002|COMPLETED|Overall Study||307||
59825826|NCT00453986|75949006|FG003|COMPLETED|Overall Study||310||
59825827|NCT00453986|75949007|FG004|COMPLETED|Overall Study||105||
59825828|NCT00453986|75949003|FG000|NOT COMPLETED|Overall Study||6||
59825829|NCT00453986|75949004|FG001|NOT COMPLETED|Overall Study||5||
59825830|NCT00453986|75949005|FG002|NOT COMPLETED|Overall Study||6||
59825831|NCT00453986|75949006|FG003|NOT COMPLETED|Overall Study||2||
59825832|NCT00453986|75949007|FG004|NOT COMPLETED|Overall Study||0||
59825833|NCT00435942|75949025|FG000|STARTED|Overall Study||120||
59825834|NCT00435942|75949026|FG001|STARTED|Overall Study||60||
59825835|NCT00435942|75949025|FG000|COMPLETED|Overall Study||97|97 patients|
59825836|NCT00435942|75949026|FG001|COMPLETED|Overall Study||33|97 patients|
59825837|NCT00435942|75949025|FG000|NOT COMPLETED|Overall Study||23||
60117581|NCT01710527|76238529|FG001|STARTED|Period 2: Washout Period (7 Days)||16||
60117582|NCT01710527|76238528|FG000|COMPLETED|Period 2: Washout Period (7 Days)||16||
59567360|NCT02746263|75670291|FG001|STARTED|Overall Study||1||
59825838|NCT00435942|75949026|FG001|NOT COMPLETED|Overall Study||27||
59825839|NCT00453362|75949032|FG000|STARTED|Overall Study|14 participants consented but did not receive drug and are not represented in the baseline data|88||
59825840|NCT00453362|75949032|FG000|Treated With Erlotinib|Overall Study||74||
59825841|NCT00453362|75949032|FG000|FDG-PET Evaluable|Overall Study|Participants who completed all FDG-PET scans through day 56.|51||
59825842|NCT00453362|75949032|FG000|FLT-PET Evaluable|Overall Study|Participants who completed all FLT-PET scans through day 56.|50||
59825843|NCT00453362|75949032|FG000|COMPLETED|Overall Study||1||
59825844|NCT00453362|75949032|FG000|NOT COMPLETED|Overall Study||87||
59825845|NCT00424398|75949051|FG000|STARTED|Overall Study||35||
59825846|NCT00424398|75949052|FG001|STARTED|Overall Study||36||
59825847|NCT00424398|75949053|FG002|STARTED|Overall Study||36||
59825848|NCT00424398|75949051|FG000|COMPLETED|Overall Study||32||
59825849|NCT00424398|75949052|FG001|COMPLETED|Overall Study||35||
59825850|NCT00424398|75949053|FG002|COMPLETED|Overall Study||36||
59825851|NCT00424398|75949051|FG000|NOT COMPLETED|Overall Study||3||
59825852|NCT00424398|75949052|FG001|NOT COMPLETED|Overall Study||1||
59825853|NCT00424398|75949053|FG002|NOT COMPLETED|Overall Study||0||
59825854|NCT00461786|75949061|FG000|STARTED|Overall Study||51||
59825855|NCT00461786|75949061|FG000|COMPLETED|Overall Study|Completed means the patient was evaluable for response.|48||
59825856|NCT00461786|75949061|FG000|NOT COMPLETED|Overall Study||3||
59825857|NCT00435162|75949068|FG000|STARTED|Period 1 (6 Weeks)||15||
59825858|NCT00435162|75949069|FG001|STARTED|Period 1 (6 Weeks)||15||
59825859|NCT00435162|75949070|FG002|STARTED|Period 1 (6 Weeks)||6||
59825860|NCT00435162|75949071|FG003|STARTED|Period 1 (6 Weeks)||8||
59825861|NCT00435162|75949072|FG004|STARTED|Period 1 (6 Weeks)||15||
59825862|NCT00435162|75949073|FG005|STARTED|Period 1 (6 Weeks)||15||
59825863|NCT00435162|75949068|FG000|COMPLETED|Period 1 (6 Weeks)||15||
59825864|NCT00435162|75949069|FG001|COMPLETED|Period 1 (6 Weeks)||15||
59825865|NCT00435162|75949070|FG002|COMPLETED|Period 1 (6 Weeks)||6||
59825866|NCT00435162|75949071|FG003|COMPLETED|Period 1 (6 Weeks)||8||
59825867|NCT00435162|75949072|FG004|COMPLETED|Period 1 (6 Weeks)||15||
59825868|NCT00435162|75949073|FG005|COMPLETED|Period 1 (6 Weeks)||15||
59825869|NCT00435162|75949068|FG000|NOT COMPLETED|Period 1 (6 Weeks)||0||
59825870|NCT00435162|75949069|FG001|NOT COMPLETED|Period 1 (6 Weeks)||0||
59825871|NCT00435162|75949070|FG002|NOT COMPLETED|Period 1 (6 Weeks)||0||
59825872|NCT00435162|75949071|FG003|NOT COMPLETED|Period 1 (6 Weeks)||0||
59825873|NCT00435162|75949072|FG004|NOT COMPLETED|Period 1 (6 Weeks)||0||
59825874|NCT00435162|75949073|FG005|NOT COMPLETED|Period 1 (6 Weeks)||0||
59825875|NCT00435162|75949068|FG000|STARTED|Period 2 (2 Weeks)||15||
59825876|NCT00435162|75949069|FG001|STARTED|Period 2 (2 Weeks)||15||
59825877|NCT00435162|75949070|FG002|STARTED|Period 2 (2 Weeks)||6||
59825878|NCT00435162|75949071|FG003|STARTED|Period 2 (2 Weeks)||8||
59825879|NCT00435162|75949072|FG004|STARTED|Period 2 (2 Weeks)||15||
59825880|NCT00435162|75949073|FG005|STARTED|Period 2 (2 Weeks)||15||
59825881|NCT00435162|75949068|FG000|COMPLETED|Period 2 (2 Weeks)||15||
59825882|NCT00435162|75949069|FG001|COMPLETED|Period 2 (2 Weeks)||14||
59825883|NCT00435162|75949070|FG002|COMPLETED|Period 2 (2 Weeks)||6||
59825884|NCT00435162|75949071|FG003|COMPLETED|Period 2 (2 Weeks)||8||
59825885|NCT00435162|75949072|FG004|COMPLETED|Period 2 (2 Weeks)||15||
59825886|NCT00435162|75949073|FG005|COMPLETED|Period 2 (2 Weeks)||15||
59825887|NCT00435162|75949068|FG000|NOT COMPLETED|Period 2 (2 Weeks)||0||
59825888|NCT00435162|75949069|FG001|NOT COMPLETED|Period 2 (2 Weeks)||1||
59825889|NCT00435162|75949070|FG002|NOT COMPLETED|Period 2 (2 Weeks)||0||
59825890|NCT00435162|75949071|FG003|NOT COMPLETED|Period 2 (2 Weeks)||0||
59825891|NCT00435162|75949072|FG004|NOT COMPLETED|Period 2 (2 Weeks)||0||
59825892|NCT00435162|75949073|FG005|NOT COMPLETED|Period 2 (2 Weeks)||0||
59825893|NCT03836664|75949088|FG000|STARTED|Overall Study||14||
59825894|NCT03836664|75949089|FG001|STARTED|Overall Study||11||
59825895|NCT03836664|75949088|FG000|COMPLETED|Overall Study||11||
59825896|NCT03836664|75949089|FG001|COMPLETED|Overall Study||8||
59825897|NCT03836664|75949088|FG000|NOT COMPLETED|Overall Study||3||
59825898|NCT03836664|75949089|FG001|NOT COMPLETED|Overall Study||3||
59825899|NCT00350727|75949102|FG000|STARTED|Phase I: Dose Escalation||34||
59825900|NCT00350727|75949103|FG001|STARTED|Phase I: Dose Escalation||0||
59825901|NCT00350727|75949104|FG002|STARTED|Phase I: Dose Escalation||0||
59825902|NCT00350727|75949102|FG000|COMPLETED|Phase I: Dose Escalation||0||
59825903|NCT00350727|75949103|FG001|COMPLETED|Phase I: Dose Escalation||0||
59825904|NCT00350727|75949104|FG002|COMPLETED|Phase I: Dose Escalation||0||
59825905|NCT00350727|75949102|FG000|NOT COMPLETED|Phase I: Dose Escalation||34||
59825906|NCT00350727|75949103|FG001|NOT COMPLETED|Phase I: Dose Escalation||0||
59825907|NCT00350727|75949104|FG002|NOT COMPLETED|Phase I: Dose Escalation||0||
59825908|NCT00350727|75949102|FG000|STARTED|Phase II||0||
59825909|NCT00350727|75949103|FG001|STARTED|Phase II||19||
59825910|NCT00350727|75949104|FG002|STARTED|Phase II||22||
59825911|NCT00350727|75949102|FG000|COMPLETED|Phase II||0||
59825912|NCT00350727|75949103|FG001|COMPLETED|Phase II||0||
59825913|NCT00350727|75949104|FG002|COMPLETED|Phase II||0||
59825914|NCT00350727|75949102|FG000|NOT COMPLETED|Phase II||0||
59825915|NCT00350727|75949103|FG001|NOT COMPLETED|Phase II||19||
60117583|NCT01710527|76238529|FG001|COMPLETED|Period 2: Washout Period (7 Days)||15||
60117584|NCT01710527|76238528|FG000|NOT COMPLETED|Period 2: Washout Period (7 Days)||0||
59825916|NCT00350727|75949104|FG002|NOT COMPLETED|Phase II||22||
59825917|NCT00434304|75949123|FG000|STARTED|Overall Study||62||
59825918|NCT00434304|75949123|FG000|COMPLETED|Overall Study||42||
59825919|NCT00434304|75949123|FG000|NOT COMPLETED|Overall Study||20||
59825920|NCT00424008|75949130|FG000|STARTED|Overall Study||371||
59825921|NCT00424008|75949131|FG001|STARTED|Overall Study||351||
59825922|NCT00424008|75949130|FG000|COMPLETED|Overall Study||22||
59825923|NCT00424008|75949131|FG001|COMPLETED|Overall Study||16||
59825924|NCT00424008|75949130|FG000|NOT COMPLETED|Overall Study||349||
59825925|NCT00424008|75949131|FG001|NOT COMPLETED|Overall Study||335||
59825926|NCT00423930|75949138|FG000|STARTED|Overall Study||44||
59825927|NCT00423930|75949138|FG000|COMPLETED|Overall Study||42||
59825928|NCT00423930|75949138|FG000|NOT COMPLETED|Overall Study||2||
59825929|NCT00423852|75949142|FG000|STARTED|Overall Study||26||
59825930|NCT00423852|75949142|FG000|COMPLETED|Overall Study||23||
59825931|NCT00423852|75949142|FG000|NOT COMPLETED|Overall Study||3||
59825932|NCT00461708|75949148|FG000|STARTED|Overall Study||115||
59825933|NCT00461708|75949149|FG001|STARTED|Overall Study||38||
59825934|NCT00461708|75949148|FG000|COMPLETED|Overall Study||0||
59825935|NCT00461708|75949149|FG001|COMPLETED|Overall Study||0||
59825936|NCT00461708|75949148|FG000|NOT COMPLETED|Overall Study||115||
59825937|NCT00461708|75949149|FG001|NOT COMPLETED|Overall Study||38||
59825938|NCT00327171|75949160|FG000|STARTED|Overall Study||109||
59715702|NCT01179737|75834463|FG000|STARTED|Cohort 1 & Cohort 2||12||
59715703|NCT01179737|75834464|FG001|STARTED|Cohort 1 & Cohort 2|One patient was missing the end of study evaluation|3||
59715704|NCT01179737|75834465|FG002|STARTED|Cohort 1 & Cohort 2||4||
59715705|NCT01179737|75834466|FG003|STARTED|Cohort 1 & Cohort 2||4||
59715706|NCT01179737|75834463|FG000|COMPLETED|Cohort 1 & Cohort 2||7||
59715707|NCT01179737|75834464|FG001|COMPLETED|Cohort 1 & Cohort 2||1||
59825939|NCT00327171|75949161|FG001|STARTED|Overall Study||109||
59825940|NCT00327171|75949160|FG000|COMPLETED|Overall Study|Participants received treatment until they met treatment discontinuation criteria|1||
59825941|NCT00327171|75949161|FG001|COMPLETED|Overall Study|Participants received treatment until they met treatment discontinuation criteria|0||
59825942|NCT00327171|75949160|FG000|NOT COMPLETED|Overall Study||108||
59825943|NCT00327171|75949161|FG001|NOT COMPLETED|Overall Study||109||
59825944|NCT00461630|75949169|FG000|STARTED|Overall Study||12838||
59825945|NCT00461630|75949170|FG001|STARTED|Overall Study||12835||
59825946|NCT00461630|75949169|FG000|COMPLETED|Overall Study||11932||
59825947|NCT00461630|75949170|FG001|COMPLETED|Overall Study||12008||
59825948|NCT00461630|75949169|FG000|NOT COMPLETED|Overall Study||906||
59825949|NCT00461630|75949170|FG001|NOT COMPLETED|Overall Study||827||
59825950|NCT00461552|75949178|FG000|STARTED|Overall Study||7||
59825951|NCT00461552|75949179|FG001|STARTED|Overall Study||7||
59825952|NCT00461552|75949178|FG000|COMPLETED|Overall Study||7||
59825953|NCT00461552|75949179|FG001|COMPLETED|Overall Study||5||
59825954|NCT00461552|75949178|FG000|NOT COMPLETED|Overall Study||0||
59825955|NCT00461552|75949179|FG001|NOT COMPLETED|Overall Study||2||
59825956|NCT00453206|75949185|FG000|STARTED|Overall Study||66||
59825957|NCT00453206|75949185|FG000|COMPLETED|Overall Study||65||
59825958|NCT00453206|75949185|FG000|NOT COMPLETED|Overall Study||1||
59825959|NCT03850496|75949192|FG000|STARTED|Overall Study||26||
59825960|NCT03850496|75949193|FG001|STARTED|Overall Study||25||
59825961|NCT03850496|75949194|FG002|STARTED|Overall Study||25||
59825962|NCT03850496|75949192|FG000|COMPLETED|Overall Study||25||
59825963|NCT03850496|75949193|FG001|COMPLETED|Overall Study||24||
59825964|NCT03850496|75949194|FG002|COMPLETED|Overall Study||21||
59825965|NCT03850496|75949192|FG000|NOT COMPLETED|Overall Study||1||
59825966|NCT03850496|75949193|FG001|NOT COMPLETED|Overall Study||1||
59825967|NCT03850496|75949194|FG002|NOT COMPLETED|Overall Study||4||
59825968|NCT00327015|75949206|FG000|STARTED|Overall Study||320||
59825969|NCT00327015|75949207|FG001|STARTED|Overall Study||323||
59825970|NCT00327015|75949208|FG002|STARTED|Overall Study||335||
59825971|NCT00327015|75949209|FG003|STARTED|Overall Study||328||
60117585|NCT01710527|76238529|FG001|NOT COMPLETED|Period 2: Washout Period (7 Days)||1||
60117586|NCT01710527|76238528|FG000|STARTED|Period 3: Intervention Period 2||16||
60117587|NCT01710527|76238529|FG001|STARTED|Period 3: Intervention Period 2||15||
59825972|NCT00327015|75949206|FG000|Completed Study Without Being Rescued|Overall Study||179||
59825973|NCT00327015|75949207|FG001|Completed Study Without Being Rescued|Overall Study||177||
59825974|NCT00327015|75949208|FG002|Completed Study Without Being Rescued|Overall Study||113||
60117588|NCT01710527|76238528|FG000|COMPLETED|Period 3: Intervention Period 2||16||
60117589|NCT01710527|76238529|FG001|COMPLETED|Period 3: Intervention Period 2||15||
60117590|NCT01710527|76238528|FG000|NOT COMPLETED|Period 3: Intervention Period 2||0||
59715708|NCT01179737|75834465|FG002|COMPLETED|Cohort 1 & Cohort 2||0||
59715709|NCT01179737|75834466|FG003|COMPLETED|Cohort 1 & Cohort 2||0||
59825975|NCT00327015|75949209|FG003|Completed Study Without Being Rescued|Overall Study||144||
59825976|NCT00327015|75949206|FG000|COMPLETED|Overall Study||229||
60117591|NCT01710527|76238529|FG001|NOT COMPLETED|Period 3: Intervention Period 2||0||
60117592|NCT01706939|76238537|FG000|STARTED|Pre Randomization||23||
60117593|NCT01706939|76238538|FG001|STARTED|Pre Randomization||0||
60117594|NCT01706939|76238539|FG002|STARTED|Pre Randomization||0||
60117595|NCT01706939|76238537|FG000|COMPLETED|Pre Randomization||20||
59715710|NCT01179737|75834463|FG000|NOT COMPLETED|Cohort 1 & Cohort 2||5||
59715711|NCT01179737|75834464|FG001|NOT COMPLETED|Cohort 1 & Cohort 2||2||
59825977|NCT00327015|75949207|FG001|COMPLETED|Overall Study||231||
59825978|NCT00327015|75949208|FG002|COMPLETED|Overall Study||209||
59825979|NCT00327015|75949209|FG003|COMPLETED|Overall Study||219||
59825980|NCT00327015|75949206|FG000|NOT COMPLETED|Overall Study||91||
59825981|NCT00327015|75949207|FG001|NOT COMPLETED|Overall Study||92||
59825982|NCT00327015|75949208|FG002|NOT COMPLETED|Overall Study||126||
59825983|NCT00327015|75949209|FG003|NOT COMPLETED|Overall Study||109||
59825984|NCT00434148|75949221|FG000|STARTED|Overall Study|"Started indicates Full Analysis Set. Patients randomized and treated."|82||
59825985|NCT00434148|75949222|FG001|STARTED|Overall Study||80||
59825986|NCT00434148|75949221|FG000|Completed Month 12|Overall Study||39||
59825987|NCT00434148|75949222|FG001|Completed Month 12|Overall Study||39||
59825988|NCT00434148|75949221|FG000|Completed m. 12; Did Not Enter Extension|Overall Study||13||
59825989|NCT00434148|75949222|FG001|Completed m. 12; Did Not Enter Extension|Overall Study||7||
59825990|NCT00434148|75949221|FG000|Completed Month 12; Entered Extension|Overall Study||26||
59825991|NCT00434148|75949222|FG001|Completed Month 12; Entered Extension|Overall Study||32||
59825992|NCT00434148|75949221|FG000|COMPLETED|Overall Study||13||
59825993|NCT00434148|75949222|FG001|COMPLETED|Overall Study||7||
59825994|NCT00434148|75949221|FG000|NOT COMPLETED|Overall Study||69||
59825995|NCT00434148|75949222|FG001|NOT COMPLETED|Overall Study||73||
59825996|NCT00468728|75949230|FG000|STARTED|Enrollment||264||
59825997|NCT00468728|75949231|FG001|STARTED|Enrollment||271||
59825998|NCT00468728|75949230|FG000|COMPLETED|Enrollment|1 fidaxomicin subject received vancomycin, 11 subjects didn't take drug|260||
60117596|NCT01706939|76238538|FG001|COMPLETED|Pre Randomization||0||
60117597|NCT01706939|76238539|FG002|COMPLETED|Pre Randomization||0||
60117598|NCT01706939|76238537|FG000|NOT COMPLETED|Pre Randomization||3||
60117599|NCT01706939|76238538|FG001|NOT COMPLETED|Pre Randomization||0||
60117600|NCT01706939|76238539|FG002|NOT COMPLETED|Pre Randomization||0||
60117601|NCT01706939|76238537|FG000|STARTED|Randomization||0||
60117602|NCT01706939|76238538|FG001|STARTED|Randomization||12||
60117603|NCT01706939|76238539|FG002|STARTED|Randomization||8||
59567361|NCT02746263|75670290|FG000|Per Protocol Analysis Set|Overall Study||0||
59715712|NCT01179737|75834465|FG002|NOT COMPLETED|Cohort 1 & Cohort 2||4||
59715713|NCT01179737|75834466|FG003|NOT COMPLETED|Cohort 1 & Cohort 2||4||
60117604|NCT01706939|76238537|FG000|COMPLETED|Randomization||0||
60117605|NCT01706939|76238538|FG001|COMPLETED|Randomization||9||
59567362|NCT02746263|75670291|FG001|Per Protocol Analysis Set|Overall Study||0||
59715714|NCT01179737|75834463|FG000|STARTED|Cohort 1 & Cohort 2 Expansion|2 participants did not enroll in extension|5||
59715715|NCT01179737|75834464|FG001|STARTED|Cohort 1 & Cohort 2 Expansion||1||
59715716|NCT01179737|75834465|FG002|STARTED|Cohort 1 & Cohort 2 Expansion||0||
59715717|NCT01179737|75834466|FG003|STARTED|Cohort 1 & Cohort 2 Expansion||0||
59715718|NCT01179737|75834463|FG000|COMPLETED|Cohort 1 & Cohort 2 Expansion||4||
59715719|NCT01179737|75834464|FG001|COMPLETED|Cohort 1 & Cohort 2 Expansion||1||
59715720|NCT01179737|75834465|FG002|COMPLETED|Cohort 1 & Cohort 2 Expansion||0||
60117606|NCT01706939|76238539|FG002|COMPLETED|Randomization||6||
60117607|NCT01706939|76238537|FG000|NOT COMPLETED|Randomization||0||
60117608|NCT01706939|76238538|FG001|NOT COMPLETED|Randomization||3||
60117609|NCT01706939|76238539|FG002|NOT COMPLETED|Randomization||2||
60117610|NCT01709903|76238548|FG000|STARTED|Overall Study|Randomized set|372||
60117611|NCT01709903|76238549|FG001|STARTED|Overall Study|Randomized set|372||
60117612|NCT01709903|76238548|FG000|COMPLETED|Overall Study||343||
60117613|NCT01709903|76238549|FG001|COMPLETED|Overall Study||333||
60117614|NCT01709903|76238548|FG000|NOT COMPLETED|Overall Study||29||
60117615|NCT01709903|76238549|FG001|NOT COMPLETED|Overall Study||39||
60117616|NCT04492618|76238555|FG000|STARTED|Overall Study||12||
59715721|NCT01179737|75834466|FG003|COMPLETED|Cohort 1 & Cohort 2 Expansion||0||
59715722|NCT01179737|75834463|FG000|NOT COMPLETED|Cohort 1 & Cohort 2 Expansion||1||
59715723|NCT01179737|75834464|FG001|NOT COMPLETED|Cohort 1 & Cohort 2 Expansion||0||
59825999|NCT00468728|75949231|FG001|COMPLETED|Enrollment|1 fidaxomicin subject received vancomycin, 11 subjects didn't take drug|264||
59826000|NCT00468728|75949230|FG000|NOT COMPLETED|Enrollment||4||
59826001|NCT00468728|75949231|FG001|NOT COMPLETED|Enrollment||7||
59826002|NCT00468728|75949230|FG000|STARTED|Treatment||260||
59826003|NCT00468728|75949231|FG001|STARTED|Treatment||264||
59826004|NCT00468728|75949230|FG000|COMPLETED|Treatment||256||
59826005|NCT00468728|75949231|FG001|COMPLETED|Treatment||253||
59826006|NCT00468728|75949230|FG000|NOT COMPLETED|Treatment||4||
59826007|NCT00468728|75949231|FG001|NOT COMPLETED|Treatment||11||
59826008|NCT00468728|75949230|FG000|STARTED|Follow-up||256||
59826009|NCT00468728|75949231|FG001|STARTED|Follow-up||253||
59826010|NCT00468728|75949230|FG000|COMPLETED|Follow-up||222||
59826011|NCT00468728|75949231|FG001|COMPLETED|Follow-up||222||
59826012|NCT00468728|75949230|FG000|NOT COMPLETED|Follow-up||34||
59826013|NCT00468728|75949231|FG001|NOT COMPLETED|Follow-up||31||
59826014|NCT00433914|75949241|FG000|STARTED|Overall Study||30||
59826015|NCT00433914|75949242|FG001|STARTED|Overall Study||30||
59826016|NCT00433914|75949241|FG000|COMPLETED|Overall Study||30||
59826017|NCT00433914|75949242|FG001|COMPLETED|Overall Study||27||
59826018|NCT00433914|75949241|FG000|NOT COMPLETED|Overall Study||0||
59826019|NCT00433914|75949242|FG001|NOT COMPLETED|Overall Study||3||
59826020|NCT00468650|75949248|FG000|STARTED|Overall Study||117||
59826021|NCT00468650|75949248|FG000|COMPLETED|Overall Study||110||
59826022|NCT00468650|75949248|FG000|NOT COMPLETED|Overall Study||7||
59826023|NCT00423150|75949253|FG000|STARTED|Overall Study||86||
59826024|NCT00423150|75949253|FG000|COMPLETED|Overall Study||0||
59826025|NCT00423150|75949253|FG000|NOT COMPLETED|Overall Study||86||
59826026|NCT00433836|75949259|FG000|STARTED|Overall Study||151||
59826027|NCT00433836|75949260|FG001|STARTED|Overall Study||149||
59826028|NCT00433836|75949259|FG000|COMPLETED|Overall Study||138||
59826029|NCT00433836|75949260|FG001|COMPLETED|Overall Study||143||
59826030|NCT00433836|75949259|FG000|NOT COMPLETED|Overall Study||13||
59826031|NCT00433836|75949260|FG001|NOT COMPLETED|Overall Study||6||
59826032|NCT00433446|75949266|FG000|STARTED|Overall Study||62||
59826033|NCT00433446|75949266|FG000|Eligible|Overall Study||53||
59826034|NCT00433446|75949266|FG000|Eligible and Began Protocol Therapy|Overall Study||53||
59826035|NCT00433446|75949266|FG000|COMPLETED|Overall Study||1||
59826036|NCT00433446|75949266|FG000|NOT COMPLETED|Overall Study||61||
59826037|NCT00468104|75949270|FG000|STARTED|First Intervention||54||
59826038|NCT00468104|75949271|FG001|STARTED|First Intervention||46||
59826039|NCT00468104|75949270|FG000|COMPLETED|First Intervention||45||
59826040|NCT00468104|75949271|FG001|COMPLETED|First Intervention||45||
59826041|NCT00468104|75949270|FG000|NOT COMPLETED|First Intervention||9||
59826042|NCT00468104|75949271|FG001|NOT COMPLETED|First Intervention||1||
59826043|NCT00468104|75949270|FG000|STARTED|Second Intervention|37 responded to Alteplase and did not go to the second intervention|8||
59826044|NCT00468104|75949271|FG001|STARTED|Second Intervention|4 patients responded to Placebo and did not go to the second intervention|41||
59826045|NCT00468104|75949270|FG000|COMPLETED|Second Intervention||3||
59826046|NCT00468104|75949271|FG001|COMPLETED|Second Intervention||37||
59826047|NCT00468104|75949270|FG000|NOT COMPLETED|Second Intervention||5||
59826048|NCT00468104|75949271|FG001|NOT COMPLETED|Second Intervention||4||
59826049|NCT00326625|75949282|FG000|STARTED|Overall Study||184||
59826050|NCT00326625|75949283|FG001|STARTED|Overall Study||182||
59826051|NCT00326625|75949282|FG000|COMPLETED|Overall Study||130||
59826052|NCT00326625|75949283|FG001|COMPLETED|Overall Study||144||
59826053|NCT00326625|75949282|FG000|NOT COMPLETED|Overall Study||54||
59826054|NCT00326625|75949283|FG001|NOT COMPLETED|Overall Study||38||
59826055|NCT00433290|75949291|FG000|STARTED|Overall Study||128||
59826056|NCT00433290|75949292|FG001|STARTED|Overall Study||128||
59826057|NCT00433290|75949291|FG000|COMPLETED|Overall Study||93||
59826058|NCT00433290|75949292|FG001|COMPLETED|Overall Study||111||
59826059|NCT00433290|75949291|FG000|NOT COMPLETED|Overall Study||35||
59826060|NCT00433290|75949292|FG001|NOT COMPLETED|Overall Study||17||
59826061|NCT00467870|75949304|FG000|STARTED|Overall Study||120||
60117617|NCT04492618|76238555|FG000|COMPLETED|Overall Study||11||
60117618|NCT04492618|76238555|FG000|NOT COMPLETED|Overall Study||1||
60117619|NCT04978090|76238559|FG000|STARTED|Overall Study||2||
60117620|NCT04978090|76238559|FG000|COMPLETED|Overall Study||0||
60117621|NCT04978090|76238559|FG000|NOT COMPLETED|Overall Study||2||
59826062|NCT00467870|75949305|FG001|STARTED|Overall Study||117||
60117622|NCT04677504|76238565|FG000|STARTED|Overall Study||83||
60117623|NCT04677504|76238566|FG001|STARTED|Overall Study||79||
60117624|NCT04677504|76238565|FG000|COMPLETED|Overall Study||0||
59826063|NCT00467870|75949306|FG002|STARTED|Overall Study||22||
59826064|NCT00467870|75949307|FG003|STARTED|Overall Study||112||
59826065|NCT00467870|75949308|FG004|STARTED|Overall Study||130||
59826066|NCT00467870|75949309|FG005|STARTED|Overall Study||23||
59826067|NCT00467870|75949304|FG000|COMPLETED|Overall Study||75||
59826068|NCT00467870|75949305|FG001|COMPLETED|Overall Study||74||
59826069|NCT00467870|75949306|FG002|COMPLETED|Overall Study||18||
59826070|NCT00467870|75949307|FG003|COMPLETED|Overall Study||79||
59826071|NCT00467870|75949308|FG004|COMPLETED|Overall Study||93||
59826072|NCT00467870|75949309|FG005|COMPLETED|Overall Study||21||
59826073|NCT00467870|75949304|FG000|NOT COMPLETED|Overall Study||45||
59826074|NCT00467870|75949305|FG001|NOT COMPLETED|Overall Study||43||
59826075|NCT00467870|75949306|FG002|NOT COMPLETED|Overall Study||4||
59826076|NCT00467870|75949307|FG003|NOT COMPLETED|Overall Study||33||
59826077|NCT00467870|75949308|FG004|NOT COMPLETED|Overall Study||37||
59826078|NCT00467870|75949309|FG005|NOT COMPLETED|Overall Study||2||
59826079|NCT00467558|75949321|FG000|STARTED|Overall Study||4||
59826080|NCT00467558|75949322|FG001|STARTED|Overall Study||3||
59826081|NCT00467558|75949321|FG000|COMPLETED|Overall Study||2||
59826082|NCT00467558|75949322|FG001|COMPLETED|Overall Study||3||
59826083|NCT00467558|75949321|FG000|NOT COMPLETED|Overall Study||2||
59826084|NCT00467558|75949322|FG001|NOT COMPLETED|Overall Study||0||
59826085|NCT00422292|75949332|FG000|STARTED|Overall Study||257||
59826086|NCT00422292|75949333|FG001|STARTED|Overall Study||664||
59826087|NCT00422292|75949334|FG002|STARTED|Overall Study||246||
59826088|NCT00422292|75949335|FG003|STARTED|Overall Study||476||
59826089|NCT00422292|75949332|FG000|COMPLETED|Overall Study||239||
59826090|NCT00422292|75949333|FG001|COMPLETED|Overall Study||598||
59826091|NCT00422292|75949334|FG002|COMPLETED|Overall Study||224||
59826092|NCT00422292|75949335|FG003|COMPLETED|Overall Study||452||
59826093|NCT00422292|75949332|FG000|NOT COMPLETED|Overall Study||18||
59826094|NCT00422292|75949333|FG001|NOT COMPLETED|Overall Study||66||
59826095|NCT00422292|75949334|FG002|NOT COMPLETED|Overall Study||22||
59826096|NCT00422292|75949335|FG003|NOT COMPLETED|Overall Study||24||
59826097|NCT00452348|75949347|FG000|STARTED|Overall Study||310||
59826098|NCT00452348|75949348|FG001|STARTED|Overall Study||318||
59826099|NCT00452348|75949347|FG000|COMPLETED|Overall Study||231||
59826100|NCT00452348|75949348|FG001|COMPLETED|Overall Study||234||
59826101|NCT00452348|75949347|FG000|NOT COMPLETED|Overall Study||79||
59826102|NCT00452348|75949348|FG001|NOT COMPLETED|Overall Study||84||
59826103|NCT00452114|75949356|FG000|STARTED|Overall Study||15||
59826104|NCT00452114|75949357|FG001|STARTED|Overall Study||13||
59826105|NCT00452114|75949356|FG000|COMPLETED|Overall Study||12||
59826106|NCT00452114|75949357|FG001|COMPLETED|Overall Study||10||
59826107|NCT00452114|75949356|FG000|NOT COMPLETED|Overall Study||3||
59826108|NCT00452114|75949357|FG001|NOT COMPLETED|Overall Study||3||
59826109|NCT00320541|75949365|FG000|STARTED|Overall Study||94||
59826110|NCT00320541|75949366|FG001|STARTED|Overall Study||93||
59826111|NCT00320541|75949365|FG000|COMPLETED|Overall Study||44||
59826112|NCT00320541|75949366|FG001|COMPLETED|Overall Study||36||
59826113|NCT00320541|75949365|FG000|NOT COMPLETED|Overall Study||50||
60117625|NCT04677504|76238566|FG001|COMPLETED|Overall Study||0||
60117626|NCT04677504|76238565|FG000|NOT COMPLETED|Overall Study||83||
59567363|NCT02746263|75670290|FG000|COMPLETED|Overall Study||0||
59567364|NCT02746263|75670291|FG001|COMPLETED|Overall Study||1||
59826114|NCT00320541|75949366|FG001|NOT COMPLETED|Overall Study||57||
59826115|NCT00320385|75949374|FG000|STARTED|Overall Study||148||
59826116|NCT00320385|75949375|FG001|STARTED|Overall Study||148||
59826117|NCT00320385|75949374|FG000|COMPLETED|Overall Study||130||
59826118|NCT00320385|75949375|FG001|COMPLETED|Overall Study||126||
59826119|NCT00320385|75949374|FG000|NOT COMPLETED|Overall Study||18||
59826120|NCT00320385|75949375|FG001|NOT COMPLETED|Overall Study||22||
59826121|NCT00326001|75949383|FG000|STARTED|Overall Study||236||
59826122|NCT00326001|75949384|FG001|STARTED|Overall Study||227||
59826123|NCT00326001|75949383|FG000|COMPLETED|Overall Study||229||
59826124|NCT00326001|75949384|FG001|COMPLETED|Overall Study||219||
59826125|NCT00326001|75949383|FG000|NOT COMPLETED|Overall Study||7||
59826126|NCT00326001|75949384|FG001|NOT COMPLETED|Overall Study||8||
59826127|NCT00309777|75949394|FG000|STARTED|Overall Study||315||
60117627|NCT04677504|76238566|FG001|NOT COMPLETED|Overall Study||79||
60117628|NCT04635631|76238574|FG000|STARTED|Overall Study||15||
60117629|NCT04635631|76238574|FG000|COMPLETED|Overall Study||0||
60117630|NCT04635631|76238574|FG000|NOT COMPLETED|Overall Study||15||
60117631|NCT04456413|76238581|FG000|STARTED|Overall Study||10||
60117632|NCT04456413|76238582|FG001|STARTED|Overall Study||11||
60117633|NCT04456413|76238581|FG000|COMPLETED|Overall Study||10||
60117634|NCT04456413|76238582|FG001|COMPLETED|Overall Study||11||
60117635|NCT04456413|76238581|FG000|NOT COMPLETED|Overall Study||0||
60117636|NCT04456413|76238582|FG001|NOT COMPLETED|Overall Study||0||
60117637|NCT04269395|76238591|FG000|STARTED|Overall Study||87||
60117638|NCT04269395|76238592|FG001|STARTED|Overall Study||38||
60117639|NCT04269395|76238591|FG000|COMPLETED|Overall Study||73||
60117640|NCT04269395|76238592|FG001|COMPLETED|Overall Study||28||
60117641|NCT04269395|76238591|FG000|NOT COMPLETED|Overall Study||14||
60117642|NCT04269395|76238592|FG001|NOT COMPLETED|Overall Study||10||
60117643|NCT04143594|76238602|FG000|STARTED|Overall Study||52||
60117644|NCT04143594|76238603|FG001|STARTED|Overall Study||53||
60117645|NCT04143594|76238604|FG002|STARTED|Overall Study||52||
60117646|NCT04143594|76238605|FG003|STARTED|Overall Study||26||
60117647|NCT04143594|76238602|FG000|COMPLETED|Overall Study||1||
60117648|NCT04143594|76238603|FG001|COMPLETED|Overall Study||0||
59826128|NCT00309777|75949395|FG001|STARTED|Overall Study||108||
59826129|NCT00309777|75949396|FG002|STARTED|Overall Study||323||
59826130|NCT00309777|75949397|FG003|STARTED|Overall Study||111||
59826131|NCT00309777|75949394|FG000|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|311||
59826132|NCT00309777|75949395|FG001|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|107||
59826133|NCT00309777|75949396|FG002|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|320||
59826134|NCT00309777|75949397|FG003|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|110||
59826135|NCT00309777|75949394|FG000|COMPLETED|Overall Study||292||
59826136|NCT00309777|75949395|FG001|COMPLETED|Overall Study||99||
59826137|NCT00309777|75949396|FG002|COMPLETED|Overall Study||304||
59826138|NCT00309777|75949397|FG003|COMPLETED|Overall Study||107||
59826139|NCT00309777|75949394|FG000|NOT COMPLETED|Overall Study||23||
59826140|NCT00309777|75949395|FG001|NOT COMPLETED|Overall Study||9||
59826141|NCT00309777|75949396|FG002|NOT COMPLETED|Overall Study||19||
59826142|NCT00309777|75949397|FG003|NOT COMPLETED|Overall Study||4||
59826143|NCT00309387|75949409|FG000|STARTED|Overall Study||510||
59826144|NCT00309387|75949410|FG001|STARTED|Overall Study||510||
59826145|NCT00309387|75949409|FG000|COMPLETED|Overall Study||368||
59826146|NCT00309387|75949410|FG001|COMPLETED|Overall Study||351||
59826147|NCT00309387|75949409|FG000|NOT COMPLETED|Overall Study||142||
59826148|NCT00309387|75949410|FG001|NOT COMPLETED|Overall Study||159||
59826149|NCT00325143|75949417|FG000|STARTED|Overall Study||702||
59826150|NCT00325143|75949417|FG000|COMPLETED|Overall Study||676||
59826151|NCT00325143|75949417|FG000|NOT COMPLETED|Overall Study||26||
59826152|NCT00319839|75949421|FG000|STARTED|Overall Study||7||
59826153|NCT00319839|75949421|FG000|COMPLETED|Overall Study||1||
59826154|NCT00319839|75949421|FG000|NOT COMPLETED|Overall Study||6||
59826155|NCT00319449|75949427|FG000|STARTED|Overall Study||10||
59826156|NCT00319449|75949428|FG001|STARTED|Overall Study||12||
59826157|NCT00319449|75949427|FG000|COMPLETED|Overall Study||8||
60117649|NCT04143594|76238604|FG002|COMPLETED|Overall Study||0||
60117650|NCT04143594|76238605|FG003|COMPLETED|Overall Study||6||
60117651|NCT04143594|76238602|FG000|NOT COMPLETED|Overall Study||51||
60117652|NCT04143594|76238603|FG001|NOT COMPLETED|Overall Study||53||
60117653|NCT04143594|76238604|FG002|NOT COMPLETED|Overall Study||52||
59567365|NCT02746263|75670290|FG000|NOT COMPLETED|Overall Study||0||
59567366|NCT02746263|75670291|FG001|NOT COMPLETED|Overall Study||0||
59567367|NCT01394211|75670297|FG000|STARTED|Overall Study||2||
59567368|NCT01394211|75670297|FG000|COMPLETED|Overall Study||0||
59567369|NCT01394211|75670297|FG000|NOT COMPLETED|Overall Study||2||
59567370|NCT02278640|75670301|FG000|STARTED|Overall Study||40||
59567371|NCT02278640|75670301|FG000|COMPLETED|Overall Study||40||
59715724|NCT01179737|75834465|FG002|NOT COMPLETED|Cohort 1 & Cohort 2 Expansion||0||
59715725|NCT01179737|75834466|FG003|NOT COMPLETED|Cohort 1 & Cohort 2 Expansion||0||
59715726|NCT01179737|75834463|FG000|STARTED|Extension|Two patients did not enrol in the extension|3||
59715727|NCT01179737|75834464|FG001|STARTED|Extension|One patient did not enrol in the extension|0||
59715728|NCT01179737|75834465|FG002|STARTED|Extension||0||
59715729|NCT01179737|75834466|FG003|STARTED|Extension||0||
59715730|NCT01179737|75834463|FG000|COMPLETED|Extension||0||
59715731|NCT01179737|75834464|FG001|COMPLETED|Extension||0||
59715732|NCT01179737|75834465|FG002|COMPLETED|Extension||0||
59715733|NCT01179737|75834466|FG003|COMPLETED|Extension||0||
59715734|NCT01179737|75834463|FG000|NOT COMPLETED|Extension||3||
59715735|NCT01179737|75834464|FG001|NOT COMPLETED|Extension||0||
59715736|NCT01179737|75834465|FG002|NOT COMPLETED|Extension||0||
59715737|NCT01179737|75834466|FG003|NOT COMPLETED|Extension||0||
59715738|NCT00929110|75834478|FG000|STARTED|Overall Study||529||
59715739|NCT00929110|75834479|FG001|STARTED|Overall Study||269||
59715740|NCT00929110|75834480|FG002|STARTED|Overall Study||268||
59715741|NCT00929110|75834478|FG000|COMPLETED|Overall Study||411||
59715742|NCT00929110|75834479|FG001|COMPLETED|Overall Study||193||
59715743|NCT00929110|75834480|FG002|COMPLETED|Overall Study||206||
59715744|NCT00929110|75834478|FG000|NOT COMPLETED|Overall Study||118||
59715745|NCT00929110|75834479|FG001|NOT COMPLETED|Overall Study||76||
59715746|NCT00929110|75834480|FG002|NOT COMPLETED|Overall Study||62||
59715747|NCT01147068|75834495|FG000|STARTED|Subjects That Received 1st Dose||60||
59715748|NCT01147068|75834496|FG001|STARTED|Subjects That Received 1st Dose||57||
59715749|NCT01147068|75834497|FG002|STARTED|Subjects That Received 1st Dose||55||
59715750|NCT01147068|75834498|FG003|STARTED|Subjects That Received 1st Dose||56||
59715751|NCT01147068|75834499|FG004|STARTED|Subjects That Received 1st Dose||56||
59715752|NCT01147068|75834500|FG005|STARTED|Subjects That Received 1st Dose||53||
59715753|NCT01147068|75834501|FG006|STARTED|Subjects That Received 1st Dose||55||
59715754|NCT01147068|75834495|FG000|COMPLETED|Subjects That Received 1st Dose||60||
59715755|NCT01147068|75834496|FG001|COMPLETED|Subjects That Received 1st Dose||57||
59715756|NCT01147068|75834497|FG002|COMPLETED|Subjects That Received 1st Dose||55||
59715757|NCT01147068|75834498|FG003|COMPLETED|Subjects That Received 1st Dose||56||
59715758|NCT01147068|75834499|FG004|COMPLETED|Subjects That Received 1st Dose||56||
59715759|NCT01147068|75834500|FG005|COMPLETED|Subjects That Received 1st Dose||53||
60117654|NCT04143594|76238605|FG003|NOT COMPLETED|Overall Study||20||
60117655|NCT04068051|76238618|FG000|STARTED|Overall Study||706||
60117656|NCT04068051|76238618|FG000|COMPLETED|Overall Study||138||
60117657|NCT04068051|76238618|FG000|NOT COMPLETED|Overall Study||568||
60117658|NCT04046549|76238622|FG000|STARTED|Overall Study||23|enrolled and treated|
60117659|NCT04046549|76238622|FG000|Enrolled Prior to Protocol V3.0|Overall Study||3||
60117660|NCT04046549|76238622|FG000|COMPLETED|Overall Study||13||
60117661|NCT04046549|76238622|FG000|NOT COMPLETED|Overall Study||10||
60117662|NCT03403205|76238631|FG000|STARTED|Overall Study||105||
60117663|NCT03403205|76238632|FG001|STARTED|Overall Study||56||
60117664|NCT03403205|76238633|FG002|STARTED|Overall Study||37||
60117665|NCT03403205|76238634|FG003|STARTED|Overall Study||16||
60117666|NCT03403205|76238631|FG000|Received at Least 1 Dose of Randomized Treatment|Overall Study||104||
60117667|NCT03403205|76238632|FG001|Received at Least 1 Dose of Randomized Treatment|Overall Study||56||
60117668|NCT03403205|76238633|FG002|Received at Least 1 Dose of Randomized Treatment|Overall Study||33||
60117669|NCT03403205|76238634|FG003|Received at Least 1 Dose of Randomized Treatment|Overall Study||14||
60117670|NCT03403205|76238631|FG000|Completed Primary Evaluation Period, Enter Extension|Overall Study||89||
60117671|NCT03403205|76238632|FG001|Completed Primary Evaluation Period, Enter Extension|Overall Study||49||
60117672|NCT03403205|76238633|FG002|Completed Primary Evaluation Period, Enter Extension|Overall Study||28||
60117673|NCT03403205|76238634|FG003|Completed Primary Evaluation Period, Enter Extension|Overall Study||12||
60117674|NCT03403205|76238631|FG000|Completed Primary Evaluation Period, Not Into Extension|Overall Study||4||
60117675|NCT03403205|76238632|FG001|Completed Primary Evaluation Period, Not Into Extension|Overall Study||3||
60117676|NCT03403205|76238633|FG002|Completed Primary Evaluation Period, Not Into Extension|Overall Study||1||
60117677|NCT03403205|76238634|FG003|Completed Primary Evaluation Period, Not Into Extension|Overall Study||1||
60117678|NCT03403205|76238631|FG000|COMPLETED|Overall Study||93||
60117679|NCT03403205|76238632|FG001|COMPLETED|Overall Study||52||
60117680|NCT03403205|76238633|FG002|COMPLETED|Overall Study||29||
60117681|NCT03403205|76238634|FG003|COMPLETED|Overall Study||13||
60117682|NCT03403205|76238631|FG000|NOT COMPLETED|Overall Study||12||
60117683|NCT03403205|76238632|FG001|NOT COMPLETED|Overall Study||4||
60117684|NCT03403205|76238633|FG002|NOT COMPLETED|Overall Study||8||
60117685|NCT03403205|76238634|FG003|NOT COMPLETED|Overall Study||3||
60117686|NCT03375112|76238646|FG000|STARTED|Overall Study||62||
60117687|NCT03375112|76238647|FG001|STARTED|Overall Study||60||
60117688|NCT03375112|76238646|FG000|COMPLETED|Overall Study||59||
60117689|NCT03375112|76238647|FG001|COMPLETED|Overall Study||60||
60117690|NCT03375112|76238646|FG000|NOT COMPLETED|Overall Study||3||
60117691|NCT03375112|76238647|FG001|NOT COMPLETED|Overall Study||0||
60117692|NCT03122106|76238653|FG000|STARTED|Overall Study||15||
60117693|NCT03122106|76238653|FG000|COMPLETED|Overall Study||11||
60117694|NCT03122106|76238653|FG000|NOT COMPLETED|Overall Study||4||
60117695|NCT02923739|76238661|FG000|STARTED|Overall Study||9||
60117696|NCT02923739|76238662|FG001|STARTED|Overall Study||0||
60117697|NCT02923739|76238663|FG002|STARTED|Overall Study||0||
60117698|NCT02923739|76238664|FG003|STARTED|Overall Study||0||
60117699|NCT02923739|76238661|FG000|COMPLETED|Overall Study||4||
60117700|NCT02923739|76238662|FG001|COMPLETED|Overall Study||0||
60117701|NCT02923739|76238663|FG002|COMPLETED|Overall Study||0||
60117702|NCT02923739|76238664|FG003|COMPLETED|Overall Study||0||
60117703|NCT02923739|76238661|FG000|NOT COMPLETED|Overall Study||5||
60117704|NCT02923739|76238662|FG001|NOT COMPLETED|Overall Study||0||
60117705|NCT02923739|76238663|FG002|NOT COMPLETED|Overall Study||0||
60117706|NCT02923739|76238664|FG003|NOT COMPLETED|Overall Study||0||
60117707|NCT02920892|76238676|FG000|STARTED|Placebo Lead-In Period||110||
60117708|NCT02920892|76238677|FG001|STARTED|Placebo Lead-In Period||0||
60117709|NCT02920892|76238678|FG002|STARTED|Placebo Lead-In Period||0||
60117710|NCT02920892|76238676|FG000|COMPLETED|Placebo Lead-In Period||99||
60117711|NCT02920892|76238677|FG001|COMPLETED|Placebo Lead-In Period||0||
60117712|NCT02920892|76238678|FG002|COMPLETED|Placebo Lead-In Period||0||
60117713|NCT02920892|76238676|FG000|NOT COMPLETED|Placebo Lead-In Period||11||
60117714|NCT02920892|76238677|FG001|NOT COMPLETED|Placebo Lead-In Period||0||
60117715|NCT02920892|76238678|FG002|NOT COMPLETED|Placebo Lead-In Period||0||
60117716|NCT02920892|76238676|FG000|STARTED|Placebo-Controlled Period||0||
60117717|NCT02920892|76238677|FG001|STARTED|Placebo-Controlled Period||49||
60117718|NCT02920892|76238678|FG002|STARTED|Placebo-Controlled Period||50||
60117719|NCT02920892|76238676|FG000|COMPLETED|Placebo-Controlled Period||0||
60117720|NCT02920892|76238677|FG001|COMPLETED|Placebo-Controlled Period||46||
60117721|NCT02920892|76238678|FG002|COMPLETED|Placebo-Controlled Period||43||
60117722|NCT02920892|76238676|FG000|NOT COMPLETED|Placebo-Controlled Period||0||
60117723|NCT02920892|76238677|FG001|NOT COMPLETED|Placebo-Controlled Period||3||
60117724|NCT02920892|76238678|FG002|NOT COMPLETED|Placebo-Controlled Period||7||
60117725|NCT02920892|76238676|FG000|STARTED|Open-Label Extension (OLE) Period||0||
60117726|NCT02920892|76238677|FG001|STARTED|Open-Label Extension (OLE) Period||46||
60117727|NCT02920892|76238678|FG002|STARTED|Open-Label Extension (OLE) Period||43||
60117728|NCT02920892|76238676|FG000|COMPLETED|Open-Label Extension (OLE) Period||0||
60117729|NCT02920892|76238677|FG001|COMPLETED|Open-Label Extension (OLE) Period||37||
59567372|NCT02278640|75670301|FG000|NOT COMPLETED|Overall Study||0||
59567373|NCT02717949|75670307|FG000|STARTED|Overall Study||0|data not reported due to confidentiality|
59715760|NCT01147068|75834501|FG006|COMPLETED|Subjects That Received 1st Dose||55||
59715761|NCT01147068|75834495|FG000|NOT COMPLETED|Subjects That Received 1st Dose||0||
59715762|NCT01147068|75834496|FG001|NOT COMPLETED|Subjects That Received 1st Dose||0||
59715763|NCT01147068|75834497|FG002|NOT COMPLETED|Subjects That Received 1st Dose||0||
59715764|NCT01147068|75834498|FG003|NOT COMPLETED|Subjects That Received 1st Dose||0||
59715765|NCT01147068|75834499|FG004|NOT COMPLETED|Subjects That Received 1st Dose||0||
59715766|NCT01147068|75834500|FG005|NOT COMPLETED|Subjects That Received 1st Dose||0||
59715767|NCT01147068|75834501|FG006|NOT COMPLETED|Subjects That Received 1st Dose||0||
59715768|NCT01147068|75834495|FG000|STARTED|Subjects That Received 2nd Dose||60||
60117730|NCT02920892|76238678|FG002|COMPLETED|Open-Label Extension (OLE) Period||39||
60117731|NCT02920892|76238676|FG000|NOT COMPLETED|Open-Label Extension (OLE) Period||0||
60117732|NCT02920892|76238677|FG001|NOT COMPLETED|Open-Label Extension (OLE) Period||9||
60117733|NCT02920892|76238678|FG002|NOT COMPLETED|Open-Label Extension (OLE) Period||4||
60117734|NCT02509052|76238689|FG000|STARTED|Overall Study||3||
60117735|NCT02509052|76238690|FG001|STARTED|Overall Study||3||
60117736|NCT02509052|76238691|FG002|STARTED|Overall Study||6||
60117737|NCT02509052|76238689|FG000|COMPLETED|Overall Study||3||
60117738|NCT02509052|76238690|FG001|COMPLETED|Overall Study||3||
60117739|NCT02509052|76238691|FG002|COMPLETED|Overall Study||5||
59715769|NCT01147068|75834496|FG001|STARTED|Subjects That Received 2nd Dose||57||
59715770|NCT01147068|75834497|FG002|STARTED|Subjects That Received 2nd Dose||55||
59715771|NCT01147068|75834498|FG003|STARTED|Subjects That Received 2nd Dose||56||
59715772|NCT01147068|75834499|FG004|STARTED|Subjects That Received 2nd Dose||56||
59715773|NCT01147068|75834500|FG005|STARTED|Subjects That Received 2nd Dose||53||
60117740|NCT02509052|76238689|FG000|NOT COMPLETED|Overall Study||0||
60117741|NCT02509052|76238690|FG001|NOT COMPLETED|Overall Study||0||
60117742|NCT02509052|76238691|FG002|NOT COMPLETED|Overall Study||1||
60117743|NCT02365597|76238704|FG000|STARTED|Overall Study||33||
60117744|NCT02365597|76238705|FG001|STARTED|Overall Study||79||
60117745|NCT02365597|76238706|FG002|STARTED|Overall Study||102||
60117746|NCT02365597|76238707|FG003|STARTED|Overall Study||25||
60117747|NCT02365597|76238704|FG000|Treated (Safety Analysis Set)|Overall Study||33||
60117748|NCT02365597|76238705|FG001|Treated (Safety Analysis Set)|Overall Study||78||
60117749|NCT02365597|76238706|FG002|Treated (Safety Analysis Set)|Overall Study||101||
60117750|NCT02365597|76238707|FG003|Treated (Safety Analysis Set)|Overall Study||25||
60117751|NCT02365597|76238704|FG000|COMPLETED|Overall Study||31||
60117752|NCT02365597|76238705|FG001|COMPLETED|Overall Study||62||
60117753|NCT02365597|76238706|FG002|COMPLETED|Overall Study||83||
60117754|NCT02365597|76238707|FG003|COMPLETED|Overall Study||6||
60117755|NCT02365597|76238704|FG000|NOT COMPLETED|Overall Study||2||
60117756|NCT02365597|76238705|FG001|NOT COMPLETED|Overall Study||17||
60117757|NCT02365597|76238706|FG002|NOT COMPLETED|Overall Study||19||
60117758|NCT02365597|76238707|FG003|NOT COMPLETED|Overall Study||19||
60117759|NCT02220894|76238724|FG000|STARTED|Overall Study|1 additional participant was randomized in error|637||
60117760|NCT02220894|76238725|FG001|STARTED|Overall Study||637||
60117761|NCT02220894|76238724|FG000|Treated|Overall Study||636||
59826158|NCT00319449|75949428|FG001|COMPLETED|Overall Study||12||
59826159|NCT00319449|75949427|FG000|NOT COMPLETED|Overall Study||2||
59826160|NCT00319449|75949428|FG001|NOT COMPLETED|Overall Study||0||
59826161|NCT00308997|75949436|FG000|STARTED|Overall Study||56||
59826162|NCT00308997|75949437|FG001|STARTED|Overall Study||29||
60117762|NCT02220894|76238725|FG001|Treated|Overall Study||615||
60117763|NCT02220894|76238724|FG000|COMPLETED|Overall Study||0||
60117764|NCT02220894|76238725|FG001|COMPLETED|Overall Study||0||
60117765|NCT02220894|76238724|FG000|NOT COMPLETED|Overall Study||637||
60117766|NCT02220894|76238725|FG001|NOT COMPLETED|Overall Study||637||
60117767|NCT02068092|76238732|FG000|STARTED|Overall Study||51||
60117768|NCT02068092|76238732|FG000|COMPLETED|Overall Study||41||
60117769|NCT02068092|76238732|FG000|NOT COMPLETED|Overall Study||10||
60117770|NCT01959672|76238736|FG000|STARTED|Overall Study||11||
60117771|NCT01959672|76238736|FG000|COMPLETED|Overall Study||10||
60117772|NCT01959672|76238736|FG000|NOT COMPLETED|Overall Study||1||
60117773|NCT01958593|76238745|FG000|STARTED|Stage 1||2||
60117774|NCT01958593|76238746|FG001|STARTED|Stage 1||4||
60117775|NCT01958593|76238745|FG000|COMPLETED|Stage 1||2||
60117776|NCT01958593|76238746|FG001|COMPLETED|Stage 1||4||
60117777|NCT01958593|76238745|FG000|NOT COMPLETED|Stage 1||0||
60117778|NCT01958593|76238746|FG001|NOT COMPLETED|Stage 1||0||
60117779|NCT01958593|76238745|FG000|STARTED|Stage 2||2||
60117780|NCT01958593|76238746|FG001|STARTED|Stage 2||0||
60117781|NCT01958593|76238745|FG000|COMPLETED|Stage 2||2||
60117782|NCT01958593|76238746|FG001|COMPLETED|Stage 2||0||
60117783|NCT01958593|76238745|FG000|NOT COMPLETED|Stage 2||0||
60117784|NCT01958593|76238746|FG001|NOT COMPLETED|Stage 2||0||
60117785|NCT01712308|76238755|FG000|STARTED|Overall Study||35||
60117786|NCT01712308|76238756|FG001|STARTED|Overall Study||21||
60117787|NCT01712308|76238755|FG000|COMPLETED|Overall Study||35||
60117788|NCT01712308|76238756|FG001|COMPLETED|Overall Study||21||
60117789|NCT01712308|76238755|FG000|NOT COMPLETED|Overall Study||0||
59826163|NCT00308997|75949436|FG000|COMPLETED|Overall Study||55||
59826164|NCT00308997|75949437|FG001|COMPLETED|Overall Study||28||
59826165|NCT00308997|75949436|FG000|NOT COMPLETED|Overall Study||1||
59826166|NCT00308997|75949437|FG001|NOT COMPLETED|Overall Study||1||
59826167|NCT00308685|75949445|FG000|STARTED|Overall Study||50||
60117790|NCT01712308|76238756|FG001|NOT COMPLETED|Overall Study||0||
60117791|NCT00071760|76238764|FG000|STARTED|Overall Study||28||
60117792|NCT00071760|76238765|FG001|STARTED|Overall Study||26||
60117793|NCT00071760|76238764|FG000|COMPLETED|Overall Study||21||
60117794|NCT00071760|76238765|FG001|COMPLETED|Overall Study||18||
60117795|NCT00071760|76238764|FG000|NOT COMPLETED|Overall Study||7||
60117796|NCT00071760|76238765|FG001|NOT COMPLETED|Overall Study||8||
60117797|NCT01605227|76238783|FG000|STARTED|Overall Study||682|Randomized|
60117798|NCT01605227|76238784|FG001|STARTED|Overall Study||346|Randomized|
60117799|NCT01605227|76238783|FG000|COMPLETED|Overall Study||61|Subjects still on study treatment at data cut-off date|
60117800|NCT01605227|76238784|FG001|COMPLETED|Overall Study||17|Subjects still on study treatment at data cut-off date|
60117801|NCT01605227|76238783|FG000|NOT COMPLETED|Overall Study||621||
60117802|NCT01605227|76238784|FG001|NOT COMPLETED|Overall Study||329||
60117803|NCT01709513|76238793|FG000|STARTED|Overall Study||63||
60117804|NCT01709513|76238794|FG001|STARTED|Overall Study||125||
60117805|NCT01709513|76238795|FG002|STARTED|Overall Study||126||
60117806|NCT01709513|76238793|FG000|Treated|Overall Study||63||
60117807|NCT01709513|76238794|FG001|Treated|Overall Study||124||
60117808|NCT01709513|76238795|FG002|Treated|Overall Study||126||
59826168|NCT00308685|75949446|FG001|STARTED|Overall Study||45||
59826169|NCT00308685|75949445|FG000|Received at Least 1 Dose of Study Drug|Overall Study||50||
59826170|NCT00308685|75949446|FG001|Received at Least 1 Dose of Study Drug|Overall Study||45||
59826171|NCT00308685|75949445|FG000|COMPLETED|Overall Study||47||
59826172|NCT00308685|75949446|FG001|COMPLETED|Overall Study||40||
60117809|NCT01709513|76238793|FG000|COMPLETED|Overall Study||42||
60117810|NCT01709513|76238794|FG001|COMPLETED|Overall Study||82||
60117811|NCT01709513|76238795|FG002|COMPLETED|Overall Study||96||
60117812|NCT01709513|76238793|FG000|NOT COMPLETED|Overall Study||21||
60117813|NCT01709513|76238794|FG001|NOT COMPLETED|Overall Study||43||
60117814|NCT01709513|76238795|FG002|NOT COMPLETED|Overall Study||30||
60117815|NCT01605071|76238808|FG000|STARTED|Overall Study||27|Includes those who were randomized and dropped or randomized, completed initial testing then dropped|
60117816|NCT01605071|76238809|FG001|STARTED|Overall Study||26|Includes those who were randomized and dropped or randomized, completed initial testing then dropped|
60117817|NCT01605071|76238808|FG000|COMPLETED|Overall Study||24||
60117818|NCT01605071|76238809|FG001|COMPLETED|Overall Study||24||
60117819|NCT01605071|76238808|FG000|NOT COMPLETED|Overall Study||3||
60117820|NCT01605071|76238809|FG001|NOT COMPLETED|Overall Study||2||
60117821|NCT02710422|76238819|FG000|STARTED|Overall Study||12||
60117822|NCT02710422|76238820|FG001|STARTED|Overall Study||12||
59826173|NCT00308685|75949445|FG000|NOT COMPLETED|Overall Study||3||
60117823|NCT02710422|76238819|FG000|3 Month Visit|Overall Study||9||
60117824|NCT02710422|76238820|FG001|3 Month Visit|Overall Study||11||
59826174|NCT00308685|75949446|FG001|NOT COMPLETED|Overall Study||5||
59826175|NCT00317109|75949454|FG000|STARTED|Overall Study||84||
59826176|NCT00317109|75949455|FG001|STARTED|Overall Study||84||
59567374|NCT02717949|75670308|FG001|STARTED|Overall Study||0|data not reported due to confidentiality|
59715774|NCT01147068|75834501|FG006|STARTED|Subjects That Received 2nd Dose||55||
60117825|NCT02710422|76238819|FG000|6 Month Visit|Overall Study||7||
59826177|NCT00317109|75949454|FG000|COMPLETED|Overall Study||81||
60117826|NCT02710422|76238820|FG001|6 Month Visit|Overall Study||8||
60117827|NCT02710422|76238819|FG000|9 Month Visit|Overall Study||5||
60117828|NCT02710422|76238820|FG001|9 Month Visit|Overall Study||5||
59826178|NCT00317109|75949455|FG001|COMPLETED|Overall Study||84||
59826179|NCT00317109|75949454|FG000|NOT COMPLETED|Overall Study||3||
59826180|NCT00317109|75949455|FG001|NOT COMPLETED|Overall Study||0||
59826181|NCT00316719|75949463|FG000|STARTED|Overall Study||52||
59826182|NCT00316719|75949464|FG001|STARTED|Overall Study||53||
59826183|NCT00316719|75949463|FG000|COMPLETED|Overall Study||50||
59826184|NCT00316719|75949464|FG001|COMPLETED|Overall Study||47||
59826185|NCT00316719|75949463|FG000|NOT COMPLETED|Overall Study||2||
59826186|NCT00316719|75949464|FG001|NOT COMPLETED|Overall Study||6||
59826187|NCT00422058|75949476|FG000|STARTED|Double-Blind, Week 0-20||98||
59826188|NCT00422058|75949477|FG001|STARTED|Double-Blind, Week 0-20||95||
59826189|NCT00422058|75949478|FG002|STARTED|Double-Blind, Week 0-20||90||
59826190|NCT00422058|75949479|FG003|STARTED|Double-Blind, Week 0-20||93||
59826191|NCT00422058|75949480|FG004|STARTED|Double-Blind, Week 0-20||93||
59826192|NCT00422058|75949481|FG005|STARTED|Double-Blind, Week 0-20||95||
59826193|NCT00422058|75949476|FG000|COMPLETED|Double-Blind, Week 0-20||79||
60117829|NCT02710422|76238819|FG000|12 Month Visit|Overall Study||3||
60117830|NCT02710422|76238820|FG001|12 Month Visit|Overall Study||3||
60117831|NCT02710422|76238819|FG000|COMPLETED|Overall Study||3||
60117832|NCT02710422|76238820|FG001|COMPLETED|Overall Study||3||
60117833|NCT02710422|76238819|FG000|NOT COMPLETED|Overall Study||9||
60117834|NCT02710422|76238820|FG001|NOT COMPLETED|Overall Study||9||
60117835|NCT01706159|76238830|FG000|STARTED|Overall Study||14||
60117836|NCT01706159|76238831|FG001|STARTED|Overall Study||6||
60117837|NCT01706159|76238830|FG000|Exposed|Overall Study|One subject was not exposed to rFXIII.|13||
60117838|NCT01706159|76238831|FG001|Exposed|Overall Study|One subject was not exposed to placebo.|5||
60117839|NCT01706159|76238830|FG000|Completers (With Baron Score at Week 8)|Overall Study||6||
60117840|NCT01706159|76238831|FG001|Completers (With Baron Score at Week 8)|Overall Study||3||
60117841|NCT01706159|76238830|FG000|COMPLETED|Overall Study||6||
60117842|NCT01706159|76238831|FG001|COMPLETED|Overall Study||4||
60117843|NCT01706159|76238830|FG000|NOT COMPLETED|Overall Study||8||
60117844|NCT01706159|76238831|FG001|NOT COMPLETED|Overall Study||2||
60117845|NCT01706003|76238839|FG000|STARTED|Overall Study||23||
60117846|NCT01706003|76238840|FG001|STARTED|Overall Study||22||
60117847|NCT01706003|76238839|FG000|COMPLETED|Overall Study||12||
60117848|NCT01706003|76238840|FG001|COMPLETED|Overall Study||18||
60117849|NCT01706003|76238839|FG000|NOT COMPLETED|Overall Study||11||
60117850|NCT01706003|76238840|FG001|NOT COMPLETED|Overall Study||4||
60117851|NCT01705691|76238848|FG000|STARTED|Overall Study||19||
59567375|NCT02717949|75670307|FG000|COMPLETED|Overall Study||0||
59567376|NCT02717949|75670308|FG001|COMPLETED|Overall Study||0||
59715775|NCT01147068|75834495|FG000|COMPLETED|Subjects That Received 2nd Dose||59||
59715776|NCT01147068|75834496|FG001|COMPLETED|Subjects That Received 2nd Dose||52||
59715777|NCT01147068|75834497|FG002|COMPLETED|Subjects That Received 2nd Dose||52||
59715778|NCT01147068|75834498|FG003|COMPLETED|Subjects That Received 2nd Dose||56||
59715779|NCT01147068|75834499|FG004|COMPLETED|Subjects That Received 2nd Dose||55||
59715780|NCT01147068|75834500|FG005|COMPLETED|Subjects That Received 2nd Dose||51||
59715781|NCT01147068|75834501|FG006|COMPLETED|Subjects That Received 2nd Dose||55||
59715782|NCT01147068|75834495|FG000|NOT COMPLETED|Subjects That Received 2nd Dose||1||
59715783|NCT01147068|75834496|FG001|NOT COMPLETED|Subjects That Received 2nd Dose||5||
59715784|NCT01147068|75834497|FG002|NOT COMPLETED|Subjects That Received 2nd Dose||3||
59715785|NCT01147068|75834498|FG003|NOT COMPLETED|Subjects That Received 2nd Dose||0||
59715786|NCT01147068|75834499|FG004|NOT COMPLETED|Subjects That Received 2nd Dose||1||
59715787|NCT01147068|75834500|FG005|NOT COMPLETED|Subjects That Received 2nd Dose||2||
59826194|NCT00422058|75949477|FG001|COMPLETED|Double-Blind, Week 0-20||85||
59826195|NCT00422058|75949478|FG002|COMPLETED|Double-Blind, Week 0-20||74||
59826196|NCT00422058|75949479|FG003|COMPLETED|Double-Blind, Week 0-20||73||
59826197|NCT00422058|75949480|FG004|COMPLETED|Double-Blind, Week 0-20||82||
59715788|NCT01147068|75834501|FG006|NOT COMPLETED|Subjects That Received 2nd Dose||0||
60117852|NCT01705691|76238849|FG001|STARTED|Overall Study||30||
60117853|NCT01705691|76238848|FG000|COMPLETED|Overall Study||16||
59826198|NCT00422058|75949481|FG005|COMPLETED|Double-Blind, Week 0-20||79||
59826199|NCT00422058|75949476|FG000|NOT COMPLETED|Double-Blind, Week 0-20||19||
59826200|NCT00422058|75949477|FG001|NOT COMPLETED|Double-Blind, Week 0-20||10||
59826201|NCT00422058|75949478|FG002|NOT COMPLETED|Double-Blind, Week 0-20||16||
59826202|NCT00422058|75949479|FG003|NOT COMPLETED|Double-Blind, Week 0-20||20||
59826203|NCT00422058|75949480|FG004|NOT COMPLETED|Double-Blind, Week 0-20||11||
59826204|NCT00422058|75949481|FG005|NOT COMPLETED|Double-Blind, Week 0-20||16||
59826205|NCT00422058|75949476|FG000|STARTED|Open-Label Extension, Week 20-104||79||
59826206|NCT00422058|75949477|FG001|STARTED|Open-Label Extension, Week 20-104||85||
59826207|NCT00422058|75949478|FG002|STARTED|Open-Label Extension, Week 20-104||74||
59826208|NCT00422058|75949479|FG003|STARTED|Open-Label Extension, Week 20-104||73||
59826209|NCT00422058|75949480|FG004|STARTED|Open-Label Extension, Week 20-104||82||
59826210|NCT00422058|75949481|FG005|STARTED|Open-Label Extension, Week 20-104||79||
59826211|NCT00422058|75949476|FG000|Enrolled in Extension|Open-Label Extension, Week 20-104||67||
59826212|NCT00422058|75949477|FG001|Enrolled in Extension|Open-Label Extension, Week 20-104||68||
59826213|NCT00422058|75949478|FG002|Enrolled in Extension|Open-Label Extension, Week 20-104||59||
59826214|NCT00422058|75949479|FG003|Enrolled in Extension|Open-Label Extension, Week 20-104||65||
59826215|NCT00422058|75949480|FG004|Enrolled in Extension|Open-Label Extension, Week 20-104||72||
59826216|NCT00422058|75949481|FG005|Enrolled in Extension|Open-Label Extension, Week 20-104||67||
59826217|NCT00422058|75949476|FG000|COMPLETED|Open-Label Extension, Week 20-104||47||
59826218|NCT00422058|75949477|FG001|COMPLETED|Open-Label Extension, Week 20-104||46||
59826219|NCT00422058|75949478|FG002|COMPLETED|Open-Label Extension, Week 20-104||38||
59826220|NCT00422058|75949479|FG003|COMPLETED|Open-Label Extension, Week 20-104||45||
59826221|NCT00422058|75949480|FG004|COMPLETED|Open-Label Extension, Week 20-104||47||
59826222|NCT00422058|75949481|FG005|COMPLETED|Open-Label Extension, Week 20-104||45||
59826223|NCT00422058|75949476|FG000|NOT COMPLETED|Open-Label Extension, Week 20-104||32||
59826224|NCT00422058|75949477|FG001|NOT COMPLETED|Open-Label Extension, Week 20-104||39||
59826225|NCT00422058|75949478|FG002|NOT COMPLETED|Open-Label Extension, Week 20-104||36||
59826226|NCT00422058|75949479|FG003|NOT COMPLETED|Open-Label Extension, Week 20-104||28||
59826227|NCT00422058|75949480|FG004|NOT COMPLETED|Open-Label Extension, Week 20-104||35||
59826228|NCT00422058|75949481|FG005|NOT COMPLETED|Open-Label Extension, Week 20-104||34||
59826229|NCT02720952|75949495|FG000|STARTED|Overall Study||24||
59826230|NCT02720952|75949495|FG000|COMPLETED|Overall Study||24||
59826231|NCT02720952|75949495|FG000|NOT COMPLETED|Overall Study||0||
59826232|NCT00413244|75949505|FG000|STARTED|Overall Study||31||
59826233|NCT00413244|75949506|FG001|STARTED|Overall Study||20||
59826234|NCT00413244|75949505|FG000|COMPLETED|Overall Study||21||
59826235|NCT00413244|75949506|FG001|COMPLETED|Overall Study||19||
59826236|NCT00413244|75949505|FG000|NOT COMPLETED|Overall Study||10||
59826237|NCT00413244|75949506|FG001|NOT COMPLETED|Overall Study||1||
59826238|NCT01033032|75949517|FG000|STARTED|Overall Study||3||
60117854|NCT01705691|76238849|FG001|COMPLETED|Overall Study||24||
60117855|NCT01705691|76238848|FG000|NOT COMPLETED|Overall Study||3||
59715789|NCT01147068|75834495|FG000|STARTED|Subjects That Completed Safety Follow-up|Participants were eligible for follow-up regardless of number of doses received.|60||
59715790|NCT01147068|75834496|FG001|STARTED|Subjects That Completed Safety Follow-up|One subject was ineligible, one subject did not complete the study, and the other data is unknown.|57||
59715791|NCT01147068|75834497|FG002|STARTED|Subjects That Completed Safety Follow-up|Data on three subjects is unknown.|55||
59715792|NCT01147068|75834498|FG003|STARTED|Subjects That Completed Safety Follow-up||56||
59715793|NCT01147068|75834499|FG004|STARTED|Subjects That Completed Safety Follow-up|Data for one subject is unknown.|56||
59715794|NCT01147068|75834500|FG005|STARTED|Subjects That Completed Safety Follow-up|One subject was lost to follow up and one subject did not complete the study.|53||
59715795|NCT01147068|75834501|FG006|STARTED|Subjects That Completed Safety Follow-up||55||
59715796|NCT01147068|75834495|FG000|COMPLETED|Subjects That Completed Safety Follow-up||59||
59715797|NCT01147068|75834496|FG001|COMPLETED|Subjects That Completed Safety Follow-up||56||
59715798|NCT01147068|75834497|FG002|COMPLETED|Subjects That Completed Safety Follow-up||55||
59715799|NCT01147068|75834498|FG003|COMPLETED|Subjects That Completed Safety Follow-up||54||
59715800|NCT01147068|75834499|FG004|COMPLETED|Subjects That Completed Safety Follow-up||56||
59715801|NCT01147068|75834500|FG005|COMPLETED|Subjects That Completed Safety Follow-up||52||
59826239|NCT01033032|75949518|FG001|STARTED|Overall Study||3||
59826240|NCT01033032|75949519|FG002|STARTED|Overall Study||3||
59826241|NCT01033032|75949520|FG003|STARTED|Overall Study||6||
59826242|NCT01033032|75949521|FG004|STARTED|Overall Study||63||
59826243|NCT01033032|75949517|FG000|COMPLETED|Overall Study|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0||
59826244|NCT01033032|75949518|FG001|COMPLETED|Overall Study|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0||
59826245|NCT01033032|75949519|FG002|COMPLETED|Overall Study||3||
59826246|NCT01033032|75949520|FG003|COMPLETED|Overall Study|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0||
59826247|NCT01033032|75949521|FG004|COMPLETED|Overall Study||0||
59826248|NCT01033032|75949517|FG000|NOT COMPLETED|Overall Study||3||
59826249|NCT01033032|75949518|FG001|NOT COMPLETED|Overall Study||3||
59826250|NCT01033032|75949519|FG002|NOT COMPLETED|Overall Study||0||
59826251|NCT01033032|75949520|FG003|NOT COMPLETED|Overall Study||6||
60117856|NCT01705691|76238849|FG001|NOT COMPLETED|Overall Study||6||
59826252|NCT01033032|75949521|FG004|NOT COMPLETED|Overall Study||63||
59826253|NCT00420420|75949534|FG000|STARTED|Overall Study|Number of patients randomized.|73||
59826254|NCT00420420|75949535|FG001|STARTED|Overall Study|Number of patients randomized.|71||
59826255|NCT00420420|75949534|FG000|COMPLETED|Overall Study|One patient from the MK-0249 arm discontinued the trial due to an AE prior to receiving study drug.|65||
59826256|NCT00420420|75949535|FG001|COMPLETED|Overall Study||67||
59826257|NCT00420420|75949534|FG000|NOT COMPLETED|Overall Study||8||
59826258|NCT00420420|75949535|FG001|NOT COMPLETED|Overall Study||4||
59826259|NCT00420342|75949544|FG000|STARTED|Overall Study||30||
59826260|NCT00420342|75949545|FG001|STARTED|Overall Study||33||
59826261|NCT00420342|75949546|FG002|STARTED|Overall Study||29||
59826262|NCT00420342|75949544|FG000|Received Treatment|Overall Study|1 subject did not confirm if she ever took the study medication.|29||
59826263|NCT00420342|75949545|FG001|Received Treatment|Overall Study|1 subject did not confirm if she ever took the study medication.|32||
59826264|NCT00420342|75949546|FG002|Received Treatment|Overall Study||29||
59826265|NCT00420342|75949544|FG000|COMPLETED|Overall Study||29||
59826266|NCT00420342|75949545|FG001|COMPLETED|Overall Study||31||
59826267|NCT00420342|75949546|FG002|COMPLETED|Overall Study||28||
59826268|NCT00420342|75949544|FG000|NOT COMPLETED|Overall Study||1||
59826269|NCT00420342|75949545|FG001|NOT COMPLETED|Overall Study||2||
59826270|NCT00420342|75949546|FG002|NOT COMPLETED|Overall Study||1||
59826271|NCT00432744|75949556|FG000|STARTED|Months 0-6||12||
59826272|NCT00432744|75949557|FG001|STARTED|Months 0-6||12||
59826273|NCT00432744|75949556|FG000|COMPLETED|Months 0-6||7||
59826274|NCT00432744|75949557|FG001|COMPLETED|Months 0-6|"One patient in period 1 other reason for loss became too disabled to complete the 6 month test."|8||
59826275|NCT00432744|75949556|FG000|NOT COMPLETED|Months 0-6||5||
59826276|NCT00432744|75949557|FG001|NOT COMPLETED|Months 0-6||4||
59826277|NCT00432744|75949556|FG000|STARTED|Months 7 - 12||7||
59826278|NCT00432744|75949557|FG001|STARTED|Months 7 - 12||8||
59826279|NCT00432744|75949556|FG000|COMPLETED|Months 7 - 12||6||
59826280|NCT00432744|75949557|FG001|COMPLETED|Months 7 - 12||7||
59826281|NCT00432744|75949556|FG000|NOT COMPLETED|Months 7 - 12||1||
59826282|NCT00432744|75949557|FG001|NOT COMPLETED|Months 7 - 12||1||
59826283|NCT00432666|75949565|FG000|STARTED|Main Period||73||
59826284|NCT00432666|75949566|FG001|STARTED|Main Period||75||
59826285|NCT00432666|75949565|FG000|COMPLETED|Main Period||71||
59826286|NCT00432666|75949566|FG001|COMPLETED|Main Period||74||
59826287|NCT00432666|75949565|FG000|NOT COMPLETED|Main Period||2||
59826288|NCT00432666|75949566|FG001|NOT COMPLETED|Main Period||1||
59826289|NCT00432666|75949565|FG000|STARTED|Open-Label Extension Period||145||
59826290|NCT00432666|75949566|FG001|STARTED|Open-Label Extension Period|In the Open-Label Extension Period no placebo treatment arm was given.|0||
59826291|NCT00432666|75949565|FG000|COMPLETED|Open-Label Extension Period||120||
59826292|NCT00432666|75949566|FG001|COMPLETED|Open-Label Extension Period||0||
59826293|NCT00432666|75949565|FG000|NOT COMPLETED|Open-Label Extension Period||25||
59826294|NCT00432666|75949566|FG001|NOT COMPLETED|Open-Label Extension Period||0||
59826295|NCT00451958|75949576|FG000|STARTED|CS21 (NCT00295750)|CS21 intention-to-treat (ITT) population.|210||
60117857|NCT03766906|76238855|FG000|STARTED|Overall Study|50 dyads = 100 unique participants.|50||
60117858|NCT03766906|76238855|FG000|COMPLETED|Overall Study|44 dyads = 88 unique participants.|44||
60117859|NCT03766906|76238855|FG000|NOT COMPLETED|Overall Study||6||
59567377|NCT02717949|75670307|FG000|NOT COMPLETED|Overall Study||0||
59567378|NCT02717949|75670308|FG001|NOT COMPLETED|Overall Study||0||
59567379|NCT02300610|75670319|FG000|STARTED|Overall Study||3||
59567380|NCT02300610|75670320|FG001|STARTED|Overall Study||3||
59567381|NCT02300610|75670321|FG002|STARTED|Overall Study||4||
59567382|NCT02300610|75670319|FG000|COMPLETED|Overall Study||2||
59567383|NCT02300610|75670320|FG001|COMPLETED|Overall Study||3||
59567384|NCT02300610|75670321|FG002|COMPLETED|Overall Study||3||
59567385|NCT02300610|75670319|FG000|NOT COMPLETED|Overall Study||1||
59567386|NCT02300610|75670320|FG001|NOT COMPLETED|Overall Study||0||
59567387|NCT02300610|75670321|FG002|NOT COMPLETED|Overall Study||1||
59567388|NCT01880840|75670333|FG000|STARTED|Overall Study||95||
59567389|NCT01880840|75670334|FG001|STARTED|Overall Study||96||
59567390|NCT01880840|75670333|FG000|COMPLETED|Overall Study||87||
59826296|NCT00451958|75949577|FG001|STARTED|CS21 (NCT00295750)|CS21 ITT population.|206||
59826297|NCT00451958|75949578|FG002|STARTED|CS21 (NCT00295750)|Participants were switched from the leuprolide 7.5 mg group when CS21 was completed.|0||
59826298|NCT00451958|75949579|FG003|STARTED|CS21 (NCT00295750)|Participants were switched from the leuprolide 7.5 mg group when CS21 was completed.|0||
59826299|NCT00451958|75949580|FG004|STARTED|CS21 (NCT00295750)||204||
59826300|NCT00451958|75949576|FG000|COMPLETED|CS21 (NCT00295750)||169||
59826301|NCT00451958|75949577|FG001|COMPLETED|CS21 (NCT00295750)||163||
59826302|NCT00451958|75949578|FG002|COMPLETED|CS21 (NCT00295750)||0||
59826303|NCT00451958|75949579|FG003|COMPLETED|CS21 (NCT00295750)||0||
59826304|NCT00451958|75949580|FG004|COMPLETED|CS21 (NCT00295750)||172||
59826305|NCT00451958|75949576|FG000|NOT COMPLETED|CS21 (NCT00295750)||41||
59826306|NCT00451958|75949577|FG001|NOT COMPLETED|CS21 (NCT00295750)||43||
59826307|NCT00451958|75949578|FG002|NOT COMPLETED|CS21 (NCT00295750)||0||
59826308|NCT00451958|75949579|FG003|NOT COMPLETED|CS21 (NCT00295750)||0||
59826309|NCT00451958|75949580|FG004|NOT COMPLETED|CS21 (NCT00295750)||32||
60117860|NCT01705145|76238859|FG000|STARTED|Part A||9||
59826310|NCT00451958|75949576|FG000|STARTED|CS21A (NCT00451958)|CS21A intention-to-treat (ITT) population.|125||
59826311|NCT00451958|75949577|FG001|STARTED|CS21A (NCT00451958)|CS21A ITT population.|126||
59826312|NCT00451958|75949578|FG002|STARTED|CS21A (NCT00451958)|CS21A ITT population.|69||
59826313|NCT00451958|75949579|FG003|STARTED|CS21A (NCT00451958)|One of the enrolled participants never received any treatment, i.e. the CS21A ITT population=65.|66||
59826314|NCT00451958|75949580|FG004|STARTED|CS21A (NCT00451958)|Participants were switched to the degarelix groups when CS21 was completed.|0||
59826315|NCT00451958|75949576|FG000|COMPLETED|CS21A (NCT00451958)||60||
59826316|NCT00451958|75949577|FG001|COMPLETED|CS21A (NCT00451958)||49||
59826317|NCT00451958|75949578|FG002|COMPLETED|CS21A (NCT00451958)||27||
59826318|NCT00451958|75949579|FG003|COMPLETED|CS21A (NCT00451958)||27||
59826319|NCT00451958|75949580|FG004|COMPLETED|CS21A (NCT00451958)||0||
59826320|NCT00451958|75949576|FG000|NOT COMPLETED|CS21A (NCT00451958)||65||
59826321|NCT00451958|75949577|FG001|NOT COMPLETED|CS21A (NCT00451958)||77||
59826322|NCT00451958|75949578|FG002|NOT COMPLETED|CS21A (NCT00451958)||42||
59826323|NCT00451958|75949579|FG003|NOT COMPLETED|CS21A (NCT00451958)||39||
59826324|NCT00451958|75949580|FG004|NOT COMPLETED|CS21A (NCT00451958)||0||
59826325|NCT00432276|75949596|FG000|STARTED|Overall Study||404||
59826326|NCT00432276|75949597|FG001|STARTED|Overall Study||399||
59826327|NCT00432276|75949596|FG000|Per Protocol Set|Overall Study|Patients who received at least 1 dose of study medication and who had no major protocol violations.|303||
59826328|NCT00432276|75949597|FG001|Per Protocol Set|Overall Study||306||
59826329|NCT00432276|75949596|FG000|COMPLETED|Overall Study||283||
59826330|NCT00432276|75949597|FG001|COMPLETED|Overall Study||243||
59826331|NCT00432276|75949596|FG000|NOT COMPLETED|Overall Study||121||
59826332|NCT00432276|75949597|FG001|NOT COMPLETED|Overall Study||156||
59826333|NCT00413010|75949605|FG000|STARTED|Overall Study||180||
59826334|NCT00413010|75949606|FG001|STARTED|Overall Study||176||
59826335|NCT00413010|75949605|FG000|COMPLETED|Overall Study||108||
59826336|NCT00413010|75949606|FG001|COMPLETED|Overall Study||113||
59826337|NCT00413010|75949605|FG000|NOT COMPLETED|Overall Study||72||
59826338|NCT00413010|75949606|FG001|NOT COMPLETED|Overall Study||63||
59826339|NCT00459290|75949612|FG000|STARTED|Overall Study||24||
59826340|NCT00459290|75949612|FG000|COMPLETED|Overall Study|Patients treated until disease progression; completed defined as off treatment due to progression.|19||
59826341|NCT00459290|75949612|FG000|NOT COMPLETED|Overall Study||5||
59826342|NCT00443534|75949623|FG000|STARTED|Overall Study||123||
59826343|NCT00443534|75949623|FG000|Treated|Overall Study||122||
59826344|NCT00443534|75949623|FG000|COMPLETED|Overall Study||0||
59826345|NCT00443534|75949623|FG000|NOT COMPLETED|Overall Study||123||
59826346|NCT00419952|75949629|FG000|STARTED|Overall Study||377||
59826347|NCT00419952|75949630|FG001|STARTED|Overall Study||365||
59826348|NCT00419952|75949629|FG000|COMPLETED|Overall Study||228||
59826349|NCT00419952|75949630|FG001|COMPLETED|Overall Study||240||
59826350|NCT00419952|75949629|FG000|NOT COMPLETED|Overall Study||149||
59826351|NCT00419952|75949630|FG001|NOT COMPLETED|Overall Study||125||
59826352|NCT00443456|75949636|FG000|STARTED|Overall Study||134||
59826353|NCT00443456|75949636|FG000|COMPLETED|Overall Study||116||
59826354|NCT00443456|75949636|FG000|NOT COMPLETED|Overall Study||18||
59826355|NCT00419562|75949646|FG000|STARTED|Overall Study||283||
59826356|NCT00419562|75949647|FG001|STARTED|Overall Study||277||
59826357|NCT00419562|75949646|FG000|COMPLETED|Overall Study||250||
59826358|NCT00419562|75949647|FG001|COMPLETED|Overall Study||246||
59826359|NCT00419562|75949646|FG000|NOT COMPLETED|Overall Study||33||
59826360|NCT00419562|75949647|FG001|NOT COMPLETED|Overall Study||31||
59826361|NCT00432042|75949656|FG000|STARTED|Overall Study|Number randomized.|479||
59826362|NCT00432042|75949657|FG001|STARTED|Overall Study|Number randomized.|235||
59826363|NCT00432042|75949658|FG002|STARTED|Overall Study|Number randomized.|241||
59826364|NCT00432042|75949656|FG000|Vaccinated|Overall Study||477||
59826365|NCT00432042|75949657|FG001|Vaccinated|Overall Study||235||
59826366|NCT00432042|75949658|FG002|Vaccinated|Overall Study||240||
59826367|NCT00432042|75949656|FG000|COMPLETED|Overall Study||472||
59826368|NCT00432042|75949657|FG001|COMPLETED|Overall Study||234||
59826369|NCT00432042|75949658|FG002|COMPLETED|Overall Study||239||
59826370|NCT00432042|75949656|FG000|NOT COMPLETED|Overall Study||7||
59826371|NCT00432042|75949657|FG001|NOT COMPLETED|Overall Study||1||
59826372|NCT00432042|75949658|FG002|NOT COMPLETED|Overall Study||2||
59826373|NCT00308139|75949668|FG000|STARTED|Overall Study||152||
59826374|NCT00308139|75949669|FG001|STARTED|Overall Study||151||
59826375|NCT00308139|75949668|FG000|Intent to Treat (ITT)|Overall Study|Subjects who received at least one injection of lead-in exenatide 5 mcg.|148||
59826376|NCT00308139|75949669|FG001|Intent to Treat (ITT)|Overall Study|Subjects who received at least one injection of lead-in exenatide 5 mcg.|147||
59826377|NCT00308139|75949668|FG000|ITT in the 30-Week Assessment|Overall Study|ITT Subjects who received at least one injection of randomized dose.|148||
60117861|NCT01705145|76238859|FG000|COMPLETED|Part A||9||
60117862|NCT01705145|76238859|FG000|NOT COMPLETED|Part A||0||
59826378|NCT00308139|75949669|FG001|ITT in the 30-Week Assessment|Overall Study|ITT Subjects who received at least one injection of randomized dose.|145||
59826379|NCT00308139|75949668|FG000|Pharmacokinetics Population|Overall Study||129||
59826380|NCT00308139|75949669|FG001|Pharmacokinetics Population|Overall Study||0||
59826381|NCT00308139|75949668|FG000|Evaluable Meal Tolerance Cohort|Overall Study||27||
59826382|NCT00308139|75949669|FG001|Evaluable Meal Tolerance Cohort|Overall Study||24||
59826383|NCT00308139|75949668|FG000|30-Week Completed|Overall Study|Subjects who completed 30 weeks of assessment|128||
59826384|NCT00308139|75949669|FG001|30-Week Completed|Overall Study|Subjects who completed 30 weeks of assessment|130||
59826385|NCT00308139|75949668|FG000|COMPLETED|Overall Study|Subjects who completed 364 weeks of assessment|58||
59826386|NCT00308139|75949669|FG001|COMPLETED|Overall Study|Subjects who completed 364 weeks of assessment|64||
59826387|NCT00308139|75949668|FG000|NOT COMPLETED|Overall Study||94||
59826388|NCT00308139|75949669|FG001|NOT COMPLETED|Overall Study||87||
59826389|NCT00459134|75949697|FG000|STARTED|Overall Study||94||
59826390|NCT00459134|75949698|FG001|STARTED|Overall Study||92||
59826391|NCT00459134|75949697|FG000|COMPLETED|Overall Study||71||
59826392|NCT00459134|75949698|FG001|COMPLETED|Overall Study||67||
59826393|NCT00459134|75949697|FG000|NOT COMPLETED|Overall Study||23||
59826394|NCT00459134|75949698|FG001|NOT COMPLETED|Overall Study||25||
59826395|NCT00459056|75949706|FG000|STARTED|First Intervention (First Three Months)||10||
59826396|NCT00459056|75949707|FG001|STARTED|First Intervention (First Three Months)||15||
59826397|NCT00459056|75949706|FG000|COMPLETED|First Intervention (First Three Months)||9||
59826398|NCT00459056|75949707|FG001|COMPLETED|First Intervention (First Three Months)||14||
59826399|NCT00459056|75949706|FG000|NOT COMPLETED|First Intervention (First Three Months)||1||
59826400|NCT00459056|75949707|FG001|NOT COMPLETED|First Intervention (First Three Months)||1||
59826401|NCT00459056|75949706|FG000|STARTED|Washout (1 Month)||9||
59826402|NCT00459056|75949707|FG001|STARTED|Washout (1 Month)||14||
59826403|NCT00459056|75949706|FG000|COMPLETED|Washout (1 Month)||9||
59826404|NCT00459056|75949707|FG001|COMPLETED|Washout (1 Month)||14||
59826405|NCT00459056|75949706|FG000|NOT COMPLETED|Washout (1 Month)||0||
59826406|NCT00459056|75949707|FG001|NOT COMPLETED|Washout (1 Month)||0||
59826407|NCT00459056|75949706|FG000|STARTED|Second Intervention (Final Three Months)||9||
59826408|NCT00459056|75949707|FG001|STARTED|Second Intervention (Final Three Months)||14||
59826409|NCT00459056|75949706|FG000|COMPLETED|Second Intervention (Final Three Months)||9||
59826410|NCT00459056|75949707|FG001|COMPLETED|Second Intervention (Final Three Months)||14||
59826411|NCT00459056|75949706|FG000|NOT COMPLETED|Second Intervention (Final Three Months)||0||
59826412|NCT00459056|75949707|FG001|NOT COMPLETED|Second Intervention (Final Three Months)||0||
59826413|NCT00431964|75949715|FG000|STARTED|Overall Study||131||
59826414|NCT00431964|75949716|FG001|STARTED|Overall Study||132||
59826415|NCT00431964|75949715|FG000|Randomized/Received Drug|Overall Study||131||
59826416|NCT00431964|75949716|FG001|Randomized/Received Drug|Overall Study||129||
59826417|NCT00431964|75949715|FG000|Did Not Receive Drug|Overall Study||0||
59826418|NCT00431964|75949716|FG001|Did Not Receive Drug|Overall Study||3||
59826419|NCT00431964|75949715|FG000|Withdrew From Study|Overall Study||6||
59826420|NCT00431964|75949716|FG001|Withdrew From Study|Overall Study||5||
59826421|NCT00431964|75949715|FG000|COMPLETED|Overall Study||125||
59826422|NCT00431964|75949716|FG001|COMPLETED|Overall Study||124||
59826423|NCT00431964|75949715|FG000|NOT COMPLETED|Overall Study||6||
59826424|NCT00431964|75949716|FG001|NOT COMPLETED|Overall Study||8||
59826425|NCT00412854|75949724|FG000|STARTED|Overall Study||330||
59826426|NCT00412854|75949725|FG001|STARTED|Overall Study||330||
59826427|NCT00412854|75949724|FG000|COMPLETED|Overall Study||316||
59715802|NCT01147068|75834501|FG006|COMPLETED|Subjects That Completed Safety Follow-up||54||
59715803|NCT01147068|75834495|FG000|NOT COMPLETED|Subjects That Completed Safety Follow-up||1||
59715804|NCT01147068|75834496|FG001|NOT COMPLETED|Subjects That Completed Safety Follow-up||1||
59715805|NCT01147068|75834497|FG002|NOT COMPLETED|Subjects That Completed Safety Follow-up||0||
59715806|NCT01147068|75834498|FG003|NOT COMPLETED|Subjects That Completed Safety Follow-up||2||
59715807|NCT01147068|75834499|FG004|NOT COMPLETED|Subjects That Completed Safety Follow-up||0||
59715808|NCT01147068|75834500|FG005|NOT COMPLETED|Subjects That Completed Safety Follow-up||1||
59715809|NCT01147068|75834501|FG006|NOT COMPLETED|Subjects That Completed Safety Follow-up||1||
59715810|NCT01146912|75834524|FG000|STARTED|Overall Study||4607||
59715811|NCT01146912|75834525|FG001|STARTED|Overall Study||4606||
59715812|NCT01146912|75834526|FG002|STARTED|Overall Study||593||
59826428|NCT00412854|75949725|FG001|COMPLETED|Overall Study||314||
59826429|NCT00412854|75949724|FG000|NOT COMPLETED|Overall Study||14||
59826430|NCT00412854|75949725|FG001|NOT COMPLETED|Overall Study||16||
59826431|NCT00431496|75949731|FG000|STARTED|Overall Study||71||
59826432|NCT00431496|75949731|FG000|COMPLETED|Overall Study||60||
59826433|NCT00431496|75949731|FG000|NOT COMPLETED|Overall Study||11||
59826434|NCT00316173|75949737|FG000|STARTED|Run-in Phase||22||
59826435|NCT00316173|75949738|FG001|STARTED|Run-in Phase||0||
59715813|NCT01146912|75834527|FG003|STARTED|Overall Study||594||
59715814|NCT01146912|75834528|FG004|STARTED|Overall Study||1821||
59715815|NCT01146912|75834529|FG005|STARTED|Overall Study||1821||
59826436|NCT00316173|75949737|FG000|COMPLETED|Run-in Phase||15||
59826437|NCT00316173|75949738|FG001|COMPLETED|Run-in Phase||0||
59826438|NCT00316173|75949737|FG000|NOT COMPLETED|Run-in Phase||7||
59826439|NCT00316173|75949738|FG001|NOT COMPLETED|Run-in Phase||0||
59826440|NCT00316173|75949737|FG000|STARTED|Treatment Phase||0||
59826441|NCT00316173|75949738|FG001|STARTED|Treatment Phase||55||
59826442|NCT00316173|75949737|FG000|COMPLETED|Treatment Phase||0||
59826443|NCT00316173|75949738|FG001|COMPLETED|Treatment Phase||13||
59826444|NCT00316173|75949737|FG000|NOT COMPLETED|Treatment Phase||0||
59826445|NCT00316173|75949738|FG001|NOT COMPLETED|Treatment Phase||42||
59826446|NCT00412542|75949745|FG000|STARTED|Overall Study||33||
59715816|NCT01146912|75834530|FG006|STARTED|Overall Study||1820||
59715817|NCT01146912|75834531|FG007|STARTED|Overall Study||14675||
59715818|NCT01146912|75834524|FG000|COMPLETED|Overall Study||3790||
59826447|NCT00412542|75949746|FG001|STARTED|Overall Study||45||
59826448|NCT00412542|75949745|FG000|COMPLETED|Overall Study||33||
59826449|NCT00412542|75949746|FG001|COMPLETED|Overall Study||42||
59826450|NCT00412542|75949745|FG000|NOT COMPLETED|Overall Study||0||
59826451|NCT00412542|75949746|FG001|NOT COMPLETED|Overall Study||3||
59826452|NCT00316017|75949753|FG000|STARTED|Overall Study|"11 of 11 not completed due to Bag Opened Not Given (BONG)"|231||
59826453|NCT00316017|75949754|FG001|STARTED|Overall Study|12 of 13 not completed due to BONG; 1 not completed was a prisoner who was excluded|269||
59826454|NCT00316017|75949755|FG002|STARTED|Overall Study|19 of 19 not complete due to BONG|395||
59826455|NCT00316017|75949753|FG000|COMPLETED|Overall Study||220||
59826456|NCT00316017|75949754|FG001|COMPLETED|Overall Study||256||
59826457|NCT00316017|75949755|FG002|COMPLETED|Overall Study||376||
59826458|NCT00316017|75949753|FG000|NOT COMPLETED|Overall Study||11||
59826459|NCT00316017|75949754|FG001|NOT COMPLETED|Overall Study||13||
59826460|NCT00316017|75949755|FG002|NOT COMPLETED|Overall Study||19||
59826461|NCT00451178|75949765|FG000|STARTED|Chemotherapy (Up To Six 21-Day Cycles)||58||
59826462|NCT00451178|75949766|FG001|STARTED|Chemotherapy (Up To Six 21-Day Cycles)||43||
59826463|NCT00451178|75949765|FG000|Received At Least 1 Dose Study Treatment|Chemotherapy (Up To Six 21-Day Cycles)||57||
59567391|NCT01880840|75670334|FG001|COMPLETED|Overall Study||91||
59715819|NCT01146912|75834525|FG001|COMPLETED|Overall Study||3784||
59715820|NCT01146912|75834526|FG002|COMPLETED|Overall Study||576||
60117863|NCT01705145|76238859|FG000|STARTED|Part B|Eight participants from Part A continued in Part B of the study.|34||
59715821|NCT01146912|75834527|FG003|COMPLETED|Overall Study||577||
59826464|NCT00451178|75949766|FG001|Received At Least 1 Dose Study Treatment|Chemotherapy (Up To Six 21-Day Cycles)||43||
59826465|NCT00451178|75949765|FG000|COMPLETED|Chemotherapy (Up To Six 21-Day Cycles)||40||
59826466|NCT00451178|75949766|FG001|COMPLETED|Chemotherapy (Up To Six 21-Day Cycles)||26||
60117864|NCT01705145|76238859|FG000|COMPLETED|Part B||33||
59715822|NCT01146912|75834528|FG004|COMPLETED|Overall Study||1780||
59715823|NCT01146912|75834529|FG005|COMPLETED|Overall Study||1760||
59715824|NCT01146912|75834530|FG006|COMPLETED|Overall Study||1764||
59715825|NCT01146912|75834531|FG007|COMPLETED|Overall Study|Parents are considered subjects but outcomes are on child level|14675||
59715826|NCT01146912|75834524|FG000|NOT COMPLETED|Overall Study||817||
59715827|NCT01146912|75834525|FG001|NOT COMPLETED|Overall Study||822||
59715828|NCT01146912|75834526|FG002|NOT COMPLETED|Overall Study||17||
59715829|NCT01146912|75834527|FG003|NOT COMPLETED|Overall Study||17||
59715830|NCT01146912|75834528|FG004|NOT COMPLETED|Overall Study||41||
59715831|NCT01146912|75834529|FG005|NOT COMPLETED|Overall Study||61||
59715832|NCT01146912|75834530|FG006|NOT COMPLETED|Overall Study||56||
59826467|NCT00451178|75949765|FG000|NOT COMPLETED|Chemotherapy (Up To Six 21-Day Cycles)||18||
59826468|NCT00451178|75949766|FG001|NOT COMPLETED|Chemotherapy (Up To Six 21-Day Cycles)||17||
59826469|NCT00451178|75949765|FG000|STARTED|Prior to Maintenance Therapy||40||
60117865|NCT01705145|76238859|FG000|NOT COMPLETED|Part B||1||
60117866|NCT01704755|76238877|FG000|STARTED|Overall Study||208||
60117867|NCT01704755|76238878|FG001|STARTED|Overall Study||172||
59715833|NCT01146912|75834531|FG007|NOT COMPLETED|Overall Study||0||
59826470|NCT00451178|75949766|FG001|STARTED|Prior to Maintenance Therapy|R-CHOP participants were excluded from maintenance therapy and went directly to long-term follow-up.|0||
59826471|NCT00451178|75949765|FG000|COMPLETED|Prior to Maintenance Therapy||36||
59826472|NCT00451178|75949766|FG001|COMPLETED|Prior to Maintenance Therapy||0||
59826473|NCT00451178|75949765|FG000|NOT COMPLETED|Prior to Maintenance Therapy||4||
59826474|NCT00451178|75949766|FG001|NOT COMPLETED|Prior to Maintenance Therapy||0||
59826475|NCT00451178|75949765|FG000|STARTED|Maintenance Therapy (up to 3 Years)||36||
59826476|NCT00451178|75949766|FG001|STARTED|Maintenance Therapy (up to 3 Years)|R-CHOP participants were excluded from maintenance therapy and went directly to long-term follow-up.|0||
59826477|NCT00451178|75949765|FG000|COMPLETED|Maintenance Therapy (up to 3 Years)||6||
59826478|NCT00451178|75949766|FG001|COMPLETED|Maintenance Therapy (up to 3 Years)||0||
59826479|NCT00451178|75949765|FG000|NOT COMPLETED|Maintenance Therapy (up to 3 Years)||30||
59826480|NCT00451178|75949766|FG001|NOT COMPLETED|Maintenance Therapy (up to 3 Years)||0||
59826481|NCT00451178|75949765|FG000|STARTED|Long-Term Follow-Up (Up to 2 Years)||6||
59826482|NCT00451178|75949766|FG001|STARTED|Long-Term Follow-Up (Up to 2 Years)||26||
59826483|NCT00451178|75949765|FG000|COMPLETED|Long-Term Follow-Up (Up to 2 Years)||0||
59826484|NCT00451178|75949766|FG001|COMPLETED|Long-Term Follow-Up (Up to 2 Years)||0||
59826485|NCT00451178|75949765|FG000|NOT COMPLETED|Long-Term Follow-Up (Up to 2 Years)||6||
59826486|NCT00451178|75949766|FG001|NOT COMPLETED|Long-Term Follow-Up (Up to 2 Years)||26||
59826487|NCT00450866|75949776|FG000|STARTED|Overall Study||45||
59826488|NCT00450866|75949777|FG001|STARTED|Overall Study||10||
59826489|NCT00450866|75949776|FG000|COMPLETED|Overall Study||38||
59826490|NCT00450866|75949777|FG001|COMPLETED|Overall Study||7||
59826491|NCT00450866|75949776|FG000|NOT COMPLETED|Overall Study||7||
59826492|NCT00450866|75949777|FG001|NOT COMPLETED|Overall Study||3||
59826493|NCT00442598|75949786|FG000|STARTED|Overall Study||7||
59826494|NCT00442598|75949787|FG001|STARTED|Overall Study||10||
59826495|NCT00442598|75949788|FG002|STARTED|Overall Study||0||
59826496|NCT00442598|75949786|FG000|Two Cycles|Overall Study||5||
59826497|NCT00442598|75949787|FG001|Two Cycles|Overall Study||6||
59826498|NCT00442598|75949788|FG002|Two Cycles|Overall Study||0||
59826499|NCT00442598|75949786|FG000|COMPLETED|Overall Study||1||
59826500|NCT00442598|75949787|FG001|COMPLETED|Overall Study||2||
59826501|NCT00442598|75949788|FG002|COMPLETED|Overall Study||0||
59826502|NCT00442598|75949786|FG000|NOT COMPLETED|Overall Study||6||
59826503|NCT00442598|75949787|FG001|NOT COMPLETED|Overall Study||8||
59826504|NCT00442598|75949788|FG002|NOT COMPLETED|Overall Study||0||
59826505|NCT00442286|75949798|FG000|STARTED|Overall Study||181||
59826506|NCT00442286|75949799|FG001|STARTED|Overall Study||84||
59826507|NCT00442286|75949798|FG000|6 Months|Overall Study||177||
59826508|NCT00442286|75949799|FG001|6 Months|Overall Study||83||
59826509|NCT00442286|75949798|FG000|12 Months|Overall Study||174||
59826510|NCT00442286|75949799|FG001|12 Months|Overall Study||82||
59826511|NCT00442286|75949798|FG000|COMPLETED|Overall Study||174||
59826512|NCT00442286|75949799|FG001|COMPLETED|Overall Study||82||
59826513|NCT00442286|75949798|FG000|NOT COMPLETED|Overall Study||7||
59826514|NCT00442286|75949799|FG001|NOT COMPLETED|Overall Study||2||
59826515|NCT00441974|75949807|FG000|STARTED|Overall Study||1470||
59826516|NCT00441974|75949807|FG000|COMPLETED|Overall Study||1342||
59826517|NCT00441974|75949807|FG000|NOT COMPLETED|Overall Study||128||
59826518|NCT00441584|75949814|FG000|STARTED|Overall Study||117||
59826519|NCT00441584|75949814|FG000|COMPLETED|Overall Study||12||
59826520|NCT00441584|75949814|FG000|NOT COMPLETED|Overall Study||105||
59826521|NCT00430716|75949821|FG000|STARTED|Double Blind Phase||42||
59826522|NCT00430716|75949822|FG001|STARTED|Double Blind Phase||43||
59826523|NCT00430716|75949823|FG002|STARTED|Double Blind Phase||45||
59826524|NCT00430716|75949821|FG000|Treated|Double Blind Phase||41||
59826525|NCT00430716|75949822|FG001|Treated|Double Blind Phase||43||
60117868|NCT01704755|76238877|FG000|Completed Study Drug|Overall Study||204||
59826526|NCT00430716|75949823|FG002|Treated|Double Blind Phase||45||
59826527|NCT00430716|75949821|FG000|COMPLETED|Double Blind Phase||36||
59826528|NCT00430716|75949822|FG001|COMPLETED|Double Blind Phase||38||
59826529|NCT00430716|75949823|FG002|COMPLETED|Double Blind Phase||39||
59826530|NCT00430716|75949821|FG000|NOT COMPLETED|Double Blind Phase||6||
59826531|NCT00430716|75949822|FG001|NOT COMPLETED|Double Blind Phase||5||
59826532|NCT00430716|75949823|FG002|NOT COMPLETED|Double Blind Phase||6||
59826533|NCT00430716|75949821|FG000|STARTED|Open Label Phase||36||
59826534|NCT00430716|75949822|FG001|STARTED|Open Label Phase||38||
59826535|NCT00430716|75949823|FG002|STARTED|Open Label Phase||39||
59826536|NCT00430716|75949821|FG000|COMPLETED|Open Label Phase||27||
59826537|NCT00430716|75949822|FG001|COMPLETED|Open Label Phase||31||
59826538|NCT00430716|75949823|FG002|COMPLETED|Open Label Phase||32||
59826539|NCT00430716|75949821|FG000|NOT COMPLETED|Open Label Phase||9||
59826540|NCT00430716|75949822|FG001|NOT COMPLETED|Open Label Phase||7||
60117869|NCT01704755|76238878|FG001|Completed Study Drug|Overall Study||163||
59826541|NCT00430716|75949823|FG002|NOT COMPLETED|Open Label Phase||7||
59826542|NCT00441272|75949833|FG000|STARTED|Overall Study||25||
59826543|NCT00441272|75949834|FG001|STARTED|Overall Study||25||
59826544|NCT00441272|75949833|FG000|COMPLETED|Overall Study|Study terminated prior to enrollment.|0||
59826545|NCT00441272|75949834|FG001|COMPLETED|Overall Study|Study terminated prior to enrollment.|0||
59826546|NCT00441272|75949833|FG000|NOT COMPLETED|Overall Study||25||
59826547|NCT00441272|75949834|FG001|NOT COMPLETED|Overall Study||25||
59826548|NCT00430638|75949842|FG000|STARTED|Overall Study||138||
59826549|NCT00430638|75949843|FG001|STARTED|Overall Study|2 participants were erroneously assigned to olmesartan 40 mg instead of 20 mg|140||
59826550|NCT00430638|75949842|FG000|COMPLETED|Overall Study||60||
59826551|NCT00430638|75949843|FG001|COMPLETED|Overall Study||92||
59826552|NCT00430638|75949842|FG000|NOT COMPLETED|Overall Study||78||
59826553|NCT00430638|75949843|FG001|NOT COMPLETED|Overall Study||48||
59826554|NCT00430482|75949855|FG000|STARTED|Completed Treatment||41||
59826555|NCT00430482|75949856|FG001|STARTED|Completed Treatment||37||
59826556|NCT00430482|75949855|FG000|Completed ASI at Midpoint|Completed Treatment||35||
59826557|NCT00430482|75949856|FG001|Completed ASI at Midpoint|Completed Treatment||29||
59826558|NCT00430482|75949855|FG000|COMPLETED|Completed Treatment||34|Non-completion was operationalized as a failure to complete at least 12 of 15 treatment sessions.|
59826559|NCT00430482|75949856|FG001|COMPLETED|Completed Treatment||26|Non-completion was operationalized as a failure to complete at least 12 of 15 treatment sessions.|
59826560|NCT00430482|75949855|FG000|NOT COMPLETED|Completed Treatment||7||
59826561|NCT00430482|75949856|FG001|NOT COMPLETED|Completed Treatment||11||
59826562|NCT00430482|75949855|FG000|STARTED|Completed 2 Follow-Up Visits||34||
59826563|NCT00430482|75949856|FG001|STARTED|Completed 2 Follow-Up Visits||26||
59826564|NCT00430482|75949855|FG000|Completed ASI at Follow-Up #1|Completed 2 Follow-Up Visits||27||
59826565|NCT00430482|75949856|FG001|Completed ASI at Follow-Up #1|Completed 2 Follow-Up Visits||20||
59826566|NCT00430482|75949855|FG000|Completed ASI at Follow-Up #2|Completed 2 Follow-Up Visits||29||
59826567|NCT00430482|75949856|FG001|Completed ASI at Follow-Up #2|Completed 2 Follow-Up Visits||20||
59826568|NCT00430482|75949855|FG000|COMPLETED|Completed 2 Follow-Up Visits||29||
59826569|NCT00430482|75949856|FG001|COMPLETED|Completed 2 Follow-Up Visits||20||
59826570|NCT00430482|75949855|FG000|NOT COMPLETED|Completed 2 Follow-Up Visits||5||
59826571|NCT00430482|75949856|FG001|NOT COMPLETED|Completed 2 Follow-Up Visits||6||
59826572|NCT00449930|75949864|FG000|STARTED|Overall Study||528||
59826573|NCT00449930|75949865|FG001|STARTED|Overall Study||522||
59826574|NCT00449930|75949864|FG000|COMPLETED|Overall Study||467||
59826575|NCT00449930|75949865|FG001|COMPLETED|Overall Study||447||
59826576|NCT00449930|75949864|FG000|NOT COMPLETED|Overall Study||61||
59826577|NCT00449930|75949865|FG001|NOT COMPLETED|Overall Study||75||
59826578|NCT00449696|75949873|FG000|STARTED|Overall Study||251||
59826579|NCT00449696|75949874|FG001|STARTED|Overall Study||128||
59826580|NCT00449696|75949873|FG000|Received Injection|Overall Study||249||
59826581|NCT00449696|75949874|FG001|Received Injection|Overall Study||128||
59826582|NCT00449696|75949873|FG000|Analyzed Participants|Overall Study|2 subjects removed from ITT analyses because of no post treatment data (pre-defined criteria).|247||
59826583|NCT00449696|75949874|FG001|Analyzed Participants|Overall Study||128||
59826584|NCT00449696|75949873|FG000|COMPLETED|Overall Study||231||
59826585|NCT00449696|75949874|FG001|COMPLETED|Overall Study||119||
59826586|NCT00449696|75949873|FG000|NOT COMPLETED|Overall Study||20||
59826587|NCT00449696|75949874|FG001|NOT COMPLETED|Overall Study||9||
59826588|NCT00441116|75949882|FG000|STARTED|Overall Study||76||
59826589|NCT00441116|75949883|FG001|STARTED|Overall Study||77||
59826590|NCT00441116|75949882|FG000|COMPLETED|Overall Study||73||
59826591|NCT00441116|75949883|FG001|COMPLETED|Overall Study||75||
59826592|NCT00441116|75949882|FG000|NOT COMPLETED|Overall Study||3||
59826593|NCT00441116|75949883|FG001|NOT COMPLETED|Overall Study||2||
59826594|NCT00430248|75949892|FG000|STARTED|Overall Study||757||
59826595|NCT00430248|75949893|FG001|STARTED|Overall Study||756||
59826596|NCT00430248|75949894|FG002|STARTED|Overall Study||756||
59826597|NCT00430248|75949892|FG000|COMPLETED|Overall Study||632||
59826598|NCT00430248|75949893|FG001|COMPLETED|Overall Study||598||
59826599|NCT00430248|75949894|FG002|COMPLETED|Overall Study||621||
59826600|NCT00430248|75949892|FG000|NOT COMPLETED|Overall Study||125||
59826601|NCT00430248|75949893|FG001|NOT COMPLETED|Overall Study||158||
59826602|NCT00430248|75949894|FG002|NOT COMPLETED|Overall Study||135||
59826603|NCT00449540|75949904|FG000|STARTED|Pretreatment Phase||267||
59826604|NCT00449540|75949905|FG001|STARTED|Pretreatment Phase||0||
59826605|NCT00449540|75949906|FG002|STARTED|Pretreatment Phase||0||
59826606|NCT00449540|75949904|FG000|COMPLETED|Pretreatment Phase||201||
60117870|NCT01704755|76238877|FG000|COMPLETED|Overall Study||196||
59826607|NCT00449540|75949905|FG001|COMPLETED|Pretreatment Phase||0||
59826608|NCT00449540|75949906|FG002|COMPLETED|Pretreatment Phase||0||
59826609|NCT00449540|75949904|FG000|NOT COMPLETED|Pretreatment Phase||66||
59826610|NCT00449540|75949905|FG001|NOT COMPLETED|Pretreatment Phase||0||
59826611|NCT00449540|75949906|FG002|NOT COMPLETED|Pretreatment Phase||0||
59826612|NCT00449540|75949904|FG000|STARTED|Treatment Phase||0||
59826613|NCT00449540|75949905|FG001|STARTED|Treatment Phase||102||
59826614|NCT00449540|75949906|FG002|STARTED|Treatment Phase||99||
59826615|NCT00449540|75949904|FG000|COMPLETED|Treatment Phase||0||
59826616|NCT00449540|75949905|FG001|COMPLETED|Treatment Phase||82||
59826617|NCT00449540|75949906|FG002|COMPLETED|Treatment Phase||82||
59826618|NCT00449540|75949904|FG000|NOT COMPLETED|Treatment Phase||0||
59826619|NCT00449540|75949905|FG001|NOT COMPLETED|Treatment Phase||20||
59826620|NCT00449540|75949906|FG002|NOT COMPLETED|Treatment Phase||17||
59826621|NCT00411762|75949914|FG000|STARTED|Overall Study||25||
59826622|NCT00411762|75949914|FG000|COMPLETED|Overall Study||20||
59826623|NCT00411762|75949914|FG000|NOT COMPLETED|Overall Study||5||
59826624|NCT00429858|75949918|FG000|STARTED|Overall Study||21||
59826625|NCT00429858|75949918|FG000|COMPLETED|Overall Study||19||
59826626|NCT00429858|75949918|FG000|NOT COMPLETED|Overall Study||2||
59826627|NCT00449150|75949926|FG000|STARTED|Overall Study||219||
59826628|NCT00449150|75949927|FG001|STARTED|Overall Study||230||
59826629|NCT00449150|75949928|FG002|STARTED|Overall Study||218||
59826630|NCT00449150|75949926|FG000|COMPLETED|Overall Study|Subjects could have more than one reason for not completing.|173||
59826631|NCT00449150|75949927|FG001|COMPLETED|Overall Study|Subjects could have more than one reason for not completing.|177||
59826632|NCT00449150|75949928|FG002|COMPLETED|Overall Study|Subjects could have more than one reason for not completing.|171||
59826633|NCT00449150|75949926|FG000|NOT COMPLETED|Overall Study||46||
59826634|NCT00449150|75949927|FG001|NOT COMPLETED|Overall Study||53||
59826635|NCT00449150|75949928|FG002|NOT COMPLETED|Overall Study||47||
59826636|NCT00428844|75949942|FG000|STARTED|Completed Study Drug Treatment||25||
59826637|NCT00428844|75949943|FG001|STARTED|Completed Study Drug Treatment||24||
59826638|NCT00428844|75949944|FG002|STARTED|Completed Study Drug Treatment||26||
59826639|NCT00428844|75949942|FG000|Received First Dose|Completed Study Drug Treatment||25||
59826640|NCT00428844|75949943|FG001|Received First Dose|Completed Study Drug Treatment||24||
59826641|NCT00428844|75949944|FG002|Received First Dose|Completed Study Drug Treatment||25||
59826642|NCT00428844|75949942|FG000|COMPLETED|Completed Study Drug Treatment||23||
60117871|NCT01704755|76238878|FG001|COMPLETED|Overall Study||165||
60117872|NCT01704755|76238877|FG000|NOT COMPLETED|Overall Study||12||
60117873|NCT01704755|76238878|FG001|NOT COMPLETED|Overall Study||7||
60117874|NCT01704599|76238884|FG000|STARTED|Overall Study|Study was started January 22, 2010|8||
60117875|NCT01704599|76238884|FG000|COMPLETED|Overall Study|11 screened 8 entered study 1 terminated.|7||
59715834|NCT01134042|75834553|FG000|STARTED|Overall Study||194||
59826643|NCT00428844|75949943|FG001|COMPLETED|Completed Study Drug Treatment||18||
59826644|NCT00428844|75949944|FG002|COMPLETED|Completed Study Drug Treatment||19||
59826645|NCT00428844|75949942|FG000|NOT COMPLETED|Completed Study Drug Treatment||2||
59826646|NCT00428844|75949943|FG001|NOT COMPLETED|Completed Study Drug Treatment||6||
59826647|NCT00428844|75949944|FG002|NOT COMPLETED|Completed Study Drug Treatment||7||
59826648|NCT00428844|75949942|FG000|STARTED|Completed Test of Cure (TOC) Visit||23||
59826649|NCT00428844|75949943|FG001|STARTED|Completed Test of Cure (TOC) Visit||18||
59826650|NCT00428844|75949944|FG002|STARTED|Completed Test of Cure (TOC) Visit||19||
59826651|NCT00428844|75949942|FG000|COMPLETED|Completed Test of Cure (TOC) Visit||20||
59826652|NCT00428844|75949943|FG001|COMPLETED|Completed Test of Cure (TOC) Visit||16||
59826653|NCT00428844|75949944|FG002|COMPLETED|Completed Test of Cure (TOC) Visit||17||
59826654|NCT00428844|75949942|FG000|NOT COMPLETED|Completed Test of Cure (TOC) Visit||3||
59826655|NCT00428844|75949943|FG001|NOT COMPLETED|Completed Test of Cure (TOC) Visit||2||
59826656|NCT00428844|75949944|FG002|NOT COMPLETED|Completed Test of Cure (TOC) Visit||2||
59826657|NCT00457418|75949952|FG000|STARTED|Pharmacokinetic (PK) Sampling Phase||32||
59826658|NCT00457418|75949952|FG000|COMPLETED|Pharmacokinetic (PK) Sampling Phase||27||
59826659|NCT00457418|75949952|FG000|NOT COMPLETED|Pharmacokinetic (PK) Sampling Phase||5||
59826660|NCT00457418|75949952|FG000|STARTED|Post PK Maintenance|4 participants didn't complete the PK sampling phase but continued to post PK maintenance treatment.|31||
59715835|NCT01134042|75834554|FG001|STARTED|Overall Study||197||
59715836|NCT01134042|75834555|FG002|STARTED|Overall Study||195||
59715837|NCT01134042|75834553|FG000|COMPLETED|Overall Study||146||
59715838|NCT01134042|75834554|FG001|COMPLETED|Overall Study||169||
59715839|NCT01134042|75834555|FG002|COMPLETED|Overall Study||161||
59715840|NCT01134042|75834553|FG000|NOT COMPLETED|Overall Study||48||
59826661|NCT00457418|75949952|FG000|COMPLETED|Post PK Maintenance||3||
59826662|NCT00457418|75949952|FG000|NOT COMPLETED|Post PK Maintenance||28||
59826663|NCT00449072|75949958|FG000|STARTED|Overall Study||148||
59715841|NCT01134042|75834554|FG001|NOT COMPLETED|Overall Study||28||
59715842|NCT01134042|75834555|FG002|NOT COMPLETED|Overall Study||34||
59715843|NCT01179347|75834566|FG000|STARTED|Double-blind Period (12 Weeks)|Entered and treated in double-blind period.|155||
59715844|NCT01179347|75834567|FG001|STARTED|Double-blind Period (12 Weeks)|Entered and treated in double-blind period.|308||
59715845|NCT01179347|75834566|FG000|COMPLETED|Double-blind Period (12 Weeks)|Completed double-blind period.|147||
59715846|NCT01179347|75834567|FG001|COMPLETED|Double-blind Period (12 Weeks)|Completed double-blind period.|294||
60117876|NCT01704599|76238884|FG000|NOT COMPLETED|Overall Study||1||
60117877|NCT03599518|76238916|FG000|STARTED|Overall Study||5||
59826664|NCT00449072|75949959|FG001|STARTED|Overall Study||151||
59826665|NCT00449072|75949958|FG000|COMPLETED|Overall Study||107||
59826666|NCT00449072|75949959|FG001|COMPLETED|Overall Study||109||
59826667|NCT00449072|75949958|FG000|NOT COMPLETED|Overall Study||41||
59826668|NCT00449072|75949959|FG001|NOT COMPLETED|Overall Study||42||
59826669|NCT00428610|75949968|FG000|STARTED|Overall Study||53||
59826670|NCT00428610|75949969|FG001|STARTED|Overall Study||18||
59826671|NCT00428610|75949970|FG002|STARTED|Overall Study||32||
59826672|NCT00428610|75949968|FG000|Received at Least One Dose of Study Drug|Overall Study||53||
59826673|NCT00428610|75949969|FG001|Received at Least One Dose of Study Drug|Overall Study||18||
59826674|NCT00428610|75949970|FG002|Received at Least One Dose of Study Drug|Overall Study||32||
59826675|NCT00428610|75949968|FG000|COMPLETED|Overall Study||0||
59826676|NCT00428610|75949969|FG001|COMPLETED|Overall Study||0||
59826677|NCT00428610|75949970|FG002|COMPLETED|Overall Study||0||
59826678|NCT00428610|75949968|FG000|NOT COMPLETED|Overall Study||53||
59826679|NCT00428610|75949969|FG001|NOT COMPLETED|Overall Study||18||
59826680|NCT00428610|75949970|FG002|NOT COMPLETED|Overall Study||32||
59826681|NCT00419094|75949980|FG000|STARTED|Overall Study|Number started refers to number randomized; 303 subjects were screened/enrolled and 228 randomized.|57||
59826682|NCT00419094|75949981|FG001|STARTED|Overall Study||171||
59826683|NCT00419094|75949980|FG000|COMPLETED|Overall Study||50||
59826684|NCT00419094|75949981|FG001|COMPLETED|Overall Study||141||
59826685|NCT00419094|75949980|FG000|NOT COMPLETED|Overall Study||7||
59826686|NCT00419094|75949981|FG001|NOT COMPLETED|Overall Study||30||
59826687|NCT00448916|75949991|FG000|STARTED|Overall Study||16||
59826688|NCT00448916|75949992|FG001|STARTED|Overall Study||15||
59826689|NCT00448916|75949993|FG002|STARTED|Overall Study||12||
59826690|NCT00448916|75949994|FG003|STARTED|Overall Study||11||
59826691|NCT00448916|75949991|FG000|COMPLETED|Overall Study||9||
59826692|NCT00448916|75949992|FG001|COMPLETED|Overall Study||9||
59826693|NCT00448916|75949993|FG002|COMPLETED|Overall Study||6||
59826694|NCT00448916|75949994|FG003|COMPLETED|Overall Study||5||
59826695|NCT00448916|75949991|FG000|NOT COMPLETED|Overall Study||7||
59826696|NCT00448916|75949992|FG001|NOT COMPLETED|Overall Study||6||
59826697|NCT00448916|75949993|FG002|NOT COMPLETED|Overall Study||6||
59826698|NCT00448916|75949994|FG003|NOT COMPLETED|Overall Study||6||
59826699|NCT00418938|75950008|FG000|STARTED|Overall Study||133||
59826700|NCT00418938|75950009|FG001|STARTED|Overall Study||131||
59826701|NCT00418938|75950008|FG000|COMPLETED|Overall Study||109||
59826702|NCT00418938|75950009|FG001|COMPLETED|Overall Study||108||
59826703|NCT00418938|75950008|FG000|NOT COMPLETED|Overall Study||24||
59826704|NCT00418938|75950009|FG001|NOT COMPLETED|Overall Study||23||
59826705|NCT00448760|75950015|FG000|STARTED|Overall Study||29||
59826706|NCT00448760|75950015|FG000|COMPLETED|Overall Study||26||
59826707|NCT00448760|75950015|FG000|NOT COMPLETED|Overall Study||3||
59826708|NCT00418314|75950021|FG000|STARTED|Overall Study||817||
59826709|NCT00418314|75950022|FG001|STARTED|Overall Study||830||
59826710|NCT00418314|75950021|FG000|COMPLETED|Overall Study||816||
59826711|NCT00418314|75950022|FG001|COMPLETED|Overall Study||828||
59826712|NCT00418314|75950021|FG000|NOT COMPLETED|Overall Study||1||
60117878|NCT03599518|76238917|FG001|STARTED|Overall Study||4||
60117879|NCT03599518|76238918|FG002|STARTED|Overall Study||6||
60117880|NCT03599518|76238919|FG003|STARTED|Overall Study||1||
59715847|NCT01179347|75834566|FG000|NOT COMPLETED|Double-blind Period (12 Weeks)||8||
59715848|NCT01179347|75834567|FG001|NOT COMPLETED|Double-blind Period (12 Weeks)||14||
59715849|NCT01179347|75834566|FG000|STARTED|Open-label Period (12 Weeks)|Treated in open-label period.|147||
59715850|NCT01179347|75834567|FG001|STARTED|Open-label Period (12 Weeks)|Treated in open-label period.|294||
59715851|NCT01179347|75834566|FG000|COMPLETED|Open-label Period (12 Weeks)|Completed open-label period.|132||
59715852|NCT01179347|75834567|FG001|COMPLETED|Open-label Period (12 Weeks)|Completed open-label period.|278||
59715853|NCT01179347|75834566|FG000|NOT COMPLETED|Open-label Period (12 Weeks)||15||
59715854|NCT01179347|75834567|FG001|NOT COMPLETED|Open-label Period (12 Weeks)||16||
59715855|NCT01146288|75834577|FG000|STARTED|First Intervention(1 Day)||7||
59715856|NCT01146288|75834578|FG001|STARTED|First Intervention(1 Day)||6||
59826713|NCT00418314|75950022|FG001|NOT COMPLETED|Overall Study||2||
59826714|NCT00448448|75950030|FG000|STARTED|Overall Study||246||
59826715|NCT00448448|75950031|FG001|STARTED|Overall Study||137||
59826716|NCT00448448|75950030|FG000|COMPLETED|Overall Study||146||
59826717|NCT00448448|75950031|FG001|COMPLETED|Overall Study||96||
60117881|NCT03599518|76238920|FG004|STARTED|Overall Study||4||
60117882|NCT03599518|76238916|FG000|COMPLETED|Overall Study||0||
59826718|NCT00448448|75950030|FG000|NOT COMPLETED|Overall Study||100||
59826719|NCT00448448|75950031|FG001|NOT COMPLETED|Overall Study||41||
59826720|NCT00405912|75950040|FG000|STARTED|Overall Study||39||
59826721|NCT00405912|75950041|FG001|STARTED|Overall Study||40||
59826722|NCT00405912|75950042|FG002|STARTED|Overall Study||39||
59826723|NCT00405912|75950040|FG000|COMPLETED|Overall Study||23||
59826724|NCT00405912|75950041|FG001|COMPLETED|Overall Study||21||
59826725|NCT00405912|75950042|FG002|COMPLETED|Overall Study||23||
59826726|NCT00405912|75950040|FG000|NOT COMPLETED|Overall Study||16||
59826727|NCT00405912|75950041|FG001|NOT COMPLETED|Overall Study||19||
60117883|NCT03599518|76238917|FG001|COMPLETED|Overall Study||0||
60117884|NCT03599518|76238918|FG002|COMPLETED|Overall Study||0||
59826728|NCT00405912|75950042|FG002|NOT COMPLETED|Overall Study||16||
59826729|NCT00448136|75950052|FG000|STARTED|Overall Study||34||
59826730|NCT00448136|75950053|FG001|STARTED|Overall Study||49||
59826731|NCT00448136|75950052|FG000|COMPLETED|Overall Study||30||
59826732|NCT00448136|75950053|FG001|COMPLETED|Overall Study||41||
59826733|NCT00448136|75950052|FG000|NOT COMPLETED|Overall Study||4||
59826734|NCT00448136|75950053|FG001|NOT COMPLETED|Overall Study||8||
59826735|NCT00447902|75950061|FG000|STARTED|Overall Study||5||
59826736|NCT00447902|75950062|FG001|STARTED|Overall Study||6||
59826737|NCT00447902|75950061|FG000|COMPLETED|Overall Study||1||
59826738|NCT00447902|75950062|FG001|COMPLETED|Overall Study||0||
59826739|NCT00447902|75950061|FG000|NOT COMPLETED|Overall Study||4||
59826740|NCT00447902|75950062|FG001|NOT COMPLETED|Overall Study||6||
59826741|NCT00307437|75950071|FG000|STARTED|Controlled Period||410||
59826742|NCT00307437|75950072|FG001|STARTED|Controlled Period||409||
59826743|NCT00307437|75950073|FG002|STARTED|Controlled Period||411||
59826744|NCT00307437|75950074|FG003|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0||
59826745|NCT00307437|75950075|FG004|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0||
59826746|NCT00307437|75950076|FG005|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0||
59826747|NCT00307437|75950077|FG006|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0||
59826748|NCT00307437|75950071|FG000|COMPLETED|Controlled Period||394||
59826749|NCT00307437|75950072|FG001|COMPLETED|Controlled Period||403||
59826750|NCT00307437|75950073|FG002|COMPLETED|Controlled Period||402||
59826751|NCT00307437|75950074|FG003|COMPLETED|Controlled Period||0||
59826752|NCT00307437|75950075|FG004|COMPLETED|Controlled Period||0||
59826753|NCT00307437|75950076|FG005|COMPLETED|Controlled Period||0||
59826754|NCT00307437|75950077|FG006|COMPLETED|Controlled Period||0||
59826755|NCT00307437|75950071|FG000|NOT COMPLETED|Controlled Period||16||
59826756|NCT00307437|75950072|FG001|NOT COMPLETED|Controlled Period||6||
59826757|NCT00307437|75950073|FG002|NOT COMPLETED|Controlled Period||9||
59826758|NCT00307437|75950074|FG003|NOT COMPLETED|Controlled Period||0||
59826759|NCT00307437|75950075|FG004|NOT COMPLETED|Controlled Period||0||
59826760|NCT00307437|75950076|FG005|NOT COMPLETED|Controlled Period||0||
59826761|NCT00307437|75950077|FG006|NOT COMPLETED|Controlled Period||0||
59826762|NCT00307437|75950071|FG000|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0||
59826763|NCT00307437|75950072|FG001|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0||
59826764|NCT00307437|75950073|FG002|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0||
59826765|NCT00307437|75950074|FG003|STARTED|After Controlled Period||197||
59826766|NCT00307437|75950075|FG004|STARTED|After Controlled Period|2 participants from placebo group in CP did not crossover to this group after CP.|195||
59826767|NCT00307437|75950076|FG005|STARTED|After Controlled Period||403||
59826768|NCT00307437|75950077|FG006|STARTED|After Controlled Period||402||
59826769|NCT00307437|75950071|FG000|COMPLETED|After Controlled Period||0||
59826770|NCT00307437|75950072|FG001|COMPLETED|After Controlled Period||0||
59826771|NCT00307437|75950073|FG002|COMPLETED|After Controlled Period||0||
59826772|NCT00307437|75950074|FG003|COMPLETED|After Controlled Period||139||
59826773|NCT00307437|75950075|FG004|COMPLETED|After Controlled Period||140||
59826774|NCT00307437|75950076|FG005|COMPLETED|After Controlled Period||281||
59826775|NCT00307437|75950077|FG006|COMPLETED|After Controlled Period||289||
59826776|NCT00307437|75950071|FG000|NOT COMPLETED|After Controlled Period||0||
59826777|NCT00307437|75950072|FG001|NOT COMPLETED|After Controlled Period||0||
59826778|NCT00307437|75950073|FG002|NOT COMPLETED|After Controlled Period||0||
59826779|NCT00307437|75950074|FG003|NOT COMPLETED|After Controlled Period||58||
59826780|NCT00307437|75950075|FG004|NOT COMPLETED|After Controlled Period||55||
59826781|NCT00307437|75950076|FG005|NOT COMPLETED|After Controlled Period||122||
59826782|NCT00307437|75950077|FG006|NOT COMPLETED|After Controlled Period||113||
59826783|NCT00440726|75950102|FG000|STARTED|Phase 1||4||
59826784|NCT00440726|75950103|FG001|STARTED|Phase 1||6||
59826785|NCT00440726|75950104|FG002|STARTED|Phase 1||0||
59826786|NCT00440726|75950102|FG000|COMPLETED|Phase 1||3||
59826787|NCT00440726|75950103|FG001|COMPLETED|Phase 1||5||
59826788|NCT00440726|75950104|FG002|COMPLETED|Phase 1||0||
59826789|NCT00440726|75950102|FG000|NOT COMPLETED|Phase 1||1||
59826790|NCT00440726|75950103|FG001|NOT COMPLETED|Phase 1||1||
59826791|NCT00440726|75950104|FG002|NOT COMPLETED|Phase 1||0||
59826792|NCT00440726|75950102|FG000|STARTED|Phase 2||0||
59826793|NCT00440726|75950103|FG001|STARTED|Phase 2||0||
59826794|NCT00440726|75950104|FG002|STARTED|Phase 2||22||
59826795|NCT00440726|75950102|FG000|COMPLETED|Phase 2||0||
59826796|NCT00440726|75950103|FG001|COMPLETED|Phase 2||0||
59826797|NCT00440726|75950104|FG002|COMPLETED|Phase 2||20||
59826798|NCT00440726|75950102|FG000|NOT COMPLETED|Phase 2||0||
59826799|NCT00440726|75950103|FG001|NOT COMPLETED|Phase 2||0||
60117885|NCT03599518|76238919|FG003|COMPLETED|Overall Study||0||
59567392|NCT01880840|75670333|FG000|NOT COMPLETED|Overall Study||8||
59826800|NCT00440726|75950104|FG002|NOT COMPLETED|Phase 2||2||
59826801|NCT00447590|75950115|FG000|STARTED|Overall Study|153 participants were treated with the LAP-BAND System.|153||
59826802|NCT00447590|75950115|FG000|COMPLETED|Overall Study|Completing the study was defined as the number of participants in the study at month 60 (5 years).|93||
59826803|NCT00447590|75950115|FG000|NOT COMPLETED|Overall Study||60||
59826804|NCT00447278|75950121|FG000|STARTED|Period II (6 Month Open-Label)||199||
59826805|NCT00447278|75950122|FG001|STARTED|Period II (6 Month Open-Label)||200||
59826806|NCT00447278|75950121|FG000|Received at Least One Dose of Study Drug|Period II (6 Month Open-Label)||199||
59826807|NCT00447278|75950122|FG001|Received at Least One Dose of Study Drug|Period II (6 Month Open-Label)|1 patient withdrew due to parent/guardian decision prior to receiving study drug.|199||
59826808|NCT00447278|75950121|FG000|COMPLETED|Period II (6 Month Open-Label)||157||
59826809|NCT00447278|75950122|FG001|COMPLETED|Period II (6 Month Open-Label)||171||
59826810|NCT00447278|75950121|FG000|NOT COMPLETED|Period II (6 Month Open-Label)||42||
59826811|NCT00447278|75950122|FG001|NOT COMPLETED|Period II (6 Month Open-Label)||29||
59826812|NCT00447278|75950121|FG000|STARTED|Period III (Optional 6 Month Extension)|18 choose not to enter this optional period.|139||
59826813|NCT00447278|75950122|FG001|STARTED|Period III (Optional 6 Month Extension)|16 choose not to enter this optional period.|155||
59826814|NCT00447278|75950121|FG000|COMPLETED|Period III (Optional 6 Month Extension)||109||
59826815|NCT00447278|75950122|FG001|COMPLETED|Period III (Optional 6 Month Extension)||140||
59826816|NCT00447278|75950121|FG000|NOT COMPLETED|Period III (Optional 6 Month Extension)||30||
59826817|NCT00447278|75950122|FG001|NOT COMPLETED|Period III (Optional 6 Month Extension)||15||
59826818|NCT00446966|75950131|FG000|STARTED|Overall Study||130||
59826819|NCT00446966|75950132|FG001|STARTED|Overall Study||130||
59826820|NCT00446966|75950131|FG000|COMPLETED|Overall Study||120||
59826821|NCT00446966|75950132|FG001|COMPLETED|Overall Study||123||
59826822|NCT00446966|75950131|FG000|NOT COMPLETED|Overall Study||10||
59826823|NCT00446966|75950132|FG001|NOT COMPLETED|Overall Study||7||
59826824|NCT00446654|75950140|FG000|STARTED|Overall Study||21||
59826825|NCT00446654|75950141|FG001|STARTED|Overall Study||22||
59826826|NCT00446654|75950140|FG000|COMPLETED|Overall Study||19||
59826827|NCT00446654|75950141|FG001|COMPLETED|Overall Study||22||
59826828|NCT00446654|75950140|FG000|NOT COMPLETED|Overall Study||2||
59826829|NCT00446654|75950141|FG001|NOT COMPLETED|Overall Study||0||
59826830|NCT00405756|75950150|FG000|STARTED|Double-blind Treatment|Intent to treat population of all randomized participants|152||
59826831|NCT00405756|75950151|FG001|STARTED|Double-blind Treatment||153||
59826832|NCT00405756|75950152|FG002|STARTED|Double-blind Treatment||154||
59826833|NCT00405756|75950150|FG000|Safety Population|Double-blind Treatment|Participants who took at least one dose of study drug.|150||
59826834|NCT00405756|75950151|FG001|Safety Population|Double-blind Treatment||152||
59826835|NCT00405756|75950152|FG002|Safety Population|Double-blind Treatment||153||
59826836|NCT00405756|75950150|FG000|COMPLETED|Double-blind Treatment|Double-blind Treatment Period had no defined completion.|0||
59826837|NCT00405756|75950151|FG001|COMPLETED|Double-blind Treatment||0||
59826838|NCT00405756|75950152|FG002|COMPLETED|Double-blind Treatment||0||
59826839|NCT00405756|75950150|FG000|NOT COMPLETED|Double-blind Treatment||152||
59826840|NCT00405756|75950151|FG001|NOT COMPLETED|Double-blind Treatment||153||
59826841|NCT00405756|75950152|FG002|NOT COMPLETED|Double-blind Treatment||154||
59826842|NCT00405756|75950150|FG000|STARTED|Open-label Extension||19||
59826843|NCT00405756|75950151|FG001|STARTED|Open-label Extension||47||
59826844|NCT00405756|75950152|FG002|STARTED|Open-label Extension||72||
59826845|NCT00405756|75950150|FG000|COMPLETED|Open-label Extension|Participants continue until disease progression or other reason for discontinuing.|0||
59826846|NCT00405756|75950151|FG001|COMPLETED|Open-label Extension||0||
59826847|NCT00405756|75950152|FG002|COMPLETED|Open-label Extension||0||
59826848|NCT00405756|75950150|FG000|NOT COMPLETED|Open-label Extension||19||
59826849|NCT00405756|75950151|FG001|NOT COMPLETED|Open-label Extension||47||
59826850|NCT00405756|75950152|FG002|NOT COMPLETED|Open-label Extension||72||
59826851|NCT00405756|75950150|FG000|STARTED|Follow-up|66 participants from Double-blind and 9 from the Open Label Extension|75||
59826852|NCT00405756|75950151|FG001|STARTED|Follow-up|65 participants from the Double-blind and 25 from the Open Label Extension|90||
59826853|NCT00405756|75950152|FG002|STARTED|Follow-up|52 participants from the Double-blind and 36 from the Open Label Extension|88||
59826854|NCT00405756|75950150|FG000|COMPLETED|Follow-up||0||
59826855|NCT00405756|75950151|FG001|COMPLETED|Follow-up||0||
59826856|NCT00405756|75950152|FG002|COMPLETED|Follow-up||0||
59826857|NCT00405756|75950150|FG000|NOT COMPLETED|Follow-up||75||
59826858|NCT00405756|75950151|FG001|NOT COMPLETED|Follow-up||90||
59826859|NCT00405756|75950152|FG002|NOT COMPLETED|Follow-up||88||
59826860|NCT00456092|75950163|FG000|STARTED|Extension Phase|The Extension Phase was only open to participants enrolled after amendment 1 was in effect.|46||
59826861|NCT00456092|75950164|FG001|STARTED|Extension Phase|The Extension Phase was only open to participants enrolled after amendment 1 was in effect.|40||
59826862|NCT00456092|75950165|FG002|STARTED|Extension Phase||0||
59826863|NCT00456092|75950166|FG003|STARTED|Extension Phase|The Extension Phase was only open to participants enrolled after amendment 1 was in effect.|20||
59826864|NCT00456092|75950167|FG004|STARTED|Extension Phase|The Extension Phase was only open to participants enrolled after amendment 1 was in effect.|20||
59826865|NCT00456092|75950163|FG000|COMPLETED|Extension Phase||35||
59826866|NCT00456092|75950164|FG001|COMPLETED|Extension Phase||36||
59826867|NCT00456092|75950165|FG002|COMPLETED|Extension Phase||0||
59826868|NCT00456092|75950166|FG003|COMPLETED|Extension Phase||19||
59826869|NCT00456092|75950167|FG004|COMPLETED|Extension Phase||13||
59826870|NCT00456092|75950163|FG000|NOT COMPLETED|Extension Phase||11||
59826871|NCT00456092|75950164|FG001|NOT COMPLETED|Extension Phase||4||
59826872|NCT00456092|75950165|FG002|NOT COMPLETED|Extension Phase||0||
59826873|NCT00456092|75950166|FG003|NOT COMPLETED|Extension Phase||1||
59826874|NCT00456092|75950167|FG004|NOT COMPLETED|Extension Phase||7||
59826875|NCT00456092|75950163|FG000|STARTED|Treatment Phase (12 Weeks)||67||
59826876|NCT00456092|75950164|FG001|STARTED|Treatment Phase (12 Weeks)||69||
59826877|NCT00456092|75950165|FG002|STARTED|Treatment Phase (12 Weeks)||68||
59826878|NCT00456092|75950166|FG003|STARTED|Treatment Phase (12 Weeks)||0||
59826879|NCT00456092|75950167|FG004|STARTED|Treatment Phase (12 Weeks)||0||
59826880|NCT00456092|75950163|FG000|COMPLETED|Treatment Phase (12 Weeks)||60||
59826881|NCT00456092|75950164|FG001|COMPLETED|Treatment Phase (12 Weeks)||55||
59826882|NCT00456092|75950165|FG002|COMPLETED|Treatment Phase (12 Weeks)||50||
59826883|NCT00456092|75950166|FG003|COMPLETED|Treatment Phase (12 Weeks)||0||
59826884|NCT00456092|75950167|FG004|COMPLETED|Treatment Phase (12 Weeks)||0||
59826885|NCT00456092|75950163|FG000|NOT COMPLETED|Treatment Phase (12 Weeks)||7||
59826886|NCT00456092|75950164|FG001|NOT COMPLETED|Treatment Phase (12 Weeks)||14||
59826887|NCT00456092|75950165|FG002|NOT COMPLETED|Treatment Phase (12 Weeks)||18||
59826888|NCT00456092|75950166|FG003|NOT COMPLETED|Treatment Phase (12 Weeks)||0||
59826889|NCT00456092|75950167|FG004|NOT COMPLETED|Treatment Phase (12 Weeks)||0||
59826890|NCT00411450|75950181|FG000|STARTED|Overall Study||116||
59826891|NCT00411450|75950181|FG000|Received Treatment|Overall Study||115||
59826892|NCT00411450|75950181|FG000|COMPLETED|Overall Study|Ended second-line treatment|113||
59826893|NCT00411450|75950181|FG000|NOT COMPLETED|Overall Study||3||
59826894|NCT00404820|75950189|FG000|STARTED|Overall Study||408||
59826895|NCT00404820|75950190|FG001|STARTED|Overall Study||196||
59826896|NCT00404820|75950189|FG000|Started Treatment|Overall Study||408||
59826897|NCT00404820|75950190|FG001|Started Treatment|Overall Study|The reason why 2 patients did not start treatment is unavailable.|194||
59826898|NCT00404820|75950189|FG000|COMPLETED|Overall Study||389||
59826899|NCT00404820|75950190|FG001|COMPLETED|Overall Study||172||
59826900|NCT00404820|75950189|FG000|NOT COMPLETED|Overall Study||19||
59826901|NCT00404820|75950190|FG001|NOT COMPLETED|Overall Study||24||
59826902|NCT00417612|75950198|FG000|STARTED|Overall Study||22||
59826903|NCT00417612|75950199|FG001|STARTED|Overall Study||11||
59826904|NCT00417612|75950198|FG000|COMPLETED|Overall Study||19||
59826905|NCT00417612|75950199|FG001|COMPLETED|Overall Study||8||
59826906|NCT00417612|75950198|FG000|NOT COMPLETED|Overall Study||3||
59826907|NCT00417612|75950199|FG001|NOT COMPLETED|Overall Study||3||
59826908|NCT00446030|75950209|FG000|STARTED|TREATMENT (up to 52 Weeks)||93||
59826909|NCT00446030|75950210|FG001|STARTED|TREATMENT (up to 52 Weeks)||34||
59826910|NCT00446030|75950209|FG000|RECEIVED TREATMENT|TREATMENT (up to 52 Weeks)||92||
59826911|NCT00446030|75950210|FG001|RECEIVED TREATMENT|TREATMENT (up to 52 Weeks)||34||
59826912|NCT00446030|75950209|FG000|COMPLETED|TREATMENT (up to 52 Weeks)|Participants who completed treatment|49||
59826913|NCT00446030|75950210|FG001|COMPLETED|TREATMENT (up to 52 Weeks)|Participants who completed treatment|25||
59826914|NCT00446030|75950209|FG000|NOT COMPLETED|TREATMENT (up to 52 Weeks)||44||
59826915|NCT00446030|75950210|FG001|NOT COMPLETED|TREATMENT (up to 52 Weeks)||9||
59826916|NCT00446030|75950209|FG000|STARTED|FOLLOW-UP (up to 2-years)|All participants, including those who discontinued treatment, continued to the follow-up period.|93||
59826917|NCT00446030|75950210|FG001|STARTED|FOLLOW-UP (up to 2-years)||34||
59826918|NCT00446030|75950209|FG000|COMPLETED|FOLLOW-UP (up to 2-years)||63||
59715857|NCT01146288|75834577|FG000|COMPLETED|First Intervention(1 Day)||7||
59715858|NCT01146288|75834578|FG001|COMPLETED|First Intervention(1 Day)||5||
59715859|NCT01146288|75834577|FG000|NOT COMPLETED|First Intervention(1 Day)||0||
59715860|NCT01146288|75834578|FG001|NOT COMPLETED|First Intervention(1 Day)||1||
59715861|NCT01146288|75834577|FG000|STARTED|Second Intervention (1 Day)||7||
59715862|NCT01146288|75834578|FG001|STARTED|Second Intervention (1 Day)||5||
59715863|NCT01146288|75834577|FG000|COMPLETED|Second Intervention (1 Day)||7||
59715864|NCT01146288|75834578|FG001|COMPLETED|Second Intervention (1 Day)||5||
59826919|NCT00446030|75950210|FG001|COMPLETED|FOLLOW-UP (up to 2-years)||25||
59826920|NCT00446030|75950209|FG000|NOT COMPLETED|FOLLOW-UP (up to 2-years)||30||
59826921|NCT00446030|75950210|FG001|NOT COMPLETED|FOLLOW-UP (up to 2-years)||9||
59826922|NCT00411216|75950218|FG000|STARTED|Overall Study||13||
59826923|NCT00411216|75950219|FG001|STARTED|Overall Study||10||
59826924|NCT00411216|75950218|FG000|COMPLETED|Overall Study||13||
59826925|NCT00411216|75950219|FG001|COMPLETED|Overall Study||8||
59826926|NCT00411216|75950218|FG000|NOT COMPLETED|Overall Study||0||
59826927|NCT00411216|75950219|FG001|NOT COMPLETED|Overall Study||2||
59826928|NCT00410514|75950228|FG000|STARTED|Overall Study||65||
59826929|NCT00410514|75950229|FG001|STARTED|Overall Study||70||
59826930|NCT00410514|75950230|FG002|STARTED|Overall Study||65||
59826931|NCT00410514|75950228|FG000|Safety Analysis Set (SAF)|Overall Study|All patients who received at least 1 dose of double-blind study drug.|65||
59826932|NCT00410514|75950229|FG001|Safety Analysis Set (SAF)|Overall Study|All patients who received at least 1 dose of double-blind study drug.|70||
59826933|NCT00410514|75950230|FG002|Safety Analysis Set (SAF)|Overall Study|All patients who received at least 1 dose of double-blind study drug.|65||
59826934|NCT00410514|75950228|FG000|Full Analysis Set (FAS)|Overall Study|SAF patients with both Qmax & PdetQmax measurements at baseline and 1 or both measured postbaseline.|63||
59826935|NCT00410514|75950229|FG001|Full Analysis Set (FAS)|Overall Study|SAF patients with both Qmax & PdetQmax measurements at baseline and 1 or both measured postbaseline.|64||
59826936|NCT00410514|75950230|FG002|Full Analysis Set (FAS)|Overall Study|SAF patients with both Qmax & PdetQmax measurements at baseline and 1 or both measured postbaseline.|58||
59826937|NCT00410514|75950228|FG000|COMPLETED|Overall Study||63||
59826938|NCT00410514|75950229|FG001|COMPLETED|Overall Study||67||
59826939|NCT00410514|75950230|FG002|COMPLETED|Overall Study||58||
59826940|NCT00410514|75950228|FG000|NOT COMPLETED|Overall Study||2||
59826941|NCT00410514|75950229|FG001|NOT COMPLETED|Overall Study||3||
59826942|NCT00410514|75950230|FG002|NOT COMPLETED|Overall Study||7||
59826943|NCT03847610|75950238|FG000|STARTED|Overall Study||11||
59826944|NCT03847610|75950238|FG000|COMPLETED|Overall Study||10||
59826945|NCT03847610|75950238|FG000|NOT COMPLETED|Overall Study||1||
59826946|NCT03843632|75950246|FG000|STARTED|Overall Study||50||
59826947|NCT03843632|75950247|FG001|STARTED|Overall Study||30||
59826948|NCT03843632|75950248|FG002|STARTED|Overall Study||33||
59826949|NCT03843632|75950249|FG003|STARTED|Overall Study||37||
59826950|NCT03843632|75950246|FG000|Vaccination 1|Overall Study||50||
59826951|NCT03843632|75950247|FG001|Vaccination 1|Overall Study||30||
59826952|NCT03843632|75950248|FG002|Vaccination 1|Overall Study||33||
59826953|NCT03843632|75950249|FG003|Vaccination 1|Overall Study||37||
59826954|NCT03843632|75950246|FG000|Vaccination 2|Overall Study||49||
59826955|NCT03843632|75950247|FG001|Vaccination 2|Overall Study||30||
59826956|NCT03843632|75950248|FG002|Vaccination 2|Overall Study||0||
59826957|NCT03843632|75950249|FG003|Vaccination 2|Overall Study||0||
59826958|NCT03843632|75950246|FG000|COMPLETED|Overall Study||49||
59826959|NCT03843632|75950247|FG001|COMPLETED|Overall Study||30||
59826960|NCT03843632|75950248|FG002|COMPLETED|Overall Study||33||
59826961|NCT03843632|75950249|FG003|COMPLETED|Overall Study||37||
59826962|NCT03843632|75950246|FG000|NOT COMPLETED|Overall Study||1||
59826963|NCT03843632|75950247|FG001|NOT COMPLETED|Overall Study||0||
59826964|NCT03843632|75950248|FG002|NOT COMPLETED|Overall Study||0||
59826965|NCT03843632|75950249|FG003|NOT COMPLETED|Overall Study||0||
59826966|NCT00455858|75950259|FG000|STARTED|Overall Study|Enrolled in study and exposed to study drug|87||
59826967|NCT00455858|75950259|FG000|COMPLETED|Overall Study||81||
59826968|NCT00455858|75950259|FG000|NOT COMPLETED|Overall Study||6||
59826969|NCT00439556|75950266|FG000|STARTED|Overall Study||36||
59826970|NCT00439556|75950267|FG001|STARTED|Overall Study||4||
59826971|NCT00439556|75950268|FG002|STARTED|Overall Study||0||
59826972|NCT00439556|75950266|FG000|COMPLETED|Overall Study||36||
59826973|NCT00439556|75950267|FG001|COMPLETED|Overall Study||3||
59826974|NCT00439556|75950268|FG002|COMPLETED|Overall Study||0||
59826975|NCT00439556|75950266|FG000|NOT COMPLETED|Overall Study||0||
59826976|NCT00439556|75950267|FG001|NOT COMPLETED|Overall Study||1||
59826977|NCT00439556|75950268|FG002|NOT COMPLETED|Overall Study||0||
59826978|NCT00410202|75950280|FG000|STARTED|On-Treatment||138||
59826979|NCT00410202|75950281|FG001|STARTED|On-Treatment||140||
59826980|NCT00410202|75950282|FG002|STARTED|On-Treatment||137||
59826981|NCT00410202|75950280|FG000|Discontinued Prior to Week 48 Visit|On-Treatment||4||
59826982|NCT00410202|75950281|FG001|Discontinued Prior to Week 48 Visit|On-Treatment||2||
59826983|NCT00410202|75950282|FG002|Discontinued Prior to Week 48 Visit|On-Treatment||2||
59826984|NCT00410202|75950280|FG000|Discontinued at or After Week 48 Visit|On-Treatment||2||
59826985|NCT00410202|75950281|FG001|Discontinued at or After Week 48 Visit|On-Treatment||6||
59826986|NCT00410202|75950282|FG002|Discontinued at or After Week 48 Visit|On-Treatment||3||
59567393|NCT01880840|75670334|FG001|NOT COMPLETED|Overall Study||5||
59826987|NCT00410202|75950280|FG000|COMPLETED|On-Treatment|Completed the 100 week dosing|63||
59826988|NCT00410202|75950281|FG001|COMPLETED|On-Treatment|Completed the 100 week dosing|61||
59567394|NCT03795753|75670342|FG000|STARTED|Overall Study||23||
59567395|NCT03795753|75670343|FG001|STARTED|Overall Study||13||
59715865|NCT01146288|75834577|FG000|NOT COMPLETED|Second Intervention (1 Day)||0||
59715866|NCT01146288|75834578|FG001|NOT COMPLETED|Second Intervention (1 Day)||0||
59715867|NCT01146054|75834585|FG000|STARTED|Overall Study||59||
59715868|NCT01146054|75834585|FG000|COMPLETED|Overall Study||49||
59715869|NCT01146054|75834585|FG000|NOT COMPLETED|Overall Study||10||
59715870|NCT01145898|75834591|FG000|STARTED|6-month Treatment||12||
59715871|NCT01145898|75834592|FG001|STARTED|6-month Treatment||44||
59715872|NCT01145898|75834591|FG000|COMPLETED|6-month Treatment||12||
59715873|NCT01145898|75834592|FG001|COMPLETED|6-month Treatment||44||
59715874|NCT01145898|75834591|FG000|NOT COMPLETED|6-month Treatment||0||
59715875|NCT01145898|75834592|FG001|NOT COMPLETED|6-month Treatment||0||
59715876|NCT01145898|75834591|FG000|STARTED|3-year Treatment||12||
59715877|NCT01145898|75834592|FG001|STARTED|3-year Treatment||44||
59715878|NCT01145898|75834591|FG000|COMPLETED|3-year Treatment||9||
59715879|NCT01145898|75834592|FG001|COMPLETED|3-year Treatment||28||
59826989|NCT00410202|75950282|FG002|COMPLETED|On-Treatment|Completed the 100 week dosing|66||
59826990|NCT00410202|75950280|FG000|NOT COMPLETED|On-Treatment||75||
59826991|NCT00410202|75950281|FG001|NOT COMPLETED|On-Treatment||79||
59826992|NCT00410202|75950282|FG002|NOT COMPLETED|On-Treatment||71||
59826993|NCT00410202|75950280|FG000|STARTED|Off-treatment Follow up||15||
59826994|NCT00410202|75950281|FG001|STARTED|Off-treatment Follow up||8||
59826995|NCT00410202|75950282|FG002|STARTED|Off-treatment Follow up||14||
59826996|NCT00410202|75950280|FG000|COMPLETED|Off-treatment Follow up||1||
59826997|NCT00410202|75950281|FG001|COMPLETED|Off-treatment Follow up||0||
59826998|NCT00410202|75950282|FG002|COMPLETED|Off-treatment Follow up||2||
59826999|NCT00410202|75950280|FG000|NOT COMPLETED|Off-treatment Follow up||14||
59827000|NCT00410202|75950281|FG001|NOT COMPLETED|Off-treatment Follow up||8||
59827001|NCT00410202|75950282|FG002|NOT COMPLETED|Off-treatment Follow up||12||
59827002|NCT00445328|75950293|FG000|STARTED|Overall Study||42||
59827003|NCT00445328|75950294|FG001|STARTED|Overall Study||42||
59827004|NCT00445328|75950293|FG000|Received Treatment|Overall Study|1 subject discontinued after enrollment but prior to study treatment.|41||
59827005|NCT00445328|75950294|FG001|Received Treatment|Overall Study||42||
59827006|NCT00445328|75950293|FG000|COMPLETED|Overall Study||39||
59827007|NCT00445328|75950294|FG001|COMPLETED|Overall Study||36||
59827008|NCT00445328|75950293|FG000|NOT COMPLETED|Overall Study||3||
59827009|NCT00445328|75950294|FG001|NOT COMPLETED|Overall Study||6||
59827010|NCT00455312|75950302|FG000|STARTED|Overall Study||15||
59827011|NCT00455312|75950303|FG001|STARTED|Overall Study||21||
59827012|NCT00455312|75950302|FG000|COMPLETED|Overall Study||15||
59827013|NCT00455312|75950303|FG001|COMPLETED|Overall Study||20||
59827014|NCT00455312|75950302|FG000|NOT COMPLETED|Overall Study||0||
59827015|NCT00455312|75950303|FG001|NOT COMPLETED|Overall Study||1||
59827016|NCT00444626|75950309|FG000|STARTED|Initial Treatment Period||140||
59827017|NCT00444626|75950309|FG000|COMPLETED|Initial Treatment Period||128||
59827018|NCT00444626|75950309|FG000|NOT COMPLETED|Initial Treatment Period||12||
59827019|NCT00444626|75950309|FG000|STARTED|Repeat Treatment Period|23 subjects withdrew after completing the Initial Treatment and did not enter the Repeat Treatment|105||
59827020|NCT00444626|75950309|FG000|COMPLETED|Repeat Treatment Period||105||
59827021|NCT00444626|75950309|FG000|NOT COMPLETED|Repeat Treatment Period||0||
59827022|NCT04748120|75950324|FG000|STARTED|Overall Study||1||
59827023|NCT04748120|75950325|FG001|STARTED|Overall Study||1||
59827024|NCT04748120|75950324|FG000|COMPLETED|Overall Study||1||
59827025|NCT04748120|75950325|FG001|COMPLETED|Overall Study||1||
59827026|NCT04748120|75950324|FG000|NOT COMPLETED|Overall Study||0||
59827027|NCT04748120|75950325|FG001|NOT COMPLETED|Overall Study||0||
59827028|NCT00404352|75950336|FG000|STARTED|Double Blind (up to 24 Month)||171||
59827029|NCT00404352|75950337|FG001|STARTED|Double Blind (up to 24 Month)||175||
59827030|NCT00404352|75950338|FG002|STARTED|Double Blind (up to 24 Month)||171||
59827031|NCT00404352|75950339|FG003|STARTED|Double Blind (up to 24 Month)||0||
59827032|NCT00404352|75950340|FG004|STARTED|Double Blind (up to 24 Month)||0||
59827033|NCT00404352|75950341|FG005|STARTED|Double Blind (up to 24 Month)||0||
59827034|NCT00404352|75950342|FG006|STARTED|Double Blind (up to 24 Month)||0||
59827035|NCT00404352|75950343|FG007|STARTED|Double Blind (up to 24 Month)||0||
59827036|NCT00404352|75950344|FG008|STARTED|Double Blind (up to 24 Month)||0||
59827037|NCT00404352|75950336|FG000|Treated|Double Blind (up to 24 Month)||171||
59827038|NCT00404352|75950337|FG001|Treated|Double Blind (up to 24 Month)||173||
59827039|NCT00404352|75950338|FG002|Treated|Double Blind (up to 24 Month)||171||
59827040|NCT00404352|75950339|FG003|Treated|Double Blind (up to 24 Month)||0||
59827041|NCT00404352|75950340|FG004|Treated|Double Blind (up to 24 Month)||0||
59827042|NCT00404352|75950341|FG005|Treated|Double Blind (up to 24 Month)||0||
59827043|NCT00404352|75950342|FG006|Treated|Double Blind (up to 24 Month)||0||
59827044|NCT00404352|75950343|FG007|Treated|Double Blind (up to 24 Month)||0||
59827045|NCT00404352|75950344|FG008|Treated|Double Blind (up to 24 Month)||0||
59827046|NCT00404352|75950336|FG000|COMPLETED|Double Blind (up to 24 Month)||119||
59827047|NCT00404352|75950337|FG001|COMPLETED|Double Blind (up to 24 Month)||128||
59827048|NCT00404352|75950338|FG002|COMPLETED|Double Blind (up to 24 Month)||92||
59827049|NCT00404352|75950339|FG003|COMPLETED|Double Blind (up to 24 Month)||0||
59827050|NCT00404352|75950340|FG004|COMPLETED|Double Blind (up to 24 Month)||0||
59827051|NCT00404352|75950341|FG005|COMPLETED|Double Blind (up to 24 Month)||0||
59827052|NCT00404352|75950342|FG006|COMPLETED|Double Blind (up to 24 Month)||0||
59827053|NCT00404352|75950343|FG007|COMPLETED|Double Blind (up to 24 Month)||0||
59827054|NCT00404352|75950344|FG008|COMPLETED|Double Blind (up to 24 Month)||0||
59827055|NCT00404352|75950336|FG000|NOT COMPLETED|Double Blind (up to 24 Month)||52||
59827056|NCT00404352|75950337|FG001|NOT COMPLETED|Double Blind (up to 24 Month)||47||
59827057|NCT00404352|75950338|FG002|NOT COMPLETED|Double Blind (up to 24 Month)||79||
59827058|NCT00404352|75950339|FG003|NOT COMPLETED|Double Blind (up to 24 Month)||0||
59827059|NCT00404352|75950340|FG004|NOT COMPLETED|Double Blind (up to 24 Month)||0||
59827060|NCT00404352|75950341|FG005|NOT COMPLETED|Double Blind (up to 24 Month)||0||
60117886|NCT03599518|76238920|FG004|COMPLETED|Overall Study||0||
60117887|NCT03599518|76238916|FG000|NOT COMPLETED|Overall Study||5||
60117888|NCT03599518|76238917|FG001|NOT COMPLETED|Overall Study||4||
60117889|NCT03599518|76238918|FG002|NOT COMPLETED|Overall Study||6||
60117890|NCT03599518|76238919|FG003|NOT COMPLETED|Overall Study||1||
59827061|NCT00404352|75950342|FG006|NOT COMPLETED|Double Blind (up to 24 Month)||0||
59827062|NCT00404352|75950343|FG007|NOT COMPLETED|Double Blind (up to 24 Month)||0||
60117891|NCT03599518|76238920|FG004|NOT COMPLETED|Overall Study||4||
60117892|NCT03099486|76238932|FG000|STARTED|Overall Study||2||
60117893|NCT03099486|76238932|FG000|COMPLETED|Overall Study||2||
59827063|NCT00404352|75950344|FG008|NOT COMPLETED|Double Blind (up to 24 Month)||0||
59827064|NCT00404352|75950336|FG000|STARTED|Open Label (up to 24 Month)||0||
59827065|NCT00404352|75950337|FG001|STARTED|Open Label (up to 24 Month)||0||
59827066|NCT00404352|75950338|FG002|STARTED|Open Label (up to 24 Month)||0||
59827067|NCT00404352|75950339|FG003|STARTED|Open Label (up to 24 Month)|From DB period, 31 participants converted to CDMS and switched to OL period in this study|31||
59827068|NCT00404352|75950340|FG004|STARTED|Open Label (up to 24 Month)|From DB period, 30 participants converted to CDMS and switched to OL period in this study|30||
59827069|NCT00404352|75950341|FG005|STARTED|Open Label (up to 24 Month)|From DB period, 59 participants converted to CDMS and switched to OL period in this study|59||
59827070|NCT00404352|75950342|FG006|STARTED|Open Label (up to 24 Month)||0||
59827071|NCT00404352|75950343|FG007|STARTED|Open Label (up to 24 Month)||0||
59827072|NCT00404352|75950344|FG008|STARTED|Open Label (up to 24 Month)||0||
59827073|NCT00404352|75950336|FG000|COMPLETED|Open Label (up to 24 Month)||0||
59827074|NCT00404352|75950337|FG001|COMPLETED|Open Label (up to 24 Month)||0||
59827075|NCT00404352|75950338|FG002|COMPLETED|Open Label (up to 24 Month)||0||
59827076|NCT00404352|75950339|FG003|COMPLETED|Open Label (up to 24 Month)||28||
59827077|NCT00404352|75950340|FG004|COMPLETED|Open Label (up to 24 Month)||28||
59827078|NCT00404352|75950341|FG005|COMPLETED|Open Label (up to 24 Month)||52||
59827079|NCT00404352|75950342|FG006|COMPLETED|Open Label (up to 24 Month)||0||
59827080|NCT00404352|75950343|FG007|COMPLETED|Open Label (up to 24 Month)||0||
59827081|NCT00404352|75950344|FG008|COMPLETED|Open Label (up to 24 Month)||0||
59827082|NCT00404352|75950336|FG000|NOT COMPLETED|Open Label (up to 24 Month)||0||
59827083|NCT00404352|75950337|FG001|NOT COMPLETED|Open Label (up to 24 Month)||0||
59827084|NCT00404352|75950338|FG002|NOT COMPLETED|Open Label (up to 24 Month)||0||
59827085|NCT00404352|75950339|FG003|NOT COMPLETED|Open Label (up to 24 Month)||3||
59827086|NCT00404352|75950340|FG004|NOT COMPLETED|Open Label (up to 24 Month)||2||
59827087|NCT00404352|75950341|FG005|NOT COMPLETED|Open Label (up to 24 Month)||7||
59827088|NCT00404352|75950342|FG006|NOT COMPLETED|Open Label (up to 24 Month)||0||
59827089|NCT00404352|75950343|FG007|NOT COMPLETED|Open Label (up to 24 Month)||0||
59827090|NCT00404352|75950344|FG008|NOT COMPLETED|Open Label (up to 24 Month)||0||
59827091|NCT00404352|75950336|FG000|STARTED|Open Label Extension (up to 36 Months)||0||
59827092|NCT00404352|75950337|FG001|STARTED|Open Label Extension (up to 36 Months)||0||
59827093|NCT00404352|75950338|FG002|STARTED|Open Label Extension (up to 36 Months)||0||
59827094|NCT00404352|75950339|FG003|STARTED|Open Label Extension (up to 36 Months)||0||
59827095|NCT00404352|75950340|FG004|STARTED|Open Label Extension (up to 36 Months)||0||
59827096|NCT00404352|75950341|FG005|STARTED|Open Label Extension (up to 36 Months)||0||
59827097|NCT00404352|75950342|FG006|STARTED|Open Label Extension (up to 36 Months)|4 participants who did not convert to CDMS in 24 months and gave consent to enroll in OLE period|4||
59827098|NCT00404352|75950343|FG007|STARTED|Open Label Extension (up to 36 Months)|5 participants who did not convert to CDMS in 24 months and gave consent to enroll in OLE period|5||
59827099|NCT00404352|75950344|FG008|STARTED|Open Label Extension (up to 36 Months)|11 participants who did not convert to CDMS in 24 months and gave consent to enroll in OLE period|11||
59827100|NCT00404352|75950336|FG000|COMPLETED|Open Label Extension (up to 36 Months)||0||
59827101|NCT00404352|75950337|FG001|COMPLETED|Open Label Extension (up to 36 Months)||0||
59715880|NCT01145898|75834591|FG000|NOT COMPLETED|3-year Treatment||3||
59715881|NCT01145898|75834592|FG001|NOT COMPLETED|3-year Treatment||16||
59715882|NCT01133418|75834599|FG000|STARTED|Overall Study||34||
59715883|NCT01133418|75834600|FG001|STARTED|Overall Study||38||
59715884|NCT01133418|75834599|FG000|COMPLETED|Overall Study||29||
59715885|NCT01133418|75834600|FG001|COMPLETED|Overall Study||32||
59715886|NCT01133418|75834599|FG000|NOT COMPLETED|Overall Study||5||
59715887|NCT01133418|75834600|FG001|NOT COMPLETED|Overall Study||6||
59715888|NCT00931918|75834608|FG000|STARTED|Overall Study||103||
59715889|NCT00931918|75834609|FG001|STARTED|Overall Study||103||
59715890|NCT00931918|75834608|FG000|Safety Population: Received Study Drug|Overall Study||100||
59715891|NCT00931918|75834609|FG001|Safety Population: Received Study Drug|Overall Study||101||
59715892|NCT00931918|75834608|FG000|COMPLETED|Overall Study|Completed the maximum of 6 cycles.|86||
59827102|NCT00404352|75950338|FG002|COMPLETED|Open Label Extension (up to 36 Months)||0||
59827103|NCT00404352|75950339|FG003|COMPLETED|Open Label Extension (up to 36 Months)||0||
59827104|NCT00404352|75950340|FG004|COMPLETED|Open Label Extension (up to 36 Months)||0||
59827105|NCT00404352|75950341|FG005|COMPLETED|Open Label Extension (up to 36 Months)||0||
59827106|NCT00404352|75950342|FG006|COMPLETED|Open Label Extension (up to 36 Months)||3||
59715893|NCT00931918|75834609|FG001|COMPLETED|Overall Study|Completed the maximum of 6 cycles.|86||
59715894|NCT00931918|75834608|FG000|NOT COMPLETED|Overall Study||17||
59715895|NCT00931918|75834609|FG001|NOT COMPLETED|Overall Study||17||
59715896|NCT01179191|75834615|FG000|STARTED|Titration Phase (up to 6 Weeks)||684||
59715897|NCT01179191|75834615|FG000|COMPLETED|Titration Phase (up to 6 Weeks)||351||
59715898|NCT01179191|75834615|FG000|NOT COMPLETED|Titration Phase (up to 6 Weeks)||333||
59715899|NCT01179191|75834615|FG000|STARTED|Maintenance Phase (8 Weeks)||351||
59715900|NCT01179191|75834615|FG000|COMPLETED|Maintenance Phase (8 Weeks)||234||
59827107|NCT00404352|75950343|FG007|COMPLETED|Open Label Extension (up to 36 Months)||4||
59827108|NCT00404352|75950344|FG008|COMPLETED|Open Label Extension (up to 36 Months)||9||
59827109|NCT00404352|75950336|FG000|NOT COMPLETED|Open Label Extension (up to 36 Months)||0||
59827110|NCT00404352|75950337|FG001|NOT COMPLETED|Open Label Extension (up to 36 Months)||0||
59827111|NCT00404352|75950338|FG002|NOT COMPLETED|Open Label Extension (up to 36 Months)||0||
59827112|NCT00404352|75950339|FG003|NOT COMPLETED|Open Label Extension (up to 36 Months)||0||
59827113|NCT00404352|75950340|FG004|NOT COMPLETED|Open Label Extension (up to 36 Months)||0||
59827114|NCT00404352|75950341|FG005|NOT COMPLETED|Open Label Extension (up to 36 Months)||0||
59715901|NCT01179191|75834615|FG000|NOT COMPLETED|Maintenance Phase (8 Weeks)||117||
59715902|NCT01169844|75834621|FG000|STARTED|Overall Study||19||
59715903|NCT01169844|75834622|FG001|STARTED|Overall Study||9||
59715904|NCT01169844|75834621|FG000|COMPLETED|Overall Study||14||
59715905|NCT01169844|75834622|FG001|COMPLETED|Overall Study||8||
59715906|NCT01169844|75834621|FG000|NOT COMPLETED|Overall Study||5||
59715907|NCT01169844|75834622|FG001|NOT COMPLETED|Overall Study||1||
59715908|NCT01132482|75834630|FG000|STARTED|Overall Study||13||
59715909|NCT01132482|75834631|FG001|STARTED|Overall Study||6||
59715910|NCT01132482|75834630|FG000|COMPLETED|Overall Study||12||
59715911|NCT01132482|75834631|FG001|COMPLETED|Overall Study||6||
59715912|NCT01132482|75834630|FG000|NOT COMPLETED|Overall Study||1||
59827115|NCT00404352|75950342|FG006|NOT COMPLETED|Open Label Extension (up to 36 Months)||1||
59827116|NCT00404352|75950343|FG007|NOT COMPLETED|Open Label Extension (up to 36 Months)||1||
59827117|NCT00404352|75950344|FG008|NOT COMPLETED|Open Label Extension (up to 36 Months)||2||
59827118|NCT00439244|75950364|FG000|STARTED|Overall Study|"Started indicates randomized as well as intent to treat (ITT) population enrolled to study."|137||
59827119|NCT00439244|75950365|FG001|STARTED|Overall Study||137||
59827120|NCT00439244|75950366|FG002|STARTED|Overall Study||138||
59827121|NCT00439244|75950364|FG000|Safety Population|Overall Study|Total safety population is 411. One patient was randomized, but never received any study medication.|137||
59827122|NCT00439244|75950365|FG001|Safety Population|Overall Study||137||
59827123|NCT00439244|75950366|FG002|Safety Population|Overall Study||137||
59827124|NCT00439244|75950364|FG000|COMPLETED|Overall Study||126||
60117894|NCT03099486|76238932|FG000|NOT COMPLETED|Overall Study||0||
60117895|NCT00105027|76238942|FG000|STARTED|Overall Study||88||
59715913|NCT01132482|75834631|FG001|NOT COMPLETED|Overall Study||0||
59715914|NCT00931762|75834637|FG000|STARTED|Overall Study||35||
59715915|NCT00931762|75834637|FG000|COMPLETED|Overall Study||0||
59715916|NCT00931762|75834637|FG000|NOT COMPLETED|Overall Study||35||
59827125|NCT00439244|75950365|FG001|COMPLETED|Overall Study||131||
59827126|NCT00439244|75950366|FG002|COMPLETED|Overall Study||131||
59827127|NCT00439244|75950364|FG000|NOT COMPLETED|Overall Study||11||
59827128|NCT00439244|75950365|FG001|NOT COMPLETED|Overall Study||6||
59827129|NCT00439244|75950366|FG002|NOT COMPLETED|Overall Study||7||
59827130|NCT03794024|75950376|FG000|STARTED|Overall Study||1||
59827131|NCT03794024|75950377|FG001|STARTED|Overall Study||0||
59827132|NCT03794024|75950376|FG000|COMPLETED|Overall Study||0||
59827133|NCT03794024|75950377|FG001|COMPLETED|Overall Study||0||
59827134|NCT03794024|75950376|FG000|NOT COMPLETED|Overall Study||1||
59827135|NCT03794024|75950377|FG001|NOT COMPLETED|Overall Study||0||
59827136|NCT00438464|75950385|FG000|STARTED|Overall Study||103||
59827137|NCT00438464|75950386|FG001|STARTED|Overall Study||101||
59827138|NCT00438464|75950385|FG000|Received Assigned Intervention|Overall Study||89||
59827139|NCT00438464|75950386|FG001|Received Assigned Intervention|Overall Study||94||
59827140|NCT00438464|75950385|FG000|COMPLETED|Overall Study||89||
59827141|NCT00438464|75950386|FG001|COMPLETED|Overall Study||94||
59827142|NCT00438464|75950385|FG000|NOT COMPLETED|Overall Study||14||
59827143|NCT00438464|75950386|FG001|NOT COMPLETED|Overall Study||7||
59827144|NCT00437294|75950406|FG000|STARTED|Overall Study||43||
59827145|NCT00437294|75950407|FG001|STARTED|Overall Study||43||
59827146|NCT00437294|75950406|FG000|Received at Least 1 Dose of Study Drug|Overall Study||42||
59827147|NCT00437294|75950407|FG001|Received at Least 1 Dose of Study Drug|Overall Study||43||
59827148|NCT00437294|75950406|FG000|COMPLETED|Overall Study||0||
59827149|NCT00437294|75950407|FG001|COMPLETED|Overall Study||0||
59827150|NCT00437294|75950406|FG000|NOT COMPLETED|Overall Study||43||
59827151|NCT00437294|75950407|FG001|NOT COMPLETED|Overall Study||43||
59827152|NCT00436982|75950421|FG000|STARTED|Overall Study||30||
59827153|NCT00436982|75950422|FG001|STARTED|Overall Study||30||
59827154|NCT00436982|75950421|FG000|COMPLETED|Overall Study||26|Completed/Not completed counts based on participants status at the 2 year primary outcome interval|
60117896|NCT00105027|76238943|FG001|STARTED|Overall Study||92||
60117897|NCT00105027|76238944|FG002|STARTED|Overall Study||91||
60117898|NCT00105027|76238945|FG003|STARTED|Overall Study||137||
60117899|NCT00105027|76238946|FG004|STARTED|Overall Study||136||
60117900|NCT00105027|76238947|FG005|STARTED|Overall Study||138||
59715917|NCT01132326|75834641|FG000|STARTED|Overall Study||350||
59715918|NCT01132326|75834641|FG000|COMPLETED|Overall Study||132||
59715919|NCT01132326|75834641|FG000|NOT COMPLETED|Overall Study||218||
59715920|NCT01178411|75834645|FG000|STARTED|Overall Study||60||
59715921|NCT01178411|75834645|FG000|COMPLETED|Overall Study||0||
59715922|NCT01178411|75834645|FG000|NOT COMPLETED|Overall Study||60||
59715923|NCT01145508|75834651|FG000|STARTED|Overall Study||7||
59827155|NCT00436982|75950422|FG001|COMPLETED|Overall Study||26|Completed/Not completed counts based on participants status at the 2 year primary outcome interval|
59827156|NCT00436982|75950421|FG000|NOT COMPLETED|Overall Study||4||
59827157|NCT00436982|75950422|FG001|NOT COMPLETED|Overall Study||4||
59827158|NCT00443846|75950434|FG000|STARTED|Overall Study||124||
59827159|NCT00443846|75950435|FG001|STARTED|Overall Study||123||
59827160|NCT00443846|75950434|FG000|Vaccinated|Overall Study||116||
59827161|NCT00443846|75950435|FG001|Vaccinated|Overall Study||123||
59827162|NCT00443846|75950434|FG000|COMPLETED|Overall Study||113||
59827163|NCT00443846|75950435|FG001|COMPLETED|Overall Study||117||
59827164|NCT00443846|75950434|FG000|NOT COMPLETED|Overall Study||11||
59827165|NCT00443846|75950435|FG001|NOT COMPLETED|Overall Study||6||
59827166|NCT00436826|75950443|FG000|STARTED|Double Blind Period (DBP)||124||
59827167|NCT00436826|75950444|FG001|STARTED|Double Blind Period (DBP)||48||
59827168|NCT00436826|75950445|FG002|STARTED|Double Blind Period (DBP)||0||
60117901|NCT00105027|76238942|FG000|COMPLETED|Overall Study||73||
60117902|NCT00105027|76238943|FG001|COMPLETED|Overall Study||83||
60117903|NCT00105027|76238944|FG002|COMPLETED|Overall Study||82||
59567396|NCT03795753|75670342|FG000|COMPLETED|Overall Study||23||
59715924|NCT01145508|75834652|FG001|STARTED|Overall Study||3||
59715925|NCT01145508|75834651|FG000|Treated|Overall Study||6||
59715926|NCT01145508|75834652|FG001|Treated|Overall Study||2||
59715927|NCT01145508|75834651|FG000|COMPLETED|Overall Study||2||
59715928|NCT01145508|75834652|FG001|COMPLETED|Overall Study||1||
59715929|NCT01145508|75834651|FG000|NOT COMPLETED|Overall Study||5||
59715930|NCT01145508|75834652|FG001|NOT COMPLETED|Overall Study||2||
60117904|NCT00105027|76238945|FG003|COMPLETED|Overall Study||121||
60117905|NCT00105027|76238946|FG004|COMPLETED|Overall Study||121||
60117906|NCT00105027|76238947|FG005|COMPLETED|Overall Study||125||
60117907|NCT00105027|76238942|FG000|NOT COMPLETED|Overall Study||15||
60117908|NCT00105027|76238943|FG001|NOT COMPLETED|Overall Study||9||
60117909|NCT00105027|76238944|FG002|NOT COMPLETED|Overall Study||9||
60117910|NCT00105027|76238945|FG003|NOT COMPLETED|Overall Study||16||
60117911|NCT00105027|76238946|FG004|NOT COMPLETED|Overall Study||15||
60117912|NCT00105027|76238947|FG005|NOT COMPLETED|Overall Study||13||
60117913|NCT00106119|76238961|FG000|STARTED|First Intervention||7||
60117914|NCT00106119|76238962|FG001|STARTED|First Intervention||7||
60117915|NCT00106119|76238961|FG000|COMPLETED|First Intervention||7||
60117916|NCT00106119|76238962|FG001|COMPLETED|First Intervention||7||
60117917|NCT00106119|76238961|FG000|NOT COMPLETED|First Intervention||0||
60117918|NCT00106119|76238962|FG001|NOT COMPLETED|First Intervention||0||
59715931|NCT00931528|75834660|FG000|STARTED|Overall Study||121||
59715932|NCT00931528|75834661|FG001|STARTED|Overall Study||121||
59827169|NCT00436826|75950446|FG003|STARTED|Double Blind Period (DBP)||0||
59827170|NCT00436826|75950447|FG004|STARTED|Double Blind Period (DBP)||0||
60117919|NCT00106119|76238961|FG000|STARTED|Washout Period of 30 Days||7||
60117920|NCT00106119|76238962|FG001|STARTED|Washout Period of 30 Days||7||
60117921|NCT00106119|76238961|FG000|COMPLETED|Washout Period of 30 Days||7||
60117922|NCT00106119|76238962|FG001|COMPLETED|Washout Period of 30 Days||7||
59567397|NCT03795753|75670343|FG001|COMPLETED|Overall Study||13||
59715933|NCT00931528|75834660|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|80||
59715934|NCT00931528|75834661|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|61||
59715935|NCT00931528|75834660|FG000|NOT COMPLETED|Overall Study||41||
59715936|NCT00931528|75834661|FG001|NOT COMPLETED|Overall Study||60||
59827171|NCT00436826|75950448|FG005|STARTED|Double Blind Period (DBP)||0||
59827172|NCT00436826|75950443|FG000|COMPLETED|Double Blind Period (DBP)||111||
59827173|NCT00436826|75950444|FG001|COMPLETED|Double Blind Period (DBP)||37||
59827174|NCT00436826|75950445|FG002|COMPLETED|Double Blind Period (DBP)||0||
59827175|NCT00436826|75950446|FG003|COMPLETED|Double Blind Period (DBP)||0||
59827176|NCT00436826|75950447|FG004|COMPLETED|Double Blind Period (DBP)||0||
59827177|NCT00436826|75950448|FG005|COMPLETED|Double Blind Period (DBP)||0||
59827178|NCT00436826|75950443|FG000|NOT COMPLETED|Double Blind Period (DBP)||13||
59827179|NCT00436826|75950444|FG001|NOT COMPLETED|Double Blind Period (DBP)||11||
59827180|NCT00436826|75950445|FG002|NOT COMPLETED|Double Blind Period (DBP)||0||
59827181|NCT00436826|75950446|FG003|NOT COMPLETED|Double Blind Period (DBP)||0||
59827182|NCT00436826|75950447|FG004|NOT COMPLETED|Double Blind Period (DBP)||0||
59827183|NCT00436826|75950448|FG005|NOT COMPLETED|Double Blind Period (DBP)||0||
59827184|NCT00436826|75950443|FG000|STARTED|Ext. Period (With Cladribine Treatment)||0||
59827185|NCT00436826|75950444|FG001|STARTED|Ext. Period (With Cladribine Treatment)||0||
59827186|NCT00436826|75950445|FG002|STARTED|Ext. Period (With Cladribine Treatment)||47||
59827187|NCT00436826|75950446|FG003|STARTED|Ext. Period (With Cladribine Treatment)||28||
59827188|NCT00436826|75950447|FG004|STARTED|Ext. Period (With Cladribine Treatment)||0||
59827189|NCT00436826|75950448|FG005|STARTED|Ext. Period (With Cladribine Treatment)||0||
59827190|NCT00436826|75950443|FG000|COMPLETED|Ext. Period (With Cladribine Treatment)||0||
59827191|NCT00436826|75950444|FG001|COMPLETED|Ext. Period (With Cladribine Treatment)||0||
59827192|NCT00436826|75950445|FG002|COMPLETED|Ext. Period (With Cladribine Treatment)||1||
59827193|NCT00436826|75950446|FG003|COMPLETED|Ext. Period (With Cladribine Treatment)||2||
59827194|NCT00436826|75950447|FG004|COMPLETED|Ext. Period (With Cladribine Treatment)||0||
59827195|NCT00436826|75950448|FG005|COMPLETED|Ext. Period (With Cladribine Treatment)||0||
59827196|NCT00436826|75950443|FG000|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||0||
59827197|NCT00436826|75950444|FG001|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||0||
59827198|NCT00436826|75950445|FG002|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||46||
59827199|NCT00436826|75950446|FG003|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||26||
59827200|NCT00436826|75950447|FG004|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||0||
59827201|NCT00436826|75950448|FG005|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||0||
59827202|NCT00436826|75950443|FG000|STARTED|Ext. Period (No Cladribine Treatment)||0||
59827203|NCT00436826|75950444|FG001|STARTED|Ext. Period (No Cladribine Treatment)||0||
59827204|NCT00436826|75950445|FG002|STARTED|Ext. Period (No Cladribine Treatment)||0||
59827205|NCT00436826|75950446|FG003|STARTED|Ext. Period (No Cladribine Treatment)||0||
59827206|NCT00436826|75950447|FG004|STARTED|Ext. Period (No Cladribine Treatment)||52||
59827207|NCT00436826|75950448|FG005|STARTED|Ext. Period (No Cladribine Treatment)||7||
59827208|NCT00436826|75950443|FG000|COMPLETED|Ext. Period (No Cladribine Treatment)||0||
59827209|NCT00436826|75950444|FG001|COMPLETED|Ext. Period (No Cladribine Treatment)||0||
59827210|NCT00436826|75950445|FG002|COMPLETED|Ext. Period (No Cladribine Treatment)||0||
59827211|NCT00436826|75950446|FG003|COMPLETED|Ext. Period (No Cladribine Treatment)||0||
59827212|NCT00436826|75950447|FG004|COMPLETED|Ext. Period (No Cladribine Treatment)||1||
59827213|NCT00436826|75950448|FG005|COMPLETED|Ext. Period (No Cladribine Treatment)||0||
59715937|NCT00975195|75834670|FG000|STARTED|Overall Study||1244||
59715938|NCT00975195|75834671|FG001|STARTED|Overall Study||1244||
59715939|NCT00975195|75834670|FG000|COMPLETED|Overall Study|Includes open-label treatment if appropriate|1016||
59715940|NCT00975195|75834671|FG001|COMPLETED|Overall Study|Includes open-label treatment if appropriate|1011||
59715941|NCT00975195|75834670|FG000|NOT COMPLETED|Overall Study||228||
59715942|NCT00975195|75834671|FG001|NOT COMPLETED|Overall Study||233||
59715943|NCT01145352|75834677|FG000|STARTED|Overall Study||113||
59715944|NCT01145352|75834677|FG000|COMPLETED|Overall Study||102||
59715945|NCT01145352|75834677|FG000|NOT COMPLETED|Overall Study||11||
59715946|NCT01178099|75834685|FG000|STARTED|Overall Study||13||
59827214|NCT00436826|75950443|FG000|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||0||
59827215|NCT00436826|75950444|FG001|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||0||
59827216|NCT00436826|75950445|FG002|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||0||
59827217|NCT00436826|75950446|FG003|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||0||
59827218|NCT00436826|75950447|FG004|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||51||
59827219|NCT00436826|75950448|FG005|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||7||
59827220|NCT00410124|75950466|FG000|STARTED|Core Phase Double Blind (15 Months)|Started indicates randomized (FAS) and treated|277||
59827221|NCT00410124|75950467|FG001|STARTED|Core Phase Double Blind (15 Months)||139||
59827222|NCT00410124|75950466|FG000|Ongoing|Core Phase Double Blind (15 Months)||13||
59827223|NCT00410124|75950467|FG001|Ongoing|Core Phase Double Blind (15 Months)||4||
59827224|NCT00410124|75950466|FG000|Completed Double Blind Treatment|Core Phase Double Blind (15 Months)||62||
59827225|NCT00410124|75950467|FG001|Completed Double Blind Treatment|Core Phase Double Blind (15 Months)||2||
59827226|NCT00410124|75950466|FG000|COMPLETED|Core Phase Double Blind (15 Months)|Patients ongoing/completed double blind phase had option entering extension phase continuing RAD001.|75||
59827227|NCT00410124|75950467|FG001|COMPLETED|Core Phase Double Blind (15 Months)|All patients ongoing/completed/not completed in core had option to enter extension taking RAD001.|6||
59827228|NCT00410124|75950466|FG000|NOT COMPLETED|Core Phase Double Blind (15 Months)||202||
59827229|NCT00410124|75950467|FG001|NOT COMPLETED|Core Phase Double Blind (15 Months)||133||
59827230|NCT00410124|75950466|FG000|STARTED|Extension Phase - Open Label (45 Months)||67||
59827231|NCT00410124|75950467|FG001|STARTED|Extension Phase - Open Label (45 Months)|Patients on placebo in core received RAD001 in extension phase.|111||
59827232|NCT00410124|75950466|FG000|COMPLETED|Extension Phase - Open Label (45 Months)||0||
59827233|NCT00410124|75950467|FG001|COMPLETED|Extension Phase - Open Label (45 Months)||0||
59827234|NCT00410124|75950466|FG000|NOT COMPLETED|Extension Phase - Open Label (45 Months)||67||
59827235|NCT00410124|75950467|FG001|NOT COMPLETED|Extension Phase - Open Label (45 Months)||111||
59827236|NCT00410046|75950477|FG000|STARTED|Overall Study||84||
59827237|NCT00410046|75950477|FG000|COMPLETED|Overall Study||79||
59827238|NCT00410046|75950477|FG000|NOT COMPLETED|Overall Study||5||
59827239|NCT00416624|75950486|FG000|STARTED|Overall Study||61||
59827240|NCT00416624|75950487|FG001|STARTED|Overall Study||60||
59827241|NCT00416624|75950488|FG002|STARTED|Overall Study||58||
59827242|NCT00416624|75950489|FG003|STARTED|Overall Study||57||
59827243|NCT00416624|75950486|FG000|COMPLETED|Overall Study||39||
59827244|NCT00416624|75950487|FG001|COMPLETED|Overall Study||33||
59827245|NCT00416624|75950488|FG002|COMPLETED|Overall Study||40||
60117923|NCT00106119|76238961|FG000|NOT COMPLETED|Washout Period of 30 Days||0||
60117924|NCT00106119|76238962|FG001|NOT COMPLETED|Washout Period of 30 Days||0||
60117925|NCT00106119|76238961|FG000|STARTED|Second Intervention||7||
59715947|NCT01178099|75834686|FG001|STARTED|Overall Study||13||
59715948|NCT01178099|75834685|FG000|COMPLETED|Overall Study||13||
59715949|NCT01178099|75834686|FG001|COMPLETED|Overall Study||12||
59715950|NCT01178099|75834685|FG000|NOT COMPLETED|Overall Study||0||
59715951|NCT01178099|75834686|FG001|NOT COMPLETED|Overall Study||1||
59715952|NCT01169532|75834696|FG000|STARTED|Overall Study||16||
59715953|NCT01169532|75834696|FG000|COMPLETED|Overall Study||15||
60117926|NCT00106119|76238962|FG001|STARTED|Second Intervention||7||
60117927|NCT00106119|76238961|FG000|COMPLETED|Second Intervention||7||
60117928|NCT00106119|76238962|FG001|COMPLETED|Second Intervention||7||
60117929|NCT00106119|76238961|FG000|NOT COMPLETED|Second Intervention||0||
59715954|NCT01169532|75834696|FG000|NOT COMPLETED|Overall Study||1||
59715955|NCT00928564|75834702|FG000|STARTED|Overall Study||28||
59715956|NCT00928564|75834703|FG001|STARTED|Overall Study||12||
59715957|NCT00928564|75834702|FG000|COMPLETED|Overall Study||22||
59715958|NCT00928564|75834703|FG001|COMPLETED|Overall Study||12||
60117930|NCT00106119|76238962|FG001|NOT COMPLETED|Second Intervention||0||
60117931|NCT00006411|76238970|FG000|STARTED|Overall Study||707||
59827246|NCT00416624|75950489|FG003|COMPLETED|Overall Study||40||
59827247|NCT00416624|75950486|FG000|NOT COMPLETED|Overall Study||22||
59827248|NCT00416624|75950487|FG001|NOT COMPLETED|Overall Study||27||
59827249|NCT00416624|75950488|FG002|NOT COMPLETED|Overall Study||18||
59827250|NCT00416624|75950489|FG003|NOT COMPLETED|Overall Study||17||
59827251|NCT00262600|75950502|FG000|STARTED|Overall Study||6015||
59827252|NCT00262600|75950503|FG001|STARTED|Overall Study||6076||
59827253|NCT00262600|75950504|FG002|STARTED|Overall Study||6022||
59827254|NCT00262600|75950502|FG000|COMPLETED|Overall Study||5780||
60117932|NCT00006411|76238971|FG001|STARTED|Overall Study||383||
60117933|NCT00006411|76238970|FG000|COMPLETED|Overall Study||707||
60117934|NCT00006411|76238971|FG001|COMPLETED|Overall Study||383||
60117935|NCT00006411|76238970|FG000|NOT COMPLETED|Overall Study||0||
60117936|NCT00006411|76238971|FG001|NOT COMPLETED|Overall Study||0||
60117937|NCT00030147|76238981|FG000|STARTED|Overall Study||17||
60117938|NCT00030147|76238982|FG001|STARTED|Overall Study||19||
59567398|NCT03795753|75670342|FG000|NOT COMPLETED|Overall Study||0||
59567399|NCT03795753|75670343|FG001|NOT COMPLETED|Overall Study||0||
59567400|NCT01377441|75670351|FG000|STARTED|Overall Study||0||
59567401|NCT01377441|75670352|FG001|STARTED|Overall Study||0||
59567402|NCT01377441|75670351|FG000|COMPLETED|Overall Study|All data for this study was lost after Hurricane Sandy.|0||
59567403|NCT01377441|75670352|FG001|COMPLETED|Overall Study|All data for this study was lost after Hurricane Sandy.|0||
59567404|NCT01377441|75670351|FG000|NOT COMPLETED|Overall Study||0||
59715959|NCT00928564|75834702|FG000|NOT COMPLETED|Overall Study||6||
59715960|NCT00928564|75834703|FG001|NOT COMPLETED|Overall Study||0||
59715961|NCT01177943|75834711|FG000|STARTED|First Intervention||21||
59715962|NCT01177943|75834712|FG001|STARTED|First Intervention||21||
59715963|NCT01177943|75834711|FG000|COMPLETED|First Intervention||19||
59715964|NCT01177943|75834712|FG001|COMPLETED|First Intervention||21||
59715965|NCT01177943|75834711|FG000|NOT COMPLETED|First Intervention||2||
59715966|NCT01177943|75834712|FG001|NOT COMPLETED|First Intervention||0||
59715967|NCT01177943|75834711|FG000|STARTED|Second Intervention||19||
59715968|NCT01177943|75834712|FG001|STARTED|Second Intervention||21||
59715969|NCT01177943|75834711|FG000|COMPLETED|Second Intervention||19||
59715970|NCT01177943|75834712|FG001|COMPLETED|Second Intervention||21||
59715971|NCT01177943|75834711|FG000|NOT COMPLETED|Second Intervention||0||
59715972|NCT01177943|75834712|FG001|NOT COMPLETED|Second Intervention||0||
59715973|NCT01131312|75834721|FG000|STARTED|Overall Study||1839||
59715974|NCT01131312|75834722|FG001|STARTED|Overall Study||1385||
59715975|NCT01131312|75834723|FG002|STARTED|Overall Study||1836||
59715976|NCT01131312|75834721|FG000|COMPLETED|Overall Study||1414||
59715977|NCT01131312|75834722|FG001|COMPLETED|Overall Study||1156||
59715978|NCT01131312|75834723|FG002|COMPLETED|Overall Study||1485||
59715979|NCT01131312|75834721|FG000|NOT COMPLETED|Overall Study||425||
59715980|NCT01131312|75834722|FG001|NOT COMPLETED|Overall Study||229||
59715981|NCT01131312|75834723|FG002|NOT COMPLETED|Overall Study||351||
59715982|NCT01177787|75834731|FG000|STARTED|Clinical Efficacy of Cryolipolysis||28||
59715983|NCT01177787|75834731|FG000|COMPLETED|Clinical Efficacy of Cryolipolysis||28||
59715984|NCT01177787|75834731|FG000|NOT COMPLETED|Clinical Efficacy of Cryolipolysis||0||
59715985|NCT01177787|75834731|FG000|STARTED|Cryolipolysis on Thigh||28||
59715986|NCT01177787|75834731|FG000|COMPLETED|Cryolipolysis on Thigh||14||
59715987|NCT01177787|75834731|FG000|NOT COMPLETED|Cryolipolysis on Thigh||14||
59715988|NCT00928486|75834743|FG000|STARTED|Overall Study||25||
59827255|NCT00262600|75950503|FG001|COMPLETED|Overall Study||5824||
60117939|NCT00030147|76238983|FG002|STARTED|Overall Study||16||
60117940|NCT00030147|76238984|FG003|STARTED|Overall Study||11||
59827256|NCT00262600|75950504|FG002|COMPLETED|Overall Study||5756||
59827257|NCT00262600|75950502|FG000|NOT COMPLETED|Overall Study||235||
59827258|NCT00262600|75950503|FG001|NOT COMPLETED|Overall Study||252||
59827259|NCT00262600|75950504|FG002|NOT COMPLETED|Overall Study||266||
59827260|NCT00409578|75950516|FG000|STARTED|Overall Study||280||
59827261|NCT00409578|75950517|FG001|STARTED|Overall Study||271||
59827262|NCT00409578|75950518|FG002|STARTED|Overall Study||269||
59827263|NCT00409578|75950519|FG003|STARTED|Overall Study||281||
59827264|NCT00409578|75950516|FG000|COMPLETED|Overall Study||228||
59827265|NCT00409578|75950517|FG001|COMPLETED|Overall Study||201||
59827266|NCT00409578|75950518|FG002|COMPLETED|Overall Study||215||
59827267|NCT00409578|75950519|FG003|COMPLETED|Overall Study||214||
59827268|NCT00409578|75950516|FG000|NOT COMPLETED|Overall Study||52||
59827269|NCT00409578|75950517|FG001|NOT COMPLETED|Overall Study||70||
59827270|NCT00409578|75950518|FG002|NOT COMPLETED|Overall Study||54||
59827271|NCT00409578|75950519|FG003|NOT COMPLETED|Overall Study||67||
59827272|NCT00428090|75950533|FG000|STARTED|Overall Study||165||
59827273|NCT00428090|75950534|FG001|STARTED|Overall Study||166||
59827274|NCT00428090|75950535|FG002|STARTED|Overall Study||165||
59827275|NCT00428090|75950536|FG003|STARTED|Overall Study||83||
59827276|NCT00428090|75950533|FG000|COMPLETED|Overall Study||131||
59827277|NCT00428090|75950534|FG001|COMPLETED|Overall Study||135||
59827278|NCT00428090|75950535|FG002|COMPLETED|Overall Study||127||
59827279|NCT00428090|75950536|FG003|COMPLETED|Overall Study||55||
59827280|NCT00428090|75950533|FG000|NOT COMPLETED|Overall Study||34||
59827281|NCT00428090|75950534|FG001|NOT COMPLETED|Overall Study||31||
59827282|NCT00428090|75950535|FG002|NOT COMPLETED|Overall Study||38||
59827283|NCT00428090|75950536|FG003|NOT COMPLETED|Overall Study||28||
59827284|NCT00416312|75950554|FG000|STARTED|Overall Study||9||
59827285|NCT00416312|75950554|FG000|Conventional Dosimetry|Overall Study||9||
59827286|NCT00416312|75950554|FG000|Patient-specific Dosimetry|Overall Study||9||
59827287|NCT00416312|75950554|FG000|COMPLETED|Overall Study||7||
59827288|NCT00416312|75950554|FG000|NOT COMPLETED|Overall Study||2||
59827289|NCT00436436|75950558|FG000|STARTED|Overall Study||12||
59827290|NCT00436436|75950558|FG000|COMPLETED|Overall Study||0||
59827291|NCT00436436|75950558|FG000|NOT COMPLETED|Overall Study||12||
59827292|NCT00262522|75950566|FG000|STARTED|Study Start Through 8 Weeks||167||
59827293|NCT00262522|75950567|FG001|STARTED|Study Start Through 8 Weeks||166||
59827294|NCT00262522|75950568|FG002|STARTED|Study Start Through 8 Weeks||166||
59827295|NCT00262522|75950569|FG003|STARTED|Study Start Through 8 Weeks||165||
59827296|NCT00262522|75950566|FG000|COMPLETED|Study Start Through 8 Weeks||163||
59827297|NCT00262522|75950567|FG001|COMPLETED|Study Start Through 8 Weeks||161||
59827298|NCT00262522|75950568|FG002|COMPLETED|Study Start Through 8 Weeks||155||
59827299|NCT00262522|75950569|FG003|COMPLETED|Study Start Through 8 Weeks||160||
59827300|NCT00262522|75950566|FG000|NOT COMPLETED|Study Start Through 8 Weeks||4||
59827301|NCT00262522|75950567|FG001|NOT COMPLETED|Study Start Through 8 Weeks||5||
59827302|NCT00262522|75950568|FG002|NOT COMPLETED|Study Start Through 8 Weeks||11||
59827303|NCT00262522|75950569|FG003|NOT COMPLETED|Study Start Through 8 Weeks||5||
59827304|NCT00262522|75950566|FG000|STARTED|Study Start Through 48 Weeks|Number of subjects who started the study, not the number who completed the first 8 weeks.|333||
59827305|NCT00262522|75950567|FG001|STARTED|Study Start Through 48 Weeks|After Week 8, these subjects received the tablet formulation once daily through the end of study.|0||
59827306|NCT00262522|75950568|FG002|STARTED|Study Start Through 48 Weeks|Number of subjects who started the study, not the number who completed the first 8 weeks.|331||
59827307|NCT00262522|75950569|FG003|STARTED|Study Start Through 48 Weeks|After Week 8, these subjects received the tablet formulation twice daily through the end of study.|0||
59827308|NCT00262522|75950566|FG000|COMPLETED|Study Start Through 48 Weeks||284||
59827309|NCT00262522|75950567|FG001|COMPLETED|Study Start Through 48 Weeks||0||
60117941|NCT00030147|76238981|FG000|COMPLETED|Overall Study||17||
59827310|NCT00262522|75950568|FG002|COMPLETED|Study Start Through 48 Weeks||276||
59827311|NCT00262522|75950569|FG003|COMPLETED|Study Start Through 48 Weeks||0||
59827312|NCT00262522|75950566|FG000|NOT COMPLETED|Study Start Through 48 Weeks||49||
60117942|NCT00030147|76238982|FG001|COMPLETED|Overall Study||18||
60117943|NCT00030147|76238983|FG002|COMPLETED|Overall Study||16||
60117944|NCT00030147|76238984|FG003|COMPLETED|Overall Study||11||
60117945|NCT00030147|76238981|FG000|NOT COMPLETED|Overall Study||0||
60117946|NCT00030147|76238982|FG001|NOT COMPLETED|Overall Study||1||
60117947|NCT00030147|76238983|FG002|NOT COMPLETED|Overall Study||0||
60117948|NCT00030147|76238984|FG003|NOT COMPLETED|Overall Study||0||
59827313|NCT00262522|75950567|FG001|NOT COMPLETED|Study Start Through 48 Weeks||0||
59827314|NCT00262522|75950568|FG002|NOT COMPLETED|Study Start Through 48 Weeks||55||
59827315|NCT00262522|75950569|FG003|NOT COMPLETED|Study Start Through 48 Weeks||0||
59827316|NCT00262522|75950566|FG000|STARTED|Study Start Through 96 Weeks|Number of subjects who started the study, not the number who completed the first 48 weeks.|333||
59827317|NCT00262522|75950567|FG001|STARTED|Study Start Through 96 Weeks|After Week 8, these subjects received the tablet formulation once daily through the end of study.|0||
60117949|NCT02709486|76238997|FG000|STARTED|Overall Study||282||
60117950|NCT02709486|76238998|FG001|STARTED|Overall Study||283||
60117951|NCT02709486|76238999|FG002|STARTED|Overall Study||284||
59827318|NCT00262522|75950568|FG002|STARTED|Study Start Through 96 Weeks|Number of subjects who started the study, not the number who completed the first 48 weeks.|331||
59827319|NCT00262522|75950569|FG003|STARTED|Study Start Through 96 Weeks|After Week 8, these subjects received the tablet formulation twice daily through the end of study.|0||
59827320|NCT00262522|75950566|FG000|COMPLETED|Study Start Through 96 Weeks||256||
59827321|NCT00262522|75950567|FG001|COMPLETED|Study Start Through 96 Weeks||0||
59827322|NCT00262522|75950568|FG002|COMPLETED|Study Start Through 96 Weeks||254||
59827323|NCT00262522|75950569|FG003|COMPLETED|Study Start Through 96 Weeks||0||
59827324|NCT00262522|75950566|FG000|NOT COMPLETED|Study Start Through 96 Weeks||77||
59827325|NCT00262522|75950567|FG001|NOT COMPLETED|Study Start Through 96 Weeks||0||
59827326|NCT00262522|75950568|FG002|NOT COMPLETED|Study Start Through 96 Weeks||77||
59827327|NCT00262522|75950569|FG003|NOT COMPLETED|Study Start Through 96 Weeks||0||
59827328|NCT00436280|75950577|FG000|STARTED|Period 1: Induction||68||
59827329|NCT00436280|75950577|FG000|Received at Least 1 Dose of Study Drug|Period 1: Induction||68||
59827330|NCT00436280|75950577|FG000|COMPLETED|Period 1: Induction||40||
59827331|NCT00436280|75950577|FG000|NOT COMPLETED|Period 1: Induction||28||
59827332|NCT00436280|75950577|FG000|STARTED|Period 2: Consolidation||40||
59827333|NCT00436280|75950577|FG000|COMPLETED|Period 2: Consolidation||23||
59827334|NCT00436280|75950577|FG000|NOT COMPLETED|Period 2: Consolidation||17||
59827335|NCT00436280|75950577|FG000|STARTED|Period 3: Maintenance||23||
59827336|NCT00436280|75950577|FG000|COMPLETED|Period 3: Maintenance||5||
59827337|NCT00436280|75950577|FG000|NOT COMPLETED|Period 3: Maintenance||18||
59827338|NCT00394836|75950583|FG000|STARTED|Teatment or Follow-up Phase||30||
59827339|NCT00394836|75950584|FG001|STARTED|Teatment or Follow-up Phase||86||
59827340|NCT00394836|75950583|FG000|Early Follow-up Entry|Teatment or Follow-up Phase|Did not complete treatment.|4||
59827341|NCT00394836|75950584|FG001|Early Follow-up Entry|Teatment or Follow-up Phase|Did not complete treatment.|8||
59827342|NCT00394836|75950583|FG000|COMPLETED|Teatment or Follow-up Phase||2||
59827343|NCT00394836|75950584|FG001|COMPLETED|Teatment or Follow-up Phase||8||
59827344|NCT00394836|75950583|FG000|NOT COMPLETED|Teatment or Follow-up Phase||28||
59827345|NCT00394836|75950584|FG001|NOT COMPLETED|Teatment or Follow-up Phase||78||
59827346|NCT00394836|75950583|FG000|STARTED|Extended Follow-up Phase (2-5 Years)|Not all participants went into extended follow up per protocol.|20||
59827347|NCT00394836|75950584|FG001|STARTED|Extended Follow-up Phase (2-5 Years)|Not all participants went into extended follow up per protocol.|58||
59827348|NCT00394836|75950583|FG000|COMPLETED|Extended Follow-up Phase (2-5 Years)||0||
59827349|NCT00394836|75950584|FG001|COMPLETED|Extended Follow-up Phase (2-5 Years)||5||
59827350|NCT00394836|75950583|FG000|NOT COMPLETED|Extended Follow-up Phase (2-5 Years)||20||
59827351|NCT00394836|75950584|FG001|NOT COMPLETED|Extended Follow-up Phase (2-5 Years)||53||
59827352|NCT00250588|75950595|FG000|STARTED|Overall Study||81||
59827353|NCT00250588|75950596|FG001|STARTED|Overall Study||84||
59827354|NCT00250588|75950597|FG002|STARTED|Overall Study||87||
59827355|NCT00250588|75950595|FG000|COMPLETED|Overall Study||72||
59827356|NCT00250588|75950596|FG001|COMPLETED|Overall Study||65||
59827357|NCT00250588|75950597|FG002|COMPLETED|Overall Study||74||
59827358|NCT00250588|75950595|FG000|NOT COMPLETED|Overall Study||9||
59827359|NCT00250588|75950596|FG001|NOT COMPLETED|Overall Study||19||
59827360|NCT00250588|75950597|FG002|NOT COMPLETED|Overall Study||13||
59827361|NCT00416078|75950607|FG000|STARTED|Overall Study||29||
59827362|NCT00416078|75950608|FG001|STARTED|Overall Study||24||
59827363|NCT00416078|75950607|FG000|COMPLETED|Overall Study||18||
59827364|NCT00416078|75950608|FG001|COMPLETED|Overall Study||16||
59827365|NCT00416078|75950607|FG000|NOT COMPLETED|Overall Study||11||
59827366|NCT00416078|75950608|FG001|NOT COMPLETED|Overall Study||8||
59827367|NCT00394524|75950616|FG000|STARTED|Overall Study||80||
59827368|NCT00394524|75950617|FG001|STARTED|Overall Study||80||
59827369|NCT00394524|75950616|FG000|COMPLETED|Overall Study||77||
59827370|NCT00394524|75950617|FG001|COMPLETED|Overall Study||76||
59827371|NCT00394524|75950616|FG000|NOT COMPLETED|Overall Study||3||
59827372|NCT00394524|75950617|FG001|NOT COMPLETED|Overall Study||4||
59827373|NCT00409344|75950627|FG000|STARTED|Overall Study|No participants enrolled|0||
59827374|NCT00409344|75950628|FG001|STARTED|Overall Study|No participants enrolled|0||
59827375|NCT00409344|75950627|FG000|COMPLETED|Overall Study|No participants were enrolled to completion|0||
59827376|NCT00409344|75950628|FG001|COMPLETED|Overall Study|No participants were enrolled to completion|0||
59827377|NCT00409344|75950627|FG000|NOT COMPLETED|Overall Study||0||
59827378|NCT00409344|75950628|FG001|NOT COMPLETED|Overall Study||0||
59827379|NCT00415610|75950637|FG000|STARTED|Overall Study||18||
59827380|NCT00415610|75950638|FG001|STARTED|Overall Study||20||
59827381|NCT00415610|75950639|FG002|STARTED|Overall Study||22||
59827382|NCT00415610|75950637|FG000|COMPLETED|Overall Study||15||
59827383|NCT00415610|75950638|FG001|COMPLETED|Overall Study||18||
59827384|NCT00415610|75950639|FG002|COMPLETED|Overall Study||17||
59827385|NCT00415610|75950637|FG000|NOT COMPLETED|Overall Study||3||
59827386|NCT00415610|75950638|FG001|NOT COMPLETED|Overall Study||2||
59827387|NCT00415610|75950639|FG002|NOT COMPLETED|Overall Study||5||
59827388|NCT00394212|75950649|FG000|STARTED|Overall Study|2 subjects assigned to suturing underwent sham procedure, results based on Intent-To-Treat (ITT)|50||
59827389|NCT00394212|75950650|FG001|STARTED|Overall Study||27||
59827390|NCT00394212|75950649|FG000|6 Week Follow-up|Overall Study||45||
59827391|NCT00394212|75950650|FG001|6 Week Follow-up|Overall Study||26||
59827392|NCT00394212|75950649|FG000|3 Month Follow-up|Overall Study||45||
59827393|NCT00394212|75950650|FG001|3 Month Follow-up|Overall Study||26||
59827394|NCT00394212|75950649|FG000|6 Month Follow-up|Overall Study||43||
59827395|NCT00394212|75950650|FG001|6 Month Follow-up|Overall Study||26||
59827396|NCT00394212|75950649|FG000|COMPLETED|Overall Study||43||
59827397|NCT00394212|75950650|FG001|COMPLETED|Overall Study||26||
59827398|NCT00394212|75950649|FG000|NOT COMPLETED|Overall Study||7||
59827399|NCT00394212|75950650|FG001|NOT COMPLETED|Overall Study||1||
59715989|NCT00928486|75834743|FG000|Efficacy Evaluable (EE)|Overall Study|EE population = given at least 1 dose of study drug, evaluated for efficacy and met eligibility|24||
59715990|NCT00928486|75834743|FG000|COMPLETED|Overall Study|Completed = those who continued responding to treatment; upon marketing approval, given lenalidomide|15||
59715991|NCT00928486|75834743|FG000|NOT COMPLETED|Overall Study||10||
59715992|NCT01168596|75834749|FG000|STARTED|Overall Study||16||
59715993|NCT01168596|75834750|FG001|STARTED|Overall Study||14||
59827400|NCT00250432|75950658|FG000|STARTED|Overall Study||104||
59827401|NCT00250432|75950659|FG001|STARTED|Overall Study||100||
59827402|NCT00250432|75950658|FG000|COMPLETED|Overall Study||59||
59827403|NCT00250432|75950659|FG001|COMPLETED|Overall Study||53||
60117952|NCT02709486|76238997|FG000|COMPLETED|Overall Study||238||
60117953|NCT02709486|76238998|FG001|COMPLETED|Overall Study||249||
60117954|NCT02709486|76238999|FG002|COMPLETED|Overall Study||239||
60117955|NCT02709486|76238997|FG000|NOT COMPLETED|Overall Study||44||
60117956|NCT02709486|76238998|FG001|NOT COMPLETED|Overall Study||34||
60117957|NCT02709486|76238999|FG002|NOT COMPLETED|Overall Study||45||
60117958|NCT00106431|76239007|FG000|STARTED|Overall Study||102||
60117959|NCT00106431|76239007|FG000|COMPLETED|Overall Study|37 represents the number of patients who reached at least 6 months treatment|37||
60117960|NCT00106431|76239007|FG000|NOT COMPLETED|Overall Study||65||
60117961|NCT03110770|76239016|FG000|STARTED|Overall Study||30||
60117962|NCT03110770|76239017|FG001|STARTED|Overall Study||30||
60117963|NCT03110770|76239018|FG002|STARTED|Overall Study||30||
60117964|NCT03110770|76239019|FG003|STARTED|Overall Study||1170||
60117965|NCT03110770|76239020|FG004|STARTED|Overall Study||1168||
60117966|NCT03110770|76239016|FG000|Received First Product Administration|Overall Study||30||
60117967|NCT03110770|76239017|FG001|Received First Product Administration|Overall Study||30||
60117968|NCT03110770|76239018|FG002|Received First Product Administration|Overall Study||30||
60117969|NCT03110770|76239019|FG003|Received First Product Administration|Overall Study||1162||
60117970|NCT03110770|76239020|FG004|Received First Product Administration|Overall Study||1161||
60117971|NCT03110770|76239016|FG000|Received Second Product Administration|Overall Study||30||
60117972|NCT03110770|76239017|FG001|Received Second Product Administration|Overall Study||29||
60117973|NCT03110770|76239018|FG002|Received Second Product Administration|Overall Study||29||
60117974|NCT03110770|76239019|FG003|Received Second Product Administration|Overall Study||1126||
60117975|NCT03110770|76239020|FG004|Received Second Product Administration|Overall Study||1127||
60117976|NCT03110770|76239016|FG000|Received Third Product Administration|Overall Study||29||
60117977|NCT03110770|76239017|FG001|Received Third Product Administration|Overall Study||27||
60117978|NCT03110770|76239018|FG002|Received Third Product Administration|Overall Study||28||
60117979|NCT03110770|76239019|FG003|Received Third Product Administration|Overall Study||1107||
60117980|NCT03110770|76239020|FG004|Received Third Product Administration|Overall Study||1107||
60117981|NCT03110770|76239016|FG000|COMPLETED|Overall Study||24||
59827404|NCT00250432|75950658|FG000|NOT COMPLETED|Overall Study||45||
60117982|NCT03110770|76239017|FG001|COMPLETED|Overall Study||30||
60117983|NCT03110770|76239018|FG002|COMPLETED|Overall Study||28||
60117984|NCT03110770|76239019|FG003|COMPLETED|Overall Study||1037||
60117985|NCT03110770|76239020|FG004|COMPLETED|Overall Study||1045||
60117986|NCT03110770|76239016|FG000|NOT COMPLETED|Overall Study||6||
60117987|NCT03110770|76239017|FG001|NOT COMPLETED|Overall Study||0||
60117988|NCT03110770|76239018|FG002|NOT COMPLETED|Overall Study||2||
60117989|NCT03110770|76239019|FG003|NOT COMPLETED|Overall Study||133||
60117990|NCT03110770|76239020|FG004|NOT COMPLETED|Overall Study||123||
60117991|NCT02831998|76239034|FG000|STARTED|Overall Study||440||440
60117992|NCT02831998|76239034|FG000|ZP|Overall Study||400||400
60117993|NCT02831998|76239034|FG000|CP|Overall Study||400||400
60117994|NCT02831998|76239034|FG000|Vehicle|Overall Study||80||80
60117995|NCT02831998|76239034|FG000|COMPLETED|Overall Study||440||440
60117996|NCT02831998|76239034|FG000|NOT COMPLETED|Overall Study||0||0
60117997|NCT00214539|76239047|FG000|STARTED|Randomized||17||
60117998|NCT00214539|76239048|FG001|STARTED|Randomized||17||
59715994|NCT01168596|75834749|FG000|COMPLETED|Overall Study||13||
59715995|NCT01168596|75834750|FG001|COMPLETED|Overall Study||13||
59715996|NCT01168596|75834749|FG000|NOT COMPLETED|Overall Study||3||
59827405|NCT00250432|75950659|FG001|NOT COMPLETED|Overall Study||47||
60117999|NCT00214539|76239047|FG000|COMPLETED|Randomized||15||
60118000|NCT00214539|76239048|FG001|COMPLETED|Randomized||17||
60118001|NCT00214539|76239047|FG000|NOT COMPLETED|Randomized||2||
60118002|NCT00214539|76239048|FG001|NOT COMPLETED|Randomized||0||
60118003|NCT00214539|76239047|FG000|STARTED|Treatment Period||15||
60118004|NCT00214539|76239048|FG001|STARTED|Treatment Period||17||
60118005|NCT00214539|76239047|FG000|COMPLETED|Treatment Period||15||
60118006|NCT00214539|76239048|FG001|COMPLETED|Treatment Period||17||
60118007|NCT00214539|76239047|FG000|NOT COMPLETED|Treatment Period||0||
59827406|NCT00250276|75950669|FG000|STARTED|Overall Study||199||
59827407|NCT00250276|75950670|FG001|STARTED|Overall Study||198||
59827408|NCT00250276|75950671|FG002|STARTED|Overall Study||201||
59827409|NCT00250276|75950672|FG003|STARTED|Overall Study||200||
59827410|NCT00250276|75950669|FG000|COMPLETED|Overall Study||182||
59827411|NCT00250276|75950670|FG001|COMPLETED|Overall Study||177||
59827412|NCT00250276|75950671|FG002|COMPLETED|Overall Study||182||
59827413|NCT00250276|75950672|FG003|COMPLETED|Overall Study||181||
59827414|NCT00250276|75950669|FG000|NOT COMPLETED|Overall Study||17||
59827415|NCT00250276|75950670|FG001|NOT COMPLETED|Overall Study||21||
59827416|NCT00250276|75950671|FG002|NOT COMPLETED|Overall Study||19||
59827417|NCT00250276|75950672|FG003|NOT COMPLETED|Overall Study||19||
59827418|NCT00249808|75950687|FG000|STARTED|Overall Study||1266||
59827419|NCT00249808|75950687|FG000|COMPLETED|Overall Study||1084||
59827420|NCT00249808|75950687|FG000|NOT COMPLETED|Overall Study||182||
59827421|NCT00278512|75950693|FG000|STARTED|Overall Study||7||
59827422|NCT00278512|75950694|FG001|STARTED|Overall Study||0||
59827423|NCT00278512|75950693|FG000|COMPLETED|Overall Study||6||
59827424|NCT00278512|75950694|FG001|COMPLETED|Overall Study||0||
59827425|NCT00278512|75950693|FG000|NOT COMPLETED|Overall Study||1||
59827426|NCT00278512|75950694|FG001|NOT COMPLETED|Overall Study||0||
59827427|NCT00427934|75950704|FG000|STARTED|Overall Study||8||
59827428|NCT00427934|75950705|FG001|STARTED|Overall Study||8||
59827429|NCT00427934|75950706|FG002|STARTED|Overall Study||78||
59827430|NCT00427934|75950707|FG003|STARTED|Overall Study||34||
59827431|NCT00427934|75950704|FG000|Treated|Overall Study||8||
59827432|NCT00427934|75950705|FG001|Treated|Overall Study||8||
59827433|NCT00427934|75950706|FG002|Treated|Overall Study||77||
59827434|NCT00427934|75950707|FG003|Treated|Overall Study||33||
59827435|NCT00427934|75950704|FG000|COMPLETED|Overall Study||7||
59827436|NCT00427934|75950705|FG001|COMPLETED|Overall Study||8||
59827437|NCT00427934|75950706|FG002|COMPLETED|Overall Study||55||
59827438|NCT00427934|75950707|FG003|COMPLETED|Overall Study||19||
59827439|NCT00427934|75950704|FG000|NOT COMPLETED|Overall Study||1||
59827440|NCT00427934|75950705|FG001|NOT COMPLETED|Overall Study||0||
59827441|NCT00427934|75950706|FG002|NOT COMPLETED|Overall Study||23||
59827442|NCT00427934|75950707|FG003|NOT COMPLETED|Overall Study||15||
59827443|NCT00435188|75950721|FG000|STARTED|Overall Study||199||
59827444|NCT00435188|75950722|FG001|STARTED|Overall Study||199||
59827445|NCT00435188|75950721|FG000|COMPLETED|Overall Study||177||
59827446|NCT00435188|75950722|FG001|COMPLETED|Overall Study||176||
59827447|NCT00435188|75950721|FG000|NOT COMPLETED|Overall Study||22||
59827448|NCT00435188|75950722|FG001|NOT COMPLETED|Overall Study||23||
59827449|NCT00427778|75950730|FG000|STARTED|First Intervention (4 Weeks)||14||
59827450|NCT00427778|75950731|FG001|STARTED|First Intervention (4 Weeks)||15||
59827451|NCT00427778|75950730|FG000|COMPLETED|First Intervention (4 Weeks)||10||
59827452|NCT00427778|75950731|FG001|COMPLETED|First Intervention (4 Weeks)||14||
59827453|NCT00427778|75950730|FG000|NOT COMPLETED|First Intervention (4 Weeks)||4||
59827454|NCT00427778|75950731|FG001|NOT COMPLETED|First Intervention (4 Weeks)||1||
59827455|NCT00427778|75950730|FG000|STARTED|Wash Out (2 Weeks)||10||
59827456|NCT00427778|75950731|FG001|STARTED|Wash Out (2 Weeks)||14||
59827457|NCT00427778|75950730|FG000|COMPLETED|Wash Out (2 Weeks)||10||
59827458|NCT00427778|75950731|FG001|COMPLETED|Wash Out (2 Weeks)||14||
59827459|NCT00427778|75950730|FG000|NOT COMPLETED|Wash Out (2 Weeks)||0||
59827460|NCT00427778|75950731|FG001|NOT COMPLETED|Wash Out (2 Weeks)||0||
60118008|NCT00214539|76239048|FG001|NOT COMPLETED|Treatment Period||0||
60118009|NCT00214539|76239047|FG000|STARTED|Steroid Stable (Post-Tx to 22-Weeks)||15||
60118010|NCT00214539|76239048|FG001|STARTED|Steroid Stable (Post-Tx to 22-Weeks)||17||
60118011|NCT00214539|76239047|FG000|COMPLETED|Steroid Stable (Post-Tx to 22-Weeks)||15||
60118012|NCT00214539|76239048|FG001|COMPLETED|Steroid Stable (Post-Tx to 22-Weeks)||17||
59567405|NCT01377441|75670352|FG001|NOT COMPLETED|Overall Study||0||
59827461|NCT00427778|75950730|FG000|STARTED|Second Intervention (4 Weeks)||10||
60118013|NCT00214539|76239047|FG000|NOT COMPLETED|Steroid Stable (Post-Tx to 22-Weeks)||0||
59715997|NCT01168596|75834750|FG001|NOT COMPLETED|Overall Study||1||
59715998|NCT01177553|75834758|FG000|STARTED|Overall Study||3||
59715999|NCT01177553|75834759|FG001|STARTED|Overall Study||2||
59716000|NCT01177553|75834758|FG000|COMPLETED|Overall Study|data as of March 2009|2||
59716001|NCT01177553|75834759|FG001|COMPLETED|Overall Study|data as of March 2009|2||
59716002|NCT01177553|75834758|FG000|NOT COMPLETED|Overall Study||1||
59716003|NCT01177553|75834759|FG001|NOT COMPLETED|Overall Study||0||
59716004|NCT00928408|75834765|FG000|STARTED|Overall Study|Number Enrolled|305||
59716005|NCT00928408|75834765|FG000|Full Analysis Set|Overall Study|All enrolled participants who fulfilled the study inclusion/exclusion criteria|303||
59716006|NCT00928408|75834765|FG000|COMPLETED|Overall Study||282||
59716007|NCT00928408|75834765|FG000|NOT COMPLETED|Overall Study||23||
59716008|NCT00928252|75834769|FG000|STARTED|Overall Study||45||
59716009|NCT00928252|75834769|FG000|COMPLETED|Overall Study||42||
59716010|NCT00928252|75834769|FG000|NOT COMPLETED|Overall Study||3||
59716011|NCT01177007|75834775|FG000|STARTED|Overall Study||50||
59827462|NCT00427778|75950731|FG001|STARTED|Second Intervention (4 Weeks)||14||
59827463|NCT00427778|75950730|FG000|COMPLETED|Second Intervention (4 Weeks)||10||
59827464|NCT00427778|75950731|FG001|COMPLETED|Second Intervention (4 Weeks)||14||
59827465|NCT00427778|75950730|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0||
59827466|NCT00427778|75950731|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||0||
59827467|NCT00427700|75950752|FG000|STARTED|Overall Study||40||
59827468|NCT00427700|75950753|FG001|STARTED|Overall Study||42||
59827469|NCT00427700|75950752|FG000|COMPLETED|Overall Study||37||
59827470|NCT00427700|75950753|FG001|COMPLETED|Overall Study||31||
59827471|NCT00427700|75950752|FG000|NOT COMPLETED|Overall Study||3||
59827472|NCT00427700|75950753|FG001|NOT COMPLETED|Overall Study||11||
59827473|NCT00409188|75950762|FG000|STARTED|Overall Study||1006||
59827474|NCT00409188|75950763|FG001|STARTED|Overall Study||507||
59827475|NCT00409188|75950762|FG000|COMPLETED|Overall Study||623||
59827476|NCT00409188|75950763|FG001|COMPLETED|Overall Study||332||
59827477|NCT00409188|75950762|FG000|NOT COMPLETED|Overall Study||383||
59827478|NCT00409188|75950763|FG001|NOT COMPLETED|Overall Study||175||
59827479|NCT00434954|75950771|FG000|STARTED|Overall Study||248||
59827480|NCT00434954|75950772|FG001|STARTED|Overall Study||246||
59827481|NCT00434954|75950771|FG000|Started - Previous Treatment MET Only|Overall Study||182||
59827482|NCT00434954|75950772|FG001|Started - Previous Treatment MET Only|Overall Study||181||
59827483|NCT00434954|75950771|FG000|Started - Previous Treatment MET + SU|Overall Study||66||
59827484|NCT00434954|75950772|FG001|Started - Previous Treatment MET + SU|Overall Study||65||
59827485|NCT00434954|75950771|FG000|Full Analysis Set (FAS) Overall|Overall Study|FAS=received >=1 dose of study drug. Adverse event data reported for Overall FAS.|247||
59827486|NCT00434954|75950772|FG001|Full Analysis Set (FAS) Overall|Overall Study|FAS=received >=1 dose of study drug. Adverse event data reported for Overall FAS.|233||
59827487|NCT00434954|75950771|FG000|FAS - Previous Treatment MET Only|Overall Study|"Baseline and efficacy data reported for FAS-Previous Treatment MET Only group."|181||
59827488|NCT00434954|75950772|FG001|FAS - Previous Treatment MET Only|Overall Study|"Baseline and efficacy data reported for FAS-Previous Treatment MET Only group."|173||
59827489|NCT00434954|75950771|FG000|FAS - Previous Treatment MET + SU|Overall Study||66||
59827490|NCT00434954|75950772|FG001|FAS - Previous Treatment MET + SU|Overall Study||60||
59827491|NCT00434954|75950771|FG000|Completed - Previous Treatment MET Only|Overall Study||135||
59827492|NCT00434954|75950772|FG001|Completed - Previous Treatment MET Only|Overall Study||137||
59827493|NCT00434954|75950771|FG000|Completed - Previous Treatment MET + SU|Overall Study||31||
59827494|NCT00434954|75950772|FG001|Completed - Previous Treatment MET + SU|Overall Study||38||
59827495|NCT00434954|75950771|FG000|COMPLETED|Overall Study||166||
59827496|NCT00434954|75950772|FG001|COMPLETED|Overall Study||175||
59827497|NCT00434954|75950771|FG000|NOT COMPLETED|Overall Study||82||
59827498|NCT00434954|75950772|FG001|NOT COMPLETED|Overall Study||71||
59827499|NCT00276484|75950780|FG000|STARTED|Overall Study||288||
59827500|NCT00276484|75950781|FG001|STARTED|Overall Study||291||
59827501|NCT00276484|75950780|FG000|COMPLETED|Overall Study||279||
59827502|NCT00276484|75950781|FG001|COMPLETED|Overall Study||278||
59827503|NCT00276484|75950780|FG000|NOT COMPLETED|Overall Study||9||
59827504|NCT00276484|75950781|FG001|NOT COMPLETED|Overall Study||13||
59567406|NCT01882868|75670358|FG000|STARTED|Overall Study||62||
59827505|NCT00426842|75950787|FG000|STARTED|Overall Study||11||
59827506|NCT00426842|75950787|FG000|COMPLETED|Overall Study||10||
59827507|NCT00426842|75950787|FG000|NOT COMPLETED|Overall Study||1||
59827508|NCT00434876|75950795|FG000|STARTED|Overall Study||11||
59827509|NCT00434876|75950796|FG001|STARTED|Overall Study||11||
59827510|NCT00434876|75950795|FG000|COMPLETED|Overall Study||10||
59567407|NCT01882868|75670358|FG000|COMPLETED|Overall Study||62||
59567408|NCT01882868|75670358|FG000|NOT COMPLETED|Overall Study||0||
59567409|NCT01383447|75670362|FG000|STARTED|Overall Study||2||
59567410|NCT01383447|75670362|FG000|COMPLETED|Overall Study||0||
59567411|NCT01383447|75670362|FG000|NOT COMPLETED|Overall Study||2||
59567412|NCT02300298|75670366|FG000|STARTED|Disposition for Nintedanib||10||
59567413|NCT02300298|75670367|FG001|STARTED|Disposition for Nintedanib||0||
59567414|NCT02300298|75670366|FG000|COMPLETED|Disposition for Nintedanib||0||
59567415|NCT02300298|75670367|FG001|COMPLETED|Disposition for Nintedanib||0||
59567416|NCT02300298|75670366|FG000|NOT COMPLETED|Disposition for Nintedanib||10||
59567417|NCT02300298|75670367|FG001|NOT COMPLETED|Disposition for Nintedanib||0||
59567418|NCT02300298|75670366|FG000|STARTED|Disposition for Docetaxel||0||
59567419|NCT02300298|75670367|FG001|STARTED|Disposition for Docetaxel||10||
59827511|NCT00434876|75950796|FG001|COMPLETED|Overall Study||10||
59827512|NCT00434876|75950795|FG000|NOT COMPLETED|Overall Study||1||
59827513|NCT00434876|75950796|FG001|NOT COMPLETED|Overall Study||1||
59827514|NCT00276094|75950805|FG000|STARTED|Overall Study||282||
59827515|NCT00276094|75950806|FG001|STARTED|Overall Study||276||
59827516|NCT00276094|75950807|FG002|STARTED|Overall Study||268||
59827517|NCT00276094|75950805|FG000|COMPLETED|Overall Study||225||
59827518|NCT00276094|75950806|FG001|COMPLETED|Overall Study||234||
59827519|NCT00276094|75950807|FG002|COMPLETED|Overall Study||230||
59827520|NCT00276094|75950805|FG000|NOT COMPLETED|Overall Study||57||
59827521|NCT00276094|75950806|FG001|NOT COMPLETED|Overall Study||42||
59827522|NCT00276094|75950807|FG002|NOT COMPLETED|Overall Study||38||
59827523|NCT00276016|75950821|FG000|STARTED|Intervention 1||7||
59827524|NCT00276016|75950822|FG001|STARTED|Intervention 1||7||
59567420|NCT02300298|75670366|FG000|COMPLETED|Disposition for Docetaxel||0||
59567421|NCT02300298|75670367|FG001|COMPLETED|Disposition for Docetaxel||0||
59567422|NCT02300298|75670366|FG000|NOT COMPLETED|Disposition for Docetaxel||0||
59827525|NCT00276016|75950823|FG002|STARTED|Intervention 1||7||
59827526|NCT00276016|75950824|FG003|STARTED|Intervention 1||6||
59827527|NCT00276016|75950825|FG004|STARTED|Intervention 1||6||
59827528|NCT00276016|75950826|FG005|STARTED|Intervention 1||6||
59827529|NCT00276016|75950821|FG000|COMPLETED|Intervention 1||7||
59827530|NCT00276016|75950822|FG001|COMPLETED|Intervention 1||6||
59827531|NCT00276016|75950823|FG002|COMPLETED|Intervention 1||7||
59827532|NCT00276016|75950824|FG003|COMPLETED|Intervention 1||6||
59827533|NCT00276016|75950825|FG004|COMPLETED|Intervention 1||6||
59827534|NCT00276016|75950826|FG005|COMPLETED|Intervention 1||6||
59827535|NCT00276016|75950821|FG000|NOT COMPLETED|Intervention 1||0||
59827536|NCT00276016|75950822|FG001|NOT COMPLETED|Intervention 1||1||
59827537|NCT00276016|75950823|FG002|NOT COMPLETED|Intervention 1||0||
59827538|NCT00276016|75950824|FG003|NOT COMPLETED|Intervention 1||0||
59827539|NCT00276016|75950825|FG004|NOT COMPLETED|Intervention 1||0||
59827540|NCT00276016|75950826|FG005|NOT COMPLETED|Intervention 1||0||
59827541|NCT00276016|75950821|FG000|STARTED|Wash Out 1||7||
59827542|NCT00276016|75950822|FG001|STARTED|Wash Out 1||6||
59827543|NCT00276016|75950823|FG002|STARTED|Wash Out 1||7||
59827544|NCT00276016|75950824|FG003|STARTED|Wash Out 1||6||
59827545|NCT00276016|75950825|FG004|STARTED|Wash Out 1||6||
59827546|NCT00276016|75950826|FG005|STARTED|Wash Out 1||6||
59827547|NCT00276016|75950821|FG000|COMPLETED|Wash Out 1||7||
59827548|NCT00276016|75950822|FG001|COMPLETED|Wash Out 1||6||
59827549|NCT00276016|75950823|FG002|COMPLETED|Wash Out 1||7||
59827550|NCT00276016|75950824|FG003|COMPLETED|Wash Out 1||6||
59827551|NCT00276016|75950825|FG004|COMPLETED|Wash Out 1||6||
59827552|NCT00276016|75950826|FG005|COMPLETED|Wash Out 1||6||
59827553|NCT00276016|75950821|FG000|NOT COMPLETED|Wash Out 1||0||
59827554|NCT00276016|75950822|FG001|NOT COMPLETED|Wash Out 1||0||
59827555|NCT00276016|75950823|FG002|NOT COMPLETED|Wash Out 1||0||
59827556|NCT00276016|75950824|FG003|NOT COMPLETED|Wash Out 1||0||
59827557|NCT00276016|75950825|FG004|NOT COMPLETED|Wash Out 1||0||
59827558|NCT00276016|75950826|FG005|NOT COMPLETED|Wash Out 1||0||
59827559|NCT00276016|75950821|FG000|STARTED|Intervention 2||7||
59827560|NCT00276016|75950822|FG001|STARTED|Intervention 2||6||
59827561|NCT00276016|75950823|FG002|STARTED|Intervention 2||7||
59827562|NCT00276016|75950824|FG003|STARTED|Intervention 2||6||
59827563|NCT00276016|75950825|FG004|STARTED|Intervention 2||6||
59827564|NCT00276016|75950826|FG005|STARTED|Intervention 2||6||
59827565|NCT00276016|75950821|FG000|COMPLETED|Intervention 2||7||
59827566|NCT00276016|75950822|FG001|COMPLETED|Intervention 2||6||
59827567|NCT00276016|75950823|FG002|COMPLETED|Intervention 2||7||
59827568|NCT00276016|75950824|FG003|COMPLETED|Intervention 2||6||
59827569|NCT00276016|75950825|FG004|COMPLETED|Intervention 2||6||
59827570|NCT00276016|75950826|FG005|COMPLETED|Intervention 2||6||
59827571|NCT00276016|75950821|FG000|NOT COMPLETED|Intervention 2||0||
59827572|NCT00276016|75950822|FG001|NOT COMPLETED|Intervention 2||0||
59827573|NCT00276016|75950823|FG002|NOT COMPLETED|Intervention 2||0||
59827574|NCT00276016|75950824|FG003|NOT COMPLETED|Intervention 2||0||
59827575|NCT00276016|75950825|FG004|NOT COMPLETED|Intervention 2||0||
60118014|NCT00214539|76239048|FG001|NOT COMPLETED|Steroid Stable (Post-Tx to 22-Weeks)||0||
60118015|NCT00214539|76239047|FG000|STARTED|Reduced Steroid (Post-SS to 52-Weeks)||15||
60118016|NCT00214539|76239048|FG001|STARTED|Reduced Steroid (Post-SS to 52-Weeks)||17||
59716012|NCT01177007|75834775|FG000|Completed First Y90 Treatment|Overall Study||50|Patients completing this milestone were analyzed for survival, safety, and dose outcomes|
59716013|NCT01177007|75834775|FG000|Completed First Clinical and Imaging|Overall Study||43|Patients completing this milestones were assessed for image response outcomes|
59716014|NCT01177007|75834775|FG000|COMPLETED|Overall Study||12|Patients who completed all 12 months on protocol.|
59716015|NCT01177007|75834775|FG000|NOT COMPLETED|Overall Study||38||
59716016|NCT00930982|75834783|FG000|STARTED|Overall Study||60||
59716017|NCT00930982|75834784|FG001|STARTED|Overall Study||64||
59716018|NCT00930982|75834783|FG000|COMPLETED|Overall Study||39||
59716019|NCT00930982|75834784|FG001|COMPLETED|Overall Study||35||
59716020|NCT00930982|75834783|FG000|NOT COMPLETED|Overall Study||21||
59827576|NCT00276016|75950826|FG005|NOT COMPLETED|Intervention 2||0||
59716021|NCT00930982|75834784|FG001|NOT COMPLETED|Overall Study||29||
59716022|NCT01176773|75834790|FG000|STARTED|Overall Study||62||
59827577|NCT00276016|75950821|FG000|STARTED|Wash Out 2||7||
59827578|NCT00276016|75950822|FG001|STARTED|Wash Out 2||6||
59827579|NCT00276016|75950823|FG002|STARTED|Wash Out 2||7||
59827580|NCT00276016|75950824|FG003|STARTED|Wash Out 2||6||
59827581|NCT00276016|75950825|FG004|STARTED|Wash Out 2||6||
59827582|NCT00276016|75950826|FG005|STARTED|Wash Out 2||6||
59827583|NCT00276016|75950821|FG000|COMPLETED|Wash Out 2||7||
59827584|NCT00276016|75950822|FG001|COMPLETED|Wash Out 2||6||
59827585|NCT00276016|75950823|FG002|COMPLETED|Wash Out 2||7||
59827586|NCT00276016|75950824|FG003|COMPLETED|Wash Out 2||6||
59827587|NCT00276016|75950825|FG004|COMPLETED|Wash Out 2||6||
59827588|NCT00276016|75950826|FG005|COMPLETED|Wash Out 2||6||
59827589|NCT00276016|75950821|FG000|NOT COMPLETED|Wash Out 2||0||
59827590|NCT00276016|75950822|FG001|NOT COMPLETED|Wash Out 2||0||
59827591|NCT00276016|75950823|FG002|NOT COMPLETED|Wash Out 2||0||
59827592|NCT00276016|75950824|FG003|NOT COMPLETED|Wash Out 2||0||
59827593|NCT00276016|75950825|FG004|NOT COMPLETED|Wash Out 2||0||
59827594|NCT00276016|75950826|FG005|NOT COMPLETED|Wash Out 2||0||
59827595|NCT00276016|75950821|FG000|STARTED|Intervention 3||7||
59827596|NCT00276016|75950822|FG001|STARTED|Intervention 3||6||
59827597|NCT00276016|75950823|FG002|STARTED|Intervention 3||7||
59827598|NCT00276016|75950824|FG003|STARTED|Intervention 3||6||
59827599|NCT00276016|75950825|FG004|STARTED|Intervention 3||6||
59827600|NCT00276016|75950826|FG005|STARTED|Intervention 3||6||
59827601|NCT00276016|75950821|FG000|COMPLETED|Intervention 3||7||
59827602|NCT00276016|75950822|FG001|COMPLETED|Intervention 3||6||
59827603|NCT00276016|75950823|FG002|COMPLETED|Intervention 3||7||
59827604|NCT00276016|75950824|FG003|COMPLETED|Intervention 3||6||
59827605|NCT00276016|75950825|FG004|COMPLETED|Intervention 3||6||
59827606|NCT00276016|75950826|FG005|COMPLETED|Intervention 3||6||
59827607|NCT00276016|75950821|FG000|NOT COMPLETED|Intervention 3||0||
59827608|NCT00276016|75950822|FG001|NOT COMPLETED|Intervention 3||0||
59827609|NCT00276016|75950823|FG002|NOT COMPLETED|Intervention 3||0||
59827610|NCT00276016|75950824|FG003|NOT COMPLETED|Intervention 3||0||
59827611|NCT00276016|75950825|FG004|NOT COMPLETED|Intervention 3||0||
59827612|NCT00276016|75950826|FG005|NOT COMPLETED|Intervention 3||0||
59827613|NCT00434642|75950837|FG000|STARTED|Blinded Treatment Phase||242||
59827614|NCT00434642|75950838|FG001|STARTED|Blinded Treatment Phase||242||
59827615|NCT00434642|75950837|FG000|COMPLETED|Blinded Treatment Phase||0||
59827616|NCT00434642|75950838|FG001|COMPLETED|Blinded Treatment Phase||13||
59827617|NCT00434642|75950837|FG000|NOT COMPLETED|Blinded Treatment Phase||242||
59827618|NCT00434642|75950838|FG001|NOT COMPLETED|Blinded Treatment Phase||229||
59827619|NCT00434642|75950837|FG000|STARTED|Open-label Treatment Phase||0||
59827620|NCT00434642|75950838|FG001|STARTED|Open-label Treatment Phase|One participant did not continue into the open-label treatment phase.|12||
59827621|NCT00434642|75950837|FG000|COMPLETED|Open-label Treatment Phase||0||
59827622|NCT00434642|75950838|FG001|COMPLETED|Open-label Treatment Phase||1||
59827623|NCT00434642|75950837|FG000|NOT COMPLETED|Open-label Treatment Phase||0||
59827624|NCT00434642|75950838|FG001|NOT COMPLETED|Open-label Treatment Phase||11||
59827625|NCT00434330|75950850|FG000|STARTED|Overall Study||15||
59827626|NCT00434330|75950851|FG001|STARTED|Overall Study||15||
59827627|NCT00434330|75950852|FG002|STARTED|Overall Study||16||
59827628|NCT00434330|75950853|FG003|STARTED|Overall Study||15||
59827629|NCT00434330|75950854|FG004|STARTED|Overall Study||15||
59827630|NCT00434330|75950855|FG005|STARTED|Overall Study||15||
59827631|NCT00434330|75950850|FG000|COMPLETED|Overall Study||14||
59827632|NCT00434330|75950851|FG001|COMPLETED|Overall Study||15||
59827633|NCT00434330|75950852|FG002|COMPLETED|Overall Study||13||
59827634|NCT00434330|75950853|FG003|COMPLETED|Overall Study||13||
59827635|NCT00434330|75950854|FG004|COMPLETED|Overall Study||14||
59827636|NCT00434330|75950855|FG005|COMPLETED|Overall Study||14||
59827637|NCT00434330|75950850|FG000|NOT COMPLETED|Overall Study||1||
59827638|NCT00434330|75950851|FG001|NOT COMPLETED|Overall Study||0||
59827639|NCT00434330|75950852|FG002|NOT COMPLETED|Overall Study||3||
59827640|NCT00434330|75950853|FG003|NOT COMPLETED|Overall Study||2||
59827641|NCT00434330|75950854|FG004|NOT COMPLETED|Overall Study||1||
59827642|NCT00434330|75950855|FG005|NOT COMPLETED|Overall Study||1||
59827643|NCT00426764|75950869|FG000|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|131||
59827644|NCT00426764|75950869|FG000|Discontinued Prior to or During Cycle 6|Overall Study||98||
59827645|NCT00426764|75950869|FG000|Discontinued at End of or After Cycle 6|Overall Study||33||
59827646|NCT00426764|75950869|FG000|COMPLETED|Overall Study||0||
59827647|NCT00426764|75950869|FG000|NOT COMPLETED|Overall Study||131||
59827648|NCT00434252|75950881|FG000|STARTED|Overall Study||71||
59827649|NCT00434252|75950882|FG001|STARTED|Overall Study||143||
59827650|NCT00434252|75950881|FG000|Treated|Overall Study|One patient died and one patient withdrew prior to receiving study treatment|69||
59827651|NCT00434252|75950882|FG001|Treated|Overall Study||143||
59827652|NCT00434252|75950881|FG000|COMPLETED|Overall Study|Continuing study drug treatment at the time of the data cutoff.|7||
59827653|NCT00434252|75950882|FG001|COMPLETED|Overall Study|Continuing study drug treatment at the time of the data cutoff.|12||
59827654|NCT00434252|75950881|FG000|NOT COMPLETED|Overall Study||64||
59827655|NCT00434252|75950882|FG001|NOT COMPLETED|Overall Study||131||
59827656|NCT00425750|75950888|FG000|STARTED|Overall Study||25||
59827657|NCT00425750|75950888|FG000|COMPLETED|Overall Study||0||
59827658|NCT00425750|75950888|FG000|NOT COMPLETED|Overall Study||25||
59827659|NCT00414908|75950894|FG000|STARTED|Overall Study||25||
59827660|NCT00414908|75950895|FG001|STARTED|Overall Study||29||
59827661|NCT00414908|75950894|FG000|COMPLETED|Overall Study||24||
59827662|NCT00414908|75950895|FG001|COMPLETED|Overall Study||28||
59827663|NCT00414908|75950894|FG000|NOT COMPLETED|Overall Study||1||
59827664|NCT00414908|75950895|FG001|NOT COMPLETED|Overall Study||1||
59827665|NCT00242710|75950907|FG000|STARTED|Core Study (up to Year 1)||373||
59827666|NCT00242710|75950908|FG001|STARTED|Core Study (up to Year 1)||353||
59827667|NCT00242710|75950909|FG002|STARTED|Core Study (up to Year 1)||183||
59827668|NCT00242710|75950910|FG003|STARTED|Core Study (up to Year 1)||174||
59827669|NCT00242710|75950907|FG000|Treated|Core Study (up to Year 1)||361||
59827670|NCT00242710|75950908|FG001|Treated|Core Study (up to Year 1)||349||
59827671|NCT00242710|75950909|FG002|Treated|Core Study (up to Year 1)||179||
59827672|NCT00242710|75950910|FG003|Treated|Core Study (up to Year 1)||172||
59827673|NCT00242710|75950907|FG000|COMPLETED|Core Study (up to Year 1)||287||
59827674|NCT00242710|75950908|FG001|COMPLETED|Core Study (up to Year 1)||289||
59827675|NCT00242710|75950909|FG002|COMPLETED|Core Study (up to Year 1)||132||
59827676|NCT00242710|75950910|FG003|COMPLETED|Core Study (up to Year 1)||143||
59827677|NCT00242710|75950907|FG000|NOT COMPLETED|Core Study (up to Year 1)||86||
59827678|NCT00242710|75950908|FG001|NOT COMPLETED|Core Study (up to Year 1)||64||
59827679|NCT00242710|75950909|FG002|NOT COMPLETED|Core Study (up to Year 1)||51||
59827680|NCT00242710|75950910|FG003|NOT COMPLETED|Core Study (up to Year 1)||31||
59827681|NCT00242710|75950907|FG000|STARTED|Period Between Core Study and Extension||287||
59827682|NCT00242710|75950908|FG001|STARTED|Period Between Core Study and Extension||289||
59827683|NCT00242710|75950909|FG002|STARTED|Period Between Core Study and Extension||132||
59827684|NCT00242710|75950910|FG003|STARTED|Period Between Core Study and Extension||143||
59827685|NCT00242710|75950907|FG000|COMPLETED|Period Between Core Study and Extension||168||
59827686|NCT00242710|75950908|FG001|COMPLETED|Period Between Core Study and Extension||177||
59827687|NCT00242710|75950909|FG002|COMPLETED|Period Between Core Study and Extension||84||
59827688|NCT00242710|75950910|FG003|COMPLETED|Period Between Core Study and Extension||94||
59827689|NCT00242710|75950907|FG000|NOT COMPLETED|Period Between Core Study and Extension||119||
59827690|NCT00242710|75950908|FG001|NOT COMPLETED|Period Between Core Study and Extension||112||
59827691|NCT00242710|75950909|FG002|NOT COMPLETED|Period Between Core Study and Extension||48||
59827692|NCT00242710|75950910|FG003|NOT COMPLETED|Period Between Core Study and Extension||49||
59827693|NCT00242710|75950907|FG000|STARTED|Study Extension (up to Year 2)||168||
59827694|NCT00242710|75950908|FG001|STARTED|Study Extension (up to Year 2)||177||
59827695|NCT00242710|75950909|FG002|STARTED|Study Extension (up to Year 2)||84||
59827696|NCT00242710|75950910|FG003|STARTED|Study Extension (up to Year 2)||94||
59827697|NCT00242710|75950907|FG000|COMPLETED|Study Extension (up to Year 2)||141||
59827698|NCT00242710|75950908|FG001|COMPLETED|Study Extension (up to Year 2)||148||
59827699|NCT00242710|75950909|FG002|COMPLETED|Study Extension (up to Year 2)||69||
59827700|NCT00242710|75950910|FG003|COMPLETED|Study Extension (up to Year 2)||84||
59827701|NCT00242710|75950907|FG000|NOT COMPLETED|Study Extension (up to Year 2)||27||
59827702|NCT00242710|75950908|FG001|NOT COMPLETED|Study Extension (up to Year 2)||29||
59827703|NCT00242710|75950909|FG002|NOT COMPLETED|Study Extension (up to Year 2)||15||
59827704|NCT00242710|75950910|FG003|NOT COMPLETED|Study Extension (up to Year 2)||10||
59827705|NCT00408876|75950924|FG000|STARTED|Overall Study||59||
59827706|NCT00408876|75950925|FG001|STARTED|Overall Study||116||
59827707|NCT00408876|75950926|FG002|STARTED|Overall Study||112||
59827708|NCT00408876|75950927|FG003|STARTED|Overall Study||117||
59827709|NCT00408876|75950924|FG000|COMPLETED|Overall Study||43||
59827710|NCT00408876|75950925|FG001|COMPLETED|Overall Study||80||
59827711|NCT00408876|75950926|FG002|COMPLETED|Overall Study||62||
59827712|NCT00408876|75950927|FG003|COMPLETED|Overall Study||82||
59827713|NCT00408876|75950924|FG000|NOT COMPLETED|Overall Study||16||
59827714|NCT00408876|75950925|FG001|NOT COMPLETED|Overall Study||36||
59827715|NCT00408876|75950926|FG002|NOT COMPLETED|Overall Study||50||
59827716|NCT00408876|75950927|FG003|NOT COMPLETED|Overall Study||35||
59827717|NCT00240994|75950937|FG000|STARTED|Overall Study||35||
59827718|NCT00240994|75950937|FG000|COMPLETED|Overall Study||32||
59827719|NCT00240994|75950937|FG000|NOT COMPLETED|Overall Study||3||
59827720|NCT00239590|75950941|FG000|STARTED|Randomized||14||
59827721|NCT00239590|75950942|FG001|STARTED|Randomized||14||
59827722|NCT00239590|75950941|FG000|COMPLETED|Randomized||14||
59827723|NCT00239590|75950942|FG001|COMPLETED|Randomized||12||
59827724|NCT00239590|75950941|FG000|NOT COMPLETED|Randomized||0||
59827725|NCT00239590|75950942|FG001|NOT COMPLETED|Randomized||2||
59827726|NCT00239590|75950941|FG000|STARTED|Started Intervention After Randomization||14||
59827727|NCT00239590|75950942|FG001|STARTED|Started Intervention After Randomization||12||
59827728|NCT00239590|75950941|FG000|COMPLETED|Started Intervention After Randomization||14||
59827729|NCT00239590|75950942|FG001|COMPLETED|Started Intervention After Randomization||12||
59827730|NCT00239590|75950941|FG000|NOT COMPLETED|Started Intervention After Randomization||0||
59827731|NCT00239590|75950942|FG001|NOT COMPLETED|Started Intervention After Randomization||0||
59827732|NCT00239590|75950941|FG000|STARTED|Completed Study Protocol||14||
59827733|NCT00239590|75950942|FG001|STARTED|Completed Study Protocol||12||
59827734|NCT00239590|75950941|FG000|COMPLETED|Completed Study Protocol||13||
60118017|NCT00214539|76239047|FG000|COMPLETED|Reduced Steroid (Post-SS to 52-Weeks)||15||
59827735|NCT00239590|75950942|FG001|COMPLETED|Completed Study Protocol||10||
60118018|NCT00214539|76239048|FG001|COMPLETED|Reduced Steroid (Post-SS to 52-Weeks)||17||
59827736|NCT00239590|75950941|FG000|NOT COMPLETED|Completed Study Protocol||1||
59827737|NCT00239590|75950942|FG001|NOT COMPLETED|Completed Study Protocol||2||
59827738|NCT00433160|75950952|FG000|STARTED|52-Week Double-Blind (DB) Period||137||
59827739|NCT00433160|75950953|FG001|STARTED|52-Week Double-Blind (DB) Period||70||
59827740|NCT00433160|75950952|FG000|Received Treatment|52-Week Double-Blind (DB) Period||136||
60118019|NCT00214539|76239047|FG000|NOT COMPLETED|Reduced Steroid (Post-SS to 52-Weeks)||0||
60118020|NCT00214539|76239048|FG001|NOT COMPLETED|Reduced Steroid (Post-SS to 52-Weeks)||0||
60118021|NCT00215787|76239058|FG000|STARTED|Overall Study||20||
60118022|NCT00215787|76239058|FG000|COMPLETED|Overall Study||20||
59827741|NCT00433160|75950953|FG001|Received Treatment|52-Week Double-Blind (DB) Period||68||
59827742|NCT00433160|75950952|FG000|COMPLETED|52-Week Double-Blind (DB) Period||120||
59827743|NCT00433160|75950953|FG001|COMPLETED|52-Week Double-Blind (DB) Period||60||
59827744|NCT00433160|75950952|FG000|NOT COMPLETED|52-Week Double-Blind (DB) Period||17||
59827745|NCT00433160|75950953|FG001|NOT COMPLETED|52-Week Double-Blind (DB) Period||10||
59827746|NCT00433160|75950952|FG000|STARTED|76 Weeks, 24-Week Open Label (OL) Period|One participant did not continue to first OL period due to adverse event after completing DB period.|119||
59827747|NCT00433160|75950953|FG001|STARTED|76 Weeks, 24-Week Open Label (OL) Period|One participant did not continue to first OL period due to adverse event after completing DB period.|59||
59827748|NCT00433160|75950952|FG000|Received Treatment|76 Weeks, 24-Week Open Label (OL) Period||119||
59827749|NCT00433160|75950953|FG001|Received Treatment|76 Weeks, 24-Week Open Label (OL) Period||59||
59827750|NCT00433160|75950952|FG000|COMPLETED|76 Weeks, 24-Week Open Label (OL) Period||113||
59827751|NCT00433160|75950953|FG001|COMPLETED|76 Weeks, 24-Week Open Label (OL) Period||55||
59827752|NCT00433160|75950952|FG000|NOT COMPLETED|76 Weeks, 24-Week Open Label (OL) Period||6||
59827753|NCT00433160|75950953|FG001|NOT COMPLETED|76 Weeks, 24-Week Open Label (OL) Period||4||
59827754|NCT00433160|75950952|FG000|STARTED|104 Weeks, 28-Week OL Period|Eleven participants withdrew at end of first OL period and did not continue on to second OL period.|102||
59827755|NCT00433160|75950953|FG001|STARTED|104 Weeks, 28-Week OL Period|Five participants withdrew at end of first OL period and did not continue on to second OL period.|50||
59827756|NCT00433160|75950952|FG000|Received Treatment|104 Weeks, 28-Week OL Period||102||
59827757|NCT00433160|75950953|FG001|Received Treatment|104 Weeks, 28-Week OL Period||50||
59827758|NCT00433160|75950952|FG000|COMPLETED|104 Weeks, 28-Week OL Period||92||
59827759|NCT00433160|75950953|FG001|COMPLETED|104 Weeks, 28-Week OL Period||47||
59827760|NCT00433160|75950952|FG000|NOT COMPLETED|104 Weeks, 28-Week OL Period||10||
59827761|NCT00433160|75950953|FG001|NOT COMPLETED|104 Weeks, 28-Week OL Period||3||
59827762|NCT00239356|75950965|FG000|STARTED|Overall Study||97||
59827763|NCT00239356|75950966|FG001|STARTED|Overall Study||20||
59827764|NCT00239356|75950965|FG000|COMPLETED|Overall Study||58||
59827765|NCT00239356|75950966|FG001|COMPLETED|Overall Study||11||
59827766|NCT00239356|75950965|FG000|NOT COMPLETED|Overall Study||39||
59827767|NCT00239356|75950966|FG001|NOT COMPLETED|Overall Study||9||
59827768|NCT00393510|75950974|FG000|STARTED|Overall Study||40||
59827769|NCT00393510|75950975|FG001|STARTED|Overall Study||40||
59827770|NCT00393510|75950974|FG000|COMPLETED|Overall Study||37||
59827771|NCT00393510|75950975|FG001|COMPLETED|Overall Study||31||
59827772|NCT00393510|75950974|FG000|NOT COMPLETED|Overall Study||3||
59827773|NCT00393510|75950975|FG001|NOT COMPLETED|Overall Study||9||
59827774|NCT00425438|75950983|FG000|STARTED|Overall Study||25||
59827775|NCT00425438|75950984|FG001|STARTED|Overall Study||27||
59827776|NCT00425438|75950983|FG000|COMPLETED|Overall Study||0||
59827777|NCT00425438|75950984|FG001|COMPLETED|Overall Study||0||
59827778|NCT00425438|75950983|FG000|NOT COMPLETED|Overall Study||25||
59827779|NCT00425438|75950984|FG001|NOT COMPLETED|Overall Study||27||
59827780|NCT00275002|75950992|FG000|STARTED|Overall Study||25||
59827781|NCT00275002|75950993|FG001|STARTED|Overall Study||16||
59827782|NCT00275002|75950992|FG000|COMPLETED|Overall Study||3||
59827783|NCT00275002|75950993|FG001|COMPLETED|Overall Study||0||
59827784|NCT00275002|75950992|FG000|NOT COMPLETED|Overall Study||22||
59827785|NCT00275002|75950993|FG001|NOT COMPLETED|Overall Study||16||
59827786|NCT00433004|75951001|FG000|STARTED|Overall Study||27||
59827787|NCT00433004|75951002|FG001|STARTED|Overall Study||23||
59827788|NCT00433004|75951001|FG000|COMPLETED|Overall Study||22||
59827789|NCT00433004|75951002|FG001|COMPLETED|Overall Study||16||
59827790|NCT00433004|75951001|FG000|NOT COMPLETED|Overall Study||5||
59827791|NCT00433004|75951002|FG001|NOT COMPLETED|Overall Study||7||
59827792|NCT00238264|75951008|FG000|STARTED|Overall Study||92||
59827793|NCT00238264|75951008|FG000|COMPLETED|Overall Study||56||
59827794|NCT00238264|75951008|FG000|NOT COMPLETED|Overall Study||36||
60118023|NCT00215787|76239058|FG000|NOT COMPLETED|Overall Study||0||
60118024|NCT00955552|76239064|FG000|STARTED|Overall Study||50||
59716023|NCT01176773|75834790|FG000|COMPLETED|Overall Study||59||
59716024|NCT01176773|75834790|FG000|NOT COMPLETED|Overall Study||3||
59716025|NCT00928018|75834797|FG000|STARTED|Overall Study|One Arm A patient withdrew consent, treated as Arm B, but analyzed on Arm A based on intent-to-treat|66||
59716026|NCT00928018|75834798|FG001|STARTED|Overall Study||73||
59716027|NCT00928018|75834797|FG000|COMPLETED|Overall Study||65||
59716028|NCT00928018|75834798|FG001|COMPLETED|Overall Study||73||
59716029|NCT00928018|75834797|FG000|NOT COMPLETED|Overall Study||1||
59716030|NCT00928018|75834798|FG001|NOT COMPLETED|Overall Study||0||
59716031|NCT00927940|75834808|FG000|STARTED|Overall Study||100||
59716032|NCT00927940|75834808|FG000|COMPLETED|Overall Study|A patient died before 30 days follow up. This pasitent is excluded from primary analysis.|99||
59716033|NCT00927940|75834808|FG000|NOT COMPLETED|Overall Study||1||
59827795|NCT00414596|75951012|FG000|STARTED|Overall Study|December 2006|20||
59827796|NCT00414596|75951012|FG000|COMPLETED|Overall Study|April 2007|18||
59827797|NCT00414596|75951012|FG000|NOT COMPLETED|Overall Study||2||
59827798|NCT00393042|75951016|FG000|STARTED|First Intervention||31||
60118025|NCT00955552|76239065|FG001|STARTED|Overall Study||50||
59716034|NCT00927862|75834815|FG000|STARTED|Overall Study||504||
59716035|NCT00927862|75834816|FG001|STARTED|Overall Study||1911||
59716036|NCT00927862|75834815|FG000|COMPLETED|Overall Study|477 patients evaluated in primary analyses and 488 evaluated in secondary analyses.|477||
59716037|NCT00927862|75834816|FG001|COMPLETED|Overall Study||1866||
59716038|NCT00927862|75834815|FG000|NOT COMPLETED|Overall Study||27||
59716039|NCT00927862|75834816|FG001|NOT COMPLETED|Overall Study||45||
59716040|NCT00976989|75834827|FG000|STARTED|Overall Study||73||
59716041|NCT00976989|75834828|FG001|STARTED|Overall Study||75||
59716042|NCT00976989|75834829|FG002|STARTED|Overall Study||77||
59716043|NCT00976989|75834827|FG000|COMPLETED|Overall Study||60||
59716044|NCT00976989|75834828|FG001|COMPLETED|Overall Study||63||
59716045|NCT00976989|75834829|FG002|COMPLETED|Overall Study||60||
59716046|NCT00976989|75834827|FG000|NOT COMPLETED|Overall Study||13||
59716047|NCT00976989|75834828|FG001|NOT COMPLETED|Overall Study||12||
59716048|NCT00976989|75834829|FG002|NOT COMPLETED|Overall Study||17||
59716049|NCT00927784|75834839|FG000|STARTED|Overall Study||8||
59716050|NCT00927784|75834840|FG001|STARTED|Overall Study||2||
59716051|NCT00927784|75834839|FG000|COMPLETED|Overall Study||6||
59716052|NCT00927784|75834840|FG001|COMPLETED|Overall Study||2||
59716053|NCT00927784|75834839|FG000|NOT COMPLETED|Overall Study||2||
59716054|NCT00927784|75834840|FG001|NOT COMPLETED|Overall Study||0||
59716055|NCT05736874|75834848|FG000|STARTED|Overall Study||715||
59716056|NCT05736874|75834849|FG001|STARTED|Overall Study||692||
59716057|NCT05736874|75834848|FG000|COMPLETED|Overall Study||656||
59716058|NCT05736874|75834849|FG001|COMPLETED|Overall Study||621||
59716059|NCT05736874|75834848|FG000|NOT COMPLETED|Overall Study||59||
59716060|NCT05736874|75834849|FG001|NOT COMPLETED|Overall Study||71||
59716061|NCT05056987|75834857|FG000|STARTED|First Wear Period, Day 14 or Day 28||18||36
59716062|NCT05056987|75834858|FG001|STARTED|First Wear Period, Day 14 or Day 28||18||36
59716063|NCT05056987|75834857|FG000|COMPLETED|First Wear Period, Day 14 or Day 28||17||34
59716064|NCT05056987|75834858|FG001|COMPLETED|First Wear Period, Day 14 or Day 28||16||32
59716065|NCT05056987|75834857|FG000|NOT COMPLETED|First Wear Period, Day 14 or Day 28||1||2
59716066|NCT05056987|75834858|FG001|NOT COMPLETED|First Wear Period, Day 14 or Day 28||2||4
59716067|NCT05056987|75834857|FG000|STARTED|Second Wear Period, Day 14 or Day 28||17||34
59716068|NCT05056987|75834858|FG001|STARTED|Second Wear Period, Day 14 or Day 28||16||32
59716069|NCT05056987|75834857|FG000|COMPLETED|Second Wear Period, Day 14 or Day 28||17||34
59716070|NCT05056987|75834858|FG001|COMPLETED|Second Wear Period, Day 14 or Day 28||16||32
59716071|NCT05056987|75834857|FG000|NOT COMPLETED|Second Wear Period, Day 14 or Day 28||0||0
59716072|NCT05056987|75834858|FG001|NOT COMPLETED|Second Wear Period, Day 14 or Day 28||0||0
59716073|NCT03853707|75834870|FG000|STARTED|Overall Study||10||
59716074|NCT03853707|75834871|FG001|STARTED|Overall Study||12||
59716075|NCT03853707|75834872|FG002|STARTED|Overall Study||6||
59716076|NCT03853707|75834870|FG000|COMPLETED|Overall Study||10||
59716077|NCT03853707|75834871|FG001|COMPLETED|Overall Study||12||
59716078|NCT03853707|75834872|FG002|COMPLETED|Overall Study||6||
59716079|NCT03853707|75834870|FG000|NOT COMPLETED|Overall Study||0||
59716080|NCT03853707|75834871|FG001|NOT COMPLETED|Overall Study||0||
59716081|NCT03853707|75834872|FG002|NOT COMPLETED|Overall Study||0||
59716082|NCT03751371|75834882|FG000|STARTED|Overall Study||23||
59716083|NCT03751371|75834883|FG001|STARTED|Overall Study||22||
59716084|NCT03751371|75834882|FG000|COMPLETED|Overall Study||20||
59716085|NCT03751371|75834883|FG001|COMPLETED|Overall Study||20||
59716086|NCT03751371|75834882|FG000|NOT COMPLETED|Overall Study||3||
59716087|NCT03751371|75834883|FG001|NOT COMPLETED|Overall Study||2||
59716088|NCT03439852|75834891|FG000|STARTED|Baseline to 12 Weeks||12|baseline enrollment|
59716089|NCT03439852|75834892|FG001|STARTED|Baseline to 12 Weeks||23|baseline enrollment|
59716090|NCT03439852|75834891|FG000|COMPLETED|Baseline to 12 Weeks||8|Completed 12 wk survey|
59716091|NCT03439852|75834892|FG001|COMPLETED|Baseline to 12 Weeks||16|Completed 12 wk survey|
59827799|NCT00393042|75951017|FG001|STARTED|First Intervention||33||
59827800|NCT00393042|75951016|FG000|Completed the Placebo Dosage|First Intervention||27||
59827801|NCT00393042|75951017|FG001|Completed the Placebo Dosage|First Intervention||29||
59827802|NCT00393042|75951016|FG000|Completed 10mg Dosage|First Intervention||29||
59827803|NCT00393042|75951017|FG001|Completed 10mg Dosage|First Intervention||29||
59827804|NCT00393042|75951016|FG000|Completed 20 mg Dosage|First Intervention||26||
59827805|NCT00393042|75951017|FG001|Completed 20 mg Dosage|First Intervention||28||
59827806|NCT00393042|75951016|FG000|Completed 25/30mg Dosage|First Intervention||27||
59827807|NCT00393042|75951017|FG001|Completed 25/30mg Dosage|First Intervention||27||
59827808|NCT00393042|75951016|FG000|COMPLETED|First Intervention||26||
59827809|NCT00393042|75951017|FG001|COMPLETED|First Intervention||27||
59827810|NCT00393042|75951016|FG000|NOT COMPLETED|First Intervention||5||
59827811|NCT00393042|75951017|FG001|NOT COMPLETED|First Intervention||6||
59827812|NCT00393042|75951016|FG000|STARTED|Second Intervetion||26||
59827813|NCT00393042|75951017|FG001|STARTED|Second Intervetion||27||
59827814|NCT00393042|75951016|FG000|Completed Placebo Dosage|Second Intervetion||25||
59827815|NCT00393042|75951017|FG001|Completed Placebo Dosage|Second Intervetion||21||
59827816|NCT00393042|75951016|FG000|Completed 10 mg Dosage|Second Intervetion||26||
59827817|NCT00393042|75951017|FG001|Completed 10 mg Dosage|Second Intervetion||24||
59827818|NCT00393042|75951016|FG000|Completed the 20mg Dosage|Second Intervetion||24||
59827819|NCT00393042|75951017|FG001|Completed the 20mg Dosage|Second Intervetion||21||
59827820|NCT00393042|75951016|FG000|Completed 25/30 mg Dosage|Second Intervetion||24||
59827821|NCT00393042|75951017|FG001|Completed 25/30 mg Dosage|Second Intervetion||20||
59827822|NCT00393042|75951016|FG000|COMPLETED|Second Intervetion||24||
59827823|NCT00393042|75951017|FG001|COMPLETED|Second Intervetion||19||
59827824|NCT00393042|75951016|FG000|NOT COMPLETED|Second Intervetion||2||
59827825|NCT00393042|75951017|FG001|NOT COMPLETED|Second Intervetion||8||
59827826|NCT00392808|75951075|FG000|STARTED|Overall Study||87||
59827827|NCT00392808|75951076|FG001|STARTED|Overall Study||89||
59827828|NCT00392808|75951077|FG002|STARTED|Overall Study||109||
59827829|NCT00392808|75951078|FG003|STARTED|Overall Study||104||
59827830|NCT00392808|75951075|FG000|COMPLETED|Overall Study||81||
59827831|NCT00392808|75951076|FG001|COMPLETED|Overall Study||86||
59827832|NCT00392808|75951077|FG002|COMPLETED|Overall Study||107||
59827833|NCT00392808|75951078|FG003|COMPLETED|Overall Study||100||
59827834|NCT00392808|75951075|FG000|NOT COMPLETED|Overall Study||6||
59827835|NCT00392808|75951076|FG001|NOT COMPLETED|Overall Study||3||
59827836|NCT00392808|75951077|FG002|NOT COMPLETED|Overall Study||2||
59827837|NCT00392808|75951078|FG003|NOT COMPLETED|Overall Study||4||
59827838|NCT03546192|75951090|FG000|STARTED|Overall Study||60||
59827839|NCT03546192|75951091|FG001|STARTED|Overall Study||60||
59827840|NCT03546192|75951090|FG000|COMPLETED|Overall Study||60||
59827841|NCT03546192|75951091|FG001|COMPLETED|Overall Study||60||
59827842|NCT03546192|75951090|FG000|NOT COMPLETED|Overall Study||0||
59827843|NCT03546192|75951091|FG001|NOT COMPLETED|Overall Study||0||
59827844|NCT00274846|75951097|FG000|STARTED|Overall Study||21||
59827845|NCT00274846|75951097|FG000|COMPLETED|Overall Study|Evaluable patients - received adequate natural killer (NK) cells|20||
59827846|NCT00274846|75951097|FG000|NOT COMPLETED|Overall Study||1||
59827847|NCT00237796|75951104|FG000|STARTED|Overall Study||41||
59827848|NCT00237796|75951105|FG001|STARTED|Overall Study||38||
59827849|NCT00237796|75951104|FG000|COMPLETED|Overall Study||31||
59827850|NCT00237796|75951105|FG001|COMPLETED|Overall Study||33||
59827851|NCT00237796|75951104|FG000|NOT COMPLETED|Overall Study||10||
59827852|NCT00237796|75951105|FG001|NOT COMPLETED|Overall Study||5||
59827853|NCT00414440|75951114|FG000|STARTED|Core Period|Core period|214||
59827854|NCT00414440|75951115|FG001|STARTED|Core Period|Core period|217||
59827855|NCT00414440|75951114|FG000|COMPLETED|Core Period|Core period|144||
59827856|NCT00414440|75951115|FG001|COMPLETED|Core Period|Core period|185||
59827857|NCT00414440|75951114|FG000|NOT COMPLETED|Core Period||70||
59827858|NCT00414440|75951115|FG001|NOT COMPLETED|Core Period||32||
59827859|NCT00414440|75951114|FG000|STARTED|Extension Period|Extension|214||
59827860|NCT00414440|75951115|FG001|STARTED|Extension Period|Extension|217||
59827861|NCT00414440|75951114|FG000|COMPLETED|Extension Period|Extension|64||
59827862|NCT00414440|75951115|FG001|COMPLETED|Extension Period|Extension|77||
59827863|NCT00414440|75951114|FG000|NOT COMPLETED|Extension Period||150||
59827864|NCT00414440|75951115|FG001|NOT COMPLETED|Extension Period||140||
59827865|NCT00209560|75951123|FG000|STARTED|Overall Study||121||
59827866|NCT00209560|75951124|FG001|STARTED|Overall Study||42||
59827867|NCT00209560|75951123|FG000|COMPLETED|Overall Study||120||
59827868|NCT00209560|75951124|FG001|COMPLETED|Overall Study||42||
59827869|NCT00209560|75951123|FG000|NOT COMPLETED|Overall Study||1||
59827870|NCT00209560|75951124|FG001|NOT COMPLETED|Overall Study||0||
59827871|NCT00236080|75951135|FG000|STARTED|Overall Study||29||
59827872|NCT00236080|75951136|FG001|STARTED|Overall Study||28||
59827873|NCT00236080|75951137|FG002|STARTED|Overall Study||27||
59827874|NCT00236080|75951138|FG003|STARTED|Overall Study||25||
59827875|NCT00236080|75951139|FG004|STARTED|Overall Study||27||
59827876|NCT00236080|75951135|FG000|COMPLETED|Overall Study||27||
59827877|NCT00236080|75951136|FG001|COMPLETED|Overall Study||27||
59827878|NCT00236080|75951137|FG002|COMPLETED|Overall Study||22||
59827879|NCT00236080|75951138|FG003|COMPLETED|Overall Study||23||
59827880|NCT00236080|75951139|FG004|COMPLETED|Overall Study||26||
59827881|NCT00236080|75951135|FG000|NOT COMPLETED|Overall Study||2||
59827882|NCT00236080|75951136|FG001|NOT COMPLETED|Overall Study||1||
59827883|NCT00236080|75951137|FG002|NOT COMPLETED|Overall Study||5||
59827884|NCT00236080|75951138|FG003|NOT COMPLETED|Overall Study||2||
59827885|NCT00236080|75951139|FG004|NOT COMPLETED|Overall Study||1||
59827886|NCT00432380|75951154|FG000|STARTED|Overall Study||150||
59827887|NCT00432380|75951155|FG001|STARTED|Overall Study||150||
59827888|NCT00432380|75951156|FG002|STARTED|Overall Study||75||
59827889|NCT00432380|75951154|FG000|COMPLETED|Overall Study||146||
59827890|NCT00432380|75951155|FG001|COMPLETED|Overall Study||146||
59827891|NCT00432380|75951156|FG002|COMPLETED|Overall Study||74||
59827892|NCT00432380|75951154|FG000|NOT COMPLETED|Overall Study||4||
59827893|NCT00432380|75951155|FG001|NOT COMPLETED|Overall Study||4||
59827894|NCT00432380|75951156|FG002|NOT COMPLETED|Overall Study||1||
59827895|NCT00234052|75951165|FG000|STARTED|Treatment||51||
59827896|NCT00234052|75951165|FG000|Started Treatment|Treatment||50||
59827897|NCT00234052|75951165|FG000|Completed 6 Cycles|Treatment||33||
59827898|NCT00234052|75951165|FG000|Went Into Maintenance Phase|Treatment||30||
59827899|NCT00234052|75951165|FG000|COMPLETED|Treatment||30||
59827900|NCT00234052|75951165|FG000|NOT COMPLETED|Treatment||21||
59827901|NCT00234052|75951165|FG000|STARTED|Follow-up for 5 Years|All patients that are treated on study go into the follow up period.|50||
59827902|NCT00234052|75951165|FG000|COMPLETED|Follow-up for 5 Years||1||
59827903|NCT00234052|75951165|FG000|NOT COMPLETED|Follow-up for 5 Years||49||
59827904|NCT00408408|75951175|FG000|STARTED|Overall Study||201||
59827905|NCT00408408|75951176|FG001|STARTED|Overall Study||199||
59827906|NCT00408408|75951177|FG002|STARTED|Overall Study||204||
59827907|NCT00408408|75951178|FG003|STARTED|Overall Study||201||
59827908|NCT00408408|75951179|FG004|STARTED|Overall Study||197||
59827909|NCT00408408|75951180|FG005|STARTED|Overall Study||204||
59827910|NCT00408408|75951175|FG000|COMPLETED|Overall Study||199||
59827911|NCT00408408|75951176|FG001|COMPLETED|Overall Study||196||
59827912|NCT00408408|75951177|FG002|COMPLETED|Overall Study||204||
59827913|NCT00408408|75951178|FG003|COMPLETED|Overall Study||194||
59827914|NCT00408408|75951179|FG004|COMPLETED|Overall Study||192||
59827915|NCT00408408|75951180|FG005|COMPLETED|Overall Study||201||
59827916|NCT00408408|75951175|FG000|NOT COMPLETED|Overall Study||2||
59827917|NCT00408408|75951176|FG001|NOT COMPLETED|Overall Study||3||
59827918|NCT00408408|75951177|FG002|NOT COMPLETED|Overall Study||0||
59827919|NCT00408408|75951178|FG003|NOT COMPLETED|Overall Study||7||
59827920|NCT00408408|75951179|FG004|NOT COMPLETED|Overall Study||5||
59827921|NCT00408408|75951180|FG005|NOT COMPLETED|Overall Study||3||
59827922|NCT00414050|75951198|FG000|STARTED|Overall Study||431||
59827923|NCT00414050|75951199|FG001|STARTED|Overall Study||427||
59827924|NCT00414050|75951200|FG002|STARTED|Overall Study||429||
59827925|NCT00414050|75951201|FG003|STARTED|Overall Study||431||
59827926|NCT00414050|75951198|FG000|Received Vaccination 1|Overall Study||431||
59827927|NCT00414050|75951199|FG001|Received Vaccination 1|Overall Study||426||
59827928|NCT00414050|75951200|FG002|Received Vaccination 1|Overall Study||429||
59827929|NCT00414050|75951201|FG003|Received Vaccination 1|Overall Study||431||
59827930|NCT00414050|75951198|FG000|Received Vaccination 2|Overall Study||425||
59827931|NCT00414050|75951199|FG001|Received Vaccination 2|Overall Study||421||
59827932|NCT00414050|75951200|FG002|Received Vaccination 2|Overall Study||425||
59827933|NCT00414050|75951201|FG003|Received Vaccination 2|Overall Study||425||
59827934|NCT00414050|75951198|FG000|Received Vaccination 3|Overall Study||424||
59827935|NCT00414050|75951199|FG001|Received Vaccination 3|Overall Study||419||
59827936|NCT00414050|75951200|FG002|Received Vaccination 3|Overall Study||425||
59827937|NCT00414050|75951201|FG003|Received Vaccination 3|Overall Study||424||
59827938|NCT00414050|75951198|FG000|COMPLETED|Overall Study||422||
59827939|NCT00414050|75951199|FG001|COMPLETED|Overall Study||419||
59827940|NCT00414050|75951200|FG002|COMPLETED|Overall Study||423||
59827941|NCT00414050|75951201|FG003|COMPLETED|Overall Study||423||
59827942|NCT00414050|75951198|FG000|NOT COMPLETED|Overall Study||9||
59827943|NCT00414050|75951199|FG001|NOT COMPLETED|Overall Study||8||
59827944|NCT00414050|75951200|FG002|NOT COMPLETED|Overall Study||6||
59827945|NCT00414050|75951201|FG003|NOT COMPLETED|Overall Study||8||
60118026|NCT00955552|76239064|FG000|COMPLETED|Overall Study||44||
59827946|NCT00413972|75951215|FG000|STARTED|Overall Study|1 of the 98 randomized subjects was not treated and was excluded from the ITT data set.|98||
59827947|NCT00413972|75951216|FG001|STARTED|Overall Study|1 of the 98 randomized subjects was not treated and was excluded from the ITT data set.|98||
59827948|NCT00413972|75951217|FG002|STARTED|Overall Study||98||
59827949|NCT00413972|75951218|FG003|STARTED|Overall Study|1 of the 98 randomized subjects was not treated and was excluded from the ITT data set.|98||
59827950|NCT00413972|75951215|FG000|COMPLETED|Overall Study||91||
59827951|NCT00413972|75951216|FG001|COMPLETED|Overall Study||90||
59827952|NCT00413972|75951217|FG002|COMPLETED|Overall Study||88||
59827953|NCT00413972|75951218|FG003|COMPLETED|Overall Study||95||
59827954|NCT00413972|75951215|FG000|NOT COMPLETED|Overall Study||7||
59827955|NCT00413972|75951216|FG001|NOT COMPLETED|Overall Study||8||
59827956|NCT00413972|75951217|FG002|NOT COMPLETED|Overall Study||10||
59827957|NCT00413972|75951218|FG003|NOT COMPLETED|Overall Study||3||
59827958|NCT00259012|75951230|FG000|STARTED|Overall Study||33||
59827959|NCT00259012|75951231|FG001|STARTED|Overall Study||34||
59827960|NCT00259012|75951230|FG000|COMPLETED|Overall Study||31||
59827961|NCT00259012|75951231|FG001|COMPLETED|Overall Study||30||
59827962|NCT00259012|75951230|FG000|NOT COMPLETED|Overall Study||2||
59827963|NCT00259012|75951231|FG001|NOT COMPLETED|Overall Study||4||
59567423|NCT02300298|75670367|FG001|NOT COMPLETED|Disposition for Docetaxel||10||
59567424|NCT02300220|75670373|FG000|STARTED|Overall Study||72||
59567425|NCT02300220|75670374|FG001|STARTED|Overall Study||72||
59567426|NCT02300220|75670373|FG000|COMPLETED|Overall Study||68||
59567427|NCT02300220|75670374|FG001|COMPLETED|Overall Study||65||
59567428|NCT02300220|75670373|FG000|NOT COMPLETED|Overall Study||4||
59567429|NCT02300220|75670374|FG001|NOT COMPLETED|Overall Study||7||
59567430|NCT01379469|75670382|FG000|STARTED|Overall Study||13||
59567431|NCT01379469|75670383|FG001|STARTED|Overall Study||7||
59567432|NCT01379469|75670382|FG000|COMPLETED|Overall Study||1||
59567433|NCT01379469|75670383|FG001|COMPLETED|Overall Study||3||
59567434|NCT01379469|75670382|FG000|NOT COMPLETED|Overall Study||12||
59567435|NCT01379469|75670383|FG001|NOT COMPLETED|Overall Study||4||
59567436|NCT01309581|75670391|FG000|STARTED|Overall Study||2||
59567437|NCT01309581|75670392|FG001|STARTED|Overall Study||1||
59567438|NCT01309581|75670391|FG000|COMPLETED|Overall Study||2||
59567439|NCT01309581|75670392|FG001|COMPLETED|Overall Study||1||
59567440|NCT01309581|75670391|FG000|NOT COMPLETED|Overall Study||0||
59567441|NCT01309581|75670392|FG001|NOT COMPLETED|Overall Study||0||
59567442|NCT02327130|75670398|FG000|STARTED|Overall Study||32||
59716092|NCT03439852|75834891|FG000|NOT COMPLETED|Baseline to 12 Weeks||4||
59716093|NCT03439852|75834892|FG001|NOT COMPLETED|Baseline to 12 Weeks||7||
59716094|NCT03439852|75834891|FG000|STARTED|12weeks to 24weeks||8||
59716095|NCT03439852|75834892|FG001|STARTED|12weeks to 24weeks||16||
59716096|NCT03439852|75834891|FG000|COMPLETED|12weeks to 24weeks||6||
59716097|NCT03439852|75834892|FG001|COMPLETED|12weeks to 24weeks||16||
59716098|NCT03439852|75834891|FG000|NOT COMPLETED|12weeks to 24weeks||2||
59716099|NCT03439852|75834892|FG001|NOT COMPLETED|12weeks to 24weeks||0||
59716100|NCT03439852|75834891|FG000|STARTED|24 Weeks to 36 Weeks Follow up||6||
59716101|NCT03439852|75834892|FG001|STARTED|24 Weeks to 36 Weeks Follow up||16||
59827964|NCT00209170|75951239|FG000|STARTED|Overall Study||7||
59827965|NCT00209170|75951240|FG001|STARTED|Overall Study||7||
59827966|NCT00209170|75951239|FG000|COMPLETED|Overall Study||5||
59827967|NCT00209170|75951240|FG001|COMPLETED|Overall Study||4||
59827968|NCT00209170|75951239|FG000|NOT COMPLETED|Overall Study||2||
59827969|NCT00209170|75951240|FG001|NOT COMPLETED|Overall Study||3||
59567443|NCT02327130|75670398|FG000|COMPLETED|Overall Study||20||
59567444|NCT02327130|75670398|FG000|NOT COMPLETED|Overall Study||12||
59567445|NCT02665221|75670407|FG000|STARTED|Overall Study||15||
59716102|NCT03439852|75834891|FG000|COMPLETED|24 Weeks to 36 Weeks Follow up||5||
59716103|NCT03439852|75834892|FG001|COMPLETED|24 Weeks to 36 Weeks Follow up||16||
59716104|NCT03439852|75834891|FG000|NOT COMPLETED|24 Weeks to 36 Weeks Follow up||1||
59716105|NCT03439852|75834892|FG001|NOT COMPLETED|24 Weeks to 36 Weeks Follow up||0||
59716106|NCT03355300|75834903|FG000|STARTED|Overall Study||5||
59716107|NCT03355300|75834904|FG001|STARTED|Overall Study||6||
59827970|NCT00413894|75951246|FG000|STARTED|Overall Study||424||
59827971|NCT00413894|75951246|FG000|COMPLETED|Overall Study||344||
59827972|NCT00413894|75951246|FG000|NOT COMPLETED|Overall Study||80||
59827973|NCT00407550|75951255|FG000|STARTED|Overall Study||10||
59827974|NCT00407550|75951256|FG001|STARTED|Overall Study||9||
59827975|NCT00407550|75951255|FG000|COMPLETED|Overall Study||7||
59827976|NCT00407550|75951256|FG001|COMPLETED|Overall Study||5||
59827977|NCT00407550|75951255|FG000|NOT COMPLETED|Overall Study||3||
59827978|NCT00407550|75951256|FG001|NOT COMPLETED|Overall Study||4||
59827979|NCT00209092|75951264|FG000|STARTED|Overall Study||25||
59567446|NCT02665221|75670408|FG001|STARTED|Overall Study||15||
60118027|NCT00955552|76239065|FG001|COMPLETED|Overall Study||45||
59567447|NCT02665221|75670407|FG000|COMPLETED|Overall Study||0||
59827980|NCT00209092|75951265|FG001|STARTED|Overall Study||26||
59567448|NCT02665221|75670408|FG001|COMPLETED|Overall Study||0||
59567449|NCT02665221|75670407|FG000|NOT COMPLETED|Overall Study||15||
59567450|NCT02665221|75670408|FG001|NOT COMPLETED|Overall Study||15||
59827981|NCT00209092|75951264|FG000|COMPLETED|Overall Study||17||
59827982|NCT00209092|75951265|FG001|COMPLETED|Overall Study||24||
59827983|NCT00209092|75951264|FG000|NOT COMPLETED|Overall Study||8||
59827984|NCT00209092|75951265|FG001|NOT COMPLETED|Overall Study||2||
59827985|NCT00403494|75951273|FG000|STARTED|Overall Study||96||
59827986|NCT00403494|75951274|FG001|STARTED|Overall Study||94||
59827987|NCT00403494|75951273|FG000|Intent to Treat|Overall Study||87|All subjects who were randomized, received 1 dose of study drug and had at least 1 post-baseline treadmill assessment,|
59827988|NCT00403494|75951274|FG001|Intent to Treat|Overall Study||83|All subjects who were randomized, received 1 dose of study drug and had at least 1 post-baseline treadmill assessment,|
59827989|NCT00403494|75951273|FG000|Per-protocol|Overall Study||69|The Per-protocol population will exclude subjects with major protocol deviations or noncompliance of study procedures. Including subjects that did not complete week 24 treadmill test, took less than 80% of the randomized study drug, and/or experienced any acute confounding events preventing them from taking proper treadmill tests.|
59827990|NCT00403494|75951274|FG001|Per-protocol|Overall Study||69|The Per-protocol population will exclude subjects with major protocol deviations or noncompliance of study procedures. Including subjects that did not complete week 24 treadmill test, took less than 80% of the randomized study drug, and/or experienced any acute confounding events preventing them from taking proper treadmill tests.|
59827991|NCT00403494|75951273|FG000|Safety Population|Overall Study||97|Of the 188 patients (96 randomized to study drug and 94 to placebo.) 2 subjects randomized to receive placebo, received at least 1 dose of study drug and were included in the study drug group. 1 participant from each group was excluded from the safety analysis because they did not have at least 1 post-Baseline safety assessment.|
59827992|NCT00403494|75951274|FG001|Safety Population|Overall Study||91|Of the 188 patients (96 randomized to study drug and 94 to placebo.) 2 subjects randomized to receive placebo, received at least 1 dose of study drug and were included in the study drug group. 1 participant from each group was excluded from the safety analysis because they did not have at least 1 post-Baseline safety assessment.|
59827993|NCT00403494|75951273|FG000|COMPLETED|Overall Study||81||
59827994|NCT00403494|75951274|FG001|COMPLETED|Overall Study||80||
59827995|NCT00403494|75951273|FG000|NOT COMPLETED|Overall Study||15||
59827996|NCT00403494|75951274|FG001|NOT COMPLETED|Overall Study||14||
59827997|NCT00403260|75951284|FG000|STARTED|Overall Study|Patients randomized and treated.|848||
59827998|NCT00403260|75951285|FG001|STARTED|Overall Study|Patients randomized and treated.|423||
59827999|NCT00403260|75951284|FG000|COMPLETED|Overall Study||723||
59828000|NCT00403260|75951285|FG001|COMPLETED|Overall Study||357||
59828001|NCT00403260|75951284|FG000|NOT COMPLETED|Overall Study||125||
59828002|NCT00403260|75951285|FG001|NOT COMPLETED|Overall Study||66||
59828003|NCT00406848|75951293|FG000|STARTED|Overall Study|Represents full safety analysis population. Efficacy analysis population (c,d,e) N=204.|249||
59828004|NCT00406848|75951294|FG001|STARTED|Overall Study|Represents full safety analysis population. Efficacy analysis population (c,d,e) N=95.|121||
59828005|NCT00406848|75951293|FG000|COMPLETED|Overall Study||156||
59828006|NCT00406848|75951294|FG001|COMPLETED|Overall Study||67||
59828007|NCT00406848|75951293|FG000|NOT COMPLETED|Overall Study||93||
59828008|NCT00406848|75951294|FG001|NOT COMPLETED|Overall Study||54||
59828009|NCT00406692|75951303|FG000|STARTED|Overall Study||16||
59828010|NCT00406692|75951303|FG000|COMPLETED|Overall Study||9||
59828011|NCT00406692|75951303|FG000|NOT COMPLETED|Overall Study||7||
59828012|NCT00315705|75951309|FG000|STARTED|Phase 1||25||
59828013|NCT00315705|75951309|FG000|COMPLETED|Phase 1|No Phase 1 participants completed the treatment period (i.e. all 8 cycles and follow-up)|0||
59828014|NCT00315705|75951309|FG000|NOT COMPLETED|Phase 1||25||
59828015|NCT00315705|75951309|FG000|STARTED|Phase 2|Phase 1 and phase 2 are separate populations|25||
59828016|NCT00315705|75951309|FG000|COMPLETED|Phase 2|No Phase 2 participants completed the treatment period (i.e. all 8 cycles and follow-up)|0||
59828017|NCT00315705|75951309|FG000|NOT COMPLETED|Phase 2||25||
59828018|NCT00307125|75951328|FG000|STARTED|Screening Phase||757||
59828019|NCT00307125|75951329|FG001|STARTED|Screening Phase||0||
60118028|NCT00955552|76239064|FG000|NOT COMPLETED|Overall Study||6||
60118029|NCT00955552|76239065|FG001|NOT COMPLETED|Overall Study||5||
60118030|NCT00216099|76239071|FG000|STARTED|Overall Study||49||
60118031|NCT00216099|76239071|FG000|Toxicity Analysis|Overall Study||49||
60118032|NCT00216099|76239071|FG000|Response Analysis|Overall Study||48||
60118033|NCT00216099|76239071|FG000|COMPLETED|Overall Study||48||
60118034|NCT00216099|76239071|FG000|NOT COMPLETED|Overall Study||1||
60118035|NCT00039195|76239075|FG000|STARTED|Overall Study||98||
60118036|NCT00039195|76239075|FG000|COMPLETED|Overall Study||98||
60118037|NCT00039195|76239075|FG000|NOT COMPLETED|Overall Study||0||
60118038|NCT00218439|76239081|FG000|STARTED|First Intervention (4 Weeks)||58||
60118039|NCT00218439|76239082|FG001|STARTED|First Intervention (4 Weeks)||47||
60118040|NCT00218439|76239081|FG000|COMPLETED|First Intervention (4 Weeks)||40||
59567451|NCT00554294|75670416|FG000|STARTED|Overall Study||1469||
59828020|NCT00307125|75951330|FG002|STARTED|Screening Phase||0||
59828021|NCT00307125|75951328|FG000|COMPLETED|Screening Phase||303||
59828022|NCT00307125|75951329|FG001|COMPLETED|Screening Phase||0||
59828023|NCT00307125|75951330|FG002|COMPLETED|Screening Phase||0||
59828024|NCT00307125|75951328|FG000|NOT COMPLETED|Screening Phase||454||
59828025|NCT00307125|75951329|FG001|NOT COMPLETED|Screening Phase||0||
59828026|NCT00307125|75951330|FG002|NOT COMPLETED|Screening Phase||0||
59828027|NCT00307125|75951328|FG000|STARTED|Pilot Phase||0||
59828028|NCT00307125|75951329|FG001|STARTED|Pilot Phase||15||
59828029|NCT00307125|75951330|FG002|STARTED|Pilot Phase||7||
59828030|NCT00307125|75951328|FG000|COMPLETED|Pilot Phase||0||
59828031|NCT00307125|75951329|FG001|COMPLETED|Pilot Phase|2 participants had reduced follow-up|13||
59828032|NCT00307125|75951330|FG002|COMPLETED|Pilot Phase|1 participant had reduced follow-up|6||
59828033|NCT00307125|75951328|FG000|NOT COMPLETED|Pilot Phase||0||
59828034|NCT00307125|75951329|FG001|NOT COMPLETED|Pilot Phase||2||
59828035|NCT00307125|75951330|FG002|NOT COMPLETED|Pilot Phase||1||
59828036|NCT00307047|75951342|FG000|STARTED|Overall Study||2458||
59828037|NCT00307047|75951343|FG001|STARTED|Overall Study||1229||
59828038|NCT00307047|75951342|FG000|COMPLETED|Overall Study||2389||
59828039|NCT00307047|75951343|FG001|COMPLETED|Overall Study||1180||
59828040|NCT00307047|75951342|FG000|NOT COMPLETED|Overall Study||69||
59828041|NCT00307047|75951343|FG001|NOT COMPLETED|Overall Study||49||
59828042|NCT00306891|75951353|FG000|STARTED|Part A||23||
59828043|NCT00306891|75951354|FG001|STARTED|Part A||22||
59828044|NCT00306891|75951355|FG002|STARTED|Part A||0||
59828045|NCT00306891|75951356|FG003|STARTED|Part A||0||
59828046|NCT00306891|75951353|FG000|COMPLETED|Part A||18||
59828047|NCT00306891|75951354|FG001|COMPLETED|Part A||16||
59828048|NCT00306891|75951355|FG002|COMPLETED|Part A||0||
59828049|NCT00306891|75951356|FG003|COMPLETED|Part A||0||
59828050|NCT00306891|75951353|FG000|NOT COMPLETED|Part A||5||
59828051|NCT00306891|75951354|FG001|NOT COMPLETED|Part A||6||
59828052|NCT00306891|75951355|FG002|NOT COMPLETED|Part A||0||
59828053|NCT00306891|75951356|FG003|NOT COMPLETED|Part A||0||
59828054|NCT00306891|75951353|FG000|STARTED|Part B||0||
59828055|NCT00306891|75951354|FG001|STARTED|Part B||0||
59828056|NCT00306891|75951355|FG002|STARTED|Part B|In Part B: Cediranib 45 mg Fixed Dose 4 new patients were randomized|16||
59828057|NCT00306891|75951356|FG003|STARTED|Part B|in Part B: Cediranib Dose Escalation 11 new patients were randomized.|31||
59828058|NCT00306891|75951353|FG000|COMPLETED|Part B||0||
59828059|NCT00306891|75951354|FG001|COMPLETED|Part B||0||
59828060|NCT00306891|75951355|FG002|COMPLETED|Part B||5||
59828061|NCT00306891|75951356|FG003|COMPLETED|Part B||14||
59828062|NCT00306891|75951353|FG000|NOT COMPLETED|Part B||0||
59828063|NCT00306891|75951354|FG001|NOT COMPLETED|Part B||0||
59828064|NCT00306891|75951355|FG002|NOT COMPLETED|Part B||11||
59828065|NCT00306891|75951356|FG003|NOT COMPLETED|Part B||17||
59828066|NCT00314145|75951369|FG000|STARTED|Overall Study||410||
59828067|NCT00314145|75951370|FG001|STARTED|Overall Study||410||
59828068|NCT00314145|75951369|FG000|COMPLETED|Overall Study||389||
59828069|NCT00314145|75951370|FG001|COMPLETED|Overall Study||381||
59828070|NCT00314145|75951369|FG000|NOT COMPLETED|Overall Study||21||
59828071|NCT00314145|75951370|FG001|NOT COMPLETED|Overall Study||29||
59828072|NCT00313911|75951379|FG000|STARTED|Overall Study|N for outcomes adjusted to include participant in Group 2 that got vaccine assigned to this group.|1422||
59828073|NCT00313911|75951380|FG001|STARTED|Overall Study|A participant in this group mistakenly got Group 1 vaccine. N in outcomes adjusted accordingly.|711||
59828074|NCT00313911|75951379|FG000|COMPLETED|Overall Study||1328||
59828075|NCT00313911|75951380|FG001|COMPLETED|Overall Study||670||
59828076|NCT00313911|75951379|FG000|NOT COMPLETED|Overall Study||94||
59828077|NCT00313911|75951380|FG001|NOT COMPLETED|Overall Study||41||
59828078|NCT00391872|75951388|FG000|STARTED|Overall Study||9333||
59828079|NCT00391872|75951389|FG001|STARTED|Overall Study||9291||
59828080|NCT00391872|75951388|FG000|COMPLETED|Overall Study||9026||
59828081|NCT00391872|75951389|FG001|COMPLETED|Overall Study||9036||
59828082|NCT00391872|75951388|FG000|NOT COMPLETED|Overall Study||307||
59828083|NCT00391872|75951389|FG001|NOT COMPLETED|Overall Study||255||
59828084|NCT00391170|75951397|FG000|STARTED|Overall Study||27||
59828085|NCT00391170|75951398|FG001|STARTED|Overall Study||27||
59828086|NCT00391170|75951397|FG000|COMPLETED|Overall Study||21||
59828087|NCT00391170|75951398|FG001|COMPLETED|Overall Study||23||
59828088|NCT00391170|75951397|FG000|NOT COMPLETED|Overall Study||6||
59828089|NCT00391170|75951398|FG001|NOT COMPLETED|Overall Study||4||
59828090|NCT00402324|75951406|FG000|STARTED|Overall Study||101||
60118041|NCT00218439|76239082|FG001|COMPLETED|First Intervention (4 Weeks)||35||
60118042|NCT00218439|76239081|FG000|NOT COMPLETED|First Intervention (4 Weeks)||18||
60118043|NCT00218439|76239082|FG001|NOT COMPLETED|First Intervention (4 Weeks)||12||
59828091|NCT00402324|75951407|FG001|STARTED|Overall Study||101||
59828092|NCT00402324|75951406|FG000|COMPLETED|Overall Study||58||
59828093|NCT00402324|75951407|FG001|COMPLETED|Overall Study||60||
59828094|NCT00402324|75951406|FG000|NOT COMPLETED|Overall Study||43||
59828095|NCT00402324|75951407|FG001|NOT COMPLETED|Overall Study||41||
59828096|NCT00294723|75951416|FG000|STARTED|Double-Blind Period 52 Weeks|Randomised|247||
59828097|NCT00294723|75951417|FG001|STARTED|Double-Blind Period 52 Weeks|Randomised|251||
59828098|NCT00294723|75951418|FG002|STARTED|Double-Blind Period 52 Weeks|Randomised|248||
59828099|NCT00294723|75951416|FG000|Exposed to Study Drug|Double-Blind Period 52 Weeks|Subject withdrew before exposure to drug, and thus not included in the safety and ITT analysis sets|246||
59828100|NCT00294723|75951417|FG001|Exposed to Study Drug|Double-Blind Period 52 Weeks||251||
59828101|NCT00294723|75951418|FG002|Exposed to Study Drug|Double-Blind Period 52 Weeks||248||
59828102|NCT00294723|75951416|FG000|COMPLETED|Double-Blind Period 52 Weeks||173||
59828103|NCT00294723|75951417|FG001|COMPLETED|Double-Blind Period 52 Weeks||162||
59828104|NCT00294723|75951418|FG002|COMPLETED|Double-Blind Period 52 Weeks||152||
59828105|NCT00294723|75951416|FG000|NOT COMPLETED|Double-Blind Period 52 Weeks||74||
59828106|NCT00294723|75951417|FG001|NOT COMPLETED|Double-Blind Period 52 Weeks||89||
59828107|NCT00294723|75951418|FG002|NOT COMPLETED|Double-Blind Period 52 Weeks||96||
59828108|NCT00294723|75951416|FG000|STARTED|Open-Label Extension 52 Weeks|19 subjects did not continue into the extension period|154||
59828109|NCT00294723|75951417|FG001|STARTED|Open-Label Extension 52 Weeks|13 subjects did not continue into the extension period|149||
59828110|NCT00294723|75951418|FG002|STARTED|Open-Label Extension 52 Weeks|15 subjects did not continue into the extension period|137||
59828111|NCT00294723|75951416|FG000|COMPLETED|Open-Label Extension 52 Weeks||114||
59828112|NCT00294723|75951417|FG001|COMPLETED|Open-Label Extension 52 Weeks||110||
59828113|NCT00294723|75951418|FG002|COMPLETED|Open-Label Extension 52 Weeks||97||
59828114|NCT00294723|75951416|FG000|NOT COMPLETED|Open-Label Extension 52 Weeks||40||
59828115|NCT00294723|75951417|FG001|NOT COMPLETED|Open-Label Extension 52 Weeks||39||
59828116|NCT00294723|75951418|FG002|NOT COMPLETED|Open-Label Extension 52 Weeks||40||
59828117|NCT00294723|75951416|FG000|STARTED|Additional Open-Label Extension 91 Weeks|52 subjects did not continue into the extension period|62||
59828118|NCT00294723|75951417|FG001|STARTED|Additional Open-Label Extension 91 Weeks|57 subjects did not continue into the extension period|53||
59828119|NCT00294723|75951418|FG002|STARTED|Additional Open-Label Extension 91 Weeks|69 subjects did not continue into the extension period|28||
59828120|NCT00294723|75951416|FG000|COMPLETED|Additional Open-Label Extension 91 Weeks||34||
59828121|NCT00294723|75951417|FG001|COMPLETED|Additional Open-Label Extension 91 Weeks||32||
59828122|NCT00294723|75951418|FG002|COMPLETED|Additional Open-Label Extension 91 Weeks||8||
59828123|NCT00294723|75951416|FG000|NOT COMPLETED|Additional Open-Label Extension 91 Weeks||28||
59828124|NCT00294723|75951417|FG001|NOT COMPLETED|Additional Open-Label Extension 91 Weeks||21||
59828125|NCT00294723|75951418|FG002|NOT COMPLETED|Additional Open-Label Extension 91 Weeks||20||
59828126|NCT00402246|75951431|FG000|STARTED|Overall Study||1014||
59828127|NCT00402246|75951432|FG001|STARTED|Overall Study||983||
59828128|NCT00402246|75951431|FG000|COMPLETED|Overall Study||794||
59828129|NCT00402246|75951432|FG001|COMPLETED|Overall Study||749||
59828130|NCT00402246|75951431|FG000|NOT COMPLETED|Overall Study||220||
59828131|NCT00402246|75951432|FG001|NOT COMPLETED|Overall Study||234||
59828132|NCT00375492|75951442|FG000|STARTED|Overall Study||96||
59828133|NCT00375492|75951443|FG001|STARTED|Overall Study||98||
59828134|NCT00375492|75951442|FG000|COMPLETED|Overall Study||70||
59828135|NCT00375492|75951443|FG001|COMPLETED|Overall Study||72||
59828136|NCT00375492|75951442|FG000|NOT COMPLETED|Overall Study||26||
59828137|NCT00375492|75951443|FG001|NOT COMPLETED|Overall Study||26||
59828138|NCT00306189|75951453|FG000|STARTED|Overall Study||57||
59828139|NCT00306189|75951454|FG001|STARTED|Overall Study||56||
59828140|NCT00306189|75951455|FG002|STARTED|Overall Study||56||
59828141|NCT00306189|75951456|FG003|STARTED|Overall Study||57||
59828142|NCT00306189|75951453|FG000|COMPLETED|Overall Study||48||
59828143|NCT00306189|75951454|FG001|COMPLETED|Overall Study||50||
59828144|NCT00306189|75951455|FG002|COMPLETED|Overall Study||45||
60118044|NCT00218439|76239081|FG000|STARTED|Second Intervention (4 Weeks)||40||
59716108|NCT03355300|75834903|FG000|COMPLETED|Overall Study|One participant completed the study and 1 participant was ongoing at the time of discontinuation of the study which is neither considered completed nor discontinued.|2||
59716109|NCT03355300|75834904|FG001|COMPLETED|Overall Study|One participant completed the study and 3 participants were ongoing at the time of discontinuation of the study which is neither considered completed nor discontinued.|4||
59716110|NCT03355300|75834903|FG000|NOT COMPLETED|Overall Study||3||
59716111|NCT03355300|75834904|FG001|NOT COMPLETED|Overall Study||2||
59716112|NCT03332056|75834912|FG000|STARTED|Overall Study||35||
59716113|NCT03332056|75834913|FG001|STARTED|Overall Study||36||
59716114|NCT03332056|75834912|FG000|COMPLETED|Overall Study||26||
59716115|NCT03332056|75834913|FG001|COMPLETED|Overall Study||26||
59716116|NCT03332056|75834912|FG000|NOT COMPLETED|Overall Study||9||
59716117|NCT03332056|75834913|FG001|NOT COMPLETED|Overall Study||10||
59716118|NCT03093350|75834919|FG000|STARTED|Overall Study||12||
59716119|NCT03093350|75834919|FG000|Started Treatment|Overall Study||10||
59716120|NCT03093350|75834919|FG000|COMPLETED|Overall Study||10||
59716121|NCT03093350|75834919|FG000|NOT COMPLETED|Overall Study||2||
59716122|NCT02901041|75834925|FG000|STARTED|Overall Study||40||
59716123|NCT02901041|75834926|FG001|STARTED|Overall Study||41||
59716124|NCT02901041|75834925|FG000|COMPLETED|Overall Study||29||
59716125|NCT02901041|75834926|FG001|COMPLETED|Overall Study||30||
59716126|NCT02901041|75834925|FG000|NOT COMPLETED|Overall Study||11||
59716127|NCT02901041|75834926|FG001|NOT COMPLETED|Overall Study||11||
59716128|NCT02797964|75834938|FG000|STARTED|Overall Study||32||
59828145|NCT00306189|75951456|FG003|COMPLETED|Overall Study||52||
59828146|NCT00306189|75951453|FG000|NOT COMPLETED|Overall Study||9||
60118045|NCT00218439|76239082|FG001|STARTED|Second Intervention (4 Weeks)||35||
59828147|NCT00306189|75951454|FG001|NOT COMPLETED|Overall Study||6||
59828148|NCT00306189|75951455|FG002|NOT COMPLETED|Overall Study||11||
59828149|NCT00306189|75951456|FG003|NOT COMPLETED|Overall Study||5||
59828150|NCT00312897|75951468|FG000|STARTED|Overall Study||27||
59828151|NCT00312897|75951469|FG001|STARTED|Overall Study||24||
59828152|NCT00312897|75951468|FG000|COMPLETED|Overall Study||21||
59828153|NCT00312897|75951469|FG001|COMPLETED|Overall Study||18||
59828154|NCT00312897|75951468|FG000|NOT COMPLETED|Overall Study||6||
59828155|NCT00312897|75951469|FG001|NOT COMPLETED|Overall Study||6||
59828156|NCT00312663|75951478|FG000|STARTED|Immunization Phase||5||
59828157|NCT00312663|75951479|FG001|STARTED|Immunization Phase||13||
59828158|NCT00312663|75951480|FG002|STARTED|Immunization Phase||0||
59828159|NCT00312663|75951478|FG000|COMPLETED|Immunization Phase||5||
59828160|NCT00312663|75951479|FG001|COMPLETED|Immunization Phase||12||
59828161|NCT00312663|75951480|FG002|COMPLETED|Immunization Phase||0||
59828162|NCT00312663|75951478|FG000|NOT COMPLETED|Immunization Phase||0||
59828163|NCT00312663|75951479|FG001|NOT COMPLETED|Immunization Phase||1||
59828164|NCT00312663|75951480|FG002|NOT COMPLETED|Immunization Phase||0||
59828165|NCT00312663|75951478|FG000|STARTED|Challenge Phase|low dose subjects didn't participate in the challenge phase|0||
59828166|NCT00312663|75951479|FG001|STARTED|Challenge Phase|10 subjects from the high dose group participated in the challenge phase|10||
59828167|NCT00312663|75951480|FG002|STARTED|Challenge Phase|6 non-immunized subjects participated in the challenge phase|6||
59828168|NCT00312663|75951478|FG000|COMPLETED|Challenge Phase||0||
59828169|NCT00312663|75951479|FG001|COMPLETED|Challenge Phase||10||
59828170|NCT00312663|75951480|FG002|COMPLETED|Challenge Phase||6||
59828171|NCT00312663|75951478|FG000|NOT COMPLETED|Challenge Phase||0||
59828172|NCT00312663|75951479|FG001|NOT COMPLETED|Challenge Phase||0||
59828173|NCT00312663|75951480|FG002|NOT COMPLETED|Challenge Phase||0||
59828174|NCT00294645|75951491|FG000|STARTED|Overall Study||295||
59828175|NCT00294645|75951492|FG001|STARTED|Overall Study||602||
59828176|NCT00294645|75951491|FG000|COMPLETED|Overall Study||247||
59828177|NCT00294645|75951492|FG001|COMPLETED|Overall Study||510||
59828178|NCT00294645|75951491|FG000|NOT COMPLETED|Overall Study||48||
59828179|NCT00294645|75951492|FG001|NOT COMPLETED|Overall Study||92||
59828180|NCT00305877|75951500|FG000|STARTED|Overall Study||69||
59828181|NCT00305877|75951501|FG001|STARTED|Overall Study||68||
59828182|NCT00305877|75951500|FG000|Treated|Overall Study||67||
59828183|NCT00305877|75951501|FG001|Treated|Overall Study||63||
59828184|NCT00305877|75951500|FG000|Eligible|Overall Study||66||
59828185|NCT00305877|75951501|FG001|Eligible|Overall Study||66||
59828186|NCT00305877|75951500|FG000|Included in Efficacy Analysis|Overall Study||65||
59828187|NCT00305877|75951501|FG001|Included in Efficacy Analysis|Overall Study||62||
59828188|NCT00305877|75951500|FG000|COMPLETED|Overall Study||45||
59828189|NCT00305877|75951501|FG001|COMPLETED|Overall Study||34||
59828190|NCT00305877|75951500|FG000|NOT COMPLETED|Overall Study||24||
59828191|NCT00305877|75951501|FG001|NOT COMPLETED|Overall Study||34||
59828192|NCT00312195|75951509|FG000|STARTED|Overall Study||138||
59828193|NCT00312195|75951510|FG001|STARTED|Overall Study||129||
59716129|NCT02797964|75834939|FG001|STARTED|Overall Study||37||
59716130|NCT02797964|75834940|FG002|STARTED|Overall Study||10||
59716131|NCT02797964|75834941|FG003|STARTED|Overall Study||16||
59716132|NCT02797964|75834942|FG004|STARTED|Overall Study||4||
59716133|NCT02797964|75834943|FG005|STARTED|Overall Study||8||
59716134|NCT02797964|75834938|FG000|COMPLETED|Overall Study||32||
59716135|NCT02797964|75834939|FG001|COMPLETED|Overall Study||37||
59716136|NCT02797964|75834940|FG002|COMPLETED|Overall Study||10||
59716137|NCT02797964|75834941|FG003|COMPLETED|Overall Study||16||
59716138|NCT02797964|75834942|FG004|COMPLETED|Overall Study||4||
59716139|NCT02797964|75834943|FG005|COMPLETED|Overall Study||8||
59716140|NCT02797964|75834938|FG000|NOT COMPLETED|Overall Study||0||
59716141|NCT02797964|75834939|FG001|NOT COMPLETED|Overall Study||0||
59716142|NCT02797964|75834940|FG002|NOT COMPLETED|Overall Study||0||
59716143|NCT02797964|75834941|FG003|NOT COMPLETED|Overall Study||0||
59716144|NCT02797964|75834942|FG004|NOT COMPLETED|Overall Study||0||
59716145|NCT02797964|75834943|FG005|NOT COMPLETED|Overall Study||0||
59716146|NCT02673398|75834956|FG000|STARTED|Overall Study||25||
59716147|NCT02673398|75834956|FG000|COMPLETED|Overall Study||25||
59716148|NCT02673398|75834956|FG000|NOT COMPLETED|Overall Study||0||
59716149|NCT02547987|75834960|FG000|STARTED|Overall Study||25||
59716150|NCT02547987|75834960|FG000|COMPLETED|Overall Study||22||
59716151|NCT02547987|75834960|FG000|NOT COMPLETED|Overall Study||3||
59716152|NCT02513199|75834964|FG000|STARTED|Treatment||32||
59716153|NCT02513199|75834964|FG000|COMPLETED|Treatment||30||
59716154|NCT02513199|75834964|FG000|NOT COMPLETED|Treatment||2||
59716155|NCT02513199|75834964|FG000|STARTED|Follow-Up||30||
59716156|NCT02513199|75834964|FG000|COMPLETED|Follow-Up||19||
59716157|NCT02513199|75834964|FG000|NOT COMPLETED|Follow-Up||11||
59716158|NCT01525966|75834969|FG000|STARTED|Overall Study||67||
59716159|NCT01525966|75834969|FG000|COMPLETED|Overall Study||67||
59828194|NCT00312195|75951509|FG000|COMPLETED|Overall Study||132||
59828195|NCT00312195|75951510|FG001|COMPLETED|Overall Study||123||
59828196|NCT00312195|75951509|FG000|NOT COMPLETED|Overall Study||6||
59828197|NCT00312195|75951510|FG001|NOT COMPLETED|Overall Study||6||
59828198|NCT00305253|75951520|FG000|STARTED|Overall Study||432||
59828199|NCT00305253|75951521|FG001|STARTED|Overall Study||559||
59828200|NCT00305253|75951520|FG000|COMPLETED|Overall Study||432||
59828201|NCT00305253|75951521|FG001|COMPLETED|Overall Study||558||
59828202|NCT00305253|75951520|FG000|NOT COMPLETED|Overall Study||0||
59828203|NCT00305253|75951521|FG001|NOT COMPLETED|Overall Study||1||
59828204|NCT00293709|75951527|FG000|STARTED|Overall Study||149||
59828205|NCT00293709|75951527|FG000|COMPLETED|Overall Study||102||
59828206|NCT00293709|75951527|FG000|NOT COMPLETED|Overall Study||47||
59828207|NCT00311181|75951531|FG000|STARTED|Overall Study||217||
59828208|NCT00311181|75951531|FG000|COMPLETED|Overall Study||121||
59828209|NCT00311181|75951531|FG000|NOT COMPLETED|Overall Study||96||
59828210|NCT00293397|75951535|FG000|STARTED|Overall Study||20||
59828211|NCT00293397|75951535|FG000|Received First DEB-TACE|Overall Study|1 patient death after baseline inclusion screening and before first treatment|19||
59828212|NCT00293397|75951535|FG000|COMPLETED|Overall Study|1 patient death within 30 days post-TACE - not attributed to TACE procedure|18||
59828213|NCT00293397|75951535|FG000|NOT COMPLETED|Overall Study||2||
59828214|NCT00290745|75951540|FG000|STARTED|Overall Study||79||
59828215|NCT00290745|75951540|FG000|COMPLETED|Overall Study||67||
59828216|NCT00290745|75951540|FG000|NOT COMPLETED|Overall Study||12||
59828217|NCT00402168|75951546|FG000|STARTED|Randomized||84||
59828218|NCT00402168|75951547|FG001|STARTED|Randomized||89||
59828219|NCT00402168|75951546|FG000|COMPLETED|Randomized||83||
59828220|NCT00402168|75951547|FG001|COMPLETED|Randomized||88||
59828221|NCT00402168|75951546|FG000|NOT COMPLETED|Randomized||1||
59828222|NCT00402168|75951547|FG001|NOT COMPLETED|Randomized||1||
59828223|NCT00402168|75951546|FG000|STARTED|Treatment (up to 12 Months)||83||
59828224|NCT00402168|75951547|FG001|STARTED|Treatment (up to 12 Months)||88||
59828225|NCT00402168|75951546|FG000|COMPLETED|Treatment (up to 12 Months)||81||
59828226|NCT00402168|75951547|FG001|COMPLETED|Treatment (up to 12 Months)||86||
59828227|NCT00402168|75951546|FG000|NOT COMPLETED|Treatment (up to 12 Months)||2||
59828228|NCT00402168|75951547|FG001|NOT COMPLETED|Treatment (up to 12 Months)||2||
59828229|NCT00402168|75951546|FG000|STARTED|Long Term (LT)||81||
59828230|NCT00402168|75951547|FG001|STARTED|Long Term (LT)|5 completed 12 months, did not enter long term: 1 AE, 1 lack of efficacy, 3 other(non-specified).|81||
59828231|NCT00402168|75951546|FG000|COMPLETED|Long Term (LT)||70||
59828232|NCT00402168|75951547|FG001|COMPLETED|Long Term (LT)||64||
59828233|NCT00402168|75951546|FG000|NOT COMPLETED|Long Term (LT)||11||
59828234|NCT00402168|75951547|FG001|NOT COMPLETED|Long Term (LT)||17||
59828235|NCT00402168|75951546|FG000|STARTED|Switched From CNI to Belatacept in LT|Participants switched from CNI to Belatacept during LT period.|38||
59828236|NCT00402168|75951547|FG001|STARTED|Switched From CNI to Belatacept in LT|Out of 81 starting LT period in CNI group, 38 switched from CNI to Belatacept during the LT period.|0||
59828237|NCT00402168|75951546|FG000|COMPLETED|Switched From CNI to Belatacept in LT||32||
59828238|NCT00402168|75951547|FG001|COMPLETED|Switched From CNI to Belatacept in LT||0||
59828239|NCT00402168|75951546|FG000|NOT COMPLETED|Switched From CNI to Belatacept in LT||6||
59828240|NCT00402168|75951547|FG001|NOT COMPLETED|Switched From CNI to Belatacept in LT||0||
59828241|NCT00290589|75951563|FG000|STARTED|Overall Study||39||
59828242|NCT00290589|75951564|FG001|STARTED|Overall Study||43||
59828243|NCT00290589|75951563|FG000|COMPLETED|Overall Study||37||
59828244|NCT00290589|75951564|FG001|COMPLETED|Overall Study||41||
59828245|NCT00290589|75951563|FG000|NOT COMPLETED|Overall Study||2||
59828246|NCT00290589|75951564|FG001|NOT COMPLETED|Overall Study||2||
59828247|NCT00290511|75951570|FG000|STARTED|Overall Study||49||
59828248|NCT00290511|75951570|FG000|No Treatment Per Protocol|Overall Study||2||
59828249|NCT00290511|75951570|FG000|Toxicity Assessment|Overall Study||47||
59828250|NCT00290511|75951570|FG000|Response Assessment|Overall Study||45||
59828251|NCT00290511|75951570|FG000|COMPLETED|Overall Study||45||
59828252|NCT00290511|75951570|FG000|NOT COMPLETED|Overall Study||4||
59828253|NCT00290433|75951574|FG000|STARTED|Overall Study||53||
59828254|NCT00290433|75951574|FG000|COMPLETED|Overall Study||17||
59828255|NCT00290433|75951574|FG000|NOT COMPLETED|Overall Study||36||
59828256|NCT00304083|75951580|FG000|STARTED|Overall Study||34||
59828257|NCT00304083|75951581|FG001|STARTED|Overall Study||14||
59828258|NCT00304083|75951580|FG000|Completed 4 Cycles|Overall Study||22||
59828259|NCT00304083|75951581|FG001|Completed 4 Cycles|Overall Study||7||
59828260|NCT00304083|75951580|FG000|Patients Treated With Surgery|Overall Study||7||
59828261|NCT00304083|75951581|FG001|Patients Treated With Surgery|Overall Study||3||
60118046|NCT00218439|76239081|FG000|COMPLETED|Second Intervention (4 Weeks)||33||
60118047|NCT00218439|76239082|FG001|COMPLETED|Second Intervention (4 Weeks)||30||
59567452|NCT00554294|75670417|FG001|STARTED|Overall Study||1721||
59567453|NCT00554294|75670416|FG000|COMPLETED|Overall Study||1309||
59567454|NCT00554294|75670417|FG001|COMPLETED|Overall Study||1641||
59828262|NCT00304083|75951580|FG000|Patients Treated With Surgery and RT|Overall Study||5||
59828263|NCT00304083|75951581|FG001|Patients Treated With Surgery and RT|Overall Study||1||
59828264|NCT00304083|75951580|FG000|Patients Treated With RT Only|Overall Study||4||
59828265|NCT00304083|75951581|FG001|Patients Treated With RT Only|Overall Study||2||
59828266|NCT00304083|75951580|FG000|Patients Had Neither RT or Surgery|Overall Study||6||
59828267|NCT00304083|75951581|FG001|Patients Had Neither RT or Surgery|Overall Study||1||
59828268|NCT00304083|75951580|FG000|COMPLETED|Overall Study||12||
59828269|NCT00304083|75951581|FG001|COMPLETED|Overall Study||6||
59828270|NCT00304083|75951580|FG000|NOT COMPLETED|Overall Study||22||
59828271|NCT00304083|75951581|FG001|NOT COMPLETED|Overall Study||8||
59828272|NCT00293241|75951589|FG000|STARTED|Overall Study||299||
59828273|NCT00293241|75951590|FG001|STARTED|Overall Study||306||
59828274|NCT00293241|75951589|FG000|COMPLETED|Overall Study||263||
59828275|NCT00293241|75951590|FG001|COMPLETED|Overall Study||265||
59828276|NCT00293241|75951589|FG000|NOT COMPLETED|Overall Study||36||
59828277|NCT00293241|75951590|FG001|NOT COMPLETED|Overall Study||41||
59828278|NCT00391092|75951601|FG000|STARTED|Overall Study||208||
59828279|NCT00391092|75951602|FG001|STARTED|Overall Study||216||
59828280|NCT00391092|75951601|FG000|Received Treatment|Overall Study||206||
59828281|NCT00391092|75951602|FG001|Received Treatment|Overall Study||215||
59828282|NCT00391092|75951601|FG000|COMPLETED|Overall Study|This was using a data cutoff of 30 June 2011.|0||
59828283|NCT00391092|75951602|FG001|COMPLETED|Overall Study|This was using a data cutoff of 30 June 2011.|0||
59828284|NCT00391092|75951601|FG000|NOT COMPLETED|Overall Study||208||
59828285|NCT00391092|75951602|FG001|NOT COMPLETED|Overall Study||216||
59828286|NCT00374868|75951608|FG000|STARTED|Overall Study||38||
59828287|NCT00374868|75951608|FG000|COMPLETED|Overall Study||2||
59828288|NCT00374868|75951608|FG000|NOT COMPLETED|Overall Study||36||
59828289|NCT00374556|75951614|FG000|STARTED|Overall Study||14||
59828290|NCT00374556|75951615|FG001|STARTED|Overall Study||16||
59828291|NCT00374556|75951614|FG000|COMPLETED|Overall Study||13||
59828292|NCT00374556|75951615|FG001|COMPLETED|Overall Study||15||
59828293|NCT00374556|75951614|FG000|NOT COMPLETED|Overall Study||1||
59828294|NCT00374556|75951615|FG001|NOT COMPLETED|Overall Study||1||
59828295|NCT00290355|75951623|FG000|STARTED|Overall Study||122||
59828296|NCT00290355|75951624|FG001|STARTED|Overall Study||60||
59828297|NCT00290355|75951623|FG000|COMPLETED|Overall Study||105||
59828298|NCT00290355|75951624|FG001|COMPLETED|Overall Study||55||
59828299|NCT00290355|75951623|FG000|NOT COMPLETED|Overall Study||17||
59828300|NCT00290355|75951624|FG001|NOT COMPLETED|Overall Study||5||
59828301|NCT00374322|75951632|FG000|STARTED|Overall Study||1579||
59828302|NCT00374322|75951633|FG001|STARTED|Overall Study||1582||
59828303|NCT00374322|75951632|FG000|Received >=1 Dose of Study Treatment|Overall Study||1571||
59828304|NCT00374322|75951633|FG001|Received >=1 Dose of Study Treatment|Overall Study||1576||
59828305|NCT00374322|75951632|FG000|COMPLETED|Overall Study||322||
59828306|NCT00374322|75951633|FG001|COMPLETED|Overall Study||278||
59828307|NCT00374322|75951632|FG000|NOT COMPLETED|Overall Study||1257||
59828308|NCT00374322|75951633|FG001|NOT COMPLETED|Overall Study||1304||
59828309|NCT00303459|75951642|FG000|STARTED|Overall Study||159||
59828310|NCT00303459|75951643|FG001|STARTED|Overall Study|One subject randomized to placebo did not receive study treatment|175||
59828311|NCT00303459|75951642|FG000|COMPLETED|Overall Study||76||
59828312|NCT00303459|75951643|FG001|COMPLETED|Overall Study||86||
59828313|NCT00303459|75951642|FG000|NOT COMPLETED|Overall Study||83||
59828314|NCT00303459|75951643|FG001|NOT COMPLETED|Overall Study||89||
59828315|NCT00289887|75951652|FG000|STARTED|Overall Study||127||
59828316|NCT00289887|75951653|FG001|STARTED|Overall Study||134||
59828317|NCT00289887|75951652|FG000|COMPLETED|Overall Study||105||
59828318|NCT00289887|75951653|FG001|COMPLETED|Overall Study||105||
59828319|NCT00289887|75951652|FG000|NOT COMPLETED|Overall Study||22||
59828320|NCT00289887|75951653|FG001|NOT COMPLETED|Overall Study||29||
59828321|NCT00303069|75951663|FG000|STARTED|Overall Study||31||
59828322|NCT00303069|75951664|FG001|STARTED|Overall Study||28||
59828323|NCT00303069|75951665|FG002|STARTED|Overall Study||34||
59828324|NCT00303069|75951666|FG003|STARTED|Overall Study||31||
59828325|NCT00303069|75951663|FG000|COMPLETED|Overall Study||29||
59828326|NCT00303069|75951664|FG001|COMPLETED|Overall Study||28||
59716160|NCT01525966|75834969|FG000|NOT COMPLETED|Overall Study||0||
59716161|NCT01273610|75834976|FG000|STARTED|Overall Study||30||
59716162|NCT01273610|75834977|FG001|STARTED|Overall Study||10||
59716163|NCT01273610|75834976|FG000|COMPLETED|Overall Study||30||
59716164|NCT01273610|75834977|FG001|COMPLETED|Overall Study||10||
59716165|NCT01273610|75834976|FG000|NOT COMPLETED|Overall Study||0||
59716166|NCT01273610|75834977|FG001|NOT COMPLETED|Overall Study||0||
59716167|NCT00999804|75834986|FG000|STARTED|Overall Study||85||
59716168|NCT00999804|75834987|FG001|STARTED|Overall Study||43||
59716169|NCT00999804|75834986|FG000|COMPLETED|Overall Study||64||
59716170|NCT00999804|75834987|FG001|COMPLETED|Overall Study||38||
59716171|NCT00999804|75834986|FG000|NOT COMPLETED|Overall Study||21||
59716172|NCT00999804|75834987|FG001|NOT COMPLETED|Overall Study||5||
59716173|NCT00544830|75834993|FG000|STARTED|Overall Study||29||
59716174|NCT00544830|75834993|FG000|COMPLETED|Overall Study||29||
59716175|NCT00544830|75834993|FG000|NOT COMPLETED|Overall Study||0||
59716176|NCT00927472|75834999|FG000|STARTED|Overall Study||126||
59828327|NCT00303069|75951665|FG002|COMPLETED|Overall Study||33||
59828328|NCT00303069|75951666|FG003|COMPLETED|Overall Study||29||
59828329|NCT00303069|75951663|FG000|NOT COMPLETED|Overall Study||2||
59828330|NCT00303069|75951664|FG001|NOT COMPLETED|Overall Study||0||
59828331|NCT00303069|75951665|FG002|NOT COMPLETED|Overall Study||1||
59828332|NCT00303069|75951666|FG003|NOT COMPLETED|Overall Study||2||
59828333|NCT00401544|75951680|FG000|STARTED|Overall Study|Randomized and treated|56||
59828334|NCT00401544|75951681|FG001|STARTED|Overall Study|Randomized and treated|62||
59828335|NCT00401544|75951682|FG002|STARTED|Overall Study|Randomized and treated|60||
59828336|NCT00401544|75951683|FG003|STARTED|Overall Study|Randomized and treated|60||
59828337|NCT00401544|75951680|FG000|COMPLETED|Overall Study||38||
59828338|NCT00401544|75951681|FG001|COMPLETED|Overall Study||44||
59828339|NCT00401544|75951682|FG002|COMPLETED|Overall Study||48||
59828340|NCT00401544|75951683|FG003|COMPLETED|Overall Study||44||
59828341|NCT00401544|75951680|FG000|NOT COMPLETED|Overall Study||18||
59828342|NCT00401544|75951681|FG001|NOT COMPLETED|Overall Study||18||
59828343|NCT00401544|75951682|FG002|NOT COMPLETED|Overall Study||12||
59828344|NCT00401544|75951683|FG003|NOT COMPLETED|Overall Study||16||
59828345|NCT00289731|75951701|FG000|STARTED|Overall Study||199||
59828346|NCT00289731|75951702|FG001|STARTED|Overall Study||200||
59828347|NCT00289731|75951703|FG002|STARTED|Overall Study||197||
59828348|NCT00289731|75951701|FG000|COMPLETED|Overall Study||197||
59828349|NCT00289731|75951702|FG001|COMPLETED|Overall Study||198||
59828350|NCT00289731|75951703|FG002|COMPLETED|Overall Study||195||
59828351|NCT00289731|75951701|FG000|NOT COMPLETED|Overall Study||2||
59828352|NCT00289731|75951702|FG001|NOT COMPLETED|Overall Study||2||
59828353|NCT00289731|75951703|FG002|NOT COMPLETED|Overall Study||2||
59828354|NCT00289185|75951715|FG000|STARTED|Overall Study||170||
59828355|NCT00289185|75951716|FG001|STARTED|Overall Study||170||
59828356|NCT00289185|75951715|FG000|COMPLETED|Overall Study||142||
59828357|NCT00289185|75951716|FG001|COMPLETED|Overall Study||144||
59828358|NCT00289185|75951715|FG000|NOT COMPLETED|Overall Study||28||
59828359|NCT00289185|75951716|FG001|NOT COMPLETED|Overall Study||26||
59828360|NCT00292461|75951725|FG000|STARTED|Overall Study||34||
59828361|NCT00292461|75951726|FG001|STARTED|Overall Study||30||
59828362|NCT00292461|75951725|FG000|COMPLETED|Overall Study||24||
59828363|NCT00292461|75951726|FG001|COMPLETED|Overall Study||24||
59828364|NCT00292461|75951725|FG000|NOT COMPLETED|Overall Study||10||
59828365|NCT00292461|75951726|FG001|NOT COMPLETED|Overall Study||6||
59828366|NCT00288639|75951732|FG000|STARTED|Overall Study||98||
59828367|NCT00288639|75951732|FG000|COMPLETED|Overall Study||86||
59828368|NCT00288639|75951732|FG000|NOT COMPLETED|Overall Study||12||
59828369|NCT00390858|75951738|FG000|STARTED|Overall Study|20 participants started the Core Study|20||
59828370|NCT00390858|75951739|FG001|STARTED|Overall Study|20 Participants started the Core Study|20||
59828371|NCT00390858|75951738|FG000|Completed Core & Entered Extension Study|Overall Study||19||
59828372|NCT00390858|75951739|FG001|Completed Core & Entered Extension Study|Overall Study||20||
59828373|NCT00390858|75951738|FG000|COMPLETED|Overall Study|11 participants Completed the Extension Study|11||
59828374|NCT00390858|75951739|FG001|COMPLETED|Overall Study|13 Participants completed the Extension Study|13||
59828375|NCT00390858|75951738|FG000|NOT COMPLETED|Overall Study||9||
59828376|NCT00390858|75951739|FG001|NOT COMPLETED|Overall Study||7||
59828377|NCT00390780|75951747|FG000|STARTED|Overall Study||291||
59828378|NCT00390780|75951748|FG001|STARTED|Overall Study||287||
59828379|NCT00390780|75951747|FG000|Treatment|Overall Study|One patient randomized to miconazole lost study drug, never started treatment, and was discontinued.|290||
59828380|NCT00390780|75951748|FG001|Treatment|Overall Study||287||
59828381|NCT00390780|75951747|FG000|COMPLETED|Overall Study||268||
59828382|NCT00390780|75951748|FG001|COMPLETED|Overall Study||260||
59828383|NCT00390780|75951747|FG000|NOT COMPLETED|Overall Study||23||
59828384|NCT00390780|75951748|FG001|NOT COMPLETED|Overall Study||27||
59828385|NCT00390546|75951756|FG000|STARTED|Overall Study||33||
59828386|NCT00390546|75951757|FG001|STARTED|Overall Study||39||
59828387|NCT00390546|75951756|FG000|COMPLETED|Overall Study||27||
59828388|NCT00390546|75951757|FG001|COMPLETED|Overall Study||34||
59828389|NCT00390546|75951756|FG000|NOT COMPLETED|Overall Study||6||
59828390|NCT00390546|75951757|FG001|NOT COMPLETED|Overall Study||5||
59828391|NCT00390468|75951764|FG000|STARTED|Overall Study||18||
59828392|NCT00390468|75951764|FG000|COMPLETED|Overall Study||15||
59828393|NCT00390468|75951764|FG000|NOT COMPLETED|Overall Study||3||
59828394|NCT00400764|75951773|FG000|STARTED|Phase Ib||6||
59828395|NCT00400764|75951774|FG001|STARTED|Phase Ib||6||
59828396|NCT00400764|75951775|FG002|STARTED|Phase Ib||0||
59828397|NCT00400764|75951776|FG003|STARTED|Phase Ib||0||
59828398|NCT00400764|75951777|FG004|STARTED|Phase Ib||0||
59828399|NCT00400764|75951773|FG000|Treated|Phase Ib||6||
59828400|NCT00400764|75951774|FG001|Treated|Phase Ib||6||
59828401|NCT00400764|75951775|FG002|Treated|Phase Ib||0||
59828402|NCT00400764|75951776|FG003|Treated|Phase Ib||0||
59828403|NCT00400764|75951777|FG004|Treated|Phase Ib||0||
60118048|NCT00218439|76239081|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||7||
60118049|NCT00218439|76239082|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||5||
59828404|NCT00400764|75951773|FG000|COMPLETED|Phase Ib|One patient reported as discontinued due to an AE should have been reported as death.|0||
59828405|NCT00400764|75951774|FG001|COMPLETED|Phase Ib||2||
60118050|NCT00108303|76239099|FG000|STARTED|Overall Study||179||
59828406|NCT00400764|75951775|FG002|COMPLETED|Phase Ib||0||
59828407|NCT00400764|75951776|FG003|COMPLETED|Phase Ib||0||
59828408|NCT00400764|75951777|FG004|COMPLETED|Phase Ib||0||
59828409|NCT00400764|75951773|FG000|NOT COMPLETED|Phase Ib||6||
60118051|NCT00108303|76239100|FG001|STARTED|Overall Study||179||
59828410|NCT00400764|75951774|FG001|NOT COMPLETED|Phase Ib||4||
60118052|NCT00108303|76239101|FG002|STARTED|Overall Study||180||
59828411|NCT00400764|75951775|FG002|NOT COMPLETED|Phase Ib||0||
59828412|NCT00400764|75951776|FG003|NOT COMPLETED|Phase Ib||0||
59828413|NCT00400764|75951777|FG004|NOT COMPLETED|Phase Ib||0||
59828414|NCT00400764|75951773|FG000|STARTED|Phase II||0||
59828415|NCT00400764|75951774|FG001|STARTED|Phase II||0||
59828416|NCT00400764|75951775|FG002|STARTED|Phase II||23||
59828417|NCT00400764|75951776|FG003|STARTED|Phase II||26||
59828418|NCT00400764|75951777|FG004|STARTED|Phase II||11||
59828419|NCT00400764|75951773|FG000|Treated|Phase II||0||
59828420|NCT00400764|75951774|FG001|Treated|Phase II||0||
59828421|NCT00400764|75951775|FG002|Treated|Phase II|One patient in the Rituximab arm withdrew prior to treatment|22||
59828422|NCT00400764|75951776|FG003|Treated|Phase II||26||
59828423|NCT00400764|75951777|FG004|Treated|Phase II||11||
59828424|NCT00400764|75951773|FG000|COMPLETED|Phase II||0||
59828425|NCT00400764|75951774|FG001|COMPLETED|Phase II||0||
59828426|NCT00400764|75951775|FG002|COMPLETED|Phase II||0||
59828427|NCT00400764|75951776|FG003|COMPLETED|Phase II||0||
59828428|NCT00400764|75951777|FG004|COMPLETED|Phase II||0||
59828429|NCT00400764|75951773|FG000|NOT COMPLETED|Phase II||0||
59828430|NCT00400764|75951774|FG001|NOT COMPLETED|Phase II||0||
59828431|NCT00400764|75951775|FG002|NOT COMPLETED|Phase II||23||
59828432|NCT00400764|75951776|FG003|NOT COMPLETED|Phase II||26||
59828433|NCT00400764|75951777|FG004|NOT COMPLETED|Phase II||11||
59828434|NCT00302211|75951797|FG000|STARTED|Double Blind Period (New Patients)|These subjects had the option to continue with the same dose of iloprost during the OL period|26||
59828435|NCT00302211|75951798|FG001|STARTED|Double Blind Period (New Patients)|These subjects had the option to continue with the same dose of iloprost during the OL period|27||
59828436|NCT00302211|75951799|FG002|STARTED|Double Blind Period (New Patients)|These subjects could receive either iloprost 4x/day or 6x/day in the OL period|14||
59828437|NCT00302211|75951800|FG003|STARTED|Double Blind Period (New Patients)||0||
59828438|NCT00302211|75951801|FG004|STARTED|Double Blind Period (New Patients)||0||
59828439|NCT00302211|75951797|FG000|COMPLETED|Double Blind Period (New Patients)||23||
59828440|NCT00302211|75951798|FG001|COMPLETED|Double Blind Period (New Patients)||25||
59828441|NCT00302211|75951799|FG002|COMPLETED|Double Blind Period (New Patients)||10||
59828442|NCT00302211|75951800|FG003|COMPLETED|Double Blind Period (New Patients)||0||
59828443|NCT00302211|75951801|FG004|COMPLETED|Double Blind Period (New Patients)||0||
59828444|NCT00302211|75951797|FG000|NOT COMPLETED|Double Blind Period (New Patients)||3||
59828445|NCT00302211|75951798|FG001|NOT COMPLETED|Double Blind Period (New Patients)||2||
59828446|NCT00302211|75951799|FG002|NOT COMPLETED|Double Blind Period (New Patients)||4||
59828447|NCT00302211|75951800|FG003|NOT COMPLETED|Double Blind Period (New Patients)||0||
59828448|NCT00302211|75951801|FG004|NOT COMPLETED|Double Blind Period (New Patients)||0||
59828449|NCT00302211|75951797|FG000|STARTED|Open Label-Patients From Double-Blind||0||
59828450|NCT00302211|75951798|FG001|STARTED|Open Label-Patients From Double-Blind||0||
59828451|NCT00302211|75951799|FG002|STARTED|Open Label-Patients From Double-Blind||0||
59828452|NCT00302211|75951800|FG003|STARTED|Open Label-Patients From Double-Blind|21 patients (pts) in 6x/day DB phase & 5 patients in placebo 6x/day DB phase enrolled in OL 6x/day|26||
59828453|NCT00302211|75951801|FG004|STARTED|Open Label-Patients From Double-Blind|26 pts in 4x/day + placebo 2x/day DB phase & 6 pts in placebo 6x/day DB phase enrolled in OL 4x/day|32||
59828454|NCT00302211|75951797|FG000|COMPLETED|Open Label-Patients From Double-Blind||0||
59828455|NCT00302211|75951798|FG001|COMPLETED|Open Label-Patients From Double-Blind||0||
59828456|NCT00302211|75951799|FG002|COMPLETED|Open Label-Patients From Double-Blind||0||
59828457|NCT00302211|75951800|FG003|COMPLETED|Open Label-Patients From Double-Blind||18||
59828458|NCT00302211|75951801|FG004|COMPLETED|Open Label-Patients From Double-Blind||24||
59828459|NCT00302211|75951797|FG000|NOT COMPLETED|Open Label-Patients From Double-Blind||0||
59828460|NCT00302211|75951798|FG001|NOT COMPLETED|Open Label-Patients From Double-Blind||0||
59828461|NCT00302211|75951799|FG002|NOT COMPLETED|Open Label-Patients From Double-Blind||0||
59828462|NCT00302211|75951800|FG003|NOT COMPLETED|Open Label-Patients From Double-Blind||8||
59828463|NCT00302211|75951801|FG004|NOT COMPLETED|Open Label-Patients From Double-Blind||8||
59828464|NCT00288015|75951813|FG000|STARTED|Registered to Study||32||
59828465|NCT00288015|75951813|FG000|COMPLETED|Registered to Study||32||
59828466|NCT00288015|75951813|FG000|NOT COMPLETED|Registered to Study||0||
59828467|NCT00288015|75951813|FG000|STARTED|Bevacizumab Treatment Cycles 1-2||32||
59828468|NCT00288015|75951813|FG000|COMPLETED|Bevacizumab Treatment Cycles 1-2||30||
59828469|NCT00288015|75951813|FG000|NOT COMPLETED|Bevacizumab Treatment Cycles 1-2||2||
59828470|NCT00288015|75951813|FG000|STARTED|First Response Assessment||30||
59828471|NCT00288015|75951813|FG000|COMPLETED|First Response Assessment||26||
59828472|NCT00288015|75951813|FG000|NOT COMPLETED|First Response Assessment||4||
59828473|NCT00288015|75951813|FG000|STARTED|Continued Bevacizumab Cycle 3+||26||
59828474|NCT00288015|75951813|FG000|COMPLETED|Continued Bevacizumab Cycle 3+||19||
59828475|NCT00288015|75951813|FG000|NOT COMPLETED|Continued Bevacizumab Cycle 3+||7||
59828476|NCT00288015|75951813|FG000|STARTED|Follow up for Survival x 2 Years||29|Includes all patients who received bevacizumab cycle 1 and were still living.|
59828477|NCT00288015|75951813|FG000|COMPLETED|Follow up for Survival x 2 Years||3||
59828478|NCT00288015|75951813|FG000|NOT COMPLETED|Follow up for Survival x 2 Years||26||
59828479|NCT00389064|75951819|FG000|STARTED|Overall Study||223||
59828480|NCT00389064|75951820|FG001|STARTED|Overall Study||227||
59828481|NCT00389064|75951819|FG000|COMPLETED|Overall Study||178||
59828482|NCT00389064|75951820|FG001|COMPLETED|Overall Study||168||
59828483|NCT00389064|75951819|FG000|NOT COMPLETED|Overall Study||45||
59828484|NCT00389064|75951820|FG001|NOT COMPLETED|Overall Study||59||
59828485|NCT00388674|75951828|FG000|STARTED|Initial Treatment||6216||
59828486|NCT00388674|75951829|FG001|STARTED|Initial Treatment||6162||
59828487|NCT00388674|75951828|FG000|COMPLETED|Initial Treatment|Completed=Reason of 'successful treatment', 'other: successful treatment' or 'other: end of study'|4388||
59828488|NCT00388674|75951829|FG001|COMPLETED|Initial Treatment|"Completed=discontinued initial treatment reason of successful treatment or end of study"|3576||
59828489|NCT00388674|75951828|FG000|NOT COMPLETED|Initial Treatment||1828||
59828490|NCT00388674|75951829|FG001|NOT COMPLETED|Initial Treatment||2586||
59828491|NCT00388674|75951828|FG000|STARTED|End of Study||6216||
59828492|NCT00388674|75951829|FG001|STARTED|End of Study||6162||
59828493|NCT00388674|75951828|FG000|COMPLETED|End of Study|Completed=Reason of 'other: end of study'|4482||
59828494|NCT00388674|75951829|FG001|COMPLETED|End of Study|Completed=Reason of 'other: end of study'|3993||
59828495|NCT00388674|75951828|FG000|NOT COMPLETED|End of Study||1734||
59828496|NCT00388674|75951829|FG001|NOT COMPLETED|End of Study||2169||
59828497|NCT00388362|75951835|FG000|STARTED|Enrolled||36||
59828498|NCT00388362|75951835|FG000|COMPLETED|Enrolled||23||
59828499|NCT00388362|75951835|FG000|NOT COMPLETED|Enrolled||13||
59828500|NCT00388362|75951835|FG000|STARTED|Remained on Study Median of 514 Days||23||
59828501|NCT00388362|75951835|FG000|COMPLETED|Remained on Study Median of 514 Days||21||
59828502|NCT00388362|75951835|FG000|NOT COMPLETED|Remained on Study Median of 514 Days||2||
59828503|NCT00387894|75951839|FG000|STARTED|Overall Study||6||
59828504|NCT00387894|75951839|FG000|COMPLETED|Overall Study||5||
59828505|NCT00387894|75951839|FG000|NOT COMPLETED|Overall Study||1||
59828506|NCT00387426|75951843|FG000|STARTED|Overall Study||14||
59828507|NCT00387426|75951843|FG000|COMPLETED|Overall Study||0||
59828508|NCT00387426|75951843|FG000|NOT COMPLETED|Overall Study||14||
59828509|NCT00387348|75951850|FG000|STARTED|Overall Study||8||
59828510|NCT00387348|75951851|FG001|STARTED|Overall Study||5||
59828511|NCT00387348|75951852|FG002|STARTED|Overall Study||11||
59828512|NCT00387348|75951850|FG000|COMPLETED|Overall Study||5||
59828513|NCT00387348|75951851|FG001|COMPLETED|Overall Study||2||
59828514|NCT00387348|75951852|FG002|COMPLETED|Overall Study||7||
59828515|NCT00387348|75951850|FG000|NOT COMPLETED|Overall Study||3||
59828516|NCT00387348|75951851|FG001|NOT COMPLETED|Overall Study||3||
59828517|NCT00387348|75951852|FG002|NOT COMPLETED|Overall Study||4||
59828518|NCT00413660|75951872|FG000|STARTED|Up To Week 12||71||
59828519|NCT00413660|75951873|FG001|STARTED|Up To Week 12||68||
59828520|NCT00413660|75951874|FG002|STARTED|Up To Week 12||71||
59828521|NCT00413660|75951875|FG003|STARTED|Up To Week 12||75||
59828522|NCT00413660|75951876|FG004|STARTED|Up To Week 12||75||
59828523|NCT00413660|75951877|FG005|STARTED|Up To Week 12||80||
59828524|NCT00413660|75951878|FG006|STARTED|Up To Week 12||69||
59828525|NCT00413660|75951879|FG007|STARTED|Up To Week 12||0||
59828526|NCT00413660|75951880|FG008|STARTED|Up To Week 12||0||
59828527|NCT00413660|75951881|FG009|STARTED|Up To Week 12||0||
59828528|NCT00413660|75951882|FG010|STARTED|Up To Week 12||0||
59828529|NCT00413660|75951872|FG000|Treated|Up To Week 12||70||
59828530|NCT00413660|75951873|FG001|Treated|Up To Week 12||68||
59828531|NCT00413660|75951874|FG002|Treated|Up To Week 12||71||
59828532|NCT00413660|75951875|FG003|Treated|Up To Week 12||74||
59828533|NCT00413660|75951876|FG004|Treated|Up To Week 12||75||
59828534|NCT00413660|75951877|FG005|Treated|Up To Week 12||80||
59828535|NCT00413660|75951878|FG006|Treated|Up To Week 12||69||
59828536|NCT00413660|75951879|FG007|Treated|Up To Week 12||0||
59828537|NCT00413660|75951880|FG008|Treated|Up To Week 12||0||
59828538|NCT00413660|75951881|FG009|Treated|Up To Week 12||0||
59828539|NCT00413660|75951882|FG010|Treated|Up To Week 12||0||
59828540|NCT00413660|75951872|FG000|COMPLETED|Up To Week 12||64||
60118053|NCT00108303|76239099|FG000|COMPLETED|Overall Study||179||
60118054|NCT00108303|76239100|FG001|COMPLETED|Overall Study||179||
60118055|NCT00108303|76239101|FG002|COMPLETED|Overall Study||180||
60118056|NCT00108303|76239099|FG000|NOT COMPLETED|Overall Study||0||
60118057|NCT00108303|76239100|FG001|NOT COMPLETED|Overall Study||0||
60118058|NCT00108303|76239101|FG002|NOT COMPLETED|Overall Study||0||
60118059|NCT00109005|76239115|FG000|STARTED|Overall Study||8||
60118060|NCT00109005|76239116|FG001|STARTED|Overall Study||9||
60118061|NCT00109005|76239115|FG000|COMPLETED|Overall Study||8||
59828541|NCT00413660|75951873|FG001|COMPLETED|Up To Week 12||61||
59828542|NCT00413660|75951874|FG002|COMPLETED|Up To Week 12||64||
59828543|NCT00413660|75951875|FG003|COMPLETED|Up To Week 12||67||
59828544|NCT00413660|75951876|FG004|COMPLETED|Up To Week 12||66||
59828545|NCT00413660|75951877|FG005|COMPLETED|Up To Week 12||70||
59828546|NCT00413660|75951878|FG006|COMPLETED|Up To Week 12||58||
59828547|NCT00413660|75951879|FG007|COMPLETED|Up To Week 12||0||
60118062|NCT00109005|76239116|FG001|COMPLETED|Overall Study||9||
60118063|NCT00109005|76239115|FG000|NOT COMPLETED|Overall Study||0||
59828548|NCT00413660|75951880|FG008|COMPLETED|Up To Week 12||0||
59828549|NCT00413660|75951881|FG009|COMPLETED|Up To Week 12||0||
59828550|NCT00413660|75951882|FG010|COMPLETED|Up To Week 12||0||
59828551|NCT00413660|75951872|FG000|NOT COMPLETED|Up To Week 12||7||
59828552|NCT00413660|75951873|FG001|NOT COMPLETED|Up To Week 12||7||
59828553|NCT00413660|75951874|FG002|NOT COMPLETED|Up To Week 12||7||
59828554|NCT00413660|75951875|FG003|NOT COMPLETED|Up To Week 12||8||
59828555|NCT00413660|75951876|FG004|NOT COMPLETED|Up To Week 12||9||
59828556|NCT00413660|75951877|FG005|NOT COMPLETED|Up To Week 12||10||
59828557|NCT00413660|75951878|FG006|NOT COMPLETED|Up To Week 12||11||
59828558|NCT00413660|75951879|FG007|NOT COMPLETED|Up To Week 12||0||
59828559|NCT00413660|75951880|FG008|NOT COMPLETED|Up To Week 12||0||
59828560|NCT00413660|75951881|FG009|NOT COMPLETED|Up To Week 12||0||
59828561|NCT00413660|75951882|FG010|NOT COMPLETED|Up To Week 12||0||
59828562|NCT00413660|75951872|FG000|STARTED|Post Week 12||43||
59828563|NCT00413660|75951873|FG001|STARTED|Post Week 12||48||
59828564|NCT00413660|75951874|FG002|STARTED|Post Week 12||64||
59828565|NCT00413660|75951875|FG003|STARTED|Post Week 12||67||
59828566|NCT00413660|75951876|FG004|STARTED|Post Week 12||66||
59828567|NCT00413660|75951877|FG005|STARTED|Post Week 12||57||
59828568|NCT00413660|75951878|FG006|STARTED|Post Week 12||40||
59828569|NCT00413660|75951879|FG007|STARTED|Post Week 12||21||
59828570|NCT00413660|75951880|FG008|STARTED|Post Week 12||13||
59828571|NCT00413660|75951881|FG009|STARTED|Post Week 12||13||
59828572|NCT00413660|75951882|FG010|STARTED|Post Week 12||18||
59828573|NCT00413660|75951872|FG000|COMPLETED|Post Week 12||40||
59828574|NCT00413660|75951873|FG001|COMPLETED|Post Week 12||44||
59828575|NCT00413660|75951874|FG002|COMPLETED|Post Week 12||56||
59828576|NCT00413660|75951875|FG003|COMPLETED|Post Week 12||66||
59828577|NCT00413660|75951876|FG004|COMPLETED|Post Week 12||60||
59828578|NCT00413660|75951877|FG005|COMPLETED|Post Week 12||54||
59828579|NCT00413660|75951878|FG006|COMPLETED|Post Week 12||37||
59828580|NCT00413660|75951879|FG007|COMPLETED|Post Week 12||21||
59828581|NCT00413660|75951880|FG008|COMPLETED|Post Week 12||13||
59828582|NCT00413660|75951881|FG009|COMPLETED|Post Week 12||12||
59828583|NCT00413660|75951882|FG010|COMPLETED|Post Week 12||17||
59828584|NCT00413660|75951872|FG000|NOT COMPLETED|Post Week 12||3||
59828585|NCT00413660|75951873|FG001|NOT COMPLETED|Post Week 12||4||
59828586|NCT00413660|75951874|FG002|NOT COMPLETED|Post Week 12||8||
59828587|NCT00413660|75951875|FG003|NOT COMPLETED|Post Week 12||1||
59828588|NCT00413660|75951876|FG004|NOT COMPLETED|Post Week 12||6||
59828589|NCT00413660|75951877|FG005|NOT COMPLETED|Post Week 12||3||
59828590|NCT00413660|75951878|FG006|NOT COMPLETED|Post Week 12||3||
59828591|NCT00413660|75951879|FG007|NOT COMPLETED|Post Week 12||0||
59828592|NCT00413660|75951880|FG008|NOT COMPLETED|Post Week 12||0||
59828593|NCT00413660|75951881|FG009|NOT COMPLETED|Post Week 12||1||
59828594|NCT00413660|75951882|FG010|NOT COMPLETED|Post Week 12||1||
59828595|NCT01234532|75951912|FG000|STARTED|Overall Study||5||
59828596|NCT01234532|75951912|FG000|COMPLETED|Overall Study||5||
59828597|NCT01234532|75951912|FG000|NOT COMPLETED|Overall Study||0||
59828598|NCT00431834|75951916|FG000|STARTED|Overall Study||75||
59828599|NCT00431834|75951916|FG000|COMPLETED|Overall Study||62||
59828600|NCT00431834|75951916|FG000|NOT COMPLETED|Overall Study||13||
59716177|NCT00927472|75835000|FG001|STARTED|Overall Study||128||
59716178|NCT00927472|75834999|FG000|COMPLETED|Overall Study||115||
59716179|NCT00927472|75835000|FG001|COMPLETED|Overall Study||106||
59716180|NCT00927472|75834999|FG000|NOT COMPLETED|Overall Study||11||
59716181|NCT00927472|75835000|FG001|NOT COMPLETED|Overall Study||22||
59716182|NCT00927394|75835008|FG000|STARTED|Overall Study||575||
59716183|NCT00927394|75835009|FG001|STARTED|Overall Study|One patient was randomized in error and was discontinued by site.|568||
59716184|NCT00927394|75835008|FG000|Cohort 1 (Randomized)|Overall Study|Cohort 1 includes patients with specific eligibility criteria mentioned in protocol section|157||
59828601|NCT00431444|75951925|FG000|STARTED|Overall Study||56||
59828602|NCT00431444|75951926|FG001|STARTED|Overall Study|"Initially 110 randomized, 1 participant of Raloxifene group never took study drug."|53||
59828603|NCT00431444|75951925|FG000|COMPLETED|Overall Study||51||
59828604|NCT00431444|75951926|FG001|COMPLETED|Overall Study||46||
59828605|NCT00431444|75951925|FG000|NOT COMPLETED|Overall Study||5||
59828606|NCT00431444|75951926|FG001|NOT COMPLETED|Overall Study||7||
59828607|NCT00430352|75951932|FG000|STARTED|Overall Study||545||
59828608|NCT00430352|75951932|FG000|COMPLETED|Overall Study||407||
59828609|NCT00430352|75951932|FG000|NOT COMPLETED|Overall Study||138||
59828610|NCT00287469|75951938|FG000|STARTED|Overall Study||1000||
59716185|NCT00927394|75835009|FG001|Cohort 1 (Randomized)|Overall Study||165||
59828611|NCT00287469|75951939|FG001|STARTED|Overall Study||1000||
59828612|NCT00287469|75951938|FG000|COMPLETED|Overall Study||780||
59828613|NCT00287469|75951939|FG001|COMPLETED|Overall Study||786||
59828614|NCT00287469|75951938|FG000|NOT COMPLETED|Overall Study||220||
59828615|NCT00287469|75951939|FG001|NOT COMPLETED|Overall Study||214||
59828616|NCT00429572|75951947|FG000|STARTED|Overall Study||19||
59828617|NCT00429572|75951947|FG000|COMPLETED|Overall Study||18||
59828618|NCT00429572|75951947|FG000|NOT COMPLETED|Overall Study||1||
59828619|NCT00287079|75951953|FG000|STARTED|Overall Study||32||
59828620|NCT00287079|75951954|FG001|STARTED|Overall Study||3||
59828621|NCT00287079|75951953|FG000|COMPLETED|Overall Study||10||
59828622|NCT00287079|75951954|FG001|COMPLETED|Overall Study||2||
59828623|NCT00287079|75951953|FG000|NOT COMPLETED|Overall Study||22||
59828624|NCT00287079|75951954|FG001|NOT COMPLETED|Overall Study||1||
59828625|NCT00429494|75951960|FG000|STARTED|Overall Study||59||
59828626|NCT00429494|75951960|FG000|COMPLETED|Overall Study||44||
59828627|NCT00429494|75951960|FG000|NOT COMPLETED|Overall Study||15||
59828628|NCT00429416|75951964|FG000|STARTED|Overall Study||14||
59828629|NCT00429416|75951964|FG000|COMPLETED|Overall Study||13||
59828630|NCT00429416|75951964|FG000|NOT COMPLETED|Overall Study||1||
59828631|NCT00429182|75951968|FG000|STARTED|Overall Study||32||
59828632|NCT00429182|75951968|FG000|COMPLETED|Overall Study||25||
59828633|NCT00429182|75951968|FG000|NOT COMPLETED|Overall Study||7||
59828634|NCT00429104|75951972|FG000|STARTED|Overall Study||18||
59828635|NCT00429104|75951972|FG000|COMPLETED|Overall Study||17||
59828636|NCT00429104|75951972|FG000|NOT COMPLETED|Overall Study||1||
59828637|NCT00429026|75951976|FG000|STARTED|Overall Study||40||
59828638|NCT00429026|75951976|FG000|COMPLETED|Overall Study||0||
59828639|NCT00429026|75951976|FG000|NOT COMPLETED|Overall Study||40||
59828640|NCT00301821|75951980|FG000|STARTED|Overall Study||107||
59828641|NCT00301821|75951980|FG000|COMPLETED|Overall Study||81||
59828642|NCT00301821|75951980|FG000|NOT COMPLETED|Overall Study||26||
59828643|NCT00372996|75951986|FG000|STARTED|Overall Study||79||
59828644|NCT00372996|75951987|FG001|STARTED|Overall Study||36||
59828645|NCT00372996|75951988|FG002|STARTED|Overall Study||61||
59828646|NCT00372996|75951989|FG003|STARTED|Overall Study||43||
59828647|NCT00372996|75951986|FG000|COMPLETED|Overall Study||42||
59828648|NCT00372996|75951987|FG001|COMPLETED|Overall Study||22||
59828649|NCT00372996|75951988|FG002|COMPLETED|Overall Study||33||
59828650|NCT00372996|75951989|FG003|COMPLETED|Overall Study||23||
59828651|NCT00372996|75951986|FG000|NOT COMPLETED|Overall Study||37||
59828652|NCT00372996|75951987|FG001|NOT COMPLETED|Overall Study||14||
59828653|NCT00372996|75951988|FG002|NOT COMPLETED|Overall Study||28||
59828654|NCT00372996|75951989|FG003|NOT COMPLETED|Overall Study||20||
59828655|NCT00399516|75951999|FG000|STARTED|Overall Study||21||
59828656|NCT00399516|75951999|FG000|COMPLETED|Overall Study||19||
59828657|NCT00399516|75951999|FG000|NOT COMPLETED|Overall Study||2||
59828658|NCT00399360|75952007|FG000|STARTED|Overall Study||11||
59828659|NCT00399360|75952008|FG001|STARTED|Overall Study||11||
59828660|NCT00399360|75952009|FG002|STARTED|Overall Study||13||
59828661|NCT00399360|75952010|FG003|STARTED|Overall Study||15||
59828662|NCT00399360|75952007|FG000|COMPLETED|Overall Study||9||
59828663|NCT00399360|75952008|FG001|COMPLETED|Overall Study||8||
59828664|NCT00399360|75952009|FG002|COMPLETED|Overall Study||10||
59828665|NCT00399360|75952010|FG003|COMPLETED|Overall Study||9||
59828666|NCT00399360|75952007|FG000|NOT COMPLETED|Overall Study||2||
59828667|NCT00399360|75952008|FG001|NOT COMPLETED|Overall Study||3||
59828668|NCT00399360|75952009|FG002|NOT COMPLETED|Overall Study||3||
59828669|NCT00399360|75952010|FG003|NOT COMPLETED|Overall Study||6||
59828670|NCT00428948|75952027|FG000|STARTED|Overall Study||961||
59828671|NCT00428948|75952028|FG001|STARTED|Overall Study||484||
59828672|NCT00428948|75952027|FG000|Received Treatment|Overall Study||961||
59828673|NCT00428948|75952028|FG001|Received Treatment|Overall Study||483||
59828674|NCT00428948|75952027|FG000|COMPLETED|Overall Study||740||
59828675|NCT00428948|75952028|FG001|COMPLETED|Overall Study||417||
59828676|NCT00428948|75952027|FG000|NOT COMPLETED|Overall Study||221||
59828677|NCT00428948|75952028|FG001|NOT COMPLETED|Overall Study||67||
59828678|NCT00428792|75952036|FG000|STARTED|Overall Study||80||
59828679|NCT00428792|75952037|FG001|STARTED|Overall Study||70||
59828680|NCT00428792|75952036|FG000|COMPLETED|Overall Study|Information is not available during which cross-over period patients discontinued.|79||
59828681|NCT00428792|75952037|FG001|COMPLETED|Overall Study|Information is not available during which cross-over period patients discontinued.|66||
59828682|NCT00428792|75952036|FG000|NOT COMPLETED|Overall Study||1||
59828683|NCT00428792|75952037|FG001|NOT COMPLETED|Overall Study||4||
59828684|NCT00300885|75952045|FG000|STARTED|Treatment||464||
59828685|NCT00300885|75952046|FG001|STARTED|Treatment|ongoing in double -blind treatment at data cut-off|462||
59828686|NCT00300885|75952045|FG000|Received Treatment|Treatment||463||
59828687|NCT00300885|75952046|FG001|Received Treatment|Treatment||459||
59828688|NCT00300885|75952045|FG000|COMPLETED|Treatment||91||
59828689|NCT00300885|75952046|FG001|COMPLETED|Treatment||88||
59828690|NCT00300885|75952045|FG000|NOT COMPLETED|Treatment||373||
59828691|NCT00300885|75952046|FG001|NOT COMPLETED|Treatment||374||
59828692|NCT00300885|75952045|FG000|STARTED|Follow-up|Subjects entered Follow-up period after termination of Treatment period due to any reason.|354||
59828693|NCT00300885|75952046|FG001|STARTED|Follow-up|Subjects entered Follow-up period after termination of Treatment period due to any reason.|369||
60118064|NCT00109005|76239116|FG001|NOT COMPLETED|Overall Study||0||
59828694|NCT00300885|75952045|FG000|COMPLETED|Follow-up|Subjects still in Follow up period at data cut-off date.|176||
59828695|NCT00300885|75952046|FG001|COMPLETED|Follow-up|Subjects still in Follow up period at data cut-off date.|174||
59828696|NCT00300885|75952045|FG000|NOT COMPLETED|Follow-up||178||
59828697|NCT00300885|75952046|FG001|NOT COMPLETED|Follow-up||195||
59828698|NCT00386334|75952054|FG000|STARTED|Double Blind Period||194||
59828699|NCT00386334|75952055|FG001|STARTED|Double Blind Period||194||
59828700|NCT00386334|75952054|FG000|COMPLETED|Double Blind Period||148||
59716186|NCT00927394|75835008|FG000|Cohort 2 (Randomized)|Overall Study|Cohort 2 includes patients with specific eligibility criteria mentioned in protocol section|418||
59716187|NCT00927394|75835009|FG001|Cohort 2 (Randomized)|Overall Study||403||
59716188|NCT00927394|75835008|FG000|Combined Safety Set (Cohort 1 and 2)|Overall Study||574||
59716189|NCT00927394|75835009|FG001|Combined Safety Set (Cohort 1 and 2)|Overall Study||565||
59716190|NCT00927394|75835008|FG000|Cohort 1: Full Analysis Set 1 (FAS 1)|Overall Study|FAS 1 includes all patients in Cohort 1 to whom study treatments were given through randomization.|157||
59716191|NCT00927394|75835009|FG001|Cohort 1: Full Analysis Set 1 (FAS 1)|Overall Study||164||
59716192|NCT00927394|75835008|FG000|Cohort 2: Full Analysis Set 2 (FAS 2)|Overall Study|FAS 2= all patients randomized to Cohort 2 and who had a valid baseline assessment of 24 hours ABPM.|417||
59716193|NCT00927394|75835009|FG001|Cohort 2: Full Analysis Set 2 (FAS 2)|Overall Study||398||
59716194|NCT00927394|75835008|FG000|FAS 2 :Ambulatory Blood Pressure Monitor|Overall Study|consists of all patients in FAS 2 who had both valid baseline and post-baseline ABPM assessments.|342||
59716195|NCT00927394|75835009|FG001|FAS 2 :Ambulatory Blood Pressure Monitor|Overall Study||323||
59716196|NCT00927394|75835008|FG000|Combined Full Analysis Set (FAS 1+FAS 2)|Overall Study||574||
59716197|NCT00927394|75835009|FG001|Combined Full Analysis Set (FAS 1+FAS 2)|Overall Study||562||
59716198|NCT00927394|75835008|FG000|COMPLETED|Overall Study||498||
59716199|NCT00927394|75835009|FG001|COMPLETED|Overall Study||483||
59716200|NCT00927394|75835008|FG000|NOT COMPLETED|Overall Study||77||
59716201|NCT00927394|75835009|FG001|NOT COMPLETED|Overall Study||85||
59716202|NCT00976911|75835018|FG000|STARTED|Overall Study||182||
59716203|NCT00976911|75835019|FG001|STARTED|Overall Study||179||
59828701|NCT00386334|75952055|FG001|COMPLETED|Double Blind Period||147||
59828702|NCT00386334|75952054|FG000|NOT COMPLETED|Double Blind Period||46||
59828703|NCT00386334|75952055|FG001|NOT COMPLETED|Double Blind Period||47||
59828704|NCT00386334|75952054|FG000|STARTED|Follow up:2 Week Placebo, 2 Week no Drug|Two subjects withdrew consent prior to starting the follow up period.|146||
59828705|NCT00386334|75952055|FG001|STARTED|Follow up:2 Week Placebo, 2 Week no Drug|Two subjects withdrew consent prior to starting the follow up period.|145||
59828706|NCT00386334|75952054|FG000|COMPLETED|Follow up:2 Week Placebo, 2 Week no Drug||143||
59828707|NCT00386334|75952055|FG001|COMPLETED|Follow up:2 Week Placebo, 2 Week no Drug||144||
59828708|NCT00386334|75952054|FG000|NOT COMPLETED|Follow up:2 Week Placebo, 2 Week no Drug||3||
59828709|NCT00386334|75952055|FG001|NOT COMPLETED|Follow up:2 Week Placebo, 2 Week no Drug||1||
59828710|NCT01143116|75952063|FG000|STARTED|Overall Study||10||
59828711|NCT01143116|75952064|FG001|STARTED|Overall Study||10||
59828712|NCT01143116|75952063|FG000|COMPLETED|Overall Study||10||
59828713|NCT01143116|75952064|FG001|COMPLETED|Overall Study||10||
59828714|NCT01143116|75952063|FG000|NOT COMPLETED|Overall Study||0||
59828715|NCT01143116|75952064|FG001|NOT COMPLETED|Overall Study||0||
59828716|NCT00428714|75952072|FG000|STARTED|Overall Study||31||
59828717|NCT00428714|75952073|FG001|STARTED|Overall Study||42||
59828718|NCT00428714|75952072|FG000|Received at Least 1 Dose of Study Drug|Overall Study||31||
59828719|NCT00428714|75952073|FG001|Received at Least 1 Dose of Study Drug|Overall Study||42||
59828720|NCT00428714|75952072|FG000|COMPLETED|Overall Study||0||
59828721|NCT00428714|75952073|FG001|COMPLETED|Overall Study||0||
59828722|NCT00428714|75952072|FG000|NOT COMPLETED|Overall Study||31||
59828723|NCT00428714|75952073|FG001|NOT COMPLETED|Overall Study||42||
59828724|NCT00292227|75952082|FG000|STARTED|Patch Period||66||
59828725|NCT00292227|75952083|FG001|STARTED|Patch Period||31||
59828726|NCT00292227|75952084|FG002|STARTED|Patch Period||33||
59828727|NCT00292227|75952082|FG000|COMPLETED|Patch Period||65||
59828728|NCT00292227|75952083|FG001|COMPLETED|Patch Period||31||
59828729|NCT00292227|75952084|FG002|COMPLETED|Patch Period||30||
59828730|NCT00292227|75952082|FG000|NOT COMPLETED|Patch Period||1||
59828731|NCT00292227|75952083|FG001|NOT COMPLETED|Patch Period||0||
59828732|NCT00292227|75952084|FG002|NOT COMPLETED|Patch Period||3||
59828733|NCT00292227|75952082|FG000|STARTED|Cross-over Period 1 (Day 32)||65||
59828734|NCT00292227|75952083|FG001|STARTED|Cross-over Period 1 (Day 32)||31||
59828735|NCT00292227|75952084|FG002|STARTED|Cross-over Period 1 (Day 32)||30||
59828736|NCT00292227|75952082|FG000|COMPLETED|Cross-over Period 1 (Day 32)||65||
59828737|NCT00292227|75952083|FG001|COMPLETED|Cross-over Period 1 (Day 32)||31||
59828738|NCT00292227|75952084|FG002|COMPLETED|Cross-over Period 1 (Day 32)||30||
59828739|NCT00292227|75952082|FG000|NOT COMPLETED|Cross-over Period 1 (Day 32)||0||
59828740|NCT00292227|75952083|FG001|NOT COMPLETED|Cross-over Period 1 (Day 32)||0||
59828741|NCT00292227|75952084|FG002|NOT COMPLETED|Cross-over Period 1 (Day 32)||0||
59828742|NCT00292227|75952082|FG000|STARTED|Cross-over Period 2 (Day 39)||65||
59828743|NCT00292227|75952083|FG001|STARTED|Cross-over Period 2 (Day 39)||31||
59828744|NCT00292227|75952084|FG002|STARTED|Cross-over Period 2 (Day 39)||30||
59828745|NCT00292227|75952082|FG000|COMPLETED|Cross-over Period 2 (Day 39)||65||
59828746|NCT00292227|75952083|FG001|COMPLETED|Cross-over Period 2 (Day 39)||31||
59828747|NCT00292227|75952084|FG002|COMPLETED|Cross-over Period 2 (Day 39)||30||
59828748|NCT00292227|75952082|FG000|NOT COMPLETED|Cross-over Period 2 (Day 39)||0||
59828749|NCT00292227|75952083|FG001|NOT COMPLETED|Cross-over Period 2 (Day 39)||0||
59828750|NCT00292227|75952084|FG002|NOT COMPLETED|Cross-over Period 2 (Day 39)||0||
59828751|NCT00386100|75952094|FG000|STARTED|Overall Study||340||
59828752|NCT00386100|75952095|FG001|STARTED|Overall Study||348||
59828753|NCT00386100|75952094|FG000|COMPLETED|Overall Study||186||
59828754|NCT00386100|75952095|FG001|COMPLETED|Overall Study||217||
59828755|NCT00386100|75952094|FG000|NOT COMPLETED|Overall Study||154||
59828756|NCT00386100|75952095|FG001|NOT COMPLETED|Overall Study||131||
59828757|NCT00300495|75952103|FG000|STARTED|Overall Study||10||
59828758|NCT00300495|75952104|FG001|STARTED|Overall Study||9||
59828759|NCT00300495|75952103|FG000|COMPLETED|Overall Study||6||
59828760|NCT00300495|75952104|FG001|COMPLETED|Overall Study||8||
59828761|NCT00300495|75952103|FG000|NOT COMPLETED|Overall Study||4||
59828762|NCT00300495|75952104|FG001|NOT COMPLETED|Overall Study||1||
59828763|NCT00386022|75952112|FG000|STARTED|Baseline||10||
59828764|NCT00386022|75952113|FG001|STARTED|Baseline||9||
59828765|NCT00386022|75952112|FG000|All Doses of GnRH|Baseline||10||
59828766|NCT00386022|75952113|FG001|All Doses of GnRH|Baseline||9||
59828767|NCT00386022|75952112|FG000|COMPLETED|Baseline||10||
59828768|NCT00386022|75952113|FG001|COMPLETED|Baseline||9||
59828769|NCT00386022|75952112|FG000|NOT COMPLETED|Baseline||0||
59828770|NCT00386022|75952113|FG001|NOT COMPLETED|Baseline||0||
59828771|NCT00386022|75952112|FG000|STARTED|Plus Estrogen||10||
59828772|NCT00386022|75952113|FG001|STARTED|Plus Estrogen||9||
59828773|NCT00386022|75952112|FG000|Estrogen Patch|Plus Estrogen||8||
59828774|NCT00386022|75952113|FG001|Estrogen Patch|Plus Estrogen||9||
59828775|NCT00386022|75952112|FG000|All Doses GnRH|Plus Estrogen||8||
59828776|NCT00386022|75952113|FG001|All Doses GnRH|Plus Estrogen||8||
59828777|NCT00386022|75952112|FG000|COMPLETED|Plus Estrogen||8||
59828778|NCT00386022|75952113|FG001|COMPLETED|Plus Estrogen||8||
59828779|NCT00386022|75952112|FG000|NOT COMPLETED|Plus Estrogen||2||
59828780|NCT00386022|75952113|FG001|NOT COMPLETED|Plus Estrogen||1||
59716204|NCT00976911|75835018|FG000|COMPLETED|Overall Study|At time of clinical cutoff for overall survival and safety (25 January 2013)|0||
59828781|NCT00286455|75952124|FG000|STARTED|Overall Study||65||
59828782|NCT00286455|75952125|FG001|STARTED|Overall Study||133||
59828783|NCT00286455|75952126|FG002|STARTED|Overall Study||131||
59828784|NCT00286455|75952124|FG000|COMPLETED|Overall Study||40||
59828785|NCT00286455|75952125|FG001|COMPLETED|Overall Study||105||
59828786|NCT00286455|75952126|FG002|COMPLETED|Overall Study||107||
59828787|NCT00286455|75952124|FG000|NOT COMPLETED|Overall Study||25||
59828788|NCT00286455|75952125|FG001|NOT COMPLETED|Overall Study||28||
59828789|NCT00286455|75952126|FG002|NOT COMPLETED|Overall Study||24||
59828790|NCT00385944|75952136|FG000|STARTED|Loading Dose||0||
59828791|NCT00385944|75952137|FG001|STARTED|Loading Dose||0||
59828792|NCT00385944|75952138|FG002|STARTED|Loading Dose||56||
59828793|NCT00385944|75952136|FG000|COMPLETED|Loading Dose||0||
59828794|NCT00385944|75952137|FG001|COMPLETED|Loading Dose||0||
59828795|NCT00385944|75952138|FG002|COMPLETED|Loading Dose||56||
59828796|NCT00385944|75952136|FG000|NOT COMPLETED|Loading Dose||0||
59716205|NCT00976911|75835019|FG001|COMPLETED|Overall Study|At time of clinical cutoff for overall survival and safety (25 January 2013)|0||
59716206|NCT00976911|75835018|FG000|NOT COMPLETED|Overall Study||182||
59716207|NCT00976911|75835019|FG001|NOT COMPLETED|Overall Study||179||
59716208|NCT00934648|75835025|FG000|STARTED|Overall Study||15||
59716209|NCT00934648|75835025|FG000|COMPLETED|Overall Study||6||
59716210|NCT00934648|75835025|FG000|NOT COMPLETED|Overall Study||9||
59716211|NCT01175213|75835033|FG000|STARTED|IGSC, 10%/rHuPH20||63||
59716212|NCT01175213|75835034|FG001|STARTED|IGSC, 10%/rHuPH20|3 participants treated IV with IGIV,10% without rHuPH20 throughout the study.|3||
59716213|NCT01175213|75835033|FG000|COMPLETED|IGSC, 10%/rHuPH20||48||
59716214|NCT01175213|75835034|FG001|COMPLETED|IGSC, 10%/rHuPH20||3||
59716215|NCT01175213|75835033|FG000|NOT COMPLETED|IGSC, 10%/rHuPH20||15||
59716216|NCT01175213|75835034|FG001|NOT COMPLETED|IGSC, 10%/rHuPH20||0||
59716217|NCT01175213|75835033|FG000|STARTED|Safety Follow-up||48||
59716218|NCT01175213|75835034|FG001|STARTED|Safety Follow-up||3||
59716219|NCT01175213|75835033|FG000|COMPLETED|Safety Follow-up||47||
59716220|NCT01175213|75835034|FG001|COMPLETED|Safety Follow-up||3||
59716221|NCT01175213|75835033|FG000|NOT COMPLETED|Safety Follow-up||1||
59828797|NCT00385944|75952137|FG001|NOT COMPLETED|Loading Dose||0||
59828798|NCT00385944|75952138|FG002|NOT COMPLETED|Loading Dose||0||
59828799|NCT00385944|75952136|FG000|STARTED|1st Maintenance Dose Period||29||
59716222|NCT01175213|75835034|FG001|NOT COMPLETED|Safety Follow-up||0||
59716223|NCT00974259|75835045|FG000|STARTED|Overall Study||59||
59716224|NCT00974259|75835046|FG001|STARTED|Overall Study||63||
59716225|NCT00974259|75835045|FG000|COMPLETED|Overall Study||57||
59716226|NCT00974259|75835046|FG001|COMPLETED|Overall Study||62||
59716227|NCT00974259|75835045|FG000|NOT COMPLETED|Overall Study||2||
59716228|NCT00974259|75835046|FG001|NOT COMPLETED|Overall Study||1||
59828800|NCT00385944|75952137|FG001|STARTED|1st Maintenance Dose Period|Two patients withdrew from the study after randomization but prior to receiving the 1st MD.|25||
59828801|NCT00385944|75952138|FG002|STARTED|1st Maintenance Dose Period||0||
59828802|NCT00385944|75952136|FG000|COMPLETED|1st Maintenance Dose Period||25||
59828803|NCT00385944|75952137|FG001|COMPLETED|1st Maintenance Dose Period||24||
59828804|NCT00385944|75952138|FG002|COMPLETED|1st Maintenance Dose Period||0||
59828805|NCT00385944|75952136|FG000|NOT COMPLETED|1st Maintenance Dose Period||4||
60118065|NCT00109473|76239125|FG000|STARTED|Baseline (0 Through 12 Weeks)|11 subjects allocated to Group A; one withdrew consent, only 10 receieved intervention.|10||
60118066|NCT00109473|76239126|FG001|STARTED|Baseline (0 Through 12 Weeks)||10||
60118067|NCT00109473|76239125|FG000|Analyzed|Baseline (0 Through 12 Weeks)||10||
60118068|NCT00109473|76239126|FG001|Analyzed|Baseline (0 Through 12 Weeks)||10||
59716229|NCT00927082|75835056|FG000|STARTED|Overall Study||91||
59716230|NCT00927082|75835057|FG001|STARTED|Overall Study||87||
59716231|NCT00927082|75835058|FG002|STARTED|Overall Study||108||
59716232|NCT00927082|75835059|FG003|STARTED|Overall Study||97||
59716233|NCT00927082|75835056|FG000|COMPLETED|Overall Study||79||
59716234|NCT00927082|75835057|FG001|COMPLETED|Overall Study||77||
59716235|NCT00927082|75835058|FG002|COMPLETED|Overall Study||86||
59716236|NCT00927082|75835059|FG003|COMPLETED|Overall Study||78||
59716237|NCT00927082|75835056|FG000|NOT COMPLETED|Overall Study||12||
59716238|NCT00927082|75835057|FG001|NOT COMPLETED|Overall Study||10||
59716239|NCT00927082|75835058|FG002|NOT COMPLETED|Overall Study||22||
59716240|NCT00927082|75835059|FG003|NOT COMPLETED|Overall Study||19||
59716241|NCT00976677|75835075|FG000|STARTED|Overall Study||5||
59716242|NCT00976677|75835076|FG001|STARTED|Overall Study||5||
59716243|NCT00976677|75835075|FG000|COMPLETED|Overall Study||0||
59716244|NCT00976677|75835076|FG001|COMPLETED|Overall Study||0||
59716245|NCT00976677|75835075|FG000|NOT COMPLETED|Overall Study||5||
59716246|NCT00976677|75835076|FG001|NOT COMPLETED|Overall Study||5||
59716247|NCT00926536|75835084|FG000|STARTED|Overall Study||44||
59716248|NCT00926536|75835085|FG001|STARTED|Overall Study||43||
59716249|NCT00926536|75835084|FG000|COMPLETED|Overall Study||43||
59716250|NCT00926536|75835085|FG001|COMPLETED|Overall Study||41||
59716251|NCT00926536|75835084|FG000|NOT COMPLETED|Overall Study||1||
59716252|NCT00926536|75835085|FG001|NOT COMPLETED|Overall Study||2||
59716253|NCT00923260|75835093|FG000|STARTED|Overall Study||12||
59716254|NCT00923260|75835094|FG001|STARTED|Overall Study||12||
59716255|NCT00923260|75835093|FG000|COMPLETED|Overall Study|Patient didn't complete the follow-up period after surgery|11||
59716256|NCT00923260|75835094|FG001|COMPLETED|Overall Study|Patient didn't complete the follow-up period after surgery|11||
59828806|NCT00385944|75952137|FG001|NOT COMPLETED|1st Maintenance Dose Period||1||
59828807|NCT00385944|75952138|FG002|NOT COMPLETED|1st Maintenance Dose Period||0||
59828808|NCT00385944|75952136|FG000|STARTED|2nd Maintenance Dose Period|1 patient discontinued prior to the 2nd MD Period (Sponsor decision due to early study termination)|24||
59828809|NCT00385944|75952137|FG001|STARTED|2nd Maintenance Dose Period|2 patients discontinued prior to the 2nd MD Period (Sponsor decision due to early study termination)|22||
59828810|NCT00385944|75952138|FG002|STARTED|2nd Maintenance Dose Period||0||
59828811|NCT00385944|75952136|FG000|COMPLETED|2nd Maintenance Dose Period||22||
59828812|NCT00385944|75952137|FG001|COMPLETED|2nd Maintenance Dose Period||19||
59828813|NCT00385944|75952138|FG002|COMPLETED|2nd Maintenance Dose Period||0||
60118069|NCT00109473|76239125|FG000|COMPLETED|Baseline (0 Through 12 Weeks)||10||
60118070|NCT00109473|76239126|FG001|COMPLETED|Baseline (0 Through 12 Weeks)|One subject discontinued intervention because of active disease requiring imfliximab|9||
60118071|NCT00109473|76239125|FG000|NOT COMPLETED|Baseline (0 Through 12 Weeks)||0||
60118072|NCT00109473|76239126|FG001|NOT COMPLETED|Baseline (0 Through 12 Weeks)||1||
60118073|NCT00109473|76239125|FG000|STARTED|Week 12 to Week 24||10||
60118074|NCT00109473|76239126|FG001|STARTED|Week 12 to Week 24||9||
60118075|NCT00109473|76239125|FG000|Analyzed|Week 12 to Week 24||9||
60118076|NCT00109473|76239126|FG001|Analyzed|Week 12 to Week 24||9||
60118077|NCT00109473|76239125|FG000|COMPLETED|Week 12 to Week 24|One subject withdrew consent|9||
60118078|NCT00109473|76239126|FG001|COMPLETED|Week 12 to Week 24|one subject discontinued intervention due to active disease requiring surgery|9||
60118079|NCT00109473|76239125|FG000|NOT COMPLETED|Week 12 to Week 24||1||
60118080|NCT00109473|76239126|FG001|NOT COMPLETED|Week 12 to Week 24||0||
60118081|NCT00109473|76239125|FG000|STARTED|52 Week Extension Phase||9||
60118082|NCT00109473|76239126|FG001|STARTED|52 Week Extension Phase||8||
60118083|NCT00109473|76239125|FG000|Analyzed|52 Week Extension Phase||9||
60118084|NCT00109473|76239126|FG001|Analyzed|52 Week Extension Phase||8||
60118085|NCT00109473|76239125|FG000|COMPLETED|52 Week Extension Phase|Extension phase ends when subjects discontinue intervention due to active disease or reaches week 64|5||
60118086|NCT00109473|76239126|FG001|COMPLETED|52 Week Extension Phase|Extension phase ends when subjects discontinue intervention due to active disease or reaches week 64|3||
60118087|NCT00109473|76239125|FG000|NOT COMPLETED|52 Week Extension Phase||4||
60118088|NCT00109473|76239126|FG001|NOT COMPLETED|52 Week Extension Phase||5||
60118089|NCT00040443|76239137|FG000|STARTED|Overall Study||84||
60118090|NCT00040443|76239138|FG001|STARTED|Overall Study||91||
60118091|NCT00040443|76239137|FG000|COMPLETED|Overall Study||84||
60118092|NCT00040443|76239138|FG001|COMPLETED|Overall Study||91||
60118093|NCT00040443|76239137|FG000|NOT COMPLETED|Overall Study||0||
60118094|NCT00040443|76239138|FG001|NOT COMPLETED|Overall Study||0||
60118095|NCT00044655|76239146|FG000|STARTED|Overall Study||102||
60118096|NCT00044655|76239147|FG001|STARTED|Overall Study||117||
60118097|NCT00044655|76239146|FG000|COMPLETED|Overall Study||82||
60118098|NCT00044655|76239147|FG001|COMPLETED|Overall Study||79||
60118099|NCT00044655|76239146|FG000|NOT COMPLETED|Overall Study||20||
60118100|NCT00044655|76239147|FG001|NOT COMPLETED|Overall Study||38||
59828814|NCT00385944|75952136|FG000|NOT COMPLETED|2nd Maintenance Dose Period||2||
59828815|NCT00385944|75952137|FG001|NOT COMPLETED|2nd Maintenance Dose Period||3||
59828816|NCT00385944|75952138|FG002|NOT COMPLETED|2nd Maintenance Dose Period||0||
59828817|NCT00286221|75952157|FG000|STARTED|Overall Study||39||
59828818|NCT00286221|75952158|FG001|STARTED|Overall Study||40||
59828819|NCT00286221|75952159|FG002|STARTED|Overall Study||40||
59828820|NCT00286221|75952160|FG003|STARTED|Overall Study||40||
59828821|NCT00286221|75952157|FG000|COMPLETED|Overall Study||29||
59828822|NCT00286221|75952158|FG001|COMPLETED|Overall Study||35||
59828823|NCT00286221|75952159|FG002|COMPLETED|Overall Study||31||
59828824|NCT00286221|75952160|FG003|COMPLETED|Overall Study||34||
59828825|NCT00286221|75952157|FG000|NOT COMPLETED|Overall Study||10||
59828826|NCT00286221|75952158|FG001|NOT COMPLETED|Overall Study||5||
59828827|NCT00286221|75952159|FG002|NOT COMPLETED|Overall Study||9||
59828828|NCT00286221|75952160|FG003|NOT COMPLETED|Overall Study||6||
59716257|NCT00923260|75835093|FG000|NOT COMPLETED|Overall Study||1||
59716258|NCT00923260|75835094|FG001|NOT COMPLETED|Overall Study||1||
59716259|NCT00934102|75835100|FG000|STARTED|Period 1, One Night of Wear||16||
59716260|NCT00934102|75835101|FG001|STARTED|Period 1, One Night of Wear||15||
59716261|NCT00934102|75835102|FG002|STARTED|Period 1, One Night of Wear||15||
59716262|NCT00934102|75835100|FG000|COMPLETED|Period 1, One Night of Wear||15||
59716263|NCT00934102|75835101|FG001|COMPLETED|Period 1, One Night of Wear||15||
59716264|NCT00934102|75835102|FG002|COMPLETED|Period 1, One Night of Wear||15||
59716265|NCT00934102|75835100|FG000|NOT COMPLETED|Period 1, One Night of Wear||1||
59828829|NCT00285207|75952172|FG000|STARTED|Overall Study||70||
59828830|NCT00285207|75952173|FG001|STARTED|Overall Study||77||
59828831|NCT00285207|75952172|FG000|Treated|Overall Study||63||
59828832|NCT00285207|75952173|FG001|Treated|Overall Study||75||
59828833|NCT00285207|75952172|FG000|COMPLETED|Overall Study||61||
59828834|NCT00285207|75952173|FG001|COMPLETED|Overall Study||71||
59828835|NCT00285207|75952172|FG000|NOT COMPLETED|Overall Study||9||
59828836|NCT00285207|75952173|FG001|NOT COMPLETED|Overall Study||6||
59828837|NCT00398112|75952179|FG000|STARTED|Overall Study||18||
59828838|NCT00398112|75952179|FG000|COMPLETED|Overall Study||0||
59828839|NCT00398112|75952179|FG000|NOT COMPLETED|Overall Study||18||
59828840|NCT00424346|75952187|FG000|STARTED|Core Study||71||
59828841|NCT00424346|75952188|FG001|STARTED|Core Study||64||
59828842|NCT00424346|75952189|FG002|STARTED|Core Study||69||
59828843|NCT00424346|75952190|FG003|STARTED|Core Study||70||
59828844|NCT00424346|75952187|FG000|COMPLETED|Core Study||62||
59828845|NCT00424346|75952188|FG001|COMPLETED|Core Study||56||
59828846|NCT00424346|75952189|FG002|COMPLETED|Core Study||65||
59828847|NCT00424346|75952190|FG003|COMPLETED|Core Study||63||
59828848|NCT00424346|75952187|FG000|NOT COMPLETED|Core Study||9||
59828849|NCT00424346|75952188|FG001|NOT COMPLETED|Core Study||8||
59828850|NCT00424346|75952189|FG002|NOT COMPLETED|Core Study||4||
59828851|NCT00424346|75952190|FG003|NOT COMPLETED|Core Study||7||
59828852|NCT00424346|75952187|FG000|STARTED|Extension Phase|Participants are represented in the Canakinumab 300 mg q2wk treatment group.|0||
59716266|NCT00934102|75835101|FG001|NOT COMPLETED|Period 1, One Night of Wear||0||
59716267|NCT00934102|75835102|FG002|NOT COMPLETED|Period 1, One Night of Wear||0||
59716268|NCT00934102|75835100|FG000|STARTED|Period 2, 7 Days/6 Nights of Wear||15||
59716269|NCT00934102|75835101|FG001|STARTED|Period 2, 7 Days/6 Nights of Wear||15||
59716270|NCT00934102|75835102|FG002|STARTED|Period 2, 7 Days/6 Nights of Wear||15||
59716271|NCT00934102|75835100|FG000|COMPLETED|Period 2, 7 Days/6 Nights of Wear||15||
59716272|NCT00934102|75835101|FG001|COMPLETED|Period 2, 7 Days/6 Nights of Wear||15||
59716273|NCT00934102|75835102|FG002|COMPLETED|Period 2, 7 Days/6 Nights of Wear||15||
59828853|NCT00424346|75952188|FG001|STARTED|Extension Phase|Includes participants who completed the Core phase in the Canakinumab 600 mg IV + 300 mg q2wk group.|110||
59828854|NCT00424346|75952189|FG002|STARTED|Extension Phase||59||
59828855|NCT00424346|75952190|FG003|STARTED|Extension Phase||58||
59828856|NCT00424346|75952187|FG000|COMPLETED|Extension Phase||0||
59828857|NCT00424346|75952188|FG001|COMPLETED|Extension Phase||8||
59828858|NCT00424346|75952189|FG002|COMPLETED|Extension Phase||4||
59828859|NCT00424346|75952190|FG003|COMPLETED|Extension Phase||3||
59828860|NCT00424346|75952187|FG000|NOT COMPLETED|Extension Phase||0||
59716274|NCT00934102|75835100|FG000|NOT COMPLETED|Period 2, 7 Days/6 Nights of Wear||0||
59716275|NCT00934102|75835101|FG001|NOT COMPLETED|Period 2, 7 Days/6 Nights of Wear||0||
59716276|NCT00934102|75835102|FG002|NOT COMPLETED|Period 2, 7 Days/6 Nights of Wear||0||
59716277|NCT03760419|75835112|FG000|STARTED|Overall Study||535||
59716278|NCT03760419|75835113|FG001|STARTED|Overall Study||492||
59828861|NCT00424346|75952188|FG001|NOT COMPLETED|Extension Phase||102||
59828862|NCT00424346|75952189|FG002|NOT COMPLETED|Extension Phase||55||
59828863|NCT00424346|75952190|FG003|NOT COMPLETED|Extension Phase||55||
59828864|NCT00283959|75952203|FG000|STARTED|Treatment Period||4||
59828865|NCT00283959|75952203|FG000|Safety Population|Treatment Period||4|All enrolled participants who received at least 1 dose of study drug|
59828866|NCT00283959|75952203|FG000|Pharmacodynamics (PD) Population|Treatment Period||4|Received study drug and had a non-missing baseline and postbaseline PD parameter recorded|
59828867|NCT00283959|75952203|FG000|COMPLETED|Treatment Period||4||
59828868|NCT00283959|75952203|FG000|NOT COMPLETED|Treatment Period||0||
59828869|NCT00283959|75952203|FG000|STARTED|Extension Period||4||
59828870|NCT00283959|75952203|FG000|COMPLETED|Extension Period||3||
59828871|NCT00283959|75952203|FG000|NOT COMPLETED|Extension Period||1||
59828872|NCT00372528|75952207|FG000|STARTED|Overall Study||21||
59828873|NCT00372528|75952207|FG000|COMPLETED|Overall Study||0||
59828874|NCT00372528|75952207|FG000|NOT COMPLETED|Overall Study||21||
59828875|NCT00283803|75952211|FG000|STARTED|Overall Study||32||
59828876|NCT00283803|75952211|FG000|COMPLETED|Overall Study||19||
59828877|NCT00283803|75952211|FG000|NOT COMPLETED|Overall Study||13||
59828878|NCT00397488|75952215|FG000|STARTED|Overall Study||78||
59828879|NCT00397488|75952215|FG000|COMPLETED|Overall Study||71||
59828880|NCT00397488|75952215|FG000|NOT COMPLETED|Overall Study||7||
59828881|NCT00424190|75952221|FG000|STARTED|Overall Study||351||
59828882|NCT00424190|75952222|FG001|STARTED|Overall Study||347||
59828883|NCT00424190|75952221|FG000|COMPLETED|Overall Study||329||
59828884|NCT00424190|75952222|FG001|COMPLETED|Overall Study||317||
59828885|NCT00424190|75952221|FG000|NOT COMPLETED|Overall Study||22||
59828886|NCT00424190|75952222|FG001|NOT COMPLETED|Overall Study||30||
59828887|NCT00428246|75952231|FG000|STARTED|Overall Study||8||
59828888|NCT00428246|75952232|FG001|STARTED|Overall Study||8||
59828889|NCT00428246|75952233|FG002|STARTED|Overall Study||8||
59828890|NCT00428246|75952231|FG000|COMPLETED|Overall Study||7||
59828891|NCT00428246|75952232|FG001|COMPLETED|Overall Study||8||
59828892|NCT00428246|75952233|FG002|COMPLETED|Overall Study||7||
59828893|NCT00428246|75952231|FG000|NOT COMPLETED|Overall Study||1||
59828894|NCT00428246|75952232|FG001|NOT COMPLETED|Overall Study||0||
59828895|NCT00428246|75952233|FG002|NOT COMPLETED|Overall Study||1||
59828896|NCT00274287|75952241|FG000|STARTED|Overall Study||15||
59828897|NCT00274287|75952241|FG000|COMPLETED|Overall Study||13||
59828898|NCT00274287|75952241|FG000|NOT COMPLETED|Overall Study||2||
59828899|NCT00423800|75952248|FG000|STARTED|Overall Study||3||
59828900|NCT00423800|75952249|FG001|STARTED|Overall Study||2||
59828901|NCT00423800|75952248|FG000|COMPLETED|Overall Study||3||
59828902|NCT00423800|75952249|FG001|COMPLETED|Overall Study||1||
59828903|NCT00423800|75952248|FG000|NOT COMPLETED|Overall Study||0||
59828904|NCT00423800|75952249|FG001|NOT COMPLETED|Overall Study||1||
59828905|NCT00405548|75952258|FG000|STARTED|Overall Study||28||
59828906|NCT00405548|75952259|FG001|STARTED|Overall Study||13||
59828907|NCT00405548|75952258|FG000|COMPLETED|Overall Study||24||
59828908|NCT00405548|75952259|FG001|COMPLETED|Overall Study||12||
59828909|NCT00405548|75952258|FG000|NOT COMPLETED|Overall Study||4||
59828910|NCT00405548|75952259|FG001|NOT COMPLETED|Overall Study||1||
59828911|NCT00405392|75952267|FG000|STARTED|Overall Study||183||
59828912|NCT00405392|75952268|FG001|STARTED|Overall Study||182||
59828913|NCT00405392|75952267|FG000|COMPLETED|Overall Study||153||
59828914|NCT00405392|75952268|FG001|COMPLETED|Overall Study||155||
59828915|NCT00405392|75952267|FG000|NOT COMPLETED|Overall Study||30||
59828916|NCT00405392|75952268|FG001|NOT COMPLETED|Overall Study||27||
59828917|NCT00282243|75952274|FG000|STARTED|Pharmacokinetic Treatment Period||70||
59828918|NCT00282243|75952274|FG000|Received Tacrolimus|Pharmacokinetic Treatment Period||70||
59828919|NCT00282243|75952274|FG000|Received Tacrolimus MR|Pharmacokinetic Treatment Period||69||
59828920|NCT00282243|75952274|FG000|COMPLETED|Pharmacokinetic Treatment Period||65||
59828921|NCT00282243|75952274|FG000|NOT COMPLETED|Pharmacokinetic Treatment Period||5||
59828922|NCT00282243|75952274|FG000|STARTED|Extension Treatment Period||65||
59828923|NCT00282243|75952274|FG000|COMPLETED|Extension Treatment Period||43||
59828924|NCT00282243|75952274|FG000|NOT COMPLETED|Extension Treatment Period||22||
59828925|NCT00272961|75952283|FG000|STARTED|Placebo Run-in Phase: Up to Week 2||60||
59828926|NCT00272961|75952284|FG001|STARTED|Placebo Run-in Phase: Up to Week 2||0||
59567455|NCT00554294|75670416|FG000|NOT COMPLETED|Overall Study||160||
59828927|NCT00272961|75952285|FG002|STARTED|Placebo Run-in Phase: Up to Week 2||0||
59828928|NCT00272961|75952286|FG003|STARTED|Placebo Run-in Phase: Up to Week 2||0||
59828929|NCT00272961|75952287|FG004|STARTED|Placebo Run-in Phase: Up to Week 2||0||
59828930|NCT00272961|75952283|FG000|COMPLETED|Placebo Run-in Phase: Up to Week 2||49||
59828931|NCT00272961|75952284|FG001|COMPLETED|Placebo Run-in Phase: Up to Week 2||0||
59828932|NCT00272961|75952285|FG002|COMPLETED|Placebo Run-in Phase: Up to Week 2||0||
59828933|NCT00272961|75952286|FG003|COMPLETED|Placebo Run-in Phase: Up to Week 2||0||
59828934|NCT00272961|75952287|FG004|COMPLETED|Placebo Run-in Phase: Up to Week 2||0||
59828935|NCT00272961|75952283|FG000|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||11||
59828936|NCT00272961|75952284|FG001|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||0||
59828937|NCT00272961|75952285|FG002|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||0||
59828938|NCT00272961|75952286|FG003|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||0||
59828939|NCT00272961|75952287|FG004|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||0||
59828940|NCT00272961|75952283|FG000|STARTED|Treatment Phase: Week 3 Up to Week 12||10||
59828941|NCT00272961|75952284|FG001|STARTED|Treatment Phase: Week 3 Up to Week 12||8||
59828942|NCT00272961|75952285|FG002|STARTED|Treatment Phase: Week 3 Up to Week 12||11||
59828943|NCT00272961|75952286|FG003|STARTED|Treatment Phase: Week 3 Up to Week 12||10||
59828944|NCT00272961|75952287|FG004|STARTED|Treatment Phase: Week 3 Up to Week 12||10||
59828945|NCT00272961|75952283|FG000|COMPLETED|Treatment Phase: Week 3 Up to Week 12||8||
59828946|NCT00272961|75952284|FG001|COMPLETED|Treatment Phase: Week 3 Up to Week 12||4||
59828947|NCT00272961|75952285|FG002|COMPLETED|Treatment Phase: Week 3 Up to Week 12||7||
59828948|NCT00272961|75952286|FG003|COMPLETED|Treatment Phase: Week 3 Up to Week 12||7||
59828949|NCT00272961|75952287|FG004|COMPLETED|Treatment Phase: Week 3 Up to Week 12||6||
59828950|NCT00272961|75952283|FG000|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||2||
59828951|NCT00272961|75952284|FG001|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||4||
59828952|NCT00272961|75952285|FG002|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||4||
59828953|NCT00272961|75952286|FG003|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||3||
59828954|NCT00272961|75952287|FG004|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||4||
59828955|NCT00282087|75952299|FG000|STARTED|Overall Study||47||
59828956|NCT00282087|75952299|FG000|COMPLETED|Overall Study|One patient died during cycle 1 of treatment because of infectious complications of AIDS.|46||
59828957|NCT00282087|75952299|FG000|NOT COMPLETED|Overall Study||1||
59828958|NCT00404924|75952306|FG000|STARTED|Overall Study|randomised patients|617||
59828959|NCT00404924|75952307|FG001|STARTED|Overall Study|randomised patients|307||
59828960|NCT00404924|75952306|FG000|COMPLETED|Overall Study|ongoing study treatment at data cut-off|14||
59828961|NCT00404924|75952307|FG001|COMPLETED|Overall Study|ongoing study treatment at data cut-off|1||
59828962|NCT00404924|75952306|FG000|NOT COMPLETED|Overall Study||603||
59828963|NCT00404924|75952307|FG001|NOT COMPLETED|Overall Study||306||
59828964|NCT00281697|75952315|FG000|STARTED|Overall Study||459||
59828965|NCT00281697|75952316|FG001|STARTED|Overall Study||225||
59828966|NCT00281697|75952315|FG000|COMPLETED|Overall Study||58||
59828967|NCT00281697|75952316|FG001|COMPLETED|Overall Study||28||
59828968|NCT00281697|75952315|FG000|NOT COMPLETED|Overall Study||401||
59828969|NCT00281697|75952316|FG001|NOT COMPLETED|Overall Study||197||
59828970|NCT00271947|75952322|FG000|STARTED|Overall Study||1||
59828971|NCT00271947|75952322|FG000|COMPLETED|Overall Study||0||
59828972|NCT00271947|75952322|FG000|NOT COMPLETED|Overall Study||1||
59828973|NCT00232180|75952328|FG000|STARTED|Double-blind (DB) Phase|Three participants in each arm were enrolled after data cut-off.|1367||
59828974|NCT00232180|75952329|FG001|STARTED|Double-blind (DB) Phase|Three participants in each arm were enrolled after data cut-off.|1376||
59828975|NCT00232180|75952330|FG002|STARTED|Double-blind (DB) Phase||0||
59828976|NCT00232180|75952328|FG000|Treated|Double-blind (DB) Phase||1364||
59828977|NCT00232180|75952329|FG001|Treated|Double-blind (DB) Phase||1372||
59828978|NCT00232180|75952330|FG002|Treated|Double-blind (DB) Phase||0||
59828979|NCT00232180|75952328|FG000|COMPLETED|Double-blind (DB) Phase||826||
59828980|NCT00232180|75952329|FG001|COMPLETED|Double-blind (DB) Phase||771||
59828981|NCT00232180|75952330|FG002|COMPLETED|Double-blind (DB) Phase||0||
59828982|NCT00232180|75952328|FG000|NOT COMPLETED|Double-blind (DB) Phase||541||
59828983|NCT00232180|75952329|FG001|NOT COMPLETED|Double-blind (DB) Phase||605||
59828984|NCT00232180|75952330|FG002|NOT COMPLETED|Double-blind (DB) Phase||0||
59828985|NCT00232180|75952328|FG000|STARTED|Open Label Phase||0||
59828986|NCT00232180|75952329|FG001|STARTED|Open Label Phase||0||
59828987|NCT00232180|75952330|FG002|STARTED|Open Label Phase||1246||
59828988|NCT00232180|75952328|FG000|Treated|Open Label Phase||0||
59828989|NCT00232180|75952329|FG001|Treated|Open Label Phase||0||
59716279|NCT03760419|75835112|FG000|Received Intervention|Overall Study||214||
59716280|NCT03760419|75835113|FG001|Received Intervention|Overall Study||335||
59716281|NCT03760419|75835112|FG000|Received Contol|Overall Study||321||
59716282|NCT03760419|75835113|FG001|Received Contol|Overall Study||157||
59716283|NCT03760419|75835112|FG000|COMPLETED|Overall Study||535||
59716284|NCT03760419|75835113|FG001|COMPLETED|Overall Study||492||
59716285|NCT03760419|75835112|FG000|NOT COMPLETED|Overall Study||0||
59716286|NCT03760419|75835113|FG001|NOT COMPLETED|Overall Study||0||
59716287|NCT00970281|75835121|FG000|STARTED|Overall Study||46||
59716288|NCT00970281|75835122|FG001|STARTED|Overall Study||45||
59716289|NCT00970281|75835121|FG000|Full Analysis Set|Overall Study|1 participant in the olanzapine arm discontinued before the first intramuscular (IM) injection.|45||
59716290|NCT00970281|75835122|FG001|Full Analysis Set|Overall Study||45||
59716291|NCT00970281|75835121|FG000|COMPLETED|Overall Study||44||
59716292|NCT00970281|75835122|FG001|COMPLETED|Overall Study||29||
59716293|NCT00970281|75835121|FG000|NOT COMPLETED|Overall Study||2||
60118101|NCT02093793|76239156|FG000|STARTED|Overall Study||98||
59716294|NCT00970281|75835122|FG001|NOT COMPLETED|Overall Study||16||
59716295|NCT00976209|75835130|FG000|STARTED|Treatment Period 1||165||
60118102|NCT02093793|76239157|FG001|STARTED|Overall Study||90||
60118103|NCT02093793|76239158|FG002|STARTED|Overall Study||68||
60118104|NCT02093793|76239156|FG000|COMPLETED|Overall Study||91||
60118105|NCT02093793|76239157|FG001|COMPLETED|Overall Study||80||
60118106|NCT02093793|76239158|FG002|COMPLETED|Overall Study||65||
60118107|NCT02093793|76239156|FG000|NOT COMPLETED|Overall Study||7||
59716296|NCT00976209|75835131|FG001|STARTED|Treatment Period 1||166||
59716297|NCT00976209|75835130|FG000|COMPLETED|Treatment Period 1||162||
59716298|NCT00976209|75835131|FG001|COMPLETED|Treatment Period 1||165||
59716299|NCT00976209|75835130|FG000|NOT COMPLETED|Treatment Period 1||3||
60118108|NCT02093793|76239157|FG001|NOT COMPLETED|Overall Study||10||
60118109|NCT02093793|76239158|FG002|NOT COMPLETED|Overall Study||3||
59716300|NCT00976209|75835131|FG001|NOT COMPLETED|Treatment Period 1||1||
59716301|NCT00976209|75835130|FG000|STARTED|Wash-out Period||162||
59716302|NCT00976209|75835131|FG001|STARTED|Wash-out Period||165||
59716303|NCT00976209|75835130|FG000|COMPLETED|Wash-out Period||158||
59716304|NCT00976209|75835131|FG001|COMPLETED|Wash-out Period||163||
59716305|NCT00976209|75835130|FG000|NOT COMPLETED|Wash-out Period||4||
59828990|NCT00232180|75952330|FG002|Treated|Open Label Phase||1245||
59828991|NCT00232180|75952328|FG000|COMPLETED|Open Label Phase||0||
59828992|NCT00232180|75952329|FG001|COMPLETED|Open Label Phase||0||
59828993|NCT00232180|75952330|FG002|COMPLETED|Open Label Phase||1098||
59828994|NCT00232180|75952328|FG000|NOT COMPLETED|Open Label Phase||0||
59828995|NCT00232180|75952329|FG001|NOT COMPLETED|Open Label Phase||0||
59828996|NCT00232180|75952330|FG002|NOT COMPLETED|Open Label Phase||148||
59828997|NCT00280683|75952341|FG000|STARTED|Overall Study||10||
59828998|NCT00280683|75952342|FG001|STARTED|Overall Study||10||
59828999|NCT00280683|75952341|FG000|COMPLETED|Overall Study|Reasons for subjects discontinuing included inability to adhere to the schedule or adverse event.|8||
59829000|NCT00280683|75952342|FG001|COMPLETED|Overall Study||7||
59829001|NCT00280683|75952341|FG000|NOT COMPLETED|Overall Study||2||
59829002|NCT00280683|75952342|FG001|NOT COMPLETED|Overall Study||3||
59829003|NCT00270855|75952352|FG000|STARTED|Overall Study||15||
59829004|NCT00270855|75952353|FG001|STARTED|Overall Study||14||
59829005|NCT00270855|75952352|FG000|COMPLETED|Overall Study||7||
59829006|NCT00270855|75952353|FG001|COMPLETED|Overall Study||6||
59829007|NCT00270855|75952352|FG000|NOT COMPLETED|Overall Study||8||
59829008|NCT00270855|75952353|FG001|NOT COMPLETED|Overall Study||8||
59829009|NCT00404768|75952365|FG000|STARTED|Part A and B||20||
59829010|NCT00404768|75952366|FG001|STARTED|Part A and B||9||
59829011|NCT00404768|75952367|FG002|STARTED|Part A and B||0||
59829012|NCT00404768|75952368|FG003|STARTED|Part A and B||0||
59829013|NCT00404768|75952365|FG000|COMPLETED|Part A and B||19||
59829014|NCT00404768|75952366|FG001|COMPLETED|Part A and B||8||
59829015|NCT00404768|75952367|FG002|COMPLETED|Part A and B||0||
59829016|NCT00404768|75952368|FG003|COMPLETED|Part A and B||0||
59829017|NCT00404768|75952365|FG000|NOT COMPLETED|Part A and B||1||
59829018|NCT00404768|75952366|FG001|NOT COMPLETED|Part A and B||1||
59829019|NCT00404768|75952367|FG002|NOT COMPLETED|Part A and B||0||
59829020|NCT00404768|75952368|FG003|NOT COMPLETED|Part A and B||0||
59829021|NCT00404768|75952365|FG000|STARTED|Part C||0||
59829022|NCT00404768|75952366|FG001|STARTED|Part C||0||
59829023|NCT00404768|75952367|FG002|STARTED|Part C||30||
59829024|NCT00404768|75952368|FG003|STARTED|Part C||34||
59829025|NCT00404768|75952365|FG000|COMPLETED|Part C||0||
59829026|NCT00404768|75952366|FG001|COMPLETED|Part C||0||
59829027|NCT00404768|75952367|FG002|COMPLETED|Part C||22||
59829028|NCT00404768|75952368|FG003|COMPLETED|Part C||20||
59829029|NCT00404768|75952365|FG000|NOT COMPLETED|Part C||0||
59829030|NCT00404768|75952366|FG001|NOT COMPLETED|Part C||0||
59829031|NCT00404768|75952367|FG002|NOT COMPLETED|Part C||8||
59829032|NCT00404768|75952368|FG003|NOT COMPLETED|Part C||14||
59829033|NCT00270231|75952383|FG000|STARTED|First Intervention||32||
59829034|NCT00270231|75952384|FG001|STARTED|First Intervention||32||
59829035|NCT00270231|75952383|FG000|COMPLETED|First Intervention||31||
59829036|NCT00270231|75952384|FG001|COMPLETED|First Intervention||31||
59829037|NCT00270231|75952383|FG000|NOT COMPLETED|First Intervention||1||
59829038|NCT00270231|75952384|FG001|NOT COMPLETED|First Intervention||1||
59829039|NCT00270231|75952383|FG000|STARTED|Washout Period||31||
59716306|NCT00976209|75835131|FG001|NOT COMPLETED|Wash-out Period||2||
59716307|NCT00976209|75835130|FG000|STARTED|Treatment Period 2||158||
59716308|NCT00976209|75835131|FG001|STARTED|Treatment Period 2||163||
59716309|NCT00976209|75835130|FG000|COMPLETED|Treatment Period 2||158||
59716310|NCT00976209|75835131|FG001|COMPLETED|Treatment Period 2||161||
59716311|NCT00976209|75835130|FG000|NOT COMPLETED|Treatment Period 2||0||
59716312|NCT00976209|75835131|FG001|NOT COMPLETED|Treatment Period 2||2||
59716313|NCT00925990|75835138|FG000|STARTED|Overall Study||35||
59716314|NCT00925990|75835139|FG001|STARTED|Overall Study||35||
59716315|NCT00925990|75835138|FG000|COMPLETED|Overall Study||30||
59716316|NCT00925990|75835139|FG001|COMPLETED|Overall Study||24||
59716317|NCT00925990|75835138|FG000|NOT COMPLETED|Overall Study||5||
59716318|NCT00925990|75835139|FG001|NOT COMPLETED|Overall Study||11||
59716319|NCT01131078|75835148|FG000|STARTED|Overall Study||101||
59716320|NCT01131078|75835149|FG001|STARTED|Overall Study||102||
59716321|NCT01131078|75835150|FG002|STARTED|Overall Study||103||
59716322|NCT01131078|75835148|FG000|COMPLETED|Overall Study||0||
59716323|NCT01131078|75835149|FG001|COMPLETED|Overall Study||1||
59716324|NCT01131078|75835150|FG002|COMPLETED|Overall Study||1||
59716325|NCT01131078|75835148|FG000|NOT COMPLETED|Overall Study||101||
59829040|NCT00270231|75952384|FG001|STARTED|Washout Period||31||
59829041|NCT00270231|75952383|FG000|COMPLETED|Washout Period||30||
59829042|NCT00270231|75952384|FG001|COMPLETED|Washout Period||31||
59829043|NCT00270231|75952383|FG000|NOT COMPLETED|Washout Period||1||
59829044|NCT00270231|75952384|FG001|NOT COMPLETED|Washout Period||0||
59829045|NCT00270231|75952383|FG000|STARTED|Second Intervention||30||
59829046|NCT00270231|75952384|FG001|STARTED|Second Intervention||31||
59829047|NCT00270231|75952383|FG000|COMPLETED|Second Intervention||30||
59829048|NCT00270231|75952384|FG001|COMPLETED|Second Intervention||30||
59829049|NCT00270231|75952383|FG000|NOT COMPLETED|Second Intervention||0||
59829050|NCT00270231|75952384|FG001|NOT COMPLETED|Second Intervention||1||
59829051|NCT00258856|75952394|FG000|STARTED|Overall Study||59||
59829052|NCT00258856|75952395|FG001|STARTED|Overall Study||58||
59829053|NCT00258856|75952396|FG002|STARTED|Overall Study||58||
59829054|NCT00258856|75952397|FG003|STARTED|Overall Study||59||
59829055|NCT00258856|75952394|FG000|COMPLETED|Overall Study||56||
59829056|NCT00258856|75952395|FG001|COMPLETED|Overall Study||58||
59829057|NCT00258856|75952396|FG002|COMPLETED|Overall Study||56||
59829058|NCT00258856|75952397|FG003|COMPLETED|Overall Study||58||
59829059|NCT00258856|75952394|FG000|NOT COMPLETED|Overall Study||3||
59829060|NCT00258856|75952395|FG001|NOT COMPLETED|Overall Study||0||
59829061|NCT00258856|75952396|FG002|NOT COMPLETED|Overall Study||2||
59829062|NCT00258856|75952397|FG003|NOT COMPLETED|Overall Study||1||
59829063|NCT00269919|75952407|FG000|STARTED|Overall Study||40||
59829064|NCT00269919|75952407|FG000|Treated|Overall Study||39||
59829065|NCT00269919|75952407|FG000|COMPLETED|Overall Study||13||
59829066|NCT00269919|75952407|FG000|NOT COMPLETED|Overall Study||27||
59829067|NCT00258154|75952414|FG000|STARTED|Overall Study|Healthy infants who started in the RotaTeq™ concomitantly with INFANRIX™ hexa group.|201||
59829068|NCT00258154|75952415|FG001|STARTED|Overall Study|Healthy infants who started in the Placebo concomitantly with INFANRIX™ hexa group.|202||
59829069|NCT00258154|75952414|FG000|Vaccinated at Visit 1|Overall Study||201||
59829070|NCT00258154|75952415|FG001|Vaccinated at Visit 1|Overall Study||202||
60118110|NCT02093949|76239168|FG000|STARTED|Overall Study||105||
60118111|NCT02093949|76239169|FG001|STARTED|Overall Study||47||
60118112|NCT02093949|76239168|FG000|COMPLETED|Overall Study||105||
60118113|NCT02093949|76239169|FG001|COMPLETED|Overall Study||47||
60118114|NCT02093949|76239168|FG000|NOT COMPLETED|Overall Study||0||
60118115|NCT02093949|76239169|FG001|NOT COMPLETED|Overall Study||0||
60118116|NCT00223665|76239183|FG000|STARTED|Overall Study||102||
60118117|NCT00223665|76239183|FG000|COMPLETED|Overall Study||102||
60118118|NCT00223665|76239183|FG000|NOT COMPLETED|Overall Study||0||
60118119|NCT00223821|76239190|FG000|STARTED|Overall Study||32||
60118120|NCT00223821|76239191|FG001|STARTED|Overall Study||32||
60118121|NCT00223821|76239190|FG000|Completed Therapy|Overall Study||31||
60118122|NCT00223821|76239191|FG001|Completed Therapy|Overall Study||28||
60118123|NCT00223821|76239190|FG000|Completed Post-treatment Assessment|Overall Study||31||
60118124|NCT00223821|76239191|FG001|Completed Post-treatment Assessment|Overall Study||27||
60118125|NCT00223821|76239190|FG000|Completed 6-month Follow-up|Overall Study||28||
60118126|NCT00223821|76239191|FG001|Completed 6-month Follow-up|Overall Study||25||
60118127|NCT00223821|76239190|FG000|COMPLETED|Overall Study||28||
60118128|NCT00223821|76239191|FG001|COMPLETED|Overall Study||22||
60118129|NCT00223821|76239190|FG000|NOT COMPLETED|Overall Study||4||
60118130|NCT00223821|76239191|FG001|NOT COMPLETED|Overall Study||10||
60118131|NCT00224289|76239197|FG000|STARTED|Overall Study||17||
60118132|NCT00224289|76239197|FG000|COMPLETED|Overall Study||17||
60118133|NCT00224289|76239197|FG000|NOT COMPLETED|Overall Study||0||
60118134|NCT00045435|76239201|FG000|STARTED|Overall Study||17||
60118135|NCT00045435|76239201|FG000|COMPLETED|Overall Study||17||
60118136|NCT00045435|76239201|FG000|NOT COMPLETED|Overall Study||0||
60118137|NCT00047619|76239207|FG000|STARTED|Overall Study||14||
60118138|NCT00047619|76239208|FG001|STARTED|Overall Study||14||
60118139|NCT00047619|76239207|FG000|COMPLETED|Overall Study||14||
60118140|NCT00047619|76239208|FG001|COMPLETED|Overall Study||14||
60118141|NCT00047619|76239207|FG000|NOT COMPLETED|Overall Study||0||
60118142|NCT00047619|76239208|FG001|NOT COMPLETED|Overall Study||0||
60118143|NCT00111657|76239214|FG000|STARTED|Overall Study|37 consented. 30 initiated treatment. 29 completed at least 1 dose.|37||
60118144|NCT00111657|76239214|FG000|COMPLETED|Overall Study|Completed all intended doses.|21||
60118145|NCT00111657|76239214|FG000|NOT COMPLETED|Overall Study||16||
60118146|NCT02097303|76239220|FG000|STARTED|Overall Study||36||
60118147|NCT02097303|76239220|FG000|COMPLETED|Overall Study||31||
60118148|NCT02097303|76239220|FG000|NOT COMPLETED|Overall Study||5||
60118149|NCT00703326|76239226|FG000|STARTED|Overall Study||759||
60118150|NCT00703326|76239227|FG001|STARTED|Overall Study||385||
60118151|NCT00703326|76239226|FG000|Received at Least 1 Dose of Study Drug|Overall Study||752||
60118152|NCT00703326|76239227|FG001|Received at Least 1 Dose of Study Drug|Overall Study||382||
60118153|NCT00703326|76239226|FG000|COMPLETED|Overall Study||657||
60118154|NCT00703326|76239227|FG001|COMPLETED|Overall Study||347||
60118155|NCT00703326|76239226|FG000|NOT COMPLETED|Overall Study||102||
60118156|NCT00703326|76239227|FG001|NOT COMPLETED|Overall Study||38||
60118157|NCT02097537|76239234|FG000|STARTED|Overall Study||10|Informed consent|
59829071|NCT00258154|75952414|FG000|Vaccinated at Visit 2|Overall Study||198||
59829072|NCT00258154|75952415|FG001|Vaccinated at Visit 2|Overall Study||198||
59829073|NCT00258154|75952414|FG000|Vaccinated at Visit 3|Overall Study||195||
59829074|NCT00258154|75952415|FG001|Vaccinated at Visit 3|Overall Study||197||
59829075|NCT00258154|75952414|FG000|COMPLETED|Overall Study|Subjects who completed the study.|192||
59829076|NCT00258154|75952415|FG001|COMPLETED|Overall Study|Subjects who completed the study.|195||
59829077|NCT00258154|75952414|FG000|NOT COMPLETED|Overall Study||9||
60118158|NCT02097537|76239234|FG000|Enrollment|Overall Study|Inhalation of Methacholine Chloride|10||
60118159|NCT02097537|76239234|FG000|Follow-Up|Overall Study||10||
60118160|NCT02097537|76239234|FG000|COMPLETED|Overall Study||10||
60118161|NCT02097537|76239234|FG000|NOT COMPLETED|Overall Study||0||
60118162|NCT02097849|76239240|FG000|STARTED|Overall Study||33||
60118163|NCT02097849|76239241|FG001|STARTED|Overall Study||38||
60118164|NCT02097849|76239240|FG000|COMPLETED|Overall Study||33||
59829078|NCT00258154|75952415|FG001|NOT COMPLETED|Overall Study||7||
59829079|NCT00257920|75952423|FG000|STARTED|Period: First Intervention||21||
59829080|NCT00257920|75952424|FG001|STARTED|Period: First Intervention||20||
59829081|NCT00257920|75952423|FG000|COMPLETED|Period: First Intervention||21||
59829082|NCT00257920|75952424|FG001|COMPLETED|Period: First Intervention||20||
59829083|NCT00257920|75952423|FG000|NOT COMPLETED|Period: First Intervention||0||
59829084|NCT00257920|75952424|FG001|NOT COMPLETED|Period: First Intervention||0||
59829085|NCT00257920|75952423|FG000|STARTED|Period: Washout Period of Two Weeks||21||
59829086|NCT00257920|75952424|FG001|STARTED|Period: Washout Period of Two Weeks||20||
59829087|NCT00257920|75952423|FG000|COMPLETED|Period: Washout Period of Two Weeks||21||
59829088|NCT00257920|75952424|FG001|COMPLETED|Period: Washout Period of Two Weeks||19||
59829089|NCT00257920|75952423|FG000|NOT COMPLETED|Period: Washout Period of Two Weeks||0||
59829090|NCT00257920|75952424|FG001|NOT COMPLETED|Period: Washout Period of Two Weeks||1||
59829091|NCT00257920|75952423|FG000|STARTED|Period: Second Intervention||21||
59829092|NCT00257920|75952424|FG001|STARTED|Period: Second Intervention||19||
59829093|NCT00257920|75952423|FG000|COMPLETED|Period: Second Intervention||19||
59829094|NCT00257920|75952424|FG001|COMPLETED|Period: Second Intervention||18||
59829095|NCT00257920|75952423|FG000|NOT COMPLETED|Period: Second Intervention||2||
59829096|NCT00257920|75952424|FG001|NOT COMPLETED|Period: Second Intervention||1||
59829097|NCT00268983|75952433|FG000|STARTED|Overall Study||6||
59829098|NCT00268983|75952434|FG001|STARTED|Overall Study||8||
59829099|NCT00268983|75952433|FG000|COMPLETED|Overall Study||3||
59829100|NCT00268983|75952434|FG001|COMPLETED|Overall Study||8||
59829101|NCT00268983|75952433|FG000|NOT COMPLETED|Overall Study||3||
59829102|NCT00268983|75952434|FG001|NOT COMPLETED|Overall Study||0||
59829103|NCT00257608|75952442|FG000|STARTED|Chemotherapy Phase||1145||
59829104|NCT00257608|75952443|FG001|STARTED|Chemotherapy Phase||0||
59829105|NCT00257608|75952444|FG002|STARTED|Chemotherapy Phase||0||
59829106|NCT00257608|75952442|FG000|COMPLETED|Chemotherapy Phase||769||
59829107|NCT00257608|75952443|FG001|COMPLETED|Chemotherapy Phase||0||
59829108|NCT00257608|75952444|FG002|COMPLETED|Chemotherapy Phase||0||
59829109|NCT00257608|75952442|FG000|NOT COMPLETED|Chemotherapy Phase||376||
59829110|NCT00257608|75952443|FG001|NOT COMPLETED|Chemotherapy Phase||0||
59829111|NCT00257608|75952444|FG002|NOT COMPLETED|Chemotherapy Phase||0||
59829112|NCT00257608|75952442|FG000|STARTED|Post Chemotherapy Phase||0||
59829113|NCT00257608|75952443|FG001|STARTED|Post Chemotherapy Phase||373||
59829114|NCT00257608|75952444|FG002|STARTED|Post Chemotherapy Phase||370||
59829115|NCT00257608|75952442|FG000|COMPLETED|Post Chemotherapy Phase||0||
59829116|NCT00257608|75952443|FG001|COMPLETED|Post Chemotherapy Phase||109||
59829117|NCT00257608|75952444|FG002|COMPLETED|Post Chemotherapy Phase||126||
59829118|NCT00257608|75952442|FG000|NOT COMPLETED|Post Chemotherapy Phase||0||
59829119|NCT00257608|75952443|FG001|NOT COMPLETED|Post Chemotherapy Phase||264||
59829120|NCT00257608|75952444|FG002|NOT COMPLETED|Post Chemotherapy Phase||244||
59829121|NCT00231478|75952459|FG000|STARTED|Overall Study||87||
59829122|NCT00231478|75952460|FG001|STARTED|Overall Study||84||
59829123|NCT00231478|75952459|FG000|COMPLETED|Overall Study||79||
60118165|NCT02097849|76239241|FG001|COMPLETED|Overall Study||38||
59829124|NCT00231478|75952460|FG001|COMPLETED|Overall Study||78||
59829125|NCT00231478|75952459|FG000|NOT COMPLETED|Overall Study||8||
59829126|NCT00231478|75952460|FG001|NOT COMPLETED|Overall Study||6||
59829127|NCT00413192|75952470|FG000|STARTED|Overall Study||37||
59829128|NCT00413192|75952471|FG001|STARTED|Overall Study||40||
59829129|NCT00413192|75952472|FG002|STARTED|Overall Study||19||
59829130|NCT00413192|75952473|FG003|STARTED|Overall Study||32||
59829131|NCT00413192|75952470|FG000|COMPLETED|Overall Study||0||
59829132|NCT00413192|75952471|FG001|COMPLETED|Overall Study||0||
59829133|NCT00413192|75952472|FG002|COMPLETED|Overall Study||0||
59829134|NCT00413192|75952473|FG003|COMPLETED|Overall Study||0||
59716326|NCT01131078|75835149|FG001|NOT COMPLETED|Overall Study||101||
59716327|NCT01131078|75835150|FG002|NOT COMPLETED|Overall Study||102||
59716328|NCT01167582|75835162|FG000|STARTED|Overall Study||55||
59716329|NCT01167582|75835163|FG001|STARTED|Overall Study||55||
59716330|NCT01167582|75835162|FG000|COMPLETED|Overall Study||55||
59716331|NCT01167582|75835163|FG001|COMPLETED|Overall Study||54||
59716332|NCT01167582|75835162|FG000|NOT COMPLETED|Overall Study||0||
59716333|NCT01167582|75835163|FG001|NOT COMPLETED|Overall Study||1||
59716334|NCT01167426|75835169|FG000|STARTED|Overall Study||148||
59716335|NCT01167426|75835169|FG000|COMPLETED|Overall Study||138||
59716336|NCT01167426|75835169|FG000|NOT COMPLETED|Overall Study||10||
59716337|NCT00922636|75835179|FG000|STARTED|Overall Study||36||
59716338|NCT00922636|75835180|FG001|STARTED|Overall Study||78||
59716339|NCT00922636|75835181|FG002|STARTED|Overall Study||76||
59829135|NCT00413192|75952470|FG000|NOT COMPLETED|Overall Study||37||
59567456|NCT00554294|75670417|FG001|NOT COMPLETED|Overall Study||80||
59716340|NCT00922636|75835182|FG003|STARTED|Overall Study||75||
59716341|NCT00922636|75835183|FG004|STARTED|Overall Study||75||
59829136|NCT00413192|75952471|FG001|NOT COMPLETED|Overall Study||40||
59829137|NCT00413192|75952472|FG002|NOT COMPLETED|Overall Study||19||
59567457|NCT03782181|75670423|FG000|STARTED|Overall Study||20||
59567458|NCT03782181|75670424|FG001|STARTED|Overall Study||20||
59716342|NCT00922636|75835179|FG000|Entered Optional Taper Phase|Overall Study||4||
59716343|NCT00922636|75835180|FG001|Entered Optional Taper Phase|Overall Study||10||
59716344|NCT00922636|75835181|FG002|Entered Optional Taper Phase|Overall Study||15||
59567459|NCT03782181|75670423|FG000|COMPLETED|Overall Study||20||
59567460|NCT03782181|75670424|FG001|COMPLETED|Overall Study||20||
59567461|NCT03782181|75670423|FG000|NOT COMPLETED|Overall Study||0||
59567462|NCT03782181|75670424|FG001|NOT COMPLETED|Overall Study||0||
59829138|NCT00413192|75952473|FG003|NOT COMPLETED|Overall Study||32||
59829139|NCT00207142|75952486|FG000|STARTED|Induction Phase||252||
59829140|NCT00207142|75952487|FG001|STARTED|Induction Phase||0||
59829141|NCT00207142|75952488|FG002|STARTED|Induction Phase||0||
59829142|NCT00207142|75952489|FG003|STARTED|Induction Phase||0||
59829143|NCT00207142|75952486|FG000|COMPLETED|Induction Phase|Subjects randomized into Maintenance Phase=172 (87 ATV +85 ATV/RTV); Rescue Phase subjects=50|222||
59829144|NCT00207142|75952487|FG001|COMPLETED|Induction Phase||0||
59829145|NCT00207142|75952488|FG002|COMPLETED|Induction Phase||0||
59829146|NCT00207142|75952489|FG003|COMPLETED|Induction Phase||0||
59829147|NCT00207142|75952486|FG000|NOT COMPLETED|Induction Phase||30||
59829148|NCT00207142|75952487|FG001|NOT COMPLETED|Induction Phase||0||
59829149|NCT00207142|75952488|FG002|NOT COMPLETED|Induction Phase||0||
59829150|NCT00207142|75952489|FG003|NOT COMPLETED|Induction Phase||0||
59829151|NCT00207142|75952486|FG000|STARTED|Maintenance Phase/Rescue Phase||0||
59829152|NCT00207142|75952487|FG001|STARTED|Maintenance Phase/Rescue Phase||87||
59829153|NCT00207142|75952488|FG002|STARTED|Maintenance Phase/Rescue Phase||85||
59829154|NCT00207142|75952489|FG003|STARTED|Maintenance Phase/Rescue Phase||50||
59829155|NCT00207142|75952486|FG000|COMPLETED|Maintenance Phase/Rescue Phase||0||
59829156|NCT00207142|75952487|FG001|COMPLETED|Maintenance Phase/Rescue Phase||78||
59829157|NCT00207142|75952488|FG002|COMPLETED|Maintenance Phase/Rescue Phase||72||
59829158|NCT00207142|75952489|FG003|COMPLETED|Maintenance Phase/Rescue Phase||41||
59829159|NCT00207142|75952486|FG000|NOT COMPLETED|Maintenance Phase/Rescue Phase||0||
59829160|NCT00207142|75952487|FG001|NOT COMPLETED|Maintenance Phase/Rescue Phase||9||
59829161|NCT00207142|75952488|FG002|NOT COMPLETED|Maintenance Phase/Rescue Phase||13||
59829162|NCT00207142|75952489|FG003|NOT COMPLETED|Maintenance Phase/Rescue Phase||9||
59829163|NCT00268905|75952507|FG000|STARTED|Overall Study||43||
59829164|NCT00268905|75952508|FG001|STARTED|Overall Study||9||
59829165|NCT00268905|75952509|FG002|STARTED|Overall Study||12||
59829166|NCT00268905|75952507|FG000|COMPLETED|Overall Study||0||
59829167|NCT00268905|75952508|FG001|COMPLETED|Overall Study||0||
59829168|NCT00268905|75952509|FG002|COMPLETED|Overall Study||0||
59829169|NCT00268905|75952507|FG000|NOT COMPLETED|Overall Study||43||
59829170|NCT00268905|75952508|FG001|NOT COMPLETED|Overall Study||9||
59829171|NCT00268905|75952509|FG002|NOT COMPLETED|Overall Study||12||
59829172|NCT00206518|75952519|FG000|STARTED|Overall Study||83||
59829173|NCT00206518|75952520|FG001|STARTED|Overall Study||84||
59829174|NCT00206518|75952519|FG000|COMPLETED|Overall Study||73||
59829175|NCT00206518|75952520|FG001|COMPLETED|Overall Study||78||
59829176|NCT00206518|75952519|FG000|NOT COMPLETED|Overall Study||10||
59829177|NCT00206518|75952520|FG001|NOT COMPLETED|Overall Study||6||
59829178|NCT00423722|75952528|FG000|STARTED|Overall Study||63||
59829179|NCT00423722|75952529|FG001|STARTED|Overall Study||66||
59829180|NCT00423722|75952528|FG000|COMPLETED|Overall Study||49||
59829181|NCT00423722|75952529|FG001|COMPLETED|Overall Study||53||
59829182|NCT00423722|75952528|FG000|NOT COMPLETED|Overall Study||14||
59829183|NCT00423722|75952529|FG001|NOT COMPLETED|Overall Study||13||
59829184|NCT00206440|75952543|FG000|STARTED|Overall Study||21||
59829185|NCT00206440|75952544|FG001|STARTED|Overall Study||22||
59829186|NCT00206440|75952543|FG000|COMPLETED|Overall Study||16||
59829187|NCT00206440|75952544|FG001|COMPLETED|Overall Study||18||
59829188|NCT00206440|75952543|FG000|NOT COMPLETED|Overall Study||5||
59829189|NCT00206440|75952544|FG001|NOT COMPLETED|Overall Study||4||
59829190|NCT00268437|75952550|FG000|STARTED|Overall Study||27||
59829191|NCT00268437|75952550|FG000|COMPLETED|Overall Study||26||
59829192|NCT00268437|75952550|FG000|NOT COMPLETED|Overall Study||1||
59829193|NCT00423488|75952557|FG000|STARTED|Overall Study||42||
59829194|NCT00423488|75952558|FG001|STARTED|Overall Study||51||
59829195|NCT00423488|75952557|FG000|COMPLETED|Overall Study||37||
59829196|NCT00423488|75952558|FG001|COMPLETED|Overall Study||50||
59829197|NCT00423488|75952557|FG000|NOT COMPLETED|Overall Study||5||
59829198|NCT00423488|75952558|FG001|NOT COMPLETED|Overall Study||1||
59829199|NCT00404066|75952564|FG000|STARTED|Overall Study|1 subject started but withdrew after adriamycin+cytoxan, but before study drugs lapatinib+docetaxel.|21||
59829200|NCT00404066|75952564|FG000|COMPLETED|Overall Study||18||
59829201|NCT00404066|75952564|FG000|NOT COMPLETED|Overall Study||3||
59829202|NCT00423332|75952570|FG000|STARTED|Overall Study|Randomised|53||
59829203|NCT00423332|75952571|FG001|STARTED|Overall Study|Number randomised|18||
59829204|NCT00423332|75952570|FG000|Continuing After Unblinding|Overall Study|Number starting/ continuing AZD2171 after unblinding|44||
59829205|NCT00423332|75952571|FG001|Continuing After Unblinding|Overall Study|Number starting/ continuing AZD2171 after unblinding|14||
59829206|NCT00423332|75952570|FG000|Ongoing at Data Cut Off (8th March 2009)|Overall Study|Number ongoing at data cut off (8th March 2009)|22||
59829207|NCT00423332|75952571|FG001|Ongoing at Data Cut Off (8th March 2009)|Overall Study|Number ongoing at data cut off (8th March 2009)|4||
59829208|NCT00423332|75952570|FG000|COMPLETED|Overall Study|Number completing 12 weeks blinded randomised treatment|44||
59829209|NCT00423332|75952571|FG001|COMPLETED|Overall Study|Number completing 12 weeks blinded randomised treatment|11||
59829210|NCT00423332|75952570|FG000|NOT COMPLETED|Overall Study||9||
59829211|NCT00423332|75952571|FG001|NOT COMPLETED|Overall Study||7||
59829212|NCT00413036|75952578|FG000|STARTED|Overall Study||217||
59829213|NCT00413036|75952578|FG000|COMPLETED|Overall Study|Participants remain on study drug until progressive disease or unacceptable adverse events develop.|0||
59829214|NCT00413036|75952578|FG000|NOT COMPLETED|Overall Study||217||
59829215|NCT00412958|75952586|FG000|STARTED|Overall Study||29||
59829216|NCT00412958|75952587|FG001|STARTED|Overall Study||33||
59829217|NCT00412958|75952588|FG002|STARTED|Overall Study||32||
59829218|NCT00412958|75952589|FG003|STARTED|Overall Study||31||
59829219|NCT00412958|75952586|FG000|COMPLETED|Overall Study||26||
59829220|NCT00412958|75952587|FG001|COMPLETED|Overall Study||29||
59829221|NCT00412958|75952588|FG002|COMPLETED|Overall Study||32||
59829222|NCT00412958|75952589|FG003|COMPLETED|Overall Study||30||
59829223|NCT00412958|75952586|FG000|NOT COMPLETED|Overall Study||3||
59829224|NCT00412958|75952587|FG001|NOT COMPLETED|Overall Study||4||
59829225|NCT00412958|75952588|FG002|NOT COMPLETED|Overall Study||0||
59829226|NCT00412958|75952589|FG003|NOT COMPLETED|Overall Study||1||
59829227|NCT00423176|75952601|FG000|STARTED|Overall Study||114||
59829228|NCT00423176|75952602|FG001|STARTED|Overall Study||123||
59829229|NCT00423176|75952601|FG000|COMPLETED|Overall Study||98||
59829230|NCT00423176|75952602|FG001|COMPLETED|Overall Study||94||
59829231|NCT00423176|75952601|FG000|NOT COMPLETED|Overall Study||16||
59829232|NCT00423176|75952602|FG001|NOT COMPLETED|Overall Study||29||
59829233|NCT00412880|75952608|FG000|STARTED|Overall Study||23||
59829234|NCT00412880|75952608|FG000|COMPLETED|Overall Study||0||
59829235|NCT00412880|75952608|FG000|NOT COMPLETED|Overall Study||23||
59829236|NCT00268203|75952612|FG000|STARTED|Overall Study||765||
59829237|NCT00268203|75952612|FG000|Completed 2 Years of Follow-up|Overall Study||62||
59829238|NCT00268203|75952612|FG000|COMPLETED|Overall Study|These participants completed 10 years of follow-up.|118||
59829239|NCT00268203|75952612|FG000|NOT COMPLETED|Overall Study||647||
59829240|NCT00384930|75952621|FG000|STARTED|Overall Study||212||
59829241|NCT00384930|75952622|FG001|STARTED|Overall Study||209||
59829242|NCT00384930|75952623|FG002|STARTED|Overall Study||212||
59829243|NCT00384930|75952624|FG003|STARTED|Overall Study||216||
59829244|NCT00384930|75952625|FG004|STARTED|Overall Study||209||
59829245|NCT00384930|75952621|FG000|Received Double-Blind Study Drug|Overall Study||211||
59829246|NCT00384930|75952622|FG001|Received Double-Blind Study Drug|Overall Study||208||
59829247|NCT00384930|75952623|FG002|Received Double-Blind Study Drug|Overall Study||212||
59829248|NCT00384930|75952624|FG003|Received Double-Blind Study Drug|Overall Study||216||
59829249|NCT00384930|75952625|FG004|Received Double-Blind Study Drug|Overall Study||209||
59829250|NCT00384930|75952621|FG000|COMPLETED|Overall Study||185||
59829251|NCT00384930|75952622|FG001|COMPLETED|Overall Study||182||
59829252|NCT00384930|75952623|FG002|COMPLETED|Overall Study||182||
59829253|NCT00384930|75952624|FG003|COMPLETED|Overall Study||175||
59829254|NCT00384930|75952625|FG004|COMPLETED|Overall Study||162||
59829255|NCT00384930|75952621|FG000|NOT COMPLETED|Overall Study||27||
59829256|NCT00384930|75952622|FG001|NOT COMPLETED|Overall Study||27||
59829257|NCT00384930|75952623|FG002|NOT COMPLETED|Overall Study||30||
59829258|NCT00384930|75952624|FG003|NOT COMPLETED|Overall Study||41||
59829259|NCT00384930|75952625|FG004|NOT COMPLETED|Overall Study||47||
59829260|NCT00423098|75952642|FG000|STARTED|Overall Study|Total number of patients screened was 90, but the total number of randomized patients was 81.|42||
59829261|NCT00423098|75952643|FG001|STARTED|Overall Study||39||
59829262|NCT00423098|75952642|FG000|COMPLETED|Overall Study|Completed 24 weeks of study medication.|39||
59829263|NCT00423098|75952643|FG001|COMPLETED|Overall Study||35||
59829264|NCT00423098|75952642|FG000|NOT COMPLETED|Overall Study||3||
59829265|NCT00423098|75952643|FG001|NOT COMPLETED|Overall Study||4||
59829266|NCT00750698|75952651|FG000|STARTED|Overall Study||6||
59829267|NCT00750698|75952652|FG001|STARTED|Overall Study||2||
60118166|NCT02097849|76239240|FG000|NOT COMPLETED|Overall Study||0||
60118167|NCT02097849|76239241|FG001|NOT COMPLETED|Overall Study||0||
60118168|NCT00047697|76239249|FG000|STARTED|Overall Study||18||
60118169|NCT00047697|76239250|FG001|STARTED|Overall Study||16||
60118170|NCT00047697|76239249|FG000|COMPLETED|Overall Study||18||
60118171|NCT00047697|76239250|FG001|COMPLETED|Overall Study||14||
59829268|NCT00750698|75952651|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6||
59829269|NCT00750698|75952652|FG001|Received at Least 1 Dose of Study Drug|Overall Study||2||
59829270|NCT00750698|75952651|FG000|COMPLETED|Overall Study||0||
59829271|NCT00750698|75952652|FG001|COMPLETED|Overall Study||0||
59829272|NCT00750698|75952651|FG000|NOT COMPLETED|Overall Study||6||
59829273|NCT00750698|75952652|FG001|NOT COMPLETED|Overall Study||2||
59829274|NCT00411788|75952658|FG000|STARTED|Overall Study||11||
59829275|NCT00411788|75952658|FG000|COMPLETED|Overall Study||9||
59829276|NCT00411788|75952658|FG000|NOT COMPLETED|Overall Study||2||
59829277|NCT00422942|75952662|FG000|STARTED|Overall Study||3||
59829278|NCT00422942|75952662|FG000|COMPLETED|Overall Study||0||
59829279|NCT00422942|75952662|FG000|NOT COMPLETED|Overall Study||3||
59829280|NCT00422162|75952668|FG000|STARTED|Overall Study||167||
59829281|NCT00422162|75952669|FG001|STARTED|Overall Study||172||
59829282|NCT00422162|75952668|FG000|Received Treatment|Overall Study||167||
59829283|NCT00422162|75952669|FG001|Received Treatment|Overall Study||171||
59829284|NCT00422162|75952668|FG000|COMPLETED|Overall Study||143||
59829285|NCT00422162|75952669|FG001|COMPLETED|Overall Study||142||
59829286|NCT00422162|75952668|FG000|NOT COMPLETED|Overall Study||24||
59829287|NCT00422162|75952669|FG001|NOT COMPLETED|Overall Study||30||
59829288|NCT00411632|75952685|FG000|STARTED|Overall Study||37||
60118172|NCT00047697|76239249|FG000|NOT COMPLETED|Overall Study||0||
59829289|NCT00411632|75952685|FG000|COMPLETED|Overall Study||36||
59829290|NCT00411632|75952685|FG000|NOT COMPLETED|Overall Study||1||
59829291|NCT00422084|75952691|FG000|STARTED|Overall Study||849||
59829292|NCT00422084|75952692|FG001|STARTED|Overall Study||423||
59829293|NCT00422084|75952691|FG000|COMPLETED|Overall Study||751||
59829294|NCT00422084|75952692|FG001|COMPLETED|Overall Study||347||
59829295|NCT00422084|75952691|FG000|NOT COMPLETED|Overall Study||98||
59829296|NCT00422084|75952692|FG001|NOT COMPLETED|Overall Study||76||
59829297|NCT00421928|75952701|FG000|STARTED|Overall Study|2 randomly assigned to this treatment group did not receive drug|344||
59829298|NCT00421928|75952702|FG001|STARTED|Overall Study|2 randomly assigned to this treatment group did not receive drug. One subject was enrolled twice.|342||
59829299|NCT00421928|75952703|FG002|STARTED|Overall Study|2 randomly assigned to this treatment group did not receive drug|337||
59829300|NCT00421928|75952701|FG000|COMPLETED|Overall Study||181||
59829301|NCT00421928|75952702|FG001|COMPLETED|Overall Study||118||
59829302|NCT00421928|75952703|FG002|COMPLETED|Overall Study||203||
59829303|NCT00421928|75952701|FG000|NOT COMPLETED|Overall Study||163||
59829304|NCT00421928|75952702|FG001|NOT COMPLETED|Overall Study||224||
59829305|NCT00421928|75952703|FG002|NOT COMPLETED|Overall Study||134||
59829306|NCT00383292|75952714|FG000|STARTED|Overall Study||68||
59829307|NCT00383292|75952715|FG001|STARTED|Overall Study||32||
59829308|NCT00383292|75952716|FG002|STARTED|Overall Study||30||
59829309|NCT00383292|75952714|FG000|Received at Least One Dose of Study Drug|Overall Study||68||
59829310|NCT00383292|75952715|FG001|Received at Least One Dose of Study Drug|Overall Study||32||
59829311|NCT00383292|75952716|FG002|Received at Least One Dose of Study Drug|Overall Study||30||
59829312|NCT00383292|75952714|FG000|COMPLETED|Overall Study||53||
59829313|NCT00383292|75952715|FG001|COMPLETED|Overall Study||26||
59829314|NCT00383292|75952716|FG002|COMPLETED|Overall Study||22||
59829315|NCT00383292|75952714|FG000|NOT COMPLETED|Overall Study||15||
59829316|NCT00383292|75952715|FG001|NOT COMPLETED|Overall Study||6||
59829317|NCT00383292|75952716|FG002|NOT COMPLETED|Overall Study||8||
59829318|NCT00372060|75952727|FG000|STARTED|Period I - Double-blind (Weeks 0-12)|The planned number of enrolled patients was 130. The actual number of enrolled patients was 134.|66||
59829319|NCT00372060|75952728|FG001|STARTED|Period I - Double-blind (Weeks 0-12)||68||
59829320|NCT00372060|75952727|FG000|COMPLETED|Period I - Double-blind (Weeks 0-12)||63||
59829321|NCT00372060|75952728|FG001|COMPLETED|Period I - Double-blind (Weeks 0-12)||67||
59829322|NCT00372060|75952727|FG000|NOT COMPLETED|Period I - Double-blind (Weeks 0-12)||3||
59829323|NCT00372060|75952728|FG001|NOT COMPLETED|Period I - Double-blind (Weeks 0-12)||1||
59829324|NCT00372060|75952727|FG000|STARTED|Period II - Open-label (Weeks 12-52)||63||
59829325|NCT00372060|75952728|FG001|STARTED|Period II - Open-label (Weeks 12-52)||67||
59567463|NCT01292265|75670431|FG000|STARTED|Overall Study||3||
59567464|NCT01292265|75670431|FG000|COMPLETED|Overall Study||3||
59716345|NCT00922636|75835182|FG003|Entered Optional Taper Phase|Overall Study||7||
59716346|NCT00922636|75835183|FG004|Entered Optional Taper Phase|Overall Study||12||
59716347|NCT00922636|75835179|FG000|COMPLETED|Overall Study||29||
59716348|NCT00922636|75835180|FG001|COMPLETED|Overall Study||62||
59716349|NCT00922636|75835181|FG002|COMPLETED|Overall Study||56||
59716350|NCT00922636|75835182|FG003|COMPLETED|Overall Study||58||
59716351|NCT00922636|75835183|FG004|COMPLETED|Overall Study||59||
59716352|NCT00922636|75835179|FG000|NOT COMPLETED|Overall Study||7||
59716353|NCT00922636|75835180|FG001|NOT COMPLETED|Overall Study||16||
59716354|NCT00922636|75835181|FG002|NOT COMPLETED|Overall Study||20||
59716355|NCT00922636|75835182|FG003|NOT COMPLETED|Overall Study||17||
59829326|NCT00372060|75952727|FG000|COMPLETED|Period II - Open-label (Weeks 12-52)||49||
59829327|NCT00372060|75952728|FG001|COMPLETED|Period II - Open-label (Weeks 12-52)||59||
59829328|NCT00372060|75952727|FG000|NOT COMPLETED|Period II - Open-label (Weeks 12-52)||14||
59829329|NCT00372060|75952728|FG001|NOT COMPLETED|Period II - Open-label (Weeks 12-52)||8||
59829330|NCT00421304|75952740|FG000|STARTED|Overall Study||40||
59829331|NCT00421304|75952741|FG001|STARTED|Overall Study||39||
59829332|NCT00421304|75952742|FG002|STARTED|Overall Study||39||
59829333|NCT00421304|75952740|FG000|COMPLETED|Overall Study||32||
59567465|NCT01292265|75670431|FG000|NOT COMPLETED|Overall Study||0||
59567466|NCT01885910|75670435|FG000|STARTED|Overall Study||32||
59567467|NCT01885910|75670435|FG000|COMPLETED|Overall Study||24||
59567468|NCT01885910|75670435|FG000|NOT COMPLETED|Overall Study||8||
59567469|NCT02658357|75670443|FG000|STARTED|Overall Study||0||
59567470|NCT02658357|75670444|FG001|STARTED|Overall Study||0||
59567471|NCT02658357|75670443|FG000|COMPLETED|Overall Study||0||
59567472|NCT02658357|75670444|FG001|COMPLETED|Overall Study||0||
59567473|NCT02658357|75670443|FG000|NOT COMPLETED|Overall Study||0||
59716356|NCT00922636|75835183|FG004|NOT COMPLETED|Overall Study||16||
59716357|NCT01175135|75835204|FG000|STARTED|Overall Study||74||
59716358|NCT01175135|75835205|FG001|STARTED|Overall Study||74||
59716359|NCT01175135|75835206|FG002|STARTED|Overall Study||37||
59716360|NCT01175135|75835207|FG003|STARTED|Overall Study||74||
59716361|NCT01175135|75835204|FG000|Treated|Overall Study||74||
59716362|NCT01175135|75835205|FG001|Treated|Overall Study||74||
59829334|NCT00421304|75952741|FG001|COMPLETED|Overall Study||35||
59829335|NCT00421304|75952742|FG002|COMPLETED|Overall Study||31||
59829336|NCT00421304|75952740|FG000|NOT COMPLETED|Overall Study||8||
59829337|NCT00421304|75952741|FG001|NOT COMPLETED|Overall Study||4||
59829338|NCT00421304|75952742|FG002|NOT COMPLETED|Overall Study||8||
59829339|NCT00396630|75952754|FG000|STARTED|Overall Study||100||
59829340|NCT00396630|75952755|FG001|STARTED|Overall Study||100||
59829341|NCT00396630|75952754|FG000|COMPLETED|Overall Study|Completed Visit 4 (Week 17).|95||
59829342|NCT00396630|75952755|FG001|COMPLETED|Overall Study|Completed Visit 4 (Week 17).|95||
59829343|NCT00396630|75952754|FG000|NOT COMPLETED|Overall Study||5||
59829344|NCT00396630|75952755|FG001|NOT COMPLETED|Overall Study||5||
59829345|NCT00396318|75952762|FG000|STARTED|At Least One Dose of Tenecteplase (MITT)||246||
59829346|NCT00396318|75952762|FG000|COMPLETED|At Least One Dose of Tenecteplase (MITT)||241||
59829347|NCT00396318|75952762|FG000|NOT COMPLETED|At Least One Dose of Tenecteplase (MITT)||5||
59829348|NCT00396318|75952762|FG000|STARTED|48- to 96-Hour Follow-Up Period||246||
59829349|NCT00396318|75952762|FG000|COMPLETED|48- to 96-Hour Follow-Up Period||241||
59829350|NCT00396318|75952762|FG000|NOT COMPLETED|48- to 96-Hour Follow-Up Period||5||
59829351|NCT00396318|75952762|FG000|STARTED|7-Day Post-Treatment Contact||241||
59829352|NCT00396318|75952762|FG000|COMPLETED|7-Day Post-Treatment Contact||240||
59829353|NCT00396318|75952762|FG000|NOT COMPLETED|7-Day Post-Treatment Contact||1||
59829354|NCT00396162|75952768|FG000|STARTED|Overall Study||39||
59829355|NCT00396162|75952769|FG001|STARTED|Overall Study||38||
59829356|NCT00396162|75952768|FG000|COMPLETED|Overall Study||37||
59829357|NCT00396162|75952769|FG001|COMPLETED|Overall Study||35||
59829358|NCT00396162|75952768|FG000|NOT COMPLETED|Overall Study||2||
59829359|NCT00396162|75952769|FG001|NOT COMPLETED|Overall Study||3||
59829360|NCT00381888|75952779|FG000|STARTED|Overall Study||44||
59829361|NCT00381888|75952779|FG000|COMPLETED|Overall Study||27||
59829362|NCT00381888|75952779|FG000|NOT COMPLETED|Overall Study||17||
59829363|NCT00267969|75952786|FG000|STARTED|Controlled Period|Number of patients randomized|255||
59829364|NCT00267969|75952787|FG001|STARTED|Controlled Period|Number of patients randomized|255||
59829365|NCT00267969|75952788|FG002|STARTED|Controlled Period|Number of patients randomized|256||
59829366|NCT00267969|75952789|FG003|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0||
59829367|NCT00267969|75952790|FG004|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0||
59829368|NCT00267969|75952791|FG005|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0||
59829369|NCT00267969|75952792|FG006|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0||
59829370|NCT00267969|75952786|FG000|COMPLETED|Controlled Period||243||
59829371|NCT00267969|75952787|FG001|COMPLETED|Controlled Period||254||
59829372|NCT00267969|75952788|FG002|COMPLETED|Controlled Period||245||
59829373|NCT00267969|75952789|FG003|COMPLETED|Controlled Period||0||
59829374|NCT00267969|75952790|FG004|COMPLETED|Controlled Period||0||
59829375|NCT00267969|75952791|FG005|COMPLETED|Controlled Period||0||
59829376|NCT00267969|75952792|FG006|COMPLETED|Controlled Period||0||
59829377|NCT00267969|75952786|FG000|NOT COMPLETED|Controlled Period||12||
59829378|NCT00267969|75952787|FG001|NOT COMPLETED|Controlled Period||1||
59829379|NCT00267969|75952788|FG002|NOT COMPLETED|Controlled Period||11||
59829380|NCT00267969|75952789|FG003|NOT COMPLETED|Controlled Period||0||
59829381|NCT00267969|75952790|FG004|NOT COMPLETED|Controlled Period||0||
59829382|NCT00267969|75952791|FG005|NOT COMPLETED|Controlled Period||0||
59829383|NCT00267969|75952792|FG006|NOT COMPLETED|Controlled Period||0||
59829384|NCT00267969|75952786|FG000|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0||
59829385|NCT00267969|75952787|FG001|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0||
59829386|NCT00267969|75952788|FG002|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0||
59829387|NCT00267969|75952789|FG003|STARTED|After Controlled Period||123||
59829388|NCT00267969|75952790|FG004|STARTED|After Controlled Period||120||
59829389|NCT00267969|75952791|FG005|STARTED|After Controlled Period||254||
59829390|NCT00267969|75952792|FG006|STARTED|After Controlled Period||245||
59829391|NCT00267969|75952786|FG000|COMPLETED|After Controlled Period||0||
59829392|NCT00267969|75952787|FG001|COMPLETED|After Controlled Period||0||
59829393|NCT00267969|75952788|FG002|COMPLETED|After Controlled Period||0||
59829394|NCT00267969|75952789|FG003|COMPLETED|After Controlled Period||87||
59829395|NCT00267969|75952790|FG004|COMPLETED|After Controlled Period||85||
59829396|NCT00267969|75952791|FG005|COMPLETED|After Controlled Period||172||
59829397|NCT00267969|75952792|FG006|COMPLETED|After Controlled Period||173||
59829398|NCT00267969|75952786|FG000|NOT COMPLETED|After Controlled Period||0||
59829399|NCT00267969|75952787|FG001|NOT COMPLETED|After Controlled Period||0||
59829400|NCT00267969|75952788|FG002|NOT COMPLETED|After Controlled Period||0||
59829401|NCT00267969|75952789|FG003|NOT COMPLETED|After Controlled Period||36||
59829402|NCT00267969|75952790|FG004|NOT COMPLETED|After Controlled Period||35||
59829403|NCT00267969|75952791|FG005|NOT COMPLETED|After Controlled Period||82||
60118173|NCT00047697|76239250|FG001|NOT COMPLETED|Overall Study||2||
59829404|NCT00267969|75952792|FG006|NOT COMPLETED|After Controlled Period||72||
59829405|NCT00280293|75952812|FG000|STARTED|Overall Study||55||
59829406|NCT00280293|75952813|FG001|STARTED|Overall Study||57||
59829407|NCT00280293|75952812|FG000|COMPLETED|Overall Study||29||
60118174|NCT00112125|76239259|FG000|STARTED|Overall Study||213||
59567474|NCT02658357|75670444|FG001|NOT COMPLETED|Overall Study||0||
59829408|NCT00280293|75952813|FG001|COMPLETED|Overall Study||34||
59829409|NCT00280293|75952812|FG000|NOT COMPLETED|Overall Study||26||
59829410|NCT00280293|75952813|FG001|NOT COMPLETED|Overall Study||23||
59829411|NCT00421148|75952839|FG000|STARTED|Overall Study||2||
59829412|NCT00421148|75952840|FG001|STARTED|Overall Study||2||
59829413|NCT00421148|75952841|FG002|STARTED|Overall Study||2||
59829414|NCT00421148|75952842|FG003|STARTED|Overall Study||1||
59829415|NCT00421148|75952843|FG004|STARTED|Overall Study||1||
59829416|NCT00421148|75952844|FG005|STARTED|Overall Study||5||
59829417|NCT00421148|75952845|FG006|STARTED|Overall Study||6||
59829418|NCT00421148|75952846|FG007|STARTED|Overall Study||5||
59829419|NCT00421148|75952847|FG008|STARTED|Overall Study||5||
59829420|NCT00421148|75952848|FG009|STARTED|Overall Study||5||
59829421|NCT00421148|75952849|FG010|STARTED|Overall Study||6||
59829422|NCT00421148|75952850|FG011|STARTED|Overall Study||6||
59829423|NCT00421148|75952851|FG012|STARTED|Overall Study||6||
59829424|NCT00421148|75952852|FG013|STARTED|Overall Study||6||
59829425|NCT00421148|75952853|FG014|STARTED|Overall Study||6||
59829426|NCT00421148|75952854|FG015|STARTED|Overall Study||6||
59829427|NCT00421148|75952855|FG016|STARTED|Overall Study||6||
59829428|NCT00421148|75952856|FG017|STARTED|Overall Study||6||
59829429|NCT00421148|75952857|FG018|STARTED|Overall Study||6||
59829430|NCT00421148|75952858|FG019|STARTED|Overall Study||6||
59829431|NCT00421148|75952839|FG000|Treated|Overall Study||2||
59829432|NCT00421148|75952840|FG001|Treated|Overall Study||2||
59829433|NCT00421148|75952841|FG002|Treated|Overall Study||2||
59829434|NCT00421148|75952842|FG003|Treated|Overall Study||1||
59829435|NCT00421148|75952843|FG004|Treated|Overall Study||1||
59829436|NCT00421148|75952844|FG005|Treated|Overall Study|1 additional participant discontinued prior to receiving study treatment|4||
59829437|NCT00421148|75952845|FG006|Treated|Overall Study||6||
59829438|NCT00421148|75952846|FG007|Treated|Overall Study||5||
59829439|NCT00421148|75952847|FG008|Treated|Overall Study||5||
59829440|NCT00421148|75952848|FG009|Treated|Overall Study|Includes 1 participant who was inadvertently randomized to group but was an adolescent|5||
59829441|NCT00421148|75952849|FG010|Treated|Overall Study||6||
59829442|NCT00421148|75952850|FG011|Treated|Overall Study|Includes 1 participant who was inadvertently randomized to group but received 5 mg/kg sugammadex|6||
59829443|NCT00421148|75952851|FG012|Treated|Overall Study||6||
59829444|NCT00421148|75952852|FG013|Treated|Overall Study||6||
59829445|NCT00421148|75952853|FG014|Treated|Overall Study||6||
59829446|NCT00421148|75952854|FG015|Treated|Overall Study||6||
59829447|NCT00421148|75952855|FG016|Treated|Overall Study||6||
59829448|NCT00421148|75952856|FG017|Treated|Overall Study|1 additional participant discontinued prior to receiving study treatment|5||
59829449|NCT00421148|75952857|FG018|Treated|Overall Study|1 additional participant discontinued prior to receiving study treatment|5||
59829450|NCT00421148|75952858|FG019|Treated|Overall Study||6||
59829451|NCT00421148|75952839|FG000|COMPLETED|Overall Study||2||
59829452|NCT00421148|75952840|FG001|COMPLETED|Overall Study||2||
59829453|NCT00421148|75952841|FG002|COMPLETED|Overall Study||2||
59829454|NCT00421148|75952842|FG003|COMPLETED|Overall Study||1||
59829455|NCT00421148|75952843|FG004|COMPLETED|Overall Study||1||
59829456|NCT00421148|75952844|FG005|COMPLETED|Overall Study||4||
59829457|NCT00421148|75952845|FG006|COMPLETED|Overall Study||6||
59829458|NCT00421148|75952846|FG007|COMPLETED|Overall Study||5||
59829459|NCT00421148|75952847|FG008|COMPLETED|Overall Study||5||
59829460|NCT00421148|75952848|FG009|COMPLETED|Overall Study||5||
59829461|NCT00421148|75952849|FG010|COMPLETED|Overall Study||6||
59829462|NCT00421148|75952850|FG011|COMPLETED|Overall Study||6||
59829463|NCT00421148|75952851|FG012|COMPLETED|Overall Study||6||
59829464|NCT00421148|75952852|FG013|COMPLETED|Overall Study||6||
59829465|NCT00421148|75952853|FG014|COMPLETED|Overall Study||6||
59829466|NCT00421148|75952854|FG015|COMPLETED|Overall Study||6||
59829467|NCT00421148|75952855|FG016|COMPLETED|Overall Study||6||
59716363|NCT01175135|75835206|FG002|Treated|Overall Study||36||
59716364|NCT01175135|75835207|FG003|Treated|Overall Study||74||
59716365|NCT01175135|75835204|FG000|Analyzed for Efficacy|Overall Study||74||
59716366|NCT01175135|75835205|FG001|Analyzed for Efficacy|Overall Study||73||
59716367|NCT01175135|75835206|FG002|Analyzed for Efficacy|Overall Study||34||
59716368|NCT01175135|75835207|FG003|Analyzed for Efficacy|Overall Study||73||
59716369|NCT01175135|75835204|FG000|COMPLETED|Overall Study||58||
59716370|NCT01175135|75835205|FG001|COMPLETED|Overall Study||52||
59829468|NCT00421148|75952856|FG017|COMPLETED|Overall Study||4||
59829469|NCT00421148|75952857|FG018|COMPLETED|Overall Study||5||
59829470|NCT00421148|75952858|FG019|COMPLETED|Overall Study||6||
59829471|NCT00421148|75952839|FG000|NOT COMPLETED|Overall Study||0||
59829472|NCT00421148|75952840|FG001|NOT COMPLETED|Overall Study||0||
59829473|NCT00421148|75952841|FG002|NOT COMPLETED|Overall Study||0||
59829474|NCT00421148|75952842|FG003|NOT COMPLETED|Overall Study||0||
59716371|NCT01175135|75835206|FG002|COMPLETED|Overall Study||25||
59716372|NCT01175135|75835207|FG003|COMPLETED|Overall Study||60||
59716373|NCT01175135|75835204|FG000|NOT COMPLETED|Overall Study||16||
59716374|NCT01175135|75835205|FG001|NOT COMPLETED|Overall Study||22||
59716375|NCT01175135|75835206|FG002|NOT COMPLETED|Overall Study||12||
59829475|NCT00421148|75952843|FG004|NOT COMPLETED|Overall Study||0||
59829476|NCT00421148|75952844|FG005|NOT COMPLETED|Overall Study||1||
59829477|NCT00421148|75952845|FG006|NOT COMPLETED|Overall Study||0||
59829478|NCT00421148|75952846|FG007|NOT COMPLETED|Overall Study||0||
59829479|NCT00421148|75952847|FG008|NOT COMPLETED|Overall Study||0||
59829480|NCT00421148|75952848|FG009|NOT COMPLETED|Overall Study||0||
59829481|NCT00421148|75952849|FG010|NOT COMPLETED|Overall Study||0||
59829482|NCT00421148|75952850|FG011|NOT COMPLETED|Overall Study||0||
59829483|NCT00421148|75952851|FG012|NOT COMPLETED|Overall Study||0||
59829484|NCT00421148|75952852|FG013|NOT COMPLETED|Overall Study||0||
59829485|NCT00421148|75952853|FG014|NOT COMPLETED|Overall Study||0||
59829486|NCT00421148|75952854|FG015|NOT COMPLETED|Overall Study||0||
59829487|NCT00421148|75952855|FG016|NOT COMPLETED|Overall Study||0||
59829488|NCT00421148|75952856|FG017|NOT COMPLETED|Overall Study||2||
59829489|NCT00421148|75952857|FG018|NOT COMPLETED|Overall Study||1||
59829490|NCT00421148|75952858|FG019|NOT COMPLETED|Overall Study||0||
59829491|NCT00403754|75952900|FG000|STARTED|Core Treatment Period 1||11||
59829492|NCT00403754|75952901|FG001|STARTED|Core Treatment Period 1||10||
59829493|NCT00403754|75952902|FG002|STARTED|Core Treatment Period 1||9||
59829494|NCT00403754|75952903|FG003|STARTED|Core Treatment Period 1||11||
59829495|NCT00403754|75952900|FG000|COMPLETED|Core Treatment Period 1||11||
59829496|NCT00403754|75952901|FG001|COMPLETED|Core Treatment Period 1||9||
59829497|NCT00403754|75952902|FG002|COMPLETED|Core Treatment Period 1||9||
59829498|NCT00403754|75952903|FG003|COMPLETED|Core Treatment Period 1||11||
59829499|NCT00403754|75952900|FG000|NOT COMPLETED|Core Treatment Period 1||0||
59829500|NCT00403754|75952901|FG001|NOT COMPLETED|Core Treatment Period 1||1||
59829501|NCT00403754|75952902|FG002|NOT COMPLETED|Core Treatment Period 1||0||
59829502|NCT00403754|75952903|FG003|NOT COMPLETED|Core Treatment Period 1||0||
59829503|NCT00403754|75952900|FG000|STARTED|Core Treatment Period 2||11||
59829504|NCT00403754|75952901|FG001|STARTED|Core Treatment Period 2||9||
59829505|NCT00403754|75952902|FG002|STARTED|Core Treatment Period 2||9||
59829506|NCT00403754|75952903|FG003|STARTED|Core Treatment Period 2||11||
59829507|NCT00403754|75952900|FG000|COMPLETED|Core Treatment Period 2||11||
59829508|NCT00403754|75952901|FG001|COMPLETED|Core Treatment Period 2||9||
59829509|NCT00403754|75952902|FG002|COMPLETED|Core Treatment Period 2||8||
59829510|NCT00403754|75952903|FG003|COMPLETED|Core Treatment Period 2||11||
59829511|NCT00403754|75952900|FG000|NOT COMPLETED|Core Treatment Period 2||0||
59829512|NCT00403754|75952901|FG001|NOT COMPLETED|Core Treatment Period 2||0||
59829513|NCT00403754|75952902|FG002|NOT COMPLETED|Core Treatment Period 2||1||
59829514|NCT00403754|75952903|FG003|NOT COMPLETED|Core Treatment Period 2||0||
59829515|NCT00403754|75952900|FG000|STARTED|Core Treatment Period 3||11||
59829516|NCT00403754|75952901|FG001|STARTED|Core Treatment Period 3||9||
59829517|NCT00403754|75952902|FG002|STARTED|Core Treatment Period 3||8||
59829518|NCT00403754|75952903|FG003|STARTED|Core Treatment Period 3||11||
59829519|NCT00403754|75952900|FG000|COMPLETED|Core Treatment Period 3||11||
59716376|NCT01175135|75835207|FG003|NOT COMPLETED|Overall Study||14||
59716377|NCT00922480|75835219|FG000|STARTED|Main Study||250||
59716378|NCT00922480|75835220|FG001|STARTED|Main Study||255||
59716379|NCT00922480|75835219|FG000|COMPLETED|Main Study||213||
59829520|NCT00403754|75952901|FG001|COMPLETED|Core Treatment Period 3||9||
59829521|NCT00403754|75952902|FG002|COMPLETED|Core Treatment Period 3||8||
59829522|NCT00403754|75952903|FG003|COMPLETED|Core Treatment Period 3||11||
59716380|NCT00922480|75835220|FG001|COMPLETED|Main Study||226||
59716381|NCT00922480|75835219|FG000|NOT COMPLETED|Main Study||37||
59716382|NCT00922480|75835220|FG001|NOT COMPLETED|Main Study||29||
59716383|NCT00922480|75835219|FG000|STARTED|Extension Study||73||
59716384|NCT00922480|75835220|FG001|STARTED|Extension Study||85||
59716385|NCT00922480|75835219|FG000|COMPLETED|Extension Study||68||
59716386|NCT00922480|75835220|FG001|COMPLETED|Extension Study||82||
59716387|NCT00922480|75835219|FG000|NOT COMPLETED|Extension Study||5||
59716388|NCT00922480|75835220|FG001|NOT COMPLETED|Extension Study||3||
59716389|NCT00973479|75835230|FG000|STARTED|Overall Study||197||
59716390|NCT00973479|75835231|FG001|STARTED|Overall Study||395||
59716391|NCT00973479|75835230|FG000|COMPLETED|Overall Study||160||
59716392|NCT00973479|75835231|FG001|COMPLETED|Overall Study||326||
59716393|NCT00973479|75835230|FG000|NOT COMPLETED|Overall Study||37||
59716394|NCT00973479|75835231|FG001|NOT COMPLETED|Overall Study||69||
59716395|NCT01173653|75835241|FG000|STARTED|Overall Study||109||
59716396|NCT01173653|75835242|FG001|STARTED|Overall Study||90||
59829523|NCT00403754|75952900|FG000|NOT COMPLETED|Core Treatment Period 3||0||
59829524|NCT00403754|75952901|FG001|NOT COMPLETED|Core Treatment Period 3||0||
59829525|NCT00403754|75952902|FG002|NOT COMPLETED|Core Treatment Period 3||0||
59829526|NCT00403754|75952903|FG003|NOT COMPLETED|Core Treatment Period 3||0||
59829527|NCT00403754|75952900|FG000|STARTED|Core Treatment Period 4||11||
59716397|NCT01173653|75835241|FG000|COMPLETED|Overall Study||56||
59716398|NCT01173653|75835242|FG001|COMPLETED|Overall Study||49||
59716399|NCT01173653|75835241|FG000|NOT COMPLETED|Overall Study||53||
59829528|NCT00403754|75952901|FG001|STARTED|Core Treatment Period 4||9||
59829529|NCT00403754|75952902|FG002|STARTED|Core Treatment Period 4||8||
59829530|NCT00403754|75952903|FG003|STARTED|Core Treatment Period 4||11||
59829531|NCT00403754|75952900|FG000|COMPLETED|Core Treatment Period 4||11||
59829532|NCT00403754|75952901|FG001|COMPLETED|Core Treatment Period 4||9||
59716400|NCT01173653|75835242|FG001|NOT COMPLETED|Overall Study||41||
59829533|NCT00403754|75952902|FG002|COMPLETED|Core Treatment Period 4||8||
59829534|NCT00403754|75952903|FG003|COMPLETED|Core Treatment Period 4||11||
59829535|NCT00403754|75952900|FG000|NOT COMPLETED|Core Treatment Period 4||0||
59829536|NCT00403754|75952901|FG001|NOT COMPLETED|Core Treatment Period 4||0||
59829537|NCT00403754|75952902|FG002|NOT COMPLETED|Core Treatment Period 4||0||
59829538|NCT00403754|75952903|FG003|NOT COMPLETED|Core Treatment Period 4||0||
59829539|NCT00403754|75952900|FG000|STARTED|Open Label: Salmeterol||11||
59829540|NCT00403754|75952901|FG001|STARTED|Open Label: Salmeterol||9||
59829541|NCT00403754|75952902|FG002|STARTED|Open Label: Salmeterol||8||
59829542|NCT00403754|75952903|FG003|STARTED|Open Label: Salmeterol||11||
59829543|NCT00403754|75952900|FG000|COMPLETED|Open Label: Salmeterol||11||
59829544|NCT00403754|75952901|FG001|COMPLETED|Open Label: Salmeterol||9||
59829545|NCT00403754|75952902|FG002|COMPLETED|Open Label: Salmeterol||8||
59829546|NCT00403754|75952903|FG003|COMPLETED|Open Label: Salmeterol||11||
59829547|NCT00403754|75952900|FG000|NOT COMPLETED|Open Label: Salmeterol||0||
59829548|NCT00403754|75952901|FG001|NOT COMPLETED|Open Label: Salmeterol||0||
59829549|NCT00403754|75952902|FG002|NOT COMPLETED|Open Label: Salmeterol||0||
59829550|NCT00403754|75952903|FG003|NOT COMPLETED|Open Label: Salmeterol||0||
59829551|NCT00280059|75952917|FG000|STARTED|Efficacy Assessment Phase||330||
59829552|NCT00280059|75952918|FG001|STARTED|Efficacy Assessment Phase||330||
59829553|NCT00280059|75952917|FG000|COMPLETED|Efficacy Assessment Phase|Week 56: up to end of efficacy assessment phase (excluding extension phase).|236||
59567475|NCT02326272|75670453|FG000|STARTED|Initial Period (Week 0 to Week 16)||49||
59567476|NCT02326272|75670454|FG001|STARTED|Initial Period (Week 0 to Week 16)||91||
59567477|NCT02326272|75670455|FG002|STARTED|Initial Period (Week 0 to Week 16)||87||
59716401|NCT01172873|75835250|FG000|STARTED|Overall Study||11||
59716402|NCT01172873|75835251|FG001|STARTED|Overall Study||5||
59716403|NCT01172873|75835250|FG000|COMPLETED|Overall Study||8||
59716404|NCT01172873|75835251|FG001|COMPLETED|Overall Study||3||
59716405|NCT01172873|75835250|FG000|NOT COMPLETED|Overall Study||3||
59716406|NCT01172873|75835251|FG001|NOT COMPLETED|Overall Study||2||
59716407|NCT04075279|75835257|FG000|STARTED|Overall Study||19||
59716408|NCT04075279|75835257|FG000|COMPLETED|Overall Study||19||
59716409|NCT04075279|75835257|FG000|NOT COMPLETED|Overall Study||0||
59716410|NCT00925600|75835263|FG000|STARTED|Overall Study||386||
59716411|NCT00925600|75835264|FG001|STARTED|Overall Study||383||
59716412|NCT00925600|75835263|FG000|Received Treatment|Overall Study|Three participants received at least 1 dose of denosumab in error|383||
59829554|NCT00280059|75952918|FG001|COMPLETED|Efficacy Assessment Phase|Week 56: up to end of efficacy assessment phase (excluding extension phase).|250||
59829555|NCT00280059|75952917|FG000|NOT COMPLETED|Efficacy Assessment Phase||94||
59829556|NCT00280059|75952918|FG001|NOT COMPLETED|Efficacy Assessment Phase||80||
59829557|NCT00280059|75952917|FG000|STARTED|Extension Phase|Optional phase; number entered was less than the number who completed the efficacy assessment phase.|194||
59829558|NCT00280059|75952918|FG001|STARTED|Extension Phase|Optional phase; number entered was less than the number who completed the efficacy assessment phase.|215||
59829559|NCT00280059|75952917|FG000|COMPLETED|Extension Phase||145||
59829560|NCT00280059|75952918|FG001|COMPLETED|Extension Phase||177||
59829561|NCT00280059|75952917|FG000|NOT COMPLETED|Extension Phase||49||
59829562|NCT00280059|75952918|FG001|NOT COMPLETED|Extension Phase||38||
59829563|NCT00403130|75952932|FG000|STARTED|2 Years From Start of Treatment||31||
59829564|NCT00403130|75952932|FG000|COMPLETED|2 Years From Start of Treatment||26||
59829565|NCT00403130|75952932|FG000|NOT COMPLETED|2 Years From Start of Treatment||5||
59829566|NCT00403130|75952932|FG000|STARTED|Survival Follow-up up to 6 Years||26||
59829567|NCT00403130|75952932|FG000|COMPLETED|Survival Follow-up up to 6 Years||16||
59829568|NCT00403130|75952932|FG000|NOT COMPLETED|Survival Follow-up up to 6 Years||10||
59829569|NCT00402740|75952936|FG000|STARTED|Overall Study||322||
59829570|NCT00402740|75952936|FG000|COMPLETED|Overall Study||242||
59829571|NCT00402740|75952936|FG000|NOT COMPLETED|Overall Study||80||
59829572|NCT00420290|75952946|FG000|STARTED|Overall Study||11||
59829573|NCT00420290|75952947|FG001|STARTED|Overall Study||11||
59716413|NCT00925600|75835264|FG001|Received Treatment|Overall Study||382||
59829574|NCT00420290|75952946|FG000|COMPLETED|Overall Study||7||
59829575|NCT00420290|75952947|FG001|COMPLETED|Overall Study||7||
59829576|NCT00420290|75952946|FG000|NOT COMPLETED|Overall Study||4||
59829577|NCT00420290|75952947|FG001|NOT COMPLETED|Overall Study||4||
59829578|NCT00267189|75952955|FG000|STARTED|Overall Study|Intention to treat (ITT) population.|72||
59716414|NCT00925600|75835263|FG000|COMPLETED|Overall Study||354||
59716415|NCT00925600|75835264|FG001|COMPLETED|Overall Study||355||
59716416|NCT00925600|75835263|FG000|NOT COMPLETED|Overall Study||32||
59829579|NCT00267189|75952956|FG001|STARTED|Overall Study||73||
59829580|NCT00267189|75952955|FG000|Completed Study Medication|Overall Study||54||
59829581|NCT00267189|75952956|FG001|Completed Study Medication|Overall Study||72||
59829582|NCT00267189|75952955|FG000|COMPLETED|Overall Study|"Completed indicates completed study."|67||
59829583|NCT00267189|75952956|FG001|COMPLETED|Overall Study||72||
59829584|NCT00267189|75952955|FG000|NOT COMPLETED|Overall Study||5||
60118175|NCT00112125|76239260|FG001|STARTED|Overall Study||215||
59829585|NCT00267189|75952956|FG001|NOT COMPLETED|Overall Study||1||
59829586|NCT03834350|75952962|FG000|STARTED|Overall Study||71||
59829587|NCT03834350|75952962|FG000|COMPLETED|Overall Study||70||
59829588|NCT03834350|75952962|FG000|NOT COMPLETED|Overall Study||1||
59829589|NCT00402116|75952970|FG000|STARTED|Overall Study||6||
59829590|NCT00402116|75952971|FG001|STARTED|Overall Study||6||
59829591|NCT00402116|75952972|FG002|STARTED|Overall Study||60||
59829592|NCT00402116|75952970|FG000|COMPLETED|Overall Study||3||
59829593|NCT00402116|75952971|FG001|COMPLETED|Overall Study||0||
59829594|NCT00402116|75952972|FG002|COMPLETED|Overall Study||5||
59829595|NCT00402116|75952970|FG000|NOT COMPLETED|Overall Study||3||
59829596|NCT00402116|75952971|FG001|NOT COMPLETED|Overall Study||6||
59829597|NCT00402116|75952972|FG002|NOT COMPLETED|Overall Study||55||
59829598|NCT00401960|75953002|FG000|STARTED|Overall Study||5||
59829599|NCT00401960|75953003|FG001|STARTED|Overall Study||1||
59829600|NCT00401960|75953002|FG000|COMPLETED|Overall Study||0||
59829601|NCT00401960|75953003|FG001|COMPLETED|Overall Study||1||
59829602|NCT00401960|75953002|FG000|NOT COMPLETED|Overall Study||5||
59829603|NCT00401960|75953003|FG001|NOT COMPLETED|Overall Study||0||
59829604|NCT00401726|75953013|FG000|STARTED|Overall Study||269||
59829605|NCT00401726|75953014|FG001|STARTED|Overall Study||268||
59829606|NCT00401726|75953013|FG000|COMPLETED|Overall Study||172||
59829607|NCT00401726|75953014|FG001|COMPLETED|Overall Study||156||
59829608|NCT00401726|75953013|FG000|NOT COMPLETED|Overall Study||97||
59829609|NCT00401726|75953014|FG001|NOT COMPLETED|Overall Study||112||
59829610|NCT00371826|75953023|FG000|STARTED|Core Phase (12 Months)|"Started indicates patients in Randomized, Intent to treat (ITT) and Safety set."|49||
59829611|NCT00371826|75953024|FG001|STARTED|Core Phase (12 Months)||47||
59829612|NCT00371826|75953025|FG002|STARTED|Core Phase (12 Months)||30||
59829613|NCT00371826|75953023|FG000|Modified Intent to Treat (mITT)- Add|Core Phase (12 Months)||46||
59829614|NCT00371826|75953024|FG001|Modified Intent to Treat (mITT)- Add|Core Phase (12 Months)||44||
59829615|NCT00371826|75953025|FG002|Modified Intent to Treat (mITT)- Add|Core Phase (12 Months)||20||
59829616|NCT00371826|75953023|FG000|Modified Intent to Treat (mITT)|Core Phase (12 Months)||27||
59829617|NCT00371826|75953024|FG001|Modified Intent to Treat (mITT)|Core Phase (12 Months)||39||
59829618|NCT00371826|75953025|FG002|Modified Intent to Treat (mITT)|Core Phase (12 Months)||6||
59829619|NCT00371826|75953023|FG000|COMPLETED|Core Phase (12 Months)|"Completed means patients were still on study medication by month 12."|25||
59829620|NCT00371826|75953024|FG001|COMPLETED|Core Phase (12 Months)||39||
59829621|NCT00371826|75953025|FG002|COMPLETED|Core Phase (12 Months)||6||
59829622|NCT00371826|75953023|FG000|NOT COMPLETED|Core Phase (12 Months)||24||
59829623|NCT00371826|75953024|FG001|NOT COMPLETED|Core Phase (12 Months)||8||
59829624|NCT00371826|75953025|FG002|NOT COMPLETED|Core Phase (12 Months)||24||
59829625|NCT00371826|75953023|FG000|STARTED|Extension Phase (24 Months)|2 patients who completed 12 month core did not wish to continue in extension.|23||
59829626|NCT00371826|75953024|FG001|STARTED|Extension Phase (24 Months)||39||
59829627|NCT00371826|75953025|FG002|STARTED|Extension Phase (24 Months)|One patient completed core, did not wish to continue to extension.|5||
59829628|NCT00371826|75953023|FG000|Intention to Treat - Extenstion (ITT-Ex)|Extension Phase (24 Months)||23||
59829629|NCT00371826|75953024|FG001|Intention to Treat - Extenstion (ITT-Ex)|Extension Phase (24 Months)||39||
59829630|NCT00371826|75953025|FG002|Intention to Treat - Extenstion (ITT-Ex)|Extension Phase (24 Months)|One patient entered extension, was withdrawn (no efficacy data in extension) due to DMC suggestion|4||
59829631|NCT00371826|75953023|FG000|Safety Set|Extension Phase (24 Months)|One patient randomized to this arm, was treated with the control regimen (CNI+MPA+Steroid)|22||
59829632|NCT00371826|75953024|FG001|Safety Set|Extension Phase (24 Months)|One patient mis-randomised to 1st arm but treated in this arm, evaluated for safety in this arm.|40||
59829633|NCT00371826|75953025|FG002|Safety Set|Extension Phase (24 Months)|Patient withdrawn as per DMC suggestion had no efficacy data, but was included in safety set.|5||
59829634|NCT00371826|75953023|FG000|COMPLETED|Extension Phase (24 Months)||18||
59829635|NCT00371826|75953024|FG001|COMPLETED|Extension Phase (24 Months)||29||
59829636|NCT00371826|75953025|FG002|COMPLETED|Extension Phase (24 Months)||3||
59829637|NCT00371826|75953023|FG000|NOT COMPLETED|Extension Phase (24 Months)||5||
59829638|NCT00371826|75953024|FG001|NOT COMPLETED|Extension Phase (24 Months)||10||
59829639|NCT00371826|75953025|FG002|NOT COMPLETED|Extension Phase (24 Months)||2||
60118176|NCT00112125|76239259|FG000|COMPLETED|Overall Study||189||
59567478|NCT02326272|75670456|FG003|STARTED|Initial Period (Week 0 to Week 16)||0||
59567479|NCT02326272|75670457|FG004|STARTED|Initial Period (Week 0 to Week 16)||0||
59567480|NCT02326272|75670458|FG005|STARTED|Initial Period (Week 0 to Week 16)||0||
59567481|NCT02326272|75670459|FG006|STARTED|Initial Period (Week 0 to Week 16)||0||
59567482|NCT02326272|75670460|FG007|STARTED|Initial Period (Week 0 to Week 16)||0||
59829640|NCT00396084|75953039|FG000|STARTED|Overall Study||10||
59829641|NCT00396084|75953040|FG001|STARTED|Overall Study||10||
59829642|NCT00396084|75953041|FG002|STARTED|Overall Study||10||
59829643|NCT00396084|75953042|FG003|STARTED|Overall Study||10||
59829644|NCT00396084|75953043|FG004|STARTED|Overall Study||10||
59829645|NCT00396084|75953044|FG005|STARTED|Overall Study||20||
59829646|NCT00396084|75953039|FG000|COMPLETED|Overall Study||10||
59829647|NCT00396084|75953040|FG001|COMPLETED|Overall Study||10||
59829648|NCT00396084|75953041|FG002|COMPLETED|Overall Study||10||
59829649|NCT00396084|75953042|FG003|COMPLETED|Overall Study||9||
59829650|NCT00396084|75953043|FG004|COMPLETED|Overall Study||9||
59829651|NCT00396084|75953044|FG005|COMPLETED|Overall Study||18||
59829652|NCT00396084|75953039|FG000|NOT COMPLETED|Overall Study||0||
59829653|NCT00396084|75953040|FG001|NOT COMPLETED|Overall Study||0||
59829654|NCT00396084|75953041|FG002|NOT COMPLETED|Overall Study||0||
59829655|NCT00396084|75953042|FG003|NOT COMPLETED|Overall Study||1||
59829656|NCT00396084|75953043|FG004|NOT COMPLETED|Overall Study||1||
59829657|NCT00396084|75953044|FG005|NOT COMPLETED|Overall Study||2||
59829658|NCT00395850|75953066|FG000|STARTED|Pre-randomization Baseline/Induction|Pre-randomization and disulfiram (disulf) administration|118||
59829659|NCT00395850|75953067|FG001|STARTED|Pre-randomization Baseline/Induction||0||
59829660|NCT00395850|75953068|FG002|STARTED|Pre-randomization Baseline/Induction||0||
59829661|NCT00395850|75953069|FG003|STARTED|Pre-randomization Baseline/Induction||0||
59829662|NCT00395850|75953066|FG000|COMPLETED|Pre-randomization Baseline/Induction||107||
59829663|NCT00395850|75953067|FG001|COMPLETED|Pre-randomization Baseline/Induction||0||
59829664|NCT00395850|75953068|FG002|COMPLETED|Pre-randomization Baseline/Induction||0||
59829665|NCT00395850|75953069|FG003|COMPLETED|Pre-randomization Baseline/Induction||0||
59829666|NCT00395850|75953066|FG000|NOT COMPLETED|Pre-randomization Baseline/Induction||11||
59829667|NCT00395850|75953067|FG001|NOT COMPLETED|Pre-randomization Baseline/Induction||0||
59829668|NCT00395850|75953068|FG002|NOT COMPLETED|Pre-randomization Baseline/Induction||0||
59829669|NCT00395850|75953069|FG003|NOT COMPLETED|Pre-randomization Baseline/Induction||0||
59829670|NCT00395850|75953066|FG000|STARTED|Randomization to Disulfiram/ Pre-admin||27||
59829671|NCT00395850|75953067|FG001|STARTED|Randomization to Disulfiram/ Pre-admin||25||
59829672|NCT00395850|75953068|FG002|STARTED|Randomization to Disulfiram/ Pre-admin||30||
59829673|NCT00395850|75953069|FG003|STARTED|Randomization to Disulfiram/ Pre-admin||25||
59829674|NCT00395850|75953066|FG000|COMPLETED|Randomization to Disulfiram/ Pre-admin||22||
59829675|NCT00395850|75953067|FG001|COMPLETED|Randomization to Disulfiram/ Pre-admin||23||
59829676|NCT00395850|75953068|FG002|COMPLETED|Randomization to Disulfiram/ Pre-admin||24||
59829677|NCT00395850|75953069|FG003|COMPLETED|Randomization to Disulfiram/ Pre-admin||21||
59829678|NCT00395850|75953066|FG000|NOT COMPLETED|Randomization to Disulfiram/ Pre-admin||5||
59829679|NCT00395850|75953067|FG001|NOT COMPLETED|Randomization to Disulfiram/ Pre-admin||2||
59829680|NCT00395850|75953068|FG002|NOT COMPLETED|Randomization to Disulfiram/ Pre-admin||6||
59829681|NCT00395850|75953069|FG003|NOT COMPLETED|Randomization to Disulfiram/ Pre-admin||4||
59829682|NCT00395850|75953066|FG000|STARTED|Disulfiram/Placebo Treatment|Received >= 1 disulfiram dose. Two baseline/randomized subjects dropped out before receiving disulf|20||
59829683|NCT00395850|75953067|FG001|STARTED|Disulfiram/Placebo Treatment|Received at least one dose of disulfiram|23||
59829684|NCT00395850|75953068|FG002|STARTED|Disulfiram/Placebo Treatment|Received at least one dose of disulfiram|24||
59829685|NCT00395850|75953069|FG003|STARTED|Disulfiram/Placebo Treatment|Received at least one dose of disulfiram|21||
59829686|NCT00395850|75953066|FG000|COMPLETED|Disulfiram/Placebo Treatment||11||
59829687|NCT00395850|75953067|FG001|COMPLETED|Disulfiram/Placebo Treatment||9||
59829688|NCT00395850|75953068|FG002|COMPLETED|Disulfiram/Placebo Treatment||5||
59829689|NCT00395850|75953069|FG003|COMPLETED|Disulfiram/Placebo Treatment||8||
59829690|NCT00395850|75953066|FG000|NOT COMPLETED|Disulfiram/Placebo Treatment||9||
59829691|NCT00395850|75953067|FG001|NOT COMPLETED|Disulfiram/Placebo Treatment||14||
59829692|NCT00395850|75953068|FG002|NOT COMPLETED|Disulfiram/Placebo Treatment||19||
59829693|NCT00395850|75953069|FG003|NOT COMPLETED|Disulfiram/Placebo Treatment||13||
59829694|NCT00420212|75953082|FG000|STARTED|Overall Study|408 participants were dosed; 410 participants were randomized|408||
59829695|NCT00420212|75953083|FG001|STARTED|Overall Study|410 participants were dosed; 411 participants were randomized|410||
59829696|NCT00420212|75953084|FG002|STARTED|Overall Study|416 participants were dosed; 416 participants were randomized|416||
59829697|NCT00420212|75953082|FG000|COMPLETED|Overall Study||317||
59829698|NCT00420212|75953083|FG001|COMPLETED|Overall Study||315||
59829699|NCT00420212|75953084|FG002|COMPLETED|Overall Study||320||
59829700|NCT00420212|75953082|FG000|NOT COMPLETED|Overall Study||91||
59829701|NCT00420212|75953083|FG001|NOT COMPLETED|Overall Study||95||
59829702|NCT00420212|75953084|FG002|NOT COMPLETED|Overall Study||96||
59829703|NCT00401258|75953095|FG000|STARTED|Overall Study||15||
59829704|NCT00401258|75953095|FG000|COMPLETED|Overall Study||8||
59829705|NCT00401258|75953095|FG000|NOT COMPLETED|Overall Study||7||
59829706|NCT00380874|75953101|FG000|STARTED|Overall Study||32||
59829707|NCT00380874|75953102|FG001|STARTED|Overall Study||29||
59829708|NCT00380874|75953101|FG000|COMPLETED|Overall Study||19||
59829709|NCT00380874|75953102|FG001|COMPLETED|Overall Study||19||
59829710|NCT00380874|75953101|FG000|NOT COMPLETED|Overall Study||13||
59829711|NCT00380874|75953102|FG001|NOT COMPLETED|Overall Study||10||
59829712|NCT00420056|75953108|FG000|STARTED|Overall Study||17||
59829713|NCT00420056|75953108|FG000|COMPLETED|Overall Study||0||
60118177|NCT00112125|76239260|FG001|COMPLETED|Overall Study||193||
60118178|NCT00112125|76239259|FG000|NOT COMPLETED|Overall Study||24||
60118179|NCT00112125|76239260|FG001|NOT COMPLETED|Overall Study||22||
60118180|NCT00112593|76239266|FG000|STARTED|Overall Study||5||
60118181|NCT00112593|76239266|FG000|COMPLETED|Overall Study||5||
60118182|NCT00112593|76239266|FG000|NOT COMPLETED|Overall Study||0||
60118183|NCT00112671|76239270|FG000|STARTED|Overall Study||17||
60118184|NCT00112671|76239270|FG000|COMPLETED|Overall Study||17||
60118185|NCT00112671|76239270|FG000|NOT COMPLETED|Overall Study||0||
59829714|NCT00420056|75953108|FG000|NOT COMPLETED|Overall Study||17||
59829715|NCT00411554|75953114|FG000|STARTED|Overall Study|Study enrolled slightly more than the target of N=155|163||
59829716|NCT00411554|75953115|FG001|STARTED|Overall Study|Study enrolled slightly more than the target of N=155|156||
59829717|NCT00411554|75953114|FG000|COMPLETED|Overall Study||155||
59829718|NCT00411554|75953115|FG001|COMPLETED|Overall Study||147||
59829719|NCT00411554|75953114|FG000|NOT COMPLETED|Overall Study||8||
59829720|NCT00411554|75953115|FG001|NOT COMPLETED|Overall Study||9||
59829721|NCT00400712|75953123|FG000|STARTED|Overall Study||52||
59829722|NCT00400712|75953124|FG001|STARTED|Overall Study||51||
59829723|NCT00400712|75953123|FG000|COMPLETED|Overall Study||35||
59829724|NCT00400712|75953124|FG001|COMPLETED|Overall Study||35||
59829725|NCT00400712|75953123|FG000|NOT COMPLETED|Overall Study||17||
59829726|NCT00400712|75953124|FG001|NOT COMPLETED|Overall Study||16||
59829727|NCT00380718|75953132|FG000|STARTED|Overall Study||33||
59829728|NCT00380718|75953132|FG000|Received at Least One Dose of Study Drug|Overall Study||33||
59829729|NCT00380718|75953132|FG000|Received Escalated Dose in Cycle 2|Overall Study||25||
59829730|NCT00380718|75953132|FG000|COMPLETED|Overall Study||15||
59829731|NCT00380718|75953132|FG000|NOT COMPLETED|Overall Study||18||
59829732|NCT00380250|75953138|FG000|STARTED|Overall Study||396||
59829733|NCT00380250|75953139|FG001|STARTED|Overall Study||194||
59829734|NCT00380250|75953138|FG000|COMPLETED|Overall Study||297||
59829735|NCT00380250|75953139|FG001|COMPLETED|Overall Study||139||
59829736|NCT00380250|75953138|FG000|NOT COMPLETED|Overall Study||99||
59829737|NCT00380250|75953139|FG001|NOT COMPLETED|Overall Study||55||
59829738|NCT00400400|75953147|FG000|STARTED|Overall Study||200||
59829739|NCT00400400|75953148|FG001|STARTED|Overall Study||200||
59829740|NCT00400400|75953147|FG000|Intent-to-Treat Population|Overall Study|Participants who received study drug.|199||
59829741|NCT00400400|75953148|FG001|Intent-to-Treat Population|Overall Study||197||
59829742|NCT00400400|75953147|FG000|COMPLETED|Overall Study||186||
59829743|NCT00400400|75953148|FG001|COMPLETED|Overall Study||185||
59829744|NCT00400400|75953147|FG000|NOT COMPLETED|Overall Study||14||
59829745|NCT00400400|75953148|FG001|NOT COMPLETED|Overall Study||15||
60118186|NCT05218018|76239274|FG000|STARTED|Overall Study||30||
60118187|NCT05218018|76239274|FG000|COMPLETED|Overall Study|All participants completed the study (only one visit)|30||
60118188|NCT05218018|76239274|FG000|NOT COMPLETED|Overall Study||0||
60118189|NCT04868500|76239280|FG000|STARTED|Overall Study||42||
60118190|NCT04868500|76239281|FG001|STARTED|Overall Study||7||
60118191|NCT04868500|76239280|FG000|Not Started|Overall Study||4|Participants and Clinical Site Staff who terminated early due to clinician's decision and who never opened the Application (App)|
60118192|NCT04868500|76239281|FG001|Not Started|Overall Study||1|Participants and Clinical Site Staff who terminated early due to clinician's decision and who never opened the Application (App)|
59829746|NCT00395694|75953156|FG000|STARTED|Escalation Phase + Maintenance Phase||51||
59829747|NCT00395694|75953157|FG001|STARTED|Escalation Phase + Maintenance Phase||51||
59829748|NCT00395694|75953156|FG000|COMPLETED|Escalation Phase + Maintenance Phase||50||
59829749|NCT00395694|75953157|FG001|COMPLETED|Escalation Phase + Maintenance Phase||49||
59829750|NCT00395694|75953156|FG000|NOT COMPLETED|Escalation Phase + Maintenance Phase||1||
59829751|NCT00395694|75953157|FG001|NOT COMPLETED|Escalation Phase + Maintenance Phase||2||
59829752|NCT00395694|75953156|FG000|STARTED|Continuation Phase|One participant completing the Escalation/Maintenance Phase did not start the Continuation Phase.|49||
59829753|NCT00395694|75953157|FG001|STARTED|Continuation Phase|One participant completing the Escalation/Maintenance Phase did not start the Continuation Phase.|48||
59829754|NCT00395694|75953156|FG000|COMPLETED|Continuation Phase||34||
59829755|NCT00395694|75953157|FG001|COMPLETED|Continuation Phase||35||
59829756|NCT00395694|75953156|FG000|NOT COMPLETED|Continuation Phase||15||
59829757|NCT00395694|75953157|FG001|NOT COMPLETED|Continuation Phase||13||
59829758|NCT00419744|75953169|FG000|STARTED|Overall Study||407||
59829759|NCT00419744|75953170|FG001|STARTED|Overall Study||408||
59829760|NCT00419744|75953171|FG002|STARTED|Overall Study||404||
59829761|NCT00419744|75953169|FG000|COMPLETED|Overall Study||290||
59829762|NCT00419744|75953170|FG001|COMPLETED|Overall Study||290||
59829763|NCT00419744|75953171|FG002|COMPLETED|Overall Study||271||
59829764|NCT00419744|75953169|FG000|NOT COMPLETED|Overall Study||117||
59829765|NCT00419744|75953170|FG001|NOT COMPLETED|Overall Study||118||
59829766|NCT00419744|75953171|FG002|NOT COMPLETED|Overall Study||133||
59829767|NCT00395538|75953182|FG000|STARTED|Overall Study||8|Previously enrolled in original protocol or (for Cohort 3) newly enrolled in current protocol|
59829768|NCT00395538|75953183|FG001|STARTED|Overall Study||15|Previously enrolled in original protocol or (for Cohort 3) newly enrolled in current protocol|
59829769|NCT00395538|75953184|FG002|STARTED|Overall Study||23|Previously enrolled in original protocol or (for Cohort 3) newly enrolled in current protocol|
59829770|NCT00395538|75953182|FG000|Signed Consent to the New Protocol|Overall Study||7||
59829771|NCT00395538|75953183|FG001|Signed Consent to the New Protocol|Overall Study||5||
59829772|NCT00395538|75953184|FG002|Signed Consent to the New Protocol|Overall Study||23||
59829773|NCT00395538|75953182|FG000|Received HPTH on New Protocol|Overall Study||7|This category identifies the subset of subjects in the Safety Population.|
59829774|NCT00395538|75953183|FG001|Received HPTH on New Protocol|Overall Study||5|This category identifies the subset of subjects in the Safety Population.|
59829775|NCT00395538|75953184|FG002|Received HPTH on New Protocol|Overall Study||19|This category identifies the subset of subjects in the Safety Population.|
59829776|NCT00395538|75953182|FG000|Randomized to Bone Biopsy Year 1|Overall Study||0||
59829777|NCT00395538|75953183|FG001|Randomized to Bone Biopsy Year 1|Overall Study||1||
59829778|NCT00395538|75953184|FG002|Randomized to Bone Biopsy Year 1|Overall Study||5||
59829779|NCT00395538|75953182|FG000|Randomized to Bone Biopsy Year 2|Overall Study||0||
59829780|NCT00395538|75953183|FG001|Randomized to Bone Biopsy Year 2|Overall Study||2||
59829781|NCT00395538|75953184|FG002|Randomized to Bone Biopsy Year 2|Overall Study||6||
59829782|NCT00395538|75953182|FG000|Randomized to Bone Biospy Year 4|Overall Study||0||
59829783|NCT00395538|75953183|FG001|Randomized to Bone Biospy Year 4|Overall Study||2||
59829784|NCT00395538|75953184|FG002|Randomized to Bone Biospy Year 4|Overall Study||8||
59829785|NCT00395538|75953182|FG000|Completed Bone Biopsy Year 1|Overall Study||0||
59829786|NCT00395538|75953183|FG001|Completed Bone Biopsy Year 1|Overall Study||1||
59829787|NCT00395538|75953184|FG002|Completed Bone Biopsy Year 1|Overall Study||4||
59829788|NCT00395538|75953182|FG000|Completed Bone Biopsy Year 2|Overall Study||0||
59829789|NCT00395538|75953183|FG001|Completed Bone Biopsy Year 2|Overall Study||2||
59829790|NCT00395538|75953184|FG002|Completed Bone Biopsy Year 2|Overall Study||3||
59829791|NCT00395538|75953182|FG000|Completed Bone Biopsy Year 4|Overall Study||0||
59829792|NCT00395538|75953183|FG001|Completed Bone Biopsy Year 4|Overall Study||1||
59829793|NCT00395538|75953184|FG002|Completed Bone Biopsy Year 4|Overall Study||1||
59829794|NCT00395538|75953182|FG000|COMPLETED|Overall Study||5|Completed 5 years of HPTH therapy and 6 month safety follow-up visit.|
59829795|NCT00395538|75953183|FG001|COMPLETED|Overall Study||2|Completed 5 years of HPTH therapy and 6 month safety follow-up visit.|
59829796|NCT00395538|75953184|FG002|COMPLETED|Overall Study||0|Completed 5 years of HPTH therapy and 6 month safety follow-up visit.|
59829797|NCT00395538|75953182|FG000|NOT COMPLETED|Overall Study||3||
59829798|NCT00395538|75953183|FG001|NOT COMPLETED|Overall Study||13||
59829799|NCT00395538|75953184|FG002|NOT COMPLETED|Overall Study||23||
59829800|NCT00395460|75953194|FG000|STARTED|Overall Study||72||
59829801|NCT00395460|75953195|FG001|STARTED|Overall Study||75||
59829802|NCT00395460|75953194|FG000|Received Treatment|Overall Study|1 participant withdrew consent prior to study drug injection and did not receive any study drug.|71||
59829803|NCT00395460|75953195|FG001|Received Treatment|Overall Study||75||
59829804|NCT00395460|75953194|FG000|COMPLETED|Overall Study||71||
59829805|NCT00395460|75953195|FG001|COMPLETED|Overall Study||75||
59829806|NCT00395460|75953194|FG000|NOT COMPLETED|Overall Study||1||
59829807|NCT00395460|75953195|FG001|NOT COMPLETED|Overall Study||0||
59829808|NCT00395304|75953201|FG000|STARTED|Treatment Period 1||31||
59829809|NCT00395304|75953202|FG001|STARTED|Treatment Period 1||30||
59829810|NCT00395304|75953203|FG002|STARTED|Treatment Period 1||30||
59829811|NCT00395304|75953204|FG003|STARTED|Treatment Period 1||31||
59829812|NCT00395304|75953205|FG004|STARTED|Treatment Period 1||28||
59829813|NCT00395304|75953206|FG005|STARTED|Treatment Period 1||32||
59829814|NCT00395304|75953201|FG000|COMPLETED|Treatment Period 1||30||
59829815|NCT00395304|75953202|FG001|COMPLETED|Treatment Period 1||26||
59829816|NCT00395304|75953203|FG002|COMPLETED|Treatment Period 1||30||
59829817|NCT00395304|75953204|FG003|COMPLETED|Treatment Period 1||28||
59829818|NCT00395304|75953205|FG004|COMPLETED|Treatment Period 1||27||
59829819|NCT00395304|75953206|FG005|COMPLETED|Treatment Period 1||30||
60118193|NCT04868500|76239280|FG000|COMPLETED|Overall Study||38||
59716417|NCT00925600|75835264|FG001|NOT COMPLETED|Overall Study||28||
59716418|NCT00968253|75835277|FG000|STARTED|Overall Study||3||
59716419|NCT00968253|75835278|FG001|STARTED|Overall Study||9||
59716420|NCT00968253|75835279|FG002|STARTED|Overall Study||12||
59716421|NCT00968253|75835277|FG000|COMPLETED|Overall Study||3||
59716422|NCT00968253|75835278|FG001|COMPLETED|Overall Study||6||
59716423|NCT00968253|75835279|FG002|COMPLETED|Overall Study||5||
59716424|NCT00968253|75835277|FG000|NOT COMPLETED|Overall Study||0||
59716425|NCT00968253|75835278|FG001|NOT COMPLETED|Overall Study||3||
59716426|NCT00968253|75835279|FG002|NOT COMPLETED|Overall Study||7||
59716427|NCT00964743|75835288|FG000|STARTED|Overall Study||2||
59716428|NCT00964743|75835288|FG000|COMPLETED|Overall Study||0||
60118194|NCT04868500|76239281|FG001|COMPLETED|Overall Study||6||
60118195|NCT04868500|76239280|FG000|NOT COMPLETED|Overall Study||4||
60118196|NCT04868500|76239281|FG001|NOT COMPLETED|Overall Study||1||
60118197|NCT04372186|76239289|FG000|STARTED|Overall Study||249||
60118198|NCT04372186|76239290|FG001|STARTED|Overall Study||128||
60118199|NCT04372186|76239289|FG000|COMPLETED|Overall Study||225||
60118200|NCT04372186|76239290|FG001|COMPLETED|Overall Study||115||
60118201|NCT04372186|76239289|FG000|NOT COMPLETED|Overall Study||24||
60118202|NCT04372186|76239290|FG001|NOT COMPLETED|Overall Study||13||
60118203|NCT00112827|76239301|FG000|STARTED|Overall Study||3||
60118204|NCT00112827|76239302|FG001|STARTED|Overall Study||4||
60118205|NCT00112827|76239303|FG002|STARTED|Overall Study||4||
60118206|NCT00112827|76239304|FG003|STARTED|Overall Study||36||
60118207|NCT00112827|76239305|FG004|STARTED|Overall Study||7||
60118208|NCT00112827|76239301|FG000|COMPLETED|Overall Study||3||
60118209|NCT00112827|76239302|FG001|COMPLETED|Overall Study||4||
60118210|NCT00112827|76239303|FG002|COMPLETED|Overall Study||4||
60118211|NCT00112827|76239304|FG003|COMPLETED|Overall Study||36||
60118212|NCT00112827|76239305|FG004|COMPLETED|Overall Study||7||
60118213|NCT00112827|76239301|FG000|NOT COMPLETED|Overall Study||0||
60118214|NCT00112827|76239302|FG001|NOT COMPLETED|Overall Study||0||
59829820|NCT00395304|75953201|FG000|NOT COMPLETED|Treatment Period 1||1||
59829821|NCT00395304|75953202|FG001|NOT COMPLETED|Treatment Period 1||4||
59829822|NCT00395304|75953203|FG002|NOT COMPLETED|Treatment Period 1||0||
59829823|NCT00395304|75953204|FG003|NOT COMPLETED|Treatment Period 1||3||
59829824|NCT00395304|75953205|FG004|NOT COMPLETED|Treatment Period 1||1||
59829825|NCT00395304|75953206|FG005|NOT COMPLETED|Treatment Period 1||2||
59829826|NCT00395304|75953201|FG000|STARTED|Treatment Period 2||30||
59829827|NCT00395304|75953202|FG001|STARTED|Treatment Period 2||26||
59829828|NCT00395304|75953203|FG002|STARTED|Treatment Period 2||30||
59829829|NCT00395304|75953204|FG003|STARTED|Treatment Period 2||28||
59829830|NCT00395304|75953205|FG004|STARTED|Treatment Period 2||27||
59829831|NCT00395304|75953206|FG005|STARTED|Treatment Period 2||30||
59829832|NCT00395304|75953201|FG000|COMPLETED|Treatment Period 2||30||
59829833|NCT00395304|75953202|FG001|COMPLETED|Treatment Period 2||22||
59829834|NCT00395304|75953203|FG002|COMPLETED|Treatment Period 2||29||
59829835|NCT00395304|75953204|FG003|COMPLETED|Treatment Period 2||27||
59829836|NCT00395304|75953205|FG004|COMPLETED|Treatment Period 2||27||
59829837|NCT00395304|75953206|FG005|COMPLETED|Treatment Period 2||28||
59829838|NCT00395304|75953201|FG000|NOT COMPLETED|Treatment Period 2||0||
59829839|NCT00395304|75953202|FG001|NOT COMPLETED|Treatment Period 2||4||
59829840|NCT00395304|75953203|FG002|NOT COMPLETED|Treatment Period 2||1||
59829841|NCT00395304|75953204|FG003|NOT COMPLETED|Treatment Period 2||1||
59829842|NCT00395304|75953205|FG004|NOT COMPLETED|Treatment Period 2||0||
59829843|NCT00395304|75953206|FG005|NOT COMPLETED|Treatment Period 2||2||
59829844|NCT00395304|75953201|FG000|STARTED|Treatment Period 3||30||
59829845|NCT00395304|75953202|FG001|STARTED|Treatment Period 3||22||
59829846|NCT00395304|75953203|FG002|STARTED|Treatment Period 3||29||
59829847|NCT00395304|75953204|FG003|STARTED|Treatment Period 3||27||
59829848|NCT00395304|75953205|FG004|STARTED|Treatment Period 3||27||
59829849|NCT00395304|75953206|FG005|STARTED|Treatment Period 3||28||
59829850|NCT00395304|75953201|FG000|COMPLETED|Treatment Period 3||29||
59829851|NCT00395304|75953202|FG001|COMPLETED|Treatment Period 3||20||
59829852|NCT00395304|75953203|FG002|COMPLETED|Treatment Period 3||29||
59829853|NCT00395304|75953204|FG003|COMPLETED|Treatment Period 3||25||
59829854|NCT00395304|75953205|FG004|COMPLETED|Treatment Period 3||27||
59829855|NCT00395304|75953206|FG005|COMPLETED|Treatment Period 3||27||
59829856|NCT00395304|75953201|FG000|NOT COMPLETED|Treatment Period 3||1||
59829857|NCT00395304|75953202|FG001|NOT COMPLETED|Treatment Period 3||2||
59829858|NCT00395304|75953203|FG002|NOT COMPLETED|Treatment Period 3||0||
59829859|NCT00395304|75953204|FG003|NOT COMPLETED|Treatment Period 3||2||
59829860|NCT00395304|75953205|FG004|NOT COMPLETED|Treatment Period 3||0||
59829861|NCT00395304|75953206|FG005|NOT COMPLETED|Treatment Period 3||1||
59829862|NCT00395226|75953215|FG000|STARTED|Overall Study||26||
59829863|NCT00395226|75953216|FG001|STARTED|Overall Study||27||
59829864|NCT00395226|75953215|FG000|COMPLETED|Overall Study||22||
59829865|NCT00395226|75953216|FG001|COMPLETED|Overall Study||22||
59829866|NCT00395226|75953215|FG000|NOT COMPLETED|Overall Study||4||
59829867|NCT00395226|75953216|FG001|NOT COMPLETED|Overall Study||5||
59829868|NCT00394914|75953224|FG000|STARTED|Screening Period||311||
59829869|NCT00394914|75953225|FG001|STARTED|Screening Period||0||
59829870|NCT00394914|75953226|FG002|STARTED|Screening Period||0||
59829871|NCT00394914|75953224|FG000|COMPLETED|Screening Period||311||
59829872|NCT00394914|75953225|FG001|COMPLETED|Screening Period||0||
59829873|NCT00394914|75953226|FG002|COMPLETED|Screening Period||0||
59829874|NCT00394914|75953224|FG000|NOT COMPLETED|Screening Period||0||
59829875|NCT00394914|75953225|FG001|NOT COMPLETED|Screening Period||0||
59829876|NCT00394914|75953226|FG002|NOT COMPLETED|Screening Period||0||
59829877|NCT00394914|75953224|FG000|STARTED|Pre-exposure Period||311||
59829878|NCT00394914|75953225|FG001|STARTED|Pre-exposure Period||0||
59829879|NCT00394914|75953226|FG002|STARTED|Pre-exposure Period||0||
59829880|NCT00394914|75953224|FG000|COMPLETED|Pre-exposure Period||311||
59829881|NCT00394914|75953225|FG001|COMPLETED|Pre-exposure Period||0||
59829882|NCT00394914|75953226|FG002|COMPLETED|Pre-exposure Period||0||
59829883|NCT00394914|75953224|FG000|NOT COMPLETED|Pre-exposure Period||0||
59829884|NCT00394914|75953225|FG001|NOT COMPLETED|Pre-exposure Period||0||
59829885|NCT00394914|75953226|FG002|NOT COMPLETED|Pre-exposure Period||0||
59829886|NCT00394914|75953224|FG000|STARTED|Treatment Period||0||
60118215|NCT00112827|76239303|FG002|NOT COMPLETED|Overall Study||0||
60118216|NCT00112827|76239304|FG003|NOT COMPLETED|Overall Study||0||
60118217|NCT00112827|76239305|FG004|NOT COMPLETED|Overall Study||0||
59829887|NCT00394914|75953225|FG001|STARTED|Treatment Period||154||
59829888|NCT00394914|75953226|FG002|STARTED|Treatment Period||157||
59829889|NCT00394914|75953224|FG000|COMPLETED|Treatment Period||0||
59829890|NCT00394914|75953225|FG001|COMPLETED|Treatment Period||144||
59829891|NCT00394914|75953226|FG002|COMPLETED|Treatment Period||151||
59829892|NCT00394914|75953224|FG000|NOT COMPLETED|Treatment Period||0||
60118218|NCT04317040|76239320|FG000|STARTED|Overall Study||116||
60118219|NCT04317040|76239321|FG001|STARTED|Overall Study||118||
59829893|NCT00394914|75953225|FG001|NOT COMPLETED|Treatment Period||10||
59829894|NCT00394914|75953226|FG002|NOT COMPLETED|Treatment Period||6||
59829895|NCT00366444|75953234|FG000|STARTED|Overall Study||102||
59829896|NCT00366444|75953235|FG001|STARTED|Overall Study||99||
59829897|NCT00366444|75953234|FG000|COMPLETED|Overall Study||101||
59829898|NCT00366444|75953235|FG001|COMPLETED|Overall Study||97||
59829899|NCT00366444|75953234|FG000|NOT COMPLETED|Overall Study||1||
59829900|NCT00366444|75953235|FG001|NOT COMPLETED|Overall Study||2||
59829901|NCT00365976|75953243|FG000|STARTED|Overall Study||33||
59829902|NCT00365976|75953244|FG001|STARTED|Overall Study||25||
59829903|NCT00365976|75953243|FG000|COMPLETED|Overall Study||32||
59829904|NCT00365976|75953244|FG001|COMPLETED|Overall Study||20||
59829905|NCT00365976|75953243|FG000|NOT COMPLETED|Overall Study||1||
59829906|NCT00365976|75953244|FG001|NOT COMPLETED|Overall Study||5||
59829907|NCT00379236|75953252|FG000|STARTED|Double-blind||293||
59829908|NCT00379236|75953253|FG001|STARTED|Double-blind||295||
59829909|NCT00379236|75953254|FG002|STARTED|Double-blind||0||
59829910|NCT00379236|75953252|FG000|COMPLETED|Double-blind|Data could not be retrieved for two participants|257||
59829911|NCT00379236|75953253|FG001|COMPLETED|Double-blind|Data could not be retrieved for two participants|259||
59829912|NCT00379236|75953254|FG002|COMPLETED|Double-blind||0||
59829913|NCT00379236|75953252|FG000|NOT COMPLETED|Double-blind||36||
59829914|NCT00379236|75953253|FG001|NOT COMPLETED|Double-blind||36||
59829915|NCT00379236|75953254|FG002|NOT COMPLETED|Double-blind||0||
59829916|NCT00379236|75953252|FG000|STARTED|Open-label Extension||0||
59829917|NCT00379236|75953253|FG001|STARTED|Open-label Extension||0||
59829918|NCT00379236|75953254|FG002|STARTED|Open-label Extension||433||
59829919|NCT00379236|75953252|FG000|COMPLETED|Open-label Extension||0||
59829920|NCT00379236|75953253|FG001|COMPLETED|Open-label Extension||0||
59829921|NCT00379236|75953254|FG002|COMPLETED|Open-label Extension||378||
59829922|NCT00379236|75953252|FG000|NOT COMPLETED|Open-label Extension||0||
59829923|NCT00379236|75953253|FG001|NOT COMPLETED|Open-label Extension||0||
59829924|NCT00379236|75953254|FG002|NOT COMPLETED|Open-label Extension||55||
59829925|NCT00379080|75953269|FG000|STARTED|Overall Study||6||
59829926|NCT00379080|75953270|FG001|STARTED|Overall Study||19||
59829927|NCT00379080|75953271|FG002|STARTED|Overall Study||31||
59829928|NCT00379080|75953269|FG000|COMPLETED|Overall Study||6||
59829929|NCT00379080|75953270|FG001|COMPLETED|Overall Study||15||
59829930|NCT00379080|75953271|FG002|COMPLETED|Overall Study||31||
59829931|NCT00379080|75953269|FG000|NOT COMPLETED|Overall Study||0||
59829932|NCT00379080|75953270|FG001|NOT COMPLETED|Overall Study||4||
59829933|NCT00379080|75953271|FG002|NOT COMPLETED|Overall Study||0||
59829934|NCT00378534|75953296|FG000|STARTED|Overall Study||58||
59829935|NCT00378534|75953297|FG001|STARTED|Overall Study||58||
59829936|NCT00378534|75953296|FG000|COMPLETED|Overall Study||55||
59829937|NCT00378534|75953297|FG001|COMPLETED|Overall Study||58||
59829938|NCT00378534|75953296|FG000|NOT COMPLETED|Overall Study||3||
59829939|NCT00378534|75953297|FG001|NOT COMPLETED|Overall Study||0||
59829940|NCT00377676|75953304|FG000|STARTED|Overall Study|25 subjects did not receive study drug - thus 3070 were randomized and received drug|2054||
59829941|NCT00377676|75953305|FG001|STARTED|Overall Study||1016||
59829942|NCT00377676|75953304|FG000|COMPLETED|Overall Study||1093||
59829943|NCT00377676|75953305|FG001|COMPLETED|Overall Study||694||
59829944|NCT00377676|75953304|FG000|NOT COMPLETED|Overall Study||961||
59829945|NCT00377676|75953305|FG001|NOT COMPLETED|Overall Study||322||
59829946|NCT00377520|75953311|FG000|STARTED|Overall Study||27||
59829947|NCT00377520|75953311|FG000|COMPLETED|Overall Study|Completed means the patient was evaluable for response.|26||
59829948|NCT00377520|75953311|FG000|NOT COMPLETED|Overall Study||1||
59829949|NCT00377364|75953317|FG000|STARTED|Overall Study||16||
59829950|NCT00377364|75953318|FG001|STARTED|Overall Study||14||
59829951|NCT00377364|75953317|FG000|COMPLETED|Overall Study||14||
59829952|NCT00377364|75953318|FG001|COMPLETED|Overall Study||14||
59829953|NCT00377364|75953317|FG000|NOT COMPLETED|Overall Study||2||
59829954|NCT00377364|75953318|FG001|NOT COMPLETED|Overall Study||0||
59829955|NCT03831282|75953326|FG000|STARTED|Overall Study||12||
59829956|NCT03831282|75953326|FG000|COMPLETED|Overall Study||11||
59829957|NCT03831282|75953326|FG000|NOT COMPLETED|Overall Study||1||
59829958|NCT00365508|75953332|FG000|STARTED|Overall Study||321||
59829959|NCT00365508|75953333|FG001|STARTED|Overall Study||321||
59829960|NCT00365508|75953332|FG000|COMPLETED|Overall Study||182||
59829961|NCT00365508|75953333|FG001|COMPLETED|Overall Study||167||
59829962|NCT00365508|75953332|FG000|NOT COMPLETED|Overall Study||139||
59829963|NCT00365508|75953333|FG001|NOT COMPLETED|Overall Study||154||
59829964|NCT00365352|75953342|FG000|STARTED|Overall Study||97||
59829965|NCT00365352|75953343|FG001|STARTED|Overall Study||115||
59829966|NCT00365352|75953344|FG002|STARTED|Overall Study||113||
59829967|NCT00365352|75953342|FG000|Safety Population|Overall Study||96||
59829968|NCT00365352|75953343|FG001|Safety Population|Overall Study||115||
59829969|NCT00365352|75953344|FG002|Safety Population|Overall Study||111||
59829970|NCT00365352|75953342|FG000|Modified Intent-to-Treat Population|Overall Study||96||
59829971|NCT00365352|75953343|FG001|Modified Intent-to-Treat Population|Overall Study||114||
59829972|NCT00365352|75953344|FG002|Modified Intent-to-Treat Population|Overall Study||111||
59829973|NCT00365352|75953342|FG000|COMPLETED|Overall Study||77||
59829974|NCT00365352|75953343|FG001|COMPLETED|Overall Study||104||
59829975|NCT00365352|75953344|FG002|COMPLETED|Overall Study||98||
59829976|NCT00365352|75953342|FG000|NOT COMPLETED|Overall Study||20||
59829977|NCT00365352|75953343|FG001|NOT COMPLETED|Overall Study||11||
59829978|NCT00365352|75953344|FG002|NOT COMPLETED|Overall Study||15||
59829979|NCT00376506|75953357|FG000|STARTED|Overall Study||4||
59829980|NCT00376506|75953358|FG001|STARTED|Overall Study||6||
59829981|NCT00376506|75953357|FG000|COMPLETED|Overall Study||4||
59829982|NCT00376506|75953358|FG001|COMPLETED|Overall Study||4||
59829983|NCT00376506|75953357|FG000|NOT COMPLETED|Overall Study||0||
59829984|NCT00376506|75953358|FG001|NOT COMPLETED|Overall Study||2||
59829985|NCT00410384|75953370|FG000|STARTED|Overall Study||275||
59829986|NCT00410384|75953371|FG001|STARTED|Overall Study||271||
59829987|NCT00410384|75953372|FG002|STARTED|Overall Study||273||
59829988|NCT00410384|75953370|FG000|COMPLETED|Overall Study||186||
59829989|NCT00410384|75953371|FG001|COMPLETED|Overall Study||199||
59829990|NCT00410384|75953372|FG002|COMPLETED|Overall Study||191||
59829991|NCT00410384|75953370|FG000|NOT COMPLETED|Overall Study||89||
59829992|NCT00410384|75953371|FG001|NOT COMPLETED|Overall Study||72||
59829993|NCT00410384|75953372|FG002|NOT COMPLETED|Overall Study||82||
59829994|NCT00370032|75953382|FG000|STARTED|Treatment Period 1|Safety Population - all subjects who took at least one dose of study medication.|24||
59829995|NCT00370032|75953383|FG001|STARTED|Treatment Period 1|Safety Population - all subjects who took at least one dose of study medication.|25||
59829996|NCT00370032|75953382|FG000|COMPLETED|Treatment Period 1||24||
59829997|NCT00370032|75953383|FG001|COMPLETED|Treatment Period 1||24||
59829998|NCT00370032|75953382|FG000|NOT COMPLETED|Treatment Period 1||0||
59829999|NCT00370032|75953383|FG001|NOT COMPLETED|Treatment Period 1||1||
59830000|NCT00370032|75953382|FG000|STARTED|Washout Period||24||
59830001|NCT00370032|75953383|FG001|STARTED|Washout Period||24||
59830002|NCT00370032|75953382|FG000|COMPLETED|Washout Period||23||
59830003|NCT00370032|75953383|FG001|COMPLETED|Washout Period||22||
59830004|NCT00370032|75953382|FG000|NOT COMPLETED|Washout Period||1||
59567483|NCT02326272|75670461|FG008|STARTED|Initial Period (Week 0 to Week 16)||0||
59716429|NCT00964743|75835288|FG000|NOT COMPLETED|Overall Study||2||
59716430|NCT00925522|75835292|FG000|STARTED|Overall Study||20||
59716431|NCT00925522|75835292|FG000|COMPLETED|Overall Study||0||
59716432|NCT00925522|75835292|FG000|NOT COMPLETED|Overall Study||20||
59716433|NCT01130532|75835299|FG000|STARTED|Period III (Weeks 0-12)||207||
59716434|NCT01130532|75835300|FG001|STARTED|Period III (Weeks 0-12)||207||
59716435|NCT01130532|75835301|FG002|STARTED|Period III (Weeks 0-12)||209||
59716436|NCT01130532|75835302|FG003|STARTED|Period III (Weeks 0-12)||0||
59716437|NCT01130532|75835299|FG000|Received at Least 1 Dose of Study Drug|Period III (Weeks 0-12)||205||
59716438|NCT01130532|75835300|FG001|Received at Least 1 Dose of Study Drug|Period III (Weeks 0-12)||205||
59716439|NCT01130532|75835301|FG002|Received at Least 1 Dose of Study Drug|Period III (Weeks 0-12)||207||
59716440|NCT01130532|75835302|FG003|Received at Least 1 Dose of Study Drug|Period III (Weeks 0-12)||0||
59716441|NCT01130532|75835299|FG000|COMPLETED|Period III (Weeks 0-12)||186||
59716442|NCT01130532|75835300|FG001|COMPLETED|Period III (Weeks 0-12)||189||
59716443|NCT01130532|75835301|FG002|COMPLETED|Period III (Weeks 0-12)||190||
59830005|NCT00370032|75953383|FG001|NOT COMPLETED|Washout Period||2||
59830006|NCT00370032|75953382|FG000|STARTED|Treatment Period 2||23||
59830007|NCT00370032|75953383|FG001|STARTED|Treatment Period 2||22||
59830008|NCT00370032|75953382|FG000|COMPLETED|Treatment Period 2||23||
59830009|NCT00370032|75953383|FG001|COMPLETED|Treatment Period 2||22||
59830010|NCT00370032|75953382|FG000|NOT COMPLETED|Treatment Period 2||0||
60118220|NCT04317040|76239320|FG000|Treated|Overall Study||114||
60118221|NCT04317040|76239321|FG001|Treated|Overall Study||115||
60118222|NCT04317040|76239320|FG000|COMPLETED|Overall Study||98||
60118223|NCT04317040|76239321|FG001|COMPLETED|Overall Study||98||
60118224|NCT04317040|76239320|FG000|NOT COMPLETED|Overall Study||18||
60118225|NCT04317040|76239321|FG001|NOT COMPLETED|Overall Study||20||
60118226|NCT00226239|76239327|FG000|STARTED|TPE, Induction Therapy||39||
60118227|NCT00226239|76239327|FG000|COMPLETED|TPE, Induction Therapy||37||
60118228|NCT00226239|76239327|FG000|NOT COMPLETED|TPE, Induction Therapy||2||
60118229|NCT00226239|76239327|FG000|STARTED|XPE, Definitive Therapy||37||
60118230|NCT00226239|76239327|FG000|COMPLETED|XPE, Definitive Therapy||33||
60118231|NCT00226239|76239327|FG000|NOT COMPLETED|XPE, Definitive Therapy||4||
59716444|NCT01130532|75835302|FG003|COMPLETED|Period III (Weeks 0-12)||0||
59716445|NCT01130532|75835299|FG000|NOT COMPLETED|Period III (Weeks 0-12)||21||
59716446|NCT01130532|75835300|FG001|NOT COMPLETED|Period III (Weeks 0-12)||18||
59716447|NCT01130532|75835301|FG002|NOT COMPLETED|Period III (Weeks 0-12)||19||
59716448|NCT01130532|75835302|FG003|NOT COMPLETED|Period III (Weeks 0-12)||0||
59830011|NCT00370032|75953383|FG001|NOT COMPLETED|Treatment Period 2||0||
59830012|NCT00370032|75953382|FG000|STARTED|Follow-up Period||23||
59830013|NCT00370032|75953383|FG001|STARTED|Follow-up Period||22||
59830014|NCT00370032|75953382|FG000|COMPLETED|Follow-up Period||22||
59830015|NCT00370032|75953383|FG001|COMPLETED|Follow-up Period||22||
59830016|NCT00370032|75953382|FG000|NOT COMPLETED|Follow-up Period||1||
59830017|NCT00370032|75953383|FG001|NOT COMPLETED|Follow-up Period||0||
60118232|NCT00226239|76239327|FG000|STARTED|Maintenance Cetuximab||31||
60118233|NCT00226239|76239327|FG000|COMPLETED|Maintenance Cetuximab||17||
60118234|NCT00226239|76239327|FG000|NOT COMPLETED|Maintenance Cetuximab||14||
59830018|NCT00410072|75953400|FG000|STARTED|Day 1 to Week 48|Number of participants randomized and treated; 4 more were randomized but not treated.|182||
59830019|NCT00410072|75953401|FG001|STARTED|Day 1 to Week 48|Number of participants randomized and treated; 1 more was randomized but not treated.|197||
59830020|NCT00410072|75953400|FG000|COMPLETED|Day 1 to Week 48||176||
59830021|NCT00410072|75953401|FG001|COMPLETED|Day 1 to Week 48||185||
59830022|NCT00410072|75953400|FG000|NOT COMPLETED|Day 1 to Week 48||6||
59830023|NCT00410072|75953401|FG001|NOT COMPLETED|Day 1 to Week 48||12||
59830024|NCT00410072|75953400|FG000|STARTED|After Week 48 to Week 96||176||
59830025|NCT00410072|75953401|FG001|STARTED|After Week 48 to Week 96||185||
59830026|NCT00410072|75953400|FG000|COMPLETED|After Week 48 to Week 96||170||
59830027|NCT00410072|75953401|FG001|COMPLETED|After Week 48 to Week 96||174||
59716449|NCT01130532|75835299|FG000|STARTED|Period IV (Weeks 13-16)||0||
59716450|NCT01130532|75835300|FG001|STARTED|Period IV (Weeks 13-16)||0||
59716451|NCT01130532|75835301|FG002|STARTED|Period IV (Weeks 13-16)||0||
59716452|NCT01130532|75835302|FG003|STARTED|Period IV (Weeks 13-16)|Three participants who completed Period III chose not to continue into Period IV.|562||
59716453|NCT01130532|75835299|FG000|Received at Least 1 Dose of Study Drug|Period IV (Weeks 13-16)||0||
59716454|NCT01130532|75835300|FG001|Received at Least 1 Dose of Study Drug|Period IV (Weeks 13-16)||0||
59716455|NCT01130532|75835301|FG002|Received at Least 1 Dose of Study Drug|Period IV (Weeks 13-16)||0||
59716456|NCT01130532|75835302|FG003|Received at Least 1 Dose of Study Drug|Period IV (Weeks 13-16)||546||
59716457|NCT01130532|75835299|FG000|COMPLETED|Period IV (Weeks 13-16)||0||
59716458|NCT01130532|75835300|FG001|COMPLETED|Period IV (Weeks 13-16)||0||
59716459|NCT01130532|75835301|FG002|COMPLETED|Period IV (Weeks 13-16)||0||
59716460|NCT01130532|75835302|FG003|COMPLETED|Period IV (Weeks 13-16)||552||
59716461|NCT01130532|75835299|FG000|NOT COMPLETED|Period IV (Weeks 13-16)||0||
59716462|NCT01130532|75835300|FG001|NOT COMPLETED|Period IV (Weeks 13-16)||0||
59716463|NCT01130532|75835301|FG002|NOT COMPLETED|Period IV (Weeks 13-16)||0||
59716464|NCT01130532|75835302|FG003|NOT COMPLETED|Period IV (Weeks 13-16)||10||
59716465|NCT00972777|75835316|FG000|STARTED|Overall Study||231||
59716466|NCT00972777|75835317|FG001|STARTED|Overall Study||243||
59716467|NCT00972777|75835316|FG000|COMPLETED|Overall Study||217||
59716468|NCT00972777|75835317|FG001|COMPLETED|Overall Study||229||
59716469|NCT00972777|75835316|FG000|NOT COMPLETED|Overall Study||14||
59716470|NCT00972777|75835317|FG001|NOT COMPLETED|Overall Study||14||
59716471|NCT00918736|75835323|FG000|STARTED|Overall Study|October, 2007|50||
59716472|NCT00918736|75835323|FG000|COMPLETED|Overall Study|October, 2008|46||
59716473|NCT00918736|75835323|FG000|NOT COMPLETED|Overall Study||4||
59716474|NCT01172639|75835332|FG000|STARTED|Overall Study||98||
59716475|NCT01172639|75835333|FG001|STARTED|Overall Study||98||
59716476|NCT01172639|75835334|FG002|STARTED|Overall Study||93||
59716477|NCT01172639|75835335|FG003|STARTED|Overall Study||43||
59716478|NCT01172639|75835336|FG004|STARTED|Overall Study||47||
59716479|NCT01172639|75835332|FG000|Week 16|Overall Study||94||
59716480|NCT01172639|75835333|FG001|Week 16|Overall Study||96||
59716481|NCT01172639|75835334|FG002|Week 16|Overall Study||91||
59716482|NCT01172639|75835335|FG003|Week 16|Overall Study||39||
59716483|NCT01172639|75835336|FG004|Week 16|Overall Study||47||
59716484|NCT01172639|75835332|FG000|Week 52|Overall Study||89||
59716485|NCT01172639|75835333|FG001|Week 52|Overall Study||89||
59716486|NCT01172639|75835334|FG002|Week 52|Overall Study||88||
59716487|NCT01172639|75835335|FG003|Week 52|Overall Study||38||
59716488|NCT01172639|75835336|FG004|Week 52|Overall Study||45||
59716489|NCT01172639|75835332|FG000|COMPLETED|Overall Study||85||
59716490|NCT01172639|75835333|FG001|COMPLETED|Overall Study||87||
59716491|NCT01172639|75835334|FG002|COMPLETED|Overall Study||77||
59830028|NCT00410072|75953400|FG000|NOT COMPLETED|After Week 48 to Week 96||6||
59830029|NCT00410072|75953401|FG001|NOT COMPLETED|After Week 48 to Week 96||11||
59830030|NCT00409838|75953409|FG000|STARTED|Short-term Period|Randomized|56||
59830031|NCT00409838|75953410|FG001|STARTED|Short-term Period|Randomized|57||
59830032|NCT00409838|75953409|FG000|Treated (Baseline) Population|Short-term Period||55||
60118235|NCT00227019|76239332|FG000|STARTED|Overall Study||16||
60118236|NCT00227019|76239332|FG000|COMPLETED|Overall Study||16||
59716492|NCT01172639|75835335|FG003|COMPLETED|Overall Study||32||
59716493|NCT01172639|75835336|FG004|COMPLETED|Overall Study||41||
59716494|NCT01172639|75835332|FG000|NOT COMPLETED|Overall Study||13||
59716495|NCT01172639|75835333|FG001|NOT COMPLETED|Overall Study||11||
59716496|NCT01172639|75835334|FG002|NOT COMPLETED|Overall Study||16||
59830033|NCT00409838|75953410|FG001|Treated (Baseline) Population|Short-term Period||57||
59830034|NCT00409838|75953409|FG000|COMPLETED|Short-term Period||53||
59830035|NCT00409838|75953410|FG001|COMPLETED|Short-term Period|Participants who received placebo in this period received abatacept in next period.|52||
59830036|NCT00409838|75953409|FG000|NOT COMPLETED|Short-term Period||3||
59830037|NCT00409838|75953410|FG001|NOT COMPLETED|Short-term Period||5||
59830038|NCT00409838|75953409|FG000|STARTED|Long-term Extension Period||105||
59830039|NCT00409838|75953410|FG001|STARTED|Long-term Extension Period||0||
59830040|NCT00409838|75953409|FG000|COMPLETED|Long-term Extension Period||87||
59830041|NCT00409838|75953410|FG001|COMPLETED|Long-term Extension Period||0||
59830042|NCT00409838|75953409|FG000|NOT COMPLETED|Long-term Extension Period||18||
59830043|NCT00409838|75953410|FG001|NOT COMPLETED|Long-term Extension Period||0||
59830044|NCT00399542|75953435|FG000|STARTED|Overall Study||387||
59830045|NCT00399542|75953436|FG001|STARTED|Overall Study||194||
59830046|NCT00399542|75953435|FG000|COMPLETED|Overall Study||303||
59830047|NCT00399542|75953436|FG001|COMPLETED|Overall Study||151||
59830048|NCT00399542|75953435|FG000|NOT COMPLETED|Overall Study||84||
59830049|NCT00399542|75953436|FG001|NOT COMPLETED|Overall Study||43||
59830050|NCT00409682|75953445|FG000|STARTED|Open-label Induction Period||192||
59830051|NCT00409682|75953446|FG001|STARTED|Open-label Induction Period||0||
59830052|NCT00409682|75953447|FG002|STARTED|Open-label Induction Period||0||
59830053|NCT00409682|75953445|FG000|COMPLETED|Open-label Induction Period||188||
59830054|NCT00409682|75953446|FG001|COMPLETED|Open-label Induction Period||0||
59830055|NCT00409682|75953447|FG002|COMPLETED|Open-label Induction Period||0||
59830056|NCT00409682|75953445|FG000|NOT COMPLETED|Open-label Induction Period||4||
59830057|NCT00409682|75953446|FG001|NOT COMPLETED|Open-label Induction Period||0||
59830058|NCT00409682|75953447|FG002|NOT COMPLETED|Open-label Induction Period||0||
59830059|NCT00409682|75953445|FG000|STARTED|EOW Double-blind Maintenance Period||0||
59830060|NCT00409682|75953446|FG001|STARTED|EOW Double-blind Maintenance Period||95||
59830061|NCT00409682|75953447|FG002|STARTED|EOW Double-blind Maintenance Period||93||
59830062|NCT00409682|75953445|FG000|COMPLETED|EOW Double-blind Maintenance Period||0||
59830063|NCT00409682|75953446|FG001|COMPLETED|EOW Double-blind Maintenance Period||58||
59830064|NCT00409682|75953447|FG002|COMPLETED|EOW Double-blind Maintenance Period||66||
59830065|NCT00409682|75953445|FG000|NOT COMPLETED|EOW Double-blind Maintenance Period||0||
59830066|NCT00409682|75953446|FG001|NOT COMPLETED|EOW Double-blind Maintenance Period||37||
59830067|NCT00409682|75953447|FG002|NOT COMPLETED|EOW Double-blind Maintenance Period||27||
59830068|NCT00398216|75953459|FG000|STARTED|Overall Study||192||
59830069|NCT00398216|75953460|FG001|STARTED|Overall Study||170||
59830070|NCT00398216|75953461|FG002|STARTED|Overall Study||185||
59830071|NCT00398216|75953462|FG003|STARTED|Overall Study||177||
59830072|NCT00398216|75953463|FG004|STARTED|Overall Study||172||
59830073|NCT00398216|75953459|FG000|COMPLETED|Overall Study||181||
59830074|NCT00398216|75953460|FG001|COMPLETED|Overall Study||151||
59830075|NCT00398216|75953461|FG002|COMPLETED|Overall Study||164||
59830076|NCT00398216|75953462|FG003|COMPLETED|Overall Study||155||
59830077|NCT00398216|75953463|FG004|COMPLETED|Overall Study||157||
59830078|NCT00398216|75953459|FG000|NOT COMPLETED|Overall Study||11||
59830079|NCT00398216|75953460|FG001|NOT COMPLETED|Overall Study||19||
59830080|NCT00398216|75953461|FG002|NOT COMPLETED|Overall Study||21||
59830081|NCT00398216|75953462|FG003|NOT COMPLETED|Overall Study||22||
59830082|NCT00398216|75953463|FG004|NOT COMPLETED|Overall Study||15||
59830083|NCT00398138|75953475|FG000|STARTED|Overall Study||12||
59830084|NCT00398138|75953475|FG000|COMPLETED|Overall Study||10||
59830085|NCT00398138|75953475|FG000|NOT COMPLETED|Overall Study||2||
59830086|NCT00397982|75953479|FG000|STARTED|Overall Study||17||
59830087|NCT00397982|75953479|FG000|COMPLETED|Overall Study||13||
59830088|NCT00397982|75953479|FG000|NOT COMPLETED|Overall Study||4||
59830089|NCT00408902|75953484|FG000|STARTED|Overall Study||10||
59830090|NCT00408902|75953484|FG000|COMPLETED|Overall Study||0||
59830091|NCT00408902|75953484|FG000|NOT COMPLETED|Overall Study||10||
59830092|NCT00397514|75953489|FG000|STARTED|Overall Study||34||
59830093|NCT00397514|75953489|FG000|COMPLETED|Overall Study||25||
59830094|NCT00397514|75953489|FG000|NOT COMPLETED|Overall Study||9||
59830095|NCT00397046|75953503|FG000|STARTED|Overall Study||3||
59830096|NCT00397046|75953504|FG001|STARTED|Overall Study||3||
59830097|NCT00397046|75953505|FG002|STARTED|Overall Study||10||
59830098|NCT00397046|75953506|FG003|STARTED|Overall Study||5||
59830099|NCT00397046|75953503|FG000|COMPLETED|Overall Study||0||
59830100|NCT00397046|75953504|FG001|COMPLETED|Overall Study||0||
60118237|NCT00227019|76239332|FG000|NOT COMPLETED|Overall Study||0||
59830101|NCT00397046|75953505|FG002|COMPLETED|Overall Study||0||
59830102|NCT00397046|75953506|FG003|COMPLETED|Overall Study||0||
59830103|NCT00397046|75953503|FG000|NOT COMPLETED|Overall Study||3||
59830104|NCT00397046|75953504|FG001|NOT COMPLETED|Overall Study||3||
59830105|NCT00397046|75953505|FG002|NOT COMPLETED|Overall Study||10||
59830106|NCT00397046|75953506|FG003|NOT COMPLETED|Overall Study||5||
59830107|NCT00396812|75953517|FG000|STARTED|Overall Study||4||
59830108|NCT00396812|75953517|FG000|COMPLETED|Overall Study|4 subjects completed treatment, but 1 subject terminated early due to disease progression|3||
59830109|NCT00396812|75953517|FG000|NOT COMPLETED|Overall Study||1||
59830110|NCT00396656|75953521|FG000|STARTED|First Treatment Period||15||
59830111|NCT00396656|75953522|FG001|STARTED|First Treatment Period||15||
59830112|NCT00396656|75953521|FG000|COMPLETED|First Treatment Period||15||
59830113|NCT00396656|75953522|FG001|COMPLETED|First Treatment Period||13||
59830114|NCT00396656|75953521|FG000|NOT COMPLETED|First Treatment Period||0||
59830115|NCT00396656|75953522|FG001|NOT COMPLETED|First Treatment Period||2||
59830116|NCT00396656|75953521|FG000|STARTED|Second Treatment Period||15||
59830117|NCT00396656|75953522|FG001|STARTED|Second Treatment Period||13||
59830118|NCT00396656|75953521|FG000|COMPLETED|Second Treatment Period||15||
59830119|NCT00396656|75953522|FG001|COMPLETED|Second Treatment Period||12||
59830120|NCT00396656|75953521|FG000|NOT COMPLETED|Second Treatment Period||0||
59830121|NCT00396656|75953522|FG001|NOT COMPLETED|Second Treatment Period||1||
59830122|NCT00408434|75953535|FG000|STARTED|Overall Study||6||
59830123|NCT00408434|75953536|FG001|STARTED|Overall Study||3||
59830124|NCT00408434|75953537|FG002|STARTED|Overall Study||6||
59830125|NCT00408434|75953538|FG003|STARTED|Overall Study||3||
59830126|NCT00408434|75953539|FG004|STARTED|Overall Study||6||
59830127|NCT00408434|75953540|FG005|STARTED|Overall Study||3||
59830128|NCT00408434|75953541|FG006|STARTED|Overall Study||4||
59830129|NCT00408434|75953535|FG000|COMPLETED|Overall Study||0||
59830130|NCT00408434|75953536|FG001|COMPLETED|Overall Study||0||
59830131|NCT00408434|75953537|FG002|COMPLETED|Overall Study||0||
59830132|NCT00408434|75953538|FG003|COMPLETED|Overall Study||0||
59830133|NCT00408434|75953539|FG004|COMPLETED|Overall Study||0||
59830134|NCT00408434|75953540|FG005|COMPLETED|Overall Study||0||
59830135|NCT00408434|75953541|FG006|COMPLETED|Overall Study||0||
59830136|NCT00408434|75953535|FG000|NOT COMPLETED|Overall Study||6||
59830137|NCT00408434|75953536|FG001|NOT COMPLETED|Overall Study||3||
59830138|NCT00408434|75953537|FG002|NOT COMPLETED|Overall Study||6||
59830139|NCT00408434|75953538|FG003|NOT COMPLETED|Overall Study||3||
59830140|NCT00408434|75953539|FG004|NOT COMPLETED|Overall Study||6||
59830141|NCT00408434|75953540|FG005|NOT COMPLETED|Overall Study||3||
59830142|NCT00408434|75953541|FG006|NOT COMPLETED|Overall Study||4||
59830143|NCT00418184|75953560|FG000|STARTED|Double-blind Phase||137||
59830144|NCT00418184|75953561|FG001|STARTED|Double-blind Phase||63||
59830145|NCT00418184|75953560|FG000|COMPLETED|Double-blind Phase||110||
59830146|NCT00418184|75953561|FG001|COMPLETED|Double-blind Phase||52||
59830147|NCT00418184|75953560|FG000|NOT COMPLETED|Double-blind Phase||27||
59830148|NCT00418184|75953561|FG001|NOT COMPLETED|Double-blind Phase||11||
59830149|NCT00418184|75953560|FG000|STARTED|Open-label Phase|3 were not included due to low compliance in the double blind phase, 5 didn't want to participate.|102||
59830150|NCT00418184|75953561|FG001|STARTED|Open-label Phase|1 was not included due to low compliance in the double blind phase, 3 didn't want to participate.|48||
59830151|NCT00418184|75953560|FG000|COMPLETED|Open-label Phase|5 dropped out|97||
59830152|NCT00418184|75953561|FG001|COMPLETED|Open-label Phase|5 dropped out|43||
59830153|NCT00418184|75953560|FG000|NOT COMPLETED|Open-label Phase||5||
59830154|NCT00418184|75953561|FG001|NOT COMPLETED|Open-label Phase||5||
59830155|NCT00407030|75953570|FG000|STARTED|Main Period - 8 to 20 Weeks||81||
59830156|NCT00407030|75953571|FG001|STARTED|Main Period - 8 to 20 Weeks||78||
59830157|NCT00407030|75953572|FG002|STARTED|Main Period - 8 to 20 Weeks||74||
59830158|NCT00407030|75953570|FG000|COMPLETED|Main Period - 8 to 20 Weeks||76||
59830159|NCT00407030|75953571|FG001|COMPLETED|Main Period - 8 to 20 Weeks||75||
59830160|NCT00407030|75953572|FG002|COMPLETED|Main Period - 8 to 20 Weeks||68||
59830161|NCT00407030|75953570|FG000|NOT COMPLETED|Main Period - 8 to 20 Weeks||5||
59830162|NCT00407030|75953571|FG001|NOT COMPLETED|Main Period - 8 to 20 Weeks||3||
59830163|NCT00407030|75953572|FG002|NOT COMPLETED|Main Period - 8 to 20 Weeks||6||
59830164|NCT00407030|75953570|FG000|STARTED|Extension Period - up to 68 Weeks|2 subjects did not enter the Ext. Period, 3 subjects never expressed any need for a new injection|111||
59830165|NCT00407030|75953571|FG001|STARTED|Extension Period - up to 68 Weeks|2 subjects did not enter the Ext. Period, 3 subjects never expressed any need for a new injection|103||
59830166|NCT00407030|75953572|FG002|STARTED|Extension Period - up to 68 Weeks|After the Main Period all patients were randomly assigned to the 2 active treatment arms.|0||
59830167|NCT00407030|75953570|FG000|COMPLETED|Extension Period - up to 68 Weeks||84||
59830168|NCT00407030|75953571|FG001|COMPLETED|Extension Period - up to 68 Weeks||74||
59830169|NCT00407030|75953572|FG002|COMPLETED|Extension Period - up to 68 Weeks||0||
59830170|NCT00407030|75953570|FG000|NOT COMPLETED|Extension Period - up to 68 Weeks||27||
59830171|NCT00407030|75953571|FG001|NOT COMPLETED|Extension Period - up to 68 Weeks||29||
59830172|NCT00407030|75953572|FG002|NOT COMPLETED|Extension Period - up to 68 Weeks||0||
59830173|NCT00406718|75953585|FG000|STARTED|Overall Study||47||
59830174|NCT00406718|75953586|FG001|STARTED|Overall Study||48||
59830175|NCT00406718|75953587|FG002|STARTED|Overall Study||47||
59830176|NCT00406718|75953585|FG000|COMPLETED|Overall Study||43||
59830177|NCT00406718|75953586|FG001|COMPLETED|Overall Study||34||
59830178|NCT00406718|75953587|FG002|COMPLETED|Overall Study||39||
59830179|NCT00406718|75953585|FG000|NOT COMPLETED|Overall Study||4||
59830180|NCT00406718|75953586|FG001|NOT COMPLETED|Overall Study||14||
59830181|NCT00406718|75953587|FG002|NOT COMPLETED|Overall Study||8||
59830182|NCT00394706|75953605|FG000|STARTED|Overall Study||1819||
59830183|NCT00394706|75953606|FG001|STARTED|Overall Study||1862||
59830184|NCT00394706|75953607|FG002|STARTED|Overall Study||1624||
59830185|NCT00394706|75953608|FG003|STARTED|Overall Study||1633||
59830186|NCT00394706|75953609|FG004|STARTED|Overall Study||1636||
60118238|NCT00113217|76239337|FG000|STARTED|Overall Study||50||
60118239|NCT00113217|76239337|FG000|COMPLETED|Overall Study||50||
59830187|NCT00394706|75953610|FG005|STARTED|Overall Study||1384||
59830188|NCT00394706|75953611|FG006|STARTED|Overall Study||929||
59830189|NCT00394706|75953612|FG007|STARTED|Overall Study||851||
59830190|NCT00394706|75953605|FG000|COMPLETED|Overall Study||1815||
59830191|NCT00394706|75953606|FG001|COMPLETED|Overall Study||1860||
59830192|NCT00394706|75953607|FG002|COMPLETED|Overall Study||1615||
59830193|NCT00394706|75953608|FG003|COMPLETED|Overall Study||1632||
59830194|NCT00394706|75953609|FG004|COMPLETED|Overall Study||1634||
59830195|NCT00394706|75953610|FG005|COMPLETED|Overall Study||1377||
59830196|NCT00394706|75953611|FG006|COMPLETED|Overall Study||926||
59830197|NCT00394706|75953612|FG007|COMPLETED|Overall Study||851||
59830198|NCT00394706|75953605|FG000|NOT COMPLETED|Overall Study||4||
59830199|NCT00394706|75953606|FG001|NOT COMPLETED|Overall Study||2||
59830200|NCT00394706|75953607|FG002|NOT COMPLETED|Overall Study||9||
59830201|NCT00394706|75953608|FG003|NOT COMPLETED|Overall Study||1||
59830202|NCT00394706|75953609|FG004|NOT COMPLETED|Overall Study||2||
59830203|NCT00394706|75953610|FG005|NOT COMPLETED|Overall Study||7||
59830204|NCT00394706|75953611|FG006|NOT COMPLETED|Overall Study||3||
59830205|NCT00394706|75953612|FG007|NOT COMPLETED|Overall Study||0||
59830206|NCT00394472|75953628|FG000|STARTED|Overall Study||122||
59830207|NCT00394472|75953629|FG001|STARTED|Overall Study||122||
59830208|NCT00394472|75953628|FG000|COMPLETED|Overall Study||113||
59830209|NCT00394472|75953629|FG001|COMPLETED|Overall Study||111||
59830210|NCT00394472|75953628|FG000|NOT COMPLETED|Overall Study||9||
59830211|NCT00394472|75953629|FG001|NOT COMPLETED|Overall Study||11||
59830212|NCT00419120|75953635|FG000|STARTED|Primary Study Period||10||
59830213|NCT00419120|75953635|FG000|COMPLETED|Primary Study Period||10||
59830214|NCT00419120|75953635|FG000|NOT COMPLETED|Primary Study Period||0||
59830215|NCT00419120|75953635|FG000|STARTED|Long Term Follow up Period|10 patients are being followed in long term follow up.|10||
59830216|NCT00419120|75953635|FG000|COMPLETED|Long Term Follow up Period||0||
59830217|NCT00419120|75953635|FG000|NOT COMPLETED|Long Term Follow up Period||10||
59830218|NCT00395642|75953639|FG000|STARTED|Overall Study||66||
59830219|NCT00395642|75953639|FG000|COMPLETED|Overall Study||53||
59830220|NCT00395642|75953639|FG000|NOT COMPLETED|Overall Study||13||
59830221|NCT00395486|75953645|FG000|STARTED|Overall Study|Randomized subjects|132||
59830222|NCT00395486|75953646|FG001|STARTED|Overall Study|Randomized subjects|126||
59830223|NCT00395486|75953645|FG000|COMPLETED|Overall Study|Completed subjects|126||
59830224|NCT00395486|75953646|FG001|COMPLETED|Overall Study|Completed subjects|121||
59830225|NCT00395486|75953645|FG000|NOT COMPLETED|Overall Study||6||
59830226|NCT00395486|75953646|FG001|NOT COMPLETED|Overall Study||5||
59830227|NCT00395018|75953652|FG000|STARTED|On-Treatment|Started = treated (participants who received at least 1 dose of study therapy)|65||
59830228|NCT00395018|75953652|FG000|DISCONTINUED PRIOR TO WEEK 72 VISIT|On-Treatment||10||
59830229|NCT00395018|75953652|FG000|DISCONTINUED AT OR AFTER WEEK 72 VISIT|On-Treatment||0||
59830230|NCT00395018|75953652|FG000|COMPLETED|On-Treatment|"Completed means received treatment through Week 72"|55||
59830231|NCT00395018|75953652|FG000|NOT COMPLETED|On-Treatment||10||
59830232|NCT00395018|75953652|FG000|STARTED|Off-Treatment Follow-up|Treated participants who discontinued =<72 weeks and did not start other anti-HBV therapy|5||
60118240|NCT00113217|76239337|FG000|NOT COMPLETED|Overall Study||0||
60118241|NCT00115869|76239343|FG000|STARTED|Overall Study||4211||
60118242|NCT00115869|76239344|FG001|STARTED|Overall Study||4177||
60118243|NCT00115869|76239343|FG000|Completed Data Collection at 12th Grade|Overall Study||3876||
59716497|NCT01172639|75835335|FG003|NOT COMPLETED|Overall Study||11||
59716498|NCT01172639|75835336|FG004|NOT COMPLETED|Overall Study||6||
59716499|NCT01144182|75835350|FG000|STARTED|Overall Study||68||
59716500|NCT01144182|75835351|FG001|STARTED|Overall Study||68||
59716501|NCT01144182|75835350|FG000|COMPLETED|Overall Study||51||
59716502|NCT01144182|75835351|FG001|COMPLETED|Overall Study||47||
59716503|NCT01144182|75835350|FG000|NOT COMPLETED|Overall Study||17||
59716504|NCT01144182|75835351|FG001|NOT COMPLETED|Overall Study||21||
59716505|NCT01225562|75835361|FG000|STARTED|Overall Study||7050||
59716506|NCT01225562|75835362|FG001|STARTED|Overall Study||7045||
59716507|NCT01225562|75835363|FG002|STARTED|Overall Study||7067||
59716508|NCT01225562|75835361|FG000|COMPLETED|Overall Study||6995||
59716509|NCT01225562|75835362|FG001|COMPLETED|Overall Study||6989||
59716510|NCT01225562|75835363|FG002|COMPLETED|Overall Study||7014||
59716511|NCT01225562|75835361|FG000|NOT COMPLETED|Overall Study||55||
59716512|NCT01225562|75835362|FG001|NOT COMPLETED|Overall Study||56||
59716513|NCT01225562|75835363|FG002|NOT COMPLETED|Overall Study||53||
59716514|NCT00925288|75835373|FG000|STARTED|Overall Study||100||
59716515|NCT00925288|75835374|FG001|STARTED|Overall Study||100||
59716516|NCT00925288|75835373|FG000|COMPLETED|Overall Study||91||
59716517|NCT00925288|75835374|FG001|COMPLETED|Overall Study||93||
59716518|NCT00925288|75835373|FG000|NOT COMPLETED|Overall Study||9||
59716519|NCT00925288|75835374|FG001|NOT COMPLETED|Overall Study||7||
59716520|NCT01143714|75835384|FG000|STARTED|Overall Study||29||
59716521|NCT01143714|75835385|FG001|STARTED|Overall Study||28||
59830233|NCT00395018|75953652|FG000|COMPLETED|Off-Treatment Follow-up|"Completed means completed the study"|1||
59830234|NCT00395018|75953652|FG000|NOT COMPLETED|Off-Treatment Follow-up||4||
59830235|NCT00375518|75953658|FG000|STARTED|Overall Study||80||
59830236|NCT00375518|75953659|FG001|STARTED|Overall Study||82||
59830237|NCT00375518|75953658|FG000|COMPLETED|Overall Study||72||
59830238|NCT00375518|75953659|FG001|COMPLETED|Overall Study||65||
59830239|NCT00375518|75953658|FG000|NOT COMPLETED|Overall Study||8||
59830240|NCT00375518|75953659|FG001|NOT COMPLETED|Overall Study||17||
59830241|NCT00256750|75953668|FG000|STARTED|Transplanted Pre-Treatment||221||
59830242|NCT00256750|75953669|FG001|STARTED|Transplanted Pre-Treatment||226||
59830243|NCT00256750|75953670|FG002|STARTED|Transplanted Pre-Treatment||219||
59830244|NCT00256750|75953668|FG000|COMPLETED|Transplanted Pre-Treatment||215||
59830245|NCT00256750|75953669|FG001|COMPLETED|Transplanted Pre-Treatment||226||
59716522|NCT01143714|75835384|FG000|COMPLETED|Overall Study||22||
59716523|NCT01143714|75835385|FG001|COMPLETED|Overall Study||25||
59716524|NCT01143714|75835384|FG000|NOT COMPLETED|Overall Study||7||
59716525|NCT01143714|75835385|FG001|NOT COMPLETED|Overall Study||3||
59830246|NCT00256750|75953670|FG002|COMPLETED|Transplanted Pre-Treatment||219||
59830247|NCT00256750|75953668|FG000|NOT COMPLETED|Transplanted Pre-Treatment||6||
59830248|NCT00256750|75953669|FG001|NOT COMPLETED|Transplanted Pre-Treatment||0||
59830249|NCT00256750|75953670|FG002|NOT COMPLETED|Transplanted Pre-Treatment||0||
59830250|NCT00256750|75953668|FG000|STARTED|Post-Transplant Treated (12 Months)||215||
59830251|NCT00256750|75953669|FG001|STARTED|Post-Transplant Treated (12 Months)||226||
59830252|NCT00256750|75953670|FG002|STARTED|Post-Transplant Treated (12 Months)||219||
59830253|NCT00256750|75953668|FG000|COMPLETED|Post-Transplant Treated (12 Months)||174||
59830254|NCT00256750|75953669|FG001|COMPLETED|Post-Transplant Treated (12 Months)||183||
59830255|NCT00256750|75953670|FG002|COMPLETED|Post-Transplant Treated (12 Months)||173||
59830256|NCT00256750|75953668|FG000|NOT COMPLETED|Post-Transplant Treated (12 Months)||41||
59830257|NCT00256750|75953669|FG001|NOT COMPLETED|Post-Transplant Treated (12 Months)||43||
59830258|NCT00256750|75953670|FG002|NOT COMPLETED|Post-Transplant Treated (12 Months)||46||
59830259|NCT00256750|75953668|FG000|STARTED|Post-Transplant Treated (24 Months)||174||
59830260|NCT00256750|75953669|FG001|STARTED|Post-Transplant Treated (24 Months)||183||
59830261|NCT00256750|75953670|FG002|STARTED|Post-Transplant Treated (24 Months)||173||
59830262|NCT00256750|75953668|FG000|COMPLETED|Post-Transplant Treated (24 Months)||153||
59830263|NCT00256750|75953669|FG001|COMPLETED|Post-Transplant Treated (24 Months)||176||
59830264|NCT00256750|75953670|FG002|COMPLETED|Post-Transplant Treated (24 Months)||164||
59830265|NCT00256750|75953668|FG000|NOT COMPLETED|Post-Transplant Treated (24 Months)||21||
59830266|NCT00256750|75953669|FG001|NOT COMPLETED|Post-Transplant Treated (24 Months)||7||
59830267|NCT00256750|75953670|FG002|NOT COMPLETED|Post-Transplant Treated (24 Months)||9||
59830268|NCT00256750|75953668|FG000|STARTED|Post-Transplant Treated (36 Months)||153||
59830269|NCT00256750|75953669|FG001|STARTED|Post-Transplant Treated (36 Months)||176||
59830270|NCT00256750|75953670|FG002|STARTED|Post-Transplant Treated (36 Months)||164||
59830271|NCT00256750|75953668|FG000|COMPLETED|Post-Transplant Treated (36 Months)||143||
59830272|NCT00256750|75953669|FG001|COMPLETED|Post-Transplant Treated (36 Months)||170||
59830273|NCT00256750|75953670|FG002|COMPLETED|Post-Transplant Treated (36 Months)||158||
59830274|NCT00256750|75953668|FG000|NOT COMPLETED|Post-Transplant Treated (36 Months)||10||
59830275|NCT00256750|75953669|FG001|NOT COMPLETED|Post-Transplant Treated (36 Months)||6||
59830276|NCT00256750|75953670|FG002|NOT COMPLETED|Post-Transplant Treated (36 Months)||6||
59830277|NCT00256750|75953668|FG000|STARTED|Long Term Extension (LTE; 84 Months)|Participants on drug through month 36 eligible to enroll in LTE; 2 ineligible, 5 withdrew or refused|136||
59830278|NCT00256750|75953669|FG001|STARTED|Long Term Extension (LTE; 84 Months)|Participants on drug through month 36 were eligible to enroll in LTE; 4 withdrew or refused.|166||
59830279|NCT00256750|75953670|FG002|STARTED|Long Term Extension (LTE; 84 Months)|Participants on drug through month 36 were eligible to enroll in LTE; 3 withdrew or refused.|155||
59830280|NCT00256750|75953668|FG000|COMPLETED|Long Term Extension (LTE; 84 Months)||89||
59830281|NCT00256750|75953669|FG001|COMPLETED|Long Term Extension (LTE; 84 Months)||136||
59830282|NCT00256750|75953670|FG002|COMPLETED|Long Term Extension (LTE; 84 Months)||127||
59830283|NCT00256750|75953668|FG000|NOT COMPLETED|Long Term Extension (LTE; 84 Months)||47||
60118244|NCT00115869|76239344|FG001|Completed Data Collection at 12th Grade|Overall Study||3847||
59716526|NCT04800757|75835394|FG000|STARTED|Overall Study||113||10
59716527|NCT04800757|75835395|FG001|STARTED|Overall Study||102||10
59716528|NCT04800757|75835396|FG002|STARTED|Overall Study||110||10
59716529|NCT04800757|75835394|FG000|Completed Baseline Assessment|Overall Study|One subject did not complete baseline survey|112||10
59716530|NCT04800757|75835395|FG001|Completed Baseline Assessment|Overall Study|2 subjects did not complete baseline survey|100||10
59716531|NCT04800757|75835396|FG002|Completed Baseline Assessment|Overall Study|4 subjects did not complete baseline survey|106||10
59716532|NCT04800757|75835394|FG000|Completed Post-Intervention Assessment|Overall Study||91||10
59716533|NCT04800757|75835395|FG001|Completed Post-Intervention Assessment|Overall Study||82||10
59716534|NCT04800757|75835396|FG002|Completed Post-Intervention Assessment|Overall Study||75||10
59716535|NCT04800757|75835394|FG000|COMPLETED|Overall Study||91||10
59716536|NCT04800757|75835395|FG001|COMPLETED|Overall Study||82||10
59716537|NCT04800757|75835396|FG002|COMPLETED|Overall Study||75||10
59716538|NCT04800757|75835394|FG000|NOT COMPLETED|Overall Study||22||0
59716539|NCT04800757|75835395|FG001|NOT COMPLETED|Overall Study||20||0
59716540|NCT04800757|75835396|FG002|NOT COMPLETED|Overall Study||35||0
59716541|NCT00972543|75835406|FG000|STARTED|Overall Study||5||
59830284|NCT00256750|75953669|FG001|NOT COMPLETED|Long Term Extension (LTE; 84 Months)||30||
60118245|NCT00115869|76239343|FG000|COMPLETED|Overall Study||3894||
59830285|NCT00256750|75953670|FG002|NOT COMPLETED|Long Term Extension (LTE; 84 Months)||28||
59830286|NCT00279201|75953681|FG000|STARTED|Initiation||1046||
59830287|NCT00279201|75953682|FG001|STARTED|Initiation||1045||
59830288|NCT00279201|75953683|FG002|STARTED|Initiation||0||
59830289|NCT00279201|75953684|FG003|STARTED|Initiation||0||
59830290|NCT00279201|75953685|FG004|STARTED|Initiation||0||
59830291|NCT00279201|75953686|FG005|STARTED|Initiation||0||
59830292|NCT00279201|75953681|FG000|COMPLETED|Initiation||918||
59830293|NCT00279201|75953682|FG001|COMPLETED|Initiation||900||
59830294|NCT00279201|75953683|FG002|COMPLETED|Initiation||0||
59830295|NCT00279201|75953684|FG003|COMPLETED|Initiation||0||
59830296|NCT00279201|75953685|FG004|COMPLETED|Initiation||0||
59830297|NCT00279201|75953686|FG005|COMPLETED|Initiation||0||
59830298|NCT00279201|75953681|FG000|NOT COMPLETED|Initiation||128||
59830299|NCT00279201|75953682|FG001|NOT COMPLETED|Initiation||145||
59830300|NCT00279201|75953683|FG002|NOT COMPLETED|Initiation||0||
59830301|NCT00279201|75953684|FG003|NOT COMPLETED|Initiation||0||
59830302|NCT00279201|75953685|FG004|NOT COMPLETED|Initiation||0||
59830303|NCT00279201|75953686|FG005|NOT COMPLETED|Initiation||0||
59830304|NCT00279201|75953681|FG000|STARTED|Maintenance|100 left the study after initiation. 399 had HbA1c>7% and enrolled in intensification addendum.|419||
59830305|NCT00279201|75953682|FG001|STARTED|Maintenance|82 left the study after initiation. 345 had HbA1c>7% and enrolled in intensification addendum.|473||
59830306|NCT00279201|75953683|FG002|STARTED|Maintenance||0||
59830307|NCT00279201|75953684|FG003|STARTED|Maintenance||0||
59830308|NCT00279201|75953685|FG004|STARTED|Maintenance||0||
59830309|NCT00279201|75953686|FG005|STARTED|Maintenance||0||
59830310|NCT00279201|75953681|FG000|COMPLETED|Maintenance||188||
59830311|NCT00279201|75953682|FG001|COMPLETED|Maintenance||239||
59830312|NCT00279201|75953683|FG002|COMPLETED|Maintenance||0||
59830313|NCT00279201|75953684|FG003|COMPLETED|Maintenance||0||
59830314|NCT00279201|75953685|FG004|COMPLETED|Maintenance||0||
59830315|NCT00279201|75953686|FG005|COMPLETED|Maintenance||0||
59830316|NCT00279201|75953681|FG000|NOT COMPLETED|Maintenance||231||
59830317|NCT00279201|75953682|FG001|NOT COMPLETED|Maintenance||234||
59830318|NCT00279201|75953683|FG002|NOT COMPLETED|Maintenance||0||
59830319|NCT00279201|75953684|FG003|NOT COMPLETED|Maintenance||0||
59830320|NCT00279201|75953685|FG004|NOT COMPLETED|Maintenance||0||
59830321|NCT00279201|75953686|FG005|NOT COMPLETED|Maintenance||0||
59830322|NCT00279201|75953681|FG000|STARTED|Intensification Addendum||0||
59830323|NCT00279201|75953682|FG001|STARTED|Intensification Addendum||0||
59830324|NCT00279201|75953683|FG002|STARTED|Intensification Addendum||174||
59830325|NCT00279201|75953684|FG003|STARTED|Intensification Addendum||200||
59830326|NCT00279201|75953685|FG004|STARTED|Intensification Addendum||171||
59830327|NCT00279201|75953686|FG005|STARTED|Intensification Addendum||199||
60118246|NCT00115869|76239344|FG001|COMPLETED|Overall Study|Follow-up at two years post high school.|3881||
60118247|NCT00115869|76239343|FG000|NOT COMPLETED|Overall Study||317||
60118248|NCT00115869|76239344|FG001|NOT COMPLETED|Overall Study||296||
60118249|NCT00053703|76239355|FG000|STARTED|Overall Study||35||
59567484|NCT02326272|75670462|FG009|STARTED|Initial Period (Week 0 to Week 16)||0||
59716542|NCT00972543|75835407|FG001|STARTED|Overall Study||1||
59716543|NCT00972543|75835406|FG000|COMPLETED|Overall Study||0||
59716544|NCT00972543|75835407|FG001|COMPLETED|Overall Study||0||
59716545|NCT00972543|75835406|FG000|NOT COMPLETED|Overall Study||5||
59716546|NCT00972543|75835407|FG001|NOT COMPLETED|Overall Study||1||
59716547|NCT00925132|75835413|FG000|STARTED|Overall Study||5||
59716548|NCT00925132|75835414|FG001|STARTED|Overall Study||4||
59716549|NCT00925132|75835415|FG002|STARTED|Overall Study||4||
59716550|NCT00925132|75835416|FG003|STARTED|Overall Study||4||
59716551|NCT00925132|75835417|FG004|STARTED|Overall Study||22||
59716552|NCT00925132|75835413|FG000|COMPLETED|Overall Study||3||
59716553|NCT00925132|75835414|FG001|COMPLETED|Overall Study||4||
59716554|NCT00925132|75835415|FG002|COMPLETED|Overall Study||4||
59830328|NCT00279201|75953681|FG000|COMPLETED|Intensification Addendum||0||
59830329|NCT00279201|75953682|FG001|COMPLETED|Intensification Addendum||0||
59830330|NCT00279201|75953683|FG002|COMPLETED|Intensification Addendum||151||
59830331|NCT00279201|75953684|FG003|COMPLETED|Intensification Addendum||172||
59830332|NCT00279201|75953685|FG004|COMPLETED|Intensification Addendum||142||
59830333|NCT00279201|75953686|FG005|COMPLETED|Intensification Addendum||162||
59830334|NCT00279201|75953681|FG000|NOT COMPLETED|Intensification Addendum||0||
59830335|NCT00279201|75953682|FG001|NOT COMPLETED|Intensification Addendum||0||
59830336|NCT00279201|75953683|FG002|NOT COMPLETED|Intensification Addendum||23||
59716555|NCT00925132|75835416|FG003|COMPLETED|Overall Study||4||
59716556|NCT00925132|75835417|FG004|COMPLETED|Overall Study||17||
59830337|NCT00279201|75953684|FG003|NOT COMPLETED|Intensification Addendum||28||
59830338|NCT00279201|75953685|FG004|NOT COMPLETED|Intensification Addendum||29||
59830339|NCT00279201|75953686|FG005|NOT COMPLETED|Intensification Addendum||37||
59830340|NCT00203476|75953722|FG000|STARTED|Overall Study||10||
59830341|NCT00203476|75953723|FG001|STARTED|Overall Study||10||
59830342|NCT00203476|75953724|FG002|STARTED|Overall Study||10||
59830343|NCT00203476|75953722|FG000|COMPLETED|Overall Study||9||
59830344|NCT00203476|75953723|FG001|COMPLETED|Overall Study||9||
59830345|NCT00203476|75953724|FG002|COMPLETED|Overall Study||10||
60118250|NCT00053703|76239356|FG001|STARTED|Overall Study||41||
60118251|NCT00053703|76239357|FG002|STARTED|Overall Study||40||
60118252|NCT00053703|76239355|FG000|COMPLETED|Overall Study||17||
59716557|NCT00925132|75835413|FG000|NOT COMPLETED|Overall Study||2||
59716558|NCT00925132|75835414|FG001|NOT COMPLETED|Overall Study||0||
59716559|NCT00925132|75835415|FG002|NOT COMPLETED|Overall Study||0||
59716560|NCT00925132|75835416|FG003|NOT COMPLETED|Overall Study||0||
59716561|NCT00925132|75835417|FG004|NOT COMPLETED|Overall Study||5||
59716562|NCT01143402|75835426|FG000|STARTED|Overall Study||51||
59716563|NCT01143402|75835427|FG001|STARTED|Overall Study||50||
59716564|NCT01143402|75835428|FG002|STARTED|Overall Study||19||
60118253|NCT00053703|76239356|FG001|COMPLETED|Overall Study||28||
60118254|NCT00053703|76239357|FG002|COMPLETED|Overall Study||25||
60118255|NCT00053703|76239355|FG000|NOT COMPLETED|Overall Study||18||
59716565|NCT01143402|75835426|FG000|COMPLETED|Overall Study||50||
59716566|NCT01143402|75835427|FG001|COMPLETED|Overall Study||49||
59716567|NCT01143402|75835428|FG002|COMPLETED|Overall Study||18||
59716568|NCT01143402|75835426|FG000|NOT COMPLETED|Overall Study||1||
59716569|NCT01143402|75835427|FG001|NOT COMPLETED|Overall Study||1||
59716570|NCT01143402|75835428|FG002|NOT COMPLETED|Overall Study||1||
59716571|NCT01171625|75835435|FG000|STARTED|Overall Study||283||
59716572|NCT01171625|75835435|FG000|Subjects Implanted With Device|Overall Study||258||
59716573|NCT01171625|75835435|FG000|COMPLETED|Overall Study||103||
60118256|NCT00053703|76239356|FG001|NOT COMPLETED|Overall Study||13||
60118257|NCT00053703|76239357|FG002|NOT COMPLETED|Overall Study||15||
60118258|NCT00231309|76239365|FG000|STARTED|Overall Study||10||
60118259|NCT00231309|76239365|FG000|COMPLETED|Overall Study||10||
60118260|NCT00231309|76239365|FG000|NOT COMPLETED|Overall Study||0||
60118261|NCT00116337|76239370|FG000|STARTED|Overall Study||17||
60118262|NCT00116337|76239370|FG000|COMPLETED|Overall Study||17||
59567485|NCT02326272|75670463|FG010|STARTED|Initial Period (Week 0 to Week 16)||0||
59567486|NCT02326272|75670464|FG011|STARTED|Initial Period (Week 0 to Week 16)||0||
59716574|NCT01171625|75835435|FG000|NOT COMPLETED|Overall Study||180||
60118263|NCT00116337|76239370|FG000|NOT COMPLETED|Overall Study||0||
60118264|NCT00232479|76239381|FG000|STARTED|Overall Study||44||
60118265|NCT00232479|76239381|FG000|COMPLETED|Overall Study||44||
60118266|NCT00232479|76239381|FG000|NOT COMPLETED|Overall Study||0||
60118267|NCT00233103|76239388|FG000|STARTED|Overall Study||27||
60118268|NCT00233103|76239389|FG001|STARTED|Overall Study||25||
60118269|NCT00233103|76239388|FG000|COMPLETED|Overall Study||22||
60118270|NCT00233103|76239389|FG001|COMPLETED|Overall Study||19||
60118271|NCT00233103|76239388|FG000|NOT COMPLETED|Overall Study||5||
60118272|NCT00233103|76239389|FG001|NOT COMPLETED|Overall Study||6||
60118273|NCT00117585|76239395|FG000|STARTED|Overall Study||341||
60118274|NCT00117585|76239395|FG000|COMPLETED|Overall Study||341||
60118275|NCT00117585|76239395|FG000|NOT COMPLETED|Overall Study||0||
60118276|NCT00703014|76239401|FG000|STARTED|Mothers Base Trial P05787 (NCT00696800)|Randomized in Base Trial P05787 (NCT00696800)|757||
60118277|NCT00703014|76239402|FG001|STARTED|Mothers Base Trial P05787 (NCT00696800)|Randomized in Base Trial P05787 (NCT00696800)|752||
60118278|NCT00703014|76239403|FG002|STARTED|Mothers Base Trial P05787 (NCT00696800)||0||
60118279|NCT00703014|76239404|FG003|STARTED|Mothers Base Trial P05787 (NCT00696800)||0||
60118280|NCT00703014|76239401|FG000|Treated|Mothers Base Trial P05787 (NCT00696800)|Intent-To-Treat (ITT) group in Base Trial P05787 (NCT00696800)|756||
60118281|NCT00703014|76239402|FG001|Treated|Mothers Base Trial P05787 (NCT00696800)|ITT group in Base Trial P05787 (NCT006968000)|750||
60118282|NCT00703014|76239403|FG002|Treated|Mothers Base Trial P05787 (NCT00696800)||0||
59567487|NCT02326272|75670465|FG012|STARTED|Initial Period (Week 0 to Week 16)||0||
59716575|NCT00924898|75835447|FG000|STARTED|Overall Study||92||
59716576|NCT00924898|75835447|FG000|COMPLETED|Overall Study||90||
59716577|NCT00924898|75835447|FG000|NOT COMPLETED|Overall Study||2||
60118283|NCT00703014|76239404|FG003|Treated|Mothers Base Trial P05787 (NCT00696800)||0||
60118284|NCT00703014|76239401|FG000|Embryo Transfer|Mothers Base Trial P05787 (NCT00696800)|Embryo transfer (ET) in Base Trial P05787 (NCT006968000)|672||
60118285|NCT00703014|76239402|FG001|Embryo Transfer|Mothers Base Trial P05787 (NCT00696800)|Embryo transfer (ET) in Base Trial P05787 (NCT006968000)|704||
60118286|NCT00703014|76239403|FG002|Embryo Transfer|Mothers Base Trial P05787 (NCT00696800)||0||
60118287|NCT00703014|76239404|FG003|Embryo Transfer|Mothers Base Trial P05787 (NCT00696800)||0||
60118288|NCT00703014|76239401|FG000|COMPLETED|Mothers Base Trial P05787 (NCT00696800)|ITT group in P05712, ongoing pregnancy at 10 weeks after ET in Base Trial P05787 (NCT006968000)|295||
60118289|NCT00703014|76239402|FG001|COMPLETED|Mothers Base Trial P05787 (NCT00696800)|ITT group in P05712, ongoing pregnancy at 10 weeks after ET in Base Trial P05787 (NCT006968000)|286||
60118290|NCT00703014|76239403|FG002|COMPLETED|Mothers Base Trial P05787 (NCT00696800)||0||
60118291|NCT00703014|76239404|FG003|COMPLETED|Mothers Base Trial P05787 (NCT00696800)||0||
60118292|NCT00703014|76239401|FG000|NOT COMPLETED|Mothers Base Trial P05787 (NCT00696800)||462||
60118293|NCT00703014|76239402|FG001|NOT COMPLETED|Mothers Base Trial P05787 (NCT00696800)||466||
60118294|NCT00703014|76239403|FG002|NOT COMPLETED|Mothers Base Trial P05787 (NCT00696800)||0||
60118295|NCT00703014|76239404|FG003|NOT COMPLETED|Mothers Base Trial P05787 (NCT00696800)||0||
60118296|NCT00703014|76239401|FG000|STARTED|Mothers Follow Up Trial P05712|Eligible participants who completed Base Trial P05787 and then enrolled in Follow Up Trial P05712|274||
60118297|NCT00703014|76239402|FG001|STARTED|Mothers Follow Up Trial P05712|Eligible participants who completed Base Trial P05787 and then enrolled in Follow Up Trial P05712|267||
60118298|NCT00703014|76239403|FG002|STARTED|Mothers Follow Up Trial P05712||0||
60118299|NCT00703014|76239404|FG003|STARTED|Mothers Follow Up Trial P05712||0||
60118300|NCT00703014|76239401|FG000|COMPLETED|Mothers Follow Up Trial P05712|Completed Follow Up in Trial P05712|241||
60118301|NCT00703014|76239402|FG001|COMPLETED|Mothers Follow Up Trial P05712|Completed Follow Up in Trial P05712|235||
60118302|NCT00703014|76239403|FG002|COMPLETED|Mothers Follow Up Trial P05712||0||
59716578|NCT01167192|75835456|FG000|STARTED|Overall Study||10||
59716579|NCT01167192|75835456|FG000|COMPLETED|Overall Study||6||
60118303|NCT00703014|76239404|FG003|COMPLETED|Mothers Follow Up Trial P05712||0||
59830346|NCT00203476|75953722|FG000|NOT COMPLETED|Overall Study||1||
59830347|NCT00203476|75953723|FG001|NOT COMPLETED|Overall Study||1||
60118304|NCT00703014|76239401|FG000|NOT COMPLETED|Mothers Follow Up Trial P05712||33||
60118305|NCT00703014|76239402|FG001|NOT COMPLETED|Mothers Follow Up Trial P05712||32||
60118306|NCT00703014|76239403|FG002|NOT COMPLETED|Mothers Follow Up Trial P05712||0||
60118307|NCT00703014|76239404|FG003|NOT COMPLETED|Mothers Follow Up Trial P05712||0||
60118308|NCT00703014|76239401|FG000|STARTED|Fetuses/Infants Follow Up Trial P05712||0||
60118309|NCT00703014|76239402|FG001|STARTED|Fetuses/Infants Follow Up Trial P05712||0||
60118310|NCT00703014|76239403|FG002|STARTED|Fetuses/Infants Follow Up Trial P05712|Fetuses in Follow Up Trial P05712|352||
60118311|NCT00703014|76239404|FG003|STARTED|Fetuses/Infants Follow Up Trial P05712|Fetuses in Follow Up Trial P05712|326||
60118312|NCT00703014|76239401|FG000|Live Born Infants|Fetuses/Infants Follow Up Trial P05712||0||
60118313|NCT00703014|76239402|FG001|Live Born Infants|Fetuses/Infants Follow Up Trial P05712||0||
60118314|NCT00703014|76239403|FG002|Live Born Infants|Fetuses/Infants Follow Up Trial P05712|Live born infants in Follow Up Trail P05712|344||
60118315|NCT00703014|76239404|FG003|Live Born Infants|Fetuses/Infants Follow Up Trial P05712|Live born infants in Follow Up Trail P05712|315||
60118316|NCT00703014|76239401|FG000|COMPLETED|Fetuses/Infants Follow Up Trial P05712||0||
60118317|NCT00703014|76239402|FG001|COMPLETED|Fetuses/Infants Follow Up Trial P05712||0||
60118318|NCT00703014|76239403|FG002|COMPLETED|Fetuses/Infants Follow Up Trial P05712|Infants in P05712 with Follow Up Completed|305||
60118319|NCT00703014|76239404|FG003|COMPLETED|Fetuses/Infants Follow Up Trial P05712|Infants in P05712 with Follow Up Completed|284||
60118320|NCT00703014|76239401|FG000|NOT COMPLETED|Fetuses/Infants Follow Up Trial P05712||0||
60118321|NCT00703014|76239402|FG001|NOT COMPLETED|Fetuses/Infants Follow Up Trial P05712||0||
60118322|NCT00703014|76239403|FG002|NOT COMPLETED|Fetuses/Infants Follow Up Trial P05712||47||
60118323|NCT00703014|76239404|FG003|NOT COMPLETED|Fetuses/Infants Follow Up Trial P05712||42||
60118324|NCT00255177|76239418|FG000|STARTED|Overall Study||11||
60118325|NCT00255177|76239419|FG001|STARTED|Overall Study||14||
60118326|NCT00255177|76239420|FG002|STARTED|Overall Study||13||
60118327|NCT00255177|76239421|FG003|STARTED|Overall Study||6||
60118328|NCT00255177|76239418|FG000|COMPLETED|Overall Study||9||
60118329|NCT00255177|76239419|FG001|COMPLETED|Overall Study||13||
60118330|NCT00255177|76239420|FG002|COMPLETED|Overall Study||12||
60118331|NCT00255177|76239421|FG003|COMPLETED|Overall Study||4||
60118332|NCT00255177|76239418|FG000|NOT COMPLETED|Overall Study||2||
60118333|NCT00255177|76239419|FG001|NOT COMPLETED|Overall Study||1||
60118334|NCT00255177|76239420|FG002|NOT COMPLETED|Overall Study||1||
60118335|NCT00255177|76239421|FG003|NOT COMPLETED|Overall Study||2||
60118336|NCT00702624|76239433|FG000|STARTED|Base Study P05690 (NCT00702845)||268||
60118337|NCT00702624|76239434|FG001|STARTED|Base Study P05690 (NCT00702845)||128||
60118338|NCT00702624|76239435|FG002|STARTED|Base Study P05690 (NCT00702845)||0||
60118339|NCT00702624|76239436|FG003|STARTED|Base Study P05690 (NCT00702845)||0||
60118340|NCT00702624|76239433|FG000|COMPLETED|Base Study P05690 (NCT00702845)|To complete study, participants from the base study P05690 (NCT00702845) had embryos transferred.|246||
60118341|NCT00702624|76239434|FG001|COMPLETED|Base Study P05690 (NCT00702845)|To complete study, participants from the base study P05690 (NCT00702845) had embryos transferred.|121||
60118342|NCT00702624|76239435|FG002|COMPLETED|Base Study P05690 (NCT00702845)||0||
60118343|NCT00702624|76239436|FG003|COMPLETED|Base Study P05690 (NCT00702845)||0||
60118344|NCT00702624|76239433|FG000|NOT COMPLETED|Base Study P05690 (NCT00702845)||22||
60118345|NCT00702624|76239434|FG001|NOT COMPLETED|Base Study P05690 (NCT00702845)||7||
60118346|NCT00702624|76239435|FG002|NOT COMPLETED|Base Study P05690 (NCT00702845)||0||
60118347|NCT00702624|76239436|FG003|NOT COMPLETED|Base Study P05690 (NCT00702845)||0||
60118348|NCT00702624|76239433|FG000|STARTED|Expectant Mother Follow-up||68||
60118349|NCT00702624|76239434|FG001|STARTED|Expectant Mother Follow-up||45||
60118350|NCT00702624|76239435|FG002|STARTED|Expectant Mother Follow-up||0||
60118351|NCT00702624|76239436|FG003|STARTED|Expectant Mother Follow-up||0||
60118352|NCT00702624|76239433|FG000|COMPLETED|Expectant Mother Follow-up|To complete the study, participants must have completed a follow-up visit at 4-12 weeks postpartum.|61||
60118353|NCT00702624|76239434|FG001|COMPLETED|Expectant Mother Follow-up|To complete the study, participants must have completed a follow-up visit at 4-12 weeks postpartum.|45||
60118354|NCT00702624|76239435|FG002|COMPLETED|Expectant Mother Follow-up||0||
60118355|NCT00702624|76239436|FG003|COMPLETED|Expectant Mother Follow-up||0||
60118356|NCT00702624|76239433|FG000|NOT COMPLETED|Expectant Mother Follow-up||7||
60118357|NCT00702624|76239434|FG001|NOT COMPLETED|Expectant Mother Follow-up||0||
60118358|NCT00702624|76239435|FG002|NOT COMPLETED|Expectant Mother Follow-up||0||
60118359|NCT00702624|76239436|FG003|NOT COMPLETED|Expectant Mother Follow-up||0||
60118360|NCT00702624|76239433|FG000|STARTED|Fetuses/Infant Follow-up||0||
60118361|NCT00702624|76239434|FG001|STARTED|Fetuses/Infant Follow-up||0||
60118362|NCT00702624|76239435|FG002|STARTED|Fetuses/Infant Follow-up||88||
60118363|NCT00702624|76239436|FG003|STARTED|Fetuses/Infant Follow-up||55||
60118364|NCT00702624|76239433|FG000|Live Born Infants|Fetuses/Infant Follow-up||0||
60118365|NCT00702624|76239434|FG001|Live Born Infants|Fetuses/Infant Follow-up||0||
60118366|NCT00702624|76239435|FG002|Live Born Infants|Fetuses/Infant Follow-up|Infants born to eligible mothers were followed for safety and efficacy|80||
60118367|NCT00702624|76239436|FG003|Live Born Infants|Fetuses/Infant Follow-up|Infants born to eligible mothers were followed for safety and efficacy.|55||
60118368|NCT00702624|76239433|FG000|COMPLETED|Fetuses/Infant Follow-up||0||
60118369|NCT00702624|76239434|FG001|COMPLETED|Fetuses/Infant Follow-up||0||
60118370|NCT00702624|76239435|FG002|COMPLETED|Fetuses/Infant Follow-up|To complete the study, infants must have completed a follow-up visit at 4-12 weeks postpartum.|78||
60118371|NCT00702624|76239436|FG003|COMPLETED|Fetuses/Infant Follow-up|To complete the study, infants must have completed a follow-up visit at 4-12 weeks postpartum.|55||
60118372|NCT00702624|76239433|FG000|NOT COMPLETED|Fetuses/Infant Follow-up||0||
60118373|NCT00702624|76239434|FG001|NOT COMPLETED|Fetuses/Infant Follow-up||0||
60118374|NCT00702624|76239435|FG002|NOT COMPLETED|Fetuses/Infant Follow-up||10||
60118375|NCT00702624|76239436|FG003|NOT COMPLETED|Fetuses/Infant Follow-up||0||
60118376|NCT03915496|76239452|FG000|STARTED|Overall Study||16||
60118377|NCT03915496|76239453|FG001|STARTED|Overall Study||14||
60118378|NCT03915496|76239454|FG002|STARTED|Overall Study||16||
59716580|NCT01167192|75835456|FG000|NOT COMPLETED|Overall Study||4||
60118379|NCT03915496|76239452|FG000|COMPLETED|Overall Study||14||
60118380|NCT03915496|76239453|FG001|COMPLETED|Overall Study||13||
60118381|NCT03915496|76239454|FG002|COMPLETED|Overall Study||14||
60118382|NCT03915496|76239452|FG000|NOT COMPLETED|Overall Study||2||
60118383|NCT03915496|76239453|FG001|NOT COMPLETED|Overall Study||1||
60118384|NCT03915496|76239454|FG002|NOT COMPLETED|Overall Study||2||
60118385|NCT00702546|76239464|FG000|STARTED|Base Study P05690 (NCT00702845)||268||
59830348|NCT00203476|75953724|FG002|NOT COMPLETED|Overall Study||0||
59830349|NCT00203242|75953732|FG000|STARTED|Overall Study||15||
59830350|NCT00203242|75953732|FG000|COMPLETED|Overall Study||14||
59830351|NCT00203242|75953732|FG000|NOT COMPLETED|Overall Study||1||
59830352|NCT00200356|75953738|FG000|STARTED|Overall Study||199||
59830353|NCT00200356|75953739|FG001|STARTED|Overall Study||202||
59830354|NCT00200356|75953738|FG000|Safety Analysis Set|Overall Study||194||
59830355|NCT00200356|75953739|FG001|Safety Analysis Set|Overall Study||198||
59830356|NCT00200356|75953738|FG000|COMPLETED|Overall Study||191||
59830357|NCT00200356|75953739|FG001|COMPLETED|Overall Study||195||
59830358|NCT00200356|75953738|FG000|NOT COMPLETED|Overall Study||8||
59830359|NCT00200356|75953739|FG001|NOT COMPLETED|Overall Study||7||
59830360|NCT00227344|75953747|FG000|STARTED|Overall Study||87||
59830361|NCT00227344|75953748|FG001|STARTED|Overall Study||42||
59830362|NCT00227344|75953747|FG000|COMPLETED|Overall Study||75||
59830363|NCT00227344|75953748|FG001|COMPLETED|Overall Study||37||
59830364|NCT00227344|75953747|FG000|NOT COMPLETED|Overall Study||12||
59830365|NCT00227344|75953748|FG001|NOT COMPLETED|Overall Study||5||
59830366|NCT00227266|75953757|FG000|STARTED|Overall Study||31||
59830367|NCT00227266|75953758|FG001|STARTED|Overall Study||30||
59830368|NCT00227266|75953759|FG002|STARTED|Overall Study||33||
59830369|NCT00227266|75953757|FG000|COMPLETED|Overall Study||30||
59830370|NCT00227266|75953758|FG001|COMPLETED|Overall Study||30||
59830371|NCT00227266|75953759|FG002|COMPLETED|Overall Study||29||
59830372|NCT00227266|75953757|FG000|NOT COMPLETED|Overall Study||1||
59830373|NCT00227266|75953758|FG001|NOT COMPLETED|Overall Study||0||
59830374|NCT00227266|75953759|FG002|NOT COMPLETED|Overall Study||4||
59830375|NCT00256282|75953770|FG000|STARTED|Overall Study||52||
59830376|NCT00256282|75953770|FG000|COMPLETED|Overall Study||36||
59830377|NCT00256282|75953770|FG000|NOT COMPLETED|Overall Study||16||
59830378|NCT00266877|75953777|FG000|STARTED|Overall Study||91||
59830379|NCT00266877|75953778|FG001|STARTED|Overall Study||48||
59830380|NCT00266877|75953779|FG002|STARTED|Overall Study||28||
59830381|NCT00266877|75953777|FG000|COMPLETED|Overall Study||0||
59830382|NCT00266877|75953778|FG001|COMPLETED|Overall Study||0||
59830383|NCT00266877|75953779|FG002|COMPLETED|Overall Study||0||
59830384|NCT00266877|75953777|FG000|NOT COMPLETED|Overall Study||91||
59830385|NCT00266877|75953778|FG001|NOT COMPLETED|Overall Study||48||
59830386|NCT00266877|75953779|FG002|NOT COMPLETED|Overall Study||28||
59830387|NCT00256204|75953791|FG000|STARTED|Overall Study||298||
59830388|NCT00256204|75953792|FG001|STARTED|Overall Study||288||
59830389|NCT00256204|75953793|FG002|STARTED|Overall Study||295||
59830390|NCT00256204|75953794|FG003|STARTED|Overall Study||293||
59830391|NCT00256204|75953791|FG000|COMPLETED|Overall Study||231||
59830392|NCT00256204|75953792|FG001|COMPLETED|Overall Study||238||
59830393|NCT00256204|75953793|FG002|COMPLETED|Overall Study||241||
59830394|NCT00256204|75953794|FG003|COMPLETED|Overall Study||244||
59830395|NCT00256204|75953791|FG000|NOT COMPLETED|Overall Study||67||
59830396|NCT00256204|75953792|FG001|NOT COMPLETED|Overall Study||50||
59830397|NCT00256204|75953793|FG002|NOT COMPLETED|Overall Study||54||
59830398|NCT00256204|75953794|FG003|NOT COMPLETED|Overall Study||49||
59830399|NCT00256126|75953809|FG000|STARTED|Overall Study||149||
59830400|NCT00256126|75953810|FG001|STARTED|Overall Study||169||
59830401|NCT00256126|75953809|FG000|COMPLETED|Overall Study||147||
59830402|NCT00256126|75953810|FG001|COMPLETED|Overall Study||167||
59830403|NCT00256126|75953809|FG000|NOT COMPLETED|Overall Study||2||
59830404|NCT00256126|75953810|FG001|NOT COMPLETED|Overall Study||2||
59830405|NCT00278889|75953819|FG000|STARTED|Overall Study|Randomised|73||
59830406|NCT00278889|75953820|FG001|STARTED|Overall Study|Randomised|74||
59830407|NCT00278889|75953821|FG002|STARTED|Overall Study|Randomised|68||
59830408|NCT00278889|75953819|FG000|Overall Survival Analysis|Overall Study|Ongoing at data cut-off for OS analysis (30 January 2009)|16||
59830409|NCT00278889|75953820|FG001|Overall Survival Analysis|Overall Study|Ongoing at data cut-off for OS analysis (30 January 2009)|20||
59830410|NCT00278889|75953821|FG002|Overall Survival Analysis|Overall Study|Ongoing at data cut-off for OS analysis (30 January 2009)|19||
59830411|NCT00278889|75953819|FG000|COMPLETED|Overall Study|Ongoing at data cut-off for PFS analysis (November 2007)|48||
59830412|NCT00278889|75953820|FG001|COMPLETED|Overall Study|Ongoing at data cut-off for PFS analysis (November 2007)|47||
59830413|NCT00278889|75953821|FG002|COMPLETED|Overall Study|Ongoing at data cut-off for PFS analysis (November 2007)|48||
59830414|NCT00278889|75953819|FG000|NOT COMPLETED|Overall Study||25||
59830415|NCT00278889|75953820|FG001|NOT COMPLETED|Overall Study||27||
60118386|NCT00702546|76239465|FG001|STARTED|Base Study P05690 (NCT00702845)||128||
59830416|NCT00278889|75953821|FG002|NOT COMPLETED|Overall Study||20||
59830417|NCT00278109|75953829|FG000|STARTED|Overall Study||25||
59830418|NCT00278109|75953829|FG000|Completed 3 Cycles of Chemotherapy|Overall Study||25||
59830419|NCT00278109|75953829|FG000|COMPLETED|Overall Study||21||
59830420|NCT00278109|75953829|FG000|NOT COMPLETED|Overall Study||4||
59830421|NCT00296517|75953835|FG000|STARTED|Dose Level 1 - Week 1||159||
59830422|NCT00296517|75953836|FG001|STARTED|Dose Level 1 - Week 1||166||
59830423|NCT00296517|75953835|FG000|COMPLETED|Dose Level 1 - Week 1||159||
59830424|NCT00296517|75953836|FG001|COMPLETED|Dose Level 1 - Week 1||166||
59830425|NCT00296517|75953835|FG000|NOT COMPLETED|Dose Level 1 - Week 1||0||
59830426|NCT00296517|75953836|FG001|NOT COMPLETED|Dose Level 1 - Week 1||0||
59830427|NCT00296517|75953835|FG000|STARTED|Dose Level 2 - Week 2||159||
59830428|NCT00296517|75953836|FG001|STARTED|Dose Level 2 - Week 2||166||
59830429|NCT00296517|75953835|FG000|COMPLETED|Dose Level 2 - Week 2||157||
59830430|NCT00296517|75953836|FG001|COMPLETED|Dose Level 2 - Week 2||161||
59830431|NCT00296517|75953835|FG000|NOT COMPLETED|Dose Level 2 - Week 2||2||
59830432|NCT00296517|75953836|FG001|NOT COMPLETED|Dose Level 2 - Week 2||5||
59830433|NCT00296517|75953835|FG000|STARTED|Dose Level 3 - Weeks 3-12||157||
59830434|NCT00296517|75953836|FG001|STARTED|Dose Level 3 - Weeks 3-12||161||
59830435|NCT00296517|75953835|FG000|COMPLETED|Dose Level 3 - Weeks 3-12||112||
59830436|NCT00296517|75953836|FG001|COMPLETED|Dose Level 3 - Weeks 3-12||99||
59830437|NCT00296517|75953835|FG000|NOT COMPLETED|Dose Level 3 - Weeks 3-12||45||
59830438|NCT00296517|75953836|FG001|NOT COMPLETED|Dose Level 3 - Weeks 3-12||62||
59830439|NCT00224770|75953845|FG000|STARTED|Overall Study||42||
59830440|NCT00224770|75953846|FG001|STARTED|Overall Study||54||
59830441|NCT00224770|75953847|FG002|STARTED|Overall Study||14||
59830442|NCT00224770|75953845|FG000|COMPLETED|Overall Study||38||
59830443|NCT00224770|75953846|FG001|COMPLETED|Overall Study||52||
59830444|NCT00224770|75953847|FG002|COMPLETED|Overall Study||14||
59830445|NCT00224770|75953845|FG000|NOT COMPLETED|Overall Study||4||
59830446|NCT00224770|75953846|FG001|NOT COMPLETED|Overall Study||2||
59830447|NCT00224770|75953847|FG002|NOT COMPLETED|Overall Study||0||
59830448|NCT00266409|75953860|FG000|STARTED|Overall Study||137||
59830449|NCT00266409|75953861|FG001|STARTED|Overall Study||138||
59830450|NCT00266409|75953862|FG002|STARTED|Overall Study||72||
59830451|NCT00266409|75953863|FG003|STARTED|Overall Study||71||
59830452|NCT00266409|75953860|FG000|COMPLETED|Overall Study||92||
59830453|NCT00266409|75953861|FG001|COMPLETED|Overall Study||92||
59830454|NCT00266409|75953862|FG002|COMPLETED|Overall Study||55||
59830455|NCT00266409|75953863|FG003|COMPLETED|Overall Study||49||
59830456|NCT00266409|75953860|FG000|NOT COMPLETED|Overall Study||45||
59830457|NCT00266409|75953861|FG001|NOT COMPLETED|Overall Study||46||
59830458|NCT00266409|75953862|FG002|NOT COMPLETED|Overall Study||17||
59830459|NCT00266409|75953863|FG003|NOT COMPLETED|Overall Study||22||
59830460|NCT00277095|75953873|FG000|STARTED|Overall Study|Anatomy of 1 patient did not allow ProACT to be implanted, hence only 123 patients were implanted.|124||
59830461|NCT00277095|75953873|FG000|COMPLETED|Overall Study|Details of patients who did not complete study are given below.|103||
59830462|NCT00277095|75953873|FG000|NOT COMPLETED|Overall Study||21||
59830463|NCT00265785|75953877|FG000|STARTED|Overall Study||27||
59830464|NCT00265785|75953877|FG000|Eligible|Overall Study||26||
59830465|NCT00265785|75953877|FG000|Eligible and Began Protocol Treatment|Overall Study||24||
59830466|NCT00265785|75953877|FG000|COMPLETED|Overall Study||0||
59830467|NCT00265785|75953877|FG000|NOT COMPLETED|Overall Study||27||
59830468|NCT00276159|75953881|FG000|STARTED|Overall Study||6||
59830469|NCT00276159|75953881|FG000|COMPLETED|Overall Study||0||
59830470|NCT00276159|75953881|FG000|NOT COMPLETED|Overall Study||6||
59830471|NCT00265395|75953887|FG000|STARTED|Overall Study||86||
59830472|NCT00265395|75953888|FG001|STARTED|Overall Study||73||
59830473|NCT00265395|75953887|FG000|COMPLETED|Overall Study||78||
59830474|NCT00265395|75953888|FG001|COMPLETED|Overall Study||56||
59830475|NCT00265395|75953887|FG000|NOT COMPLETED|Overall Study||8||
59830476|NCT00265395|75953888|FG001|NOT COMPLETED|Overall Study||17||
59830477|NCT00195442|75953893|FG000|STARTED|Overall Study||288||
59830478|NCT00195442|75953893|FG000|COMPLETED|Overall Study||152||
59830479|NCT00195442|75953893|FG000|NOT COMPLETED|Overall Study||136||
59830480|NCT00275301|75953897|FG000|STARTED|Overall Study||19||
59830481|NCT00275301|75953897|FG000|COMPLETED|Overall Study||14||
59716581|NCT01166958|75835462|FG000|STARTED|Overall Study||13||
59716582|NCT01166958|75835463|FG001|STARTED|Overall Study||13||
59716583|NCT01166958|75835462|FG000|COMPLETED|Overall Study||12||
59830482|NCT00275301|75953897|FG000|NOT COMPLETED|Overall Study||5||
59716584|NCT01166958|75835463|FG001|COMPLETED|Overall Study||13||
59716585|NCT01166958|75835462|FG000|NOT COMPLETED|Overall Study||1||
59716586|NCT01166958|75835463|FG001|NOT COMPLETED|Overall Study||0||
59716587|NCT01170221|75835471|FG000|STARTED|Overall Study||332||
59716588|NCT01170221|75835472|FG001|STARTED|Overall Study||335||
59716589|NCT01170221|75835471|FG000|COMPLETED|Overall Study||299||
59830483|NCT00251745|75953904|FG000|STARTED|Overall Study||292||
59830484|NCT00251745|75953905|FG001|STARTED|Overall Study||312||
59830485|NCT00251745|75953906|FG002|STARTED|Overall Study||304||
59830486|NCT00251745|75953904|FG000|COMPLETED|Overall Study||264||
59830487|NCT00251745|75953905|FG001|COMPLETED|Overall Study||285||
59716590|NCT01170221|75835472|FG001|COMPLETED|Overall Study||307||
59716591|NCT01170221|75835471|FG000|NOT COMPLETED|Overall Study||33||
59830488|NCT00251745|75953906|FG002|COMPLETED|Overall Study||277||
59830489|NCT00251745|75953904|FG000|NOT COMPLETED|Overall Study||28||
59830490|NCT00251745|75953905|FG001|NOT COMPLETED|Overall Study||27||
59830491|NCT00251745|75953906|FG002|NOT COMPLETED|Overall Study||27||
59830492|NCT00255190|75953916|FG000|STARTED|Overall Study||153||
59830493|NCT00255190|75953917|FG001|STARTED|Overall Study||438||
59830494|NCT00255190|75953916|FG000|COMPLETED|Overall Study||103||
59830495|NCT00255190|75953917|FG001|COMPLETED|Overall Study||281||
59830496|NCT00255190|75953916|FG000|NOT COMPLETED|Overall Study||50||
59830497|NCT00255190|75953917|FG001|NOT COMPLETED|Overall Study||157||
59830498|NCT00359424|75953925|FG000|STARTED|Overall Study||434||
59830499|NCT00359424|75953926|FG001|STARTED|Overall Study||222||
59830500|NCT00359424|75953925|FG000|90 Day Follow up|Overall Study||343||
59830501|NCT00359424|75953926|FG001|90 Day Follow up|Overall Study||172||
59830502|NCT00359424|75953925|FG000|180 Day Follow up|Overall Study||325||
59830503|NCT00359424|75953926|FG001|180 Day Follow up|Overall Study||167||
59830504|NCT00359424|75953925|FG000|270 Day Follow up|Overall Study||313||
59830505|NCT00359424|75953926|FG001|270 Day Follow up|Overall Study||159||
59830506|NCT00359424|75953925|FG000|COMPLETED|Overall Study||304||
59830507|NCT00359424|75953926|FG001|COMPLETED|Overall Study||155||
59830508|NCT00359424|75953925|FG000|NOT COMPLETED|Overall Study||130||
59830509|NCT00359424|75953926|FG001|NOT COMPLETED|Overall Study||67||
59830510|NCT00255034|75953934|FG000|STARTED|Overall Study||79||
59830511|NCT00255034|75953935|FG001|STARTED|Overall Study||64||
59830512|NCT00255034|75953934|FG000|COMPLETED|Overall Study||64||
59830513|NCT00255034|75953935|FG001|COMPLETED|Overall Study||26||
59830514|NCT00255034|75953934|FG000|NOT COMPLETED|Overall Study||15||
59830515|NCT00255034|75953935|FG001|NOT COMPLETED|Overall Study||38||
59830516|NCT00254566|75953943|FG000|STARTED|Overall Study||198||
59830517|NCT00254566|75953944|FG001|STARTED|Overall Study||198||
59830518|NCT00254566|75953943|FG000|COMPLETED|Overall Study||167||
59830519|NCT00254566|75953944|FG001|COMPLETED|Overall Study||172||
59830520|NCT00254566|75953943|FG000|NOT COMPLETED|Overall Study||31||
59830521|NCT00254566|75953944|FG001|NOT COMPLETED|Overall Study||26||
59830522|NCT00358956|75953950|FG000|STARTED|Overall Study||19||
59830523|NCT00358956|75953950|FG000|COMPLETED|Overall Study|ongoing study treatment at data cut-off|11||
59830524|NCT00358956|75953950|FG000|NOT COMPLETED|Overall Study||8||
59830525|NCT03830892|75953956|FG000|STARTED|Overall Study||25||
59830526|NCT03830892|75953957|FG001|STARTED|Overall Study||23||
59830527|NCT03830892|75953956|FG000|15 Watts, 10 mg Nicotine|Overall Study||19||
59830528|NCT03830892|75953957|FG001|15 Watts, 10 mg Nicotine|Overall Study||17||
59830529|NCT03830892|75953956|FG000|15 Watts, 30 mg Nicotine|Overall Study||19||
59830530|NCT03830892|75953957|FG001|15 Watts, 30 mg Nicotine|Overall Study||17||
59830531|NCT03830892|75953956|FG000|30 Watts, 10 mg Nicotine|Overall Study||19||
59830532|NCT03830892|75953957|FG001|30 Watts, 10 mg Nicotine|Overall Study||17||
59830533|NCT03830892|75953956|FG000|30 Watts, 30 mg Nicotine|Overall Study||19||
59830534|NCT03830892|75953957|FG001|30 Watts, 30 mg Nicotine|Overall Study||17||
59830535|NCT03830892|75953956|FG000|Own Brand|Overall Study||19|Exclusive e-cigarette users only used e-cigarettes during own brand session, dual users used either their cigarettes and e-cigarettes. Completion of either one considered a milestone depending on study arm|
59830536|NCT03830892|75953957|FG001|Own Brand|Overall Study||17|Exclusive e-cigarette users only used e-cigarettes during own brand session, dual users used either their cigarettes and e-cigarettes. Completion of either one considered a milestone depending on study arm|
59830537|NCT03830892|75953956|FG000|COMPLETED|Overall Study||19||
59830538|NCT03830892|75953957|FG001|COMPLETED|Overall Study||17||
59830539|NCT03830892|75953956|FG000|NOT COMPLETED|Overall Study||6||
59830540|NCT03830892|75953957|FG001|NOT COMPLETED|Overall Study||6||
59830541|NCT00253630|75953963|FG000|STARTED|Overall Study||37||
59830542|NCT00253630|75953963|FG000|COMPLETED|Overall Study||35||
59830543|NCT00253630|75953963|FG000|NOT COMPLETED|Overall Study||2||
59830544|NCT00358644|75953967|FG000|STARTED|Overall Study||55||
59830545|NCT00358644|75953967|FG000|COMPLETED|Overall Study||5||
59830546|NCT00358644|75953967|FG000|NOT COMPLETED|Overall Study||50||
59830547|NCT00364182|75953974|FG000|STARTED|First Intervention||3||
59716592|NCT01170221|75835472|FG001|NOT COMPLETED|Overall Study||28||
59716593|NCT01166646|75835480|FG000|STARTED|Overall Study||21||
59716594|NCT01166646|75835481|FG001|STARTED|Overall Study||22||
59830548|NCT00364182|75953975|FG001|STARTED|First Intervention||22||
59716595|NCT01166646|75835480|FG000|COMPLETED|Overall Study||20||
59830549|NCT00364182|75953976|FG002|STARTED|First Intervention||25||
59830550|NCT00364182|75953974|FG000|COMPLETED|First Intervention||0||
59830551|NCT00364182|75953975|FG001|COMPLETED|First Intervention||22||
59830552|NCT00364182|75953976|FG002|COMPLETED|First Intervention||25||
59716596|NCT01166646|75835481|FG001|COMPLETED|Overall Study||21||
59716597|NCT01166646|75835480|FG000|NOT COMPLETED|Overall Study||1||
59716598|NCT01166646|75835481|FG001|NOT COMPLETED|Overall Study||1||
59716599|NCT01129284|75835490|FG000|STARTED|Overall Study||5||
59716600|NCT01129284|75835491|FG001|STARTED|Overall Study||5||
59716601|NCT01129284|75835492|FG002|STARTED|Overall Study||5||
59830553|NCT00364182|75953974|FG000|NOT COMPLETED|First Intervention||3||
59830554|NCT00364182|75953975|FG001|NOT COMPLETED|First Intervention||0||
59830555|NCT00364182|75953976|FG002|NOT COMPLETED|First Intervention||0||
59830556|NCT00364182|75953974|FG000|STARTED|Second Intervention||0||
59830557|NCT00364182|75953975|FG001|STARTED|Second Intervention||22||
59716602|NCT01129284|75835490|FG000|COMPLETED|Overall Study||3||
59716603|NCT01129284|75835491|FG001|COMPLETED|Overall Study||5||
59830558|NCT00364182|75953976|FG002|STARTED|Second Intervention||25||
59830559|NCT00364182|75953974|FG000|Randomized|Second Intervention||0||
59830560|NCT00364182|75953975|FG001|Randomized|Second Intervention||22||
59830561|NCT00364182|75953976|FG002|Randomized|Second Intervention||25||
59830562|NCT00364182|75953974|FG000|COMPLETED|Second Intervention||0||
59830563|NCT00364182|75953975|FG001|COMPLETED|Second Intervention||20||
59830564|NCT00364182|75953976|FG002|COMPLETED|Second Intervention||23||
59830565|NCT00364182|75953974|FG000|NOT COMPLETED|Second Intervention||0||
59830566|NCT00364182|75953975|FG001|NOT COMPLETED|Second Intervention||2||
59830567|NCT00364182|75953976|FG002|NOT COMPLETED|Second Intervention||2||
59830568|NCT00364182|75953974|FG000|STARTED|Third Intervention||0||
59830569|NCT00364182|75953975|FG001|STARTED|Third Intervention||20||
59830570|NCT00364182|75953976|FG002|STARTED|Third Intervention||23||
59830571|NCT00364182|75953974|FG000|COMPLETED|Third Intervention||0||
59830572|NCT00364182|75953975|FG001|COMPLETED|Third Intervention||19||
59830573|NCT00364182|75953976|FG002|COMPLETED|Third Intervention||22||
59830574|NCT00364182|75953974|FG000|NOT COMPLETED|Third Intervention||0||
59830575|NCT00364182|75953975|FG001|NOT COMPLETED|Third Intervention||1||
59830576|NCT00364182|75953976|FG002|NOT COMPLETED|Third Intervention||1||
59830577|NCT00364182|75953974|FG000|STARTED|Fourth Intervention||0||
59830578|NCT00364182|75953975|FG001|STARTED|Fourth Intervention||19||
59830579|NCT00364182|75953976|FG002|STARTED|Fourth Intervention||22||
59830580|NCT00364182|75953974|FG000|COMPLETED|Fourth Intervention||0||
59830581|NCT00364182|75953975|FG001|COMPLETED|Fourth Intervention||19||
59830582|NCT00364182|75953976|FG002|COMPLETED|Fourth Intervention||22||
59830583|NCT00364182|75953974|FG000|NOT COMPLETED|Fourth Intervention||0||
59830584|NCT00364182|75953975|FG001|NOT COMPLETED|Fourth Intervention||0||
59830585|NCT00364182|75953976|FG002|NOT COMPLETED|Fourth Intervention||0||
59830586|NCT00369486|75953991|FG000|STARTED|4-Week Visit|Number of eyes|38||
59830587|NCT00369486|75953992|FG001|STARTED|4-Week Visit|Number of eyes|21||
59830588|NCT00369486|75953993|FG002|STARTED|4-Week Visit|Number of eyes|23||
59830589|NCT00369486|75953994|FG003|STARTED|4-Week Visit|Number of eyes|22||
59830590|NCT00369486|75953995|FG004|STARTED|4-Week Visit|Number of eyes|25||
59830591|NCT00369486|75953991|FG000|COMPLETED|4-Week Visit|Number of eyes|36||
59830592|NCT00369486|75953992|FG001|COMPLETED|4-Week Visit|Number of eyes;|19||
59830593|NCT00369486|75953993|FG002|COMPLETED|4-Week Visit|Number of eyes|22||
59830594|NCT00369486|75953994|FG003|COMPLETED|4-Week Visit|Number of eyes|20||
59830595|NCT00369486|75953995|FG004|COMPLETED|4-Week Visit|Number of eyes|24||
59830596|NCT00369486|75953991|FG000|NOT COMPLETED|4-Week Visit||2||
59830597|NCT00369486|75953992|FG001|NOT COMPLETED|4-Week Visit||2||
59830598|NCT00369486|75953993|FG002|NOT COMPLETED|4-Week Visit||1||
59830599|NCT00369486|75953994|FG003|NOT COMPLETED|4-Week Visit||2||
59830600|NCT00369486|75953995|FG004|NOT COMPLETED|4-Week Visit||1||
59830601|NCT00369486|75953991|FG000|STARTED|8-Week Visit|Number of eyes|38||
59830602|NCT00369486|75953992|FG001|STARTED|8-Week Visit|Number of eyes|21||
59830603|NCT00369486|75953993|FG002|STARTED|8-Week Visit|Number of eyes|22||
59830604|NCT00369486|75953994|FG003|STARTED|8-Week Visit|Number of eyes|22||
59830605|NCT00369486|75953995|FG004|STARTED|8-Week Visit|Number of eyes|25||
59830606|NCT00369486|75953991|FG000|COMPLETED|8-Week Visit|Number of eyes|38||
60118387|NCT00702546|76239464|FG000|COMPLETED|Base Study P05690 (NCT00702845)|To complete study, participants from the base study P05690 (NCT00702845) had embryos transferred.|246||
60118388|NCT00702546|76239465|FG001|COMPLETED|Base Study P05690 (NCT00702845)|To complete study, participants from the base study P05690 (NCT00702845) had embryos transferred.|121||
60118389|NCT00702546|76239464|FG000|NOT COMPLETED|Base Study P05690 (NCT00702845)||22||
60118390|NCT00702546|76239465|FG001|NOT COMPLETED|Base Study P05690 (NCT00702845)||7||
59716604|NCT01129284|75835492|FG002|COMPLETED|Overall Study||4||
59716605|NCT01129284|75835490|FG000|NOT COMPLETED|Overall Study||2||
59716606|NCT01129284|75835491|FG001|NOT COMPLETED|Overall Study||0||
59716607|NCT01129284|75835492|FG002|NOT COMPLETED|Overall Study||1||
59716608|NCT01166568|75835503|FG000|STARTED|Deferred Implantation- Randomized||0||0
59716609|NCT01166568|75835504|FG001|STARTED|Deferred Implantation- Randomized||0||0
59716610|NCT01166568|75835505|FG002|STARTED|Deferred Implantation- Randomized||16||32
59716611|NCT01166568|75835503|FG000|COMPLETED|Deferred Implantation- Randomized||0||0
59716612|NCT01166568|75835504|FG001|COMPLETED|Deferred Implantation- Randomized||0||0
59716613|NCT01166568|75835505|FG002|COMPLETED|Deferred Implantation- Randomized|From the randomized sub-study control group (n=16), 1 subject withdrew during the observation phase|15||30
59716614|NCT01166568|75835503|FG000|NOT COMPLETED|Deferred Implantation- Randomized||0||0
59716615|NCT01166568|75835504|FG001|NOT COMPLETED|Deferred Implantation- Randomized||0||0
59716616|NCT01166568|75835505|FG002|NOT COMPLETED|Deferred Implantation- Randomized||1||2
59830607|NCT00369486|75953992|FG001|COMPLETED|8-Week Visit|Number of eyes|20||
59830608|NCT00369486|75953993|FG002|COMPLETED|8-Week Visit|Number of eyes|22||
59830609|NCT00369486|75953994|FG003|COMPLETED|8-Week Visit|Number of eyes|21||
59830610|NCT00369486|75953995|FG004|COMPLETED|8-Week Visit|Number of eyes|24||
59830611|NCT00369486|75953991|FG000|NOT COMPLETED|8-Week Visit||0||
59830612|NCT00369486|75953992|FG001|NOT COMPLETED|8-Week Visit||1||
59830613|NCT00369486|75953993|FG002|NOT COMPLETED|8-Week Visit||0||
59830614|NCT00369486|75953994|FG003|NOT COMPLETED|8-Week Visit||1||
59830615|NCT00369486|75953995|FG004|NOT COMPLETED|8-Week Visit||1||
59830616|NCT00369486|75953991|FG000|STARTED|17-Week Visit|Number of eyes|38||
59830617|NCT00369486|75953992|FG001|STARTED|17-Week Visit|Number of eyes|21||
59830618|NCT00369486|75953993|FG002|STARTED|17-Week Visit|Number of eyes|23||
59830619|NCT00369486|75953994|FG003|STARTED|17-Week Visit|Number of eyes|22||
59830620|NCT00369486|75953995|FG004|STARTED|17-Week Visit|Number of eyes|25||
59830621|NCT00369486|75953991|FG000|COMPLETED|17-Week Visit|Number of eyes|38||
60118391|NCT00702546|76239464|FG000|STARTED|Follow Up Study P05711 (NCT00702546)|Participants from base study P05690 with at least one embryo thawed for use in FTET cycle.|77||
60118392|NCT00702546|76239465|FG001|STARTED|Follow Up Study P05711 (NCT00702546)|Participants from base study P05690 with at least one embryo thawed for use in FTET cycle.|25||
60118393|NCT00702546|76239464|FG000|COMPLETED|Follow Up Study P05711 (NCT00702546)|Participants with embryo transfer in any FTET cycle|72||
60118394|NCT00702546|76239465|FG001|COMPLETED|Follow Up Study P05711 (NCT00702546)|Participants with embryo transfer in any FTET cycle|24||
60118395|NCT00702546|76239464|FG000|NOT COMPLETED|Follow Up Study P05711 (NCT00702546)||5||
60118396|NCT00702546|76239465|FG001|NOT COMPLETED|Follow Up Study P05711 (NCT00702546)||1||
60118397|NCT02709330|76239471|FG000|STARTED|Overall Study||50||
60118398|NCT02709330|76239472|FG001|STARTED|Overall Study||10||
60118399|NCT02709330|76239471|FG000|COMPLETED|Overall Study||37||
60118400|NCT02709330|76239472|FG001|COMPLETED|Overall Study||10||
59830622|NCT00369486|75953992|FG001|COMPLETED|17-Week Visit|Number of eyes|21||
59830623|NCT00369486|75953993|FG002|COMPLETED|17-Week Visit|Number of eyes|22||
59830624|NCT00369486|75953994|FG003|COMPLETED|17-Week Visit|Number of eyes|21||
59830625|NCT00369486|75953995|FG004|COMPLETED|17-Week Visit|Number of eyes|24||
59830626|NCT00369486|75953991|FG000|NOT COMPLETED|17-Week Visit||0||
59830627|NCT00369486|75953992|FG001|NOT COMPLETED|17-Week Visit||0||
59830628|NCT00369486|75953993|FG002|NOT COMPLETED|17-Week Visit||1||
59830629|NCT00369486|75953994|FG003|NOT COMPLETED|17-Week Visit||1||
59830630|NCT00369486|75953995|FG004|NOT COMPLETED|17-Week Visit||1||
59830631|NCT00369486|75953991|FG000|STARTED|34-Week Visit|Number of eyes|38||
59830632|NCT00369486|75953992|FG001|STARTED|34-Week Visit|Number of eyes|21||
59830633|NCT00369486|75953993|FG002|STARTED|34-Week Visit|Number of eyes|23||
59830634|NCT00369486|75953994|FG003|STARTED|34-Week Visit|Number of eyes|22||
59830635|NCT00369486|75953995|FG004|STARTED|34-Week Visit|Number of eyes that|25||
59830636|NCT00369486|75953991|FG000|COMPLETED|34-Week Visit|Number of eyes|38||
59830637|NCT00369486|75953992|FG001|COMPLETED|34-Week Visit|Number of eyes|20||
59830638|NCT00369486|75953993|FG002|COMPLETED|34-Week Visit|Number of eyes|22||
59830639|NCT00369486|75953994|FG003|COMPLETED|34-Week Visit|Number of eyes|19||
59830640|NCT00369486|75953995|FG004|COMPLETED|34-Week Visit|Number of eyes|22||
59830641|NCT00369486|75953991|FG000|NOT COMPLETED|34-Week Visit||0||
59830642|NCT00369486|75953992|FG001|NOT COMPLETED|34-Week Visit||1||
59830643|NCT00369486|75953993|FG002|NOT COMPLETED|34-Week Visit||1||
59830644|NCT00369486|75953994|FG003|NOT COMPLETED|34-Week Visit||3||
59830645|NCT00369486|75953995|FG004|NOT COMPLETED|34-Week Visit||3||
59830646|NCT00363480|75954007|FG000|STARTED|Overall Study||221||
59830647|NCT00363480|75954007|FG000|COMPLETED|Overall Study||204||
59830648|NCT00363480|75954007|FG000|NOT COMPLETED|Overall Study||17||
59830649|NCT00363246|75954011|FG000|STARTED|Overall Study||766||
59830650|NCT00363246|75954011|FG000|COMPLETED|Overall Study||669||
60118401|NCT02709330|76239471|FG000|NOT COMPLETED|Overall Study||13||
59716617|NCT01166568|75835503|FG000|STARTED|Implantation- Nonrandomized & Randomized||288||562
59716618|NCT01166568|75835504|FG001|STARTED|Implantation- Nonrandomized & Randomized||33||66
59716619|NCT01166568|75835505|FG002|STARTED|Implantation- Nonrandomized & Randomized|15 subjects completed the observation phase and 9 subjects (17 eyes) proceeded with implantation.|9||17
59716620|NCT01166568|75835503|FG000|COMPLETED|Implantation- Nonrandomized & Randomized||274||537
59716621|NCT01166568|75835504|FG001|COMPLETED|Implantation- Nonrandomized & Randomized||32||64
59830651|NCT00363246|75954011|FG000|NOT COMPLETED|Overall Study||97||
59830652|NCT00223990|75954018|FG000|STARTED|Overall Study||200||
59830653|NCT00223990|75954019|FG001|STARTED|Overall Study||200||
59830654|NCT00223990|75954018|FG000|COMPLETED|Overall Study||193||
59830655|NCT00223990|75954019|FG001|COMPLETED|Overall Study||191||
59830656|NCT00223990|75954018|FG000|NOT COMPLETED|Overall Study||7||
59830657|NCT00223990|75954019|FG001|NOT COMPLETED|Overall Study||9||
59830658|NCT00221104|75954027|FG000|STARTED|Overall Study||793||
59830659|NCT00221104|75954028|FG001|STARTED|Overall Study||785||
59830660|NCT00221104|75954027|FG000|COMPLETED|Overall Study||710||
59830661|NCT00221104|75954028|FG001|COMPLETED|Overall Study||709||
59830662|NCT00221104|75954027|FG000|NOT COMPLETED|Overall Study||83||
60118402|NCT02709330|76239472|FG001|NOT COMPLETED|Overall Study||0||
60118403|NCT02709096|76239480|FG000|STARTED|Overall Study||22||
59830663|NCT00221104|75954028|FG001|NOT COMPLETED|Overall Study||76||
59830664|NCT00189202|75954036|FG000|STARTED|Overall Study||49||
59830665|NCT00189202|75954036|FG000|COMPLETED|Overall Study||44||
59830666|NCT00189202|75954036|FG000|NOT COMPLETED|Overall Study||5||
59830667|NCT00187486|75954040|FG000|STARTED|Overall Study||66||
59830668|NCT00187486|75954040|FG000|COMPLETED|Overall Study||65||
59830669|NCT00187486|75954040|FG000|NOT COMPLETED|Overall Study||1||
59830670|NCT00220636|75954044|FG000|STARTED|Overall Study||15||
59830671|NCT00220636|75954044|FG000|COMPLETED|Overall Study||11||
59830672|NCT00220636|75954044|FG000|NOT COMPLETED|Overall Study||4||
59830673|NCT00362232|75954051|FG000|STARTED|Treatment (12 +/- 2 Days)||1584||
59830674|NCT00362232|75954052|FG001|STARTED|Treatment (12 +/- 2 Days)||1564||
59830675|NCT00362232|75954051|FG000|Received Treatment|Treatment (12 +/- 2 Days)|Safety population|1526||
59830676|NCT00362232|75954052|FG001|Received Treatment|Treatment (12 +/- 2 Days)|Safety population|1508||
59830677|NCT00362232|75954051|FG000|COMPLETED|Treatment (12 +/- 2 Days)||1425||
59830678|NCT00362232|75954052|FG001|COMPLETED|Treatment (12 +/- 2 Days)||1413||
59830679|NCT00362232|75954051|FG000|NOT COMPLETED|Treatment (12 +/- 2 Days)||159||
59830680|NCT00362232|75954052|FG001|NOT COMPLETED|Treatment (12 +/- 2 Days)||151||
59830681|NCT00362232|75954051|FG000|STARTED|Follow-up (30 (+ 5) Days)||1471||
59830682|NCT00362232|75954052|FG001|STARTED|Follow-up (30 (+ 5) Days)||1455||
59830683|NCT00362232|75954051|FG000|COMPLETED|Follow-up (30 (+ 5) Days)||1433||
59830684|NCT00362232|75954052|FG001|COMPLETED|Follow-up (30 (+ 5) Days)||1416||
59830685|NCT00362232|75954051|FG000|NOT COMPLETED|Follow-up (30 (+ 5) Days)||38||
59830686|NCT00362232|75954052|FG001|NOT COMPLETED|Follow-up (30 (+ 5) Days)||39||
59830687|NCT00219544|75954058|FG000|STARTED|Single Blind Treatment Period||256||
59830688|NCT00219544|75954059|FG001|STARTED|Single Blind Treatment Period||0||
59830689|NCT00219544|75954058|FG000|COMPLETED|Single Blind Treatment Period||234||
59830690|NCT00219544|75954059|FG001|COMPLETED|Single Blind Treatment Period||0||
59830691|NCT00219544|75954058|FG000|NOT COMPLETED|Single Blind Treatment Period||22||
59830692|NCT00219544|75954059|FG001|NOT COMPLETED|Single Blind Treatment Period||0||
59830693|NCT00219544|75954058|FG000|STARTED|Double Blind Treatment Period||80||
59830694|NCT00219544|75954059|FG001|STARTED|Double Blind Treatment Period||77||
59830695|NCT00219544|75954058|FG000|COMPLETED|Double Blind Treatment Period||80||
59830696|NCT00219544|75954059|FG001|COMPLETED|Double Blind Treatment Period||77||
59830697|NCT00219544|75954058|FG000|NOT COMPLETED|Double Blind Treatment Period||0||
59830698|NCT00219544|75954059|FG001|NOT COMPLETED|Double Blind Treatment Period||0||
59830699|NCT00357552|75954067|FG000|STARTED|Screening|The number of participants who started this period, is the number of participants who screened.|207||
59830700|NCT00357552|75954067|FG000|COMPLETED|Screening|The number of participants who completed this period, is the number of participants who enrolled.|123||
59830701|NCT00357552|75954067|FG000|NOT COMPLETED|Screening||84||
59830702|NCT00357552|75954067|FG000|STARTED|Weeks 0 to 24||123||
59830703|NCT00357552|75954067|FG000|COMPLETED|Weeks 0 to 24|One subject died prior to week 24.|122||
59830704|NCT00357552|75954067|FG000|NOT COMPLETED|Weeks 0 to 24||1||
59830705|NCT00357552|75954067|FG000|STARTED|Weeks 24 to 104||122||
59830706|NCT00357552|75954067|FG000|COMPLETED|Weeks 24 to 104||117||
59830707|NCT00357552|75954067|FG000|NOT COMPLETED|Weeks 24 to 104||5||
59830708|NCT00187096|75954078|FG000|STARTED|Overall Study||10||
59830709|NCT00187096|75954079|FG001|STARTED|Overall Study||3||
59830710|NCT00187096|75954080|FG002|STARTED|Overall Study||12||
59830711|NCT00187096|75954078|FG000|COMPLETED|Overall Study||10||
59830712|NCT00187096|75954079|FG001|COMPLETED|Overall Study||3||
59830713|NCT00187096|75954080|FG002|COMPLETED|Overall Study||11||
59830714|NCT00187096|75954078|FG000|NOT COMPLETED|Overall Study||0||
59830715|NCT00187096|75954079|FG001|NOT COMPLETED|Overall Study||0||
59830716|NCT00187096|75954080|FG002|NOT COMPLETED|Overall Study||1||
59830717|NCT00357396|75954090|FG000|STARTED|Overall Study||6||
60118404|NCT02709096|76239481|FG001|STARTED|Overall Study||11||
60118405|NCT02709096|76239480|FG000|COMPLETED|Overall Study||21||
60118406|NCT02709096|76239481|FG001|COMPLETED|Overall Study||10||
60118407|NCT02709096|76239480|FG000|NOT COMPLETED|Overall Study||1||
60118408|NCT02709096|76239481|FG001|NOT COMPLETED|Overall Study||1||
60118409|NCT01372410|76239487|FG000|STARTED|Treatment Period 1 (7 Days)||20||
60118410|NCT01372410|76239488|FG001|STARTED|Treatment Period 1 (7 Days)||21||
59830718|NCT00357396|75954091|FG001|STARTED|Overall Study||4||
59830719|NCT00357396|75954090|FG000|COMPLETED|Overall Study||5||
59830720|NCT00357396|75954091|FG001|COMPLETED|Overall Study||4||
59830721|NCT00357396|75954090|FG000|NOT COMPLETED|Overall Study||1||
59830722|NCT00357396|75954091|FG001|NOT COMPLETED|Overall Study||0||
59830723|NCT00186628|75954096|FG000|STARTED|Overall Study||36||
59830724|NCT00186628|75954096|FG000|COMPLETED|Overall Study||33||
59830725|NCT00186628|75954096|FG000|NOT COMPLETED|Overall Study||3||
59830726|NCT00368550|75954104|FG000|STARTED|Overall Study||63||
59830727|NCT00368550|75954105|FG001|STARTED|Overall Study||71||
59830728|NCT00368550|75954104|FG000|COMPLETED|Overall Study||35||
59830729|NCT00368550|75954105|FG001|COMPLETED|Overall Study||48||
59830730|NCT00368550|75954104|FG000|NOT COMPLETED|Overall Study||28||
59830731|NCT00368550|75954105|FG001|NOT COMPLETED|Overall Study||23||
59830732|NCT00368472|75954111|FG000|STARTED|Overall Study||138||
59830733|NCT00368472|75954111|FG000|COMPLETED|Overall Study||33||
59830734|NCT00368472|75954111|FG000|NOT COMPLETED|Overall Study||105||
59830735|NCT00357006|75954118|FG000|STARTED|Overall Study||62||
59830736|NCT00357006|75954119|FG001|STARTED|Overall Study||56||
59830737|NCT00357006|75954120|FG002|STARTED|Overall Study||62||
59830738|NCT00357006|75954118|FG000|COMPLETED|Overall Study||60||
59830739|NCT00357006|75954119|FG001|COMPLETED|Overall Study||51||
59830740|NCT00357006|75954120|FG002|COMPLETED|Overall Study||59||
59830741|NCT00357006|75954118|FG000|NOT COMPLETED|Overall Study||2||
59830742|NCT00357006|75954119|FG001|NOT COMPLETED|Overall Study||5||
60118411|NCT01372410|76239489|FG002|STARTED|Treatment Period 1 (7 Days)||19||
59830743|NCT00357006|75954120|FG002|NOT COMPLETED|Overall Study||3||
59830744|NCT00165646|75954131|FG000|STARTED|Overall Study||93||
59830745|NCT00165646|75954132|FG001|STARTED|Overall Study||93||
59830746|NCT00165646|75954133|FG002|STARTED|Overall Study||102||
59830747|NCT00165646|75954131|FG000|COMPLETED|Overall Study||88||
59830748|NCT00165646|75954132|FG001|COMPLETED|Overall Study||88||
59830749|NCT00165646|75954133|FG002|COMPLETED|Overall Study||98||
59830750|NCT00165646|75954131|FG000|NOT COMPLETED|Overall Study||5||
59830751|NCT00165646|75954132|FG001|NOT COMPLETED|Overall Study||5||
59830752|NCT00165646|75954133|FG002|NOT COMPLETED|Overall Study||4||
59830753|NCT00367770|75954141|FG000|STARTED|Overall Study||37||
59830754|NCT00367770|75954141|FG000|COMPLETED|Overall Study||35||
59830755|NCT00367770|75954141|FG000|NOT COMPLETED|Overall Study||2||
59830756|NCT00185614|75954145|FG000|STARTED|Autologous HCT (Auto-HCT)||63||
59830757|NCT00185614|75954145|FG000|COMPLETED|Autologous HCT (Auto-HCT)||63||
59830758|NCT00185614|75954145|FG000|NOT COMPLETED|Autologous HCT (Auto-HCT)||0||
59830759|NCT00185614|75954145|FG000|STARTED|Inter-treatment Period|Not all participants who received autologous transplant continued to receive allogeneic transplant.|63||
59830760|NCT00185614|75954145|FG000|COMPLETED|Inter-treatment Period||59||
59830761|NCT00185614|75954145|FG000|NOT COMPLETED|Inter-treatment Period||4||
59830762|NCT00185614|75954145|FG000|STARTED|Allogenic HCT (Allo-HCT)||59||
59830763|NCT00185614|75954145|FG000|COMPLETED|Allogenic HCT (Allo-HCT)||59||
59830764|NCT00185614|75954145|FG000|NOT COMPLETED|Allogenic HCT (Allo-HCT)||0||
59830765|NCT00162370|75954149|FG000|STARTED|Completed Echocardiography Imaging|Received at least one dose of Definity|366||
59830766|NCT00162370|75954149|FG000|COMPLETED|Completed Echocardiography Imaging|number of subjects who under went Definity-enhanced rest and stress echocardiogram|366||
59830767|NCT00162370|75954149|FG000|NOT COMPLETED|Completed Echocardiography Imaging||0||
59830768|NCT00162370|75954149|FG000|STARTED|Efficacy Population||366||
59830769|NCT00162370|75954149|FG000|COMPLETED|Efficacy Population|Efficacy population, completed rest/stress echo with Definity & completed 2 and/or 5 year follow up|315||
59830770|NCT00162370|75954149|FG000|NOT COMPLETED|Efficacy Population||51||
59830771|NCT00361842|75954158|FG000|STARTED|Overall Study||28||
59830772|NCT00361842|75954159|FG001|STARTED|Overall Study||35||
59830773|NCT00361842|75954158|FG000|COMPLETED|Overall Study||1||
59830774|NCT00361842|75954159|FG001|COMPLETED|Overall Study||1||
59830775|NCT00361842|75954158|FG000|NOT COMPLETED|Overall Study||27||
59830776|NCT00361842|75954159|FG001|NOT COMPLETED|Overall Study||34||
59830777|NCT00361296|75954167|FG000|STARTED|Overall Study||5||
59830778|NCT00361296|75954167|FG000|COMPLETED|Overall Study||2||
59830779|NCT00361296|75954167|FG000|NOT COMPLETED|Overall Study||3||
59830780|NCT00356148|75954173|FG000|STARTED|Overall Study||189||
59830781|NCT00356148|75954174|FG001|STARTED|Overall Study||183||
59830782|NCT00356148|75954173|FG000|COMPLETED|Overall Study||187||
59830783|NCT00356148|75954174|FG001|COMPLETED|Overall Study||182||
59830784|NCT00356148|75954173|FG000|NOT COMPLETED|Overall Study||2||
59830785|NCT00356148|75954174|FG001|NOT COMPLETED|Overall Study||1||
59830786|NCT00361218|75954181|FG000|STARTED|Overall Study|met eligibility criteria and enrolled in the study|53||
59830787|NCT00361218|75954181|FG000|Completed Baseline Assessment|Overall Study||47||
59830788|NCT00361218|75954181|FG000|COMPLETED|Overall Study||30||
59830789|NCT00361218|75954181|FG000|NOT COMPLETED|Overall Study||23||
59830790|NCT00367458|75954187|FG000|STARTED|First Intervention - 8 Weeks||12||
59830791|NCT00367458|75954188|FG001|STARTED|First Intervention - 8 Weeks||12||
59567488|NCT02326272|75670466|FG013|STARTED|Initial Period (Week 0 to Week 16)||0||
59567489|NCT02326272|75670467|FG014|STARTED|Initial Period (Week 0 to Week 16)||0||
59567490|NCT02326272|75670453|FG000|Completed Week 16|Initial Period (Week 0 to Week 16)||45||
59716622|NCT01166568|75835505|FG002|COMPLETED|Implantation- Nonrandomized & Randomized|(1) Primary eye implanted only subject withdrew consent after implantation of the device.|8||16
59716623|NCT01166568|75835503|FG000|NOT COMPLETED|Implantation- Nonrandomized & Randomized||14||25
59716624|NCT01166568|75835504|FG001|NOT COMPLETED|Implantation- Nonrandomized & Randomized||1||2
59716625|NCT01166568|75835505|FG002|NOT COMPLETED|Implantation- Nonrandomized & Randomized||1||1
59716626|NCT01166178|75835513|FG000|STARTED|Overall Study||21||
59716627|NCT01166178|75835514|FG001|STARTED|Overall Study||8||
59716628|NCT01166178|75835513|FG000|COMPLETED|Overall Study||0||
59716629|NCT01166178|75835514|FG001|COMPLETED|Overall Study||0||
59716630|NCT01166178|75835513|FG000|NOT COMPLETED|Overall Study||21||
59716631|NCT01166178|75835514|FG001|NOT COMPLETED|Overall Study||8||
59716632|NCT00924820|75835520|FG000|STARTED|Overall Study||20||
59716633|NCT00924820|75835520|FG000|COMPLETED|Overall Study||13||
59716634|NCT00924820|75835520|FG000|NOT COMPLETED|Overall Study||7||
59830792|NCT00367458|75954187|FG000|COMPLETED|First Intervention - 8 Weeks||10||
59830793|NCT00367458|75954188|FG001|COMPLETED|First Intervention - 8 Weeks||12||
59830794|NCT00367458|75954187|FG000|NOT COMPLETED|First Intervention - 8 Weeks||2||
59830795|NCT00367458|75954188|FG001|NOT COMPLETED|First Intervention - 8 Weeks||0||
59830796|NCT00367458|75954187|FG000|STARTED|Washout Period - 4-6 Weeks||10||
59830797|NCT00367458|75954188|FG001|STARTED|Washout Period - 4-6 Weeks||12||
59830798|NCT00367458|75954187|FG000|COMPLETED|Washout Period - 4-6 Weeks||10||
59830799|NCT00367458|75954188|FG001|COMPLETED|Washout Period - 4-6 Weeks||12||
59830800|NCT00367458|75954187|FG000|NOT COMPLETED|Washout Period - 4-6 Weeks||0||
59830801|NCT00367458|75954188|FG001|NOT COMPLETED|Washout Period - 4-6 Weeks||0||
59830802|NCT00367458|75954187|FG000|STARTED|Second Intervention - 8 Weeks||10||
59830803|NCT00367458|75954188|FG001|STARTED|Second Intervention - 8 Weeks||12||
59830804|NCT00367458|75954187|FG000|COMPLETED|Second Intervention - 8 Weeks||10||
59830805|NCT00367458|75954188|FG001|COMPLETED|Second Intervention - 8 Weeks||12||
59830806|NCT00367458|75954187|FG000|NOT COMPLETED|Second Intervention - 8 Weeks||0||
59830807|NCT00367458|75954188|FG001|NOT COMPLETED|Second Intervention - 8 Weeks||0||
59830808|NCT00162136|75954200|FG000|STARTED|Overall Study||35||
59830809|NCT00162136|75954200|FG000|COMPLETED|Overall Study|Number of Participants still on treatment at study termination|0||
59830810|NCT00162136|75954200|FG000|NOT COMPLETED|Overall Study||35||
59830811|NCT00252694|75954226|FG000|STARTED|Overall Study||951||
59830812|NCT00252694|75954227|FG001|STARTED|Overall Study||954||
59830813|NCT00252694|75954226|FG000|COMPLETED|Overall Study||807||
59830814|NCT00252694|75954227|FG001|COMPLETED|Overall Study||800||
59830815|NCT00252694|75954226|FG000|NOT COMPLETED|Overall Study||144||
59830816|NCT00252694|75954227|FG001|NOT COMPLETED|Overall Study||154||
59830817|NCT00185458|75954233|FG000|STARTED|Contraception Phase||394||
59830818|NCT00185458|75954233|FG000|COMPLETED|Contraception Phase||336||
59830819|NCT00185458|75954233|FG000|NOT COMPLETED|Contraception Phase||58||
59830820|NCT00185458|75954233|FG000|STARTED|HRT Phase|168 subjects were eligible for the HRT phase out 336 who completed contraception phase.|168||
59830821|NCT00185458|75954233|FG000|COMPLETED|HRT Phase||141||
59830822|NCT00185458|75954233|FG000|NOT COMPLETED|HRT Phase||27||
59830823|NCT00185380|75954248|FG000|STARTED|Overall Study||240||
59830824|NCT00185380|75954249|FG001|STARTED|Overall Study||246||
59830825|NCT00185380|75954250|FG002|STARTED|Overall Study||256||
59830826|NCT00185380|75954248|FG000|Subjects Received Treatment|Overall Study||239||
59830827|NCT00185380|75954249|FG001|Subjects Received Treatment|Overall Study||245||
59830828|NCT00185380|75954250|FG002|Subjects Received Treatment|Overall Study||254||
59830829|NCT00185380|75954248|FG000|COMPLETED|Overall Study||174||
59830830|NCT00185380|75954249|FG001|COMPLETED|Overall Study||174||
59830831|NCT00185380|75954250|FG002|COMPLETED|Overall Study||182||
59830832|NCT00185380|75954248|FG000|NOT COMPLETED|Overall Study||66||
59830833|NCT00185380|75954249|FG001|NOT COMPLETED|Overall Study||72||
59830834|NCT00185380|75954250|FG002|NOT COMPLETED|Overall Study||74||
59830835|NCT00160654|75954258|FG000|STARTED|Overall Study||251||
59830836|NCT00160654|75954258|FG000|COMPLETED|Overall Study||218||
59830837|NCT00160654|75954258|FG000|NOT COMPLETED|Overall Study||33||
59830838|NCT00366678|75954264|FG000|STARTED|Infant Series||304||
59830839|NCT00366678|75954265|FG001|STARTED|Infant Series||309||
59830840|NCT00366678|75954266|FG002|STARTED|Infant Series||0||
59830841|NCT00366678|75954264|FG000|Vaccinated Dose 1|Infant Series||302||
59830842|NCT00366678|75954265|FG001|Vaccinated Dose 1|Infant Series||309||
59830843|NCT00366678|75954266|FG002|Vaccinated Dose 1|Infant Series||0||
59830844|NCT00366678|75954264|FG000|Vaccinated Dose 2|Infant Series||295||
59830845|NCT00366678|75954265|FG001|Vaccinated Dose 2|Infant Series||304||
59830846|NCT00366678|75954266|FG002|Vaccinated Dose 2|Infant Series||0||
59830847|NCT00366678|75954264|FG000|Vaccinated Dose 3|Infant Series||291||
59830848|NCT00366678|75954265|FG001|Vaccinated Dose 3|Infant Series||302||
59830849|NCT00366678|75954266|FG002|Vaccinated Dose 3|Infant Series||0||
59830850|NCT00366678|75954264|FG000|COMPLETED|Infant Series||290||
59830851|NCT00366678|75954265|FG001|COMPLETED|Infant Series||299||
59830852|NCT00366678|75954266|FG002|COMPLETED|Infant Series||0||
59830853|NCT00366678|75954264|FG000|NOT COMPLETED|Infant Series||14||
59830854|NCT00366678|75954265|FG001|NOT COMPLETED|Infant Series||10||
59830855|NCT00366678|75954266|FG002|NOT COMPLETED|Infant Series||0||
59830856|NCT00366678|75954264|FG000|STARTED|After Infant||290||
59830857|NCT00366678|75954265|FG001|STARTED|After Infant||299||
59830858|NCT00366678|75954266|FG002|STARTED|After Infant||0||
59830859|NCT00366678|75954264|FG000|COMPLETED|After Infant||273||
59830860|NCT00366678|75954265|FG001|COMPLETED|After Infant||289||
59830861|NCT00366678|75954266|FG002|COMPLETED|After Infant||0||
59830862|NCT00366678|75954264|FG000|NOT COMPLETED|After Infant||17||
59830863|NCT00366678|75954265|FG001|NOT COMPLETED|After Infant||10||
59830864|NCT00366678|75954266|FG002|NOT COMPLETED|After Infant||0||
59830865|NCT00366678|75954264|FG000|STARTED|Toddler Dose||273||
59716635|NCT01225172|75835526|FG000|STARTED|Overall Study||52||
59716636|NCT01225172|75835527|FG001|STARTED|Overall Study||7||
59716637|NCT01225172|75835526|FG000|COMPLETED|Overall Study||46||
59716638|NCT01225172|75835527|FG001|COMPLETED|Overall Study||6||
59716639|NCT01225172|75835526|FG000|NOT COMPLETED|Overall Study||6||
59716640|NCT01225172|75835527|FG001|NOT COMPLETED|Overall Study||1||
59716641|NCT01143324|75835533|FG000|STARTED|Overall Study||252||
59716642|NCT01143324|75835533|FG000|COMPLETED|Overall Study||233||
59716643|NCT01143324|75835533|FG000|NOT COMPLETED|Overall Study||19||
59716644|NCT01224782|75835537|FG000|STARTED|Overall Study||994||
59716645|NCT01224782|75835537|FG000|COMPLETED|Overall Study||730||
59716646|NCT01224782|75835537|FG000|NOT COMPLETED|Overall Study||264||
59716647|NCT01224158|75835543|FG000|STARTED|Overall Study||76||
59716648|NCT01224158|75835544|FG001|STARTED|Overall Study||77||
59716649|NCT01224158|75835543|FG000|COMPLETED|Overall Study||75||
59716650|NCT01224158|75835544|FG001|COMPLETED|Overall Study||77||
59716651|NCT01224158|75835543|FG000|NOT COMPLETED|Overall Study||1||
59830866|NCT00366678|75954265|FG001|STARTED|Toddler Dose||152||
59830867|NCT00366678|75954266|FG002|STARTED|Toddler Dose||137||
59830868|NCT00366678|75954264|FG000|COMPLETED|Toddler Dose||268||
59830869|NCT00366678|75954265|FG001|COMPLETED|Toddler Dose||151||
59830870|NCT00366678|75954266|FG002|COMPLETED|Toddler Dose||137||
59830871|NCT00366678|75954264|FG000|NOT COMPLETED|Toddler Dose||5||
59830872|NCT00366678|75954265|FG001|NOT COMPLETED|Toddler Dose||1||
59830873|NCT00366678|75954266|FG002|NOT COMPLETED|Toddler Dose||0||
59830874|NCT00355368|75954313|FG000|STARTED|Overall Study||210||
59830875|NCT00355368|75954314|FG001|STARTED|Overall Study||210||
59830876|NCT00355368|75954313|FG000|COMPLETED|Overall Study||200||
59830877|NCT00355368|75954314|FG001|COMPLETED|Overall Study||201||
59830878|NCT00355368|75954313|FG000|NOT COMPLETED|Overall Study||10||
59830879|NCT00355368|75954314|FG001|NOT COMPLETED|Overall Study||9||
59830880|NCT00360282|75954320|FG000|STARTED|First Intervention||6||
59830881|NCT00360282|75954321|FG001|STARTED|First Intervention||8||
59830882|NCT00360282|75954322|FG002|STARTED|First Intervention||7||
59830883|NCT00360282|75954323|FG003|STARTED|First Intervention||6||
59830884|NCT00360282|75954320|FG000|COMPLETED|First Intervention||6||
59830885|NCT00360282|75954321|FG001|COMPLETED|First Intervention||8||
59830886|NCT00360282|75954322|FG002|COMPLETED|First Intervention||7||
59830887|NCT00360282|75954323|FG003|COMPLETED|First Intervention||6||
59830888|NCT00360282|75954320|FG000|NOT COMPLETED|First Intervention||0||
59830889|NCT00360282|75954321|FG001|NOT COMPLETED|First Intervention||0||
59830890|NCT00360282|75954322|FG002|NOT COMPLETED|First Intervention||0||
59830891|NCT00360282|75954323|FG003|NOT COMPLETED|First Intervention||0||
59830892|NCT00360282|75954320|FG000|STARTED|Washout 1-3 Weeks||6||
59830893|NCT00360282|75954321|FG001|STARTED|Washout 1-3 Weeks||8||
59830894|NCT00360282|75954322|FG002|STARTED|Washout 1-3 Weeks||7||
59830895|NCT00360282|75954323|FG003|STARTED|Washout 1-3 Weeks||6||
59830896|NCT00360282|75954320|FG000|COMPLETED|Washout 1-3 Weeks||6||
59830897|NCT00360282|75954321|FG001|COMPLETED|Washout 1-3 Weeks||8||
59830898|NCT00360282|75954322|FG002|COMPLETED|Washout 1-3 Weeks||6||
59830899|NCT00360282|75954323|FG003|COMPLETED|Washout 1-3 Weeks||6||
59830900|NCT00360282|75954320|FG000|NOT COMPLETED|Washout 1-3 Weeks||0||
59830901|NCT00360282|75954321|FG001|NOT COMPLETED|Washout 1-3 Weeks||0||
59830902|NCT00360282|75954322|FG002|NOT COMPLETED|Washout 1-3 Weeks||1||
59830903|NCT00360282|75954323|FG003|NOT COMPLETED|Washout 1-3 Weeks||0||
59830904|NCT00360282|75954320|FG000|STARTED|Second Intervention||6||
59830905|NCT00360282|75954321|FG001|STARTED|Second Intervention||8||
59830906|NCT00360282|75954322|FG002|STARTED|Second Intervention||6||
59830907|NCT00360282|75954323|FG003|STARTED|Second Intervention||6||
59830908|NCT00360282|75954320|FG000|COMPLETED|Second Intervention||6||
59830909|NCT00360282|75954321|FG001|COMPLETED|Second Intervention||7||
59830910|NCT00360282|75954322|FG002|COMPLETED|Second Intervention||6||
59830911|NCT00360282|75954323|FG003|COMPLETED|Second Intervention||6||
59830912|NCT00360282|75954320|FG000|NOT COMPLETED|Second Intervention||0||
59830913|NCT00360282|75954321|FG001|NOT COMPLETED|Second Intervention||1||
59830914|NCT00360282|75954322|FG002|NOT COMPLETED|Second Intervention||0||
59830915|NCT00360282|75954323|FG003|NOT COMPLETED|Second Intervention||0||
59830916|NCT00373958|75954333|FG000|STARTED|Infant Series|One participant was prerandomized but not consented.|334||
59830917|NCT00373958|75954334|FG001|STARTED|Infant Series||332||
59830918|NCT00373958|75954333|FG000|Vaccinated Dose 1|Infant Series||332||
59830919|NCT00373958|75954334|FG001|Vaccinated Dose 1|Infant Series||331||
59830920|NCT00373958|75954333|FG000|Vaccinated Dose 2|Infant Series||309||
59830921|NCT00373958|75954334|FG001|Vaccinated Dose 2|Infant Series||305||
59830922|NCT00373958|75954333|FG000|Vaccinated Dose 3|Infant Series||298||
59830923|NCT00373958|75954334|FG001|Vaccinated Dose 3|Infant Series||300||
59830924|NCT00373958|75954333|FG000|COMPLETED|Infant Series||294||
59830925|NCT00373958|75954334|FG001|COMPLETED|Infant Series||290||
59830926|NCT00373958|75954333|FG000|NOT COMPLETED|Infant Series||40||
59830927|NCT00373958|75954334|FG001|NOT COMPLETED|Infant Series||42||
59830928|NCT00373958|75954333|FG000|STARTED|Toddler Dose||294||
59830929|NCT00373958|75954334|FG001|STARTED|Toddler Dose||290||
59830930|NCT00373958|75954333|FG000|Withdrawn After Infant Series|Toddler Dose||22||
59830931|NCT00373958|75954334|FG001|Withdrawn After Infant Series|Toddler Dose||25||
59830932|NCT00373958|75954333|FG000|Vaccinated Toddler Dose|Toddler Dose||272||
59830933|NCT00373958|75954334|FG001|Vaccinated Toddler Dose|Toddler Dose||265||
59830934|NCT00373958|75954333|FG000|COMPLETED|Toddler Dose||264||
59830935|NCT00373958|75954334|FG001|COMPLETED|Toddler Dose||252||
59830936|NCT00373958|75954333|FG000|NOT COMPLETED|Toddler Dose||30||
59830937|NCT00373958|75954334|FG001|NOT COMPLETED|Toddler Dose||38||
59830938|NCT00373880|75954363|FG000|STARTED|Overall Study||26||
59830939|NCT00373880|75954363|FG000|COMPLETED|Overall Study||8||
59830940|NCT00373880|75954363|FG000|NOT COMPLETED|Overall Study||18||
59830941|NCT00184600|75954378|FG000|STARTED|Overall Study||234||
59830942|NCT00184600|75954379|FG001|STARTED|Overall Study||239||
59830943|NCT00184600|75954380|FG002|STARTED|Overall Study||235||
59830944|NCT00184600|75954378|FG000|COMPLETED|Overall Study||189||
59830945|NCT00184600|75954379|FG001|COMPLETED|Overall Study||188||
59830946|NCT00184600|75954380|FG002|COMPLETED|Overall Study||201||
59830947|NCT00184600|75954378|FG000|NOT COMPLETED|Overall Study||45||
59830948|NCT00184600|75954379|FG001|NOT COMPLETED|Overall Study||51||
59830949|NCT00184600|75954380|FG002|NOT COMPLETED|Overall Study||34||
59830950|NCT00265317|75954392|FG000|STARTED|Lead-In||13||
59830951|NCT00265317|75954393|FG001|STARTED|Lead-In||17||
59830952|NCT00265317|75954394|FG002|STARTED|Lead-In||0||
59830953|NCT00265317|75954395|FG003|STARTED|Lead-In||0||
59830954|NCT00265317|75954392|FG000|COMPLETED|Lead-In||1||
59830955|NCT00265317|75954393|FG001|COMPLETED|Lead-In||0||
59830956|NCT00265317|75954394|FG002|COMPLETED|Lead-In||0||
59830957|NCT00265317|75954395|FG003|COMPLETED|Lead-In||0||
59830958|NCT00265317|75954392|FG000|NOT COMPLETED|Lead-In||12||
59830959|NCT00265317|75954393|FG001|NOT COMPLETED|Lead-In||17||
59830960|NCT00265317|75954394|FG002|NOT COMPLETED|Lead-In||0||
59830961|NCT00265317|75954395|FG003|NOT COMPLETED|Lead-In||0||
59830962|NCT00265317|75954392|FG000|STARTED|Phase 2||0||
59830963|NCT00265317|75954393|FG001|STARTED|Phase 2||0||
59830964|NCT00265317|75954394|FG002|STARTED|Phase 2||65||
59830965|NCT00265317|75954395|FG003|STARTED|Phase 2||67||
59830966|NCT00265317|75954392|FG000|COMPLETED|Phase 2||0||
59830967|NCT00265317|75954393|FG001|COMPLETED|Phase 2||0||
59830968|NCT00265317|75954394|FG002|COMPLETED|Phase 2||1||
59830969|NCT00265317|75954395|FG003|COMPLETED|Phase 2||2||
59830970|NCT00265317|75954392|FG000|NOT COMPLETED|Phase 2||0||
59830971|NCT00265317|75954393|FG001|NOT COMPLETED|Phase 2||0||
59830972|NCT00265317|75954394|FG002|NOT COMPLETED|Phase 2||64||
59830973|NCT00265317|75954395|FG003|NOT COMPLETED|Phase 2||65||
59830974|NCT00373490|75954416|FG000|STARTED|Overall Study||10||
59830975|NCT00373490|75954417|FG001|STARTED|Overall Study||6||
59830976|NCT00373490|75954416|FG000|COMPLETED|Overall Study||1||
59830977|NCT00373490|75954417|FG001|COMPLETED|Overall Study||0||
59830978|NCT00373490|75954416|FG000|NOT COMPLETED|Overall Study||9||
59830979|NCT00373490|75954417|FG001|NOT COMPLETED|Overall Study||6||
59830980|NCT00251589|75954427|FG000|STARTED|Overall Study|4 of the 16 patients participated in Phase I and II portions. 12 participated in Phase II only.|16||
59830981|NCT00251589|75954428|FG001|STARTED|Overall Study||3||
59830982|NCT00251589|75954429|FG002|STARTED|Overall Study||2||
59830983|NCT00251589|75954430|FG003|STARTED|Overall Study||2||
59830984|NCT00251589|75954427|FG000|COMPLETED|Overall Study||1||
59830985|NCT00251589|75954428|FG001|COMPLETED|Overall Study||0||
59830986|NCT00251589|75954429|FG002|COMPLETED|Overall Study||0||
59830987|NCT00251589|75954430|FG003|COMPLETED|Overall Study||0||
59830988|NCT00251589|75954427|FG000|NOT COMPLETED|Overall Study||15||
59830989|NCT00251589|75954428|FG001|NOT COMPLETED|Overall Study||3||
59830990|NCT00251589|75954429|FG002|NOT COMPLETED|Overall Study||2||
59830991|NCT00251589|75954430|FG003|NOT COMPLETED|Overall Study||2||
59830992|NCT00265239|75954442|FG000|STARTED|Overall Study||52||
59830993|NCT00265239|75954443|FG001|STARTED|Overall Study||52||
59830994|NCT00265239|75954442|FG000|COMPLETED|Overall Study||50||
59830995|NCT00265239|75954443|FG001|COMPLETED|Overall Study||51||
59830996|NCT00265239|75954442|FG000|NOT COMPLETED|Overall Study||2||
59830997|NCT00265239|75954443|FG001|NOT COMPLETED|Overall Study||1||
59830998|NCT00350298|75954451|FG000|STARTED|Overall Study||101||
59830999|NCT00350298|75954452|FG001|STARTED|Overall Study||99||
59831000|NCT00350298|75954451|FG000|COMPLETED|Overall Study||92||
59831001|NCT00350298|75954452|FG001|COMPLETED|Overall Study||86||
59831002|NCT00350298|75954451|FG000|NOT COMPLETED|Overall Study||9||
59831003|NCT00350298|75954452|FG001|NOT COMPLETED|Overall Study||13||
59831004|NCT00159874|75954465|FG000|STARTED|Overall Study||42||
59831005|NCT00159874|75954466|FG001|STARTED|Overall Study||55||
59831006|NCT00159874|75954467|FG002|STARTED|Overall Study||77||
59831007|NCT00159874|75954468|FG003|STARTED|Overall Study||13||
59831008|NCT00159874|75954469|FG004|STARTED|Overall Study||19||
59831009|NCT00159874|75954470|FG005|STARTED|Overall Study||23||
59831010|NCT00159874|75954471|FG006|STARTED|Overall Study||5||
59831011|NCT00159874|75954465|FG000|Treated|Overall Study||42||
59831012|NCT00159874|75954466|FG001|Treated|Overall Study||55||
59831013|NCT00159874|75954467|FG002|Treated|Overall Study||77||
59831014|NCT00159874|75954468|FG003|Treated|Overall Study||13||
59831015|NCT00159874|75954469|FG004|Treated|Overall Study||19||
59831016|NCT00159874|75954470|FG005|Treated|Overall Study||23||
59831017|NCT00159874|75954471|FG006|Treated|Overall Study||5||
59831018|NCT00159874|75954465|FG000|COMPLETED|Overall Study||22||
59831019|NCT00159874|75954466|FG001|COMPLETED|Overall Study||25||
59831020|NCT00159874|75954467|FG002|COMPLETED|Overall Study||34||
59831021|NCT00159874|75954468|FG003|COMPLETED|Overall Study||7||
59831022|NCT00159874|75954469|FG004|COMPLETED|Overall Study||11||
59831023|NCT00159874|75954470|FG005|COMPLETED|Overall Study||11||
59831024|NCT00159874|75954471|FG006|COMPLETED|Overall Study||0||
59831025|NCT00159874|75954465|FG000|NOT COMPLETED|Overall Study||20||
59831026|NCT00159874|75954466|FG001|NOT COMPLETED|Overall Study||30||
59831027|NCT00159874|75954467|FG002|NOT COMPLETED|Overall Study||43||
59831028|NCT00159874|75954468|FG003|NOT COMPLETED|Overall Study||6||
59831029|NCT00159874|75954469|FG004|NOT COMPLETED|Overall Study||8||
59831030|NCT00159874|75954470|FG005|NOT COMPLETED|Overall Study||12||
59831031|NCT00159874|75954471|FG006|NOT COMPLETED|Overall Study||5||
59831032|NCT00349908|75954489|FG000|STARTED|Overall Study||10||
59831033|NCT00349908|75954490|FG001|STARTED|Overall Study||10||
59831034|NCT00349908|75954489|FG000|COMPLETED|Overall Study||10||
59831035|NCT00349908|75954490|FG001|COMPLETED|Overall Study|9 returned for 30 day follow-up, 7 returned for 6 month and 6/7 had 6 month angiogram|6||
59831036|NCT00349908|75954489|FG000|NOT COMPLETED|Overall Study||0||
59831037|NCT00349908|75954490|FG001|NOT COMPLETED|Overall Study||4||
59831038|NCT00184054|75954497|FG000|STARTED|Overall Study||11||
59831039|NCT00184054|75954497|FG000|COMPLETED|Overall Study||10||
59831040|NCT00184054|75954497|FG000|NOT COMPLETED|Overall Study||1||
59831041|NCT00183430|75954503|FG000|STARTED|Overall Study||9||
59831042|NCT00183430|75954504|FG001|STARTED|Overall Study||11||
59831043|NCT00183430|75954503|FG000|COMPLETED|Overall Study||3||
59831044|NCT00183430|75954504|FG001|COMPLETED|Overall Study||11||
59831045|NCT00183430|75954503|FG000|NOT COMPLETED|Overall Study||6||
59831046|NCT00183430|75954504|FG001|NOT COMPLETED|Overall Study||0||
59831047|NCT00183274|75954510|FG000|STARTED|Phase 1: Open-Label||268||
59831048|NCT00183274|75954511|FG001|STARTED|Phase 1: Open-Label||0||
59831049|NCT00183274|75954512|FG002|STARTED|Phase 1: Open-Label||0||
59831050|NCT00183274|75954513|FG003|STARTED|Phase 1: Open-Label||0||
59831051|NCT00183274|75954514|FG004|STARTED|Phase 1: Open-Label||0||
59716652|NCT01224158|75835544|FG001|NOT COMPLETED|Overall Study||0||
59716653|NCT01129128|75835553|FG000|STARTED|Overall Study||22||
59716654|NCT01129128|75835554|FG001|STARTED|Overall Study||22||
59716655|NCT01129128|75835555|FG002|STARTED|Overall Study||23||
59716656|NCT01129128|75835553|FG000|COMPLETED|Overall Study||19||
59716657|NCT01129128|75835554|FG001|COMPLETED|Overall Study||18||
59831052|NCT00183274|75954515|FG005|STARTED|Phase 1: Open-Label||0||
59831053|NCT00183274|75954510|FG000|COMPLETED|Phase 1: Open-Label|110 dropouts during phase 1|158||
59831054|NCT00183274|75954511|FG001|COMPLETED|Phase 1: Open-Label||0||
59831055|NCT00183274|75954512|FG002|COMPLETED|Phase 1: Open-Label||0||
59831056|NCT00183274|75954513|FG003|COMPLETED|Phase 1: Open-Label||0||
59831057|NCT00183274|75954514|FG004|COMPLETED|Phase 1: Open-Label||0||
59831058|NCT00183274|75954515|FG005|COMPLETED|Phase 1: Open-Label||0||
59831059|NCT00183274|75954510|FG000|NOT COMPLETED|Phase 1: Open-Label||110||
60118412|NCT01372410|76239490|FG003|STARTED|Treatment Period 1 (7 Days)||20||
60118413|NCT01372410|76239491|FG004|STARTED|Treatment Period 1 (7 Days)||21||
60118414|NCT01372410|76239492|FG005|STARTED|Treatment Period 1 (7 Days)||21||
60118415|NCT01372410|76239493|FG006|STARTED|Treatment Period 1 (7 Days)||22||
60118416|NCT01372410|76239494|FG007|STARTED|Treatment Period 1 (7 Days)||19||
60118417|NCT01372410|76239487|FG000|COMPLETED|Treatment Period 1 (7 Days)||19||
60118418|NCT01372410|76239488|FG001|COMPLETED|Treatment Period 1 (7 Days)||19||
60118419|NCT01372410|76239489|FG002|COMPLETED|Treatment Period 1 (7 Days)||19||
60118420|NCT01372410|76239490|FG003|COMPLETED|Treatment Period 1 (7 Days)||20||
60118421|NCT01372410|76239491|FG004|COMPLETED|Treatment Period 1 (7 Days)||19||
60118422|NCT01372410|76239492|FG005|COMPLETED|Treatment Period 1 (7 Days)||21||
60118423|NCT01372410|76239493|FG006|COMPLETED|Treatment Period 1 (7 Days)||20||
60118424|NCT01372410|76239494|FG007|COMPLETED|Treatment Period 1 (7 Days)||19||
60118425|NCT01372410|76239487|FG000|NOT COMPLETED|Treatment Period 1 (7 Days)||1||
60118426|NCT01372410|76239488|FG001|NOT COMPLETED|Treatment Period 1 (7 Days)||2||
60118427|NCT01372410|76239489|FG002|NOT COMPLETED|Treatment Period 1 (7 Days)||0||
60118428|NCT01372410|76239490|FG003|NOT COMPLETED|Treatment Period 1 (7 Days)||0||
60118429|NCT01372410|76239491|FG004|NOT COMPLETED|Treatment Period 1 (7 Days)||2||
60118430|NCT01372410|76239492|FG005|NOT COMPLETED|Treatment Period 1 (7 Days)||0||
60118431|NCT01372410|76239493|FG006|NOT COMPLETED|Treatment Period 1 (7 Days)||2||
60118432|NCT01372410|76239494|FG007|NOT COMPLETED|Treatment Period 1 (7 Days)||0||
60118433|NCT01372410|76239487|FG000|STARTED|Washout Period 1 (10-14 Days)||19||
60118434|NCT01372410|76239488|FG001|STARTED|Washout Period 1 (10-14 Days)||19||
60118435|NCT01372410|76239489|FG002|STARTED|Washout Period 1 (10-14 Days)||19||
60118436|NCT01372410|76239490|FG003|STARTED|Washout Period 1 (10-14 Days)||20||
60118437|NCT01372410|76239491|FG004|STARTED|Washout Period 1 (10-14 Days)||19||
59716658|NCT01129128|75835555|FG002|COMPLETED|Overall Study||19||
59716659|NCT01129128|75835553|FG000|NOT COMPLETED|Overall Study||3||
59716660|NCT01129128|75835554|FG001|NOT COMPLETED|Overall Study||4||
59716661|NCT01129128|75835555|FG002|NOT COMPLETED|Overall Study||4||
59716662|NCT01222520|75835565|FG000|STARTED|Open-label run-in Period||0||
59716663|NCT01222520|75835566|FG001|STARTED|Open-label run-in Period||197||
59716664|NCT01222520|75835565|FG000|COMPLETED|Open-label run-in Period||0||
59716665|NCT01222520|75835566|FG001|COMPLETED|Open-label run-in Period||174||
59716666|NCT01222520|75835565|FG000|NOT COMPLETED|Open-label run-in Period||0||
59716667|NCT01222520|75835566|FG001|NOT COMPLETED|Open-label run-in Period||23||
59716668|NCT01222520|75835565|FG000|STARTED|Double-blind Period||87||
59831060|NCT00183274|75954511|FG001|NOT COMPLETED|Phase 1: Open-Label||0||
59831061|NCT00183274|75954512|FG002|NOT COMPLETED|Phase 1: Open-Label||0||
59831062|NCT00183274|75954513|FG003|NOT COMPLETED|Phase 1: Open-Label||0||
59831063|NCT00183274|75954514|FG004|NOT COMPLETED|Phase 1: Open-Label||0||
59831064|NCT00183274|75954515|FG005|NOT COMPLETED|Phase 1: Open-Label||0||
59831065|NCT00183274|75954510|FG000|STARTED|Phase 2: Double-Blind|This phase ended after 6 months. There were no longer participants in this phase.|0||
60118438|NCT01372410|76239492|FG005|STARTED|Washout Period 1 (10-14 Days)||21||
60118439|NCT01372410|76239493|FG006|STARTED|Washout Period 1 (10-14 Days)||20||
60118440|NCT01372410|76239494|FG007|STARTED|Washout Period 1 (10-14 Days)||19||
60118441|NCT01372410|76239487|FG000|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|18||
60118442|NCT01372410|76239488|FG001|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|19||
60118443|NCT01372410|76239489|FG002|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|19||
60118444|NCT01372410|76239490|FG003|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|20||
60118445|NCT01372410|76239491|FG004|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|19||
60118446|NCT01372410|76239492|FG005|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|21||
60118447|NCT01372410|76239493|FG006|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|20||
60118448|NCT01372410|76239494|FG007|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|18||
60118449|NCT01372410|76239487|FG000|NOT COMPLETED|Washout Period 1 (10-14 Days)||1||
60118450|NCT01372410|76239488|FG001|NOT COMPLETED|Washout Period 1 (10-14 Days)||0||
60118451|NCT01372410|76239489|FG002|NOT COMPLETED|Washout Period 1 (10-14 Days)||0||
60118452|NCT01372410|76239490|FG003|NOT COMPLETED|Washout Period 1 (10-14 Days)||0||
60118453|NCT01372410|76239491|FG004|NOT COMPLETED|Washout Period 1 (10-14 Days)||0||
60118454|NCT01372410|76239492|FG005|NOT COMPLETED|Washout Period 1 (10-14 Days)||0||
60118455|NCT01372410|76239493|FG006|NOT COMPLETED|Washout Period 1 (10-14 Days)||0||
60118456|NCT01372410|76239494|FG007|NOT COMPLETED|Washout Period 1 (10-14 Days)||1||
60118457|NCT01372410|76239487|FG000|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|19||
60118458|NCT01372410|76239488|FG001|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|21||
60118459|NCT01372410|76239489|FG002|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|22||
60118460|NCT01372410|76239490|FG003|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|17||
60118461|NCT01372410|76239491|FG004|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|19||
60118462|NCT01372410|76239492|FG005|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|16||
60118463|NCT01372410|76239493|FG006|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|21||
60118464|NCT01372410|76239494|FG007|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|19||
60118465|NCT01372410|76239487|FG000|COMPLETED|Treatment Period 2 (7 Days)||19||
60118466|NCT01372410|76239488|FG001|COMPLETED|Treatment Period 2 (7 Days)||21||
60118467|NCT01372410|76239489|FG002|COMPLETED|Treatment Period 2 (7 Days)||22||
60118468|NCT01372410|76239490|FG003|COMPLETED|Treatment Period 2 (7 Days)||17||
60118469|NCT01372410|76239491|FG004|COMPLETED|Treatment Period 2 (7 Days)||19||
60118470|NCT01372410|76239492|FG005|COMPLETED|Treatment Period 2 (7 Days)||16||
60118471|NCT01372410|76239493|FG006|COMPLETED|Treatment Period 2 (7 Days)||21||
60118472|NCT01372410|76239494|FG007|COMPLETED|Treatment Period 2 (7 Days)||19||
60118473|NCT01372410|76239487|FG000|NOT COMPLETED|Treatment Period 2 (7 Days)||0||
60118474|NCT01372410|76239488|FG001|NOT COMPLETED|Treatment Period 2 (7 Days)||0||
60118475|NCT01372410|76239489|FG002|NOT COMPLETED|Treatment Period 2 (7 Days)||0||
60118476|NCT01372410|76239490|FG003|NOT COMPLETED|Treatment Period 2 (7 Days)||0||
60118477|NCT01372410|76239491|FG004|NOT COMPLETED|Treatment Period 2 (7 Days)||0||
60118478|NCT01372410|76239492|FG005|NOT COMPLETED|Treatment Period 2 (7 Days)||0||
60118479|NCT01372410|76239493|FG006|NOT COMPLETED|Treatment Period 2 (7 Days)||0||
60118480|NCT01372410|76239494|FG007|NOT COMPLETED|Treatment Period 2 (7 Days)||0||
60118481|NCT01372410|76239487|FG000|STARTED|Washout Period 2 (10-14 Days)||19||
60118482|NCT01372410|76239488|FG001|STARTED|Washout Period 2 (10-14 Days)||21||
60118483|NCT01372410|76239489|FG002|STARTED|Washout Period 2 (10-14 Days)||22||
60118484|NCT01372410|76239490|FG003|STARTED|Washout Period 2 (10-14 Days)||17||
60118485|NCT01372410|76239491|FG004|STARTED|Washout Period 2 (10-14 Days)||19||
60118486|NCT01372410|76239492|FG005|STARTED|Washout Period 2 (10-14 Days)||16||
60118487|NCT01372410|76239493|FG006|STARTED|Washout Period 2 (10-14 Days)||21||
60118488|NCT01372410|76239494|FG007|STARTED|Washout Period 2 (10-14 Days)||19||
60118489|NCT01372410|76239487|FG000|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|19||
60118490|NCT01372410|76239488|FG001|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|21||
59831066|NCT00183274|75954511|FG001|STARTED|Phase 2: Double-Blind|22 did not enter phase 2 due to lack of efficacy and withdrawal of consent|82||
60118491|NCT01372410|76239489|FG002|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|22||
59716669|NCT01222520|75835566|FG001|STARTED|Double-blind Period||87||
59716670|NCT01222520|75835565|FG000|COMPLETED|Double-blind Period||86||
59716671|NCT01222520|75835566|FG001|COMPLETED|Double-blind Period||85||
59716672|NCT01222520|75835565|FG000|NOT COMPLETED|Double-blind Period||1||
59716673|NCT01222520|75835566|FG001|NOT COMPLETED|Double-blind Period||2||
59716674|NCT01221350|75835574|FG000|STARTED|Overall Study||28||
59716675|NCT01221350|75835575|FG001|STARTED|Overall Study||27||
59716676|NCT01221350|75835574|FG000|Received Intervention|Overall Study||28||
59716677|NCT01221350|75835575|FG001|Received Intervention|Overall Study||27||
59716678|NCT01221350|75835574|FG000|Analysis Population|Overall Study||23||
59716679|NCT01221350|75835575|FG001|Analysis Population|Overall Study||24||
59716680|NCT01221350|75835574|FG000|COMPLETED|Overall Study||23||
59716681|NCT01221350|75835575|FG001|COMPLETED|Overall Study||24||
59716682|NCT01221350|75835574|FG000|NOT COMPLETED|Overall Study||5||
59716683|NCT01221350|75835575|FG001|NOT COMPLETED|Overall Study||3||
59716684|NCT01221272|75835583|FG000|STARTED|Period 1||41||
59716685|NCT01221272|75835584|FG001|STARTED|Period 1||40||
59716686|NCT01221272|75835583|FG000|COMPLETED|Period 1||39||
59716687|NCT01221272|75835584|FG001|COMPLETED|Period 1||38||
59716688|NCT01221272|75835583|FG000|NOT COMPLETED|Period 1||2||
59716689|NCT01221272|75835584|FG001|NOT COMPLETED|Period 1||2||
59716690|NCT01221272|75835583|FG000|STARTED|Period 2||39||
59716691|NCT01221272|75835584|FG001|STARTED|Period 2|1 participant did not complete Period 1, but started and completed Period 2.|39||
59716692|NCT01221272|75835583|FG000|COMPLETED|Period 2||39||
59716693|NCT01221272|75835584|FG001|COMPLETED|Period 2||37||
59716694|NCT01221272|75835583|FG000|NOT COMPLETED|Period 2||0||
59716695|NCT01221272|75835584|FG001|NOT COMPLETED|Period 2||2||
59716696|NCT01220414|75835595|FG000|STARTED|Overall Study||15||
59716697|NCT01220414|75835596|FG001|STARTED|Overall Study||14||
59716698|NCT01220414|75835597|FG002|STARTED|Overall Study||14||
59716699|NCT01220414|75835598|FG003|STARTED|Overall Study||15||
59716700|NCT01220414|75835595|FG000|COMPLETED|Overall Study||14||
59716701|NCT01220414|75835596|FG001|COMPLETED|Overall Study||14||
59716702|NCT01220414|75835597|FG002|COMPLETED|Overall Study||14||
59716703|NCT01220414|75835598|FG003|COMPLETED|Overall Study||14||
59716704|NCT01220414|75835595|FG000|NOT COMPLETED|Overall Study||1||
59716705|NCT01220414|75835596|FG001|NOT COMPLETED|Overall Study||0||
59716706|NCT01220414|75835597|FG002|NOT COMPLETED|Overall Study||0||
59716707|NCT01220414|75835598|FG003|NOT COMPLETED|Overall Study||1||
59716708|NCT01128894|75835607|FG000|STARTED|Overall Study||404||
59716709|NCT01128894|75835608|FG001|STARTED|Overall Study||408||
59716710|NCT01128894|75835607|FG000|COMPLETED|Overall Study||346||
59716711|NCT01128894|75835608|FG001|COMPLETED|Overall Study||340||
59716712|NCT01128894|75835607|FG000|NOT COMPLETED|Overall Study||58||
59716713|NCT01128894|75835608|FG001|NOT COMPLETED|Overall Study||68||
59716714|NCT01220180|75835617|FG000|STARTED|Overall Study||4175||
59716715|NCT01220180|75835617|FG000|Treated|Overall Study||4174||
59716716|NCT01220180|75835617|FG000|COMPLETED|Overall Study||3968||
59716717|NCT01220180|75835617|FG000|NOT COMPLETED|Overall Study||207||
59716718|NCT01220024|75835623|FG000|STARTED|Overall Study||25||
59716719|NCT01220024|75835624|FG001|STARTED|Overall Study||25||
59716720|NCT01220024|75835623|FG000|COMPLETED|Overall Study||24||
59716721|NCT01220024|75835624|FG001|COMPLETED|Overall Study||24||
59716722|NCT01220024|75835623|FG000|NOT COMPLETED|Overall Study||1||
59716723|NCT01220024|75835624|FG001|NOT COMPLETED|Overall Study||1||
59716724|NCT01128738|75835632|FG000|STARTED|First Treatment Phase (TP)||78||
59716725|NCT01128738|75835633|FG001|STARTED|First Treatment Phase (TP)||74||
59716726|NCT01128738|75835632|FG000|COMPLETED|First Treatment Phase (TP)||74||
59716727|NCT01128738|75835633|FG001|COMPLETED|First Treatment Phase (TP)||73||
59716728|NCT01128738|75835632|FG000|NOT COMPLETED|First Treatment Phase (TP)||4||
59716729|NCT01128738|75835633|FG001|NOT COMPLETED|First Treatment Phase (TP)||1||
59716730|NCT01128738|75835632|FG000|STARTED|Second TP|Only participants who received a second treatment entered this phase.|34||
59716731|NCT01128738|75835633|FG001|STARTED|Second TP|Only participants who received a second treatment entered this phase.|66||
59716732|NCT01128738|75835632|FG000|COMPLETED|Second TP||34||
59831067|NCT00183274|75954512|FG002|STARTED|Phase 2: Double-Blind|22 did not enter phase 2 due to lack of efficacy and withdrawal of consent|54||
59831068|NCT00183274|75954513|FG003|STARTED|Phase 2: Double-Blind||0||
59716733|NCT01128738|75835633|FG001|COMPLETED|Second TP||63||
59831069|NCT00183274|75954514|FG004|STARTED|Phase 2: Double-Blind||0||
59716734|NCT01128738|75835632|FG000|NOT COMPLETED|Second TP||0||
59716735|NCT01128738|75835633|FG001|NOT COMPLETED|Second TP||3||
59716736|NCT01143090|75835640|FG000|STARTED|Overall Study||149||
59716737|NCT01143090|75835640|FG000|COMPLETED|Overall Study||98||
59716738|NCT01143090|75835640|FG000|NOT COMPLETED|Overall Study||51||
59716739|NCT01165554|75835644|FG000|STARTED|Overall Study|This was the number of subjects that started the study.|203||
59716740|NCT01165554|75835644|FG000|COMPLETED|Overall Study||180||
59716741|NCT01165554|75835644|FG000|NOT COMPLETED|Overall Study||23||
59831070|NCT00183274|75954515|FG005|STARTED|Phase 2: Double-Blind||0||
59831071|NCT00183274|75954510|FG000|COMPLETED|Phase 2: Double-Blind||0||
59831072|NCT00183274|75954511|FG001|COMPLETED|Phase 2: Double-Blind|8 lost to relapse, 18 lost to dropout|56||
59831073|NCT00183274|75954512|FG002|COMPLETED|Phase 2: Double-Blind|29 lost to relapse, 14 lost to dropout|11||
59831074|NCT00183274|75954513|FG003|COMPLETED|Phase 2: Double-Blind||0||
59831075|NCT00183274|75954514|FG004|COMPLETED|Phase 2: Double-Blind||0||
59831076|NCT00183274|75954515|FG005|COMPLETED|Phase 2: Double-Blind||0||
59831077|NCT00183274|75954510|FG000|NOT COMPLETED|Phase 2: Double-Blind||0||
59831078|NCT00183274|75954511|FG001|NOT COMPLETED|Phase 2: Double-Blind||26||
59831079|NCT00183274|75954512|FG002|NOT COMPLETED|Phase 2: Double-Blind||43||
59831080|NCT00183274|75954513|FG003|NOT COMPLETED|Phase 2: Double-Blind||0||
59831081|NCT00183274|75954514|FG004|NOT COMPLETED|Phase 2: Double-Blind||0||
59831082|NCT00183274|75954515|FG005|NOT COMPLETED|Phase 2: Double-Blind||0||
59831083|NCT00183274|75954510|FG000|STARTED|Phase 3: Double-Blind||0||
59831084|NCT00183274|75954511|FG001|STARTED|Phase 3: Double-Blind|Phase 2 ended at the end of 12 months of study.|0||
59831085|NCT00183274|75954512|FG002|STARTED|Phase 3: Double-Blind|Phase 2 ended at the end of 12 months of study.|0||
59831086|NCT00183274|75954513|FG003|STARTED|Phase 3: Double-Blind|8 completed Phase 2 but did not enter phase 3|15||
59831087|NCT00183274|75954514|FG004|STARTED|Phase 3: Double-Blind|8 completed Phase 2 but did not enter phase 3|34||
59831088|NCT00183274|75954515|FG005|STARTED|Phase 3: Double-Blind|8 completed Phase 2 but did not enter phase 3|10||
59831089|NCT00183274|75954510|FG000|COMPLETED|Phase 3: Double-Blind||0||
59831090|NCT00183274|75954511|FG001|COMPLETED|Phase 3: Double-Blind||0||
59831091|NCT00183274|75954512|FG002|COMPLETED|Phase 3: Double-Blind||0||
59831092|NCT00183274|75954513|FG003|COMPLETED|Phase 3: Double-Blind|1 lost to relapse and 1 lost to dropout|13||
59831093|NCT00183274|75954514|FG004|COMPLETED|Phase 3: Double-Blind|11 lost to relapse and 9 lost to dropout|14||
59831094|NCT00183274|75954515|FG005|COMPLETED|Phase 3: Double-Blind|2 lost to relapse and 2 lost to dropout|6||
59831095|NCT00183274|75954510|FG000|NOT COMPLETED|Phase 3: Double-Blind||0||
59831096|NCT00183274|75954511|FG001|NOT COMPLETED|Phase 3: Double-Blind||0||
59831097|NCT00183274|75954512|FG002|NOT COMPLETED|Phase 3: Double-Blind||0||
59831098|NCT00183274|75954513|FG003|NOT COMPLETED|Phase 3: Double-Blind||2||
59831099|NCT00183274|75954514|FG004|NOT COMPLETED|Phase 3: Double-Blind||20||
59831100|NCT00183274|75954515|FG005|NOT COMPLETED|Phase 3: Double-Blind||4||
59831101|NCT00183196|75954533|FG000|STARTED|Overall Study|2 subjects had no post-randomization data|50||
59831102|NCT00183196|75954534|FG001|STARTED|Overall Study|1 subject had no post-randomization data|50||
59831103|NCT00183196|75954535|FG002|STARTED|Overall Study|1 subject had no post-randomization data|50||
59831104|NCT00183196|75954533|FG000|COMPLETED|Overall Study||30||
59831105|NCT00183196|75954534|FG001|COMPLETED|Overall Study||35||
59831106|NCT00183196|75954535|FG002|COMPLETED|Overall Study||32||
59831107|NCT00183196|75954533|FG000|NOT COMPLETED|Overall Study||20||
59831108|NCT00183196|75954534|FG001|NOT COMPLETED|Overall Study||15||
59831109|NCT00183196|75954535|FG002|NOT COMPLETED|Overall Study||18||
59831110|NCT00349752|75954545|FG000|STARTED|Overall Study||87||
59831111|NCT00349752|75954546|FG001|STARTED|Overall Study||87||
59831112|NCT00349752|75954545|FG000|COMPLETED|Overall Study||28||
59831113|NCT00349752|75954546|FG001|COMPLETED|Overall Study||23||
59831114|NCT00349752|75954545|FG000|NOT COMPLETED|Overall Study||59||
59831115|NCT00349752|75954546|FG001|NOT COMPLETED|Overall Study||64||
59831116|NCT00174460|75954554|FG000|STARTED|Overall Study||18||
59831117|NCT00174460|75954555|FG001|STARTED|Overall Study||15||
59831118|NCT00174460|75954554|FG000|Received Study Treatment|Overall Study||18||
59831119|NCT00174460|75954555|FG001|Received Study Treatment|Overall Study||14||
59831120|NCT00174460|75954554|FG000|COMPLETED|Overall Study||18||
59831121|NCT00174460|75954555|FG001|COMPLETED|Overall Study||14||
59831122|NCT00174460|75954554|FG000|NOT COMPLETED|Overall Study||0||
59831123|NCT00174460|75954555|FG001|NOT COMPLETED|Overall Study||1||
59831124|NCT00348816|75954562|FG000|STARTED|Overall Study||20||
59831125|NCT00348816|75954562|FG000|COMPLETED|Overall Study||19||
59831126|NCT00348816|75954562|FG000|NOT COMPLETED|Overall Study||1||
59831127|NCT00265083|75954571|FG000|STARTED|Overall Study||78||
59831128|NCT00265083|75954572|FG001|STARTED|Overall Study|One patient did not receive study agent.|138||
59831129|NCT00265083|75954573|FG002|STARTED|Overall Study||140||
59831130|NCT00265083|75954571|FG000|COMPLETED|Overall Study||61||
59831131|NCT00265083|75954572|FG001|COMPLETED|Overall Study|One patient did not receive study agent.|96||
59831132|NCT00265083|75954573|FG002|COMPLETED|Overall Study||98||
59831133|NCT00265083|75954571|FG000|NOT COMPLETED|Overall Study||17||
59831134|NCT00265083|75954572|FG001|NOT COMPLETED|Overall Study||42||
59831135|NCT00265083|75954573|FG002|NOT COMPLETED|Overall Study||42||
59831136|NCT00264849|75954584|FG000|STARTED|Overall Study||275||
59831137|NCT00264849|75954585|FG001|STARTED|Overall Study||131||
59831138|NCT00264849|75954584|FG000|COMPLETED|Overall Study||253||
59831139|NCT00264849|75954585|FG001|COMPLETED|Overall Study||106||
59831140|NCT00264849|75954584|FG000|NOT COMPLETED|Overall Study||22||
59831141|NCT00264849|75954585|FG001|NOT COMPLETED|Overall Study||25||
59831142|NCT00211809|75954591|FG000|STARTED|Overall Study||17||
59831143|NCT00211809|75954591|FG000|COMPLETED|Overall Study||11||
59831144|NCT00211809|75954591|FG000|NOT COMPLETED|Overall Study||6||
59831145|NCT00129766|75954599|FG000|STARTED|Overall Study||3306||
59831146|NCT00129766|75954600|FG001|STARTED|Overall Study||3329||
59831147|NCT00129766|75954599|FG000|COMPLETED|Overall Study||3246||
59831148|NCT00129766|75954600|FG001|COMPLETED|Overall Study||3270||
59831149|NCT00129766|75954599|FG000|NOT COMPLETED|Overall Study||60||
59831150|NCT00129766|75954600|FG001|NOT COMPLETED|Overall Study||59||
59831151|NCT00150592|75954609|FG000|STARTED|Overall Study||121||
59831152|NCT00150592|75954610|FG001|STARTED|Overall Study||57||
59831153|NCT00150592|75954609|FG000|COMPLETED|Overall Study||114||
59831154|NCT00150592|75954610|FG001|COMPLETED|Overall Study||54||
60118492|NCT01372410|76239490|FG003|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|17||
60118493|NCT01372410|76239491|FG004|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|17||
60118494|NCT01372410|76239492|FG005|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|16||
60118495|NCT01372410|76239493|FG006|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|20||
60118496|NCT01372410|76239494|FG007|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|17||
59716742|NCT01218308|75835653|FG000|STARTED|Overall Study||2584||
59716743|NCT01218308|75835654|FG001|STARTED|Overall Study||2584||
59716744|NCT01218308|75835653|FG000|COMPLETED|Overall Study||2481||
59716745|NCT01218308|75835654|FG001|COMPLETED|Overall Study||2464||
59716746|NCT01218308|75835653|FG000|NOT COMPLETED|Overall Study||103||
59716747|NCT01218308|75835654|FG001|NOT COMPLETED|Overall Study||120||
59716748|NCT01165320|75835662|FG000|STARTED|Overall Study||12||
59716749|NCT01165320|75835663|FG001|STARTED|Overall Study||8||
59716750|NCT01165320|75835664|FG002|STARTED|Overall Study|No participants with esophageal candidiasis were identified for inclusion in the study|0||
59716751|NCT01165320|75835662|FG000|COMPLETED|Overall Study||9||
59716752|NCT01165320|75835663|FG001|COMPLETED|Overall Study||4||
59716753|NCT01165320|75835664|FG002|COMPLETED|Overall Study||0||
59716754|NCT01165320|75835662|FG000|NOT COMPLETED|Overall Study||3||
59716755|NCT01165320|75835663|FG001|NOT COMPLETED|Overall Study||4||
59716756|NCT01165320|75835664|FG002|NOT COMPLETED|Overall Study||0||
59716757|NCT01217606|75835672|FG000|STARTED|Initial Treatment Phase||90||
59831155|NCT00150592|75954609|FG000|NOT COMPLETED|Overall Study||7||
59831156|NCT00150592|75954610|FG001|NOT COMPLETED|Overall Study||3||
59831157|NCT00149890|75954618|FG000|STARTED|Overall Study|"Started indicates all screened and treated participants."|39||
59831158|NCT00149890|75954619|FG001|STARTED|Overall Study||38||
59831159|NCT00149890|75954618|FG000|COMPLETED|Overall Study||26||
59831160|NCT00149890|75954619|FG001|COMPLETED|Overall Study||20||
59831161|NCT00149890|75954618|FG000|NOT COMPLETED|Overall Study||13||
59831162|NCT00149890|75954619|FG001|NOT COMPLETED|Overall Study||18||
59831163|NCT00174382|75954625|FG000|STARTED|Overall Study|148 are summarized below: 1 subject entered the study but was lost to follow up.|149||
59831164|NCT00174382|75954625|FG000|COMPLETED|Overall Study||116||
59831165|NCT00174382|75954625|FG000|NOT COMPLETED|Overall Study||33||
59831166|NCT00355134|75954634|FG000|STARTED|Core Phase||370||
59831167|NCT00355134|75954635|FG001|STARTED|Core Phase||358||
60118497|NCT01372410|76239487|FG000|NOT COMPLETED|Washout Period 2 (10-14 Days)||0||
60118498|NCT01372410|76239488|FG001|NOT COMPLETED|Washout Period 2 (10-14 Days)||0||
60118499|NCT01372410|76239489|FG002|NOT COMPLETED|Washout Period 2 (10-14 Days)||0||
60118500|NCT01372410|76239490|FG003|NOT COMPLETED|Washout Period 2 (10-14 Days)||0||
60118501|NCT01372410|76239491|FG004|NOT COMPLETED|Washout Period 2 (10-14 Days)||2||
59716758|NCT01217606|75835673|FG001|STARTED|Initial Treatment Phase||95||
59716759|NCT01217606|75835672|FG000|COMPLETED|Initial Treatment Phase||76||
59831168|NCT00355134|75954636|FG002|STARTED|Core Phase||355||
59831169|NCT00355134|75954637|FG003|STARTED|Core Phase||0||
59831170|NCT00355134|75954638|FG004|STARTED|Core Phase||0||
59716760|NCT01217606|75835673|FG001|COMPLETED|Initial Treatment Phase||83||
59716761|NCT01217606|75835672|FG000|NOT COMPLETED|Initial Treatment Phase||14||
59716762|NCT01217606|75835673|FG001|NOT COMPLETED|Initial Treatment Phase||12||
59716763|NCT01217606|75835672|FG000|STARTED|9-Month Masked Extension||67||
59716764|NCT01217606|75835673|FG001|STARTED|9-Month Masked Extension||73||
59716765|NCT01217606|75835672|FG000|Not Enrolled in Masked Extension|9-Month Masked Extension||9||
59716766|NCT01217606|75835673|FG001|Not Enrolled in Masked Extension|9-Month Masked Extension||10||
59716767|NCT01217606|75835672|FG000|COMPLETED|9-Month Masked Extension||54||
59831171|NCT00355134|75954634|FG000|COMPLETED|Core Phase||251||
59831172|NCT00355134|75954635|FG001|COMPLETED|Core Phase||272||
59831173|NCT00355134|75954636|FG002|COMPLETED|Core Phase||255||
59831174|NCT00355134|75954637|FG003|COMPLETED|Core Phase||0||
59831175|NCT00355134|75954638|FG004|COMPLETED|Core Phase||0||
59831176|NCT00355134|75954634|FG000|NOT COMPLETED|Core Phase||119||
59716768|NCT01217606|75835673|FG001|COMPLETED|9-Month Masked Extension||62||
59716769|NCT01217606|75835672|FG000|NOT COMPLETED|9-Month Masked Extension||13||
59831177|NCT00355134|75954635|FG001|NOT COMPLETED|Core Phase||86||
59831178|NCT00355134|75954636|FG002|NOT COMPLETED|Core Phase||100||
59831179|NCT00355134|75954637|FG003|NOT COMPLETED|Core Phase||0||
59831180|NCT00355134|75954638|FG004|NOT COMPLETED|Core Phase||0||
59831181|NCT00355134|75954634|FG000|STARTED|Extension Phase||203||
60118502|NCT01372410|76239492|FG005|NOT COMPLETED|Washout Period 2 (10-14 Days)||0||
60118503|NCT01372410|76239493|FG006|NOT COMPLETED|Washout Period 2 (10-14 Days)||1||
60118504|NCT01372410|76239494|FG007|NOT COMPLETED|Washout Period 2 (10-14 Days)||2||
59716770|NCT01217606|75835673|FG001|NOT COMPLETED|9-Month Masked Extension||11||
59716771|NCT01128114|75835679|FG000|STARTED|Overall Study||32||
59716772|NCT01128114|75835679|FG000|COMPLETED|Overall Study||24||
59716773|NCT01128114|75835679|FG000|NOT COMPLETED|Overall Study||8||
59716774|NCT01217060|75835683|FG000|STARTED|Overall Study||4||
59716775|NCT01217060|75835683|FG000|COMPLETED|Overall Study||3||
59716776|NCT01217060|75835683|FG000|NOT COMPLETED|Overall Study||1||
59716777|NCT04816669|75835691|FG000|STARTED|Part 1||279||
59716778|NCT04816669|75835692|FG001|STARTED|Part 1||280||
59716779|NCT04816669|75835693|FG002|STARTED|Part 1||0||
59716780|NCT04816669|75835694|FG003|STARTED|Part 1||0||
59716781|NCT04816669|75835691|FG000|Vaccinated at Dose 1|Part 1||279||
59716782|NCT04816669|75835692|FG001|Vaccinated at Dose 1|Part 1||280||
59716783|NCT04816669|75835693|FG002|Vaccinated at Dose 1|Part 1||0||
59716784|NCT04816669|75835694|FG003|Vaccinated at Dose 1|Part 1||0||
59716785|NCT04816669|75835691|FG000|Vaccinated at Dose 2|Part 1||276||
59716786|NCT04816669|75835692|FG001|Vaccinated at Dose 2|Part 1||277||
59716787|NCT04816669|75835693|FG002|Vaccinated at Dose 2|Part 1||0||
59716788|NCT04816669|75835694|FG003|Vaccinated at Dose 2|Part 1||0||
59716789|NCT04816669|75835691|FG000|Vaccination at Dose 3|Part 1|Participants who received 2 doses of lyophilized formulation of BNT162b2 in Part 1, were offered to receive Dose 3 of frozen-liquid formulation.|114||
59716790|NCT04816669|75835692|FG001|Vaccination at Dose 3|Part 1||0||
59716791|NCT04816669|75835693|FG002|Vaccination at Dose 3|Part 1||0||
59716792|NCT04816669|75835694|FG003|Vaccination at Dose 3|Part 1||0||
59716793|NCT04816669|75835691|FG000|COMPLETED|Part 1||275||
59716794|NCT04816669|75835692|FG001|COMPLETED|Part 1||274||
59716795|NCT04816669|75835693|FG002|COMPLETED|Part 1||0||
59716796|NCT04816669|75835694|FG003|COMPLETED|Part 1||0||
59716797|NCT04816669|75835691|FG000|NOT COMPLETED|Part 1||4||
59716798|NCT04816669|75835692|FG001|NOT COMPLETED|Part 1||6||
59716799|NCT04816669|75835693|FG002|NOT COMPLETED|Part 1||0||
59716800|NCT04816669|75835694|FG003|NOT COMPLETED|Part 1||0||
59716801|NCT04816669|75835691|FG000|STARTED|Part 2||0||
59716802|NCT04816669|75835692|FG001|STARTED|Part 2||0||
59716803|NCT04816669|75835693|FG002|STARTED|Part 2||35||
59716804|NCT04816669|75835694|FG003|STARTED|Part 2||35||
59716805|NCT04816669|75835691|FG000|Vaccinated at Dose 1|Part 2||0||
59716806|NCT04816669|75835692|FG001|Vaccinated at Dose 1|Part 2||0||
59716807|NCT04816669|75835693|FG002|Vaccinated at Dose 1|Part 2||35||
59716808|NCT04816669|75835694|FG003|Vaccinated at Dose 1|Part 2||35||
59831182|NCT00355134|75954635|FG001|STARTED|Extension Phase||217||
59831183|NCT00355134|75954636|FG002|STARTED|Extension Phase||0||
59831184|NCT00355134|75954637|FG003|STARTED|Extension Phase||105||
59831185|NCT00355134|75954638|FG004|STARTED|Extension Phase||107||
59716809|NCT04816669|75835691|FG000|Vaccinated at Dose 2|Part 2||0||
59716810|NCT04816669|75835692|FG001|Vaccinated at Dose 2|Part 2||0||
59716811|NCT04816669|75835693|FG002|Vaccinated at Dose 2|Part 2||35||
59716812|NCT04816669|75835694|FG003|Vaccinated at Dose 2|Part 2||35||
59716813|NCT04816669|75835691|FG000|COMPLETED|Part 2||0||
59716814|NCT04816669|75835692|FG001|COMPLETED|Part 2||0||
59716815|NCT04816669|75835693|FG002|COMPLETED|Part 2||33||
59716816|NCT04816669|75835694|FG003|COMPLETED|Part 2||34||
59716817|NCT04816669|75835691|FG000|NOT COMPLETED|Part 2||0||
59716818|NCT04816669|75835692|FG001|NOT COMPLETED|Part 2||0||
59831186|NCT00355134|75954634|FG000|COMPLETED|Extension Phase||172||
59831187|NCT00355134|75954635|FG001|COMPLETED|Extension Phase||180||
60118505|NCT01372410|76239487|FG000|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|21||
59716819|NCT04816669|75835693|FG002|NOT COMPLETED|Part 2||2||
59716820|NCT04816669|75835694|FG003|NOT COMPLETED|Part 2||1||
59716821|NCT01165242|75835711|FG000|STARTED|Overall Study||337||
59716822|NCT01165242|75835712|FG001|STARTED|Overall Study||336||
59716823|NCT01165242|75835713|FG002|STARTED|Overall Study||338||
59716824|NCT01165242|75835711|FG000|COMPLETED|Overall Study||327||
59716825|NCT01165242|75835712|FG001|COMPLETED|Overall Study||326||
59716826|NCT01165242|75835713|FG002|COMPLETED|Overall Study||324||
59716827|NCT01165242|75835711|FG000|NOT COMPLETED|Overall Study||10||
59716828|NCT01165242|75835712|FG001|NOT COMPLETED|Overall Study||10||
59716829|NCT01165242|75835713|FG002|NOT COMPLETED|Overall Study||14||
59716830|NCT01170065|75835726|FG000|STARTED|Overall Study||37||
59716831|NCT01170065|75835727|FG001|STARTED|Overall Study||126||
59716832|NCT01170065|75835728|FG002|STARTED|Overall Study||35||
59716833|NCT01170065|75835726|FG000|COMPLETED|Overall Study|Planned observation time is from first trial drug intake to follow-up visit|9||
59831188|NCT00355134|75954636|FG002|COMPLETED|Extension Phase||0||
59831189|NCT00355134|75954637|FG003|COMPLETED|Extension Phase||89||
59831190|NCT00355134|75954638|FG004|COMPLETED|Extension Phase||88||
59831191|NCT00355134|75954634|FG000|NOT COMPLETED|Extension Phase||31||
59831192|NCT00355134|75954635|FG001|NOT COMPLETED|Extension Phase||37||
59831193|NCT00355134|75954636|FG002|NOT COMPLETED|Extension Phase||0||
59831194|NCT00355134|75954637|FG003|NOT COMPLETED|Extension Phase||16||
59831195|NCT00355134|75954638|FG004|NOT COMPLETED|Extension Phase||19||
59831196|NCT00171730|75954648|FG000|STARTED|Overall Study||30||
59831197|NCT00171730|75954648|FG000|COMPLETED|Overall Study||15||
59831198|NCT00171730|75954648|FG000|NOT COMPLETED|Overall Study||15||
59831199|NCT00355056|75954660|FG000|STARTED|Randomization Period||107||
59831200|NCT00355056|75954661|FG001|STARTED|Randomization Period||123||
59831201|NCT00355056|75954660|FG000|COMPLETED|Randomization Period||103||
59831202|NCT00355056|75954661|FG001|COMPLETED|Randomization Period||117||
59831203|NCT00355056|75954660|FG000|NOT COMPLETED|Randomization Period||4||
59831204|NCT00355056|75954661|FG001|NOT COMPLETED|Randomization Period||6||
59831205|NCT00355056|75954660|FG000|STARTED|Optional Patent Foramen Ovale Closure|A sham procedure was not part of this period.|0||
59831206|NCT00355056|75954661|FG001|STARTED|Optional Patent Foramen Ovale Closure|Participants who completed Sham Procedure randomization Arm were eligible. 87/103 consented.|87||
59716834|NCT01170065|75835727|FG001|COMPLETED|Overall Study|Planned observation time is from first trial drug intake to follow-up visit|34||
59716835|NCT01170065|75835728|FG002|COMPLETED|Overall Study|Planned observation time is from first trial drug intake to follow-up visit|9||
59716836|NCT01170065|75835726|FG000|NOT COMPLETED|Overall Study||28||
59716837|NCT01170065|75835727|FG001|NOT COMPLETED|Overall Study||92||
59716838|NCT01170065|75835728|FG002|NOT COMPLETED|Overall Study||26||
59716839|NCT00966693|75835740|FG000|STARTED|Overall Study||3||
59716840|NCT00966693|75835741|FG001|STARTED|Overall Study||3||
59716841|NCT00966693|75835742|FG002|STARTED|Overall Study||9||
59716842|NCT00966693|75835743|FG003|STARTED|Overall Study||49||
59716843|NCT00966693|75835740|FG000|Phase 1 Completed|Overall Study||2||
59716844|NCT00966693|75835741|FG001|Phase 1 Completed|Overall Study||3||
59716845|NCT00966693|75835742|FG002|Phase 1 Completed|Overall Study||6||
59831207|NCT00355056|75954660|FG000|COMPLETED|Optional Patent Foramen Ovale Closure||0||
59831208|NCT00355056|75954661|FG001|COMPLETED|Optional Patent Foramen Ovale Closure||84||
59831209|NCT00355056|75954660|FG000|NOT COMPLETED|Optional Patent Foramen Ovale Closure||0||
59831210|NCT00355056|75954661|FG001|NOT COMPLETED|Optional Patent Foramen Ovale Closure||3||
59831211|NCT00348348|75954677|FG000|STARTED|Overall Study|Received at least one drop of study medication (Safety Population)|579||
59831212|NCT00348348|75954678|FG001|STARTED|Overall Study|Received at least one drop of study medication(Safety Population)|582||
59831213|NCT00348348|75954677|FG000|COMPLETED|Overall Study||554||
59831214|NCT00348348|75954678|FG001|COMPLETED|Overall Study||555||
59831215|NCT00348348|75954677|FG000|NOT COMPLETED|Overall Study||25||
59831216|NCT00348348|75954678|FG001|NOT COMPLETED|Overall Study||27||
59831217|NCT00347958|75954684|FG000|STARTED|Overall Study||544||
59831218|NCT00347958|75954684|FG000|COMPLETED|Overall Study||540||
59831219|NCT00347958|75954684|FG000|NOT COMPLETED|Overall Study||4||
59831220|NCT00354744|75954688|FG000|STARTED|Overall Study||109||
59831221|NCT00354744|75954688|FG000|COMPLETED|Overall Study||67||
59831222|NCT00354744|75954688|FG000|NOT COMPLETED|Overall Study||42||
59831223|NCT00373256|75954696|FG000|STARTED|Overall Study||241||
59831224|NCT00373256|75954697|FG001|STARTED|Overall Study||247||
59831225|NCT00373256|75954696|FG000|Treated|Overall Study||235||
59831226|NCT00373256|75954697|FG001|Treated|Overall Study||236||
59831227|NCT00373256|75954696|FG000|COMPLETED|Overall Study||0||
59831228|NCT00373256|75954697|FG001|COMPLETED|Overall Study||0||
59831229|NCT00373256|75954696|FG000|NOT COMPLETED|Overall Study||241||
59831230|NCT00373256|75954697|FG001|NOT COMPLETED|Overall Study||247||
59831231|NCT00394082|75954703|FG000|STARTED|Overall Study||50||
59831232|NCT00394082|75954703|FG000|At Least One Response Assessment|Overall Study||43||
59831233|NCT00394082|75954703|FG000|COMPLETED|Overall Study|Treatment completed upon disease progression|24||
59831234|NCT00394082|75954703|FG000|NOT COMPLETED|Overall Study||26||
59831235|NCT00393848|75954711|FG000|STARTED|Overall Study||16||
59716846|NCT00966693|75835743|FG003|Phase 1 Completed|Overall Study||0||
59716847|NCT00966693|75835740|FG000|Phase 2 Completed|Overall Study||0||
59716848|NCT00966693|75835741|FG001|Phase 2 Completed|Overall Study||0||
59716849|NCT00966693|75835742|FG002|Phase 2 Completed|Overall Study||0||
59716850|NCT00966693|75835743|FG003|Phase 2 Completed|Overall Study||46||
59716851|NCT00966693|75835740|FG000|COMPLETED|Overall Study||2||
59716852|NCT00966693|75835741|FG001|COMPLETED|Overall Study||3||
59716853|NCT00966693|75835742|FG002|COMPLETED|Overall Study||6||
59831236|NCT00393848|75954712|FG001|STARTED|Overall Study||9||
59831237|NCT00393848|75954713|FG002|STARTED|Overall Study||6||
59831238|NCT00393848|75954714|FG003|STARTED|Overall Study||9||
59831239|NCT00393848|75954711|FG000|COMPLETED|Overall Study||16||
59831240|NCT00393848|75954712|FG001|COMPLETED|Overall Study||9||
59716854|NCT00966693|75835743|FG003|COMPLETED|Overall Study||26||
59716855|NCT00966693|75835740|FG000|NOT COMPLETED|Overall Study||1||
59716856|NCT00966693|75835741|FG001|NOT COMPLETED|Overall Study||0||
59716857|NCT00966693|75835742|FG002|NOT COMPLETED|Overall Study||3||
59831241|NCT00393848|75954713|FG002|COMPLETED|Overall Study||4||
59831242|NCT00393848|75954714|FG003|COMPLETED|Overall Study||8||
59831243|NCT00393848|75954711|FG000|NOT COMPLETED|Overall Study||0||
59831244|NCT00393848|75954712|FG001|NOT COMPLETED|Overall Study||0||
59831245|NCT00393848|75954713|FG002|NOT COMPLETED|Overall Study||2||
59831246|NCT00393848|75954714|FG003|NOT COMPLETED|Overall Study||1||
59831247|NCT00393458|75954729|FG000|STARTED|Overall Study||437||
59831248|NCT00393458|75954730|FG001|STARTED|Overall Study||428||
59831249|NCT00393458|75954731|FG002|STARTED|Overall Study||435||
59831250|NCT00393458|75954732|FG003|STARTED|Overall Study||432||
59831251|NCT00393458|75954729|FG000|Exposed to Study Medication or Placebo|Overall Study||437||
59831252|NCT00393458|75954730|FG001|Exposed to Study Medication or Placebo|Overall Study||425||
59831253|NCT00393458|75954731|FG002|Exposed to Study Medication or Placebo|Overall Study||434||
59831254|NCT00393458|75954732|FG003|Exposed to Study Medication or Placebo|Overall Study||432||
59831255|NCT00393458|75954729|FG000|COMPLETED|Overall Study||338||
59831256|NCT00393458|75954730|FG001|COMPLETED|Overall Study||326||
59831257|NCT00393458|75954731|FG002|COMPLETED|Overall Study||323||
59831258|NCT00393458|75954732|FG003|COMPLETED|Overall Study||295||
59831259|NCT00393458|75954729|FG000|NOT COMPLETED|Overall Study||99||
59831260|NCT00393458|75954730|FG001|NOT COMPLETED|Overall Study||102||
59831261|NCT00393458|75954731|FG002|NOT COMPLETED|Overall Study||112||
59831262|NCT00393458|75954732|FG003|NOT COMPLETED|Overall Study||137||
59831263|NCT00417482|75954745|FG000|STARTED|Phase B 1st 16 Weeks|Risperidone 16 weeks.|32||
59831264|NCT00417482|75954746|FG001|STARTED|Phase B 1st 16 Weeks|Risperidone 16 weeks.|38||
59831265|NCT00417482|75954747|FG002|STARTED|Phase B 1st 16 Weeks|Placebo 16 weeks.|40||
59831266|NCT00417482|75954745|FG000|COMPLETED|Phase B 1st 16 Weeks||13||
59831267|NCT00417482|75954746|FG001|COMPLETED|Phase B 1st 16 Weeks||27||
59831268|NCT00417482|75954747|FG002|COMPLETED|Phase B 1st 16 Weeks||13||
59831269|NCT00417482|75954745|FG000|NOT COMPLETED|Phase B 1st 16 Weeks||19||
59831270|NCT00417482|75954746|FG001|NOT COMPLETED|Phase B 1st 16 Weeks||11||
59831271|NCT00417482|75954747|FG002|NOT COMPLETED|Phase B 1st 16 Weeks||27||
59831272|NCT00417482|75954745|FG000|STARTED|Phase B 2nd 16 Weeks|Risperidone for 16 weeks.|13||
59831273|NCT00417482|75954746|FG001|STARTED|Phase B 2nd 16 Weeks|Placebo for 16 weeks.|27||
59831274|NCT00417482|75954747|FG002|STARTED|Phase B 2nd 16 Weeks|Placebo for 16 weeks.|13||
59831275|NCT00417482|75954745|FG000|COMPLETED|Phase B 2nd 16 Weeks||10||
59831276|NCT00417482|75954746|FG001|COMPLETED|Phase B 2nd 16 Weeks||14||
59831277|NCT00417482|75954747|FG002|COMPLETED|Phase B 2nd 16 Weeks||10||
59831278|NCT00417482|75954745|FG000|NOT COMPLETED|Phase B 2nd 16 Weeks||3||
59831279|NCT00417482|75954746|FG001|NOT COMPLETED|Phase B 2nd 16 Weeks||13||
59831280|NCT00417482|75954747|FG002|NOT COMPLETED|Phase B 2nd 16 Weeks||3||
59831281|NCT00417248|75954761|FG000|STARTED|Overall Study||8||
59831282|NCT00417248|75954761|FG000|COMPLETED|Overall Study||0||
59831283|NCT00417248|75954761|FG000|NOT COMPLETED|Overall Study||8||
59831284|NCT00392288|75954769|FG000|STARTED|Overall Study|Number of randomized subjects is different to number of ITT population in Outcome Measures.|175||
59831285|NCT00392288|75954770|FG001|STARTED|Overall Study|Number of randomized subjects is different to number of ITT population in Outcome Measures.|177||
59831286|NCT00392288|75954771|FG002|STARTED|Overall Study|Number of randomized subjects is different to number of ITT population in Outcome Measures.|176||
59831287|NCT00392288|75954769|FG000|Treatment Period|Overall Study||172||
59831288|NCT00392288|75954770|FG001|Treatment Period|Overall Study||174||
59831289|NCT00392288|75954771|FG002|Treatment Period|Overall Study||175||
59831290|NCT00392288|75954769|FG000|COMPLETED|Overall Study|ITT set = 163 patients|143||
59831291|NCT00392288|75954770|FG001|COMPLETED|Overall Study|ITT set = 166 patients|155||
59831292|NCT00392288|75954771|FG002|COMPLETED|Overall Study|ITT set = 172 patients|159||
59831293|NCT00392288|75954769|FG000|NOT COMPLETED|Overall Study||32||
59831294|NCT00392288|75954770|FG001|NOT COMPLETED|Overall Study||22||
59831295|NCT00392288|75954771|FG002|NOT COMPLETED|Overall Study||17||
59831296|NCT00417170|75954781|FG000|STARTED|Overall Study|"Started indicates Safety population."|23||
59831297|NCT00417170|75954782|FG001|STARTED|Overall Study||25||
59831298|NCT00417170|75954781|FG000|Pharmacodynamics Population|Overall Study||21||
59831299|NCT00417170|75954782|FG001|Pharmacodynamics Population|Overall Study||23||
59831300|NCT00417170|75954781|FG000|COMPLETED|Overall Study||21||
59831301|NCT00417170|75954782|FG001|COMPLETED|Overall Study||22||
59831302|NCT00417170|75954781|FG000|NOT COMPLETED|Overall Study||2||
59831303|NCT00417170|75954782|FG001|NOT COMPLETED|Overall Study||3||
59831304|NCT00392990|75954790|FG000|STARTED|Treatment on Study||20||
59831305|NCT00392990|75954791|FG001|STARTED|Treatment on Study||5||
59831306|NCT00392990|75954790|FG000|COMPLETED|Treatment on Study||17||
59831307|NCT00392990|75954791|FG001|COMPLETED|Treatment on Study||4||
59831308|NCT00392990|75954790|FG000|NOT COMPLETED|Treatment on Study||3||
59831309|NCT00392990|75954791|FG001|NOT COMPLETED|Treatment on Study||1||
59831310|NCT00392990|75954790|FG000|STARTED|Follow up for 2 Years||20|All patients that receive one dose of study drug go into the follow-up phase.|
59831311|NCT00392990|75954791|FG001|STARTED|Follow up for 2 Years||5|All patients that receive one dose of study drug go into the follow-up phase.|
60118506|NCT01372410|76239488|FG001|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|18||
59831312|NCT00392990|75954790|FG000|COMPLETED|Follow up for 2 Years||16||
59831313|NCT00392990|75954791|FG001|COMPLETED|Follow up for 2 Years||5||
59831314|NCT00392990|75954790|FG000|NOT COMPLETED|Follow up for 2 Years||4||
59831315|NCT00392990|75954791|FG001|NOT COMPLETED|Follow up for 2 Years||0||
59831316|NCT00249873|75954799|FG000|STARTED|Overall Study|randomized patients: patients remained in the study whether treated or not until planned study end|3772||
59831317|NCT00249873|75954800|FG001|STARTED|Overall Study|randomized patients: patients remained in the study whether treated or not until planned study end|3782||
59831318|NCT00249873|75954799|FG000|COMPLETED|Overall Study|started and completed study drug|2442||
59831319|NCT00249873|75954800|FG001|COMPLETED|Overall Study|started and completed study drug|2528||
59831320|NCT00249873|75954799|FG000|NOT COMPLETED|Overall Study||1330||
59831321|NCT00249873|75954800|FG001|NOT COMPLETED|Overall Study||1254||
59831322|NCT00392210|75954808|FG000|STARTED|First Voiding Trial||36||
59831323|NCT00392210|75954809|FG001|STARTED|First Voiding Trial||33||
59831324|NCT00392210|75954808|FG000|COMPLETED|First Voiding Trial||34||
59831325|NCT00392210|75954809|FG001|COMPLETED|First Voiding Trial||31||
59831326|NCT00392210|75954808|FG000|NOT COMPLETED|First Voiding Trial||2||
59831327|NCT00392210|75954809|FG001|NOT COMPLETED|First Voiding Trial||2||
59831328|NCT00392210|75954808|FG000|STARTED|Second Voiding Trial||34||
59831329|NCT00392210|75954809|FG001|STARTED|Second Voiding Trial||31||
59831330|NCT00392210|75954808|FG000|COMPLETED|Second Voiding Trial||34||
59831331|NCT00392210|75954809|FG001|COMPLETED|Second Voiding Trial||31||
59831332|NCT00392210|75954808|FG000|NOT COMPLETED|Second Voiding Trial||0||
59831333|NCT00392210|75954809|FG001|NOT COMPLETED|Second Voiding Trial||0||
59831334|NCT00391976|75954818|FG000|STARTED|Overall Study|Started indicates all patients who were enrolled at Visit 1|45||
59831335|NCT00391976|75954819|FG001|STARTED|Overall Study||43||
59831336|NCT00391976|75954820|FG002|STARTED|Overall Study||35||
59831337|NCT00391976|75954818|FG000|Randomized|Overall Study|Randomization occurred after 28 days of treatment & negative antibody test aeruginosa antibody test|45||
59831338|NCT00391976|75954819|FG001|Randomized|Overall Study||43||
59831339|NCT00391976|75954820|FG002|Randomized|Overall Study||0||
60118507|NCT01372410|76239489|FG002|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|16||
60118508|NCT01372410|76239490|FG003|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|22||
60118509|NCT01372410|76239491|FG004|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|20||
59567491|NCT02326272|75670454|FG001|Completed Week 16|Initial Period (Week 0 to Week 16)||84||
59716858|NCT00966693|75835743|FG003|NOT COMPLETED|Overall Study||23||
59716859|NCT01215968|75835755|FG000|STARTED|Overall Study||13||
59716860|NCT01215968|75835756|FG001|STARTED|Overall Study||25||
59716861|NCT01215968|75835755|FG000|Received at Least 1 Dose of Study Drug|Overall Study||13||
59716862|NCT01215968|75835756|FG001|Received at Least 1 Dose of Study Drug|Overall Study|25 participants received placebo during Week 1.|24||
59716863|NCT01215968|75835755|FG000|COMPLETED|Overall Study||11||
59716864|NCT01215968|75835756|FG001|COMPLETED|Overall Study||18||
59716865|NCT01215968|75835755|FG000|NOT COMPLETED|Overall Study||2||
59716866|NCT01215968|75835756|FG001|NOT COMPLETED|Overall Study||7||
59716867|NCT00963807|75835765|FG000|STARTED|Overall Study||26||
59716868|NCT00963807|75835765|FG000|Completed Baseline Imaging|Overall Study||11||
59716869|NCT00963807|75835765|FG000|Completed Post-Cycle 1 Imaging|Overall Study||9||
59716870|NCT00963807|75835765|FG000|Completed Post-Cycle 2 FLT Imaging|Overall Study||9||
59716871|NCT00963807|75835765|FG000|Completed Post-Cycle 2 FDG Imaging|Overall Study||8||
59716872|NCT00963807|75835765|FG000|COMPLETED|Overall Study||8||
59716873|NCT00963807|75835765|FG000|NOT COMPLETED|Overall Study||18||
59716874|NCT01142466|75835773|FG000|STARTED|Overall Study||15||
59716875|NCT01142466|75835774|FG001|STARTED|Overall Study||15||
59716876|NCT01142466|75835773|FG000|COMPLETED|Overall Study||12||
59716877|NCT01142466|75835774|FG001|COMPLETED|Overall Study||13||
59716878|NCT01142466|75835773|FG000|NOT COMPLETED|Overall Study||3||
59716879|NCT01142466|75835774|FG001|NOT COMPLETED|Overall Study||2||
59716880|NCT01215734|75835782|FG000|STARTED|Overall Study||29||
59716881|NCT01215734|75835783|FG001|STARTED|Overall Study||15||
59716882|NCT01215734|75835782|FG000|COMPLETED|Overall Study||29||
59716883|NCT01215734|75835783|FG001|COMPLETED|Overall Study||14||
59716884|NCT01215734|75835782|FG000|NOT COMPLETED|Overall Study||0||
59716885|NCT01215734|75835783|FG001|NOT COMPLETED|Overall Study||1||
59716886|NCT01169987|75835789|FG000|STARTED|Overall Study||191||
59716887|NCT01169987|75835789|FG000|COMPLETED|Overall Study||160||
59716888|NCT01169987|75835789|FG000|NOT COMPLETED|Overall Study||31||
59716889|NCT01215422|75835803|FG000|STARTED|Overall Study||14||
59716890|NCT01215422|75835804|FG001|STARTED|Overall Study||249||
59716891|NCT01215422|75835805|FG002|STARTED|Overall Study||196||
59831340|NCT00391976|75954818|FG000|Safety Population|Overall Study|Patients who were enrolled and received at least one dose of study medication.|44||
59831341|NCT00391976|75954819|FG001|Safety Population|Overall Study||43||
59831342|NCT00391976|75954820|FG002|Safety Population|Overall Study||35||
59831343|NCT00391976|75954818|FG000|COMPLETED|Overall Study||18||
59831344|NCT00391976|75954819|FG001|COMPLETED|Overall Study||18||
59831345|NCT00391976|75954820|FG002|COMPLETED|Overall Study||0||
59831346|NCT00391976|75954818|FG000|NOT COMPLETED|Overall Study||27||
59831347|NCT00391976|75954819|FG001|NOT COMPLETED|Overall Study||25||
59831348|NCT00391976|75954820|FG002|NOT COMPLETED|Overall Study||35||
59831349|NCT00391898|75954832|FG000|STARTED|Overall Study|Safety population for Levodopa/carbidopa/entacapone is 45, for Levodopa/carbidopa, per randomized.|46||
59831350|NCT00391898|75954833|FG001|STARTED|Overall Study||49||
59831351|NCT00391898|75954832|FG000|COMPLETED|Overall Study||35||
59831352|NCT00391898|75954833|FG001|COMPLETED|Overall Study||39||
59831353|NCT00391898|75954832|FG000|NOT COMPLETED|Overall Study||11||
59831354|NCT00391898|75954833|FG001|NOT COMPLETED|Overall Study||10||
59831355|NCT00391586|75954839|FG000|STARTED|Overall Study||45||
59831356|NCT00391586|75954839|FG000|Received First-line Erlotinib|Overall Study|These patients received at least one dose of on-study first-line erlotinib|43||
59831357|NCT00391586|75954839|FG000|Received Platinum-based Chemotherapy|Overall Study|Total number of patients who received platinum-based chemotherapy after erlotinib treatment|10||
59831358|NCT00391586|75954839|FG000|COMPLETED|Overall Study|These patients received at least 2 cycles of erlotinib|21||
59831359|NCT00391586|75954839|FG000|NOT COMPLETED|Overall Study||24||
59831360|NCT00391430|75954846|FG000|STARTED|Overall Study||8||
59831361|NCT00391430|75954847|FG001|STARTED|Overall Study||0||
59831362|NCT00391430|75954848|FG002|STARTED|Overall Study||31||
59831363|NCT00391430|75954846|FG000|COMPLETED|Overall Study||5||
59831364|NCT00391430|75954847|FG001|COMPLETED|Overall Study||0||
59831365|NCT00391430|75954848|FG002|COMPLETED|Overall Study||19||
59831366|NCT00391430|75954846|FG000|NOT COMPLETED|Overall Study||3||
59831367|NCT00391430|75954847|FG001|NOT COMPLETED|Overall Study||0||
59831368|NCT00391430|75954848|FG002|NOT COMPLETED|Overall Study||12||
59831369|NCT00391274|75954858|FG000|STARTED|Overall Study||107||
59831370|NCT00391274|75954859|FG001|STARTED|Overall Study||104||
59831371|NCT00391274|75954858|FG000|Received at Least One Dose of Study Drug|Overall Study||106||
59831372|NCT00391274|75954859|FG001|Received at Least One Dose of Study Drug|Overall Study||102||
59831373|NCT00391274|75954858|FG000|COMPLETED|Overall Study||46||
59831374|NCT00391274|75954859|FG001|COMPLETED|Overall Study||47||
59831375|NCT00391274|75954858|FG000|NOT COMPLETED|Overall Study||61||
59831376|NCT00391274|75954859|FG001|NOT COMPLETED|Overall Study||57||
59831377|NCT00391118|75954868|FG000|STARTED|Overall Study||11||
59831378|NCT00391118|75954869|FG001|STARTED|Overall Study||69||
59831379|NCT00391118|75954870|FG002|STARTED|Overall Study||73||
59831380|NCT00391118|75954868|FG000|Received ≥1 Dose of Assigned Study Drug|Overall Study||11||
59831381|NCT00391118|75954869|FG001|Received ≥1 Dose of Assigned Study Drug|Overall Study||67||
59831382|NCT00391118|75954870|FG002|Received ≥1 Dose of Assigned Study Drug|Overall Study||72||
59831383|NCT00391118|75954868|FG000|COMPLETED|Overall Study||0||
59831384|NCT00391118|75954869|FG001|COMPLETED|Overall Study||14||
59831385|NCT00391118|75954870|FG002|COMPLETED|Overall Study||15||
59831386|NCT00391118|75954868|FG000|NOT COMPLETED|Overall Study||11||
59831387|NCT00391118|75954869|FG001|NOT COMPLETED|Overall Study||55||
59831388|NCT00391118|75954870|FG002|NOT COMPLETED|Overall Study||58||
59831389|NCT00390884|75954883|FG000|STARTED|Overall Study||116||
59831390|NCT00390884|75954884|FG001|STARTED|Overall Study||57||
59831391|NCT00390884|75954883|FG000|COMPLETED|Overall Study||114||
59831392|NCT00390884|75954884|FG001|COMPLETED|Overall Study||55||
59831393|NCT00390884|75954883|FG000|NOT COMPLETED|Overall Study||2||
59831394|NCT00390884|75954884|FG001|NOT COMPLETED|Overall Study||2||
59831395|NCT00365846|75954890|FG000|STARTED|Overall Study||29||
59831396|NCT00365846|75954890|FG000|COMPLETED|Overall Study||28||
59831397|NCT00365846|75954890|FG000|NOT COMPLETED|Overall Study||1||
59831398|NCT00264537|75954900|FG000|STARTED|Overall Study||160||
59831399|NCT00264537|75954901|FG001|STARTED|Overall Study||159||
59831400|NCT00264537|75954902|FG002|STARTED|Overall Study||159||
59831401|NCT00264537|75954903|FG003|STARTED|Overall Study||159||
59831402|NCT00264537|75954900|FG000|COMPLETED|Overall Study||110||
59831403|NCT00264537|75954901|FG001|COMPLETED|Overall Study||101||
59831404|NCT00264537|75954902|FG002|COMPLETED|Overall Study||109||
59831405|NCT00264537|75954903|FG003|COMPLETED|Overall Study||99||
59831406|NCT00264537|75954900|FG000|NOT COMPLETED|Overall Study||50||
59831407|NCT00264537|75954901|FG001|NOT COMPLETED|Overall Study||58||
59831408|NCT00264537|75954902|FG002|NOT COMPLETED|Overall Study||50||
59831409|NCT00264537|75954903|FG003|NOT COMPLETED|Overall Study||60||
59831410|NCT00371462|75954917|FG000|STARTED|Overall Study||35||
59831411|NCT00371462|75954918|FG001|STARTED|Overall Study||35||
59831412|NCT00371462|75954917|FG000|COMPLETED|Overall Study||27||
59831413|NCT00371462|75954918|FG001|COMPLETED|Overall Study||27||
59831414|NCT00371462|75954917|FG000|NOT COMPLETED|Overall Study||8||
59831415|NCT00371462|75954918|FG001|NOT COMPLETED|Overall Study||8||
59831416|NCT00371150|75954926|FG000|STARTED|Overall Study||40||
59831417|NCT00371150|75954927|FG001|STARTED|Overall Study||6||
59831418|NCT00371150|75954926|FG000|Discontinued Prior to Week 48 Visit|Overall Study||1||
59831419|NCT00371150|75954927|FG001|Discontinued Prior to Week 48 Visit|Overall Study||1||
59831420|NCT00371150|75954926|FG000|Discontinued at or After Week 48 Visit|Overall Study||2||
59831421|NCT00371150|75954927|FG001|Discontinued at or After Week 48 Visit|Overall Study||1||
59831422|NCT00371150|75954926|FG000|COMPLETED|Overall Study|"Completion of treatment means received treatment through Week 52"|37||
59831423|NCT00371150|75954927|FG001|COMPLETED|Overall Study|"Completion of treatment means received treatment through Week 52"|4||
59831424|NCT00371150|75954926|FG000|NOT COMPLETED|Overall Study||3||
59831425|NCT00371150|75954927|FG001|NOT COMPLETED|Overall Study||2||
59831426|NCT00264303|75954939|FG000|STARTED|Overall Study||438||
59831427|NCT00264303|75954940|FG001|STARTED|Overall Study||448||
59831428|NCT00264303|75954939|FG000|COMPLETED|Overall Study||413||
59831429|NCT00264303|75954940|FG001|COMPLETED|Overall Study||419||
59831430|NCT00264303|75954939|FG000|NOT COMPLETED|Overall Study||25||
59831431|NCT00264303|75954940|FG001|NOT COMPLETED|Overall Study||29||
59831432|NCT00370682|75954949|FG000|STARTED|Overall Study||40||
59831433|NCT00370682|75954950|FG001|STARTED|Overall Study||40||
59831434|NCT00370682|75954951|FG002|STARTED|Overall Study||40||
59831435|NCT00370682|75954949|FG000|COMPLETED|Overall Study||40||
59831436|NCT00370682|75954950|FG001|COMPLETED|Overall Study||37||
59831437|NCT00370682|75954951|FG002|COMPLETED|Overall Study||39||
59831438|NCT00370682|75954949|FG000|NOT COMPLETED|Overall Study||0||
59831439|NCT00370682|75954950|FG001|NOT COMPLETED|Overall Study||3||
59831440|NCT00370682|75954951|FG002|NOT COMPLETED|Overall Study||1||
59831441|NCT00264147|75954968|FG000|STARTED|Treatment I Period||161||
59831442|NCT00264147|75954969|FG001|STARTED|Treatment I Period||154||
59831443|NCT00264147|75954970|FG002|STARTED|Treatment I Period||151||
59831444|NCT00264147|75954971|FG003|STARTED|Treatment I Period||140||
59831445|NCT00264147|75954972|FG004|STARTED|Treatment I Period||155||
59831446|NCT00264147|75954973|FG005|STARTED|Treatment I Period||0||
59831447|NCT00264147|75954968|FG000|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|63||
59831448|NCT00264147|75954969|FG001|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|71||
59831449|NCT00264147|75954970|FG002|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|74||
59831450|NCT00264147|75954971|FG003|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|68||
59831451|NCT00264147|75954972|FG004|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|99||
59831452|NCT00264147|75954973|FG005|COMPLETED|Treatment I Period||0||
59831453|NCT00264147|75954968|FG000|NOT COMPLETED|Treatment I Period||98||
59831454|NCT00264147|75954969|FG001|NOT COMPLETED|Treatment I Period||83||
59831455|NCT00264147|75954970|FG002|NOT COMPLETED|Treatment I Period||77||
59831456|NCT00264147|75954971|FG003|NOT COMPLETED|Treatment I Period||72||
59831457|NCT00264147|75954972|FG004|NOT COMPLETED|Treatment I Period||56||
59831458|NCT00264147|75954973|FG005|NOT COMPLETED|Treatment I Period||0||
59831459|NCT00264147|75954968|FG000|STARTED|Treatment II Period||0||
59831460|NCT00264147|75954969|FG001|STARTED|Treatment II Period||0||
59831461|NCT00264147|75954970|FG002|STARTED|Treatment II Period||0||
59831462|NCT00264147|75954971|FG003|STARTED|Treatment II Period||0||
59831463|NCT00264147|75954972|FG004|STARTED|Treatment II Period|Etoricoxib 10 mg (38), 30 mg (28), 60 mg (33), 90 mg (45) and placebo (36) reassigned to 90 mg (180)|180||
59831464|NCT00264147|75954973|FG005|STARTED|Treatment II Period|Etoricoxib 10 mg (34), 30 mg (37), 60 mg (29), and placebo (49) reassigned to diclofenac (149)|149||
59831465|NCT00264147|75954968|FG000|COMPLETED|Treatment II Period||0||
59831466|NCT00264147|75954969|FG001|COMPLETED|Treatment II Period||0||
59831467|NCT00264147|75954970|FG002|COMPLETED|Treatment II Period||0||
59567492|NCT02326272|75670455|FG002|Completed Week 16|Initial Period (Week 0 to Week 16)||83||
59567493|NCT02326272|75670456|FG003|Completed Week 16|Initial Period (Week 0 to Week 16)||0||
59716892|NCT01215422|75835806|FG003|STARTED|Overall Study||201||
59716893|NCT01215422|75835803|FG000|COMPLETED|Overall Study||6||
59716894|NCT01215422|75835804|FG001|COMPLETED|Overall Study||249||
59716895|NCT01215422|75835805|FG002|COMPLETED|Overall Study||193||
59567494|NCT02326272|75670457|FG004|Completed Week 16|Initial Period (Week 0 to Week 16)||0||
59716896|NCT01215422|75835806|FG003|COMPLETED|Overall Study||193||
59716897|NCT01215422|75835803|FG000|NOT COMPLETED|Overall Study||8||
59716898|NCT01215422|75835804|FG001|NOT COMPLETED|Overall Study||0||
59716899|NCT01215422|75835805|FG002|NOT COMPLETED|Overall Study||3||
59716900|NCT01215422|75835806|FG003|NOT COMPLETED|Overall Study||8||
59716901|NCT00972153|75835831|FG000|STARTED|Overall Study||12||
59716902|NCT00972153|75835832|FG001|STARTED|Overall Study||12||
59831468|NCT00264147|75954971|FG003|COMPLETED|Treatment II Period||0||
59831469|NCT00264147|75954972|FG004|COMPLETED|Treatment II Period||147||
59831470|NCT00264147|75954973|FG005|COMPLETED|Treatment II Period||116||
59831471|NCT00264147|75954968|FG000|NOT COMPLETED|Treatment II Period||0||
59831472|NCT00264147|75954969|FG001|NOT COMPLETED|Treatment II Period||0||
59831473|NCT00264147|75954970|FG002|NOT COMPLETED|Treatment II Period||0||
59831474|NCT00264147|75954971|FG003|NOT COMPLETED|Treatment II Period||0||
59831475|NCT00264147|75954972|FG004|NOT COMPLETED|Treatment II Period||33||
59831476|NCT00264147|75954973|FG005|NOT COMPLETED|Treatment II Period||33||
60118510|NCT01372410|76239492|FG005|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|19||
60118511|NCT01372410|76239493|FG006|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|15||
60118512|NCT01372410|76239494|FG007|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|18||
60118513|NCT01372410|76239487|FG000|COMPLETED|Treatment Period 3 (7 Days)||21||
60118514|NCT01372410|76239488|FG001|COMPLETED|Treatment Period 3 (7 Days)||18||
60118515|NCT01372410|76239489|FG002|COMPLETED|Treatment Period 3 (7 Days)||15||
60118516|NCT01372410|76239490|FG003|COMPLETED|Treatment Period 3 (7 Days)||22||
60118517|NCT01372410|76239491|FG004|COMPLETED|Treatment Period 3 (7 Days)||20||
60118518|NCT01372410|76239492|FG005|COMPLETED|Treatment Period 3 (7 Days)||18||
60118519|NCT01372410|76239493|FG006|COMPLETED|Treatment Period 3 (7 Days)||15||
60118520|NCT01372410|76239494|FG007|COMPLETED|Treatment Period 3 (7 Days)||18||
60118521|NCT01372410|76239487|FG000|NOT COMPLETED|Treatment Period 3 (7 Days)||0||
60118522|NCT01372410|76239488|FG001|NOT COMPLETED|Treatment Period 3 (7 Days)||0||
60118523|NCT01372410|76239489|FG002|NOT COMPLETED|Treatment Period 3 (7 Days)||1||
60118524|NCT01372410|76239490|FG003|NOT COMPLETED|Treatment Period 3 (7 Days)||0||
60118525|NCT01372410|76239491|FG004|NOT COMPLETED|Treatment Period 3 (7 Days)||0||
60118526|NCT01372410|76239492|FG005|NOT COMPLETED|Treatment Period 3 (7 Days)||1||
60118527|NCT01372410|76239493|FG006|NOT COMPLETED|Treatment Period 3 (7 Days)||0||
60118528|NCT01372410|76239494|FG007|NOT COMPLETED|Treatment Period 3 (7 Days)||0||
60118529|NCT04072432|76239516|FG000|STARTED|Overall Study||6||
60118530|NCT04072432|76239517|FG001|STARTED|Overall Study||6||
60118531|NCT04072432|76239518|FG002|STARTED|Overall Study||6||
60118532|NCT04072432|76239516|FG000|COMPLETED|Overall Study||6||
60118533|NCT04072432|76239517|FG001|COMPLETED|Overall Study||6||
60118534|NCT04072432|76239518|FG002|COMPLETED|Overall Study||6||
60118535|NCT04072432|76239516|FG000|NOT COMPLETED|Overall Study||0||
59716903|NCT00972153|75835833|FG002|STARTED|Overall Study||12||
59716904|NCT00972153|75835831|FG000|COMPLETED|Overall Study||12||
59716905|NCT00972153|75835832|FG001|COMPLETED|Overall Study|One case excluded due to technical problem with measuring equipment.|11||
59716906|NCT00972153|75835833|FG002|COMPLETED|Overall Study||12||
59716907|NCT00972153|75835831|FG000|NOT COMPLETED|Overall Study||0||
59716908|NCT00972153|75835832|FG001|NOT COMPLETED|Overall Study||1||
59716909|NCT00972153|75835833|FG002|NOT COMPLETED|Overall Study||0||
59716910|NCT00971997|75835841|FG000|STARTED|Overall Study||135||
59716911|NCT00971997|75835841|FG000|COMPLETED|Overall Study||116||
59716912|NCT00971997|75835841|FG000|NOT COMPLETED|Overall Study||19||
59831477|NCT00263757|75954989|FG000|STARTED|Overall Study||12||
59831478|NCT00263757|75954990|FG001|STARTED|Overall Study||13||
59831479|NCT00263757|75954989|FG000|COMPLETED|Overall Study||4||
59831480|NCT00263757|75954990|FG001|COMPLETED|Overall Study||5||
59831481|NCT00263757|75954989|FG000|NOT COMPLETED|Overall Study||8||
59831482|NCT00263757|75954990|FG001|NOT COMPLETED|Overall Study||8||
59831483|NCT00263211|75954998|FG000|STARTED|Overall Study||24||
60118536|NCT04072432|76239517|FG001|NOT COMPLETED|Overall Study||0||
60118537|NCT04072432|76239518|FG002|NOT COMPLETED|Overall Study||0||
60118538|NCT01704287|76239532|FG000|STARTED|Initial Treatment Period||180||
60118539|NCT01704287|76239533|FG001|STARTED|Initial Treatment Period||181||
60118540|NCT01704287|76239534|FG002|STARTED|Initial Treatment Period||179||
60118541|NCT01704287|76239535|FG003|STARTED|Initial Treatment Period||0||
60118542|NCT01704287|76239536|FG004|STARTED|Initial Treatment Period||0||
60118543|NCT01704287|76239532|FG000|Treated|Initial Treatment Period||178||
60118544|NCT01704287|76239533|FG001|Treated|Initial Treatment Period||179||
60118545|NCT01704287|76239534|FG002|Treated|Initial Treatment Period||171||
60118546|NCT01704287|76239535|FG003|Treated|Initial Treatment Period||0||
60118547|NCT01704287|76239536|FG004|Treated|Initial Treatment Period||0||
60118548|NCT01704287|76239532|FG000|COMPLETED|Initial Treatment Period||33||
59716913|NCT01127646|75835850|FG000|STARTED|Overall Study||15||
59716914|NCT01127646|75835851|FG001|STARTED|Overall Study||8||
59716915|NCT01127646|75835850|FG000|COMPLETED|Overall Study||14||
59831484|NCT00263211|75954999|FG001|STARTED|Overall Study||24||
59831485|NCT00263211|75954998|FG000|COMPLETED|Overall Study||19||
59831486|NCT00263211|75954999|FG001|COMPLETED|Overall Study||23||
59831487|NCT00263211|75954998|FG000|NOT COMPLETED|Overall Study||5||
59831488|NCT00263211|75954999|FG001|NOT COMPLETED|Overall Study||1||
59831489|NCT00248625|75955010|FG000|STARTED|Overall Study||92||
59831490|NCT00248625|75955011|FG001|STARTED|Overall Study||92||
59831491|NCT00248625|75955010|FG000|COMPLETED|Overall Study||92||
59831492|NCT00248625|75955011|FG001|COMPLETED|Overall Study||90||
59831493|NCT00248625|75955010|FG000|NOT COMPLETED|Overall Study||0||
59831494|NCT00248625|75955011|FG001|NOT COMPLETED|Overall Study||2||
59831495|NCT00262821|75955019|FG000|STARTED|Overall Study||198||
59831496|NCT00262821|75955020|FG001|STARTED|Overall Study||204||
59831497|NCT00262821|75955019|FG000|COMPLETED|Overall Study||194||
59831498|NCT00262821|75955020|FG001|COMPLETED|Overall Study||185||
59831499|NCT00262821|75955019|FG000|NOT COMPLETED|Overall Study||4||
59831500|NCT00262821|75955020|FG001|NOT COMPLETED|Overall Study||19||
59831501|NCT00262743|75955028|FG000|STARTED|Overall Study||27||
59831502|NCT00262743|75955029|FG001|STARTED|Overall Study||42||
59831503|NCT00262743|75955028|FG000|COMPLETED|Overall Study||27||
59831504|NCT00262743|75955029|FG001|COMPLETED|Overall Study||30||
59831505|NCT00262743|75955028|FG000|NOT COMPLETED|Overall Study||0||
59831506|NCT00262743|75955029|FG001|NOT COMPLETED|Overall Study||12||
59831507|NCT00262119|75955036|FG000|STARTED|Overall Study||385||
59831508|NCT00262119|75955037|FG001|STARTED|Overall Study||398||
59831509|NCT00262119|75955038|FG002|STARTED|Overall Study||383||
59831510|NCT00262119|75955036|FG000|COMPLETED|Overall Study||327||
59831511|NCT00262119|75955037|FG001|COMPLETED|Overall Study||328||
59831512|NCT00262119|75955038|FG002|COMPLETED|Overall Study||325||
59831513|NCT00262119|75955036|FG000|NOT COMPLETED|Overall Study||58||
59831514|NCT00262119|75955037|FG001|NOT COMPLETED|Overall Study||70||
59831515|NCT00262119|75955038|FG002|NOT COMPLETED|Overall Study||58||
59831516|NCT00170950|75955048|FG000|STARTED|Overall Study||5744||
59831517|NCT00170950|75955049|FG001|STARTED|Overall Study||5762||
59831518|NCT00170950|75955048|FG000|COMPLETED|Overall Study||4859||
59831519|NCT00170950|75955049|FG001|COMPLETED|Overall Study||4852||
59831520|NCT00170950|75955048|FG000|NOT COMPLETED|Overall Study||885||
59831521|NCT00170950|75955049|FG001|NOT COMPLETED|Overall Study||910||
59831522|NCT00239577|75955059|FG000|STARTED|Primary Phase||22||
59716916|NCT01127646|75835851|FG001|COMPLETED|Overall Study||7||
59831523|NCT00239577|75955060|FG001|STARTED|Primary Phase||22||
60118549|NCT01704287|76239533|FG001|COMPLETED|Initial Treatment Period||47||
59716917|NCT01127646|75835850|FG000|NOT COMPLETED|Overall Study||1||
59716918|NCT01127646|75835851|FG001|NOT COMPLETED|Overall Study||1||
59716919|NCT01215188|75835862|FG000|STARTED|Overall Study||378||
59716920|NCT01215188|75835863|FG001|STARTED|Overall Study||386||
59716921|NCT01215188|75835864|FG002|STARTED|Overall Study||378||
59716922|NCT01215188|75835862|FG000|COMPLETED|Overall Study||320||
59716923|NCT01215188|75835863|FG001|COMPLETED|Overall Study||327||
59716924|NCT01215188|75835864|FG002|COMPLETED|Overall Study||326||
59716925|NCT01215188|75835862|FG000|NOT COMPLETED|Overall Study||58||
59716926|NCT01215188|75835863|FG001|NOT COMPLETED|Overall Study||59||
59716927|NCT01215188|75835864|FG002|NOT COMPLETED|Overall Study||52||
59831524|NCT00239577|75955061|FG002|STARTED|Primary Phase||21||
59831525|NCT00239577|75955062|FG003|STARTED|Primary Phase||21||
59831526|NCT00239577|75955059|FG000|COMPLETED|Primary Phase||17||
59831527|NCT00239577|75955060|FG001|COMPLETED|Primary Phase||19||
59831528|NCT00239577|75955061|FG002|COMPLETED|Primary Phase||18||
59831529|NCT00239577|75955062|FG003|COMPLETED|Primary Phase||21||
59831530|NCT00239577|75955059|FG000|NOT COMPLETED|Primary Phase||5||
59831531|NCT00239577|75955060|FG001|NOT COMPLETED|Primary Phase||3||
59831532|NCT00239577|75955061|FG002|NOT COMPLETED|Primary Phase||3||
59831533|NCT00239577|75955062|FG003|NOT COMPLETED|Primary Phase||0||
59831534|NCT00239577|75955059|FG000|STARTED|Booster Phase|The subjects belonging to this group did not receive a booster dose of Dengue vaccine.|0||
59716928|NCT01215032|75835872|FG000|STARTED|Overall Study||21||
59716929|NCT01215032|75835872|FG000|COMPLETED|Overall Study||1||
59716930|NCT01215032|75835872|FG000|NOT COMPLETED|Overall Study||20||
59716931|NCT00962247|75835878|FG000|STARTED|Usual Sedentary||61||
59716932|NCT00962247|75835878|FG000|COMPLETED|Usual Sedentary||61||
59716933|NCT00962247|75835878|FG000|NOT COMPLETED|Usual Sedentary||0||
59831535|NCT00239577|75955060|FG001|STARTED|Booster Phase||9||
59831536|NCT00239577|75955061|FG002|STARTED|Booster Phase||12||
59831537|NCT00239577|75955062|FG003|STARTED|Booster Phase|The subjects belonging to this group did not receive an additional dose of Placebo.|0||
59831538|NCT00239577|75955059|FG000|COMPLETED|Booster Phase|The subjects belonging to this group did not receive a booster dose of Dengue vaccine.|0||
59831539|NCT00239577|75955060|FG001|COMPLETED|Booster Phase||9||
59831540|NCT00239577|75955061|FG002|COMPLETED|Booster Phase||12||
59831541|NCT00239577|75955062|FG003|COMPLETED|Booster Phase|The subjects belonging to this group did not receive an additional dose of Placebo.|0||
60118550|NCT01704287|76239534|FG002|COMPLETED|Initial Treatment Period||6||
59716934|NCT00962247|75835878|FG000|STARTED|25% Reduction of Sedentary Activity||61||
59716935|NCT00962247|75835878|FG000|COMPLETED|25% Reduction of Sedentary Activity||56||
59716936|NCT00962247|75835878|FG000|NOT COMPLETED|25% Reduction of Sedentary Activity||5||
59716937|NCT00962247|75835878|FG000|STARTED|50% Reduction of Sedentary Activity||56||
59831542|NCT00239577|75955059|FG000|NOT COMPLETED|Booster Phase||0||
59831543|NCT00239577|75955060|FG001|NOT COMPLETED|Booster Phase||0||
59831544|NCT00239577|75955061|FG002|NOT COMPLETED|Booster Phase||0||
59831545|NCT00239577|75955062|FG003|NOT COMPLETED|Booster Phase||0||
59831546|NCT00262041|75955078|FG000|STARTED|Overall Study||164||
59831547|NCT00262041|75955079|FG001|STARTED|Overall Study||151||
59831548|NCT00262041|75955080|FG002|STARTED|Overall Study||209||
59831549|NCT00262041|75955078|FG000|COMPLETED|Overall Study||162||
59831550|NCT00262041|75955079|FG001|COMPLETED|Overall Study||147||
59831551|NCT00262041|75955080|FG002|COMPLETED|Overall Study||203||
59831552|NCT00262041|75955078|FG000|NOT COMPLETED|Overall Study||2||
59831553|NCT00262041|75955079|FG001|NOT COMPLETED|Overall Study||4||
59831554|NCT00262041|75955080|FG002|NOT COMPLETED|Overall Study||6||
59831555|NCT00208767|75955096|FG000|STARTED|Overall Study||80||
59831556|NCT00208767|75955097|FG001|STARTED|Overall Study||40||
59831557|NCT00208767|75955096|FG000|COMPLETED|Overall Study||53||
59831558|NCT00208767|75955097|FG001|COMPLETED|Overall Study||33||
59831559|NCT00208767|75955096|FG000|NOT COMPLETED|Overall Study||27||
59831560|NCT00208767|75955097|FG001|NOT COMPLETED|Overall Study||7||
59831561|NCT00390806|75955105|FG000|STARTED|Overall Study||236||
59831562|NCT00390806|75955106|FG001|STARTED|Overall Study||236||
59831563|NCT00390806|75955105|FG000|Ongoing|Overall Study||4||
59831564|NCT00390806|75955106|FG001|Ongoing|Overall Study||2||
59831565|NCT00390806|75955105|FG000|COMPLETED|Overall Study||206||
59831566|NCT00390806|75955106|FG001|COMPLETED|Overall Study||204||
59831567|NCT00390806|75955105|FG000|NOT COMPLETED|Overall Study||30||
59831568|NCT00390806|75955106|FG001|NOT COMPLETED|Overall Study||32||
59831569|NCT00390572|75955114|FG000|STARTED|Overall Study||68||
59831570|NCT00390572|75955115|FG001|STARTED|Overall Study||69||
59831571|NCT00390572|75955114|FG000|COMPLETED|Overall Study||60||
59831572|NCT00390572|75955115|FG001|COMPLETED|Overall Study||64||
59831573|NCT00390572|75955114|FG000|NOT COMPLETED|Overall Study||8||
59831574|NCT00390572|75955115|FG001|NOT COMPLETED|Overall Study||5||
59831575|NCT00135200|75955121|FG000|STARTED|Overall Study||16||
59831576|NCT00135200|75955121|FG000|COMPLETED|Overall Study||16||
59831577|NCT00135200|75955121|FG000|NOT COMPLETED|Overall Study||0||
59831578|NCT00390416|75955125|FG000|STARTED|Overall Study||48||
59831579|NCT00390416|75955125|FG000|COMPLETED|Overall Study||44||
59831580|NCT00390416|75955125|FG000|NOT COMPLETED|Overall Study||4||
59831581|NCT00261495|75955131|FG000|STARTED|Titration Phase (Weeks 0 to 4)||254||
59831582|NCT00261495|75955132|FG001|STARTED|Titration Phase (Weeks 0 to 4)||250||
59831583|NCT00261495|75955131|FG000|COMPLETED|Titration Phase (Weeks 0 to 4)||206||
59831584|NCT00261495|75955132|FG001|COMPLETED|Titration Phase (Weeks 0 to 4)||185||
59831585|NCT00261495|75955131|FG000|NOT COMPLETED|Titration Phase (Weeks 0 to 4)||48||
59831586|NCT00261495|75955132|FG001|NOT COMPLETED|Titration Phase (Weeks 0 to 4)||65||
59831587|NCT00261495|75955131|FG000|STARTED|Maintenance Phase (Weeks 4 to 24)||206||
59831588|NCT00261495|75955132|FG001|STARTED|Maintenance Phase (Weeks 4 to 24)||185||
59831589|NCT00261495|75955131|FG000|COMPLETED|Maintenance Phase (Weeks 4 to 24)||140||
59831590|NCT00261495|75955132|FG001|COMPLETED|Maintenance Phase (Weeks 4 to 24)||137||
59831591|NCT00261495|75955131|FG000|NOT COMPLETED|Maintenance Phase (Weeks 4 to 24)||66||
59831592|NCT00261495|75955132|FG001|NOT COMPLETED|Maintenance Phase (Weeks 4 to 24)||48||
59831593|NCT00261495|75955131|FG000|STARTED|Extension Phase (Weeks 24 to 52)|Number started is different to number completed maintenance phase owing to drop outs (80 subjects).|60||
59831594|NCT00261495|75955132|FG001|STARTED|Extension Phase (Weeks 24 to 52)|Number started is different to number completed maintenance phase owing to drop outs (85 subjects).|52||
59831595|NCT00261495|75955131|FG000|COMPLETED|Extension Phase (Weeks 24 to 52)||50||
59831596|NCT00261495|75955132|FG001|COMPLETED|Extension Phase (Weeks 24 to 52)||47||
59716938|NCT00962247|75835878|FG000|COMPLETED|50% Reduction of Sedentary Activity||56||
59716939|NCT00962247|75835878|FG000|NOT COMPLETED|50% Reduction of Sedentary Activity||0||
59716940|NCT00918580|75835884|FG000|STARTED|Up to 6-month Follow-up(FU)||158||
59716941|NCT00918580|75835884|FG000|Vaccinated Dose 1|Up to 6-month Follow-up(FU)||158||
59716942|NCT00918580|75835884|FG000|Vaccinated Dose 2|Up to 6-month Follow-up(FU)||146||
59831597|NCT00261495|75955131|FG000|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||10||
59831598|NCT00261495|75955132|FG001|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||5||
59831599|NCT00168844|75955141|FG000|STARTED|Overall Study||332||
59831600|NCT00168844|75955142|FG001|STARTED|Overall Study||332||
59831601|NCT00168844|75955143|FG002|STARTED|Overall Study||319||
59831602|NCT00168844|75955141|FG000|COMPLETED|Overall Study||277||
59831603|NCT00168844|75955142|FG001|COMPLETED|Overall Study||277||
59831604|NCT00168844|75955143|FG002|COMPLETED|Overall Study||228||
59831605|NCT00168844|75955141|FG000|NOT COMPLETED|Overall Study||55||
59831606|NCT00168844|75955142|FG001|NOT COMPLETED|Overall Study||55||
59831607|NCT00168844|75955143|FG002|NOT COMPLETED|Overall Study||91||
59716943|NCT00918580|75835884|FG000|COMPLETED|Up to 6-month Follow-up(FU)|Completed include 1 participant:withdrew before Dose 2 (protocol violation) but completed 6-month FU|147||
59716944|NCT00918580|75835884|FG000|NOT COMPLETED|Up to 6-month Follow-up(FU)||11||
59716945|NCT00918580|75835884|FG000|STARTED|After 6-month FU to 1-year FU||147||
59831608|NCT00365456|75955151|FG000|STARTED|Trial Period I (12 Months)||407||
59831609|NCT00365456|75955152|FG001|STARTED|Trial Period I (12 Months)||0||
59831610|NCT00365456|75955151|FG000|COMPLETED|Trial Period I (12 Months)||282||
59831611|NCT00365456|75955152|FG001|COMPLETED|Trial Period I (12 Months)||0||
59831612|NCT00365456|75955151|FG000|NOT COMPLETED|Trial Period I (12 Months)||125||
59831613|NCT00365456|75955152|FG001|NOT COMPLETED|Trial Period I (12 Months)||0||
59831614|NCT00365456|75955151|FG000|STARTED|Trial Period II (12 Months)||0||
59831615|NCT00365456|75955152|FG001|STARTED|Trial Period II (12 Months)||282||
59831616|NCT00365456|75955151|FG000|COMPLETED|Trial Period II (12 Months)||0||
59831617|NCT00365456|75955152|FG001|COMPLETED|Trial Period II (12 Months)||268||
59831618|NCT00365456|75955151|FG000|NOT COMPLETED|Trial Period II (12 Months)||0||
59831619|NCT00365456|75955152|FG001|NOT COMPLETED|Trial Period II (12 Months)||14||
59831620|NCT00365456|75955151|FG000|STARTED|Trial Period III (12 Months)||136||
59831621|NCT00365456|75955152|FG001|STARTED|Trial Period III (12 Months)||132||
59831622|NCT00365456|75955151|FG000|COMPLETED|Trial Period III (12 Months)||118||
59831623|NCT00365456|75955152|FG001|COMPLETED|Trial Period III (12 Months)||127||
59831624|NCT00365456|75955151|FG000|NOT COMPLETED|Trial Period III (12 Months)||18||
59831625|NCT00365456|75955152|FG001|NOT COMPLETED|Trial Period III (12 Months)||5||
59831626|NCT00147238|75955158|FG000|STARTED|Overall Study||10||
59831627|NCT00147238|75955158|FG000|COMPLETED|Overall Study||2||
59831628|NCT00147238|75955158|FG000|NOT COMPLETED|Overall Study||8||
59831629|NCT00206427|75955162|FG000|STARTED|Overall Study|Received First Dose|49||
59831630|NCT00206427|75955162|FG000|COMPLETED|Overall Study|Complete 6-week therapy|47||
59831631|NCT00206427|75955162|FG000|NOT COMPLETED|Overall Study||2||
59831632|NCT00146848|75955169|FG000|STARTED|Pre-randomization|Registered|1742||
59831633|NCT00146848|75955170|FG001|STARTED|Pre-randomization||0||
59831634|NCT00146848|75955171|FG002|STARTED|Pre-randomization||0||
59831635|NCT00146848|75955169|FG000|COMPLETED|Pre-randomization|Reached 6-week visit and were randomized|1433||
59831636|NCT00146848|75955170|FG001|COMPLETED|Pre-randomization||0||
59831637|NCT00146848|75955171|FG002|COMPLETED|Pre-randomization||0||
59831638|NCT00146848|75955169|FG000|NOT COMPLETED|Pre-randomization||309||
59831639|NCT00146848|75955170|FG001|NOT COMPLETED|Pre-randomization||0||
59831640|NCT00146848|75955171|FG002|NOT COMPLETED|Pre-randomization||0||
59831641|NCT00146848|75955169|FG000|STARTED|Post-randomization||475||
59831642|NCT00146848|75955170|FG001|STARTED|Post-randomization||488||
59831643|NCT00146848|75955171|FG002|STARTED|Post-randomization||470||
59831644|NCT00146848|75955169|FG000|COMPLETED|Post-randomization||437||
59831645|NCT00146848|75955170|FG001|COMPLETED|Post-randomization||441||
59831646|NCT00146848|75955171|FG002|COMPLETED|Post-randomization||431||
59831647|NCT00146848|75955169|FG000|NOT COMPLETED|Post-randomization||38||
59831648|NCT00146848|75955170|FG001|NOT COMPLETED|Post-randomization||47||
59831649|NCT00146848|75955171|FG002|NOT COMPLETED|Post-randomization||39||
59831650|NCT00205881|75955179|FG000|STARTED|Overall Study||32||
59831651|NCT00205881|75955179|FG000|COMPLETED|Overall Study|32 enrolled. 1 unilateral. 25 bilateral for data analysis at 8 months. 16 completed study.|16||
59831652|NCT00205881|75955179|FG000|NOT COMPLETED|Overall Study||16||
59831653|NCT00365378|75955186|FG000|STARTED|Vaccination (Day 1 to Month 7)||1204||
59831654|NCT00365378|75955187|FG001|STARTED|Vaccination (Day 1 to Month 7)||1205||
59831655|NCT00365378|75955188|FG002|STARTED|Vaccination (Day 1 to Month 7)||0||
59831656|NCT00365378|75955186|FG000|Entered Vaccination Period|Vaccination (Day 1 to Month 7)||1193||
59831657|NCT00365378|75955187|FG001|Entered Vaccination Period|Vaccination (Day 1 to Month 7)||1198||
59831658|NCT00365378|75955188|FG002|Entered Vaccination Period|Vaccination (Day 1 to Month 7)||0||
59831659|NCT00365378|75955186|FG000|COMPLETED|Vaccination (Day 1 to Month 7)||993||
59831660|NCT00365378|75955187|FG001|COMPLETED|Vaccination (Day 1 to Month 7)||1038||
59831661|NCT00365378|75955188|FG002|COMPLETED|Vaccination (Day 1 to Month 7)||0||
59831662|NCT00365378|75955186|FG000|NOT COMPLETED|Vaccination (Day 1 to Month 7)||211||
59831663|NCT00365378|75955187|FG001|NOT COMPLETED|Vaccination (Day 1 to Month 7)||167||
59831664|NCT00365378|75955188|FG002|NOT COMPLETED|Vaccination (Day 1 to Month 7)||0||
59831665|NCT00365378|75955186|FG000|STARTED|Follow-up (Month 7 Though Month 48)||993||
59831666|NCT00365378|75955187|FG001|STARTED|Follow-up (Month 7 Though Month 48)||1038||
59831667|NCT00365378|75955188|FG002|STARTED|Follow-up (Month 7 Though Month 48)||0||
59831668|NCT00365378|75955186|FG000|COMPLETED|Follow-up (Month 7 Though Month 48)||835||
59831669|NCT00365378|75955187|FG001|COMPLETED|Follow-up (Month 7 Though Month 48)||836||
59831670|NCT00365378|75955188|FG002|COMPLETED|Follow-up (Month 7 Though Month 48)||0||
59831671|NCT00365378|75955186|FG000|NOT COMPLETED|Follow-up (Month 7 Though Month 48)||158||
59831672|NCT00365378|75955187|FG001|NOT COMPLETED|Follow-up (Month 7 Though Month 48)||202||
59831673|NCT00365378|75955188|FG002|NOT COMPLETED|Follow-up (Month 7 Though Month 48)||0||
59831674|NCT00365378|75955186|FG000|STARTED|Extension||0||
59831675|NCT00365378|75955187|FG001|STARTED|Extension||0||
59831676|NCT00365378|75955188|FG002|STARTED|Extension||400||
59831677|NCT00365378|75955186|FG000|COMPLETED|Extension||0||
60118551|NCT01704287|76239535|FG003|COMPLETED|Initial Treatment Period||0||
59831678|NCT00365378|75955187|FG001|COMPLETED|Extension||0||
59831679|NCT00365378|75955188|FG002|COMPLETED|Extension||203||
59831680|NCT00365378|75955186|FG000|NOT COMPLETED|Extension||0||
59831681|NCT00365378|75955187|FG001|NOT COMPLETED|Extension||0||
59831682|NCT00365378|75955188|FG002|NOT COMPLETED|Extension||197||
59831683|NCT00389324|75955195|FG000|STARTED|Run-In Phase||21||
59831684|NCT00389324|75955195|FG000|COMPLETED|Run-In Phase||18||
59831685|NCT00389324|75955195|FG000|NOT COMPLETED|Run-In Phase||3||
59831686|NCT00389324|75955195|FG000|STARTED|Intravenous Phase|18 subjects entered from the Run-in Phase and 14 new participants entered directly|32||
59831687|NCT00389324|75955195|FG000|COMPLETED|Intravenous Phase||32||
59831688|NCT00389324|75955195|FG000|NOT COMPLETED|Intravenous Phase||0||
59831689|NCT00389324|75955195|FG000|STARTED|Subcutaneous Phase||32||
59831690|NCT00389324|75955195|FG000|COMPLETED|Subcutaneous Phase||25||
59831691|NCT00389324|75955195|FG000|NOT COMPLETED|Subcutaneous Phase||7||
59831692|NCT00365300|75955204|FG000|STARTED|Open-label Phase||129||
59831693|NCT00365300|75955205|FG001|STARTED|Open-label Phase||0||
59831694|NCT00365300|75955204|FG000|COMPLETED|Open-label Phase||107||
59831695|NCT00365300|75955205|FG001|COMPLETED|Open-label Phase||0||
59831696|NCT00365300|75955204|FG000|NOT COMPLETED|Open-label Phase||22||
59831697|NCT00365300|75955205|FG001|NOT COMPLETED|Open-label Phase||0||
59831698|NCT00365300|75955204|FG000|STARTED|Double-blind Phase||54||
59831699|NCT00365300|75955205|FG001|STARTED|Double-blind Phase||54||
59831700|NCT00365300|75955204|FG000|COMPLETED|Double-blind Phase||43||
59831701|NCT00365300|75955205|FG001|COMPLETED|Double-blind Phase||45||
59831702|NCT00365300|75955204|FG000|NOT COMPLETED|Double-blind Phase||11||
59831703|NCT00365300|75955205|FG001|NOT COMPLETED|Double-blind Phase||9||
59831704|NCT00370292|75955216|FG000|STARTED|Overall Study||19||
59831705|NCT00370292|75955216|FG000|COMPLETED|Overall Study||6||
59831706|NCT00370292|75955216|FG000|NOT COMPLETED|Overall Study||13||
59831707|NCT00369824|75955233|FG000|STARTED|Overall Study||212||
59831708|NCT00369824|75955234|FG001|STARTED|Overall Study||214||
59831709|NCT00369824|75955235|FG002|STARTED|Overall Study||214||
59831710|NCT00369824|75955236|FG003|STARTED|Overall Study||214||
59831711|NCT00369824|75955237|FG004|STARTED|Overall Study||214||
59831712|NCT00369824|75955238|FG005|STARTED|Overall Study||215||
59831713|NCT00369824|75955233|FG000|COMPLETED|Overall Study||197||
59831714|NCT00369824|75955234|FG001|COMPLETED|Overall Study||195||
59831715|NCT00369824|75955235|FG002|COMPLETED|Overall Study||202||
59831716|NCT00369824|75955236|FG003|COMPLETED|Overall Study||199||
59831717|NCT00369824|75955237|FG004|COMPLETED|Overall Study||196||
59831718|NCT00369824|75955238|FG005|COMPLETED|Overall Study||204||
59831719|NCT00369824|75955233|FG000|NOT COMPLETED|Overall Study||15||
59831720|NCT00369824|75955234|FG001|NOT COMPLETED|Overall Study||19||
59831721|NCT00369824|75955235|FG002|NOT COMPLETED|Overall Study||12||
59831722|NCT00369824|75955236|FG003|NOT COMPLETED|Overall Study||15||
59831723|NCT00369824|75955237|FG004|NOT COMPLETED|Overall Study||18||
59831724|NCT00369824|75955238|FG005|NOT COMPLETED|Overall Study||11||
59831725|NCT00369668|75955255|FG000|STARTED|Overall Study|Original number of participants to be recruited for each group.|10||
59831726|NCT00369668|75955256|FG001|STARTED|Overall Study||10||
59831727|NCT00369668|75955257|FG002|STARTED|Overall Study||10||
59831728|NCT00369668|75955255|FG000|COMPLETED|Overall Study||6||
59831729|NCT00369668|75955256|FG001|COMPLETED|Overall Study||5||
59831730|NCT00369668|75955257|FG002|COMPLETED|Overall Study||3||
59831731|NCT00369668|75955255|FG000|NOT COMPLETED|Overall Study||4||
59831732|NCT00369668|75955256|FG001|NOT COMPLETED|Overall Study||5||
59831733|NCT00369668|75955257|FG002|NOT COMPLETED|Overall Study||7||
59831734|NCT00388154|75955268|FG000|STARTED|Overall Study||21||
59831735|NCT00388154|75955268|FG000|COMPLETED|Overall Study||20||
59831736|NCT00388154|75955268|FG000|NOT COMPLETED|Overall Study||1||
59831737|NCT00387764|75955272|FG000|STARTED|Overall Study||80||
59831738|NCT00387764|75955272|FG000|COMPLETED|Overall Study|Participants completed treatment (until disease progression), but may not have completed the study.|49||
59716946|NCT00918580|75835884|FG000|Continued After 6-Month FU|After 6-month FU to 1-year FU||89||
59716947|NCT00918580|75835884|FG000|COMPLETED|After 6-month FU to 1-year FU||87||
59716948|NCT00918580|75835884|FG000|NOT COMPLETED|After 6-month FU to 1-year FU||60||
59716949|NCT00920686|75835894|FG000|STARTED|Overall Study||82||
59716950|NCT00920686|75835895|FG001|STARTED|Overall Study||82||
59716951|NCT00920686|75835896|FG002|STARTED|Overall Study||75||
59716952|NCT00920686|75835894|FG000|COMPLETED|Overall Study||63||
59831739|NCT00387764|75955272|FG000|NOT COMPLETED|Overall Study||31||
59831740|NCT00386360|75955278|FG000|STARTED|Overall Study||49||
59831741|NCT00386360|75955279|FG001|STARTED|Overall Study||112||
59831742|NCT00386360|75955278|FG000|Intent to Treat Population (ITT)|Overall Study|Includes all patients randomized and took at least one dose of study drug.|49||
59831743|NCT00386360|75955279|FG001|Intent to Treat Population (ITT)|Overall Study||110||
59716953|NCT00920686|75835895|FG001|COMPLETED|Overall Study||60||
59716954|NCT00920686|75835896|FG002|COMPLETED|Overall Study||62||
59716955|NCT00920686|75835894|FG000|NOT COMPLETED|Overall Study||19||
59716956|NCT00920686|75835895|FG001|NOT COMPLETED|Overall Study||22||
59716957|NCT00920686|75835896|FG002|NOT COMPLETED|Overall Study||13||
59716958|NCT01214720|75835910|FG000|STARTED|Overall Study||306||
59716959|NCT01214720|75835911|FG001|STARTED|Overall Study||301||
59716960|NCT01214720|75835910|FG000|COMPLETED|Overall Study|Indicates patients who had died at the time of the data cut-off|221||
59831744|NCT00386360|75955278|FG000|Primary Efficacy|Overall Study|Per-protocol patients with evaluable BVTV (trabecular bone volume/tissue volume) at baseline & M12.|36||
59831745|NCT00386360|75955279|FG001|Primary Efficacy|Overall Study||77||
59831746|NCT00386360|75955278|FG000|COMPLETED|Overall Study||40||
59831747|NCT00386360|75955279|FG001|COMPLETED|Overall Study||95||
59831748|NCT00386360|75955278|FG000|NOT COMPLETED|Overall Study||9||
59831749|NCT00386360|75955279|FG001|NOT COMPLETED|Overall Study||17||
59831750|NCT00369278|75955287|FG000|STARTED|Overall Study||63||
59831751|NCT00369278|75955288|FG001|STARTED|Overall Study||65||
59831752|NCT00369278|75955287|FG000|COMPLETED|Overall Study||39||
59831753|NCT00369278|75955288|FG001|COMPLETED|Overall Study||44||
59831754|NCT00369278|75955287|FG000|NOT COMPLETED|Overall Study||24||
59831755|NCT00369278|75955288|FG001|NOT COMPLETED|Overall Study||21||
59831756|NCT00529373|75955296|FG000|STARTED|Base Study||8043||
59831757|NCT00529373|75955297|FG001|STARTED|Base Study||8028||
59831758|NCT00529373|75955296|FG000|COMPLETED|Base Study||4297||
59831759|NCT00529373|75955297|FG001|COMPLETED|Base Study||3960||
59831760|NCT00529373|75955296|FG000|NOT COMPLETED|Base Study||3746||
59831761|NCT00529373|75955297|FG001|NOT COMPLETED|Base Study||4068||
59831762|NCT00529373|75955296|FG000|STARTED|First Extension Study||4297||
59831763|NCT00529373|75955297|FG001|STARTED|First Extension Study||3960||
59831764|NCT00529373|75955296|FG000|COMPLETED|First Extension Study||3144||
59831765|NCT00529373|75955297|FG001|COMPLETED|First Extension Study||2309||
59831766|NCT00529373|75955296|FG000|NOT COMPLETED|First Extension Study||1153||
59831767|NCT00529373|75955297|FG001|NOT COMPLETED|First Extension Study||1651||
59831768|NCT00529373|75955296|FG000|STARTED|Second Extension Study||3144||
59831769|NCT00529373|75955297|FG001|STARTED|Second Extension Study||2309||
59831770|NCT00529373|75955296|FG000|COMPLETED|Second Extension Study||2844||
59831771|NCT00529373|75955297|FG001|COMPLETED|Second Extension Study||2112||
59831772|NCT00529373|75955296|FG000|NOT COMPLETED|Second Extension Study||300||
59831773|NCT00529373|75955297|FG001|NOT COMPLETED|Second Extension Study||197||
59831774|NCT00369122|75955311|FG000|STARTED|Overall Study||60||
59831775|NCT00369122|75955311|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|49||
59831776|NCT00369122|75955311|FG000|NOT COMPLETED|Overall Study||11||
59831777|NCT03687125|75955317|FG000|STARTED|Overall Study||3||
59831778|NCT03687125|75955318|FG001|STARTED|Overall Study||3||
59831779|NCT03687125|75955317|FG000|COMPLETED|Overall Study||0||
59831780|NCT03687125|75955318|FG001|COMPLETED|Overall Study||2||
59831781|NCT03687125|75955317|FG000|NOT COMPLETED|Overall Study||3||
59831782|NCT03687125|75955318|FG001|NOT COMPLETED|Overall Study||1||
59831783|NCT03872843|75955328|FG000|STARTED|Overall Study||12||
59831784|NCT03872843|75955329|FG001|STARTED|Overall Study||10||
59831785|NCT03872843|75955328|FG000|COMPLETED|Overall Study||7||
59831786|NCT03872843|75955329|FG001|COMPLETED|Overall Study||3||
59831787|NCT03872843|75955328|FG000|NOT COMPLETED|Overall Study||5||
59831788|NCT03872843|75955329|FG001|NOT COMPLETED|Overall Study||7||
60118552|NCT01704287|76239536|FG004|COMPLETED|Initial Treatment Period||0||
60118553|NCT01704287|76239532|FG000|NOT COMPLETED|Initial Treatment Period||147||
60118554|NCT01704287|76239533|FG001|NOT COMPLETED|Initial Treatment Period||134||
60118555|NCT01704287|76239534|FG002|NOT COMPLETED|Initial Treatment Period||173||
60118556|NCT01704287|76239535|FG003|NOT COMPLETED|Initial Treatment Period||0||
60118557|NCT01704287|76239536|FG004|NOT COMPLETED|Initial Treatment Period||0||
60118558|NCT01704287|76239532|FG000|STARTED|Switch to Pembrolizumab Treatment Period||0||
60118559|NCT01704287|76239533|FG001|STARTED|Switch to Pembrolizumab Treatment Period||0||
60118560|NCT01704287|76239534|FG002|STARTED|Switch to Pembrolizumab Treatment Period||0||
60118561|NCT01704287|76239535|FG003|STARTED|Switch to Pembrolizumab Treatment Period||53||
59831789|NCT00146770|75955337|FG000|STARTED|Overall Study||23||
60118562|NCT01704287|76239536|FG004|STARTED|Switch to Pembrolizumab Treatment Period||45||
60118563|NCT01704287|76239532|FG000|COMPLETED|Switch to Pembrolizumab Treatment Period||0||
60118564|NCT01704287|76239533|FG001|COMPLETED|Switch to Pembrolizumab Treatment Period||0||
60118565|NCT01704287|76239534|FG002|COMPLETED|Switch to Pembrolizumab Treatment Period||0||
60118566|NCT01704287|76239535|FG003|COMPLETED|Switch to Pembrolizumab Treatment Period||15||
60118567|NCT01704287|76239536|FG004|COMPLETED|Switch to Pembrolizumab Treatment Period||7||
60118568|NCT01704287|76239532|FG000|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||0||
60118569|NCT01704287|76239533|FG001|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||0||
60118570|NCT01704287|76239534|FG002|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||0||
60118571|NCT01704287|76239535|FG003|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||38||
60118572|NCT01704287|76239536|FG004|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||38||
60118573|NCT00118209|76239557|FG000|STARTED|Overall Study||262||
59831790|NCT00146770|75955338|FG001|STARTED|Overall Study||22||
59831791|NCT00146770|75955337|FG000|COMPLETED|Overall Study||18||
59831792|NCT00146770|75955338|FG001|COMPLETED|Overall Study||22||
59831793|NCT00146770|75955337|FG000|NOT COMPLETED|Overall Study||5||
59831794|NCT00146770|75955338|FG001|NOT COMPLETED|Overall Study||0||
59831795|NCT03874013|75955346|FG000|STARTED|Overall Study||22||
60118574|NCT00118209|76239558|FG001|STARTED|Overall Study||262||
60118575|NCT00118209|76239557|FG000|Evaluable for Primary Endpoint|Overall Study||250||
60118576|NCT00118209|76239558|FG001|Evaluable for Primary Endpoint|Overall Study||241||
59831796|NCT03874013|75955347|FG001|STARTED|Overall Study||22||
59831797|NCT03874013|75955346|FG000|COMPLETED|Overall Study||22||
59831798|NCT03874013|75955347|FG001|COMPLETED|Overall Study||21||
59831799|NCT03874013|75955346|FG000|NOT COMPLETED|Overall Study||0||
59831800|NCT03874013|75955347|FG001|NOT COMPLETED|Overall Study||1||
59831801|NCT00168064|75955355|FG000|STARTED|Overall Study|128 participants received PG formulation|130||
59831802|NCT00168064|75955356|FG001|STARTED|Overall Study|127 participants received AP formulation|130||
59831803|NCT00168064|75955355|FG000|COMPLETED|Overall Study||81||
59831804|NCT00168064|75955356|FG001|COMPLETED|Overall Study||86||
59831805|NCT00168064|75955355|FG000|NOT COMPLETED|Overall Study||49||
59831806|NCT00168064|75955356|FG001|NOT COMPLETED|Overall Study||44||
59831807|NCT00166114|75955366|FG000|STARTED|Overall Study||21||
59831808|NCT00166114|75955367|FG001|STARTED|Overall Study||19||
59831809|NCT00166114|75955366|FG000|COMPLETED|Overall Study||7||
59831810|NCT00166114|75955367|FG001|COMPLETED|Overall Study||13||
59831811|NCT00166114|75955366|FG000|NOT COMPLETED|Overall Study||14||
59831812|NCT00166114|75955367|FG001|NOT COMPLETED|Overall Study||6||
59831813|NCT03686969|75955375|FG000|STARTED|Overall Study||1||
59831814|NCT03686969|75955376|FG001|STARTED|Overall Study||0||
59831815|NCT03686969|75955375|FG000|COMPLETED|Overall Study||0||
59831816|NCT03686969|75955376|FG001|COMPLETED|Overall Study||0||
59831817|NCT03686969|75955375|FG000|NOT COMPLETED|Overall Study||1||
59831818|NCT03686969|75955376|FG001|NOT COMPLETED|Overall Study||0||
59831819|NCT00145600|75955386|FG000|STARTED|Overall Study||91||
59831820|NCT00145600|75955387|FG001|STARTED|Overall Study||46||
59831821|NCT00145600|75955388|FG002|STARTED|Overall Study||13||
59831822|NCT00145600|75955389|FG003|STARTED|Overall Study||146||
59831823|NCT00145600|75955386|FG000|COMPLETED|Overall Study||83||
59831824|NCT00145600|75955387|FG001|COMPLETED|Overall Study||36||
59831825|NCT00145600|75955388|FG002|COMPLETED|Overall Study||8||
59831826|NCT00145600|75955389|FG003|COMPLETED|Overall Study||130||
59831827|NCT00145600|75955386|FG000|NOT COMPLETED|Overall Study||8||
59831828|NCT00145600|75955387|FG001|NOT COMPLETED|Overall Study||10||
59831829|NCT00145600|75955388|FG002|NOT COMPLETED|Overall Study||5||
59831830|NCT00145600|75955389|FG003|NOT COMPLETED|Overall Study||16||
59831831|NCT00129376|75955413|FG000|STARTED|Overall Study||63||
59831832|NCT00129376|75955413|FG000|COMPLETED|Overall Study||61||
59831833|NCT00129376|75955413|FG000|NOT COMPLETED|Overall Study||2||
59831834|NCT00129220|75955420|FG000|STARTED|Study Period II||105||
59831835|NCT00129220|75955421|FG001|STARTED|Study Period II||20||
59831836|NCT00129220|75955422|FG002|STARTED|Study Period II||99||
59831837|NCT00129220|75955420|FG000|Received at Least One Dose of Study Drug|Study Period II||104||
59831838|NCT00129220|75955421|FG001|Received at Least One Dose of Study Drug|Study Period II||20||
59831839|NCT00129220|75955422|FG002|Received at Least One Dose of Study Drug|Study Period II||97||
59831840|NCT00129220|75955420|FG000|COMPLETED|Study Period II||72||
59831841|NCT00129220|75955421|FG001|COMPLETED|Study Period II||8||
59831842|NCT00129220|75955422|FG002|COMPLETED|Study Period II||52||
59831843|NCT00129220|75955420|FG000|NOT COMPLETED|Study Period II||33||
59831844|NCT00129220|75955421|FG001|NOT COMPLETED|Study Period II||12||
59831845|NCT00129220|75955422|FG002|NOT COMPLETED|Study Period II||47||
59831846|NCT00129220|75955420|FG000|STARTED|Study Period III||72||
59831847|NCT00129220|75955421|FG001|STARTED|Study Period III||8||
59831848|NCT00129220|75955422|FG002|STARTED|Study Period III||52||
59831849|NCT00129220|75955420|FG000|COMPLETED|Study Period III||59||
59831850|NCT00129220|75955421|FG001|COMPLETED|Study Period III||7||
59831851|NCT00129220|75955422|FG002|COMPLETED|Study Period III||42||
59831852|NCT00129220|75955420|FG000|NOT COMPLETED|Study Period III||13||
59831853|NCT00129220|75955421|FG001|NOT COMPLETED|Study Period III||1||
59831854|NCT00129220|75955422|FG002|NOT COMPLETED|Study Period III||10||
59831855|NCT03686813|75955434|FG000|STARTED|Overall Study||10||
59831856|NCT03686813|75955435|FG001|STARTED|Overall Study||8||
59831857|NCT03686813|75955434|FG000|COMPLETED|Overall Study||10||
59831858|NCT03686813|75955435|FG001|COMPLETED|Overall Study||8||
59831859|NCT03686813|75955434|FG000|NOT COMPLETED|Overall Study||0||
59831860|NCT03686813|75955435|FG001|NOT COMPLETED|Overall Study||0||
59831861|NCT00128830|75955442|FG000|STARTED|Overall Study||211||
59831862|NCT00128830|75955442|FG000|COMPLETED|Overall Study||139||
59831863|NCT00128830|75955442|FG000|NOT COMPLETED|Overall Study||72||
59831864|NCT03686033|75955448|FG000|STARTED|Treatment Period 1 (1 Day)||1||
59831865|NCT03686033|75955449|FG001|STARTED|Treatment Period 1 (1 Day)||1||
59831866|NCT03686033|75955450|FG002|STARTED|Treatment Period 1 (1 Day)||1||
60118577|NCT00118209|76239557|FG000|Evaluable for Safety Analysis|Overall Study||243|Evaluable for adverse events|
60118578|NCT00118209|76239558|FG001|Evaluable for Safety Analysis|Overall Study||237|Evaluable for adverse events|
60118579|NCT00118209|76239557|FG000|COMPLETED|Overall Study||250||
60118580|NCT00118209|76239558|FG001|COMPLETED|Overall Study||241||
59831867|NCT03686033|75955451|FG003|STARTED|Treatment Period 1 (1 Day)||1||
59831868|NCT03686033|75955452|FG004|STARTED|Treatment Period 1 (1 Day)||1||
59831869|NCT03686033|75955453|FG005|STARTED|Treatment Period 1 (1 Day)||0||
59831870|NCT03686033|75955448|FG000|COMPLETED|Treatment Period 1 (1 Day)||1||
60118581|NCT00118209|76239557|FG000|NOT COMPLETED|Overall Study||12||
59831871|NCT03686033|75955449|FG001|COMPLETED|Treatment Period 1 (1 Day)||1||
59831872|NCT03686033|75955450|FG002|COMPLETED|Treatment Period 1 (1 Day)||1||
59831873|NCT03686033|75955451|FG003|COMPLETED|Treatment Period 1 (1 Day)||1||
60118582|NCT00118209|76239558|FG001|NOT COMPLETED|Overall Study||21||
60118583|NCT01682837|76239564|FG000|STARTED|Baseline||35||
59831874|NCT03686033|75955452|FG004|COMPLETED|Treatment Period 1 (1 Day)||1||
59831875|NCT03686033|75955453|FG005|COMPLETED|Treatment Period 1 (1 Day)||0||
59831876|NCT03686033|75955448|FG000|NOT COMPLETED|Treatment Period 1 (1 Day)||0||
59831877|NCT03686033|75955449|FG001|NOT COMPLETED|Treatment Period 1 (1 Day)||0||
59831878|NCT03686033|75955450|FG002|NOT COMPLETED|Treatment Period 1 (1 Day)||0||
59831879|NCT03686033|75955451|FG003|NOT COMPLETED|Treatment Period 1 (1 Day)||0||
59831880|NCT03686033|75955452|FG004|NOT COMPLETED|Treatment Period 1 (1 Day)||0||
59831881|NCT03686033|75955453|FG005|NOT COMPLETED|Treatment Period 1 (1 Day)||0||
59831882|NCT03686033|75955448|FG000|STARTED|Washout Phase (at Least 2 Weeks)||1||
59831883|NCT03686033|75955449|FG001|STARTED|Washout Phase (at Least 2 Weeks)||1||
59831884|NCT03686033|75955450|FG002|STARTED|Washout Phase (at Least 2 Weeks)||1||
59831885|NCT03686033|75955451|FG003|STARTED|Washout Phase (at Least 2 Weeks)||1||
59831886|NCT03686033|75955452|FG004|STARTED|Washout Phase (at Least 2 Weeks)||1||
59831887|NCT03686033|75955453|FG005|STARTED|Washout Phase (at Least 2 Weeks)||0||
59831888|NCT03686033|75955448|FG000|COMPLETED|Washout Phase (at Least 2 Weeks)||1||
59831889|NCT03686033|75955449|FG001|COMPLETED|Washout Phase (at Least 2 Weeks)||1||
59831890|NCT03686033|75955450|FG002|COMPLETED|Washout Phase (at Least 2 Weeks)||1||
59831891|NCT03686033|75955451|FG003|COMPLETED|Washout Phase (at Least 2 Weeks)||1||
59831892|NCT03686033|75955452|FG004|COMPLETED|Washout Phase (at Least 2 Weeks)||1||
59831893|NCT03686033|75955453|FG005|COMPLETED|Washout Phase (at Least 2 Weeks)||0||
59831894|NCT03686033|75955448|FG000|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0||
59831895|NCT03686033|75955449|FG001|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0||
59831896|NCT03686033|75955450|FG002|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0||
59831897|NCT03686033|75955451|FG003|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0||
59831898|NCT03686033|75955452|FG004|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0||
59831899|NCT03686033|75955453|FG005|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0||
59831900|NCT03686033|75955448|FG000|STARTED|Treatment Period 2 (1 Day)||1||
59831901|NCT03686033|75955449|FG001|STARTED|Treatment Period 2 (1 Day)||1||
59831902|NCT03686033|75955450|FG002|STARTED|Treatment Period 2 (1 Day)||1||
59831903|NCT03686033|75955451|FG003|STARTED|Treatment Period 2 (1 Day)||1||
59831904|NCT03686033|75955452|FG004|STARTED|Treatment Period 2 (1 Day)||1||
59831905|NCT03686033|75955453|FG005|STARTED|Treatment Period 2 (1 Day)||0||
59831906|NCT03686033|75955448|FG000|COMPLETED|Treatment Period 2 (1 Day)||1||
59831907|NCT03686033|75955449|FG001|COMPLETED|Treatment Period 2 (1 Day)||1||
59831908|NCT03686033|75955450|FG002|COMPLETED|Treatment Period 2 (1 Day)||1||
59831909|NCT03686033|75955451|FG003|COMPLETED|Treatment Period 2 (1 Day)||1||
59831910|NCT03686033|75955452|FG004|COMPLETED|Treatment Period 2 (1 Day)||0||
59831911|NCT03686033|75955453|FG005|COMPLETED|Treatment Period 2 (1 Day)||0||
59831912|NCT03686033|75955448|FG000|NOT COMPLETED|Treatment Period 2 (1 Day)||0||
59831913|NCT03686033|75955449|FG001|NOT COMPLETED|Treatment Period 2 (1 Day)||0||
59831914|NCT03686033|75955450|FG002|NOT COMPLETED|Treatment Period 2 (1 Day)||0||
59831915|NCT03686033|75955451|FG003|NOT COMPLETED|Treatment Period 2 (1 Day)||0||
59831916|NCT03686033|75955452|FG004|NOT COMPLETED|Treatment Period 2 (1 Day)||1||
59831917|NCT03686033|75955453|FG005|NOT COMPLETED|Treatment Period 2 (1 Day)||0||
59831918|NCT03686033|75955448|FG000|STARTED|Washout Phase (at Least 2 Weeks)||1||
59831919|NCT03686033|75955449|FG001|STARTED|Washout Phase (at Least 2 Weeks)||1||
59831920|NCT03686033|75955450|FG002|STARTED|Washout Phase (at Least 2 Weeks)||1||
59831921|NCT03686033|75955451|FG003|STARTED|Washout Phase (at Least 2 Weeks)||1||
59831922|NCT03686033|75955452|FG004|STARTED|Washout Phase (at Least 2 Weeks)||0||
59831923|NCT03686033|75955453|FG005|STARTED|Washout Phase (at Least 2 Weeks)||0||
59831924|NCT03686033|75955448|FG000|COMPLETED|Washout Phase (at Least 2 Weeks)||1||
59831925|NCT03686033|75955449|FG001|COMPLETED|Washout Phase (at Least 2 Weeks)||1||
59831926|NCT03686033|75955450|FG002|COMPLETED|Washout Phase (at Least 2 Weeks)||1||
59831927|NCT03686033|75955451|FG003|COMPLETED|Washout Phase (at Least 2 Weeks)||1||
59716961|NCT01214720|75835911|FG001|COMPLETED|Overall Study|Indicates patients who had died at the time of the data cut-off|233||
59716962|NCT01214720|75835910|FG000|NOT COMPLETED|Overall Study||85||
59716963|NCT01214720|75835911|FG001|NOT COMPLETED|Overall Study||68||
59716964|NCT01142232|75835922|FG000|STARTED|Overall Study||3||
59716965|NCT01142232|75835923|FG001|STARTED|Overall Study||4||
59831928|NCT03686033|75955452|FG004|COMPLETED|Washout Phase (at Least 2 Weeks)||0||
59831929|NCT03686033|75955453|FG005|COMPLETED|Washout Phase (at Least 2 Weeks)||0||
59831930|NCT03686033|75955448|FG000|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0||
59831931|NCT03686033|75955449|FG001|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0||
59831932|NCT03686033|75955450|FG002|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0||
59831933|NCT03686033|75955451|FG003|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0||
59831934|NCT03686033|75955452|FG004|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0||
59831935|NCT03686033|75955453|FG005|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0||
59831936|NCT03686033|75955448|FG000|STARTED|Treatment Period 3 (1 Day)||1||
59831937|NCT03686033|75955449|FG001|STARTED|Treatment Period 3 (1 Day)||1||
59716966|NCT01142232|75835924|FG002|STARTED|Overall Study||3||
59716967|NCT01142232|75835925|FG003|STARTED|Overall Study||6||
59716968|NCT01142232|75835926|FG004|STARTED|Overall Study||44||
59716969|NCT01142232|75835922|FG000|COMPLETED|Overall Study||0||
59831938|NCT03686033|75955450|FG002|STARTED|Treatment Period 3 (1 Day)||1||
59831939|NCT03686033|75955451|FG003|STARTED|Treatment Period 3 (1 Day)||1||
59831940|NCT03686033|75955452|FG004|STARTED|Treatment Period 3 (1 Day)||0||
59831941|NCT03686033|75955453|FG005|STARTED|Treatment Period 3 (1 Day)||0||
59831942|NCT03686033|75955448|FG000|COMPLETED|Treatment Period 3 (1 Day)||1||
59831943|NCT03686033|75955449|FG001|COMPLETED|Treatment Period 3 (1 Day)||1||
59831944|NCT03686033|75955450|FG002|COMPLETED|Treatment Period 3 (1 Day)||1||
59831945|NCT03686033|75955451|FG003|COMPLETED|Treatment Period 3 (1 Day)||1||
59831946|NCT03686033|75955452|FG004|COMPLETED|Treatment Period 3 (1 Day)||0||
59831947|NCT03686033|75955453|FG005|COMPLETED|Treatment Period 3 (1 Day)||0||
59831948|NCT03686033|75955448|FG000|NOT COMPLETED|Treatment Period 3 (1 Day)||0||
59831949|NCT03686033|75955449|FG001|NOT COMPLETED|Treatment Period 3 (1 Day)||0||
59831950|NCT03686033|75955450|FG002|NOT COMPLETED|Treatment Period 3 (1 Day)||0||
59831951|NCT03686033|75955451|FG003|NOT COMPLETED|Treatment Period 3 (1 Day)||0||
59831952|NCT03686033|75955452|FG004|NOT COMPLETED|Treatment Period 3 (1 Day)||0||
59831953|NCT03686033|75955453|FG005|NOT COMPLETED|Treatment Period 3 (1 Day)||0||
59831954|NCT03686033|75955448|FG000|STARTED|Washout Phase (at Least 2 Weeks)||1||
59831955|NCT03686033|75955449|FG001|STARTED|Washout Phase (at Least 2 Weeks)||1||
59831956|NCT03686033|75955450|FG002|STARTED|Washout Phase (at Least 2 Weeks)||1||
59831957|NCT03686033|75955451|FG003|STARTED|Washout Phase (at Least 2 Weeks)||1||
59831958|NCT03686033|75955452|FG004|STARTED|Washout Phase (at Least 2 Weeks)||0||
59831959|NCT03686033|75955453|FG005|STARTED|Washout Phase (at Least 2 Weeks)||0||
59831960|NCT03686033|75955448|FG000|COMPLETED|Washout Phase (at Least 2 Weeks)||1||
59831961|NCT03686033|75955449|FG001|COMPLETED|Washout Phase (at Least 2 Weeks)||1||
59831962|NCT03686033|75955450|FG002|COMPLETED|Washout Phase (at Least 2 Weeks)||1||
59831963|NCT03686033|75955451|FG003|COMPLETED|Washout Phase (at Least 2 Weeks)||1||
59831964|NCT03686033|75955452|FG004|COMPLETED|Washout Phase (at Least 2 Weeks)||0||
59831965|NCT03686033|75955453|FG005|COMPLETED|Washout Phase (at Least 2 Weeks)||0||
59831966|NCT03686033|75955448|FG000|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0||
59831967|NCT03686033|75955449|FG001|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0||
59831968|NCT03686033|75955450|FG002|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0||
59831969|NCT03686033|75955451|FG003|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0||
59831970|NCT03686033|75955452|FG004|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0||
59831971|NCT03686033|75955453|FG005|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0||
59831972|NCT03686033|75955448|FG000|STARTED|Treatment Period 4 (1 Day)||1||
59831973|NCT03686033|75955449|FG001|STARTED|Treatment Period 4 (1 Day)||1||
59831974|NCT03686033|75955450|FG002|STARTED|Treatment Period 4 (1 Day)||1||
59831975|NCT03686033|75955451|FG003|STARTED|Treatment Period 4 (1 Day)||1||
59831976|NCT03686033|75955452|FG004|STARTED|Treatment Period 4 (1 Day)||0||
59831977|NCT03686033|75955453|FG005|STARTED|Treatment Period 4 (1 Day)||0||
59831978|NCT03686033|75955448|FG000|COMPLETED|Treatment Period 4 (1 Day)||1||
59831979|NCT03686033|75955449|FG001|COMPLETED|Treatment Period 4 (1 Day)||1||
59831980|NCT03686033|75955450|FG002|COMPLETED|Treatment Period 4 (1 Day)||1||
59831981|NCT03686033|75955451|FG003|COMPLETED|Treatment Period 4 (1 Day)||1||
59831982|NCT03686033|75955452|FG004|COMPLETED|Treatment Period 4 (1 Day)||0||
59831983|NCT03686033|75955453|FG005|COMPLETED|Treatment Period 4 (1 Day)||0||
59831984|NCT03686033|75955448|FG000|NOT COMPLETED|Treatment Period 4 (1 Day)||0||
59831985|NCT03686033|75955449|FG001|NOT COMPLETED|Treatment Period 4 (1 Day)||0||
59831986|NCT03686033|75955450|FG002|NOT COMPLETED|Treatment Period 4 (1 Day)||0||
59831987|NCT03686033|75955451|FG003|NOT COMPLETED|Treatment Period 4 (1 Day)||0||
59831988|NCT03686033|75955452|FG004|NOT COMPLETED|Treatment Period 4 (1 Day)||0||
59831989|NCT03686033|75955453|FG005|NOT COMPLETED|Treatment Period 4 (1 Day)||0||
59831990|NCT00128206|75955469|FG000|STARTED|Overall Study||184||
59831991|NCT00128206|75955470|FG001|STARTED|Overall Study||180||
59831992|NCT00128206|75955469|FG000|COMPLETED|Overall Study||47||
59831993|NCT00128206|75955470|FG001|COMPLETED|Overall Study||60||
59831994|NCT00128206|75955469|FG000|NOT COMPLETED|Overall Study||137||
59831995|NCT00128206|75955470|FG001|NOT COMPLETED|Overall Study||120||
59831996|NCT03685643|75955478|FG000|STARTED|Overall Study||290||
60118584|NCT01682837|76239564|FG000|COMPLETED|Baseline||30||
60118585|NCT01682837|76239564|FG000|NOT COMPLETED|Baseline||5||
60118586|NCT01682837|76239564|FG000|STARTED|First Intervention (4 Weeks)||30||
59716970|NCT01142232|75835923|FG001|COMPLETED|Overall Study||0||
59831997|NCT03685643|75955479|FG001|STARTED|Overall Study||288||
59831998|NCT03685643|75955478|FG000|COMPLETED|Overall Study||276||
59831999|NCT03685643|75955479|FG001|COMPLETED|Overall Study||266||
60118587|NCT01682837|76239564|FG000|Received KMgCit|First Intervention (4 Weeks)||8||
60118588|NCT01682837|76239564|FG000|Received KCit|First Intervention (4 Weeks)||8||
59716971|NCT01142232|75835924|FG002|COMPLETED|Overall Study||0||
59716972|NCT01142232|75835925|FG003|COMPLETED|Overall Study||1||
59716973|NCT01142232|75835926|FG004|COMPLETED|Overall Study||10||
59716974|NCT01142232|75835922|FG000|NOT COMPLETED|Overall Study||3||
59716975|NCT01142232|75835923|FG001|NOT COMPLETED|Overall Study||4||
59716976|NCT01142232|75835924|FG002|NOT COMPLETED|Overall Study||3||
59716977|NCT01142232|75835925|FG003|NOT COMPLETED|Overall Study||5||
59716978|NCT01142232|75835926|FG004|NOT COMPLETED|Overall Study||34||
59716979|NCT01140906|75835942|FG000|STARTED|Overall Study||158||
59832000|NCT03685643|75955478|FG000|NOT COMPLETED|Overall Study||14||
59832001|NCT03685643|75955479|FG001|NOT COMPLETED|Overall Study||22||
59832002|NCT03823378|75955491|FG000|STARTED|Overall Study||28||
59832003|NCT03823378|75955492|FG001|STARTED|Overall Study||16||
59832004|NCT03823378|75955493|FG002|STARTED|Overall Study||12||
59832005|NCT03823378|75955494|FG003|STARTED|Overall Study||12||
59832006|NCT03823378|75955495|FG004|STARTED|Overall Study||20||
59832007|NCT03823378|75955496|FG005|STARTED|Overall Study||9||
59832008|NCT03823378|75955491|FG000|COMPLETED|Overall Study||7||
59832009|NCT03823378|75955492|FG001|COMPLETED|Overall Study||0||
59832010|NCT03823378|75955493|FG002|COMPLETED|Overall Study||2||
59832011|NCT03823378|75955494|FG003|COMPLETED|Overall Study||2||
59832012|NCT03823378|75955495|FG004|COMPLETED|Overall Study||2||
59832013|NCT03823378|75955496|FG005|COMPLETED|Overall Study||1||
59832014|NCT03823378|75955491|FG000|NOT COMPLETED|Overall Study||21||
59832015|NCT03823378|75955492|FG001|NOT COMPLETED|Overall Study||16||
59832016|NCT03823378|75955493|FG002|NOT COMPLETED|Overall Study||10||
59832017|NCT03823378|75955494|FG003|NOT COMPLETED|Overall Study||10||
59832018|NCT03823378|75955495|FG004|NOT COMPLETED|Overall Study||18||
59832019|NCT03823378|75955496|FG005|NOT COMPLETED|Overall Study||8||
59832020|NCT00142792|75955513|FG000|STARTED|Overall Study||39||
59832021|NCT00142792|75955514|FG001|STARTED|Overall Study||41||
59832022|NCT00142792|75955515|FG002|STARTED|Overall Study||42||
59832023|NCT00142792|75955513|FG000|Completed Intervention|Overall Study||35||
59832024|NCT00142792|75955514|FG001|Completed Intervention|Overall Study||37||
59832025|NCT00142792|75955515|FG002|Completed Intervention|Overall Study||37||
59832026|NCT00142792|75955513|FG000|COMPLETED|Overall Study||27||
59832027|NCT00142792|75955514|FG001|COMPLETED|Overall Study||26||
59832028|NCT00142792|75955515|FG002|COMPLETED|Overall Study||30||
59832029|NCT00142792|75955513|FG000|NOT COMPLETED|Overall Study||12||
59832030|NCT00142792|75955514|FG001|NOT COMPLETED|Overall Study||15||
59832031|NCT00142792|75955515|FG002|NOT COMPLETED|Overall Study||12||
59832032|NCT00141778|75955526|FG000|STARTED|Randomization Prior to Study Med||152||
59832033|NCT00141778|75955527|FG001|STARTED|Randomization Prior to Study Med||153||
59832034|NCT00141778|75955528|FG002|STARTED|Randomization Prior to Study Med||153||
59832035|NCT00141778|75955526|FG000|COMPLETED|Randomization Prior to Study Med||147||
59832036|NCT00141778|75955527|FG001|COMPLETED|Randomization Prior to Study Med||151||
59832037|NCT00141778|75955528|FG002|COMPLETED|Randomization Prior to Study Med||147||
59832038|NCT00141778|75955526|FG000|NOT COMPLETED|Randomization Prior to Study Med||5||
59832039|NCT00141778|75955527|FG001|NOT COMPLETED|Randomization Prior to Study Med||2||
59832040|NCT00141778|75955528|FG002|NOT COMPLETED|Randomization Prior to Study Med||6||
59832041|NCT00141778|75955526|FG000|STARTED|Started Study Medication||147||
59832042|NCT00141778|75955527|FG001|STARTED|Started Study Medication||151||
59832043|NCT00141778|75955528|FG002|STARTED|Started Study Medication||147||
59832044|NCT00141778|75955526|FG000|COMPLETED|Started Study Medication||145||
59832045|NCT00141778|75955527|FG001|COMPLETED|Started Study Medication||144||
59832046|NCT00141778|75955528|FG002|COMPLETED|Started Study Medication||143||
59832047|NCT00141778|75955526|FG000|NOT COMPLETED|Started Study Medication||2||
59832048|NCT00141778|75955527|FG001|NOT COMPLETED|Started Study Medication||7||
59832049|NCT00141778|75955528|FG002|NOT COMPLETED|Started Study Medication||4||
59832050|NCT00127660|75955540|FG000|STARTED|Overall Study||153||
59832051|NCT00127660|75955541|FG001|STARTED|Overall Study||154||
59832052|NCT00127660|75955542|FG002|STARTED|Overall Study||148||
59832053|NCT00127660|75955543|FG003|STARTED|Overall Study||150||
59832054|NCT00127660|75955540|FG000|COMPLETED|Overall Study||150||
59832055|NCT00127660|75955541|FG001|COMPLETED|Overall Study||151||
59832056|NCT00127660|75955542|FG002|COMPLETED|Overall Study||143||
59832057|NCT00127660|75955543|FG003|COMPLETED|Overall Study||150||
59832058|NCT00127660|75955540|FG000|NOT COMPLETED|Overall Study||3||
59832059|NCT00127660|75955541|FG001|NOT COMPLETED|Overall Study||3||
59832060|NCT00127660|75955542|FG002|NOT COMPLETED|Overall Study||5||
59832061|NCT00127660|75955543|FG003|NOT COMPLETED|Overall Study||0||
59832062|NCT03817528|75955553|FG000|STARTED|Overall Study||4||
59832063|NCT03817528|75955553|FG000|COMPLETED|Overall Study||1||
59832064|NCT03817528|75955553|FG000|NOT COMPLETED|Overall Study||3||
59832065|NCT00115336|75955559|FG000|STARTED|Overall Study||6||
59832066|NCT00115336|75955560|FG001|STARTED|Overall Study||4||
59832067|NCT00115336|75955559|FG000|COMPLETED|Overall Study||6||
59832068|NCT00115336|75955560|FG001|COMPLETED|Overall Study||3||
59832069|NCT00115336|75955559|FG000|NOT COMPLETED|Overall Study||0||
59832070|NCT00115336|75955560|FG001|NOT COMPLETED|Overall Study||1||
59832071|NCT00205803|75955570|FG000|STARTED|Infant Series||122||
59832072|NCT00205803|75955571|FG001|STARTED|Infant Series||127||
59832073|NCT00205803|75955570|FG000|Vaccinated Dose 1|Infant Series||121||
59832074|NCT00205803|75955571|FG001|Vaccinated Dose 1|Infant Series||126||
59832075|NCT00205803|75955570|FG000|Vaccinated Dose 2|Infant Series||115||
59832076|NCT00205803|75955571|FG001|Vaccinated Dose 2|Infant Series||122||
59832077|NCT00205803|75955570|FG000|Vaccinated Dose 3|Infant Series||110||
59832078|NCT00205803|75955571|FG001|Vaccinated Dose 3|Infant Series||118||
59832079|NCT00205803|75955570|FG000|COMPLETED|Infant Series||104||
59832080|NCT00205803|75955571|FG001|COMPLETED|Infant Series||116||
59832081|NCT00205803|75955570|FG000|NOT COMPLETED|Infant Series||18||
59832082|NCT00205803|75955571|FG001|NOT COMPLETED|Infant Series||11||
59832083|NCT00205803|75955570|FG000|STARTED|After Infant Series||104||
59832084|NCT00205803|75955571|FG001|STARTED|After Infant Series||116||
59832085|NCT00205803|75955570|FG000|COMPLETED|After Infant Series||86||
59832086|NCT00205803|75955571|FG001|COMPLETED|After Infant Series||103||
59832087|NCT00205803|75955570|FG000|NOT COMPLETED|After Infant Series||18||
59832088|NCT00205803|75955571|FG001|NOT COMPLETED|After Infant Series||13||
59716980|NCT01140906|75835943|FG001|STARTED|Overall Study||151||
59716981|NCT01140906|75835944|FG002|STARTED|Overall Study||151||
59716982|NCT01140906|75835945|FG003|STARTED|Overall Study||147||
59716983|NCT01140906|75835942|FG000|COMPLETED|Overall Study||133||
59716984|NCT01140906|75835943|FG001|COMPLETED|Overall Study||117||
59716985|NCT01140906|75835944|FG002|COMPLETED|Overall Study||125||
59716986|NCT01140906|75835945|FG003|COMPLETED|Overall Study||131||
59716987|NCT01140906|75835942|FG000|NOT COMPLETED|Overall Study||25||
59716988|NCT01140906|75835943|FG001|NOT COMPLETED|Overall Study||34||
59716989|NCT01140906|75835944|FG002|NOT COMPLETED|Overall Study||26||
59716990|NCT01140906|75835945|FG003|NOT COMPLETED|Overall Study||16||
59716991|NCT00962091|75835962|FG000|STARTED|Overall Study||4||
59716992|NCT00962091|75835963|FG001|STARTED|Overall Study||9||
59716993|NCT00962091|75835964|FG002|STARTED|Overall Study||10||
59716994|NCT00962091|75835965|FG003|STARTED|Overall Study||3||
59716995|NCT00962091|75835966|FG004|STARTED|Overall Study||3||
59716996|NCT00962091|75835967|FG005|STARTED|Overall Study||12||
59716997|NCT00962091|75835968|FG006|STARTED|Overall Study||12||
59716998|NCT00962091|75835962|FG000|COMPLETED|Overall Study||3||
59716999|NCT00962091|75835963|FG001|COMPLETED|Overall Study||7||
59717000|NCT00962091|75835964|FG002|COMPLETED|Overall Study||9||
59717001|NCT00962091|75835965|FG003|COMPLETED|Overall Study||2||
59717002|NCT00962091|75835966|FG004|COMPLETED|Overall Study||3||
59717003|NCT00962091|75835967|FG005|COMPLETED|Overall Study||11||
59717004|NCT00962091|75835968|FG006|COMPLETED|Overall Study||11||
59717005|NCT00962091|75835962|FG000|NOT COMPLETED|Overall Study||1||
59717006|NCT00962091|75835963|FG001|NOT COMPLETED|Overall Study||2||
59717007|NCT00962091|75835964|FG002|NOT COMPLETED|Overall Study||1||
59717008|NCT00962091|75835965|FG003|NOT COMPLETED|Overall Study||1||
59717009|NCT00962091|75835966|FG004|NOT COMPLETED|Overall Study||0||
59717010|NCT00962091|75835967|FG005|NOT COMPLETED|Overall Study||1||
59717011|NCT00962091|75835968|FG006|NOT COMPLETED|Overall Study||1||
59717012|NCT01163916|75835995|FG000|STARTED|Overall Study||126||
59717013|NCT01163916|75835996|FG001|STARTED|Overall Study||35||
59717014|NCT01163916|75835997|FG002|STARTED|Overall Study||91||
59717015|NCT01163916|75835995|FG000|Safety Population|Overall Study|One patient discontinued prior to receiving treatment with adalimumab due to absence of medication.|125||
59717016|NCT01163916|75835996|FG001|Safety Population|Overall Study||35||
59717017|NCT01163916|75835997|FG002|Safety Population|Overall Study||91||
59717018|NCT01163916|75835995|FG000|COMPLETED|Overall Study|Completed 12-months treatment with adalimumab|96||
59717019|NCT01163916|75835996|FG001|COMPLETED|Overall Study|Completed 12-months treatment with adalimumab|31||
59717020|NCT01163916|75835997|FG002|COMPLETED|Overall Study|Completed 12-months treatment with adalimumab|71||
59717021|NCT01163916|75835995|FG000|NOT COMPLETED|Overall Study||30||
59717022|NCT01163916|75835996|FG001|NOT COMPLETED|Overall Study||4||
59717023|NCT01163916|75835997|FG002|NOT COMPLETED|Overall Study||20||
59717024|NCT01122576|75836013|FG000|STARTED|Pre-Cataract Surgery||26||
59717025|NCT01122576|75836014|FG001|STARTED|Pre-Cataract Surgery||26||
59717026|NCT01122576|75836015|FG002|STARTED|Pre-Cataract Surgery||26||
59717027|NCT01122576|75836013|FG000|COMPLETED|Pre-Cataract Surgery||26||
59832089|NCT00205803|75955570|FG000|STARTED|Toddler Dose||86||
59832090|NCT00205803|75955571|FG001|STARTED|Toddler Dose||103||
59832091|NCT00205803|75955570|FG000|COMPLETED|Toddler Dose||84||
59832092|NCT00205803|75955571|FG001|COMPLETED|Toddler Dose||100||
59832093|NCT00205803|75955570|FG000|NOT COMPLETED|Toddler Dose||2||
59832094|NCT00205803|75955571|FG001|NOT COMPLETED|Toddler Dose||3||
59832095|NCT00127192|75955600|FG000|STARTED|Overall Study|Study enrolled slightly more than the target of N=70|80||
59996503|NCT00701311|76112479|FG000|COMPLETED|Overall Study|Eight subjects did not complete full period of treatment but their data was included in analysis.|9||
59717028|NCT01122576|75836014|FG001|COMPLETED|Pre-Cataract Surgery||25||
59717029|NCT01122576|75836015|FG002|COMPLETED|Pre-Cataract Surgery||24||
59717030|NCT01122576|75836013|FG000|NOT COMPLETED|Pre-Cataract Surgery||0||
59717031|NCT01122576|75836014|FG001|NOT COMPLETED|Pre-Cataract Surgery||1||
59717032|NCT01122576|75836015|FG002|NOT COMPLETED|Pre-Cataract Surgery||2||
59996504|NCT00701311|76112479|FG000|NOT COMPLETED|Overall Study||8||
59996505|NCT02730377|76112485|FG000|STARTED|Overall Study||996||
59717033|NCT01122576|75836013|FG000|STARTED|Post-Cataract Surgery||26||
59832096|NCT00127192|75955601|FG001|STARTED|Overall Study|Study enrolled slightly more than the target of N=70|72||
59996506|NCT02730377|76112486|FG001|STARTED|Overall Study||995||
59996507|NCT02730377|76112485|FG000|Treated|Overall Study||980||
59996508|NCT02730377|76112486|FG001|Treated|Overall Study||984||
59996509|NCT02730377|76112485|FG000|Full Analysis Set (FAS)|Overall Study||996||
59996510|NCT02730377|76112486|FG001|Full Analysis Set (FAS)|Overall Study||995||
59832097|NCT00127192|75955602|FG002|STARTED|Overall Study|Study enrolled as per the target of N=70|70||
59832098|NCT00127192|75955603|FG003|STARTED|Overall Study|Study enrolled slightly less than the target of N=70|68||
59832099|NCT00127192|75955604|FG004|STARTED|Overall Study|Study enrolled slightly more than the target of N=70|73||
59832100|NCT00127192|75955600|FG000|COMPLETED|Overall Study||77||
59832101|NCT00127192|75955601|FG001|COMPLETED|Overall Study||71||
59832102|NCT00127192|75955602|FG002|COMPLETED|Overall Study||68||
59832103|NCT00127192|75955603|FG003|COMPLETED|Overall Study||67||
59832104|NCT00127192|75955604|FG004|COMPLETED|Overall Study||68||
59832105|NCT00127192|75955600|FG000|NOT COMPLETED|Overall Study||3||
59832106|NCT00127192|75955601|FG001|NOT COMPLETED|Overall Study||1||
59832107|NCT00127192|75955602|FG002|NOT COMPLETED|Overall Study||2||
59832108|NCT00127192|75955603|FG003|NOT COMPLETED|Overall Study||1||
59832109|NCT00127192|75955604|FG004|NOT COMPLETED|Overall Study||5||
59832110|NCT00205179|75955618|FG000|STARTED|Overall Study||32||
59832111|NCT00205179|75955619|FG001|STARTED|Overall Study||33||
59832112|NCT00205179|75955618|FG000|COMPLETED|Overall Study||30||
59832113|NCT00205179|75955619|FG001|COMPLETED|Overall Study||29||
59832114|NCT00205179|75955618|FG000|NOT COMPLETED|Overall Study||2||
59832115|NCT00205179|75955619|FG001|NOT COMPLETED|Overall Study||4||
59832116|NCT00127036|75955628|FG000|STARTED|Overall Study||34||
59832117|NCT00127036|75955629|FG001|STARTED|Overall Study||31||
59832118|NCT00127036|75955628|FG000|COMPLETED|Overall Study|26 Participants were evaluable.|26||
59832119|NCT00127036|75955629|FG001|COMPLETED|Overall Study|20 Participants were evaluable.|20||
59832120|NCT00127036|75955628|FG000|NOT COMPLETED|Overall Study||8||
59832121|NCT00127036|75955629|FG001|NOT COMPLETED|Overall Study||11||
59832122|NCT00259857|75955637|FG000|STARTED|12 Months Treatment||11||
59832123|NCT00259857|75955638|FG001|STARTED|12 Months Treatment||11||
59832124|NCT00259857|75955637|FG000|COMPLETED|12 Months Treatment||10||
59832125|NCT00259857|75955638|FG001|COMPLETED|12 Months Treatment||9||
59832126|NCT00259857|75955637|FG000|NOT COMPLETED|12 Months Treatment||1||
59832127|NCT00259857|75955638|FG001|NOT COMPLETED|12 Months Treatment||2||
59832128|NCT00259857|75955637|FG000|STARTED|24 Months Treatment||10||
59832129|NCT00259857|75955638|FG001|STARTED|24 Months Treatment||9||
59832130|NCT00259857|75955637|FG000|COMPLETED|24 Months Treatment||10||
59832131|NCT00259857|75955638|FG001|COMPLETED|24 Months Treatment||6||
59832132|NCT00259857|75955637|FG000|NOT COMPLETED|24 Months Treatment||0||
59832133|NCT00259857|75955638|FG001|NOT COMPLETED|24 Months Treatment||3||
59832134|NCT00203307|75955646|FG000|STARTED|First Intervention|Double-blind cross-over design. Study terminated early. Results not analyzed.|3||
59832135|NCT00203307|75955647|FG001|STARTED|First Intervention||0||
59832136|NCT00203307|75955646|FG000|COMPLETED|First Intervention||1||
59832137|NCT00203307|75955647|FG001|COMPLETED|First Intervention||0||
59832138|NCT00203307|75955646|FG000|NOT COMPLETED|First Intervention||2||
59832139|NCT00203307|75955647|FG001|NOT COMPLETED|First Intervention||0||
59832140|NCT00203307|75955646|FG000|STARTED|Second Intervention|2 subjects dropped out of the 1st intervention period, due to fatugue.|1||
59832141|NCT00203307|75955647|FG001|STARTED|Second Intervention||0||
59832142|NCT00203307|75955646|FG000|COMPLETED|Second Intervention||1||
59832143|NCT00203307|75955647|FG001|COMPLETED|Second Intervention||0||
59832144|NCT00203307|75955646|FG000|NOT COMPLETED|Second Intervention||0||
59832145|NCT00203307|75955647|FG001|NOT COMPLETED|Second Intervention||0||
59832146|NCT00126568|75955653|FG000|STARTED|Overall Study||20||
59832147|NCT00126568|75955653|FG000|COMPLETED|Overall Study|Disease progression at beginning of study, not evaluable|18||
59832148|NCT00126568|75955653|FG000|NOT COMPLETED|Overall Study||2||
59832149|NCT00114634|75955658|FG000|STARTED|Overall Study||13||
59832150|NCT00114634|75955658|FG000|COMPLETED|Overall Study|Assessment forms lost by one failure to complete and return forms by two|10||
59832151|NCT00114634|75955658|FG000|NOT COMPLETED|Overall Study||3||
60118589|NCT01682837|76239564|FG000|Received KCl|First Intervention (4 Weeks)||7||
60118590|NCT01682837|76239564|FG000|Received Placebo|First Intervention (4 Weeks)||7||
60118591|NCT01682837|76239564|FG000|COMPLETED|First Intervention (4 Weeks)||30||
59717034|NCT01122576|75836014|FG001|STARTED|Post-Cataract Surgery||25||
59717035|NCT01122576|75836015|FG002|STARTED|Post-Cataract Surgery||24||
59717036|NCT01122576|75836013|FG000|COMPLETED|Post-Cataract Surgery||26||
59717037|NCT01122576|75836014|FG001|COMPLETED|Post-Cataract Surgery||25||
59717038|NCT01122576|75836015|FG002|COMPLETED|Post-Cataract Surgery||22||
59717039|NCT01122576|75836013|FG000|NOT COMPLETED|Post-Cataract Surgery||0||
59717040|NCT01122576|75836014|FG001|NOT COMPLETED|Post-Cataract Surgery||0||
59717041|NCT01122576|75836015|FG002|NOT COMPLETED|Post-Cataract Surgery||2||
59717042|NCT00965523|75836026|FG000|STARTED|Study 221|Study 221 (Safety Analysis Set).|81||
59717043|NCT00965523|75836026|FG000|COMPLETED|Study 221||74||
59717044|NCT00965523|75836026|FG000|NOT COMPLETED|Study 221||7||
59832152|NCT00202839|75955666|FG000|STARTED|Overall Study||78||
59832153|NCT00202839|75955667|FG001|STARTED|Overall Study||82||
59832154|NCT00202839|75955666|FG000|COMPLETED|Overall Study||54||
59832155|NCT00202839|75955667|FG001|COMPLETED|Overall Study||72||
59832156|NCT00202839|75955666|FG000|NOT COMPLETED|Overall Study||24||
59832157|NCT00202839|75955667|FG001|NOT COMPLETED|Overall Study||10||
59832158|NCT00201201|75955675|FG000|STARTED|Overall Study||87||
59832159|NCT00201201|75955676|FG001|STARTED|Overall Study||73||
60118592|NCT01682837|76239564|FG000|NOT COMPLETED|First Intervention (4 Weeks)||0||
59832160|NCT00201201|75955675|FG000|COMPLETED|Overall Study||82||
59832161|NCT00201201|75955676|FG001|COMPLETED|Overall Study||66||
59832162|NCT00201201|75955675|FG000|NOT COMPLETED|Overall Study||5||
59832163|NCT00201201|75955676|FG001|NOT COMPLETED|Overall Study||7||
59832164|NCT00126490|75955682|FG000|STARTED|Overall Study||19||
59832165|NCT00126490|75955682|FG000|COMPLETED|Overall Study||18||
59832166|NCT00126490|75955682|FG000|NOT COMPLETED|Overall Study||1||
59832167|NCT00346632|75955688|FG000|STARTED|Overall Study||3||
59832168|NCT00346632|75955689|FG001|STARTED|Overall Study||3||
59832169|NCT00346632|75955690|FG002|STARTED|Overall Study||6||
59832170|NCT00346632|75955691|FG003|STARTED|Overall Study||3||
59832171|NCT00346632|75955692|FG004|STARTED|Overall Study||4||
59832172|NCT00346632|75955693|FG005|STARTED|Overall Study||2||
59832173|NCT00346632|75955694|FG006|STARTED|Overall Study||5||
59832174|NCT00346632|75955695|FG007|STARTED|Overall Study||4||
59832175|NCT00346632|75955696|FG008|STARTED|Overall Study||4||
59832176|NCT00346632|75955697|FG009|STARTED|Overall Study||3||
59832177|NCT00346632|75955688|FG000|COMPLETED|Overall Study||0||
59832178|NCT00346632|75955689|FG001|COMPLETED|Overall Study||0||
59832179|NCT00346632|75955690|FG002|COMPLETED|Overall Study||0||
59832180|NCT00346632|75955691|FG003|COMPLETED|Overall Study||0||
59832181|NCT00346632|75955692|FG004|COMPLETED|Overall Study||0||
59832182|NCT00346632|75955693|FG005|COMPLETED|Overall Study||0||
59832183|NCT00346632|75955694|FG006|COMPLETED|Overall Study||0||
59832184|NCT00346632|75955695|FG007|COMPLETED|Overall Study||0||
59832185|NCT00346632|75955696|FG008|COMPLETED|Overall Study||0||
59832186|NCT00346632|75955697|FG009|COMPLETED|Overall Study||0||
59832187|NCT00346632|75955688|FG000|NOT COMPLETED|Overall Study||3||
59832188|NCT00346632|75955689|FG001|NOT COMPLETED|Overall Study||3||
59832189|NCT00346632|75955690|FG002|NOT COMPLETED|Overall Study||6||
59832190|NCT00346632|75955691|FG003|NOT COMPLETED|Overall Study||3||
59832191|NCT00346632|75955692|FG004|NOT COMPLETED|Overall Study||4||
59832192|NCT00346632|75955693|FG005|NOT COMPLETED|Overall Study||2||
59832193|NCT00346632|75955694|FG006|NOT COMPLETED|Overall Study||5||
59832194|NCT00346632|75955695|FG007|NOT COMPLETED|Overall Study||4||
59832195|NCT00346632|75955696|FG008|NOT COMPLETED|Overall Study||4||
59717045|NCT00965523|75836026|FG000|STARTED|Study 224|Six subjects continued into Study 224 from Study 221.|6||
59717046|NCT00965523|75836026|FG000|COMPLETED|Study 224||0||
59717047|NCT00965523|75836026|FG000|NOT COMPLETED|Study 224||6||
59717048|NCT01122264|75836033|FG000|STARTED|Overall Study||252||
59717049|NCT01122264|75836034|FG001|STARTED|Overall Study||257||
59717050|NCT01122264|75836035|FG002|STARTED|Overall Study||261||
59717051|NCT01122264|75836033|FG000|Received at Least 1 Dose of Study Drug|Overall Study||250||
59717052|NCT01122264|75836034|FG001|Received at Least 1 Dose of Study Drug|Overall Study||257||
59717053|NCT01122264|75836035|FG002|Received at Least 1 Dose of Study Drug|Overall Study||260||
59717054|NCT01122264|75836033|FG000|COMPLETED|Overall Study||220||
59717055|NCT01122264|75836034|FG001|COMPLETED|Overall Study||228||
59717056|NCT01122264|75836035|FG002|COMPLETED|Overall Study||214||
59717057|NCT01122264|75836033|FG000|NOT COMPLETED|Overall Study||32||
59717058|NCT01122264|75836034|FG001|NOT COMPLETED|Overall Study||29||
59717059|NCT01122264|75836035|FG002|NOT COMPLETED|Overall Study||47||
59832196|NCT00346632|75955697|FG009|NOT COMPLETED|Overall Study||3||
59832197|NCT00200967|75955761|FG000|STARTED|First Treatment Period||42||
59832198|NCT00200967|75955762|FG001|STARTED|First Treatment Period||45||
59832199|NCT00200967|75955761|FG000|First Treatment Period|First Treatment Period||42||
59832200|NCT00200967|75955762|FG001|First Treatment Period|First Treatment Period||45||
59832201|NCT00200967|75955761|FG000|COMPLETED|First Treatment Period||36||
59832202|NCT00200967|75955762|FG001|COMPLETED|First Treatment Period||44||
59832203|NCT00200967|75955761|FG000|NOT COMPLETED|First Treatment Period||6||
59832204|NCT00200967|75955762|FG001|NOT COMPLETED|First Treatment Period||1||
59832205|NCT00200967|75955761|FG000|STARTED|Wash-out Period||36||
59717060|NCT00920218|75836051|FG000|STARTED|Overall Study||30||
59717061|NCT00920218|75836052|FG001|STARTED|Overall Study||29||
59717062|NCT00920218|75836053|FG002|STARTED|Overall Study||31||
59717063|NCT00920218|75836054|FG003|STARTED|Overall Study||30||
59717064|NCT00920218|75836051|FG000|COMPLETED|Overall Study||28||
59717065|NCT00920218|75836052|FG001|COMPLETED|Overall Study||24||
59717066|NCT00920218|75836053|FG002|COMPLETED|Overall Study||23||
59717067|NCT00920218|75836054|FG003|COMPLETED|Overall Study||23||
59717068|NCT00920218|75836051|FG000|NOT COMPLETED|Overall Study||2||
59717069|NCT00920218|75836052|FG001|NOT COMPLETED|Overall Study||5||
59717070|NCT00920218|75836053|FG002|NOT COMPLETED|Overall Study||8||
59832206|NCT00200967|75955762|FG001|STARTED|Wash-out Period||44||
59832207|NCT00200967|75955761|FG000|COMPLETED|Wash-out Period||36||
59832208|NCT00200967|75955762|FG001|COMPLETED|Wash-out Period||43||
59832209|NCT00200967|75955761|FG000|NOT COMPLETED|Wash-out Period||0||
59832210|NCT00200967|75955762|FG001|NOT COMPLETED|Wash-out Period||1||
59832211|NCT00200967|75955761|FG000|STARTED|Second Treatment Period||36||
59832212|NCT00200967|75955762|FG001|STARTED|Second Treatment Period||43||
59832213|NCT00200967|75955761|FG000|COMPLETED|Second Treatment Period||35||
59717071|NCT00920218|75836054|FG003|NOT COMPLETED|Overall Study||7||
59832214|NCT00200967|75955762|FG001|COMPLETED|Second Treatment Period||41||
59832215|NCT00200967|75955761|FG000|NOT COMPLETED|Second Treatment Period||1||
59832216|NCT00200967|75955762|FG001|NOT COMPLETED|Second Treatment Period||2||
59832217|NCT00200967|75955761|FG000|STARTED|Run-out Period||35||
59832218|NCT00200967|75955762|FG001|STARTED|Run-out Period||41||
59832219|NCT00200967|75955761|FG000|COMPLETED|Run-out Period||34||
59832220|NCT00200967|75955762|FG001|COMPLETED|Run-out Period||41||
59832221|NCT00200967|75955761|FG000|NOT COMPLETED|Run-out Period||1||
59832222|NCT00200967|75955762|FG001|NOT COMPLETED|Run-out Period||0||
59832223|NCT00354432|75955772|FG000|STARTED|Overall Study||30||
59832224|NCT00354432|75955773|FG001|STARTED|Overall Study||30||
59832225|NCT00354432|75955774|FG002|STARTED|Overall Study||30||
59832226|NCT00354432|75955775|FG003|STARTED|Overall Study||30||
59832227|NCT00354432|75955772|FG000|COMPLETED|Overall Study||24||
59832228|NCT00354432|75955773|FG001|COMPLETED|Overall Study||22||
59832229|NCT00354432|75955774|FG002|COMPLETED|Overall Study||20||
59832230|NCT00354432|75955775|FG003|COMPLETED|Overall Study||20||
59832231|NCT00354432|75955772|FG000|NOT COMPLETED|Overall Study||6||
59832232|NCT00354432|75955773|FG001|NOT COMPLETED|Overall Study||8||
59832233|NCT00354432|75955774|FG002|NOT COMPLETED|Overall Study||10||
59832234|NCT00354432|75955775|FG003|NOT COMPLETED|Overall Study||10||
59832235|NCT00140140|75955788|FG000|STARTED|Overall Study||4||
59832236|NCT00140140|75955789|FG001|STARTED|Overall Study||6||
59832237|NCT00140140|75955790|FG002|STARTED|Overall Study||6||
59832238|NCT00140140|75955788|FG000|COMPLETED|Overall Study|Progressive disease|2||
59832239|NCT00140140|75955789|FG001|COMPLETED|Overall Study|Progressive disease|4||
59832240|NCT00140140|75955790|FG002|COMPLETED|Overall Study|Progressive disease|4||
59832241|NCT00140140|75955788|FG000|NOT COMPLETED|Overall Study||2||
59832242|NCT00140140|75955789|FG001|NOT COMPLETED|Overall Study||2||
59832243|NCT00140140|75955790|FG002|NOT COMPLETED|Overall Study||2||
59832244|NCT00346398|75955799|FG000|STARTED|Overall Study||25||
59832245|NCT00346398|75955800|FG001|STARTED|Overall Study||26||
59832246|NCT00346398|75955799|FG000|COMPLETED|Overall Study||22||
59832247|NCT00346398|75955800|FG001|COMPLETED|Overall Study||24||
59832248|NCT00346398|75955799|FG000|NOT COMPLETED|Overall Study||3||
59832249|NCT00346398|75955800|FG001|NOT COMPLETED|Overall Study||2||
59832250|NCT00346164|75955810|FG000|STARTED|Overall Study||222||
59832251|NCT00346164|75955811|FG001|STARTED|Overall Study||21||
59832252|NCT00346164|75955812|FG002|STARTED|Overall Study||122||
59832253|NCT00346164|75955813|FG003|STARTED|Overall Study||223||
59832254|NCT00346164|75955810|FG000|COMPLETED|Overall Study||205||
59832255|NCT00346164|75955811|FG001|COMPLETED|Overall Study||14||
59832256|NCT00346164|75955812|FG002|COMPLETED|Overall Study||96||
59832257|NCT00346164|75955813|FG003|COMPLETED|Overall Study||117||
59832258|NCT00346164|75955810|FG000|NOT COMPLETED|Overall Study||17||
59832259|NCT00346164|75955811|FG001|NOT COMPLETED|Overall Study||7||
59832260|NCT00346164|75955812|FG002|NOT COMPLETED|Overall Study||26||
59832261|NCT00346164|75955813|FG003|NOT COMPLETED|Overall Study||106||
59832262|NCT00114244|75955841|FG000|STARTED|Overall Study||15||
59832263|NCT00114244|75955842|FG001|STARTED|Overall Study||37||
59832264|NCT00114244|75955841|FG000|COMPLETED|Overall Study||13||
59832265|NCT00114244|75955842|FG001|COMPLETED|Overall Study||30||
59832266|NCT00114244|75955841|FG000|NOT COMPLETED|Overall Study||2||
59832267|NCT00114244|75955842|FG001|NOT COMPLETED|Overall Study||7||
59832268|NCT00138658|75955848|FG000|STARTED|Overall Study||81||
59832269|NCT00138658|75955848|FG000|COMPLETED|Overall Study||20||
59832270|NCT00138658|75955848|FG000|NOT COMPLETED|Overall Study||61||
59832271|NCT00337662|75955857|FG000|STARTED|Study Period II||0||
59832272|NCT00337662|75955858|FG001|STARTED|Study Period II||0||
59832273|NCT00337662|75955859|FG002|STARTED|Study Period II||0||
59832274|NCT00337662|75955860|FG003|STARTED|Study Period II||628||
59717072|NCT01121562|75836068|FG000|STARTED|Overall Study||12||
59832275|NCT00337662|75955857|FG000|COMPLETED|Study Period II||0||
59832276|NCT00337662|75955858|FG001|COMPLETED|Study Period II||0||
59832277|NCT00337662|75955859|FG002|COMPLETED|Study Period II||0||
60118593|NCT01682837|76239564|FG000|STARTED|Second Intervention (4 Weeks)||30||
59717073|NCT01121562|75836068|FG000|COMPLETED|Overall Study||0||
59717074|NCT01121562|75836068|FG000|NOT COMPLETED|Overall Study||12||
59717075|NCT01121484|75836074|FG000|STARTED|Overall Study||218||
59717076|NCT01121484|75836075|FG001|STARTED|Overall Study||221||
60118594|NCT01682837|76239564|FG000|Received KMgCit|Second Intervention (4 Weeks)||7||
60118595|NCT01682837|76239564|FG000|Received KCit|Second Intervention (4 Weeks)||6||
59717077|NCT01121484|75836074|FG000|Treated|Overall Study||217||
59717078|NCT01121484|75836075|FG001|Treated|Overall Study||217||
59832278|NCT00337662|75955860|FG003|COMPLETED|Study Period II||522||
59832279|NCT00337662|75955857|FG000|NOT COMPLETED|Study Period II||0||
60118596|NCT01682837|76239564|FG000|Received KCl|Second Intervention (4 Weeks)||8||
60118597|NCT01682837|76239564|FG000|Received Placebo|Second Intervention (4 Weeks)||9||
60118598|NCT01682837|76239564|FG000|COMPLETED|Second Intervention (4 Weeks)||30||
59717079|NCT01121484|75836074|FG000|COMPLETED|Overall Study||185||
59717080|NCT01121484|75836075|FG001|COMPLETED|Overall Study||178||
59832280|NCT00337662|75955858|FG001|NOT COMPLETED|Study Period II||0||
59832281|NCT00337662|75955859|FG002|NOT COMPLETED|Study Period II||0||
59832282|NCT00337662|75955860|FG003|NOT COMPLETED|Study Period II||106||
59832283|NCT00337662|75955857|FG000|STARTED|Study Period III||186||
59832284|NCT00337662|75955858|FG001|STARTED|Study Period III||192||
59832285|NCT00337662|75955859|FG002|STARTED|Study Period III||144||
59832286|NCT00337662|75955860|FG003|STARTED|Study Period III||0||
59832287|NCT00337662|75955857|FG000|COMPLETED|Study Period III||126||
59832288|NCT00337662|75955858|FG001|COMPLETED|Study Period III||134||
59832289|NCT00337662|75955859|FG002|COMPLETED|Study Period III||100||
59832290|NCT00337662|75955860|FG003|COMPLETED|Study Period III||0||
59832291|NCT00337662|75955857|FG000|NOT COMPLETED|Study Period III||60||
59832292|NCT00337662|75955858|FG001|NOT COMPLETED|Study Period III||58||
59832293|NCT00337662|75955859|FG002|NOT COMPLETED|Study Period III||44||
59832294|NCT00337662|75955860|FG003|NOT COMPLETED|Study Period III||0||
59832295|NCT00138424|75955875|FG000|STARTED|Overall Study||9||
59832296|NCT00138424|75955876|FG001|STARTED|Overall Study||5||
59832297|NCT00138424|75955877|FG002|STARTED|Overall Study||5||
59832298|NCT00138424|75955878|FG003|STARTED|Overall Study||3||
59832299|NCT00138424|75955875|FG000|COMPLETED|Overall Study||9||
59832300|NCT00138424|75955876|FG001|COMPLETED|Overall Study||4||
59832301|NCT00138424|75955877|FG002|COMPLETED|Overall Study||5||
59832302|NCT00138424|75955878|FG003|COMPLETED|Overall Study||3||
59832303|NCT00138424|75955875|FG000|NOT COMPLETED|Overall Study||0||
59832304|NCT00138424|75955876|FG001|NOT COMPLETED|Overall Study||1||
59832305|NCT00138424|75955877|FG002|NOT COMPLETED|Overall Study||0||
59832306|NCT00138424|75955878|FG003|NOT COMPLETED|Overall Study||0||
59832307|NCT00368966|75955892|FG000|STARTED|Infant Series||315||
59832308|NCT00368966|75955893|FG001|STARTED|Infant Series||304||
59832309|NCT00368966|75955892|FG000|Vaccinated Dose 1|Infant Series||314||
59832310|NCT00368966|75955893|FG001|Vaccinated Dose 1|Infant Series|1 randomized to 7vPnC but given 13vPnC vaccine; 1 was withdrawn before receiving 7vPnC vaccine|302||
59832311|NCT00368966|75955892|FG000|Vaccinated Dose 2|Infant Series|1 randomized but incorrectly given 7vPnC|307||
59832312|NCT00368966|75955893|FG001|Vaccinated Dose 2|Infant Series||298||
59832313|NCT00368966|75955892|FG000|Vaccinated Dose 3|Infant Series||301||
59832314|NCT00368966|75955893|FG001|Vaccinated Dose 3|Infant Series|1 randomized but incorrectly given 13vPnC|296||
59832315|NCT00368966|75955892|FG000|COMPLETED|Infant Series||299||
59832316|NCT00368966|75955893|FG001|COMPLETED|Infant Series||294||
59832317|NCT00368966|75955892|FG000|NOT COMPLETED|Infant Series||16||
59832318|NCT00368966|75955893|FG001|NOT COMPLETED|Infant Series||10||
59832319|NCT00368966|75955892|FG000|STARTED|After Infant||299||
59832320|NCT00368966|75955893|FG001|STARTED|After Infant||294||
59832321|NCT00368966|75955892|FG000|COMPLETED|After Infant||293||
59832322|NCT00368966|75955893|FG001|COMPLETED|After Infant||289||
59832323|NCT00368966|75955892|FG000|NOT COMPLETED|After Infant||6||
59832324|NCT00368966|75955893|FG001|NOT COMPLETED|After Infant||5||
59832325|NCT00368966|75955892|FG000|STARTED|Toddler Dose||293||
59832326|NCT00368966|75955893|FG001|STARTED|Toddler Dose||289||
59832327|NCT00368966|75955892|FG000|COMPLETED|Toddler Dose||292||
59832328|NCT00368966|75955893|FG001|COMPLETED|Toddler Dose||286||
59832329|NCT00368966|75955892|FG000|NOT COMPLETED|Toddler Dose||1||
59832330|NCT00368966|75955893|FG001|NOT COMPLETED|Toddler Dose||3||
59832331|NCT00114166|75955926|FG000|STARTED|Overall Study||15||
59832332|NCT00114166|75955927|FG001|STARTED|Overall Study||66||
59832333|NCT00114166|75955926|FG000|COMPLETED|Overall Study||15||
59832334|NCT00114166|75955927|FG001|COMPLETED|Overall Study||65||
59832335|NCT00114166|75955926|FG000|NOT COMPLETED|Overall Study||0||
59832336|NCT00114166|75955927|FG001|NOT COMPLETED|Overall Study||1||
59832337|NCT00125242|75955937|FG000|STARTED|Overall Study||94||
59832338|NCT00125242|75955938|FG001|STARTED|Overall Study||16||
59832339|NCT00125242|75955937|FG000|COMPLETED|Overall Study||87||
59832340|NCT00125242|75955938|FG001|COMPLETED|Overall Study||14||
59832341|NCT00125242|75955937|FG000|NOT COMPLETED|Overall Study||7||
59832342|NCT00125242|75955938|FG001|NOT COMPLETED|Overall Study||2||
59832343|NCT00337428|75955945|FG000|STARTED|Overall Study||419||
59832344|NCT00337428|75955946|FG001|STARTED|Overall Study||424||
59832345|NCT00337428|75955945|FG000|COMPLETED|Overall Study||415||
59832346|NCT00337428|75955946|FG001|COMPLETED|Overall Study||421||
59832347|NCT00337428|75955945|FG000|NOT COMPLETED|Overall Study||4||
59832348|NCT00337428|75955946|FG001|NOT COMPLETED|Overall Study||3||
59832349|NCT00235989|75955956|FG000|STARTED|Core Treatment Period (CT)||0||
59832350|NCT00235989|75955957|FG001|STARTED|Core Treatment Period (CT)||0||
59832351|NCT00235989|75955958|FG002|STARTED|Core Treatment Period (CT)||0||
59832352|NCT00235989|75955959|FG003|STARTED|Core Treatment Period (CT)||0||
59832353|NCT00235989|75955960|FG004|STARTED|Core Treatment Period (CT)||36||
59832354|NCT00235989|75955961|FG005|STARTED|Core Treatment Period (CT)||27||
59832355|NCT00235989|75955956|FG000|COMPLETED|Core Treatment Period (CT)||0||
59832356|NCT00235989|75955957|FG001|COMPLETED|Core Treatment Period (CT)||0||
59832357|NCT00235989|75955958|FG002|COMPLETED|Core Treatment Period (CT)||0||
59832358|NCT00235989|75955959|FG003|COMPLETED|Core Treatment Period (CT)||0||
59832359|NCT00235989|75955960|FG004|COMPLETED|Core Treatment Period (CT)||36||
59832360|NCT00235989|75955961|FG005|COMPLETED|Core Treatment Period (CT)||25||
59832361|NCT00235989|75955956|FG000|NOT COMPLETED|Core Treatment Period (CT)||0||
59832362|NCT00235989|75955957|FG001|NOT COMPLETED|Core Treatment Period (CT)||0||
59832363|NCT00235989|75955958|FG002|NOT COMPLETED|Core Treatment Period (CT)||0||
59832364|NCT00235989|75955959|FG003|NOT COMPLETED|Core Treatment Period (CT)||0||
59832365|NCT00235989|75955960|FG004|NOT COMPLETED|Core Treatment Period (CT)||0||
59832366|NCT00235989|75955961|FG005|NOT COMPLETED|Core Treatment Period (CT)||2||
59832367|NCT00235989|75955956|FG000|STARTED|Extension Treatment Period (ET)||16||
59832368|NCT00235989|75955957|FG001|STARTED|Extension Treatment Period (ET)||6||
59832369|NCT00235989|75955958|FG002|STARTED|Extension Treatment Period (ET)||19||
59832370|NCT00235989|75955959|FG003|STARTED|Extension Treatment Period (ET)||20||
59832371|NCT00235989|75955960|FG004|STARTED|Extension Treatment Period (ET)||0||
59832372|NCT00235989|75955961|FG005|STARTED|Extension Treatment Period (ET)||0||
59832373|NCT00235989|75955956|FG000|COMPLETED|Extension Treatment Period (ET)||8||
59832374|NCT00235989|75955957|FG001|COMPLETED|Extension Treatment Period (ET)||2||
59832375|NCT00235989|75955958|FG002|COMPLETED|Extension Treatment Period (ET)||14||
59832376|NCT00235989|75955959|FG003|COMPLETED|Extension Treatment Period (ET)||14||
59832377|NCT00235989|75955960|FG004|COMPLETED|Extension Treatment Period (ET)||0||
59832378|NCT00235989|75955961|FG005|COMPLETED|Extension Treatment Period (ET)||0||
59832379|NCT00235989|75955956|FG000|NOT COMPLETED|Extension Treatment Period (ET)||8||
59832380|NCT00235989|75955957|FG001|NOT COMPLETED|Extension Treatment Period (ET)||4||
59832381|NCT00235989|75955958|FG002|NOT COMPLETED|Extension Treatment Period (ET)||5||
59832382|NCT00235989|75955959|FG003|NOT COMPLETED|Extension Treatment Period (ET)||6||
59832383|NCT00235989|75955960|FG004|NOT COMPLETED|Extension Treatment Period (ET)||0||
59832384|NCT00235989|75955961|FG005|NOT COMPLETED|Extension Treatment Period (ET)||0||
59832385|NCT00113386|75955973|FG000|STARTED|Overall Study||10||
59832386|NCT00113386|75955974|FG001|STARTED|Overall Study||9||
59832387|NCT00113386|75955973|FG000|COMPLETED|Overall Study||3||
59832388|NCT00113386|75955974|FG001|COMPLETED|Overall Study||5||
59832389|NCT00113386|75955973|FG000|NOT COMPLETED|Overall Study||7||
59832390|NCT00113386|75955974|FG001|NOT COMPLETED|Overall Study||4||
59832391|NCT00353262|75955980|FG000|STARTED|Overall Study||36||
59832392|NCT00353262|75955980|FG000|COMPLETED|Overall Study||7||
59832393|NCT00353262|75955980|FG000|NOT COMPLETED|Overall Study||29||
59832394|NCT00337272|75955986|FG000|STARTED|Screening Period (Pre-randomization)|22 subjects were consented. All subjects received placebo during the 2 week screening period.|22||
59832395|NCT00337272|75955987|FG001|STARTED|Screening Period (Pre-randomization)||0||
59832396|NCT00337272|75955986|FG000|COMPLETED|Screening Period (Pre-randomization)|16 subjects completed the screening period and were eligible for randomization.|16||
59832397|NCT00337272|75955987|FG001|COMPLETED|Screening Period (Pre-randomization)||0||
59832398|NCT00337272|75955986|FG000|NOT COMPLETED|Screening Period (Pre-randomization)||6||
59832399|NCT00337272|75955987|FG001|NOT COMPLETED|Screening Period (Pre-randomization)||0||
59832400|NCT00337272|75955986|FG000|STARTED|Treatment Period|16 subjects were randomized to either placebo or ramelteon before starting treatment period.|7||
59832401|NCT00337272|75955987|FG001|STARTED|Treatment Period|16 subjects were randomized to either placebo or ramelteon before starting treatment period.|9||
59832402|NCT00337272|75955986|FG000|Randomization|Treatment Period||7||
59832403|NCT00337272|75955987|FG001|Randomization|Treatment Period||9||
59832404|NCT00337272|75955986|FG000|COMPLETED|Treatment Period||6||
59832405|NCT00337272|75955987|FG001|COMPLETED|Treatment Period||7||
59832406|NCT00337272|75955986|FG000|NOT COMPLETED|Treatment Period||1||
59832407|NCT00337272|75955987|FG001|NOT COMPLETED|Treatment Period||2||
59832408|NCT00337272|75955986|FG000|STARTED|Withdrawal Period|Subjects in both groups received placebo for one week.|6||
59832409|NCT00337272|75955987|FG001|STARTED|Withdrawal Period|Subjects in both groups received placebo for one week.|7||
59832410|NCT00337272|75955986|FG000|COMPLETED|Withdrawal Period||6||
59832411|NCT00337272|75955987|FG001|COMPLETED|Withdrawal Period||6||
59717081|NCT01121484|75836074|FG000|NOT COMPLETED|Overall Study||33||
59717082|NCT01121484|75836075|FG001|NOT COMPLETED|Overall Study||43||
59717083|NCT01169675|75836086|FG000|STARTED|Overall Study||20||
59717084|NCT01169675|75836087|FG001|STARTED|Overall Study||3||
59717085|NCT01169675|75836088|FG002|STARTED|Overall Study||7||
59717086|NCT01169675|75836089|FG003|STARTED|Overall Study||17||
59717087|NCT01169675|75836090|FG004|STARTED|Overall Study||6||
59717088|NCT01169675|75836086|FG000|COMPLETED|Overall Study||0||
59717089|NCT01169675|75836087|FG001|COMPLETED|Overall Study||0||
59717090|NCT01169675|75836088|FG002|COMPLETED|Overall Study||0||
59717091|NCT01169675|75836089|FG003|COMPLETED|Overall Study||0||
59832412|NCT00337272|75955986|FG000|NOT COMPLETED|Withdrawal Period||0||
59832413|NCT00337272|75955987|FG001|NOT COMPLETED|Withdrawal Period||1||
59832414|NCT00125164|75955997|FG000|STARTED|Overall Study||25||
59832415|NCT00125164|75955998|FG001|STARTED|Overall Study||16||
59832416|NCT00125164|75955999|FG002|STARTED|Overall Study||44||
59832417|NCT00125164|75956000|FG003|STARTED|Overall Study||51||
59832418|NCT00125164|75955997|FG000|COMPLETED|Overall Study||23||
59717092|NCT01169675|75836090|FG004|COMPLETED|Overall Study||0||
59717093|NCT01169675|75836086|FG000|NOT COMPLETED|Overall Study||20||
59717094|NCT01169675|75836087|FG001|NOT COMPLETED|Overall Study||3||
59717095|NCT01169675|75836088|FG002|NOT COMPLETED|Overall Study||7||
59717096|NCT01169675|75836089|FG003|NOT COMPLETED|Overall Study||17||
59717097|NCT01169675|75836090|FG004|NOT COMPLETED|Overall Study||6||
59717098|NCT00924664|75836104|FG000|STARTED|Overall Study||322||
59717099|NCT00924664|75836105|FG001|STARTED|Overall Study||527||
59717100|NCT00924664|75836104|FG000|Treated|Overall Study||321||
59717101|NCT00924664|75836105|FG001|Treated|Overall Study||527||
59832419|NCT00125164|75955998|FG001|COMPLETED|Overall Study||16||
59832420|NCT00125164|75955999|FG002|COMPLETED|Overall Study||40||
59832421|NCT00125164|75956000|FG003|COMPLETED|Overall Study||45||
59832422|NCT00125164|75955997|FG000|NOT COMPLETED|Overall Study||2||
59832423|NCT00125164|75955998|FG001|NOT COMPLETED|Overall Study||0||
59832424|NCT00125164|75955999|FG002|NOT COMPLETED|Overall Study||4||
59832425|NCT00125164|75956000|FG003|NOT COMPLETED|Overall Study||6||
59832426|NCT00136318|75956012|FG000|STARTED|Overall Study|Took first dose of study medication|90||
59832427|NCT00136318|75956013|FG001|STARTED|Overall Study|Took first dose of study medication|91||
59832428|NCT00136318|75956012|FG000|COMPLETED|Overall Study|reached end-point of antiviral treatment|83||
59832429|NCT00136318|75956013|FG001|COMPLETED|Overall Study||84||
59832430|NCT00136318|75956012|FG000|NOT COMPLETED|Overall Study||7||
59832431|NCT00136318|75956013|FG001|NOT COMPLETED|Overall Study||7||
59832432|NCT00136084|75956022|FG000|STARTED|Overall Study||109||
59832433|NCT00136084|75956023|FG001|STARTED|Overall Study||114||
59832434|NCT00136084|75956022|FG000|COMPLETED|Overall Study||61||
59832435|NCT00136084|75956023|FG001|COMPLETED|Overall Study||72||
59832436|NCT00136084|75956022|FG000|NOT COMPLETED|Overall Study||48||
59832437|NCT00136084|75956023|FG001|NOT COMPLETED|Overall Study||42||
59832438|NCT00364832|75956044|FG000|STARTED|Core Period||16||
59832439|NCT00364832|75956045|FG001|STARTED|Core Period||15||
59832440|NCT00364832|75956046|FG002|STARTED|Core Period||15||
59832441|NCT00364832|75956047|FG003|STARTED|Core Period||16||
59832442|NCT00364832|75956048|FG004|STARTED|Core Period||16||
59832443|NCT00364832|75956049|FG005|STARTED|Core Period||12||
59832444|NCT00364832|75956050|FG006|STARTED|Core Period||16||
59832445|NCT00364832|75956051|FG007|STARTED|Core Period||15||
59832446|NCT00364832|75956052|FG008|STARTED|Core Period||16||
59832447|NCT00364832|75956053|FG009|STARTED|Core Period||0||
59832448|NCT00364832|75956054|FG010|STARTED|Core Period||0||
59832449|NCT00364832|75956055|FG011|STARTED|Core Period||0||
59832450|NCT00364832|75956044|FG000|COMPLETED|Core Period||14||
59832451|NCT00364832|75956045|FG001|COMPLETED|Core Period||13||
59832452|NCT00364832|75956046|FG002|COMPLETED|Core Period||14||
59832453|NCT00364832|75956047|FG003|COMPLETED|Core Period||15||
59832454|NCT00364832|75956048|FG004|COMPLETED|Core Period||16||
59832455|NCT00364832|75956049|FG005|COMPLETED|Core Period||12||
59832456|NCT00364832|75956050|FG006|COMPLETED|Core Period||12||
59832457|NCT00364832|75956051|FG007|COMPLETED|Core Period||14||
59832458|NCT00364832|75956052|FG008|COMPLETED|Core Period||16||
59832459|NCT00364832|75956053|FG009|COMPLETED|Core Period||0||
59832460|NCT00364832|75956054|FG010|COMPLETED|Core Period||0||
59832461|NCT00364832|75956055|FG011|COMPLETED|Core Period||0||
59832462|NCT00364832|75956044|FG000|NOT COMPLETED|Core Period||2||
59832463|NCT00364832|75956045|FG001|NOT COMPLETED|Core Period||2||
59832464|NCT00364832|75956046|FG002|NOT COMPLETED|Core Period||1||
59832465|NCT00364832|75956047|FG003|NOT COMPLETED|Core Period||1||
59832466|NCT00364832|75956048|FG004|NOT COMPLETED|Core Period||0||
59832467|NCT00364832|75956049|FG005|NOT COMPLETED|Core Period||0||
59832468|NCT00364832|75956050|FG006|NOT COMPLETED|Core Period||4||
59832469|NCT00364832|75956051|FG007|NOT COMPLETED|Core Period||1||
59832470|NCT00364832|75956052|FG008|NOT COMPLETED|Core Period||0||
59832471|NCT00364832|75956053|FG009|NOT COMPLETED|Core Period||0||
59832472|NCT00364832|75956054|FG010|NOT COMPLETED|Core Period||0||
59832473|NCT00364832|75956055|FG011|NOT COMPLETED|Core Period||0||
59717102|NCT00924664|75836104|FG000|COMPLETED|Overall Study||0||
59717103|NCT00924664|75836105|FG001|COMPLETED|Overall Study||0||
59717104|NCT00924664|75836104|FG000|NOT COMPLETED|Overall Study||322||
59717105|NCT00924664|75836105|FG001|NOT COMPLETED|Overall Study||527||
59717106|NCT00600067|75836113|FG000|STARTED|Overall Study||55||
59717107|NCT00600067|75836114|FG001|STARTED|Overall Study||75||
59717108|NCT00600067|75836113|FG000|COMPLETED|Overall Study||52||
59717109|NCT00600067|75836114|FG001|COMPLETED|Overall Study||68||
59717110|NCT00600067|75836113|FG000|NOT COMPLETED|Overall Study||3||
59717111|NCT00600067|75836114|FG001|NOT COMPLETED|Overall Study||7||
59717112|NCT00970593|75836128|FG000|STARTED|Overall Study||11||
59717113|NCT00970593|75836129|FG001|STARTED|Overall Study||15||
59832474|NCT00364832|75956044|FG000|STARTED|Extension Year 1||0||
59832475|NCT00364832|75956045|FG001|STARTED|Extension Year 1||0||
59832476|NCT00364832|75956046|FG002|STARTED|Extension Year 1||0||
59832477|NCT00364832|75956047|FG003|STARTED|Extension Year 1||0||
59832478|NCT00364832|75956048|FG004|STARTED|Extension Year 1||0||
59717114|NCT00970593|75836130|FG002|STARTED|Overall Study||13||
59717115|NCT00970593|75836131|FG003|STARTED|Overall Study||12||
59717116|NCT00970593|75836132|FG004|STARTED|Overall Study||20||
59717117|NCT00970593|75836133|FG005|STARTED|Overall Study||5||
59717118|NCT00970593|75836134|FG006|STARTED|Overall Study||16||
59717119|NCT00970593|75836128|FG000|COMPLETED|Overall Study||10||
59832479|NCT00364832|75956049|FG005|STARTED|Extension Year 1||0||
59832480|NCT00364832|75956050|FG006|STARTED|Extension Year 1||0||
59832481|NCT00364832|75956051|FG007|STARTED|Extension Year 1||0||
59832482|NCT00364832|75956052|FG008|STARTED|Extension Year 1||0||
59832483|NCT00364832|75956053|FG009|STARTED|Extension Year 1|Participants (Cohorts A, D, and G) who completed core, entered extension period (entry optional).|18||
59832484|NCT00364832|75956054|FG010|STARTED|Extension Year 1|Participants (Cohorts B, E, and H) who completed core, entered extension period (entry optional).|17||
59717120|NCT00970593|75836129|FG001|COMPLETED|Overall Study||14||
59832485|NCT00364832|75956055|FG011|STARTED|Extension Year 1|Participants (Cohorts C, F, and I) who completed core, entered extension period (entry optional).|27||
59832486|NCT00364832|75956044|FG000|COMPLETED|Extension Year 1||0||
59832487|NCT00364832|75956045|FG001|COMPLETED|Extension Year 1||0||
59832488|NCT00364832|75956046|FG002|COMPLETED|Extension Year 1||0||
59832489|NCT00364832|75956047|FG003|COMPLETED|Extension Year 1||0||
59832490|NCT00364832|75956048|FG004|COMPLETED|Extension Year 1||0||
59832491|NCT00364832|75956049|FG005|COMPLETED|Extension Year 1||0||
59832492|NCT00364832|75956050|FG006|COMPLETED|Extension Year 1||0||
59832493|NCT00364832|75956051|FG007|COMPLETED|Extension Year 1||0||
59832494|NCT00364832|75956052|FG008|COMPLETED|Extension Year 1||0||
59832495|NCT00364832|75956053|FG009|COMPLETED|Extension Year 1||14||
59832496|NCT00364832|75956054|FG010|COMPLETED|Extension Year 1||15||
59832497|NCT00364832|75956055|FG011|COMPLETED|Extension Year 1||17||
59832498|NCT00364832|75956044|FG000|NOT COMPLETED|Extension Year 1||0||
59832499|NCT00364832|75956045|FG001|NOT COMPLETED|Extension Year 1||0||
59832500|NCT00364832|75956046|FG002|NOT COMPLETED|Extension Year 1||0||
59832501|NCT00364832|75956047|FG003|NOT COMPLETED|Extension Year 1||0||
59832502|NCT00364832|75956048|FG004|NOT COMPLETED|Extension Year 1||0||
59832503|NCT00364832|75956049|FG005|NOT COMPLETED|Extension Year 1||0||
59832504|NCT00364832|75956050|FG006|NOT COMPLETED|Extension Year 1||0||
59832505|NCT00364832|75956051|FG007|NOT COMPLETED|Extension Year 1||0||
59832506|NCT00364832|75956052|FG008|NOT COMPLETED|Extension Year 1||0||
59832507|NCT00364832|75956053|FG009|NOT COMPLETED|Extension Year 1||4||
59832508|NCT00364832|75956054|FG010|NOT COMPLETED|Extension Year 1||2||
59832509|NCT00364832|75956055|FG011|NOT COMPLETED|Extension Year 1||10||
59832510|NCT00364832|75956044|FG000|STARTED|Extension Year 2||0||
59832511|NCT00364832|75956045|FG001|STARTED|Extension Year 2||0||
59832512|NCT00364832|75956046|FG002|STARTED|Extension Year 2||0||
59832513|NCT00364832|75956047|FG003|STARTED|Extension Year 2||0||
59832514|NCT00364832|75956048|FG004|STARTED|Extension Year 2||0||
59832515|NCT00364832|75956049|FG005|STARTED|Extension Year 2||0||
59832516|NCT00364832|75956050|FG006|STARTED|Extension Year 2||0||
59832517|NCT00364832|75956051|FG007|STARTED|Extension Year 2||0||
59832518|NCT00364832|75956052|FG008|STARTED|Extension Year 2||0||
59832519|NCT00364832|75956053|FG009|STARTED|Extension Year 2||14||
59832520|NCT00364832|75956054|FG010|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|14||
59832521|NCT00364832|75956055|FG011|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|14||
59832522|NCT00364832|75956044|FG000|COMPLETED|Extension Year 2||0||
59832523|NCT00364832|75956045|FG001|COMPLETED|Extension Year 2||0||
59832524|NCT00364832|75956046|FG002|COMPLETED|Extension Year 2||0||
59832525|NCT00364832|75956047|FG003|COMPLETED|Extension Year 2||0||
59832526|NCT00364832|75956048|FG004|COMPLETED|Extension Year 2||0||
59832527|NCT00364832|75956049|FG005|COMPLETED|Extension Year 2||0||
59832528|NCT00364832|75956050|FG006|COMPLETED|Extension Year 2||0||
59832529|NCT00364832|75956051|FG007|COMPLETED|Extension Year 2||0||
59832530|NCT00364832|75956052|FG008|COMPLETED|Extension Year 2||0||
59832531|NCT00364832|75956053|FG009|COMPLETED|Extension Year 2||9||
59832532|NCT00364832|75956054|FG010|COMPLETED|Extension Year 2||9||
59832533|NCT00364832|75956055|FG011|COMPLETED|Extension Year 2||11||
59832534|NCT00364832|75956044|FG000|NOT COMPLETED|Extension Year 2||0||
59832535|NCT00364832|75956045|FG001|NOT COMPLETED|Extension Year 2||0||
59832536|NCT00364832|75956046|FG002|NOT COMPLETED|Extension Year 2||0||
59832537|NCT00364832|75956047|FG003|NOT COMPLETED|Extension Year 2||0||
59832538|NCT00364832|75956048|FG004|NOT COMPLETED|Extension Year 2||0||
59832539|NCT00364832|75956049|FG005|NOT COMPLETED|Extension Year 2||0||
59832540|NCT00364832|75956050|FG006|NOT COMPLETED|Extension Year 2||0||
59832541|NCT00364832|75956051|FG007|NOT COMPLETED|Extension Year 2||0||
59832542|NCT00364832|75956052|FG008|NOT COMPLETED|Extension Year 2||0||
59832543|NCT00364832|75956053|FG009|NOT COMPLETED|Extension Year 2||5||
59832544|NCT00364832|75956054|FG010|NOT COMPLETED|Extension Year 2||5||
59832545|NCT00364832|75956055|FG011|NOT COMPLETED|Extension Year 2||3||
59832546|NCT00235755|75956075|FG000|STARTED|4-Week Titration Phase||179||
59832547|NCT00235755|75956076|FG001|STARTED|4-Week Titration Phase||181||
59832548|NCT00235755|75956077|FG002|STARTED|4-Week Titration Phase||179||
59832549|NCT00235755|75956075|FG000|COMPLETED|4-Week Titration Phase||168||
59832550|NCT00235755|75956076|FG001|COMPLETED|4-Week Titration Phase||162||
59832551|NCT00235755|75956077|FG002|COMPLETED|4-Week Titration Phase||153||
59832552|NCT00235755|75956075|FG000|NOT COMPLETED|4-Week Titration Phase||11||
59832553|NCT00235755|75956076|FG001|NOT COMPLETED|4-Week Titration Phase||19||
59832554|NCT00235755|75956077|FG002|NOT COMPLETED|4-Week Titration Phase||26||
59832555|NCT00235755|75956075|FG000|STARTED|12-Week Maintenance Phase||168||
59832556|NCT00235755|75956076|FG001|STARTED|12-Week Maintenance Phase||162||
59832557|NCT00235755|75956077|FG002|STARTED|12-Week Maintenance Phase||153||
59832558|NCT00235755|75956075|FG000|COMPLETED|12-Week Maintenance Phase||152||
59832559|NCT00235755|75956076|FG001|COMPLETED|12-Week Maintenance Phase||135||
59832560|NCT00235755|75956077|FG002|COMPLETED|12-Week Maintenance Phase||122||
59832561|NCT00235755|75956075|FG000|NOT COMPLETED|12-Week Maintenance Phase||16||
59832562|NCT00235755|75956076|FG001|NOT COMPLETED|12-Week Maintenance Phase||27||
59832563|NCT00235755|75956077|FG002|NOT COMPLETED|12-Week Maintenance Phase||31||
59832564|NCT00337194|75956102|FG000|STARTED|Overall Study||23||
59832565|NCT00337194|75956103|FG001|STARTED|Overall Study||7||
59832566|NCT00337194|75956102|FG000|COMPLETED|Overall Study||11||
59832567|NCT00337194|75956103|FG001|COMPLETED|Overall Study||3||
59832568|NCT00337194|75956102|FG000|NOT COMPLETED|Overall Study||12||
59832569|NCT00337194|75956103|FG001|NOT COMPLETED|Overall Study||4||
59832570|NCT03826914|75956113|FG000|STARTED|Overall Study||35||
59832571|NCT03826914|75956114|FG001|STARTED|Overall Study||34||
59832572|NCT03826914|75956113|FG000|COMPLETED|Overall Study||34||
59832573|NCT03826914|75956114|FG001|COMPLETED|Overall Study||33||
59832574|NCT03826914|75956113|FG000|NOT COMPLETED|Overall Study||1||
59832575|NCT03826914|75956114|FG001|NOT COMPLETED|Overall Study||1||
59832576|NCT00385736|75956125|FG000|STARTED|Efficacy Analysis Set - Induction|Enrolled under Amendment 3 or 4 of the protocol.|130||
59832577|NCT00385736|75956126|FG001|STARTED|Efficacy Analysis Set - Induction|Enrolled under Amendment 3 or 4 of the protocol.|130||
59832578|NCT00385736|75956127|FG002|STARTED|Efficacy Analysis Set - Induction|Enrolled under Amendment 3 or 4 of the protocol.|130||
59832579|NCT00385736|75956125|FG000|COMPLETED|Efficacy Analysis Set - Induction|Completed Week 8 of the study.|121||
59832580|NCT00385736|75956126|FG001|COMPLETED|Efficacy Analysis Set - Induction|Completed Week 8 of the study.|118||
59832581|NCT00385736|75956127|FG002|COMPLETED|Efficacy Analysis Set - Induction|Completed Week 8 of the study.|121||
59832582|NCT00385736|75956125|FG000|NOT COMPLETED|Efficacy Analysis Set - Induction||9||
59832583|NCT00385736|75956126|FG001|NOT COMPLETED|Efficacy Analysis Set - Induction||12||
59832584|NCT00385736|75956127|FG002|NOT COMPLETED|Efficacy Analysis Set - Induction||9||
59832585|NCT00385736|75956125|FG000|STARTED|Efficacy Analysis Set - Maintenance|Includes all subjects with confirmed UC enrolled since the start of the study|222||
59832586|NCT00385736|75956126|FG001|STARTED|Efficacy Analysis Set - Maintenance|Includes all subjects with confirmed UC enrolled since the start of the study|130||
59832587|NCT00385736|75956127|FG002|STARTED|Efficacy Analysis Set - Maintenance|Includes all subjects with confirmed UC enrolled since the start of the study|223||
59832588|NCT00385736|75956125|FG000|COMPLETED|Efficacy Analysis Set - Maintenance||153||
59832589|NCT00385736|75956126|FG001|COMPLETED|Efficacy Analysis Set - Maintenance||86||
59832590|NCT00385736|75956127|FG002|COMPLETED|Efficacy Analysis Set - Maintenance||143||
59832591|NCT00385736|75956125|FG000|NOT COMPLETED|Efficacy Analysis Set - Maintenance||69||
59832592|NCT00385736|75956126|FG001|NOT COMPLETED|Efficacy Analysis Set - Maintenance||44||
59832593|NCT00385736|75956127|FG002|NOT COMPLETED|Efficacy Analysis Set - Maintenance||80||
59717121|NCT00970593|75836130|FG002|COMPLETED|Overall Study||7||
59717122|NCT00970593|75836131|FG003|COMPLETED|Overall Study||12||
59717123|NCT00970593|75836132|FG004|COMPLETED|Overall Study||20||
59717124|NCT00970593|75836133|FG005|COMPLETED|Overall Study||5||
59717125|NCT00970593|75836134|FG006|COMPLETED|Overall Study||14||
59717126|NCT00970593|75836128|FG000|NOT COMPLETED|Overall Study||1||
59717127|NCT00970593|75836129|FG001|NOT COMPLETED|Overall Study||1||
59717128|NCT00970593|75836130|FG002|NOT COMPLETED|Overall Study||6||
59717129|NCT00970593|75836131|FG003|NOT COMPLETED|Overall Study||0||
59717130|NCT00970593|75836132|FG004|NOT COMPLETED|Overall Study||0||
59717131|NCT00970593|75836133|FG005|NOT COMPLETED|Overall Study||0||
59717132|NCT00970593|75836134|FG006|NOT COMPLETED|Overall Study||2||
59717133|NCT00962013|75836154|FG000|STARTED|Overall Study||120||
59717134|NCT00962013|75836154|FG000|COMPLETED|Overall Study|Number of participants with 5 year primary endpoint data|52||
59717135|NCT00962013|75836154|FG000|NOT COMPLETED|Overall Study||68||
59717136|NCT00970359|75836158|FG000|STARTED|Overall Study||24||
59717137|NCT00970359|75836158|FG000|COMPLETED|Overall Study||20||
59717138|NCT00970359|75836158|FG000|NOT COMPLETED|Overall Study||4||
59717139|NCT01121406|75836164|FG000|STARTED|Overall Study||55||
59717140|NCT01121406|75836165|FG001|STARTED|Overall Study|24 patients switched to Volasertib (BI 6727) due to disease progression or occurrence of toxicity|55||
59717141|NCT01121406|75836164|FG000|COMPLETED|Overall Study||0||
59717142|NCT01121406|75836165|FG001|COMPLETED|Overall Study||0||
59717143|NCT01121406|75836164|FG000|NOT COMPLETED|Overall Study||55||
59717144|NCT01121406|75836165|FG001|NOT COMPLETED|Overall Study||55||
59717145|NCT00960687|75836174|FG000|STARTED|First Intervention||27||
59717146|NCT00960687|75836175|FG001|STARTED|First Intervention||27||
59717147|NCT00960687|75836174|FG000|COMPLETED|First Intervention||27||
59717148|NCT00960687|75836175|FG001|COMPLETED|First Intervention||27||
59717149|NCT00960687|75836174|FG000|NOT COMPLETED|First Intervention||0||
59717150|NCT00960687|75836175|FG001|NOT COMPLETED|First Intervention||0||
59717151|NCT00960687|75836174|FG000|STARTED|Washout Period of 7 Days||27||
59717152|NCT00960687|75836175|FG001|STARTED|Washout Period of 7 Days||27||
59717153|NCT00960687|75836174|FG000|COMPLETED|Washout Period of 7 Days|three subjects withdrew due to adverse events and one subject withdrew for personal reasons.|23||
59717154|NCT00960687|75836175|FG001|COMPLETED|Washout Period of 7 Days|two subjects withdrew due to adverse events and one subject withdrew for personal reasons.|24||
59717155|NCT00960687|75836174|FG000|NOT COMPLETED|Washout Period of 7 Days||4||
59717156|NCT00960687|75836175|FG001|NOT COMPLETED|Washout Period of 7 Days||3||
59832594|NCT00385736|75956125|FG000|STARTED|Safety Analysis Set|Includes all subjects enrolled since the start of the study.|223||
59717157|NCT00960687|75836174|FG000|STARTED|Second Intervention||23||
59717158|NCT00960687|75836175|FG001|STARTED|Second Intervention||24||
59717159|NCT00960687|75836174|FG000|COMPLETED|Second Intervention||23||
59832595|NCT00385736|75956126|FG001|STARTED|Safety Analysis Set|Includes all subjects enrolled since the start of the study.|130||
59832596|NCT00385736|75956127|FG002|STARTED|Safety Analysis Set|Includes all subjects enrolled since the start of the study.|223||
59832597|NCT00385736|75956125|FG000|COMPLETED|Safety Analysis Set||153||
59832598|NCT00385736|75956126|FG001|COMPLETED|Safety Analysis Set||86||
59832599|NCT00385736|75956127|FG002|COMPLETED|Safety Analysis Set||143||
59832600|NCT00385736|75956125|FG000|NOT COMPLETED|Safety Analysis Set||70||
59832601|NCT00385736|75956126|FG001|NOT COMPLETED|Safety Analysis Set||44||
59832602|NCT00385736|75956127|FG002|NOT COMPLETED|Safety Analysis Set||80||
59832603|NCT00195819|75956138|FG000|STARTED|Double-Blind||44||
59832604|NCT00195819|75956139|FG001|STARTED|Double-Blind||38||
59832605|NCT00195819|75956138|FG000|COMPLETED|Double-Blind||42||
59832606|NCT00195819|75956139|FG001|COMPLETED|Double-Blind||38||
59832607|NCT00195819|75956138|FG000|NOT COMPLETED|Double-Blind||2||
59832608|NCT00195819|75956139|FG001|NOT COMPLETED|Double-Blind||0||
59832609|NCT00195819|75956138|FG000|STARTED|Open-label||0||
59832610|NCT00195819|75956139|FG001|STARTED|Open-label||82||
59832611|NCT00195819|75956138|FG000|COMPLETED|Open-label||0||
59832612|NCT00195819|75956139|FG001|COMPLETED|Open-label||62||
59832613|NCT00195819|75956138|FG000|NOT COMPLETED|Open-label||0||
59832614|NCT00195819|75956139|FG001|NOT COMPLETED|Open-label||20||
59832615|NCT00527735|75956154|FG000|STARTED|Overall Study|Treated|113||
59832616|NCT00527735|75956155|FG001|STARTED|Overall Study|Treated|109||
59832617|NCT00527735|75956156|FG002|STARTED|Overall Study|Treated|109||
59832618|NCT00527735|75956154|FG000|COMPLETED|Overall Study|Still on treatment|5||
59832619|NCT00527735|75956155|FG001|COMPLETED|Overall Study|Still on treatment|2||
59832620|NCT00527735|75956156|FG002|COMPLETED|Overall Study|Still on treatment|2||
59832621|NCT00527735|75956154|FG000|NOT COMPLETED|Overall Study||108||
59832622|NCT00527735|75956155|FG001|NOT COMPLETED|Overall Study||107||
59832623|NCT00527735|75956156|FG002|NOT COMPLETED|Overall Study||107||
59832624|NCT00336492|75956179|FG000|STARTED|Overall Study||15||
59832625|NCT00336492|75956180|FG001|STARTED|Overall Study||22||
59832626|NCT00336492|75956181|FG002|STARTED|Overall Study||23||
59832627|NCT00336492|75956179|FG000|COMPLETED|Overall Study||0||
59832628|NCT00336492|75956180|FG001|COMPLETED|Overall Study||18||
59832629|NCT00336492|75956181|FG002|COMPLETED|Overall Study||12||
59832630|NCT00336492|75956179|FG000|NOT COMPLETED|Overall Study||15||
59832631|NCT00336492|75956180|FG001|NOT COMPLETED|Overall Study||4||
59832632|NCT00336492|75956181|FG002|NOT COMPLETED|Overall Study||11||
59832633|NCT00194025|75956189|FG000|STARTED|Overall Study|The intent-to-treat population received at least one dose of valproate semisodium.|20||
59832634|NCT00194025|75956189|FG000|COMPLETED|Overall Study|5 participants withdrew prematurely|15||
59832635|NCT00194025|75956189|FG000|NOT COMPLETED|Overall Study||5||
59832636|NCT00368108|75956196|FG000|STARTED|Overall Study|One subject had stopped medication prior to notifying staff. Remaining results will have 250.|251||
59832637|NCT00368108|75956197|FG001|STARTED|Overall Study||251||
59832638|NCT00368108|75956198|FG002|STARTED|Overall Study||250||
59832639|NCT00368108|75956196|FG000|COMPLETED|Overall Study||187||
59832640|NCT00368108|75956197|FG001|COMPLETED|Overall Study||198||
59832641|NCT00368108|75956198|FG002|COMPLETED|Overall Study||182||
59832642|NCT00368108|75956196|FG000|NOT COMPLETED|Overall Study||64||
59832643|NCT00368108|75956197|FG001|NOT COMPLETED|Overall Study||53||
59832644|NCT00368108|75956198|FG002|NOT COMPLETED|Overall Study||68||
59832645|NCT00364130|75956208|FG000|STARTED|Intervention Period||69||
59832646|NCT00364130|75956209|FG001|STARTED|Intervention Period||69||
59832647|NCT00364130|75956208|FG000|COMPLETED|Intervention Period||60||
59832648|NCT00364130|75956209|FG001|COMPLETED|Intervention Period||61||
59832649|NCT00364130|75956208|FG000|NOT COMPLETED|Intervention Period||9||
59832650|NCT00364130|75956209|FG001|NOT COMPLETED|Intervention Period||8||
59832651|NCT00364130|75956208|FG000|STARTED|Post Intervention Follow-up Period||60||
59832652|NCT00364130|75956209|FG001|STARTED|Post Intervention Follow-up Period||61||
59832653|NCT00364130|75956208|FG000|COMPLETED|Post Intervention Follow-up Period||55||
59832654|NCT00364130|75956209|FG001|COMPLETED|Post Intervention Follow-up Period||50||
59832655|NCT00364130|75956208|FG000|NOT COMPLETED|Post Intervention Follow-up Period||5||
59832656|NCT00364130|75956209|FG001|NOT COMPLETED|Post Intervention Follow-up Period||11||
59832657|NCT00521339|75956217|FG000|STARTED|Treatment Phase||31||
59832658|NCT00521339|75956218|FG001|STARTED|Treatment Phase||0||
59832659|NCT00521339|75956219|FG002|STARTED|Treatment Phase||0||
59832660|NCT00521339|75956217|FG000|Received Apremilast|Treatment Phase|1 participant withdrew consent prior to first visit and was excluded from safety population|30||
59832661|NCT00521339|75956218|FG001|Received Apremilast|Treatment Phase||0||
59832662|NCT00521339|75956219|FG002|Received Apremilast|Treatment Phase||0||
59832663|NCT00521339|75956217|FG000|COMPLETED|Treatment Phase||19||
59832664|NCT00521339|75956218|FG001|COMPLETED|Treatment Phase||0||
59832665|NCT00521339|75956219|FG002|COMPLETED|Treatment Phase||0||
59832666|NCT00521339|75956217|FG000|NOT COMPLETED|Treatment Phase||12||
59832667|NCT00521339|75956218|FG001|NOT COMPLETED|Treatment Phase||0||
59832668|NCT00521339|75956219|FG002|NOT COMPLETED|Treatment Phase||0||
59832669|NCT00521339|75956217|FG000|STARTED|Treatment Extension Phase||0||
59832670|NCT00521339|75956218|FG001|STARTED|Treatment Extension Phase|Some participants had completed the treatment phase prior to inception of extension phase|4||
60118599|NCT01682837|76239564|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0||
59717160|NCT00960687|75836175|FG001|COMPLETED|Second Intervention||24||
59717161|NCT00960687|75836174|FG000|NOT COMPLETED|Second Intervention||0||
59717162|NCT00960687|75836175|FG001|NOT COMPLETED|Second Intervention||0||
59717163|NCT00920140|75836186|FG000|STARTED|Phase 1 (Dose Escalation)||5||
59717164|NCT00920140|75836187|FG001|STARTED|Phase 1 (Dose Escalation)||9||
59717165|NCT00920140|75836188|FG002|STARTED|Phase 1 (Dose Escalation)||0||
59717166|NCT00920140|75836189|FG003|STARTED|Phase 1 (Dose Escalation)||0||
59717167|NCT00920140|75836190|FG004|STARTED|Phase 1 (Dose Escalation)||0||
59717168|NCT00920140|75836186|FG000|COMPLETED|Phase 1 (Dose Escalation)||0||
59717169|NCT00920140|75836187|FG001|COMPLETED|Phase 1 (Dose Escalation)||0||
59717170|NCT00920140|75836188|FG002|COMPLETED|Phase 1 (Dose Escalation)||0||
59717171|NCT00920140|75836189|FG003|COMPLETED|Phase 1 (Dose Escalation)||0||
59717172|NCT00920140|75836190|FG004|COMPLETED|Phase 1 (Dose Escalation)||0||
59717173|NCT00920140|75836186|FG000|NOT COMPLETED|Phase 1 (Dose Escalation)||5||
59717174|NCT00920140|75836187|FG001|NOT COMPLETED|Phase 1 (Dose Escalation)||9||
59717175|NCT00920140|75836188|FG002|NOT COMPLETED|Phase 1 (Dose Escalation)||0||
59717176|NCT00920140|75836189|FG003|NOT COMPLETED|Phase 1 (Dose Escalation)||0||
59717177|NCT00920140|75836190|FG004|NOT COMPLETED|Phase 1 (Dose Escalation)||0||
59717178|NCT00920140|75836186|FG000|STARTED|Phase 2||0||
59717179|NCT00920140|75836187|FG001|STARTED|Phase 2||0||
59717180|NCT00920140|75836188|FG002|STARTED|Phase 2||50||
59717181|NCT00920140|75836189|FG003|STARTED|Phase 2||22||
59717182|NCT00920140|75836190|FG004|STARTED|Phase 2||11||
59717183|NCT00920140|75836186|FG000|COMPLETED|Phase 2||0||
59717184|NCT00920140|75836187|FG001|COMPLETED|Phase 2||0||
59717185|NCT00920140|75836188|FG002|COMPLETED|Phase 2||0||
59717186|NCT00920140|75836189|FG003|COMPLETED|Phase 2||0||
59717187|NCT00920140|75836190|FG004|COMPLETED|Phase 2||0||
59717188|NCT00920140|75836186|FG000|NOT COMPLETED|Phase 2||0||
59717189|NCT00920140|75836187|FG001|NOT COMPLETED|Phase 2||0||
59717190|NCT00920140|75836188|FG002|NOT COMPLETED|Phase 2||50||
59717191|NCT00920140|75836189|FG003|NOT COMPLETED|Phase 2||22||
59717192|NCT00920140|75836190|FG004|NOT COMPLETED|Phase 2||11||
59717193|NCT01120782|75836203|FG000|STARTED|Overall Study||45||
59717194|NCT01120782|75836203|FG000|COMPLETED|Overall Study||34||
59717195|NCT01120782|75836203|FG000|NOT COMPLETED|Overall Study||11||
59717196|NCT01120626|75836209|FG000|STARTED|Overall Study||20||
59717197|NCT01120626|75836210|FG001|STARTED|Overall Study||22||
59717198|NCT01120626|75836209|FG000|COMPLETED|Overall Study||19||
59717199|NCT01120626|75836210|FG001|COMPLETED|Overall Study||22||
59717200|NCT01120626|75836209|FG000|NOT COMPLETED|Overall Study||1||
59717201|NCT01120626|75836210|FG001|NOT COMPLETED|Overall Study||0||
59717202|NCT00924508|75836216|FG000|STARTED|Overall Study||23||
59717203|NCT00924508|75836216|FG000|COMPLETED|Overall Study||20||
59717204|NCT00924508|75836216|FG000|NOT COMPLETED|Overall Study||3||
59717205|NCT01139658|75836225|FG000|STARTED|Overall Study||747||
59717206|NCT01139658|75836226|FG001|STARTED|Overall Study||929||
59717207|NCT01139658|75836225|FG000|COMPLETED|Overall Study||691||
59717208|NCT01139658|75836226|FG001|COMPLETED|Overall Study||816||
59717209|NCT01139658|75836225|FG000|NOT COMPLETED|Overall Study||56||
59717210|NCT01139658|75836226|FG001|NOT COMPLETED|Overall Study||113||
59717211|NCT01139580|75836234|FG000|STARTED|Overall Study||181||
59717212|NCT01139580|75836235|FG001|STARTED|Overall Study||182||
59717213|NCT01139580|75836234|FG000|COMPLETED|Overall Study||158||
59717214|NCT01139580|75836235|FG001|COMPLETED|Overall Study||164||
59717215|NCT01139580|75836234|FG000|NOT COMPLETED|Overall Study||23||
59717216|NCT01139580|75836235|FG001|NOT COMPLETED|Overall Study||18||
59717217|NCT00917644|75836241|FG000|STARTED|Period 1: First Intervention||39||
59717218|NCT00917644|75836242|FG001|STARTED|Period 1: First Intervention||37||
59717219|NCT00917644|75836241|FG000|COMPLETED|Period 1: First Intervention||39||
59832671|NCT00521339|75956219|FG002|STARTED|Treatment Extension Phase|Some participants had completed the treatment phase prior to inception of extension phase|7||
60118600|NCT01682837|76239564|FG000|STARTED|Third Intervention (4 Weeks)||30||
59717220|NCT00917644|75836242|FG001|COMPLETED|Period 1: First Intervention||37||
59717221|NCT00917644|75836241|FG000|NOT COMPLETED|Period 1: First Intervention||0||
59717222|NCT00917644|75836242|FG001|NOT COMPLETED|Period 1: First Intervention||0||
59717223|NCT00917644|75836241|FG000|STARTED|Period: Washout Period of > = 2 Weeks||39||
59832672|NCT00521339|75956217|FG000|COMPLETED|Treatment Extension Phase||0||
59832673|NCT00521339|75956218|FG001|COMPLETED|Treatment Extension Phase||4||
60118601|NCT01682837|76239564|FG000|Received KMgCit|Third Intervention (4 Weeks)||9||
59717224|NCT00917644|75836242|FG001|STARTED|Period: Washout Period of > = 2 Weeks||37||
59717225|NCT00917644|75836241|FG000|COMPLETED|Period: Washout Period of > = 2 Weeks||37||
59717226|NCT00917644|75836242|FG001|COMPLETED|Period: Washout Period of > = 2 Weeks||37||
59717227|NCT00917644|75836241|FG000|NOT COMPLETED|Period: Washout Period of > = 2 Weeks||2||
59717228|NCT00917644|75836242|FG001|NOT COMPLETED|Period: Washout Period of > = 2 Weeks||0||
59717229|NCT00917644|75836241|FG000|STARTED|Period 2: Second Intervention|Washout: Test drug 1st, completed = 37; 2nd period: Test drug 2nd, completed = 37.|37||
60118602|NCT01682837|76239564|FG000|Received KCit|Third Intervention (4 Weeks)||7||
60118603|NCT01682837|76239564|FG000|Received KCl|Third Intervention (4 Weeks)||7||
60118604|NCT01682837|76239564|FG000|Received Placebo|Third Intervention (4 Weeks)||7||
59832674|NCT00521339|75956219|FG002|COMPLETED|Treatment Extension Phase||4||
59832675|NCT00521339|75956217|FG000|NOT COMPLETED|Treatment Extension Phase||0||
59832676|NCT00521339|75956218|FG001|NOT COMPLETED|Treatment Extension Phase||0||
59832677|NCT00521339|75956219|FG002|NOT COMPLETED|Treatment Extension Phase||3||
59832678|NCT00521339|75956217|FG000|STARTED|Observational Follow Up Phase||14||
59832679|NCT00521339|75956218|FG001|STARTED|Observational Follow Up Phase||4||
59832680|NCT00521339|75956219|FG002|STARTED|Observational Follow Up Phase||4||
59832681|NCT00521339|75956217|FG000|COMPLETED|Observational Follow Up Phase||14||
59832682|NCT00521339|75956218|FG001|COMPLETED|Observational Follow Up Phase||4||
59832683|NCT00521339|75956219|FG002|COMPLETED|Observational Follow Up Phase||4||
60118605|NCT01682837|76239564|FG000|COMPLETED|Third Intervention (4 Weeks)||30||
59567495|NCT02326272|75670458|FG005|Completed Week 16|Initial Period (Week 0 to Week 16)||0||
59567496|NCT02326272|75670459|FG006|Completed Week 16|Initial Period (Week 0 to Week 16)||0||
59567497|NCT02326272|75670460|FG007|Completed Week 16|Initial Period (Week 0 to Week 16)||0||
59717230|NCT00917644|75836242|FG001|STARTED|Period 2: Second Intervention|Washout: Reference drug (Ref) 1st, completed = 37; 2nd period: Ref drug 2nd, completed = 36.|37||
59717231|NCT00917644|75836241|FG000|COMPLETED|Period 2: Second Intervention|Total number of subjects completed Test drug = 74.|36||
59717232|NCT00917644|75836242|FG001|COMPLETED|Period 2: Second Intervention|Total number of subjects completed Ref drug = 73.|37||
59717233|NCT00917644|75836241|FG000|NOT COMPLETED|Period 2: Second Intervention||1||
59717234|NCT00917644|75836242|FG001|NOT COMPLETED|Period 2: Second Intervention||0||
59717235|NCT01137786|75836250|FG000|STARTED|Overall Study||25||
59717236|NCT01137786|75836251|FG001|STARTED|Overall Study||24||
59717237|NCT01137786|75836250|FG000|COMPLETED|Overall Study||24||
59832684|NCT00521339|75956217|FG000|NOT COMPLETED|Observational Follow Up Phase||0||
59832685|NCT00521339|75956218|FG001|NOT COMPLETED|Observational Follow Up Phase||0||
59832686|NCT00521339|75956219|FG002|NOT COMPLETED|Observational Follow Up Phase||0||
59832687|NCT00363896|75956242|FG000|STARTED|Overall Study||627||
59832688|NCT00363896|75956243|FG001|STARTED|Overall Study||216||
60118606|NCT01682837|76239564|FG000|NOT COMPLETED|Third Intervention (4 Weeks)||0||
60118607|NCT01682837|76239564|FG000|STARTED|Fourth Intervention (4 Weeks)||30||
60118608|NCT01682837|76239564|FG000|Received KMgCit|Fourth Intervention (4 Weeks)||6||
60118609|NCT01682837|76239564|FG000|Received KCit|Fourth Intervention (4 Weeks)||9||
60118610|NCT01682837|76239564|FG000|Received KCl|Fourth Intervention (4 Weeks)||8||
59832689|NCT00363896|75956242|FG000|COMPLETED|Overall Study||538||
59832690|NCT00363896|75956243|FG001|COMPLETED|Overall Study||169||
60118611|NCT01682837|76239564|FG000|Received Placebo|Fourth Intervention (4 Weeks)||7||
60118612|NCT01682837|76239564|FG000|COMPLETED|Fourth Intervention (4 Weeks)||30||
60118613|NCT01682837|76239564|FG000|NOT COMPLETED|Fourth Intervention (4 Weeks)||0||
60118614|NCT02213068|76239577|FG000|STARTED|Overall Study||9||
60118615|NCT02213068|76239578|FG001|STARTED|Overall Study||8||
60118616|NCT02213068|76239579|FG002|STARTED|Overall Study||10||
60118617|NCT02213068|76239577|FG000|COMPLETED|Overall Study||9||
60118618|NCT02213068|76239578|FG001|COMPLETED|Overall Study||8||
60118619|NCT02213068|76239579|FG002|COMPLETED|Overall Study||10||
60118620|NCT02213068|76239577|FG000|NOT COMPLETED|Overall Study||0||
60118621|NCT02213068|76239578|FG001|NOT COMPLETED|Overall Study||0||
60118622|NCT02213068|76239579|FG002|NOT COMPLETED|Overall Study||0||
60118623|NCT00702234|76239587|FG000|STARTED|Base Study (NCT00696878)||682||
60118624|NCT00702234|76239588|FG001|STARTED|Base Study (NCT00696878)||0||
60118625|NCT00702234|76239587|FG000|COMPLETED|Base Study (NCT00696878)||178||
60118626|NCT00702234|76239588|FG001|COMPLETED|Base Study (NCT00696878)||0||
59832691|NCT00363896|75956242|FG000|NOT COMPLETED|Overall Study||89||
59832692|NCT00363896|75956243|FG001|NOT COMPLETED|Overall Study||47||
59832693|NCT00527423|75956252|FG000|STARTED|Overall Study||157||
59832694|NCT00527423|75956252|FG000|COMPLETED|Overall Study||120||
59832695|NCT00527423|75956252|FG000|NOT COMPLETED|Overall Study||37||
59832696|NCT00527111|75956260|FG000|STARTED|Overall Study||70||
59832697|NCT00527111|75956261|FG001|STARTED|Overall Study||69||
59832698|NCT00527111|75956260|FG000|COMPLETED|Overall Study||50||
59832699|NCT00527111|75956261|FG001|COMPLETED|Overall Study||47||
59832700|NCT00527111|75956260|FG000|NOT COMPLETED|Overall Study||20||
59832701|NCT00527111|75956261|FG001|NOT COMPLETED|Overall Study||22||
59832702|NCT00384956|75956267|FG000|STARTED|Overall Study||25||
59832703|NCT00384956|75956267|FG000|COMPLETED|Overall Study||22||
59832704|NCT00384956|75956267|FG000|NOT COMPLETED|Overall Study||3||
59832705|NCT00367640|75956275|FG000|STARTED|Overall Study||157||
59832706|NCT00367640|75956276|FG001|STARTED|Overall Study||155||
59832707|NCT00367640|75956277|FG002|STARTED|Overall Study||160||
59832708|NCT00367640|75956278|FG003|STARTED|Overall Study||156||
59832709|NCT00367640|75956275|FG000|COMPLETED|Overall Study||139||
59832710|NCT00367640|75956276|FG001|COMPLETED|Overall Study||133||
59832711|NCT00367640|75956277|FG002|COMPLETED|Overall Study||141||
59832712|NCT00367640|75956278|FG003|COMPLETED|Overall Study||146||
59832713|NCT00367640|75956275|FG000|NOT COMPLETED|Overall Study||18||
59832714|NCT00367640|75956276|FG001|NOT COMPLETED|Overall Study||22||
59832715|NCT00367640|75956277|FG002|NOT COMPLETED|Overall Study||19||
59832716|NCT00367640|75956278|FG003|NOT COMPLETED|Overall Study||10||
59832717|NCT00367484|75956288|FG000|STARTED|Overall Study||460||
59832718|NCT00367484|75956288|FG000|COMPLETED|Overall Study|Safety population = 460 Intent To Treat (ITT) population = 458|443||
59832719|NCT00367484|75956288|FG000|NOT COMPLETED|Overall Study||17||
59832720|NCT00526799|75956294|FG000|STARTED|Overall Study||16||
59832721|NCT00526799|75956295|FG001|STARTED|Overall Study||14||
59832722|NCT00526799|75956294|FG000|COMPLETED|Overall Study||15||
59832723|NCT00526799|75956295|FG001|COMPLETED|Overall Study||13||
59832724|NCT00526799|75956294|FG000|NOT COMPLETED|Overall Study||1||
59832725|NCT00526799|75956295|FG001|NOT COMPLETED|Overall Study||1||
59832726|NCT00526331|75956301|FG000|STARTED|Overall Study||55||
59832727|NCT00526331|75956301|FG000|COMPLETED|Overall Study||0||
59832728|NCT00526331|75956301|FG000|NOT COMPLETED|Overall Study||55||
59832729|NCT00520481|75956307|FG000|STARTED|Overall Study||31||
59832730|NCT00520481|75956308|FG001|STARTED|Overall Study||10||
59832731|NCT00520481|75956307|FG000|Received at Least 1 Dose of Study Drug|Overall Study||31||
59832732|NCT00520481|75956308|FG001|Received at Least 1 Dose of Study Drug|Overall Study||10||
59832733|NCT00520481|75956307|FG000|COMPLETED|Overall Study||24||
59832734|NCT00520481|75956308|FG001|COMPLETED|Overall Study||9||
59832735|NCT00520481|75956307|FG000|NOT COMPLETED|Overall Study||7||
59832736|NCT00520481|75956308|FG001|NOT COMPLETED|Overall Study||1||
59832737|NCT00520403|75956316|FG000|STARTED|Bevacizumab + IFN/Vinblastine||25||
59832738|NCT00520403|75956316|FG000|COMPLETED|Bevacizumab + IFN/Vinblastine||7||
59832739|NCT00520403|75956316|FG000|NOT COMPLETED|Bevacizumab + IFN/Vinblastine||18||
59832740|NCT00520403|75956316|FG000|STARTED|Bevacizumab Monotherapy|2 of 7 participants completing Bevacizumab+IFN/vinblastine cycles initiated bevacizumab monotherapy|2||
59832741|NCT00520403|75956316|FG000|COMPLETED|Bevacizumab Monotherapy||0||
59832742|NCT00520403|75956316|FG000|NOT COMPLETED|Bevacizumab Monotherapy||2||
59832743|NCT00520013|75956323|FG000|STARTED|Overall Study||23||
59832744|NCT00520013|75956324|FG001|STARTED|Overall Study||25||
59832745|NCT00520013|75956325|FG002|STARTED|Overall Study|Excludes a pt who went off-study (on reg day) due to consent that may not have been informed (ESL).|11||
59832746|NCT00520013|75956323|FG000|Treated|Overall Study||23||
59832747|NCT00520013|75956324|FG001|Treated|Overall Study||25||
59832748|NCT00520013|75956325|FG002|Treated|Overall Study||11||
59832749|NCT00520013|75956323|FG000|COMPLETED|Overall Study||11||
59832750|NCT00520013|75956324|FG001|COMPLETED|Overall Study||10||
59832751|NCT00520013|75956325|FG002|COMPLETED|Overall Study||0||
59832752|NCT00520013|75956323|FG000|NOT COMPLETED|Overall Study||12||
59832753|NCT00520013|75956324|FG001|NOT COMPLETED|Overall Study||15||
59832754|NCT00520013|75956325|FG002|NOT COMPLETED|Overall Study||11||
59832755|NCT00519779|75956333|FG000|STARTED|Overall Study||34||
59832756|NCT00519779|75956334|FG001|STARTED|Overall Study||34||
59832757|NCT00519779|75956333|FG000|COMPLETED|Overall Study||34||
59832758|NCT00519779|75956334|FG001|COMPLETED|Overall Study||33||
59832759|NCT00519779|75956333|FG000|NOT COMPLETED|Overall Study||0||
59832760|NCT00519779|75956334|FG001|NOT COMPLETED|Overall Study||1||
59832761|NCT00526097|75956342|FG000|STARTED|Overall Study|Started: Participant was randomised and took at least one dose of randomised study medication|121||
59832762|NCT00526097|75956343|FG001|STARTED|Overall Study|Started: Participant was randomised and took at least one dose of randomised study medication|247||
59832763|NCT00526097|75956342|FG000|COMPLETED|Overall Study|Completed: Participant without premature discontinuation in the randomised treatment period|106||
59832764|NCT00526097|75956343|FG001|COMPLETED|Overall Study|Completed: Participant without premature discontinuation in the randomised treatment period|191||
59832765|NCT00526097|75956342|FG000|NOT COMPLETED|Overall Study||15||
59832766|NCT00526097|75956343|FG001|NOT COMPLETED|Overall Study||56||
59832767|NCT00525785|75956349|FG000|STARTED|Overall Study||58||
59832768|NCT00525785|75956349|FG000|COMPLETED|Overall Study||55||
59832769|NCT00525785|75956349|FG000|NOT COMPLETED|Overall Study||3||
59832770|NCT00525161|75956353|FG000|STARTED|Overall Study||11||
59832771|NCT00525161|75956353|FG000|COMPLETED|Overall Study||10||
59832772|NCT00525161|75956353|FG000|NOT COMPLETED|Overall Study||1||
59832773|NCT00524771|75956359|FG000|STARTED|Overall Study||17084||
59832774|NCT00524771|75956360|FG001|STARTED|Overall Study||17016||
59832775|NCT00524771|75956359|FG000|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 0.5 and 4.0 years.|16864||
59832776|NCT00524771|75956360|FG001|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 0.5 and 4.0 years.|16431||
59832777|NCT00524771|75956359|FG000|NOT COMPLETED|Overall Study||220||
59832778|NCT00524771|75956360|FG001|NOT COMPLETED|Overall Study||585||
59832779|NCT00135694|75956370|FG000|STARTED|Overall Study||180||
59832780|NCT00135694|75956371|FG001|STARTED|Overall Study||77||
59832781|NCT00135694|75956372|FG002|STARTED|Overall Study||18||
59832782|NCT00135694|75956370|FG000|COMPLETED|Overall Study|Subjects were assessed as ineligible for random assignment and subsequently terminated per protocol.|0||
59832783|NCT00135694|75956371|FG001|COMPLETED|Overall Study||56||
59832784|NCT00135694|75956372|FG002|COMPLETED|Overall Study||11||
59832785|NCT00135694|75956370|FG000|NOT COMPLETED|Overall Study||180||
59832786|NCT00135694|75956371|FG001|NOT COMPLETED|Overall Study||21||
59832787|NCT00135694|75956372|FG002|NOT COMPLETED|Overall Study||7||
59832788|NCT00524459|75956380|FG000|STARTED|Overall Study||6||
59832789|NCT00524459|75956380|FG000|COMPLETED|Overall Study||4||
59832790|NCT00524459|75956380|FG000|NOT COMPLETED|Overall Study||2||
59832791|NCT00519623|75956384|FG000|STARTED|Overall Study||9||
59832792|NCT00519623|75956384|FG000|COMPLETED|Overall Study||8||
59832793|NCT00519623|75956384|FG000|NOT COMPLETED|Overall Study||1||
59832794|NCT00519077|75956388|FG000|STARTED|Overall Study||44||
59832795|NCT00519077|75956388|FG000|COMPLETED|Overall Study||36||
59832796|NCT00519077|75956388|FG000|NOT COMPLETED|Overall Study||8||
59832797|NCT00124618|75956392|FG000|STARTED|Overall Study||58||
59832798|NCT00124618|75956392|FG000|COMPLETED|Overall Study||57||
59832799|NCT00124618|75956392|FG000|NOT COMPLETED|Overall Study||1||
59832800|NCT00124462|75956398|FG000|STARTED|Overall Study||40||
59832801|NCT00124462|75956399|FG001|STARTED|Overall Study||40||
59832802|NCT00124462|75956398|FG000|COMPLETED|Overall Study||29||
59832803|NCT00124462|75956399|FG001|COMPLETED|Overall Study||27||
59832804|NCT00124462|75956398|FG000|NOT COMPLETED|Overall Study||11||
59832805|NCT00124462|75956399|FG001|NOT COMPLETED|Overall Study||13||
59832806|NCT00124072|75956409|FG000|STARTED|Overall Study||3017||
59832807|NCT00124072|75956410|FG001|STARTED|Overall Study||3016||
59832808|NCT00124072|75956411|FG002|STARTED|Overall Study||3016||
59832809|NCT00124072|75956412|FG003|STARTED|Overall Study||3015||
59832810|NCT00124072|75956409|FG000|COMPLETED|Overall Study||2503||
59832811|NCT00124072|75956410|FG001|COMPLETED|Overall Study||2504||
59832812|NCT00124072|75956411|FG002|COMPLETED|Overall Study||2524||
59832813|NCT00124072|75956412|FG003|COMPLETED|Overall Study||2515||
59832814|NCT00124072|75956409|FG000|NOT COMPLETED|Overall Study||514||
59832815|NCT00124072|75956410|FG001|NOT COMPLETED|Overall Study||512||
59832816|NCT00124072|75956411|FG002|NOT COMPLETED|Overall Study||492||
59832817|NCT00124072|75956412|FG003|NOT COMPLETED|Overall Study||500||
59832818|NCT00362648|75956426|FG000|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|2733||
59832819|NCT00362648|75956427|FG001|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|2735||
59832820|NCT00362648|75956428|FG002|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|1018||
59832821|NCT00362648|75956429|FG003|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|1018||
59832822|NCT00362648|75956426|FG000|Vaccinated at Visit 1|Overall Study||2733||
59832823|NCT00362648|75956427|FG001|Vaccinated at Visit 1|Overall Study||2735||
59832824|NCT00362648|75956428|FG002|Vaccinated at Visit 1|Overall Study||1018||
59832825|NCT00362648|75956429|FG003|Vaccinated at Visit 1|Overall Study||1018||
60118627|NCT00702234|76239587|FG000|NOT COMPLETED|Base Study (NCT00696878)||504||
60118628|NCT00702234|76239588|FG001|NOT COMPLETED|Base Study (NCT00696878)||0||
60118629|NCT00702234|76239587|FG000|STARTED|Follow-up Study: Expectant Mothers|"A participant could enter follow-up study without meeting definition for Completion of base study"|268||
59832826|NCT00362648|75956426|FG000|Vaccinated at Visit 2|Overall Study||2657||
59832827|NCT00362648|75956427|FG001|Vaccinated at Visit 2|Overall Study||2666||
59832828|NCT00362648|75956428|FG002|Vaccinated at Visit 2|Overall Study||1013||
59832829|NCT00362648|75956429|FG003|Vaccinated at Visit 2|Overall Study||1009||
59832830|NCT00362648|75956426|FG000|Vaccinated at Visit 3|Overall Study||2613||
59832831|NCT00362648|75956427|FG001|Vaccinated at Visit 3|Overall Study||2612||
59832832|NCT00362648|75956428|FG002|Vaccinated at Visit 3|Overall Study||1009||
59832833|NCT00362648|75956429|FG003|Vaccinated at Visit 3|Overall Study||1007||
59832834|NCT00362648|75956426|FG000|COMPLETED|Overall Study|Subjects vaccinated and followed up to 14 days after each dose|2607||
59832835|NCT00362648|75956427|FG001|COMPLETED|Overall Study|Subjects vaccinated and followed up to 14 days after each dose|2601||
59832836|NCT00362648|75956428|FG002|COMPLETED|Overall Study|Subjects vaccinated and followed up to 14 days after each dose|1009||
59832837|NCT00362648|75956429|FG003|COMPLETED|Overall Study|Subjects vaccinated and followed up to 14 days after each dose|1007||
59832838|NCT00362648|75956426|FG000|NOT COMPLETED|Overall Study||126||
59832839|NCT00362648|75956427|FG001|NOT COMPLETED|Overall Study||134||
59832840|NCT00362648|75956428|FG002|NOT COMPLETED|Overall Study||9||
59832841|NCT00362648|75956429|FG003|NOT COMPLETED|Overall Study||11||
59832842|NCT00524303|75956446|FG000|STARTED|Overall Study||33||
59832843|NCT00524303|75956447|FG001|STARTED|Overall Study||34||
59832844|NCT00524303|75956448|FG002|STARTED|Overall Study||33||
59832845|NCT00524303|75956446|FG000|COMPLETED|Overall Study||21||
59832846|NCT00524303|75956447|FG001|COMPLETED|Overall Study||24||
59832847|NCT00524303|75956448|FG002|COMPLETED|Overall Study||15||
59832848|NCT00524303|75956446|FG000|NOT COMPLETED|Overall Study||12||
59832849|NCT00524303|75956447|FG001|NOT COMPLETED|Overall Study||10||
59832850|NCT00524303|75956448|FG002|NOT COMPLETED|Overall Study||18||
59832851|NCT00335556|75956465|FG000|STARTED|Overall Study||68||
59832852|NCT00335556|75956466|FG001|STARTED|Overall Study||98||
59832853|NCT00335556|75956467|FG002|STARTED|Overall Study||7||
59832854|NCT00335556|75956468|FG003|STARTED|Overall Study||10||
59832855|NCT00335556|75956469|FG004|STARTED|Overall Study||78||
59832856|NCT00335556|75956470|FG005|STARTED|Overall Study||30||
59832857|NCT00335556|75956465|FG000|COMPLETED|Overall Study||66||
59832858|NCT00335556|75956466|FG001|COMPLETED|Overall Study||64||
59832859|NCT00335556|75956467|FG002|COMPLETED|Overall Study||2||
59832860|NCT00335556|75956468|FG003|COMPLETED|Overall Study||5||
59832861|NCT00335556|75956469|FG004|COMPLETED|Overall Study||77||
59832862|NCT00335556|75956470|FG005|COMPLETED|Overall Study||29||
59832863|NCT00335556|75956465|FG000|NOT COMPLETED|Overall Study||2||
59832864|NCT00335556|75956466|FG001|NOT COMPLETED|Overall Study||34||
59832865|NCT00335556|75956467|FG002|NOT COMPLETED|Overall Study||5||
59832866|NCT00335556|75956468|FG003|NOT COMPLETED|Overall Study||5||
59832867|NCT00335556|75956469|FG004|NOT COMPLETED|Overall Study||1||
59832868|NCT00335556|75956470|FG005|NOT COMPLETED|Overall Study||1||
59832869|NCT00518687|75956491|FG000|STARTED|Overall Study|An additional 10 participants were not analyzed because of questionable clinical practices at 1 site|4005||
59832870|NCT00518687|75956492|FG001|STARTED|Overall Study|An additional 11 participants were not analyzed because of questionable clinical practices at 1 site|4005||
59832871|NCT00518687|75956491|FG000|Vaccinated|Overall Study||3981||
59832872|NCT00518687|75956492|FG001|Vaccinated|Overall Study||3982||
59832873|NCT00518687|75956491|FG000|COMPLETED|Overall Study||2568||
59717238|NCT01137786|75836251|FG001|COMPLETED|Overall Study||21||
59717239|NCT01137786|75836250|FG000|NOT COMPLETED|Overall Study||1||
59832874|NCT00518687|75956492|FG001|COMPLETED|Overall Study||2585||
59832875|NCT00518687|75956491|FG000|NOT COMPLETED|Overall Study||1437||
59832876|NCT00518687|75956492|FG001|NOT COMPLETED|Overall Study||1420||
59832877|NCT00134056|75956500|FG000|STARTED|Randomization||518||
59832878|NCT00134056|75956501|FG001|STARTED|Randomization||520||
59832879|NCT00134056|75956500|FG000|COMPLETED|Randomization||496||
59832880|NCT00134056|75956501|FG001|COMPLETED|Randomization||500||
59832881|NCT00134056|75956500|FG000|NOT COMPLETED|Randomization||22||
59832882|NCT00134056|75956501|FG001|NOT COMPLETED|Randomization||20||
59832883|NCT00134056|75956500|FG000|STARTED|Eligible for Protocol Assigned Treatment||496||
59832884|NCT00134056|75956501|FG001|STARTED|Eligible for Protocol Assigned Treatment||500||
59832885|NCT00134056|75956500|FG000|COMPLETED|Eligible for Protocol Assigned Treatment||169||
59832886|NCT00134056|75956501|FG001|COMPLETED|Eligible for Protocol Assigned Treatment||185||
59832887|NCT00134056|75956500|FG000|NOT COMPLETED|Eligible for Protocol Assigned Treatment||327||
59832888|NCT00134056|75956501|FG001|NOT COMPLETED|Eligible for Protocol Assigned Treatment||315||
59832889|NCT00518531|75956512|FG000|STARTED|Treatment Period 1||124||
59832890|NCT00518531|75956513|FG001|STARTED|Treatment Period 1||126||
59832891|NCT00518531|75956512|FG000|Received Treatment|Treatment Period 1||119||
59832892|NCT00518531|75956513|FG001|Received Treatment|Treatment Period 1||124||
59832893|NCT00518531|75956512|FG000|COMPLETED|Treatment Period 1||106||
59832894|NCT00518531|75956513|FG001|COMPLETED|Treatment Period 1|Participants who completed Treatment Period 1 may choose not to start Treatment Period 2|114||
59832895|NCT00518531|75956512|FG000|NOT COMPLETED|Treatment Period 1||18||
59717240|NCT01137786|75836251|FG001|NOT COMPLETED|Overall Study||3||
59717241|NCT00599755|75836259|FG000|STARTED|Overall Study||68||
59717242|NCT00599755|75836259|FG000|COMPLETED|Overall Study||49||
59717243|NCT00599755|75836259|FG000|NOT COMPLETED|Overall Study||19||
59717244|NCT00600613|75836263|FG000|STARTED|Overall Study||6||
59832896|NCT00518531|75956513|FG001|NOT COMPLETED|Treatment Period 1||12||
59717245|NCT00600613|75836263|FG000|COMPLETED|Overall Study||5||
59717246|NCT00600613|75836263|FG000|NOT COMPLETED|Overall Study||1||
59832897|NCT00518531|75956512|FG000|STARTED|Treatment Period 2||106||
59832898|NCT00518531|75956513|FG001|STARTED|Treatment Period 2|Participants can start Treatment Period 2 without completing Treatment Period 1.|115||
59832899|NCT00518531|75956512|FG000|Received Treatment|Treatment Period 2||106||
59832900|NCT00518531|75956513|FG001|Received Treatment|Treatment Period 2||110||
59832901|NCT00518531|75956512|FG000|COMPLETED|Treatment Period 2||103||
59832902|NCT00518531|75956513|FG001|COMPLETED|Treatment Period 2||95||
59717247|NCT01125930|75836269|FG000|STARTED|Overall Study||22||
59717248|NCT01125930|75836270|FG001|STARTED|Overall Study||46||
59717249|NCT01125930|75836269|FG000|COMPLETED|Overall Study||21||
59832903|NCT00518531|75956512|FG000|NOT COMPLETED|Treatment Period 2||3||
59832904|NCT00518531|75956513|FG001|NOT COMPLETED|Treatment Period 2||20||
59832905|NCT00351468|75956521|FG000|STARTED|Overall Study||302||
59832906|NCT00351468|75956521|FG000|Subjects From TRA100773A|Overall Study||51||
59832907|NCT00351468|75956521|FG000|Subjects From TRA100773B|Overall Study||61||
59832908|NCT00351468|75956521|FG000|Subjects From TRA102537 Raise|Overall Study||146||
59832909|NCT00351468|75956521|FG000|Subjects From TRA108057 Repeat|Overall Study||43||
59832910|NCT00351468|75956521|FG000|Unknown - Not From Previous Trial|Overall Study|Mistakenly enrolled (not in any of the 3 trials) On 50 mg/d eltrombopag for 18 days and withdrawn|1||
59832911|NCT00351468|75956521|FG000|COMPLETED|Overall Study||135||
59832912|NCT00351468|75956521|FG000|NOT COMPLETED|Overall Study||167||
59832913|NCT00523991|75956528|FG000|STARTED|Overall Study||219||
59832914|NCT00523991|75956529|FG001|STARTED|Overall Study||238||
59832915|NCT00523991|75956528|FG000|COMPLETED|Overall Study||198||
59832916|NCT00523991|75956529|FG001|COMPLETED|Overall Study||211||
59832917|NCT00523991|75956528|FG000|NOT COMPLETED|Overall Study||21||
59832918|NCT00523991|75956529|FG001|NOT COMPLETED|Overall Study||27||
59832919|NCT00350844|75956535|FG000|STARTED|Overall Study||6||
59832920|NCT00350844|75956535|FG000|COMPLETED|Overall Study||5||
59832921|NCT00350844|75956535|FG000|NOT COMPLETED|Overall Study||1||
59832922|NCT00345540|75956539|FG000|STARTED|Overall Study|1 subject enrolled but not treated (off-trial for patient discretion)|16||
59832923|NCT00345540|75956539|FG000|COMPLETED|Overall Study||15||
59832924|NCT00345540|75956539|FG000|NOT COMPLETED|Overall Study||1||
59832925|NCT00335322|75956546|FG000|STARTED|Overall Study||115||
59832926|NCT00335322|75956547|FG001|STARTED|Overall Study||107||
59832927|NCT00335322|75956548|FG002|STARTED|Overall Study||105||
59832928|NCT00335322|75956546|FG000|COMPLETED|Overall Study||114||
59832929|NCT00335322|75956547|FG001|COMPLETED|Overall Study||105||
59832930|NCT00335322|75956548|FG002|COMPLETED|Overall Study||103||
59832931|NCT00335322|75956546|FG000|NOT COMPLETED|Overall Study||1||
59832932|NCT00335322|75956547|FG001|NOT COMPLETED|Overall Study||2||
59832933|NCT00335322|75956548|FG002|NOT COMPLETED|Overall Study||2||
59832934|NCT00523367|75956559|FG000|STARTED|Overall Study||25||
59832935|NCT00523367|75956559|FG000|COMPLETED|Overall Study||2||
59832936|NCT00523367|75956559|FG000|NOT COMPLETED|Overall Study||23||
59832937|NCT03755765|75956566|FG000|STARTED|Overall Study||20||
59832938|NCT03755765|75956567|FG001|STARTED|Overall Study||42||
59832939|NCT03755765|75956568|FG002|STARTED|Overall Study||4||
59832940|NCT03755765|75956566|FG000|COMPLETED|Overall Study||18||
59832941|NCT03755765|75956567|FG001|COMPLETED|Overall Study||38||
59832942|NCT03755765|75956568|FG002|COMPLETED|Overall Study||0||
59832943|NCT03755765|75956566|FG000|NOT COMPLETED|Overall Study||2||
59832944|NCT03755765|75956567|FG001|NOT COMPLETED|Overall Study||4||
59832945|NCT03755765|75956568|FG002|NOT COMPLETED|Overall Study||4||
59832946|NCT00344448|75956576|FG000|STARTED|Screening|No randomization during the screening phase|6||
59832947|NCT00344448|75956577|FG001|STARTED|Screening||4||
59832948|NCT00344448|75956576|FG000|COMPLETED|Screening||6||
59832949|NCT00344448|75956577|FG001|COMPLETED|Screening||3||
59832950|NCT00344448|75956576|FG000|NOT COMPLETED|Screening||0||
59832951|NCT00344448|75956577|FG001|NOT COMPLETED|Screening||1||
59832952|NCT00344448|75956576|FG000|STARTED|Double Blind, Placebo Controlled||6||
59832953|NCT00344448|75956577|FG001|STARTED|Double Blind, Placebo Controlled||3||
59832954|NCT00344448|75956576|FG000|COMPLETED|Double Blind, Placebo Controlled||4||
59832955|NCT00344448|75956577|FG001|COMPLETED|Double Blind, Placebo Controlled||3||
59832956|NCT00344448|75956576|FG000|NOT COMPLETED|Double Blind, Placebo Controlled||2||
59832957|NCT00344448|75956577|FG001|NOT COMPLETED|Double Blind, Placebo Controlled||0||
59832958|NCT00344448|75956576|FG000|STARTED|Open Label||4||
59832959|NCT00344448|75956577|FG001|STARTED|Open Label||3||
59832960|NCT00344448|75956576|FG000|COMPLETED|Open Label||2||
59832961|NCT00344448|75956577|FG001|COMPLETED|Open Label||2||
59832962|NCT00344448|75956576|FG000|NOT COMPLETED|Open Label||2||
59832963|NCT00344448|75956577|FG001|NOT COMPLETED|Open Label||1||
59832964|NCT00324168|75956585|FG000|STARTED|Overall Study||250||
59832965|NCT00324168|75956586|FG001|STARTED|Overall Study||250||
59567498|NCT02326272|75670461|FG008|Completed Week 16|Initial Period (Week 0 to Week 16)||0||
59717250|NCT01125930|75836270|FG001|COMPLETED|Overall Study||36||
59832966|NCT00324168|75956585|FG000|COMPLETED|Overall Study||222||
59567499|NCT02326272|75670462|FG009|Completed Week 16|Initial Period (Week 0 to Week 16)||0||
59717251|NCT01125930|75836269|FG000|NOT COMPLETED|Overall Study||1||
59717252|NCT01125930|75836270|FG001|NOT COMPLETED|Overall Study||10||
59717253|NCT04015219|75836294|FG000|STARTED|Overall Study||2||
59717254|NCT04015219|75836295|FG001|STARTED|Overall Study||1||
59717255|NCT04015219|75836294|FG000|COMPLETED|Overall Study||2||
59717256|NCT04015219|75836295|FG001|COMPLETED|Overall Study||1||
59832967|NCT00324168|75956586|FG001|COMPLETED|Overall Study||220||
59832968|NCT00324168|75956585|FG000|NOT COMPLETED|Overall Study||28||
59832969|NCT00324168|75956586|FG001|NOT COMPLETED|Overall Study||30||
59717257|NCT04015219|75836294|FG000|NOT COMPLETED|Overall Study||0||
59717258|NCT04015219|75836295|FG001|NOT COMPLETED|Overall Study||0||
59717259|NCT00918346|75836301|FG000|STARTED|First Treatment Period (4 Weeks)||21||
59717260|NCT00918346|75836302|FG001|STARTED|First Treatment Period (4 Weeks)||22||
59717261|NCT00918346|75836301|FG000|COMPLETED|First Treatment Period (4 Weeks)||21||
59832970|NCT00517829|75956594|FG000|STARTED|Overall Study||75||
59832971|NCT00517829|75956595|FG001|STARTED|Overall Study||75||
59832972|NCT00517829|75956594|FG000|COMPLETED|Overall Study||0||
59832973|NCT00517829|75956595|FG001|COMPLETED|Overall Study||0||
59832974|NCT00517829|75956594|FG000|NOT COMPLETED|Overall Study||75||
59832975|NCT00517829|75956595|FG001|NOT COMPLETED|Overall Study||75||
59832976|NCT00343512|75956601|FG000|STARTED|Overall Study||34||
59832977|NCT00343512|75956601|FG000|COMPLETED|Overall Study||32||
59832978|NCT00343512|75956601|FG000|NOT COMPLETED|Overall Study||2||
59717262|NCT00918346|75836302|FG001|COMPLETED|First Treatment Period (4 Weeks)|A patient completed the first treatment period but discontinued thereafter (did not start washout).|21||
59717263|NCT00918346|75836301|FG000|NOT COMPLETED|First Treatment Period (4 Weeks)||0||
59717264|NCT00918346|75836302|FG001|NOT COMPLETED|First Treatment Period (4 Weeks)||1||
59717265|NCT00918346|75836301|FG000|STARTED|Washout (at Least 4 Weeks)||21||
59717266|NCT00918346|75836302|FG001|STARTED|Washout (at Least 4 Weeks)||21||
59717267|NCT00918346|75836301|FG000|COMPLETED|Washout (at Least 4 Weeks)||21||
59717268|NCT00918346|75836302|FG001|COMPLETED|Washout (at Least 4 Weeks)||21||
59717269|NCT00918346|75836301|FG000|NOT COMPLETED|Washout (at Least 4 Weeks)||0||
59717270|NCT00918346|75836302|FG001|NOT COMPLETED|Washout (at Least 4 Weeks)||0||
59717271|NCT00918346|75836301|FG000|STARTED|Second Treatment Period (4 Weeks)||21||
59717272|NCT00918346|75836302|FG001|STARTED|Second Treatment Period (4 Weeks)||21||
59832979|NCT00334542|75956606|FG000|STARTED|Overall Study||50||
59832980|NCT00334542|75956606|FG000|COMPLETED|Overall Study||45||
59832981|NCT00334542|75956606|FG000|NOT COMPLETED|Overall Study||5||
59832982|NCT00112294|75956613|FG000|STARTED|Overall Study|338 randomized and 325 treated.|325||
59832983|NCT00112294|75956614|FG001|STARTED|Overall Study|338 randomized and 320 treated.|320||
59832984|NCT00112294|75956613|FG000|Never Treated|Overall Study|Number by randomized group = 11, but 2 participants received C/T/C instead of T/C.|13||
59832985|NCT00112294|75956614|FG001|Never Treated|Overall Study|Number by randomized group = 20, but 2 participants received C/T/C instead of T/C.|18||
59832986|NCT00112294|75956613|FG000|COMPLETED|Overall Study|Off all study therapies.|320||
59832987|NCT00112294|75956614|FG001|COMPLETED|Overall Study|Off all study therapies.|320||
60118630|NCT00702234|76239588|FG001|STARTED|Follow-up Study: Expectant Mothers||0||
60118631|NCT00702234|76239587|FG000|COMPLETED|Follow-up Study: Expectant Mothers||246||
59832988|NCT00112294|75956613|FG000|NOT COMPLETED|Overall Study||5||
59832989|NCT00112294|75956614|FG001|NOT COMPLETED|Overall Study||0||
59832990|NCT00235443|75956626|FG000|STARTED|Overall Study||11||
59832991|NCT00235443|75956627|FG001|STARTED|Overall Study||57||
59832992|NCT00235443|75956628|FG002|STARTED|Overall Study||85||
59832993|NCT00235443|75956629|FG003|STARTED|Overall Study||205||
59832994|NCT00235443|75956630|FG004|STARTED|Overall Study||39||
59832995|NCT00235443|75956631|FG005|STARTED|Overall Study||54||
59832996|NCT00235443|75956626|FG000|COMPLETED|Overall Study||3||
59832997|NCT00235443|75956627|FG001|COMPLETED|Overall Study||19||
59832998|NCT00235443|75956628|FG002|COMPLETED|Overall Study||23||
59832999|NCT00235443|75956629|FG003|COMPLETED|Overall Study||108||
59833000|NCT00235443|75956630|FG004|COMPLETED|Overall Study||9||
59833001|NCT00235443|75956631|FG005|COMPLETED|Overall Study||9||
59833002|NCT00235443|75956626|FG000|NOT COMPLETED|Overall Study||8||
59833003|NCT00235443|75956627|FG001|NOT COMPLETED|Overall Study||38||
59833004|NCT00235443|75956628|FG002|NOT COMPLETED|Overall Study||62||
59833005|NCT00235443|75956629|FG003|NOT COMPLETED|Overall Study||97||
59833006|NCT00235443|75956630|FG004|NOT COMPLETED|Overall Study||30||
59833007|NCT00235443|75956631|FG005|NOT COMPLETED|Overall Study||45||
59833008|NCT00234039|75956647|FG000|STARTED|Overall Study||58||
59833009|NCT00234039|75956647|FG000|Eligible|Overall Study||49||
59833010|NCT00234039|75956647|FG000|Eligible and Began Protocol Therapy|Overall Study||47||
59833011|NCT00234039|75956647|FG000|COMPLETED|Overall Study||8||
59833012|NCT00234039|75956647|FG000|NOT COMPLETED|Overall Study||50||
59833013|NCT00323622|75956659|FG000|STARTED|Overall Study||176||
59833014|NCT00323622|75956660|FG001|STARTED|Overall Study||515||
59833015|NCT00323622|75956661|FG002|STARTED|Overall Study||42||
59833016|NCT00323622|75956662|FG003|STARTED|Overall Study||134||
60118632|NCT00702234|76239588|FG001|COMPLETED|Follow-up Study: Expectant Mothers||0||
60118633|NCT00702234|76239587|FG000|NOT COMPLETED|Follow-up Study: Expectant Mothers||22||
60118634|NCT00702234|76239588|FG001|NOT COMPLETED|Follow-up Study: Expectant Mothers||0||
60118635|NCT00702234|76239587|FG000|STARTED|Follow-up Study: Fetuses/Infants||0||
60118636|NCT00702234|76239588|FG001|STARTED|Follow-up Study: Fetuses/Infants|Fetuses present 10 weeks after fresh ET and/or at enrollment of expectant mother in follow-up study|315||
60118637|NCT00702234|76239587|FG000|Live Born Infants|Follow-up Study: Fetuses/Infants||0||
59833017|NCT00323622|75956663|FG004|STARTED|Overall Study||159||
59833018|NCT00323622|75956664|FG005|STARTED|Overall Study||528||
60118638|NCT00702234|76239588|FG001|Live Born Infants|Follow-up Study: Fetuses/Infants|Of the 11 that were not live born infants, outcome is known for 8 (fetus was lost) and unknown for 3|304||
59833019|NCT00323622|75956665|FG006|STARTED|Overall Study||43||
59833020|NCT00323622|75956666|FG007|STARTED|Overall Study||140||
59833021|NCT00323622|75956659|FG000|COMPLETED|Overall Study||145||
59833022|NCT00323622|75956660|FG001|COMPLETED|Overall Study||423||
59833023|NCT00323622|75956661|FG002|COMPLETED|Overall Study||38||
59833024|NCT00323622|75956662|FG003|COMPLETED|Overall Study||122||
59833025|NCT00323622|75956663|FG004|COMPLETED|Overall Study||120||
59833026|NCT00323622|75956664|FG005|COMPLETED|Overall Study||454||
59833027|NCT00323622|75956665|FG006|COMPLETED|Overall Study||38||
59833028|NCT00323622|75956666|FG007|COMPLETED|Overall Study||125||
59833029|NCT00323622|75956659|FG000|NOT COMPLETED|Overall Study||31||
59833030|NCT00323622|75956660|FG001|NOT COMPLETED|Overall Study||92||
59833031|NCT00323622|75956661|FG002|NOT COMPLETED|Overall Study||4||
59833032|NCT00323622|75956662|FG003|NOT COMPLETED|Overall Study||12||
59833033|NCT00323622|75956663|FG004|NOT COMPLETED|Overall Study||39||
59833034|NCT00323622|75956664|FG005|NOT COMPLETED|Overall Study||74||
59833035|NCT00323622|75956665|FG006|NOT COMPLETED|Overall Study||5||
59833036|NCT00323622|75956666|FG007|NOT COMPLETED|Overall Study||15||
59833037|NCT00189423|75956694|FG000|STARTED|Overall Study||813||
59833038|NCT00189423|75956695|FG001|STARTED|Overall Study||840||
59833039|NCT00189423|75956694|FG000|COMPLETED|Overall Study||48||
59833040|NCT00189423|75956695|FG001|COMPLETED|Overall Study||74||
59833041|NCT00189423|75956694|FG000|NOT COMPLETED|Overall Study||765||
59833042|NCT00189423|75956695|FG001|NOT COMPLETED|Overall Study||766||
59833043|NCT00323310|75956701|FG000|STARTED|Overall Study||92||
59833044|NCT00323310|75956701|FG000|COMPLETED|Overall Study||89||
59833045|NCT00323310|75956701|FG000|NOT COMPLETED|Overall Study||3||
59833046|NCT00186537|75956708|FG000|STARTED|Overall Study||19||
59833047|NCT00186537|75956709|FG001|STARTED|Overall Study||12||
59833048|NCT00186537|75956710|FG002|STARTED|Overall Study||16||
59833049|NCT00186537|75956708|FG000|COMPLETED|Overall Study||12||
59833050|NCT00186537|75956709|FG001|COMPLETED|Overall Study||12||
59833051|NCT00186537|75956710|FG002|COMPLETED|Overall Study||13||
59833052|NCT00186537|75956708|FG000|NOT COMPLETED|Overall Study||7||
59833053|NCT00186537|75956709|FG001|NOT COMPLETED|Overall Study||0||
59833054|NCT00186537|75956710|FG002|NOT COMPLETED|Overall Study||3||
59833055|NCT00517751|75956718|FG000|STARTED|Overall Study||162||
59833056|NCT00517751|75956718|FG000|COMPLETED|Overall Study||33||
59833057|NCT00517751|75956718|FG000|NOT COMPLETED|Overall Study||129||
59833058|NCT00322842|75956724|FG000|STARTED|Overall Study||4||
59833059|NCT00322842|75956725|FG001|STARTED|Overall Study||31||
59833060|NCT00322842|75956724|FG000|COMPLETED|Overall Study|One participant discontinued (d/c) treatment early, received a transplant, and completed the study.|2||
59833061|NCT00322842|75956725|FG001|COMPLETED|Overall Study|One participant d/c treatment early, received a transplant, and was lost to follow-up after 6 months|29||
59833062|NCT00322842|75956724|FG000|NOT COMPLETED|Overall Study||2||
59833063|NCT00322842|75956725|FG001|NOT COMPLETED|Overall Study||2||
59833064|NCT00255723|75956734|FG000|STARTED|Overall Study||56||
59833065|NCT00255723|75956735|FG001|STARTED|Overall Study||41||
59833066|NCT00255723|75956734|FG000|COMPLETED|Overall Study||54||
59833067|NCT00255723|75956735|FG001|COMPLETED|Overall Study||39||
59833068|NCT00255723|75956734|FG000|NOT COMPLETED|Overall Study||2||
59833069|NCT00255723|75956735|FG001|NOT COMPLETED|Overall Study||2||
59717273|NCT00918346|75836301|FG000|COMPLETED|Second Treatment Period (4 Weeks)||21||
59717274|NCT00918346|75836302|FG001|COMPLETED|Second Treatment Period (4 Weeks)||21||
59717275|NCT00918346|75836301|FG000|NOT COMPLETED|Second Treatment Period (4 Weeks)||0||
59717276|NCT00918346|75836302|FG001|NOT COMPLETED|Second Treatment Period (4 Weeks)||0||
59717277|NCT00918346|75836301|FG000|STARTED|Post Study Period||21||
59717278|NCT00918346|75836302|FG001|STARTED|Post Study Period||21||
59717279|NCT00918346|75836301|FG000|COMPLETED|Post Study Period||21||
59717280|NCT00918346|75836302|FG001|COMPLETED|Post Study Period||21||
59717281|NCT00918346|75836301|FG000|NOT COMPLETED|Post Study Period||0||
59717282|NCT00918346|75836302|FG001|NOT COMPLETED|Post Study Period||0||
59717283|NCT00913978|75836313|FG000|STARTED|Overall Study||26||
59717284|NCT00913978|75836314|FG001|STARTED|Overall Study||24||
59717285|NCT00913978|75836313|FG000|COMPLETED|Overall Study||25||
59717286|NCT00913978|75836314|FG001|COMPLETED|Overall Study||21||
59717287|NCT00913978|75836313|FG000|NOT COMPLETED|Overall Study||1||
59717288|NCT00913978|75836314|FG001|NOT COMPLETED|Overall Study||3||
59833070|NCT00132808|75956744|FG000|STARTED|Stratum I||77||
59833071|NCT00132808|75956745|FG001|STARTED|Stratum I||70||
59833072|NCT00132808|75956746|FG002|STARTED|Stratum I||77||
59833073|NCT00132808|75956744|FG000|COMPLETED|Stratum I||68||
59833074|NCT00132808|75956745|FG001|COMPLETED|Stratum I||58||
59833075|NCT00132808|75956746|FG002|COMPLETED|Stratum I||72||
59833076|NCT00132808|75956744|FG000|NOT COMPLETED|Stratum I||9||
59833077|NCT00132808|75956745|FG001|NOT COMPLETED|Stratum I||12||
59833078|NCT00132808|75956746|FG002|NOT COMPLETED|Stratum I||5||
59833079|NCT00132808|75956744|FG000|STARTED|Stratum II||121||
59833080|NCT00132808|75956745|FG001|STARTED|Stratum II||111||
59833081|NCT00132808|75956746|FG002|STARTED|Stratum II||125||
59833082|NCT00132808|75956744|FG000|COMPLETED|Stratum II||113||
59833083|NCT00132808|75956745|FG001|COMPLETED|Stratum II||96||
59833084|NCT00132808|75956746|FG002|COMPLETED|Stratum II||116||
59833085|NCT00132808|75956744|FG000|NOT COMPLETED|Stratum II||8||
59833086|NCT00132808|75956745|FG001|NOT COMPLETED|Stratum II||15||
59833087|NCT00132808|75956746|FG002|NOT COMPLETED|Stratum II||9||
59833088|NCT00517361|75956754|FG000|STARTED|Overall Study||11||
59996511|NCT02730377|76112485|FG000|Safety Analysis Set (SAS)|Overall Study||980||
60118639|NCT00702234|76239587|FG000|COMPLETED|Follow-up Study: Fetuses/Infants||0||
60118640|NCT00702234|76239588|FG001|COMPLETED|Follow-up Study: Fetuses/Infants|All 288 who completed were live born infants|288||
60118641|NCT00702234|76239587|FG000|NOT COMPLETED|Follow-up Study: Fetuses/Infants||0||
60118642|NCT00702234|76239588|FG001|NOT COMPLETED|Follow-up Study: Fetuses/Infants||27||
60118643|NCT00235833|76239595|FG000|STARTED|Overall Study||25||
60118644|NCT00235833|76239595|FG000|COMPLETED|Overall Study||9||
60118645|NCT00235833|76239595|FG000|NOT COMPLETED|Overall Study||16||
59717289|NCT01137474|75836324|FG000|STARTED|Overall Study||311||
59717290|NCT01137474|75836325|FG001|STARTED|Overall Study||166||
59717291|NCT01137474|75836326|FG002|STARTED|Overall Study||165||
59717292|NCT01137474|75836327|FG003|STARTED|Overall Study||302||
59717293|NCT01137474|75836324|FG000|Received Treatment|Overall Study||311||
59717294|NCT01137474|75836325|FG001|Received Treatment|Overall Study||166||
59717295|NCT01137474|75836326|FG002|Received Treatment|Overall Study||165||
59717296|NCT01137474|75836327|FG003|Received Treatment|Overall Study||302||
59717297|NCT01137474|75836324|FG000|COMPLETED|Overall Study||287||
59717298|NCT01137474|75836325|FG001|COMPLETED|Overall Study||154||
60118646|NCT01703819|76239601|FG000|STARTED|Overall Study||34||
60118647|NCT01703819|76239602|FG001|STARTED|Overall Study||32||
60118648|NCT01703819|76239601|FG000|COMPLETED|Overall Study||34||
60118649|NCT01703819|76239602|FG001|COMPLETED|Overall Study||30||
60118650|NCT01703819|76239601|FG000|NOT COMPLETED|Overall Study||0||
60118651|NCT01703819|76239602|FG001|NOT COMPLETED|Overall Study||2||
60118652|NCT00255801|76239608|FG000|STARTED|Overall Study||37||
60118653|NCT00255801|76239608|FG000|COMPLETED|Overall Study||37||
60118654|NCT00255801|76239608|FG000|NOT COMPLETED|Overall Study||0||
60118655|NCT01682759|76239614|FG000|STARTED|Overall Study||376||
60118656|NCT01682759|76239615|FG001|STARTED|Overall Study||375||
60118657|NCT01682759|76239614|FG000|Treated|Overall Study||375||
60118658|NCT01682759|76239615|FG001|Treated|Overall Study||375||
60118659|NCT01682759|76239614|FG000|COMPLETED|Overall Study||307||
60118660|NCT01682759|76239615|FG001|COMPLETED|Overall Study||305||
60118661|NCT01682759|76239614|FG000|NOT COMPLETED|Overall Study||69||
60118662|NCT01682759|76239615|FG001|NOT COMPLETED|Overall Study||70||
60118663|NCT00239733|76239621|FG000|STARTED|Overall Study||6||
60118664|NCT00239733|76239621|FG000|COMPLETED|Overall Study||6||
60118665|NCT00239733|76239621|FG000|NOT COMPLETED|Overall Study||0||
59833089|NCT00517361|75956754|FG000|COMPLETED|Overall Study|This study has been terminated due to poor accrual.|0||
59833090|NCT00517361|75956754|FG000|NOT COMPLETED|Overall Study||11||
59833091|NCT00516893|75956758|FG000|STARTED|Overall Study||113||
59833092|NCT00516893|75956758|FG000|Received Study Treatment|Overall Study||112||
60118666|NCT01682681|76239625|FG000|STARTED|Overall Study||1234||
60118667|NCT01682681|76239625|FG000|Treated|Overall Study|2 Participants were not compliant with eligibility criteria|1232||
60118668|NCT01682681|76239625|FG000|COMPLETED|Overall Study||902||
60118669|NCT01682681|76239625|FG000|NOT COMPLETED|Overall Study||332||
59717299|NCT01137474|75836326|FG002|COMPLETED|Overall Study||158||
59717300|NCT01137474|75836327|FG003|COMPLETED|Overall Study||281||
60118670|NCT01682603|76239629|FG000|STARTED|Overall Study||37||
60118671|NCT01682603|76239629|FG000|COMPLETED|Overall Study||34||
60118672|NCT01682603|76239629|FG000|NOT COMPLETED|Overall Study||3||
59833093|NCT00516893|75956758|FG000|COMPLETED|Overall Study||92||
59833094|NCT00516893|75956758|FG000|NOT COMPLETED|Overall Study||21||
59833095|NCT00522431|75956762|FG000|STARTED|Overall Study||149||
59833096|NCT00522431|75956762|FG000|COMPLETED|Overall Study||138||
59833097|NCT00522431|75956762|FG000|NOT COMPLETED|Overall Study||11||
59833098|NCT00185211|75956768|FG000|STARTED|Placebo-controlled Study (92012)||292||
59833099|NCT00185211|75956769|FG001|STARTED|Placebo-controlled Study (92012)||176||
59833100|NCT00185211|75956768|FG000|COMPLETED|Placebo-controlled Study (92012)||271||
59833101|NCT00185211|75956769|FG001|COMPLETED|Placebo-controlled Study (92012)||166||
59833102|NCT00185211|75956768|FG000|NOT COMPLETED|Placebo-controlled Study (92012)||21||
59833103|NCT00185211|75956769|FG001|NOT COMPLETED|Placebo-controlled Study (92012)||10||
59833104|NCT00185211|75956768|FG000|STARTED|Follow-up Study (91031 - This Study)|10 of the 271 subjects completing the placebo-controlled study did not consent to the Follow-up.|261||
59833105|NCT00185211|75956769|FG001|STARTED|Follow-up Study (91031 - This Study)|9 of the 166 subjects completing the placebo-controlled study did not consent to the Follow-up.|157||
59833106|NCT00185211|75956768|FG000|COMPLETED|Follow-up Study (91031 - This Study)||235||
59833107|NCT00185211|75956769|FG001|COMPLETED|Follow-up Study (91031 - This Study)||123||
59833108|NCT00185211|75956768|FG000|NOT COMPLETED|Follow-up Study (91031 - This Study)||26||
59833109|NCT00185211|75956769|FG001|NOT COMPLETED|Follow-up Study (91031 - This Study)||34||
59833110|NCT00516737|75956778|FG000|STARTED|Overall Study||103||
59833111|NCT00516737|75956779|FG001|STARTED|Overall Study||104||
59833112|NCT00516737|75956778|FG000|COMPLETED|Overall Study||92||
59833113|NCT00516737|75956779|FG001|COMPLETED|Overall Study||96||
59833114|NCT00516737|75956778|FG000|NOT COMPLETED|Overall Study||11||
59833115|NCT00516737|75956779|FG001|NOT COMPLETED|Overall Study||8||
59833116|NCT00132730|75956789|FG000|STARTED|Period I - Placebo Run-in (Base)||150||
59833117|NCT00132730|75956790|FG001|STARTED|Period I - Placebo Run-in (Base)||148||
59833118|NCT00132730|75956791|FG002|STARTED|Period I - Placebo Run-in (Base)||153||
59833119|NCT00132730|75956792|FG003|STARTED|Period I - Placebo Run-in (Base)||153||
59833120|NCT00132730|75956793|FG004|STARTED|Period I - Placebo Run-in (Base)||0||
59833121|NCT00132730|75956794|FG005|STARTED|Period I - Placebo Run-in (Base)||0||
59833122|NCT00132730|75956789|FG000|COMPLETED|Period I - Placebo Run-in (Base)||150||
59833123|NCT00132730|75956790|FG001|COMPLETED|Period I - Placebo Run-in (Base)||148||
59833124|NCT00132730|75956791|FG002|COMPLETED|Period I - Placebo Run-in (Base)||153||
59833125|NCT00132730|75956792|FG003|COMPLETED|Period I - Placebo Run-in (Base)||153||
59833126|NCT00132730|75956793|FG004|COMPLETED|Period I - Placebo Run-in (Base)||0||
59833127|NCT00132730|75956794|FG005|COMPLETED|Period I - Placebo Run-in (Base)||0||
59833128|NCT00132730|75956789|FG000|NOT COMPLETED|Period I - Placebo Run-in (Base)||0||
59833129|NCT00132730|75956790|FG001|NOT COMPLETED|Period I - Placebo Run-in (Base)||0||
59833130|NCT00132730|75956791|FG002|NOT COMPLETED|Period I - Placebo Run-in (Base)||0||
59833131|NCT00132730|75956792|FG003|NOT COMPLETED|Period I - Placebo Run-in (Base)||0||
59833132|NCT00132730|75956793|FG004|NOT COMPLETED|Period I - Placebo Run-in (Base)||0||
59833133|NCT00132730|75956794|FG005|NOT COMPLETED|Period I - Placebo Run-in (Base)||0||
59833134|NCT00132730|75956789|FG000|STARTED|Period II - 12-week Treatment (Base)||150||
59833135|NCT00132730|75956790|FG001|STARTED|Period II - 12-week Treatment (Base)||148||
59833136|NCT00132730|75956791|FG002|STARTED|Period II - 12-week Treatment (Base)||153||
59833137|NCT00132730|75956792|FG003|STARTED|Period II - 12-week Treatment (Base)||153||
59833138|NCT00132730|75956793|FG004|STARTED|Period II - 12-week Treatment (Base)||0||
59833139|NCT00132730|75956794|FG005|STARTED|Period II - 12-week Treatment (Base)||0||
59833140|NCT00132730|75956789|FG000|COMPLETED|Period II - 12-week Treatment (Base)||127||
59833141|NCT00132730|75956790|FG001|COMPLETED|Period II - 12-week Treatment (Base)||133||
59833142|NCT00132730|75956791|FG002|COMPLETED|Period II - 12-week Treatment (Base)||135||
59833143|NCT00132730|75956792|FG003|COMPLETED|Period II - 12-week Treatment (Base)||131||
59833144|NCT00132730|75956793|FG004|COMPLETED|Period II - 12-week Treatment (Base)||0||
59833145|NCT00132730|75956794|FG005|COMPLETED|Period II - 12-week Treatment (Base)||0||
59833146|NCT00132730|75956789|FG000|NOT COMPLETED|Period II - 12-week Treatment (Base)||23||
59833147|NCT00132730|75956790|FG001|NOT COMPLETED|Period II - 12-week Treatment (Base)||15||
59833148|NCT00132730|75956791|FG002|NOT COMPLETED|Period II - 12-week Treatment (Base)||18||
59833149|NCT00132730|75956792|FG003|NOT COMPLETED|Period II - 12-week Treatment (Base)||22||
59833150|NCT00132730|75956793|FG004|NOT COMPLETED|Period II - 12-week Treatment (Base)||0||
59833151|NCT00132730|75956794|FG005|NOT COMPLETED|Period II - 12-week Treatment (Base)||0||
59833152|NCT00132730|75956789|FG000|STARTED|Period III - Blinded Extension (EXT1)||0||
59833153|NCT00132730|75956790|FG001|STARTED|Period III - Blinded Extension (EXT1)||0||
59833154|NCT00132730|75956791|FG002|STARTED|Period III - Blinded Extension (EXT1)|Includes all MK-0873 participants from Period II. Not all eligible participants entered EXT1|317||
59833155|NCT00132730|75956792|FG003|STARTED|Period III - Blinded Extension (EXT1)|Not all eligible participants entered EXT1|107||
59717301|NCT01137474|75836324|FG000|NOT COMPLETED|Overall Study||24||
59717302|NCT01137474|75836325|FG001|NOT COMPLETED|Overall Study||12||
59717303|NCT01137474|75836326|FG002|NOT COMPLETED|Overall Study||7||
59717304|NCT01137474|75836327|FG003|NOT COMPLETED|Overall Study||21||
59717305|NCT01168973|75836339|FG000|STARTED|Overall Study||628||
59717306|NCT01168973|75836340|FG001|STARTED|Overall Study||625||
59717307|NCT01168973|75836339|FG000|Received Any Quantity of Any Study Drug|Overall Study||624||
59833156|NCT00132730|75956793|FG004|STARTED|Period III - Blinded Extension (EXT1)||0||
59833157|NCT00132730|75956794|FG005|STARTED|Period III - Blinded Extension (EXT1)||0||
59833158|NCT00132730|75956789|FG000|COMPLETED|Period III - Blinded Extension (EXT1)||0||
59833159|NCT00132730|75956790|FG001|COMPLETED|Period III - Blinded Extension (EXT1)||0||
59833160|NCT00132730|75956791|FG002|COMPLETED|Period III - Blinded Extension (EXT1)||235||
59833161|NCT00132730|75956792|FG003|COMPLETED|Period III - Blinded Extension (EXT1)||82||
59833162|NCT00132730|75956793|FG004|COMPLETED|Period III - Blinded Extension (EXT1)||0||
59833163|NCT00132730|75956794|FG005|COMPLETED|Period III - Blinded Extension (EXT1)||0||
59833164|NCT00132730|75956789|FG000|NOT COMPLETED|Period III - Blinded Extension (EXT1)||0||
59833165|NCT00132730|75956790|FG001|NOT COMPLETED|Period III - Blinded Extension (EXT1)||0||
59833166|NCT00132730|75956791|FG002|NOT COMPLETED|Period III - Blinded Extension (EXT1)||82||
59833167|NCT00132730|75956792|FG003|NOT COMPLETED|Period III - Blinded Extension (EXT1)||25||
59833168|NCT00132730|75956793|FG004|NOT COMPLETED|Period III - Blinded Extension (EXT1)||0||
59833169|NCT00132730|75956794|FG005|NOT COMPLETED|Period III - Blinded Extension (EXT1)||0||
59833170|NCT00132730|75956789|FG000|STARTED|Period IV - Open-label Extension (EXT2)||0||
59833171|NCT00132730|75956790|FG001|STARTED|Period IV - Open-label Extension (EXT2)||0||
59833172|NCT00132730|75956791|FG002|STARTED|Period IV - Open-label Extension (EXT2)||0||
59833173|NCT00132730|75956792|FG003|STARTED|Period IV - Open-label Extension (EXT2)||0||
59833174|NCT00132730|75956793|FG004|STARTED|Period IV - Open-label Extension (EXT2)|Includes participants from Period III. Not all eligible participants entered EXT2|187||
59833175|NCT00132730|75956794|FG005|STARTED|Period IV - Open-label Extension (EXT2)|Includes paricipants from Period III. Not all eligible participants entered EXT2|71||
59833176|NCT00132730|75956789|FG000|COMPLETED|Period IV - Open-label Extension (EXT2)||0||
59833177|NCT00132730|75956790|FG001|COMPLETED|Period IV - Open-label Extension (EXT2)||0||
59833178|NCT00132730|75956791|FG002|COMPLETED|Period IV - Open-label Extension (EXT2)||0||
59833179|NCT00132730|75956792|FG003|COMPLETED|Period IV - Open-label Extension (EXT2)||0||
59833180|NCT00132730|75956793|FG004|COMPLETED|Period IV - Open-label Extension (EXT2)||8||
59833181|NCT00132730|75956794|FG005|COMPLETED|Period IV - Open-label Extension (EXT2)||3||
59833182|NCT00132730|75956789|FG000|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||0||
59833183|NCT00132730|75956790|FG001|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||0||
59833184|NCT00132730|75956791|FG002|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||0||
59833185|NCT00132730|75956792|FG003|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||0||
59833186|NCT00132730|75956793|FG004|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||179||
59833187|NCT00132730|75956794|FG005|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||68||
59833188|NCT00132730|75956789|FG000|STARTED|Period V - Open-label Extension (EXT2)||0||
59833189|NCT00132730|75956790|FG001|STARTED|Period V - Open-label Extension (EXT2)||0||
59833190|NCT00132730|75956791|FG002|STARTED|Period V - Open-label Extension (EXT2)||0||
59833191|NCT00132730|75956792|FG003|STARTED|Period V - Open-label Extension (EXT2)||0||
59833192|NCT00132730|75956793|FG004|STARTED|Period V - Open-label Extension (EXT2)|Not all participants who completed Period IV entered Period V|7||
59833193|NCT00132730|75956794|FG005|STARTED|Period V - Open-label Extension (EXT2)|Not all participants who completed Period IV entered Period V|2||
59833194|NCT00132730|75956789|FG000|COMPLETED|Period V - Open-label Extension (EXT2)||0||
59833195|NCT00132730|75956790|FG001|COMPLETED|Period V - Open-label Extension (EXT2)||0||
59833196|NCT00132730|75956791|FG002|COMPLETED|Period V - Open-label Extension (EXT2)||0||
59833197|NCT00132730|75956792|FG003|COMPLETED|Period V - Open-label Extension (EXT2)||0||
59833198|NCT00132730|75956793|FG004|COMPLETED|Period V - Open-label Extension (EXT2)||0||
59833199|NCT00132730|75956794|FG005|COMPLETED|Period V - Open-label Extension (EXT2)||0||
59833200|NCT00132730|75956789|FG000|NOT COMPLETED|Period V - Open-label Extension (EXT2)||0||
59833201|NCT00132730|75956790|FG001|NOT COMPLETED|Period V - Open-label Extension (EXT2)||0||
59833202|NCT00132730|75956791|FG002|NOT COMPLETED|Period V - Open-label Extension (EXT2)||0||
59833203|NCT00132730|75956792|FG003|NOT COMPLETED|Period V - Open-label Extension (EXT2)||0||
59833204|NCT00132730|75956793|FG004|NOT COMPLETED|Period V - Open-label Extension (EXT2)||7||
59833205|NCT00132730|75956794|FG005|NOT COMPLETED|Period V - Open-label Extension (EXT2)||2||
59833206|NCT00232557|75956810|FG000|STARTED|Overall Study||71||
59833207|NCT00232557|75956811|FG001|STARTED|Overall Study||65||
59833208|NCT00232557|75956810|FG000|COMPLETED|Overall Study||68||
59833209|NCT00232557|75956811|FG001|COMPLETED|Overall Study||60||
59833210|NCT00232557|75956810|FG000|NOT COMPLETED|Overall Study||3||
59833211|NCT00232557|75956811|FG001|NOT COMPLETED|Overall Study||5||
59833212|NCT00522275|75956817|FG000|STARTED|Overall Study||308||
59833213|NCT00522275|75956817|FG000|COMPLETED|Overall Study||138||
59833214|NCT00522275|75956817|FG000|NOT COMPLETED|Overall Study||170||
59833215|NCT00522041|75956823|FG000|STARTED|Overall Study||123||
59833216|NCT00522041|75956824|FG001|STARTED|Overall Study||125||
59833217|NCT00522041|75956823|FG000|Received Treatment|Overall Study||123||
59833218|NCT00522041|75956824|FG001|Received Treatment|Overall Study||124||
59833219|NCT00522041|75956823|FG000|COMPLETED|Overall Study||106||
59833220|NCT00522041|75956824|FG001|COMPLETED|Overall Study||113||
59833221|NCT00522041|75956823|FG000|NOT COMPLETED|Overall Study||17||
59833222|NCT00522041|75956824|FG001|NOT COMPLETED|Overall Study||12||
59833223|NCT00122980|75956833|FG000|STARTED|Overall Study|Randomized sample: 67; Intent-to-treat sample: 67|67||
59833224|NCT00122980|75956834|FG001|STARTED|Overall Study|Randomized sample: 67; Intent-to-treat sample: 66|66||
59833225|NCT00122980|75956833|FG000|COMPLETED|Overall Study|Study terminated early|24||
59833226|NCT00122980|75956834|FG001|COMPLETED|Overall Study|Study terminated early|26||
59833227|NCT00122980|75956833|FG000|NOT COMPLETED|Overall Study||43||
59833228|NCT00122980|75956834|FG001|NOT COMPLETED|Overall Study||40||
59833229|NCT03868631|75956842|FG000|STARTED|Baseline to Week 6||30||
59833230|NCT03868631|75956843|FG001|STARTED|Baseline to Week 6||31||
59833231|NCT03868631|75956842|FG000|COMPLETED|Baseline to Week 6||26||
59833232|NCT03868631|75956843|FG001|COMPLETED|Baseline to Week 6||27||
59833233|NCT03868631|75956842|FG000|NOT COMPLETED|Baseline to Week 6||4||
59833234|NCT03868631|75956843|FG001|NOT COMPLETED|Baseline to Week 6||4||
59833235|NCT03868631|75956842|FG000|STARTED|Week 6 to Week 12 (Study Completion)||26||
59833236|NCT03868631|75956843|FG001|STARTED|Week 6 to Week 12 (Study Completion)||27||
59833237|NCT03868631|75956842|FG000|COMPLETED|Week 6 to Week 12 (Study Completion)||22||
59833238|NCT03868631|75956843|FG001|COMPLETED|Week 6 to Week 12 (Study Completion)||26||
59833239|NCT03868631|75956842|FG000|NOT COMPLETED|Week 6 to Week 12 (Study Completion)||4||
59833240|NCT03868631|75956843|FG001|NOT COMPLETED|Week 6 to Week 12 (Study Completion)||1||
59833241|NCT05142332|75956851|FG000|STARTED|Overall Study||166|Participant came in on the day site was randomized to this condition and participant was consented|
59833242|NCT05142332|75956852|FG001|STARTED|Overall Study||27|Participant came in on the day site was randomized to this condition and participant was consented|
59833243|NCT05142332|75956853|FG002|STARTED|Overall Study||110|Participant came in on the day site was randomized to this condition and participant was consented|
59833244|NCT05142332|75956854|FG003|STARTED|Overall Study||97|Participant came in on the day site was randomized to this condition and participant was consented|
59833245|NCT05142332|75956855|FG004|STARTED|Overall Study||12|Participant came in on the day site was randomized to this condition and participant was consented|
59833246|NCT05142332|75956856|FG005|STARTED|Overall Study||12|Participant came in on the day site was randomized to this condition and participant was consented|
59833247|NCT05142332|75956857|FG006|STARTED|Overall Study||117|Participant came in on the day site was randomized to this condition and participant was consented|
59833248|NCT05142332|75956851|FG000|Received PROCOVAXED Intervention|Overall Study||82||
59833249|NCT05142332|75956852|FG001|Received PROCOVAXED Intervention|Overall Study||8||
59833250|NCT05142332|75956853|FG002|Received PROCOVAXED Intervention|Overall Study||49||
59833251|NCT05142332|75956854|FG003|Received PROCOVAXED Intervention|Overall Study||27||
59833252|NCT05142332|75956855|FG004|Received PROCOVAXED Intervention|Overall Study||2||
59833253|NCT05142332|75956856|FG005|Received PROCOVAXED Intervention|Overall Study||3||
59833254|NCT05142332|75956857|FG006|Received PROCOVAXED Intervention|Overall Study||50||
59833255|NCT05142332|75956851|FG000|C C Control|Overall Study||79||
59833256|NCT05142332|75956852|FG001|C C Control|Overall Study||18||
59833257|NCT05142332|75956853|FG002|C C Control|Overall Study||52||
59833258|NCT05142332|75956854|FG003|C C Control|Overall Study||61||
59833259|NCT05142332|75956855|FG004|C C Control|Overall Study||9||
59833260|NCT05142332|75956856|FG005|C C Control|Overall Study||4||
59833261|NCT05142332|75956857|FG006|C C Control|Overall Study||52||
59833262|NCT05142332|75956851|FG000|COMPLETED|Overall Study||161||
59833263|NCT05142332|75956852|FG001|COMPLETED|Overall Study||26||
59833264|NCT05142332|75956853|FG002|COMPLETED|Overall Study||101||
59833265|NCT05142332|75956854|FG003|COMPLETED|Overall Study||88||
59833266|NCT05142332|75956855|FG004|COMPLETED|Overall Study||11||
59833267|NCT05142332|75956856|FG005|COMPLETED|Overall Study||7||
59833268|NCT05142332|75956857|FG006|COMPLETED|Overall Study||102||
59833269|NCT05142332|75956851|FG000|NOT COMPLETED|Overall Study||5||
59833270|NCT05142332|75956852|FG001|NOT COMPLETED|Overall Study||1||
59833271|NCT05142332|75956853|FG002|NOT COMPLETED|Overall Study||9||
59717308|NCT01168973|75836340|FG001|Received Any Quantity of Any Study Drug|Overall Study|Three participants randomized to placebo and docetaxel received 1 dose of ramucirumab in error.|621||
59717309|NCT01168973|75836339|FG000|COMPLETED|Overall Study||15||
59717310|NCT01168973|75836340|FG001|COMPLETED|Overall Study||14||
59717311|NCT01168973|75836339|FG000|NOT COMPLETED|Overall Study||613||
59717312|NCT01168973|75836340|FG001|NOT COMPLETED|Overall Study||611||
59717313|NCT03918109|75836350|FG000|STARTED|Overall Study||6||
59717314|NCT03918109|75836351|FG001|STARTED|Overall Study||2||
59833272|NCT05142332|75956854|FG003|NOT COMPLETED|Overall Study||9||
59833273|NCT05142332|75956855|FG004|NOT COMPLETED|Overall Study||1||
59833274|NCT05142332|75956856|FG005|NOT COMPLETED|Overall Study||5||
59833275|NCT05142332|75956857|FG006|NOT COMPLETED|Overall Study||15||
59833276|NCT04899921|75956866|FG000|STARTED|Overall Study||0||
59833277|NCT04899921|75956867|FG001|STARTED|Overall Study||0||
59833278|NCT04899921|75956868|FG002|STARTED|Overall Study||0||
59833279|NCT04899921|75956866|FG000|COMPLETED|Overall Study||0|Terminated with 1 patient enrolled, no data due to patient privacy.|
59833280|NCT04899921|75956867|FG001|COMPLETED|Overall Study||0|Terminated with 1 patient enrolled, no data due to patient privacy.|
59833281|NCT04899921|75956868|FG002|COMPLETED|Overall Study||0|Terminated with 1 patient enrolled, no data due to patient privacy.|
59833282|NCT04899921|75956866|FG000|NOT COMPLETED|Overall Study||0||
60118673|NCT00240981|76239637|FG000|STARTED|Overall Study||106||
60118674|NCT00240981|76239638|FG001|STARTED|Overall Study||103||
59717315|NCT03918109|75836352|FG002|STARTED|Overall Study||17||
59717316|NCT03918109|75836353|FG003|STARTED|Overall Study||18||
59717317|NCT03918109|75836350|FG000|COMPLETED|Overall Study||6||
59717318|NCT03918109|75836351|FG001|COMPLETED|Overall Study||2||
59833283|NCT04899921|75956867|FG001|NOT COMPLETED|Overall Study||0||
59833284|NCT04899921|75956868|FG002|NOT COMPLETED|Overall Study||0||
59833285|NCT04745832|75956880|FG000|STARTED|Overall Study||41||
59833286|NCT04745832|75956881|FG001|STARTED|Overall Study||41||
59833287|NCT04745832|75956880|FG000|COMPLETED|Overall Study||41||
59833288|NCT04745832|75956881|FG001|COMPLETED|Overall Study||41||
59833289|NCT04745832|75956880|FG000|NOT COMPLETED|Overall Study||0||
59833290|NCT04745832|75956881|FG001|NOT COMPLETED|Overall Study||0||
59833291|NCT04711356|75956889|FG000|STARTED|Overall Study||50||
59833292|NCT04711356|75956889|FG000|COMPLETED|Overall Study||50||
59833293|NCT04711356|75956889|FG000|NOT COMPLETED|Overall Study||0||
59833294|NCT04561375|75956896|FG000|STARTED|Overall Study||35||
59833295|NCT04561375|75956897|FG001|STARTED|Overall Study||26||
59833296|NCT04561375|75956896|FG000|COMPLETED|Overall Study||35||
59833297|NCT04561375|75956897|FG001|COMPLETED|Overall Study||26||
59833298|NCT04561375|75956896|FG000|NOT COMPLETED|Overall Study||0||
59833299|NCT04561375|75956897|FG001|NOT COMPLETED|Overall Study||0||
59833300|NCT04556838|75956906|FG000|STARTED|Overall Study||57||
59833301|NCT04556838|75956907|FG001|STARTED|Overall Study||56||
59717319|NCT03918109|75836352|FG002|COMPLETED|Overall Study||15||
59717320|NCT03918109|75836353|FG003|COMPLETED|Overall Study||16||
59717321|NCT03918109|75836350|FG000|NOT COMPLETED|Overall Study||0||
59717322|NCT03918109|75836351|FG001|NOT COMPLETED|Overall Study||0||
59717323|NCT03918109|75836352|FG002|NOT COMPLETED|Overall Study||2||
59717324|NCT03918109|75836353|FG003|NOT COMPLETED|Overall Study||2||
59717325|NCT01168427|75836363|FG000|STARTED|Overall Study||66||
59717326|NCT01168427|75836363|FG000|COMPLETED|Overall Study||65||
59717327|NCT01168427|75836363|FG000|NOT COMPLETED|Overall Study||1||
59833302|NCT04556838|75956908|FG002|STARTED|Overall Study||56||
59833303|NCT04556838|75956906|FG000|COMPLETED|Overall Study||53||
59833304|NCT04556838|75956907|FG001|COMPLETED|Overall Study||53||
59833305|NCT04556838|75956908|FG002|COMPLETED|Overall Study||51||
59833306|NCT04556838|75956906|FG000|NOT COMPLETED|Overall Study||4||
59833307|NCT04556838|75956907|FG001|NOT COMPLETED|Overall Study||3||
59833308|NCT04556838|75956908|FG002|NOT COMPLETED|Overall Study||5||
60118675|NCT00240981|76239637|FG000|Intent to Treat Sample|Overall Study||82||
60118676|NCT00240981|76239638|FG001|Intent to Treat Sample|Overall Study||83||
60118677|NCT00240981|76239637|FG000|COMPLETED|Overall Study||68||
60118678|NCT00240981|76239638|FG001|COMPLETED|Overall Study||70||
60118679|NCT00240981|76239637|FG000|NOT COMPLETED|Overall Study||38||
60118680|NCT00240981|76239638|FG001|NOT COMPLETED|Overall Study||33||
60118681|NCT01682213|76239645|FG000|STARTED|Overall Study||23||
60118682|NCT01682213|76239645|FG000|COMPLETED|Overall Study||21||
60118683|NCT01682213|76239645|FG000|NOT COMPLETED|Overall Study||2||
60118684|NCT02126553|76239650|FG000|STARTED|Overall Study||29||
60118685|NCT02126553|76239650|FG000|COMPLETED|Overall Study||29||
60118686|NCT02126553|76239650|FG000|NOT COMPLETED|Overall Study||0||
60118687|NCT01703741|76239654|FG000|STARTED|Overall Study||145||
59833309|NCT04549363|75956918|FG000|STARTED|Overall Study||6|All treated population|
59567500|NCT02326272|75670463|FG010|Completed Week 16|Initial Period (Week 0 to Week 16)||0||
59717328|NCT01124916|75836369|FG000|STARTED|Overall Study||38||
59833310|NCT04549363|75956919|FG001|STARTED|Overall Study||3|All treated population|
60118688|NCT01703741|76239654|FG000|Per Protocol (PP) Population|Overall Study|Subjects having 24 hr pharmacokinetic (PK) data for testosterone, with no major protocol violations.|106||
59833311|NCT04549363|75956918|FG000|ICSK Population|Overall Study||6|IC or SK (ICSK) population is defined as participants from all-treated population who had a tissue sample collected using Impression Cytology (IC) or Superficial Keratectomy (SK) procedure, whether or not the specimen is evaluable.|
59833312|NCT04549363|75956919|FG001|ICSK Population|Overall Study||3|IC or SK (ICSK) population is defined as participants from all-treated population who had a tissue sample collected using Impression Cytology (IC) or Superficial Keratectomy (SK) procedure, whether or not the specimen is evaluable.|
59833313|NCT04549363|75956918|FG000|EICSK Population|Overall Study||4|Evaluable IC or SK (EICSK) population included participants from all-treated population who had an evaluable tissue sample collected using IC or SK procedure. A tissue sample specimen were determined to be evaluable by the pathologist in the pathology report.|
59833314|NCT04549363|75956919|FG001|EICSK Population|Overall Study||2|Evaluable IC or SK (EICSK) population included participants from all-treated population who had an evaluable tissue sample collected using IC or SK procedure. A tissue sample specimen were determined to be evaluable by the pathologist in the pathology report.|
59833315|NCT04549363|75956918|FG000|COMPLETED|Overall Study||6||
59833316|NCT04549363|75956919|FG001|COMPLETED|Overall Study||3||
59833317|NCT04549363|75956918|FG000|NOT COMPLETED|Overall Study||0||
59833318|NCT04549363|75956919|FG001|NOT COMPLETED|Overall Study||0||
59833319|NCT04523181|75956927|FG000|STARTED|Overall Study|Patients Randomized|62||
59833320|NCT04523181|75956928|FG001|STARTED|Overall Study|Patients Randomized|62||
59833321|NCT04523181|75956927|FG000|Treated|Overall Study||60|In the Antroquinonol with SOC group, 2 patients were randomized but not treated.|
59833322|NCT04523181|75956928|FG001|Treated|Overall Study||62|In the Antroquinonol with SOC group, 2 patients were randomized but not treated.|
59833323|NCT04523181|75956927|FG000|COMPLETED|Overall Study|Completed Study|54||
59833324|NCT04523181|75956928|FG001|COMPLETED|Overall Study|Completed Study|53||
59833325|NCT04523181|75956927|FG000|NOT COMPLETED|Overall Study||8||
59833326|NCT04523181|75956928|FG001|NOT COMPLETED|Overall Study||9||
59833327|NCT04439799|75956938|FG000|STARTED|Overall Study||41||
59833328|NCT04439799|75956939|FG001|STARTED|Overall Study||40||
59833329|NCT04439799|75956938|FG000|COMPLETED|Overall Study||31||
59833330|NCT04439799|75956939|FG001|COMPLETED|Overall Study||23||
59833331|NCT04439799|75956938|FG000|NOT COMPLETED|Overall Study||10||
59833332|NCT04439799|75956939|FG001|NOT COMPLETED|Overall Study||17||
59833333|NCT04395391|75956945|FG000|STARTED|Overall Study||30||
59833334|NCT04395391|75956945|FG000|COMPLETED|Overall Study||30||
59833335|NCT04395391|75956945|FG000|NOT COMPLETED|Overall Study||0||
59833336|NCT04254666|75956949|FG000|STARTED|Overall Study||6||
59833337|NCT04254666|75956949|FG000|COMPLETED|Overall Study||6||
59833338|NCT04254666|75956949|FG000|NOT COMPLETED|Overall Study||0||
59833339|NCT04198701|75956957|FG000|STARTED|Overall Study||38||
59833340|NCT04198701|75956958|FG001|STARTED|Overall Study||60||
59833341|NCT04198701|75956959|FG002|STARTED|Overall Study||164||
59833342|NCT04198701|75956960|FG003|STARTED|Overall Study||159||
59833343|NCT04198701|75956957|FG000|Had Ablation Procedure|Overall Study||38||
59833344|NCT04198701|75956958|FG001|Had Ablation Procedure|Overall Study||60||
59833345|NCT04198701|75956959|FG002|Had Ablation Procedure|Overall Study||150||
59833346|NCT04198701|75956960|FG003|Had Ablation Procedure|Overall Study||150||
59833347|NCT04198701|75956957|FG000|COMPLETED|Overall Study||35||
59833348|NCT04198701|75956958|FG001|COMPLETED|Overall Study||57||
59833349|NCT04198701|75956959|FG002|COMPLETED|Overall Study||146||
59833350|NCT04198701|75956960|FG003|COMPLETED|Overall Study||141||
59833351|NCT04198701|75956957|FG000|NOT COMPLETED|Overall Study||3||
59833352|NCT04198701|75956958|FG001|NOT COMPLETED|Overall Study||3||
59833353|NCT04198701|75956959|FG002|NOT COMPLETED|Overall Study||18||
59833354|NCT04198701|75956960|FG003|NOT COMPLETED|Overall Study||18||
59833355|NCT04071626|75956971|FG000|STARTED|Overall Study||5||
59833356|NCT04071626|75956972|FG001|STARTED|Overall Study||4||
59833357|NCT04071626|75956971|FG000|COMPLETED|Overall Study||4||
59833358|NCT04071626|75956972|FG001|COMPLETED|Overall Study||2||
59833359|NCT04071626|75956971|FG000|NOT COMPLETED|Overall Study||1||
59833360|NCT04071626|75956972|FG001|NOT COMPLETED|Overall Study||2||
60118689|NCT01703741|76239654|FG000|COMPLETED|Overall Study||127||
60118690|NCT01703741|76239654|FG000|NOT COMPLETED|Overall Study||18||
60118691|NCT01681511|76239660|FG000|STARTED|Overall Study|All randomized subjects in the Lubri-Sil arm.|46||
60118692|NCT01681511|76239661|FG001|STARTED|Overall Study|All randomized subjects in the TIC arm.|49||
60118693|NCT01681511|76239660|FG000|Intent to Treat (ITT) Population|Overall Study|Any subject receiving the Lubri-Sil treatment after randomization.|45||
60118694|NCT01681511|76239661|FG001|Intent to Treat (ITT) Population|Overall Study|Any subject receiving the TIC treatment after randomization.|46||
60118695|NCT01681511|76239660|FG000|Evaluable Population|Overall Study|Subjects w/ positive urine culture results also removed from the Lubri-Sil arm of this population.|16||
60118696|NCT01681511|76239661|FG001|Evaluable Population|Overall Study|Subjects w/ positive urine culture results also removed from the TIC arm of this population.|14||
60118697|NCT01681511|76239660|FG000|COMPLETED|Overall Study||28||
60118698|NCT01681511|76239661|FG001|COMPLETED|Overall Study||35||
60118699|NCT01681511|76239660|FG000|NOT COMPLETED|Overall Study||18||
60118700|NCT01681511|76239661|FG001|NOT COMPLETED|Overall Study||14||
60118701|NCT01681433|76239669|FG000|STARTED|Overall Study||36||
60118702|NCT01681433|76239670|FG001|STARTED|Overall Study||36||
60118703|NCT01681433|76239669|FG000|COMPLETED|Overall Study||4||
60118704|NCT01681433|76239670|FG001|COMPLETED|Overall Study||3||
60118705|NCT01681433|76239669|FG000|NOT COMPLETED|Overall Study||32||
59833361|NCT04051008|75956981|FG000|STARTED|Overall Study||21||
59833362|NCT04051008|75956982|FG001|STARTED|Overall Study||21||
59833363|NCT04051008|75956983|FG002|STARTED|Overall Study||23||
59833364|NCT04051008|75956981|FG000|COMPLETED|Overall Study||19||
59833365|NCT04051008|75956982|FG001|COMPLETED|Overall Study||21||
59833366|NCT04051008|75956983|FG002|COMPLETED|Overall Study||22||
59833367|NCT04051008|75956981|FG000|NOT COMPLETED|Overall Study||2||
59833368|NCT04051008|75956982|FG001|NOT COMPLETED|Overall Study||0||
59833369|NCT04051008|75956983|FG002|NOT COMPLETED|Overall Study||1||
59833370|NCT04002167|75956993|FG000|STARTED|Overall Study||33||
59833371|NCT04002167|75956994|FG001|STARTED|Overall Study||32||
59833372|NCT04002167|75956995|FG002|STARTED|Overall Study||0||
59833373|NCT04002167|75956993|FG000|COMPLETED|Overall Study||21||
59833374|NCT04002167|75956994|FG001|COMPLETED|Overall Study||15||
59833375|NCT04002167|75956995|FG002|COMPLETED|Overall Study||0||
59833376|NCT04002167|75956993|FG000|NOT COMPLETED|Overall Study||12||
59833377|NCT04002167|75956994|FG001|NOT COMPLETED|Overall Study||17||
59833378|NCT04002167|75956995|FG002|NOT COMPLETED|Overall Study||0||
59833379|NCT03831711|75957001|FG000|STARTED|Overall Study||5||
59833380|NCT03831711|75957001|FG000|COMPLETED|Overall Study||5||
59833381|NCT03831711|75957001|FG000|NOT COMPLETED|Overall Study||0||
59833382|NCT03812185|75957005|FG000|STARTED|TEE Imaging Before Suctioning||53||
59833383|NCT03812185|75957005|FG000|COMPLETED|TEE Imaging Before Suctioning||50||
59833384|NCT03812185|75957005|FG000|NOT COMPLETED|TEE Imaging Before Suctioning||3||
59833385|NCT03812185|75957005|FG000|STARTED|TEE Imaging After Suctioning||50||
59833386|NCT03812185|75957005|FG000|COMPLETED|TEE Imaging After Suctioning||50||
59833387|NCT03812185|75957005|FG000|NOT COMPLETED|TEE Imaging After Suctioning||0||
59833388|NCT03789110|75957011|FG000|STARTED|Overall Study||30||
59833389|NCT03789110|75957011|FG000|COMPLETED|Overall Study||0||
59833390|NCT03789110|75957011|FG000|NOT COMPLETED|Overall Study||30||
59833391|NCT03777176|75957017|FG000|STARTED|Treatment Period 1||16||
59833392|NCT03777176|75957018|FG001|STARTED|Treatment Period 1||16||
59833393|NCT03777176|75957019|FG002|STARTED|Treatment Period 1|This arm was not applicable to Treatment Period 1.|0||
59833394|NCT03777176|75957017|FG000|COMPLETED|Treatment Period 1||16||
59833395|NCT03777176|75957018|FG001|COMPLETED|Treatment Period 1||16||
59833396|NCT03777176|75957019|FG002|COMPLETED|Treatment Period 1||0||
59833397|NCT03777176|75957017|FG000|NOT COMPLETED|Treatment Period 1||0||
59833398|NCT03777176|75957018|FG001|NOT COMPLETED|Treatment Period 1||0||
59833399|NCT03777176|75957019|FG002|NOT COMPLETED|Treatment Period 1||0||
59833400|NCT03777176|75957017|FG000|STARTED|Treatment Period 2|This arm was not applicable to Treatment Period 2.|0||
59833401|NCT03777176|75957018|FG001|STARTED|Treatment Period 2|This arm was not applicable to Treatment Period 2.|0||
59833402|NCT03777176|75957019|FG002|STARTED|Treatment Period 2||32||
59833403|NCT03777176|75957017|FG000|Completed Study But Discontinued Treatment Due to an AE|Treatment Period 2||0||
59833404|NCT03777176|75957018|FG001|Completed Study But Discontinued Treatment Due to an AE|Treatment Period 2||0||
59833405|NCT03777176|75957019|FG002|Completed Study But Discontinued Treatment Due to an AE|Treatment Period 2||1||
59833406|NCT03777176|75957017|FG000|COMPLETED|Treatment Period 2||0||
59833407|NCT03777176|75957018|FG001|COMPLETED|Treatment Period 2||0||
59833408|NCT03777176|75957019|FG002|COMPLETED|Treatment Period 2||32||
59833409|NCT03777176|75957017|FG000|NOT COMPLETED|Treatment Period 2||0||
59833410|NCT03777176|75957018|FG001|NOT COMPLETED|Treatment Period 2||0||
59833411|NCT03777176|75957019|FG002|NOT COMPLETED|Treatment Period 2||0||
59833412|NCT03692910|75957028|FG000|STARTED|Overall Study||35||
59833413|NCT03692910|75957029|FG001|STARTED|Overall Study||0||
59833414|NCT03692910|75957030|FG002|STARTED|Overall Study||0||
59833415|NCT03692910|75957028|FG000|COMPLETED|Overall Study||29||
59833416|NCT03692910|75957029|FG001|COMPLETED|Overall Study||0||
59833417|NCT03692910|75957030|FG002|COMPLETED|Overall Study||0||
59717329|NCT01124916|75836370|FG001|STARTED|Overall Study||40||
59717330|NCT01124916|75836369|FG000|COMPLETED|Overall Study||35||
59717331|NCT01124916|75836370|FG001|COMPLETED|Overall Study||38||
59717332|NCT01124916|75836369|FG000|NOT COMPLETED|Overall Study||3||
59717333|NCT01124916|75836370|FG001|NOT COMPLETED|Overall Study||2||
59717334|NCT00916006|75836378|FG000|STARTED|Overall Study||135||
59717335|NCT00916006|75836379|FG001|STARTED|Overall Study||134||
59833418|NCT03692910|75957028|FG000|NOT COMPLETED|Overall Study||6||
59833419|NCT03692910|75957029|FG001|NOT COMPLETED|Overall Study||0||
59833420|NCT03692910|75957030|FG002|NOT COMPLETED|Overall Study||0||
59833421|NCT03645863|75957039|FG000|STARTED|Overall Study||21||
59833422|NCT03645863|75957040|FG001|STARTED|Overall Study||20||
59833423|NCT03645863|75957041|FG002|STARTED|Overall Study||20||
59833424|NCT03645863|75957039|FG000|COMPLETED|Overall Study||20||
59833425|NCT03645863|75957040|FG001|COMPLETED|Overall Study||20||
59833426|NCT03645863|75957041|FG002|COMPLETED|Overall Study||20||
59833427|NCT03645863|75957039|FG000|NOT COMPLETED|Overall Study||1||
59833428|NCT03645863|75957040|FG001|NOT COMPLETED|Overall Study||0||
59833429|NCT03645863|75957041|FG002|NOT COMPLETED|Overall Study||0||
59717336|NCT00916006|75836378|FG000|COMPLETED|Overall Study||132||
59717337|NCT00916006|75836379|FG001|COMPLETED|Overall Study||127||
59717338|NCT00916006|75836378|FG000|NOT COMPLETED|Overall Study||3||
59717339|NCT00916006|75836379|FG001|NOT COMPLETED|Overall Study||7||
59833430|NCT03584100|75957049|FG000|STARTED|Overall Study||12||
59833431|NCT03584100|75957049|FG000|COMPLETED|Overall Study||12||
59833432|NCT03584100|75957049|FG000|NOT COMPLETED|Overall Study||0||
59833433|NCT03220776|75957062|FG000|STARTED|Overall Study||9||
59833434|NCT03220776|75957063|FG001|STARTED|Overall Study||9||
59833435|NCT03220776|75957064|FG002|STARTED|Overall Study||9||
59833436|NCT03220776|75957065|FG003|STARTED|Overall Study||9||
59833437|NCT03220776|75957066|FG004|STARTED|Overall Study||9||
59833438|NCT03220776|75957067|FG005|STARTED|Overall Study||9||
59833439|NCT03220776|75957062|FG000|COMPLETED|Overall Study||7||
59833440|NCT03220776|75957063|FG001|COMPLETED|Overall Study||8||
59833441|NCT03220776|75957064|FG002|COMPLETED|Overall Study||8||
59833442|NCT03220776|75957065|FG003|COMPLETED|Overall Study||5||
59833443|NCT03220776|75957066|FG004|COMPLETED|Overall Study||8||
59833444|NCT03220776|75957067|FG005|COMPLETED|Overall Study||7||
59833445|NCT03220776|75957062|FG000|NOT COMPLETED|Overall Study||2||
59833446|NCT03220776|75957063|FG001|NOT COMPLETED|Overall Study||1||
59833447|NCT03220776|75957064|FG002|NOT COMPLETED|Overall Study||1||
59833448|NCT03220776|75957065|FG003|NOT COMPLETED|Overall Study||4||
59833449|NCT03220776|75957066|FG004|NOT COMPLETED|Overall Study||1||
59833450|NCT03220776|75957067|FG005|NOT COMPLETED|Overall Study||2||
59833451|NCT03201874|75957077|FG000|STARTED|Baseline||54|Parents started Education Control: 54, Adolescents started Education Control: 54, Parents started Pain Self-Management Intervention: 56, Adolescents started Pain Self-Management Intervention: 57|
59833452|NCT03201874|75957078|FG001|STARTED|Baseline||57|Parents started Education Control: 54, Adolescents started Education Control: 54, Parents started Pain Self-Management Intervention: 56, Adolescents started Pain Self-Management Intervention: 57|
59833453|NCT03201874|75957077|FG000|COMPLETED|Baseline||54|Parents completed Education Control: 50, Adolescents completed Education Control: 54, Parents completed Pain Self-Management Intervention: 55, Adolescents completed Pain Self-Management Intervention: 57|
59833454|NCT03201874|75957078|FG001|COMPLETED|Baseline||57|Parents completed Education Control: 50, Adolescents completed Education Control: 54, Parents completed Pain Self-Management Intervention: 55, Adolescents completed Pain Self-Management Intervention: 57|
59833455|NCT03201874|75957077|FG000|NOT COMPLETED|Baseline||0||
59833456|NCT03201874|75957078|FG001|NOT COMPLETED|Baseline||0||
59833457|NCT03201874|75957077|FG000|STARTED|Post-Treatment (12 Weeks)||54|Parents started Education Control: 51, Adolescents started Education Control: 54, Parents started Pain Self-Management Intervention: 56, Adolescents started Pain Self-Management Intervention: 57|
59833458|NCT03201874|75957078|FG001|STARTED|Post-Treatment (12 Weeks)||57|Parents started Education Control: 51, Adolescents started Education Control: 54, Parents started Pain Self-Management Intervention: 56, Adolescents started Pain Self-Management Intervention: 57|
59833459|NCT03201874|75957077|FG000|COMPLETED|Post-Treatment (12 Weeks)||50|Parents completed Education Control: 43, Adolescents completed Education Control: 50, Parents completed Pain Self-Management Intervention: 43, Adolescents completed Pain Self-Management Intervention: 52|
59833460|NCT03201874|75957078|FG001|COMPLETED|Post-Treatment (12 Weeks)||52|Parents completed Education Control: 43, Adolescents completed Education Control: 50, Parents completed Pain Self-Management Intervention: 43, Adolescents completed Pain Self-Management Intervention: 52|
59833461|NCT03201874|75957077|FG000|NOT COMPLETED|Post-Treatment (12 Weeks)||4||
59833462|NCT03201874|75957078|FG001|NOT COMPLETED|Post-Treatment (12 Weeks)||5||
59833463|NCT03201874|75957077|FG000|STARTED|Follow-up (26 Weeks)||54|Parents started Education Control: 51, Adolescents started Education Control: 54, Parents started Pain Self-Management Intervention: 56, Adolescents started Pain Self-Management Intervention: 57|
59833464|NCT03201874|75957078|FG001|STARTED|Follow-up (26 Weeks)||57|Parents started Education Control: 51, Adolescents started Education Control: 54, Parents started Pain Self-Management Intervention: 56, Adolescents started Pain Self-Management Intervention: 57|
59833465|NCT03201874|75957077|FG000|COMPLETED|Follow-up (26 Weeks)||49|Parents completed Education Control: 44, Adolescents completed Education Control: 49, Parents completed Pain Self-Management Intervention: 41, Adolescents completed Pain Self-Management Intervention: 49|
59996512|NCT02730377|76112486|FG001|Safety Analysis Set (SAS)|Overall Study||984||
59996513|NCT02730377|76112485|FG000|COMPLETED|Overall Study||446||
59996514|NCT02730377|76112486|FG001|COMPLETED|Overall Study||362||
59996515|NCT02730377|76112485|FG000|NOT COMPLETED|Overall Study||550||
59717340|NCT04701814|75836387|FG000|STARTED|Overall Study||20||
59717341|NCT04701814|75836388|FG001|STARTED|Overall Study||18||
59717342|NCT04701814|75836387|FG000|COMPLETED|Overall Study||15||
59717343|NCT04701814|75836388|FG001|COMPLETED|Overall Study||15||
59717344|NCT04701814|75836387|FG000|NOT COMPLETED|Overall Study||5||
59717345|NCT04701814|75836388|FG001|NOT COMPLETED|Overall Study||3||
59717346|NCT01168349|75836396|FG000|STARTED|Overall Study||1055||
59717347|NCT01168349|75836396|FG000|COMPLETED|Overall Study||754||
59717348|NCT01168349|75836396|FG000|NOT COMPLETED|Overall Study||301||
59717349|NCT00915772|75836419|FG000|STARTED|Overall Study||170||
59717350|NCT00915772|75836420|FG001|STARTED|Overall Study||225||
59717351|NCT00915772|75836421|FG002|STARTED|Overall Study||171||
59717352|NCT00915772|75836419|FG000|COMPLETED|Overall Study||134||
59717353|NCT00915772|75836420|FG001|COMPLETED|Overall Study||179||
59717354|NCT00915772|75836421|FG002|COMPLETED|Overall Study||142||
59717355|NCT00915772|75836419|FG000|NOT COMPLETED|Overall Study||36||
59717356|NCT00915772|75836420|FG001|NOT COMPLETED|Overall Study||46||
59717357|NCT00915772|75836421|FG002|NOT COMPLETED|Overall Study||29||
59717358|NCT00912964|75836433|FG000|STARTED|Overall Study||433||
59717359|NCT00912964|75836434|FG001|STARTED|Overall Study||433||
59717360|NCT00912964|75836435|FG002|STARTED|Overall Study||440||
59833466|NCT03201874|75957078|FG001|COMPLETED|Follow-up (26 Weeks)||49|Parents completed Education Control: 44, Adolescents completed Education Control: 49, Parents completed Pain Self-Management Intervention: 41, Adolescents completed Pain Self-Management Intervention: 49|
60118706|NCT01681433|76239670|FG001|NOT COMPLETED|Overall Study||33||
60118707|NCT01681277|76239681|FG000|STARTED|Overall Study||12||
59717361|NCT00912964|75836433|FG000|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|433||
59717362|NCT00912964|75836434|FG001|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|432||
59717363|NCT00912964|75836435|FG002|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|440||
59717364|NCT00912964|75836433|FG000|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 post-baseline micturition measurement.|415||
59717365|NCT00912964|75836434|FG001|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 post-baseline micturition measurement.|410||
59717366|NCT00912964|75836435|FG002|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 post-baseline micturition measurement.|426||
59717367|NCT00912964|75836433|FG000|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at Baseline.|262||
59717368|NCT00912964|75836434|FG001|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at Baseline.|254||
59717369|NCT00912964|75836435|FG002|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at Baseline.|257||
59717370|NCT00912964|75836433|FG000|COMPLETED|Overall Study||367||
59717371|NCT00912964|75836434|FG001|COMPLETED|Overall Study||387||
59717372|NCT00912964|75836435|FG002|COMPLETED|Overall Study||386||
59717373|NCT00912964|75836433|FG000|NOT COMPLETED|Overall Study||66||
59717374|NCT00912964|75836434|FG001|NOT COMPLETED|Overall Study||46||
59717375|NCT00912964|75836435|FG002|NOT COMPLETED|Overall Study||54||
59717376|NCT00913744|75836445|FG000|STARTED|Overall Study||75||
59717377|NCT00913744|75836446|FG001|STARTED|Overall Study||25||
59717378|NCT00913744|75836445|FG000|COMPLETED|Overall Study||70||
59717379|NCT00913744|75836446|FG001|COMPLETED|Overall Study||24||
59717380|NCT00913744|75836445|FG000|NOT COMPLETED|Overall Study||5||
59717381|NCT00913744|75836446|FG001|NOT COMPLETED|Overall Study||1||
59717382|NCT00912808|75836454|FG000|STARTED|First Intervention (6 Weeks)||11||
59717383|NCT00912808|75836455|FG001|STARTED|First Intervention (6 Weeks)||12||
59717384|NCT00912808|75836454|FG000|Received Intervention|First Intervention (6 Weeks)||11||
59717385|NCT00912808|75836455|FG001|Received Intervention|First Intervention (6 Weeks)||12||
59717386|NCT00912808|75836454|FG000|COMPLETED|First Intervention (6 Weeks)||9||
59717387|NCT00912808|75836455|FG001|COMPLETED|First Intervention (6 Weeks)||11||
59717388|NCT00912808|75836454|FG000|NOT COMPLETED|First Intervention (6 Weeks)||2||
59717389|NCT00912808|75836455|FG001|NOT COMPLETED|First Intervention (6 Weeks)||1||
59717390|NCT00912808|75836454|FG000|STARTED|Washout||9||
59717391|NCT00912808|75836455|FG001|STARTED|Washout||11||
59717392|NCT00912808|75836454|FG000|COMPLETED|Washout||9||
59717393|NCT00912808|75836455|FG001|COMPLETED|Washout||10||
59717394|NCT00912808|75836454|FG000|NOT COMPLETED|Washout||0||
59717395|NCT00912808|75836455|FG001|NOT COMPLETED|Washout||1||
59717396|NCT00912808|75836454|FG000|STARTED|Second Intervention (6 Weeks)||9||
59717397|NCT00912808|75836455|FG001|STARTED|Second Intervention (6 Weeks)||10||
59717398|NCT00912808|75836454|FG000|Received Intervention|Second Intervention (6 Weeks)||9||
59717399|NCT00912808|75836455|FG001|Received Intervention|Second Intervention (6 Weeks)||10||
59717400|NCT00912808|75836454|FG000|COMPLETED|Second Intervention (6 Weeks)||8||
59717401|NCT00912808|75836455|FG001|COMPLETED|Second Intervention (6 Weeks)||9||
59717402|NCT00912808|75836454|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||1||
59717403|NCT00912808|75836455|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||1||
59717404|NCT00960531|75836472|FG000|STARTED|Overall Study|Started=Randomized|21||
59833467|NCT03201874|75957077|FG000|NOT COMPLETED|Follow-up (26 Weeks)||5||
60118708|NCT01681277|76239682|FG001|STARTED|Overall Study||9||
60118709|NCT01681277|76239683|FG002|STARTED|Overall Study||9||
60118710|NCT01681277|76239684|FG003|STARTED|Overall Study||9||
60118711|NCT01681277|76239685|FG004|STARTED|Overall Study||9||
60118712|NCT01681277|76239681|FG000|COMPLETED|Overall Study||11||
60118713|NCT01681277|76239682|FG001|COMPLETED|Overall Study||9||
60118714|NCT01681277|76239683|FG002|COMPLETED|Overall Study||9||
60118715|NCT01681277|76239684|FG003|COMPLETED|Overall Study||9||
59717405|NCT00960531|75836473|FG001|STARTED|Overall Study|Started=Randomized|6||
59717406|NCT00960531|75836474|FG002|STARTED|Overall Study|Started=Randomized|41||
59717407|NCT00960531|75836475|FG003|STARTED|Overall Study|Started=Randomized.|25||
59717408|NCT00960531|75836476|FG004|STARTED|Overall Study|Started=Randomized|5||
59717409|NCT00960531|75836477|FG005|STARTED|Overall Study|Started=Randomized|9||
59717410|NCT00960531|75836478|FG006|STARTED|Overall Study|Started=Randomized|27||
59717411|NCT00960531|75836479|FG007|STARTED|Overall Study|Started=Randomized|6||
59717412|NCT00960531|75836480|FG008|STARTED|Overall Study|Started=Randomized|16||
59717413|NCT00960531|75836481|FG009|STARTED|Overall Study|Started=Randomized|4||
59717414|NCT00960531|75836472|FG000|Treated|Overall Study||21||
59717415|NCT00960531|75836473|FG001|Treated|Overall Study||6||
59717416|NCT00960531|75836474|FG002|Treated|Overall Study||41||
59717417|NCT00960531|75836475|FG003|Treated|Overall Study||24||
59717418|NCT00960531|75836476|FG004|Treated|Overall Study||5||
59833468|NCT03201874|75957078|FG001|NOT COMPLETED|Follow-up (26 Weeks)||8||
59833469|NCT03014648|75957089|FG000|STARTED|Overall Study||28||
59833470|NCT03014648|75957089|FG000|COMPLETED|Overall Study||28||
59833471|NCT03014648|75957089|FG000|NOT COMPLETED|Overall Study||0||
59833472|NCT03009045|75957099|FG000|STARTED|Overall Study||44||
59833473|NCT03009045|75957099|FG000|COMPLETED|Overall Study||37||
59833474|NCT03009045|75957099|FG000|NOT COMPLETED|Overall Study||7||
59833475|NCT03006926|75957105|FG000|STARTED|Overall Study||6||
59833476|NCT03006926|75957106|FG001|STARTED|Overall Study||98||
59833477|NCT03006926|75957105|FG000|Japanese Population|Overall Study||6||
59833478|NCT03006926|75957106|FG001|Japanese Population|Overall Study||16||
59833479|NCT03006926|75957105|FG000|Non-Japanese Population|Overall Study||0||
59833480|NCT03006926|75957106|FG001|Non-Japanese Population|Overall Study||82||
59833481|NCT03006926|75957105|FG000|COMPLETED|Overall Study||6||
59833482|NCT03006926|75957106|FG001|COMPLETED|Overall Study||0||
59833483|NCT03006926|75957105|FG000|NOT COMPLETED|Overall Study||0||
59833484|NCT03006926|75957106|FG001|NOT COMPLETED|Overall Study||98||
59833485|NCT02807636|75957122|FG000|STARTED|Overall Study||400||
59833486|NCT02807636|75957123|FG001|STARTED|Overall Study||451||
59833487|NCT02807636|75957124|FG002|STARTED|Overall Study||362||
59833488|NCT02807636|75957122|FG000|COMPLETED|Overall Study||0||
59833489|NCT02807636|75957123|FG001|COMPLETED|Overall Study||0||
59833490|NCT02807636|75957124|FG002|COMPLETED|Overall Study||0||
59833491|NCT02807636|75957122|FG000|NOT COMPLETED|Overall Study||400||
59717419|NCT00960531|75836477|FG005|Treated|Overall Study||9||
59717420|NCT00960531|75836478|FG006|Treated|Overall Study||27||
59717421|NCT00960531|75836479|FG007|Treated|Overall Study||6||
59717422|NCT00960531|75836480|FG008|Treated|Overall Study||16||
59717423|NCT00960531|75836481|FG009|Treated|Overall Study||4||
59717424|NCT00960531|75836472|FG000|Completed Treatment|Overall Study||12||
59717425|NCT00960531|75836473|FG001|Completed Treatment|Overall Study||5||
59717426|NCT00960531|75836474|FG002|Completed Treatment|Overall Study||15||
59833492|NCT02807636|75957123|FG001|NOT COMPLETED|Overall Study||451||
59833493|NCT02807636|75957124|FG002|NOT COMPLETED|Overall Study||362||
59833494|NCT02769338|75957135|FG000|STARTED|Baseline Period||162||6
59833495|NCT02769338|75957136|FG001|STARTED|Baseline Period||973||36
59833496|NCT02769338|75957135|FG000|COMPLETED|Baseline Period||162||6
59833497|NCT02769338|75957136|FG001|COMPLETED|Baseline Period||973||36
59833498|NCT02769338|75957135|FG000|NOT COMPLETED|Baseline Period||0||0
59833499|NCT02769338|75957136|FG001|NOT COMPLETED|Baseline Period||0||0
59833500|NCT02769338|75957135|FG000|STARTED|Active Implementation Period|As described in the baseline characteristics tab, there were 6 PREVENT intervention sites and 36 control sites. Different patients were cared for at these sites during the baseline period versus the active implementation period: PREVENT Intervention baseline N=162, intervention implementation N=189; control baseline N=973, control implementation N=968.|189||6
59833501|NCT02769338|75957136|FG001|STARTED|Active Implementation Period||968||36
59833502|NCT02769338|75957135|FG000|COMPLETED|Active Implementation Period||189||6
59833503|NCT02769338|75957136|FG001|COMPLETED|Active Implementation Period||968||36
59833504|NCT02769338|75957135|FG000|NOT COMPLETED|Active Implementation Period||0||0
59833505|NCT02769338|75957136|FG001|NOT COMPLETED|Active Implementation Period||0||0
60118716|NCT01681277|76239685|FG004|COMPLETED|Overall Study||9||
60118717|NCT01681277|76239681|FG000|NOT COMPLETED|Overall Study||1||
60118718|NCT01681277|76239682|FG001|NOT COMPLETED|Overall Study||0||
60118719|NCT01681277|76239683|FG002|NOT COMPLETED|Overall Study||0||
60118720|NCT01681277|76239684|FG003|NOT COMPLETED|Overall Study||0||
59717427|NCT00960531|75836475|FG003|Completed Treatment|Overall Study||17||
59717428|NCT00960531|75836476|FG004|Completed Treatment|Overall Study||3||
59717429|NCT00960531|75836477|FG005|Completed Treatment|Overall Study||7||
60118721|NCT01681277|76239685|FG004|NOT COMPLETED|Overall Study||0||
59717430|NCT00960531|75836478|FG006|Completed Treatment|Overall Study||4||
59833506|NCT02684058|75957146|FG000|STARTED|Treatment Period||73||
59833507|NCT02684058|75957147|FG001|STARTED|Treatment Period||37||
59833508|NCT02684058|75957148|FG002|STARTED|Treatment Period||41||
59833509|NCT02684058|75957146|FG000|Treated|Treatment Period||73||
59833510|NCT02684058|75957147|FG001|Treated|Treatment Period||33||
59833511|NCT02684058|75957148|FG002|Treated|Treatment Period||41||
59833512|NCT02684058|75957146|FG000|COMPLETED|Treatment Period||56||
59833513|NCT02684058|75957147|FG001|COMPLETED|Treatment Period||14||
59833514|NCT02684058|75957148|FG002|COMPLETED|Treatment Period||17||
59833515|NCT02684058|75957146|FG000|NOT COMPLETED|Treatment Period||17||
59717431|NCT00960531|75836479|FG007|Completed Treatment|Overall Study||3||
59717432|NCT00960531|75836480|FG008|Completed Treatment|Overall Study||2||
59717433|NCT00960531|75836481|FG009|Completed Treatment|Overall Study||4||
59717434|NCT00960531|75836472|FG000|COMPLETED|Overall Study|Completed study|11||
59717435|NCT00960531|75836473|FG001|COMPLETED|Overall Study|Completed study|5||
59833516|NCT02684058|75957147|FG001|NOT COMPLETED|Treatment Period||23||
60118722|NCT01703117|76239703|FG000|STARTED|Overall Study||26||
60118723|NCT01703117|76239704|FG001|STARTED|Overall Study||24||
59833517|NCT02684058|75957148|FG002|NOT COMPLETED|Treatment Period||24||
59833518|NCT02684058|75957146|FG000|STARTED|Post-treatment Efficacy Follow-up||9|Participants who discontinued study treatment for reasons other than disease progression, death, loss to follow up, or withdrawal of consent|
59833519|NCT02684058|75957147|FG001|STARTED|Post-treatment Efficacy Follow-up||22|Participants who discontinued study treatment for reasons other than disease progression, death, loss to follow up, or withdrawal of consent|
59833520|NCT02684058|75957148|FG002|STARTED|Post-treatment Efficacy Follow-up||5|Participants who discontinued study treatment for reasons other than disease progression, death, loss to follow up, or withdrawal of consent|
59833521|NCT02684058|75957146|FG000|COMPLETED|Post-treatment Efficacy Follow-up||2||
59833522|NCT02684058|75957147|FG001|COMPLETED|Post-treatment Efficacy Follow-up||14||
59833523|NCT02684058|75957148|FG002|COMPLETED|Post-treatment Efficacy Follow-up||2||
59833524|NCT02684058|75957146|FG000|NOT COMPLETED|Post-treatment Efficacy Follow-up||7||
59833525|NCT02684058|75957147|FG001|NOT COMPLETED|Post-treatment Efficacy Follow-up||8||
59833526|NCT02684058|75957148|FG002|NOT COMPLETED|Post-treatment Efficacy Follow-up||3||
59833527|NCT02684058|75957146|FG000|STARTED|Post-treatment Survival Follow-up||11||
59833528|NCT02684058|75957147|FG001|STARTED|Post-treatment Survival Follow-up||1||
59833529|NCT02684058|75957148|FG002|STARTED|Post-treatment Survival Follow-up||9||
59833530|NCT02684058|75957146|FG000|COMPLETED|Post-treatment Survival Follow-up||10|Alive at the end of the study|
59833531|NCT02684058|75957147|FG001|COMPLETED|Post-treatment Survival Follow-up||1|Alive at the end of the study|
59833532|NCT02684058|75957148|FG002|COMPLETED|Post-treatment Survival Follow-up||2|Alive at the end of the study|
59833533|NCT02684058|75957146|FG000|NOT COMPLETED|Post-treatment Survival Follow-up||1||
59833534|NCT02684058|75957147|FG001|NOT COMPLETED|Post-treatment Survival Follow-up||0||
59833535|NCT02684058|75957148|FG002|NOT COMPLETED|Post-treatment Survival Follow-up||7||
59833536|NCT02684058|75957146|FG000|STARTED|Crossover Treatment Period||0|Participants randomized to the carboplatin with vincristine treatment arm were allowed to cross-over to receive dabrafenib in combination with trametinib treatment after centrally confirmed and RANO-defined disease progression|
59833537|NCT02684058|75957147|FG001|STARTED|Crossover Treatment Period||12|Participants randomized to the carboplatin with vincristine treatment arm were allowed to cross-over to receive dabrafenib in combination with trametinib treatment after centrally confirmed and RANO-defined disease progression|
59833538|NCT02684058|75957148|FG002|STARTED|Crossover Treatment Period||0|Participants randomized to the carboplatin with vincristine treatment arm were allowed to cross-over to receive dabrafenib in combination with trametinib treatment after centrally confirmed and RANO-defined disease progression|
59833539|NCT02684058|75957146|FG000|COMPLETED|Crossover Treatment Period||0||
59833540|NCT02684058|75957147|FG001|COMPLETED|Crossover Treatment Period||11||
59833541|NCT02684058|75957148|FG002|COMPLETED|Crossover Treatment Period||0||
59833542|NCT02684058|75957146|FG000|NOT COMPLETED|Crossover Treatment Period||0||
59833543|NCT02684058|75957147|FG001|NOT COMPLETED|Crossover Treatment Period||1||
59833544|NCT02684058|75957148|FG002|NOT COMPLETED|Crossover Treatment Period||0||
59833545|NCT02561273|75957165|FG000|STARTED|Overall Study||40||
59833546|NCT02561273|75957166|FG001|STARTED|Overall Study||4||
59833547|NCT02561273|75957165|FG000|COMPLETED|Overall Study||39||
59833548|NCT02561273|75957166|FG001|COMPLETED|Overall Study||4||
60118724|NCT01703117|76239703|FG000|COMPLETED|Overall Study||22||
60118725|NCT01703117|76239704|FG001|COMPLETED|Overall Study||20||
60118726|NCT01703117|76239703|FG000|NOT COMPLETED|Overall Study||4||
60118727|NCT01703117|76239704|FG001|NOT COMPLETED|Overall Study||4||
60118728|NCT01702961|76239712|FG000|STARTED|Overall Study||75||
60118729|NCT01702961|76239712|FG000|COMPLETED|Overall Study||28||
60118730|NCT01702961|76239712|FG000|NOT COMPLETED|Overall Study||47||
60118731|NCT01593917|76239716|FG000|STARTED|Overall Study||329||
60118732|NCT01593917|76239716|FG000|COMPLETED|Overall Study||159||
60118733|NCT01593917|76239716|FG000|NOT COMPLETED|Overall Study||170||
60118734|NCT01593761|76239720|FG000|STARTED|Overall Study||20||
60118735|NCT01593761|76239720|FG000|COMPLETED|Overall Study||12||
60118736|NCT01593761|76239720|FG000|NOT COMPLETED|Overall Study||8||
60118737|NCT02706834|76239741|FG000|STARTED|Overall Study||3||
60118738|NCT02706834|76239742|FG001|STARTED|Overall Study||3||
60118739|NCT02706834|76239743|FG002|STARTED|Overall Study||3||
60118740|NCT02706834|76239744|FG003|STARTED|Overall Study||3||
60118741|NCT02706834|76239745|FG004|STARTED|Overall Study||3||
60118742|NCT02706834|76239746|FG005|STARTED|Overall Study||3||
60118743|NCT02706834|76239747|FG006|STARTED|Overall Study||3||
60118744|NCT02706834|76239748|FG007|STARTED|Overall Study||3||
60118745|NCT02706834|76239749|FG008|STARTED|Overall Study||4||
60118746|NCT02706834|76239750|FG009|STARTED|Overall Study||4||
60118747|NCT02706834|76239751|FG010|STARTED|Overall Study||4||
60118748|NCT02706834|76239741|FG000|COMPLETED|Overall Study|Completed = completed study drug|1||
60118749|NCT02706834|76239742|FG001|COMPLETED|Overall Study||2||
60118750|NCT02706834|76239743|FG002|COMPLETED|Overall Study||2||
60118751|NCT02706834|76239744|FG003|COMPLETED|Overall Study||3||
60118752|NCT02706834|76239745|FG004|COMPLETED|Overall Study||2||
59567501|NCT02326272|75670464|FG011|Completed Week 16|Initial Period (Week 0 to Week 16)||0||
60118753|NCT02706834|76239746|FG005|COMPLETED|Overall Study||3||
60118754|NCT02706834|76239747|FG006|COMPLETED|Overall Study||3||
60118755|NCT02706834|76239748|FG007|COMPLETED|Overall Study||3||
59833549|NCT02561273|75957165|FG000|NOT COMPLETED|Overall Study||1||
59833550|NCT02561273|75957166|FG001|NOT COMPLETED|Overall Study||0||
59833551|NCT02502006|75957174|FG000|STARTED|Celecoxib||16||
59833552|NCT02502006|75957174|FG000|COMPLETED|Celecoxib||16||
59833553|NCT02502006|75957174|FG000|NOT COMPLETED|Celecoxib||0||
59833554|NCT02502006|75957174|FG000|STARTED|Naproxen||16||
59833555|NCT02502006|75957174|FG000|COMPLETED|Naproxen||16||
59833556|NCT02502006|75957174|FG000|NOT COMPLETED|Naproxen||0||
59833557|NCT02502006|75957174|FG000|STARTED|Placebo||16||
59833558|NCT02502006|75957174|FG000|COMPLETED|Placebo||16||
59833559|NCT02502006|75957174|FG000|NOT COMPLETED|Placebo||0||
59833560|NCT02323698|75957185|FG000|STARTED|Overall Study||2||
59833561|NCT02323698|75957186|FG001|STARTED|Overall Study||2||
59833562|NCT02323698|75957187|FG002|STARTED|Overall Study||2||
59833563|NCT02323698|75957188|FG003|STARTED|Overall Study||2||
59833564|NCT02323698|75957189|FG004|STARTED|Overall Study||2||
59833565|NCT02323698|75957190|FG005|STARTED|Overall Study||2||
59833566|NCT02323698|75957185|FG000|Completed First Intervention (5 Days)|Overall Study||2||
59833567|NCT02323698|75957186|FG001|Completed First Intervention (5 Days)|Overall Study||2||
59833568|NCT02323698|75957187|FG002|Completed First Intervention (5 Days)|Overall Study||2||
59833569|NCT02323698|75957188|FG003|Completed First Intervention (5 Days)|Overall Study||2||
59833570|NCT02323698|75957189|FG004|Completed First Intervention (5 Days)|Overall Study||2||
59833571|NCT02323698|75957190|FG005|Completed First Intervention (5 Days)|Overall Study||2||
59833572|NCT02323698|75957185|FG000|Completed Second Intervention (5 Days)|Overall Study||2||
59833573|NCT02323698|75957186|FG001|Completed Second Intervention (5 Days)|Overall Study||2||
59833574|NCT02323698|75957187|FG002|Completed Second Intervention (5 Days)|Overall Study||1||
59833575|NCT02323698|75957188|FG003|Completed Second Intervention (5 Days)|Overall Study||2||
59833576|NCT02323698|75957189|FG004|Completed Second Intervention (5 Days)|Overall Study||2||
59833577|NCT02323698|75957190|FG005|Completed Second Intervention (5 Days)|Overall Study||2||
59833578|NCT02323698|75957185|FG000|Completed Third Intervention (5 Days)|Overall Study||2||
59833579|NCT02323698|75957186|FG001|Completed Third Intervention (5 Days)|Overall Study||2||
59833580|NCT02323698|75957187|FG002|Completed Third Intervention (5 Days)|Overall Study||0||
59833581|NCT02323698|75957188|FG003|Completed Third Intervention (5 Days)|Overall Study||2||
59833582|NCT02323698|75957189|FG004|Completed Third Intervention (5 Days)|Overall Study||1||
59833583|NCT02323698|75957190|FG005|Completed Third Intervention (5 Days)|Overall Study||2||
59833584|NCT02323698|75957185|FG000|COMPLETED|Overall Study||2||
59717436|NCT00960531|75836474|FG002|COMPLETED|Overall Study|Completed study|15||
59717437|NCT00960531|75836475|FG003|COMPLETED|Overall Study|Completed study|17||
59717438|NCT00960531|75836476|FG004|COMPLETED|Overall Study|Completed study|3||
59717439|NCT00960531|75836477|FG005|COMPLETED|Overall Study|Completed study|6||
59833585|NCT02323698|75957186|FG001|COMPLETED|Overall Study||2||
59833586|NCT02323698|75957187|FG002|COMPLETED|Overall Study||0||
59833587|NCT02323698|75957188|FG003|COMPLETED|Overall Study||2||
59833588|NCT02323698|75957189|FG004|COMPLETED|Overall Study||1||
59833589|NCT02323698|75957190|FG005|COMPLETED|Overall Study||2||
59833590|NCT02323698|75957185|FG000|NOT COMPLETED|Overall Study||0||
59833591|NCT02323698|75957186|FG001|NOT COMPLETED|Overall Study||0||
59833592|NCT02323698|75957187|FG002|NOT COMPLETED|Overall Study||2||
59833593|NCT02323698|75957188|FG003|NOT COMPLETED|Overall Study||0||
59833594|NCT02323698|75957189|FG004|NOT COMPLETED|Overall Study||1||
60118756|NCT02706834|76239749|FG008|COMPLETED|Overall Study||4||
60118757|NCT02706834|76239750|FG009|COMPLETED|Overall Study||3||
60118758|NCT02706834|76239751|FG010|COMPLETED|Overall Study||3||
60118759|NCT02706834|76239741|FG000|NOT COMPLETED|Overall Study||2||
60118760|NCT02706834|76239742|FG001|NOT COMPLETED|Overall Study||1||
59717440|NCT00960531|75836478|FG006|COMPLETED|Overall Study|Completed study|3||
59717441|NCT00960531|75836479|FG007|COMPLETED|Overall Study|Completed study|2||
59717442|NCT00960531|75836480|FG008|COMPLETED|Overall Study|Completed study|2||
60118761|NCT02706834|76239743|FG002|NOT COMPLETED|Overall Study||1||
60118762|NCT02706834|76239744|FG003|NOT COMPLETED|Overall Study||0||
59717443|NCT00960531|75836481|FG009|COMPLETED|Overall Study|Completed study|3||
59717444|NCT00960531|75836472|FG000|NOT COMPLETED|Overall Study||10||
59717445|NCT00960531|75836473|FG001|NOT COMPLETED|Overall Study||1||
59717446|NCT00960531|75836474|FG002|NOT COMPLETED|Overall Study||26||
59833595|NCT02323698|75957190|FG005|NOT COMPLETED|Overall Study||0||
59833596|NCT02101008|75957198|FG000|STARTED|Overall Study||12||
59833597|NCT02101008|75957198|FG000|COMPLETED|Overall Study||12||
59833598|NCT02101008|75957198|FG000|NOT COMPLETED|Overall Study||0||
59833599|NCT02025010|75957202|FG000|STARTED|Overall Study||60||
59833600|NCT02025010|75957202|FG000|COMPLETED|Overall Study||0||
59833601|NCT02025010|75957202|FG000|NOT COMPLETED|Overall Study||60||
59833602|NCT02006576|75957211|FG000|STARTED|Overall Study||35||
59833603|NCT02006576|75957212|FG001|STARTED|Overall Study||51||
59833604|NCT02006576|75957213|FG002|STARTED|Overall Study||32||
59833605|NCT02006576|75957211|FG000|COMPLETED|Overall Study||17||
59833606|NCT02006576|75957212|FG001|COMPLETED|Overall Study||44||
59833607|NCT02006576|75957213|FG002|COMPLETED|Overall Study||15||
59833608|NCT02006576|75957211|FG000|NOT COMPLETED|Overall Study||18||
60118763|NCT02706834|76239745|FG004|NOT COMPLETED|Overall Study||1||
60118764|NCT02706834|76239746|FG005|NOT COMPLETED|Overall Study||0||
60118765|NCT02706834|76239747|FG006|NOT COMPLETED|Overall Study||0||
60118766|NCT02706834|76239748|FG007|NOT COMPLETED|Overall Study||0||
60118767|NCT02706834|76239749|FG008|NOT COMPLETED|Overall Study||0||
59567502|NCT02326272|75670465|FG012|Completed Week 16|Initial Period (Week 0 to Week 16)||0||
59567503|NCT02326272|75670466|FG013|Completed Week 16|Initial Period (Week 0 to Week 16)||0||
59717447|NCT00960531|75836475|FG003|NOT COMPLETED|Overall Study||8||
59717448|NCT00960531|75836476|FG004|NOT COMPLETED|Overall Study||2||
59717449|NCT00960531|75836477|FG005|NOT COMPLETED|Overall Study||3||
59717450|NCT00960531|75836478|FG006|NOT COMPLETED|Overall Study||24||
59717451|NCT00960531|75836479|FG007|NOT COMPLETED|Overall Study||4||
59717452|NCT00960531|75836480|FG008|NOT COMPLETED|Overall Study||14||
59717453|NCT00960531|75836481|FG009|NOT COMPLETED|Overall Study||1||
59717454|NCT00960375|75836509|FG000|STARTED|Overall Study||92||
59717455|NCT00960375|75836510|FG001|STARTED|Overall Study||87||
59717456|NCT00960375|75836509|FG000|COMPLETED|Overall Study||72||
59717457|NCT00960375|75836510|FG001|COMPLETED|Overall Study||65||
59717458|NCT00960375|75836509|FG000|NOT COMPLETED|Overall Study||20||
59717459|NCT00960375|75836510|FG001|NOT COMPLETED|Overall Study||22||
59717460|NCT02964585|75836518|FG000|STARTED|Overall Study||15||
59717461|NCT02964585|75836519|FG001|STARTED|Overall Study||14||
59717462|NCT02964585|75836518|FG000|COMPLETED|Overall Study||15||
60118768|NCT02706834|76239750|FG009|NOT COMPLETED|Overall Study||1||
60118769|NCT02706834|76239751|FG010|NOT COMPLETED|Overall Study||1||
60118770|NCT01702025|76239800|FG000|STARTED|Overall Study||11||
60118771|NCT01702025|76239801|FG001|STARTED|Overall Study||10||
60118772|NCT01702025|76239802|FG002|STARTED|Overall Study||10||
60118773|NCT01702025|76239803|FG003|STARTED|Overall Study||10||
59833609|NCT02006576|75957212|FG001|NOT COMPLETED|Overall Study||7||
59833610|NCT02006576|75957213|FG002|NOT COMPLETED|Overall Study||17||
59833611|NCT01651403|75957223|FG000|STARTED|Double-Blind Period (Through Week 48/72)||60||
59833612|NCT01651403|75957224|FG001|STARTED|Double-Blind Period (Through Week 48/72)||30||
59833613|NCT01651403|75957223|FG000|COMPLETED|Double-Blind Period (Through Week 48/72)||56||
59833614|NCT01651403|75957224|FG001|COMPLETED|Double-Blind Period (Through Week 48/72)||25||
59833615|NCT01651403|75957223|FG000|NOT COMPLETED|Double-Blind Period (Through Week 48/72)||4||
59833616|NCT01651403|75957224|FG001|NOT COMPLETED|Double-Blind Period (Through Week 48/72)||5||
59833617|NCT01651403|75957223|FG000|STARTED|Open-Label Phase (Weeks 49/73-192)||56||
59833618|NCT01651403|75957224|FG001|STARTED|Open-Label Phase (Weeks 49/73-192)||25||
59833619|NCT01651403|75957223|FG000|COMPLETED|Open-Label Phase (Weeks 49/73-192)||35||
59833620|NCT01651403|75957224|FG001|COMPLETED|Open-Label Phase (Weeks 49/73-192)||11||
59833621|NCT01651403|75957223|FG000|NOT COMPLETED|Open-Label Phase (Weeks 49/73-192)||21||
59833622|NCT01651403|75957224|FG001|NOT COMPLETED|Open-Label Phase (Weeks 49/73-192)||14||
59833623|NCT01515748|75957237|FG000|STARTED|Overall Study||264|Randomized|
59833624|NCT01515748|75957238|FG001|STARTED|Overall Study||266|Randomized|
59833625|NCT01515748|75957237|FG000|Treated|Overall Study||195||
59833626|NCT01515748|75957238|FG001|Treated|Overall Study||241||
59833627|NCT01515748|75957237|FG000|COMPLETED|Overall Study||225||
59833628|NCT01515748|75957238|FG001|COMPLETED|Overall Study||211||
59833629|NCT01515748|75957237|FG000|NOT COMPLETED|Overall Study||39||
59833630|NCT01515748|75957238|FG001|NOT COMPLETED|Overall Study||55||
59833631|NCT01309672|75957245|FG000|STARTED|Overall Study||41||
59833632|NCT01309672|75957245|FG000|Received Protocol Treatment|Overall Study||40||
59833633|NCT01309672|75957245|FG000|COMPLETED|Overall Study||4||
59833634|NCT01309672|75957245|FG000|NOT COMPLETED|Overall Study||37||
59833635|NCT01085435|75957250|FG000|STARTED|Overall Study||994|signed consent|
59833636|NCT01085435|75957250|FG000|Baseline|Overall Study||984|implanted & followed|
59833637|NCT01085435|75957250|FG000|COMPLETED|Overall Study||703||
59833638|NCT01085435|75957250|FG000|NOT COMPLETED|Overall Study||291||
59833639|NCT00340704|75957263|FG000|STARTED|PK Study||10||
59833640|NCT00340704|75957264|FG001|STARTED|PK Study||10||
59833641|NCT00340704|75957265|FG002|STARTED|PK Study||11||
59833642|NCT00340704|75957266|FG003|STARTED|PK Study||0||
59833643|NCT00340704|75957267|FG004|STARTED|PK Study||0||
59833644|NCT00340704|75957268|FG005|STARTED|PK Study||0||
59833645|NCT00340704|75957269|FG006|STARTED|PK Study||0||
59833646|NCT00340704|75957270|FG007|STARTED|PK Study||0||
59833647|NCT00340704|75957271|FG008|STARTED|PK Study||0||
59833648|NCT00340704|75957263|FG000|COMPLETED|PK Study||10||
59833649|NCT00340704|75957264|FG001|COMPLETED|PK Study||9||
59833650|NCT00340704|75957265|FG002|COMPLETED|PK Study||10||
59833651|NCT00340704|75957266|FG003|COMPLETED|PK Study||0||
59833652|NCT00340704|75957267|FG004|COMPLETED|PK Study||0||
59833653|NCT00340704|75957268|FG005|COMPLETED|PK Study||0||
59833654|NCT00340704|75957269|FG006|COMPLETED|PK Study||0||
59833655|NCT00340704|75957270|FG007|COMPLETED|PK Study||0||
59717463|NCT02964585|75836519|FG001|COMPLETED|Overall Study||14||
59717464|NCT02964585|75836518|FG000|NOT COMPLETED|Overall Study||0||
59717465|NCT02964585|75836519|FG001|NOT COMPLETED|Overall Study||0||
59717466|NCT00957801|75836529|FG000|STARTED|Overall Study||7||
59717467|NCT00957801|75836530|FG001|STARTED|Overall Study||7||
59717468|NCT00957801|75836531|FG002|STARTED|Overall Study||7||
59717469|NCT00957801|75836532|FG003|STARTED|Overall Study||8||
59717470|NCT00957801|75836529|FG000|COMPLETED|Overall Study||7||
59717471|NCT00957801|75836530|FG001|COMPLETED|Overall Study||7||
59717472|NCT00957801|75836531|FG002|COMPLETED|Overall Study||7||
59717473|NCT00957801|75836532|FG003|COMPLETED|Overall Study||7||
59717474|NCT00957801|75836529|FG000|NOT COMPLETED|Overall Study||0||
59717475|NCT00957801|75836530|FG001|NOT COMPLETED|Overall Study||0||
59717476|NCT00957801|75836531|FG002|NOT COMPLETED|Overall Study||0||
59717477|NCT00957801|75836532|FG003|NOT COMPLETED|Overall Study||1||
59833656|NCT00340704|75957271|FG008|COMPLETED|PK Study||0||
59833657|NCT00340704|75957263|FG000|NOT COMPLETED|PK Study||0||
59717478|NCT00957723|75836542|FG000|STARTED|Overall Study||411||
59833658|NCT00340704|75957264|FG001|NOT COMPLETED|PK Study||1||
59833659|NCT00340704|75957265|FG002|NOT COMPLETED|PK Study||1||
59833660|NCT00340704|75957266|FG003|NOT COMPLETED|PK Study||0||
59833661|NCT00340704|75957267|FG004|NOT COMPLETED|PK Study||0||
59833662|NCT00340704|75957268|FG005|NOT COMPLETED|PK Study||0||
59833663|NCT00340704|75957269|FG006|NOT COMPLETED|PK Study||0||
59833664|NCT00340704|75957270|FG007|NOT COMPLETED|PK Study||0||
59833665|NCT00340704|75957271|FG008|NOT COMPLETED|PK Study||0||
59833666|NCT00340704|75957263|FG000|STARTED|Group D- Denovo & 527.51 Rollover Study||0||
59833667|NCT00340704|75957264|FG001|STARTED|Group D- Denovo & 527.51 Rollover Study||0||
59833668|NCT00340704|75957265|FG002|STARTED|Group D- Denovo & 527.51 Rollover Study||0||
59833669|NCT00340704|75957266|FG003|STARTED|Group D- Denovo & 527.51 Rollover Study||29||
59996516|NCT02730377|76112486|FG001|NOT COMPLETED|Overall Study||633||
59996517|NCT02714569|76112503|FG000|STARTED|Part A First Intervention||3||
59996518|NCT02714569|76112504|FG001|STARTED|Part A First Intervention||3||
59996519|NCT02714569|76112505|FG002|STARTED|Part A First Intervention||3||
59996520|NCT02714569|76112506|FG003|STARTED|Part A First Intervention||3||
59717479|NCT00957723|75836542|FG000|COMPLETED|Overall Study|Completed/Not completed counts are based on participant status at the 2yr primary outcome interval.|298||
59717480|NCT00957723|75836542|FG000|NOT COMPLETED|Overall Study||113||
59717481|NCT03778021|75836550|FG000|STARTED|Overall Study||100|Schools were the unit of randomization. School was the unit of intervention. Evaluation used data from students in each participating school. Details about baseline characteristics and results of evaluation all rely on student data.|2
59717482|NCT03778021|75836551|FG001|STARTED|Overall Study||194|Schools were the unit of randomization. School was the unit of intervention. Evaluation used data from students in each participating school. Details about baseline characteristics and results of evaluation all rely on student data.|4
59717483|NCT03778021|75836550|FG000|COMPLETED|Overall Study||72|"At the student level, completion refers to providing follow-up data.~At the school level, completion refers to completion of intervention or comparison condition, and of permission to collect follow up data from the students.~All students in grade 3 or 4 in the schools were exposed to the intervention condition to which their school was assigned."|2
59833670|NCT00340704|75957267|FG004|STARTED|Group D- Denovo & 527.51 Rollover Study||21||
59833671|NCT00340704|75957268|FG005|STARTED|Group D- Denovo & 527.51 Rollover Study||37||
59833672|NCT00340704|75957269|FG006|STARTED|Group D- Denovo & 527.51 Rollover Study||54||
59833673|NCT00340704|75957270|FG007|STARTED|Group D- Denovo & 527.51 Rollover Study||13||
59833674|NCT00340704|75957271|FG008|STARTED|Group D- Denovo & 527.51 Rollover Study||29||
59833675|NCT00340704|75957263|FG000|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0||
59833676|NCT00340704|75957264|FG001|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0||
59833677|NCT00340704|75957265|FG002|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0||
59833678|NCT00340704|75957266|FG003|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||7||
59833679|NCT00340704|75957267|FG004|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||5||
59833680|NCT00340704|75957268|FG005|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||18||
59833681|NCT00340704|75957269|FG006|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0||
59833682|NCT00340704|75957270|FG007|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0||
59833683|NCT00340704|75957271|FG008|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0||
59833684|NCT00340704|75957263|FG000|COMPLETED|Group D- Denovo & 527.51 Rollover Study||0||
59833685|NCT00340704|75957264|FG001|COMPLETED|Group D- Denovo & 527.51 Rollover Study||0||
59833686|NCT00340704|75957265|FG002|COMPLETED|Group D- Denovo & 527.51 Rollover Study||0||
59833687|NCT00340704|75957266|FG003|COMPLETED|Group D- Denovo & 527.51 Rollover Study||27||
59833688|NCT00340704|75957267|FG004|COMPLETED|Group D- Denovo & 527.51 Rollover Study||16||
59833689|NCT00340704|75957268|FG005|COMPLETED|Group D- Denovo & 527.51 Rollover Study||30||
59833690|NCT00340704|75957269|FG006|COMPLETED|Group D- Denovo & 527.51 Rollover Study||1||
59833691|NCT00340704|75957270|FG007|COMPLETED|Group D- Denovo & 527.51 Rollover Study||1||
59833692|NCT00340704|75957271|FG008|COMPLETED|Group D- Denovo & 527.51 Rollover Study||0||
59833693|NCT00340704|75957263|FG000|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||0||
59833694|NCT00340704|75957264|FG001|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||0||
59833695|NCT00340704|75957265|FG002|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||0||
59833696|NCT00340704|75957266|FG003|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||2||
59833697|NCT00340704|75957267|FG004|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||5||
59833698|NCT00340704|75957268|FG005|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||7||
59833699|NCT00340704|75957269|FG006|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||53||
59833700|NCT00340704|75957270|FG007|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||12||
59833701|NCT00340704|75957271|FG008|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||29||
59833702|NCT00132496|75957299|FG000|STARTED|Overall Study||54||
59833703|NCT00132496|75957300|FG001|STARTED|Overall Study||57||
59833704|NCT00132496|75957299|FG000|COMPLETED|Overall Study||52||
59833705|NCT00132496|75957300|FG001|COMPLETED|Overall Study||55||
59833706|NCT00132496|75957299|FG000|NOT COMPLETED|Overall Study||2||
59833707|NCT00132496|75957300|FG001|NOT COMPLETED|Overall Study||2||
59833708|NCT00231777|75957308|FG000|STARTED|Overall Study||170||
59833709|NCT00231777|75957309|FG001|STARTED|Overall Study||46||
59717484|NCT03778021|75836551|FG001|COMPLETED|Overall Study||141|"At the student level, completion refers to providing follow-up data.~At the school level, completion refers to completion of intervention or comparison condition, and of permission to collect follow up data from the students.~All students in grade 3 or 4 in the schools were exposed to the intervention condition to which their school was assigned."|4
59717485|NCT03778021|75836550|FG000|NOT COMPLETED|Overall Study||28||0
59717486|NCT03778021|75836551|FG001|NOT COMPLETED|Overall Study||53||0
59833710|NCT00231777|75957308|FG000|COMPLETED|Overall Study||164||
59833711|NCT00231777|75957309|FG001|COMPLETED|Overall Study||44||
59833712|NCT00231777|75957308|FG000|NOT COMPLETED|Overall Study||6||
59833713|NCT00231777|75957309|FG001|NOT COMPLETED|Overall Study||2||
59833714|NCT00231465|75957315|FG000|STARTED|Overall Study||44||
59833715|NCT00231465|75957315|FG000|COMPLETED|Overall Study||42||
59833716|NCT00231465|75957315|FG000|NOT COMPLETED|Overall Study||2||
59833717|NCT00254397|75957323|FG000|STARTED|Overall Study||10||
59833718|NCT00254397|75957324|FG001|STARTED|Overall Study||6||
59833719|NCT00254397|75957325|FG002|STARTED|Overall Study||37||
60118774|NCT01702025|76239800|FG000|COMPLETED|Overall Study||9||
60118775|NCT01702025|76239801|FG001|COMPLETED|Overall Study||9||
60118776|NCT01702025|76239802|FG002|COMPLETED|Overall Study||9||
59833720|NCT00254397|75957326|FG003|STARTED|Overall Study||45||
59833721|NCT00254397|75957323|FG000|COMPLETED|Overall Study||4||
59833722|NCT00254397|75957324|FG001|COMPLETED|Overall Study||5||
59833723|NCT00254397|75957325|FG002|COMPLETED|Overall Study||18||
59833724|NCT00254397|75957326|FG003|COMPLETED|Overall Study||20||
59833725|NCT00254397|75957323|FG000|NOT COMPLETED|Overall Study||6||
59833726|NCT00254397|75957324|FG001|NOT COMPLETED|Overall Study||1||
59833727|NCT00254397|75957325|FG002|NOT COMPLETED|Overall Study||19||
59833728|NCT00254397|75957326|FG003|NOT COMPLETED|Overall Study||25||
59833729|NCT00254163|75957337|FG000|STARTED|Overall Study||92||
59833730|NCT00254163|75957338|FG001|STARTED|Overall Study||92||
59833731|NCT00254163|75957337|FG000|COMPLETED|Overall Study||47||
59833732|NCT00254163|75957338|FG001|COMPLETED|Overall Study||46||
59833733|NCT00254163|75957337|FG000|NOT COMPLETED|Overall Study||45||
59833734|NCT00254163|75957338|FG001|NOT COMPLETED|Overall Study||46||
59833735|NCT03869333|75957348|FG000|STARTED|Overall Study||14||
59833736|NCT03869333|75957349|FG001|STARTED|Overall Study||16||
59833737|NCT03869333|75957350|FG002|STARTED|Overall Study||16||
59833738|NCT03869333|75957351|FG003|STARTED|Overall Study||12||
59833739|NCT03869333|75957348|FG000|Received First Dose|Overall Study||14||
59833740|NCT03869333|75957349|FG001|Received First Dose|Overall Study||16||
59833741|NCT03869333|75957350|FG002|Received First Dose|Overall Study||16||
59833742|NCT03869333|75957351|FG003|Received First Dose|Overall Study||12||
59833743|NCT03869333|75957348|FG000|Received Second Dose|Overall Study||13||
59833744|NCT03869333|75957349|FG001|Received Second Dose|Overall Study||15||
59833745|NCT03869333|75957350|FG002|Received Second Dose|Overall Study||16||
59833746|NCT03869333|75957351|FG003|Received Second Dose|Overall Study||12||
59833747|NCT03869333|75957348|FG000|Received Third Dose|Overall Study||13||
59833748|NCT03869333|75957349|FG001|Received Third Dose|Overall Study||15||
59833749|NCT03869333|75957350|FG002|Received Third Dose|Overall Study||16||
59833750|NCT03869333|75957351|FG003|Received Third Dose|Overall Study||11||
59833751|NCT03869333|75957348|FG000|COMPLETED|Overall Study||12|Completed Day 71 visit|
59833752|NCT03869333|75957349|FG001|COMPLETED|Overall Study||15|Completed Day 71 visit|
59833753|NCT03869333|75957350|FG002|COMPLETED|Overall Study||16|Completed Day 71 visit|
59833754|NCT03869333|75957351|FG003|COMPLETED|Overall Study||12|Completed Day 71 visit|
59833755|NCT03869333|75957348|FG000|NOT COMPLETED|Overall Study||2||
59833756|NCT03869333|75957349|FG001|NOT COMPLETED|Overall Study||1||
59833757|NCT03869333|75957350|FG002|NOT COMPLETED|Overall Study||0||
59833758|NCT03869333|75957351|FG003|NOT COMPLETED|Overall Study||0||
59833759|NCT00110890|75957363|FG000|STARTED|Overall Study||368||
59833760|NCT00110890|75957364|FG001|STARTED|Overall Study||184||
59833761|NCT00110890|75957363|FG000|End of Dose Optimization Phase|Overall Study|Weeks 1 to 16|316||
59833762|NCT00110890|75957364|FG001|End of Dose Optimization Phase|Overall Study|Weeks 1 to 16|170||
59833763|NCT00110890|75957363|FG000|End of Efficacy Assessment Phase|Overall Study|Weeks 17 to 23|280||
59833764|NCT00110890|75957364|FG001|End of Efficacy Assessment Phase|Overall Study|Weeks 17 to 23|150||
59833765|NCT00110890|75957363|FG000|COMPLETED|Overall Study|Follow-up Phase|7||
59833766|NCT00110890|75957364|FG001|COMPLETED|Overall Study|Follow-up Phase|5||
59833767|NCT00110890|75957363|FG000|NOT COMPLETED|Overall Study||361||
59833768|NCT00110890|75957364|FG001|NOT COMPLETED|Overall Study||179||
59833769|NCT00182637|75957370|FG000|STARTED|Overall Study|active/on treatment date|5||
59833770|NCT00182637|75957370|FG000|COMPLETED|Overall Study|off study date|2||
59833771|NCT00182637|75957370|FG000|NOT COMPLETED|Overall Study||3||
59833772|NCT00182325|75957377|FG000|STARTED|Overall Study||97||
59833773|NCT00182325|75957378|FG001|STARTED|Overall Study||96||
59717487|NCT00911170|75836560|FG000|STARTED|Treatment Period||424||
59717488|NCT00911170|75836561|FG001|STARTED|Treatment Period||423||
59717489|NCT00911170|75836560|FG000|Received Chemotherapy|Treatment Period|Primary Analysis Set|423||
59717490|NCT00911170|75836561|FG001|Received Chemotherapy|Treatment Period|Primary Analysis Set|422||
59717491|NCT00911170|75836560|FG000|Received Bevacizumab|Treatment Period||423||
59717492|NCT00911170|75836561|FG001|Received Bevacizumab|Treatment Period||420||
59717493|NCT00911170|75836560|FG000|Received Investigational Product|Treatment Period|Includes one participant who received pegfilgrastim in error.|422||
59717494|NCT00911170|75836561|FG001|Received Investigational Product|Treatment Period||419||
59717495|NCT00911170|75836560|FG000|COMPLETED|Treatment Period|Completed 4 cycles of treatment including chemotherapy, bevacizumab and investigational product.|397||
59717496|NCT00911170|75836561|FG001|COMPLETED|Treatment Period|Completed 4 cycles of treatment including chemotherapy, bevacizumab and investigational product.|386||
59717497|NCT00911170|75836560|FG000|NOT COMPLETED|Treatment Period||27||
59717498|NCT00911170|75836561|FG001|NOT COMPLETED|Treatment Period||37||
59833774|NCT00182325|75957377|FG000|COMPLETED|Overall Study|63 completed survey, 85 included in intention-to-treat analysis|63||
59717499|NCT00911170|75836560|FG000|STARTED|Long Term Follow-Up|Participants who received treatment in the Treatment Period|423||
59833775|NCT00182325|75957378|FG001|COMPLETED|Overall Study|43 completed survey, 89 included in intention-to-treat analysis|43||
59833776|NCT00182325|75957377|FG000|NOT COMPLETED|Overall Study||34||
59833777|NCT00182325|75957378|FG001|NOT COMPLETED|Overall Study||53||
59833778|NCT00122278|75957386|FG000|STARTED|Overall Study||106||
59833779|NCT00122278|75957387|FG001|STARTED|Overall Study||99||
59833780|NCT00122278|75957386|FG000|COMPLETED|Overall Study||104||
59833781|NCT00122278|75957387|FG001|COMPLETED|Overall Study||99||
59833782|NCT00122278|75957386|FG000|NOT COMPLETED|Overall Study||2||
59833783|NCT00122278|75957387|FG001|NOT COMPLETED|Overall Study||0||
59833784|NCT00182091|75957397|FG000|STARTED|Overall Study||15||
59833785|NCT00182091|75957398|FG001|STARTED|Overall Study||15||
59833786|NCT00182091|75957399|FG002|STARTED|Overall Study||25||
59833787|NCT00182091|75957400|FG003|STARTED|Overall Study||20||
59833788|NCT00182091|75957397|FG000|COMPLETED|Overall Study||14||
59833789|NCT00182091|75957398|FG001|COMPLETED|Overall Study||15||
59833790|NCT00182091|75957399|FG002|COMPLETED|Overall Study||25||
59833791|NCT00182091|75957400|FG003|COMPLETED|Overall Study||20||
59833792|NCT00182091|75957397|FG000|NOT COMPLETED|Overall Study||1||
59833793|NCT00182091|75957398|FG001|NOT COMPLETED|Overall Study||0||
59833794|NCT00182091|75957399|FG002|NOT COMPLETED|Overall Study||0||
59833795|NCT00182091|75957400|FG003|NOT COMPLETED|Overall Study||0||
59833796|NCT00181155|75957408|FG000|STARTED|Overall Study||15||
59833797|NCT00181155|75957409|FG001|STARTED|Overall Study||3||
59833798|NCT00181155|75957408|FG000|COMPLETED|Overall Study||13||
59833799|NCT00181155|75957409|FG001|COMPLETED|Overall Study||3||
59833800|NCT00181155|75957408|FG000|NOT COMPLETED|Overall Study||2||
59833801|NCT00181155|75957409|FG001|NOT COMPLETED|Overall Study||0||
59833802|NCT00322452|75957418|FG000|STARTED|Overall Study|Number of patients randomized|609||
59833803|NCT00322452|75957419|FG001|STARTED|Overall Study|Number of patients randomized|608||
59717500|NCT00911170|75836561|FG001|STARTED|Long Term Follow-Up|Participants who received treatment in the Treatment Period|422||
59717501|NCT00911170|75836560|FG000|COMPLETED|Long Term Follow-Up|As of the data cut-off date of 8 June 2012|0||
59717502|NCT00911170|75836561|FG001|COMPLETED|Long Term Follow-Up|As of the data cut-off date of 8 June 2012|0||
59717503|NCT00911170|75836560|FG000|NOT COMPLETED|Long Term Follow-Up||423||
59717504|NCT00911170|75836561|FG001|NOT COMPLETED|Long Term Follow-Up||422||
59717505|NCT01167881|75836569|FG000|STARTED|Overall Study||769||
59717506|NCT01167881|75836570|FG001|STARTED|Overall Study||780||
59717507|NCT01167881|75836569|FG000|Completed After 2 Years Treatment|Overall Study||95||
59717508|NCT01167881|75836570|FG001|Completed After 2 Years Treatment|Overall Study||127||
59717509|NCT01167881|75836569|FG000|Completed After 4 Years Treatment|Overall Study||515||
59717510|NCT01167881|75836570|FG001|Completed After 4 Years Treatment|Overall Study||462||
59833804|NCT00322452|75957418|FG000|COMPLETED|Overall Study|Patients still in study at PFS Data Cut Off (14 April 2008), 97 remained at OS DCO (14 June 2010)|362||
59833805|NCT00322452|75957419|FG001|COMPLETED|Overall Study|Patients still in study at PFS Data Cut Off (14 April 2008), 84 remained at OS DCO (14 June 2010)|332||
59833806|NCT00322452|75957418|FG000|NOT COMPLETED|Overall Study||247||
59833807|NCT00322452|75957419|FG001|NOT COMPLETED|Overall Study||276||
59833808|NCT00110812|75957428|FG000|STARTED|Main Study||91||
59833809|NCT00110812|75957429|FG001|STARTED|Main Study||89||
59833810|NCT00110812|75957430|FG002|STARTED|Main Study||87||
59833811|NCT00110812|75957428|FG000|COMPLETED|Main Study||83||
59833812|NCT00110812|75957429|FG001|COMPLETED|Main Study||78||
59833813|NCT00110812|75957430|FG002|COMPLETED|Main Study||74||
59833814|NCT00110812|75957428|FG000|NOT COMPLETED|Main Study||8||
59833815|NCT00110812|75957429|FG001|NOT COMPLETED|Main Study||11||
59833816|NCT00110812|75957430|FG002|NOT COMPLETED|Main Study||13||
59833817|NCT00110812|75957428|FG000|STARTED|Extended Follow-up||80||
59833818|NCT00110812|75957429|FG001|STARTED|Extended Follow-up||69||
59833819|NCT00110812|75957430|FG002|STARTED|Extended Follow-up||73||
59833820|NCT00110812|75957428|FG000|COMPLETED|Extended Follow-up||78||
59833821|NCT00110812|75957429|FG001|COMPLETED|Extended Follow-up||65||
59833822|NCT00110812|75957430|FG002|COMPLETED|Extended Follow-up||69||
59833823|NCT00110812|75957428|FG000|NOT COMPLETED|Extended Follow-up||2||
59833824|NCT00110812|75957429|FG001|NOT COMPLETED|Extended Follow-up||4||
59833825|NCT00110812|75957430|FG002|NOT COMPLETED|Extended Follow-up||4||
59833826|NCT00516269|75957445|FG000|STARTED|Overall Study||19||
59833827|NCT00516269|75957446|FG001|STARTED|Overall Study||19||
59833828|NCT00516269|75957445|FG000|COMPLETED|Overall Study|2 patients had an early termination|17||
59833829|NCT00516269|75957446|FG001|COMPLETED|Overall Study|2 patients did not complete the study and 1 randomized to placebo twice.|16||
59833830|NCT00516269|75957445|FG000|NOT COMPLETED|Overall Study||2||
59833831|NCT00516269|75957446|FG001|NOT COMPLETED|Overall Study||3||
59833832|NCT00229203|75957454|FG000|STARTED|Overall Study||32||
59833833|NCT00229203|75957455|FG001|STARTED|Overall Study||19||
59833834|NCT00229203|75957454|FG000|COMPLETED|Overall Study||0||
59833835|NCT00229203|75957455|FG001|COMPLETED|Overall Study||0||
59833836|NCT00229203|75957454|FG000|NOT COMPLETED|Overall Study||32||
59833837|NCT00229203|75957455|FG001|NOT COMPLETED|Overall Study||19||
59833838|NCT00228813|75957461|FG000|STARTED|Overall Study||8||
59833839|NCT00228813|75957461|FG000|COMPLETED|Overall Study||4||
59833840|NCT00228813|75957461|FG000|NOT COMPLETED|Overall Study||4||
59833841|NCT00322374|75957468|FG000|STARTED|Enrollment||0||
59833842|NCT00322374|75957469|FG001|STARTED|Enrollment||0||
59833843|NCT00322374|75957470|FG002|STARTED|Enrollment||0||
59833844|NCT00322374|75957471|FG003|STARTED|Enrollment||42||
59833845|NCT00322374|75957468|FG000|COMPLETED|Enrollment||0||
59833846|NCT00322374|75957469|FG001|COMPLETED|Enrollment||0||
59833847|NCT00322374|75957470|FG002|COMPLETED|Enrollment||0||
59833848|NCT00322374|75957471|FG003|COMPLETED|Enrollment||42||
59833849|NCT00322374|75957468|FG000|NOT COMPLETED|Enrollment||0||
59833850|NCT00322374|75957469|FG001|NOT COMPLETED|Enrollment||0||
59833851|NCT00322374|75957470|FG002|NOT COMPLETED|Enrollment||0||
59833852|NCT00322374|75957471|FG003|NOT COMPLETED|Enrollment||0||
59833853|NCT00322374|75957468|FG000|STARTED|Starting Dose||6||
59833854|NCT00322374|75957469|FG001|STARTED|Starting Dose||0||
59833855|NCT00322374|75957470|FG002|STARTED|Starting Dose||0||
59833856|NCT00322374|75957471|FG003|STARTED|Starting Dose||0||
59833857|NCT00322374|75957468|FG000|COMPLETED|Starting Dose||0||
59833858|NCT00322374|75957469|FG001|COMPLETED|Starting Dose||0||
59833859|NCT00322374|75957470|FG002|COMPLETED|Starting Dose||0||
59833860|NCT00322374|75957471|FG003|COMPLETED|Starting Dose||0||
59833861|NCT00322374|75957468|FG000|NOT COMPLETED|Starting Dose||6||
59833862|NCT00322374|75957469|FG001|NOT COMPLETED|Starting Dose||0||
59833863|NCT00322374|75957470|FG002|NOT COMPLETED|Starting Dose||0||
59833864|NCT00322374|75957471|FG003|NOT COMPLETED|Starting Dose||0||
59833865|NCT00322374|75957468|FG000|STARTED|First Escalation||0||
59833866|NCT00322374|75957469|FG001|STARTED|First Escalation||30||
59833867|NCT00322374|75957470|FG002|STARTED|First Escalation||0||
59833868|NCT00322374|75957471|FG003|STARTED|First Escalation||0||
59833869|NCT00322374|75957468|FG000|COMPLETED|First Escalation||0||
59833870|NCT00322374|75957469|FG001|COMPLETED|First Escalation||0||
59833871|NCT00322374|75957470|FG002|COMPLETED|First Escalation||0||
59833872|NCT00322374|75957471|FG003|COMPLETED|First Escalation||0||
59833873|NCT00322374|75957468|FG000|NOT COMPLETED|First Escalation||0||
59833874|NCT00322374|75957469|FG001|NOT COMPLETED|First Escalation||30||
59833875|NCT00322374|75957470|FG002|NOT COMPLETED|First Escalation||0||
59833876|NCT00322374|75957471|FG003|NOT COMPLETED|First Escalation||0||
59833877|NCT00322374|75957468|FG000|STARTED|Second Escalation||0||
59833878|NCT00322374|75957469|FG001|STARTED|Second Escalation||0||
59833879|NCT00322374|75957470|FG002|STARTED|Second Escalation||6||
59833880|NCT00322374|75957471|FG003|STARTED|Second Escalation||0||
59833881|NCT00322374|75957468|FG000|COMPLETED|Second Escalation||0||
59833882|NCT00322374|75957469|FG001|COMPLETED|Second Escalation||0||
59833883|NCT00322374|75957470|FG002|COMPLETED|Second Escalation||0||
59833884|NCT00322374|75957471|FG003|COMPLETED|Second Escalation||0||
59833885|NCT00322374|75957468|FG000|NOT COMPLETED|Second Escalation||0||
59833886|NCT00322374|75957469|FG001|NOT COMPLETED|Second Escalation||0||
59833887|NCT00322374|75957470|FG002|NOT COMPLETED|Second Escalation||6||
59833888|NCT00322374|75957471|FG003|NOT COMPLETED|Second Escalation||0||
59833889|NCT00174447|75957484|FG000|STARTED|Overall Study||43||
59833890|NCT00174447|75957484|FG000|COMPLETED|Overall Study||5||
59833891|NCT00174447|75957484|FG000|NOT COMPLETED|Overall Study||38||
59833892|NCT00321984|75957491|FG000|STARTED|Overall Study||317||
59833893|NCT00321984|75957492|FG001|STARTED|Overall Study||315||
59833894|NCT00321984|75957493|FG002|STARTED|Overall Study||315||
59833895|NCT00321984|75957491|FG000|COMPLETED|Overall Study||290||
59833896|NCT00321984|75957492|FG001|COMPLETED|Overall Study||294||
59833897|NCT00321984|75957493|FG002|COMPLETED|Overall Study||289||
59833898|NCT00321984|75957491|FG000|NOT COMPLETED|Overall Study||27||
59833899|NCT00321984|75957492|FG001|NOT COMPLETED|Overall Study||21||
59833900|NCT00321984|75957493|FG002|NOT COMPLETED|Overall Study||26||
60118777|NCT01702025|76239803|FG003|COMPLETED|Overall Study||10||
59833901|NCT00515099|75957503|FG000|STARTED|Overall Study||38||
59833902|NCT00515099|75957504|FG001|STARTED|Overall Study||20||
59833903|NCT00515099|75957503|FG000|COMPLETED|Overall Study||35||
59833904|NCT00515099|75957504|FG001|COMPLETED|Overall Study||16||
59833905|NCT00515099|75957503|FG000|NOT COMPLETED|Overall Study||3||
59833906|NCT00515099|75957504|FG001|NOT COMPLETED|Overall Study||4||
60118778|NCT01702025|76239800|FG000|NOT COMPLETED|Overall Study||2||
59833907|NCT00110266|75957510|FG000|STARTED|Overall Study||173||
59833908|NCT00110266|75957510|FG000|COMPLETED|Overall Study||95||
59833909|NCT00110266|75957510|FG000|NOT COMPLETED|Overall Study||78||
59833910|NCT00174291|75957517|FG000|STARTED|Overall Study||11||
59833911|NCT00174291|75957518|FG001|STARTED|Overall Study||10||
60118779|NCT01702025|76239801|FG001|NOT COMPLETED|Overall Study||1||
60118780|NCT01702025|76239802|FG002|NOT COMPLETED|Overall Study||1||
60118781|NCT01702025|76239803|FG003|NOT COMPLETED|Overall Study||0||
60118782|NCT01592747|76239820|FG000|STARTED|Overall Study|Based on Randomized Population|160||
60118783|NCT01592747|76239821|FG001|STARTED|Overall Study|Based on Randomized Population|161||
60118784|NCT01592747|76239822|FG002|STARTED|Overall Study|Based on Randomized Population|158||
60118785|NCT01592747|76239820|FG000|COMPLETED|Overall Study||44||
59833912|NCT00174291|75957517|FG000|COMPLETED|Overall Study||6||
59833913|NCT00174291|75957518|FG001|COMPLETED|Overall Study||4||
59833914|NCT00174291|75957517|FG000|NOT COMPLETED|Overall Study||5||
59833915|NCT00174291|75957518|FG001|NOT COMPLETED|Overall Study||6||
59833916|NCT00366548|75957526|FG000|STARTED|Infant Series||250||
59833917|NCT00366548|75957527|FG001|STARTED|Infant Series||250||
59833918|NCT00366548|75957526|FG000|Vaccinated Dose 1|Infant Series||250||
59833919|NCT00366548|75957527|FG001|Vaccinated Dose 1|Infant Series||250||
59833920|NCT00366548|75957526|FG000|Vaccinated Dose 2|Infant Series||246||
59833921|NCT00366548|75957527|FG001|Vaccinated Dose 2|Infant Series||249||
59833922|NCT00366548|75957526|FG000|Vaccinated Dose 3|Infant Series||246||
59833923|NCT00366548|75957527|FG001|Vaccinated Dose 3|Infant Series||247||
60118786|NCT01592747|76239821|FG001|COMPLETED|Overall Study||50||
59833924|NCT00366548|75957526|FG000|COMPLETED|Infant Series||246||
59833925|NCT00366548|75957527|FG001|COMPLETED|Infant Series||245||
59833926|NCT00366548|75957526|FG000|NOT COMPLETED|Infant Series||4||
59833927|NCT00366548|75957527|FG001|NOT COMPLETED|Infant Series||5||
59833928|NCT00366548|75957526|FG000|STARTED|After Infant Series||246||
59833929|NCT00366548|75957527|FG001|STARTED|After Infant Series||245||
59833930|NCT00366548|75957526|FG000|COMPLETED|After Infant Series||240||
59833931|NCT00366548|75957527|FG001|COMPLETED|After Infant Series||244||
59833932|NCT00366548|75957526|FG000|NOT COMPLETED|After Infant Series||6||
59833933|NCT00366548|75957527|FG001|NOT COMPLETED|After Infant Series||1||
59833934|NCT00366548|75957526|FG000|STARTED|Toddler Dose||240||
59833935|NCT00366548|75957527|FG001|STARTED|Toddler Dose||244||
59833936|NCT00366548|75957526|FG000|COMPLETED|Toddler Dose||240||
59833937|NCT00366548|75957527|FG001|COMPLETED|Toddler Dose||244||
59833938|NCT00366548|75957526|FG000|NOT COMPLETED|Toddler Dose||0||
59833939|NCT00366548|75957527|FG001|NOT COMPLETED|Toddler Dose||0||
59833940|NCT00252057|75957553|FG000|STARTED|Overall Study||373||
59833941|NCT00252057|75957554|FG001|STARTED|Overall Study||376||
59833942|NCT00252057|75957553|FG000|COMPLETED|Overall Study||370||
59833943|NCT00252057|75957554|FG001|COMPLETED|Overall Study||368||
59833944|NCT00252057|75957553|FG000|NOT COMPLETED|Overall Study||3||
59833945|NCT00252057|75957554|FG001|NOT COMPLETED|Overall Study||8||
59833946|NCT00132028|75957560|FG000|STARTED|Overall Study||27||
59833947|NCT00132028|75957560|FG000|Eligible|Overall Study||25||
59833948|NCT00132028|75957560|FG000|Eligible and Began Protocol Therapy|Overall Study||25||
59833949|NCT00132028|75957560|FG000|COMPLETED|Overall Study|"Since there was no maximum number of cycles, patients could not complete treatment."|0||
59833950|NCT00132028|75957560|FG000|NOT COMPLETED|Overall Study||27||
59833951|NCT00131248|75957564|FG000|STARTED|Intervention 1 (3-day Course)||9||
59833952|NCT00131248|75957565|FG001|STARTED|Intervention 1 (3-day Course)||9||
59833953|NCT00131248|75957564|FG000|COMPLETED|Intervention 1 (3-day Course)||8||
59833954|NCT00131248|75957565|FG001|COMPLETED|Intervention 1 (3-day Course)||9||
59833955|NCT00131248|75957564|FG000|NOT COMPLETED|Intervention 1 (3-day Course)||1||
59833956|NCT00131248|75957565|FG001|NOT COMPLETED|Intervention 1 (3-day Course)||0||
59833957|NCT00131248|75957564|FG000|STARTED|Washout (24 Hour)||8||
59833958|NCT00131248|75957565|FG001|STARTED|Washout (24 Hour)||9||
59833959|NCT00131248|75957564|FG000|COMPLETED|Washout (24 Hour)||8||
59833960|NCT00131248|75957565|FG001|COMPLETED|Washout (24 Hour)||9||
59833961|NCT00131248|75957564|FG000|NOT COMPLETED|Washout (24 Hour)||0||
59833962|NCT00131248|75957565|FG001|NOT COMPLETED|Washout (24 Hour)||0||
59717511|NCT01167881|75836569|FG000|COMPLETED|Overall Study||610||
59717512|NCT01167881|75836570|FG001|COMPLETED|Overall Study||589||
59717513|NCT01167881|75836569|FG000|NOT COMPLETED|Overall Study||159||
59717514|NCT01167881|75836570|FG001|NOT COMPLETED|Overall Study||191||
59717515|NCT00960063|75836579|FG000|STARTED|Overall Study||1||
59717516|NCT00960063|75836580|FG001|STARTED|Overall Study||0||
59717517|NCT00960063|75836581|FG002|STARTED|Overall Study||3||
59717518|NCT00960063|75836579|FG000|COMPLETED|Overall Study||0||
59717519|NCT00960063|75836580|FG001|COMPLETED|Overall Study||0||
59717520|NCT00960063|75836581|FG002|COMPLETED|Overall Study||0||
59717521|NCT00960063|75836579|FG000|NOT COMPLETED|Overall Study||1||
59717522|NCT00960063|75836580|FG001|NOT COMPLETED|Overall Study||0||
59717523|NCT00960063|75836581|FG002|NOT COMPLETED|Overall Study||3||
59717524|NCT00959907|75836591|FG000|STARTED|Overall Study||30||
59717525|NCT00959907|75836592|FG001|STARTED|Overall Study||29||
59717526|NCT00959907|75836591|FG000|COMPLETED|Overall Study||27||
59833963|NCT00131248|75957564|FG000|STARTED|Intervention 2 (7-day Course)||8||
59833964|NCT00131248|75957565|FG001|STARTED|Intervention 2 (7-day Course)||9||
59833965|NCT00131248|75957564|FG000|COMPLETED|Intervention 2 (7-day Course)||8||
59833966|NCT00131248|75957565|FG001|COMPLETED|Intervention 2 (7-day Course)||9||
59833967|NCT00131248|75957564|FG000|NOT COMPLETED|Intervention 2 (7-day Course)||0||
59833968|NCT00131248|75957565|FG001|NOT COMPLETED|Intervention 2 (7-day Course)||0||
59833969|NCT00131248|75957564|FG000|STARTED|Washout 2 (24 Hours)||8||
59833970|NCT00131248|75957565|FG001|STARTED|Washout 2 (24 Hours)||9||
59833971|NCT00131248|75957564|FG000|COMPLETED|Washout 2 (24 Hours)||8||
59833972|NCT00131248|75957565|FG001|COMPLETED|Washout 2 (24 Hours)||9||
59833973|NCT00131248|75957564|FG000|NOT COMPLETED|Washout 2 (24 Hours)||0||
59833974|NCT00131248|75957565|FG001|NOT COMPLETED|Washout 2 (24 Hours)||0||
59833975|NCT00131248|75957564|FG000|STARTED|Intervention 3 (4-day Course)||8||
60118787|NCT01592747|76239822|FG002|COMPLETED|Overall Study||50||
59717527|NCT00959907|75836592|FG001|COMPLETED|Overall Study||28||
59717528|NCT00959907|75836591|FG000|NOT COMPLETED|Overall Study||3||
59717529|NCT00959907|75836592|FG001|NOT COMPLETED|Overall Study||1||
59717530|NCT00912340|75836601|FG000|STARTED|Overall Study||24||
59717531|NCT00912340|75836602|FG001|STARTED|Overall Study||30||
59833976|NCT00131248|75957565|FG001|STARTED|Intervention 3 (4-day Course)||9||
59833977|NCT00131248|75957564|FG000|COMPLETED|Intervention 3 (4-day Course)||8||
59833978|NCT00131248|75957565|FG001|COMPLETED|Intervention 3 (4-day Course)||9||
59833979|NCT00131248|75957564|FG000|NOT COMPLETED|Intervention 3 (4-day Course)||0||
59833980|NCT00131248|75957565|FG001|NOT COMPLETED|Intervention 3 (4-day Course)||0||
59717532|NCT00912340|75836603|FG002|STARTED|Overall Study||4||
59833981|NCT00362414|75957571|FG000|STARTED|Overall Study||15||
59833982|NCT00362414|75957571|FG000|COMPLETED|Overall Study||12||
59833983|NCT00362414|75957571|FG000|NOT COMPLETED|Overall Study||3||
59833984|NCT00096382|75957580|FG000|STARTED|Overall Study||23||
59833985|NCT00096382|75957581|FG001|STARTED|Overall Study||3||
59833986|NCT00096382|75957580|FG000|COMPLETED|Overall Study||21||
59833987|NCT00096382|75957581|FG001|COMPLETED|Overall Study||3||
59833988|NCT00096382|75957580|FG000|NOT COMPLETED|Overall Study||2||
59833989|NCT00096382|75957581|FG001|NOT COMPLETED|Overall Study||0||
59833990|NCT00359294|75957592|FG000|STARTED|Overall Study||1||
59833991|NCT00359294|75957593|FG001|STARTED|Overall Study||1||
59833992|NCT00359294|75957594|FG002|STARTED|Overall Study||3||
59833993|NCT00359294|75957595|FG003|STARTED|Overall Study||4||
59833994|NCT00359294|75957596|FG004|STARTED|Overall Study||3||
59833995|NCT00359294|75957592|FG000|COMPLETED|Overall Study||0||
59833996|NCT00359294|75957593|FG001|COMPLETED|Overall Study||0||
59833997|NCT00359294|75957594|FG002|COMPLETED|Overall Study||0||
59833998|NCT00359294|75957595|FG003|COMPLETED|Overall Study||0||
59833999|NCT00359294|75957596|FG004|COMPLETED|Overall Study||0||
59834000|NCT00359294|75957592|FG000|NOT COMPLETED|Overall Study||1||
59834001|NCT00359294|75957593|FG001|NOT COMPLETED|Overall Study||1||
59834002|NCT00359294|75957594|FG002|NOT COMPLETED|Overall Study||3||
59834003|NCT00359294|75957595|FG003|NOT COMPLETED|Overall Study||4||
59834004|NCT00359294|75957596|FG004|NOT COMPLETED|Overall Study||3||
59834005|NCT00384332|75957606|FG000|STARTED|Overall Study||13||
59834006|NCT00384332|75957607|FG001|STARTED|Overall Study||10||
59834007|NCT00384332|75957606|FG000|COMPLETED|Overall Study||9||
59834008|NCT00384332|75957607|FG001|COMPLETED|Overall Study||10||
59834009|NCT00384332|75957606|FG000|NOT COMPLETED|Overall Study||4||
59834010|NCT00384332|75957607|FG001|NOT COMPLETED|Overall Study||0||
59834011|NCT00096226|75957615|FG000|STARTED|Overall Study||60||
59834012|NCT00096226|75957615|FG000|Eligible|Overall Study||57||
59834013|NCT00096226|75957615|FG000|Eligible and Underwent Surgery|Overall Study||37||
59834014|NCT00096226|75957615|FG000|COMPLETED|Overall Study|Subjects contributing any data to analysis are considered to have completed the study|57||
59834015|NCT00096226|75957615|FG000|NOT COMPLETED|Overall Study||3||
59834016|NCT00105508|75957621|FG000|STARTED|Overall Study||253||
59834017|NCT00105508|75957622|FG001|STARTED|Overall Study||253||
59834018|NCT00105508|75957621|FG000|COMPLETED|Overall Study||213||
59834019|NCT00105508|75957622|FG001|COMPLETED|Overall Study||217||
59834020|NCT00105508|75957621|FG000|NOT COMPLETED|Overall Study||40||
59834021|NCT00105508|75957622|FG001|NOT COMPLETED|Overall Study||36||
59834022|NCT00105196|75957630|FG000|STARTED|Overall Study||177||
59834023|NCT00105196|75957631|FG001|STARTED|Overall Study||172||
59834024|NCT00105196|75957630|FG000|COMPLETED|Overall Study||147||
59834025|NCT00105196|75957631|FG001|COMPLETED|Overall Study||149||
59834026|NCT00105196|75957630|FG000|NOT COMPLETED|Overall Study||30||
59834027|NCT00105196|75957631|FG001|NOT COMPLETED|Overall Study||23||
59834028|NCT03820024|75957639|FG000|STARTED|Overall Study||19||
59834029|NCT03820024|75957640|FG001|STARTED|Overall Study||20||
59834030|NCT03820024|75957639|FG000|COMPLETED|Overall Study||18||
59834031|NCT03820024|75957640|FG001|COMPLETED|Overall Study||18||
59834032|NCT03820024|75957639|FG000|NOT COMPLETED|Overall Study||1||
59834033|NCT03820024|75957640|FG001|NOT COMPLETED|Overall Study||2||
59834034|NCT03819634|75957646|FG000|STARTED|Overall Study||24||
59834035|NCT03819634|75957646|FG000|COMPLETED|Overall Study||22||
59834036|NCT03819634|75957646|FG000|NOT COMPLETED|Overall Study||2||
59834037|NCT00104572|75957653|FG000|STARTED|Overall Study|These are the analysed subjects|13||
59834038|NCT00104572|75957654|FG001|STARTED|Overall Study|These are the analysed subjects|13||
59834039|NCT00104572|75957655|FG002|STARTED|Overall Study|(N=11) in placebo, physician removed 2 men due to total testosterone>450 ng/DL, N=9 analysed.|9||
60118788|NCT01592747|76239820|FG000|NOT COMPLETED|Overall Study||116||
60118789|NCT01592747|76239821|FG001|NOT COMPLETED|Overall Study||111||
60118790|NCT01592747|76239822|FG002|NOT COMPLETED|Overall Study||108||
60118791|NCT02051608|76239835|FG000|STARTED|Part 1: Double Blind Treatment||195||
60118792|NCT02051608|76239836|FG001|STARTED|Part 1: Double Blind Treatment||192||
60118793|NCT02051608|76239837|FG002|STARTED|Part 1: Double Blind Treatment||0||
60118794|NCT02051608|76239838|FG003|STARTED|Part 1: Double Blind Treatment||0||
60118795|NCT02051608|76239835|FG000|COMPLETED|Part 1: Double Blind Treatment||134||
60118796|NCT02051608|76239836|FG001|COMPLETED|Part 1: Double Blind Treatment||136||
60118797|NCT02051608|76239837|FG002|COMPLETED|Part 1: Double Blind Treatment||0||
60118798|NCT02051608|76239838|FG003|COMPLETED|Part 1: Double Blind Treatment||0||
60118799|NCT02051608|76239835|FG000|NOT COMPLETED|Part 1: Double Blind Treatment||61||
59834040|NCT00104572|75957653|FG000|COMPLETED|Overall Study||10||
59834041|NCT00104572|75957654|FG001|COMPLETED|Overall Study||10||
59834042|NCT00104572|75957655|FG002|COMPLETED|Overall Study||9||
59834043|NCT00104572|75957653|FG000|NOT COMPLETED|Overall Study||3||
59834044|NCT00104572|75957654|FG001|NOT COMPLETED|Overall Study||3||
59834045|NCT00104572|75957655|FG002|NOT COMPLETED|Overall Study||0||
59834046|NCT00514943|75957665|FG000|STARTED|Stage 1|1 randomized patient was not treated|62||
59834047|NCT00514943|75957666|FG001|STARTED|Stage 1|2 randomized patients were not treated|62||
59834048|NCT00514943|75957665|FG000|COMPLETED|Stage 1||32||
59834049|NCT00514943|75957666|FG001|COMPLETED|Stage 1||36||
59834050|NCT00514943|75957665|FG000|NOT COMPLETED|Stage 1||30||
59834051|NCT00514943|75957666|FG001|NOT COMPLETED|Stage 1||26||
59834052|NCT00514943|75957665|FG000|STARTED|Stage 2||32||
59834053|NCT00514943|75957666|FG001|STARTED|Stage 2||36||
59834054|NCT00514943|75957665|FG000|COMPLETED|Stage 2||0||
59834055|NCT00514943|75957666|FG001|COMPLETED|Stage 2||0||
59834056|NCT00514943|75957665|FG000|NOT COMPLETED|Stage 2||32||
59834057|NCT00514943|75957666|FG001|NOT COMPLETED|Stage 2||36||
59834058|NCT03864653|75957687|FG000|STARTED|Overall Study||39||
59834059|NCT03864653|75957687|FG000|COMPLETED|Overall Study||38||
59834060|NCT03864653|75957687|FG000|NOT COMPLETED|Overall Study||1||
59834061|NCT00103402|75957693|FG000|STARTED|Overall Study||138||
59834062|NCT00103402|75957694|FG001|STARTED|Overall Study||134||
59834063|NCT00103402|75957693|FG000|COMPLETED|Overall Study||116||
59834064|NCT00103402|75957694|FG001|COMPLETED|Overall Study||117||
59834065|NCT00103402|75957693|FG000|NOT COMPLETED|Overall Study||22||
59834066|NCT00103402|75957694|FG001|NOT COMPLETED|Overall Study||17||
59834067|NCT03864341|75957700|FG000|STARTED|Overall Study||40||
59834068|NCT03864341|75957700|FG000|COMPLETED|Overall Study||39||
59834069|NCT03864341|75957700|FG000|NOT COMPLETED|Overall Study||1||
59834070|NCT00095836|75957704|FG000|STARTED|Overall Study||27||
59834071|NCT00095836|75957704|FG000|COMPLETED|Overall Study||23||
59834072|NCT00095836|75957704|FG000|NOT COMPLETED|Overall Study||4||
59834073|NCT00168831|75957711|FG000|STARTED|Overall Study||338||
59834074|NCT00168831|75957712|FG001|STARTED|Overall Study||335||
59834075|NCT00168831|75957713|FG002|STARTED|Overall Study||334||
59834076|NCT00168831|75957711|FG000|COMPLETED|Overall Study||278||
59834077|NCT00168831|75957712|FG001|COMPLETED|Overall Study||254||
59834078|NCT00168831|75957713|FG002|COMPLETED|Overall Study||220||
59834079|NCT00168831|75957711|FG000|NOT COMPLETED|Overall Study||60||
59834080|NCT00168831|75957712|FG001|NOT COMPLETED|Overall Study||81||
59834081|NCT00168831|75957713|FG002|NOT COMPLETED|Overall Study||114||
59834082|NCT00103012|75957724|FG000|STARTED|Overall Study||17||
59834083|NCT00103012|75957725|FG001|STARTED|Overall Study||14||
59834084|NCT00103012|75957726|FG002|STARTED|Overall Study||16||
59834085|NCT00103012|75957724|FG000|COMPLETED|Overall Study||14||
59834086|NCT00103012|75957725|FG001|COMPLETED|Overall Study||13||
59834087|NCT00103012|75957726|FG002|COMPLETED|Overall Study||12||
59834088|NCT00103012|75957724|FG000|NOT COMPLETED|Overall Study||3||
59834089|NCT00103012|75957725|FG001|NOT COMPLETED|Overall Study||1||
59834090|NCT00103012|75957726|FG002|NOT COMPLETED|Overall Study||4||
59834091|NCT00512135|75957734|FG000|STARTED|Overall Study||801||
59834092|NCT00512135|75957734|FG000|Treated|Overall Study||796||
59834093|NCT00512135|75957734|FG000|COMPLETED|Overall Study||717||
59834094|NCT00512135|75957734|FG000|NOT COMPLETED|Overall Study||84||
59834095|NCT00251979|75957741|FG000|STARTED|Overall Study|ITT population|375||
59834096|NCT00251979|75957742|FG001|STARTED|Overall Study|ITT population|389||
59834097|NCT00251979|75957741|FG000|COMPLETED|Overall Study||337||
59834098|NCT00251979|75957742|FG001|COMPLETED|Overall Study||349||
59834099|NCT00251979|75957741|FG000|NOT COMPLETED|Overall Study||38||
59834100|NCT00251979|75957742|FG001|NOT COMPLETED|Overall Study||40||
59834101|NCT00511901|75957750|FG000|STARTED|Overall Study||11||
59834102|NCT00511901|75957751|FG001|STARTED|Overall Study||11||
59834103|NCT00511901|75957750|FG000|COMPLETED|Overall Study||10||
59834104|NCT00511901|75957751|FG001|COMPLETED|Overall Study||8||
59834105|NCT00511901|75957750|FG000|NOT COMPLETED|Overall Study||1||
59834106|NCT00511901|75957751|FG001|NOT COMPLETED|Overall Study||3||
59834107|NCT03862625|75957759|FG000|STARTED|Overall Study||15||
59834108|NCT03862625|75957760|FG001|STARTED|Overall Study||15||
59834109|NCT03862625|75957759|FG000|COMPLETED|Overall Study||15||
59834110|NCT03862625|75957760|FG001|COMPLETED|Overall Study||14||
59834111|NCT03862625|75957759|FG000|NOT COMPLETED|Overall Study||0||
59834112|NCT03862625|75957760|FG001|NOT COMPLETED|Overall Study||1||
59834113|NCT00163215|75957766|FG000|STARTED|Overall Study||46||
59834114|NCT00163215|75957766|FG000|COMPLETED|Overall Study||31||
59834115|NCT00163215|75957766|FG000|NOT COMPLETED|Overall Study||15||
59834116|NCT00228423|75957772|FG000|STARTED|Overall Study||56||
59834117|NCT00228423|75957773|FG001|STARTED|Overall Study||57||
59834118|NCT00228423|75957772|FG000|COMPLETED|Overall Study||46||
59834119|NCT00228423|75957773|FG001|COMPLETED|Overall Study||45||
59834120|NCT00228423|75957772|FG000|NOT COMPLETED|Overall Study||10||
59834121|NCT00228423|75957773|FG001|NOT COMPLETED|Overall Study||12||
59834122|NCT00511667|75957781|FG000|STARTED|Overall Study||52||
59834123|NCT00511667|75957782|FG001|STARTED|Overall Study||18||
59834124|NCT00511667|75957781|FG000|COMPLETED|Overall Study||40||
59834125|NCT00511667|75957782|FG001|COMPLETED|Overall Study||15||
59834126|NCT00511667|75957781|FG000|NOT COMPLETED|Overall Study||12||
59834127|NCT00511667|75957782|FG001|NOT COMPLETED|Overall Study||3||
59834128|NCT00227877|75957798|FG000|STARTED|Pre-visit Assessment||1075||
59834129|NCT00227877|75957799|FG001|STARTED|Pre-visit Assessment||1031||
59834130|NCT00227877|75957800|FG002|STARTED|Pre-visit Assessment||297||
59834131|NCT00227877|75957801|FG003|STARTED|Pre-visit Assessment||292||
59834132|NCT00227877|75957798|FG000|COMPLETED|Pre-visit Assessment|Final analysis sample|1068||
59996521|NCT02714569|76112507|FG004|STARTED|Part A First Intervention||3||
59717533|NCT00912340|75836601|FG000|COMPLETED|Overall Study||22||
59717534|NCT00912340|75836602|FG001|COMPLETED|Overall Study||26||
59717535|NCT00912340|75836603|FG002|COMPLETED|Overall Study||0||
59717536|NCT00912340|75836601|FG000|NOT COMPLETED|Overall Study||2||
59717537|NCT00912340|75836602|FG001|NOT COMPLETED|Overall Study||4||
59717538|NCT00912340|75836603|FG002|NOT COMPLETED|Overall Study||4||
59717539|NCT01167257|75836613|FG000|STARTED|Overall Study||31||
59717540|NCT01167257|75836614|FG001|STARTED|Overall Study||31||
59717541|NCT01167257|75836613|FG000|COMPLETED|Overall Study||28||
59717542|NCT01167257|75836614|FG001|COMPLETED|Overall Study||28||
59717543|NCT01167257|75836613|FG000|NOT COMPLETED|Overall Study||3||
59717544|NCT01167257|75836614|FG001|NOT COMPLETED|Overall Study||3||
59717545|NCT01119846|75836627|FG000|STARTED|Overall Study||13||
59717546|NCT01119846|75836628|FG001|STARTED|Overall Study||4||
59717547|NCT01119846|75836629|FG002|STARTED|Overall Study||83||
59717548|NCT01119846|75836627|FG000|COMPLETED|Overall Study||11||
59717549|NCT01119846|75836628|FG001|COMPLETED|Overall Study||4||
59717550|NCT01119846|75836629|FG002|COMPLETED|Overall Study||72||
59717551|NCT01119846|75836627|FG000|NOT COMPLETED|Overall Study||2||
59717552|NCT01119846|75836628|FG001|NOT COMPLETED|Overall Study||0||
59717553|NCT01119846|75836629|FG002|NOT COMPLETED|Overall Study||11||
59717554|NCT01167179|75836666|FG000|STARTED|Overall Study||80||
59717555|NCT01167179|75836667|FG001|STARTED|Overall Study||80||
59717556|NCT01167179|75836666|FG000|COMPLETED|Overall Study||65||
59717557|NCT01167179|75836667|FG001|COMPLETED|Overall Study||59||
59717558|NCT01167179|75836666|FG000|NOT COMPLETED|Overall Study||15||
59717559|NCT01167179|75836667|FG001|NOT COMPLETED|Overall Study||21||
59717560|NCT02951455|75836689|FG000|STARTED|Overall Study||37||
59717561|NCT02951455|75836690|FG001|STARTED|Overall Study||37||
59717562|NCT02951455|75836691|FG002|STARTED|Overall Study||39||
59717563|NCT02951455|75836692|FG003|STARTED|Overall Study||39||
59717564|NCT02951455|75836693|FG004|STARTED|Overall Study||36||
59717565|NCT02951455|75836694|FG005|STARTED|Overall Study||37||
59717566|NCT02951455|75836695|FG006|STARTED|Overall Study||39||
59717567|NCT02951455|75836696|FG007|STARTED|Overall Study||37||
59717568|NCT02951455|75836697|FG008|STARTED|Overall Study||39||
59717569|NCT02951455|75836698|FG009|STARTED|Overall Study||37||
59717570|NCT02951455|75836699|FG010|STARTED|Overall Study||37||
59717571|NCT02951455|75836700|FG011|STARTED|Overall Study||39||
59717572|NCT02951455|75836701|FG012|STARTED|Overall Study||37||
59717573|NCT02951455|75836702|FG013|STARTED|Overall Study||37||
59717574|NCT02951455|75836703|FG014|STARTED|Overall Study||39||
59717575|NCT02951455|75836704|FG015|STARTED|Overall Study||36||
59717576|NCT02951455|75836689|FG000|COMPLETED|Overall Study||14||
59717577|NCT02951455|75836690|FG001|COMPLETED|Overall Study||24||
59717578|NCT02951455|75836691|FG002|COMPLETED|Overall Study||27||
59717579|NCT02951455|75836692|FG003|COMPLETED|Overall Study||32||
59717580|NCT02951455|75836693|FG004|COMPLETED|Overall Study||26||
59717581|NCT02951455|75836694|FG005|COMPLETED|Overall Study||17||
59834133|NCT00227877|75957799|FG001|COMPLETED|Pre-visit Assessment|Final analysis sample|1028||
59834134|NCT00227877|75957800|FG002|COMPLETED|Pre-visit Assessment|Final analysis sample|297||
59717582|NCT02951455|75836695|FG006|COMPLETED|Overall Study||30||
59717583|NCT02951455|75836696|FG007|COMPLETED|Overall Study||30||
59717584|NCT02951455|75836697|FG008|COMPLETED|Overall Study||26||
59717585|NCT02951455|75836698|FG009|COMPLETED|Overall Study||26||
59717586|NCT02951455|75836699|FG010|COMPLETED|Overall Study||26||
59717587|NCT02951455|75836700|FG011|COMPLETED|Overall Study||30||
59717588|NCT02951455|75836701|FG012|COMPLETED|Overall Study||25||
59717589|NCT02951455|75836702|FG013|COMPLETED|Overall Study||29||
59717590|NCT02951455|75836703|FG014|COMPLETED|Overall Study||35||
59717591|NCT02951455|75836704|FG015|COMPLETED|Overall Study||28||
59717592|NCT02951455|75836689|FG000|NOT COMPLETED|Overall Study||23||
59717593|NCT02951455|75836690|FG001|NOT COMPLETED|Overall Study||13||
59717594|NCT02951455|75836691|FG002|NOT COMPLETED|Overall Study||12||
59717595|NCT02951455|75836692|FG003|NOT COMPLETED|Overall Study||7||
59717596|NCT02951455|75836693|FG004|NOT COMPLETED|Overall Study||10||
59717597|NCT02951455|75836694|FG005|NOT COMPLETED|Overall Study||20||
59717598|NCT02951455|75836695|FG006|NOT COMPLETED|Overall Study||9||
59717599|NCT02951455|75836696|FG007|NOT COMPLETED|Overall Study||7||
59717600|NCT02951455|75836697|FG008|NOT COMPLETED|Overall Study||13||
59717601|NCT02951455|75836698|FG009|NOT COMPLETED|Overall Study||11||
59717602|NCT02951455|75836699|FG010|NOT COMPLETED|Overall Study||11||
59717603|NCT02951455|75836700|FG011|NOT COMPLETED|Overall Study||9||
59717604|NCT02951455|75836701|FG012|NOT COMPLETED|Overall Study||12||
59717605|NCT02951455|75836702|FG013|NOT COMPLETED|Overall Study||8||
59717606|NCT02951455|75836703|FG014|NOT COMPLETED|Overall Study||4||
59717607|NCT02951455|75836704|FG015|NOT COMPLETED|Overall Study||8||
59717608|NCT01167023|75836740|FG000|STARTED|Overall Study||0||
59717609|NCT01167023|75836741|FG001|STARTED|Overall Study||21||
59717610|NCT01167023|75836742|FG002|STARTED|Overall Study||41||
59717611|NCT01167023|75836740|FG000|Received at Least 1 Dose of Study Drug|Overall Study||0||
59717612|NCT01167023|75836741|FG001|Received at Least 1 Dose of Study Drug|Overall Study||19||
59717613|NCT01167023|75836742|FG002|Received at Least 1 Dose of Study Drug|Overall Study||41||
59717614|NCT01167023|75836740|FG000|COMPLETED|Overall Study||0||
59834135|NCT00227877|75957801|FG003|COMPLETED|Pre-visit Assessment|Final analysis sample|292||
59834136|NCT00227877|75957798|FG000|NOT COMPLETED|Pre-visit Assessment||7||
59834137|NCT00227877|75957799|FG001|NOT COMPLETED|Pre-visit Assessment||3||
59834138|NCT00227877|75957800|FG002|NOT COMPLETED|Pre-visit Assessment||0||
59834139|NCT00227877|75957801|FG003|NOT COMPLETED|Pre-visit Assessment||0||
59834140|NCT00227877|75957798|FG000|STARTED|Post-visit Checklist||1068||
59834141|NCT00227877|75957799|FG001|STARTED|Post-visit Checklist||1028||
59834142|NCT00227877|75957800|FG002|STARTED|Post-visit Checklist||297||
59834143|NCT00227877|75957801|FG003|STARTED|Post-visit Checklist||292||
59834144|NCT00227877|75957798|FG000|COMPLETED|Post-visit Checklist||1044||
59834145|NCT00227877|75957799|FG001|COMPLETED|Post-visit Checklist||1015||
59717615|NCT01167023|75836741|FG001|COMPLETED|Overall Study||18||
59717616|NCT01167023|75836742|FG002|COMPLETED|Overall Study||39||
59717617|NCT01167023|75836740|FG000|NOT COMPLETED|Overall Study||0||
59717618|NCT01167023|75836741|FG001|NOT COMPLETED|Overall Study||3||
59717619|NCT01167023|75836742|FG002|NOT COMPLETED|Overall Study||2||
59717620|NCT03484117|75836750|FG000|STARTED|Overall Study||32||
59717621|NCT03484117|75836751|FG001|STARTED|Overall Study||35||
59834146|NCT00227877|75957800|FG002|COMPLETED|Post-visit Checklist||296||
59834147|NCT00227877|75957801|FG003|COMPLETED|Post-visit Checklist||292||
59834148|NCT00227877|75957798|FG000|NOT COMPLETED|Post-visit Checklist||24||
59834149|NCT00227877|75957799|FG001|NOT COMPLETED|Post-visit Checklist||13||
59834150|NCT00227877|75957800|FG002|NOT COMPLETED|Post-visit Checklist||1||
59834151|NCT00227877|75957801|FG003|NOT COMPLETED|Post-visit Checklist||0||
59834152|NCT00227877|75957798|FG000|STARTED|3-months Follow-up||1068|"These Started numbers reflect those who completed the pre-visit assessment."|
59834153|NCT00227877|75957799|FG001|STARTED|3-months Follow-up||1028|"These Started numbers reflect those who completed the pre-visit assessment."|
59834154|NCT00227877|75957800|FG002|STARTED|3-months Follow-up||297|"These Started numbers reflect those who completed the pre-visit assessment."|
59834155|NCT00227877|75957801|FG003|STARTED|3-months Follow-up||292|"These Started numbers reflect those who completed the pre-visit assessment."|
59834156|NCT00227877|75957798|FG000|COMPLETED|3-months Follow-up||755||
59834157|NCT00227877|75957799|FG001|COMPLETED|3-months Follow-up||761||
59834158|NCT00227877|75957800|FG002|COMPLETED|3-months Follow-up||245||
59834159|NCT00227877|75957801|FG003|COMPLETED|3-months Follow-up||271||
59834160|NCT00227877|75957798|FG000|NOT COMPLETED|3-months Follow-up||313||
59834161|NCT00227877|75957799|FG001|NOT COMPLETED|3-months Follow-up||267||
59834162|NCT00227877|75957800|FG002|NOT COMPLETED|3-months Follow-up||52||
59834163|NCT00227877|75957801|FG003|NOT COMPLETED|3-months Follow-up||21||
59834164|NCT00227877|75957798|FG000|STARTED|12-months Follow-up||1068|"These Started numbers reflect those who completed the pre-visit assessment."|
59834165|NCT00227877|75957799|FG001|STARTED|12-months Follow-up||1028|"These Started numbers reflect those who completed the pre-visit assessment."|
59834166|NCT00227877|75957800|FG002|STARTED|12-months Follow-up||297|"These Started numbers reflect those who completed the pre-visit assessment."|
59834167|NCT00227877|75957801|FG003|STARTED|12-months Follow-up||292|"These Started numbers reflect those who completed the pre-visit assessment."|
59834168|NCT00227877|75957798|FG000|COMPLETED|12-months Follow-up||758||
59834169|NCT00227877|75957799|FG001|COMPLETED|12-months Follow-up||765||
59834170|NCT00227877|75957800|FG002|COMPLETED|12-months Follow-up||266||
59834171|NCT00227877|75957801|FG003|COMPLETED|12-months Follow-up||266||
59834172|NCT00227877|75957798|FG000|NOT COMPLETED|12-months Follow-up||310||
59834173|NCT00227877|75957799|FG001|NOT COMPLETED|12-months Follow-up||263||
59834174|NCT00227877|75957800|FG002|NOT COMPLETED|12-months Follow-up||31||
59834175|NCT00227877|75957801|FG003|NOT COMPLETED|12-months Follow-up||26||
59717622|NCT03484117|75836750|FG000|COMPLETED|Overall Study||30||
59717623|NCT03484117|75836751|FG001|COMPLETED|Overall Study||31||
59717624|NCT03484117|75836750|FG000|NOT COMPLETED|Overall Study||2||
59834176|NCT00513695|75957813|FG000|STARTED|Overall Study||68||
60118800|NCT02051608|76239836|FG001|NOT COMPLETED|Part 1: Double Blind Treatment||56||
60118801|NCT02051608|76239837|FG002|NOT COMPLETED|Part 1: Double Blind Treatment||0||
59717625|NCT03484117|75836751|FG001|NOT COMPLETED|Overall Study||4||
59717626|NCT01166945|75836759|FG000|STARTED|Randomized||51||
59717627|NCT01166945|75836760|FG001|STARTED|Randomized||47||
59717628|NCT01166945|75836759|FG000|COMPLETED|Randomized||47||
59717629|NCT01166945|75836760|FG001|COMPLETED|Randomized||43||
59834177|NCT00513695|75957813|FG000|COMPLETED|Overall Study||63||
59834178|NCT00513695|75957813|FG000|NOT COMPLETED|Overall Study||5||
59834179|NCT00162981|75957819|FG000|STARTED|Overall Study||32||
59834180|NCT00162981|75957820|FG001|STARTED|Overall Study||36||
59834181|NCT00162981|75957819|FG000|COMPLETED|Overall Study||28||
59834182|NCT00162981|75957820|FG001|COMPLETED|Overall Study||30||
59834183|NCT00162981|75957819|FG000|NOT COMPLETED|Overall Study||4||
59834184|NCT00162981|75957820|FG001|NOT COMPLETED|Overall Study||6||
59834185|NCT00511433|75957828|FG000|STARTED|Overall Study||32||
59834186|NCT00511433|75957829|FG001|STARTED|Overall Study||16||
59834187|NCT00511433|75957828|FG000|COMPLETED|Overall Study||26||
59834188|NCT00511433|75957829|FG001|COMPLETED|Overall Study||15||
59834189|NCT00511433|75957828|FG000|NOT COMPLETED|Overall Study||6||
59717630|NCT01166945|75836759|FG000|NOT COMPLETED|Randomized||4||
59717631|NCT01166945|75836760|FG001|NOT COMPLETED|Randomized||4||
59717632|NCT01166945|75836759|FG000|STARTED|Day 5||47||
60118802|NCT02051608|76239838|FG003|NOT COMPLETED|Part 1: Double Blind Treatment||0||
60118803|NCT02051608|76239835|FG000|STARTED|Part 2: Open-label Extension||0||
59717633|NCT01166945|75836760|FG001|STARTED|Day 5||43||
59717634|NCT01166945|75836759|FG000|COMPLETED|Day 5||47||
59717635|NCT01166945|75836760|FG001|COMPLETED|Day 5||43||
59717636|NCT01166945|75836759|FG000|NOT COMPLETED|Day 5||0||
59717637|NCT01166945|75836760|FG001|NOT COMPLETED|Day 5||0||
59717638|NCT01166945|75836759|FG000|STARTED|Day 10||47||
59717639|NCT01166945|75836760|FG001|STARTED|Day 10||43||
59717640|NCT01166945|75836759|FG000|COMPLETED|Day 10||44||
59717641|NCT01166945|75836760|FG001|COMPLETED|Day 10||41||
59717642|NCT01166945|75836759|FG000|NOT COMPLETED|Day 10||3||
59717643|NCT01166945|75836760|FG001|NOT COMPLETED|Day 10||2||
59717644|NCT01166945|75836759|FG000|STARTED|Day 15||44||
59717645|NCT01166945|75836760|FG001|STARTED|Day 15||41||
59717646|NCT01166945|75836759|FG000|COMPLETED|Day 15||42||
59717647|NCT01166945|75836760|FG001|COMPLETED|Day 15||40||
59717648|NCT01166945|75836759|FG000|NOT COMPLETED|Day 15||2||
59717649|NCT01166945|75836760|FG001|NOT COMPLETED|Day 15||1||
59717650|NCT01166945|75836759|FG000|STARTED|Day 20||42||
59717651|NCT01166945|75836760|FG001|STARTED|Day 20||40||
59717652|NCT01166945|75836759|FG000|COMPLETED|Day 20||42||
59717653|NCT01166945|75836760|FG001|COMPLETED|Day 20||40||
59717654|NCT01166945|75836759|FG000|NOT COMPLETED|Day 20||0||
59717655|NCT01166945|75836760|FG001|NOT COMPLETED|Day 20||0||
59717656|NCT01166945|75836759|FG000|STARTED|Day 30||42||
60118804|NCT02051608|76239836|FG001|STARTED|Part 2: Open-label Extension||0||
60118805|NCT02051608|76239837|FG002|STARTED|Part 2: Open-label Extension||119||
60118806|NCT02051608|76239838|FG003|STARTED|Part 2: Open-label Extension||111||
60118807|NCT02051608|76239835|FG000|COMPLETED|Part 2: Open-label Extension||0||
60118808|NCT02051608|76239836|FG001|COMPLETED|Part 2: Open-label Extension||0||
60118809|NCT02051608|76239837|FG002|COMPLETED|Part 2: Open-label Extension||49||
60118810|NCT02051608|76239838|FG003|COMPLETED|Part 2: Open-label Extension||50||
60118811|NCT02051608|76239835|FG000|NOT COMPLETED|Part 2: Open-label Extension||0||
60118812|NCT02051608|76239836|FG001|NOT COMPLETED|Part 2: Open-label Extension||0||
60118813|NCT02051608|76239837|FG002|NOT COMPLETED|Part 2: Open-label Extension||70||
60118814|NCT02051608|76239838|FG003|NOT COMPLETED|Part 2: Open-label Extension||61||
60118815|NCT02705586|76239851|FG000|STARTED|Overall Study||13||
60118816|NCT02705586|76239851|FG000|COMPLETED|Overall Study||5||
60118817|NCT02705586|76239851|FG000|NOT COMPLETED|Overall Study||8||
59717657|NCT01166945|75836760|FG001|STARTED|Day 30||40||
59717658|NCT01166945|75836759|FG000|COMPLETED|Day 30||38||
59717659|NCT01166945|75836760|FG001|COMPLETED|Day 30||37||
59717660|NCT01166945|75836759|FG000|NOT COMPLETED|Day 30||4||
60118818|NCT01592045|76239857|FG000|STARTED|Overall Study||14||
60118819|NCT01592045|76239858|FG001|STARTED|Overall Study||14||
60118820|NCT01592045|76239857|FG000|Completed Course 1|Overall Study||13||
60118821|NCT01592045|76239858|FG001|Completed Course 1|Overall Study||14||
60118822|NCT01592045|76239857|FG000|Completed Course 2|Overall Study||13||
60118823|NCT01592045|76239858|FG001|Completed Course 2|Overall Study||13||
60118824|NCT01592045|76239857|FG000|Completed Course 3|Overall Study||11||
60118825|NCT01592045|76239858|FG001|Completed Course 3|Overall Study||13||
60118826|NCT01592045|76239857|FG000|Completed Course 4|Overall Study||11||
60118827|NCT01592045|76239858|FG001|Completed Course 4|Overall Study||12||
60118828|NCT01592045|76239857|FG000|Completed Course 5|Overall Study||9||
60118829|NCT01592045|76239858|FG001|Completed Course 5|Overall Study||12||
60118830|NCT01592045|76239857|FG000|COMPLETED|Overall Study||9||
60118831|NCT01592045|76239858|FG001|COMPLETED|Overall Study||12||
60118832|NCT01592045|76239857|FG000|NOT COMPLETED|Overall Study||5||
60118833|NCT01592045|76239858|FG001|NOT COMPLETED|Overall Study||2||
60118834|NCT01591499|76239866|FG000|STARTED|Baseline Visit||33||
60118835|NCT01591499|76239867|FG001|STARTED|Baseline Visit||39||
60118836|NCT01591499|76239868|FG002|STARTED|Baseline Visit||31||
60118837|NCT01591499|76239869|FG003|STARTED|Baseline Visit||39||
60118838|NCT01591499|76239866|FG000|COMPLETED|Baseline Visit||33||
60118839|NCT01591499|76239867|FG001|COMPLETED|Baseline Visit||37||
60118840|NCT01591499|76239868|FG002|COMPLETED|Baseline Visit||31||
60118841|NCT01591499|76239869|FG003|COMPLETED|Baseline Visit||37||
60118842|NCT01591499|76239866|FG000|NOT COMPLETED|Baseline Visit||0||
60118843|NCT01591499|76239867|FG001|NOT COMPLETED|Baseline Visit||2||
60118844|NCT01591499|76239868|FG002|NOT COMPLETED|Baseline Visit||0||
60118845|NCT01591499|76239869|FG003|NOT COMPLETED|Baseline Visit||2||
60118846|NCT01591499|76239866|FG000|STARTED|First Intervention (up to 24 Days)||33||
60118847|NCT01591499|76239867|FG001|STARTED|First Intervention (up to 24 Days)||37||
60118848|NCT01591499|76239868|FG002|STARTED|First Intervention (up to 24 Days)||31||
59717661|NCT01166945|75836760|FG001|NOT COMPLETED|Day 30||3||
59717662|NCT00910000|75836774|FG000|STARTED|Overall Study||3||
59717663|NCT00910000|75836775|FG001|STARTED|Overall Study||3||
60118849|NCT01591499|76239869|FG003|STARTED|First Intervention (up to 24 Days)||37||
60118850|NCT01591499|76239866|FG000|COMPLETED|First Intervention (up to 24 Days)||33||
60118851|NCT01591499|76239867|FG001|COMPLETED|First Intervention (up to 24 Days)||37||
60118852|NCT01591499|76239868|FG002|COMPLETED|First Intervention (up to 24 Days)||31||
59834190|NCT00511433|75957829|FG001|NOT COMPLETED|Overall Study||1||
59834191|NCT00099268|75957839|FG000|STARTED|Overall Study||374||
59834192|NCT00099268|75957840|FG001|STARTED|Overall Study||373||
59834193|NCT00099268|75957839|FG000|Intent-to-Treat|Overall Study|One patient from each group discontinued without receiving a single dose of study drug.|373||
59834194|NCT00099268|75957840|FG001|Intent-to-Treat|Overall Study||372||
59834195|NCT00099268|75957839|FG000|COMPLETED|Overall Study|Plus 1 death in the carbidopa/levodopa/entacapone group within 30 days of treatment discontinuation|282||
59834196|NCT00099268|75957840|FG001|COMPLETED|Overall Study|Plus 1 death in the carbidopa/levodopa group within 30 days of treatment discontinuation|291||
59834197|NCT00099268|75957839|FG000|NOT COMPLETED|Overall Study||92||
59834198|NCT00099268|75957840|FG001|NOT COMPLETED|Overall Study||82||
59834199|NCT00511355|75957848|FG000|STARTED|Overall Study||60||
59834200|NCT00511355|75957849|FG001|STARTED|Overall Study||61||
59834201|NCT00511355|75957848|FG000|COMPLETED|Overall Study||53||
59834202|NCT00511355|75957849|FG001|COMPLETED|Overall Study||52||
59834203|NCT00511355|75957848|FG000|NOT COMPLETED|Overall Study||7||
59834204|NCT00511355|75957849|FG001|NOT COMPLETED|Overall Study||9||
59834205|NCT00095212|75957859|FG000|STARTED|Overall Study||13||
59834206|NCT00095212|75957860|FG001|STARTED|Overall Study||12||
59834207|NCT00095212|75957859|FG000|COMPLETED|Overall Study||12||
59834208|NCT00095212|75957860|FG001|COMPLETED|Overall Study||9||
59834209|NCT00095212|75957859|FG000|NOT COMPLETED|Overall Study||1||
59834210|NCT00095212|75957860|FG001|NOT COMPLETED|Overall Study||3||
59834211|NCT00120874|75957868|FG000|STARTED|Overall Study||10||
59834212|NCT00120874|75957869|FG001|STARTED|Overall Study||10||
59834213|NCT00120874|75957868|FG000|Completed Study; Started Extension Study|Overall Study||10||
59834214|NCT00120874|75957869|FG001|Completed Study; Started Extension Study|Overall Study||10||
59834215|NCT00120874|75957868|FG000|COMPLETED|Overall Study||10||
59834216|NCT00120874|75957869|FG001|COMPLETED|Overall Study||9||
59834217|NCT00120874|75957868|FG000|NOT COMPLETED|Overall Study||0||
59834218|NCT00120874|75957869|FG001|NOT COMPLETED|Overall Study||1||
59834219|NCT00120406|75957877|FG000|STARTED|Overall Study||236||
59834220|NCT00120406|75957878|FG001|STARTED|Overall Study||238||
59834221|NCT00120406|75957877|FG000|COMPLETED|Overall Study||217||
59834222|NCT00120406|75957878|FG001|COMPLETED|Overall Study||222||
59834223|NCT00120406|75957877|FG000|NOT COMPLETED|Overall Study||19||
59834224|NCT00120406|75957878|FG001|NOT COMPLETED|Overall Study||16||
59834225|NCT00120250|75957884|FG000|STARTED|Overall Study||13||
59834226|NCT00120250|75957885|FG001|STARTED|Overall Study||14||
59834227|NCT00120250|75957884|FG000|COMPLETED|Overall Study||12||
59834228|NCT00120250|75957885|FG001|COMPLETED|Overall Study||12||
59834229|NCT00120250|75957884|FG000|NOT COMPLETED|Overall Study||1||
59834230|NCT00120250|75957885|FG001|NOT COMPLETED|Overall Study||2||
59834231|NCT00511199|75957894|FG000|STARTED|Overall Study||1591||
59834232|NCT00511199|75957895|FG001|STARTED|Overall Study||535||
59834233|NCT00511199|75957894|FG000|COMPLETED|Overall Study||1142||
59834234|NCT00511199|75957895|FG001|COMPLETED|Overall Study||410||
59834235|NCT00511199|75957894|FG000|NOT COMPLETED|Overall Study||449||
59834236|NCT00511199|75957895|FG001|NOT COMPLETED|Overall Study||125||
59834237|NCT00384176|75957906|FG000|STARTED|Overall Study||709||
59834238|NCT00384176|75957907|FG001|STARTED|Overall Study||713||
59834239|NCT00384176|75957908|FG002|STARTED|Overall Study||192||
59834240|NCT00384176|75957906|FG000|COMPLETED|Overall Study||397||
59834241|NCT00384176|75957907|FG001|COMPLETED|Overall Study||394||
59834242|NCT00384176|75957908|FG002|COMPLETED|Overall Study||60||
59834243|NCT00384176|75957906|FG000|NOT COMPLETED|Overall Study||312||
59834244|NCT00384176|75957907|FG001|NOT COMPLETED|Overall Study||319||
59834245|NCT00384176|75957908|FG002|NOT COMPLETED|Overall Study||132||
59834246|NCT00513305|75957918|FG000|STARTED|Overall Study||33||
59834247|NCT00513305|75957919|FG001|STARTED|Overall Study|One subject withdrew prior to receiving study medication|34||
59834248|NCT00513305|75957918|FG000|COMPLETED|Overall Study||5||
59834249|NCT00513305|75957919|FG001|COMPLETED|Overall Study||7||
59834250|NCT00513305|75957918|FG000|NOT COMPLETED|Overall Study||28||
59834251|NCT00513305|75957919|FG001|NOT COMPLETED|Overall Study||27||
59834252|NCT00513071|75957925|FG000|STARTED|Overall Study||28||
59834253|NCT00513071|75957925|FG000|COMPLETED|Overall Study||23||
59834254|NCT00513071|75957925|FG000|NOT COMPLETED|Overall Study||5||
59834255|NCT00510887|75957929|FG000|STARTED|Overall Study||12||
59834256|NCT00510887|75957929|FG000|COMPLETED|Overall Study||11||
59834257|NCT00510887|75957929|FG000|NOT COMPLETED|Overall Study||1||
59834258|NCT00358826|75957937|FG000|STARTED|Core Study||49||
59834259|NCT00358826|75957938|FG001|STARTED|Core Study||46||
59834260|NCT00358826|75957939|FG002|STARTED|Core Study||44||
59834261|NCT00358826|75957940|FG003|STARTED|Core Study||52||
59834262|NCT00358826|75957941|FG004|STARTED|Core Study||0||
59834263|NCT00358826|75957942|FG005|STARTED|Core Study||0||
59834264|NCT00358826|75957943|FG006|STARTED|Core Study||0||
59834265|NCT00358826|75957944|FG007|STARTED|Core Study||0||
59834266|NCT00358826|75957937|FG000|COMPLETED|Core Study||46||
59834267|NCT00358826|75957938|FG001|COMPLETED|Core Study||41||
59834268|NCT00358826|75957939|FG002|COMPLETED|Core Study||42||
59834269|NCT00358826|75957940|FG003|COMPLETED|Core Study||50||
59834270|NCT00358826|75957941|FG004|COMPLETED|Core Study||0||
59834271|NCT00358826|75957942|FG005|COMPLETED|Core Study||0||
60118853|NCT01591499|76239869|FG003|COMPLETED|First Intervention (up to 24 Days)||37||
60118854|NCT01591499|76239866|FG000|NOT COMPLETED|First Intervention (up to 24 Days)||0||
60118855|NCT01591499|76239867|FG001|NOT COMPLETED|First Intervention (up to 24 Days)||0||
60118856|NCT01591499|76239868|FG002|NOT COMPLETED|First Intervention (up to 24 Days)||0||
60118857|NCT01591499|76239869|FG003|NOT COMPLETED|First Intervention (up to 24 Days)||0||
59834272|NCT00358826|75957943|FG006|COMPLETED|Core Study||0||
59834273|NCT00358826|75957944|FG007|COMPLETED|Core Study||0||
60118858|NCT01591499|76239866|FG000|STARTED|Second Intervention (up to 24 Days)||33||
60118859|NCT01591499|76239867|FG001|STARTED|Second Intervention (up to 24 Days)||37||
60118860|NCT01591499|76239868|FG002|STARTED|Second Intervention (up to 24 Days)||31||
60118861|NCT01591499|76239869|FG003|STARTED|Second Intervention (up to 24 Days)||37||
60118862|NCT01591499|76239866|FG000|COMPLETED|Second Intervention (up to 24 Days)||27||
60118863|NCT01591499|76239867|FG001|COMPLETED|Second Intervention (up to 24 Days)||34||
60118864|NCT01591499|76239868|FG002|COMPLETED|Second Intervention (up to 24 Days)||28||
60118865|NCT01591499|76239869|FG003|COMPLETED|Second Intervention (up to 24 Days)||34||
60118866|NCT01591499|76239866|FG000|NOT COMPLETED|Second Intervention (up to 24 Days)||6||
60118867|NCT01591499|76239867|FG001|NOT COMPLETED|Second Intervention (up to 24 Days)||3||
60118868|NCT01591499|76239868|FG002|NOT COMPLETED|Second Intervention (up to 24 Days)||3||
60118869|NCT01591499|76239869|FG003|NOT COMPLETED|Second Intervention (up to 24 Days)||3||
60118870|NCT01590797|76239895|FG000|STARTED|Overall Study||234||
60118871|NCT01590797|76239896|FG001|STARTED|Overall Study||233||
60118872|NCT01590797|76239895|FG000|COMPLETED|Overall Study||217||
60118873|NCT01590797|76239896|FG001|COMPLETED|Overall Study||217||
60118874|NCT01590797|76239895|FG000|NOT COMPLETED|Overall Study||17||
60118875|NCT01590797|76239896|FG001|NOT COMPLETED|Overall Study||16||
60118876|NCT01590563|76239902|FG000|STARTED|Overall Study||15||
60118877|NCT01590563|76239902|FG000|COMPLETED|Overall Study||14||
60118878|NCT01590563|76239902|FG000|NOT COMPLETED|Overall Study||1||
60118879|NCT01701401|76239911|FG000|STARTED|Overall Study||217||
60118880|NCT01701401|76239912|FG001|STARTED|Overall Study||218||
60118881|NCT01701401|76239913|FG002|STARTED|Overall Study||217||
60118882|NCT01701401|76239914|FG003|STARTED|Overall Study||218||
60118883|NCT01701401|76239911|FG000|COMPLETED|Overall Study||207||
60118884|NCT01701401|76239912|FG001|COMPLETED|Overall Study||209||
60118885|NCT01701401|76239913|FG002|COMPLETED|Overall Study||212||
60118886|NCT01701401|76239914|FG003|COMPLETED|Overall Study||212||
60118887|NCT01701401|76239911|FG000|NOT COMPLETED|Overall Study||10||
60118888|NCT01701401|76239912|FG001|NOT COMPLETED|Overall Study||9||
60118889|NCT01701401|76239913|FG002|NOT COMPLETED|Overall Study||5||
60118890|NCT01701401|76239914|FG003|NOT COMPLETED|Overall Study||6||
60118891|NCT01701245|76239926|FG000|STARTED|Overall Study||49||
60118892|NCT01701245|76239927|FG001|STARTED|Overall Study||48||
60118893|NCT01701245|76239926|FG000|FAS Unmatched Data|Overall Study|1 patient protocol violation|48||
60118894|NCT01701245|76239927|FG001|FAS Unmatched Data|Overall Study|3 patients protocol violation|45||
60118895|NCT01701245|76239926|FG000|FAS Matched Data|Overall Study||42||
60118896|NCT01701245|76239927|FG001|FAS Matched Data|Overall Study||32||
60118897|NCT01701245|76239926|FG000|COMPLETED|Overall Study||37||
60118898|NCT01701245|76239927|FG001|COMPLETED|Overall Study||33||
60118899|NCT01701245|76239926|FG000|NOT COMPLETED|Overall Study||12||
60118900|NCT01701245|76239927|FG001|NOT COMPLETED|Overall Study||15||
60118901|NCT01590017|76239933|FG000|STARTED|Overall Study||41||
60118902|NCT01590017|76239933|FG000|COMPLETED|Overall Study||37||
60118903|NCT01590017|76239933|FG000|NOT COMPLETED|Overall Study||4||
60118904|NCT01700621|76239939|FG000|STARTED|Received Study Vaccines||240||
60118905|NCT01700621|76239940|FG001|STARTED|Received Study Vaccines||240||
60118906|NCT01700621|76239939|FG000|COMPLETED|Received Study Vaccines||240||
59834274|NCT00358826|75957937|FG000|NOT COMPLETED|Core Study||3||
59834275|NCT00358826|75957938|FG001|NOT COMPLETED|Core Study||5||
59834276|NCT00358826|75957939|FG002|NOT COMPLETED|Core Study||2||
60118907|NCT01700621|76239940|FG001|COMPLETED|Received Study Vaccines||240||
60118908|NCT01700621|76239939|FG000|NOT COMPLETED|Received Study Vaccines||0||
60118909|NCT01700621|76239940|FG001|NOT COMPLETED|Received Study Vaccines||0||
60118910|NCT01700621|76239939|FG000|STARTED|Analyzed for Immunogenicity||240||
59834277|NCT00358826|75957940|FG003|NOT COMPLETED|Core Study||2||
59834278|NCT00358826|75957941|FG004|NOT COMPLETED|Core Study||0||
59834279|NCT00358826|75957942|FG005|NOT COMPLETED|Core Study||0||
59834280|NCT00358826|75957943|FG006|NOT COMPLETED|Core Study||0||
59834281|NCT00358826|75957944|FG007|NOT COMPLETED|Core Study||0||
59834282|NCT00358826|75957937|FG000|STARTED|MDCT Substudy||0||
59834283|NCT00358826|75957938|FG001|STARTED|MDCT Substudy||0||
59834284|NCT00358826|75957939|FG002|STARTED|MDCT Substudy||0||
59834285|NCT00358826|75957940|FG003|STARTED|MDCT Substudy||0||
59834286|NCT00358826|75957941|FG004|STARTED|MDCT Substudy||25||
59834287|NCT00358826|75957942|FG005|STARTED|MDCT Substudy||22||
59834288|NCT00358826|75957943|FG006|STARTED|MDCT Substudy||19||
59834289|NCT00358826|75957944|FG007|STARTED|MDCT Substudy||27||
59834290|NCT00358826|75957937|FG000|COMPLETED|MDCT Substudy||0||
59834291|NCT00358826|75957938|FG001|COMPLETED|MDCT Substudy||0||
59834292|NCT00358826|75957939|FG002|COMPLETED|MDCT Substudy||0||
59834293|NCT00358826|75957940|FG003|COMPLETED|MDCT Substudy||0||
59834294|NCT00358826|75957941|FG004|COMPLETED|MDCT Substudy||24||
59834295|NCT00358826|75957942|FG005|COMPLETED|MDCT Substudy||20||
59834296|NCT00358826|75957943|FG006|COMPLETED|MDCT Substudy||19||
59834297|NCT00358826|75957944|FG007|COMPLETED|MDCT Substudy||27||
59834298|NCT00358826|75957937|FG000|NOT COMPLETED|MDCT Substudy||0||
59834299|NCT00358826|75957938|FG001|NOT COMPLETED|MDCT Substudy||0||
59834300|NCT00358826|75957939|FG002|NOT COMPLETED|MDCT Substudy||0||
59834301|NCT00358826|75957940|FG003|NOT COMPLETED|MDCT Substudy||0||
59834302|NCT00358826|75957941|FG004|NOT COMPLETED|MDCT Substudy||1||
59834303|NCT00358826|75957942|FG005|NOT COMPLETED|MDCT Substudy||2||
59834304|NCT00358826|75957943|FG006|NOT COMPLETED|MDCT Substudy||0||
59834305|NCT00358826|75957944|FG007|NOT COMPLETED|MDCT Substudy||0||
59834306|NCT00510653|75957958|FG000|STARTED|Overall Study||24||
59834307|NCT00510653|75957958|FG000|COMPLETED|Overall Study||13||
59834308|NCT00510653|75957958|FG000|NOT COMPLETED|Overall Study||11||
59834309|NCT00362336|75957965|FG000|STARTED|Overall Study||243||
59834310|NCT00362336|75957966|FG001|STARTED|Overall Study||242||
59834311|NCT00362336|75957967|FG002|STARTED|Overall Study||137||
59834312|NCT00362336|75957965|FG000|COMPLETED|Overall Study||233||
59834313|NCT00362336|75957966|FG001|COMPLETED|Overall Study||235||
59834314|NCT00362336|75957967|FG002|COMPLETED|Overall Study||134||
59834315|NCT00362336|75957965|FG000|NOT COMPLETED|Overall Study||10||
59834316|NCT00362336|75957966|FG001|NOT COMPLETED|Overall Study||7||
59834317|NCT00362336|75957967|FG002|NOT COMPLETED|Overall Study||3||
59834318|NCT00506285|75957984|FG000|STARTED|3 Week Screening Phase||46||
59834319|NCT00506285|75957985|FG001|STARTED|3 Week Screening Phase||46||
59834320|NCT00506285|75957984|FG000|COMPLETED|3 Week Screening Phase||29||
59834321|NCT00506285|75957985|FG001|COMPLETED|3 Week Screening Phase||36||
59834322|NCT00506285|75957984|FG000|NOT COMPLETED|3 Week Screening Phase||17||
59834323|NCT00506285|75957985|FG001|NOT COMPLETED|3 Week Screening Phase||10||
59834324|NCT00506285|75957984|FG000|STARTED|Double Blind Cross-Over Phase||29||
59834325|NCT00506285|75957985|FG001|STARTED|Double Blind Cross-Over Phase||36||
59834326|NCT00506285|75957984|FG000|Received at Least 1 Dose MTS|Double Blind Cross-Over Phase||29||
59834327|NCT00506285|75957985|FG001|Received at Least 1 Dose MTS|Double Blind Cross-Over Phase||31||
59834328|NCT00506285|75957984|FG000|COMPLETED|Double Blind Cross-Over Phase||20||
59834329|NCT00506285|75957985|FG001|COMPLETED|Double Blind Cross-Over Phase||31||
59834330|NCT00506285|75957984|FG000|NOT COMPLETED|Double Blind Cross-Over Phase||9||
59834331|NCT00506285|75957985|FG001|NOT COMPLETED|Double Blind Cross-Over Phase||5||
59834332|NCT00506285|75957984|FG000|STARTED|6-month Open Label Phase||20||
59834333|NCT00506285|75957985|FG001|STARTED|6-month Open Label Phase||31||
59834334|NCT00506285|75957984|FG000|COMPLETED|6-month Open Label Phase||10||
59567504|NCT02326272|75670467|FG014|Completed Week 16|Initial Period (Week 0 to Week 16)||0||
59834335|NCT00506285|75957985|FG001|COMPLETED|6-month Open Label Phase||19||
59834336|NCT00506285|75957984|FG000|NOT COMPLETED|6-month Open Label Phase||10||
59834337|NCT00506285|75957985|FG001|NOT COMPLETED|6-month Open Label Phase||12||
59567505|NCT02326272|75670453|FG000|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||45||
59834338|NCT00506129|75957993|FG000|STARTED|Overall Study||33||
59834339|NCT00506129|75957993|FG000|COMPLETED|Overall Study||11||
59834340|NCT00506129|75957993|FG000|NOT COMPLETED|Overall Study||22||
59834341|NCT00358670|75957999|FG000|STARTED|Overall Study||222||
59834342|NCT00358670|75958000|FG001|STARTED|Overall Study||219||
59834343|NCT00358670|75957999|FG000|COMPLETED|Overall Study||0||
59834344|NCT00358670|75958000|FG001|COMPLETED|Overall Study||0||
59834345|NCT00358670|75957999|FG000|NOT COMPLETED|Overall Study||222||
59834346|NCT00358670|75958000|FG001|NOT COMPLETED|Overall Study||219||
59834347|NCT00505661|75958006|FG000|STARTED|Overall Study||16||
59834348|NCT00505661|75958006|FG000|COMPLETED|Overall Study||12||
59834349|NCT00505661|75958006|FG000|NOT COMPLETED|Overall Study||4||
59834350|NCT00383786|75958012|FG000|STARTED|Overall Study||22||
59834351|NCT00383786|75958013|FG001|STARTED|Overall Study||25||
59834352|NCT00383786|75958012|FG000|COMPLETED|Overall Study||18||
59834353|NCT00383786|75958013|FG001|COMPLETED|Overall Study||13||
59834354|NCT00383786|75958012|FG000|NOT COMPLETED|Overall Study||4||
59834355|NCT00383786|75958013|FG001|NOT COMPLETED|Overall Study||12||
59834356|NCT00383708|75958019|FG000|STARTED|Enrolment Through Start Treatment||125||
59834357|NCT00383708|75958019|FG000|COMPLETED|Enrolment Through Start Treatment||92||
59834358|NCT00383708|75958019|FG000|NOT COMPLETED|Enrolment Through Start Treatment||33||
59834359|NCT00383708|75958019|FG000|STARTED|Run-in Period||92||
59834360|NCT00383708|75958019|FG000|COMPLETED|Run-in Period||85||
59834361|NCT00383708|75958019|FG000|NOT COMPLETED|Run-in Period||7||
59834362|NCT00383708|75958019|FG000|STARTED|Co-administration Period||57|28 subjects were not eligible for co-administration period based on IGF-1 levels and were withdrawn|
59834363|NCT00383708|75958019|FG000|COMPLETED|Co-administration Period||52||
59834364|NCT00383708|75958019|FG000|NOT COMPLETED|Co-administration Period||5||
59834365|NCT00504881|75958026|FG000|STARTED|Overall Study||121||
59834366|NCT00504881|75958027|FG001|STARTED|Overall Study||359||
59834367|NCT00504881|75958026|FG000|COMPLETED|Overall Study||111||
59834368|NCT00504881|75958027|FG001|COMPLETED|Overall Study||323||
59834369|NCT00504881|75958026|FG000|NOT COMPLETED|Overall Study||10||
59834370|NCT00504881|75958027|FG001|NOT COMPLETED|Overall Study||36||
59834371|NCT00504725|75958037|FG000|STARTED|Overall Study||21||
59834372|NCT00504725|75958038|FG001|STARTED|Overall Study||20||
59834373|NCT00504725|75958037|FG000|COMPLETED|Overall Study|Prior to unblinding, one subject was discontinued due to elevated CRP levels at baseline.|20||
59834374|NCT00504725|75958038|FG001|COMPLETED|Overall Study||20||
59834375|NCT00504725|75958037|FG000|NOT COMPLETED|Overall Study||1||
59834376|NCT00504725|75958038|FG001|NOT COMPLETED|Overall Study||0||
59834377|NCT00383240|75958048|FG000|STARTED|Overall Study||191||
59834378|NCT00383240|75958049|FG001|STARTED|Overall Study||192||
59717664|NCT00910000|75836776|FG002|STARTED|Overall Study||3||
59717665|NCT00910000|75836777|FG003|STARTED|Overall Study||2||
59717666|NCT00910000|75836778|FG004|STARTED|Overall Study||3||
59717667|NCT00910000|75836779|FG005|STARTED|Overall Study||1||
59717668|NCT00910000|75836774|FG000|COMPLETED|Overall Study||3||
59717669|NCT00910000|75836775|FG001|COMPLETED|Overall Study||0||
59717670|NCT00910000|75836776|FG002|COMPLETED|Overall Study||0||
59717671|NCT00910000|75836777|FG003|COMPLETED|Overall Study||0||
59717672|NCT00910000|75836778|FG004|COMPLETED|Overall Study||2||
59717673|NCT00910000|75836779|FG005|COMPLETED|Overall Study||0||
59717674|NCT00910000|75836774|FG000|NOT COMPLETED|Overall Study||0||
59717675|NCT00910000|75836775|FG001|NOT COMPLETED|Overall Study||3||
59717676|NCT00910000|75836776|FG002|NOT COMPLETED|Overall Study||3||
59717677|NCT00910000|75836777|FG003|NOT COMPLETED|Overall Study||2||
59717678|NCT00910000|75836778|FG004|NOT COMPLETED|Overall Study||1||
59717679|NCT00910000|75836779|FG005|NOT COMPLETED|Overall Study||1||
59717680|NCT02700945|75836791|FG000|STARTED|Overall Study||242||
59717681|NCT02700945|75836792|FG001|STARTED|Overall Study||250||
59717682|NCT02700945|75836791|FG000|COMPLETED|Overall Study||210||
59717683|NCT02700945|75836792|FG001|COMPLETED|Overall Study||207||
59717684|NCT02700945|75836791|FG000|NOT COMPLETED|Overall Study||32||
59717685|NCT02700945|75836792|FG001|NOT COMPLETED|Overall Study||43||
59717686|NCT01119768|75836800|FG000|STARTED|Treatment Period||154||
59717687|NCT01119768|75836801|FG001|STARTED|Treatment Period||151||
59717688|NCT01119768|75836800|FG000|COMPLETED|Treatment Period||136||
59717689|NCT01119768|75836801|FG001|COMPLETED|Treatment Period||126||
59717690|NCT01119768|75836800|FG000|NOT COMPLETED|Treatment Period||18||
59717691|NCT01119768|75836801|FG001|NOT COMPLETED|Treatment Period||25||
59717692|NCT01119768|75836800|FG000|STARTED|Follow-up||136||
59717693|NCT01119768|75836801|FG001|STARTED|Follow-up||124||
59717694|NCT01119768|75836800|FG000|COMPLETED|Follow-up||135||
59717695|NCT01119768|75836801|FG001|COMPLETED|Follow-up||122||
59717696|NCT01119768|75836800|FG000|NOT COMPLETED|Follow-up||1||
59717697|NCT01119768|75836801|FG001|NOT COMPLETED|Follow-up||2||
59717698|NCT01165307|75836809|FG000|STARTED|Overall Study||33||
59717699|NCT01165307|75836810|FG001|STARTED|Overall Study||34||
59717700|NCT01165307|75836809|FG000|COMPLETED|Overall Study||19||
59717701|NCT01165307|75836810|FG001|COMPLETED|Overall Study||31||
59717702|NCT01165307|75836809|FG000|NOT COMPLETED|Overall Study||14||
59717703|NCT01165307|75836810|FG001|NOT COMPLETED|Overall Study||3||
59717704|NCT00960999|75836818|FG000|STARTED|Overall Study||47||
59717705|NCT00960999|75836819|FG001|STARTED|Overall Study||47||
59717706|NCT00960999|75836818|FG000|Eligible|Overall Study||39||
59717707|NCT00960999|75836819|FG001|Eligible|Overall Study||45||
59717708|NCT00960999|75836818|FG000|Started Protocol Treatment|Overall Study||39|Eligible participants who started protocol treatment|
59834379|NCT00383240|75958050|FG002|STARTED|Overall Study||202||
59834380|NCT00383240|75958051|FG003|STARTED|Overall Study||196||
59834381|NCT00383240|75958048|FG000|COMPLETED|Overall Study||156||
59717709|NCT00960999|75836819|FG001|Started Protocol Treatment|Overall Study||45|Eligible participants who started protocol treatment|
59834382|NCT00383240|75958049|FG001|COMPLETED|Overall Study||159||
59834383|NCT00383240|75958050|FG002|COMPLETED|Overall Study||117||
59834384|NCT00383240|75958051|FG003|COMPLETED|Overall Study||119||
59834385|NCT00383240|75958048|FG000|NOT COMPLETED|Overall Study||35||
59834386|NCT00383240|75958049|FG001|NOT COMPLETED|Overall Study||33||
59834387|NCT00383240|75958050|FG002|NOT COMPLETED|Overall Study||85||
59834388|NCT00383240|75958051|FG003|NOT COMPLETED|Overall Study||77||
59834389|NCT00362180|75958071|FG000|STARTED|Treated Period||4||
59834390|NCT00362180|75958072|FG001|STARTED|Treated Period||2||
59834391|NCT00362180|75958073|FG002|STARTED|Treated Period||1||
59834392|NCT00362180|75958074|FG003|STARTED|Treated Period||0||
59834393|NCT00362180|75958075|FG004|STARTED|Treated Period||11||
59834394|NCT00362180|75958076|FG005|STARTED|Treated Period||10||
59834395|NCT00362180|75958077|FG006|STARTED|Treated Period||6||
59834396|NCT00362180|75958078|FG007|STARTED|Treated Period||3||
59834397|NCT00362180|75958079|FG008|STARTED|Treated Period||1||
59834398|NCT00362180|75958071|FG000|COMPLETED|Treated Period||3||
59834399|NCT00362180|75958072|FG001|COMPLETED|Treated Period||2||
59834400|NCT00362180|75958073|FG002|COMPLETED|Treated Period||1||
59834401|NCT00362180|75958074|FG003|COMPLETED|Treated Period||0||
59834402|NCT00362180|75958075|FG004|COMPLETED|Treated Period||11||
59834403|NCT00362180|75958076|FG005|COMPLETED|Treated Period||9||
59834404|NCT00362180|75958077|FG006|COMPLETED|Treated Period||6||
59834405|NCT00362180|75958078|FG007|COMPLETED|Treated Period||2||
59834406|NCT00362180|75958079|FG008|COMPLETED|Treated Period||1||
59834407|NCT00362180|75958071|FG000|NOT COMPLETED|Treated Period||1||
59834408|NCT00362180|75958072|FG001|NOT COMPLETED|Treated Period||0||
59834409|NCT00362180|75958073|FG002|NOT COMPLETED|Treated Period||0||
59834410|NCT00362180|75958074|FG003|NOT COMPLETED|Treated Period||0||
59834411|NCT00362180|75958075|FG004|NOT COMPLETED|Treated Period||0||
59834412|NCT00362180|75958076|FG005|NOT COMPLETED|Treated Period||1||
59834413|NCT00362180|75958077|FG006|NOT COMPLETED|Treated Period||0||
59834414|NCT00362180|75958078|FG007|NOT COMPLETED|Treated Period||1||
59834415|NCT00362180|75958079|FG008|NOT COMPLETED|Treated Period||0||
59834416|NCT00362180|75958071|FG000|STARTED|20 Week Safety Follow-up||3||
59834417|NCT00362180|75958072|FG001|STARTED|20 Week Safety Follow-up||2||
59834418|NCT00362180|75958073|FG002|STARTED|20 Week Safety Follow-up||1||
59834419|NCT00362180|75958074|FG003|STARTED|20 Week Safety Follow-up||0||
59834420|NCT00362180|75958075|FG004|STARTED|20 Week Safety Follow-up||11||
59834421|NCT00362180|75958076|FG005|STARTED|20 Week Safety Follow-up||9||
59834422|NCT00362180|75958077|FG006|STARTED|20 Week Safety Follow-up|This observational cohort did not include a safety follow-up period.|0||
59834423|NCT00362180|75958078|FG007|STARTED|20 Week Safety Follow-up||3||
59834424|NCT00362180|75958079|FG008|STARTED|20 Week Safety Follow-up||1||
59834425|NCT00362180|75958071|FG000|COMPLETED|20 Week Safety Follow-up||3||
59834426|NCT00362180|75958072|FG001|COMPLETED|20 Week Safety Follow-up||2||
59834427|NCT00362180|75958073|FG002|COMPLETED|20 Week Safety Follow-up||1||
59834428|NCT00362180|75958074|FG003|COMPLETED|20 Week Safety Follow-up||0||
59834429|NCT00362180|75958075|FG004|COMPLETED|20 Week Safety Follow-up||11||
59834430|NCT00362180|75958076|FG005|COMPLETED|20 Week Safety Follow-up||9||
59834431|NCT00362180|75958077|FG006|COMPLETED|20 Week Safety Follow-up||0||
59834432|NCT00362180|75958078|FG007|COMPLETED|20 Week Safety Follow-up||3||
59834433|NCT00362180|75958079|FG008|COMPLETED|20 Week Safety Follow-up||1||
60118911|NCT01700621|76239940|FG001|STARTED|Analyzed for Immunogenicity||240||
60118912|NCT01700621|76239939|FG000|COMPLETED|Analyzed for Immunogenicity||227||
60118913|NCT01700621|76239940|FG001|COMPLETED|Analyzed for Immunogenicity||233||
60118914|NCT01700621|76239939|FG000|NOT COMPLETED|Analyzed for Immunogenicity||13||
60118915|NCT01700621|76239940|FG001|NOT COMPLETED|Analyzed for Immunogenicity||7||
60118916|NCT01589237|76239951|FG000|STARTED|Part A (52 Weeks)|"Started = Full analysis set/safety set"|11||
60118917|NCT01589237|76239952|FG001|STARTED|Part A (52 Weeks)||12||
60118918|NCT01589237|76239953|FG002|STARTED|Part A (52 Weeks)||10||
60118919|NCT01589237|76239954|FG003|STARTED|Part A (52 Weeks)||5||
60118920|NCT01589237|76239951|FG000|COMPLETED|Part A (52 Weeks)||9||
60118921|NCT01589237|76239952|FG001|COMPLETED|Part A (52 Weeks)||9||
59834434|NCT00362180|75958071|FG000|NOT COMPLETED|20 Week Safety Follow-up||0||
59834435|NCT00362180|75958072|FG001|NOT COMPLETED|20 Week Safety Follow-up||0||
59834436|NCT00362180|75958073|FG002|NOT COMPLETED|20 Week Safety Follow-up||0||
59834437|NCT00362180|75958074|FG003|NOT COMPLETED|20 Week Safety Follow-up||0||
59834438|NCT00362180|75958075|FG004|NOT COMPLETED|20 Week Safety Follow-up||0||
59834439|NCT00362180|75958076|FG005|NOT COMPLETED|20 Week Safety Follow-up||0||
59834440|NCT00362180|75958077|FG006|NOT COMPLETED|20 Week Safety Follow-up||0||
59834441|NCT00362180|75958078|FG007|NOT COMPLETED|20 Week Safety Follow-up||0||
59834442|NCT00362180|75958079|FG008|NOT COMPLETED|20 Week Safety Follow-up||0||
59834443|NCT00383162|75958097|FG000|STARTED|Migraine Attack 1 (Period 1)||87||
59834444|NCT00383162|75958098|FG001|STARTED|Migraine Attack 1 (Period 1)||86||
59834445|NCT00383162|75958097|FG000|COMPLETED|Migraine Attack 1 (Period 1)|Participants completing a period treated a migraine with investigational product.|67||
60118922|NCT01589237|76239953|FG002|COMPLETED|Part A (52 Weeks)||8||
59567506|NCT02326272|75670454|FG001|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||84||
59834446|NCT00383162|75958098|FG001|COMPLETED|Migraine Attack 1 (Period 1)|Participants not completing did not take investigational product.|73||
59834447|NCT00383162|75958097|FG000|NOT COMPLETED|Migraine Attack 1 (Period 1)||20||
59834448|NCT00383162|75958098|FG001|NOT COMPLETED|Migraine Attack 1 (Period 1)||13||
59834449|NCT00383162|75958097|FG000|STARTED|Migraine Attack 2 (Period 2)||67||
59834450|NCT00383162|75958098|FG001|STARTED|Migraine Attack 2 (Period 2)||73||
59834451|NCT00383162|75958097|FG000|COMPLETED|Migraine Attack 2 (Period 2)||65||
59834452|NCT00383162|75958098|FG001|COMPLETED|Migraine Attack 2 (Period 2)||66||
59834453|NCT00383162|75958097|FG000|NOT COMPLETED|Migraine Attack 2 (Period 2)||2||
59834454|NCT00383162|75958098|FG001|NOT COMPLETED|Migraine Attack 2 (Period 2)||7||
59834455|NCT00358436|75958106|FG000|STARTED|Overall Study||600||
59834456|NCT00358436|75958107|FG001|STARTED|Overall Study||204||
59834457|NCT00358436|75958106|FG000|COMPLETED|Overall Study||446||
59834458|NCT00358436|75958107|FG001|COMPLETED|Overall Study||118||
59834459|NCT00358436|75958106|FG000|NOT COMPLETED|Overall Study||154||
59834460|NCT00358436|75958107|FG001|NOT COMPLETED|Overall Study||86||
59834461|NCT00383084|75958117|FG000|STARTED|Overall Study||46||
59834462|NCT00383084|75958118|FG001|STARTED|Overall Study||38||
59834463|NCT00383084|75958117|FG000|COMPLETED|Overall Study||34||
59834464|NCT00383084|75958118|FG001|COMPLETED|Overall Study||28||
59834465|NCT00383084|75958117|FG000|NOT COMPLETED|Overall Study||12||
59834466|NCT00383084|75958118|FG001|NOT COMPLETED|Overall Study||10||
59834467|NCT00361634|75958124|FG000|STARTED|Overall Study||14||
59834468|NCT00361634|75958124|FG000|Treated|Overall Study|The safety analysis set consisted of all patients who received at least one dose of etanercept.|13||
59834469|NCT00361634|75958124|FG000|COMPLETED|Overall Study||12||
59834470|NCT00361634|75958124|FG000|NOT COMPLETED|Overall Study||2||
59834471|NCT00357968|75958130|FG000|STARTED|First Maintenance Dose Phase||102||
59834472|NCT00357968|75958131|FG001|STARTED|First Maintenance Dose Phase||99||
59834473|NCT00357968|75958130|FG000|Received Loading Dose|First Maintenance Dose Phase||102||
59834474|NCT00357968|75958131|FG001|Received Loading Dose|First Maintenance Dose Phase||99||
59834475|NCT00357968|75958130|FG000|Percutaneous Coronary Intervention (PCI)|First Maintenance Dose Phase||55||
59834476|NCT00357968|75958131|FG001|Percutaneous Coronary Intervention (PCI)|First Maintenance Dose Phase||57||
59834477|NCT00357968|75958130|FG000|Started Maintenance Dose|First Maintenance Dose Phase||55||
59834478|NCT00357968|75958131|FG001|Started Maintenance Dose|First Maintenance Dose Phase||55||
59834479|NCT00357968|75958130|FG000|COMPLETED|First Maintenance Dose Phase||54||
59834480|NCT00357968|75958131|FG001|COMPLETED|First Maintenance Dose Phase||55||
59834481|NCT00357968|75958130|FG000|NOT COMPLETED|First Maintenance Dose Phase||48||
59834482|NCT00357968|75958131|FG001|NOT COMPLETED|First Maintenance Dose Phase||44||
59834483|NCT00357968|75958130|FG000|STARTED|Crossover Maintenance Dose Phase|1 subject discontinued study drug-did not take clopidogrel during the 2nd phase but completed study|54||
59834484|NCT00357968|75958131|FG001|STARTED|Crossover Maintenance Dose Phase||55||
59834485|NCT00357968|75958130|FG000|COMPLETED|Crossover Maintenance Dose Phase||54||
59834486|NCT00357968|75958131|FG001|COMPLETED|Crossover Maintenance Dose Phase||55||
59834487|NCT00357968|75958130|FG000|NOT COMPLETED|Crossover Maintenance Dose Phase||0||
59834488|NCT00357968|75958131|FG001|NOT COMPLETED|Crossover Maintenance Dose Phase||0||
59834489|NCT00357656|75958154|FG000|STARTED|Overall Study||31||
59834490|NCT00357656|75958155|FG001|STARTED|Overall Study||32||
59834491|NCT00357656|75958154|FG000|COMPLETED|Overall Study||31||
59717710|NCT00960999|75836818|FG000|Primary Endpoint Population|Overall Study||38|First 38 eligible participants on each arm who started treatment|
59834492|NCT00357656|75958155|FG001|COMPLETED|Overall Study||29||
59834493|NCT00357656|75958154|FG000|NOT COMPLETED|Overall Study||0||
59834494|NCT00357656|75958155|FG001|NOT COMPLETED|Overall Study||3||
59834495|NCT00357500|75958173|FG000|STARTED|Overall Study||101||
59834496|NCT00357500|75958173|FG000|Began Protocol Therapy|Overall Study|4 pts did not start treatment due either to removal of consent or inability to get insurance.|97||
59834497|NCT00357500|75958173|FG000|COMPLETED|Overall Study||24||
59834498|NCT00357500|75958173|FG000|NOT COMPLETED|Overall Study||77||
59834499|NCT00357110|75958179|FG000|STARTED|Overall Study||6||
59834500|NCT00357110|75958180|FG001|STARTED|Overall Study||7||
59834501|NCT00357110|75958179|FG000|COMPLETED|Overall Study||1||
59834502|NCT00357110|75958180|FG001|COMPLETED|Overall Study||2||
59834503|NCT00357110|75958179|FG000|NOT COMPLETED|Overall Study||5||
59717711|NCT00960999|75836819|FG001|Primary Endpoint Population|Overall Study||38|First 38 eligible participants on each arm who started treatment|
59717712|NCT00960999|75836818|FG000|Peak SUV at 8 Weeks|Overall Study||3|Eligible participants with peak standardized uptake value (SUV) at baseline and 8 weeks|
59717713|NCT00960999|75836819|FG001|Peak SUV at 8 Weeks|Overall Study||11|Eligible participants with peak standardized uptake value (SUV) at baseline and 8 weeks|
59717714|NCT00960999|75836818|FG000|Peak SUV at 1 Year|Overall Study||4|Eligible participants with peak standardized uptake value (SUV) at baseline and one year|
59717715|NCT00960999|75836819|FG001|Peak SUV at 1 Year|Overall Study||7|Eligible participants with peak standardized uptake value (SUV) at baseline and one year|
59717716|NCT00960999|75836818|FG000|Normalized SUV at 8 Weeks|Overall Study||3|Eligible participants with normalized standardized uptake value (SUV) at baseline and 8 weeks|
59717717|NCT00960999|75836819|FG001|Normalized SUV at 8 Weeks|Overall Study||9|Eligible participants with normalized standardized uptake value (SUV) at baseline and 8 weeks|
59834504|NCT00357110|75958180|FG001|NOT COMPLETED|Overall Study||5||
59834505|NCT00098722|75958189|FG000|STARTED|Double Blind Phase||186||
59834506|NCT00098722|75958190|FG001|STARTED|Double Blind Phase||194||
59834507|NCT00098722|75958191|FG002|STARTED|Double Blind Phase||94||
59834508|NCT00098722|75958192|FG003|STARTED|Double Blind Phase||0||
59834509|NCT00098722|75958193|FG004|STARTED|Double Blind Phase||0||
59834510|NCT00098722|75958194|FG005|STARTED|Double Blind Phase||0||
59834511|NCT00098722|75958195|FG006|STARTED|Double Blind Phase||0||
59834512|NCT00098722|75958189|FG000|Treated|Double Blind Phase||182||
59834513|NCT00098722|75958190|FG001|Treated|Double Blind Phase||191||
59834514|NCT00098722|75958191|FG002|Treated|Double Blind Phase||91||
59834515|NCT00098722|75958192|FG003|Treated|Double Blind Phase||0||
59834516|NCT00098722|75958193|FG004|Treated|Double Blind Phase||0||
59834517|NCT00098722|75958194|FG005|Treated|Double Blind Phase||0||
59834518|NCT00098722|75958195|FG006|Treated|Double Blind Phase||0||
59834519|NCT00098722|75958189|FG000|COMPLETED|Double Blind Phase||0||
59834520|NCT00098722|75958190|FG001|COMPLETED|Double Blind Phase||0||
59834521|NCT00098722|75958191|FG002|COMPLETED|Double Blind Phase||0||
59834522|NCT00098722|75958192|FG003|COMPLETED|Double Blind Phase||0||
59834523|NCT00098722|75958193|FG004|COMPLETED|Double Blind Phase||0||
59834524|NCT00098722|75958194|FG005|COMPLETED|Double Blind Phase||0||
59834525|NCT00098722|75958195|FG006|COMPLETED|Double Blind Phase||0||
59834526|NCT00098722|75958189|FG000|NOT COMPLETED|Double Blind Phase||186||
59834527|NCT00098722|75958190|FG001|NOT COMPLETED|Double Blind Phase||194||
59834528|NCT00098722|75958191|FG002|NOT COMPLETED|Double Blind Phase||94||
59834529|NCT00098722|75958192|FG003|NOT COMPLETED|Double Blind Phase||0||
59834530|NCT00098722|75958193|FG004|NOT COMPLETED|Double Blind Phase||0||
59834531|NCT00098722|75958194|FG005|NOT COMPLETED|Double Blind Phase||0||
59834532|NCT00098722|75958195|FG006|NOT COMPLETED|Double Blind Phase||0||
59834533|NCT00098722|75958189|FG000|STARTED|Open Label Phase||0||
59834534|NCT00098722|75958190|FG001|STARTED|Open Label Phase||0||
59834535|NCT00098722|75958191|FG002|STARTED|Open Label Phase||0||
59834536|NCT00098722|75958192|FG003|STARTED|Open Label Phase||272||
59834537|NCT00098722|75958193|FG004|STARTED|Open Label Phase||50||
59834538|NCT00098722|75958194|FG005|STARTED|Open Label Phase||0||
59834539|NCT00098722|75958195|FG006|STARTED|Open Label Phase||0||
59834540|NCT00098722|75958189|FG000|COMPLETED|Open Label Phase||0||
59834541|NCT00098722|75958190|FG001|COMPLETED|Open Label Phase||0||
59834542|NCT00098722|75958191|FG002|COMPLETED|Open Label Phase||0||
59834543|NCT00098722|75958192|FG003|COMPLETED|Open Label Phase||0||
59834544|NCT00098722|75958193|FG004|COMPLETED|Open Label Phase||0||
59834545|NCT00098722|75958194|FG005|COMPLETED|Open Label Phase||0||
59834546|NCT00098722|75958195|FG006|COMPLETED|Open Label Phase||0||
59834547|NCT00098722|75958189|FG000|NOT COMPLETED|Open Label Phase||0||
59834548|NCT00098722|75958190|FG001|NOT COMPLETED|Open Label Phase||0||
59834549|NCT00098722|75958191|FG002|NOT COMPLETED|Open Label Phase||0||
59834550|NCT00098722|75958192|FG003|NOT COMPLETED|Open Label Phase||272||
59834551|NCT00098722|75958193|FG004|NOT COMPLETED|Open Label Phase||50||
59834552|NCT00098722|75958194|FG005|NOT COMPLETED|Open Label Phase||0||
59834553|NCT00098722|75958195|FG006|NOT COMPLETED|Open Label Phase||0||
59834554|NCT00098722|75958189|FG000|STARTED|Observation Phase||0||
59834555|NCT00098722|75958190|FG001|STARTED|Observation Phase||0||
59834556|NCT00098722|75958191|FG002|STARTED|Observation Phase||0||
59834557|NCT00098722|75958192|FG003|STARTED|Observation Phase||0||
59834558|NCT00098722|75958193|FG004|STARTED|Observation Phase||0||
59834559|NCT00098722|75958194|FG005|STARTED|Observation Phase||205||
59834560|NCT00098722|75958195|FG006|STARTED|Observation Phase||65||
60118923|NCT01589237|76239954|FG003|COMPLETED|Part A (52 Weeks)||5||
60118924|NCT01589237|76239951|FG000|NOT COMPLETED|Part A (52 Weeks)||2||
59834561|NCT00098722|75958189|FG000|COMPLETED|Observation Phase||0||
59834562|NCT00098722|75958190|FG001|COMPLETED|Observation Phase||0||
59834563|NCT00098722|75958191|FG002|COMPLETED|Observation Phase||0||
59834564|NCT00098722|75958192|FG003|COMPLETED|Observation Phase||0||
60118925|NCT01589237|76239952|FG001|NOT COMPLETED|Part A (52 Weeks)||3||
59834565|NCT00098722|75958193|FG004|COMPLETED|Observation Phase||0||
59834566|NCT00098722|75958194|FG005|COMPLETED|Observation Phase||160||
59834567|NCT00098722|75958195|FG006|COMPLETED|Observation Phase||48||
59834568|NCT00098722|75958189|FG000|NOT COMPLETED|Observation Phase||0||
60118926|NCT01589237|76239953|FG002|NOT COMPLETED|Part A (52 Weeks)||2||
60118927|NCT01589237|76239954|FG003|NOT COMPLETED|Part A (52 Weeks)||0||
60118928|NCT01589237|76239951|FG000|STARTED|Part B (Planned for 78 Week-terminated)||5||
60118929|NCT01589237|76239952|FG001|STARTED|Part B (Planned for 78 Week-terminated)||6||
60118930|NCT01589237|76239953|FG002|STARTED|Part B (Planned for 78 Week-terminated)||4||
60118931|NCT01589237|76239954|FG003|STARTED|Part B (Planned for 78 Week-terminated)||4||
60118932|NCT01589237|76239951|FG000|COMPLETED|Part B (Planned for 78 Week-terminated)||0||
60118933|NCT01589237|76239952|FG001|COMPLETED|Part B (Planned for 78 Week-terminated)||0||
59834569|NCT00098722|75958190|FG001|NOT COMPLETED|Observation Phase||0||
59834570|NCT00098722|75958191|FG002|NOT COMPLETED|Observation Phase||0||
59834571|NCT00098722|75958192|FG003|NOT COMPLETED|Observation Phase||0||
59834572|NCT00098722|75958193|FG004|NOT COMPLETED|Observation Phase||0||
60118934|NCT01589237|76239953|FG002|COMPLETED|Part B (Planned for 78 Week-terminated)||0||
60118935|NCT01589237|76239954|FG003|COMPLETED|Part B (Planned for 78 Week-terminated)||0||
60118936|NCT01589237|76239951|FG000|NOT COMPLETED|Part B (Planned for 78 Week-terminated)||5||
60118937|NCT01589237|76239952|FG001|NOT COMPLETED|Part B (Planned for 78 Week-terminated)||6||
60118938|NCT01589237|76239953|FG002|NOT COMPLETED|Part B (Planned for 78 Week-terminated)||4||
60118939|NCT01589237|76239954|FG003|NOT COMPLETED|Part B (Planned for 78 Week-terminated)||4||
60118940|NCT01700387|76239970|FG000|STARTED|Overall Study||10||
60118941|NCT01700387|76239971|FG001|STARTED|Overall Study||10||
60118942|NCT01700387|76239970|FG000|COMPLETED|Overall Study||6||
60118943|NCT01700387|76239971|FG001|COMPLETED|Overall Study||6||
60118944|NCT01700387|76239970|FG000|NOT COMPLETED|Overall Study||4||
60118945|NCT01700387|76239971|FG001|NOT COMPLETED|Overall Study||4||
60118946|NCT01699685|76239983|FG000|STARTED|Period 1||39||
60118947|NCT01699685|76239984|FG001|STARTED|Period 1||39||
60118948|NCT01699685|76239983|FG000|Safety Population|Period 1||39||
60118949|NCT01699685|76239984|FG001|Safety Population|Period 1||38||
60118950|NCT01699685|76239983|FG000|Full Analysis Population (FAS)|Period 1||38||
60118951|NCT01699685|76239984|FG001|Full Analysis Population (FAS)|Period 1||38||
60118952|NCT01699685|76239983|FG000|COMPLETED|Period 1||36||
60118953|NCT01699685|76239984|FG001|COMPLETED|Period 1||36||
60118954|NCT01699685|76239983|FG000|NOT COMPLETED|Period 1||3||
60118955|NCT01699685|76239984|FG001|NOT COMPLETED|Period 1||3||
60118956|NCT01699685|76239983|FG000|STARTED|Period 2||36||
60118957|NCT01699685|76239984|FG001|STARTED|Period 2||36||
60118958|NCT01699685|76239983|FG000|COMPLETED|Period 2||35||
60118959|NCT01699685|76239984|FG001|COMPLETED|Period 2||36||
60118960|NCT01699685|76239983|FG000|NOT COMPLETED|Period 2||1||
60118961|NCT01699685|76239984|FG001|NOT COMPLETED|Period 2||0||
60118962|NCT01587989|76239992|FG000|STARTED|12-Week Open-Label Run-In Period||77||
60118963|NCT01587989|76239993|FG001|STARTED|12-Week Open-Label Run-In Period||0||
60118964|NCT01587989|76239994|FG002|STARTED|12-Week Open-Label Run-In Period||0||
60118965|NCT01587989|76239992|FG000|COMPLETED|12-Week Open-Label Run-In Period||65||
60118966|NCT01587989|76239993|FG001|COMPLETED|12-Week Open-Label Run-In Period||0||
60118967|NCT01587989|76239994|FG002|COMPLETED|12-Week Open-Label Run-In Period||0||
60118968|NCT01587989|76239992|FG000|NOT COMPLETED|12-Week Open-Label Run-In Period||12||
60118969|NCT01587989|76239993|FG001|NOT COMPLETED|12-Week Open-Label Run-In Period||0||
60118970|NCT01587989|76239994|FG002|NOT COMPLETED|12-Week Open-Label Run-In Period||0||
60118971|NCT01587989|76239992|FG000|STARTED|Randomized Study Treatment||0||
60118972|NCT01587989|76239993|FG001|STARTED|Randomized Study Treatment||32||
60118973|NCT01587989|76239994|FG002|STARTED|Randomized Study Treatment||33||
60118974|NCT01587989|76239992|FG000|COMPLETED|Randomized Study Treatment||0||
60118975|NCT01587989|76239993|FG001|COMPLETED|Randomized Study Treatment||30||
60118976|NCT01587989|76239994|FG002|COMPLETED|Randomized Study Treatment||32||
59717718|NCT00960999|75836818|FG000|Normalized SUV at 1 Year|Overall Study||4|Eligible participants with normalized standardized uptake value (SUV) at baseline and one year|
59717719|NCT00960999|75836819|FG001|Normalized SUV at 1 Year|Overall Study||7|Eligible participants with normalized standardized uptake value (SUV) at baseline and one year|
59717720|NCT00960999|75836818|FG000|FEV1 by Best Response|Overall Study||26|Eligible; FEV1 at baseline and 6 months; complete or partial response, or stable disease|
59717721|NCT00960999|75836819|FG001|FEV1 by Best Response|Overall Study||33|Eligible; FEV1 at baseline and 6 months; complete or partial response, or stable disease|
59717722|NCT00960999|75836818|FG000|DLCO by Best Response|Overall Study||23|Eligible; DLCO at baseline and 6 months; complete or partial response, or stable disease|
59717723|NCT00960999|75836819|FG001|DLCO by Best Response|Overall Study||28|Eligible; DLCO at baseline and 6 months; complete or partial response, or stable disease|
59717724|NCT00960999|75836818|FG000|COMPLETED|Overall Study||39|Subjects contributing data to results are considered to have completed the study.|
59717725|NCT00960999|75836819|FG001|COMPLETED|Overall Study||45|Subjects contributing data to results are considered to have completed the study.|
59717726|NCT00960999|75836818|FG000|NOT COMPLETED|Overall Study||8||
59717727|NCT00960999|75836819|FG001|NOT COMPLETED|Overall Study||2||
59717728|NCT01124838|75836827|FG000|STARTED|Overall Study||130||
59717729|NCT01124838|75836828|FG001|STARTED|Overall Study||131||
59717730|NCT01124838|75836827|FG000|Enrolled in Main Study|Overall Study||114||
59717731|NCT01124838|75836828|FG001|Enrolled in Main Study|Overall Study||115||
59717732|NCT01124838|75836827|FG000|Enrolled in Japan Sub-study|Overall Study||16||
59717733|NCT01124838|75836828|FG001|Enrolled in Japan Sub-study|Overall Study||16||
59717734|NCT01124838|75836827|FG000|COMPLETED|Overall Study||112||
59717735|NCT01124838|75836828|FG001|COMPLETED|Overall Study||116||
59717736|NCT01124838|75836827|FG000|NOT COMPLETED|Overall Study||18||
59717737|NCT01124838|75836828|FG001|NOT COMPLETED|Overall Study||15||
59717738|NCT00959751|75836838|FG000|STARTED|Overall Study||97||
59717739|NCT00959751|75836839|FG001|STARTED|Overall Study||98||
59717740|NCT00959751|75836838|FG000|COMPLETED|Overall Study||88||
59717741|NCT00959751|75836839|FG001|COMPLETED|Overall Study||86||
59717742|NCT00959751|75836838|FG000|NOT COMPLETED|Overall Study||9||
59717743|NCT00959751|75836839|FG001|NOT COMPLETED|Overall Study||12||
60118977|NCT01587989|76239992|FG000|NOT COMPLETED|Randomized Study Treatment||0||
60118978|NCT01587989|76239993|FG001|NOT COMPLETED|Randomized Study Treatment||2||
60118979|NCT01587989|76239994|FG002|NOT COMPLETED|Randomized Study Treatment||1||
59834573|NCT00098722|75958194|FG005|NOT COMPLETED|Observation Phase||45||
59834574|NCT00098722|75958195|FG006|NOT COMPLETED|Observation Phase||17||
59834575|NCT00098254|75958207|FG000|STARTED|Overall Study||37||
59834576|NCT00098254|75958207|FG000|COMPLETED|Overall Study||34||
59834577|NCT00098254|75958207|FG000|NOT COMPLETED|Overall Study||3||
59834578|NCT00095056|75958213|FG000|STARTED|Phase A (Weeks 0-12)||65||
59834579|NCT00095056|75958214|FG001|STARTED|Phase A (Weeks 0-12)||26||
59834580|NCT00095056|75958213|FG000|COMPLETED|Phase A (Weeks 0-12)||58||
59834581|NCT00095056|75958214|FG001|COMPLETED|Phase A (Weeks 0-12)||25||
59834582|NCT00095056|75958213|FG000|NOT COMPLETED|Phase A (Weeks 0-12)||7||
59834583|NCT00095056|75958214|FG001|NOT COMPLETED|Phase A (Weeks 0-12)||1||
59834584|NCT00095056|75958213|FG000|STARTED|Phase B (Weeks 12-54)|2 randomized patients completed Period 1 but did not enter Period 2.|56||
59834585|NCT00095056|75958214|FG001|STARTED|Phase B (Weeks 12-54)||25||
59834586|NCT00095056|75958213|FG000|COMPLETED|Phase B (Weeks 12-54)||46||
59834587|NCT00095056|75958214|FG001|COMPLETED|Phase B (Weeks 12-54)||20||
59834588|NCT00095056|75958213|FG000|NOT COMPLETED|Phase B (Weeks 12-54)||10||
59834589|NCT00095056|75958214|FG001|NOT COMPLETED|Phase B (Weeks 12-54)||5||
59834590|NCT00098020|75958220|FG000|STARTED|Overall Study||12||
59834591|NCT00098020|75958220|FG000|Started Isotretinoin|Overall Study||8||
59834592|NCT00098020|75958220|FG000|COMPLETED|Overall Study||6||
59834593|NCT00098020|75958220|FG000|NOT COMPLETED|Overall Study||6||
59567507|NCT02326272|75670455|FG002|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||81||
59717744|NCT00910858|75836848|FG000|STARTED|Pharmacokinetic Phase||9||
59717745|NCT00910858|75836849|FG001|STARTED|Pharmacokinetic Phase||0||
59717746|NCT00910858|75836850|FG002|STARTED|Pharmacokinetic Phase||3||
59717747|NCT00910858|75836848|FG000|COMPLETED|Pharmacokinetic Phase||8||
59717748|NCT00910858|75836849|FG001|COMPLETED|Pharmacokinetic Phase||0||
59717749|NCT00910858|75836850|FG002|COMPLETED|Pharmacokinetic Phase||3||
59717750|NCT00910858|75836848|FG000|NOT COMPLETED|Pharmacokinetic Phase||1||
59717751|NCT00910858|75836849|FG001|NOT COMPLETED|Pharmacokinetic Phase||0||
59717752|NCT00910858|75836850|FG002|NOT COMPLETED|Pharmacokinetic Phase||0||
59717753|NCT00910858|75836848|FG000|STARTED|Monotherapy Phase|Includes 8 participants from the PK Phase and 9 newly enrolled participants.|17||
59717754|NCT00910858|75836849|FG001|STARTED|Monotherapy Phase|All 15 participants were newly enrolled into the Monotherapy Phase.|15||
59717755|NCT00910858|75836850|FG002|STARTED|Monotherapy Phase|Includes 3 participants from the PK Phase and 4 newly enrolled participants.|7||
59717756|NCT00910858|75836848|FG000|Safety Population|Monotherapy Phase|All patients who took at least 1 dose of study drug during Monotherapy or Combined Treatment Phase.|17||
59717757|NCT00910858|75836849|FG001|Safety Population|Monotherapy Phase|All patients who took at least 1 dose of study drug during Monotherapy or Combined Treatment Phase.|15||
59717758|NCT00910858|75836850|FG002|Safety Population|Monotherapy Phase|All patients who took at least 1 dose of study drug during Monotherapy or Combined Treatment Phase.|7||
59717759|NCT00910858|75836848|FG000|Pharmacokinetic Population|Monotherapy Phase||17||
59717760|NCT00910858|75836849|FG001|Pharmacokinetic Population|Monotherapy Phase|Patients in the 15 mg Non-del 5q group were not included in the pharmacokinetic assessment.|0||
59717761|NCT00910858|75836850|FG002|Pharmacokinetic Population|Monotherapy Phase||7||
59717762|NCT00910858|75836848|FG000|COMPLETED|Monotherapy Phase||0||
59717763|NCT00910858|75836849|FG001|COMPLETED|Monotherapy Phase||0||
59717764|NCT00910858|75836850|FG002|COMPLETED|Monotherapy Phase||0||
59717765|NCT00910858|75836848|FG000|NOT COMPLETED|Monotherapy Phase||17||
59717766|NCT00910858|75836849|FG001|NOT COMPLETED|Monotherapy Phase||15||
59834594|NCT00381680|75958226|FG000|STARTED|Overall Study||206||
59834595|NCT00381680|75958227|FG001|STARTED|Overall Study||69||
59834596|NCT00381680|75958226|FG000|COMPLETED|Overall Study||81||
59834597|NCT00381680|75958227|FG001|COMPLETED|Overall Study||19||
59834598|NCT00381680|75958226|FG000|NOT COMPLETED|Overall Study||125||
59834599|NCT00381680|75958227|FG001|NOT COMPLETED|Overall Study||50||
59834600|NCT00360698|75958239|FG000|STARTED|Run-In||0||
59834601|NCT00360698|75958240|FG001|STARTED|Run-In||135||
59834602|NCT00360698|75958239|FG000|COMPLETED|Run-In||0||
59834603|NCT00360698|75958240|FG001|COMPLETED|Run-In|19 patients completed the run-in but were not eligible for randomization in the treatment period|125||
59834604|NCT00360698|75958239|FG000|NOT COMPLETED|Run-In||0||
59834605|NCT00360698|75958240|FG001|NOT COMPLETED|Run-In||10||
59834606|NCT00360698|75958239|FG000|STARTED|Treatment Period||49||
59834607|NCT00360698|75958240|FG001|STARTED|Treatment Period||57||
59834608|NCT00360698|75958239|FG000|COMPLETED|Treatment Period||48||
59834609|NCT00360698|75958240|FG001|COMPLETED|Treatment Period||56||
59834610|NCT00360698|75958239|FG000|NOT COMPLETED|Treatment Period||1||
59834611|NCT00360698|75958240|FG001|NOT COMPLETED|Treatment Period||1||
59834612|NCT00380978|75958248|FG000|STARTED|Overall Study||408||
59834613|NCT00380978|75958249|FG001|STARTED|Overall Study||410||
59834614|NCT00380978|75958248|FG000|COMPLETED|Overall Study||406||
59834615|NCT00380978|75958249|FG001|COMPLETED|Overall Study||400||
59834616|NCT00380978|75958248|FG000|NOT COMPLETED|Overall Study||2||
59834617|NCT00380978|75958249|FG001|NOT COMPLETED|Overall Study||10||
59834618|NCT00162123|75958263|FG000|STARTED|Overall Study|Enrolled|53||
59834619|NCT00162123|75958264|FG001|STARTED|Overall Study|Enrolled|34||
59834620|NCT00162123|75958265|FG002|STARTED|Overall Study|Enrolled|24||
59834621|NCT00162123|75958266|FG003|STARTED|Overall Study|Enrolled|11||
59834622|NCT00162123|75958267|FG004|STARTED|Overall Study|Enrolled|45||
59834623|NCT00162123|75958268|FG005|STARTED|Overall Study|Enrolled|13||
59834624|NCT00162123|75958269|FG006|STARTED|Overall Study|Enrolled|4||
59834625|NCT00162123|75958270|FG007|STARTED|Overall Study|Enrolled|58||
59834626|NCT00162123|75958263|FG000|Received Treatment|Overall Study||53||
59834627|NCT00162123|75958264|FG001|Received Treatment|Overall Study||34||
59834628|NCT00162123|75958265|FG002|Received Treatment|Overall Study||24||
59834629|NCT00162123|75958266|FG003|Received Treatment|Overall Study||11||
59834630|NCT00162123|75958267|FG004|Received Treatment|Overall Study||33||
59834631|NCT00162123|75958268|FG005|Received Treatment|Overall Study||12||
60118980|NCT01697969|76240000|FG000|STARTED|Overall Study||13||
60118981|NCT01697969|76240000|FG000|COMPLETED|Overall Study||10||
60118982|NCT01697969|76240000|FG000|NOT COMPLETED|Overall Study||3||
60118983|NCT01586819|76240007|FG000|STARTED|Overall Study||12||
60118984|NCT01586819|76240008|FG001|STARTED|Overall Study||14||
60118985|NCT01586819|76240007|FG000|COMPLETED|Overall Study||11||
60118986|NCT01586819|76240008|FG001|COMPLETED|Overall Study||14||
60118987|NCT01586819|76240007|FG000|NOT COMPLETED|Overall Study||1||
60118988|NCT01586819|76240008|FG001|NOT COMPLETED|Overall Study||0||
59834632|NCT00162123|75958269|FG006|Received Treatment|Overall Study||4||
59834633|NCT00162123|75958270|FG007|Received Treatment|Overall Study||0||
59834634|NCT00162123|75958263|FG000|COMPLETED|Overall Study|Still on treatment|9||
59834635|NCT00162123|75958264|FG001|COMPLETED|Overall Study|Still on treatment|5||
59834636|NCT00162123|75958265|FG002|COMPLETED|Overall Study|Still on treatment|3||
59834637|NCT00162123|75958266|FG003|COMPLETED|Overall Study|Still on treatment|3||
59834638|NCT00162123|75958267|FG004|COMPLETED|Overall Study|Still on treatment|14||
59834639|NCT00162123|75958268|FG005|COMPLETED|Overall Study|Still on treatment|4||
59834640|NCT00162123|75958269|FG006|COMPLETED|Overall Study|Still on treatment|0||
59996522|NCT02714569|76112508|FG005|STARTED|Part A First Intervention||3||
60118989|NCT01697579|76240019|FG000|STARTED|Base Study-Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6 arms.|74||
60118990|NCT01697579|76240020|FG001|STARTED|Base Study-Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6 arms.|43||
60118991|NCT01697579|76240021|FG002|STARTED|Base Study-Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6 arms.|44||
60118992|NCT01697579|76240022|FG003|STARTED|Base Study-Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6 arms.|41||
59834641|NCT00162123|75958270|FG007|COMPLETED|Overall Study|Still on treatment|0||
59834642|NCT00162123|75958263|FG000|NOT COMPLETED|Overall Study||44||
59834643|NCT00162123|75958264|FG001|NOT COMPLETED|Overall Study||29||
59834644|NCT00162123|75958265|FG002|NOT COMPLETED|Overall Study||21||
59996523|NCT02714569|76112509|FG006|STARTED|Part A First Intervention||0||
59996524|NCT02714569|76112510|FG007|STARTED|Part A First Intervention||0||
59996525|NCT02714569|76112511|FG008|STARTED|Part A First Intervention||0||
59996526|NCT02714569|76112512|FG009|STARTED|Part A First Intervention||0||
59996527|NCT02714569|76112513|FG010|STARTED|Part A First Intervention||0||
59996528|NCT02714569|76112503|FG000|Received at Least One Dose of Study Drug|Part A First Intervention||3||
59996529|NCT02714569|76112504|FG001|Received at Least One Dose of Study Drug|Part A First Intervention||3||
59996530|NCT02714569|76112505|FG002|Received at Least One Dose of Study Drug|Part A First Intervention||3||
59996531|NCT02714569|76112506|FG003|Received at Least One Dose of Study Drug|Part A First Intervention||3||
59996532|NCT02714569|76112507|FG004|Received at Least One Dose of Study Drug|Part A First Intervention||3||
59996533|NCT02714569|76112508|FG005|Received at Least One Dose of Study Drug|Part A First Intervention||3||
59567508|NCT02326272|75670456|FG003|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0||
59567509|NCT02326272|75670457|FG004|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0||
59567510|NCT02326272|75670458|FG005|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0||
59567511|NCT02326272|75670459|FG006|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0||
59567512|NCT02326272|75670460|FG007|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0||
59567513|NCT02326272|75670461|FG008|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0||
59567514|NCT02326272|75670462|FG009|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0||
59567515|NCT02326272|75670463|FG010|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0||
59567516|NCT02326272|75670464|FG011|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0||
59567517|NCT02326272|75670465|FG012|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0||
59567518|NCT02326272|75670466|FG013|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0||
59717767|NCT00910858|75836850|FG002|NOT COMPLETED|Monotherapy Phase||7||
59834645|NCT00162123|75958266|FG003|NOT COMPLETED|Overall Study||8||
60118993|NCT01697579|76240023|FG004|STARTED|Base Study-Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6 arms.|38||
59834646|NCT00162123|75958267|FG004|NOT COMPLETED|Overall Study||31||
59834647|NCT00162123|75958268|FG005|NOT COMPLETED|Overall Study||9||
59834648|NCT00162123|75958269|FG006|NOT COMPLETED|Overall Study||4||
59834649|NCT00162123|75958270|FG007|NOT COMPLETED|Overall Study||58||
59834650|NCT00227721|75958289|FG000|STARTED|Overall Study||30||
59834651|NCT00227721|75958289|FG000|COMPLETED|Overall Study||29||
59834652|NCT00227721|75958289|FG000|NOT COMPLETED|Overall Study||1||
59834653|NCT00226941|75958297|FG000|STARTED|Overall Study||6||
59834654|NCT00226941|75958298|FG001|STARTED|Overall Study||6||
59834655|NCT00226941|75958299|FG002|STARTED|Overall Study||4||
59834656|NCT00226941|75958300|FG003|STARTED|Overall Study||7||
59834657|NCT00226941|75958297|FG000|COMPLETED|Overall Study||6||
59834658|NCT00226941|75958298|FG001|COMPLETED|Overall Study||6||
59834659|NCT00226941|75958299|FG002|COMPLETED|Overall Study||4||
59834660|NCT00226941|75958300|FG003|COMPLETED|Overall Study||5||
59834661|NCT00226941|75958297|FG000|NOT COMPLETED|Overall Study||0||
59834662|NCT00226941|75958298|FG001|NOT COMPLETED|Overall Study||0||
59834663|NCT00226941|75958299|FG002|NOT COMPLETED|Overall Study||0||
59834664|NCT00226941|75958300|FG003|NOT COMPLETED|Overall Study||2||
59834665|NCT00356408|75958320|FG000|STARTED|Overall Study|106 subjects enrolled, however only 103 were included in the Intent to Treat (ITT) population.|103||
59834666|NCT00356408|75958320|FG000|COMPLETED|Overall Study||43||
59834667|NCT00356408|75958320|FG000|NOT COMPLETED|Overall Study||60||
59834668|NCT00509795|75958335|FG000|STARTED|Overall Study||306||
59834669|NCT00509795|75958336|FG001|STARTED|Overall Study||304||
59834670|NCT00509795|75958337|FG002|STARTED|Overall Study||304||
59834671|NCT00509795|75958338|FG003|STARTED|Overall Study||303||
59834672|NCT00509795|75958335|FG000|Patients Received Treatment (SAF)|Overall Study||304||
59834673|NCT00509795|75958336|FG001|Patients Received Treatment (SAF)|Overall Study||304||
59834674|NCT00509795|75958337|FG002|Patients Received Treatment (SAF)|Overall Study||304||
59834675|NCT00509795|75958338|FG003|Patients Received Treatment (SAF)|Overall Study||303||
59834676|NCT00509795|75958335|FG000|Full Analysis Set (FAS) Population|Overall Study||304||
59834677|NCT00509795|75958336|FG001|Full Analysis Set (FAS) Population|Overall Study||304||
59834678|NCT00509795|75958337|FG002|Full Analysis Set (FAS) Population|Overall Study||301||
59834679|NCT00509795|75958338|FG003|Full Analysis Set (FAS) Population|Overall Study||301||
59834680|NCT00509795|75958335|FG000|Per Protocol Set (PPS) Population|Overall Study||269||
59834681|NCT00509795|75958336|FG001|Per Protocol Set (PPS) Population|Overall Study||285||
59834682|NCT00509795|75958337|FG002|Per Protocol Set (PPS) Population|Overall Study||270||
59834683|NCT00509795|75958338|FG003|Per Protocol Set (PPS) Population|Overall Study||265||
59834684|NCT00509795|75958335|FG000|COMPLETED|Overall Study||284||
59834685|NCT00509795|75958336|FG001|COMPLETED|Overall Study||293||
59834686|NCT00509795|75958337|FG002|COMPLETED|Overall Study||277||
59834687|NCT00509795|75958338|FG003|COMPLETED|Overall Study||276||
59834688|NCT00509795|75958335|FG000|NOT COMPLETED|Overall Study||22||
59834689|NCT00509795|75958336|FG001|NOT COMPLETED|Overall Study||11||
59834690|NCT00509795|75958337|FG002|NOT COMPLETED|Overall Study||27||
59834691|NCT00509795|75958338|FG003|NOT COMPLETED|Overall Study||27||
59834692|NCT00165789|75958353|FG000|STARTED|Overall Study||8||
59834693|NCT00165789|75958354|FG001|STARTED|Overall Study||20||
59834694|NCT00165789|75958355|FG002|STARTED|Overall Study||12||
60118994|NCT01697579|76240024|FG005|STARTED|Base Study-Cycle 1|Enrollment in Cycles 2-6 was optional.|0||
60118995|NCT01697579|76240025|FG006|STARTED|Base Study-Cycle 1|Enrollment in Cycles 2-6 was optional.|0||
59834695|NCT00165789|75958356|FG003|STARTED|Overall Study||35||
59834696|NCT00165789|75958353|FG000|COMPLETED|Overall Study||8||
59834697|NCT00165789|75958354|FG001|COMPLETED|Overall Study||16||
59834698|NCT00165789|75958355|FG002|COMPLETED|Overall Study||11||
59834699|NCT00165789|75958356|FG003|COMPLETED|Overall Study||21||
59834700|NCT00165789|75958353|FG000|NOT COMPLETED|Overall Study||0||
60118996|NCT01697579|76240019|FG000|COMPLETED|Base Study-Cycle 1||72||
60118997|NCT01697579|76240020|FG001|COMPLETED|Base Study-Cycle 1||42||
59834701|NCT00165789|75958354|FG001|NOT COMPLETED|Overall Study||4||
59834702|NCT00165789|75958355|FG002|NOT COMPLETED|Overall Study||1||
59834703|NCT00165789|75958356|FG003|NOT COMPLETED|Overall Study||14||
59834704|NCT00504257|75958366|FG000|STARTED|Overall Study||45||
59834705|NCT00504257|75958366|FG000|COMPLETED|Overall Study||41||
59834706|NCT00504257|75958366|FG000|NOT COMPLETED|Overall Study||4||
59834707|NCT00509093|75958370|FG000|STARTED|Overall Study||32||
59834708|NCT00509093|75958370|FG000|COMPLETED|Overall Study||8||
59834709|NCT00509093|75958370|FG000|NOT COMPLETED|Overall Study||24||
59834710|NCT00160641|75958374|FG000|STARTED|Overall Study||567||
59834711|NCT00160641|75958374|FG000|COMPLETED|Overall Study||346||
59834712|NCT00160641|75958374|FG000|NOT COMPLETED|Overall Study||221||
59834713|NCT00493025|75958378|FG000|STARTED|Overall Study||19||
59834714|NCT00493025|75958378|FG000|COMPLETED|Overall Study|Trial stopped due to early stopping rule|0||
59834715|NCT00493025|75958378|FG000|NOT COMPLETED|Overall Study||19||
59834716|NCT00160563|75958386|FG000|STARTED|Overall Study||59||
59834717|NCT00160563|75958387|FG001|STARTED|Overall Study||47||
59834718|NCT00160563|75958388|FG002|STARTED|Overall Study||101||
59834719|NCT00160563|75958386|FG000|COMPLETED|Overall Study||8||
59834720|NCT00160563|75958387|FG001|COMPLETED|Overall Study||2||
59834721|NCT00160563|75958388|FG002|COMPLETED|Overall Study||11||
59834722|NCT00160563|75958386|FG000|NOT COMPLETED|Overall Study||51||
59834723|NCT00160563|75958387|FG001|NOT COMPLETED|Overall Study||45||
59834724|NCT00160563|75958388|FG002|NOT COMPLETED|Overall Study||90||
59834725|NCT00380744|75958404|FG000|STARTED|Overall Study||20||
59834726|NCT00380744|75958405|FG001|STARTED|Overall Study||4||
59834727|NCT00380744|75958406|FG002|STARTED|Overall Study||20||
59834728|NCT00380744|75958407|FG003|STARTED|Overall Study||4||
59834729|NCT00380744|75958408|FG004|STARTED|Overall Study||23||
59834730|NCT00380744|75958409|FG005|STARTED|Overall Study||25||
59834731|NCT00380744|75958410|FG006|STARTED|Overall Study||25||
59834732|NCT00380744|75958404|FG000|Received at Least 1 Dose of Study Drug|Overall Study||20||
59834733|NCT00380744|75958405|FG001|Received at Least 1 Dose of Study Drug|Overall Study||4||
59834734|NCT00380744|75958406|FG002|Received at Least 1 Dose of Study Drug|Overall Study||20||
59834735|NCT00380744|75958407|FG003|Received at Least 1 Dose of Study Drug|Overall Study||4||
59834736|NCT00380744|75958408|FG004|Received at Least 1 Dose of Study Drug|Overall Study||23||
59834737|NCT00380744|75958409|FG005|Received at Least 1 Dose of Study Drug|Overall Study||25||
59834738|NCT00380744|75958410|FG006|Received at Least 1 Dose of Study Drug|Overall Study||25||
59834739|NCT00380744|75958404|FG000|COMPLETED|Overall Study||19||
59834740|NCT00380744|75958405|FG001|COMPLETED|Overall Study||4||
59834741|NCT00380744|75958406|FG002|COMPLETED|Overall Study||20||
59834742|NCT00380744|75958407|FG003|COMPLETED|Overall Study||4||
59834743|NCT00380744|75958408|FG004|COMPLETED|Overall Study||23||
59834744|NCT00380744|75958409|FG005|COMPLETED|Overall Study||25||
59834745|NCT00380744|75958410|FG006|COMPLETED|Overall Study||24||
59834746|NCT00380744|75958404|FG000|NOT COMPLETED|Overall Study||1||
59834747|NCT00380744|75958405|FG001|NOT COMPLETED|Overall Study||0||
59834748|NCT00380744|75958406|FG002|NOT COMPLETED|Overall Study||0||
59834749|NCT00380744|75958407|FG003|NOT COMPLETED|Overall Study||0||
59834750|NCT00380744|75958408|FG004|NOT COMPLETED|Overall Study||0||
59834751|NCT00380744|75958409|FG005|NOT COMPLETED|Overall Study||0||
59834752|NCT00380744|75958410|FG006|NOT COMPLETED|Overall Study||1||
60118998|NCT01697579|76240021|FG002|COMPLETED|Base Study-Cycle 1||43||
60118999|NCT01697579|76240022|FG003|COMPLETED|Base Study-Cycle 1||40||
60119000|NCT01697579|76240023|FG004|COMPLETED|Base Study-Cycle 1||35||
60119001|NCT01697579|76240024|FG005|COMPLETED|Base Study-Cycle 1||0||
59834753|NCT00380588|75958429|FG000|STARTED|Overall Study||42||
59834754|NCT00380588|75958430|FG001|STARTED|Overall Study||42||
59834755|NCT00380588|75958429|FG000|Received at Least One Dose of Study Drug|Overall Study||41||
59834756|NCT00380588|75958430|FG001|Received at Least One Dose of Study Drug|Overall Study||42||
59834757|NCT00380588|75958429|FG000|COMPLETED|Overall Study|Treatment period reached 48 week maximum.|3||
59834758|NCT00380588|75958430|FG001|COMPLETED|Overall Study|Treatment period reached 48 week maximum.|2||
59834759|NCT00380588|75958429|FG000|NOT COMPLETED|Overall Study||39||
59834760|NCT00380588|75958430|FG001|NOT COMPLETED|Overall Study||40||
59834761|NCT00379808|75958436|FG000|STARTED|Intervention Period 1 (4 Weeks)||11||
59834762|NCT00379808|75958437|FG001|STARTED|Intervention Period 1 (4 Weeks)||11||
59834763|NCT00379808|75958436|FG000|COMPLETED|Intervention Period 1 (4 Weeks)||11||
60119002|NCT01697579|76240025|FG006|COMPLETED|Base Study-Cycle 1||0||
60119003|NCT01697579|76240019|FG000|NOT COMPLETED|Base Study-Cycle 1||2||
60119004|NCT01697579|76240020|FG001|NOT COMPLETED|Base Study-Cycle 1||1||
60119005|NCT01697579|76240021|FG002|NOT COMPLETED|Base Study-Cycle 1||1||
59834764|NCT00379808|75958437|FG001|COMPLETED|Intervention Period 1 (4 Weeks)||11||
59834765|NCT00379808|75958436|FG000|NOT COMPLETED|Intervention Period 1 (4 Weeks)||0||
59834766|NCT00379808|75958437|FG001|NOT COMPLETED|Intervention Period 1 (4 Weeks)||0||
60119006|NCT01697579|76240022|FG003|NOT COMPLETED|Base Study-Cycle 1||1||
59834767|NCT00379808|75958436|FG000|STARTED|Intervention Period 2 (4 Weeks)||11||
60119007|NCT01697579|76240023|FG004|NOT COMPLETED|Base Study-Cycle 1||3||
59834768|NCT00379808|75958437|FG001|STARTED|Intervention Period 2 (4 Weeks)||11||
59834769|NCT00379808|75958436|FG000|COMPLETED|Intervention Period 2 (4 Weeks)||11||
59834770|NCT00379808|75958437|FG001|COMPLETED|Intervention Period 2 (4 Weeks)||10||
59834771|NCT00379808|75958436|FG000|NOT COMPLETED|Intervention Period 2 (4 Weeks)||0||
59834772|NCT00379808|75958437|FG001|NOT COMPLETED|Intervention Period 2 (4 Weeks)||1||
59834773|NCT00355784|75958446|FG000|STARTED|Overall Study||9||
59834774|NCT00355784|75958447|FG001|STARTED|Overall Study||8||
59834775|NCT00355784|75958448|FG002|STARTED|Overall Study||7||
59834776|NCT00355784|75958446|FG000|COMPLETED|Overall Study||9||
59834777|NCT00355784|75958447|FG001|COMPLETED|Overall Study||8||
59834778|NCT00355784|75958448|FG002|COMPLETED|Overall Study||5||
59834779|NCT00355784|75958446|FG000|NOT COMPLETED|Overall Study||0||
59834780|NCT00355784|75958447|FG001|NOT COMPLETED|Overall Study||0||
59834781|NCT00355784|75958448|FG002|NOT COMPLETED|Overall Study||2||
59834782|NCT00355472|75958457|FG000|STARTED|Overall Study||16||
59834783|NCT00355472|75958457|FG000|COMPLETED|Overall Study||15||
59834784|NCT00355472|75958457|FG000|NOT COMPLETED|Overall Study||1||
59834785|NCT00492557|75958471|FG000|STARTED|Overall Study||580||
59834786|NCT00492557|75958472|FG001|STARTED|Overall Study||580||
59834787|NCT00492557|75958471|FG000|Vaccinated Dose 1|Overall Study||577||
59834788|NCT00492557|75958472|FG001|Vaccinated Dose 1|Overall Study||575||
59834789|NCT00492557|75958471|FG000|Vaccinated Dose 2|Overall Study||560||
59834790|NCT00492557|75958472|FG001|Vaccinated Dose 2|Overall Study||558||
59834791|NCT00492557|75958471|FG000|COMPLETED|Overall Study||556||
59834792|NCT00492557|75958472|FG001|COMPLETED|Overall Study||557||
59834793|NCT00492557|75958471|FG000|NOT COMPLETED|Overall Study||24||
59834794|NCT00492557|75958472|FG001|NOT COMPLETED|Overall Study||23||
59834795|NCT00508391|75958483|FG000|STARTED|First Treatment||60||
59834796|NCT00508391|75958484|FG001|STARTED|First Treatment||62||
59834797|NCT00508391|75958483|FG000|COMPLETED|First Treatment||54||
59834798|NCT00508391|75958484|FG001|COMPLETED|First Treatment||59||
59834799|NCT00508391|75958483|FG000|NOT COMPLETED|First Treatment||6||
59834800|NCT00508391|75958484|FG001|NOT COMPLETED|First Treatment||3||
59834801|NCT00508391|75958483|FG000|STARTED|Second Treatment||54||
59834802|NCT00508391|75958484|FG001|STARTED|Second Treatment||59||
59834803|NCT00508391|75958483|FG000|COMPLETED|Second Treatment||52||
59834804|NCT00508391|75958484|FG001|COMPLETED|Second Treatment||59||
59834805|NCT00508391|75958483|FG000|NOT COMPLETED|Second Treatment||2||
59834806|NCT00508391|75958484|FG001|NOT COMPLETED|Second Treatment||0||
59834807|NCT00508157|75958494|FG000|STARTED|Overall Study||26||
59834808|NCT00508157|75958495|FG001|STARTED|Overall Study||26||
59834809|NCT00508157|75958494|FG000|Randomized Sample|Overall Study||26||
59834810|NCT00508157|75958495|FG001|Randomized Sample|Overall Study||26||
59834811|NCT00508157|75958494|FG000|Safety Sample|Overall Study||26||
59834812|NCT00508157|75958495|FG001|Safety Sample|Overall Study|1 participant was withdrawn from study prior to receiving study drug & excluded from safety sample.|25||
59834813|NCT00508157|75958494|FG000|COMPLETED|Overall Study||24||
59834814|NCT00508157|75958495|FG001|COMPLETED|Overall Study||23||
59834815|NCT00508157|75958494|FG000|NOT COMPLETED|Overall Study||2||
59834816|NCT00508157|75958495|FG001|NOT COMPLETED|Overall Study||3||
59834817|NCT00378560|75958503|FG000|STARTED|Overall Study||509||
59834818|NCT00378560|75958504|FG001|STARTED|Overall Study||512||
59834819|NCT00378560|75958503|FG000|Vaccinated|Overall Study||509||
59834820|NCT00378560|75958504|FG001|Vaccinated|Overall Study||512||
59834821|NCT00378560|75958503|FG000|COMPLETED|Overall Study||453||
59834822|NCT00378560|75958504|FG001|COMPLETED|Overall Study||454||
59834823|NCT00378560|75958503|FG000|NOT COMPLETED|Overall Study||56||
59834824|NCT00378560|75958504|FG001|NOT COMPLETED|Overall Study||58||
59834825|NCT00508001|75958513|FG000|STARTED|Overall Study||19||
59834826|NCT00508001|75958514|FG001|STARTED|Overall Study||25||
59834827|NCT00508001|75958515|FG002|STARTED|Overall Study||23||
59834828|NCT00508001|75958513|FG000|Secondary Treatment Phase|Overall Study||0||
59834829|NCT00508001|75958514|FG001|Secondary Treatment Phase|Overall Study||13||
59834830|NCT00508001|75958515|FG002|Secondary Treatment Phase|Overall Study||16||
59834831|NCT00508001|75958513|FG000|COMPLETED|Overall Study||0||
59834832|NCT00508001|75958514|FG001|COMPLETED|Overall Study||13||
59834833|NCT00508001|75958515|FG002|COMPLETED|Overall Study||16||
59834834|NCT00508001|75958513|FG000|NOT COMPLETED|Overall Study||19||
59834835|NCT00508001|75958514|FG001|NOT COMPLETED|Overall Study||12||
60119008|NCT01697579|76240024|FG005|NOT COMPLETED|Base Study-Cycle 1||0||
59834836|NCT00508001|75958515|FG002|NOT COMPLETED|Overall Study||7||
59834837|NCT00507689|75958526|FG000|STARTED|Pre-Randomization Period||40||
59834838|NCT00507689|75958527|FG001|STARTED|Pre-Randomization Period||0||
59834839|NCT00507689|75958526|FG000|COMPLETED|Pre-Randomization Period||37||
59834840|NCT00507689|75958527|FG001|COMPLETED|Pre-Randomization Period||0||
59834841|NCT00507689|75958526|FG000|NOT COMPLETED|Pre-Randomization Period||3||
59834842|NCT00507689|75958527|FG001|NOT COMPLETED|Pre-Randomization Period||0||
59834843|NCT00507689|75958526|FG000|STARTED|Randomized Period|19 of 37 participants who completed the pre-randomization period were randomized to FTC/TDF+HBIg.|19||
59834844|NCT00507689|75958527|FG001|STARTED|Randomized Period|18 of 37 participants who completed the pre-randomization period were randomized to FTC/TDF.|18||
59834845|NCT00507689|75958526|FG000|COMPLETED|Randomized Period||18||
59834846|NCT00507689|75958527|FG001|COMPLETED|Randomized Period||16||
59834847|NCT00507689|75958526|FG000|NOT COMPLETED|Randomized Period||1||
59834848|NCT00507689|75958527|FG001|NOT COMPLETED|Randomized Period||2||
59834849|NCT00491387|75958534|FG000|STARTED|Overall Study||24||
59834850|NCT00491387|75958534|FG000|Study Enrollment|Overall Study||24||
59834851|NCT00491387|75958534|FG000|COMPLETED|Overall Study||4||
59834852|NCT00491387|75958534|FG000|NOT COMPLETED|Overall Study||20||
59834853|NCT00491075|75958538|FG000|STARTED|Overall Study||16||
59834854|NCT00491075|75958538|FG000|COMPLETED|Overall Study||14||
59834855|NCT00491075|75958538|FG000|NOT COMPLETED|Overall Study||2||
59834856|NCT00507455|75958545|FG000|STARTED|Overall Study||74||
59834857|NCT00507455|75958546|FG001|STARTED|Overall Study||74||
59834858|NCT00507455|75958547|FG002|STARTED|Overall Study||74||
59834859|NCT00507455|75958545|FG000|COMPLETED|Overall Study||62||
59834860|NCT00507455|75958546|FG001|COMPLETED|Overall Study||68||
59834861|NCT00507455|75958547|FG002|COMPLETED|Overall Study||62||
59834862|NCT00507455|75958545|FG000|NOT COMPLETED|Overall Study||12||
59834863|NCT00507455|75958546|FG001|NOT COMPLETED|Overall Study||6||
59834864|NCT00507455|75958547|FG002|NOT COMPLETED|Overall Study||12||
59834865|NCT00506831|75958555|FG000|STARTED|Overall Study||9||
59834866|NCT00506831|75958555|FG000|COMPLETED|Overall Study||7||
59834867|NCT00506831|75958555|FG000|NOT COMPLETED|Overall Study||2||
59834868|NCT00506753|75958561|FG000|STARTED|Overall Study||100||
59834869|NCT00506753|75958562|FG001|STARTED|Overall Study||99||
59834870|NCT00506753|75958561|FG000|COMPLETED|Overall Study||79||
59834871|NCT00506753|75958562|FG001|COMPLETED|Overall Study||84||
59834872|NCT00506753|75958561|FG000|NOT COMPLETED|Overall Study||21||
59834873|NCT00506753|75958562|FG001|NOT COMPLETED|Overall Study||15||
59834874|NCT00490919|75958570|FG000|STARTED|Open-label Run-in Period||1024||
59834875|NCT00490919|75958571|FG001|STARTED|Open-label Run-in Period||0||
59834876|NCT00490919|75958572|FG002|STARTED|Open-label Run-in Period||0||
59834877|NCT00490919|75958570|FG000|COMPLETED|Open-label Run-in Period|Completed run-in and randomized; however 2 had no safety data after randomization visit (N = 539)|541||
59567519|NCT02326272|75670467|FG014|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0||
59567520|NCT02326272|75670453|FG000|COMPLETED|Initial Period (Week 0 to Week 16)||45||
59567521|NCT02326272|75670454|FG001|COMPLETED|Initial Period (Week 0 to Week 16)||84||
59834878|NCT00490919|75958571|FG001|COMPLETED|Open-label Run-in Period||0||
59834879|NCT00490919|75958572|FG002|COMPLETED|Open-label Run-in Period||0||
59834880|NCT00490919|75958570|FG000|NOT COMPLETED|Open-label Run-in Period||483||
59834881|NCT00490919|75958571|FG001|NOT COMPLETED|Open-label Run-in Period||0||
59834882|NCT00490919|75958572|FG002|NOT COMPLETED|Open-label Run-in Period||0||
59834883|NCT00490919|75958570|FG000|STARTED|Double-blind Phase||0||
59834884|NCT00490919|75958571|FG001|STARTED|Double-blind Phase|1 subject had no safety data in DB phase; therefore is excluded from randomized safety population.|256||
59834885|NCT00490919|75958572|FG002|STARTED|Double-blind Phase|1 subject had no safety data in DB phase; therefore is excluded from randomized safety population.|283||
59834886|NCT00490919|75958570|FG000|COMPLETED|Double-blind Phase||0||
59834887|NCT00490919|75958571|FG001|COMPLETED|Double-blind Phase||170||
59834888|NCT00490919|75958572|FG002|COMPLETED|Double-blind Phase||199||
59834889|NCT00490919|75958570|FG000|NOT COMPLETED|Double-blind Phase||0||
59834890|NCT00490919|75958571|FG001|NOT COMPLETED|Double-blind Phase||86||
59834891|NCT00490919|75958572|FG002|NOT COMPLETED|Double-blind Phase||84||
59834892|NCT00503867|75958579|FG000|STARTED|Overall Study||10||
59834893|NCT00503867|75958579|FG000|COMPLETED|Overall Study||8||
59834894|NCT00503867|75958579|FG000|NOT COMPLETED|Overall Study||2||
60119009|NCT01697579|76240025|FG006|NOT COMPLETED|Base Study-Cycle 1||0||
59834895|NCT00503399|75958585|FG000|STARTED|Overall Study||45||
59834896|NCT00503399|75958586|FG001|STARTED|Overall Study||47||
59834897|NCT00503399|75958585|FG000|COMPLETED|Overall Study||38||
59834898|NCT00503399|75958586|FG001|COMPLETED|Overall Study||39||
59834899|NCT00503399|75958585|FG000|NOT COMPLETED|Overall Study||7||
59834900|NCT00503399|75958586|FG001|NOT COMPLETED|Overall Study||8||
59834901|NCT00506519|75958595|FG000|STARTED|Overall Study||10||
59834902|NCT00506519|75958596|FG001|STARTED|Overall Study||10||
59834903|NCT00506519|75958597|FG002|STARTED|Overall Study||5||
59834904|NCT00506519|75958595|FG000|Completed Treatment (Day 5)|Overall Study||8||
59834905|NCT00506519|75958596|FG001|Completed Treatment (Day 5)|Overall Study||7||
59834906|NCT00506519|75958597|FG002|Completed Treatment (Day 5)|Overall Study||5||
59834907|NCT00506519|75958595|FG000|Day 28 Follow up|Overall Study||8||
59834908|NCT00506519|75958596|FG001|Day 28 Follow up|Overall Study||6||
59834909|NCT00506519|75958597|FG002|Day 28 Follow up|Overall Study||5||
59834910|NCT00506519|75958595|FG000|COMPLETED|Overall Study||5|Day 90 follow up (trial completed)|
59834911|NCT00506519|75958596|FG001|COMPLETED|Overall Study||4|Day 90 follow up (trial completed)|
59834912|NCT00506519|75958597|FG002|COMPLETED|Overall Study||5|Day 90 follow up (trial completed)|
59834913|NCT00506519|75958595|FG000|NOT COMPLETED|Overall Study||5||
59834914|NCT00506519|75958596|FG001|NOT COMPLETED|Overall Study||6||
59834915|NCT00506519|75958597|FG002|NOT COMPLETED|Overall Study||0||
59834916|NCT00503009|75958611|FG000|STARTED|Overall Study||5||
59834917|NCT00503009|75958612|FG001|STARTED|Overall Study||5||
59834918|NCT00503009|75958613|FG002|STARTED|Overall Study||6||
59834919|NCT00503009|75958611|FG000|COMPLETED|Overall Study||4||
59834920|NCT00503009|75958612|FG001|COMPLETED|Overall Study||3||
59834921|NCT00503009|75958613|FG002|COMPLETED|Overall Study||3||
59834922|NCT00503009|75958611|FG000|NOT COMPLETED|Overall Study||1||
59834923|NCT00503009|75958612|FG001|NOT COMPLETED|Overall Study||2||
59834924|NCT00503009|75958613|FG002|NOT COMPLETED|Overall Study||3||
59834925|NCT00160251|75958627|FG000|STARTED|Prior to Amendment 2||15||
59834926|NCT00160251|75958628|FG001|STARTED|Prior to Amendment 2||34||
59834927|NCT00160251|75958629|FG002|STARTED|Prior to Amendment 2||48||
59834928|NCT00160251|75958630|FG003|STARTED|Prior to Amendment 2||49||
59834929|NCT00160251|75958631|FG004|STARTED|Prior to Amendment 2||49||
59834930|NCT00160251|75958632|FG005|STARTED|Prior to Amendment 2||97||
59834931|NCT00160251|75958633|FG006|STARTED|Prior to Amendment 2||65||
59834932|NCT00160251|75958634|FG007|STARTED|Prior to Amendment 2||0||
59834933|NCT00160251|75958627|FG000|COMPLETED|Prior to Amendment 2||6||
59834934|NCT00160251|75958628|FG001|COMPLETED|Prior to Amendment 2||28||
59834935|NCT00160251|75958629|FG002|COMPLETED|Prior to Amendment 2||4||
59834936|NCT00160251|75958630|FG003|COMPLETED|Prior to Amendment 2||9||
59834937|NCT00160251|75958631|FG004|COMPLETED|Prior to Amendment 2||21||
59834938|NCT00160251|75958632|FG005|COMPLETED|Prior to Amendment 2||14||
59834939|NCT00160251|75958633|FG006|COMPLETED|Prior to Amendment 2||61||
59834940|NCT00160251|75958634|FG007|COMPLETED|Prior to Amendment 2||0||
59834941|NCT00160251|75958627|FG000|NOT COMPLETED|Prior to Amendment 2||9||
59834942|NCT00160251|75958628|FG001|NOT COMPLETED|Prior to Amendment 2||6||
59834943|NCT00160251|75958629|FG002|NOT COMPLETED|Prior to Amendment 2||44||
59834944|NCT00160251|75958630|FG003|NOT COMPLETED|Prior to Amendment 2||40||
59834945|NCT00160251|75958631|FG004|NOT COMPLETED|Prior to Amendment 2||28||
59834946|NCT00160251|75958632|FG005|NOT COMPLETED|Prior to Amendment 2||83||
59834947|NCT00160251|75958633|FG006|NOT COMPLETED|Prior to Amendment 2||4||
59834948|NCT00160251|75958634|FG007|NOT COMPLETED|Prior to Amendment 2||0||
59834949|NCT00160251|75958627|FG000|STARTED|Post-amendment 2||0||
59834950|NCT00160251|75958628|FG001|STARTED|Post-amendment 2||0||
59834951|NCT00160251|75958629|FG002|STARTED|Post-amendment 2||0||
59834952|NCT00160251|75958630|FG003|STARTED|Post-amendment 2||0||
59834953|NCT00160251|75958631|FG004|STARTED|Post-amendment 2||0||
59834954|NCT00160251|75958632|FG005|STARTED|Post-amendment 2||0||
59834955|NCT00160251|75958633|FG006|STARTED|Post-amendment 2||0||
59834956|NCT00160251|75958634|FG007|STARTED|Post-amendment 2||143||
59834957|NCT00160251|75958627|FG000|COMPLETED|Post-amendment 2||0||
59834958|NCT00160251|75958628|FG001|COMPLETED|Post-amendment 2||0||
59834959|NCT00160251|75958629|FG002|COMPLETED|Post-amendment 2||0||
59834960|NCT00160251|75958630|FG003|COMPLETED|Post-amendment 2||0||
59834961|NCT00160251|75958631|FG004|COMPLETED|Post-amendment 2||0||
59834962|NCT00160251|75958632|FG005|COMPLETED|Post-amendment 2||0||
59834963|NCT00160251|75958633|FG006|COMPLETED|Post-amendment 2||0||
59834964|NCT00160251|75958634|FG007|COMPLETED|Post-amendment 2||88||
59834965|NCT00160251|75958627|FG000|NOT COMPLETED|Post-amendment 2||0||
59834966|NCT00160251|75958628|FG001|NOT COMPLETED|Post-amendment 2||0||
59834967|NCT00160251|75958629|FG002|NOT COMPLETED|Post-amendment 2||0||
59834968|NCT00160251|75958630|FG003|NOT COMPLETED|Post-amendment 2||0||
59834969|NCT00160251|75958631|FG004|NOT COMPLETED|Post-amendment 2||0||
59834970|NCT00160251|75958632|FG005|NOT COMPLETED|Post-amendment 2||0||
59834971|NCT00160251|75958633|FG006|NOT COMPLETED|Post-amendment 2||0||
59834972|NCT00160251|75958634|FG007|NOT COMPLETED|Post-amendment 2||55||
59834973|NCT00506441|75958691|FG000|STARTED|Period 1; Open-label Period||245||
59834974|NCT00506441|75958692|FG001|STARTED|Period 1; Open-label Period||0||
59834975|NCT00506441|75958691|FG000|COMPLETED|Period 1; Open-label Period||169||
59834976|NCT00506441|75958692|FG001|COMPLETED|Period 1; Open-label Period||0||
59834977|NCT00506441|75958691|FG000|NOT COMPLETED|Period 1; Open-label Period||76||
59834978|NCT00506441|75958692|FG001|NOT COMPLETED|Period 1; Open-label Period||0||
59834979|NCT00506441|75958691|FG000|STARTED|Period 2; Double-blind Period||85||
59834980|NCT00506441|75958692|FG001|STARTED|Period 2; Double-blind Period||84||
59834981|NCT00506441|75958691|FG000|COMPLETED|Period 2; Double-blind Period||82||
59834982|NCT00506441|75958692|FG001|COMPLETED|Period 2; Double-blind Period||79||
59834983|NCT00506441|75958691|FG000|NOT COMPLETED|Period 2; Double-blind Period||3||
59834984|NCT00506441|75958692|FG001|NOT COMPLETED|Period 2; Double-blind Period||5||
59834985|NCT04190693|75958704|FG000|STARTED|Overall Study||4||
59834986|NCT04190693|75958705|FG001|STARTED|Overall Study||7||
59834987|NCT04190693|75958706|FG002|STARTED|Overall Study||12||
59834988|NCT04190693|75958707|FG003|STARTED|Overall Study||7||
59834989|NCT04190693|75958704|FG000|COMPLETED|Overall Study||4||
59834990|NCT04190693|75958705|FG001|COMPLETED|Overall Study||7||
59834991|NCT04190693|75958706|FG002|COMPLETED|Overall Study||12||
59834992|NCT04190693|75958707|FG003|COMPLETED|Overall Study||7||
59834993|NCT04190693|75958704|FG000|NOT COMPLETED|Overall Study||0||
59834994|NCT04190693|75958705|FG001|NOT COMPLETED|Overall Study||0||
59834995|NCT04190693|75958706|FG002|NOT COMPLETED|Overall Study||0||
59834996|NCT04190693|75958707|FG003|NOT COMPLETED|Overall Study||0||
59834997|NCT00378014|75958719|FG000|STARTED|Core (Randomization to Month 11)||101||
59834998|NCT00378014|75958720|FG001|STARTED|Core (Randomization to Month 11)||102||
59834999|NCT00378014|75958719|FG000|Intent-to-treat (ITT) Population|Core (Randomization to Month 11)|ITT contained all randomized patients who had at least one post baseline GFR measurement.|96||
59835000|NCT00378014|75958720|FG001|Intent-to-treat (ITT) Population|Core (Randomization to Month 11)|ITT contained all randomized patients who had at least one post baseline GFR measurement.|98||
59835001|NCT00378014|75958719|FG000|COMPLETED|Core (Randomization to Month 11)||87||
59835002|NCT00378014|75958720|FG001|COMPLETED|Core (Randomization to Month 11)||90||
59835003|NCT00378014|75958719|FG000|NOT COMPLETED|Core (Randomization to Month 11)||14||
59835004|NCT00378014|75958720|FG001|NOT COMPLETED|Core (Randomization to Month 11)||12||
59835005|NCT00378014|75958719|FG000|STARTED|Extension (Month 12 to Month 59)||41||
60119010|NCT01697579|76240019|FG000|STARTED|Optional Extension-Cycles 2-6|47 participants from this arm in Cycle 1 entered optional Cycles 2-6 at 5 mg/kg|0||
59835006|NCT00378014|75958720|FG001|STARTED|Extension (Month 12 to Month 59)||40||
59835007|NCT00378014|75958719|FG000|COMPLETED|Extension (Month 12 to Month 59)||27||
59835008|NCT00378014|75958720|FG001|COMPLETED|Extension (Month 12 to Month 59)||26||
59835009|NCT00378014|75958719|FG000|NOT COMPLETED|Extension (Month 12 to Month 59)||14||
59835010|NCT00378014|75958720|FG001|NOT COMPLETED|Extension (Month 12 to Month 59)||14||
59835011|NCT00485303|75958728|FG000|STARTED|Overall Study||58||
59835012|NCT00485303|75958728|FG000|COMPLETED|Overall Study||2||
59835013|NCT00485303|75958728|FG000|NOT COMPLETED|Overall Study||56||
59835014|NCT00490841|75958732|FG000|STARTED|Overall Study||202||
59835015|NCT00490841|75958732|FG000|COMPLETED|Overall Study||189||
59835016|NCT00490841|75958732|FG000|NOT COMPLETED|Overall Study||13||
59835017|NCT00377858|75958739|FG000|STARTED|Overall Study||242||
59835018|NCT00377858|75958740|FG001|STARTED|Overall Study||242||
59835019|NCT00377858|75958739|FG000|Had at Least One Post-Baseline Value|Overall Study||239||
59835020|NCT00377858|75958740|FG001|Had at Least One Post-Baseline Value|Overall Study||240||
59835021|NCT00377858|75958739|FG000|COMPLETED|Overall Study||211||
59835022|NCT00377858|75958740|FG001|COMPLETED|Overall Study||215||
59835023|NCT00377858|75958739|FG000|NOT COMPLETED|Overall Study||31||
59835024|NCT00377858|75958740|FG001|NOT COMPLETED|Overall Study||27||
59835025|NCT00502775|75958749|FG000|STARTED|Overall Study||229||
59835026|NCT00502775|75958750|FG001|STARTED|Overall Study||224||
59835027|NCT00502775|75958751|FG002|STARTED|Overall Study||227||
59835028|NCT00502775|75958749|FG000|COMPLETED|Overall Study||219||
59835029|NCT00502775|75958750|FG001|COMPLETED|Overall Study||209||
59835030|NCT00502775|75958751|FG002|COMPLETED|Overall Study||214||
59835031|NCT00502775|75958749|FG000|NOT COMPLETED|Overall Study||10||
59835032|NCT00502775|75958750|FG001|NOT COMPLETED|Overall Study||15||
59835033|NCT00502775|75958751|FG002|NOT COMPLETED|Overall Study||13||
59835034|NCT00502697|75958761|FG000|STARTED|Overall Study||122||
59835035|NCT00502697|75958762|FG001|STARTED|Overall Study||114||
59835036|NCT00502697|75958761|FG000|COMPLETED|Overall Study||109||
59835037|NCT00502697|75958762|FG001|COMPLETED|Overall Study||102||
59835038|NCT00502697|75958761|FG000|NOT COMPLETED|Overall Study||13||
59835039|NCT00502697|75958762|FG001|NOT COMPLETED|Overall Study||12||
59835040|NCT00485069|75958770|FG000|STARTED|Overall Study||65||
59835041|NCT00485069|75958771|FG001|STARTED|Overall Study||58||
59835042|NCT00485069|75958770|FG000|COMPLETED|Overall Study||47||
59835043|NCT00485069|75958771|FG001|COMPLETED|Overall Study||46||
59835044|NCT00485069|75958770|FG000|NOT COMPLETED|Overall Study||18||
59835045|NCT00485069|75958771|FG001|NOT COMPLETED|Overall Study||12||
59835046|NCT00355082|75958786|FG000|STARTED|Double-Blind (DB) Treatment Phase|112 participants have baseline data; 1 participant did not receive study drug.|113||
59835047|NCT00355082|75958787|FG001|STARTED|Double-Blind (DB) Treatment Phase|111 participants have baseline data; 2 participants did not receive study drug.|113||
59835048|NCT00355082|75958788|FG002|STARTED|Double-Blind (DB) Treatment Phase||0||
59835049|NCT00355082|75958786|FG000|COMPLETED|Double-Blind (DB) Treatment Phase||94||
59835050|NCT00355082|75958787|FG001|COMPLETED|Double-Blind (DB) Treatment Phase||79||
59835051|NCT00355082|75958788|FG002|COMPLETED|Double-Blind (DB) Treatment Phase||0||
59835052|NCT00355082|75958786|FG000|NOT COMPLETED|Double-Blind (DB) Treatment Phase||19||
59835053|NCT00355082|75958787|FG001|NOT COMPLETED|Double-Blind (DB) Treatment Phase||34||
59835054|NCT00355082|75958788|FG002|NOT COMPLETED|Double-Blind (DB) Treatment Phase||0||
59835055|NCT00355082|75958786|FG000|STARTED|Continuation Phase|83 and 101 participants from the 250 and 300 mg groups (DB Phase), respectively, entered the CP.|184||
59835056|NCT00355082|75958787|FG001|STARTED|Continuation Phase||0||
59835057|NCT00355082|75958788|FG002|STARTED|Continuation Phase|"See Pre-assign. Details for reasons why number starting CP does not equal number completing TP."|11||
59835058|NCT00355082|75958786|FG000|COMPLETED|Continuation Phase||160||
59835059|NCT00355082|75958787|FG001|COMPLETED|Continuation Phase||0||
59835060|NCT00355082|75958788|FG002|COMPLETED|Continuation Phase||8||
59835061|NCT00355082|75958786|FG000|NOT COMPLETED|Continuation Phase||24||
59835062|NCT00355082|75958787|FG001|NOT COMPLETED|Continuation Phase||0||
59835063|NCT00355082|75958788|FG002|NOT COMPLETED|Continuation Phase||3||
59835064|NCT00502307|75958799|FG000|STARTED|Open Label Period (16 Weeks)||272||
59835065|NCT00502307|75958800|FG001|STARTED|Open Label Period (16 Weeks)||0||
59835066|NCT00502307|75958801|FG002|STARTED|Open Label Period (16 Weeks)||0||
59835067|NCT00502307|75958799|FG000|COMPLETED|Open Label Period (16 Weeks)||196||
59835068|NCT00502307|75958800|FG001|COMPLETED|Open Label Period (16 Weeks)||0||
59835069|NCT00502307|75958801|FG002|COMPLETED|Open Label Period (16 Weeks)||0||
59835070|NCT00502307|75958799|FG000|NOT COMPLETED|Open Label Period (16 Weeks)||76||
59835071|NCT00502307|75958800|FG001|NOT COMPLETED|Open Label Period (16 Weeks)||0||
59835072|NCT00502307|75958801|FG002|NOT COMPLETED|Open Label Period (16 Weeks)||0||
59835073|NCT00502307|75958799|FG000|STARTED|Double-Blind Period (12 Weeks)||0||
59835074|NCT00502307|75958800|FG001|STARTED|Double-Blind Period (12 Weeks)||61||
59835075|NCT00502307|75958801|FG002|STARTED|Double-Blind Period (12 Weeks)||57||
59835076|NCT00502307|75958799|FG000|COMPLETED|Double-Blind Period (12 Weeks)||0||
59835077|NCT00502307|75958800|FG001|COMPLETED|Double-Blind Period (12 Weeks)||35||
59835078|NCT00502307|75958801|FG002|COMPLETED|Double-Blind Period (12 Weeks)||48||
59835079|NCT00502307|75958799|FG000|NOT COMPLETED|Double-Blind Period (12 Weeks)||0||
59835080|NCT00502307|75958800|FG001|NOT COMPLETED|Double-Blind Period (12 Weeks)||26||
59835081|NCT00502307|75958801|FG002|NOT COMPLETED|Double-Blind Period (12 Weeks)||9||
59835082|NCT00502307|75958799|FG000|STARTED|Maintenance Period||148||
59835083|NCT00502307|75958800|FG001|STARTED|Maintenance Period||0||
59835084|NCT00502307|75958801|FG002|STARTED|Maintenance Period||0||
59835085|NCT00502307|75958799|FG000|COMPLETED|Maintenance Period||0||
59835086|NCT00502307|75958800|FG001|COMPLETED|Maintenance Period||0||
59835087|NCT00502307|75958801|FG002|COMPLETED|Maintenance Period||0||
59835088|NCT00502307|75958799|FG000|NOT COMPLETED|Maintenance Period||148||
59835089|NCT00502307|75958800|FG001|NOT COMPLETED|Maintenance Period||0||
59835090|NCT00502307|75958801|FG002|NOT COMPLETED|Maintenance Period||0||
59835091|NCT00484679|75958818|FG000|STARTED|Overall Study||18||
59835092|NCT00484679|75958818|FG000|COMPLETED|Overall Study||15||
59835093|NCT00484679|75958818|FG000|NOT COMPLETED|Overall Study||3||
59835094|NCT00377312|75958824|FG000|STARTED|Overall Study||6||
59835095|NCT00377312|75958825|FG001|STARTED|Overall Study||5||
59835096|NCT00377312|75958824|FG000|COMPLETED|Overall Study||5||
59835097|NCT00377312|75958825|FG001|COMPLETED|Overall Study||4||
59835098|NCT00377312|75958824|FG000|NOT COMPLETED|Overall Study||1||
59835099|NCT00377312|75958825|FG001|NOT COMPLETED|Overall Study||1||
59835100|NCT00377234|75958833|FG000|STARTED|Overall Study||180||
59835101|NCT00377234|75958834|FG001|STARTED|Overall Study||176||
59835102|NCT00377234|75958833|FG000|Randomized|Overall Study||180||
59835103|NCT00377234|75958834|FG001|Randomized|Overall Study||176||
59835104|NCT00377234|75958833|FG000|Did Not Receive Study Treatment|Overall Study||3||
59835105|NCT00377234|75958834|FG001|Did Not Receive Study Treatment|Overall Study||2||
59835106|NCT00377234|75958833|FG000|Received Treatment|Overall Study||177||
59835107|NCT00377234|75958834|FG001|Received Treatment|Overall Study||174||
59835108|NCT00377234|75958833|FG000|Safety Analysis Set: Period 1|Overall Study||177||
59835109|NCT00377234|75958834|FG001|Safety Analysis Set: Period 1|Overall Study||174||
59835110|NCT00377234|75958833|FG000|Safety Analysis Set: Period 2|Overall Study||153||
59835111|NCT00377234|75958834|FG001|Safety Analysis Set: Period 2|Overall Study||150||
60119011|NCT01697579|76240020|FG001|STARTED|Optional Extension-Cycles 2-6|33 participants from this arm in Cycle 1 entered optional Cycles 2-6 at 3 mg/kg|0||
60119012|NCT01697579|76240021|FG002|STARTED|Optional Extension-Cycles 2-6|25 participants from this arm in Cycle 1 entered optional Cycles 2-6 at 3 mg/kg|0||
60119013|NCT01697579|76240022|FG003|STARTED|Optional Extension-Cycles 2-6|27 participants from this arm in Cycle 1 entered optional Cycles 2-6 at 3 mg/kg|0||
60119014|NCT01697579|76240023|FG004|STARTED|Optional Extension-Cycles 2-6|21 participants from this arm in Cycle 1 entered optional Cycles 2-6 at 3 mg/kg|0||
60119015|NCT01697579|76240024|FG005|STARTED|Optional Extension-Cycles 2-6|Enrollment in Cycles 2-6 was optional.|47||
60119016|NCT01697579|76240025|FG006|STARTED|Optional Extension-Cycles 2-6|Enrollment in Cycles 2-6 was optional.|106||
59567522|NCT02326272|75670455|FG002|COMPLETED|Initial Period (Week 0 to Week 16)||81||
59567523|NCT02326272|75670456|FG003|COMPLETED|Initial Period (Week 0 to Week 16)||0||
59567524|NCT02326272|75670457|FG004|COMPLETED|Initial Period (Week 0 to Week 16)||0||
59717768|NCT00910858|75836848|FG000|STARTED|Combined Treatment Phase|Patients who discontinued the Monotherapy Phase due to erythroid non-response or erythroid relapse.|9||
59717769|NCT00910858|75836849|FG001|STARTED|Combined Treatment Phase|Patients who discontinued the Monotherapy Phase due to erythroid non-response or erythroid relapse.|10||
59717770|NCT00910858|75836850|FG002|STARTED|Combined Treatment Phase|Patients who discontinued the Monotherapy Phase due to erythroid non-response or erythroid relapse.|4||
59717771|NCT00910858|75836848|FG000|COMPLETED|Combined Treatment Phase||0||
59717772|NCT00910858|75836849|FG001|COMPLETED|Combined Treatment Phase||0||
59717773|NCT00910858|75836850|FG002|COMPLETED|Combined Treatment Phase||0||
59717774|NCT00910858|75836848|FG000|NOT COMPLETED|Combined Treatment Phase||9||
59717775|NCT00910858|75836849|FG001|NOT COMPLETED|Combined Treatment Phase||10||
59835112|NCT00377234|75958833|FG000|Safety Analysis Set: Ibandronate|Overall Study||177||
59835113|NCT00377234|75958834|FG001|Safety Analysis Set: Ibandronate|Overall Study||150||
59835114|NCT00377234|75958833|FG000|Safety Analysis Set: Risedronate|Overall Study||153||
59835115|NCT00377234|75958834|FG001|Safety Analysis Set: Risedronate|Overall Study||174||
59835116|NCT00377234|75958833|FG000|COMPLETED|Overall Study||146||
59835117|NCT00377234|75958834|FG001|COMPLETED|Overall Study||145||
59835118|NCT00377234|75958833|FG000|NOT COMPLETED|Overall Study||34||
59835119|NCT00377234|75958834|FG001|NOT COMPLETED|Overall Study||31||
59835120|NCT00377156|75958848|FG000|STARTED|Overall Study||111||
59835121|NCT00377156|75958849|FG001|STARTED|Overall Study||102||
59835122|NCT00377156|75958848|FG000|COMPLETED|Overall Study||63||
59835123|NCT00377156|75958849|FG001|COMPLETED|Overall Study||48||
59835124|NCT00377156|75958848|FG000|NOT COMPLETED|Overall Study||48||
59835125|NCT00377156|75958849|FG001|NOT COMPLETED|Overall Study||54||
59835126|NCT00376688|75958857|FG000|STARTED|Overall Study||31||
59835127|NCT00376688|75958857|FG000|COMPLETED|Overall Study||27||
59835128|NCT00376688|75958857|FG000|NOT COMPLETED|Overall Study||4||
59835129|NCT00376532|75958863|FG000|STARTED|Overall Study|Subjects with an event were enrolled beginning 09/14/2006.|31||
59835130|NCT00376532|75958864|FG001|STARTED|Overall Study|Subjects without an event were enrolled beginning 09/15/2006.|32||
59835131|NCT00376532|75958863|FG000|COMPLETED|Overall Study|Last event subject enrolled 2/22/2008|25||
59835132|NCT00376532|75958864|FG001|COMPLETED|Overall Study|Last non-event subject enrolled 3/18/2008.|26||
59835133|NCT00376532|75958863|FG000|NOT COMPLETED|Overall Study||6||
59835134|NCT00376532|75958864|FG001|NOT COMPLETED|Overall Study||6||
59835135|NCT00376220|75958872|FG000|STARTED|Overall Study||47||
59835136|NCT00376220|75958873|FG001|STARTED|Overall Study||47||
59835137|NCT00376220|75958872|FG000|COMPLETED|Overall Study||37||
59835138|NCT00376220|75958873|FG001|COMPLETED|Overall Study||35||
59835139|NCT00376220|75958872|FG000|NOT COMPLETED|Overall Study||10||
59835140|NCT00376220|75958873|FG001|NOT COMPLETED|Overall Study||12||
59835141|NCT00375752|75958881|FG000|STARTED|Overall Study||79||
59835142|NCT00375752|75958882|FG001|STARTED|Overall Study||89||
59835143|NCT00375752|75958881|FG000|COMPLETED|Overall Study||67||
59835144|NCT00375752|75958882|FG001|COMPLETED|Overall Study||74||
59835145|NCT00375752|75958881|FG000|NOT COMPLETED|Overall Study||12||
59835146|NCT00375752|75958882|FG001|NOT COMPLETED|Overall Study||15||
59835147|NCT00484289|75958891|FG000|STARTED|Long Term Phase||13||
59835148|NCT00484289|75958892|FG001|STARTED|Long Term Phase||178||
59835149|NCT00484289|75958893|FG002|STARTED|Long Term Phase||26||
59835150|NCT00484289|75958891|FG000|COMPLETED|Long Term Phase|Completed participants entered postmarketing phase.|10||
59835151|NCT00484289|75958892|FG001|COMPLETED|Long Term Phase|Completed participants entered postmarketing phase.|142||
59835152|NCT00484289|75958893|FG002|COMPLETED|Long Term Phase|Completed participants entered postmarketing phase.|10||
59835153|NCT00484289|75958891|FG000|NOT COMPLETED|Long Term Phase||3||
59835154|NCT00484289|75958892|FG001|NOT COMPLETED|Long Term Phase||36||
59835155|NCT00484289|75958893|FG002|NOT COMPLETED|Long Term Phase||16||
59835156|NCT00484289|75958891|FG000|STARTED|Post Marketing Phase||10||
59835157|NCT00484289|75958892|FG001|STARTED|Post Marketing Phase||142||
59835158|NCT00484289|75958893|FG002|STARTED|Post Marketing Phase||10||
59835159|NCT00484289|75958891|FG000|COMPLETED|Post Marketing Phase||10||
59835160|NCT00484289|75958892|FG001|COMPLETED|Post Marketing Phase||141||
59835161|NCT00484289|75958893|FG002|COMPLETED|Post Marketing Phase||10||
59835162|NCT00484289|75958891|FG000|NOT COMPLETED|Post Marketing Phase||0||
59835163|NCT00484289|75958892|FG001|NOT COMPLETED|Post Marketing Phase||1||
59835164|NCT00484289|75958893|FG002|NOT COMPLETED|Post Marketing Phase||0||
59835165|NCT00490529|75958902|FG000|STARTED|Completed Pre-CpG-MCL Vaccine Procedures||59||
59835166|NCT00490529|75958902|FG000|COMPLETED|Completed Pre-CpG-MCL Vaccine Procedures||48||
59835167|NCT00490529|75958902|FG000|NOT COMPLETED|Completed Pre-CpG-MCL Vaccine Procedures||11||
59835168|NCT00490529|75958902|FG000|STARTED|Treatment With CpG-MCL Vaccine||48||
59835169|NCT00490529|75958902|FG000|COMPLETED|Treatment With CpG-MCL Vaccine||47||
59835170|NCT00490529|75958902|FG000|NOT COMPLETED|Treatment With CpG-MCL Vaccine||1||
59835171|NCT00333840|75958908|FG000|STARTED|First-line Treatment Period||553||
59835172|NCT00333840|75958909|FG001|STARTED|First-line Treatment Period||553||
59835173|NCT00333840|75958910|FG002|STARTED|First-line Treatment Period||0||
59835174|NCT00333840|75958911|FG003|STARTED|First-line Treatment Period||0||
59835175|NCT00333840|75958908|FG000|Safety Population; Received Study Drug|First-line Treatment Period||551||
59835176|NCT00333840|75958909|FG001|Safety Population; Received Study Drug|First-line Treatment Period||533||
60119017|NCT01697579|76240019|FG000|COMPLETED|Optional Extension-Cycles 2-6||0||
60119018|NCT01697579|76240020|FG001|COMPLETED|Optional Extension-Cycles 2-6||0||
60119019|NCT01697579|76240021|FG002|COMPLETED|Optional Extension-Cycles 2-6||0||
60119020|NCT01697579|76240022|FG003|COMPLETED|Optional Extension-Cycles 2-6||0||
59717776|NCT00910858|75836850|FG002|NOT COMPLETED|Combined Treatment Phase||4||
59717777|NCT00598975|75836868|FG000|STARTED|Overall Study||12||
59717778|NCT00598975|75836869|FG001|STARTED|Overall Study||6||
59717779|NCT00598975|75836868|FG000|Completed Cycle 1|Overall Study||12||
59717780|NCT00598975|75836869|FG001|Completed Cycle 1|Overall Study||6||
59717781|NCT00598975|75836868|FG000|COMPLETED|Overall Study||0||
59717782|NCT00598975|75836869|FG001|COMPLETED|Overall Study||0||
59717783|NCT00598975|75836868|FG000|NOT COMPLETED|Overall Study||12||
59717784|NCT00598975|75836869|FG001|NOT COMPLETED|Overall Study||6||
59717785|NCT00957021|75836877|FG000|STARTED|Overall Study||354||
59717786|NCT00957021|75836877|FG000|COMPLETED|Overall Study|Completed/Not completed counts are based on participant status at the 2 yr primary outcome interval.|237||
59835177|NCT00333840|75958910|FG002|Safety Population; Received Study Drug|First-line Treatment Period||0||
59835178|NCT00333840|75958911|FG003|Safety Population; Received Study Drug|First-line Treatment Period||0||
59835179|NCT00333840|75958908|FG000|COMPLETED|First-line Treatment Period||267||
59835180|NCT00333840|75958909|FG001|COMPLETED|First-line Treatment Period||7||
59835181|NCT00333840|75958910|FG002|COMPLETED|First-line Treatment Period||0||
59835182|NCT00333840|75958911|FG003|COMPLETED|First-line Treatment Period||0||
59835183|NCT00333840|75958908|FG000|NOT COMPLETED|First-line Treatment Period||286||
59835184|NCT00333840|75958909|FG001|NOT COMPLETED|First-line Treatment Period||546||
59835185|NCT00333840|75958910|FG002|NOT COMPLETED|First-line Treatment Period||0||
59835186|NCT00333840|75958911|FG003|NOT COMPLETED|First-line Treatment Period||0||
59835187|NCT00333840|75958908|FG000|STARTED|Second-line Treatment Period||0||
59835188|NCT00333840|75958909|FG001|STARTED|Second-line Treatment Period||0||
59835189|NCT00333840|75958910|FG002|STARTED|Second-line Treatment Period||14||
59835190|NCT00333840|75958911|FG003|STARTED|Second-line Treatment Period||363||
59835191|NCT00333840|75958908|FG000|COMPLETED|Second-line Treatment Period||0||
59835192|NCT00333840|75958909|FG001|COMPLETED|Second-line Treatment Period||0||
59835193|NCT00333840|75958910|FG002|COMPLETED|Second-line Treatment Period||0||
59835194|NCT00333840|75958911|FG003|COMPLETED|Second-line Treatment Period||175||
59835195|NCT00333840|75958908|FG000|NOT COMPLETED|Second-line Treatment Period||0||
59835196|NCT00333840|75958909|FG001|NOT COMPLETED|Second-line Treatment Period||0||
59835197|NCT00333840|75958910|FG002|NOT COMPLETED|Second-line Treatment Period||14||
59835198|NCT00333840|75958911|FG003|NOT COMPLETED|Second-line Treatment Period||188||
59835199|NCT00490451|75958927|FG000|STARTED|Overall Study||63||
59835200|NCT00490451|75958928|FG001|STARTED|Overall Study||38||
59835201|NCT00490451|75958927|FG000|COMPLETED|Overall Study||0||
59835202|NCT00490451|75958928|FG001|COMPLETED|Overall Study||0||
59835203|NCT00490451|75958927|FG000|NOT COMPLETED|Overall Study||63||
59835204|NCT00490451|75958928|FG001|NOT COMPLETED|Overall Study||38||
59835205|NCT00321906|75958936|FG000|STARTED|Overall Study||94||
59835206|NCT00321906|75958937|FG001|STARTED|Overall Study||87||
60119021|NCT01697579|76240023|FG004|COMPLETED|Optional Extension-Cycles 2-6||0||
60119022|NCT01697579|76240024|FG005|COMPLETED|Optional Extension-Cycles 2-6||12||
60119023|NCT01697579|76240025|FG006|COMPLETED|Optional Extension-Cycles 2-6||37||
60119024|NCT01697579|76240019|FG000|NOT COMPLETED|Optional Extension-Cycles 2-6||0||
60119025|NCT01697579|76240020|FG001|NOT COMPLETED|Optional Extension-Cycles 2-6||0||
60119026|NCT01697579|76240021|FG002|NOT COMPLETED|Optional Extension-Cycles 2-6||0||
60119027|NCT01697579|76240022|FG003|NOT COMPLETED|Optional Extension-Cycles 2-6||0||
60119028|NCT01697579|76240023|FG004|NOT COMPLETED|Optional Extension-Cycles 2-6||0||
60119029|NCT01697579|76240024|FG005|NOT COMPLETED|Optional Extension-Cycles 2-6||35||
60119030|NCT01697579|76240025|FG006|NOT COMPLETED|Optional Extension-Cycles 2-6||69||
60119031|NCT01586195|76240053|FG000|STARTED|Overall Study||31||
60119032|NCT01586195|76240053|FG000|COMPLETED|Overall Study||5||
60119033|NCT01586195|76240053|FG000|NOT COMPLETED|Overall Study||26||
60119034|NCT01585961|76240057|FG000|STARTED|Overall Study||511||
59567525|NCT02326272|75670458|FG005|COMPLETED|Initial Period (Week 0 to Week 16)||0||
59567526|NCT02326272|75670459|FG006|COMPLETED|Initial Period (Week 0 to Week 16)||0||
59567527|NCT02326272|75670460|FG007|COMPLETED|Initial Period (Week 0 to Week 16)||0||
59567528|NCT02326272|75670461|FG008|COMPLETED|Initial Period (Week 0 to Week 16)||0||
59567529|NCT02326272|75670462|FG009|COMPLETED|Initial Period (Week 0 to Week 16)||0||
59567530|NCT02326272|75670463|FG010|COMPLETED|Initial Period (Week 0 to Week 16)||0||
59567531|NCT02326272|75670464|FG011|COMPLETED|Initial Period (Week 0 to Week 16)||0||
59717787|NCT00957021|75836877|FG000|NOT COMPLETED|Overall Study||117||
60119035|NCT01585961|76240057|FG000|Safety|Overall Study|Patients ablated with study catheter|508||
59717788|NCT01124604|75836884|FG000|STARTED|Overall Study||60||
59717789|NCT01124604|75836885|FG001|STARTED|Overall Study||31||
59717790|NCT01124604|75836884|FG000|COMPLETED|Overall Study||45||
60119036|NCT01585961|76240057|FG000|COMPLETED|Overall Study||478||
60119037|NCT01585961|76240057|FG000|NOT COMPLETED|Overall Study||33||
59717791|NCT01124604|75836885|FG001|COMPLETED|Overall Study||29||
59717792|NCT01124604|75836884|FG000|NOT COMPLETED|Overall Study||15||
59717793|NCT01124604|75836885|FG001|NOT COMPLETED|Overall Study||2||
59717794|NCT00909844|75836891|FG000|STARTED|Overall Study||35||
59717795|NCT00909844|75836891|FG000|COMPLETED|Overall Study||31||
59717796|NCT00909844|75836891|FG000|NOT COMPLETED|Overall Study||4||
59717797|NCT01124448|75836898|FG000|STARTED|Overall Study||25||
59717798|NCT01124448|75836899|FG001|STARTED|Overall Study||15||
59835207|NCT00321906|75958936|FG000|COMPLETED|Overall Study||48||
59835208|NCT00321906|75958937|FG001|COMPLETED|Overall Study||31||
59835209|NCT00321906|75958936|FG000|NOT COMPLETED|Overall Study||46||
59835210|NCT00321906|75958937|FG001|NOT COMPLETED|Overall Study||56||
59835211|NCT00339144|75958946|FG000|STARTED|Overall Study|Number of participants enrolled and treated|9||
59835212|NCT00339144|75958947|FG001|STARTED|Overall Study|Number of participants enrolled and treated|3||
59835213|NCT00339144|75958948|FG002|STARTED|Overall Study|Number of participants enrolled and treated|4||
59835214|NCT00339144|75958946|FG000|COMPLETED|Overall Study||0||
59835215|NCT00339144|75958947|FG001|COMPLETED|Overall Study||0||
59835216|NCT00339144|75958948|FG002|COMPLETED|Overall Study||0||
59835217|NCT00339144|75958946|FG000|NOT COMPLETED|Overall Study||9||
59835218|NCT00339144|75958947|FG001|NOT COMPLETED|Overall Study||3||
59835219|NCT00339144|75958948|FG002|NOT COMPLETED|Overall Study||4||
59835220|NCT00321828|75958957|FG000|STARTED|Overall Study||90||
59835221|NCT00321828|75958957|FG000|COMPLETED|Overall Study||86||
59835222|NCT00321828|75958957|FG000|NOT COMPLETED|Overall Study||4||
59835223|NCT00333138|75958964|FG000|STARTED|Core Study (6 Months)||93||
59835224|NCT00333138|75958965|FG001|STARTED|Core Study (6 Months)||94||
59835225|NCT00333138|75958966|FG002|STARTED|Core Study (6 Months)||94||
59835226|NCT00333138|75958964|FG000|COMPLETED|Core Study (6 Months)||86||
59835227|NCT00333138|75958965|FG001|COMPLETED|Core Study (6 Months)||88||
59835228|NCT00333138|75958966|FG002|COMPLETED|Core Study (6 Months)||82||
59835229|NCT00333138|75958964|FG000|NOT COMPLETED|Core Study (6 Months)||7||
59835230|NCT00333138|75958965|FG001|NOT COMPLETED|Core Study (6 Months)||6||
59835231|NCT00333138|75958966|FG002|NOT COMPLETED|Core Study (6 Months)||12||
59835232|NCT00333138|75958964|FG000|STARTED|Extension Study (Month6 to End of Study)||83||
59835233|NCT00333138|75958965|FG001|STARTED|Extension Study (Month6 to End of Study)||87||
59835234|NCT00333138|75958966|FG002|STARTED|Extension Study (Month6 to End of Study)||80||
59835235|NCT00333138|75958964|FG000|COMPLETED|Extension Study (Month6 to End of Study)||40||
59835236|NCT00333138|75958965|FG001|COMPLETED|Extension Study (Month6 to End of Study)||45||
59835237|NCT00333138|75958966|FG002|COMPLETED|Extension Study (Month6 to End of Study)||37||
59835238|NCT00333138|75958964|FG000|NOT COMPLETED|Extension Study (Month6 to End of Study)||43||
59835239|NCT00333138|75958965|FG001|NOT COMPLETED|Extension Study (Month6 to End of Study)||42||
59835240|NCT00333138|75958966|FG002|NOT COMPLETED|Extension Study (Month6 to End of Study)||43||
59835241|NCT00332202|75958978|FG000|STARTED|Overall Study||504||
59835242|NCT00332202|75958979|FG001|STARTED|Overall Study||254||
59835243|NCT00332202|75958978|FG000|Received At Least One Dose of Study Drug|Overall Study||493||
59835244|NCT00332202|75958979|FG001|Received At Least One Dose of Study Drug|Overall Study||249||
59835245|NCT00332202|75958978|FG000|COMPLETED|Overall Study||263||
59835246|NCT00332202|75958979|FG001|COMPLETED|Overall Study||129||
59835247|NCT00332202|75958978|FG000|NOT COMPLETED|Overall Study||241||
59835248|NCT00332202|75958979|FG001|NOT COMPLETED|Overall Study||125||
59835249|NCT00331422|75958994|FG000|STARTED|Overall Study|Patients who met study criteria and received at least one dose of study drug.|7||
59835250|NCT00331422|75958994|FG000|COMPLETED|Overall Study|Completed all 6 courses of chemotherapy and had surgery to remove all tumor lesions.|2||
59835251|NCT00331422|75958994|FG000|NOT COMPLETED|Overall Study||5||
59835252|NCT00331344|75958999|FG000|STARTED|Phase I||3||
59835253|NCT00331344|75959000|FG001|STARTED|Phase I||3||
59835254|NCT00331344|75959001|FG002|STARTED|Phase I||3||
59835255|NCT00331344|75959002|FG003|STARTED|Phase I||6||
59835256|NCT00331344|75959003|FG004|STARTED|Phase I||6||
59835257|NCT00331344|75959004|FG005|STARTED|Phase I||5||
59835258|NCT00331344|75959005|FG006|STARTED|Phase I||4||
59835259|NCT00331344|75959006|FG007|STARTED|Phase I|1 participant who was enrolled died prior to initiating protocol therapy.|6||
59835260|NCT00331344|75959007|FG008|STARTED|Phase I||0||
59835261|NCT00331344|75958999|FG000|COMPLETED|Phase I||3||
59835262|NCT00331344|75959000|FG001|COMPLETED|Phase I||3||
59835263|NCT00331344|75959001|FG002|COMPLETED|Phase I||3||
60119038|NCT01697501|76240061|FG000|STARTED|Overall Study||88||
59835264|NCT00331344|75959002|FG003|COMPLETED|Phase I|1 participant reached dose limiting toxicity|5||
59835265|NCT00331344|75959003|FG004|COMPLETED|Phase I|2 participants reached dose limiting toxicity|4||
59835266|NCT00331344|75959004|FG005|COMPLETED|Phase I|2 participants reached dose limiting toxicity|3||
59835267|NCT00331344|75959005|FG006|COMPLETED|Phase I||4||
59835268|NCT00331344|75959006|FG007|COMPLETED|Phase I|1 participant reached dose limiting toxicity|5||
59835269|NCT00331344|75959007|FG008|COMPLETED|Phase I||0||
59835270|NCT00331344|75958999|FG000|NOT COMPLETED|Phase I||0||
59835271|NCT00331344|75959000|FG001|NOT COMPLETED|Phase I||0||
59835272|NCT00331344|75959001|FG002|NOT COMPLETED|Phase I||0||
59835273|NCT00331344|75959002|FG003|NOT COMPLETED|Phase I||1||
59835274|NCT00331344|75959003|FG004|NOT COMPLETED|Phase I||2||
59835275|NCT00331344|75959004|FG005|NOT COMPLETED|Phase I||2||
59835276|NCT00331344|75959005|FG006|NOT COMPLETED|Phase I||0||
59835277|NCT00331344|75959006|FG007|NOT COMPLETED|Phase I||1||
59835278|NCT00331344|75959007|FG008|NOT COMPLETED|Phase I||0||
59835279|NCT00331344|75958999|FG000|STARTED|Phase II||0||
59835280|NCT00331344|75959000|FG001|STARTED|Phase II||0||
59835281|NCT00331344|75959001|FG002|STARTED|Phase II||0||
59835282|NCT00331344|75959002|FG003|STARTED|Phase II||0||
60119039|NCT01697501|76240061|FG000|COMPLETED|Overall Study||86||
60119040|NCT01697501|76240061|FG000|NOT COMPLETED|Overall Study||2||
60119041|NCT01697345|76240074|FG000|STARTED|Overall Study||13||
60119042|NCT01697345|76240074|FG000|COMPLETED|Overall Study|One patient withdrew due to symptoms of recurrent Gardnerella vaginalis.|12||
60119043|NCT01697345|76240074|FG000|NOT COMPLETED|Overall Study||1||
60119044|NCT02441062|76240093|FG000|STARTED|Overall Study||122||
60119045|NCT02441062|76240093|FG000|COMPLETED|Overall Study||122||
60119046|NCT02441062|76240093|FG000|NOT COMPLETED|Overall Study||0||
60119047|NCT02442700|76240099|FG000|STARTED|First 12 Weeks||12||
60119048|NCT02442700|76240100|FG001|STARTED|First 12 Weeks||12||
60119049|NCT02442700|76240099|FG000|COMPLETED|First 12 Weeks||12||
60119050|NCT02442700|76240100|FG001|COMPLETED|First 12 Weeks||12||
60119051|NCT02442700|76240099|FG000|NOT COMPLETED|First 12 Weeks||0||
60119052|NCT02442700|76240100|FG001|NOT COMPLETED|First 12 Weeks||0||
60119053|NCT02442700|76240099|FG000|STARTED|Later 12 Weeks||12||
60119054|NCT02442700|76240100|FG001|STARTED|Later 12 Weeks||12||
60119055|NCT02442700|76240099|FG000|COMPLETED|Later 12 Weeks||12||
59717799|NCT01124448|75836898|FG000|COMPLETED|Overall Study||23||
59717800|NCT01124448|75836899|FG001|COMPLETED|Overall Study||12||
60119056|NCT02442700|76240100|FG001|COMPLETED|Later 12 Weeks||12||
60119057|NCT02442700|76240099|FG000|NOT COMPLETED|Later 12 Weeks||0||
60119058|NCT02442700|76240100|FG001|NOT COMPLETED|Later 12 Weeks||0||
60119059|NCT02442856|76240106|FG000|STARTED|Overall Study||21||
60119060|NCT02442856|76240106|FG000|COMPLETED|Overall Study||21||
59717801|NCT01124448|75836898|FG000|NOT COMPLETED|Overall Study||2||
59717802|NCT01124448|75836899|FG001|NOT COMPLETED|Overall Study||3||
59717803|NCT01124292|75836908|FG000|STARTED|Overall Study||16||
59717804|NCT01124292|75836909|FG001|STARTED|Overall Study||24||
59717805|NCT01124292|75836910|FG002|STARTED|Overall Study||21||
59717806|NCT01124292|75836908|FG000|COMPLETED|Overall Study||14||
59717807|NCT01124292|75836909|FG001|COMPLETED|Overall Study||9||
59835283|NCT00331344|75959003|FG004|STARTED|Phase II||0||
59835284|NCT00331344|75959004|FG005|STARTED|Phase II||0||
59835285|NCT00331344|75959005|FG006|STARTED|Phase II||0||
59835286|NCT00331344|75959006|FG007|STARTED|Phase II|6 patients in Phase I Group VIa continued to the Phase II period.|6||
59835287|NCT00331344|75959007|FG008|STARTED|Phase II|Protocol enrollment (63) minus 11 ineligible prior to receiving treatment.|52||
60119061|NCT02442856|76240106|FG000|NOT COMPLETED|Overall Study||0||
60119062|NCT02443792|76240112|FG000|STARTED|Overall Study||50||
60119063|NCT02443792|76240113|FG001|STARTED|Overall Study||25||
60119064|NCT02443792|76240112|FG000|COMPLETED|Overall Study||43||
59835288|NCT00331344|75958999|FG000|COMPLETED|Phase II||0||
59835289|NCT00331344|75959000|FG001|COMPLETED|Phase II||0||
59835290|NCT00331344|75959001|FG002|COMPLETED|Phase II||0||
59835291|NCT00331344|75959002|FG003|COMPLETED|Phase II||0||
59835292|NCT00331344|75959003|FG004|COMPLETED|Phase II||0||
59835293|NCT00331344|75959004|FG005|COMPLETED|Phase II||0||
59835294|NCT00331344|75959005|FG006|COMPLETED|Phase II||0||
59835295|NCT00331344|75959006|FG007|COMPLETED|Phase II||6||
59835296|NCT00331344|75959007|FG008|COMPLETED|Phase II||48||
59835297|NCT00331344|75958999|FG000|NOT COMPLETED|Phase II||0||
59835298|NCT00331344|75959000|FG001|NOT COMPLETED|Phase II||0||
59835299|NCT00331344|75959001|FG002|NOT COMPLETED|Phase II||0||
59835300|NCT00331344|75959002|FG003|NOT COMPLETED|Phase II||0||
59835301|NCT00331344|75959003|FG004|NOT COMPLETED|Phase II||0||
59835302|NCT00331344|75959004|FG005|NOT COMPLETED|Phase II||0||
59835303|NCT00331344|75959005|FG006|NOT COMPLETED|Phase II||0||
59835304|NCT00331344|75959006|FG007|NOT COMPLETED|Phase II||0||
59835305|NCT00331344|75959007|FG008|NOT COMPLETED|Phase II||4||
59835306|NCT00321672|75959024|FG000|STARTED|Overall Study||165||
59835307|NCT00321672|75959025|FG001|STARTED|Overall Study|One randomized to 30 minutes received 60 minutes. Under 30 for efficacy and under 60 for safety.|89||
59835308|NCT00321672|75959026|FG002|STARTED|Overall Study||167||
59835309|NCT00321672|75959027|FG003|STARTED|Overall Study|One randomized to 30 minutes received 60 minutes. Under 30 for efficacy and under 60 for safety.|73||
59835310|NCT00321672|75959024|FG000|COMPLETED|Overall Study||153||
59835311|NCT00321672|75959025|FG001|COMPLETED|Overall Study||81||
59835312|NCT00321672|75959026|FG002|COMPLETED|Overall Study||156||
59835313|NCT00321672|75959027|FG003|COMPLETED|Overall Study||71||
59835314|NCT00321672|75959024|FG000|NOT COMPLETED|Overall Study||12||
59835315|NCT00321672|75959025|FG001|NOT COMPLETED|Overall Study||8||
59835316|NCT00321672|75959026|FG002|NOT COMPLETED|Overall Study||11||
59835317|NCT00321672|75959027|FG003|NOT COMPLETED|Overall Study||2||
59835318|NCT00321048|75959043|FG000|STARTED|Overall Study||28||
59835319|NCT00321048|75959044|FG001|STARTED|Overall Study||29||
59835320|NCT00321048|75959043|FG000|COMPLETED|Overall Study||22||
59835321|NCT00321048|75959044|FG001|COMPLETED|Overall Study||21||
59835322|NCT00321048|75959043|FG000|NOT COMPLETED|Overall Study||6||
59835323|NCT00321048|75959044|FG001|NOT COMPLETED|Overall Study||8||
59835324|NCT00330174|75959052|FG000|STARTED|Overall Study||45||
59835325|NCT00330174|75959053|FG001|STARTED|Overall Study||45||
59835326|NCT00330174|75959052|FG000|COMPLETED|Overall Study||23||
59835327|NCT00330174|75959053|FG001|COMPLETED|Overall Study||26||
59835328|NCT00330174|75959052|FG000|NOT COMPLETED|Overall Study||22||
59835329|NCT00330174|75959053|FG001|NOT COMPLETED|Overall Study||19||
59835330|NCT00320424|75959059|FG000|STARTED|Overall Study||48||
59835331|NCT00320424|75959059|FG000|COMPLETED|Overall Study||42||
59835332|NCT00320424|75959059|FG000|NOT COMPLETED|Overall Study||6||
59835333|NCT00338286|75959065|FG000|STARTED|Overall Study||1048||
59835334|NCT00338286|75959066|FG001|STARTED|Overall Study||1050||
59835335|NCT00338286|75959065|FG000|COMPLETED|Overall Study||815||
59835336|NCT00338286|75959066|FG001|COMPLETED|Overall Study||837||
59835337|NCT00338286|75959065|FG000|NOT COMPLETED|Overall Study||233||
59835338|NCT00338286|75959066|FG001|NOT COMPLETED|Overall Study||213||
59835339|NCT00329784|75959076|FG000|STARTED|Overall Study||270||
59835340|NCT00329784|75959077|FG001|STARTED|Overall Study||272||
59835341|NCT00329784|75959078|FG002|STARTED|Overall Study||51||
59835342|NCT00329784|75959079|FG003|STARTED|Overall Study||47||
59835343|NCT00329784|75959076|FG000|COMPLETED|Overall Study||265||
59835344|NCT00329784|75959077|FG001|COMPLETED|Overall Study||267||
59835345|NCT00329784|75959078|FG002|COMPLETED|Overall Study||51||
59835346|NCT00329784|75959079|FG003|COMPLETED|Overall Study||47||
59835347|NCT00329784|75959076|FG000|NOT COMPLETED|Overall Study||5||
59835348|NCT00329784|75959077|FG001|NOT COMPLETED|Overall Study||5||
59835349|NCT00329784|75959078|FG002|NOT COMPLETED|Overall Study||0||
59835350|NCT00329784|75959079|FG003|NOT COMPLETED|Overall Study||0||
59835351|NCT00337818|75959094|FG000|STARTED|Overall Study||458||
59835352|NCT00337818|75959095|FG001|STARTED|Overall Study||154||
59835353|NCT00337818|75959096|FG002|STARTED|Overall Study||158||
59835354|NCT00337818|75959094|FG000|COMPLETED|Overall Study||169||
59835355|NCT00337818|75959095|FG001|COMPLETED|Overall Study||63||
60119065|NCT02443792|76240113|FG001|COMPLETED|Overall Study||23||
60119066|NCT02443792|76240112|FG000|NOT COMPLETED|Overall Study||7||
60119067|NCT02443792|76240113|FG001|NOT COMPLETED|Overall Study||2||
59835356|NCT00337818|75959096|FG002|COMPLETED|Overall Study||51||
59835357|NCT00337818|75959094|FG000|NOT COMPLETED|Overall Study||289||
59835358|NCT00337818|75959095|FG001|NOT COMPLETED|Overall Study||91||
59835359|NCT00337818|75959096|FG002|NOT COMPLETED|Overall Study||107||
59835360|NCT00329550|75959107|FG000|STARTED|Overall Study||9||
59835361|NCT00329550|75959108|FG001|STARTED|Overall Study||15||
59835362|NCT00329550|75959109|FG002|STARTED|Overall Study|1 subject in Safety Set is not in Full Analysis Set due to Good Clinical Practice non-compliance.|16||
59835363|NCT00329550|75959107|FG000|COMPLETED|Overall Study||5||
59835364|NCT00329550|75959108|FG001|COMPLETED|Overall Study||11||
59835365|NCT00329550|75959109|FG002|COMPLETED|Overall Study||12||
59835366|NCT00329550|75959107|FG000|NOT COMPLETED|Overall Study||4||
59835367|NCT00329550|75959108|FG001|NOT COMPLETED|Overall Study||4||
60119068|NCT02445196|76240121|FG000|STARTED|Overall Study||62||
60119069|NCT02445196|76240122|FG001|STARTED|Overall Study||58||
60119070|NCT02445196|76240121|FG000|COMPLETED|Overall Study||51||
60119071|NCT02445196|76240122|FG001|COMPLETED|Overall Study||52||
60119072|NCT02445196|76240121|FG000|NOT COMPLETED|Overall Study||11||
60119073|NCT02445196|76240122|FG001|NOT COMPLETED|Overall Study||6||
60119074|NCT02447926|76240128|FG000|STARTED|Overall Study||1||
60119075|NCT02447926|76240128|FG000|COMPLETED|Overall Study||1||
60119076|NCT02447926|76240128|FG000|NOT COMPLETED|Overall Study||0||
60119077|NCT02448862|76240134|FG000|STARTED|Overall Study||4525||
60119078|NCT02448862|76240135|FG001|STARTED|Overall Study||6050||
60119079|NCT02448862|76240134|FG000|COMPLETED|Overall Study||4525||
60119080|NCT02448862|76240135|FG001|COMPLETED|Overall Study||6050||
60119081|NCT02448862|76240134|FG000|NOT COMPLETED|Overall Study||0||
60119082|NCT02448862|76240135|FG001|NOT COMPLETED|Overall Study||0||
60119083|NCT01697267|76240143|FG000|STARTED|Overall Study||85||
60119084|NCT01697267|76240144|FG001|STARTED|Overall Study||85||
60119085|NCT01697267|76240143|FG000|Month 24|Overall Study||78||
60119086|NCT01697267|76240144|FG001|Month 24|Overall Study||78||
60119087|NCT01697267|76240143|FG000|COMPLETED|Overall Study||71||
60119088|NCT01697267|76240144|FG001|COMPLETED|Overall Study||70||
60119089|NCT01697267|76240143|FG000|NOT COMPLETED|Overall Study||14||
60119090|NCT01697267|76240144|FG001|NOT COMPLETED|Overall Study||15||
60119091|NCT02449174|76240152|FG000|STARTED|Overall Study||36||
60119092|NCT02449174|76240153|FG001|STARTED|Overall Study||32||
60119093|NCT02449174|76240152|FG000|COMPLETED|Overall Study||36||
60119094|NCT02449174|76240153|FG001|COMPLETED|Overall Study||32||
60119095|NCT02449174|76240152|FG000|NOT COMPLETED|Overall Study||0||
60119096|NCT02449174|76240153|FG001|NOT COMPLETED|Overall Study||0||
60119097|NCT02449798|76240159|FG000|STARTED|Overall Study||120||
60119098|NCT02449798|76240159|FG000|COMPLETED|Overall Study||120||
60119099|NCT02449798|76240159|FG000|NOT COMPLETED|Overall Study||0||
60119100|NCT02451202|76240165|FG000|STARTED|Overall Study||51||
60119101|NCT02451202|76240166|FG001|STARTED|Overall Study||51||
60119102|NCT02451202|76240165|FG000|COMPLETED|Overall Study||49||
60119103|NCT02451202|76240166|FG001|COMPLETED|Overall Study||48||
60119104|NCT02451202|76240165|FG000|NOT COMPLETED|Overall Study||2||
60119105|NCT02451202|76240166|FG001|NOT COMPLETED|Overall Study||3||
60119106|NCT02451514|76240177|FG000|STARTED|Overall Study||33||
60119107|NCT02451514|76240178|FG001|STARTED|Overall Study||46||
60119108|NCT02451514|76240179|FG002|STARTED|Overall Study||50||
59717808|NCT01124292|75836910|FG002|COMPLETED|Overall Study||11||
59717809|NCT01124292|75836908|FG000|NOT COMPLETED|Overall Study||2||
59717810|NCT01124292|75836909|FG001|NOT COMPLETED|Overall Study||15||
59717811|NCT01124292|75836910|FG002|NOT COMPLETED|Overall Study||10||
59717812|NCT01136772|75836923|FG000|STARTED|Overall Study||157||
59717813|NCT01136772|75836924|FG001|STARTED|Overall Study||154||
59717814|NCT01136772|75836923|FG000|Safety Population|Overall Study|Includes all randomized participants who received at least one dose of the injectable medication|147||
59717815|NCT01136772|75836924|FG001|Safety Population|Overall Study|Includes all randomized participants who received at least one dose of the injectable medication|147||
59717816|NCT01136772|75836923|FG000|COMPLETED|Overall Study||41||
59717817|NCT01136772|75836924|FG001|COMPLETED|Overall Study||44||
59717818|NCT01136772|75836923|FG000|NOT COMPLETED|Overall Study||116||
59835368|NCT00329550|75959109|FG002|NOT COMPLETED|Overall Study||4||
59835369|NCT00375674|75959121|FG000|STARTED|Overall Study||309||
59835370|NCT00375674|75959122|FG001|STARTED|Overall Study||306||
59835371|NCT00375674|75959121|FG000|Intent-to-Treat Population|Overall Study||309|All randomized participants, who received study drug/a different drug to which they were randomized|
59835372|NCT00375674|75959122|FG001|Intent-to-Treat Population|Overall Study||306|All randomized participants, who received study drug/a different drug to which they were randomized|
59835373|NCT00375674|75959121|FG000|As-Treated Population|Overall Study|3 were randomized but not treated: 2 refused treatment & 1 withdrew before receiving study drug|306|All participants, who received at least 1 dose of study drug according to actual study treatment|
59835374|NCT00375674|75959122|FG001|As-Treated Population|Overall Study|2 were randomized but not treated: 1 was screening failure & 1 discontinued due to new liver lesions|304|All participants, who received at least 1 dose of study drug according to actual study treatment|
59835375|NCT00375674|75959121|FG000|COMPLETED|Overall Study||165||
59835376|NCT00375674|75959122|FG001|COMPLETED|Overall Study||165||
59835377|NCT00375674|75959121|FG000|NOT COMPLETED|Overall Study||144||
59835378|NCT00375674|75959122|FG001|NOT COMPLETED|Overall Study||141||
60119109|NCT02451514|76240177|FG000|COMPLETED|Overall Study||33||
60119110|NCT02451514|76240178|FG001|COMPLETED|Overall Study||46||
60119111|NCT02451514|76240179|FG002|COMPLETED|Overall Study||50||
60119112|NCT02451514|76240177|FG000|NOT COMPLETED|Overall Study||0||
60119113|NCT02451514|76240178|FG001|NOT COMPLETED|Overall Study||0||
60119114|NCT02451514|76240179|FG002|NOT COMPLETED|Overall Study||0||
60119115|NCT02452060|76240197|FG000|STARTED|Overall Study||46||
60119116|NCT02452060|76240198|FG001|STARTED|Overall Study||44||
60119117|NCT02452060|76240197|FG000|COMPLETED|Overall Study||46||
60119118|NCT02452060|76240198|FG001|COMPLETED|Overall Study||44||
59835379|NCT00350402|75959130|FG000|STARTED|Overall Study||21||
59835380|NCT00350402|75959131|FG001|STARTED|Overall Study||21||
59835381|NCT00350402|75959130|FG000|COMPLETED|Overall Study||20||
59835382|NCT00350402|75959131|FG001|COMPLETED|Overall Study||20||
59835383|NCT00350402|75959130|FG000|NOT COMPLETED|Overall Study||1||
59835384|NCT00350402|75959131|FG001|NOT COMPLETED|Overall Study||1||
59835385|NCT00320190|75959145|FG000|STARTED|First 12 Months||19||
59835386|NCT00320190|75959146|FG001|STARTED|First 12 Months||13||
59835387|NCT00320190|75959145|FG000|COMPLETED|First 12 Months||11||
59835388|NCT00320190|75959146|FG001|COMPLETED|First 12 Months||3||
59835389|NCT00320190|75959145|FG000|NOT COMPLETED|First 12 Months||8||
59835390|NCT00320190|75959146|FG001|NOT COMPLETED|First 12 Months||10||
59835391|NCT00320190|75959145|FG000|STARTED|Long-term (12-month) Extension||11||
59835392|NCT00320190|75959146|FG001|STARTED|Long-term (12-month) Extension||3||
59835393|NCT00320190|75959145|FG000|COMPLETED|Long-term (12-month) Extension||2||
59835394|NCT00320190|75959146|FG001|COMPLETED|Long-term (12-month) Extension||1||
59835395|NCT00320190|75959145|FG000|NOT COMPLETED|Long-term (12-month) Extension||9||
59835396|NCT00320190|75959146|FG001|NOT COMPLETED|Long-term (12-month) Extension||2||
59835397|NCT00320112|75959154|FG000|STARTED|Overall Study||125||
59835398|NCT00320112|75959155|FG001|STARTED|Overall Study||119||
59835399|NCT00320112|75959154|FG000|COMPLETED|Overall Study||117||
59835400|NCT00320112|75959155|FG001|COMPLETED|Overall Study||114||
59835401|NCT00320112|75959154|FG000|NOT COMPLETED|Overall Study||8||
59835402|NCT00320112|75959155|FG001|NOT COMPLETED|Overall Study||5||
59835403|NCT00319956|75959169|FG000|STARTED|Overall Study||111||
59835404|NCT00319956|75959170|FG001|STARTED|Overall Study||109||
59835405|NCT00319956|75959169|FG000|COMPLETED|Overall Study||91||
59835406|NCT00319956|75959170|FG001|COMPLETED|Overall Study||85||
59835407|NCT00319956|75959169|FG000|NOT COMPLETED|Overall Study||20||
59835408|NCT00319956|75959170|FG001|NOT COMPLETED|Overall Study||24||
59835409|NCT00349622|75959178|FG000|STARTED|Overall Study||340||
59835410|NCT00349622|75959179|FG001|STARTED|Overall Study||173||
59835411|NCT00349622|75959178|FG000|COMPLETED|Overall Study||162||
59835412|NCT00349622|75959179|FG001|COMPLETED|Overall Study||77||
59835413|NCT00349622|75959178|FG000|NOT COMPLETED|Overall Study||178||
59835414|NCT00349622|75959179|FG001|NOT COMPLETED|Overall Study||96||
59835415|NCT00354614|75959185|FG000|STARTED|Overall Study||81||
59835416|NCT00354614|75959185|FG000|COMPLETED|Overall Study||53||
59835417|NCT00354614|75959185|FG000|NOT COMPLETED|Overall Study||28||
59835418|NCT00360308|75959192|FG000|STARTED|Overall Study||247||
59835419|NCT00360308|75959193|FG001|STARTED|Overall Study||234||
59835420|NCT00360308|75959194|FG002|STARTED|Overall Study||242||
59835421|NCT00360308|75959192|FG000|COMPLETED|Overall Study||171||
59835422|NCT00360308|75959193|FG001|COMPLETED|Overall Study||155||
59835423|NCT00360308|75959194|FG002|COMPLETED|Overall Study||154||
59835424|NCT00360308|75959192|FG000|NOT COMPLETED|Overall Study||76||
59835425|NCT00360308|75959193|FG001|NOT COMPLETED|Overall Study||79||
59835426|NCT00360308|75959194|FG002|NOT COMPLETED|Overall Study||88||
59835427|NCT00348686|75959206|FG000|STARTED|Overall Study||315||
59835428|NCT00348686|75959206|FG000|COMPLETED|Overall Study||249||
59835429|NCT00348686|75959206|FG000|NOT COMPLETED|Overall Study||66||
59835430|NCT00360230|75959217|FG000|STARTED|Overall Study||90||
59835431|NCT00360230|75959218|FG001|STARTED|Overall Study||90||
59835432|NCT00360230|75959219|FG002|STARTED|Overall Study||45||
59835433|NCT00360230|75959220|FG003|STARTED|Overall Study||90||
59835434|NCT00360230|75959221|FG004|STARTED|Overall Study||90||
59835435|NCT00360230|75959222|FG005|STARTED|Overall Study||90||
59835436|NCT00360230|75959223|FG006|STARTED|Overall Study||45||
59835437|NCT00360230|75959217|FG000|COMPLETED|Overall Study||84||
59835438|NCT00360230|75959218|FG001|COMPLETED|Overall Study||87||
59835439|NCT00360230|75959219|FG002|COMPLETED|Overall Study||42||
59835440|NCT00360230|75959220|FG003|COMPLETED|Overall Study||88||
59835441|NCT00360230|75959221|FG004|COMPLETED|Overall Study||85||
59835442|NCT00360230|75959222|FG005|COMPLETED|Overall Study||86||
59835443|NCT00360230|75959223|FG006|COMPLETED|Overall Study||43||
59835444|NCT00360230|75959217|FG000|NOT COMPLETED|Overall Study||6||
59835445|NCT00360230|75959218|FG001|NOT COMPLETED|Overall Study||3||
59835446|NCT00360230|75959219|FG002|NOT COMPLETED|Overall Study||3||
59835447|NCT00360230|75959220|FG003|NOT COMPLETED|Overall Study||2||
59835448|NCT00360230|75959221|FG004|NOT COMPLETED|Overall Study||5||
59835449|NCT00360230|75959222|FG005|NOT COMPLETED|Overall Study||4||
59835450|NCT00360230|75959223|FG006|NOT COMPLETED|Overall Study||2||
59835451|NCT00348374|75959243|FG000|STARTED|Overall Study||88||
59835452|NCT00348374|75959244|FG001|STARTED|Overall Study||103||
60119119|NCT02452060|76240197|FG000|NOT COMPLETED|Overall Study||0||
59835453|NCT00348374|75959243|FG000|Received Study Treatment|Overall Study||88||
59835454|NCT00348374|75959244|FG001|Received Study Treatment|Overall Study||96||
59835455|NCT00348374|75959243|FG000|COMPLETED|Overall Study||69||
59835456|NCT00348374|75959244|FG001|COMPLETED|Overall Study||71||
59835457|NCT00348374|75959243|FG000|NOT COMPLETED|Overall Study||19||
59835458|NCT00348374|75959244|FG001|NOT COMPLETED|Overall Study||32||
59835459|NCT00353366|75959251|FG000|STARTED|Overall Study||1439||
59835460|NCT00353366|75959251|FG000|COMPLETED|Overall Study||1296||
59835461|NCT00353366|75959251|FG000|NOT COMPLETED|Overall Study||143||
59835462|NCT00352664|75959257|FG000|STARTED|Overall Study||27||
59835463|NCT00352664|75959258|FG001|STARTED|Overall Study||0||
59835464|NCT00352664|75959257|FG000|COMPLETED|Overall Study||20||
59835465|NCT00352664|75959258|FG001|COMPLETED|Overall Study||0||
59835466|NCT00352664|75959257|FG000|NOT COMPLETED|Overall Study||7||
59835467|NCT00352664|75959258|FG001|NOT COMPLETED|Overall Study||0||
59835468|NCT00490139|75959268|FG000|STARTED|Overall Study||2093||
59835469|NCT00490139|75959269|FG001|STARTED|Overall Study||2091||
59835470|NCT00490139|75959270|FG002|STARTED|Overall Study||2100||
59835471|NCT00490139|75959271|FG003|STARTED|Overall Study||2097||
59835472|NCT00490139|75959268|FG000|COMPLETED|Overall Study||1785||
59835473|NCT00490139|75959269|FG001|COMPLETED|Overall Study||1816||
59835474|NCT00490139|75959270|FG002|COMPLETED|Overall Study||1666||
59835475|NCT00490139|75959271|FG003|COMPLETED|Overall Study||1790||
59835476|NCT00490139|75959268|FG000|NOT COMPLETED|Overall Study||308||
59835477|NCT00490139|75959269|FG001|NOT COMPLETED|Overall Study||275||
59835478|NCT00490139|75959270|FG002|NOT COMPLETED|Overall Study||434||
59835479|NCT00490139|75959271|FG003|NOT COMPLETED|Overall Study||307||
59835480|NCT00348140|75959286|FG000|STARTED|Overall Study||487||
59835481|NCT00348140|75959287|FG001|STARTED|Overall Study||490||
59835482|NCT00348140|75959288|FG002|STARTED|Overall Study||491||
59835483|NCT00348140|75959286|FG000|COMPLETED|Overall Study||361||
59835484|NCT00348140|75959287|FG001|COMPLETED|Overall Study||351||
59835485|NCT00348140|75959288|FG002|COMPLETED|Overall Study||328||
59835486|NCT00348140|75959286|FG000|NOT COMPLETED|Overall Study||126||
59835487|NCT00348140|75959287|FG001|NOT COMPLETED|Overall Study||139||
59835488|NCT00348140|75959288|FG002|NOT COMPLETED|Overall Study||163||
59835489|NCT00490061|75959297|FG000|STARTED|Overall Study||17||
59835490|NCT00490061|75959297|FG000|COMPLETED|Overall Study||16||
59835491|NCT00490061|75959297|FG000|NOT COMPLETED|Overall Study||1||
59835492|NCT00483119|75959303|FG000|STARTED|Overall Study||5||
59835493|NCT00483119|75959304|FG001|STARTED|Overall Study||4||
59835494|NCT00483119|75959303|FG000|COMPLETED|Overall Study||4||
59835495|NCT00483119|75959304|FG001|COMPLETED|Overall Study||3||
59835496|NCT00483119|75959303|FG000|NOT COMPLETED|Overall Study||1||
59835497|NCT00483119|75959304|FG001|NOT COMPLETED|Overall Study||1||
59835498|NCT00483041|75959312|FG000|STARTED|Overall Study||5||
59835499|NCT00483041|75959313|FG001|STARTED|Overall Study||6||
59835500|NCT00483041|75959312|FG000|COMPLETED|Overall Study||5||
59835501|NCT00483041|75959313|FG001|COMPLETED|Overall Study||5||
59835502|NCT00483041|75959312|FG000|NOT COMPLETED|Overall Study||0||
59835503|NCT00483041|75959313|FG001|NOT COMPLETED|Overall Study||1||
59835504|NCT00501293|75959321|FG000|STARTED|Optimization Period||110||
59835505|NCT00501293|75959322|FG001|STARTED|Optimization Period||53||
59835506|NCT00501293|75959321|FG000|COMPLETED|Optimization Period||109||
59835507|NCT00501293|75959322|FG001|COMPLETED|Optimization Period||53||
59835508|NCT00501293|75959321|FG000|NOT COMPLETED|Optimization Period||1||
59835509|NCT00501293|75959322|FG001|NOT COMPLETED|Optimization Period||0||
59835510|NCT00501293|75959321|FG000|STARTED|Maintenance Period||109||
59835511|NCT00501293|75959322|FG001|STARTED|Maintenance Period||53||
59835512|NCT00501293|75959321|FG000|COMPLETED|Maintenance Period||63||
59835513|NCT00501293|75959322|FG001|COMPLETED|Maintenance Period||25||
59835514|NCT00501293|75959321|FG000|NOT COMPLETED|Maintenance Period||46||
59835515|NCT00501293|75959322|FG001|NOT COMPLETED|Maintenance Period||28||
59835516|NCT00482729|75959331|FG000|STARTED|Overall Study|Site 079011301 was identified as non-compliant and 1 patient was excluded from all analysis|626||
59835517|NCT00482729|75959332|FG001|STARTED|Overall Study|Site 079011301 was identified as non-compliant and 3 patients were excluded from all analysis|624||
59835518|NCT00482729|75959331|FG000|Completed Phase A|Overall Study||484||
59835519|NCT00482729|75959332|FG001|Completed Phase A|Overall Study||482||
59835520|NCT00482729|75959331|FG000|Completed Phase B|Overall Study||409||
59835521|NCT00482729|75959332|FG001|Completed Phase B|Overall Study||406||
59835522|NCT00482729|75959331|FG000|COMPLETED|Overall Study||409||
59835523|NCT00482729|75959332|FG001|COMPLETED|Overall Study||406||
59835524|NCT00482729|75959331|FG000|NOT COMPLETED|Overall Study||217||
59835525|NCT00482729|75959332|FG001|NOT COMPLETED|Overall Study||218||
60119120|NCT02452060|76240198|FG001|NOT COMPLETED|Overall Study||0||
60119121|NCT01696955|76240206|FG000|STARTED|Main Study||42||
60119122|NCT01696955|76240207|FG001|STARTED|Main Study||39||
59835526|NCT00359762|75959340|FG000|STARTED|Period II||514||
59835527|NCT00359762|75959341|FG001|STARTED|Period II||0||
59835528|NCT00359762|75959342|FG002|STARTED|Period II||0||
59835529|NCT00359762|75959343|FG003|STARTED|Period II||0||
59835530|NCT00359762|75959344|FG004|STARTED|Period II||515||
59835531|NCT00359762|75959340|FG000|Intent to Treat (ITT) Safety Population|Period II||508||
59835532|NCT00359762|75959341|FG001|Intent to Treat (ITT) Safety Population|Period II||0||
59835533|NCT00359762|75959342|FG002|Intent to Treat (ITT) Safety Population|Period II||0||
59835534|NCT00359762|75959343|FG003|Intent to Treat (ITT) Safety Population|Period II||0||
59835535|NCT00359762|75959344|FG004|Intent to Treat (ITT) Safety Population|Period II||511||
59835536|NCT00359762|75959340|FG000|ITT Efficacy Population|Period II||487||
59835537|NCT00359762|75959341|FG001|ITT Efficacy Population|Period II||0||
59835538|NCT00359762|75959342|FG002|ITT Efficacy Population|Period II||0||
59835539|NCT00359762|75959343|FG003|ITT Efficacy Population|Period II||0||
60119123|NCT01696955|76240206|FG000|COMPLETED|Main Study||40||
59835540|NCT00359762|75959344|FG004|ITT Efficacy Population|Period II||490||
59835541|NCT00359762|75959340|FG000|Met Primary Endpoint|Period II||262||
59835542|NCT00359762|75959341|FG001|Met Primary Endpoint|Period II||0||
59835543|NCT00359762|75959342|FG002|Met Primary Endpoint|Period II||0||
59835544|NCT00359762|75959343|FG003|Met Primary Endpoint|Period II||0||
59835545|NCT00359762|75959344|FG004|Met Primary Endpoint|Period II||203||
59835546|NCT00359762|75959340|FG000|Without Treatment Failure|Period II||124||
59835547|NCT00359762|75959341|FG001|Without Treatment Failure|Period II||0||
59835548|NCT00359762|75959342|FG002|Without Treatment Failure|Period II||0||
59835549|NCT00359762|75959343|FG003|Without Treatment Failure|Period II||0||
59835550|NCT00359762|75959344|FG004|Without Treatment Failure|Period II||138||
59835551|NCT00359762|75959340|FG000|COMPLETED|Period II||386||
59835552|NCT00359762|75959341|FG001|COMPLETED|Period II||0||
59835553|NCT00359762|75959342|FG002|COMPLETED|Period II||0||
59835554|NCT00359762|75959343|FG003|COMPLETED|Period II||0||
59835555|NCT00359762|75959344|FG004|COMPLETED|Period II||341||
59835556|NCT00359762|75959340|FG000|NOT COMPLETED|Period II||128||
59835557|NCT00359762|75959341|FG001|NOT COMPLETED|Period II||0||
59835558|NCT00359762|75959342|FG002|NOT COMPLETED|Period II||0||
59835559|NCT00359762|75959343|FG003|NOT COMPLETED|Period II||0||
59835560|NCT00359762|75959344|FG004|NOT COMPLETED|Period II||174||
59835561|NCT00359762|75959340|FG000|STARTED|Period III||0||
59835562|NCT00359762|75959341|FG001|STARTED|Period III||77||
59835563|NCT00359762|75959342|FG002|STARTED|Period III||77||
59835564|NCT00359762|75959343|FG003|STARTED|Period III||166||
59835565|NCT00359762|75959344|FG004|STARTED|Period III||0||
59835566|NCT00359762|75959340|FG000|Extension ITT Safety Population|Period III||0||
59835567|NCT00359762|75959341|FG001|Extension ITT Safety Population|Period III||74||
59835568|NCT00359762|75959342|FG002|Extension ITT Safety Population|Period III||76||
59835569|NCT00359762|75959343|FG003|Extension ITT Safety Population|Period III||166||
59835570|NCT00359762|75959344|FG004|Extension ITT Safety Population|Period III||0||
59835571|NCT00359762|75959340|FG000|Extension ITT Efficacy Population|Period III||0||
59835572|NCT00359762|75959341|FG001|Extension ITT Efficacy Population|Period III||73||
59835573|NCT00359762|75959342|FG002|Extension ITT Efficacy Population|Period III||75||
59835574|NCT00359762|75959343|FG003|Extension ITT Efficacy Population|Period III||164||
59835575|NCT00359762|75959344|FG004|Extension ITT Efficacy Population|Period III||0||
59835576|NCT00359762|75959340|FG000|COMPLETED|Period III||0||
59835577|NCT00359762|75959341|FG001|COMPLETED|Period III||48||
59835578|NCT00359762|75959342|FG002|COMPLETED|Period III||47||
59835579|NCT00359762|75959343|FG003|COMPLETED|Period III||101||
59835580|NCT00359762|75959344|FG004|COMPLETED|Period III||0||
59835581|NCT00359762|75959340|FG000|NOT COMPLETED|Period III||0||
59835582|NCT00359762|75959341|FG001|NOT COMPLETED|Period III||29||
59835583|NCT00359762|75959342|FG002|NOT COMPLETED|Period III||30||
59835584|NCT00359762|75959343|FG003|NOT COMPLETED|Period III||65||
59835585|NCT00359762|75959344|FG004|NOT COMPLETED|Period III||0||
59835586|NCT00359762|75959340|FG000|STARTED|Period I||0||
59835587|NCT00359762|75959341|FG001|STARTED|Period I||0||
59835588|NCT00359762|75959342|FG002|STARTED|Period I||0||
59835589|NCT00359762|75959343|FG003|STARTED|Period I||0||
59835590|NCT00359762|75959344|FG004|STARTED|Period I||0||
59835591|NCT00359762|75959340|FG000|COMPLETED|Period I||0||
59835592|NCT00359762|75959341|FG001|COMPLETED|Period I||0||
59835593|NCT00359762|75959342|FG002|COMPLETED|Period I||0||
59835594|NCT00359762|75959343|FG003|COMPLETED|Period I||0||
59835595|NCT00359762|75959344|FG004|COMPLETED|Period I||0||
59835596|NCT00359762|75959340|FG000|NOT COMPLETED|Period I||0||
59835597|NCT00359762|75959341|FG001|NOT COMPLETED|Period I||0||
59835598|NCT00359762|75959342|FG002|NOT COMPLETED|Period I||0||
59835599|NCT00359762|75959343|FG003|NOT COMPLETED|Period I||0||
59835600|NCT00359762|75959344|FG004|NOT COMPLETED|Period I||0||
59835601|NCT00347438|75959358|FG000|STARTED|Overall Study||18||
59835602|NCT00347438|75959358|FG000|COMPLETED|Overall Study||16||
59835603|NCT00347438|75959358|FG000|NOT COMPLETED|Overall Study||2||
59835604|NCT00329238|75959364|FG000|STARTED|Overall Study|2866 were randomized. A total of ten did not receive treatment resulting in 2856 starting study.|1430||
59835605|NCT00329238|75959365|FG001|STARTED|Overall Study|2866 were randomized. A total of ten did not receive treatment resulting in 2856 starting study.|1426||
59835606|NCT00329238|75959364|FG000|COMPLETED|Overall Study||1154||
59835607|NCT00329238|75959365|FG001|COMPLETED|Overall Study||1145||
59835608|NCT00329238|75959364|FG000|NOT COMPLETED|Overall Study||276||
59835609|NCT00329238|75959365|FG001|NOT COMPLETED|Overall Study||281||
59835610|NCT00329160|75959373|FG000|STARTED|Overall Study||214||
59835611|NCT00329160|75959373|FG000|Observation Period|Overall Study||214||
59835612|NCT00329160|75959373|FG000|Treatment Period|Overall Study||214||
59835613|NCT00329160|75959373|FG000|COMPLETED|Overall Study||126||
59835614|NCT00329160|75959373|FG000|NOT COMPLETED|Overall Study||88||
59835615|NCT00328926|75959380|FG000|STARTED|Overall Study||5||
59835616|NCT00328926|75959381|FG001|STARTED|Overall Study||3||
59835617|NCT00328926|75959382|FG002|STARTED|Overall Study||3||
59835618|NCT00328926|75959380|FG000|COMPLETED|Overall Study||3||
59835619|NCT00328926|75959381|FG001|COMPLETED|Overall Study||0||
59835620|NCT00328926|75959382|FG002|COMPLETED|Overall Study||1||
59835621|NCT00328926|75959380|FG000|NOT COMPLETED|Overall Study||2||
59835622|NCT00328926|75959381|FG001|NOT COMPLETED|Overall Study||3||
59835623|NCT00328926|75959382|FG002|NOT COMPLETED|Overall Study||2||
59835624|NCT00319254|75959390|FG000|STARTED|Overall Study||75||
59835625|NCT00319254|75959390|FG000|Treated|Overall Study||73||
59835626|NCT00319254|75959390|FG000|COMPLETED|Overall Study||21||
59835627|NCT00319254|75959390|FG000|NOT COMPLETED|Overall Study||54||
59835628|NCT00319098|75959398|FG000|STARTED|Overall Study||3802||
59835629|NCT00319098|75959399|FG001|STARTED|Overall Study||1269||
59835630|NCT00319098|75959398|FG000|COMPLETED|Overall Study||3667||
59835631|NCT00319098|75959399|FG001|COMPLETED|Overall Study||1237||
59835632|NCT00319098|75959398|FG000|NOT COMPLETED|Overall Study||135||
59835633|NCT00319098|75959399|FG001|NOT COMPLETED|Overall Study||32||
59835634|NCT00347360|75959424|FG000|STARTED|Overall Study||44||
59835635|NCT00347360|75959425|FG001|STARTED|Overall Study||43||
59835636|NCT00347360|75959426|FG002|STARTED|Overall Study||43||
59835637|NCT00347360|75959427|FG003|STARTED|Overall Study||43||
59835638|NCT00347360|75959428|FG004|STARTED|Overall Study||44||
59835639|NCT00347360|75959429|FG005|STARTED|Overall Study||44||
59835640|NCT00347360|75959430|FG006|STARTED|Overall Study||44||
59835641|NCT00347360|75959431|FG007|STARTED|Overall Study||43||
59835642|NCT00347360|75959432|FG008|STARTED|Overall Study||44||
59835643|NCT00347360|75959433|FG009|STARTED|Overall Study||44||
59835644|NCT00347360|75959434|FG010|STARTED|Overall Study||44||
59835645|NCT00347360|75959435|FG011|STARTED|Overall Study||43||
59835646|NCT00347360|75959436|FG012|STARTED|Overall Study||44||
59835647|NCT00347360|75959437|FG013|STARTED|Overall Study||44||
59835648|NCT00347360|75959438|FG014|STARTED|Overall Study||43||
59835649|NCT00347360|75959424|FG000|COMPLETED|Overall Study||39||
59835650|NCT00347360|75959425|FG001|COMPLETED|Overall Study||35||
59835651|NCT00347360|75959426|FG002|COMPLETED|Overall Study||37||
59835652|NCT00347360|75959427|FG003|COMPLETED|Overall Study||30||
59835653|NCT00347360|75959428|FG004|COMPLETED|Overall Study||39||
59835654|NCT00347360|75959429|FG005|COMPLETED|Overall Study||36||
59835655|NCT00347360|75959430|FG006|COMPLETED|Overall Study||37||
59835656|NCT00347360|75959431|FG007|COMPLETED|Overall Study||40||
59835657|NCT00347360|75959432|FG008|COMPLETED|Overall Study||38||
59835658|NCT00347360|75959433|FG009|COMPLETED|Overall Study||35||
59835659|NCT00347360|75959434|FG010|COMPLETED|Overall Study||39||
59835660|NCT00347360|75959435|FG011|COMPLETED|Overall Study||37||
59835661|NCT00347360|75959436|FG012|COMPLETED|Overall Study||34||
59835662|NCT00347360|75959437|FG013|COMPLETED|Overall Study||36||
59835663|NCT00347360|75959438|FG014|COMPLETED|Overall Study||39||
59835664|NCT00347360|75959424|FG000|NOT COMPLETED|Overall Study||5||
59835665|NCT00347360|75959425|FG001|NOT COMPLETED|Overall Study||8||
59835666|NCT00347360|75959426|FG002|NOT COMPLETED|Overall Study||6||
59835667|NCT00347360|75959427|FG003|NOT COMPLETED|Overall Study||13||
59835668|NCT00347360|75959428|FG004|NOT COMPLETED|Overall Study||5||
59835669|NCT00347360|75959429|FG005|NOT COMPLETED|Overall Study||8||
59835670|NCT00347360|75959430|FG006|NOT COMPLETED|Overall Study||7||
60119124|NCT01696955|76240207|FG001|COMPLETED|Main Study||38||
59717819|NCT01136772|75836924|FG001|NOT COMPLETED|Overall Study||110||
59717820|NCT00909532|75836932|FG000|STARTED|Overall Study|All subjects who received at least 1 dose of study drug (placebo).|78||
59717821|NCT00909532|75836933|FG001|STARTED|Overall Study|All subjects who received at least 1 dose of study drug (ivacaftor).|83||
59717822|NCT00909532|75836932|FG000|Completed Treatment Period, Week 24|Overall Study||71||
59717823|NCT00909532|75836933|FG001|Completed Treatment Period, Week 24|Overall Study||80||
59717824|NCT00909532|75836932|FG000|COMPLETED|Overall Study|Completed Treatment and Extension Periods (Through Week 48)|68||
59717825|NCT00909532|75836933|FG001|COMPLETED|Overall Study|Completed Treatment and Extension Periods (Through Week 48)|77||
59717826|NCT00909532|75836932|FG000|NOT COMPLETED|Overall Study||10||
59717827|NCT00909532|75836933|FG001|NOT COMPLETED|Overall Study||6||
59717828|NCT01136382|75836942|FG000|STARTED|Overall Study||152||
59717829|NCT01136382|75836943|FG001|STARTED|Overall Study||152||
59835671|NCT00347360|75959431|FG007|NOT COMPLETED|Overall Study||3||
59835672|NCT00347360|75959432|FG008|NOT COMPLETED|Overall Study||6||
59835673|NCT00347360|75959433|FG009|NOT COMPLETED|Overall Study||9||
59835674|NCT00347360|75959434|FG010|NOT COMPLETED|Overall Study||5||
59835675|NCT00347360|75959435|FG011|NOT COMPLETED|Overall Study||6||
59835676|NCT00347360|75959436|FG012|NOT COMPLETED|Overall Study||10||
59835677|NCT00347360|75959437|FG013|NOT COMPLETED|Overall Study||8||
59835678|NCT00347360|75959438|FG014|NOT COMPLETED|Overall Study||4||
59835679|NCT00319020|75959472|FG000|STARTED|Overall Study||15||
59835680|NCT00319020|75959473|FG001|STARTED|Overall Study||21||
59835681|NCT00319020|75959472|FG000|Enrollment in FUTURE 2 (F-2)|Overall Study||13||
59835682|NCT00319020|75959473|FG001|Enrollment in FUTURE 2 (F-2)|Overall Study||20||
59835683|NCT00319020|75959472|FG000|COMPLETED|Overall Study||8||
59835684|NCT00319020|75959473|FG001|COMPLETED|Overall Study||8||
59835685|NCT00319020|75959472|FG000|NOT COMPLETED|Overall Study||7||
59835686|NCT00319020|75959473|FG001|NOT COMPLETED|Overall Study||13||
59835687|NCT00352118|75959481|FG000|STARTED|Overall Study||4||
59835688|NCT00352118|75959481|FG000|COMPLETED|Overall Study||0||
59835689|NCT00352118|75959481|FG000|NOT COMPLETED|Overall Study||4||
59717830|NCT01136382|75836942|FG000|COMPLETED|Overall Study||92||
59835690|NCT00318474|75959487|FG000|STARTED|Overall Study||25||
59835691|NCT00318474|75959488|FG001|STARTED|Overall Study||27||
59835692|NCT00318474|75959487|FG000|COMPLETED|Overall Study||7||
59835693|NCT00318474|75959488|FG001|COMPLETED|Overall Study||10||
59835694|NCT00318474|75959487|FG000|NOT COMPLETED|Overall Study||18||
59835695|NCT00318474|75959488|FG001|NOT COMPLETED|Overall Study||17||
59835696|NCT00350870|75959498|FG000|STARTED|Overall Study||27||
60119125|NCT01696955|76240206|FG000|NOT COMPLETED|Main Study||2||
60119126|NCT01696955|76240207|FG001|NOT COMPLETED|Main Study||1||
60119127|NCT01696955|76240206|FG000|STARTED|Failure on Cetuximab-Received Tivantinib||0||
59717831|NCT01136382|75836943|FG001|COMPLETED|Overall Study||121||
59717832|NCT01136382|75836942|FG000|NOT COMPLETED|Overall Study||60||
59717833|NCT01136382|75836943|FG001|NOT COMPLETED|Overall Study||31||
59717834|NCT00912028|75836952|FG000|STARTED|Overall Study||35||
59717835|NCT00912028|75836953|FG001|STARTED|Overall Study||3||
59717836|NCT00912028|75836954|FG002|STARTED|Overall Study||13||
59717837|NCT00912028|75836955|FG003|STARTED|Overall Study||17||
59717838|NCT00912028|75836956|FG004|STARTED|Overall Study||3||
59717839|NCT00912028|75836952|FG000|COMPLETED|Overall Study||30||
59717840|NCT00912028|75836953|FG001|COMPLETED|Overall Study||0||
59717841|NCT00912028|75836954|FG002|COMPLETED|Overall Study||13||
59717842|NCT00912028|75836955|FG003|COMPLETED|Overall Study||16||
59717843|NCT00912028|75836956|FG004|COMPLETED|Overall Study||0||
59717844|NCT00912028|75836952|FG000|NOT COMPLETED|Overall Study||5||
59717845|NCT00912028|75836953|FG001|NOT COMPLETED|Overall Study||3||
59717846|NCT00912028|75836954|FG002|NOT COMPLETED|Overall Study||0||
59717847|NCT00912028|75836955|FG003|NOT COMPLETED|Overall Study||1||
59717848|NCT00912028|75836956|FG004|NOT COMPLETED|Overall Study||3||
59717849|NCT02731729|75836968|FG000|STARTED|Overall Study||10||
59717850|NCT02731729|75836969|FG001|STARTED|Overall Study||10||
59717851|NCT02731729|75836968|FG000|COMPLETED|Overall Study||1||
59717852|NCT02731729|75836969|FG001|COMPLETED|Overall Study||2||
59717853|NCT02731729|75836968|FG000|NOT COMPLETED|Overall Study||9||
59717854|NCT02731729|75836969|FG001|NOT COMPLETED|Overall Study||8||
59717855|NCT01119066|75836979|FG000|STARTED|Overall Study||132||1
59717856|NCT01119066|75836980|FG001|STARTED|Overall Study||227||0
59717857|NCT01119066|75836981|FG002|STARTED|Overall Study||52||1
59717858|NCT01119066|75836982|FG003|STARTED|Overall Study||11||0
59717859|NCT01119066|75836979|FG000|COMPLETED|Overall Study||125||1
59717860|NCT01119066|75836980|FG001|COMPLETED|Overall Study||213||0
59717861|NCT01119066|75836981|FG002|COMPLETED|Overall Study||52||1
59717862|NCT01119066|75836982|FG003|COMPLETED|Overall Study||11||0
59717863|NCT01119066|75836979|FG000|NOT COMPLETED|Overall Study||7||0
59717864|NCT01119066|75836980|FG001|NOT COMPLETED|Overall Study||14||0
59717865|NCT01119066|75836981|FG002|NOT COMPLETED|Overall Study||0||0
59717866|NCT01119066|75836982|FG003|NOT COMPLETED|Overall Study||0||0
59717867|NCT00910624|75836996|FG000|STARTED|Treatment Phase||52||
59717868|NCT00910624|75836997|FG001|STARTED|Treatment Phase||85||
59717869|NCT00910624|75836998|FG002|STARTED|Treatment Phase||29||
59717870|NCT00910624|75836999|FG003|STARTED|Treatment Phase||2||
59717871|NCT00910624|75836996|FG000|COMPLETED|Treatment Phase||22||
59717872|NCT00910624|75836997|FG001|COMPLETED|Treatment Phase||64||
59717873|NCT00910624|75836998|FG002|COMPLETED|Treatment Phase||20||
59717874|NCT00910624|75836999|FG003|COMPLETED|Treatment Phase||2||
59717875|NCT00910624|75836996|FG000|NOT COMPLETED|Treatment Phase||30||
59717876|NCT00910624|75836997|FG001|NOT COMPLETED|Treatment Phase||21||
60119128|NCT01696955|76240207|FG001|STARTED|Failure on Cetuximab-Received Tivantinib||15||
60119129|NCT01696955|76240206|FG000|COMPLETED|Failure on Cetuximab-Received Tivantinib||0||
60119130|NCT01696955|76240207|FG001|COMPLETED|Failure on Cetuximab-Received Tivantinib|23 patients did not cross over|15||
60119131|NCT01696955|76240206|FG000|NOT COMPLETED|Failure on Cetuximab-Received Tivantinib||0||
60119132|NCT01696955|76240207|FG001|NOT COMPLETED|Failure on Cetuximab-Received Tivantinib||0||
60119133|NCT02452528|76240222|FG000|STARTED|Overall Study||2||
60119134|NCT02452528|76240223|FG001|STARTED|Overall Study||2||
60119135|NCT02452528|76240222|FG000|COMPLETED|Overall Study||1||
59717877|NCT00910624|75836998|FG002|NOT COMPLETED|Treatment Phase||9||
59717878|NCT00910624|75836999|FG003|NOT COMPLETED|Treatment Phase||0||
59717879|NCT00910624|75836996|FG000|STARTED|Follow-Up Phase||48||
59717880|NCT00910624|75836997|FG001|STARTED|Follow-Up Phase||80||
59717881|NCT00910624|75836998|FG002|STARTED|Follow-Up Phase||29||
59717882|NCT00910624|75836999|FG003|STARTED|Follow-Up Phase||2||
59835697|NCT00350870|75959499|FG001|STARTED|Overall Study||28||
59717883|NCT00910624|75836996|FG000|COMPLETED|Follow-Up Phase||42||
59717884|NCT00910624|75836997|FG001|COMPLETED|Follow-Up Phase||76||
59717885|NCT00910624|75836998|FG002|COMPLETED|Follow-Up Phase||25||
59717886|NCT00910624|75836999|FG003|COMPLETED|Follow-Up Phase||2||
59717887|NCT00910624|75836996|FG000|NOT COMPLETED|Follow-Up Phase||6||
59717888|NCT00910624|75836997|FG001|NOT COMPLETED|Follow-Up Phase||4||
59717889|NCT00910624|75836998|FG002|NOT COMPLETED|Follow-Up Phase||4||
59717890|NCT00910624|75836999|FG003|NOT COMPLETED|Follow-Up Phase||0||
59717891|NCT04066738|75837007|FG000|STARTED|Overall Study||2||
59835698|NCT00350870|75959500|FG002|STARTED|Overall Study||22||
59835699|NCT00350870|75959501|FG003|STARTED|Overall Study||22||
59717892|NCT04066738|75837007|FG000|COMPLETED|Overall Study||2||
60119136|NCT02452528|76240223|FG001|COMPLETED|Overall Study||1||
59835700|NCT00350870|75959498|FG000|Had at Least 1 Day of Med|Overall Study||19||
59835701|NCT00350870|75959499|FG001|Had at Least 1 Day of Med|Overall Study||24||
59835702|NCT00350870|75959500|FG002|Had at Least 1 Day of Med|Overall Study||18||
59835703|NCT00350870|75959501|FG003|Had at Least 1 Day of Med|Overall Study||19||
59835704|NCT00350870|75959498|FG000|COMPLETED|Overall Study||5||
59835705|NCT00350870|75959499|FG001|COMPLETED|Overall Study||11||
59835706|NCT00350870|75959500|FG002|COMPLETED|Overall Study||6||
59835707|NCT00350870|75959501|FG003|COMPLETED|Overall Study||7||
59835708|NCT00350870|75959498|FG000|NOT COMPLETED|Overall Study||22||
59835709|NCT00350870|75959499|FG001|NOT COMPLETED|Overall Study||17||
59835710|NCT00350870|75959500|FG002|NOT COMPLETED|Overall Study||16||
59835711|NCT00350870|75959501|FG003|NOT COMPLETED|Overall Study||15||
59835712|NCT00350792|75959511|FG000|STARTED|Overall Study||62||
59835713|NCT00350792|75959511|FG000|COMPLETED|Overall Study||29||
59835714|NCT00350792|75959511|FG000|NOT COMPLETED|Overall Study||33||
59835715|NCT00317772|75959519|FG000|STARTED|Overall Study||3||
59567532|NCT02326272|75670465|FG012|COMPLETED|Initial Period (Week 0 to Week 16)||0||
59567533|NCT02326272|75670466|FG013|COMPLETED|Initial Period (Week 0 to Week 16)||0||
59567534|NCT02326272|75670467|FG014|COMPLETED|Initial Period (Week 0 to Week 16)||0||
59567535|NCT02326272|75670453|FG000|NOT COMPLETED|Initial Period (Week 0 to Week 16)||4||
59567536|NCT02326272|75670454|FG001|NOT COMPLETED|Initial Period (Week 0 to Week 16)||7||
59567537|NCT02326272|75670455|FG002|NOT COMPLETED|Initial Period (Week 0 to Week 16)||6||
59567538|NCT02326272|75670456|FG003|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0||
59567539|NCT02326272|75670457|FG004|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0||
59567540|NCT02326272|75670458|FG005|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0||
59717893|NCT04066738|75837007|FG000|NOT COMPLETED|Overall Study||0||
59717894|NCT01123980|75837013|FG000|STARTED|Overall Study||261||
59717895|NCT01123980|75837014|FG001|STARTED|Overall Study||260||
59717896|NCT01123980|75837013|FG000|COMPLETED|Overall Study||242||
59717897|NCT01123980|75837014|FG001|COMPLETED|Overall Study||236||
59717898|NCT01123980|75837013|FG000|NOT COMPLETED|Overall Study||19||
59717899|NCT01123980|75837014|FG001|NOT COMPLETED|Overall Study||24||
59835716|NCT00317772|75959520|FG001|STARTED|Overall Study||3||
59835717|NCT00317772|75959521|FG002|STARTED|Overall Study||3||
59835718|NCT00317772|75959522|FG003|STARTED|Overall Study||10||
59835719|NCT00317772|75959519|FG000|COMPLETED|Overall Study||1||
59835720|NCT00317772|75959520|FG001|COMPLETED|Overall Study||1||
59835721|NCT00317772|75959521|FG002|COMPLETED|Overall Study||2||
59835722|NCT00317772|75959522|FG003|COMPLETED|Overall Study||1||
59835723|NCT00317772|75959519|FG000|NOT COMPLETED|Overall Study||2||
59835724|NCT00317772|75959520|FG001|NOT COMPLETED|Overall Study||2||
59835725|NCT00317772|75959521|FG002|NOT COMPLETED|Overall Study||1||
59835726|NCT00317772|75959522|FG003|NOT COMPLETED|Overall Study||9||
59835727|NCT00350636|75959535|FG000|STARTED|Overall Study||389||
59835728|NCT00350636|75959536|FG001|STARTED|Overall Study||400||
59835729|NCT00350636|75959535|FG000|COMPLETED|Overall Study||346||
59835730|NCT00350636|75959536|FG001|COMPLETED|Overall Study||355||
59835731|NCT00350636|75959535|FG000|NOT COMPLETED|Overall Study||43||
59835732|NCT00350636|75959536|FG001|NOT COMPLETED|Overall Study||45||
59835733|NCT00346268|75959544|FG000|STARTED|Overall Study||52||
59835734|NCT00346268|75959545|FG001|STARTED|Overall Study||53||
59835735|NCT00346268|75959544|FG000|COMPLETED|Overall Study||50||
59835736|NCT00346268|75959545|FG001|COMPLETED|Overall Study||50||
59835737|NCT00346268|75959544|FG000|NOT COMPLETED|Overall Study||2||
59567541|NCT02326272|75670459|FG006|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0||
59717900|NCT01118520|75837023|FG000|STARTED|Overall Study||73||
59717901|NCT01118520|75837024|FG001|STARTED|Overall Study||72||
59717902|NCT01118520|75837025|FG002|STARTED|Overall Study||79||
59835738|NCT00346268|75959545|FG001|NOT COMPLETED|Overall Study||3||
59835739|NCT00327444|75959553|FG000|STARTED|Double Blind Treatment (DB) Period||26||
59835740|NCT00327444|75959554|FG001|STARTED|Double Blind Treatment (DB) Period||29||
59835741|NCT00327444|75959553|FG000|SAFETY|Double Blind Treatment (DB) Period|Excludes one participant from the Placebo arm who received aflibercept in error in the DB period.|25||
59835742|NCT00327444|75959554|FG001|SAFETY|Double Blind Treatment (DB) Period|Includes 1 from Placebo who received aflibercept in DB period|30||
59835743|NCT00327444|75959553|FG000|COMPLETED|Double Blind Treatment (DB) Period||0||
59835744|NCT00327444|75959554|FG001|COMPLETED|Double Blind Treatment (DB) Period||0||
59567542|NCT02326272|75670460|FG007|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0||
59567543|NCT02326272|75670461|FG008|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0||
59717903|NCT01118520|75837023|FG000|COMPLETED|Overall Study||53||
59717904|NCT01118520|75837024|FG001|COMPLETED|Overall Study||49||
59717905|NCT01118520|75837025|FG002|COMPLETED|Overall Study||59||
59717906|NCT01118520|75837023|FG000|NOT COMPLETED|Overall Study||20||
59717907|NCT01118520|75837024|FG001|NOT COMPLETED|Overall Study||23||
59717908|NCT01118520|75837025|FG002|NOT COMPLETED|Overall Study||20||
59717909|NCT01135992|75837033|FG000|STARTED|Overall Study||143||
59717910|NCT01135992|75837033|FG000|Exposed|Overall Study|One subject was withdrawn before being exposed.|142||
59717911|NCT01135992|75837033|FG000|Full Analysis Set|Overall Study||129||
59717912|NCT01135992|75837033|FG000|COMPLETED|Overall Study||122||
59717913|NCT01135992|75837033|FG000|NOT COMPLETED|Overall Study||21||
59717914|NCT00959049|75837043|FG000|STARTED|Overall Study||231||
59717915|NCT00959049|75837044|FG001|STARTED|Overall Study||254||
59717916|NCT00959049|75837045|FG002|STARTED|Overall Study||254||
59717917|NCT00959049|75837046|FG003|STARTED|Overall Study||228||
59717918|NCT00959049|75837047|FG004|STARTED|Overall Study||257||
59717919|NCT00959049|75837048|FG005|STARTED|Overall Study||250||
59717920|NCT00959049|75837043|FG000|COMPLETED|Overall Study||213||
59717921|NCT00959049|75837044|FG001|COMPLETED|Overall Study||247||
59717922|NCT00959049|75837045|FG002|COMPLETED|Overall Study||253||
59717923|NCT00959049|75837046|FG003|COMPLETED|Overall Study||217||
59717924|NCT00959049|75837047|FG004|COMPLETED|Overall Study||248||
59717925|NCT00959049|75837048|FG005|COMPLETED|Overall Study||249||
59717926|NCT00959049|75837043|FG000|NOT COMPLETED|Overall Study||18||
59717927|NCT00959049|75837044|FG001|NOT COMPLETED|Overall Study||7||
59717928|NCT00959049|75837045|FG002|NOT COMPLETED|Overall Study||1||
59717929|NCT00959049|75837046|FG003|NOT COMPLETED|Overall Study||11||
59717930|NCT00959049|75837047|FG004|NOT COMPLETED|Overall Study||9||
59717931|NCT00959049|75837048|FG005|NOT COMPLETED|Overall Study||1||
59717932|NCT00956943|75837075|FG000|STARTED|Overall Study||43||
59717933|NCT00956943|75837076|FG001|STARTED|Overall Study||44||
59717934|NCT00956943|75837075|FG000|Baseline|Overall Study||43||
59717935|NCT00956943|75837076|FG001|Baseline|Overall Study||44||
59717936|NCT00956943|75837075|FG000|COMPLETED|Overall Study||34||
59717937|NCT00956943|75837076|FG001|COMPLETED|Overall Study||34||
59717938|NCT00956943|75837075|FG000|NOT COMPLETED|Overall Study||9||
59717939|NCT00956943|75837076|FG001|NOT COMPLETED|Overall Study||10||
59717940|NCT00958893|75837082|FG000|STARTED|Overall Study||4||
59717941|NCT00958893|75837082|FG000|COMPLETED|Overall Study||0||
59717942|NCT00958893|75837082|FG000|NOT COMPLETED|Overall Study||4||
59567544|NCT02326272|75670462|FG009|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0||
59567545|NCT02326272|75670463|FG010|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0||
59567546|NCT02326272|75670464|FG011|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0||
59567547|NCT02326272|75670465|FG012|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0||
59717943|NCT01135914|75837089|FG000|STARTED|Overall Study||78||
59717944|NCT01135914|75837090|FG001|STARTED|Overall Study||80||
59717945|NCT01135914|75837091|FG002|STARTED|Overall Study||81||
59717946|NCT01135914|75837089|FG000|Intent to Treat (ITT) Population|Overall Study||73||
59717947|NCT01135914|75837090|FG001|Intent to Treat (ITT) Population|Overall Study||75||
59717948|NCT01135914|75837091|FG002|Intent to Treat (ITT) Population|Overall Study||72||
59717949|NCT01135914|75837089|FG000|Safety Population|Overall Study||73||
59717950|NCT01135914|75837090|FG001|Safety Population|Overall Study||75||
59717951|NCT01135914|75837091|FG002|Safety Population|Overall Study||74||
59717952|NCT01135914|75837089|FG000|COMPLETED|Overall Study||74||
59717953|NCT01135914|75837090|FG001|COMPLETED|Overall Study||75||
59717954|NCT01135914|75837091|FG002|COMPLETED|Overall Study||59||
59717955|NCT01135914|75837089|FG000|NOT COMPLETED|Overall Study||4||
59717956|NCT01135914|75837090|FG001|NOT COMPLETED|Overall Study||5||
59717957|NCT01135914|75837091|FG002|NOT COMPLETED|Overall Study||22||
59717958|NCT00907738|75837104|FG000|STARTED|Overall Study||13||
59717959|NCT00907738|75837105|FG001|STARTED|Overall Study||1||
59717960|NCT00907738|75837106|FG002|STARTED|Overall Study||7||
59717961|NCT00907738|75837107|FG003|STARTED|Overall Study||4||
59717962|NCT00907738|75837108|FG004|STARTED|Overall Study||2||
59717963|NCT00907738|75837104|FG000|COMPLETED|Overall Study||0||
59717964|NCT00907738|75837105|FG001|COMPLETED|Overall Study||0||
59717965|NCT00907738|75837106|FG002|COMPLETED|Overall Study||0||
59835745|NCT00327444|75959553|FG000|NOT COMPLETED|Double Blind Treatment (DB) Period||26||
59835746|NCT00327444|75959554|FG001|NOT COMPLETED|Double Blind Treatment (DB) Period||29||
59835747|NCT00327444|75959553|FG000|STARTED|Open Label Treatment (OL) Period||11||
59835748|NCT00327444|75959554|FG001|STARTED|Open Label Treatment (OL) Period||10||
59835749|NCT00327444|75959553|FG000|ONGOING TREATMENT|Open Label Treatment (OL) Period||1||
59835750|NCT00327444|75959554|FG001|ONGOING TREATMENT|Open Label Treatment (OL) Period||0||
59835751|NCT00327444|75959553|FG000|COMPLETED|Open Label Treatment (OL) Period|All participants were treated till they met treatment discontinuation criteria|0||
59835752|NCT00327444|75959554|FG001|COMPLETED|Open Label Treatment (OL) Period|All participants were treated till they met treatment discontinuation criteria|0||
59567548|NCT02326272|75670466|FG013|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0||
59567549|NCT02326272|75670467|FG014|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0||
59717966|NCT00907738|75837107|FG003|COMPLETED|Overall Study||0||
59717967|NCT00907738|75837108|FG004|COMPLETED|Overall Study||0||
59717968|NCT00907738|75837104|FG000|NOT COMPLETED|Overall Study||13||
59717969|NCT00907738|75837105|FG001|NOT COMPLETED|Overall Study||1||
59835753|NCT00327444|75959553|FG000|NOT COMPLETED|Open Label Treatment (OL) Period||11||
59835754|NCT00327444|75959554|FG001|NOT COMPLETED|Open Label Treatment (OL) Period||10||
59835755|NCT00337610|75959564|FG000|STARTED|Overall Study||96||
59835756|NCT00337610|75959565|FG001|STARTED|Overall Study||94||
59835757|NCT00337610|75959564|FG000|Completed Week 18|Overall Study||89||
59835758|NCT00337610|75959565|FG001|Completed Week 18|Overall Study||82||
59835759|NCT00337610|75959564|FG000|COMPLETED|Overall Study||79||
59835760|NCT00337610|75959565|FG001|COMPLETED|Overall Study||80||
59835761|NCT00337610|75959564|FG000|NOT COMPLETED|Overall Study||17||
59835762|NCT00337610|75959565|FG001|NOT COMPLETED|Overall Study||14||
59835763|NCT00316914|75959573|FG000|STARTED|Overall Study||50||
59835764|NCT00316914|75959574|FG001|STARTED|Overall Study||52||
59835765|NCT00316914|75959573|FG000|COMPLETED|Overall Study||17||
59835766|NCT00316914|75959574|FG001|COMPLETED|Overall Study||16||
59835767|NCT00316914|75959573|FG000|NOT COMPLETED|Overall Study||33||
59835768|NCT00316914|75959574|FG001|NOT COMPLETED|Overall Study||36||
59835769|NCT00336284|75959582|FG000|STARTED|Overall Study||977||
59835770|NCT00336284|75959583|FG001|STARTED|Overall Study||473||
59835771|NCT00336284|75959582|FG000|COMPLETED|Overall Study||741||
59835772|NCT00336284|75959583|FG001|COMPLETED|Overall Study||322||
59835773|NCT00336284|75959582|FG000|NOT COMPLETED|Overall Study||236||
59835774|NCT00336284|75959583|FG001|NOT COMPLETED|Overall Study||151||
59835775|NCT00316602|75959591|FG000|STARTED|Overall Study||282||
59835776|NCT00316602|75959592|FG001|STARTED|Overall Study||350||
59835777|NCT00316602|75959591|FG000|COMPLETED|Overall Study||272||
59835778|NCT00316602|75959592|FG001|COMPLETED|Overall Study||325||
59835779|NCT00316602|75959591|FG000|NOT COMPLETED|Overall Study||10||
59835780|NCT00316602|75959592|FG001|NOT COMPLETED|Overall Study||25||
59835781|NCT00335972|75959600|FG000|STARTED|Overall Study||71||
59835782|NCT00335972|75959601|FG001|STARTED|Overall Study||71||
59835783|NCT00335972|75959600|FG000|COMPLETED|Overall Study||71||
59835784|NCT00335972|75959601|FG001|COMPLETED|Overall Study||68||
59835785|NCT00335972|75959600|FG000|NOT COMPLETED|Overall Study||0||
59835786|NCT00335972|75959601|FG001|NOT COMPLETED|Overall Study||3||
59835787|NCT00346034|75959607|FG000|STARTED|Overall Study||357||
59835788|NCT00346034|75959607|FG000|COMPLETED|Overall Study||300||
59835789|NCT00346034|75959607|FG000|NOT COMPLETED|Overall Study||57||
59835790|NCT00345878|75959613|FG000|STARTED|Overall Study||135||
59835791|NCT00345878|75959614|FG001|STARTED|Overall Study||136||
59835792|NCT00345878|75959613|FG000|COMPLETED|Overall Study||131||
59835793|NCT00345878|75959614|FG001|COMPLETED|Overall Study||135||
59835794|NCT00345878|75959613|FG000|NOT COMPLETED|Overall Study||4||
60119137|NCT02452528|76240222|FG000|NOT COMPLETED|Overall Study||1||
60119138|NCT02452528|76240223|FG001|NOT COMPLETED|Overall Study||1||
60119139|NCT02702388|76240231|FG000|STARTED|Overall Study||75||
59717970|NCT00907738|75837106|FG002|NOT COMPLETED|Overall Study||7||
59717971|NCT00907738|75837107|FG003|NOT COMPLETED|Overall Study||4||
59717972|NCT00907738|75837108|FG004|NOT COMPLETED|Overall Study||2||
59717973|NCT01123356|75837124|FG000|STARTED|Overall Study||21||
59835795|NCT00345878|75959614|FG001|NOT COMPLETED|Overall Study||1||
60119140|NCT02702388|76240232|FG001|STARTED|Overall Study||77||
59567550|NCT02326272|75670453|FG000|STARTED|Maintenance Period (Week 16 to Week 48)||0||
59567551|NCT02326272|75670454|FG001|STARTED|Maintenance Period (Week 16 to Week 48)||0||
59835796|NCT00335738|75959622|FG000|STARTED|Overall Study||108||
59835797|NCT00335738|75959623|FG001|STARTED|Overall Study||223||
59835798|NCT00335738|75959622|FG000|COMPLETED|Overall Study||97||
59835799|NCT00335738|75959623|FG001|COMPLETED|Overall Study||219||
59835800|NCT00335738|75959622|FG000|NOT COMPLETED|Overall Study||11||
59835801|NCT00335738|75959623|FG001|NOT COMPLETED|Overall Study||4||
59835802|NCT01059500|75959632|FG000|STARTED|Overall Study||264||
59835803|NCT01059500|75959633|FG001|STARTED|Overall Study||277||
59835804|NCT01059500|75959632|FG000|COMPLETED|Overall Study||264||
60119141|NCT02702388|76240231|FG000|COMPLETED|Overall Study||35||
59717974|NCT01123356|75837124|FG000|COMPLETED|Overall Study||14||
59835805|NCT01059500|75959633|FG001|COMPLETED|Overall Study||277||
60119142|NCT02702388|76240232|FG001|COMPLETED|Overall Study||26||
59717975|NCT01123356|75837124|FG000|NOT COMPLETED|Overall Study||7||
59835806|NCT01059500|75959632|FG000|NOT COMPLETED|Overall Study||0||
59835807|NCT01059500|75959633|FG001|NOT COMPLETED|Overall Study||0||
59835808|NCT00334958|75959641|FG000|STARTED|Overall Study||176||
59835809|NCT00334958|75959642|FG001|STARTED|Overall Study|1 participant withdrawn prior to study drug dosing due to not obtaining labs|180||
59717976|NCT00908596|75837133|FG000|STARTED|Overall Study||47||
59717977|NCT00908596|75837134|FG001|STARTED|Overall Study||32||
59717978|NCT00908596|75837135|FG002|STARTED|Overall Study||193||
59835810|NCT00334958|75959641|FG000|COMPLETED|Overall Study||139||
59835811|NCT00334958|75959642|FG001|COMPLETED|Overall Study||156||
59835812|NCT00334958|75959641|FG000|NOT COMPLETED|Overall Study||37||
59835813|NCT00334958|75959642|FG001|NOT COMPLETED|Overall Study||24||
59835814|NCT00326898|75959651|FG000|STARTED|Overall Study||647||
59835815|NCT00326898|75959652|FG001|STARTED|Overall Study||649||
59835816|NCT00326898|75959653|FG002|STARTED|Overall Study||647||
59835817|NCT00326898|75959651|FG000|Patients With Toxicity Data|Overall Study||625||
59835818|NCT00326898|75959652|FG001|Patients With Toxicity Data|Overall Study||628||
59835819|NCT00326898|75959653|FG002|Patients With Toxicity Data|Overall Study||626||
59835820|NCT00326898|75959651|FG000|Patients With Clear Cell Histology|Overall Study||542||
59835821|NCT00326898|75959652|FG001|Patients With Clear Cell Histology|Overall Study||540||
59835822|NCT00326898|75959653|FG002|Patients With Clear Cell Histology|Overall Study||540||
59835823|NCT00326898|75959651|FG000|Patients With >=1 Follow-up MUGA Scan|Overall Study||513||
59835824|NCT00326898|75959652|FG001|Patients With >=1 Follow-up MUGA Scan|Overall Study||510||
59835825|NCT00326898|75959653|FG002|Patients With >=1 Follow-up MUGA Scan|Overall Study||580||
59835826|NCT00326898|75959651|FG000|COMPLETED|Overall Study||296||
59835827|NCT00326898|75959652|FG001|COMPLETED|Overall Study||306||
59835828|NCT00326898|75959653|FG002|COMPLETED|Overall Study||444||
59835829|NCT00326898|75959651|FG000|NOT COMPLETED|Overall Study||351||
59835830|NCT00326898|75959652|FG001|NOT COMPLETED|Overall Study||343||
59835831|NCT00326898|75959653|FG002|NOT COMPLETED|Overall Study||203||
59835832|NCT00326118|75959663|FG000|STARTED|Active Phase||324||
59835833|NCT00326118|75959664|FG001|STARTED|Active Phase||109||
59835834|NCT00326118|75959663|FG000|COMPLETED|Active Phase||320||
59835835|NCT00326118|75959664|FG001|COMPLETED|Active Phase||108||
59835836|NCT00326118|75959663|FG000|NOT COMPLETED|Active Phase||4||
59835837|NCT00326118|75959664|FG001|NOT COMPLETED|Active Phase||1||
59835838|NCT00326118|75959663|FG000|STARTED|Year 1 Follow-up||295||
59835839|NCT00326118|75959664|FG001|STARTED|Year 1 Follow-up||100||
59835840|NCT00326118|75959663|FG000|COMPLETED|Year 1 Follow-up||295||
59835841|NCT00326118|75959664|FG001|COMPLETED|Year 1 Follow-up||100||
59835842|NCT00326118|75959663|FG000|NOT COMPLETED|Year 1 Follow-up||0||
59835843|NCT00326118|75959664|FG001|NOT COMPLETED|Year 1 Follow-up||0||
59835844|NCT00326118|75959663|FG000|STARTED|Year 2 Follow-up||270||
59835845|NCT00326118|75959664|FG001|STARTED|Year 2 Follow-up||92||
59835846|NCT00326118|75959663|FG000|COMPLETED|Year 2 Follow-up||270||
59835847|NCT00326118|75959664|FG001|COMPLETED|Year 2 Follow-up||92||
59835848|NCT00326118|75959663|FG000|NOT COMPLETED|Year 2 Follow-up||0||
59835849|NCT00326118|75959664|FG001|NOT COMPLETED|Year 2 Follow-up||0||
59835850|NCT00326118|75959663|FG000|STARTED|Year 3 Follow-up||256||
59835851|NCT00326118|75959664|FG001|STARTED|Year 3 Follow-up||89||
59835852|NCT00326118|75959663|FG000|COMPLETED|Year 3 Follow-up||256||
59835853|NCT00326118|75959664|FG001|COMPLETED|Year 3 Follow-up||89||
59835854|NCT00326118|75959663|FG000|NOT COMPLETED|Year 3 Follow-up||0||
59835855|NCT00326118|75959664|FG001|NOT COMPLETED|Year 3 Follow-up||0||
59835856|NCT00326118|75959663|FG000|STARTED|Year 4 Follow-up||228||
59835857|NCT00326118|75959664|FG001|STARTED|Year 4 Follow-up||80||
59835858|NCT00326118|75959663|FG000|COMPLETED|Year 4 Follow-up||228||
59835859|NCT00326118|75959664|FG001|COMPLETED|Year 4 Follow-up||80||
59835860|NCT00326118|75959663|FG000|NOT COMPLETED|Year 4 Follow-up||0||
59717979|NCT00908596|75837136|FG003|STARTED|Overall Study||85||
59717980|NCT00908596|75837133|FG000|COMPLETED|Overall Study||0||
59717981|NCT00908596|75837134|FG001|COMPLETED|Overall Study||19||
59717982|NCT00908596|75837135|FG002|COMPLETED|Overall Study||119||
59717983|NCT00908596|75837136|FG003|COMPLETED|Overall Study||48||
59717984|NCT00908596|75837133|FG000|NOT COMPLETED|Overall Study||47||
59717985|NCT00908596|75837134|FG001|NOT COMPLETED|Overall Study||13||
59717986|NCT00908596|75837135|FG002|NOT COMPLETED|Overall Study||74||
59717987|NCT00908596|75837136|FG003|NOT COMPLETED|Overall Study||37||
59717988|NCT01118052|75837146|FG000|STARTED|Overall Study||22||
59717989|NCT01118052|75837146|FG000|COMPLETED|Overall Study||20||
59835861|NCT00326118|75959664|FG001|NOT COMPLETED|Year 4 Follow-up||0||
59835862|NCT00326118|75959663|FG000|STARTED|Year 5 Follow up||217||
59835863|NCT00326118|75959664|FG001|STARTED|Year 5 Follow up||78||
59835864|NCT00326118|75959663|FG000|COMPLETED|Year 5 Follow up||217||
59835865|NCT00326118|75959664|FG001|COMPLETED|Year 5 Follow up||78||
59835866|NCT00326118|75959663|FG000|NOT COMPLETED|Year 5 Follow up||0||
59835867|NCT00326118|75959664|FG001|NOT COMPLETED|Year 5 Follow up||0||
59835868|NCT00334802|75959673|FG000|STARTED|Overall Study||6||
59835869|NCT00334802|75959674|FG001|STARTED|Overall Study||56||
59835870|NCT00334802|75959673|FG000|COMPLETED|Overall Study||0||
59835871|NCT00334802|75959674|FG001|COMPLETED|Overall Study||16||
59835872|NCT00334802|75959673|FG000|NOT COMPLETED|Overall Study||6||
59835873|NCT00334802|75959674|FG001|NOT COMPLETED|Overall Study||40||
59835874|NCT00307164|75959685|FG000|STARTED|Overall Study||83||
59835875|NCT00307164|75959686|FG001|STARTED|Overall Study||82||
59835876|NCT00307164|75959685|FG000|COMPLETED|Overall Study||68||
59835877|NCT00307164|75959686|FG001|COMPLETED|Overall Study||68||
59835878|NCT00307164|75959685|FG000|NOT COMPLETED|Overall Study||15||
59835879|NCT00307164|75959686|FG001|NOT COMPLETED|Overall Study||14||
59835880|NCT03827564|75959694|FG000|STARTED|Overall Study||9||
59835881|NCT03827564|75959695|FG001|STARTED|Overall Study||5||
59835882|NCT03827564|75959694|FG000|COMPLETED|Overall Study||8||
59835883|NCT03827564|75959695|FG001|COMPLETED|Overall Study||5||
59835884|NCT03827564|75959694|FG000|NOT COMPLETED|Overall Study||1||
59835885|NCT03827564|75959695|FG001|NOT COMPLETED|Overall Study||0||
59835886|NCT00307086|75959701|FG000|STARTED|Overall Study||30||
59835887|NCT00307086|75959701|FG000|COMPLETED|Overall Study||25||
59835888|NCT00307086|75959701|FG000|NOT COMPLETED|Overall Study||5||
59835889|NCT00325416|75959707|FG000|STARTED|Phase I: Dose Escalation||70||
59835890|NCT00325416|75959708|FG001|STARTED|Phase I: Dose Escalation||60||
59835891|NCT00325416|75959707|FG000|COMPLETED|Phase I: Dose Escalation||48||
59835892|NCT00325416|75959708|FG001|COMPLETED|Phase I: Dose Escalation||44||
59835893|NCT00325416|75959707|FG000|NOT COMPLETED|Phase I: Dose Escalation||22||
59835894|NCT00325416|75959708|FG001|NOT COMPLETED|Phase I: Dose Escalation||16||
59835895|NCT00325416|75959707|FG000|STARTED|Phase II: Treatment at MTD||78||
59835896|NCT00325416|75959708|FG001|STARTED|Phase II: Treatment at MTD||42||
59835897|NCT00325416|75959707|FG000|Proceeded From Phase I to Phase II|Phase II: Treatment at MTD||38||
59835898|NCT00325416|75959708|FG001|Proceeded From Phase I to Phase II|Phase II: Treatment at MTD||34||
60119143|NCT02702388|76240231|FG000|NOT COMPLETED|Overall Study||40||
60119144|NCT02702388|76240232|FG001|NOT COMPLETED|Overall Study||51||
60119145|NCT02456896|76240249|FG000|STARTED|Overall Study||25||
60119146|NCT02456896|76240250|FG001|STARTED|Overall Study||25||
60119147|NCT02456896|76240249|FG000|COMPLETED|Overall Study||19||
60119148|NCT02456896|76240250|FG001|COMPLETED|Overall Study||21||
60119149|NCT02456896|76240249|FG000|NOT COMPLETED|Overall Study||6||
60119150|NCT02456896|76240250|FG001|NOT COMPLETED|Overall Study||4||
60119151|NCT01696877|76240258|FG000|STARTED|Overall Study||15||
60119152|NCT01696877|76240259|FG001|STARTED|Overall Study||14||
60119153|NCT01696877|76240258|FG000|COMPLETED|Overall Study||15||
60119154|NCT01696877|76240259|FG001|COMPLETED|Overall Study||13||
60119155|NCT01696877|76240258|FG000|NOT COMPLETED|Overall Study||0||
60119156|NCT01696877|76240259|FG001|NOT COMPLETED|Overall Study||1||
60119157|NCT02416102|76240270|FG000|STARTED|Overall Study||16||
60119158|NCT02416102|76240271|FG001|STARTED|Overall Study||15||
60119159|NCT02416102|76240272|FG002|STARTED|Overall Study||0||
60119160|NCT02416102|76240270|FG000|COMPLETED|Overall Study||7||
60119161|NCT02416102|76240271|FG001|COMPLETED|Overall Study||7||
60119162|NCT02416102|76240272|FG002|COMPLETED|Overall Study||0||
60119163|NCT02416102|76240270|FG000|NOT COMPLETED|Overall Study||9||
60119164|NCT02416102|76240271|FG001|NOT COMPLETED|Overall Study||8||
60119165|NCT02416102|76240272|FG002|NOT COMPLETED|Overall Study||0||
60119166|NCT02458768|76240282|FG000|STARTED|Overall Study||57||
60119167|NCT02458768|76240283|FG001|STARTED|Overall Study||55||
60119168|NCT02458768|76240282|FG000|COMPLETED|Overall Study||50||
60119169|NCT02458768|76240283|FG001|COMPLETED|Overall Study||50||
60119170|NCT02458768|76240282|FG000|NOT COMPLETED|Overall Study||7||
60119171|NCT02458768|76240283|FG001|NOT COMPLETED|Overall Study||5||
60119172|NCT02418676|76240292|FG000|STARTED|Overall Study||5||
60119173|NCT02418676|76240293|FG001|STARTED|Overall Study||5||
60119174|NCT02418676|76240294|FG002|STARTED|Overall Study||5||
60119175|NCT02418676|76240292|FG000|COMPLETED|Overall Study||5||
60119176|NCT02418676|76240293|FG001|COMPLETED|Overall Study||5||
60119177|NCT02418676|76240294|FG002|COMPLETED|Overall Study||5||
60119178|NCT02418676|76240292|FG000|NOT COMPLETED|Overall Study||0||
60119179|NCT02418676|76240293|FG001|NOT COMPLETED|Overall Study||0||
60119180|NCT02418676|76240294|FG002|NOT COMPLETED|Overall Study||0||
60119181|NCT02419690|76240304|FG000|STARTED|Overall Study||122||
60119182|NCT02419690|76240305|FG001|STARTED|Overall Study||122||
60119183|NCT02419690|76240304|FG000|COMPLETED|Overall Study||122||
60119184|NCT02419690|76240305|FG001|COMPLETED|Overall Study||122||
59835899|NCT00325416|75959707|FG000|Enrolled During Phase II|Phase II: Treatment at MTD||40||
59835900|NCT00325416|75959708|FG001|Enrolled During Phase II|Phase II: Treatment at MTD||8||
60119185|NCT02419690|76240304|FG000|NOT COMPLETED|Overall Study||0||
60119186|NCT02419690|76240305|FG001|NOT COMPLETED|Overall Study||0||
59835901|NCT00325416|75959707|FG000|COMPLETED|Phase II: Treatment at MTD||78||
59835902|NCT00325416|75959708|FG001|COMPLETED|Phase II: Treatment at MTD||40||
59835903|NCT00325416|75959707|FG000|NOT COMPLETED|Phase II: Treatment at MTD||0||
60119187|NCT02460172|76240311|FG000|STARTED|Overall Study||25|This is a split-person study|50
60119188|NCT02460172|76240311|FG000|COMPLETED|Overall Study||25||50
60119189|NCT02460172|76240311|FG000|NOT COMPLETED|Overall Study||0||0
60119190|NCT02419924|76240317|FG000|STARTED|Overall Study||12||
60119191|NCT02419924|76240317|FG000|COMPLETED|Overall Study||12||
60119192|NCT02419924|76240317|FG000|NOT COMPLETED|Overall Study||0||
59835904|NCT00325416|75959708|FG001|NOT COMPLETED|Phase II: Treatment at MTD||2||
59835905|NCT00314808|75959714|FG000|STARTED|Overall Study||33||
59835906|NCT00314808|75959714|FG000|COMPLETED|Overall Study|Completed 2 cycles of Dronabinol or terminated early due to treatment-related adverse events (AE)|25||
59835907|NCT00314808|75959714|FG000|NOT COMPLETED|Overall Study||8||
59835908|NCT00314574|75959720|FG000|STARTED|Overall Study||423||
59835909|NCT00314574|75959721|FG001|STARTED|Overall Study||427||
59835910|NCT00314574|75959720|FG000|Received at Least One Dose of Study Drug|Overall Study||421||
59835911|NCT00314574|75959721|FG001|Received at Least One Dose of Study Drug|Overall Study||427||
59835912|NCT00314574|75959720|FG000|Safety Population|Overall Study|1 patient in the placebo arm received Xolair and was added to the Xolair arm for Safety analyses.|420||
59835913|NCT00314574|75959721|FG001|Safety Population|Overall Study||428||
59835914|NCT00314574|75959720|FG000|COMPLETED|Overall Study||329||
59835915|NCT00314574|75959721|FG001|COMPLETED|Overall Study||344||
59835916|NCT00314574|75959720|FG000|NOT COMPLETED|Overall Study||94||
59835917|NCT00314574|75959721|FG001|NOT COMPLETED|Overall Study||83||
59835918|NCT00314340|75959727|FG000|STARTED|Overall Study||12||
59835919|NCT00314340|75959727|FG000|ER Morphine|Overall Study||11||
59835920|NCT00314340|75959727|FG000|Hydrocodone Plus APAP|Overall Study||12||
59835921|NCT00314340|75959727|FG000|Placebo|Overall Study||12||
59835922|NCT00314340|75959727|FG000|COMPLETED|Overall Study||11||
59835923|NCT00314340|75959727|FG000|NOT COMPLETED|Overall Study||1||
59835924|NCT00306852|75959735|FG000|STARTED|Overall Study||105||
59835925|NCT00306852|75959736|FG001|STARTED|Overall Study||107||
59835926|NCT00306852|75959735|FG000|COMPLETED|Overall Study||76||
59835927|NCT00306852|75959736|FG001|COMPLETED|Overall Study||69||
59835928|NCT00306852|75959735|FG000|NOT COMPLETED|Overall Study||29||
59835929|NCT00306852|75959736|FG001|NOT COMPLETED|Overall Study||38||
59835930|NCT00314262|75959742|FG000|STARTED|Overall Study||12||
59835931|NCT00314262|75959742|FG000|COMPLETED|Overall Study||7||
59835932|NCT00314262|75959742|FG000|NOT COMPLETED|Overall Study||5||
59835933|NCT00333866|75959750|FG000|STARTED|Overall Study||189||
59835934|NCT00333866|75959751|FG001|STARTED|Overall Study||187||
59835935|NCT00333866|75959752|FG002|STARTED|Overall Study||184||
59835936|NCT00333866|75959753|FG003|STARTED|Overall Study||187||
59835937|NCT00333866|75959750|FG000|TREATED|Overall Study||184||
59835938|NCT00333866|75959751|FG001|TREATED|Overall Study||184||
59835939|NCT00333866|75959752|FG002|TREATED|Overall Study||182||
59835940|NCT00333866|75959753|FG003|TREATED|Overall Study||186||
59835941|NCT00333866|75959750|FG000|COMPLETED|Overall Study||141||
59835942|NCT00333866|75959751|FG001|COMPLETED|Overall Study||123||
59835943|NCT00333866|75959752|FG002|COMPLETED|Overall Study||133||
59835944|NCT00333866|75959753|FG003|COMPLETED|Overall Study||121||
59835945|NCT00333866|75959750|FG000|NOT COMPLETED|Overall Study||48||
59835946|NCT00333866|75959751|FG001|NOT COMPLETED|Overall Study||64||
59835947|NCT00333866|75959752|FG002|NOT COMPLETED|Overall Study||51||
59835948|NCT00333866|75959753|FG003|NOT COMPLETED|Overall Study||66||
59835949|NCT00324740|75959763|FG000|STARTED|Overall Study||7||
59835950|NCT00324740|75959764|FG001|STARTED|Overall Study||3||
59835951|NCT00324740|75959765|FG002|STARTED|Overall Study||4||
59835952|NCT00324740|75959763|FG000|COMPLETED|Overall Study||6||
59835953|NCT00324740|75959764|FG001|COMPLETED|Overall Study||3||
59835954|NCT00324740|75959765|FG002|COMPLETED|Overall Study||3||
59835955|NCT00324740|75959763|FG000|NOT COMPLETED|Overall Study||1||
59835956|NCT00324740|75959764|FG001|NOT COMPLETED|Overall Study||0||
59835957|NCT00324740|75959765|FG002|NOT COMPLETED|Overall Study||1||
59835958|NCT00333788|75959772|FG000|STARTED|Overall Study|Participant flow based on All Subjects population; Baseline characteristics based on ITT population.|233||
59835959|NCT00333788|75959772|FG000|COMPLETED|Overall Study||71||
59835960|NCT00333788|75959772|FG000|NOT COMPLETED|Overall Study||162||
59835961|NCT00324116|75959776|FG000|STARTED|Overall Study|subjects received treatment|81||
59835962|NCT00324116|75959776|FG000|COMPLETED|Overall Study||49||
59835963|NCT00324116|75959776|FG000|NOT COMPLETED|Overall Study||32||
60119193|NCT02461966|76240324|FG000|STARTED|Overall Study||160||
60119194|NCT02461966|76240325|FG001|STARTED|Overall Study||80||
59835964|NCT00332696|75959782|FG000|STARTED|Overall Study||32||
59835965|NCT00332696|75959783|FG001|STARTED|Overall Study||32||
59835966|NCT00332696|75959782|FG000|Completed Day 14 Visit|Overall Study|Primary Endpoint|21||
59835967|NCT00332696|75959783|FG001|Completed Day 14 Visit|Overall Study||15||
59835968|NCT00332696|75959782|FG000|COMPLETED|Overall Study|Completed Month 3 Visit|2||
60119195|NCT02461966|76240326|FG002|STARTED|Overall Study||60||
59835969|NCT00332696|75959783|FG001|COMPLETED|Overall Study||2||
59835970|NCT00332696|75959782|FG000|NOT COMPLETED|Overall Study||30||
59835971|NCT00332696|75959783|FG001|NOT COMPLETED|Overall Study||30||
59835972|NCT00313716|75959795|FG000|STARTED|Overall Study||18||
59835973|NCT00313716|75959796|FG001|STARTED|Overall Study||31||
59835974|NCT00313716|75959797|FG002|STARTED|Overall Study||50||
59835975|NCT00313716|75959798|FG003|STARTED|Overall Study||20||
59835976|NCT00313716|75959799|FG004|STARTED|Overall Study||33||
59835977|NCT00313716|75959800|FG005|STARTED|Overall Study||48||
59835978|NCT00313716|75959795|FG000|COMPLETED|Overall Study||13||
59835979|NCT00313716|75959796|FG001|COMPLETED|Overall Study||23||
59835980|NCT00313716|75959797|FG002|COMPLETED|Overall Study||38||
60119196|NCT02461966|76240324|FG000|COMPLETED|Overall Study||160||
59835981|NCT00313716|75959798|FG003|COMPLETED|Overall Study||16||
59835982|NCT00313716|75959799|FG004|COMPLETED|Overall Study||27||
59835983|NCT00313716|75959800|FG005|COMPLETED|Overall Study||35||
59835984|NCT00313716|75959795|FG000|NOT COMPLETED|Overall Study||5||
59835985|NCT00313716|75959796|FG001|NOT COMPLETED|Overall Study||8||
59835986|NCT00313716|75959797|FG002|NOT COMPLETED|Overall Study||12||
59835987|NCT00313716|75959798|FG003|NOT COMPLETED|Overall Study||4||
59835988|NCT00313716|75959799|FG004|NOT COMPLETED|Overall Study||6||
59835989|NCT00313716|75959800|FG005|NOT COMPLETED|Overall Study||13||
59835990|NCT00313170|75959821|FG000|STARTED|Overall Study||47||
59835991|NCT00313170|75959822|FG001|STARTED|Overall Study||51||
59835992|NCT00313170|75959823|FG002|STARTED|Overall Study||46||
59835993|NCT00313170|75959821|FG000|COMPLETED|Overall Study||11||
59835994|NCT00313170|75959822|FG001|COMPLETED|Overall Study||17||
59835995|NCT00313170|75959823|FG002|COMPLETED|Overall Study||14||
59835996|NCT00313170|75959821|FG000|NOT COMPLETED|Overall Study||36||
59835997|NCT00313170|75959822|FG001|NOT COMPLETED|Overall Study||34||
59835998|NCT00313170|75959823|FG002|NOT COMPLETED|Overall Study||32||
60119197|NCT02461966|76240325|FG001|COMPLETED|Overall Study||80||
60119198|NCT02461966|76240326|FG002|COMPLETED|Overall Study||60||
60119199|NCT02461966|76240324|FG000|NOT COMPLETED|Overall Study||0||
60119200|NCT02461966|76240325|FG001|NOT COMPLETED|Overall Study||0||
59567552|NCT02326272|75670455|FG002|STARTED|Maintenance Period (Week 16 to Week 48)||0||
59567553|NCT02326272|75670456|FG003|STARTED|Maintenance Period (Week 16 to Week 48)||6||
59567554|NCT02326272|75670457|FG004|STARTED|Maintenance Period (Week 16 to Week 48)||5||
59567555|NCT02326272|75670458|FG005|STARTED|Maintenance Period (Week 16 to Week 48)||76||
59567556|NCT02326272|75670459|FG006|STARTED|Maintenance Period (Week 16 to Week 48)||69||
59567557|NCT02326272|75670460|FG007|STARTED|Maintenance Period (Week 16 to Week 48)||34||
59567558|NCT02326272|75670461|FG008|STARTED|Maintenance Period (Week 16 to Week 48)||8||
59717990|NCT01118052|75837146|FG000|NOT COMPLETED|Overall Study||2||
59717991|NCT01123200|75837156|FG000|STARTED|Overall Study||1||
59717992|NCT01123200|75837156|FG000|COMPLETED|Overall Study||0||
59717993|NCT01123200|75837156|FG000|NOT COMPLETED|Overall Study||1||
59717994|NCT00955617|75837160|FG000|STARTED|First MRA (Between Day0 and Day21)||10||
59717995|NCT00955617|75837161|FG001|STARTED|First MRA (Between Day0 and Day21)||10||
59717996|NCT00955617|75837160|FG000|COMPLETED|First MRA (Between Day0 and Day21)||10||
59717997|NCT00955617|75837161|FG001|COMPLETED|First MRA (Between Day0 and Day21)||10||
59717998|NCT00955617|75837160|FG000|NOT COMPLETED|First MRA (Between Day0 and Day21)||0||
59717999|NCT00955617|75837161|FG001|NOT COMPLETED|First MRA (Between Day0 and Day21)||0||
59718000|NCT00955617|75837160|FG000|STARTED|Second MRA (Between Day 1 and Day 51)||10||
59835999|NCT00332462|75959832|FG000|STARTED|Overall Study|Safety and Intention to treat population.|34||
59836000|NCT00332462|75959832|FG000|Patients Treated With Sandimmun® i.v.|Overall Study||34||
59836001|NCT00332462|75959832|FG000|Patients Treated With Sandimmun® Optoral|Overall Study||29||
59567559|NCT02326272|75670462|FG009|STARTED|Maintenance Period (Week 16 to Week 48)||12||
59718001|NCT00955617|75837161|FG001|STARTED|Second MRA (Between Day 1 and Day 51)||10||
59718002|NCT00955617|75837160|FG000|COMPLETED|Second MRA (Between Day 1 and Day 51)||7||
59718003|NCT00955617|75837161|FG001|COMPLETED|Second MRA (Between Day 1 and Day 51)||7||
59718004|NCT00955617|75837160|FG000|NOT COMPLETED|Second MRA (Between Day 1 and Day 51)||3||
59718005|NCT00955617|75837161|FG001|NOT COMPLETED|Second MRA (Between Day 1 and Day 51)||3||
59718006|NCT00958347|75837167|FG000|STARTED|Overall Study||226||
59718007|NCT00958347|75837167|FG000|COMPLETED|Overall Study|11 revisions total, one was a bilateral participant with the other hip counted as not completed.|0||
59718008|NCT00958347|75837167|FG000|NOT COMPLETED|Overall Study||226||
59718009|NCT00958191|75837171|FG000|STARTED|Overall Study||221||240
59718010|NCT00958191|75837171|FG000|COMPLETED|Overall Study||110|Complete/Not completed counts are based on participant status at the 5 yr primary outcome interval.|118
59718011|NCT00958191|75837171|FG000|NOT COMPLETED|Overall Study||111||122
59718012|NCT00960843|75837179|FG000|STARTED|Overall Study||25||
59718013|NCT00960843|75837180|FG001|STARTED|Overall Study||26||
59718014|NCT00960843|75837179|FG000|COMPLETED|Overall Study||23||
59718015|NCT00960843|75837180|FG001|COMPLETED|Overall Study||21||
59718016|NCT00960843|75837179|FG000|NOT COMPLETED|Overall Study||2||
59718017|NCT00960843|75837180|FG001|NOT COMPLETED|Overall Study||5||
59718018|NCT01605253|75837188|FG000|STARTED|Overall Study||13||
59718019|NCT01605253|75837189|FG001|STARTED|Overall Study||12||
59718020|NCT01605253|75837188|FG000|COMPLETED|Overall Study||7||
59718021|NCT01605253|75837189|FG001|COMPLETED|Overall Study||9||
59718022|NCT01605253|75837188|FG000|NOT COMPLETED|Overall Study||6||
59718023|NCT01605253|75837189|FG001|NOT COMPLETED|Overall Study||3||
59718024|NCT00955305|75837199|FG000|STARTED|Overall Study||88||
59718025|NCT00955305|75837200|FG001|STARTED|Overall Study||87||
59718026|NCT00955305|75837199|FG000|Treated|Overall Study||83||
59718027|NCT00955305|75837200|FG001|Treated|Overall Study||82||
59718028|NCT00955305|75837199|FG000|Eligible and Treated|Overall Study||78||
59718029|NCT00955305|75837200|FG001|Eligible and Treated|Overall Study||75||
59718030|NCT00955305|75837199|FG000|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicities.|0||
59836002|NCT00332462|75959832|FG000|COMPLETED|Overall Study||18||
59836003|NCT00332462|75959832|FG000|NOT COMPLETED|Overall Study||16||
60119201|NCT02461966|76240326|FG002|NOT COMPLETED|Overall Study||0||
59836004|NCT00324038|75959841|FG000|STARTED|Overall Study||110||
59836005|NCT00324038|75959842|FG001|STARTED|Overall Study||109||
59836006|NCT00324038|75959841|FG000|COMPLETED|Overall Study||61||
59836007|NCT00324038|75959842|FG001|COMPLETED|Overall Study||58||
59836008|NCT00324038|75959841|FG000|NOT COMPLETED|Overall Study||49||
59836009|NCT00324038|75959842|FG001|NOT COMPLETED|Overall Study||51||
59836010|NCT00159861|75959850|FG000|STARTED|Core Study - 16 Weeks||133||
59567560|NCT02326272|75670463|FG010|STARTED|Maintenance Period (Week 16 to Week 48)||0||
59567561|NCT02326272|75670464|FG011|STARTED|Maintenance Period (Week 16 to Week 48)||0||
59567562|NCT02326272|75670465|FG012|STARTED|Maintenance Period (Week 16 to Week 48)||0||
59567563|NCT02326272|75670466|FG013|STARTED|Maintenance Period (Week 16 to Week 48)||0||
59567564|NCT02326272|75670467|FG014|STARTED|Maintenance Period (Week 16 to Week 48)||0||
59567565|NCT02326272|75670453|FG000|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0||
59718031|NCT00955305|75837200|FG001|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicities.|0||
59718032|NCT00955305|75837199|FG000|NOT COMPLETED|Overall Study||88||
59718033|NCT00955305|75837200|FG001|NOT COMPLETED|Overall Study||87||
59718034|NCT00598585|75837208|FG000|STARTED|Overall Study||6||
59718035|NCT00598585|75837209|FG001|STARTED|Overall Study||6||
59718036|NCT00598585|75837208|FG000|COMPLETED|Overall Study||5||
59718037|NCT00598585|75837209|FG001|COMPLETED|Overall Study||6||
59718038|NCT00598585|75837208|FG000|NOT COMPLETED|Overall Study||1||
59718039|NCT00598585|75837209|FG001|NOT COMPLETED|Overall Study||0||
59718040|NCT00953667|75837215|FG000|STARTED|Overall Study||400||
59718041|NCT00953667|75837215|FG000|COMPLETED|Overall Study||277||
59718042|NCT00953667|75837215|FG000|NOT COMPLETED|Overall Study||123||
59718043|NCT00883129|75837221|FG000|STARTED|Overall Study||69||
59718044|NCT00883129|75837222|FG001|STARTED|Overall Study||73||
60119202|NCT02421094|76240336|FG000|STARTED|Overall Study||15||
60119203|NCT02421094|76240337|FG001|STARTED|Overall Study||15||
60119204|NCT02421094|76240336|FG000|COMPLETED|Overall Study||15||
59718045|NCT00883129|75837221|FG000|COMPLETED|Overall Study|53 subjects provided a 24 month outcome, 4 of whom had prematurely withdrawn from drug treatment.|49||
59718046|NCT00883129|75837222|FG001|COMPLETED|Overall Study|53 subjects provided a 24 month outcome, 16 of whom had prematurely withdrawn from drug treatment.|37||
59718047|NCT00883129|75837221|FG000|NOT COMPLETED|Overall Study||20||
59718048|NCT00883129|75837222|FG001|NOT COMPLETED|Overall Study||36||
59718049|NCT01278927|75837232|FG000|STARTED|Overall Study||180||
59718050|NCT01278927|75837233|FG001|STARTED|Overall Study||178||
59718051|NCT01278927|75837234|FG002|STARTED|Overall Study||178||
59718052|NCT01278927|75837235|FG003|STARTED|Overall Study||175||
59718053|NCT01278927|75837232|FG000|COMPLETED|Overall Study||180||
59718054|NCT01278927|75837233|FG001|COMPLETED|Overall Study||178||
59718055|NCT01278927|75837234|FG002|COMPLETED|Overall Study||178||
59718056|NCT01278927|75837235|FG003|COMPLETED|Overall Study||175||
59718057|NCT01278927|75837232|FG000|NOT COMPLETED|Overall Study||0||
59718058|NCT01278927|75837233|FG001|NOT COMPLETED|Overall Study||0||
59718059|NCT01278927|75837234|FG002|NOT COMPLETED|Overall Study||0||
59836011|NCT00159861|75959851|FG001|STARTED|Core Study - 16 Weeks||134||
59836012|NCT00159861|75959850|FG000|Treated|Core Study - 16 Weeks||131||
59836013|NCT00159861|75959851|FG001|Treated|Core Study - 16 Weeks||134||
59836014|NCT00159861|75959850|FG000|COMPLETED|Core Study - 16 Weeks|Entered A1481153: 115; Did not enter A1481153: 16|108||
59836015|NCT00159861|75959851|FG001|COMPLETED|Core Study - 16 Weeks|Entered A1481153: 127; Did not enter A1481153: 7|122||
59836016|NCT00159861|75959850|FG000|NOT COMPLETED|Core Study - 16 Weeks||25||
59836017|NCT00159861|75959851|FG001|NOT COMPLETED|Core Study - 16 Weeks||12||
59836018|NCT00159861|75959850|FG000|STARTED|Extension Study - up to 3 Years|Subjects may have entered extension study after 4 weeks in core study (prior to completion).|115||
59836019|NCT00159861|75959851|FG001|STARTED|Extension Study - up to 3 Years|Subjects may have entered extension study after 4 weeks in core study (prior to completion).|127||
59836020|NCT00159861|75959850|FG000|Treated|Extension Study - up to 3 Years||115||
59836021|NCT00159861|75959851|FG001|Treated|Extension Study - up to 3 Years||127||
60119205|NCT02421094|76240337|FG001|COMPLETED|Overall Study||15||
59718060|NCT01278927|75837235|FG003|NOT COMPLETED|Overall Study||0||
59718061|NCT00905632|75837253|FG000|STARTED|Overall Study||8||
59718062|NCT00905632|75837254|FG001|STARTED|Overall Study||6||
59718063|NCT00905632|75837255|FG002|STARTED|Overall Study||7||
59718064|NCT00905632|75837256|FG003|STARTED|Overall Study||6||
59718065|NCT00905632|75837257|FG004|STARTED|Overall Study||10||
59718066|NCT00905632|75837258|FG005|STARTED|Overall Study||9||
59718067|NCT00905632|75837259|FG006|STARTED|Overall Study||11||
59718068|NCT00905632|75837253|FG000|COMPLETED|Overall Study||8||
59718069|NCT00905632|75837254|FG001|COMPLETED|Overall Study||6||
59718070|NCT00905632|75837255|FG002|COMPLETED|Overall Study||7||
59836022|NCT00159861|75959850|FG000|COMPLETED|Extension Study - up to 3 Years||53||
59836023|NCT00159861|75959851|FG001|COMPLETED|Extension Study - up to 3 Years||56||
59836024|NCT00159861|75959850|FG000|NOT COMPLETED|Extension Study - up to 3 Years||62||
59836025|NCT00159861|75959851|FG001|NOT COMPLETED|Extension Study - up to 3 Years||71||
59836026|NCT00331760|75959864|FG000|STARTED|Overall Study||58||
59836027|NCT00331760|75959865|FG001|STARTED|Overall Study||48||
59836028|NCT00331760|75959864|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|43||
59836029|NCT00331760|75959865|FG001|COMPLETED|Overall Study||40||
59836030|NCT00331760|75959864|FG000|NOT COMPLETED|Overall Study||15||
59836031|NCT00331760|75959865|FG001|NOT COMPLETED|Overall Study||8||
59836032|NCT00225147|75959876|FG000|STARTED|Double-blind Phase||13||
59836033|NCT00225147|75959877|FG001|STARTED|Double-blind Phase||12||
59836034|NCT00225147|75959878|FG002|STARTED|Double-blind Phase||13||
59836035|NCT00225147|75959879|FG003|STARTED|Double-blind Phase||0||
59836036|NCT00225147|75959876|FG000|COMPLETED|Double-blind Phase||13||
59836037|NCT00225147|75959877|FG001|COMPLETED|Double-blind Phase||12||
59836038|NCT00225147|75959878|FG002|COMPLETED|Double-blind Phase||13||
59836039|NCT00225147|75959879|FG003|COMPLETED|Double-blind Phase||0||
59836040|NCT00225147|75959876|FG000|NOT COMPLETED|Double-blind Phase||0||
59836041|NCT00225147|75959877|FG001|NOT COMPLETED|Double-blind Phase||0||
59836042|NCT00225147|75959878|FG002|NOT COMPLETED|Double-blind Phase||0||
59836043|NCT00225147|75959879|FG003|NOT COMPLETED|Double-blind Phase||0||
59836044|NCT00225147|75959876|FG000|STARTED|Open-label Phase||0||
59836045|NCT00225147|75959877|FG001|STARTED|Open-label Phase||0||
59836046|NCT00225147|75959878|FG002|STARTED|Open-label Phase||0||
59836047|NCT00225147|75959879|FG003|STARTED|Open-label Phase||62||
59836048|NCT00225147|75959876|FG000|COMPLETED|Open-label Phase||0||
59836049|NCT00225147|75959877|FG001|COMPLETED|Open-label Phase||0||
59836050|NCT00225147|75959878|FG002|COMPLETED|Open-label Phase||0||
59836051|NCT00225147|75959879|FG003|COMPLETED|Open-label Phase||52||
59836052|NCT00225147|75959876|FG000|NOT COMPLETED|Open-label Phase||0||
59836053|NCT00225147|75959877|FG001|NOT COMPLETED|Open-label Phase||0||
59836054|NCT00225147|75959878|FG002|NOT COMPLETED|Open-label Phase||0||
59836055|NCT00225147|75959879|FG003|NOT COMPLETED|Open-label Phase||10||
59836056|NCT00313014|75959894|FG000|STARTED|Overall Study||221||
59836057|NCT00313014|75959895|FG001|STARTED|Overall Study||219||
59836058|NCT00313014|75959896|FG002|STARTED|Overall Study||220||
59836059|NCT00313014|75959894|FG000|COMPLETED|Overall Study||128||
59836060|NCT00313014|75959895|FG001|COMPLETED|Overall Study||146||
59836061|NCT00313014|75959896|FG002|COMPLETED|Overall Study||159||
59836062|NCT00313014|75959894|FG000|NOT COMPLETED|Overall Study||93||
59836063|NCT00313014|75959895|FG001|NOT COMPLETED|Overall Study||73||
59836064|NCT00313014|75959896|FG002|NOT COMPLETED|Overall Study||61||
59836065|NCT00157209|75959907|FG000|STARTED|Overall Study||88||
59836066|NCT00157209|75959908|FG001|STARTED|Overall Study||83||
59836067|NCT00157209|75959907|FG000|COMPLETED|Overall Study||78||
60119206|NCT02421094|76240336|FG000|NOT COMPLETED|Overall Study||0||
60119207|NCT02421094|76240337|FG001|NOT COMPLETED|Overall Study||0||
60119208|NCT02462122|76240345|FG000|STARTED|Overall Study||141||
60119209|NCT02462122|76240346|FG001|STARTED|Overall Study||74||
59718071|NCT00905632|75837256|FG003|COMPLETED|Overall Study||6||
59718072|NCT00905632|75837257|FG004|COMPLETED|Overall Study||10||
59718073|NCT00905632|75837258|FG005|COMPLETED|Overall Study||8||
59718074|NCT00905632|75837259|FG006|COMPLETED|Overall Study||7||
59718075|NCT00905632|75837253|FG000|NOT COMPLETED|Overall Study||0||
59718076|NCT00905632|75837254|FG001|NOT COMPLETED|Overall Study||0||
59718077|NCT00905632|75837255|FG002|NOT COMPLETED|Overall Study||0||
59718078|NCT00905632|75837256|FG003|NOT COMPLETED|Overall Study||0||
59718079|NCT00905632|75837257|FG004|NOT COMPLETED|Overall Study||0||
59718080|NCT00905632|75837258|FG005|NOT COMPLETED|Overall Study||1||
59718081|NCT00905632|75837259|FG006|NOT COMPLETED|Overall Study||4||
59718082|NCT00954447|75837284|FG000|STARTED|Overall Study||630||
59836068|NCT00157209|75959908|FG001|COMPLETED|Overall Study||83||
59836069|NCT00157209|75959907|FG000|NOT COMPLETED|Overall Study||10||
59836070|NCT00157209|75959908|FG001|NOT COMPLETED|Overall Study||0||
59836071|NCT00312858|75959916|FG000|STARTED|Overall Study||330||
59836072|NCT00312858|75959917|FG001|STARTED|Overall Study||323||
59836073|NCT00312858|75959916|FG000|Visit 1|Overall Study||330||
59836074|NCT00312858|75959917|FG001|Visit 1|Overall Study||323||
59836075|NCT00312858|75959916|FG000|Visit 2|Overall Study||305||
59836076|NCT00312858|75959917|FG001|Visit 2|Overall Study||294||
59836077|NCT00312858|75959916|FG000|Visit 3|Overall Study||273||
59836078|NCT00312858|75959917|FG001|Visit 3|Overall Study||261||
59836079|NCT00312858|75959916|FG000|Visit 4|Overall Study||262||
59836080|NCT00312858|75959917|FG001|Visit 4|Overall Study||240||
59836081|NCT00312858|75959916|FG000|COMPLETED|Overall Study||262||
59836082|NCT00312858|75959917|FG001|COMPLETED|Overall Study||230||
59836083|NCT00312858|75959916|FG000|NOT COMPLETED|Overall Study||68||
59836084|NCT00312858|75959917|FG001|NOT COMPLETED|Overall Study||93||
59836085|NCT00312702|75959926|FG000|STARTED|Immunization Phase||5||
59836086|NCT00312702|75959927|FG001|STARTED|Immunization Phase||13||
59836087|NCT00312702|75959928|FG002|STARTED|Immunization Phase||0||
60119210|NCT02462122|76240345|FG000|COMPLETED|Overall Study||120||
59836088|NCT00312702|75959926|FG000|COMPLETED|Immunization Phase||5||
59836089|NCT00312702|75959927|FG001|COMPLETED|Immunization Phase||12||
59836090|NCT00312702|75959928|FG002|COMPLETED|Immunization Phase||0||
59836091|NCT00312702|75959926|FG000|NOT COMPLETED|Immunization Phase||0||
59836092|NCT00312702|75959927|FG001|NOT COMPLETED|Immunization Phase||1||
59836093|NCT00312702|75959928|FG002|NOT COMPLETED|Immunization Phase||0||
59836094|NCT00312702|75959926|FG000|STARTED|Challenge Phase|low dose subjects didn't participate in the challenge phase|0||
59836095|NCT00312702|75959927|FG001|STARTED|Challenge Phase|12 subjects from the high dose group participated in the challenge phase|12||
59836096|NCT00312702|75959928|FG002|STARTED|Challenge Phase|1 non-immunized subjects participated in the challenge phase.|1||
59836097|NCT00312702|75959926|FG000|COMPLETED|Challenge Phase||0||
59836098|NCT00312702|75959927|FG001|COMPLETED|Challenge Phase||12||
59836099|NCT00312702|75959928|FG002|COMPLETED|Challenge Phase||1||
59836100|NCT00312702|75959926|FG000|NOT COMPLETED|Challenge Phase||0||
59836101|NCT00312702|75959927|FG001|NOT COMPLETED|Challenge Phase||0||
59836102|NCT00312702|75959928|FG002|NOT COMPLETED|Challenge Phase||0||
59836103|NCT00156819|75959939|FG000|STARTED|Overall Study||169||
59836104|NCT00156819|75959940|FG001|STARTED|Overall Study||166||
59836105|NCT00156819|75959941|FG002|STARTED|Overall Study||165||
59836106|NCT00156819|75959939|FG000|COMPLETED|Overall Study||168||
59836107|NCT00156819|75959940|FG001|COMPLETED|Overall Study||165||
59836108|NCT00156819|75959941|FG002|COMPLETED|Overall Study||162||
59836109|NCT00156819|75959939|FG000|NOT COMPLETED|Overall Study||1||
59836110|NCT00156819|75959940|FG001|NOT COMPLETED|Overall Study||1||
59836111|NCT00156819|75959941|FG002|NOT COMPLETED|Overall Study||3||
59836112|NCT03825042|75959951|FG000|STARTED|Overall Study||40||
59836113|NCT03825042|75959952|FG001|STARTED|Overall Study||40||
59836114|NCT03825042|75959951|FG000|COMPLETED|Overall Study||38||
59836115|NCT03825042|75959952|FG001|COMPLETED|Overall Study||40||
59836116|NCT03825042|75959951|FG000|NOT COMPLETED|Overall Study||2||
59836117|NCT03825042|75959952|FG001|NOT COMPLETED|Overall Study||0||
59836118|NCT00129987|75959960|FG000|STARTED|1st Educational Session||287||
59836119|NCT00129987|75959961|FG001|STARTED|1st Educational Session||280||
59836120|NCT00129987|75959960|FG000|COMPLETED|1st Educational Session||146||
59836121|NCT00129987|75959961|FG001|COMPLETED|1st Educational Session||171||
59836122|NCT00129987|75959960|FG000|NOT COMPLETED|1st Educational Session||141||
59836123|NCT00129987|75959961|FG001|NOT COMPLETED|1st Educational Session||109||
59836124|NCT00129987|75959960|FG000|STARTED|1 Year||146||
59836125|NCT00129987|75959961|FG001|STARTED|1 Year||171||
59836126|NCT00129987|75959960|FG000|COMPLETED|1 Year||114||
59836127|NCT00129987|75959961|FG001|COMPLETED|1 Year||150||
59836128|NCT00129987|75959960|FG000|NOT COMPLETED|1 Year||32||
59836129|NCT00129987|75959961|FG001|NOT COMPLETED|1 Year||21||
59836130|NCT00224133|75959967|FG000|STARTED|Overall Study||661||
59836131|NCT00224133|75959967|FG000|COMPLETED|Overall Study||435||
59836132|NCT00224133|75959967|FG000|NOT COMPLETED|Overall Study||226||
59836133|NCT00224055|75959973|FG000|STARTED|Overall Study||44||
59836134|NCT00224055|75959974|FG001|STARTED|Overall Study||45||
59836135|NCT00224055|75959973|FG000|COMPLETED|Overall Study||29||
59836136|NCT00224055|75959974|FG001|COMPLETED|Overall Study||31||
59836137|NCT00224055|75959973|FG000|NOT COMPLETED|Overall Study||15||
59836138|NCT00224055|75959974|FG001|NOT COMPLETED|Overall Study||14||
59836139|NCT00150345|75959982|FG000|STARTED|Overall Study||81||
59836140|NCT00150345|75959983|FG001|STARTED|Overall Study||66||
59836141|NCT00150345|75959982|FG000|COMPLETED|Overall Study||47||
59836142|NCT00150345|75959983|FG001|COMPLETED|Overall Study||34||
59836143|NCT00150345|75959982|FG000|NOT COMPLETED|Overall Study||34||
59836144|NCT00150345|75959983|FG001|NOT COMPLETED|Overall Study||32||
59836145|NCT00223977|75959993|FG000|STARTED|Overall Study||46||
59836146|NCT00223977|75959994|FG001|STARTED|Overall Study||58||
59836147|NCT00223977|75959995|FG002|STARTED|Overall Study||42||
59836148|NCT00223977|75959993|FG000|COMPLETED|Overall Study||37||
59836149|NCT00223977|75959994|FG001|COMPLETED|Overall Study||47||
59836150|NCT00223977|75959995|FG002|COMPLETED|Overall Study||39||
59836151|NCT00223977|75959993|FG000|NOT COMPLETED|Overall Study||9||
59836152|NCT00223977|75959994|FG001|NOT COMPLETED|Overall Study||11||
59836153|NCT00223977|75959995|FG002|NOT COMPLETED|Overall Study||3||
59836154|NCT00148941|75960007|FG000|STARTED|Overall Study||1053||
59836155|NCT00148941|75960008|FG001|STARTED|Overall Study||1051||
59836156|NCT00148941|75960009|FG002|STARTED|Overall Study||1052||
59836157|NCT00148941|75960010|FG003|STARTED|Overall Study||1053||
59836158|NCT00148941|75960007|FG000|COMPLETED|Overall Study||1035||
59836159|NCT00148941|75960008|FG001|COMPLETED|Overall Study||1027||
59836160|NCT00148941|75960009|FG002|COMPLETED|Overall Study||1032||
59836161|NCT00148941|75960010|FG003|COMPLETED|Overall Study||1029||
59836162|NCT00148941|75960007|FG000|NOT COMPLETED|Overall Study||18||
59836163|NCT00148941|75960008|FG001|NOT COMPLETED|Overall Study||24||
59836164|NCT00148941|75960009|FG002|NOT COMPLETED|Overall Study||20||
59836165|NCT00148941|75960010|FG003|NOT COMPLETED|Overall Study||24||
59836166|NCT00148317|75960020|FG000|STARTED|Consolidation (VEL + DEX)||38||
59836167|NCT00148317|75960020|FG000|DOXIL Added at Cycle 3|Consolidation (VEL + DEX)||16||
59836168|NCT00148317|75960020|FG000|DOXIL Added at Cycle 5|Consolidation (VEL + DEX)||12||
59836169|NCT00148317|75960020|FG000|no DOXIL Added|Consolidation (VEL + DEX)||10||
59836170|NCT00148317|75960020|FG000|COMPLETED|Consolidation (VEL + DEX)||38||
59836171|NCT00148317|75960020|FG000|NOT COMPLETED|Consolidation (VEL + DEX)||0||
59836172|NCT00148317|75960020|FG000|STARTED|Mobilization (VEL+CYTOXAN+FILGRASTIM)||38||
59836173|NCT00148317|75960020|FG000|COMPLETED|Mobilization (VEL+CYTOXAN+FILGRASTIM)||27||
59567566|NCT02326272|75670454|FG001|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0||
59567567|NCT02326272|75670455|FG002|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0||
59567568|NCT02326272|75670456|FG003|Completed Week 48|Maintenance Period (Week 16 to Week 48)||5||
59567569|NCT02326272|75670457|FG004|Completed Week 48|Maintenance Period (Week 16 to Week 48)||3||
59567570|NCT02326272|75670458|FG005|Completed Week 48|Maintenance Period (Week 16 to Week 48)||64||
59567571|NCT02326272|75670459|FG006|Completed Week 48|Maintenance Period (Week 16 to Week 48)||61||
59836174|NCT00148317|75960020|FG000|NOT COMPLETED|Mobilization (VEL+CYTOXAN+FILGRASTIM)||11||
59836175|NCT00323882|75960032|FG000|STARTED|Overall Study||8||
59836176|NCT00323882|75960033|FG001|STARTED|Overall Study||6||
59836177|NCT00323882|75960034|FG002|STARTED|Overall Study||16||
59836178|NCT00323882|75960035|FG003|STARTED|Overall Study||7||
59836179|NCT00323882|75960036|FG004|STARTED|Overall Study||34||
59836180|NCT00323882|75960032|FG000|COMPLETED|Overall Study||0||
59836181|NCT00323882|75960033|FG001|COMPLETED|Overall Study||0||
59836182|NCT00323882|75960034|FG002|COMPLETED|Overall Study||3||
59836183|NCT00323882|75960035|FG003|COMPLETED|Overall Study||0||
59836184|NCT00323882|75960036|FG004|COMPLETED|Overall Study||2||
59836185|NCT00323882|75960032|FG000|NOT COMPLETED|Overall Study||8||
59836186|NCT00323882|75960033|FG001|NOT COMPLETED|Overall Study||6||
59836187|NCT00323882|75960034|FG002|NOT COMPLETED|Overall Study||13||
59836188|NCT00323882|75960035|FG003|NOT COMPLETED|Overall Study||7||
59836189|NCT00323882|75960036|FG004|NOT COMPLETED|Overall Study||32||
59836190|NCT00331682|75960057|FG000|STARTED|Overall Study||10||
59836191|NCT00331682|75960057|FG000|COMPLETED|Overall Study||9||
59836192|NCT00331682|75960057|FG000|NOT COMPLETED|Overall Study||1||
59836193|NCT00323492|75960063|FG000|STARTED|Study Phase 1||47||
59836194|NCT00323492|75960064|FG001|STARTED|Study Phase 1||45||
59836195|NCT00323492|75960065|FG002|STARTED|Study Phase 1|Not applicable to Phase 1.|0||
59836196|NCT00323492|75960063|FG000|Intent-to-Treat (ITT) Analysis Set|Study Phase 1|One subject was excluded from ITT analysis set due to protocol violation.|46||
59836197|NCT00323492|75960064|FG001|Intent-to-Treat (ITT) Analysis Set|Study Phase 1||45||
59836198|NCT00323492|75960065|FG002|Intent-to-Treat (ITT) Analysis Set|Study Phase 1||0||
59836199|NCT00323492|75960063|FG000|COMPLETED|Study Phase 1||45||
59836200|NCT00323492|75960064|FG001|COMPLETED|Study Phase 1||45||
59836201|NCT00323492|75960065|FG002|COMPLETED|Study Phase 1||0||
59836202|NCT00323492|75960063|FG000|NOT COMPLETED|Study Phase 1||2||
59836203|NCT00323492|75960064|FG001|NOT COMPLETED|Study Phase 1||0||
59836204|NCT00323492|75960065|FG002|NOT COMPLETED|Study Phase 1||0||
59836205|NCT00323492|75960063|FG000|STARTED|Study Phase 2|1/45 subjects completed Phase 1 but did not start Phase 2. Week 48 ITT N=46|44||
59836206|NCT00323492|75960064|FG001|STARTED|Study Phase 2|2/45 subjects completed Phase 1 but did not start Phase 2. Week 48 ITT N=20 (no switch to Truvada)|18||
59836207|NCT00323492|75960065|FG002|STARTED|Study Phase 2|N=25 switched to Truvada in Phase 2.|25||
59836208|NCT00323492|75960063|FG000|COMPLETED|Study Phase 2||40||
59836209|NCT00323492|75960064|FG001|COMPLETED|Study Phase 2||17||
59836210|NCT00323492|75960065|FG002|COMPLETED|Study Phase 2||24||
59836211|NCT00323492|75960063|FG000|NOT COMPLETED|Study Phase 2||4||
59836212|NCT00323492|75960064|FG001|NOT COMPLETED|Study Phase 2||1||
59567572|NCT02326272|75670460|FG007|Completed Week 48|Maintenance Period (Week 16 to Week 48)||27||
59567573|NCT02326272|75670461|FG008|Completed Week 48|Maintenance Period (Week 16 to Week 48)||3||
59567574|NCT02326272|75670462|FG009|Completed Week 48|Maintenance Period (Week 16 to Week 48)||10||
59567575|NCT02326272|75670463|FG010|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0||
59567576|NCT02326272|75670464|FG011|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0||
59567577|NCT02326272|75670465|FG012|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0||
59718083|NCT00954447|75837285|FG001|STARTED|Overall Study||631||
59718084|NCT00954447|75837284|FG000|COMPLETED|Overall Study||520||
59718085|NCT00954447|75837285|FG001|COMPLETED|Overall Study||543||
59718086|NCT00954447|75837284|FG000|NOT COMPLETED|Overall Study||110||
59718087|NCT00954447|75837285|FG001|NOT COMPLETED|Overall Study||88||
59718088|NCT00904150|75837293|FG000|STARTED|Saliva Samples (DNA)||285||
59718089|NCT00904150|75837294|FG001|STARTED|Saliva Samples (DNA)||300||
59718090|NCT00904150|75837293|FG000|COMPLETED|Saliva Samples (DNA)||282||
59567578|NCT02326272|75670466|FG013|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0||
59567579|NCT02326272|75670467|FG014|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0||
59718091|NCT00904150|75837294|FG001|COMPLETED|Saliva Samples (DNA)||155||
59718092|NCT00904150|75837293|FG000|NOT COMPLETED|Saliva Samples (DNA)||3||
59718093|NCT00904150|75837294|FG001|NOT COMPLETED|Saliva Samples (DNA)||145||
59836213|NCT00323492|75960065|FG002|NOT COMPLETED|Study Phase 2||1||
59836214|NCT00331136|75960076|FG000|STARTED|Overall Study||15||
59836215|NCT00331136|75960077|FG001|STARTED|Overall Study||15||
59836216|NCT00331136|75960078|FG002|STARTED|Overall Study||15||
59836217|NCT00331136|75960079|FG003|STARTED|Overall Study||15||
59718094|NCT00904150|75837293|FG000|STARTED|Blood Samples (RNA): Follicular Phase||37||
59718095|NCT00904150|75837294|FG001|STARTED|Blood Samples (RNA): Follicular Phase||32||
59836218|NCT00331136|75960076|FG000|COMPLETED|Overall Study||10||
59836219|NCT00331136|75960077|FG001|COMPLETED|Overall Study||8||
59836220|NCT00331136|75960078|FG002|COMPLETED|Overall Study||15||
59836221|NCT00331136|75960079|FG003|COMPLETED|Overall Study||14||
59836222|NCT00331136|75960076|FG000|NOT COMPLETED|Overall Study||5||
59836223|NCT00331136|75960077|FG001|NOT COMPLETED|Overall Study||7||
59836224|NCT00331136|75960078|FG002|NOT COMPLETED|Overall Study||0||
59836225|NCT00331136|75960079|FG003|NOT COMPLETED|Overall Study||1||
59836226|NCT00323414|75960091|FG000|STARTED|Overall Study||18||
59836227|NCT00323414|75960092|FG001|STARTED|Overall Study||19||
59836228|NCT00323414|75960091|FG000|COMPLETED|Overall Study||18||
59836229|NCT00323414|75960092|FG001|COMPLETED|Overall Study||18||
59836230|NCT00323414|75960091|FG000|NOT COMPLETED|Overall Study||0||
59836231|NCT00323414|75960092|FG001|NOT COMPLETED|Overall Study||1||
59836232|NCT00330668|75960098|FG000|STARTED|BID Dosing Period||114||
59836233|NCT00330668|75960098|FG000|COMPLETED|BID Dosing Period||78||
59836234|NCT00330668|75960098|FG000|NOT COMPLETED|BID Dosing Period||36||
59836235|NCT00330668|75960098|FG000|STARTED|QD Dosing Period||78||
59836236|NCT00330668|75960098|FG000|COMPLETED|QD Dosing Period||0||
59836237|NCT00330668|75960098|FG000|NOT COMPLETED|QD Dosing Period||78||
59836238|NCT00306384|75960105|FG000|STARTED|Overall Study||1396||
59836239|NCT00306384|75960106|FG001|STARTED|Overall Study||1399||
59836240|NCT00306384|75960107|FG002|STARTED|Overall Study||528||
59836241|NCT00306384|75960105|FG000|Safety Set|Overall Study|Patients who received at least one dose of study drug|1395||
59836242|NCT00306384|75960106|FG001|Safety Set|Overall Study|Patients who received at least one dose of study drug|1398||
59836243|NCT00306384|75960107|FG002|Safety Set|Overall Study|Patients who received at least one dose of study drug|527||
59836244|NCT00306384|75960105|FG000|COMPLETED|Overall Study||854||
59836245|NCT00306384|75960106|FG001|COMPLETED|Overall Study||891||
59836246|NCT00306384|75960107|FG002|COMPLETED|Overall Study||251||
59836247|NCT00306384|75960105|FG000|NOT COMPLETED|Overall Study||542||
59836248|NCT00306384|75960106|FG001|NOT COMPLETED|Overall Study||508||
59836249|NCT00306384|75960107|FG002|NOT COMPLETED|Overall Study||277||
59836250|NCT00305604|75960117|FG000|STARTED|Overall Study||102||
59836251|NCT00305604|75960118|FG001|STARTED|Overall Study||104||
59836252|NCT00305604|75960117|FG000|COMPLETED|Overall Study||70||
59836253|NCT00305604|75960118|FG001|COMPLETED|Overall Study||57||
59836254|NCT00305604|75960117|FG000|NOT COMPLETED|Overall Study||32||
59836255|NCT00305604|75960118|FG001|NOT COMPLETED|Overall Study||47||
59836256|NCT00501059|75960126|FG000|STARTED|Overall Study||6270||
59836257|NCT00501059|75960127|FG001|STARTED|Overall Study||6276||
59836258|NCT00501059|75960126|FG000|COMPLETED|Overall Study||4402||
59836259|NCT00501059|75960127|FG001|COMPLETED|Overall Study||4384||
59836260|NCT00501059|75960126|FG000|NOT COMPLETED|Overall Study||1868||
59836261|NCT00501059|75960127|FG001|NOT COMPLETED|Overall Study||1892||
59836262|NCT00344318|75960139|FG000|STARTED|Overall Study||300||
59836263|NCT00344318|75960140|FG001|STARTED|Overall Study||303||
59836264|NCT00344318|75960141|FG002|STARTED|Overall Study||100||
59836265|NCT00344318|75960142|FG003|STARTED|Overall Study||103||
59836266|NCT00344318|75960139|FG000|COMPLETED|Overall Study||296||
59836267|NCT00344318|75960140|FG001|COMPLETED|Overall Study||298||
59836268|NCT00344318|75960141|FG002|COMPLETED|Overall Study||99||
59836269|NCT00344318|75960142|FG003|COMPLETED|Overall Study||100||
59836270|NCT00344318|75960139|FG000|NOT COMPLETED|Overall Study||4||
59836271|NCT00344318|75960140|FG001|NOT COMPLETED|Overall Study||5||
59836272|NCT00344318|75960141|FG002|NOT COMPLETED|Overall Study||1||
59836273|NCT00344318|75960142|FG003|NOT COMPLETED|Overall Study||3||
59836274|NCT00323258|75960156|FG000|STARTED|Primary Outcome (Phone Call at 6 Months)||71||
59836275|NCT00323258|75960157|FG001|STARTED|Primary Outcome (Phone Call at 6 Months)||72||
59836276|NCT00323258|75960156|FG000|COMPLETED|Primary Outcome (Phone Call at 6 Months)||55||
59836277|NCT00323258|75960157|FG001|COMPLETED|Primary Outcome (Phone Call at 6 Months)||53||
59836278|NCT00323258|75960156|FG000|NOT COMPLETED|Primary Outcome (Phone Call at 6 Months)||16||
59836279|NCT00323258|75960157|FG001|NOT COMPLETED|Primary Outcome (Phone Call at 6 Months)||19||
59836280|NCT00323258|75960156|FG000|STARTED|Secondary Outcome (6 Mon Refill Records)||71||
59836281|NCT00323258|75960157|FG001|STARTED|Secondary Outcome (6 Mon Refill Records)||72||
59836282|NCT00323258|75960156|FG000|COMPLETED|Secondary Outcome (6 Mon Refill Records)||57||
59836283|NCT00323258|75960157|FG001|COMPLETED|Secondary Outcome (6 Mon Refill Records)||58||
59836284|NCT00323258|75960156|FG000|NOT COMPLETED|Secondary Outcome (6 Mon Refill Records)||14||
59836285|NCT00323258|75960157|FG001|NOT COMPLETED|Secondary Outcome (6 Mon Refill Records)||14||
59836286|NCT00322868|75960163|FG000|STARTED|Overall Study||21||
59836287|NCT00322868|75960163|FG000|COMPLETED|Overall Study||20||
59836288|NCT00322868|75960163|FG000|NOT COMPLETED|Overall Study||1||
59836289|NCT00322712|75960168|FG000|STARTED|Overall Study||12||
59836290|NCT00322712|75960168|FG000|COMPLETED|Overall Study||11||
59836291|NCT00322712|75960168|FG000|NOT COMPLETED|Overall Study||1||
59836292|NCT00343382|75960175|FG000|STARTED|Overall Study||64||
59836293|NCT00343382|75960176|FG001|STARTED|Overall Study||65||
59836294|NCT00343382|75960177|FG002|STARTED|Overall Study||66||
59836295|NCT00343382|75960175|FG000|COMPLETED|Overall Study||60||
59836296|NCT00343382|75960176|FG001|COMPLETED|Overall Study||51||
59836297|NCT00343382|75960177|FG002|COMPLETED|Overall Study||49||
59836298|NCT00343382|75960175|FG000|NOT COMPLETED|Overall Study||4||
59836299|NCT00343382|75960176|FG001|NOT COMPLETED|Overall Study||14||
59836300|NCT00343382|75960177|FG002|NOT COMPLETED|Overall Study||17||
59836301|NCT00481871|75960190|FG000|STARTED|Overall Study||7||
59836302|NCT00481871|75960191|FG001|STARTED|Overall Study||10||
59836303|NCT00481871|75960192|FG002|STARTED|Overall Study||18||
59836304|NCT00481871|75960193|FG003|STARTED|Overall Study||38||
59836305|NCT00481871|75960194|FG004|STARTED|Overall Study||34||
59836306|NCT00481871|75960190|FG000|COMPLETED|Overall Study||7||
59836307|NCT00481871|75960191|FG001|COMPLETED|Overall Study||10||
59836308|NCT00481871|75960192|FG002|COMPLETED|Overall Study||17||
59836309|NCT00481871|75960193|FG003|COMPLETED|Overall Study||38||
59836310|NCT00481871|75960194|FG004|COMPLETED|Overall Study||34||
59836311|NCT00481871|75960190|FG000|NOT COMPLETED|Overall Study||0||
59836312|NCT00481871|75960191|FG001|NOT COMPLETED|Overall Study||0||
59836313|NCT00481871|75960192|FG002|NOT COMPLETED|Overall Study||1||
59836314|NCT00481871|75960193|FG003|NOT COMPLETED|Overall Study||0||
59836315|NCT00481871|75960194|FG004|NOT COMPLETED|Overall Study||0||
59836316|NCT00329420|75960205|FG000|STARTED|Re-induction Phase||18||
59836317|NCT00329420|75960206|FG001|STARTED|Re-induction Phase||13||
59836318|NCT00329420|75960207|FG002|STARTED|Re-induction Phase||15||
59836319|NCT00329420|75960205|FG000|COMPLETED|Re-induction Phase|Completed = Reached Week 14 (end of re-induction phase) and responded to re-induction at that time.|12||
59836320|NCT00329420|75960206|FG001|COMPLETED|Re-induction Phase|Completed = Reached Week 14 (end of re-induction phase) and responded to re-induction at that time.|7||
59836321|NCT00329420|75960207|FG002|COMPLETED|Re-induction Phase|Completed = Reached Week 14 (end of re-induction phase) and responded to re-induction at that time.|7||
59836322|NCT00329420|75960205|FG000|NOT COMPLETED|Re-induction Phase||6||
59836323|NCT00329420|75960206|FG001|NOT COMPLETED|Re-induction Phase||6||
59836324|NCT00329420|75960207|FG002|NOT COMPLETED|Re-induction Phase||8||
59836325|NCT00329420|75960205|FG000|STARTED|4-weekly Dosing Phase (Responders Only)||12||
59836326|NCT00329420|75960206|FG001|STARTED|4-weekly Dosing Phase (Responders Only)||7||
59836327|NCT00329420|75960207|FG002|STARTED|4-weekly Dosing Phase (Responders Only)||7||
59836328|NCT00329420|75960205|FG000|COMPLETED|4-weekly Dosing Phase (Responders Only)||8||
59836329|NCT00329420|75960206|FG001|COMPLETED|4-weekly Dosing Phase (Responders Only)||5||
59836330|NCT00329420|75960207|FG002|COMPLETED|4-weekly Dosing Phase (Responders Only)||6||
59836331|NCT00329420|75960205|FG000|NOT COMPLETED|4-weekly Dosing Phase (Responders Only)||4||
60119211|NCT02462122|76240346|FG001|COMPLETED|Overall Study||61||
60119212|NCT02462122|76240345|FG000|NOT COMPLETED|Overall Study||21||
60119213|NCT02462122|76240346|FG001|NOT COMPLETED|Overall Study||13||
60119214|NCT02423122|76240354|FG000|STARTED|Overall Study||9||
60119215|NCT02423122|76240355|FG001|STARTED|Overall Study||7||
60119216|NCT02423122|76240354|FG000|COMPLETED|Overall Study||9||
60119217|NCT02423122|76240355|FG001|COMPLETED|Overall Study||7||
60119218|NCT02423122|76240354|FG000|NOT COMPLETED|Overall Study||0||
60119219|NCT02423122|76240355|FG001|NOT COMPLETED|Overall Study||0||
60119220|NCT02464540|76240361|FG000|STARTED|Overall Study||11|Participants enrolled in both arms, luting material to be used was randomly selected.|17
59567580|NCT02326272|75670453|FG000|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0||
59718096|NCT00904150|75837293|FG000|COMPLETED|Blood Samples (RNA): Follicular Phase||37||
59718097|NCT00904150|75837294|FG001|COMPLETED|Blood Samples (RNA): Follicular Phase||32||
59718098|NCT00904150|75837293|FG000|NOT COMPLETED|Blood Samples (RNA): Follicular Phase||0||
59718099|NCT00904150|75837294|FG001|NOT COMPLETED|Blood Samples (RNA): Follicular Phase||0||
59718100|NCT00904150|75837293|FG000|STARTED|Blood Samples (RNA): Luteal Phase||34||
59718101|NCT00904150|75837294|FG001|STARTED|Blood Samples (RNA): Luteal Phase||30||
59718102|NCT00904150|75837293|FG000|COMPLETED|Blood Samples (RNA): Luteal Phase||34||
59836332|NCT00329420|75960206|FG001|NOT COMPLETED|4-weekly Dosing Phase (Responders Only)||2||
59836333|NCT00329420|75960207|FG002|NOT COMPLETED|4-weekly Dosing Phase (Responders Only)||1||
60119221|NCT02464540|76240362|FG001|STARTED|Overall Study||11|Participants enrolled in both arms, luting material to be used was randomly selected.|21
60119222|NCT02464540|76240361|FG000|COMPLETED|Overall Study||11||17
59567581|NCT02326272|75670454|FG001|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0||
59567582|NCT02326272|75670455|FG002|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0||
59567583|NCT02326272|75670456|FG003|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||5||
59567584|NCT02326272|75670457|FG004|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||3||
59567585|NCT02326272|75670458|FG005|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||63||
59567586|NCT02326272|75670459|FG006|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||60||
59718103|NCT00904150|75837294|FG001|COMPLETED|Blood Samples (RNA): Luteal Phase||30||
59718104|NCT00904150|75837293|FG000|NOT COMPLETED|Blood Samples (RNA): Luteal Phase||0||
59836334|NCT00329108|75960219|FG000|STARTED|Overall Study|study terminated due to poor recruitment|15||
59836335|NCT00329108|75960220|FG001|STARTED|Overall Study|study terminated due to poor recruitment|14||
59836336|NCT00329108|75960219|FG000|COMPLETED|Overall Study||5||
59836337|NCT00329108|75960220|FG001|COMPLETED|Overall Study||2||
59836338|NCT00329108|75960219|FG000|NOT COMPLETED|Overall Study||10||
59836339|NCT00329108|75960220|FG001|NOT COMPLETED|Overall Study||12||
59836340|NCT00329030|75960228|FG000|STARTED|Overall Study||111||
59836341|NCT00329030|75960229|FG001|STARTED|Overall Study||113||
60119223|NCT02464540|76240362|FG001|COMPLETED|Overall Study||11||21
59836342|NCT00329030|75960228|FG000|COMPLETED|Overall Study||103||
59836343|NCT00329030|75960229|FG001|COMPLETED|Overall Study||107||
59836344|NCT00329030|75960228|FG000|NOT COMPLETED|Overall Study||8||
59836345|NCT00329030|75960229|FG001|NOT COMPLETED|Overall Study||6||
59836346|NCT00328562|75960235|FG000|STARTED|Overall Study||13||
59836347|NCT00328562|75960235|FG000|COMPLETED|Overall Study||12||
59836348|NCT00328562|75960235|FG000|NOT COMPLETED|Overall Study||1||
59836349|NCT00328172|75960244|FG000|STARTED|Overall Study||67||
59836350|NCT00328172|75960245|FG001|STARTED|Overall Study||58||
59836351|NCT00328172|75960246|FG002|STARTED|Overall Study||57||
59836352|NCT00328172|75960247|FG003|STARTED|Overall Study||55||
59836353|NCT00328172|75960248|FG004|STARTED|Overall Study||65||
59836354|NCT00328172|75960244|FG000|COMPLETED|Overall Study||45||
59836355|NCT00328172|75960245|FG001|COMPLETED|Overall Study||44||
59836356|NCT00328172|75960246|FG002|COMPLETED|Overall Study||47||
59836357|NCT00328172|75960247|FG003|COMPLETED|Overall Study||42||
59836358|NCT00328172|75960248|FG004|COMPLETED|Overall Study||60||
59836359|NCT00328172|75960244|FG000|NOT COMPLETED|Overall Study||22||
59836360|NCT00328172|75960245|FG001|NOT COMPLETED|Overall Study||14||
59836361|NCT00328172|75960246|FG002|NOT COMPLETED|Overall Study||10||
59836362|NCT00328172|75960247|FG003|NOT COMPLETED|Overall Study||13||
59836363|NCT00328172|75960248|FG004|NOT COMPLETED|Overall Study||5||
59836364|NCT00328094|75960262|FG000|STARTED|Overall Study||117||
59836365|NCT00328094|75960263|FG001|STARTED|Overall Study||125||
59836366|NCT00328094|75960262|FG000|COMPLETED|Overall Study|2 did not receive intervention. 1 patient refusal|114||
59836367|NCT00328094|75960263|FG001|COMPLETED|Overall Study|3 did not receive interevention. 1 post induction arrest. 1 case cancelled.|122||
59836368|NCT00328094|75960262|FG000|NOT COMPLETED|Overall Study||3||
59836369|NCT00328094|75960263|FG001|NOT COMPLETED|Overall Study||3||
59836370|NCT00500903|75960272|FG000|STARTED|Overall Study||65||
59836371|NCT00500903|75960273|FG001|STARTED|Overall Study||2||
59836372|NCT00500903|75960274|FG002|STARTED|Overall Study||20||
59836373|NCT00500903|75960272|FG000|COMPLETED|Overall Study||0||
59836374|NCT00500903|75960273|FG001|COMPLETED|Overall Study||0||
59836375|NCT00500903|75960274|FG002|COMPLETED|Overall Study||0||
59836376|NCT00500903|75960272|FG000|NOT COMPLETED|Overall Study||65||
59836377|NCT00500903|75960273|FG001|NOT COMPLETED|Overall Study||2||
59836378|NCT00500903|75960274|FG002|NOT COMPLETED|Overall Study||20||
59836379|NCT00295932|75960323|FG000|STARTED|Overall Study||4||
59836380|NCT00295932|75960324|FG001|STARTED|Overall Study||6||
59836381|NCT00295932|75960325|FG002|STARTED|Overall Study||3||
59836382|NCT00295932|75960326|FG003|STARTED|Overall Study||4||
59836383|NCT00295932|75960327|FG004|STARTED|Overall Study||2||
59567587|NCT02326272|75670460|FG007|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||27||
59567588|NCT02326272|75670461|FG008|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||3||
59567589|NCT02326272|75670462|FG009|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||10||
59836384|NCT00295932|75960328|FG005|STARTED|Overall Study||18||
59836385|NCT00295932|75960329|FG006|STARTED|Overall Study||3||
59836386|NCT00295932|75960330|FG007|STARTED|Overall Study||4||
59836387|NCT00295932|75960331|FG008|STARTED|Overall Study||10||
59836388|NCT00295932|75960332|FG009|STARTED|Overall Study||12||
59836389|NCT00295932|75960333|FG010|STARTED|Overall Study||13||
59836390|NCT00295932|75960323|FG000|COMPLETED|Overall Study||4||
59836391|NCT00295932|75960324|FG001|COMPLETED|Overall Study||6||
59836392|NCT00295932|75960325|FG002|COMPLETED|Overall Study||3||
59836393|NCT00295932|75960326|FG003|COMPLETED|Overall Study||4||
59836394|NCT00295932|75960327|FG004|COMPLETED|Overall Study||2||
59836395|NCT00295932|75960328|FG005|COMPLETED|Overall Study||18||
59836396|NCT00295932|75960329|FG006|COMPLETED|Overall Study||3||
59836397|NCT00295932|75960330|FG007|COMPLETED|Overall Study||4||
59836398|NCT00295932|75960331|FG008|COMPLETED|Overall Study||10||
59836399|NCT00295932|75960332|FG009|COMPLETED|Overall Study||12||
59836400|NCT00295932|75960333|FG010|COMPLETED|Overall Study||12||
59836401|NCT00295932|75960323|FG000|NOT COMPLETED|Overall Study||0||
59836402|NCT00295932|75960324|FG001|NOT COMPLETED|Overall Study||0||
59836403|NCT00295932|75960325|FG002|NOT COMPLETED|Overall Study||0||
59836404|NCT00295932|75960326|FG003|NOT COMPLETED|Overall Study||0||
59836405|NCT00295932|75960327|FG004|NOT COMPLETED|Overall Study||0||
59836406|NCT00295932|75960328|FG005|NOT COMPLETED|Overall Study||0||
59836407|NCT00295932|75960329|FG006|NOT COMPLETED|Overall Study||0||
59836408|NCT00295932|75960330|FG007|NOT COMPLETED|Overall Study||0||
59836409|NCT00295932|75960331|FG008|NOT COMPLETED|Overall Study||0||
59836410|NCT00295932|75960332|FG009|NOT COMPLETED|Overall Study||0||
59836411|NCT00295932|75960333|FG010|NOT COMPLETED|Overall Study||1||
59836412|NCT00305448|75960362|FG000|STARTED|Overall Study||45||
59836413|NCT00305448|75960363|FG001|STARTED|Overall Study||51||
59836414|NCT00305448|75960364|FG002|STARTED|Overall Study||47||
59836415|NCT00305448|75960362|FG000|COMPLETED|Overall Study||14||
59567590|NCT02326272|75670463|FG010|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0||
59836416|NCT00305448|75960363|FG001|COMPLETED|Overall Study||17||
59836417|NCT00305448|75960364|FG002|COMPLETED|Overall Study||14||
59836418|NCT00305448|75960362|FG000|NOT COMPLETED|Overall Study||31||
59836419|NCT00305448|75960363|FG001|NOT COMPLETED|Overall Study||34||
59836420|NCT00305448|75960364|FG002|NOT COMPLETED|Overall Study||33||
59836421|NCT00305058|75960375|FG000|STARTED|Overall Study||97||
59836422|NCT00305058|75960376|FG001|STARTED|Overall Study||97||
59836423|NCT00305058|75960375|FG000|Inclusion/Exclusion Verification|Overall Study||96||
59836424|NCT00305058|75960376|FG001|Inclusion/Exclusion Verification|Overall Study||97||
59836425|NCT00305058|75960375|FG000|All Outcome Data Collected|Overall Study||93||
59836426|NCT00305058|75960376|FG001|All Outcome Data Collected|Overall Study||95||
59836427|NCT00305058|75960375|FG000|Data Collection Forms Filed for Analysis|Overall Study||90||
59836428|NCT00305058|75960376|FG001|Data Collection Forms Filed for Analysis|Overall Study||93||
59836429|NCT00305058|75960375|FG000|COMPLETED|Overall Study||90||
59836430|NCT00305058|75960376|FG001|COMPLETED|Overall Study||93||
59836431|NCT00305058|75960375|FG000|NOT COMPLETED|Overall Study||7||
59836432|NCT00305058|75960376|FG001|NOT COMPLETED|Overall Study||4||
59836433|NCT00295854|75960385|FG000|STARTED|Overall Study||95||
59836434|NCT00295854|75960386|FG001|STARTED|Overall Study||108||
59836435|NCT00295854|75960387|FG002|STARTED|Overall Study||102||
59836436|NCT00295854|75960385|FG000|Safety Population (N=304)|Overall Study||95||
59836437|NCT00295854|75960386|FG001|Safety Population (N=304)|Overall Study||108||
59836438|NCT00295854|75960387|FG002|Safety Population (N=304)|Overall Study||101||
59836439|NCT00295854|75960385|FG000|ITT Population (N=296)|Overall Study||92||
59836440|NCT00295854|75960386|FG001|ITT Population (N=296)|Overall Study||105||
59836441|NCT00295854|75960387|FG002|ITT Population (N=296)|Overall Study||99||
59836442|NCT00295854|75960385|FG000|COMPLETED|Overall Study||77||
59836443|NCT00295854|75960386|FG001|COMPLETED|Overall Study||87||
59836444|NCT00295854|75960387|FG002|COMPLETED|Overall Study||87||
59836445|NCT00295854|75960385|FG000|NOT COMPLETED|Overall Study||18||
59836446|NCT00295854|75960386|FG001|NOT COMPLETED|Overall Study||21||
59836447|NCT00295854|75960387|FG002|NOT COMPLETED|Overall Study||15||
59836448|NCT00327470|75960397|FG000|STARTED|Overall Study||107||
59836449|NCT00327470|75960398|FG001|STARTED|Overall Study||181||
59836450|NCT00327470|75960397|FG000|Treated|Overall Study||107||
59836451|NCT00327470|75960398|FG001|Treated|Overall Study||179||
59836452|NCT00327470|75960397|FG000|COMPLETED|Overall Study||78||
59836453|NCT00327470|75960398|FG001|COMPLETED|Overall Study||118||
59836454|NCT00327470|75960397|FG000|NOT COMPLETED|Overall Study||29||
59836455|NCT00327470|75960398|FG001|NOT COMPLETED|Overall Study||63||
59836456|NCT00322556|75960404|FG000|STARTED|Overall Study||55||
59836457|NCT00322556|75960404|FG000|COMPLETED|Overall Study||43||
59836458|NCT00322556|75960404|FG000|NOT COMPLETED|Overall Study||12||
59567591|NCT02326272|75670464|FG011|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0||
59567592|NCT02326272|75670465|FG012|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0||
59836459|NCT00321932|75960413|FG000|STARTED|Overall Study||29||
60119224|NCT02464540|76240361|FG000|NOT COMPLETED|Overall Study||0||0
60119225|NCT02464540|76240362|FG001|NOT COMPLETED|Overall Study||0||0
59567593|NCT02326272|75670466|FG013|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0||
59567594|NCT02326272|75670467|FG014|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0||
59836460|NCT00321932|75960414|FG001|STARTED|Overall Study||32||
59836461|NCT00321932|75960413|FG000|COMPLETED|Overall Study||19||
59836462|NCT00321932|75960414|FG001|COMPLETED|Overall Study||11||
59836463|NCT00321932|75960413|FG000|NOT COMPLETED|Overall Study||10||
59836464|NCT00321932|75960414|FG001|NOT COMPLETED|Overall Study||21||
59836465|NCT00326612|75960423|FG000|STARTED|Overall Study||179||
59836466|NCT00326612|75960424|FG001|STARTED|Overall Study||179||
59836467|NCT00326612|75960423|FG000|COMPLETED|Overall Study||50||
59836468|NCT00326612|75960424|FG001|COMPLETED|Overall Study||42||
59836469|NCT00326612|75960423|FG000|NOT COMPLETED|Overall Study||129||
59836470|NCT00326612|75960424|FG001|NOT COMPLETED|Overall Study||137||
59836471|NCT00325130|75960436|FG000|STARTED|Overall Study||518||
59836472|NCT00325130|75960437|FG001|STARTED|Overall Study||524||
59836473|NCT00325130|75960436|FG000|COMPLETED|Overall Study||499||
59836474|NCT00325130|75960437|FG001|COMPLETED|Overall Study||494||
59836475|NCT00325130|75960436|FG000|NOT COMPLETED|Overall Study||19||
59836476|NCT00325130|75960437|FG001|NOT COMPLETED|Overall Study||30||
59836477|NCT00321854|75960445|FG000|STARTED|Overall Study||261||
59836478|NCT00321854|75960446|FG001|STARTED|Overall Study||274||
59836479|NCT00321854|75960445|FG000|COMPLETED|Overall Study||198||
59836480|NCT00321854|75960446|FG001|COMPLETED|Overall Study||192||
59836481|NCT00321854|75960445|FG000|NOT COMPLETED|Overall Study||63||
59836482|NCT00321854|75960446|FG001|NOT COMPLETED|Overall Study||82||
59836483|NCT00310388|75960454|FG000|STARTED|Primary Reporting Phase||376||
59836484|NCT00310388|75960455|FG001|STARTED|Primary Reporting Phase||0||
59836485|NCT00310388|75960454|FG000|COMPLETED|Primary Reporting Phase||30|Discontinued from Study and Switched to commercial product.|
59836486|NCT00310388|75960455|FG001|COMPLETED|Primary Reporting Phase||0|Discontinued from Study and Switched to commercial product.|
59836487|NCT00310388|75960454|FG000|NOT COMPLETED|Primary Reporting Phase||346||
59836488|NCT00310388|75960455|FG001|NOT COMPLETED|Primary Reporting Phase||0||
59836489|NCT00310388|75960454|FG000|STARTED|Safety Follow-up Continuation Phase||0||
59836490|NCT00310388|75960455|FG001|STARTED|Safety Follow-up Continuation Phase||26||
59836491|NCT00310388|75960454|FG000|COMPLETED|Safety Follow-up Continuation Phase||0||
59836492|NCT00310388|75960455|FG001|COMPLETED|Safety Follow-up Continuation Phase||13||
59836493|NCT00310388|75960454|FG000|NOT COMPLETED|Safety Follow-up Continuation Phase||0||
59836494|NCT00310388|75960455|FG001|NOT COMPLETED|Safety Follow-up Continuation Phase||13||
59836495|NCT00500357|75960460|FG000|STARTED|Overall Study||105||
59836496|NCT00500357|75960460|FG000|Received 13vPnC (Vax 3)|Overall Study||105||
59836497|NCT00500357|75960460|FG000|Evaluable Immunogenicity Population|Overall Study|Administered Vax 1 and Vax 2 in study 6115A1-500; Vax 3 and at least 1 assay result in 6115A1-3009.|98||
59836498|NCT00500357|75960460|FG000|COMPLETED|Overall Study||104||
59836499|NCT00500357|75960460|FG000|NOT COMPLETED|Overall Study||1||
59836500|NCT00309842|75960475|FG000|STARTED|Overall Study||213||
59836501|NCT00309842|75960475|FG000|COMPLETED|Overall Study||212||
59836502|NCT00309842|75960475|FG000|NOT COMPLETED|Overall Study||1||
59836503|NCT00325754|75960481|FG000|STARTED|Overall Study||11||
59836504|NCT00325754|75960482|FG001|STARTED|Overall Study||11||
59836505|NCT00325754|75960481|FG000|COMPLETED|Overall Study||7||
59836506|NCT00325754|75960482|FG001|COMPLETED|Overall Study||10||
59836507|NCT00325754|75960481|FG000|NOT COMPLETED|Overall Study||4||
59836508|NCT00325754|75960482|FG001|NOT COMPLETED|Overall Study||1||
59836509|NCT00499889|75960488|FG000|STARTED|Overall Study||42||
59836510|NCT00499889|75960488|FG000|COMPLETED|Overall Study||41||
59836511|NCT00499889|75960488|FG000|NOT COMPLETED|Overall Study||1||
59836512|NCT00309608|75960497|FG000|STARTED|Overall Study||71||
59836513|NCT00309608|75960498|FG001|STARTED|Overall Study||65||
59836514|NCT00309608|75960499|FG002|STARTED|Overall Study||66||
59836515|NCT00309608|75960500|FG003|STARTED|Overall Study||66||
59836516|NCT00309608|75960501|FG004|STARTED|Overall Study||65||
59836517|NCT00309608|75960497|FG000|COMPLETED|Overall Study||57||
59836518|NCT00309608|75960498|FG001|COMPLETED|Overall Study||52||
59836519|NCT00309608|75960499|FG002|COMPLETED|Overall Study||56||
59836520|NCT00309608|75960500|FG003|COMPLETED|Overall Study||60||
59836521|NCT00309608|75960501|FG004|COMPLETED|Overall Study||61||
59836522|NCT00309608|75960497|FG000|NOT COMPLETED|Overall Study||14||
59836523|NCT00309608|75960498|FG001|NOT COMPLETED|Overall Study||13||
59836524|NCT00309608|75960499|FG002|NOT COMPLETED|Overall Study||10||
59836525|NCT00309608|75960500|FG003|NOT COMPLETED|Overall Study||6||
59836526|NCT00309608|75960501|FG004|NOT COMPLETED|Overall Study||4||
59836527|NCT00309452|75960515|FG000|STARTED|Overall Study||60||
59836528|NCT00309452|75960516|FG001|STARTED|Overall Study||60||
59836529|NCT00309452|75960515|FG000|COMPLETED|Overall Study||57||
59836530|NCT00309452|75960516|FG001|COMPLETED|Overall Study||60||
59718105|NCT00904150|75837294|FG001|NOT COMPLETED|Blood Samples (RNA): Luteal Phase||0||
59718106|NCT00903760|75837302|FG000|STARTED|Overall Study||19||
59718107|NCT00903760|75837303|FG001|STARTED|Overall Study||18||
59718108|NCT00903760|75837302|FG000|COMPLETED|Overall Study|Completed all 24 courses|0||
59718109|NCT00903760|75837303|FG001|COMPLETED|Overall Study|Completed all 24 courses|2||
59718110|NCT00903760|75837302|FG000|NOT COMPLETED|Overall Study||19||
59718111|NCT00903760|75837303|FG001|NOT COMPLETED|Overall Study||16||
59718112|NCT00883051|75837314|FG000|STARTED|Overall Study||106||
59718113|NCT00883051|75837315|FG001|STARTED|Overall Study||104||
59718114|NCT00883051|75837316|FG002|STARTED|Overall Study||100||
59836531|NCT00309452|75960515|FG000|NOT COMPLETED|Overall Study||3||
59836532|NCT00309452|75960516|FG001|NOT COMPLETED|Overall Study||0||
59836533|NCT00308750|75960525|FG000|STARTED|Overall Study||72||
59836534|NCT00308750|75960526|FG001|STARTED|Overall Study||74||
59836535|NCT00308750|75960527|FG002|STARTED|Overall Study||72||
59836536|NCT00308750|75960525|FG000|Received at Least 1 Dose of Study Drug|Overall Study||67||
59836537|NCT00308750|75960526|FG001|Received at Least 1 Dose of Study Drug|Overall Study||72||
59836538|NCT00308750|75960527|FG002|Received at Least 1 Dose of Study Drug|Overall Study||70||
59718115|NCT00883051|75837317|FG003|STARTED|Overall Study||99||
59718116|NCT00883051|75837318|FG004|STARTED|Overall Study||103||
59836539|NCT00308750|75960525|FG000|COMPLETED|Overall Study||0||
59836540|NCT00308750|75960526|FG001|COMPLETED|Overall Study||34||
59836541|NCT00308750|75960527|FG002|COMPLETED|Overall Study||23||
59836542|NCT00308750|75960525|FG000|NOT COMPLETED|Overall Study||72||
59836543|NCT00308750|75960526|FG001|NOT COMPLETED|Overall Study||40||
59836544|NCT00308750|75960527|FG002|NOT COMPLETED|Overall Study||49||
59836545|NCT00489359|75960538|FG000|STARTED|Overall Study||20||
59836546|NCT00489359|75960539|FG001|STARTED|Overall Study||66||
59836547|NCT00489359|75960538|FG000|COMPLETED|Overall Study|Received at least 6 cycles of therapy. Not completed implies participant received <6 cycles.|13||
59836548|NCT00489359|75960539|FG001|COMPLETED|Overall Study|Received at least 6 cycles of therapy. Not completed implies participant received <6 cycles.|37||
59836549|NCT00489359|75960538|FG000|NOT COMPLETED|Overall Study||7||
59836550|NCT00489359|75960539|FG001|NOT COMPLETED|Overall Study||29||
59836551|NCT00481247|75960552|FG000|STARTED|Overall Study|Randomized|259||
59836552|NCT00481247|75960553|FG001|STARTED|Overall Study|Randomized|260||
59836553|NCT00481247|75960552|FG000|Received Treatment|Overall Study||258||
59836554|NCT00481247|75960553|FG001|Received Treatment|Overall Study||258||
59836555|NCT00481247|75960552|FG000|COMPLETED|Overall Study||0||
59836556|NCT00481247|75960553|FG001|COMPLETED|Overall Study||0||
59836557|NCT00481247|75960552|FG000|NOT COMPLETED|Overall Study||259||
59836558|NCT00481247|75960553|FG001|NOT COMPLETED|Overall Study||260||
59836559|NCT00480857|75960559|FG000|STARTED|Overall Study||19||
59836560|NCT00480857|75960559|FG000|COMPLETED|Overall Study||17||
59836561|NCT00480857|75960559|FG000|NOT COMPLETED|Overall Study||2||
59836562|NCT00480779|75960565|FG000|STARTED|Overall Study||26||
59836563|NCT00480779|75960566|FG001|STARTED|Overall Study||22||
59836564|NCT00480779|75960565|FG000|COMPLETED|Overall Study||24||
59836565|NCT00480779|75960566|FG001|COMPLETED|Overall Study||19||
59836566|NCT00480779|75960565|FG000|NOT COMPLETED|Overall Study||2||
59836567|NCT00480779|75960566|FG001|NOT COMPLETED|Overall Study||3||
59836568|NCT00499031|75960572|FG000|STARTED|Overall Study|Total number participants enrolled on study|38||
59836569|NCT00499031|75960572|FG000|COMPLETED|Overall Study|Total number participants that are eligible and evaluable.|35||
59836570|NCT00499031|75960572|FG000|NOT COMPLETED|Overall Study||3||
59836571|NCT00498797|75960578|FG000|STARTED|Overall Study|randomised patients|43||
59836572|NCT00498797|75960579|FG001|STARTED|Overall Study|randomised patients|43||
59836573|NCT00498797|75960578|FG000|COMPLETED|Overall Study|ongoing study treatment at data cut-off|5||
59836574|NCT00498797|75960579|FG001|COMPLETED|Overall Study|ongoing study treatment at data cut-off|14||
59836575|NCT00498797|75960578|FG000|NOT COMPLETED|Overall Study||38||
59836576|NCT00498797|75960579|FG001|NOT COMPLETED|Overall Study||29||
59718117|NCT00883051|75837314|FG000|No Study Medication Used|Overall Study||24||
59718118|NCT00883051|75837315|FG001|No Study Medication Used|Overall Study||22||
59718119|NCT00883051|75837316|FG002|No Study Medication Used|Overall Study||29||
59718120|NCT00883051|75837317|FG003|No Study Medication Used|Overall Study||29||
59718121|NCT00883051|75837318|FG004|No Study Medication Used|Overall Study||17||
59718122|NCT00883051|75837314|FG000|Received at Least 1 Dose of Study Drug|Overall Study||82||
59718123|NCT00883051|75837315|FG001|Received at Least 1 Dose of Study Drug|Overall Study||82||
59718124|NCT00883051|75837316|FG002|Received at Least 1 Dose of Study Drug|Overall Study||71||
59718125|NCT00883051|75837317|FG003|Received at Least 1 Dose of Study Drug|Overall Study||70||
59718126|NCT00883051|75837318|FG004|Received at Least 1 Dose of Study Drug|Overall Study||86||
59718127|NCT00883051|75837314|FG000|COMPLETED|Overall Study||82||
59718128|NCT00883051|75837315|FG001|COMPLETED|Overall Study||82||
59718129|NCT00883051|75837316|FG002|COMPLETED|Overall Study||71||
59718130|NCT00883051|75837317|FG003|COMPLETED|Overall Study||70||
59718131|NCT00883051|75837318|FG004|COMPLETED|Overall Study|One participant was lost to follow up and did not provide adverse event data.|85||
59718132|NCT00883051|75837314|FG000|NOT COMPLETED|Overall Study||24||
59718133|NCT00883051|75837315|FG001|NOT COMPLETED|Overall Study||22||
59718134|NCT00883051|75837316|FG002|NOT COMPLETED|Overall Study||29||
59718135|NCT00883051|75837317|FG003|NOT COMPLETED|Overall Study||29||
59718136|NCT00883051|75837318|FG004|NOT COMPLETED|Overall Study||18||
59718137|NCT00903682|75837332|FG000|STARTED|Overall Study||79||
59718138|NCT00903682|75837333|FG001|STARTED|Overall Study||78||
59718139|NCT00903682|75837332|FG000|COMPLETED|Overall Study||63||
59836577|NCT00498485|75960587|FG000|STARTED|Overall Study||7||
59836578|NCT00498485|75960588|FG001|STARTED|Overall Study||10||
59836579|NCT00498485|75960587|FG000|COMPLETED|Overall Study||6||
59836580|NCT00498485|75960588|FG001|COMPLETED|Overall Study||5||
60119226|NCT02423200|76240370|FG000|STARTED|Overall Study||8||
60119227|NCT02423200|76240371|FG001|STARTED|Overall Study||1||
60119228|NCT02423200|76240370|FG000|COMPLETED|Overall Study||7||
59718140|NCT00903682|75837333|FG001|COMPLETED|Overall Study||63||
59718141|NCT00903682|75837332|FG000|NOT COMPLETED|Overall Study||16||
59836581|NCT00498485|75960587|FG000|NOT COMPLETED|Overall Study||1||
59836582|NCT00498485|75960588|FG001|NOT COMPLETED|Overall Study||5||
59836583|NCT00480077|75960598|FG000|STARTED|Overall Study||168||
59836584|NCT00480077|75960599|FG001|STARTED|Overall Study||167||
59836585|NCT00480077|75960598|FG000|COMPLETED|Overall Study||137||
59836586|NCT00480077|75960599|FG001|COMPLETED|Overall Study||141||
59836587|NCT00480077|75960598|FG000|NOT COMPLETED|Overall Study||31||
60119229|NCT02423200|76240371|FG001|COMPLETED|Overall Study||1||
59836588|NCT00480077|75960599|FG001|NOT COMPLETED|Overall Study||26||
59836589|NCT00498173|75960607|FG000|STARTED|Phase 1-Blinded Randomization (8 Weeks)||29||
59836590|NCT00498173|75960608|FG001|STARTED|Phase 1-Blinded Randomization (8 Weeks)||31||
59836591|NCT00498173|75960609|FG002|STARTED|Phase 1-Blinded Randomization (8 Weeks)||0||
59836592|NCT00498173|75960607|FG000|COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||27||
59836593|NCT00498173|75960608|FG001|COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||30||
59836594|NCT00498173|75960609|FG002|COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||0||
59836595|NCT00498173|75960607|FG000|NOT COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||2||
59836596|NCT00498173|75960608|FG001|NOT COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||1||
59836597|NCT00498173|75960609|FG002|NOT COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||0||
59836598|NCT00498173|75960607|FG000|STARTED|Phase 2-Atomoxetine Open Label (8 Weeks)||0||
59836599|NCT00498173|75960608|FG001|STARTED|Phase 2-Atomoxetine Open Label (8 Weeks)||0||
59836600|NCT00498173|75960609|FG002|STARTED|Phase 2-Atomoxetine Open Label (8 Weeks)||26||
59836601|NCT00498173|75960607|FG000|COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0||
59836602|NCT00498173|75960608|FG001|COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0||
59836603|NCT00498173|75960609|FG002|COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||26||
59836604|NCT00498173|75960607|FG000|NOT COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0||
59836605|NCT00498173|75960608|FG001|NOT COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0||
59836606|NCT00498173|75960609|FG002|NOT COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0||
59836607|NCT00295620|75960619|FG000|STARTED|Overall Study||1732|ITT: all randomized, signed Informed Consent|
59836608|NCT00295620|75960620|FG001|STARTED|Overall Study||1738|ITT: all randomized, signed Informed Consent|
59836609|NCT00295620|75960619|FG000|Safety Analysis Set|Overall Study||1705|All randomized, at least one dose|
59836610|NCT00295620|75960620|FG001|Safety Analysis Set|Overall Study||1710|All randomized, at least one dose|
59836611|NCT00295620|75960619|FG000|COMPLETED|Overall Study||860||
59836612|NCT00295620|75960620|FG001|COMPLETED|Overall Study||842||
59836613|NCT00295620|75960619|FG000|NOT COMPLETED|Overall Study||872||
59836614|NCT00295620|75960620|FG001|NOT COMPLETED|Overall Study||896||
59836615|NCT00310440|75960628|FG000|STARTED|Overall Study||165||
59836616|NCT00310440|75960629|FG001|STARTED|Overall Study||154||
59836617|NCT00310440|75960628|FG000|COMPLETED|Overall Study||139||
59836618|NCT00310440|75960629|FG001|COMPLETED|Overall Study||141||
59836619|NCT00310440|75960628|FG000|NOT COMPLETED|Overall Study||26||
59836620|NCT00310440|75960629|FG001|NOT COMPLETED|Overall Study||13||
59836621|NCT00304356|75960635|FG000|STARTED|Nitazoxanide||27||
59836622|NCT00304356|75960635|FG000|COMPLETED|Nitazoxanide||22||
59836623|NCT00304356|75960635|FG000|NOT COMPLETED|Nitazoxanide||5||
59836624|NCT00304356|75960635|FG000|STARTED|Nitazoxanide||27||
59836625|NCT00304356|75960635|FG000|COMPLETED|Nitazoxanide||22||
59836626|NCT00304356|75960635|FG000|NOT COMPLETED|Nitazoxanide||5||
59836627|NCT00321620|75960641|FG000|STARTED|Overall Study||951||
59836628|NCT00321620|75960642|FG001|STARTED|Overall Study||950||
59836629|NCT00321620|75960641|FG000|Received Investigational Product|Overall Study||946||
59836630|NCT00321620|75960642|FG001|Received Investigational Product|Overall Study||942||
59836631|NCT00321620|75960641|FG000|COMPLETED|Overall Study||208||
59836632|NCT00321620|75960642|FG001|COMPLETED|Overall Study||228||
59836633|NCT00321620|75960641|FG000|NOT COMPLETED|Overall Study||743||
59836634|NCT00321620|75960642|FG001|NOT COMPLETED|Overall Study||722||
59836635|NCT00304278|75960648|FG000|STARTED|Overall Study||21||
59836636|NCT00304278|75960648|FG000|COMPLETED|Overall Study||19||
59836637|NCT00304278|75960648|FG000|NOT COMPLETED|Overall Study||2||
59836638|NCT00291018|75960655|FG000|STARTED|Overall Study|Enrolled and Treated. 111 PDC subjects were Enrolled but only 103 were Treated.|103||
59836639|NCT00291018|75960656|FG001|STARTED|Overall Study|Enrolled and Treated. 117 ACDF subjects were Enrolled but only 106 were Treated.|106||
59836640|NCT00291018|75960657|FG002|STARTED|Overall Study|Enrolled and Treated. 140 PDC-CA subjects were Enrolled but only 136 were Treated.|136||
59836641|NCT00291018|75960655|FG000|Evaluated at 24 Months|Overall Study||99||
59836642|NCT00291018|75960656|FG001|Evaluated at 24 Months|Overall Study||92||
59836643|NCT00291018|75960657|FG002|Evaluated at 24 Months|Overall Study||105||
59836644|NCT00291018|75960655|FG000|COMPLETED|Overall Study|Evaluated at 84 Months|78||
59836645|NCT00291018|75960656|FG001|COMPLETED|Overall Study|Evaluated at 84 Months|64||
59836646|NCT00291018|75960657|FG002|COMPLETED|Overall Study|Evaluated at 84 Months|93||
59836647|NCT00291018|75960655|FG000|NOT COMPLETED|Overall Study||25||
59836648|NCT00291018|75960656|FG001|NOT COMPLETED|Overall Study||42||
59836649|NCT00291018|75960657|FG002|NOT COMPLETED|Overall Study||43||
59836650|NCT00320606|75960668|FG000|STARTED|Overall Study||20||
59836651|NCT00320606|75960668|FG000|COMPLETED|Overall Study||17||
59836652|NCT00320606|75960668|FG000|NOT COMPLETED|Overall Study||3||
59836653|NCT00307736|75960673|FG000|STARTED|Overall Study||3||
59836654|NCT00307736|75960674|FG001|STARTED|Overall Study||3||
59836655|NCT00307736|75960675|FG002|STARTED|Overall Study||3||
59836656|NCT00307736|75960676|FG003|STARTED|Overall Study||23||
59836657|NCT00307736|75960673|FG000|COMPLETED|Overall Study||3||
59836658|NCT00307736|75960674|FG001|COMPLETED|Overall Study||3||
59836659|NCT00307736|75960675|FG002|COMPLETED|Overall Study||0||
59836660|NCT00307736|75960676|FG003|COMPLETED|Overall Study||20||
59836661|NCT00307736|75960673|FG000|NOT COMPLETED|Overall Study||0||
59836662|NCT00307736|75960674|FG001|NOT COMPLETED|Overall Study||0||
59836663|NCT00307736|75960675|FG002|NOT COMPLETED|Overall Study||3||
59836664|NCT00307736|75960676|FG003|NOT COMPLETED|Overall Study||3||
59836665|NCT00320528|75960690|FG000|STARTED|Study Period II||98||
59836666|NCT00320528|75960691|FG001|STARTED|Study Period II||41||
59836667|NCT00320528|75960692|FG002|STARTED|Study Period II||130||
59836668|NCT00320528|75960690|FG000|Received at Least One Dose of Study Drug|Study Period II||97||
59836669|NCT00320528|75960691|FG001|Received at Least One Dose of Study Drug|Study Period II||38||
59836670|NCT00320528|75960692|FG002|Received at Least One Dose of Study Drug|Study Period II||128||
59836671|NCT00320528|75960690|FG000|COMPLETED|Study Period II||87||
59836672|NCT00320528|75960691|FG001|COMPLETED|Study Period II||31||
59836673|NCT00320528|75960692|FG002|COMPLETED|Study Period II||108||
59836674|NCT00320528|75960690|FG000|NOT COMPLETED|Study Period II||11||
59836675|NCT00320528|75960691|FG001|NOT COMPLETED|Study Period II||10||
59836676|NCT00320528|75960692|FG002|NOT COMPLETED|Study Period II||22||
59836677|NCT00320528|75960690|FG000|STARTED|Study Period III||87||
59836678|NCT00320528|75960691|FG001|STARTED|Study Period III||31||
59836679|NCT00320528|75960692|FG002|STARTED|Study Period III||108||
59836680|NCT00320528|75960690|FG000|COMPLETED|Study Period III||0||
59836681|NCT00320528|75960691|FG001|COMPLETED|Study Period III||0||
59836682|NCT00320528|75960692|FG002|COMPLETED|Study Period III||2||
59836683|NCT00320528|75960690|FG000|NOT COMPLETED|Study Period III||87||
59836684|NCT00320528|75960691|FG001|NOT COMPLETED|Study Period III||31||
59836685|NCT00320528|75960692|FG002|NOT COMPLETED|Study Period III||106||
59836686|NCT00320372|75960703|FG000|STARTED|Overall Study||494||
59836687|NCT00320372|75960704|FG001|STARTED|Overall Study||301||
59836688|NCT00320372|75960703|FG000|VNS Therapy D-23 Original|Overall Study||335||
59836689|NCT00320372|75960704|FG001|VNS Therapy D-23 Original|Overall Study||0||
59836690|NCT00320372|75960703|FG000|VNS Therapy D-21 (NCT00305565) Rollovers|Overall Study||159||
59836691|NCT00320372|75960704|FG001|VNS Therapy D-21 (NCT00305565) Rollovers|Overall Study||0||
59836692|NCT00320372|75960703|FG000|COMPLETED|Overall Study||299||
59836693|NCT00320372|75960704|FG001|COMPLETED|Overall Study||138||
59836694|NCT00320372|75960703|FG000|NOT COMPLETED|Overall Study||195||
59836695|NCT00320372|75960704|FG001|NOT COMPLETED|Overall Study||163||
59836696|NCT00294762|75960720|FG000|STARTED|Overall Study||72||
59836697|NCT00294762|75960721|FG001|STARTED|Overall Study||71||
59836698|NCT00294762|75960720|FG000|COMPLETED|Overall Study||69||
59836699|NCT00294762|75960721|FG001|COMPLETED|Overall Study||68||
59836700|NCT00294762|75960720|FG000|NOT COMPLETED|Overall Study||3||
59836701|NCT00294762|75960721|FG001|NOT COMPLETED|Overall Study||3||
59836702|NCT00294684|75960729|FG000|STARTED|Overall Study||70||
59836703|NCT00294684|75960730|FG001|STARTED|Overall Study||70||
59836704|NCT00294684|75960729|FG000|COMPLETED|Overall Study||65||
59836705|NCT00294684|75960730|FG001|COMPLETED|Overall Study||62||
59836706|NCT00294684|75960729|FG000|NOT COMPLETED|Overall Study||5||
59836707|NCT00294684|75960730|FG001|NOT COMPLETED|Overall Study||8||
59836708|NCT00307034|75960738|FG000|STARTED|Overall Study||175||
59836709|NCT00307034|75960739|FG001|STARTED|Overall Study||176||
59836710|NCT00307034|75960738|FG000|COMPLETED|Overall Study||173||
59836711|NCT00307034|75960739|FG001|COMPLETED|Overall Study||169||
59836712|NCT00307034|75960738|FG000|NOT COMPLETED|Overall Study||2||
59836713|NCT00307034|75960739|FG001|NOT COMPLETED|Overall Study||7||
59836714|NCT00320216|75960750|FG000|STARTED|Overall Study||64||
59836715|NCT00320216|75960751|FG001|STARTED|Overall Study|1 patient randomized but not treated was included as discontinued due to Other reason.|64||
59836716|NCT00320216|75960752|FG002|STARTED|Overall Study|1 patient randomized but not treated was included as discontinued due to Other reason.|64||
59836717|NCT00320216|75960753|FG003|STARTED|Overall Study||64||
59836718|NCT00320216|75960754|FG004|STARTED|Overall Study||64||
59836719|NCT00320216|75960750|FG000|COMPLETED|Overall Study||48||
59836720|NCT00320216|75960751|FG001|COMPLETED|Overall Study||54||
59836721|NCT00320216|75960752|FG002|COMPLETED|Overall Study||58||
59836722|NCT00320216|75960753|FG003|COMPLETED|Overall Study||61||
59836723|NCT00320216|75960754|FG004|COMPLETED|Overall Study||58||
59836724|NCT00320216|75960750|FG000|NOT COMPLETED|Overall Study||16||
59836725|NCT00320216|75960751|FG001|NOT COMPLETED|Overall Study||10||
59836726|NCT00320216|75960752|FG002|NOT COMPLETED|Overall Study||6||
59836727|NCT00320216|75960753|FG003|NOT COMPLETED|Overall Study||3||
59836728|NCT00320216|75960754|FG004|NOT COMPLETED|Overall Study||6||
59836729|NCT00290706|75960775|FG000|STARTED|Overall Study||5||
59836730|NCT00290706|75960776|FG001|STARTED|Overall Study||6||
59836731|NCT00290706|75960777|FG002|STARTED|Overall Study||7||
59836732|NCT00290706|75960778|FG003|STARTED|Overall Study||14||
59836733|NCT00290706|75960775|FG000|Attempted1st Cycle|Overall Study||5|DLT period in phase I (Cohort 1 and Cohort 2) =20 days post Cycle 1|
59836734|NCT00290706|75960776|FG001|Attempted1st Cycle|Overall Study||6|DLT period in phase I (Cohort 1 and Cohort 2) =20 days post Cycle 1|
59996534|NCT02714569|76112509|FG006|Received at Least One Dose of Study Drug|Part A First Intervention||0||
59836735|NCT00290706|75960777|FG002|Attempted1st Cycle|Overall Study||7|DLT period in phase I (Cohort 1 and Cohort 2) =20 days post Cycle 1|
59836736|NCT00290706|75960778|FG003|Attempted1st Cycle|Overall Study||14|DLT period in phase I (Cohort 1 and Cohort 2) =20 days post Cycle 1|
59836737|NCT00290706|75960775|FG000|Reached 1st Response/Cycle 3|Overall Study||0||
59836738|NCT00290706|75960776|FG001|Reached 1st Response/Cycle 3|Overall Study||0||
59836739|NCT00290706|75960777|FG002|Reached 1st Response/Cycle 3|Overall Study||1||
59836740|NCT00290706|75960778|FG003|Reached 1st Response/Cycle 3|Overall Study||2||
59836741|NCT00290706|75960775|FG000|COMPLETED|Overall Study||0||
59836742|NCT00290706|75960776|FG001|COMPLETED|Overall Study||0||
59836743|NCT00290706|75960777|FG002|COMPLETED|Overall Study||1||
59836744|NCT00290706|75960778|FG003|COMPLETED|Overall Study||2||
59836745|NCT00290706|75960775|FG000|NOT COMPLETED|Overall Study||5||
59836746|NCT00290706|75960776|FG001|NOT COMPLETED|Overall Study||6||
59836747|NCT00290706|75960777|FG002|NOT COMPLETED|Overall Study||6||
59836748|NCT00290706|75960778|FG003|NOT COMPLETED|Overall Study||12||
59836749|NCT00303186|75960789|FG000|STARTED|Overall Study||107||
59836750|NCT00303186|75960789|FG000|COMPLETED|Overall Study||55||
59718142|NCT00903682|75837333|FG001|NOT COMPLETED|Overall Study||15||
59718143|NCT01117428|75837345|FG000|STARTED|Overall Study|"0.4 mg/kg=1~0.75 mg/kg=1~1.5 mg/kg=3~3 mg/kg=3~6 mg/kg=3~9 mg/kg=6~12 mg/kg=3"|20||
59718144|NCT01117428|75837346|FG001|STARTED|Overall Study||29||
59718145|NCT01117428|75837347|FG002|STARTED|Overall Study||13||
59718146|NCT01117428|75837348|FG003|STARTED|Overall Study||12||
59718147|NCT01117428|75837349|FG004|STARTED|Overall Study||17||
59718148|NCT01117428|75837350|FG005|STARTED|Overall Study||20||
59836751|NCT00303186|75960789|FG000|NOT COMPLETED|Overall Study||52||
59718149|NCT01117428|75837345|FG000|COMPLETED|Overall Study||0||
59718150|NCT01117428|75837346|FG001|COMPLETED|Overall Study||0||
59718151|NCT01117428|75837347|FG002|COMPLETED|Overall Study||0||
59718152|NCT01117428|75837348|FG003|COMPLETED|Overall Study||0||
59718153|NCT01117428|75837349|FG004|COMPLETED|Overall Study||0||
59836752|NCT00294060|75960793|FG000|STARTED|Overall Study||2013||
59836753|NCT00294060|75960793|FG000|COMPLETED|Overall Study||840||
59836754|NCT00294060|75960793|FG000|NOT COMPLETED|Overall Study||1173||
59836755|NCT00303108|75960800|FG000|STARTED|Overall Study||43||
59836756|NCT00303108|75960801|FG001|STARTED|Overall Study||46||
60119230|NCT02423200|76240370|FG000|NOT COMPLETED|Overall Study||1||
59718154|NCT01117428|75837350|FG005|COMPLETED|Overall Study||0||
59718155|NCT01117428|75837345|FG000|NOT COMPLETED|Overall Study||20||
59718156|NCT01117428|75837346|FG001|NOT COMPLETED|Overall Study||29||
59718157|NCT01117428|75837347|FG002|NOT COMPLETED|Overall Study||13||
59836757|NCT00303108|75960802|FG002|STARTED|Overall Study||47||
59836758|NCT00303108|75960800|FG000|COMPLETED|Overall Study||31||
59836759|NCT00303108|75960801|FG001|COMPLETED|Overall Study||37||
59836760|NCT00303108|75960802|FG002|COMPLETED|Overall Study||31||
60119231|NCT02423200|76240371|FG001|NOT COMPLETED|Overall Study||0||
60119232|NCT02423980|76240378|FG000|STARTED|Overall Study||7||
60119233|NCT02423980|76240378|FG000|COMPLETED|Overall Study||7||
60119234|NCT02423980|76240378|FG000|NOT COMPLETED|Overall Study||0||
59718158|NCT01117428|75837348|FG003|NOT COMPLETED|Overall Study||12||
59718159|NCT01117428|75837349|FG004|NOT COMPLETED|Overall Study||17||
60119235|NCT02424526|76240386|FG000|STARTED|Overall Study||9||
60119236|NCT02424526|76240387|FG001|STARTED|Overall Study||10||
60119237|NCT02424526|76240386|FG000|COMPLETED|Overall Study||9||
60119238|NCT02424526|76240387|FG001|COMPLETED|Overall Study||10||
60119239|NCT02424526|76240386|FG000|NOT COMPLETED|Overall Study||0||
59718160|NCT01117428|75837350|FG005|NOT COMPLETED|Overall Study||20||
59718161|NCT00655681|75837368|FG000|STARTED|Overall Study||12||
59718162|NCT00655681|75837369|FG001|STARTED|Overall Study||10||
59836761|NCT00303108|75960800|FG000|NOT COMPLETED|Overall Study||12||
59836762|NCT00303108|75960801|FG001|NOT COMPLETED|Overall Study||9||
59836763|NCT00303108|75960802|FG002|NOT COMPLETED|Overall Study||16||
59836764|NCT00302952|75960811|FG000|STARTED|Overall Study||34||
60119240|NCT02424526|76240387|FG001|NOT COMPLETED|Overall Study||0||
60119241|NCT02426476|76240397|FG000|STARTED|Overall Study||57||
59718163|NCT00655681|75837368|FG000|COMPLETED|Overall Study|Did not return for final DXA|11||
60119242|NCT02426476|76240398|FG001|STARTED|Overall Study||56||
59836765|NCT00302952|75960812|FG001|STARTED|Overall Study||30||
59836766|NCT00302952|75960811|FG000|Started Intent-to-Treat (ITT)|Overall Study||34||
59718164|NCT00655681|75837369|FG001|COMPLETED|Overall Study||9||
59836767|NCT00302952|75960812|FG001|Started Intent-to-Treat (ITT)|Overall Study||30||
59836768|NCT00302952|75960811|FG000|Completed Intent-to-Treat (ITT)|Overall Study||34||
59836769|NCT00302952|75960812|FG001|Completed Intent-to-Treat (ITT)|Overall Study|One participant did not have a baseline C-reactive Protein and was excluded from the ITT population.|29||
59836770|NCT00302952|75960811|FG000|COMPLETED|Overall Study||31||
59836771|NCT00302952|75960812|FG001|COMPLETED|Overall Study||25||
59836772|NCT00302952|75960811|FG000|NOT COMPLETED|Overall Study||3||
59836773|NCT00302952|75960812|FG001|NOT COMPLETED|Overall Study||5||
59836774|NCT00302718|75960822|FG000|STARTED|Overall Study||20||
59836775|NCT00302718|75960823|FG001|STARTED|Overall Study||21||
59836776|NCT00302718|75960824|FG002|STARTED|Overall Study||21||
59836777|NCT00302718|75960825|FG003|STARTED|Overall Study||21||
59836778|NCT00302718|75960822|FG000|COMPLETED|Overall Study||19||
59836779|NCT00302718|75960823|FG001|COMPLETED|Overall Study||20||
59836780|NCT00302718|75960824|FG002|COMPLETED|Overall Study||19||
59836781|NCT00302718|75960825|FG003|COMPLETED|Overall Study||19||
59836782|NCT00302718|75960822|FG000|NOT COMPLETED|Overall Study||1||
59836783|NCT00302718|75960823|FG001|NOT COMPLETED|Overall Study||1||
59836784|NCT00302718|75960824|FG002|NOT COMPLETED|Overall Study||2||
59836785|NCT00302718|75960825|FG003|NOT COMPLETED|Overall Study||2||
59836786|NCT00302328|75960843|FG000|STARTED|Overall Study||25||
59836787|NCT00302328|75960844|FG001|STARTED|Overall Study||35||
59836788|NCT00302328|75960845|FG002|STARTED|Overall Study||18||
59836789|NCT00302328|75960843|FG000|COMPLETED|Overall Study||25||
60119243|NCT02426476|76240397|FG000|COMPLETED|Overall Study||38||
60119244|NCT02426476|76240398|FG001|COMPLETED|Overall Study||39||
60119245|NCT02426476|76240397|FG000|NOT COMPLETED|Overall Study||19||
60119246|NCT02426476|76240398|FG001|NOT COMPLETED|Overall Study||17||
60119247|NCT02465632|76240409|FG000|STARTED|Overall Study||440||
60119248|NCT02465632|76240410|FG001|STARTED|Overall Study||440||
60119249|NCT02465632|76240411|FG002|STARTED|Overall Study||220||
60119250|NCT02465632|76240409|FG000|COMPLETED|Overall Study||409||
59567595|NCT02326272|75670453|FG000|COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
59718165|NCT00655681|75837368|FG000|NOT COMPLETED|Overall Study||1||
59718166|NCT00655681|75837369|FG001|NOT COMPLETED|Overall Study||1||
59718167|NCT02707198|75837378|FG000|STARTED|Overall Study||2||
59718168|NCT02707198|75837379|FG001|STARTED|Overall Study||0||
60119251|NCT02465632|76240410|FG001|COMPLETED|Overall Study||417||
60119252|NCT02465632|76240411|FG002|COMPLETED|Overall Study||203||
60119253|NCT02465632|76240409|FG000|NOT COMPLETED|Overall Study||31||
59567596|NCT02326272|75670454|FG001|COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
59567597|NCT02326272|75670455|FG002|COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
59567598|NCT02326272|75670456|FG003|COMPLETED|Maintenance Period (Week 16 to Week 48)||5||
59567599|NCT02326272|75670457|FG004|COMPLETED|Maintenance Period (Week 16 to Week 48)||3||
59567600|NCT02326272|75670458|FG005|COMPLETED|Maintenance Period (Week 16 to Week 48)||63||
59567601|NCT02326272|75670459|FG006|COMPLETED|Maintenance Period (Week 16 to Week 48)||60||
59567602|NCT02326272|75670460|FG007|COMPLETED|Maintenance Period (Week 16 to Week 48)||27||
59718169|NCT02707198|75837380|FG002|STARTED|Overall Study||0||
59718170|NCT02707198|75837378|FG000|COMPLETED|Overall Study||2||
59718171|NCT02707198|75837379|FG001|COMPLETED|Overall Study||0||
59567603|NCT02326272|75670461|FG008|COMPLETED|Maintenance Period (Week 16 to Week 48)||3||
59718172|NCT02707198|75837380|FG002|COMPLETED|Overall Study||0||
59718173|NCT02707198|75837378|FG000|NOT COMPLETED|Overall Study||0||
59718174|NCT02707198|75837379|FG001|NOT COMPLETED|Overall Study||0||
59718175|NCT02707198|75837380|FG002|NOT COMPLETED|Overall Study||0||
59718176|NCT01135524|75837388|FG000|STARTED|Overall Study||196||
59718177|NCT01135524|75837388|FG000|COMPLETED|Overall Study||0||
59836790|NCT00302328|75960844|FG001|COMPLETED|Overall Study|developed cancer during the study|34||
59836791|NCT00302328|75960845|FG002|COMPLETED|Overall Study||18||
59836792|NCT00302328|75960843|FG000|NOT COMPLETED|Overall Study||0||
59567604|NCT02326272|75670462|FG009|COMPLETED|Maintenance Period (Week 16 to Week 48)||10||
59718178|NCT01135524|75837388|FG000|NOT COMPLETED|Overall Study||196||
59718179|NCT00948675|75837394|FG000|STARTED|Overall Study||182||
59718180|NCT00948675|75837395|FG001|STARTED|Overall Study||179||
59836793|NCT00302328|75960844|FG001|NOT COMPLETED|Overall Study||1||
60119254|NCT02465632|76240410|FG001|NOT COMPLETED|Overall Study||23||
60119255|NCT02465632|76240411|FG002|NOT COMPLETED|Overall Study||17||
59836794|NCT00302328|75960845|FG002|NOT COMPLETED|Overall Study||0||
59836795|NCT00301080|75960856|FG000|STARTED|Original Version (2 Arms & 4 Weeks)||4||
59836796|NCT00301080|75960857|FG001|STARTED|Original Version (2 Arms & 4 Weeks)||3||
59836797|NCT00301080|75960858|FG002|STARTED|Original Version (2 Arms & 4 Weeks)|This arm not part of the original version.|0||
59836798|NCT00301080|75960859|FG003|STARTED|Original Version (2 Arms & 4 Weeks)|This arm not part of the original version.|0||
59836799|NCT00301080|75960860|FG004|STARTED|Original Version (2 Arms & 4 Weeks)|This arm not part of the original version.|0||
59836800|NCT00301080|75960856|FG000|Received an Intervention|Original Version (2 Arms & 4 Weeks)||3||
59836801|NCT00301080|75960857|FG001|Received an Intervention|Original Version (2 Arms & 4 Weeks)||3||
59836802|NCT00301080|75960858|FG002|Received an Intervention|Original Version (2 Arms & 4 Weeks)||0||
59836803|NCT00301080|75960859|FG003|Received an Intervention|Original Version (2 Arms & 4 Weeks)||0||
59836804|NCT00301080|75960860|FG004|Received an Intervention|Original Version (2 Arms & 4 Weeks)||0||
59836805|NCT00301080|75960856|FG000|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||3||
59836806|NCT00301080|75960857|FG001|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||3||
59836807|NCT00301080|75960858|FG002|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||0||
59836808|NCT00301080|75960859|FG003|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||0||
59836809|NCT00301080|75960860|FG004|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||0||
59836810|NCT00301080|75960856|FG000|COMPLETED|Original Version (2 Arms & 4 Weeks)||3||
59836811|NCT00301080|75960857|FG001|COMPLETED|Original Version (2 Arms & 4 Weeks)||3||
59836812|NCT00301080|75960858|FG002|COMPLETED|Original Version (2 Arms & 4 Weeks)||0||
59836813|NCT00301080|75960859|FG003|COMPLETED|Original Version (2 Arms & 4 Weeks)||0||
59836814|NCT00301080|75960860|FG004|COMPLETED|Original Version (2 Arms & 4 Weeks)||0||
59836815|NCT00301080|75960856|FG000|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||1||
59836816|NCT00301080|75960857|FG001|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||0||
59836817|NCT00301080|75960858|FG002|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||0||
59836818|NCT00301080|75960859|FG003|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||0||
59836819|NCT00301080|75960860|FG004|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||0||
59836820|NCT00301080|75960856|FG000|STARTED|Revised Version (3 Arms & 12 Weeks)|This arm was not a part of the revised study design.|0||
59836821|NCT00301080|75960857|FG001|STARTED|Revised Version (3 Arms & 12 Weeks)|This arm was not a part of the revised study design.|0||
59836822|NCT00301080|75960858|FG002|STARTED|Revised Version (3 Arms & 12 Weeks)||0||
59836823|NCT00301080|75960859|FG003|STARTED|Revised Version (3 Arms & 12 Weeks)||0||
59836824|NCT00301080|75960860|FG004|STARTED|Revised Version (3 Arms & 12 Weeks)||0||
59836825|NCT00301080|75960856|FG000|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0||
59836826|NCT00301080|75960857|FG001|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0||
59836827|NCT00301080|75960858|FG002|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0||
59836828|NCT00301080|75960859|FG003|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0||
59836829|NCT00301080|75960860|FG004|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0||
59836830|NCT00301080|75960856|FG000|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0||
59836831|NCT00301080|75960857|FG001|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0||
59836832|NCT00301080|75960858|FG002|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0||
59836833|NCT00301080|75960859|FG003|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0||
59836834|NCT00301080|75960860|FG004|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0||
59836835|NCT00290238|75960871|FG000|STARTED|Overall Study||57||
59836836|NCT00290238|75960872|FG001|STARTED|Overall Study|One subject had an invalid birth date and was excluded from the Age Categorical counts.|65||
59836837|NCT00290238|75960871|FG000|COMPLETED|Overall Study||15||
60119256|NCT02466412|76240422|FG000|STARTED|Washout Period of 1 Day (Day -1)||24||
60119257|NCT02466412|76240423|FG001|STARTED|Washout Period of 1 Day (Day -1)||24||
59567605|NCT02326272|75670463|FG010|COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
59567606|NCT02326272|75670464|FG011|COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
59567607|NCT02326272|75670465|FG012|COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
59718181|NCT00948675|75837394|FG000|Received Any Amount of Study Drug|Overall Study||171||
59718182|NCT00948675|75837395|FG001|Received Any Amount of Study Drug|Overall Study||166||
59718183|NCT00948675|75837394|FG000|COMPLETED|Overall Study||181||
59718184|NCT00948675|75837395|FG001|COMPLETED|Overall Study||179||
59718185|NCT00948675|75837394|FG000|NOT COMPLETED|Overall Study||1||
59718186|NCT00948675|75837395|FG001|NOT COMPLETED|Overall Study||0||
59718187|NCT00903370|75837403|FG000|STARTED|Overall Study||127||
59718188|NCT00903370|75837404|FG001|STARTED|Overall Study||133||
59718189|NCT00903370|75837403|FG000|COMPLETED|Overall Study||99||
59718190|NCT00903370|75837404|FG001|COMPLETED|Overall Study||109||
59718191|NCT00903370|75837403|FG000|NOT COMPLETED|Overall Study||28||
59567608|NCT02326272|75670466|FG013|COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
59567609|NCT02326272|75670467|FG014|COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
59567610|NCT02326272|75670453|FG000|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
59567611|NCT02326272|75670454|FG001|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
59567612|NCT02326272|75670455|FG002|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
59567613|NCT02326272|75670456|FG003|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||1||
59718192|NCT00903370|75837404|FG001|NOT COMPLETED|Overall Study||24||
59718193|NCT01110408|75837412|FG000|STARTED|Overall Study||31||
59836838|NCT00290238|75960872|FG001|COMPLETED|Overall Study||24||
59836839|NCT00290238|75960871|FG000|NOT COMPLETED|Overall Study||42||
59836840|NCT00290238|75960872|FG001|NOT COMPLETED|Overall Study||41||
59836841|NCT00289848|75960880|FG000|STARTED|Overall Study||352||
59836842|NCT00289848|75960881|FG001|STARTED|Overall Study||178||
59836843|NCT00289848|75960880|FG000|COMPLETED|Overall Study||306||
59836844|NCT00289848|75960881|FG001|COMPLETED|Overall Study||133||
59836845|NCT00289848|75960880|FG000|NOT COMPLETED|Overall Study||46||
59836846|NCT00289848|75960881|FG001|NOT COMPLETED|Overall Study||45||
59836847|NCT00289770|75960887|FG000|STARTED|Year 11||37||
59836848|NCT00289770|75960887|FG000|COMPLETED|Year 11||37||
59836849|NCT00289770|75960887|FG000|NOT COMPLETED|Year 11||0||
59836850|NCT00289770|75960887|FG000|STARTED|Year 12||40||
59836851|NCT00289770|75960887|FG000|COMPLETED|Year 12||40||
59836852|NCT00289770|75960887|FG000|NOT COMPLETED|Year 12||0||
59836853|NCT00289770|75960887|FG000|STARTED|Year 13||37||
59836854|NCT00289770|75960887|FG000|COMPLETED|Year 13||37||
59836855|NCT00289770|75960887|FG000|NOT COMPLETED|Year 13||0||
59836856|NCT00289770|75960887|FG000|STARTED|Year 14||43||
59836857|NCT00289770|75960887|FG000|COMPLETED|Year 14||43||
59836858|NCT00289770|75960887|FG000|NOT COMPLETED|Year 14||0||
59836859|NCT00289770|75960887|FG000|STARTED|Year 15||50||
59836860|NCT00289770|75960887|FG000|COMPLETED|Year 15||49||
59836861|NCT00289770|75960887|FG000|NOT COMPLETED|Year 15||1||
59836862|NCT00289536|75960891|FG000|STARTED|Period 1||9||
59836863|NCT00289536|75960892|FG001|STARTED|Period 1||8||
59836864|NCT00289536|75960893|FG002|STARTED|Period 1||9||
59836865|NCT00289536|75960891|FG000|COMPLETED|Period 1||9||
59836866|NCT00289536|75960892|FG001|COMPLETED|Period 1||8||
59718194|NCT01110408|75837413|FG001|STARTED|Overall Study||10||
59718195|NCT01110408|75837412|FG000|COMPLETED|Overall Study||30||
59718196|NCT01110408|75837413|FG001|COMPLETED|Overall Study||10||
59718197|NCT01110408|75837412|FG000|NOT COMPLETED|Overall Study||1||
59718198|NCT01110408|75837413|FG001|NOT COMPLETED|Overall Study||0||
59718199|NCT00953043|75837421|FG000|STARTED|Overall Study||30||
59718200|NCT00953043|75837422|FG001|STARTED|Overall Study||30||
59718201|NCT00953043|75837421|FG000|COMPLETED|Overall Study||26||
59718202|NCT00953043|75837422|FG001|COMPLETED|Overall Study||28||
59718203|NCT00953043|75837421|FG000|NOT COMPLETED|Overall Study||4||
59718204|NCT00953043|75837422|FG001|NOT COMPLETED|Overall Study||2||
59718205|NCT01135134|75837430|FG000|STARTED|Overall Study||220||
59718206|NCT01135134|75837431|FG001|STARTED|Overall Study||113||
59718207|NCT01135134|75837430|FG000|COMPLETED|Overall Study||218||
59718208|NCT01135134|75837431|FG001|COMPLETED|Overall Study||112||
59718209|NCT01135134|75837430|FG000|NOT COMPLETED|Overall Study||2||
59836867|NCT00289536|75960893|FG002|COMPLETED|Period 1||9||
59836868|NCT00289536|75960891|FG000|NOT COMPLETED|Period 1||0||
59836869|NCT00289536|75960892|FG001|NOT COMPLETED|Period 1||0||
59836870|NCT00289536|75960893|FG002|NOT COMPLETED|Period 1||0||
59836871|NCT00289536|75960891|FG000|STARTED|Period 2|5 participants received Medium Dose and 5 participants received High Dose in Period 1|10||
59836872|NCT00289536|75960892|FG001|STARTED|Period 2|5 participants received Low Dose and 4 participants received High Dose in Period 1|9||
59836873|NCT00289536|75960893|FG002|STARTED|Period 2|4 participants received Low Dose and 3 participants received Medium Dose in Period 1|7||
59836874|NCT00289536|75960891|FG000|COMPLETED|Period 2||10||
59836875|NCT00289536|75960892|FG001|COMPLETED|Period 2||9||
59836876|NCT00289536|75960893|FG002|COMPLETED|Period 2||7||
59836877|NCT00289536|75960891|FG000|NOT COMPLETED|Period 2||0||
59836878|NCT00289536|75960892|FG001|NOT COMPLETED|Period 2||0||
59836879|NCT00289536|75960893|FG002|NOT COMPLETED|Period 2||0||
59836880|NCT00289536|75960891|FG000|STARTED|Period 3|3 participants received Medium Dose and 4 participants received High Dose in Period 2|7||
59836881|NCT00289536|75960892|FG001|STARTED|Period 3|5 participants received Low Dose and 4 participants received High Dose in Period 2|9||
59836882|NCT00289536|75960893|FG002|STARTED|Period 3|5 participants received Low Dose and 5 participants received Medium Dose in Period 2|10||
59836883|NCT00289536|75960891|FG000|COMPLETED|Period 3||7||
59836884|NCT00289536|75960892|FG001|COMPLETED|Period 3||9||
59836885|NCT00289536|75960893|FG002|COMPLETED|Period 3||9||
59836886|NCT00289536|75960891|FG000|NOT COMPLETED|Period 3||0||
59836887|NCT00289536|75960892|FG001|NOT COMPLETED|Period 3||0||
59836888|NCT00289536|75960893|FG002|NOT COMPLETED|Period 3||1||
59836889|NCT00289458|75960902|FG000|STARTED|Overall Study||25||
59836890|NCT00289458|75960903|FG001|STARTED|Overall Study||26||
59836891|NCT00289458|75960904|FG002|STARTED|Overall Study||28||
59836892|NCT00289458|75960902|FG000|COMPLETED|Overall Study||19||
59836893|NCT00289458|75960903|FG001|COMPLETED|Overall Study||20||
59836894|NCT00289458|75960904|FG002|COMPLETED|Overall Study||22||
59836895|NCT00289458|75960902|FG000|NOT COMPLETED|Overall Study||6||
59836896|NCT00289458|75960903|FG001|NOT COMPLETED|Overall Study||6||
59836897|NCT00289458|75960904|FG002|NOT COMPLETED|Overall Study||6||
59836898|NCT00288912|75960915|FG000|STARTED|Overall Study||175||
59836899|NCT00288912|75960916|FG001|STARTED|Overall Study||174||
59836900|NCT00288912|75960917|FG002|STARTED|Overall Study||174||
59836901|NCT00288912|75960915|FG000|COMPLETED|Overall Study||158||
59836902|NCT00288912|75960916|FG001|COMPLETED|Overall Study||157||
59836903|NCT00288912|75960917|FG002|COMPLETED|Overall Study||146||
59836904|NCT00288912|75960915|FG000|NOT COMPLETED|Overall Study||17||
59836905|NCT00288912|75960916|FG001|NOT COMPLETED|Overall Study||17||
59836906|NCT00288912|75960917|FG002|NOT COMPLETED|Overall Study||28||
59836907|NCT00305864|75960929|FG000|STARTED|Overall Study||7||
59836908|NCT00305864|75960930|FG001|STARTED|Overall Study||10||
59836909|NCT00305864|75960931|FG002|STARTED|Overall Study||7||
59836910|NCT00305864|75960932|FG003|STARTED|Overall Study||94||
59836911|NCT00305864|75960929|FG000|COMPLETED|Overall Study||7||
59836912|NCT00305864|75960930|FG001|COMPLETED|Overall Study||9||
59836913|NCT00305864|75960931|FG002|COMPLETED|Overall Study||6||
59836914|NCT00305864|75960932|FG003|COMPLETED|Overall Study||81||
59836915|NCT00305864|75960929|FG000|NOT COMPLETED|Overall Study||0||
59836916|NCT00305864|75960930|FG001|NOT COMPLETED|Overall Study||1||
59836917|NCT00305864|75960931|FG002|NOT COMPLETED|Overall Study||1||
59836918|NCT00305864|75960932|FG003|NOT COMPLETED|Overall Study||13||
59836919|NCT00295880|75960942|FG000|STARTED|Overall Study||12||
59836920|NCT00295880|75960942|FG000|COMPLETED|Overall Study||10||
59836921|NCT00295880|75960942|FG000|NOT COMPLETED|Overall Study||2||
59836922|NCT00319982|75960948|FG000|STARTED|Overall Study||19||
59836923|NCT00319982|75960949|FG001|STARTED|Overall Study||20||
59836924|NCT00319982|75960948|FG000|COMPLETED|Overall Study||18||
59836925|NCT00319982|75960949|FG001|COMPLETED|Overall Study||20||
59836926|NCT00319982|75960948|FG000|NOT COMPLETED|Overall Study||1||
59836927|NCT00319982|75960949|FG001|NOT COMPLETED|Overall Study||0||
59836928|NCT00319592|75960957|FG000|STARTED|Overall Study||30||
59836929|NCT00319592|75960958|FG001|STARTED|Overall Study||30||
60119258|NCT02466412|76240422|FG000|COMPLETED|Washout Period of 1 Day (Day -1)||24||
60119259|NCT02466412|76240423|FG001|COMPLETED|Washout Period of 1 Day (Day -1)||24||
60119260|NCT02466412|76240422|FG000|NOT COMPLETED|Washout Period of 1 Day (Day -1)||0||
60119261|NCT02466412|76240423|FG001|NOT COMPLETED|Washout Period of 1 Day (Day -1)||0||
60119262|NCT02466412|76240422|FG000|STARTED|First Intervention (Day 1)||24||
60119263|NCT02466412|76240423|FG001|STARTED|First Intervention (Day 1)||24||
59836930|NCT00319592|75960957|FG000|COMPLETED|Overall Study||29||
59836931|NCT00319592|75960958|FG001|COMPLETED|Overall Study||29||
59836932|NCT00319592|75960957|FG000|NOT COMPLETED|Overall Study||1||
59836933|NCT00319592|75960958|FG001|NOT COMPLETED|Overall Study||1||
59836934|NCT00295490|75960968|FG000|STARTED|Overall Study||15||
60119264|NCT02466412|76240422|FG000|COMPLETED|First Intervention (Day 1)||24||
60119265|NCT02466412|76240423|FG001|COMPLETED|First Intervention (Day 1)||24||
59836935|NCT00295490|75960969|FG001|STARTED|Overall Study||19||
59836936|NCT00295490|75960970|FG002|STARTED|Overall Study||16||
59836937|NCT00295490|75960971|FG003|STARTED|Overall Study||17||
59836938|NCT00295490|75960968|FG000|COMPLETED|Overall Study||14||
59836939|NCT00295490|75960969|FG001|COMPLETED|Overall Study||15||
59836940|NCT00295490|75960970|FG002|COMPLETED|Overall Study||12||
59836941|NCT00295490|75960971|FG003|COMPLETED|Overall Study||12||
59836942|NCT00295490|75960968|FG000|NOT COMPLETED|Overall Study||1||
59836943|NCT00295490|75960969|FG001|NOT COMPLETED|Overall Study||4||
59836944|NCT00295490|75960970|FG002|NOT COMPLETED|Overall Study||4||
59836945|NCT00295490|75960971|FG003|NOT COMPLETED|Overall Study||5||
59836946|NCT00305006|75960983|FG000|STARTED|Overall Study||22||
59836947|NCT00305006|75960984|FG001|STARTED|Overall Study||22||
59836948|NCT00305006|75960983|FG000|COMPLETED|Overall Study||21||
60119266|NCT02466412|76240422|FG000|NOT COMPLETED|First Intervention (Day 1)||0||
60119267|NCT02466412|76240423|FG001|NOT COMPLETED|First Intervention (Day 1)||0||
60119268|NCT02466412|76240422|FG000|STARTED|Washout Period of 1 Day (Day 2)||24||
60119269|NCT02466412|76240423|FG001|STARTED|Washout Period of 1 Day (Day 2)||24||
60119270|NCT02466412|76240422|FG000|COMPLETED|Washout Period of 1 Day (Day 2)||24||
60119271|NCT02466412|76240423|FG001|COMPLETED|Washout Period of 1 Day (Day 2)||24||
60119272|NCT02466412|76240422|FG000|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0||
60119273|NCT02466412|76240423|FG001|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0||
60119274|NCT02466412|76240422|FG000|STARTED|Second Intervention (Day 3)||24||
59718210|NCT01135134|75837431|FG001|NOT COMPLETED|Overall Study||1||
59718211|NCT00948441|75837439|FG000|STARTED|Overall Study||8||
59836949|NCT00305006|75960984|FG001|COMPLETED|Overall Study||21||
59836950|NCT00305006|75960983|FG000|NOT COMPLETED|Overall Study||1||
59836951|NCT00305006|75960984|FG001|NOT COMPLETED|Overall Study||1||
59836952|NCT00319436|75960992|FG000|STARTED|Overall Study||23||
60119275|NCT02466412|76240423|FG001|STARTED|Second Intervention (Day 3)||24||
59718212|NCT00948441|75837440|FG001|STARTED|Overall Study||8||
59718213|NCT00948441|75837439|FG000|COMPLETED|Overall Study||7||
59718214|NCT00948441|75837440|FG001|COMPLETED|Overall Study||4||
59718215|NCT00948441|75837439|FG000|NOT COMPLETED|Overall Study||1||
59718216|NCT00948441|75837440|FG001|NOT COMPLETED|Overall Study||4||
59718217|NCT01117350|75837450|FG000|STARTED|Comparative Period|STARTED: randomized|489||
59718218|NCT01117350|75837451|FG001|STARTED|Comparative Period||489||
59718219|NCT01117350|75837450|FG000|TREATED = Safety Population|Comparative Period|Safety population: all randomized and treated patients (received at least one dose)|484||
59718220|NCT01117350|75837451|FG001|TREATED = Safety Population|Comparative Period||481||
59718221|NCT01117350|75837450|FG000|mITT Population|Comparative Period|modified Intent-To-Treat population: treated patients with at least one efficacy post-baseline value|474||
59718222|NCT01117350|75837451|FG001|mITT Population|Comparative Period||470||
59718223|NCT01117350|75837450|FG000|COMPLETED|Comparative Period||447||
59718224|NCT01117350|75837451|FG001|COMPLETED|Comparative Period||414||
59718225|NCT01117350|75837450|FG000|NOT COMPLETED|Comparative Period||42||
59718226|NCT01117350|75837451|FG001|NOT COMPLETED|Comparative Period||75||
59718227|NCT01117350|75837450|FG000|STARTED|Extension Period||0||
59718228|NCT01117350|75837451|FG001|STARTED|Extension Period|STARTED: patients having completed the comparative period and eligible for the extension period|210||
59718229|NCT01117350|75837450|FG000|TREATED = Safety Population (Extension)|Extension Period||0||
59718230|NCT01117350|75837451|FG001|TREATED = Safety Population (Extension)|Extension Period|Safety population (extension): treated with insulin glargine during the extension period|160||
59718231|NCT01117350|75837450|FG000|mITT Population (Extension)|Extension Period||0||
59718232|NCT01117350|75837451|FG001|mITT Population (Extension)|Extension Period|mITT (extension): treated patients with at least 1 efficacy value both at entry and during extension|154||
59718233|NCT01117350|75837450|FG000|COMPLETED|Extension Period||0||
59718234|NCT01117350|75837451|FG001|COMPLETED|Extension Period||147||
59718235|NCT01117350|75837450|FG000|NOT COMPLETED|Extension Period||0||
59718236|NCT01117350|75837451|FG001|NOT COMPLETED|Extension Period||63||
59718237|NCT00952731|75837462|FG000|STARTED|Overall Study||13||
59718238|NCT00952731|75837463|FG001|STARTED|Overall Study||14||
59718239|NCT00952731|75837462|FG000|Randomization|Overall Study||13||
59718240|NCT00952731|75837463|FG001|Randomization|Overall Study||14||
59718241|NCT00952731|75837462|FG000|Treatment & Pre-Surgery|Overall Study||12||
59718242|NCT00952731|75837463|FG001|Treatment & Pre-Surgery|Overall Study||14||
59718243|NCT00952731|75837462|FG000|Surgery|Overall Study||12||
59718244|NCT00952731|75837463|FG001|Surgery|Overall Study||14||
59718245|NCT00952731|75837462|FG000|Follow-up|Overall Study||12||
59718246|NCT00952731|75837463|FG001|Follow-up|Overall Study||14||
59718247|NCT00952731|75837462|FG000|COMPLETED|Overall Study||12||
59718248|NCT00952731|75837463|FG001|COMPLETED|Overall Study||14||
59718249|NCT00952731|75837462|FG000|NOT COMPLETED|Overall Study||1||
59718250|NCT00952731|75837463|FG001|NOT COMPLETED|Overall Study||0||
59718251|NCT00947427|75837471|FG000|STARTED|Overall Study||22||
59718252|NCT00947427|75837472|FG001|STARTED|Overall Study|2 participants discontinued prior to any study drug administration|49||
59718253|NCT00947427|75837471|FG000|COMPLETED|Overall Study||21||
59836953|NCT00319436|75960993|FG001|STARTED|Overall Study||24||
59836954|NCT00319436|75960992|FG000|COMPLETED|Overall Study||17||
60119276|NCT02466412|76240422|FG000|COMPLETED|Second Intervention (Day 3)||24||
60119277|NCT02466412|76240423|FG001|COMPLETED|Second Intervention (Day 3)||24||
60119278|NCT02466412|76240422|FG000|NOT COMPLETED|Second Intervention (Day 3)||0||
60119279|NCT02466412|76240423|FG001|NOT COMPLETED|Second Intervention (Day 3)||0||
59718254|NCT00947427|75837472|FG001|COMPLETED|Overall Study||45||
59718255|NCT00947427|75837471|FG000|NOT COMPLETED|Overall Study||1||
59718256|NCT00947427|75837472|FG001|NOT COMPLETED|Overall Study||4||
59718257|NCT01116882|75837480|FG000|STARTED|30-day||2774||
59718258|NCT01116882|75837481|FG001|STARTED|30-day||917||
59718259|NCT01116882|75837480|FG000|COMPLETED|30-day||2706||
59718260|NCT01116882|75837481|FG001|COMPLETED|30-day||886||
59718261|NCT01116882|75837480|FG000|NOT COMPLETED|30-day||68||
60119280|NCT02466646|76240433|FG000|STARTED|Overall Study||14||
59836955|NCT00319436|75960993|FG001|COMPLETED|Overall Study||17||
59836956|NCT00319436|75960992|FG000|NOT COMPLETED|Overall Study||6||
59836957|NCT00319436|75960993|FG001|NOT COMPLETED|Overall Study||7||
59836958|NCT00319046|75960999|FG000|STARTED|Overall Study|One patient was excluded from analysis as the baseline liver volume not available|42||
59836959|NCT00319046|75960999|FG000|COMPLETED|Overall Study||34||
59836960|NCT00319046|75960999|FG000|NOT COMPLETED|Overall Study||8||
59836961|NCT00303602|75961005|FG000|STARTED|Overall Study||84||
59836962|NCT00303602|75961006|FG001|STARTED|Overall Study||65||
59836963|NCT00303602|75961005|FG000|COMPLETED|Overall Study||65||
59836964|NCT00303602|75961006|FG001|COMPLETED|Overall Study||50||
59836965|NCT00303602|75961005|FG000|NOT COMPLETED|Overall Study||19||
59836966|NCT00303602|75961006|FG001|NOT COMPLETED|Overall Study||15||
59836967|NCT00299130|75961015|FG000|STARTED|Treatment Period (up to 5 Years)||172||
59836968|NCT00299130|75961016|FG001|STARTED|Treatment Period (up to 5 Years)||168||
59836969|NCT00299130|75961017|FG002|STARTED|Treatment Period (up to 5 Years)||171||
59836970|NCT00299130|75961015|FG000|Treated|Treatment Period (up to 5 Years)|155 participants in placebo arm switched to active therapy (rituximab 2 x 0.5g) between Weeks 16-48.|172||
59836971|NCT00299130|75961016|FG001|Treated|Treatment Period (up to 5 Years)||167||
59836972|NCT00299130|75961017|FG002|Treated|Treatment Period (up to 5 Years)||170||
59836973|NCT00299130|75961015|FG000|Completed 24 Weeks|Treatment Period (up to 5 Years)||159||
59836974|NCT00299130|75961016|FG001|Completed 24 Weeks|Treatment Period (up to 5 Years)||162||
59836975|NCT00299130|75961017|FG002|Completed 24 Weeks|Treatment Period (up to 5 Years)||166||
59836976|NCT00299130|75961015|FG000|Completed 48 Weeks|Treatment Period (up to 5 Years)||155||
59836977|NCT00299130|75961016|FG001|Completed 48 Weeks|Treatment Period (up to 5 Years)||157||
59836978|NCT00299130|75961017|FG002|Completed 48 Weeks|Treatment Period (up to 5 Years)||158||
59836979|NCT00299130|75961015|FG000|Completed 144 Weeks|Treatment Period (up to 5 Years)||133||
59836980|NCT00299130|75961016|FG001|Completed 144 Weeks|Treatment Period (up to 5 Years)||138||
59836981|NCT00299130|75961017|FG002|Completed 144 Weeks|Treatment Period (up to 5 Years)||132||
59836982|NCT00299130|75961015|FG000|COMPLETED|Treatment Period (up to 5 Years)||119||
59836983|NCT00299130|75961016|FG001|COMPLETED|Treatment Period (up to 5 Years)||125||
59836984|NCT00299130|75961017|FG002|COMPLETED|Treatment Period (up to 5 Years)||121||
59836985|NCT00299130|75961015|FG000|NOT COMPLETED|Treatment Period (up to 5 Years)||53||
59836986|NCT00299130|75961016|FG001|NOT COMPLETED|Treatment Period (up to 5 Years)||43||
59836987|NCT00299130|75961017|FG002|NOT COMPLETED|Treatment Period (up to 5 Years)||50||
59836988|NCT00299130|75961015|FG000|STARTED|Safety Follow-up (SFU) (48 Weeks)||167||
59836989|NCT00299130|75961016|FG001|STARTED|Safety Follow-up (SFU) (48 Weeks)||165||
59718262|NCT01116882|75837481|FG001|NOT COMPLETED|30-day||31||
59718263|NCT01116882|75837480|FG000|STARTED|12-month||2706||
59718264|NCT01116882|75837481|FG001|STARTED|12-month||886||
59718265|NCT01116882|75837480|FG000|COMPLETED|12-month||2439||
59718266|NCT01116882|75837481|FG001|COMPLETED|12-month||787||
59718267|NCT01116882|75837480|FG000|NOT COMPLETED|12-month||267||
59718268|NCT01116882|75837481|FG001|NOT COMPLETED|12-month||99||
59836990|NCT00299130|75961017|FG002|STARTED|Safety Follow-up (SFU) (48 Weeks)||168||
59836991|NCT00299130|75961015|FG000|COMPLETED|Safety Follow-up (SFU) (48 Weeks)||122||
59836992|NCT00299130|75961016|FG001|COMPLETED|Safety Follow-up (SFU) (48 Weeks)||120||
59836993|NCT00299130|75961017|FG002|COMPLETED|Safety Follow-up (SFU) (48 Weeks)||123||
59836994|NCT00299130|75961015|FG000|NOT COMPLETED|Safety Follow-up (SFU) (48 Weeks)||45||
59836995|NCT00299130|75961016|FG001|NOT COMPLETED|Safety Follow-up (SFU) (48 Weeks)||45||
59836996|NCT00299130|75961017|FG002|NOT COMPLETED|Safety Follow-up (SFU) (48 Weeks)||45||
59836997|NCT00299130|75961015|FG000|STARTED|Extended SFU (ESFU) (up to 5.1 Years)||0||
59836998|NCT00299130|75961016|FG001|STARTED|Extended SFU (ESFU) (up to 5.1 Years)||82||
59836999|NCT00299130|75961017|FG002|STARTED|Extended SFU (ESFU) (up to 5.1 Years)||44||
59837000|NCT00299130|75961015|FG000|COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||0||
59837001|NCT00299130|75961016|FG001|COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||74||
59837002|NCT00299130|75961017|FG002|COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||38||
59837003|NCT00299130|75961015|FG000|NOT COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||0||
59837004|NCT00299130|75961016|FG001|NOT COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||8||
59837005|NCT00299130|75961017|FG002|NOT COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||6||
59837006|NCT00288054|75961032|FG000|STARTED|Overall Study||24||
59837007|NCT00288054|75961032|FG000|COMPLETED|Overall Study||0||
59837008|NCT00288054|75961032|FG000|NOT COMPLETED|Overall Study||24||
59837009|NCT00287586|75961040|FG000|STARTED|Overall Study||156||
59837010|NCT00287586|75961041|FG001|STARTED|Overall Study||152||
59718269|NCT00953745|75837492|FG000|STARTED|Phase 1: 8 Weeks Escitalopram + Placebo||37||
59718270|NCT00953745|75837493|FG001|STARTED|Phase 1: 8 Weeks Escitalopram + Placebo||6||
59718271|NCT00953745|75837492|FG000|COMPLETED|Phase 1: 8 Weeks Escitalopram + Placebo||24||
59718272|NCT00953745|75837493|FG001|COMPLETED|Phase 1: 8 Weeks Escitalopram + Placebo||6||
59718273|NCT00953745|75837492|FG000|NOT COMPLETED|Phase 1: 8 Weeks Escitalopram + Placebo||13||
59718274|NCT00953745|75837493|FG001|NOT COMPLETED|Phase 1: 8 Weeks Escitalopram + Placebo||0||
59718275|NCT00953745|75837492|FG000|STARTED|Phase 2: 2 Weeks Escitalopram + Placebo||18||
59837011|NCT00287586|75961040|FG000|Intent-to-treat: Received Study Drug|Overall Study||155||
59837012|NCT00287586|75961041|FG001|Intent-to-treat: Received Study Drug|Overall Study||151||
59837013|NCT00287586|75961040|FG000|COMPLETED|Overall Study||111||
59837014|NCT00287586|75961041|FG001|COMPLETED|Overall Study||100||
59837015|NCT00287586|75961040|FG000|NOT COMPLETED|Overall Study||45||
59837016|NCT00287586|75961041|FG001|NOT COMPLETED|Overall Study||52||
59837017|NCT00287118|75961047|FG000|STARTED|Overall Study||189||
59837018|NCT00287118|75961047|FG000|COMPLETED|Overall Study||137||
59837019|NCT00287118|75961047|FG000|NOT COMPLETED|Overall Study||52||
59837020|NCT00293202|75961053|FG000|STARTED|Overall Study||5||
59837021|NCT00293202|75961054|FG001|STARTED|Overall Study||5||
59837022|NCT00293202|75961053|FG000|COMPLETED|Overall Study||2||
59837023|NCT00293202|75961054|FG001|COMPLETED|Overall Study||3||
59837024|NCT00293202|75961053|FG000|NOT COMPLETED|Overall Study||3||
59837025|NCT00293202|75961054|FG001|NOT COMPLETED|Overall Study||2||
59837026|NCT00298896|75961064|FG000|STARTED|Overall Study||55||
59837027|NCT00298896|75961064|FG000|COMPLETED|Overall Study||5||
59837028|NCT00298896|75961064|FG000|NOT COMPLETED|Overall Study||50||
59837029|NCT00286494|75961071|FG000|STARTED|Overall Study||97||
59837030|NCT00286494|75961072|FG001|STARTED|Overall Study||197||
59837031|NCT00286494|75961073|FG002|STARTED|Overall Study||199||
59837032|NCT00286494|75961071|FG000|COMPLETED|Overall Study||71||
59837033|NCT00286494|75961072|FG001|COMPLETED|Overall Study||153||
59837034|NCT00286494|75961073|FG002|COMPLETED|Overall Study||160||
59837035|NCT00286494|75961071|FG000|NOT COMPLETED|Overall Study||26||
59837036|NCT00286494|75961072|FG001|NOT COMPLETED|Overall Study||44||
59837037|NCT00286494|75961073|FG002|NOT COMPLETED|Overall Study||39||
59837038|NCT00298740|75961081|FG000|STARTED|Overall Study||12||
59837039|NCT00298740|75961081|FG000|COMPLETED|Overall Study||3||
59837040|NCT00298740|75961081|FG000|NOT COMPLETED|Overall Study||9||
59837041|NCT00285012|75961087|FG000|STARTED|Assigned to Study Treatment (Tx)||250||
59837042|NCT00285012|75961088|FG001|STARTED|Assigned to Study Treatment (Tx)||254||
59837043|NCT00285012|75961087|FG000|COMPLETED|Assigned to Study Treatment (Tx)||248||
59837044|NCT00285012|75961088|FG001|COMPLETED|Assigned to Study Treatment (Tx)||251||
59837045|NCT00285012|75961087|FG000|NOT COMPLETED|Assigned to Study Treatment (Tx)||2||
59837046|NCT00285012|75961088|FG001|NOT COMPLETED|Assigned to Study Treatment (Tx)||3||
59837047|NCT00285012|75961087|FG000|STARTED|Received Study Tx||248||
59837048|NCT00285012|75961088|FG001|STARTED|Received Study Tx||251||
59837049|NCT00285012|75961087|FG000|Completed Tx (May Continue in Study)|Received Study Tx|After treatment completion at Wk 12, subjects may continue in nontreatment follow-up phase|207||
59837050|NCT00285012|75961088|FG001|Completed Tx (May Continue in Study)|Received Study Tx|After treatment completion at Wk 12, subjects may continue in nontreatment follow-up phase|193||
59837051|NCT00285012|75961087|FG000|Discontinued Tx (May Continue in Study)|Received Study Tx|Discontinued Tx=12 Adverse Event (AE); 10 Lost to follow up; 13 subject withdrawal; 6 other, unknown|41||
59837052|NCT00285012|75961088|FG001|Discontinued Tx (May Continue in Study)|Received Study Tx|Discontinued Tx=14 AE;3 Lack of efficacy;10 Lost to follow up;25 subject withdrawal;6 other, unknown|58||
59837053|NCT00285012|75961087|FG000|COMPLETED|Received Study Tx|Completed study through nontreatment follow-up phase Week 13 to Week 52|176||
59837054|NCT00285012|75961088|FG001|COMPLETED|Received Study Tx|Completed study through nontreatment follow-up phase Week 13 to Week 52|157||
59837055|NCT00285012|75961087|FG000|NOT COMPLETED|Received Study Tx||72||
60119281|NCT02466646|76240434|FG001|STARTED|Overall Study||14||
60119282|NCT02466646|76240435|FG002|STARTED|Overall Study||14||
60119283|NCT02466646|76240433|FG000|COMPLETED|Overall Study||14||
60119284|NCT02466646|76240434|FG001|COMPLETED|Overall Study||14||
59718276|NCT00953745|75837493|FG001|STARTED|Phase 2: 2 Weeks Escitalopram + Placebo||0||
59718277|NCT00953745|75837492|FG000|COMPLETED|Phase 2: 2 Weeks Escitalopram + Placebo||17||
59718278|NCT00953745|75837493|FG001|COMPLETED|Phase 2: 2 Weeks Escitalopram + Placebo||0||
59718279|NCT00953745|75837492|FG000|NOT COMPLETED|Phase 2: 2 Weeks Escitalopram + Placebo||1||
59718280|NCT00953745|75837493|FG001|NOT COMPLETED|Phase 2: 2 Weeks Escitalopram + Placebo||0||
59718281|NCT00953745|75837492|FG000|STARTED|ARP Phase: 6 Weeks Escitalopram + ARP||17||
59837056|NCT00285012|75961088|FG001|NOT COMPLETED|Received Study Tx||94||
59837057|NCT00284934|75961096|FG000|STARTED|Overall Study||48||
59837058|NCT00284934|75961097|FG001|STARTED|Overall Study||46||
59837059|NCT00284934|75961096|FG000|Intent-to-treat Population (ITT)|Overall Study||47||
59837060|NCT00284934|75961097|FG001|Intent-to-treat Population (ITT)|Overall Study||45||
60119285|NCT02466646|76240435|FG002|COMPLETED|Overall Study||14||
59837061|NCT00284934|75961096|FG000|COMPLETED|Overall Study||44||
59837062|NCT00284934|75961097|FG001|COMPLETED|Overall Study||43||
59837063|NCT00284934|75961096|FG000|NOT COMPLETED|Overall Study||4||
59837064|NCT00284934|75961097|FG001|NOT COMPLETED|Overall Study||3||
59837065|NCT00284856|75961106|FG000|STARTED|Overall Study||347||
59837066|NCT00284856|75961107|FG001|STARTED|Overall Study||336||
59837067|NCT00284856|75961108|FG002|STARTED|Overall Study||336||
60119286|NCT02466646|76240433|FG000|NOT COMPLETED|Overall Study||0||
60119287|NCT02466646|76240434|FG001|NOT COMPLETED|Overall Study||0||
60119288|NCT02466646|76240435|FG002|NOT COMPLETED|Overall Study||0||
59718282|NCT00953745|75837493|FG001|STARTED|ARP Phase: 6 Weeks Escitalopram + ARP||0||
59837068|NCT00284856|75961106|FG000|COMPLETED|Overall Study||296||
60119289|NCT02703636|76240446|FG000|STARTED|Overall Study||118||
60119290|NCT02703636|76240446|FG000|COMPLETED|Overall Study||102||
59837069|NCT00284856|75961107|FG001|COMPLETED|Overall Study||286||
59837070|NCT00284856|75961108|FG002|COMPLETED|Overall Study||276||
59837071|NCT00284856|75961106|FG000|NOT COMPLETED|Overall Study||51||
59837072|NCT00284856|75961107|FG001|NOT COMPLETED|Overall Study||50||
59837073|NCT00284856|75961108|FG002|NOT COMPLETED|Overall Study||60||
59837074|NCT00298272|75961118|FG000|STARTED|Double-blind Phase|enrolled and randomized (2:1 scheme)|36||
59837075|NCT00298272|75961119|FG001|STARTED|Double-blind Phase||18||
59837076|NCT00298272|75961118|FG000|Safety Population|Double-blind Phase|received treatment|33||
59837077|NCT00298272|75961119|FG001|Safety Population|Double-blind Phase||18||
59837078|NCT00298272|75961118|FG000|Completed to Week 24|Double-blind Phase|received full course of rituximab therapy|31||
59837079|NCT00298272|75961119|FG001|Completed to Week 24|Double-blind Phase|received full course of placebo therapy|18||
59837080|NCT00298272|75961118|FG000|Completed to Week 56|Double-blind Phase||8||
59837081|NCT00298272|75961119|FG001|Completed to Week 56|Double-blind Phase||3||
59837082|NCT00298272|75961118|FG000|COMPLETED|Double-blind Phase||28||
59837083|NCT00298272|75961119|FG001|COMPLETED|Double-blind Phase||18||
59837084|NCT00298272|75961118|FG000|NOT COMPLETED|Double-blind Phase||8||
59837085|NCT00298272|75961119|FG001|NOT COMPLETED|Double-blind Phase||0||
59837086|NCT00298272|75961118|FG000|STARTED|Open Label Retreatment Phase||22||
59837087|NCT00298272|75961119|FG001|STARTED|Open Label Retreatment Phase||16||
59837088|NCT00298272|75961118|FG000|Completed to Week 24|Open Label Retreatment Phase|received full course of open-label rituximab therapy|22||
59837089|NCT00298272|75961119|FG001|Completed to Week 24|Open Label Retreatment Phase|received full course of open-label rituximab therapy|15||
59837090|NCT00298272|75961118|FG000|Completed to Week 56|Open Label Retreatment Phase||13||
59837091|NCT00298272|75961119|FG001|Completed to Week 56|Open Label Retreatment Phase||12||
59837092|NCT00298272|75961118|FG000|COMPLETED|Open Label Retreatment Phase||13||
59837093|NCT00298272|75961119|FG001|COMPLETED|Open Label Retreatment Phase||12||
59837094|NCT00298272|75961118|FG000|NOT COMPLETED|Open Label Retreatment Phase||9||
59837095|NCT00298272|75961119|FG001|NOT COMPLETED|Open Label Retreatment Phase||4||
59837096|NCT00298272|75961118|FG000|STARTED|Safety Follow-up Phase||22||
59837097|NCT00298272|75961119|FG001|STARTED|Safety Follow-up Phase||17||
59837098|NCT00298272|75961118|FG000|COMPLETED|Safety Follow-up Phase||18||
59837099|NCT00298272|75961119|FG001|COMPLETED|Safety Follow-up Phase||13||
59837100|NCT00298272|75961118|FG000|NOT COMPLETED|Safety Follow-up Phase||4||
59837101|NCT00298272|75961119|FG001|NOT COMPLETED|Safety Follow-up Phase||4||
59837102|NCT00283842|75961133|FG000|STARTED|Overall Study||63||
59837103|NCT00283842|75961134|FG001|STARTED|Overall Study||87||
59837104|NCT00283842|75961135|FG002|STARTED|Overall Study||99||
59837105|NCT00283842|75961136|FG003|STARTED|Overall Study||69||
59837106|NCT00283842|75961137|FG004|STARTED|Overall Study||90||
59837107|NCT00283842|75961133|FG000|COMPLETED|Overall Study||51||
59837108|NCT00283842|75961134|FG001|COMPLETED|Overall Study||69||
59837109|NCT00283842|75961135|FG002|COMPLETED|Overall Study||68||
59837110|NCT00283842|75961136|FG003|COMPLETED|Overall Study||42||
59837111|NCT00283842|75961137|FG004|COMPLETED|Overall Study||75||
59837112|NCT00283842|75961133|FG000|NOT COMPLETED|Overall Study||12||
59837113|NCT00283842|75961134|FG001|NOT COMPLETED|Overall Study||18||
59837114|NCT00283842|75961135|FG002|NOT COMPLETED|Overall Study||31||
59837115|NCT00283842|75961136|FG003|NOT COMPLETED|Overall Study||27||
59837116|NCT00283842|75961137|FG004|NOT COMPLETED|Overall Study||15||
59837117|NCT00298038|75961151|FG000|STARTED|Overall Study||140||
59837118|NCT00298038|75961152|FG001|STARTED|Overall Study||159||
59837119|NCT00298038|75961151|FG000|Received At Least 1 Dose Of Study Drug|Overall Study||140||
59837120|NCT00298038|75961152|FG001|Received At Least 1 Dose Of Study Drug|Overall Study||159||
59837121|NCT00298038|75961151|FG000|COMPLETED|Overall Study||88||
59837122|NCT00298038|75961152|FG001|COMPLETED|Overall Study||66||
59837123|NCT00298038|75961151|FG000|NOT COMPLETED|Overall Study||52||
59837124|NCT00298038|75961152|FG001|NOT COMPLETED|Overall Study||93||
59837125|NCT00283686|75961162|FG000|STARTED|Overall Study||140||
59837126|NCT00283686|75961163|FG001|STARTED|Overall Study||133||
59837127|NCT00283686|75961164|FG002|STARTED|Overall Study||144||
59837128|NCT00283686|75961165|FG003|STARTED|Overall Study||141||
59837129|NCT00283686|75961162|FG000|COMPLETED|Overall Study||111||
59837130|NCT00283686|75961163|FG001|COMPLETED|Overall Study||92||
59837131|NCT00283686|75961164|FG002|COMPLETED|Overall Study||111||
59837132|NCT00283686|75961165|FG003|COMPLETED|Overall Study||109||
59837133|NCT00283686|75961162|FG000|NOT COMPLETED|Overall Study||29||
59837134|NCT00283686|75961163|FG001|NOT COMPLETED|Overall Study||41||
59837135|NCT00283686|75961164|FG002|NOT COMPLETED|Overall Study||33||
59837136|NCT00283686|75961165|FG003|NOT COMPLETED|Overall Study||32||
59837137|NCT00297882|75961177|FG000|STARTED|Day 14||204||
59837138|NCT00297882|75961178|FG001|STARTED|Day 14||612||
59837139|NCT00297882|75961177|FG000|COMPLETED|Day 14||192||
59837140|NCT00297882|75961178|FG001|COMPLETED|Day 14||563||
59837141|NCT00297882|75961177|FG000|NOT COMPLETED|Day 14||12||
59837142|NCT00297882|75961178|FG001|NOT COMPLETED|Day 14||49||
59837143|NCT00297882|75961177|FG000|STARTED|Day 28||192||
59837144|NCT00297882|75961178|FG001|STARTED|Day 28||563||
59837145|NCT00297882|75961177|FG000|COMPLETED|Day 28||176||
59837146|NCT00297882|75961178|FG001|COMPLETED|Day 28||540||
59837147|NCT00297882|75961177|FG000|NOT COMPLETED|Day 28||16||
59837148|NCT00297882|75961178|FG001|NOT COMPLETED|Day 28||23||
59837149|NCT00297648|75961186|FG000|STARTED|Overall Study||89||
59837150|NCT00297648|75961186|FG000|COMPLETED|Overall Study||53||
59837151|NCT00297648|75961186|FG000|NOT COMPLETED|Overall Study||36||
59837152|NCT00283296|75961190|FG000|STARTED|Overall Study||14||
59837153|NCT00283296|75961190|FG000|COMPLETED|Overall Study|Completed in-lab and in-home trial.|9||
59837154|NCT00283296|75961190|FG000|NOT COMPLETED|Overall Study||5||
59837155|NCT00297492|75961198|FG000|STARTED|Set Quit Date||297||
59837156|NCT00297492|75961199|FG001|STARTED|Set Quit Date||299||
59837157|NCT00297492|75961200|FG002|STARTED|Set Quit Date||150||
59837158|NCT00297492|75961198|FG000|COMPLETED|Set Quit Date||290||
59837159|NCT00297492|75961199|FG001|COMPLETED|Set Quit Date||286||
59837160|NCT00297492|75961200|FG002|COMPLETED|Set Quit Date||145||
59837161|NCT00297492|75961198|FG000|NOT COMPLETED|Set Quit Date||7||
59837162|NCT00297492|75961199|FG001|NOT COMPLETED|Set Quit Date||13||
59837163|NCT00297492|75961200|FG002|NOT COMPLETED|Set Quit Date||5||
59837164|NCT00297492|75961198|FG000|STARTED|6 Month Follow-up||290||
59837165|NCT00297492|75961199|FG001|STARTED|6 Month Follow-up||286||
59837166|NCT00297492|75961200|FG002|STARTED|6 Month Follow-up||145||
59837167|NCT00297492|75961198|FG000|COMPLETED|6 Month Follow-up||227||
59837168|NCT00297492|75961199|FG001|COMPLETED|6 Month Follow-up||237||
59837169|NCT00297492|75961200|FG002|COMPLETED|6 Month Follow-up||118||
59837170|NCT00297492|75961198|FG000|NOT COMPLETED|6 Month Follow-up||63||
59837171|NCT00297492|75961199|FG001|NOT COMPLETED|6 Month Follow-up||49||
59837172|NCT00297492|75961200|FG002|NOT COMPLETED|6 Month Follow-up||27||
59837173|NCT00297258|75961208|FG000|STARTED|Overall Study||142||
59837174|NCT00297258|75961208|FG000|COMPLETED|Overall Study||0||
59837175|NCT00297258|75961208|FG000|NOT COMPLETED|Overall Study||142||
59837176|NCT00496769|75961217|FG000|STARTED|Double Blind|Randomized|2807||
59837177|NCT00496769|75961218|FG001|STARTED|Double Blind|Randomized|2791||
59837178|NCT00496769|75961219|FG002|STARTED|Double Blind||0||
59837179|NCT00496769|75961217|FG000|Received Treatment|Double Blind||2798||
59837180|NCT00496769|75961218|FG001|Received Treatment|Double Blind||2708||
59837181|NCT00496769|75961219|FG002|Received Treatment|Double Blind||0||
59837182|NCT00496769|75961217|FG000|COMPLETED|Double Blind||2249||
59837183|NCT00496769|75961218|FG001|COMPLETED|Double Blind||2142||
59837184|NCT00496769|75961219|FG002|COMPLETED|Double Blind||0||
59837185|NCT00496769|75961217|FG000|NOT COMPLETED|Double Blind||558||
59837186|NCT00496769|75961218|FG001|NOT COMPLETED|Double Blind||649||
59837187|NCT00496769|75961219|FG002|NOT COMPLETED|Double Blind||0||
59837188|NCT00496769|75961217|FG000|STARTED|Open Label||0||
59837189|NCT00496769|75961218|FG001|STARTED|Open Label||0||
59837190|NCT00496769|75961219|FG002|STARTED|Open Label||3275||
59837191|NCT00496769|75961217|FG000|COMPLETED|Open Label||0||
59837192|NCT00496769|75961218|FG001|COMPLETED|Open Label||0||
59837193|NCT00496769|75961219|FG002|COMPLETED|Open Label||2264||
59837194|NCT00496769|75961217|FG000|NOT COMPLETED|Open Label||0||
59837195|NCT00496769|75961218|FG001|NOT COMPLETED|Open Label||0||
59837196|NCT00496769|75961219|FG002|NOT COMPLETED|Open Label||1011||
59837197|NCT00478673|75961228|FG000|STARTED|30-Days Post-Procedure||298||
59837198|NCT00478673|75961228|FG000|COMPLETED|30-Days Post-Procedure|"7 participants who did not complete this Period due to Missed Visit still continued on to Period 2"|288||
59837199|NCT00478673|75961228|FG000|NOT COMPLETED|30-Days Post-Procedure||10||
59837200|NCT00478673|75961228|FG000|STARTED|12-Months Post-Procedure|3 participants who did not complete Period 1 due to death (2) and withdrawal (1) are not included.|295||
59837201|NCT00478673|75961228|FG000|COMPLETED|12-Months Post-Procedure||231||
59837202|NCT00478673|75961228|FG000|NOT COMPLETED|12-Months Post-Procedure||64||
59718283|NCT00953745|75837492|FG000|COMPLETED|ARP Phase: 6 Weeks Escitalopram + ARP||17||
59718284|NCT00953745|75837493|FG001|COMPLETED|ARP Phase: 6 Weeks Escitalopram + ARP||0||
59718285|NCT00953745|75837492|FG000|NOT COMPLETED|ARP Phase: 6 Weeks Escitalopram + ARP||0||
59718286|NCT00953745|75837493|FG001|NOT COMPLETED|ARP Phase: 6 Weeks Escitalopram + ARP||0||
59718287|NCT01551550|75837503|FG000|STARTED|Overall Study||41||
59718288|NCT01551550|75837504|FG001|STARTED|Overall Study||41||
59718289|NCT01551550|75837503|FG000|COMPLETED|Overall Study||41||
59718290|NCT01551550|75837504|FG001|COMPLETED|Overall Study||40||
59718291|NCT01551550|75837503|FG000|NOT COMPLETED|Overall Study||0||
59718292|NCT01551550|75837504|FG001|NOT COMPLETED|Overall Study||1||
59718293|NCT00902746|75837510|FG000|STARTED|Overall Study||149||
59718294|NCT00902746|75837510|FG000|Initiation of Study Drug Administration|Overall Study||148||
59837203|NCT00488345|75961235|FG000|STARTED|Overall Study||17||
59837204|NCT00488345|75961236|FG001|STARTED|Overall Study||21||
59837205|NCT00488345|75961237|FG002|STARTED|Overall Study||20||
59837206|NCT00488345|75961235|FG000|COMPLETED|Overall Study||17||
59837207|NCT00488345|75961236|FG001|COMPLETED|Overall Study||17||
59837208|NCT00488345|75961237|FG002|COMPLETED|Overall Study||17||
59837209|NCT00488345|75961235|FG000|NOT COMPLETED|Overall Study||0||
59837210|NCT00488345|75961236|FG001|NOT COMPLETED|Overall Study||4||
59837211|NCT00488345|75961237|FG002|NOT COMPLETED|Overall Study||3||
59837212|NCT00283062|75961250|FG000|STARTED|Overall Study||55||
59837213|NCT00283062|75961251|FG001|STARTED|Overall Study||55||
59837214|NCT00283062|75961252|FG002|STARTED|Overall Study||56||
59837215|NCT00283062|75961253|FG003|STARTED|Overall Study||62||
59837216|NCT00283062|75961250|FG000|ADMINISTERED STUDY TREATMENT|Overall Study||50||
59837217|NCT00283062|75961251|FG001|ADMINISTERED STUDY TREATMENT|Overall Study||51||
59837218|NCT00283062|75961252|FG002|ADMINISTERED STUDY TREATMENT|Overall Study||20||
59837219|NCT00283062|75961253|FG003|ADMINISTERED STUDY TREATMENT|Overall Study||17||
59837220|NCT00283062|75961250|FG000|COMPLETED HORMONAL THERAPY (6 Cycles)|Overall Study||44||
59837221|NCT00283062|75961251|FG001|COMPLETED HORMONAL THERAPY (6 Cycles)|Overall Study||48||
59837222|NCT00283062|75961252|FG002|COMPLETED HORMONAL THERAPY (6 Cycles)|Overall Study||15||
59837223|NCT00283062|75961253|FG003|COMPLETED HORMONAL THERAPY (6 Cycles)|Overall Study||13||
59837224|NCT00283062|75961250|FG000|COMPLETED CHEMOTHERAPY (6 Cycles)|Overall Study||43||
59837225|NCT00283062|75961251|FG001|COMPLETED CHEMOTHERAPY (6 Cycles)|Overall Study|Not applicable, since participants in this arm did not receive chemotherapy.|0||
59837226|NCT00283062|75961252|FG002|COMPLETED CHEMOTHERAPY (6 Cycles)|Overall Study||15||
59837227|NCT00283062|75961253|FG003|COMPLETED CHEMOTHERAPY (6 Cycles)|Overall Study|Not applicable, since participants in this arm did not receive chemotherapy.|0||
59837228|NCT00283062|75961250|FG000|COMPLETED|Overall Study||43||
59837229|NCT00283062|75961251|FG001|COMPLETED|Overall Study||48||
59837230|NCT00283062|75961252|FG002|COMPLETED|Overall Study||15||
59837231|NCT00283062|75961253|FG003|COMPLETED|Overall Study||13||
59837232|NCT00283062|75961250|FG000|NOT COMPLETED|Overall Study||12||
59837233|NCT00283062|75961251|FG001|NOT COMPLETED|Overall Study||7||
59837234|NCT00283062|75961252|FG002|NOT COMPLETED|Overall Study||41||
59837235|NCT00283062|75961253|FG003|NOT COMPLETED|Overall Study||49||
59837236|NCT00282984|75961265|FG000|STARTED|Overall Study||353||
59837237|NCT00282984|75961266|FG001|STARTED|Overall Study||350||
59837238|NCT00282984|75961265|FG000|COMPLETED|Overall Study||302||
59837239|NCT00282984|75961266|FG001|COMPLETED|Overall Study||289||
59837240|NCT00282984|75961265|FG000|NOT COMPLETED|Overall Study||51||
59837241|NCT00282984|75961266|FG001|NOT COMPLETED|Overall Study||61||
59837242|NCT00282438|75961274|FG000|STARTED|Overall Study||1||
59837243|NCT00282438|75961275|FG001|STARTED|Overall Study||1||
59837244|NCT00282438|75961274|FG000|COMPLETED|Overall Study||0||
59837245|NCT00282438|75961275|FG001|COMPLETED|Overall Study||0||
59837246|NCT00282438|75961274|FG000|NOT COMPLETED|Overall Study||1||
59837247|NCT00282438|75961275|FG001|NOT COMPLETED|Overall Study||1||
59837248|NCT00296400|75961284|FG000|STARTED|Overall Study||70||
59837249|NCT00296400|75961285|FG001|STARTED|Overall Study||87||
59837250|NCT00296400|75961286|FG002|STARTED|Overall Study||80||
59837251|NCT00296400|75961284|FG000|COMPLETED|Overall Study||53||
59837252|NCT00296400|75961285|FG001|COMPLETED|Overall Study||69||
59837253|NCT00296400|75961286|FG002|COMPLETED|Overall Study||67||
59837254|NCT00296400|75961284|FG000|NOT COMPLETED|Overall Study||17||
59837255|NCT00296400|75961285|FG001|NOT COMPLETED|Overall Study||18||
59837256|NCT00296400|75961286|FG002|NOT COMPLETED|Overall Study||13||
59837257|NCT00296244|75961299|FG000|STARTED|Overall Study||20||
59837258|NCT00296244|75961300|FG001|STARTED|Overall Study||20||
59837259|NCT00296244|75961299|FG000|COMPLETED|Overall Study||20||
59837260|NCT00296244|75961300|FG001|COMPLETED|Overall Study||19||
59837261|NCT00296244|75961299|FG000|NOT COMPLETED|Overall Study||0||
59837262|NCT00296244|75961300|FG001|NOT COMPLETED|Overall Study||1||
59837263|NCT00274716|75961317|FG000|STARTED|Phase A||54||
59837264|NCT00274716|75961318|FG001|STARTED|Phase A||54||
59837265|NCT00274716|75961319|FG002|STARTED|Phase A||52||
59837266|NCT00274716|75961320|FG003|STARTED|Phase A||51||
59837267|NCT00274716|75961321|FG004|STARTED|Phase A||19||
59837268|NCT00274716|75961322|FG005|STARTED|Phase A||19||
59837269|NCT00274716|75961317|FG000|COMPLETED|Phase A||43||
59837270|NCT00274716|75961318|FG001|COMPLETED|Phase A||44||
59837271|NCT00274716|75961319|FG002|COMPLETED|Phase A||44||
59837272|NCT00274716|75961320|FG003|COMPLETED|Phase A||42||
59837273|NCT00274716|75961321|FG004|COMPLETED|Phase A||16||
59837274|NCT00274716|75961322|FG005|COMPLETED|Phase A||15||
59837275|NCT00274716|75961317|FG000|NOT COMPLETED|Phase A||11||
59837276|NCT00274716|75961318|FG001|NOT COMPLETED|Phase A||10||
59837277|NCT00274716|75961319|FG002|NOT COMPLETED|Phase A||8||
59837278|NCT00274716|75961320|FG003|NOT COMPLETED|Phase A||9||
59837279|NCT00274716|75961321|FG004|NOT COMPLETED|Phase A||3||
59837280|NCT00274716|75961322|FG005|NOT COMPLETED|Phase A||4||
59837281|NCT00274716|75961317|FG000|STARTED|Phase B||43||
59837282|NCT00274716|75961318|FG001|STARTED|Phase B||44||
59837283|NCT00274716|75961319|FG002|STARTED|Phase B||44||
59837284|NCT00274716|75961320|FG003|STARTED|Phase B||42||
59837285|NCT00274716|75961321|FG004|STARTED|Phase B||16||
59837286|NCT00274716|75961322|FG005|STARTED|Phase B||15||
59837287|NCT00274716|75961317|FG000|COMPLETED|Phase B||42||
59837288|NCT00274716|75961318|FG001|COMPLETED|Phase B||40||
59837289|NCT00274716|75961319|FG002|COMPLETED|Phase B||41||
59837290|NCT00274716|75961320|FG003|COMPLETED|Phase B||41||
59837291|NCT00274716|75961321|FG004|COMPLETED|Phase B||16||
59837292|NCT00274716|75961322|FG005|COMPLETED|Phase B||14||
59837293|NCT00274716|75961317|FG000|NOT COMPLETED|Phase B||1||
59837294|NCT00274716|75961318|FG001|NOT COMPLETED|Phase B||4||
59837295|NCT00274716|75961319|FG002|NOT COMPLETED|Phase B||3||
59837296|NCT00274716|75961320|FG003|NOT COMPLETED|Phase B||1||
59837297|NCT00274716|75961321|FG004|NOT COMPLETED|Phase B||0||
59837298|NCT00274716|75961322|FG005|NOT COMPLETED|Phase B||1||
59837299|NCT00282048|75961340|FG000|STARTED|Overall Study||62||
59837300|NCT00282048|75961340|FG000|COMPLETED|Overall Study||0||
59837301|NCT00282048|75961340|FG000|NOT COMPLETED|Overall Study||62||
59837302|NCT00474539|75961346|FG000|STARTED|Infant Series|One participant was randomized to 7vPnC, but received 13vPnC.|223||
59837303|NCT00474539|75961347|FG001|STARTED|Infant Series|One participant was randomized to 7vPnC, but received 13vPnC.|226||
59837304|NCT00474539|75961346|FG000|Vaccinated Dose 1|Infant Series||218||
59837305|NCT00474539|75961347|FG001|Vaccinated Dose 1|Infant Series||226||
59837306|NCT00474539|75961346|FG000|Vaccinated Dose 2|Infant Series||217||
59837307|NCT00474539|75961347|FG001|Vaccinated Dose 2|Infant Series||222||
59837308|NCT00474539|75961346|FG000|Vaccinated Dose 3|Infant Series||214||
59837309|NCT00474539|75961347|FG001|Vaccinated Dose 3|Infant Series||221||
59837310|NCT00474539|75961346|FG000|COMPLETED|Infant Series||213||
59837311|NCT00474539|75961347|FG001|COMPLETED|Infant Series||220||
59837312|NCT00474539|75961346|FG000|NOT COMPLETED|Infant Series||10||
59837313|NCT00474539|75961347|FG001|NOT COMPLETED|Infant Series||6||
59837314|NCT00474539|75961346|FG000|STARTED|After Infant Series||213||
59837315|NCT00474539|75961347|FG001|STARTED|After Infant Series||220||
59837316|NCT00474539|75961346|FG000|COMPLETED|After Infant Series||209||
59837317|NCT00474539|75961347|FG001|COMPLETED|After Infant Series||220||
59837318|NCT00474539|75961346|FG000|NOT COMPLETED|After Infant Series||4||
59837319|NCT00474539|75961347|FG001|NOT COMPLETED|After Infant Series||0||
59837320|NCT00474539|75961346|FG000|STARTED|Toddler Dose||209||
59837321|NCT00474539|75961347|FG001|STARTED|Toddler Dose||220||
59837322|NCT00474539|75961346|FG000|COMPLETED|Toddler Dose||208||
59837323|NCT00474539|75961347|FG001|COMPLETED|Toddler Dose||220||
59837324|NCT00474539|75961346|FG000|NOT COMPLETED|Toddler Dose||1||
59837325|NCT00474539|75961347|FG001|NOT COMPLETED|Toddler Dose||0||
59837326|NCT00281580|75961394|FG000|STARTED|Overall Study||46||
59837327|NCT00281580|75961395|FG001|STARTED|Overall Study||42||
59837328|NCT00281580|75961396|FG002|STARTED|Overall Study||130||
59837329|NCT00281580|75961397|FG003|STARTED|Overall Study||135||
59837330|NCT00281580|75961398|FG004|STARTED|Overall Study||44||
59837331|NCT00281580|75961399|FG005|STARTED|Overall Study||46||
59837332|NCT00281580|75961400|FG006|STARTED|Overall Study||44||
59837333|NCT00281580|75961401|FG007|STARTED|Overall Study||47||
59837334|NCT00281580|75961402|FG008|STARTED|Overall Study||143||
59837335|NCT00281580|75961403|FG009|STARTED|Overall Study||129||
59837336|NCT00281580|75961404|FG010|STARTED|Overall Study||48||
59837337|NCT00281580|75961405|FG011|STARTED|Overall Study||146||
59837338|NCT00281580|75961406|FG012|STARTED|Overall Study||142||
59837339|NCT00281580|75961407|FG013|STARTED|Overall Study||50||
59837340|NCT00281580|75961408|FG014|STARTED|Overall Study||140||
59837341|NCT00281580|75961409|FG015|STARTED|Overall Study||129||
59837342|NCT00281580|75961394|FG000|COMPLETED|Overall Study||39||
59837343|NCT00281580|75961395|FG001|COMPLETED|Overall Study||41||
59837344|NCT00281580|75961396|FG002|COMPLETED|Overall Study||125||
59837345|NCT00281580|75961397|FG003|COMPLETED|Overall Study||118||
59837346|NCT00281580|75961398|FG004|COMPLETED|Overall Study||40||
59837347|NCT00281580|75961399|FG005|COMPLETED|Overall Study||43||
59837348|NCT00281580|75961400|FG006|COMPLETED|Overall Study||39||
59837349|NCT00281580|75961401|FG007|COMPLETED|Overall Study||46||
59837350|NCT00281580|75961402|FG008|COMPLETED|Overall Study||135||
59837351|NCT00281580|75961403|FG009|COMPLETED|Overall Study||117||
59837352|NCT00281580|75961404|FG010|COMPLETED|Overall Study||44||
59837353|NCT00281580|75961405|FG011|COMPLETED|Overall Study||136||
59837354|NCT00281580|75961406|FG012|COMPLETED|Overall Study||129||
59837355|NCT00281580|75961407|FG013|COMPLETED|Overall Study||43||
59837356|NCT00281580|75961408|FG014|COMPLETED|Overall Study||133||
60119291|NCT02703636|76240446|FG000|NOT COMPLETED|Overall Study||16||
59837357|NCT00281580|75961409|FG015|COMPLETED|Overall Study||116||
59837358|NCT00281580|75961394|FG000|NOT COMPLETED|Overall Study||7||
59837359|NCT00281580|75961395|FG001|NOT COMPLETED|Overall Study||1||
59837360|NCT00281580|75961396|FG002|NOT COMPLETED|Overall Study||5||
59837361|NCT00281580|75961397|FG003|NOT COMPLETED|Overall Study||17||
59837362|NCT00281580|75961398|FG004|NOT COMPLETED|Overall Study||4||
59837363|NCT00281580|75961399|FG005|NOT COMPLETED|Overall Study||3||
59837364|NCT00281580|75961400|FG006|NOT COMPLETED|Overall Study||5||
60119292|NCT02466958|76240452|FG000|STARTED|Overall Study||17||
59837365|NCT00281580|75961401|FG007|NOT COMPLETED|Overall Study||1||
59837366|NCT00281580|75961402|FG008|NOT COMPLETED|Overall Study||8||
59837367|NCT00281580|75961403|FG009|NOT COMPLETED|Overall Study||12||
59837368|NCT00281580|75961404|FG010|NOT COMPLETED|Overall Study||4||
60119293|NCT02466958|76240453|FG001|STARTED|Overall Study||12||
59837369|NCT00281580|75961405|FG011|NOT COMPLETED|Overall Study||10||
59837370|NCT00281580|75961406|FG012|NOT COMPLETED|Overall Study||13||
59837371|NCT00281580|75961407|FG013|NOT COMPLETED|Overall Study||7||
59837372|NCT00281580|75961408|FG014|NOT COMPLETED|Overall Study||7||
59837373|NCT00281580|75961409|FG015|NOT COMPLETED|Overall Study||13||
59837374|NCT00495755|75961478|FG000|STARTED|Overall Study||13||
60119294|NCT02466958|76240452|FG000|COMPLETED|Overall Study||7||
59837375|NCT00495755|75961478|FG000|COMPLETED|Overall Study||10||
59837376|NCT00495755|75961478|FG000|NOT COMPLETED|Overall Study||3||
59837377|NCT00495677|75961490|FG000|STARTED|Stage 1 (25 Days)||2||
59837378|NCT00495677|75961491|FG001|STARTED|Stage 1 (25 Days)||6||
59837379|NCT00495677|75961492|FG002|STARTED|Stage 1 (25 Days)||6||
59837380|NCT00495677|75961493|FG003|STARTED|Stage 1 (25 Days)||6||
59837381|NCT00495677|75961494|FG004|STARTED|Stage 1 (25 Days)||0||
59837382|NCT00495677|75961495|FG005|STARTED|Stage 1 (25 Days)||0||
59837383|NCT00495677|75961496|FG006|STARTED|Stage 1 (25 Days)||0||
59837384|NCT00495677|75961490|FG000|COMPLETED|Stage 1 (25 Days)||2||
59837385|NCT00495677|75961491|FG001|COMPLETED|Stage 1 (25 Days)||6||
59837386|NCT00495677|75961492|FG002|COMPLETED|Stage 1 (25 Days)||5||
59837387|NCT00495677|75961493|FG003|COMPLETED|Stage 1 (25 Days)||6||
59837388|NCT00495677|75961494|FG004|COMPLETED|Stage 1 (25 Days)||0||
59837389|NCT00495677|75961495|FG005|COMPLETED|Stage 1 (25 Days)||0||
59837390|NCT00495677|75961496|FG006|COMPLETED|Stage 1 (25 Days)||0||
59837391|NCT00495677|75961490|FG000|NOT COMPLETED|Stage 1 (25 Days)||0||
59837392|NCT00495677|75961491|FG001|NOT COMPLETED|Stage 1 (25 Days)||0||
59837393|NCT00495677|75961492|FG002|NOT COMPLETED|Stage 1 (25 Days)||1||
59837394|NCT00495677|75961493|FG003|NOT COMPLETED|Stage 1 (25 Days)||0||
59837395|NCT00495677|75961494|FG004|NOT COMPLETED|Stage 1 (25 Days)||0||
59837396|NCT00495677|75961495|FG005|NOT COMPLETED|Stage 1 (25 Days)||0||
59837397|NCT00495677|75961496|FG006|NOT COMPLETED|Stage 1 (25 Days)||0||
59837398|NCT00495677|75961490|FG000|STARTED|Stage 2 (25 Days)||0||
59837399|NCT00495677|75961491|FG001|STARTED|Stage 2 (25 Days)||0||
59837400|NCT00495677|75961492|FG002|STARTED|Stage 2 (25 Days)||0||
59837401|NCT00495677|75961493|FG003|STARTED|Stage 2 (25 Days)||0||
60119295|NCT02466958|76240453|FG001|COMPLETED|Overall Study||9||
60119296|NCT02466958|76240452|FG000|NOT COMPLETED|Overall Study||10||
60119297|NCT02466958|76240453|FG001|NOT COMPLETED|Overall Study||3||
60119298|NCT02467504|76240461|FG000|STARTED|Overall Study||23||
60119299|NCT02467504|76240462|FG001|STARTED|Overall Study||24||
60119300|NCT02467504|76240461|FG000|COMPLETED|Overall Study||17||
60119301|NCT02467504|76240462|FG001|COMPLETED|Overall Study||23||
60119302|NCT02467504|76240461|FG000|NOT COMPLETED|Overall Study||6||
60119303|NCT02467504|76240462|FG001|NOT COMPLETED|Overall Study||1||
60119304|NCT02468830|76240468|FG000|STARTED|Overall Study||58||
60119305|NCT02468830|76240468|FG000|COMPLETED|Overall Study||55||
60119306|NCT02468830|76240468|FG000|NOT COMPLETED|Overall Study||3||
60119307|NCT02470234|76240475|FG000|STARTED|Overall Study||5||
60119308|NCT02470234|76240476|FG001|STARTED|Overall Study||3||
60119309|NCT02470234|76240477|FG002|STARTED|Overall Study||2||
60119310|NCT02470234|76240475|FG000|COMPLETED|Overall Study||5||
60119311|NCT02470234|76240476|FG001|COMPLETED|Overall Study||3||
59718295|NCT00902746|75837510|FG000|Transfer to Step 2|Overall Study||133||
59718296|NCT00902746|75837510|FG000|COMPLETED|Overall Study||113||
59718297|NCT00902746|75837510|FG000|NOT COMPLETED|Overall Study||36||
59718298|NCT01199380|75837516|FG000|STARTED|Overall Study||88||
59718299|NCT01199380|75837517|FG001|STARTED|Overall Study||96||
59718300|NCT01199380|75837516|FG000|COMPLETED|Overall Study||78||
59718301|NCT01199380|75837517|FG001|COMPLETED|Overall Study||81||
59718302|NCT01199380|75837516|FG000|NOT COMPLETED|Overall Study||10||
59718303|NCT01199380|75837517|FG001|NOT COMPLETED|Overall Study||15||
59718304|NCT00902668|75837523|FG000|STARTED|Overall Study||3||
59837402|NCT00495677|75961494|FG004|STARTED|Stage 2 (25 Days)||8||
59837403|NCT00495677|75961495|FG005|STARTED|Stage 2 (25 Days)||8||
59837404|NCT00495677|75961496|FG006|STARTED|Stage 2 (25 Days)||7||
59837405|NCT00495677|75961490|FG000|COMPLETED|Stage 2 (25 Days)||0||
59837406|NCT00495677|75961491|FG001|COMPLETED|Stage 2 (25 Days)||0||
59837407|NCT00495677|75961492|FG002|COMPLETED|Stage 2 (25 Days)||0||
59837408|NCT00495677|75961493|FG003|COMPLETED|Stage 2 (25 Days)||0||
59837409|NCT00495677|75961494|FG004|COMPLETED|Stage 2 (25 Days)||8||
59837410|NCT00495677|75961495|FG005|COMPLETED|Stage 2 (25 Days)||8||
59837411|NCT00495677|75961496|FG006|COMPLETED|Stage 2 (25 Days)||7||
59837412|NCT00495677|75961490|FG000|NOT COMPLETED|Stage 2 (25 Days)||0||
59837413|NCT00495677|75961491|FG001|NOT COMPLETED|Stage 2 (25 Days)||0||
59837414|NCT00495677|75961492|FG002|NOT COMPLETED|Stage 2 (25 Days)||0||
59837415|NCT00495677|75961493|FG003|NOT COMPLETED|Stage 2 (25 Days)||0||
59837416|NCT00495677|75961494|FG004|NOT COMPLETED|Stage 2 (25 Days)||0||
59837417|NCT00495677|75961495|FG005|NOT COMPLETED|Stage 2 (25 Days)||0||
59837418|NCT00495677|75961496|FG006|NOT COMPLETED|Stage 2 (25 Days)||0||
59837419|NCT00495521|75961514|FG000|STARTED|Overall Study||1||
59837420|NCT00495521|75961515|FG001|STARTED|Overall Study||1||
59837421|NCT00495521|75961514|FG000|COMPLETED|Overall Study||1||
59718305|NCT00902668|75837523|FG000|COMPLETED|Overall Study||0||
59837422|NCT00495521|75961515|FG001|COMPLETED|Overall Study||0||
59837423|NCT00495521|75961514|FG000|NOT COMPLETED|Overall Study||0||
60119312|NCT02470234|76240477|FG002|COMPLETED|Overall Study||2||
59718306|NCT00902668|75837523|FG000|NOT COMPLETED|Overall Study||3||
59837424|NCT00495521|75961515|FG001|NOT COMPLETED|Overall Study||1||
59837425|NCT00273858|75961521|FG000|STARTED|Overall Study||880||
59837426|NCT00273858|75961521|FG000|COMPLETED|Overall Study||343||
60119313|NCT02470234|76240475|FG000|NOT COMPLETED|Overall Study||0||
60119314|NCT02470234|76240476|FG001|NOT COMPLETED|Overall Study||0||
60119315|NCT02470234|76240477|FG002|NOT COMPLETED|Overall Study||0||
60119316|NCT02432716|76240490|FG000|STARTED|Overall Study||6||
60119317|NCT02432716|76240491|FG001|STARTED|Overall Study||6||
60119318|NCT02432716|76240490|FG000|COMPLETED|Overall Study||6||
60119319|NCT02432716|76240491|FG001|COMPLETED|Overall Study||6||
60119320|NCT02432716|76240490|FG000|NOT COMPLETED|Overall Study||0||
60119321|NCT02432716|76240491|FG001|NOT COMPLETED|Overall Study||0||
60119322|NCT02433496|76240502|FG000|STARTED|Overall Study|This includes patients (29956) and providers (34).|29990||4
60119323|NCT02433496|76240503|FG001|STARTED|Overall Study|This includes patients (13296) and providers (13).|13309||4
60119324|NCT02433496|76240504|FG002|STARTED|Overall Study|This includes patients (9813) and providers (20).|9833||3
60119325|NCT02433496|76240502|FG000|COMPLETED|Overall Study|This includes patients (29956) and providers (34).|29990||4
60119326|NCT02433496|76240503|FG001|COMPLETED|Overall Study|This includes patients (13296) and providers (13).|13309||4
60119327|NCT02433496|76240504|FG002|COMPLETED|Overall Study|This includes patients (9813) and providers (20).|9833||3
60119328|NCT02433496|76240502|FG000|NOT COMPLETED|Overall Study||0||0
60119329|NCT02433496|76240503|FG001|NOT COMPLETED|Overall Study||0||0
60119330|NCT02433496|76240504|FG002|NOT COMPLETED|Overall Study||0||0
60119331|NCT02435524|76240515|FG000|STARTED|Baseline Survey||1111||18
59718307|NCT00947349|75837531|FG000|STARTED|Triple Treatment Combination Period||4||
59718308|NCT00947349|75837532|FG001|STARTED|Triple Treatment Combination Period||6||
59718309|NCT00947349|75837533|FG002|STARTED|Triple Treatment Combination Period||6||
59718310|NCT00947349|75837534|FG003|STARTED|Triple Treatment Combination Period||6||
59718311|NCT00947349|75837531|FG000|COMPLETED|Triple Treatment Combination Period||4||
59718312|NCT00947349|75837532|FG001|COMPLETED|Triple Treatment Combination Period||5||
59718313|NCT00947349|75837533|FG002|COMPLETED|Triple Treatment Combination Period||6||
59718314|NCT00947349|75837534|FG003|COMPLETED|Triple Treatment Combination Period||6||
59718315|NCT00947349|75837531|FG000|NOT COMPLETED|Triple Treatment Combination Period||0||
59718316|NCT00947349|75837532|FG001|NOT COMPLETED|Triple Treatment Combination Period||1||
59718317|NCT00947349|75837533|FG002|NOT COMPLETED|Triple Treatment Combination Period||0||
59718318|NCT00947349|75837534|FG003|NOT COMPLETED|Triple Treatment Combination Period||0||
59718319|NCT00947349|75837531|FG000|STARTED|Overall Study Standard of Care||4||
59718320|NCT00947349|75837532|FG001|STARTED|Overall Study Standard of Care||5||
59718321|NCT00947349|75837533|FG002|STARTED|Overall Study Standard of Care||6||
59718322|NCT00947349|75837534|FG003|STARTED|Overall Study Standard of Care||6||
59718323|NCT00947349|75837531|FG000|COMPLETED|Overall Study Standard of Care||4||
59718324|NCT00947349|75837532|FG001|COMPLETED|Overall Study Standard of Care||5||
59718325|NCT00947349|75837533|FG002|COMPLETED|Overall Study Standard of Care||4||
59718326|NCT00947349|75837534|FG003|COMPLETED|Overall Study Standard of Care||4||
59718327|NCT00947349|75837531|FG000|NOT COMPLETED|Overall Study Standard of Care||0||
59718328|NCT00947349|75837532|FG001|NOT COMPLETED|Overall Study Standard of Care||0||
59718329|NCT00947349|75837533|FG002|NOT COMPLETED|Overall Study Standard of Care||2||
59718330|NCT00947349|75837534|FG003|NOT COMPLETED|Overall Study Standard of Care||2||
59718331|NCT00947193|75837562|FG000|STARTED|Overall Study||3||
59718332|NCT00947193|75837563|FG001|STARTED|Overall Study||10||
59718333|NCT00947193|75837562|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3||
59718334|NCT00947193|75837563|FG001|Received at Least 1 Dose of Study Drug|Overall Study||10||
59718335|NCT00947193|75837562|FG000|COMPLETED|Overall Study||0||
59718336|NCT00947193|75837563|FG001|COMPLETED|Overall Study||10||
59718337|NCT00947193|75837562|FG000|NOT COMPLETED|Overall Study||3||
59718338|NCT00947193|75837563|FG001|NOT COMPLETED|Overall Study||0||
59718339|NCT00947115|75837571|FG000|STARTED|Overall Study||159||
59718340|NCT00947115|75837572|FG001|STARTED|Overall Study||194||
59718341|NCT00947115|75837573|FG002|STARTED|Overall Study||171||
59718342|NCT00947115|75837571|FG000|COMPLETED|Overall Study||142||
59718343|NCT00947115|75837572|FG001|COMPLETED|Overall Study||172||
59718344|NCT00947115|75837573|FG002|COMPLETED|Overall Study||156||
59718345|NCT00947115|75837571|FG000|NOT COMPLETED|Overall Study||17||
59718346|NCT00947115|75837572|FG001|NOT COMPLETED|Overall Study||22||
59718347|NCT00947115|75837573|FG002|NOT COMPLETED|Overall Study||15||
59718348|NCT00952419|75837584|FG000|STARTED|Overall Study||215||
59718349|NCT00952419|75837585|FG001|STARTED|Overall Study||208||
59718350|NCT00952419|75837586|FG002|STARTED|Overall Study||51||
59718351|NCT00952419|75837584|FG000|COMPLETED|Overall Study||209||
59718352|NCT00952419|75837585|FG001|COMPLETED|Overall Study||198||
59718353|NCT00952419|75837586|FG002|COMPLETED|Overall Study||51||
59718354|NCT00952419|75837584|FG000|NOT COMPLETED|Overall Study||6||
59718355|NCT00952419|75837585|FG001|NOT COMPLETED|Overall Study||10||
60119332|NCT02435524|76240516|FG001|STARTED|Baseline Survey||1177||19
60119333|NCT02435524|76240515|FG000|COMPLETED|Baseline Survey|Design: 2 independent cross-sectional surveys; baseline & endline participants not same individuals|1111||18
60119334|NCT02435524|76240516|FG001|COMPLETED|Baseline Survey|Design: 2 independent cross-sectional surveys; baseline & endline participants not same individuals|1177||19
60119335|NCT02435524|76240515|FG000|NOT COMPLETED|Baseline Survey||0||0
60119336|NCT02435524|76240516|FG001|NOT COMPLETED|Baseline Survey||0||0
60119337|NCT02435524|76240515|FG000|STARTED|Endline Survey||1092||18
60119338|NCT02435524|76240516|FG001|STARTED|Endline Survey||1161||19
60119339|NCT02435524|76240515|FG000|COMPLETED|Endline Survey|Design: 2 independent cross-sectional surveys; baseline & endline participants not same individuals|1092||18
60119340|NCT02435524|76240516|FG001|COMPLETED|Endline Survey|Design: 2 independent cross-sectional surveys; baseline & endline participants not same individuals|1161||19
60119341|NCT02435524|76240515|FG000|NOT COMPLETED|Endline Survey||0||0
60119342|NCT02435524|76240516|FG001|NOT COMPLETED|Endline Survey||0||0
60119343|NCT02439814|76240524|FG000|STARTED|Overall Study||11||
59837427|NCT00273858|75961521|FG000|NOT COMPLETED|Overall Study||537||
59837428|NCT00494507|75961529|FG000|STARTED|Double-Blind Phase||12||
59837429|NCT00494507|75961530|FG001|STARTED|Double-Blind Phase||9||
59837430|NCT00494507|75961531|FG002|STARTED|Double-Blind Phase||24||
59837431|NCT00494507|75961532|FG003|STARTED|Double-Blind Phase||20||
59837432|NCT00494507|75961529|FG000|Reached Endpoint of Acute Worsening|Double-Blind Phase||0||
59837433|NCT00494507|75961530|FG001|Reached Endpoint of Acute Worsening|Double-Blind Phase||2||
59837434|NCT00494507|75961531|FG002|Reached Endpoint of Acute Worsening|Double-Blind Phase||0||
59837435|NCT00494507|75961532|FG003|Reached Endpoint of Acute Worsening|Double-Blind Phase||5||
59837436|NCT00494507|75961529|FG000|COMPLETED|Double-Blind Phase||9||
59837437|NCT00494507|75961530|FG001|COMPLETED|Double-Blind Phase||9||
59837438|NCT00494507|75961531|FG002|COMPLETED|Double-Blind Phase||22||
59837439|NCT00494507|75961532|FG003|COMPLETED|Double-Blind Phase||19||
59837440|NCT00494507|75961529|FG000|NOT COMPLETED|Double-Blind Phase||3||
59837441|NCT00494507|75961530|FG001|NOT COMPLETED|Double-Blind Phase||0||
59837442|NCT00494507|75961531|FG002|NOT COMPLETED|Double-Blind Phase||2||
59837443|NCT00494507|75961532|FG003|NOT COMPLETED|Double-Blind Phase||1||
59837444|NCT00494507|75961529|FG000|STARTED|Open-Label Phase||9||
59837445|NCT00494507|75961530|FG001|STARTED|Open-Label Phase|1 subject randomized to Acetazolamide in this phase is not included-drug arm was removed from trial.|8||
59837446|NCT00494507|75961531|FG002|STARTED|Open-Label Phase||22||
59837447|NCT00494507|75961532|FG003|STARTED|Open-Label Phase||19||
59837448|NCT00494507|75961529|FG000|COMPLETED|Open-Label Phase||9||
59837449|NCT00494507|75961530|FG001|COMPLETED|Open-Label Phase||7||
59837450|NCT00494507|75961531|FG002|COMPLETED|Open-Label Phase||17||
59837451|NCT00494507|75961532|FG003|COMPLETED|Open-Label Phase||14||
59837452|NCT00494507|75961529|FG000|NOT COMPLETED|Open-Label Phase||0||
59837453|NCT00494507|75961530|FG001|NOT COMPLETED|Open-Label Phase||1||
59837454|NCT00494507|75961531|FG002|NOT COMPLETED|Open-Label Phase||5||
59837455|NCT00494507|75961532|FG003|NOT COMPLETED|Open-Label Phase||5||
59837456|NCT00292188|75961554|FG000|STARTED|Single-Blind||368||
59837457|NCT00292188|75961555|FG001|STARTED|Single-Blind||0||
59837458|NCT00292188|75961556|FG002|STARTED|Single-Blind||0||
59837459|NCT00292188|75961554|FG000|Received Treatment|Single-Blind||367||
59837460|NCT00292188|75961555|FG001|Received Treatment|Single-Blind||0||
59837461|NCT00292188|75961556|FG002|Received Treatment|Single-Blind||0||
59837462|NCT00292188|75961554|FG000|COMPLETED|Single-Blind||254||
59837463|NCT00292188|75961555|FG001|COMPLETED|Single-Blind||0||
59837464|NCT00292188|75961556|FG002|COMPLETED|Single-Blind||0||
59837465|NCT00292188|75961554|FG000|NOT COMPLETED|Single-Blind||114||
59837466|NCT00292188|75961555|FG001|NOT COMPLETED|Single-Blind||0||
59837467|NCT00292188|75961556|FG002|NOT COMPLETED|Single-Blind||0||
59837468|NCT00292188|75961554|FG000|STARTED|Double-Blind||0||
59837469|NCT00292188|75961555|FG001|STARTED|Double-Blind||127||
59837470|NCT00292188|75961556|FG002|STARTED|Double-Blind||127||
59837471|NCT00292188|75961554|FG000|COMPLETED|Double-Blind||0||
59837472|NCT00292188|75961555|FG001|COMPLETED|Double-Blind||96||
59837473|NCT00292188|75961556|FG002|COMPLETED|Double-Blind||98||
59837474|NCT00292188|75961554|FG000|NOT COMPLETED|Double-Blind||0||
59837475|NCT00292188|75961555|FG001|NOT COMPLETED|Double-Blind||31||
59837476|NCT00292188|75961556|FG002|NOT COMPLETED|Double-Blind||29||
59837477|NCT00272844|75961563|FG000|STARTED|Overall Study||23||
59837478|NCT00272844|75961563|FG000|COMPLETED|Overall Study||18||
59837479|NCT00272844|75961563|FG000|NOT COMPLETED|Overall Study||5||
59837480|NCT00271596|75961569|FG000|STARTED|Overall Study||17||
59837481|NCT00271596|75961570|FG001|STARTED|Overall Study||16||
59837482|NCT00271596|75961569|FG000|COMPLETED|Overall Study||16||
59837483|NCT00271596|75961570|FG001|COMPLETED|Overall Study||15||
59837484|NCT00271596|75961569|FG000|NOT COMPLETED|Overall Study||1||
59837485|NCT00271596|75961570|FG001|NOT COMPLETED|Overall Study||1||
59837486|NCT00291642|75961581|FG000|STARTED|Overall Study||78||
59837487|NCT00291642|75961582|FG001|STARTED|Overall Study||116||
59837488|NCT00291642|75961583|FG002|STARTED|Overall Study||119||
59837489|NCT00291642|75961584|FG003|STARTED|Overall Study||119||
59837490|NCT00291642|75961585|FG004|STARTED|Overall Study||119||
59837491|NCT00291642|75961581|FG000|COMPLETED|Overall Study||76||
59837492|NCT00291642|75961582|FG001|COMPLETED|Overall Study||116||
59837493|NCT00291642|75961583|FG002|COMPLETED|Overall Study||117||
59837494|NCT00291642|75961584|FG003|COMPLETED|Overall Study||119||
59837495|NCT00291642|75961585|FG004|COMPLETED|Overall Study||118||
59837496|NCT00291642|75961581|FG000|NOT COMPLETED|Overall Study||2||
59837497|NCT00291642|75961582|FG001|NOT COMPLETED|Overall Study||0||
59837498|NCT00291642|75961583|FG002|NOT COMPLETED|Overall Study||2||
59837499|NCT00291642|75961584|FG003|NOT COMPLETED|Overall Study||0||
59837500|NCT00291642|75961585|FG004|NOT COMPLETED|Overall Study||1||
60119344|NCT02439814|76240525|FG001|STARTED|Overall Study||10||
59837501|NCT00280566|75961599|FG000|STARTED|Period 1 Open Label Ziprasidone|1 subject inappropriately randomized into 2 different sites. Data from this subject was excluded.|584||
59837502|NCT00280566|75961600|FG001|STARTED|Period 1 Open Label Ziprasidone||0||
59837503|NCT00280566|75961601|FG002|STARTED|Period 1 Open Label Ziprasidone||0||
59837504|NCT00280566|75961599|FG000|COMPLETED|Period 1 Open Label Ziprasidone|Subject excluded as described above is counted as 2; enrolled in 2 sites (2 identification numbers)|241||
59837505|NCT00280566|75961600|FG001|COMPLETED|Period 1 Open Label Ziprasidone||0||
59837506|NCT00280566|75961601|FG002|COMPLETED|Period 1 Open Label Ziprasidone||0||
59837507|NCT00280566|75961599|FG000|NOT COMPLETED|Period 1 Open Label Ziprasidone||343||
59837508|NCT00280566|75961600|FG001|NOT COMPLETED|Period 1 Open Label Ziprasidone||0||
59837509|NCT00280566|75961601|FG002|NOT COMPLETED|Period 1 Open Label Ziprasidone||0||
59837510|NCT00280566|75961599|FG000|STARTED|Period 2 Double Blind|1 subject in Period 1 did not want to be randomized into Period 2|0||
59837511|NCT00280566|75961600|FG001|STARTED|Period 2 Double Blind||127||
59837512|NCT00280566|75961601|FG002|STARTED|Period 2 Double Blind||111||
59837513|NCT00280566|75961599|FG000|COMPLETED|Period 2 Double Blind||0||
59837514|NCT00280566|75961600|FG001|COMPLETED|Period 2 Double Blind||84||
59837515|NCT00280566|75961601|FG002|COMPLETED|Period 2 Double Blind||54||
59837516|NCT00280566|75961599|FG000|NOT COMPLETED|Period 2 Double Blind||0||
59837517|NCT00280566|75961600|FG001|NOT COMPLETED|Period 2 Double Blind||43||
59837518|NCT00280566|75961601|FG002|NOT COMPLETED|Period 2 Double Blind||57||
59837519|NCT00270894|75961608|FG000|STARTED|Overall Study||30||
59837520|NCT00270894|75961608|FG000|COMPLETED|Overall Study||28||
59837521|NCT00270894|75961608|FG000|NOT COMPLETED|Overall Study||2||
59837522|NCT00317642|75961614|FG000|STARTED|Overall Study||163||
59837523|NCT00317642|75961615|FG001|STARTED|Overall Study||163||
59837524|NCT00317642|75961614|FG000|Full Analysis Set|Overall Study|AML Centrally Confirmed|162||
59837525|NCT00317642|75961615|FG001|Full Analysis Set|Overall Study|AML Centrally Confirmed|158||
59837526|NCT00317642|75961614|FG000|Received >= 1 Study Drug (Safety Set)|Overall Study||161||
59837527|NCT00317642|75961615|FG001|Received >= 1 Study Drug (Safety Set)|Overall Study||155||
59837528|NCT00317642|75961614|FG000|COMPLETED|Overall Study|achieved remission and completed consolidation|41||
59837529|NCT00317642|75961615|FG001|COMPLETED|Overall Study|achieved remission and completed consolidation|28||
59837530|NCT00317642|75961614|FG000|NOT COMPLETED|Overall Study||122||
59837531|NCT00317642|75961615|FG001|NOT COMPLETED|Overall Study||135||
59837532|NCT00295022|75961631|FG000|STARTED|Overall Study||105||
59837533|NCT00295022|75961632|FG001|STARTED|Overall Study||157||
59837534|NCT00295022|75961633|FG002|STARTED|Overall Study||156||
59837535|NCT00295022|75961631|FG000|COMPLETED|Overall Study||104||
59837536|NCT00295022|75961632|FG001|COMPLETED|Overall Study||156||
59837537|NCT00295022|75961633|FG002|COMPLETED|Overall Study||151||
59837538|NCT00295022|75961631|FG000|NOT COMPLETED|Overall Study||1||
59837539|NCT00295022|75961632|FG001|NOT COMPLETED|Overall Study||1||
59837540|NCT00295022|75961633|FG002|NOT COMPLETED|Overall Study||5||
59837541|NCT00303446|75961645|FG000|STARTED|Overall Study||25||
59837542|NCT00303446|75961646|FG001|STARTED|Overall Study||25||
59837543|NCT00303446|75961645|FG000|COMPLETED|Overall Study||23||
59837544|NCT00303446|75961646|FG001|COMPLETED|Overall Study||21||
59837545|NCT00303446|75961645|FG000|NOT COMPLETED|Overall Study||2||
59837546|NCT00303446|75961646|FG001|NOT COMPLETED|Overall Study||4||
59837547|NCT00316706|75961654|FG000|STARTED|Overall Study||626||
59837548|NCT00316706|75961655|FG001|STARTED|Overall Study||619||
59837549|NCT00316706|75961654|FG000|COMPLETED|Overall Study|Subjects in Cervarix group that completed the study at Month 48|588||
59837550|NCT00316706|75961655|FG001|COMPLETED|Overall Study|Subjects in Havrix group that completed the study at Month 24|571||
59837551|NCT00316706|75961654|FG000|NOT COMPLETED|Overall Study||38||
59837552|NCT00316706|75961655|FG001|NOT COMPLETED|Overall Study||48||
59718356|NCT00952419|75837586|FG002|NOT COMPLETED|Overall Study||0||
59718357|NCT00902278|75837599|FG000|STARTED|Overall Study||54||
59718358|NCT00902278|75837600|FG001|STARTED|Overall Study||36||
59718359|NCT00902278|75837601|FG002|STARTED|Overall Study||54||
59718360|NCT00902278|75837602|FG003|STARTED|Overall Study||12||
59718361|NCT00902278|75837603|FG004|STARTED|Overall Study||37||
59718362|NCT00902278|75837599|FG000|COMPLETED|Overall Study||50||
59718363|NCT00902278|75837600|FG001|COMPLETED|Overall Study||34||
59718364|NCT00902278|75837601|FG002|COMPLETED|Overall Study||49||
59837553|NCT00291486|75961666|FG000|STARTED|Overall Study||3||
59837554|NCT00291486|75961667|FG001|STARTED|Overall Study||6||
59837555|NCT00291486|75961668|FG002|STARTED|Overall Study||3||
59837556|NCT00291486|75961669|FG003|STARTED|Overall Study||3||
59837557|NCT00291486|75961670|FG004|STARTED|Overall Study||4||
59837558|NCT00291486|75961666|FG000|COMPLETED|Overall Study||2||
59837559|NCT00291486|75961667|FG001|COMPLETED|Overall Study||3||
59837560|NCT00291486|75961668|FG002|COMPLETED|Overall Study||2||
59837561|NCT00291486|75961669|FG003|COMPLETED|Overall Study||2||
59837562|NCT00291486|75961670|FG004|COMPLETED|Overall Study||3||
59837563|NCT00291486|75961666|FG000|NOT COMPLETED|Overall Study||1||
59837564|NCT00291486|75961667|FG001|NOT COMPLETED|Overall Study||3||
59837565|NCT00291486|75961668|FG002|NOT COMPLETED|Overall Study||1||
59837566|NCT00291486|75961669|FG003|NOT COMPLETED|Overall Study||1||
59837567|NCT00291486|75961670|FG004|NOT COMPLETED|Overall Study||1||
59837568|NCT00301964|75961691|FG000|STARTED|Overall Study||56||
59837569|NCT00301964|75961691|FG000|COMPLETED|Overall Study|Total number of eligible and evaluable participants|52||
59837570|NCT00301964|75961691|FG000|NOT COMPLETED|Overall Study||4||
59837571|NCT00268242|75961701|FG000|STARTED|Overall Study||24||
59837572|NCT00268242|75961701|FG000|COMPLETED|Overall Study||23||
59837573|NCT00268242|75961701|FG000|NOT COMPLETED|Overall Study||1||
59837574|NCT00294554|75961707|FG000|STARTED|Overall Study||10||
59837575|NCT00294554|75961708|FG001|STARTED|Overall Study||10||
59837576|NCT00294554|75961707|FG000|COMPLETED|Overall Study||10||
59837577|NCT00294554|75961708|FG001|COMPLETED|Overall Study|"1 S withdrew @ 20 wks for lack perceived benefit~1 S withdrawn @ 13 wks b/o extreme agitation"|8||
59837578|NCT00294554|75961707|FG000|NOT COMPLETED|Overall Study||0||
59837579|NCT00294554|75961708|FG001|NOT COMPLETED|Overall Study||2||
59837580|NCT00294398|75961716|FG000|STARTED|Overall Study||78||
59837581|NCT00294398|75961717|FG001|STARTED|Overall Study||74||
59837582|NCT00294398|75961716|FG000|COMPLETED|Overall Study||57||
59837583|NCT00294398|75961717|FG001|COMPLETED|Overall Study||48||
59837584|NCT00294398|75961716|FG000|NOT COMPLETED|Overall Study||21||
59837585|NCT00294398|75961717|FG001|NOT COMPLETED|Overall Study||26||
59837586|NCT00279708|75961725|FG000|STARTED|Overall Study|"Started meaning randomized"|27||
59837587|NCT00279708|75961726|FG001|STARTED|Overall Study||28||
59837588|NCT00279708|75961725|FG000|COMPLETED|Overall Study||24||
59837589|NCT00279708|75961726|FG001|COMPLETED|Overall Study||24||
59837590|NCT00279708|75961725|FG000|NOT COMPLETED|Overall Study||3||
59837591|NCT00279708|75961726|FG001|NOT COMPLETED|Overall Study||4||
59837592|NCT00299702|75961734|FG000|STARTED|Overall Study||179||
59837593|NCT00299702|75961735|FG001|STARTED|Overall Study||176||
59837594|NCT00299702|75961734|FG000|COMPLETED|Overall Study||126||
59837595|NCT00299702|75961735|FG001|COMPLETED|Overall Study||126||
59837596|NCT00299702|75961734|FG000|NOT COMPLETED|Overall Study||53||
59837597|NCT00299702|75961735|FG001|NOT COMPLETED|Overall Study||50||
59837598|NCT00291330|75961743|FG000|STARTED|Overall Study|Started Treatment|1273||
59837599|NCT00291330|75961744|FG001|STARTED|Overall Study|Started Treatment|1266||
59837600|NCT00291330|75961743|FG000|COMPLETED|Overall Study|Completed planned observation time|1172||
59837601|NCT00291330|75961744|FG001|COMPLETED|Overall Study|Completed planned observation time|1169||
59837602|NCT00291330|75961743|FG000|NOT COMPLETED|Overall Study||101||
59837603|NCT00291330|75961744|FG001|NOT COMPLETED|Overall Study||97||
59837604|NCT00267150|75961750|FG000|STARTED|Overall Study||31||
59837605|NCT00267150|75961750|FG000|COMPLETED|Overall Study||30||
59837606|NCT00267150|75961750|FG000|NOT COMPLETED|Overall Study||1||
59837607|NCT00278148|75961754|FG000|STARTED|Phase I - Dose Escalation||4||
59837608|NCT00278148|75961755|FG001|STARTED|Phase I - Dose Escalation||2||
59837609|NCT00278148|75961756|FG002|STARTED|Phase I - Dose Escalation||3||
59837610|NCT00278148|75961754|FG000|COMPLETED|Phase I - Dose Escalation||4||
59837611|NCT00278148|75961755|FG001|COMPLETED|Phase I - Dose Escalation||2||
59837612|NCT00278148|75961756|FG002|COMPLETED|Phase I - Dose Escalation||3||
59837613|NCT00278148|75961754|FG000|NOT COMPLETED|Phase I - Dose Escalation||0||
59837614|NCT00278148|75961755|FG001|NOT COMPLETED|Phase I - Dose Escalation||0||
59837615|NCT00278148|75961756|FG002|NOT COMPLETED|Phase I - Dose Escalation||0||
59837616|NCT00278148|75961754|FG000|STARTED|Phase II - Expansion Phase||0||
59837617|NCT00278148|75961755|FG001|STARTED|Phase II - Expansion Phase||0||
59837618|NCT00278148|75961756|FG002|STARTED|Phase II - Expansion Phase|Includes the 3 participants from phase I|26||
59837619|NCT00278148|75961754|FG000|COMPLETED|Phase II - Expansion Phase||0||
59837620|NCT00278148|75961755|FG001|COMPLETED|Phase II - Expansion Phase||0||
59837621|NCT00278148|75961756|FG002|COMPLETED|Phase II - Expansion Phase||20||
59837622|NCT00278148|75961754|FG000|NOT COMPLETED|Phase II - Expansion Phase||0||
59837623|NCT00278148|75961755|FG001|NOT COMPLETED|Phase II - Expansion Phase||0||
59837624|NCT00278148|75961756|FG002|NOT COMPLETED|Phase II - Expansion Phase||6||
59837625|NCT00299546|75961766|FG000|STARTED|Overall Study||155||
59837626|NCT00299546|75961767|FG001|STARTED|Overall Study||153||
59837627|NCT00299546|75961768|FG002|STARTED|Overall Study||153||
59837628|NCT00299546|75961766|FG000|COMPLETED|Overall Study||55||
59837629|NCT00299546|75961767|FG001|COMPLETED|Overall Study||61||
60119345|NCT02439814|76240524|FG000|COMPLETED|Overall Study||11||
60119346|NCT02439814|76240525|FG001|COMPLETED|Overall Study||10||
60119347|NCT02439814|76240524|FG000|NOT COMPLETED|Overall Study||0||
60119348|NCT02439814|76240525|FG001|NOT COMPLETED|Overall Study||0||
60119349|NCT02440204|76240534|FG000|STARTED|Overall Study||22||
60119350|NCT02440204|76240535|FG001|STARTED|Overall Study||24||
59837630|NCT00299546|75961768|FG002|COMPLETED|Overall Study||67||
60119351|NCT02440204|76240536|FG002|STARTED|Overall Study||22||
59837631|NCT00299546|75961766|FG000|NOT COMPLETED|Overall Study||100||
59837632|NCT00299546|75961767|FG001|NOT COMPLETED|Overall Study||92||
59837633|NCT00299546|75961768|FG002|NOT COMPLETED|Overall Study||86||
59837634|NCT00299156|75961780|FG000|STARTED|Period 1 (Non-Randomized)||32||
59837635|NCT00299156|75961781|FG001|STARTED|Period 1 (Non-Randomized)||0||
59837636|NCT00299156|75961782|FG002|STARTED|Period 1 (Non-Randomized)||0||
59837637|NCT00299156|75961780|FG000|COMPLETED|Period 1 (Non-Randomized)||32||
59837638|NCT00299156|75961781|FG001|COMPLETED|Period 1 (Non-Randomized)||0||
59837639|NCT00299156|75961782|FG002|COMPLETED|Period 1 (Non-Randomized)||0||
59837640|NCT00299156|75961780|FG000|NOT COMPLETED|Period 1 (Non-Randomized)||0||
59837641|NCT00299156|75961781|FG001|NOT COMPLETED|Period 1 (Non-Randomized)||0||
59837642|NCT00299156|75961782|FG002|NOT COMPLETED|Period 1 (Non-Randomized)||0||
59837643|NCT00299156|75961780|FG000|STARTED|Period 2 (Randomized)||0||
59837644|NCT00299156|75961781|FG001|STARTED|Period 2 (Randomized)||17||
59837645|NCT00299156|75961782|FG002|STARTED|Period 2 (Randomized)||16||
59837646|NCT00299156|75961780|FG000|COMPLETED|Period 2 (Randomized)||0||
59837647|NCT00299156|75961781|FG001|COMPLETED|Period 2 (Randomized)||16||
59837648|NCT00299156|75961782|FG002|COMPLETED|Period 2 (Randomized)||16||
59837649|NCT00299156|75961780|FG000|NOT COMPLETED|Period 2 (Randomized)||0||
59837650|NCT00299156|75961781|FG001|NOT COMPLETED|Period 2 (Randomized)||1||
59837651|NCT00299156|75961782|FG002|NOT COMPLETED|Period 2 (Randomized)||0||
59837652|NCT00277212|75961790|FG000|STARTED|Phase 1 - Single-Blind Treatment||787||
59837653|NCT00277212|75961791|FG001|STARTED|Phase 1 - Single-Blind Treatment||0||
59837654|NCT00277212|75961792|FG002|STARTED|Phase 1 - Single-Blind Treatment||0||
59837655|NCT00277212|75961790|FG000|Phase 1 Safety Sample|Phase 1 - Single-Blind Treatment||787||
59837656|NCT00277212|75961791|FG001|Phase 1 Safety Sample|Phase 1 - Single-Blind Treatment||0||
59837657|NCT00277212|75961792|FG002|Phase 1 Safety Sample|Phase 1 - Single-Blind Treatment||0||
59837658|NCT00277212|75961790|FG000|Phase 1 Efficacy Sample|Phase 1 - Single-Blind Treatment||756||
59837659|NCT00277212|75961791|FG001|Phase 1 Efficacy Sample|Phase 1 - Single-Blind Treatment||0||
59837660|NCT00277212|75961792|FG002|Phase 1 Efficacy Sample|Phase 1 - Single-Blind Treatment||0||
59837661|NCT00277212|75961790|FG000|COMPLETED|Phase 1 - Single-Blind Treatment||352||
59837662|NCT00277212|75961791|FG001|COMPLETED|Phase 1 - Single-Blind Treatment||0||
59837663|NCT00277212|75961792|FG002|COMPLETED|Phase 1 - Single-Blind Treatment||0||
59837664|NCT00277212|75961790|FG000|NOT COMPLETED|Phase 1 - Single-Blind Treatment||435||
59837665|NCT00277212|75961791|FG001|NOT COMPLETED|Phase 1 - Single-Blind Treatment||0||
59837666|NCT00277212|75961792|FG002|NOT COMPLETED|Phase 1 - Single-Blind Treatment||0||
59837667|NCT00277212|75961790|FG000|STARTED|Phase 2 - Double-Blind Treatment||0||
59837668|NCT00277212|75961791|FG001|STARTED|Phase 2 - Double-Blind Treatment||173||
59837669|NCT00277212|75961792|FG002|STARTED|Phase 2 - Double-Blind Treatment|1 participant did not want to continue in the study for personal reasons, and did not enter Phase 2.|178||
59837670|NCT00277212|75961790|FG000|Phase 2 Safety Sample|Phase 2 - Double-Blind Treatment||0||
59837671|NCT00277212|75961791|FG001|Phase 2 Safety Sample|Phase 2 - Double-Blind Treatment||165||
59837672|NCT00277212|75961792|FG002|Phase 2 Safety Sample|Phase 2 - Double-Blind Treatment||176||
59837673|NCT00277212|75961790|FG000|Phase 2 Efficacy Sample|Phase 2 - Double-Blind Treatment||0||
59837674|NCT00277212|75961791|FG001|Phase 2 Efficacy Sample|Phase 2 - Double-Blind Treatment||164||
59837675|NCT00277212|75961792|FG002|Phase 2 Efficacy Sample|Phase 2 - Double-Blind Treatment||174||
59837676|NCT00277212|75961790|FG000|COMPLETED|Phase 2 - Double-Blind Treatment||0||
59837677|NCT00277212|75961791|FG001|COMPLETED|Phase 2 - Double-Blind Treatment||53||
59837678|NCT00277212|75961792|FG002|COMPLETED|Phase 2 - Double-Blind Treatment||65||
59837679|NCT00277212|75961790|FG000|NOT COMPLETED|Phase 2 - Double-Blind Treatment||0||
59837680|NCT00277212|75961791|FG001|NOT COMPLETED|Phase 2 - Double-Blind Treatment||120||
59837681|NCT00277212|75961792|FG002|NOT COMPLETED|Phase 2 - Double-Blind Treatment||113||
59837682|NCT00276744|75961800|FG000|STARTED|PART A||240||
59837683|NCT00276744|75961800|FG000|COMPLETED|PART A||142||
59837684|NCT00276744|75961800|FG000|NOT COMPLETED|PART A||98||
59837685|NCT00276744|75961800|FG000|STARTED|PART B|This study was terminated before participants could reach this stage of the study.|0||
59837686|NCT00276744|75961800|FG000|COMPLETED|PART B||0||
59837687|NCT00276744|75961800|FG000|NOT COMPLETED|PART B||0||
59837688|NCT00251316|75961806|FG000|STARTED|Overall Study||17||
59837689|NCT00251316|75961807|FG001|STARTED|Overall Study||17||
59837690|NCT00251316|75961806|FG000|COMPLETED|Overall Study||15||
59837691|NCT00251316|75961807|FG001|COMPLETED|Overall Study||14||
59837692|NCT00251316|75961806|FG000|NOT COMPLETED|Overall Study||2||
59567614|NCT02326272|75670457|FG004|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||2||
59837693|NCT00251316|75961807|FG001|NOT COMPLETED|Overall Study||3||
59837694|NCT00293462|75961816|FG000|STARTED|Overall Study||31||
59837695|NCT00293462|75961817|FG001|STARTED|Overall Study||29||
59837696|NCT00293462|75961818|FG002|STARTED|Overall Study||31||
59837697|NCT00293462|75961816|FG000|COMPLETED|Overall Study||24||
59837698|NCT00293462|75961817|FG001|COMPLETED|Overall Study||21||
59837699|NCT00293462|75961818|FG002|COMPLETED|Overall Study||19||
59837700|NCT00293462|75961816|FG000|NOT COMPLETED|Overall Study||7||
59837701|NCT00293462|75961817|FG001|NOT COMPLETED|Overall Study||8||
59837702|NCT00293462|75961818|FG002|NOT COMPLETED|Overall Study||12||
59837703|NCT00316082|75961831|FG000|STARTED|Overall Study||74||
59837704|NCT00316082|75961832|FG001|STARTED|Overall Study||74||
59837705|NCT00316082|75961833|FG002|STARTED|Overall Study||71||
59837706|NCT00316082|75961834|FG003|STARTED|Overall Study||72||
59837707|NCT00316082|75961835|FG004|STARTED|Overall Study||74||
59837708|NCT00316082|75961831|FG000|Completed Study Without Being Rescued|Overall Study||25||
59837709|NCT00316082|75961832|FG001|Completed Study Without Being Rescued|Overall Study||35||
59837710|NCT00316082|75961833|FG002|Completed Study Without Being Rescued|Overall Study||29||
59837711|NCT00316082|75961834|FG003|Completed Study Without Being Rescued|Overall Study||27||
59837712|NCT00316082|75961835|FG004|Completed Study Without Being Rescued|Overall Study||31||
59837713|NCT00316082|75961831|FG000|COMPLETED|Overall Study||41||
59837714|NCT00316082|75961832|FG001|COMPLETED|Overall Study||52||
59837715|NCT00316082|75961833|FG002|COMPLETED|Overall Study||44||
59837716|NCT00316082|75961834|FG003|COMPLETED|Overall Study||46||
59837717|NCT00316082|75961835|FG004|COMPLETED|Overall Study||48||
59837718|NCT00316082|75961831|FG000|NOT COMPLETED|Overall Study||33||
59837719|NCT00316082|75961832|FG001|NOT COMPLETED|Overall Study||22||
59837720|NCT00316082|75961833|FG002|NOT COMPLETED|Overall Study||27||
59837721|NCT00316082|75961834|FG003|NOT COMPLETED|Overall Study||26||
59837722|NCT00316082|75961835|FG004|NOT COMPLETED|Overall Study||26||
59837723|NCT00316004|75961854|FG000|STARTED|Overall Study||373||
59837724|NCT00316004|75961855|FG001|STARTED|Overall Study||355||
59837725|NCT00316004|75961856|FG002|STARTED|Overall Study||603||
59837726|NCT00316004|75961854|FG000|COMPLETED|Overall Study||359||
59837727|NCT00316004|75961855|FG001|COMPLETED|Overall Study||341||
59837728|NCT00316004|75961856|FG002|COMPLETED|Overall Study||582||
59837729|NCT00316004|75961854|FG000|NOT COMPLETED|Overall Study||14||
59837730|NCT00316004|75961855|FG001|NOT COMPLETED|Overall Study||14||
59837731|NCT00316004|75961856|FG002|NOT COMPLETED|Overall Study||21||
59837732|NCT00298766|75961864|FG000|STARTED|Overall Study||70||
59837733|NCT00298766|75961864|FG000|COMPLETED|Overall Study||24||
59837734|NCT00298766|75961864|FG000|NOT COMPLETED|Overall Study||46||
59837735|NCT00315458|75961870|FG000|STARTED|Overall Study||51||
59837736|NCT00315458|75961871|FG001|STARTED|Overall Study||56||
59837737|NCT00315458|75961872|FG002|STARTED|Overall Study||159||
59837738|NCT00315458|75961873|FG003|STARTED|Overall Study||39||
59837739|NCT00315458|75961870|FG000|COMPLETED|Overall Study||48||
59837740|NCT00315458|75961871|FG001|COMPLETED|Overall Study||44||
59837741|NCT00315458|75961872|FG002|COMPLETED|Overall Study||107||
59837742|NCT00315458|75961873|FG003|COMPLETED|Overall Study||10||
59837743|NCT00315458|75961870|FG000|NOT COMPLETED|Overall Study||3||
59837744|NCT00315458|75961871|FG001|NOT COMPLETED|Overall Study||12||
59837745|NCT00315458|75961872|FG002|NOT COMPLETED|Overall Study||52||
59837746|NCT00315458|75961873|FG003|NOT COMPLETED|Overall Study||29||
59837747|NCT00293384|75961883|FG000|STARTED|Overall Study||40||
59837748|NCT00293384|75961883|FG000|COMPLETED|Overall Study||35||
59837749|NCT00293384|75961883|FG000|NOT COMPLETED|Overall Study||5||
59837750|NCT00297830|75961890|FG000|STARTED|Baseline||41||
59837751|NCT00297830|75961891|FG001|STARTED|Baseline||43||
59837752|NCT00297830|75961892|FG002|STARTED|Baseline||27||
59837753|NCT00297830|75961890|FG000|COMPLETED|Baseline||41||
60119352|NCT02440204|76240534|FG000|COMPLETED|Overall Study||22||
60119353|NCT02440204|76240535|FG001|COMPLETED|Overall Study||24||
60119354|NCT02440204|76240536|FG002|COMPLETED|Overall Study||22||
60119355|NCT02440204|76240534|FG000|NOT COMPLETED|Overall Study||0||
60119356|NCT02440204|76240535|FG001|NOT COMPLETED|Overall Study||0||
59718365|NCT00902278|75837602|FG003|COMPLETED|Overall Study||12||
59837754|NCT00297830|75961891|FG001|COMPLETED|Baseline||43||
59837755|NCT00297830|75961892|FG002|COMPLETED|Baseline||27||
59837756|NCT00297830|75961890|FG000|NOT COMPLETED|Baseline||0||
59837757|NCT00297830|75961891|FG001|NOT COMPLETED|Baseline||0||
60119357|NCT02440204|76240536|FG002|NOT COMPLETED|Overall Study||0||
59718366|NCT00902278|75837603|FG004|COMPLETED|Overall Study||35||
59718367|NCT00902278|75837599|FG000|NOT COMPLETED|Overall Study||4||
59718368|NCT00902278|75837600|FG001|NOT COMPLETED|Overall Study||2||
59718369|NCT00902278|75837601|FG002|NOT COMPLETED|Overall Study||5||
59718370|NCT00902278|75837602|FG003|NOT COMPLETED|Overall Study||0||
59718371|NCT00902278|75837603|FG004|NOT COMPLETED|Overall Study||2||
59718372|NCT01998633|75837617|FG000|STARTED|Overall Study||47||
59718373|NCT01998633|75837617|FG000|COMPLETED|Overall Study||46||
59718374|NCT01998633|75837617|FG000|NOT COMPLETED|Overall Study||1||
59718375|NCT00952341|75837627|FG000|STARTED|Cycle 1||209||
59718376|NCT00952341|75837628|FG001|STARTED|Cycle 1||212||
59718377|NCT00952341|75837627|FG000|COMPLETED|Cycle 1||189||
59837758|NCT00297830|75961892|FG002|NOT COMPLETED|Baseline||0||
59837759|NCT00297830|75961890|FG000|STARTED|6 Month Visit||41||
59837760|NCT00297830|75961891|FG001|STARTED|6 Month Visit||43||
59837761|NCT00297830|75961892|FG002|STARTED|6 Month Visit||27||
59837762|NCT00297830|75961890|FG000|COMPLETED|6 Month Visit||38||
59837763|NCT00297830|75961891|FG001|COMPLETED|6 Month Visit||41||
59837764|NCT00297830|75961892|FG002|COMPLETED|6 Month Visit||24||
59837765|NCT00297830|75961890|FG000|NOT COMPLETED|6 Month Visit||3||
59837766|NCT00297830|75961891|FG001|NOT COMPLETED|6 Month Visit||2||
59837767|NCT00297830|75961892|FG002|NOT COMPLETED|6 Month Visit||3||
59837768|NCT00297830|75961890|FG000|STARTED|12 Month Visit||38||
59837769|NCT00297830|75961891|FG001|STARTED|12 Month Visit||41||
59837770|NCT00297830|75961892|FG002|STARTED|12 Month Visit||24||
59837771|NCT00297830|75961890|FG000|COMPLETED|12 Month Visit||37||
59837772|NCT00297830|75961891|FG001|COMPLETED|12 Month Visit||35||
59837773|NCT00297830|75961892|FG002|COMPLETED|12 Month Visit||24||
59837774|NCT00297830|75961890|FG000|NOT COMPLETED|12 Month Visit||1||
59837775|NCT00297830|75961891|FG001|NOT COMPLETED|12 Month Visit||6||
59837776|NCT00297830|75961892|FG002|NOT COMPLETED|12 Month Visit||0||
59837777|NCT00296816|75961902|FG000|STARTED|Overall Study||132||
59837778|NCT00296816|75961902|FG000|COMPLETED|Overall Study|Completed study treatment for a minimum of three years|58||
59837779|NCT00296816|75961902|FG000|NOT COMPLETED|Overall Study||74||
59837780|NCT00314132|75961908|FG000|STARTED|Overall Study||403||
59837781|NCT00314132|75961909|FG001|STARTED|Overall Study||1601||
59837782|NCT00314132|75961908|FG000|COMPLETED|Overall Study||395||
59837783|NCT00314132|75961909|FG001|COMPLETED|Overall Study||1583||
59837784|NCT00314132|75961908|FG000|NOT COMPLETED|Overall Study||8||
59837785|NCT00314132|75961909|FG001|NOT COMPLETED|Overall Study||18||
59837786|NCT00117988|75961917|FG000|STARTED|Overall Study||22||
59837787|NCT00117988|75961917|FG000|COMPLETED|Overall Study||18||
59837788|NCT00117988|75961917|FG000|NOT COMPLETED|Overall Study||4||
59837789|NCT00117676|75961923|FG000|STARTED|Double-blind Period Through Week 48||254||
59837790|NCT00117676|75961924|FG001|STARTED|Double-blind Period Through Week 48||128||
59837791|NCT00117676|75961923|FG000|COMPLETED|Double-blind Period Through Week 48||244||
59837792|NCT00117676|75961924|FG001|COMPLETED|Double-blind Period Through Week 48||121||
59837793|NCT00117676|75961923|FG000|NOT COMPLETED|Double-blind Period Through Week 48||10||
59837794|NCT00117676|75961924|FG001|NOT COMPLETED|Double-blind Period Through Week 48||7||
59837795|NCT00117676|75961923|FG000|STARTED|Open-label Period: Weeks 49 - 96|9 participants completed 48 weeks but did not continue on study.|235||
59837796|NCT00117676|75961924|FG001|STARTED|Open-label Period: Weeks 49 - 96|9 participants completed 48 weeks but did not continue on study.|112||
59837797|NCT00117676|75961923|FG000|COMPLETED|Open-label Period: Weeks 49 - 96||225||
59837798|NCT00117676|75961924|FG001|COMPLETED|Open-label Period: Weeks 49 - 96||110||
59837799|NCT00117676|75961923|FG000|NOT COMPLETED|Open-label Period: Weeks 49 - 96||10||
59837800|NCT00117676|75961924|FG001|NOT COMPLETED|Open-label Period: Weeks 49 - 96||2||
59837801|NCT00117676|75961923|FG000|STARTED|Open-label Period: Weeks 97 - 144||225||
59996535|NCT02714569|76112510|FG007|Received at Least One Dose of Study Drug|Part A First Intervention||0||
59996536|NCT02714569|76112511|FG008|Received at Least One Dose of Study Drug|Part A First Intervention||0||
59996537|NCT02714569|76112512|FG009|Received at Least One Dose of Study Drug|Part A First Intervention||0||
59996538|NCT02714569|76112513|FG010|Received at Least One Dose of Study Drug|Part A First Intervention||0||
59996539|NCT02714569|76112503|FG000|COMPLETED|Part A First Intervention||3||
59996540|NCT02714569|76112504|FG001|COMPLETED|Part A First Intervention||3||
59996541|NCT02714569|76112505|FG002|COMPLETED|Part A First Intervention||3||
59837802|NCT00117676|75961924|FG001|STARTED|Open-label Period: Weeks 97 - 144||110||
59837803|NCT00117676|75961923|FG000|COMPLETED|Open-label Period: Weeks 97 - 144||219||
59837804|NCT00117676|75961924|FG001|COMPLETED|Open-label Period: Weeks 97 - 144||109||
59837805|NCT00117676|75961923|FG000|NOT COMPLETED|Open-label Period: Weeks 97 - 144||6||
59837806|NCT00117676|75961924|FG001|NOT COMPLETED|Open-label Period: Weeks 97 - 144||1||
59837807|NCT00117676|75961923|FG000|STARTED|Open-label Period: Weeks 145 - 192||219||
59837808|NCT00117676|75961924|FG001|STARTED|Open-label Period: Weeks 145 - 192||109||
59996542|NCT02714569|76112506|FG003|COMPLETED|Part A First Intervention||3||
59996543|NCT02714569|76112507|FG004|COMPLETED|Part A First Intervention||3||
59996544|NCT02714569|76112508|FG005|COMPLETED|Part A First Intervention||3||
59996545|NCT02714569|76112509|FG006|COMPLETED|Part A First Intervention||0||
59996546|NCT02714569|76112510|FG007|COMPLETED|Part A First Intervention||0||
59837809|NCT00117676|75961923|FG000|COMPLETED|Open-label Period: Weeks 145 - 192||209||
59837810|NCT00117676|75961924|FG001|COMPLETED|Open-label Period: Weeks 145 - 192||106||
59837811|NCT00117676|75961923|FG000|NOT COMPLETED|Open-label Period: Weeks 145 - 192||10||
59837812|NCT00117676|75961924|FG001|NOT COMPLETED|Open-label Period: Weeks 145 - 192||3||
59837813|NCT00117676|75961923|FG000|STARTED|Open-label Period: Weeks 193 - 240||209||
59837814|NCT00117676|75961924|FG001|STARTED|Open-label Period: Weeks 193 - 240||106||
59837815|NCT00117676|75961923|FG000|COMPLETED|Open-label Period: Weeks 193 - 240||202||
59837816|NCT00117676|75961924|FG001|COMPLETED|Open-label Period: Weeks 193 - 240||103||
59837817|NCT00117676|75961923|FG000|NOT COMPLETED|Open-label Period: Weeks 193 - 240||7||
59837818|NCT00117676|75961924|FG001|NOT COMPLETED|Open-label Period: Weeks 193 - 240||3||
59837819|NCT00117676|75961923|FG000|STARTED|Open-label Period: Weeks 241 - 288||202||
59837820|NCT00117676|75961924|FG001|STARTED|Open-label Period: Weeks 241 - 288||103||
59837821|NCT00117676|75961923|FG000|COMPLETED|Open-label Period: Weeks 241 - 288||192||
59837822|NCT00117676|75961924|FG001|COMPLETED|Open-label Period: Weeks 241 - 288||100||
59837823|NCT00117676|75961923|FG000|NOT COMPLETED|Open-label Period: Weeks 241 - 288||10||
59837824|NCT00117676|75961924|FG001|NOT COMPLETED|Open-label Period: Weeks 241 - 288||3||
59837825|NCT00117676|75961923|FG000|STARTED|Open-label Period: Weeks 289 - 336||192||
59837826|NCT00117676|75961924|FG001|STARTED|Open-label Period: Weeks 289 - 336||100||
59837827|NCT00117676|75961923|FG000|COMPLETED|Open-label Period: Weeks 289 - 336||183||
59837828|NCT00117676|75961924|FG001|COMPLETED|Open-label Period: Weeks 289 - 336||93||
59837829|NCT00117676|75961923|FG000|NOT COMPLETED|Open-label Period: Weeks 289 - 336||9||
59837830|NCT00117676|75961924|FG001|NOT COMPLETED|Open-label Period: Weeks 289 - 336||7||
59837831|NCT00117676|75961923|FG000|STARTED|Open-label Period: Weeks 337 - 384||183||
59837832|NCT00117676|75961924|FG001|STARTED|Open-label Period: Weeks 337 - 384||93||
59837833|NCT00117676|75961923|FG000|COMPLETED|Open-label Period: Weeks 337 - 384||176||
59837834|NCT00117676|75961924|FG001|COMPLETED|Open-label Period: Weeks 337 - 384||90||
59837835|NCT00117676|75961923|FG000|NOT COMPLETED|Open-label Period: Weeks 337 - 384||7||
59837836|NCT00117676|75961924|FG001|NOT COMPLETED|Open-label Period: Weeks 337 - 384||3||
59837837|NCT00117676|75961923|FG000|STARTED|Open-label Period: Weeks 385 - 432|94 participants completed 384 weeks but did not continue on study.|82||
59837838|NCT00117676|75961924|FG001|STARTED|Open-label Period: Weeks 385 - 432|44 participants completed 384 weeks but did not continue on study.|46||
59837839|NCT00117676|75961923|FG000|COMPLETED|Open-label Period: Weeks 385 - 432||82||
59837840|NCT00117676|75961924|FG001|COMPLETED|Open-label Period: Weeks 385 - 432||44||
59837841|NCT00117676|75961923|FG000|NOT COMPLETED|Open-label Period: Weeks 385 - 432||0||
59837842|NCT00117676|75961924|FG001|NOT COMPLETED|Open-label Period: Weeks 385 - 432||2||
59837843|NCT00117676|75961923|FG000|STARTED|Open-label Period: Weeks 433 - 480||82||
59837844|NCT00117676|75961924|FG001|STARTED|Open-label Period: Weeks 433 - 480|1 participant completed 432 weeks but did not continue on study.|43||
59837845|NCT00117676|75961923|FG000|COMPLETED|Open-label Period: Weeks 433 - 480||80||
59837846|NCT00117676|75961924|FG001|COMPLETED|Open-label Period: Weeks 433 - 480||41||
60119358|NCT02517580|76240544|FG000|STARTED|Overall Study||60||
60119359|NCT02517580|76240544|FG000|COMPLETED|Overall Study||56||
60119360|NCT02517580|76240544|FG000|NOT COMPLETED|Overall Study||4||
60119361|NCT02517658|76240551|FG000|STARTED|Overall Study||33||
60119362|NCT02517658|76240552|FG001|STARTED|Overall Study||33||
60119363|NCT02517658|76240553|FG002|STARTED|Overall Study||33||
60119364|NCT02517658|76240551|FG000|COMPLETED|Overall Study||33||
60119365|NCT02517658|76240552|FG001|COMPLETED|Overall Study||33||
60119366|NCT02517658|76240553|FG002|COMPLETED|Overall Study||33||
60119367|NCT02517658|76240551|FG000|NOT COMPLETED|Overall Study||0||
60119368|NCT02517658|76240552|FG001|NOT COMPLETED|Overall Study||0||
60119369|NCT02517658|76240553|FG002|NOT COMPLETED|Overall Study||0||
60119370|NCT02522104|76240564|FG000|STARTED|Overall Study||13||
60119371|NCT02522104|76240565|FG001|STARTED|Overall Study||15||
60119372|NCT02522104|76240566|FG002|STARTED|Overall Study||12||
60119373|NCT02522104|76240564|FG000|COMPLETED|Overall Study||10||
60119374|NCT02522104|76240565|FG001|COMPLETED|Overall Study||12||
60119375|NCT02522104|76240566|FG002|COMPLETED|Overall Study||5||
60119376|NCT02522104|76240564|FG000|NOT COMPLETED|Overall Study||3||
60119377|NCT02522104|76240565|FG001|NOT COMPLETED|Overall Study||3||
60119378|NCT02522104|76240566|FG002|NOT COMPLETED|Overall Study||7||
60119379|NCT02523196|76240577|FG000|STARTED|Overall Study||20||
60119380|NCT02523196|76240577|FG000|Received HVPG|Overall Study||20||
60119381|NCT02523196|76240577|FG000|Received HQ Shunt|Overall Study||20||
60119382|NCT02523196|76240577|FG000|COMPLETED|Overall Study||20||
60119383|NCT02523196|76240577|FG000|NOT COMPLETED|Overall Study||0||
59837847|NCT00117676|75961923|FG000|NOT COMPLETED|Open-label Period: Weeks 433 - 480||2||
59837848|NCT00117676|75961924|FG001|NOT COMPLETED|Open-label Period: Weeks 433 - 480||2||
60119384|NCT02523586|76240586|FG000|STARTED|Overall Study||14||
60119385|NCT02523586|76240586|FG000|COMPLETED|Overall Study||10||
60119386|NCT02523586|76240586|FG000|NOT COMPLETED|Overall Study||4||
60119387|NCT02524054|76240599|FG000|STARTED|Overall Study||7||
60119388|NCT02524054|76240600|FG001|STARTED|Overall Study||9||
60119389|NCT02524054|76240601|FG002|STARTED|Overall Study||8||
60119390|NCT02524054|76240599|FG000|COMPLETED|Overall Study||7||
60119391|NCT02524054|76240600|FG001|COMPLETED|Overall Study||9||
60119392|NCT02524054|76240601|FG002|COMPLETED|Overall Study||8||
59837849|NCT00251004|75961938|FG000|STARTED|Overall Study||277||
59837850|NCT00251004|75961939|FG001|STARTED|Overall Study||279||
59837851|NCT00251004|75961940|FG002|STARTED|Overall Study||277||
59837852|NCT00251004|75961938|FG000|12 Month Analysis|Overall Study|Under 12 month analysis under group 1, 179 Completed study medication.|241||
59837853|NCT00251004|75961939|FG001|12 Month Analysis|Overall Study|Under 12 month analysis under group 2, 175 Completed study medication.|249||
59837854|NCT00251004|75961940|FG002|12 Month Analysis|Overall Study|Under 12 month analysis under group 3, 200 Completed study medication.|253||
59837855|NCT00251004|75961938|FG000|24 Month Analysis|Overall Study|Under 24 month analysis under group 1, 167 Completed study medication.|232||
59837856|NCT00251004|75961939|FG001|24 Month Analysis|Overall Study|Under 24 month analysis under group 2, 161 Completed study medication.|238||
59837857|NCT00251004|75961940|FG002|24 Month Analysis|Overall Study|Under 24 month analysis under group 3, 185 Completed study medication.|246||
59837858|NCT00251004|75961938|FG000|COMPLETED|Overall Study||232||
59837859|NCT00251004|75961939|FG001|COMPLETED|Overall Study||238||
59837860|NCT00251004|75961940|FG002|COMPLETED|Overall Study||246||
59837861|NCT00251004|75961938|FG000|NOT COMPLETED|Overall Study||45||
59837862|NCT00251004|75961939|FG001|NOT COMPLETED|Overall Study||41||
59837863|NCT00251004|75961940|FG002|NOT COMPLETED|Overall Study||31||
59837864|NCT00275340|75961950|FG000|STARTED|Overall Study||52||
59837865|NCT00275340|75961951|FG001|STARTED|Overall Study||49||
59837866|NCT00275340|75961950|FG000|COMPLETED|Overall Study||50||
59837867|NCT00275340|75961951|FG001|COMPLETED|Overall Study||45||
59837868|NCT00275340|75961950|FG000|NOT COMPLETED|Overall Study||2||
59837869|NCT00275340|75961951|FG001|NOT COMPLETED|Overall Study||4||
59837870|NCT00275262|75961957|FG000|STARTED|Overall Study||12||
59837871|NCT00275262|75961958|FG001|STARTED|Overall Study||13||
59837872|NCT00275262|75961957|FG000|COMPLETED|Overall Study|Patients who completed the entire 12 month study period|6||
59837873|NCT00275262|75961958|FG001|COMPLETED|Overall Study|Patients who completed the entire 12 month study period|4||
59837874|NCT00275262|75961957|FG000|NOT COMPLETED|Overall Study||6||
59837875|NCT00275262|75961958|FG001|NOT COMPLETED|Overall Study||9||
59837876|NCT00275028|75961964|FG000|STARTED|Overall Study||47||
59837877|NCT00275028|75961964|FG000|COMPLETED|Overall Study|Participants are treated until one of the below milestones is reached. Completion is N/A.|0||
59837878|NCT00275028|75961964|FG000|NOT COMPLETED|Overall Study||47||
59837879|NCT00471497|75961971|FG000|STARTED|Core Treatment Phase||283||
59837880|NCT00471497|75961972|FG001|STARTED|Core Treatment Phase||282||
59837881|NCT00471497|75961973|FG002|STARTED|Core Treatment Phase||281||
59837882|NCT00471497|75961971|FG000|Safety Analysis Set|Core Treatment Phase|Safety set contained patients who received at least one dose of study medication.|280||
59837883|NCT00471497|75961972|FG001|Safety Analysis Set|Core Treatment Phase|Safety set contained patients who received at least one dose of study medication.|279||
60119393|NCT02524054|76240599|FG000|NOT COMPLETED|Overall Study||0||
60119394|NCT02524054|76240600|FG001|NOT COMPLETED|Overall Study||0||
60119395|NCT02524054|76240601|FG002|NOT COMPLETED|Overall Study||0||
60119396|NCT02525536|76240614|FG000|STARTED|Overall Study||6||
60119397|NCT02525536|76240615|FG001|STARTED|Overall Study||6||
59567615|NCT02326272|75670458|FG005|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||13||
59837884|NCT00471497|75961973|FG002|Safety Analysis Set|Core Treatment Phase|Safety set contained patients who received at least one dose of study medication.|277||
59837885|NCT00471497|75961971|FG000|Discon. Core/Did Not Enter Ext.|Core Treatment Phase||235||
59837886|NCT00471497|75961972|FG001|Discon. Core/Did Not Enter Ext.|Core Treatment Phase||256||
59837887|NCT00471497|75961973|FG002|Discon. Core/Did Not Enter Ext.|Core Treatment Phase||278||
59837888|NCT00471497|75961971|FG000|Discontinued Core/Entered Ext.|Core Treatment Phase||48||
59837889|NCT00471497|75961972|FG001|Discontinued Core/Entered Ext.|Core Treatment Phase||26||
59837890|NCT00471497|75961973|FG002|Discontinued Core/Entered Ext.|Core Treatment Phase||3||
59837891|NCT00471497|75961971|FG000|COMPLETED|Core Treatment Phase||99|Completed = Completed Core phase as per protocol|
59837892|NCT00471497|75961972|FG001|COMPLETED|Core Treatment Phase||107|Completed = Completed Core phase as per protocol|
59837893|NCT00471497|75961973|FG002|COMPLETED|Core Treatment Phase||99|Completed = Completed Core phase as per protocol|
59837894|NCT00471497|75961971|FG000|NOT COMPLETED|Core Treatment Phase||184||
59837895|NCT00471497|75961972|FG001|NOT COMPLETED|Core Treatment Phase||175||
59837896|NCT00471497|75961973|FG002|NOT COMPLETED|Core Treatment Phase||182||
59837897|NCT00471497|75961971|FG000|STARTED|Extension Phase||48||
59837898|NCT00471497|75961972|FG001|STARTED|Extension Phase||26||
59837899|NCT00471497|75961973|FG002|STARTED|Extension Phase||3||
59837900|NCT00471497|75961971|FG000|COMPLETED|Extension Phase||21|Completed = Completed Ext. phase as per protocol|
59837901|NCT00471497|75961972|FG001|COMPLETED|Extension Phase||12|Completed = Completed Ext. phase as per protocol|
59837902|NCT00471497|75961973|FG002|COMPLETED|Extension Phase||2|Completed = Completed Ext. phase as per protocol|
59837903|NCT00471497|75961971|FG000|NOT COMPLETED|Extension Phase||27||
59837904|NCT00471497|75961972|FG001|NOT COMPLETED|Extension Phase||14||
60119398|NCT02525536|76240616|FG002|STARTED|Overall Study||6||
60119399|NCT02525536|76240614|FG000|COMPLETED|Overall Study||6||
59837905|NCT00471497|75961973|FG002|NOT COMPLETED|Extension Phase||1||
59837906|NCT00493649|75961984|FG000|STARTED|Overall Study||493||
59837907|NCT00493649|75961984|FG000|COMPLETED|Overall Study||411||
59837908|NCT00493649|75961984|FG000|NOT COMPLETED|Overall Study||82||
60119400|NCT02525536|76240615|FG001|COMPLETED|Overall Study||6||
59837909|NCT00471107|75961994|FG000|STARTED|Overall Study||15||
59837910|NCT00471107|75961995|FG001|STARTED|Overall Study||15||
59837911|NCT00471107|75961996|FG002|STARTED|Overall Study||15||
59837912|NCT00471107|75961994|FG000|COMPLETED|Overall Study||12||
59837913|NCT00471107|75961995|FG001|COMPLETED|Overall Study||14||
59837914|NCT00471107|75961996|FG002|COMPLETED|Overall Study||12||
59837915|NCT00471107|75961994|FG000|NOT COMPLETED|Overall Study||3||
59837916|NCT00471107|75961995|FG001|NOT COMPLETED|Overall Study||1||
59837917|NCT00471107|75961996|FG002|NOT COMPLETED|Overall Study||3||
59837918|NCT00488033|75962006|FG000|STARTED|Overall Study||448||
59837919|NCT00488033|75962007|FG001|STARTED|Overall Study||452||
59837920|NCT00488033|75962006|FG000|COMPLETED|Overall Study||447||
59837921|NCT00488033|75962007|FG001|COMPLETED|Overall Study||452||
59837922|NCT00488033|75962006|FG000|NOT COMPLETED|Overall Study||1||
59837923|NCT00488033|75962007|FG001|NOT COMPLETED|Overall Study||0||
59837924|NCT00117598|75962016|FG000|STARTED|Prior to Treatment Cross Over||57||
59837925|NCT00117598|75962017|FG001|STARTED|Prior to Treatment Cross Over||56||
59837926|NCT00117598|75962018|FG002|STARTED|Prior to Treatment Cross Over||56||
59837927|NCT00117598|75962019|FG003|STARTED|Prior to Treatment Cross Over||0||
59837928|NCT00117598|75962020|FG004|STARTED|Prior to Treatment Cross Over||0||
59837929|NCT00117598|75962016|FG000|COMPLETED|Prior to Treatment Cross Over||0||
59837930|NCT00117598|75962017|FG001|COMPLETED|Prior to Treatment Cross Over||3||
59837931|NCT00117598|75962018|FG002|COMPLETED|Prior to Treatment Cross Over||4||
59837932|NCT00117598|75962019|FG003|COMPLETED|Prior to Treatment Cross Over||0||
59837933|NCT00117598|75962020|FG004|COMPLETED|Prior to Treatment Cross Over||0||
59837934|NCT00117598|75962016|FG000|NOT COMPLETED|Prior to Treatment Cross Over||57||
59837935|NCT00117598|75962017|FG001|NOT COMPLETED|Prior to Treatment Cross Over||53||
59837936|NCT00117598|75962018|FG002|NOT COMPLETED|Prior to Treatment Cross Over||52||
59837937|NCT00117598|75962019|FG003|NOT COMPLETED|Prior to Treatment Cross Over||0||
59837938|NCT00117598|75962020|FG004|NOT COMPLETED|Prior to Treatment Cross Over||0||
59837939|NCT00117598|75962016|FG000|STARTED|After Treament Cross Over||0||
59837940|NCT00117598|75962017|FG001|STARTED|After Treament Cross Over||0||
59837941|NCT00117598|75962018|FG002|STARTED|After Treament Cross Over||0||
59837942|NCT00117598|75962019|FG003|STARTED|After Treament Cross Over||3||
59837943|NCT00117598|75962020|FG004|STARTED|After Treament Cross Over||4||
59837944|NCT00117598|75962016|FG000|COMPLETED|After Treament Cross Over||0||
59837945|NCT00117598|75962017|FG001|COMPLETED|After Treament Cross Over||0||
59837946|NCT00117598|75962018|FG002|COMPLETED|After Treament Cross Over||0||
59837947|NCT00117598|75962019|FG003|COMPLETED|After Treament Cross Over||0||
59837948|NCT00117598|75962020|FG004|COMPLETED|After Treament Cross Over||0||
59837949|NCT00117598|75962016|FG000|NOT COMPLETED|After Treament Cross Over||0||
59837950|NCT00117598|75962017|FG001|NOT COMPLETED|After Treament Cross Over||0||
59837951|NCT00117598|75962018|FG002|NOT COMPLETED|After Treament Cross Over||0||
59837952|NCT00117598|75962019|FG003|NOT COMPLETED|After Treament Cross Over||3||
59837953|NCT00117598|75962020|FG004|NOT COMPLETED|After Treament Cross Over||4||
59837954|NCT00469859|75962032|FG000|STARTED|Overall Study||6||
59837955|NCT00469859|75962033|FG001|STARTED|Overall Study||8||
59837956|NCT00469859|75962032|FG000|COMPLETED|Overall Study||6||
59837957|NCT00469859|75962033|FG001|COMPLETED|Overall Study||6||
59837958|NCT00469859|75962032|FG000|NOT COMPLETED|Overall Study||0||
60119401|NCT02525536|76240616|FG002|COMPLETED|Overall Study||6||
60119402|NCT02525536|76240614|FG000|NOT COMPLETED|Overall Study||0||
60119403|NCT02525536|76240615|FG001|NOT COMPLETED|Overall Study||0||
60119404|NCT02525536|76240616|FG002|NOT COMPLETED|Overall Study||0||
60119405|NCT02530294|76240626|FG000|STARTED|Overall Study||234||
60119406|NCT02530294|76240627|FG001|STARTED|Overall Study||119||
60119407|NCT02530294|76240626|FG000|COMPLETED|Overall Study||218||
60119408|NCT02530294|76240627|FG001|COMPLETED|Overall Study||113||
59837959|NCT00469859|75962033|FG001|NOT COMPLETED|Overall Study||2||
59837960|NCT00093808|75962039|FG000|STARTED|Overall Study||47||
59837961|NCT00093808|75962039|FG000|COMPLETED|Overall Study||45||
59837962|NCT00093808|75962039|FG000|NOT COMPLETED|Overall Study||2||
59837963|NCT00469079|75962046|FG000|STARTED|Overall Study||27||
59837964|NCT00469079|75962047|FG001|STARTED|Overall Study||52||
59837965|NCT00469079|75962048|FG002|STARTED|Overall Study||51||
59837966|NCT00469079|75962046|FG000|COMPLETED|Overall Study||18||
59837967|NCT00469079|75962047|FG001|COMPLETED|Overall Study||30||
59837968|NCT00469079|75962048|FG002|COMPLETED|Overall Study||32||
59837969|NCT00469079|75962046|FG000|NOT COMPLETED|Overall Study||9||
59837970|NCT00469079|75962047|FG001|NOT COMPLETED|Overall Study||22||
60119409|NCT02530294|76240626|FG000|NOT COMPLETED|Overall Study||16||
60119410|NCT02530294|76240627|FG001|NOT COMPLETED|Overall Study||6||
59837971|NCT00469079|75962048|FG002|NOT COMPLETED|Overall Study||19||
59837972|NCT00093496|75962064|FG000|STARTED|Overall Study||15||
59837973|NCT00093496|75962065|FG001|STARTED|Overall Study||14||
59837974|NCT00093496|75962064|FG000|COMPLETED|Overall Study||14||
59837975|NCT00093496|75962065|FG001|COMPLETED|Overall Study||11||
59837976|NCT00093496|75962064|FG000|NOT COMPLETED|Overall Study||1||
59837977|NCT00093496|75962065|FG001|NOT COMPLETED|Overall Study||3||
59837978|NCT00117286|75962072|FG000|STARTED|Overall Study|Safety analysis set|30||
59837979|NCT00117286|75962073|FG001|STARTED|Overall Study||27||
59837980|NCT00117286|75962072|FG000|Switched to Higher Dose|Overall Study|A protocol amendment changed the dosage to 160 mg (40 mg/mL)|17||
59837981|NCT00117286|75962073|FG001|Switched to Higher Dose|Overall Study||17||
59837982|NCT00117286|75962072|FG000|COMPLETED|Overall Study|Participants ongoing at the time of study closure were considered to have completed the study|2||
59837983|NCT00117286|75962073|FG001|COMPLETED|Overall Study||6||
59837984|NCT00117286|75962072|FG000|NOT COMPLETED|Overall Study||28||
59837985|NCT00117286|75962073|FG001|NOT COMPLETED|Overall Study||21||
59837986|NCT00265122|75962085|FG000|STARTED|Intervention Period 1 (Weeks 0 to 8):||26||
59837987|NCT00265122|75962086|FG001|STARTED|Intervention Period 1 (Weeks 0 to 8):||25||
59837988|NCT00265122|75962087|FG002|STARTED|Intervention Period 1 (Weeks 0 to 8):||27||
59837989|NCT00265122|75962088|FG003|STARTED|Intervention Period 1 (Weeks 0 to 8):||26||
59837990|NCT00265122|75962089|FG004|STARTED|Intervention Period 1 (Weeks 0 to 8):||14||
59837991|NCT00265122|75962090|FG005|STARTED|Intervention Period 1 (Weeks 0 to 8):||13||
59837992|NCT00265122|75962085|FG000|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||24||
59837993|NCT00265122|75962086|FG001|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||23||
59837994|NCT00265122|75962087|FG002|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||22||
59837995|NCT00265122|75962088|FG003|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||24||
59837996|NCT00265122|75962089|FG004|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||13||
59837997|NCT00265122|75962090|FG005|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||13||
59837998|NCT00265122|75962085|FG000|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||2||
59837999|NCT00265122|75962086|FG001|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||2||
59838000|NCT00265122|75962087|FG002|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||5||
59838001|NCT00265122|75962088|FG003|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||2||
59838002|NCT00265122|75962089|FG004|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||1||
59838003|NCT00265122|75962090|FG005|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||0||
59838004|NCT00265122|75962085|FG000|STARTED|Intervention Period 2 (Weeks 8 to 28):||24||
59838005|NCT00265122|75962086|FG001|STARTED|Intervention Period 2 (Weeks 8 to 28):||23||
59838006|NCT00265122|75962087|FG002|STARTED|Intervention Period 2 (Weeks 8 to 28):||22||
59838007|NCT00265122|75962088|FG003|STARTED|Intervention Period 2 (Weeks 8 to 28):||24||
59838008|NCT00265122|75962089|FG004|STARTED|Intervention Period 2 (Weeks 8 to 28):||13||
59838009|NCT00265122|75962090|FG005|STARTED|Intervention Period 2 (Weeks 8 to 28):||13||
59838010|NCT00265122|75962085|FG000|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||17||
59838011|NCT00265122|75962086|FG001|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||22||
59838012|NCT00265122|75962087|FG002|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||18||
59838013|NCT00265122|75962088|FG003|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||20||
59838014|NCT00265122|75962089|FG004|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||8||
59838015|NCT00265122|75962090|FG005|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||12||
59838016|NCT00265122|75962085|FG000|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||7||
59838017|NCT00265122|75962086|FG001|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||1||
59838018|NCT00265122|75962087|FG002|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||4||
59838019|NCT00265122|75962088|FG003|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||4||
59838020|NCT00265122|75962089|FG004|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||5||
59838021|NCT00265122|75962090|FG005|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||1||
59838022|NCT00116584|75962111|FG000|STARTED|Overall Study||36||
59838023|NCT00116584|75962112|FG001|STARTED|Overall Study||36||
59838024|NCT00116584|75962111|FG000|COMPLETED|Overall Study||34||
59838025|NCT00116584|75962112|FG001|COMPLETED|Overall Study||35||
59838026|NCT00116584|75962111|FG000|NOT COMPLETED|Overall Study||2||
59838027|NCT00116584|75962112|FG001|NOT COMPLETED|Overall Study||1||
59838028|NCT00096538|75962118|FG000|STARTED|Overall Study||6||
59838029|NCT00096538|75962118|FG000|COMPLETED|Overall Study||5||
59838030|NCT00096538|75962118|FG000|NOT COMPLETED|Overall Study||1||
59838031|NCT00239928|75962122|FG000|STARTED|Overall Study||61||
59838032|NCT00239928|75962122|FG000|COMPLETED|Overall Study||51||
59838033|NCT00239928|75962122|FG000|NOT COMPLETED|Overall Study||10||
59838034|NCT00116428|75962128|FG000|STARTED|Overall Study||106||
59838035|NCT00116428|75962129|FG001|STARTED|Overall Study||61||
59838036|NCT00116428|75962128|FG000|Underwent Study Ablation Procedure|Overall Study||103||
59838037|NCT00116428|75962129|FG001|Underwent Study Ablation Procedure|Overall Study||36||
59838038|NCT00116428|75962128|FG000|COMPLETED|Overall Study||103||
59838039|NCT00116428|75962129|FG001|COMPLETED|Overall Study||56||
59838040|NCT00116428|75962128|FG000|NOT COMPLETED|Overall Study||3||
59838041|NCT00116428|75962129|FG001|NOT COMPLETED|Overall Study||5||
59838042|NCT00468845|75962141|FG000|STARTED|Overall Study||162||
59838043|NCT00468845|75962142|FG001|STARTED|Overall Study||170||
59838044|NCT00468845|75962143|FG002|STARTED|Overall Study||169||
59838045|NCT00468845|75962141|FG000|Received Treatment|Overall Study||161||
59838046|NCT00468845|75962142|FG001|Received Treatment|Overall Study||166||
59838047|NCT00468845|75962143|FG002|Received Treatment|Overall Study||167||
59838048|NCT00468845|75962141|FG000|COMPLETED|Overall Study||141||
59838049|NCT00468845|75962142|FG001|COMPLETED|Overall Study||136||
59838050|NCT00468845|75962143|FG002|COMPLETED|Overall Study||139||
59838051|NCT00468845|75962141|FG000|NOT COMPLETED|Overall Study||21||
59838052|NCT00468845|75962142|FG001|NOT COMPLETED|Overall Study||34||
59838053|NCT00468845|75962143|FG002|NOT COMPLETED|Overall Study||30||
59838054|NCT00468299|75962153|FG000|STARTED|Overall Study||9||
59838055|NCT00468299|75962154|FG001|STARTED|Overall Study||8||
59838056|NCT00468299|75962153|FG000|COMPLETED|Overall Study||9||
59838057|NCT00468299|75962154|FG001|COMPLETED|Overall Study||7||
59838058|NCT00468299|75962153|FG000|NOT COMPLETED|Overall Study||0||
59838059|NCT00468299|75962154|FG001|NOT COMPLETED|Overall Study||1||
59838060|NCT00468143|75962162|FG000|STARTED|First Intervention (3 Weeks)||31||
59838061|NCT00468143|75962163|FG001|STARTED|First Intervention (3 Weeks)||31||
59838062|NCT00468143|75962162|FG000|COMPLETED|First Intervention (3 Weeks)||28||
59838063|NCT00468143|75962163|FG001|COMPLETED|First Intervention (3 Weeks)||27||
59838064|NCT00468143|75962162|FG000|NOT COMPLETED|First Intervention (3 Weeks)||3||
59838065|NCT00468143|75962163|FG001|NOT COMPLETED|First Intervention (3 Weeks)||4||
59838066|NCT00468143|75962162|FG000|STARTED|Second Intervention (3 Weeks)||28||
59838067|NCT00468143|75962163|FG001|STARTED|Second Intervention (3 Weeks)||27||
60119411|NCT02530450|76240635|FG000|STARTED|Overall Study||16||
60119412|NCT02530450|76240636|FG001|STARTED|Overall Study||14||
59838068|NCT00468143|75962162|FG000|COMPLETED|Second Intervention (3 Weeks)||25||
59838069|NCT00468143|75962163|FG001|COMPLETED|Second Intervention (3 Weeks)||24||
59838070|NCT00468143|75962162|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||3||
59838071|NCT00468143|75962163|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||3||
59838072|NCT00467831|75962169|FG000|STARTED|Overall Study||3||
60119413|NCT02530450|76240635|FG000|COMPLETED|Overall Study||10||
59838073|NCT00467831|75962169|FG000|COMPLETED|Overall Study||0||
59838074|NCT00467831|75962169|FG000|NOT COMPLETED|Overall Study||3||
59838075|NCT00467753|75962175|FG000|STARTED|Overall Study||3||
59838076|NCT00467753|75962176|FG001|STARTED|Overall Study||2||
59838077|NCT00467753|75962175|FG000|COMPLETED|Overall Study||0||
59838078|NCT00467753|75962176|FG001|COMPLETED|Overall Study||0||
59838079|NCT00467753|75962175|FG000|NOT COMPLETED|Overall Study||3||
59838080|NCT00467753|75962176|FG001|NOT COMPLETED|Overall Study||2||
60119414|NCT02530450|76240636|FG001|COMPLETED|Overall Study||9||
59838081|NCT00467597|75962190|FG000|STARTED|Overall Study||26||
59838082|NCT00467597|75962191|FG001|STARTED|Overall Study||6||
59838083|NCT00467597|75962190|FG000|COMPLETED|Overall Study||24||
59838084|NCT00467597|75962191|FG001|COMPLETED|Overall Study||6||
59838085|NCT00467597|75962190|FG000|NOT COMPLETED|Overall Study||2||
59838086|NCT00467597|75962191|FG001|NOT COMPLETED|Overall Study||0||
59838087|NCT00115804|75962201|FG000|STARTED|Overall Study||6||
59838088|NCT00115804|75962201|FG000|COMPLETED|Overall Study||4||
59838089|NCT00115804|75962201|FG000|NOT COMPLETED|Overall Study||2||
59838090|NCT00467519|75962209|FG000|STARTED|Overall Study||531||
59838091|NCT00467519|75962210|FG001|STARTED|Overall Study||511||
59838092|NCT00467519|75962209|FG000|COMPLETED|Overall Study||517||
59838093|NCT00467519|75962210|FG001|COMPLETED|Overall Study||488||
59838094|NCT00467519|75962209|FG000|NOT COMPLETED|Overall Study||14||
59838095|NCT00467519|75962210|FG001|NOT COMPLETED|Overall Study||23||
59838096|NCT00264810|75962218|FG000|STARTED|Baseline|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|120||
59838097|NCT00264810|75962219|FG001|STARTED|Baseline|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|120||
59838098|NCT00264810|75962218|FG000|COMPLETED|Baseline|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|97||
59838099|NCT00264810|75962219|FG001|COMPLETED|Baseline|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|94||
59838100|NCT00264810|75962218|FG000|NOT COMPLETED|Baseline||23||
59838101|NCT00264810|75962219|FG001|NOT COMPLETED|Baseline||26||
59838102|NCT00264810|75962218|FG000|STARTED|Post-Operative Stabilization Period|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|97||
59838103|NCT00264810|75962219|FG001|STARTED|Post-Operative Stabilization Period|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|94||
59838104|NCT00264810|75962218|FG000|COMPLETED|Post-Operative Stabilization Period||97||
59838105|NCT00264810|75962219|FG001|COMPLETED|Post-Operative Stabilization Period||94||
59838106|NCT00264810|75962218|FG000|NOT COMPLETED|Post-Operative Stabilization Period||0||
59838107|NCT00264810|75962219|FG001|NOT COMPLETED|Post-Operative Stabilization Period||0||
59838108|NCT00264810|75962218|FG000|STARTED|Stimulation Optimization Period||97||
59838109|NCT00264810|75962219|FG001|STARTED|Stimulation Optimization Period||94||
59838110|NCT00264810|75962218|FG000|COMPLETED|Stimulation Optimization Period||96||
59838111|NCT00264810|75962219|FG001|COMPLETED|Stimulation Optimization Period||93||
59838112|NCT00264810|75962218|FG000|NOT COMPLETED|Stimulation Optimization Period||1||
59838113|NCT00264810|75962219|FG001|NOT COMPLETED|Stimulation Optimization Period||1||
59838114|NCT00264810|75962218|FG000|STARTED|Blinded Evaluation Period||96||
59838115|NCT00264810|75962219|FG001|STARTED|Blinded Evaluation Period||93||
59838116|NCT00264810|75962218|FG000|COMPLETED|Blinded Evaluation Period||95||
59838117|NCT00264810|75962219|FG001|COMPLETED|Blinded Evaluation Period||92||
59838118|NCT00264810|75962218|FG000|NOT COMPLETED|Blinded Evaluation Period||1||
59838119|NCT00264810|75962219|FG001|NOT COMPLETED|Blinded Evaluation Period||1||
59838120|NCT00264810|75962218|FG000|STARTED|Open Label Evaluation Period||95||
59838121|NCT00264810|75962219|FG001|STARTED|Open Label Evaluation Period||92||
59838122|NCT00264810|75962218|FG000|1-year Post-implant|Open Label Evaluation Period||92||
59838123|NCT00264810|75962219|FG001|1-year Post-implant|Open Label Evaluation Period||90||
59838124|NCT00264810|75962218|FG000|COMPLETED|Open Label Evaluation Period||89||
59838125|NCT00264810|75962219|FG001|COMPLETED|Open Label Evaluation Period||86||
59838126|NCT00264810|75962218|FG000|NOT COMPLETED|Open Label Evaluation Period||6||
59838127|NCT00264810|75962219|FG001|NOT COMPLETED|Open Label Evaluation Period||6||
59838128|NCT00467363|75962229|FG000|STARTED|Overall Study||615||
59838129|NCT00467363|75962230|FG001|STARTED|Overall Study||613||
59838130|NCT00467363|75962229|FG000|COMPLETED|Overall Study||535||
59838131|NCT00467363|75962230|FG001|COMPLETED|Overall Study||543||
59838132|NCT00467363|75962229|FG000|NOT COMPLETED|Overall Study||80||
59838133|NCT00467363|75962230|FG001|NOT COMPLETED|Overall Study||70||
59838134|NCT00091390|75962236|FG000|STARTED|Overall Study||129||
59838135|NCT00091390|75962236|FG000|Eligible and Started Study Treatment|Overall Study||125||
59838136|NCT00091390|75962236|FG000|Eligible, Started Treatment, Has AE Data|Overall Study||115|Eligible, started study treatment, and has adverse event (AE) data|
59838137|NCT00091390|75962236|FG000|COMPLETED|Overall Study|Subjects contributing data to results are considered to have completed the study.|125||
59838138|NCT00091390|75962236|FG000|NOT COMPLETED|Overall Study||4||
59838139|NCT00239226|75962244|FG000|STARTED|Overall Study||30||
59838140|NCT00239226|75962245|FG001|STARTED|Overall Study||18||
59838141|NCT00239226|75962246|FG002|STARTED|Overall Study||37||
59838142|NCT00239226|75962247|FG003|STARTED|Overall Study||17||
59567616|NCT02326272|75670459|FG006|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||9||
59718378|NCT00952341|75837628|FG001|COMPLETED|Cycle 1||199||
59718379|NCT00952341|75837627|FG000|NOT COMPLETED|Cycle 1||20||
59718380|NCT00952341|75837628|FG001|NOT COMPLETED|Cycle 1||13||
59718381|NCT00952341|75837627|FG000|STARTED|Cycle 2||110||
59718382|NCT00952341|75837628|FG001|STARTED|Cycle 2||130||
59718383|NCT00952341|75837627|FG000|COMPLETED|Cycle 2||101||
59718384|NCT00952341|75837628|FG001|COMPLETED|Cycle 2||118||
59718385|NCT00952341|75837627|FG000|NOT COMPLETED|Cycle 2||9||
59718386|NCT00952341|75837628|FG001|NOT COMPLETED|Cycle 2||12||
59718387|NCT00946881|75837634|FG000|STARTED|First Treatment||30||
59838143|NCT00239226|75962244|FG000|COMPLETED|Overall Study||29||
59838144|NCT00239226|75962245|FG001|COMPLETED|Overall Study||18||
59838145|NCT00239226|75962246|FG002|COMPLETED|Overall Study||36||
59838146|NCT00239226|75962247|FG003|COMPLETED|Overall Study||14||
59838147|NCT00239226|75962244|FG000|NOT COMPLETED|Overall Study||1||
59838148|NCT00239226|75962245|FG001|NOT COMPLETED|Overall Study||0||
59838149|NCT00239226|75962246|FG002|NOT COMPLETED|Overall Study||1||
60119415|NCT02530450|76240635|FG000|NOT COMPLETED|Overall Study||6||
60119416|NCT02530450|76240636|FG001|NOT COMPLETED|Overall Study||5||
60119417|NCT02530528|76240642|FG000|STARTED|Overall Study||13||13
60119418|NCT02530528|76240643|FG001|STARTED|Overall Study||13||13
60119419|NCT02530528|76240644|FG002|STARTED|Overall Study||14||14
60119420|NCT02530528|76240645|FG003|STARTED|Overall Study||14||14
60119421|NCT02530528|76240646|FG004|STARTED|Overall Study||13||13
60119422|NCT02530528|76240647|FG005|STARTED|Overall Study||13||13
59567617|NCT02326272|75670460|FG007|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||7||
59567618|NCT02326272|75670461|FG008|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||5||
59567619|NCT02326272|75670462|FG009|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||2||
59567620|NCT02326272|75670463|FG010|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
59567621|NCT02326272|75670464|FG011|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
59567622|NCT02326272|75670465|FG012|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
59567623|NCT02326272|75670466|FG013|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
59718388|NCT00946881|75837634|FG000|COMPLETED|First Treatment||28||
59718389|NCT00946881|75837634|FG000|NOT COMPLETED|First Treatment||2||
59718390|NCT00946881|75837634|FG000|STARTED|Retreatment||8||
59718391|NCT00946881|75837634|FG000|COMPLETED|Retreatment||7||
59718392|NCT00946881|75837634|FG000|NOT COMPLETED|Retreatment||1||
59718393|NCT01214642|75837671|FG000|STARTED|Overall Study||3||
59718394|NCT01214642|75837672|FG001|STARTED|Overall Study||3||
59718395|NCT01214642|75837673|FG002|STARTED|Overall Study||6||
59718396|NCT01214642|75837674|FG003|STARTED|Overall Study||6||
59718397|NCT01214642|75837675|FG004|STARTED|Overall Study||6||
59718398|NCT01214642|75837676|FG005|STARTED|Overall Study||3||
59838150|NCT00239226|75962247|FG003|NOT COMPLETED|Overall Study||3||
59838151|NCT00467285|75962259|FG000|STARTED|Overall Study||32||
59838152|NCT00467285|75962260|FG001|STARTED|Overall Study||64||
59838153|NCT00467285|75962259|FG000|COMPLETED|Overall Study||28||
59838154|NCT00467285|75962260|FG001|COMPLETED|Overall Study||60||
59838155|NCT00467285|75962259|FG000|NOT COMPLETED|Overall Study||4||
59838156|NCT00467285|75962260|FG001|NOT COMPLETED|Overall Study||4||
59838157|NCT00264576|75962270|FG000|STARTED|Overall Study||308||
59838158|NCT00264576|75962271|FG001|STARTED|Overall Study||305||
59838159|NCT00264576|75962270|FG000|COMPLETED|Overall Study||307||
59838160|NCT00264576|75962271|FG001|COMPLETED|Overall Study||304||
59838161|NCT00264576|75962270|FG000|NOT COMPLETED|Overall Study||1||
59838162|NCT00264576|75962271|FG001|NOT COMPLETED|Overall Study||1||
59838163|NCT00466505|75962278|FG000|STARTED|Overall Study||17||
59838164|NCT00466505|75962278|FG000|COMPLETED|Overall Study||0||
59838165|NCT00466505|75962278|FG000|NOT COMPLETED|Overall Study||17||
59838166|NCT00467051|75962282|FG000|STARTED|Overall Study||20||
59838167|NCT00467051|75962282|FG000|COMPLETED|Overall Study||18||
59838168|NCT00467051|75962282|FG000|NOT COMPLETED|Overall Study||2||
59838169|NCT00264498|75962289|FG000|STARTED|Randomized Treatment||17||
59838170|NCT00264498|75962290|FG001|STARTED|Randomized Treatment||18||
59838171|NCT00264498|75962289|FG000|COMPLETED|Randomized Treatment|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0||
59838172|NCT00264498|75962290|FG001|COMPLETED|Randomized Treatment|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0||
59838173|NCT00264498|75962289|FG000|NOT COMPLETED|Randomized Treatment||17||
59838174|NCT00264498|75962290|FG001|NOT COMPLETED|Randomized Treatment||18||
59838175|NCT00264498|75962289|FG000|STARTED|Crossover Treatment||6||
59838176|NCT00264498|75962290|FG001|STARTED|Crossover Treatment||9||
59838177|NCT00264498|75962289|FG000|COMPLETED|Crossover Treatment|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0||
59838178|NCT00264498|75962290|FG001|COMPLETED|Crossover Treatment|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0||
59838179|NCT00264498|75962289|FG000|NOT COMPLETED|Crossover Treatment||6||
59838180|NCT00264498|75962290|FG001|NOT COMPLETED|Crossover Treatment||9||
59838181|NCT00466193|75962298|FG000|STARTED|Overall Study||150||
59838182|NCT00466193|75962299|FG001|STARTED|Overall Study||145||
59838183|NCT00466193|75962298|FG000|COMPLETED|Overall Study||138||
59838184|NCT00466193|75962299|FG001|COMPLETED|Overall Study|One patient did not report at least one Latency Sleep Onset following middle-of-the-night awakening.|137||
59838185|NCT00466193|75962298|FG000|NOT COMPLETED|Overall Study||12||
59838186|NCT00466193|75962299|FG001|NOT COMPLETED|Overall Study||8||
59838187|NCT00263562|75962307|FG000|STARTED|Overall Study||9|This study was terminated early and not completed.|
59838188|NCT00263562|75962308|FG001|STARTED|Overall Study||9|This study was terminated early and not completed.|
59838189|NCT00263562|75962307|FG000|COMPLETED|Overall Study||6||
59838190|NCT00263562|75962308|FG001|COMPLETED|Overall Study||9||
59838191|NCT00263562|75962307|FG000|NOT COMPLETED|Overall Study||3||
59838192|NCT00263562|75962308|FG001|NOT COMPLETED|Overall Study||0||
59838193|NCT00454181|75962318|FG000|STARTED|Overall Study||45||
59838194|NCT00454181|75962319|FG001|STARTED|Overall Study||14||
59838195|NCT00454181|75962318|FG000|COMPLETED|Overall Study||30||
59838196|NCT00454181|75962319|FG001|COMPLETED|Overall Study||11||
59838197|NCT00454181|75962318|FG000|NOT COMPLETED|Overall Study||15||
59838198|NCT00454181|75962319|FG001|NOT COMPLETED|Overall Study||3||
59838199|NCT00237744|75962328|FG000|STARTED|Overall Study||11||
59838200|NCT00237744|75962329|FG001|STARTED|Overall Study||11||
59838201|NCT00237744|75962330|FG002|STARTED|Overall Study||18||
59838202|NCT00237744|75962328|FG000|COMPLETED|Overall Study||8||
59838203|NCT00237744|75962329|FG001|COMPLETED|Overall Study||10||
59838204|NCT00237744|75962330|FG002|COMPLETED|Overall Study||18||
59838205|NCT00237744|75962328|FG000|NOT COMPLETED|Overall Study||3||
59838206|NCT00237744|75962329|FG001|NOT COMPLETED|Overall Study||1||
59838207|NCT00237744|75962330|FG002|NOT COMPLETED|Overall Study||0||
59838208|NCT00237042|75962344|FG000|STARTED|Treatment||60||
59838209|NCT00237042|75962345|FG001|STARTED|Treatment||57||
59838210|NCT00237042|75962346|FG002|STARTED|Treatment||74||
59838211|NCT00237042|75962344|FG000|COMPLETED|Treatment||54||
59838212|NCT00237042|75962345|FG001|COMPLETED|Treatment||50||
59838213|NCT00237042|75962346|FG002|COMPLETED|Treatment||36||
59838214|NCT00237042|75962344|FG000|NOT COMPLETED|Treatment||6||
59838215|NCT00237042|75962345|FG001|NOT COMPLETED|Treatment||7||
59838216|NCT00237042|75962346|FG002|NOT COMPLETED|Treatment||38||
59838217|NCT00237042|75962344|FG000|STARTED|Short Term (6 Month) Follow up|Greater than number completing treatment: intent to treat analysis|59||
59838218|NCT00237042|75962345|FG001|STARTED|Short Term (6 Month) Follow up|Greater than number completing treatment: intent to treat analysis|55||
59838219|NCT00237042|75962346|FG002|STARTED|Short Term (6 Month) Follow up|Greater than number completing treatment: intent to treat analysis|57||
59838220|NCT00237042|75962344|FG000|COMPLETED|Short Term (6 Month) Follow up||50||
59838221|NCT00237042|75962345|FG001|COMPLETED|Short Term (6 Month) Follow up||47||
59838222|NCT00237042|75962346|FG002|COMPLETED|Short Term (6 Month) Follow up||46||
59838223|NCT00237042|75962344|FG000|NOT COMPLETED|Short Term (6 Month) Follow up||9||
59838224|NCT00237042|75962345|FG001|NOT COMPLETED|Short Term (6 Month) Follow up||8||
59838225|NCT00237042|75962346|FG002|NOT COMPLETED|Short Term (6 Month) Follow up||11||
59838226|NCT00237042|75962344|FG000|STARTED|Long Term (12 Month) Follow up|Greater than number completing treatment: intent to treat analysis|59||
59838227|NCT00237042|75962345|FG001|STARTED|Long Term (12 Month) Follow up|Greater than number completing treatment: intent to treat analysis|55||
59838228|NCT00237042|75962346|FG002|STARTED|Long Term (12 Month) Follow up|Greater than number completing treatment: intent to treat analysis|57||
59838229|NCT00237042|75962344|FG000|COMPLETED|Long Term (12 Month) Follow up||48||
59838230|NCT00237042|75962345|FG001|COMPLETED|Long Term (12 Month) Follow up||46||
59838231|NCT00237042|75962346|FG002|COMPLETED|Long Term (12 Month) Follow up||48||
59838232|NCT00237042|75962344|FG000|NOT COMPLETED|Long Term (12 Month) Follow up||11||
59838233|NCT00237042|75962345|FG001|NOT COMPLETED|Long Term (12 Month) Follow up||9||
59838234|NCT00237042|75962346|FG002|NOT COMPLETED|Long Term (12 Month) Follow up||9||
59838235|NCT00465647|75962358|FG000|STARTED|Overall Study||39||
59838236|NCT00465647|75962359|FG001|STARTED|Overall Study||23||
59838237|NCT00465647|75962360|FG002|STARTED|Overall Study||29||
59838238|NCT00465647|75962361|FG003|STARTED|Overall Study||25||
59838239|NCT00465647|75962358|FG000|COMPLETED|Overall Study||26||
59838240|NCT00465647|75962359|FG001|COMPLETED|Overall Study||15||
59838241|NCT00465647|75962360|FG002|COMPLETED|Overall Study||18||
59838242|NCT00465647|75962361|FG003|COMPLETED|Overall Study||12||
59838243|NCT00465647|75962358|FG000|NOT COMPLETED|Overall Study||13||
59838244|NCT00465647|75962359|FG001|NOT COMPLETED|Overall Study||8||
59838245|NCT00465647|75962360|FG002|NOT COMPLETED|Overall Study||11||
59838246|NCT00465647|75962361|FG003|NOT COMPLETED|Overall Study||13||
59838247|NCT00465569|75962383|FG000|STARTED|Overall Study||13||
59838248|NCT00465569|75962384|FG001|STARTED|Overall Study||7||
59838249|NCT00465569|75962383|FG000|COMPLETED|Overall Study||12||
59838250|NCT00465569|75962384|FG001|COMPLETED|Overall Study||7||
59838251|NCT00465569|75962383|FG000|NOT COMPLETED|Overall Study||1||
59838252|NCT00465569|75962384|FG001|NOT COMPLETED|Overall Study||0||
59838253|NCT00090766|75962393|FG000|STARTED|Overall Study||17||
59838254|NCT00090766|75962394|FG001|STARTED|Overall Study||21||
59838255|NCT00090766|75962395|FG002|STARTED|Overall Study||25||
59838256|NCT00090766|75962393|FG000|COMPLETED|Overall Study||14||
59838257|NCT00090766|75962394|FG001|COMPLETED|Overall Study||19||
59838258|NCT00090766|75962395|FG002|COMPLETED|Overall Study||22||
59838259|NCT00090766|75962393|FG000|NOT COMPLETED|Overall Study||3||
59838260|NCT00090766|75962394|FG001|NOT COMPLETED|Overall Study||2||
59838261|NCT00090766|75962395|FG002|NOT COMPLETED|Overall Study||3||
59838262|NCT00465179|75962405|FG000|STARTED|Overall Study||57||
59838263|NCT00465179|75962405|FG000|COMPLETED|Overall Study||4||
59838264|NCT00465179|75962405|FG000|NOT COMPLETED|Overall Study||53||
59838265|NCT00465101|75962409|FG000|STARTED|Overall Study||150||
59838266|NCT00465101|75962409|FG000|COMPLETED|Overall Study||91||
59838267|NCT00465101|75962409|FG000|NOT COMPLETED|Overall Study||59||
59838268|NCT00084136|75962438|FG000|STARTED|PI Comparison||519||
59838269|NCT00084136|75962439|FG001|STARTED|PI Comparison||526||
59838270|NCT00084136|75962440|FG002|STARTED|PI Comparison||0||
59838271|NCT00084136|75962438|FG000|COMPLETED|PI Comparison|Follow-up was until ddI+FTC+ATV arm was closed per DSMB recommendation on May 23, 2008.|464||
59838272|NCT00084136|75962439|FG001|COMPLETED|PI Comparison|Follow-up was until ddI+FTC+ATV arm was closed per DSMB recommendation on May 23, 2008.|479||
59838273|NCT00084136|75962440|FG002|COMPLETED|PI Comparison||0||
59838274|NCT00084136|75962438|FG000|NOT COMPLETED|PI Comparison||55||
59838275|NCT00084136|75962439|FG001|NOT COMPLETED|PI Comparison||47||
59838276|NCT00084136|75962440|FG002|NOT COMPLETED|PI Comparison||0||
59838277|NCT00084136|75962438|FG000|STARTED|NRTI Comparison||519||
59838278|NCT00084136|75962439|FG001|STARTED|NRTI Comparison||0||
59838279|NCT00084136|75962440|FG002|STARTED|NRTI Comparison||526||
59838280|NCT00084136|75962438|FG000|COMPLETED|NRTI Comparison|Follow-up though study closeout period (final visit between April 1 and May 31, 2010).|418||
59838281|NCT00084136|75962439|FG001|COMPLETED|NRTI Comparison||0||
59838282|NCT00084136|75962440|FG002|COMPLETED|NRTI Comparison|Follow-up though study closeout period (final visit between April 1 and May 31, 2010).|444||
59838283|NCT00084136|75962438|FG000|NOT COMPLETED|NRTI Comparison||101||
59838284|NCT00084136|75962439|FG001|NOT COMPLETED|NRTI Comparison||0||
59838285|NCT00084136|75962440|FG002|NOT COMPLETED|NRTI Comparison||82||
59838286|NCT03812380|75962451|FG000|STARTED|Overall Study||22||
59838287|NCT03812380|75962452|FG001|STARTED|Overall Study||22||
59838288|NCT03812380|75962451|FG000|COMPLETED|Overall Study||0||
59838289|NCT03812380|75962452|FG001|COMPLETED|Overall Study||1||
59838290|NCT03812380|75962451|FG000|NOT COMPLETED|Overall Study||22||
59838291|NCT03812380|75962452|FG001|NOT COMPLETED|Overall Study||21||
59838292|NCT00464945|75962460|FG000|STARTED|Infant Series||135||
59838293|NCT00464945|75962461|FG001|STARTED|Infant Series||134||
59838294|NCT00464945|75962460|FG000|Vaccinated Dose 1|Infant Series||134||
59996547|NCT02714569|76112511|FG008|COMPLETED|Part A First Intervention||0||
59996548|NCT02714569|76112512|FG009|COMPLETED|Part A First Intervention||0||
59996549|NCT02714569|76112513|FG010|COMPLETED|Part A First Intervention||0||
59996550|NCT02714569|76112503|FG000|NOT COMPLETED|Part A First Intervention||0||
59996551|NCT02714569|76112504|FG001|NOT COMPLETED|Part A First Intervention||0||
59996552|NCT02714569|76112505|FG002|NOT COMPLETED|Part A First Intervention||0||
59996553|NCT02714569|76112506|FG003|NOT COMPLETED|Part A First Intervention||0||
60119423|NCT02530528|76240648|FG006|STARTED|Overall Study||14||14
60119424|NCT02530528|76240649|FG007|STARTED|Overall Study||14||14
59838295|NCT00464945|75962461|FG001|Vaccinated Dose 1|Infant Series||134||
59838296|NCT00464945|75962460|FG000|Vaccinated Dose 2|Infant Series||132||
59838297|NCT00464945|75962461|FG001|Vaccinated Dose 2|Infant Series||133||
59838298|NCT00464945|75962460|FG000|Vaccinated Dose 3|Infant Series||132||
59838299|NCT00464945|75962461|FG001|Vaccinated Dose 3|Infant Series||133||
59996554|NCT02714569|76112507|FG004|NOT COMPLETED|Part A First Intervention||0||
59996555|NCT02714569|76112508|FG005|NOT COMPLETED|Part A First Intervention||0||
59838300|NCT00464945|75962460|FG000|COMPLETED|Infant Series||131||
59838301|NCT00464945|75962461|FG001|COMPLETED|Infant Series||133||
59838302|NCT00464945|75962460|FG000|NOT COMPLETED|Infant Series||4||
59838303|NCT00464945|75962461|FG001|NOT COMPLETED|Infant Series||1||
59838304|NCT00464945|75962460|FG000|STARTED|After Infant Series||131||
59838305|NCT00464945|75962461|FG001|STARTED|After Infant Series||133||
59838306|NCT00464945|75962460|FG000|COMPLETED|After Infant Series||131||
59838307|NCT00464945|75962461|FG001|COMPLETED|After Infant Series||131||
59838308|NCT00464945|75962460|FG000|NOT COMPLETED|After Infant Series||0||
59838309|NCT00464945|75962461|FG001|NOT COMPLETED|After Infant Series||2||
59838310|NCT00464945|75962460|FG000|STARTED|Toddler Dose||131||
59838311|NCT00464945|75962461|FG001|STARTED|Toddler Dose||131||
59838312|NCT00464945|75962460|FG000|COMPLETED|Toddler Dose||131||
59996556|NCT02714569|76112509|FG006|NOT COMPLETED|Part A First Intervention||0||
59838313|NCT00464945|75962461|FG001|COMPLETED|Toddler Dose||130||
59838314|NCT00464945|75962460|FG000|NOT COMPLETED|Toddler Dose||0||
59838315|NCT00464945|75962461|FG001|NOT COMPLETED|Toddler Dose||1||
59838316|NCT00464087|75962486|FG000|STARTED|Overall Study||49||
59838317|NCT00464087|75962487|FG001|STARTED|Overall Study||51||
59838318|NCT00464087|75962488|FG002|STARTED|Overall Study||29||
59838319|NCT00464087|75962486|FG000|COMPLETED|Overall Study||49||
59838320|NCT00464087|75962487|FG001|COMPLETED|Overall Study||51||
59838321|NCT00464087|75962488|FG002|COMPLETED|Overall Study||0||
59838322|NCT00464087|75962486|FG000|NOT COMPLETED|Overall Study||0||
59838323|NCT00464087|75962487|FG001|NOT COMPLETED|Overall Study||0||
59838324|NCT00464087|75962488|FG002|NOT COMPLETED|Overall Study||29||
59838325|NCT00452699|75962498|FG000|STARTED|Overall Study||306||
59838326|NCT00452699|75962499|FG001|STARTED|Overall Study||315||
59838327|NCT00452699|75962498|FG000|COMPLETED|Overall Study||225||
59838328|NCT00452699|75962499|FG001|COMPLETED|Overall Study||242||
59838329|NCT00452699|75962498|FG000|NOT COMPLETED|Overall Study||81||
59838330|NCT00452699|75962499|FG001|NOT COMPLETED|Overall Study||73||
59838331|NCT00069784|75962507|FG000|STARTED|Overall Study|randomized participants = intent-to-treat (ITT) population|6264||
59838332|NCT00069784|75962508|FG001|STARTED|Overall Study|randomized participants = intent-to-treat (ITT) population|6273||
59838333|NCT00069784|75962507|FG000|Safety Population (Treated)|Overall Study|randomized patients who received at least one dose of insulin glargine|6231||
59838334|NCT00069784|75962508|FG001|Safety Population (Treated)|Overall Study|patients randomized to standard care arm|6273||
59838335|NCT00069784|75962507|FG000|COMPLETED|Overall Study|completed study treatment|5052||
59838336|NCT00069784|75962508|FG001|COMPLETED|Overall Study|not applicable (no treatment)|6273||
59838337|NCT00069784|75962507|FG000|NOT COMPLETED|Overall Study||1212||
59838338|NCT00069784|75962508|FG001|NOT COMPLETED|Overall Study||0||
59838339|NCT03811834|75962514|FG000|STARTED|Period 1 ( 7 Days)||7||
59838340|NCT03811834|75962514|FG000|COMPLETED|Period 1 ( 7 Days)||6||
59838341|NCT03811834|75962514|FG000|NOT COMPLETED|Period 1 ( 7 Days)||1||
59838342|NCT03811834|75962514|FG000|STARTED|Washout Period (9 Days)||6||
59838343|NCT03811834|75962514|FG000|COMPLETED|Washout Period (9 Days)||6||
59838344|NCT03811834|75962514|FG000|NOT COMPLETED|Washout Period (9 Days)||0||
59838345|NCT03811834|75962514|FG000|STARTED|Period 2 (10 Days)||6||
59838346|NCT03811834|75962514|FG000|COMPLETED|Period 2 (10 Days)||6||
59838347|NCT03811834|75962514|FG000|NOT COMPLETED|Period 2 (10 Days)||0||
59838348|NCT00090610|75962529|FG000|STARTED|Overall Study||75||
59838349|NCT00090610|75962530|FG001|STARTED|Overall Study||75||
59838350|NCT00090610|75962529|FG000|COMPLETED|Overall Study||74||
59838351|NCT00090610|75962530|FG001|COMPLETED|Overall Study||74||
59838352|NCT00090610|75962529|FG000|NOT COMPLETED|Overall Study||1||
59838353|NCT00090610|75962530|FG001|NOT COMPLETED|Overall Study||1||
59838354|NCT00463385|75962540|FG000|STARTED|Overall Study||22||
59838355|NCT00463385|75962541|FG001|STARTED|Overall Study||22||
59838356|NCT00463385|75962542|FG002|STARTED|Overall Study||22||
59838357|NCT00463385|75962543|FG003|STARTED|Overall Study||22||
59838358|NCT00463385|75962540|FG000|Treated|Overall Study||22||
59838359|NCT00463385|75962541|FG001|Treated|Overall Study||22||
59838360|NCT00463385|75962542|FG002|Treated|Overall Study||19||
59838361|NCT00463385|75962543|FG003|Treated|Overall Study||22||
59838362|NCT00463385|75962540|FG000|COMPLETED|Overall Study||0||
59838363|NCT00463385|75962541|FG001|COMPLETED|Overall Study||0||
59838364|NCT00463385|75962542|FG002|COMPLETED|Overall Study||0||
59838365|NCT00463385|75962543|FG003|COMPLETED|Overall Study||0||
59838366|NCT00463385|75962540|FG000|NOT COMPLETED|Overall Study||22||
59838367|NCT00463385|75962541|FG001|NOT COMPLETED|Overall Study||22||
59838368|NCT00463385|75962542|FG002|NOT COMPLETED|Overall Study||22||
59838369|NCT00463385|75962543|FG003|NOT COMPLETED|Overall Study||22||
59838370|NCT00463229|75962563|FG000|STARTED|Overall Study||52||
59838371|NCT00463229|75962564|FG001|STARTED|Overall Study||49||
59838372|NCT00463229|75962563|FG000|COMPLETED|Overall Study||43||
59838373|NCT00463229|75962564|FG001|COMPLETED|Overall Study||39||
59838374|NCT00463229|75962563|FG000|NOT COMPLETED|Overall Study||9||
59838375|NCT00463229|75962564|FG001|NOT COMPLETED|Overall Study||10||
59838376|NCT03839693|75962574|FG000|STARTED|Overall Study||25||
59838377|NCT03839693|75962575|FG001|STARTED|Overall Study||30||
59838378|NCT03839693|75962576|FG002|STARTED|Overall Study||20||
59838379|NCT03839693|75962574|FG000|COMPLETED|Overall Study||23||
59838380|NCT03839693|75962575|FG001|COMPLETED|Overall Study||28||
59838381|NCT03839693|75962576|FG002|COMPLETED|Overall Study||16||
59838382|NCT03839693|75962574|FG000|NOT COMPLETED|Overall Study||2||
59838383|NCT03839693|75962575|FG001|NOT COMPLETED|Overall Study||2||
59838384|NCT03839693|75962576|FG002|NOT COMPLETED|Overall Study||4||
59838385|NCT00068692|75962589|FG000|STARTED|Step 1: Registration||128|Randomization (arms I-III in both groups) was step 2.|
59838386|NCT00068692|75962590|FG001|STARTED|Step 1: Registration|Group II patients were registered and randomized at the same time, and were reported in Step 2.|97|Randomization (arms I-III in both groups) was step 2.|
59838387|NCT00068692|75962591|FG002|STARTED|Step 1: Registration||0|Randomization (arms I-III in both groups) was step 2.|
59838388|NCT00068692|75962592|FG003|STARTED|Step 1: Registration||0|Randomization (arms I-III in both groups) was step 2.|
59838389|NCT00068692|75962593|FG004|STARTED|Step 1: Registration||0|Randomization (arms I-III in both groups) was step 2.|
59838390|NCT00068692|75962594|FG005|STARTED|Step 1: Registration|Group II patients was registered and randomized at the same time, and reported in step 2|0|Randomization (arms I-III in both groups) was step 2.|
59838391|NCT00068692|75962595|FG006|STARTED|Step 1: Registration|Group II patients was registered and randomized at the same time, and reported in step 2|0|Randomization (arms I-III in both groups) was step 2.|
59838392|NCT00068692|75962596|FG007|STARTED|Step 1: Registration|Group II patients was registered and randomized at the same time, and reported in step 2|0|Randomization (arms I-III in both groups) was step 2.|
59838393|NCT00068692|75962589|FG000|Started Concurrent Chemo/Radiation|Step 1: Registration||125||
59838394|NCT00068692|75962590|FG001|Started Concurrent Chemo/Radiation|Step 1: Registration|Group II patients receive protocol therapy in Step 2 after randomization|0||
59838395|NCT00068692|75962591|FG002|Started Concurrent Chemo/Radiation|Step 1: Registration||0||
59838396|NCT00068692|75962592|FG003|Started Concurrent Chemo/Radiation|Step 1: Registration||0||
59838397|NCT00068692|75962593|FG004|Started Concurrent Chemo/Radiation|Step 1: Registration||0||
59838398|NCT00068692|75962594|FG005|Started Concurrent Chemo/Radiation|Step 1: Registration||0||
59838399|NCT00068692|75962595|FG006|Started Concurrent Chemo/Radiation|Step 1: Registration||0||
59838400|NCT00068692|75962596|FG007|Started Concurrent Chemo/Radiation|Step 1: Registration||0||
59838401|NCT00068692|75962589|FG000|Reported AE Data|Step 1: Registration||123||
59838402|NCT00068692|75962590|FG001|Reported AE Data|Step 1: Registration||0||
59838403|NCT00068692|75962591|FG002|Reported AE Data|Step 1: Registration||0||
59838404|NCT00068692|75962592|FG003|Reported AE Data|Step 1: Registration||0||
59838405|NCT00068692|75962593|FG004|Reported AE Data|Step 1: Registration||0||
59838406|NCT00068692|75962594|FG005|Reported AE Data|Step 1: Registration||0||
59838407|NCT00068692|75962595|FG006|Reported AE Data|Step 1: Registration||0||
59838408|NCT00068692|75962596|FG007|Reported AE Data|Step 1: Registration||0||
59838409|NCT00068692|75962589|FG000|COMPLETED|Step 1: Registration||88|Of the 88 patients completed step 1 treatment, 5 of them decided not to randomize to step 2|
59838410|NCT00068692|75962590|FG001|COMPLETED|Step 1: Registration|Case 32191 entered the study as Group II patient but was never randomized.|96|Of the 88 patients completed step 1 treatment, 5 of them decided not to randomize to step 2|
59838411|NCT00068692|75962591|FG002|COMPLETED|Step 1: Registration||0|Of the 88 patients completed step 1 treatment, 5 of them decided not to randomize to step 2|
59838412|NCT00068692|75962592|FG003|COMPLETED|Step 1: Registration||0|Of the 88 patients completed step 1 treatment, 5 of them decided not to randomize to step 2|
59838413|NCT00068692|75962593|FG004|COMPLETED|Step 1: Registration||0|Of the 88 patients completed step 1 treatment, 5 of them decided not to randomize to step 2|
59838414|NCT00068692|75962594|FG005|COMPLETED|Step 1: Registration||0|Of the 88 patients completed step 1 treatment, 5 of them decided not to randomize to step 2|
59838415|NCT00068692|75962595|FG006|COMPLETED|Step 1: Registration||0|Of the 88 patients completed step 1 treatment, 5 of them decided not to randomize to step 2|
59838416|NCT00068692|75962596|FG007|COMPLETED|Step 1: Registration||0|Of the 88 patients completed step 1 treatment, 5 of them decided not to randomize to step 2|
59838417|NCT00068692|75962589|FG000|NOT COMPLETED|Step 1: Registration||40||
59838418|NCT00068692|75962590|FG001|NOT COMPLETED|Step 1: Registration||1||
59838419|NCT00068692|75962591|FG002|NOT COMPLETED|Step 1: Registration||0||
59838420|NCT00068692|75962592|FG003|NOT COMPLETED|Step 1: Registration||0||
59838421|NCT00068692|75962593|FG004|NOT COMPLETED|Step 1: Registration||0||
59838422|NCT00068692|75962594|FG005|NOT COMPLETED|Step 1: Registration||0||
59838423|NCT00068692|75962595|FG006|NOT COMPLETED|Step 1: Registration||0||
59838424|NCT00068692|75962596|FG007|NOT COMPLETED|Step 1: Registration||0||
59838425|NCT00068692|75962589|FG000|STARTED|Step 2: Randomization|Patients on arm S completing step 1 treatment were randomized to step 2 (Arms I-III).|0|Randomization (arms I-III in both groups) was step 2.|
59838426|NCT00068692|75962590|FG001|STARTED|Step 2: Randomization|Group II patients were registered and randomized at the same time, reported as arms I,II,III here.|0|Randomization (arms I-III in both groups) was step 2.|
59996557|NCT02714569|76112510|FG007|NOT COMPLETED|Part A First Intervention||0||
59996558|NCT02714569|76112511|FG008|NOT COMPLETED|Part A First Intervention||0||
59838427|NCT00068692|75962591|FG002|STARTED|Step 2: Randomization|Of the 128 patients registered to step 1in group 1, 83 were randomized to step 2(arms I-III).|28|Randomization (arms I-III in both groups) was step 2.|
59838428|NCT00068692|75962592|FG003|STARTED|Step 2: Randomization|Of the 128 patients registered to step 1in group 1, 83 were randomized to step 2(arms I-III).|25|Randomization (arms I-III in both groups) was step 2.|
59838429|NCT00068692|75962593|FG004|STARTED|Step 2: Randomization|Of the 128 patients registered to step 1in group 1, 83 were randomized to step 2(arms I-III).|30|Randomization (arms I-III in both groups) was step 2.|
59838430|NCT00068692|75962594|FG005|STARTED|Step 2: Randomization|Group 2 patients were registered and randomized at the same time.|31|Randomization (arms I-III in both groups) was step 2.|
59838431|NCT00068692|75962595|FG006|STARTED|Step 2: Randomization|Group 2 patients were registered and randomized at the same time.|33|Randomization (arms I-III in both groups) was step 2.|
59838432|NCT00068692|75962596|FG007|STARTED|Step 2: Randomization|Group 2 patients were registered and randomized at the same time.|32|Randomization (arms I-III in both groups) was step 2.|
59838433|NCT00068692|75962589|FG000|Treated|Step 2: Randomization||0||
59838434|NCT00068692|75962590|FG001|Treated|Step 2: Randomization||0||
59838435|NCT00068692|75962591|FG002|Treated|Step 2: Randomization||27||
59838436|NCT00068692|75962592|FG003|Treated|Step 2: Randomization||25||
59838437|NCT00068692|75962593|FG004|Treated|Step 2: Randomization||29||
59838438|NCT00068692|75962594|FG005|Treated|Step 2: Randomization||31||
59838439|NCT00068692|75962595|FG006|Treated|Step 2: Randomization||33||
59838440|NCT00068692|75962596|FG007|Treated|Step 2: Randomization||32||
59838441|NCT00068692|75962589|FG000|Had Sphincter Preservation|Step 2: Randomization||0||
59838442|NCT00068692|75962590|FG001|Had Sphincter Preservation|Step 2: Randomization||0||
59838443|NCT00068692|75962591|FG002|Had Sphincter Preservation|Step 2: Randomization||28||
59838444|NCT00068692|75962592|FG003|Had Sphincter Preservation|Step 2: Randomization||25||
59838445|NCT00068692|75962593|FG004|Had Sphincter Preservation|Step 2: Randomization||28||
59838446|NCT00068692|75962594|FG005|Had Sphincter Preservation|Step 2: Randomization||31||
59838447|NCT00068692|75962595|FG006|Had Sphincter Preservation|Step 2: Randomization||33||
59838448|NCT00068692|75962596|FG007|Had Sphincter Preservation|Step 2: Randomization||30||
59838449|NCT00068692|75962589|FG000|Reported AE Data|Step 2: Randomization||0||
59838450|NCT00068692|75962590|FG001|Reported AE Data|Step 2: Randomization||0||
59838451|NCT00068692|75962591|FG002|Reported AE Data|Step 2: Randomization||27||
59838452|NCT00068692|75962592|FG003|Reported AE Data|Step 2: Randomization||22||
59838453|NCT00068692|75962593|FG004|Reported AE Data|Step 2: Randomization||28||
59838454|NCT00068692|75962594|FG005|Reported AE Data|Step 2: Randomization||31||
59838455|NCT00068692|75962595|FG006|Reported AE Data|Step 2: Randomization||33||
59838456|NCT00068692|75962596|FG007|Reported AE Data|Step 2: Randomization||32||
59838457|NCT00068692|75962589|FG000|COMPLETED|Step 2: Randomization||0||
59838458|NCT00068692|75962590|FG001|COMPLETED|Step 2: Randomization||0||
59838459|NCT00068692|75962591|FG002|COMPLETED|Step 2: Randomization||18||
59838460|NCT00068692|75962592|FG003|COMPLETED|Step 2: Randomization||13||
59838461|NCT00068692|75962593|FG004|COMPLETED|Step 2: Randomization||21||
59838462|NCT00068692|75962594|FG005|COMPLETED|Step 2: Randomization||25||
59838463|NCT00068692|75962595|FG006|COMPLETED|Step 2: Randomization||29||
59838464|NCT00068692|75962596|FG007|COMPLETED|Step 2: Randomization||24||
59838465|NCT00068692|75962589|FG000|NOT COMPLETED|Step 2: Randomization||0||
59838466|NCT00068692|75962590|FG001|NOT COMPLETED|Step 2: Randomization||0||
59838467|NCT00068692|75962591|FG002|NOT COMPLETED|Step 2: Randomization||10||
59838468|NCT00068692|75962592|FG003|NOT COMPLETED|Step 2: Randomization||12||
59838469|NCT00068692|75962593|FG004|NOT COMPLETED|Step 2: Randomization||9||
59838470|NCT00068692|75962594|FG005|NOT COMPLETED|Step 2: Randomization||6||
59838471|NCT00068692|75962595|FG006|NOT COMPLETED|Step 2: Randomization||4||
59838472|NCT00068692|75962596|FG007|NOT COMPLETED|Step 2: Randomization||8||
59838473|NCT00463151|75962613|FG000|STARTED|Overall Study||35||
59838474|NCT00463151|75962614|FG001|STARTED|Overall Study||29||
59838475|NCT00463151|75962615|FG002|STARTED|Overall Study||29||
59838476|NCT00463151|75962616|FG003|STARTED|Overall Study||31||
59838477|NCT00463151|75962613|FG000|COMPLETED|Overall Study||33||
59838478|NCT00463151|75962614|FG001|COMPLETED|Overall Study||24||
59838479|NCT00463151|75962615|FG002|COMPLETED|Overall Study||26||
59838480|NCT00463151|75962616|FG003|COMPLETED|Overall Study||24||
59838481|NCT00463151|75962613|FG000|NOT COMPLETED|Overall Study||2||
59838482|NCT00463151|75962614|FG001|NOT COMPLETED|Overall Study||5||
59838483|NCT00463151|75962615|FG002|NOT COMPLETED|Overall Study||3||
59838484|NCT00463151|75962616|FG003|NOT COMPLETED|Overall Study||7||
59838485|NCT00068380|75962626|FG000|STARTED|Overall Study||17||
59838486|NCT00068380|75962626|FG000|COMPLETED|Overall Study||12||
59838487|NCT00068380|75962626|FG000|NOT COMPLETED|Overall Study||5||
59838488|NCT00067990|75962632|FG000|STARTED|Overall Study||77||
59838489|NCT00067990|75962633|FG001|STARTED|Overall Study||76||
59838490|NCT00067990|75962632|FG000|COMPLETED|Overall Study||67||
59838491|NCT00067990|75962633|FG001|COMPLETED|Overall Study||54||
59838492|NCT00067990|75962632|FG000|NOT COMPLETED|Overall Study||10||
59838493|NCT00067990|75962633|FG001|NOT COMPLETED|Overall Study||22||
59838494|NCT00090220|75962641|FG000|STARTED|Base Study Vaccination Period||1911||
59838495|NCT00090220|75962642|FG001|STARTED|Base Study Vaccination Period||1908||
59838496|NCT00090220|75962643|FG002|STARTED|Base Study Vaccination Period||0||
59838497|NCT00090220|75962644|FG003|STARTED|Base Study Vaccination Period||0||
59838498|NCT00090220|75962645|FG004|STARTED|Base Study Vaccination Period||0||
59838499|NCT00090220|75962646|FG005|STARTED|Base Study Vaccination Period||0||
59838500|NCT00090220|75962641|FG000|Vaccinated|Base Study Vaccination Period||1910||
59838501|NCT00090220|75962642|FG001|Vaccinated|Base Study Vaccination Period||1907||
59838502|NCT00090220|75962643|FG002|Vaccinated|Base Study Vaccination Period||0||
59838503|NCT00090220|75962644|FG003|Vaccinated|Base Study Vaccination Period||0||
59838504|NCT00090220|75962645|FG004|Vaccinated|Base Study Vaccination Period||0||
59838505|NCT00090220|75962646|FG005|Vaccinated|Base Study Vaccination Period||0||
59838506|NCT00090220|75962641|FG000|COMPLETED|Base Study Vaccination Period||1847||
59838507|NCT00090220|75962642|FG001|COMPLETED|Base Study Vaccination Period||1845||
59838508|NCT00090220|75962643|FG002|COMPLETED|Base Study Vaccination Period||0||
59838509|NCT00090220|75962644|FG003|COMPLETED|Base Study Vaccination Period||0||
59838510|NCT00090220|75962645|FG004|COMPLETED|Base Study Vaccination Period||0||
59838511|NCT00090220|75962646|FG005|COMPLETED|Base Study Vaccination Period||0||
59838512|NCT00090220|75962641|FG000|NOT COMPLETED|Base Study Vaccination Period||64||
59838513|NCT00090220|75962642|FG001|NOT COMPLETED|Base Study Vaccination Period||63||
59838514|NCT00090220|75962643|FG002|NOT COMPLETED|Base Study Vaccination Period||0||
59838515|NCT00090220|75962644|FG003|NOT COMPLETED|Base Study Vaccination Period||0||
59838516|NCT00090220|75962645|FG004|NOT COMPLETED|Base Study Vaccination Period||0||
59838517|NCT00090220|75962646|FG005|NOT COMPLETED|Base Study Vaccination Period||0||
59838518|NCT00090220|75962641|FG000|STARTED|Base Study Follow-up Period|8 participants did not complete the Vaccination Period but entered the Follow-up Period.|1855||
59838519|NCT00090220|75962642|FG001|STARTED|Base Study Follow-up Period|5 participants did not complete the Vaccination Period but entered the Follow-up Period.|1851||
59838520|NCT00090220|75962643|FG002|STARTED|Base Study Follow-up Period||0||
59838521|NCT00090220|75962644|FG003|STARTED|Base Study Follow-up Period||0||
59838522|NCT00090220|75962645|FG004|STARTED|Base Study Follow-up Period||0||
59838523|NCT00090220|75962646|FG005|STARTED|Base Study Follow-up Period||0||
59838524|NCT00090220|75962641|FG000|COMPLETED|Base Study Follow-up Period||1695||
59838525|NCT00090220|75962642|FG001|COMPLETED|Base Study Follow-up Period||1687||
59838526|NCT00090220|75962643|FG002|COMPLETED|Base Study Follow-up Period||0||
59838527|NCT00090220|75962644|FG003|COMPLETED|Base Study Follow-up Period||0||
59838528|NCT00090220|75962645|FG004|COMPLETED|Base Study Follow-up Period||0||
59838529|NCT00090220|75962646|FG005|COMPLETED|Base Study Follow-up Period||0||
59838530|NCT00090220|75962641|FG000|NOT COMPLETED|Base Study Follow-up Period||160||
59838531|NCT00090220|75962642|FG001|NOT COMPLETED|Base Study Follow-up Period||164||
59838532|NCT00090220|75962643|FG002|NOT COMPLETED|Base Study Follow-up Period||0||
59838533|NCT00090220|75962644|FG003|NOT COMPLETED|Base Study Follow-up Period||0||
59838534|NCT00090220|75962645|FG004|NOT COMPLETED|Base Study Follow-up Period||0||
59838535|NCT00090220|75962646|FG005|NOT COMPLETED|Base Study Follow-up Period||0||
59838536|NCT00090220|75962641|FG000|STARTED|Extension 1 (EXT1)||0||
59838537|NCT00090220|75962642|FG001|STARTED|Extension 1 (EXT1)||0||
59838538|NCT00090220|75962643|FG002|STARTED|Extension 1 (EXT1)|Participation in EXT1 was voluntary; not all participants eligible for EXT1 enrolled.|1322||
60119425|NCT02530528|76240642|FG000|COMPLETED|Overall Study|13 participants received CHG Cloth|12|27 were treated with both interventions, though interventions differ with application time. 24 subjects completed with passing treatment baseline values.|12
60119426|NCT02530528|76240643|FG001|COMPLETED|Overall Study||12|27 were treated with both interventions, though interventions differ with application time. 24 subjects completed with passing treatment baseline values.|12
59838539|NCT00090220|75962644|FG003|STARTED|Extension 1 (EXT1)|Participation in EXT1 was voluntary; not all participants eligible for EXT1 enrolled.|7||
59838540|NCT00090220|75962645|FG004|STARTED|Extension 1 (EXT1)||0||
59838541|NCT00090220|75962646|FG005|STARTED|Extension 1 (EXT1)||0||
59838542|NCT00090220|75962641|FG000|Vaccinated|Extension 1 (EXT1)||0||
59838543|NCT00090220|75962642|FG001|Vaccinated|Extension 1 (EXT1)||0||
59838544|NCT00090220|75962643|FG002|Vaccinated|Extension 1 (EXT1)||1321||
59838545|NCT00090220|75962644|FG003|Vaccinated|Extension 1 (EXT1)||7||
59838546|NCT00090220|75962645|FG004|Vaccinated|Extension 1 (EXT1)||0||
59838547|NCT00090220|75962646|FG005|Vaccinated|Extension 1 (EXT1)||0||
59838548|NCT00090220|75962641|FG000|COMPLETED|Extension 1 (EXT1)||0||
59838549|NCT00090220|75962642|FG001|COMPLETED|Extension 1 (EXT1)||0||
59838550|NCT00090220|75962643|FG002|COMPLETED|Extension 1 (EXT1)||1267||
59838551|NCT00090220|75962644|FG003|COMPLETED|Extension 1 (EXT1)||5||
59838552|NCT00090220|75962645|FG004|COMPLETED|Extension 1 (EXT1)||0||
59838553|NCT00090220|75962646|FG005|COMPLETED|Extension 1 (EXT1)||0||
59838554|NCT00090220|75962641|FG000|NOT COMPLETED|Extension 1 (EXT1)||0||
59838555|NCT00090220|75962642|FG001|NOT COMPLETED|Extension 1 (EXT1)||0||
59838556|NCT00090220|75962643|FG002|NOT COMPLETED|Extension 1 (EXT1)||55||
59838557|NCT00090220|75962644|FG003|NOT COMPLETED|Extension 1 (EXT1)||2||
59838558|NCT00090220|75962645|FG004|NOT COMPLETED|Extension 1 (EXT1)||0||
59838559|NCT00090220|75962646|FG005|NOT COMPLETED|Extension 1 (EXT1)||0||
59838560|NCT00090220|75962641|FG000|STARTED|Long-term Follow-up (EXT2)||0||
59838561|NCT00090220|75962642|FG001|STARTED|Long-term Follow-up (EXT2)||0||
59838562|NCT00090220|75962643|FG002|STARTED|Long-term Follow-up (EXT2)||0||
59838563|NCT00090220|75962644|FG003|STARTED|Long-term Follow-up (EXT2)||0||
59838564|NCT00090220|75962645|FG004|STARTED|Long-term Follow-up (EXT2)|Participation in LTFU was voluntary; not all participants eligible for LTFU enrolled.|685||
59838565|NCT00090220|75962646|FG005|STARTED|Long-term Follow-up (EXT2)|Participation in LTFU was voluntary; not all participants eligible for LTFU enrolled.|651||
59838566|NCT00090220|75962641|FG000|COMPLETED|Long-term Follow-up (EXT2)||0||
59838567|NCT00090220|75962642|FG001|COMPLETED|Long-term Follow-up (EXT2)||0||
59838568|NCT00090220|75962643|FG002|COMPLETED|Long-term Follow-up (EXT2)||0||
59838569|NCT00090220|75962644|FG003|COMPLETED|Long-term Follow-up (EXT2)||0||
59838570|NCT00090220|75962645|FG004|COMPLETED|Long-term Follow-up (EXT2)||641||
59838571|NCT00090220|75962646|FG005|COMPLETED|Long-term Follow-up (EXT2)||623||
59838572|NCT00090220|75962641|FG000|NOT COMPLETED|Long-term Follow-up (EXT2)||0||
59838573|NCT00090220|75962642|FG001|NOT COMPLETED|Long-term Follow-up (EXT2)||0||
59838574|NCT00090220|75962643|FG002|NOT COMPLETED|Long-term Follow-up (EXT2)||0||
59838575|NCT00090220|75962644|FG003|NOT COMPLETED|Long-term Follow-up (EXT2)||0||
59838576|NCT00090220|75962645|FG004|NOT COMPLETED|Long-term Follow-up (EXT2)||44||
59838577|NCT00090220|75962646|FG005|NOT COMPLETED|Long-term Follow-up (EXT2)||28||
59838578|NCT00263328|75962666|FG000|STARTED|Overall Study||18||
59838579|NCT00263328|75962667|FG001|STARTED|Overall Study||14||
59838580|NCT00263328|75962668|FG002|STARTED|Overall Study||13||
59838581|NCT00263328|75962666|FG000|COMPLETED|Overall Study||10||
59838582|NCT00263328|75962667|FG001|COMPLETED|Overall Study||12||
59838583|NCT00263328|75962668|FG002|COMPLETED|Overall Study||6||
59838584|NCT00263328|75962666|FG000|NOT COMPLETED|Overall Study||8||
59838585|NCT00263328|75962667|FG001|NOT COMPLETED|Overall Study||2||
59838586|NCT00263328|75962668|FG002|NOT COMPLETED|Overall Study||7||
59838587|NCT00262860|75962678|FG000|STARTED|Overall Study||18||
59838588|NCT00262860|75962678|FG000|COMPLETED|Overall Study||16||
59838589|NCT00262860|75962678|FG000|NOT COMPLETED|Overall Study||2||
59838590|NCT00236184|75962684|FG000|STARTED|Overall Study||310||
59838591|NCT00236184|75962685|FG001|STARTED|Overall Study||319||
59838592|NCT00236184|75962684|FG000|COMPLETED|Overall Study||292||
59838593|NCT00236184|75962685|FG001|COMPLETED|Overall Study||308||
59838594|NCT00236184|75962684|FG000|NOT COMPLETED|Overall Study||18||
59838595|NCT00236184|75962685|FG001|NOT COMPLETED|Overall Study||11||
59838596|NCT00296504|75962699|FG000|STARTED|Interim Analysis||119||
59838597|NCT00296504|75962700|FG001|STARTED|Interim Analysis||18||
59838598|NCT00296504|75962701|FG002|STARTED|Interim Analysis||221||
59838599|NCT00296504|75962702|FG003|STARTED|Interim Analysis||54||
59838600|NCT00296504|75962703|FG004|STARTED|Interim Analysis||73||
59838601|NCT00296504|75962704|FG005|STARTED|Interim Analysis||78||
59838602|NCT00296504|75962705|FG006|STARTED|Interim Analysis||104||
59838603|NCT00296504|75962706|FG007|STARTED|Interim Analysis||86||
59838604|NCT00296504|75962707|FG008|STARTED|Interim Analysis||0||
59838605|NCT00296504|75962699|FG000|Ongoing|Interim Analysis||32||
59838606|NCT00296504|75962700|FG001|Ongoing|Interim Analysis||12||
59567624|NCT02326272|75670467|FG014|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0||
59838607|NCT00296504|75962701|FG002|Ongoing|Interim Analysis||16||
59838608|NCT00296504|75962702|FG003|Ongoing|Interim Analysis||22||
59838609|NCT00296504|75962703|FG004|Ongoing|Interim Analysis||0||
59838610|NCT00296504|75962704|FG005|Ongoing|Interim Analysis||0||
59838611|NCT00296504|75962705|FG006|Ongoing|Interim Analysis||30||
59838612|NCT00296504|75962706|FG007|Ongoing|Interim Analysis||1||
59838613|NCT00296504|75962707|FG008|Ongoing|Interim Analysis||0||
59838614|NCT00296504|75962699|FG000|COMPLETED|Interim Analysis||43||
59838615|NCT00296504|75962700|FG001|COMPLETED|Interim Analysis||0||
59838616|NCT00296504|75962701|FG002|COMPLETED|Interim Analysis||116||
59838617|NCT00296504|75962702|FG003|COMPLETED|Interim Analysis||11||
59838618|NCT00296504|75962703|FG004|COMPLETED|Interim Analysis||36||
59838619|NCT00296504|75962704|FG005|COMPLETED|Interim Analysis||41||
59838620|NCT00296504|75962705|FG006|COMPLETED|Interim Analysis||30||
59838621|NCT00296504|75962706|FG007|COMPLETED|Interim Analysis||37||
59838622|NCT00296504|75962707|FG008|COMPLETED|Interim Analysis||0||
59838623|NCT00296504|75962699|FG000|NOT COMPLETED|Interim Analysis||76||
59838624|NCT00296504|75962700|FG001|NOT COMPLETED|Interim Analysis||18||
59838625|NCT00296504|75962701|FG002|NOT COMPLETED|Interim Analysis||105||
59838626|NCT00296504|75962702|FG003|NOT COMPLETED|Interim Analysis||43||
59838627|NCT00296504|75962703|FG004|NOT COMPLETED|Interim Analysis||37||
59838628|NCT00296504|75962704|FG005|NOT COMPLETED|Interim Analysis||37||
59838629|NCT00296504|75962705|FG006|NOT COMPLETED|Interim Analysis||74||
59838630|NCT00296504|75962706|FG007|NOT COMPLETED|Interim Analysis||49||
59838631|NCT00296504|75962707|FG008|NOT COMPLETED|Interim Analysis||0||
59838632|NCT00296504|75962699|FG000|STARTED|Final Analysis||0||
59838633|NCT00296504|75962700|FG001|STARTED|Final Analysis||0||
59838634|NCT00296504|75962701|FG002|STARTED|Final Analysis||0||
59838635|NCT00296504|75962702|FG003|STARTED|Final Analysis||0||
59838636|NCT00296504|75962703|FG004|STARTED|Final Analysis||0||
59838637|NCT00296504|75962704|FG005|STARTED|Final Analysis||0||
59838638|NCT00296504|75962705|FG006|STARTED|Final Analysis||0||
59838639|NCT00296504|75962706|FG007|STARTED|Final Analysis||0||
59838640|NCT00296504|75962707|FG008|STARTED|Final Analysis|Continued in study; commercial supplies of FPV were unavailable locally at end of Interim Analysis.|111||
59838641|NCT00296504|75962699|FG000|COMPLETED|Final Analysis||0||
59838642|NCT00296504|75962700|FG001|COMPLETED|Final Analysis||0||
59838643|NCT00296504|75962701|FG002|COMPLETED|Final Analysis||0||
59838644|NCT00296504|75962702|FG003|COMPLETED|Final Analysis||0||
59838645|NCT00296504|75962703|FG004|COMPLETED|Final Analysis||0||
59838646|NCT00296504|75962704|FG005|COMPLETED|Final Analysis||0||
59838647|NCT00296504|75962705|FG006|COMPLETED|Final Analysis||0||
59838648|NCT00296504|75962706|FG007|COMPLETED|Final Analysis||0||
59838649|NCT00296504|75962707|FG008|COMPLETED|Final Analysis||90||
59838650|NCT00296504|75962699|FG000|NOT COMPLETED|Final Analysis||0||
59838651|NCT00296504|75962700|FG001|NOT COMPLETED|Final Analysis||0||
59838652|NCT00296504|75962701|FG002|NOT COMPLETED|Final Analysis||0||
59838653|NCT00296504|75962702|FG003|NOT COMPLETED|Final Analysis||0||
59838654|NCT00296504|75962703|FG004|NOT COMPLETED|Final Analysis||0||
59838655|NCT00296504|75962704|FG005|NOT COMPLETED|Final Analysis||0||
59838656|NCT00296504|75962705|FG006|NOT COMPLETED|Final Analysis||0||
59838657|NCT00296504|75962706|FG007|NOT COMPLETED|Final Analysis||0||
59838658|NCT00296504|75962707|FG008|NOT COMPLETED|Final Analysis||21||
59838659|NCT00313820|75962734|FG000|STARTED|Assigned to Treatment||111||
59838660|NCT00313820|75962735|FG001|STARTED|Assigned to Treatment||109||
59838661|NCT00313820|75962734|FG000|COMPLETED|Assigned to Treatment||110||
59838662|NCT00313820|75962735|FG001|COMPLETED|Assigned to Treatment||109||
59838663|NCT00313820|75962734|FG000|NOT COMPLETED|Assigned to Treatment||1||
59838664|NCT00313820|75962735|FG001|NOT COMPLETED|Assigned to Treatment||0||
59838665|NCT00313820|75962734|FG000|STARTED|Pregabalin or Placebo Treatment Period||110||
59838666|NCT00313820|75962735|FG001|STARTED|Pregabalin or Placebo Treatment Period||109||
59838667|NCT00313820|75962734|FG000|COMPLETED|Pregabalin or Placebo Treatment Period||93||
59838668|NCT00313820|75962735|FG001|COMPLETED|Pregabalin or Placebo Treatment Period||90||
59838669|NCT00313820|75962734|FG000|NOT COMPLETED|Pregabalin or Placebo Treatment Period||17||
59838670|NCT00313820|75962735|FG001|NOT COMPLETED|Pregabalin or Placebo Treatment Period||19||
59838671|NCT00462761|75962741|FG000|STARTED|Overall Study||76||
59838672|NCT00462761|75962741|FG000|COMPLETED|Overall Study||0||
59838673|NCT00462761|75962741|FG000|NOT COMPLETED|Overall Study||76||
59838674|NCT00235872|75962773|FG000|STARTED|Overall Study||309||
59838675|NCT00235872|75962773|FG000|COMPLETED|Overall Study||162||
59838676|NCT00235872|75962773|FG000|NOT COMPLETED|Overall Study||147||
59838677|NCT00461981|75962779|FG000|STARTED|Overall Study||50||
59838678|NCT00461981|75962780|FG001|STARTED|Overall Study||51||
59838679|NCT00461981|75962779|FG000|COMPLETED|Overall Study||39||
59838680|NCT00461981|75962780|FG001|COMPLETED|Overall Study||42||
59838681|NCT00461981|75962779|FG000|NOT COMPLETED|Overall Study||11||
59838682|NCT00461981|75962780|FG001|NOT COMPLETED|Overall Study||9||
59838683|NCT00296036|75962788|FG000|STARTED|Overall Study||19||
59838684|NCT00296036|75962789|FG001|STARTED|Overall Study||18||
59567625|NCT02326272|75670453|FG000|STARTED|Open-label Period (Week 48 to Week 144)||0||
59838685|NCT00296036|75962790|FG002|STARTED|Overall Study||18||
59838686|NCT00296036|75962791|FG003|STARTED|Overall Study||17||
59838687|NCT00296036|75962792|FG004|STARTED|Overall Study||33||
59838688|NCT00296036|75962793|FG005|STARTED|Overall Study||32||
59838689|NCT00296036|75962788|FG000|COMPLETED|Overall Study||18||
59838690|NCT00296036|75962789|FG001|COMPLETED|Overall Study||18||
59838691|NCT00296036|75962790|FG002|COMPLETED|Overall Study||16||
59838692|NCT00296036|75962791|FG003|COMPLETED|Overall Study||16||
59838693|NCT00296036|75962792|FG004|COMPLETED|Overall Study||31||
59838694|NCT00296036|75962793|FG005|COMPLETED|Overall Study||28||
59838695|NCT00296036|75962788|FG000|NOT COMPLETED|Overall Study||1||
59838696|NCT00296036|75962789|FG001|NOT COMPLETED|Overall Study||0||
59838697|NCT00296036|75962790|FG002|NOT COMPLETED|Overall Study||2||
59838698|NCT00296036|75962791|FG003|NOT COMPLETED|Overall Study||1||
59838699|NCT00296036|75962792|FG004|NOT COMPLETED|Overall Study||2||
59838700|NCT00296036|75962793|FG005|NOT COMPLETED|Overall Study||4||
59838701|NCT00089674|75962812|FG000|STARTED|Overall Study||734||
59838702|NCT00089674|75962813|FG001|STARTED|Overall Study||734||
59838703|NCT00089674|75962812|FG000|Received Study Drug|Overall Study||730||
59838704|NCT00089674|75962813|FG001|Received Study Drug|Overall Study||726||
59838705|NCT00089674|75962812|FG000|COMPLETED|Overall Study||445||
59838706|NCT00089674|75962813|FG001|COMPLETED|Overall Study||467||
59838707|NCT00089674|75962812|FG000|NOT COMPLETED|Overall Study||289||
59838708|NCT00089674|75962813|FG001|NOT COMPLETED|Overall Study||267||
59838709|NCT00313586|75962823|FG000|STARTED|Overall Study||75||
59838710|NCT00313586|75962824|FG001|STARTED|Overall Study||75||
59838711|NCT00313586|75962825|FG002|STARTED|Overall Study||24||
59838712|NCT00313586|75962826|FG003|STARTED|Overall Study||23||
59838713|NCT00313586|75962823|FG000|Treated|Overall Study||74||
59838714|NCT00313586|75962824|FG001|Treated|Overall Study||75||
59838715|NCT00313586|75962825|FG002|Treated|Overall Study||24||
59838716|NCT00313586|75962826|FG003|Treated|Overall Study||23||
59838717|NCT00313586|75962823|FG000|COMPLETED|Overall Study||5||
59838718|NCT00313586|75962824|FG001|COMPLETED|Overall Study||5||
59838719|NCT00313586|75962825|FG002|COMPLETED|Overall Study||0||
59838720|NCT00313586|75962826|FG003|COMPLETED|Overall Study||0||
59838721|NCT00313586|75962823|FG000|NOT COMPLETED|Overall Study||70||
59838722|NCT00313586|75962824|FG001|NOT COMPLETED|Overall Study||70||
59838723|NCT00313586|75962825|FG002|NOT COMPLETED|Overall Study||24||
59838724|NCT00313586|75962826|FG003|NOT COMPLETED|Overall Study||23||
59838725|NCT00312572|75962836|FG000|STARTED|Overall Study||101||
59838726|NCT00312572|75962837|FG001|STARTED|Overall Study||103||
59838727|NCT00312572|75962836|FG000|COMPLETED|Overall Study||85||
59838728|NCT00312572|75962837|FG001|COMPLETED|Overall Study||82||
59838729|NCT00312572|75962836|FG000|NOT COMPLETED|Overall Study||16||
59838730|NCT00312572|75962837|FG001|NOT COMPLETED|Overall Study||21||
59838731|NCT00290888|75962847|FG000|STARTED|Overall Study||41||
59838732|NCT00290888|75962848|FG001|STARTED|Overall Study||45||
59838733|NCT00290888|75962847|FG000|COMPLETED|Overall Study||38||
59838734|NCT00290888|75962848|FG001|COMPLETED|Overall Study||44||
59838735|NCT00290888|75962847|FG000|NOT COMPLETED|Overall Study||3||
59838736|NCT00290888|75962848|FG001|NOT COMPLETED|Overall Study||1||
59838737|NCT00290732|75962857|FG000|STARTED|Overall Study||3||
59838738|NCT00290732|75962858|FG001|STARTED|Overall Study||4||
59838739|NCT00290732|75962859|FG002|STARTED|Overall Study||4||
59838740|NCT00290732|75962860|FG003|STARTED|Overall Study||6||
59838741|NCT00290732|75962861|FG004|STARTED|Overall Study||3||
59838742|NCT00290732|75962857|FG000|COMPLETED|Overall Study||3||
59838743|NCT00290732|75962858|FG001|COMPLETED|Overall Study||3||
59838744|NCT00290732|75962859|FG002|COMPLETED|Overall Study||3||
59838745|NCT00290732|75962860|FG003|COMPLETED|Overall Study||6||
59838746|NCT00290732|75962861|FG004|COMPLETED|Overall Study||3||
59838747|NCT00290732|75962857|FG000|NOT COMPLETED|Overall Study||0||
59838748|NCT00290732|75962858|FG001|NOT COMPLETED|Overall Study||1||
59838749|NCT00290732|75962859|FG002|NOT COMPLETED|Overall Study||1||
59838750|NCT00290732|75962860|FG003|NOT COMPLETED|Overall Study||0||
59838751|NCT00290732|75962861|FG004|NOT COMPLETED|Overall Study||0||
59838752|NCT00312494|75962877|FG000|STARTED|Overall Study||232||
59838753|NCT00312494|75962878|FG001|STARTED|Overall Study||226||
59838754|NCT00312494|75962879|FG002|STARTED|Overall Study||222||
59838755|NCT00312494|75962877|FG000|Received Study Treatment|Overall Study|1 subject randomized to higher dose; received lower dose at baseline, higher dose weeks 1 and 2.|223||
59838756|NCT00312494|75962878|FG001|Received Study Treatment|Overall Study||216||
59838757|NCT00312494|75962879|FG002|Received Study Treatment|Overall Study||217||
59838758|NCT00312494|75962877|FG000|COMPLETED|Overall Study|1 subject randomized to higher dose; received lower dose baseline and/or week 1; higher dose week 2.|161||
59838759|NCT00312494|75962878|FG001|COMPLETED|Overall Study||168||
59838760|NCT00312494|75962879|FG002|COMPLETED|Overall Study||179||
59838761|NCT00312494|75962877|FG000|NOT COMPLETED|Overall Study||71||
59838762|NCT00312494|75962878|FG001|NOT COMPLETED|Overall Study||58||
59838763|NCT00312494|75962879|FG002|NOT COMPLETED|Overall Study||43||
59838764|NCT00312338|75962889|FG000|STARTED|Overall Study||105||
59838765|NCT00312338|75962890|FG001|STARTED|Overall Study||57||
59838766|NCT00312338|75962889|FG000|COMPLETED|Overall Study||83||
59838767|NCT00312338|75962890|FG001|COMPLETED|Overall Study||54||
59838768|NCT00312338|75962889|FG000|NOT COMPLETED|Overall Study||22||
59838769|NCT00312338|75962890|FG001|NOT COMPLETED|Overall Study||3||
59838770|NCT00290498|75962898|FG000|STARTED|Overall Study||49||
59838771|NCT00290498|75962899|FG001|STARTED|Overall Study||10||
59838772|NCT00290498|75962898|FG000|COMPLETED|Overall Study||41||
59838773|NCT00290498|75962899|FG001|COMPLETED|Overall Study||10||
59838774|NCT00290498|75962898|FG000|NOT COMPLETED|Overall Study||8||
59838775|NCT00290498|75962899|FG001|NOT COMPLETED|Overall Study||0||
59838776|NCT00451451|75962910|FG000|STARTED|Overall Study|363 participants were dosed; 363 participants were randomized|363||
59838777|NCT00451451|75962911|FG001|STARTED|Overall Study|359 participants were dosed; 362 participants were randomized|359||
59838778|NCT00451451|75962912|FG002|STARTED|Overall Study|345 participants were dosed; 345 participants were randomized|345||
59838779|NCT00451451|75962913|FG003|STARTED|Overall Study|350 participants were dosed; 360 participants were randomized|350||
59838780|NCT00451451|75962910|FG000|COMPLETED|Overall Study||278||
59838781|NCT00451451|75962911|FG001|COMPLETED|Overall Study||284||
59838782|NCT00451451|75962912|FG002|COMPLETED|Overall Study||273||
59838783|NCT00451451|75962913|FG003|COMPLETED|Overall Study||292||
59838784|NCT00451451|75962910|FG000|NOT COMPLETED|Overall Study||85||
59838785|NCT00451451|75962911|FG001|NOT COMPLETED|Overall Study||75||
59838786|NCT00451451|75962912|FG002|NOT COMPLETED|Overall Study||72||
60119427|NCT02530528|76240644|FG002|COMPLETED|Overall Study|14 participants received CHG cloth|12|27 were treated with both interventions, though interventions differ with application time. 24 subjects completed with passing treatment baseline values.|12
60119428|NCT02530528|76240645|FG003|COMPLETED|Overall Study||12|27 were treated with both interventions, though interventions differ with application time. 24 subjects completed with passing treatment baseline values.|12
60119429|NCT02530528|76240646|FG004|COMPLETED|Overall Study|13 participants received CHG cloth|12|27 were treated with both interventions, though interventions differ with application time. 24 subjects completed with passing treatment baseline values.|12
60119430|NCT02530528|76240647|FG005|COMPLETED|Overall Study||12|27 were treated with both interventions, though interventions differ with application time. 24 subjects completed with passing treatment baseline values.|12
59567626|NCT02326272|75670454|FG001|STARTED|Open-label Period (Week 48 to Week 144)||0||
59567627|NCT02326272|75670455|FG002|STARTED|Open-label Period (Week 48 to Week 144)||0||
59567628|NCT02326272|75670456|FG003|STARTED|Open-label Period (Week 48 to Week 144)||0||
59567629|NCT02326272|75670457|FG004|STARTED|Open-label Period (Week 48 to Week 144)||0||
59567630|NCT02326272|75670458|FG005|STARTED|Open-label Period (Week 48 to Week 144)||0||
59567631|NCT02326272|75670459|FG006|STARTED|Open-label Period (Week 48 to Week 144)||0||
59567632|NCT02326272|75670460|FG007|STARTED|Open-label Period (Week 48 to Week 144)||0||
59838787|NCT00451451|75962913|FG003|NOT COMPLETED|Overall Study||58||
59838788|NCT03824912|75962928|FG000|STARTED|Overall Study||332||
59838789|NCT03824912|75962929|FG001|STARTED|Overall Study||335||
59838790|NCT03824912|75962930|FG002|STARTED|Overall Study||164||
59838791|NCT03824912|75962928|FG000|COMPLETED|Overall Study||192||
59838792|NCT03824912|75962929|FG001|COMPLETED|Overall Study||201||
59838793|NCT03824912|75962930|FG002|COMPLETED|Overall Study||96||
59838794|NCT03824912|75962928|FG000|NOT COMPLETED|Overall Study||140||
59838795|NCT03824912|75962929|FG001|NOT COMPLETED|Overall Study||134||
59838796|NCT03824912|75962930|FG002|NOT COMPLETED|Overall Study||68||
59838797|NCT00461123|75962940|FG000|STARTED|Overall Study||25||
59838798|NCT00461123|75962941|FG001|STARTED|Overall Study||25||
59838799|NCT00461123|75962940|FG000|COMPLETED|Overall Study||19||
59838800|NCT00461123|75962941|FG001|COMPLETED|Overall Study||19||
59838801|NCT00461123|75962940|FG000|NOT COMPLETED|Overall Study||6||
59567633|NCT02326272|75670461|FG008|STARTED|Open-label Period (Week 48 to Week 144)||0||
59838802|NCT00461123|75962941|FG001|NOT COMPLETED|Overall Study||6||
59838803|NCT00290342|75962949|FG000|STARTED|Overall Study||224||
59838804|NCT00290342|75962950|FG001|STARTED|Overall Study||228||
59838805|NCT00290342|75962949|FG000|COMPLETED|Overall Study||217||
59838806|NCT00290342|75962950|FG001|COMPLETED|Overall Study||223||
59567634|NCT02326272|75670462|FG009|STARTED|Open-label Period (Week 48 to Week 144)||0||
59838807|NCT00290342|75962949|FG000|NOT COMPLETED|Overall Study||7||
59838808|NCT00290342|75962950|FG001|NOT COMPLETED|Overall Study||5||
59838809|NCT00460811|75962961|FG000|STARTED|Overall Study||79||
59838810|NCT00460811|75962962|FG001|STARTED|Overall Study||82||
59838811|NCT00460811|75962963|FG002|STARTED|Overall Study||85||
59838812|NCT00460811|75962964|FG003|STARTED|Overall Study||89||
59838813|NCT00460811|75962965|FG004|STARTED|Overall Study||85||
59838814|NCT00460811|75962961|FG000|COMPLETED|Overall Study||63||
59838815|NCT00460811|75962962|FG001|COMPLETED|Overall Study||67||
59838816|NCT00460811|75962963|FG002|COMPLETED|Overall Study||71||
59838817|NCT00460811|75962964|FG003|COMPLETED|Overall Study||71||
59838818|NCT00460811|75962965|FG004|COMPLETED|Overall Study||65||
59838819|NCT00460811|75962961|FG000|NOT COMPLETED|Overall Study||16||
59838820|NCT00460811|75962962|FG001|NOT COMPLETED|Overall Study||15||
59838821|NCT00460811|75962963|FG002|NOT COMPLETED|Overall Study||14||
59838822|NCT00460811|75962964|FG003|NOT COMPLETED|Overall Study||18||
59838823|NCT00460811|75962965|FG004|NOT COMPLETED|Overall Study||20||
59838824|NCT00290186|75962984|FG000|STARTED|Overall Study||25||
59838825|NCT00290186|75962985|FG001|STARTED|Overall Study||24||
59838826|NCT00290186|75962984|FG000|Completed Baseline Assessments|Overall Study||25||
59838827|NCT00290186|75962985|FG001|Completed Baseline Assessments|Overall Study||24||
59838828|NCT00290186|75962984|FG000|Completed 8 Weeks of Treatment|Overall Study||24||
59838829|NCT00290186|75962985|FG001|Completed 8 Weeks of Treatment|Overall Study||22||
60119431|NCT02530528|76240648|FG006|COMPLETED|Overall Study|14 participants received comparator CHG.|12|27 were treated with both interventions, though interventions differ with application time. 24 subjects completed with passing treatment baseline values.|12
60119432|NCT02530528|76240649|FG007|COMPLETED|Overall Study||12|27 were treated with both interventions, though interventions differ with application time. 24 subjects completed with passing treatment baseline values.|12
60119433|NCT02530528|76240642|FG000|NOT COMPLETED|Overall Study||1||1
60119434|NCT02530528|76240643|FG001|NOT COMPLETED|Overall Study||1||1
60119435|NCT02530528|76240644|FG002|NOT COMPLETED|Overall Study||2||2
59718399|NCT01214642|75837677|FG006|STARTED|Overall Study||6||
59718400|NCT01214642|75837678|FG007|STARTED|Overall Study||3||
59718401|NCT01214642|75837679|FG008|STARTED|Overall Study|All participants who received 12 mg/m2/day on Days 1 and 5 plus PEG in Part A and Part B.|13||
59718402|NCT01214642|75837680|FG009|STARTED|Overall Study||4||
59718403|NCT01214642|75837681|FG010|STARTED|Overall Study||4||
59718404|NCT01214642|75837682|FG011|STARTED|Overall Study||6||
59718405|NCT01214642|75837671|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3||
59718406|NCT01214642|75837672|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3||
59718407|NCT01214642|75837673|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6||
59718408|NCT01214642|75837674|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6||
59718409|NCT01214642|75837675|FG004|Received at Least 1 Dose of Study Drug|Overall Study||6||
59718410|NCT01214642|75837676|FG005|Received at Least 1 Dose of Study Drug|Overall Study||3||
59718411|NCT01214642|75837677|FG006|Received at Least 1 Dose of Study Drug|Overall Study||6||
59718412|NCT01214642|75837678|FG007|Received at Least 1 Dose of Study Drug|Overall Study||3||
59718413|NCT01214642|75837679|FG008|Received at Least 1 Dose of Study Drug|Overall Study||13||
59718414|NCT01214642|75837680|FG009|Received at Least 1 Dose of Study Drug|Overall Study||4||
59718415|NCT01214642|75837681|FG010|Received at Least 1 Dose of Study Drug|Overall Study||4||
59567635|NCT02326272|75670463|FG010|STARTED|Open-label Period (Week 48 to Week 144)||5||
59567636|NCT02326272|75670464|FG011|STARTED|Open-label Period (Week 48 to Week 144)||66||
59567637|NCT02326272|75670465|FG012|STARTED|Open-label Period (Week 48 to Week 144)||59||
59567638|NCT02326272|75670466|FG013|STARTED|Open-label Period (Week 48 to Week 144)||1||
59567639|NCT02326272|75670467|FG014|STARTED|Open-label Period (Week 48 to Week 144)||40||
59567640|NCT02326272|75670453|FG000|COMPLETED|Open-label Period (Week 48 to Week 144)||0||
59567641|NCT02326272|75670454|FG001|COMPLETED|Open-label Period (Week 48 to Week 144)||0||
59567642|NCT02326272|75670455|FG002|COMPLETED|Open-label Period (Week 48 to Week 144)||0||
59718416|NCT01214642|75837682|FG011|Received at Least 1 Dose of Study Drug|Overall Study||6||
59838830|NCT00290186|75962984|FG000|Completed Post-treatment Assessments|Overall Study||24||
59838831|NCT00290186|75962985|FG001|Completed Post-treatment Assessments|Overall Study||22||
59838832|NCT00290186|75962984|FG000|Completed 3-month Followup Assessments|Overall Study||20||
59838833|NCT00290186|75962985|FG001|Completed 3-month Followup Assessments|Overall Study||21||
59838834|NCT00290186|75962984|FG000|Completed 6-month Followup Assessments|Overall Study||20||
59838835|NCT00290186|75962985|FG001|Completed 6-month Followup Assessments|Overall Study||19||
59838836|NCT00290186|75962984|FG000|COMPLETED|Overall Study||20||
59838837|NCT00290186|75962985|FG001|COMPLETED|Overall Study||19||
59838838|NCT00290186|75962984|FG000|NOT COMPLETED|Overall Study||5||
59838839|NCT00290186|75962985|FG001|NOT COMPLETED|Overall Study||5||
59838840|NCT00460655|75962995|FG000|STARTED|Double-Blind Phase (12 Weeks)||58||
59838841|NCT00460655|75962996|FG001|STARTED|Double-Blind Phase (12 Weeks)||62||
59838842|NCT00460655|75962997|FG002|STARTED|Double-Blind Phase (12 Weeks)||0||
59838843|NCT00460655|75962998|FG003|STARTED|Double-Blind Phase (12 Weeks)||0||
59838844|NCT00460655|75962995|FG000|COMPLETED|Double-Blind Phase (12 Weeks)||52||
59838845|NCT00460655|75962996|FG001|COMPLETED|Double-Blind Phase (12 Weeks)||61||
59838846|NCT00460655|75962997|FG002|COMPLETED|Double-Blind Phase (12 Weeks)||0||
59838847|NCT00460655|75962998|FG003|COMPLETED|Double-Blind Phase (12 Weeks)||0||
59838848|NCT00460655|75962995|FG000|NOT COMPLETED|Double-Blind Phase (12 Weeks)||6||
59838849|NCT00460655|75962996|FG001|NOT COMPLETED|Double-Blind Phase (12 Weeks)||1||
59838850|NCT00460655|75962997|FG002|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0||
59838851|NCT00460655|75962998|FG003|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0||
59838852|NCT00460655|75962995|FG000|STARTED|Open-Label Phase (36 Weeks)||0||
59838853|NCT00460655|75962996|FG001|STARTED|Open-Label Phase (36 Weeks)||0||
59838854|NCT00460655|75962997|FG002|STARTED|Open-Label Phase (36 Weeks)||52||
59838855|NCT00460655|75962998|FG003|STARTED|Open-Label Phase (36 Weeks)||61||
59838856|NCT00460655|75962995|FG000|COMPLETED|Open-Label Phase (36 Weeks)||0||
59838857|NCT00460655|75962996|FG001|COMPLETED|Open-Label Phase (36 Weeks)||0||
59838858|NCT00460655|75962997|FG002|COMPLETED|Open-Label Phase (36 Weeks)||45||
59838859|NCT00460655|75962998|FG003|COMPLETED|Open-Label Phase (36 Weeks)||52||
59838860|NCT00460655|75962995|FG000|NOT COMPLETED|Open-Label Phase (36 Weeks)||0||
59838861|NCT00460655|75962996|FG001|NOT COMPLETED|Open-Label Phase (36 Weeks)||0||
59838862|NCT00460655|75962997|FG002|NOT COMPLETED|Open-Label Phase (36 Weeks)||7||
59838863|NCT00460655|75962998|FG003|NOT COMPLETED|Open-Label Phase (36 Weeks)||9||
59838864|NCT00460577|75963010|FG000|STARTED|Overall Study|148 patients were screened; however, 22 did not consent and 66 did not meet inclusion/exclusion.|30||
59838865|NCT00460577|75963011|FG001|STARTED|Overall Study||30||
59838866|NCT00460577|75963010|FG000|COMPLETED|Overall Study||28||
59838867|NCT00460577|75963011|FG001|COMPLETED|Overall Study||24||
59838868|NCT00460577|75963010|FG000|NOT COMPLETED|Overall Study||2||
59838869|NCT00460577|75963011|FG001|NOT COMPLETED|Overall Study||6||
59838870|NCT00289016|75963017|FG000|STARTED|Overall Study||50||
59838871|NCT00289016|75963017|FG000|COMPLETED|Overall Study||13||
59838872|NCT00289016|75963017|FG000|NOT COMPLETED|Overall Study||37||
59838873|NCT00288860|75963023|FG000|STARTED|Overall Study||412||
59838874|NCT00288860|75963024|FG001|STARTED|Overall Study||425||
59838875|NCT00288860|75963023|FG000|Completed Intake Survey|Overall Study||408||
59838876|NCT00288860|75963024|FG001|Completed Intake Survey|Overall Study||417||
59838877|NCT00288860|75963023|FG000|Completed 4 Month fu Survey|Overall Study||275||
59838878|NCT00288860|75963024|FG001|Completed 4 Month fu Survey|Overall Study||299||
59838879|NCT00288860|75963023|FG000|Completed 12 Month fu Survey|Overall Study||257||
59838880|NCT00288860|75963024|FG001|Completed 12 Month fu Survey|Overall Study||281||
59838881|NCT00288860|75963023|FG000|COMPLETED|Overall Study|310 completed either 4 or 12 month survey. Used all with intake (n = 408) in intent-to-treat.|310||
59838882|NCT00288860|75963024|FG001|COMPLETED|Overall Study|328 completed 4 or 12 month survey. Used all with intake (n=417) in intent to treat.|328||
59838883|NCT00288860|75963023|FG000|NOT COMPLETED|Overall Study||102||
59838884|NCT00288860|75963024|FG001|NOT COMPLETED|Overall Study||97||
59838885|NCT00288704|75963036|FG000|STARTED|Part A, Double Blind, Weeks 1-6||24||
59838886|NCT00288704|75963037|FG001|STARTED|Part A, Double Blind, Weeks 1-6||23||
59838887|NCT00288704|75963038|FG002|STARTED|Part A, Double Blind, Weeks 1-6|Subjects enrolled into the open-label phase do not complete this part of the study.|0||
59838888|NCT00288704|75963036|FG000|COMPLETED|Part A, Double Blind, Weeks 1-6||24||
59838889|NCT00288704|75963037|FG001|COMPLETED|Part A, Double Blind, Weeks 1-6||22||
59838890|NCT00288704|75963038|FG002|COMPLETED|Part A, Double Blind, Weeks 1-6||0||
59838891|NCT00288704|75963036|FG000|NOT COMPLETED|Part A, Double Blind, Weeks 1-6||0||
59838892|NCT00288704|75963037|FG001|NOT COMPLETED|Part A, Double Blind, Weeks 1-6||1||
59838893|NCT00288704|75963038|FG002|NOT COMPLETED|Part A, Double Blind, Weeks 1-6||0||
59838894|NCT00288704|75963036|FG000|STARTED|Part B, Randomized Withdrawal, Wks 15-24|1 subject discontinued during weeks 6-14 due to non-compliance with study drug dosing procedures.|23||
59838895|NCT00288704|75963037|FG001|STARTED|Part B, Randomized Withdrawal, Wks 15-24||22||
59838896|NCT00288704|75963038|FG002|STARTED|Part B, Randomized Withdrawal, Wks 15-24||0||
60119436|NCT02530528|76240645|FG003|NOT COMPLETED|Overall Study||2||2
60119437|NCT02530528|76240646|FG004|NOT COMPLETED|Overall Study||1||1
60119438|NCT02530528|76240647|FG005|NOT COMPLETED|Overall Study||1||1
60119439|NCT02530528|76240648|FG006|NOT COMPLETED|Overall Study||2||2
60119440|NCT02530528|76240649|FG007|NOT COMPLETED|Overall Study||2||2
60119441|NCT02530996|76240663|FG000|STARTED|First Intervention||6||
60119442|NCT02530996|76240664|FG001|STARTED|First Intervention||6||
60119443|NCT02530996|76240663|FG000|COMPLETED|First Intervention||6||
60119444|NCT02530996|76240664|FG001|COMPLETED|First Intervention||6||
60119445|NCT02530996|76240663|FG000|NOT COMPLETED|First Intervention||0||
60119446|NCT02530996|76240664|FG001|NOT COMPLETED|First Intervention||0||
60119447|NCT02530996|76240663|FG000|STARTED|Washout (5 Days)||6||
60119448|NCT02530996|76240664|FG001|STARTED|Washout (5 Days)||6||
60119449|NCT02530996|76240663|FG000|COMPLETED|Washout (5 Days)||6||
60119450|NCT02530996|76240664|FG001|COMPLETED|Washout (5 Days)||6||
59567643|NCT02326272|75670456|FG003|COMPLETED|Open-label Period (Week 48 to Week 144)||0||
59567644|NCT02326272|75670457|FG004|COMPLETED|Open-label Period (Week 48 to Week 144)||0||
59567645|NCT02326272|75670458|FG005|COMPLETED|Open-label Period (Week 48 to Week 144)||0||
59567646|NCT02326272|75670459|FG006|COMPLETED|Open-label Period (Week 48 to Week 144)||0||
59567647|NCT02326272|75670460|FG007|COMPLETED|Open-label Period (Week 48 to Week 144)||0||
59567648|NCT02326272|75670461|FG008|COMPLETED|Open-label Period (Week 48 to Week 144)||0||
59567649|NCT02326272|75670462|FG009|COMPLETED|Open-label Period (Week 48 to Week 144)||0||
59567650|NCT02326272|75670463|FG010|COMPLETED|Open-label Period (Week 48 to Week 144)||2||
59567651|NCT02326272|75670464|FG011|COMPLETED|Open-label Period (Week 48 to Week 144)||51||
59567652|NCT02326272|75670465|FG012|COMPLETED|Open-label Period (Week 48 to Week 144)||48||
59567653|NCT02326272|75670466|FG013|COMPLETED|Open-label Period (Week 48 to Week 144)||1||
59567654|NCT02326272|75670467|FG014|COMPLETED|Open-label Period (Week 48 to Week 144)||31||
59567655|NCT02326272|75670453|FG000|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0||
59567656|NCT02326272|75670454|FG001|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0||
59567657|NCT02326272|75670455|FG002|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0||
59718417|NCT01214642|75837671|FG000|Complete at Least 2 Cycles of Study Drug|Overall Study||3||
59718418|NCT01214642|75837672|FG001|Complete at Least 2 Cycles of Study Drug|Overall Study||1||
59718419|NCT01214642|75837673|FG002|Complete at Least 2 Cycles of Study Drug|Overall Study||5||
59718420|NCT01214642|75837674|FG003|Complete at Least 2 Cycles of Study Drug|Overall Study||4||
59718421|NCT01214642|75837675|FG004|Complete at Least 2 Cycles of Study Drug|Overall Study||6||
60119451|NCT02530996|76240663|FG000|NOT COMPLETED|Washout (5 Days)||0||
60119452|NCT02530996|76240664|FG001|NOT COMPLETED|Washout (5 Days)||0||
60119453|NCT02530996|76240663|FG000|STARTED|Second Intervention||6||
60119454|NCT02530996|76240664|FG001|STARTED|Second Intervention||6||
60119455|NCT02530996|76240663|FG000|COMPLETED|Second Intervention||6||
60119456|NCT02530996|76240664|FG001|COMPLETED|Second Intervention||6||
60119457|NCT02530996|76240663|FG000|NOT COMPLETED|Second Intervention||0||
60119458|NCT02530996|76240664|FG001|NOT COMPLETED|Second Intervention||0||
59567658|NCT02326272|75670456|FG003|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0||
59567659|NCT02326272|75670457|FG004|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0||
59567660|NCT02326272|75670458|FG005|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0||
59567661|NCT02326272|75670459|FG006|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0||
59567662|NCT02326272|75670460|FG007|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0||
59567663|NCT02326272|75670461|FG008|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0||
59567664|NCT02326272|75670462|FG009|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0||
59567665|NCT02326272|75670463|FG010|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||3||
59567666|NCT02326272|75670464|FG011|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||15||
59567667|NCT02326272|75670465|FG012|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||11||
59567668|NCT02326272|75670466|FG013|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0||
59567669|NCT02326272|75670467|FG014|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||9||
59567670|NCT02279108|75670478|FG000|STARTED|Overall Study||50||
59567671|NCT02279108|75670479|FG001|STARTED|Overall Study||50||
59567672|NCT02279108|75670478|FG000|COMPLETED|Overall Study||50||
59567673|NCT02279108|75670479|FG001|COMPLETED|Overall Study||49||
59567674|NCT02279108|75670478|FG000|NOT COMPLETED|Overall Study||0||
59567675|NCT02279108|75670479|FG001|NOT COMPLETED|Overall Study||1||
59567676|NCT01887470|75670489|FG000|STARTED|Overall Study||10||
59567677|NCT01887470|75670490|FG001|STARTED|Overall Study||10||
59567678|NCT01887470|75670491|FG002|STARTED|Overall Study||10||
59567679|NCT01887470|75670492|FG003|STARTED|Overall Study||10||
59567680|NCT01887470|75670489|FG000|COMPLETED|Overall Study||10||
59567681|NCT01887470|75670490|FG001|COMPLETED|Overall Study||10||
59567682|NCT01887470|75670491|FG002|COMPLETED|Overall Study||10||
59567683|NCT01887470|75670492|FG003|COMPLETED|Overall Study||10||
59567684|NCT01887470|75670489|FG000|NOT COMPLETED|Overall Study||0||
59567685|NCT01887470|75670490|FG001|NOT COMPLETED|Overall Study||0||
59567686|NCT01887470|75670491|FG002|NOT COMPLETED|Overall Study||0||
59567687|NCT01887470|75670492|FG003|NOT COMPLETED|Overall Study||0||
59567688|NCT02325414|75670504|FG000|STARTED|Overall Study||30||
60119459|NCT02703324|76240674|FG000|STARTED|Period One||5||
60119460|NCT02703324|76240675|FG001|STARTED|Period One||5||
59838897|NCT00288704|75963036|FG000|COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||23||
59838898|NCT00288704|75963037|FG001|COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||21||
59838899|NCT00288704|75963038|FG002|COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||0||
59838900|NCT00288704|75963036|FG000|NOT COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||0||
59838901|NCT00288704|75963037|FG001|NOT COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||1||
59838902|NCT00288704|75963038|FG002|NOT COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||0||
59838903|NCT00288704|75963036|FG000|STARTED|Open-Label Extension (OLE) Weeks 24-117|After week 24, all subjects are treated with Open label rilonacept.|0||
59838904|NCT00288704|75963037|FG001|STARTED|Open-Label Extension (OLE) Weeks 24-117||0||
59838905|NCT00288704|75963038|FG002|STARTED|Open-Label Extension (OLE) Weeks 24-117||101||
59838906|NCT00288704|75963036|FG000|COMPLETED|Open-Label Extension (OLE) Weeks 24-117||0||
59838907|NCT00288704|75963037|FG001|COMPLETED|Open-Label Extension (OLE) Weeks 24-117||0||
59838908|NCT00288704|75963038|FG002|COMPLETED|Open-Label Extension (OLE) Weeks 24-117||81||
59838909|NCT00288704|75963036|FG000|NOT COMPLETED|Open-Label Extension (OLE) Weeks 24-117||0||
59838910|NCT00288704|75963037|FG001|NOT COMPLETED|Open-Label Extension (OLE) Weeks 24-117||0||
59838911|NCT00288704|75963038|FG002|NOT COMPLETED|Open-Label Extension (OLE) Weeks 24-117||20||
59838912|NCT00288626|75963045|FG000|STARTED|Overall Study||24||
59838913|NCT00288626|75963045|FG000|COMPLETED|Overall Study||17||
59838914|NCT00288626|75963045|FG000|NOT COMPLETED|Overall Study||7||
59838915|NCT00087490|75963053|FG000|STARTED|Overall Study||544||
59838916|NCT00087490|75963054|FG001|STARTED|Overall Study||533||
59838917|NCT00087490|75963053|FG000|Treated|Overall Study||537||
59838918|NCT00087490|75963054|FG001|Treated|Overall Study||515||
59838919|NCT00087490|75963053|FG000|COMPLETED|Overall Study||286||
59838920|NCT00087490|75963054|FG001|COMPLETED|Overall Study||264||
59838921|NCT00087490|75963053|FG000|NOT COMPLETED|Overall Study||258||
59838922|NCT00087490|75963054|FG001|NOT COMPLETED|Overall Study||269||
59838923|NCT00087178|75963062|FG000|STARTED|Overall Study||1361||
59838924|NCT00087178|75963063|FG001|STARTED|Overall Study||1361||
59838925|NCT00087178|75963062|FG000|COMPLETED|Overall Study||1355||
59838926|NCT00087178|75963063|FG001|COMPLETED|Overall Study||1343||
59838927|NCT00087178|75963062|FG000|NOT COMPLETED|Overall Study||6||
59838928|NCT00087178|75963063|FG001|NOT COMPLETED|Overall Study||18||
59838929|NCT00288080|75963071|FG000|STARTED|Overall Study||307||
59838930|NCT00288080|75963072|FG001|STARTED|Overall Study||305||
59838931|NCT00288080|75963071|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|281||
59838932|NCT00288080|75963072|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|282||
59838933|NCT00288080|75963071|FG000|NOT COMPLETED|Overall Study||26||
59838934|NCT00288080|75963072|FG001|NOT COMPLETED|Overall Study||23||
59838935|NCT00287690|75963080|FG000|STARTED|Overall Study||33||
59838936|NCT00287690|75963081|FG001|STARTED|Overall Study||38||
59838937|NCT00287690|75963080|FG000|COMPLETED|Overall Study||13||
59838938|NCT00287690|75963081|FG001|COMPLETED|Overall Study||12||
59838939|NCT00287690|75963080|FG000|NOT COMPLETED|Overall Study||20||
59838940|NCT00287690|75963081|FG001|NOT COMPLETED|Overall Study||26||
59838941|NCT00286754|75963090|FG000|STARTED|Overall Study||176||
59838942|NCT00286754|75963091|FG001|STARTED|Overall Study||177||
59838943|NCT00286754|75963092|FG002|STARTED|Overall Study||180||
59838944|NCT00286754|75963090|FG000|COMPLETED|Overall Study||156||
59838945|NCT00286754|75963091|FG001|COMPLETED|Overall Study||159||
59567689|NCT02325414|75670505|FG001|STARTED|Overall Study||30||
59718422|NCT01214642|75837676|FG005|Complete at Least 2 Cycles of Study Drug|Overall Study||1||
59718423|NCT01214642|75837677|FG006|Complete at Least 2 Cycles of Study Drug|Overall Study||6||
59718424|NCT01214642|75837678|FG007|Complete at Least 2 Cycles of Study Drug|Overall Study||3||
59718425|NCT01214642|75837679|FG008|Complete at Least 2 Cycles of Study Drug|Overall Study||12||
59718426|NCT01214642|75837680|FG009|Complete at Least 2 Cycles of Study Drug|Overall Study||2||
59718427|NCT01214642|75837681|FG010|Complete at Least 2 Cycles of Study Drug|Overall Study||2||
59718428|NCT01214642|75837682|FG011|Complete at Least 2 Cycles of Study Drug|Overall Study||5||
59718429|NCT01214642|75837671|FG000|COMPLETED|Overall Study||0||
59718430|NCT01214642|75837672|FG001|COMPLETED|Overall Study||0||
59718431|NCT01214642|75837673|FG002|COMPLETED|Overall Study||0||
59718432|NCT01214642|75837674|FG003|COMPLETED|Overall Study||0||
59718433|NCT01214642|75837675|FG004|COMPLETED|Overall Study||0||
59718434|NCT01214642|75837676|FG005|COMPLETED|Overall Study||0||
59718435|NCT01214642|75837677|FG006|COMPLETED|Overall Study||0||
59718436|NCT01214642|75837678|FG007|COMPLETED|Overall Study||0||
60119461|NCT02703324|76240676|FG002|STARTED|Period One||5||
60119462|NCT02703324|76240677|FG003|STARTED|Period One||5||
60119463|NCT02703324|76240678|FG004|STARTED|Period One||5||
59567690|NCT02325414|75670504|FG000|COMPLETED|Overall Study||22||
59718437|NCT01214642|75837679|FG008|COMPLETED|Overall Study||0||
59718438|NCT01214642|75837680|FG009|COMPLETED|Overall Study||0||
59718439|NCT01214642|75837681|FG010|COMPLETED|Overall Study||0||
59838946|NCT00286754|75963092|FG002|COMPLETED|Overall Study||170||
59838947|NCT00286754|75963090|FG000|NOT COMPLETED|Overall Study||20||
59838948|NCT00286754|75963091|FG001|NOT COMPLETED|Overall Study||18||
59838949|NCT00286754|75963092|FG002|NOT COMPLETED|Overall Study||10||
59838950|NCT00066742|75963106|FG000|STARTED|Induction Chemoradiotherapy||72||
59838951|NCT00066742|75963106|FG000|Eligible|Induction Chemoradiotherapy||69||
59838952|NCT00066742|75963106|FG000|Began Protocol Treatment|Induction Chemoradiotherapy||68||
59838953|NCT00066742|75963106|FG000|COMPLETED|Induction Chemoradiotherapy||43||
59838954|NCT00066742|75963106|FG000|NOT COMPLETED|Induction Chemoradiotherapy||29||
59838955|NCT00066742|75963106|FG000|STARTED|Consolidation Chemotherapy||42||
59838956|NCT00066742|75963106|FG000|Eligible|Consolidation Chemotherapy||40||
59838957|NCT00066742|75963106|FG000|COMPLETED|Consolidation Chemotherapy||39||
59838958|NCT00066742|75963106|FG000|NOT COMPLETED|Consolidation Chemotherapy||3||
59838959|NCT00460265|75963114|FG000|STARTED|Overall Study||328||
59838960|NCT00460265|75963115|FG001|STARTED|Overall Study||330||
59838961|NCT00460265|75963114|FG000|Randomized While Alive|Overall Study|1 subject was randomized by error after death|327||
59838962|NCT00460265|75963115|FG001|Randomized While Alive|Overall Study||330||
59838963|NCT00460265|75963114|FG000|Received Study Medication|Overall Study||325||
59838964|NCT00460265|75963115|FG001|Received Study Medication|Overall Study||325||
59838965|NCT00460265|75963114|FG000|COMPLETED|Overall Study|Completed study=death|243||
59838966|NCT00460265|75963115|FG001|COMPLETED|Overall Study|Completed study=death|241||
59838967|NCT00460265|75963114|FG000|NOT COMPLETED|Overall Study||85||
59838968|NCT00460265|75963115|FG001|NOT COMPLETED|Overall Study||89||
59838969|NCT00460109|75963121|FG000|STARTED|Overall Study||24||
59838970|NCT00460109|75963121|FG000|COMPLETED|Overall Study||23||
59838971|NCT00460109|75963121|FG000|NOT COMPLETED|Overall Study||1||
59838972|NCT00065260|75963127|FG000|STARTED|Overall Study||27||
59838973|NCT00065260|75963128|FG001|STARTED|Overall Study||27||
59838974|NCT00065260|75963127|FG000|COMPLETED|Overall Study||27||
59838975|NCT00065260|75963128|FG001|COMPLETED|Overall Study||26||
59838976|NCT00065260|75963127|FG000|NOT COMPLETED|Overall Study||0||
59838977|NCT00065260|75963128|FG001|NOT COMPLETED|Overall Study||1||
59838978|NCT00460031|75963134|FG000|STARTED|Overall Study||34||
59838979|NCT00460031|75963134|FG000|COMPLETED|Overall Study||23||
59838980|NCT00460031|75963134|FG000|NOT COMPLETED|Overall Study||11||
59838981|NCT00451217|75963142|FG000|STARTED|Overall Study||49||
59838982|NCT00451217|75963143|FG001|STARTED|Overall Study||49||
59838983|NCT00451217|75963144|FG002|STARTED|Overall Study||51||
59838984|NCT00451217|75963145|FG003|STARTED|Overall Study||49||
59838985|NCT00451217|75963142|FG000|Treated|Overall Study||48||
59838986|NCT00451217|75963143|FG001|Treated|Overall Study||48||
59838987|NCT00451217|75963144|FG002|Treated|Overall Study||48||
59838988|NCT00451217|75963145|FG003|Treated|Overall Study||45||
59838989|NCT00451217|75963142|FG000|COMPLETED|Overall Study||47||
59838990|NCT00451217|75963143|FG001|COMPLETED|Overall Study||47||
59718440|NCT01214642|75837682|FG011|COMPLETED|Overall Study||0||
59718441|NCT01214642|75837671|FG000|NOT COMPLETED|Overall Study||3||
59718442|NCT01214642|75837672|FG001|NOT COMPLETED|Overall Study||3||
59718443|NCT01214642|75837673|FG002|NOT COMPLETED|Overall Study||6||
59718444|NCT01214642|75837674|FG003|NOT COMPLETED|Overall Study||6||
59718445|NCT01214642|75837675|FG004|NOT COMPLETED|Overall Study||6||
59718446|NCT01214642|75837676|FG005|NOT COMPLETED|Overall Study||3||
59718447|NCT01214642|75837677|FG006|NOT COMPLETED|Overall Study||6||
59718448|NCT01214642|75837678|FG007|NOT COMPLETED|Overall Study||3||
59718449|NCT01214642|75837679|FG008|NOT COMPLETED|Overall Study||13||
59718450|NCT01214642|75837680|FG009|NOT COMPLETED|Overall Study||4||
59718451|NCT01214642|75837681|FG010|NOT COMPLETED|Overall Study||4||
59718452|NCT01214642|75837682|FG011|NOT COMPLETED|Overall Study||6||
59718453|NCT01214252|75837725|FG000|STARTED|Overall Study||425||
59718454|NCT01214252|75837725|FG000|COMPLETED|Overall Study||343||
59718455|NCT01214252|75837725|FG000|NOT COMPLETED|Overall Study||82||
59718456|NCT01214174|75837733|FG000|STARTED|Overall Study||13||
59718457|NCT01214174|75837734|FG001|STARTED|Overall Study||16||
59718458|NCT01214174|75837735|FG002|STARTED|Overall Study||14||
59718459|NCT01214174|75837733|FG000|COMPLETED|Overall Study||13||
59718460|NCT01214174|75837734|FG001|COMPLETED|Overall Study||16||
59718461|NCT01214174|75837735|FG002|COMPLETED|Overall Study||13||
59718462|NCT01214174|75837733|FG000|NOT COMPLETED|Overall Study||0||
59718463|NCT01214174|75837734|FG001|NOT COMPLETED|Overall Study||0||
59718464|NCT01214174|75837735|FG002|NOT COMPLETED|Overall Study||1||
59718465|NCT00901342|75837743|FG000|STARTED|Overall Study||104||
59718466|NCT00901342|75837743|FG000|Received at Least 1 Infusion|Overall Study||98||
59718467|NCT00901342|75837743|FG000|COMPLETED|Overall Study|89 subjects completed the study completion visit|89||
59838991|NCT00451217|75963144|FG002|COMPLETED|Overall Study||47||
59838992|NCT00451217|75963145|FG003|COMPLETED|Overall Study||44||
59838993|NCT00451217|75963142|FG000|NOT COMPLETED|Overall Study||2||
59838994|NCT00451217|75963143|FG001|NOT COMPLETED|Overall Study||2||
60119464|NCT02703324|76240679|FG005|STARTED|Period One||5||
59718468|NCT00901342|75837743|FG000|NOT COMPLETED|Overall Study||15||
59718469|NCT00901186|75837749|FG000|STARTED|Overall Study||40||
59718470|NCT00901186|75837750|FG001|STARTED|Overall Study||43||
59718471|NCT00901186|75837749|FG000|Safety Set|Overall Study|One participant did not receive one intravitreal RFB002 injection.|39||
59718472|NCT00901186|75837750|FG001|Safety Set|Overall Study||43||
59838995|NCT00451217|75963144|FG002|NOT COMPLETED|Overall Study||4||
59838996|NCT00451217|75963145|FG003|NOT COMPLETED|Overall Study||5||
59838997|NCT00459953|75963157|FG000|STARTED|Overall Study||72||
59838998|NCT00459953|75963158|FG001|STARTED|Overall Study||71||
59838999|NCT00459953|75963157|FG000|COMPLETED|Overall Study||71||
59839000|NCT00459953|75963158|FG001|COMPLETED|Overall Study||70||
59839001|NCT00459953|75963157|FG000|NOT COMPLETED|Overall Study||1||
59839002|NCT00459953|75963158|FG001|NOT COMPLETED|Overall Study||1||
59839003|NCT00459875|75963164|FG000|STARTED|Overall Study||24||
59839004|NCT00459875|75963164|FG000|COMPLETED|Overall Study||21||
59839005|NCT00459875|75963164|FG000|NOT COMPLETED|Overall Study||3||
59839006|NCT00311402|75963170|FG000|STARTED|Overall Study||655||
59839007|NCT00311402|75963171|FG001|STARTED|Overall Study||639||
59839008|NCT00311402|75963170|FG000|COMPLETED|Overall Study||445||
59839009|NCT00311402|75963171|FG001|COMPLETED|Overall Study||462||
59839010|NCT00311402|75963170|FG000|NOT COMPLETED|Overall Study||210||
59839011|NCT00311402|75963171|FG001|NOT COMPLETED|Overall Study||177||
59839012|NCT00450749|75963180|FG000|STARTED|Overall Study||3||
59839013|NCT00450749|75963181|FG001|STARTED|Overall Study||3||
59839014|NCT00450749|75963182|FG002|STARTED|Overall Study||4||
59839015|NCT00450749|75963180|FG000|COMPLETED|Overall Study||3||
59839016|NCT00450749|75963181|FG001|COMPLETED|Overall Study||2||
59839017|NCT00450749|75963182|FG002|COMPLETED|Overall Study||2||
59839018|NCT00450749|75963180|FG000|NOT COMPLETED|Overall Study||0||
59839019|NCT00450749|75963181|FG001|NOT COMPLETED|Overall Study||1||
59839020|NCT00450749|75963182|FG002|NOT COMPLETED|Overall Study||2||
59839021|NCT00292370|75963193|FG000|STARTED|Phase I - Open-Label Paroxetine (OLP)||124||
59839022|NCT00292370|75963194|FG001|STARTED|Phase I - Open-Label Paroxetine (OLP)||0||
59839023|NCT00292370|75963195|FG002|STARTED|Phase I - Open-Label Paroxetine (OLP)||0||
59839024|NCT00292370|75963193|FG000|COMPLETED|Phase I - Open-Label Paroxetine (OLP)||78||
59839025|NCT00292370|75963194|FG001|COMPLETED|Phase I - Open-Label Paroxetine (OLP)||0||
59839026|NCT00292370|75963195|FG002|COMPLETED|Phase I - Open-Label Paroxetine (OLP)||0||
59839027|NCT00292370|75963193|FG000|NOT COMPLETED|Phase I - Open-Label Paroxetine (OLP)||46||
59839028|NCT00292370|75963194|FG001|NOT COMPLETED|Phase I - Open-Label Paroxetine (OLP)||0||
59839029|NCT00292370|75963195|FG002|NOT COMPLETED|Phase I - Open-Label Paroxetine (OLP)||0||
59839030|NCT00292370|75963193|FG000|STARTED|Phase II: OLP + DB Quetiapine or Placebo|"78 Completed Ph I~28 Excluded Ph II:~20 responded~7 declined~1 medical~50 to Arm 2 & 3"|0||
59839031|NCT00292370|75963194|FG001|STARTED|Phase II: OLP + DB Quetiapine or Placebo|25 out of 50 in Arm I PhI, eligible for Ph II|25||
59839032|NCT00292370|75963195|FG002|STARTED|Phase II: OLP + DB Quetiapine or Placebo|25 out of 50 in Arm I PhI, eligible for Ph II|25||
59839033|NCT00292370|75963193|FG000|COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||0||
59839034|NCT00292370|75963194|FG001|COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||21||
59839035|NCT00292370|75963195|FG002|COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||18||
59839036|NCT00292370|75963193|FG000|NOT COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||0||
59839037|NCT00292370|75963194|FG001|NOT COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||4||
59839038|NCT00292370|75963195|FG002|NOT COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||7||
59839039|NCT00065182|75963204|FG000|STARTED|Overall Study||202||
59839040|NCT00065182|75963205|FG001|STARTED|Overall Study||197||
59839041|NCT00065182|75963204|FG000|COMPLETED|Overall Study||154||
59839042|NCT00065182|75963205|FG001|COMPLETED|Overall Study||160||
59839043|NCT00065182|75963204|FG000|NOT COMPLETED|Overall Study||48||
59839044|NCT00065182|75963205|FG001|NOT COMPLETED|Overall Study||37||
59839045|NCT00064792|75963213|FG000|STARTED|Overall Study||13||
59839046|NCT00064792|75963214|FG001|STARTED|Overall Study||10||
59839047|NCT00064792|75963213|FG000|COMPLETED|Overall Study||8||
59839048|NCT00064792|75963214|FG001|COMPLETED|Overall Study||10||
59839049|NCT00064792|75963213|FG000|NOT COMPLETED|Overall Study||5||
59839050|NCT00064792|75963214|FG001|NOT COMPLETED|Overall Study||0||
59839051|NCT00450437|75963222|FG000|STARTED|Overall Study||1640||
59839052|NCT00450437|75963223|FG001|STARTED|Overall Study||540||
59839053|NCT00450437|75963224|FG002|STARTED|Overall Study||1023||
59839054|NCT00450437|75963225|FG003|STARTED|Overall Study||336||
59839055|NCT00450437|75963222|FG000|COMPLETED|Overall Study||1594||
59839056|NCT00450437|75963223|FG001|COMPLETED|Overall Study||524||
59839057|NCT00450437|75963224|FG002|COMPLETED|Overall Study||999||
60119465|NCT02703324|76240674|FG000|Received Study Drug|Period One||5||
60119466|NCT02703324|76240675|FG001|Received Study Drug|Period One||5||
60119467|NCT02703324|76240676|FG002|Received Study Drug|Period One||5||
59839058|NCT00450437|75963225|FG003|COMPLETED|Overall Study||325||
59839059|NCT00450437|75963222|FG000|NOT COMPLETED|Overall Study||46||
59839060|NCT00450437|75963223|FG001|NOT COMPLETED|Overall Study||16||
59839061|NCT00450437|75963224|FG002|NOT COMPLETED|Overall Study||24||
59839062|NCT00450437|75963225|FG003|NOT COMPLETED|Overall Study||11||
59839063|NCT00286442|75963242|FG000|STARTED|Overall Study||213||
59839064|NCT00286442|75963243|FG001|STARTED|Overall Study||210||
59839065|NCT00286442|75963244|FG002|STARTED|Overall Study||104||
60119468|NCT02703324|76240677|FG003|Received Study Drug|Period One||5||
60119469|NCT02703324|76240678|FG004|Received Study Drug|Period One||5||
59567691|NCT02325414|75670505|FG001|COMPLETED|Overall Study||24||
59839066|NCT00286442|75963242|FG000|COMPLETED|Overall Study||176||
59839067|NCT00286442|75963243|FG001|COMPLETED|Overall Study||165||
59839068|NCT00286442|75963244|FG002|COMPLETED|Overall Study||72||
60119470|NCT02703324|76240679|FG005|Received Study Drug|Period One||5||
60119471|NCT02703324|76240674|FG000|COMPLETED|Period One||5||
59839069|NCT00286442|75963242|FG000|NOT COMPLETED|Overall Study||37||
59839070|NCT00286442|75963243|FG001|NOT COMPLETED|Overall Study||45||
59839071|NCT00286442|75963244|FG002|NOT COMPLETED|Overall Study||32||
59839072|NCT00063934|75963252|FG000|STARTED|Overall Study||31||
59839073|NCT00063934|75963252|FG000|COMPLETED|Overall Study||30||
59839074|NCT00063934|75963252|FG000|NOT COMPLETED|Overall Study||1||
59839075|NCT00458783|75963258|FG000|STARTED|Overall Study||1914||
59839076|NCT00458783|75963259|FG001|STARTED|Overall Study||1921||
59839077|NCT00458783|75963258|FG000|COMPLETED|Overall Study||686||
59839078|NCT00458783|75963259|FG001|COMPLETED|Overall Study||701||
59839079|NCT00458783|75963258|FG000|NOT COMPLETED|Overall Study||1228||
59839080|NCT00458783|75963259|FG001|NOT COMPLETED|Overall Study||1220||
59839081|NCT00063154|75963265|FG000|STARTED|Overall Study||51||
59839082|NCT00063154|75963265|FG000|COMPLETED|Overall Study||0||
59839083|NCT00063154|75963265|FG000|NOT COMPLETED|Overall Study||51||
59839084|NCT00311168|75963271|FG000|STARTED|First Intervention||66||
59839085|NCT00311168|75963272|FG001|STARTED|First Intervention||68||
59839086|NCT00311168|75963271|FG000|COMPLETED|First Intervention||59||
59839087|NCT00311168|75963272|FG001|COMPLETED|First Intervention||62||
59839088|NCT00311168|75963271|FG000|NOT COMPLETED|First Intervention||7||
59839089|NCT00311168|75963272|FG001|NOT COMPLETED|First Intervention||6||
59839090|NCT00311168|75963271|FG000|STARTED|Second Intervention||59||
59839091|NCT00311168|75963272|FG001|STARTED|Second Intervention||62||
59839092|NCT00311168|75963271|FG000|COMPLETED|Second Intervention||49||
59839093|NCT00311168|75963272|FG001|COMPLETED|Second Intervention||58||
59839094|NCT00311168|75963271|FG000|NOT COMPLETED|Second Intervention||10||
59718473|NCT00901186|75837749|FG000|Intent to Treat|Overall Study|Four treated participants did not have at least a baseline and one post-treatment BCVA.|35||
59718474|NCT00901186|75837750|FG001|Intent to Treat|Overall Study|Five treated participants did not have at least a baseline and one post-treatment BCVA.|38||
59718475|NCT00901186|75837749|FG000|COMPLETED|Overall Study||31||
59839095|NCT00311168|75963272|FG001|NOT COMPLETED|Second Intervention||4||
59839096|NCT00458705|75963280|FG000|STARTED|Overall Study||45||
59839097|NCT00458705|75963280|FG000|COMPLETED|Overall Study||40||
59718476|NCT00901186|75837750|FG001|COMPLETED|Overall Study||32||
59718477|NCT00901186|75837749|FG000|NOT COMPLETED|Overall Study||9||
59718478|NCT00901186|75837750|FG001|NOT COMPLETED|Overall Study||11||
59718479|NCT01213472|75837756|FG000|STARTED|Overall Study||33||
59718480|NCT01213472|75837756|FG000|COMPLETED|Overall Study||6||
59718481|NCT01213472|75837756|FG000|NOT COMPLETED|Overall Study||27||
59718482|NCT00900796|75837760|FG000|STARTED|Phase 1||132||
59718483|NCT00900796|75837760|FG000|COMPLETED|Phase 1||121||
59839098|NCT00458705|75963280|FG000|NOT COMPLETED|Overall Study||5||
59839099|NCT00062374|75963284|FG000|STARTED|Overall Study||55||
59839100|NCT00062374|75963284|FG000|COMPLETED|Overall Study||43||
59839101|NCT00062374|75963284|FG000|NOT COMPLETED|Overall Study||12||
60119472|NCT02703324|76240675|FG001|COMPLETED|Period One||5||
60119473|NCT02703324|76240676|FG002|COMPLETED|Period One||5||
60119474|NCT02703324|76240677|FG003|COMPLETED|Period One||5||
60119475|NCT02703324|76240678|FG004|COMPLETED|Period One||5||
60119476|NCT02703324|76240679|FG005|COMPLETED|Period One||5||
60119477|NCT02703324|76240674|FG000|NOT COMPLETED|Period One||0||
60119478|NCT02703324|76240675|FG001|NOT COMPLETED|Period One||0||
60119479|NCT02703324|76240676|FG002|NOT COMPLETED|Period One||0||
60119480|NCT02703324|76240677|FG003|NOT COMPLETED|Period One||0||
60119481|NCT02703324|76240678|FG004|NOT COMPLETED|Period One||0||
60119482|NCT02703324|76240679|FG005|NOT COMPLETED|Period One||0||
60119483|NCT02703324|76240674|FG000|STARTED|Period Two||5||
60119484|NCT02703324|76240675|FG001|STARTED|Period Two||5||
60119485|NCT02703324|76240676|FG002|STARTED|Period Two||5||
60119486|NCT02703324|76240677|FG003|STARTED|Period Two||5||
60119487|NCT02703324|76240678|FG004|STARTED|Period Two||5||
59718484|NCT00900796|75837760|FG000|NOT COMPLETED|Phase 1||11||
59718485|NCT00900796|75837760|FG000|STARTED|Between Phase 1 and Phase 2||121||
59718486|NCT00900796|75837760|FG000|COMPLETED|Between Phase 1 and Phase 2||11||
59839102|NCT00285818|75963290|FG000|STARTED|Overall Study||6||
59839103|NCT00285818|75963291|FG001|STARTED|Overall Study||5||
59839104|NCT00285818|75963290|FG000|COMPLETED|Overall Study||2||
59839105|NCT00285818|75963291|FG001|COMPLETED|Overall Study||3||
59839106|NCT00285818|75963290|FG000|NOT COMPLETED|Overall Study||4||
59839107|NCT00285818|75963291|FG001|NOT COMPLETED|Overall Study||2||
59839108|NCT05330234|75963297|FG000|STARTED|Overall Study||10||
59839109|NCT05330234|75963297|FG000|COMPLETED|Overall Study||10||
59839110|NCT05330234|75963297|FG000|NOT COMPLETED|Overall Study||0||
59839111|NCT05321810|75963308|FG000|STARTED|Overall Study||57560||
59839112|NCT05321810|75963309|FG001|STARTED|Overall Study||90636||
59839113|NCT05321810|75963310|FG002|STARTED|Overall Study||18216||
59839114|NCT05321810|75963311|FG003|STARTED|Overall Study||27153||
59839115|NCT05321810|75963308|FG000|COMPLETED|Overall Study||57560||
60119488|NCT02703324|76240679|FG005|STARTED|Period Two||5||
60119489|NCT02703324|76240674|FG000|Received Study Drug|Period Two||5||
60119490|NCT02703324|76240675|FG001|Received Study Drug|Period Two||5||
60119491|NCT02703324|76240676|FG002|Received Study Drug|Period Two||5||
59839116|NCT05321810|75963309|FG001|COMPLETED|Overall Study||90636||
59839117|NCT05321810|75963310|FG002|COMPLETED|Overall Study||18216||
59839118|NCT05321810|75963311|FG003|COMPLETED|Overall Study||27153||
59839119|NCT05321810|75963308|FG000|NOT COMPLETED|Overall Study||0||
59839120|NCT05321810|75963309|FG001|NOT COMPLETED|Overall Study||0||
59839121|NCT05321810|75963310|FG002|NOT COMPLETED|Overall Study||0||
59839122|NCT05321810|75963311|FG003|NOT COMPLETED|Overall Study||0||
59839123|NCT05093530|75963329|FG000|STARTED|Overall Study||12||
59839124|NCT05093530|75963330|FG001|STARTED|Overall Study||4||
59839125|NCT05093530|75963331|FG002|STARTED|Overall Study||4||
59839126|NCT05093530|75963332|FG003|STARTED|Overall Study||4||
59839127|NCT05093530|75963333|FG004|STARTED|Overall Study||6||
59839128|NCT05093530|75963334|FG005|STARTED|Overall Study||6||
59839129|NCT05093530|75963335|FG006|STARTED|Overall Study||6||
59839130|NCT05093530|75963336|FG007|STARTED|Overall Study||6||
59839131|NCT05093530|75963337|FG008|STARTED|Overall Study||6||
59839132|NCT05093530|75963338|FG009|STARTED|Overall Study||6||
59839133|NCT05093530|75963329|FG000|COMPLETED|Overall Study||12||
59839134|NCT05093530|75963330|FG001|COMPLETED|Overall Study||4||
59839135|NCT05093530|75963331|FG002|COMPLETED|Overall Study||4||
59839136|NCT05093530|75963332|FG003|COMPLETED|Overall Study||4||
59839137|NCT05093530|75963333|FG004|COMPLETED|Overall Study||6||
59839138|NCT05093530|75963334|FG005|COMPLETED|Overall Study||6||
59839139|NCT05093530|75963335|FG006|COMPLETED|Overall Study||5||
59839140|NCT05093530|75963336|FG007|COMPLETED|Overall Study||6||
59839141|NCT05093530|75963337|FG008|COMPLETED|Overall Study||6||
59839142|NCT05093530|75963338|FG009|COMPLETED|Overall Study||6||
59839143|NCT05093530|75963329|FG000|NOT COMPLETED|Overall Study||0||
59839144|NCT05093530|75963330|FG001|NOT COMPLETED|Overall Study||0||
59839145|NCT05093530|75963331|FG002|NOT COMPLETED|Overall Study||0||
59839146|NCT05093530|75963332|FG003|NOT COMPLETED|Overall Study||0||
59839147|NCT05093530|75963333|FG004|NOT COMPLETED|Overall Study||0||
59839148|NCT05093530|75963334|FG005|NOT COMPLETED|Overall Study||0||
59839149|NCT05093530|75963335|FG006|NOT COMPLETED|Overall Study||1||
59839150|NCT05093530|75963336|FG007|NOT COMPLETED|Overall Study||0||
59839151|NCT05093530|75963337|FG008|NOT COMPLETED|Overall Study||0||
59839152|NCT05093530|75963338|FG009|NOT COMPLETED|Overall Study||0||
59839153|NCT04841967|75963362|FG000|STARTED|Overall Study||41||
59839154|NCT04841967|75963363|FG001|STARTED|Overall Study||34||
59839155|NCT04841967|75963362|FG000|Recruitment Goal Achieved|Overall Study||41||
59839156|NCT04841967|75963363|FG001|Recruitment Goal Achieved|Overall Study||34||
59839157|NCT04841967|75963362|FG000|COMPLETED|Overall Study||30||
59839158|NCT04841967|75963363|FG001|COMPLETED|Overall Study||30||
59839159|NCT04841967|75963362|FG000|NOT COMPLETED|Overall Study||11||
59839160|NCT04841967|75963363|FG001|NOT COMPLETED|Overall Study||4||
59839161|NCT04821063|75963369|FG000|STARTED|Period 1 (1 Day)||1||
59839162|NCT04821063|75963370|FG001|STARTED|Period 1 (1 Day)||1||
59839163|NCT04821063|75963371|FG002|STARTED|Period 1 (1 Day)||2||
59839164|NCT04821063|75963372|FG003|STARTED|Period 1 (1 Day)||3||
59839165|NCT04821063|75963373|FG004|STARTED|Period 1 (1 Day)||3||
59839166|NCT04821063|75963374|FG005|STARTED|Period 1 (1 Day)||3||
59839167|NCT04821063|75963375|FG006|STARTED|Period 1 (1 Day)||3||
60119492|NCT02703324|76240677|FG003|Received Study Drug|Period Two||5||
60119493|NCT02703324|76240678|FG004|Received Study Drug|Period Two||5||
60119494|NCT02703324|76240679|FG005|Received Study Drug|Period Two||5||
59839168|NCT04821063|75963376|FG007|STARTED|Period 1 (1 Day)||3||
59839169|NCT04821063|75963377|FG008|STARTED|Period 1 (1 Day)||3||
59839170|NCT04821063|75963378|FG009|STARTED|Period 1 (1 Day)||3||
59839171|NCT04821063|75963379|FG010|STARTED|Period 1 (1 Day)||3||
60119495|NCT02703324|76240674|FG000|COMPLETED|Period Two||5||
59839172|NCT04821063|75963380|FG011|STARTED|Period 1 (1 Day)||3||
59839173|NCT04821063|75963369|FG000|COMPLETED|Period 1 (1 Day)||1||
59839174|NCT04821063|75963370|FG001|COMPLETED|Period 1 (1 Day)||1||
59839175|NCT04821063|75963371|FG002|COMPLETED|Period 1 (1 Day)||2||
59839176|NCT04821063|75963372|FG003|COMPLETED|Period 1 (1 Day)||3||
60119496|NCT02703324|76240675|FG001|COMPLETED|Period Two||5||
59839177|NCT04821063|75963373|FG004|COMPLETED|Period 1 (1 Day)||3||
59839178|NCT04821063|75963374|FG005|COMPLETED|Period 1 (1 Day)||3||
59839179|NCT04821063|75963375|FG006|COMPLETED|Period 1 (1 Day)||3||
59839180|NCT04821063|75963376|FG007|COMPLETED|Period 1 (1 Day)||3||
59839181|NCT04821063|75963377|FG008|COMPLETED|Period 1 (1 Day)||3||
60119497|NCT02703324|76240676|FG002|COMPLETED|Period Two||4||
59839182|NCT04821063|75963378|FG009|COMPLETED|Period 1 (1 Day)||3||
59839183|NCT04821063|75963379|FG010|COMPLETED|Period 1 (1 Day)||3||
59839184|NCT04821063|75963380|FG011|COMPLETED|Period 1 (1 Day)||3||
59839185|NCT04821063|75963369|FG000|NOT COMPLETED|Period 1 (1 Day)||0||
59839186|NCT04821063|75963370|FG001|NOT COMPLETED|Period 1 (1 Day)||0||
59839187|NCT04821063|75963371|FG002|NOT COMPLETED|Period 1 (1 Day)||0||
59839188|NCT04821063|75963372|FG003|NOT COMPLETED|Period 1 (1 Day)||0||
59839189|NCT04821063|75963373|FG004|NOT COMPLETED|Period 1 (1 Day)||0||
59839190|NCT04821063|75963374|FG005|NOT COMPLETED|Period 1 (1 Day)||0||
59839191|NCT04821063|75963375|FG006|NOT COMPLETED|Period 1 (1 Day)||0||
59839192|NCT04821063|75963376|FG007|NOT COMPLETED|Period 1 (1 Day)||0||
59839193|NCT04821063|75963377|FG008|NOT COMPLETED|Period 1 (1 Day)||0||
59839194|NCT04821063|75963378|FG009|NOT COMPLETED|Period 1 (1 Day)||0||
59839195|NCT04821063|75963379|FG010|NOT COMPLETED|Period 1 (1 Day)||0||
59839196|NCT04821063|75963380|FG011|NOT COMPLETED|Period 1 (1 Day)||0||
59839197|NCT04821063|75963369|FG000|STARTED|Washout Period (7 Days )||1||
59839198|NCT04821063|75963370|FG001|STARTED|Washout Period (7 Days )||1||
59839199|NCT04821063|75963371|FG002|STARTED|Washout Period (7 Days )||2||
59839200|NCT04821063|75963372|FG003|STARTED|Washout Period (7 Days )||3||
59839201|NCT04821063|75963373|FG004|STARTED|Washout Period (7 Days )||3||
59839202|NCT04821063|75963374|FG005|STARTED|Washout Period (7 Days )||3||
59839203|NCT04821063|75963375|FG006|STARTED|Washout Period (7 Days )||3||
59839204|NCT04821063|75963376|FG007|STARTED|Washout Period (7 Days )||3||
59839205|NCT04821063|75963377|FG008|STARTED|Washout Period (7 Days )||3||
59839206|NCT04821063|75963378|FG009|STARTED|Washout Period (7 Days )||3||
59839207|NCT04821063|75963379|FG010|STARTED|Washout Period (7 Days )||3||
59839208|NCT04821063|75963380|FG011|STARTED|Washout Period (7 Days )||3||
59839209|NCT04821063|75963369|FG000|COMPLETED|Washout Period (7 Days )||1||
59839210|NCT04821063|75963370|FG001|COMPLETED|Washout Period (7 Days )||1||
59839211|NCT04821063|75963371|FG002|COMPLETED|Washout Period (7 Days )||2||
59839212|NCT04821063|75963372|FG003|COMPLETED|Washout Period (7 Days )||3||
59839213|NCT04821063|75963373|FG004|COMPLETED|Washout Period (7 Days )||3||
59839214|NCT04821063|75963374|FG005|COMPLETED|Washout Period (7 Days )||3||
59839215|NCT04821063|75963375|FG006|COMPLETED|Washout Period (7 Days )||3||
59839216|NCT04821063|75963376|FG007|COMPLETED|Washout Period (7 Days )||3||
59839217|NCT04821063|75963377|FG008|COMPLETED|Washout Period (7 Days )||3||
59839218|NCT04821063|75963378|FG009|COMPLETED|Washout Period (7 Days )||3||
59839219|NCT04821063|75963379|FG010|COMPLETED|Washout Period (7 Days )||3||
59839220|NCT04821063|75963380|FG011|COMPLETED|Washout Period (7 Days )||3||
59839221|NCT04821063|75963369|FG000|NOT COMPLETED|Washout Period (7 Days )||0||
59839222|NCT04821063|75963370|FG001|NOT COMPLETED|Washout Period (7 Days )||0||
59839223|NCT04821063|75963371|FG002|NOT COMPLETED|Washout Period (7 Days )||0||
59839224|NCT04821063|75963372|FG003|NOT COMPLETED|Washout Period (7 Days )||0||
59839225|NCT04821063|75963373|FG004|NOT COMPLETED|Washout Period (7 Days )||0||
59839226|NCT04821063|75963374|FG005|NOT COMPLETED|Washout Period (7 Days )||0||
59839227|NCT04821063|75963375|FG006|NOT COMPLETED|Washout Period (7 Days )||0||
59839228|NCT04821063|75963376|FG007|NOT COMPLETED|Washout Period (7 Days )||0||
59839229|NCT04821063|75963377|FG008|NOT COMPLETED|Washout Period (7 Days )||0||
59839230|NCT04821063|75963378|FG009|NOT COMPLETED|Washout Period (7 Days )||0||
59839231|NCT04821063|75963379|FG010|NOT COMPLETED|Washout Period (7 Days )||0||
59839232|NCT04821063|75963380|FG011|NOT COMPLETED|Washout Period (7 Days )||0||
59839233|NCT04821063|75963369|FG000|STARTED|Period 2 (1 Day)||1||
59839234|NCT04821063|75963370|FG001|STARTED|Period 2 (1 Day)||1||
59839235|NCT04821063|75963371|FG002|STARTED|Period 2 (1 Day)||2||
59839236|NCT04821063|75963372|FG003|STARTED|Period 2 (1 Day)||3||
59839237|NCT04821063|75963373|FG004|STARTED|Period 2 (1 Day)||3||
59839238|NCT04821063|75963374|FG005|STARTED|Period 2 (1 Day)||3||
59839239|NCT04821063|75963375|FG006|STARTED|Period 2 (1 Day)||3||
59839240|NCT04821063|75963376|FG007|STARTED|Period 2 (1 Day)||3||
59839241|NCT04821063|75963377|FG008|STARTED|Period 2 (1 Day)||3||
59839242|NCT04821063|75963378|FG009|STARTED|Period 2 (1 Day)||3||
59839243|NCT04821063|75963379|FG010|STARTED|Period 2 (1 Day)||3||
59839244|NCT04821063|75963380|FG011|STARTED|Period 2 (1 Day)||3||
59839245|NCT04821063|75963369|FG000|COMPLETED|Period 2 (1 Day)||1||
59839246|NCT04821063|75963370|FG001|COMPLETED|Period 2 (1 Day)||1||
59839247|NCT04821063|75963371|FG002|COMPLETED|Period 2 (1 Day)||2||
59839248|NCT04821063|75963372|FG003|COMPLETED|Period 2 (1 Day)||3||
59839249|NCT04821063|75963373|FG004|COMPLETED|Period 2 (1 Day)||3||
59839250|NCT04821063|75963374|FG005|COMPLETED|Period 2 (1 Day)||3||
59839251|NCT04821063|75963375|FG006|COMPLETED|Period 2 (1 Day)||3||
59839252|NCT04821063|75963376|FG007|COMPLETED|Period 2 (1 Day)||3||
59839253|NCT04821063|75963377|FG008|COMPLETED|Period 2 (1 Day)||3||
59839254|NCT04821063|75963378|FG009|COMPLETED|Period 2 (1 Day)||3||
59839255|NCT04821063|75963379|FG010|COMPLETED|Period 2 (1 Day)||3||
59996559|NCT02714569|76112512|FG009|NOT COMPLETED|Part A First Intervention||0||
59839256|NCT04821063|75963380|FG011|COMPLETED|Period 2 (1 Day)||3||
59996560|NCT02714569|76112513|FG010|NOT COMPLETED|Part A First Intervention||0||
59996561|NCT02714569|76112503|FG000|STARTED|Part A Second Intervention||3||
59996562|NCT02714569|76112504|FG001|STARTED|Part A Second Intervention||3||
59996563|NCT02714569|76112505|FG002|STARTED|Part A Second Intervention||3||
59839257|NCT04821063|75963369|FG000|NOT COMPLETED|Period 2 (1 Day)||0||
59839258|NCT04821063|75963370|FG001|NOT COMPLETED|Period 2 (1 Day)||0||
59839259|NCT04821063|75963371|FG002|NOT COMPLETED|Period 2 (1 Day)||0||
59839260|NCT04821063|75963372|FG003|NOT COMPLETED|Period 2 (1 Day)||0||
59839261|NCT04821063|75963373|FG004|NOT COMPLETED|Period 2 (1 Day)||0||
59839262|NCT04821063|75963374|FG005|NOT COMPLETED|Period 2 (1 Day)||0||
59839263|NCT04821063|75963375|FG006|NOT COMPLETED|Period 2 (1 Day)||0||
59839264|NCT04821063|75963376|FG007|NOT COMPLETED|Period 2 (1 Day)||0||
59839265|NCT04821063|75963377|FG008|NOT COMPLETED|Period 2 (1 Day)||0||
59839266|NCT04821063|75963378|FG009|NOT COMPLETED|Period 2 (1 Day)||0||
59839267|NCT04821063|75963379|FG010|NOT COMPLETED|Period 2 (1 Day)||0||
59839268|NCT04821063|75963380|FG011|NOT COMPLETED|Period 2 (1 Day)||0||
59839269|NCT04821063|75963369|FG000|STARTED|Washout Period (7 Days)||1||
59839270|NCT04821063|75963370|FG001|STARTED|Washout Period (7 Days)||1||
59839271|NCT04821063|75963371|FG002|STARTED|Washout Period (7 Days)||2||
59839272|NCT04821063|75963372|FG003|STARTED|Washout Period (7 Days)||3||
59839273|NCT04821063|75963373|FG004|STARTED|Washout Period (7 Days)||3||
59839274|NCT04821063|75963374|FG005|STARTED|Washout Period (7 Days)||3||
59839275|NCT04821063|75963375|FG006|STARTED|Washout Period (7 Days)||3||
59839276|NCT04821063|75963376|FG007|STARTED|Washout Period (7 Days)||3||
59839277|NCT04821063|75963377|FG008|STARTED|Washout Period (7 Days)||3||
59839278|NCT04821063|75963378|FG009|STARTED|Washout Period (7 Days)||3||
59839279|NCT04821063|75963379|FG010|STARTED|Washout Period (7 Days)||3||
59839280|NCT04821063|75963380|FG011|STARTED|Washout Period (7 Days)||3||
59839281|NCT04821063|75963369|FG000|COMPLETED|Washout Period (7 Days)||1||
59839282|NCT04821063|75963370|FG001|COMPLETED|Washout Period (7 Days)||1||
59839283|NCT04821063|75963371|FG002|COMPLETED|Washout Period (7 Days)||2||
59839284|NCT04821063|75963372|FG003|COMPLETED|Washout Period (7 Days)||3||
59839285|NCT04821063|75963373|FG004|COMPLETED|Washout Period (7 Days)||3||
59839286|NCT04821063|75963374|FG005|COMPLETED|Washout Period (7 Days)||3||
59839287|NCT04821063|75963375|FG006|COMPLETED|Washout Period (7 Days)||3||
59839288|NCT04821063|75963376|FG007|COMPLETED|Washout Period (7 Days)||3||
59839289|NCT04821063|75963377|FG008|COMPLETED|Washout Period (7 Days)||3||
59839290|NCT04821063|75963378|FG009|COMPLETED|Washout Period (7 Days)||3||
59839291|NCT04821063|75963379|FG010|COMPLETED|Washout Period (7 Days)||3||
59839292|NCT04821063|75963380|FG011|COMPLETED|Washout Period (7 Days)||3||
59839293|NCT04821063|75963369|FG000|NOT COMPLETED|Washout Period (7 Days)||0||
59839294|NCT04821063|75963370|FG001|NOT COMPLETED|Washout Period (7 Days)||0||
59839295|NCT04821063|75963371|FG002|NOT COMPLETED|Washout Period (7 Days)||0||
59839296|NCT04821063|75963372|FG003|NOT COMPLETED|Washout Period (7 Days)||0||
59839297|NCT04821063|75963373|FG004|NOT COMPLETED|Washout Period (7 Days)||0||
59839298|NCT04821063|75963374|FG005|NOT COMPLETED|Washout Period (7 Days)||0||
59839299|NCT04821063|75963375|FG006|NOT COMPLETED|Washout Period (7 Days)||0||
59839300|NCT04821063|75963376|FG007|NOT COMPLETED|Washout Period (7 Days)||0||
59839301|NCT04821063|75963377|FG008|NOT COMPLETED|Washout Period (7 Days)||0||
59839302|NCT04821063|75963378|FG009|NOT COMPLETED|Washout Period (7 Days)||0||
59718487|NCT00900796|75837760|FG000|NOT COMPLETED|Between Phase 1 and Phase 2||110||
59718488|NCT00900796|75837760|FG000|STARTED|Phase 2||11||
59718489|NCT00900796|75837760|FG000|COMPLETED|Phase 2||6||
59718490|NCT00900796|75837760|FG000|NOT COMPLETED|Phase 2||5||
59718491|NCT01213082|75837768|FG000|STARTED|Overall Study||12||
59718492|NCT01213082|75837769|FG001|STARTED|Overall Study||11||
59718493|NCT01213082|75837770|FG002|STARTED|Overall Study||11||
59718494|NCT01213082|75837768|FG000|COMPLETED|Overall Study||6||
59718495|NCT01213082|75837769|FG001|COMPLETED|Overall Study||4||
59718496|NCT01213082|75837770|FG002|COMPLETED|Overall Study||6||
59718497|NCT01213082|75837768|FG000|NOT COMPLETED|Overall Study||6||
59718498|NCT01213082|75837769|FG001|NOT COMPLETED|Overall Study||7||
59839303|NCT04821063|75963379|FG010|NOT COMPLETED|Washout Period (7 Days)||0||
59839304|NCT04821063|75963380|FG011|NOT COMPLETED|Washout Period (7 Days)||0||
59839305|NCT04821063|75963369|FG000|STARTED|Period 3 (1 Day)||1||
59839306|NCT04821063|75963370|FG001|STARTED|Period 3 (1 Day)||1||
59839307|NCT04821063|75963371|FG002|STARTED|Period 3 (1 Day)||2||
59839308|NCT04821063|75963372|FG003|STARTED|Period 3 (1 Day)||3||
59839309|NCT04821063|75963373|FG004|STARTED|Period 3 (1 Day)||3||
59839310|NCT04821063|75963374|FG005|STARTED|Period 3 (1 Day)||3||
59839311|NCT04821063|75963375|FG006|STARTED|Period 3 (1 Day)||3||
59839312|NCT04821063|75963376|FG007|STARTED|Period 3 (1 Day)||3||
59839313|NCT04821063|75963377|FG008|STARTED|Period 3 (1 Day)||3||
59839314|NCT04821063|75963378|FG009|STARTED|Period 3 (1 Day)||3||
59839315|NCT04821063|75963379|FG010|STARTED|Period 3 (1 Day)||3||
59839316|NCT04821063|75963380|FG011|STARTED|Period 3 (1 Day)||3||
59839317|NCT04821063|75963369|FG000|COMPLETED|Period 3 (1 Day)||1||
59839318|NCT04821063|75963370|FG001|COMPLETED|Period 3 (1 Day)||1||
59718499|NCT01213082|75837770|FG002|NOT COMPLETED|Overall Study||5||
59718500|NCT00885703|75837785|FG000|STARTED|Overall Study||22||
59718501|NCT00885703|75837786|FG001|STARTED|Overall Study||26||
59718502|NCT00885703|75837787|FG002|STARTED|Overall Study||24||
59718503|NCT00885703|75837788|FG003|STARTED|Overall Study||24||
59718504|NCT00885703|75837789|FG004|STARTED|Overall Study||24||
59839319|NCT04821063|75963371|FG002|COMPLETED|Period 3 (1 Day)||2||
59839320|NCT04821063|75963372|FG003|COMPLETED|Period 3 (1 Day)||3||
59839321|NCT04821063|75963373|FG004|COMPLETED|Period 3 (1 Day)||3||
59839322|NCT04821063|75963374|FG005|COMPLETED|Period 3 (1 Day)||3||
59839323|NCT04821063|75963375|FG006|COMPLETED|Period 3 (1 Day)||3||
59839324|NCT04821063|75963376|FG007|COMPLETED|Period 3 (1 Day)||3||
59839325|NCT04821063|75963377|FG008|COMPLETED|Period 3 (1 Day)||3||
59839326|NCT04821063|75963378|FG009|COMPLETED|Period 3 (1 Day)||3||
59839327|NCT04821063|75963379|FG010|COMPLETED|Period 3 (1 Day)||3||
59839328|NCT04821063|75963380|FG011|COMPLETED|Period 3 (1 Day)||3||
59839329|NCT04821063|75963369|FG000|NOT COMPLETED|Period 3 (1 Day)||0||
59839330|NCT04821063|75963370|FG001|NOT COMPLETED|Period 3 (1 Day)||0||
59839331|NCT04821063|75963371|FG002|NOT COMPLETED|Period 3 (1 Day)||0||
59839332|NCT04821063|75963372|FG003|NOT COMPLETED|Period 3 (1 Day)||0||
59839333|NCT04821063|75963373|FG004|NOT COMPLETED|Period 3 (1 Day)||0||
59839334|NCT04821063|75963374|FG005|NOT COMPLETED|Period 3 (1 Day)||0||
59839335|NCT04821063|75963375|FG006|NOT COMPLETED|Period 3 (1 Day)||0||
59839336|NCT04821063|75963376|FG007|NOT COMPLETED|Period 3 (1 Day)||0||
59839337|NCT04821063|75963377|FG008|NOT COMPLETED|Period 3 (1 Day)||0||
59839338|NCT04821063|75963378|FG009|NOT COMPLETED|Period 3 (1 Day)||0||
59839339|NCT04821063|75963379|FG010|NOT COMPLETED|Period 3 (1 Day)||0||
59839340|NCT04821063|75963380|FG011|NOT COMPLETED|Period 3 (1 Day)||0||
59839341|NCT04821063|75963369|FG000|STARTED|Washout Period 3 (7 Days)||1||
59839342|NCT04821063|75963370|FG001|STARTED|Washout Period 3 (7 Days)||1||
59839343|NCT04821063|75963371|FG002|STARTED|Washout Period 3 (7 Days)||2||
59839344|NCT04821063|75963372|FG003|STARTED|Washout Period 3 (7 Days)||3||
59839345|NCT04821063|75963373|FG004|STARTED|Washout Period 3 (7 Days)||3||
59839346|NCT04821063|75963374|FG005|STARTED|Washout Period 3 (7 Days)||3||
59839347|NCT04821063|75963375|FG006|STARTED|Washout Period 3 (7 Days)||3||
59839348|NCT04821063|75963376|FG007|STARTED|Washout Period 3 (7 Days)||3||
59839349|NCT04821063|75963377|FG008|STARTED|Washout Period 3 (7 Days)||3||
59839350|NCT04821063|75963378|FG009|STARTED|Washout Period 3 (7 Days)||3||
59839351|NCT04821063|75963379|FG010|STARTED|Washout Period 3 (7 Days)||3||
59839352|NCT04821063|75963380|FG011|STARTED|Washout Period 3 (7 Days)||3||
59839353|NCT04821063|75963369|FG000|COMPLETED|Washout Period 3 (7 Days)||1||
59839354|NCT04821063|75963370|FG001|COMPLETED|Washout Period 3 (7 Days)||1||
59839355|NCT04821063|75963371|FG002|COMPLETED|Washout Period 3 (7 Days)||2||
59839356|NCT04821063|75963372|FG003|COMPLETED|Washout Period 3 (7 Days)||3||
59839357|NCT04821063|75963373|FG004|COMPLETED|Washout Period 3 (7 Days)||3||
59839358|NCT04821063|75963374|FG005|COMPLETED|Washout Period 3 (7 Days)||3||
59839359|NCT04821063|75963375|FG006|COMPLETED|Washout Period 3 (7 Days)||3||
59839360|NCT04821063|75963376|FG007|COMPLETED|Washout Period 3 (7 Days)||3||
59839361|NCT04821063|75963377|FG008|COMPLETED|Washout Period 3 (7 Days)||3||
59839362|NCT04821063|75963378|FG009|COMPLETED|Washout Period 3 (7 Days)||3||
59839363|NCT04821063|75963379|FG010|COMPLETED|Washout Period 3 (7 Days)||3||
59839364|NCT04821063|75963380|FG011|COMPLETED|Washout Period 3 (7 Days)||3||
59839365|NCT04821063|75963369|FG000|NOT COMPLETED|Washout Period 3 (7 Days)||0||
59839366|NCT04821063|75963370|FG001|NOT COMPLETED|Washout Period 3 (7 Days)||0||
59839367|NCT04821063|75963371|FG002|NOT COMPLETED|Washout Period 3 (7 Days)||0||
59839368|NCT04821063|75963372|FG003|NOT COMPLETED|Washout Period 3 (7 Days)||0||
59718505|NCT00885703|75837790|FG005|STARTED|Overall Study||24||
59718506|NCT00885703|75837791|FG006|STARTED|Overall Study||24||
59718507|NCT00885703|75837785|FG000|COMPLETED|Overall Study||12||
59718508|NCT00885703|75837786|FG001|COMPLETED|Overall Study||16||
59718509|NCT00885703|75837787|FG002|COMPLETED|Overall Study||13||
59718510|NCT00885703|75837788|FG003|COMPLETED|Overall Study||15||
59718511|NCT00885703|75837789|FG004|COMPLETED|Overall Study||12||
59718512|NCT00885703|75837790|FG005|COMPLETED|Overall Study||11||
59718513|NCT00885703|75837791|FG006|COMPLETED|Overall Study||18||
59718514|NCT00885703|75837785|FG000|NOT COMPLETED|Overall Study||10||
59718515|NCT00885703|75837786|FG001|NOT COMPLETED|Overall Study||10||
59718516|NCT00885703|75837787|FG002|NOT COMPLETED|Overall Study||11||
59718517|NCT00885703|75837788|FG003|NOT COMPLETED|Overall Study||9||
59718518|NCT00885703|75837789|FG004|NOT COMPLETED|Overall Study||12||
59718519|NCT00885703|75837790|FG005|NOT COMPLETED|Overall Study||13||
59839369|NCT04821063|75963373|FG004|NOT COMPLETED|Washout Period 3 (7 Days)||0||
59839370|NCT04821063|75963374|FG005|NOT COMPLETED|Washout Period 3 (7 Days)||0||
59839371|NCT04821063|75963375|FG006|NOT COMPLETED|Washout Period 3 (7 Days)||0||
59839372|NCT04821063|75963376|FG007|NOT COMPLETED|Washout Period 3 (7 Days)||0||
59839373|NCT04821063|75963377|FG008|NOT COMPLETED|Washout Period 3 (7 Days)||0||
59839374|NCT04821063|75963378|FG009|NOT COMPLETED|Washout Period 3 (7 Days)||0||
59718520|NCT00885703|75837791|FG006|NOT COMPLETED|Overall Study||6||
59718521|NCT00901576|75837817|FG000|STARTED|First Intervention||6||
59718522|NCT00901576|75837818|FG001|STARTED|First Intervention||7||
59718523|NCT00901576|75837819|FG002|STARTED|First Intervention||7||
59718524|NCT00901576|75837820|FG003|STARTED|First Intervention||6||
59718525|NCT00901576|75837821|FG004|STARTED|First Intervention||6||
59839375|NCT04821063|75963379|FG010|NOT COMPLETED|Washout Period 3 (7 Days)||0||
59839376|NCT04821063|75963380|FG011|NOT COMPLETED|Washout Period 3 (7 Days)||0||
59839377|NCT04821063|75963369|FG000|STARTED|Period 4 (1 Day)||1||
59839378|NCT04821063|75963370|FG001|STARTED|Period 4 (1 Day)||1||
59839379|NCT04821063|75963371|FG002|STARTED|Period 4 (1 Day)||2||
59839380|NCT04821063|75963372|FG003|STARTED|Period 4 (1 Day)||3||
59839381|NCT04821063|75963373|FG004|STARTED|Period 4 (1 Day)||3||
59839382|NCT04821063|75963374|FG005|STARTED|Period 4 (1 Day)||3||
59839383|NCT04821063|75963375|FG006|STARTED|Period 4 (1 Day)||3||
59839384|NCT04821063|75963376|FG007|STARTED|Period 4 (1 Day)||3||
59839385|NCT04821063|75963377|FG008|STARTED|Period 4 (1 Day)||3||
59839386|NCT04821063|75963378|FG009|STARTED|Period 4 (1 Day)||3||
59839387|NCT04821063|75963379|FG010|STARTED|Period 4 (1 Day)||3||
59839388|NCT04821063|75963380|FG011|STARTED|Period 4 (1 Day)||3||
59839389|NCT04821063|75963369|FG000|COMPLETED|Period 4 (1 Day)||1||
59839390|NCT04821063|75963370|FG001|COMPLETED|Period 4 (1 Day)||1||
59839391|NCT04821063|75963371|FG002|COMPLETED|Period 4 (1 Day)||2||
59839392|NCT04821063|75963372|FG003|COMPLETED|Period 4 (1 Day)||3||
59839393|NCT04821063|75963373|FG004|COMPLETED|Period 4 (1 Day)||3||
59839394|NCT04821063|75963374|FG005|COMPLETED|Period 4 (1 Day)||3||
59839395|NCT04821063|75963375|FG006|COMPLETED|Period 4 (1 Day)||3||
59839396|NCT04821063|75963376|FG007|COMPLETED|Period 4 (1 Day)||3||
59839397|NCT04821063|75963377|FG008|COMPLETED|Period 4 (1 Day)||3||
59839398|NCT04821063|75963378|FG009|COMPLETED|Period 4 (1 Day)||3||
59839399|NCT04821063|75963379|FG010|COMPLETED|Period 4 (1 Day)||3||
59839400|NCT04821063|75963380|FG011|COMPLETED|Period 4 (1 Day)||3||
59839401|NCT04821063|75963369|FG000|NOT COMPLETED|Period 4 (1 Day)||0||
59839402|NCT04821063|75963370|FG001|NOT COMPLETED|Period 4 (1 Day)||0||
59839403|NCT04821063|75963371|FG002|NOT COMPLETED|Period 4 (1 Day)||0||
59839404|NCT04821063|75963372|FG003|NOT COMPLETED|Period 4 (1 Day)||0||
59839405|NCT04821063|75963373|FG004|NOT COMPLETED|Period 4 (1 Day)||0||
59839406|NCT04821063|75963374|FG005|NOT COMPLETED|Period 4 (1 Day)||0||
59839407|NCT04821063|75963375|FG006|NOT COMPLETED|Period 4 (1 Day)||0||
59839408|NCT04821063|75963376|FG007|NOT COMPLETED|Period 4 (1 Day)||0||
59839409|NCT04821063|75963377|FG008|NOT COMPLETED|Period 4 (1 Day)||0||
59839410|NCT04821063|75963378|FG009|NOT COMPLETED|Period 4 (1 Day)||0||
59839411|NCT04821063|75963379|FG010|NOT COMPLETED|Period 4 (1 Day)||0||
59839412|NCT04821063|75963380|FG011|NOT COMPLETED|Period 4 (1 Day)||0||
59839413|NCT04761627|75963395|FG000|STARTED|Run-in Period||494||
59839414|NCT04761627|75963396|FG001|STARTED|Run-in Period||0||
59839415|NCT04761627|75963397|FG002|STARTED|Run-in Period||0||
59839416|NCT04761627|75963395|FG000|COMPLETED|Run-in Period||453||
59839417|NCT04761627|75963396|FG001|COMPLETED|Run-in Period||0||
59839418|NCT04761627|75963397|FG002|COMPLETED|Run-in Period||0||
59839419|NCT04761627|75963395|FG000|NOT COMPLETED|Run-in Period||41||
59839420|NCT04761627|75963396|FG001|NOT COMPLETED|Run-in Period||0||
59839421|NCT04761627|75963397|FG002|NOT COMPLETED|Run-in Period||0||
59839422|NCT04761627|75963395|FG000|STARTED|Post-randomization Period||0||
59839423|NCT04761627|75963396|FG001|STARTED|Post-randomization Period||228||
59839424|NCT04761627|75963397|FG002|STARTED|Post-randomization Period||225||
59839425|NCT04761627|75963395|FG000|Full Analysis Set|Post-randomization Period||0||
59839426|NCT04761627|75963396|FG001|Full Analysis Set|Post-randomization Period||228||
59839427|NCT04761627|75963397|FG002|Full Analysis Set|Post-randomization Period||225||
59839428|NCT04761627|75963395|FG000|Safety Analysis Set|Post-randomization Period||0||
59839429|NCT04761627|75963396|FG001|Safety Analysis Set|Post-randomization Period||228||
59839430|NCT04761627|75963397|FG002|Safety Analysis Set|Post-randomization Period||224||
59839431|NCT04761627|75963395|FG000|COMPLETED|Post-randomization Period||0||
59839432|NCT04761627|75963396|FG001|COMPLETED|Post-randomization Period||209||
59839433|NCT04761627|75963397|FG002|COMPLETED|Post-randomization Period||209||
59839434|NCT04761627|75963395|FG000|NOT COMPLETED|Post-randomization Period||0||
59839435|NCT04761627|75963396|FG001|NOT COMPLETED|Post-randomization Period||19||
59839436|NCT04761627|75963397|FG002|NOT COMPLETED|Post-randomization Period||16||
60119498|NCT02703324|76240677|FG003|COMPLETED|Period Two||5||
60119499|NCT02703324|76240678|FG004|COMPLETED|Period Two||5||
59839437|NCT04621786|75963414|FG000|STARTED|Overall Study||41||
59839438|NCT04621786|75963414|FG000|COMPLETED|Overall Study||29||
59839439|NCT04621786|75963414|FG000|NOT COMPLETED|Overall Study||12||
59839440|NCT04533438|75963420|FG000|STARTED|Initial Enrollment||77||
59839441|NCT04533438|75963421|FG001|STARTED|Initial Enrollment||39||
60119500|NCT02703324|76240679|FG005|COMPLETED|Period Two||5||
60119501|NCT02703324|76240674|FG000|NOT COMPLETED|Period Two||0||
60119502|NCT02703324|76240675|FG001|NOT COMPLETED|Period Two||0||
60119503|NCT02703324|76240676|FG002|NOT COMPLETED|Period Two||1||
60119504|NCT02703324|76240677|FG003|NOT COMPLETED|Period Two||0||
60119505|NCT02703324|76240678|FG004|NOT COMPLETED|Period Two||0||
59839442|NCT04533438|75963420|FG000|COMPLETED|Initial Enrollment||77||
59839443|NCT04533438|75963421|FG001|COMPLETED|Initial Enrollment||39||
59839444|NCT04533438|75963420|FG000|NOT COMPLETED|Initial Enrollment||0||
59839445|NCT04533438|75963421|FG001|NOT COMPLETED|Initial Enrollment||0||
59839446|NCT04533438|75963420|FG000|STARTED|Crossover Period||0|The Crossover Period does not apply to subjects that were randomized to Rhinaer Treatment Arm|
60119506|NCT02703324|76240679|FG005|NOT COMPLETED|Period Two||0||
60119507|NCT02703324|76240674|FG000|STARTED|Period Three||5||
60119508|NCT02703324|76240675|FG001|STARTED|Period Three||5||
60119509|NCT02703324|76240676|FG002|STARTED|Period Three||4||
59839447|NCT04533438|75963421|FG001|STARTED|Crossover Period||39|The Crossover Period does not apply to subjects that were randomized to Rhinaer Treatment Arm|
59839448|NCT04533438|75963420|FG000|COMPLETED|Crossover Period||0||
59839449|NCT04533438|75963421|FG001|COMPLETED|Crossover Period|Subjects who received SHAM randomization were permitted to crossover to treatment are after 3M evaluation, only if they continued to meet the inclusion/exclusion criteria for the study. Subjects that did not meet inclusion/exclusion to crossover were exited as completed|28||
59839450|NCT04533438|75963420|FG000|NOT COMPLETED|Crossover Period||0||
59839451|NCT04533438|75963421|FG001|NOT COMPLETED|Crossover Period||11||
59839452|NCT04460911|75963429|FG000|STARTED|Overall Study||317||
59839453|NCT04460911|75963429|FG000|COMPLETED|Overall Study||317||
59839454|NCT04460911|75963429|FG000|NOT COMPLETED|Overall Study||0||
59839455|NCT04408963|75963435|FG000|STARTED|Overall Study||5||
59839456|NCT04408963|75963436|FG001|STARTED|Overall Study||5||
59839457|NCT04408963|75963435|FG000|Received Study Product|Overall Study||5||
59839458|NCT04408963|75963436|FG001|Received Study Product|Overall Study||5||
59839459|NCT04408963|75963435|FG000|COMPLETED|Overall Study||5||
59839460|NCT04408963|75963436|FG001|COMPLETED|Overall Study||5||
59839461|NCT04408963|75963435|FG000|NOT COMPLETED|Overall Study||0||
59839462|NCT04408963|75963436|FG001|NOT COMPLETED|Overall Study||0||
59839463|NCT04025710|75963442|FG000|STARTED|Overall Study||167||
59839464|NCT04025710|75963442|FG000|COMPLETED|Overall Study||116||
59839465|NCT04025710|75963442|FG000|NOT COMPLETED|Overall Study||51||
59839466|NCT04009213|75963448|FG000|STARTED|Overall Study||142||
59839467|NCT04009213|75963449|FG001|STARTED|Overall Study||142||
59839468|NCT04009213|75963448|FG000|COMPLETED|Overall Study||132||
59839469|NCT04009213|75963449|FG001|COMPLETED|Overall Study||134||
59839470|NCT04009213|75963448|FG000|NOT COMPLETED|Overall Study||10||
59839471|NCT04009213|75963449|FG001|NOT COMPLETED|Overall Study||8||
59839472|NCT03967054|75963459|FG000|STARTED|Overall Study||2191||7
59839473|NCT03967054|75963460|FG001|STARTED|Overall Study||1933||7
59839474|NCT03967054|75963459|FG000|COMPLETED|Overall Study||2191||7
59839475|NCT03967054|75963460|FG001|COMPLETED|Overall Study||1933||7
59839476|NCT03967054|75963459|FG000|NOT COMPLETED|Overall Study||0||0
59839477|NCT03967054|75963460|FG001|NOT COMPLETED|Overall Study||0||0
59839478|NCT03809078|75963468|FG000|STARTED|First Scan||7||
59839479|NCT03809078|75963469|FG001|STARTED|First Scan||7||
59839480|NCT03809078|75963468|FG000|COMPLETED|First Scan||7||
59839481|NCT03809078|75963469|FG001|COMPLETED|First Scan||7||
59839482|NCT03809078|75963468|FG000|NOT COMPLETED|First Scan||0||
59839483|NCT03809078|75963469|FG001|NOT COMPLETED|First Scan||0||
59839484|NCT03809078|75963468|FG000|STARTED|Second Scan|1 participant withdrew prior to receiving the second scan.|6||
59839485|NCT03809078|75963469|FG001|STARTED|Second Scan||7||
59839486|NCT03809078|75963468|FG000|COMPLETED|Second Scan||6||
59839487|NCT03809078|75963469|FG001|COMPLETED|Second Scan||7||
59839488|NCT03809078|75963468|FG000|NOT COMPLETED|Second Scan||0||
59839489|NCT03809078|75963469|FG001|NOT COMPLETED|Second Scan||0||
59839490|NCT03716869|75963477|FG000|STARTED|Overall Study||6436||
59839491|NCT03716869|75963478|FG001|STARTED|Overall Study||6473||
59839492|NCT03716869|75963477|FG000|COMPLETED|Overall Study||6436||
59839493|NCT03716869|75963478|FG001|COMPLETED|Overall Study||6473||
59839494|NCT03716869|75963477|FG000|NOT COMPLETED|Overall Study||0||
59839495|NCT03716869|75963478|FG001|NOT COMPLETED|Overall Study||0||
59839496|NCT03624478|75963502|FG000|STARTED|Overall Study||25||
59839497|NCT03624478|75963502|FG000|COMPLETED|Overall Study||24||
59839498|NCT03624478|75963502|FG000|NOT COMPLETED|Overall Study||1||
59839499|NCT03593356|75963508|FG000|STARTED|Overall Study||400||
59839500|NCT03593356|75963509|FG001|STARTED|Overall Study||600||
59839501|NCT03593356|75963508|FG000|COMPLETED|Overall Study||380||
59839502|NCT03593356|75963509|FG001|COMPLETED|Overall Study||542||
59839503|NCT03593356|75963508|FG000|NOT COMPLETED|Overall Study||20||
59839504|NCT03593356|75963509|FG001|NOT COMPLETED|Overall Study||58||
59839505|NCT03501979|75963515|FG000|STARTED|Overall Study||17||
59839506|NCT03501979|75963515|FG000|COMPLETED|Overall Study||17||
59839507|NCT03501979|75963515|FG000|NOT COMPLETED|Overall Study||0||
59839508|NCT03474107|75963521|FG000|STARTED|Overall Study||301||
59839509|NCT03474107|75963522|FG001|STARTED|Overall Study||307||
59839510|NCT03474107|75963521|FG000|Treated|Overall Study||296||
59839511|NCT03474107|75963522|FG001|Treated|Overall Study||291||
59839512|NCT03474107|75963521|FG000|COMPLETED|Overall Study|Participants still on treatment as of data cut-off date 15-Jul-2020|56||
59839513|NCT03474107|75963522|FG001|COMPLETED|Overall Study|Participants still on treatment as of data cut-off date 15-Jul-2020|22||
59839514|NCT03474107|75963521|FG000|NOT COMPLETED|Overall Study||245||
59839515|NCT03474107|75963522|FG001|NOT COMPLETED|Overall Study||285||
59839516|NCT03147287|75963531|FG000|STARTED|Overall Study||55||
59839517|NCT03147287|75963532|FG001|STARTED|Overall Study||111||
59839518|NCT03147287|75963533|FG002|STARTED|Overall Study||54||
59839519|NCT03147287|75963531|FG000|COMPLETED|Overall Study||0||
59839520|NCT03147287|75963532|FG001|COMPLETED|Overall Study||0||
59839521|NCT03147287|75963533|FG002|COMPLETED|Overall Study||0||
59839522|NCT03147287|75963531|FG000|NOT COMPLETED|Overall Study||55||
59839523|NCT03147287|75963532|FG001|NOT COMPLETED|Overall Study||111||
59839524|NCT03147287|75963533|FG002|NOT COMPLETED|Overall Study||54||
59839525|NCT02865135|75963544|FG000|STARTED|Overall Study||6||
59839526|NCT02865135|75963545|FG001|STARTED|Overall Study||3||
59839527|NCT02865135|75963546|FG002|STARTED|Overall Study||2||
59839528|NCT02865135|75963544|FG000|Evaluable for T Cell Analysis|Overall Study||6||
59839529|NCT02865135|75963545|FG001|Evaluable for T Cell Analysis|Overall Study||3||
59839530|NCT02865135|75963546|FG002|Evaluable for T Cell Analysis|Overall Study||0||
59839531|NCT02865135|75963544|FG000|COMPLETED|Overall Study||0||
59839532|NCT02865135|75963545|FG001|COMPLETED|Overall Study||0||
59839533|NCT02865135|75963546|FG002|COMPLETED|Overall Study||0||
59839534|NCT02865135|75963544|FG000|NOT COMPLETED|Overall Study||6||
59839535|NCT02865135|75963545|FG001|NOT COMPLETED|Overall Study||3||
59839536|NCT02865135|75963546|FG002|NOT COMPLETED|Overall Study||2||
59839537|NCT02811744|75963557|FG000|STARTED|Overall Study||6||
59839538|NCT02811744|75963558|FG001|STARTED|Overall Study||5||
59839539|NCT02811744|75963557|FG000|COMPLETED|Overall Study|6 MCI patients were enrolled and completed the PET/CT scan|6||
59839540|NCT02811744|75963558|FG001|COMPLETED|Overall Study||5||
59839541|NCT02811744|75963557|FG000|NOT COMPLETED|Overall Study||0||
59839542|NCT02811744|75963558|FG001|NOT COMPLETED|Overall Study||0||
59839543|NCT02709720|75963564|FG000|STARTED|Overall Study||68||
59839544|NCT02709720|75963564|FG000|COMPLETED|Overall Study||65||
59839545|NCT02709720|75963564|FG000|NOT COMPLETED|Overall Study||3||
59839546|NCT02652260|75963570|FG000|STARTED|Overall Study||43||
59839547|NCT02652260|75963571|FG001|STARTED|Overall Study||43||
59839548|NCT02652260|75963570|FG000|COMPLETED|Overall Study||43||
59839549|NCT02652260|75963571|FG001|COMPLETED|Overall Study||41||
59839550|NCT02652260|75963570|FG000|NOT COMPLETED|Overall Study||0||
59839551|NCT02652260|75963571|FG001|NOT COMPLETED|Overall Study||2||
59839552|NCT02593526|75963584|FG000|STARTED|Overall Study|Participants did not meet randomizations. Zero participants randomized to this arm.|0||
59839553|NCT02593526|75963585|FG001|STARTED|Overall Study|Participants did not meet randomizations. Zero participants randomized to this arm.|0||
59839554|NCT02593526|75963586|FG002|STARTED|Overall Study|Participants did not meet randomizations. Zero participants randomized to this arm.|0||
59839555|NCT02593526|75963587|FG003|STARTED|Overall Study||1||
59839556|NCT02593526|75963584|FG000|COMPLETED|Overall Study||0||
59839557|NCT02593526|75963585|FG001|COMPLETED|Overall Study||0||
59839558|NCT02593526|75963586|FG002|COMPLETED|Overall Study||0||
59839559|NCT02593526|75963587|FG003|COMPLETED|Overall Study||1||
59839560|NCT02593526|75963584|FG000|NOT COMPLETED|Overall Study||0||
59839561|NCT02593526|75963585|FG001|NOT COMPLETED|Overall Study||0||
59839562|NCT02593526|75963586|FG002|NOT COMPLETED|Overall Study||0||
59839563|NCT02593526|75963587|FG003|NOT COMPLETED|Overall Study||0||
59839564|NCT02364557|75963599|FG000|STARTED|Overall Study||68||
59839565|NCT02364557|75963600|FG001|STARTED|Overall Study||61||
59839566|NCT02364557|75963599|FG000|Eligible Population|Overall Study||65||
59839567|NCT02364557|75963600|FG001|Eligible Population|Overall Study||60||
59839568|NCT02364557|75963599|FG000|AE Population|Overall Study||62|Eligible and received systemic therapy and/or ablation.|
59839569|NCT02364557|75963600|FG001|AE Population|Overall Study||57|Eligible and received systemic therapy and/or ablation.|
59839570|NCT02364557|75963599|FG000|Circulating Tumor Cells (CTC) Population|Overall Study||36|Eligible with blood collection consent and baseline CTC data|
59839571|NCT02364557|75963600|FG001|Circulating Tumor Cells (CTC) Population|Overall Study||26|Eligible with blood collection consent and baseline CTC data|
59839572|NCT02364557|75963599|FG000|COMPLETED|Overall Study||65|Participants contributing data to results are considered to have completed the study.|
59839573|NCT02364557|75963600|FG001|COMPLETED|Overall Study||60|Participants contributing data to results are considered to have completed the study.|
59839574|NCT02364557|75963599|FG000|NOT COMPLETED|Overall Study||3||
59839575|NCT02364557|75963600|FG001|NOT COMPLETED|Overall Study||1||
59839576|NCT01774487|75963615|FG000|STARTED|Overall Study||12||
59839577|NCT01774487|75963616|FG001|STARTED|Overall Study||5||
59839578|NCT01774487|75963615|FG000|COMPLETED|Overall Study||8||
59839579|NCT01774487|75963616|FG001|COMPLETED|Overall Study||1||
59839580|NCT01774487|75963615|FG000|NOT COMPLETED|Overall Study||4||
59839581|NCT01774487|75963616|FG001|NOT COMPLETED|Overall Study||4||
59839582|NCT01763645|75963634|FG000|STARTED|Overall Study||211||
59839583|NCT01763645|75963635|FG001|STARTED|Overall Study||142||
59839584|NCT01763645|75963634|FG000|Received at Least 1 Dose of Study Drug|Overall Study||206||
59839585|NCT01763645|75963635|FG001|Received at Least 1 Dose of Study Drug|Overall Study||137||
59839586|NCT01763645|75963634|FG000|COMPLETED|Overall Study|Completed the study according the protocol.|87||
59839587|NCT01763645|75963635|FG001|COMPLETED|Overall Study|Completed the study according the protocol.|56||
59839588|NCT01763645|75963634|FG000|NOT COMPLETED|Overall Study||124||
59839589|NCT01763645|75963635|FG001|NOT COMPLETED|Overall Study||86||
60119510|NCT02703324|76240677|FG003|STARTED|Period Three||5||
60119511|NCT02703324|76240678|FG004|STARTED|Period Three||5||
59839590|NCT01740596|75963642|FG000|STARTED|Overall Study||19||16
59839591|NCT01740596|75963643|FG001|STARTED|Overall Study||19||0
59839592|NCT01740596|75963642|FG000|COMPLETED|Overall Study||0||0
59839593|NCT01740596|75963643|FG001|COMPLETED|Overall Study||0||0
59839594|NCT01740596|75963642|FG000|NOT COMPLETED|Overall Study||19||16
59839595|NCT01740596|75963643|FG001|NOT COMPLETED|Overall Study||19||0
59839596|NCT00905645|75963654|FG000|STARTED|Overall Study||1116||
59839597|NCT00905645|75963655|FG001|STARTED|Overall Study||363||
59839598|NCT00905645|75963656|FG002|STARTED|Overall Study||225||
59839599|NCT00905645|75963657|FG003|STARTED|Overall Study||84||
59839600|NCT00905645|75963654|FG000|COMPLETED|Overall Study||688||
59839601|NCT00905645|75963655|FG001|COMPLETED|Overall Study||192||
59839602|NCT00905645|75963656|FG002|COMPLETED|Overall Study||118||
59839603|NCT00905645|75963657|FG003|COMPLETED|Overall Study||32||
59839604|NCT00905645|75963654|FG000|NOT COMPLETED|Overall Study||428||
59839605|NCT00905645|75963655|FG001|NOT COMPLETED|Overall Study||171||
59839606|NCT00905645|75963656|FG002|NOT COMPLETED|Overall Study||107||
59839607|NCT00905645|75963657|FG003|NOT COMPLETED|Overall Study||52||
59839608|NCT00285584|75963669|FG000|STARTED|Enrollment (Month 0)||20||
59839609|NCT00285584|75963670|FG001|STARTED|Enrollment (Month 0)||21||
59839610|NCT00285584|75963669|FG000|COMPLETED|Enrollment (Month 0)||20||
59839611|NCT00285584|75963670|FG001|COMPLETED|Enrollment (Month 0)||21||
59839612|NCT00285584|75963669|FG000|NOT COMPLETED|Enrollment (Month 0)||0||
59839613|NCT00285584|75963670|FG001|NOT COMPLETED|Enrollment (Month 0)||0||
59839614|NCT00285584|75963669|FG000|STARTED|Month 3||20||
59839615|NCT00285584|75963670|FG001|STARTED|Month 3||21||
59839616|NCT00285584|75963669|FG000|COMPLETED|Month 3||16||
59839617|NCT00285584|75963670|FG001|COMPLETED|Month 3||18||
59839618|NCT00285584|75963669|FG000|NOT COMPLETED|Month 3||4||
59839619|NCT00285584|75963670|FG001|NOT COMPLETED|Month 3||3||
59839620|NCT00285584|75963669|FG000|STARTED|Month 6||16||
59839621|NCT00285584|75963670|FG001|STARTED|Month 6||18||
59839622|NCT00285584|75963669|FG000|COMPLETED|Month 6||16||
59839623|NCT00285584|75963670|FG001|COMPLETED|Month 6||17||
59839624|NCT00285584|75963669|FG000|NOT COMPLETED|Month 6||0||
59839625|NCT00285584|75963670|FG001|NOT COMPLETED|Month 6||1||
59839626|NCT00285584|75963669|FG000|STARTED|Month 9||16||
59839627|NCT00285584|75963670|FG001|STARTED|Month 9||17||
59839628|NCT00285584|75963669|FG000|COMPLETED|Month 9||15||
59839629|NCT00285584|75963670|FG001|COMPLETED|Month 9||14||
59839630|NCT00285584|75963669|FG000|NOT COMPLETED|Month 9||1||
59839631|NCT00285584|75963670|FG001|NOT COMPLETED|Month 9||3||
59839632|NCT03807700|75963682|FG000|STARTED|Overall Study||60||
59839633|NCT03807700|75963683|FG001|STARTED|Overall Study||59||
59839634|NCT03807700|75963682|FG000|COMPLETED|Overall Study||58||
59839635|NCT03807700|75963683|FG001|COMPLETED|Overall Study||58||
59839636|NCT03807700|75963682|FG000|NOT COMPLETED|Overall Study||2||
59839637|NCT03807700|75963683|FG001|NOT COMPLETED|Overall Study||1||
59839638|NCT00291668|75963693|FG000|STARTED|Overall Study||32||
59839639|NCT00291668|75963694|FG001|STARTED|Overall Study||30||
59839640|NCT00291668|75963695|FG002|STARTED|Overall Study||32||
59839641|NCT00291668|75963693|FG000|COMPLETED|Overall Study||28||
59839642|NCT00291668|75963694|FG001|COMPLETED|Overall Study||29||
59839643|NCT00291668|75963695|FG002|COMPLETED|Overall Study||31||
59839644|NCT00291668|75963693|FG000|NOT COMPLETED|Overall Study||4||
59839645|NCT00291668|75963694|FG001|NOT COMPLETED|Overall Study||1||
59839646|NCT00291668|75963695|FG002|NOT COMPLETED|Overall Study||1||
59839647|NCT00458393|75963705|FG000|STARTED|Overall Study||1251||
59839648|NCT00458393|75963706|FG001|STARTED|Overall Study||1248||
59839649|NCT00458393|75963705|FG000|COMPLETED|Overall Study||942||
59567692|NCT02325414|75670504|FG000|NOT COMPLETED|Overall Study||8||
59839650|NCT00458393|75963706|FG001|COMPLETED|Overall Study||953||
59839651|NCT00458393|75963705|FG000|NOT COMPLETED|Overall Study||309||
59839652|NCT00458393|75963706|FG001|NOT COMPLETED|Overall Study||295||
59839653|NCT00310856|75963717|FG000|STARTED|Overall Study||64||
59839654|NCT00310856|75963718|FG001|STARTED|Overall Study||61||
59839655|NCT00310856|75963719|FG002|STARTED|Overall Study||50||
59839656|NCT00310856|75963717|FG000|COMPLETED|Overall Study||59||
59839657|NCT00310856|75963718|FG001|COMPLETED|Overall Study||56||
59839658|NCT00310856|75963719|FG002|COMPLETED|Overall Study||42||
59839659|NCT00310856|75963717|FG000|NOT COMPLETED|Overall Study||5||
59839660|NCT00310856|75963718|FG001|NOT COMPLETED|Overall Study||5||
59839661|NCT00310856|75963719|FG002|NOT COMPLETED|Overall Study||8||
59839662|NCT00283712|75963730|FG000|STARTED|Overall Study||10||
59839663|NCT00283712|75963731|FG001|STARTED|Overall Study||10||
59839664|NCT00283712|75963730|FG000|Intent-to-treat Sample|Overall Study||10||
59839665|NCT00283712|75963731|FG001|Intent-to-treat Sample|Overall Study||10||
59567693|NCT02325414|75670505|FG001|NOT COMPLETED|Overall Study||6||
59567694|NCT01888484|75670513|FG000|STARTED|Overall Study||12||
59567695|NCT01888484|75670514|FG001|STARTED|Overall Study||14||
59567696|NCT01888484|75670515|FG002|STARTED|Overall Study||12||
59567697|NCT01888484|75670516|FG003|STARTED|Overall Study||37||
59567698|NCT01888484|75670513|FG000|COMPLETED|Overall Study||12||
59567699|NCT01888484|75670514|FG001|COMPLETED|Overall Study||14||
59567700|NCT01888484|75670515|FG002|COMPLETED|Overall Study||8||
59567701|NCT01888484|75670516|FG003|COMPLETED|Overall Study||34||
59567702|NCT01888484|75670513|FG000|NOT COMPLETED|Overall Study||0||
59567703|NCT01888484|75670514|FG001|NOT COMPLETED|Overall Study||0||
59567704|NCT01888484|75670515|FG002|NOT COMPLETED|Overall Study||4||
59839666|NCT00283712|75963730|FG000|Safety Sample|Overall Study||10||
59839667|NCT00283712|75963731|FG001|Safety Sample|Overall Study||10||
59839668|NCT00283712|75963730|FG000|Per-Protocol Sample|Overall Study||6||
59839669|NCT00283712|75963731|FG001|Per-Protocol Sample|Overall Study||7||
59839670|NCT00283712|75963730|FG000|COMPLETED|Overall Study||10||
59567705|NCT01888484|75670516|FG003|NOT COMPLETED|Overall Study||3||
59567706|NCT02349048|75670523|FG000|STARTED|Overall Study||59||
59567707|NCT02349048|75670524|FG001|STARTED|Overall Study||9||
59718526|NCT00901576|75837822|FG005|STARTED|First Intervention||6||
59718527|NCT00901576|75837817|FG000|COMPLETED|First Intervention||6||
59718528|NCT00901576|75837818|FG001|COMPLETED|First Intervention||7||
59718529|NCT00901576|75837819|FG002|COMPLETED|First Intervention||7||
59718530|NCT00901576|75837820|FG003|COMPLETED|First Intervention||6||
59718531|NCT00901576|75837821|FG004|COMPLETED|First Intervention||6||
59718532|NCT00901576|75837822|FG005|COMPLETED|First Intervention||6||
59718533|NCT00901576|75837817|FG000|NOT COMPLETED|First Intervention||0||
59718534|NCT00901576|75837818|FG001|NOT COMPLETED|First Intervention||0||
59718535|NCT00901576|75837819|FG002|NOT COMPLETED|First Intervention||0||
59718536|NCT00901576|75837820|FG003|NOT COMPLETED|First Intervention||0||
59718537|NCT00901576|75837821|FG004|NOT COMPLETED|First Intervention||0||
59718538|NCT00901576|75837822|FG005|NOT COMPLETED|First Intervention||0||
59718539|NCT00901576|75837817|FG000|STARTED|Washout||6||
59718540|NCT00901576|75837818|FG001|STARTED|Washout||7||
59718541|NCT00901576|75837819|FG002|STARTED|Washout||7||
59718542|NCT00901576|75837820|FG003|STARTED|Washout||6||
59718543|NCT00901576|75837821|FG004|STARTED|Washout||6||
59718544|NCT00901576|75837822|FG005|STARTED|Washout||6||
59718545|NCT00901576|75837817|FG000|COMPLETED|Washout||6||
59718546|NCT00901576|75837818|FG001|COMPLETED|Washout||7||
59718547|NCT00901576|75837819|FG002|COMPLETED|Washout||7||
59718548|NCT00901576|75837820|FG003|COMPLETED|Washout||6||
59718549|NCT00901576|75837821|FG004|COMPLETED|Washout||6||
59718550|NCT00901576|75837822|FG005|COMPLETED|Washout||6||
59718551|NCT00901576|75837817|FG000|NOT COMPLETED|Washout||0||
59718552|NCT00901576|75837818|FG001|NOT COMPLETED|Washout||0||
59718553|NCT00901576|75837819|FG002|NOT COMPLETED|Washout||0||
59718554|NCT00901576|75837820|FG003|NOT COMPLETED|Washout||0||
59718555|NCT00901576|75837821|FG004|NOT COMPLETED|Washout||0||
59718556|NCT00901576|75837822|FG005|NOT COMPLETED|Washout||0||
59718557|NCT00901576|75837817|FG000|STARTED|Second Intervention||6||
59718558|NCT00901576|75837818|FG001|STARTED|Second Intervention||7||
59718559|NCT00901576|75837819|FG002|STARTED|Second Intervention||7||
59718560|NCT00901576|75837820|FG003|STARTED|Second Intervention||6||
59718561|NCT00901576|75837821|FG004|STARTED|Second Intervention||6||
59718562|NCT00901576|75837822|FG005|STARTED|Second Intervention||6||
59718563|NCT00901576|75837817|FG000|COMPLETED|Second Intervention||5||
59718564|NCT00901576|75837818|FG001|COMPLETED|Second Intervention||7||
59718565|NCT00901576|75837819|FG002|COMPLETED|Second Intervention||7||
59718566|NCT00901576|75837820|FG003|COMPLETED|Second Intervention||5||
59718567|NCT00901576|75837821|FG004|COMPLETED|Second Intervention||6||
59718568|NCT00901576|75837822|FG005|COMPLETED|Second Intervention||5||
59718569|NCT00901576|75837817|FG000|NOT COMPLETED|Second Intervention||1||
59718570|NCT00901576|75837818|FG001|NOT COMPLETED|Second Intervention||0||
59718571|NCT00901576|75837819|FG002|NOT COMPLETED|Second Intervention||0||
59718572|NCT00901576|75837820|FG003|NOT COMPLETED|Second Intervention||1||
59718573|NCT00901576|75837821|FG004|NOT COMPLETED|Second Intervention||0||
59718574|NCT00901576|75837822|FG005|NOT COMPLETED|Second Intervention||1||
59718575|NCT00901576|75837817|FG000|STARTED|Washout||5||
59718576|NCT00901576|75837818|FG001|STARTED|Washout||7||
59718577|NCT00901576|75837819|FG002|STARTED|Washout||7||
59718578|NCT00901576|75837820|FG003|STARTED|Washout||5||
59718579|NCT00901576|75837821|FG004|STARTED|Washout||6||
59718580|NCT00901576|75837822|FG005|STARTED|Washout||5||
59718581|NCT00901576|75837817|FG000|COMPLETED|Washout||5||
59718582|NCT00901576|75837818|FG001|COMPLETED|Washout||7||
59718583|NCT00901576|75837819|FG002|COMPLETED|Washout||7||
59718584|NCT00901576|75837820|FG003|COMPLETED|Washout||5||
59718585|NCT00901576|75837821|FG004|COMPLETED|Washout||6||
59718586|NCT00901576|75837822|FG005|COMPLETED|Washout||5||
59567708|NCT02349048|75670523|FG000|COMPLETED|Overall Study||54||
59718587|NCT00901576|75837817|FG000|NOT COMPLETED|Washout||0||
59718588|NCT00901576|75837818|FG001|NOT COMPLETED|Washout||0||
59567709|NCT02349048|75670524|FG001|COMPLETED|Overall Study||9||
59567710|NCT02349048|75670523|FG000|NOT COMPLETED|Overall Study||5||
59567711|NCT02349048|75670524|FG001|NOT COMPLETED|Overall Study||0||
59567712|NCT01280643|75670539|FG000|STARTED|Overall Study||0||
59567713|NCT01280643|75670540|FG001|STARTED|Overall Study||1||
59567714|NCT01280643|75670541|FG002|STARTED|Overall Study||1||
59567715|NCT01280643|75670542|FG003|STARTED|Overall Study||1||
59567716|NCT01280643|75670543|FG004|STARTED|Overall Study||0||
59718589|NCT00901576|75837819|FG002|NOT COMPLETED|Washout||0||
59718590|NCT00901576|75837820|FG003|NOT COMPLETED|Washout||0||
59718591|NCT00901576|75837821|FG004|NOT COMPLETED|Washout||0||
59718592|NCT00901576|75837822|FG005|NOT COMPLETED|Washout||0||
59718593|NCT00901576|75837817|FG000|STARTED|Third Intervention||5||
59718594|NCT00901576|75837818|FG001|STARTED|Third Intervention||7||
59718595|NCT00901576|75837819|FG002|STARTED|Third Intervention||7||
59567717|NCT01280643|75670544|FG005|STARTED|Overall Study||0||
59567718|NCT01280643|75670545|FG006|STARTED|Overall Study||0||
59567719|NCT01280643|75670546|FG007|STARTED|Overall Study||0||
59718596|NCT00901576|75837820|FG003|STARTED|Third Intervention||5||
59718597|NCT00901576|75837821|FG004|STARTED|Third Intervention||6||
59839671|NCT00283712|75963731|FG001|COMPLETED|Overall Study|One subject in placebo arm died prior to study completion.|9||
59839672|NCT00283712|75963730|FG000|NOT COMPLETED|Overall Study||0||
59839673|NCT00283712|75963731|FG001|NOT COMPLETED|Overall Study||1||
59839674|NCT00048724|75963739|FG000|STARTED|Overall Study||311||
59839675|NCT00048724|75963740|FG001|STARTED|Overall Study||315||
59839676|NCT00048724|75963739|FG000|COMPLETED|Overall Study||195||
59839677|NCT00048724|75963740|FG001|COMPLETED|Overall Study||197||
59839678|NCT00048724|75963739|FG000|NOT COMPLETED|Overall Study||116||
59839679|NCT00048724|75963740|FG001|NOT COMPLETED|Overall Study||118||
59839680|NCT00449033|75963748|FG000|STARTED|Treatment Period||452||
59839681|NCT00449033|75963749|FG001|STARTED|Treatment Period|Reasons for not treated: Adverse event (N=1); Consent withdrawn (N=1); Reason missing (N=1)|452||
59839682|NCT00449033|75963748|FG000|Received Treatment|Treatment Period||452||
59839683|NCT00449033|75963749|FG001|Received Treatment|Treatment Period||449||
59839684|NCT00449033|75963748|FG000|COMPLETED|Treatment Period||0||
59839685|NCT00449033|75963749|FG001|COMPLETED|Treatment Period||0||
59839686|NCT00449033|75963748|FG000|NOT COMPLETED|Treatment Period||452||
59839687|NCT00449033|75963749|FG001|NOT COMPLETED|Treatment Period||452||
59839688|NCT00449033|75963748|FG000|STARTED|Follow-up Period|425 entered, comprising 452 randomized less 21 deaths & 6 ongoing on treatment|425||
59839689|NCT00449033|75963749|FG001|STARTED|Follow-up Period|434 entered, comprising 452 randomized less 12 deaths, 2 lost to follow-up & 4 ongoing on treatment|434||
59839690|NCT00449033|75963748|FG000|COMPLETED|Follow-up Period||0||
59839691|NCT00449033|75963749|FG001|COMPLETED|Follow-up Period||0||
59839692|NCT00449033|75963748|FG000|NOT COMPLETED|Follow-up Period||425||
59839693|NCT00449033|75963749|FG001|NOT COMPLETED|Follow-up Period||434||
59839694|NCT00448019|75963755|FG000|STARTED|Overall Study||64||
59839695|NCT00448019|75963755|FG000|COMPLETED|Overall Study||57||
59839696|NCT00448019|75963755|FG000|NOT COMPLETED|Overall Study||7||
59839697|NCT00457691|75963761|FG000|STARTED|Overall Study||386||
59839698|NCT00457691|75963762|FG001|STARTED|Overall Study||382||
59839699|NCT00457691|75963761|FG000|COMPLETED|Overall Study||0||
59839700|NCT00457691|75963762|FG001|COMPLETED|Overall Study||0||
59839701|NCT00457691|75963761|FG000|NOT COMPLETED|Overall Study||386||
59839702|NCT00457691|75963762|FG001|NOT COMPLETED|Overall Study||382||
59839703|NCT00457301|75963770|FG000|STARTED|Overall Study||105||
59839704|NCT00457301|75963771|FG001|STARTED|Overall Study||108||
59839705|NCT00457301|75963770|FG000|COMPLETED|Overall Study||82||
59839706|NCT00457301|75963771|FG001|COMPLETED|Overall Study||84||
59839707|NCT00457301|75963770|FG000|NOT COMPLETED|Overall Study||23||
59839708|NCT00457301|75963771|FG001|NOT COMPLETED|Overall Study||24||
59839709|NCT00456755|75963779|FG000|STARTED|Overall Study||63||
59839710|NCT00456755|75963780|FG001|STARTED|Overall Study||63||
59718598|NCT00901576|75837822|FG005|STARTED|Third Intervention||5||
59718599|NCT00901576|75837817|FG000|COMPLETED|Third Intervention||5||
59718600|NCT00901576|75837818|FG001|COMPLETED|Third Intervention||7||
59718601|NCT00901576|75837819|FG002|COMPLETED|Third Intervention||7||
59718602|NCT00901576|75837820|FG003|COMPLETED|Third Intervention||5||
59718603|NCT00901576|75837821|FG004|COMPLETED|Third Intervention||6||
59718604|NCT00901576|75837822|FG005|COMPLETED|Third Intervention||5||
59718605|NCT00901576|75837817|FG000|NOT COMPLETED|Third Intervention||0||
59718606|NCT00901576|75837818|FG001|NOT COMPLETED|Third Intervention||0||
59718607|NCT00901576|75837819|FG002|NOT COMPLETED|Third Intervention||0||
59718608|NCT00901576|75837820|FG003|NOT COMPLETED|Third Intervention||0||
59839711|NCT00456755|75963779|FG000|COMPLETED|Overall Study||61||
59839712|NCT00456755|75963780|FG001|COMPLETED|Overall Study||62||
59839713|NCT00456755|75963779|FG000|NOT COMPLETED|Overall Study||2||
59839714|NCT00456755|75963780|FG001|NOT COMPLETED|Overall Study||1||
59839715|NCT00447005|75963786|FG000|STARTED|Overall Study||12||
59839716|NCT00447005|75963786|FG000|COMPLETED|Overall Study||0||
59839717|NCT00447005|75963786|FG000|NOT COMPLETED|Overall Study||12||
59839718|NCT00446849|75963790|FG000|STARTED|Acute Phase||138||
59839719|NCT00446849|75963790|FG000|COMPLETED|Acute Phase||56||
59839720|NCT00446849|75963790|FG000|NOT COMPLETED|Acute Phase||82||
59839721|NCT00446849|75963790|FG000|STARTED|Maintenance Phase||208||
59839722|NCT00446849|75963790|FG000|COMPLETED|Maintenance Phase||138||
59839723|NCT00446849|75963790|FG000|NOT COMPLETED|Maintenance Phase||70||
59718609|NCT00901576|75837821|FG004|NOT COMPLETED|Third Intervention||0||
59718610|NCT00901576|75837822|FG005|NOT COMPLETED|Third Intervention||0||
59718611|NCT00882583|75837832|FG000|STARTED|Overall Study||7||
60119512|NCT02703324|76240679|FG005|STARTED|Period Three||5||
59839724|NCT00446459|75963795|FG000|STARTED|8 Months|34 subjects received any amount of MMF.|34||
59839725|NCT00446459|75963795|FG000|COMPLETED|8 Months|22 subjects were on study at month 8.|22||
59839726|NCT00446459|75963795|FG000|NOT COMPLETED|8 Months||12||
59839727|NCT00446459|75963795|FG000|STARTED|12 Months|22 subjects remained on-study at month 8|22||
59839728|NCT00446459|75963795|FG000|COMPLETED|12 Months|4 subjects remained at month 12|4||
59839729|NCT00446459|75963795|FG000|NOT COMPLETED|12 Months||18||
59839730|NCT00456599|75963799|FG000|STARTED|Overall Study||71||
59839731|NCT00456599|75963799|FG000|Completed Cycle 1|Overall Study|Of the 71 patients, 1 was removed for noncompliance; 2 withdrew; 2 did not complete cycle 1.|66||
59839732|NCT00456599|75963799|FG000|Initiated Cycle 2|Overall Study|5 patients were removed from study prior to initiation of a second cycle.|61||
59839733|NCT00456599|75963799|FG000|Completed Protocol Surgery|Overall Study|Forty-eight patients (71%) underwent laparotomy according to the protocol.|48||
59839734|NCT00456599|75963799|FG000|Completed Resection|Overall Study|43 patients underwent resection.|43||
59839735|NCT00456599|75963799|FG000|Post-Surgery Adjuvent Therapy|Overall Study|After resection, 26 patients (68%) initiated adjuvant therapy.|26||
59839736|NCT00456599|75963799|FG000|Completed 4th Cycle of Chemotherapy|Overall Study|24 patients (63%) completed a fourth cycle of chemotherapy.|24||
59839737|NCT00456599|75963799|FG000|COMPLETED|Overall Study||68||
59839738|NCT00456599|75963799|FG000|NOT COMPLETED|Overall Study||3||
59839739|NCT00456521|75963805|FG000|STARTED|Overall Study||591||
59839740|NCT00456521|75963806|FG001|STARTED|Overall Study||202||
59839741|NCT00456521|75963805|FG000|COMPLETED|Overall Study||342||
59839742|NCT00456521|75963806|FG001|COMPLETED|Overall Study||118||
59839743|NCT00456521|75963805|FG000|NOT COMPLETED|Overall Study||249||
59839744|NCT00456521|75963806|FG001|NOT COMPLETED|Overall Study||84||
59839745|NCT00456365|75963815|FG000|STARTED|Overall Study||56||
59839746|NCT00456365|75963816|FG001|STARTED|Overall Study||54||
59839747|NCT00456365|75963815|FG000|COMPLETED|Overall Study||49||
59839748|NCT00456365|75963816|FG001|COMPLETED|Overall Study||42||
59839749|NCT00456365|75963815|FG000|NOT COMPLETED|Overall Study||7||
59839750|NCT00456365|75963816|FG001|NOT COMPLETED|Overall Study||12||
59839751|NCT00455741|75963826|FG000|STARTED|Overall Study||13||
59839752|NCT00455741|75963827|FG001|STARTED|Overall Study||12||
59839753|NCT00455741|75963826|FG000|COMPLETED|Overall Study||13||
59839754|NCT00455741|75963827|FG001|COMPLETED|Overall Study||11||
59839755|NCT00455741|75963826|FG000|NOT COMPLETED|Overall Study||0||
59839756|NCT00455741|75963827|FG001|NOT COMPLETED|Overall Study||1||
59839757|NCT00445679|75963847|FG000|STARTED|Overall Study||203||
59839758|NCT00445679|75963848|FG001|STARTED|Overall Study||203||
59839759|NCT00445679|75963849|FG002|STARTED|Overall Study||205||
59839760|NCT00445679|75963850|FG003|STARTED|Overall Study||196||
59839761|NCT00445679|75963847|FG000|COMPLETED|Overall Study||155||
59839762|NCT00445679|75963848|FG001|COMPLETED|Overall Study||157||
59839763|NCT00445679|75963849|FG002|COMPLETED|Overall Study||139||
59839764|NCT00445679|75963850|FG003|COMPLETED|Overall Study||149||
59839765|NCT00445679|75963847|FG000|NOT COMPLETED|Overall Study||48||
59839766|NCT00445679|75963848|FG001|NOT COMPLETED|Overall Study||46||
59839767|NCT00445679|75963849|FG002|NOT COMPLETED|Overall Study||66||
59718612|NCT00882583|75837833|FG001|STARTED|Overall Study||12||
59718613|NCT00882583|75837832|FG000|COMPLETED|Overall Study||6||
59718614|NCT00882583|75837833|FG001|COMPLETED|Overall Study||11||
59718615|NCT00882583|75837832|FG000|NOT COMPLETED|Overall Study||1||
59718616|NCT00882583|75837833|FG001|NOT COMPLETED|Overall Study||1||
59718617|NCT00900562|75837841|FG000|STARTED|Overall Study||12||
59718618|NCT00900562|75837842|FG001|STARTED|Overall Study||7||
59718619|NCT00900562|75837841|FG000|COMPLETED|Overall Study||0||
59718620|NCT00900562|75837842|FG001|COMPLETED|Overall Study||0||
59718621|NCT00900562|75837841|FG000|NOT COMPLETED|Overall Study||12||
59718622|NCT00900562|75837842|FG001|NOT COMPLETED|Overall Study||7||
59718623|NCT00599521|75837851|FG000|STARTED|Overall Study||535||
59718624|NCT00599521|75837852|FG001|STARTED|Overall Study||531||
59718625|NCT00599521|75837851|FG000|COMPLETED|Overall Study||475||
59718626|NCT00599521|75837852|FG001|COMPLETED|Overall Study||462||
59718627|NCT00599521|75837851|FG000|NOT COMPLETED|Overall Study||60||
59718628|NCT00599521|75837852|FG001|NOT COMPLETED|Overall Study||69||
59839768|NCT00445679|75963850|FG003|NOT COMPLETED|Overall Study||47||
59839769|NCT00455429|75963864|FG000|STARTED|Overall Study||18||
59839770|NCT00455429|75963865|FG001|STARTED|Overall Study||15||
59839771|NCT00455429|75963866|FG002|STARTED|Overall Study||17||
59839772|NCT00455429|75963867|FG003|STARTED|Overall Study||34||
59718629|NCT00882115|75837858|FG000|STARTED|Overall Study||38||
59718630|NCT00882115|75837858|FG000|COMPLETED|Overall Study||29||
59718631|NCT00882115|75837858|FG000|NOT COMPLETED|Overall Study||9||
59839773|NCT00455429|75963864|FG000|Treated|Overall Study||18||
59839774|NCT00455429|75963865|FG001|Treated|Overall Study||15||
59839775|NCT00455429|75963866|FG002|Treated|Overall Study||17||
59839776|NCT00455429|75963867|FG003|Treated|Overall Study||32||
59839777|NCT00455429|75963864|FG000|COMPLETED|Overall Study||16||
59718632|NCT00881959|75837864|FG000|STARTED|Overall Study||38||
59718633|NCT00881959|75837865|FG001|STARTED|Overall Study||42||
59718634|NCT00881959|75837864|FG000|COMPLETED|Overall Study||36||
59718635|NCT00881959|75837865|FG001|COMPLETED|Overall Study||38||
59839778|NCT00455429|75963865|FG001|COMPLETED|Overall Study||10||
59839779|NCT00455429|75963866|FG002|COMPLETED|Overall Study||16||
59839780|NCT00455429|75963867|FG003|COMPLETED|Overall Study||20||
59839781|NCT00455429|75963864|FG000|NOT COMPLETED|Overall Study||2||
59839782|NCT00455429|75963865|FG001|NOT COMPLETED|Overall Study||5||
59839783|NCT00455429|75963866|FG002|NOT COMPLETED|Overall Study||1||
59839784|NCT00455429|75963867|FG003|NOT COMPLETED|Overall Study||14||
60119513|NCT02703324|76240674|FG000|Received Study Drug|Period Three||5||
60119514|NCT02703324|76240675|FG001|Received Study Drug|Period Three||5||
60119515|NCT02703324|76240676|FG002|Received Study Drug|Period Three||4||
60119516|NCT02703324|76240677|FG003|Received Study Drug|Period Three||5||
60119517|NCT02703324|76240678|FG004|Received Study Drug|Period Three||5||
60119518|NCT02703324|76240679|FG005|Received Study Drug|Period Three||5||
60119519|NCT02703324|76240674|FG000|COMPLETED|Period Three||5||
60119520|NCT02703324|76240675|FG001|COMPLETED|Period Three|One participant discontinued after Period 3. Did not enter Period 4.|5||
60119521|NCT02703324|76240676|FG002|COMPLETED|Period Three||4||
60119522|NCT02703324|76240677|FG003|COMPLETED|Period Three||5||
60119523|NCT02703324|76240678|FG004|COMPLETED|Period Three||5||
60119524|NCT02703324|76240679|FG005|COMPLETED|Period Three||5||
60119525|NCT02703324|76240674|FG000|NOT COMPLETED|Period Three||0||
60119526|NCT02703324|76240675|FG001|NOT COMPLETED|Period Three||0||
60119527|NCT02703324|76240676|FG002|NOT COMPLETED|Period Three||0||
60119528|NCT02703324|76240677|FG003|NOT COMPLETED|Period Three||0||
60119529|NCT02703324|76240678|FG004|NOT COMPLETED|Period Three||0||
60119530|NCT02703324|76240679|FG005|NOT COMPLETED|Period Three||0||
60119531|NCT02703324|76240674|FG000|STARTED|Period Four||5||
60119532|NCT02703324|76240675|FG001|STARTED|Period Four|One participant discontinued after Period 3. Did not enter Period 4.|4||
60119533|NCT02703324|76240676|FG002|STARTED|Period Four||4||
60119534|NCT02703324|76240677|FG003|STARTED|Period Four||5||
60119535|NCT02703324|76240678|FG004|STARTED|Period Four||5||
60119536|NCT02703324|76240679|FG005|STARTED|Period Four||5||
60119537|NCT02703324|76240674|FG000|Received Study Drug|Period Four||5||
60119538|NCT02703324|76240675|FG001|Received Study Drug|Period Four||4||
60119539|NCT02703324|76240676|FG002|Received Study Drug|Period Four||4||
60119540|NCT02703324|76240677|FG003|Received Study Drug|Period Four||5||
60119541|NCT02703324|76240678|FG004|Received Study Drug|Period Four||5||
60119542|NCT02703324|76240679|FG005|Received Study Drug|Period Four||5||
60119543|NCT02703324|76240674|FG000|COMPLETED|Period Four||5||
60119544|NCT02703324|76240675|FG001|COMPLETED|Period Four||4||
60119545|NCT02703324|76240676|FG002|COMPLETED|Period Four||4||
60119546|NCT02703324|76240677|FG003|COMPLETED|Period Four||5||
60119547|NCT02703324|76240678|FG004|COMPLETED|Period Four||5||
60119548|NCT02703324|76240679|FG005|COMPLETED|Period Four||5||
60119549|NCT02703324|76240674|FG000|NOT COMPLETED|Period Four||0||
60119550|NCT02703324|76240675|FG001|NOT COMPLETED|Period Four||0||
60119551|NCT02703324|76240676|FG002|NOT COMPLETED|Period Four||0||
60119552|NCT02703324|76240677|FG003|NOT COMPLETED|Period Four||0||
60119553|NCT02703324|76240678|FG004|NOT COMPLETED|Period Four||0||
60119554|NCT02703324|76240679|FG005|NOT COMPLETED|Period Four||0||
60119555|NCT02701764|76240690|FG000|STARTED|Overall Study||21||
60119556|NCT02701764|76240691|FG001|STARTED|Overall Study||22||
60119557|NCT02701764|76240690|FG000|COMPLETED|Overall Study||21||
60119558|NCT02701764|76240691|FG001|COMPLETED|Overall Study||21||
59718636|NCT00881959|75837864|FG000|NOT COMPLETED|Overall Study||2||
59718637|NCT00881959|75837865|FG001|NOT COMPLETED|Overall Study||4||
59718638|NCT00884377|75837873|FG000|STARTED|Overall Study|1 not treated because infecting parasite could not be confirmed as L. major on rapid PCR testing,|28||
59718639|NCT00884377|75837874|FG001|STARTED|Overall Study|1 was not treated due to concerns arising from the location of cutaneous leishmaniasis lesion|28||
59718640|NCT00884377|75837873|FG000|COMPLETED|Overall Study|1 received full course of therapy,withdrew consent before completion of the 12 month follow up|26||
59718641|NCT00884377|75837874|FG001|COMPLETED|Overall Study||27||
59718642|NCT00884377|75837873|FG000|NOT COMPLETED|Overall Study||2||
59718643|NCT00884377|75837874|FG001|NOT COMPLETED|Overall Study||1||
59718644|NCT00884221|75837888|FG000|STARTED|Overall Study||374||
59718645|NCT00884221|75837889|FG001|STARTED|Overall Study||375||
59718646|NCT00884221|75837888|FG000|COMPLETED|Overall Study||340||
59718647|NCT00884221|75837889|FG001|COMPLETED|Overall Study||343||
59718648|NCT00884221|75837888|FG000|NOT COMPLETED|Overall Study||34||
60119559|NCT02701764|76240690|FG000|NOT COMPLETED|Overall Study||0||
60119560|NCT02701764|76240691|FG001|NOT COMPLETED|Overall Study||1||
60119561|NCT02532010|76240699|FG000|STARTED|Overall Study||9||
60119562|NCT02532010|76240700|FG001|STARTED|Overall Study||4||
60119563|NCT02532010|76240699|FG000|COMPLETED|Overall Study||0||
60119564|NCT02532010|76240700|FG001|COMPLETED|Overall Study||0||
60119565|NCT02532010|76240699|FG000|NOT COMPLETED|Overall Study||9||
60119566|NCT02532010|76240700|FG001|NOT COMPLETED|Overall Study||4||
59839785|NCT00445601|75963882|FG000|STARTED|Overall Study||201|Randomized to Treatment Arm|
59839786|NCT00445601|75963883|FG001|STARTED|Overall Study||205|Randomized to Treatment Arm|
59839787|NCT00445601|75963882|FG000|Received TURBT|Overall Study||190||
59839788|NCT00445601|75963883|FG001|Received TURBT|Overall Study||193||
59839789|NCT00445601|75963882|FG000|COMPLETED|Overall Study||168|Received Drug Instillation|
59839790|NCT00445601|75963883|FG001|COMPLETED|Overall Study||177|Received Drug Instillation|
59839791|NCT00445601|75963882|FG000|NOT COMPLETED|Overall Study||33||
59839792|NCT00445601|75963883|FG001|NOT COMPLETED|Overall Study||28||
59839793|NCT00444587|75963895|FG000|STARTED|Overall Study||93||
59839794|NCT00444587|75963896|FG001|STARTED|Overall Study||16||
59839795|NCT00444587|75963895|FG000|COMPLETED|Overall Study||10||
59839796|NCT00444587|75963896|FG001|COMPLETED|Overall Study||1||
59839797|NCT00444587|75963895|FG000|NOT COMPLETED|Overall Study||83||
59839798|NCT00444587|75963896|FG001|NOT COMPLETED|Overall Study||15||
59839799|NCT00455195|75963906|FG000|STARTED|Double-blind Study AGLU02704|Patients randomized to alglucosidase alfa treatment group in AGLU02704 (NCT00158600).|60||
59839800|NCT00455195|75963907|FG001|STARTED|Double-blind Study AGLU02704|See study AGLU02704 (NCT00158600) for results while on placebo.|30||
59839801|NCT00455195|75963906|FG000|COMPLETED|Double-blind Study AGLU02704||55||
59839802|NCT00455195|75963907|FG001|COMPLETED|Double-blind Study AGLU02704||26||
59839803|NCT00455195|75963906|FG000|NOT COMPLETED|Double-blind Study AGLU02704||5||
59839804|NCT00455195|75963907|FG001|NOT COMPLETED|Double-blind Study AGLU02704||4||
59839805|NCT00455195|75963906|FG000|STARTED|Extension Study AGLU03206||55||
59839806|NCT00455195|75963907|FG001|STARTED|Extension Study AGLU03206|These 26 participants completed placebo double-blind treatment in the AGLU02704 (NCT00158600) study.|26||
59839807|NCT00455195|75963906|FG000|COMPLETED|Extension Study AGLU03206||55||
59839808|NCT00455195|75963907|FG001|COMPLETED|Extension Study AGLU03206||26||
59839809|NCT00455195|75963906|FG000|NOT COMPLETED|Extension Study AGLU03206||0||
59839810|NCT00455195|75963907|FG001|NOT COMPLETED|Extension Study AGLU03206||0||
59839811|NCT00235716|75963917|FG000|STARTED|Overall Study||152||
59839812|NCT00235716|75963918|FG001|STARTED|Overall Study||155||
59839813|NCT00235716|75963919|FG002|STARTED|Overall Study||154||
59839814|NCT00235716|75963920|FG003|STARTED|Overall Study||152||
59839815|NCT00235716|75963917|FG000|COMPLETED|Overall Study||90||
59839816|NCT00235716|75963918|FG001|COMPLETED|Overall Study||88||
59839817|NCT00235716|75963919|FG002|COMPLETED|Overall Study||89||
59839818|NCT00235716|75963920|FG003|COMPLETED|Overall Study||90||
59839819|NCT00235716|75963917|FG000|NOT COMPLETED|Overall Study||62||
59839820|NCT00235716|75963918|FG001|NOT COMPLETED|Overall Study||67||
59839821|NCT00235716|75963919|FG002|NOT COMPLETED|Overall Study||65||
59839822|NCT00235716|75963920|FG003|NOT COMPLETED|Overall Study||62||
59839823|NCT00274742|75963936|FG000|STARTED|Overall Study||12||
59839824|NCT00274742|75963937|FG001|STARTED|Overall Study||13||
59839825|NCT00274742|75963938|FG002|STARTED|Overall Study||6||
59839826|NCT00274742|75963939|FG003|STARTED|Overall Study||9||
59839827|NCT00274742|75963940|FG004|STARTED|Overall Study||32||
59839828|NCT00274742|75963941|FG005|STARTED|Overall Study||4||
59839829|NCT00274742|75963936|FG000|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|12||
59839830|NCT00274742|75963937|FG001|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|5||
59839831|NCT00274742|75963938|FG002|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|4||
59839832|NCT00274742|75963939|FG003|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|4||
59839833|NCT00274742|75963940|FG004|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|16||
59839834|NCT00274742|75963941|FG005|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|1||
59839835|NCT00274742|75963936|FG000|NOT COMPLETED|Overall Study||0||
59839836|NCT00274742|75963937|FG001|NOT COMPLETED|Overall Study||8||
59839837|NCT00274742|75963938|FG002|NOT COMPLETED|Overall Study||2||
59839838|NCT00274742|75963939|FG003|NOT COMPLETED|Overall Study||5||
59839839|NCT00274742|75963940|FG004|NOT COMPLETED|Overall Study||16||
59839840|NCT00274742|75963941|FG005|NOT COMPLETED|Overall Study||3||
59839841|NCT00262314|75963961|FG000|STARTED|Overall Study|Patients with validated data who received at least 1 dose of Novantrone®|509||
59567720|NCT01280643|75670547|FG008|STARTED|Overall Study||0||
59839842|NCT00262314|75963961|FG000|COMPLETED|Overall Study|Patients in the study for 5 years +/-3 months are considered to have completed the 5-year study|172||
59839843|NCT00262314|75963961|FG000|NOT COMPLETED|Overall Study||337||
59839844|NCT00283400|75963969|FG000|STARTED|Overall Study||20||
59839845|NCT00283400|75963970|FG001|STARTED|Overall Study||20||
59839846|NCT00283400|75963971|FG002|STARTED|Overall Study||7||
59839847|NCT00283400|75963972|FG003|STARTED|Overall Study||0||
59839848|NCT00283400|75963969|FG000|COMPLETED|Overall Study||18||
59839849|NCT00283400|75963970|FG001|COMPLETED|Overall Study||19||
59839850|NCT00283400|75963971|FG002|COMPLETED|Overall Study||6||
59839851|NCT00283400|75963972|FG003|COMPLETED|Overall Study||0||
59839852|NCT00283400|75963969|FG000|NOT COMPLETED|Overall Study||2||
59567721|NCT01280643|75670539|FG000|COMPLETED|Overall Study||0||
59839853|NCT00283400|75963970|FG001|NOT COMPLETED|Overall Study||1||
59839854|NCT00283400|75963971|FG002|NOT COMPLETED|Overall Study||1||
59996564|NCT02714569|76112506|FG003|STARTED|Part A Second Intervention||3||
59839855|NCT00283400|75963972|FG003|NOT COMPLETED|Overall Study||0||
59839856|NCT00444275|75963985|FG000|STARTED|Initial Treatment Phase||2156||
59839857|NCT00444275|75963986|FG001|STARTED|Initial Treatment Phase||873||
59839858|NCT00444275|75963987|FG002|STARTED|Initial Treatment Phase||0||
59839859|NCT00444275|75963988|FG003|STARTED|Initial Treatment Phase||0||
59839860|NCT00444275|75963989|FG004|STARTED|Initial Treatment Phase||0||
59839861|NCT00444275|75963985|FG000|COMPLETED|Initial Treatment Phase||1908||
59839862|NCT00444275|75963986|FG001|COMPLETED|Initial Treatment Phase||777||
59839863|NCT00444275|75963987|FG002|COMPLETED|Initial Treatment Phase||0||
59839864|NCT00444275|75963988|FG003|COMPLETED|Initial Treatment Phase||0||
59839865|NCT00444275|75963989|FG004|COMPLETED|Initial Treatment Phase||0||
59839866|NCT00444275|75963985|FG000|NOT COMPLETED|Initial Treatment Phase||248||
59839867|NCT00444275|75963986|FG001|NOT COMPLETED|Initial Treatment Phase||96||
59839868|NCT00444275|75963987|FG002|NOT COMPLETED|Initial Treatment Phase||0||
59839869|NCT00444275|75963988|FG003|NOT COMPLETED|Initial Treatment Phase||0||
59718649|NCT00884221|75837889|FG001|NOT COMPLETED|Overall Study||32||
59718650|NCT02153632|75837900|FG000|STARTED|Overall Study||45||
59718651|NCT02153632|75837901|FG001|STARTED|Overall Study||46||
59839870|NCT00444275|75963989|FG004|NOT COMPLETED|Initial Treatment Phase||0||
59839871|NCT00444275|75963985|FG000|STARTED|Maintenance Treatment Phase||0||
59839872|NCT00444275|75963986|FG001|STARTED|Maintenance Treatment Phase||0||
59839873|NCT00444275|75963987|FG002|STARTED|Maintenance Treatment Phase||908||
59839874|NCT00444275|75963988|FG003|STARTED|Maintenance Treatment Phase||897||
59839875|NCT00444275|75963989|FG004|STARTED|Maintenance Treatment Phase||880||
59839876|NCT00444275|75963985|FG000|COMPLETED|Maintenance Treatment Phase||0||
59839877|NCT00444275|75963986|FG001|COMPLETED|Maintenance Treatment Phase||0||
59839878|NCT00444275|75963987|FG002|COMPLETED|Maintenance Treatment Phase||747||
59839879|NCT00444275|75963988|FG003|COMPLETED|Maintenance Treatment Phase||764||
59839880|NCT00444275|75963989|FG004|COMPLETED|Maintenance Treatment Phase||701||
59839881|NCT00444275|75963985|FG000|NOT COMPLETED|Maintenance Treatment Phase||0||
59839882|NCT00444275|75963986|FG001|NOT COMPLETED|Maintenance Treatment Phase||0||
59839883|NCT00444275|75963987|FG002|NOT COMPLETED|Maintenance Treatment Phase||161||
59839884|NCT00444275|75963988|FG003|NOT COMPLETED|Maintenance Treatment Phase||133||
59839885|NCT00444275|75963989|FG004|NOT COMPLETED|Maintenance Treatment Phase||179||
59839886|NCT00454805|75964006|FG000|STARTED|Overall Study|Randomised|31||
59839887|NCT00454805|75964007|FG001|STARTED|Overall Study|Randomised|31||
59839888|NCT00454805|75964006|FG000|COMPLETED|Overall Study|Ongoing at data cut-off|5||
59839889|NCT00454805|75964007|FG001|COMPLETED|Overall Study|Ongoing at data cut-off|8||
59839890|NCT00454805|75964006|FG000|NOT COMPLETED|Overall Study||26||
59839891|NCT00454805|75964007|FG001|NOT COMPLETED|Overall Study||23||
59839892|NCT00283244|75964016|FG000|STARTED|Overall Study||44||
59839893|NCT00283244|75964017|FG001|STARTED|Overall Study||51||
59839894|NCT00283244|75964018|FG002|STARTED|Overall Study||51||
59839895|NCT00283244|75964016|FG000|COMPLETED|Overall Study|19 patients went on to receive second line Erlotinib|26||
59839896|NCT00283244|75964017|FG001|COMPLETED|Overall Study|Patients treated until progression or unacceptable toxicity; 12 patients received 2nd line therapy|0||
59839897|NCT00283244|75964018|FG002|COMPLETED|Overall Study|Patients treated until progression or unacceptable toxicity; 9 patients received 2nd line therapy|0||
59839898|NCT00283244|75964016|FG000|NOT COMPLETED|Overall Study||18||
59839899|NCT00283244|75964017|FG001|NOT COMPLETED|Overall Study||51||
59839900|NCT00283244|75964018|FG002|NOT COMPLETED|Overall Study||51||
59839901|NCT00282464|75964029|FG000|STARTED|Overall Study||185||
59839902|NCT00282464|75964030|FG001|STARTED|Overall Study||196||
59839903|NCT00282464|75964029|FG000|COMPLETED|Overall Study||112||
59839904|NCT00282464|75964030|FG001|COMPLETED|Overall Study||134||
59839905|NCT00282464|75964029|FG000|NOT COMPLETED|Overall Study||73||
59567722|NCT01280643|75670540|FG001|COMPLETED|Overall Study||0||
59567723|NCT01280643|75670541|FG002|COMPLETED|Overall Study||1||
59567724|NCT01280643|75670542|FG003|COMPLETED|Overall Study||1||
59718652|NCT02153632|75837902|FG002|STARTED|Overall Study||44||
59718653|NCT02153632|75837900|FG000|COMPLETED|Overall Study||27||
59718654|NCT02153632|75837901|FG001|COMPLETED|Overall Study||27||
59567725|NCT01280643|75670543|FG004|COMPLETED|Overall Study||0||
59718655|NCT02153632|75837902|FG002|COMPLETED|Overall Study||25||
59718656|NCT02153632|75837900|FG000|NOT COMPLETED|Overall Study||18||
59718657|NCT02153632|75837901|FG001|NOT COMPLETED|Overall Study||19||
59718658|NCT02153632|75837902|FG002|NOT COMPLETED|Overall Study||19||
59567726|NCT01280643|75670544|FG005|COMPLETED|Overall Study||0||
59567727|NCT01280643|75670545|FG006|COMPLETED|Overall Study||0||
59567728|NCT01280643|75670546|FG007|COMPLETED|Overall Study||0||
59718659|NCT00899548|75837910|FG000|STARTED|Overall Study||182||
59718660|NCT00899548|75837910|FG000|COMPLETED|Overall Study||179||
59567729|NCT01280643|75670547|FG008|COMPLETED|Overall Study||0||
59567730|NCT01280643|75670539|FG000|NOT COMPLETED|Overall Study||0||
59567731|NCT01280643|75670540|FG001|NOT COMPLETED|Overall Study||1||
59567732|NCT01280643|75670541|FG002|NOT COMPLETED|Overall Study||0||
59718661|NCT00899548|75837910|FG000|NOT COMPLETED|Overall Study||3||
59718662|NCT00899392|75837920|FG000|STARTED|Overall Study||68||
59839906|NCT00282464|75964030|FG001|NOT COMPLETED|Overall Study||62||
59839907|NCT00273182|75964036|FG000|STARTED|Overall Study||1999||
59839908|NCT00273182|75964036|FG000|COMPLETED|Overall Study||1014||
59839909|NCT00273182|75964036|FG000|NOT COMPLETED|Overall Study||985||
59839910|NCT00209274|75964043|FG000|STARTED|Overall Study||184||
59839911|NCT00209274|75964044|FG001|STARTED|Overall Study||95||
59839912|NCT00209274|75964043|FG000|COMPLETED|Overall Study||113||
59839913|NCT00209274|75964044|FG001|COMPLETED|Overall Study||48||
59839914|NCT00209274|75964043|FG000|NOT COMPLETED|Overall Study||71||
59839915|NCT00209274|75964044|FG001|NOT COMPLETED|Overall Study||47||
59839916|NCT03841331|75964052|FG000|STARTED|Overall Study||117||
59839917|NCT03841331|75964053|FG001|STARTED|Overall Study||116||
59839918|NCT03841331|75964052|FG000|COMPLETED|Overall Study||108||
59839919|NCT03841331|75964053|FG001|COMPLETED|Overall Study||106||
59839920|NCT03841331|75964052|FG000|NOT COMPLETED|Overall Study||9||
59839921|NCT03841331|75964053|FG001|NOT COMPLETED|Overall Study||10||
59839922|NCT00262080|75964062|FG000|STARTED|Double Blind Treatment Period|One patient was randomized to receive ecallantide but was treated with placebo.|36||
59839923|NCT00262080|75964063|FG001|STARTED|Double Blind Treatment Period|One patient was randomized to receive placebo but was treated with ecallantide.|36||
59839924|NCT00262080|75964064|FG002|STARTED|Double Blind Treatment Period||0||
59839925|NCT00262080|75964062|FG000|COMPLETED|Double Blind Treatment Period||35||
59839926|NCT00262080|75964063|FG001|COMPLETED|Double Blind Treatment Period||36||
59839927|NCT00262080|75964064|FG002|COMPLETED|Double Blind Treatment Period||0||
59839928|NCT00262080|75964062|FG000|NOT COMPLETED|Double Blind Treatment Period||1||
59839929|NCT00262080|75964063|FG001|NOT COMPLETED|Double Blind Treatment Period||0||
59839930|NCT00262080|75964064|FG002|NOT COMPLETED|Double Blind Treatment Period||0||
59839931|NCT00262080|75964062|FG000|STARTED|Repeat Dose Treatment Period|Not all patients treated in the double-blind part came for treatment in the repeat-dose part.|22||
59839932|NCT00262080|75964063|FG001|STARTED|Repeat Dose Treatment Period|Not all patients treated in the double-blind part came for treatment in the repeat-dose part.|26||
59839933|NCT00262080|75964064|FG002|STARTED|Repeat Dose Treatment Period|This arm represents new patients, not treated in the double-blind part of the study.|19||
59839934|NCT00262080|75964062|FG000|COMPLETED|Repeat Dose Treatment Period|Some patients participated in only the double-blind or the open label phase.|18||
59839935|NCT00262080|75964063|FG001|COMPLETED|Repeat Dose Treatment Period||25||
59839936|NCT00262080|75964064|FG002|COMPLETED|Repeat Dose Treatment Period||14||
59839937|NCT00262080|75964062|FG000|NOT COMPLETED|Repeat Dose Treatment Period||4||
59839938|NCT00262080|75964063|FG001|NOT COMPLETED|Repeat Dose Treatment Period||1||
59839939|NCT00262080|75964064|FG002|NOT COMPLETED|Repeat Dose Treatment Period||5||
59839940|NCT00282308|75964074|FG000|STARTED|Treatment Period||69||
59839941|NCT00282308|75964075|FG001|STARTED|Treatment Period||34||
59839942|NCT00282308|75964076|FG002|STARTED|Treatment Period|Participant Flow is reported separately for the treatment groups for this Period.|0||
59839943|NCT00282308|75964074|FG000|COMPLETED|Treatment Period||65||
59839944|NCT00282308|75964075|FG001|COMPLETED|Treatment Period||28||
59839945|NCT00282308|75964076|FG002|COMPLETED|Treatment Period||0||
59839946|NCT00282308|75964074|FG000|NOT COMPLETED|Treatment Period||4||
59839947|NCT00282308|75964075|FG001|NOT COMPLETED|Treatment Period||6||
59839948|NCT00282308|75964076|FG002|NOT COMPLETED|Treatment Period||0||
59839949|NCT00282308|75964074|FG000|STARTED|Optional Extension Re-treatment Period|Participant Flow is reported for the combined treatment groups for this Period.|0||
59839950|NCT00282308|75964075|FG001|STARTED|Optional Extension Re-treatment Period|Participant Flow is reported for the combined treatment groups for this Period.|0||
59839951|NCT00282308|75964076|FG002|STARTED|Optional Extension Re-treatment Period|Not all patients who completed the Treatment Period entered this Optional Re-treatment Period.|78||
59839952|NCT00282308|75964074|FG000|COMPLETED|Optional Extension Re-treatment Period||0||
59839953|NCT00282308|75964075|FG001|COMPLETED|Optional Extension Re-treatment Period||0||
59839954|NCT00282308|75964076|FG002|COMPLETED|Optional Extension Re-treatment Period||72||
59839955|NCT00282308|75964074|FG000|NOT COMPLETED|Optional Extension Re-treatment Period||0||
59839956|NCT00282308|75964075|FG001|NOT COMPLETED|Optional Extension Re-treatment Period||0||
59839957|NCT00282308|75964076|FG002|NOT COMPLETED|Optional Extension Re-treatment Period||6||
59839958|NCT00282308|75964074|FG000|STARTED|Safety Follow-up Period|Participant Flow is reported for the combined treatment groups for this Period.|0||
59839959|NCT00282308|75964075|FG001|STARTED|Safety Follow-up Period|Participant Flow is reported for the combined treatment groups for this Period.|0||
59839960|NCT00282308|75964076|FG002|STARTED|Safety Follow-up Period|Some patients entered this Safety Follow-up Period directly from the Treatment Period.|100||
59839961|NCT00282308|75964074|FG000|COMPLETED|Safety Follow-up Period||0||
59718663|NCT00899392|75837921|FG001|STARTED|Overall Study||74||
59718664|NCT00899392|75837920|FG000|COMPLETED|Overall Study|Subjects:PerVariableStudied Consent:47-EAC 50-FBC Anxiety:60-EAC 3-FBC Satisfaction:63-EAC 67-FBC|47||
59718665|NCT00899392|75837921|FG001|COMPLETED|Overall Study|Subjects:PerVariableStudied Consent:47-EAC 50-FBC Anxiety:60-EAC 3-FBC Satisfaction:63-EAC 67-FBC|50||
59718666|NCT00899392|75837920|FG000|NOT COMPLETED|Overall Study||21||
59718667|NCT00899392|75837921|FG001|NOT COMPLETED|Overall Study||24||
59718668|NCT00690898|75837927|FG000|STARTED|SCREENING|Total of patients screened for the study.|108||
59718669|NCT00690898|75837927|FG000|COMPLETED|SCREENING|Number of patients included in the study.|90||
59718670|NCT00690898|75837927|FG000|NOT COMPLETED|SCREENING||18||
59718671|NCT00690898|75837927|FG000|STARTED|TREATMENT|Total number of patients treated.|90||
59718672|NCT00690898|75837927|FG000|COMPLETED|TREATMENT||64||
59718673|NCT00690898|75837927|FG000|NOT COMPLETED|TREATMENT||26||
59839962|NCT00282308|75964075|FG001|COMPLETED|Safety Follow-up Period||0||
59839963|NCT00282308|75964076|FG002|COMPLETED|Safety Follow-up Period||81||
59839964|NCT00282308|75964074|FG000|NOT COMPLETED|Safety Follow-up Period||0||
59839965|NCT00282308|75964075|FG001|NOT COMPLETED|Safety Follow-up Period||0||
59839966|NCT00282308|75964076|FG002|NOT COMPLETED|Safety Follow-up Period||19||
59839967|NCT00282152|75964088|FG000|STARTED|Overall Study||15||
59839968|NCT00282152|75964089|FG001|STARTED|Overall Study||15||
59839969|NCT00282152|75964088|FG000|COMPLETED|Overall Study||14||
59839970|NCT00282152|75964089|FG001|COMPLETED|Overall Study||15||
59839971|NCT00282152|75964088|FG000|NOT COMPLETED|Overall Study||1||
59839972|NCT00282152|75964089|FG001|NOT COMPLETED|Overall Study||0||
59839973|NCT00281840|75964096|FG000|STARTED|Overall Study||30||
59839974|NCT00281840|75964096|FG000|COMPLETED|Overall Study||5||
59839975|NCT00281840|75964096|FG000|NOT COMPLETED|Overall Study||25||
59839976|NCT00281684|75964105|FG000|STARTED|Overall Study||37||
59839977|NCT00281684|75964106|FG001|STARTED|Overall Study||36||
59839978|NCT00281684|75964107|FG002|STARTED|Overall Study||34||
59839979|NCT00281684|75964108|FG003|STARTED|Overall Study||38||
59839980|NCT00281684|75964105|FG000|COMPLETED|Overall Study||36||
59839981|NCT00281684|75964106|FG001|COMPLETED|Overall Study||36||
59839982|NCT00281684|75964107|FG002|COMPLETED|Overall Study||33||
59839983|NCT00281684|75964108|FG003|COMPLETED|Overall Study||38||
59839984|NCT00281684|75964105|FG000|NOT COMPLETED|Overall Study||1||
59839985|NCT00281684|75964106|FG001|NOT COMPLETED|Overall Study||0||
59839986|NCT00281684|75964107|FG002|NOT COMPLETED|Overall Study||1||
59839987|NCT00281684|75964108|FG003|NOT COMPLETED|Overall Study||0||
59839988|NCT00272792|75964122|FG000|STARTED|Part 1: Responsiveness||90||
59839989|NCT00272792|75964123|FG001|STARTED|Part 1: Responsiveness||0||
59839990|NCT00272792|75964122|FG000|COMPLETED|Part 1: Responsiveness||89||
59839991|NCT00272792|75964123|FG001|COMPLETED|Part 1: Responsiveness||0||
59839992|NCT00272792|75964122|FG000|NOT COMPLETED|Part 1: Responsiveness||1||
59839993|NCT00272792|75964123|FG001|NOT COMPLETED|Part 1: Responsiveness||0||
59839994|NCT00272792|75964122|FG000|STARTED|Part 2: Blinded, Placebo Control Period||33||
59839995|NCT00272792|75964123|FG001|STARTED|Part 2: Blinded, Placebo Control Period||12||
59839996|NCT00272792|75964122|FG000|COMPLETED|Part 2: Blinded, Placebo Control Period||32||
59839997|NCT00272792|75964123|FG001|COMPLETED|Part 2: Blinded, Placebo Control Period||9||
59839998|NCT00272792|75964122|FG000|NOT COMPLETED|Part 2: Blinded, Placebo Control Period||1||
59839999|NCT00272792|75964123|FG001|NOT COMPLETED|Part 2: Blinded, Placebo Control Period||3||
59840000|NCT00048568|75964131|FG000|STARTED|Double-Blind Period Days 1 to 169||433||
59840001|NCT00048568|75964132|FG001|STARTED|Double-Blind Period Days 1 to 169||219||
59840002|NCT00048568|75964133|FG002|STARTED|Double-Blind Period Days 1 to 169||0||
59840003|NCT00048568|75964131|FG000|COMPLETED|Double-Blind Period Days 1 to 169||401||
59840004|NCT00048568|75964132|FG001|COMPLETED|Double-Blind Period Days 1 to 169||174||
59840005|NCT00048568|75964133|FG002|COMPLETED|Double-Blind Period Days 1 to 169||0||
59840006|NCT00048568|75964131|FG000|NOT COMPLETED|Double-Blind Period Days 1 to 169||32||
59840007|NCT00048568|75964132|FG001|NOT COMPLETED|Double-Blind Period Days 1 to 169||45||
59840008|NCT00048568|75964133|FG002|NOT COMPLETED|Double-Blind Period Days 1 to 169||0||
59840009|NCT00048568|75964131|FG000|STARTED|Double-Blind Period Days 170 to 365||401||
59840010|NCT00048568|75964132|FG001|STARTED|Double-Blind Period Days 170 to 365||174||
59840011|NCT00048568|75964133|FG002|STARTED|Double-Blind Period Days 170 to 365||0||
59840012|NCT00048568|75964131|FG000|COMPLETED|Double-Blind Period Days 170 to 365||385||
59840013|NCT00048568|75964132|FG001|COMPLETED|Double-Blind Period Days 170 to 365||162||
59840014|NCT00048568|75964133|FG002|COMPLETED|Double-Blind Period Days 170 to 365||0||
59840015|NCT00048568|75964131|FG000|NOT COMPLETED|Double-Blind Period Days 170 to 365||16||
59840016|NCT00048568|75964132|FG001|NOT COMPLETED|Double-Blind Period Days 170 to 365||12||
59840017|NCT00048568|75964133|FG002|NOT COMPLETED|Double-Blind Period Days 170 to 365||0||
59840018|NCT00048568|75964131|FG000|STARTED|Open-Label Period||0||
59840019|NCT00048568|75964132|FG001|STARTED|Open-Label Period||0||
59840020|NCT00048568|75964133|FG002|STARTED|Open-Label Period||539||
59840021|NCT00048568|75964131|FG000|COMPLETED|Open-Label Period||0||
59840022|NCT00048568|75964132|FG001|COMPLETED|Open-Label Period||0||
59840023|NCT00048568|75964133|FG002|COMPLETED|Open-Label Period||379||
59840024|NCT00048568|75964131|FG000|NOT COMPLETED|Open-Label Period||0||
59718674|NCT00895414|75837931|FG000|STARTED|First Intervention (14 Days)||9||
59718675|NCT00895414|75837932|FG001|STARTED|First Intervention (14 Days)||10||
59718676|NCT00895414|75837931|FG000|COMPLETED|First Intervention (14 Days)||8||
59718677|NCT00895414|75837932|FG001|COMPLETED|First Intervention (14 Days)||9||
59718678|NCT00895414|75837931|FG000|NOT COMPLETED|First Intervention (14 Days)||1||
59718679|NCT00895414|75837932|FG001|NOT COMPLETED|First Intervention (14 Days)||1||
59718680|NCT00895414|75837931|FG000|STARTED|Second Intervention (14 Days)||8||
59718681|NCT00895414|75837932|FG001|STARTED|Second Intervention (14 Days)||9||
59718682|NCT00895414|75837931|FG000|COMPLETED|Second Intervention (14 Days)||8||
59718683|NCT00895414|75837932|FG001|COMPLETED|Second Intervention (14 Days)||9||
59718684|NCT00895414|75837931|FG000|NOT COMPLETED|Second Intervention (14 Days)||0||
59718685|NCT00895414|75837932|FG001|NOT COMPLETED|Second Intervention (14 Days)||0||
59718686|NCT01212770|75837941|FG000|STARTED|Placebo-controlled Phase (Week 0 - 24)||169||
59718687|NCT01212770|75837942|FG001|STARTED|Placebo-controlled Phase (Week 0 - 24)||169||
59840025|NCT00048568|75964132|FG001|NOT COMPLETED|Open-Label Period||0||
59840026|NCT00048568|75964133|FG002|NOT COMPLETED|Open-Label Period||160||
59840027|NCT00262002|75964161|FG000|STARTED|Overall Study||90||
59840028|NCT00262002|75964162|FG001|STARTED|Overall Study||90||
59840029|NCT00262002|75964163|FG002|STARTED|Overall Study||45||
59840030|NCT00262002|75964164|FG003|STARTED|Overall Study||98||
59840031|NCT00262002|75964165|FG004|STARTED|Overall Study||98||
59840032|NCT00262002|75964166|FG005|STARTED|Overall Study||90||
59840033|NCT00262002|75964167|FG006|STARTED|Overall Study||90||
59840034|NCT00262002|75964161|FG000|COMPLETED|Overall Study||79||
59840035|NCT00262002|75964162|FG001|COMPLETED|Overall Study||84||
59840036|NCT00262002|75964163|FG002|COMPLETED|Overall Study||45||
59840037|NCT00262002|75964164|FG003|COMPLETED|Overall Study||93||
59840038|NCT00262002|75964165|FG004|COMPLETED|Overall Study||91||
59840039|NCT00262002|75964166|FG005|COMPLETED|Overall Study||83||
59840040|NCT00262002|75964167|FG006|COMPLETED|Overall Study||84||
59840041|NCT00262002|75964161|FG000|NOT COMPLETED|Overall Study||11||
59840042|NCT00262002|75964162|FG001|NOT COMPLETED|Overall Study||6||
59840043|NCT00262002|75964163|FG002|NOT COMPLETED|Overall Study||0||
59840044|NCT00262002|75964164|FG003|NOT COMPLETED|Overall Study||5||
59840045|NCT00262002|75964165|FG004|NOT COMPLETED|Overall Study||7||
59840046|NCT00262002|75964166|FG005|NOT COMPLETED|Overall Study||7||
59840047|NCT00262002|75964167|FG006|NOT COMPLETED|Overall Study||6||
59840048|NCT00281528|75964235|FG000|STARTED|Overall Study||75||
59840049|NCT00281528|75964236|FG001|STARTED|Overall Study||54||
59840050|NCT00281528|75964237|FG002|STARTED|Overall Study||79||
59840051|NCT00281528|75964235|FG000|COMPLETED|Overall Study|No participants completed because they continued in the study until disease progression|0||
59840052|NCT00281528|75964236|FG001|COMPLETED|Overall Study|No participants completed because they continued in the study until disease progression|0||
59840053|NCT00281528|75964237|FG002|COMPLETED|Overall Study|No participants completed because they continued in the study until disease progression|0||
59840054|NCT00281528|75964235|FG000|NOT COMPLETED|Overall Study||75||
59840055|NCT00281528|75964236|FG001|NOT COMPLETED|Overall Study||54||
59840056|NCT00281528|75964237|FG002|NOT COMPLETED|Overall Study||79||
59840057|NCT00280748|75964245|FG000|STARTED|Overall Study||10||
59567733|NCT01280643|75670542|FG003|NOT COMPLETED|Overall Study||0||
59567734|NCT01280643|75670543|FG004|NOT COMPLETED|Overall Study||0||
59567735|NCT01280643|75670544|FG005|NOT COMPLETED|Overall Study||0||
59567736|NCT01280643|75670545|FG006|NOT COMPLETED|Overall Study||0||
59567737|NCT01280643|75670546|FG007|NOT COMPLETED|Overall Study||0||
59567738|NCT01280643|75670547|FG008|NOT COMPLETED|Overall Study||0||
59567739|NCT01888952|75670567|FG000|STARTED|Overall Study||10||
59567740|NCT01888952|75670567|FG000|COMPLETED|Overall Study||10||
59567741|NCT01888952|75670567|FG000|NOT COMPLETED|Overall Study||0||
59567742|NCT02299206|75670571|FG000|STARTED|Overall Study||4||
59567743|NCT02299206|75670571|FG000|COMPLETED|Overall Study||2||
59718688|NCT01212770|75837943|FG002|STARTED|Placebo-controlled Phase (Week 0 - 24)||167||
59718689|NCT01212770|75837944|FG003|STARTED|Placebo-controlled Phase (Week 0 - 24)||0||
59718690|NCT01212770|75837945|FG004|STARTED|Placebo-controlled Phase (Week 0 - 24)||0||
59718691|NCT01212770|75837946|FG005|STARTED|Placebo-controlled Phase (Week 0 - 24)||0||
59718692|NCT01212770|75837947|FG006|STARTED|Placebo-controlled Phase (Week 0 - 24)||0||
59718693|NCT01212770|75837948|FG007|STARTED|Placebo-controlled Phase (Week 0 - 24)||0||
59718694|NCT01212770|75837949|FG008|STARTED|Placebo-controlled Phase (Week 0 - 24)||0||
59567744|NCT02299206|75670571|FG000|NOT COMPLETED|Overall Study||2||
59718695|NCT01212770|75837941|FG000|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||169||
59718696|NCT01212770|75837942|FG001|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||169||
59718697|NCT01212770|75837943|FG002|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||167||
59567745|NCT01892306|75670577|FG000|STARTED|Overall Study||13||
59840058|NCT00280748|75964245|FG000|COMPLETED|Overall Study||6||
59840059|NCT00280748|75964245|FG000|NOT COMPLETED|Overall Study||4||
59840060|NCT00271856|75964251|FG000|STARTED|Overall Study||89||
59840061|NCT00271856|75964252|FG001|STARTED|Overall Study||88||
59840062|NCT00271856|75964251|FG000|COMPLETED|Overall Study||78||
59840063|NCT00271856|75964252|FG001|COMPLETED|Overall Study||70||
59840064|NCT00271856|75964251|FG000|NOT COMPLETED|Overall Study||11||
59840065|NCT00271856|75964252|FG001|NOT COMPLETED|Overall Study||18||
59840066|NCT00061048|75964258|FG000|STARTED|Overall Study||29||
59840067|NCT00061048|75964258|FG000|COMPLETED|Overall Study|Began protocol specified follow-up period.|7||
59840068|NCT00061048|75964258|FG000|NOT COMPLETED|Overall Study||22||
59840069|NCT00270998|75964265|FG000|STARTED|3 Month Follow-up||149||
59840070|NCT00270998|75964266|FG001|STARTED|3 Month Follow-up||146||
59840071|NCT00270998|75964267|FG002|STARTED|3 Month Follow-up|1 participant randomized to combined found ineligible at first treatment visit, removed from study.|150||
59840072|NCT00270998|75964265|FG000|COMPLETED|3 Month Follow-up||110||
59840073|NCT00270998|75964266|FG001|COMPLETED|3 Month Follow-up||124||
59840074|NCT00270998|75964267|FG002|COMPLETED|3 Month Follow-up||132||
59840075|NCT00270998|75964265|FG000|NOT COMPLETED|3 Month Follow-up||39||
59840076|NCT00270998|75964266|FG001|NOT COMPLETED|3 Month Follow-up||22||
59840077|NCT00270998|75964267|FG002|NOT COMPLETED|3 Month Follow-up||18||
59840078|NCT00270998|75964265|FG000|STARTED|12 Month Follow-up||110||
59840079|NCT00270998|75964266|FG001|STARTED|12 Month Follow-up||124||
59840080|NCT00270998|75964267|FG002|STARTED|12 Month Follow-up||132||
59840081|NCT00270998|75964265|FG000|COMPLETED|12 Month Follow-up||96||
59840082|NCT00270998|75964266|FG001|COMPLETED|12 Month Follow-up||99||
59840083|NCT00270998|75964267|FG002|COMPLETED|12 Month Follow-up||111||
59840084|NCT00270998|75964265|FG000|NOT COMPLETED|12 Month Follow-up||14||
59840085|NCT00270998|75964266|FG001|NOT COMPLETED|12 Month Follow-up||25||
59840086|NCT00270998|75964267|FG002|NOT COMPLETED|12 Month Follow-up||21||
59840087|NCT00279812|75964283|FG000|STARTED|Overall Study||21||
59840088|NCT00279812|75964284|FG001|STARTED|Overall Study||26||
59840089|NCT00279812|75964285|FG002|STARTED|Overall Study||24||
59840090|NCT00279812|75964286|FG003|STARTED|Overall Study||23||
59840091|NCT00279812|75964287|FG004|STARTED|Overall Study||20||
59840092|NCT00279812|75964288|FG005|STARTED|Overall Study||19||
59840093|NCT00279812|75964283|FG000|COMPLETED|Overall Study||20||
59840094|NCT00279812|75964284|FG001|COMPLETED|Overall Study||20||
59567746|NCT01892306|75670578|FG001|STARTED|Overall Study||16||
59567747|NCT01892306|75670577|FG000|COMPLETED|Overall Study||8||
59567748|NCT01892306|75670578|FG001|COMPLETED|Overall Study||10||
59718698|NCT01212770|75837944|FG003|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0||
59718699|NCT01212770|75837945|FG004|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0||
59718700|NCT01212770|75837946|FG005|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0||
59718701|NCT01212770|75837947|FG006|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0||
59718702|NCT01212770|75837948|FG007|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0||
59718703|NCT01212770|75837949|FG008|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0||
59718704|NCT01212770|75837941|FG000|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||156||
59718705|NCT01212770|75837942|FG001|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||157||
59718706|NCT01212770|75837943|FG002|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||156||
59718707|NCT01212770|75837944|FG003|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0||
59718708|NCT01212770|75837945|FG004|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0||
59718709|NCT01212770|75837946|FG005|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0||
59718710|NCT01212770|75837947|FG006|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0||
59718711|NCT01212770|75837948|FG007|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0||
59718712|NCT01212770|75837949|FG008|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0||
59718713|NCT01212770|75837941|FG000|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|1 participant who escaped early did not complete Week (Wk) 24|97||
59718714|NCT01212770|75837942|FG001|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||76||
59718715|NCT01212770|75837943|FG002|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|1 participant who escaped early did not complete Week 24|53||
59718716|NCT01212770|75837944|FG003|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0||
59718717|NCT01212770|75837945|FG004|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0||
59718718|NCT01212770|75837946|FG005|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0||
59718719|NCT01212770|75837947|FG006|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0||
59718720|NCT01212770|75837948|FG007|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0||
59718721|NCT01212770|75837949|FG008|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0||
59840095|NCT00279812|75964285|FG002|COMPLETED|Overall Study||21||
59840096|NCT00279812|75964286|FG003|COMPLETED|Overall Study||23||
59840097|NCT00279812|75964287|FG004|COMPLETED|Overall Study||17||
59840098|NCT00279812|75964288|FG005|COMPLETED|Overall Study||18||
59840099|NCT00279812|75964283|FG000|NOT COMPLETED|Overall Study||1||
59840100|NCT00279812|75964284|FG001|NOT COMPLETED|Overall Study||6||
59840101|NCT00279812|75964285|FG002|NOT COMPLETED|Overall Study||3||
59840102|NCT00279812|75964286|FG003|NOT COMPLETED|Overall Study||0||
59840103|NCT00279812|75964287|FG004|NOT COMPLETED|Overall Study||3||
59840104|NCT00279812|75964288|FG005|NOT COMPLETED|Overall Study||1||
59840105|NCT00207714|75964307|FG000|STARTED|Overall Study||35||
59840106|NCT00207714|75964308|FG001|STARTED|Overall Study||35||
59840107|NCT00207714|75964309|FG002|STARTED|Overall Study||34||
59840108|NCT00207714|75964310|FG003|STARTED|Overall Study||34||
59840109|NCT00207714|75964311|FG004|STARTED|Overall Study||34||
59840110|NCT00207714|75964307|FG000|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|21||
59840111|NCT00207714|75964308|FG001|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|28||
59840112|NCT00207714|75964309|FG002|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|24||
59840113|NCT00207714|75964310|FG003|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|26||
59840114|NCT00207714|75964311|FG004|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|29||
59840115|NCT00207714|75964307|FG000|NOT COMPLETED|Overall Study||14||
59840116|NCT00207714|75964308|FG001|NOT COMPLETED|Overall Study||7||
59840117|NCT00207714|75964309|FG002|NOT COMPLETED|Overall Study||10||
59840118|NCT00207714|75964310|FG003|NOT COMPLETED|Overall Study||8||
59840119|NCT00207714|75964311|FG004|NOT COMPLETED|Overall Study||5||
59840120|NCT00207090|75964330|FG000|STARTED|Overall Study|Number of participants treated|15||
59840121|NCT00207090|75964330|FG000|COMPLETED|Overall Study||8||
59840122|NCT00207090|75964330|FG000|NOT COMPLETED|Overall Study||7||
59840123|NCT00059332|75964341|FG000|STARTED|Overall Study||843||
59840124|NCT00059332|75964342|FG001|STARTED|Overall Study||857||
59840125|NCT00059332|75964341|FG000|COMPLETED|Overall Study||840||
59840126|NCT00059332|75964342|FG001|COMPLETED|Overall Study||855||
59840127|NCT00059332|75964341|FG000|NOT COMPLETED|Overall Study||3||
59840128|NCT00059332|75964342|FG001|NOT COMPLETED|Overall Study||2||
59840129|NCT00233454|75964348|FG000|STARTED|Overall Study||26||
59840130|NCT00233454|75964348|FG000|2 Months (for Response Rate)|Overall Study||26||
59840131|NCT00233454|75964348|FG000|COMPLETED|Overall Study||20||
59840132|NCT00233454|75964348|FG000|NOT COMPLETED|Overall Study||6||
59840133|NCT00047320|75964352|FG000|STARTED|Overall Study||104||
59840134|NCT00047320|75964352|FG000|COMPLETED|Overall Study||76||
59840135|NCT00047320|75964352|FG000|NOT COMPLETED|Overall Study||28||
59840136|NCT00233064|75964358|FG000|STARTED|Overall Study||211||
59840137|NCT00233064|75964359|FG001|STARTED|Overall Study||202||
59840138|NCT00233064|75964358|FG000|COMPLETED|Overall Study||197||
59840139|NCT00233064|75964359|FG001|COMPLETED|Overall Study||190||
59840140|NCT00233064|75964358|FG000|NOT COMPLETED|Overall Study||14||
59840141|NCT00233064|75964359|FG001|NOT COMPLETED|Overall Study||12||
59840142|NCT00268892|75964369|FG000|STARTED|Overall Study||90||
59840143|NCT00268892|75964370|FG001|STARTED|Overall Study||95||
59840144|NCT00268892|75964371|FG002|STARTED|Overall Study||93||
59840145|NCT00268892|75964369|FG000|Switched to Higher Dose|Overall Study||59||
59840146|NCT00268892|75964370|FG001|Switched to Higher Dose|Overall Study||68||
59840147|NCT00268892|75964371|FG002|Switched to Higher Dose|Overall Study||76||
59840148|NCT00268892|75964369|FG000|COMPLETED|Overall Study||51||
59840149|NCT00268892|75964370|FG001|COMPLETED|Overall Study||53||
59840150|NCT00268892|75964371|FG002|COMPLETED|Overall Study||54||
59840151|NCT00268892|75964369|FG000|NOT COMPLETED|Overall Study||39||
59840152|NCT00268892|75964370|FG001|NOT COMPLETED|Overall Study||42||
59840153|NCT00268892|75964371|FG002|NOT COMPLETED|Overall Study||39||
59840154|NCT00206076|75964381|FG000|STARTED|Overall Study||9||
59840155|NCT00206076|75964382|FG001|STARTED|Overall Study||10||
59840156|NCT00206076|75964381|FG000|COMPLETED|Overall Study||6||
59840157|NCT00206076|75964382|FG001|COMPLETED|Overall Study||9||
59840158|NCT00206076|75964381|FG000|NOT COMPLETED|Overall Study||3||
59840159|NCT00206076|75964382|FG001|NOT COMPLETED|Overall Study||1||
59840160|NCT00278954|75964390|FG000|STARTED|Overall Study||50||
59840161|NCT00278954|75964390|FG000|COMPLETED|Overall Study||45||
59840162|NCT00278954|75964390|FG000|NOT COMPLETED|Overall Study||5||
59840163|NCT00278564|75964394|FG000|STARTED|Overall Study||7||
59840164|NCT00278564|75964394|FG000|COMPLETED|Overall Study||3||
59840165|NCT00278564|75964394|FG000|NOT COMPLETED|Overall Study||4||
59840166|NCT00268346|75964400|FG000|STARTED|Overall Study||18||
59840167|NCT00268346|75964401|FG001|STARTED|Overall Study||40||
59840168|NCT00268346|75964400|FG000|Started Treatment|Overall Study||18||
59840169|NCT00268346|75964401|FG001|Started Treatment|Overall Study||40||
59840170|NCT00268346|75964400|FG000|COMPLETED|Overall Study||18||
59840171|NCT00268346|75964401|FG001|COMPLETED|Overall Study||37||
59840172|NCT00268346|75964400|FG000|NOT COMPLETED|Overall Study||0||
59840173|NCT00268346|75964401|FG001|NOT COMPLETED|Overall Study||3||
59840174|NCT00203892|75964410|FG000|STARTED|Overall Study||7||
59840175|NCT00203892|75964411|FG001|STARTED|Overall Study||10||
59840176|NCT00203892|75964412|FG002|STARTED|Overall Study||6||
59996565|NCT02714569|76112507|FG004|STARTED|Part A Second Intervention||3||
59840177|NCT00203892|75964410|FG000|Received at Least 3 Doses of CEA Vaccine|Overall Study|This group of patients were evaluable for the primary outcome.|5||
59840178|NCT00203892|75964411|FG001|Received at Least 3 Doses of CEA Vaccine|Overall Study|This group of patients were evaluable for the primary outcome.|5||
59840179|NCT00203892|75964412|FG002|Received at Least 3 Doses of CEA Vaccine|Overall Study|This group of patients were evaluable for the primary outcome.|4||
59840180|NCT00203892|75964410|FG000|COMPLETED|Overall Study|2 patients not completing study were randomized but never treated|5||
59840181|NCT00203892|75964411|FG001|COMPLETED|Overall Study|2 patients not completing study were randomized but never treated|8||
59840182|NCT00203892|75964412|FG002|COMPLETED|Overall Study||6||
59840183|NCT00203892|75964410|FG000|NOT COMPLETED|Overall Study||2||
59840184|NCT00203892|75964411|FG001|NOT COMPLETED|Overall Study||2||
59840185|NCT00203892|75964412|FG002|NOT COMPLETED|Overall Study||0||
59840186|NCT00250718|75964420|FG000|STARTED|Overall Study||17||
59840187|NCT00250718|75964420|FG000|Received Treatment|Overall Study||16||
59840188|NCT00250718|75964420|FG000|COMPLETED|Overall Study||14||
59840189|NCT00250718|75964420|FG000|NOT COMPLETED|Overall Study||3||
59840190|NCT00276614|75964424|FG000|STARTED|Overall Study||4||
59840191|NCT00276614|75964424|FG000|COMPLETED|Overall Study||1||
59840192|NCT00276614|75964424|FG000|NOT COMPLETED|Overall Study||3||
59840193|NCT00276458|75964430|FG000|STARTED|Overall Study||98||
59840194|NCT00276458|75964431|FG001|STARTED|Overall Study||98||
59840195|NCT00276458|75964430|FG000|COMPLETED|Overall Study||92||
59840196|NCT00276458|75964431|FG001|COMPLETED|Overall Study||91||
59840197|NCT00276458|75964430|FG000|NOT COMPLETED|Overall Study||6||
59840198|NCT00276458|75964431|FG001|NOT COMPLETED|Overall Study||7||
59840199|NCT00276380|75964439|FG000|STARTED|Overall Study||102||
59840200|NCT00276380|75964440|FG001|STARTED|Overall Study||102||
59840201|NCT00276380|75964439|FG000|COMPLETED|Overall Study||88||
59840202|NCT00276380|75964440|FG001|COMPLETED|Overall Study||88||
59840203|NCT00276380|75964439|FG000|NOT COMPLETED|Overall Study||14||
59840204|NCT00276380|75964440|FG001|NOT COMPLETED|Overall Study||14||
59840205|NCT00267956|75964449|FG000|STARTED|Controlled Period||70||
59840206|NCT00267956|75964450|FG001|STARTED|Controlled Period||76||
59840207|NCT00267956|75964451|FG002|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0||
59840208|NCT00267956|75964452|FG003|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0||
59840209|NCT00267956|75964449|FG000|COMPLETED|Controlled Period||57||
59840210|NCT00267956|75964450|FG001|COMPLETED|Controlled Period||72||
59840211|NCT00267956|75964451|FG002|COMPLETED|Controlled Period||0||
59840212|NCT00267956|75964452|FG003|COMPLETED|Controlled Period||0||
59840213|NCT00267956|75964449|FG000|NOT COMPLETED|Controlled Period||13||
59840214|NCT00267956|75964450|FG001|NOT COMPLETED|Controlled Period||4||
59840215|NCT00267956|75964451|FG002|NOT COMPLETED|Controlled Period||0||
59840216|NCT00267956|75964452|FG003|NOT COMPLETED|Controlled Period||0||
60119567|NCT02532556|76240706|FG000|STARTED|Overall Study||12||
60119568|NCT02532556|76240706|FG000|COMPLETED|Overall Study||12||
59840217|NCT00267956|75964449|FG000|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0||
59840218|NCT00267956|75964450|FG001|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0||
59840219|NCT00267956|75964451|FG002|STARTED|After Controlled Period||57||
59840220|NCT00267956|75964452|FG003|STARTED|After Controlled Period||72||
59840221|NCT00267956|75964449|FG000|COMPLETED|After Controlled Period||0||
59840222|NCT00267956|75964450|FG001|COMPLETED|After Controlled Period||0||
59840223|NCT00267956|75964451|FG002|COMPLETED|After Controlled Period||52||
59840224|NCT00267956|75964452|FG003|COMPLETED|After Controlled Period||70||
59840225|NCT00267956|75964449|FG000|NOT COMPLETED|After Controlled Period||0||
59840226|NCT00267956|75964450|FG001|NOT COMPLETED|After Controlled Period||0||
59840227|NCT00267956|75964451|FG002|NOT COMPLETED|After Controlled Period||5||
59840228|NCT00267956|75964452|FG003|NOT COMPLETED|After Controlled Period||2||
59840229|NCT00267488|75964460|FG000|STARTED|Overall Study||37||
59840230|NCT00267488|75964460|FG000|COMPLETED|Overall Study||26||
59840231|NCT00267488|75964460|FG000|NOT COMPLETED|Overall Study||11||
59840232|NCT00058552|75964466|FG000|STARTED|Overall Study||65||
59840233|NCT00058552|75964467|FG001|STARTED|Overall Study||64||
59840234|NCT00058552|75964466|FG000|COMPLETED|Overall Study||0||
59840235|NCT00058552|75964467|FG001|COMPLETED|Overall Study||2||
59840236|NCT00058552|75964466|FG000|NOT COMPLETED|Overall Study||65||
59840237|NCT00058552|75964467|FG001|NOT COMPLETED|Overall Study||62||
59840238|NCT00044512|75964475|FG000|STARTED|Treatment||137||
59840239|NCT00044512|75964475|FG000|COMPLETED|Treatment||137||
59840240|NCT00044512|75964475|FG000|NOT COMPLETED|Treatment||0||
59840241|NCT00044512|75964475|FG000|STARTED|Follow Up||137||
59840242|NCT00044512|75964475|FG000|COMPLETED|Follow Up||135||
59840243|NCT00044512|75964475|FG000|NOT COMPLETED|Follow Up||2||
59840244|NCT03805438|75964479|FG000|STARTED|Overall Study||47||
59840245|NCT03805438|75964479|FG000|COMPLETED|Overall Study||45||
59840246|NCT03805438|75964479|FG000|NOT COMPLETED|Overall Study||2||
59840247|NCT05560386|75964485|FG000|STARTED|Overall Study||13||
59840248|NCT05560386|75964486|FG001|STARTED|Overall Study||41||
59840249|NCT05560386|75964485|FG000|COMPLETED|Overall Study||13||
59840250|NCT05560386|75964486|FG001|COMPLETED|Overall Study||24||
60119569|NCT02532556|76240706|FG000|NOT COMPLETED|Overall Study||0||
59840251|NCT05560386|75964485|FG000|NOT COMPLETED|Overall Study||0||
59840252|NCT05560386|75964486|FG001|NOT COMPLETED|Overall Study||17||
59840253|NCT05369806|75964492|FG000|STARTED|Overall Study||80||
59840254|NCT05369806|75964492|FG000|COMPLETED|Overall Study||79||
59840255|NCT05369806|75964492|FG000|NOT COMPLETED|Overall Study||1||
59840256|NCT05202223|75964496|FG000|STARTED|Overall Study|"80 individuals were consented in dyads. 40 caregivers and 40 persons with cognitive impairment.~1 dyad dropped out prior to baseline data collection, therefore a total of 78 participants completed baseline data."|80||
59840257|NCT05202223|75964496|FG000|COMPLETED|Overall Study|26 dyads completed the intervention, this includes 26 caregivers and 26 individuals with cognitive impairment.|52||
59840258|NCT05202223|75964496|FG000|NOT COMPLETED|Overall Study||28||
59840259|NCT05195528|75964503|FG000|STARTED|Placebo-controlled Treatment Period||259||
59840260|NCT05195528|75964504|FG001|STARTED|Placebo-controlled Treatment Period||258||
59840261|NCT05195528|75964505|FG002|STARTED|Placebo-controlled Treatment Period||259||
59840262|NCT05195528|75964506|FG003|STARTED|Placebo-controlled Treatment Period||0||
59840263|NCT05195528|75964507|FG004|STARTED|Placebo-controlled Treatment Period||0||
59840264|NCT05195528|75964503|FG000|Intent to Treat Analysis Set|Placebo-controlled Treatment Period||258|Intent-to-treat (ITT): all efficacy analyses were conducted on the ITT Set using the planned treatment even if the participant received a different incorrect treatment.|
59840265|NCT05195528|75964504|FG001|Intent to Treat Analysis Set|Placebo-controlled Treatment Period||257|Intent-to-treat (ITT): all efficacy analyses were conducted on the ITT Set using the planned treatment even if the participant received a different incorrect treatment.|
59840266|NCT05195528|75964505|FG002|Intent to Treat Analysis Set|Placebo-controlled Treatment Period||257|Intent-to-treat (ITT): all efficacy analyses were conducted on the ITT Set using the planned treatment even if the participant received a different incorrect treatment.|
59840267|NCT05195528|75964506|FG003|Intent to Treat Analysis Set|Placebo-controlled Treatment Period||0|Intent-to-treat (ITT): all efficacy analyses were conducted on the ITT Set using the planned treatment even if the participant received a different incorrect treatment.|
59840268|NCT05195528|75964507|FG004|Intent to Treat Analysis Set|Placebo-controlled Treatment Period||0|Intent-to-treat (ITT): all efficacy analyses were conducted on the ITT Set using the planned treatment even if the participant received a different incorrect treatment.|
59840269|NCT05195528|75964503|FG000|Safety Analysis Set|Placebo-controlled Treatment Period||256|Safety Analysis Set (SAS): all safety analyses were conducted on the Safety Set using the actual treatment the participant received even if the participant was randomized to receive a different treatment.|
60119570|NCT02533726|76240718|FG000|STARTED|Initial Allocation||659||
60119571|NCT02533726|76240719|FG001|STARTED|Initial Allocation||653||
60119572|NCT02533726|76240718|FG000|COMPLETED|Initial Allocation||659||
60119573|NCT02533726|76240719|FG001|COMPLETED|Initial Allocation||653||
59718722|NCT01212770|75837941|FG000|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||146||
59718723|NCT01212770|75837942|FG001|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||147||
59718724|NCT01212770|75837943|FG002|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||145||
59718725|NCT01212770|75837944|FG003|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0||
59718726|NCT01212770|75837945|FG004|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0||
59718727|NCT01212770|75837946|FG005|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0||
59718728|NCT01212770|75837947|FG006|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0||
59718729|NCT01212770|75837948|FG007|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0||
59718730|NCT01212770|75837949|FG008|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0||
59718731|NCT01212770|75837941|FG000|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||23||
59718732|NCT01212770|75837942|FG001|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||22||
59718733|NCT01212770|75837943|FG002|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||22||
59718734|NCT01212770|75837944|FG003|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0||
59718735|NCT01212770|75837945|FG004|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0||
59718736|NCT01212770|75837946|FG005|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0||
59718737|NCT01212770|75837947|FG006|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0||
59718738|NCT01212770|75837948|FG007|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0||
59718739|NCT01212770|75837949|FG008|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0||
59718740|NCT01212770|75837941|FG000|STARTED|Active Treatment Phase (Weeks 25 - 52)||0||
59718741|NCT01212770|75837942|FG001|STARTED|Active Treatment Phase (Weeks 25 - 52)|8 participants who completed Week 24 did not enter the Week 24-52 active treatment phase|139||
59718742|NCT01212770|75837943|FG002|STARTED|Active Treatment Phase (Weeks 25 - 52)|7 participants who completed Week 24 did not enter the Week 24-52 active treatment phase|138||
59718743|NCT01212770|75837944|FG003|STARTED|Active Treatment Phase (Weeks 25 - 52)|3 participants who EE completed Week 24 did not enter the Week 24-52 active treatment phase|43||
59718744|NCT01212770|75837945|FG004|STARTED|Active Treatment Phase (Weeks 25 - 52)||25||
59718745|NCT01212770|75837946|FG005|STARTED|Active Treatment Phase (Weeks 25 - 52)|3 participants who EE completed Week 24 did not enter the Week 24-52 active treatment phase|47||
59718746|NCT01212770|75837947|FG006|STARTED|Active Treatment Phase (Weeks 25 - 52)||25||
59718747|NCT01212770|75837948|FG007|STARTED|Active Treatment Phase (Weeks 25 - 52)||0||
59718748|NCT01212770|75837949|FG008|STARTED|Active Treatment Phase (Weeks 25 - 52)||0||
59718749|NCT01212770|75837941|FG000|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0||
59718750|NCT01212770|75837942|FG001|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||120||
59718751|NCT01212770|75837943|FG002|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||126||
59718752|NCT01212770|75837944|FG003|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||32||
59718753|NCT01212770|75837945|FG004|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||23||
59718754|NCT01212770|75837946|FG005|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||44||
59718755|NCT01212770|75837947|FG006|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||23||
59718756|NCT01212770|75837948|FG007|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0||
59718757|NCT01212770|75837949|FG008|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0||
59718758|NCT01212770|75837941|FG000|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0||
59718759|NCT01212770|75837942|FG001|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||19||
59718760|NCT01212770|75837943|FG002|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||12||
59718761|NCT01212770|75837944|FG003|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||11||
59718762|NCT01212770|75837945|FG004|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||2||
59718763|NCT01212770|75837946|FG005|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||3||
59996566|NCT02714569|76112508|FG005|STARTED|Part A Second Intervention||3||
59567749|NCT01892306|75670577|FG000|NOT COMPLETED|Overall Study||5||
59567750|NCT01892306|75670578|FG001|NOT COMPLETED|Overall Study||6||
59567751|NCT02640573|75670584|FG000|STARTED|Overall Study||1||
59567752|NCT02640573|75670584|FG000|COMPLETED|Overall Study||0||
59567753|NCT02640573|75670584|FG000|NOT COMPLETED|Overall Study||1||
59567754|NCT02298192|75670590|FG000|STARTED|Overall Study||210||
59567755|NCT02298192|75670591|FG001|STARTED|Overall Study||210||
59567756|NCT02298192|75670590|FG000|COMPLETED|Overall Study||191||
59567757|NCT02298192|75670591|FG001|COMPLETED|Overall Study||204||
59567758|NCT02298192|75670590|FG000|NOT COMPLETED|Overall Study||19||
59567759|NCT02298192|75670591|FG001|NOT COMPLETED|Overall Study||6||
59840270|NCT05195528|75964504|FG001|Safety Analysis Set|Placebo-controlled Treatment Period|Planned and actual treatment differed for 2 participants.|259|Safety Analysis Set (SAS): all safety analyses were conducted on the Safety Set using the actual treatment the participant received even if the participant was randomized to receive a different treatment.|
59840271|NCT05195528|75964505|FG002|Safety Analysis Set|Placebo-controlled Treatment Period||257|Safety Analysis Set (SAS): all safety analyses were conducted on the Safety Set using the actual treatment the participant received even if the participant was randomized to receive a different treatment.|
59840272|NCT05195528|75964506|FG003|Safety Analysis Set|Placebo-controlled Treatment Period||0|Safety Analysis Set (SAS): all safety analyses were conducted on the Safety Set using the actual treatment the participant received even if the participant was randomized to receive a different treatment.|
59840273|NCT05195528|75964507|FG004|Safety Analysis Set|Placebo-controlled Treatment Period||0|Safety Analysis Set (SAS): all safety analyses were conducted on the Safety Set using the actual treatment the participant received even if the participant was randomized to receive a different treatment.|
59840274|NCT05195528|75964503|FG000|COMPLETED|Placebo-controlled Treatment Period||247||
59840275|NCT05195528|75964504|FG001|COMPLETED|Placebo-controlled Treatment Period||250||
59840276|NCT05195528|75964505|FG002|COMPLETED|Placebo-controlled Treatment Period||242||
59840277|NCT05195528|75964506|FG003|COMPLETED|Placebo-controlled Treatment Period||0||
59840278|NCT05195528|75964507|FG004|COMPLETED|Placebo-controlled Treatment Period||0||
59840279|NCT05195528|75964503|FG000|NOT COMPLETED|Placebo-controlled Treatment Period||12||
59840280|NCT05195528|75964504|FG001|NOT COMPLETED|Placebo-controlled Treatment Period||8||
59840281|NCT05195528|75964505|FG002|NOT COMPLETED|Placebo-controlled Treatment Period||17||
59840282|NCT05195528|75964506|FG003|NOT COMPLETED|Placebo-controlled Treatment Period||0||
59840283|NCT05195528|75964507|FG004|NOT COMPLETED|Placebo-controlled Treatment Period||0||
59840284|NCT05195528|75964503|FG000|STARTED|Extension Period||0||
59840285|NCT05195528|75964504|FG001|STARTED|Extension Period||247||
59840286|NCT05195528|75964505|FG002|STARTED|Extension Period||237||
59840287|NCT05195528|75964506|FG003|STARTED|Extension Period||122||
59840288|NCT05195528|75964507|FG004|STARTED|Extension Period||122||
59840289|NCT05195528|75964503|FG000|Intent to Treat Analysis Set|Extension Period||0|ITT: all efficacy analyses were conducted on the ITT Set using the planned treatment even if the participant received a different incorrect treatment.|
59840290|NCT05195528|75964504|FG001|Intent to Treat Analysis Set|Extension Period||247|ITT: all efficacy analyses were conducted on the ITT Set using the planned treatment even if the participant received a different incorrect treatment.|
59840291|NCT05195528|75964505|FG002|Intent to Treat Analysis Set|Extension Period||235|ITT: all efficacy analyses were conducted on the ITT Set using the planned treatment even if the participant received a different incorrect treatment.|
59840292|NCT05195528|75964506|FG003|Intent to Treat Analysis Set|Extension Period||119|ITT: all efficacy analyses were conducted on the ITT Set using the planned treatment even if the participant received a different incorrect treatment.|
59840293|NCT05195528|75964507|FG004|Intent to Treat Analysis Set|Extension Period||122|ITT: all efficacy analyses were conducted on the ITT Set using the planned treatment even if the participant received a different incorrect treatment.|
59840294|NCT05195528|75964503|FG000|Safety Analysis Set|Extension Period||0|SAS: all safety analyses were conducted on the Safety Set using the actual treatment the participant received even if the participant was randomized to receive a different treatment.|
59840295|NCT05195528|75964504|FG001|Safety Analysis Set|Extension Period|Planned and actual treatment differed for 1 participant.|248|SAS: all safety analyses were conducted on the Safety Set using the actual treatment the participant received even if the participant was randomized to receive a different treatment.|
59840296|NCT05195528|75964505|FG002|Safety Analysis Set|Extension Period|Planned and actual treatment differed for 1 participant.|236|SAS: all safety analyses were conducted on the Safety Set using the actual treatment the participant received even if the participant was randomized to receive a different treatment.|
59840297|NCT05195528|75964506|FG003|Safety Analysis Set|Extension Period||118|SAS: all safety analyses were conducted on the Safety Set using the actual treatment the participant received even if the participant was randomized to receive a different treatment.|
59840298|NCT05195528|75964507|FG004|Safety Analysis Set|Extension Period||121|SAS: all safety analyses were conducted on the Safety Set using the actual treatment the participant received even if the participant was randomized to receive a different treatment.|
59840299|NCT05195528|75964503|FG000|COMPLETED|Extension Period||0||
59840300|NCT05195528|75964504|FG001|COMPLETED|Extension Period||219||
59840301|NCT05195528|75964505|FG002|COMPLETED|Extension Period||206||
59840302|NCT05195528|75964506|FG003|COMPLETED|Extension Period||106||
59840303|NCT05195528|75964507|FG004|COMPLETED|Extension Period||103||
59840304|NCT05195528|75964503|FG000|NOT COMPLETED|Extension Period||0||
59840305|NCT05195528|75964504|FG001|NOT COMPLETED|Extension Period||28||
59840306|NCT05195528|75964505|FG002|NOT COMPLETED|Extension Period||31||
59840307|NCT05195528|75964506|FG003|NOT COMPLETED|Extension Period||16||
59840308|NCT05195528|75964507|FG004|NOT COMPLETED|Extension Period||19||
59840309|NCT05135156|75964521|FG000|STARTED|Overall Study||25||
59840310|NCT05135156|75964522|FG001|STARTED|Overall Study||25||
59840311|NCT05135156|75964523|FG002|STARTED|Overall Study||2||
59840312|NCT05135156|75964521|FG000|COMPLETED|Overall Study||25||
59840313|NCT05135156|75964522|FG001|COMPLETED|Overall Study||25||
59840314|NCT05135156|75964523|FG002|COMPLETED|Overall Study||0||
59840315|NCT05135156|75964521|FG000|NOT COMPLETED|Overall Study||0||
59840316|NCT05135156|75964522|FG001|NOT COMPLETED|Overall Study||0||
59567760|NCT01893632|75670599|FG000|STARTED|Overall Study||1||
59567761|NCT01893632|75670600|FG001|STARTED|Overall Study||1||
59567762|NCT01893632|75670599|FG000|COMPLETED|Overall Study||1||
59840317|NCT05135156|75964523|FG002|NOT COMPLETED|Overall Study||2||
59840318|NCT04956666|75964530|FG000|STARTED|Overall Study|"One patient, included here in the 75 that started the study, dropped out before treatment due to the investigator's decision of a change in treatment strategy. Therefore, a total of 74 patients were treated and analyzed. This patient was also included in the reason not completed physician decision count."|75||
59840319|NCT04956666|75964530|FG000|COMPLETED|Overall Study||52||
59840320|NCT04956666|75964530|FG000|NOT COMPLETED|Overall Study||23||
59840321|NCT04738318|75964536|FG000|STARTED|Overall Study||2||
59840322|NCT04738318|75964537|FG001|STARTED|Overall Study||0||
59840323|NCT04738318|75964536|FG000|COMPLETED|Overall Study||1||
59840324|NCT04738318|75964537|FG001|COMPLETED|Overall Study||0||
59840325|NCT04738318|75964536|FG000|NOT COMPLETED|Overall Study||1||
59840326|NCT04738318|75964537|FG001|NOT COMPLETED|Overall Study||0||
59840327|NCT04726709|75964545|FG000|STARTED|Overall Study||16||
59840328|NCT04726709|75964546|FG001|STARTED|Overall Study||14||
59840329|NCT04726709|75964545|FG000|COMPLETED|Overall Study|These numbers refer to individual participants, not dyads.|14||
59840330|NCT04726709|75964546|FG001|COMPLETED|Overall Study||12||
59840331|NCT04726709|75964545|FG000|NOT COMPLETED|Overall Study||2||
59840332|NCT04726709|75964546|FG001|NOT COMPLETED|Overall Study||2||
59840333|NCT04684420|75964559|FG000|STARTED|Treatment Period 1 (Day 1)||24||
59840334|NCT04684420|75964560|FG001|STARTED|Treatment Period 1 (Day 1)||24||
59840335|NCT04684420|75964561|FG002|STARTED|Treatment Period 1 (Day 1)||17||
59840336|NCT04684420|75964562|FG003|STARTED|Treatment Period 1 (Day 1)||16||
59840337|NCT04684420|75964559|FG000|COMPLETED|Treatment Period 1 (Day 1)||24||
59840338|NCT04684420|75964560|FG001|COMPLETED|Treatment Period 1 (Day 1)||23||
59840339|NCT04684420|75964561|FG002|COMPLETED|Treatment Period 1 (Day 1)||15||
59840340|NCT04684420|75964562|FG003|COMPLETED|Treatment Period 1 (Day 1)||15||
59840341|NCT04684420|75964559|FG000|NOT COMPLETED|Treatment Period 1 (Day 1)||0||
59840342|NCT04684420|75964560|FG001|NOT COMPLETED|Treatment Period 1 (Day 1)||1||
59840343|NCT04684420|75964561|FG002|NOT COMPLETED|Treatment Period 1 (Day 1)||2||
59840344|NCT04684420|75964562|FG003|NOT COMPLETED|Treatment Period 1 (Day 1)||1||
59840345|NCT04684420|75964559|FG000|STARTED|Period 2(Day 8 up to 3 Months)||24||
59840346|NCT04684420|75964560|FG001|STARTED|Period 2(Day 8 up to 3 Months)||23||
59840347|NCT04684420|75964561|FG002|STARTED|Period 2(Day 8 up to 3 Months)||15||
59840348|NCT04684420|75964562|FG003|STARTED|Period 2(Day 8 up to 3 Months)||15||
59840349|NCT04684420|75964559|FG000|COMPLETED|Period 2(Day 8 up to 3 Months)||24||
59840350|NCT04684420|75964560|FG001|COMPLETED|Period 2(Day 8 up to 3 Months)||23||
59840351|NCT04684420|75964561|FG002|COMPLETED|Period 2(Day 8 up to 3 Months)||15||
59840352|NCT04684420|75964562|FG003|COMPLETED|Period 2(Day 8 up to 3 Months)||15||
59840353|NCT04684420|75964559|FG000|NOT COMPLETED|Period 2(Day 8 up to 3 Months)||0||
59840354|NCT04684420|75964560|FG001|NOT COMPLETED|Period 2(Day 8 up to 3 Months)||0||
59840355|NCT04684420|75964561|FG002|NOT COMPLETED|Period 2(Day 8 up to 3 Months)||0||
59840356|NCT04684420|75964562|FG003|NOT COMPLETED|Period 2(Day 8 up to 3 Months)||0||
59840357|NCT04352101|75964575|FG000|STARTED|Overall Study||10||
59840358|NCT04352101|75964576|FG001|STARTED|Overall Study||8||
59840359|NCT04352101|75964575|FG000|COMPLETED|Overall Study||8||
59840360|NCT04352101|75964576|FG001|COMPLETED|Overall Study||7||
59840361|NCT04352101|75964575|FG000|NOT COMPLETED|Overall Study||2||
59840362|NCT04352101|75964576|FG001|NOT COMPLETED|Overall Study||1||
59840363|NCT04208087|75964587|FG000|STARTED|Overall Study||8||
59840364|NCT04208087|75964588|FG001|STARTED|Overall Study||6||
59840365|NCT04208087|75964589|FG002|STARTED|Overall Study||6||
59840366|NCT04208087|75964590|FG003|STARTED|Overall Study||6||
59840367|NCT04208087|75964591|FG004|STARTED|Overall Study||7||
59840368|NCT04208087|75964587|FG000|COMPLETED|Overall Study||7||
59840369|NCT04208087|75964588|FG001|COMPLETED|Overall Study||6||
59840370|NCT04208087|75964589|FG002|COMPLETED|Overall Study||5||
59840371|NCT04208087|75964590|FG003|COMPLETED|Overall Study||6||
59718764|NCT01212770|75837947|FG006|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||2||
59718765|NCT01212770|75837948|FG007|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0||
59718766|NCT01212770|75837949|FG008|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0||
59718767|NCT01212770|75837941|FG000|STARTED|Long-term Safety Phase (Year 2)||0||
59718768|NCT01212770|75837942|FG001|STARTED|Long-term Safety Phase (Year 2)|9 participants who completed Week 52 did not enter the long-term safety phase (LTSP)|111||
59718769|NCT01212770|75837943|FG002|STARTED|Long-term Safety Phase (Year 2)|5 participants who completed Week 52 did not enter the long-term safety phase|121||
59718770|NCT01212770|75837944|FG003|STARTED|Long-term Safety Phase (Year 2)||0||
59718771|NCT01212770|75837945|FG004|STARTED|Long-term Safety Phase (Year 2)||0||
59718772|NCT01212770|75837946|FG005|STARTED|Long-term Safety Phase (Year 2)||0||
59718773|NCT01212770|75837947|FG006|STARTED|Long-term Safety Phase (Year 2)||0||
59840372|NCT04208087|75964591|FG004|COMPLETED|Overall Study||6||
59840373|NCT04208087|75964587|FG000|NOT COMPLETED|Overall Study||1||
59840374|NCT04208087|75964588|FG001|NOT COMPLETED|Overall Study||0||
59840375|NCT04208087|75964589|FG002|NOT COMPLETED|Overall Study||1||
59840376|NCT04208087|75964590|FG003|NOT COMPLETED|Overall Study||0||
59840377|NCT04208087|75964591|FG004|NOT COMPLETED|Overall Study||1||
59840378|NCT04187053|75964604|FG000|STARTED|Overall Study||30||
59840379|NCT04187053|75964605|FG001|STARTED|Overall Study||26||
59840380|NCT04187053|75964604|FG000|COMPLETED|Overall Study||26||
59840381|NCT04187053|75964605|FG001|COMPLETED|Overall Study||19||
59840382|NCT04187053|75964604|FG000|NOT COMPLETED|Overall Study||4||
59840383|NCT04187053|75964605|FG001|NOT COMPLETED|Overall Study||7||
59840384|NCT04140227|75964611|FG000|STARTED|Overall Study||256||
59840385|NCT04140227|75964611|FG000|COMPLETED|Overall Study||208||
59840386|NCT04140227|75964611|FG000|NOT COMPLETED|Overall Study||48||
59840387|NCT03782259|75964617|FG000|STARTED|Overall Study||31||
59840388|NCT03782259|75964618|FG001|STARTED|Overall Study||31||
59840389|NCT03782259|75964617|FG000|COMPLETED|Overall Study||29||
59840390|NCT03782259|75964618|FG001|COMPLETED|Overall Study||27||
59840391|NCT03782259|75964617|FG000|NOT COMPLETED|Overall Study||2||
59840392|NCT03782259|75964618|FG001|NOT COMPLETED|Overall Study||4||
59840393|NCT03749460|75964625|FG000|STARTED|Overall Study||20||
59840394|NCT03749460|75964625|FG000|COMPLETED|Overall Study||20||
59840395|NCT03749460|75964625|FG000|NOT COMPLETED|Overall Study||0||
59840396|NCT03743194|75964631|FG000|STARTED|Overall Study||105||
59840397|NCT03743194|75964632|FG001|STARTED|Overall Study||105||
59840398|NCT03743194|75964631|FG000|COMPLETED|Overall Study||98||
59840399|NCT03743194|75964632|FG001|COMPLETED|Overall Study||96||
59840400|NCT03743194|75964631|FG000|NOT COMPLETED|Overall Study||7||
59840401|NCT03743194|75964632|FG001|NOT COMPLETED|Overall Study||9||
59840402|NCT03702244|75964640|FG000|STARTED|Overall Study||1057||
59840403|NCT03702244|75964641|FG001|STARTED|Overall Study||1046||
59840404|NCT03702244|75964640|FG000|COMPLETED|Overall Study||1057||
59840405|NCT03702244|75964641|FG001|COMPLETED|Overall Study||1046||
59840406|NCT03702244|75964640|FG000|NOT COMPLETED|Overall Study||0||
59840407|NCT03702244|75964641|FG001|NOT COMPLETED|Overall Study||0||
59840408|NCT03461146|75964647|FG000|STARTED|Overall Study||24||
59840409|NCT03461146|75964647|FG000|COMPLETED|Overall Study||21||
59840410|NCT03461146|75964647|FG000|NOT COMPLETED|Overall Study||3||
59840411|NCT03460704|75964653|FG000|STARTED|Overall Study||152||
59840412|NCT03460704|75964654|FG001|STARTED|Overall Study||135||
59840413|NCT03460704|75964653|FG000|Modified Intention to Treat Population - (mITT)|Overall Study||152||
59840414|NCT03460704|75964654|FG001|Modified Intention to Treat Population - (mITT)|Overall Study||135||
59840415|NCT03460704|75964653|FG000|Safety Population - (SAF)|Overall Study||152||
59840416|NCT03460704|75964654|FG001|Safety Population - (SAF)|Overall Study||135||
59840417|NCT03460704|75964653|FG000|Per-Protocol Population - (PP)|Overall Study||112||
59840418|NCT03460704|75964654|FG001|Per-Protocol Population - (PP)|Overall Study||98||
59840419|NCT03460704|75964653|FG000|COMPLETED|Overall Study||94||
59840420|NCT03460704|75964654|FG001|COMPLETED|Overall Study||89||
60119574|NCT02533726|76240718|FG000|NOT COMPLETED|Initial Allocation||0||
59567763|NCT01893632|75670600|FG001|COMPLETED|Overall Study||1||
59718774|NCT01212770|75837948|FG007|STARTED|Long-term Safety Phase (Year 2)|Patients from the PBO/APR 20 mg EE and XO are combined;5 patients finished Wk 52;no entry into LTSP|51||
59718775|NCT01212770|75837949|FG008|STARTED|Long-term Safety Phase (Year 2)|Patients from the PBO/APR 30 mg EE and XO are combined;3 patients finished Wk 52;no entry into LTSP|64||
59718776|NCT01212770|75837941|FG000|COMPLETED|Long-term Safety Phase (Year 2)||0||
59718777|NCT01212770|75837942|FG001|COMPLETED|Long-term Safety Phase (Year 2)||88||
59718778|NCT01212770|75837943|FG002|COMPLETED|Long-term Safety Phase (Year 2)||106||
59718779|NCT01212770|75837944|FG003|COMPLETED|Long-term Safety Phase (Year 2)||0||
59718780|NCT01212770|75837945|FG004|COMPLETED|Long-term Safety Phase (Year 2)||0||
59840421|NCT03460704|75964653|FG000|NOT COMPLETED|Overall Study||58||
59840422|NCT03460704|75964654|FG001|NOT COMPLETED|Overall Study||46||
59840423|NCT03430843|75964662|FG000|STARTED|Overall Study||256||
60119575|NCT02533726|76240719|FG001|NOT COMPLETED|Initial Allocation||0||
60119576|NCT02533726|76240718|FG000|STARTED|Treatment|54 participants allocated to Standard Care actually received Optimal Turning|709|54 participants allocated to Standard Care actually received Optimal Turning|
60119577|NCT02533726|76240719|FG001|STARTED|Treatment|4 participants allocated to Optimal Turning actually received Standard Care|603|54 participants allocated to Standard Care actually received Optimal Turning|
60119578|NCT02533726|76240718|FG000|Per Protocol Population|Treatment||671|Met minimum monitoring period (>2h) and did not receive both interventions|
60119579|NCT02533726|76240719|FG001|Per Protocol Population|Treatment||555|Met minimum monitoring period (>2h) and did not receive both interventions|
59567764|NCT01893632|75670599|FG000|NOT COMPLETED|Overall Study||0||
59567765|NCT01893632|75670600|FG001|NOT COMPLETED|Overall Study||0||
59567766|NCT01272141|75670606|FG000|STARTED|Overall Study||5||
59567767|NCT01272141|75670606|FG000|COMPLETED|Overall Study||5||
59567768|NCT01272141|75670606|FG000|NOT COMPLETED|Overall Study||0||
59567769|NCT01270581|75670612|FG000|STARTED|Overall Study||4||
59567770|NCT01270581|75670613|FG001|STARTED|Overall Study||3||
59567771|NCT01270581|75670612|FG000|COMPLETED|Overall Study||3||
59567772|NCT01270581|75670613|FG001|COMPLETED|Overall Study||3||
59567773|NCT01270581|75670612|FG000|NOT COMPLETED|Overall Study||1||
59567774|NCT01270581|75670613|FG001|NOT COMPLETED|Overall Study||0||
59567775|NCT01894178|75670621|FG000|STARTED|Overall Study||30||
59840424|NCT03430843|75964663|FG001|STARTED|Overall Study||256||
59840425|NCT03430843|75964662|FG000|Treated|Overall Study||255||
59840426|NCT03430843|75964663|FG001|Treated|Overall Study||240||
59840427|NCT03430843|75964662|FG000|COMPLETED|Overall Study||0||
59840428|NCT03430843|75964663|FG001|COMPLETED|Overall Study||0||
59840429|NCT03430843|75964662|FG000|NOT COMPLETED|Overall Study||256||
59840430|NCT03430843|75964663|FG001|NOT COMPLETED|Overall Study||256||
59840431|NCT03422198|75964671|FG000|STARTED|Overall Study||54||
59840432|NCT03422198|75964672|FG001|STARTED|Overall Study||54||
59840433|NCT03422198|75964671|FG000|COMPLETED|Overall Study||54||
59840434|NCT03422198|75964672|FG001|COMPLETED|Overall Study||54||
59840435|NCT03422198|75964671|FG000|NOT COMPLETED|Overall Study||0||
59840436|NCT03422198|75964672|FG001|NOT COMPLETED|Overall Study||0||
59840437|NCT03382600|75964680|FG000|STARTED|Overall Study||54||
59840438|NCT03382600|75964681|FG001|STARTED|Overall Study||46||
59840439|NCT03382600|75964680|FG000|COMPLETED|Overall Study||0||
59840440|NCT03382600|75964681|FG001|COMPLETED|Overall Study||0||
59840441|NCT03382600|75964680|FG000|NOT COMPLETED|Overall Study||54||
59840442|NCT03382600|75964681|FG001|NOT COMPLETED|Overall Study||46||
59840443|NCT03288311|75964689|FG000|STARTED|Overall Study||359||
59840444|NCT03288311|75964690|FG001|STARTED|Overall Study||392||
59840445|NCT03288311|75964689|FG000|COMPLETED|Overall Study||359||
59840446|NCT03288311|75964690|FG001|COMPLETED|Overall Study||392||
59840447|NCT03288311|75964689|FG000|NOT COMPLETED|Overall Study||0||
59840448|NCT03288311|75964690|FG001|NOT COMPLETED|Overall Study||0||
59840449|NCT03207009|75964696|FG000|STARTED|Overall Study||19||
59840450|NCT03207009|75964696|FG000|Intent-to-Treat (ITT) Population|Overall Study||19|ITT population included all 19 participants who initiated any study procedures, beginning with mobilization by G-CSF and/or plerixafor.|
59840451|NCT03207009|75964696|FG000|Transplant Population (TP)|Overall Study||18|TP included all participants who received beti-cel.|
59840452|NCT03207009|75964696|FG000|COMPLETED|Overall Study||18||
59840453|NCT03207009|75964696|FG000|NOT COMPLETED|Overall Study||1||
59840454|NCT02759861|75964700|FG000|STARTED|Overall Study||16||
59840455|NCT02759861|75964700|FG000|COMPLETED|Overall Study||15||
59840456|NCT02759861|75964700|FG000|NOT COMPLETED|Overall Study||1||
59840457|NCT02520063|75964709|FG000|STARTED|Overall Study||6||
59840458|NCT02520063|75964710|FG001|STARTED|Overall Study||4||
59840459|NCT02520063|75964711|FG002|STARTED|Overall Study||0||
59840460|NCT02520063|75964712|FG003|STARTED|Overall Study||5||
59840461|NCT02520063|75964709|FG000|COMPLETED|Overall Study||5||
59840462|NCT02520063|75964710|FG001|COMPLETED|Overall Study||3||
59840463|NCT02520063|75964711|FG002|COMPLETED|Overall Study||0||
59840464|NCT02520063|75964712|FG003|COMPLETED|Overall Study||5||
59840465|NCT02520063|75964709|FG000|NOT COMPLETED|Overall Study||1||
59840466|NCT02520063|75964710|FG001|NOT COMPLETED|Overall Study||1||
59840467|NCT02520063|75964711|FG002|NOT COMPLETED|Overall Study||0||
59840468|NCT02520063|75964712|FG003|NOT COMPLETED|Overall Study||0||
59840469|NCT02472314|75964723|FG000|STARTED|Overall Study||34||
59840470|NCT02472314|75964724|FG001|STARTED|Overall Study||36||
59840471|NCT02472314|75964723|FG000|COMPLETED|Overall Study||34||
59840472|NCT02472314|75964724|FG001|COMPLETED|Overall Study||36||
59840473|NCT02472314|75964723|FG000|NOT COMPLETED|Overall Study||0||
59840474|NCT02472314|75964724|FG001|NOT COMPLETED|Overall Study||0||
59840475|NCT02141074|75964730|FG000|STARTED|Pre-prophylaxis||34||
60119580|NCT02533726|76240718|FG000|COMPLETED|Treatment||709||
60119581|NCT02533726|76240719|FG001|COMPLETED|Treatment||603||
60119582|NCT02533726|76240718|FG000|NOT COMPLETED|Treatment||0||
59567776|NCT01894178|75670622|FG001|STARTED|Overall Study||30||
59718781|NCT01212770|75837946|FG005|COMPLETED|Long-term Safety Phase (Year 2)||0||
59840476|NCT02141074|75964731|FG001|STARTED|Pre-prophylaxis||0||
59840477|NCT02141074|75964730|FG000|COMPLETED|Pre-prophylaxis||31||
59840478|NCT02141074|75964731|FG001|COMPLETED|Pre-prophylaxis||0||
59840479|NCT02141074|75964730|FG000|NOT COMPLETED|Pre-prophylaxis||3||
59840480|NCT02141074|75964731|FG001|NOT COMPLETED|Pre-prophylaxis||0||
59840481|NCT02141074|75964730|FG000|STARTED|Prophylaxis||0||
59718782|NCT01212770|75837947|FG006|COMPLETED|Long-term Safety Phase (Year 2)||0||
59718783|NCT01212770|75837948|FG007|COMPLETED|Long-term Safety Phase (Year 2)||42||
59718784|NCT01212770|75837949|FG008|COMPLETED|Long-term Safety Phase (Year 2)||50||
59718785|NCT01212770|75837941|FG000|NOT COMPLETED|Long-term Safety Phase (Year 2)||0||
59718786|NCT01212770|75837942|FG001|NOT COMPLETED|Long-term Safety Phase (Year 2)||23||
59718787|NCT01212770|75837943|FG002|NOT COMPLETED|Long-term Safety Phase (Year 2)||15||
59840482|NCT02141074|75964731|FG001|STARTED|Prophylaxis|31 participants from Pre-prophylaxis period continued to the Prophylaxis period and additional 20 participants directly started the Prophylaxis period.|51||
59840483|NCT02141074|75964730|FG000|COMPLETED|Prophylaxis||0||
59840484|NCT02141074|75964731|FG001|COMPLETED|Prophylaxis||41||
59840485|NCT02141074|75964730|FG000|NOT COMPLETED|Prophylaxis||0||
59840486|NCT02141074|75964731|FG001|NOT COMPLETED|Prophylaxis||10||
60119583|NCT02533726|76240719|FG001|NOT COMPLETED|Treatment||0||
59567777|NCT01894178|75670621|FG000|COMPLETED|Overall Study||30||
59718788|NCT01212770|75837944|FG003|NOT COMPLETED|Long-term Safety Phase (Year 2)||0||
59718789|NCT01212770|75837945|FG004|NOT COMPLETED|Long-term Safety Phase (Year 2)||0||
59718790|NCT01212770|75837946|FG005|NOT COMPLETED|Long-term Safety Phase (Year 2)||0||
59718791|NCT01212770|75837947|FG006|NOT COMPLETED|Long-term Safety Phase (Year 2)||0||
59718792|NCT01212770|75837948|FG007|NOT COMPLETED|Long-term Safety Phase (Year 2)||9||
59840487|NCT01524705|75964741|FG000|STARTED|Overall Study||52||
59840488|NCT01524705|75964742|FG001|STARTED|Overall Study||50||
59840489|NCT01524705|75964741|FG000|COMPLETED|Overall Study||49||
59840490|NCT01524705|75964742|FG001|COMPLETED|Overall Study||47||
59840491|NCT01524705|75964741|FG000|NOT COMPLETED|Overall Study||3||
60119584|NCT02538016|76240725|FG000|STARTED|Overall Study||4||
59840492|NCT01524705|75964742|FG001|NOT COMPLETED|Overall Study||3||
59840493|NCT01072539|75964754|FG000|STARTED|Overall Study||3172||
59840494|NCT01072539|75964754|FG000|COMPLETED|Overall Study|Refer to the Safety Analysis Set. Data for completion were not collected.|3169||
59840495|NCT01072539|75964754|FG000|NOT COMPLETED|Overall Study||3||
59840496|NCT00147537|75964762|FG000|STARTED|Phase 1b||3||
60119585|NCT02538016|76240725|FG000|COMPLETED|Overall Study||4||
60119586|NCT02538016|76240725|FG000|NOT COMPLETED|Overall Study||0||
60119587|NCT02539108|76240731|FG000|STARTED|Overall Study||30||
60119588|NCT02539108|76240732|FG001|STARTED|Overall Study||30||
59567778|NCT01894178|75670622|FG001|COMPLETED|Overall Study||30||
59567779|NCT01894178|75670621|FG000|NOT COMPLETED|Overall Study||0||
59718793|NCT01212770|75837949|FG008|NOT COMPLETED|Long-term Safety Phase (Year 2)||14||
59718794|NCT01212770|75837941|FG000|STARTED|Long-term Safety Phase (Year 3)||0||
59718795|NCT01212770|75837942|FG001|STARTED|Long-term Safety Phase (Year 3)|1 participant who completed Year 2 did not continue treatment in Year 3|87||
59718796|NCT01212770|75837943|FG002|STARTED|Long-term Safety Phase (Year 3)|1 participant who completed Year 2 did not continue treatment in Year 3|105||
59718797|NCT01212770|75837944|FG003|STARTED|Long-term Safety Phase (Year 3)||0||
59718798|NCT01212770|75837945|FG004|STARTED|Long-term Safety Phase (Year 3)||0||
59718799|NCT01212770|75837946|FG005|STARTED|Long-term Safety Phase (Year 3)||0||
59840497|NCT00147537|75964763|FG001|STARTED|Phase 1b||2||
59840498|NCT00147537|75964764|FG002|STARTED|Phase 1b||4||
59840499|NCT00147537|75964765|FG003|STARTED|Phase 1b||3||
59840500|NCT00147537|75964766|FG004|STARTED|Phase 1b||3||
59840501|NCT00147537|75964767|FG005|STARTED|Phase 1b||3||
59840502|NCT00147537|75964768|FG006|STARTED|Phase 1b|18 participants randomized; 17 participants treated|18||
59840503|NCT00147537|75964769|FG007|STARTED|Phase 1b||7||
59840504|NCT00147537|75964770|FG008|STARTED|Phase 1b|18 participants randomized; 17 participants treated|18||
59840505|NCT00147537|75964771|FG009|STARTED|Phase 1b||0||
60119589|NCT02539108|76240731|FG000|COMPLETED|Overall Study||30||
60119590|NCT02539108|76240732|FG001|COMPLETED|Overall Study||30||
60119591|NCT02539108|76240731|FG000|NOT COMPLETED|Overall Study||0||
60119592|NCT02539108|76240732|FG001|NOT COMPLETED|Overall Study||0||
60119593|NCT02539342|76240740|FG000|STARTED|Overall Study||1||
60119594|NCT02539342|76240741|FG001|STARTED|Overall Study||0||
60119595|NCT02539342|76240740|FG000|COMPLETED|Overall Study||1||
60119596|NCT02539342|76240741|FG001|COMPLETED|Overall Study||0||
60119597|NCT02539342|76240740|FG000|NOT COMPLETED|Overall Study||0||
60119598|NCT02539342|76240741|FG001|NOT COMPLETED|Overall Study||0||
60119599|NCT02539654|76240747|FG000|STARTED|Overall Study||14||
60119600|NCT02539654|76240747|FG000|COMPLETED|Overall Study||14||
60119601|NCT02539654|76240747|FG000|NOT COMPLETED|Overall Study||0||
60119602|NCT02542150|76240754|FG000|STARTED|Overall Study||12||
60119603|NCT02542150|76240755|FG001|STARTED|Overall Study||12||
60119604|NCT02542150|76240754|FG000|Completed Placebo|Overall Study||12||
60119605|NCT02542150|76240755|FG001|Completed Placebo|Overall Study||12||
60119606|NCT02542150|76240754|FG000|Started Intervention|Overall Study||12||
60119607|NCT02542150|76240755|FG001|Started Intervention|Overall Study||12||
60119608|NCT02542150|76240754|FG000|COMPLETED|Overall Study||12||
60119609|NCT02542150|76240755|FG001|COMPLETED|Overall Study||12||
60119610|NCT02542150|76240754|FG000|NOT COMPLETED|Overall Study||0||
60119611|NCT02542150|76240755|FG001|NOT COMPLETED|Overall Study||0||
60119612|NCT02542462|76240769|FG000|STARTED|Overall Study||25||
60119613|NCT02542462|76240770|FG001|STARTED|Overall Study||25||
60119614|NCT02542462|76240771|FG002|STARTED|Overall Study||25||
60119615|NCT02542462|76240772|FG003|STARTED|Overall Study||26||
60119616|NCT02542462|76240769|FG000|COMPLETED|Overall Study||25||
60119617|NCT02542462|76240770|FG001|COMPLETED|Overall Study||25||
60119618|NCT02542462|76240771|FG002|COMPLETED|Overall Study||25||
60119619|NCT02542462|76240772|FG003|COMPLETED|Overall Study||25||
60119620|NCT02542462|76240769|FG000|NOT COMPLETED|Overall Study||0||
60119621|NCT02542462|76240770|FG001|NOT COMPLETED|Overall Study||0||
60119622|NCT02542462|76240771|FG002|NOT COMPLETED|Overall Study||0||
60119623|NCT02542462|76240772|FG003|NOT COMPLETED|Overall Study||1||
59840506|NCT00147537|75964772|FG010|STARTED|Phase 1b||0||
59840507|NCT00147537|75964762|FG000|COMPLETED|Phase 1b||1||
59840508|NCT00147537|75964763|FG001|COMPLETED|Phase 1b||0||
59840509|NCT00147537|75964764|FG002|COMPLETED|Phase 1b||0||
59840510|NCT00147537|75964765|FG003|COMPLETED|Phase 1b||1||
59840511|NCT00147537|75964766|FG004|COMPLETED|Phase 1b||0||
59840512|NCT00147537|75964767|FG005|COMPLETED|Phase 1b||0||
59840513|NCT00147537|75964768|FG006|COMPLETED|Phase 1b||0||
59840514|NCT00147537|75964769|FG007|COMPLETED|Phase 1b||0||
59840515|NCT00147537|75964770|FG008|COMPLETED|Phase 1b||1||
59840516|NCT00147537|75964771|FG009|COMPLETED|Phase 1b||0||
59840517|NCT00147537|75964772|FG010|COMPLETED|Phase 1b||0||
59840518|NCT00147537|75964762|FG000|NOT COMPLETED|Phase 1b||2||
59840519|NCT00147537|75964763|FG001|NOT COMPLETED|Phase 1b||2||
59840520|NCT00147537|75964764|FG002|NOT COMPLETED|Phase 1b||4||
59840521|NCT00147537|75964765|FG003|NOT COMPLETED|Phase 1b||2||
59840522|NCT00147537|75964766|FG004|NOT COMPLETED|Phase 1b||3||
59840523|NCT00147537|75964767|FG005|NOT COMPLETED|Phase 1b||3||
59840524|NCT00147537|75964768|FG006|NOT COMPLETED|Phase 1b||18||
59840525|NCT00147537|75964769|FG007|NOT COMPLETED|Phase 1b||7||
59840526|NCT00147537|75964770|FG008|NOT COMPLETED|Phase 1b||17||
59840527|NCT00147537|75964771|FG009|NOT COMPLETED|Phase 1b||0||
59840528|NCT00147537|75964772|FG010|NOT COMPLETED|Phase 1b||0||
59840529|NCT00147537|75964762|FG000|STARTED|Phase 2||0||
59840530|NCT00147537|75964763|FG001|STARTED|Phase 2||0||
59840531|NCT00147537|75964764|FG002|STARTED|Phase 2||0||
59840532|NCT00147537|75964765|FG003|STARTED|Phase 2||0||
59840533|NCT00147537|75964766|FG004|STARTED|Phase 2||0||
59840534|NCT00147537|75964767|FG005|STARTED|Phase 2||0||
59840535|NCT00147537|75964768|FG006|STARTED|Phase 2||0||
59840536|NCT00147537|75964769|FG007|STARTED|Phase 2||0||
59840537|NCT00147537|75964770|FG008|STARTED|Phase 2||0||
59840538|NCT00147537|75964771|FG009|STARTED|Phase 2|166 particpants randomized; 163 participants treated|166||
59840539|NCT00147537|75964772|FG010|STARTED|Phase 2|55 randomized; 56 treated-1 randomized but not treated, 2 randomized to F+P+C rec'd P+C|55||
59840540|NCT00147537|75964762|FG000|COMPLETED|Phase 2||0||
59840541|NCT00147537|75964763|FG001|COMPLETED|Phase 2||0||
59840542|NCT00147537|75964764|FG002|COMPLETED|Phase 2||0||
59840543|NCT00147537|75964765|FG003|COMPLETED|Phase 2||0||
59840544|NCT00147537|75964766|FG004|COMPLETED|Phase 2||0||
59840545|NCT00147537|75964767|FG005|COMPLETED|Phase 2||0||
59840546|NCT00147537|75964768|FG006|COMPLETED|Phase 2||0||
59840547|NCT00147537|75964769|FG007|COMPLETED|Phase 2||0||
59840548|NCT00147537|75964770|FG008|COMPLETED|Phase 2||0||
59840549|NCT00147537|75964771|FG009|COMPLETED|Phase 2||5||
59840550|NCT00147537|75964772|FG010|COMPLETED|Phase 2||3||
59840551|NCT00147537|75964762|FG000|NOT COMPLETED|Phase 2||0||
59840552|NCT00147537|75964763|FG001|NOT COMPLETED|Phase 2||0||
59840553|NCT00147537|75964764|FG002|NOT COMPLETED|Phase 2||0||
59840554|NCT00147537|75964765|FG003|NOT COMPLETED|Phase 2||0||
59840555|NCT00147537|75964766|FG004|NOT COMPLETED|Phase 2||0||
59840556|NCT00147537|75964767|FG005|NOT COMPLETED|Phase 2||0||
59840557|NCT00147537|75964768|FG006|NOT COMPLETED|Phase 2||0||
59840558|NCT00147537|75964769|FG007|NOT COMPLETED|Phase 2||0||
59840559|NCT00147537|75964770|FG008|NOT COMPLETED|Phase 2||0||
59840560|NCT00147537|75964771|FG009|NOT COMPLETED|Phase 2||161||
59840561|NCT00147537|75964772|FG010|NOT COMPLETED|Phase 2||52||
59718800|NCT01212770|75837947|FG006|STARTED|Long-term Safety Phase (Year 3)||0||
59718801|NCT01212770|75837948|FG007|STARTED|Long-term Safety Phase (Year 3)|The PBO/APR 20 mg EE and XO participants from week 24-52 are combined within the LTSP.|42||
59718802|NCT01212770|75837949|FG008|STARTED|Long-term Safety Phase (Year 3)|Patients from the PBO/APR 30 mg EE and XO are combined;1 patient finished Wk 52;no entry into LTSP|49||
59718803|NCT01212770|75837941|FG000|COMPLETED|Long-term Safety Phase (Year 3)||0||
59718804|NCT01212770|75837942|FG001|COMPLETED|Long-term Safety Phase (Year 3)|1 participant missed due to APR dispensed late|76||
59718805|NCT01212770|75837943|FG002|COMPLETED|Long-term Safety Phase (Year 3)||94||
59718806|NCT01212770|75837944|FG003|COMPLETED|Long-term Safety Phase (Year 3)||0||
59718807|NCT01212770|75837945|FG004|COMPLETED|Long-term Safety Phase (Year 3)||0||
59718808|NCT01212770|75837946|FG005|COMPLETED|Long-term Safety Phase (Year 3)||0||
59718809|NCT01212770|75837947|FG006|COMPLETED|Long-term Safety Phase (Year 3)||0||
59718810|NCT01212770|75837948|FG007|COMPLETED|Long-term Safety Phase (Year 3)||35||
59718811|NCT01212770|75837949|FG008|COMPLETED|Long-term Safety Phase (Year 3)||44||
59718812|NCT01212770|75837941|FG000|NOT COMPLETED|Long-term Safety Phase (Year 3)||0||
59718813|NCT01212770|75837942|FG001|NOT COMPLETED|Long-term Safety Phase (Year 3)||11||
59718814|NCT01212770|75837943|FG002|NOT COMPLETED|Long-term Safety Phase (Year 3)||11||
59718815|NCT01212770|75837944|FG003|NOT COMPLETED|Long-term Safety Phase (Year 3)||0||
59840562|NCT00222729|75964817|FG000|STARTED|Overall Study||40||
59840563|NCT00222729|75964817|FG000|COMPLETED|Overall Study||37||
59840564|NCT00222729|75964817|FG000|NOT COMPLETED|Overall Study||3||
59840565|NCT00147225|75964827|FG000|STARTED|Overall Study||7||
59840566|NCT00147225|75964828|FG001|STARTED|Overall Study||6||
59718816|NCT01212770|75837945|FG004|NOT COMPLETED|Long-term Safety Phase (Year 3)||0||
59718817|NCT01212770|75837946|FG005|NOT COMPLETED|Long-term Safety Phase (Year 3)||0||
59840567|NCT00147225|75964829|FG002|STARTED|Overall Study||8||
59840568|NCT00147225|75964830|FG003|STARTED|Overall Study||11||
59840569|NCT00147225|75964831|FG004|STARTED|Overall Study||11||
59840570|NCT00147225|75964832|FG005|STARTED|Overall Study||12||
59840571|NCT00147225|75964827|FG000|COMPLETED|Overall Study||6||
59840572|NCT00147225|75964828|FG001|COMPLETED|Overall Study||6||
59840573|NCT00147225|75964829|FG002|COMPLETED|Overall Study||6||
60119624|NCT02543398|76240785|FG000|STARTED|Overall Study||20||
60119625|NCT02543398|76240786|FG001|STARTED|Overall Study||20||
60119626|NCT02543398|76240785|FG000|COMPLETED|Overall Study||20||
60119627|NCT02543398|76240786|FG001|COMPLETED|Overall Study||20||
60119628|NCT02543398|76240785|FG000|NOT COMPLETED|Overall Study||0||
60119629|NCT02543398|76240786|FG001|NOT COMPLETED|Overall Study||0||
60119630|NCT02543554|76240794|FG000|STARTED|Overall Study||1192||
60119631|NCT02543554|76240795|FG001|STARTED|Overall Study||513||
60119632|NCT02543554|76240794|FG000|COMPLETED|Overall Study||1192||
60119633|NCT02543554|76240795|FG001|COMPLETED|Overall Study||513||
60119634|NCT02543554|76240794|FG000|NOT COMPLETED|Overall Study||0||
60119635|NCT02543554|76240795|FG001|NOT COMPLETED|Overall Study||0||
60119636|NCT02547064|76240803|FG000|STARTED|Overall Study||81||
60119637|NCT02547064|76240804|FG001|STARTED|Overall Study||81||
60119638|NCT02547064|76240803|FG000|COMPLETED|Overall Study||78||
60119639|NCT02547064|76240804|FG001|COMPLETED|Overall Study||79||
60119640|NCT02547064|76240803|FG000|NOT COMPLETED|Overall Study||3||
60119641|NCT02547064|76240804|FG001|NOT COMPLETED|Overall Study||2||
60119642|NCT02548312|76240818|FG000|STARTED|Overall Study||133||
60119643|NCT02548312|76240819|FG001|STARTED|Overall Study||133||
60119644|NCT02548312|76240820|FG002|STARTED|Overall Study||134||
60119645|NCT02548312|76240821|FG003|STARTED|Overall Study||133||
60119646|NCT02548312|76240822|FG004|STARTED|Overall Study||133||
60119647|NCT02548312|76240823|FG005|STARTED|Overall Study||133||
60119648|NCT02548312|76240824|FG006|STARTED|Overall Study||133||
60119649|NCT02548312|76240825|FG007|STARTED|Overall Study||133||
60119650|NCT02548312|76240818|FG000|COMPLETED|Overall Study||100||
60119651|NCT02548312|76240819|FG001|COMPLETED|Overall Study||90||
60119652|NCT02548312|76240820|FG002|COMPLETED|Overall Study||96||
60119653|NCT02548312|76240821|FG003|COMPLETED|Overall Study||87||
60119654|NCT02548312|76240822|FG004|COMPLETED|Overall Study||99||
60119655|NCT02548312|76240823|FG005|COMPLETED|Overall Study||93||
60119656|NCT02548312|76240824|FG006|COMPLETED|Overall Study||93||
60119657|NCT02548312|76240825|FG007|COMPLETED|Overall Study||91||
60119658|NCT02548312|76240818|FG000|NOT COMPLETED|Overall Study||33||
60119659|NCT02548312|76240819|FG001|NOT COMPLETED|Overall Study||43||
60119660|NCT02548312|76240820|FG002|NOT COMPLETED|Overall Study||38||
60119661|NCT02548312|76240821|FG003|NOT COMPLETED|Overall Study||46||
60119662|NCT02548312|76240822|FG004|NOT COMPLETED|Overall Study||34||
60119663|NCT02548312|76240823|FG005|NOT COMPLETED|Overall Study||40||
60119664|NCT02548312|76240824|FG006|NOT COMPLETED|Overall Study||40||
60119665|NCT02548312|76240825|FG007|NOT COMPLETED|Overall Study||42||
60119666|NCT02549014|76240845|FG000|STARTED|Overall Study||8||
60119667|NCT02549014|76240846|FG001|STARTED|Overall Study||8||
60119668|NCT02549014|76240845|FG000|COMPLETED|Overall Study||8||
60119669|NCT02549014|76240846|FG001|COMPLETED|Overall Study||8||
60119670|NCT02549014|76240845|FG000|NOT COMPLETED|Overall Study||0||
60119671|NCT02549014|76240846|FG001|NOT COMPLETED|Overall Study||0||
60119672|NCT01696643|76240872|FG000|STARTED|Overall Study||703||
60119673|NCT01696643|76240873|FG001|STARTED|Overall Study||704||
59718818|NCT01212770|75837947|FG006|NOT COMPLETED|Long-term Safety Phase (Year 3)||0||
59718819|NCT01212770|75837948|FG007|NOT COMPLETED|Long-term Safety Phase (Year 3)||7||
59718820|NCT01212770|75837949|FG008|NOT COMPLETED|Long-term Safety Phase (Year 3)||5||
59718821|NCT01212770|75837941|FG000|STARTED|Long-term Safety Phase (Year 4)||0||
59718822|NCT01212770|75837942|FG001|STARTED|Long-term Safety Phase (Year 4)|1 participant was counted in Year 4 but not in year 3 due to late APR dispensing|77||
59718823|NCT01212770|75837943|FG002|STARTED|Long-term Safety Phase (Year 4)||94||
59718824|NCT01212770|75837944|FG003|STARTED|Long-term Safety Phase (Year 4)||0||
59718825|NCT01212770|75837945|FG004|STARTED|Long-term Safety Phase (Year 4)||0||
60119674|NCT01696643|76240872|FG000|Received at Least 1 Dose of Study Drug|Overall Study||701||
59718826|NCT01212770|75837946|FG005|STARTED|Long-term Safety Phase (Year 4)||0||
59718827|NCT01212770|75837947|FG006|STARTED|Long-term Safety Phase (Year 4)||0||
59840574|NCT00147225|75964830|FG003|COMPLETED|Overall Study||10||
59840575|NCT00147225|75964831|FG004|COMPLETED|Overall Study||10||
59840576|NCT00147225|75964832|FG005|COMPLETED|Overall Study||10||
59840577|NCT00147225|75964827|FG000|NOT COMPLETED|Overall Study||1||
60119675|NCT01696643|76240873|FG001|Received at Least 1 Dose of Study Drug|Overall Study|2 participants randomized to placebo took CB-5945. Their results are included in the CB-5945 group.|702||
60119676|NCT01696643|76240872|FG000|COMPLETED|Overall Study||174||
60119677|NCT01696643|76240873|FG001|COMPLETED|Overall Study||169||
59840578|NCT00147225|75964828|FG001|NOT COMPLETED|Overall Study||0||
60119678|NCT01696643|76240872|FG000|NOT COMPLETED|Overall Study||529||
60119679|NCT01696643|76240873|FG001|NOT COMPLETED|Overall Study||535||
60119680|NCT02551432|76240879|FG000|STARTED|Overall Study||26||
60119681|NCT02551432|76240879|FG000|COMPLETED|Overall Study||26||
60119682|NCT02551432|76240879|FG000|NOT COMPLETED|Overall Study||0||
60119683|NCT01695317|76240885|FG000|STARTED|Period 1 in the Cross-over Design||36||
60119684|NCT01695317|76240886|FG001|STARTED|Period 1 in the Cross-over Design||36||
60119685|NCT01695317|76240885|FG000|COMPLETED|Period 1 in the Cross-over Design||34||
59840579|NCT00147225|75964829|FG002|NOT COMPLETED|Overall Study||2||
59840580|NCT00147225|75964830|FG003|NOT COMPLETED|Overall Study||1||
59840581|NCT00147225|75964831|FG004|NOT COMPLETED|Overall Study||1||
59840582|NCT00147225|75964832|FG005|NOT COMPLETED|Overall Study||2||
59840583|NCT00222105|75964846|FG000|STARTED|Overall Study||25||
59840584|NCT00222105|75964846|FG000|COMPLETED|Overall Study||11||
59840585|NCT00222105|75964846|FG000|NOT COMPLETED|Overall Study||14||
59840586|NCT00146757|75964850|FG000|STARTED|Overall Study||16||
59840587|NCT00146757|75964851|FG001|STARTED|Overall Study||4||
59840588|NCT00146757|75964850|FG000|COMPLETED|Overall Study||14||
59840589|NCT00146757|75964851|FG001|COMPLETED|Overall Study||4||
59840590|NCT00146757|75964850|FG000|NOT COMPLETED|Overall Study||2||
59840591|NCT00146757|75964851|FG001|NOT COMPLETED|Overall Study||0||
59840592|NCT00267098|75964865|FG000|STARTED|Overall Study||109||
59840593|NCT00267098|75964866|FG001|STARTED|Overall Study||51||
59840594|NCT00267098|75964867|FG002|STARTED|Overall Study||243||
59840595|NCT00267098|75964868|FG003|STARTED|Overall Study||241||
59840596|NCT00267098|75964869|FG004|STARTED|Overall Study||47||
59840597|NCT00267098|75964870|FG005|STARTED|Overall Study||106||
59840598|NCT00267098|75964871|FG006|STARTED|Overall Study||101||
59840599|NCT00267098|75964872|FG007|STARTED|Overall Study||20||
59840600|NCT00267098|75964865|FG000|COMPLETED|Overall Study||0||
59840601|NCT00267098|75964866|FG001|COMPLETED|Overall Study||0||
59840602|NCT00267098|75964867|FG002|COMPLETED|Overall Study||149||
59840603|NCT00267098|75964868|FG003|COMPLETED|Overall Study||135||
59840604|NCT00267098|75964869|FG004|COMPLETED|Overall Study||10||
59840605|NCT00267098|75964870|FG005|COMPLETED|Overall Study||66||
59840606|NCT00267098|75964871|FG006|COMPLETED|Overall Study||55||
59840607|NCT00267098|75964872|FG007|COMPLETED|Overall Study||5||
59840608|NCT00267098|75964865|FG000|NOT COMPLETED|Overall Study||109||
59840609|NCT00267098|75964866|FG001|NOT COMPLETED|Overall Study||51||
59840610|NCT00267098|75964867|FG002|NOT COMPLETED|Overall Study||94||
59840611|NCT00267098|75964868|FG003|NOT COMPLETED|Overall Study||106||
59840612|NCT00267098|75964869|FG004|NOT COMPLETED|Overall Study||37||
59840613|NCT00267098|75964870|FG005|NOT COMPLETED|Overall Study||40||
59840614|NCT00267098|75964871|FG006|NOT COMPLETED|Overall Study||46||
59840615|NCT00267098|75964872|FG007|NOT COMPLETED|Overall Study||15||
59840616|NCT00247676|75964895|FG000|STARTED|Overall Study||37||
59840617|NCT00247676|75964895|FG000|COMPLETED|Overall Study||1||
59840618|NCT00247676|75964895|FG000|NOT COMPLETED|Overall Study||36||
59840619|NCT00267020|75964901|FG000|STARTED|Overall Study||86||
59840620|NCT00267020|75964902|FG001|STARTED|Overall Study||44||
59840621|NCT00267020|75964901|FG000|Received at Least 1 Dose|Overall Study||82||
59840622|NCT00267020|75964902|FG001|Received at Least 1 Dose|Overall Study||39||
59840623|NCT00267020|75964901|FG000|Per-Protocol Population|Overall Study|With: cancer of the pancreas;no other chemotherapy;disease at baseline;received 1 dose of study drug|81||
59840624|NCT00267020|75964902|FG001|Per-Protocol Population|Overall Study|With: cancer of the pancreas;no other chemotherapy;disease at baseline;received 1 dose of study drug|38||
59840625|NCT00267020|75964901|FG000|COMPLETED|Overall Study||0||
59840626|NCT00267020|75964902|FG001|COMPLETED|Overall Study||1||
59840627|NCT00267020|75964901|FG000|NOT COMPLETED|Overall Study||86||
59840628|NCT00267020|75964902|FG001|NOT COMPLETED|Overall Study||43||
59840629|NCT00242216|75964910|FG000|STARTED|Overall Study||39||
59840630|NCT00242216|75964911|FG001|STARTED|Overall Study||37||
59840631|NCT00242216|75964910|FG000|COMPLETED|Overall Study||21||
59840632|NCT00242216|75964911|FG001|COMPLETED|Overall Study||15||
59840633|NCT00242216|75964910|FG000|NOT COMPLETED|Overall Study||18||
59840634|NCT00242216|75964911|FG001|NOT COMPLETED|Overall Study||22||
59840635|NCT00240110|75964919|FG000|STARTED|Overall Study||13||
59840636|NCT00240110|75964920|FG001|STARTED|Overall Study||13||
59840637|NCT00240110|75964919|FG000|COMPLETED|Overall Study||7||
59840638|NCT00240110|75964920|FG001|COMPLETED|Overall Study||6||
59840639|NCT00240110|75964919|FG000|NOT COMPLETED|Overall Study||6||
59840640|NCT00240110|75964920|FG001|NOT COMPLETED|Overall Study||7||
59840641|NCT00239720|75964930|FG000|STARTED|Overall Study||3||
59840642|NCT00239720|75964931|FG001|STARTED|Overall Study||1||
59840643|NCT00239720|75964930|FG000|COMPLETED|Overall Study|One participant discontinued due to an adverse event|2||
59840644|NCT00239720|75964931|FG001|COMPLETED|Overall Study|One participant lost to follow-up|0||
59840645|NCT00239720|75964930|FG000|NOT COMPLETED|Overall Study||1||
59840646|NCT00239720|75964931|FG001|NOT COMPLETED|Overall Study||1||
59840647|NCT00266864|75964939|FG000|STARTED|Overall Study||18||
59840648|NCT00266864|75964940|FG001|STARTED|Overall Study||13||
59840649|NCT00266864|75964939|FG000|COMPLETED|Overall Study||13||
59840650|NCT00266864|75964940|FG001|COMPLETED|Overall Study||11||
59840651|NCT00266864|75964939|FG000|NOT COMPLETED|Overall Study||5||
59840652|NCT00266864|75964940|FG001|NOT COMPLETED|Overall Study||2||
59840653|NCT00266708|75964948|FG000|STARTED|Overall Study||20|Randomize|
59840654|NCT00266708|75964949|FG001|STARTED|Overall Study||22|Randomize|
59840655|NCT00266708|75964948|FG000|COMPLETED|Overall Study||16||
59840656|NCT00266708|75964949|FG001|COMPLETED|Overall Study||13||
59840657|NCT00266708|75964948|FG000|NOT COMPLETED|Overall Study||4||
59840658|NCT00266708|75964949|FG001|NOT COMPLETED|Overall Study||9||
59840659|NCT00266630|75964957|FG000|STARTED|Overall Study||100||
59840660|NCT00266630|75964958|FG001|STARTED|Overall Study||39||
59840661|NCT00266630|75964957|FG000|COMPLETED|Overall Study||58||
59840662|NCT00266630|75964958|FG001|COMPLETED|Overall Study||11||
59840663|NCT00266630|75964957|FG000|NOT COMPLETED|Overall Study||42||
59840664|NCT00266630|75964958|FG001|NOT COMPLETED|Overall Study||28||
59840665|NCT00129129|75964969|FG000|STARTED|Primary Phase||287||
59840666|NCT00129129|75964970|FG001|STARTED|Primary Phase||319||
59840667|NCT00129129|75964971|FG002|STARTED|Primary Phase||150||
59840668|NCT00129129|75964972|FG003|STARTED|Primary Phase||0||
59840669|NCT00129129|75964973|FG004|STARTED|Primary Phase||0||
59840670|NCT00129129|75964969|FG000|COMPLETED|Primary Phase||262||
59840671|NCT00129129|75964970|FG001|COMPLETED|Primary Phase||294||
59840672|NCT00129129|75964971|FG002|COMPLETED|Primary Phase||150||
59840673|NCT00129129|75964972|FG003|COMPLETED|Primary Phase||0||
59840674|NCT00129129|75964973|FG004|COMPLETED|Primary Phase||0||
59840675|NCT00129129|75964969|FG000|NOT COMPLETED|Primary Phase||25||
59840676|NCT00129129|75964970|FG001|NOT COMPLETED|Primary Phase||25||
59840677|NCT00129129|75964971|FG002|NOT COMPLETED|Primary Phase||0||
59840678|NCT00129129|75964972|FG003|NOT COMPLETED|Primary Phase||0||
59840679|NCT00129129|75964973|FG004|NOT COMPLETED|Primary Phase||0||
59840680|NCT00129129|75964969|FG000|STARTED|Fourth Dose Phase||236||
59840681|NCT00129129|75964970|FG001|STARTED|Fourth Dose Phase||0||
59840682|NCT00129129|75964971|FG002|STARTED|Fourth Dose Phase||0||
59840683|NCT00129129|75964972|FG003|STARTED|Fourth Dose Phase||132||
59840684|NCT00129129|75964973|FG004|STARTED|Fourth Dose Phase||130||
59840685|NCT00129129|75964969|FG000|COMPLETED|Fourth Dose Phase||232||
59840686|NCT00129129|75964970|FG001|COMPLETED|Fourth Dose Phase||0||
59840687|NCT00129129|75964971|FG002|COMPLETED|Fourth Dose Phase||0||
59840688|NCT00129129|75964972|FG003|COMPLETED|Fourth Dose Phase||128||
59840689|NCT00129129|75964973|FG004|COMPLETED|Fourth Dose Phase||124||
59840690|NCT00129129|75964969|FG000|NOT COMPLETED|Fourth Dose Phase||4||
59840691|NCT00129129|75964970|FG001|NOT COMPLETED|Fourth Dose Phase||0||
59840692|NCT00129129|75964971|FG002|NOT COMPLETED|Fourth Dose Phase||0||
60119686|NCT01695317|76240886|FG001|COMPLETED|Period 1 in the Cross-over Design||35||
59567780|NCT01894178|75670622|FG001|NOT COMPLETED|Overall Study||0||
59718828|NCT01212770|75837948|FG007|STARTED|Long-term Safety Phase (Year 4)||35||
59718829|NCT01212770|75837949|FG008|STARTED|Long-term Safety Phase (Year 4)||44||
59718830|NCT01212770|75837941|FG000|COMPLETED|Long-term Safety Phase (Year 4)||0||
59718831|NCT01212770|75837942|FG001|COMPLETED|Long-term Safety Phase (Year 4)||71||
59718832|NCT01212770|75837943|FG002|COMPLETED|Long-term Safety Phase (Year 4)||83||
59718833|NCT01212770|75837944|FG003|COMPLETED|Long-term Safety Phase (Year 4)||0||
60119687|NCT01695317|76240885|FG000|NOT COMPLETED|Period 1 in the Cross-over Design||2||
60119688|NCT01695317|76240886|FG001|NOT COMPLETED|Period 1 in the Cross-over Design||1||
60119689|NCT01695317|76240885|FG000|STARTED|Cross-over to Period 2||34||
60119690|NCT01695317|76240886|FG001|STARTED|Cross-over to Period 2||35||
60119691|NCT01695317|76240885|FG000|COMPLETED|Cross-over to Period 2||30||
59718834|NCT01212770|75837945|FG004|COMPLETED|Long-term Safety Phase (Year 4)||0||
59840693|NCT00129129|75964972|FG003|NOT COMPLETED|Fourth Dose Phase||4||
59840694|NCT00129129|75964973|FG004|NOT COMPLETED|Fourth Dose Phase||6||
59840695|NCT00221403|75964996|FG000|STARTED|Overall Study||18||
60119692|NCT01695317|76240886|FG001|COMPLETED|Cross-over to Period 2||1||
60119693|NCT01695317|76240885|FG000|NOT COMPLETED|Cross-over to Period 2||4||
59718835|NCT01212770|75837946|FG005|COMPLETED|Long-term Safety Phase (Year 4)||0||
59718836|NCT01212770|75837947|FG006|COMPLETED|Long-term Safety Phase (Year 4)||0||
59718837|NCT01212770|75837948|FG007|COMPLETED|Long-term Safety Phase (Year 4)||32||
59718838|NCT01212770|75837949|FG008|COMPLETED|Long-term Safety Phase (Year 4)||42||
59840696|NCT00221403|75964997|FG001|STARTED|Overall Study||21||
59840697|NCT00221403|75964998|FG002|STARTED|Overall Study||7||
59840698|NCT00221403|75964996|FG000|COMPLETED|Overall Study||16||
60119694|NCT01695317|76240886|FG001|NOT COMPLETED|Cross-over to Period 2||34||
60119695|NCT02551744|76240894|FG000|STARTED|Overall Study||50||
59718839|NCT01212770|75837941|FG000|NOT COMPLETED|Long-term Safety Phase (Year 4)||0||
59840699|NCT00221403|75964997|FG001|COMPLETED|Overall Study||16||
59840700|NCT00221403|75964998|FG002|COMPLETED|Overall Study||7||
59840701|NCT00221403|75964996|FG000|NOT COMPLETED|Overall Study||2||
59840702|NCT00221403|75964997|FG001|NOT COMPLETED|Overall Study||5||
59840703|NCT00221403|75964998|FG002|NOT COMPLETED|Overall Study||0||
59840704|NCT00145977|75965008|FG000|STARTED|Overall Study||19||
60119696|NCT02551744|76240895|FG001|STARTED|Overall Study||51||
59840705|NCT00145977|75965009|FG001|STARTED|Overall Study||17||
59840706|NCT00145977|75965008|FG000|COMPLETED|Overall Study||17||
59840707|NCT00145977|75965009|FG001|COMPLETED|Overall Study||13||
59840708|NCT00145977|75965008|FG000|NOT COMPLETED|Overall Study||2||
59840709|NCT00145977|75965009|FG001|NOT COMPLETED|Overall Study||4||
59840710|NCT00238238|75965018|FG000|STARTED|Overall Study||3||
59840711|NCT00238238|75965019|FG001|STARTED|Overall Study||48||
59840712|NCT00238238|75965020|FG002|STARTED|Overall Study||46||
59840713|NCT00238238|75965018|FG000|COMPLETED|Overall Study||3||
59840714|NCT00238238|75965019|FG001|COMPLETED|Overall Study||45||
59840715|NCT00238238|75965020|FG002|COMPLETED|Overall Study||46||
59840716|NCT00238238|75965018|FG000|NOT COMPLETED|Overall Study||0||
59840717|NCT00238238|75965019|FG001|NOT COMPLETED|Overall Study||3||
59840718|NCT00238238|75965020|FG002|NOT COMPLETED|Overall Study||0||
59840719|NCT00128661|75965030|FG000|STARTED|Overall Study||3727||
59840720|NCT00128661|75965031|FG001|STARTED|Overall Study||3739||
59840721|NCT00128661|75965030|FG000|COMPLETED|Overall Study||3453||
59840722|NCT00128661|75965031|FG001|COMPLETED|Overall Study||3481||
59840723|NCT00128661|75965030|FG000|NOT COMPLETED|Overall Study||274||
59840724|NCT00128661|75965031|FG001|NOT COMPLETED|Overall Study||258||
59840725|NCT00145509|75965039|FG000|STARTED|Overall Study||41||
59840726|NCT00145509|75965040|FG001|STARTED|Overall Study||36||
59840727|NCT00145509|75965039|FG000|COMPLETED|Overall Study||19||
59840728|NCT00145509|75965040|FG001|COMPLETED|Overall Study||15||
59840729|NCT00145509|75965039|FG000|NOT COMPLETED|Overall Study||22||
59840730|NCT00145509|75965040|FG001|NOT COMPLETED|Overall Study||21||
59840731|NCT00145119|75965046|FG000|STARTED|Overall Study||312||
59840732|NCT00145119|75965046|FG000|COMPLETED|Overall Study||267||
59840733|NCT00145119|75965046|FG000|NOT COMPLETED|Overall Study||45||
59840734|NCT00220779|75965053|FG000|STARTED|Overall Study||45||
59840735|NCT00220779|75965054|FG001|STARTED|Overall Study||42||
59840736|NCT00220779|75965055|FG002|STARTED|Overall Study||41||
59840737|NCT00220779|75965053|FG000|COMPLETED|Overall Study||38||
59718840|NCT01212770|75837942|FG001|NOT COMPLETED|Long-term Safety Phase (Year 4)||6||
59718841|NCT01212770|75837943|FG002|NOT COMPLETED|Long-term Safety Phase (Year 4)||11||
59718842|NCT01212770|75837944|FG003|NOT COMPLETED|Long-term Safety Phase (Year 4)||0||
59718843|NCT01212770|75837945|FG004|NOT COMPLETED|Long-term Safety Phase (Year 4)||0||
59718844|NCT01212770|75837946|FG005|NOT COMPLETED|Long-term Safety Phase (Year 4)||0||
59718845|NCT01212770|75837947|FG006|NOT COMPLETED|Long-term Safety Phase (Year 4)||0||
59718846|NCT01212770|75837948|FG007|NOT COMPLETED|Long-term Safety Phase (Year 4)||3||
59718847|NCT01212770|75837949|FG008|NOT COMPLETED|Long-term Safety Phase (Year 4)||2||
59718848|NCT01212770|75837941|FG000|STARTED|Long-term Safety Phase (Year 5)||0||
59718849|NCT01212770|75837942|FG001|STARTED|Long-term Safety Phase (Year 5)|1 participant who completed Year 4 did not continue treatment in Year 5|70||
59718850|NCT01212770|75837943|FG002|STARTED|Long-term Safety Phase (Year 5)||83||
59718851|NCT01212770|75837944|FG003|STARTED|Long-term Safety Phase (Year 5)||0||
59718852|NCT01212770|75837945|FG004|STARTED|Long-term Safety Phase (Year 5)||0||
59718853|NCT01212770|75837946|FG005|STARTED|Long-term Safety Phase (Year 5)||0||
59718854|NCT01212770|75837947|FG006|STARTED|Long-term Safety Phase (Year 5)||0||
59718855|NCT01212770|75837948|FG007|STARTED|Long-term Safety Phase (Year 5)||32||
59840738|NCT00220779|75965054|FG001|COMPLETED|Overall Study||38||
59840739|NCT00220779|75965055|FG002|COMPLETED|Overall Study||37||
59840740|NCT00220779|75965053|FG000|NOT COMPLETED|Overall Study||7||
59840741|NCT00220779|75965054|FG001|NOT COMPLETED|Overall Study||4||
59840742|NCT00220779|75965055|FG002|NOT COMPLETED|Overall Study||4||
59840743|NCT00207740|75965067|FG000|STARTED|Overall Study||78||
60119697|NCT02551744|76240894|FG000|COMPLETED|Overall Study||50||
59718856|NCT01212770|75837949|FG008|STARTED|Long-term Safety Phase (Year 5)||42||
59718857|NCT01212770|75837941|FG000|COMPLETED|Long-term Safety Phase (Year 5)||0||
59718858|NCT01212770|75837942|FG001|COMPLETED|Long-term Safety Phase (Year 5)||68||
59718859|NCT01212770|75837943|FG002|COMPLETED|Long-term Safety Phase (Year 5)||72||
59718860|NCT01212770|75837944|FG003|COMPLETED|Long-term Safety Phase (Year 5)||0||
59718861|NCT01212770|75837945|FG004|COMPLETED|Long-term Safety Phase (Year 5)||0||
59718862|NCT01212770|75837946|FG005|COMPLETED|Long-term Safety Phase (Year 5)||0||
59718863|NCT01212770|75837947|FG006|COMPLETED|Long-term Safety Phase (Year 5)||0||
59718864|NCT01212770|75837948|FG007|COMPLETED|Long-term Safety Phase (Year 5)||30||
59718865|NCT01212770|75837949|FG008|COMPLETED|Long-term Safety Phase (Year 5)||41||
59718866|NCT01212770|75837941|FG000|NOT COMPLETED|Long-term Safety Phase (Year 5)||0||
59840744|NCT00207740|75965068|FG001|STARTED|Overall Study||77||
59840745|NCT00207740|75965069|FG002|STARTED|Overall Study||76||
59840746|NCT00207740|75965070|FG003|STARTED|Overall Study||78||
59840747|NCT00207740|75965067|FG000|COMPLETED|Overall Study|Indicates number of patients who received subcutaneous study medication through Week 52|49||
59996567|NCT02714569|76112509|FG006|STARTED|Part A Second Intervention||0||
59996568|NCT02714569|76112510|FG007|STARTED|Part A Second Intervention||0||
59996569|NCT02714569|76112511|FG008|STARTED|Part A Second Intervention||0||
59996570|NCT02714569|76112512|FG009|STARTED|Part A Second Intervention||0||
59996571|NCT02714569|76112513|FG010|STARTED|Part A Second Intervention||0||
59996572|NCT02714569|76112503|FG000|Received at Least One Dose of Study Drug|Part A Second Intervention||3||
59996573|NCT02714569|76112504|FG001|Received at Least One Dose of Study Drug|Part A Second Intervention||2||
59718867|NCT01212770|75837942|FG001|NOT COMPLETED|Long-term Safety Phase (Year 5)||2||
59718868|NCT01212770|75837943|FG002|NOT COMPLETED|Long-term Safety Phase (Year 5)||11||
59718869|NCT01212770|75837944|FG003|NOT COMPLETED|Long-term Safety Phase (Year 5)||0||
59840748|NCT00207740|75965068|FG001|COMPLETED|Overall Study|Indicates number of patients who received subcutaneous study medication through Week 52|36||
59840749|NCT00207740|75965069|FG002|COMPLETED|Overall Study|Indicates number of patients who received subcutaneous study medication through Week 52|36||
59840750|NCT00207740|75965070|FG003|COMPLETED|Overall Study|Indicates number of patients who received subcutaneous study medication through Week 52|35||
59840751|NCT00207740|75965067|FG000|NOT COMPLETED|Overall Study||29||
59840752|NCT00207740|75965068|FG001|NOT COMPLETED|Overall Study||41||
59840753|NCT00207740|75965069|FG002|NOT COMPLETED|Overall Study||40||
59840754|NCT00207740|75965070|FG003|NOT COMPLETED|Overall Study||43||
59840755|NCT00265382|75965084|FG000|STARTED|Overall Study||221||
59840756|NCT00265382|75965084|FG000|COMPLETED|Overall Study||76||
59840757|NCT00265382|75965084|FG000|NOT COMPLETED|Overall Study||145||
59840758|NCT00206726|75965088|FG000|STARTED|Overall Study||60||
59840759|NCT00206726|75965088|FG000|Treatment Started|Overall Study|Safety population (3 withdrew consent prior to receiving study drug)|57||
59840760|NCT00206726|75965088|FG000|4 Cycles Completed|Overall Study|per protocol population|41||
59840761|NCT00206726|75965088|FG000|COMPLETED|Overall Study|4-6 cycles of treatment with assessments at 2, 6, and 9 months post last dose|9||
59840762|NCT00206726|75965088|FG000|NOT COMPLETED|Overall Study||51||
59840763|NCT00237692|75965096|FG000|STARTED|Overall Study||147||
59840764|NCT00237692|75965097|FG001|STARTED|Overall Study||148||
59840765|NCT00237692|75965098|FG002|STARTED|Overall Study||149||
59840766|NCT00237692|75965099|FG003|STARTED|Overall Study||147||
59840767|NCT00237692|75965096|FG000|6 Month f/u|Overall Study||132||
59840768|NCT00237692|75965097|FG001|6 Month f/u|Overall Study||134||
59840769|NCT00237692|75965098|FG002|6 Month f/u|Overall Study||135||
59840770|NCT00237692|75965099|FG003|6 Month f/u|Overall Study||134||
59840771|NCT00237692|75965096|FG000|12 Month f/u|Overall Study||137||
59840772|NCT00237692|75965097|FG001|12 Month f/u|Overall Study||127||
59840773|NCT00237692|75965098|FG002|12 Month f/u|Overall Study||132||
59840774|NCT00237692|75965099|FG003|12 Month f/u|Overall Study||127||
59840775|NCT00237692|75965096|FG000|18 Month f/u|Overall Study||124||
59840776|NCT00237692|75965097|FG001|18 Month f/u|Overall Study||131||
59840777|NCT00237692|75965098|FG002|18 Month f/u|Overall Study||126||
59840778|NCT00237692|75965099|FG003|18 Month f/u|Overall Study||122||
59840779|NCT00237692|75965096|FG000|COMPLETED|Overall Study||129||
59840780|NCT00237692|75965097|FG001|COMPLETED|Overall Study||134||
59840781|NCT00237692|75965098|FG002|COMPLETED|Overall Study||127||
59840782|NCT00237692|75965099|FG003|COMPLETED|Overall Study||128||
59840783|NCT00237692|75965096|FG000|NOT COMPLETED|Overall Study||18||
59840784|NCT00237692|75965097|FG001|NOT COMPLETED|Overall Study||14||
59840785|NCT00237692|75965098|FG002|NOT COMPLETED|Overall Study||22||
59840786|NCT00237692|75965099|FG003|NOT COMPLETED|Overall Study||19||
60119698|NCT02551744|76240895|FG001|COMPLETED|Overall Study||51||
60119699|NCT02551744|76240894|FG000|NOT COMPLETED|Overall Study||0||
60119700|NCT02551744|76240895|FG001|NOT COMPLETED|Overall Study||0||
60119701|NCT02551822|76240903|FG000|STARTED|Overall Study||11||
60119702|NCT02551822|76240904|FG001|STARTED|Overall Study||12||
60119703|NCT02551822|76240903|FG000|COMPLETED|Overall Study||9||
60119704|NCT02551822|76240904|FG001|COMPLETED|Overall Study||10||
59718870|NCT01212770|75837945|FG004|NOT COMPLETED|Long-term Safety Phase (Year 5)||0||
59718871|NCT01212770|75837946|FG005|NOT COMPLETED|Long-term Safety Phase (Year 5)||0||
59718872|NCT01212770|75837947|FG006|NOT COMPLETED|Long-term Safety Phase (Year 5)||0||
59718873|NCT01212770|75837948|FG007|NOT COMPLETED|Long-term Safety Phase (Year 5)||2||
59718874|NCT01212770|75837949|FG008|NOT COMPLETED|Long-term Safety Phase (Year 5)||1||
59840787|NCT00237458|75965109|FG000|STARTED|Overall Study||7||
59840788|NCT00237458|75965109|FG000|COMPLETED|Overall Study||4||
59840789|NCT00237458|75965109|FG000|NOT COMPLETED|Overall Study||3||
59840790|NCT00265148|75965115|FG000|STARTED|Overall Study||40||
59840791|NCT00265148|75965116|FG001|STARTED|Overall Study||40||
59840792|NCT00265148|75965115|FG000|COMPLETED|Overall Study||31||
59840793|NCT00265148|75965116|FG001|COMPLETED|Overall Study||31||
59840794|NCT00265148|75965115|FG000|NOT COMPLETED|Overall Study||9||
59840795|NCT00265148|75965116|FG001|NOT COMPLETED|Overall Study||9||
59840796|NCT00043186|75965132|FG000|STARTED|Overall Study||46||
59840797|NCT00043186|75965133|FG001|STARTED|Overall Study||44||
59840798|NCT00043186|75965134|FG002|STARTED|Overall Study||44||
59840799|NCT00043186|75965135|FG003|STARTED|Overall Study||41||
59840800|NCT00043186|75965136|FG004|STARTED|Overall Study||54||
59840801|NCT00043186|75965137|FG005|STARTED|Overall Study||47||
59840802|NCT00043186|75965138|FG006|STARTED|Overall Study||42||
59840803|NCT00043186|75965139|FG007|STARTED|Overall Study||47||
59840804|NCT00043186|75965140|FG008|STARTED|Overall Study||47||
59840805|NCT00043186|75965132|FG000|COMPLETED|Overall Study||29||
59840806|NCT00043186|75965133|FG001|COMPLETED|Overall Study||29||
59840807|NCT00043186|75965134|FG002|COMPLETED|Overall Study||24||
59840808|NCT00043186|75965135|FG003|COMPLETED|Overall Study||19||
60119705|NCT02551822|76240903|FG000|NOT COMPLETED|Overall Study||2||
59840809|NCT00043186|75965136|FG004|COMPLETED|Overall Study||36||
59840810|NCT00043186|75965137|FG005|COMPLETED|Overall Study||39||
59840811|NCT00043186|75965138|FG006|COMPLETED|Overall Study||25||
59840812|NCT00043186|75965139|FG007|COMPLETED|Overall Study||31||
59840813|NCT00043186|75965140|FG008|COMPLETED|Overall Study||30||
59840814|NCT00043186|75965132|FG000|NOT COMPLETED|Overall Study||17||
59840815|NCT00043186|75965133|FG001|NOT COMPLETED|Overall Study||15||
59840816|NCT00043186|75965134|FG002|NOT COMPLETED|Overall Study||20||
59840817|NCT00043186|75965135|FG003|NOT COMPLETED|Overall Study||22||
59840818|NCT00043186|75965136|FG004|NOT COMPLETED|Overall Study||18||
59840819|NCT00043186|75965137|FG005|NOT COMPLETED|Overall Study||8||
59840820|NCT00043186|75965138|FG006|NOT COMPLETED|Overall Study||17||
59840821|NCT00043186|75965139|FG007|NOT COMPLETED|Overall Study||16||
59840822|NCT00043186|75965140|FG008|NOT COMPLETED|Overall Study||17||
59840823|NCT00041470|75965161|FG000|STARTED|Overall Study||38||
59840824|NCT00041470|75965161|FG000|COMPLETED|Overall Study||0||
59840825|NCT00041470|75965161|FG000|NOT COMPLETED|Overall Study||38||
59840826|NCT00206102|75965167|FG000|STARTED|Overall Study||596||
59840827|NCT00206102|75965168|FG001|STARTED|Overall Study||502||
59840828|NCT00206102|75965167|FG000|COMPLETED|Overall Study||188||
59840829|NCT00206102|75965168|FG001|COMPLETED|Overall Study||187||
59840830|NCT00206102|75965167|FG000|NOT COMPLETED|Overall Study||408||
59840831|NCT00206102|75965168|FG001|NOT COMPLETED|Overall Study||315||
59840832|NCT00041080|75965176|FG000|STARTED|Overall Study|number patients enrolled on study|69||
59840833|NCT00041080|75965177|FG001|STARTED|Overall Study|number patients enrolled on study|70||
59840834|NCT00041080|75965176|FG000|COMPLETED|Overall Study||39||
59840835|NCT00041080|75965177|FG001|COMPLETED|Overall Study||60||
59840836|NCT00041080|75965176|FG000|NOT COMPLETED|Overall Study||30||
59840837|NCT00041080|75965177|FG001|NOT COMPLETED|Overall Study||10||
59840838|NCT00205712|75965185|FG000|STARTED|Overall Study||20||
59840839|NCT00205712|75965186|FG001|STARTED|Overall Study||20||
59840840|NCT00205712|75965185|FG000|COMPLETED|Overall Study||20||
59840841|NCT00205712|75965186|FG001|COMPLETED|Overall Study||19||
59840842|NCT00205712|75965185|FG000|NOT COMPLETED|Overall Study||0||
59840843|NCT00205712|75965186|FG001|NOT COMPLETED|Overall Study||1||
59840844|NCT00203294|75965196|FG000|STARTED|Overall Study||22||
59840845|NCT00203294|75965197|FG001|STARTED|Overall Study||23||
59840846|NCT00203294|75965196|FG000|COMPLETED|Overall Study||14||
59840847|NCT00203294|75965197|FG001|COMPLETED|Overall Study||10||
59840848|NCT00203294|75965196|FG000|NOT COMPLETED|Overall Study||8||
59840849|NCT00203294|75965197|FG001|NOT COMPLETED|Overall Study||13||
59840850|NCT00264290|75965205|FG000|STARTED|Intervention (8 Weeks)||16||
59840851|NCT00264290|75965206|FG001|STARTED|Intervention (8 Weeks)||14||
59840852|NCT00264290|75965205|FG000|COMPLETED|Intervention (8 Weeks)||15||
59840853|NCT00264290|75965206|FG001|COMPLETED|Intervention (8 Weeks)||14||
59840854|NCT00264290|75965205|FG000|NOT COMPLETED|Intervention (8 Weeks)||1||
59840855|NCT00264290|75965206|FG001|NOT COMPLETED|Intervention (8 Weeks)||0||
59840856|NCT00264290|75965205|FG000|STARTED|Observation (4 Weeks)||15||
59840857|NCT00264290|75965206|FG001|STARTED|Observation (4 Weeks)||14||
59718875|NCT00598273|75837974|FG000|STARTED|Overall Study||161||
59718876|NCT00598273|75837975|FG001|STARTED|Overall Study||165||
59718877|NCT00598273|75837976|FG002|STARTED|Overall Study||164||
59718878|NCT00598273|75837974|FG000|COMPLETED|Overall Study||120||
59718879|NCT00598273|75837975|FG001|COMPLETED|Overall Study||127||
59840858|NCT00264290|75965205|FG000|COMPLETED|Observation (4 Weeks)||15||
59840859|NCT00264290|75965206|FG001|COMPLETED|Observation (4 Weeks)||14||
59840860|NCT00264290|75965205|FG000|NOT COMPLETED|Observation (4 Weeks)||0||
59840861|NCT00264290|75965206|FG001|NOT COMPLETED|Observation (4 Weeks)||0||
59840862|NCT00234494|75965216|FG000|STARTED|Overall Study||45||
59840863|NCT00234494|75965216|FG000|COMPLETED|Overall Study||43||
59840864|NCT00234494|75965216|FG000|NOT COMPLETED|Overall Study||2||
59840865|NCT00234104|75965224|FG000|STARTED|Overall Study||30||
59840866|NCT00234104|75965225|FG001|STARTED|Overall Study||29||
59840867|NCT00234104|75965226|FG002|STARTED|Overall Study||34||
59840868|NCT00234104|75965227|FG003|STARTED|Overall Study||29||
59840869|NCT00234104|75965224|FG000|COMPLETED|Overall Study||26||
59718880|NCT00598273|75837976|FG002|COMPLETED|Overall Study||125||
59718881|NCT00598273|75837974|FG000|NOT COMPLETED|Overall Study||41||
59718882|NCT00598273|75837975|FG001|NOT COMPLETED|Overall Study||38||
59718883|NCT00598273|75837976|FG002|NOT COMPLETED|Overall Study||39||
59718884|NCT01211522|75837987|FG000|STARTED|Overall Study||192||
59718885|NCT01211522|75837988|FG001|STARTED|Overall Study||190||
59718886|NCT01211522|75837989|FG002|STARTED|Overall Study||184||
59840870|NCT00234104|75965225|FG001|COMPLETED|Overall Study||28||
59840871|NCT00234104|75965226|FG002|COMPLETED|Overall Study||29||
59840872|NCT00234104|75965227|FG003|COMPLETED|Overall Study||21||
59840873|NCT00234104|75965224|FG000|NOT COMPLETED|Overall Study||4||
59840874|NCT00234104|75965225|FG001|NOT COMPLETED|Overall Study||1||
59840875|NCT00234104|75965226|FG002|NOT COMPLETED|Overall Study||5||
59840876|NCT00234104|75965227|FG003|NOT COMPLETED|Overall Study||8||
59718887|NCT01211522|75837987|FG000|COMPLETED|Overall Study||189||
59840877|NCT00263666|75965239|FG000|STARTED|Overall Study||50||
59840878|NCT00263666|75965240|FG001|STARTED|Overall Study||50||
59840879|NCT00263666|75965239|FG000|COMPLETED|Overall Study||43||
59840880|NCT00263666|75965240|FG001|COMPLETED|Overall Study||39||
59840881|NCT00263666|75965239|FG000|NOT COMPLETED|Overall Study||7||
59840882|NCT00263666|75965240|FG001|NOT COMPLETED|Overall Study||11||
59840883|NCT00195338|75965246|FG000|STARTED|Overall Study||25||
59840884|NCT00195338|75965246|FG000|COMPLETED|Overall Study||13||
59840885|NCT00195338|75965246|FG000|NOT COMPLETED|Overall Study||12||
59840886|NCT00035932|75965253|FG000|STARTED|Overall Study|120 randomized, 119 treated|119||
59840887|NCT00035932|75965254|FG001|STARTED|Overall Study|115 randomized, 110 treated|110||
59840888|NCT00035932|75965255|FG002|STARTED|Overall Study|123 randomized, 118 treated|118||
59840889|NCT00035932|75965253|FG000|Discontinued Prior to Week 48 Visit|Overall Study||26||
59840890|NCT00035932|75965254|FG001|Discontinued Prior to Week 48 Visit|Overall Study||29||
59840891|NCT00035932|75965255|FG002|Discontinued Prior to Week 48 Visit|Overall Study||13||
59840892|NCT00035932|75965253|FG000|Discontinued Between Weeks 48 and 96|Overall Study||26||
59840893|NCT00035932|75965254|FG001|Discontinued Between Weeks 48 and 96|Overall Study||27||
59840894|NCT00035932|75965255|FG002|Discontinued Between Weeks 48 and 96|Overall Study||30||
59840895|NCT00035932|75965253|FG000|Discontinued on or After Week 96|Overall Study||4||
59840896|NCT00035932|75965254|FG001|Discontinued on or After Week 96|Overall Study||4||
59840897|NCT00035932|75965255|FG002|Discontinued on or After Week 96|Overall Study||6||
59840898|NCT00035932|75965253|FG000|COMPLETED|Overall Study|63 remained on treatment, 0 completed at Week 96|63||
59840899|NCT00035932|75965254|FG001|COMPLETED|Overall Study|50 remained on treatment, 0 completed at Week 96|50||
59840900|NCT00035932|75965255|FG002|COMPLETED|Overall Study|59 remained on treatment, 10 completed at Week 96|69||
59840901|NCT00035932|75965253|FG000|NOT COMPLETED|Overall Study||56||
59840902|NCT00035932|75965254|FG001|NOT COMPLETED|Overall Study||60||
59840903|NCT00035932|75965255|FG002|NOT COMPLETED|Overall Study||49||
59840904|NCT00022516|75965270|FG000|STARTED|Overall Study||542||
59840905|NCT00022516|75965271|FG001|STARTED|Overall Study||544||
59840906|NCT00022516|75965270|FG000|COMPLETED|Overall Study||539||
59840907|NCT00022516|75965271|FG001|COMPLETED|Overall Study||314||
59840908|NCT00022516|75965270|FG000|NOT COMPLETED|Overall Study||3||
59840909|NCT00022516|75965271|FG001|NOT COMPLETED|Overall Study||230||
59840910|NCT00033514|75965279|FG000|STARTED|Overall Study||16||
59840911|NCT00033514|75965280|FG001|STARTED|Overall Study||11||
59840912|NCT00033514|75965279|FG000|COMPLETED|Overall Study||15||
59840913|NCT00033514|75965280|FG001|COMPLETED|Overall Study||7||
59840914|NCT00033514|75965279|FG000|NOT COMPLETED|Overall Study||1||
59840915|NCT00033514|75965280|FG001|NOT COMPLETED|Overall Study||4||
59840916|NCT00006916|75965287|FG000|STARTED|Overall Study||19||
59840917|NCT00006916|75965287|FG000|COMPLETED|Overall Study|Subjects with survival data for the primary analysis are considered to have completed the study.|14||
59840918|NCT00006916|75965287|FG000|NOT COMPLETED|Overall Study||5||
59840919|NCT00454649|75965301|FG000|STARTED|Overall Study||3||
59840920|NCT00454649|75965302|FG001|STARTED|Overall Study||5||
59840921|NCT00454649|75965303|FG002|STARTED|Overall Study||20||
59840922|NCT00454649|75965304|FG003|STARTED|Overall Study||7||
59840923|NCT00454649|75965305|FG004|STARTED|Overall Study||1||
59840924|NCT00454649|75965306|FG005|STARTED|Overall Study||7||
59840925|NCT00454649|75965307|FG006|STARTED|Overall Study||9||
59840926|NCT00454649|75965308|FG007|STARTED|Overall Study||19||
59840927|NCT00454649|75965309|FG008|STARTED|Overall Study||21||
59840928|NCT00454649|75965310|FG009|STARTED|Overall Study||6||
59840929|NCT00454649|75965301|FG000|COMPLETED|Overall Study||0||
59840930|NCT00454649|75965302|FG001|COMPLETED|Overall Study||1||
59840931|NCT00454649|75965303|FG002|COMPLETED|Overall Study||1||
59840932|NCT00454649|75965304|FG003|COMPLETED|Overall Study||1||
59840933|NCT00454649|75965305|FG004|COMPLETED|Overall Study||0||
59840934|NCT00454649|75965306|FG005|COMPLETED|Overall Study||0||
59840935|NCT00454649|75965307|FG006|COMPLETED|Overall Study||0||
59840936|NCT00454649|75965308|FG007|COMPLETED|Overall Study||0||
59840937|NCT00454649|75965309|FG008|COMPLETED|Overall Study||1||
59840938|NCT00454649|75965310|FG009|COMPLETED|Overall Study||1||
59840939|NCT00454649|75965301|FG000|NOT COMPLETED|Overall Study||3||
60119706|NCT02551822|76240904|FG001|NOT COMPLETED|Overall Study||2||
59840940|NCT00454649|75965302|FG001|NOT COMPLETED|Overall Study||4||
59840941|NCT00454649|75965303|FG002|NOT COMPLETED|Overall Study||19||
59840942|NCT00454649|75965304|FG003|NOT COMPLETED|Overall Study||6||
59840943|NCT00454649|75965305|FG004|NOT COMPLETED|Overall Study||1||
59840944|NCT00454649|75965306|FG005|NOT COMPLETED|Overall Study||7||
59840945|NCT00454649|75965307|FG006|NOT COMPLETED|Overall Study||9||
59840946|NCT00454649|75965308|FG007|NOT COMPLETED|Overall Study||19||
59840947|NCT00454649|75965309|FG008|NOT COMPLETED|Overall Study||20||
59840948|NCT00454649|75965310|FG009|NOT COMPLETED|Overall Study||5||
59840949|NCT00454571|75965353|FG000|STARTED|Overall Study||18||
60119707|NCT02552368|76240910|FG000|STARTED|Overall Study||23||
60119708|NCT02552368|76240910|FG000|COMPLETED|Overall Study||10||
59840950|NCT00454571|75965354|FG001|STARTED|Overall Study||19||
59840951|NCT00454571|75965353|FG000|COMPLETED|Overall Study||5||
59840952|NCT00454571|75965354|FG001|COMPLETED|Overall Study||13||
59840953|NCT00454571|75965353|FG000|NOT COMPLETED|Overall Study||13||
59840954|NCT00454571|75965354|FG001|NOT COMPLETED|Overall Study||6||
60119709|NCT02552368|76240910|FG000|NOT COMPLETED|Overall Study||13||
60119710|NCT02555098|76240915|FG000|STARTED|First Intervention||12||
59840955|NCT03837743|75965360|FG000|STARTED|Overall Study||25||50
60119711|NCT02555098|76240916|FG001|STARTED|First Intervention||11||
60119712|NCT02555098|76240915|FG000|COMPLETED|First Intervention||12||
60119713|NCT02555098|76240916|FG001|COMPLETED|First Intervention||11||
60119714|NCT02555098|76240915|FG000|NOT COMPLETED|First Intervention||0||
60119715|NCT02555098|76240916|FG001|NOT COMPLETED|First Intervention||0||
60119716|NCT02555098|76240915|FG000|STARTED|Second Intervention||12||
60119717|NCT02555098|76240916|FG001|STARTED|Second Intervention||11||
60119718|NCT02555098|76240915|FG000|COMPLETED|Second Intervention||12||
60119719|NCT02555098|76240916|FG001|COMPLETED|Second Intervention||11||
60119720|NCT02555098|76240915|FG000|NOT COMPLETED|Second Intervention||0||
60119721|NCT02555098|76240916|FG001|NOT COMPLETED|Second Intervention||0||
60119722|NCT02556112|76240929|FG000|STARTED|Overall Study||40||
60119723|NCT02556112|76240930|FG001|STARTED|Overall Study||40||
60119724|NCT02556112|76240931|FG002|STARTED|Overall Study||42||
60119725|NCT02556112|76240929|FG000|COMPLETED|Overall Study||30||
60119726|NCT02556112|76240930|FG001|COMPLETED|Overall Study||23||
60119727|NCT02556112|76240931|FG002|COMPLETED|Overall Study||30||
60119728|NCT02556112|76240929|FG000|NOT COMPLETED|Overall Study||10||
60119729|NCT02556112|76240930|FG001|NOT COMPLETED|Overall Study||17||
60119730|NCT02556112|76240931|FG002|NOT COMPLETED|Overall Study||12||
60119731|NCT02701296|76240942|FG000|STARTED|Overall Study||42||
60119732|NCT02701296|76240943|FG001|STARTED|Overall Study||38||
60119733|NCT02701296|76240942|FG000|COMPLETED|Overall Study||42||
60119734|NCT02701296|76240943|FG001|COMPLETED|Overall Study|Data was incomplete for two participants their data was not included in the overall data analysis.|36||
60119735|NCT02701296|76240942|FG000|NOT COMPLETED|Overall Study||0||
60119736|NCT02701296|76240943|FG001|NOT COMPLETED|Overall Study||2||
60119737|NCT02558374|76240951|FG000|STARTED|Overall Study||351||
60119738|NCT02558374|76240952|FG001|STARTED|Overall Study||357||
60119739|NCT02558374|76240951|FG000|COMPLETED|Overall Study||243||
60119740|NCT02558374|76240952|FG001|COMPLETED|Overall Study||314||
60119741|NCT02558374|76240951|FG000|NOT COMPLETED|Overall Study||108||
60119742|NCT02558374|76240952|FG001|NOT COMPLETED|Overall Study||43||
59718888|NCT01211522|75837988|FG001|COMPLETED|Overall Study||183||
59718889|NCT01211522|75837989|FG002|COMPLETED|Overall Study||179||
59718890|NCT01211522|75837987|FG000|NOT COMPLETED|Overall Study||3||
59718891|NCT01211522|75837988|FG001|NOT COMPLETED|Overall Study||7||
60119743|NCT01582451|76240960|FG000|STARTED|Overall Study||307||
60119744|NCT01582451|76240961|FG001|STARTED|Overall Study||159||
60119745|NCT01582451|76240960|FG000|Received at Least 1 Dose of Study Drug|Overall Study||305||
60119746|NCT01582451|76240961|FG001|Received at Least 1 Dose of Study Drug|Overall Study||159||
60119747|NCT01582451|76240960|FG000|COMPLETED|Overall Study||275||
60119748|NCT01582451|76240961|FG001|COMPLETED|Overall Study||139||
60119749|NCT01582451|76240960|FG000|NOT COMPLETED|Overall Study||32||
60119750|NCT01582451|76240961|FG001|NOT COMPLETED|Overall Study||20||
60119751|NCT02560324|76240969|FG000|STARTED|Period 1 (2 Weeks)||35||
60119752|NCT02560324|76240970|FG001|STARTED|Period 1 (2 Weeks)||34||
60119753|NCT02560324|76240969|FG000|COMPLETED|Period 1 (2 Weeks)||23||
60119754|NCT02560324|76240970|FG001|COMPLETED|Period 1 (2 Weeks)||25||
60119755|NCT02560324|76240969|FG000|NOT COMPLETED|Period 1 (2 Weeks)||12||
60119756|NCT02560324|76240970|FG001|NOT COMPLETED|Period 1 (2 Weeks)||9||
60119757|NCT02560324|76240969|FG000|STARTED|Washout (2 Weeks)||23||
60119758|NCT02560324|76240970|FG001|STARTED|Washout (2 Weeks)||25||
60119759|NCT02560324|76240969|FG000|COMPLETED|Washout (2 Weeks)||23||
60119760|NCT02560324|76240970|FG001|COMPLETED|Washout (2 Weeks)||23||
60119761|NCT02560324|76240969|FG000|NOT COMPLETED|Washout (2 Weeks)||0||
60119762|NCT02560324|76240970|FG001|NOT COMPLETED|Washout (2 Weeks)||2||
60119763|NCT02560324|76240969|FG000|STARTED|Period 2 (2 Weeks)||23||
60119764|NCT02560324|76240970|FG001|STARTED|Period 2 (2 Weeks)||23||
60119765|NCT02560324|76240969|FG000|COMPLETED|Period 2 (2 Weeks)||22||
60119766|NCT02560324|76240970|FG001|COMPLETED|Period 2 (2 Weeks)||21||
60119767|NCT02560324|76240969|FG000|NOT COMPLETED|Period 2 (2 Weeks)||1||
59567781|NCT02624739|75670630|FG000|STARTED|Overall Study||0||
60119768|NCT02560324|76240970|FG001|NOT COMPLETED|Period 2 (2 Weeks)||2||
60119769|NCT02561338|76240985|FG000|STARTED|Overall Study||53||
60119770|NCT02561338|76240986|FG001|STARTED|Overall Study||50||
59718892|NCT01211522|75837989|FG002|NOT COMPLETED|Overall Study||5||
59718893|NCT01211288|75837999|FG000|STARTED|Overall Study||21||
59718894|NCT01211288|75838000|FG001|STARTED|Overall Study||20||
59718895|NCT01211288|75837999|FG000|COMPLETED|Overall Study||20||
59718896|NCT01211288|75838000|FG001|COMPLETED|Overall Study||19||
59718897|NCT01211288|75837999|FG000|NOT COMPLETED|Overall Study||1||
60119771|NCT02561338|76240987|FG002|STARTED|Overall Study||51||
60119772|NCT02561338|76240988|FG003|STARTED|Overall Study||51||
60119773|NCT02561338|76240989|FG004|STARTED|Overall Study||53||
60119774|NCT02561338|76240985|FG000|COMPLETED|Overall Study||45||
60119775|NCT02561338|76240986|FG001|COMPLETED|Overall Study||44||
60119776|NCT02561338|76240987|FG002|COMPLETED|Overall Study||42||
60119777|NCT02561338|76240988|FG003|COMPLETED|Overall Study||46||
60119778|NCT02561338|76240989|FG004|COMPLETED|Overall Study||51||
60119779|NCT02561338|76240985|FG000|NOT COMPLETED|Overall Study||8||
60119780|NCT02561338|76240986|FG001|NOT COMPLETED|Overall Study||6||
60119781|NCT02561338|76240987|FG002|NOT COMPLETED|Overall Study||9||
59840956|NCT03837743|75965360|FG000|DUR-928 Topical Solution Lesion|Overall Study||25||25
59840957|NCT03837743|75965360|FG000|Vehicle Topical Solution Lesion|Overall Study||25||25
59840958|NCT03837743|75965360|FG000|COMPLETED|Overall Study||22||44
59840959|NCT03837743|75965360|FG000|NOT COMPLETED|Overall Study||3||6
59840960|NCT03836729|75965368|FG000|STARTED|Treatment Period 1 (Up to Day 14)||16||
59840961|NCT03836729|75965368|FG000|COMPLETED|Treatment Period 1 (Up to Day 14)||16||
59840962|NCT03836729|75965368|FG000|NOT COMPLETED|Treatment Period 1 (Up to Day 14)||0||
59840963|NCT03836729|75965368|FG000|STARTED|Treatment Period 2 (Up to Day 7)||16||
59840964|NCT03836729|75965368|FG000|COMPLETED|Treatment Period 2 (Up to Day 7)||15||
59840965|NCT03836729|75965368|FG000|NOT COMPLETED|Treatment Period 2 (Up to Day 7)||1||
59840966|NCT00443729|75965378|FG000|STARTED|Overall Study||176||
59840967|NCT00443729|75965379|FG001|STARTED|Overall Study||179||
59840968|NCT00443729|75965378|FG000|Treated|Overall Study||176||
59840969|NCT00443729|75965379|FG001|Treated|Overall Study||178||
59840970|NCT00443729|75965378|FG000|COMPLETED|Overall Study||166||
59840971|NCT00443729|75965379|FG001|COMPLETED|Overall Study||172||
59840972|NCT00443729|75965378|FG000|NOT COMPLETED|Overall Study||10||
59840973|NCT00443729|75965379|FG001|NOT COMPLETED|Overall Study||7||
59840974|NCT00443651|75965387|FG000|STARTED|Overall Study||401||
59840975|NCT00443651|75965388|FG001|STARTED|Overall Study||176||
59840976|NCT00443651|75965387|FG000|Week 24|Overall Study||376||
59840977|NCT00443651|75965388|FG001|Week 24|Overall Study||160||
59840978|NCT00443651|75965387|FG000|Week 48|Overall Study||338||
59840979|NCT00443651|75965388|FG001|Week 48|Overall Study||134||
59840980|NCT00443651|75965387|FG000|COMPLETED|Overall Study|Completed the study or the safety follow-up period.|306||
59840981|NCT00443651|75965388|FG001|COMPLETED|Overall Study|Completed the study or the safety follow-up period.|118||
59840982|NCT00443651|75965387|FG000|NOT COMPLETED|Overall Study||95||
59840983|NCT00443651|75965388|FG001|NOT COMPLETED|Overall Study||58||
59840984|NCT00443261|75965394|FG000|STARTED|Overall Study||1||
59840985|NCT00443261|75965394|FG000|Accrual in 10 Months|Overall Study|Patient died due to progressive disease after cycle 1 of treatment|1||
59840986|NCT00443261|75965394|FG000|COMPLETED|Overall Study|Study terminated due to poor accrual and only patient enrolled died|0||
59840987|NCT00443261|75965394|FG000|NOT COMPLETED|Overall Study||1||
60119782|NCT02561338|76240988|FG003|NOT COMPLETED|Overall Study||5||
60119783|NCT02561338|76240989|FG004|NOT COMPLETED|Overall Study||2||
60119784|NCT02562898|76241005|FG000|STARTED|Overall Study||10||
60119785|NCT02562898|76241006|FG001|STARTED|Overall Study||8||
60119786|NCT02562898|76241005|FG000|COMPLETED|Overall Study||10||
60119787|NCT02562898|76241006|FG001|COMPLETED|Overall Study||8||
60119788|NCT02562898|76241005|FG000|NOT COMPLETED|Overall Study||0||
60119789|NCT02562898|76241006|FG001|NOT COMPLETED|Overall Study||0||
60119790|NCT02563834|76241014|FG000|STARTED|Control (Saline) Infusion (*Day 1)||10||
60119791|NCT02563834|76241015|FG001|STARTED|Control (Saline) Infusion (*Day 1)||8||
60119792|NCT02563834|76241014|FG000|COMPLETED|Control (Saline) Infusion (*Day 1)||10||
59840988|NCT00439517|75965400|FG000|STARTED|Overall Study||152||
59840989|NCT00439517|75965401|FG001|STARTED|Overall Study||150||
59840990|NCT00439517|75965400|FG000|COMPLETED|Overall Study||150||
59840991|NCT00439517|75965401|FG001|COMPLETED|Overall Study||150||
59840992|NCT00439517|75965400|FG000|NOT COMPLETED|Overall Study||2||
59840993|NCT00439517|75965401|FG001|NOT COMPLETED|Overall Study||0||
59840994|NCT00438815|75965407|FG000|STARTED|Overall Study||113||
59840995|NCT00438815|75965407|FG000|COMPLETED|Overall Study||43||
59840996|NCT00438815|75965407|FG000|NOT COMPLETED|Overall Study||70||
59840997|NCT00438659|75965413|FG000|STARTED|Overall Study||90||
59840998|NCT00438659|75965414|FG001|STARTED|Overall Study||86||
59840999|NCT00438659|75965413|FG000|COMPLETED|Overall Study||84||
59841000|NCT00438659|75965414|FG001|COMPLETED|Overall Study||82||
59841001|NCT00438659|75965413|FG000|NOT COMPLETED|Overall Study||6||
59841002|NCT00438659|75965414|FG001|NOT COMPLETED|Overall Study||4||
59841003|NCT00437645|75965423|FG000|STARTED|Overall Study||592||
59841004|NCT00437645|75965424|FG001|STARTED|Overall Study||591||
59841005|NCT00437645|75965423|FG000|COMPLETED|Overall Study||557||
59841006|NCT00437645|75965424|FG001|COMPLETED|Overall Study||476||
59841007|NCT00437645|75965423|FG000|NOT COMPLETED|Overall Study||35||
59841008|NCT00437645|75965424|FG001|NOT COMPLETED|Overall Study||115||
60119793|NCT02563834|76241015|FG001|COMPLETED|Control (Saline) Infusion (*Day 1)||8||
60119794|NCT02563834|76241014|FG000|NOT COMPLETED|Control (Saline) Infusion (*Day 1)||0||
59841009|NCT00437489|75965432|FG000|STARTED|Overall Study||25||
59841010|NCT00437489|75965433|FG001|STARTED|Overall Study||24||
59841011|NCT00437489|75965432|FG000|COMPLETED|Overall Study|2 subjects completed prior to study termination.|2||
59841012|NCT00437489|75965433|FG001|COMPLETED|Overall Study|2 subjects completed prior to study termination.|2||
59841013|NCT00437489|75965432|FG000|NOT COMPLETED|Overall Study||23||
59841014|NCT00437489|75965433|FG001|NOT COMPLETED|Overall Study||22||
59841015|NCT00442559|75965441|FG000|STARTED|Overall Study||100||
59841016|NCT00442559|75965442|FG001|STARTED|Overall Study||91||
60119795|NCT02563834|76241015|FG001|NOT COMPLETED|Control (Saline) Infusion (*Day 1)||0||
60119796|NCT02563834|76241014|FG000|STARTED|Insulin Infusion (*Day 2)||10||
59841017|NCT00442559|75965441|FG000|12 Weeks After Randomization|Overall Study|12 weeks after randomization was pre-specified as the time point for analysis|68||
59841018|NCT00442559|75965442|FG001|12 Weeks After Randomization|Overall Study|12 weeks after randomization was pre-specified as the time point for analysis|60||
59841019|NCT00442559|75965441|FG000|COMPLETED|Overall Study|12 weeks after randomization was pre-specified as the time point for analysis|66||
59841020|NCT00442559|75965442|FG001|COMPLETED|Overall Study|12 weeks after randomization was pre-specified as the time point for analysis|56||
59841021|NCT00442559|75965441|FG000|NOT COMPLETED|Overall Study||34||
59841022|NCT00442559|75965442|FG001|NOT COMPLETED|Overall Study||35||
59841023|NCT00441701|75965464|FG000|STARTED|Overall Study||22||
59841024|NCT00441701|75965465|FG001|STARTED|Overall Study||11||
59841025|NCT00441701|75965466|FG002|STARTED|Overall Study||22||
59841026|NCT00441701|75965467|FG003|STARTED|Overall Study||11||
59841027|NCT00441701|75965468|FG004|STARTED|Overall Study||22||
59841028|NCT00441701|75965469|FG005|STARTED|Overall Study||11||
59841029|NCT00441701|75965470|FG006|STARTED|Overall Study||0||
59841030|NCT00441701|75965471|FG007|STARTED|Overall Study||0||
59567782|NCT02624739|75670631|FG001|STARTED|Overall Study||0||
59841031|NCT00441701|75965472|FG008|STARTED|Overall Study||0||
59841032|NCT00441701|75965473|FG009|STARTED|Overall Study||0||
59841033|NCT00441701|75965464|FG000|COMPLETED|Overall Study||17||
59841034|NCT00441701|75965465|FG001|COMPLETED|Overall Study||7||
59841035|NCT00441701|75965466|FG002|COMPLETED|Overall Study||18||
59841036|NCT00441701|75965467|FG003|COMPLETED|Overall Study||8||
59841037|NCT00441701|75965468|FG004|COMPLETED|Overall Study||20||
59841038|NCT00441701|75965469|FG005|COMPLETED|Overall Study||8||
59841039|NCT00441701|75965470|FG006|COMPLETED|Overall Study||0||
59841040|NCT00441701|75965471|FG007|COMPLETED|Overall Study||0||
59841041|NCT00441701|75965472|FG008|COMPLETED|Overall Study||0||
59841042|NCT00441701|75965473|FG009|COMPLETED|Overall Study||0||
59841043|NCT00441701|75965464|FG000|NOT COMPLETED|Overall Study||5||
59841044|NCT00441701|75965465|FG001|NOT COMPLETED|Overall Study||4||
59841045|NCT00441701|75965466|FG002|NOT COMPLETED|Overall Study||4||
59841046|NCT00441701|75965467|FG003|NOT COMPLETED|Overall Study||3||
59841047|NCT00441701|75965468|FG004|NOT COMPLETED|Overall Study||2||
59841048|NCT00441701|75965469|FG005|NOT COMPLETED|Overall Study||3||
59841049|NCT00441701|75965470|FG006|NOT COMPLETED|Overall Study||0||
59841050|NCT00441701|75965471|FG007|NOT COMPLETED|Overall Study||0||
59841051|NCT00441701|75965472|FG008|NOT COMPLETED|Overall Study||0||
59841052|NCT00441701|75965473|FG009|NOT COMPLETED|Overall Study||0||
59841053|NCT00441545|75965491|FG000|STARTED|First Intervention||95||
59841054|NCT00441545|75965492|FG001|STARTED|First Intervention||87||
59841055|NCT00441545|75965491|FG000|COMPLETED|First Intervention||77||
59841056|NCT00441545|75965492|FG001|COMPLETED|First Intervention||75||
59841057|NCT00441545|75965491|FG000|NOT COMPLETED|First Intervention||18||
59841058|NCT00441545|75965492|FG001|NOT COMPLETED|First Intervention||12||
59841059|NCT00441545|75965491|FG000|STARTED|Washout||77||
59841060|NCT00441545|75965492|FG001|STARTED|Washout||75||
59841061|NCT00441545|75965491|FG000|COMPLETED|Washout||77||
59841062|NCT00441545|75965492|FG001|COMPLETED|Washout||75||
59841063|NCT00441545|75965491|FG000|NOT COMPLETED|Washout||0||
59841064|NCT00441545|75965492|FG001|NOT COMPLETED|Washout||0||
59841065|NCT00441545|75965491|FG000|STARTED|Second Intervention||77||
59841066|NCT00441545|75965492|FG001|STARTED|Second Intervention||75||
59718898|NCT01211288|75838000|FG001|NOT COMPLETED|Overall Study||1||
59718899|NCT00883753|75838008|FG000|STARTED|Overall Study||934||
59718900|NCT00883753|75838008|FG000|COMPLETED|Overall Study||827||
59718901|NCT00883753|75838008|FG000|NOT COMPLETED|Overall Study||107||
59718902|NCT01210664|75838015|FG000|STARTED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||3||
59718903|NCT01210664|75838016|FG001|STARTED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0||
59718904|NCT01210664|75838017|FG002|STARTED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0||
59718905|NCT01210664|75838018|FG003|STARTED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0||
59718906|NCT01210664|75838015|FG000|Received Study Treatment|Cohort 1: PolyTregs 0.05 x 10^8 Cells||3||
59718907|NCT01210664|75838016|FG001|Received Study Treatment|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0||
59718908|NCT01210664|75838017|FG002|Received Study Treatment|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0||
59718909|NCT01210664|75838018|FG003|Received Study Treatment|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0||
59718910|NCT01210664|75838015|FG000|COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||3||
59718911|NCT01210664|75838016|FG001|COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0||
59718912|NCT01210664|75838017|FG002|COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0||
59841067|NCT00441545|75965491|FG000|COMPLETED|Second Intervention||65||
59841068|NCT00441545|75965492|FG001|COMPLETED|Second Intervention||68||
59841069|NCT00441545|75965491|FG000|NOT COMPLETED|Second Intervention||12||
59841070|NCT00441545|75965492|FG001|NOT COMPLETED|Second Intervention||7||
59841071|NCT00436553|75965501|FG000|STARTED|Overall Study|"The table shows 12 month data. Started indicates Randomized set of population."|104||
59841072|NCT00436553|75965502|FG001|STARTED|Overall Study||105||
59841073|NCT00436553|75965503|FG002|STARTED|Overall Study||112||
59841074|NCT00436553|75965501|FG000|COMPLETED|Overall Study|Completed the 12 month study phase.|91||
59841075|NCT00436553|75965502|FG001|COMPLETED|Overall Study||93||
59841076|NCT00436553|75965503|FG002|COMPLETED|Overall Study||102||
59841077|NCT00436553|75965501|FG000|NOT COMPLETED|Overall Study||13||
59841078|NCT00436553|75965502|FG001|NOT COMPLETED|Overall Study||12||
59841079|NCT00436553|75965503|FG002|NOT COMPLETED|Overall Study||10||
59841080|NCT00441467|75965511|FG000|STARTED|Overall Study||22||
59841081|NCT00441467|75965511|FG000|2 Cycles|Overall Study||17||
59841082|NCT00441467|75965511|FG000|4 Cycles|Overall Study||7||
59841083|NCT00441467|75965511|FG000|COMPLETED|Overall Study||4||
59841084|NCT00441467|75965511|FG000|NOT COMPLETED|Overall Study||18||
59841085|NCT00436163|75965515|FG000|STARTED|Overall Study||39||
59841086|NCT00436163|75965515|FG000|COMPLETED|Overall Study||36||
59841087|NCT00436163|75965515|FG000|NOT COMPLETED|Overall Study||3||
59841088|NCT00006604|75965527|FG000|STARTED|Overall Study||6||
59841089|NCT00006604|75965528|FG001|STARTED|Overall Study||2||
59841090|NCT00006604|75965529|FG002|STARTED|Overall Study||5||
59841091|NCT00006604|75965530|FG003|STARTED|Overall Study||6||
59841092|NCT00006604|75965531|FG004|STARTED|Overall Study||5||
59841093|NCT00006604|75965532|FG005|STARTED|Overall Study||5||
59841094|NCT00006604|75965533|FG006|STARTED|Overall Study||21||
59841095|NCT00006604|75965534|FG007|STARTED|Overall Study||5||
59841096|NCT00006604|75965535|FG008|STARTED|Overall Study||5||
59841097|NCT00006604|75965536|FG009|STARTED|Overall Study||25||
59841098|NCT00006604|75965537|FG010|STARTED|Overall Study||21||
59841099|NCT00006604|75965538|FG011|STARTED|Overall Study||12||
59841100|NCT00006604|75965539|FG012|STARTED|Overall Study||26||
59841101|NCT00006604|75965540|FG013|STARTED|Overall Study||6||
59841102|NCT00006604|75965541|FG014|STARTED|Overall Study||24||
59841103|NCT00006604|75965542|FG015|STARTED|Overall Study||6||
59841104|NCT00006604|75965543|FG016|STARTED|Overall Study||15||
59841105|NCT00006604|75965527|FG000|COMPLETED|Overall Study||4||
59841106|NCT00006604|75965528|FG001|COMPLETED|Overall Study||2||
59841107|NCT00006604|75965529|FG002|COMPLETED|Overall Study||1||
59841108|NCT00006604|75965530|FG003|COMPLETED|Overall Study||1||
59841109|NCT00006604|75965531|FG004|COMPLETED|Overall Study||3||
59841110|NCT00006604|75965532|FG005|COMPLETED|Overall Study||2||
59841111|NCT00006604|75965533|FG006|COMPLETED|Overall Study||12||
59841112|NCT00006604|75965534|FG007|COMPLETED|Overall Study||2||
59841113|NCT00006604|75965535|FG008|COMPLETED|Overall Study||4||
59841114|NCT00006604|75965536|FG009|COMPLETED|Overall Study||6||
59841115|NCT00006604|75965537|FG010|COMPLETED|Overall Study||13||
59841116|NCT00006604|75965538|FG011|COMPLETED|Overall Study||6||
59841117|NCT00006604|75965539|FG012|COMPLETED|Overall Study||22||
59841118|NCT00006604|75965540|FG013|COMPLETED|Overall Study||0||
59841119|NCT00006604|75965541|FG014|COMPLETED|Overall Study||14||
59841120|NCT00006604|75965542|FG015|COMPLETED|Overall Study||1||
59841121|NCT00006604|75965543|FG016|COMPLETED|Overall Study||6||
59841122|NCT00006604|75965527|FG000|NOT COMPLETED|Overall Study||2||
59841123|NCT00006604|75965528|FG001|NOT COMPLETED|Overall Study||0||
59841124|NCT00006604|75965529|FG002|NOT COMPLETED|Overall Study||4||
59841125|NCT00006604|75965530|FG003|NOT COMPLETED|Overall Study||5||
59841126|NCT00006604|75965531|FG004|NOT COMPLETED|Overall Study||2||
59718913|NCT01210664|75838018|FG003|COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0||
59718914|NCT01210664|75838015|FG000|NOT COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0||
59718915|NCT01210664|75838016|FG001|NOT COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0||
59718916|NCT01210664|75838017|FG002|NOT COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0||
59718917|NCT01210664|75838018|FG003|NOT COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0||
59718918|NCT01210664|75838015|FG000|STARTED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0||
59841127|NCT00006604|75965532|FG005|NOT COMPLETED|Overall Study||3||
59841128|NCT00006604|75965533|FG006|NOT COMPLETED|Overall Study||9||
59841129|NCT00006604|75965534|FG007|NOT COMPLETED|Overall Study||3||
59841130|NCT00006604|75965535|FG008|NOT COMPLETED|Overall Study||1||
59841131|NCT00006604|75965536|FG009|NOT COMPLETED|Overall Study||19||
59718919|NCT01210664|75838016|FG001|STARTED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||3||
59718920|NCT01210664|75838017|FG002|STARTED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0||
59718921|NCT01210664|75838018|FG003|STARTED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0||
59718922|NCT01210664|75838015|FG000|Received Study Treatment|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0||
59841132|NCT00006604|75965537|FG010|NOT COMPLETED|Overall Study||8||
59841133|NCT00006604|75965538|FG011|NOT COMPLETED|Overall Study||6||
59841134|NCT00006604|75965539|FG012|NOT COMPLETED|Overall Study||4||
59841135|NCT00006604|75965540|FG013|NOT COMPLETED|Overall Study||6||
59841136|NCT00006604|75965541|FG014|NOT COMPLETED|Overall Study||10||
59841137|NCT00006604|75965542|FG015|NOT COMPLETED|Overall Study||5||
59841138|NCT00006604|75965543|FG016|NOT COMPLETED|Overall Study||9||
59841139|NCT00436007|75965569|FG000|STARTED|Overall Study||170||
59841140|NCT00436007|75965570|FG001|STARTED|Overall Study||170||
59841141|NCT00436007|75965571|FG002|STARTED|Overall Study||171||
59841142|NCT00436007|75965569|FG000|COMPLETED|Overall Study||151||
59841143|NCT00436007|75965570|FG001|COMPLETED|Overall Study||156||
59841144|NCT00436007|75965571|FG002|COMPLETED|Overall Study||148||
59841145|NCT00436007|75965569|FG000|NOT COMPLETED|Overall Study||19||
59841146|NCT00436007|75965570|FG001|NOT COMPLETED|Overall Study||14||
59841147|NCT00436007|75965571|FG002|NOT COMPLETED|Overall Study||23||
59841148|NCT00435461|75965587|FG000|STARTED|Overall Study||313||
59841149|NCT00435461|75965588|FG001|STARTED|Overall Study||312||
59841150|NCT00435461|75965589|FG002|STARTED|Overall Study||311||
59841151|NCT00435461|75965587|FG000|COMPLETED|Overall Study||290||
59841152|NCT00435461|75965588|FG001|COMPLETED|Overall Study||298||
59841153|NCT00435461|75965589|FG002|COMPLETED|Overall Study||287||
59841154|NCT00435461|75965587|FG000|NOT COMPLETED|Overall Study||23||
59841155|NCT00435461|75965588|FG001|NOT COMPLETED|Overall Study||14||
59841156|NCT00435461|75965589|FG002|NOT COMPLETED|Overall Study||24||
59841157|NCT00434759|75965599|FG000|STARTED|Overall Study||46||
59841158|NCT00434759|75965600|FG001|STARTED|Overall Study||43||
59841159|NCT00434759|75965599|FG000|COMPLETED|Overall Study||22||
59841160|NCT00434759|75965600|FG001|COMPLETED|Overall Study||38||
59841161|NCT00434759|75965599|FG000|NOT COMPLETED|Overall Study||24||
59841162|NCT00434759|75965600|FG001|NOT COMPLETED|Overall Study||5||
59841163|NCT00440999|75965610|FG000|STARTED|Overall Study||228||
59841164|NCT00440999|75965611|FG001|STARTED|Overall Study||228||
59841165|NCT00440999|75965610|FG000|COMPLETED|Overall Study||193||
59841166|NCT00440999|75965611|FG001|COMPLETED|Overall Study||187||
59841167|NCT00440999|75965610|FG000|NOT COMPLETED|Overall Study||35||
59567783|NCT02624739|75670630|FG000|COMPLETED|Overall Study||0||
59567784|NCT02624739|75670631|FG001|COMPLETED|Overall Study||0||
59567785|NCT02624739|75670630|FG000|NOT COMPLETED|Overall Study||0||
59567786|NCT02624739|75670631|FG001|NOT COMPLETED|Overall Study||0||
59567787|NCT01895036|75670637|FG000|STARTED|Overall Study||6||
59567788|NCT01895036|75670637|FG000|COMPLETED|Overall Study||6||
59567789|NCT01895036|75670637|FG000|NOT COMPLETED|Overall Study||0||
59567790|NCT03781479|75670644|FG000|STARTED|Overall Study||6||
59567791|NCT03781479|75670645|FG001|STARTED|Overall Study||6||
59718923|NCT01210664|75838016|FG001|Received Study Treatment|Cohort 2: PolyTregs 0.4 x 10^8 Cells||3||
59718924|NCT01210664|75838017|FG002|Received Study Treatment|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0||
59718925|NCT01210664|75838018|FG003|Received Study Treatment|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0||
59718926|NCT01210664|75838015|FG000|COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0||
59718927|NCT01210664|75838016|FG001|COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||3||
59718928|NCT01210664|75838017|FG002|COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0||
59718929|NCT01210664|75838018|FG003|COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0||
59841168|NCT00440999|75965611|FG001|NOT COMPLETED|Overall Study||41||
59841169|NCT00434213|75965619|FG000|STARTED|Overall Study||309||
59841170|NCT00434213|75965619|FG000|COMPLETED|Overall Study||260||
59841171|NCT00434213|75965619|FG000|NOT COMPLETED|Overall Study||49||
59841172|NCT00006184|75965625|FG000|STARTED|Overall Study||10||
59841173|NCT00006184|75965626|FG001|STARTED|Overall Study||10||
59841174|NCT00006184|75965625|FG000|COMPLETED|Overall Study||9||
59841175|NCT00006184|75965626|FG001|COMPLETED|Overall Study||10||
59841176|NCT00006184|75965625|FG000|NOT COMPLETED|Overall Study||1||
59567792|NCT03781479|75670646|FG002|STARTED|Overall Study||1||
59567793|NCT03781479|75670644|FG000|COMPLETED|Overall Study||6||
59567794|NCT03781479|75670645|FG001|COMPLETED|Overall Study||6||
59567795|NCT03781479|75670646|FG002|COMPLETED|Overall Study||0||
59567796|NCT03781479|75670644|FG000|NOT COMPLETED|Overall Study||0||
59567797|NCT03781479|75670645|FG001|NOT COMPLETED|Overall Study||0||
59718930|NCT01210664|75838015|FG000|NOT COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0||
59718931|NCT01210664|75838016|FG001|NOT COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0||
59718932|NCT01210664|75838017|FG002|NOT COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0||
59718933|NCT01210664|75838018|FG003|NOT COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0||
59718934|NCT01210664|75838015|FG000|STARTED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0||
59718935|NCT01210664|75838016|FG001|STARTED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0||
59718936|NCT01210664|75838017|FG002|STARTED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||5||
59718937|NCT01210664|75838018|FG003|STARTED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0||
59718938|NCT01210664|75838015|FG000|Received Study Treatment|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0||
59718939|NCT01210664|75838016|FG001|Received Study Treatment|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0||
59718940|NCT01210664|75838017|FG002|Received Study Treatment|Cohort 3: PolyTregs 3.2 x 10^8 Cells||4||
59718941|NCT01210664|75838018|FG003|Received Study Treatment|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0||
59718942|NCT01210664|75838015|FG000|COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0||
59841177|NCT00006184|75965626|FG001|NOT COMPLETED|Overall Study||0||
59841178|NCT00434057|75965632|FG000|STARTED|Overall Study||1383||
59841179|NCT00434057|75965632|FG000|COMPLETED|Overall Study|One patient withdrew from the study after signing the Informed Consent Form|1382||
59841180|NCT00434057|75965632|FG000|NOT COMPLETED|Overall Study||1||
59567798|NCT03781479|75670646|FG002|NOT COMPLETED|Overall Study||1||
59567799|NCT01223001|75670654|FG000|STARTED|Overall Study||4||
59841181|NCT00433199|75965638|FG000|STARTED|Double-Blind Period||40||
59841182|NCT00433199|75965639|FG001|STARTED|Double-Blind Period||234||
59841183|NCT00433199|75965638|FG000|COMPLETED|Double-Blind Period||28||
59841184|NCT00433199|75965639|FG001|COMPLETED|Double-Blind Period||168||
59841185|NCT00433199|75965638|FG000|NOT COMPLETED|Double-Blind Period||12||
59841186|NCT00433199|75965639|FG001|NOT COMPLETED|Double-Blind Period||66||
59841187|NCT00433199|75965638|FG000|STARTED|Open-Label Period||0||
59841188|NCT00433199|75965639|FG001|STARTED|Open-Label Period||219||
59841189|NCT00433199|75965638|FG000|COMPLETED|Open-Label Period||0||
59841190|NCT00433199|75965639|FG001|COMPLETED|Open-Label Period||185||
59841191|NCT00433199|75965638|FG000|NOT COMPLETED|Open-Label Period||0||
59841192|NCT00433199|75965639|FG001|NOT COMPLETED|Open-Label Period||34||
59841193|NCT00005908|75965650|FG000|STARTED|Overall Study||10||
59841194|NCT00005908|75965651|FG001|STARTED|Overall Study||20||
59841195|NCT00005908|75965650|FG000|COMPLETED|Overall Study||9||
59841196|NCT00005908|75965651|FG001|COMPLETED|Overall Study||20||
59841197|NCT00005908|75965650|FG000|NOT COMPLETED|Overall Study||1||
59841198|NCT00005908|75965651|FG001|NOT COMPLETED|Overall Study||0||
59841199|NCT00432965|75965662|FG000|STARTED|Overall Study||169||
59841200|NCT00432965|75965663|FG001|STARTED|Overall Study||166||
59841201|NCT00432965|75965662|FG000|COMPLETED|Overall Study||75||
59841202|NCT00432965|75965663|FG001|COMPLETED|Overall Study||80||
59841203|NCT00432965|75965662|FG000|NOT COMPLETED|Overall Study||94||
59841204|NCT00432965|75965663|FG001|NOT COMPLETED|Overall Study||86||
59841205|NCT00440297|75965671|FG000|STARTED|Overall Study||139||
59841206|NCT00440297|75965672|FG001|STARTED|Overall Study||138||
59841207|NCT00440297|75965671|FG000|Vaccination Visit 1|Overall Study||138||
59841208|NCT00440297|75965672|FG001|Vaccination Visit 1|Overall Study||138||
59841209|NCT00440297|75965671|FG000|Vaccination Visit 2|Overall Study||136||
59841210|NCT00440297|75965672|FG001|Vaccination Visit 2|Overall Study||134||
59841211|NCT00440297|75965671|FG000|Vaccination Visit 3|Overall Study||124||
59841212|NCT00440297|75965672|FG001|Vaccination Visit 3|Overall Study||125||
59841213|NCT00440297|75965671|FG000|Vaccination Visit 4|Overall Study||116||
59841214|NCT00440297|75965672|FG001|Vaccination Visit 4|Overall Study||122||
59841215|NCT00440297|75965671|FG000|COMPLETED|Overall Study||116||
59841216|NCT00440297|75965672|FG001|COMPLETED|Overall Study||120||
59841217|NCT00440297|75965671|FG000|NOT COMPLETED|Overall Study||23||
59841218|NCT00440297|75965672|FG001|NOT COMPLETED|Overall Study||18||
59841219|NCT00432809|75965681|FG000|STARTED|1 Year Follow-up||50||
59841220|NCT00432809|75965682|FG001|STARTED|1 Year Follow-up||50||
59841221|NCT00432809|75965683|FG002|STARTED|1 Year Follow-up||50||
59841222|NCT00432809|75965681|FG000|COMPLETED|1 Year Follow-up||41||
59841223|NCT00432809|75965682|FG001|COMPLETED|1 Year Follow-up||50||
59841224|NCT00432809|75965683|FG002|COMPLETED|1 Year Follow-up||49||
59841225|NCT00432809|75965681|FG000|NOT COMPLETED|1 Year Follow-up||9||
59841226|NCT00432809|75965682|FG001|NOT COMPLETED|1 Year Follow-up||0||
59841227|NCT00432809|75965683|FG002|NOT COMPLETED|1 Year Follow-up||1||
59841228|NCT00432809|75965681|FG000|STARTED|2 Year Sub-study||20||
59841229|NCT00432809|75965682|FG001|STARTED|2 Year Sub-study||20||
59841230|NCT00432809|75965683|FG002|STARTED|2 Year Sub-study||20||
59718943|NCT01210664|75838016|FG001|COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0||
59718944|NCT01210664|75838017|FG002|COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||3||
59718945|NCT01210664|75838018|FG003|COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0||
59718946|NCT01210664|75838015|FG000|NOT COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0||
59718947|NCT01210664|75838016|FG001|NOT COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0||
59718948|NCT01210664|75838017|FG002|NOT COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||2||
59718949|NCT01210664|75838018|FG003|NOT COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0||
59841231|NCT00432809|75965681|FG000|COMPLETED|2 Year Sub-study||17||
59718950|NCT01210664|75838015|FG000|STARTED|Cohort 4: PolyTregs 26 x 10^8 Cells||0||
59718951|NCT01210664|75838016|FG001|STARTED|Cohort 4: PolyTregs 26 x 10^8 Cells||0||
59718952|NCT01210664|75838017|FG002|STARTED|Cohort 4: PolyTregs 26 x 10^8 Cells||0||
59718953|NCT01210664|75838018|FG003|STARTED|Cohort 4: PolyTregs 26 x 10^8 Cells||5||
59841232|NCT00432809|75965682|FG001|COMPLETED|2 Year Sub-study||18||
59841233|NCT00432809|75965683|FG002|COMPLETED|2 Year Sub-study||19||
59841234|NCT00432809|75965681|FG000|NOT COMPLETED|2 Year Sub-study||3||
59841235|NCT00432809|75965682|FG001|NOT COMPLETED|2 Year Sub-study||2||
59841236|NCT00432809|75965683|FG002|NOT COMPLETED|2 Year Sub-study||1||
59841237|NCT00431951|75965695|FG000|STARTED|Overall Study||8||
59841238|NCT00431951|75965696|FG001|STARTED|Overall Study||8||
60119797|NCT02563834|76241015|FG001|STARTED|Insulin Infusion (*Day 2)||8||
59841239|NCT00431951|75965697|FG002|STARTED|Overall Study||8||
59841240|NCT00431951|75965698|FG003|STARTED|Overall Study||6||
59841241|NCT00431951|75965695|FG000|COMPLETED|Overall Study||7||
59841242|NCT00431951|75965696|FG001|COMPLETED|Overall Study||6||
59841243|NCT00431951|75965697|FG002|COMPLETED|Overall Study||6||
59841244|NCT00431951|75965698|FG003|COMPLETED|Overall Study||4||
59841245|NCT00431951|75965695|FG000|NOT COMPLETED|Overall Study||1||
59841246|NCT00431951|75965696|FG001|NOT COMPLETED|Overall Study||2||
59841247|NCT00431951|75965697|FG002|NOT COMPLETED|Overall Study||2||
59841248|NCT00431951|75965698|FG003|NOT COMPLETED|Overall Study||2||
59841249|NCT00004978|75965714|FG000|STARTED|Overall Study|includes patients participating in Vanguard studies from the sites which participated in ESPRIT|2090||
59996574|NCT02714569|76112505|FG002|Received at Least One Dose of Study Drug|Part A Second Intervention||3||
59996575|NCT02714569|76112506|FG003|Received at Least One Dose of Study Drug|Part A Second Intervention||3||
60119798|NCT02563834|76241014|FG000|COMPLETED|Insulin Infusion (*Day 2)||10||
60119799|NCT02563834|76241015|FG001|COMPLETED|Insulin Infusion (*Day 2)||8||
59718954|NCT01210664|75838015|FG000|Received Study Treatment|Cohort 4: PolyTregs 26 x 10^8 Cells||0||
59718955|NCT01210664|75838016|FG001|Received Study Treatment|Cohort 4: PolyTregs 26 x 10^8 Cells||0||
59718956|NCT01210664|75838017|FG002|Received Study Treatment|Cohort 4: PolyTregs 26 x 10^8 Cells||0||
59718957|NCT01210664|75838018|FG003|Received Study Treatment|Cohort 4: PolyTregs 26 x 10^8 Cells||4||
59718958|NCT01210664|75838015|FG000|COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0||
59718959|NCT01210664|75838016|FG001|COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0||
59718960|NCT01210664|75838017|FG002|COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0||
59718961|NCT01210664|75838018|FG003|COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||4||
59718962|NCT01210664|75838015|FG000|NOT COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0||
59718963|NCT01210664|75838016|FG001|NOT COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0||
59718964|NCT01210664|75838017|FG002|NOT COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0||
59718965|NCT01210664|75838018|FG003|NOT COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||1||
60119800|NCT02563834|76241014|FG000|NOT COMPLETED|Insulin Infusion (*Day 2)||0||
60119801|NCT02563834|76241015|FG001|NOT COMPLETED|Insulin Infusion (*Day 2)||0||
60119802|NCT02563990|76241025|FG000|STARTED|Overall Study||12||
60119803|NCT02563990|76241026|FG001|STARTED|Overall Study||14||
60119804|NCT02563990|76241025|FG000|COMPLETED|Overall Study||12||
60119805|NCT02563990|76241026|FG001|COMPLETED|Overall Study||14||
60119806|NCT02563990|76241025|FG000|NOT COMPLETED|Overall Study||0||
60119807|NCT02563990|76241026|FG001|NOT COMPLETED|Overall Study||0||
60119808|NCT02564926|76241036|FG000|STARTED|Overall Study||60|121 patients received study treatment and were included in the SAF population.|
60119809|NCT02564926|76241037|FG001|STARTED|Overall Study||61|121 patients received study treatment and were included in the SAF population.|
60119810|NCT02564926|76241036|FG000|COMPLETED|Overall Study||52|Study Treatment/Entire Study Completed|
60119811|NCT02564926|76241037|FG001|COMPLETED|Overall Study||54|Study Treatment/Entire Study Completed|
60119812|NCT02564926|76241036|FG000|NOT COMPLETED|Overall Study||8||
60119813|NCT02564926|76241037|FG001|NOT COMPLETED|Overall Study||7||
60119814|NCT02700984|76241045|FG000|STARTED|Overall Study||215|All enrolled subjects|
60119815|NCT02700984|76241046|FG001|STARTED|Overall Study||67|All enrolled subjects|
60119816|NCT02700984|76241045|FG000|COMPLETED|Overall Study||200|All subjects who completed the 60-month assessment|
60119817|NCT02700984|76241046|FG001|COMPLETED|Overall Study||53|All subjects who completed the 60-month assessment|
60119818|NCT02700984|76241045|FG000|NOT COMPLETED|Overall Study||15||
60119819|NCT02700984|76241046|FG001|NOT COMPLETED|Overall Study||14||
60119820|NCT02567968|76241062|FG000|STARTED|First Intervention||4||
60119821|NCT02567968|76241063|FG001|STARTED|First Intervention||4||
60119822|NCT02567968|76241062|FG000|COMPLETED|First Intervention||4||
60119823|NCT02567968|76241063|FG001|COMPLETED|First Intervention||4||
60119824|NCT02567968|76241062|FG000|NOT COMPLETED|First Intervention||0||
60119825|NCT02567968|76241063|FG001|NOT COMPLETED|First Intervention||0||
60119826|NCT02567968|76241062|FG000|STARTED|Washout (2 Weeks)||4||
59718966|NCT00881569|75838030|FG000|STARTED|Overall Study||1||
59841250|NCT00004978|75965715|FG001|STARTED|Overall Study|includes patients participating in Vanguard studies from the sites which participated in ESPRIT|2060||
59841251|NCT00004978|75965714|FG000|COMPLETED|Overall Study||1846||
59841252|NCT00004978|75965715|FG001|COMPLETED|Overall Study||1790||
59841253|NCT00004978|75965714|FG000|NOT COMPLETED|Overall Study||244||
59841254|NCT00004978|75965715|FG001|NOT COMPLETED|Overall Study||270||
59841255|NCT00430937|75965723|FG000|STARTED|Overall Study|Additional 5 participants were randomized; however, they were not exposed to study drug by mistake.|97||
59841256|NCT00430937|75965724|FG001|STARTED|Overall Study||92||
59841257|NCT00430937|75965723|FG000|COMPLETED|Overall Study||70||
59841258|NCT00430937|75965724|FG001|COMPLETED|Overall Study||64||
59841259|NCT00430937|75965723|FG000|NOT COMPLETED|Overall Study||27||
59841260|NCT00430937|75965724|FG001|NOT COMPLETED|Overall Study||28||
59841261|NCT00004888|75965732|FG000|STARTED|Overall Study|Of the 41 pts, 3 were ineligible.|38||
59841262|NCT00004888|75965733|FG001|STARTED|Overall Study|Of the 48 pts, 2 were ineligible.|46||
59841263|NCT00004888|75965732|FG000|COMPLETED|Overall Study||27||
59841264|NCT00004888|75965733|FG001|COMPLETED|Overall Study||22||
59841265|NCT00004888|75965732|FG000|NOT COMPLETED|Overall Study||11||
59841266|NCT00004888|75965733|FG001|NOT COMPLETED|Overall Study||24||
59841267|NCT00004732|75965741|FG000|STARTED|Overall Study||1262||
59841268|NCT00004732|75965742|FG001|STARTED|Overall Study||1240||
59841269|NCT00004732|75965741|FG000|COMPLETED|Overall Study||1193||
59841270|NCT00004732|75965742|FG001|COMPLETED|Overall Study||1129||
59841271|NCT00004732|75965741|FG000|NOT COMPLETED|Overall Study||69||
59841272|NCT00004732|75965742|FG001|NOT COMPLETED|Overall Study||111||
59841273|NCT00430781|75965753|FG000|STARTED|Interim Analysis; 11 February 2008||59||
59841274|NCT00430781|75965754|FG001|STARTED|Interim Analysis; 11 February 2008||58||
59841275|NCT00430781|75965755|FG002|STARTED|Interim Analysis; 11 February 2008||60||
59841276|NCT00430781|75965753|FG000|Ongoing|Interim Analysis; 11 February 2008||23||
59841277|NCT00430781|75965754|FG001|Ongoing|Interim Analysis; 11 February 2008||20||
59841278|NCT00430781|75965755|FG002|Ongoing|Interim Analysis; 11 February 2008||25||
59841279|NCT00430781|75965753|FG000|COMPLETED|Interim Analysis; 11 February 2008||0||
59718967|NCT00881569|75838031|FG001|STARTED|Overall Study||1||
59718968|NCT00881569|75838030|FG000|COMPLETED|Overall Study||0||
59718969|NCT00881569|75838031|FG001|COMPLETED|Overall Study||0||
59718970|NCT00881569|75838030|FG000|NOT COMPLETED|Overall Study||1||
59718971|NCT00881569|75838031|FG001|NOT COMPLETED|Overall Study||1||
59718972|NCT00881335|75838039|FG000|STARTED|Overall Study||30||
59718973|NCT00881335|75838040|FG001|STARTED|Overall Study||30||
59718974|NCT00881335|75838039|FG000|COMPLETED|Overall Study|3 participants did not complete the period|27||
59841280|NCT00430781|75965754|FG001|COMPLETED|Interim Analysis; 11 February 2008||0||
59841281|NCT00430781|75965755|FG002|COMPLETED|Interim Analysis; 11 February 2008||0||
59841282|NCT00430781|75965753|FG000|NOT COMPLETED|Interim Analysis; 11 February 2008||59||
59841283|NCT00430781|75965754|FG001|NOT COMPLETED|Interim Analysis; 11 February 2008||58||
59841284|NCT00430781|75965755|FG002|NOT COMPLETED|Interim Analysis; 11 February 2008||60||
59841285|NCT00430781|75965753|FG000|STARTED|Final Analysis; 31 July 2008||0||
59841286|NCT00430781|75965754|FG001|STARTED|Final Analysis; 31 July 2008||78||
59841287|NCT00430781|75965755|FG002|STARTED|Final Analysis; 31 July 2008||74||
59841288|NCT00430781|75965753|FG000|Ongoing|Final Analysis; 31 July 2008||0||
59841289|NCT00430781|75965754|FG001|Ongoing|Final Analysis; 31 July 2008||29||
59841290|NCT00430781|75965755|FG002|Ongoing|Final Analysis; 31 July 2008||32||
59841291|NCT00430781|75965753|FG000|COMPLETED|Final Analysis; 31 July 2008||0||
59841292|NCT00430781|75965754|FG001|COMPLETED|Final Analysis; 31 July 2008||39||
60119827|NCT02567968|76241063|FG001|STARTED|Washout (2 Weeks)||4||
59718975|NCT00881335|75838040|FG001|COMPLETED|Overall Study|2 participants did not complete the period|28||
59718976|NCT00881335|75838039|FG000|NOT COMPLETED|Overall Study||3||
59718977|NCT00881335|75838040|FG001|NOT COMPLETED|Overall Study||2||
59718978|NCT02357992|75838048|FG000|STARTED|Overall Study||36||
59718979|NCT02357992|75838049|FG001|STARTED|Overall Study||80||
59718980|NCT02357992|75838048|FG000|COMPLETED|Overall Study||36||
59718981|NCT02357992|75838049|FG001|COMPLETED|Overall Study||80||
59718982|NCT02357992|75838048|FG000|NOT COMPLETED|Overall Study||0||
59841293|NCT00430781|75965755|FG002|COMPLETED|Final Analysis; 31 July 2008||26||
59841294|NCT00430781|75965753|FG000|NOT COMPLETED|Final Analysis; 31 July 2008||0||
59841295|NCT00430781|75965754|FG001|NOT COMPLETED|Final Analysis; 31 July 2008||39||
59841296|NCT00430781|75965755|FG002|NOT COMPLETED|Final Analysis; 31 July 2008||48||
59841297|NCT00430781|75965753|FG000|STARTED|End-of-Study Analysis; 28 July 2011|Enrollment continued in this arm after data cut for Interim Analysis and before arm closed.|77||
59841298|NCT00430781|75965754|FG001|STARTED|End-of-Study Analysis; 28 July 2011|1 participant randomized to lapatinib (final analysis table) actually received combination therapy.|77||
59841299|NCT00430781|75965755|FG002|STARTED|End-of-Study Analysis; 28 July 2011||74||
59718983|NCT02357992|75838049|FG001|NOT COMPLETED|Overall Study||0||
59718984|NCT00879775|75838057|FG000|STARTED|Overall Study||20||
59718985|NCT00879775|75838058|FG001|STARTED|Overall Study||21||
59718986|NCT00879775|75838057|FG000|COMPLETED|Overall Study||18||
59718987|NCT00879775|75838058|FG001|COMPLETED|Overall Study||20||
59841300|NCT00430781|75965753|FG000|COMPLETED|End-of-Study Analysis; 28 July 2011||53||
59841301|NCT00430781|75965754|FG001|COMPLETED|End-of-Study Analysis; 28 July 2011||59||
59841302|NCT00430781|75965755|FG002|COMPLETED|End-of-Study Analysis; 28 July 2011||54||
59841303|NCT00430781|75965753|FG000|NOT COMPLETED|End-of-Study Analysis; 28 July 2011||24||
59841304|NCT00430781|75965754|FG001|NOT COMPLETED|End-of-Study Analysis; 28 July 2011||18||
59841305|NCT00430781|75965755|FG002|NOT COMPLETED|End-of-Study Analysis; 28 July 2011||20||
59841306|NCT00429299|75965769|FG000|STARTED|Overall Study||36||
59841307|NCT00429299|75965770|FG001|STARTED|Overall Study||39||
59841308|NCT00429299|75965771|FG002|STARTED|Overall Study||46||
59841309|NCT00429299|75965769|FG000|COMPLETED|Overall Study||32||
59841310|NCT00429299|75965770|FG001|COMPLETED|Overall Study||32||
59841311|NCT00429299|75965771|FG002|COMPLETED|Overall Study||42||
59841312|NCT00429299|75965769|FG000|NOT COMPLETED|Overall Study||4||
59841313|NCT00429299|75965770|FG001|NOT COMPLETED|Overall Study||7||
59841314|NCT00429299|75965771|FG002|NOT COMPLETED|Overall Study||4||
59841315|NCT00428597|75965781|FG000|STARTED|Overall Study||86||
59841316|NCT00428597|75965782|FG001|STARTED|Overall Study||85||
59841317|NCT00428597|75965781|FG000|Received Treatment|Overall Study||83||
59841318|NCT00428597|75965782|FG001|Received Treatment|Overall Study||82||
59841319|NCT00428597|75965781|FG000|COMPLETED|Overall Study||0||
59841320|NCT00428597|75965782|FG001|COMPLETED|Overall Study||0||
59841321|NCT00428597|75965781|FG000|NOT COMPLETED|Overall Study||86||
59841322|NCT00428597|75965782|FG001|NOT COMPLETED|Overall Study||85||
59841323|NCT00428441|75965788|FG000|STARTED|Overall Study||75||
59841324|NCT00428441|75965788|FG000|COMPLETED|Overall Study||74||
59841325|NCT00428441|75965788|FG000|NOT COMPLETED|Overall Study||1||
59841326|NCT00144339|75965794|FG000|STARTED|Overall Study||3006||
59841327|NCT00144339|75965795|FG001|STARTED|Overall Study||2986||
59841328|NCT00144339|75965794|FG000|COMPLETED|Overall Study||1648||
59841329|NCT00144339|75965795|FG001|COMPLETED|Overall Study||1887||
59841330|NCT00144339|75965794|FG000|NOT COMPLETED|Overall Study||1358||
59841331|NCT00144339|75965795|FG001|NOT COMPLETED|Overall Study||1099||
59841332|NCT00144027|75965803|FG000|STARTED|Overall Study|participants who consented|39||
59841333|NCT00144027|75965804|FG001|STARTED|Overall Study|participants who consented|36||
59841334|NCT00144027|75965803|FG000|Completed Baseline Assessment|Overall Study||39||
59841335|NCT00144027|75965804|FG001|Completed Baseline Assessment|Overall Study||29||
59841336|NCT00144027|75965803|FG000|Completed 6 Month Assessment|Overall Study||37||
59841337|NCT00144027|75965804|FG001|Completed 6 Month Assessment|Overall Study||24||
59841338|NCT00144027|75965803|FG000|COMPLETED|Overall Study|participants who completed 12-month follow-up|36||
59841339|NCT00144027|75965804|FG001|COMPLETED|Overall Study|participants who completed 12-month follow-up|25||
59841340|NCT00144027|75965803|FG000|NOT COMPLETED|Overall Study||3||
59841341|NCT00144027|75965804|FG001|NOT COMPLETED|Overall Study||11||
59841342|NCT00127803|75965814|FG000|STARTED|Overall Study||13||
59841343|NCT00127803|75965815|FG001|STARTED|Overall Study||13||
59841344|NCT00127803|75965816|FG002|STARTED|Overall Study||12||
59841345|NCT00127803|75965817|FG003|STARTED|Overall Study||12||
59841346|NCT00127803|75965814|FG000|COMPLETED|Overall Study||10||
59841347|NCT00127803|75965815|FG001|COMPLETED|Overall Study||13||
59841348|NCT00127803|75965816|FG002|COMPLETED|Overall Study||12||
59841349|NCT00127803|75965817|FG003|COMPLETED|Overall Study||11||
59841350|NCT00127803|75965814|FG000|NOT COMPLETED|Overall Study||3||
59841351|NCT00127803|75965815|FG001|NOT COMPLETED|Overall Study||0||
59841352|NCT00127803|75965816|FG002|NOT COMPLETED|Overall Study||0||
59841353|NCT00127803|75965817|FG003|NOT COMPLETED|Overall Study||1||
59841354|NCT00127413|75965831|FG000|STARTED|Overall Study||12||
59841355|NCT00127413|75965832|FG001|STARTED|Overall Study||10||
59841356|NCT00127413|75965833|FG002|STARTED|Overall Study||13||
59841357|NCT00127413|75965834|FG003|STARTED|Overall Study||7||
59841358|NCT00127413|75965831|FG000|COMPLETED|Overall Study||6||
59841359|NCT00127413|75965832|FG001|COMPLETED|Overall Study||6||
59841360|NCT00127413|75965833|FG002|COMPLETED|Overall Study||5||
59841361|NCT00127413|75965834|FG003|COMPLETED|Overall Study||5||
59841362|NCT00127413|75965831|FG000|NOT COMPLETED|Overall Study||6||
59841363|NCT00127413|75965832|FG001|NOT COMPLETED|Overall Study||4||
59841364|NCT00127413|75965833|FG002|NOT COMPLETED|Overall Study||8||
59841365|NCT00127413|75965834|FG003|NOT COMPLETED|Overall Study||2||
59841366|NCT00143403|75965846|FG000|STARTED|Overall Study||160||
59841367|NCT00143403|75965847|FG001|STARTED|Overall Study||161||
59841368|NCT00143403|75965846|FG000|Treated|Overall Study||153||
59841369|NCT00143403|75965847|FG001|Treated|Overall Study||153||
59841370|NCT00143403|75965846|FG000|COMPLETED|Overall Study|Received maximum number of cycles.|125||
59841371|NCT00143403|75965847|FG001|COMPLETED|Overall Study|Received maximum number of cycles.|115||
59841372|NCT00143403|75965846|FG000|NOT COMPLETED|Overall Study||35||
59841373|NCT00143403|75965847|FG001|NOT COMPLETED|Overall Study||46||
59841374|NCT00220701|75965855|FG000|STARTED|Overall Study||17||
59841375|NCT00220701|75965856|FG001|STARTED|Overall Study||17||
59841376|NCT00220701|75965855|FG000|COMPLETED|Overall Study||12||
59841377|NCT00220701|75965856|FG001|COMPLETED|Overall Study||13||
59841378|NCT00220701|75965855|FG000|NOT COMPLETED|Overall Study||5||
59841379|NCT00220701|75965856|FG001|NOT COMPLETED|Overall Study||4||
59841380|NCT00127101|75965868|FG000|STARTED|Base Protocol||3||
59841381|NCT00127101|75965869|FG001|STARTED|Base Protocol||5||
59841382|NCT00127101|75965870|FG002|STARTED|Base Protocol||3||
59841383|NCT00127101|75965871|FG003|STARTED|Base Protocol||3||
59841384|NCT00127101|75965872|FG004|STARTED|Base Protocol||5||
59841385|NCT00127101|75965873|FG005|STARTED|Base Protocol||4||
59841386|NCT00127101|75965868|FG000|COMPLETED|Base Protocol||1||
59841387|NCT00127101|75965869|FG001|COMPLETED|Base Protocol||1||
59841388|NCT00127101|75965870|FG002|COMPLETED|Base Protocol||1||
59841389|NCT00127101|75965871|FG003|COMPLETED|Base Protocol||3||
59841390|NCT00127101|75965872|FG004|COMPLETED|Base Protocol||3||
59841391|NCT00127101|75965873|FG005|COMPLETED|Base Protocol||3||
59841392|NCT00127101|75965868|FG000|NOT COMPLETED|Base Protocol||2||
59841393|NCT00127101|75965869|FG001|NOT COMPLETED|Base Protocol||4||
59841394|NCT00127101|75965870|FG002|NOT COMPLETED|Base Protocol||2||
59841395|NCT00127101|75965871|FG003|NOT COMPLETED|Base Protocol||0||
59841396|NCT00127101|75965872|FG004|NOT COMPLETED|Base Protocol||2||
59841397|NCT00127101|75965873|FG005|NOT COMPLETED|Base Protocol||1||
59841398|NCT00127101|75965868|FG000|STARTED|Continuation Phase||0||
59841399|NCT00127101|75965869|FG001|STARTED|Continuation Phase||0||
59841400|NCT00127101|75965870|FG002|STARTED|Continuation Phase||1||
59841401|NCT00127101|75965871|FG003|STARTED|Continuation Phase|No patients from the 2b Cohort entered into the extension phase|0||
59841402|NCT00127101|75965872|FG004|STARTED|Continuation Phase||3||
59841403|NCT00127101|75965873|FG005|STARTED|Continuation Phase||3||
59841404|NCT00127101|75965868|FG000|COMPLETED|Continuation Phase||0||
59841405|NCT00127101|75965869|FG001|COMPLETED|Continuation Phase||0||
59841406|NCT00127101|75965870|FG002|COMPLETED|Continuation Phase||0||
59841407|NCT00127101|75965871|FG003|COMPLETED|Continuation Phase||0||
59841408|NCT00127101|75965872|FG004|COMPLETED|Continuation Phase||0||
59718988|NCT00879775|75838057|FG000|NOT COMPLETED|Overall Study||2||
59718989|NCT00879775|75838058|FG001|NOT COMPLETED|Overall Study||1||
59718990|NCT00894790|75838066|FG000|STARTED|Overall Study||4||
59718991|NCT00894790|75838067|FG001|STARTED|Overall Study||4||
59718992|NCT00894790|75838066|FG000|COMPLETED|Overall Study||3||
59718993|NCT00894790|75838067|FG001|COMPLETED|Overall Study||2||
59718994|NCT00894790|75838066|FG000|NOT COMPLETED|Overall Study||1||
59718995|NCT00894790|75838067|FG001|NOT COMPLETED|Overall Study||2||
59718996|NCT00879229|75838075|FG000|STARTED|Overall Study||25||
59718997|NCT00879229|75838076|FG001|STARTED|Overall Study||15||
59718998|NCT00879229|75838075|FG000|COMPLETED|Overall Study||3||
59718999|NCT00879229|75838076|FG001|COMPLETED|Overall Study||1||
59719000|NCT00879229|75838075|FG000|NOT COMPLETED|Overall Study||22||
59719001|NCT00879229|75838076|FG001|NOT COMPLETED|Overall Study||14||
59719002|NCT00878995|75838084|FG000|STARTED|Baseline Study - Midpoint Study||12||
59719003|NCT00878995|75838085|FG001|STARTED|Baseline Study - Midpoint Study||12||
59719004|NCT00878995|75838084|FG000|Baseline Study|Baseline Study - Midpoint Study||12||
59719005|NCT00878995|75838085|FG001|Baseline Study|Baseline Study - Midpoint Study||12||
59719006|NCT00878995|75838084|FG000|COMPLETED|Baseline Study - Midpoint Study||12||
59719007|NCT00878995|75838085|FG001|COMPLETED|Baseline Study - Midpoint Study|2 subjects dropped after the baseline study. They decided to seek treatment closer to home.|10||
59841409|NCT00127101|75965873|FG005|COMPLETED|Continuation Phase||0||
59841410|NCT00127101|75965868|FG000|NOT COMPLETED|Continuation Phase||0||
59841411|NCT00127101|75965869|FG001|NOT COMPLETED|Continuation Phase||0||
59841412|NCT00127101|75965870|FG002|NOT COMPLETED|Continuation Phase||1||
59841413|NCT00127101|75965871|FG003|NOT COMPLETED|Continuation Phase||0||
59841414|NCT00127101|75965872|FG004|NOT COMPLETED|Continuation Phase||3||
59841415|NCT00127101|75965873|FG005|NOT COMPLETED|Continuation Phase||3||
59841416|NCT00126555|75965887|FG000|STARTED|Overall Study||23||
59841417|NCT00126555|75965887|FG000|Stratum 1- Resectable|Overall Study|1 participant did not participate|18||
59841418|NCT00126555|75965887|FG000|Stratum 2- Unresectable|Overall Study||4||
59841419|NCT00126555|75965887|FG000|COMPLETED|Overall Study||17||
59841420|NCT00126555|75965887|FG000|NOT COMPLETED|Overall Study||6||
59841421|NCT00004228|75965910|FG000|STARTED|Overall Study||60||
59841422|NCT00004228|75965911|FG001|STARTED|Overall Study||66||
59841423|NCT00004228|75965912|FG002|STARTED|Overall Study||65||
59841424|NCT00004228|75965913|FG003|STARTED|Overall Study||13||
59841425|NCT00004228|75965914|FG004|STARTED|Overall Study||67||
59841426|NCT00004228|75965915|FG005|STARTED|Overall Study||65||
59841427|NCT00004228|75965916|FG006|STARTED|Overall Study||57||
59841428|NCT00004228|75965910|FG000|COMPLETED|Overall Study||51||
59841429|NCT00004228|75965911|FG001|COMPLETED|Overall Study||51||
59841430|NCT00004228|75965912|FG002|COMPLETED|Overall Study||46||
59841431|NCT00004228|75965913|FG003|COMPLETED|Overall Study||6||
59841432|NCT00004228|75965914|FG004|COMPLETED|Overall Study||51||
59841433|NCT00004228|75965915|FG005|COMPLETED|Overall Study||51||
59841434|NCT00004228|75965916|FG006|COMPLETED|Overall Study||45||
59841435|NCT00004228|75965910|FG000|NOT COMPLETED|Overall Study||9||
59841436|NCT00004228|75965911|FG001|NOT COMPLETED|Overall Study||15||
59841437|NCT00004228|75965912|FG002|NOT COMPLETED|Overall Study||19||
59841438|NCT00004228|75965913|FG003|NOT COMPLETED|Overall Study||7||
59841439|NCT00004228|75965914|FG004|NOT COMPLETED|Overall Study||16||
59841440|NCT00004228|75965915|FG005|NOT COMPLETED|Overall Study||14||
59841441|NCT00004228|75965916|FG006|NOT COMPLETED|Overall Study||12||
59841442|NCT00003526|75965933|FG000|STARTED|Overall Study||8||
59841443|NCT00003526|75965933|FG000|COMPLETED|Overall Study||2||
59841444|NCT00003526|75965933|FG000|NOT COMPLETED|Overall Study||6||
59841445|NCT00195260|75965939|FG000|STARTED|Part 1: Dose Escalation||4||
59841446|NCT00195260|75965940|FG001|STARTED|Part 1: Dose Escalation||4||
59841447|NCT00195260|75965941|FG002|STARTED|Part 1: Dose Escalation||6||
59841448|NCT00195260|75965942|FG003|STARTED|Part 1: Dose Escalation||7||
59841449|NCT00195260|75965943|FG004|STARTED|Part 1: Dose Escalation||7||
59841450|NCT00195260|75965944|FG005|STARTED|Part 1: Dose Escalation||7||
59841451|NCT00195260|75965945|FG006|STARTED|Part 1: Dose Escalation||10||
59841452|NCT00195260|75965946|FG007|STARTED|Part 1: Dose Escalation||6||
59841453|NCT00195260|75965947|FG008|STARTED|Part 1: Dose Escalation||0||
59841454|NCT00195260|75965948|FG009|STARTED|Part 1: Dose Escalation||0||
59841455|NCT00195260|75965949|FG010|STARTED|Part 1: Dose Escalation||0||
59841456|NCT00195260|75965939|FG000|COMPLETED|Part 1: Dose Escalation||0||
59841457|NCT00195260|75965940|FG001|COMPLETED|Part 1: Dose Escalation||0||
59841458|NCT00195260|75965941|FG002|COMPLETED|Part 1: Dose Escalation||0||
59841459|NCT00195260|75965942|FG003|COMPLETED|Part 1: Dose Escalation||0||
59841460|NCT00195260|75965943|FG004|COMPLETED|Part 1: Dose Escalation||0||
59841461|NCT00195260|75965944|FG005|COMPLETED|Part 1: Dose Escalation||0||
59841462|NCT00195260|75965945|FG006|COMPLETED|Part 1: Dose Escalation||0||
59841463|NCT00195260|75965946|FG007|COMPLETED|Part 1: Dose Escalation||0||
59841464|NCT00195260|75965947|FG008|COMPLETED|Part 1: Dose Escalation||0||
59841465|NCT00195260|75965948|FG009|COMPLETED|Part 1: Dose Escalation||0||
59841466|NCT00195260|75965949|FG010|COMPLETED|Part 1: Dose Escalation||0||
59841467|NCT00195260|75965939|FG000|NOT COMPLETED|Part 1: Dose Escalation||4||
60119828|NCT02567968|76241062|FG000|COMPLETED|Washout (2 Weeks)||4||
59567800|NCT01223001|75670655|FG001|STARTED|Overall Study||4||
59841468|NCT00195260|75965940|FG001|NOT COMPLETED|Part 1: Dose Escalation||4||
59841469|NCT00195260|75965941|FG002|NOT COMPLETED|Part 1: Dose Escalation||6||
59841470|NCT00195260|75965942|FG003|NOT COMPLETED|Part 1: Dose Escalation||7||
59841471|NCT00195260|75965943|FG004|NOT COMPLETED|Part 1: Dose Escalation||7||
60119829|NCT02567968|76241063|FG001|COMPLETED|Washout (2 Weeks)||4||
60119830|NCT02567968|76241062|FG000|NOT COMPLETED|Washout (2 Weeks)||0||
59841472|NCT00195260|75965944|FG005|NOT COMPLETED|Part 1: Dose Escalation||7||
59841473|NCT00195260|75965945|FG006|NOT COMPLETED|Part 1: Dose Escalation||10||
59841474|NCT00195260|75965946|FG007|NOT COMPLETED|Part 1: Dose Escalation||6||
59841475|NCT00195260|75965947|FG008|NOT COMPLETED|Part 1: Dose Escalation||0||
59841476|NCT00195260|75965948|FG009|NOT COMPLETED|Part 1: Dose Escalation||0||
59841477|NCT00195260|75965949|FG010|NOT COMPLETED|Part 1: Dose Escalation||0||
59841478|NCT00195260|75965939|FG000|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0||
59841479|NCT00195260|75965940|FG001|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0||
59841480|NCT00195260|75965941|FG002|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0||
59841481|NCT00195260|75965942|FG003|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0||
59841482|NCT00195260|75965943|FG004|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0||
59841483|NCT00195260|75965944|FG005|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0||
59841484|NCT00195260|75965945|FG006|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0||
59841485|NCT00195260|75965946|FG007|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0||
59841486|NCT00195260|75965947|FG008|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||37||
59841487|NCT00195260|75965948|FG009|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||38||
60119831|NCT02567968|76241063|FG001|NOT COMPLETED|Washout (2 Weeks)||0||
60119832|NCT02567968|76241062|FG000|STARTED|Second Intervention||4||
60119833|NCT02567968|76241063|FG001|STARTED|Second Intervention||4||
59841488|NCT00195260|75965949|FG010|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||25||
59841489|NCT00195260|75965939|FG000|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0||
59841490|NCT00195260|75965940|FG001|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0||
59841491|NCT00195260|75965941|FG002|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0||
59841492|NCT00195260|75965942|FG003|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0||
59841493|NCT00195260|75965943|FG004|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0||
59841494|NCT00195260|75965944|FG005|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0||
59841495|NCT00195260|75965945|FG006|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0||
59841496|NCT00195260|75965946|FG007|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0||
59841497|NCT00195260|75965947|FG008|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||4||
59841498|NCT00195260|75965948|FG009|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0||
59841499|NCT00195260|75965949|FG010|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||2||
59841500|NCT00195260|75965939|FG000|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0||
59841501|NCT00195260|75965940|FG001|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0||
59841502|NCT00195260|75965941|FG002|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0||
59841503|NCT00195260|75965942|FG003|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0||
59841504|NCT00195260|75965943|FG004|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0||
59841505|NCT00195260|75965944|FG005|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0||
59841506|NCT00195260|75965945|FG006|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0||
59841507|NCT00195260|75965946|FG007|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0||
60119834|NCT02567968|76241062|FG000|COMPLETED|Second Intervention||4||
60119835|NCT02567968|76241063|FG001|COMPLETED|Second Intervention||4||
60119836|NCT02567968|76241062|FG000|NOT COMPLETED|Second Intervention||0||
60119837|NCT02567968|76241063|FG001|NOT COMPLETED|Second Intervention||0||
60119838|NCT02571634|76241069|FG000|STARTED|Overall Study|First subject wasn't enrolled until July related to receipt of medications from sponsor.|23||
60119839|NCT02571634|76241069|FG000|COMPLETED|Overall Study|The final subject was enrolled on this date.|23||
60119840|NCT02571634|76241069|FG000|NOT COMPLETED|Overall Study||0||
60119841|NCT02574598|76241076|FG000|STARTED|Overall Study||40||
60119842|NCT02574598|76241077|FG001|STARTED|Overall Study||38||
60119843|NCT02574598|76241076|FG000|COMPLETED|Overall Study||40||
60119844|NCT02574598|76241077|FG001|COMPLETED|Overall Study||38||
60119845|NCT02574598|76241076|FG000|NOT COMPLETED|Overall Study||0||
60119846|NCT02574598|76241077|FG001|NOT COMPLETED|Overall Study||0||
60119847|NCT02574832|76241083|FG000|STARTED|Overall Study||2||
60119848|NCT02574832|76241083|FG000|COMPLETED|Overall Study||2||
60119849|NCT02574832|76241083|FG000|NOT COMPLETED|Overall Study||0||
60119850|NCT02575300|76241087|FG000|STARTED|Overall Study||20||
60119851|NCT02575300|76241087|FG000|COMPLETED|Overall Study||20||
60119852|NCT02575300|76241087|FG000|NOT COMPLETED|Overall Study||0||
60119853|NCT02577640|76241095|FG000|STARTED|Dose Escalation Group 1||4||
60119854|NCT02577640|76241096|FG001|STARTED|Dose Escalation Group 1||0||
60119855|NCT02577640|76241097|FG002|STARTED|Dose Escalation Group 1||0||
59719008|NCT00878995|75838084|FG000|NOT COMPLETED|Baseline Study - Midpoint Study||0||
59719009|NCT00878995|75838085|FG001|NOT COMPLETED|Baseline Study - Midpoint Study||2||
59719010|NCT00878995|75838084|FG000|STARTED|Midpoint Study - Post Study||12||
59719011|NCT00878995|75838085|FG001|STARTED|Midpoint Study - Post Study||10||
59719012|NCT00878995|75838084|FG000|COMPLETED|Midpoint Study - Post Study||12||
59719013|NCT00878995|75838085|FG001|COMPLETED|Midpoint Study - Post Study||10||
59719014|NCT00878995|75838084|FG000|NOT COMPLETED|Midpoint Study - Post Study||0||
59719015|NCT00878995|75838085|FG001|NOT COMPLETED|Midpoint Study - Post Study||0||
59719016|NCT00879697|75838093|FG000|STARTED|Overall Study|Seventeen patients achieved inclusion and exclusion criteria|17||
59719017|NCT00879697|75838094|FG001|STARTED|Overall Study|Seventeen patients achieved inclusion and exclusion criteria|17||
59719018|NCT00879697|75838093|FG000|COMPLETED|Overall Study|Two patients did not finish the trial|15||
59719019|NCT00879697|75838094|FG001|COMPLETED|Overall Study|Two patients did not finish the trial|15||
59719020|NCT00879697|75838093|FG000|NOT COMPLETED|Overall Study||2||
59719021|NCT00879697|75838094|FG001|NOT COMPLETED|Overall Study||2||
59719022|NCT00894556|75838103|FG000|STARTED|Baseline Phase||0||
59567801|NCT01223001|75670654|FG000|COMPLETED|Overall Study||0||
59567802|NCT01223001|75670655|FG001|COMPLETED|Overall Study||0||
59567803|NCT01223001|75670654|FG000|NOT COMPLETED|Overall Study||4||
59567804|NCT01223001|75670655|FG001|NOT COMPLETED|Overall Study||4||
59567805|NCT01895972|75670661|FG000|STARTED|Overall Study||130||
59567806|NCT01895972|75670661|FG000|COMPLETED|Overall Study||121||
59567807|NCT01895972|75670661|FG000|NOT COMPLETED|Overall Study||9||
59841508|NCT00195260|75965947|FG008|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||33||
59841509|NCT00195260|75965948|FG009|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||38||
59841510|NCT00195260|75965949|FG010|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||23||
59841511|NCT00031486|75965979|FG000|STARTED|Overall Study||40||
59841512|NCT00031486|75965980|FG001|STARTED|Overall Study||47||
59841513|NCT00031486|75965979|FG000|COMPLETED|Overall Study||33||
59841514|NCT00031486|75965980|FG001|COMPLETED|Overall Study||35||
59841515|NCT00031486|75965979|FG000|NOT COMPLETED|Overall Study||7||
59841516|NCT00031486|75965980|FG001|NOT COMPLETED|Overall Study||12||
59841517|NCT00003508|75965988|FG000|STARTED|Overall Study||8||
59841518|NCT00003508|75965988|FG000|COMPLETED|Overall Study||3||
59841519|NCT00003508|75965988|FG000|NOT COMPLETED|Overall Study||5||
59841520|NCT00003472|75965992|FG000|STARTED|Overall Study||13||
59841521|NCT00003472|75965992|FG000|COMPLETED|Overall Study||10||
59841522|NCT00003472|75965992|FG000|NOT COMPLETED|Overall Study||3||
59841523|NCT00003298|75965996|FG000|STARTED|Step 1 (Neoadjuvant Therapy)||39||
59841524|NCT00003298|75965996|FG000|Eligible and Treated|Step 1 (Neoadjuvant Therapy)||38||
59841525|NCT00003298|75965996|FG000|Complete 3 Cycles of Neoadjuvant Therapy|Step 1 (Neoadjuvant Therapy)||35||
59841526|NCT00003298|75965996|FG000|COMPLETED|Step 1 (Neoadjuvant Therapy)||35||
59841527|NCT00003298|75965996|FG000|NOT COMPLETED|Step 1 (Neoadjuvant Therapy)||4||
59841528|NCT00003298|75965996|FG000|STARTED|Surgery||35||
59841529|NCT00003298|75965996|FG000|COMPLETED|Surgery|1 patient did not complete neoadjuvant therapy but went to surgery anyway, not included here.|28||
59841530|NCT00003298|75965996|FG000|NOT COMPLETED|Surgery||7||
59841531|NCT00003298|75965996|FG000|STARTED|Re-register to Step 2 After Surgery||28||
59841532|NCT00003298|75965996|FG000|COMPLETED|Re-register to Step 2 After Surgery||10||
59841533|NCT00003298|75965996|FG000|NOT COMPLETED|Re-register to Step 2 After Surgery||18||
59841534|NCT00003298|75965996|FG000|STARTED|Step 2 (Adjuvant Therapy)||10||
59841535|NCT00003298|75965996|FG000|Eligible and Treated on Step 2|Step 2 (Adjuvant Therapy)||7||
59841536|NCT00003298|75965996|FG000|COMPLETED|Step 2 (Adjuvant Therapy)||4||
59841537|NCT00003298|75965996|FG000|NOT COMPLETED|Step 2 (Adjuvant Therapy)||6||
59841538|NCT00002842|75966001|FG000|STARTED|Overall Study||49||
59841539|NCT00002842|75966001|FG000|COMPLETED|Overall Study||22||
59841540|NCT00002842|75966001|FG000|NOT COMPLETED|Overall Study||27||
59841541|NCT00143247|75966005|FG000|STARTED|Overall Study|173=total subjects of current + 3 previous protocols|173||
59841542|NCT00143247|75966005|FG000|COMPLETED|Overall Study||17||
59841543|NCT00143247|75966005|FG000|NOT COMPLETED|Overall Study||156||
59841544|NCT00125853|75966009|FG000|STARTED|Wash-out (4 Weeks)||27||
59841545|NCT00125853|75966010|FG001|STARTED|Wash-out (4 Weeks)||27||
59841546|NCT00125853|75966009|FG000|COMPLETED|Wash-out (4 Weeks)||27||
59841547|NCT00125853|75966010|FG001|COMPLETED|Wash-out (4 Weeks)||27||
59841548|NCT00125853|75966009|FG000|NOT COMPLETED|Wash-out (4 Weeks)||0||
59841549|NCT00125853|75966010|FG001|NOT COMPLETED|Wash-out (4 Weeks)||0||
59841550|NCT00125853|75966009|FG000|STARTED|First Intervention (8 Weeks)||27||
59841551|NCT00125853|75966010|FG001|STARTED|First Intervention (8 Weeks)||27||
59841552|NCT00125853|75966009|FG000|COMPLETED|First Intervention (8 Weeks)||27||
59841553|NCT00125853|75966010|FG001|COMPLETED|First Intervention (8 Weeks)||27||
59841554|NCT00125853|75966009|FG000|NOT COMPLETED|First Intervention (8 Weeks)||0||
59841555|NCT00125853|75966010|FG001|NOT COMPLETED|First Intervention (8 Weeks)||0||
59567808|NCT03779997|75670667|FG000|STARTED|Overall Study||39||
59567809|NCT03779997|75670668|FG001|STARTED|Overall Study||39||
59567810|NCT03779997|75670667|FG000|Completed at Least One Visit|Overall Study||39||
59841556|NCT00125853|75966009|FG000|STARTED|Wash-out (4 Weeks)||27||
59841557|NCT00125853|75966010|FG001|STARTED|Wash-out (4 Weeks)||27||
59841558|NCT00125853|75966009|FG000|COMPLETED|Wash-out (4 Weeks)||24||
59841559|NCT00125853|75966010|FG001|COMPLETED|Wash-out (4 Weeks)||20||
59841560|NCT00125853|75966009|FG000|NOT COMPLETED|Wash-out (4 Weeks)||3||
59841561|NCT00125853|75966010|FG001|NOT COMPLETED|Wash-out (4 Weeks)||7||
59719023|NCT00894556|75838104|FG001|STARTED|Baseline Phase||0||
59719024|NCT00894556|75838105|FG002|STARTED|Baseline Phase||0||
59719025|NCT00894556|75838106|FG003|STARTED|Baseline Phase||194||
59719026|NCT00894556|75838103|FG000|COMPLETED|Baseline Phase||0||
59719027|NCT00894556|75838104|FG001|COMPLETED|Baseline Phase||0||
59719028|NCT00894556|75838105|FG002|COMPLETED|Baseline Phase||0||
59719029|NCT00894556|75838106|FG003|COMPLETED|Baseline Phase||109||
59719030|NCT00894556|75838103|FG000|NOT COMPLETED|Baseline Phase||0||
59719031|NCT00894556|75838104|FG001|NOT COMPLETED|Baseline Phase||0||
59719032|NCT00894556|75838105|FG002|NOT COMPLETED|Baseline Phase||0||
59719033|NCT00894556|75838106|FG003|NOT COMPLETED|Baseline Phase||85||
59719034|NCT00894556|75838103|FG000|STARTED|Treatment Phase|Participants who were randomized into the treatment phase|37||
60119856|NCT02577640|76241098|FG003|STARTED|Dose Escalation Group 1||0||
60119857|NCT02577640|76241095|FG000|COMPLETED|Dose Escalation Group 1||3||
60119858|NCT02577640|76241096|FG001|COMPLETED|Dose Escalation Group 1||0||
60119859|NCT02577640|76241097|FG002|COMPLETED|Dose Escalation Group 1||0||
60119860|NCT02577640|76241098|FG003|COMPLETED|Dose Escalation Group 1||0||
60119861|NCT02577640|76241095|FG000|NOT COMPLETED|Dose Escalation Group 1||1||
59567811|NCT03779997|75670668|FG001|Completed at Least One Visit|Overall Study||39||
59567812|NCT03779997|75670667|FG000|COMPLETED|Overall Study||39||
59567813|NCT03779997|75670668|FG001|COMPLETED|Overall Study||39||
59567814|NCT03779997|75670667|FG000|NOT COMPLETED|Overall Study||0||
59567815|NCT03779997|75670668|FG001|NOT COMPLETED|Overall Study||0||
59567816|NCT01896206|75670674|FG000|STARTED|Overall Study||21||
59719035|NCT00894556|75838104|FG001|STARTED|Treatment Phase|Participants who were randomized into the treatment phase|36||
59719036|NCT00894556|75838105|FG002|STARTED|Treatment Phase|Participants who were randomized into the treatment phase|36||
59719037|NCT00894556|75838106|FG003|STARTED|Treatment Phase||0||
59719038|NCT00894556|75838103|FG000|COMPLETED|Treatment Phase|Participants who treated 3 acute migraine attacks with study medication during the treatment phase|33||
59719039|NCT00894556|75838104|FG001|COMPLETED|Treatment Phase|Participants who treated 3 acute migraine attacks with study medication during the treatment phase|32||
59719040|NCT00894556|75838105|FG002|COMPLETED|Treatment Phase|Participants who treated 3 acute migraine attacks with study medication during the treatment phase|35||
59719041|NCT00894556|75838106|FG003|COMPLETED|Treatment Phase||0||
59719042|NCT00894556|75838103|FG000|NOT COMPLETED|Treatment Phase||4||
59719043|NCT00894556|75838104|FG001|NOT COMPLETED|Treatment Phase||4||
59719044|NCT00894556|75838105|FG002|NOT COMPLETED|Treatment Phase||1||
59719045|NCT00894556|75838106|FG003|NOT COMPLETED|Treatment Phase||0||
59719046|NCT01210352|75838122|FG000|STARTED|Overall Study||6||
59719047|NCT01210352|75838123|FG001|STARTED|Overall Study||6||
59719048|NCT01210352|75838124|FG002|STARTED|Overall Study||7||
59719049|NCT01210352|75838125|FG003|STARTED|Overall Study||7||
59719050|NCT01210352|75838126|FG004|STARTED|Overall Study||6||
59719051|NCT01210352|75838127|FG005|STARTED|Overall Study||6||
59719052|NCT01210352|75838128|FG006|STARTED|Overall Study||7||
59719053|NCT01210352|75838129|FG007|STARTED|Overall Study||10||
59719054|NCT01210352|75838130|FG008|STARTED|Overall Study||6||
59719055|NCT01210352|75838122|FG000|COMPLETED|Overall Study||6||
59719056|NCT01210352|75838123|FG001|COMPLETED|Overall Study||6||
59719057|NCT01210352|75838124|FG002|COMPLETED|Overall Study||5||
59719058|NCT01210352|75838125|FG003|COMPLETED|Overall Study||7||
59719059|NCT01210352|75838126|FG004|COMPLETED|Overall Study||6||
59567817|NCT01896206|75670674|FG000|COMPLETED|Overall Study||21||
59567818|NCT01896206|75670674|FG000|NOT COMPLETED|Overall Study||0||
59567819|NCT02608905|75670680|FG000|STARTED|Overall Study||7||
59567820|NCT02608905|75670681|FG001|STARTED|Overall Study||10||
59567821|NCT02608905|75670680|FG000|COMPLETED|Overall Study||5||
59719060|NCT01210352|75838127|FG005|COMPLETED|Overall Study||6||
59719061|NCT01210352|75838128|FG006|COMPLETED|Overall Study||5||
59719062|NCT01210352|75838129|FG007|COMPLETED|Overall Study||7||
59719063|NCT01210352|75838130|FG008|COMPLETED|Overall Study||2||
59719064|NCT01210352|75838122|FG000|NOT COMPLETED|Overall Study||0||
59719065|NCT01210352|75838123|FG001|NOT COMPLETED|Overall Study||0||
59719066|NCT01210352|75838124|FG002|NOT COMPLETED|Overall Study||2||
59719067|NCT01210352|75838125|FG003|NOT COMPLETED|Overall Study||0||
60119862|NCT02577640|76241096|FG001|NOT COMPLETED|Dose Escalation Group 1||0||
60119863|NCT02577640|76241097|FG002|NOT COMPLETED|Dose Escalation Group 1||0||
60119864|NCT02577640|76241098|FG003|NOT COMPLETED|Dose Escalation Group 1||0||
59567822|NCT02608905|75670681|FG001|COMPLETED|Overall Study||10||
59567823|NCT02608905|75670680|FG000|NOT COMPLETED|Overall Study||2||
59719068|NCT01210352|75838126|FG004|NOT COMPLETED|Overall Study||0||
59719069|NCT01210352|75838127|FG005|NOT COMPLETED|Overall Study||0||
59719070|NCT01210352|75838128|FG006|NOT COMPLETED|Overall Study||2||
59719071|NCT01210352|75838129|FG007|NOT COMPLETED|Overall Study||3||
59719072|NCT01210352|75838130|FG008|NOT COMPLETED|Overall Study||4||
59719073|NCT01210118|75838237|FG000|STARTED|Overall Study||45||
59841562|NCT00125853|75966009|FG000|STARTED|Second Intervention (8 Weeks)||24||
59841563|NCT00125853|75966010|FG001|STARTED|Second Intervention (8 Weeks)||20||
59719074|NCT01210118|75838238|FG001|STARTED|Overall Study||47||
59719075|NCT01210118|75838237|FG000|COMPLETED|Overall Study||42||
59841564|NCT00125853|75966009|FG000|COMPLETED|Second Intervention (8 Weeks)||24||
59841565|NCT00125853|75966010|FG001|COMPLETED|Second Intervention (8 Weeks)||20||
59841566|NCT00125853|75966009|FG000|NOT COMPLETED|Second Intervention (8 Weeks)||0||
59841567|NCT00125853|75966010|FG001|NOT COMPLETED|Second Intervention (8 Weeks)||0||
59841568|NCT00219141|75966019|FG000|STARTED|Overall Study||154||
59841569|NCT00219141|75966020|FG001|STARTED|Overall Study||152||
60119865|NCT02577640|76241095|FG000|STARTED|Dose Escalation Group 2||0||
60119866|NCT02577640|76241096|FG001|STARTED|Dose Escalation Group 2||3||
60119867|NCT02577640|76241097|FG002|STARTED|Dose Escalation Group 2||0||
60119868|NCT02577640|76241098|FG003|STARTED|Dose Escalation Group 2||0||
60119869|NCT02577640|76241095|FG000|COMPLETED|Dose Escalation Group 2||0||
60119870|NCT02577640|76241096|FG001|COMPLETED|Dose Escalation Group 2||3||
60119871|NCT02577640|76241097|FG002|COMPLETED|Dose Escalation Group 2||0||
60119872|NCT02577640|76241098|FG003|COMPLETED|Dose Escalation Group 2||0||
60119873|NCT02577640|76241095|FG000|NOT COMPLETED|Dose Escalation Group 2||0||
60119874|NCT02577640|76241096|FG001|NOT COMPLETED|Dose Escalation Group 2||0||
60119875|NCT02577640|76241097|FG002|NOT COMPLETED|Dose Escalation Group 2||0||
60119876|NCT02577640|76241098|FG003|NOT COMPLETED|Dose Escalation Group 2||0||
60119877|NCT02577640|76241095|FG000|STARTED|Dose Escalation Group 3||0||
59719076|NCT01210118|75838238|FG001|COMPLETED|Overall Study||42||
59719077|NCT01210118|75838237|FG000|NOT COMPLETED|Overall Study||3||
59719078|NCT01210118|75838238|FG001|NOT COMPLETED|Overall Study||5||
59719079|NCT01208870|75838249|FG000|STARTED|Overall Study|The same group was run as Pilot 1 Spring 2012 and Pilot 2 Summer 2013|46||
60119878|NCT02577640|76241096|FG001|STARTED|Dose Escalation Group 3||0||
59841570|NCT00219141|75966021|FG002|STARTED|Overall Study||154||
59841571|NCT00219141|75966019|FG000|COMPLETED|Overall Study||140||
59841572|NCT00219141|75966020|FG001|COMPLETED|Overall Study||131||
59841573|NCT00219141|75966021|FG002|COMPLETED|Overall Study||142||
59841574|NCT00219141|75966019|FG000|NOT COMPLETED|Overall Study||14||
59841575|NCT00219141|75966020|FG001|NOT COMPLETED|Overall Study||21||
59841576|NCT00219141|75966021|FG002|NOT COMPLETED|Overall Study||12||
59841577|NCT00142935|75966032|FG000|STARTED|Overall Study||29||
59841578|NCT00142935|75966033|FG001|STARTED|Overall Study||28||
59841579|NCT00142935|75966034|FG002|STARTED|Overall Study||30||
59841580|NCT00142935|75966032|FG000|COMPLETED|Overall Study||26||
59841581|NCT00142935|75966033|FG001|COMPLETED|Overall Study||20||
59841582|NCT00142935|75966034|FG002|COMPLETED|Overall Study||23||
59841583|NCT00142935|75966032|FG000|NOT COMPLETED|Overall Study||3||
59841584|NCT00142935|75966033|FG001|NOT COMPLETED|Overall Study||8||
59841585|NCT00142935|75966034|FG002|NOT COMPLETED|Overall Study||7||
59841586|NCT00233948|75966048|FG000|STARTED|Overall Study||4||
59841587|NCT00233948|75966049|FG001|STARTED|Overall Study||3||
59841588|NCT00233948|75966050|FG002|STARTED|Overall Study||3||
59841589|NCT00233948|75966051|FG003|STARTED|Overall Study||3||
59841590|NCT00233948|75966052|FG004|STARTED|Overall Study||4||
59841591|NCT00233948|75966053|FG005|STARTED|Overall Study||12||
59841592|NCT00233948|75966048|FG000|COMPLETED|Overall Study||3||
59841593|NCT00233948|75966049|FG001|COMPLETED|Overall Study||3||
59841594|NCT00233948|75966050|FG002|COMPLETED|Overall Study||3||
59841595|NCT00233948|75966051|FG003|COMPLETED|Overall Study||3||
59841596|NCT00233948|75966052|FG004|COMPLETED|Overall Study||4||
59841597|NCT00233948|75966053|FG005|COMPLETED|Overall Study||12||
59841598|NCT00233948|75966048|FG000|NOT COMPLETED|Overall Study||1||
59841599|NCT00233948|75966049|FG001|NOT COMPLETED|Overall Study||0||
59841600|NCT00233948|75966050|FG002|NOT COMPLETED|Overall Study||0||
59841601|NCT00233948|75966051|FG003|NOT COMPLETED|Overall Study||0||
59841602|NCT00233948|75966052|FG004|NOT COMPLETED|Overall Study||0||
59841603|NCT00233948|75966053|FG005|NOT COMPLETED|Overall Study||0||
59841604|NCT00233480|75966070|FG000|STARTED|Overall Study||14||
59841605|NCT00233480|75966071|FG001|STARTED|Overall Study||13||
59841606|NCT00233480|75966070|FG000|COMPLETED|Overall Study||14||
59841607|NCT00233480|75966071|FG001|COMPLETED|Overall Study||12||
59841608|NCT00233480|75966070|FG000|NOT COMPLETED|Overall Study||0||
59841609|NCT00233480|75966071|FG001|NOT COMPLETED|Overall Study||1||
59841610|NCT03801928|75966085|FG000|STARTED|Overall Study||18||
59841611|NCT03801928|75966086|FG001|STARTED|Overall Study||21||
59841612|NCT03801928|75966087|FG002|STARTED|Overall Study||9||
59841613|NCT03801928|75966088|FG003|STARTED|Overall Study||21||
59841614|NCT03801928|75966089|FG004|STARTED|Overall Study||36||
59841615|NCT03801928|75966090|FG005|STARTED|Overall Study||10||
59841616|NCT03801928|75966085|FG000|COMPLETED|Overall Study||12||
59841617|NCT03801928|75966086|FG001|COMPLETED|Overall Study||18||
59841618|NCT03801928|75966087|FG002|COMPLETED|Overall Study||4||
59841619|NCT03801928|75966088|FG003|COMPLETED|Overall Study||13||
59841620|NCT03801928|75966089|FG004|COMPLETED|Overall Study||32||
59841621|NCT03801928|75966090|FG005|COMPLETED|Overall Study||5||
59841622|NCT03801928|75966085|FG000|NOT COMPLETED|Overall Study||6||
59841623|NCT03801928|75966086|FG001|NOT COMPLETED|Overall Study||3||
59841624|NCT03801928|75966087|FG002|NOT COMPLETED|Overall Study||5||
59841625|NCT03801928|75966088|FG003|NOT COMPLETED|Overall Study||8||
59841626|NCT03801928|75966089|FG004|NOT COMPLETED|Overall Study||4||
59841627|NCT03801928|75966090|FG005|NOT COMPLETED|Overall Study||5||
59567824|NCT02608905|75670681|FG001|NOT COMPLETED|Overall Study||0||
59841628|NCT00263588|75966109|FG000|STARTED|Overall Study||95||
59841629|NCT00263588|75966110|FG001|STARTED|Overall Study||147||
59841630|NCT00263588|75966109|FG000|COMPLETED|Overall Study||14||
59841631|NCT00263588|75966110|FG001|COMPLETED|Overall Study||15||
59841632|NCT00263588|75966109|FG000|NOT COMPLETED|Overall Study||81||
59841633|NCT00263588|75966110|FG001|NOT COMPLETED|Overall Study||132||
59841634|NCT00213135|75966120|FG000|STARTED|Overall Study||456||
59841635|NCT00213135|75966121|FG001|STARTED|Overall Study||433||
59841636|NCT00213135|75966122|FG002|STARTED|Overall Study||437||
59841637|NCT00213135|75966120|FG000|COMPLETED|Overall Study||406||
59841638|NCT00213135|75966121|FG001|COMPLETED|Overall Study||398||
59841639|NCT00213135|75966122|FG002|COMPLETED|Overall Study||380||
59841640|NCT00213135|75966120|FG000|NOT COMPLETED|Overall Study||50||
59841641|NCT00213135|75966121|FG001|NOT COMPLETED|Overall Study||35||
59841642|NCT00213135|75966122|FG002|NOT COMPLETED|Overall Study||57||
59841643|NCT00077974|75966130|FG000|STARTED|Overall Study||106||
59841644|NCT00077974|75966130|FG000|COMPLETED|Overall Study||2||
59841645|NCT00077974|75966130|FG000|NOT COMPLETED|Overall Study||104||
59841646|NCT00124917|75966134|FG000|STARTED|Overall Study||6||
59841647|NCT00124917|75966134|FG000|COMPLETED|Overall Study||3||
59841648|NCT00124917|75966134|FG000|NOT COMPLETED|Overall Study||3||
59841649|NCT00141921|75966139|FG000|STARTED|Overall Study||182||
59841650|NCT00141921|75966139|FG000|Received Treatment|Overall Study||181||
59841651|NCT00141921|75966139|FG000|COMPLETED|Overall Study||41||
59841652|NCT00141921|75966139|FG000|NOT COMPLETED|Overall Study||141||
59841653|NCT00029146|75966145|FG000|STARTED|Overall Study||97||
59841654|NCT00029146|75966146|FG001|STARTED|Overall Study||98||
59841655|NCT00029146|75966145|FG000|COMPLETED|Overall Study||95||
59841656|NCT00029146|75966146|FG001|COMPLETED|Overall Study||97||
59841657|NCT00029146|75966145|FG000|NOT COMPLETED|Overall Study||2||
59841658|NCT00029146|75966146|FG001|NOT COMPLETED|Overall Study||1||
59841659|NCT00026494|75966156|FG000|STARTED|Overall Study||7||
59841660|NCT00026494|75966157|FG001|STARTED|Overall Study||4||
59841661|NCT00026494|75966158|FG002|STARTED|Overall Study||22||
59841662|NCT00026494|75966159|FG003|STARTED|Overall Study||16||
59841663|NCT00026494|75966156|FG000|COMPLETED|Overall Study||5||
59841664|NCT00026494|75966157|FG001|COMPLETED|Overall Study||4||
59841665|NCT00026494|75966158|FG002|COMPLETED|Overall Study||16||
60119879|NCT02577640|76241097|FG002|STARTED|Dose Escalation Group 3||3||
60119880|NCT02577640|76241098|FG003|STARTED|Dose Escalation Group 3||0||
60119881|NCT02577640|76241095|FG000|COMPLETED|Dose Escalation Group 3||0||
59567825|NCT01213329|75670689|FG000|STARTED|Screening||25||
59841666|NCT00026494|75966159|FG003|COMPLETED|Overall Study||16||
59841667|NCT00026494|75966156|FG000|NOT COMPLETED|Overall Study||2||
59841668|NCT00026494|75966157|FG001|NOT COMPLETED|Overall Study||0||
59841669|NCT00026494|75966158|FG002|NOT COMPLETED|Overall Study||6||
59841670|NCT00026494|75966159|FG003|NOT COMPLETED|Overall Study||0||
59841671|NCT00023764|75966169|FG000|STARTED|Overall Study||103||
59841672|NCT00023764|75966169|FG000|COMPLETED|Overall Study||89||
59841673|NCT00023764|75966169|FG000|NOT COMPLETED|Overall Study||14||
59841674|NCT00189488|75966176|FG000|STARTED|Overall Study||78||
59841675|NCT00189488|75966177|FG001|STARTED|Overall Study||77||
59841676|NCT00189488|75966176|FG000|Received Palifermin/Placebo|Overall Study||75||
59841677|NCT00189488|75966177|FG001|Received Palifermin/Placebo|Overall Study||76||
59841678|NCT00189488|75966176|FG000|COMPLETED|Overall Study||63||
59841679|NCT00189488|75966177|FG001|COMPLETED|Overall Study||55||
59841680|NCT00189488|75966176|FG000|NOT COMPLETED|Overall Study||15||
59841681|NCT00189488|75966177|FG001|NOT COMPLETED|Overall Study||22||
59841682|NCT00233402|75966186|FG000|STARTED|Overall Study||384||
59841683|NCT00233402|75966187|FG001|STARTED|Overall Study||395||
59841684|NCT00233402|75966186|FG000|COMPLETED|Overall Study||280||
59841685|NCT00233402|75966187|FG001|COMPLETED|Overall Study||271||
59841686|NCT00233402|75966186|FG000|NOT COMPLETED|Overall Study||104||
59841687|NCT00233402|75966187|FG001|NOT COMPLETED|Overall Study||124||
59841688|NCT00233324|75966199|FG000|STARTED|Main Study||318||
59841689|NCT00233324|75966200|FG001|STARTED|Main Study||335||
59841690|NCT00233324|75966201|FG002|STARTED|Main Study||336||
59841691|NCT00233324|75966202|FG003|STARTED|Main Study||327||
59841692|NCT00233324|75966199|FG000|COMPLETED|Main Study||250||
59841693|NCT00233324|75966200|FG001|COMPLETED|Main Study||275||
59841694|NCT00233324|75966201|FG002|COMPLETED|Main Study||274||
59841695|NCT00233324|75966202|FG003|COMPLETED|Main Study||280||
59841696|NCT00233324|75966199|FG000|NOT COMPLETED|Main Study||68||
59841697|NCT00233324|75966200|FG001|NOT COMPLETED|Main Study||60||
59841698|NCT00233324|75966201|FG002|NOT COMPLETED|Main Study||62||
59841699|NCT00233324|75966202|FG003|NOT COMPLETED|Main Study||47||
59841700|NCT00233324|75966199|FG000|STARTED|Follow up at 18-22 Months Corrected Age||250||
59841701|NCT00233324|75966200|FG001|STARTED|Follow up at 18-22 Months Corrected Age||275||
59841702|NCT00233324|75966201|FG002|STARTED|Follow up at 18-22 Months Corrected Age||274||
59841703|NCT00233324|75966202|FG003|STARTED|Follow up at 18-22 Months Corrected Age||280||
59841704|NCT00233324|75966199|FG000|COMPLETED|Follow up at 18-22 Months Corrected Age||237||
60119882|NCT02577640|76241096|FG001|COMPLETED|Dose Escalation Group 3||0||
59841705|NCT00233324|75966200|FG001|COMPLETED|Follow up at 18-22 Months Corrected Age||261||
59841706|NCT00233324|75966201|FG002|COMPLETED|Follow up at 18-22 Months Corrected Age||256||
59841707|NCT00233324|75966202|FG003|COMPLETED|Follow up at 18-22 Months Corrected Age||269||
59841708|NCT00233324|75966199|FG000|NOT COMPLETED|Follow up at 18-22 Months Corrected Age||13||
59841709|NCT00233324|75966200|FG001|NOT COMPLETED|Follow up at 18-22 Months Corrected Age||14||
59841710|NCT00233324|75966201|FG002|NOT COMPLETED|Follow up at 18-22 Months Corrected Age||18||
59841711|NCT00233324|75966202|FG003|NOT COMPLETED|Follow up at 18-22 Months Corrected Age||11||
59841712|NCT00023452|75966221|FG000|STARTED|Overall Study||3908||
59841713|NCT00023452|75966222|FG001|STARTED|Overall Study||4145||
59841714|NCT00023452|75966221|FG000|Randomized|Overall Study||3190||
59841715|NCT00023452|75966222|FG001|Randomized|Overall Study||3174||
59841716|NCT00023452|75966221|FG000|Enrolled as Part of a Cluster|Overall Study||718||
59841717|NCT00023452|75966222|FG001|Enrolled as Part of a Cluster|Overall Study||971||
59841718|NCT00023452|75966221|FG000|Completed Treatment|Overall Study||2585||
59841719|NCT00023452|75966222|FG001|Completed Treatment|Overall Study||3273||
59841720|NCT00023452|75966221|FG000|Not Treated|Overall Study||149||
59841721|NCT00023452|75966222|FG001|Not Treated|Overall Study||105||
59841722|NCT00023452|75966221|FG000|Completed Study|Overall Study||3174||
59841723|NCT00023452|75966222|FG001|Completed Study|Overall Study||3475||
59841724|NCT00023452|75966221|FG000|COMPLETED|Overall Study||2585||
59841725|NCT00023452|75966222|FG001|COMPLETED|Overall Study||3273||
59841726|NCT00023452|75966221|FG000|NOT COMPLETED|Overall Study||1323||
59841727|NCT00023452|75966222|FG001|NOT COMPLETED|Overall Study||872||
59841728|NCT00022672|75966234|FG000|STARTED|Main Phase: 24 Months||103||
59841729|NCT00022672|75966235|FG001|STARTED|Main Phase: 24 Months||104||
59841730|NCT00022672|75966234|FG000|Safety Set: Received Study Drug|Main Phase: 24 Months||103||
59841731|NCT00022672|75966235|FG001|Safety Set: Received Study Drug|Main Phase: 24 Months||104||
59841732|NCT00022672|75966234|FG000|COMPLETED|Main Phase: 24 Months||16||
59841733|NCT00022672|75966235|FG001|COMPLETED|Main Phase: 24 Months||4||
59841734|NCT00022672|75966234|FG000|NOT COMPLETED|Main Phase: 24 Months||87||
59841735|NCT00022672|75966235|FG001|NOT COMPLETED|Main Phase: 24 Months||100||
59841736|NCT00022672|75966234|FG000|STARTED|Extension Phase|2 patients completed Main Phase; but did not enter Extension (1-did not cooperate and 1-withdrew).|14||
59841737|NCT00022672|75966235|FG001|STARTED|Extension Phase||58||
59841738|NCT00022672|75966234|FG000|Safety Set: Received Study Drug|Extension Phase||14||
59841739|NCT00022672|75966235|FG001|Safety Set: Received Study Drug|Extension Phase||58||
59841740|NCT00022672|75966234|FG000|COMPLETED|Extension Phase||11||
59841741|NCT00022672|75966235|FG001|COMPLETED|Extension Phase||7||
59841742|NCT00022672|75966234|FG000|NOT COMPLETED|Extension Phase||3||
59841743|NCT00022672|75966235|FG001|NOT COMPLETED|Extension Phase||51||
59841744|NCT00076804|75966244|FG000|STARTED|Overall Study||137||
59841745|NCT00076804|75966245|FG001|STARTED|Overall Study||137||
59841746|NCT00076804|75966244|FG000|COMPLETED|Overall Study|111 completed week 48, 77 completed week 96.|77||
59841747|NCT00076804|75966245|FG001|COMPLETED|Overall Study|102 completed week 48, 68 completed week 96|68||
59841748|NCT00076804|75966244|FG000|NOT COMPLETED|Overall Study||60||
59841749|NCT00076804|75966245|FG001|NOT COMPLETED|Overall Study||69||
59841750|NCT00141453|75966253|FG000|STARTED|Overall Study||288||
59841751|NCT00141453|75966254|FG001|STARTED|Overall Study||289||
59841752|NCT00141453|75966253|FG000|COMPLETED|Overall Study||282||
59841753|NCT00141453|75966254|FG001|COMPLETED|Overall Study||284||
59841754|NCT00141453|75966253|FG000|NOT COMPLETED|Overall Study||6||
59841755|NCT00141453|75966254|FG001|NOT COMPLETED|Overall Study||5||
59841756|NCT00076570|75966262|FG000|STARTED|Overall Study||15||
59841757|NCT00076570|75966263|FG001|STARTED|Overall Study||16||
59841758|NCT00076570|75966262|FG000|COMPLETED|Overall Study||7||
59841759|NCT00076570|75966263|FG001|COMPLETED|Overall Study||8||
59841760|NCT00076570|75966262|FG000|NOT COMPLETED|Overall Study||8||
59841761|NCT00076570|75966263|FG001|NOT COMPLETED|Overall Study||8||
59841762|NCT00124449|75966271|FG000|STARTED|6-month Double-Blind Treatment Period||28||
59841763|NCT00124449|75966272|FG001|STARTED|6-month Double-Blind Treatment Period||28||
59841764|NCT00124449|75966271|FG000|COMPLETED|6-month Double-Blind Treatment Period||22||
59841765|NCT00124449|75966272|FG001|COMPLETED|6-month Double-Blind Treatment Period||17||
59841766|NCT00124449|75966271|FG000|NOT COMPLETED|6-month Double-Blind Treatment Period||6||
59841767|NCT00124449|75966272|FG001|NOT COMPLETED|6-month Double-Blind Treatment Period||11||
59841768|NCT00124449|75966271|FG000|STARTED|18-Month Untreated Observation Period||22||
59841769|NCT00124449|75966272|FG001|STARTED|18-Month Untreated Observation Period||17||
59841770|NCT00124449|75966271|FG000|Completed Year 1 of Study|18-Month Untreated Observation Period||14||
59841771|NCT00124449|75966272|FG001|Completed Year 1 of Study|18-Month Untreated Observation Period||9||
59841772|NCT00124449|75966271|FG000|COMPLETED|18-Month Untreated Observation Period||7||
59841773|NCT00124449|75966272|FG001|COMPLETED|18-Month Untreated Observation Period||4||
59841774|NCT00124449|75966271|FG000|NOT COMPLETED|18-Month Untreated Observation Period||15||
59841775|NCT00124449|75966272|FG001|NOT COMPLETED|18-Month Untreated Observation Period||13||
59841776|NCT00076336|75966281|FG000|STARTED|Overall Study||116||
59841777|NCT00076336|75966282|FG001|STARTED|Overall Study||116||
59841778|NCT00076336|75966281|FG000|Safety Population|Overall Study|1 patient was randomized but never received study drug and not included in safety population.|115||
59841779|NCT00076336|75966282|FG001|Safety Population|Overall Study||116||
59841780|NCT00076336|75966281|FG000|Intent to Treat (ITT) Population|Overall Study|1 patient had no HBV DNA assessments after baseline and was excluded from ITT population.|114||
59841781|NCT00076336|75966282|FG001|Intent to Treat (ITT) Population|Overall Study|2 patients had no HBV DNA assessments after baseline and were excluded from ITT population.|114||
59841782|NCT00076336|75966281|FG000|Completed Week 52|Overall Study||97||
59841783|NCT00076336|75966282|FG001|Completed Week 52|Overall Study||94||
59841784|NCT00076336|75966281|FG000|Completed Week 104|Overall Study||70||
59841785|NCT00076336|75966282|FG001|Completed Week 104|Overall Study||62||
59841786|NCT00076336|75966281|FG000|COMPLETED|Overall Study||64||
59841787|NCT00076336|75966282|FG001|COMPLETED|Overall Study||60||
59841788|NCT00076336|75966281|FG000|NOT COMPLETED|Overall Study||52||
59841789|NCT00076336|75966282|FG001|NOT COMPLETED|Overall Study||56||
59841790|NCT00185588|75966292|FG000|STARTED|Overall Study||6||
59841791|NCT00185588|75966293|FG001|STARTED|Overall Study||4||
59841792|NCT00185588|75966294|FG002|STARTED|Overall Study||6||
59841793|NCT00185588|75966295|FG003|STARTED|Overall Study||17||
59841794|NCT00185588|75966292|FG000|COMPLETED|Overall Study||3||
59841795|NCT00185588|75966293|FG001|COMPLETED|Overall Study||2||
59841796|NCT00185588|75966294|FG002|COMPLETED|Overall Study||0||
59841797|NCT00185588|75966295|FG003|COMPLETED|Overall Study||13||
59841798|NCT00185588|75966292|FG000|NOT COMPLETED|Overall Study||3||
59841799|NCT00185588|75966293|FG001|NOT COMPLETED|Overall Study||2||
59841800|NCT00185588|75966294|FG002|NOT COMPLETED|Overall Study||6||
59841801|NCT00185588|75966295|FG003|NOT COMPLETED|Overall Study||4||
59841802|NCT00232544|75966307|FG000|STARTED|Overall Study||124||
59841803|NCT00232544|75966308|FG001|STARTED|Overall Study||126||
59841804|NCT00232544|75966307|FG000|COMPLETED|Overall Study||104||
59841805|NCT00232544|75966308|FG001|COMPLETED|Overall Study||111||
59841806|NCT00232544|75966307|FG000|NOT COMPLETED|Overall Study||20||
59841807|NCT00232544|75966308|FG001|NOT COMPLETED|Overall Study||15||
59841808|NCT00231842|75966314|FG000|STARTED|Overall Study||30||
59841809|NCT00231842|75966314|FG000|Initiated Therapy|Overall Study||27||
59841810|NCT00231842|75966314|FG000|Completed First 3 Cycles|Overall Study||27|27 participants completed the first 3 cycles of chemotherapy followed by RT|
59841811|NCT00231842|75966314|FG000|Completed Prescribed RT|Overall Study||27|26 participants had EBRT + Brachytherapy; 1 had EBRT alone|
59841812|NCT00231842|75966314|FG000|Completed Full Prescribed Therapy|Overall Study||19||
59841813|NCT00231842|75966314|FG000|COMPLETED|Overall Study||19||
59841814|NCT00231842|75966314|FG000|NOT COMPLETED|Overall Study||11||
59841815|NCT00076102|75966319|FG000|STARTED|Overall Study||36||
59841816|NCT00076102|75966319|FG000|COMPLETED|Overall Study||31||
59841817|NCT00076102|75966319|FG000|NOT COMPLETED|Overall Study||5||
59841818|NCT03974282|75966327|FG000|STARTED|Overall Study||18||
59841819|NCT03974282|75966328|FG001|STARTED|Overall Study||18||
59841820|NCT03974282|75966327|FG000|COMPLETED|Overall Study||18||
59841821|NCT03974282|75966328|FG001|COMPLETED|Overall Study||18||
59841822|NCT03974282|75966327|FG000|NOT COMPLETED|Overall Study||0||
59841823|NCT03974282|75966328|FG001|NOT COMPLETED|Overall Study||0||
59841824|NCT00231062|75966333|FG000|STARTED|Overall Study||115||
59841825|NCT00231062|75966333|FG000|COMPLETED|Overall Study||109||
59841826|NCT00231062|75966333|FG000|NOT COMPLETED|Overall Study||6||
59841827|NCT00184028|75966337|FG000|STARTED|Overall Study||12||
59841828|NCT00184028|75966337|FG000|COMPLETED|Overall Study||2||
59841829|NCT00184028|75966337|FG000|NOT COMPLETED|Overall Study||10||
59841830|NCT00183872|75966342|FG000|STARTED|Overall Study||40||
59841831|NCT00183872|75966342|FG000|COMPLETED|Overall Study||24||
59841832|NCT00183872|75966342|FG000|NOT COMPLETED|Overall Study||16||
59841833|NCT03815175|75966346|FG000|STARTED|Overall Study||1605||
59841834|NCT03815175|75966346|FG000|COMPLETED|Overall Study||1439||
59841835|NCT03815175|75966346|FG000|NOT COMPLETED|Overall Study||166||
59841836|NCT00262028|75966359|FG000|STARTED|Overall Study||152||
59719080|NCT01208870|75838250|FG001|STARTED|Overall Study|The same group was run as Pilot 1 Spring 2012 and Pilot 2 Summer 2013.|44||
59719081|NCT01208870|75838249|FG000|Pilot 1|Overall Study||20||
59719082|NCT01208870|75838250|FG001|Pilot 1|Overall Study||22||
59719083|NCT01208870|75838249|FG000|Pilot 2|Overall Study||26||
59719084|NCT01208870|75838250|FG001|Pilot 2|Overall Study||22||
59719085|NCT01208870|75838249|FG000|COMPLETED|Overall Study||44||
59719086|NCT01208870|75838250|FG001|COMPLETED|Overall Study||36||
59719087|NCT01208870|75838249|FG000|NOT COMPLETED|Overall Study||2||
59719088|NCT01208870|75838250|FG001|NOT COMPLETED|Overall Study||8||
59719089|NCT00880555|75838261|FG000|STARTED|Overall Study||23||
59841837|NCT00262028|75966360|FG001|STARTED|Overall Study||153||
59841838|NCT00262028|75966361|FG002|STARTED|Overall Study||157||
59841839|NCT00262028|75966362|FG003|STARTED|Overall Study||157||
59841840|NCT00262028|75966363|FG004|STARTED|Overall Study||74||
59841841|NCT00262028|75966364|FG005|STARTED|Overall Study||73||
59841842|NCT00262028|75966365|FG006|STARTED|Overall Study||71||
59841843|NCT00262028|75966366|FG007|STARTED|Overall Study||73||
59841844|NCT00262028|75966367|FG008|STARTED|Overall Study||100||
59719090|NCT00880555|75838262|FG001|STARTED|Overall Study||40||
59719091|NCT00880555|75838263|FG002|STARTED|Overall Study||11||
59719092|NCT00880555|75838264|FG003|STARTED|Overall Study||2||
59841845|NCT00262028|75966359|FG000|COMPLETED|Overall Study||128||
59841846|NCT00262028|75966360|FG001|COMPLETED|Overall Study||126||
59719093|NCT00880555|75838265|FG004|STARTED|Overall Study||1||
59719094|NCT00880555|75838266|FG005|STARTED|Overall Study||1||
59841847|NCT00262028|75966361|FG002|COMPLETED|Overall Study||137||
59841848|NCT00262028|75966362|FG003|COMPLETED|Overall Study||134||
59841849|NCT00262028|75966363|FG004|COMPLETED|Overall Study||62||
59841850|NCT00262028|75966364|FG005|COMPLETED|Overall Study||60||
59841851|NCT00262028|75966365|FG006|COMPLETED|Overall Study||59||
59841852|NCT00262028|75966366|FG007|COMPLETED|Overall Study||55||
59841853|NCT00262028|75966367|FG008|COMPLETED|Overall Study||81||
59841854|NCT00262028|75966359|FG000|NOT COMPLETED|Overall Study||24||
59841855|NCT00262028|75966360|FG001|NOT COMPLETED|Overall Study||27||
59841856|NCT00262028|75966361|FG002|NOT COMPLETED|Overall Study||20||
59841857|NCT00262028|75966362|FG003|NOT COMPLETED|Overall Study||23||
59841858|NCT00262028|75966363|FG004|NOT COMPLETED|Overall Study||12||
59841859|NCT00262028|75966364|FG005|NOT COMPLETED|Overall Study||13||
59841860|NCT00262028|75966365|FG006|NOT COMPLETED|Overall Study||12||
59841861|NCT00262028|75966366|FG007|NOT COMPLETED|Overall Study||18||
59841862|NCT00262028|75966367|FG008|NOT COMPLETED|Overall Study||19||
59841863|NCT00183248|75966411|FG000|STARTED|Overall Study||4||
59841864|NCT00183248|75966412|FG001|STARTED|Overall Study||5||
59841865|NCT00183248|75966411|FG000|COMPLETED|Overall Study||3||
59841866|NCT00183248|75966412|FG001|COMPLETED|Overall Study||4||
59841867|NCT00183248|75966411|FG000|NOT COMPLETED|Overall Study||1||
59841868|NCT00183248|75966412|FG001|NOT COMPLETED|Overall Study||1||
59841869|NCT00183170|75966420|FG000|STARTED|First Intervention||103||
59841870|NCT00183170|75966421|FG001|STARTED|First Intervention||109||
59841871|NCT00183170|75966420|FG000|COMPLETED|First Intervention||101||
59841872|NCT00183170|75966421|FG001|COMPLETED|First Intervention||109||
59841873|NCT00183170|75966420|FG000|NOT COMPLETED|First Intervention||2||
59841874|NCT00183170|75966421|FG001|NOT COMPLETED|First Intervention||0||
59841875|NCT00183170|75966420|FG000|STARTED|Washout 1 Week||101||
59841876|NCT00183170|75966421|FG001|STARTED|Washout 1 Week||109||
59841877|NCT00183170|75966420|FG000|COMPLETED|Washout 1 Week||95||
59841878|NCT00183170|75966421|FG001|COMPLETED|Washout 1 Week||101||
59841879|NCT00183170|75966420|FG000|NOT COMPLETED|Washout 1 Week||6||
59841880|NCT00183170|75966421|FG001|NOT COMPLETED|Washout 1 Week||8||
59841881|NCT00183170|75966420|FG000|STARTED|Second Intervention||95||
59841882|NCT00183170|75966421|FG001|STARTED|Second Intervention||101||
59841883|NCT00183170|75966420|FG000|COMPLETED|Second Intervention||94||
59841884|NCT00183170|75966421|FG001|COMPLETED|Second Intervention||99||
59841885|NCT00183170|75966420|FG000|NOT COMPLETED|Second Intervention||1||
59841886|NCT00183170|75966421|FG001|NOT COMPLETED|Second Intervention||2||
60119883|NCT02577640|76241097|FG002|COMPLETED|Dose Escalation Group 3||3||
60119884|NCT02577640|76241098|FG003|COMPLETED|Dose Escalation Group 3||0||
59567826|NCT01213329|75670690|FG001|STARTED|Screening||25||
59719095|NCT00880555|75838261|FG000|COMPLETED|Overall Study||13||
59719096|NCT00880555|75838262|FG001|COMPLETED|Overall Study||23||
59719097|NCT00880555|75838263|FG002|COMPLETED|Overall Study||6||
59719098|NCT00880555|75838264|FG003|COMPLETED|Overall Study||0||
59719099|NCT00880555|75838265|FG004|COMPLETED|Overall Study||0||
59719100|NCT00880555|75838266|FG005|COMPLETED|Overall Study||0||
59719101|NCT00880555|75838261|FG000|NOT COMPLETED|Overall Study||10||
59719102|NCT00880555|75838262|FG001|NOT COMPLETED|Overall Study||17||
59719103|NCT00880555|75838263|FG002|NOT COMPLETED|Overall Study||5||
59719104|NCT00880555|75838264|FG003|NOT COMPLETED|Overall Study||2||
59719105|NCT00880555|75838265|FG004|NOT COMPLETED|Overall Study||1||
59719106|NCT00880555|75838266|FG005|NOT COMPLETED|Overall Study||1||
59719107|NCT01208402|75838279|FG000|STARTED|Overall Study||31||
59719108|NCT01208402|75838280|FG001|STARTED|Overall Study||28||
59719109|NCT01208402|75838279|FG000|COMPLETED|Overall Study||30||
59719110|NCT01208402|75838280|FG001|COMPLETED|Overall Study||28||
59719111|NCT01208402|75838279|FG000|NOT COMPLETED|Overall Study||1||
59719112|NCT01208402|75838280|FG001|NOT COMPLETED|Overall Study||0||
59719113|NCT01208324|75838290|FG000|STARTED|Pre-randomization of Patch||14||
59719114|NCT01208324|75838291|FG001|STARTED|Pre-randomization of Patch||15||
59841887|NCT00230282|75966427|FG000|STARTED|Fludarabine + Cyclophosphamide||25||
59841888|NCT00230282|75966427|FG000|COMPLETED|Fludarabine + Cyclophosphamide||17||
59841889|NCT00230282|75966427|FG000|NOT COMPLETED|Fludarabine + Cyclophosphamide||8||
59841890|NCT00230282|75966427|FG000|STARTED|Maintanence Therapy With Alemtuzumab||17||
59841891|NCT00230282|75966427|FG000|COMPLETED|Maintanence Therapy With Alemtuzumab||17||
59841892|NCT00230282|75966427|FG000|NOT COMPLETED|Maintanence Therapy With Alemtuzumab||0||
59841893|NCT00261950|75966431|FG000|STARTED|Overall Study||110||
59841894|NCT00261950|75966431|FG000|COMPLETED|Overall Study||84||
59841895|NCT00261950|75966431|FG000|NOT COMPLETED|Overall Study||26||
59841896|NCT00230048|75966437|FG000|STARTED|Overall Study||52||
59841897|NCT00230048|75966438|FG001|STARTED|Overall Study||55||
59841898|NCT00230048|75966437|FG000|Completed Intervention/Control Session|Overall Study||52||
59841899|NCT00230048|75966438|FG001|Completed Intervention/Control Session|Overall Study||55||
59841900|NCT00230048|75966437|FG000|COMPLETED|Overall Study||39||
59841901|NCT00230048|75966438|FG001|COMPLETED|Overall Study||37||
59841902|NCT00230048|75966437|FG000|NOT COMPLETED|Overall Study||13||
59841903|NCT00230048|75966438|FG001|NOT COMPLETED|Overall Study||18||
59841904|NCT00229658|75966448|FG000|STARTED|Overall Study||766||
59841905|NCT00229658|75966449|FG001|STARTED|Overall Study||531||
59841906|NCT00229658|75966448|FG000|COMPLETED|Overall Study||541||
59841907|NCT00229658|75966449|FG001|COMPLETED|Overall Study||364||
59841908|NCT00229658|75966448|FG000|NOT COMPLETED|Overall Study||225||
59841909|NCT00229658|75966449|FG001|NOT COMPLETED|Overall Study||167||
59841910|NCT00182078|75966457|FG000|STARTED|Overall Study||9||
59841911|NCT00182078|75966458|FG001|STARTED|Overall Study||17||
59841912|NCT00182078|75966457|FG000|COMPLETED|Overall Study||8||
59841913|NCT00182078|75966458|FG001|COMPLETED|Overall Study||17||
59841914|NCT00182078|75966457|FG000|NOT COMPLETED|Overall Study||1||
59841915|NCT00182078|75966458|FG001|NOT COMPLETED|Overall Study||0||
59841916|NCT00181844|75966464|FG000|STARTED|Signed Consent||51||
59841917|NCT00181844|75966464|FG000|COMPLETED|Signed Consent||39||
59841918|NCT00181844|75966464|FG000|NOT COMPLETED|Signed Consent||12||
59841919|NCT00181844|75966464|FG000|STARTED|Exposed to Study Medication||39||
59841920|NCT00181844|75966464|FG000|COMPLETED|Exposed to Study Medication||22||
59841921|NCT00181844|75966464|FG000|NOT COMPLETED|Exposed to Study Medication||17||
59841922|NCT00181766|75966468|FG000|STARTED|Overall Study|Number of subjects enrolled and treated with Atomoxetine.|45||
59841923|NCT00181766|75966468|FG000|COMPLETED|Overall Study|Completed the trial.|33||
59841924|NCT00181766|75966468|FG000|NOT COMPLETED|Overall Study||12||
59841925|NCT00180674|75966472|FG000|STARTED|Phase 1, Observation Period||14||
59841926|NCT00180674|75966472|FG000|COMPLETED|Phase 1, Observation Period||10||
59841927|NCT00180674|75966472|FG000|NOT COMPLETED|Phase 1, Observation Period||4||
59841928|NCT00180674|75966472|FG000|STARTED|Phase 2, Warfarin Treatment Period||10||
59841929|NCT00180674|75966472|FG000|COMPLETED|Phase 2, Warfarin Treatment Period||9||
59841930|NCT00180674|75966472|FG000|NOT COMPLETED|Phase 2, Warfarin Treatment Period||1||
59841931|NCT00076024|75966483|FG000|STARTED|Phase 1, Lead-in||6||
59841932|NCT00076024|75966484|FG001|STARTED|Phase 1, Lead-in||0||
59841933|NCT00076024|75966485|FG002|STARTED|Phase 1, Lead-in||0||
59841934|NCT00076024|75966486|FG003|STARTED|Phase 1, Lead-in||0||
59841935|NCT00076024|75966483|FG000|COMPLETED|Phase 1, Lead-in||0||
59841936|NCT00076024|75966484|FG001|COMPLETED|Phase 1, Lead-in||0||
59841937|NCT00076024|75966485|FG002|COMPLETED|Phase 1, Lead-in||0||
59841938|NCT00076024|75966486|FG003|COMPLETED|Phase 1, Lead-in||0||
59841939|NCT00076024|75966483|FG000|NOT COMPLETED|Phase 1, Lead-in||6||
59841940|NCT00076024|75966484|FG001|NOT COMPLETED|Phase 1, Lead-in||0||
59841941|NCT00076024|75966485|FG002|NOT COMPLETED|Phase 1, Lead-in||0||
59841942|NCT00076024|75966486|FG003|NOT COMPLETED|Phase 1, Lead-in||0||
59841943|NCT00076024|75966483|FG000|STARTED|Phase 2, Double-blind||0||
59841944|NCT00076024|75966484|FG001|STARTED|Phase 2, Double-blind||112||
59841945|NCT00076024|75966485|FG002|STARTED|Phase 2, Double-blind||56||
59841946|NCT00076024|75966486|FG003|STARTED|Phase 2, Double-blind||0||
59841947|NCT00076024|75966483|FG000|Treated|Phase 2, Double-blind||0||
59841948|NCT00076024|75966484|FG001|Treated|Phase 2, Double-blind||111||
59841949|NCT00076024|75966485|FG002|Treated|Phase 2, Double-blind||56||
59841950|NCT00076024|75966486|FG003|Treated|Phase 2, Double-blind||0||
59841951|NCT00076024|75966483|FG000|COMPLETED|Phase 2, Double-blind||0||
59719115|NCT01208324|75838292|FG002|STARTED|Pre-randomization of Patch||10||
59841952|NCT00076024|75966484|FG001|COMPLETED|Phase 2, Double-blind||0||
59841953|NCT00076024|75966485|FG002|COMPLETED|Phase 2, Double-blind||0||
59841954|NCT00076024|75966486|FG003|COMPLETED|Phase 2, Double-blind||0||
59841955|NCT00076024|75966483|FG000|NOT COMPLETED|Phase 2, Double-blind||0||
59841956|NCT00076024|75966484|FG001|NOT COMPLETED|Phase 2, Double-blind||112||
59841957|NCT00076024|75966485|FG002|NOT COMPLETED|Phase 2, Double-blind||56||
59841958|NCT00076024|75966486|FG003|NOT COMPLETED|Phase 2, Double-blind||0||
59841959|NCT00076024|75966483|FG000|STARTED|Phase 2, Open-label||0||
59719116|NCT01208324|75838293|FG003|STARTED|Pre-randomization of Patch||8||
59719117|NCT01208324|75838290|FG000|Test Day 1|Pre-randomization of Patch||14|1 Sham Patch: Sham Tryptophan, then Active Tryptophan participant did not comp|
59719118|NCT01208324|75838291|FG001|Test Day 1|Pre-randomization of Patch||15|1 Sham Patch: Sham Tryptophan, then Active Tryptophan participant did not comp|
59719119|NCT01208324|75838292|FG002|Test Day 1|Pre-randomization of Patch||10|1 Sham Patch: Sham Tryptophan, then Active Tryptophan participant did not comp|
59719120|NCT01208324|75838293|FG003|Test Day 1|Pre-randomization of Patch||8|1 Sham Patch: Sham Tryptophan, then Active Tryptophan participant did not comp|
59841960|NCT00076024|75966484|FG001|STARTED|Phase 2, Open-label||0||
59841961|NCT00076024|75966485|FG002|STARTED|Phase 2, Open-label||0||
59841962|NCT00076024|75966486|FG003|STARTED|Phase 2, Open-label||16||
59841963|NCT00076024|75966483|FG000|COMPLETED|Phase 2, Open-label||0||
59841964|NCT00076024|75966484|FG001|COMPLETED|Phase 2, Open-label||0||
59841965|NCT00076024|75966485|FG002|COMPLETED|Phase 2, Open-label||0||
59841966|NCT00076024|75966486|FG003|COMPLETED|Phase 2, Open-label||0||
59841967|NCT00076024|75966483|FG000|NOT COMPLETED|Phase 2, Open-label||0||
59841968|NCT00076024|75966484|FG001|NOT COMPLETED|Phase 2, Open-label||0||
59841969|NCT00076024|75966485|FG002|NOT COMPLETED|Phase 2, Open-label||0||
59841970|NCT00076024|75966486|FG003|NOT COMPLETED|Phase 2, Open-label||16||
59841971|NCT00075478|75966497|FG000|STARTED|Overall Study||42||
59841972|NCT00075478|75966498|FG001|STARTED|Overall Study||45||
59841973|NCT00075478|75966497|FG000|COMPLETED|Overall Study||41||
59841974|NCT00075478|75966498|FG001|COMPLETED|Overall Study||44||
59841975|NCT00075478|75966497|FG000|NOT COMPLETED|Overall Study||1||
59841976|NCT00075478|75966498|FG001|NOT COMPLETED|Overall Study||1||
59841977|NCT00175916|75966504|FG000|STARTED|Overall Study||853||
59841978|NCT00175916|75966504|FG000|COMPLETED|Overall Study||234||
59841979|NCT00175916|75966504|FG000|NOT COMPLETED|Overall Study||619||
59841980|NCT00075400|75966509|FG000|STARTED|Overall Study||26||
59841981|NCT00075400|75966509|FG000|COMPLETED|Overall Study|Eligible and treated patients.|23||
59841982|NCT00075400|75966509|FG000|NOT COMPLETED|Overall Study||3||
59841983|NCT00228566|75966518|FG000|STARTED|Overall Study||247||
59841984|NCT00228566|75966518|FG000|COMPLETED|Overall Study||176||
59841985|NCT00228566|75966518|FG000|NOT COMPLETED|Overall Study||71||
59841986|NCT00074152|75966524|FG000|STARTED|Overall Study||77||
59841987|NCT00074152|75966525|FG001|STARTED|Overall Study||85||
59841988|NCT00074152|75966524|FG000|COMPLETED|Overall Study||22||
59841989|NCT00074152|75966525|FG001|COMPLETED|Overall Study||52||
59841990|NCT00074152|75966524|FG000|NOT COMPLETED|Overall Study||55||
59841991|NCT00074152|75966525|FG001|NOT COMPLETED|Overall Study||33||
59841992|NCT00261846|75966541|FG000|STARTED|Period 1: Part 1 (Dose Escalation)||3||
59841993|NCT00261846|75966542|FG001|STARTED|Period 1: Part 1 (Dose Escalation)||3||
59841994|NCT00261846|75966543|FG002|STARTED|Period 1: Part 1 (Dose Escalation)||12||
59841995|NCT00261846|75966544|FG003|STARTED|Period 1: Part 1 (Dose Escalation)||0||
59841996|NCT00261846|75966545|FG004|STARTED|Period 1: Part 1 (Dose Escalation)||0||
59841997|NCT00261846|75966546|FG005|STARTED|Period 1: Part 1 (Dose Escalation)||0||
59841998|NCT00261846|75966547|FG006|STARTED|Period 1: Part 1 (Dose Escalation)||0||
59841999|NCT00261846|75966548|FG007|STARTED|Period 1: Part 1 (Dose Escalation)||0||
59842000|NCT00261846|75966549|FG008|STARTED|Period 1: Part 1 (Dose Escalation)||0||
59842001|NCT00261846|75966550|FG009|STARTED|Period 1: Part 1 (Dose Escalation)||0||
59842002|NCT00261846|75966551|FG010|STARTED|Period 1: Part 1 (Dose Escalation)||0||
59842003|NCT00261846|75966552|FG011|STARTED|Period 1: Part 1 (Dose Escalation)||0||
59842004|NCT00261846|75966541|FG000|COMPLETED|Period 1: Part 1 (Dose Escalation)||0||
59842005|NCT00261846|75966542|FG001|COMPLETED|Period 1: Part 1 (Dose Escalation)||0||
59842006|NCT00261846|75966543|FG002|COMPLETED|Period 1: Part 1 (Dose Escalation)||0||
59842007|NCT00261846|75966544|FG003|COMPLETED|Period 1: Part 1 (Dose Escalation)||0||
59842008|NCT00261846|75966545|FG004|COMPLETED|Period 1: Part 1 (Dose Escalation)||0||
59842009|NCT00261846|75966546|FG005|COMPLETED|Period 1: Part 1 (Dose Escalation)||0||
59842010|NCT00261846|75966547|FG006|COMPLETED|Period 1: Part 1 (Dose Escalation)||0||
59842011|NCT00261846|75966548|FG007|COMPLETED|Period 1: Part 1 (Dose Escalation)||0||
59842012|NCT00261846|75966549|FG008|COMPLETED|Period 1: Part 1 (Dose Escalation)||0||
59842013|NCT00261846|75966550|FG009|COMPLETED|Period 1: Part 1 (Dose Escalation)||0||
59842014|NCT00261846|75966551|FG010|COMPLETED|Period 1: Part 1 (Dose Escalation)||0||
59842015|NCT00261846|75966552|FG011|COMPLETED|Period 1: Part 1 (Dose Escalation)||0||
59842016|NCT00261846|75966541|FG000|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||3||
59842017|NCT00261846|75966542|FG001|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||3||
59842018|NCT00261846|75966543|FG002|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||12||
59842019|NCT00261846|75966544|FG003|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0||
59842020|NCT00261846|75966545|FG004|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0||
59842021|NCT00261846|75966546|FG005|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0||
59842022|NCT00261846|75966547|FG006|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0||
59842023|NCT00261846|75966548|FG007|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0||
59842024|NCT00261846|75966549|FG008|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0||
59842025|NCT00261846|75966550|FG009|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0||
59842026|NCT00261846|75966551|FG010|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0||
59842027|NCT00261846|75966552|FG011|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0||
59842028|NCT00261846|75966541|FG000|STARTED|Period 2: Part 2 (Efficacy)||0||
59842029|NCT00261846|75966542|FG001|STARTED|Period 2: Part 2 (Efficacy)||0||
59842030|NCT00261846|75966543|FG002|STARTED|Period 2: Part 2 (Efficacy)||0||
59842031|NCT00261846|75966544|FG003|STARTED|Period 2: Part 2 (Efficacy)|17 participants from Part 1 (Bosutinib 400mg, 500mg, 600mg cohort) continued in Part 2 of the study.|195||
60119885|NCT02577640|76241095|FG000|NOT COMPLETED|Dose Escalation Group 3||0||
59719121|NCT01208324|75838290|FG000|Test Day 2|Pre-randomization of Patch||14||
59719122|NCT01208324|75838291|FG001|Test Day 2|Pre-randomization of Patch||15||
59719123|NCT01208324|75838292|FG002|Test Day 2|Pre-randomization of Patch||8||
59719124|NCT01208324|75838293|FG003|Test Day 2|Pre-randomization of Patch||5||
59719125|NCT01208324|75838290|FG000|COMPLETED|Pre-randomization of Patch||14|Five participants did not make it to Test Day 2|
59719126|NCT01208324|75838291|FG001|COMPLETED|Pre-randomization of Patch||15|Five participants did not make it to Test Day 2|
59719127|NCT01208324|75838292|FG002|COMPLETED|Pre-randomization of Patch||8|Five participants did not make it to Test Day 2|
59719128|NCT01208324|75838293|FG003|COMPLETED|Pre-randomization of Patch||5|Five participants did not make it to Test Day 2|
59842032|NCT00261846|75966545|FG004|STARTED|Period 2: Part 2 (Efficacy)||89||
59842033|NCT00261846|75966546|FG005|STARTED|Period 2: Part 2 (Efficacy)||5||
59842034|NCT00261846|75966547|FG006|STARTED|Period 2: Part 2 (Efficacy)||38||
59842035|NCT00261846|75966548|FG007|STARTED|Period 2: Part 2 (Efficacy)||50||
59842036|NCT00261846|75966549|FG008|STARTED|Period 2: Part 2 (Efficacy)||26||
59842037|NCT00261846|75966550|FG009|STARTED|Period 2: Part 2 (Efficacy)|1 participant from Part 1 (Bosutinib 600mg cohort) continued in Part 2 of the study.|79||
59842038|NCT00261846|75966551|FG010|STARTED|Period 2: Part 2 (Efficacy)||64||
60119886|NCT02577640|76241096|FG001|NOT COMPLETED|Dose Escalation Group 3||0||
60119887|NCT02577640|76241097|FG002|NOT COMPLETED|Dose Escalation Group 3||0||
60119888|NCT02577640|76241098|FG003|NOT COMPLETED|Dose Escalation Group 3||0||
60119889|NCT02577640|76241095|FG000|STARTED|Maximally Tolerated Dose||0||
60119890|NCT02577640|76241096|FG001|STARTED|Maximally Tolerated Dose||0||
60119891|NCT02577640|76241097|FG002|STARTED|Maximally Tolerated Dose||0||
60119892|NCT02577640|76241098|FG003|STARTED|Maximally Tolerated Dose||1||
59567827|NCT01213329|75670689|FG000|COMPLETED|Screening||25||
59567828|NCT01213329|75670690|FG001|COMPLETED|Screening||25||
59719129|NCT01208324|75838290|FG000|NOT COMPLETED|Pre-randomization of Patch||0||
59719130|NCT01208324|75838291|FG001|NOT COMPLETED|Pre-randomization of Patch||0||
59719131|NCT01208324|75838292|FG002|NOT COMPLETED|Pre-randomization of Patch||2||
59719132|NCT01208324|75838293|FG003|NOT COMPLETED|Pre-randomization of Patch||3||
59719133|NCT01208324|75838290|FG000|STARTED|Post-randomization of Patch||14|One participant withdrew post Test Day 2|
59719134|NCT01208324|75838291|FG001|STARTED|Post-randomization of Patch||15|One participant withdrew post Test Day 2|
59719135|NCT01208324|75838292|FG002|STARTED|Post-randomization of Patch||8|One participant withdrew post Test Day 2|
59719136|NCT01208324|75838293|FG003|STARTED|Post-randomization of Patch||5|One participant withdrew post Test Day 2|
59719137|NCT01208324|75838290|FG000|Test Day 3|Post-randomization of Patch||13||
59719138|NCT01208324|75838291|FG001|Test Day 3|Post-randomization of Patch||15||
59719139|NCT01208324|75838292|FG002|Test Day 3|Post-randomization of Patch||8||
59719140|NCT01208324|75838293|FG003|Test Day 3|Post-randomization of Patch||5||
59719141|NCT01208324|75838290|FG000|Test Day 4|Post-randomization of Patch||13||
59719142|NCT01208324|75838291|FG001|Test Day 4|Post-randomization of Patch||15||
59719143|NCT01208324|75838292|FG002|Test Day 4|Post-randomization of Patch||8||
59719144|NCT01208324|75838293|FG003|Test Day 4|Post-randomization of Patch||5||
59719145|NCT01208324|75838290|FG000|COMPLETED|Post-randomization of Patch||13||
59719146|NCT01208324|75838291|FG001|COMPLETED|Post-randomization of Patch||15||
59719147|NCT01208324|75838292|FG002|COMPLETED|Post-randomization of Patch||8||
59719148|NCT01208324|75838293|FG003|COMPLETED|Post-randomization of Patch||5||
59719149|NCT01208324|75838290|FG000|NOT COMPLETED|Post-randomization of Patch||1||
59719150|NCT01208324|75838291|FG001|NOT COMPLETED|Post-randomization of Patch||0||
59719151|NCT01208324|75838292|FG002|NOT COMPLETED|Post-randomization of Patch||0||
59719152|NCT01208324|75838293|FG003|NOT COMPLETED|Post-randomization of Patch||0||
59719153|NCT00880399|75838306|FG000|STARTED|Overall Study||108||
59842039|NCT00261846|75966552|FG011|STARTED|Period 2: Part 2 (Efficacy)||24||
59842040|NCT00261846|75966541|FG000|COMPLETED|Period 2: Part 2 (Efficacy)||0||
59842041|NCT00261846|75966542|FG001|COMPLETED|Period 2: Part 2 (Efficacy)||0||
60119893|NCT02577640|76241095|FG000|COMPLETED|Maximally Tolerated Dose||0||
60119894|NCT02577640|76241096|FG001|COMPLETED|Maximally Tolerated Dose||0||
60119895|NCT02577640|76241097|FG002|COMPLETED|Maximally Tolerated Dose||0||
60119896|NCT02577640|76241098|FG003|COMPLETED|Maximally Tolerated Dose||1||
60119897|NCT02577640|76241095|FG000|NOT COMPLETED|Maximally Tolerated Dose||0||
60119898|NCT02577640|76241096|FG001|NOT COMPLETED|Maximally Tolerated Dose||0||
60119899|NCT02577640|76241097|FG002|NOT COMPLETED|Maximally Tolerated Dose||0||
60119900|NCT02577640|76241098|FG003|NOT COMPLETED|Maximally Tolerated Dose||0||
60119901|NCT02581384|76241110|FG000|STARTED|Overall Study||3||
60119902|NCT02581384|76241111|FG001|STARTED|Overall Study||2||
60119903|NCT02581384|76241110|FG000|COMPLETED|Overall Study||3||
60119904|NCT02581384|76241111|FG001|COMPLETED|Overall Study||2||
60119905|NCT02581384|76241110|FG000|NOT COMPLETED|Overall Study||0||
60119906|NCT02581384|76241111|FG001|NOT COMPLETED|Overall Study||0||
60119907|NCT02696850|76241120|FG000|STARTED|Overall Study||40||
60119908|NCT02696850|76241121|FG001|STARTED|Overall Study||40||
60119909|NCT02696850|76241120|FG000|COMPLETED|Overall Study||29||
60119910|NCT02696850|76241121|FG001|COMPLETED|Overall Study||32||
60119911|NCT02696850|76241120|FG000|NOT COMPLETED|Overall Study||11||
60119912|NCT02696850|76241121|FG001|NOT COMPLETED|Overall Study||8||
60119913|NCT02594644|76241129|FG000|STARTED|Overall Study||16||
60119914|NCT02594644|76241130|FG001|STARTED|Overall Study||16||
60119915|NCT02594644|76241129|FG000|COMPLETED|Overall Study||16||
60119916|NCT02594644|76241130|FG001|COMPLETED|Overall Study||15||
60119917|NCT02594644|76241129|FG000|NOT COMPLETED|Overall Study||0||
60119918|NCT02594644|76241130|FG001|NOT COMPLETED|Overall Study||1||
60119919|NCT02596750|76241148|FG000|STARTED|Baseline||21|21 participants total started|21
60119920|NCT02596750|76241149|FG001|STARTED|Baseline||21|21 participants total started|21
60119921|NCT02596750|76241148|FG000|COMPLETED|Baseline||21|21 participants total completed|21
60119922|NCT02596750|76241149|FG001|COMPLETED|Baseline||21|21 participants total completed|21
60119923|NCT02596750|76241148|FG000|NOT COMPLETED|Baseline||0||0
59842042|NCT00261846|75966543|FG002|COMPLETED|Period 2: Part 2 (Efficacy)||0||
59842043|NCT00261846|75966544|FG003|COMPLETED|Period 2: Part 2 (Efficacy)||60||
59842044|NCT00261846|75966545|FG004|COMPLETED|Period 2: Part 2 (Efficacy)||39||
59842045|NCT00261846|75966546|FG005|COMPLETED|Period 2: Part 2 (Efficacy)||3||
59842046|NCT00261846|75966547|FG006|COMPLETED|Period 2: Part 2 (Efficacy)||16||
59842047|NCT00261846|75966548|FG007|COMPLETED|Period 2: Part 2 (Efficacy)||21||
59842048|NCT00261846|75966549|FG008|COMPLETED|Period 2: Part 2 (Efficacy)||12||
59842049|NCT00261846|75966550|FG009|COMPLETED|Period 2: Part 2 (Efficacy)||30||
59842050|NCT00261846|75966551|FG010|COMPLETED|Period 2: Part 2 (Efficacy)||15||
59842051|NCT00261846|75966552|FG011|COMPLETED|Period 2: Part 2 (Efficacy)||1||
59842052|NCT00261846|75966541|FG000|NOT COMPLETED|Period 2: Part 2 (Efficacy)||0||
59842053|NCT00261846|75966542|FG001|NOT COMPLETED|Period 2: Part 2 (Efficacy)||0||
59842054|NCT00261846|75966543|FG002|NOT COMPLETED|Period 2: Part 2 (Efficacy)||0||
59842055|NCT00261846|75966544|FG003|NOT COMPLETED|Period 2: Part 2 (Efficacy)||135||
59842056|NCT00261846|75966545|FG004|NOT COMPLETED|Period 2: Part 2 (Efficacy)||50||
59842057|NCT00261846|75966546|FG005|NOT COMPLETED|Period 2: Part 2 (Efficacy)||2||
59842058|NCT00261846|75966547|FG006|NOT COMPLETED|Period 2: Part 2 (Efficacy)||22||
59842059|NCT00261846|75966548|FG007|NOT COMPLETED|Period 2: Part 2 (Efficacy)||29||
59842060|NCT00261846|75966549|FG008|NOT COMPLETED|Period 2: Part 2 (Efficacy)||14||
59842061|NCT00261846|75966550|FG009|NOT COMPLETED|Period 2: Part 2 (Efficacy)||49||
59842062|NCT00261846|75966551|FG010|NOT COMPLETED|Period 2: Part 2 (Efficacy)||49||
59842063|NCT00261846|75966552|FG011|NOT COMPLETED|Period 2: Part 2 (Efficacy)||23||
59842064|NCT00169442|75966597|FG000|STARTED|Overall Study||119||
59842065|NCT00169442|75966598|FG001|STARTED|Overall Study||124||
59842066|NCT00169442|75966599|FG002|STARTED|Overall Study||167||
59842067|NCT00169442|75966600|FG003|STARTED|Overall Study||250||
59842068|NCT00169442|75966601|FG004|STARTED|Overall Study||42||
59842069|NCT00169442|75966602|FG005|STARTED|Overall Study||43||
59842070|NCT00169442|75966597|FG000|COMPLETED|Overall Study||119||
59842071|NCT00169442|75966598|FG001|COMPLETED|Overall Study||123||
59842072|NCT00169442|75966599|FG002|COMPLETED|Overall Study||166||
59842073|NCT00169442|75966600|FG003|COMPLETED|Overall Study||250||
59842074|NCT00169442|75966601|FG004|COMPLETED|Overall Study||41||
59842075|NCT00169442|75966602|FG005|COMPLETED|Overall Study||41||
59842076|NCT00169442|75966597|FG000|NOT COMPLETED|Overall Study||0||
59842077|NCT00169442|75966598|FG001|NOT COMPLETED|Overall Study||1||
59842078|NCT00169442|75966599|FG002|NOT COMPLETED|Overall Study||1||
59842079|NCT00169442|75966600|FG003|NOT COMPLETED|Overall Study||0||
59842080|NCT00169442|75966601|FG004|NOT COMPLETED|Overall Study||1||
59842081|NCT00169442|75966602|FG005|NOT COMPLETED|Overall Study||2||
59842082|NCT00261716|75966620|FG000|STARTED|Overall Study||17||
59842083|NCT00261716|75966621|FG001|STARTED|Overall Study||21||
59842084|NCT00261716|75966620|FG000|COMPLETED|Overall Study||11||
59842085|NCT00261716|75966621|FG001|COMPLETED|Overall Study||11||
59842086|NCT00261716|75966620|FG000|NOT COMPLETED|Overall Study||6||
59842087|NCT00261716|75966621|FG001|NOT COMPLETED|Overall Study||10||
59842088|NCT03809104|75966631|FG000|STARTED|Overall Study||43||
59842089|NCT03809104|75966631|FG000|COMPLETED|Overall Study||40||
59842090|NCT03809104|75966631|FG000|NOT COMPLETED|Overall Study||3||
59842091|NCT00203502|75966635|FG000|STARTED|Overall Study||40||
59842092|NCT00203502|75966635|FG000|COMPLETED|Overall Study||39||
59842093|NCT00203502|75966635|FG000|NOT COMPLETED|Overall Study||1||
59842094|NCT03799198|75966641|FG000|STARTED|Overall Study||100||
59842095|NCT03799198|75966642|FG001|STARTED|Overall Study||100||
59842096|NCT03799198|75966641|FG000|Full Analysis Set (FAS)|Overall Study||100||
59842097|NCT03799198|75966642|FG001|Full Analysis Set (FAS)|Overall Study||100||
60119924|NCT02596750|76241149|FG001|NOT COMPLETED|Baseline||0||0
59842098|NCT03799198|75966641|FG000|COMPLETED|Overall Study||96||
60119925|NCT02596750|76241148|FG000|STARTED|2 Minutes||21||21
60119926|NCT02596750|76241149|FG001|STARTED|2 Minutes||21||21
59842099|NCT03799198|75966642|FG001|COMPLETED|Overall Study||91||
59842100|NCT03799198|75966641|FG000|NOT COMPLETED|Overall Study||4||
59842101|NCT03799198|75966642|FG001|NOT COMPLETED|Overall Study||9||
59842102|NCT00232596|75966650|FG000|STARTED|6-Week Titration Phase||152||
59842103|NCT00232596|75966651|FG001|STARTED|6-Week Titration Phase||154||
59842104|NCT00232596|75966650|FG000|COMPLETED|6-Week Titration Phase||138||
59842105|NCT00232596|75966651|FG001|COMPLETED|6-Week Titration Phase||125||
59842106|NCT00232596|75966650|FG000|NOT COMPLETED|6-Week Titration Phase||14||
60119927|NCT02596750|76241148|FG000|COMPLETED|2 Minutes||21||21
60119928|NCT02596750|76241149|FG001|COMPLETED|2 Minutes||21||21
60119929|NCT02596750|76241148|FG000|NOT COMPLETED|2 Minutes||0||0
59842107|NCT00232596|75966651|FG001|NOT COMPLETED|6-Week Titration Phase||29||
59842108|NCT00232596|75966650|FG000|STARTED|12-Week Maintenance Phase||138||
59842109|NCT00232596|75966651|FG001|STARTED|12-Week Maintenance Phase||125||
59842110|NCT00232596|75966650|FG000|COMPLETED|12-Week Maintenance Phase|"One participant withdrew after being considered a completer and is listed as an early withdraw."|126||
59842111|NCT00232596|75966651|FG001|COMPLETED|12-Week Maintenance Phase||97||
59842112|NCT00232596|75966650|FG000|NOT COMPLETED|12-Week Maintenance Phase||12||
59842113|NCT00232596|75966651|FG001|NOT COMPLETED|12-Week Maintenance Phase||28||
60119930|NCT02596750|76241149|FG001|NOT COMPLETED|2 Minutes||0||0
60119931|NCT02596750|76241148|FG000|STARTED|5 Minutes||21||21
59842114|NCT00073918|75966669|FG000|STARTED|Overall Study||111||
59842115|NCT00073918|75966669|FG000|COMPLETED|Overall Study||107||
59842116|NCT00073918|75966669|FG000|NOT COMPLETED|Overall Study||4||
59842117|NCT00231894|75966675|FG000|STARTED|Overall Study||31||
59842118|NCT00231894|75966676|FG001|STARTED|Overall Study||25||
59842119|NCT00231894|75966675|FG000|COMPLETED|Overall Study||30||
59842120|NCT00231894|75966676|FG001|COMPLETED|Overall Study||24||
59842121|NCT00231894|75966675|FG000|NOT COMPLETED|Overall Study||1||
59842122|NCT00231894|75966676|FG001|NOT COMPLETED|Overall Study||1||
59996576|NCT02714569|76112507|FG004|Received at Least One Dose of Study Drug|Part A Second Intervention||3||
59996577|NCT02714569|76112508|FG005|Received at Least One Dose of Study Drug|Part A Second Intervention||3||
59996578|NCT02714569|76112509|FG006|Received at Least One Dose of Study Drug|Part A Second Intervention||0||
59996579|NCT02714569|76112510|FG007|Received at Least One Dose of Study Drug|Part A Second Intervention||0||
59996580|NCT02714569|76112511|FG008|Received at Least One Dose of Study Drug|Part A Second Intervention||0||
59996581|NCT02714569|76112512|FG009|Received at Least One Dose of Study Drug|Part A Second Intervention||0||
59996582|NCT02714569|76112513|FG010|Received at Least One Dose of Study Drug|Part A Second Intervention||0||
60119932|NCT02596750|76241149|FG001|STARTED|5 Minutes||21||21
60119933|NCT02596750|76241148|FG000|COMPLETED|5 Minutes||21||21
60119934|NCT02596750|76241149|FG001|COMPLETED|5 Minutes||21||21
60119935|NCT02596750|76241148|FG000|NOT COMPLETED|5 Minutes||0||0
60119936|NCT02596750|76241149|FG001|NOT COMPLETED|5 Minutes||0||0
60119937|NCT02596750|76241148|FG000|STARTED|10 Minutes||21||21
60119938|NCT02596750|76241149|FG001|STARTED|10 Minutes||21||21
60119939|NCT02596750|76241148|FG000|COMPLETED|10 Minutes||21||21
60119940|NCT02596750|76241149|FG001|COMPLETED|10 Minutes||21||21
60119941|NCT02596750|76241148|FG000|NOT COMPLETED|10 Minutes||0||0
60119942|NCT02596750|76241149|FG001|NOT COMPLETED|10 Minutes||0||0
60119943|NCT02596750|76241148|FG000|STARTED|30 Minutes||21||21
60119944|NCT02596750|76241149|FG001|STARTED|30 Minutes||21||21
60119945|NCT02596750|76241148|FG000|COMPLETED|30 Minutes||21||21
60119946|NCT02596750|76241149|FG001|COMPLETED|30 Minutes||21||21
60119947|NCT02596750|76241148|FG000|NOT COMPLETED|30 Minutes||0||0
60119948|NCT02596750|76241149|FG001|NOT COMPLETED|30 Minutes||0||0
60119949|NCT02601976|76241156|FG000|STARTED|Overall Study||64||
60119950|NCT02601976|76241156|FG000|COMPLETED|Overall Study||64||
60119951|NCT02601976|76241156|FG000|NOT COMPLETED|Overall Study||0||
60119952|NCT02603926|76241160|FG000|STARTED|Overall Study||6||
60119953|NCT02603926|76241160|FG000|COMPLETED|Overall Study||6||
60119954|NCT02603926|76241160|FG000|NOT COMPLETED|Overall Study||0||
60119955|NCT02605876|76241168|FG000|STARTED|Overall Study||25||
60119956|NCT02605876|76241169|FG001|STARTED|Overall Study||25||
60119957|NCT02605876|76241170|FG002|STARTED|Overall Study||25||
60119958|NCT02605876|76241168|FG000|COMPLETED|Overall Study||25||
60119959|NCT02605876|76241169|FG001|COMPLETED|Overall Study||25||
60119960|NCT02605876|76241170|FG002|COMPLETED|Overall Study||25||
59567829|NCT01213329|75670689|FG000|NOT COMPLETED|Screening||0||
59719154|NCT00880399|75838307|FG001|STARTED|Overall Study||113||
59719155|NCT00880399|75838308|FG002|STARTED|Overall Study||107||
59719156|NCT00880399|75838306|FG000|COMPLETED|Overall Study||77||
59719157|NCT00880399|75838307|FG001|COMPLETED|Overall Study||84||
59719158|NCT00880399|75838308|FG002|COMPLETED|Overall Study||81||
59719159|NCT00880399|75838306|FG000|NOT COMPLETED|Overall Study||31||
59719160|NCT00880399|75838307|FG001|NOT COMPLETED|Overall Study||29||
59719161|NCT00880399|75838308|FG002|NOT COMPLETED|Overall Study||26||
59996583|NCT02714569|76112503|FG000|COMPLETED|Part A Second Intervention||3||
59996584|NCT02714569|76112504|FG001|COMPLETED|Part A Second Intervention||2||
59719162|NCT01207388|75838316|FG000|STARTED|Overall Study||116||
59719163|NCT01207388|75838316|FG000|COMPLETED|Overall Study||48||
59996585|NCT02714569|76112505|FG002|COMPLETED|Part A Second Intervention||3||
59996586|NCT02714569|76112506|FG003|COMPLETED|Part A Second Intervention||3||
59996587|NCT02714569|76112507|FG004|COMPLETED|Part A Second Intervention||3||
59996588|NCT02714569|76112508|FG005|COMPLETED|Part A Second Intervention||3||
59996589|NCT02714569|76112509|FG006|COMPLETED|Part A Second Intervention||0||
59996590|NCT02714569|76112510|FG007|COMPLETED|Part A Second Intervention||0||
59996591|NCT02714569|76112511|FG008|COMPLETED|Part A Second Intervention||0||
59996592|NCT02714569|76112512|FG009|COMPLETED|Part A Second Intervention||0||
59996593|NCT02714569|76112513|FG010|COMPLETED|Part A Second Intervention||0||
59996594|NCT02714569|76112503|FG000|NOT COMPLETED|Part A Second Intervention||0||
59996595|NCT02714569|76112504|FG001|NOT COMPLETED|Part A Second Intervention||1||
59996596|NCT02714569|76112505|FG002|NOT COMPLETED|Part A Second Intervention||0||
59996597|NCT02714569|76112506|FG003|NOT COMPLETED|Part A Second Intervention||0||
60119961|NCT02605876|76241168|FG000|NOT COMPLETED|Overall Study||0||
60119962|NCT02605876|76241169|FG001|NOT COMPLETED|Overall Study||0||
60119963|NCT02605876|76241170|FG002|NOT COMPLETED|Overall Study||0||
60119964|NCT02606500|76241180|FG000|STARTED|Overall Study||35||
60119965|NCT02606500|76241181|FG001|STARTED|Overall Study||35||
60119966|NCT02606500|76241180|FG000|COMPLETED|Overall Study||35||
60119967|NCT02606500|76241181|FG001|COMPLETED|Overall Study||35||
59842123|NCT00203424|75966688|FG000|STARTED|Treatment Period|23 subjects registered for treatment, 1 withdrew consent after registration,22 received treatment.|22||
59842124|NCT00203424|75966688|FG000|COMPLETED|Treatment Period|Of 11 pts that did not complete treatment,5 stopped due to adverse event and entered followup period|11||
59842125|NCT00203424|75966688|FG000|NOT COMPLETED|Treatment Period||11||
59842126|NCT00203424|75966688|FG000|STARTED|Follow-up Period|followup includes 11 pts that completed treatment + 5 pts who stopped treatment due to adverse event|16||
59842127|NCT00203424|75966688|FG000|COMPLETED|Follow-up Period||10||
59842128|NCT00203424|75966688|FG000|NOT COMPLETED|Follow-up Period||6||
59842129|NCT00203268|75966692|FG000|STARTED|Early Treatment||13||
59842130|NCT00203268|75966692|FG000|COMPLETED|Early Treatment||9||
59842131|NCT00203268|75966692|FG000|NOT COMPLETED|Early Treatment||4||
59842132|NCT00203268|75966692|FG000|STARTED|Late Treatment||9||
59842133|NCT00203268|75966692|FG000|COMPLETED|Late Treatment||9||
59842134|NCT00203268|75966692|FG000|NOT COMPLETED|Late Treatment||0||
59842135|NCT00168818|75966701|FG000|STARTED|Overall Study||1146||
59842136|NCT00168818|75966702|FG001|STARTED|Overall Study||1163||
59842137|NCT00168818|75966703|FG002|STARTED|Overall Study||1154||
59842138|NCT00168818|75966701|FG000|COMPLETED|Overall Study||1029||
59842139|NCT00168818|75966702|FG001|COMPLETED|Overall Study||1054||
59842140|NCT00168818|75966703|FG002|COMPLETED|Overall Study||1030||
59842141|NCT00168818|75966701|FG000|NOT COMPLETED|Overall Study||117||
59842142|NCT00168818|75966702|FG001|NOT COMPLETED|Overall Study||109||
59842143|NCT00168818|75966703|FG002|NOT COMPLETED|Overall Study||124||
59842144|NCT00168818|75966701|FG000|STARTED|Treatment||1146||
59842145|NCT00168818|75966702|FG001|STARTED|Treatment||1163||
59842146|NCT00168818|75966703|FG002|STARTED|Treatment||1154||
59842147|NCT00168818|75966701|FG000|COMPLETED|Treatment||1013||
59842148|NCT00168818|75966702|FG001|COMPLETED|Treatment||1012||
59842149|NCT00168818|75966703|FG002|COMPLETED|Treatment||1021||
59842150|NCT00168818|75966701|FG000|NOT COMPLETED|Treatment||133||
59842151|NCT00168818|75966702|FG001|NOT COMPLETED|Treatment||151||
59842152|NCT00168818|75966703|FG002|NOT COMPLETED|Treatment||133||
59842153|NCT00260832|75966713|FG000|STARTED|Overall Study||243||
59842154|NCT00260832|75966714|FG001|STARTED|Overall Study||242||
59842155|NCT00260832|75966713|FG000|COMPLETED|Overall Study|At study completion, these subjects chose to remain on treatment|15||
59842156|NCT00260832|75966714|FG001|COMPLETED|Overall Study|At study completion, these subjects chose to remain on treatment|31||
59842157|NCT00260832|75966713|FG000|NOT COMPLETED|Overall Study||228||
59842158|NCT00260832|75966714|FG001|NOT COMPLETED|Overall Study||211||
59842159|NCT00168038|75966720|FG000|STARTED|Overall Study||57||
59842160|NCT00168038|75966720|FG000|COMPLETED|Overall Study||55||
59719164|NCT01207388|75838316|FG000|NOT COMPLETED|Overall Study||68||
59719165|NCT01206764|75838328|FG000|STARTED|Overall Study||142||
59719166|NCT01206764|75838328|FG000|COMPLETED|Overall Study||4||
59719167|NCT01206764|75838328|FG000|NOT COMPLETED|Overall Study||138||
59719168|NCT00894322|75838335|FG000|STARTED|Overall Study||30||
59719169|NCT00894322|75838336|FG001|STARTED|Overall Study||23||
59719170|NCT00894322|75838337|FG002|STARTED|Overall Study||12||
59842161|NCT00168038|75966720|FG000|NOT COMPLETED|Overall Study||2||
59842162|NCT00167414|75966724|FG000|STARTED|Overall Study||49||
59842163|NCT00167414|75966724|FG000|COMPLETED|Overall Study||39||
59842164|NCT00167414|75966724|FG000|NOT COMPLETED|Overall Study||10||
59842165|NCT00166712|75966730|FG000|STARTED|Overall Study|Consented:Randomized-Group 1. Given MMF prior to surgery, Alemtuzumab & TAC (Prograf) day of surgery|24||
59842166|NCT00166712|75966731|FG001|STARTED|Overall Study|Consented: Randomized-Group 2. Given Sirolimus & MMF prior to surgery, Alemtuzumab day of surgery.|16||
59842167|NCT00166712|75966730|FG000|Phase 1|Overall Study|Evaluated for rejection at 6months post-transplant|22||
59842168|NCT00166712|75966731|FG001|Phase 1|Overall Study|Evaluated at 6 month post-transplant to potentially be weaned off Sirolimus.|12||
59842169|NCT00166712|75966730|FG000|Phase 2a|Overall Study|Subjects who remained on Prograf at 6mo post-transplant.|19||
60119968|NCT02606500|76241180|FG000|NOT COMPLETED|Overall Study||0||
59719171|NCT00894322|75838335|FG000|COMPLETED|Overall Study||29||
59719172|NCT00894322|75838336|FG001|COMPLETED|Overall Study||23||
59719173|NCT00894322|75838337|FG002|COMPLETED|Overall Study||12||
59842170|NCT00166712|75966731|FG001|Phase 2a|Overall Study|Subject who remained on Sirolimus at 6 months post-transplant.|12||
59842171|NCT00166712|75966730|FG000|Phase 2b|Overall Study|Subjects converted to Sirolimus post-transplant.|3||
59842172|NCT00166712|75966731|FG001|Phase 2b|Overall Study|Subjects weaned off Sirolimus|0||
59842173|NCT00166712|75966730|FG000|Phase 3|Overall Study|Subjects from Phase 2b who were weaned off Sirolimus @ 12 months post-transplant.|0||
59842174|NCT00166712|75966731|FG001|Phase 3|Overall Study|# weaned off Sirolimus at 12 months post-transplant.|0||
59842175|NCT00166712|75966730|FG000|COMPLETED|Overall Study|Completed study participation.|22||
59842176|NCT00166712|75966731|FG001|COMPLETED|Overall Study|Completed study participation.|11||
59842177|NCT00166712|75966730|FG000|NOT COMPLETED|Overall Study||2||
59842178|NCT00166712|75966731|FG001|NOT COMPLETED|Overall Study||5||
59842179|NCT00073528|75966743|FG000|STARTED|Overall Study||644|All participants included in the Intent-To-Treat (ITT) population|
59842180|NCT00073528|75966744|FG001|STARTED|Overall Study||642|All participants included in the Intent-To-Treat (ITT) population|
59842181|NCT00073528|75966743|FG000|COMPLETED|Overall Study||14||
59842182|NCT00073528|75966744|FG001|COMPLETED|Overall Study||14||
59842183|NCT00073528|75966743|FG000|NOT COMPLETED|Overall Study||630||
59842184|NCT00073528|75966744|FG001|NOT COMPLETED|Overall Study||628||
59842185|NCT03801148|75966754|FG000|STARTED|Period 1 (2 Days)||31||
59842186|NCT03801148|75966755|FG001|STARTED|Period 1 (2 Days)||31||
59842187|NCT03801148|75966756|FG002|STARTED|Period 1 (2 Days)||30||
59842188|NCT03801148|75966757|FG003|STARTED|Period 1 (2 Days)||30||
59842189|NCT03801148|75966754|FG000|COMPLETED|Period 1 (2 Days)||30||
59842190|NCT03801148|75966755|FG001|COMPLETED|Period 1 (2 Days)||30||
59842191|NCT03801148|75966756|FG002|COMPLETED|Period 1 (2 Days)||30||
59842192|NCT03801148|75966757|FG003|COMPLETED|Period 1 (2 Days)||30||
59842193|NCT03801148|75966754|FG000|NOT COMPLETED|Period 1 (2 Days)||1||
59842194|NCT03801148|75966755|FG001|NOT COMPLETED|Period 1 (2 Days)||1||
59842195|NCT03801148|75966756|FG002|NOT COMPLETED|Period 1 (2 Days)||0||
59842196|NCT03801148|75966757|FG003|NOT COMPLETED|Period 1 (2 Days)||0||
59842197|NCT03801148|75966754|FG000|STARTED|Washout Period (at Least 5 Days)||30||
59842198|NCT03801148|75966755|FG001|STARTED|Washout Period (at Least 5 Days)||30||
59842199|NCT03801148|75966756|FG002|STARTED|Washout Period (at Least 5 Days)||30||
59842200|NCT03801148|75966757|FG003|STARTED|Washout Period (at Least 5 Days)||30||
59842201|NCT03801148|75966754|FG000|COMPLETED|Washout Period (at Least 5 Days)||30||
59842202|NCT03801148|75966755|FG001|COMPLETED|Washout Period (at Least 5 Days)||30||
59842203|NCT03801148|75966756|FG002|COMPLETED|Washout Period (at Least 5 Days)||29||
59842204|NCT03801148|75966757|FG003|COMPLETED|Washout Period (at Least 5 Days)||29||
59842205|NCT03801148|75966754|FG000|NOT COMPLETED|Washout Period (at Least 5 Days)||0||
59842206|NCT03801148|75966755|FG001|NOT COMPLETED|Washout Period (at Least 5 Days)||0||
59842207|NCT03801148|75966756|FG002|NOT COMPLETED|Washout Period (at Least 5 Days)||1||
59842208|NCT03801148|75966757|FG003|NOT COMPLETED|Washout Period (at Least 5 Days)||1||
59842209|NCT03801148|75966754|FG000|STARTED|Period 2 (2 Days)||30||
59842210|NCT03801148|75966755|FG001|STARTED|Period 2 (2 Days)||30||
59842211|NCT03801148|75966756|FG002|STARTED|Period 2 (2 Days)||29||
59842212|NCT03801148|75966757|FG003|STARTED|Period 2 (2 Days)||29||
59842213|NCT03801148|75966754|FG000|COMPLETED|Period 2 (2 Days)||30||
59842214|NCT03801148|75966755|FG001|COMPLETED|Period 2 (2 Days)||30||
59842215|NCT03801148|75966756|FG002|COMPLETED|Period 2 (2 Days)||29||
59842216|NCT03801148|75966757|FG003|COMPLETED|Period 2 (2 Days)||29||
59842217|NCT03801148|75966754|FG000|NOT COMPLETED|Period 2 (2 Days)||0||
59842218|NCT03801148|75966755|FG001|NOT COMPLETED|Period 2 (2 Days)||0||
59842219|NCT03801148|75966756|FG002|NOT COMPLETED|Period 2 (2 Days)||0||
59842220|NCT03801148|75966757|FG003|NOT COMPLETED|Period 2 (2 Days)||0||
59842221|NCT03801148|75966754|FG000|STARTED|Follow-Up (12 Days)||30||
59842222|NCT03801148|75966755|FG001|STARTED|Follow-Up (12 Days)||30||
59842223|NCT03801148|75966756|FG002|STARTED|Follow-Up (12 Days)||29||
59842224|NCT03801148|75966757|FG003|STARTED|Follow-Up (12 Days)||29||
59842225|NCT03801148|75966754|FG000|COMPLETED|Follow-Up (12 Days)||30||
59842226|NCT03801148|75966755|FG001|COMPLETED|Follow-Up (12 Days)||29||
59842227|NCT03801148|75966756|FG002|COMPLETED|Follow-Up (12 Days)||28||
59842228|NCT03801148|75966757|FG003|COMPLETED|Follow-Up (12 Days)||29||
59842229|NCT03801148|75966754|FG000|NOT COMPLETED|Follow-Up (12 Days)||0||
59842230|NCT03801148|75966755|FG001|NOT COMPLETED|Follow-Up (12 Days)||1||
59842231|NCT03801148|75966756|FG002|NOT COMPLETED|Follow-Up (12 Days)||1||
59842232|NCT03801148|75966757|FG003|NOT COMPLETED|Follow-Up (12 Days)||0||
59842233|NCT00072280|75966769|FG000|STARTED|Treatment||3||
59842234|NCT00072280|75966770|FG001|STARTED|Treatment||4||
59842235|NCT00072280|75966769|FG000|COMPLETED|Treatment||2||
59842236|NCT00072280|75966770|FG001|COMPLETED|Treatment||2||
59842237|NCT00072280|75966769|FG000|NOT COMPLETED|Treatment||1||
59842238|NCT00072280|75966770|FG001|NOT COMPLETED|Treatment||2||
59842239|NCT00072280|75966769|FG000|STARTED|Follow-up||2||
59842240|NCT00072280|75966770|FG001|STARTED|Follow-up||2||
59842241|NCT00072280|75966769|FG000|COMPLETED|Follow-up||0||
59842242|NCT00072280|75966770|FG001|COMPLETED|Follow-up||0||
59842243|NCT00072280|75966769|FG000|NOT COMPLETED|Follow-up||2||
59842244|NCT00072280|75966770|FG001|NOT COMPLETED|Follow-up||2||
59842245|NCT00071812|75966779|FG000|STARTED|24-Week Double-Blind Period||69||
59842246|NCT00071812|75966780|FG001|STARTED|24-Week Double-Blind Period||72||
59842247|NCT00071812|75966781|FG002|STARTED|24-Week Double-Blind Period||71||
59842248|NCT00071812|75966782|FG003|STARTED|24-Week Double-Blind Period||71||
59842249|NCT00071812|75966779|FG000|COMPLETED|24-Week Double-Blind Period||59||
59842250|NCT00071812|75966780|FG001|COMPLETED|24-Week Double-Blind Period||66||
59842251|NCT00071812|75966781|FG002|COMPLETED|24-Week Double-Blind Period||63||
59842252|NCT00071812|75966782|FG003|COMPLETED|24-Week Double-Blind Period||60||
59842253|NCT00071812|75966779|FG000|NOT COMPLETED|24-Week Double-Blind Period||10||
59842254|NCT00071812|75966780|FG001|NOT COMPLETED|24-Week Double-Blind Period||6||
59842255|NCT00071812|75966781|FG002|NOT COMPLETED|24-Week Double-Blind Period||8||
59842256|NCT00071812|75966782|FG003|NOT COMPLETED|24-Week Double-Blind Period||11||
59842257|NCT00071812|75966779|FG000|STARTED|24-Week Open-Label Extension Period|Of 59: 56 switched to 10 mg/kg; 3 elected not to continue in the open-label extension.|0||
59842258|NCT00071812|75966780|FG001|STARTED|24-Week Open-Label Extension Period|Of 66: 53 switched to 10 mg/kg; 2 elected not continue in the open-label extension.|11||
59842259|NCT00071812|75966781|FG002|STARTED|24-Week Open-Label Extension Period|Of 63: 53 switched to 10 mg/kg; 2 elected not continue in the open-label extension.|8||
59842260|NCT00071812|75966782|FG003|STARTED|24-Week Open-Label Extension Period|Of 60: 56 continued with 10 mg/kg; 4 elected not to continue in the open-label extension.|218||
59842261|NCT00071812|75966779|FG000|COMPLETED|24-Week Open-Label Extension Period||0||
59842262|NCT00071812|75966780|FG001|COMPLETED|24-Week Open-Label Extension Period||11||
60119969|NCT02606500|76241181|FG001|NOT COMPLETED|Overall Study||0||
60119970|NCT02606734|76241187|FG000|STARTED|Overall Study||44||
60119971|NCT02606734|76241187|FG000|COMPLETED|Overall Study||44||
60119972|NCT02606734|76241187|FG000|NOT COMPLETED|Overall Study||0||
60119973|NCT02607124|76241191|FG000|STARTED|Overall Study|11 participants were enrolled however 1 participant withdrew before starting study treatment.|10||
60119974|NCT02607124|76241191|FG000|COMPLETED|Overall Study||10||
60119975|NCT02607124|76241191|FG000|NOT COMPLETED|Overall Study||0||
60119976|NCT02609308|76241198|FG000|STARTED|Overall Study||10||
60119977|NCT02609308|76241199|FG001|STARTED|Overall Study||11||
60119978|NCT02609308|76241198|FG000|COMPLETED|Overall Study||10||
60119979|NCT02609308|76241199|FG001|COMPLETED|Overall Study||11||
60119980|NCT02609308|76241198|FG000|NOT COMPLETED|Overall Study||0||
60119981|NCT02609308|76241199|FG001|NOT COMPLETED|Overall Study||0||
60119982|NCT02610634|76241207|FG000|STARTED|Overall Study||60||
60119983|NCT02610634|76241208|FG001|STARTED|Overall Study||40||
60119984|NCT02610634|76241207|FG000|COMPLETED|Overall Study||60||
60119985|NCT02610634|76241208|FG001|COMPLETED|Overall Study||40||
60119986|NCT02610634|76241207|FG000|NOT COMPLETED|Overall Study||0||
60119987|NCT02610634|76241208|FG001|NOT COMPLETED|Overall Study||0||
60119988|NCT02610868|76241214|FG000|STARTED|MYOBLOC: Treatment Session 1||187||
60119989|NCT02610868|76241214|FG000|COMPLETED|MYOBLOC: Treatment Session 1||180||
60119990|NCT02610868|76241214|FG000|NOT COMPLETED|MYOBLOC: Treatment Session 1||7||
60119991|NCT02610868|76241214|FG000|STARTED|MYOBLOC: Treatment Session 2||177||
60119992|NCT02610868|76241214|FG000|COMPLETED|MYOBLOC: Treatment Session 2||165||
60119993|NCT02610868|76241214|FG000|NOT COMPLETED|MYOBLOC: Treatment Session 2||12||
60119994|NCT02610868|76241214|FG000|STARTED|MYOBLOC: Treatment Session 3||50||
60119995|NCT02610868|76241214|FG000|COMPLETED|MYOBLOC: Treatment Session 3||43||
60119996|NCT02610868|76241214|FG000|NOT COMPLETED|MYOBLOC: Treatment Session 3||7||
60119997|NCT02610868|76241214|FG000|STARTED|MYOBLOC: Treatment Session 4||24||
60119998|NCT02610868|76241214|FG000|COMPLETED|MYOBLOC: Treatment Session 4||22||
60119999|NCT02610868|76241214|FG000|NOT COMPLETED|MYOBLOC: Treatment Session 4||2||
59842263|NCT00071812|75966781|FG002|COMPLETED|24-Week Open-Label Extension Period||7||
59842264|NCT00071812|75966782|FG003|COMPLETED|24-Week Open-Label Extension Period||178||
59842265|NCT00071812|75966779|FG000|NOT COMPLETED|24-Week Open-Label Extension Period||0||
59842266|NCT00071812|75966780|FG001|NOT COMPLETED|24-Week Open-Label Extension Period||0||
59842267|NCT00071812|75966781|FG002|NOT COMPLETED|24-Week Open-Label Extension Period||1||
59842268|NCT00071812|75966782|FG003|NOT COMPLETED|24-Week Open-Label Extension Period||40||
59842269|NCT00071110|75966796|FG000|STARTED|Overall Study||28||
59842270|NCT00071110|75966797|FG001|STARTED|Overall Study||29||
59842271|NCT00071110|75966796|FG000|COMPLETED|Overall Study||28||
59842272|NCT00071110|75966797|FG001|COMPLETED|Overall Study||25||
59842273|NCT00071110|75966796|FG000|NOT COMPLETED|Overall Study||0||
59842274|NCT00071110|75966797|FG001|NOT COMPLETED|Overall Study||4||
59842275|NCT00071032|75966805|FG000|STARTED|Overall Study||1007||
59842276|NCT00071032|75966806|FG001|STARTED|Overall Study||1009||
59842277|NCT00071032|75966805|FG000|COMPLETED|Overall Study||998||
59842278|NCT00071032|75966806|FG001|COMPLETED|Overall Study||1001||
59842279|NCT00071032|75966805|FG000|NOT COMPLETED|Overall Study||9||
59842280|NCT00071032|75966806|FG001|NOT COMPLETED|Overall Study||8||
59842281|NCT00259610|75966817|FG000|STARTED|Overall Study||244||
59842282|NCT00259610|75966818|FG001|STARTED|Overall Study||132||
59842283|NCT00259610|75966819|FG002|STARTED|Overall Study||255||
59842284|NCT00259610|75966820|FG003|STARTED|Overall Study||124||
59842285|NCT00259610|75966817|FG000|COMPLETED|Overall Study||168||
59842286|NCT00259610|75966818|FG001|COMPLETED|Overall Study||86||
59842287|NCT00259610|75966819|FG002|COMPLETED|Overall Study||182||
59842288|NCT00259610|75966820|FG003|COMPLETED|Overall Study||81||
59842289|NCT00259610|75966817|FG000|NOT COMPLETED|Overall Study||76||
59842290|NCT00259610|75966818|FG001|NOT COMPLETED|Overall Study||46||
59842291|NCT00259610|75966819|FG002|NOT COMPLETED|Overall Study||73||
59842292|NCT00259610|75966820|FG003|NOT COMPLETED|Overall Study||43||
59842293|NCT00165776|75966834|FG000|STARTED|Overall Study||35||
59842294|NCT00165776|75966835|FG001|STARTED|Overall Study||34||
59842295|NCT00165776|75966836|FG002|STARTED|Overall Study||33||
59842296|NCT00165776|75966837|FG003|STARTED|Overall Study||31||
59842297|NCT00165776|75966834|FG000|COMPLETED|Overall Study||31||
59842298|NCT00165776|75966835|FG001|COMPLETED|Overall Study||33||
59842299|NCT00165776|75966836|FG002|COMPLETED|Overall Study||31||
59842300|NCT00165776|75966837|FG003|COMPLETED|Overall Study||29||
59842301|NCT00165776|75966834|FG000|NOT COMPLETED|Overall Study||4||
59842302|NCT00165776|75966835|FG001|NOT COMPLETED|Overall Study||1||
59842303|NCT00165776|75966836|FG002|NOT COMPLETED|Overall Study||2||
59842304|NCT00165776|75966837|FG003|NOT COMPLETED|Overall Study||2||
59842305|NCT00165698|75966849|FG000|STARTED|Overall Study||120||
59842306|NCT00165698|75966850|FG001|STARTED|Overall Study||120||
59842307|NCT00165698|75966849|FG000|COMPLETED|Overall Study||112||
59842308|NCT00165698|75966850|FG001|COMPLETED|Overall Study||105||
59842309|NCT00165698|75966849|FG000|NOT COMPLETED|Overall Study||8||
59842310|NCT00165698|75966850|FG001|NOT COMPLETED|Overall Study||15||
59842311|NCT00225758|75966856|FG000|STARTED|Overall Study||27||
59842312|NCT00225758|75966856|FG000|COMPLETED|Overall Study||23||
59842313|NCT00225758|75966856|FG000|NOT COMPLETED|Overall Study||4||
60120000|NCT02614222|76241236|FG000|STARTED|Overall Study||13||
60120001|NCT02614222|76241237|FG001|STARTED|Overall Study||14||
60120002|NCT02614222|76241236|FG000|COMPLETED|Overall Study||13||
60120003|NCT02614222|76241237|FG001|COMPLETED|Overall Study||14||
59719174|NCT00894322|75838335|FG000|NOT COMPLETED|Overall Study||1||
59719175|NCT00894322|75838336|FG001|NOT COMPLETED|Overall Study||0||
59719176|NCT00894322|75838337|FG002|NOT COMPLETED|Overall Study||0||
59719177|NCT00596635|75838350|FG000|STARTED|Overall Study||17||
59719178|NCT00596635|75838351|FG001|STARTED|Overall Study||20||
59719179|NCT00596635|75838352|FG002|STARTED|Overall Study||19||
59719180|NCT00596635|75838350|FG000|COMPLETED|Overall Study||10||
59719181|NCT00596635|75838351|FG001|COMPLETED|Overall Study||7||
59719182|NCT00596635|75838352|FG002|COMPLETED|Overall Study||11||
59719183|NCT00596635|75838350|FG000|NOT COMPLETED|Overall Study||7||
59719184|NCT00596635|75838351|FG001|NOT COMPLETED|Overall Study||13||
59719185|NCT00596635|75838352|FG002|NOT COMPLETED|Overall Study||8||
59719186|NCT00894166|75838368|FG000|STARTED|Overall Study||132||
59719187|NCT00894166|75838369|FG001|STARTED|Overall Study||109||
59719188|NCT00894166|75838370|FG002|STARTED|Overall Study||112||
59842314|NCT00259298|75966862|FG000|STARTED|Overall Study||12||
59842315|NCT00259298|75966862|FG000|Received at Least 1 Dose of Study Drug|Overall Study||10||
59842316|NCT00259298|75966862|FG000|COMPLETED|Overall Study||9||
59842317|NCT00259298|75966862|FG000|NOT COMPLETED|Overall Study||3||
59842318|NCT03789292|75966868|FG000|STARTED|Treatment Period I (Week 0 to Week 26)||324||
59842319|NCT03789292|75966869|FG001|STARTED|Treatment Period I (Week 0 to Week 26)||324||
59842320|NCT03789292|75966870|FG002|STARTED|Treatment Period I (Week 0 to Week 26)||0||
59842321|NCT03789292|75966868|FG000|COMPLETED|Treatment Period I (Week 0 to Week 26)||303||
59842322|NCT03789292|75966869|FG001|COMPLETED|Treatment Period I (Week 0 to Week 26)||305||
59719189|NCT00894166|75838371|FG003|STARTED|Overall Study||114||
59719190|NCT00894166|75838372|FG004|STARTED|Overall Study||34||
60120004|NCT02614222|76241236|FG000|NOT COMPLETED|Overall Study||0||
59842323|NCT03789292|75966870|FG002|COMPLETED|Treatment Period I (Week 0 to Week 26)||0||
59842324|NCT03789292|75966868|FG000|NOT COMPLETED|Treatment Period I (Week 0 to Week 26)||21||
59842325|NCT03789292|75966869|FG001|NOT COMPLETED|Treatment Period I (Week 0 to Week 26)||19||
59842326|NCT03789292|75966870|FG002|NOT COMPLETED|Treatment Period I (Week 0 to Week 26)||0||
59842327|NCT03789292|75966868|FG000|STARTED|Treatment Period II (Week 26 to Week 52)||303||
59842328|NCT03789292|75966869|FG001|STARTED|Treatment Period II (Week 26 to Week 52)|Patients who had administrated Humira SC during Treatment Period 1 has been devided into 2 groups - maintaining Humira SC and switched to CT-P17.|153||
59842329|NCT03789292|75966870|FG002|STARTED|Treatment Period II (Week 26 to Week 52)|Patients who had administrated Humira SC during Treatment Period 1 has been devided into 2 groups - maintaining Humira SC and switched to CT-P17.|152||
59842330|NCT03789292|75966868|FG000|COMPLETED|Treatment Period II (Week 26 to Week 52)||287||
59842331|NCT03789292|75966869|FG001|COMPLETED|Treatment Period II (Week 26 to Week 52)||147||
59842332|NCT03789292|75966870|FG002|COMPLETED|Treatment Period II (Week 26 to Week 52)||143||
59842333|NCT03789292|75966868|FG000|NOT COMPLETED|Treatment Period II (Week 26 to Week 52)||16||
59842334|NCT03789292|75966869|FG001|NOT COMPLETED|Treatment Period II (Week 26 to Week 52)||6||
59842335|NCT03789292|75966870|FG002|NOT COMPLETED|Treatment Period II (Week 26 to Week 52)||9||
59842336|NCT03781336|75966886|FG000|STARTED|Overall Study||45||
59842337|NCT03781336|75966887|FG001|STARTED|Overall Study||37||
59842338|NCT03781336|75966886|FG000|COMPLETED|Overall Study|All participants were included in the analysis (Intent to treat)|43||
59842339|NCT03781336|75966887|FG001|COMPLETED|Overall Study|All participants were included in the analysis (Intent to treat)|35||
59842340|NCT03781336|75966886|FG000|NOT COMPLETED|Overall Study||2||
59842341|NCT03781336|75966887|FG001|NOT COMPLETED|Overall Study||2||
59842342|NCT03780400|75966893|FG000|STARTED|Overall Study||60||
59842343|NCT03780400|75966893|FG000|COMPLETED|Overall Study||53||
59842344|NCT03780400|75966893|FG000|NOT COMPLETED|Overall Study||7||
59842345|NCT03780244|75966899|FG000|STARTED|Overall Study||59||
59842346|NCT03780244|75966900|FG001|STARTED|Overall Study||21||
59842347|NCT03780244|75966899|FG000|COMPLETED|Overall Study||58||
59842348|NCT03780244|75966900|FG001|COMPLETED|Overall Study||21||
59842349|NCT03780244|75966899|FG000|NOT COMPLETED|Overall Study||1||
59842350|NCT03780244|75966900|FG001|NOT COMPLETED|Overall Study||0||
59842351|NCT03785548|75966908|FG000|STARTED|Overall Study||73||
59842352|NCT03785548|75966909|FG001|STARTED|Overall Study||74||
59842353|NCT03785548|75966908|FG000|COMPLETED|Overall Study||71||
59842354|NCT03785548|75966909|FG001|COMPLETED|Overall Study||74||
59842355|NCT03785548|75966908|FG000|NOT COMPLETED|Overall Study||2||
59842356|NCT03785548|75966909|FG001|NOT COMPLETED|Overall Study||0||
59842357|NCT00141297|75966917|FG000|STARTED|Overall Study||3||
59842358|NCT00141297|75966918|FG001|STARTED|Overall Study||3||
59842359|NCT00141297|75966919|FG002|STARTED|Overall Study||7||
59842360|NCT00141297|75966920|FG003|STARTED|Overall Study||3||
59842361|NCT00141297|75966921|FG004|STARTED|Overall Study||22||
59842362|NCT00141297|75966922|FG005|STARTED|Overall Study||3||
59842363|NCT00141297|75966923|FG006|STARTED|Overall Study||3||
59842364|NCT00141297|75966924|FG007|STARTED|Overall Study||4||
59842365|NCT00141297|75966925|FG008|STARTED|Overall Study||20||
59842366|NCT00141297|75966926|FG009|STARTED|Overall Study||6||
59842367|NCT00141297|75966917|FG000|COMPLETED|Overall Study||0||
59842368|NCT00141297|75966918|FG001|COMPLETED|Overall Study||0||
59842369|NCT00141297|75966919|FG002|COMPLETED|Overall Study||0||
59842370|NCT00141297|75966920|FG003|COMPLETED|Overall Study||0||
59842371|NCT00141297|75966921|FG004|COMPLETED|Overall Study||0||
59842372|NCT00141297|75966922|FG005|COMPLETED|Overall Study||0||
59842373|NCT00141297|75966923|FG006|COMPLETED|Overall Study||0||
59842374|NCT00141297|75966924|FG007|COMPLETED|Overall Study||0||
59842375|NCT00141297|75966925|FG008|COMPLETED|Overall Study||0||
59842376|NCT00141297|75966926|FG009|COMPLETED|Overall Study||0||
59842377|NCT00141297|75966917|FG000|NOT COMPLETED|Overall Study||3||
59842378|NCT00141297|75966918|FG001|NOT COMPLETED|Overall Study||3||
59842379|NCT00141297|75966919|FG002|NOT COMPLETED|Overall Study||7||
59842380|NCT00141297|75966920|FG003|NOT COMPLETED|Overall Study||3||
59842381|NCT00141297|75966921|FG004|NOT COMPLETED|Overall Study||22||
59842382|NCT00141297|75966922|FG005|NOT COMPLETED|Overall Study||3||
59842383|NCT00141297|75966923|FG006|NOT COMPLETED|Overall Study||3||
59842384|NCT00141297|75966924|FG007|NOT COMPLETED|Overall Study||4||
59842385|NCT00141297|75966925|FG008|NOT COMPLETED|Overall Study||20||
59842386|NCT00141297|75966926|FG009|NOT COMPLETED|Overall Study||6||
59842387|NCT00141219|75966961|FG000|STARTED|Overall Study||162||
59842388|NCT00141219|75966962|FG001|STARTED|Overall Study||78||
59842389|NCT00141219|75966961|FG000|COMPLETED|Overall Study||138||
59842390|NCT00141219|75966962|FG001|COMPLETED|Overall Study||62||
59842391|NCT00141219|75966961|FG000|NOT COMPLETED|Overall Study||24||
59842392|NCT00141219|75966962|FG001|NOT COMPLETED|Overall Study||16||
59842393|NCT00162266|75966971|FG000|STARTED|Double-Blind Period||115||
59842394|NCT00162266|75966972|FG001|STARTED|Double-Blind Period||105||
59842395|NCT00162266|75966973|FG002|STARTED|Double-Blind Period||119||
59842396|NCT00162266|75966974|FG003|STARTED|Double-Blind Period||0||
59842397|NCT00162266|75966971|FG000|Completed Day 1 to Day 181|Double-Blind Period||98||
59842398|NCT00162266|75966972|FG001|Completed Day 1 to Day 181|Double-Blind Period||80||
59842399|NCT00162266|75966973|FG002|Completed Day 1 to Day 181|Double-Blind Period||78||
59842400|NCT00162266|75966974|FG003|Completed Day 1 to Day 181|Double-Blind Period||0||
59842401|NCT00162266|75966971|FG000|COMPLETED|Double-Blind Period||90||
59842402|NCT00162266|75966972|FG001|COMPLETED|Double-Blind Period||74||
59842403|NCT00162266|75966973|FG002|COMPLETED|Double-Blind Period||71||
59842404|NCT00162266|75966974|FG003|COMPLETED|Double-Blind Period||0||
59842405|NCT00162266|75966971|FG000|NOT COMPLETED|Double-Blind Period||25||
59842406|NCT00162266|75966972|FG001|NOT COMPLETED|Double-Blind Period||31||
59842407|NCT00162266|75966973|FG002|NOT COMPLETED|Double-Blind Period||48||
59842408|NCT00162266|75966974|FG003|NOT COMPLETED|Double-Blind Period||0||
59842409|NCT00162266|75966971|FG000|STARTED|Open-Label Period||0||
59842410|NCT00162266|75966972|FG001|STARTED|Open-Label Period||0||
59842411|NCT00162266|75966973|FG002|STARTED|Open-Label Period||0||
59842412|NCT00162266|75966974|FG003|STARTED|Open-Label Period||219||
59842413|NCT00162266|75966971|FG000|COMPLETED|Open-Label Period||0||
59842414|NCT00162266|75966972|FG001|COMPLETED|Open-Label Period||0||
59842415|NCT00162266|75966973|FG002|COMPLETED|Open-Label Period||0||
59842416|NCT00162266|75966974|FG003|COMPLETED|Open-Label Period||82||
59842417|NCT00162266|75966971|FG000|NOT COMPLETED|Open-Label Period||0||
59842418|NCT00162266|75966972|FG001|NOT COMPLETED|Open-Label Period||0||
59842419|NCT00162266|75966973|FG002|NOT COMPLETED|Open-Label Period||0||
59842420|NCT00162266|75966974|FG003|NOT COMPLETED|Open-Label Period||137||
59842421|NCT00225212|75967026|FG000|STARTED|Overall Study||35||
59842422|NCT00225212|75967026|FG000|COMPLETED|Overall Study||29||
59842423|NCT00225212|75967026|FG000|NOT COMPLETED|Overall Study||6||
59842424|NCT00162032|75967032|FG000|STARTED|Overall Study||329||
59842425|NCT00162032|75967033|FG001|STARTED|Overall Study||116||
59842426|NCT00162032|75967032|FG000|COMPLETED|Overall Study|Completed is all subjects who completed 3 yr FU whether or not they were seen in the previous year.|324||
59842427|NCT00162032|75967033|FG001|COMPLETED|Overall Study|Completed is all subjects who completed 3 yr FU whether or not they were seen in the previous year.|114||
59842428|NCT00162032|75967032|FG000|NOT COMPLETED|Overall Study||5||
59842429|NCT00162032|75967033|FG001|NOT COMPLETED|Overall Study||2||
59842430|NCT00258674|75967047|FG000|STARTED|Overall Study||597||
59842431|NCT00258674|75967048|FG001|STARTED|Overall Study||811||
59842432|NCT00258674|75967049|FG002|STARTED|Overall Study||602||
59842433|NCT00258674|75967047|FG000|COMPLETED|Overall Study||565||
59842434|NCT00258674|75967048|FG001|COMPLETED|Overall Study||758||
59842435|NCT00258674|75967049|FG002|COMPLETED|Overall Study||568||
59842436|NCT00258674|75967047|FG000|NOT COMPLETED|Overall Study||32||
59842437|NCT00258674|75967048|FG001|NOT COMPLETED|Overall Study||53||
59842438|NCT00258674|75967049|FG002|NOT COMPLETED|Overall Study||34||
59842439|NCT00258440|75967060|FG000|STARTED|Overall Study||1||
59842440|NCT00258440|75967061|FG001|STARTED|Overall Study||0||
59842441|NCT00258440|75967062|FG002|STARTED|Overall Study||6||
59842442|NCT00258440|75967060|FG000|COMPLETED|Overall Study||1||
59842443|NCT00258440|75967061|FG001|COMPLETED|Overall Study||0||
59842444|NCT00258440|75967062|FG002|COMPLETED|Overall Study||5||
59842445|NCT00258440|75967060|FG000|NOT COMPLETED|Overall Study||0||
59842446|NCT00258440|75967061|FG001|NOT COMPLETED|Overall Study||0||
59842447|NCT00258440|75967062|FG002|NOT COMPLETED|Overall Study||1||
59842448|NCT00224120|75967072|FG000|STARTED|Overall Study||233||
60120005|NCT02614222|76241237|FG001|NOT COMPLETED|Overall Study||0||
60120006|NCT02614924|76241245|FG000|STARTED|Overall Study||20||
60120007|NCT02614924|76241246|FG001|STARTED|Overall Study||20||
60120008|NCT02614924|76241245|FG000|COMPLETED|Overall Study||20||
59842449|NCT00224120|75967073|FG001|STARTED|Overall Study||229||
59842450|NCT00224120|75967072|FG000|COMPLETED|Overall Study||211||
59842451|NCT00224120|75967073|FG001|COMPLETED|Overall Study||205||
59842452|NCT00224120|75967072|FG000|NOT COMPLETED|Overall Study||22||
59842453|NCT00224120|75967073|FG001|NOT COMPLETED|Overall Study||24||
59842454|NCT00257660|75967081|FG000|STARTED|Overall Study||55||
59842455|NCT00257660|75967082|FG001|STARTED|Overall Study||61||
59842456|NCT00257660|75967081|FG000|COMPLETED|Overall Study||45||
59842457|NCT00257660|75967082|FG001|COMPLETED|Overall Study||38||
59842458|NCT00257660|75967081|FG000|NOT COMPLETED|Overall Study||10||
59842459|NCT00257660|75967082|FG001|NOT COMPLETED|Overall Study||23||
59842460|NCT00224042|75967090|FG000|STARTED|Overall Study||26||
59842461|NCT00224042|75967091|FG001|STARTED|Overall Study||26||
59842462|NCT00224042|75967090|FG000|COMPLETED|Overall Study||20||
59842463|NCT00224042|75967091|FG001|COMPLETED|Overall Study||20||
59842464|NCT00224042|75967090|FG000|NOT COMPLETED|Overall Study||6||
59842465|NCT00224042|75967091|FG001|NOT COMPLETED|Overall Study||6||
59842466|NCT00160706|75967097|FG000|STARTED|Overall Study||310||
60120009|NCT02614924|76241246|FG001|COMPLETED|Overall Study||20||
60120010|NCT02614924|76241245|FG000|NOT COMPLETED|Overall Study||0||
60120011|NCT02614924|76241246|FG001|NOT COMPLETED|Overall Study||0||
59567830|NCT01213329|75670690|FG001|NOT COMPLETED|Screening||0||
60120012|NCT02615158|76241256|FG000|STARTED|Overall Study||94||
60120013|NCT02615158|76241257|FG001|STARTED|Overall Study||92||
59842467|NCT00160706|75967097|FG000|COMPLETED|Overall Study||24||
59842468|NCT00160706|75967097|FG000|NOT COMPLETED|Overall Study||286||
59842469|NCT00257192|75967103|FG000|STARTED|Overall Study||193||
59842470|NCT00257192|75967104|FG001|STARTED|Overall Study|Includes 1 subject randomized but not treated|91||
59842471|NCT00257192|75967103|FG000|Received Study Treatment|Overall Study||193||
59842472|NCT00257192|75967104|FG001|Received Study Treatment|Overall Study||90||
59842473|NCT00257192|75967103|FG000|COMPLETED|Overall Study||135||
59842474|NCT00257192|75967104|FG001|COMPLETED|Overall Study||52||
59842475|NCT00257192|75967103|FG000|NOT COMPLETED|Overall Study||58||
59842476|NCT00257192|75967104|FG001|NOT COMPLETED|Overall Study||39||
59842477|NCT00256724|75967112|FG000|STARTED|Overall Study||23||
59842478|NCT00256724|75967113|FG001|STARTED|Overall Study||24||
59842479|NCT00256724|75967112|FG000|COMPLETED|Overall Study||18||
59842480|NCT00256724|75967113|FG001|COMPLETED|Overall Study||16||
59842481|NCT00256724|75967112|FG000|NOT COMPLETED|Overall Study||5||
59842482|NCT00256724|75967113|FG001|NOT COMPLETED|Overall Study||8||
59842483|NCT00157820|75967122|FG000|STARTED|Randomized||118||
59842484|NCT00157820|75967123|FG001|STARTED|Randomized||116||
59842485|NCT00157820|75967124|FG002|STARTED|Randomized||120||
59842486|NCT00157820|75967122|FG000|COMPLETED|Randomized||111||
59842487|NCT00157820|75967123|FG001|COMPLETED|Randomized||111||
59842488|NCT00157820|75967124|FG002|COMPLETED|Randomized||112||
59842489|NCT00157820|75967122|FG000|NOT COMPLETED|Randomized||7||
59842490|NCT00157820|75967123|FG001|NOT COMPLETED|Randomized||5||
59842491|NCT00157820|75967124|FG002|NOT COMPLETED|Randomized||8||
59842492|NCT00157820|75967122|FG000|STARTED|1st 8 Month||111||
59842493|NCT00157820|75967123|FG001|STARTED|1st 8 Month||111||
59842494|NCT00157820|75967124|FG002|STARTED|1st 8 Month||112||
59842495|NCT00157820|75967122|FG000|COMPLETED|1st 8 Month||103||
59842496|NCT00157820|75967123|FG001|COMPLETED|1st 8 Month||99||
59842497|NCT00157820|75967124|FG002|COMPLETED|1st 8 Month||106||
59842498|NCT00157820|75967122|FG000|NOT COMPLETED|1st 8 Month||8||
59842499|NCT00157820|75967123|FG001|NOT COMPLETED|1st 8 Month||12||
59842500|NCT00157820|75967124|FG002|NOT COMPLETED|1st 8 Month||6||
59842501|NCT00157820|75967122|FG000|STARTED|1 Month Wash Out Period||103||
59842502|NCT00157820|75967123|FG001|STARTED|1 Month Wash Out Period|2 patients had crossed over prematurely in SC sim period, that are now carried to DC true period|101||
59842503|NCT00157820|75967124|FG002|STARTED|1 Month Wash Out Period|2 patients had crossed over prematurely in DC true period, that are now carried to SC sim period|108||
59842504|NCT00157820|75967122|FG000|COMPLETED|1 Month Wash Out Period||103||
59842505|NCT00157820|75967123|FG001|COMPLETED|1 Month Wash Out Period||101||
59842506|NCT00157820|75967124|FG002|COMPLETED|1 Month Wash Out Period||108||
59842507|NCT00157820|75967122|FG000|NOT COMPLETED|1 Month Wash Out Period||0||
59842508|NCT00157820|75967123|FG001|NOT COMPLETED|1 Month Wash Out Period||0||
59842509|NCT00157820|75967124|FG002|NOT COMPLETED|1 Month Wash Out Period||0||
59842510|NCT00157820|75967122|FG000|STARTED|2nd 8 Months||103||
59842511|NCT00157820|75967123|FG001|STARTED|2nd 8 Months||101||
59842512|NCT00157820|75967124|FG002|STARTED|2nd 8 Months||108||
59719191|NCT00894166|75838373|FG005|STARTED|Overall Study||36||
59719192|NCT00894166|75838374|FG006|STARTED|Overall Study||35||
59719193|NCT00894166|75838375|FG007|STARTED|Overall Study||34||
59719194|NCT00894166|75838368|FG000|COMPLETED|Overall Study||71||
59719195|NCT00894166|75838369|FG001|COMPLETED|Overall Study||46||
59719196|NCT00894166|75838370|FG002|COMPLETED|Overall Study||50||
59719197|NCT00894166|75838371|FG003|COMPLETED|Overall Study||45||
59719198|NCT00894166|75838372|FG004|COMPLETED|Overall Study||10||
59719199|NCT00894166|75838373|FG005|COMPLETED|Overall Study||20||
59719200|NCT00894166|75838374|FG006|COMPLETED|Overall Study||19||
59719201|NCT00894166|75838375|FG007|COMPLETED|Overall Study||0||
59719202|NCT00894166|75838368|FG000|NOT COMPLETED|Overall Study||61||
59719203|NCT00894166|75838369|FG001|NOT COMPLETED|Overall Study||63||
59719204|NCT00894166|75838370|FG002|NOT COMPLETED|Overall Study||62||
59719205|NCT00894166|75838371|FG003|NOT COMPLETED|Overall Study||69||
59719206|NCT00894166|75838372|FG004|NOT COMPLETED|Overall Study||24||
59719207|NCT00894166|75838373|FG005|NOT COMPLETED|Overall Study||16||
59719208|NCT00894166|75838374|FG006|NOT COMPLETED|Overall Study||16||
59719209|NCT00894166|75838375|FG007|NOT COMPLETED|Overall Study||34||
59719210|NCT00880165|75838400|FG000|STARTED|Overall Study||148||
59719211|NCT00880165|75838401|FG001|STARTED|Overall Study||148||
59719212|NCT00880165|75838400|FG000|COMPLETED|Overall Study||86||
59719213|NCT00880165|75838401|FG001|COMPLETED|Overall Study||98||
59719214|NCT00880165|75838400|FG000|NOT COMPLETED|Overall Study||62||
59719215|NCT00880165|75838401|FG001|NOT COMPLETED|Overall Study||50||
59719216|NCT01165229|75838409|FG000|STARTED|Overall Study||6950||
59719217|NCT01165229|75838410|FG001|STARTED|Overall Study||6950||
59719218|NCT01165229|75838409|FG000|COMPLETED|Overall Study||5770||
59719219|NCT01165229|75838410|FG001|COMPLETED|Overall Study||5760||
59719220|NCT01165229|75838409|FG000|NOT COMPLETED|Overall Study||1180||
59719221|NCT01165229|75838410|FG001|NOT COMPLETED|Overall Study||1190||
59719222|NCT00596011|75838448|FG000|STARTED|Overall Study||49||
59719223|NCT00596011|75838449|FG001|STARTED|Overall Study||48||
59719224|NCT00596011|75838448|FG000|COMPLETED|Overall Study||36||
59719225|NCT00596011|75838449|FG001|COMPLETED|Overall Study||38||
59842513|NCT00157820|75967122|FG000|COMPLETED|2nd 8 Months||98||
59842514|NCT00157820|75967123|FG001|COMPLETED|2nd 8 Months||88||
59842515|NCT00157820|75967124|FG002|COMPLETED|2nd 8 Months||94||
59842516|NCT00157820|75967122|FG000|NOT COMPLETED|2nd 8 Months||5||
59842517|NCT00157820|75967123|FG001|NOT COMPLETED|2nd 8 Months||13||
59842518|NCT00157820|75967124|FG002|NOT COMPLETED|2nd 8 Months||14||
59842519|NCT00223808|75967136|FG000|STARTED|Overall Study||22||
59842520|NCT00223808|75967137|FG001|STARTED|Overall Study||22||
59842521|NCT00223808|75967138|FG002|STARTED|Overall Study||23||
59842522|NCT00223808|75967136|FG000|COMPLETED|Overall Study|Completed at least the immediate post-treatment testing with 5 or more hours of treatment.|19||
59842523|NCT00223808|75967137|FG001|COMPLETED|Overall Study|Completed at least the immediate post-treatment testing with 5 or more hours of treatment.|17||
59842524|NCT00223808|75967138|FG002|COMPLETED|Overall Study|Completed at least the immediate post-treatment testing with 5 or more hours of treatment.|18||
59842525|NCT00223808|75967136|FG000|NOT COMPLETED|Overall Study||3||
59842526|NCT00223808|75967137|FG001|NOT COMPLETED|Overall Study||5||
59842527|NCT00223808|75967138|FG002|NOT COMPLETED|Overall Study||5||
59842528|NCT00154310|75967148|FG000|STARTED|Overall Study|"Started indicates enrolled participants. Randomized participants for two arms are 154 and 146."|155||
59842529|NCT00154310|75967149|FG001|STARTED|Overall Study||145||
59842530|NCT00154310|75967148|FG000|COMPLETED|Overall Study||118||
59842531|NCT00154310|75967149|FG001|COMPLETED|Overall Study||117||
59842532|NCT00154310|75967148|FG000|NOT COMPLETED|Overall Study||37||
59842533|NCT00154310|75967149|FG001|NOT COMPLETED|Overall Study||28||
59842534|NCT03771352|75967155|FG000|STARTED|Overall Study||55||110
59842535|NCT03771352|75967155|FG000|COMPLETED|Overall Study|The fellow eye of one subject was not implanted per the discretion of the investigator.|51||101
59842536|NCT03771352|75967155|FG000|NOT COMPLETED|Overall Study||4||9
59842537|NCT03770728|75967163|FG000|STARTED|Overall Study||79||
59842538|NCT03770728|75967164|FG001|STARTED|Overall Study||78||
59842539|NCT03770728|75967165|FG002|STARTED|Overall Study||77||
59842540|NCT03770728|75967166|FG003|STARTED|Overall Study||78||
59842541|NCT03770728|75967163|FG000|Safety Population|Overall Study||79|Participants who received at least 1 dose or part of a dose of the Investigational Medicinal Product (IMP), analyzed according to the treatment actually received.|
59842542|NCT03770728|75967164|FG001|Safety Population|Overall Study||78|Participants who received at least 1 dose or part of a dose of the Investigational Medicinal Product (IMP), analyzed according to the treatment actually received.|
59842543|NCT03770728|75967165|FG002|Safety Population|Overall Study|For safety analysis, participants were included in the treatment group that they were exposed for longer duration. 3 participants randomized to Efpeglenatide 6 mg received 4 mg dose for longer duration; and considered in Efpeglenatide 4 mg group for safety analysis.|80|Participants who received at least 1 dose or part of a dose of the Investigational Medicinal Product (IMP), analyzed according to the treatment actually received.|
59842544|NCT03770728|75967166|FG003|Safety Population|Overall Study||75|Participants who received at least 1 dose or part of a dose of the Investigational Medicinal Product (IMP), analyzed according to the treatment actually received.|
59842545|NCT03770728|75967163|FG000|COMPLETED|Overall Study||41||
59842546|NCT03770728|75967164|FG001|COMPLETED|Overall Study||47||
59842547|NCT03770728|75967165|FG002|COMPLETED|Overall Study||45||
59842548|NCT03770728|75967166|FG003|COMPLETED|Overall Study||43||
59842549|NCT03770728|75967163|FG000|NOT COMPLETED|Overall Study||38||
59842550|NCT03770728|75967164|FG001|NOT COMPLETED|Overall Study||31||
59842551|NCT03770728|75967165|FG002|NOT COMPLETED|Overall Study||32||
59842552|NCT03770728|75967166|FG003|NOT COMPLETED|Overall Study||35||
59842553|NCT03769090|75967181|FG000|STARTED|Overall Study||1016||
59842554|NCT03769090|75967182|FG001|STARTED|Overall Study||1057||
59842555|NCT03769090|75967183|FG002|STARTED|Overall Study||1059||
59842556|NCT03769090|75967181|FG000|COMPLETED|Overall Study||915||
59842557|NCT03769090|75967182|FG001|COMPLETED|Overall Study||933||
59842558|NCT03769090|75967183|FG002|COMPLETED|Overall Study||916||
59842559|NCT03769090|75967181|FG000|NOT COMPLETED|Overall Study||101||
59842560|NCT03769090|75967182|FG001|NOT COMPLETED|Overall Study||124||
59842561|NCT03769090|75967183|FG002|NOT COMPLETED|Overall Study||143||
59842562|NCT01136980|75967196|FG000|STARTED|Overall Study||42||
59842563|NCT01136980|75967197|FG001|STARTED|Overall Study||87||
59842564|NCT01136980|75967196|FG000|COMPLETED|Overall Study||28||
59842565|NCT01136980|75967197|FG001|COMPLETED|Overall Study||76||
59842566|NCT01136980|75967196|FG000|NOT COMPLETED|Overall Study||14||
59842567|NCT01136980|75967197|FG001|NOT COMPLETED|Overall Study||11||
59842568|NCT03559270|75967207|FG000|STARTED|Overall Study||117||
59842569|NCT03559270|75967208|FG001|STARTED|Overall Study||119||
59842570|NCT03559270|75967209|FG002|STARTED|Overall Study||108||
59842571|NCT03559270|75967210|FG003|STARTED|Overall Study||30||
59842572|NCT03559270|75967207|FG000|Received at Least One Dose of Study Drug|Overall Study||117||
59842573|NCT03559270|75967208|FG001|Received at Least One Dose of Study Drug|Overall Study||119||
59842574|NCT03559270|75967209|FG002|Received at Least One Dose of Study Drug|Overall Study||108||
59842575|NCT03559270|75967210|FG003|Received at Least One Dose of Study Drug|Overall Study||30||
59842576|NCT03559270|75967207|FG000|COMPLETED|Overall Study||0||
59842577|NCT03559270|75967208|FG001|COMPLETED|Overall Study||1||
59842578|NCT03559270|75967209|FG002|COMPLETED|Overall Study||0||
59842579|NCT03559270|75967210|FG003|COMPLETED|Overall Study||0||
59842580|NCT03559270|75967207|FG000|NOT COMPLETED|Overall Study||117||
59842581|NCT03559270|75967208|FG001|NOT COMPLETED|Overall Study||118||
59842582|NCT03559270|75967209|FG002|NOT COMPLETED|Overall Study||108||
59842583|NCT03559270|75967210|FG003|NOT COMPLETED|Overall Study||30||
59842584|NCT03467932|75967229|FG000|STARTED|Overall Study||69||
59842585|NCT03467932|75967230|FG001|STARTED|Overall Study||68||
59842586|NCT03467932|75967231|FG002|STARTED|Overall Study||69||
59842587|NCT03467932|75967232|FG003|STARTED|Overall Study||66||
59842588|NCT03467932|75967233|FG004|STARTED|Overall Study||20||
59842589|NCT03467932|75967234|FG005|STARTED|Overall Study||15||
59842590|NCT03467932|75967235|FG006|STARTED|Overall Study||17||
59842591|NCT03467932|75967236|FG007|STARTED|Overall Study||18||
59842592|NCT03467932|75967237|FG008|STARTED|Overall Study||15||
59842593|NCT03467932|75967238|FG009|STARTED|Overall Study||16||
59842594|NCT03467932|75967229|FG000|COMPLETED|Overall Study||62||
59842595|NCT03467932|75967230|FG001|COMPLETED|Overall Study||58||
59842596|NCT03467932|75967231|FG002|COMPLETED|Overall Study||58||
59842597|NCT03467932|75967232|FG003|COMPLETED|Overall Study||56||
59842598|NCT03467932|75967233|FG004|COMPLETED|Overall Study||19||
59842599|NCT03467932|75967234|FG005|COMPLETED|Overall Study||13||
59842600|NCT03467932|75967235|FG006|COMPLETED|Overall Study||15||
59842601|NCT03467932|75967236|FG007|COMPLETED|Overall Study||16||
59842602|NCT03467932|75967237|FG008|COMPLETED|Overall Study||11||
59842603|NCT03467932|75967238|FG009|COMPLETED|Overall Study||14||
59842604|NCT03467932|75967229|FG000|NOT COMPLETED|Overall Study||7||
59842605|NCT03467932|75967230|FG001|NOT COMPLETED|Overall Study||10||
59842606|NCT03467932|75967231|FG002|NOT COMPLETED|Overall Study||11||
59842607|NCT03467932|75967232|FG003|NOT COMPLETED|Overall Study||10||
59842608|NCT03467932|75967233|FG004|NOT COMPLETED|Overall Study||1||
59842609|NCT03467932|75967234|FG005|NOT COMPLETED|Overall Study||2||
59842610|NCT03467932|75967235|FG006|NOT COMPLETED|Overall Study||2||
59842611|NCT03467932|75967236|FG007|NOT COMPLETED|Overall Study||2||
59842612|NCT03467932|75967237|FG008|NOT COMPLETED|Overall Study||4||
59842613|NCT03467932|75967238|FG009|NOT COMPLETED|Overall Study||2||
59842614|NCT00114777|75967265|FG000|STARTED|Randomization to Month 36||184||
59842615|NCT00114777|75967266|FG001|STARTED|Randomization to Month 36||175||
59842616|NCT00114777|75967267|FG002|STARTED|Randomization to Month 36||184||
59842617|NCT00114777|75967265|FG000|COMPLETED|Randomization to Month 36||109||
59842618|NCT00114777|75967266|FG001|COMPLETED|Randomization to Month 36||114||
59842619|NCT00114777|75967267|FG002|COMPLETED|Randomization to Month 36||100||
59842620|NCT00114777|75967265|FG000|NOT COMPLETED|Randomization to Month 36||75||
59842621|NCT00114777|75967266|FG001|NOT COMPLETED|Randomization to Month 36||61||
59842622|NCT00114777|75967267|FG002|NOT COMPLETED|Randomization to Month 36||84||
59842623|NCT00114777|75967265|FG000|STARTED|Long-Term Extension to Month 84||104||
59842624|NCT00114777|75967266|FG001|STARTED|Long-Term Extension to Month 84||113||
59842625|NCT00114777|75967267|FG002|STARTED|Long-Term Extension to Month 84||87||
59842626|NCT00114777|75967265|FG000|COMPLETED|Long-Term Extension to Month 84||74||
59842627|NCT00114777|75967266|FG001|COMPLETED|Long-Term Extension to Month 84||84||
59842628|NCT00114777|75967267|FG002|COMPLETED|Long-Term Extension to Month 84||57||
59842629|NCT00114777|75967265|FG000|NOT COMPLETED|Long-Term Extension to Month 84||30||
59842630|NCT00114777|75967266|FG001|NOT COMPLETED|Long-Term Extension to Month 84||29||
59842631|NCT00114777|75967267|FG002|NOT COMPLETED|Long-Term Extension to Month 84||30||
59842632|NCT00139737|75967276|FG000|STARTED|Overall Study||344||
59842633|NCT00139737|75967276|FG000|Received Treatment|Overall Study||331||
59842634|NCT00139737|75967276|FG000|COMPLETED|Overall Study||3||
60120014|NCT02615158|76241258|FG002|STARTED|Overall Study||91||
59719226|NCT00596011|75838448|FG000|NOT COMPLETED|Overall Study||13||
59719227|NCT00596011|75838449|FG001|NOT COMPLETED|Overall Study||10||
59719228|NCT01163747|75838457|FG000|STARTED|Overall Study||31||
59719229|NCT01163747|75838458|FG001|STARTED|Overall Study||60||
59719230|NCT01163747|75838457|FG000|Per Protocol Population|Overall Study|Participants who received at least 1 dose of study treatment excluding major protocol violators.|27||
59719231|NCT01163747|75838458|FG001|Per Protocol Population|Overall Study|Participants who received at least 1 dose of study treatment excluding major protocol violators.|54||
59719232|NCT01163747|75838457|FG000|COMPLETED|Overall Study||25||
59719233|NCT01163747|75838458|FG001|COMPLETED|Overall Study||49||
59719234|NCT01163747|75838457|FG000|NOT COMPLETED|Overall Study||6||
59719235|NCT01163747|75838458|FG001|NOT COMPLETED|Overall Study||11||
59842635|NCT00139737|75967276|FG000|NOT COMPLETED|Overall Study||341||
59842636|NCT00122187|75967282|FG000|STARTED|Overall Study||4||
59842637|NCT00122187|75967283|FG001|STARTED|Overall Study||4||
59842638|NCT00122187|75967282|FG000|Matched by Colonoscopy Volume|Overall Study||4||
59842639|NCT00122187|75967283|FG001|Matched by Colonoscopy Volume|Overall Study||4||
59842640|NCT00122187|75967282|FG000|Randomized to Intervention or Usual Care|Overall Study||4||
59842641|NCT00122187|75967283|FG001|Randomized to Intervention or Usual Care|Overall Study||4||
59719236|NCT01163279|75838466|FG000|STARTED|Overall Study||10||
59719237|NCT01163279|75838467|FG001|STARTED|Overall Study||9||
59842642|NCT00122187|75967282|FG000|Intervention Implemented|Overall Study||3||
59842643|NCT00122187|75967283|FG001|Intervention Implemented|Overall Study||4||
59842644|NCT00122187|75967282|FG000|Post-intervention Data Collection|Overall Study||2||
59842645|NCT00122187|75967283|FG001|Post-intervention Data Collection|Overall Study||2||
59842646|NCT00122187|75967282|FG000|COMPLETED|Overall Study||2||
59842647|NCT00122187|75967283|FG001|COMPLETED|Overall Study||2||
59842648|NCT00122187|75967282|FG000|NOT COMPLETED|Overall Study||2||
59842649|NCT00122187|75967283|FG001|NOT COMPLETED|Overall Study||2||
59842650|NCT00139659|75967293|FG000|STARTED|Overall Study|1 subject randomized was DC'd prior to receiving inhaled insulin but received subcutaneous insulin|146||
59842651|NCT00139659|75967294|FG001|STARTED|Overall Study|1 subject randomized DC'd before receiving subcutaneous insulin and is not included in # of subjects|141||
59842652|NCT00139659|75967293|FG000|COMPLETED|Overall Study||106||
59842653|NCT00139659|75967294|FG001|COMPLETED|Overall Study||123||
59842654|NCT00139659|75967293|FG000|NOT COMPLETED|Overall Study||40||
59842655|NCT00139659|75967294|FG001|NOT COMPLETED|Overall Study||18||
59842656|NCT00137631|75967306|FG000|STARTED|Overall Study||164||
59842657|NCT00137631|75967307|FG001|STARTED|Overall Study||174||
59842658|NCT00137631|75967306|FG000|Complete 3-month Follow-up|Overall Study||120||
59842659|NCT00137631|75967307|FG001|Complete 3-month Follow-up|Overall Study||125||
59842660|NCT00137631|75967306|FG000|Completed 6-month Follow-up|Overall Study|7 participants who were lost to follow-up at 3-months were retained at 6-months|127||
59842661|NCT00137631|75967307|FG001|Completed 6-month Follow-up|Overall Study|8 participants who were lost to follow-up at 3-months were retained at 6-months|133||
59842662|NCT00137631|75967306|FG000|COMPLETED|Overall Study||127||
59842663|NCT00137631|75967307|FG001|COMPLETED|Overall Study||133||
59842664|NCT00137631|75967306|FG000|NOT COMPLETED|Overall Study||37||
59842665|NCT00137631|75967307|FG001|NOT COMPLETED|Overall Study||41||
59842666|NCT00114231|75967315|FG000|STARTED|Overall Study||62||
59842667|NCT00114231|75967316|FG001|STARTED|Overall Study||28||
59842668|NCT00114231|75967315|FG000|COMPLETED|Overall Study||53||
59842669|NCT00114231|75967316|FG001|COMPLETED|Overall Study||26||
59842670|NCT00114231|75967315|FG000|NOT COMPLETED|Overall Study||9||
59842671|NCT00114231|75967316|FG001|NOT COMPLETED|Overall Study||2||
59842672|NCT00113919|75967321|FG000|STARTED|Overall Study||14||
59842673|NCT00113919|75967321|FG000|COMPLETED|Overall Study||0||
59842674|NCT00113919|75967321|FG000|NOT COMPLETED|Overall Study||14||
59842675|NCT00113841|75967327|FG000|STARTED|Overall Study||16||
59842676|NCT00113841|75967328|FG001|STARTED|Overall Study||17||
59842677|NCT00113841|75967327|FG000|COMPLETED|Overall Study||15||
59842678|NCT00113841|75967328|FG001|COMPLETED|Overall Study||15||
59842679|NCT00113841|75967327|FG000|NOT COMPLETED|Overall Study||1||
59842680|NCT00113841|75967328|FG001|NOT COMPLETED|Overall Study||2||
59842681|NCT00113607|75967336|FG000|STARTED|Overall Study|Number of randomized participants|335||
59842682|NCT00113607|75967337|FG001|STARTED|Overall Study|Number of randomized participants|337||
59842683|NCT00113607|75967336|FG000|COMPLETED|Overall Study||0||
59842684|NCT00113607|75967337|FG001|COMPLETED|Overall Study||0||
59842685|NCT00113607|75967336|FG000|NOT COMPLETED|Overall Study||335||
59842686|NCT00113607|75967337|FG001|NOT COMPLETED|Overall Study||337||
59842687|NCT00113529|75967344|FG000|STARTED|Overall Study|Phase 2 included 4 subjects from Phase 1 and 31 from Phase 2, for a total of 35 subjects.|35||
59842688|NCT00113529|75967344|FG000|COMPLETED|Overall Study|Subject discontinued from the study and continued treatment on commercially available sunitinib.|1||
59842689|NCT00113529|75967344|FG000|NOT COMPLETED|Overall Study||34||
59842690|NCT00134901|75967350|FG000|STARTED|Overall Study||39||
59842691|NCT00134901|75967351|FG001|STARTED|Overall Study||42||
59842692|NCT00134901|75967350|FG000|COMPLETED|Overall Study||22||
59842693|NCT00134901|75967351|FG001|COMPLETED|Overall Study||27||
59842694|NCT00134901|75967350|FG000|NOT COMPLETED|Overall Study||17||
59842695|NCT00134901|75967351|FG001|NOT COMPLETED|Overall Study||15||
59842696|NCT00122109|75967361|FG000|STARTED|Overall Study|ITT|61||
59842697|NCT00122109|75967362|FG001|STARTED|Overall Study|ITT|64||
59842698|NCT00122109|75967361|FG000|COMPLETED|Overall Study||55||
59842699|NCT00122109|75967362|FG001|COMPLETED|Overall Study||57||
59842700|NCT00122109|75967361|FG000|NOT COMPLETED|Overall Study||6||
59842701|NCT00122109|75967362|FG001|NOT COMPLETED|Overall Study||7||
59842702|NCT00113373|75967371|FG000|STARTED|Overall Study||28||
59842703|NCT00113373|75967371|FG000|COMPLETED|Overall Study|Eligible and treated patients.|25||
59842704|NCT00113373|75967371|FG000|NOT COMPLETED|Overall Study||3||
59842705|NCT00113295|75967382|FG000|STARTED|Overall Study||11||
59842706|NCT00113295|75967383|FG001|STARTED|Overall Study||11||
59842707|NCT00113295|75967382|FG000|COMPLETED|Overall Study||6||
59842708|NCT00113295|75967383|FG001|COMPLETED|Overall Study||10||
59842709|NCT00113295|75967382|FG000|NOT COMPLETED|Overall Study||5||
59842710|NCT00113295|75967383|FG001|NOT COMPLETED|Overall Study||1||
59842711|NCT00112905|75967391|FG000|STARTED|Overall Study||27||
59842712|NCT00112905|75967391|FG000|Eligible and Treated|Overall Study||22||
59842713|NCT00112905|75967391|FG000|COMPLETED|Overall Study||15||
59842714|NCT00112905|75967391|FG000|NOT COMPLETED|Overall Study||12||
59842715|NCT00427895|75967399|FG000|STARTED|Between 6-Month Follow-up - Year 1||411||
59842716|NCT00427895|75967400|FG001|STARTED|Between 6-Month Follow-up - Year 1||411||
59842717|NCT00427895|75967401|FG002|STARTED|Between 6-Month Follow-up - Year 1||392||
59842718|NCT00427895|75967402|FG003|STARTED|Between 6-Month Follow-up - Year 1||854||
59842719|NCT00427895|75967403|FG004|STARTED|Between 6-Month Follow-up - Year 1||0||
59842720|NCT00427895|75967404|FG005|STARTED|Between 6-Month Follow-up - Year 1||0||
59842721|NCT00427895|75967405|FG006|STARTED|Between 6-Month Follow-up - Year 1||0||
59842722|NCT00427895|75967406|FG007|STARTED|Between 6-Month Follow-up - Year 1||0||
59842723|NCT00427895|75967399|FG000|COMPLETED|Between 6-Month Follow-up - Year 1||411||
59842724|NCT00427895|75967400|FG001|COMPLETED|Between 6-Month Follow-up - Year 1||411||
59842725|NCT00427895|75967401|FG002|COMPLETED|Between 6-Month Follow-up - Year 1||392||
59842726|NCT00427895|75967402|FG003|COMPLETED|Between 6-Month Follow-up - Year 1||502||
59842727|NCT00427895|75967403|FG004|COMPLETED|Between 6-Month Follow-up - Year 1||0||
59842728|NCT00427895|75967404|FG005|COMPLETED|Between 6-Month Follow-up - Year 1||0||
59842729|NCT00427895|75967405|FG006|COMPLETED|Between 6-Month Follow-up - Year 1||0||
59842730|NCT00427895|75967406|FG007|COMPLETED|Between 6-Month Follow-up - Year 1||0||
59842731|NCT00427895|75967399|FG000|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0||
59842732|NCT00427895|75967400|FG001|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0||
59842733|NCT00427895|75967401|FG002|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0||
59842734|NCT00427895|75967402|FG003|NOT COMPLETED|Between 6-Month Follow-up - Year 1||352||
59842735|NCT00427895|75967403|FG004|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0||
59842736|NCT00427895|75967404|FG005|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0||
59842737|NCT00427895|75967405|FG006|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0||
59842738|NCT00427895|75967406|FG007|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0||
59842739|NCT00427895|75967399|FG000|STARTED|Vax 2/Year 3 to 4||0||
59842740|NCT00427895|75967400|FG001|STARTED|Vax 2/Year 3 to 4||0||
59842741|NCT00427895|75967401|FG002|STARTED|Vax 2/Year 3 to 4||0||
59842742|NCT00427895|75967402|FG003|STARTED|Vax 2/Year 3 to 4||0||
59842743|NCT00427895|75967403|FG004|STARTED|Vax 2/Year 3 to 4||108||
59842744|NCT00427895|75967404|FG005|STARTED|Vax 2/Year 3 to 4||108||
59842745|NCT00427895|75967405|FG006|STARTED|Vax 2/Year 3 to 4||189||
59842746|NCT00427895|75967406|FG007|STARTED|Vax 2/Year 3 to 4||214||
60120015|NCT02615158|76241256|FG000|COMPLETED|Overall Study||73||
60120016|NCT02615158|76241257|FG001|COMPLETED|Overall Study||76||
60120017|NCT02615158|76241258|FG002|COMPLETED|Overall Study||75||
60120018|NCT02615158|76241256|FG000|NOT COMPLETED|Overall Study||21||
60120019|NCT02615158|76241257|FG001|NOT COMPLETED|Overall Study||16||
60120020|NCT02615158|76241258|FG002|NOT COMPLETED|Overall Study||16||
60120021|NCT02616250|76241268|FG000|STARTED|Overall Study||95||
60120022|NCT02616250|76241269|FG001|STARTED|Overall Study||95||
60120023|NCT02616250|76241268|FG000|COMPLETED|Overall Study||85||
60120024|NCT02616250|76241269|FG001|COMPLETED|Overall Study||86||
60120025|NCT02616250|76241268|FG000|NOT COMPLETED|Overall Study||10||
60120026|NCT02616250|76241269|FG001|NOT COMPLETED|Overall Study||9||
60120027|NCT02698410|76241275|FG000|STARTED|Overall Study||40||
60120028|NCT02698410|76241275|FG000|COMPLETED|Overall Study||36||
60120029|NCT02698410|76241275|FG000|NOT COMPLETED|Overall Study||4||
60120030|NCT02699892|76241279|FG000|STARTED|Overall Study||130||
59719238|NCT01163279|75838466|FG000|COMPLETED|Overall Study||8||
59719239|NCT01163279|75838467|FG001|COMPLETED|Overall Study||9||
59719240|NCT01163279|75838466|FG000|NOT COMPLETED|Overall Study||2||
59719241|NCT01163279|75838467|FG001|NOT COMPLETED|Overall Study||0||
59719242|NCT01162499|75838474|FG000|STARTED|Intervention 1 (4 Hours)||3||
59719243|NCT01162499|75838475|FG001|STARTED|Intervention 1 (4 Hours)||4||
59719244|NCT01162499|75838474|FG000|Received Intervention|Intervention 1 (4 Hours)||3||
59719245|NCT01162499|75838475|FG001|Received Intervention|Intervention 1 (4 Hours)||3||
59719246|NCT01162499|75838474|FG000|COMPLETED|Intervention 1 (4 Hours)||3||
59719247|NCT01162499|75838475|FG001|COMPLETED|Intervention 1 (4 Hours)||3||
59842747|NCT00427895|75967399|FG000|COMPLETED|Vax 2/Year 3 to 4||0||
59842748|NCT00427895|75967400|FG001|COMPLETED|Vax 2/Year 3 to 4||0||
59996598|NCT02714569|76112507|FG004|NOT COMPLETED|Part A Second Intervention||0||
59996599|NCT02714569|76112508|FG005|NOT COMPLETED|Part A Second Intervention||0||
59996600|NCT02714569|76112509|FG006|NOT COMPLETED|Part A Second Intervention||0||
59996601|NCT02714569|76112510|FG007|NOT COMPLETED|Part A Second Intervention||0||
59996602|NCT02714569|76112511|FG008|NOT COMPLETED|Part A Second Intervention||0||
59996603|NCT02714569|76112512|FG009|NOT COMPLETED|Part A Second Intervention||0||
59996604|NCT02714569|76112513|FG010|NOT COMPLETED|Part A Second Intervention||0||
59996605|NCT02714569|76112503|FG000|STARTED|Part A Third Intervention||3||
59996606|NCT02714569|76112504|FG001|STARTED|Part A Third Intervention||2||
59996607|NCT02714569|76112505|FG002|STARTED|Part A Third Intervention||3||
59996608|NCT02714569|76112506|FG003|STARTED|Part A Third Intervention||3||
59996609|NCT02714569|76112507|FG004|STARTED|Part A Third Intervention||3||
59996610|NCT02714569|76112508|FG005|STARTED|Part A Third Intervention||3||
59996611|NCT02714569|76112509|FG006|STARTED|Part A Third Intervention||0||
59996612|NCT02714569|76112510|FG007|STARTED|Part A Third Intervention||0||
59996613|NCT02714569|76112511|FG008|STARTED|Part A Third Intervention||0||
59996614|NCT02714569|76112512|FG009|STARTED|Part A Third Intervention||0||
59996615|NCT02714569|76112513|FG010|STARTED|Part A Third Intervention||0||
59996616|NCT02714569|76112503|FG000|Received at Least One Dose of Study Drug|Part A Third Intervention||3||
60120031|NCT02699892|76241279|FG000|COMPLETED|Overall Study||94||
60120032|NCT02699892|76241279|FG000|NOT COMPLETED|Overall Study||36||
60120033|NCT02698176|76241286|FG000|STARTED|Overall Study||9||
60120034|NCT02698176|76241287|FG001|STARTED|Overall Study||3||
59842749|NCT00427895|75967401|FG002|COMPLETED|Vax 2/Year 3 to 4||0||
59842750|NCT00427895|75967402|FG003|COMPLETED|Vax 2/Year 3 to 4||0||
59842751|NCT00427895|75967403|FG004|COMPLETED|Vax 2/Year 3 to 4||107||
59842752|NCT00427895|75967404|FG005|COMPLETED|Vax 2/Year 3 to 4||108||
59842753|NCT00427895|75967405|FG006|COMPLETED|Vax 2/Year 3 to 4||189||
59842754|NCT00427895|75967406|FG007|COMPLETED|Vax 2/Year 3 to 4||212||
59842755|NCT00427895|75967399|FG000|NOT COMPLETED|Vax 2/Year 3 to 4||0||
59842756|NCT00427895|75967400|FG001|NOT COMPLETED|Vax 2/Year 3 to 4||0||
59842757|NCT00427895|75967401|FG002|NOT COMPLETED|Vax 2/Year 3 to 4||0||
59842758|NCT00427895|75967402|FG003|NOT COMPLETED|Vax 2/Year 3 to 4||0||
59842759|NCT00427895|75967403|FG004|NOT COMPLETED|Vax 2/Year 3 to 4||1||
59842760|NCT00427895|75967404|FG005|NOT COMPLETED|Vax 2/Year 3 to 4||0||
59842761|NCT00427895|75967405|FG006|NOT COMPLETED|Vax 2/Year 3 to 4||0||
59842762|NCT00427895|75967406|FG007|NOT COMPLETED|Vax 2/Year 3 to 4||2||
59842763|NCT00427895|75967399|FG000|STARTED|Vax 1 Baseline/6-Month Follow-up||418||
59842764|NCT00427895|75967400|FG001|STARTED|Vax 1 Baseline/6-Month Follow-up||417||
59842765|NCT00427895|75967401|FG002|STARTED|Vax 1 Baseline/6-Month Follow-up||406||
59842766|NCT00427895|75967402|FG003|STARTED|Vax 1 Baseline/6-Month Follow-up||900||
59842767|NCT00427895|75967403|FG004|STARTED|Vax 1 Baseline/6-Month Follow-up||0||
59842768|NCT00427895|75967404|FG005|STARTED|Vax 1 Baseline/6-Month Follow-up||0||
59842769|NCT00427895|75967405|FG006|STARTED|Vax 1 Baseline/6-Month Follow-up||0||
59842770|NCT00427895|75967406|FG007|STARTED|Vax 1 Baseline/6-Month Follow-up||0||
59842771|NCT00427895|75967399|FG000|Vaccinated|Vax 1 Baseline/6-Month Follow-up||417||
59842772|NCT00427895|75967400|FG001|Vaccinated|Vax 1 Baseline/6-Month Follow-up||414||
59842773|NCT00427895|75967401|FG002|Vaccinated|Vax 1 Baseline/6-Month Follow-up||404||
59842774|NCT00427895|75967402|FG003|Vaccinated|Vax 1 Baseline/6-Month Follow-up||899||
59842775|NCT00427895|75967403|FG004|Vaccinated|Vax 1 Baseline/6-Month Follow-up||0||
59842776|NCT00427895|75967404|FG005|Vaccinated|Vax 1 Baseline/6-Month Follow-up||0||
59842777|NCT00427895|75967405|FG006|Vaccinated|Vax 1 Baseline/6-Month Follow-up||0||
59842778|NCT00427895|75967406|FG007|Vaccinated|Vax 1 Baseline/6-Month Follow-up||0||
59842779|NCT00427895|75967399|FG000|COMPLETED|Vax 1 Baseline/6-Month Follow-up||411||
59842780|NCT00427895|75967400|FG001|COMPLETED|Vax 1 Baseline/6-Month Follow-up||411||
59842781|NCT00427895|75967401|FG002|COMPLETED|Vax 1 Baseline/6-Month Follow-up||392||
59842782|NCT00427895|75967402|FG003|COMPLETED|Vax 1 Baseline/6-Month Follow-up||854||
59842783|NCT00427895|75967403|FG004|COMPLETED|Vax 1 Baseline/6-Month Follow-up||0||
59842784|NCT00427895|75967404|FG005|COMPLETED|Vax 1 Baseline/6-Month Follow-up||0||
59842785|NCT00427895|75967405|FG006|COMPLETED|Vax 1 Baseline/6-Month Follow-up||0||
59842786|NCT00427895|75967406|FG007|COMPLETED|Vax 1 Baseline/6-Month Follow-up||0||
59842787|NCT00427895|75967399|FG000|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||7||
59842788|NCT00427895|75967400|FG001|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||6||
59842789|NCT00427895|75967401|FG002|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||14||
59842790|NCT00427895|75967402|FG003|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||46||
59842791|NCT00427895|75967403|FG004|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||0||
59842792|NCT00427895|75967404|FG005|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||0||
59842793|NCT00427895|75967405|FG006|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||0||
59842794|NCT00427895|75967406|FG007|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||0||
59842795|NCT00427895|75967399|FG000|STARTED|Vax 1/Year 1 Follow-up||411||
59842796|NCT00427895|75967400|FG001|STARTED|Vax 1/Year 1 Follow-up||411||
60120035|NCT02698176|76241288|FG002|STARTED|Overall Study||1||
59842797|NCT00427895|75967401|FG002|STARTED|Vax 1/Year 1 Follow-up||392||
59842798|NCT00427895|75967402|FG003|STARTED|Vax 1/Year 1 Follow-up||502||
59842799|NCT00427895|75967403|FG004|STARTED|Vax 1/Year 1 Follow-up||0||
59842800|NCT00427895|75967404|FG005|STARTED|Vax 1/Year 1 Follow-up||0||
59842801|NCT00427895|75967405|FG006|STARTED|Vax 1/Year 1 Follow-up||0||
59842802|NCT00427895|75967406|FG007|STARTED|Vax 1/Year 1 Follow-up||0||
59842803|NCT00427895|75967399|FG000|COMPLETED|Vax 1/Year 1 Follow-up||404||
59842804|NCT00427895|75967400|FG001|COMPLETED|Vax 1/Year 1 Follow-up||396||
59842805|NCT00427895|75967401|FG002|COMPLETED|Vax 1/Year 1 Follow-up||373||
59842806|NCT00427895|75967402|FG003|COMPLETED|Vax 1/Year 1 Follow-up||469||
59842807|NCT00427895|75967403|FG004|COMPLETED|Vax 1/Year 1 Follow-up||0||
59842808|NCT00427895|75967404|FG005|COMPLETED|Vax 1/Year 1 Follow-up||0||
59842809|NCT00427895|75967405|FG006|COMPLETED|Vax 1/Year 1 Follow-up||0||
59842810|NCT00427895|75967406|FG007|COMPLETED|Vax 1/Year 1 Follow-up||0||
59842811|NCT00427895|75967399|FG000|NOT COMPLETED|Vax 1/Year 1 Follow-up||7||
59842812|NCT00427895|75967400|FG001|NOT COMPLETED|Vax 1/Year 1 Follow-up||15||
59842813|NCT00427895|75967401|FG002|NOT COMPLETED|Vax 1/Year 1 Follow-up||19||
59842814|NCT00427895|75967402|FG003|NOT COMPLETED|Vax 1/Year 1 Follow-up||33||
59842815|NCT00427895|75967403|FG004|NOT COMPLETED|Vax 1/Year 1 Follow-up||0||
60120036|NCT02698176|76241289|FG003|STARTED|Overall Study|No participants were enrolled in Part B.|0||
60120037|NCT02698176|76241286|FG000|COMPLETED|Overall Study||0||
60120038|NCT02698176|76241287|FG001|COMPLETED|Overall Study||0||
60120039|NCT02698176|76241288|FG002|COMPLETED|Overall Study||0||
59842816|NCT00427895|75967404|FG005|NOT COMPLETED|Vax 1/Year 1 Follow-up||0||
59842817|NCT00427895|75967405|FG006|NOT COMPLETED|Vax 1/Year 1 Follow-up||0||
60120040|NCT02698176|76241289|FG003|COMPLETED|Overall Study||0||
60120041|NCT02698176|76241286|FG000|NOT COMPLETED|Overall Study||9||
59842818|NCT00427895|75967406|FG007|NOT COMPLETED|Vax 1/Year 1 Follow-up||0||
59842819|NCT00427895|75967399|FG000|STARTED|Between Year 1 - Vax 2/Year 3 to 4||404||
59842820|NCT00427895|75967400|FG001|STARTED|Between Year 1 - Vax 2/Year 3 to 4||396||
59842821|NCT00427895|75967401|FG002|STARTED|Between Year 1 - Vax 2/Year 3 to 4||373||
59842822|NCT00427895|75967402|FG003|STARTED|Between Year 1 - Vax 2/Year 3 to 4||469||
59842823|NCT00427895|75967403|FG004|STARTED|Between Year 1 - Vax 2/Year 3 to 4||0||
59842824|NCT00427895|75967404|FG005|STARTED|Between Year 1 - Vax 2/Year 3 to 4||0||
59842825|NCT00427895|75967405|FG006|STARTED|Between Year 1 - Vax 2/Year 3 to 4||0||
59842826|NCT00427895|75967406|FG007|STARTED|Between Year 1 - Vax 2/Year 3 to 4||0||
59842827|NCT00427895|75967399|FG000|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||216||
59842828|NCT00427895|75967400|FG001|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||189||
59842829|NCT00427895|75967401|FG002|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||214||
59842830|NCT00427895|75967402|FG003|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0||
59842831|NCT00427895|75967403|FG004|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0||
59842832|NCT00427895|75967404|FG005|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0||
59719248|NCT01162499|75838474|FG000|NOT COMPLETED|Intervention 1 (4 Hours)||0||
59719249|NCT01162499|75838475|FG001|NOT COMPLETED|Intervention 1 (4 Hours)||1||
59719250|NCT01162499|75838474|FG000|STARTED|Intervention 2 (4 Hours)||3||
59719251|NCT01162499|75838475|FG001|STARTED|Intervention 2 (4 Hours)||3||
59719252|NCT01162499|75838474|FG000|COMPLETED|Intervention 2 (4 Hours)||3||
59719253|NCT01162499|75838475|FG001|COMPLETED|Intervention 2 (4 Hours)||3||
59719254|NCT01162499|75838474|FG000|NOT COMPLETED|Intervention 2 (4 Hours)||0||
59719255|NCT01162499|75838475|FG001|NOT COMPLETED|Intervention 2 (4 Hours)||0||
59719256|NCT01206140|75838485|FG000|STARTED|Overall Study||35||
59719257|NCT01206140|75838486|FG001|STARTED|Overall Study||35||
59719258|NCT01206140|75838485|FG000|COMPLETED|Overall Study||34||
59719259|NCT01206140|75838486|FG001|COMPLETED|Overall Study||35||
59719260|NCT01206140|75838485|FG000|NOT COMPLETED|Overall Study||1||
59719261|NCT01206140|75838486|FG001|NOT COMPLETED|Overall Study||0||
59842833|NCT00427895|75967405|FG006|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0||
59842834|NCT00427895|75967406|FG007|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0||
59842835|NCT00427895|75967399|FG000|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||188||
60120042|NCT02698176|76241287|FG001|NOT COMPLETED|Overall Study||3||
60120043|NCT02698176|76241288|FG002|NOT COMPLETED|Overall Study||1||
60120044|NCT02698176|76241289|FG003|NOT COMPLETED|Overall Study||0||
60120045|NCT02693418|76241305|FG000|STARTED|Overall Study||22||
60120046|NCT02693418|76241306|FG001|STARTED|Overall Study||21||
60120047|NCT02693418|76241307|FG002|STARTED|Overall Study||21||
60120048|NCT02693418|76241308|FG003|STARTED|Overall Study||20||
60120049|NCT02693418|76241309|FG004|STARTED|Overall Study||21||
60120050|NCT02693418|76241305|FG000|COMPLETED|Overall Study||21||
60120051|NCT02693418|76241306|FG001|COMPLETED|Overall Study||19||
60120052|NCT02693418|76241307|FG002|COMPLETED|Overall Study||19||
59719262|NCT01162421|75838494|FG000|STARTED|Overall Study||37||
59719263|NCT01162421|75838495|FG001|STARTED|Overall Study||40||
59719264|NCT01162421|75838494|FG000|COMPLETED|Overall Study||29||
60120053|NCT02693418|76241308|FG003|COMPLETED|Overall Study||20||
60120054|NCT02693418|76241309|FG004|COMPLETED|Overall Study||21||
60120055|NCT02693418|76241305|FG000|NOT COMPLETED|Overall Study||1||
60120056|NCT02693418|76241306|FG001|NOT COMPLETED|Overall Study||2||
60120057|NCT02693418|76241307|FG002|NOT COMPLETED|Overall Study||2||
59719265|NCT01162421|75838495|FG001|COMPLETED|Overall Study||27||
59719266|NCT01162421|75838494|FG000|NOT COMPLETED|Overall Study||8||
59842836|NCT00427895|75967400|FG001|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||207||
59842837|NCT00427895|75967401|FG002|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||159||
59842838|NCT00427895|75967402|FG003|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||469||
59842839|NCT00427895|75967403|FG004|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0||
60120058|NCT02693418|76241308|FG003|NOT COMPLETED|Overall Study||0||
60120059|NCT02693418|76241309|FG004|NOT COMPLETED|Overall Study||0||
59842840|NCT00427895|75967404|FG005|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0||
59842841|NCT00427895|75967405|FG006|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0||
59842842|NCT00427895|75967406|FG007|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0||
59842843|NCT00425945|75967447|FG000|STARTED|Overall Study||64||
59842844|NCT00425945|75967448|FG001|STARTED|Overall Study||66||
59842845|NCT00425945|75967447|FG000|COMPLETED|Overall Study||60||
59842846|NCT00425945|75967448|FG001|COMPLETED|Overall Study||61||
59842847|NCT00425945|75967447|FG000|NOT COMPLETED|Overall Study||4||
59842848|NCT00425945|75967448|FG001|NOT COMPLETED|Overall Study||5||
59842849|NCT00416195|75967458|FG000|STARTED|Overall Study||10||
59842850|NCT00416195|75967459|FG001|STARTED|Overall Study||38||
59842851|NCT00416195|75967458|FG000|COMPLETED|Overall Study||8||
59842852|NCT00416195|75967459|FG001|COMPLETED|Overall Study||34||
59842853|NCT00416195|75967458|FG000|NOT COMPLETED|Overall Study||2||
59842854|NCT00416195|75967459|FG001|NOT COMPLETED|Overall Study||4||
59842855|NCT00121641|75967469|FG000|STARTED|24-week Short-term Treatment Period||102||
59842856|NCT00121641|75967470|FG001|STARTED|24-week Short-term Treatment Period||106||
59842857|NCT00121641|75967471|FG002|STARTED|24-week Short-term Treatment Period||98||
59842858|NCT00121641|75967472|FG003|STARTED|24-week Short-term Treatment Period||95||
59842859|NCT00121641|75967473|FG004|STARTED|24-week Short-term Treatment Period||66||
59842860|NCT00121641|75967469|FG000|COMPLETED|24-week Short-term Treatment Period||73||
59842861|NCT00121641|75967470|FG001|COMPLETED|24-week Short-term Treatment Period||68||
59842862|NCT00121641|75967471|FG002|COMPLETED|24-week Short-term Treatment Period||69||
59842863|NCT00121641|75967472|FG003|COMPLETED|24-week Short-term Treatment Period||55||
59842864|NCT00121641|75967473|FG004|COMPLETED|24-week Short-term Treatment Period||25||
59842865|NCT00121641|75967469|FG000|NOT COMPLETED|24-week Short-term Treatment Period||29||
59842866|NCT00121641|75967470|FG001|NOT COMPLETED|24-week Short-term Treatment Period||38||
59842867|NCT00121641|75967471|FG002|NOT COMPLETED|24-week Short-term Treatment Period||29||
59842868|NCT00121641|75967472|FG003|NOT COMPLETED|24-week Short-term Treatment Period||40||
59842869|NCT00121641|75967473|FG004|NOT COMPLETED|24-week Short-term Treatment Period||41||
59842870|NCT00121641|75967469|FG000|STARTED|48-month Short Term + Long Term Period||102||
59842871|NCT00121641|75967470|FG001|STARTED|48-month Short Term + Long Term Period||106||
59842872|NCT00121641|75967471|FG002|STARTED|48-month Short Term + Long Term Period||98||
59842873|NCT00121641|75967472|FG003|STARTED|48-month Short Term + Long Term Period||95||
59842874|NCT00121641|75967473|FG004|STARTED|48-month Short Term + Long Term Period||66||
59842875|NCT00121641|75967469|FG000|COMPLETED|48-month Short Term + Long Term Period||23||
59842876|NCT00121641|75967470|FG001|COMPLETED|48-month Short Term + Long Term Period||24||
59842877|NCT00121641|75967471|FG002|COMPLETED|48-month Short Term + Long Term Period||28||
59842878|NCT00121641|75967472|FG003|COMPLETED|48-month Short Term + Long Term Period||24||
59842879|NCT00121641|75967473|FG004|COMPLETED|48-month Short Term + Long Term Period||8||
59842880|NCT00121641|75967469|FG000|NOT COMPLETED|48-month Short Term + Long Term Period||79||
59842881|NCT00121641|75967470|FG001|NOT COMPLETED|48-month Short Term + Long Term Period||82||
59842882|NCT00121641|75967471|FG002|NOT COMPLETED|48-month Short Term + Long Term Period||70||
59842883|NCT00121641|75967472|FG003|NOT COMPLETED|48-month Short Term + Long Term Period||71||
59842884|NCT00121641|75967473|FG004|NOT COMPLETED|48-month Short Term + Long Term Period||58||
59842885|NCT00425555|75967489|FG000|STARTED|Overall Study||79||
59842886|NCT00425555|75967490|FG001|STARTED|Overall Study||60||
59842887|NCT00425555|75967489|FG000|COMPLETED|Overall Study||0||
59842888|NCT00425555|75967490|FG001|COMPLETED|Overall Study||0||
59842889|NCT00425555|75967489|FG000|NOT COMPLETED|Overall Study||79||
59842890|NCT00425555|75967490|FG001|NOT COMPLETED|Overall Study||60||
59842891|NCT00424775|75967499|FG000|STARTED|Overall Study||3||
59842892|NCT00424775|75967500|FG001|STARTED|Overall Study||0||
59842893|NCT00424775|75967499|FG000|COMPLETED|Overall Study||0||
59842894|NCT00424775|75967500|FG001|COMPLETED|Overall Study||0||
59842895|NCT00424775|75967499|FG000|NOT COMPLETED|Overall Study||3||
59842896|NCT00424775|75967500|FG001|NOT COMPLETED|Overall Study||0||
59842897|NCT00121485|75967506|FG000|STARTED|Overall Study||134||
59842898|NCT00121485|75967507|FG001|STARTED|Overall Study||66||
59842899|NCT00121485|75967506|FG000|COMPLETED|Overall Study||133||
59842900|NCT00121485|75967507|FG001|COMPLETED|Overall Study||59||
59842901|NCT00121485|75967506|FG000|NOT COMPLETED|Overall Study||1||
59842902|NCT00121485|75967507|FG001|NOT COMPLETED|Overall Study||7||
59719267|NCT01162421|75838495|FG001|NOT COMPLETED|Overall Study||13||
59719268|NCT01162343|75838501|FG000|STARTED|Overall Study||498||
59719269|NCT01162343|75838501|FG000|COMPLETED|Overall Study||406||
59719270|NCT01162343|75838501|FG000|NOT COMPLETED|Overall Study||92||
59719271|NCT01188551|75838509|FG000|STARTED|Overall Study||25||
59719272|NCT01188551|75838510|FG001|STARTED|Overall Study||25||
59719273|NCT01188551|75838511|FG002|STARTED|Overall Study||25||
59719274|NCT01188551|75838512|FG003|STARTED|Overall Study||25||
59719275|NCT01188551|75838509|FG000|COMPLETED|Overall Study||24||
59719276|NCT01188551|75838510|FG001|COMPLETED|Overall Study||25||
59719277|NCT01188551|75838511|FG002|COMPLETED|Overall Study||25||
59719278|NCT01188551|75838512|FG003|COMPLETED|Overall Study||25||
59719279|NCT01188551|75838509|FG000|NOT COMPLETED|Overall Study||1||
59842903|NCT01763866|75967538|FG000|STARTED|Overall Study||56||
59842904|NCT01763866|75967539|FG001|STARTED|Overall Study||55||
59842905|NCT01763866|75967540|FG002|STARTED|Overall Study||56||
59842906|NCT01763866|75967541|FG003|STARTED|Overall Study||55||
59842907|NCT01763866|75967542|FG004|STARTED|Overall Study||110||
59842908|NCT01763866|75967543|FG005|STARTED|Overall Study||110||
59842909|NCT01763866|75967544|FG006|STARTED|Overall Study||55||
59842910|NCT01763866|75967545|FG007|STARTED|Overall Study||55||
59842911|NCT01763866|75967546|FG008|STARTED|Overall Study||56||
59842912|NCT01763866|75967547|FG009|STARTED|Overall Study||54||
59842913|NCT01763866|75967548|FG010|STARTED|Overall Study||110||
59842914|NCT01763866|75967549|FG011|STARTED|Overall Study||110||
59842915|NCT01763866|75967550|FG012|STARTED|Overall Study||58||
59842916|NCT01763866|75967551|FG013|STARTED|Overall Study||57||
59842917|NCT01763866|75967552|FG014|STARTED|Overall Study||114||
59842918|NCT01763866|75967553|FG015|STARTED|Overall Study||115||
59842919|NCT01763866|75967554|FG016|STARTED|Overall Study||56||
59842920|NCT01763866|75967555|FG017|STARTED|Overall Study||56||
59842921|NCT01763866|75967556|FG018|STARTED|Overall Study||111||
59842922|NCT01763866|75967557|FG019|STARTED|Overall Study||112||
59842923|NCT01763866|75967558|FG020|STARTED|Overall Study||56||
59842924|NCT01763866|75967559|FG021|STARTED|Overall Study||55||
59842925|NCT01763866|75967560|FG022|STARTED|Overall Study||112||
59842926|NCT01763866|75967561|FG023|STARTED|Overall Study||115||
59842927|NCT01763866|75967538|FG000|Received Treatment|Overall Study||56||
59842928|NCT01763866|75967539|FG001|Received Treatment|Overall Study||55||
59842929|NCT01763866|75967540|FG002|Received Treatment|Overall Study||56||
59842930|NCT01763866|75967541|FG003|Received Treatment|Overall Study||55||
59842931|NCT01763866|75967542|FG004|Received Treatment|Overall Study||110||
59842932|NCT01763866|75967543|FG005|Received Treatment|Overall Study||110||
59842933|NCT01763866|75967544|FG006|Received Treatment|Overall Study||55||
59842934|NCT01763866|75967545|FG007|Received Treatment|Overall Study||55||
59842935|NCT01763866|75967546|FG008|Received Treatment|Overall Study||56||
59842936|NCT01763866|75967547|FG009|Received Treatment|Overall Study||54||
59842937|NCT01763866|75967548|FG010|Received Treatment|Overall Study||109||
59842938|NCT01763866|75967549|FG011|Received Treatment|Overall Study||110||
59842939|NCT01763866|75967550|FG012|Received Treatment|Overall Study||58||
59842940|NCT01763866|75967551|FG013|Received Treatment|Overall Study||57||
59842941|NCT01763866|75967552|FG014|Received Treatment|Overall Study||113||
59842942|NCT01763866|75967553|FG015|Received Treatment|Overall Study||115||
59842943|NCT01763866|75967554|FG016|Received Treatment|Overall Study||56||
59842944|NCT01763866|75967555|FG017|Received Treatment|Overall Study||55||
59842945|NCT01763866|75967556|FG018|Received Treatment|Overall Study||111||
59842946|NCT01763866|75967557|FG019|Received Treatment|Overall Study||112||
59842947|NCT01763866|75967558|FG020|Received Treatment|Overall Study||56||
59842948|NCT01763866|75967559|FG021|Received Treatment|Overall Study||55||
59842949|NCT01763866|75967560|FG022|Received Treatment|Overall Study||112||
59842950|NCT01763866|75967561|FG023|Received Treatment|Overall Study||115||
59842951|NCT01763866|75967538|FG000|COMPLETED|Overall Study||54||
59842952|NCT01763866|75967539|FG001|COMPLETED|Overall Study||54||
59842953|NCT01763866|75967540|FG002|COMPLETED|Overall Study||51||
59842954|NCT01763866|75967541|FG003|COMPLETED|Overall Study||55||
59842955|NCT01763866|75967542|FG004|COMPLETED|Overall Study||108||
59842956|NCT01763866|75967543|FG005|COMPLETED|Overall Study||107||
59842957|NCT01763866|75967544|FG006|COMPLETED|Overall Study||48||
59719280|NCT01188551|75838510|FG001|NOT COMPLETED|Overall Study||0||
59719281|NCT01188551|75838511|FG002|NOT COMPLETED|Overall Study||0||
59719282|NCT01188551|75838512|FG003|NOT COMPLETED|Overall Study||0||
59719283|NCT01161407|75838524|FG000|STARTED|Overall Study||6||
59719284|NCT01161407|75838525|FG001|STARTED|Overall Study||6||
59719285|NCT01161407|75838524|FG000|COMPLETED|Overall Study||3||
59719286|NCT01161407|75838525|FG001|COMPLETED|Overall Study||5||
59719287|NCT01161407|75838524|FG000|NOT COMPLETED|Overall Study||3||
59719288|NCT01161407|75838525|FG001|NOT COMPLETED|Overall Study||1||
59719289|NCT01161173|75838531|FG000|STARTED|Overall Study||347||
59719290|NCT01161173|75838531|FG000|COMPLETED|Overall Study||0||
59719291|NCT01161173|75838531|FG000|NOT COMPLETED|Overall Study||347||
59719292|NCT01159769|75838535|FG000|STARTED|Overall Study||215||
59719293|NCT01159769|75838535|FG000|COMPLETED|Overall Study||214||
59719294|NCT01159769|75838535|FG000|NOT COMPLETED|Overall Study||1||
59719295|NCT01159691|75838539|FG000|STARTED|Overall Study||76||
59719296|NCT01159691|75838539|FG000|COMPLETED|Overall Study|Multiple discontinuation reasons were possible.|54||
59842958|NCT01763866|75967545|FG007|COMPLETED|Overall Study||55||
59842959|NCT01763866|75967546|FG008|COMPLETED|Overall Study||53||
59842960|NCT01763866|75967547|FG009|COMPLETED|Overall Study||53||
59842961|NCT01763866|75967548|FG010|COMPLETED|Overall Study||102||
59842962|NCT01763866|75967549|FG011|COMPLETED|Overall Study||108||
59842963|NCT01763866|75967550|FG012|COMPLETED|Overall Study||54||
59842964|NCT01763866|75967551|FG013|COMPLETED|Overall Study||57||
59842965|NCT01763866|75967552|FG014|COMPLETED|Overall Study||102||
59842966|NCT01763866|75967553|FG015|COMPLETED|Overall Study||112||
59842967|NCT01763866|75967554|FG016|COMPLETED|Overall Study||55||
59842968|NCT01763866|75967555|FG017|COMPLETED|Overall Study||55||
59842969|NCT01763866|75967556|FG018|COMPLETED|Overall Study||105||
59842970|NCT01763866|75967557|FG019|COMPLETED|Overall Study||110||
59842971|NCT01763866|75967558|FG020|COMPLETED|Overall Study||52||
59842972|NCT01763866|75967559|FG021|COMPLETED|Overall Study||54||
59842973|NCT01763866|75967560|FG022|COMPLETED|Overall Study||109||
59842974|NCT01763866|75967561|FG023|COMPLETED|Overall Study||113||
59842975|NCT01763866|75967538|FG000|NOT COMPLETED|Overall Study||2||
59842976|NCT01763866|75967539|FG001|NOT COMPLETED|Overall Study||1||
59842977|NCT01763866|75967540|FG002|NOT COMPLETED|Overall Study||5||
59842978|NCT01763866|75967541|FG003|NOT COMPLETED|Overall Study||0||
59842979|NCT01763866|75967542|FG004|NOT COMPLETED|Overall Study||2||
59842980|NCT01763866|75967543|FG005|NOT COMPLETED|Overall Study||3||
59842981|NCT01763866|75967544|FG006|NOT COMPLETED|Overall Study||7||
59842982|NCT01763866|75967545|FG007|NOT COMPLETED|Overall Study||0||
59842983|NCT01763866|75967546|FG008|NOT COMPLETED|Overall Study||3||
59842984|NCT01763866|75967547|FG009|NOT COMPLETED|Overall Study||1||
59842985|NCT01763866|75967548|FG010|NOT COMPLETED|Overall Study||8||
59842986|NCT01763866|75967549|FG011|NOT COMPLETED|Overall Study||2||
59842987|NCT01763866|75967550|FG012|NOT COMPLETED|Overall Study||4||
59842988|NCT01763866|75967551|FG013|NOT COMPLETED|Overall Study||0||
59842989|NCT01763866|75967552|FG014|NOT COMPLETED|Overall Study||12||
59842990|NCT01763866|75967553|FG015|NOT COMPLETED|Overall Study||3||
59842991|NCT01763866|75967554|FG016|NOT COMPLETED|Overall Study||1||
59842992|NCT01763866|75967555|FG017|NOT COMPLETED|Overall Study||1||
59842993|NCT01763866|75967556|FG018|NOT COMPLETED|Overall Study||6||
59842994|NCT01763866|75967557|FG019|NOT COMPLETED|Overall Study||2||
59842995|NCT01763866|75967558|FG020|NOT COMPLETED|Overall Study||4||
59842996|NCT01763866|75967559|FG021|NOT COMPLETED|Overall Study||1||
59842997|NCT01763866|75967560|FG022|NOT COMPLETED|Overall Study||3||
59842998|NCT01763866|75967561|FG023|NOT COMPLETED|Overall Study||2||
59842999|NCT00132873|75967611|FG000|STARTED|Overall Study||59||
59843000|NCT00132873|75967611|FG000|COMPLETED|Overall Study||50||
59843001|NCT00132873|75967611|FG000|NOT COMPLETED|Overall Study||9||
59843002|NCT00120627|75967617|FG000|STARTED|Overall Study|This is the number who enrolled and was randomly assigned to receive the Mantram Repetition Program.|71||
59843003|NCT00120627|75967618|FG001|STARTED|Overall Study|This was the number that enrolled and was randomly assigned to receive the control condition.|75||
59843004|NCT00120627|75967617|FG000|Began Interventions|Overall Study|Two people dropped due to scheduling conflict and illness.|69||
59843005|NCT00120627|75967618|FG001|Began Interventions|Overall Study|Two people dropped due to scheduling conflict and an unknown reason.|73||
59843006|NCT00120627|75967617|FG000|Did Not Complete Post-tx Assessments|Overall Study|One person had a scheduling conflict and two people were incarcerated.|3||
59843007|NCT00120627|75967618|FG001|Did Not Complete Post-tx Assessments|Overall Study|Three people dropped out but no reason given.|3||
59843008|NCT00120627|75967617|FG000|COMPLETED|Overall Study||66||
59843009|NCT00120627|75967618|FG001|COMPLETED|Overall Study|Three people refused the post-assessments CAPS interview only.|70||
59843010|NCT00120627|75967617|FG000|NOT COMPLETED|Overall Study||5||
59843011|NCT00120627|75967618|FG001|NOT COMPLETED|Overall Study||5||
59843012|NCT03762616|75967633|FG000|STARTED|Overall Study||120||
59843013|NCT03762616|75967633|FG000|COMPLETED|Overall Study||118||
59843014|NCT03762616|75967633|FG000|NOT COMPLETED|Overall Study||2||
60120060|NCT03081052|76241325|FG000|STARTED|Overall Study||98|"Since these agents are standard of care at our institution for these operations, and either agent could be used outside of the study, participants were included in the analysis if they:~Did not die while awaiting surgery~Did not develop changes to enrollment criteria in the duration between consent and operation.~Was not withdrawn from study by physician before surgery"|
60120061|NCT03081052|76241326|FG001|STARTED|Overall Study||103|"Since these agents are standard of care at our institution for these operations, and either agent could be used outside of the study, participants were included in the analysis if they:~Did not die while awaiting surgery~Did not develop changes to enrollment criteria in the duration between consent and operation.~Was not withdrawn from study by physician before surgery"|
59843015|NCT04246996|75967641|FG000|STARTED|Overall Study||185|Randomized to study arm|
59843016|NCT04246996|75967642|FG001|STARTED|Overall Study||185|Randomized to study arm|
59843017|NCT04246996|75967641|FG000|COMPLETED|Overall Study||183|Analyzed|
59843018|NCT04246996|75967642|FG001|COMPLETED|Overall Study||180|Analyzed|
59843019|NCT04246996|75967641|FG000|NOT COMPLETED|Overall Study||2||
59843020|NCT04246996|75967642|FG001|NOT COMPLETED|Overall Study||5||
59843021|NCT00424463|75967651|FG000|STARTED|Overall Study||45||
59843022|NCT00424463|75967652|FG001|STARTED|Overall Study||48||
59843023|NCT00424463|75967653|FG002|STARTED|Overall Study||88||
59843024|NCT00424463|75967651|FG000|COMPLETED|Overall Study||38||
59843025|NCT00424463|75967652|FG001|COMPLETED|Overall Study||34||
59843026|NCT00424463|75967653|FG002|COMPLETED|Overall Study||72||
59843027|NCT00424463|75967651|FG000|NOT COMPLETED|Overall Study||7||
59843028|NCT00424463|75967652|FG001|NOT COMPLETED|Overall Study||14||
59843029|NCT00424463|75967653|FG002|NOT COMPLETED|Overall Study||16||
59843030|NCT00424385|75967661|FG000|STARTED|Cohort 0||12||
59843031|NCT00424385|75967661|FG000|COMPLETED|Cohort 0||6||
59843032|NCT00424385|75967661|FG000|NOT COMPLETED|Cohort 0||6||
59843033|NCT00424385|75967661|FG000|STARTED|Cohort 1||5||
59843034|NCT00424385|75967661|FG000|COMPLETED|Cohort 1||4||
59843035|NCT00424385|75967661|FG000|NOT COMPLETED|Cohort 1||1||
59843036|NCT00423917|75967667|FG000|STARTED|Overall Study||36||
59843037|NCT00423917|75967667|FG000|COMPLETED|Overall Study||33||
59843038|NCT00423917|75967667|FG000|NOT COMPLETED|Overall Study||3||
59843039|NCT00845026|75967673|FG000|STARTED|Study Period III||130||
59843040|NCT00845026|75967674|FG001|STARTED|Study Period III||131||
59843041|NCT00845026|75967673|FG000|COMPLETED|Study Period III|7 completed, left study; 28 completed, entered Study Phase IV.|35||
59843042|NCT00845026|75967674|FG001|COMPLETED|Study Period III|9 completed, left study; 50 completed, entered Study Phase IV.|59||
59843043|NCT00845026|75967673|FG000|NOT COMPLETED|Study Period III||95||
59843044|NCT00845026|75967674|FG001|NOT COMPLETED|Study Period III||72||
59843045|NCT00845026|75967673|FG000|STARTED|Study Period IV|7 completed period III but left study; 28 completed period III AND entered period IV.|28||
59843046|NCT00845026|75967674|FG001|STARTED|Study Period IV|9 completed period III, left study; 50 completed period III AND entered period IV.|50||
59843047|NCT00845026|75967673|FG000|COMPLETED|Study Period IV||12||
59843048|NCT00845026|75967674|FG001|COMPLETED|Study Period IV||46||
59843049|NCT00845026|75967673|FG000|NOT COMPLETED|Study Period IV||16||
59843050|NCT00845026|75967674|FG001|NOT COMPLETED|Study Period IV||4||
59843051|NCT00691678|75967682|FG000|STARTED|Overall Study||53||
59843052|NCT00691678|75967682|FG000|COMPLETED|Overall Study||37||
59843053|NCT00691678|75967682|FG000|NOT COMPLETED|Overall Study||16||
59843054|NCT00423605|75967686|FG000|STARTED|Overall Study||560||
59843055|NCT00423605|75967686|FG000|COMPLETED|Overall Study||319||
59843056|NCT00423605|75967686|FG000|NOT COMPLETED|Overall Study||241||
59843057|NCT00423449|75967690|FG000|STARTED|Overall Study||4||
59843058|NCT00423449|75967691|FG001|STARTED|Overall Study||6||
59843059|NCT00423449|75967692|FG002|STARTED|Overall Study||17||
59843060|NCT00423449|75967693|FG003|STARTED|Overall Study||27||
59843061|NCT00423449|75967694|FG004|STARTED|Overall Study||7||
59843062|NCT00423449|75967690|FG000|COMPLETED|Overall Study||1||
59843063|NCT00423449|75967691|FG001|COMPLETED|Overall Study||2||
59843064|NCT00423449|75967692|FG002|COMPLETED|Overall Study||2||
59843065|NCT00423449|75967693|FG003|COMPLETED|Overall Study||5||
59843066|NCT00423449|75967694|FG004|COMPLETED|Overall Study||0||
59843067|NCT00423449|75967690|FG000|NOT COMPLETED|Overall Study||3||
59843068|NCT00423449|75967691|FG001|NOT COMPLETED|Overall Study||4||
59843069|NCT00423449|75967692|FG002|NOT COMPLETED|Overall Study||15||
59843070|NCT00423449|75967693|FG003|NOT COMPLETED|Overall Study||22||
59843071|NCT00423449|75967694|FG004|NOT COMPLETED|Overall Study||7||
59843072|NCT00423293|75967707|FG000|STARTED|Overall Study||63||
59843073|NCT00423293|75967707|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|52||
59843074|NCT00423293|75967707|FG000|NOT COMPLETED|Overall Study||11||
59843075|NCT00423137|75967715|FG000|STARTED|Overall Study||11||
59843076|NCT00423137|75967716|FG001|STARTED|Overall Study||12||
59843077|NCT00423137|75967717|FG002|STARTED|Overall Study||13||
59843078|NCT00423137|75967718|FG003|STARTED|Overall Study||12||
59843079|NCT00423137|75967715|FG000|COMPLETED|Overall Study||10||
59843080|NCT00423137|75967716|FG001|COMPLETED|Overall Study||12||
59843081|NCT00423137|75967717|FG002|COMPLETED|Overall Study||7||
59843082|NCT00423137|75967718|FG003|COMPLETED|Overall Study||10||
59843083|NCT00423137|75967715|FG000|NOT COMPLETED|Overall Study||1||
59843084|NCT00423137|75967716|FG001|NOT COMPLETED|Overall Study||0||
59843085|NCT00423137|75967717|FG002|NOT COMPLETED|Overall Study||6||
59843086|NCT00423137|75967718|FG003|NOT COMPLETED|Overall Study||2||
59843087|NCT00422903|75967733|FG000|STARTED|Overall Study||49||
59843088|NCT00422903|75967734|FG001|STARTED|Overall Study||43||
59843089|NCT00422903|75967733|FG000|COMPLETED|Overall Study||45||
59843090|NCT00422903|75967734|FG001|COMPLETED|Overall Study||38||
59843091|NCT00422903|75967733|FG000|NOT COMPLETED|Overall Study||4||
59843092|NCT00422903|75967734|FG001|NOT COMPLETED|Overall Study||5||
59843093|NCT00422669|75967743|FG000|STARTED|Overall Study|Data required for analysis was not collected due to early termination. Analysis will not be done.|98||
59843094|NCT00422669|75967744|FG001|STARTED|Overall Study|Data required for analysis was not collected due to early termination. Analysis will not be done.|100||
59843095|NCT00422669|75967745|FG002|STARTED|Overall Study||7||
59843096|NCT00422669|75967743|FG000|COMPLETED|Overall Study|Data required for analysis was not collected due to early termination. Analysis will not be done.|0||
59843097|NCT00422669|75967744|FG001|COMPLETED|Overall Study|Data required for analysis was not collected due to early termination. Analysis will not be done.|0||
59843098|NCT00422669|75967745|FG002|COMPLETED|Overall Study||0||
59843099|NCT00422669|75967743|FG000|NOT COMPLETED|Overall Study||98||
59843100|NCT00422669|75967744|FG001|NOT COMPLETED|Overall Study||100||
59843101|NCT00422669|75967745|FG002|NOT COMPLETED|Overall Study||7||
59843102|NCT00422591|75967751|FG000|STARTED|Overall Study||175||
59843103|NCT00422591|75967751|FG000|COMPLETED|Overall Study||169||
59843104|NCT00422591|75967751|FG000|NOT COMPLETED|Overall Study||6||
59843105|NCT00422513|75967757|FG000|STARTED|Overall Study||130||
59843106|NCT00422513|75967758|FG001|STARTED|Overall Study||130||
59843107|NCT00422513|75967757|FG000|COMPLETED|Overall Study||23||
59843108|NCT00422513|75967758|FG001|COMPLETED|Overall Study||24||
59843109|NCT00422513|75967757|FG000|NOT COMPLETED|Overall Study||107||
59843110|NCT00422513|75967758|FG001|NOT COMPLETED|Overall Study||106||
59843111|NCT00202878|75967766|FG000|STARTED|Overall Study||9067||
59843112|NCT00202878|75967767|FG001|STARTED|Overall Study||9077||
59843113|NCT00202878|75967766|FG000|COMPLETED|Overall Study||6868||
59843114|NCT00202878|75967767|FG001|COMPLETED|Overall Study||6860||
59843115|NCT00202878|75967766|FG000|NOT COMPLETED|Overall Study||2199||
59843116|NCT00202878|75967767|FG001|NOT COMPLETED|Overall Study||2217||
59843117|NCT00414011|75967773|FG000|STARTED|Overall Study||40||
59843118|NCT00414011|75967773|FG000|COMPLETED|Overall Study||35||
59843119|NCT00414011|75967773|FG000|NOT COMPLETED|Overall Study||5||
59843120|NCT00231816|75967780|FG000|STARTED|Overall Study||382||
59843121|NCT00231816|75967781|FG001|STARTED|Overall Study||381||
59843122|NCT00231816|75967780|FG000|Vaccinated at Visit 1|Overall Study||382||
59843123|NCT00231816|75967781|FG001|Vaccinated at Visit 1|Overall Study|One participant was randomized but not vaccinated|380||
59843124|NCT00231816|75967780|FG000|Vaccinated at Visit 2|Overall Study||369||
59843125|NCT00231816|75967781|FG001|Vaccinated at Visit 2|Overall Study||371||
59843126|NCT00231816|75967780|FG000|COMPLETED|Overall Study|Participant received required vaccines and returned completed vaccination report cards at Visits 2&3|366||
59843127|NCT00231816|75967781|FG001|COMPLETED|Overall Study|Participant received required vaccines and returned completed vaccination report cards at Visits 2&3|369||
59843128|NCT00231816|75967780|FG000|NOT COMPLETED|Overall Study||16||
59843129|NCT00231816|75967781|FG001|NOT COMPLETED|Overall Study||12||
59843130|NCT00260208|75967790|FG000|STARTED|Overall Study|"Started indicates safety population."|184||
59843131|NCT00260208|75967791|FG001|STARTED|Overall Study||172||
59843132|NCT00260208|75967790|FG000|Intent to Treat (ITT) Population|Overall Study||182||
59843133|NCT00260208|75967791|FG001|Intent to Treat (ITT) Population|Overall Study||169||
59843134|NCT00260208|75967790|FG000|Modified ITT|Overall Study||101||
59843135|NCT00260208|75967791|FG001|Modified ITT|Overall Study||96||
59843136|NCT00260208|75967790|FG000|COMPLETED|Overall Study||137||
59843137|NCT00260208|75967791|FG001|COMPLETED|Overall Study||138||
59843138|NCT00260208|75967790|FG000|NOT COMPLETED|Overall Study||47||
59843139|NCT00260208|75967791|FG001|NOT COMPLETED|Overall Study||34||
59843140|NCT00202644|75967799|FG000|STARTED|Overall Study|One participant not randomized but treated.|76||
59843141|NCT00202644|75967800|FG001|STARTED|Overall Study||70||
59843142|NCT00202644|75967799|FG000|COMPLETED|Overall Study||41||
59843143|NCT00202644|75967800|FG001|COMPLETED|Overall Study||43||
59843144|NCT00202644|75967799|FG000|NOT COMPLETED|Overall Study||35||
59843145|NCT00202644|75967800|FG001|NOT COMPLETED|Overall Study||27||
59843146|NCT01235962|75967810|FG000|STARTED|Overall Study||198||
59843147|NCT01235962|75967811|FG001|STARTED|Overall Study||205||
59843148|NCT01235962|75967812|FG002|STARTED|Overall Study||571||
59843149|NCT01235962|75967813|FG003|STARTED|Overall Study||564||
59843150|NCT01235962|75967810|FG000|Prem. Withdrawn = Did Not Complete Study|Overall Study||46||
59843151|NCT01235962|75967811|FG001|Prem. Withdrawn = Did Not Complete Study|Overall Study||35||
59843152|NCT01235962|75967812|FG002|Prem. Withdrawn = Did Not Complete Study|Overall Study||118||
59843153|NCT01235962|75967813|FG003|Prem. Withdrawn = Did Not Complete Study|Overall Study||86||
59843154|NCT01235962|75967810|FG000|All Deaths|Overall Study||43||
59843155|NCT01235962|75967811|FG001|All Deaths|Overall Study||46||
59843156|NCT01235962|75967812|FG002|All Deaths|Overall Study||102||
59843157|NCT01235962|75967813|FG003|All Deaths|Overall Study||104||
59843158|NCT01235962|75967810|FG000|COMPLETED|Overall Study||152|Completed means dead or completed survival follow-up until the study completed.|
59843159|NCT01235962|75967811|FG001|COMPLETED|Overall Study||170|Completed means dead or completed survival follow-up until the study completed.|
59843160|NCT01235962|75967812|FG002|COMPLETED|Overall Study||453|Completed means dead or completed survival follow-up until the study completed.|
59843161|NCT01235962|75967813|FG003|COMPLETED|Overall Study||478|Completed means dead or completed survival follow-up until the study completed.|
59843162|NCT01235962|75967810|FG000|NOT COMPLETED|Overall Study||46||
59843163|NCT01235962|75967811|FG001|NOT COMPLETED|Overall Study||35||
59843164|NCT01235962|75967812|FG002|NOT COMPLETED|Overall Study||118||
59843165|NCT01235962|75967813|FG003|NOT COMPLETED|Overall Study||86||
59843166|NCT00259740|75967833|FG000|STARTED|Overall Study||43||
59843167|NCT00259740|75967834|FG001|STARTED|Overall Study||53||
59843168|NCT00259740|75967833|FG000|Received Study Medication|Overall Study||42||
59843169|NCT00259740|75967834|FG001|Received Study Medication|Overall Study||53||
59843170|NCT00259740|75967833|FG000|COMPLETED|Overall Study||0||
59843171|NCT00259740|75967834|FG001|COMPLETED|Overall Study||0||
59843172|NCT00259740|75967833|FG000|NOT COMPLETED|Overall Study||43||
59843173|NCT00259740|75967834|FG001|NOT COMPLETED|Overall Study||53||
59843174|NCT00201006|75967843|FG000|STARTED|Overall Study||83||
59843175|NCT00201006|75967844|FG001|STARTED|Overall Study||72||
59843176|NCT00201006|75967845|FG002|STARTED|Overall Study||79||
59843177|NCT00201006|75967843|FG000|COMPLETED|Overall Study||75||
59843178|NCT00201006|75967844|FG001|COMPLETED|Overall Study||70||
59843179|NCT00201006|75967845|FG002|COMPLETED|Overall Study||75||
59843180|NCT00201006|75967843|FG000|NOT COMPLETED|Overall Study||8||
59843181|NCT00201006|75967844|FG001|NOT COMPLETED|Overall Study||2||
59843182|NCT00201006|75967845|FG002|NOT COMPLETED|Overall Study||4||
59843183|NCT00200850|75967856|FG000|STARTED|Overall Study||10||
59843184|NCT00200850|75967857|FG001|STARTED|Overall Study||10||
59843185|NCT00200850|75967858|FG002|STARTED|Overall Study||11||
59843186|NCT00200850|75967856|FG000|COMPLETED|Overall Study||7||
59843187|NCT00200850|75967857|FG001|COMPLETED|Overall Study||9||
59843188|NCT00200850|75967858|FG002|COMPLETED|Overall Study||5||
59843189|NCT00200850|75967856|FG000|NOT COMPLETED|Overall Study||3||
59843190|NCT00200850|75967857|FG001|NOT COMPLETED|Overall Study||1||
59843191|NCT00200850|75967858|FG002|NOT COMPLETED|Overall Study||6||
59843192|NCT03812224|75967868|FG000|STARTED|Double-blind Treatment Period||131||
59843193|NCT03812224|75967869|FG001|STARTED|Double-blind Treatment Period||130||
59843194|NCT03812224|75967868|FG000|COMPLETED|Double-blind Treatment Period||127||
59843195|NCT03812224|75967869|FG001|COMPLETED|Double-blind Treatment Period||127||
59843196|NCT03812224|75967868|FG000|NOT COMPLETED|Double-blind Treatment Period||4||
59843197|NCT03812224|75967869|FG001|NOT COMPLETED|Double-blind Treatment Period||3||
59843198|NCT03812224|75967868|FG000|STARTED|Open-label Treatment Period||127||
59843199|NCT03812224|75967869|FG001|STARTED|Open-label Treatment Period||127||
59843200|NCT03812224|75967868|FG000|COMPLETED|Open-label Treatment Period||125||
59843201|NCT03812224|75967869|FG001|COMPLETED|Open-label Treatment Period||124||
59843202|NCT03812224|75967868|FG000|NOT COMPLETED|Open-label Treatment Period||2||
59843203|NCT03812224|75967869|FG001|NOT COMPLETED|Open-label Treatment Period||3||
59843204|NCT00231114|75967878|FG000|STARTED|Randomized||196||
59843205|NCT00231114|75967879|FG001|STARTED|Randomized||101||
59843206|NCT00231114|75967878|FG000|COMPLETED|Randomized||190||
59843207|NCT00231114|75967879|FG001|COMPLETED|Randomized||98||
59843208|NCT00231114|75967878|FG000|NOT COMPLETED|Randomized||6||
59843209|NCT00231114|75967879|FG001|NOT COMPLETED|Randomized||3||
59843210|NCT00231114|75967878|FG000|STARTED|Treatment Period||190||
59843211|NCT00231114|75967879|FG001|STARTED|Treatment Period||98||
59843212|NCT00231114|75967878|FG000|COMPLETED|Treatment Period||189||
59843213|NCT00231114|75967879|FG001|COMPLETED|Treatment Period||98||
59843214|NCT00231114|75967878|FG000|NOT COMPLETED|Treatment Period||1||
59843215|NCT00231114|75967879|FG001|NOT COMPLETED|Treatment Period||0||
59843216|NCT00231114|75967878|FG000|STARTED|Post-Treatment Period||189||
59843217|NCT00231114|75967879|FG001|STARTED|Post-Treatment Period||98||
59843218|NCT00231114|75967878|FG000|COMPLETED|Post-Treatment Period||181||
59843219|NCT00231114|75967879|FG001|COMPLETED|Post-Treatment Period||97||
59843220|NCT00231114|75967878|FG000|NOT COMPLETED|Post-Treatment Period||8||
60120062|NCT03081052|76241327|FG002|STARTED|Overall Study||111|"Since these agents are standard of care at our institution for these operations, and either agent could be used outside of the study, participants were included in the analysis if they:~Did not die while awaiting surgery~Did not develop changes to enrollment criteria in the duration between consent and operation.~Was not withdrawn from study by physician before surgery"|
60120063|NCT03081052|76241328|FG003|STARTED|Overall Study||120|"Since these agents are standard of care at our institution for these operations, and either agent could be used outside of the study, participants were included in the analysis if they:~Did not die while awaiting surgery~Did not develop changes to enrollment criteria in the duration between consent and operation.~Was not withdrawn from study by physician before surgery"|
60120064|NCT03081052|76241325|FG000|COMPLETED|Overall Study||98|The number of patients who completed primary outcome follow-up|
60120065|NCT03081052|76241326|FG001|COMPLETED|Overall Study||103|The number of patients who completed primary outcome follow-up|
60120066|NCT03081052|76241327|FG002|COMPLETED|Overall Study||111|The number of patients who completed primary outcome follow-up|
60120067|NCT03081052|76241328|FG003|COMPLETED|Overall Study||120|The number of patients who completed primary outcome follow-up|
60120068|NCT03081052|76241325|FG000|NOT COMPLETED|Overall Study||0||
60120069|NCT03081052|76241326|FG001|NOT COMPLETED|Overall Study||0||
60120070|NCT03081052|76241327|FG002|NOT COMPLETED|Overall Study||0||
60120071|NCT03081052|76241328|FG003|NOT COMPLETED|Overall Study||0||
60120072|NCT02693106|76241342|FG000|STARTED|Overall Study||13||
60120073|NCT02693106|76241342|FG000|COMPLETED|Overall Study||10||
59719297|NCT01159691|75838539|FG000|NOT COMPLETED|Overall Study||22||
59719298|NCT01157897|75838547|FG000|STARTED|Overall Study||10||
59719299|NCT01157897|75838548|FG001|STARTED|Overall Study||10||
59719300|NCT01157897|75838549|FG002|STARTED|Overall Study||10||
59719301|NCT01157897|75838550|FG003|STARTED|Overall Study||6||
59719302|NCT01157897|75838547|FG000|COMPLETED|Overall Study||8||
59719303|NCT01157897|75838548|FG001|COMPLETED|Overall Study||8||
59719304|NCT01157897|75838549|FG002|COMPLETED|Overall Study||10||
59719305|NCT01157897|75838550|FG003|COMPLETED|Overall Study||5||
59719306|NCT01157897|75838547|FG000|NOT COMPLETED|Overall Study||2||
59719307|NCT01157897|75838548|FG001|NOT COMPLETED|Overall Study||2||
59719308|NCT01157897|75838549|FG002|NOT COMPLETED|Overall Study||0||
59719309|NCT01157897|75838550|FG003|NOT COMPLETED|Overall Study||1||
59719310|NCT01185821|75838565|FG000|STARTED|Overall Study||33||
59719311|NCT01185821|75838566|FG001|STARTED|Overall Study||29||
59843221|NCT00231114|75967879|FG001|NOT COMPLETED|Post-Treatment Period||1||
59843222|NCT03543046|75967889|FG000|STARTED|Overall Study||14||
59843223|NCT03543046|75967890|FG001|STARTED|Overall Study||13||
59719312|NCT01185821|75838567|FG002|STARTED|Overall Study||43||
59719313|NCT01185821|75838568|FG003|STARTED|Overall Study||29||
59719314|NCT01185821|75838569|FG004|STARTED|Overall Study||50||
59843224|NCT03543046|75967889|FG000|COMPLETED|Overall Study||11||
59843225|NCT03543046|75967890|FG001|COMPLETED|Overall Study||11||
59843226|NCT03543046|75967889|FG000|NOT COMPLETED|Overall Study||3||
59843227|NCT03543046|75967890|FG001|NOT COMPLETED|Overall Study||2||
59843228|NCT03530800|75967898|FG000|STARTED|Overall Study||25||
59843229|NCT03530800|75967899|FG001|STARTED|Overall Study||25||
59843230|NCT03530800|75967898|FG000|COMPLETED|Overall Study||14||
59843231|NCT03530800|75967899|FG001|COMPLETED|Overall Study||16||
59843232|NCT03530800|75967898|FG000|NOT COMPLETED|Overall Study||11||
59843233|NCT03530800|75967899|FG001|NOT COMPLETED|Overall Study||9||
59843234|NCT00259272|75967909|FG000|STARTED|Overall Study||36||
59843235|NCT00259272|75967910|FG001|STARTED|Overall Study||31||
59843236|NCT00259272|75967911|FG002|STARTED|Overall Study||26||
59843237|NCT00259272|75967912|FG003|STARTED|Overall Study||48||
59843238|NCT00259272|75967909|FG000|COMPLETED|Overall Study||21||
59843239|NCT00259272|75967910|FG001|COMPLETED|Overall Study||24||
59843240|NCT00259272|75967911|FG002|COMPLETED|Overall Study||21||
59843241|NCT00259272|75967912|FG003|COMPLETED|Overall Study||27||
59843242|NCT00259272|75967909|FG000|NOT COMPLETED|Overall Study||15||
59843243|NCT00259272|75967910|FG001|NOT COMPLETED|Overall Study||7||
59843244|NCT00259272|75967911|FG002|NOT COMPLETED|Overall Study||5||
59843245|NCT00259272|75967912|FG003|NOT COMPLETED|Overall Study||21||
59843246|NCT03090412|75967929|FG000|STARTED|Overall Study||1||
59843247|NCT03090412|75967930|FG001|STARTED|Overall Study||1||
59843248|NCT03090412|75967929|FG000|COMPLETED|Overall Study||1||
59843249|NCT03090412|75967930|FG001|COMPLETED|Overall Study||1||
59843250|NCT03090412|75967929|FG000|NOT COMPLETED|Overall Study||0||
59843251|NCT03090412|75967930|FG001|NOT COMPLETED|Overall Study||0||
59843252|NCT00421889|75967945|FG000|STARTED|Overall Study||5||
59843253|NCT00421889|75967946|FG001|STARTED|Overall Study||5||
59843254|NCT00421889|75967947|FG002|STARTED|Overall Study||3||
59843255|NCT00421889|75967948|FG003|STARTED|Overall Study||4||
59843256|NCT00421889|75967949|FG004|STARTED|Overall Study||6||
59843257|NCT00421889|75967950|FG005|STARTED|Overall Study||35||
59843258|NCT00421889|75967951|FG006|STARTED|Overall Study||4||
59843259|NCT00421889|75967952|FG007|STARTED|Overall Study||3||
59843260|NCT00421889|75967953|FG008|STARTED|Overall Study||15||
59843261|NCT00421889|75967945|FG000|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 5.20|0||
59843262|NCT00421889|75967946|FG001|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 8.20|0||
59843263|NCT00421889|75967947|FG002|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 3.33|0||
59843264|NCT00421889|75967948|FG003|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 9.25|0||
59843265|NCT00421889|75967949|FG004|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 5.00|0||
59843266|NCT00421889|75967950|FG005|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 7.69|0||
59843267|NCT00421889|75967951|FG006|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 5.50|0||
59843268|NCT00421889|75967952|FG007|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 3.33|1||
59843269|NCT00421889|75967953|FG008|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 4.27|4||
59843270|NCT00421889|75967945|FG000|NOT COMPLETED|Overall Study||5||
59843271|NCT00421889|75967946|FG001|NOT COMPLETED|Overall Study||5||
59843272|NCT00421889|75967947|FG002|NOT COMPLETED|Overall Study||3||
59843273|NCT00421889|75967948|FG003|NOT COMPLETED|Overall Study||4||
59843274|NCT00421889|75967949|FG004|NOT COMPLETED|Overall Study||6||
59843275|NCT00421889|75967950|FG005|NOT COMPLETED|Overall Study||35||
59843276|NCT00421889|75967951|FG006|NOT COMPLETED|Overall Study||4||
59843277|NCT00421889|75967952|FG007|NOT COMPLETED|Overall Study||2||
59843278|NCT00421889|75967953|FG008|NOT COMPLETED|Overall Study||11||
59843279|NCT00421733|75967980|FG000|STARTED|Overall Study||93||
59843280|NCT00421733|75967981|FG001|STARTED|Overall Study||95||
59719315|NCT01185821|75838565|FG000|Patients With Washout|Overall Study||33||
59719316|NCT01185821|75838566|FG001|Patients With Washout|Overall Study||29||
59719317|NCT01185821|75838567|FG002|Patients With Washout|Overall Study||39||
59719318|NCT01185821|75838568|FG003|Patients With Washout|Overall Study||29||
59719319|NCT01185821|75838569|FG004|Patients With Washout|Overall Study||33||
59719320|NCT01185821|75838565|FG000|Patients Without Washout|Overall Study||0||
59719321|NCT01185821|75838566|FG001|Patients Without Washout|Overall Study||0||
59719322|NCT01185821|75838567|FG002|Patients Without Washout|Overall Study||4||
59719323|NCT01185821|75838568|FG003|Patients Without Washout|Overall Study||0||
59719324|NCT01185821|75838569|FG004|Patients Without Washout|Overall Study||17||
59843281|NCT00421733|75967982|FG002|STARTED|Overall Study||93||
59843282|NCT00421733|75967980|FG000|COMPLETED|Overall Study||78||
59843283|NCT00421733|75967981|FG001|COMPLETED|Overall Study||69||
59843284|NCT00421733|75967982|FG002|COMPLETED|Overall Study||73||
59843285|NCT00421733|75967980|FG000|NOT COMPLETED|Overall Study||15||
59843286|NCT00421733|75967981|FG001|NOT COMPLETED|Overall Study||26||
59843287|NCT00421733|75967982|FG002|NOT COMPLETED|Overall Study||20||
59843288|NCT00421343|75967994|FG000|STARTED|Overall Study||29||
59843289|NCT00421343|75967994|FG000|COMPLETED|Overall Study||23||
59843290|NCT00421343|75967994|FG000|NOT COMPLETED|Overall Study||6||
59843291|NCT00230178|75968001|FG000|STARTED|Overall Study|Intent-to-treat (ITT)population: randomized patients|94||
59843292|NCT00230178|75968002|FG001|STARTED|Overall Study||93||
59843293|NCT00230178|75968003|FG002|STARTED|Overall Study||93||
59843294|NCT00230178|75968001|FG000|Treated|Overall Study|Modified ITT population: ITT patients with at least 1 dose of study drug|92||
59843295|NCT00230178|75968002|FG001|Treated|Overall Study||92||
59843296|NCT00230178|75968003|FG002|Treated|Overall Study||91||
59843297|NCT00230178|75968001|FG000|COMPLETED|Overall Study||90||
59843298|NCT00230178|75968002|FG001|COMPLETED|Overall Study||86||
59843299|NCT00230178|75968003|FG002|COMPLETED|Overall Study||86||
59843300|NCT00230178|75968001|FG000|NOT COMPLETED|Overall Study||4||
59843301|NCT00230178|75968002|FG001|NOT COMPLETED|Overall Study||7||
59843302|NCT00230178|75968003|FG002|NOT COMPLETED|Overall Study||7||
59843303|NCT00413777|75968013|FG000|STARTED|Fixed-dose Period||22|Screened N=47; Titration period N=46; Subjects were randomized only at Fixed dose period, as above|
59843304|NCT00413777|75968014|FG001|STARTED|Fixed-dose Period||24|Screened N=47; Titration period N=46; Subjects were randomized only at Fixed dose period, as above|
59843305|NCT00413777|75968013|FG000|COMPLETED|Fixed-dose Period||18||
59843306|NCT00413777|75968014|FG001|COMPLETED|Fixed-dose Period||21||
59843307|NCT00413777|75968013|FG000|NOT COMPLETED|Fixed-dose Period||4||
59843308|NCT00413777|75968014|FG001|NOT COMPLETED|Fixed-dose Period||3||
59843309|NCT00413777|75968013|FG000|STARTED|Extension Period||17||
59843310|NCT00413777|75968014|FG001|STARTED|Extension Period||18||
59843311|NCT00413777|75968013|FG000|COMPLETED|Extension Period||17||
59843312|NCT00413777|75968014|FG001|COMPLETED|Extension Period||18||
59843313|NCT00413777|75968013|FG000|NOT COMPLETED|Extension Period||0||
59843314|NCT00413777|75968014|FG001|NOT COMPLETED|Extension Period||0||
59843315|NCT00197028|75968022|FG000|STARTED|Overall Study||107||
59843316|NCT00197028|75968023|FG001|STARTED|Overall Study||107||
59843317|NCT00197028|75968022|FG000|COMPLETED|Overall Study||91||
59843318|NCT00197028|75968023|FG001|COMPLETED|Overall Study||86||
59843319|NCT00197028|75968022|FG000|NOT COMPLETED|Overall Study||16||
59843320|NCT00197028|75968023|FG001|NOT COMPLETED|Overall Study||21||
59843321|NCT00420641|75968032|FG000|STARTED|Overall Study||160||
59843322|NCT00420641|75968033|FG001|STARTED|Overall Study||172||
59843323|NCT00420641|75968034|FG002|STARTED|Overall Study||172||
59843324|NCT00420641|75968032|FG000|COMPLETED|Overall Study||115||
59843325|NCT00420641|75968033|FG001|COMPLETED|Overall Study||100||
59843326|NCT00420641|75968034|FG002|COMPLETED|Overall Study||128||
59843327|NCT00420641|75968032|FG000|NOT COMPLETED|Overall Study||45||
59843328|NCT00420641|75968033|FG001|NOT COMPLETED|Overall Study||72||
59843329|NCT00420641|75968034|FG002|NOT COMPLETED|Overall Study||44||
59843330|NCT00257556|75968044|FG000|STARTED|Overall Study||38||
59843331|NCT00257556|75968045|FG001|STARTED|Overall Study||42||
59843332|NCT00257556|75968044|FG000|All Patients Treated Population|Overall Study|Also the safety population. One randomized patient did not receive study medication.|37||
59843333|NCT00257556|75968045|FG001|All Patients Treated Population|Overall Study|Also the safety population. Three randomized patients did not receive study medication.|39||
59843334|NCT00257556|75968044|FG000|COMPLETED|Overall Study||24||
59843335|NCT00257556|75968045|FG001|COMPLETED|Overall Study||32||
59843336|NCT00257556|75968044|FG000|NOT COMPLETED|Overall Study||14||
59843337|NCT00257556|75968045|FG001|NOT COMPLETED|Overall Study||10||
59843338|NCT00228384|75968053|FG000|STARTED|Overall Study||72||
59843339|NCT00228384|75968054|FG001|STARTED|Overall Study||76||
59843340|NCT00228384|75968053|FG000|Baseline|Overall Study||72||
59843341|NCT00228384|75968054|FG001|Baseline|Overall Study||76||
59843342|NCT00228384|75968053|FG000|30-Day Follow-up (Safety Outcome)|Overall Study||69||
59843343|NCT00228384|75968054|FG001|30-Day Follow-up (Safety Outcome)|Overall Study||72||
59843344|NCT00228384|75968053|FG000|Three Year Follow-up (Final)|Overall Study||43||
59843345|NCT00228384|75968054|FG001|Three Year Follow-up (Final)|Overall Study||47||
59843346|NCT00228384|75968053|FG000|COMPLETED|Overall Study||43||
59843347|NCT00228384|75968054|FG001|COMPLETED|Overall Study||47||
59843348|NCT00228384|75968053|FG000|NOT COMPLETED|Overall Study||29||
59843349|NCT00228384|75968054|FG001|NOT COMPLETED|Overall Study||29||
59843350|NCT00257166|75968062|FG000|STARTED|Overall Study||150||
59843351|NCT00257166|75968063|FG001|STARTED|Overall Study||88||
59843352|NCT00257166|75968062|FG000|Treated|Overall Study||149||
59843353|NCT00257166|75968063|FG001|Treated|Overall Study||88||
59567831|NCT01213329|75670689|FG000|STARTED|Phase 2|No subjects continued into phase 2.This is due to a loss of samples from a processing inconsistency.|0||
59843354|NCT00257166|75968062|FG000|COMPLETED|Overall Study||97||
59843355|NCT00257166|75968063|FG001|COMPLETED|Overall Study||51||
59843356|NCT00257166|75968062|FG000|NOT COMPLETED|Overall Study||53||
59843357|NCT00257166|75968063|FG001|NOT COMPLETED|Overall Study||37||
59843358|NCT00227370|75968071|FG000|STARTED|Overall Study|Placebo Group|66||
59843359|NCT00227370|75968072|FG001|STARTED|Overall Study|Treatment Group|70||
59843360|NCT00227370|75968071|FG000|COMPLETED|Overall Study||45||
59843361|NCT00227370|75968072|FG001|COMPLETED|Overall Study||46||
59567832|NCT01213329|75670690|FG001|STARTED|Phase 2|No subjects continued into phase 2.This is due to a loss of samples from a processing inconsistency.|0||
59567833|NCT01213329|75670689|FG000|COMPLETED|Phase 2||0||
59843362|NCT00227370|75968071|FG000|NOT COMPLETED|Overall Study||21||
59843363|NCT00227370|75968072|FG001|NOT COMPLETED|Overall Study||24||
59843364|NCT00191100|75968080|FG000|STARTED|Overall Study||259||
59843365|NCT00191100|75968081|FG001|STARTED|Overall Study||256||
59843366|NCT00191100|75968080|FG000|COMPLETED|Overall Study||217||
59843367|NCT00191100|75968081|FG001|COMPLETED|Overall Study||244||
59843368|NCT00191100|75968080|FG000|NOT COMPLETED|Overall Study||42||
59843369|NCT00191100|75968081|FG001|NOT COMPLETED|Overall Study||12||
59843370|NCT00189540|75968089|FG000|STARTED|Overall Study||21||
59843371|NCT00189540|75968090|FG001|STARTED|Overall Study||6||
59843372|NCT00189540|75968089|FG000|COMPLETED|Overall Study||14||
59843373|NCT00189540|75968090|FG001|COMPLETED|Overall Study||5||
59843374|NCT00189540|75968089|FG000|NOT COMPLETED|Overall Study||7||
59843375|NCT00189540|75968090|FG001|NOT COMPLETED|Overall Study||1||
59843376|NCT00257010|75968096|FG000|STARTED|Overall Study||447||
59843377|NCT00257010|75968096|FG000|COMPLETED|Overall Study||319||
59843378|NCT00257010|75968096|FG000|NOT COMPLETED|Overall Study||128||
59843379|NCT00256854|75968106|FG000|STARTED|Overall Study||26||
59843380|NCT00256854|75968107|FG001|STARTED|Overall Study||26||
59843381|NCT00256854|75968108|FG002|STARTED|Overall Study||26||
59843382|NCT00256854|75968109|FG003|STARTED|Overall Study||27||
59843383|NCT00256854|75968110|FG004|STARTED|Overall Study||16||
59843384|NCT00256854|75968111|FG005|STARTED|Overall Study||14||
59843385|NCT00256854|75968106|FG000|COMPLETED|Overall Study||23||
59843386|NCT00256854|75968107|FG001|COMPLETED|Overall Study||22||
59843387|NCT00256854|75968108|FG002|COMPLETED|Overall Study||23||
59843388|NCT00256854|75968109|FG003|COMPLETED|Overall Study||24||
59843389|NCT00256854|75968110|FG004|COMPLETED|Overall Study||15||
59843390|NCT00256854|75968111|FG005|COMPLETED|Overall Study||13||
59843391|NCT00256854|75968106|FG000|NOT COMPLETED|Overall Study||3||
59843392|NCT00256854|75968107|FG001|NOT COMPLETED|Overall Study||4||
59843393|NCT00256854|75968108|FG002|NOT COMPLETED|Overall Study||3||
59843394|NCT00256854|75968109|FG003|NOT COMPLETED|Overall Study||3||
59843395|NCT00256854|75968110|FG004|NOT COMPLETED|Overall Study||1||
59843396|NCT00256854|75968111|FG005|NOT COMPLETED|Overall Study||1||
59843397|NCT00189462|75968128|FG000|STARTED|Overall Study||50||
59843398|NCT00189462|75968129|FG001|STARTED|Overall Study||49||
59843399|NCT00189462|75968128|FG000|COMPLETED|Overall Study||27||
59843400|NCT00189462|75968129|FG001|COMPLETED|Overall Study||28||
59843401|NCT00189462|75968128|FG000|NOT COMPLETED|Overall Study||23||
59843402|NCT00189462|75968129|FG001|NOT COMPLETED|Overall Study||21||
59843403|NCT00256698|75968137|FG000|STARTED|Overall Study||258||
59843404|NCT00256698|75968138|FG001|STARTED|Overall Study||256||
59843405|NCT00256698|75968137|FG000|COMPLETED|Overall Study||91||
59843406|NCT00256698|75968138|FG001|COMPLETED|Overall Study||84||
59843407|NCT00256698|75968137|FG000|NOT COMPLETED|Overall Study||167||
59843408|NCT00256698|75968138|FG001|NOT COMPLETED|Overall Study||172||
59843409|NCT00189306|75968144|FG000|STARTED|Treatment Period||169||
59843410|NCT00189306|75968144|FG000|COMPLETED|Treatment Period|5 subjects discontinued during treatment - 4 subjects returned for the Posttreatment Period|164||
59843411|NCT00189306|75968144|FG000|NOT COMPLETED|Treatment Period||5||
59843412|NCT00189306|75968144|FG000|STARTED|Posttreatment Period|5 of the 169 discontinued, but 4 returned for the Posttreatment Period|169||
59843413|NCT00189306|75968144|FG000|COMPLETED|Posttreatment Period|11 subjects discontinued during the 12-week Posttreatment Period|157||
59843414|NCT00189306|75968144|FG000|NOT COMPLETED|Posttreatment Period||12||
59843415|NCT00189306|75968144|FG000|STARTED|Long-Term Follow-up||157||
59843416|NCT00189306|75968144|FG000|COMPLETED|Long-Term Follow-up||119||
59843417|NCT00189306|75968144|FG000|NOT COMPLETED|Long-Term Follow-up||38||
59843418|NCT00187278|75968150|FG000|STARTED|Overall Study||918||
59843419|NCT00187278|75968151|FG001|STARTED|Overall Study||915||
59843420|NCT00187278|75968150|FG000|COMPLETED|Overall Study||908||
59843421|NCT00187278|75968151|FG001|COMPLETED|Overall Study||902||
59843422|NCT00187278|75968150|FG000|NOT COMPLETED|Overall Study||10||
59843423|NCT00187278|75968151|FG001|NOT COMPLETED|Overall Study||13||
59843424|NCT00256308|75968159|FG000|STARTED|Overall Study||6||
59843425|NCT00256308|75968159|FG000|COMPLETED|Overall Study||4||
59843426|NCT00256308|75968159|FG000|NOT COMPLETED|Overall Study||2||
59843427|NCT00255840|75968165|FG000|STARTED|Overall Study||408||
59843428|NCT00255840|75968166|FG001|STARTED|Overall Study||404||
59843429|NCT00255840|75968165|FG000|COMPLETED|Overall Study||345||
59843430|NCT00255840|75968166|FG001|COMPLETED|Overall Study||334||
59843431|NCT00255840|75968165|FG000|NOT COMPLETED|Overall Study||63||
59843432|NCT00255840|75968166|FG001|NOT COMPLETED|Overall Study||70||
59843433|NCT00224874|75968176|FG000|STARTED|Overall Study||46||
59843434|NCT00224874|75968177|FG001|STARTED|Overall Study||45||
59843435|NCT00224874|75968178|FG002|STARTED|Overall Study||47||
59843436|NCT00224874|75968179|FG003|STARTED|Overall Study||42||
59567834|NCT01213329|75670690|FG001|COMPLETED|Phase 2||0||
59843437|NCT00224874|75968176|FG000|COMPLETED|Overall Study||46||
59843438|NCT00224874|75968177|FG001|COMPLETED|Overall Study||45||
59843439|NCT00224874|75968178|FG002|COMPLETED|Overall Study||46||
59843440|NCT00224874|75968179|FG003|COMPLETED|Overall Study||42||
59843441|NCT00224874|75968176|FG000|NOT COMPLETED|Overall Study||0||
59843442|NCT00224874|75968177|FG001|NOT COMPLETED|Overall Study||0||
59843443|NCT00224874|75968178|FG002|NOT COMPLETED|Overall Study||1||
59567835|NCT01213329|75670689|FG000|NOT COMPLETED|Phase 2||0||
59843444|NCT00224874|75968179|FG003|NOT COMPLETED|Overall Study||0||
59843445|NCT00186186|75968189|FG000|STARTED|Overall Study||28||
59843446|NCT00186186|75968189|FG000|COMPLETED|Overall Study||20||
59843447|NCT00186186|75968189|FG000|NOT COMPLETED|Overall Study||8||
59843448|NCT00185640|75968194|FG000|STARTED|Overall Study||303||
59843449|NCT00185640|75968194|FG000|Transplanted|Overall Study||296||
59843450|NCT00185640|75968194|FG000|90 Days Post-transplant|Overall Study||161||
59843451|NCT00185640|75968194|FG000|COMPLETED|Overall Study||158||
59843452|NCT00185640|75968194|FG000|NOT COMPLETED|Overall Study||145||
59843453|NCT03760666|75968201|FG000|STARTED|Overall Study||5||
59843454|NCT03760666|75968202|FG001|STARTED|Overall Study||11||
59843455|NCT03760666|75968203|FG002|STARTED|Overall Study||1||
59843456|NCT03760666|75968201|FG000|COMPLETED|Overall Study||0||
59843457|NCT03760666|75968202|FG001|COMPLETED|Overall Study||0||
59843458|NCT03760666|75968203|FG002|COMPLETED|Overall Study||0||
59843459|NCT03760666|75968201|FG000|NOT COMPLETED|Overall Study||5||
59843460|NCT03760666|75968202|FG001|NOT COMPLETED|Overall Study||11||
59843461|NCT03760666|75968203|FG002|NOT COMPLETED|Overall Study||1||
59843462|NCT03760510|75968216|FG000|STARTED|Overall Study||250||
59843463|NCT03760510|75968217|FG001|STARTED|Overall Study||250||
59843464|NCT03760510|75968216|FG000|COMPLETED|Overall Study||145||
59843465|NCT03760510|75968217|FG001|COMPLETED|Overall Study||153||
59843466|NCT03760510|75968216|FG000|NOT COMPLETED|Overall Study||105||
59843467|NCT03760510|75968217|FG001|NOT COMPLETED|Overall Study||97||
59843468|NCT00224484|75968226|FG000|STARTED|Overall Study||2977|5960 subjects were randomized, but only 5955 received vaccination|
59843469|NCT00224484|75968227|FG001|STARTED|Overall Study||1491|5960 subjects were randomized, but only 5955 received vaccination|
59843470|NCT00224484|75968228|FG002|STARTED|Overall Study||1487|5960 subjects were randomized, but only 5955 received vaccination|
59843471|NCT00224484|75968226|FG000|COMPLETED|Overall Study||2831||
59843472|NCT00224484|75968227|FG001|COMPLETED|Overall Study||1426||
59843473|NCT00224484|75968228|FG002|COMPLETED|Overall Study||1425||
59843474|NCT00224484|75968226|FG000|NOT COMPLETED|Overall Study||146||
59843475|NCT00224484|75968227|FG001|NOT COMPLETED|Overall Study||65||
59843476|NCT00224484|75968228|FG002|NOT COMPLETED|Overall Study||62||
59843477|NCT00254982|75968241|FG000|STARTED|Overall Study||297||
59843478|NCT00254982|75968242|FG001|STARTED|Overall Study||296||
59843479|NCT00254982|75968241|FG000|COMPLETED|Overall Study||261||
59843480|NCT00254982|75968242|FG001|COMPLETED|Overall Study||265||
59843481|NCT00254982|75968241|FG000|NOT COMPLETED|Overall Study||36||
59843482|NCT00254982|75968242|FG001|NOT COMPLETED|Overall Study||31||
59843483|NCT03759340|75968248|FG000|STARTED|Overall Study||56||
59843484|NCT03759340|75968248|FG000|COMPLETED|Overall Study||0||
59843485|NCT03759340|75968248|FG000|NOT COMPLETED|Overall Study||56||
59843486|NCT00224016|75968254|FG000|STARTED|Titration Period||39||
59843487|NCT00224016|75968255|FG001|STARTED|Titration Period||16||
59843488|NCT00224016|75968254|FG000|COMPLETED|Titration Period||38||
59843489|NCT00224016|75968255|FG001|COMPLETED|Titration Period||15||
59843490|NCT00224016|75968254|FG000|NOT COMPLETED|Titration Period||1||
59843491|NCT00224016|75968255|FG001|NOT COMPLETED|Titration Period||1||
59843492|NCT00224016|75968254|FG000|STARTED|Maintenance Period||38||
59843493|NCT00224016|75968255|FG001|STARTED|Maintenance Period||15||
59843494|NCT00224016|75968254|FG000|COMPLETED|Maintenance Period||36||
59843495|NCT00224016|75968255|FG001|COMPLETED|Maintenance Period||14||
59843496|NCT00224016|75968254|FG000|NOT COMPLETED|Maintenance Period||2||
59843497|NCT00224016|75968255|FG001|NOT COMPLETED|Maintenance Period||1||
59843498|NCT00224016|75968254|FG000|STARTED|Follow-Up Period||35||
59843499|NCT00224016|75968255|FG001|STARTED|Follow-Up Period|This group of subjects did not proceed to follow-up period.|0||
59843500|NCT00224016|75968254|FG000|COMPLETED|Follow-Up Period||35||
59843501|NCT00224016|75968255|FG001|COMPLETED|Follow-Up Period||0||
59843502|NCT00224016|75968254|FG000|NOT COMPLETED|Follow-Up Period||0||
59843503|NCT00224016|75968255|FG001|NOT COMPLETED|Follow-Up Period||0||
60120074|NCT02693106|76241342|FG000|NOT COMPLETED|Overall Study||3||
60120075|NCT02546986|76241354|FG000|STARTED|Treatment Period||51||
60120076|NCT02546986|76241355|FG001|STARTED|Treatment Period||49||
60120077|NCT02546986|76241354|FG000|COMPLETED|Treatment Period||0|Completed = Not applicable according to the study design|
59843504|NCT03757234|75968266|FG000|STARTED|Overall Study||75||
59843505|NCT03757234|75968267|FG001|STARTED|Overall Study||18||
59843506|NCT03757234|75968268|FG002|STARTED|Overall Study||17||
59843507|NCT03757234|75968269|FG003|STARTED|Overall Study||17||
59843508|NCT03757234|75968270|FG004|STARTED|Overall Study||74||
60120078|NCT02546986|76241355|FG001|COMPLETED|Treatment Period||0|Completed = Not applicable according to the study design|
60120079|NCT02546986|76241354|FG000|NOT COMPLETED|Treatment Period||51||
59843509|NCT03757234|75968266|FG000|Completed PTE Visit|Overall Study||72||
59843510|NCT03757234|75968267|FG001|Completed PTE Visit|Overall Study||16||
59843511|NCT03757234|75968268|FG002|Completed PTE Visit|Overall Study||17||
59843512|NCT03757234|75968269|FG003|Completed PTE Visit|Overall Study||16||
59843513|NCT03757234|75968270|FG004|Completed PTE Visit|Overall Study||71||
59843514|NCT03757234|75968266|FG000|COMPLETED|Overall Study||72||
59843515|NCT03757234|75968267|FG001|COMPLETED|Overall Study||16||
59843516|NCT03757234|75968268|FG002|COMPLETED|Overall Study||17||
59843517|NCT03757234|75968269|FG003|COMPLETED|Overall Study||16||
59843518|NCT03757234|75968270|FG004|COMPLETED|Overall Study||70||
59843519|NCT03757234|75968266|FG000|NOT COMPLETED|Overall Study||3||
59843520|NCT03757234|75968267|FG001|NOT COMPLETED|Overall Study||2||
59843521|NCT03757234|75968268|FG002|NOT COMPLETED|Overall Study||0||
59843522|NCT03757234|75968269|FG003|NOT COMPLETED|Overall Study||1||
59843523|NCT03757234|75968270|FG004|NOT COMPLETED|Overall Study||4||
59843524|NCT00223080|75968284|FG000|STARTED|Overall Study||8197||
59843525|NCT00223080|75968285|FG001|STARTED|Overall Study||8198||
59843526|NCT00223080|75968284|FG000|COMPLETED|Overall Study||7401||
59843527|NCT00223080|75968285|FG001|COMPLETED|Overall Study||7401||
59843528|NCT00223080|75968284|FG000|NOT COMPLETED|Overall Study||796||
59843529|NCT00223080|75968285|FG001|NOT COMPLETED|Overall Study||797||
59843530|NCT00220740|75968293|FG000|STARTED|Efficacy Period||59||
59843531|NCT00220740|75968294|FG001|STARTED|Efficacy Period||58||
59843532|NCT00220740|75968293|FG000|COMPLETED|Efficacy Period||33||
59843533|NCT00220740|75968294|FG001|COMPLETED|Efficacy Period||12||
59843534|NCT00220740|75968293|FG000|NOT COMPLETED|Efficacy Period||26||
59843535|NCT00220740|75968294|FG001|NOT COMPLETED|Efficacy Period||46||
59843536|NCT00220740|75968293|FG000|STARTED|Rescue Treatment|Only the subjects who failed the treatment in the Efficacy period entered the Rescue period.|45||
59843537|NCT00220740|75968294|FG001|STARTED|Rescue Treatment|Only the subjects who failed the treatment in the Efficacy period entered the Rescue period.|23||
59843538|NCT00220740|75968293|FG000|COMPLETED|Rescue Treatment||26||
59843539|NCT00220740|75968294|FG001|COMPLETED|Rescue Treatment||5||
59843540|NCT00220740|75968293|FG000|NOT COMPLETED|Rescue Treatment||19||
59843541|NCT00220740|75968294|FG001|NOT COMPLETED|Rescue Treatment||18||
59843542|NCT00220740|75968293|FG000|STARTED|Withdrawal Period|The subjects who were success in Efficacy or Rescue Period were re-randomized to Withdrawal period.|43||
59843543|NCT00220740|75968294|FG001|STARTED|Withdrawal Period|The subjects who were success in Efficacy or Rescue Period were re-randomized to Withdrawal period.|31||
59843544|NCT00220740|75968293|FG000|COMPLETED|Withdrawal Period||37||
59843545|NCT00220740|75968294|FG001|COMPLETED|Withdrawal Period||16||
59843546|NCT00220740|75968293|FG000|NOT COMPLETED|Withdrawal Period||6||
59843547|NCT00220740|75968294|FG001|NOT COMPLETED|Withdrawal Period||15||
59843548|NCT00184002|75968302|FG000|STARTED|Overall Study||68||
59843549|NCT00184002|75968302|FG000|COMPLETED|Overall Study||51||
59843550|NCT00184002|75968302|FG000|NOT COMPLETED|Overall Study||17||
59843551|NCT00165672|75968308|FG000|STARTED|Overall Study||13||
59843552|NCT00165672|75968309|FG001|STARTED|Overall Study||13||
59843553|NCT00165672|75968308|FG000|COMPLETED|Overall Study||13||
59843554|NCT00165672|75968309|FG001|COMPLETED|Overall Study||12||
59843555|NCT00165672|75968308|FG000|NOT COMPLETED|Overall Study||0||
59843556|NCT00165672|75968309|FG001|NOT COMPLETED|Overall Study||1||
59843557|NCT00180414|75968317|FG000|STARTED|Overall Study||4||
59843558|NCT00180414|75968318|FG001|STARTED|Overall Study||4||
59843559|NCT00180414|75968317|FG000|COMPLETED|Overall Study||0||
59843560|NCT00180414|75968318|FG001|COMPLETED|Overall Study||0||
59843561|NCT00180414|75968317|FG000|NOT COMPLETED|Overall Study||4||
59843562|NCT00180414|75968318|FG001|NOT COMPLETED|Overall Study||4||
59843563|NCT00174252|75968324|FG000|STARTED|Overall Study||57||
59843564|NCT00174252|75968324|FG000|COMPLETED|Overall Study||55||
59843565|NCT00174252|75968324|FG000|NOT COMPLETED|Overall Study||2||
59843566|NCT00169104|75968332|FG000|STARTED|Overall Study||13||
59843567|NCT00169104|75968333|FG001|STARTED|Overall Study||10||
59843568|NCT00169104|75968332|FG000|COMPLETED|Overall Study||11||
59843569|NCT00169104|75968333|FG001|COMPLETED|Overall Study||8||
59843570|NCT00169104|75968332|FG000|NOT COMPLETED|Overall Study||2||
59843571|NCT00169104|75968333|FG001|NOT COMPLETED|Overall Study||2||
59843572|NCT00163020|75968342|FG000|STARTED|Overall Study|Twins = 160 Triplets = 56|216||
59843573|NCT00163020|75968343|FG001|STARTED|Overall Study|Twins = 80 Triplets = 25|105||
59843574|NCT00163020|75968342|FG000|COMPLETED|Overall Study|Twins = 160 Triplets = 56|216||
59843575|NCT00163020|75968343|FG001|COMPLETED|Overall Study|Twins = 78 Triplets = 25|103||
59843576|NCT00163020|75968342|FG000|NOT COMPLETED|Overall Study||0||
59843577|NCT00163020|75968343|FG001|NOT COMPLETED|Overall Study||2||
59843578|NCT00252720|75968353|FG000|STARTED|Overall Study||951||
59843579|NCT00252720|75968354|FG001|STARTED|Overall Study||954||
59843580|NCT00252720|75968353|FG000|COMPLETED|Overall Study||819||
59843581|NCT00252720|75968354|FG001|COMPLETED|Overall Study||789||
59843582|NCT00252720|75968353|FG000|NOT COMPLETED|Overall Study||132||
59843583|NCT00252720|75968354|FG001|NOT COMPLETED|Overall Study||165||
59843584|NCT00167778|75968360|FG000|STARTED|Overall Study||11||
59843585|NCT00167778|75968360|FG000|COMPLETED|Overall Study||10||
59843586|NCT00167778|75968360|FG000|NOT COMPLETED|Overall Study||1||
59843587|NCT00167310|75968367|FG000|STARTED|Overall Study||29||
59843588|NCT00167310|75968368|FG001|STARTED|Overall Study||28||
59843589|NCT00167310|75968367|FG000|COMPLETED|Overall Study||21||
59843590|NCT00167310|75968368|FG001|COMPLETED|Overall Study||18||
59843591|NCT00167310|75968367|FG000|NOT COMPLETED|Overall Study||8||
59843592|NCT00167310|75968368|FG001|NOT COMPLETED|Overall Study||10||
59843593|NCT03754582|75968374|FG000|STARTED|Pretreatment Phase||21||
59843594|NCT03754582|75968375|FG001|STARTED|Pretreatment Phase||0||
59843595|NCT03754582|75968376|FG002|STARTED|Pretreatment Phase||0||
59843596|NCT03754582|75968374|FG000|COMPLETED|Pretreatment Phase||21||
59843597|NCT03754582|75968375|FG001|COMPLETED|Pretreatment Phase||0||
59843598|NCT03754582|75968376|FG002|COMPLETED|Pretreatment Phase||0||
59843599|NCT03754582|75968374|FG000|NOT COMPLETED|Pretreatment Phase||0||
59843600|NCT03754582|75968375|FG001|NOT COMPLETED|Pretreatment Phase||0||
59843601|NCT03754582|75968376|FG002|NOT COMPLETED|Pretreatment Phase||0||
59843602|NCT03754582|75968374|FG000|STARTED|Treatment Phase||0||
59843603|NCT03754582|75968375|FG001|STARTED|Treatment Phase||21||
59843604|NCT03754582|75968376|FG002|STARTED|Treatment Phase||0||
59843605|NCT03754582|75968374|FG000|COMPLETED|Treatment Phase||0||
59843606|NCT03754582|75968375|FG001|COMPLETED|Treatment Phase||20||
59843607|NCT03754582|75968376|FG002|COMPLETED|Treatment Phase||0||
59843608|NCT03754582|75968374|FG000|NOT COMPLETED|Treatment Phase||0||
59843609|NCT03754582|75968375|FG001|NOT COMPLETED|Treatment Phase||1||
59843610|NCT03754582|75968376|FG002|NOT COMPLETED|Treatment Phase||0||
59843611|NCT03754582|75968374|FG000|STARTED|Follow-up Phase||0||
59843612|NCT03754582|75968375|FG001|STARTED|Follow-up Phase||0||
59843613|NCT03754582|75968376|FG002|STARTED|Follow-up Phase|1 participant who discontinued in Treatment Phase was assessed at Follow-up Visit.|21||
59843614|NCT03754582|75968374|FG000|COMPLETED|Follow-up Phase||0||
59843615|NCT03754582|75968375|FG001|COMPLETED|Follow-up Phase||0||
59843616|NCT03754582|75968376|FG002|COMPLETED|Follow-up Phase||20||
59843617|NCT03754582|75968374|FG000|NOT COMPLETED|Follow-up Phase||0||
59843618|NCT03754582|75968375|FG001|NOT COMPLETED|Follow-up Phase||0||
60120080|NCT02546986|76241355|FG001|NOT COMPLETED|Treatment Period||49||
60120081|NCT02546986|76241354|FG000|STARTED|Survival Follow-Up Phase||36||
60120082|NCT02546986|76241355|FG001|STARTED|Survival Follow-Up Phase||35||
60120083|NCT02546986|76241354|FG000|COMPLETED|Survival Follow-Up Phase||0|Participants remained in follow-up until withdrawal of consent, death or lost to follow-up|
60120084|NCT02546986|76241355|FG001|COMPLETED|Survival Follow-Up Phase||0|Participants remained in follow-up until withdrawal of consent, death or lost to follow-up|
60120085|NCT02546986|76241354|FG000|NOT COMPLETED|Survival Follow-Up Phase||36||
60120086|NCT02546986|76241355|FG001|NOT COMPLETED|Survival Follow-Up Phase||35||
60120087|NCT02689206|76241366|FG000|STARTED|Overall Study||20||
60120088|NCT02689206|76241367|FG001|STARTED|Overall Study||20||
60120089|NCT02689206|76241368|FG002|STARTED|Overall Study||20||
60120090|NCT02689206|76241369|FG003|STARTED|Overall Study||21||
60120091|NCT02689206|76241370|FG004|STARTED|Overall Study||22||
60120092|NCT02689206|76241366|FG000|COMPLETED|Overall Study||17||
59719325|NCT01185821|75838565|FG000|Patients on Placebo in Core|Overall Study||8||
59719326|NCT01185821|75838566|FG001|Patients on Placebo in Core|Overall Study||7||
59719327|NCT01185821|75838567|FG002|Patients on Placebo in Core|Overall Study||9||
59719328|NCT01185821|75838568|FG003|Patients on Placebo in Core|Overall Study||8||
59719329|NCT01185821|75838569|FG004|Patients on Placebo in Core|Overall Study||2||
59719330|NCT01185821|75838565|FG000|COMPLETED|Overall Study||26||
59719331|NCT01185821|75838566|FG001|COMPLETED|Overall Study||20||
59843619|NCT03754582|75968376|FG002|NOT COMPLETED|Follow-up Phase||1||
59843620|NCT00161616|75968394|FG000|STARTED|Overall Study||139||
59843621|NCT00161616|75968395|FG001|STARTED|Overall Study||138||
59843622|NCT00161616|75968394|FG000|COMPLETED|Overall Study||113||
59843623|NCT00161616|75968395|FG001|COMPLETED|Overall Study||119||
59843624|NCT00161616|75968394|FG000|NOT COMPLETED|Overall Study||26||
59843625|NCT00161616|75968395|FG001|NOT COMPLETED|Overall Study||19||
59843626|NCT00252564|75968403|FG000|STARTED|Overall Study|From randomization|124||
59843627|NCT00252564|75968404|FG001|STARTED|Overall Study|From randomization|123||
59843628|NCT00252564|75968403|FG000|COMPLETED|Overall Study|Received 6+ cycles OR had response (RECIST criteria, CR or PR)|85||
59843629|NCT00252564|75968404|FG001|COMPLETED|Overall Study|Received 6+ cycles OR had response (RECIST criteria, CR or PR)|79||
59843630|NCT00252564|75968403|FG000|NOT COMPLETED|Overall Study||39||
59843631|NCT00252564|75968404|FG001|NOT COMPLETED|Overall Study||44||
59843632|NCT00166296|75968412|FG000|STARTED|Overall Study|Randomized patients|67||
59843633|NCT00166296|75968413|FG001|STARTED|Overall Study|Randomized patients|66||
59843634|NCT00166296|75968412|FG000|ANALYZED|Overall Study|Patients who did receive at least the first dose of study medications, included in the analysis|66||
59843635|NCT00166296|75968413|FG001|ANALYZED|Overall Study|Patients who did receive at least the first dose of study medications, included in the analysis|63||
59843636|NCT00166296|75968412|FG000|COMPLETED|Overall Study|Patients who completed both trial medication and interferon+ribavirin treatment for 12 weeks|60||
59843637|NCT00166296|75968413|FG001|COMPLETED|Overall Study|Patients who completed both trial medication and interferon+ribavirin treatment for 12 weeks|57||
59843638|NCT00166296|75968412|FG000|NOT COMPLETED|Overall Study||7||
59843639|NCT00166296|75968413|FG001|NOT COMPLETED|Overall Study||9||
59843640|NCT00252174|75968422|FG000|STARTED|Overall Study|No subjects were randomized into Active Arm as only 2 subjects were randomized into the Control Arm.|0||
59843641|NCT00252174|75968423|FG001|STARTED|Overall Study|2 subjects entered the control arm in total|2||
60120093|NCT02689206|76241367|FG001|COMPLETED|Overall Study||19||
60120094|NCT02689206|76241368|FG002|COMPLETED|Overall Study||16||
59719332|NCT01185821|75838567|FG002|COMPLETED|Overall Study||33||
59719333|NCT01185821|75838568|FG003|COMPLETED|Overall Study||23||
59719334|NCT01185821|75838569|FG004|COMPLETED|Overall Study||26||
59719335|NCT01185821|75838565|FG000|NOT COMPLETED|Overall Study||7||
59843642|NCT00252174|75968424|FG002|STARTED|Overall Study|No subjects entered Stage 2|0||
59843643|NCT00252174|75968422|FG000|COMPLETED|Overall Study||0||
59843644|NCT00252174|75968423|FG001|COMPLETED|Overall Study||1||
59843645|NCT00252174|75968424|FG002|COMPLETED|Overall Study||0||
59843646|NCT00252174|75968422|FG000|NOT COMPLETED|Overall Study||0||
59843647|NCT00252174|75968423|FG001|NOT COMPLETED|Overall Study||1||
59843648|NCT00252174|75968424|FG002|NOT COMPLETED|Overall Study||0||
59843649|NCT00165984|75968432|FG000|STARTED|Overall Study||165||
59843650|NCT00165984|75968432|FG000|COMPLETED|Overall Study||150||
59843651|NCT00165984|75968432|FG000|NOT COMPLETED|Overall Study||15||
59843652|NCT00160524|75968439|FG000|STARTED|Overall Study|One subject was enrolled erroneously and has no data in the database.|595||
59843653|NCT00160524|75968439|FG000|COMPLETED|Overall Study||117||
59843654|NCT00160524|75968439|FG000|NOT COMPLETED|Overall Study||478||
59843655|NCT00159822|75968443|FG000|STARTED|Voriconazole Treatment Period||48||
59843656|NCT00159822|75968443|FG000|COMPLETED|Voriconazole Treatment Period|Number of subjects completed treatment: 36 up to month 6 (M6); 26 after M6.|26||
59843657|NCT00159822|75968443|FG000|NOT COMPLETED|Voriconazole Treatment Period||22||
59843658|NCT00159822|75968443|FG000|STARTED|Post-treatment Follow-up Period||26||
59843659|NCT00159822|75968443|FG000|COMPLETED|Post-treatment Follow-up Period||23||
59843660|NCT00159822|75968443|FG000|NOT COMPLETED|Post-treatment Follow-up Period||3||
59843661|NCT00158262|75968449|FG000|STARTED|Overall Study||21||
59843662|NCT00158262|75968450|FG001|STARTED|Overall Study||22||
59843663|NCT00158262|75968449|FG000|COMPLETED|Overall Study||20||
59843664|NCT00158262|75968450|FG001|COMPLETED|Overall Study||21||
59843665|NCT00158262|75968449|FG000|NOT COMPLETED|Overall Study||1||
59843666|NCT00158262|75968450|FG001|NOT COMPLETED|Overall Study||1||
59843667|NCT00157950|75968458|FG000|STARTED|Overall Study||117||
59843668|NCT00157950|75968459|FG001|STARTED|Overall Study||59||
59843669|NCT00157950|75968458|FG000|Vaccinated at Dose 1|Overall Study||117||
59843670|NCT00157950|75968459|FG001|Vaccinated at Dose 1|Overall Study||59||
59843671|NCT00157950|75968458|FG000|Vaccinated at Dose 2|Overall Study||117||
59843672|NCT00157950|75968459|FG001|Vaccinated at Dose 2|Overall Study||59||
59843673|NCT00157950|75968458|FG000|Vaccinated at Dose 3|Overall Study||116||
59843674|NCT00157950|75968459|FG001|Vaccinated at Dose 3|Overall Study||59||
59843675|NCT00157950|75968458|FG000|COMPLETED|Overall Study||116||
59843676|NCT00157950|75968459|FG001|COMPLETED|Overall Study||59||
60120095|NCT02689206|76241369|FG003|COMPLETED|Overall Study||17||
59719336|NCT01185821|75838566|FG001|NOT COMPLETED|Overall Study||9||
59719337|NCT01185821|75838567|FG002|NOT COMPLETED|Overall Study||10||
59719338|NCT01185821|75838568|FG003|NOT COMPLETED|Overall Study||6||
59719339|NCT01185821|75838569|FG004|NOT COMPLETED|Overall Study||24||
59719340|NCT00893464|75838591|FG000|STARTED|Overall Study||1||
59719341|NCT00893464|75838592|FG001|STARTED|Overall Study||1||
59719342|NCT00893464|75838593|FG002|STARTED|Overall Study||1||
59719343|NCT00893464|75838594|FG003|STARTED|Overall Study||1||
59719344|NCT00893464|75838595|FG004|STARTED|Overall Study||4||
59719345|NCT00893464|75838596|FG005|STARTED|Overall Study||7||
59719346|NCT00893464|75838597|FG006|STARTED|Overall Study||10||
59719347|NCT00893464|75838598|FG007|STARTED|Overall Study||5||
59719348|NCT00893464|75838591|FG000|COMPLETED|Overall Study||1||
59719349|NCT00893464|75838592|FG001|COMPLETED|Overall Study||1||
59719350|NCT00893464|75838593|FG002|COMPLETED|Overall Study||1||
59719351|NCT00893464|75838594|FG003|COMPLETED|Overall Study||1||
59719352|NCT00893464|75838595|FG004|COMPLETED|Overall Study||4||
59719353|NCT00893464|75838596|FG005|COMPLETED|Overall Study||7||
59719354|NCT00893464|75838597|FG006|COMPLETED|Overall Study||8||
59719355|NCT00893464|75838598|FG007|COMPLETED|Overall Study||3||
59843677|NCT00157950|75968458|FG000|NOT COMPLETED|Overall Study||1||
59843678|NCT00157950|75968459|FG001|NOT COMPLETED|Overall Study||0||
59843679|NCT03745768|75968467|FG000|STARTED|Overall Study||10||
59843680|NCT03745768|75968468|FG001|STARTED|Overall Study||9||
59843681|NCT03745768|75968467|FG000|COMPLETED|Overall Study||8||
59843682|NCT03745768|75968468|FG001|COMPLETED|Overall Study||9||
59843683|NCT03745768|75968467|FG000|NOT COMPLETED|Overall Study||2||
59843684|NCT03745768|75968468|FG001|NOT COMPLETED|Overall Study||0||
59843685|NCT03745222|75968477|FG000|STARTED|Overall Study||0||
59719356|NCT00893464|75838591|FG000|NOT COMPLETED|Overall Study||0||
59719357|NCT00893464|75838592|FG001|NOT COMPLETED|Overall Study||0||
59843686|NCT03745222|75968478|FG001|STARTED|Overall Study||1||
59719358|NCT00893464|75838593|FG002|NOT COMPLETED|Overall Study||0||
59843687|NCT03745222|75968479|FG002|STARTED|Overall Study||0||
59843688|NCT03745222|75968477|FG000|COMPLETED|Overall Study||0||
59719359|NCT00893464|75838594|FG003|NOT COMPLETED|Overall Study||0||
59719360|NCT00893464|75838595|FG004|NOT COMPLETED|Overall Study||0||
59719361|NCT00893464|75838596|FG005|NOT COMPLETED|Overall Study||0||
59719362|NCT00893464|75838597|FG006|NOT COMPLETED|Overall Study||2||
59719363|NCT00893464|75838598|FG007|NOT COMPLETED|Overall Study||2||
59719364|NCT00891904|75838621|FG000|STARTED|Overall Study||2||
59843689|NCT03745222|75968478|FG001|COMPLETED|Overall Study||0||
59843690|NCT03745222|75968479|FG002|COMPLETED|Overall Study||0||
59843691|NCT03745222|75968477|FG000|NOT COMPLETED|Overall Study||0||
59843692|NCT03745222|75968478|FG001|NOT COMPLETED|Overall Study||1||
59843693|NCT03745222|75968479|FG002|NOT COMPLETED|Overall Study||0||
59843694|NCT03743038|75968487|FG000|STARTED|Overall Study||12|Test Article A and Test Article B|24
59843695|NCT03743038|75968487|FG000|Test Article A|Overall Study||12||12
59843696|NCT03743038|75968487|FG000|Test Article B|Overall Study||12||12
59843697|NCT03743038|75968487|FG000|COMPLETED|Overall Study||11|Test Article A and Test Article B|22
59843698|NCT03743038|75968487|FG000|NOT COMPLETED|Overall Study||1||2
59843699|NCT00153816|75968499|FG000|STARTED|Overall Study||415||
59843700|NCT00153816|75968500|FG001|STARTED|Overall Study||419||
59843701|NCT00153816|75968501|FG002|STARTED|Overall Study||420||
59843702|NCT00153816|75968502|FG003|STARTED|Overall Study||421||
59843703|NCT00153816|75968503|FG004|STARTED|Overall Study||295||
59843704|NCT00153816|75968504|FG005|STARTED|Overall Study||289||
59843705|NCT00153816|75968499|FG000|COMPLETED|Overall Study||383||
59843706|NCT00153816|75968500|FG001|COMPLETED|Overall Study||387||
59843707|NCT00153816|75968501|FG002|COMPLETED|Overall Study||388||
59843708|NCT00153816|75968502|FG003|COMPLETED|Overall Study||390||
59843709|NCT00153816|75968503|FG004|COMPLETED|Overall Study||278||
59843710|NCT00153816|75968504|FG005|COMPLETED|Overall Study||262||
59843711|NCT00153816|75968499|FG000|NOT COMPLETED|Overall Study||32||
59843712|NCT00153816|75968500|FG001|NOT COMPLETED|Overall Study||32||
59843713|NCT00153816|75968501|FG002|NOT COMPLETED|Overall Study||32||
59843714|NCT00153816|75968502|FG003|NOT COMPLETED|Overall Study||31||
59843715|NCT00153816|75968503|FG004|NOT COMPLETED|Overall Study||17||
59843716|NCT00153816|75968504|FG005|NOT COMPLETED|Overall Study||27||
59843717|NCT00151476|75968521|FG000|STARTED|FAP Identified Subjects||13||
59843718|NCT00151476|75968522|FG001|STARTED|FAP Identified Subjects||55||
59843719|NCT00151476|75968521|FG000|COMPLETED|FAP Identified Subjects||13||
59843720|NCT00151476|75968522|FG001|COMPLETED|FAP Identified Subjects||54||
59843721|NCT00151476|75968521|FG000|NOT COMPLETED|FAP Identified Subjects||0||
59843722|NCT00151476|75968522|FG001|NOT COMPLETED|FAP Identified Subjects||1||
59843723|NCT00151476|75968521|FG000|STARTED|FAP Analyzed Subjects||13||
59843724|NCT00151476|75968522|FG001|STARTED|FAP Analyzed Subjects||54||
59843725|NCT00151476|75968521|FG000|COMPLETED|FAP Analyzed Subjects||13||
59843726|NCT00151476|75968522|FG001|COMPLETED|FAP Analyzed Subjects||51||
59843727|NCT00151476|75968521|FG000|NOT COMPLETED|FAP Analyzed Subjects||0||
59843728|NCT00151476|75968522|FG001|NOT COMPLETED|FAP Analyzed Subjects||3||
59843729|NCT00149994|75968531|FG000|STARTED|Overall Study|"Started indicates Safety population."|85||
59843730|NCT00149994|75968532|FG001|STARTED|Overall Study||86||
59843731|NCT00149994|75968531|FG000|COMPLETED|Overall Study|"Completed indicates intention to treat (ITT) population."|84||
59843732|NCT00149994|75968532|FG001|COMPLETED|Overall Study||85||
59843733|NCT00149994|75968531|FG000|NOT COMPLETED|Overall Study||1||
59843734|NCT00149994|75968532|FG001|NOT COMPLETED|Overall Study||1||
59843735|NCT00149214|75968540|FG000|STARTED|Overall Study|One patient randomized to Pemetrexed (P) was treated with Cyclophosphamide (C).|135||
59843736|NCT00149214|75968541|FG001|STARTED|Overall Study||122||
59843737|NCT00149214|75968540|FG000|COMPLETED|Overall Study|The patient treated with Cyclophosphamide (C) was included in that arm (C) for safety analysis.|109||
59843738|NCT00149214|75968541|FG001|COMPLETED|Overall Study||105||
59843739|NCT00149214|75968540|FG000|NOT COMPLETED|Overall Study||26||
59843740|NCT00149214|75968541|FG001|NOT COMPLETED|Overall Study||17||
59843741|NCT03034018|75968549|FG000|STARTED|Overall Study||30||
59843742|NCT03034018|75968550|FG001|STARTED|Overall Study||30||
59843743|NCT03034018|75968549|FG000|Initiated Assigned Treatment|Overall Study||27||
59843744|NCT03034018|75968550|FG001|Initiated Assigned Treatment|Overall Study||29||
59843745|NCT03034018|75968549|FG000|COMPLETED|Overall Study||25||
59843746|NCT03034018|75968550|FG001|COMPLETED|Overall Study||28||
59843747|NCT03034018|75968549|FG000|NOT COMPLETED|Overall Study||5||
59843748|NCT03034018|75968550|FG001|NOT COMPLETED|Overall Study||2||
59843749|NCT00114972|75968558|FG000|STARTED|Overall Study||897||
59843750|NCT00114972|75968559|FG001|STARTED|Overall Study||903||
59843751|NCT00114972|75968558|FG000|COMPLETED|Overall Study||849||
59843752|NCT00114972|75968559|FG001|COMPLETED|Overall Study||891||
59843753|NCT00114972|75968558|FG000|NOT COMPLETED|Overall Study||48||
59843754|NCT00114972|75968559|FG001|NOT COMPLETED|Overall Study||12||
59843755|NCT00129402|75968567|FG000|STARTED|Start Period1 to End Period1 (Week 1-6)||43||
59843756|NCT00129402|75968568|FG001|STARTED|Start Period1 to End Period1 (Week 1-6)||40||
59843757|NCT00129402|75968569|FG002|STARTED|Start Period1 to End Period1 (Week 1-6)||43||
59843758|NCT00129402|75968570|FG003|STARTED|Start Period1 to End Period1 (Week 1-6)||40||
59843759|NCT00129402|75968571|FG004|STARTED|Start Period1 to End Period1 (Week 1-6)||40||
59843760|NCT00129402|75968572|FG005|STARTED|Start Period1 to End Period1 (Week 1-6)||42||
59843761|NCT00129402|75968573|FG006|STARTED|Start Period1 to End Period1 (Week 1-6)||0||
59843762|NCT00129402|75968567|FG000|COMPLETED|Start Period1 to End Period1 (Week 1-6)||43||
59843763|NCT00129402|75968568|FG001|COMPLETED|Start Period1 to End Period1 (Week 1-6)||39||
59843764|NCT00129402|75968569|FG002|COMPLETED|Start Period1 to End Period1 (Week 1-6)||41||
59843765|NCT00129402|75968570|FG003|COMPLETED|Start Period1 to End Period1 (Week 1-6)||39||
59843766|NCT00129402|75968571|FG004|COMPLETED|Start Period1 to End Period1 (Week 1-6)||39||
60120096|NCT02689206|76241370|FG004|COMPLETED|Overall Study||14||
59843767|NCT00129402|75968572|FG005|COMPLETED|Start Period1 to End Period1 (Week 1-6)||40||
59843768|NCT00129402|75968573|FG006|COMPLETED|Start Period1 to End Period1 (Week 1-6)||0||
59843769|NCT00129402|75968567|FG000|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||0||
59843770|NCT00129402|75968568|FG001|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||1||
59843771|NCT00129402|75968569|FG002|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||2||
59843772|NCT00129402|75968570|FG003|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||1||
59843773|NCT00129402|75968571|FG004|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||1||
59843774|NCT00129402|75968572|FG005|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||2||
59843775|NCT00129402|75968573|FG006|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||0||
59843776|NCT00129402|75968567|FG000|STARTED|Start Period2 to End Period2 (Week 7-33)||0||
59843777|NCT00129402|75968568|FG001|STARTED|Start Period2 to End Period2 (Week 7-33)||0||
59843778|NCT00129402|75968569|FG002|STARTED|Start Period2 to End Period2 (Week 7-33)|# of subjects were combined from the 3 arms in Period 1 who received ezetimibe with simvastatin|122||
59843779|NCT00129402|75968570|FG003|STARTED|Start Period2 to End Period2 (Week 7-33)||0||
59843780|NCT00129402|75968571|FG004|STARTED|Start Period2 to End Period2 (Week 7-33)||0||
59843781|NCT00129402|75968572|FG005|STARTED|Start Period2 to End Period2 (Week 7-33)|# of subjects were combined from the 3 arms in Period 1 who received simvastatin monotherapy|118||
59843782|NCT00129402|75968573|FG006|STARTED|Start Period2 to End Period2 (Week 7-33)||0||
59843783|NCT00129402|75968567|FG000|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0||
59843784|NCT00129402|75968568|FG001|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0||
59843785|NCT00129402|75968569|FG002|COMPLETED|Start Period2 to End Period2 (Week 7-33)|One subject who completed Period 1, did not enter Period 2, but entered and completed Period 3.|114||
59843786|NCT00129402|75968570|FG003|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0||
59843787|NCT00129402|75968571|FG004|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0||
59843788|NCT00129402|75968572|FG005|COMPLETED|Start Period2 to End Period2 (Week 7-33)|One subject who completed Period 1, did not enter Period 2, but entered and completed Period 3.|113||
59843789|NCT00129402|75968573|FG006|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0||
59843790|NCT00129402|75968567|FG000|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0||
59843791|NCT00129402|75968568|FG001|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0||
59843792|NCT00129402|75968569|FG002|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||8||
59843793|NCT00129402|75968570|FG003|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0||
59843794|NCT00129402|75968571|FG004|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0||
59843795|NCT00129402|75968572|FG005|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||5||
59843796|NCT00129402|75968573|FG006|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0||
59843797|NCT00129402|75968567|FG000|STARTED|Start Period3 to End Period3(Week 34-53)||0||
59719365|NCT00891904|75838621|FG000|COMPLETED|Overall Study||0||
59719366|NCT00891904|75838621|FG000|NOT COMPLETED|Overall Study||2||
59719367|NCT01157351|75838627|FG000|STARTED|Overall Study||230||
59719368|NCT01157351|75838628|FG001|STARTED|Overall Study||220||
59719369|NCT01157351|75838627|FG000|Treated|Overall Study||226||
59719370|NCT01157351|75838628|FG001|Treated|Overall Study||218||
59719371|NCT01157351|75838627|FG000|COMPLETED|Overall Study||93||
59719372|NCT01157351|75838628|FG001|COMPLETED|Overall Study||88||
59719373|NCT01157351|75838627|FG000|NOT COMPLETED|Overall Study||137||
59719374|NCT01157351|75838628|FG001|NOT COMPLETED|Overall Study||132||
59719375|NCT01157117|75838637|FG000|STARTED|Overall Study||28||
59719376|NCT01157117|75838638|FG001|STARTED|Overall Study||29||
59719377|NCT01157117|75838639|FG002|STARTED|Overall Study||20||
59719378|NCT01157117|75838637|FG000|Began Omalizumab or Placebo Dosing|Overall Study||27||
59719379|NCT01157117|75838638|FG001|Began Omalizumab or Placebo Dosing|Overall Study||28||
59719380|NCT01157117|75838639|FG002|Began Omalizumab or Placebo Dosing|Overall Study||0||
59719381|NCT01157117|75838637|FG000|Began Milk OIT Dosing at Month 4|Overall Study||27||
59719382|NCT01157117|75838638|FG001|Began Milk OIT Dosing at Month 4|Overall Study||28||
59719383|NCT01157117|75838639|FG002|Began Milk OIT Dosing at Month 4|Overall Study||0||
59719384|NCT01157117|75838637|FG000|Reached Milk OIT Maintenance Dosing|Overall Study||26||
59719385|NCT01157117|75838638|FG001|Reached Milk OIT Maintenance Dosing|Overall Study||26||
59719386|NCT01157117|75838639|FG002|Reached Milk OIT Maintenance Dosing|Overall Study||0||
59719387|NCT01157117|75838637|FG000|Unblinded at Month 16|Overall Study||26||
59719388|NCT01157117|75838638|FG001|Unblinded at Month 16|Overall Study||26||
59719389|NCT01157117|75838639|FG002|Unblinded at Month 16|Overall Study||0||
59719390|NCT01157117|75838637|FG000|Completed Month 28 Desensitization OFC|Overall Study||26||
59719391|NCT01157117|75838638|FG001|Completed Month 28 Desensitization OFC|Overall Study||24||
59719392|NCT01157117|75838639|FG002|Completed Month 28 Desensitization OFC|Overall Study||0||
59719393|NCT01157117|75838637|FG000|Discontinued Milk OIT at Month 30|Overall Study||24||
59719394|NCT01157117|75838638|FG001|Discontinued Milk OIT at Month 30|Overall Study||20||
59719395|NCT01157117|75838639|FG002|Discontinued Milk OIT at Month 30|Overall Study||0||
59843798|NCT00129402|75968568|FG001|STARTED|Start Period3 to End Period3(Week 34-53)||0||
59843799|NCT00129402|75968569|FG002|STARTED|Start Period3 to End Period3(Week 34-53)||0||
59843800|NCT00129402|75968570|FG003|STARTED|Start Period3 to End Period3(Week 34-53)||0||
59843801|NCT00129402|75968571|FG004|STARTED|Start Period3 to End Period3(Week 34-53)||0||
59843802|NCT00129402|75968572|FG005|STARTED|Start Period3 to End Period3(Week 34-53)||0||
60120097|NCT02689206|76241366|FG000|NOT COMPLETED|Overall Study||3||
60120098|NCT02689206|76241367|FG001|NOT COMPLETED|Overall Study||1||
60120099|NCT02689206|76241368|FG002|NOT COMPLETED|Overall Study||4||
60120100|NCT02689206|76241369|FG003|NOT COMPLETED|Overall Study||4||
60120101|NCT02689206|76241370|FG004|NOT COMPLETED|Overall Study||8||
60120102|NCT01695239|76241390|FG000|STARTED|Double-Blind (DB) Treatment Period||106||
60120103|NCT01695239|76241391|FG001|STARTED|Double-Blind (DB) Treatment Period||101||
60120104|NCT01695239|76241392|FG002|STARTED|Double-Blind (DB) Treatment Period||107||
60120105|NCT01695239|76241393|FG003|STARTED|Double-Blind (DB) Treatment Period||103||
60120106|NCT01695239|76241394|FG004|STARTED|Double-Blind (DB) Treatment Period||0||
60120107|NCT01695239|76241395|FG005|STARTED|Double-Blind (DB) Treatment Period||0||
60120108|NCT01695239|76241396|FG006|STARTED|Double-Blind (DB) Treatment Period||0||
60120109|NCT01695239|76241397|FG007|STARTED|Double-Blind (DB) Treatment Period||0||
60120110|NCT01695239|76241398|FG008|STARTED|Double-Blind (DB) Treatment Period||0||
60120111|NCT01695239|76241399|FG009|STARTED|Double-Blind (DB) Treatment Period||0||
60120112|NCT01695239|76241400|FG010|STARTED|Double-Blind (DB) Treatment Period||0||
60120113|NCT01695239|76241401|FG011|STARTED|Double-Blind (DB) Treatment Period||0||
60120114|NCT01695239|76241402|FG012|STARTED|Double-Blind (DB) Treatment Period||0||
60120115|NCT01695239|76241403|FG013|STARTED|Double-Blind (DB) Treatment Period||0||
60120116|NCT01695239|76241390|FG000|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||106||
60120117|NCT01695239|76241391|FG001|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||101||
60120118|NCT01695239|76241392|FG002|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||107||
60120119|NCT01695239|76241393|FG003|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||102||
60120120|NCT01695239|76241394|FG004|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0||
60120121|NCT01695239|76241395|FG005|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0||
60120122|NCT01695239|76241396|FG006|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0||
60120123|NCT01695239|76241397|FG007|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0||
60120124|NCT01695239|76241398|FG008|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0||
60120125|NCT01695239|76241399|FG009|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0||
60120126|NCT01695239|76241400|FG010|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0||
60120127|NCT01695239|76241401|FG011|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0||
60120128|NCT01695239|76241402|FG012|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0||
60120129|NCT01695239|76241403|FG013|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0||
60120130|NCT01695239|76241390|FG000|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||27||
60120131|NCT01695239|76241391|FG001|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||9||
60120132|NCT01695239|76241392|FG002|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||11||
60120133|NCT01695239|76241393|FG003|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||10||
60120134|NCT01695239|76241394|FG004|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0||
60120135|NCT01695239|76241395|FG005|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0||
60120136|NCT01695239|76241396|FG006|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0||
60120137|NCT01695239|76241397|FG007|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0||
60120138|NCT01695239|76241398|FG008|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0||
59567836|NCT01213329|75670690|FG001|NOT COMPLETED|Phase 2||0||
59567837|NCT01897766|75670696|FG000|STARTED|Overall Study||482||
59567838|NCT01897766|75670696|FG000|COMPLETED|Overall Study||482||
59567839|NCT01897766|75670696|FG000|NOT COMPLETED|Overall Study||0||
59719396|NCT01157117|75838637|FG000|Completed Month 32 Tolerance OFC|Overall Study||24||
59719397|NCT01157117|75838638|FG001|Completed Month 32 Tolerance OFC|Overall Study||20||
59719398|NCT01157117|75838639|FG002|Completed Month 32 Tolerance OFC|Overall Study||0||
59719399|NCT01157117|75838637|FG000|Completed Final Month 38 Study Visit|Overall Study||19||
59719400|NCT01157117|75838638|FG001|Completed Final Month 38 Study Visit|Overall Study||18||
59719401|NCT01157117|75838639|FG002|Completed Final Month 38 Study Visit|Overall Study||3||
59719402|NCT01157117|75838637|FG000|COMPLETED|Overall Study|Completed final study visit at Month 38, 6 months after final Month 32 OFC.|19||
59719403|NCT01157117|75838638|FG001|COMPLETED|Overall Study|Completed final study visit at Month 38, 6 months after final Month 32 OFC.|18||
59719404|NCT01157117|75838639|FG002|COMPLETED|Overall Study|Completed final study visit at Month 38, 6 months after final Month 32 OFC.|5||
59719405|NCT01157117|75838637|FG000|NOT COMPLETED|Overall Study||9||
59843803|NCT00129402|75968573|FG006|STARTED|Start Period3 to End Period3(Week 34-53)|In Period 3, all subjects from Period 1 and Period 2 were combined into one treatment group.|228||
60120139|NCT01695239|76241399|FG009|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0||
59843804|NCT00129402|75968567|FG000|COMPLETED|Start Period3 to End Period3(Week 34-53)||0||
59843805|NCT00129402|75968568|FG001|COMPLETED|Start Period3 to End Period3(Week 34-53)||0||
59843806|NCT00129402|75968569|FG002|COMPLETED|Start Period3 to End Period3(Week 34-53)||0||
59843807|NCT00129402|75968570|FG003|COMPLETED|Start Period3 to End Period3(Week 34-53)||0||
59843808|NCT00129402|75968571|FG004|COMPLETED|Start Period3 to End Period3(Week 34-53)||0||
59843809|NCT00129402|75968572|FG005|COMPLETED|Start Period3 to End Period3(Week 34-53)||0||
59843810|NCT00129402|75968573|FG006|COMPLETED|Start Period3 to End Period3(Week 34-53)|One subject who completed Period 1, did not enter Period 2, but entered and completed Period 3.|222||
59843811|NCT00129402|75968567|FG000|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0||
59843812|NCT00129402|75968568|FG001|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0||
59843813|NCT00129402|75968569|FG002|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0||
59843814|NCT00129402|75968570|FG003|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0||
59843815|NCT00129402|75968571|FG004|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0||
59843816|NCT00129402|75968572|FG005|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0||
59843817|NCT00129402|75968573|FG006|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||6||
59843818|NCT03739528|75968583|FG000|STARTED|Overall Study||403||
59843819|NCT03739528|75968584|FG001|STARTED|Overall Study||405||
59843820|NCT03739528|75968583|FG000|Received at Least One Treatment|Overall Study||395||
59843821|NCT03739528|75968584|FG001|Received at Least One Treatment|Overall Study||393||
59843822|NCT03739528|75968583|FG000|COMPLETED|Overall Study||388||
59843823|NCT03739528|75968584|FG001|COMPLETED|Overall Study||388||
59843824|NCT03739528|75968583|FG000|NOT COMPLETED|Overall Study||15||
59843825|NCT03739528|75968584|FG001|NOT COMPLETED|Overall Study||17||
59843826|NCT00114738|75968593|FG000|STARTED|Bortezomib Then Bortezomib + Induction||53||
59843827|NCT00114738|75968594|FG001|STARTED|Bortezomib Then Bortezomib + Induction||0||
59843828|NCT00114738|75968595|FG002|STARTED|Bortezomib Then Bortezomib + Induction||0||
59843829|NCT00114738|75968593|FG000|Started With Bortezomib Alone|Bortezomib Then Bortezomib + Induction||47||
59843830|NCT00114738|75968594|FG001|Started With Bortezomib Alone|Bortezomib Then Bortezomib + Induction||0||
59843831|NCT00114738|75968595|FG002|Started With Bortezomib Alone|Bortezomib Then Bortezomib + Induction||0||
59843832|NCT00114738|75968593|FG000|Skipped Bortezomib Alone|Bortezomib Then Bortezomib + Induction||6||
59843833|NCT00114738|75968594|FG001|Skipped Bortezomib Alone|Bortezomib Then Bortezomib + Induction||0||
59843834|NCT00114738|75968595|FG002|Skipped Bortezomib Alone|Bortezomib Then Bortezomib + Induction||0||
59843835|NCT00114738|75968593|FG000|COMPLETED|Bortezomib Then Bortezomib + Induction||51||
59843836|NCT00114738|75968594|FG001|COMPLETED|Bortezomib Then Bortezomib + Induction||0||
59843837|NCT00114738|75968595|FG002|COMPLETED|Bortezomib Then Bortezomib + Induction||0||
59843838|NCT00114738|75968593|FG000|NOT COMPLETED|Bortezomib Then Bortezomib + Induction||2||
59843839|NCT00114738|75968594|FG001|NOT COMPLETED|Bortezomib Then Bortezomib + Induction||0||
59843840|NCT00114738|75968595|FG002|NOT COMPLETED|Bortezomib Then Bortezomib + Induction||0||
59843841|NCT00114738|75968593|FG000|STARTED|Screening for Randomization||51||
59843842|NCT00114738|75968594|FG001|STARTED|Screening for Randomization||0||
59843843|NCT00114738|75968595|FG002|STARTED|Screening for Randomization||0||
59843844|NCT00114738|75968593|FG000|COMPLETED|Screening for Randomization||30||
59843845|NCT00114738|75968594|FG001|COMPLETED|Screening for Randomization||0||
59843846|NCT00114738|75968595|FG002|COMPLETED|Screening for Randomization||0||
59843847|NCT00114738|75968593|FG000|NOT COMPLETED|Screening for Randomization||21||
59843848|NCT00114738|75968594|FG001|NOT COMPLETED|Screening for Randomization||0||
59843849|NCT00114738|75968595|FG002|NOT COMPLETED|Screening for Randomization||0||
59843850|NCT00114738|75968593|FG000|STARTED|Randomization||0||
59843851|NCT00114738|75968594|FG001|STARTED|Randomization||14||
59843852|NCT00114738|75968595|FG002|STARTED|Randomization||16||
59843853|NCT00114738|75968593|FG000|COMPLETED|Randomization||0||
59843854|NCT00114738|75968594|FG001|COMPLETED|Randomization||14||
59843855|NCT00114738|75968595|FG002|COMPLETED|Randomization||16||
59843856|NCT00114738|75968593|FG000|NOT COMPLETED|Randomization||0||
59843857|NCT00114738|75968594|FG001|NOT COMPLETED|Randomization||0||
59843858|NCT00114738|75968595|FG002|NOT COMPLETED|Randomization||0||
59843859|NCT00148122|75968602|FG000|STARTED|Overall Study||40||
59843860|NCT00148122|75968602|FG000|COMPLETED|Overall Study||38||
59843861|NCT00148122|75968602|FG000|NOT COMPLETED|Overall Study||2||
59843862|NCT00147498|75968610|FG000|STARTED|Overall Study||61||
59843863|NCT00147498|75968611|FG001|STARTED|Overall Study||69||
59843864|NCT00147498|75968612|FG002|STARTED|Overall Study||69||
59843865|NCT00147498|75968613|FG003|STARTED|Overall Study||65||
59843866|NCT00147498|75968610|FG000|COMPLETED|Overall Study||58||
59843867|NCT00147498|75968611|FG001|COMPLETED|Overall Study||60||
59843868|NCT00147498|75968612|FG002|COMPLETED|Overall Study||52||
59843869|NCT00147498|75968613|FG003|COMPLETED|Overall Study||48||
59843870|NCT00147498|75968610|FG000|NOT COMPLETED|Overall Study||3||
59843871|NCT00147498|75968611|FG001|NOT COMPLETED|Overall Study||9||
59843872|NCT00147498|75968612|FG002|NOT COMPLETED|Overall Study||17||
59843873|NCT00147498|75968613|FG003|NOT COMPLETED|Overall Study||17||
59843874|NCT00113568|75968623|FG000|STARTED|Overall Study||784||
59843875|NCT00113568|75968623|FG000|Intent to Treat Population|Overall Study||723||
59843876|NCT00113568|75968623|FG000|COMPLETED|Overall Study||239||
59843877|NCT00113568|75968623|FG000|NOT COMPLETED|Overall Study||545||
59843878|NCT00113490|75968629|FG000|STARTED|Overall Study||66||
59843879|NCT00113490|75968630|FG001|STARTED|Overall Study||70||
59843880|NCT00113490|75968629|FG000|COMPLETED|Overall Study||64||
59843881|NCT00113490|75968630|FG001|COMPLETED|Overall Study||67||
59843882|NCT00113490|75968629|FG000|NOT COMPLETED|Overall Study||2||
59843883|NCT00113490|75968630|FG001|NOT COMPLETED|Overall Study||3||
59843884|NCT00146640|75968638|FG000|STARTED|Overall Study||144||
59843885|NCT00146640|75968639|FG001|STARTED|Overall Study||144||
59843886|NCT00146640|75968638|FG000|COMPLETED|Overall Study||121||
59843887|NCT00146640|75968639|FG001|COMPLETED|Overall Study||130||
59843888|NCT00146640|75968638|FG000|NOT COMPLETED|Overall Study||23||
59843889|NCT00146640|75968639|FG001|NOT COMPLETED|Overall Study||14||
59843890|NCT01353118|75968647|FG000|STARTED|Overall Study||21||
59843891|NCT01353118|75968648|FG001|STARTED|Overall Study||20||
59843892|NCT01353118|75968647|FG000|COMPLETED|Overall Study||21||
59843893|NCT01353118|75968648|FG001|COMPLETED|Overall Study||20||
59843894|NCT01353118|75968647|FG000|NOT COMPLETED|Overall Study||0||
59843895|NCT01353118|75968648|FG001|NOT COMPLETED|Overall Study||0||
59843896|NCT00146328|75968657|FG000|STARTED|Overall Study||291||
59843897|NCT00146328|75968658|FG001|STARTED|Overall Study||255||
59843898|NCT00146328|75968659|FG002|STARTED|Overall Study||449||
59843899|NCT00146328|75968657|FG000|COMPLETED|Overall Study||150||
59843900|NCT00146328|75968658|FG001|COMPLETED|Overall Study||101||
59843901|NCT00146328|75968659|FG002|COMPLETED|Overall Study||158||
59843902|NCT00146328|75968657|FG000|NOT COMPLETED|Overall Study||141||
59843903|NCT00146328|75968658|FG001|NOT COMPLETED|Overall Study||154||
59843904|NCT00146328|75968659|FG002|NOT COMPLETED|Overall Study||291||
59843905|NCT03733444|75968670|FG000|STARTED|Overall Study||260||
59719406|NCT01157117|75838638|FG001|NOT COMPLETED|Overall Study||11||
59719407|NCT01157117|75838639|FG002|NOT COMPLETED|Overall Study||15||
59719408|NCT00891202|75838649|FG000|STARTED|PAP (Up To Week 39)||20||
59719409|NCT00891202|75838650|FG001|STARTED|PAP (Up To Week 39)||20||
59719410|NCT00891202|75838651|FG002|STARTED|PAP (Up To Week 39)||0||
59719411|NCT00891202|75838652|FG003|STARTED|PAP (Up To Week 39)||0||
59719412|NCT00891202|75838649|FG000|COMPLETED|PAP (Up To Week 39)||19||
59719413|NCT00891202|75838650|FG001|COMPLETED|PAP (Up To Week 39)||20||
59719414|NCT00891202|75838651|FG002|COMPLETED|PAP (Up To Week 39)||0||
59719415|NCT00891202|75838652|FG003|COMPLETED|PAP (Up To Week 39)||0||
59719416|NCT00891202|75838649|FG000|NOT COMPLETED|PAP (Up To Week 39)||1||
59719417|NCT00891202|75838650|FG001|NOT COMPLETED|PAP (Up To Week 39)||0||
59719418|NCT00891202|75838651|FG002|NOT COMPLETED|PAP (Up To Week 39)||0||
59719419|NCT00891202|75838652|FG003|NOT COMPLETED|PAP (Up To Week 39)||0||
59719420|NCT00891202|75838649|FG000|STARTED|LTTP (Post-Week 39 up to Week 312)||0||
59719421|NCT00891202|75838650|FG001|STARTED|LTTP (Post-Week 39 up to Week 312)||0||
59719422|NCT00891202|75838651|FG002|STARTED|LTTP (Post-Week 39 up to Week 312)||19||
59719423|NCT00891202|75838652|FG003|STARTED|LTTP (Post-Week 39 up to Week 312)||20||
59719424|NCT00891202|75838649|FG000|COMPLETED|LTTP (Post-Week 39 up to Week 312)||0||
59719425|NCT00891202|75838650|FG001|COMPLETED|LTTP (Post-Week 39 up to Week 312)||0||
59719426|NCT00891202|75838651|FG002|COMPLETED|LTTP (Post-Week 39 up to Week 312)||12||
59719427|NCT00891202|75838652|FG003|COMPLETED|LTTP (Post-Week 39 up to Week 312)||15||
59719428|NCT00891202|75838649|FG000|NOT COMPLETED|LTTP (Post-Week 39 up to Week 312)||0||
59719429|NCT00891202|75838650|FG001|NOT COMPLETED|LTTP (Post-Week 39 up to Week 312)||0||
59719430|NCT00891202|75838651|FG002|NOT COMPLETED|LTTP (Post-Week 39 up to Week 312)||7||
59719431|NCT00891202|75838652|FG003|NOT COMPLETED|LTTP (Post-Week 39 up to Week 312)||5||
59719432|NCT01185509|75838662|FG000|STARTED|Overall Study||11||
59719433|NCT01185509|75838663|FG001|STARTED|Overall Study||20||
59719434|NCT01185509|75838662|FG000|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0||
59719435|NCT01185509|75838663|FG001|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0||
59719436|NCT01185509|75838662|FG000|NOT COMPLETED|Overall Study||11||
59719437|NCT01185509|75838663|FG001|NOT COMPLETED|Overall Study||20||
59843906|NCT03733444|75968671|FG001|STARTED|Overall Study||262||
59843907|NCT03733444|75968672|FG002|STARTED|Overall Study||259||
59843908|NCT03733444|75968670|FG000|Treated|Overall Study||259||
59843909|NCT03733444|75968671|FG001|Treated|Overall Study||260||
59843910|NCT03733444|75968672|FG002|Treated|Overall Study||258||
59843911|NCT03733444|75968670|FG000|COMPLETED|Overall Study||0||
59843912|NCT03733444|75968671|FG001|COMPLETED|Overall Study||0||
59843913|NCT03733444|75968672|FG002|COMPLETED|Overall Study||0||
59843914|NCT03733444|75968670|FG000|NOT COMPLETED|Overall Study||260||
59843915|NCT03733444|75968671|FG001|NOT COMPLETED|Overall Study||262||
59843916|NCT03733444|75968672|FG002|NOT COMPLETED|Overall Study||259||
59843917|NCT03731182|75968692|FG000|STARTED|Overall Study||70||
59843918|NCT03731182|75968693|FG001|STARTED|Overall Study||34||
59843919|NCT03731182|75968692|FG000|V114 or Prevnar 13™ Vaccination (Day 1)|Overall Study||69||
59843920|NCT03731182|75968693|FG001|V114 or Prevnar 13™ Vaccination (Day 1)|Overall Study||34||
59843921|NCT03731182|75968692|FG000|COMPLETED|Overall Study||65||
59843922|NCT03731182|75968693|FG001|COMPLETED|Overall Study||34||
59843923|NCT03731182|75968692|FG000|NOT COMPLETED|Overall Study||5||
59843924|NCT03731182|75968693|FG001|NOT COMPLETED|Overall Study||0||
59843925|NCT03730012|75968702|FG000|STARTED|Overall Study||3||
59843926|NCT03730012|75968703|FG001|STARTED|Overall Study||8||
59843927|NCT03730012|75968702|FG000|COMPLETED|Overall Study||0||
59843928|NCT03730012|75968703|FG001|COMPLETED|Overall Study||0||
59843929|NCT03730012|75968702|FG000|NOT COMPLETED|Overall Study||3||
59843930|NCT03730012|75968703|FG001|NOT COMPLETED|Overall Study||8||
59843931|NCT03728140|75968714|FG000|STARTED|Overall Study|embryo transfer with self-spent culture medium|160||
59843932|NCT03728140|75968715|FG001|STARTED|Overall Study|embryo transfer with new culture medium|175||
59843933|NCT03728140|75968714|FG000|COMPLETED|Overall Study||150||
59843934|NCT03728140|75968715|FG001|COMPLETED|Overall Study||168||
59843935|NCT03728140|75968714|FG000|NOT COMPLETED|Overall Study||10||
59843936|NCT03728140|75968715|FG001|NOT COMPLETED|Overall Study||7||
59843937|NCT01200862|75968724|FG000|STARTED|Part 1||14|Part 1|
59843938|NCT01200862|75968725|FG001|STARTED|Part 1||0|Part 1|
59843939|NCT01200862|75968726|FG002|STARTED|Part 1||0|Part 1|
59843940|NCT01200862|75968724|FG000|COMPLETED|Part 1||13||
59843941|NCT01200862|75968725|FG001|COMPLETED|Part 1||0||
59843942|NCT01200862|75968726|FG002|COMPLETED|Part 1||0||
59843943|NCT01200862|75968724|FG000|NOT COMPLETED|Part 1||1||
59843944|NCT01200862|75968725|FG001|NOT COMPLETED|Part 1||0||
59843945|NCT01200862|75968726|FG002|NOT COMPLETED|Part 1||0||
59843946|NCT01200862|75968724|FG000|STARTED|Part 2||0||
59843947|NCT01200862|75968725|FG001|STARTED|Part 2||7||
59843948|NCT01200862|75968726|FG002|STARTED|Part 2||8||
59843949|NCT01200862|75968724|FG000|COMPLETED|Part 2||0||
59843950|NCT01200862|75968725|FG001|COMPLETED|Part 2||6||
59843951|NCT01200862|75968726|FG002|COMPLETED|Part 2||8||
59843952|NCT01200862|75968724|FG000|NOT COMPLETED|Part 2||0||
59843953|NCT01200862|75968725|FG001|NOT COMPLETED|Part 2||1||
59843954|NCT01200862|75968726|FG002|NOT COMPLETED|Part 2||0||
59843955|NCT03725722|75968740|FG000|STARTED|Overall Study||49|Number of subjects randomized|
59843956|NCT03725722|75968741|FG001|STARTED|Overall Study||50|Number of subjects randomized|
59843957|NCT03725722|75968742|FG002|STARTED|Overall Study||50|Number of subjects randomized|
59843958|NCT03725722|75968743|FG003|STARTED|Overall Study||52|Number of subjects randomized|
59843959|NCT03725722|75968744|FG004|STARTED|Overall Study||50|Number of subjects randomized|
59843960|NCT03725722|75968740|FG000|COMPLETED|Overall Study||38||
59843961|NCT03725722|75968741|FG001|COMPLETED|Overall Study||44||
59843962|NCT03725722|75968742|FG002|COMPLETED|Overall Study||44||
59843963|NCT03725722|75968743|FG003|COMPLETED|Overall Study||46||
59843964|NCT03725722|75968744|FG004|COMPLETED|Overall Study||36||
59843965|NCT03725722|75968740|FG000|NOT COMPLETED|Overall Study||11||
59843966|NCT03725722|75968741|FG001|NOT COMPLETED|Overall Study||6||
59843967|NCT03725722|75968742|FG002|NOT COMPLETED|Overall Study||6||
59843968|NCT03725722|75968743|FG003|NOT COMPLETED|Overall Study||6||
59843969|NCT03725722|75968744|FG004|NOT COMPLETED|Overall Study||14||
59843970|NCT02966314|75968758|FG000|STARTED|Overall Study||5||
59843971|NCT02966314|75968759|FG001|STARTED|Overall Study||5||
59843972|NCT02966314|75968758|FG000|COMPLETED|Overall Study||4||
59843973|NCT02966314|75968759|FG001|COMPLETED|Overall Study||5||
59843974|NCT02966314|75968758|FG000|NOT COMPLETED|Overall Study||1||
59843975|NCT02966314|75968759|FG001|NOT COMPLETED|Overall Study||0||
59843976|NCT03723070|75968765|FG000|STARTED|Overall Study||88||
59843977|NCT03723070|75968765|FG000|COMPLETED|Overall Study||79||
59843978|NCT03723070|75968765|FG000|NOT COMPLETED|Overall Study||9||
59843979|NCT00842764|75968769|FG000|STARTED|Overall Study||7||
59843980|NCT00842764|75968769|FG000|COMPLETED|Overall Study||5||
59843981|NCT00842764|75968769|FG000|NOT COMPLETED|Overall Study||2||
59843982|NCT03722524|75968773|FG000|STARTED|Overall Study||1247||
59843983|NCT03722524|75968773|FG000|COMPLETED|Overall Study||1148||
59843984|NCT03722524|75968773|FG000|NOT COMPLETED|Overall Study||99||
59843985|NCT03722446|75968779|FG000|STARTED|Overall Study||135||
59843986|NCT03722446|75968780|FG001|STARTED|Overall Study||122||
59843987|NCT03722446|75968779|FG000|COMPLETED|Overall Study||120||
59843988|NCT03722446|75968780|FG001|COMPLETED|Overall Study||120||
59843989|NCT03722446|75968779|FG000|NOT COMPLETED|Overall Study||15||
59843990|NCT03722446|75968780|FG001|NOT COMPLETED|Overall Study||2||
59843991|NCT00146172|75968794|FG000|STARTED|Overall Study||3||
59843992|NCT00146172|75968795|FG001|STARTED|Overall Study||4||
59843993|NCT00146172|75968796|FG002|STARTED|Overall Study||4||
59843994|NCT00146172|75968797|FG003|STARTED|Overall Study||6||
59843995|NCT00146172|75968798|FG004|STARTED|Overall Study||3||
59843996|NCT00146172|75968799|FG005|STARTED|Overall Study||7||
59843997|NCT00146172|75968800|FG006|STARTED|Overall Study||6||
59843998|NCT00146172|75968801|FG007|STARTED|Overall Study||40||
59843999|NCT00146172|75968794|FG000|Received Drug|Overall Study||3||
59844000|NCT00146172|75968795|FG001|Received Drug|Overall Study||4||
59844001|NCT00146172|75968796|FG002|Received Drug|Overall Study||4||
59844002|NCT00146172|75968797|FG003|Received Drug|Overall Study||6||
59844003|NCT00146172|75968798|FG004|Received Drug|Overall Study||3||
59844004|NCT00146172|75968799|FG005|Received Drug|Overall Study||7||
59844005|NCT00146172|75968800|FG006|Received Drug|Overall Study||6||
59844006|NCT00146172|75968801|FG007|Received Drug|Overall Study||39||
59844007|NCT00146172|75968794|FG000|COMPLETED|Overall Study||0||
59844008|NCT00146172|75968795|FG001|COMPLETED|Overall Study||0||
59844009|NCT00146172|75968796|FG002|COMPLETED|Overall Study||0||
59844010|NCT00146172|75968797|FG003|COMPLETED|Overall Study||0||
59844011|NCT00146172|75968798|FG004|COMPLETED|Overall Study||0||
59844012|NCT00146172|75968799|FG005|COMPLETED|Overall Study||0||
59844013|NCT00146172|75968800|FG006|COMPLETED|Overall Study||0||
59844014|NCT00146172|75968801|FG007|COMPLETED|Overall Study||0||
59844015|NCT00146172|75968794|FG000|NOT COMPLETED|Overall Study||3||
59844016|NCT00146172|75968795|FG001|NOT COMPLETED|Overall Study||4||
59844017|NCT00146172|75968796|FG002|NOT COMPLETED|Overall Study||4||
59844018|NCT00146172|75968797|FG003|NOT COMPLETED|Overall Study||6||
59844019|NCT00146172|75968798|FG004|NOT COMPLETED|Overall Study||3||
59844020|NCT00146172|75968799|FG005|NOT COMPLETED|Overall Study||7||
59844021|NCT00146172|75968800|FG006|NOT COMPLETED|Overall Study||6||
59844022|NCT00146172|75968801|FG007|NOT COMPLETED|Overall Study||40||
59844023|NCT00145626|75968829|FG000|STARTED|Overall Study||19||
59844024|NCT00145626|75968829|FG000|COMPLETED|Overall Study||14||
59844025|NCT00145626|75968829|FG000|NOT COMPLETED|Overall Study||5||
59844026|NCT00153062|75968853|FG000|STARTED|Overall Study||5086||
59844027|NCT00153062|75968854|FG001|STARTED|Overall Study||5095||
59844028|NCT00153062|75968855|FG002|STARTED|Overall Study||5060||
59844029|NCT00153062|75968856|FG003|STARTED|Overall Study||5091||
59844030|NCT00153062|75968853|FG000|COMPLETED|Overall Study||4699||
59844031|NCT00153062|75968854|FG001|COMPLETED|Overall Study||4689||
59844032|NCT00153062|75968855|FG002|COMPLETED|Overall Study||4645||
59844033|NCT00153062|75968856|FG003|COMPLETED|Overall Study||4680||
59844034|NCT00153062|75968853|FG000|NOT COMPLETED|Overall Study||387||
59844035|NCT00153062|75968854|FG001|NOT COMPLETED|Overall Study||406||
59844036|NCT00153062|75968855|FG002|NOT COMPLETED|Overall Study||415||
59844037|NCT00153062|75968856|FG003|NOT COMPLETED|Overall Study||411||
59844038|NCT00145470|75968868|FG000|STARTED|Overall Study||167||
59844039|NCT00145470|75968869|FG001|STARTED|Overall Study||159||
59844040|NCT00145470|75968868|FG000|Treated|Overall Study||166||
59844041|NCT00145470|75968869|FG001|Treated|Overall Study||158||
59844042|NCT00145470|75968868|FG000|COMPLETED|Overall Study||55||
59844043|NCT00145470|75968869|FG001|COMPLETED|Overall Study||61||
59844044|NCT00145470|75968868|FG000|NOT COMPLETED|Overall Study||112||
59844045|NCT00145470|75968869|FG001|NOT COMPLETED|Overall Study||98||
59844046|NCT00152516|75968875|FG000|STARTED|Overall Study|Subjects that were dispensed at least 1 dose of study medication|255||
59844047|NCT00152516|75968875|FG000|COMPLETED|Overall Study|Subjects ongoing until study close-out|180||
59844048|NCT00152516|75968875|FG000|NOT COMPLETED|Overall Study||75||
59844049|NCT00145158|75968881|FG000|STARTED|Overall Study||16||
59844050|NCT00145158|75968882|FG001|STARTED|Overall Study||7||
59844051|NCT00145158|75968881|FG000|COMPLETED|Overall Study||14||
59844052|NCT00145158|75968882|FG001|COMPLETED|Overall Study||4||
59844053|NCT00145158|75968881|FG000|NOT COMPLETED|Overall Study||2||
59844054|NCT00145158|75968882|FG001|NOT COMPLETED|Overall Study||3||
59844055|NCT00150800|75968889|FG000|STARTED|Overall Study||667||
59844056|NCT00150800|75968889|FG000|COMPLETED|Overall Study||171||
59844057|NCT00150800|75968889|FG000|NOT COMPLETED|Overall Study||496||
59844058|NCT00144300|75968896|FG000|STARTED|Overall Study||121||
59844059|NCT00144300|75968897|FG001|STARTED|Overall Study||125||
59844060|NCT00144300|75968896|FG000|COMPLETED|Overall Study||92||
59844061|NCT00144300|75968897|FG001|COMPLETED|Overall Study||97||
59844062|NCT00144300|75968896|FG000|NOT COMPLETED|Overall Study||29||
59844063|NCT00144300|75968897|FG001|NOT COMPLETED|Overall Study||28||
59844064|NCT00149630|75968905|FG000|STARTED|Overall Study||34||
59844065|NCT00149630|75968906|FG001|STARTED|Overall Study||40||
59844066|NCT00149630|75968905|FG000|COMPLETED|Overall Study||26||
59844067|NCT00149630|75968906|FG001|COMPLETED|Overall Study||35||
59844068|NCT00149630|75968905|FG000|NOT COMPLETED|Overall Study||8||
59844069|NCT00149630|75968906|FG001|NOT COMPLETED|Overall Study||5||
59844070|NCT00127842|75968916|FG000|STARTED|Overall Study||110||
59844071|NCT00127842|75968916|FG000|COMPLETED|Overall Study||71||
59844072|NCT00127842|75968916|FG000|NOT COMPLETED|Overall Study||39||
59844073|NCT03720652|75968922|FG000|STARTED|Overall Study||12|# of Participants to Complete Screening Questionnaire|
59844074|NCT03720652|75968923|FG001|STARTED|Overall Study||27|# of Participants to Complete Screening Questionnaire|
59844075|NCT03720652|75968922|FG000|Baseline Interview|Overall Study||12|# Participants to Complete Baseline Interview|
59844076|NCT03720652|75968923|FG001|Baseline Interview|Overall Study||22|# Participants to Complete Baseline Interview|
59844077|NCT03720652|75968922|FG000|Start Intervention|Overall Study||11|# of Participants to Start Intervention (i.e. attend at least one intervention session)|
60120140|NCT01695239|76241400|FG010|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0||
60120141|NCT01695239|76241401|FG011|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0||
59844078|NCT03720652|75968923|FG001|Start Intervention|Overall Study||21|# of Participants to Start Intervention (i.e. attend at least one intervention session)|
59844079|NCT03720652|75968922|FG000|Complete Intervention|Overall Study||10|# of Participants to Finish Intervention (i.e. attend throughout intervention)|
59844080|NCT03720652|75968923|FG001|Complete Intervention|Overall Study||20|# of Participants to Finish Intervention (i.e. attend throughout intervention)|
59844081|NCT03720652|75968922|FG000|3-Month Follow Up Interview|Overall Study||10|# Participants to Complete 3-Month Follow Up Interview|
59844082|NCT03720652|75968923|FG001|3-Month Follow Up Interview|Overall Study||19|# Participants to Complete 3-Month Follow Up Interview|
59844083|NCT03720652|75968922|FG000|6-Month Follow Up Interview|Overall Study||10|# Participants to Complete 6-Month Follow Up Interview|
59844084|NCT03720652|75968923|FG001|6-Month Follow Up Interview|Overall Study||16|# Participants to Complete 6-Month Follow Up Interview|
59844085|NCT03720652|75968922|FG000|COMPLETED|Overall Study||10||
59844086|NCT03720652|75968923|FG001|COMPLETED|Overall Study||16||
59844087|NCT03720652|75968922|FG000|NOT COMPLETED|Overall Study||2||
59844088|NCT03720652|75968923|FG001|NOT COMPLETED|Overall Study||11||
59844089|NCT00112866|75968933|FG000|STARTED|Overall Study||15||
59844090|NCT00112866|75968934|FG001|STARTED|Overall Study||15||
59844091|NCT00112866|75968933|FG000|COMPLETED|Overall Study||13||
59844092|NCT00112866|75968934|FG001|COMPLETED|Overall Study||13||
59844093|NCT00112866|75968933|FG000|NOT COMPLETED|Overall Study||2||
59844094|NCT00112866|75968934|FG001|NOT COMPLETED|Overall Study||2||
59844095|NCT00127608|75968948|FG000|STARTED|Overall Study||36||503
59844096|NCT00127608|75968948|FG000|COMPLETED|Overall Study||35||472
59844097|NCT00127608|75968948|FG000|NOT COMPLETED|Overall Study||1||31
59844098|NCT00149396|75968952|FG000|STARTED|Overall Study||32||
59844099|NCT00149396|75968952|FG000|Completed NV1020 Therapy|Overall Study||29||
59844100|NCT00149396|75968952|FG000|Completed NV1020 and Chemotherapy|Overall Study||9||
59844101|NCT00149396|75968952|FG000|COMPLETED|Overall Study||9||
59844102|NCT00149396|75968952|FG000|NOT COMPLETED|Overall Study||23||
59844103|NCT00223496|75968963|FG000|STARTED|Overall Study|32 people consented, 19 were baselined|32||
59844104|NCT00223496|75968963|FG000|COMPLETED|Overall Study||10||
59844105|NCT00223496|75968963|FG000|NOT COMPLETED|Overall Study||22||
59844106|NCT00255944|75968969|FG000|STARTED|Overall Study||1311||
59844107|NCT00255944|75968970|FG001|STARTED|Overall Study||1311||
59844108|NCT00255944|75968969|FG000|COMPLETED|Overall Study||514||
59844109|NCT00255944|75968970|FG001|COMPLETED|Overall Study||477||
59844110|NCT00255944|75968969|FG000|NOT COMPLETED|Overall Study||797||
59844111|NCT00255944|75968970|FG001|NOT COMPLETED|Overall Study||834||
59844112|NCT00143598|75968978|FG000|STARTED|Overall Study||410||
59844113|NCT00143598|75968979|FG001|STARTED|Overall Study||396||
59844114|NCT00143598|75968978|FG000|COMPLETED|Overall Study||318||
59844115|NCT00143598|75968979|FG001|COMPLETED|Overall Study||302||
59844116|NCT00143598|75968978|FG000|NOT COMPLETED|Overall Study||92||
59844117|NCT00143598|75968979|FG001|NOT COMPLETED|Overall Study||94||
59844118|NCT00126672|75968985|FG000|STARTED|Overall Study||36||
59844119|NCT00126672|75968985|FG000|COMPLETED|Overall Study||28||
59844120|NCT00126672|75968985|FG000|NOT COMPLETED|Overall Study||8||
59844121|NCT00145574|75968992|FG000|STARTED|Double Blind||65||
59844122|NCT00145574|75968993|FG001|STARTED|Double Blind||65||
59844123|NCT00145574|75968994|FG002|STARTED|Double Blind||64||
59844124|NCT00145574|75968992|FG000|COMPLETED|Double Blind||64||
59844125|NCT00145574|75968993|FG001|COMPLETED|Double Blind||60||
59844126|NCT00145574|75968994|FG002|COMPLETED|Double Blind||62||
59844127|NCT00145574|75968992|FG000|NOT COMPLETED|Double Blind||1||
59844128|NCT00145574|75968993|FG001|NOT COMPLETED|Double Blind||5||
59844129|NCT00145574|75968994|FG002|NOT COMPLETED|Double Blind||2||
59844130|NCT00145574|75968992|FG000|STARTED|Open Label Long-term Extension||0||
59844131|NCT00145574|75968993|FG001|STARTED|Open Label Long-term Extension||0||
59844132|NCT00145574|75968994|FG002|STARTED|Open Label Long-term Extension|2 participants discontinued after completing double-blind but before starting open label.|184||
59844133|NCT00145574|75968992|FG000|COMPLETED|Open Label Long-term Extension||0||
59844134|NCT00145574|75968993|FG001|COMPLETED|Open Label Long-term Extension||0||
59844135|NCT00145574|75968994|FG002|COMPLETED|Open Label Long-term Extension||173||
59844136|NCT00145574|75968992|FG000|NOT COMPLETED|Open Label Long-term Extension||0||
59844137|NCT00145574|75968993|FG001|NOT COMPLETED|Open Label Long-term Extension||0||
59844138|NCT00145574|75968994|FG002|NOT COMPLETED|Open Label Long-term Extension||11||
59844139|NCT00145496|75969009|FG000|STARTED|Overall Study|Subjects who received randomized treatment assignment and at least one dose of study medication.|244||
59844140|NCT00145496|75969010|FG001|STARTED|Overall Study|Subjects who received randomized treatment assignment and at least one dose of study medication.|224||
59844141|NCT00145496|75969009|FG000|COMPLETED|Overall Study||121||
59844142|NCT00145496|75969010|FG001|COMPLETED|Overall Study||143||
59844143|NCT00145496|75969009|FG000|NOT COMPLETED|Overall Study||123||
59844144|NCT00145496|75969010|FG001|NOT COMPLETED|Overall Study||81||
59844145|NCT00255164|75969019|FG000|STARTED|Overall Study||140||
59844146|NCT00255164|75969020|FG001|STARTED|Overall Study||159||
59844147|NCT00255164|75969021|FG002|STARTED|Overall Study||152||
59844148|NCT00255164|75969019|FG000|COMPLETED|Overall Study||17||
59844149|NCT00255164|75969020|FG001|COMPLETED|Overall Study||110||
59844150|NCT00255164|75969021|FG002|COMPLETED|Overall Study||103||
59844151|NCT00255164|75969019|FG000|NOT COMPLETED|Overall Study||123||
59844152|NCT00255164|75969020|FG001|NOT COMPLETED|Overall Study||49||
59844153|NCT00255164|75969021|FG002|NOT COMPLETED|Overall Study||49||
59844154|NCT00126594|75969031|FG000|STARTED|Overall Study||40||
59844155|NCT00126594|75969032|FG001|STARTED|Overall Study||40||
59844156|NCT00126594|75969031|FG000|COMPLETED|Overall Study||1||
59844157|NCT00126594|75969032|FG001|COMPLETED|Overall Study||3||
59844158|NCT00126594|75969031|FG000|NOT COMPLETED|Overall Study||39||
59844159|NCT00126594|75969032|FG001|NOT COMPLETED|Overall Study||37||
59844160|NCT00126438|75969041|FG000|STARTED|Overall Study||453||
59844161|NCT00126438|75969042|FG001|STARTED|Overall Study||62||
59844162|NCT00126438|75969041|FG000|COMPLETED|Overall Study||419||
59844163|NCT00126438|75969042|FG001|COMPLETED|Overall Study||52||
59844164|NCT00126438|75969041|FG000|NOT COMPLETED|Overall Study||34||
59844165|NCT00126438|75969042|FG001|NOT COMPLETED|Overall Study||10||
59844166|NCT00142584|75969050|FG000|STARTED|Overall Study||252||
59844167|NCT00142584|75969051|FG001|STARTED|Overall Study||84||
59844168|NCT00142584|75969050|FG000|COMPLETED|Overall Study||108||
59844169|NCT00142584|75969051|FG001|COMPLETED|Overall Study||28||
59844170|NCT00142584|75969050|FG000|NOT COMPLETED|Overall Study||144||
59844171|NCT00142584|75969051|FG001|NOT COMPLETED|Overall Study||56||
59844172|NCT00126126|75969061|FG000|STARTED|Overall Study||9||
59844173|NCT00126126|75969062|FG001|STARTED|Overall Study||9||
59844174|NCT00126126|75969061|FG000|COMPLETED|Overall Study||9||
59844175|NCT00126126|75969062|FG001|COMPLETED|Overall Study||7||
59844176|NCT00126126|75969061|FG000|NOT COMPLETED|Overall Study||0||
59844177|NCT00126126|75969062|FG001|NOT COMPLETED|Overall Study||2||
59844178|NCT00125268|75969070|FG000|STARTED|Overall Study||16||
59844179|NCT00125268|75969071|FG001|STARTED|Overall Study||14||
59844180|NCT00125268|75969070|FG000|COMPLETED|Overall Study||15||
59844181|NCT00125268|75969071|FG001|COMPLETED|Overall Study||13||
59996617|NCT02714569|76112504|FG001|Received at Least One Dose of Study Drug|Part A Third Intervention||2||
59996618|NCT02714569|76112505|FG002|Received at Least One Dose of Study Drug|Part A Third Intervention||2||
59996619|NCT02714569|76112506|FG003|Received at Least One Dose of Study Drug|Part A Third Intervention||2||
59996620|NCT02714569|76112507|FG004|Received at Least One Dose of Study Drug|Part A Third Intervention||3||
59996621|NCT02714569|76112508|FG005|Received at Least One Dose of Study Drug|Part A Third Intervention||3||
59996622|NCT02714569|76112509|FG006|Received at Least One Dose of Study Drug|Part A Third Intervention||0||
59996623|NCT02714569|76112510|FG007|Received at Least One Dose of Study Drug|Part A Third Intervention||0||
59996624|NCT02714569|76112511|FG008|Received at Least One Dose of Study Drug|Part A Third Intervention||0||
59996625|NCT02714569|76112512|FG009|Received at Least One Dose of Study Drug|Part A Third Intervention||0||
59996626|NCT02714569|76112513|FG010|Received at Least One Dose of Study Drug|Part A Third Intervention||0||
59996627|NCT02714569|76112503|FG000|COMPLETED|Part A Third Intervention||3||
59996628|NCT02714569|76112504|FG001|COMPLETED|Part A Third Intervention||2||
59996629|NCT02714569|76112505|FG002|COMPLETED|Part A Third Intervention||2||
59996630|NCT02714569|76112506|FG003|COMPLETED|Part A Third Intervention||2||
59996631|NCT02714569|76112507|FG004|COMPLETED|Part A Third Intervention||3||
59996632|NCT02714569|76112508|FG005|COMPLETED|Part A Third Intervention||3||
59996633|NCT02714569|76112509|FG006|COMPLETED|Part A Third Intervention||0||
59996634|NCT02714569|76112510|FG007|COMPLETED|Part A Third Intervention||0||
59996635|NCT02714569|76112511|FG008|COMPLETED|Part A Third Intervention||0||
59996636|NCT02714569|76112512|FG009|COMPLETED|Part A Third Intervention||0||
59996637|NCT02714569|76112513|FG010|COMPLETED|Part A Third Intervention||0||
59996638|NCT02714569|76112503|FG000|NOT COMPLETED|Part A Third Intervention||0||
59996639|NCT02714569|76112504|FG001|NOT COMPLETED|Part A Third Intervention||0||
59996640|NCT02714569|76112505|FG002|NOT COMPLETED|Part A Third Intervention||1||
59996641|NCT02714569|76112506|FG003|NOT COMPLETED|Part A Third Intervention||1||
59996642|NCT02714569|76112507|FG004|NOT COMPLETED|Part A Third Intervention||0||
59996643|NCT02714569|76112508|FG005|NOT COMPLETED|Part A Third Intervention||0||
59996644|NCT02714569|76112509|FG006|NOT COMPLETED|Part A Third Intervention||0||
59996645|NCT02714569|76112510|FG007|NOT COMPLETED|Part A Third Intervention||0||
59996646|NCT02714569|76112511|FG008|NOT COMPLETED|Part A Third Intervention||0||
59996647|NCT02714569|76112512|FG009|NOT COMPLETED|Part A Third Intervention||0||
59996648|NCT02714569|76112513|FG010|NOT COMPLETED|Part A Third Intervention||0||
59996649|NCT02714569|76112503|FG000|STARTED|Part A Fourth Intervention|An additional participant replaced a discontinued participant.|4||
59996650|NCT02714569|76112504|FG001|STARTED|Part A Fourth Intervention||2||
59996651|NCT02714569|76112505|FG002|STARTED|Part A Fourth Intervention|An additional participant replaced a discontinued participant.|3||
60120142|NCT01695239|76241402|FG012|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0||
60120143|NCT01695239|76241403|FG013|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0||
60120144|NCT01695239|76241390|FG000|COMPLETED|Double-Blind (DB) Treatment Period||91||
60120145|NCT01695239|76241391|FG001|COMPLETED|Double-Blind (DB) Treatment Period||97||
60120146|NCT01695239|76241392|FG002|COMPLETED|Double-Blind (DB) Treatment Period||97||
60120147|NCT01695239|76241393|FG003|COMPLETED|Double-Blind (DB) Treatment Period||96||
60120148|NCT01695239|76241394|FG004|COMPLETED|Double-Blind (DB) Treatment Period||0||
60120149|NCT01695239|76241395|FG005|COMPLETED|Double-Blind (DB) Treatment Period||0||
60120150|NCT01695239|76241396|FG006|COMPLETED|Double-Blind (DB) Treatment Period||0||
60120151|NCT01695239|76241397|FG007|COMPLETED|Double-Blind (DB) Treatment Period||0||
60120152|NCT01695239|76241398|FG008|COMPLETED|Double-Blind (DB) Treatment Period||0||
60120153|NCT01695239|76241399|FG009|COMPLETED|Double-Blind (DB) Treatment Period||0||
59844182|NCT00125268|75969070|FG000|NOT COMPLETED|Overall Study||1||
59844183|NCT00125268|75969071|FG001|NOT COMPLETED|Overall Study||1||
59996652|NCT02714569|76112506|FG003|STARTED|Part A Fourth Intervention||2||
59844184|NCT00125190|75969077|FG000|STARTED|Overall Study||45||
59844185|NCT00125190|75969077|FG000|Completed 34 Weeks of Study|Overall Study||43||
59844186|NCT00125190|75969077|FG000|COMPLETED|Overall Study||30||
59844187|NCT00125190|75969077|FG000|NOT COMPLETED|Overall Study||15||
59844188|NCT00141726|75969082|FG000|STARTED|Overall Study||34||
59844189|NCT00141726|75969082|FG000|COMPLETED|Overall Study||31||
59844190|NCT00141726|75969082|FG000|NOT COMPLETED|Overall Study||3||
59844191|NCT00111228|75969089|FG000|STARTED|Overall Study||54||
59844192|NCT00111228|75969090|FG001|STARTED|Overall Study||54||
59844193|NCT00111228|75969091|FG002|STARTED|Overall Study||54||
59844194|NCT00111228|75969089|FG000|COMPLETED|Overall Study||49||
59844195|NCT00111228|75969090|FG001|COMPLETED|Overall Study||53||
59844196|NCT00111228|75969091|FG002|COMPLETED|Overall Study||54||
59844197|NCT00111228|75969089|FG000|NOT COMPLETED|Overall Study||5||
59844198|NCT00111228|75969090|FG001|NOT COMPLETED|Overall Study||1||
59844199|NCT00111228|75969091|FG002|NOT COMPLETED|Overall Study||0||
59844200|NCT00110994|75969101|FG000|STARTED|Double-blind (DB) Treatment|ITT population|51||
59844201|NCT00110994|75969102|FG001|STARTED|Double-blind (DB) Treatment|ITT population|50||
59844202|NCT00110994|75969101|FG000|Received Treatment|Double-blind (DB) Treatment|Safety population|51||
59844203|NCT00110994|75969102|FG001|Received Treatment|Double-blind (DB) Treatment|Safety population|50||
59844204|NCT00110994|75969101|FG000|COMPLETED|Double-blind (DB) Treatment||9||
59844205|NCT00110994|75969102|FG001|COMPLETED|Double-blind (DB) Treatment||3||
59844206|NCT00110994|75969101|FG000|NOT COMPLETED|Double-blind (DB) Treatment||42||
59844207|NCT00110994|75969102|FG001|NOT COMPLETED|Double-blind (DB) Treatment||47||
59844208|NCT00110994|75969101|FG000|STARTED|Active Follow-up|Subjects discontinued DB treatment with CR, PR and SD entered this period.|1||
59844209|NCT00110994|75969102|FG001|STARTED|Active Follow-up|Subjects discontinued DB treatment with CR, PR and SD entered this period.|2||
59844210|NCT00110994|75969101|FG000|COMPLETED|Active Follow-up||0||
59844211|NCT00110994|75969102|FG001|COMPLETED|Active Follow-up||0||
59844212|NCT00110994|75969101|FG000|NOT COMPLETED|Active Follow-up||1||
59844213|NCT00110994|75969102|FG001|NOT COMPLETED|Active Follow-up||2||
59844214|NCT00110994|75969101|FG000|STARTED|Long Term Follow-up|Subjects discontinued DB treatment with DP entered this period.|41||
59844215|NCT00110994|75969102|FG001|STARTED|Long Term Follow-up|Subjects discontinued DB treatment with DP entered this period.|47||
59844216|NCT00110994|75969101|FG000|COMPLETED|Long Term Follow-up||22||
59844217|NCT00110994|75969102|FG001|COMPLETED|Long Term Follow-up||30||
59844218|NCT00110994|75969101|FG000|NOT COMPLETED|Long Term Follow-up||19||
59844219|NCT00110994|75969102|FG001|NOT COMPLETED|Long Term Follow-up||17||
59844220|NCT00144170|75969110|FG000|STARTED|Overall Study||438||
59844221|NCT00144170|75969111|FG001|STARTED|Overall Study||428||
59844222|NCT00144170|75969110|FG000|COMPLETED|Overall Study||86||
59844223|NCT00144170|75969111|FG001|COMPLETED|Overall Study||32||
59844224|NCT00144170|75969110|FG000|NOT COMPLETED|Overall Study||352||
59844225|NCT00144170|75969111|FG001|NOT COMPLETED|Overall Study||396||
59844226|NCT00255086|75969119|FG000|STARTED|Overall Study||9||
59844227|NCT00255086|75969120|FG001|STARTED|Overall Study||8||
59844228|NCT00255086|75969119|FG000|COMPLETED|Overall Study||7||
59844229|NCT00255086|75969120|FG001|COMPLETED|Overall Study||6||
59844230|NCT00255086|75969119|FG000|NOT COMPLETED|Overall Study||2||
59844231|NCT00255086|75969120|FG001|NOT COMPLETED|Overall Study||2||
59844232|NCT00110214|75969129|FG000|STARTED|Overall Study||526||
59844233|NCT00110214|75969130|FG001|STARTED|Overall Study||524||
59844234|NCT00110214|75969129|FG000|COMPLETED|Overall Study||17||
59844235|NCT00110214|75969130|FG001|COMPLETED|Overall Study||21||
59844236|NCT00110214|75969129|FG000|NOT COMPLETED|Overall Study||509||
59844237|NCT00110214|75969130|FG001|NOT COMPLETED|Overall Study||503||
59844238|NCT00124020|75969138|FG000|STARTED|Overall Study||377||
59844239|NCT00124020|75969139|FG001|STARTED|Overall Study||380||
59844240|NCT00124020|75969138|FG000|COMPLETED|Overall Study||289||
59844241|NCT00124020|75969139|FG001|COMPLETED|Overall Study||289||
59844242|NCT00124020|75969138|FG000|NOT COMPLETED|Overall Study||88||
59844243|NCT00124020|75969139|FG001|NOT COMPLETED|Overall Study||91||
59844244|NCT00215540|75969148|FG000|STARTED|Overall Study||45||
59844245|NCT00215540|75969149|FG001|STARTED|Overall Study||47||
59844246|NCT00215540|75969150|FG002|STARTED|Overall Study||44||
59844247|NCT00215540|75969148|FG000|COMPLETED|Overall Study||44||
59844248|NCT00215540|75969149|FG001|COMPLETED|Overall Study||47||
59844249|NCT00215540|75969150|FG002|COMPLETED|Overall Study||44||
59844250|NCT00215540|75969148|FG000|NOT COMPLETED|Overall Study||1||
59844251|NCT00215540|75969149|FG001|NOT COMPLETED|Overall Study||0||
59844252|NCT00215540|75969150|FG002|NOT COMPLETED|Overall Study||0||
59844253|NCT00143390|75969160|FG000|STARTED|Overall Study||149||
59844254|NCT00143390|75969161|FG001|STARTED|Overall Study||149||
59844255|NCT00143390|75969160|FG000|COMPLETED|Overall Study||0||
59844256|NCT00143390|75969161|FG001|COMPLETED|Overall Study||0||
59844257|NCT00143390|75969160|FG000|NOT COMPLETED|Overall Study||149||
59844258|NCT00143390|75969161|FG001|NOT COMPLETED|Overall Study||149||
59844259|NCT00141102|75969169|FG000|STARTED|Overall Study||2238||
59844260|NCT00141102|75969170|FG001|STARTED|Overall Study||2246||
59844261|NCT00141102|75969169|FG000|Received Treatment|Overall Study||2223||
59844262|NCT00141102|75969170|FG001|Received Treatment|Overall Study||2237||
59844263|NCT00141102|75969169|FG000|COMPLETED|Overall Study||1730||
59844264|NCT00141102|75969170|FG001|COMPLETED|Overall Study||1621||
59844265|NCT00141102|75969169|FG000|NOT COMPLETED|Overall Study||508||
59844266|NCT00141102|75969170|FG001|NOT COMPLETED|Overall Study||625||
59844267|NCT00255008|75969181|FG000|STARTED|Overall Study||45||
59844268|NCT00255008|75969182|FG001|STARTED|Overall Study||9||
59844269|NCT00255008|75969183|FG002|STARTED|Overall Study||33||
59844270|NCT00255008|75969184|FG003|STARTED|Overall Study||34||
59844271|NCT00255008|75969181|FG000|COMPLETED|Overall Study|The study was terminated early and as a result only 42 patients completed the study.|13||
59844272|NCT00255008|75969182|FG001|COMPLETED|Overall Study||0||
59844273|NCT00255008|75969183|FG002|COMPLETED|Overall Study||17||
59844274|NCT00255008|75969184|FG003|COMPLETED|Overall Study||12||
59844275|NCT00255008|75969181|FG000|NOT COMPLETED|Overall Study||32||
59844276|NCT00255008|75969182|FG001|NOT COMPLETED|Overall Study||9||
59844277|NCT00255008|75969183|FG002|NOT COMPLETED|Overall Study||16||
59844278|NCT00255008|75969184|FG003|NOT COMPLETED|Overall Study||22||
59844279|NCT03714022|75969196|FG000|STARTED|Overall Study||70||
59844280|NCT03714022|75969197|FG001|STARTED|Overall Study||70||
59844281|NCT03714022|75969196|FG000|COMPLETED|Overall Study||66||
59844282|NCT03714022|75969197|FG001|COMPLETED|Overall Study||67||
59844283|NCT03714022|75969196|FG000|NOT COMPLETED|Overall Study||4||
59844284|NCT03714022|75969197|FG001|NOT COMPLETED|Overall Study||3||
59844285|NCT00143312|75969203|FG000|STARTED|Overall Study||45||
59844286|NCT00143312|75969203|FG000|COMPLETED|Overall Study||29||
59844287|NCT00143312|75969203|FG000|NOT COMPLETED|Overall Study||16||
59844288|NCT00254540|75969209|FG000|STARTED|Overall Study|All 25 subjects enrolled were included in Intent-To Treat population.|25||
59844289|NCT00254540|75969210|FG001|STARTED|Overall Study|All 26 subjects enrolled were included in Intent-To Treat population.|26||
59844290|NCT00254540|75969209|FG000|COMPLETED|Overall Study||6||
59844291|NCT00254540|75969210|FG001|COMPLETED|Overall Study||4||
59844292|NCT00254540|75969209|FG000|NOT COMPLETED|Overall Study||19||
59844293|NCT00254540|75969210|FG001|NOT COMPLETED|Overall Study||22||
59844294|NCT03790618|75969221|FG000|STARTED|Overall Study||9||
59844295|NCT03790618|75969222|FG001|STARTED|Overall Study||9||
59844296|NCT03790618|75969223|FG002|STARTED|Overall Study||9||
59844297|NCT03790618|75969224|FG003|STARTED|Overall Study||9||
59844298|NCT03790618|75969221|FG000|COMPLETED|Overall Study||9||
59844299|NCT03790618|75969222|FG001|COMPLETED|Overall Study||9||
59844300|NCT03790618|75969223|FG002|COMPLETED|Overall Study||9||
59844301|NCT03790618|75969224|FG003|COMPLETED|Overall Study||9||
59844302|NCT03790618|75969221|FG000|NOT COMPLETED|Overall Study||0||
59844303|NCT03790618|75969222|FG001|NOT COMPLETED|Overall Study||0||
59844304|NCT03790618|75969223|FG002|NOT COMPLETED|Overall Study||0||
59844305|NCT03790618|75969224|FG003|NOT COMPLETED|Overall Study||0||
59844306|NCT00139776|75969236|FG000|STARTED|Period I||1772||
59844307|NCT00139776|75969237|FG001|STARTED|Period I||0||
59844308|NCT00139776|75969238|FG002|STARTED|Period I||0||
59844309|NCT00139776|75969239|FG003|STARTED|Period I||0||
59844310|NCT00139776|75969236|FG000|COMPLETED|Period I||1197||
59844311|NCT00139776|75969237|FG001|COMPLETED|Period I||0||
59844312|NCT00139776|75969238|FG002|COMPLETED|Period I||0||
59844313|NCT00139776|75969239|FG003|COMPLETED|Period I||0||
59844314|NCT00139776|75969236|FG000|NOT COMPLETED|Period I||575||
59844315|NCT00139776|75969237|FG001|NOT COMPLETED|Period I||0||
59844316|NCT00139776|75969238|FG002|NOT COMPLETED|Period I||0||
59844317|NCT00139776|75969239|FG003|NOT COMPLETED|Period I||0||
59844318|NCT00139776|75969236|FG000|STARTED|Period II||0||
59844319|NCT00139776|75969237|FG001|STARTED|Period II||1197||
59844320|NCT00139776|75969238|FG002|STARTED|Period II||0||
59844321|NCT00139776|75969239|FG003|STARTED|Period II||0||
59719438|NCT00891046|75838675|FG000|STARTED|Overall Study||33||
59844322|NCT00139776|75969236|FG000|COMPLETED|Period II||0||
59844323|NCT00139776|75969237|FG001|COMPLETED|Period II||875||
59844324|NCT00139776|75969238|FG002|COMPLETED|Period II||0||
59844325|NCT00139776|75969239|FG003|COMPLETED|Period II||0||
59844326|NCT00139776|75969236|FG000|NOT COMPLETED|Period II||0||
59844327|NCT00139776|75969237|FG001|NOT COMPLETED|Period II||322||
59719439|NCT00891046|75838676|FG001|STARTED|Overall Study||63||
59719440|NCT00891046|75838677|FG002|STARTED|Overall Study||40||
59719441|NCT00891046|75838678|FG003|STARTED|Overall Study||11||
59719442|NCT00891046|75838679|FG004|STARTED|Overall Study||123||
59844328|NCT00139776|75969238|FG002|NOT COMPLETED|Period II||0||
59844329|NCT00139776|75969239|FG003|NOT COMPLETED|Period II||0||
59844330|NCT00139776|75969236|FG000|STARTED|Period III||0||
59719443|NCT00891046|75838675|FG000|COMPLETED|Overall Study||21||
59719444|NCT00891046|75838676|FG001|COMPLETED|Overall Study||54||
59844331|NCT00139776|75969237|FG001|STARTED|Period III||0||
59844332|NCT00139776|75969238|FG002|STARTED|Period III|Randomized 440: 9 participants not treated|431||
59844333|NCT00139776|75969239|FG003|STARTED|Period III|Randomized 435: 8 participants not treated|427||
59719445|NCT00891046|75838677|FG002|COMPLETED|Overall Study||17||
59719446|NCT00891046|75838678|FG003|COMPLETED|Overall Study||8||
59844334|NCT00139776|75969236|FG000|COMPLETED|Period III||0||
59844335|NCT00139776|75969237|FG001|COMPLETED|Period III||0||
59719447|NCT00891046|75838679|FG004|COMPLETED|Overall Study||84||
59719448|NCT00891046|75838675|FG000|NOT COMPLETED|Overall Study||12||
59844336|NCT00139776|75969238|FG002|COMPLETED|Period III||355||
59844337|NCT00139776|75969239|FG003|COMPLETED|Period III||321||
59844338|NCT00139776|75969236|FG000|NOT COMPLETED|Period III||0||
59844339|NCT00139776|75969237|FG001|NOT COMPLETED|Period III||0||
59844340|NCT00139776|75969238|FG002|NOT COMPLETED|Period III||76||
59844341|NCT00139776|75969239|FG003|NOT COMPLETED|Period III||106||
59844342|NCT00413699|75969248|FG000|STARTED|Initial Period||1123||
59844343|NCT00413699|75969249|FG001|STARTED|Initial Period||3358||
59844344|NCT00413699|75969250|FG002|STARTED|Initial Period||0||
59844345|NCT00413699|75969248|FG000|COMPLETED|Initial Period||484||
59844346|NCT00413699|75969249|FG001|COMPLETED|Initial Period||1653||
59844347|NCT00413699|75969250|FG002|COMPLETED|Initial Period||0||
59844348|NCT00413699|75969248|FG000|NOT COMPLETED|Initial Period||639||
59844349|NCT00413699|75969249|FG001|NOT COMPLETED|Initial Period||1705||
59844350|NCT00413699|75969250|FG002|NOT COMPLETED|Initial Period||0||
59844351|NCT00413699|75969248|FG000|STARTED|Extension Period||0||
59844352|NCT00413699|75969249|FG001|STARTED|Extension Period||0||
59844353|NCT00413699|75969250|FG002|STARTED|Extension Period||48||
59844354|NCT00413699|75969248|FG000|COMPLETED|Extension Period||0||
59844355|NCT00413699|75969249|FG001|COMPLETED|Extension Period||0||
59844356|NCT00413699|75969250|FG002|COMPLETED|Extension Period||43||
59844357|NCT00413699|75969248|FG000|NOT COMPLETED|Extension Period||0||
59844358|NCT00413699|75969249|FG001|NOT COMPLETED|Extension Period||0||
59844359|NCT00413699|75969250|FG002|NOT COMPLETED|Extension Period||5||
59844360|NCT03713320|75969278|FG000|STARTED|Randomized Period||19||
59844361|NCT03713320|75969279|FG001|STARTED|Randomized Period||18||
59844362|NCT03713320|75969280|FG002|STARTED|Randomized Period||0||
59844363|NCT03713320|75969278|FG000|COMPLETED|Randomized Period||4||
59844364|NCT03713320|75969279|FG001|COMPLETED|Randomized Period||8||
59844365|NCT03713320|75969280|FG002|COMPLETED|Randomized Period||0||
59844366|NCT03713320|75969278|FG000|NOT COMPLETED|Randomized Period||15||
59844367|NCT03713320|75969279|FG001|NOT COMPLETED|Randomized Period||10||
59844368|NCT03713320|75969280|FG002|NOT COMPLETED|Randomized Period||0||
59844369|NCT03713320|75969278|FG000|STARTED|Cobomarsen Crossover Period||0||
59844370|NCT03713320|75969279|FG001|STARTED|Cobomarsen Crossover Period||0||
59844371|NCT03713320|75969280|FG002|STARTED|Cobomarsen Crossover Period||7||
59844372|NCT03713320|75969278|FG000|COMPLETED|Cobomarsen Crossover Period||0||
59844373|NCT03713320|75969279|FG001|COMPLETED|Cobomarsen Crossover Period||0||
59844374|NCT03713320|75969280|FG002|COMPLETED|Cobomarsen Crossover Period||0||
59844375|NCT03713320|75969278|FG000|NOT COMPLETED|Cobomarsen Crossover Period||0||
60120154|NCT01695239|76241400|FG010|COMPLETED|Double-Blind (DB) Treatment Period||0||
59719449|NCT00891046|75838676|FG001|NOT COMPLETED|Overall Study||9||
59719450|NCT00891046|75838677|FG002|NOT COMPLETED|Overall Study||23||
59719451|NCT00891046|75838678|FG003|NOT COMPLETED|Overall Study||3||
59719452|NCT00891046|75838679|FG004|NOT COMPLETED|Overall Study||39||
59719453|NCT00889720|75838706|FG000|STARTED|Overall Study||16||
59719454|NCT00889720|75838706|FG000|Surgical Population|Overall Study||12||
59719455|NCT00889720|75838706|FG000|COMPLETED|Overall Study||8||
59719456|NCT00889720|75838706|FG000|NOT COMPLETED|Overall Study||8||
59719457|NCT00880087|75838712|FG000|STARTED|Overall Study|Among the 166 Started, 161 received Therapeutic Hypothermia and 5 received no treatment.|166||
59719458|NCT00880087|75838713|FG001|STARTED|Overall Study|Among the 163 Started, 160 received Therapeutic Normothermia and 3 received no treatment.|163||
59719459|NCT00880087|75838712|FG000|COMPLETED|Overall Study|1-year vital status available for all 166 Started patients.|166||
59719460|NCT00880087|75838713|FG001|COMPLETED|Overall Study|Of 161 with 1-year vital status, 158 had received Therapeutic Normothermia, 3 received no treatment.|161||
59719461|NCT00880087|75838712|FG000|NOT COMPLETED|Overall Study||0||
59719462|NCT00880087|75838713|FG001|NOT COMPLETED|Overall Study||2||
59719463|NCT00889252|75838721|FG000|STARTED|Overall Study||168||
59719464|NCT00889252|75838722|FG001|STARTED|Overall Study||82||
59719465|NCT00889252|75838721|FG000|COMPLETED|Overall Study||161||
59719466|NCT00889252|75838722|FG001|COMPLETED|Overall Study||78||
59719467|NCT00889252|75838721|FG000|NOT COMPLETED|Overall Study||7||
59719468|NCT00889252|75838722|FG001|NOT COMPLETED|Overall Study||4||
59719469|NCT01110330|75838731|FG000|STARTED|Overall Study||119||
59719470|NCT01110330|75838732|FG001|STARTED|Overall Study||230||
59719471|NCT01110330|75838733|FG002|STARTED|Overall Study||234||
59719472|NCT01110330|75838731|FG000|Positive Baseline Culture Set|Overall Study||56||
59719473|NCT01110330|75838732|FG001|Positive Baseline Culture Set|Overall Study||111||
59719474|NCT01110330|75838733|FG002|Positive Baseline Culture Set|Overall Study||114||
59719475|NCT01110330|75838731|FG000|COMPLETED|Overall Study||104||
59844376|NCT03713320|75969279|FG001|NOT COMPLETED|Cobomarsen Crossover Period||0||
59844377|NCT03713320|75969280|FG002|NOT COMPLETED|Cobomarsen Crossover Period||7||
59844378|NCT03712930|75969287|FG000|STARTED|Overall Study||13||
59844379|NCT03712930|75969287|FG000|COMPLETED|Overall Study||0||
59844380|NCT03712930|75969287|FG000|NOT COMPLETED|Overall Study||13||
59844381|NCT00420407|75969293|FG000|STARTED|Overall Study||41||
59844382|NCT00420407|75969294|FG001|STARTED|Overall Study||40||
59844383|NCT00420407|75969293|FG000|COMPLETED|Overall Study||37||
59719476|NCT01110330|75838732|FG001|COMPLETED|Overall Study||207||
59719477|NCT01110330|75838733|FG002|COMPLETED|Overall Study||208||
59719478|NCT01110330|75838731|FG000|NOT COMPLETED|Overall Study||15||
59719479|NCT01110330|75838732|FG001|NOT COMPLETED|Overall Study||23||
59844384|NCT00420407|75969294|FG001|COMPLETED|Overall Study||34||
59844385|NCT00420407|75969293|FG000|NOT COMPLETED|Overall Study||4||
59844386|NCT00420407|75969294|FG001|NOT COMPLETED|Overall Study||6||
59844387|NCT00420095|75969303|FG000|STARTED|Overall Study||57||
59844388|NCT00420095|75969304|FG001|STARTED|Overall Study||60||
59844389|NCT00420095|75969303|FG000|COMPLETED|Overall Study||54||
59844390|NCT00420095|75969304|FG001|COMPLETED|Overall Study||59||
59844391|NCT00420095|75969303|FG000|NOT COMPLETED|Overall Study||3||
59844392|NCT00420095|75969304|FG001|NOT COMPLETED|Overall Study||1||
59844393|NCT00419393|75969310|FG000|STARTED|Overall Study|One subject did not receive medication|190||
59844394|NCT00419393|75969310|FG000|COMPLETED|Overall Study||166||
59844395|NCT00419393|75969310|FG000|NOT COMPLETED|Overall Study||24||
59844396|NCT00419159|75969316|FG000|STARTED|Overall Study|Full Analysis Set|99||
59844397|NCT00419159|75969317|FG001|STARTED|Overall Study||100||
59844398|NCT00419159|75969316|FG000|COMPLETED|Overall Study||0||
59844399|NCT00419159|75969317|FG001|COMPLETED|Overall Study||0||
59844400|NCT00419159|75969316|FG000|NOT COMPLETED|Overall Study||99||
59844401|NCT00419159|75969317|FG001|NOT COMPLETED|Overall Study||100||
59844402|NCT03717064|75969331|FG000|STARTED|Period 1||18||
59844403|NCT03717064|75969331|FG000|COMPLETED|Period 1||18||
59844404|NCT03717064|75969331|FG000|NOT COMPLETED|Period 1||0||
59844405|NCT03717064|75969331|FG000|STARTED|Period 2||18||
59844406|NCT03717064|75969331|FG000|COMPLETED|Period 2||17||
59844407|NCT03717064|75969331|FG000|NOT COMPLETED|Period 2||1||
59844408|NCT03716050|75969343|FG000|STARTED|Overall Study||2||
59844409|NCT03716050|75969344|FG001|STARTED|Overall Study||4||
59844410|NCT03716050|75969345|FG002|STARTED|Overall Study||1||
59844411|NCT03716050|75969346|FG003|STARTED|Overall Study||3||
59844412|NCT03716050|75969347|FG004|STARTED|Overall Study||1||
59844413|NCT03716050|75969348|FG005|STARTED|Overall Study||0||
59844414|NCT03716050|75969349|FG006|STARTED|Overall Study||4||
59844415|NCT03716050|75969350|FG007|STARTED|Overall Study||2||
59844416|NCT03716050|75969343|FG000|COMPLETED|Overall Study||2||
59844417|NCT03716050|75969344|FG001|COMPLETED|Overall Study||4||
59844418|NCT03716050|75969345|FG002|COMPLETED|Overall Study||0||
59844419|NCT03716050|75969346|FG003|COMPLETED|Overall Study||1||
59844420|NCT03716050|75969347|FG004|COMPLETED|Overall Study||1||
59844421|NCT03716050|75969348|FG005|COMPLETED|Overall Study||0||
59844422|NCT03716050|75969349|FG006|COMPLETED|Overall Study||4||
59567840|NCT02528097|75670702|FG000|STARTED|Overall Study||1||
59567841|NCT02528097|75670703|FG001|STARTED|Overall Study||1||
59567842|NCT02528097|75670702|FG000|COMPLETED|Overall Study||1||
59567843|NCT02528097|75670703|FG001|COMPLETED|Overall Study||1||
59567844|NCT02528097|75670702|FG000|NOT COMPLETED|Overall Study||0||
59567845|NCT02528097|75670703|FG001|NOT COMPLETED|Overall Study||0||
59719480|NCT01110330|75838733|FG002|NOT COMPLETED|Overall Study||26||
59719481|NCT00596947|75838743|FG000|STARTED|Overall Study||9||
59719482|NCT00596947|75838744|FG001|STARTED|Overall Study||9||
59719483|NCT00596947|75838743|FG000|COMPLETED|Overall Study||3||
59719484|NCT00596947|75838744|FG001|COMPLETED|Overall Study||6||
59719485|NCT00596947|75838743|FG000|NOT COMPLETED|Overall Study||6||
59719486|NCT00596947|75838744|FG001|NOT COMPLETED|Overall Study||3||
59719487|NCT00888940|75838752|FG000|STARTED|Overall Study||120||
59719488|NCT00888940|75838753|FG001|STARTED|Overall Study||122||
59719489|NCT00888940|75838752|FG000|Completed Therapy|Overall Study||107||
59719490|NCT00888940|75838753|FG001|Completed Therapy|Overall Study||106||
59719491|NCT00888940|75838752|FG000|COMPLETED|Overall Study||92||
59719492|NCT00888940|75838753|FG001|COMPLETED|Overall Study||101||
59719493|NCT00888940|75838752|FG000|NOT COMPLETED|Overall Study||28||
59719494|NCT00888940|75838753|FG001|NOT COMPLETED|Overall Study||21||
59719495|NCT00595621|75838761|FG000|STARTED|Open Label Run in||22||
59719496|NCT00595621|75838762|FG001|STARTED|Open Label Run in||0||
59719497|NCT00595621|75838761|FG000|COMPLETED|Open Label Run in||19||
59719498|NCT00595621|75838762|FG001|COMPLETED|Open Label Run in||0||
59719499|NCT00595621|75838761|FG000|NOT COMPLETED|Open Label Run in||3||
59719500|NCT00595621|75838762|FG001|NOT COMPLETED|Open Label Run in||0||
59719501|NCT00595621|75838761|FG000|STARTED|Randomization and Study||10||
59719502|NCT00595621|75838762|FG001|STARTED|Randomization and Study||9||
59719503|NCT00595621|75838761|FG000|COMPLETED|Randomization and Study||8||
59719504|NCT00595621|75838762|FG001|COMPLETED|Randomization and Study||8||
59719505|NCT00595621|75838761|FG000|NOT COMPLETED|Randomization and Study||2||
59719506|NCT00595621|75838762|FG001|NOT COMPLETED|Randomization and Study||1||
59719507|NCT00888238|75838769|FG000|STARTED|First Period of Treatment Intervention||4||
59719508|NCT00888238|75838770|FG001|STARTED|First Period of Treatment Intervention||4||
59719509|NCT00888238|75838771|FG002|STARTED|First Period of Treatment Intervention||4||
59719510|NCT00888238|75838769|FG000|COMPLETED|First Period of Treatment Intervention||4||
59719511|NCT00888238|75838770|FG001|COMPLETED|First Period of Treatment Intervention||4||
59719512|NCT00888238|75838771|FG002|COMPLETED|First Period of Treatment Intervention||4||
59719513|NCT00888238|75838769|FG000|NOT COMPLETED|First Period of Treatment Intervention||0||
59719514|NCT00888238|75838770|FG001|NOT COMPLETED|First Period of Treatment Intervention||0||
59719515|NCT00888238|75838771|FG002|NOT COMPLETED|First Period of Treatment Intervention||0||
59844423|NCT03716050|75969350|FG007|COMPLETED|Overall Study||0||
59844424|NCT03716050|75969343|FG000|NOT COMPLETED|Overall Study||0||
59567846|NCT02520297|75670709|FG000|STARTED|Overall Study||1||
59567847|NCT02520297|75670709|FG000|COMPLETED|Overall Study||1||
59844425|NCT03716050|75969344|FG001|NOT COMPLETED|Overall Study||0||
59844426|NCT03716050|75969345|FG002|NOT COMPLETED|Overall Study||1||
59844427|NCT03716050|75969346|FG003|NOT COMPLETED|Overall Study||2||
59844428|NCT03716050|75969347|FG004|NOT COMPLETED|Overall Study||0||
59844429|NCT03716050|75969348|FG005|NOT COMPLETED|Overall Study||0||
59844430|NCT03716050|75969349|FG006|NOT COMPLETED|Overall Study||0||
59844431|NCT03716050|75969350|FG007|NOT COMPLETED|Overall Study||2||
59844432|NCT00413231|75969367|FG000|STARTED|0 to 30-day Post Treatment||160||
59844433|NCT00413231|75969367|FG000|COMPLETED|0 to 30-day Post Treatment||152||
59844434|NCT00413231|75969367|FG000|NOT COMPLETED|0 to 30-day Post Treatment||8||
59844435|NCT00413231|75969367|FG000|STARTED|30-day to 365-day Post Treatment||152||
59844436|NCT00413231|75969367|FG000|COMPLETED|30-day to 365-day Post Treatment||139||
59844437|NCT00413231|75969367|FG000|NOT COMPLETED|30-day to 365-day Post Treatment||13||
59844438|NCT00413231|75969367|FG000|STARTED|365-day to 60-month Post Treatment||139||
59844439|NCT00413231|75969367|FG000|COMPLETED|365-day to 60-month Post Treatment||93||
59844440|NCT00413231|75969367|FG000|NOT COMPLETED|365-day to 60-month Post Treatment||46||
59844441|NCT01988584|75969374|FG000|STARTED|Blinded Phase||3||
59844442|NCT01988584|75969375|FG001|STARTED|Blinded Phase||10||
59844443|NCT01988584|75969376|FG002|STARTED|Blinded Phase||2||
59844444|NCT01988584|75969377|FG003|STARTED|Blinded Phase||5||
59844445|NCT01988584|75969374|FG000|12 Month Follow-up|Blinded Phase||3||
59844446|NCT01988584|75969375|FG001|12 Month Follow-up|Blinded Phase||9||
59844447|NCT01988584|75969376|FG002|12 Month Follow-up|Blinded Phase||2||
59844448|NCT01988584|75969377|FG003|12 Month Follow-up|Blinded Phase||5||
59844449|NCT01988584|75969374|FG000|COMPLETED|Blinded Phase||3||
59844450|NCT01988584|75969375|FG001|COMPLETED|Blinded Phase||9||
59844451|NCT01988584|75969376|FG002|COMPLETED|Blinded Phase||2||
60120155|NCT01695239|76241401|FG011|COMPLETED|Double-Blind (DB) Treatment Period||0||
60120156|NCT01695239|76241402|FG012|COMPLETED|Double-Blind (DB) Treatment Period||0||
60120157|NCT01695239|76241403|FG013|COMPLETED|Double-Blind (DB) Treatment Period||0||
60120158|NCT01695239|76241390|FG000|NOT COMPLETED|Double-Blind (DB) Treatment Period||15||
59719516|NCT00888238|75838769|FG000|STARTED|Washout Period After Period 1||4||
59719517|NCT00888238|75838770|FG001|STARTED|Washout Period After Period 1||4||
59844452|NCT01988584|75969377|FG003|COMPLETED|Blinded Phase|One BMMNC Subject Lost To Follow-up After 1yr. Cross-Over Visit|4||
59844453|NCT01988584|75969374|FG000|NOT COMPLETED|Blinded Phase||0||
59844454|NCT01988584|75969375|FG001|NOT COMPLETED|Blinded Phase||1||
59844455|NCT01988584|75969376|FG002|NOT COMPLETED|Blinded Phase||0||
59844456|NCT01988584|75969377|FG003|NOT COMPLETED|Blinded Phase||1||
59844457|NCT01988584|75969374|FG000|STARTED|Unblinded Phase - Placebo Arm Crossover||0|Placebo arms cross over to stem cell intervention 12 months after start of study.|
59844458|NCT01988584|75969375|FG001|STARTED|Unblinded Phase - Placebo Arm Crossover||0|Placebo arms cross over to stem cell intervention 12 months after start of study.|
59844459|NCT01988584|75969376|FG002|STARTED|Unblinded Phase - Placebo Arm Crossover||2|Placebo arms cross over to stem cell intervention 12 months after start of study.|
59844460|NCT01988584|75969377|FG003|STARTED|Unblinded Phase - Placebo Arm Crossover||5|Placebo arms cross over to stem cell intervention 12 months after start of study.|
59844461|NCT01988584|75969374|FG000|COMPLETED|Unblinded Phase - Placebo Arm Crossover||0|Crossover arms complete follow-up 12 months after start of stem cell intervention (which is 24 months after start of study).|
59844462|NCT01988584|75969375|FG001|COMPLETED|Unblinded Phase - Placebo Arm Crossover||0|Crossover arms complete follow-up 12 months after start of stem cell intervention (which is 24 months after start of study).|
59844463|NCT01988584|75969376|FG002|COMPLETED|Unblinded Phase - Placebo Arm Crossover||2|Crossover arms complete follow-up 12 months after start of stem cell intervention (which is 24 months after start of study).|
59844464|NCT01988584|75969377|FG003|COMPLETED|Unblinded Phase - Placebo Arm Crossover||4|Crossover arms complete follow-up 12 months after start of stem cell intervention (which is 24 months after start of study).|
59844465|NCT01988584|75969374|FG000|NOT COMPLETED|Unblinded Phase - Placebo Arm Crossover||0||
59844466|NCT01988584|75969375|FG001|NOT COMPLETED|Unblinded Phase - Placebo Arm Crossover||0||
59844467|NCT01988584|75969376|FG002|NOT COMPLETED|Unblinded Phase - Placebo Arm Crossover||0||
59844468|NCT01988584|75969377|FG003|NOT COMPLETED|Unblinded Phase - Placebo Arm Crossover||1||
59844469|NCT00413153|75969387|FG000|STARTED|Overall Study||7||
59844470|NCT00413153|75969388|FG001|STARTED|Overall Study||8||
59844471|NCT00413153|75969387|FG000|COMPLETED|Overall Study||5||
59719518|NCT00888238|75838771|FG002|STARTED|Washout Period After Period 1||4||
59719519|NCT00888238|75838769|FG000|COMPLETED|Washout Period After Period 1||4||
59719520|NCT00888238|75838770|FG001|COMPLETED|Washout Period After Period 1||4||
59719521|NCT00888238|75838771|FG002|COMPLETED|Washout Period After Period 1||4||
59719522|NCT00888238|75838769|FG000|NOT COMPLETED|Washout Period After Period 1||0||
59719523|NCT00888238|75838770|FG001|NOT COMPLETED|Washout Period After Period 1||0||
59719524|NCT00888238|75838771|FG002|NOT COMPLETED|Washout Period After Period 1||0||
59844472|NCT00413153|75969388|FG001|COMPLETED|Overall Study||7||
59844473|NCT00413153|75969387|FG000|NOT COMPLETED|Overall Study||2||
59844474|NCT00413153|75969388|FG001|NOT COMPLETED|Overall Study||1||
60120159|NCT01695239|76241391|FG001|NOT COMPLETED|Double-Blind (DB) Treatment Period||4||
59719525|NCT00888238|75838769|FG000|STARTED|Second Period of Treatment Intervention||4||
59719526|NCT00888238|75838770|FG001|STARTED|Second Period of Treatment Intervention||4||
59719527|NCT00888238|75838771|FG002|STARTED|Second Period of Treatment Intervention||4||
59719528|NCT00888238|75838769|FG000|COMPLETED|Second Period of Treatment Intervention||4||
59719529|NCT00888238|75838770|FG001|COMPLETED|Second Period of Treatment Intervention||4||
59719530|NCT00888238|75838771|FG002|COMPLETED|Second Period of Treatment Intervention||4||
59719531|NCT00888238|75838769|FG000|NOT COMPLETED|Second Period of Treatment Intervention||0||
59719532|NCT00888238|75838770|FG001|NOT COMPLETED|Second Period of Treatment Intervention||0||
59719533|NCT00888238|75838771|FG002|NOT COMPLETED|Second Period of Treatment Intervention||0||
59844475|NCT00412607|75969394|FG000|STARTED|Overall Study||249||
59844476|NCT00412607|75969394|FG000|Started Study Catheter|Overall Study||233||
59844477|NCT00412607|75969394|FG000|COMPLETED|Overall Study||145||
59844478|NCT00412607|75969394|FG000|NOT COMPLETED|Overall Study||104||
59844479|NCT00419003|75969403|FG000|STARTED|Phase I, Ketamine Infusion||13||
59844480|NCT00419003|75969404|FG001|STARTED|Phase I, Ketamine Infusion||13||
59844481|NCT00419003|75969403|FG000|COMPLETED|Phase I, Ketamine Infusion||7||
59844482|NCT00419003|75969404|FG001|COMPLETED|Phase I, Ketamine Infusion||7||
59844483|NCT00419003|75969403|FG000|NOT COMPLETED|Phase I, Ketamine Infusion||6||
59844484|NCT00419003|75969404|FG001|NOT COMPLETED|Phase I, Ketamine Infusion||6||
59844485|NCT00419003|75969403|FG000|STARTED|Phase 2, Riluzole/Placebo Follow-Up|14 completers of phase I didn't split up evenly (same way as phase I) in the riluzole/placebo phase.|6||
59844486|NCT00419003|75969404|FG001|STARTED|Phase 2, Riluzole/Placebo Follow-Up|14 completers of phase I didn't split up evenly (same way as phase I) in the riluzole/placebo phase.|8||
59844487|NCT00419003|75969403|FG000|COMPLETED|Phase 2, Riluzole/Placebo Follow-Up||5||
59844488|NCT00419003|75969404|FG001|COMPLETED|Phase 2, Riluzole/Placebo Follow-Up||8||
59844489|NCT00419003|75969403|FG000|NOT COMPLETED|Phase 2, Riluzole/Placebo Follow-Up||1||
59844490|NCT00419003|75969404|FG001|NOT COMPLETED|Phase 2, Riluzole/Placebo Follow-Up||0||
59844491|NCT00418691|75969416|FG000|STARTED|Overall Study||11||
59844492|NCT00418691|75969417|FG001|STARTED|Overall Study||12||
59844493|NCT00418691|75969418|FG002|STARTED|Overall Study||10||
59844494|NCT00418691|75969416|FG000|COMPLETED|Overall Study||9||
59844495|NCT00418691|75969417|FG001|COMPLETED|Overall Study||10||
59844496|NCT00418691|75969418|FG002|COMPLETED|Overall Study||5||
59844497|NCT00418691|75969416|FG000|NOT COMPLETED|Overall Study||2||
59844498|NCT00418691|75969417|FG001|NOT COMPLETED|Overall Study||2||
59844499|NCT00418691|75969418|FG002|NOT COMPLETED|Overall Study||5||
59844500|NCT00412373|75969428|FG000|STARTED|Overall Study|Number of Subjects in Intent-to-Treat Analysis Set.|93||
59844501|NCT00412373|75969429|FG001|STARTED|Overall Study|Number of Subjects Intent-to-Treat Analysis Set.|211||
59844502|NCT00412373|75969428|FG000|COMPLETED|Overall Study|Number of Subjects Who Completed Double-Blind Treatment.|52||
59844503|NCT00412373|75969429|FG001|COMPLETED|Overall Study|Number of Subjects Who Completed Double-Blind Treatment..|134||
59844504|NCT00412373|75969428|FG000|NOT COMPLETED|Overall Study||41||
59844505|NCT00412373|75969429|FG001|NOT COMPLETED|Overall Study||77||
59844506|NCT00418379|75969438|FG000|STARTED|Year 1||207||
59844507|NCT00418379|75969439|FG001|STARTED|Year 1||207||
59844508|NCT00418379|75969440|FG002|STARTED|Year 1||219||
59844509|NCT00418379|75969438|FG000|COMPLETED|Year 1||189||
59844510|NCT00418379|75969439|FG001|COMPLETED|Year 1||179||
59844511|NCT00418379|75969440|FG002|COMPLETED|Year 1||204||
59844512|NCT00418379|75969438|FG000|NOT COMPLETED|Year 1||18||
59844513|NCT00418379|75969439|FG001|NOT COMPLETED|Year 1||28||
59844514|NCT00418379|75969440|FG002|NOT COMPLETED|Year 1||15||
59844515|NCT00418379|75969438|FG000|STARTED|Year 2|22 patients withdrew between Year 1 and Year 2 treatment periods.|167||
59844516|NCT00418379|75969439|FG001|STARTED|Year 2|20 patients withdrew between Year 1 and Year 2 treatment periods.|159||
59844517|NCT00418379|75969440|FG002|STARTED|Year 2|22 patients withdrew between Year 1 and Year 2 treatment periods.|182||
59844518|NCT00418379|75969438|FG000|COMPLETED|Year 2||159||
59844519|NCT00418379|75969439|FG001|COMPLETED|Year 2||155||
59844520|NCT00418379|75969440|FG002|COMPLETED|Year 2||172||
59844521|NCT00418379|75969438|FG000|NOT COMPLETED|Year 2||8||
59844522|NCT00418379|75969439|FG001|NOT COMPLETED|Year 2||4||
59844523|NCT00418379|75969440|FG002|NOT COMPLETED|Year 2||10||
59844524|NCT00418379|75969438|FG000|STARTED|Year 3|8 patients withdrew between Year 2 and Year 3 treatment periods.|151||
59844525|NCT00418379|75969439|FG001|STARTED|Year 3|7 patients withdrew between Year 2 and Year 3 treatment periods.|148||
59844526|NCT00418379|75969440|FG002|STARTED|Year 3|6 patients withdrew between Year 2 and Year 3 treatment periods.|166||
59844527|NCT00418379|75969438|FG000|COMPLETED|Year 3||148||
59844528|NCT00418379|75969439|FG001|COMPLETED|Year 3||146||
59844529|NCT00418379|75969440|FG002|COMPLETED|Year 3||163||
59844530|NCT00418379|75969438|FG000|NOT COMPLETED|Year 3||3||
59844531|NCT00418379|75969439|FG001|NOT COMPLETED|Year 3||2||
59844532|NCT00418379|75969440|FG002|NOT COMPLETED|Year 3||3||
59844533|NCT00418379|75969438|FG000|STARTED|Year 4|3 patients withdrew between Year 3 and Year 4 study periods.|145||
59844534|NCT00418379|75969439|FG001|STARTED|Year 4|5 patients withdrew between Year 3 and Year 4 study periods.|141||
59844535|NCT00418379|75969440|FG002|STARTED|Year 4|7 patients withdrew between Year 3 and Year 4 study periods.|156||
59719534|NCT00888238|75838769|FG000|STARTED|Washout Period After Period 2||4||
59719535|NCT00888238|75838770|FG001|STARTED|Washout Period After Period 2||4||
59844536|NCT00418379|75969438|FG000|COMPLETED|Year 4||142||
59844537|NCT00418379|75969439|FG001|COMPLETED|Year 4||136||
59844538|NCT00418379|75969440|FG002|COMPLETED|Year 4||154||
59719536|NCT00888238|75838771|FG002|STARTED|Washout Period After Period 2||4||
59719537|NCT00888238|75838769|FG000|COMPLETED|Washout Period After Period 2||4||
59844539|NCT00418379|75969438|FG000|NOT COMPLETED|Year 4||3||
59844540|NCT00418379|75969439|FG001|NOT COMPLETED|Year 4||5||
59844541|NCT00418379|75969440|FG002|NOT COMPLETED|Year 4||2||
59844542|NCT00418379|75969438|FG000|STARTED|Year 5|14 patients withdrew between Year 4 and Year 5 study periods.|128||
60120160|NCT01695239|76241392|FG002|NOT COMPLETED|Double-Blind (DB) Treatment Period||10||
60120161|NCT01695239|76241393|FG003|NOT COMPLETED|Double-Blind (DB) Treatment Period||7||
60120162|NCT01695239|76241394|FG004|NOT COMPLETED|Double-Blind (DB) Treatment Period||0||
60120163|NCT01695239|76241395|FG005|NOT COMPLETED|Double-Blind (DB) Treatment Period||0||
60120164|NCT01695239|76241396|FG006|NOT COMPLETED|Double-Blind (DB) Treatment Period||0||
60120165|NCT01695239|76241397|FG007|NOT COMPLETED|Double-Blind (DB) Treatment Period||0||
59844543|NCT00418379|75969439|FG001|STARTED|Year 5|16 patients withdrew between Year 4 and Year 5 study periods.|120||
59844544|NCT00418379|75969440|FG002|STARTED|Year 5|20 patients withdrew between Year 4 and Year 5 study periods.|134||
59844545|NCT00418379|75969438|FG000|COMPLETED|Year 5||126||
59844546|NCT00418379|75969439|FG001|COMPLETED|Year 5||115||
59844547|NCT00418379|75969440|FG002|COMPLETED|Year 5||131||
59844548|NCT00418379|75969438|FG000|NOT COMPLETED|Year 5||2||
59844549|NCT00418379|75969439|FG001|NOT COMPLETED|Year 5||5||
59844550|NCT00418379|75969440|FG002|NOT COMPLETED|Year 5||3||
59567848|NCT02520297|75670709|FG000|NOT COMPLETED|Overall Study||0||
59567849|NCT02280408|75670717|FG000|STARTED|Overall Study||10||
59844551|NCT00418145|75969448|FG000|STARTED|Overall Study||16||
59844552|NCT00418145|75969448|FG000|COMPLETED|Overall Study||10||
59844553|NCT00418145|75969448|FG000|NOT COMPLETED|Overall Study||6||
59844554|NCT00417989|75969456|FG000|STARTED|Overall Study|Intent to Treat include safety population & subjects with baseline & 1 post baseline A1C measurement|244||
59844555|NCT00417989|75969457|FG001|STARTED|Overall Study||241||
59844556|NCT00417989|75969456|FG000|COMPLETED|Overall Study||224||
59844557|NCT00417989|75969457|FG001|COMPLETED|Overall Study||219||
59844558|NCT00417989|75969456|FG000|NOT COMPLETED|Overall Study||20||
60120166|NCT01695239|76241398|FG008|NOT COMPLETED|Double-Blind (DB) Treatment Period||0||
60120167|NCT01695239|76241399|FG009|NOT COMPLETED|Double-Blind (DB) Treatment Period||0||
60120168|NCT01695239|76241400|FG010|NOT COMPLETED|Double-Blind (DB) Treatment Period||0||
60120169|NCT01695239|76241401|FG011|NOT COMPLETED|Double-Blind (DB) Treatment Period||0||
60120170|NCT01695239|76241402|FG012|NOT COMPLETED|Double-Blind (DB) Treatment Period||0||
60120171|NCT01695239|76241403|FG013|NOT COMPLETED|Double-Blind (DB) Treatment Period||0||
60120172|NCT01695239|76241390|FG000|STARTED|IR Participants (Week 16 Up To Week 24)|Only inadequate responders were included.|0||
60120173|NCT01695239|76241391|FG001|STARTED|IR Participants (Week 16 Up To Week 24)|Only inadequate responders were included.|0||
60120174|NCT01695239|76241392|FG002|STARTED|IR Participants (Week 16 Up To Week 24)|Only inadequate responders were included.|0||
60120175|NCT01695239|76241393|FG003|STARTED|IR Participants (Week 16 Up To Week 24)|Only inadequate responders were included.|0||
60120176|NCT01695239|76241394|FG004|STARTED|IR Participants (Week 16 Up To Week 24)|IR from placebo who re-randomized to ixeQ4W and IR from ixeQ4W.|24||
60120177|NCT01695239|76241395|FG005|STARTED|IR Participants (Week 16 Up To Week 24)|IR from placebo who re-randomized to ixeQ2W and IR from ixeQ2W.|24||
59567850|NCT02280408|75670718|FG001|STARTED|Overall Study||10||
59719538|NCT00888238|75838770|FG001|COMPLETED|Washout Period After Period 2||4||
59719539|NCT00888238|75838771|FG002|COMPLETED|Washout Period After Period 2||3||
59719540|NCT00888238|75838769|FG000|NOT COMPLETED|Washout Period After Period 2||0||
59719541|NCT00888238|75838770|FG001|NOT COMPLETED|Washout Period After Period 2||0||
59719542|NCT00888238|75838771|FG002|NOT COMPLETED|Washout Period After Period 2||1||
59719543|NCT00888238|75838769|FG000|STARTED|Third Period of Treatment Intervention||4||
59719544|NCT00888238|75838770|FG001|STARTED|Third Period of Treatment Intervention||4||
59719545|NCT00888238|75838771|FG002|STARTED|Third Period of Treatment Intervention||3||
59719546|NCT00888238|75838769|FG000|COMPLETED|Third Period of Treatment Intervention||4||
59719547|NCT00888238|75838770|FG001|COMPLETED|Third Period of Treatment Intervention||4||
59844559|NCT00417989|75969457|FG001|NOT COMPLETED|Overall Study||22||
59844560|NCT00412217|75969467|FG000|STARTED|Overall Study||46||
59844561|NCT00412217|75969468|FG001|STARTED|Overall Study||48||
59844562|NCT00412217|75969467|FG000|COMPLETED|Overall Study||0||
59567851|NCT02280408|75670719|FG002|STARTED|Overall Study||10||
59567852|NCT02280408|75670720|FG003|STARTED|Overall Study||9||
59844563|NCT00412217|75969468|FG001|COMPLETED|Overall Study||0||
59844564|NCT00412217|75969467|FG000|NOT COMPLETED|Overall Study||46||
59844565|NCT00412217|75969468|FG001|NOT COMPLETED|Overall Study||48||
59844566|NCT05000164|75969474|FG000|STARTED|Overall Study||72||
59844567|NCT05000164|75969474|FG000|COMPLETED|Overall Study||62||
59844568|NCT05000164|75969474|FG000|NOT COMPLETED|Overall Study||10||
59844569|NCT00123474|75969482|FG000|STARTED|Randomized to Treatment||167||
59844570|NCT00123474|75969483|FG001|STARTED|Randomized to Treatment||167||
59844571|NCT00123474|75969484|FG002|STARTED|Randomized to Treatment||168||
59844572|NCT00123474|75969485|FG003|STARTED|Randomized to Treatment||168||
59844573|NCT00123474|75969482|FG000|COMPLETED|Randomized to Treatment||166||
59844574|NCT00123474|75969483|FG001|COMPLETED|Randomized to Treatment||163||
59844575|NCT00123474|75969484|FG002|COMPLETED|Randomized to Treatment||166||
59844576|NCT00123474|75969485|FG003|COMPLETED|Randomized to Treatment||167||
59844577|NCT00123474|75969482|FG000|NOT COMPLETED|Randomized to Treatment||1||
59844578|NCT00123474|75969483|FG001|NOT COMPLETED|Randomized to Treatment||4||
59844579|NCT00123474|75969484|FG002|NOT COMPLETED|Randomized to Treatment||2||
59844580|NCT00123474|75969485|FG003|NOT COMPLETED|Randomized to Treatment||1||
59844581|NCT00123474|75969482|FG000|STARTED|As Treated at Study Closure|Randomized to 50 mg BID but received 100 mg QD.|165||
59844582|NCT00123474|75969483|FG001|STARTED|As Treated at Study Closure||163||
59844583|NCT00123474|75969484|FG002|STARTED|As Treated at Study Closure||167||
59844584|NCT00123474|75969485|FG003|STARTED|As Treated at Study Closure||167||
59844585|NCT00123474|75969482|FG000|COMPLETED|As Treated at Study Closure||0||
59844586|NCT00123474|75969483|FG001|COMPLETED|As Treated at Study Closure||0||
59844587|NCT00123474|75969484|FG002|COMPLETED|As Treated at Study Closure|Randomized to 100 mg QD but received 50 mg BID.|0||
59844588|NCT00123474|75969485|FG003|COMPLETED|As Treated at Study Closure||0||
59844589|NCT00123474|75969482|FG000|NOT COMPLETED|As Treated at Study Closure||165||
59844590|NCT00123474|75969483|FG001|NOT COMPLETED|As Treated at Study Closure||163||
59844591|NCT00123474|75969484|FG002|NOT COMPLETED|As Treated at Study Closure||167||
59844592|NCT00123474|75969485|FG003|NOT COMPLETED|As Treated at Study Closure||167||
59844593|NCT00142298|75969526|FG000|STARTED|Overall Study||667||
59844594|NCT00142298|75969527|FG001|STARTED|Overall Study||632||
59844595|NCT00142298|75969528|FG002|STARTED|Overall Study||123||
59844596|NCT00142298|75969529|FG003|STARTED|Overall Study||206||
59844597|NCT00142298|75969530|FG004|STARTED|Overall Study||56||
59844598|NCT00142298|75969531|FG005|STARTED|Overall Study||26||
59844599|NCT00142298|75969532|FG006|STARTED|Overall Study||23||
59844600|NCT00142298|75969533|FG007|STARTED|Overall Study||66||
59844601|NCT00142298|75969534|FG008|STARTED|Overall Study||57||
60120178|NCT01695239|76241396|FG006|STARTED|IR Participants (Week 16 Up To Week 24)|Adalimumab Q2W (IR) who re-randomized to IxeQ2W or IxeQ4W and PBO for ixe and adalimumab.|9||
60120179|NCT01695239|76241397|FG007|STARTED|IR Participants (Week 16 Up To Week 24)||0||
60120180|NCT01695239|76241398|FG008|STARTED|IR Participants (Week 16 Up To Week 24)||0||
60120181|NCT01695239|76241399|FG009|STARTED|IR Participants (Week 16 Up To Week 24)||0||
60120182|NCT01695239|76241400|FG010|STARTED|IR Participants (Week 16 Up To Week 24)||0||
60120183|NCT01695239|76241401|FG011|STARTED|IR Participants (Week 16 Up To Week 24)||0||
60120184|NCT01695239|76241402|FG012|STARTED|IR Participants (Week 16 Up To Week 24)||0||
60120185|NCT01695239|76241403|FG013|STARTED|IR Participants (Week 16 Up To Week 24)||0||
59719548|NCT00888238|75838771|FG002|COMPLETED|Third Period of Treatment Intervention||3||
59719549|NCT00888238|75838769|FG000|NOT COMPLETED|Third Period of Treatment Intervention||0||
59719550|NCT00888238|75838770|FG001|NOT COMPLETED|Third Period of Treatment Intervention||0||
59719551|NCT00888238|75838771|FG002|NOT COMPLETED|Third Period of Treatment Intervention||0||
59719552|NCT00595465|75838780|FG000|STARTED|Overall Study||130||
59719553|NCT00595465|75838781|FG001|STARTED|Overall Study||129||
59844602|NCT00142298|75969535|FG009|STARTED|Overall Study||13||
59844603|NCT00142298|75969526|FG000|Safety Population|Overall Study||655||
59844604|NCT00142298|75969527|FG001|Safety Population|Overall Study||626||
59844605|NCT00142298|75969528|FG002|Safety Population|Overall Study||122||
59844606|NCT00142298|75969529|FG003|Safety Population|Overall Study||206||
60120186|NCT01695239|76241390|FG000|COMPLETED|IR Participants (Week 16 Up To Week 24)||0||
59719554|NCT00595465|75838782|FG002|STARTED|Overall Study||128||
59719555|NCT00595465|75838780|FG000|COMPLETED|Overall Study||124||
59719556|NCT00595465|75838781|FG001|COMPLETED|Overall Study||125||
59719557|NCT00595465|75838782|FG002|COMPLETED|Overall Study||121||
59719558|NCT00595465|75838780|FG000|NOT COMPLETED|Overall Study||6||
59844607|NCT00142298|75969530|FG004|Safety Population|Overall Study||50||
59844608|NCT00142298|75969531|FG005|Safety Population|Overall Study||26||
59844609|NCT00142298|75969532|FG006|Safety Population|Overall Study||23||
59844610|NCT00142298|75969533|FG007|Safety Population|Overall Study||66||
59844611|NCT00142298|75969534|FG008|Safety Population|Overall Study||57||
59844612|NCT00142298|75969535|FG009|Safety Population|Overall Study||13||
59844613|NCT00142298|75969526|FG000|Per Protocol Population|Overall Study||635||
60120187|NCT01695239|76241391|FG001|COMPLETED|IR Participants (Week 16 Up To Week 24)||0||
60120188|NCT01695239|76241392|FG002|COMPLETED|IR Participants (Week 16 Up To Week 24)||0||
59719559|NCT00595465|75838781|FG001|NOT COMPLETED|Overall Study||4||
59719560|NCT00595465|75838782|FG002|NOT COMPLETED|Overall Study||7||
59844614|NCT00142298|75969527|FG001|Per Protocol Population|Overall Study||606||
59844615|NCT00142298|75969528|FG002|Per Protocol Population|Overall Study||120||
59844616|NCT00142298|75969529|FG003|Per Protocol Population|Overall Study||202||
59844617|NCT00142298|75969530|FG004|Per Protocol Population|Overall Study||50||
59844618|NCT00142298|75969531|FG005|Per Protocol Population|Overall Study||25||
59844619|NCT00142298|75969532|FG006|Per Protocol Population|Overall Study||19||
59844620|NCT00142298|75969533|FG007|Per Protocol Population|Overall Study||64||
59844621|NCT00142298|75969534|FG008|Per Protocol Population|Overall Study||56||
59844622|NCT00142298|75969535|FG009|Per Protocol Population|Overall Study||13||
59844623|NCT00142298|75969526|FG000|COMPLETED|Overall Study|Completed week 104/week 208.|507||
59844624|NCT00142298|75969527|FG001|COMPLETED|Overall Study||456||
59844625|NCT00142298|75969528|FG002|COMPLETED|Overall Study||90||
59844626|NCT00142298|75969529|FG003|COMPLETED|Overall Study||121||
59844627|NCT00142298|75969530|FG004|COMPLETED|Overall Study||46||
59844628|NCT00142298|75969531|FG005|COMPLETED|Overall Study||10||
59844629|NCT00142298|75969532|FG006|COMPLETED|Overall Study||15||
59844630|NCT00142298|75969533|FG007|COMPLETED|Overall Study||58||
59844631|NCT00142298|75969534|FG008|COMPLETED|Overall Study||52||
59844632|NCT00142298|75969535|FG009|COMPLETED|Overall Study||13||
59844633|NCT00142298|75969526|FG000|NOT COMPLETED|Overall Study||160||
59844634|NCT00142298|75969527|FG001|NOT COMPLETED|Overall Study||176||
59844635|NCT00142298|75969528|FG002|NOT COMPLETED|Overall Study||33||
59844636|NCT00142298|75969529|FG003|NOT COMPLETED|Overall Study||85||
59719561|NCT01205438|75838793|FG000|STARTED|Overall Study||372||
59719562|NCT01205438|75838794|FG001|STARTED|Overall Study||376||
59719563|NCT01205438|75838795|FG002|STARTED|Overall Study||376||
59719564|NCT01205438|75838793|FG000|Received At Least One Dose of Study Drug|Overall Study||371||
59719565|NCT01205438|75838794|FG001|Received At Least One Dose of Study Drug|Overall Study||374||
59719566|NCT01205438|75838795|FG002|Received At Least One Dose of Study Drug|Overall Study||376||
59844637|NCT00142298|75969530|FG004|NOT COMPLETED|Overall Study||10||
59844638|NCT00142298|75969531|FG005|NOT COMPLETED|Overall Study||16||
59844639|NCT00142298|75969532|FG006|NOT COMPLETED|Overall Study||8||
59844640|NCT00142298|75969533|FG007|NOT COMPLETED|Overall Study||8||
59844641|NCT00142298|75969534|FG008|NOT COMPLETED|Overall Study||5||
59844642|NCT00142298|75969535|FG009|NOT COMPLETED|Overall Study||0||
59844643|NCT03709654|75969559|FG000|STARTED|Overall Study||23||
59844644|NCT03709654|75969560|FG001|STARTED|Overall Study||13||
59844645|NCT03709654|75969559|FG000|COMPLETED|Overall Study||20||
59844646|NCT03709654|75969560|FG001|COMPLETED|Overall Study||11||
59844647|NCT03709654|75969559|FG000|NOT COMPLETED|Overall Study||3||
59844648|NCT03709654|75969560|FG001|NOT COMPLETED|Overall Study||2||
59844649|NCT00412061|75969568|FG000|STARTED|Double Blind Phase||216||
59844650|NCT00412061|75969569|FG001|STARTED|Double Blind Phase||213||
59844651|NCT00412061|75969568|FG000|Safety Set|Double Blind Phase|1 patient did not provide at laest one valid post baseline safety assessment.|215||
59844652|NCT00412061|75969569|FG001|Safety Set|Double Blind Phase|1 pt randomized never took drug Another randomized did not have valid post BL safety assessment|211||
59844653|NCT00412061|75969568|FG000|COMPLETED|Double Blind Phase||0||
59844654|NCT00412061|75969569|FG001|COMPLETED|Double Blind Phase||0||
59844655|NCT00412061|75969568|FG000|NOT COMPLETED|Double Blind Phase||216||
59844656|NCT00412061|75969569|FG001|NOT COMPLETED|Double Blind Phase||213||
59844657|NCT00412061|75969568|FG000|STARTED|Open Label Phase||0||
59844658|NCT00412061|75969569|FG001|STARTED|Open Label Phase||170||
59844659|NCT00412061|75969568|FG000|COMPLETED|Open Label Phase||0||
59844660|NCT00412061|75969569|FG001|COMPLETED|Open Label Phase||0||
59844661|NCT00412061|75969568|FG000|NOT COMPLETED|Open Label Phase||0||
59844662|NCT00412061|75969569|FG001|NOT COMPLETED|Open Label Phase||170||
59844663|NCT04560868|75969580|FG000|STARTED|Overall Study||29||
59844664|NCT04560868|75969581|FG001|STARTED|Overall Study||28||
59844665|NCT04560868|75969580|FG000|Completed 1-month Self-report Survey|Overall Study||28||
60120189|NCT01695239|76241393|FG003|COMPLETED|IR Participants (Week 16 Up To Week 24)||0||
60120190|NCT01695239|76241394|FG004|COMPLETED|IR Participants (Week 16 Up To Week 24)||24||
60120191|NCT01695239|76241395|FG005|COMPLETED|IR Participants (Week 16 Up To Week 24)||24||
59719567|NCT01205438|75838793|FG000|Participated in Follow Up|Overall Study||72||
59719568|NCT01205438|75838794|FG001|Participated in Follow Up|Overall Study||78||
59719569|NCT01205438|75838795|FG002|Participated in Follow Up|Overall Study||66||
59719570|NCT01205438|75838793|FG000|COMPLETED|Overall Study||295||
59719571|NCT01205438|75838794|FG001|COMPLETED|Overall Study||289||
59719572|NCT01205438|75838795|FG002|COMPLETED|Overall Study||288||
59719573|NCT01205438|75838793|FG000|NOT COMPLETED|Overall Study||77||
59719574|NCT01205438|75838794|FG001|NOT COMPLETED|Overall Study||87||
59719575|NCT01205438|75838795|FG002|NOT COMPLETED|Overall Study||88||
59719576|NCT01104870|75838809|FG000|STARTED|Overall Study||11||
59719577|NCT01104870|75838810|FG001|STARTED|Overall Study||19||
59719578|NCT01104870|75838811|FG002|STARTED|Overall Study||20||
59719579|NCT01104870|75838809|FG000|COMPLETED|Overall Study||10||
59844666|NCT04560868|75969581|FG001|Completed 1-month Self-report Survey|Overall Study||21||
59844667|NCT04560868|75969580|FG000|Completed 3-month Self-report Survey|Overall Study||26||
60120192|NCT01695239|76241396|FG006|COMPLETED|IR Participants (Week 16 Up To Week 24)||9||
59719580|NCT01104870|75838810|FG001|COMPLETED|Overall Study||18||
59719581|NCT01104870|75838811|FG002|COMPLETED|Overall Study||18||
59844668|NCT04560868|75969581|FG001|Completed 3-month Self-report Survey|Overall Study||21||
59844669|NCT04560868|75969580|FG000|Completed App Utilization Period|Overall Study||29||
59844670|NCT04560868|75969581|FG001|Completed App Utilization Period|Overall Study||28||
59844671|NCT04560868|75969580|FG000|COMPLETED|Overall Study||29||
59844672|NCT04560868|75969581|FG001|COMPLETED|Overall Study||28||
59844673|NCT04560868|75969580|FG000|NOT COMPLETED|Overall Study||0||
59844674|NCT04560868|75969581|FG001|NOT COMPLETED|Overall Study||0||
59844675|NCT00411671|75969587|FG000|STARTED|Overall Study||105||
59844676|NCT00411671|75969587|FG000|COMPLETED|Overall Study||85||
59844677|NCT00411671|75969587|FG000|NOT COMPLETED|Overall Study||20||
59844678|NCT03835481|75969596|FG000|STARTED|Double-blind Period||2|Enrolled|
59844679|NCT03835481|75969597|FG001|STARTED|Double-blind Period||20|Enrolled|
59844680|NCT03835481|75969598|FG002|STARTED|Double-blind Period||16|Enrolled|
59844681|NCT03835481|75969599|FG003|STARTED|Double-blind Period||49|Enrolled|
59844682|NCT03835481|75969600|FG004|STARTED|Double-blind Period||78|Enrolled|
59844683|NCT03835481|75969596|FG000|COMPLETED|Double-blind Period||2|Completed week 12|
59844684|NCT03835481|75969597|FG001|COMPLETED|Double-blind Period||18|Completed week 12|
59844685|NCT03835481|75969598|FG002|COMPLETED|Double-blind Period||15|Completed week 12|
59844686|NCT03835481|75969599|FG003|COMPLETED|Double-blind Period||46|Completed week 12|
59844687|NCT03835481|75969600|FG004|COMPLETED|Double-blind Period||37|Completed week 12|
59844688|NCT03835481|75969596|FG000|NOT COMPLETED|Double-blind Period||0||
59844689|NCT03835481|75969597|FG001|NOT COMPLETED|Double-blind Period||2||
59844690|NCT03835481|75969598|FG002|NOT COMPLETED|Double-blind Period||1||
59844691|NCT03835481|75969599|FG003|NOT COMPLETED|Double-blind Period||3||
59844692|NCT03835481|75969600|FG004|NOT COMPLETED|Double-blind Period||41||
59844693|NCT03835481|75969596|FG000|STARTED|Open Label Period (After Week 12)|0 patients started period 2, patients were switched to 100 mg.|0|Patients assigned to 25 or 50 mg in part 1 were reassigned to 100 mg in the open label period.|
59844694|NCT03835481|75969597|FG001|STARTED|Open Label Period (After Week 12)|0 patients started period 2, patients were switched to 100 mg.|0|Patients assigned to 25 or 50 mg in part 1 were reassigned to 100 mg in the open label period.|
59844695|NCT03835481|75969598|FG002|STARTED|Open Label Period (After Week 12)|Combination of Double-blind period dose groups: 25, 50 and 100 mg.|35|Patients assigned to 25 or 50 mg in part 1 were reassigned to 100 mg in the open label period.|
59844696|NCT03835481|75969599|FG003|STARTED|Open Label Period (After Week 12)||46|Patients assigned to 25 or 50 mg in part 1 were reassigned to 100 mg in the open label period.|
59844697|NCT03835481|75969600|FG004|STARTED|Open Label Period (After Week 12)||37|Patients assigned to 25 or 50 mg in part 1 were reassigned to 100 mg in the open label period.|
59844698|NCT03835481|75969596|FG000|COMPLETED|Open Label Period (After Week 12)||0||
59844699|NCT03835481|75969597|FG001|COMPLETED|Open Label Period (After Week 12)||0||
59844700|NCT03835481|75969598|FG002|COMPLETED|Open Label Period (After Week 12)||0||
59844701|NCT03835481|75969599|FG003|COMPLETED|Open Label Period (After Week 12)||0||
59567853|NCT02280408|75670717|FG000|Vaccination 1|Overall Study||10||
59567854|NCT02280408|75670718|FG001|Vaccination 1|Overall Study||10||
59567855|NCT02280408|75670719|FG002|Vaccination 1|Overall Study||10||
59844702|NCT03835481|75969600|FG004|COMPLETED|Open Label Period (After Week 12)||0||
59844703|NCT03835481|75969596|FG000|NOT COMPLETED|Open Label Period (After Week 12)||0||
59844704|NCT03835481|75969597|FG001|NOT COMPLETED|Open Label Period (After Week 12)||0||
59844705|NCT03835481|75969598|FG002|NOT COMPLETED|Open Label Period (After Week 12)||35||
59844706|NCT03835481|75969599|FG003|NOT COMPLETED|Open Label Period (After Week 12)||46||
59844707|NCT03835481|75969600|FG004|NOT COMPLETED|Open Label Period (After Week 12)||37||
59844708|NCT03709576|75969647|FG000|STARTED|Overall Study||3||
59844709|NCT03709576|75969647|FG000|COMPLETED|Overall Study||2||
59844710|NCT03709576|75969647|FG000|NOT COMPLETED|Overall Study||1||
59844711|NCT00122460|75969654|FG000|STARTED|Overall Study|Intention To Treat population, treatment group as randomized|222||
59844712|NCT00122460|75969655|FG001|STARTED|Overall Study|Intention To Treat population, treatment group as randomized|220||
59844713|NCT00122460|75969654|FG000|COMPLETED|Overall Study||215||
59844714|NCT00122460|75969655|FG001|COMPLETED|Overall Study||219||
59844715|NCT00122460|75969654|FG000|NOT COMPLETED|Overall Study||7||
59844716|NCT00122460|75969655|FG001|NOT COMPLETED|Overall Study||1||
59844717|NCT00137436|75969661|FG000|STARTED|Overall Study|Phase 2 did not include 38 participants from Phase 1.|55||
59844718|NCT00137436|75969661|FG000|COMPLETED|Overall Study||12||
59567856|NCT02280408|75670720|FG003|Vaccination 1|Overall Study||9||
59844719|NCT00137436|75969661|FG000|NOT COMPLETED|Overall Study||43||
59844720|NCT03834623|75969667|FG000|STARTED|Overall Study||11||
59844721|NCT03834623|75969668|FG001|STARTED|Overall Study||12||
59844722|NCT03834623|75969667|FG000|COMPLETED|Overall Study||11||
59844723|NCT03834623|75969668|FG001|COMPLETED|Overall Study||11||
59844724|NCT03834623|75969667|FG000|NOT COMPLETED|Overall Study||0||
59844725|NCT03834623|75969668|FG001|NOT COMPLETED|Overall Study||1||
59844726|NCT00410813|75969676|FG000|STARTED|Overall Study||43||
59844727|NCT00410813|75969677|FG001|STARTED|Overall Study||42||
60120193|NCT01695239|76241397|FG007|COMPLETED|IR Participants (Week 16 Up To Week 24)||0||
59567857|NCT02280408|75670717|FG000|Vaccination 2|Overall Study||10||
59567858|NCT02280408|75670718|FG001|Vaccination 2|Overall Study||10||
59567859|NCT02280408|75670719|FG002|Vaccination 2|Overall Study||10||
59567860|NCT02280408|75670720|FG003|Vaccination 2|Overall Study||9||
59567861|NCT02280408|75670717|FG000|COMPLETED|Overall Study||10||
59567862|NCT02280408|75670718|FG001|COMPLETED|Overall Study||8||
59844728|NCT00410813|75969676|FG000|Eligible|Overall Study||41||
59844729|NCT00410813|75969677|FG001|Eligible|Overall Study||38||
59844730|NCT00410813|75969676|FG000|COMPLETED|Overall Study|Patients treated until progression.|0||
59844731|NCT00410813|75969677|FG001|COMPLETED|Overall Study||0||
59844732|NCT00410813|75969676|FG000|NOT COMPLETED|Overall Study||43||
59844733|NCT00410813|75969677|FG001|NOT COMPLETED|Overall Study||42||
59844734|NCT00405821|75969708|FG000|STARTED|Overall Study||220||
59844735|NCT00405821|75969709|FG001|STARTED|Overall Study||220||
59844736|NCT00405821|75969708|FG000|COMPLETED|Overall Study||198||
59844737|NCT00405821|75969709|FG001|COMPLETED|Overall Study||198||
59844738|NCT00405821|75969708|FG000|NOT COMPLETED|Overall Study||22||
59844739|NCT00405821|75969709|FG001|NOT COMPLETED|Overall Study||22||
59844740|NCT01446016|75969715|FG000|STARTED|Overall Study||38||
59844741|NCT01446016|75969715|FG000|COMPLETED|Overall Study||31||
59844742|NCT01446016|75969715|FG000|NOT COMPLETED|Overall Study||7||
59844743|NCT00137046|75969721|FG000|STARTED|Overall Study|One subject was randomized to inhaled insulin but never received treatment.|291||
59844744|NCT00137046|75969722|FG001|STARTED|Overall Study|One subject was randomized to subcutaneous insulin but never received treatment.|291||
59844745|NCT00137046|75969721|FG000|Received Study Treatment|Overall Study||290||
59844746|NCT00137046|75969722|FG001|Received Study Treatment|Overall Study||290||
59844747|NCT00137046|75969721|FG000|COMPLETED|Overall Study|Completed subjects were those subjects who did not discontinue while on active drug.|192||
59844748|NCT00137046|75969722|FG001|COMPLETED|Overall Study||198||
59844749|NCT00137046|75969721|FG000|NOT COMPLETED|Overall Study||99||
59844750|NCT00137046|75969722|FG001|NOT COMPLETED|Overall Study||93||
59844751|NCT00122382|75969734|FG000|STARTED|Double-Blind Study|participants randomized|256||
59844752|NCT00122382|75969735|FG001|STARTED|Double-Blind Study|participants randomized|255||
59844753|NCT00122382|75969736|FG002|STARTED|Double-Blind Study||0||
59844754|NCT00122382|75969734|FG000|Treated|Double-Blind Study||256||
59844755|NCT00122382|75969735|FG001|Treated|Double-Blind Study||253||
59844756|NCT00122382|75969736|FG002|Treated|Double-Blind Study||0||
59844757|NCT00122382|75969734|FG000|COMPLETED|Double-Blind Study||232||
59996653|NCT02714569|76112507|FG004|STARTED|Part A Fourth Intervention||3||
59996654|NCT02714569|76112508|FG005|STARTED|Part A Fourth Intervention||3||
59719582|NCT01104870|75838809|FG000|NOT COMPLETED|Overall Study||1||
59719583|NCT01104870|75838810|FG001|NOT COMPLETED|Overall Study||1||
59719584|NCT01104870|75838811|FG002|NOT COMPLETED|Overall Study||2||
59719585|NCT01104792|75838819|FG000|STARTED|Overall Study||752||
59719586|NCT01104792|75838819|FG000|COMPLETED|Overall Study||226||
59719587|NCT01104792|75838819|FG000|NOT COMPLETED|Overall Study||526||
59719588|NCT01205126|75838825|FG000|STARTED|Titration Phase||130||
59719589|NCT01205126|75838826|FG001|STARTED|Titration Phase||130||
59719590|NCT01205126|75838825|FG000|COMPLETED|Titration Phase||107||
59719591|NCT01205126|75838826|FG001|COMPLETED|Titration Phase||111||
59719592|NCT01205126|75838825|FG000|NOT COMPLETED|Titration Phase||23||
59719593|NCT01205126|75838826|FG001|NOT COMPLETED|Titration Phase||19||
59719594|NCT01205126|75838825|FG000|STARTED|Between Titration & Maintenance Phase||107||
59719595|NCT01205126|75838826|FG001|STARTED|Between Titration & Maintenance Phase||111||
59719596|NCT01205126|75838825|FG000|COMPLETED|Between Titration & Maintenance Phase||107||
59719597|NCT01205126|75838826|FG001|COMPLETED|Between Titration & Maintenance Phase||107||
59719598|NCT01205126|75838825|FG000|NOT COMPLETED|Between Titration & Maintenance Phase||0||
59719599|NCT01205126|75838826|FG001|NOT COMPLETED|Between Titration & Maintenance Phase||4||
59719600|NCT01205126|75838825|FG000|STARTED|Maintenance Phase||107||
59719601|NCT01205126|75838826|FG001|STARTED|Maintenance Phase||107||
59719602|NCT01205126|75838825|FG000|COMPLETED|Maintenance Phase||70||
59719603|NCT01205126|75838826|FG001|COMPLETED|Maintenance Phase||67||
59719604|NCT01205126|75838825|FG000|NOT COMPLETED|Maintenance Phase||37||
59719605|NCT01205126|75838826|FG001|NOT COMPLETED|Maintenance Phase||40||
59844758|NCT00122382|75969735|FG001|COMPLETED|Double-Blind Study||227||
59844759|NCT00122382|75969736|FG002|COMPLETED|Double-Blind Study||0||
59844760|NCT00122382|75969734|FG000|NOT COMPLETED|Double-Blind Study||24||
59844761|NCT00122382|75969735|FG001|NOT COMPLETED|Double-Blind Study||28||
59844762|NCT00122382|75969736|FG002|NOT COMPLETED|Double-Blind Study||0||
59844763|NCT00122382|75969734|FG000|STARTED|Open-Label Study||0||
59844764|NCT00122382|75969735|FG001|STARTED|Open-Label Study||0||
59844765|NCT00122382|75969736|FG002|STARTED|Open-Label Study||459||
59844766|NCT00122382|75969734|FG000|COMPLETED|Open-Label Study||0||
59844767|NCT00122382|75969735|FG001|COMPLETED|Open-Label Study||0||
59844768|NCT00122382|75969736|FG002|COMPLETED|Open-Label Study||433||
59844769|NCT00122382|75969734|FG000|NOT COMPLETED|Open-Label Study||0||
59844770|NCT00122382|75969735|FG001|NOT COMPLETED|Open-Label Study||0||
59844771|NCT00122382|75969736|FG002|NOT COMPLETED|Open-Label Study||26||
59996655|NCT02714569|76112509|FG006|STARTED|Part A Fourth Intervention||0||
59996656|NCT02714569|76112510|FG007|STARTED|Part A Fourth Intervention||0||
59996657|NCT02714569|76112511|FG008|STARTED|Part A Fourth Intervention||0||
59996658|NCT02714569|76112512|FG009|STARTED|Part A Fourth Intervention||0||
59996659|NCT02714569|76112513|FG010|STARTED|Part A Fourth Intervention||0||
59996660|NCT02714569|76112503|FG000|Received at Least One Dose of Study Drug|Part A Fourth Intervention||3||
59844772|NCT01028716|75969754|FG000|STARTED|Overall Study||46||
59844773|NCT01028716|75969754|FG000|COMPLETED|Overall Study||45||
59844774|NCT01028716|75969754|FG000|NOT COMPLETED|Overall Study||1||
59844775|NCT00106704|75969761|FG000|STARTED|Overall Study||222||
59844776|NCT00106704|75969762|FG001|STARTED|Overall Study||219||
59844777|NCT00106704|75969761|FG000|COMPLETED|Overall Study||91||
59844778|NCT00106704|75969762|FG001|COMPLETED|Overall Study||68||
59844779|NCT00106704|75969761|FG000|NOT COMPLETED|Overall Study||131||
59844780|NCT00106704|75969762|FG001|NOT COMPLETED|Overall Study||151||
59844781|NCT00105066|75969770|FG000|STARTED|Overall Study||27||
59844782|NCT00105066|75969771|FG001|STARTED|Overall Study||50||
59844783|NCT00105066|75969770|FG000|COMPLETED|Overall Study||25||
59844784|NCT00105066|75969771|FG001|COMPLETED|Overall Study||45||
59844785|NCT00105066|75969770|FG000|NOT COMPLETED|Overall Study||2||
59844786|NCT00105066|75969771|FG001|NOT COMPLETED|Overall Study||5||
59844787|NCT00104520|75969779|FG000|STARTED|Overall Study||76||
59844788|NCT00104520|75969780|FG001|STARTED|Overall Study||135||
59844789|NCT00104520|75969779|FG000|COMPLETED|Overall Study||26||
59844790|NCT00104520|75969780|FG001|COMPLETED|Overall Study||64||
59844791|NCT00104520|75969779|FG000|NOT COMPLETED|Overall Study||50||
59844792|NCT00104520|75969780|FG001|NOT COMPLETED|Overall Study||71||
59844793|NCT00135330|75969789|FG000|STARTED|Overall Study||45||
59844794|NCT00135330|75969790|FG001|STARTED|Overall Study||47||
59844795|NCT00135330|75969791|FG002|STARTED|Overall Study||45||
59844796|NCT00135330|75969789|FG000|COMPLETED|Overall Study||33||
59844797|NCT00135330|75969790|FG001|COMPLETED|Overall Study||34||
59844798|NCT00135330|75969791|FG002|COMPLETED|Overall Study||34||
59844799|NCT00135330|75969789|FG000|NOT COMPLETED|Overall Study||12||
59844800|NCT00135330|75969790|FG001|NOT COMPLETED|Overall Study||13||
59844801|NCT00135330|75969791|FG002|NOT COMPLETED|Overall Study||11||
59844802|NCT00134784|75969803|FG000|STARTED|Overall Study||29||
59844803|NCT00134784|75969804|FG001|STARTED|Overall Study||38||
59844804|NCT00134784|75969805|FG002|STARTED|Overall Study||37||
59844805|NCT00134784|75969806|FG003|STARTED|Overall Study||38||
59844806|NCT00134784|75969803|FG000|COMPLETED|Overall Study||27||
59844807|NCT00134784|75969804|FG001|COMPLETED|Overall Study||36||
59844808|NCT00134784|75969805|FG002|COMPLETED|Overall Study||35||
59844809|NCT00134784|75969806|FG003|COMPLETED|Overall Study||37||
59844810|NCT00134784|75969803|FG000|NOT COMPLETED|Overall Study||2||
59844811|NCT00134784|75969804|FG001|NOT COMPLETED|Overall Study||2||
59844812|NCT00134784|75969805|FG002|NOT COMPLETED|Overall Study||2||
59844813|NCT00134784|75969806|FG003|NOT COMPLETED|Overall Study||1||
59844814|NCT00134082|75969813|FG000|STARTED|Overall Study||30||
59844815|NCT00134082|75969813|FG000|COMPLETED|Overall Study||27||
59844816|NCT00134082|75969813|FG000|NOT COMPLETED|Overall Study||3||
59844817|NCT03703336|75969819|FG000|STARTED|Overall Study||552||
59844818|NCT03703336|75969820|FG001|STARTED|Overall Study||273||
59844819|NCT03703336|75969819|FG000|Received Dose 1|Overall Study||552||
59844820|NCT03703336|75969820|FG001|Received Dose 1|Overall Study||273||
59844821|NCT03703336|75969819|FG000|Received Dose 2|Overall Study||518||
59844822|NCT03703336|75969820|FG001|Received Dose 2|Overall Study||263||
59844823|NCT03703336|75969819|FG000|Safety Population|Overall Study||551|The safety population was defined as all participants in the enrolled population who received a study vaccination. One participant was randomized to ROTAVIN but instead received ROTAVIN-M1 and was therefore analyzed in ROTAVIN-M1 group for safety population based on the actual treatment received.|
59844824|NCT03703336|75969820|FG001|Safety Population|Overall Study||274|The safety population was defined as all participants in the enrolled population who received a study vaccination. One participant was randomized to ROTAVIN but instead received ROTAVIN-M1 and was therefore analyzed in ROTAVIN-M1 group for safety population based on the actual treatment received.|
59844825|NCT03703336|75969819|FG000|COMPLETED|Overall Study||514||
59844826|NCT03703336|75969820|FG001|COMPLETED|Overall Study||259||
59567863|NCT02280408|75670719|FG002|COMPLETED|Overall Study||10||
59567864|NCT02280408|75670720|FG003|COMPLETED|Overall Study||9||
59567865|NCT02280408|75670717|FG000|NOT COMPLETED|Overall Study||0||
59844827|NCT03703336|75969819|FG000|NOT COMPLETED|Overall Study||38||
59844828|NCT03703336|75969820|FG001|NOT COMPLETED|Overall Study||14||
59844829|NCT03702166|75969826|FG000|STARTED|Overall Study||10||
59844830|NCT03702166|75969826|FG000|COMPLETED|Overall Study||8|10 participants were started and included in baseline measures, only 8 remained at post-treatment.|
59844831|NCT03702166|75969826|FG000|NOT COMPLETED|Overall Study||2||
59844832|NCT00132678|75969833|FG000|STARTED|Period II (Open-Label Oral Risperidone)||0||
59844833|NCT00132678|75969834|FG001|STARTED|Period II (Open-Label Oral Risperidone)||0||
59844834|NCT00132678|75969835|FG002|STARTED|Period II (Open-Label Oral Risperidone)||440||
59844835|NCT00132678|75969833|FG000|COMPLETED|Period II (Open-Label Oral Risperidone)||0||
59844836|NCT00132678|75969834|FG001|COMPLETED|Period II (Open-Label Oral Risperidone)||0||
59844837|NCT00132678|75969835|FG002|COMPLETED|Period II (Open-Label Oral Risperidone)||382||
59844838|NCT00132678|75969833|FG000|NOT COMPLETED|Period II (Open-Label Oral Risperidone)||0||
59844839|NCT00132678|75969834|FG001|NOT COMPLETED|Period II (Open-Label Oral Risperidone)||0||
59844840|NCT00132678|75969835|FG002|NOT COMPLETED|Period II (Open-Label Oral Risperidone)||58||
59844841|NCT00132678|75969833|FG000|STARTED|Period III (Open-Label Stabilization)||501||
59844842|NCT00132678|75969834|FG001|STARTED|Period III (Open-Label Stabilization)||0||
59844843|NCT00132678|75969835|FG002|STARTED|Period III (Open-Label Stabilization)||0||
59844844|NCT00132678|75969833|FG000|COMPLETED|Period III (Open-Label Stabilization)||303||
59844845|NCT00132678|75969834|FG001|COMPLETED|Period III (Open-Label Stabilization)||0||
59844846|NCT00132678|75969835|FG002|COMPLETED|Period III (Open-Label Stabilization)||0||
59844847|NCT00132678|75969833|FG000|NOT COMPLETED|Period III (Open-Label Stabilization)||198||
59844848|NCT00132678|75969834|FG001|NOT COMPLETED|Period III (Open-Label Stabilization)||0||
59844849|NCT00132678|75969835|FG002|NOT COMPLETED|Period III (Open-Label Stabilization)||0||
59844850|NCT00132678|75969833|FG000|STARTED|Period IV (Double-Blind Treatment)||154||
59844851|NCT00132678|75969834|FG001|STARTED|Period IV (Double-Blind Treatment)||149||
59844852|NCT00132678|75969835|FG002|STARTED|Period IV (Double-Blind Treatment)||0||
59844853|NCT00132678|75969833|FG000|COMPLETED|Period IV (Double-Blind Treatment)||117||
59844854|NCT00132678|75969834|FG001|COMPLETED|Period IV (Double-Blind Treatment)||109||
59844855|NCT00132678|75969835|FG002|COMPLETED|Period IV (Double-Blind Treatment)||0||
59844856|NCT00132678|75969833|FG000|NOT COMPLETED|Period IV (Double-Blind Treatment)||37||
59844857|NCT00132678|75969834|FG001|NOT COMPLETED|Period IV (Double-Blind Treatment)||40||
59844858|NCT00132678|75969835|FG002|NOT COMPLETED|Period IV (Double-Blind Treatment)||0||
59844859|NCT00101868|75969845|FG000|STARTED|Overall Study|35 hospital physicians allocated to discharge software|316||
59844860|NCT00101868|75969846|FG001|STARTED|Overall Study|35 hospital physicians allocated to usual care discharge|315||
59844861|NCT00101868|75969845|FG000|COMPLETED|Overall Study|1 hospital physician with zero patients lost to follow up|287||
59844862|NCT00101868|75969846|FG001|COMPLETED|Overall Study|zero hospital physician with zero patients lost to follow up|283||
59844863|NCT00101868|75969845|FG000|NOT COMPLETED|Overall Study||29||
59844864|NCT00101868|75969846|FG001|NOT COMPLETED|Overall Study||32||
59844865|NCT00101400|75969854|FG000|STARTED|Treatment|Treated until disease progression, unacceptable sorafenib-related toxicity or withdrawal of consent.|54||
59844866|NCT00101400|75969854|FG000|COMPLETED|Treatment|Reasons for treatment termination: 4 Adverse Events, 3 Deaths, 46 Progression, 1 Withdrawal.|54||
59844867|NCT00101400|75969854|FG000|NOT COMPLETED|Treatment||0||
59844868|NCT00101400|75969854|FG000|STARTED|Survival Follow-Up|3 subjects died during previous period (completion as defined in protocol)|51||
59844869|NCT00101400|75969854|FG000|COMPLETED|Survival Follow-Up|44 subjects reached endpoint (death); 7 subjects were still alive|44||
59844870|NCT00101400|75969854|FG000|NOT COMPLETED|Survival Follow-Up||7||
59844871|NCT03821064|75969858|FG000|STARTED|Overall Study||11||
59844872|NCT03821064|75969858|FG000|COMPLETED|Overall Study||10||
59844873|NCT03821064|75969858|FG000|NOT COMPLETED|Overall Study||1||
59844874|NCT00141518|75969865|FG000|STARTED|Overall Study||37||
59844875|NCT00141518|75969866|FG001|STARTED|Overall Study||22||
59844876|NCT00141518|75969867|FG002|STARTED|Overall Study||18||
59844877|NCT00141518|75969865|FG000|Safety Sample|Overall Study||36||
59844878|NCT00141518|75969866|FG001|Safety Sample|Overall Study||22||
59844879|NCT00141518|75969867|FG002|Safety Sample|Overall Study||18||
59844880|NCT00141518|75969865|FG000|Full Analysis Sample|Overall Study||27||
59844881|NCT00141518|75969866|FG001|Full Analysis Sample|Overall Study||22||
59844882|NCT00141518|75969867|FG002|Full Analysis Sample|Overall Study||18||
59844883|NCT00141518|75969865|FG000|COMPLETED|Overall Study||21||
59844884|NCT00141518|75969866|FG001|COMPLETED|Overall Study||16||
59844885|NCT00141518|75969867|FG002|COMPLETED|Overall Study||12||
59844886|NCT00141518|75969865|FG000|NOT COMPLETED|Overall Study||16||
60120194|NCT01695239|76241398|FG008|COMPLETED|IR Participants (Week 16 Up To Week 24)||0||
59719606|NCT00946647|75838837|FG000|STARTED|Phase 1 Part||6||
59719607|NCT00946647|75838838|FG001|STARTED|Phase 1 Part||18||
59719608|NCT00946647|75838839|FG002|STARTED|Phase 1 Part||7||
59719609|NCT00946647|75838840|FG003|STARTED|Phase 1 Part||0||
59719610|NCT00946647|75838841|FG004|STARTED|Phase 1 Part||0||
59719611|NCT00946647|75838837|FG000|COMPLETED|Phase 1 Part||0||
59719612|NCT00946647|75838838|FG001|COMPLETED|Phase 1 Part||0||
59719613|NCT00946647|75838839|FG002|COMPLETED|Phase 1 Part||0||
59719614|NCT00946647|75838840|FG003|COMPLETED|Phase 1 Part||0||
59719615|NCT00946647|75838841|FG004|COMPLETED|Phase 1 Part||0||
59719616|NCT00946647|75838837|FG000|NOT COMPLETED|Phase 1 Part||6||
59719617|NCT00946647|75838838|FG001|NOT COMPLETED|Phase 1 Part||18||
59719618|NCT00946647|75838839|FG002|NOT COMPLETED|Phase 1 Part||7||
59719619|NCT00946647|75838840|FG003|NOT COMPLETED|Phase 1 Part||0||
59719620|NCT00946647|75838841|FG004|NOT COMPLETED|Phase 1 Part||0||
59719621|NCT00946647|75838837|FG000|STARTED|Phase ll Part||0||
59844887|NCT00141518|75969866|FG001|NOT COMPLETED|Overall Study||6||
59844888|NCT00141518|75969867|FG002|NOT COMPLETED|Overall Study||6||
59844889|NCT00253448|75969877|FG000|STARTED|Overall Study||35||
59844890|NCT00253448|75969877|FG000|COMPLETED|Overall Study||34||
59844891|NCT00253448|75969877|FG000|NOT COMPLETED|Overall Study||1||
59844892|NCT00098748|75969884|FG000|STARTED|Assigned to Study Treatment||63||
59844893|NCT00098748|75969885|FG001|STARTED|Assigned to Study Treatment||63||
59844894|NCT00098748|75969886|FG002|STARTED|Assigned to Study Treatment||64||
59844895|NCT00098748|75969884|FG000|COMPLETED|Assigned to Study Treatment||63||
59844896|NCT00098748|75969885|FG001|COMPLETED|Assigned to Study Treatment||61||
59844897|NCT00098748|75969886|FG002|COMPLETED|Assigned to Study Treatment||62||
59844898|NCT00098748|75969884|FG000|NOT COMPLETED|Assigned to Study Treatment||0||
59719622|NCT00946647|75838838|FG001|STARTED|Phase ll Part||0||
59844899|NCT00098748|75969885|FG001|NOT COMPLETED|Assigned to Study Treatment||2||
59844900|NCT00098748|75969886|FG002|NOT COMPLETED|Assigned to Study Treatment||2||
59844901|NCT00098748|75969884|FG000|STARTED|Received Study Treatment||63||
59844902|NCT00098748|75969885|FG001|STARTED|Received Study Treatment|Due to 1 placebo subject switched to maraviroc BID, BID = 62 subjects in Adverse event tables.|61||
59844903|NCT00098748|75969886|FG002|STARTED|Received Study Treatment|Due to 1 placebo subject switched to maraviroc BID, Placebo = 61 subjects in Adverse event tables.|62||
59844904|NCT00098748|75969884|FG000|Dual-tropic Subjects by Phenotype Assay|Received Study Treatment|Dual-tropic: Virus capable of using both CCR5 and CXCR4 coreceptors for cell entry.|57||
59844905|NCT00098748|75969885|FG001|Dual-tropic Subjects by Phenotype Assay|Received Study Treatment||52||
59844906|NCT00098748|75969886|FG002|Dual-tropic Subjects by Phenotype Assay|Received Study Treatment||58||
59844907|NCT00098748|75969884|FG000|COMPLETED|Received Study Treatment||15||
59844908|NCT00098748|75969885|FG001|COMPLETED|Received Study Treatment||25||
59844909|NCT00098748|75969886|FG002|COMPLETED|Received Study Treatment||18||
59844910|NCT00098748|75969884|FG000|NOT COMPLETED|Received Study Treatment||48||
59844911|NCT00098748|75969885|FG001|NOT COMPLETED|Received Study Treatment||36||
59844912|NCT00098748|75969886|FG002|NOT COMPLETED|Received Study Treatment||44||
59844913|NCT00098748|75969884|FG000|STARTED|Continued on Open-Label Treatment||15||
59844914|NCT00098748|75969885|FG001|STARTED|Continued on Open-Label Treatment||25||
59844915|NCT00098748|75969886|FG002|STARTED|Continued on Open-Label Treatment|Placebo group not offered open-label maraviroc due to study not reaching primary endpoint at Week 24|0||
59844916|NCT00098748|75969884|FG000|COMPLETED|Continued on Open-Label Treatment||7||
59844917|NCT00098748|75969885|FG001|COMPLETED|Continued on Open-Label Treatment||10||
59844918|NCT00098748|75969886|FG002|COMPLETED|Continued on Open-Label Treatment||0||
59844919|NCT00098748|75969884|FG000|NOT COMPLETED|Continued on Open-Label Treatment||8||
59844920|NCT00098748|75969885|FG001|NOT COMPLETED|Continued on Open-Label Treatment||15||
59844921|NCT00098748|75969886|FG002|NOT COMPLETED|Continued on Open-Label Treatment||0||
59844922|NCT00130520|75969894|FG000|STARTED|Overall Study|85 women were screened for eligibility, 56 consented, 40 treated.|40||
59844923|NCT00130520|75969894|FG000|Completion of at Least One Cycle|Overall Study||39||
59844924|NCT00130520|75969894|FG000|COMPLETED|Overall Study||1||
59844925|NCT00130520|75969894|FG000|NOT COMPLETED|Overall Study||39||
59844926|NCT00132132|75969900|FG000|STARTED|Overall Study||15||
59844927|NCT00132132|75969901|FG001|STARTED|Overall Study||15||
59844928|NCT00132132|75969900|FG000|COMPLETED|Overall Study||8||
59844929|NCT00132132|75969901|FG001|COMPLETED|Overall Study||13||
59844930|NCT00132132|75969900|FG000|NOT COMPLETED|Overall Study||7||
59844931|NCT00132132|75969901|FG001|NOT COMPLETED|Overall Study||2||
59844932|NCT00130442|75969909|FG000|STARTED|Overall Study||66||
59844933|NCT00130442|75969910|FG001|STARTED|Overall Study||68||
59844934|NCT00130442|75969909|FG000|COMPLETED|Overall Study||65||
59844935|NCT00130442|75969910|FG001|COMPLETED|Overall Study||66||
59844936|NCT00130442|75969909|FG000|NOT COMPLETED|Overall Study||1||
59844937|NCT00130442|75969910|FG001|NOT COMPLETED|Overall Study||2||
59844938|NCT00130208|75969920|FG000|STARTED|Maintenance Period (26 Weeks)||524||
59844939|NCT00130208|75969921|FG001|STARTED|Maintenance Period (26 Weeks)||532||
59844940|NCT00130208|75969920|FG000|Valid Albumin Creatinine Ratio|Maintenance Period (26 Weeks)||492|Valid albumin creatinine ratio at baseline and week 26|
59844941|NCT00130208|75969921|FG001|Valid Albumin Creatinine Ratio|Maintenance Period (26 Weeks)||494|Valid albumin creatinine ratio at baseline and week 26|
59844942|NCT00130208|75969920|FG000|COMPLETED|Maintenance Period (26 Weeks)||500||
59844943|NCT00130208|75969921|FG001|COMPLETED|Maintenance Period (26 Weeks)||502||
59844944|NCT00130208|75969920|FG000|NOT COMPLETED|Maintenance Period (26 Weeks)||24||
59844945|NCT00130208|75969921|FG001|NOT COMPLETED|Maintenance Period (26 Weeks)||30||
59844946|NCT00130208|75969920|FG000|STARTED|Washout Period (8 Weeks)||500||
59844947|NCT00130208|75969921|FG001|STARTED|Washout Period (8 Weeks)||502||
59844948|NCT00130208|75969920|FG000|COMPLETED|Washout Period (8 Weeks)||494||
59844949|NCT00130208|75969921|FG001|COMPLETED|Washout Period (8 Weeks)||490||
59844950|NCT00130208|75969920|FG000|NOT COMPLETED|Washout Period (8 Weeks)||6||
59844951|NCT00130208|75969921|FG001|NOT COMPLETED|Washout Period (8 Weeks)||12||
59567866|NCT02280408|75670718|FG001|NOT COMPLETED|Overall Study||2||
59844952|NCT00253370|75969927|FG000|STARTED|Overall Study||44||
59844953|NCT00253370|75969927|FG000|COMPLETED|Overall Study||1||
59844954|NCT00253370|75969927|FG000|NOT COMPLETED|Overall Study||43||
59844955|NCT00140426|75969934|FG000|STARTED|Overall Study||22||
59844956|NCT00140426|75969935|FG001|STARTED|Overall Study||19||
59844957|NCT00140426|75969934|FG000|COMPLETED|Overall Study||22||
59844958|NCT00140426|75969935|FG001|COMPLETED|Overall Study||16||
60120195|NCT01695239|76241399|FG009|COMPLETED|IR Participants (Week 16 Up To Week 24)||0||
59844959|NCT00140426|75969934|FG000|NOT COMPLETED|Overall Study||0||
59844960|NCT00140426|75969935|FG001|NOT COMPLETED|Overall Study||3||
59844961|NCT00121134|75969950|FG000|STARTED|Overall Study||40||
59844962|NCT00121134|75969951|FG001|STARTED|Overall Study||41||
59844963|NCT00121134|75969952|FG002|STARTED|Overall Study||41||
59996661|NCT02714569|76112504|FG001|Received at Least One Dose of Study Drug|Part A Fourth Intervention||2||
59844964|NCT00121134|75969953|FG003|STARTED|Overall Study||40||
59996662|NCT02714569|76112505|FG002|Received at Least One Dose of Study Drug|Part A Fourth Intervention||3||
59996663|NCT02714569|76112506|FG003|Received at Least One Dose of Study Drug|Part A Fourth Intervention||2||
59844965|NCT00121134|75969950|FG000|COMPLETED|Overall Study||24||
59844966|NCT00121134|75969951|FG001|COMPLETED|Overall Study||26||
59844967|NCT00121134|75969952|FG002|COMPLETED|Overall Study||20||
59844968|NCT00121134|75969953|FG003|COMPLETED|Overall Study||31||
59844969|NCT00121134|75969950|FG000|NOT COMPLETED|Overall Study||16||
59844970|NCT00121134|75969951|FG001|NOT COMPLETED|Overall Study||15||
59844971|NCT00121134|75969952|FG002|NOT COMPLETED|Overall Study||21||
59844972|NCT00121134|75969953|FG003|NOT COMPLETED|Overall Study||9||
59844973|NCT00119262|75969965|FG000|STARTED|Overall Study||104||
59844974|NCT00119262|75969966|FG001|STARTED|Overall Study||122||
59844975|NCT00119262|75969965|FG000|Eligible|Overall Study||103||
59844976|NCT00119262|75969966|FG001|Eligible|Overall Study||120||
59844977|NCT00119262|75969965|FG000|Treated|Overall Study||103||
59844978|NCT00119262|75969966|FG001|Treated|Overall Study||120||
59844979|NCT00119262|75969965|FG000|Eligible and Treated|Overall Study||102||
59844980|NCT00119262|75969966|FG001|Eligible and Treated|Overall Study||119||
59844981|NCT00119262|75969965|FG000|COMPLETED|Overall Study||58||
59844982|NCT00119262|75969966|FG001|COMPLETED|Overall Study||64||
59844983|NCT00119262|75969965|FG000|NOT COMPLETED|Overall Study||46||
59844984|NCT00119262|75969966|FG001|NOT COMPLETED|Overall Study||58||
59844985|NCT03703882|75969974|FG000|STARTED|Overall Study||88||
59844986|NCT03703882|75969975|FG001|STARTED|Overall Study||43||
59844987|NCT03703882|75969974|FG000|COMPLETED|Overall Study||85||
59844988|NCT03703882|75969975|FG001|COMPLETED|Overall Study||37||
59844989|NCT03703882|75969974|FG000|NOT COMPLETED|Overall Study||3||
59844990|NCT03703882|75969975|FG001|NOT COMPLETED|Overall Study||6||
59844991|NCT00131664|75969984|FG000|STARTED|First Period (First 6 Months)||136||
59844992|NCT00131664|75969985|FG001|STARTED|First Period (First 6 Months)||135||
59844993|NCT00131664|75969986|FG002|STARTED|First Period (First 6 Months)||120||
59844994|NCT00131664|75969987|FG003|STARTED|First Period (First 6 Months)||0||
59844995|NCT00131664|75969988|FG004|STARTED|First Period (First 6 Months)||0||
59844996|NCT00131664|75969989|FG005|STARTED|First Period (First 6 Months)||0||
59844997|NCT00131664|75969984|FG000|COMPLETED|First Period (First 6 Months)||111||
59844998|NCT00131664|75969985|FG001|COMPLETED|First Period (First 6 Months)||117||
59844999|NCT00131664|75969986|FG002|COMPLETED|First Period (First 6 Months)||104||
59845000|NCT00131664|75969987|FG003|COMPLETED|First Period (First 6 Months)||0||
59845001|NCT00131664|75969988|FG004|COMPLETED|First Period (First 6 Months)||0||
59845002|NCT00131664|75969989|FG005|COMPLETED|First Period (First 6 Months)||0||
59845003|NCT00131664|75969984|FG000|NOT COMPLETED|First Period (First 6 Months)||25||
59845004|NCT00131664|75969985|FG001|NOT COMPLETED|First Period (First 6 Months)||18||
59845005|NCT00131664|75969986|FG002|NOT COMPLETED|First Period (First 6 Months)||16||
59845006|NCT00131664|75969987|FG003|NOT COMPLETED|First Period (First 6 Months)||0||
59845007|NCT00131664|75969988|FG004|NOT COMPLETED|First Period (First 6 Months)||0||
59845008|NCT00131664|75969989|FG005|NOT COMPLETED|First Period (First 6 Months)||0||
59845009|NCT00131664|75969984|FG000|STARTED|Second Period (Additional Drug Added)|21 had added Metformin at Month 6|90||
59845010|NCT00131664|75969985|FG001|STARTED|Second Period (Additional Drug Added)|16 had added Amaryl at Month 6|101||
59845011|NCT00131664|75969986|FG002|STARTED|Second Period (Additional Drug Added)|25 had added Amaryl at Month 6|79||
59845012|NCT00131664|75969987|FG003|STARTED|Second Period (Additional Drug Added)||21||
59845013|NCT00131664|75969988|FG004|STARTED|Second Period (Additional Drug Added)||16||
59845014|NCT00131664|75969989|FG005|STARTED|Second Period (Additional Drug Added)||25||
59845015|NCT00131664|75969984|FG000|COMPLETED|Second Period (Additional Drug Added)||81||
59845016|NCT00131664|75969985|FG001|COMPLETED|Second Period (Additional Drug Added)||97||
59845017|NCT00131664|75969986|FG002|COMPLETED|Second Period (Additional Drug Added)||76||
59845018|NCT00131664|75969987|FG003|COMPLETED|Second Period (Additional Drug Added)||19||
59845019|NCT00131664|75969988|FG004|COMPLETED|Second Period (Additional Drug Added)||15||
59845020|NCT00131664|75969989|FG005|COMPLETED|Second Period (Additional Drug Added)||22||
59845021|NCT00131664|75969984|FG000|NOT COMPLETED|Second Period (Additional Drug Added)||9||
59845022|NCT00131664|75969985|FG001|NOT COMPLETED|Second Period (Additional Drug Added)||4||
59845023|NCT00131664|75969986|FG002|NOT COMPLETED|Second Period (Additional Drug Added)||3||
60120196|NCT01695239|76241400|FG010|COMPLETED|IR Participants (Week 16 Up To Week 24)||0||
59845024|NCT00131664|75969987|FG003|NOT COMPLETED|Second Period (Additional Drug Added)||2||
59845025|NCT00131664|75969988|FG004|NOT COMPLETED|Second Period (Additional Drug Added)||1||
59845026|NCT00131664|75969989|FG005|NOT COMPLETED|Second Period (Additional Drug Added)||3||
59845027|NCT00131508|75970002|FG000|STARTED|Overall Study||12||
59845028|NCT00131508|75970003|FG001|STARTED|Overall Study||13||
59845029|NCT00131508|75970002|FG000|COMPLETED|Overall Study||9||
59845030|NCT00131508|75970003|FG001|COMPLETED|Overall Study||5||
59845031|NCT00131508|75970002|FG000|NOT COMPLETED|Overall Study||3||
59845032|NCT00131508|75970003|FG001|NOT COMPLETED|Overall Study||8||
59845033|NCT05050318|75970012|FG000|STARTED|Overall Study||29||
59845034|NCT05050318|75970013|FG001|STARTED|Overall Study||31||
59845035|NCT05050318|75970014|FG002|STARTED|Overall Study||30||
60120197|NCT01695239|76241401|FG011|COMPLETED|IR Participants (Week 16 Up To Week 24)||0||
59567867|NCT02280408|75670719|FG002|NOT COMPLETED|Overall Study||0||
59845036|NCT05050318|75970012|FG000|Vaccinated|Overall Study||28||
59845037|NCT05050318|75970013|FG001|Vaccinated|Overall Study||31||
59845038|NCT05050318|75970014|FG002|Vaccinated|Overall Study||30||
59845039|NCT05050318|75970012|FG000|COMPLETED|Overall Study||28||
59845040|NCT05050318|75970013|FG001|COMPLETED|Overall Study||31||
59845041|NCT05050318|75970014|FG002|COMPLETED|Overall Study||30||
59845042|NCT05050318|75970012|FG000|NOT COMPLETED|Overall Study||1||
59845043|NCT05050318|75970013|FG001|NOT COMPLETED|Overall Study||0||
59845044|NCT05050318|75970014|FG002|NOT COMPLETED|Overall Study||0||
59845045|NCT03699124|75970025|FG000|STARTED|Overall Study||377|Randomized|
59845046|NCT03699124|75970026|FG001|STARTED|Overall Study||375|Randomized|
59845047|NCT03699124|75970027|FG002|STARTED|Overall Study||377|Randomized|
59845048|NCT03699124|75970025|FG000|COMPLETED|Overall Study||332|Active study period|
59845049|NCT03699124|75970026|FG001|COMPLETED|Overall Study||335|Active study period|
59845050|NCT03699124|75970027|FG002|COMPLETED|Overall Study||337|Active study period|
59845051|NCT03699124|75970025|FG000|NOT COMPLETED|Overall Study||45||
59845052|NCT03699124|75970026|FG001|NOT COMPLETED|Overall Study||40||
59845053|NCT03699124|75970027|FG002|NOT COMPLETED|Overall Study||40||
59845054|NCT05002972|75970035|FG000|STARTED|Overall Study||63||
59845055|NCT05002972|75970035|FG000|COMPLETED|Overall Study||61||
59845056|NCT05002972|75970035|FG000|NOT COMPLETED|Overall Study||2||
59845057|NCT04651114|75970039|FG000|STARTED|Overall Study||38||
59845058|NCT04651114|75970039|FG000|COMPLETED|Overall Study||30||
59845059|NCT04651114|75970039|FG000|NOT COMPLETED|Overall Study||8||
59845060|NCT04980040|75970043|FG000|STARTED|Overall Study||3623||
59845061|NCT04980040|75970043|FG000|COMPLETED|Overall Study||3131||
59845062|NCT04980040|75970043|FG000|NOT COMPLETED|Overall Study||492||
59845063|NCT00131352|75970049|FG000|STARTED|Initial Treatment Period|Safety population|123||
59845064|NCT00131352|75970050|FG001|STARTED|Initial Treatment Period|Safety population|130||
59845065|NCT00131352|75970049|FG000|Intent to Treat Population|Initial Treatment Period||124||
59845066|NCT00131352|75970050|FG001|Intent to Treat Population|Initial Treatment Period||129||
59845067|NCT00131352|75970049|FG000|COMPLETED|Initial Treatment Period||114||
59845068|NCT00131352|75970050|FG001|COMPLETED|Initial Treatment Period||118||
59845069|NCT00131352|75970049|FG000|NOT COMPLETED|Initial Treatment Period||9||
59845070|NCT00131352|75970050|FG001|NOT COMPLETED|Initial Treatment Period||12||
59845071|NCT00131352|75970049|FG000|STARTED|Repeat Treatment Period|Safety population: 77 Synvisc + 83 Saline Control participants from the Initial Treatment period.|160||
59845072|NCT00131352|75970050|FG001|STARTED|Repeat Treatment Period||0||
59845073|NCT00131352|75970049|FG000|COMPLETED|Repeat Treatment Period||158||
59845074|NCT00131352|75970050|FG001|COMPLETED|Repeat Treatment Period||0||
59845075|NCT00131352|75970049|FG000|NOT COMPLETED|Repeat Treatment Period||2||
59845076|NCT00131352|75970050|FG001|NOT COMPLETED|Repeat Treatment Period||0||
59845077|NCT04633642|75970060|FG000|STARTED|Overall Study|27 participants|27|November 2017|
59845078|NCT04633642|75970061|FG001|STARTED|Overall Study|24 participants|24|November 2017|
59845079|NCT04633642|75970060|FG000|COMPLETED|Overall Study|26 participants|26|December 2019|
59845080|NCT04633642|75970061|FG001|COMPLETED|Overall Study|22 participants|22|December 2019|
59845081|NCT04633642|75970060|FG000|NOT COMPLETED|Overall Study||1||
59845082|NCT04633642|75970061|FG001|NOT COMPLETED|Overall Study||2||
59845083|NCT00136916|75970069|FG000|STARTED|Overall Study||319||
59845084|NCT00136916|75970070|FG001|STARTED|Overall Study||316||
59845085|NCT00136916|75970069|FG000|Received Treatment|Overall Study||316||
59845086|NCT00136916|75970070|FG001|Received Treatment|Overall Study||311||
60120198|NCT01695239|76241402|FG012|COMPLETED|IR Participants (Week 16 Up To Week 24)||0||
60120199|NCT01695239|76241403|FG013|COMPLETED|IR Participants (Week 16 Up To Week 24)||0||
60120200|NCT01695239|76241390|FG000|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0||
60120201|NCT01695239|76241391|FG001|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0||
59719623|NCT00946647|75838839|FG002|STARTED|Phase ll Part||0||
59719624|NCT00946647|75838840|FG003|STARTED|Phase ll Part||40||
59719625|NCT00946647|75838841|FG004|STARTED|Phase ll Part||42||
59719626|NCT00946647|75838837|FG000|Safety Set|Phase ll Part||0||
59719627|NCT00946647|75838838|FG001|Safety Set|Phase ll Part||0||
59719628|NCT00946647|75838839|FG002|Safety Set|Phase ll Part||0||
59719629|NCT00946647|75838840|FG003|Safety Set|Phase ll Part|2 pts rand. to this grp did not receive PAN|38||
59719630|NCT00946647|75838841|FG004|Safety Set|Phase ll Part|2 pts rand. to PAN+5AZA, did not receive PAN but received 5AZA|42||
59719631|NCT00946647|75838837|FG000|COMPLETED|Phase ll Part||0||
59719632|NCT00946647|75838838|FG001|COMPLETED|Phase ll Part||0||
59719633|NCT00946647|75838839|FG002|COMPLETED|Phase ll Part||0||
59719634|NCT00946647|75838840|FG003|COMPLETED|Phase ll Part||0||
59719635|NCT00946647|75838841|FG004|COMPLETED|Phase ll Part||0||
59719636|NCT00946647|75838837|FG000|NOT COMPLETED|Phase ll Part||0||
59719637|NCT00946647|75838838|FG001|NOT COMPLETED|Phase ll Part||0||
59719638|NCT00946647|75838839|FG002|NOT COMPLETED|Phase ll Part||0||
59845087|NCT00136916|75970069|FG000|COMPLETED|Overall Study|At study termination, active subjects completed end-of-study assessment and 3-month follow-up visit|194||
60120202|NCT01695239|76241392|FG002|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0||
60120203|NCT01695239|76241393|FG003|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0||
59719639|NCT00946647|75838840|FG003|NOT COMPLETED|Phase ll Part||40||
59719640|NCT00946647|75838841|FG004|NOT COMPLETED|Phase ll Part||42||
59719641|NCT00946101|75838856|FG000|STARTED|Overall Study|Intent to Treat population, enrolled and randomized|261||
59719642|NCT00946101|75838857|FG001|STARTED|Overall Study||65||
59845088|NCT00136916|75970070|FG001|COMPLETED|Overall Study|At study termination, active subjects completed end-of-study assessment and 3-month follow-up visit|212||
59845089|NCT00136916|75970069|FG000|NOT COMPLETED|Overall Study||125||
59845090|NCT00136916|75970070|FG001|NOT COMPLETED|Overall Study||104||
59845091|NCT04633564|75970080|FG000|STARTED|Period 1||335||
59845092|NCT04633564|75970081|FG001|STARTED|Period 1||329||
59845093|NCT04633564|75970080|FG000|COMPLETED|Period 1||227||
59845094|NCT04633564|75970081|FG001|COMPLETED|Period 1||220||
59845095|NCT04633564|75970080|FG000|NOT COMPLETED|Period 1||108||
59845096|NCT04633564|75970081|FG001|NOT COMPLETED|Period 1||109||
59845097|NCT04633564|75970080|FG000|STARTED|Period 2||200||
59845098|NCT04633564|75970081|FG001|STARTED|Period 2||199||
59845099|NCT04633564|75970080|FG000|COMPLETED|Period 2||107||
59845100|NCT04633564|75970081|FG001|COMPLETED|Period 2||102||
59845101|NCT04633564|75970080|FG000|NOT COMPLETED|Period 2||93||
59845102|NCT04633564|75970081|FG001|NOT COMPLETED|Period 2||97||
59845103|NCT04960228|75970089|FG000|STARTED|Overall Study||1098|Randomized to intervention|
59845104|NCT04960228|75970090|FG001|STARTED|Overall Study||999|Randomized to intervention|
59845105|NCT04960228|75970089|FG000|COMPLETED|Overall Study||810|Completed full survey including post-intervention outcome measure|
59845106|NCT04960228|75970090|FG001|COMPLETED|Overall Study||813|Completed full survey including post-intervention outcome measure|
59845107|NCT04960228|75970089|FG000|NOT COMPLETED|Overall Study||288||
59845108|NCT04960228|75970090|FG001|NOT COMPLETED|Overall Study||186||
59845109|NCT04619992|75970098|FG000|STARTED|Overall Study||55||
59845110|NCT04619992|75970099|FG001|STARTED|Overall Study||7||
59845111|NCT04619992|75970098|FG000|COMPLETED|Overall Study||54||
59845112|NCT04619992|75970099|FG001|COMPLETED|Overall Study||7||
59845113|NCT04619992|75970098|FG000|NOT COMPLETED|Overall Study||1||
59845114|NCT04619992|75970099|FG001|NOT COMPLETED|Overall Study||0||
59845115|NCT00136604|75970110|FG000|STARTED|Overall Study||249||
59845116|NCT00136604|75970111|FG001|STARTED|Overall Study||123||
59845117|NCT00136604|75970112|FG002|STARTED|Overall Study||79||
59845118|NCT00136604|75970113|FG003|STARTED|Overall Study||41||
59845119|NCT00136604|75970114|FG004|STARTED|Overall Study||125||
59845120|NCT00136604|75970110|FG000|COMPLETED|Overall Study||248||
59845121|NCT00136604|75970111|FG001|COMPLETED|Overall Study||122||
59845122|NCT00136604|75970112|FG002|COMPLETED|Overall Study||79||
59845123|NCT00136604|75970113|FG003|COMPLETED|Overall Study||41||
59845124|NCT00136604|75970114|FG004|COMPLETED|Overall Study||124||
59845125|NCT00136604|75970110|FG000|NOT COMPLETED|Overall Study||1||
59845126|NCT00136604|75970111|FG001|NOT COMPLETED|Overall Study||1||
59845127|NCT00136604|75970112|FG002|NOT COMPLETED|Overall Study||0||
59845128|NCT00136604|75970113|FG003|NOT COMPLETED|Overall Study||0||
59845129|NCT00136604|75970114|FG004|NOT COMPLETED|Overall Study||1||
59845130|NCT00135512|75970130|FG000|STARTED|Overall Study||234||
59845131|NCT00135512|75970130|FG000|COMPLETED|Overall Study||111||
59845132|NCT00135512|75970130|FG000|NOT COMPLETED|Overall Study||123||
59845133|NCT00130728|75970136|FG000|STARTED|Overall Study||319||
59845134|NCT00130728|75970137|FG001|STARTED|Overall Study||317||
59845135|NCT00130728|75970136|FG000|Received Study Drug (Safety Population)|Overall Study||313||
59845136|NCT00130728|75970137|FG001|Received Study Drug (Safety Population)|Overall Study||313||
59845137|NCT00130728|75970136|FG000|COMPLETED|Overall Study||57||
59845138|NCT00130728|75970137|FG001|COMPLETED|Overall Study||57||
60120204|NCT01695239|76241394|FG004|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0||
59719643|NCT00946101|75838856|FG000|Day 15 Post Dose 1|Overall Study||260||
59719644|NCT00946101|75838857|FG001|Day 15 Post Dose 1|Overall Study||64||
59719645|NCT00946101|75838856|FG000|Day 15 Post Dose 2|Overall Study||254||
59719646|NCT00946101|75838857|FG001|Day 15 Post Dose 2|Overall Study||63||
59719647|NCT00946101|75838856|FG000|COMPLETED|Overall Study||257||
59719648|NCT00946101|75838857|FG001|COMPLETED|Overall Study||63||
59719649|NCT00946101|75838856|FG000|NOT COMPLETED|Overall Study||4||
59719650|NCT00946101|75838857|FG001|NOT COMPLETED|Overall Study||2||
59719651|NCT01109940|75838871|FG000|STARTED|Overall Study||21||
60120205|NCT01695239|76241395|FG005|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0||
59719652|NCT01109940|75838872|FG001|STARTED|Overall Study||8||
59719653|NCT01109940|75838873|FG002|STARTED|Overall Study||7||
59719654|NCT01109940|75838874|FG003|STARTED|Overall Study||3||
59845139|NCT00130728|75970136|FG000|NOT COMPLETED|Overall Study||262||
59845140|NCT00130728|75970137|FG001|NOT COMPLETED|Overall Study||260||
59845141|NCT00129974|75970143|FG000|STARTED|Overall Study||1||
59845142|NCT00129974|75970143|FG000|COMPLETED|Overall Study||0||
59845143|NCT00129974|75970143|FG000|NOT COMPLETED|Overall Study||1||
59845144|NCT04947436|75970150|FG000|STARTED|Overall Study||7||
59845145|NCT04947436|75970151|FG001|STARTED|Overall Study||10||
59845146|NCT04947436|75970152|FG002|STARTED|Overall Study||11||
59845147|NCT04947436|75970150|FG000|COMPLETED|Overall Study||3||
59845148|NCT04947436|75970151|FG001|COMPLETED|Overall Study||2||
59845149|NCT04947436|75970152|FG002|COMPLETED|Overall Study||5||
59845150|NCT04947436|75970150|FG000|NOT COMPLETED|Overall Study||4||
59845151|NCT04947436|75970151|FG001|NOT COMPLETED|Overall Study||8||
59845152|NCT04947436|75970152|FG002|NOT COMPLETED|Overall Study||6||
59845153|NCT00119106|75970162|FG000|STARTED|Overall Study||1204||
59719655|NCT01109940|75838871|FG000|COMPLETED|Overall Study||13||
59845154|NCT00119106|75970163|FG001|STARTED|Overall Study|2 participants later found to be HIV infected at baseline. Therefore 1207 in mITT analysis|1209||
59845155|NCT00119106|75970162|FG000|COMPLETED|Overall Study||1025||
59845156|NCT00119106|75970163|FG001|COMPLETED|Overall Study||1031||
59845157|NCT00119106|75970162|FG000|NOT COMPLETED|Overall Study||179||
59845158|NCT00119106|75970163|FG001|NOT COMPLETED|Overall Study||178||
59845159|NCT00135356|75970179|FG000|STARTED|Overall Study|Number randomized and treated|131||
59845160|NCT00135356|75970180|FG001|STARTED|Overall Study|Number randomized and treated(1 randomized and never treated subject not included in this number.)|69||
59845161|NCT00135356|75970179|FG000|Discontinued Prior to Week 96 Visit|Overall Study||16||
59845162|NCT00135356|75970180|FG001|Discontinued Prior to Week 96 Visit|Overall Study||9||
59845163|NCT00135356|75970179|FG000|Discontinued on or After Week 96 Visit|Overall Study||1||
59845164|NCT00135356|75970180|FG001|Discontinued on or After Week 96 Visit|Overall Study||0||
59845165|NCT00135356|75970179|FG000|COMPLETED|Overall Study||114||
59845166|NCT00135356|75970180|FG001|COMPLETED|Overall Study||60||
59845167|NCT00135356|75970179|FG000|NOT COMPLETED|Overall Study||17||
59845168|NCT00135356|75970180|FG001|NOT COMPLETED|Overall Study||9||
59845169|NCT00118716|75970188|FG000|STARTED|Overall Study||124||
59845170|NCT00118716|75970189|FG001|STARTED|Overall Study||124||
59845171|NCT00118716|75970188|FG000|COMPLETED|Overall Study||111||
59845172|NCT00118716|75970189|FG001|COMPLETED|Overall Study||102||
59845173|NCT00118716|75970188|FG000|NOT COMPLETED|Overall Study||13||
59845174|NCT00118716|75970189|FG001|NOT COMPLETED|Overall Study||22||
59845175|NCT04584346|75970197|FG000|STARTED|Phase 1 - Inpatient (Blinded)||7||
59845176|NCT04584346|75970198|FG001|STARTED|Phase 1 - Inpatient (Blinded)||9||
59845177|NCT04584346|75970197|FG000|COMPLETED|Phase 1 - Inpatient (Blinded)||7||
59845178|NCT04584346|75970198|FG001|COMPLETED|Phase 1 - Inpatient (Blinded)||9||
59845179|NCT04584346|75970197|FG000|NOT COMPLETED|Phase 1 - Inpatient (Blinded)||0||
59845180|NCT04584346|75970198|FG001|NOT COMPLETED|Phase 1 - Inpatient (Blinded)||0||
59845181|NCT04584346|75970197|FG000|STARTED|Phase 2 - At Home (Unblinded)||7||
60120206|NCT01695239|76241396|FG006|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0||
60120207|NCT01695239|76241397|FG007|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0||
60120208|NCT01695239|76241398|FG008|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0||
60120209|NCT01695239|76241399|FG009|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0||
60120210|NCT01695239|76241400|FG010|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0||
59719656|NCT01109940|75838872|FG001|COMPLETED|Overall Study||6||
59719657|NCT01109940|75838873|FG002|COMPLETED|Overall Study||6||
59719658|NCT01109940|75838874|FG003|COMPLETED|Overall Study||3||
59719659|NCT01109940|75838871|FG000|NOT COMPLETED|Overall Study||8||
59719660|NCT01109940|75838872|FG001|NOT COMPLETED|Overall Study||2||
59719661|NCT01109940|75838873|FG002|NOT COMPLETED|Overall Study||1||
59719662|NCT01109940|75838874|FG003|NOT COMPLETED|Overall Study||0||
59719663|NCT00595309|75838884|FG000|STARTED|Overall Study||198||
59719664|NCT00595309|75838884|FG000|COMPLETED|Overall Study||194||
59719665|NCT00595309|75838884|FG000|NOT COMPLETED|Overall Study||4||
59719666|NCT00595075|75838890|FG000|STARTED|Overall Study||6||
59719667|NCT00595075|75838891|FG001|STARTED|Overall Study||5||
59719668|NCT00595075|75838890|FG000|COMPLETED|Overall Study||5||
59719669|NCT00595075|75838891|FG001|COMPLETED|Overall Study||5||
59719670|NCT00595075|75838890|FG000|NOT COMPLETED|Overall Study||1||
59719671|NCT00595075|75838891|FG001|NOT COMPLETED|Overall Study||0||
59719672|NCT00887224|75838900|FG000|STARTED|Open-label Response (OLR) Phase||874||
59719673|NCT00887224|75838901|FG001|STARTED|Open-label Response (OLR) Phase||0||
59719674|NCT00887224|75838902|FG002|STARTED|Open-label Response (OLR) Phase||0||
59719675|NCT00887224|75838900|FG000|COMPLETED|Open-label Response (OLR) Phase||752||
59719676|NCT00887224|75838901|FG001|COMPLETED|Open-label Response (OLR) Phase||0||
59719677|NCT00887224|75838902|FG002|COMPLETED|Open-label Response (OLR) Phase||0||
59719678|NCT00887224|75838900|FG000|NOT COMPLETED|Open-label Response (OLR) Phase||122||
59719679|NCT00887224|75838901|FG001|NOT COMPLETED|Open-label Response (OLR) Phase||0||
59719680|NCT00887224|75838902|FG002|NOT COMPLETED|Open-label Response (OLR) Phase||0||
59719681|NCT00887224|75838900|FG000|STARTED|Between OLR and OLS Phases||752||
59719682|NCT00887224|75838901|FG001|STARTED|Between OLR and OLS Phases||0||
59719683|NCT00887224|75838902|FG002|STARTED|Between OLR and OLS Phases||0||
59719684|NCT00887224|75838900|FG000|COMPLETED|Between OLR and OLS Phases||659||
59719685|NCT00887224|75838901|FG001|COMPLETED|Between OLR and OLS Phases||0||
59719686|NCT00887224|75838902|FG002|COMPLETED|Between OLR and OLS Phases||0||
59845182|NCT04584346|75970198|FG001|STARTED|Phase 2 - At Home (Unblinded)||9||
59845183|NCT04584346|75970197|FG000|COMPLETED|Phase 2 - At Home (Unblinded)||7||
59719687|NCT00887224|75838900|FG000|NOT COMPLETED|Between OLR and OLS Phases||93||
59719688|NCT00887224|75838901|FG001|NOT COMPLETED|Between OLR and OLS Phases||0||
59719689|NCT00887224|75838902|FG002|NOT COMPLETED|Between OLR and OLS Phases||0||
59719690|NCT00887224|75838900|FG000|STARTED|Open-label Stability (OLS) Phase||659||
59719691|NCT00887224|75838901|FG001|STARTED|Open-label Stability (OLS) Phase||0||
59719692|NCT00887224|75838902|FG002|STARTED|Open-label Stability (OLS) Phase||0||
59845184|NCT04584346|75970198|FG001|COMPLETED|Phase 2 - At Home (Unblinded)||8||
59845185|NCT04584346|75970197|FG000|NOT COMPLETED|Phase 2 - At Home (Unblinded)||0||
59845186|NCT04584346|75970198|FG001|NOT COMPLETED|Phase 2 - At Home (Unblinded)||1||
59845187|NCT00118482|75970208|FG000|STARTED|Overall Study|3 patients signed the consent but did not take the study medication.|105||
59845188|NCT00118482|75970209|FG001|STARTED|Overall Study||105||
59845189|NCT00118482|75970208|FG000|COMPLETED|Overall Study|210 in the Intention To Treat analysis|75||
59845190|NCT00118482|75970209|FG001|COMPLETED|Overall Study||76||
59845191|NCT00118482|75970208|FG000|NOT COMPLETED|Overall Study||30||
59845192|NCT00118482|75970209|FG001|NOT COMPLETED|Overall Study||29||
59845193|NCT00129272|75970217|FG000|STARTED|Overall Study||71||
59845194|NCT00129272|75970218|FG001|STARTED|Overall Study||73||
59845195|NCT00129272|75970217|FG000|COMPLETED|Overall Study||54||
59719693|NCT00887224|75838900|FG000|COMPLETED|Open-label Stability (OLS) Phase||576||
59719694|NCT00887224|75838901|FG001|COMPLETED|Open-label Stability (OLS) Phase||0||
59719695|NCT00887224|75838902|FG002|COMPLETED|Open-label Stability (OLS) Phase||0||
59719696|NCT00887224|75838900|FG000|NOT COMPLETED|Open-label Stability (OLS) Phase||83||
59719697|NCT00887224|75838901|FG001|NOT COMPLETED|Open-label Stability (OLS) Phase||0||
59719698|NCT00887224|75838902|FG002|NOT COMPLETED|Open-label Stability (OLS) Phase||0||
59719699|NCT00887224|75838900|FG000|STARTED|Between OLS and DB Phases||576||
59719700|NCT00887224|75838901|FG001|STARTED|Between OLS and DB Phases||0||
59845196|NCT00129272|75970218|FG001|COMPLETED|Overall Study||51||
59845197|NCT00129272|75970217|FG000|NOT COMPLETED|Overall Study||17||
59845198|NCT00129272|75970218|FG001|NOT COMPLETED|Overall Study||22||
59845199|NCT04899232|75970227|FG000|STARTED|Screening Period||20||
59845200|NCT04899232|75970228|FG001|STARTED|Screening Period||20||
59845201|NCT04899232|75970229|FG002|STARTED|Screening Period||12||
59845202|NCT04899232|75970227|FG000|COMPLETED|Screening Period||15||
59845203|NCT04899232|75970228|FG001|COMPLETED|Screening Period||20||
59845204|NCT04899232|75970229|FG002|COMPLETED|Screening Period||12||
59845205|NCT04899232|75970227|FG000|NOT COMPLETED|Screening Period||5||
59845206|NCT04899232|75970228|FG001|NOT COMPLETED|Screening Period||0||
59845207|NCT04899232|75970229|FG002|NOT COMPLETED|Screening Period||0||
59845208|NCT04899232|75970227|FG000|STARTED|Treatment Period||15||
59845209|NCT04899232|75970228|FG001|STARTED|Treatment Period||20||
59845210|NCT04899232|75970229|FG002|STARTED|Treatment Period||12||
59845211|NCT04899232|75970227|FG000|COMPLETED|Treatment Period||15||
59845212|NCT04899232|75970228|FG001|COMPLETED|Treatment Period||20||
59845213|NCT04899232|75970229|FG002|COMPLETED|Treatment Period||12||
59845214|NCT04899232|75970227|FG000|NOT COMPLETED|Treatment Period||0||
59845215|NCT04899232|75970228|FG001|NOT COMPLETED|Treatment Period||0||
59845216|NCT04899232|75970229|FG002|NOT COMPLETED|Treatment Period||0||
59845217|NCT04574908|75970239|FG000|STARTED|Overall Study||431||
59845218|NCT04574908|75970240|FG001|STARTED|Overall Study||448||
59845219|NCT04574908|75970239|FG000|COMPLETED|Overall Study||431||
59845220|NCT04574908|75970240|FG001|COMPLETED|Overall Study||448||
59845221|NCT04574908|75970239|FG000|NOT COMPLETED|Overall Study||0||
59845222|NCT04574908|75970240|FG001|NOT COMPLETED|Overall Study||0||
59845223|NCT04559698|75970248|FG000|STARTED|Overall Study||61||
59845224|NCT04559698|75970249|FG001|STARTED|Overall Study||60||
59845225|NCT04559698|75970248|FG000|Four-month Pre-intervention|Overall Study|Participants in this arm started training immediately after randomization, and therefore, did not have a four-month waiting period prior to receiving the training.|0||
59845226|NCT04559698|75970249|FG001|Four-month Pre-intervention|Overall Study||60||
59845227|NCT04559698|75970248|FG000|Immediate Pre-intervention|Overall Study||61||
59845228|NCT04559698|75970249|FG001|Immediate Pre-intervention|Overall Study||55||
60120211|NCT01695239|76241401|FG011|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0||
60120212|NCT01695239|76241402|FG012|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0||
60120213|NCT01695239|76241403|FG013|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0||
60120214|NCT01695239|76241390|FG000|STARTED|Placebo Washout (Week 24 Up To Week 32)||0||
59567868|NCT02280408|75670720|FG003|NOT COMPLETED|Overall Study||0||
59719701|NCT00887224|75838902|FG002|STARTED|Between OLS and DB Phases||0||
59719702|NCT00887224|75838900|FG000|COMPLETED|Between OLS and DB Phases||548||
59719703|NCT00887224|75838901|FG001|COMPLETED|Between OLS and DB Phases||0||
59719704|NCT00887224|75838902|FG002|COMPLETED|Between OLS and DB Phases||0||
59719705|NCT00887224|75838900|FG000|NOT COMPLETED|Between OLS and DB Phases||28||
59719706|NCT00887224|75838901|FG001|NOT COMPLETED|Between OLS and DB Phases||0||
59719707|NCT00887224|75838902|FG002|NOT COMPLETED|Between OLS and DB Phases||0||
59719708|NCT00887224|75838900|FG000|STARTED|OL Taper Phase / OL Follow Up|Could have entered 7-day taper period at any time during either the OLR phase or OLS phase.|307||
59719709|NCT00887224|75838901|FG001|STARTED|OL Taper Phase / OL Follow Up||0||
59719710|NCT00887224|75838902|FG002|STARTED|OL Taper Phase / OL Follow Up||0||
59845229|NCT04559698|75970248|FG000|Immediate Post-intervention|Overall Study||52||
59845230|NCT04559698|75970249|FG001|Immediate Post-intervention|Overall Study||44||
59845231|NCT04559698|75970248|FG000|Four-month Post-intervention|Overall Study||47||
59845232|NCT04559698|75970249|FG001|Four-month Post-intervention|Overall Study|Participants in this arm started training four months after randomization (waitlist) and therefore, were not assessed at the four-month follow-up time point due to completion of the study.|0||
59845233|NCT04559698|75970248|FG000|COMPLETED|Overall Study||47||
59845234|NCT04559698|75970249|FG001|COMPLETED|Overall Study||44||
59845235|NCT04559698|75970248|FG000|NOT COMPLETED|Overall Study||14||
59845236|NCT04559698|75970249|FG001|NOT COMPLETED|Overall Study||16||
59845237|NCT00133952|75970257|FG000|STARTED|Overall Study||157||
59845238|NCT00133952|75970258|FG001|STARTED|Overall Study||152||
59845239|NCT00133952|75970257|FG000|Received at Least One Dose of Study Drug|Overall Study||153||
59845240|NCT00133952|75970258|FG001|Received at Least One Dose of Study Drug|Overall Study||149||
59845241|NCT00133952|75970257|FG000|COMPLETED|Overall Study||115||
59845242|NCT00133952|75970258|FG001|COMPLETED|Overall Study||124||
59845243|NCT00133952|75970257|FG000|NOT COMPLETED|Overall Study||42||
59845244|NCT00133952|75970258|FG001|NOT COMPLETED|Overall Study||28||
59845245|NCT00118092|75970264|FG000|STARTED|Overall Study||17||
59845246|NCT00118092|75970264|FG000|COMPLETED|Overall Study||15||
59845247|NCT00118092|75970264|FG000|NOT COMPLETED|Overall Study||2||
59845248|NCT04555096|75970271|FG000|STARTED|Overall Study||9||
59845249|NCT04555096|75970272|FG001|STARTED|Overall Study||7||
59845250|NCT04555096|75970271|FG000|COMPLETED|Overall Study||4||
59845251|NCT04555096|75970272|FG001|COMPLETED|Overall Study||2||
59845252|NCT04555096|75970271|FG000|NOT COMPLETED|Overall Study||5||
59845253|NCT04555096|75970272|FG001|NOT COMPLETED|Overall Study||5||
59845254|NCT00097500|75970280|FG000|STARTED|On-drug Period (Week 0 to Week 52)||36||
59845255|NCT00097500|75970281|FG001|STARTED|On-drug Period (Week 0 to Week 52)||33||
59845256|NCT00097500|75970280|FG000|COMPLETED|On-drug Period (Week 0 to Week 52)|Subjects experiencing loss of glucose control after Week 52 are considered to have completed study.|30||
59845257|NCT00097500|75970281|FG001|COMPLETED|On-drug Period (Week 0 to Week 52)|Subjects experiencing loss of glucose control after Week 52 are considered to have completed study.|30||
59845258|NCT00097500|75970280|FG000|NOT COMPLETED|On-drug Period (Week 0 to Week 52)||6||
59845259|NCT00097500|75970281|FG001|NOT COMPLETED|On-drug Period (Week 0 to Week 52)||3||
59845260|NCT00097500|75970280|FG000|STARTED|Off-drug Period (Week 52 to Week 64)|Exenatide is discontinued, metformin is continued|30||
59845261|NCT00097500|75970281|FG001|STARTED|Off-drug Period (Week 52 to Week 64)|Insulin Glargine is discontinued, metformin is continued|30||
59845262|NCT00097500|75970280|FG000|COMPLETED|Off-drug Period (Week 52 to Week 64)||25||
59845263|NCT00097500|75970281|FG001|COMPLETED|Off-drug Period (Week 52 to Week 64)||26||
59845264|NCT00097500|75970280|FG000|NOT COMPLETED|Off-drug Period (Week 52 to Week 64)||5||
59845265|NCT00097500|75970281|FG001|NOT COMPLETED|Off-drug Period (Week 52 to Week 64)||4||
59845266|NCT04551898|75970291|FG000|STARTED|Overall Study||47||
59845267|NCT04551898|75970292|FG001|STARTED|Overall Study||45||
59845268|NCT04551898|75970293|FG002|STARTED|Overall Study||43||
59845269|NCT04551898|75970294|FG003|STARTED|Overall Study||46||
59845270|NCT04551898|75970291|FG000|COMPLETED|Overall Study||39||
59845271|NCT04551898|75970292|FG001|COMPLETED|Overall Study||42||
59845272|NCT04551898|75970293|FG002|COMPLETED|Overall Study||35||
59845273|NCT04551898|75970294|FG003|COMPLETED|Overall Study||41||
59845274|NCT04551898|75970291|FG000|NOT COMPLETED|Overall Study||8||
59845275|NCT04551898|75970292|FG001|NOT COMPLETED|Overall Study||3||
59845276|NCT04551898|75970293|FG002|NOT COMPLETED|Overall Study||8||
59845277|NCT04551898|75970294|FG003|NOT COMPLETED|Overall Study||5||
59845278|NCT04849780|75970312|FG000|STARTED|Period 1||45||
59845279|NCT04849780|75970313|FG001|STARTED|Period 1||47||
59845280|NCT04849780|75970312|FG000|COMPLETED|Period 1||41||
59845281|NCT04849780|75970313|FG001|COMPLETED|Period 1||47||
59845282|NCT04849780|75970312|FG000|NOT COMPLETED|Period 1||4||
59845283|NCT04849780|75970313|FG001|NOT COMPLETED|Period 1||0||
59845284|NCT04849780|75970312|FG000|STARTED|Period 2||41||
59845285|NCT04849780|75970313|FG001|STARTED|Period 2||0||
59845286|NCT04849780|75970312|FG000|COMPLETED|Period 2||39||
59845287|NCT04849780|75970313|FG001|COMPLETED|Period 2||0||
59845288|NCT04849780|75970312|FG000|NOT COMPLETED|Period 2||2||
59845289|NCT04849780|75970313|FG001|NOT COMPLETED|Period 2||0||
59845290|NCT04823494|75970327|FG000|STARTED|Overall Study||21||
59845291|NCT04823494|75970328|FG001|STARTED|Overall Study||19||
59845292|NCT04823494|75970327|FG000|COMPLETED|Overall Study||19||
59845293|NCT04823494|75970328|FG001|COMPLETED|Overall Study||18||
59845294|NCT04823494|75970327|FG000|NOT COMPLETED|Overall Study||2||
59845295|NCT04823494|75970328|FG001|NOT COMPLETED|Overall Study||1||
59845296|NCT04542694|75970338|FG000|STARTED|Overall Study||100||
59845297|NCT04542694|75970339|FG001|STARTED|Overall Study||100||
59845298|NCT04542694|75970338|FG000|COMPLETED|Overall Study||96||
59845299|NCT04542694|75970339|FG001|COMPLETED|Overall Study||100||
59845300|NCT04542694|75970338|FG000|NOT COMPLETED|Overall Study||4||
59845301|NCT04542694|75970339|FG001|NOT COMPLETED|Overall Study||0||
59845302|NCT00117312|75970349|FG000|STARTED|Overall Study||10||
59845303|NCT00117312|75970350|FG001|STARTED|Overall Study||24||
59845304|NCT00117312|75970351|FG002|STARTED|Overall Study||24||
59845305|NCT00117312|75970352|FG003|STARTED|Overall Study||24||
59845306|NCT00117312|75970349|FG000|Started FE200486 CS06A|Overall Study||1||
59845307|NCT00117312|75970350|FG001|Started FE200486 CS06A|Overall Study||11||
59845308|NCT00117312|75970351|FG002|Started FE200486 CS06A|Overall Study||16||
59845309|NCT00117312|75970352|FG003|Started FE200486 CS06A|Overall Study||9||
59845310|NCT00117312|75970349|FG000|COMPLETED|Overall Study||0||
59845311|NCT00117312|75970350|FG001|COMPLETED|Overall Study|Defined as those patients ongoing when the extension study was terminated|4||
59845312|NCT00117312|75970351|FG002|COMPLETED|Overall Study||0||
59845313|NCT00117312|75970352|FG003|COMPLETED|Overall Study||3||
59845314|NCT00117312|75970349|FG000|NOT COMPLETED|Overall Study||10||
59845315|NCT00117312|75970350|FG001|NOT COMPLETED|Overall Study||20||
59845316|NCT00117312|75970351|FG002|NOT COMPLETED|Overall Study||24||
59845317|NCT00117312|75970352|FG003|NOT COMPLETED|Overall Study||21||
59845318|NCT00129116|75970367|FG000|STARTED|Primary Phase||78||
59845319|NCT00129116|75970368|FG001|STARTED|Primary Phase||77||
59845320|NCT00129116|75970369|FG002|STARTED|Primary Phase||78||
59845321|NCT00129116|75970370|FG003|STARTED|Primary Phase||78||
59845322|NCT00129116|75970371|FG004|STARTED|Primary Phase||77||
59845323|NCT00129116|75970367|FG000|COMPLETED|Primary Phase||76||
59845324|NCT00129116|75970368|FG001|COMPLETED|Primary Phase||73||
59845325|NCT00129116|75970369|FG002|COMPLETED|Primary Phase||77||
59845326|NCT00129116|75970370|FG003|COMPLETED|Primary Phase||77||
59845327|NCT00129116|75970371|FG004|COMPLETED|Primary Phase||76||
59845328|NCT00129116|75970367|FG000|NOT COMPLETED|Primary Phase||2||
59845329|NCT00129116|75970368|FG001|NOT COMPLETED|Primary Phase||4||
59845330|NCT00129116|75970369|FG002|NOT COMPLETED|Primary Phase||1||
59845331|NCT00129116|75970370|FG003|NOT COMPLETED|Primary Phase||1||
59845332|NCT00129116|75970371|FG004|NOT COMPLETED|Primary Phase||1||
59845333|NCT00129116|75970367|FG000|STARTED|Booster Phase||47||
59845334|NCT00129116|75970368|FG001|STARTED|Booster Phase||42||
59845335|NCT00129116|75970369|FG002|STARTED|Booster Phase||44||
59845336|NCT00129116|75970370|FG003|STARTED|Booster Phase||44||
59845337|NCT00129116|75970371|FG004|STARTED|Booster Phase||44||
59845338|NCT00129116|75970367|FG000|COMPLETED|Booster Phase||45||
59845339|NCT00129116|75970368|FG001|COMPLETED|Booster Phase||42||
59845340|NCT00129116|75970369|FG002|COMPLETED|Booster Phase||44||
59845341|NCT00129116|75970370|FG003|COMPLETED|Booster Phase||44||
59845342|NCT00129116|75970371|FG004|COMPLETED|Booster Phase||43||
59845343|NCT00129116|75970367|FG000|NOT COMPLETED|Booster Phase||2||
59845344|NCT00129116|75970368|FG001|NOT COMPLETED|Booster Phase||0||
60120215|NCT01695239|76241391|FG001|STARTED|Placebo Washout (Week 24 Up To Week 32)||0||
60120216|NCT01695239|76241392|FG002|STARTED|Placebo Washout (Week 24 Up To Week 32)||0||
60120217|NCT01695239|76241393|FG003|STARTED|Placebo Washout (Week 24 Up To Week 32)||0||
60120218|NCT01695239|76241394|FG004|STARTED|Placebo Washout (Week 24 Up To Week 32)|Only included PBO washout participants.|0||
60120219|NCT01695239|76241395|FG005|STARTED|Placebo Washout (Week 24 Up To Week 32)|Only included PBO washout participants.|0||
60120220|NCT01695239|76241396|FG006|STARTED|Placebo Washout (Week 24 Up To Week 32)|Only included PBO washout participants.|0||
60120221|NCT01695239|76241397|FG007|STARTED|Placebo Washout (Week 24 Up To Week 32)|Adalimumab Q2W responders who re-randomized to IxeQ2W or IxeQ4W and PBO for ixe and adalimumab.|88||
60120222|NCT01695239|76241398|FG008|STARTED|Placebo Washout (Week 24 Up To Week 32)||0||
60120223|NCT01695239|76241399|FG009|STARTED|Placebo Washout (Week 24 Up To Week 32)||0||
60120224|NCT01695239|76241400|FG010|STARTED|Placebo Washout (Week 24 Up To Week 32)||0||
60120225|NCT01695239|76241401|FG011|STARTED|Placebo Washout (Week 24 Up To Week 32)||0||
60120226|NCT01695239|76241402|FG012|STARTED|Placebo Washout (Week 24 Up To Week 32)||0||
60120227|NCT01695239|76241403|FG013|STARTED|Placebo Washout (Week 24 Up To Week 32)||0||
60120228|NCT01695239|76241390|FG000|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0||
60120229|NCT01695239|76241391|FG001|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0||
59567869|NCT01189071|75670732|FG000|STARTED|Overall Study||0||
59567870|NCT01189071|75670733|FG001|STARTED|Overall Study||0||
59567871|NCT01189071|75670732|FG000|COMPLETED|Overall Study||0||
59567872|NCT01189071|75670733|FG001|COMPLETED|Overall Study||0||
59567873|NCT01189071|75670732|FG000|NOT COMPLETED|Overall Study||0||
59567874|NCT01189071|75670733|FG001|NOT COMPLETED|Overall Study||0||
59567875|NCT03770091|75670742|FG000|STARTED|Overall Study||15||
59567876|NCT03770091|75670743|FG001|STARTED|Overall Study||13||
59567877|NCT03770091|75670744|FG002|STARTED|Overall Study||12||
59567878|NCT03770091|75670742|FG000|COMPLETED|Overall Study||15||
59567879|NCT03770091|75670743|FG001|COMPLETED|Overall Study||13||
59567880|NCT03770091|75670744|FG002|COMPLETED|Overall Study||12||
59567881|NCT03770091|75670742|FG000|NOT COMPLETED|Overall Study||0||
59567882|NCT03770091|75670743|FG001|NOT COMPLETED|Overall Study||0||
59567883|NCT03770091|75670744|FG002|NOT COMPLETED|Overall Study||0||
59567884|NCT02515851|75670754|FG000|STARTED|Overall Study||15||
59567885|NCT02515851|75670755|FG001|STARTED|Overall Study||15||
59567886|NCT02515851|75670754|FG000|COMPLETED|Overall Study||15||
59567887|NCT02515851|75670755|FG001|COMPLETED|Overall Study||15||
59567888|NCT02515851|75670754|FG000|NOT COMPLETED|Overall Study||0||
59567889|NCT02515851|75670755|FG001|NOT COMPLETED|Overall Study||0||
59845345|NCT00129116|75970369|FG002|NOT COMPLETED|Booster Phase||0||
59845346|NCT00129116|75970370|FG003|NOT COMPLETED|Booster Phase||0||
59845347|NCT00129116|75970371|FG004|NOT COMPLETED|Booster Phase||1||
59845348|NCT00117156|75970383|FG000|STARTED|Overall Study||26||
59845349|NCT00117156|75970383|FG000|COMPLETED|Overall Study||15||
59845350|NCT00117156|75970383|FG000|NOT COMPLETED|Overall Study||11||
59845351|NCT00096954|75970389|FG000|STARTED|Overall Study||159||
59845352|NCT00096954|75970390|FG001|STARTED|Overall Study||174||
59845353|NCT00096954|75970389|FG000|Received Study Drug|Overall Study||157||
59845354|NCT00096954|75970390|FG001|Received Study Drug|Overall Study||171||
59845355|NCT00096954|75970389|FG000|COMPLETED|Overall Study||135||
59845356|NCT00096954|75970390|FG001|COMPLETED|Overall Study||154||
59845357|NCT00096954|75970389|FG000|NOT COMPLETED|Overall Study||24||
59845358|NCT00096954|75970390|FG001|NOT COMPLETED|Overall Study||20||
59845359|NCT00096486|75970400|FG000|STARTED|Overall Study||4||
59845360|NCT00096486|75970401|FG001|STARTED|Overall Study||6||
59845361|NCT00096486|75970402|FG002|STARTED|Overall Study||26||
59845362|NCT00096486|75970403|FG003|STARTED|Overall Study||38||
59845363|NCT00096486|75970400|FG000|COMPLETED|Overall Study||4||
59845364|NCT00096486|75970401|FG001|COMPLETED|Overall Study||6||
59845365|NCT00096486|75970402|FG002|COMPLETED|Overall Study||24||
59845366|NCT00096486|75970403|FG003|COMPLETED|Overall Study||36||
59845367|NCT00096486|75970400|FG000|NOT COMPLETED|Overall Study||0||
59845368|NCT00096486|75970401|FG001|NOT COMPLETED|Overall Study||0||
59845369|NCT00096486|75970402|FG002|NOT COMPLETED|Overall Study||2||
59845370|NCT00096486|75970403|FG003|NOT COMPLETED|Overall Study||2||
59845371|NCT00116844|75970415|FG000|STARTED|Period 1: Treatment Period 1 (60 Days)||35||
59845372|NCT00116844|75970416|FG001|STARTED|Period 1: Treatment Period 1 (60 Days)||36||
59845373|NCT00116844|75970415|FG000|COMPLETED|Period 1: Treatment Period 1 (60 Days)||28||
59845374|NCT00116844|75970416|FG001|COMPLETED|Period 1: Treatment Period 1 (60 Days)||33||
59845375|NCT00116844|75970415|FG000|NOT COMPLETED|Period 1: Treatment Period 1 (60 Days)||7||
59845376|NCT00116844|75970416|FG001|NOT COMPLETED|Period 1: Treatment Period 1 (60 Days)||3||
59845377|NCT00116844|75970415|FG000|STARTED|Period 2: Washout Period (7 Days)||28||
59845378|NCT00116844|75970416|FG001|STARTED|Period 2: Washout Period (7 Days)||33||
59845379|NCT00116844|75970415|FG000|COMPLETED|Period 2: Washout Period (7 Days)||28||
59845380|NCT00116844|75970416|FG001|COMPLETED|Period 2: Washout Period (7 Days)||33||
59845381|NCT00116844|75970415|FG000|NOT COMPLETED|Period 2: Washout Period (7 Days)||0||
59845382|NCT00116844|75970416|FG001|NOT COMPLETED|Period 2: Washout Period (7 Days)||0||
59845383|NCT00116844|75970415|FG000|STARTED|Period 1: Treatment Period 2 (60 Days)||28||
59845384|NCT00116844|75970416|FG001|STARTED|Period 1: Treatment Period 2 (60 Days)||33||
59845385|NCT00116844|75970415|FG000|COMPLETED|Period 1: Treatment Period 2 (60 Days)||24||
59845386|NCT00116844|75970416|FG001|COMPLETED|Period 1: Treatment Period 2 (60 Days)||28||
59845387|NCT00116844|75970415|FG000|NOT COMPLETED|Period 1: Treatment Period 2 (60 Days)||4||
59845388|NCT00116844|75970416|FG001|NOT COMPLETED|Period 1: Treatment Period 2 (60 Days)||5||
59845389|NCT00128492|75970424|FG000|STARTED|Overall Study||85||
59845390|NCT00128492|75970425|FG001|STARTED|Overall Study||189||
59845391|NCT00128492|75970424|FG000|COMPLETED|Overall Study||65||
59845392|NCT00128492|75970425|FG001|COMPLETED|Overall Study||130||
59845393|NCT00128492|75970424|FG000|NOT COMPLETED|Overall Study||20||
59845394|NCT00128492|75970425|FG001|NOT COMPLETED|Overall Study||59||
59845395|NCT00132314|75970433|FG000|STARTED|Overall Study||190||
59845396|NCT00132314|75970434|FG001|STARTED|Overall Study||192||
59845397|NCT00132314|75970433|FG000|Received Treatment|Overall Study||188||
59845398|NCT00132314|75970434|FG001|Received Treatment|Overall Study||185||
59845399|NCT00132314|75970433|FG000|Completed Baseline Visit, Provided SSN|Overall Study|This is the ITT cohort|187||
59845400|NCT00132314|75970434|FG001|Completed Baseline Visit, Provided SSN|Overall Study|This is the ITT cohort.|182||
59845401|NCT00132314|75970433|FG000|COMPLETED|Overall Study||117||
59845402|NCT00132314|75970434|FG001|COMPLETED|Overall Study||120||
59845403|NCT00132314|75970433|FG000|NOT COMPLETED|Overall Study||73||
59845404|NCT00132314|75970434|FG001|NOT COMPLETED|Overall Study||72||
59845405|NCT04539262|75970448|FG000|STARTED|Overall Study||12||
59845406|NCT04539262|75970449|FG001|STARTED|Overall Study||13||
60120230|NCT01695239|76241392|FG002|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0||
60120231|NCT01695239|76241393|FG003|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0||
60120232|NCT01695239|76241394|FG004|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0||
60120233|NCT01695239|76241395|FG005|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0||
60120234|NCT01695239|76241396|FG006|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0||
60120235|NCT01695239|76241397|FG007|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||77||
60120236|NCT01695239|76241398|FG008|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0||
60120237|NCT01695239|76241399|FG009|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0||
60120238|NCT01695239|76241400|FG010|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0||
60120239|NCT01695239|76241401|FG011|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0||
60120240|NCT01695239|76241402|FG012|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0||
60120241|NCT01695239|76241403|FG013|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0||
60120242|NCT01695239|76241390|FG000|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0||
60120243|NCT01695239|76241391|FG001|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0||
60120244|NCT01695239|76241392|FG002|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0||
59845407|NCT04539262|75970450|FG002|STARTED|Overall Study||12||
59845408|NCT04539262|75970451|FG003|STARTED|Overall Study||12||
59845409|NCT04539262|75970452|FG004|STARTED|Overall Study||12||
59845410|NCT04539262|75970453|FG005|STARTED|Overall Study||13||
59845411|NCT04539262|75970454|FG006|STARTED|Overall Study||62||
59845412|NCT04539262|75970455|FG007|STARTED|Overall Study||20||
59845413|NCT04539262|75970448|FG000|COMPLETED|Overall Study||12||
59845414|NCT04539262|75970449|FG001|COMPLETED|Overall Study||12||
59845415|NCT04539262|75970450|FG002|COMPLETED|Overall Study||11||
59845416|NCT04539262|75970451|FG003|COMPLETED|Overall Study||11||
60120245|NCT01695239|76241393|FG003|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0||
60120246|NCT01695239|76241394|FG004|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0||
59719711|NCT00887224|75838900|FG000|Discontinued Open-label Taper|OL Taper Phase / OL Follow Up|Could have discontinued at any time during OL taper phase or OL Follow-up (7 days after last dose).|144||
60120247|NCT01695239|76241395|FG005|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0||
60120248|NCT01695239|76241396|FG006|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0||
60120249|NCT01695239|76241397|FG007|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||11||
60120250|NCT01695239|76241398|FG008|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0||
60120251|NCT01695239|76241399|FG009|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0||
60120252|NCT01695239|76241400|FG010|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0||
60120253|NCT01695239|76241401|FG011|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0||
60120254|NCT01695239|76241402|FG012|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0||
60120255|NCT01695239|76241403|FG013|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0||
60120256|NCT01695239|76241390|FG000|STARTED|Extension Long-Term Extension Periods||0||
60120257|NCT01695239|76241391|FG001|STARTED|Extension Long-Term Extension Periods||0||
60120258|NCT01695239|76241392|FG002|STARTED|Extension Long-Term Extension Periods||0||
60120259|NCT01695239|76241393|FG003|STARTED|Extension Long-Term Extension Periods||0||
60120260|NCT01695239|76241394|FG004|STARTED|Extension Long-Term Extension Periods||0||
59567890|NCT02282930|75670761|FG000|STARTED|Overall Study||20||
59719712|NCT00887224|75838901|FG001|Discontinued Open-label Taper|OL Taper Phase / OL Follow Up||0||
59719713|NCT00887224|75838902|FG002|Discontinued Open-label Taper|OL Taper Phase / OL Follow Up||0||
59845417|NCT04539262|75970452|FG004|COMPLETED|Overall Study||12||
59845418|NCT04539262|75970453|FG005|COMPLETED|Overall Study||13||
59845419|NCT04539262|75970454|FG006|COMPLETED|Overall Study||61||
59845420|NCT04539262|75970455|FG007|COMPLETED|Overall Study||20||
59845421|NCT04539262|75970448|FG000|NOT COMPLETED|Overall Study||0||
59845422|NCT04539262|75970449|FG001|NOT COMPLETED|Overall Study||1||
59845423|NCT04539262|75970450|FG002|NOT COMPLETED|Overall Study||1||
59845424|NCT04539262|75970451|FG003|NOT COMPLETED|Overall Study||1||
59845425|NCT04539262|75970452|FG004|NOT COMPLETED|Overall Study||0||
59845426|NCT04539262|75970453|FG005|NOT COMPLETED|Overall Study||0||
59845427|NCT04539262|75970454|FG006|NOT COMPLETED|Overall Study||1||
59845428|NCT04539262|75970455|FG007|NOT COMPLETED|Overall Study||0||
59845429|NCT03702010|75970478|FG000|STARTED|First Stimulation (5 Days)||13||
59845430|NCT03702010|75970479|FG001|STARTED|First Stimulation (5 Days)||14||
59845431|NCT03702010|75970478|FG000|COMPLETED|First Stimulation (5 Days)||13||
59845432|NCT03702010|75970479|FG001|COMPLETED|First Stimulation (5 Days)||14||
59845433|NCT03702010|75970478|FG000|NOT COMPLETED|First Stimulation (5 Days)||0||
59845434|NCT03702010|75970479|FG001|NOT COMPLETED|First Stimulation (5 Days)||0||
59996664|NCT02714569|76112507|FG004|Received at Least One Dose of Study Drug|Part A Fourth Intervention||3||
59996665|NCT02714569|76112508|FG005|Received at Least One Dose of Study Drug|Part A Fourth Intervention||2||
60120261|NCT01695239|76241395|FG005|STARTED|Extension Long-Term Extension Periods||0||
60120262|NCT01695239|76241396|FG006|STARTED|Extension Long-Term Extension Periods||0||
59567891|NCT02282930|75670761|FG000|COMPLETED|Overall Study||19||
59567892|NCT02282930|75670761|FG000|NOT COMPLETED|Overall Study||1||
59567893|NCT01151553|75670765|FG000|STARTED|Overall Study||5||
59567894|NCT01151553|75670765|FG000|COMPLETED|Overall Study||5||
59567895|NCT01151553|75670765|FG000|NOT COMPLETED|Overall Study||0||
59567896|NCT02492295|75670769|FG000|STARTED|Overall Study||0||
59567897|NCT02492295|75670769|FG000|COMPLETED|Overall Study||0||
59567898|NCT02492295|75670769|FG000|NOT COMPLETED|Overall Study||0||
59567899|NCT02280122|75670776|FG000|STARTED|Overall Study||15||
59567900|NCT02280122|75670777|FG001|STARTED|Overall Study||15||
59567901|NCT02280122|75670778|FG002|STARTED|Overall Study||30||
59567902|NCT02280122|75670776|FG000|COMPLETED|Overall Study||15||
59719714|NCT00887224|75838900|FG000|COMPLETED|OL Taper Phase / OL Follow Up||163||
59719715|NCT00887224|75838901|FG001|COMPLETED|OL Taper Phase / OL Follow Up||0||
59719716|NCT00887224|75838902|FG002|COMPLETED|OL Taper Phase / OL Follow Up||0||
59719717|NCT00887224|75838900|FG000|NOT COMPLETED|OL Taper Phase / OL Follow Up||144||
59996666|NCT02714569|76112509|FG006|Received at Least One Dose of Study Drug|Part A Fourth Intervention||0||
59996667|NCT02714569|76112510|FG007|Received at Least One Dose of Study Drug|Part A Fourth Intervention||0||
59567903|NCT02280122|75670777|FG001|COMPLETED|Overall Study||15||
59719718|NCT00887224|75838901|FG001|NOT COMPLETED|OL Taper Phase / OL Follow Up||0||
59719719|NCT00887224|75838902|FG002|NOT COMPLETED|OL Taper Phase / OL Follow Up||0||
59719720|NCT00887224|75838900|FG000|STARTED|Double-blind (DB) Phase||0||
59719721|NCT00887224|75838901|FG001|STARTED|Double-blind (DB) Phase|2 participants randomized in error to DB, then entered OL Taper; counted in OL Taper and DB phases.|276||
59845435|NCT03702010|75970478|FG000|STARTED|Washout + Second Stimulation (2+5days)||13||
59845436|NCT03702010|75970479|FG001|STARTED|Washout + Second Stimulation (2+5days)||14||
59845437|NCT03702010|75970478|FG000|COMPLETED|Washout + Second Stimulation (2+5days)||13||
59845438|NCT03702010|75970479|FG001|COMPLETED|Washout + Second Stimulation (2+5days)||14||
59845439|NCT03702010|75970478|FG000|NOT COMPLETED|Washout + Second Stimulation (2+5days)||0||
59996668|NCT02714569|76112511|FG008|Received at Least One Dose of Study Drug|Part A Fourth Intervention||0||
59996669|NCT02714569|76112512|FG009|Received at Least One Dose of Study Drug|Part A Fourth Intervention||0||
59996670|NCT02714569|76112513|FG010|Received at Least One Dose of Study Drug|Part A Fourth Intervention||0||
59996671|NCT02714569|76112503|FG000|COMPLETED|Part A Fourth Intervention||3||
59567904|NCT02280122|75670778|FG002|COMPLETED|Overall Study||30||
59567905|NCT02280122|75670776|FG000|NOT COMPLETED|Overall Study||0||
59996672|NCT02714569|76112504|FG001|COMPLETED|Part A Fourth Intervention||2||
59996673|NCT02714569|76112505|FG002|COMPLETED|Part A Fourth Intervention||3||
59845440|NCT03702010|75970479|FG001|NOT COMPLETED|Washout + Second Stimulation (2+5days)||0||
59845441|NCT03702010|75970478|FG000|STARTED|Follow-up (30days)||13||
59845442|NCT03702010|75970479|FG001|STARTED|Follow-up (30days)||14||
59845443|NCT03702010|75970478|FG000|COMPLETED|Follow-up (30days)||11||
59845444|NCT03702010|75970479|FG001|COMPLETED|Follow-up (30days)||12||
59845445|NCT03702010|75970478|FG000|NOT COMPLETED|Follow-up (30days)||2||
59845446|NCT03702010|75970479|FG001|NOT COMPLETED|Follow-up (30days)||2||
59845447|NCT04538170|75970493|FG000|STARTED|Overall Study||158||
59845448|NCT04538170|75970494|FG001|STARTED|Overall Study||265||
59845449|NCT04538170|75970493|FG000|COMPLETED|Overall Study||54||
59845450|NCT04538170|75970494|FG001|COMPLETED|Overall Study||55||
59845451|NCT04538170|75970493|FG000|NOT COMPLETED|Overall Study||104||
59845452|NCT04538170|75970494|FG001|NOT COMPLETED|Overall Study||210||
59845453|NCT04537234|75970506|FG000|STARTED|Overall Study||82||
59845454|NCT04537234|75970507|FG001|STARTED|Overall Study||83||
59845455|NCT04537234|75970506|FG000|COMPLETED|Overall Study||80||
59845456|NCT04537234|75970507|FG001|COMPLETED|Overall Study||83||
59845457|NCT04537234|75970506|FG000|NOT COMPLETED|Overall Study||2||
59845458|NCT04537234|75970507|FG001|NOT COMPLETED|Overall Study||0||
59845459|NCT04537078|75970515|FG000|STARTED|Overall Study||45||
59845460|NCT04537078|75970516|FG001|STARTED|Overall Study||45||
59845461|NCT04537078|75970515|FG000|COMPLETED|Overall Study||41||
59845462|NCT04537078|75970516|FG001|COMPLETED|Overall Study||42||
59845463|NCT04537078|75970515|FG000|NOT COMPLETED|Overall Study||4||
59845464|NCT04537078|75970516|FG001|NOT COMPLETED|Overall Study||3||
59845465|NCT04532164|75970529|FG000|STARTED|Overall Study||137||
59845466|NCT04532164|75970529|FG000|Treated|Overall Study||132||
59845467|NCT04532164|75970529|FG000|COMPLETED|Overall Study||113||
59845468|NCT04532164|75970529|FG000|NOT COMPLETED|Overall Study||24||
59845469|NCT00116688|75970536|FG000|STARTED|Overall Study||292||
59845470|NCT00116688|75970537|FG001|STARTED|Overall Study||21||
59845471|NCT00116688|75970536|FG000|Received Study Medication|Overall Study||291||
59845472|NCT00116688|75970537|FG001|Received Study Medication|Overall Study||20||
59845473|NCT00116688|75970536|FG000|COMPLETED|Overall Study||200||
59845474|NCT00116688|75970537|FG001|COMPLETED|Overall Study||17||
59845475|NCT00116688|75970536|FG000|NOT COMPLETED|Overall Study||92||
59845476|NCT00116688|75970537|FG001|NOT COMPLETED|Overall Study||4||
59845477|NCT04531540|75970543|FG000|STARTED|Overall Study||225||
59845478|NCT04531540|75970543|FG000|Treated|Overall Study||222||
59845479|NCT04531540|75970543|FG000|COMPLETED|Overall Study||216||
59845480|NCT04531540|75970543|FG000|NOT COMPLETED|Overall Study||9||
59845481|NCT04799782|75970547|FG000|STARTED|First Intervention||8||
59845482|NCT04799782|75970548|FG001|STARTED|First Intervention||7||
59845483|NCT04799782|75970547|FG000|COMPLETED|First Intervention||8||
59845484|NCT04799782|75970548|FG001|COMPLETED|First Intervention||7||
59845485|NCT04799782|75970547|FG000|NOT COMPLETED|First Intervention||0||
60120263|NCT01695239|76241397|FG007|STARTED|Extension Long-Term Extension Periods|Only included combined extension participants.|0||
59845486|NCT04799782|75970548|FG001|NOT COMPLETED|First Intervention||0||
59845487|NCT04799782|75970547|FG000|STARTED|Washout||8||
59845488|NCT04799782|75970548|FG001|STARTED|Washout||7||
59845489|NCT04799782|75970547|FG000|COMPLETED|Washout||6||
59845490|NCT04799782|75970548|FG001|COMPLETED|Washout||4||
59845491|NCT04799782|75970547|FG000|NOT COMPLETED|Washout||2||
59845492|NCT04799782|75970548|FG001|NOT COMPLETED|Washout||3||
59845493|NCT04799782|75970547|FG000|STARTED|Second Intervention||6||
59845494|NCT04799782|75970548|FG001|STARTED|Second Intervention||4||
59845495|NCT04799782|75970547|FG000|COMPLETED|Second Intervention||6||
59845496|NCT04799782|75970548|FG001|COMPLETED|Second Intervention||4||
59845497|NCT04799782|75970547|FG000|NOT COMPLETED|Second Intervention||0||
59845498|NCT04799782|75970548|FG001|NOT COMPLETED|Second Intervention||0||
59845499|NCT03697252|75970556|FG000|STARTED|Overall Study||90||
59845500|NCT03697252|75970557|FG001|STARTED|Overall Study||92||
59845501|NCT03697252|75970556|FG000|COMPLETED|Overall Study||72||
59845502|NCT03697252|75970557|FG001|COMPLETED|Overall Study||73||
59845503|NCT03697252|75970556|FG000|NOT COMPLETED|Overall Study||18||
59845504|NCT03697252|75970557|FG001|NOT COMPLETED|Overall Study||19||
59845505|NCT03701074|75970565|FG000|STARTED|Overall Study||1||
59845506|NCT03701074|75970566|FG001|STARTED|Overall Study||0||
59845507|NCT03701074|75970565|FG000|COMPLETED|Overall Study|Treatment was withdrawn after the 10th dose of oral medication (acetaminophen), on day 3 of treatment, as the infant developed mild abdominal distension which was as per the study protocol|0||
59845508|NCT03701074|75970566|FG001|COMPLETED|Overall Study||0||
59845509|NCT03701074|75970565|FG000|NOT COMPLETED|Overall Study||1||
59845510|NCT03701074|75970566|FG001|NOT COMPLETED|Overall Study||0||
59845511|NCT04728802|75970574|FG000|STARTED|Overall Study||317||
59845512|NCT04728802|75970575|FG001|STARTED|Overall Study||328||
59845513|NCT04728802|75970574|FG000|COMPLETED|Overall Study||288|All randomized patients were included in analysis|
59845514|NCT04728802|75970575|FG001|COMPLETED|Overall Study||292|All randomized patients were included in analysis|
59845515|NCT04728802|75970574|FG000|NOT COMPLETED|Overall Study||29||
59845516|NCT04728802|75970575|FG001|NOT COMPLETED|Overall Study||36||
59845517|NCT04715932|75970583|FG000|STARTED|Overall Study||107||
59845518|NCT04715932|75970584|FG001|STARTED|Overall Study||109||
59845519|NCT04715932|75970583|FG000|COMPLETED|Overall Study||106||
59845520|NCT04715932|75970584|FG001|COMPLETED|Overall Study||109||
59845521|NCT04715932|75970583|FG000|NOT COMPLETED|Overall Study||1||
59845522|NCT04715932|75970584|FG001|NOT COMPLETED|Overall Study||0||
59845523|NCT00130832|75970592|FG000|STARTED|Overall Study||372||
59845524|NCT00130832|75970593|FG001|STARTED|Overall Study||363||
59845525|NCT00130832|75970592|FG000|COMPLETED|Overall Study|Those who received all 3 doses of concomitant RotaTeq™/ OPV with blood draw ~42 days postdose 3|356||
59845526|NCT00130832|75970593|FG001|COMPLETED|Overall Study|Those who received all 3 doses; last 2 blood draws ~42 days postdose 3 of RotaTeq™ and postdose OPV|346||
59845527|NCT00130832|75970592|FG000|NOT COMPLETED|Overall Study||16||
59845528|NCT00130832|75970593|FG001|NOT COMPLETED|Overall Study||17||
59845529|NCT00096018|75970601|FG000|STARTED|Overall Study||13||
59845530|NCT00096018|75970602|FG001|STARTED|Overall Study||30||
59845531|NCT00096018|75970601|FG000|Treated With Study Therapy|Overall Study||13||
59845532|NCT00096018|75970602|FG001|Treated With Study Therapy|Overall Study||25||
59845533|NCT00096018|75970601|FG000|COMPLETED|Overall Study||11||
59845534|NCT00096018|75970602|FG001|COMPLETED|Overall Study||16||
59845535|NCT00096018|75970601|FG000|NOT COMPLETED|Overall Study||2||
59845536|NCT00096018|75970602|FG001|NOT COMPLETED|Overall Study||14||
59845537|NCT04713748|75970608|FG000|STARTED|Overall Study||135||
59845538|NCT04713748|75970608|FG000|COMPLETED|Overall Study||100||
59845539|NCT04713748|75970608|FG000|NOT COMPLETED|Overall Study||35||
59845540|NCT04702984|75970612|FG000|STARTED|Overall Study||39||78
59845541|NCT04702984|75970612|FG000|COMPLETED|Overall Study||38||76
59845542|NCT04702984|75970612|FG000|NOT COMPLETED|Overall Study||1||2
59845543|NCT04701658|75970618|FG000|STARTED|Overall Study||109||
59845544|NCT04701658|75970618|FG000|Received Single Dose of Bamlanivimab|Overall Study||109||
59845545|NCT04701658|75970618|FG000|COMPLETED|Overall Study||103||
59845546|NCT04701658|75970618|FG000|NOT COMPLETED|Overall Study||6||
59845547|NCT00128102|75970624|FG000|STARTED|Overall Study||329||
59845548|NCT00128102|75970625|FG001|STARTED|Overall Study||332||
59845549|NCT00128102|75970624|FG000|Treated|Overall Study||329||
59845550|NCT00128102|75970625|FG001|Treated|Overall Study||329||
59845551|NCT00128102|75970624|FG000|COMPLETED|Overall Study||1||
59845552|NCT00128102|75970625|FG001|COMPLETED|Overall Study||0||
59845553|NCT00128102|75970624|FG000|NOT COMPLETED|Overall Study||328||
59845554|NCT00128102|75970625|FG001|NOT COMPLETED|Overall Study||332||
59845555|NCT04668274|75970631|FG000|STARTED|Part 1 Study Period 1||21||
59845556|NCT04668274|75970632|FG001|STARTED|Part 1 Study Period 1||0||
59845557|NCT04668274|75970633|FG002|STARTED|Part 1 Study Period 1||0||
59845558|NCT04668274|75970634|FG003|STARTED|Part 1 Study Period 1||0||
59845559|NCT04668274|75970631|FG000|COMPLETED|Part 1 Study Period 1||16||
59845560|NCT04668274|75970632|FG001|COMPLETED|Part 1 Study Period 1||0||
59845561|NCT04668274|75970633|FG002|COMPLETED|Part 1 Study Period 1||0||
59845562|NCT04668274|75970634|FG003|COMPLETED|Part 1 Study Period 1||0||
59845563|NCT04668274|75970631|FG000|NOT COMPLETED|Part 1 Study Period 1||5||
59845564|NCT04668274|75970632|FG001|NOT COMPLETED|Part 1 Study Period 1||0||
59719722|NCT00887224|75838902|FG002|STARTED|Double-blind (DB) Phase||272||
59719723|NCT00887224|75838900|FG000|COMPLETED|Double-blind (DB) Phase||0||
59719724|NCT00887224|75838901|FG001|COMPLETED|Double-blind (DB) Phase||176||
59719725|NCT00887224|75838902|FG002|COMPLETED|Double-blind (DB) Phase||210||
59719726|NCT00887224|75838900|FG000|NOT COMPLETED|Double-blind (DB) Phase||0||
59719727|NCT00887224|75838901|FG001|NOT COMPLETED|Double-blind (DB) Phase||100||
59719728|NCT00887224|75838902|FG002|NOT COMPLETED|Double-blind (DB) Phase||62||
59719729|NCT00887224|75838900|FG000|STARTED|DB Taper Phase / Post Study Follow Up||0||
59719730|NCT00887224|75838901|FG001|STARTED|DB Taper Phase / Post Study Follow Up|Double-blind participants (DBp) could have entered 7-day taper period at any time during DB phase.|267||
59719731|NCT00887224|75838902|FG002|STARTED|DB Taper Phase / Post Study Follow Up||265||
59845565|NCT04668274|75970633|FG002|NOT COMPLETED|Part 1 Study Period 1||0||
59845566|NCT04668274|75970634|FG003|NOT COMPLETED|Part 1 Study Period 1||0||
59845567|NCT04668274|75970631|FG000|STARTED|Part 1 Study Period 2||0||
59845568|NCT04668274|75970632|FG001|STARTED|Part 1 Study Period 2||16||
59845569|NCT04668274|75970633|FG002|STARTED|Part 1 Study Period 2||0||
59845570|NCT04668274|75970634|FG003|STARTED|Part 1 Study Period 2||0||
59845571|NCT04668274|75970631|FG000|COMPLETED|Part 1 Study Period 2||0||
59845572|NCT04668274|75970632|FG001|COMPLETED|Part 1 Study Period 2||15||
59845573|NCT04668274|75970633|FG002|COMPLETED|Part 1 Study Period 2||0||
59845574|NCT04668274|75970634|FG003|COMPLETED|Part 1 Study Period 2||0||
59845575|NCT04668274|75970631|FG000|NOT COMPLETED|Part 1 Study Period 2||0||
59845576|NCT04668274|75970632|FG001|NOT COMPLETED|Part 1 Study Period 2||1||
59845577|NCT04668274|75970633|FG002|NOT COMPLETED|Part 1 Study Period 2||0||
59845578|NCT04668274|75970634|FG003|NOT COMPLETED|Part 1 Study Period 2||0||
59845579|NCT04668274|75970631|FG000|STARTED|Part 1 Study Period 3||0||
59845580|NCT04668274|75970632|FG001|STARTED|Part 1 Study Period 3||0||
59845581|NCT04668274|75970633|FG002|STARTED|Part 1 Study Period 3||18||
59845582|NCT04668274|75970634|FG003|STARTED|Part 1 Study Period 3||0||
59845583|NCT04668274|75970631|FG000|COMPLETED|Part 1 Study Period 3||0||
59845584|NCT04668274|75970632|FG001|COMPLETED|Part 1 Study Period 3||0||
59845585|NCT04668274|75970633|FG002|COMPLETED|Part 1 Study Period 3|3 participants were directly enrolled in Study Period 3 in addition to the 15 participants from the Study Period 2.|15||
59845586|NCT04668274|75970634|FG003|COMPLETED|Part 1 Study Period 3||0||
59845587|NCT04668274|75970631|FG000|NOT COMPLETED|Part 1 Study Period 3||0||
59845588|NCT04668274|75970632|FG001|NOT COMPLETED|Part 1 Study Period 3||0||
59845589|NCT04668274|75970633|FG002|NOT COMPLETED|Part 1 Study Period 3||3||
59845590|NCT04668274|75970634|FG003|NOT COMPLETED|Part 1 Study Period 3||0||
59845591|NCT04668274|75970631|FG000|STARTED|Part 2 Study Period 4||0||
59845592|NCT04668274|75970632|FG001|STARTED|Part 2 Study Period 4||0||
59845593|NCT04668274|75970633|FG002|STARTED|Part 2 Study Period 4||0||
59845594|NCT04668274|75970634|FG003|STARTED|Part 2 Study Period 4||15||
59845595|NCT04668274|75970631|FG000|COMPLETED|Part 2 Study Period 4||0||
59845596|NCT04668274|75970632|FG001|COMPLETED|Part 2 Study Period 4||0||
59845597|NCT04668274|75970633|FG002|COMPLETED|Part 2 Study Period 4||0||
59845598|NCT04668274|75970634|FG003|COMPLETED|Part 2 Study Period 4||14||
59845599|NCT04668274|75970631|FG000|NOT COMPLETED|Part 2 Study Period 4||0||
59845600|NCT04668274|75970632|FG001|NOT COMPLETED|Part 2 Study Period 4||0||
59845601|NCT04668274|75970633|FG002|NOT COMPLETED|Part 2 Study Period 4||0||
59845602|NCT04668274|75970634|FG003|NOT COMPLETED|Part 2 Study Period 4||1||
59845603|NCT04406194|75970649|FG000|STARTED|Period 1||15||
59845604|NCT04406194|75970650|FG001|STARTED|Period 1||15||
59845605|NCT04406194|75970649|FG000|COMPLETED|Period 1||15||
59845606|NCT04406194|75970650|FG001|COMPLETED|Period 1||14||
59845607|NCT04406194|75970649|FG000|NOT COMPLETED|Period 1||0||
59845608|NCT04406194|75970650|FG001|NOT COMPLETED|Period 1||1||
59845609|NCT04406194|75970649|FG000|STARTED|Period 2||15||
59845610|NCT04406194|75970650|FG001|STARTED|Period 2||14||
59845611|NCT04406194|75970649|FG000|COMPLETED|Period 2||15||
59845612|NCT04406194|75970650|FG001|COMPLETED|Period 2||14||
59845613|NCT04406194|75970649|FG000|NOT COMPLETED|Period 2||0||
59845614|NCT04406194|75970650|FG001|NOT COMPLETED|Period 2||0||
59845615|NCT03822884|75970665|FG000|STARTED|Overall Study||4||
59845616|NCT03822884|75970666|FG001|STARTED|Overall Study||4||
59845617|NCT03822884|75970667|FG002|STARTED|Overall Study||4||
59845618|NCT03822884|75970668|FG003|STARTED|Overall Study||4||
59845619|NCT03822884|75970669|FG004|STARTED|Overall Study||4||
59845620|NCT03822884|75970670|FG005|STARTED|Overall Study||4||
59845621|NCT03822884|75970665|FG000|COMPLETED|Overall Study||4||
59845622|NCT03822884|75970666|FG001|COMPLETED|Overall Study||4||
59845623|NCT03822884|75970667|FG002|COMPLETED|Overall Study||4||
59845624|NCT03822884|75970668|FG003|COMPLETED|Overall Study||4||
59845625|NCT03822884|75970669|FG004|COMPLETED|Overall Study||3||
59845626|NCT03822884|75970670|FG005|COMPLETED|Overall Study||4||
59845627|NCT03822884|75970665|FG000|NOT COMPLETED|Overall Study||0||
59845628|NCT03822884|75970666|FG001|NOT COMPLETED|Overall Study||0||
59845629|NCT03822884|75970667|FG002|NOT COMPLETED|Overall Study||0||
59845630|NCT03822884|75970668|FG003|NOT COMPLETED|Overall Study||0||
59845631|NCT03822884|75970669|FG004|NOT COMPLETED|Overall Study||1||
60120264|NCT01695239|76241398|FG008|STARTED|Extension Long-Term Extension Periods|IxeQ4W who re-randomized to ixeQ4W.|187||
59845632|NCT03822884|75970670|FG005|NOT COMPLETED|Overall Study||0||
59845633|NCT03822416|75970680|FG000|STARTED|Overall Study||19||
60120265|NCT01695239|76241399|FG009|STARTED|Extension Long-Term Extension Periods|IxeQ2W who re-randomized to ixeQ2W.|183||
60120266|NCT01695239|76241400|FG010|STARTED|Extension Long-Term Extension Periods||0||
60120267|NCT01695239|76241401|FG011|STARTED|Extension Long-Term Extension Periods||0||
60120268|NCT01695239|76241402|FG012|STARTED|Extension Long-Term Extension Periods||0||
59845634|NCT03822416|75970681|FG001|STARTED|Overall Study||19||
59845635|NCT03822416|75970680|FG000|COMPLETED|Overall Study||18||
59845636|NCT03822416|75970681|FG001|COMPLETED|Overall Study||18||
59845637|NCT03822416|75970680|FG000|NOT COMPLETED|Overall Study||1||
60120269|NCT01695239|76241403|FG013|STARTED|Extension Long-Term Extension Periods||0||
59845638|NCT03822416|75970681|FG001|NOT COMPLETED|Overall Study||1||
59845639|NCT04405570|75970691|FG000|STARTED|Overall Study||23||
59845640|NCT04405570|75970692|FG001|STARTED|Overall Study||64||
59845641|NCT04405570|75970693|FG002|STARTED|Overall Study||55||
59845642|NCT04405570|75970694|FG003|STARTED|Overall Study||62||
59845643|NCT04405570|75970691|FG000|Number of Subjects Randomized Not Dosed|Overall Study||0||
59845644|NCT04405570|75970692|FG001|Number of Subjects Randomized Not Dosed|Overall Study||2||
59845645|NCT04405570|75970693|FG002|Number of Subjects Randomized Not Dosed|Overall Study||0||
59845646|NCT04405570|75970694|FG003|Number of Subjects Randomized Not Dosed|Overall Study||0||
59845647|NCT04405570|75970691|FG000|Number of Subjects in the Safety Population|Overall Study||23||
59845648|NCT04405570|75970692|FG001|Number of Subjects in the Safety Population|Overall Study||62||
59845649|NCT04405570|75970693|FG002|Number of Subjects in the Safety Population|Overall Study||55||
59845650|NCT04405570|75970694|FG003|Number of Subjects in the Safety Population|Overall Study||62||
59845651|NCT04405570|75970691|FG000|Number of Subjects in the mITT Population|Overall Study||23||
59845652|NCT04405570|75970692|FG001|Number of Subjects in the mITT Population|Overall Study||61||
59845653|NCT04405570|75970693|FG002|Number of Subjects in the mITT Population|Overall Study||53||
59845654|NCT04405570|75970694|FG003|Number of Subjects in the mITT Population|Overall Study||61||
59845655|NCT04405570|75970691|FG000|COMPLETED|Overall Study||23||
59845656|NCT04405570|75970692|FG001|COMPLETED|Overall Study||59||
59845657|NCT04405570|75970693|FG002|COMPLETED|Overall Study||52||
59845658|NCT04405570|75970694|FG003|COMPLETED|Overall Study||61||
59845659|NCT04405570|75970691|FG000|NOT COMPLETED|Overall Study||0||
59845660|NCT04405570|75970692|FG001|NOT COMPLETED|Overall Study||5||
59845661|NCT04405570|75970693|FG002|NOT COMPLETED|Overall Study||3||
59845662|NCT04405570|75970694|FG003|NOT COMPLETED|Overall Study||1||
59845663|NCT00127712|75970709|FG000|STARTED|Overall Study||65||
59845664|NCT00127712|75970710|FG001|STARTED|Overall Study||65||
59845665|NCT00127712|75970709|FG000|COMPLETED|Overall Study||60||
59845666|NCT00127712|75970710|FG001|COMPLETED|Overall Study||65||
59845667|NCT00127712|75970709|FG000|NOT COMPLETED|Overall Study||5||
59845668|NCT00127712|75970710|FG001|NOT COMPLETED|Overall Study||0||
59845669|NCT04404010|75970718|FG000|STARTED|Overall Study|1 participant was mistakenly consented, enrolled and randomized as part of study. After randomization, but prior to study testing we realized the participant was not eligible (they were not a PGY4 or 5), therefore they were excluded prior to any further study procedures commenced. Therefore, only 9 participants completed all study procedures/were followed for purposes of study.|10||
59845670|NCT04404010|75970719|FG001|STARTED|Overall Study||9||
59845671|NCT04404010|75970718|FG000|COMPLETED|Overall Study||9||
59845672|NCT04404010|75970719|FG001|COMPLETED|Overall Study||9||
59845673|NCT04404010|75970718|FG000|NOT COMPLETED|Overall Study||1||
59845674|NCT04404010|75970719|FG001|NOT COMPLETED|Overall Study||0||
59845675|NCT04401202|75970729|FG000|STARTED|Overall Study||92||
59845676|NCT04401202|75970730|FG001|STARTED|Overall Study||91||
59845677|NCT04401202|75970729|FG000|COMPLETED|Overall Study||86||
59845678|NCT04401202|75970730|FG001|COMPLETED|Overall Study||87||
59845679|NCT04401202|75970729|FG000|NOT COMPLETED|Overall Study||6||
59845680|NCT04401202|75970730|FG001|NOT COMPLETED|Overall Study||4||
59845681|NCT00096356|75970739|FG000|STARTED|Overall Study||122||
59845682|NCT00096356|75970740|FG001|STARTED|Overall Study||114||
59845683|NCT00096356|75970739|FG000|COMPLETED|Overall Study||78||
59845684|NCT00096356|75970740|FG001|COMPLETED|Overall Study||61||
59845685|NCT00096356|75970739|FG000|NOT COMPLETED|Overall Study||44||
59845686|NCT00096356|75970740|FG001|NOT COMPLETED|Overall Study||53||
59845687|NCT04358068|75970749|FG000|STARTED|Overall Study||9|Indicates the number randomized to a given arm|
59845688|NCT04358068|75970750|FG001|STARTED|Overall Study||11|Indicates the number randomized to a given arm|
59845689|NCT04358068|75970749|FG000|COMPLETED|Overall Study||7||
59845690|NCT04358068|75970750|FG001|COMPLETED|Overall Study||9||
59845691|NCT04358068|75970749|FG000|NOT COMPLETED|Overall Study||2||
59845692|NCT04358068|75970750|FG001|NOT COMPLETED|Overall Study||2||
59845693|NCT03694210|75970756|FG000|STARTED|Overall Study||37|37 patients were screened, 7 were screen failures, 30 were enrolled and treated.|
59845694|NCT03694210|75970756|FG000|COMPLETED|Overall Study||29|1 subject passed away just prior to completing the study but all analysis points were collected prior to this.|
59845695|NCT03694210|75970756|FG000|NOT COMPLETED|Overall Study||8||
59845696|NCT04339972|75970764|FG000|STARTED|Overall Study||15||
59845697|NCT04339972|75970765|FG001|STARTED|Overall Study||14||
59845698|NCT04339972|75970764|FG000|COMPLETED|Overall Study||10||
59845699|NCT04339972|75970765|FG001|COMPLETED|Overall Study||9||
59845700|NCT04339972|75970764|FG000|NOT COMPLETED|Overall Study||5||
59845701|NCT04339972|75970765|FG001|NOT COMPLETED|Overall Study||5||
59845702|NCT00096278|75970773|FG000|STARTED|Overall Study||1356||
59845703|NCT00096278|75970774|FG001|STARTED|Overall Study||1354||
59845704|NCT00096278|75970773|FG000|COMPLETED|Overall Study||1338||
59845705|NCT00096278|75970774|FG001|COMPLETED|Overall Study||1334||
59845706|NCT00096278|75970773|FG000|NOT COMPLETED|Overall Study||18||
60120270|NCT01695239|76241390|FG000|COMPLETED|Extension Long-Term Extension Periods||0||
59719732|NCT00887224|75838900|FG000|Did Not Enter DB Taper|DB Taper Phase / Post Study Follow Up||0||
59719733|NCT00887224|75838901|FG001|Did Not Enter DB Taper|DB Taper Phase / Post Study Follow Up||9||
59719734|NCT00887224|75838902|FG002|Did Not Enter DB Taper|DB Taper Phase / Post Study Follow Up||7||
59719735|NCT00887224|75838900|FG000|Discontinued DB Taper|DB Taper Phase / Post Study Follow Up||0||
59719736|NCT00887224|75838901|FG001|Discontinued DB Taper|DB Taper Phase / Post Study Follow Up|DBp could have discontinued at anytime during DB taper period or Follow-up (7 days after last dose).|41||
59719737|NCT00887224|75838902|FG002|Discontinued DB Taper|DB Taper Phase / Post Study Follow Up||30||
59719738|NCT00887224|75838900|FG000|COMPLETED|DB Taper Phase / Post Study Follow Up||0||
59719739|NCT00887224|75838901|FG001|COMPLETED|DB Taper Phase / Post Study Follow Up||226||
59719740|NCT00887224|75838902|FG002|COMPLETED|DB Taper Phase / Post Study Follow Up||235||
59719741|NCT00887224|75838900|FG000|NOT COMPLETED|DB Taper Phase / Post Study Follow Up||0||
59719742|NCT00887224|75838901|FG001|NOT COMPLETED|DB Taper Phase / Post Study Follow Up||41||
59845707|NCT00096278|75970774|FG001|NOT COMPLETED|Overall Study||20||
59845708|NCT00095940|75970789|FG000|STARTED|Molecular Biology Phase||2||
59845709|NCT00095940|75970790|FG001|STARTED|Molecular Biology Phase||2||
59845710|NCT00095940|75970791|FG002|STARTED|Molecular Biology Phase|No surgery prior to study enrollment; not eligible for the molecular biology phase|0||
59845711|NCT00095940|75970792|FG003|STARTED|Molecular Biology Phase||0||
59845712|NCT00095940|75970793|FG004|STARTED|Molecular Biology Phase||0||
59845713|NCT00095940|75970794|FG005|STARTED|Molecular Biology Phase|No surgery prior to study enrollment; not eligible for the molecular biology phase|0||
59845714|NCT00095940|75970795|FG006|STARTED|Molecular Biology Phase||2||
59845715|NCT00095940|75970796|FG007|STARTED|Molecular Biology Phase||2||
59845716|NCT00095940|75970797|FG008|STARTED|Molecular Biology Phase|No surgery prior to study enrollment; not eligible for the molecular biology phase|0||
59845717|NCT00095940|75970789|FG000|COMPLETED|Molecular Biology Phase||2||
59845718|NCT00095940|75970790|FG001|COMPLETED|Molecular Biology Phase||2||
59845719|NCT00095940|75970791|FG002|COMPLETED|Molecular Biology Phase||0||
59845720|NCT00095940|75970792|FG003|COMPLETED|Molecular Biology Phase||0||
59845721|NCT00095940|75970793|FG004|COMPLETED|Molecular Biology Phase||0||
59845722|NCT00095940|75970794|FG005|COMPLETED|Molecular Biology Phase||0||
59845723|NCT00095940|75970795|FG006|COMPLETED|Molecular Biology Phase||2||
59845724|NCT00095940|75970796|FG007|COMPLETED|Molecular Biology Phase||2||
59845725|NCT00095940|75970797|FG008|COMPLETED|Molecular Biology Phase||0||
59845726|NCT00095940|75970789|FG000|NOT COMPLETED|Molecular Biology Phase||0||
59845727|NCT00095940|75970790|FG001|NOT COMPLETED|Molecular Biology Phase||0||
59845728|NCT00095940|75970791|FG002|NOT COMPLETED|Molecular Biology Phase||0||
59845729|NCT00095940|75970792|FG003|NOT COMPLETED|Molecular Biology Phase||0||
59845730|NCT00095940|75970793|FG004|NOT COMPLETED|Molecular Biology Phase||0||
60120271|NCT01695239|76241391|FG001|COMPLETED|Extension Long-Term Extension Periods||0||
60120272|NCT01695239|76241392|FG002|COMPLETED|Extension Long-Term Extension Periods||0||
60120273|NCT01695239|76241393|FG003|COMPLETED|Extension Long-Term Extension Periods||0||
60120274|NCT01695239|76241394|FG004|COMPLETED|Extension Long-Term Extension Periods||0||
60120275|NCT01695239|76241395|FG005|COMPLETED|Extension Long-Term Extension Periods||0||
60120276|NCT01695239|76241396|FG006|COMPLETED|Extension Long-Term Extension Periods||0||
60120277|NCT01695239|76241397|FG007|COMPLETED|Extension Long-Term Extension Periods||0||
60120278|NCT01695239|76241398|FG008|COMPLETED|Extension Long-Term Extension Periods||121||
60120279|NCT01695239|76241399|FG009|COMPLETED|Extension Long-Term Extension Periods||122||
60120280|NCT01695239|76241400|FG010|COMPLETED|Extension Long-Term Extension Periods||0||
60120281|NCT01695239|76241401|FG011|COMPLETED|Extension Long-Term Extension Periods||0||
60120282|NCT01695239|76241402|FG012|COMPLETED|Extension Long-Term Extension Periods||0||
60120283|NCT01695239|76241403|FG013|COMPLETED|Extension Long-Term Extension Periods||0||
59845731|NCT00095940|75970794|FG005|NOT COMPLETED|Molecular Biology Phase||0||
59845732|NCT00095940|75970795|FG006|NOT COMPLETED|Molecular Biology Phase||0||
59845733|NCT00095940|75970796|FG007|NOT COMPLETED|Molecular Biology Phase||0||
59845734|NCT00095940|75970797|FG008|NOT COMPLETED|Molecular Biology Phase||0||
59845735|NCT00095940|75970789|FG000|STARTED|Lapatinib Continuation/Phase II|Continued to receive lapatinib but were ineligible for the phase II.|2||
60120284|NCT01695239|76241390|FG000|NOT COMPLETED|Extension Long-Term Extension Periods||0||
60120285|NCT01695239|76241391|FG001|NOT COMPLETED|Extension Long-Term Extension Periods||0||
60120286|NCT01695239|76241392|FG002|NOT COMPLETED|Extension Long-Term Extension Periods||0||
60120287|NCT01695239|76241393|FG003|NOT COMPLETED|Extension Long-Term Extension Periods||0||
60120288|NCT01695239|76241394|FG004|NOT COMPLETED|Extension Long-Term Extension Periods||0||
60120289|NCT01695239|76241395|FG005|NOT COMPLETED|Extension Long-Term Extension Periods||0||
60120290|NCT01695239|76241396|FG006|NOT COMPLETED|Extension Long-Term Extension Periods||0||
60120291|NCT01695239|76241397|FG007|NOT COMPLETED|Extension Long-Term Extension Periods||0||
60120292|NCT01695239|76241398|FG008|NOT COMPLETED|Extension Long-Term Extension Periods||66||
60120293|NCT01695239|76241399|FG009|NOT COMPLETED|Extension Long-Term Extension Periods||61||
60120294|NCT01695239|76241400|FG010|NOT COMPLETED|Extension Long-Term Extension Periods||0||
60120295|NCT01695239|76241401|FG011|NOT COMPLETED|Extension Long-Term Extension Periods||0||
60120296|NCT01695239|76241402|FG012|NOT COMPLETED|Extension Long-Term Extension Periods||0||
60120297|NCT01695239|76241403|FG013|NOT COMPLETED|Extension Long-Term Extension Periods||0||
60120298|NCT01695239|76241390|FG000|STARTED|Post-Treatment Follow-Up Period||0||
60120299|NCT01695239|76241391|FG001|STARTED|Post-Treatment Follow-Up Period||0||
60120300|NCT01695239|76241392|FG002|STARTED|Post-Treatment Follow-Up Period||0||
60120301|NCT01695239|76241393|FG003|STARTED|Post-Treatment Follow-Up Period||0||
60120302|NCT01695239|76241394|FG004|STARTED|Post-Treatment Follow-Up Period||0||
60120303|NCT01695239|76241395|FG005|STARTED|Post-Treatment Follow-Up Period||0||
60120304|NCT01695239|76241396|FG006|STARTED|Post-Treatment Follow-Up Period||0||
59845736|NCT00095940|75970790|FG001|STARTED|Lapatinib Continuation/Phase II|No measurable disease post surgery - ineligible for the phase II. Continued to receive lapatinib.|2||
59845737|NCT00095940|75970791|FG002|STARTED|Lapatinib Continuation/Phase II||17||
59845738|NCT00095940|75970792|FG003|STARTED|Lapatinib Continuation/Phase II||0||
59845739|NCT00095940|75970793|FG004|STARTED|Lapatinib Continuation/Phase II||0||
59845740|NCT00095940|75970794|FG005|STARTED|Lapatinib Continuation/Phase II||13||
59845741|NCT00095940|75970795|FG006|STARTED|Lapatinib Continuation/Phase II|Continued to receive lapatinib but were ineligible for the phase II.|2||
59845742|NCT00095940|75970796|FG007|STARTED|Lapatinib Continuation/Phase II|No measurable disease post surgery - ineligible for the phase II. Continued to receive lapatinib.|2||
59845743|NCT00095940|75970797|FG008|STARTED|Lapatinib Continuation/Phase II||14||
59845744|NCT00095940|75970789|FG000|COMPLETED|Lapatinib Continuation/Phase II||0||
59845745|NCT00095940|75970790|FG001|COMPLETED|Lapatinib Continuation/Phase II||0||
59845746|NCT00095940|75970791|FG002|COMPLETED|Lapatinib Continuation/Phase II||1||
59845747|NCT00095940|75970792|FG003|COMPLETED|Lapatinib Continuation/Phase II||0||
59845748|NCT00095940|75970793|FG004|COMPLETED|Lapatinib Continuation/Phase II||0||
59845749|NCT00095940|75970794|FG005|COMPLETED|Lapatinib Continuation/Phase II||0||
59845750|NCT00095940|75970795|FG006|COMPLETED|Lapatinib Continuation/Phase II||0||
59845751|NCT00095940|75970796|FG007|COMPLETED|Lapatinib Continuation/Phase II||0||
59845752|NCT00095940|75970797|FG008|COMPLETED|Lapatinib Continuation/Phase II||1||
59845753|NCT00095940|75970789|FG000|NOT COMPLETED|Lapatinib Continuation/Phase II||2||
59845754|NCT00095940|75970790|FG001|NOT COMPLETED|Lapatinib Continuation/Phase II||2||
59845755|NCT00095940|75970791|FG002|NOT COMPLETED|Lapatinib Continuation/Phase II||16||
59845756|NCT00095940|75970792|FG003|NOT COMPLETED|Lapatinib Continuation/Phase II||0||
59845757|NCT00095940|75970793|FG004|NOT COMPLETED|Lapatinib Continuation/Phase II||0||
59845758|NCT00095940|75970794|FG005|NOT COMPLETED|Lapatinib Continuation/Phase II||13||
59845759|NCT00095940|75970795|FG006|NOT COMPLETED|Lapatinib Continuation/Phase II||2||
59845760|NCT00095940|75970796|FG007|NOT COMPLETED|Lapatinib Continuation/Phase II||2||
59845761|NCT00095940|75970797|FG008|NOT COMPLETED|Lapatinib Continuation/Phase II||13||
59845762|NCT00114218|75970815|FG000|STARTED|Overall Study||28||
59845763|NCT00114218|75970815|FG000|COMPLETED|Overall Study||24||
59845764|NCT00114218|75970815|FG000|NOT COMPLETED|Overall Study||4||
59845765|NCT00095628|75970819|FG000|STARTED|Overall Study||21||
59845766|NCT00095628|75970819|FG000|COMPLETED|Overall Study||20||
59845767|NCT00095628|75970819|FG000|NOT COMPLETED|Overall Study||1||
59845768|NCT04380142|75970825|FG000|STARTED|LD/CD Stabilization Period||174||
59845769|NCT04380142|75970826|FG001|STARTED|LD/CD Stabilization Period||0||
59845770|NCT04380142|75970827|FG002|STARTED|LD/CD Stabilization Period||0||
59845771|NCT04380142|75970825|FG000|COMPLETED|LD/CD Stabilization Period||145||
59845772|NCT04380142|75970826|FG001|COMPLETED|LD/CD Stabilization Period||0||
59845773|NCT04380142|75970827|FG002|COMPLETED|LD/CD Stabilization Period||0||
59845774|NCT04380142|75970825|FG000|NOT COMPLETED|LD/CD Stabilization Period||29||
59845775|NCT04380142|75970826|FG001|NOT COMPLETED|LD/CD Stabilization Period||0||
59845776|NCT04380142|75970827|FG002|NOT COMPLETED|LD/CD Stabilization Period||0||
59845777|NCT04380142|75970825|FG000|STARTED|Double-Blind Treatment Period||0|Number Randomized|
59845778|NCT04380142|75970826|FG001|STARTED|Double-Blind Treatment Period||69|Number Randomized|
59845779|NCT04380142|75970827|FG002|STARTED|Double-Blind Treatment Period||76|Number Randomized|
59845780|NCT04380142|75970825|FG000|Randomized and Treated|Double-Blind Treatment Period||0||
59845781|NCT04380142|75970826|FG001|Randomized and Treated|Double-Blind Treatment Period||67||
59845782|NCT04380142|75970827|FG002|Randomized and Treated|Double-Blind Treatment Period||74||
59845783|NCT04380142|75970825|FG000|COMPLETED|Double-Blind Treatment Period||0||
59845784|NCT04380142|75970826|FG001|COMPLETED|Double-Blind Treatment Period||62||
59845785|NCT04380142|75970827|FG002|COMPLETED|Double-Blind Treatment Period||48||
59845786|NCT04380142|75970825|FG000|NOT COMPLETED|Double-Blind Treatment Period||0||
59845787|NCT04380142|75970826|FG001|NOT COMPLETED|Double-Blind Treatment Period||7||
59845788|NCT04380142|75970827|FG002|NOT COMPLETED|Double-Blind Treatment Period||28||
59845789|NCT04335136|75970837|FG000|STARTED|Overall Study||91|Patients randomized.|
59845790|NCT04335136|75970838|FG001|STARTED|Overall Study||90|Patients randomized.|
59845791|NCT04335136|75970837|FG000|Treated|Overall Study||88||
59845792|NCT04335136|75970838|FG001|Treated|Overall Study||90||
59845793|NCT04335136|75970837|FG000|COMPLETED|Overall Study||77||
59845794|NCT04335136|75970838|FG001|COMPLETED|Overall Study||83||
59845795|NCT04335136|75970837|FG000|NOT COMPLETED|Overall Study||14||
59845796|NCT04335136|75970838|FG001|NOT COMPLETED|Overall Study||7||
59845797|NCT04171414|75970844|FG000|STARTED|Overall Study||62||
59845798|NCT04171414|75970844|FG000|COMPLETED|Overall Study||60||
59845799|NCT04171414|75970844|FG000|NOT COMPLETED|Overall Study||2||
59845800|NCT04167670|75970851|FG000|STARTED|Overall Study||349||
59845801|NCT04167670|75970852|FG001|STARTED|Overall Study||349||
59845802|NCT04167670|75970853|FG002|STARTED|Overall Study||348||
59845803|NCT04167670|75970851|FG000|Received Study Drugs|Overall Study||348||
59845804|NCT04167670|75970852|FG001|Received Study Drugs|Overall Study||346||
59845805|NCT04167670|75970853|FG002|Received Study Drugs|Overall Study||345||
59845806|NCT04167670|75970851|FG000|COMPLETED|Overall Study||334||
59845807|NCT04167670|75970852|FG001|COMPLETED|Overall Study||331||
59845808|NCT04167670|75970853|FG002|COMPLETED|Overall Study||334||
59845809|NCT04167670|75970851|FG000|NOT COMPLETED|Overall Study||15||
59845810|NCT04167670|75970852|FG001|NOT COMPLETED|Overall Study||18||
59845811|NCT04167670|75970853|FG002|NOT COMPLETED|Overall Study||14||
59845812|NCT00113516|75970861|FG000|STARTED|Part 1||84||
59845813|NCT00113516|75970862|FG001|STARTED|Part 1||0||
59845814|NCT00113516|75970861|FG000|COMPLETED|Part 1|66 subjects continued into Part 2 of the study.|0||
59845815|NCT00113516|75970862|FG001|COMPLETED|Part 1||0||
59845816|NCT00113516|75970861|FG000|NOT COMPLETED|Part 1||84||
59845817|NCT00113516|75970862|FG001|NOT COMPLETED|Part 1||0||
59845818|NCT00113516|75970861|FG000|STARTED|Part 2||0||
59845819|NCT00113516|75970862|FG001|STARTED|Part 2||66||
59845820|NCT00113516|75970861|FG000|COMPLETED|Part 2||0||
59845821|NCT00113516|75970862|FG001|COMPLETED|Part 2||0||
59845822|NCT00113516|75970861|FG000|NOT COMPLETED|Part 2||0||
59845823|NCT00113516|75970862|FG001|NOT COMPLETED|Part 2||66||
59845824|NCT03251326|75970868|FG000|STARTED|Overall Study||1||
59845825|NCT03251326|75970869|FG001|STARTED|Overall Study||1||
59845826|NCT03251326|75970870|FG002|STARTED|Overall Study||1||
59845827|NCT03251326|75970871|FG003|STARTED|Overall Study||1||
59845828|NCT03251326|75970868|FG000|COMPLETED|Overall Study||1||
59845829|NCT03251326|75970869|FG001|COMPLETED|Overall Study||1||
59845830|NCT03251326|75970870|FG002|COMPLETED|Overall Study||0||
59845831|NCT03251326|75970871|FG003|COMPLETED|Overall Study||0||
59845832|NCT03251326|75970868|FG000|NOT COMPLETED|Overall Study||0||
59845833|NCT03251326|75970869|FG001|NOT COMPLETED|Overall Study||0||
59845834|NCT03251326|75970870|FG002|NOT COMPLETED|Overall Study||1||
59845835|NCT03251326|75970871|FG003|NOT COMPLETED|Overall Study||1||
59845836|NCT04140292|75970883|FG000|STARTED|Overall Study||33||
59845837|NCT04140292|75970884|FG001|STARTED|Overall Study||42||
59845838|NCT04140292|75970883|FG000|COMPLETED|Overall Study||29||
59845839|NCT04140292|75970884|FG001|COMPLETED|Overall Study||26||
59845840|NCT04140292|75970883|FG000|NOT COMPLETED|Overall Study||4||
59845841|NCT04140292|75970884|FG001|NOT COMPLETED|Overall Study||16||
59845842|NCT04138810|75970893|FG000|STARTED|Overall Study||27||
59845843|NCT04138810|75970894|FG001|STARTED|Overall Study||27||
59845844|NCT04138810|75970893|FG000|COMPLETED|Overall Study||26||
59845845|NCT04138810|75970894|FG001|COMPLETED|Overall Study||26||
59845846|NCT04138810|75970893|FG000|NOT COMPLETED|Overall Study||1||
59845847|NCT04138810|75970894|FG001|NOT COMPLETED|Overall Study||1||
59845848|NCT00127166|75970902|FG000|STARTED|Period I||78||
59845849|NCT00127166|75970903|FG001|STARTED|Period I||76||
59845850|NCT00127166|75970902|FG000|COMPLETED|Period I||75||
59845851|NCT00127166|75970903|FG001|COMPLETED|Period I||74||
59845852|NCT00127166|75970902|FG000|NOT COMPLETED|Period I||3||
59845853|NCT00127166|75970903|FG001|NOT COMPLETED|Period I||2||
59845854|NCT00127166|75970902|FG000|STARTED|Washout Period||75||
59845855|NCT00127166|75970903|FG001|STARTED|Washout Period||74||
59845856|NCT00127166|75970902|FG000|COMPLETED|Washout Period||75||
59845857|NCT00127166|75970903|FG001|COMPLETED|Washout Period||73||
59845858|NCT00127166|75970902|FG000|NOT COMPLETED|Washout Period||0||
59845859|NCT00127166|75970903|FG001|NOT COMPLETED|Washout Period||1||
59845860|NCT00127166|75970902|FG000|STARTED|Period II||75||
59845861|NCT00127166|75970903|FG001|STARTED|Period II||73||
59845862|NCT00127166|75970902|FG000|COMPLETED|Period II||72||
59845863|NCT00127166|75970903|FG001|COMPLETED|Period II||73||
59845864|NCT00127166|75970902|FG000|NOT COMPLETED|Period II||3||
59845865|NCT00127166|75970903|FG001|NOT COMPLETED|Period II||0||
59845866|NCT00125138|75970913|FG000|STARTED|Overall Study||15||
59719743|NCT00887224|75838902|FG002|NOT COMPLETED|DB Taper Phase / Post Study Follow Up||30||
59719744|NCT01109316|75838920|FG000|STARTED|Study Period 1||22||
59719745|NCT01109316|75838921|FG001|STARTED|Study Period 1||22||
59719746|NCT01109316|75838922|FG002|STARTED|Study Period 1||22||
59719747|NCT01109316|75838923|FG003|STARTED|Study Period 1||22||
59845867|NCT00125138|75970914|FG001|STARTED|Overall Study|One subject requested withdrawal prior to treatment; data for the subject are excluded from results.|20||
59845868|NCT00125138|75970915|FG002|STARTED|Overall Study||25||
59845869|NCT00125138|75970916|FG003|STARTED|Overall Study||30||
59845870|NCT00125138|75970913|FG000|COMPLETED|Overall Study||12||
59845871|NCT00125138|75970914|FG001|COMPLETED|Overall Study||17||
59845872|NCT00125138|75970915|FG002|COMPLETED|Overall Study||21||
59845873|NCT00125138|75970916|FG003|COMPLETED|Overall Study||25||
59845874|NCT00125138|75970913|FG000|NOT COMPLETED|Overall Study||3||
59845875|NCT00125138|75970914|FG001|NOT COMPLETED|Overall Study||3||
59845876|NCT00125138|75970915|FG002|NOT COMPLETED|Overall Study||4||
59845877|NCT00125138|75970916|FG003|NOT COMPLETED|Overall Study||5||
59845878|NCT04132336|75970933|FG000|STARTED|Overall Study||32||
59845879|NCT04132336|75970934|FG001|STARTED|Overall Study||32||
59845880|NCT04132336|75970935|FG002|STARTED|Overall Study||32||
59719748|NCT01109316|75838924|FG004|STARTED|Study Period 1||22||
59719749|NCT01109316|75838925|FG005|STARTED|Study Period 1||22||
59719750|NCT01109316|75838920|FG000|Received at Least One Dose of Study Drug|Study Period 1||22||
59845881|NCT04132336|75970936|FG003|STARTED|Overall Study||32||
59845882|NCT04132336|75970937|FG004|STARTED|Overall Study||32||
59845883|NCT04132336|75970938|FG005|STARTED|Overall Study||16||
59845884|NCT04132336|75970939|FG006|STARTED|Overall Study||17||
59845885|NCT04132336|75970933|FG000|COMPLETED|Overall Study||32||
59845886|NCT04132336|75970934|FG001|COMPLETED|Overall Study||31||
59845887|NCT04132336|75970935|FG002|COMPLETED|Overall Study||32||
59845888|NCT04132336|75970936|FG003|COMPLETED|Overall Study||32||
59845889|NCT04132336|75970937|FG004|COMPLETED|Overall Study||32||
59845890|NCT04132336|75970938|FG005|COMPLETED|Overall Study||16||
59845891|NCT04132336|75970939|FG006|COMPLETED|Overall Study||17||
59845892|NCT04132336|75970933|FG000|NOT COMPLETED|Overall Study||0||
59845893|NCT04132336|75970934|FG001|NOT COMPLETED|Overall Study||1||
59845894|NCT04132336|75970935|FG002|NOT COMPLETED|Overall Study||0||
59845895|NCT04132336|75970936|FG003|NOT COMPLETED|Overall Study||0||
59845896|NCT04132336|75970937|FG004|NOT COMPLETED|Overall Study||0||
59845897|NCT04132336|75970938|FG005|NOT COMPLETED|Overall Study||0||
59845898|NCT04132336|75970939|FG006|NOT COMPLETED|Overall Study||0||
59845899|NCT04131556|75970955|FG000|STARTED|Overall Study||20||
59845900|NCT04131556|75970955|FG000|COMPLETED|Overall Study||18||
59845901|NCT04131556|75970955|FG000|NOT COMPLETED|Overall Study||2||
59845902|NCT04295356|75970964|FG000|STARTED|Overall Study||93||
59845903|NCT04295356|75970965|FG001|STARTED|Overall Study||87||
59845904|NCT04295356|75970964|FG000|COMPLETED|Overall Study||92||
59845905|NCT04295356|75970965|FG001|COMPLETED|Overall Study||83||
59845906|NCT04295356|75970964|FG000|NOT COMPLETED|Overall Study||1||
59845907|NCT04295356|75970965|FG001|NOT COMPLETED|Overall Study||4||
59845908|NCT03691948|75970973|FG000|STARTED|Overall Study||27||
59845909|NCT03691948|75970974|FG001|STARTED|Overall Study||33||
59845910|NCT03691948|75970973|FG000|COMPLETED|Overall Study||26||
59845911|NCT03691948|75970974|FG001|COMPLETED|Overall Study||30||
59845912|NCT03691948|75970973|FG000|NOT COMPLETED|Overall Study||1||
59845913|NCT03691948|75970974|FG001|NOT COMPLETED|Overall Study||3||
59845914|NCT04126174|75970981|FG000|STARTED|Overall Study||41||41
59845915|NCT04126174|75970982|FG001|STARTED|Overall Study||41||41
59845916|NCT04126174|75970981|FG000|COMPLETED|Overall Study||38||38
59845917|NCT04126174|75970982|FG001|COMPLETED|Overall Study||38||38
59845918|NCT04126174|75970981|FG000|NOT COMPLETED|Overall Study||3||3
59845919|NCT04126174|75970982|FG001|NOT COMPLETED|Overall Study||3||3
59845920|NCT04124926|75970990|FG000|STARTED|Healing Phase||514||
59845921|NCT04124926|75970991|FG001|STARTED|Healing Phase||513||
59845922|NCT04124926|75970992|FG002|STARTED|Healing Phase||0||
59845923|NCT04124926|75970993|FG003|STARTED|Healing Phase||0||
59845924|NCT04124926|75970994|FG004|STARTED|Healing Phase||0||
59845925|NCT04124926|75970990|FG000|Treated With Study Drug|Healing Phase||514||
59845926|NCT04124926|75970991|FG001|Treated With Study Drug|Healing Phase||510||
59845927|NCT04124926|75970992|FG002|Treated With Study Drug|Healing Phase||0||
59845928|NCT04124926|75970993|FG003|Treated With Study Drug|Healing Phase||0||
59845929|NCT04124926|75970994|FG004|Treated With Study Drug|Healing Phase||0||
59845930|NCT04124926|75970990|FG000|COMPLETED|Healing Phase||483||
59845931|NCT04124926|75970991|FG001|COMPLETED|Healing Phase||481||
59845932|NCT04124926|75970992|FG002|COMPLETED|Healing Phase||0||
59845933|NCT04124926|75970993|FG003|COMPLETED|Healing Phase||0||
59845934|NCT04124926|75970994|FG004|COMPLETED|Healing Phase||0||
59845935|NCT04124926|75970990|FG000|NOT COMPLETED|Healing Phase||31||
59845936|NCT04124926|75970991|FG001|NOT COMPLETED|Healing Phase||32||
59845937|NCT04124926|75970992|FG002|NOT COMPLETED|Healing Phase||0||
59845938|NCT04124926|75970993|FG003|NOT COMPLETED|Healing Phase||0||
59845939|NCT04124926|75970994|FG004|NOT COMPLETED|Healing Phase||0||
59845940|NCT04124926|75970990|FG000|STARTED|Maintenance Phase||0|Re-randomized.|
59845941|NCT04124926|75970991|FG001|STARTED|Maintenance Phase||0|Re-randomized.|
59845942|NCT04124926|75970992|FG002|STARTED|Maintenance Phase||298|Re-randomized.|
59845943|NCT04124926|75970993|FG003|STARTED|Maintenance Phase||298|Re-randomized.|
59845944|NCT04124926|75970994|FG004|STARTED|Maintenance Phase||297|Re-randomized.|
59845945|NCT04124926|75970990|FG000|Treated With Study Drug|Maintenance Phase||0||
59845946|NCT04124926|75970991|FG001|Treated With Study Drug|Maintenance Phase||0||
59845947|NCT04124926|75970992|FG002|Treated With Study Drug|Maintenance Phase||296||
59845948|NCT04124926|75970993|FG003|Treated With Study Drug|Maintenance Phase||296||
59845949|NCT04124926|75970994|FG004|Treated With Study Drug|Maintenance Phase||297||
59845950|NCT04124926|75970990|FG000|COMPLETED|Maintenance Phase||0||
59845951|NCT04124926|75970991|FG001|COMPLETED|Maintenance Phase||0||
59845952|NCT04124926|75970992|FG002|COMPLETED|Maintenance Phase||274||
59845953|NCT04124926|75970993|FG003|COMPLETED|Maintenance Phase||269||
59845954|NCT04124926|75970994|FG004|COMPLETED|Maintenance Phase||269||
59845955|NCT04124926|75970990|FG000|NOT COMPLETED|Maintenance Phase||0||
59845956|NCT04124926|75970991|FG001|NOT COMPLETED|Maintenance Phase||0||
59845957|NCT04124926|75970992|FG002|NOT COMPLETED|Maintenance Phase||24||
59845958|NCT04124926|75970993|FG003|NOT COMPLETED|Maintenance Phase||29||
59845959|NCT04124926|75970994|FG004|NOT COMPLETED|Maintenance Phase||28||
59845960|NCT04274686|75971006|FG000|STARTED|Overall Study||13||
59845961|NCT04274686|75971007|FG001|STARTED|Overall Study||12||
59845962|NCT04274686|75971006|FG000|COMPLETED|Overall Study||12||
59845963|NCT04274686|75971007|FG001|COMPLETED|Overall Study||12||
59845964|NCT04274686|75971006|FG000|NOT COMPLETED|Overall Study||1||
59845965|NCT04274686|75971007|FG001|NOT COMPLETED|Overall Study||0||
59845966|NCT04113694|75971015|FG000|STARTED|Overall Study||259||
59845967|NCT04113694|75971015|FG000|COMPLETED|Overall Study||248||
59845968|NCT04113694|75971015|FG000|NOT COMPLETED|Overall Study||11||
59845969|NCT04105972|75971024|FG000|STARTED|Overall Study||88||
59845970|NCT04105972|75971025|FG001|STARTED|Overall Study||87||
59845971|NCT04105972|75971024|FG000|COMPLETED|Overall Study||86||
59845972|NCT04105972|75971025|FG001|COMPLETED|Overall Study||86||
59845973|NCT04105972|75971024|FG000|NOT COMPLETED|Overall Study||2||
59845974|NCT04105972|75971025|FG001|NOT COMPLETED|Overall Study||1||
59845975|NCT04102540|75971031|FG000|STARTED|Overall Study||32||
59845976|NCT04102540|75971031|FG000|COMPLETED|Overall Study||24||
59845977|NCT04102540|75971031|FG000|NOT COMPLETED|Overall Study||8||
59845978|NCT00124982|75971037|FG000|STARTED|Short-term Period||449||
59845979|NCT00124982|75971038|FG001|STARTED|Short-term Period||597||
59845980|NCT00124982|75971039|FG002|STARTED|Short-term Period||0||
59845981|NCT00124982|75971037|FG000|COMPLETED|Short-term Period||377||
59845982|NCT00124982|75971038|FG001|COMPLETED|Short-term Period||483||
59845983|NCT00124982|75971039|FG002|COMPLETED|Short-term Period||0||
59845984|NCT00124982|75971037|FG000|NOT COMPLETED|Short-term Period||72||
59845985|NCT00124982|75971038|FG001|NOT COMPLETED|Short-term Period||114||
59845986|NCT00124982|75971039|FG002|NOT COMPLETED|Short-term Period||0||
59845987|NCT00124982|75971037|FG000|STARTED|Long-term Period||0||
59845988|NCT00124982|75971038|FG001|STARTED|Long-term Period||0||
59845989|NCT00124982|75971039|FG002|STARTED|Long-term Period|A large number did not continue due to a rollover from study drug to commercially available drug.|530||
59845990|NCT00124982|75971037|FG000|COMPLETED|Long-term Period||0||
59845991|NCT00124982|75971038|FG001|COMPLETED|Long-term Period||0||
59845992|NCT00124982|75971039|FG002|COMPLETED|Long-term Period||441||
59845993|NCT00124982|75971037|FG000|NOT COMPLETED|Long-term Period||0||
59845994|NCT00124982|75971038|FG001|NOT COMPLETED|Long-term Period||0||
59845995|NCT00124982|75971039|FG002|NOT COMPLETED|Long-term Period||89||
59845996|NCT04263142|75971053|FG000|STARTED|Part 1 Period 1 (Day 1)||9||
59845997|NCT04263142|75971054|FG001|STARTED|Part 1 Period 1 (Day 1)||9||
59845998|NCT04263142|75971055|FG002|STARTED|Part 1 Period 1 (Day 1)||0||
59845999|NCT04263142|75971056|FG003|STARTED|Part 1 Period 1 (Day 1)||0||
59846000|NCT04263142|75971057|FG004|STARTED|Part 1 Period 1 (Day 1)||0||
59846001|NCT04263142|75971053|FG000|COMPLETED|Part 1 Period 1 (Day 1)||9||
59846002|NCT04263142|75971054|FG001|COMPLETED|Part 1 Period 1 (Day 1)||9||
59846003|NCT04263142|75971055|FG002|COMPLETED|Part 1 Period 1 (Day 1)||0||
59846004|NCT04263142|75971056|FG003|COMPLETED|Part 1 Period 1 (Day 1)||0||
59846005|NCT04263142|75971057|FG004|COMPLETED|Part 1 Period 1 (Day 1)||0||
59846006|NCT04263142|75971053|FG000|NOT COMPLETED|Part 1 Period 1 (Day 1)||0||
59846007|NCT04263142|75971054|FG001|NOT COMPLETED|Part 1 Period 1 (Day 1)||0||
59846008|NCT04263142|75971055|FG002|NOT COMPLETED|Part 1 Period 1 (Day 1)||0||
59846009|NCT04263142|75971056|FG003|NOT COMPLETED|Part 1 Period 1 (Day 1)||0||
59846010|NCT04263142|75971057|FG004|NOT COMPLETED|Part 1 Period 1 (Day 1)||0||
59846011|NCT04263142|75971053|FG000|STARTED|Part 1 Period 2 (Up to Day 5)||9||
59846012|NCT04263142|75971054|FG001|STARTED|Part 1 Period 2 (Up to Day 5)||9||
59846013|NCT04263142|75971055|FG002|STARTED|Part 1 Period 2 (Up to Day 5)||0||
59846014|NCT04263142|75971056|FG003|STARTED|Part 1 Period 2 (Up to Day 5)||0||
59846015|NCT04263142|75971057|FG004|STARTED|Part 1 Period 2 (Up to Day 5)||0||
59846016|NCT04263142|75971053|FG000|COMPLETED|Part 1 Period 2 (Up to Day 5)||9||
59846017|NCT04263142|75971054|FG001|COMPLETED|Part 1 Period 2 (Up to Day 5)||9||
59846018|NCT04263142|75971055|FG002|COMPLETED|Part 1 Period 2 (Up to Day 5)||0||
59846019|NCT04263142|75971056|FG003|COMPLETED|Part 1 Period 2 (Up to Day 5)||0||
59846020|NCT04263142|75971057|FG004|COMPLETED|Part 1 Period 2 (Up to Day 5)||0||
59846021|NCT04263142|75971053|FG000|NOT COMPLETED|Part 1 Period 2 (Up to Day 5)||0||
59846022|NCT04263142|75971054|FG001|NOT COMPLETED|Part 1 Period 2 (Up to Day 5)||0||
59846023|NCT04263142|75971055|FG002|NOT COMPLETED|Part 1 Period 2 (Up to Day 5)||0||
59846024|NCT04263142|75971056|FG003|NOT COMPLETED|Part 1 Period 2 (Up to Day 5)||0||
59846025|NCT04263142|75971057|FG004|NOT COMPLETED|Part 1 Period 2 (Up to Day 5)||0||
59846026|NCT04263142|75971053|FG000|STARTED|Part 2 Period 1 (Day 1)||0||
59846027|NCT04263142|75971054|FG001|STARTED|Part 2 Period 1 (Day 1)||0||
59846028|NCT04263142|75971055|FG002|STARTED|Part 2 Period 1 (Day 1)||7||
59846029|NCT04263142|75971056|FG003|STARTED|Part 2 Period 1 (Day 1)||7||
59846030|NCT04263142|75971057|FG004|STARTED|Part 2 Period 1 (Day 1)||7||
59846031|NCT04263142|75971053|FG000|COMPLETED|Part 2 Period 1 (Day 1)||0||
59846032|NCT04263142|75971054|FG001|COMPLETED|Part 2 Period 1 (Day 1)||0||
59846033|NCT04263142|75971055|FG002|COMPLETED|Part 2 Period 1 (Day 1)||7||
59996674|NCT02714569|76112506|FG003|COMPLETED|Part A Fourth Intervention||2||
59996675|NCT02714569|76112507|FG004|COMPLETED|Part A Fourth Intervention||3||
59996676|NCT02714569|76112508|FG005|COMPLETED|Part A Fourth Intervention||2||
59996677|NCT02714569|76112509|FG006|COMPLETED|Part A Fourth Intervention||0||
59846034|NCT04263142|75971056|FG003|COMPLETED|Part 2 Period 1 (Day 1)||7||
59846035|NCT04263142|75971057|FG004|COMPLETED|Part 2 Period 1 (Day 1)||6||
59846036|NCT04263142|75971053|FG000|NOT COMPLETED|Part 2 Period 1 (Day 1)||0||
59846037|NCT04263142|75971054|FG001|NOT COMPLETED|Part 2 Period 1 (Day 1)||0||
59996678|NCT02714569|76112510|FG007|COMPLETED|Part A Fourth Intervention||0||
59996679|NCT02714569|76112511|FG008|COMPLETED|Part A Fourth Intervention||0||
59996680|NCT02714569|76112512|FG009|COMPLETED|Part A Fourth Intervention||0||
59996681|NCT02714569|76112513|FG010|COMPLETED|Part A Fourth Intervention||0||
59996682|NCT02714569|76112503|FG000|NOT COMPLETED|Part A Fourth Intervention||1||
59996683|NCT02714569|76112504|FG001|NOT COMPLETED|Part A Fourth Intervention||0||
59846038|NCT04263142|75971055|FG002|NOT COMPLETED|Part 2 Period 1 (Day 1)||0||
59846039|NCT04263142|75971056|FG003|NOT COMPLETED|Part 2 Period 1 (Day 1)||0||
59719751|NCT01109316|75838921|FG001|Received at Least One Dose of Study Drug|Study Period 1||22||
59719752|NCT01109316|75838922|FG002|Received at Least One Dose of Study Drug|Study Period 1||22||
59719753|NCT01109316|75838923|FG003|Received at Least One Dose of Study Drug|Study Period 1||22||
59719754|NCT01109316|75838924|FG004|Received at Least One Dose of Study Drug|Study Period 1||22||
59719755|NCT01109316|75838925|FG005|Received at Least One Dose of Study Drug|Study Period 1||20||
59846040|NCT04263142|75971057|FG004|NOT COMPLETED|Part 2 Period 1 (Day 1)||1||
59846041|NCT04263142|75971053|FG000|STARTED|Part 2 Period 2 (Day 1)||0||
59846042|NCT04263142|75971054|FG001|STARTED|Part 2 Period 2 (Day 1)||0||
59846043|NCT04263142|75971055|FG002|STARTED|Part 2 Period 2 (Day 1)||7||
59846044|NCT04263142|75971056|FG003|STARTED|Part 2 Period 2 (Day 1)||7||
59846045|NCT04263142|75971057|FG004|STARTED|Part 2 Period 2 (Day 1)||6||
59846046|NCT04263142|75971053|FG000|COMPLETED|Part 2 Period 2 (Day 1)||0||
59846047|NCT04263142|75971054|FG001|COMPLETED|Part 2 Period 2 (Day 1)||0||
59846048|NCT04263142|75971055|FG002|COMPLETED|Part 2 Period 2 (Day 1)||7||
59846049|NCT04263142|75971056|FG003|COMPLETED|Part 2 Period 2 (Day 1)||7||
59846050|NCT04263142|75971057|FG004|COMPLETED|Part 2 Period 2 (Day 1)||5||
59846051|NCT04263142|75971053|FG000|NOT COMPLETED|Part 2 Period 2 (Day 1)||0||
59846052|NCT04263142|75971054|FG001|NOT COMPLETED|Part 2 Period 2 (Day 1)||0||
59846053|NCT04263142|75971055|FG002|NOT COMPLETED|Part 2 Period 2 (Day 1)||0||
59846054|NCT04263142|75971056|FG003|NOT COMPLETED|Part 2 Period 2 (Day 1)||0||
59846055|NCT04263142|75971057|FG004|NOT COMPLETED|Part 2 Period 2 (Day 1)||1||
59846056|NCT04263142|75971053|FG000|STARTED|Part 2 Period 3 (Up to Day 5)||0||
59846057|NCT04263142|75971054|FG001|STARTED|Part 2 Period 3 (Up to Day 5)||0||
59846058|NCT04263142|75971055|FG002|STARTED|Part 2 Period 3 (Up to Day 5)||7||
59846059|NCT04263142|75971056|FG003|STARTED|Part 2 Period 3 (Up to Day 5)||7||
59846060|NCT04263142|75971057|FG004|STARTED|Part 2 Period 3 (Up to Day 5)||5||
59846061|NCT04263142|75971053|FG000|COMPLETED|Part 2 Period 3 (Up to Day 5)||0||
59846062|NCT04263142|75971054|FG001|COMPLETED|Part 2 Period 3 (Up to Day 5)||0||
59846063|NCT04263142|75971055|FG002|COMPLETED|Part 2 Period 3 (Up to Day 5)||7||
59846064|NCT04263142|75971056|FG003|COMPLETED|Part 2 Period 3 (Up to Day 5)||7||
59846065|NCT04263142|75971057|FG004|COMPLETED|Part 2 Period 3 (Up to Day 5)||5||
59846066|NCT04263142|75971053|FG000|NOT COMPLETED|Part 2 Period 3 (Up to Day 5)||0||
59846067|NCT04263142|75971054|FG001|NOT COMPLETED|Part 2 Period 3 (Up to Day 5)||0||
59846068|NCT04263142|75971055|FG002|NOT COMPLETED|Part 2 Period 3 (Up to Day 5)||0||
59846069|NCT04263142|75971056|FG003|NOT COMPLETED|Part 2 Period 3 (Up to Day 5)||0||
59846070|NCT04263142|75971057|FG004|NOT COMPLETED|Part 2 Period 3 (Up to Day 5)||0||
59846071|NCT04095286|75971070|FG000|STARTED|Period 1 (4 Days) + Washout (7days)||4||
59846072|NCT04095286|75971071|FG001|STARTED|Period 1 (4 Days) + Washout (7days)||5||
59846073|NCT04095286|75971072|FG002|STARTED|Period 1 (4 Days) + Washout (7days)||5||
59846074|NCT04095286|75971073|FG003|STARTED|Period 1 (4 Days) + Washout (7days)||5||
59846075|NCT04095286|75971074|FG004|STARTED|Period 1 (4 Days) + Washout (7days)||5||
59846076|NCT04095286|75971075|FG005|STARTED|Period 1 (4 Days) + Washout (7days)||5||
59846077|NCT04095286|75971070|FG000|COMPLETED|Period 1 (4 Days) + Washout (7days)||3||
59719756|NCT01109316|75838920|FG000|COMPLETED|Study Period 1||22||
59719757|NCT01109316|75838921|FG001|COMPLETED|Study Period 1||22||
59719758|NCT01109316|75838922|FG002|COMPLETED|Study Period 1||19||
59846078|NCT04095286|75971071|FG001|COMPLETED|Period 1 (4 Days) + Washout (7days)||4||
59719759|NCT01109316|75838923|FG003|COMPLETED|Study Period 1||21||
59719760|NCT01109316|75838924|FG004|COMPLETED|Study Period 1||20||
59719761|NCT01109316|75838925|FG005|COMPLETED|Study Period 1||20||
59719762|NCT01109316|75838920|FG000|NOT COMPLETED|Study Period 1||0||
59719763|NCT01109316|75838921|FG001|NOT COMPLETED|Study Period 1||0||
59846079|NCT04095286|75971072|FG002|COMPLETED|Period 1 (4 Days) + Washout (7days)||4||
59846080|NCT04095286|75971073|FG003|COMPLETED|Period 1 (4 Days) + Washout (7days)||5||
59567906|NCT02280122|75670777|FG001|NOT COMPLETED|Overall Study||0||
59567907|NCT02280122|75670778|FG002|NOT COMPLETED|Overall Study||0||
59567908|NCT02296476|75670787|FG000|STARTED|Overall Study||6||
59567909|NCT02296476|75670788|FG001|STARTED|Overall Study||4||
59567910|NCT02296476|75670789|FG002|STARTED|Overall Study||2||
59567911|NCT02296476|75670787|FG000|COMPLETED|Overall Study||0||
59567912|NCT02296476|75670788|FG001|COMPLETED|Overall Study||0||
59567913|NCT02296476|75670789|FG002|COMPLETED|Overall Study||0||
59719764|NCT01109316|75838922|FG002|NOT COMPLETED|Study Period 1||3||
59719765|NCT01109316|75838923|FG003|NOT COMPLETED|Study Period 1||1||
59719766|NCT01109316|75838924|FG004|NOT COMPLETED|Study Period 1||2||
59846081|NCT04095286|75971074|FG004|COMPLETED|Period 1 (4 Days) + Washout (7days)||5||
59846082|NCT04095286|75971075|FG005|COMPLETED|Period 1 (4 Days) + Washout (7days)||5||
59846083|NCT04095286|75971070|FG000|NOT COMPLETED|Period 1 (4 Days) + Washout (7days)||1||
59846084|NCT04095286|75971071|FG001|NOT COMPLETED|Period 1 (4 Days) + Washout (7days)||1||
59846085|NCT04095286|75971072|FG002|NOT COMPLETED|Period 1 (4 Days) + Washout (7days)||1||
59846086|NCT04095286|75971073|FG003|NOT COMPLETED|Period 1 (4 Days) + Washout (7days)||0||
59846087|NCT04095286|75971074|FG004|NOT COMPLETED|Period 1 (4 Days) + Washout (7days)||0||
59846088|NCT04095286|75971075|FG005|NOT COMPLETED|Period 1 (4 Days) + Washout (7days)||0||
59567914|NCT02296476|75670787|FG000|NOT COMPLETED|Overall Study||6||
59846089|NCT04095286|75971070|FG000|STARTED|Period 2 (4 Days) + Washout (7days)||3||
59846090|NCT04095286|75971071|FG001|STARTED|Period 2 (4 Days) + Washout (7days)||4||
59846091|NCT04095286|75971072|FG002|STARTED|Period 2 (4 Days) + Washout (7days)||4||
59846092|NCT04095286|75971073|FG003|STARTED|Period 2 (4 Days) + Washout (7days)||5||
59846093|NCT04095286|75971074|FG004|STARTED|Period 2 (4 Days) + Washout (7days)||5||
59846094|NCT04095286|75971075|FG005|STARTED|Period 2 (4 Days) + Washout (7days)||5||
59846095|NCT04095286|75971070|FG000|COMPLETED|Period 2 (4 Days) + Washout (7days)||3||
59846096|NCT04095286|75971071|FG001|COMPLETED|Period 2 (4 Days) + Washout (7days)||4||
59846097|NCT04095286|75971072|FG002|COMPLETED|Period 2 (4 Days) + Washout (7days)||2||
59846098|NCT04095286|75971073|FG003|COMPLETED|Period 2 (4 Days) + Washout (7days)||5||
59846099|NCT04095286|75971074|FG004|COMPLETED|Period 2 (4 Days) + Washout (7days)||4||
59846100|NCT04095286|75971075|FG005|COMPLETED|Period 2 (4 Days) + Washout (7days)||5||
59846101|NCT04095286|75971070|FG000|NOT COMPLETED|Period 2 (4 Days) + Washout (7days)||0||
59846102|NCT04095286|75971071|FG001|NOT COMPLETED|Period 2 (4 Days) + Washout (7days)||0||
59846103|NCT04095286|75971072|FG002|NOT COMPLETED|Period 2 (4 Days) + Washout (7days)||2||
59846104|NCT04095286|75971073|FG003|NOT COMPLETED|Period 2 (4 Days) + Washout (7days)||0||
59846105|NCT04095286|75971074|FG004|NOT COMPLETED|Period 2 (4 Days) + Washout (7days)||1||
59846106|NCT04095286|75971075|FG005|NOT COMPLETED|Period 2 (4 Days) + Washout (7days)||0||
59846107|NCT04095286|75971070|FG000|STARTED|Period 3 (4 Days) + Follow up (14 Days)||3||
59846108|NCT04095286|75971071|FG001|STARTED|Period 3 (4 Days) + Follow up (14 Days)||4||
59846109|NCT04095286|75971072|FG002|STARTED|Period 3 (4 Days) + Follow up (14 Days)||2||
59846110|NCT04095286|75971073|FG003|STARTED|Period 3 (4 Days) + Follow up (14 Days)||5||
59846111|NCT04095286|75971074|FG004|STARTED|Period 3 (4 Days) + Follow up (14 Days)||4||
59846112|NCT04095286|75971075|FG005|STARTED|Period 3 (4 Days) + Follow up (14 Days)||5||
59846113|NCT04095286|75971070|FG000|COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||3||
59846114|NCT04095286|75971071|FG001|COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||4||
59846115|NCT04095286|75971072|FG002|COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||2||
59846116|NCT04095286|75971073|FG003|COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||5||
59846117|NCT04095286|75971074|FG004|COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||4||
59846118|NCT04095286|75971075|FG005|COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||5||
59846119|NCT04095286|75971070|FG000|NOT COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||0||
59846120|NCT04095286|75971071|FG001|NOT COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||0||
59846121|NCT04095286|75971072|FG002|NOT COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||0||
59846122|NCT04095286|75971073|FG003|NOT COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||0||
59846123|NCT04095286|75971074|FG004|NOT COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||0||
59846124|NCT04095286|75971075|FG005|NOT COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||0||
59846125|NCT04093414|75971085|FG000|STARTED|3 Month Follow up||3||
59846126|NCT04093414|75971086|FG001|STARTED|3 Month Follow up||6||
59846127|NCT04093414|75971085|FG000|COMPLETED|3 Month Follow up||3||
59846128|NCT04093414|75971086|FG001|COMPLETED|3 Month Follow up||5||
59846129|NCT04093414|75971085|FG000|NOT COMPLETED|3 Month Follow up||0||
59846130|NCT04093414|75971086|FG001|NOT COMPLETED|3 Month Follow up||1||
59846131|NCT04093414|75971085|FG000|STARTED|6month Follow up||3||
59846132|NCT04093414|75971086|FG001|STARTED|6month Follow up||5||
59846133|NCT04093414|75971085|FG000|COMPLETED|6month Follow up||2||
59846134|NCT04093414|75971086|FG001|COMPLETED|6month Follow up||2||
59846135|NCT04093414|75971085|FG000|NOT COMPLETED|6month Follow up||1||
59846136|NCT04093414|75971086|FG001|NOT COMPLETED|6month Follow up||3||
59846137|NCT04093414|75971085|FG000|STARTED|12 Month Follow up||2||
59846138|NCT04093414|75971086|FG001|STARTED|12 Month Follow up||2||
59846139|NCT04093414|75971085|FG000|COMPLETED|12 Month Follow up||2||
59846140|NCT04093414|75971086|FG001|COMPLETED|12 Month Follow up||2||
59846141|NCT04093414|75971085|FG000|NOT COMPLETED|12 Month Follow up||0||
59846142|NCT04093414|75971086|FG001|NOT COMPLETED|12 Month Follow up||0||
59719767|NCT01109316|75838925|FG005|NOT COMPLETED|Study Period 1||2||
59719768|NCT01109316|75838920|FG000|STARTED|Study Period 2||22||
59719769|NCT01109316|75838921|FG001|STARTED|Study Period 2||22||
59719770|NCT01109316|75838922|FG002|STARTED|Study Period 2||19||
59719771|NCT01109316|75838923|FG003|STARTED|Study Period 2||21||
59719772|NCT01109316|75838924|FG004|STARTED|Study Period 2||20||
59719773|NCT01109316|75838925|FG005|STARTED|Study Period 2||20||
59719774|NCT01109316|75838920|FG000|COMPLETED|Study Period 2||21||
59719775|NCT01109316|75838921|FG001|COMPLETED|Study Period 2||21||
59719776|NCT01109316|75838922|FG002|COMPLETED|Study Period 2||18||
59719777|NCT01109316|75838923|FG003|COMPLETED|Study Period 2||20||
59719778|NCT01109316|75838924|FG004|COMPLETED|Study Period 2||20||
59719779|NCT01109316|75838925|FG005|COMPLETED|Study Period 2||19||
59846143|NCT04093258|75971092|FG000|STARTED|Period 1||21||
59846144|NCT04093258|75971093|FG001|STARTED|Period 1||20||
59719780|NCT01109316|75838920|FG000|NOT COMPLETED|Study Period 2||1||
59719781|NCT01109316|75838921|FG001|NOT COMPLETED|Study Period 2||1||
59719782|NCT01109316|75838922|FG002|NOT COMPLETED|Study Period 2||1||
59719783|NCT01109316|75838923|FG003|NOT COMPLETED|Study Period 2||1||
59719784|NCT01109316|75838924|FG004|NOT COMPLETED|Study Period 2||0||
59719785|NCT01109316|75838925|FG005|NOT COMPLETED|Study Period 2||1||
59719786|NCT01109316|75838920|FG000|STARTED|Study Period 3||21||
59719787|NCT01109316|75838921|FG001|STARTED|Study Period 3||21||
59846145|NCT04093258|75971092|FG000|COMPLETED|Period 1||21||
59846146|NCT04093258|75971093|FG001|COMPLETED|Period 1||20||
59846147|NCT04093258|75971092|FG000|NOT COMPLETED|Period 1||0||
59846148|NCT04093258|75971093|FG001|NOT COMPLETED|Period 1||0||
59846149|NCT04093258|75971092|FG000|STARTED|Period 2||21||
59846150|NCT04093258|75971093|FG001|STARTED|Period 2||20||
60120305|NCT01695239|76241397|FG007|STARTED|Post-Treatment Follow-Up Period||0||
60120306|NCT01695239|76241398|FG008|STARTED|Post-Treatment Follow-Up Period|Only included post-treatment follow-up participants.|0||
60120307|NCT01695239|76241399|FG009|STARTED|Post-Treatment Follow-Up Period|Only included post-treatment follow-up participants.|0||
60120308|NCT01695239|76241400|FG010|STARTED|Post-Treatment Follow-Up Period|Participants who discontinued early and received PBO.|20||
60120309|NCT01695239|76241401|FG011|STARTED|Post-Treatment Follow-Up Period|Participants who discontinued early and received adalimumab.|1||
60120310|NCT01695239|76241402|FG012|STARTED|Post-Treatment Follow-Up Period|IxeQ4W participants who entered post-treatment follow-up.|165||
60120311|NCT01695239|76241403|FG013|STARTED|Post-Treatment Follow-Up Period|IxeQ2W participants who entered post-treatment follow-up.|171||
59567915|NCT02296476|75670788|FG001|NOT COMPLETED|Overall Study||4||
59567916|NCT02296476|75670789|FG002|NOT COMPLETED|Overall Study||2||
59719788|NCT01109316|75838922|FG002|STARTED|Study Period 3||18||
59719789|NCT01109316|75838923|FG003|STARTED|Study Period 3||20||
59719790|NCT01109316|75838924|FG004|STARTED|Study Period 3||20||
59719791|NCT01109316|75838925|FG005|STARTED|Study Period 3||19||
59719792|NCT01109316|75838920|FG000|COMPLETED|Study Period 3||20||
59719793|NCT01109316|75838921|FG001|COMPLETED|Study Period 3||21||
59719794|NCT01109316|75838922|FG002|COMPLETED|Study Period 3||18||
59719795|NCT01109316|75838923|FG003|COMPLETED|Study Period 3||20||
59719796|NCT01109316|75838924|FG004|COMPLETED|Study Period 3||18||
59719797|NCT01109316|75838925|FG005|COMPLETED|Study Period 3||19||
59846151|NCT04093258|75971092|FG000|COMPLETED|Period 2||20||
59846152|NCT04093258|75971093|FG001|COMPLETED|Period 2||20||
59846153|NCT04093258|75971092|FG000|NOT COMPLETED|Period 2||1||
59846154|NCT04093258|75971093|FG001|NOT COMPLETED|Period 2||0||
59846155|NCT04253236|75971101|FG000|STARTED|Overall Study||5||
59846156|NCT04253236|75971102|FG001|STARTED|Overall Study||0||
60120312|NCT01695239|76241390|FG000|COMPLETED|Post-Treatment Follow-Up Period||0||
59567917|NCT03763929|75670799|FG000|STARTED|Overall Study||2||
59567918|NCT03763929|75670800|FG001|STARTED|Overall Study||4||
59567919|NCT03763929|75670799|FG000|COMPLETED|Overall Study||2||
59567920|NCT03763929|75670800|FG001|COMPLETED|Overall Study||4||
59567921|NCT03763929|75670799|FG000|NOT COMPLETED|Overall Study||0||
59567922|NCT03763929|75670800|FG001|NOT COMPLETED|Overall Study||0||
59567923|NCT03762993|75670808|FG000|STARTED|Overall Study||21||
59567924|NCT03762993|75670809|FG001|STARTED|Overall Study||10||
59846157|NCT04253236|75971101|FG000|COMPLETED|Overall Study||2||
59846158|NCT04253236|75971102|FG001|COMPLETED|Overall Study||0||
59567925|NCT03762993|75670808|FG000|COMPLETED|Overall Study||21||
59846159|NCT04253236|75971101|FG000|NOT COMPLETED|Overall Study||3||
59567926|NCT03762993|75670809|FG001|COMPLETED|Overall Study||10||
59567927|NCT03762993|75670808|FG000|NOT COMPLETED|Overall Study||0||
59567928|NCT03762993|75670809|FG001|NOT COMPLETED|Overall Study||0||
59719798|NCT01109316|75838920|FG000|NOT COMPLETED|Study Period 3||1||
59719799|NCT01109316|75838921|FG001|NOT COMPLETED|Study Period 3||0||
59719800|NCT01109316|75838922|FG002|NOT COMPLETED|Study Period 3||0||
59719801|NCT01109316|75838923|FG003|NOT COMPLETED|Study Period 3||0||
59719802|NCT01109316|75838924|FG004|NOT COMPLETED|Study Period 3||2||
59719803|NCT01109316|75838925|FG005|NOT COMPLETED|Study Period 3||0||
59719804|NCT00887068|75838935|FG000|STARTED|Overall Study||93||
59719805|NCT00887068|75838936|FG001|STARTED|Overall Study||94||
59846160|NCT04253236|75971102|FG001|NOT COMPLETED|Overall Study||0||
59846161|NCT04087720|75971108|FG000|STARTED|Overall Study||20||
59846162|NCT04087720|75971108|FG000|COMPLETED|Overall Study||15||
59846163|NCT04087720|75971108|FG000|NOT COMPLETED|Overall Study||5||
59846164|NCT04086472|75971117|FG000|STARTED|Overall Study||16||
59846165|NCT04086472|75971118|FG001|STARTED|Overall Study||16||
59846166|NCT04086472|75971119|FG002|STARTED|Overall Study||16||
59846167|NCT04086472|75971120|FG003|STARTED|Overall Study||16||
59846168|NCT04086472|75971121|FG004|STARTED|Overall Study||16||
59846169|NCT04086472|75971117|FG000|Received MK-1654 or Placebo|Overall Study||16||
59846170|NCT04086472|75971118|FG001|Received MK-1654 or Placebo|Overall Study||16||
59846171|NCT04086472|75971119|FG002|Received MK-1654 or Placebo|Overall Study||16||
59846172|NCT04086472|75971120|FG003|Received MK-1654 or Placebo|Overall Study||16||
59846173|NCT04086472|75971121|FG004|Received MK-1654 or Placebo|Overall Study||16||
59846174|NCT04086472|75971117|FG000|Inoculated With Respiratory Syncytial Virus (RSV) A Memphis 37b|Overall Study||14||
59846175|NCT04086472|75971118|FG001|Inoculated With Respiratory Syncytial Virus (RSV) A Memphis 37b|Overall Study||14||
59846176|NCT04086472|75971119|FG002|Inoculated With Respiratory Syncytial Virus (RSV) A Memphis 37b|Overall Study||14||
59846177|NCT04086472|75971120|FG003|Inoculated With Respiratory Syncytial Virus (RSV) A Memphis 37b|Overall Study||13||
59846178|NCT04086472|75971121|FG004|Inoculated With Respiratory Syncytial Virus (RSV) A Memphis 37b|Overall Study||15||
59846179|NCT04086472|75971117|FG000|Not Inoculated|Overall Study||2||
59846180|NCT04086472|75971118|FG001|Not Inoculated|Overall Study||2||
59846181|NCT04086472|75971119|FG002|Not Inoculated|Overall Study||2||
59846182|NCT04086472|75971120|FG003|Not Inoculated|Overall Study||3||
59846183|NCT04086472|75971121|FG004|Not Inoculated|Overall Study||1||
59846184|NCT04086472|75971117|FG000|COMPLETED|Overall Study||12||
59846185|NCT04086472|75971118|FG001|COMPLETED|Overall Study||14||
59846186|NCT04086472|75971119|FG002|COMPLETED|Overall Study||14||
59846187|NCT04086472|75971120|FG003|COMPLETED|Overall Study||13||
59846188|NCT04086472|75971121|FG004|COMPLETED|Overall Study||14||
59846189|NCT04086472|75971117|FG000|NOT COMPLETED|Overall Study||4||
60120313|NCT01695239|76241391|FG001|COMPLETED|Post-Treatment Follow-Up Period||0||
60120314|NCT01695239|76241392|FG002|COMPLETED|Post-Treatment Follow-Up Period||0||
60120315|NCT01695239|76241393|FG003|COMPLETED|Post-Treatment Follow-Up Period||0||
60120316|NCT01695239|76241394|FG004|COMPLETED|Post-Treatment Follow-Up Period||0||
60120317|NCT01695239|76241395|FG005|COMPLETED|Post-Treatment Follow-Up Period||0||
60120318|NCT01695239|76241396|FG006|COMPLETED|Post-Treatment Follow-Up Period||0||
60120319|NCT01695239|76241397|FG007|COMPLETED|Post-Treatment Follow-Up Period||0||
60120320|NCT01695239|76241398|FG008|COMPLETED|Post-Treatment Follow-Up Period||0||
60120321|NCT01695239|76241399|FG009|COMPLETED|Post-Treatment Follow-Up Period||0||
60120322|NCT01695239|76241400|FG010|COMPLETED|Post-Treatment Follow-Up Period||20||
60120323|NCT01695239|76241401|FG011|COMPLETED|Post-Treatment Follow-Up Period||0||
60120324|NCT01695239|76241402|FG012|COMPLETED|Post-Treatment Follow-Up Period||156||
60120325|NCT01695239|76241403|FG013|COMPLETED|Post-Treatment Follow-Up Period||166||
60120326|NCT01695239|76241390|FG000|NOT COMPLETED|Post-Treatment Follow-Up Period||0||
60120327|NCT01695239|76241391|FG001|NOT COMPLETED|Post-Treatment Follow-Up Period||0||
60120328|NCT01695239|76241392|FG002|NOT COMPLETED|Post-Treatment Follow-Up Period||0||
60120329|NCT01695239|76241393|FG003|NOT COMPLETED|Post-Treatment Follow-Up Period||0||
60120330|NCT01695239|76241394|FG004|NOT COMPLETED|Post-Treatment Follow-Up Period||0||
60120331|NCT01695239|76241395|FG005|NOT COMPLETED|Post-Treatment Follow-Up Period||0||
60120332|NCT01695239|76241396|FG006|NOT COMPLETED|Post-Treatment Follow-Up Period||0||
60120333|NCT01695239|76241397|FG007|NOT COMPLETED|Post-Treatment Follow-Up Period||0||
60120334|NCT01695239|76241398|FG008|NOT COMPLETED|Post-Treatment Follow-Up Period||0||
60120335|NCT01695239|76241399|FG009|NOT COMPLETED|Post-Treatment Follow-Up Period||0||
60120336|NCT01695239|76241400|FG010|NOT COMPLETED|Post-Treatment Follow-Up Period||0||
60120337|NCT01695239|76241401|FG011|NOT COMPLETED|Post-Treatment Follow-Up Period||1||
60120338|NCT01695239|76241402|FG012|NOT COMPLETED|Post-Treatment Follow-Up Period||9||
60120339|NCT01695239|76241403|FG013|NOT COMPLETED|Post-Treatment Follow-Up Period||5||
60120340|NCT02163694|76241427|FG000|STARTED|Overall Study||172||
60120341|NCT02163694|76241428|FG001|STARTED|Overall Study||337||
60120342|NCT02163694|76241427|FG000|COMPLETED|Overall Study||18||
60120343|NCT02163694|76241428|FG001|COMPLETED|Overall Study||70||
59846190|NCT04086472|75971118|FG001|NOT COMPLETED|Overall Study||2||
59846191|NCT04086472|75971119|FG002|NOT COMPLETED|Overall Study||2||
59846192|NCT04086472|75971120|FG003|NOT COMPLETED|Overall Study||3||
59846193|NCT04086472|75971121|FG004|NOT COMPLETED|Overall Study||2||
59846194|NCT04249336|75971137|FG000|STARTED|Overall Study||35||
59846195|NCT04249336|75971138|FG001|STARTED|Overall Study||35||
59846196|NCT04249336|75971139|FG002|STARTED|Overall Study||35||
60120344|NCT02163694|76241427|FG000|NOT COMPLETED|Overall Study||154||
59846197|NCT04249336|75971140|FG003|STARTED|Overall Study||35||
59846198|NCT04249336|75971137|FG000|Per Protocol Population Day 3|Overall Study||32||
59846199|NCT04249336|75971138|FG001|Per Protocol Population Day 3|Overall Study||32||
60120345|NCT02163694|76241428|FG001|NOT COMPLETED|Overall Study||267||
60120346|NCT04344028|76241440|FG000|STARTED|Overall Study||66||
60120347|NCT04344028|76241441|FG001|STARTED|Overall Study||68||
59846200|NCT04249336|75971139|FG002|Per Protocol Population Day 3|Overall Study||32||
59846201|NCT04249336|75971140|FG003|Per Protocol Population Day 3|Overall Study||32||
59846202|NCT04249336|75971137|FG000|Per Protocol Population Week 4|Overall Study||33||
59846203|NCT04249336|75971138|FG001|Per Protocol Population Week 4|Overall Study||35||
59846204|NCT04249336|75971139|FG002|Per Protocol Population Week 4|Overall Study||33||
59846205|NCT04249336|75971140|FG003|Per Protocol Population Week 4|Overall Study||34||
59846206|NCT04249336|75971137|FG000|COMPLETED|Overall Study||32|Out of 35 participants per group, 32 completed the 4-week clinical trial after lost to follow up and statistically analyzed for primary outcome measure.|
59846207|NCT04249336|75971138|FG001|COMPLETED|Overall Study||32|Out of 35 participants per group, 32 completed the 4-week clinical trial after lost to follow up and statistically analyzed for primary outcome measure.|
59846208|NCT04249336|75971139|FG002|COMPLETED|Overall Study||32|Out of 35 participants per group, 32 completed the 4-week clinical trial after lost to follow up and statistically analyzed for primary outcome measure.|
59846209|NCT04249336|75971140|FG003|COMPLETED|Overall Study||32|Out of 35 participants per group, 32 completed the 4-week clinical trial after lost to follow up and statistically analyzed for primary outcome measure.|
59846210|NCT04249336|75971137|FG000|NOT COMPLETED|Overall Study||3||
59846211|NCT04249336|75971138|FG001|NOT COMPLETED|Overall Study||3||
59846212|NCT04249336|75971139|FG002|NOT COMPLETED|Overall Study||3||
59846213|NCT04249336|75971140|FG003|NOT COMPLETED|Overall Study||3||
59846214|NCT04245202|75971152|FG000|STARTED|Overall Study|After getting consent.|48||
59846215|NCT04245202|75971153|FG001|STARTED|Overall Study|After getting consent|39||
59846216|NCT04245202|75971152|FG000|COMPLETED|Overall Study||38||
59846217|NCT04245202|75971153|FG001|COMPLETED|Overall Study||38||
59846218|NCT04245202|75971152|FG000|NOT COMPLETED|Overall Study||10||
59846219|NCT04245202|75971153|FG001|NOT COMPLETED|Overall Study||1||
59846220|NCT04079842|75971160|FG000|STARTED|Overall Study||29||
59846221|NCT04079842|75971160|FG000|COMPLETED|Overall Study||26||
59846222|NCT04079842|75971160|FG000|NOT COMPLETED|Overall Study||3||
59846223|NCT04078126|75971164|FG000|STARTED|Period 1||18||
59846224|NCT04078126|75971165|FG001|STARTED|Period 1||17||
59846225|NCT04078126|75971164|FG000|COMPLETED|Period 1||18||
59846226|NCT04078126|75971165|FG001|COMPLETED|Period 1||17||
59846227|NCT04078126|75971164|FG000|NOT COMPLETED|Period 1||0||
59846228|NCT04078126|75971165|FG001|NOT COMPLETED|Period 1||0||
59846229|NCT04078126|75971164|FG000|STARTED|Washout||18||
59846230|NCT04078126|75971165|FG001|STARTED|Washout||17||
59846231|NCT04078126|75971164|FG000|COMPLETED|Washout||18||
59846232|NCT04078126|75971165|FG001|COMPLETED|Washout||15||
59846233|NCT04078126|75971164|FG000|NOT COMPLETED|Washout||0||
59846234|NCT04078126|75971165|FG001|NOT COMPLETED|Washout||2||
59846235|NCT04078126|75971164|FG000|STARTED|Period 2||18||
59846236|NCT04078126|75971165|FG001|STARTED|Period 2||15||
59846237|NCT04078126|75971164|FG000|COMPLETED|Period 2||17||
59846238|NCT04078126|75971165|FG001|COMPLETED|Period 2||14||
59846239|NCT04078126|75971164|FG000|NOT COMPLETED|Period 2||1||
59846240|NCT04078126|75971165|FG001|NOT COMPLETED|Period 2||1||
59846241|NCT04073368|75971175|FG000|STARTED|Overall Study||32||
59846242|NCT04073368|75971176|FG001|STARTED|Overall Study||26||
59846243|NCT04073368|75971177|FG002|STARTED|Overall Study||29||
59846244|NCT04073368|75971178|FG003|STARTED|Overall Study||15||
59846245|NCT04073368|75971175|FG000|COMPLETED|Overall Study||20||
59846246|NCT04073368|75971176|FG001|COMPLETED|Overall Study||18||
59846247|NCT04073368|75971177|FG002|COMPLETED|Overall Study||26||
59846248|NCT04073368|75971178|FG003|COMPLETED|Overall Study||13||
59846249|NCT04073368|75971175|FG000|NOT COMPLETED|Overall Study||12||
59846250|NCT04073368|75971176|FG001|NOT COMPLETED|Overall Study||8||
59846251|NCT04073368|75971177|FG002|NOT COMPLETED|Overall Study||3||
59846252|NCT04073368|75971178|FG003|NOT COMPLETED|Overall Study||2||
59846253|NCT04380688|75971190|FG000|STARTED|Overall Study||31||
59846254|NCT04380688|75971191|FG001|STARTED|Overall Study||31||
59846255|NCT04380688|75971190|FG000|COMPLETED|Overall Study||24||
59846256|NCT04380688|75971191|FG001|COMPLETED|Overall Study||22||
59846257|NCT04380688|75971190|FG000|NOT COMPLETED|Overall Study||7||
59846258|NCT04380688|75971191|FG001|NOT COMPLETED|Overall Study||9||
59846259|NCT00124748|75971199|FG000|STARTED|Overall Study||157||
59846260|NCT00124748|75971200|FG001|STARTED|Overall Study||319||
59846261|NCT00124748|75971199|FG000|Safety Population|Overall Study||157||
59846262|NCT00124748|75971200|FG001|Safety Population|Overall Study||316||
59846263|NCT00124748|75971199|FG000|COMPLETED|Overall Study||14||
59846264|NCT00124748|75971200|FG001|COMPLETED|Overall Study||35||
59846265|NCT00124748|75971199|FG000|NOT COMPLETED|Overall Study||143||
59846266|NCT00124748|75971200|FG001|NOT COMPLETED|Overall Study||284||
59846267|NCT04070326|75971208|FG000|STARTED|Baseline Observation-12 Weeks Before TP||4||
59846268|NCT04070326|75971209|FG001|STARTED|Baseline Observation-12 Weeks Before TP||17||
59846269|NCT04070326|75971208|FG000|COMPLETED|Baseline Observation-12 Weeks Before TP||4||
59846270|NCT04070326|75971209|FG001|COMPLETED|Baseline Observation-12 Weeks Before TP||17||
59846271|NCT04070326|75971208|FG000|NOT COMPLETED|Baseline Observation-12 Weeks Before TP||0||
59846272|NCT04070326|75971209|FG001|NOT COMPLETED|Baseline Observation-12 Weeks Before TP||0||
59846273|NCT04070326|75971208|FG000|STARTED|Treatment Period A (Weeks 1 to 26)||4||
59846274|NCT04070326|75971209|FG001|STARTED|Treatment Period A (Weeks 1 to 26)||17||
59846275|NCT04070326|75971208|FG000|COMPLETED|Treatment Period A (Weeks 1 to 26)||3||
59846276|NCT04070326|75971209|FG001|COMPLETED|Treatment Period A (Weeks 1 to 26)||17||
59846277|NCT04070326|75971208|FG000|NOT COMPLETED|Treatment Period A (Weeks 1 to 26)||1||
59846278|NCT04070326|75971209|FG001|NOT COMPLETED|Treatment Period A (Weeks 1 to 26)||0||
59846279|NCT04070326|75971208|FG000|STARTED|Treatment Period B (Weeks 27 to 52)||3||
59846280|NCT04070326|75971209|FG001|STARTED|Treatment Period B (Weeks 27 to 52)||17||
59846281|NCT04070326|75971208|FG000|COMPLETED|Treatment Period B (Weeks 27 to 52)||3||
59846282|NCT04070326|75971209|FG001|COMPLETED|Treatment Period B (Weeks 27 to 52)||17||
59846283|NCT04070326|75971208|FG000|NOT COMPLETED|Treatment Period B (Weeks 27 to 52)||0||
60120348|NCT04344028|76241442|FG002|STARTED|Overall Study||66||
60120349|NCT04344028|76241443|FG003|STARTED|Overall Study||63||
60120350|NCT04344028|76241444|FG004|STARTED|Overall Study||12||
60120351|NCT04344028|76241445|FG005|STARTED|Overall Study||12||
60120352|NCT04344028|76241440|FG000|COMPLETED|Overall Study||45||
60120353|NCT04344028|76241441|FG001|COMPLETED|Overall Study||49||
60120354|NCT04344028|76241442|FG002|COMPLETED|Overall Study||50||
59719806|NCT00887068|75838935|FG000|COMPLETED|Overall Study||87||
59719807|NCT00887068|75838936|FG001|COMPLETED|Overall Study||94||
59719808|NCT00887068|75838935|FG000|NOT COMPLETED|Overall Study||6||
59719809|NCT00887068|75838936|FG001|NOT COMPLETED|Overall Study||0||
59719810|NCT00941031|75838946|FG000|STARTED|Induction Period||66||
59719811|NCT00941031|75838947|FG001|STARTED|Induction Period||138||
59719812|NCT00941031|75838948|FG002|STARTED|Induction Period||133||
59719813|NCT00941031|75838949|FG003|STARTED|Induction Period||67||
59719814|NCT00941031|75838950|FG004|STARTED|Induction Period||0||
59719815|NCT00941031|75838951|FG005|STARTED|Induction Period||0||
59719816|NCT00941031|75838952|FG006|STARTED|Induction Period||0||
59719817|NCT00941031|75838946|FG000|COMPLETED|Induction Period||61||
59719818|NCT00941031|75838947|FG001|COMPLETED|Induction Period||134||
59846284|NCT04070326|75971209|FG001|NOT COMPLETED|Treatment Period B (Weeks 27 to 52)||0||
59846285|NCT03689452|75971219|FG000|STARTED|Overall Study||15||
59846286|NCT03689452|75971220|FG001|STARTED|Overall Study||15||
59846287|NCT03689452|75971219|FG000|COMPLETED|Overall Study||14||
59846288|NCT03689452|75971220|FG001|COMPLETED|Overall Study||14||
60120355|NCT04344028|76241443|FG003|COMPLETED|Overall Study||49||
59719819|NCT00941031|75838948|FG002|COMPLETED|Induction Period||127||
59719820|NCT00941031|75838949|FG003|COMPLETED|Induction Period||58||
59719821|NCT00941031|75838950|FG004|COMPLETED|Induction Period||0||
59719822|NCT00941031|75838951|FG005|COMPLETED|Induction Period||0||
59719823|NCT00941031|75838952|FG006|COMPLETED|Induction Period||0||
59846289|NCT03689452|75971219|FG000|NOT COMPLETED|Overall Study||1||
59846290|NCT03689452|75971220|FG001|NOT COMPLETED|Overall Study||1||
60120356|NCT04344028|76241444|FG004|COMPLETED|Overall Study||9||
59719824|NCT00941031|75838946|FG000|NOT COMPLETED|Induction Period||5||
59719825|NCT00941031|75838947|FG001|NOT COMPLETED|Induction Period||4||
59846291|NCT04067050|75971228|FG000|STARTED|One Month||32||
59846292|NCT04067050|75971229|FG001|STARTED|One Month||29||
60120357|NCT04344028|76241445|FG005|COMPLETED|Overall Study||11||
60120358|NCT04344028|76241440|FG000|NOT COMPLETED|Overall Study||21||
59846293|NCT04067050|75971228|FG000|COMPLETED|One Month||28||
59846294|NCT04067050|75971229|FG001|COMPLETED|One Month||29||
59846295|NCT04067050|75971228|FG000|NOT COMPLETED|One Month||4||
59846296|NCT04067050|75971229|FG001|NOT COMPLETED|One Month||0||
59846297|NCT04067050|75971228|FG000|STARTED|Two Month|6 subjects discontinued after 1 month visit. 22 Subjects continued the study.|22||
59846298|NCT04067050|75971229|FG001|STARTED|Two Month||29||
59846299|NCT04067050|75971228|FG000|COMPLETED|Two Month||20||
59846300|NCT04067050|75971229|FG001|COMPLETED|Two Month||29||
59846301|NCT04067050|75971228|FG000|NOT COMPLETED|Two Month||2||
59846302|NCT04067050|75971229|FG001|NOT COMPLETED|Two Month||0||
59846303|NCT04060654|75971235|FG000|STARTED|Overall Study||17||
59846304|NCT04060654|75971235|FG000|COMPLETED|Overall Study||11||
59846305|NCT04060654|75971235|FG000|NOT COMPLETED|Overall Study||6||
59846306|NCT00096200|75971242|FG000|STARTED|Overall Study||9||
59846307|NCT00096200|75971243|FG001|STARTED|Overall Study||30||
59846308|NCT00096200|75971244|FG002|STARTED|Overall Study||5||
59846309|NCT00096200|75971242|FG000|COMPLETED|Overall Study||8||
59846310|NCT00096200|75971243|FG001|COMPLETED|Overall Study||23||
59846311|NCT00096200|75971244|FG002|COMPLETED|Overall Study||5||
59846312|NCT00096200|75971242|FG000|NOT COMPLETED|Overall Study||1||
59846313|NCT00096200|75971243|FG001|NOT COMPLETED|Overall Study||7||
59846314|NCT00096200|75971244|FG002|NOT COMPLETED|Overall Study||0||
59846315|NCT04059094|75971257|FG000|STARTED|Overall Study||18||
59846316|NCT04059094|75971258|FG001|STARTED|Overall Study||6||
59846317|NCT04059094|75971259|FG002|STARTED|Overall Study||5||
59846318|NCT04059094|75971260|FG003|STARTED|Overall Study||5||
59846319|NCT04059094|75971261|FG004|STARTED|Overall Study||18||
59846320|NCT04059094|75971257|FG000|COMPLETED|Overall Study||18||
59846321|NCT04059094|75971258|FG001|COMPLETED|Overall Study||4||
59846322|NCT04059094|75971259|FG002|COMPLETED|Overall Study||5||
59846323|NCT04059094|75971260|FG003|COMPLETED|Overall Study||5||
59846324|NCT04059094|75971261|FG004|COMPLETED|Overall Study||17||
59846325|NCT04059094|75971257|FG000|NOT COMPLETED|Overall Study||0||
59846326|NCT04059094|75971258|FG001|NOT COMPLETED|Overall Study||2||
59846327|NCT04059094|75971259|FG002|NOT COMPLETED|Overall Study||0||
59846328|NCT04059094|75971260|FG003|NOT COMPLETED|Overall Study||0||
59846329|NCT04059094|75971261|FG004|NOT COMPLETED|Overall Study||1||
59846330|NCT00096044|75971277|FG000|STARTED|Overall Study||45||
59846331|NCT00096044|75971277|FG000|COMPLETED|Overall Study||11||
59846332|NCT00096044|75971277|FG000|NOT COMPLETED|Overall Study||34||
59846333|NCT03689374|75971283|FG000|STARTED|Run-in Period (12 Weeks)||2274||
59846334|NCT03689374|75971284|FG001|STARTED|Run-in Period (12 Weeks)||0||
59567929|NCT03762213|75670817|FG000|STARTED|Overall Study||16||
59846335|NCT03689374|75971285|FG002|STARTED|Run-in Period (12 Weeks)||0||
59846336|NCT03689374|75971283|FG000|COMPLETED|Run-in Period (12 Weeks)||1748||
59846337|NCT03689374|75971284|FG001|COMPLETED|Run-in Period (12 Weeks)||0||
59846338|NCT03689374|75971285|FG002|COMPLETED|Run-in Period (12 Weeks)||0||
59846339|NCT03689374|75971283|FG000|NOT COMPLETED|Run-in Period (12 Weeks)||526||
59846340|NCT03689374|75971284|FG001|NOT COMPLETED|Run-in Period (12 Weeks)||0||
59846341|NCT03689374|75971285|FG002|NOT COMPLETED|Run-in Period (12 Weeks)||0||
59846342|NCT03689374|75971283|FG000|STARTED|Treatment Period (Week 0 to 52)||0||
59846343|NCT03689374|75971284|FG001|STARTED|Treatment Period (Week 0 to 52)||874||
59846344|NCT03689374|75971285|FG002|STARTED|Treatment Period (Week 0 to 52)||874||
59846345|NCT03689374|75971283|FG000|Treated|Treatment Period (Week 0 to 52)||0||
60120359|NCT04344028|76241441|FG001|NOT COMPLETED|Overall Study||19||
60120360|NCT04344028|76241442|FG002|NOT COMPLETED|Overall Study||16||
60120361|NCT04344028|76241443|FG003|NOT COMPLETED|Overall Study||14||
59846346|NCT03689374|75971284|FG001|Treated|Treatment Period (Week 0 to 52)||874||
59846347|NCT03689374|75971285|FG002|Treated|Treatment Period (Week 0 to 52)||864||
59846348|NCT03689374|75971283|FG000|Full Analysis Set|Treatment Period (Week 0 to 52)||0||
59846349|NCT03689374|75971284|FG001|Full Analysis Set|Treatment Period (Week 0 to 52)||874||
59846350|NCT03689374|75971285|FG002|Full Analysis Set|Treatment Period (Week 0 to 52)||874||
59846351|NCT03689374|75971283|FG000|Safety Analysis Set|Treatment Period (Week 0 to 52)||0||
59846352|NCT03689374|75971284|FG001|Safety Analysis Set|Treatment Period (Week 0 to 52)||874||
59846353|NCT03689374|75971285|FG002|Safety Analysis Set|Treatment Period (Week 0 to 52)||864||
59846354|NCT03689374|75971283|FG000|COMPLETED|Treatment Period (Week 0 to 52)||0||
59846355|NCT03689374|75971284|FG001|COMPLETED|Treatment Period (Week 0 to 52)||850||
59846356|NCT03689374|75971285|FG002|COMPLETED|Treatment Period (Week 0 to 52)||831||
59846357|NCT03689374|75971283|FG000|NOT COMPLETED|Treatment Period (Week 0 to 52)||0||
59846358|NCT03689374|75971284|FG001|NOT COMPLETED|Treatment Period (Week 0 to 52)||24||
59846359|NCT03689374|75971285|FG002|NOT COMPLETED|Treatment Period (Week 0 to 52)||43||
59846360|NCT00123734|75971291|FG000|STARTED|Overall Study||82||
59846361|NCT00123734|75971291|FG000|COMPLETED|Overall Study||74||
59846362|NCT00123734|75971291|FG000|NOT COMPLETED|Overall Study||8||
59846363|NCT00112736|75971301|FG000|STARTED|Overall Study||22||
59846364|NCT00112736|75971302|FG001|STARTED|Overall Study||47||
59846365|NCT00112736|75971301|FG000|COMPLETED|Overall Study|12 of Phase I pts treated at MTD and hence considered part of the Phase II analysis|21||
59846366|NCT00112736|75971302|FG001|COMPLETED|Overall Study|12 additional pts from phase 1 study were used in analysis for Phase 2 as they were treated at MTD|47||
60120362|NCT04344028|76241444|FG004|NOT COMPLETED|Overall Study||3||
59567930|NCT03762213|75670818|FG001|STARTED|Overall Study||14||
59846367|NCT00112736|75971301|FG000|NOT COMPLETED|Overall Study||1||
59846368|NCT00112736|75971302|FG001|NOT COMPLETED|Overall Study||0||
59846369|NCT00123422|75971317|FG000|STARTED|Overall Study||35||
59846370|NCT00123422|75971318|FG001|STARTED|Overall Study||33||
59846371|NCT00123422|75971319|FG002|STARTED|Overall Study||35||
59846372|NCT00123422|75971317|FG000|8-week Testing|Overall Study||32||
59846373|NCT00123422|75971318|FG001|8-week Testing|Overall Study||30||
59846374|NCT00123422|75971319|FG002|8-week Testing|Overall Study||27||
59846375|NCT00123422|75971317|FG000|COMPLETED|Overall Study||31||
59846376|NCT00123422|75971318|FG001|COMPLETED|Overall Study||27||
59846377|NCT00123422|75971319|FG002|COMPLETED|Overall Study||25||
59846378|NCT00123422|75971317|FG000|NOT COMPLETED|Overall Study||4||
59846379|NCT00123422|75971318|FG001|NOT COMPLETED|Overall Study||6||
59846380|NCT00123422|75971319|FG002|NOT COMPLETED|Overall Study||10||
59846381|NCT04052620|75971329|FG000|STARTED|Overall Study||150||
59846382|NCT04052620|75971330|FG001|STARTED|Overall Study||152||
59846383|NCT04052620|75971329|FG000|COMPLETED|Overall Study||143||
59846384|NCT04052620|75971330|FG001|COMPLETED|Overall Study||145||
59846385|NCT04052620|75971329|FG000|NOT COMPLETED|Overall Study||7||
59846386|NCT04052620|75971330|FG001|NOT COMPLETED|Overall Study||7||
59846387|NCT00112580|75971338|FG000|STARTED|Overall Study||8||
59846388|NCT00112580|75971339|FG001|STARTED|Overall Study||19||
59846389|NCT00112580|75971338|FG000|COMPLETED|Overall Study||0||
59846390|NCT00112580|75971339|FG001|COMPLETED|Overall Study||0||
59846391|NCT00112580|75971338|FG000|NOT COMPLETED|Overall Study||8||
59846392|NCT00112580|75971339|FG001|NOT COMPLETED|Overall Study||19||
59846393|NCT04238650|75971346|FG000|STARTED|Overall Study||24||
59846394|NCT04238650|75971347|FG001|STARTED|Overall Study|One subject was enrolled and randomized to EU Avastin® but the subject was not dosed (subject withdrawal before study drug administration)|25||
59846395|NCT04238650|75971346|FG000|COMPLETED|Overall Study||24||
59846396|NCT04238650|75971347|FG001|COMPLETED|Overall Study||24||
59846397|NCT04238650|75971346|FG000|NOT COMPLETED|Overall Study||0||
59846398|NCT04238650|75971347|FG001|NOT COMPLETED|Overall Study||1||
59846399|NCT00095576|75971355|FG000|STARTED|Overall Study||1484||
59846400|NCT00095576|75971356|FG001|STARTED|Overall Study||1495||
59846401|NCT00095576|75971355|FG000|VACCINATED AT VISIT 2 (Dose 1)|Overall Study||1484||
59846402|NCT00095576|75971356|FG001|VACCINATED AT VISIT 2 (Dose 1)|Overall Study||1495||
59846403|NCT00095576|75971355|FG000|VACCINATED AT VISIT 4 (Dose 2)|Overall Study||1426||
59846404|NCT00095576|75971356|FG001|VACCINATED AT VISIT 4 (Dose 2)|Overall Study||1443||
59846405|NCT00095576|75971355|FG000|VACCINATED AT VISIT 7 (Dose 3)|Overall Study||1328||
59846406|NCT00095576|75971356|FG001|VACCINATED AT VISIT 7 (Dose 3)|Overall Study||1361||
59846407|NCT00095576|75971355|FG000|COMPLETED|Overall Study|Subjects not completing entire study were eligible for observational long term follow up in V520-030|9||
59846408|NCT00095576|75971356|FG001|COMPLETED|Overall Study|Subjects not completing entire study were eligible for observational long term follow up in V520-030|14||
59846409|NCT00095576|75971355|FG000|NOT COMPLETED|Overall Study||1475||
59846410|NCT00095576|75971356|FG001|NOT COMPLETED|Overall Study||1481||
59846411|NCT04049578|75971362|FG000|STARTED|Overall Study||2||
59846412|NCT04049578|75971362|FG000|COMPLETED|Overall Study||1||
59846413|NCT04049578|75971362|FG000|NOT COMPLETED|Overall Study||1||
59567931|NCT03762213|75670817|FG000|COMPLETED|Overall Study||16||
59567932|NCT03762213|75670818|FG001|COMPLETED|Overall Study||14||
59846414|NCT04044352|75971366|FG000|STARTED|Overall Study||76||
59846415|NCT04044352|75971366|FG000|COMPLETED|Overall Study||65||
59846416|NCT04044352|75971366|FG000|NOT COMPLETED|Overall Study||11||
59846417|NCT04043962|75971371|FG000|STARTED|Baseline||85||
59846418|NCT04043962|75971371|FG000|COMPLETED|Baseline||85||
59846419|NCT04043962|75971371|FG000|NOT COMPLETED|Baseline||0||
59846420|NCT04043962|75971371|FG000|STARTED|Post-Treatment||85||
59846421|NCT04043962|75971371|FG000|COMPLETED|Post-Treatment||77||
59846422|NCT04043962|75971371|FG000|NOT COMPLETED|Post-Treatment||8||
59846423|NCT04043962|75971371|FG000|STARTED|Follow-up||80||
59846424|NCT04043962|75971371|FG000|COMPLETED|Follow-up||73||
59846425|NCT04043962|75971371|FG000|NOT COMPLETED|Follow-up||7||
59846426|NCT04043728|75971378|FG000|STARTED|Overall Study||6||
59846427|NCT04043728|75971379|FG001|STARTED|Overall Study||6||
59846428|NCT04043728|75971380|FG002|STARTED|Overall Study||6||
59846429|NCT04043728|75971378|FG000|COMPLETED|Overall Study||5||
59846430|NCT04043728|75971379|FG001|COMPLETED|Overall Study||4||
59567933|NCT03762213|75670817|FG000|NOT COMPLETED|Overall Study||0||
59846431|NCT04043728|75971380|FG002|COMPLETED|Overall Study||6||
59846432|NCT04043728|75971378|FG000|NOT COMPLETED|Overall Study||1||
59996684|NCT02714569|76112505|FG002|NOT COMPLETED|Part A Fourth Intervention||0||
59846433|NCT04043728|75971379|FG001|NOT COMPLETED|Overall Study||2||
59846434|NCT04043728|75971380|FG002|NOT COMPLETED|Overall Study||0||
59846435|NCT04043416|75971390|FG000|STARTED|Campaign 1||14||
59846436|NCT04043416|75971391|FG001|STARTED|Campaign 1||14||
59846437|NCT04043416|75971390|FG000|COMPLETED|Campaign 1||14||
59846438|NCT04043416|75971391|FG001|COMPLETED|Campaign 1||14||
59846439|NCT04043416|75971390|FG000|NOT COMPLETED|Campaign 1||0||
59846440|NCT04043416|75971391|FG001|NOT COMPLETED|Campaign 1||0||
59846441|NCT04043416|75971390|FG000|STARTED|Washout||14||
59846442|NCT04043416|75971391|FG001|STARTED|Washout||14||
59846443|NCT04043416|75971390|FG000|COMPLETED|Washout||14||
59846444|NCT04043416|75971391|FG001|COMPLETED|Washout||13||
59846445|NCT04043416|75971390|FG000|NOT COMPLETED|Washout||0||
59846446|NCT04043416|75971391|FG001|NOT COMPLETED|Washout||1||
59846447|NCT04043416|75971390|FG000|STARTED|Campaign 2||14||
59846448|NCT04043416|75971391|FG001|STARTED|Campaign 2||13||
59846449|NCT04043416|75971390|FG000|COMPLETED|Campaign 2||14||
59846450|NCT04043416|75971391|FG001|COMPLETED|Campaign 2||13||
59846451|NCT04043416|75971390|FG000|NOT COMPLETED|Campaign 2||0||
59846452|NCT04043416|75971391|FG001|NOT COMPLETED|Campaign 2||0||
59846453|NCT00095498|75971403|FG000|STARTED|Overall Study||76||
59846454|NCT00095498|75971404|FG001|STARTED|Overall Study||73||
59846455|NCT00095498|75971405|FG002|STARTED|Overall Study||78||
59846456|NCT00095498|75971403|FG000|Received Investigational Product|Overall Study||72||
59846457|NCT00095498|75971404|FG001|Received Investigational Product|Overall Study||71||
59846458|NCT00095498|75971405|FG002|Received Investigational Product|Overall Study||75||
59846459|NCT00095498|75971403|FG000|COMPLETED|Overall Study||39||
59846460|NCT00095498|75971404|FG001|COMPLETED|Overall Study||38||
59846461|NCT00095498|75971405|FG002|COMPLETED|Overall Study||39||
59846462|NCT00095498|75971403|FG000|NOT COMPLETED|Overall Study||37||
59846463|NCT00095498|75971404|FG001|NOT COMPLETED|Overall Study||35||
59846464|NCT00095498|75971405|FG002|NOT COMPLETED|Overall Study||39||
59846465|NCT04237792|75971419|FG000|STARTED|Treatment (Day 1)||21||
59846466|NCT04237792|75971420|FG001|STARTED|Treatment (Day 1)||22||
59846467|NCT04237792|75971421|FG002|STARTED|Treatment (Day 1)||20||
59846468|NCT04237792|75971422|FG003|STARTED|Treatment (Day 1)||23||
59846469|NCT04237792|75971423|FG004|STARTED|Treatment (Day 1)||21||
59846470|NCT04237792|75971424|FG005|STARTED|Treatment (Day 1)||21||
59846471|NCT04237792|75971419|FG000|Treated With DEX|Treatment (Day 1)||20||
59846472|NCT04237792|75971420|FG001|Treated With DEX|Treatment (Day 1)||21||
59846473|NCT04237792|75971421|FG002|Treated With DEX|Treatment (Day 1)||18||
59846474|NCT04237792|75971422|FG003|Treated With DEX|Treatment (Day 1)||22||
59846475|NCT04237792|75971423|FG004|Treated With DEX|Treatment (Day 1)||21||
59846476|NCT04237792|75971424|FG005|Treated With DEX|Treatment (Day 1)||20||
59846477|NCT04237792|75971419|FG000|COMPLETED|Treatment (Day 1)||19||
59846478|NCT04237792|75971420|FG001|COMPLETED|Treatment (Day 1)||21||
59846479|NCT04237792|75971421|FG002|COMPLETED|Treatment (Day 1)||17||
59846480|NCT04237792|75971422|FG003|COMPLETED|Treatment (Day 1)||22||
59846481|NCT04237792|75971423|FG004|COMPLETED|Treatment (Day 1)||20||
59846482|NCT04237792|75971424|FG005|COMPLETED|Treatment (Day 1)||18||
59846483|NCT04237792|75971419|FG000|NOT COMPLETED|Treatment (Day 1)||2||
59846484|NCT04237792|75971420|FG001|NOT COMPLETED|Treatment (Day 1)||1||
59846485|NCT04237792|75971421|FG002|NOT COMPLETED|Treatment (Day 1)||3||
59846486|NCT04237792|75971422|FG003|NOT COMPLETED|Treatment (Day 1)||1||
59846487|NCT04237792|75971423|FG004|NOT COMPLETED|Treatment (Day 1)||1||
59846488|NCT04237792|75971424|FG005|NOT COMPLETED|Treatment (Day 1)||3||
59846489|NCT04237792|75971419|FG000|STARTED|MRI Scan (Day 1)|DEX infusion could be discontinued during MRI scan, if clinically indicated.|20||
59846490|NCT04237792|75971420|FG001|STARTED|MRI Scan (Day 1)||21||
59846491|NCT04237792|75971421|FG002|STARTED|MRI Scan (Day 1)|DEX infusion could be discontinued during MRI scan, if clinically indicated.|18||
59846492|NCT04237792|75971422|FG003|STARTED|MRI Scan (Day 1)||22||
59846493|NCT04237792|75971423|FG004|STARTED|MRI Scan (Day 1)|DEX infusion could be discontinued during MRI scan, if clinically indicated.|21||
59846494|NCT04237792|75971424|FG005|STARTED|MRI Scan (Day 1)|DEX infusion could be discontinued during MRI scan, if clinically indicated.|20||
59846495|NCT04237792|75971419|FG000|COMPLETED|MRI Scan (Day 1)||20||
59846496|NCT04237792|75971420|FG001|COMPLETED|MRI Scan (Day 1)||21||
59846497|NCT04237792|75971421|FG002|COMPLETED|MRI Scan (Day 1)||18||
59846498|NCT04237792|75971422|FG003|COMPLETED|MRI Scan (Day 1)||22||
59846499|NCT04237792|75971423|FG004|COMPLETED|MRI Scan (Day 1)||21||
59846500|NCT04237792|75971424|FG005|COMPLETED|MRI Scan (Day 1)||20||
59846501|NCT04237792|75971419|FG000|NOT COMPLETED|MRI Scan (Day 1)||0||
59846502|NCT04237792|75971420|FG001|NOT COMPLETED|MRI Scan (Day 1)||0||
59846503|NCT04237792|75971421|FG002|NOT COMPLETED|MRI Scan (Day 1)||0||
59846504|NCT04237792|75971422|FG003|NOT COMPLETED|MRI Scan (Day 1)||0||
59846505|NCT04237792|75971423|FG004|NOT COMPLETED|MRI Scan (Day 1)||0||
59846506|NCT04237792|75971424|FG005|NOT COMPLETED|MRI Scan (Day 1)||0||
59846507|NCT04237792|75971419|FG000|STARTED|Post MRI Scan Recovery (Day 1)||20||
59846508|NCT04237792|75971420|FG001|STARTED|Post MRI Scan Recovery (Day 1)||21||
59846509|NCT04237792|75971421|FG002|STARTED|Post MRI Scan Recovery (Day 1)||18||
59846510|NCT04237792|75971422|FG003|STARTED|Post MRI Scan Recovery (Day 1)||22||
59846511|NCT04237792|75971423|FG004|STARTED|Post MRI Scan Recovery (Day 1)||21||
59846512|NCT04237792|75971424|FG005|STARTED|Post MRI Scan Recovery (Day 1)||20||
59846513|NCT04237792|75971419|FG000|COMPLETED|Post MRI Scan Recovery (Day 1)||20||
59846514|NCT04237792|75971420|FG001|COMPLETED|Post MRI Scan Recovery (Day 1)||21||
59846515|NCT04237792|75971421|FG002|COMPLETED|Post MRI Scan Recovery (Day 1)||18||
59846516|NCT04237792|75971422|FG003|COMPLETED|Post MRI Scan Recovery (Day 1)||22||
59846517|NCT04237792|75971423|FG004|COMPLETED|Post MRI Scan Recovery (Day 1)||21||
59846518|NCT04237792|75971424|FG005|COMPLETED|Post MRI Scan Recovery (Day 1)||20||
59846519|NCT04237792|75971419|FG000|NOT COMPLETED|Post MRI Scan Recovery (Day 1)||0||
59846520|NCT04237792|75971420|FG001|NOT COMPLETED|Post MRI Scan Recovery (Day 1)||0||
59846521|NCT04237792|75971421|FG002|NOT COMPLETED|Post MRI Scan Recovery (Day 1)||0||
59846522|NCT04237792|75971422|FG003|NOT COMPLETED|Post MRI Scan Recovery (Day 1)||0||
59846523|NCT04237792|75971423|FG004|NOT COMPLETED|Post MRI Scan Recovery (Day 1)||0||
59846524|NCT04237792|75971424|FG005|NOT COMPLETED|Post MRI Scan Recovery (Day 1)||0||
59846525|NCT04237792|75971419|FG000|STARTED|Follow-up (FU) (Day 2)||20||
59846526|NCT04237792|75971420|FG001|STARTED|Follow-up (FU) (Day 2)||21||
59846527|NCT04237792|75971421|FG002|STARTED|Follow-up (FU) (Day 2)||18||
59846528|NCT04237792|75971422|FG003|STARTED|Follow-up (FU) (Day 2)||22||
59846529|NCT04237792|75971423|FG004|STARTED|Follow-up (FU) (Day 2)||21||
59846530|NCT04237792|75971424|FG005|STARTED|Follow-up (FU) (Day 2)||20||
59846531|NCT04237792|75971419|FG000|COMPLETED|Follow-up (FU) (Day 2)||20||
59846532|NCT04237792|75971420|FG001|COMPLETED|Follow-up (FU) (Day 2)||21||
59846533|NCT04237792|75971421|FG002|COMPLETED|Follow-up (FU) (Day 2)||18||
59846534|NCT04237792|75971422|FG003|COMPLETED|Follow-up (FU) (Day 2)||22||
59846535|NCT04237792|75971423|FG004|COMPLETED|Follow-up (FU) (Day 2)||21||
59846536|NCT04237792|75971424|FG005|COMPLETED|Follow-up (FU) (Day 2)||20||
59846537|NCT04237792|75971419|FG000|NOT COMPLETED|Follow-up (FU) (Day 2)||0||
59846538|NCT04237792|75971420|FG001|NOT COMPLETED|Follow-up (FU) (Day 2)||0||
59846539|NCT04237792|75971421|FG002|NOT COMPLETED|Follow-up (FU) (Day 2)||0||
59846540|NCT04237792|75971422|FG003|NOT COMPLETED|Follow-up (FU) (Day 2)||0||
59846541|NCT04237792|75971423|FG004|NOT COMPLETED|Follow-up (FU) (Day 2)||0||
59846542|NCT04237792|75971424|FG005|NOT COMPLETED|Follow-up (FU) (Day 2)||0||
59846543|NCT04237792|75971419|FG000|STARTED|Long Term FU (Any Day From Day 29 to 32)||20||
59846544|NCT04237792|75971420|FG001|STARTED|Long Term FU (Any Day From Day 29 to 32)||21||
59846545|NCT04237792|75971421|FG002|STARTED|Long Term FU (Any Day From Day 29 to 32)||18||
59846546|NCT04237792|75971422|FG003|STARTED|Long Term FU (Any Day From Day 29 to 32)||22||
59846547|NCT04237792|75971423|FG004|STARTED|Long Term FU (Any Day From Day 29 to 32)||21||
59846548|NCT04237792|75971424|FG005|STARTED|Long Term FU (Any Day From Day 29 to 32)||20||
59846549|NCT04237792|75971419|FG000|COMPLETED|Long Term FU (Any Day From Day 29 to 32)||20||
59846550|NCT04237792|75971420|FG001|COMPLETED|Long Term FU (Any Day From Day 29 to 32)||21||
59846551|NCT04237792|75971421|FG002|COMPLETED|Long Term FU (Any Day From Day 29 to 32)||18||
59846552|NCT04237792|75971422|FG003|COMPLETED|Long Term FU (Any Day From Day 29 to 32)||22||
59846553|NCT04237792|75971423|FG004|COMPLETED|Long Term FU (Any Day From Day 29 to 32)||21||
59846554|NCT04237792|75971424|FG005|COMPLETED|Long Term FU (Any Day From Day 29 to 32)||20||
59846555|NCT04237792|75971419|FG000|NOT COMPLETED|Long Term FU (Any Day From Day 29 to 32)||0||
59846556|NCT04237792|75971420|FG001|NOT COMPLETED|Long Term FU (Any Day From Day 29 to 32)||0||
59846557|NCT04237792|75971421|FG002|NOT COMPLETED|Long Term FU (Any Day From Day 29 to 32)||0||
59846558|NCT04237792|75971422|FG003|NOT COMPLETED|Long Term FU (Any Day From Day 29 to 32)||0||
59846559|NCT04237792|75971423|FG004|NOT COMPLETED|Long Term FU (Any Day From Day 29 to 32)||0||
59846560|NCT04237792|75971424|FG005|NOT COMPLETED|Long Term FU (Any Day From Day 29 to 32)||0||
59846561|NCT00122954|75971455|FG000|STARTED|Overall Study||18||
59846562|NCT00122954|75971456|FG001|STARTED|Overall Study||21||
59846563|NCT00122954|75971455|FG000|COMPLETED|Overall Study||16||
59846564|NCT00122954|75971456|FG001|COMPLETED|Overall Study||18||
59846565|NCT00122954|75971455|FG000|NOT COMPLETED|Overall Study||2||
59846566|NCT00122954|75971456|FG001|NOT COMPLETED|Overall Study||3||
59846567|NCT04491994|75971464|FG000|STARTED|Overall Study||180|15 withdrew consent 5 became symptomatic 13 patients non compliant 7 were lost to follow up|
59846568|NCT04491994|75971465|FG001|STARTED|Overall Study||360|15 withdrew consent 5 became symptomatic 13 patients non compliant 7 were lost to follow up|
60120363|NCT04344028|76241445|FG005|NOT COMPLETED|Overall Study||1||
60120364|NCT01694849|76241462|FG000|STARTED|Treatment Period (Visit 2 to Visit 8)||93||
60120365|NCT01694849|76241463|FG001|STARTED|Treatment Period (Visit 2 to Visit 8)||90||
60120366|NCT01694849|76241464|FG002|STARTED|Treatment Period (Visit 2 to Visit 8)||92||
60120367|NCT01694849|76241462|FG000|Randomized|Treatment Period (Visit 2 to Visit 8)||93||
60120368|NCT01694849|76241463|FG001|Randomized|Treatment Period (Visit 2 to Visit 8)||90||
60120369|NCT01694849|76241464|FG002|Randomized|Treatment Period (Visit 2 to Visit 8)||92||
60120370|NCT01694849|76241462|FG000|Randomised and Received Treatment (Full Analysis Set and Safety Set)|Treatment Period (Visit 2 to Visit 8)||93||
60120371|NCT01694849|76241463|FG001|Randomised and Received Treatment (Full Analysis Set and Safety Set)|Treatment Period (Visit 2 to Visit 8)||89||
59846569|NCT04491994|75971464|FG000|COMPLETED|Overall Study||151||
59846570|NCT04491994|75971465|FG001|COMPLETED|Overall Study||349||
59846571|NCT04491994|75971464|FG000|NOT COMPLETED|Overall Study||29||
59846572|NCT04491994|75971465|FG001|NOT COMPLETED|Overall Study||11||
59846573|NCT04041700|75971471|FG000|STARTED|Overall Study||29||
59846574|NCT04041700|75971471|FG000|COMPLETED|Overall Study||27||
59846575|NCT04041700|75971471|FG000|NOT COMPLETED|Overall Study||2||
60120372|NCT01694849|76241464|FG002|Randomised and Received Treatment (Full Analysis Set and Safety Set)|Treatment Period (Visit 2 to Visit 8)||92||
60120373|NCT01694849|76241462|FG000|Efficacy Evaluable Set|Treatment Period (Visit 2 to Visit 8)||82|The Efficacy Evaluable Set included participants who completed the treatment period and did not have missing liver biopsies.|
60120374|NCT01694849|76241463|FG001|Efficacy Evaluable Set|Treatment Period (Visit 2 to Visit 8)||78|The Efficacy Evaluable Set included participants who completed the treatment period and did not have missing liver biopsies.|
60120375|NCT01694849|76241464|FG002|Efficacy Evaluable Set|Treatment Period (Visit 2 to Visit 8)||77|The Efficacy Evaluable Set included participants who completed the treatment period and did not have missing liver biopsies.|
60120376|NCT01694849|76241462|FG000|COMPLETED|Treatment Period (Visit 2 to Visit 8)||84||
60120377|NCT01694849|76241463|FG001|COMPLETED|Treatment Period (Visit 2 to Visit 8)||79||
60120378|NCT01694849|76241464|FG002|COMPLETED|Treatment Period (Visit 2 to Visit 8)||78||
60120379|NCT01694849|76241462|FG000|NOT COMPLETED|Treatment Period (Visit 2 to Visit 8)||9||
60120380|NCT01694849|76241463|FG001|NOT COMPLETED|Treatment Period (Visit 2 to Visit 8)||11||
60120381|NCT01694849|76241464|FG002|NOT COMPLETED|Treatment Period (Visit 2 to Visit 8)||14||
59846576|NCT04227340|75971477|FG000|STARTED|Overall Study||43||
59846577|NCT04227340|75971477|FG000|COMPLETED|Overall Study||40||
60120382|NCT01694849|76241462|FG000|STARTED|Follow-up Period (to Visit 9)||84||
60120383|NCT01694849|76241463|FG001|STARTED|Follow-up Period (to Visit 9)||79||
60120384|NCT01694849|76241464|FG002|STARTED|Follow-up Period (to Visit 9)||78||
60120385|NCT01694849|76241462|FG000|COMPLETED|Follow-up Period (to Visit 9)||83||
60120386|NCT01694849|76241463|FG001|COMPLETED|Follow-up Period (to Visit 9)||76||
60120387|NCT01694849|76241464|FG002|COMPLETED|Follow-up Period (to Visit 9)||77||
60120388|NCT01694849|76241462|FG000|NOT COMPLETED|Follow-up Period (to Visit 9)||1||
60120389|NCT01694849|76241463|FG001|NOT COMPLETED|Follow-up Period (to Visit 9)||3||
60120390|NCT01694849|76241464|FG002|NOT COMPLETED|Follow-up Period (to Visit 9)||1||
60120391|NCT02643862|76241474|FG000|STARTED|Overall Study||36||
59846578|NCT04227340|75971477|FG000|NOT COMPLETED|Overall Study||3||
59846579|NCT04033432|75971484|FG000|STARTED|Overall Study||14||
59846580|NCT04033432|75971484|FG000|Registered for Study|Overall Study||14||
59846581|NCT04033432|75971484|FG000|Started Cycle 1|Overall Study||14||
59846582|NCT04033432|75971484|FG000|Started Cycle 2|Overall Study||13||
59846583|NCT04033432|75971484|FG000|Started Cycle 3|Overall Study||10||
59846584|NCT04033432|75971484|FG000|Started Cycle 4|Overall Study||7||
59846585|NCT04033432|75971484|FG000|Started Cycle 5|Overall Study||1||
59846586|NCT04033432|75971484|FG000|Started Cycle 6|Overall Study||1||
59846587|NCT04033432|75971484|FG000|Started Cycle 7+|Overall Study||1|Beginning at Cycle 7, cycle length will be 21 days and patients will return for treatment on Day 1 of each cycle.|
59846588|NCT04033432|75971484|FG000|COMPLETED|Overall Study||1||
59846589|NCT04033432|75971484|FG000|NOT COMPLETED|Overall Study||13||
59846590|NCT04223830|75971489|FG000|STARTED|Overall Study||200||
59846591|NCT04223830|75971489|FG000|COMPLETED|Overall Study||190||
59846592|NCT04223830|75971489|FG000|NOT COMPLETED|Overall Study||10||
59846593|NCT04032652|75971496|FG000|STARTED|Overall Study||1||
59846594|NCT04032652|75971497|FG001|STARTED|Overall Study||1||
59846595|NCT04032652|75971496|FG000|COMPLETED|Overall Study||0||
59846596|NCT04032652|75971497|FG001|COMPLETED|Overall Study||0||
59846597|NCT04032652|75971496|FG000|NOT COMPLETED|Overall Study||1||
59846598|NCT04032652|75971497|FG001|NOT COMPLETED|Overall Study||1||
59846599|NCT04031404|75971503|FG000|STARTED|Baseline||10|Randomized|
59846600|NCT04031404|75971504|FG001|STARTED|Baseline||13|Randomized|
59846601|NCT04031404|75971503|FG000|COMPLETED|Baseline||8||
59846602|NCT04031404|75971504|FG001|COMPLETED|Baseline||8||
59846603|NCT04031404|75971503|FG000|NOT COMPLETED|Baseline||2||
59846604|NCT04031404|75971504|FG001|NOT COMPLETED|Baseline||5||
59846605|NCT04031404|75971503|FG000|STARTED|Pre-randomization||8||
59846606|NCT04031404|75971504|FG001|STARTED|Pre-randomization||8||
59846607|NCT04031404|75971503|FG000|COMPLETED|Pre-randomization||6||
59846608|NCT04031404|75971504|FG001|COMPLETED|Pre-randomization||5||
59846609|NCT04031404|75971503|FG000|NOT COMPLETED|Pre-randomization||2||
59846610|NCT04031404|75971504|FG001|NOT COMPLETED|Pre-randomization||3||
59846611|NCT04031404|75971503|FG000|STARTED|First Drink Visit||6||
59846612|NCT04031404|75971504|FG001|STARTED|First Drink Visit||5||
59846613|NCT04031404|75971503|FG000|COMPLETED|First Drink Visit||6||
59846614|NCT04031404|75971504|FG001|COMPLETED|First Drink Visit||5||
59846615|NCT04031404|75971503|FG000|NOT COMPLETED|First Drink Visit||0||
59846616|NCT04031404|75971504|FG001|NOT COMPLETED|First Drink Visit||0||
59846617|NCT04031404|75971503|FG000|STARTED|Washout (5 Day Min)||6||
59846618|NCT04031404|75971504|FG001|STARTED|Washout (5 Day Min)||5||
59846619|NCT04031404|75971503|FG000|COMPLETED|Washout (5 Day Min)||5||
59846620|NCT04031404|75971504|FG001|COMPLETED|Washout (5 Day Min)||5||
59846621|NCT04031404|75971503|FG000|NOT COMPLETED|Washout (5 Day Min)||1||
59846622|NCT04031404|75971504|FG001|NOT COMPLETED|Washout (5 Day Min)||0||
59846623|NCT04031404|75971503|FG000|STARTED|Second Drink Visit||5||
59846624|NCT04031404|75971504|FG001|STARTED|Second Drink Visit||5||
59846625|NCT04031404|75971503|FG000|COMPLETED|Second Drink Visit||5||
59846626|NCT04031404|75971504|FG001|COMPLETED|Second Drink Visit||5||
59846627|NCT04031404|75971503|FG000|NOT COMPLETED|Second Drink Visit||0||
59846628|NCT04031404|75971504|FG001|NOT COMPLETED|Second Drink Visit||0||
59846629|NCT04476784|75971520|FG000|STARTED|First Wear Period (30 Days ± 2 Days)||31||62
59846630|NCT04476784|75971521|FG001|STARTED|First Wear Period (30 Days ± 2 Days)||35||70
59846631|NCT04476784|75971520|FG000|COMPLETED|First Wear Period (30 Days ± 2 Days)||30||60
59846632|NCT04476784|75971521|FG001|COMPLETED|First Wear Period (30 Days ± 2 Days)||35||70
59846633|NCT04476784|75971520|FG000|NOT COMPLETED|First Wear Period (30 Days ± 2 Days)||1||2
60120392|NCT02643862|76241475|FG001|STARTED|Overall Study||12||
60120393|NCT02643862|76241474|FG000|COMPLETED|Overall Study||36||
60120394|NCT02643862|76241475|FG001|COMPLETED|Overall Study||12||
60120395|NCT02643862|76241474|FG000|NOT COMPLETED|Overall Study||0||
59846634|NCT04476784|75971521|FG001|NOT COMPLETED|First Wear Period (30 Days ± 2 Days)||0||0
59846635|NCT04476784|75971520|FG000|STARTED|Second Wear Period (30 Days ± 2 Days)||30||60
59846636|NCT04476784|75971521|FG001|STARTED|Second Wear Period (30 Days ± 2 Days)||35||70
59846637|NCT04476784|75971520|FG000|COMPLETED|Second Wear Period (30 Days ± 2 Days)||30||60
59846638|NCT04476784|75971521|FG001|COMPLETED|Second Wear Period (30 Days ± 2 Days)||35||70
59846639|NCT04476784|75971520|FG000|NOT COMPLETED|Second Wear Period (30 Days ± 2 Days)||0||0
59846640|NCT04476784|75971521|FG001|NOT COMPLETED|Second Wear Period (30 Days ± 2 Days)||0||0
59846641|NCT04026568|75971532|FG000|STARTED|Overall Study||0||
59846642|NCT04026568|75971533|FG001|STARTED|Overall Study||1||
59846643|NCT04026568|75971532|FG000|COMPLETED|Overall Study||0||
59846644|NCT04026568|75971533|FG001|COMPLETED|Overall Study||0||
59846645|NCT04026568|75971532|FG000|NOT COMPLETED|Overall Study||0||
59846646|NCT04026568|75971533|FG001|NOT COMPLETED|Overall Study||1||
59846647|NCT04025632|75971541|FG000|STARTED|Overall Study||15||
59846648|NCT04025632|75971542|FG001|STARTED|Overall Study||12||
60120396|NCT02643862|76241475|FG001|NOT COMPLETED|Overall Study||0||
60120397|NCT02646826|76241485|FG000|STARTED|Overall Study||21||
60120398|NCT02646826|76241486|FG001|STARTED|Overall Study||22||
59846649|NCT04025632|75971541|FG000|Completed Main Portion|Overall Study||15||
59846650|NCT04025632|75971542|FG001|Completed Main Portion|Overall Study||12||
59846651|NCT04025632|75971541|FG000|Started Main Portion Safety Follow-up|Overall Study||2|Refers to study participants who completed the 8-week blinded treatment period in the Main Portion of the study and had not entered the Extension Portion.|
59846652|NCT04025632|75971542|FG001|Started Main Portion Safety Follow-up|Overall Study||0|Refers to study participants who completed the 8-week blinded treatment period in the Main Portion of the study and had not entered the Extension Portion.|
59846653|NCT04025632|75971541|FG000|Completed Main Portion Safety Follow-up|Overall Study||0|Refers to study participants who completed the 8-week blinded treatment period in the Main Portion of the study and had not entered the Extension Portion.|
59846654|NCT04025632|75971542|FG001|Completed Main Portion Safety Follow-up|Overall Study||0|Refers to study participants who completed the 8-week blinded treatment period in the Main Portion of the study and had not entered the Extension Portion.|
59846655|NCT04025632|75971541|FG000|Started Extension Portion|Overall Study||13||
59846656|NCT04025632|75971542|FG001|Started Extension Portion|Overall Study||12||
59846657|NCT04025632|75971541|FG000|COMPLETED|Overall Study||0|Completed Main Portion, Main Portion Safety Follow-up or Extension Portion.|
59846658|NCT04025632|75971542|FG001|COMPLETED|Overall Study||0|Completed Main Portion, Main Portion Safety Follow-up or Extension Portion.|
59846659|NCT04025632|75971541|FG000|NOT COMPLETED|Overall Study||15||
59846660|NCT04025632|75971542|FG001|NOT COMPLETED|Overall Study||12||
59846661|NCT04024228|75971553|FG000|STARTED|Overall Study||774|Randomized|
59846662|NCT04024228|75971554|FG001|STARTED|Overall Study||765|Randomized|
59846663|NCT04024228|75971553|FG000|Vaccinated|Overall Study||772||
59846664|NCT04024228|75971554|FG001|Vaccinated|Overall Study||761||
59846665|NCT04024228|75971553|FG000|Full Analysis Set (FAS)|Overall Study|377 participants (60-64 years) and 392 participants (>=65 years).|769|FAS included all randomized participants who received the study vaccine and had a post-vaccination blood sample.|
59846666|NCT04024228|75971554|FG001|Full Analysis Set (FAS)|Overall Study|377 participants (60-64 years) and 381 participants (>=65 years).|758|FAS included all randomized participants who received the study vaccine and had a post-vaccination blood sample.|
59846667|NCT04024228|75971553|FG000|COMPLETED|Overall Study||770||
59846668|NCT04024228|75971554|FG001|COMPLETED|Overall Study||759||
59846669|NCT04024228|75971553|FG000|NOT COMPLETED|Overall Study||4||
59846670|NCT04024228|75971554|FG001|NOT COMPLETED|Overall Study||6||
59846671|NCT04023994|75971568|FG000|STARTED|Overall Study||10||
59846672|NCT04023994|75971569|FG001|STARTED|Overall Study||4||
59846673|NCT04023994|75971570|FG002|STARTED|Overall Study||4||
59846674|NCT04023994|75971571|FG003|STARTED|Overall Study||6||
59846675|NCT04023994|75971572|FG004|STARTED|Overall Study||6||
59846676|NCT04023994|75971573|FG005|STARTED|Overall Study||6||
59846677|NCT04023994|75971568|FG000|COMPLETED|Overall Study||10||
59846678|NCT04023994|75971569|FG001|COMPLETED|Overall Study||3||
59846679|NCT04023994|75971570|FG002|COMPLETED|Overall Study||2||
59846680|NCT04023994|75971571|FG003|COMPLETED|Overall Study||5||
59846681|NCT04023994|75971572|FG004|COMPLETED|Overall Study||6||
59846682|NCT04023994|75971573|FG005|COMPLETED|Overall Study||6||
59846683|NCT04023994|75971568|FG000|NOT COMPLETED|Overall Study||0||
59846684|NCT04023994|75971569|FG001|NOT COMPLETED|Overall Study||1||
59846685|NCT04023994|75971570|FG002|NOT COMPLETED|Overall Study||2||
59846686|NCT04023994|75971571|FG003|NOT COMPLETED|Overall Study||1||
59846687|NCT04023994|75971572|FG004|NOT COMPLETED|Overall Study||0||
59846688|NCT04023994|75971573|FG005|NOT COMPLETED|Overall Study||0||
59846689|NCT04023682|75971592|FG000|STARTED|Overall Study||31||
59846690|NCT04023682|75971592|FG000|COMPLETED|Overall Study||25||
59846691|NCT04023682|75971592|FG000|NOT COMPLETED|Overall Study||6||
59846692|NCT04018612|75971603|FG000|STARTED|Overall Study||44||
59846693|NCT04018612|75971604|FG001|STARTED|Overall Study||44||
59846694|NCT04018612|75971605|FG002|STARTED|Overall Study||22||
59846695|NCT04018612|75971603|FG000|COMPLETED|Overall Study||43||
59846696|NCT04018612|75971604|FG001|COMPLETED|Overall Study||44||
59846697|NCT04018612|75971605|FG002|COMPLETED|Overall Study||21||
59846698|NCT04018612|75971603|FG000|NOT COMPLETED|Overall Study||1||
59846699|NCT04018612|75971604|FG001|NOT COMPLETED|Overall Study||0||
59846700|NCT04018612|75971605|FG002|NOT COMPLETED|Overall Study||1||
59846701|NCT04209400|75971615|FG000|STARTED|Overall Study||50||
59846702|NCT04209400|75971616|FG001|STARTED|Overall Study||50||
59846703|NCT04209400|75971615|FG000|COMPLETED|Overall Study||50||
59846704|NCT04209400|75971616|FG001|COMPLETED|Overall Study||49||
59846705|NCT04209400|75971615|FG000|NOT COMPLETED|Overall Study||0||
59846706|NCT04209400|75971616|FG001|NOT COMPLETED|Overall Study||1||
59846707|NCT04207840|75971622|FG000|STARTED|Treatment Period 1||9||
59846708|NCT04207840|75971623|FG001|STARTED|Treatment Period 1||10||
59846709|NCT04207840|75971624|FG002|STARTED|Treatment Period 1||9||
59846710|NCT04207840|75971622|FG000|COMPLETED|Treatment Period 1||9||
59846711|NCT04207840|75971623|FG001|COMPLETED|Treatment Period 1||10||
59846712|NCT04207840|75971624|FG002|COMPLETED|Treatment Period 1||9||
59846713|NCT04207840|75971622|FG000|NOT COMPLETED|Treatment Period 1||0||
59846714|NCT04207840|75971623|FG001|NOT COMPLETED|Treatment Period 1||0||
59846715|NCT04207840|75971624|FG002|NOT COMPLETED|Treatment Period 1||0||
59846716|NCT04207840|75971622|FG000|STARTED|Washout Period 1 (2-7 Days)||9||
59846717|NCT04207840|75971623|FG001|STARTED|Washout Period 1 (2-7 Days)||10||
59846718|NCT04207840|75971624|FG002|STARTED|Washout Period 1 (2-7 Days)||9||
59846719|NCT04207840|75971622|FG000|COMPLETED|Washout Period 1 (2-7 Days)||9||
59846720|NCT04207840|75971623|FG001|COMPLETED|Washout Period 1 (2-7 Days)||10||
59846721|NCT04207840|75971624|FG002|COMPLETED|Washout Period 1 (2-7 Days)||8||
59846722|NCT04207840|75971622|FG000|NOT COMPLETED|Washout Period 1 (2-7 Days)||0||
59846723|NCT04207840|75971623|FG001|NOT COMPLETED|Washout Period 1 (2-7 Days)||0||
59846724|NCT04207840|75971624|FG002|NOT COMPLETED|Washout Period 1 (2-7 Days)||1||
59846725|NCT04207840|75971622|FG000|STARTED|Treatment Period 2||9||
59846726|NCT04207840|75971623|FG001|STARTED|Treatment Period 2||10||
59846727|NCT04207840|75971624|FG002|STARTED|Treatment Period 2||8||
59846728|NCT04207840|75971622|FG000|COMPLETED|Treatment Period 2||9||
59846729|NCT04207840|75971623|FG001|COMPLETED|Treatment Period 2||10||
59846730|NCT04207840|75971624|FG002|COMPLETED|Treatment Period 2||8||
59846731|NCT04207840|75971622|FG000|NOT COMPLETED|Treatment Period 2||0||
59846732|NCT04207840|75971623|FG001|NOT COMPLETED|Treatment Period 2||0||
59846733|NCT04207840|75971624|FG002|NOT COMPLETED|Treatment Period 2||0||
59846734|NCT04207840|75971622|FG000|STARTED|Washout Period 2 (2-7 Days)||9||
59846735|NCT04207840|75971623|FG001|STARTED|Washout Period 2 (2-7 Days)||10||
59846736|NCT04207840|75971624|FG002|STARTED|Washout Period 2 (2-7 Days)||8||
59846737|NCT04207840|75971622|FG000|COMPLETED|Washout Period 2 (2-7 Days)||9||
59846738|NCT04207840|75971623|FG001|COMPLETED|Washout Period 2 (2-7 Days)||10||
59846739|NCT04207840|75971624|FG002|COMPLETED|Washout Period 2 (2-7 Days)||7||
59846740|NCT04207840|75971622|FG000|NOT COMPLETED|Washout Period 2 (2-7 Days)||0||
59846741|NCT04207840|75971623|FG001|NOT COMPLETED|Washout Period 2 (2-7 Days)||0||
59846742|NCT04207840|75971624|FG002|NOT COMPLETED|Washout Period 2 (2-7 Days)||1||
59846743|NCT04207840|75971622|FG000|STARTED|Treatment Period 3||9||
59846744|NCT04207840|75971623|FG001|STARTED|Treatment Period 3||10||
59846745|NCT04207840|75971624|FG002|STARTED|Treatment Period 3||7||
59846746|NCT04207840|75971622|FG000|COMPLETED|Treatment Period 3||9||
59846747|NCT04207840|75971623|FG001|COMPLETED|Treatment Period 3||10||
59846748|NCT04207840|75971624|FG002|COMPLETED|Treatment Period 3||7||
59846749|NCT04207840|75971622|FG000|NOT COMPLETED|Treatment Period 3||0||
59846750|NCT04207840|75971623|FG001|NOT COMPLETED|Treatment Period 3||0||
59846751|NCT04207840|75971624|FG002|NOT COMPLETED|Treatment Period 3||0||
59846752|NCT04006366|75971632|FG000|STARTED|Overall Study||6||
59846753|NCT04006366|75971632|FG000|COMPLETED|Overall Study||5||
59846754|NCT04006366|75971632|FG000|NOT COMPLETED|Overall Study||1||
59846755|NCT04191148|75971638|FG000|STARTED|Overall Study||24||
59846756|NCT04191148|75971639|FG001|STARTED|Overall Study||12||
59846757|NCT04191148|75971638|FG000|COMPLETED|Overall Study||22||
59846758|NCT04191148|75971639|FG001|COMPLETED|Overall Study||12||
59846759|NCT04191148|75971638|FG000|NOT COMPLETED|Overall Study||2||
59846760|NCT04191148|75971639|FG001|NOT COMPLETED|Overall Study||0||
60120399|NCT02646826|76241487|FG002|STARTED|Overall Study||21||
60120400|NCT02646826|76241488|FG003|STARTED|Overall Study||22||
60120401|NCT02646826|76241485|FG000|COMPLETED|Overall Study||19||
60120402|NCT02646826|76241486|FG001|COMPLETED|Overall Study||22||
60120403|NCT02646826|76241487|FG002|COMPLETED|Overall Study||20||
60120404|NCT02646826|76241488|FG003|COMPLETED|Overall Study||21||
60120405|NCT02646826|76241485|FG000|NOT COMPLETED|Overall Study||2||
60120406|NCT02646826|76241486|FG001|NOT COMPLETED|Overall Study||0||
60120407|NCT02646826|76241487|FG002|NOT COMPLETED|Overall Study||1||
60120408|NCT02646826|76241488|FG003|NOT COMPLETED|Overall Study||1||
60120409|NCT02648230|76241498|FG000|STARTED|Overall Study||74||
59719826|NCT00941031|75838948|FG002|NOT COMPLETED|Induction Period||6||
59719827|NCT00941031|75838949|FG003|NOT COMPLETED|Induction Period||9||
59719828|NCT00941031|75838950|FG004|NOT COMPLETED|Induction Period||0||
59719829|NCT00941031|75838951|FG005|NOT COMPLETED|Induction Period||0||
59719830|NCT00941031|75838952|FG006|NOT COMPLETED|Induction Period||0||
59719831|NCT00941031|75838946|FG000|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0||
59719832|NCT00941031|75838947|FG001|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0||
59719833|NCT00941031|75838948|FG002|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0||
59719834|NCT00941031|75838949|FG003|STARTED|Maintenance Period|Non Responders treated with an open label regimen.|0||
59719835|NCT00941031|75838950|FG004|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|65||
59719836|NCT00941031|75838951|FG005|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|67||
59719837|NCT00941031|75838952|FG006|STARTED|Maintenance Period|Non Responders treated with an open label regimen.|247||
59719838|NCT00941031|75838946|FG000|COMPLETED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0||
59846761|NCT04004260|75971649|FG000|STARTED|Overall Study||79||
59846762|NCT04004260|75971650|FG001|STARTED|Overall Study||79||
59846763|NCT04004260|75971649|FG000|COMPLETED|Overall Study||37||
60120410|NCT02648230|76241498|FG000|COMPLETED|Overall Study||74||
60120411|NCT02648230|76241498|FG000|NOT COMPLETED|Overall Study||0||
60120412|NCT02649322|76241504|FG000|STARTED|Overall Study||58||
59846764|NCT04004260|75971650|FG001|COMPLETED|Overall Study||47||
59846765|NCT04004260|75971649|FG000|NOT COMPLETED|Overall Study||42||
59846766|NCT04004260|75971650|FG001|NOT COMPLETED|Overall Study||32||
59846767|NCT04470622|75971658|FG000|STARTED|Overall Study||12||
59846768|NCT04470622|75971659|FG001|STARTED|Overall Study||14||
59846769|NCT04470622|75971658|FG000|COMPLETED|Overall Study||12||
59846770|NCT04470622|75971659|FG001|COMPLETED|Overall Study||11||
59846771|NCT04470622|75971658|FG000|NOT COMPLETED|Overall Study||0||
59846772|NCT04470622|75971659|FG001|NOT COMPLETED|Overall Study||3||
59846773|NCT04465630|75971665|FG000|STARTED|Overall Study||78||
59846774|NCT04465630|75971665|FG000|COMPLETED|Overall Study||0||
59846775|NCT04465630|75971665|FG000|NOT COMPLETED|Overall Study||78||
59846776|NCT04182880|75971672|FG000|STARTED|Overall Study||5||
59846777|NCT04182880|75971673|FG001|STARTED|Overall Study||15||
59846778|NCT04182880|75971672|FG000|COMPLETED|Overall Study||4||
59846779|NCT04182880|75971673|FG001|COMPLETED|Overall Study||15||
59846780|NCT04182880|75971672|FG000|NOT COMPLETED|Overall Study||1||
59846781|NCT04182880|75971673|FG001|NOT COMPLETED|Overall Study||0||
59846782|NCT04465396|75971683|FG000|STARTED|Treatment Period 1 (Day 1)||16||
59846783|NCT04465396|75971684|FG001|STARTED|Treatment Period 1 (Day 1)||16||
59846784|NCT04465396|75971685|FG002|STARTED|Treatment Period 1 (Day 1)||16||
59846785|NCT04465396|75971686|FG003|STARTED|Treatment Period 1 (Day 1)||16||
59846786|NCT04465396|75971683|FG000|COMPLETED|Treatment Period 1 (Day 1)||16||
59846787|NCT04465396|75971684|FG001|COMPLETED|Treatment Period 1 (Day 1)||16||
59846788|NCT04465396|75971685|FG002|COMPLETED|Treatment Period 1 (Day 1)||16||
59846789|NCT04465396|75971686|FG003|COMPLETED|Treatment Period 1 (Day 1)||16||
59846790|NCT04465396|75971683|FG000|NOT COMPLETED|Treatment Period 1 (Day 1)||0||
59846791|NCT04465396|75971684|FG001|NOT COMPLETED|Treatment Period 1 (Day 1)||0||
59846792|NCT04465396|75971685|FG002|NOT COMPLETED|Treatment Period 1 (Day 1)||0||
59846793|NCT04465396|75971686|FG003|NOT COMPLETED|Treatment Period 1 (Day 1)||0||
59846794|NCT04465396|75971683|FG000|STARTED|Washout Period (7 Days)||16||
59846795|NCT04465396|75971684|FG001|STARTED|Washout Period (7 Days)||16||
59846796|NCT04465396|75971685|FG002|STARTED|Washout Period (7 Days)||16||
59846797|NCT04465396|75971686|FG003|STARTED|Washout Period (7 Days)||16||
59846798|NCT04465396|75971683|FG000|COMPLETED|Washout Period (7 Days)||16||
59846799|NCT04465396|75971684|FG001|COMPLETED|Washout Period (7 Days)||16||
59846800|NCT04465396|75971685|FG002|COMPLETED|Washout Period (7 Days)||16||
59846801|NCT04465396|75971686|FG003|COMPLETED|Washout Period (7 Days)||16||
59846802|NCT04465396|75971683|FG000|NOT COMPLETED|Washout Period (7 Days)||0||
59846803|NCT04465396|75971684|FG001|NOT COMPLETED|Washout Period (7 Days)||0||
59846804|NCT04465396|75971685|FG002|NOT COMPLETED|Washout Period (7 Days)||0||
59846805|NCT04465396|75971686|FG003|NOT COMPLETED|Washout Period (7 Days)||0||
59846806|NCT04465396|75971683|FG000|STARTED|Treatment Period 2 (Day 1)||16||
59846807|NCT04465396|75971684|FG001|STARTED|Treatment Period 2 (Day 1)||16||
59846808|NCT04465396|75971685|FG002|STARTED|Treatment Period 2 (Day 1)||16||
59846809|NCT04465396|75971686|FG003|STARTED|Treatment Period 2 (Day 1)||16||
59846810|NCT04465396|75971683|FG000|COMPLETED|Treatment Period 2 (Day 1)||16||
59846811|NCT04465396|75971684|FG001|COMPLETED|Treatment Period 2 (Day 1)||15||
59846812|NCT04465396|75971685|FG002|COMPLETED|Treatment Period 2 (Day 1)||15||
59846813|NCT04465396|75971686|FG003|COMPLETED|Treatment Period 2 (Day 1)||16||
59846814|NCT04465396|75971683|FG000|NOT COMPLETED|Treatment Period 2 (Day 1)||0||
59846815|NCT04465396|75971684|FG001|NOT COMPLETED|Treatment Period 2 (Day 1)||1||
59846816|NCT04465396|75971685|FG002|NOT COMPLETED|Treatment Period 2 (Day 1)||1||
59846817|NCT04465396|75971686|FG003|NOT COMPLETED|Treatment Period 2 (Day 1)||0||
59846818|NCT03999892|75971711|FG000|STARTED|Overall Study||17||
59846819|NCT03999892|75971711|FG000|COMPLETED|Overall Study||16||
59846820|NCT03999892|75971711|FG000|NOT COMPLETED|Overall Study||1||
59846821|NCT03996694|75971715|FG000|STARTED|First Intervention (1 Day)||3||
59846822|NCT03996694|75971716|FG001|STARTED|First Intervention (1 Day)||3||
59846823|NCT03996694|75971717|FG002|STARTED|First Intervention (1 Day)||4||
59719839|NCT00941031|75838947|FG001|COMPLETED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0||
59719840|NCT00941031|75838948|FG002|COMPLETED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0||
59719841|NCT00941031|75838949|FG003|COMPLETED|Maintenance Period|Non Responders treated with an open label regimen.|0||
59846824|NCT03996694|75971718|FG003|STARTED|First Intervention (1 Day)||3||
59846825|NCT03996694|75971719|FG004|STARTED|First Intervention (1 Day)||3||
59846826|NCT03996694|75971720|FG005|STARTED|First Intervention (1 Day)||3||
59846827|NCT03996694|75971715|FG000|COMPLETED|First Intervention (1 Day)||3||
59846828|NCT03996694|75971716|FG001|COMPLETED|First Intervention (1 Day)||3||
59846829|NCT03996694|75971717|FG002|COMPLETED|First Intervention (1 Day)||4||
59846830|NCT03996694|75971718|FG003|COMPLETED|First Intervention (1 Day)||3||
59719842|NCT00941031|75838950|FG004|COMPLETED|Maintenance Period||56||
59719843|NCT00941031|75838951|FG005|COMPLETED|Maintenance Period||61||
59719844|NCT00941031|75838952|FG006|COMPLETED|Maintenance Period||204||
59719845|NCT00941031|75838946|FG000|NOT COMPLETED|Maintenance Period||0||
59846831|NCT03996694|75971719|FG004|COMPLETED|First Intervention (1 Day)||3||
59846832|NCT03996694|75971720|FG005|COMPLETED|First Intervention (1 Day)||3||
59846833|NCT03996694|75971715|FG000|NOT COMPLETED|First Intervention (1 Day)||0||
59846834|NCT03996694|75971716|FG001|NOT COMPLETED|First Intervention (1 Day)||0||
59846835|NCT03996694|75971717|FG002|NOT COMPLETED|First Intervention (1 Day)||0||
59846836|NCT03996694|75971718|FG003|NOT COMPLETED|First Intervention (1 Day)||0||
59846837|NCT03996694|75971719|FG004|NOT COMPLETED|First Intervention (1 Day)||0||
59846838|NCT03996694|75971720|FG005|NOT COMPLETED|First Intervention (1 Day)||0||
59846839|NCT03996694|75971715|FG000|STARTED|First Washout (7 Days)||3||
59846840|NCT03996694|75971716|FG001|STARTED|First Washout (7 Days)||3||
59846841|NCT03996694|75971717|FG002|STARTED|First Washout (7 Days)||4||
59846842|NCT03996694|75971718|FG003|STARTED|First Washout (7 Days)||3||
59846843|NCT03996694|75971719|FG004|STARTED|First Washout (7 Days)||3||
59846844|NCT03996694|75971720|FG005|STARTED|First Washout (7 Days)||3||
59846845|NCT03996694|75971715|FG000|COMPLETED|First Washout (7 Days)||3||
59846846|NCT03996694|75971716|FG001|COMPLETED|First Washout (7 Days)||2||
59846847|NCT03996694|75971717|FG002|COMPLETED|First Washout (7 Days)||2||
59846848|NCT03996694|75971718|FG003|COMPLETED|First Washout (7 Days)||3||
59846849|NCT03996694|75971719|FG004|COMPLETED|First Washout (7 Days)||3||
59846850|NCT03996694|75971720|FG005|COMPLETED|First Washout (7 Days)||3||
59846851|NCT03996694|75971715|FG000|NOT COMPLETED|First Washout (7 Days)||0||
59846852|NCT03996694|75971716|FG001|NOT COMPLETED|First Washout (7 Days)||1||
59846853|NCT03996694|75971717|FG002|NOT COMPLETED|First Washout (7 Days)||2||
59846854|NCT03996694|75971718|FG003|NOT COMPLETED|First Washout (7 Days)||0||
59846855|NCT03996694|75971719|FG004|NOT COMPLETED|First Washout (7 Days)||0||
59846856|NCT03996694|75971720|FG005|NOT COMPLETED|First Washout (7 Days)||0||
59846857|NCT03996694|75971715|FG000|STARTED|Second Intervention (1 Day)||3||
59846858|NCT03996694|75971716|FG001|STARTED|Second Intervention (1 Day)||2||
59846859|NCT03996694|75971717|FG002|STARTED|Second Intervention (1 Day)||2||
59846860|NCT03996694|75971718|FG003|STARTED|Second Intervention (1 Day)||3||
59846861|NCT03996694|75971719|FG004|STARTED|Second Intervention (1 Day)||3||
59846862|NCT03996694|75971720|FG005|STARTED|Second Intervention (1 Day)||3||
59846863|NCT03996694|75971715|FG000|COMPLETED|Second Intervention (1 Day)||3||
59846864|NCT03996694|75971716|FG001|COMPLETED|Second Intervention (1 Day)||2||
59846865|NCT03996694|75971717|FG002|COMPLETED|Second Intervention (1 Day)||2||
59846866|NCT03996694|75971718|FG003|COMPLETED|Second Intervention (1 Day)||3||
59846867|NCT03996694|75971719|FG004|COMPLETED|Second Intervention (1 Day)||3||
59846868|NCT03996694|75971720|FG005|COMPLETED|Second Intervention (1 Day)||3||
59846869|NCT03996694|75971715|FG000|NOT COMPLETED|Second Intervention (1 Day)||0||
59846870|NCT03996694|75971716|FG001|NOT COMPLETED|Second Intervention (1 Day)||0||
59846871|NCT03996694|75971717|FG002|NOT COMPLETED|Second Intervention (1 Day)||0||
59846872|NCT03996694|75971718|FG003|NOT COMPLETED|Second Intervention (1 Day)||0||
59846873|NCT03996694|75971719|FG004|NOT COMPLETED|Second Intervention (1 Day)||0||
59846874|NCT03996694|75971720|FG005|NOT COMPLETED|Second Intervention (1 Day)||0||
59846875|NCT03996694|75971715|FG000|STARTED|Second Washout (7 Days)||3||
59846876|NCT03996694|75971716|FG001|STARTED|Second Washout (7 Days)||2||
59846877|NCT03996694|75971717|FG002|STARTED|Second Washout (7 Days)||2||
59846878|NCT03996694|75971718|FG003|STARTED|Second Washout (7 Days)||3||
59846879|NCT03996694|75971719|FG004|STARTED|Second Washout (7 Days)||3||
59846880|NCT03996694|75971720|FG005|STARTED|Second Washout (7 Days)||3||
59846881|NCT03996694|75971715|FG000|COMPLETED|Second Washout (7 Days)||3||
59846882|NCT03996694|75971716|FG001|COMPLETED|Second Washout (7 Days)||2||
59846883|NCT03996694|75971717|FG002|COMPLETED|Second Washout (7 Days)||2||
59846884|NCT03996694|75971718|FG003|COMPLETED|Second Washout (7 Days)||3||
59846885|NCT03996694|75971719|FG004|COMPLETED|Second Washout (7 Days)||3||
59846886|NCT03996694|75971720|FG005|COMPLETED|Second Washout (7 Days)||3||
59846887|NCT03996694|75971715|FG000|NOT COMPLETED|Second Washout (7 Days)||0||
59846888|NCT03996694|75971716|FG001|NOT COMPLETED|Second Washout (7 Days)||0||
59846889|NCT03996694|75971717|FG002|NOT COMPLETED|Second Washout (7 Days)||0||
59846890|NCT03996694|75971718|FG003|NOT COMPLETED|Second Washout (7 Days)||0||
59846891|NCT03996694|75971719|FG004|NOT COMPLETED|Second Washout (7 Days)||0||
59846892|NCT03996694|75971720|FG005|NOT COMPLETED|Second Washout (7 Days)||0||
60120413|NCT02649322|76241505|FG001|STARTED|Overall Study||57||
59846893|NCT03996694|75971715|FG000|STARTED|Third Intervention (1 Day)||3||
59846894|NCT03996694|75971716|FG001|STARTED|Third Intervention (1 Day)||2||
59846895|NCT03996694|75971717|FG002|STARTED|Third Intervention (1 Day)||2||
59846896|NCT03996694|75971718|FG003|STARTED|Third Intervention (1 Day)||3||
59846897|NCT03996694|75971719|FG004|STARTED|Third Intervention (1 Day)||3||
59846898|NCT03996694|75971720|FG005|STARTED|Third Intervention (1 Day)||3||
59846899|NCT03996694|75971715|FG000|COMPLETED|Third Intervention (1 Day)||3||
59846900|NCT03996694|75971716|FG001|COMPLETED|Third Intervention (1 Day)||2||
59846901|NCT03996694|75971717|FG002|COMPLETED|Third Intervention (1 Day)||2||
59846902|NCT03996694|75971718|FG003|COMPLETED|Third Intervention (1 Day)||3||
59846903|NCT03996694|75971719|FG004|COMPLETED|Third Intervention (1 Day)||3||
59846904|NCT03996694|75971720|FG005|COMPLETED|Third Intervention (1 Day)||3||
59846905|NCT03996694|75971715|FG000|NOT COMPLETED|Third Intervention (1 Day)||0||
59846906|NCT03996694|75971716|FG001|NOT COMPLETED|Third Intervention (1 Day)||0||
59846907|NCT03996694|75971717|FG002|NOT COMPLETED|Third Intervention (1 Day)||0||
59846908|NCT03996694|75971718|FG003|NOT COMPLETED|Third Intervention (1 Day)||0||
59846909|NCT03996694|75971719|FG004|NOT COMPLETED|Third Intervention (1 Day)||0||
59846910|NCT03996694|75971720|FG005|NOT COMPLETED|Third Intervention (1 Day)||0||
59846911|NCT03996694|75971715|FG000|STARTED|Third Washout (7 Days)||3||
59846912|NCT03996694|75971716|FG001|STARTED|Third Washout (7 Days)||2||
59846913|NCT03996694|75971717|FG002|STARTED|Third Washout (7 Days)||2||
59846914|NCT03996694|75971718|FG003|STARTED|Third Washout (7 Days)||3||
59846915|NCT03996694|75971719|FG004|STARTED|Third Washout (7 Days)||3||
59846916|NCT03996694|75971720|FG005|STARTED|Third Washout (7 Days)||3||
59846917|NCT03996694|75971715|FG000|COMPLETED|Third Washout (7 Days)||3||
59846918|NCT03996694|75971716|FG001|COMPLETED|Third Washout (7 Days)||2||
59846919|NCT03996694|75971717|FG002|COMPLETED|Third Washout (7 Days)||2||
59846920|NCT03996694|75971718|FG003|COMPLETED|Third Washout (7 Days)||3||
59846921|NCT03996694|75971719|FG004|COMPLETED|Third Washout (7 Days)||2||
59846922|NCT03996694|75971720|FG005|COMPLETED|Third Washout (7 Days)||3||
59846923|NCT03996694|75971715|FG000|NOT COMPLETED|Third Washout (7 Days)||0||
59846924|NCT03996694|75971716|FG001|NOT COMPLETED|Third Washout (7 Days)||0||
59846925|NCT03996694|75971717|FG002|NOT COMPLETED|Third Washout (7 Days)||0||
59846926|NCT03996694|75971718|FG003|NOT COMPLETED|Third Washout (7 Days)||0||
59846927|NCT03996694|75971719|FG004|NOT COMPLETED|Third Washout (7 Days)||1||
59846928|NCT03996694|75971720|FG005|NOT COMPLETED|Third Washout (7 Days)||0||
59846929|NCT03996694|75971715|FG000|STARTED|Fourth Intervention (1 Day)||3||
59846930|NCT03996694|75971716|FG001|STARTED|Fourth Intervention (1 Day)||2||
60120414|NCT02649322|76241504|FG000|COMPLETED|Overall Study||58||
59719846|NCT00941031|75838947|FG001|NOT COMPLETED|Maintenance Period||0||
59719847|NCT00941031|75838948|FG002|NOT COMPLETED|Maintenance Period||0||
59719848|NCT00941031|75838949|FG003|NOT COMPLETED|Maintenance Period||0||
59719849|NCT00941031|75838950|FG004|NOT COMPLETED|Maintenance Period||9||
59719850|NCT00941031|75838951|FG005|NOT COMPLETED|Maintenance Period||6||
59719851|NCT00941031|75838952|FG006|NOT COMPLETED|Maintenance Period||43||
59719852|NCT00886834|75838973|FG000|STARTED|Overall Study||54||
59719853|NCT00886834|75838974|FG001|STARTED|Overall Study||54||
59719854|NCT00886834|75838973|FG000|COMPLETED|Overall Study||54||
59719855|NCT00886834|75838974|FG001|COMPLETED|Overall Study||51||
59719856|NCT00886834|75838973|FG000|NOT COMPLETED|Overall Study||0||
59719857|NCT00886834|75838974|FG001|NOT COMPLETED|Overall Study||3||
59719858|NCT00880009|75838980|FG000|STARTED|Overall Study||16||
59719859|NCT00880009|75838980|FG000|COMPLETED|Overall Study||0||
59719860|NCT00880009|75838980|FG000|NOT COMPLETED|Overall Study||16||
59719861|NCT01104636|75838987|FG000|STARTED|Overall Study||1177||
59719862|NCT01104636|75838987|FG000|COMPLETED|Overall Study||999||
59719863|NCT01104636|75838987|FG000|NOT COMPLETED|Overall Study||178||
59719864|NCT01104558|75838991|FG000|STARTED|Overall Study||100||
59719865|NCT01104558|75838991|FG000|COMPLETED|Overall Study||83||
59719866|NCT01104558|75838991|FG000|NOT COMPLETED|Overall Study||17||
59719867|NCT00886288|75838997|FG000|STARTED|Overall Study|Baseline Population|2027||
59719868|NCT00886288|75838998|FG001|STARTED|Overall Study|Baseline Population|684||
59719869|NCT00886288|75838997|FG000|COMPLETED|Overall Study||1284||
59719870|NCT00886288|75838998|FG001|COMPLETED|Overall Study||457||
59719871|NCT00886288|75838997|FG000|NOT COMPLETED|Overall Study||743||
59719872|NCT00886288|75838998|FG001|NOT COMPLETED|Overall Study||227||
59719873|NCT01204658|75839010|FG000|STARTED|Primary Phase||146||
59719874|NCT01204658|75839011|FG001|STARTED|Primary Phase||142||
59719875|NCT01204658|75839012|FG002|STARTED|Primary Phase||145||
59719876|NCT01204658|75839013|FG003|STARTED|Primary Phase||142||
59719877|NCT01204658|75839010|FG000|COMPLETED|Primary Phase||146||
59719878|NCT01204658|75839011|FG001|COMPLETED|Primary Phase||142||
59719879|NCT01204658|75839012|FG002|COMPLETED|Primary Phase||144||
59719880|NCT01204658|75839013|FG003|COMPLETED|Primary Phase||142||
59719881|NCT01204658|75839010|FG000|NOT COMPLETED|Primary Phase||0||
59719882|NCT01204658|75839011|FG001|NOT COMPLETED|Primary Phase||0||
59719883|NCT01204658|75839012|FG002|NOT COMPLETED|Primary Phase||1||
59719884|NCT01204658|75839013|FG003|NOT COMPLETED|Primary Phase||0||
59719885|NCT01204658|75839010|FG000|STARTED|Booster Phase|Not all subjects completing the primary vaccination returned for the booster phase.|144||
59719886|NCT01204658|75839011|FG001|STARTED|Booster Phase|Not all subjects completing the primary vaccination returned for the booster phase.|140||
59719887|NCT01204658|75839012|FG002|STARTED|Booster Phase|Not all subjects completing the primary vaccination returned for the booster phase.|140||
59719888|NCT01204658|75839013|FG003|STARTED|Booster Phase|Not all subjects completing the primary vaccination returned for the booster phase.|140||
59719889|NCT01204658|75839010|FG000|COMPLETED|Booster Phase||144||
59719890|NCT01204658|75839011|FG001|COMPLETED|Booster Phase||140||
59719891|NCT01204658|75839012|FG002|COMPLETED|Booster Phase||140||
59719892|NCT01204658|75839013|FG003|COMPLETED|Booster Phase||140||
59719893|NCT01204658|75839010|FG000|NOT COMPLETED|Booster Phase||0||
59719894|NCT01204658|75839011|FG001|NOT COMPLETED|Booster Phase||0||
59719895|NCT01204658|75839012|FG002|NOT COMPLETED|Booster Phase||0||
59719896|NCT01204658|75839013|FG003|NOT COMPLETED|Booster Phase||0||
59719897|NCT00951483|75839028|FG000|STARTED|Overall Study||47||
59719898|NCT00951483|75839029|FG001|STARTED|Overall Study||44||
59719899|NCT00951483|75839028|FG000|COMPLETED|Overall Study||28||
59846931|NCT03996694|75971717|FG002|STARTED|Fourth Intervention (1 Day)||2||
59846932|NCT03996694|75971718|FG003|STARTED|Fourth Intervention (1 Day)||3||
59846933|NCT03996694|75971719|FG004|STARTED|Fourth Intervention (1 Day)||2||
59846934|NCT03996694|75971720|FG005|STARTED|Fourth Intervention (1 Day)||3||
59846935|NCT03996694|75971715|FG000|COMPLETED|Fourth Intervention (1 Day)||3||
59846936|NCT03996694|75971716|FG001|COMPLETED|Fourth Intervention (1 Day)||2||
59846937|NCT03996694|75971717|FG002|COMPLETED|Fourth Intervention (1 Day)||2||
59846938|NCT03996694|75971718|FG003|COMPLETED|Fourth Intervention (1 Day)||3||
59846939|NCT03996694|75971719|FG004|COMPLETED|Fourth Intervention (1 Day)||2||
59846940|NCT03996694|75971720|FG005|COMPLETED|Fourth Intervention (1 Day)||3||
59846941|NCT03996694|75971715|FG000|NOT COMPLETED|Fourth Intervention (1 Day)||0||
59846942|NCT03996694|75971716|FG001|NOT COMPLETED|Fourth Intervention (1 Day)||0||
59846943|NCT03996694|75971717|FG002|NOT COMPLETED|Fourth Intervention (1 Day)||0||
59846944|NCT03996694|75971718|FG003|NOT COMPLETED|Fourth Intervention (1 Day)||0||
59846945|NCT03996694|75971719|FG004|NOT COMPLETED|Fourth Intervention (1 Day)||0||
59846946|NCT03996694|75971720|FG005|NOT COMPLETED|Fourth Intervention (1 Day)||0||
59846947|NCT03996694|75971715|FG000|STARTED|Fourth Washout (7 Days)||3||
59846948|NCT03996694|75971716|FG001|STARTED|Fourth Washout (7 Days)||2||
59846949|NCT03996694|75971717|FG002|STARTED|Fourth Washout (7 Days)||2||
59846950|NCT03996694|75971718|FG003|STARTED|Fourth Washout (7 Days)||3||
59846951|NCT03996694|75971719|FG004|STARTED|Fourth Washout (7 Days)||2||
59846952|NCT03996694|75971720|FG005|STARTED|Fourth Washout (7 Days)||3||
59846953|NCT03996694|75971715|FG000|COMPLETED|Fourth Washout (7 Days)||3||
59846954|NCT03996694|75971716|FG001|COMPLETED|Fourth Washout (7 Days)||2||
59846955|NCT03996694|75971717|FG002|COMPLETED|Fourth Washout (7 Days)||2||
59846956|NCT03996694|75971718|FG003|COMPLETED|Fourth Washout (7 Days)||3||
59846957|NCT03996694|75971719|FG004|COMPLETED|Fourth Washout (7 Days)||2||
59846958|NCT03996694|75971720|FG005|COMPLETED|Fourth Washout (7 Days)||3||
59846959|NCT03996694|75971715|FG000|NOT COMPLETED|Fourth Washout (7 Days)||0||
59846960|NCT03996694|75971716|FG001|NOT COMPLETED|Fourth Washout (7 Days)||0||
59846961|NCT03996694|75971717|FG002|NOT COMPLETED|Fourth Washout (7 Days)||0||
59846962|NCT03996694|75971718|FG003|NOT COMPLETED|Fourth Washout (7 Days)||0||
59846963|NCT03996694|75971719|FG004|NOT COMPLETED|Fourth Washout (7 Days)||0||
59846964|NCT03996694|75971720|FG005|NOT COMPLETED|Fourth Washout (7 Days)||0||
59846965|NCT03996694|75971715|FG000|STARTED|Fifth Intervention (1 Day)||3||
59846966|NCT03996694|75971716|FG001|STARTED|Fifth Intervention (1 Day)||2||
59846967|NCT03996694|75971717|FG002|STARTED|Fifth Intervention (1 Day)||2||
59846968|NCT03996694|75971718|FG003|STARTED|Fifth Intervention (1 Day)||3||
59846969|NCT03996694|75971719|FG004|STARTED|Fifth Intervention (1 Day)||2||
59846970|NCT03996694|75971720|FG005|STARTED|Fifth Intervention (1 Day)||3||
59846971|NCT03996694|75971715|FG000|COMPLETED|Fifth Intervention (1 Day)||3||
59846972|NCT03996694|75971716|FG001|COMPLETED|Fifth Intervention (1 Day)||2||
59846973|NCT03996694|75971717|FG002|COMPLETED|Fifth Intervention (1 Day)||2||
59846974|NCT03996694|75971718|FG003|COMPLETED|Fifth Intervention (1 Day)||3||
59846975|NCT03996694|75971719|FG004|COMPLETED|Fifth Intervention (1 Day)||2||
59846976|NCT03996694|75971720|FG005|COMPLETED|Fifth Intervention (1 Day)||3||
59846977|NCT03996694|75971715|FG000|NOT COMPLETED|Fifth Intervention (1 Day)||0||
59846978|NCT03996694|75971716|FG001|NOT COMPLETED|Fifth Intervention (1 Day)||0||
59846979|NCT03996694|75971717|FG002|NOT COMPLETED|Fifth Intervention (1 Day)||0||
59846980|NCT03996694|75971718|FG003|NOT COMPLETED|Fifth Intervention (1 Day)||0||
59846981|NCT03996694|75971719|FG004|NOT COMPLETED|Fifth Intervention (1 Day)||0||
59846982|NCT03996694|75971720|FG005|NOT COMPLETED|Fifth Intervention (1 Day)||0||
59846983|NCT03996694|75971715|FG000|STARTED|Fifth Washout (7 Days)||3||
59846984|NCT03996694|75971716|FG001|STARTED|Fifth Washout (7 Days)||2||
59846985|NCT03996694|75971717|FG002|STARTED|Fifth Washout (7 Days)||2||
59846986|NCT03996694|75971718|FG003|STARTED|Fifth Washout (7 Days)||3||
59846987|NCT03996694|75971719|FG004|STARTED|Fifth Washout (7 Days)||2||
59846988|NCT03996694|75971720|FG005|STARTED|Fifth Washout (7 Days)||3||
59846989|NCT03996694|75971715|FG000|COMPLETED|Fifth Washout (7 Days)||3||
59846990|NCT03996694|75971716|FG001|COMPLETED|Fifth Washout (7 Days)||2||
59846991|NCT03996694|75971717|FG002|COMPLETED|Fifth Washout (7 Days)||2||
59846992|NCT03996694|75971718|FG003|COMPLETED|Fifth Washout (7 Days)||3||
59846993|NCT03996694|75971719|FG004|COMPLETED|Fifth Washout (7 Days)||2||
59846994|NCT03996694|75971720|FG005|COMPLETED|Fifth Washout (7 Days)||3||
60120415|NCT02649322|76241505|FG001|COMPLETED|Overall Study||57||
60120416|NCT02649322|76241504|FG000|NOT COMPLETED|Overall Study||0||
60120417|NCT02649322|76241505|FG001|NOT COMPLETED|Overall Study||0||
59846995|NCT03996694|75971715|FG000|NOT COMPLETED|Fifth Washout (7 Days)||0||
59846996|NCT03996694|75971716|FG001|NOT COMPLETED|Fifth Washout (7 Days)||0||
59567934|NCT03762213|75670818|FG001|NOT COMPLETED|Overall Study||0||
59846997|NCT03996694|75971717|FG002|NOT COMPLETED|Fifth Washout (7 Days)||0||
59846998|NCT03996694|75971718|FG003|NOT COMPLETED|Fifth Washout (7 Days)||0||
59846999|NCT03996694|75971719|FG004|NOT COMPLETED|Fifth Washout (7 Days)||0||
59847000|NCT03996694|75971720|FG005|NOT COMPLETED|Fifth Washout (7 Days)||0||
60120418|NCT01694771|76241513|FG000|STARTED|Overall Study||567||
60120419|NCT01694771|76241514|FG001|STARTED|Overall Study||565||
59847001|NCT03996694|75971715|FG000|STARTED|Sixth Intervention (1 Day)||3||
59847002|NCT03996694|75971716|FG001|STARTED|Sixth Intervention (1 Day)||2||
59847003|NCT03996694|75971717|FG002|STARTED|Sixth Intervention (1 Day)||2||
59847004|NCT03996694|75971718|FG003|STARTED|Sixth Intervention (1 Day)||3||
59847005|NCT03996694|75971719|FG004|STARTED|Sixth Intervention (1 Day)||2||
59847006|NCT03996694|75971720|FG005|STARTED|Sixth Intervention (1 Day)||3||
59847007|NCT03996694|75971715|FG000|COMPLETED|Sixth Intervention (1 Day)||3||
59847008|NCT03996694|75971716|FG001|COMPLETED|Sixth Intervention (1 Day)||2||
59847009|NCT03996694|75971717|FG002|COMPLETED|Sixth Intervention (1 Day)||2||
59847010|NCT03996694|75971718|FG003|COMPLETED|Sixth Intervention (1 Day)||3||
59847011|NCT03996694|75971719|FG004|COMPLETED|Sixth Intervention (1 Day)||2||
59847012|NCT03996694|75971720|FG005|COMPLETED|Sixth Intervention (1 Day)||3||
59847013|NCT03996694|75971715|FG000|NOT COMPLETED|Sixth Intervention (1 Day)||0||
59847014|NCT03996694|75971716|FG001|NOT COMPLETED|Sixth Intervention (1 Day)||0||
59847015|NCT03996694|75971717|FG002|NOT COMPLETED|Sixth Intervention (1 Day)||0||
59847016|NCT03996694|75971718|FG003|NOT COMPLETED|Sixth Intervention (1 Day)||0||
59847017|NCT03996694|75971719|FG004|NOT COMPLETED|Sixth Intervention (1 Day)||0||
59847018|NCT03996694|75971720|FG005|NOT COMPLETED|Sixth Intervention (1 Day)||0||
59847019|NCT04179838|75971736|FG000|STARTED|First Intervention (1 Day)||13||
59847020|NCT04179838|75971737|FG001|STARTED|First Intervention (1 Day)||16||
59847021|NCT04179838|75971736|FG000|COMPLETED|First Intervention (1 Day)||13||
59847022|NCT04179838|75971737|FG001|COMPLETED|First Intervention (1 Day)||13||
59847023|NCT04179838|75971736|FG000|NOT COMPLETED|First Intervention (1 Day)||0||
59847024|NCT04179838|75971737|FG001|NOT COMPLETED|First Intervention (1 Day)||3||
59847025|NCT04179838|75971736|FG000|STARTED|Washout (4 Weeks)||13||
59847026|NCT04179838|75971737|FG001|STARTED|Washout (4 Weeks)||13||
59847027|NCT04179838|75971736|FG000|COMPLETED|Washout (4 Weeks)||13||
59847028|NCT04179838|75971737|FG001|COMPLETED|Washout (4 Weeks)||13||
59847029|NCT04179838|75971736|FG000|NOT COMPLETED|Washout (4 Weeks)||0||
59847030|NCT04179838|75971737|FG001|NOT COMPLETED|Washout (4 Weeks)||0||
59847031|NCT04179838|75971736|FG000|STARTED|Second Intervention (1 Day)||13||
59847032|NCT04179838|75971737|FG001|STARTED|Second Intervention (1 Day)||13||
59847033|NCT04179838|75971736|FG000|COMPLETED|Second Intervention (1 Day)||13||
59847034|NCT04179838|75971737|FG001|COMPLETED|Second Intervention (1 Day)||12||
59847035|NCT04179838|75971736|FG000|NOT COMPLETED|Second Intervention (1 Day)||0||
59847036|NCT04179838|75971737|FG001|NOT COMPLETED|Second Intervention (1 Day)||1||
59847037|NCT03994120|75971745|FG000|STARTED|Overall Study||7||
59847038|NCT03994120|75971746|FG001|STARTED|Overall Study||6||
59847039|NCT03994120|75971745|FG000|COMPLETED|Overall Study||4||
59847040|NCT03994120|75971746|FG001|COMPLETED|Overall Study||5||
59847041|NCT03994120|75971745|FG000|NOT COMPLETED|Overall Study||3||
59847042|NCT03994120|75971746|FG001|NOT COMPLETED|Overall Study||1||
59847043|NCT04178590|75971752|FG000|STARTED|Overall Study||32|"split mouth - both treatment modalities were conducted in all patients"|64
59847044|NCT04178590|75971752|FG000|COMPLETED|Overall Study||30||60
59847045|NCT04178590|75971752|FG000|NOT COMPLETED|Overall Study||2||4
59847046|NCT04175392|75971780|FG000|STARTED|Overall Study||7||
59847047|NCT04175392|75971781|FG001|STARTED|Overall Study||7||
59847048|NCT04175392|75971780|FG000|COMPLETED|Overall Study||4||
59847049|NCT04175392|75971781|FG001|COMPLETED|Overall Study||5||
59847050|NCT04175392|75971780|FG000|NOT COMPLETED|Overall Study||3||
59847051|NCT04175392|75971781|FG001|NOT COMPLETED|Overall Study||2||
59847052|NCT03986866|75971789|FG000|STARTED|Overall Study||55||
59847053|NCT03986866|75971790|FG001|STARTED|Overall Study||55||
59847054|NCT03986866|75971789|FG000|COMPLETED|Overall Study||53||
59847055|NCT03986866|75971790|FG001|COMPLETED|Overall Study||50||
59847056|NCT03986866|75971789|FG000|NOT COMPLETED|Overall Study||2||
59847057|NCT03986866|75971790|FG001|NOT COMPLETED|Overall Study||5||
59847058|NCT03980938|75971798|FG000|STARTED|Treatment Period 1||7||
59847059|NCT03980938|75971799|FG001|STARTED|Treatment Period 1||8||
59847060|NCT03980938|75971798|FG000|COMPLETED|Treatment Period 1||6||
59847061|NCT03980938|75971799|FG001|COMPLETED|Treatment Period 1||7||
59847062|NCT03980938|75971798|FG000|NOT COMPLETED|Treatment Period 1||1||
59847063|NCT03980938|75971799|FG001|NOT COMPLETED|Treatment Period 1||1||
59847064|NCT03980938|75971798|FG000|STARTED|Treatment Period 2||3|"The study was halted in March 2020 due to COVID-19 pandemic and eventually terminated without resuming any study activities. At this time 5 participants had started Treatment Period 2.~2 participants were in Treatment Period 1 and 8 participants were in the Washout Period, thus 10 participants never started Treatment Period 2."|
59847065|NCT03980938|75971799|FG001|STARTED|Treatment Period 2||2|"The study was halted in March 2020 due to COVID-19 pandemic and eventually terminated without resuming any study activities. At this time 5 participants had started Treatment Period 2.~2 participants were in Treatment Period 1 and 8 participants were in the Washout Period, thus 10 participants never started Treatment Period 2."|
59847066|NCT03980938|75971798|FG000|COMPLETED|Treatment Period 2|One participant completed the study remotely. On-site visits were no longer permitted due to COVID-19 pandemic. Visits were conducted remotely for Weeks 8 and 10 of Treatment Period 2, and the follow-up visit.|1||
59847067|NCT03980938|75971799|FG001|COMPLETED|Treatment Period 2||0||
59847068|NCT03980938|75971798|FG000|NOT COMPLETED|Treatment Period 2||2||
59847069|NCT03980938|75971799|FG001|NOT COMPLETED|Treatment Period 2||2||
59847070|NCT03656692|75971805|FG000|STARTED|Overall Study||5||
59847071|NCT03656692|75971805|FG000|COMPLETED|Overall Study||2||
59847072|NCT03656692|75971805|FG000|NOT COMPLETED|Overall Study||3||
59847073|NCT04439266|75971809|FG000|STARTED|Overall Study||5||
59847074|NCT04439266|75971809|FG000|Eligible|Overall Study||4|1 patient is ineligible. This is the primary analysis population.|
59847075|NCT04439266|75971809|FG000|COMPLETED|Overall Study||0|Treatment continued until disease progression or intolerability.|
59847076|NCT04439266|75971809|FG000|NOT COMPLETED|Overall Study||5||
59847077|NCT03682120|75971817|FG000|STARTED|Overall Study||105||
59847078|NCT03682120|75971818|FG001|STARTED|Overall Study||105||
59847079|NCT03682120|75971819|FG002|STARTED|Overall Study||105||
59847080|NCT03682120|75971820|FG003|STARTED|Overall Study||57||
59847081|NCT03682120|75971817|FG000|COMPLETED|Overall Study||92||
59847082|NCT03682120|75971818|FG001|COMPLETED|Overall Study||97||
59847083|NCT03682120|75971819|FG002|COMPLETED|Overall Study||97||
59847084|NCT03682120|75971820|FG003|COMPLETED|Overall Study||55||
59847085|NCT03682120|75971817|FG000|NOT COMPLETED|Overall Study||13||
59847086|NCT03682120|75971818|FG001|NOT COMPLETED|Overall Study||8||
59847087|NCT03682120|75971819|FG002|NOT COMPLETED|Overall Study||8||
59847088|NCT03682120|75971820|FG003|NOT COMPLETED|Overall Study||2||
59847089|NCT04428502|75971832|FG000|STARTED|Overall Study||127||
59847090|NCT04428502|75971832|FG000|COMPLETED|Overall Study||113||
59847091|NCT04428502|75971832|FG000|NOT COMPLETED|Overall Study||14||
59847092|NCT04428424|75971837|FG000|STARTED|Overall Study||1493||
59847093|NCT04428424|75971837|FG000|COMPLETED|Overall Study||1246||
59847094|NCT04428424|75971837|FG000|NOT COMPLETED|Overall Study||247||
59847095|NCT03655756|75971841|FG000|STARTED|Overall Study||7||
59847096|NCT03655756|75971841|FG000|COMPLETED|Overall Study||6||
59847097|NCT03655756|75971841|FG000|NOT COMPLETED|Overall Study||1||
59847098|NCT00095238|75971847|FG000|STARTED|Overall Study|number randomized|2067||
59847099|NCT00095238|75971848|FG001|STARTED|Overall Study|number randomized|2061||
59847100|NCT00095238|75971847|FG000|Safety (Treated) Population|Overall Study|Two participants were randomized but not treated; 1 randomized to irbesartan received placebo|2064||
59847101|NCT00095238|75971848|FG001|Safety (Treated) Population|Overall Study|One participant randomized to irbesartan received placebo.|2062||
59847102|NCT00095238|75971847|FG000|COMPLETED|Overall Study|completed double-blind therapy|1210||
59847103|NCT00095238|75971848|FG001|COMPLETED|Overall Study|completed double-blind therapy|1209||
59847104|NCT00095238|75971847|FG000|NOT COMPLETED|Overall Study||857||
59847105|NCT00095238|75971848|FG001|NOT COMPLETED|Overall Study||852||
59847106|NCT00082368|75971886|FG000|STARTED|Overall Study||12||
59847107|NCT00082368|75971886|FG000|COMPLETED|Overall Study||11||
59847108|NCT00082368|75971886|FG000|NOT COMPLETED|Overall Study||1||
59847109|NCT00094770|75971892|FG000|STARTED|Year 1 ( Week 0 to Week 52)||588||
59847110|NCT00094770|75971893|FG001|STARTED|Year 1 ( Week 0 to Week 52)||584||
59847111|NCT00094770|75971892|FG000|COMPLETED|Year 1 ( Week 0 to Week 52)|4 Participants who Completed Week 52, Did NOT Enter second year|386||
59847112|NCT00094770|75971893|FG001|COMPLETED|Year 1 ( Week 0 to Week 52)|11 Participants who Completed Week 52, Did NOT Enter second year|412||
59847113|NCT00094770|75971892|FG000|NOT COMPLETED|Year 1 ( Week 0 to Week 52)||202||
59847114|NCT00094770|75971893|FG001|NOT COMPLETED|Year 1 ( Week 0 to Week 52)||172||
59847115|NCT00094770|75971892|FG000|STARTED|Year 2 (Week 0 to Week 104)||588||
59847116|NCT00094770|75971893|FG001|STARTED|Year 2 (Week 0 to Week 104)||584||
59847117|NCT00094770|75971892|FG000|COMPLETED|Year 2 (Week 0 to Week 104)||255||
59847118|NCT00094770|75971893|FG001|COMPLETED|Year 2 (Week 0 to Week 104)||264||
59719900|NCT00951483|75839029|FG001|COMPLETED|Overall Study||44||
59719901|NCT00951483|75839028|FG000|NOT COMPLETED|Overall Study||19||
59847119|NCT00094770|75971892|FG000|NOT COMPLETED|Year 2 (Week 0 to Week 104)||333||
59847120|NCT00094770|75971893|FG001|NOT COMPLETED|Year 2 (Week 0 to Week 104)||320||
59847121|NCT00069576|75971901|FG000|STARTED|Original Trial||485||
59847122|NCT00069576|75971902|FG001|STARTED|Original Trial||473||
59847123|NCT00069576|75971901|FG000|COMPLETED|Original Trial||460||
59847124|NCT00069576|75971902|FG001|COMPLETED|Original Trial||440||
59847125|NCT00069576|75971901|FG000|NOT COMPLETED|Original Trial||25||
59847126|NCT00069576|75971902|FG001|NOT COMPLETED|Original Trial||33||
59847127|NCT00069576|75971901|FG000|STARTED|Follow-up Study at 5-10 Years||460||
59847128|NCT00069576|75971902|FG001|STARTED|Follow-up Study at 5-10 Years||440||
59847129|NCT00069576|75971901|FG000|COMPLETED|Follow-up Study at 5-10 Years||264||
60120420|NCT01694771|76241513|FG000|COMPLETED|Overall Study||527||
59719902|NCT00951483|75839029|FG001|NOT COMPLETED|Overall Study||0||
59719903|NCT01104246|75839037|FG000|STARTED|Overall Study||40||
59719904|NCT01104246|75839037|FG000|Baseline Characteristics Measured|Overall Study||35||
59719905|NCT01104246|75839037|FG000|COMPLETED|Overall Study||35||
59719906|NCT01104246|75839037|FG000|NOT COMPLETED|Overall Study||5||
59719907|NCT01103778|75839041|FG000|STARTED|Overall Study||11||
59719908|NCT01103778|75839041|FG000|COMPLETED|Overall Study||8||
59719909|NCT01103778|75839041|FG000|NOT COMPLETED|Overall Study||3||
59719910|NCT01103466|75839047|FG000|STARTED|First Period (14 +/- 3 Days)||12||
59719911|NCT01103466|75839048|FG001|STARTED|First Period (14 +/- 3 Days)||12||
59719912|NCT01103466|75839049|FG002|STARTED|First Period (14 +/- 3 Days)||13||
59719913|NCT01103466|75839047|FG000|COMPLETED|First Period (14 +/- 3 Days)||10||
59847130|NCT00069576|75971902|FG001|COMPLETED|Follow-up Study at 5-10 Years||236||
59847131|NCT00069576|75971901|FG000|NOT COMPLETED|Follow-up Study at 5-10 Years||196||
59847132|NCT00069576|75971902|FG001|NOT COMPLETED|Follow-up Study at 5-10 Years||204||
59847133|NCT00069264|75971908|FG000|STARTED|Overall Study||32||
59847134|NCT00069264|75971908|FG000|COMPLETED|Overall Study||0||
59847135|NCT00069264|75971908|FG000|NOT COMPLETED|Overall Study||32||
59847136|NCT00069108|75971914|FG000|STARTED|Overall Study||313||
59847137|NCT00069108|75971915|FG001|STARTED|Overall Study||314||
60120421|NCT01694771|76241514|FG001|COMPLETED|Overall Study||525||
60120422|NCT01694771|76241513|FG000|NOT COMPLETED|Overall Study||40||
60120423|NCT01694771|76241514|FG001|NOT COMPLETED|Overall Study||40||
60120424|NCT02649556|76241524|FG000|STARTED|Overall Study||230||
59567935|NCT01118013|75670824|FG000|STARTED|Overall Study||6||
59567936|NCT01118013|75670824|FG000|COMPLETED|Overall Study||6||
60120425|NCT02649556|76241525|FG001|STARTED|Overall Study||424||
60120426|NCT02649556|76241526|FG002|STARTED|Overall Study||152||
60120427|NCT02649556|76241527|FG003|STARTED|Overall Study||51||
60120428|NCT02649556|76241524|FG000|COMPLETED|Overall Study||167||
60120429|NCT02649556|76241525|FG001|COMPLETED|Overall Study||312||
60120430|NCT02649556|76241526|FG002|COMPLETED|Overall Study||102||
60120431|NCT02649556|76241527|FG003|COMPLETED|Overall Study||28||
60120432|NCT02649556|76241524|FG000|NOT COMPLETED|Overall Study||63||
60120433|NCT02649556|76241525|FG001|NOT COMPLETED|Overall Study||112||
60120434|NCT02649556|76241526|FG002|NOT COMPLETED|Overall Study||50||
60120435|NCT02649556|76241527|FG003|NOT COMPLETED|Overall Study||23||
60120436|NCT02651272|76241537|FG000|STARTED|Overall Study||4||
60120437|NCT02651272|76241537|FG000|COMPLETED|Overall Study||1||
60120438|NCT02651272|76241537|FG000|NOT COMPLETED|Overall Study||3||
60120439|NCT01582061|76241543|FG000|STARTED|Overall Study||49||
60120440|NCT01582061|76241544|FG001|STARTED|Overall Study||55||
60120441|NCT01582061|76241543|FG000|COMPLETED|Overall Study||21||
60120442|NCT01582061|76241544|FG001|COMPLETED|Overall Study||19||
60120443|NCT01582061|76241543|FG000|NOT COMPLETED|Overall Study||28||
60120444|NCT01582061|76241544|FG001|NOT COMPLETED|Overall Study||36||
60120445|NCT01693523|76241563|FG000|STARTED|Overall Study||23||
60120446|NCT01693523|76241564|FG001|STARTED|Overall Study||21||
59567937|NCT01118013|75670824|FG000|NOT COMPLETED|Overall Study||0||
59567938|NCT00552032|75670830|FG000|STARTED|Overall Study||66||
59567939|NCT00552032|75670831|FG001|STARTED|Overall Study||66||
59567940|NCT00552032|75670830|FG000|COMPLETED|Overall Study||49||
59567941|NCT00552032|75670831|FG001|COMPLETED|Overall Study||47||
59567942|NCT00552032|75670830|FG000|NOT COMPLETED|Overall Study||17||
59847138|NCT00069108|75971914|FG000|COMPLETED|Overall Study||100||
59847139|NCT00069108|75971915|FG001|COMPLETED|Overall Study||95||
59847140|NCT00069108|75971914|FG000|NOT COMPLETED|Overall Study||213||
59847141|NCT00069108|75971915|FG001|NOT COMPLETED|Overall Study||219||
59847142|NCT00094536|75971922|FG000|STARTED|Inclusion Exclusion Evaluation||106||
59847143|NCT00094536|75971922|FG000|COMPLETED|Inclusion Exclusion Evaluation||82||
59847144|NCT00094536|75971922|FG000|NOT COMPLETED|Inclusion Exclusion Evaluation||24||
59847145|NCT00094536|75971922|FG000|STARTED|Treatment and Follow-up|82 subjects qualified for and underwent the study treatment.|82||
59847146|NCT00094536|75971922|FG000|12 Month Follow-up|Treatment and Follow-up|69 subjects were evaluated at 1-year post-treatment for the primary endpoint of success.|69||
59567943|NCT00552032|75670831|FG001|NOT COMPLETED|Overall Study||19||
59567944|NCT02429583|75670839|FG000|STARTED|Overall Study||1||
59567945|NCT02429583|75670840|FG001|STARTED|Overall Study||23||
59847147|NCT00094536|75971922|FG000|24 Month Follow-up|Treatment and Follow-up||53||
59847148|NCT00094536|75971922|FG000|36 Month Follow-up|Treatment and Follow-up||51||
60120447|NCT01693523|76241565|FG002|STARTED|Overall Study||35||
60120448|NCT01693523|76241563|FG000|COMPLETED|Overall Study||18||
60120449|NCT01693523|76241564|FG001|COMPLETED|Overall Study||13||
60120450|NCT01693523|76241565|FG002|COMPLETED|Overall Study||27||
59847149|NCT00094536|75971922|FG000|COMPLETED|Treatment and Follow-up|51 subjects successfully completed the study.|51||
59847150|NCT00094536|75971922|FG000|NOT COMPLETED|Treatment and Follow-up||31||
59847151|NCT00405587|75971930|FG000|STARTED|Overall Study||26||
59847152|NCT00405587|75971931|FG001|STARTED|Overall Study||30||
59719914|NCT01103466|75839048|FG001|COMPLETED|First Period (14 +/- 3 Days)||12||
59719915|NCT01103466|75839049|FG002|COMPLETED|First Period (14 +/- 3 Days)||13||
59567946|NCT02429583|75670839|FG000|COMPLETED|Overall Study||1||
59567947|NCT02429583|75670840|FG001|COMPLETED|Overall Study||3||
59567948|NCT02429583|75670839|FG000|NOT COMPLETED|Overall Study||0||
59567949|NCT02429583|75670840|FG001|NOT COMPLETED|Overall Study||20||
59567950|NCT02413047|75670846|FG000|STARTED|Overall Study||3||
59567951|NCT02413047|75670846|FG000|Participants on Infliximab|Overall Study||2||
59567952|NCT02413047|75670846|FG000|Participants on Adalimumab|Overall Study||1||
59567953|NCT02413047|75670846|FG000|COMPLETED|Overall Study||3||
59567954|NCT02413047|75670846|FG000|NOT COMPLETED|Overall Study||0||
59567955|NCT02277548|75670852|FG000|STARTED|Overall Study||9||
59567956|NCT02277548|75670853|FG001|STARTED|Overall Study||11||
59719916|NCT01103466|75839047|FG000|NOT COMPLETED|First Period (14 +/- 3 Days)||2||
59719917|NCT01103466|75839048|FG001|NOT COMPLETED|First Period (14 +/- 3 Days)||0||
59719918|NCT01103466|75839049|FG002|NOT COMPLETED|First Period (14 +/- 3 Days)||0||
59719919|NCT01103466|75839047|FG000|STARTED|Second Period (14 +/- 3 Days)||15||
59719920|NCT01103466|75839048|FG001|STARTED|Second Period (14 +/- 3 Days)||13||
59719921|NCT01103466|75839049|FG002|STARTED|Second Period (14 +/- 3 Days)||7||
59719922|NCT01103466|75839047|FG000|COMPLETED|Second Period (14 +/- 3 Days)||13||
59847153|NCT00405587|75971932|FG002|STARTED|Overall Study||32||
59847154|NCT00405587|75971933|FG003|STARTED|Overall Study||21||
59847155|NCT00405587|75971930|FG000|COMPLETED|Overall Study||0||
59847156|NCT00405587|75971931|FG001|COMPLETED|Overall Study||2||
59847157|NCT00405587|75971932|FG002|COMPLETED|Overall Study||10||
59847158|NCT00405587|75971933|FG003|COMPLETED|Overall Study||1||
59847159|NCT00405587|75971930|FG000|NOT COMPLETED|Overall Study||26||
59847160|NCT00405587|75971931|FG001|NOT COMPLETED|Overall Study||28||
59847161|NCT00405587|75971932|FG002|NOT COMPLETED|Overall Study||22||
59847162|NCT00405587|75971933|FG003|NOT COMPLETED|Overall Study||20||
59847163|NCT00405275|75971971|FG000|STARTED|Overall Study||178||
59847164|NCT00405275|75971972|FG001|STARTED|Overall Study||175||
59847165|NCT00405275|75971971|FG000|24 Weeks (Total)|Overall Study||163||
59847166|NCT00405275|75971972|FG001|24 Weeks (Total)|Overall Study||165||
59847167|NCT00405275|75971971|FG000|24 Week (no Switch)|Overall Study||119||
59847168|NCT00405275|75971972|FG001|24 Week (no Switch)|Overall Study||121||
59847169|NCT00405275|75971971|FG000|24 Week (Switch)|Overall Study||44||
59847170|NCT00405275|75971972|FG001|24 Week (Switch)|Overall Study||44||
59847171|NCT00405275|75971971|FG000|COMPLETED|Overall Study||155||
59847172|NCT00405275|75971972|FG001|COMPLETED|Overall Study||156||
59847173|NCT00405275|75971971|FG000|NOT COMPLETED|Overall Study||23||
59847174|NCT00405275|75971972|FG001|NOT COMPLETED|Overall Study||19||
59847175|NCT00404651|75971982|FG000|STARTED|Overall Study||340||
59847176|NCT00404651|75971983|FG001|STARTED|Overall Study||343||
59847177|NCT00404651|75971984|FG002|STARTED|Overall Study||339||
59847178|NCT00404651|75971985|FG003|STARTED|Overall Study||167||
59847179|NCT00404651|75971982|FG000|COMPLETED|Overall Study||301||
59847180|NCT00404651|75971983|FG001|COMPLETED|Overall Study||315||
59847181|NCT00404651|75971984|FG002|COMPLETED|Overall Study||294||
59847182|NCT00404651|75971985|FG003|COMPLETED|Overall Study||146||
59847183|NCT00404651|75971982|FG000|NOT COMPLETED|Overall Study||39||
59847184|NCT00404651|75971983|FG001|NOT COMPLETED|Overall Study||28||
59847185|NCT00404651|75971984|FG002|NOT COMPLETED|Overall Study||45||
59847186|NCT00404651|75971985|FG003|NOT COMPLETED|Overall Study||21||
59847187|NCT00404495|75971997|FG000|STARTED|Overall Study||66||
59847188|NCT00404495|75971998|FG001|STARTED|Overall Study||17||
59847189|NCT00404495|75971997|FG000|COMPLETED|Overall Study||22||
59847190|NCT00404495|75971998|FG001|COMPLETED|Overall Study||6||
59847191|NCT00404495|75971997|FG000|NOT COMPLETED|Overall Study||44||
59847192|NCT00404495|75971998|FG001|NOT COMPLETED|Overall Study||11||
59847193|NCT00409409|75972006|FG000|STARTED|Overall Study||139||
59847194|NCT00409409|75972007|FG001|STARTED|Overall Study||139||
59847195|NCT00409409|75972006|FG000|COMPLETED|Overall Study||131||
59847196|NCT00409409|75972007|FG001|COMPLETED|Overall Study||135||
59847197|NCT00409409|75972006|FG000|NOT COMPLETED|Overall Study||8||
59847198|NCT00409409|75972007|FG001|NOT COMPLETED|Overall Study||4||
59847199|NCT00409331|75972013|FG000|STARTED|Overall Study||1||
59847200|NCT00409331|75972013|FG000|COMPLETED|Overall Study||0||
59847201|NCT00409331|75972013|FG000|NOT COMPLETED|Overall Study||1||
59847202|NCT00409175|75972019|FG000|STARTED|Overall Study||65||
59719923|NCT01103466|75839048|FG001|COMPLETED|Second Period (14 +/- 3 Days)||11||
59719924|NCT01103466|75839049|FG002|COMPLETED|Second Period (14 +/- 3 Days)||6||
59719925|NCT01103466|75839047|FG000|NOT COMPLETED|Second Period (14 +/- 3 Days)||2||
59719926|NCT01103466|75839048|FG001|NOT COMPLETED|Second Period (14 +/- 3 Days)||2||
59719927|NCT01103466|75839049|FG002|NOT COMPLETED|Second Period (14 +/- 3 Days)||1||
59719928|NCT01103466|75839047|FG000|STARTED|Third Period (14 +/- 3 Days)||8||
59719929|NCT01103466|75839048|FG001|STARTED|Third Period (14 +/- 3 Days)||8||
59719930|NCT01103466|75839049|FG002|STARTED|Third Period (14 +/- 3 Days)||14||
59719931|NCT01103466|75839047|FG000|COMPLETED|Third Period (14 +/- 3 Days)||6||
59719932|NCT01103466|75839048|FG001|COMPLETED|Third Period (14 +/- 3 Days)||8||
59719933|NCT01103466|75839049|FG002|COMPLETED|Third Period (14 +/- 3 Days)||13||
59719934|NCT01103466|75839047|FG000|NOT COMPLETED|Third Period (14 +/- 3 Days)||2||
59847203|NCT00409175|75972020|FG001|STARTED|Overall Study||63||
59847204|NCT00409175|75972019|FG000|COMPLETED|Overall Study||47||
59847205|NCT00409175|75972020|FG001|COMPLETED|Overall Study||44||
59847206|NCT00409175|75972019|FG000|NOT COMPLETED|Overall Study||18||
59847207|NCT00409175|75972020|FG001|NOT COMPLETED|Overall Study||19||
59847208|NCT00408629|75972028|FG000|STARTED|Overall Study|10 ADA recipients from 3 noncompliant clinical sites in Safety, but not in Efficacy analyses (248).|258||
59847209|NCT00408629|75972029|FG001|STARTED|Overall Study|14 PLB recipients from 3 noncompliant clinical sites in Safety, but not in Efficacy analyses (246).|260||
59847210|NCT00408629|75972028|FG000|COMPLETED|Overall Study|1 ADA recipient did not receive study drug and discontinued due to other reasons.|161||
59567957|NCT02277548|75670852|FG000|COMPLETED|Overall Study||9||
59719935|NCT01103466|75839048|FG001|NOT COMPLETED|Third Period (14 +/- 3 Days)||0||
59847211|NCT00408629|75972029|FG001|COMPLETED|Overall Study||135||
59847212|NCT00408629|75972028|FG000|NOT COMPLETED|Overall Study||97||
59847213|NCT00408629|75972029|FG001|NOT COMPLETED|Overall Study||125||
59847214|NCT00408317|75972036|FG000|STARTED|First Intervention Period||14||
59847215|NCT00408317|75972037|FG001|STARTED|First Intervention Period||17||
59847216|NCT00408317|75972036|FG000|COMPLETED|First Intervention Period||14||
59847217|NCT00408317|75972037|FG001|COMPLETED|First Intervention Period||16||
59847218|NCT00408317|75972036|FG000|NOT COMPLETED|First Intervention Period||0||
59847219|NCT00408317|75972037|FG001|NOT COMPLETED|First Intervention Period||1||
59847220|NCT00408317|75972036|FG000|STARTED|Second Intervention Period||14||
59847221|NCT00408317|75972037|FG001|STARTED|Second Intervention Period||16||
59847222|NCT00408317|75972036|FG000|COMPLETED|Second Intervention Period||12||
59847223|NCT00408317|75972037|FG001|COMPLETED|Second Intervention Period||14||
59847224|NCT00408317|75972036|FG000|NOT COMPLETED|Second Intervention Period||2||
59847225|NCT00408317|75972037|FG001|NOT COMPLETED|Second Intervention Period||2||
59847226|NCT00112502|75972051|FG000|STARTED|Overall Study||22||
59847227|NCT00112502|75972052|FG001|STARTED|Overall Study||22||
59847228|NCT00112502|75972053|FG002|STARTED|Overall Study||22||
59847229|NCT00112502|75972054|FG003|STARTED|Overall Study||22||
59847230|NCT00112502|75972055|FG004|STARTED|Overall Study||23||
59847231|NCT00112502|75972056|FG005|STARTED|Overall Study||22||
59847232|NCT00112502|75972057|FG006|STARTED|Overall Study||23||
59847233|NCT00112502|75972058|FG007|STARTED|Overall Study||22||
59847234|NCT00112502|75972051|FG000|COMPLETED|Overall Study||22||
59847235|NCT00112502|75972052|FG001|COMPLETED|Overall Study||21||
59847236|NCT00112502|75972053|FG002|COMPLETED|Overall Study||21||
59847237|NCT00112502|75972054|FG003|COMPLETED|Overall Study||18||
59847238|NCT00112502|75972055|FG004|COMPLETED|Overall Study||21||
59847239|NCT00112502|75972056|FG005|COMPLETED|Overall Study||17||
59847240|NCT00112502|75972057|FG006|COMPLETED|Overall Study||20||
59847241|NCT00112502|75972058|FG007|COMPLETED|Overall Study||15||
59847242|NCT00112502|75972051|FG000|NOT COMPLETED|Overall Study||0||
59847243|NCT00112502|75972052|FG001|NOT COMPLETED|Overall Study||1||
59847244|NCT00112502|75972053|FG002|NOT COMPLETED|Overall Study||1||
59847245|NCT00112502|75972054|FG003|NOT COMPLETED|Overall Study||4||
59847246|NCT00112502|75972055|FG004|NOT COMPLETED|Overall Study||2||
59847247|NCT00112502|75972056|FG005|NOT COMPLETED|Overall Study||5||
59847248|NCT00112502|75972057|FG006|NOT COMPLETED|Overall Study||3||
59847249|NCT00112502|75972058|FG007|NOT COMPLETED|Overall Study||7||
59847250|NCT03822182|75972089|FG000|STARTED|Overall Study||26||
59847251|NCT03822182|75972090|FG001|STARTED|Overall Study||25||
59847252|NCT03822182|75972091|FG002|STARTED|Overall Study||27||
59847253|NCT03822182|75972089|FG000|COMPLETED|Overall Study||26||
59847254|NCT03822182|75972090|FG001|COMPLETED|Overall Study||24||
59847255|NCT03822182|75972091|FG002|COMPLETED|Overall Study||26||
59847256|NCT03822182|75972089|FG000|NOT COMPLETED|Overall Study||0||
59847257|NCT03822182|75972090|FG001|NOT COMPLETED|Overall Study||1||
59847258|NCT03822182|75972091|FG002|NOT COMPLETED|Overall Study||1||
59847259|NCT00111800|75972106|FG000|STARTED|Period 1: Main Phase (12 Weeks)||64||
59847260|NCT00111800|75972107|FG001|STARTED|Period 1: Main Phase (12 Weeks)||61||
59847261|NCT00111800|75972108|FG002|STARTED|Period 1: Main Phase (12 Weeks)||63||
59847262|NCT00111800|75972109|FG003|STARTED|Period 1: Main Phase (12 Weeks)||66||
59847263|NCT00111800|75972110|FG004|STARTED|Period 1: Main Phase (12 Weeks)||60||
59847264|NCT00111800|75972111|FG005|STARTED|Period 1: Main Phase (12 Weeks)||61||
59847265|NCT00111800|75972106|FG000|COMPLETED|Period 1: Main Phase (12 Weeks)||49||
59847266|NCT00111800|75972107|FG001|COMPLETED|Period 1: Main Phase (12 Weeks)||47||
59847267|NCT00111800|75972108|FG002|COMPLETED|Period 1: Main Phase (12 Weeks)||54||
59847268|NCT00111800|75972109|FG003|COMPLETED|Period 1: Main Phase (12 Weeks)||60||
59847269|NCT00111800|75972110|FG004|COMPLETED|Period 1: Main Phase (12 Weeks)||55||
59847270|NCT00111800|75972111|FG005|COMPLETED|Period 1: Main Phase (12 Weeks)||56||
59847271|NCT00111800|75972106|FG000|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||15||
59847272|NCT00111800|75972107|FG001|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||14||
59847273|NCT00111800|75972108|FG002|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||9||
59847274|NCT00111800|75972109|FG003|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||6||
59847275|NCT00111800|75972110|FG004|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||5||
59847276|NCT00111800|75972111|FG005|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||5||
59847277|NCT00111800|75972106|FG000|STARTED|Period 2: Extension Phase (12 Weeks)||48||
59847278|NCT00111800|75972107|FG001|STARTED|Period 2: Extension Phase (12 Weeks)||47||
59847279|NCT00111800|75972108|FG002|STARTED|Period 2: Extension Phase (12 Weeks)||54||
59847280|NCT00111800|75972109|FG003|STARTED|Period 2: Extension Phase (12 Weeks)||59||
59847281|NCT00111800|75972110|FG004|STARTED|Period 2: Extension Phase (12 Weeks)||55||
59847282|NCT00111800|75972111|FG005|STARTED|Period 2: Extension Phase (12 Weeks)||55||
59847283|NCT00111800|75972106|FG000|COMPLETED|Period 2: Extension Phase (12 Weeks)||46||
59847284|NCT00111800|75972107|FG001|COMPLETED|Period 2: Extension Phase (12 Weeks)||40||
59847285|NCT00111800|75972108|FG002|COMPLETED|Period 2: Extension Phase (12 Weeks)||47||
59847286|NCT00111800|75972109|FG003|COMPLETED|Period 2: Extension Phase (12 Weeks)||54||
59847287|NCT00111800|75972110|FG004|COMPLETED|Period 2: Extension Phase (12 Weeks)||51||
59847288|NCT00111800|75972111|FG005|COMPLETED|Period 2: Extension Phase (12 Weeks)||53||
59847289|NCT00111800|75972106|FG000|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||2||
59847290|NCT00111800|75972107|FG001|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||7||
59847291|NCT00111800|75972108|FG002|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||7||
60120451|NCT01693523|76241563|FG000|NOT COMPLETED|Overall Study||5||
59847292|NCT00111800|75972109|FG003|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||5||
59847293|NCT00111800|75972110|FG004|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||4||
59847294|NCT00111800|75972111|FG005|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||2||
59847295|NCT00094328|75972134|FG000|STARTED|Overall Study|Received treatment|14||
59847296|NCT00094328|75972134|FG000|COMPLETED|Overall Study|Completed 12 months on treatment|13||
59847297|NCT00094328|75972134|FG000|NOT COMPLETED|Overall Study||1||
59847298|NCT00094172|75972140|FG000|STARTED|Overall Study|Safety Sample: 49; Intent-to-Treat Sample: 49; Per Protocol Sample: 39|50||
59847299|NCT00094172|75972141|FG001|STARTED|Overall Study|Safety Sample: 32; Intent-to-Treat Sample: 32; Per Protocol Sample: 28|32||
59847300|NCT00094172|75972140|FG000|COMPLETED|Overall Study||36||
59847301|NCT00094172|75972141|FG001|COMPLETED|Overall Study||25||
59847302|NCT00094172|75972140|FG000|NOT COMPLETED|Overall Study||14||
59847303|NCT00094172|75972141|FG001|NOT COMPLETED|Overall Study||7||
59847304|NCT00094094|75972147|FG000|STARTED|Overall Study||32||
59847305|NCT00094094|75972147|FG000|COMPLETED|Overall Study||0||
59847306|NCT00094094|75972147|FG000|NOT COMPLETED|Overall Study||32||
59847307|NCT00110396|75972151|FG000|STARTED|Overall Study||260||
59847308|NCT00110396|75972151|FG000|COMPLETED|Overall Study|260 participants included in the Safety Population.207 completed treatment. 224 completed the trial|224||
59847309|NCT00110396|75972151|FG000|NOT COMPLETED|Overall Study||36||
59847310|NCT03819218|75972155|FG000|STARTED|Overall Study||7||
59847311|NCT03819218|75972155|FG000|COMPLETED|Overall Study||6||
59847312|NCT03819218|75972155|FG000|NOT COMPLETED|Overall Study||1||
59847313|NCT00093470|75972161|FG000|STARTED|Overall Study||73||
59847314|NCT00093470|75972162|FG001|STARTED|Overall Study||71||
59847315|NCT00093470|75972161|FG000|Treated|Overall Study||72||
59847316|NCT00093470|75972162|FG001|Treated|Overall Study||71||
59847317|NCT00093470|75972161|FG000|Patients With Toxicity Assessment|Overall Study||72||
59847318|NCT00093470|75972162|FG001|Patients With Toxicity Assessment|Overall Study||69||
59847319|NCT00093470|75972161|FG000|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicities.|0||
59847320|NCT00093470|75972162|FG001|COMPLETED|Overall Study|Patients underwent observation only.|71||
59847321|NCT00093470|75972161|FG000|NOT COMPLETED|Overall Study||73||
59847322|NCT00093470|75972162|FG001|NOT COMPLETED|Overall Study||0||
59567958|NCT02277548|75670853|FG001|COMPLETED|Overall Study||9||
59567959|NCT02277548|75670852|FG000|NOT COMPLETED|Overall Study||0||
59567960|NCT02277548|75670853|FG001|NOT COMPLETED|Overall Study||2||
59847323|NCT00407537|75972170|FG000|STARTED|Overall Study||779||
59847324|NCT00407537|75972171|FG001|STARTED|Overall Study|4 participants assigned to Caduet treatment received usual care only during the study|682||
59847325|NCT00407537|75972170|FG000|Eligible for Efficacy Analysis|Overall Study||760||
59847326|NCT00407537|75972171|FG001|Eligible for Efficacy Analysis|Overall Study||657||
59847327|NCT00407537|75972170|FG000|COMPLETED|Overall Study||686||
59847328|NCT00407537|75972171|FG001|COMPLETED|Overall Study||638||
59847329|NCT00407537|75972170|FG000|NOT COMPLETED|Overall Study||93||
59847330|NCT00407537|75972171|FG001|NOT COMPLETED|Overall Study||44||
59847331|NCT00094458|75972180|FG000|STARTED|Main Study: Through Week 30||170||
59847332|NCT00094458|75972181|FG001|STARTED|Main Study: Through Week 30||169||
59847333|NCT00094458|75972182|FG002|STARTED|Main Study: Through Week 30||169||
59847334|NCT00094458|75972183|FG003|STARTED|Main Study: Through Week 30||0||
59847335|NCT00094458|75972184|FG004|STARTED|Main Study: Through Week 30||0||
60120452|NCT01693523|76241564|FG001|NOT COMPLETED|Overall Study||8||
60120453|NCT01693523|76241565|FG002|NOT COMPLETED|Overall Study||8||
60120454|NCT03924323|76241574|FG000|STARTED|Overall Study||136||
60120455|NCT03924323|76241575|FG001|STARTED|Overall Study||137||
60120456|NCT03924323|76241574|FG000|COMPLETED|Overall Study||117||
60120457|NCT03924323|76241575|FG001|COMPLETED|Overall Study||123||
60120458|NCT03924323|76241574|FG000|NOT COMPLETED|Overall Study||19||
60120459|NCT03924323|76241575|FG001|NOT COMPLETED|Overall Study||14||
60120460|NCT01581593|76241581|FG000|STARTED|Overall Study||45||
59567961|NCT02411643|75670859|FG000|STARTED|Overall Study||2||
60120461|NCT01581593|76241581|FG000|COMPLETED|Overall Study||44||
60120462|NCT01581593|76241581|FG000|NOT COMPLETED|Overall Study||1||
60120463|NCT01581281|76241592|FG000|STARTED|Overall Study||145||
60120464|NCT01581281|76241593|FG001|STARTED|Overall Study||72||
60120465|NCT01581281|76241594|FG002|STARTED|Overall Study||144||
60120466|NCT01581281|76241592|FG000|COMPLETED|Overall Study||130||
60120467|NCT01581281|76241593|FG001|COMPLETED|Overall Study||66||
60120468|NCT01581281|76241594|FG002|COMPLETED|Overall Study||132||
60120469|NCT01581281|76241592|FG000|NOT COMPLETED|Overall Study||15||
60120470|NCT01581281|76241593|FG001|NOT COMPLETED|Overall Study||6||
60120471|NCT01581281|76241594|FG002|NOT COMPLETED|Overall Study||12||
60120472|NCT02692716|76241605|FG000|STARTED|Overall Study||1591||
60120473|NCT02692716|76241606|FG001|STARTED|Overall Study||1592||
60120474|NCT02692716|76241605|FG000|Full Analysis Set (FAS)|Overall Study||1591||
59847336|NCT00094458|75972185|FG005|STARTED|Main Study: Through Week 30||0||
59847337|NCT00094458|75972180|FG000|COMPLETED|Main Study: Through Week 30||86||
59847338|NCT00094458|75972181|FG001|COMPLETED|Main Study: Through Week 30||111||
59847339|NCT00094458|75972182|FG002|COMPLETED|Main Study: Through Week 30||121||
59847340|NCT00094458|75972183|FG003|COMPLETED|Main Study: Through Week 30||0||
59847341|NCT00094458|75972184|FG004|COMPLETED|Main Study: Through Week 30||0||
59847342|NCT00094458|75972185|FG005|COMPLETED|Main Study: Through Week 30||0||
59847343|NCT00094458|75972180|FG000|NOT COMPLETED|Main Study: Through Week 30||84||
59847344|NCT00094458|75972181|FG001|NOT COMPLETED|Main Study: Through Week 30||58||
59847345|NCT00094458|75972182|FG002|NOT COMPLETED|Main Study: Through Week 30||48||
59847346|NCT00094458|75972183|FG003|NOT COMPLETED|Main Study: Through Week 30||0||
59847347|NCT00094458|75972184|FG004|NOT COMPLETED|Main Study: Through Week 30||0||
59847348|NCT00094458|75972185|FG005|NOT COMPLETED|Main Study: Through Week 30||0||
59847349|NCT00094458|75972180|FG000|STARTED|Study Extension: Week 30 Through Week 50||75||
59847350|NCT00094458|75972181|FG001|STARTED|Study Extension: Week 30 Through Week 50||97||
59847351|NCT00094458|75972182|FG002|STARTED|Study Extension: Week 30 Through Week 50||108||
59847352|NCT00094458|75972183|FG003|STARTED|Study Extension: Week 30 Through Week 50||0||
59847353|NCT00094458|75972184|FG004|STARTED|Study Extension: Week 30 Through Week 50||0||
59847354|NCT00094458|75972185|FG005|STARTED|Study Extension: Week 30 Through Week 50||0||
59847355|NCT00094458|75972180|FG000|COMPLETED|Study Extension: Week 30 Through Week 50||67||
59847356|NCT00094458|75972181|FG001|COMPLETED|Study Extension: Week 30 Through Week 50||85||
59847357|NCT00094458|75972182|FG002|COMPLETED|Study Extension: Week 30 Through Week 50||90||
59847358|NCT00094458|75972183|FG003|COMPLETED|Study Extension: Week 30 Through Week 50||0||
59847359|NCT00094458|75972184|FG004|COMPLETED|Study Extension: Week 30 Through Week 50||0||
59847360|NCT00094458|75972185|FG005|COMPLETED|Study Extension: Week 30 Through Week 50||0||
59847361|NCT00094458|75972180|FG000|NOT COMPLETED|Study Extension: Week 30 Through Week 50||8||
59847362|NCT00094458|75972181|FG001|NOT COMPLETED|Study Extension: Week 30 Through Week 50||12||
59847363|NCT00094458|75972182|FG002|NOT COMPLETED|Study Extension: Week 30 Through Week 50||18||
59847364|NCT00094458|75972183|FG003|NOT COMPLETED|Study Extension: Week 30 Through Week 50||0||
59847365|NCT00094458|75972184|FG004|NOT COMPLETED|Study Extension: Week 30 Through Week 50||0||
59847366|NCT00094458|75972185|FG005|NOT COMPLETED|Study Extension: Week 30 Through Week 50||0||
59847367|NCT00094458|75972180|FG000|STARTED|OLE: Open-Label Extension||0||
59847368|NCT00094458|75972181|FG001|STARTED|OLE: Open-Label Extension||0||
59847369|NCT00094458|75972182|FG002|STARTED|OLE: Open-Label Extension||0||
59847370|NCT00094458|75972183|FG003|STARTED|OLE: Open-Label Extension||8||
59847371|NCT00094458|75972184|FG004|STARTED|OLE: Open-Label Extension||18||
59847372|NCT00094458|75972185|FG005|STARTED|OLE: Open-Label Extension||17||
59847373|NCT00094458|75972180|FG000|COMPLETED|OLE: Open-Label Extension||0||
59847374|NCT00094458|75972181|FG001|COMPLETED|OLE: Open-Label Extension||0||
59847375|NCT00094458|75972182|FG002|COMPLETED|OLE: Open-Label Extension||0||
59847376|NCT00094458|75972183|FG003|COMPLETED|OLE: Open-Label Extension||7||
59847377|NCT00094458|75972184|FG004|COMPLETED|OLE: Open-Label Extension||13||
59847378|NCT00094458|75972185|FG005|COMPLETED|OLE: Open-Label Extension||13||
59847379|NCT00094458|75972180|FG000|NOT COMPLETED|OLE: Open-Label Extension||0||
59847380|NCT00094458|75972181|FG001|NOT COMPLETED|OLE: Open-Label Extension||0||
59847381|NCT00094458|75972182|FG002|NOT COMPLETED|OLE: Open-Label Extension||0||
59847382|NCT00094458|75972183|FG003|NOT COMPLETED|OLE: Open-Label Extension||1||
59847383|NCT00094458|75972184|FG004|NOT COMPLETED|OLE: Open-Label Extension||5||
59847384|NCT00094458|75972185|FG005|NOT COMPLETED|OLE: Open-Label Extension||4||
59847385|NCT00406367|75972201|FG000|STARTED|Main Period - 6 to 20 Weeks||75||
59847386|NCT00406367|75972202|FG001|STARTED|Main Period - 6 to 20 Weeks||34||
59847387|NCT00406367|75972201|FG000|COMPLETED|Main Period - 6 to 20 Weeks||70||
59847388|NCT00406367|75972202|FG001|COMPLETED|Main Period - 6 to 20 Weeks||32||
59847389|NCT00406367|75972201|FG000|NOT COMPLETED|Main Period - 6 to 20 Weeks||5||
59847390|NCT00406367|75972202|FG001|NOT COMPLETED|Main Period - 6 to 20 Weeks||2||
59847391|NCT00406367|75972201|FG000|STARTED|Open-Label Ext. Period - up to 68 Weeks||102||
59847392|NCT00406367|75972202|FG001|STARTED|Open-Label Ext. Period - up to 68 Weeks|In the Open-Label Extension Period no placebo treatment arm was given.|0||
59847393|NCT00406367|75972201|FG000|COMPLETED|Open-Label Ext. Period - up to 68 Weeks||82||
59847394|NCT00406367|75972202|FG001|COMPLETED|Open-Label Ext. Period - up to 68 Weeks||0||
59847395|NCT00406367|75972201|FG000|NOT COMPLETED|Open-Label Ext. Period - up to 68 Weeks||20||
59847396|NCT00406367|75972202|FG001|NOT COMPLETED|Open-Label Ext. Period - up to 68 Weeks||0||
59847397|NCT00394589|75972211|FG000|STARTED|Overall Study||14||
59847398|NCT00394589|75972212|FG001|STARTED|Overall Study||11||
59847399|NCT00394589|75972213|FG002|STARTED|Overall Study||18||
59847400|NCT00394589|75972211|FG000|COMPLETED|Overall Study||6||
59847401|NCT00394589|75972212|FG001|COMPLETED|Overall Study||8||
59847402|NCT00394589|75972213|FG002|COMPLETED|Overall Study||11||
59847403|NCT00394589|75972211|FG000|NOT COMPLETED|Overall Study||8||
59847404|NCT00394589|75972212|FG001|NOT COMPLETED|Overall Study||3||
59847405|NCT00394589|75972213|FG002|NOT COMPLETED|Overall Study||7||
59847406|NCT00068406|75972221|FG000|STARTED|Overall Study||61||
59847407|NCT00068406|75972221|FG000|COMPLETED|Overall Study||58||
59847408|NCT00068406|75972221|FG000|NOT COMPLETED|Overall Study||3||
59847409|NCT00403559|75972227|FG000|STARTED|Overall Study||56||
59847410|NCT00403559|75972228|FG001|STARTED|Overall Study||56||
59847411|NCT00403559|75972227|FG000|COMPLETED|Overall Study||52||
59847412|NCT00403559|75972228|FG001|COMPLETED|Overall Study||52||
59847413|NCT00403559|75972227|FG000|NOT COMPLETED|Overall Study||4||
59847414|NCT00403559|75972228|FG001|NOT COMPLETED|Overall Study||4||
59847415|NCT00403481|75972236|FG000|STARTED|Olmesartan Medoxomil (Olm) 20 mg||192||
59847416|NCT00403481|75972236|FG000|COMPLETED|Olmesartan Medoxomil (Olm) 20 mg||186||
59847417|NCT00403481|75972236|FG000|NOT COMPLETED|Olmesartan Medoxomil (Olm) 20 mg||6||
59847418|NCT00403481|75972236|FG000|STARTED|Olm 40 mg|186 -4 met their blood pressure goal (remained on olmesartan 20 mg) = 182|182||
59847419|NCT00403481|75972236|FG000|COMPLETED|Olm 40 mg||177||
59847420|NCT00403481|75972236|FG000|NOT COMPLETED|Olm 40 mg||5||
59847421|NCT00403481|75972236|FG000|STARTED|Olm 40 mg + Hydrochlorothiazide 12.5 mg|177 -4 met their blood pressure goal (remained on olmesartan 40 mg)= 173|173||
59847422|NCT00403481|75972236|FG000|COMPLETED|Olm 40 mg + Hydrochlorothiazide 12.5 mg||168||
59847423|NCT00403481|75972236|FG000|NOT COMPLETED|Olm 40 mg + Hydrochlorothiazide 12.5 mg||5||
59847424|NCT00403481|75972236|FG000|STARTED|Olm 40 mg + Hydrochlorothiazide 25 mg|168 -24 met their blood pressure goal (remained on olmesartan 40 mg/hydrochlorothiazide 12.5mg)= 144|144||
59847425|NCT00403481|75972236|FG000|COMPLETED|Olm 40 mg + Hydrochlorothiazide 25 mg||142||
59847426|NCT00403481|75972236|FG000|NOT COMPLETED|Olm 40 mg + Hydrochlorothiazide 25 mg||2||
59847427|NCT00402779|75972245|FG000|STARTED|Overall Study||152||
59847428|NCT00402779|75972246|FG001|STARTED|Overall Study||151||
59847429|NCT00402779|75972245|FG000|COMPLETED|Overall Study||75||
59847430|NCT00402779|75972246|FG001|COMPLETED|Overall Study||75||
59847431|NCT00402779|75972245|FG000|NOT COMPLETED|Overall Study||77||
59847432|NCT00402779|75972246|FG001|NOT COMPLETED|Overall Study||76||
59847433|NCT00394433|75972252|FG000|STARTED|Overall Study||38||
59847434|NCT00394433|75972252|FG000|Evaluable and Treated|Overall Study||35||
59847435|NCT00394433|75972252|FG000|COMPLETED|Overall Study||35||
59847436|NCT00394433|75972252|FG000|NOT COMPLETED|Overall Study||3||
59847437|NCT00092534|75972258|FG000|STARTED|Base Study Vaccination Period||6087||
59847438|NCT00092534|75972259|FG001|STARTED|Base Study Vaccination Period||6080||
59847439|NCT00092534|75972260|FG002|STARTED|Base Study Vaccination Period||0||
59847440|NCT00092534|75972261|FG003|STARTED|Base Study Vaccination Period||0||
59847441|NCT00092534|75972262|FG004|STARTED|Base Study Vaccination Period||0||
59847442|NCT00092534|75972258|FG000|COMPLETED|Base Study Vaccination Period||5916||
59847443|NCT00092534|75972259|FG001|COMPLETED|Base Study Vaccination Period||5954||
59847444|NCT00092534|75972260|FG002|COMPLETED|Base Study Vaccination Period||0||
59847445|NCT00092534|75972261|FG003|COMPLETED|Base Study Vaccination Period||0||
59847446|NCT00092534|75972262|FG004|COMPLETED|Base Study Vaccination Period||0||
59847447|NCT00092534|75972258|FG000|NOT COMPLETED|Base Study Vaccination Period||171||
59847448|NCT00092534|75972259|FG001|NOT COMPLETED|Base Study Vaccination Period||126||
59847449|NCT00092534|75972260|FG002|NOT COMPLETED|Base Study Vaccination Period||0||
59847450|NCT00092534|75972261|FG003|NOT COMPLETED|Base Study Vaccination Period||0||
59847451|NCT00092534|75972262|FG004|NOT COMPLETED|Base Study Vaccination Period||0||
59847452|NCT00092534|75972258|FG000|STARTED|Base Study Follow-Up Period|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up.|5942||
59847453|NCT00092534|75972259|FG001|STARTED|Base Study Follow-Up Period|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up.|5971||
59847454|NCT00092534|75972260|FG002|STARTED|Base Study Follow-Up Period||0||
59847455|NCT00092534|75972261|FG003|STARTED|Base Study Follow-Up Period||0||
59847456|NCT00092534|75972262|FG004|STARTED|Base Study Follow-Up Period||0||
59847457|NCT00092534|75972258|FG000|COMPLETED|Base Study Follow-Up Period||5626||
59847458|NCT00092534|75972259|FG001|COMPLETED|Base Study Follow-Up Period||5277||
59847459|NCT00092534|75972260|FG002|COMPLETED|Base Study Follow-Up Period||0||
59847460|NCT00092534|75972261|FG003|COMPLETED|Base Study Follow-Up Period||0||
59847461|NCT00092534|75972262|FG004|COMPLETED|Base Study Follow-Up Period||0||
59847462|NCT00092534|75972258|FG000|NOT COMPLETED|Base Study Follow-Up Period||316||
59847463|NCT00092534|75972259|FG001|NOT COMPLETED|Base Study Follow-Up Period||694||
59847464|NCT00092534|75972260|FG002|NOT COMPLETED|Base Study Follow-Up Period||0||
59847465|NCT00092534|75972261|FG003|NOT COMPLETED|Base Study Follow-Up Period||0||
59847466|NCT00092534|75972262|FG004|NOT COMPLETED|Base Study Follow-Up Period||0||
59847467|NCT00092534|75972258|FG000|STARTED|Base Study EXT||0||
59847468|NCT00092534|75972259|FG001|STARTED|Base Study EXT||0||
59847469|NCT00092534|75972260|FG002|STARTED|Base Study EXT||594||
59847470|NCT00092534|75972261|FG003|STARTED|Base Study EXT||0||
59847471|NCT00092534|75972262|FG004|STARTED|Base Study EXT||0||
59847472|NCT00092534|75972258|FG000|COMPLETED|Base Study EXT||0||
59847473|NCT00092534|75972259|FG001|COMPLETED|Base Study EXT||0||
59847474|NCT00092534|75972260|FG002|COMPLETED|Base Study EXT||449||
59847475|NCT00092534|75972261|FG003|COMPLETED|Base Study EXT||0||
59847476|NCT00092534|75972262|FG004|COMPLETED|Base Study EXT||0||
59847477|NCT00092534|75972258|FG000|NOT COMPLETED|Base Study EXT||0||
59847478|NCT00092534|75972259|FG001|NOT COMPLETED|Base Study EXT||0||
59847479|NCT00092534|75972260|FG002|NOT COMPLETED|Base Study EXT||145||
59847480|NCT00092534|75972261|FG003|NOT COMPLETED|Base Study EXT||0||
59847481|NCT00092534|75972262|FG004|NOT COMPLETED|Base Study EXT||0||
59847482|NCT00092534|75972258|FG000|STARTED|Long-Term Follow-Up (LTFU) Study||0|Eligible for inclusion in the LTFU study|
59847483|NCT00092534|75972259|FG001|STARTED|Long-Term Follow-Up (LTFU) Study||0|Eligible for inclusion in the LTFU study|
59847484|NCT00092534|75972260|FG002|STARTED|Long-Term Follow-Up (LTFU) Study||0|Eligible for inclusion in the LTFU study|
59847485|NCT00092534|75972261|FG003|STARTED|Long-Term Follow-Up (LTFU) Study|Some Base Study participants did not consent for inclusion in the LTFU.|2750|Eligible for inclusion in the LTFU study|
59847486|NCT00092534|75972262|FG004|STARTED|Long-Term Follow-Up (LTFU) Study|Some Base Study participants did not consent for inclusion in the LTFU.|2097|Eligible for inclusion in the LTFU study|
59847487|NCT00092534|75972258|FG000|Started: Registry-based Effectiveness|Long-Term Follow-Up (LTFU) Study||0|Eligible and consented to inclusion in registry-based searches for effectiveness information|
59847488|NCT00092534|75972259|FG001|Started: Registry-based Effectiveness|Long-Term Follow-Up (LTFU) Study||0|Eligible and consented to inclusion in registry-based searches for effectiveness information|
59996685|NCT02714569|76112506|FG003|NOT COMPLETED|Part A Fourth Intervention||0||
59996686|NCT02714569|76112507|FG004|NOT COMPLETED|Part A Fourth Intervention||0||
59719936|NCT01103466|75839049|FG002|NOT COMPLETED|Third Period (14 +/- 3 Days)||1||
59719937|NCT00945945|75839059|FG000|STARTED|Overall Study||207||
59719938|NCT00945945|75839060|FG001|STARTED|Overall Study||217||
59719939|NCT00945945|75839059|FG000|COMPLETED|Overall Study||171||
59719940|NCT00945945|75839060|FG001|COMPLETED|Overall Study||162||
59719941|NCT00945945|75839059|FG000|NOT COMPLETED|Overall Study||36||
59719942|NCT00945945|75839060|FG001|NOT COMPLETED|Overall Study||55||
59719943|NCT01203956|75839066|FG000|STARTED|First Two-week Period||15||
59719944|NCT01203956|75839067|FG001|STARTED|First Two-week Period||13||
59719945|NCT01203956|75839066|FG000|COMPLETED|First Two-week Period|All participants continued to the second two-week period, whether or not they had evaluable results.|15||
59719946|NCT01203956|75839067|FG001|COMPLETED|First Two-week Period|All participants continued to the second two-week period, whether or not they had evaluable results.|13||
59719947|NCT01203956|75839066|FG000|NOT COMPLETED|First Two-week Period||0||
59719948|NCT01203956|75839067|FG001|NOT COMPLETED|First Two-week Period||0||
59847489|NCT00092534|75972260|FG002|Started: Registry-based Effectiveness|Long-Term Follow-Up (LTFU) Study||0|Eligible and consented to inclusion in registry-based searches for effectiveness information|
59847490|NCT00092534|75972261|FG003|Started: Registry-based Effectiveness|Long-Term Follow-Up (LTFU) Study||2650|Eligible and consented to inclusion in registry-based searches for effectiveness information|
59847491|NCT00092534|75972262|FG004|Started: Registry-based Effectiveness|Long-Term Follow-Up (LTFU) Study||2050|Eligible and consented to inclusion in registry-based searches for effectiveness information|
59847492|NCT00092534|75972258|FG000|Started: Immunogenicity Analysis|Long-Term Follow-Up (LTFU) Study||0|Eligible and consented to provide blood samples for immunogenicity anaysis|
59847493|NCT00092534|75972259|FG001|Started: Immunogenicity Analysis|Long-Term Follow-Up (LTFU) Study||0|Eligible and consented to provide blood samples for immunogenicity anaysis|
59847494|NCT00092534|75972260|FG002|Started: Immunogenicity Analysis|Long-Term Follow-Up (LTFU) Study||0|Eligible and consented to provide blood samples for immunogenicity anaysis|
59847495|NCT00092534|75972261|FG003|Started: Immunogenicity Analysis|Long-Term Follow-Up (LTFU) Study||2385|Eligible and consented to provide blood samples for immunogenicity anaysis|
59847496|NCT00092534|75972262|FG004|Started: Immunogenicity Analysis|Long-Term Follow-Up (LTFU) Study||1849|Eligible and consented to provide blood samples for immunogenicity anaysis|
59847497|NCT00092534|75972258|FG000|Started: Registry-based Safety|Long-Term Follow-Up (LTFU) Study||0|Eligible and consented to inclusion in registry-based searches for safety information|
59847498|NCT00092534|75972259|FG001|Started: Registry-based Safety|Long-Term Follow-Up (LTFU) Study||0|Eligible and consented to inclusion in registry-based searches for safety information|
59847499|NCT00092534|75972260|FG002|Started: Registry-based Safety|Long-Term Follow-Up (LTFU) Study||0|Eligible and consented to inclusion in registry-based searches for safety information|
59847500|NCT00092534|75972261|FG003|Started: Registry-based Safety|Long-Term Follow-Up (LTFU) Study||2448|Eligible and consented to inclusion in registry-based searches for safety information|
59847501|NCT00092534|75972262|FG004|Started: Registry-based Safety|Long-Term Follow-Up (LTFU) Study||1888|Eligible and consented to inclusion in registry-based searches for safety information|
59847502|NCT00092534|75972258|FG000|COMPLETED|Long-Term Follow-Up (LTFU) Study||0||
59847503|NCT00092534|75972259|FG001|COMPLETED|Long-Term Follow-Up (LTFU) Study||0||
59847504|NCT00092534|75972260|FG002|COMPLETED|Long-Term Follow-Up (LTFU) Study||0||
59847505|NCT00092534|75972261|FG003|COMPLETED|Long-Term Follow-Up (LTFU) Study||2749||
59847506|NCT00092534|75972262|FG004|COMPLETED|Long-Term Follow-Up (LTFU) Study||2097||
59847507|NCT00092534|75972258|FG000|NOT COMPLETED|Long-Term Follow-Up (LTFU) Study||0||
59847508|NCT00092534|75972259|FG001|NOT COMPLETED|Long-Term Follow-Up (LTFU) Study||0||
59847509|NCT00092534|75972260|FG002|NOT COMPLETED|Long-Term Follow-Up (LTFU) Study||0||
59847510|NCT00092534|75972261|FG003|NOT COMPLETED|Long-Term Follow-Up (LTFU) Study||1||
59847511|NCT00092534|75972262|FG004|NOT COMPLETED|Long-Term Follow-Up (LTFU) Study||0||
59847512|NCT00068250|75972275|FG000|STARTED|Phase I: Dose Level 1||6||
59847513|NCT00068250|75972276|FG001|STARTED|Phase I: Dose Level 1||0||
59847514|NCT00068250|75972277|FG002|STARTED|Phase I: Dose Level 1||0||
59847515|NCT00068250|75972278|FG003|STARTED|Phase I: Dose Level 1||0||
59996687|NCT02714569|76112508|FG005|NOT COMPLETED|Part A Fourth Intervention||1||
59996688|NCT02714569|76112509|FG006|NOT COMPLETED|Part A Fourth Intervention||0||
59996689|NCT02714569|76112510|FG007|NOT COMPLETED|Part A Fourth Intervention||0||
59996690|NCT02714569|76112511|FG008|NOT COMPLETED|Part A Fourth Intervention||0||
59996691|NCT02714569|76112512|FG009|NOT COMPLETED|Part A Fourth Intervention||0||
59996692|NCT02714569|76112513|FG010|NOT COMPLETED|Part A Fourth Intervention||0||
59996693|NCT02714569|76112503|FG000|STARTED|Part B (Overall)|Part A participants completed period 4 and were not in part B.|0||
59996694|NCT02714569|76112504|FG001|STARTED|Part B (Overall)|Part A participants completed period 4 and were not in part B.|0||
59996695|NCT02714569|76112505|FG002|STARTED|Part B (Overall)|Part A participants completed period 4 and were not in part B.|0||
59847516|NCT00068250|75972275|FG000|COMPLETED|Phase I: Dose Level 1|Subjects with data available for the primary analysis are considered to have completed the study.|6||
59847517|NCT00068250|75972276|FG001|COMPLETED|Phase I: Dose Level 1||0||
59847518|NCT00068250|75972277|FG002|COMPLETED|Phase I: Dose Level 1||0||
59847519|NCT00068250|75972278|FG003|COMPLETED|Phase I: Dose Level 1||0||
59847520|NCT00068250|75972275|FG000|NOT COMPLETED|Phase I: Dose Level 1||0||
59847521|NCT00068250|75972276|FG001|NOT COMPLETED|Phase I: Dose Level 1||0||
59847522|NCT00068250|75972277|FG002|NOT COMPLETED|Phase I: Dose Level 1||0||
59847523|NCT00068250|75972278|FG003|NOT COMPLETED|Phase I: Dose Level 1||0||
59847524|NCT00068250|75972275|FG000|STARTED|Phase I: Dose Level 2||0||
59847525|NCT00068250|75972276|FG001|STARTED|Phase I: Dose Level 2||7||
59847526|NCT00068250|75972277|FG002|STARTED|Phase I: Dose Level 2||0||
59847527|NCT00068250|75972278|FG003|STARTED|Phase I: Dose Level 2||0||
59847528|NCT00068250|75972275|FG000|COMPLETED|Phase I: Dose Level 2||0||
59847529|NCT00068250|75972276|FG001|COMPLETED|Phase I: Dose Level 2|Subjects with data available for the primary analysis are considered to have completed the study.|6||
59847530|NCT00068250|75972277|FG002|COMPLETED|Phase I: Dose Level 2||0||
59847531|NCT00068250|75972278|FG003|COMPLETED|Phase I: Dose Level 2||0||
59847532|NCT00068250|75972275|FG000|NOT COMPLETED|Phase I: Dose Level 2||0||
59847533|NCT00068250|75972276|FG001|NOT COMPLETED|Phase I: Dose Level 2||1||
59847534|NCT00068250|75972277|FG002|NOT COMPLETED|Phase I: Dose Level 2||0||
59847535|NCT00068250|75972278|FG003|NOT COMPLETED|Phase I: Dose Level 2||0||
59847536|NCT00068250|75972275|FG000|STARTED|Phase II: Dose Level 2||0||
59847537|NCT00068250|75972276|FG001|STARTED|Phase II: Dose Level 2||0||
59847538|NCT00068250|75972277|FG002|STARTED|Phase II: Dose Level 2||0||
60120475|NCT02692716|76241606|FG001|Full Analysis Set (FAS)|Overall Study||1592||
60120476|NCT02692716|76241605|FG000|Exposed|Overall Study||1591||
60120477|NCT02692716|76241606|FG001|Exposed|Overall Study||1591||
60120478|NCT02692716|76241605|FG000|COMPLETED|Overall Study||1586||
60120479|NCT02692716|76241606|FG001|COMPLETED|Overall Study||1586||
60120480|NCT02692716|76241605|FG000|NOT COMPLETED|Overall Study||5||
60120481|NCT02692716|76241606|FG001|NOT COMPLETED|Overall Study||6||
60120482|NCT01580969|76241615|FG000|STARTED|Overall Study||6||
59719949|NCT01203956|75839066|FG000|STARTED|Second Two-week Period||15||
59719950|NCT01203956|75839067|FG001|STARTED|Second Two-week Period||13||
59719951|NCT01203956|75839066|FG000|Attended Sleep Studies for 14 Nights|Second Two-week Period||15||
59719952|NCT01203956|75839067|FG001|Attended Sleep Studies for 14 Nights|Second Two-week Period||13||
59719953|NCT01203956|75839066|FG000|COMPLETED|Second Two-week Period|Completed with evaluable results, as assessed over both two-week study periods.|10||
59719954|NCT01203956|75839067|FG001|COMPLETED|Second Two-week Period|Completed with evaluable results, as assessed over both two-week study periods.|7||
59719955|NCT01203956|75839066|FG000|NOT COMPLETED|Second Two-week Period||5||
59719956|NCT01203956|75839067|FG001|NOT COMPLETED|Second Two-week Period||6||
59719957|NCT01103232|75839076|FG000|STARTED|Overall Study||13||
59719958|NCT01103232|75839077|FG001|STARTED|Overall Study||13||
59719959|NCT01103232|75839076|FG000|COMPLETED|Overall Study||12||
59719960|NCT01103232|75839077|FG001|COMPLETED|Overall Study||11||
59719961|NCT01103232|75839076|FG000|NOT COMPLETED|Overall Study||1||
59719962|NCT01103232|75839077|FG001|NOT COMPLETED|Overall Study||2||
59847539|NCT00068250|75972278|FG003|STARTED|Phase II: Dose Level 2||47||
59847540|NCT00068250|75972275|FG000|COMPLETED|Phase II: Dose Level 2||0||
59847541|NCT00068250|75972276|FG001|COMPLETED|Phase II: Dose Level 2||0||
59847542|NCT00068250|75972277|FG002|COMPLETED|Phase II: Dose Level 2||0||
59847543|NCT00068250|75972278|FG003|COMPLETED|Phase II: Dose Level 2|Subjects with data available for the primary analysis are considered to have completed the study.|47||
59847544|NCT00068250|75972275|FG000|NOT COMPLETED|Phase II: Dose Level 2||0||
59847545|NCT00068250|75972276|FG001|NOT COMPLETED|Phase II: Dose Level 2||0||
59847546|NCT00068250|75972277|FG002|NOT COMPLETED|Phase II: Dose Level 2||0||
59847547|NCT00068250|75972278|FG003|NOT COMPLETED|Phase II: Dose Level 2||0||
59847548|NCT00393887|75972288|FG000|STARTED|Overall Study||50||
59847549|NCT00393887|75972289|FG001|STARTED|Overall Study||50||
59847550|NCT00393887|75972288|FG000|1 Year|Overall Study||45||
59847551|NCT00393887|75972289|FG001|1 Year|Overall Study||50||
59847552|NCT00393887|75972288|FG000|COMPLETED|Overall Study||34||
59847553|NCT00393887|75972289|FG001|COMPLETED|Overall Study||41||
59847554|NCT00393887|75972288|FG000|NOT COMPLETED|Overall Study||16||
59847555|NCT00393887|75972289|FG001|NOT COMPLETED|Overall Study||9||
59719963|NCT01112982|75839083|FG000|STARTED|Overall Study||74||
59847556|NCT00393029|75972297|FG000|STARTED|Overall Study||2||
59847557|NCT00393029|75972298|FG001|STARTED|Overall Study||10||
60120483|NCT01580969|76241616|FG001|STARTED|Overall Study||3||
60120484|NCT01580969|76241617|FG002|STARTED|Overall Study||13||
59847558|NCT00393029|75972297|FG000|COMPLETED|Overall Study||2||
59847559|NCT00393029|75972298|FG001|COMPLETED|Overall Study||9||
59847560|NCT00393029|75972297|FG000|NOT COMPLETED|Overall Study||0||
59847561|NCT00393029|75972298|FG001|NOT COMPLETED|Overall Study||1||
59847562|NCT00402233|75972309|FG000|STARTED|Overall Study||77||
59847563|NCT00402233|75972310|FG001|STARTED|Overall Study||80||
59847564|NCT00402233|75972311|FG002|STARTED|Overall Study||81||
59847565|NCT00402233|75972312|FG003|STARTED|Overall Study||73||
59847566|NCT00402233|75972309|FG000|COMPLETED|Overall Study||72||
59847567|NCT00402233|75972310|FG001|COMPLETED|Overall Study||70||
59847568|NCT00402233|75972311|FG002|COMPLETED|Overall Study||70||
59847569|NCT00402233|75972312|FG003|COMPLETED|Overall Study||62||
59847570|NCT00402233|75972309|FG000|NOT COMPLETED|Overall Study||5||
59847571|NCT00402233|75972310|FG001|NOT COMPLETED|Overall Study||10||
59847572|NCT00402233|75972311|FG002|NOT COMPLETED|Overall Study||11||
59847573|NCT00402233|75972312|FG003|NOT COMPLETED|Overall Study||11||
59847574|NCT00092456|75972326|FG000|STARTED|Overall Study|Subject assigned to ~8.81 X 10^7 IU/Dose of RotaTeq™ - Lot 1|226||
59847575|NCT00092456|75972327|FG001|STARTED|Overall Study|Subject assigned to ~8.01 X 10^7 IU/Dose of RotaTeq™ - Lot 2|225||
59847576|NCT00092456|75972328|FG002|STARTED|Overall Study|Subject assigned to ~6.91 X 10^7 IU/Dose of RotaTeq™ - Lot 3|229||
59847577|NCT00092456|75972329|FG003|STARTED|Overall Study|Subjects assigned to Placebo-matching RotaTeq™|113||
59847578|NCT00092456|75972326|FG000|Vaccinated at Visit 1|Overall Study||226||
59847579|NCT00092456|75972327|FG001|Vaccinated at Visit 1|Overall Study||225||
59847580|NCT00092456|75972328|FG002|Vaccinated at Visit 1|Overall Study||229||
59847581|NCT00092456|75972329|FG003|Vaccinated at Visit 1|Overall Study||113||
59847582|NCT00092456|75972326|FG000|Vaccinated at Visit 2|Overall Study||208||
59847583|NCT00092456|75972327|FG001|Vaccinated at Visit 2|Overall Study||217||
59847584|NCT00092456|75972328|FG002|Vaccinated at Visit 2|Overall Study||210||
59847585|NCT00092456|75972329|FG003|Vaccinated at Visit 2|Overall Study||104||
59847586|NCT00092456|75972326|FG000|Vaccinated at Visit 3|Overall Study||202||
59847587|NCT00092456|75972327|FG001|Vaccinated at Visit 3|Overall Study||210||
59847588|NCT00092456|75972328|FG002|Vaccinated at Visit 3|Overall Study||200||
59996696|NCT02714569|76112506|FG003|STARTED|Part B (Overall)|Part A participants completed period 4 and were not in part B.|0||
59996697|NCT02714569|76112507|FG004|STARTED|Part B (Overall)|Part A participants completed period 4 and were not in part B.|0||
59847589|NCT00092456|75972329|FG003|Vaccinated at Visit 3|Overall Study||98||
59847590|NCT00092456|75972326|FG000|COMPLETED|Overall Study|Subjects who received 3 scheduled vaccinations; with up to 42 days safety follow-up after each dose|201||
59847591|NCT00092456|75972327|FG001|COMPLETED|Overall Study|Subjects who received 3 scheduled vaccinations; with up to 42 days safety follow-up after each dose|208||
59847592|NCT00092456|75972328|FG002|COMPLETED|Overall Study|Subjects who received 3 scheduled vaccinations; with up to 42 days safety follow-up after each dose|200||
59847593|NCT00092456|75972329|FG003|COMPLETED|Overall Study|Subjects who received 3 scheduled vaccinations; with up to 42 days safety follow-up after each dose|97||
59847594|NCT00092456|75972326|FG000|NOT COMPLETED|Overall Study||25||
59847595|NCT00092456|75972327|FG001|NOT COMPLETED|Overall Study||17||
59847596|NCT00092456|75972328|FG002|NOT COMPLETED|Overall Study||29||
59847597|NCT00092456|75972329|FG003|NOT COMPLETED|Overall Study||16||
59847598|NCT00067470|75972341|FG000|STARTED|Overall Study||19||
59847599|NCT00067470|75972342|FG001|STARTED|Overall Study||20||
59847600|NCT00067470|75972341|FG000|COMPLETED|Overall Study||19||
59847601|NCT00067470|75972342|FG001|COMPLETED|Overall Study||19||
59847602|NCT00067470|75972341|FG000|NOT COMPLETED|Overall Study||0||
59847603|NCT00067470|75972342|FG001|NOT COMPLETED|Overall Study||1||
59847604|NCT00401843|75972351|FG000|STARTED|Overall Study||21||
59847605|NCT00401843|75972352|FG001|STARTED|Overall Study||144||
59847606|NCT00401843|75972353|FG002|STARTED|Overall Study||142||
59847607|NCT00401843|75972351|FG000|Treated|Overall Study||21||
59847608|NCT00401843|75972352|FG001|Treated|Overall Study||142||
59847609|NCT00401843|75972353|FG002|Treated|Overall Study||139||
59847610|NCT00401843|75972351|FG000|COMPLETED|Overall Study||0||
59847611|NCT00401843|75972352|FG001|COMPLETED|Overall Study||0||
59847612|NCT00401843|75972353|FG002|COMPLETED|Overall Study||0||
59847613|NCT00401843|75972351|FG000|NOT COMPLETED|Overall Study||21||
59847614|NCT00401843|75972352|FG001|NOT COMPLETED|Overall Study||144||
59847615|NCT00401843|75972353|FG002|NOT COMPLETED|Overall Study||142||
59847616|NCT00401531|75972365|FG000|STARTED|Overall Study||206||
59847617|NCT00401531|75972366|FG001|STARTED|Overall Study||206||
59847618|NCT00401531|75972365|FG000|COMPLETED|Overall Study||197||
59847619|NCT00401531|75972366|FG001|COMPLETED|Overall Study||196||
59847620|NCT00401531|75972365|FG000|NOT COMPLETED|Overall Study||9||
59847621|NCT00401531|75972366|FG001|NOT COMPLETED|Overall Study||10||
59847622|NCT00401375|75972375|FG000|STARTED|Overall Study||174||
59847623|NCT00401375|75972376|FG001|STARTED|Overall Study||176||
59847624|NCT00401375|75972377|FG002|STARTED|Overall Study||174||
59847625|NCT00401375|75972375|FG000|Received at Least 1 Dose of Study Drug|Overall Study||171|Modified intent-to-treat (mITT)/Safety population|
59847626|NCT00401375|75972376|FG001|Received at Least 1 Dose of Study Drug|Overall Study||173|Modified intent-to-treat (mITT)/Safety population|
59847627|NCT00401375|75972377|FG002|Received at Least 1 Dose of Study Drug|Overall Study||171|Modified intent-to-treat (mITT)/Safety population|
59847628|NCT00401375|75972375|FG000|COMPLETED|Overall Study||152||
59847629|NCT00401375|75972376|FG001|COMPLETED|Overall Study||151||
59847630|NCT00401375|75972377|FG002|COMPLETED|Overall Study||149||
59847631|NCT00401375|75972375|FG000|NOT COMPLETED|Overall Study||22||
59847632|NCT00401375|75972376|FG001|NOT COMPLETED|Overall Study||25||
59847633|NCT00401375|75972377|FG002|NOT COMPLETED|Overall Study||25||
59847634|NCT00400985|75972385|FG000|STARTED|Overall Study||501||
59847635|NCT00400985|75972385|FG000|COMPLETED|Overall Study||449||
59847636|NCT00400985|75972385|FG000|NOT COMPLETED|Overall Study||52||
59847637|NCT00400517|75972389|FG000|STARTED|Overall Study|1 pt w/d consent. 1 pt found to have unresectable dx at time of sx and is exc. in tissue analysis.|28||
59847638|NCT00400517|75972389|FG000|COMPLETED|Overall Study||26||
59847639|NCT00400517|75972389|FG000|NOT COMPLETED|Overall Study||2||
59847640|NCT00392171|75972393|FG000|STARTED|Overall Study||120||
59847641|NCT00392171|75972393|FG000|COMPLETED|Overall Study||15||
59847642|NCT00392171|75972393|FG000|NOT COMPLETED|Overall Study||105||
59847643|NCT00391625|75972397|FG000|STARTED|Baseline||10||
59847644|NCT00391625|75972397|FG000|COMPLETED|Baseline||10||
59847645|NCT00391625|75972397|FG000|NOT COMPLETED|Baseline||0||
59847646|NCT00391625|75972397|FG000|STARTED|Month 14||10||
59847647|NCT00391625|75972397|FG000|COMPLETED|Month 14||9||
59847648|NCT00391625|75972397|FG000|NOT COMPLETED|Month 14||1||
59847649|NCT00391625|75972397|FG000|STARTED|Month 50||9||
59847650|NCT00391625|75972397|FG000|COMPLETED|Month 50||8||
59847651|NCT00391625|75972397|FG000|NOT COMPLETED|Month 50||1||
59847652|NCT00391625|75972397|FG000|STARTED|Month 84||8||
59847653|NCT00391625|75972397|FG000|COMPLETED|Month 84||8||
59847654|NCT00391625|75972397|FG000|NOT COMPLETED|Month 84||0||
59847655|NCT00091832|75972430|FG000|STARTED|Overall Study||43||
59847656|NCT00091832|75972431|FG001|STARTED|Overall Study||42||
59847657|NCT00091832|75972432|FG002|STARTED|Overall Study||42||
59847658|NCT00091832|75972433|FG003|STARTED|Overall Study||43||
59847659|NCT00091832|75972434|FG004|STARTED|Overall Study||42||
59847660|NCT00091832|75972435|FG005|STARTED|Overall Study||43||
59847661|NCT00091832|75972430|FG000|Received Study Medication|Overall Study||43||
59847662|NCT00091832|75972431|FG001|Received Study Medication|Overall Study||42||
59847663|NCT00091832|75972432|FG002|Received Study Medication|Overall Study||41||
59847664|NCT00091832|75972433|FG003|Received Study Medication|Overall Study||43||
59847665|NCT00091832|75972434|FG004|Received Study Medication|Overall Study||42||
59847666|NCT00091832|75972435|FG005|Received Study Medication|Overall Study||43||
59847667|NCT00091832|75972430|FG000|COMPLETED|Overall Study||29||
59847668|NCT00091832|75972431|FG001|COMPLETED|Overall Study||31||
59847669|NCT00091832|75972432|FG002|COMPLETED|Overall Study||30||
59847670|NCT00091832|75972433|FG003|COMPLETED|Overall Study||29||
59847671|NCT00091832|75972434|FG004|COMPLETED|Overall Study||27||
59719964|NCT01112982|75839083|FG000|COMPLETED|Overall Study||72||
59719965|NCT01112982|75839083|FG000|NOT COMPLETED|Overall Study||2||
59847672|NCT00091832|75972435|FG005|COMPLETED|Overall Study||32||
59847673|NCT00091832|75972430|FG000|NOT COMPLETED|Overall Study||14||
59847674|NCT00091832|75972431|FG001|NOT COMPLETED|Overall Study||11||
59847675|NCT00091832|75972432|FG002|NOT COMPLETED|Overall Study||12||
59847676|NCT00091832|75972433|FG003|NOT COMPLETED|Overall Study||14||
59847677|NCT00091832|75972434|FG004|NOT COMPLETED|Overall Study||15||
59847678|NCT00091832|75972435|FG005|NOT COMPLETED|Overall Study||11||
59847679|NCT00391391|75972453|FG000|STARTED|Overall Study|1 participant was not vaccinated.|98||
59847680|NCT00391391|75972454|FG001|STARTED|Overall Study||97||
60120485|NCT01580969|76241615|FG000|COMPLETED|Overall Study||3||
59719966|NCT01203878|75839093|FG000|STARTED|Overall Study||9||
59719967|NCT01203878|75839094|FG001|STARTED|Overall Study||9||
59719968|NCT01203878|75839095|FG002|STARTED|Overall Study||3||
59719969|NCT01203878|75839093|FG000|COMPLETED|Overall Study||9||
59719970|NCT01203878|75839094|FG001|COMPLETED|Overall Study||9||
59719971|NCT01203878|75839095|FG002|COMPLETED|Overall Study||0||
59719972|NCT01203878|75839093|FG000|NOT COMPLETED|Overall Study||0||
59847681|NCT00391391|75972455|FG002|STARTED|Overall Study|1 participant was not vaccinated.|161||
59847682|NCT00391391|75972456|FG003|STARTED|Overall Study|1 participant was not vaccinated.|164||
59847683|NCT00391391|75972453|FG000|COMPLETED|Overall Study||89||
59847684|NCT00391391|75972454|FG001|COMPLETED|Overall Study||87||
59847685|NCT00391391|75972455|FG002|COMPLETED|Overall Study||138||
59847686|NCT00391391|75972456|FG003|COMPLETED|Overall Study||145||
59847687|NCT00391391|75972453|FG000|NOT COMPLETED|Overall Study||9||
59847688|NCT00391391|75972454|FG001|NOT COMPLETED|Overall Study||10||
59847689|NCT00391391|75972455|FG002|NOT COMPLETED|Overall Study||23||
59847690|NCT00391391|75972456|FG003|NOT COMPLETED|Overall Study||19||
59847691|NCT00091442|75972468|FG000|STARTED|Overall Study||373||
59847692|NCT00091442|75972469|FG001|STARTED|Overall Study||378||
59847693|NCT00091442|75972468|FG000|COMPLETED|Overall Study|Indicates number of participants on study treatment at time of the primary objective|4||
60120486|NCT01580969|76241616|FG001|COMPLETED|Overall Study||3||
59567962|NCT02411643|75670859|FG000|COMPLETED|Overall Study||2||
59567963|NCT02411643|75670859|FG000|NOT COMPLETED|Overall Study||0||
59567964|NCT02277626|75670863|FG000|STARTED|Overall Study||6||
59567965|NCT02277626|75670864|FG001|STARTED|Overall Study||9||
59567966|NCT02277626|75670863|FG000|COMPLETED|Overall Study||6||
59567967|NCT02277626|75670864|FG001|COMPLETED|Overall Study||9||
59567968|NCT02277626|75670863|FG000|NOT COMPLETED|Overall Study||0||
59567969|NCT02277626|75670864|FG001|NOT COMPLETED|Overall Study||0||
59567970|NCT03758157|75670875|FG000|STARTED|Overall Study||110||
59567971|NCT03758157|75670875|FG000|COMPLETED|Overall Study||110||
59567972|NCT03758157|75670875|FG000|NOT COMPLETED|Overall Study||0||
59567973|NCT01107795|75670879|FG000|STARTED|Overall Study||41||
59567974|NCT01107795|75670879|FG000|COMPLETED|Overall Study||41||
59567975|NCT01107795|75670879|FG000|NOT COMPLETED|Overall Study||0||
59567976|NCT02280200|75670885|FG000|STARTED|Overall Study||15||
59567977|NCT02280200|75670886|FG001|STARTED|Overall Study||13||
59567978|NCT02280200|75670885|FG000|COMPLETED|Overall Study||12||
59567979|NCT02280200|75670886|FG001|COMPLETED|Overall Study||10||
59567980|NCT02280200|75670885|FG000|NOT COMPLETED|Overall Study||3||
59567981|NCT02280200|75670886|FG001|NOT COMPLETED|Overall Study||3||
59567982|NCT01085643|75670892|FG000|STARTED|Overall Study||4||
59567983|NCT01085643|75670892|FG000|COMPLETED|Overall Study||4||
59567984|NCT01085643|75670892|FG000|NOT COMPLETED|Overall Study||0||
59567985|NCT01071993|75670898|FG000|STARTED|Overall Study||0||
59567986|NCT01071993|75670899|FG001|STARTED|Overall Study||0||
59567987|NCT01071993|75670898|FG000|COMPLETED|Overall Study||0||
59567988|NCT01071993|75670899|FG001|COMPLETED|Overall Study||0||
59719973|NCT01203878|75839094|FG001|NOT COMPLETED|Overall Study||0||
59719974|NCT01203878|75839095|FG002|NOT COMPLETED|Overall Study||3||
59719975|NCT01112514|75839102|FG000|STARTED|Overall Study||4||
59719976|NCT01112514|75839102|FG000|COMPLETED|Overall Study||3||
59719977|NCT01112514|75839102|FG000|NOT COMPLETED|Overall Study||1||
59719978|NCT01203098|75839109|FG000|STARTED|Overall Study||89||
59719979|NCT01203098|75839110|FG001|STARTED|Overall Study||86||
59719980|NCT01203098|75839111|FG002|STARTED|Overall Study||89||
59719981|NCT01203098|75839109|FG000|Safety Analysis Dataset|Overall Study||89||
59719982|NCT01203098|75839110|FG001|Safety Analysis Dataset|Overall Study||85||
59719983|NCT01203098|75839111|FG002|Safety Analysis Dataset|Overall Study||87||
59719984|NCT01203098|75839109|FG000|COMPLETED|Overall Study||83||
59719985|NCT01203098|75839110|FG001|COMPLETED|Overall Study||82||
59719986|NCT01203098|75839111|FG002|COMPLETED|Overall Study||78||
59847694|NCT00091442|75972469|FG001|COMPLETED|Overall Study|Indicates number of participants on study treatment at time of the primary objective|5||
59847695|NCT00091442|75972468|FG000|NOT COMPLETED|Overall Study||369||
60120487|NCT01580969|76241617|FG002|COMPLETED|Overall Study||13||
60120488|NCT01580969|76241615|FG000|NOT COMPLETED|Overall Study||3||
60120489|NCT01580969|76241616|FG001|NOT COMPLETED|Overall Study||0||
60120490|NCT01580969|76241617|FG002|NOT COMPLETED|Overall Study||0||
60120491|NCT01693367|76241627|FG000|STARTED|Overall Study||2||
60120492|NCT01693367|76241628|FG001|STARTED|Overall Study||3||
60120493|NCT01693367|76241627|FG000|COMPLETED|Overall Study||1||
60120494|NCT01693367|76241628|FG001|COMPLETED|Overall Study||1||
60120495|NCT01693367|76241627|FG000|NOT COMPLETED|Overall Study||1||
60120496|NCT01693367|76241628|FG001|NOT COMPLETED|Overall Study||2||
60120497|NCT02696226|76241638|FG000|STARTED|Overall Study||1||
60120498|NCT02696226|76241639|FG001|STARTED|Overall Study||0||
59847696|NCT00091442|75972469|FG001|NOT COMPLETED|Overall Study||373||
59847697|NCT00390689|75972478|FG000|STARTED|Overall Study||48||
59847698|NCT00390689|75972479|FG001|STARTED|Overall Study||53||
59847699|NCT00390689|75972480|FG002|STARTED|Overall Study||53||
59847700|NCT00390689|75972478|FG000|COMPLETED|Overall Study||43||
59847701|NCT00390689|75972479|FG001|COMPLETED|Overall Study||48||
59847702|NCT00390689|75972480|FG002|COMPLETED|Overall Study||50||
59847703|NCT00390689|75972478|FG000|NOT COMPLETED|Overall Study||5||
59847704|NCT00390689|75972479|FG001|NOT COMPLETED|Overall Study||5||
59847705|NCT00390689|75972480|FG002|NOT COMPLETED|Overall Study||3||
59847706|NCT00121238|75972497|FG000|STARTED|Overall Study||16||
59847707|NCT00121238|75972497|FG000|COMPLETED|Overall Study|2 were later deemed ineligible (PSA rise), censored from efficacy but included for toxicity analysis|13||
59847708|NCT00121238|75972497|FG000|NOT COMPLETED|Overall Study||3||
59847709|NCT00390455|75972503|FG000|STARTED|Overall Study||148||
59847710|NCT00390455|75972504|FG001|STARTED|Overall Study||147||
59847711|NCT00390455|75972503|FG000|COMPLETED|Overall Study||116||
59847712|NCT00390455|75972504|FG001|COMPLETED|Overall Study||124||
59847713|NCT00390455|75972503|FG000|NOT COMPLETED|Overall Study||32||
59847714|NCT00390455|75972504|FG001|NOT COMPLETED|Overall Study||23||
59847715|NCT03812510|75972510|FG000|STARTED|Overall Study||426||
59847716|NCT03812510|75972510|FG000|COMPLETED|Overall Study||274||
59847717|NCT03812510|75972510|FG000|NOT COMPLETED|Overall Study||152||
59847718|NCT00390299|75972520|FG000|STARTED|Overall Study||4||
59847719|NCT00390299|75972521|FG001|STARTED|Overall Study||3||
59847720|NCT00390299|75972522|FG002|STARTED|Overall Study||3||
59847721|NCT00390299|75972523|FG003|STARTED|Overall Study||3||
59847722|NCT00390299|75972524|FG004|STARTED|Overall Study||10||
59847723|NCT00390299|75972520|FG000|COMPLETED|Overall Study||3||
59847724|NCT00390299|75972521|FG001|COMPLETED|Overall Study||3||
59847725|NCT00390299|75972522|FG002|COMPLETED|Overall Study||3||
59847726|NCT00390299|75972523|FG003|COMPLETED|Overall Study||3||
59847727|NCT00390299|75972524|FG004|COMPLETED|Overall Study||10||
59847728|NCT00390299|75972520|FG000|NOT COMPLETED|Overall Study||1||
59847729|NCT00390299|75972521|FG001|NOT COMPLETED|Overall Study||0||
59847730|NCT00390299|75972522|FG002|NOT COMPLETED|Overall Study||0||
59847731|NCT00390299|75972523|FG003|NOT COMPLETED|Overall Study||0||
59847732|NCT00390299|75972524|FG004|NOT COMPLETED|Overall Study||0||
59847733|NCT00119678|75972540|FG000|STARTED|Double-blind Treatment Period||122||
59847734|NCT00119678|75972541|FG001|STARTED|Double-blind Treatment Period||61||
59847735|NCT00119678|75972540|FG000|RANDOMIZED AND TREATED|Double-blind Treatment Period||121||
59847736|NCT00119678|75972541|FG001|RANDOMIZED AND TREATED|Double-blind Treatment Period||59||
59847737|NCT00119678|75972540|FG000|RANDOMIZED,TREATED, AND ANALYZED|Double-blind Treatment Period||118||
59847738|NCT00119678|75972541|FG001|RANDOMIZED,TREATED, AND ANALYZED|Double-blind Treatment Period||57||
59847739|NCT00119678|75972540|FG000|COMPLETED|Double-blind Treatment Period||81||
59847740|NCT00119678|75972541|FG001|COMPLETED|Double-blind Treatment Period||35||
59847741|NCT00119678|75972540|FG000|NOT COMPLETED|Double-blind Treatment Period||41||
59847742|NCT00119678|75972541|FG001|NOT COMPLETED|Double-blind Treatment Period||26||
59847743|NCT00119678|75972540|FG000|STARTED|Open-label Treatment Period|Number of participants treated|110||
59847744|NCT00119678|75972541|FG001|STARTED|Open-label Treatment Period||0||
59847745|NCT00119678|75972540|FG000|COMPLETED|Open-label Treatment Period||0||
59847746|NCT00119678|75972541|FG001|COMPLETED|Open-label Treatment Period||0||
59847747|NCT00119678|75972540|FG000|NOT COMPLETED|Open-label Treatment Period||110||
59847748|NCT00119678|75972541|FG001|NOT COMPLETED|Open-label Treatment Period||0||
59847749|NCT00110084|75972549|FG000|STARTED|Overall Study||50||
59847750|NCT00110084|75972549|FG000|COMPLETED|Overall Study||22||
59847751|NCT00110084|75972549|FG000|NOT COMPLETED|Overall Study||28||
59847752|NCT00390221|75972556|FG000|STARTED|Overall Study||204||
59847753|NCT00390221|75972557|FG001|STARTED|Overall Study||208||
59847754|NCT00390221|75972558|FG002|STARTED|Overall Study||209||
59847755|NCT00390221|75972556|FG000|COMPLETED|Overall Study||186||
59847756|NCT00390221|75972557|FG001|COMPLETED|Overall Study||188||
59847757|NCT00390221|75972558|FG002|COMPLETED|Overall Study||194||
59847758|NCT00390221|75972556|FG000|NOT COMPLETED|Overall Study||18||
59847759|NCT00390221|75972557|FG001|NOT COMPLETED|Overall Study||20||
59847760|NCT00390221|75972558|FG002|NOT COMPLETED|Overall Study||15||
59847761|NCT00389831|75972569|FG000|STARTED|Overall Study||10||
59847762|NCT00389831|75972570|FG001|STARTED|Overall Study||34||
59847763|NCT00389831|75972569|FG000|COMPLETED|Overall Study||10||
59847764|NCT00389831|75972570|FG001|COMPLETED|Overall Study||27||
59847765|NCT00389831|75972569|FG000|NOT COMPLETED|Overall Study||0||
59847766|NCT00389831|75972570|FG001|NOT COMPLETED|Overall Study||7||
59847767|NCT00389597|75972592|FG000|STARTED|Overall Study||164||
59847768|NCT00389597|75972593|FG001|STARTED|Overall Study||81||
59847769|NCT00389597|75972594|FG002|STARTED|Overall Study||225||
59847770|NCT00389597|75972595|FG003|STARTED|Overall Study||105||
59847771|NCT00389597|75972592|FG000|24 mo|Overall Study||156||
59847772|NCT00389597|75972593|FG001|24 mo|Overall Study||75||
59847773|NCT00389597|75972594|FG002|24 mo|Overall Study||221||
59847774|NCT00389597|75972595|FG003|24 mo|Overall Study||99||
59847775|NCT00389597|75972592|FG000|COMPLETED|Overall Study||156||
59847776|NCT00389597|75972593|FG001|COMPLETED|Overall Study||75||
59847777|NCT00389597|75972594|FG002|COMPLETED|Overall Study||221||
59847778|NCT00389597|75972595|FG003|COMPLETED|Overall Study||99||
59847779|NCT00389597|75972592|FG000|NOT COMPLETED|Overall Study||8||
59847780|NCT00389597|75972593|FG001|NOT COMPLETED|Overall Study||6||
59847781|NCT00389597|75972594|FG002|NOT COMPLETED|Overall Study||4||
59847782|NCT00389597|75972595|FG003|NOT COMPLETED|Overall Study||6||
59847783|NCT00389519|75972609|FG000|STARTED|Placebo Run-In||422||
59847784|NCT00389519|75972610|FG001|STARTED|Placebo Run-In||0||
59847785|NCT00389519|75972611|FG002|STARTED|Placebo Run-In||0||
59847786|NCT00389519|75972612|FG003|STARTED|Placebo Run-In||0||
59847787|NCT00389519|75972609|FG000|COMPLETED|Placebo Run-In||244||
59847788|NCT00389519|75972610|FG001|COMPLETED|Placebo Run-In||0||
59847789|NCT00389519|75972611|FG002|COMPLETED|Placebo Run-In||0||
59847790|NCT00389519|75972612|FG003|COMPLETED|Placebo Run-In||0||
59847791|NCT00389519|75972609|FG000|NOT COMPLETED|Placebo Run-In||178||
59847792|NCT00389519|75972610|FG001|NOT COMPLETED|Placebo Run-In||0||
59847793|NCT00389519|75972611|FG002|NOT COMPLETED|Placebo Run-In||0||
59847794|NCT00389519|75972612|FG003|NOT COMPLETED|Placebo Run-In||0||
59847795|NCT00389519|75972609|FG000|STARTED|Randomized||83||
59847796|NCT00389519|75972610|FG001|STARTED|Randomized||41||
59847797|NCT00389519|75972611|FG002|STARTED|Randomized||40||
59847798|NCT00389519|75972612|FG003|STARTED|Randomized||80||
59847799|NCT00389519|75972609|FG000|COMPLETED|Randomized||81||
59847800|NCT00389519|75972610|FG001|COMPLETED|Randomized||41||
59847801|NCT00389519|75972611|FG002|COMPLETED|Randomized||40||
59847802|NCT00389519|75972612|FG003|COMPLETED|Randomized||80||
59847803|NCT00389519|75972609|FG000|NOT COMPLETED|Randomized||2||
59847804|NCT00389519|75972610|FG001|NOT COMPLETED|Randomized||0||
59847805|NCT00389519|75972611|FG002|NOT COMPLETED|Randomized||0||
59847806|NCT00389519|75972612|FG003|NOT COMPLETED|Randomized||0||
59847807|NCT00389519|75972609|FG000|STARTED|Treated||81||
59847808|NCT00389519|75972610|FG001|STARTED|Treated||41||
59847809|NCT00389519|75972611|FG002|STARTED|Treated||40||
59719987|NCT01203098|75839109|FG000|NOT COMPLETED|Overall Study||6||
59719988|NCT01203098|75839110|FG001|NOT COMPLETED|Overall Study||4||
59719989|NCT01203098|75839111|FG002|NOT COMPLETED|Overall Study||11||
59847810|NCT00389519|75972612|FG003|STARTED|Treated||80||
59847811|NCT00389519|75972609|FG000|COMPLETED|Treated||79||
59847812|NCT00389519|75972610|FG001|COMPLETED|Treated||40||
59847813|NCT00389519|75972611|FG002|COMPLETED|Treated||40||
59847814|NCT00389519|75972612|FG003|COMPLETED|Treated||76||
59847815|NCT00389519|75972609|FG000|NOT COMPLETED|Treated||2||
59847816|NCT00389519|75972610|FG001|NOT COMPLETED|Treated||1||
59847817|NCT00389519|75972611|FG002|NOT COMPLETED|Treated||0||
59847818|NCT00389519|75972612|FG003|NOT COMPLETED|Treated||4||
59847819|NCT00389441|75972622|FG000|STARTED|Overall Study||52||
59847820|NCT00389441|75972622|FG000|COMPLETED|Overall Study||0||
59847821|NCT00389441|75972622|FG000|NOT COMPLETED|Overall Study||52||
59847822|NCT00118898|75972630|FG000|STARTED|Overall Study||464||
59847823|NCT00118898|75972631|FG001|STARTED|Overall Study||465||
59847824|NCT00118898|75972632|FG002|STARTED|Overall Study||465||
59847825|NCT00118898|75972633|FG003|STARTED|Overall Study||463||
59847826|NCT00118898|75972630|FG000|Initiated Treatment|Overall Study||461||
59847827|NCT00118898|75972631|FG001|Initiated Treatment|Overall Study||461||
59847828|NCT00118898|75972632|FG002|Initiated Treatment|Overall Study||464||
59847829|NCT00118898|75972633|FG003|Initiated Treatment|Overall Study||462||
59567989|NCT01071993|75670898|FG000|NOT COMPLETED|Overall Study||0||
59847830|NCT00118898|75972630|FG000|COMPLETED|Overall Study||343||
59847831|NCT00118898|75972631|FG001|COMPLETED|Overall Study||324||
59847832|NCT00118898|75972632|FG002|COMPLETED|Overall Study||342||
59847833|NCT00118898|75972633|FG003|COMPLETED|Overall Study||322||
59847834|NCT00118898|75972630|FG000|NOT COMPLETED|Overall Study||121||
59847835|NCT00118898|75972631|FG001|NOT COMPLETED|Overall Study||141||
59847836|NCT00118898|75972632|FG002|NOT COMPLETED|Overall Study||123||
59847837|NCT00118898|75972633|FG003|NOT COMPLETED|Overall Study||141||
59847838|NCT00118430|75972646|FG000|STARTED|Overall Study||123||
59567990|NCT01071993|75670899|FG001|NOT COMPLETED|Overall Study||0||
59719990|NCT00945555|75839119|FG000|STARTED|Overall Study||264||
59719991|NCT00945555|75839119|FG000|COMPLETED|Overall Study||236||
59719992|NCT00945555|75839119|FG000|NOT COMPLETED|Overall Study||28||
59847839|NCT00118430|75972647|FG001|STARTED|Overall Study||127||
59847840|NCT00118430|75972648|FG002|STARTED|Overall Study||250||
59847841|NCT00118430|75972646|FG000|COMPLETED|Overall Study|123 included in primary analysis due to repeated measures and interim 1,3 and 6 month assessments|102||
59847842|NCT00118430|75972647|FG001|COMPLETED|Overall Study|127 included in primary analysis due to repeated measures and interim 1,3 and 6 month assessments|103||
59847843|NCT00118430|75972648|FG002|COMPLETED|Overall Study||222||
59847844|NCT00118430|75972646|FG000|NOT COMPLETED|Overall Study||21||
59567991|NCT01065051|75670907|FG000|STARTED|Overall Study||1||
59567992|NCT01065051|75670908|FG001|STARTED|Overall Study||0||
59719993|NCT01108458|75839123|FG000|STARTED|Overall Study||1||
59719994|NCT01108458|75839123|FG000|COMPLETED|Overall Study||0||
59847845|NCT00118430|75972647|FG001|NOT COMPLETED|Overall Study||24||
59847846|NCT00118430|75972648|FG002|NOT COMPLETED|Overall Study||28||
59719995|NCT01108458|75839123|FG000|NOT COMPLETED|Overall Study||1||
59847847|NCT00090584|75972657|FG000|STARTED|Baseline to 10 Weeks||154||
59847848|NCT00090584|75972658|FG001|STARTED|Baseline to 10 Weeks||153||
59847849|NCT00090584|75972657|FG000|COMPLETED|Baseline to 10 Weeks||139||
59847850|NCT00090584|75972658|FG001|COMPLETED|Baseline to 10 Weeks||141||
59847851|NCT00090584|75972657|FG000|NOT COMPLETED|Baseline to 10 Weeks||15||
59847852|NCT00090584|75972658|FG001|NOT COMPLETED|Baseline to 10 Weeks||12||
59847853|NCT00090584|75972657|FG000|STARTED|Baseline to 8 Months||154||
59847854|NCT00090584|75972658|FG001|STARTED|Baseline to 8 Months||153||
59847855|NCT00090584|75972657|FG000|COMPLETED|Baseline to 8 Months||110||
59847856|NCT00090584|75972658|FG001|COMPLETED|Baseline to 8 Months||112||
59847857|NCT00090584|75972657|FG000|NOT COMPLETED|Baseline to 8 Months||44||
59847858|NCT00090584|75972658|FG001|NOT COMPLETED|Baseline to 8 Months||41||
59847859|NCT03670810|75972678|FG000|STARTED|Main Study||485||
59847860|NCT03670810|75972679|FG001|STARTED|Main Study||486||
59719996|NCT01108068|75839129|FG000|STARTED|Overall Study||10||
59719997|NCT01108068|75839130|FG001|STARTED|Overall Study||16||
59719998|NCT01108068|75839129|FG000|COMPLETED|Overall Study|Only 5 individuals were recruited into the Lithium treatment arm|4||
59847861|NCT03670810|75972680|FG002|STARTED|Main Study||249||
59847862|NCT03670810|75972681|FG003|STARTED|Main Study||251||
59847863|NCT03670810|75972682|FG004|STARTED|Main Study||55||
59847864|NCT03670810|75972683|FG005|STARTED|Main Study||53||
59847865|NCT03670810|75972684|FG006|STARTED|Main Study||28||
59847866|NCT03670810|75972685|FG007|STARTED|Main Study||26||
59847867|NCT03670810|75972686|FG008|STARTED|Main Study||0||
59847868|NCT03670810|75972678|FG000|Treated at Least One Migraine Attack|Main Study||485||
59847869|NCT03670810|75972679|FG001|Treated at Least One Migraine Attack|Main Study||486||
59847870|NCT03670810|75972680|FG002|Treated at Least One Migraine Attack|Main Study||249||
59847871|NCT03670810|75972681|FG003|Treated at Least One Migraine Attack|Main Study||251||
59847872|NCT03670810|75972682|FG004|Treated at Least One Migraine Attack|Main Study||55||
59847873|NCT03670810|75972683|FG005|Treated at Least One Migraine Attack|Main Study||53||
59847874|NCT03670810|75972684|FG006|Treated at Least One Migraine Attack|Main Study||28||
59847875|NCT03670810|75972685|FG007|Treated at Least One Migraine Attack|Main Study||26||
59847876|NCT03670810|75972686|FG008|Treated at Least One Migraine Attack|Main Study||0||
59847877|NCT03670810|75972678|FG000|COMPLETED|Main Study||403||
59847878|NCT03670810|75972679|FG001|COMPLETED|Main Study||394||
59847879|NCT03670810|75972680|FG002|COMPLETED|Main Study||219||
59847880|NCT03670810|75972681|FG003|COMPLETED|Main Study||223||
59719999|NCT01108068|75839130|FG001|COMPLETED|Overall Study||16||
59720000|NCT01108068|75839129|FG000|NOT COMPLETED|Overall Study||6||
59720001|NCT01108068|75839130|FG001|NOT COMPLETED|Overall Study||0||
59720002|NCT01201850|75839137|FG000|STARTED|Overall Study||7||
59720003|NCT01201850|75839137|FG000|COMPLETED|Overall Study||3||
59720004|NCT01201850|75839137|FG000|NOT COMPLETED|Overall Study||4||
59720005|NCT00951171|75839143|FG000|STARTED|Overall Study||40||
59720006|NCT00951171|75839144|FG001|STARTED|Overall Study||55||
59720007|NCT00951171|75839143|FG000|Pregnancy|Overall Study||1||
59720008|NCT00951171|75839144|FG001|Pregnancy|Overall Study||7||
59720009|NCT00951171|75839143|FG000|COMPLETED|Overall Study||38||
59720010|NCT00951171|75839144|FG001|COMPLETED|Overall Study|2 of the cervical occlusion group transferred to standard group because of pain during attempted IUI|55||
59720011|NCT00951171|75839143|FG000|NOT COMPLETED|Overall Study||2||
59720012|NCT00951171|75839144|FG001|NOT COMPLETED|Overall Study||0||
59847881|NCT03670810|75972682|FG004|COMPLETED|Main Study||45||
59847882|NCT03670810|75972683|FG005|COMPLETED|Main Study||46||
59847883|NCT03670810|75972684|FG006|COMPLETED|Main Study||26||
59847884|NCT03670810|75972685|FG007|COMPLETED|Main Study||23||
59847885|NCT03670810|75972686|FG008|COMPLETED|Main Study||0||
59847886|NCT03670810|75972678|FG000|NOT COMPLETED|Main Study||82||
59847887|NCT03670810|75972679|FG001|NOT COMPLETED|Main Study||92||
59847888|NCT03670810|75972680|FG002|NOT COMPLETED|Main Study||30||
59847889|NCT03670810|75972681|FG003|NOT COMPLETED|Main Study||28||
59847890|NCT03670810|75972682|FG004|NOT COMPLETED|Main Study||10||
59847891|NCT03670810|75972683|FG005|NOT COMPLETED|Main Study||7||
59847892|NCT03670810|75972684|FG006|NOT COMPLETED|Main Study||2||
59847893|NCT03670810|75972685|FG007|NOT COMPLETED|Main Study||3||
59847894|NCT03670810|75972686|FG008|NOT COMPLETED|Main Study||0||
59847895|NCT03670810|75972678|FG000|STARTED|Open Label Extension|Reported are only those participants who were enrolled in the OLE.|0||
59847896|NCT03670810|75972679|FG001|STARTED|Open Label Extension|Reported are only those participants who were enrolled in the OLE.|0||
59847897|NCT03670810|75972680|FG002|STARTED|Open Label Extension|Reported are only those participants who were enrolled in the OLE.|0||
59847898|NCT03670810|75972681|FG003|STARTED|Open Label Extension|Reported are only those participants who were enrolled in the OLE.|0||
59720013|NCT01200992|75839152|FG000|STARTED|Overall Study||39||
59720014|NCT01200992|75839153|FG001|STARTED|Overall Study||45||
59720015|NCT01200992|75839152|FG000|COMPLETED|Overall Study||2||
59847899|NCT03670810|75972682|FG004|STARTED|Open Label Extension|Reported are only those participants who were enrolled in the OLE.|0||
59847900|NCT03670810|75972683|FG005|STARTED|Open Label Extension|Reported are only those participants who were enrolled in the OLE.|0||
59847901|NCT03670810|75972684|FG006|STARTED|Open Label Extension|Reported are only those participants who were enrolled in the OLE.|0||
60120499|NCT02696226|76241640|FG002|STARTED|Overall Study||2||
59720016|NCT01200992|75839153|FG001|COMPLETED|Overall Study||4||
59847902|NCT03670810|75972685|FG007|STARTED|Open Label Extension|Reported are only those participants who were enrolled in the OLE.|0||
59847903|NCT03670810|75972686|FG008|STARTED|Open Label Extension||477||
59847904|NCT03670810|75972678|FG000|Treated at Least One Migraine Attack|Open Label Extension||0||
59847905|NCT03670810|75972679|FG001|Treated at Least One Migraine Attack|Open Label Extension||0||
59847906|NCT03670810|75972680|FG002|Treated at Least One Migraine Attack|Open Label Extension||0||
59847907|NCT03670810|75972681|FG003|Treated at Least One Migraine Attack|Open Label Extension||0||
59847908|NCT03670810|75972682|FG004|Treated at Least One Migraine Attack|Open Label Extension||0||
59847909|NCT03670810|75972683|FG005|Treated at Least One Migraine Attack|Open Label Extension||0||
59847910|NCT03670810|75972684|FG006|Treated at Least One Migraine Attack|Open Label Extension||0||
59847911|NCT03670810|75972685|FG007|Treated at Least One Migraine Attack|Open Label Extension||0||
59847912|NCT03670810|75972686|FG008|Treated at Least One Migraine Attack|Open Label Extension|One participant signed consent but decided against participating in the OLE period and was not dosed.|476||
59847913|NCT03670810|75972678|FG000|COMPLETED|Open Label Extension||0||
59847914|NCT03670810|75972679|FG001|COMPLETED|Open Label Extension||0||
59847915|NCT03670810|75972680|FG002|COMPLETED|Open Label Extension||0||
59847916|NCT03670810|75972681|FG003|COMPLETED|Open Label Extension||0||
59847917|NCT03670810|75972682|FG004|COMPLETED|Open Label Extension||0||
59847918|NCT03670810|75972683|FG005|COMPLETED|Open Label Extension||0||
59847919|NCT03670810|75972684|FG006|COMPLETED|Open Label Extension||0||
59847920|NCT03670810|75972685|FG007|COMPLETED|Open Label Extension||0||
59847921|NCT03670810|75972686|FG008|COMPLETED|Open Label Extension||324||
59847922|NCT03670810|75972678|FG000|NOT COMPLETED|Open Label Extension||0||
59847923|NCT03670810|75972679|FG001|NOT COMPLETED|Open Label Extension||0||
59847924|NCT03670810|75972680|FG002|NOT COMPLETED|Open Label Extension||0||
59847925|NCT03670810|75972681|FG003|NOT COMPLETED|Open Label Extension||0||
59847926|NCT03670810|75972682|FG004|NOT COMPLETED|Open Label Extension||0||
59847927|NCT03670810|75972683|FG005|NOT COMPLETED|Open Label Extension||0||
59847928|NCT03670810|75972684|FG006|NOT COMPLETED|Open Label Extension||0||
59847929|NCT03670810|75972685|FG007|NOT COMPLETED|Open Label Extension||0||
59847930|NCT03670810|75972686|FG008|NOT COMPLETED|Open Label Extension||153||
59847931|NCT00089648|75972700|FG000|STARTED|Overall Study||61||
59847932|NCT00089648|75972700|FG000|COMPLETED|Overall Study||20||
59847933|NCT00089648|75972700|FG000|NOT COMPLETED|Overall Study||41||
59847934|NCT00118040|75972707|FG000|STARTED|Overall Study||20||
59847935|NCT00118040|75972708|FG001|STARTED|Overall Study||20||
59847936|NCT00118040|75972709|FG002|STARTED|Overall Study||20||
59847937|NCT00118040|75972707|FG000|COMPLETED|Overall Study||19||
59847938|NCT00118040|75972708|FG001|COMPLETED|Overall Study||18||
59847939|NCT00118040|75972709|FG002|COMPLETED|Overall Study||14||
59847940|NCT00118040|75972707|FG000|NOT COMPLETED|Overall Study||1||
59847941|NCT00118040|75972708|FG001|NOT COMPLETED|Overall Study||2||
59847942|NCT00118040|75972709|FG002|NOT COMPLETED|Overall Study||6||
59847943|NCT00389207|75972725|FG000|STARTED|Overall Study|3 patients were randomized to NVP QD but not treated and so not part of the Full Analysis Set (FAS)|188||
59847944|NCT00389207|75972726|FG001|STARTED|Overall Study|4 patients were randomized to NVP BID but not treated and so are not part of the FAS|188||
59847945|NCT00389207|75972727|FG002|STARTED|Overall Study||193||
59847946|NCT00389207|75972725|FG000|COMPLETED|Overall Study||125||
59847947|NCT00389207|75972726|FG001|COMPLETED|Overall Study||116||
59847948|NCT00389207|75972727|FG002|COMPLETED|Overall Study||152||
59847949|NCT00389207|75972725|FG000|NOT COMPLETED|Overall Study||63||
59847950|NCT00389207|75972726|FG001|NOT COMPLETED|Overall Study||72||
59847951|NCT00389207|75972727|FG002|NOT COMPLETED|Overall Study||41||
59847952|NCT00388973|75972742|FG000|STARTED|Overall Study|Randomized|166||
59847953|NCT00388973|75972743|FG001|STARTED|Overall Study|Randomized|172||
59847954|NCT00388973|75972742|FG000|Completed Study|Overall Study||110||
59847955|NCT00388973|75972743|FG001|Completed Study|Overall Study||114||
59847956|NCT00388973|75972742|FG000|COMPLETED|Overall Study|Completed 9-week treatment and 2 week follow-up|110||
59847957|NCT00388973|75972743|FG001|COMPLETED|Overall Study|Completed 9-week treatment and 2 week follow-up|114||
59847958|NCT00388973|75972742|FG000|NOT COMPLETED|Overall Study||56||
59847959|NCT00388973|75972743|FG001|NOT COMPLETED|Overall Study||58||
59847960|NCT00388583|75972751|FG000|STARTED|Overall Study||407||
59847961|NCT00388583|75972752|FG001|STARTED|Overall Study||410||
59847962|NCT00388583|75972751|FG000|COMPLETED|Overall Study||401||
59847963|NCT00388583|75972752|FG001|COMPLETED|Overall Study||406||
59847964|NCT00388583|75972751|FG000|NOT COMPLETED|Overall Study||6||
59847965|NCT00388583|75972752|FG001|NOT COMPLETED|Overall Study||4||
59847966|NCT00117572|75972760|FG000|STARTED|Overall Study||144||
59847967|NCT00117572|75972761|FG001|STARTED|Overall Study||141||
59847968|NCT00117572|75972760|FG000|COMPLETED|Overall Study||138||
59847969|NCT00117572|75972761|FG001|COMPLETED|Overall Study||135||
59847970|NCT00117572|75972760|FG000|NOT COMPLETED|Overall Study||6||
59847971|NCT00117572|75972761|FG001|NOT COMPLETED|Overall Study||6||
60120500|NCT02696226|76241641|FG003|STARTED|Overall Study||0||
59847972|NCT00388505|75972769|FG000|STARTED|Overall Study|Randomized patients who received any amount of study medication|308||
59847973|NCT00388505|75972770|FG001|STARTED|Overall Study|Randomized patients who received any amount of study medication|209||
59847974|NCT00388505|75972769|FG000|COMPLETED|Overall Study||225||
59847975|NCT00388505|75972770|FG001|COMPLETED|Overall Study||171||
59847976|NCT00388505|75972769|FG000|NOT COMPLETED|Overall Study||83||
59847977|NCT00388505|75972770|FG001|NOT COMPLETED|Overall Study||38||
59847978|NCT00388349|75972776|FG000|STARTED|Phase I Dose Escalation||3||
59847979|NCT00388349|75972777|FG001|STARTED|Phase I Dose Escalation||4||
59847980|NCT00388349|75972776|FG000|COMPLETED|Phase I Dose Escalation||3||
59847981|NCT00388349|75972777|FG001|COMPLETED|Phase I Dose Escalation||1||
59847982|NCT00388349|75972776|FG000|NOT COMPLETED|Phase I Dose Escalation||0||
59847983|NCT00388349|75972777|FG001|NOT COMPLETED|Phase I Dose Escalation||3||
59847984|NCT00388349|75972776|FG000|STARTED|Phase 2 Dose Expansion|Includes the three phase 1 participants who received 1250 mg/m2 gemcitabine (MTD)|139||
59847985|NCT00388349|75972777|FG001|STARTED|Phase 2 Dose Expansion|No participants were treated in Phase 2 at 1500 mg/m2 gemcitabine (MTD exceeded)|0||
59847986|NCT00388349|75972776|FG000|COMPLETED|Phase 2 Dose Expansion||139|# pts @ 1250 mg/m^2 Gemzar in Phase 2 doesn't include the 4 pts @ 1500 mg/m2 Gemzar in Phase 1.|
59847987|NCT00388349|75972777|FG001|COMPLETED|Phase 2 Dose Expansion||0|# pts @ 1250 mg/m^2 Gemzar in Phase 2 doesn't include the 4 pts @ 1500 mg/m2 Gemzar in Phase 1.|
59720017|NCT01200992|75839152|FG000|NOT COMPLETED|Overall Study||37||
59720018|NCT01200992|75839153|FG001|NOT COMPLETED|Overall Study||41||
59720019|NCT00878215|75839165|FG000|STARTED|Overall Study||21||
59720020|NCT00878215|75839166|FG001|STARTED|Overall Study||19||
59720021|NCT00878215|75839167|FG002|STARTED|Overall Study|Phase 3 not performed because the liver imaging system became commercially available|0||
59720022|NCT00878215|75839168|FG003|STARTED|Overall Study|Phase 4 not performed because the liver imaging system became commercially available|0||
59720023|NCT00878215|75839165|FG000|COMPLETED|Overall Study||21||
59720024|NCT00878215|75839166|FG001|COMPLETED|Overall Study||9||
59720025|NCT00878215|75839167|FG002|COMPLETED|Overall Study||0||
59720026|NCT00878215|75839168|FG003|COMPLETED|Overall Study||0||
59720027|NCT00878215|75839165|FG000|NOT COMPLETED|Overall Study||0||
59720028|NCT00878215|75839166|FG001|NOT COMPLETED|Overall Study||10||
59847988|NCT00388349|75972776|FG000|NOT COMPLETED|Phase 2 Dose Expansion||0||
59847989|NCT00388349|75972777|FG001|NOT COMPLETED|Phase 2 Dose Expansion||0||
59847990|NCT00117338|75972787|FG000|STARTED|Overall Study||145||
59847991|NCT00117338|75972788|FG001|STARTED|Overall Study||131||
59847992|NCT00117338|75972787|FG000|COMPLETED|Overall Study||140||
59847993|NCT00117338|75972788|FG001|COMPLETED|Overall Study||127||
59847994|NCT00117338|75972787|FG000|NOT COMPLETED|Overall Study||5||
59847995|NCT00117338|75972788|FG001|NOT COMPLETED|Overall Study||4||
59847996|NCT00388037|75972794|FG000|STARTED|Overall Study||31||
59847997|NCT00388037|75972794|FG000|COMPLETED|Overall Study||30||
60120501|NCT02696226|76241638|FG000|COMPLETED|Overall Study||0||
60120502|NCT02696226|76241639|FG001|COMPLETED|Overall Study||0||
59720029|NCT00878215|75839167|FG002|NOT COMPLETED|Overall Study||0||
59720030|NCT00878215|75839168|FG003|NOT COMPLETED|Overall Study||0||
59720031|NCT01200758|75839180|FG000|STARTED|Stage I||64||
59720032|NCT01200758|75839181|FG001|STARTED|Stage I||63||
59847998|NCT00388037|75972794|FG000|NOT COMPLETED|Overall Study||1||
59847999|NCT00387881|75972800|FG000|STARTED|Overall Study||334||
59848000|NCT00387881|75972801|FG001|STARTED|Overall Study||345||
59848001|NCT00387881|75972800|FG000|COMPLETED|Overall Study||245||
59848002|NCT00387881|75972801|FG001|COMPLETED|Overall Study||243||
59848003|NCT00387881|75972800|FG000|NOT COMPLETED|Overall Study||89||
59848004|NCT00387881|75972801|FG001|NOT COMPLETED|Overall Study||102||
59848005|NCT00084656|75972810|FG000|STARTED|Overall Study||25||
59848006|NCT00084656|75972811|FG001|STARTED|Overall Study||25||
59848007|NCT00084656|75972812|FG002|STARTED|Overall Study||26||
59848008|NCT00084656|75972810|FG000|COMPLETED|Overall Study||0||
59848009|NCT00084656|75972811|FG001|COMPLETED|Overall Study||0||
59848010|NCT00084656|75972812|FG002|COMPLETED|Overall Study||0||
59848011|NCT00084656|75972810|FG000|NOT COMPLETED|Overall Study||25||
59848012|NCT00084656|75972811|FG001|NOT COMPLETED|Overall Study||25||
59848013|NCT00084656|75972812|FG002|NOT COMPLETED|Overall Study||26||
59848014|NCT00387725|75972826|FG000|STARTED|Overall Study||21||
60120503|NCT02696226|76241640|FG002|COMPLETED|Overall Study||0||
60120504|NCT02696226|76241641|FG003|COMPLETED|Overall Study||0||
60120505|NCT02696226|76241638|FG000|NOT COMPLETED|Overall Study||1||
60120506|NCT02696226|76241639|FG001|NOT COMPLETED|Overall Study||0||
60120507|NCT02696226|76241640|FG002|NOT COMPLETED|Overall Study||2||
60120508|NCT02696226|76241641|FG003|NOT COMPLETED|Overall Study||0||
60120509|NCT01692275|76241657|FG000|STARTED|Overall Study||375||
60120510|NCT01692275|76241658|FG001|STARTED|Overall Study||375||
59848015|NCT00387725|75972827|FG001|STARTED|Overall Study||16||
59848016|NCT00387725|75972828|FG002|STARTED|Overall Study||45||
59848017|NCT00387725|75972829|FG003|STARTED|Overall Study||45||
59848018|NCT00387725|75972826|FG000|COMPLETED|Overall Study||20||
60120511|NCT01692275|76241657|FG000|COMPLETED|Overall Study||309||
60120512|NCT01692275|76241658|FG001|COMPLETED|Overall Study||316||
59848019|NCT00387725|75972827|FG001|COMPLETED|Overall Study||15||
60120513|NCT01692275|76241657|FG000|NOT COMPLETED|Overall Study||66||
60120514|NCT01692275|76241658|FG001|NOT COMPLETED|Overall Study||59||
59848020|NCT00387725|75972828|FG002|COMPLETED|Overall Study||43||
59848021|NCT00387725|75972829|FG003|COMPLETED|Overall Study||43||
59848022|NCT00387725|75972826|FG000|NOT COMPLETED|Overall Study||1||
59848023|NCT00387725|75972827|FG001|NOT COMPLETED|Overall Study||1||
59848024|NCT00387725|75972828|FG002|NOT COMPLETED|Overall Study||2||
59848025|NCT00387725|75972829|FG003|NOT COMPLETED|Overall Study||2||
59848026|NCT00102596|75972839|FG000|STARTED|Part A||11||
59848027|NCT00102596|75972840|FG001|STARTED|Part A||0||
59848028|NCT00102596|75972839|FG000|Participants Assigned Treatment|Part A||5||
59848029|NCT00102596|75972840|FG001|Participants Assigned Treatment|Part A||0||
59848030|NCT00102596|75972839|FG000|COMPLETED|Part A||4||
59848031|NCT00102596|75972840|FG001|COMPLETED|Part A||0||
59848032|NCT00102596|75972839|FG000|NOT COMPLETED|Part A||7||
59848033|NCT00102596|75972840|FG001|NOT COMPLETED|Part A||0||
59848034|NCT00102596|75972839|FG000|STARTED|Part B|Participants from Part A did not continue to Part B|0||
59848035|NCT00102596|75972840|FG001|STARTED|Part B||10||
59848036|NCT00102596|75972839|FG000|COMPLETED|Part B||0||
59848037|NCT00102596|75972840|FG001|COMPLETED|Part B||10||
59848038|NCT00102596|75972839|FG000|NOT COMPLETED|Part B||0||
59848039|NCT00102596|75972840|FG001|NOT COMPLETED|Part B||0||
59848040|NCT00102596|75972839|FG000|STARTED|Part C||0||
59848041|NCT00102596|75972840|FG001|STARTED|Part C|Only 2 patients participated in Part C|2||
59848042|NCT00102596|75972839|FG000|COMPLETED|Part C||0||
59848043|NCT00102596|75972840|FG001|COMPLETED|Part C||2||
59848044|NCT00102596|75972839|FG000|NOT COMPLETED|Part C||0||
59848045|NCT00102596|75972840|FG001|NOT COMPLETED|Part C||0||
59848046|NCT00387647|75972847|FG000|STARTED|Overall Study||24||
59848047|NCT00387647|75972847|FG000|COMPLETED|Overall Study||6||
59848048|NCT00387647|75972847|FG000|NOT COMPLETED|Overall Study||18||
59848049|NCT00386009|75972853|FG000|STARTED|Overall Study||101||
59848050|NCT00386009|75972854|FG001|STARTED|Overall Study||99||
59848051|NCT00386009|75972853|FG000|COMPLETED|Overall Study||92||
59848052|NCT00386009|75972854|FG001|COMPLETED|Overall Study||89||
59848053|NCT00386009|75972853|FG000|NOT COMPLETED|Overall Study||9||
59848054|NCT00386009|75972854|FG001|NOT COMPLETED|Overall Study||10||
59848055|NCT00373685|75972862|FG000|STARTED|Overall Study||4035||
59848056|NCT00373685|75972863|FG001|STARTED|Overall Study||4032||
59848057|NCT00373685|75972862|FG000|Treated|Overall Study||3984||
59848058|NCT00373685|75972863|FG001|Treated|Overall Study||3955||
59848059|NCT00373685|75972862|FG000|COMPLETED|Overall Study||2596||
59848060|NCT00373685|75972863|FG001|COMPLETED|Overall Study||2611||
59848061|NCT00373685|75972862|FG000|NOT COMPLETED|Overall Study||1439||
59848062|NCT00373685|75972863|FG001|NOT COMPLETED|Overall Study||1421||
59848063|NCT00373529|75972869|FG000|STARTED|Overall Study||116||
59848064|NCT00373529|75972869|FG000|Full Analysis Set|Overall Study|3 Failed Independent Confirmation of AML; 1 consent violation|112||
59848065|NCT00373529|75972869|FG000|COMPLETED|Overall Study|Completed: initiated full 6 cycles of treatment. Not Completed: initiated <6 cycles of treatment|8||
59848066|NCT00373529|75972869|FG000|NOT COMPLETED|Overall Study||108||
59848067|NCT00373295|75972873|FG000|STARTED|Intervention 1 (8 Days)||2||
59848068|NCT00373295|75972874|FG001|STARTED|Intervention 1 (8 Days)||3||
59848069|NCT00373295|75972875|FG002|STARTED|Intervention 1 (8 Days)||1||
59848070|NCT00373295|75972876|FG003|STARTED|Intervention 1 (8 Days)||2||
59848071|NCT00373295|75972877|FG004|STARTED|Intervention 1 (8 Days)||3||
59848072|NCT00373295|75972878|FG005|STARTED|Intervention 1 (8 Days)||2||
59848073|NCT00373295|75972873|FG000|COMPLETED|Intervention 1 (8 Days)||2||
59848074|NCT00373295|75972874|FG001|COMPLETED|Intervention 1 (8 Days)||1||
59848075|NCT00373295|75972875|FG002|COMPLETED|Intervention 1 (8 Days)||1||
59848076|NCT00373295|75972876|FG003|COMPLETED|Intervention 1 (8 Days)||2||
59848077|NCT00373295|75972877|FG004|COMPLETED|Intervention 1 (8 Days)||2||
59848078|NCT00373295|75972878|FG005|COMPLETED|Intervention 1 (8 Days)||2||
59848079|NCT00373295|75972873|FG000|NOT COMPLETED|Intervention 1 (8 Days)||0||
59848080|NCT00373295|75972874|FG001|NOT COMPLETED|Intervention 1 (8 Days)||2||
59848081|NCT00373295|75972875|FG002|NOT COMPLETED|Intervention 1 (8 Days)||0||
59848082|NCT00373295|75972876|FG003|NOT COMPLETED|Intervention 1 (8 Days)||0||
59848083|NCT00373295|75972877|FG004|NOT COMPLETED|Intervention 1 (8 Days)||1||
59848084|NCT00373295|75972878|FG005|NOT COMPLETED|Intervention 1 (8 Days)||0||
59848085|NCT00373295|75972873|FG000|STARTED|Intervention 2 (8 Days)||2||
59848086|NCT00373295|75972874|FG001|STARTED|Intervention 2 (8 Days)||1||
59848087|NCT00373295|75972875|FG002|STARTED|Intervention 2 (8 Days)||1||
59848088|NCT00373295|75972876|FG003|STARTED|Intervention 2 (8 Days)||2||
59848089|NCT00373295|75972877|FG004|STARTED|Intervention 2 (8 Days)||2||
59848090|NCT00373295|75972878|FG005|STARTED|Intervention 2 (8 Days)||2||
59848091|NCT00373295|75972873|FG000|COMPLETED|Intervention 2 (8 Days)||2||
59848092|NCT00373295|75972874|FG001|COMPLETED|Intervention 2 (8 Days)||1||
59848093|NCT00373295|75972875|FG002|COMPLETED|Intervention 2 (8 Days)||1||
59848094|NCT00373295|75972876|FG003|COMPLETED|Intervention 2 (8 Days)||2||
59848095|NCT00373295|75972877|FG004|COMPLETED|Intervention 2 (8 Days)||2||
59848096|NCT00373295|75972878|FG005|COMPLETED|Intervention 2 (8 Days)||2||
59848097|NCT00373295|75972873|FG000|NOT COMPLETED|Intervention 2 (8 Days)||0||
59848098|NCT00373295|75972874|FG001|NOT COMPLETED|Intervention 2 (8 Days)||0||
59848099|NCT00373295|75972875|FG002|NOT COMPLETED|Intervention 2 (8 Days)||0||
59848100|NCT00373295|75972876|FG003|NOT COMPLETED|Intervention 2 (8 Days)||0||
59848101|NCT00373295|75972877|FG004|NOT COMPLETED|Intervention 2 (8 Days)||0||
59848102|NCT00373295|75972878|FG005|NOT COMPLETED|Intervention 2 (8 Days)||0||
59848103|NCT00373295|75972873|FG000|STARTED|Intervention 3 (8 Days)||2||
59848104|NCT00373295|75972874|FG001|STARTED|Intervention 3 (8 Days)||1||
59848105|NCT00373295|75972875|FG002|STARTED|Intervention 3 (8 Days)||1||
59848106|NCT00373295|75972876|FG003|STARTED|Intervention 3 (8 Days)||2||
59848107|NCT00373295|75972877|FG004|STARTED|Intervention 3 (8 Days)||2||
59848108|NCT00373295|75972878|FG005|STARTED|Intervention 3 (8 Days)||2||
59848109|NCT00373295|75972873|FG000|COMPLETED|Intervention 3 (8 Days)||2||
59848110|NCT00373295|75972874|FG001|COMPLETED|Intervention 3 (8 Days)||1||
59848111|NCT00373295|75972875|FG002|COMPLETED|Intervention 3 (8 Days)||1||
59848112|NCT00373295|75972876|FG003|COMPLETED|Intervention 3 (8 Days)||2||
59848113|NCT00373295|75972877|FG004|COMPLETED|Intervention 3 (8 Days)||2||
59848114|NCT00373295|75972878|FG005|COMPLETED|Intervention 3 (8 Days)||2||
59848115|NCT00373295|75972873|FG000|NOT COMPLETED|Intervention 3 (8 Days)||0||
59848116|NCT00373295|75972874|FG001|NOT COMPLETED|Intervention 3 (8 Days)||0||
59720033|NCT01200758|75839182|FG002|STARTED|Stage I|Different participants were randomized into different stages of the study.|0||
59720034|NCT01200758|75839183|FG003|STARTED|Stage I|Different participants were randomized into different stages of the study.|0||
59720035|NCT01200758|75839180|FG000|COMPLETED|Stage I|Participants completed treatment period.|46||
59720036|NCT01200758|75839181|FG001|COMPLETED|Stage I|Participants completed treatment period.|46||
59720037|NCT01200758|75839182|FG002|COMPLETED|Stage I||0||
59720038|NCT01200758|75839183|FG003|COMPLETED|Stage I||0||
59720039|NCT01200758|75839180|FG000|NOT COMPLETED|Stage I||18||
59720040|NCT01200758|75839181|FG001|NOT COMPLETED|Stage I||17||
59720041|NCT01200758|75839182|FG002|NOT COMPLETED|Stage I||0||
59720042|NCT01200758|75839183|FG003|NOT COMPLETED|Stage I||0||
59720043|NCT01200758|75839180|FG000|STARTED|Stage 2|Different participants were randomized into different stages of the study.|0||
59720044|NCT01200758|75839181|FG001|STARTED|Stage 2|Different participants were randomized into different stages of the study.|0||
59567993|NCT01065051|75670907|FG000|COMPLETED|Overall Study||1||
59720045|NCT01200758|75839182|FG002|STARTED|Stage 2||141||
59720046|NCT01200758|75839183|FG003|STARTED|Stage 2||142||
59720047|NCT01200758|75839180|FG000|COMPLETED|Stage 2||0||
59720048|NCT01200758|75839181|FG001|COMPLETED|Stage 2||0||
59720049|NCT01200758|75839182|FG002|COMPLETED|Stage 2|Participants completed treatment period.|100||
59720050|NCT01200758|75839183|FG003|COMPLETED|Stage 2|Participants completed treatment period.|92||
59720051|NCT01200758|75839180|FG000|NOT COMPLETED|Stage 2||0||
59720052|NCT01200758|75839181|FG001|NOT COMPLETED|Stage 2||0||
59848117|NCT00373295|75972875|FG002|NOT COMPLETED|Intervention 3 (8 Days)||0||
59848118|NCT00373295|75972876|FG003|NOT COMPLETED|Intervention 3 (8 Days)||0||
59848119|NCT00373295|75972877|FG004|NOT COMPLETED|Intervention 3 (8 Days)||0||
59848120|NCT00373295|75972878|FG005|NOT COMPLETED|Intervention 3 (8 Days)||0||
59848121|NCT00385541|75972888|FG000|STARTED|Overall Study||25||
59848122|NCT00385541|75972889|FG001|STARTED|Overall Study||25||
59848123|NCT00385541|75972888|FG000|COMPLETED|Overall Study||25||
59848124|NCT00385541|75972889|FG001|COMPLETED|Overall Study||24||
60120515|NCT02692560|76241678|FG000|STARTED|Overall Study||29||
59720053|NCT01200758|75839182|FG002|NOT COMPLETED|Stage 2||41||
59720054|NCT01200758|75839183|FG003|NOT COMPLETED|Stage 2||50||
59720055|NCT00876343|75839198|FG000|STARTED|Overall Study||194||
59848125|NCT00385541|75972888|FG000|NOT COMPLETED|Overall Study||0||
59567994|NCT01065051|75670908|FG001|COMPLETED|Overall Study||0||
59720056|NCT00876343|75839199|FG001|STARTED|Overall Study||197||
59567995|NCT01065051|75670907|FG000|NOT COMPLETED|Overall Study||0||
59567996|NCT01065051|75670908|FG001|NOT COMPLETED|Overall Study||0||
59567997|NCT02376933|75670914|FG000|STARTED|Overall Study||10||
59567998|NCT02376933|75670914|FG000|COMPLETED|Overall Study||8||
59567999|NCT02376933|75670914|FG000|NOT COMPLETED|Overall Study||2||
59568000|NCT02379585|75670920|FG000|STARTED|Overall Study||3||
59568001|NCT02379585|75670921|FG001|STARTED|Overall Study||5||
59568002|NCT02379585|75670920|FG000|COMPLETED|Overall Study||0||
59568003|NCT02379585|75670921|FG001|COMPLETED|Overall Study||0||
59568004|NCT02379585|75670920|FG000|NOT COMPLETED|Overall Study||3||
59720057|NCT00876343|75839200|FG002|STARTED|Overall Study||195||
59720058|NCT00876343|75839198|FG000|COMPLETED|Overall Study||177||
59720059|NCT00876343|75839199|FG001|COMPLETED|Overall Study||180||
59720060|NCT00876343|75839200|FG002|COMPLETED|Overall Study||183||
60120516|NCT02692560|76241679|FG001|STARTED|Overall Study||31||
60120517|NCT02692560|76241678|FG000|COMPLETED|Overall Study||29||
60120518|NCT02692560|76241679|FG001|COMPLETED|Overall Study||25||
60120519|NCT02692560|76241678|FG000|NOT COMPLETED|Overall Study||0||
60120520|NCT02692560|76241679|FG001|NOT COMPLETED|Overall Study||6||
60120521|NCT02688192|76241687|FG000|STARTED|Overall Study||25||
60120522|NCT02688192|76241688|FG001|STARTED|Overall Study||24||
60120523|NCT02688192|76241687|FG000|COMPLETED|Overall Study||13||
60120524|NCT02688192|76241688|FG001|COMPLETED|Overall Study||19||
60120525|NCT02688192|76241687|FG000|NOT COMPLETED|Overall Study||12||
60120526|NCT02688192|76241688|FG001|NOT COMPLETED|Overall Study||5||
60120527|NCT01579565|76241697|FG000|STARTED|Randomized||207||
60120528|NCT01579565|76241698|FG001|STARTED|Randomized||209||
60120529|NCT01579565|76241697|FG000|COMPLETED|Randomized||202||
60120530|NCT01579565|76241698|FG001|COMPLETED|Randomized||204||
60120531|NCT01579565|76241697|FG000|NOT COMPLETED|Randomized||5||
60120532|NCT01579565|76241698|FG001|NOT COMPLETED|Randomized||5||
60120533|NCT01579565|76241697|FG000|STARTED|Treated||202||
60120534|NCT01579565|76241698|FG001|STARTED|Treated||204||
60120535|NCT01579565|76241697|FG000|COMPLETED|Treated||200||
59568005|NCT02379585|75670921|FG001|NOT COMPLETED|Overall Study||5||
59568006|NCT01048125|75670932|FG000|STARTED|Overall Study||0||
59568007|NCT01048125|75670933|FG001|STARTED|Overall Study||0||
59568008|NCT01048125|75670932|FG000|COMPLETED|Overall Study||0||
59720061|NCT00876343|75839198|FG000|NOT COMPLETED|Overall Study||17||
59720062|NCT00876343|75839199|FG001|NOT COMPLETED|Overall Study||17||
59720063|NCT00876343|75839200|FG002|NOT COMPLETED|Overall Study||12||
59720064|NCT01107912|75839212|FG000|STARTED|Period 1||73||
60120536|NCT01579565|76241698|FG001|COMPLETED|Treated||201||
59568009|NCT01048125|75670933|FG001|COMPLETED|Overall Study||0||
59568010|NCT01048125|75670932|FG000|NOT COMPLETED|Overall Study||0||
59720065|NCT01107912|75839213|FG001|STARTED|Period 1||0||
60120537|NCT01579565|76241697|FG000|NOT COMPLETED|Treated||2||
60120538|NCT01579565|76241698|FG001|NOT COMPLETED|Treated||3||
59848126|NCT00385541|75972889|FG001|NOT COMPLETED|Overall Study||1||
59848127|NCT00392015|75972901|FG000|STARTED|Overall Study||6||
59848128|NCT00392015|75972902|FG001|STARTED|Overall Study||6||
59848129|NCT00392015|75972903|FG002|STARTED|Overall Study||20||
59848130|NCT00392015|75972904|FG003|STARTED|Overall Study||6||
59848131|NCT00392015|75972905|FG004|STARTED|Overall Study||15||
59848132|NCT00392015|75972906|FG005|STARTED|Overall Study||6||
59848133|NCT00392015|75972901|FG000|COMPLETED|Overall Study||4||
59848134|NCT00392015|75972902|FG001|COMPLETED|Overall Study||6||
59848135|NCT00392015|75972903|FG002|COMPLETED|Overall Study||16||
59848136|NCT00392015|75972904|FG003|COMPLETED|Overall Study||5||
59848137|NCT00392015|75972905|FG004|COMPLETED|Overall Study||12||
59848138|NCT00392015|75972906|FG005|COMPLETED|Overall Study||6||
59848139|NCT00392015|75972901|FG000|NOT COMPLETED|Overall Study||2||
59848140|NCT00392015|75972902|FG001|NOT COMPLETED|Overall Study||0||
59848141|NCT00392015|75972903|FG002|NOT COMPLETED|Overall Study||4||
59848142|NCT00392015|75972904|FG003|NOT COMPLETED|Overall Study||1||
59848143|NCT00392015|75972905|FG004|NOT COMPLETED|Overall Study||3||
59848144|NCT00392015|75972906|FG005|NOT COMPLETED|Overall Study||0||
59848145|NCT00094302|75972927|FG000|STARTED|Overall Study||1723||
59720066|NCT01107912|75839214|FG002|STARTED|Period 1||0||
59720067|NCT01107912|75839215|FG003|STARTED|Period 1||0||
59720068|NCT01107912|75839216|FG004|STARTED|Period 1||82||
59720069|NCT01107912|75839217|FG005|STARTED|Period 1||0||
59720070|NCT01107912|75839212|FG000|Received at Least 1 Dose of Study Drug|Period 1||73||
59720071|NCT01107912|75839213|FG001|Received at Least 1 Dose of Study Drug|Period 1||0||
59720072|NCT01107912|75839214|FG002|Received at Least 1 Dose of Study Drug|Period 1||0||
59720073|NCT01107912|75839215|FG003|Received at Least 1 Dose of Study Drug|Period 1||0||
59720074|NCT01107912|75839216|FG004|Received at Least 1 Dose of Study Drug|Period 1||82||
59720075|NCT01107912|75839217|FG005|Received at Least 1 Dose of Study Drug|Period 1||0||
59720076|NCT01107912|75839212|FG000|COMPLETED|Period 1||72||
59720077|NCT01107912|75839213|FG001|COMPLETED|Period 1||0||
59720078|NCT01107912|75839214|FG002|COMPLETED|Period 1||0||
59720079|NCT01107912|75839215|FG003|COMPLETED|Period 1||0||
59720080|NCT01107912|75839216|FG004|COMPLETED|Period 1||79||
59720081|NCT01107912|75839217|FG005|COMPLETED|Period 1||0||
59720082|NCT01107912|75839212|FG000|NOT COMPLETED|Period 1||1||
59720083|NCT01107912|75839213|FG001|NOT COMPLETED|Period 1||0||
59720084|NCT01107912|75839214|FG002|NOT COMPLETED|Period 1||0||
59720085|NCT01107912|75839215|FG003|NOT COMPLETED|Period 1||0||
59720086|NCT01107912|75839216|FG004|NOT COMPLETED|Period 1||3||
59720087|NCT01107912|75839217|FG005|NOT COMPLETED|Period 1||0||
59848146|NCT00094302|75972928|FG001|STARTED|Overall Study||1722||
59848147|NCT00094302|75972927|FG000|COMPLETED|Overall Study||1306||
59848148|NCT00094302|75972928|FG001|COMPLETED|Overall Study||1316||
59848149|NCT00094302|75972927|FG000|NOT COMPLETED|Overall Study||417||
59848150|NCT00094302|75972928|FG001|NOT COMPLETED|Overall Study||406||
59848151|NCT00372905|75972934|FG000|STARTED|Cohort 1: Dose Level 1.0mg/m2||3||
59848152|NCT00372905|75972935|FG001|STARTED|Cohort 1: Dose Level 1.0mg/m2||0||
59848153|NCT00372905|75972936|FG002|STARTED|Cohort 1: Dose Level 1.0mg/m2||0||
59848154|NCT00372905|75972937|FG003|STARTED|Cohort 1: Dose Level 1.0mg/m2||0||
59848155|NCT00372905|75972934|FG000|Registered to Study|Cohort 1: Dose Level 1.0mg/m2||3||
59848156|NCT00372905|75972935|FG001|Registered to Study|Cohort 1: Dose Level 1.0mg/m2||0||
59848157|NCT00372905|75972936|FG002|Registered to Study|Cohort 1: Dose Level 1.0mg/m2||0||
59848158|NCT00372905|75972937|FG003|Registered to Study|Cohort 1: Dose Level 1.0mg/m2||0||
59848159|NCT00372905|75972934|FG000|Treated 1 Cycle of Induction Therapy|Cohort 1: Dose Level 1.0mg/m2||3||
59848160|NCT00372905|75972935|FG001|Treated 1 Cycle of Induction Therapy|Cohort 1: Dose Level 1.0mg/m2||0||
59848161|NCT00372905|75972936|FG002|Treated 1 Cycle of Induction Therapy|Cohort 1: Dose Level 1.0mg/m2||0||
59720088|NCT01107912|75839212|FG000|STARTED|Period 2|Participants switched to either 10 mg prasugrel or 75 mg clopidogrel in Period 2.|0||
59720089|NCT01107912|75839213|FG001|STARTED|Period 2||36||
59720090|NCT01107912|75839214|FG002|STARTED|Period 2||36||
59720091|NCT01107912|75839215|FG003|STARTED|Period 2||41||
59720092|NCT01107912|75839216|FG004|STARTED|Period 2|Participants switched to either 5 mg prasugrel or 75 mg clopidogrel in Period 2.|0||
59720093|NCT01107912|75839217|FG005|STARTED|Period 2||38||
59720094|NCT01107912|75839212|FG000|COMPLETED|Period 2||0||
59848162|NCT00372905|75972937|FG003|Treated 1 Cycle of Induction Therapy|Cohort 1: Dose Level 1.0mg/m2||0||
59848163|NCT00372905|75972934|FG000|Completed 3 Cycles of Consolidation|Cohort 1: Dose Level 1.0mg/m2||1||
59848164|NCT00372905|75972935|FG001|Completed 3 Cycles of Consolidation|Cohort 1: Dose Level 1.0mg/m2||0||
59848165|NCT00372905|75972936|FG002|Completed 3 Cycles of Consolidation|Cohort 1: Dose Level 1.0mg/m2||0||
59848166|NCT00372905|75972937|FG003|Completed 3 Cycles of Consolidation|Cohort 1: Dose Level 1.0mg/m2||0||
59848167|NCT00372905|75972934|FG000|COMPLETED|Cohort 1: Dose Level 1.0mg/m2||1||
59848168|NCT00372905|75972935|FG001|COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0||
59848169|NCT00372905|75972936|FG002|COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0||
59848170|NCT00372905|75972937|FG003|COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0||
59848171|NCT00372905|75972934|FG000|NOT COMPLETED|Cohort 1: Dose Level 1.0mg/m2||2||
59848172|NCT00372905|75972935|FG001|NOT COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0||
59848173|NCT00372905|75972936|FG002|NOT COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0||
59848174|NCT00372905|75972937|FG003|NOT COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0||
59848175|NCT00372905|75972934|FG000|STARTED|Cohort 2: Dose Level 1.3mg/m2||0||
59848176|NCT00372905|75972935|FG001|STARTED|Cohort 2: Dose Level 1.3mg/m2||3||
59848177|NCT00372905|75972936|FG002|STARTED|Cohort 2: Dose Level 1.3mg/m2||0||
59848178|NCT00372905|75972937|FG003|STARTED|Cohort 2: Dose Level 1.3mg/m2||0||
59848179|NCT00372905|75972934|FG000|Registered to Study|Cohort 2: Dose Level 1.3mg/m2||0||
59848180|NCT00372905|75972935|FG001|Registered to Study|Cohort 2: Dose Level 1.3mg/m2||3||
59848181|NCT00372905|75972936|FG002|Registered to Study|Cohort 2: Dose Level 1.3mg/m2||0||
59848182|NCT00372905|75972937|FG003|Registered to Study|Cohort 2: Dose Level 1.3mg/m2||0||
59848183|NCT00372905|75972934|FG000|Treated 1 Cycle of Induction Therapy|Cohort 2: Dose Level 1.3mg/m2||0||
59848184|NCT00372905|75972935|FG001|Treated 1 Cycle of Induction Therapy|Cohort 2: Dose Level 1.3mg/m2||3||
59848185|NCT00372905|75972936|FG002|Treated 1 Cycle of Induction Therapy|Cohort 2: Dose Level 1.3mg/m2||0||
59848186|NCT00372905|75972937|FG003|Treated 1 Cycle of Induction Therapy|Cohort 2: Dose Level 1.3mg/m2||0||
59848187|NCT00372905|75972934|FG000|Completed 3 Cycles of Consolidation|Cohort 2: Dose Level 1.3mg/m2||0||
59848188|NCT00372905|75972935|FG001|Completed 3 Cycles of Consolidation|Cohort 2: Dose Level 1.3mg/m2||3||
59848189|NCT00372905|75972936|FG002|Completed 3 Cycles of Consolidation|Cohort 2: Dose Level 1.3mg/m2||0||
59848190|NCT00372905|75972937|FG003|Completed 3 Cycles of Consolidation|Cohort 2: Dose Level 1.3mg/m2||0||
59848191|NCT00372905|75972934|FG000|COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0||
59848192|NCT00372905|75972935|FG001|COMPLETED|Cohort 2: Dose Level 1.3mg/m2||3||
59848193|NCT00372905|75972936|FG002|COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0||
59848194|NCT00372905|75972937|FG003|COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0||
59848195|NCT00372905|75972934|FG000|NOT COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0||
59848196|NCT00372905|75972935|FG001|NOT COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0||
59848197|NCT00372905|75972936|FG002|NOT COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0||
59848198|NCT00372905|75972937|FG003|NOT COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0||
59848199|NCT00372905|75972934|FG000|STARTED|Cohort 3: Dose Level 1.6mg/m2||0||
59848200|NCT00372905|75972935|FG001|STARTED|Cohort 3: Dose Level 1.6mg/m2||0||
59848201|NCT00372905|75972936|FG002|STARTED|Cohort 3: Dose Level 1.6mg/m2||4||
59848202|NCT00372905|75972937|FG003|STARTED|Cohort 3: Dose Level 1.6mg/m2||0||
59848203|NCT00372905|75972934|FG000|Registered|Cohort 3: Dose Level 1.6mg/m2||0||
59848204|NCT00372905|75972935|FG001|Registered|Cohort 3: Dose Level 1.6mg/m2||0||
59848205|NCT00372905|75972936|FG002|Registered|Cohort 3: Dose Level 1.6mg/m2||4||
59848206|NCT00372905|75972937|FG003|Registered|Cohort 3: Dose Level 1.6mg/m2||0||
59848207|NCT00372905|75972934|FG000|Treated 1 Cycle of Induction Therapy|Cohort 3: Dose Level 1.6mg/m2||0||
59848208|NCT00372905|75972935|FG001|Treated 1 Cycle of Induction Therapy|Cohort 3: Dose Level 1.6mg/m2||0||
59848209|NCT00372905|75972936|FG002|Treated 1 Cycle of Induction Therapy|Cohort 3: Dose Level 1.6mg/m2||3||
59848210|NCT00372905|75972937|FG003|Treated 1 Cycle of Induction Therapy|Cohort 3: Dose Level 1.6mg/m2||0||
59848211|NCT00372905|75972934|FG000|Completed 3 Cycles of Consolidation|Cohort 3: Dose Level 1.6mg/m2||0||
59848212|NCT00372905|75972935|FG001|Completed 3 Cycles of Consolidation|Cohort 3: Dose Level 1.6mg/m2||0||
59848213|NCT00372905|75972936|FG002|Completed 3 Cycles of Consolidation|Cohort 3: Dose Level 1.6mg/m2||1||
59848214|NCT00372905|75972937|FG003|Completed 3 Cycles of Consolidation|Cohort 3: Dose Level 1.6mg/m2||0||
59848215|NCT00372905|75972934|FG000|COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0||
59848216|NCT00372905|75972935|FG001|COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0||
59848217|NCT00372905|75972936|FG002|COMPLETED|Cohort 3: Dose Level 1.6mg/m2||1||
59848218|NCT00372905|75972937|FG003|COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0||
59848219|NCT00372905|75972934|FG000|NOT COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0||
59848220|NCT00372905|75972935|FG001|NOT COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0||
59848221|NCT00372905|75972936|FG002|NOT COMPLETED|Cohort 3: Dose Level 1.6mg/m2||3||
59848222|NCT00372905|75972937|FG003|NOT COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0||
59848223|NCT00372905|75972934|FG000|STARTED|Expansion Phase at Dose 1.3mg/m2||0||
59848224|NCT00372905|75972935|FG001|STARTED|Expansion Phase at Dose 1.3mg/m2||0||
59848225|NCT00372905|75972936|FG002|STARTED|Expansion Phase at Dose 1.3mg/m2||0||
59848226|NCT00372905|75972937|FG003|STARTED|Expansion Phase at Dose 1.3mg/m2||8||
59848227|NCT00372905|75972934|FG000|Registration|Expansion Phase at Dose 1.3mg/m2||0||
59848228|NCT00372905|75972935|FG001|Registration|Expansion Phase at Dose 1.3mg/m2||0||
59848229|NCT00372905|75972936|FG002|Registration|Expansion Phase at Dose 1.3mg/m2||0||
59848230|NCT00372905|75972937|FG003|Registration|Expansion Phase at Dose 1.3mg/m2||8||
59848231|NCT00372905|75972934|FG000|Treated 1 Cycle Induction Therapy|Expansion Phase at Dose 1.3mg/m2||0||
60120539|NCT01578785|76241708|FG000|STARTED|Overall Study||59||
59848232|NCT00372905|75972935|FG001|Treated 1 Cycle Induction Therapy|Expansion Phase at Dose 1.3mg/m2||0||
59848233|NCT00372905|75972936|FG002|Treated 1 Cycle Induction Therapy|Expansion Phase at Dose 1.3mg/m2||0||
59848234|NCT00372905|75972937|FG003|Treated 1 Cycle Induction Therapy|Expansion Phase at Dose 1.3mg/m2||8||
59848235|NCT00372905|75972934|FG000|Completed 3 Cycles of Consolidation|Expansion Phase at Dose 1.3mg/m2||0||
59848236|NCT00372905|75972935|FG001|Completed 3 Cycles of Consolidation|Expansion Phase at Dose 1.3mg/m2||0||
59848237|NCT00372905|75972936|FG002|Completed 3 Cycles of Consolidation|Expansion Phase at Dose 1.3mg/m2||0||
59848238|NCT00372905|75972937|FG003|Completed 3 Cycles of Consolidation|Expansion Phase at Dose 1.3mg/m2||6||
59848239|NCT00372905|75972934|FG000|COMPLETED|Expansion Phase at Dose 1.3mg/m2||0||
59848240|NCT00372905|75972935|FG001|COMPLETED|Expansion Phase at Dose 1.3mg/m2||0||
59848241|NCT00372905|75972936|FG002|COMPLETED|Expansion Phase at Dose 1.3mg/m2||0||
59848242|NCT00372905|75972937|FG003|COMPLETED|Expansion Phase at Dose 1.3mg/m2||6||
59848243|NCT00372905|75972934|FG000|NOT COMPLETED|Expansion Phase at Dose 1.3mg/m2||0||
59848244|NCT00372905|75972935|FG001|NOT COMPLETED|Expansion Phase at Dose 1.3mg/m2||0||
59848245|NCT00372905|75972936|FG002|NOT COMPLETED|Expansion Phase at Dose 1.3mg/m2||0||
59848246|NCT00372905|75972937|FG003|NOT COMPLETED|Expansion Phase at Dose 1.3mg/m2||2||
59848247|NCT00372905|75972934|FG000|STARTED|Follow up Until Relapse or Progression|All patients that are treated on study move into the follow up phase at the completion of therapy.|3||
59848248|NCT00372905|75972935|FG001|STARTED|Follow up Until Relapse or Progression||3||
59848249|NCT00372905|75972936|FG002|STARTED|Follow up Until Relapse or Progression||3||
59848250|NCT00372905|75972937|FG003|STARTED|Follow up Until Relapse or Progression||8||
59848251|NCT00372905|75972934|FG000|COMPLETED|Follow up Until Relapse or Progression||3||
59848252|NCT00372905|75972935|FG001|COMPLETED|Follow up Until Relapse or Progression||2||
59848253|NCT00372905|75972936|FG002|COMPLETED|Follow up Until Relapse or Progression||3||
59848254|NCT00372905|75972937|FG003|COMPLETED|Follow up Until Relapse or Progression||5||
59848255|NCT00372905|75972934|FG000|NOT COMPLETED|Follow up Until Relapse or Progression||0||
59848256|NCT00372905|75972935|FG001|NOT COMPLETED|Follow up Until Relapse or Progression||1||
59848257|NCT00372905|75972936|FG002|NOT COMPLETED|Follow up Until Relapse or Progression||0||
59848258|NCT00372905|75972937|FG003|NOT COMPLETED|Follow up Until Relapse or Progression||3||
59848259|NCT00384839|75972947|FG000|STARTED|Overall Study||36||
59848260|NCT00384839|75972947|FG000|COMPLETED|Overall Study||28||
59848261|NCT00384839|75972947|FG000|NOT COMPLETED|Overall Study||8||
59848262|NCT00384293|75972953|FG000|STARTED|MK0524A Active Run-In, Pre-randomization||937||
59848263|NCT00384293|75972954|FG001|STARTED|MK0524A Active Run-In, Pre-randomization||0||
59848264|NCT00384293|75972955|FG002|STARTED|MK0524A Active Run-In, Pre-randomization||0||
59848265|NCT00384293|75972953|FG000|Entered Active run-in, MK0524A 1 g|MK0524A Active Run-In, Pre-randomization|Entered active run-in period and received MK0524A 1 g|937||
59848266|NCT00384293|75972954|FG001|Entered Active run-in, MK0524A 1 g|MK0524A Active Run-In, Pre-randomization||0||
59848267|NCT00384293|75972955|FG002|Entered Active run-in, MK0524A 1 g|MK0524A Active Run-In, Pre-randomization||0||
59848268|NCT00384293|75972953|FG000|MK0524A Dose Increased to 2 g|MK0524A Active Run-In, Pre-randomization|MK0524A dose increased to 2 g in active run-in period|813||
59848269|NCT00384293|75972954|FG001|MK0524A Dose Increased to 2 g|MK0524A Active Run-In, Pre-randomization||0||
59848270|NCT00384293|75972955|FG002|MK0524A Dose Increased to 2 g|MK0524A Active Run-In, Pre-randomization||0||
59720095|NCT01107912|75839213|FG001|COMPLETED|Period 2||36||
59720096|NCT01107912|75839214|FG002|COMPLETED|Period 2||35||
59720097|NCT01107912|75839215|FG003|COMPLETED|Period 2||41||
59720098|NCT01107912|75839216|FG004|COMPLETED|Period 2||0||
59720099|NCT01107912|75839217|FG005|COMPLETED|Period 2||38||
59720100|NCT01107912|75839212|FG000|NOT COMPLETED|Period 2||0||
59720101|NCT01107912|75839213|FG001|NOT COMPLETED|Period 2||0||
59720102|NCT01107912|75839214|FG002|NOT COMPLETED|Period 2||1||
59720103|NCT01107912|75839215|FG003|NOT COMPLETED|Period 2||0||
59720104|NCT01107912|75839216|FG004|NOT COMPLETED|Period 2||0||
59720105|NCT01107912|75839217|FG005|NOT COMPLETED|Period 2||0||
59720106|NCT01107912|75839212|FG000|STARTED|Period 3||0||
59720107|NCT01107912|75839213|FG001|STARTED|Period 3|Participants who received 75 mg clopidogrel in Period 2 received 10 mg prasugrel in Period 3|35||
59720108|NCT01107912|75839214|FG002|STARTED|Period 3|Participants who received 10 mg prasugrel in Period 2 received 75 mg clopidogrel in Period 3|36||
59720109|NCT01107912|75839215|FG003|STARTED|Period 3|Participants who received 75 mg clopidogrel in Period 2 received 5 mg prasugrel in Period 3|38||
59848271|NCT00384293|75972953|FG000|COMPLETED|MK0524A Active Run-In, Pre-randomization||433||
59848272|NCT00384293|75972954|FG001|COMPLETED|MK0524A Active Run-In, Pre-randomization||0||
59848273|NCT00384293|75972955|FG002|COMPLETED|MK0524A Active Run-In, Pre-randomization||0||
59848274|NCT00384293|75972953|FG000|NOT COMPLETED|MK0524A Active Run-In, Pre-randomization||504||
60120540|NCT01578785|76241709|FG001|STARTED|Overall Study||119||
59720110|NCT01107912|75839216|FG004|STARTED|Period 3||0||
59720111|NCT01107912|75839217|FG005|STARTED|Period 3|Participants who received 5 mg prasugrel in Period 2 received 75 mg clopidogrel in Period 3|41||
59720112|NCT01107912|75839212|FG000|COMPLETED|Period 3||0||
59720113|NCT01107912|75839213|FG001|COMPLETED|Period 3||34||
59848275|NCT00384293|75972954|FG001|NOT COMPLETED|MK0524A Active Run-In, Pre-randomization||0||
59848276|NCT00384293|75972955|FG002|NOT COMPLETED|MK0524A Active Run-In, Pre-randomization||0||
59848277|NCT00384293|75972953|FG000|STARTED|Post-randomization Period||0||
59848278|NCT00384293|75972954|FG001|STARTED|Post-randomization Period||214||
59848279|NCT00384293|75972955|FG002|STARTED|Post-randomization Period||219||
59848280|NCT00384293|75972953|FG000|Received ≥1 Dose of MK0524A Study Drug|Post-randomization Period||0||
59848281|NCT00384293|75972954|FG001|Received ≥1 Dose of MK0524A Study Drug|Post-randomization Period|Received at least one dose of randomized study drug (All Patients as Treated Population)|214||
59848282|NCT00384293|75972955|FG002|Received ≥1 Dose of MK0524A Study Drug|Post-randomization Period||218||
59848283|NCT00384293|75972953|FG000|COMPLETED|Post-randomization Period||0||
59848284|NCT00384293|75972954|FG001|COMPLETED|Post-randomization Period||0||
59848285|NCT00384293|75972955|FG002|COMPLETED|Post-randomization Period||0||
59848286|NCT00384293|75972953|FG000|NOT COMPLETED|Post-randomization Period||0||
59848287|NCT00384293|75972954|FG001|NOT COMPLETED|Post-randomization Period||214||
59848288|NCT00384293|75972955|FG002|NOT COMPLETED|Post-randomization Period||219||
59848289|NCT00067002|75972965|FG000|STARTED|Overall Study||52||
59848290|NCT00067002|75972966|FG001|STARTED|Overall Study||53||
59848291|NCT00067002|75972965|FG000|COMPLETED|Overall Study||45||
59848292|NCT00067002|75972966|FG001|COMPLETED|Overall Study||44||
59848293|NCT00067002|75972965|FG000|NOT COMPLETED|Overall Study||7||
59848294|NCT00067002|75972966|FG001|NOT COMPLETED|Overall Study||9||
59848295|NCT00091572|75972974|FG000|STARTED|Overall Study|10 subjects in temozolomide group not treated.|429||
59848296|NCT00091572|75972975|FG001|STARTED|Overall Study|9 subjects in dacarbazine group not treated.|430||
59848297|NCT00091572|75972974|FG000|COMPLETED|Overall Study|Progressive disease/relapse/death due to progressive disease|334||
59848298|NCT00091572|75972975|FG001|COMPLETED|Overall Study|Progressive disease/relapse/death due to progressive disease|348||
59848299|NCT00091572|75972974|FG000|NOT COMPLETED|Overall Study||95||
59848300|NCT00091572|75972975|FG001|NOT COMPLETED|Overall Study||82||
59848301|NCT00084266|75972983|FG000|STARTED|Overall Study||618||
59848302|NCT00084266|75972984|FG001|STARTED|Overall Study||607||
59848303|NCT00084266|75972983|FG000|Treated|Overall Study||597||
59848304|NCT00084266|75972984|FG001|Treated|Overall Study||587||
59848305|NCT00084266|75972983|FG000|COMPLETED|Overall Study||177||
59848306|NCT00084266|75972984|FG001|COMPLETED|Overall Study||184||
59848307|NCT00084266|75972983|FG000|NOT COMPLETED|Overall Study||441||
59848308|NCT00084266|75972984|FG001|NOT COMPLETED|Overall Study||423||
59848309|NCT00091026|75972992|FG000|STARTED|Overall Study||72||
59848310|NCT00091026|75972993|FG001|STARTED|Overall Study||71||
59848311|NCT00091026|75972992|FG000|COMPLETED|Overall Study||71||
59848312|NCT00091026|75972993|FG001|COMPLETED|Overall Study||68||
59848313|NCT00091026|75972992|FG000|NOT COMPLETED|Overall Study||1||
59848314|NCT00091026|75972993|FG001|NOT COMPLETED|Overall Study||3||
59848315|NCT00116558|75973002|FG000|STARTED|Overall Study||80||
59848316|NCT00116558|75973003|FG001|STARTED|Overall Study||26||
59848317|NCT00116558|75973004|FG002|STARTED|Overall Study||47||
59848318|NCT00116558|75973002|FG000|COMPLETED|Overall Study||49||
59848319|NCT00116558|75973003|FG001|COMPLETED|Overall Study||11||
59848320|NCT00116558|75973004|FG002|COMPLETED|Overall Study||14||
59848321|NCT00116558|75973002|FG000|NOT COMPLETED|Overall Study||31||
59848322|NCT00116558|75973003|FG001|NOT COMPLETED|Overall Study||15||
59848323|NCT00116558|75973004|FG002|NOT COMPLETED|Overall Study||33||
59848324|NCT00116168|75973015|FG000|STARTED|Overall Study||6||
59848325|NCT00116168|75973016|FG001|STARTED|Overall Study||11||
59848326|NCT00116168|75973017|FG002|STARTED|Overall Study||6||
59848327|NCT00116168|75973018|FG003|STARTED|Overall Study||6||
59848328|NCT00116168|75973015|FG000|COMPLETED|Overall Study||0||
59848329|NCT00116168|75973016|FG001|COMPLETED|Overall Study||6||
59848330|NCT00116168|75973017|FG002|COMPLETED|Overall Study||6||
59848331|NCT00116168|75973018|FG003|COMPLETED|Overall Study||6||
59848332|NCT00116168|75973015|FG000|NOT COMPLETED|Overall Study||6||
59848333|NCT00116168|75973016|FG001|NOT COMPLETED|Overall Study||5||
59848334|NCT00116168|75973017|FG002|NOT COMPLETED|Overall Study||0||
59848335|NCT00116168|75973018|FG003|NOT COMPLETED|Overall Study||0||
59848336|NCT00115934|75973030|FG000|STARTED|Overall Study|279 randomized to MBTS, but 3 did not have a Norwood surgery; one was withdrawn-with limited data.|279||
59848337|NCT00115934|75973031|FG001|STARTED|Overall Study|276 randomized to RVPAS, but 2 did not have a Norwood surgery and were excluded from analyses.|276||
59848338|NCT00115934|75973030|FG000|COMPLETED|Overall Study||275||
59848339|NCT00115934|75973031|FG001|COMPLETED|Overall Study||274||
59848340|NCT00115934|75973030|FG000|NOT COMPLETED|Overall Study||4||
59848341|NCT00115934|75973031|FG001|NOT COMPLETED|Overall Study||2||
59848342|NCT00115778|75973037|FG000|STARTED|Overall Study||6||
59848343|NCT00115778|75973038|FG001|STARTED|Overall Study||5||
59848344|NCT00115778|75973037|FG000|COMPLETED|Overall Study||6||
59848345|NCT00115778|75973038|FG001|COMPLETED|Overall Study||4||
59848346|NCT00115778|75973037|FG000|NOT COMPLETED|Overall Study||0||
59996698|NCT02714569|76112508|FG005|STARTED|Part B (Overall)|Part A participants completed period 4 and were not in part B.|0||
59848347|NCT00115778|75973038|FG001|NOT COMPLETED|Overall Study||1||
59848348|NCT00100178|75973047|FG000|STARTED|Overall Study||41||
59848349|NCT00100178|75973048|FG001|STARTED|Overall Study|12 subjects randomized to the MMF alone group were excluded from analysis due to randomization error|31||
59848350|NCT00100178|75973049|FG002|STARTED|Overall Study||42||
59848351|NCT00100178|75973047|FG000|COMPLETED|Overall Study||32||
59848352|NCT00100178|75973048|FG001|COMPLETED|Overall Study||21||
59848353|NCT00100178|75973049|FG002|COMPLETED|Overall Study||32||
59848354|NCT00100178|75973047|FG000|NOT COMPLETED|Overall Study||9||
59848355|NCT00100178|75973048|FG001|NOT COMPLETED|Overall Study||10||
59848356|NCT00100178|75973049|FG002|NOT COMPLETED|Overall Study||10||
59848357|NCT00099632|75973063|FG000|STARTED|Overall Study||73||
59848358|NCT00099632|75973064|FG001|STARTED|Overall Study||68||
59848359|NCT00099632|75973065|FG002|STARTED|Overall Study||75||
59848360|NCT00099632|75973066|FG003|STARTED|Overall Study||67||
59848361|NCT00099632|75973067|FG004|STARTED|Overall Study||71||
59848362|NCT00099632|75973068|FG005|STARTED|Overall Study||68||
59848363|NCT00099632|75973063|FG000|COMPLETED|Overall Study||72||
59848364|NCT00099632|75973064|FG001|COMPLETED|Overall Study||67||
59848365|NCT00099632|75973065|FG002|COMPLETED|Overall Study||72||
59848366|NCT00099632|75973066|FG003|COMPLETED|Overall Study||66||
59848367|NCT00099632|75973067|FG004|COMPLETED|Overall Study||70||
59848368|NCT00099632|75973068|FG005|COMPLETED|Overall Study||66||
59848369|NCT00099632|75973063|FG000|NOT COMPLETED|Overall Study||1||
59848370|NCT00099632|75973064|FG001|NOT COMPLETED|Overall Study||1||
59848371|NCT00099632|75973065|FG002|NOT COMPLETED|Overall Study||3||
59848372|NCT00099632|75973066|FG003|NOT COMPLETED|Overall Study||1||
59848373|NCT00099632|75973067|FG004|NOT COMPLETED|Overall Study||1||
59848374|NCT00099632|75973068|FG005|NOT COMPLETED|Overall Study||2||
59848375|NCT00098774|75973082|FG000|STARTED|Overall Study||44||
59848376|NCT00098774|75973082|FG000|COMPLETED|Overall Study||26||
59848377|NCT00098774|75973082|FG000|NOT COMPLETED|Overall Study||18||
59848378|NCT00384059|75973088|FG000|STARTED|Infant Series||141||
59848379|NCT00384059|75973089|FG001|STARTED|Infant Series||145||
59848380|NCT00384059|75973088|FG000|Vaccinated Dose 1|Infant Series||139||
59848381|NCT00384059|75973089|FG001|Vaccinated Dose 1|Infant Series||139||
59848382|NCT00384059|75973088|FG000|Vaccinated Dose 2|Infant Series||136||
59848383|NCT00384059|75973089|FG001|Vaccinated Dose 2|Infant Series||135||
59848384|NCT00384059|75973088|FG000|COMPLETED|Infant Series||135||
59848385|NCT00384059|75973089|FG001|COMPLETED|Infant Series||132||
59848386|NCT00384059|75973088|FG000|NOT COMPLETED|Infant Series||6||
59848387|NCT00384059|75973089|FG001|NOT COMPLETED|Infant Series||13||
59848388|NCT00384059|75973088|FG000|STARTED|After Infant Series||135||
59848389|NCT00384059|75973089|FG001|STARTED|After Infant Series||132||
59848390|NCT00384059|75973088|FG000|COMPLETED|After Infant Series||131||
59848391|NCT00384059|75973089|FG001|COMPLETED|After Infant Series||122||
59848392|NCT00384059|75973088|FG000|NOT COMPLETED|After Infant Series||4||
59848393|NCT00384059|75973089|FG001|NOT COMPLETED|After Infant Series||10||
59848394|NCT00384059|75973088|FG000|STARTED|Toddler Dose||131||
59848395|NCT00384059|75973089|FG001|STARTED|Toddler Dose||122||
59848396|NCT00384059|75973088|FG000|COMPLETED|Toddler Dose||130||
59848397|NCT00384059|75973089|FG001|COMPLETED|Toddler Dose||120||
59848398|NCT00384059|75973088|FG000|NOT COMPLETED|Toddler Dose||1||
59848399|NCT00384059|75973089|FG001|NOT COMPLETED|Toddler Dose||2||
59848400|NCT00383123|75973118|FG000|STARTED|Overall Study||2115||
59848401|NCT00383123|75973119|FG001|STARTED|Overall Study||1210||
59848402|NCT00383123|75973118|FG000|COMPLETED|Overall Study||2004||
59848403|NCT00383123|75973119|FG001|COMPLETED|Overall Study||1124||
59848404|NCT00383123|75973118|FG000|NOT COMPLETED|Overall Study||111||
59848405|NCT00383123|75973119|FG001|NOT COMPLETED|Overall Study||86||
59848406|NCT00382967|75973127|FG000|STARTED|Overall Study|135 subjects enrolled at the start of the study, however, 13 subjects withdrew prior to dosing.|122||
59848407|NCT00382967|75973128|FG001|STARTED|Overall Study||138||
59848408|NCT00382967|75973127|FG000|COMPLETED|Overall Study|Patient lost to followup and the data was not recorded.|121||
59848409|NCT00382967|75973128|FG001|COMPLETED|Overall Study|Subject dosed in error, should not have received Datscan product|137||
59848410|NCT00382967|75973127|FG000|NOT COMPLETED|Overall Study||1||
60120541|NCT01578785|76241708|FG000|COMPLETED|Overall Study||0||
60120542|NCT01578785|76241709|FG001|COMPLETED|Overall Study||0||
59848411|NCT00382967|75973128|FG001|NOT COMPLETED|Overall Study||1||
59848412|NCT00858364|75973136|FG000|STARTED|Overall Study||846||
59848413|NCT00858364|75973137|FG001|STARTED|Overall Study||1703||
59848414|NCT00858364|75973136|FG000|Received Study Drug|Overall Study||837||
59848415|NCT00858364|75973137|FG001|Received Study Drug|Overall Study||1681||
59848416|NCT00858364|75973136|FG000|COMPLETED|Overall Study||642|Participants who died|
59848417|NCT00858364|75973137|FG001|COMPLETED|Overall Study||1246|Participants who died|
59848418|NCT00858364|75973136|FG000|NOT COMPLETED|Overall Study||204||
59848419|NCT00858364|75973137|FG001|NOT COMPLETED|Overall Study||457||
59848420|NCT00382733|75973143|FG000|STARTED|Overall Study||3||
59848421|NCT00382733|75973144|FG001|STARTED|Overall Study||4||
59848422|NCT00382733|75973145|FG002|STARTED|Overall Study||3||
59848423|NCT00382733|75973146|FG003|STARTED|Overall Study||14||
59848424|NCT00382733|75973147|FG004|STARTED|Overall Study||2||
59848425|NCT00382733|75973143|FG000|COMPLETED|Overall Study||3||
59848426|NCT00382733|75973144|FG001|COMPLETED|Overall Study|1 subject withdrew consent before completing Cycle 1 - that subject was replaced|3||
59848427|NCT00382733|75973145|FG002|COMPLETED|Overall Study||3||
59848428|NCT00382733|75973146|FG003|COMPLETED|Overall Study||14||
59848429|NCT00382733|75973147|FG004|COMPLETED|Overall Study||2||
59848430|NCT00382733|75973143|FG000|NOT COMPLETED|Overall Study||0||
59848431|NCT00382733|75973144|FG001|NOT COMPLETED|Overall Study||1||
59848432|NCT00382733|75973145|FG002|NOT COMPLETED|Overall Study||0||
59848433|NCT00382733|75973146|FG003|NOT COMPLETED|Overall Study||0||
59848434|NCT00382733|75973147|FG004|NOT COMPLETED|Overall Study||0||
59848435|NCT03631732|75973162|FG000|STARTED|Randomized Phase Up to Week 24||331||
59848436|NCT03631732|75973163|FG001|STARTED|Randomized Phase Up to Week 24||165||
59848437|NCT03631732|75973162|FG000|COMPLETED|Randomized Phase Up to Week 24||324||
59568011|NCT01048125|75670933|FG001|NOT COMPLETED|Overall Study||0||
59568012|NCT01901588|75670941|FG000|STARTED|Overall Study||32||
59568013|NCT01901588|75670942|FG001|STARTED|Overall Study||31||
59568014|NCT01901588|75670941|FG000|COMPLETED|Overall Study||32||
59568015|NCT01901588|75670942|FG001|COMPLETED|Overall Study||31||
59568016|NCT01901588|75670941|FG000|NOT COMPLETED|Overall Study||0||
59568017|NCT01901588|75670942|FG001|NOT COMPLETED|Overall Study||0||
59568018|NCT01056315|75670950|FG000|STARTED|Overall Study||27||
59568019|NCT01056315|75670951|FG001|STARTED|Overall Study||23||
59568020|NCT01056315|75670950|FG000|COMPLETED|Overall Study||13||
59568021|NCT01056315|75670951|FG001|COMPLETED|Overall Study||12||
59568022|NCT01056315|75670950|FG000|NOT COMPLETED|Overall Study||14||
59568023|NCT01056315|75670951|FG001|NOT COMPLETED|Overall Study||11||
59568024|NCT01025271|75670957|FG000|STARTED|Overall Study|unable to meet enrollment no data available. Study terminated early|2||
59720114|NCT01107912|75839214|FG002|COMPLETED|Period 3||35||
59720115|NCT01107912|75839215|FG003|COMPLETED|Period 3||37||
59720116|NCT01107912|75839216|FG004|COMPLETED|Period 3||0||
59720117|NCT01107912|75839217|FG005|COMPLETED|Period 3||41||
59720118|NCT01107912|75839212|FG000|NOT COMPLETED|Period 3||0||
59720119|NCT01107912|75839213|FG001|NOT COMPLETED|Period 3||1||
59720120|NCT01107912|75839214|FG002|NOT COMPLETED|Period 3||1||
59720121|NCT01107912|75839215|FG003|NOT COMPLETED|Period 3||1||
59720122|NCT01107912|75839216|FG004|NOT COMPLETED|Period 3||0||
59720123|NCT01107912|75839217|FG005|NOT COMPLETED|Period 3||0||
59720124|NCT01200524|75839235|FG000|STARTED|Overall Study||41||
59720125|NCT01200524|75839236|FG001|STARTED|Overall Study||48||
59720126|NCT01200524|75839237|FG002|STARTED|Overall Study||44||
59720127|NCT01200524|75839235|FG000|COMPLETED|Overall Study||39||
59720128|NCT01200524|75839236|FG001|COMPLETED|Overall Study||47||
59720129|NCT01200524|75839237|FG002|COMPLETED|Overall Study||40||
59720130|NCT01200524|75839235|FG000|NOT COMPLETED|Overall Study||2||
59720131|NCT01200524|75839236|FG001|NOT COMPLETED|Overall Study||1||
59720132|NCT01200524|75839237|FG002|NOT COMPLETED|Overall Study||4||
59720133|NCT01100034|75839245|FG000|STARTED|Overall Study||72||
59848438|NCT03631732|75973163|FG001|COMPLETED|Randomized Phase Up to Week 24||163||
59848439|NCT03631732|75973162|FG000|NOT COMPLETED|Randomized Phase Up to Week 24||7||
59848440|NCT03631732|75973163|FG001|NOT COMPLETED|Randomized Phase Up to Week 24||2||
59848441|NCT03631732|75973162|FG000|STARTED|B/F/TAF Treatment Phase (After Week 24)|5 participants completed 24 weeks of the study, but did not receive study treatment after Week 24.|319||
59848442|NCT03631732|75973163|FG001|STARTED|B/F/TAF Treatment Phase (After Week 24)||163||
59848443|NCT03631732|75973162|FG000|COMPLETED|B/F/TAF Treatment Phase (After Week 24)||303||
59848444|NCT03631732|75973163|FG001|COMPLETED|B/F/TAF Treatment Phase (After Week 24)||158||
59848445|NCT03631732|75973162|FG000|NOT COMPLETED|B/F/TAF Treatment Phase (After Week 24)||16||
59848446|NCT03631732|75973163|FG001|NOT COMPLETED|B/F/TAF Treatment Phase (After Week 24)||5||
59848447|NCT03630016|75973173|FG000|STARTED|Overall Study||11||
59848448|NCT03630016|75973173|FG000|COMPLETED|Overall Study||10||
59848449|NCT03630016|75973173|FG000|NOT COMPLETED|Overall Study||1||
59848450|NCT03628924|75973180|FG000|STARTED|Placebo Controlled Period (Week 0 - 16)||62||
59848451|NCT03628924|75973181|FG001|STARTED|Placebo Controlled Period (Week 0 - 16)||59||
59848452|NCT03628924|75973182|FG002|STARTED|Placebo Controlled Period (Week 0 - 16)||60||
59848453|NCT03628924|75973183|FG003|STARTED|Placebo Controlled Period (Week 0 - 16)||0||
59848454|NCT03628924|75973184|FG004|STARTED|Placebo Controlled Period (Week 0 - 16)||0||
59848455|NCT03628924|75973185|FG005|STARTED|Placebo Controlled Period (Week 0 - 16)||0||
59848456|NCT03628924|75973186|FG006|STARTED|Placebo Controlled Period (Week 0 - 16)||0||
59848457|NCT03628924|75973180|FG000|COMPLETED|Placebo Controlled Period (Week 0 - 16)||56||
59848458|NCT03628924|75973181|FG001|COMPLETED|Placebo Controlled Period (Week 0 - 16)||56||
59848459|NCT03628924|75973182|FG002|COMPLETED|Placebo Controlled Period (Week 0 - 16)||57||
59848460|NCT03628924|75973183|FG003|COMPLETED|Placebo Controlled Period (Week 0 - 16)||0||
59848461|NCT03628924|75973184|FG004|COMPLETED|Placebo Controlled Period (Week 0 - 16)||0||
59848462|NCT03628924|75973185|FG005|COMPLETED|Placebo Controlled Period (Week 0 - 16)||0||
59848463|NCT03628924|75973186|FG006|COMPLETED|Placebo Controlled Period (Week 0 - 16)||0||
59848464|NCT03628924|75973180|FG000|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||6||
59848465|NCT03628924|75973181|FG001|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||3||
59848466|NCT03628924|75973182|FG002|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||3||
59848467|NCT03628924|75973183|FG003|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||0||
59848468|NCT03628924|75973184|FG004|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||0||
59848469|NCT03628924|75973185|FG005|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||0||
59848470|NCT03628924|75973186|FG006|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||0||
59848471|NCT03628924|75973180|FG000|STARTED|Active Treatment Period (Week 16-48)||0||
59848472|NCT03628924|75973181|FG001|STARTED|Active Treatment Period (Week 16-48)||0||
59848473|NCT03628924|75973182|FG002|STARTED|Active Treatment Period (Week 16-48)||0||
59848474|NCT03628924|75973183|FG003|STARTED|Active Treatment Period (Week 16-48)||28||
59848475|NCT03628924|75973184|FG004|STARTED|Active Treatment Period (Week 16-48)||28||
59848476|NCT03628924|75973185|FG005|STARTED|Active Treatment Period (Week 16-48)||56||
59568025|NCT01025271|75670957|FG000|COMPLETED|Overall Study|unable to meet enrollment no data available. Study terminated early|2||
59848477|NCT03628924|75973186|FG006|STARTED|Active Treatment Period (Week 16-48)||57||
59848478|NCT03628924|75973180|FG000|COMPLETED|Active Treatment Period (Week 16-48)||0||
59848479|NCT03628924|75973181|FG001|COMPLETED|Active Treatment Period (Week 16-48)||0||
59848480|NCT03628924|75973182|FG002|COMPLETED|Active Treatment Period (Week 16-48)||0||
59848481|NCT03628924|75973183|FG003|COMPLETED|Active Treatment Period (Week 16-48)||20||
59848482|NCT03628924|75973184|FG004|COMPLETED|Active Treatment Period (Week 16-48)||24||
59848483|NCT03628924|75973185|FG005|COMPLETED|Active Treatment Period (Week 16-48)||43||
59848484|NCT03628924|75973186|FG006|COMPLETED|Active Treatment Period (Week 16-48)||46||
59848485|NCT03628924|75973180|FG000|NOT COMPLETED|Active Treatment Period (Week 16-48)||0||
59848486|NCT03628924|75973181|FG001|NOT COMPLETED|Active Treatment Period (Week 16-48)||0||
59848487|NCT03628924|75973182|FG002|NOT COMPLETED|Active Treatment Period (Week 16-48)||0||
59848488|NCT03628924|75973183|FG003|NOT COMPLETED|Active Treatment Period (Week 16-48)||8||
59848489|NCT03628924|75973184|FG004|NOT COMPLETED|Active Treatment Period (Week 16-48)||4||
59848490|NCT03628924|75973185|FG005|NOT COMPLETED|Active Treatment Period (Week 16-48)||13||
59848491|NCT03628924|75973186|FG006|NOT COMPLETED|Active Treatment Period (Week 16-48)||11||
59848492|NCT03627832|75973200|FG000|STARTED|Overall Study||28||
59848493|NCT03627832|75973201|FG001|STARTED|Overall Study||28||
59848494|NCT03627832|75973200|FG000|COMPLETED|Overall Study||18||
59848495|NCT03627832|75973201|FG001|COMPLETED|Overall Study||27||
59848496|NCT03627832|75973200|FG000|NOT COMPLETED|Overall Study||10||
59848497|NCT03627832|75973201|FG001|NOT COMPLETED|Overall Study||1||
59848498|NCT00112437|75973212|FG000|STARTED|Year 1 (12-Month Base Study)||83||
59848499|NCT00112437|75973213|FG001|STARTED|Year 1 (12-Month Base Study)||82||
59848500|NCT00112437|75973214|FG002|STARTED|Year 1 (12-Month Base Study)||77||
59848501|NCT00112437|75973215|FG003|STARTED|Year 1 (12-Month Base Study)||79||
59848502|NCT00112437|75973216|FG004|STARTED|Year 1 (12-Month Base Study)||78||
59848503|NCT00112437|75973217|FG005|STARTED|Year 1 (12-Month Base Study)||0||
59848504|NCT00112437|75973218|FG006|STARTED|Year 1 (12-Month Base Study)||0||
59848505|NCT00112437|75973219|FG007|STARTED|Year 1 (12-Month Base Study)||0||
59848506|NCT00112437|75973220|FG008|STARTED|Year 1 (12-Month Base Study)||0||
59848507|NCT00112437|75973221|FG009|STARTED|Year 1 (12-Month Base Study)||0||
59848508|NCT00112437|75973222|FG010|STARTED|Year 1 (12-Month Base Study)||0||
59848509|NCT00112437|75973223|FG011|STARTED|Year 1 (12-Month Base Study)||0||
59848510|NCT00112437|75973224|FG012|STARTED|Year 1 (12-Month Base Study)||0||
59848511|NCT00112437|75973225|FG013|STARTED|Year 1 (12-Month Base Study)||0||
59848512|NCT00112437|75973226|FG014|STARTED|Year 1 (12-Month Base Study)||0||
59848513|NCT00112437|75973227|FG015|STARTED|Year 1 (12-Month Base Study)||0||
59568026|NCT01025271|75670957|FG000|NOT COMPLETED|Overall Study||0||
59568027|NCT01902758|75670964|FG000|STARTED|Overall Study||14||
59568028|NCT01902758|75670965|FG001|STARTED|Overall Study||14||
59568029|NCT01902758|75670964|FG000|COMPLETED|Overall Study||14||
59568030|NCT01902758|75670965|FG001|COMPLETED|Overall Study||14||
59568031|NCT01902758|75670964|FG000|NOT COMPLETED|Overall Study||0||
59568032|NCT01902758|75670965|FG001|NOT COMPLETED|Overall Study||0||
59568033|NCT02336763|75670971|FG000|STARTED|Overall Study||2||
59568034|NCT02336763|75670971|FG000|COMPLETED|Overall Study||2||
59720134|NCT01100034|75839245|FG000|COMPLETED|Overall Study||29||
59720135|NCT01100034|75839245|FG000|NOT COMPLETED|Overall Study||43||
59848514|NCT00112437|75973228|FG016|STARTED|Year 1 (12-Month Base Study)||0||
59848515|NCT00112437|75973229|FG017|STARTED|Year 1 (12-Month Base Study)||0||
59848516|NCT00112437|75973230|FG018|STARTED|Year 1 (12-Month Base Study)||0||
59848517|NCT00112437|75973231|FG019|STARTED|Year 1 (12-Month Base Study)||0||
59848518|NCT00112437|75973232|FG020|STARTED|Year 1 (12-Month Base Study)||0||
59848519|NCT00112437|75973233|FG021|STARTED|Year 1 (12-Month Base Study)||0||
60120543|NCT01578785|76241708|FG000|NOT COMPLETED|Overall Study||59||
60120544|NCT01578785|76241709|FG001|NOT COMPLETED|Overall Study||119||
60120545|NCT02692482|76241717|FG000|STARTED|Overall Study||177||
60120546|NCT02692482|76241718|FG001|STARTED|Overall Study||182||
60120547|NCT02692482|76241717|FG000|COMPLETED|Overall Study||174||
60120548|NCT02692482|76241718|FG001|COMPLETED|Overall Study||178||
60120549|NCT02692482|76241717|FG000|NOT COMPLETED|Overall Study||3||
60120550|NCT02692482|76241718|FG001|NOT COMPLETED|Overall Study||4||
60120551|NCT01578551|76241727|FG000|STARTED|Overall Study||19||
60120552|NCT01578551|76241728|FG001|STARTED|Overall Study||6||
60120553|NCT01578551|76241727|FG000|COMPLETED|Overall Study||18||
60120554|NCT01578551|76241728|FG001|COMPLETED|Overall Study||6||
59720136|NCT00876265|75839249|FG000|STARTED|Overall Study||118||
59720137|NCT00876265|75839249|FG000|COMPLETED|Overall Study||106||
60120555|NCT01578551|76241727|FG000|NOT COMPLETED|Overall Study||1||
59568035|NCT02336763|75670971|FG000|NOT COMPLETED|Overall Study||0||
59568036|NCT01903148|75670977|FG000|STARTED|Overall Study||441||
59720138|NCT00876265|75839249|FG000|NOT COMPLETED|Overall Study||12||
59720139|NCT01107444|75839257|FG000|STARTED|Overall Study||120||
59720140|NCT01107444|75839258|FG001|STARTED|Overall Study||60||
59720141|NCT01107444|75839257|FG000|Received At Least 1 Dose of Study Drug|Overall Study||114||
59720142|NCT01107444|75839258|FG001|Received At Least 1 Dose of Study Drug|Overall Study||48||
59720143|NCT01107444|75839257|FG000|COMPLETED|Overall Study||112||
59720144|NCT01107444|75839258|FG001|COMPLETED|Overall Study||47||
59720145|NCT01107444|75839257|FG000|NOT COMPLETED|Overall Study||8||
59848520|NCT00112437|75973234|FG022|STARTED|Year 1 (12-Month Base Study)||0||
59848521|NCT00112437|75973235|FG023|STARTED|Year 1 (12-Month Base Study)||0||
59848522|NCT00112437|75973236|FG024|STARTED|Year 1 (12-Month Base Study)||0||
60120556|NCT01578551|76241728|FG001|NOT COMPLETED|Overall Study||0||
60120557|NCT01692197|76241735|FG000|STARTED|Overall Study||43||
59568037|NCT01903148|75670977|FG000|COMPLETED|Overall Study||441||
59568038|NCT01903148|75670977|FG000|NOT COMPLETED|Overall Study||0||
59848523|NCT00112437|75973237|FG025|STARTED|Year 1 (12-Month Base Study)||0||
60120558|NCT01692197|76241735|FG000|COMPLETED|Overall Study||40||
59848524|NCT00112437|75973212|FG000|COMPLETED|Year 1 (12-Month Base Study)|1 patient completed base study after December 19, 2006 and is not included in completed total.|68||
59848525|NCT00112437|75973213|FG001|COMPLETED|Year 1 (12-Month Base Study)|1 patient completed base study after December 19, 2006 and is not included in completed total.|64||
59848526|NCT00112437|75973214|FG002|COMPLETED|Year 1 (12-Month Base Study)||65||
59848527|NCT00112437|75973215|FG003|COMPLETED|Year 1 (12-Month Base Study)||71||
59848528|NCT00112437|75973216|FG004|COMPLETED|Year 1 (12-Month Base Study)|1 patient completed base study after December 19, 2006 and is not included in the completed total.|66||
59848529|NCT00112437|75973217|FG005|COMPLETED|Year 1 (12-Month Base Study)||0||
59848530|NCT00112437|75973218|FG006|COMPLETED|Year 1 (12-Month Base Study)||0||
59848531|NCT00112437|75973219|FG007|COMPLETED|Year 1 (12-Month Base Study)||0||
59848532|NCT00112437|75973220|FG008|COMPLETED|Year 1 (12-Month Base Study)||0||
59848533|NCT00112437|75973221|FG009|COMPLETED|Year 1 (12-Month Base Study)||0||
59848534|NCT00112437|75973222|FG010|COMPLETED|Year 1 (12-Month Base Study)||0||
59848535|NCT00112437|75973223|FG011|COMPLETED|Year 1 (12-Month Base Study)||0||
59568039|NCT02318901|75670986|FG000|STARTED|Overall Study||5||
59568040|NCT02318901|75670987|FG001|STARTED|Overall Study||1||
59568041|NCT02318901|75670988|FG002|STARTED|Overall Study||10||
59568042|NCT02318901|75670986|FG000|COMPLETED|Overall Study||0||
59568043|NCT02318901|75670987|FG001|COMPLETED|Overall Study||0||
59848536|NCT00112437|75973224|FG012|COMPLETED|Year 1 (12-Month Base Study)||0||
59848537|NCT00112437|75973225|FG013|COMPLETED|Year 1 (12-Month Base Study)||0||
59848538|NCT00112437|75973226|FG014|COMPLETED|Year 1 (12-Month Base Study)||0||
59848539|NCT00112437|75973227|FG015|COMPLETED|Year 1 (12-Month Base Study)||0||
59848540|NCT00112437|75973228|FG016|COMPLETED|Year 1 (12-Month Base Study)||0||
59848541|NCT00112437|75973229|FG017|COMPLETED|Year 1 (12-Month Base Study)||0||
59848542|NCT00112437|75973230|FG018|COMPLETED|Year 1 (12-Month Base Study)||0||
59848543|NCT00112437|75973231|FG019|COMPLETED|Year 1 (12-Month Base Study)||0||
59848544|NCT00112437|75973232|FG020|COMPLETED|Year 1 (12-Month Base Study)||0||
59848545|NCT00112437|75973233|FG021|COMPLETED|Year 1 (12-Month Base Study)||0||
59848546|NCT00112437|75973234|FG022|COMPLETED|Year 1 (12-Month Base Study)||0||
59848547|NCT00112437|75973235|FG023|COMPLETED|Year 1 (12-Month Base Study)||0||
59848548|NCT00112437|75973236|FG024|COMPLETED|Year 1 (12-Month Base Study)||0||
59848549|NCT00112437|75973237|FG025|COMPLETED|Year 1 (12-Month Base Study)||0||
59848550|NCT00112437|75973212|FG000|NOT COMPLETED|Year 1 (12-Month Base Study)||15||
59848551|NCT00112437|75973213|FG001|NOT COMPLETED|Year 1 (12-Month Base Study)||18||
59848552|NCT00112437|75973214|FG002|NOT COMPLETED|Year 1 (12-Month Base Study)||12||
59848553|NCT00112437|75973215|FG003|NOT COMPLETED|Year 1 (12-Month Base Study)||8||
59848554|NCT00112437|75973216|FG004|NOT COMPLETED|Year 1 (12-Month Base Study)||12||
59848555|NCT00112437|75973217|FG005|NOT COMPLETED|Year 1 (12-Month Base Study)||0||
59848556|NCT00112437|75973218|FG006|NOT COMPLETED|Year 1 (12-Month Base Study)||0||
59848557|NCT00112437|75973219|FG007|NOT COMPLETED|Year 1 (12-Month Base Study)||0||
59848558|NCT00112437|75973220|FG008|NOT COMPLETED|Year 1 (12-Month Base Study)||0||
59848559|NCT00112437|75973221|FG009|NOT COMPLETED|Year 1 (12-Month Base Study)||0||
59848560|NCT00112437|75973222|FG010|NOT COMPLETED|Year 1 (12-Month Base Study)||0||
59848561|NCT00112437|75973223|FG011|NOT COMPLETED|Year 1 (12-Month Base Study)||0||
59848562|NCT00112437|75973224|FG012|NOT COMPLETED|Year 1 (12-Month Base Study)||0||
59848563|NCT00112437|75973225|FG013|NOT COMPLETED|Year 1 (12-Month Base Study)||0||
59848564|NCT00112437|75973226|FG014|NOT COMPLETED|Year 1 (12-Month Base Study)||0||
59848565|NCT00112437|75973227|FG015|NOT COMPLETED|Year 1 (12-Month Base Study)||0||
59848566|NCT00112437|75973228|FG016|NOT COMPLETED|Year 1 (12-Month Base Study)||0||
59848567|NCT00112437|75973229|FG017|NOT COMPLETED|Year 1 (12-Month Base Study)||0||
59848568|NCT00112437|75973230|FG018|NOT COMPLETED|Year 1 (12-Month Base Study)||0||
59848569|NCT00112437|75973231|FG019|NOT COMPLETED|Year 1 (12-Month Base Study)||0||
59848570|NCT00112437|75973232|FG020|NOT COMPLETED|Year 1 (12-Month Base Study)||0||
59848571|NCT00112437|75973233|FG021|NOT COMPLETED|Year 1 (12-Month Base Study)||0||
59848572|NCT00112437|75973234|FG022|NOT COMPLETED|Year 1 (12-Month Base Study)||0||
59848573|NCT00112437|75973235|FG023|NOT COMPLETED|Year 1 (12-Month Base Study)||0||
59848574|NCT00112437|75973236|FG024|NOT COMPLETED|Year 1 (12-Month Base Study)||0||
59848575|NCT00112437|75973237|FG025|NOT COMPLETED|Year 1 (12-Month Base Study)||0||
59848576|NCT00112437|75973212|FG000|STARTED|Year 2 (12-Month Extension)||0||
59848577|NCT00112437|75973213|FG001|STARTED|Year 2 (12-Month Extension)||0||
59848578|NCT00112437|75973214|FG002|STARTED|Year 2 (12-Month Extension)||0||
59848579|NCT00112437|75973215|FG003|STARTED|Year 2 (12-Month Extension)||0||
59848580|NCT00112437|75973216|FG004|STARTED|Year 2 (12-Month Extension)||0||
59848581|NCT00112437|75973217|FG005|STARTED|Year 2 (12-Month Extension)||63||
59848582|NCT00112437|75973218|FG006|STARTED|Year 2 (12-Month Extension)||62||
59848583|NCT00112437|75973219|FG007|STARTED|Year 2 (12-Month Extension)||63||
59848584|NCT00112437|75973220|FG008|STARTED|Year 2 (12-Month Extension)||69||
59848585|NCT00112437|75973221|FG009|STARTED|Year 2 (12-Month Extension)||63||
59848586|NCT00112437|75973222|FG010|STARTED|Year 2 (12-Month Extension)||0||
60120559|NCT01692197|76241735|FG000|NOT COMPLETED|Overall Study||3||
59568044|NCT02318901|75670988|FG002|COMPLETED|Overall Study||0||
59568045|NCT02318901|75670986|FG000|NOT COMPLETED|Overall Study||5||
59848587|NCT00112437|75973223|FG011|STARTED|Year 2 (12-Month Extension)||0||
59848588|NCT00112437|75973224|FG012|STARTED|Year 2 (12-Month Extension)||0||
59848589|NCT00112437|75973225|FG013|STARTED|Year 2 (12-Month Extension)||0||
59848590|NCT00112437|75973226|FG014|STARTED|Year 2 (12-Month Extension)||0||
59848591|NCT00112437|75973227|FG015|STARTED|Year 2 (12-Month Extension)||0||
59848592|NCT00112437|75973228|FG016|STARTED|Year 2 (12-Month Extension)||0||
59848593|NCT00112437|75973229|FG017|STARTED|Year 2 (12-Month Extension)||0||
59848594|NCT00112437|75973230|FG018|STARTED|Year 2 (12-Month Extension)||0||
59848595|NCT00112437|75973231|FG019|STARTED|Year 2 (12-Month Extension)||0||
59848596|NCT00112437|75973232|FG020|STARTED|Year 2 (12-Month Extension)||0||
59848597|NCT00112437|75973233|FG021|STARTED|Year 2 (12-Month Extension)||0||
59848598|NCT00112437|75973234|FG022|STARTED|Year 2 (12-Month Extension)||0||
59848599|NCT00112437|75973235|FG023|STARTED|Year 2 (12-Month Extension)||0||
59848600|NCT00112437|75973236|FG024|STARTED|Year 2 (12-Month Extension)||0||
59848601|NCT00112437|75973237|FG025|STARTED|Year 2 (12-Month Extension)||0||
59848602|NCT00112437|75973212|FG000|COMPLETED|Year 2 (12-Month Extension)||0||
59848603|NCT00112437|75973213|FG001|COMPLETED|Year 2 (12-Month Extension)||0||
59848604|NCT00112437|75973214|FG002|COMPLETED|Year 2 (12-Month Extension)||0||
59848605|NCT00112437|75973215|FG003|COMPLETED|Year 2 (12-Month Extension)||0||
59848606|NCT00112437|75973216|FG004|COMPLETED|Year 2 (12-Month Extension)||0||
59848607|NCT00112437|75973217|FG005|COMPLETED|Year 2 (12-Month Extension)||60||
59848608|NCT00112437|75973218|FG006|COMPLETED|Year 2 (12-Month Extension)||53||
59848609|NCT00112437|75973219|FG007|COMPLETED|Year 2 (12-Month Extension)||55||
59848610|NCT00112437|75973220|FG008|COMPLETED|Year 2 (12-Month Extension)||62||
59848611|NCT00112437|75973221|FG009|COMPLETED|Year 2 (12-Month Extension)||50||
59848612|NCT00112437|75973222|FG010|COMPLETED|Year 2 (12-Month Extension)||0||
59848613|NCT00112437|75973223|FG011|COMPLETED|Year 2 (12-Month Extension)||0||
59848614|NCT00112437|75973224|FG012|COMPLETED|Year 2 (12-Month Extension)||0||
59848615|NCT00112437|75973225|FG013|COMPLETED|Year 2 (12-Month Extension)||0||
59848616|NCT00112437|75973226|FG014|COMPLETED|Year 2 (12-Month Extension)||0||
59848617|NCT00112437|75973227|FG015|COMPLETED|Year 2 (12-Month Extension)||0||
59848618|NCT00112437|75973228|FG016|COMPLETED|Year 2 (12-Month Extension)||0||
59848619|NCT00112437|75973229|FG017|COMPLETED|Year 2 (12-Month Extension)||0||
59848620|NCT00112437|75973230|FG018|COMPLETED|Year 2 (12-Month Extension)||0||
59848621|NCT00112437|75973231|FG019|COMPLETED|Year 2 (12-Month Extension)||0||
59848622|NCT00112437|75973232|FG020|COMPLETED|Year 2 (12-Month Extension)||0||
59848623|NCT00112437|75973233|FG021|COMPLETED|Year 2 (12-Month Extension)||0||
59848624|NCT00112437|75973234|FG022|COMPLETED|Year 2 (12-Month Extension)||0||
59848625|NCT00112437|75973235|FG023|COMPLETED|Year 2 (12-Month Extension)||0||
59848626|NCT00112437|75973236|FG024|COMPLETED|Year 2 (12-Month Extension)||0||
59848627|NCT00112437|75973237|FG025|COMPLETED|Year 2 (12-Month Extension)||0||
59848628|NCT00112437|75973212|FG000|NOT COMPLETED|Year 2 (12-Month Extension)||0||
59848629|NCT00112437|75973213|FG001|NOT COMPLETED|Year 2 (12-Month Extension)||0||
59848630|NCT00112437|75973214|FG002|NOT COMPLETED|Year 2 (12-Month Extension)||0||
59848631|NCT00112437|75973215|FG003|NOT COMPLETED|Year 2 (12-Month Extension)||0||
59848632|NCT00112437|75973216|FG004|NOT COMPLETED|Year 2 (12-Month Extension)||0||
59848633|NCT00112437|75973217|FG005|NOT COMPLETED|Year 2 (12-Month Extension)||3||
59848634|NCT00112437|75973218|FG006|NOT COMPLETED|Year 2 (12-Month Extension)||9||
59848635|NCT00112437|75973219|FG007|NOT COMPLETED|Year 2 (12-Month Extension)||8||
59848636|NCT00112437|75973220|FG008|NOT COMPLETED|Year 2 (12-Month Extension)||7||
59848637|NCT00112437|75973221|FG009|NOT COMPLETED|Year 2 (12-Month Extension)||13||
59848638|NCT00112437|75973222|FG010|NOT COMPLETED|Year 2 (12-Month Extension)||0||
59848639|NCT00112437|75973223|FG011|NOT COMPLETED|Year 2 (12-Month Extension)||0||
59848640|NCT00112437|75973224|FG012|NOT COMPLETED|Year 2 (12-Month Extension)||0||
59848641|NCT00112437|75973225|FG013|NOT COMPLETED|Year 2 (12-Month Extension)||0||
59848642|NCT00112437|75973226|FG014|NOT COMPLETED|Year 2 (12-Month Extension)||0||
59720146|NCT01107444|75839258|FG001|NOT COMPLETED|Overall Study||13||
59720147|NCT00876187|75839272|FG000|STARTED|Overall Study||233||
59720148|NCT00876187|75839273|FG001|STARTED|Overall Study||233||
59720149|NCT00876187|75839274|FG002|STARTED|Overall Study||298||
59720150|NCT00876187|75839275|FG003|STARTED|Overall Study||297||
59848643|NCT00112437|75973227|FG015|NOT COMPLETED|Year 2 (12-Month Extension)||0||
59848644|NCT00112437|75973228|FG016|NOT COMPLETED|Year 2 (12-Month Extension)||0||
59720151|NCT00876187|75839276|FG004|STARTED|Overall Study||298||
59720152|NCT00876187|75839272|FG000|Treated|Overall Study||230||
59848645|NCT00112437|75973229|FG017|NOT COMPLETED|Year 2 (12-Month Extension)||0||
59848646|NCT00112437|75973230|FG018|NOT COMPLETED|Year 2 (12-Month Extension)||0||
59720153|NCT00876187|75839273|FG001|Treated|Overall Study||232||
59720154|NCT00876187|75839274|FG002|Treated|Overall Study||295||
59720155|NCT00876187|75839275|FG003|Treated|Overall Study||295||
59848647|NCT00112437|75973231|FG019|NOT COMPLETED|Year 2 (12-Month Extension)||0||
59848648|NCT00112437|75973232|FG020|NOT COMPLETED|Year 2 (12-Month Extension)||0||
59848649|NCT00112437|75973233|FG021|NOT COMPLETED|Year 2 (12-Month Extension)||0||
59848650|NCT00112437|75973234|FG022|NOT COMPLETED|Year 2 (12-Month Extension)||0||
59848651|NCT00112437|75973235|FG023|NOT COMPLETED|Year 2 (12-Month Extension)||0||
59848652|NCT00112437|75973236|FG024|NOT COMPLETED|Year 2 (12-Month Extension)||0||
59848653|NCT00112437|75973237|FG025|NOT COMPLETED|Year 2 (12-Month Extension)||0||
59848654|NCT00112437|75973212|FG000|STARTED|Year 3 (12-Month Extension)||0||
59720156|NCT00876187|75839276|FG004|Treated|Overall Study||295||
59720157|NCT00876187|75839272|FG000|Completed Treatment|Overall Study|Participants who completed treatment at Week 16 visit.|128||
59720158|NCT00876187|75839273|FG001|Completed Treatment|Overall Study|Participants who completed treatment at Week 16 visit.|146||
59720159|NCT00876187|75839274|FG002|Completed Treatment|Overall Study|Participants who completed treatment at Week 16 visit.|193||
59720160|NCT00876187|75839275|FG003|Completed Treatment|Overall Study|Participants who completed treatment at Week 16 visit.|188||
59720161|NCT00876187|75839276|FG004|Completed Treatment|Overall Study|Participants who completed treatment at Week 16 visit.|185||
59720162|NCT00876187|75839272|FG000|COMPLETED|Overall Study||23||
59720163|NCT00876187|75839273|FG001|COMPLETED|Overall Study||18||
59720164|NCT00876187|75839274|FG002|COMPLETED|Overall Study||19||
59720165|NCT00876187|75839275|FG003|COMPLETED|Overall Study||22||
59720166|NCT00876187|75839276|FG004|COMPLETED|Overall Study||27||
59720167|NCT00876187|75839272|FG000|NOT COMPLETED|Overall Study||210||
59720168|NCT00876187|75839273|FG001|NOT COMPLETED|Overall Study||215||
59720169|NCT00876187|75839274|FG002|NOT COMPLETED|Overall Study||279||
59720170|NCT00876187|75839275|FG003|NOT COMPLETED|Overall Study||275||
59720171|NCT00876187|75839276|FG004|NOT COMPLETED|Overall Study||271||
59720172|NCT01102374|75839293|FG000|STARTED|Overall Study||55||
59720173|NCT01102374|75839294|FG001|STARTED|Overall Study||52||
59720174|NCT01102374|75839293|FG000|COMPLETED|Overall Study||39||
59720175|NCT01102374|75839294|FG001|COMPLETED|Overall Study||33||
59720176|NCT01102374|75839293|FG000|NOT COMPLETED|Overall Study||16||
59720177|NCT01102374|75839294|FG001|NOT COMPLETED|Overall Study||19||
59720178|NCT01106976|75839300|FG000|STARTED|Overall Study||67||
59720179|NCT01106976|75839300|FG000|COMPLETED|Overall Study||59||
59720180|NCT01106976|75839300|FG000|NOT COMPLETED|Overall Study||8||
59720181|NCT00875485|75839306|FG000|STARTED|Year 11||99||
59720182|NCT00875485|75839307|FG001|STARTED|Year 11||111||
59720183|NCT00875485|75839306|FG000|COMPLETED|Year 11||99||
59720184|NCT00875485|75839307|FG001|COMPLETED|Year 11||111||
59720185|NCT00875485|75839306|FG000|NOT COMPLETED|Year 11||0||
59720186|NCT00875485|75839307|FG001|NOT COMPLETED|Year 11||0||
59720187|NCT00875485|75839306|FG000|STARTED|Year 12||101||
59720188|NCT00875485|75839307|FG001|STARTED|Year 12||109||
59720189|NCT00875485|75839306|FG000|COMPLETED|Year 12||101||
59720190|NCT00875485|75839307|FG001|COMPLETED|Year 12||109||
59720191|NCT00875485|75839306|FG000|NOT COMPLETED|Year 12||0||
59720192|NCT00875485|75839307|FG001|NOT COMPLETED|Year 12||0||
59720193|NCT00875485|75839306|FG000|STARTED|Year 13||102||
59720194|NCT00875485|75839307|FG001|STARTED|Year 13||113||
59848655|NCT00112437|75973213|FG001|STARTED|Year 3 (12-Month Extension)||0||
59720195|NCT00875485|75839306|FG000|COMPLETED|Year 13||102||
59720196|NCT00875485|75839307|FG001|COMPLETED|Year 13||113||
59720197|NCT00875485|75839306|FG000|NOT COMPLETED|Year 13||0||
59720198|NCT00875485|75839307|FG001|NOT COMPLETED|Year 13||0||
59720199|NCT00875485|75839306|FG000|STARTED|Year 14||100||
59720200|NCT00875485|75839307|FG001|STARTED|Year 14||113||
59720201|NCT00875485|75839306|FG000|COMPLETED|Year 14||100||
59720202|NCT00875485|75839307|FG001|COMPLETED|Year 14||113||
59720203|NCT00875485|75839306|FG000|NOT COMPLETED|Year 14||0||
59720204|NCT00875485|75839307|FG001|NOT COMPLETED|Year 14||0||
59720205|NCT00875485|75839306|FG000|STARTED|Year 15||98||
59720206|NCT00875485|75839307|FG001|STARTED|Year 15||111||
59848656|NCT00112437|75973214|FG002|STARTED|Year 3 (12-Month Extension)||0||
59848657|NCT00112437|75973215|FG003|STARTED|Year 3 (12-Month Extension)||0||
59848658|NCT00112437|75973216|FG004|STARTED|Year 3 (12-Month Extension)||0||
59848659|NCT00112437|75973217|FG005|STARTED|Year 3 (12-Month Extension)||0||
59848660|NCT00112437|75973218|FG006|STARTED|Year 3 (12-Month Extension)||0||
59848661|NCT00112437|75973219|FG007|STARTED|Year 3 (12-Month Extension)||0||
59848662|NCT00112437|75973220|FG008|STARTED|Year 3 (12-Month Extension)||0||
59848663|NCT00112437|75973221|FG009|STARTED|Year 3 (12-Month Extension)||0||
59848664|NCT00112437|75973222|FG010|STARTED|Year 3 (12-Month Extension)||19||
59848665|NCT00112437|75973223|FG011|STARTED|Year 3 (12-Month Extension)||22||
59848666|NCT00112437|75973224|FG012|STARTED|Year 3 (12-Month Extension)||18||
59848667|NCT00112437|75973225|FG013|STARTED|Year 3 (12-Month Extension)||17||
59848668|NCT00112437|75973226|FG014|STARTED|Year 3 (12-Month Extension)||18||
59848669|NCT00112437|75973227|FG015|STARTED|Year 3 (12-Month Extension)||17||
59848670|NCT00112437|75973228|FG016|STARTED|Year 3 (12-Month Extension)||19||
59848671|NCT00112437|75973229|FG017|STARTED|Year 3 (12-Month Extension)||21||
59848672|NCT00112437|75973230|FG018|STARTED|Year 3 (12-Month Extension)||18||
59848673|NCT00112437|75973231|FG019|STARTED|Year 3 (12-Month Extension)||20||
59848674|NCT00112437|75973232|FG020|STARTED|Year 3 (12-Month Extension)||0||
59848675|NCT00112437|75973233|FG021|STARTED|Year 3 (12-Month Extension)||0||
59848676|NCT00112437|75973234|FG022|STARTED|Year 3 (12-Month Extension)||0||
59848677|NCT00112437|75973235|FG023|STARTED|Year 3 (12-Month Extension)||0||
59848678|NCT00112437|75973236|FG024|STARTED|Year 3 (12-Month Extension)||0||
59848679|NCT00112437|75973237|FG025|STARTED|Year 3 (12-Month Extension)||0||
59848680|NCT00112437|75973212|FG000|COMPLETED|Year 3 (12-Month Extension)||0||
59848681|NCT00112437|75973213|FG001|COMPLETED|Year 3 (12-Month Extension)||0||
59848682|NCT00112437|75973214|FG002|COMPLETED|Year 3 (12-Month Extension)||0||
59848683|NCT00112437|75973215|FG003|COMPLETED|Year 3 (12-Month Extension)||0||
59848684|NCT00112437|75973216|FG004|COMPLETED|Year 3 (12-Month Extension)||0||
59848685|NCT00112437|75973217|FG005|COMPLETED|Year 3 (12-Month Extension)||0||
59848686|NCT00112437|75973218|FG006|COMPLETED|Year 3 (12-Month Extension)||0||
59848687|NCT00112437|75973219|FG007|COMPLETED|Year 3 (12-Month Extension)||0||
59848688|NCT00112437|75973220|FG008|COMPLETED|Year 3 (12-Month Extension)||0||
59848689|NCT00112437|75973221|FG009|COMPLETED|Year 3 (12-Month Extension)||0||
59848690|NCT00112437|75973222|FG010|COMPLETED|Year 3 (12-Month Extension)||17||
59848691|NCT00112437|75973223|FG011|COMPLETED|Year 3 (12-Month Extension)||17||
59848692|NCT00112437|75973224|FG012|COMPLETED|Year 3 (12-Month Extension)||18||
59848693|NCT00112437|75973225|FG013|COMPLETED|Year 3 (12-Month Extension)||16||
59848694|NCT00112437|75973226|FG014|COMPLETED|Year 3 (12-Month Extension)||17||
59848695|NCT00112437|75973227|FG015|COMPLETED|Year 3 (12-Month Extension)||13||
59848696|NCT00112437|75973228|FG016|COMPLETED|Year 3 (12-Month Extension)||16||
59848697|NCT00112437|75973229|FG017|COMPLETED|Year 3 (12-Month Extension)||20||
59848698|NCT00112437|75973230|FG018|COMPLETED|Year 3 (12-Month Extension)||16||
59848699|NCT00112437|75973231|FG019|COMPLETED|Year 3 (12-Month Extension)||19||
59848700|NCT00112437|75973232|FG020|COMPLETED|Year 3 (12-Month Extension)||0||
59848701|NCT00112437|75973233|FG021|COMPLETED|Year 3 (12-Month Extension)||0||
59848702|NCT00112437|75973234|FG022|COMPLETED|Year 3 (12-Month Extension)||0||
59848703|NCT00112437|75973235|FG023|COMPLETED|Year 3 (12-Month Extension)||0||
59848704|NCT00112437|75973236|FG024|COMPLETED|Year 3 (12-Month Extension)||0||
59848705|NCT00112437|75973237|FG025|COMPLETED|Year 3 (12-Month Extension)||0||
59848706|NCT00112437|75973212|FG000|NOT COMPLETED|Year 3 (12-Month Extension)||0||
59848707|NCT00112437|75973213|FG001|NOT COMPLETED|Year 3 (12-Month Extension)||0||
59848708|NCT00112437|75973214|FG002|NOT COMPLETED|Year 3 (12-Month Extension)||0||
59848709|NCT00112437|75973215|FG003|NOT COMPLETED|Year 3 (12-Month Extension)||0||
59848710|NCT00112437|75973216|FG004|NOT COMPLETED|Year 3 (12-Month Extension)||0||
59848711|NCT00112437|75973217|FG005|NOT COMPLETED|Year 3 (12-Month Extension)||0||
59848712|NCT00112437|75973218|FG006|NOT COMPLETED|Year 3 (12-Month Extension)||0||
59848713|NCT00112437|75973219|FG007|NOT COMPLETED|Year 3 (12-Month Extension)||0||
59848714|NCT00112437|75973220|FG008|NOT COMPLETED|Year 3 (12-Month Extension)||0||
59848715|NCT00112437|75973221|FG009|NOT COMPLETED|Year 3 (12-Month Extension)||0||
59720207|NCT00875485|75839306|FG000|COMPLETED|Year 15||98||
59720208|NCT00875485|75839307|FG001|COMPLETED|Year 15||111||
59720209|NCT00875485|75839306|FG000|NOT COMPLETED|Year 15||0||
59720210|NCT00875485|75839307|FG001|NOT COMPLETED|Year 15||0||
59720211|NCT00875485|75839306|FG000|STARTED|Challenge Dose Epoch||8||
59720212|NCT00875485|75839307|FG001|STARTED|Challenge Dose Epoch||11||
59720213|NCT00875485|75839306|FG000|COMPLETED|Challenge Dose Epoch||7||
59848716|NCT00112437|75973222|FG010|NOT COMPLETED|Year 3 (12-Month Extension)||2||
59848717|NCT00112437|75973223|FG011|NOT COMPLETED|Year 3 (12-Month Extension)||5||
59848718|NCT00112437|75973224|FG012|NOT COMPLETED|Year 3 (12-Month Extension)||0||
59720214|NCT00875485|75839307|FG001|COMPLETED|Challenge Dose Epoch||11||
59720215|NCT00875485|75839306|FG000|NOT COMPLETED|Challenge Dose Epoch||1||
59720216|NCT00875485|75839307|FG001|NOT COMPLETED|Challenge Dose Epoch||0||
59720217|NCT04547140|75839315|FG000|STARTED|Overall Study||29||
59720218|NCT04547140|75839316|FG001|STARTED|Overall Study||28||
59848719|NCT00112437|75973225|FG013|NOT COMPLETED|Year 3 (12-Month Extension)||1||
60120560|NCT01692119|76241742|FG000|STARTED|Overall Study||130||
59848720|NCT00112437|75973226|FG014|NOT COMPLETED|Year 3 (12-Month Extension)||1||
59848721|NCT00112437|75973227|FG015|NOT COMPLETED|Year 3 (12-Month Extension)||4||
59848722|NCT00112437|75973228|FG016|NOT COMPLETED|Year 3 (12-Month Extension)||3||
59848723|NCT00112437|75973229|FG017|NOT COMPLETED|Year 3 (12-Month Extension)||1||
59848724|NCT00112437|75973230|FG018|NOT COMPLETED|Year 3 (12-Month Extension)||2||
59848725|NCT00112437|75973231|FG019|NOT COMPLETED|Year 3 (12-Month Extension)||1||
59848726|NCT00112437|75973232|FG020|NOT COMPLETED|Year 3 (12-Month Extension)||0||
59848727|NCT00112437|75973233|FG021|NOT COMPLETED|Year 3 (12-Month Extension)||0||
59848728|NCT00112437|75973234|FG022|NOT COMPLETED|Year 3 (12-Month Extension)||0||
59848729|NCT00112437|75973235|FG023|NOT COMPLETED|Year 3 (12-Month Extension)||0||
59848730|NCT00112437|75973236|FG024|NOT COMPLETED|Year 3 (12-Month Extension)||0||
59848731|NCT00112437|75973237|FG025|NOT COMPLETED|Year 3 (12-Month Extension)||0||
59848732|NCT00112437|75973212|FG000|STARTED|Years 4-5 (24-Month Extension)||0||
59848733|NCT00112437|75973213|FG001|STARTED|Years 4-5 (24-Month Extension)||0||
59848734|NCT00112437|75973214|FG002|STARTED|Years 4-5 (24-Month Extension)||0||
59848735|NCT00112437|75973215|FG003|STARTED|Years 4-5 (24-Month Extension)||0||
59848736|NCT00112437|75973216|FG004|STARTED|Years 4-5 (24-Month Extension)||0||
59848737|NCT00112437|75973217|FG005|STARTED|Years 4-5 (24-Month Extension)||0||
59848738|NCT00112437|75973218|FG006|STARTED|Years 4-5 (24-Month Extension)||0||
59848739|NCT00112437|75973219|FG007|STARTED|Years 4-5 (24-Month Extension)||0||
59848740|NCT00112437|75973220|FG008|STARTED|Years 4-5 (24-Month Extension)||0||
59848741|NCT00112437|75973221|FG009|STARTED|Years 4-5 (24-Month Extension)||0||
59848742|NCT00112437|75973222|FG010|STARTED|Years 4-5 (24-Month Extension)||0||
59848743|NCT00112437|75973223|FG011|STARTED|Years 4-5 (24-Month Extension)||0||
59848744|NCT00112437|75973224|FG012|STARTED|Years 4-5 (24-Month Extension)||0||
59848745|NCT00112437|75973225|FG013|STARTED|Years 4-5 (24-Month Extension)||0||
59848746|NCT00112437|75973226|FG014|STARTED|Years 4-5 (24-Month Extension)||0||
59848747|NCT00112437|75973227|FG015|STARTED|Years 4-5 (24-Month Extension)||0||
59848748|NCT00112437|75973228|FG016|STARTED|Years 4-5 (24-Month Extension)||0||
59848749|NCT00112437|75973229|FG017|STARTED|Years 4-5 (24-Month Extension)||0||
59848750|NCT00112437|75973230|FG018|STARTED|Years 4-5 (24-Month Extension)||0||
59848751|NCT00112437|75973231|FG019|STARTED|Years 4-5 (24-Month Extension)||0||
59848752|NCT00112437|75973232|FG020|STARTED|Years 4-5 (24-Month Extension)||41||
59848753|NCT00112437|75973233|FG021|STARTED|Years 4-5 (24-Month Extension)||100||
59848754|NCT00112437|75973234|FG022|STARTED|Years 4-5 (24-Month Extension)||0||
59848755|NCT00112437|75973235|FG023|STARTED|Years 4-5 (24-Month Extension)||0||
59848756|NCT00112437|75973236|FG024|STARTED|Years 4-5 (24-Month Extension)||0||
59848757|NCT00112437|75973237|FG025|STARTED|Years 4-5 (24-Month Extension)||0||
59848758|NCT00112437|75973212|FG000|COMPLETED|Years 4-5 (24-Month Extension)||0||
59848759|NCT00112437|75973213|FG001|COMPLETED|Years 4-5 (24-Month Extension)||0||
59848760|NCT00112437|75973214|FG002|COMPLETED|Years 4-5 (24-Month Extension)||0||
59848761|NCT00112437|75973215|FG003|COMPLETED|Years 4-5 (24-Month Extension)||0||
60120561|NCT01692119|76241743|FG001|STARTED|Overall Study||128||
60120562|NCT01692119|76241742|FG000|COMPLETED|Overall Study||110||
60120563|NCT01692119|76241743|FG001|COMPLETED|Overall Study||127||
59568046|NCT02318901|75670987|FG001|NOT COMPLETED|Overall Study||1||
59720219|NCT04547140|75839315|FG000|Safety Population|Overall Study||27|Safety population included all participants who received at least any amount of liquid Alpha1-PI (Human) plus SMT or placebo plus SMT.|
60120564|NCT01692119|76241742|FG000|NOT COMPLETED|Overall Study||20||
60120565|NCT01692119|76241743|FG001|NOT COMPLETED|Overall Study||1||
60120566|NCT01691885|76241749|FG000|STARTED|Treatment Period 1(7-14 Days)||22||
60120567|NCT01691885|76241750|FG001|STARTED|Treatment Period 1(7-14 Days)||23||
60120568|NCT01691885|76241749|FG000|COMPLETED|Treatment Period 1(7-14 Days)||21||
60120569|NCT01691885|76241750|FG001|COMPLETED|Treatment Period 1(7-14 Days)||22||
60120570|NCT01691885|76241749|FG000|NOT COMPLETED|Treatment Period 1(7-14 Days)||1||
59720220|NCT04547140|75839316|FG001|Safety Population|Overall Study||27|Safety population included all participants who received at least any amount of liquid Alpha1-PI (Human) plus SMT or placebo plus SMT.|
59720221|NCT04547140|75839315|FG000|COMPLETED|Overall Study||19||
59720222|NCT04547140|75839316|FG001|COMPLETED|Overall Study||22||
59720223|NCT04547140|75839315|FG000|NOT COMPLETED|Overall Study||10||
59720224|NCT04547140|75839316|FG001|NOT COMPLETED|Overall Study||6||
59720225|NCT01098474|75839328|FG000|STARTED|Active Phase||50||
59720226|NCT01098474|75839329|FG001|STARTED|Active Phase||50||
59720227|NCT01098474|75839330|FG002|STARTED|Active Phase||50||
59848762|NCT00112437|75973216|FG004|COMPLETED|Years 4-5 (24-Month Extension)||0||
59848763|NCT00112437|75973217|FG005|COMPLETED|Years 4-5 (24-Month Extension)||0||
59848764|NCT00112437|75973218|FG006|COMPLETED|Years 4-5 (24-Month Extension)||0||
59848765|NCT00112437|75973219|FG007|COMPLETED|Years 4-5 (24-Month Extension)||0||
59848766|NCT00112437|75973220|FG008|COMPLETED|Years 4-5 (24-Month Extension)||0||
59848767|NCT00112437|75973221|FG009|COMPLETED|Years 4-5 (24-Month Extension)||0||
59848768|NCT00112437|75973222|FG010|COMPLETED|Years 4-5 (24-Month Extension)||0||
59848769|NCT00112437|75973223|FG011|COMPLETED|Years 4-5 (24-Month Extension)||0||
59848770|NCT00112437|75973224|FG012|COMPLETED|Years 4-5 (24-Month Extension)||0||
59848771|NCT00112437|75973225|FG013|COMPLETED|Years 4-5 (24-Month Extension)||0||
59848772|NCT00112437|75973226|FG014|COMPLETED|Years 4-5 (24-Month Extension)||0||
59848773|NCT00112437|75973227|FG015|COMPLETED|Years 4-5 (24-Month Extension)||0||
59848774|NCT00112437|75973228|FG016|COMPLETED|Years 4-5 (24-Month Extension)||0||
59848775|NCT00112437|75973229|FG017|COMPLETED|Years 4-5 (24-Month Extension)||0||
59848776|NCT00112437|75973230|FG018|COMPLETED|Years 4-5 (24-Month Extension)||0||
59848777|NCT00112437|75973231|FG019|COMPLETED|Years 4-5 (24-Month Extension)||0||
59848778|NCT00112437|75973232|FG020|COMPLETED|Years 4-5 (24-Month Extension)||37||
59848779|NCT00112437|75973233|FG021|COMPLETED|Years 4-5 (24-Month Extension)||92||
59848780|NCT00112437|75973234|FG022|COMPLETED|Years 4-5 (24-Month Extension)||0||
59848781|NCT00112437|75973235|FG023|COMPLETED|Years 4-5 (24-Month Extension)||0||
59848782|NCT00112437|75973236|FG024|COMPLETED|Years 4-5 (24-Month Extension)||0||
59848783|NCT00112437|75973237|FG025|COMPLETED|Years 4-5 (24-Month Extension)||0||
59568047|NCT02318901|75670988|FG002|NOT COMPLETED|Overall Study||10||
59568048|NCT01904864|75670998|FG000|STARTED|Overall Study||40||
59720228|NCT01098474|75839331|FG003|STARTED|Active Phase||49||
59720229|NCT01098474|75839332|FG004|STARTED|Active Phase||52||
59720230|NCT01098474|75839333|FG005|STARTED|Active Phase||49||
59720231|NCT01098474|75839328|FG000|COMPLETED|Active Phase||48||
59720232|NCT01098474|75839329|FG001|COMPLETED|Active Phase||49||
59720233|NCT01098474|75839330|FG002|COMPLETED|Active Phase||45||
59720234|NCT01098474|75839331|FG003|COMPLETED|Active Phase||49||
59720235|NCT01098474|75839332|FG004|COMPLETED|Active Phase||52||
59720236|NCT01098474|75839333|FG005|COMPLETED|Active Phase||49||
59720237|NCT01098474|75839328|FG000|NOT COMPLETED|Active Phase||2||
59720238|NCT01098474|75839329|FG001|NOT COMPLETED|Active Phase||1||
59720239|NCT01098474|75839330|FG002|NOT COMPLETED|Active Phase||5||
59720240|NCT01098474|75839331|FG003|NOT COMPLETED|Active Phase||0||
59720241|NCT01098474|75839332|FG004|NOT COMPLETED|Active Phase||0||
59720242|NCT01098474|75839333|FG005|NOT COMPLETED|Active Phase||0||
59720243|NCT01098474|75839328|FG000|STARTED|Follow Up Phase||48||
59720244|NCT01098474|75839329|FG001|STARTED|Follow Up Phase||49||
59720245|NCT01098474|75839330|FG002|STARTED|Follow Up Phase||45||
59720246|NCT01098474|75839331|FG003|STARTED|Follow Up Phase||49||
59848784|NCT00112437|75973212|FG000|NOT COMPLETED|Years 4-5 (24-Month Extension)||0||
59848785|NCT00112437|75973213|FG001|NOT COMPLETED|Years 4-5 (24-Month Extension)||0||
59848786|NCT00112437|75973214|FG002|NOT COMPLETED|Years 4-5 (24-Month Extension)||0||
59848787|NCT00112437|75973215|FG003|NOT COMPLETED|Years 4-5 (24-Month Extension)||0||
59848788|NCT00112437|75973216|FG004|NOT COMPLETED|Years 4-5 (24-Month Extension)||0||
59848789|NCT00112437|75973217|FG005|NOT COMPLETED|Years 4-5 (24-Month Extension)||0||
59848790|NCT00112437|75973218|FG006|NOT COMPLETED|Years 4-5 (24-Month Extension)||0||
59848791|NCT00112437|75973219|FG007|NOT COMPLETED|Years 4-5 (24-Month Extension)||0||
59848792|NCT00112437|75973220|FG008|NOT COMPLETED|Years 4-5 (24-Month Extension)||0||
59848793|NCT00112437|75973221|FG009|NOT COMPLETED|Years 4-5 (24-Month Extension)||0||
59848794|NCT00112437|75973222|FG010|NOT COMPLETED|Years 4-5 (24-Month Extension)||0||
59848795|NCT00112437|75973223|FG011|NOT COMPLETED|Years 4-5 (24-Month Extension)||0||
59568049|NCT01904864|75670999|FG001|STARTED|Overall Study||40||
59568050|NCT01904864|75670998|FG000|COMPLETED|Overall Study||31||
59568051|NCT01904864|75670999|FG001|COMPLETED|Overall Study||28||
59568052|NCT01904864|75670998|FG000|NOT COMPLETED|Overall Study||9||
59568053|NCT01904864|75670999|FG001|NOT COMPLETED|Overall Study||12||
59568054|NCT01016847|75671007|FG000|STARTED|Overall Study||1||
59568055|NCT01016847|75671008|FG001|STARTED|Overall Study||2||
59568056|NCT01016847|75671007|FG000|COMPLETED|Overall Study||1||
59568057|NCT01016847|75671008|FG001|COMPLETED|Overall Study||2||
59568058|NCT01016847|75671007|FG000|NOT COMPLETED|Overall Study||0||
59568059|NCT01016847|75671008|FG001|NOT COMPLETED|Overall Study||0||
59568060|NCT00989937|75671014|FG000|STARTED|Overall Study||0||
59568061|NCT00989937|75671014|FG000|COMPLETED|Overall Study||0||
59568062|NCT00989937|75671014|FG000|NOT COMPLETED|Overall Study||0||
59568063|NCT00982995|75671018|FG000|STARTED|Overall Study||3||
59568064|NCT00982995|75671018|FG000|COMPLETED|Overall Study||3||
59568065|NCT00982995|75671018|FG000|NOT COMPLETED|Overall Study||0||
59568066|NCT01905254|75671022|FG000|STARTED|Overall Study||34||
59720247|NCT01098474|75839332|FG004|STARTED|Follow Up Phase||52||
59720248|NCT01098474|75839333|FG005|STARTED|Follow Up Phase||49||
59720249|NCT01098474|75839328|FG000|COMPLETED|Follow Up Phase||48||
59720250|NCT01098474|75839329|FG001|COMPLETED|Follow Up Phase||49||
59720251|NCT01098474|75839330|FG002|COMPLETED|Follow Up Phase||45||
59720252|NCT01098474|75839331|FG003|COMPLETED|Follow Up Phase||47||
59720253|NCT01098474|75839332|FG004|COMPLETED|Follow Up Phase||50||
59720254|NCT01098474|75839333|FG005|COMPLETED|Follow Up Phase||44||
59848796|NCT00112437|75973224|FG012|NOT COMPLETED|Years 4-5 (24-Month Extension)||0||
59848797|NCT00112437|75973225|FG013|NOT COMPLETED|Years 4-5 (24-Month Extension)||0||
59848798|NCT00112437|75973226|FG014|NOT COMPLETED|Years 4-5 (24-Month Extension)||0||
59848799|NCT00112437|75973227|FG015|NOT COMPLETED|Years 4-5 (24-Month Extension)||0||
59848800|NCT00112437|75973228|FG016|NOT COMPLETED|Years 4-5 (24-Month Extension)||0||
59848801|NCT00112437|75973229|FG017|NOT COMPLETED|Years 4-5 (24-Month Extension)||0||
59848802|NCT00112437|75973230|FG018|NOT COMPLETED|Years 4-5 (24-Month Extension)||0||
59848803|NCT00112437|75973231|FG019|NOT COMPLETED|Years 4-5 (24-Month Extension)||0||
59848804|NCT00112437|75973232|FG020|NOT COMPLETED|Years 4-5 (24-Month Extension)||4||
59848805|NCT00112437|75973233|FG021|NOT COMPLETED|Years 4-5 (24-Month Extension)||8||
59848806|NCT00112437|75973234|FG022|NOT COMPLETED|Years 4-5 (24-Month Extension)||0||
59848807|NCT00112437|75973235|FG023|NOT COMPLETED|Years 4-5 (24-Month Extension)||0||
59848808|NCT00112437|75973236|FG024|NOT COMPLETED|Years 4-5 (24-Month Extension)||0||
59848809|NCT00112437|75973237|FG025|NOT COMPLETED|Years 4-5 (24-Month Extension)||0||
59848810|NCT00112437|75973212|FG000|STARTED|Years 6-10 (60-Month Extension)||0||
59848811|NCT00112437|75973213|FG001|STARTED|Years 6-10 (60-Month Extension)||0||
59848812|NCT00112437|75973214|FG002|STARTED|Years 6-10 (60-Month Extension)||0||
59848813|NCT00112437|75973215|FG003|STARTED|Years 6-10 (60-Month Extension)||0||
59848814|NCT00112437|75973216|FG004|STARTED|Years 6-10 (60-Month Extension)||0||
59848815|NCT00112437|75973217|FG005|STARTED|Years 6-10 (60-Month Extension)||0||
59848816|NCT00112437|75973218|FG006|STARTED|Years 6-10 (60-Month Extension)||0||
59848817|NCT00112437|75973219|FG007|STARTED|Years 6-10 (60-Month Extension)||0||
59848818|NCT00112437|75973220|FG008|STARTED|Years 6-10 (60-Month Extension)||0||
59848819|NCT00112437|75973221|FG009|STARTED|Years 6-10 (60-Month Extension)||0||
59848820|NCT00112437|75973222|FG010|STARTED|Years 6-10 (60-Month Extension)||0||
59848821|NCT00112437|75973223|FG011|STARTED|Years 6-10 (60-Month Extension)||0||
59848822|NCT00112437|75973224|FG012|STARTED|Years 6-10 (60-Month Extension)||0||
59848823|NCT00112437|75973225|FG013|STARTED|Years 6-10 (60-Month Extension)||0||
59848824|NCT00112437|75973226|FG014|STARTED|Years 6-10 (60-Month Extension)||0||
59848825|NCT00112437|75973227|FG015|STARTED|Years 6-10 (60-Month Extension)||0||
59848826|NCT00112437|75973228|FG016|STARTED|Years 6-10 (60-Month Extension)||0||
59848827|NCT00112437|75973229|FG017|STARTED|Years 6-10 (60-Month Extension)||0||
59848828|NCT00112437|75973230|FG018|STARTED|Years 6-10 (60-Month Extension)||0||
59848829|NCT00112437|75973231|FG019|STARTED|Years 6-10 (60-Month Extension)||0||
59848830|NCT00112437|75973232|FG020|STARTED|Years 6-10 (60-Month Extension)||0||
59848831|NCT00112437|75973233|FG021|STARTED|Years 6-10 (60-Month Extension)||0||
59848832|NCT00112437|75973234|FG022|STARTED|Years 6-10 (60-Month Extension)||28||
59848833|NCT00112437|75973235|FG023|STARTED|Years 6-10 (60-Month Extension)||34||
59848834|NCT00112437|75973236|FG024|STARTED|Years 6-10 (60-Month Extension)||23||
59848835|NCT00112437|75973237|FG025|STARTED|Years 6-10 (60-Month Extension)||32||
59848836|NCT00112437|75973212|FG000|COMPLETED|Years 6-10 (60-Month Extension)||0||
59720255|NCT01098474|75839328|FG000|NOT COMPLETED|Follow Up Phase||0||
59720256|NCT01098474|75839329|FG001|NOT COMPLETED|Follow Up Phase||0||
59720257|NCT01098474|75839330|FG002|NOT COMPLETED|Follow Up Phase||0||
59720258|NCT01098474|75839331|FG003|NOT COMPLETED|Follow Up Phase||2||
59720259|NCT01098474|75839332|FG004|NOT COMPLETED|Follow Up Phase||2||
59720260|NCT01098474|75839333|FG005|NOT COMPLETED|Follow Up Phase||5||
59720261|NCT00876733|75839361|FG000|STARTED|Overall Study||288||
59720262|NCT00876733|75839362|FG001|STARTED|Overall Study||203||
59720263|NCT00876733|75839363|FG002|STARTED|Overall Study||93||
59720264|NCT00876733|75839364|FG003|STARTED|Overall Study||21||
59720265|NCT00876733|75839361|FG000|COMPLETED|Overall Study||197||
59720266|NCT00876733|75839362|FG001|COMPLETED|Overall Study||161||
59720267|NCT00876733|75839363|FG002|COMPLETED|Overall Study||63||
59720268|NCT00876733|75839364|FG003|COMPLETED|Overall Study||14||
59720269|NCT00876733|75839361|FG000|NOT COMPLETED|Overall Study||91||
59720270|NCT00876733|75839362|FG001|NOT COMPLETED|Overall Study||42||
59848837|NCT00112437|75973213|FG001|COMPLETED|Years 6-10 (60-Month Extension)||0||
59848838|NCT00112437|75973214|FG002|COMPLETED|Years 6-10 (60-Month Extension)||0||
59848839|NCT00112437|75973215|FG003|COMPLETED|Years 6-10 (60-Month Extension)||0||
59720271|NCT00876733|75839363|FG002|NOT COMPLETED|Overall Study||30||
59720272|NCT00876733|75839364|FG003|NOT COMPLETED|Overall Study||7||
59720273|NCT04425538|75839374|FG000|STARTED|Overall Study||17||
59720274|NCT04425538|75839374|FG000|COMPLETED|Overall Study||17||
59720275|NCT04425538|75839374|FG000|NOT COMPLETED|Overall Study||0||
59720276|NCT00875017|75839384|FG000|STARTED|First Intervention||5||
59720277|NCT00875017|75839385|FG001|STARTED|First Intervention||5||
59720278|NCT00875017|75839386|FG002|STARTED|First Intervention||5||
59720279|NCT00875017|75839387|FG003|STARTED|First Intervention||6||
59720280|NCT00875017|75839388|FG004|STARTED|First Intervention||5||
59720281|NCT00875017|75839389|FG005|STARTED|First Intervention||5||
59848840|NCT00112437|75973216|FG004|COMPLETED|Years 6-10 (60-Month Extension)||0||
59848841|NCT00112437|75973217|FG005|COMPLETED|Years 6-10 (60-Month Extension)||0||
59848842|NCT00112437|75973218|FG006|COMPLETED|Years 6-10 (60-Month Extension)||0||
59848843|NCT00112437|75973219|FG007|COMPLETED|Years 6-10 (60-Month Extension)||0||
59848844|NCT00112437|75973220|FG008|COMPLETED|Years 6-10 (60-Month Extension)||0||
59848845|NCT00112437|75973221|FG009|COMPLETED|Years 6-10 (60-Month Extension)||0||
59848846|NCT00112437|75973222|FG010|COMPLETED|Years 6-10 (60-Month Extension)||0||
59848847|NCT00112437|75973223|FG011|COMPLETED|Years 6-10 (60-Month Extension)||0||
59848848|NCT00112437|75973224|FG012|COMPLETED|Years 6-10 (60-Month Extension)||0||
59848849|NCT00112437|75973225|FG013|COMPLETED|Years 6-10 (60-Month Extension)||0||
59848850|NCT00112437|75973226|FG014|COMPLETED|Years 6-10 (60-Month Extension)||0||
59848851|NCT00112437|75973227|FG015|COMPLETED|Years 6-10 (60-Month Extension)||0||
59848852|NCT00112437|75973228|FG016|COMPLETED|Years 6-10 (60-Month Extension)||0||
59848853|NCT00112437|75973229|FG017|COMPLETED|Years 6-10 (60-Month Extension)||0||
59848854|NCT00112437|75973230|FG018|COMPLETED|Years 6-10 (60-Month Extension)||0||
59848855|NCT00112437|75973231|FG019|COMPLETED|Years 6-10 (60-Month Extension)||0||
59848856|NCT00112437|75973232|FG020|COMPLETED|Years 6-10 (60-Month Extension)||0||
59848857|NCT00112437|75973233|FG021|COMPLETED|Years 6-10 (60-Month Extension)||0||
59848858|NCT00112437|75973234|FG022|COMPLETED|Years 6-10 (60-Month Extension)||23||
59848859|NCT00112437|75973235|FG023|COMPLETED|Years 6-10 (60-Month Extension)||22||
59848860|NCT00112437|75973236|FG024|COMPLETED|Years 6-10 (60-Month Extension)||22||
59848861|NCT00112437|75973237|FG025|COMPLETED|Years 6-10 (60-Month Extension)||27||
59848862|NCT00112437|75973212|FG000|NOT COMPLETED|Years 6-10 (60-Month Extension)||0||
59848863|NCT00112437|75973213|FG001|NOT COMPLETED|Years 6-10 (60-Month Extension)||0||
59848864|NCT00112437|75973214|FG002|NOT COMPLETED|Years 6-10 (60-Month Extension)||0||
59848865|NCT00112437|75973215|FG003|NOT COMPLETED|Years 6-10 (60-Month Extension)||0||
59848866|NCT00112437|75973216|FG004|NOT COMPLETED|Years 6-10 (60-Month Extension)||0||
59848867|NCT00112437|75973217|FG005|NOT COMPLETED|Years 6-10 (60-Month Extension)||0||
59848868|NCT00112437|75973218|FG006|NOT COMPLETED|Years 6-10 (60-Month Extension)||0||
59848869|NCT00112437|75973219|FG007|NOT COMPLETED|Years 6-10 (60-Month Extension)||0||
59848870|NCT00112437|75973220|FG008|NOT COMPLETED|Years 6-10 (60-Month Extension)||0||
59848871|NCT00112437|75973221|FG009|NOT COMPLETED|Years 6-10 (60-Month Extension)||0||
59848872|NCT00112437|75973222|FG010|NOT COMPLETED|Years 6-10 (60-Month Extension)||0||
59848873|NCT00112437|75973223|FG011|NOT COMPLETED|Years 6-10 (60-Month Extension)||0||
59848874|NCT00112437|75973224|FG012|NOT COMPLETED|Years 6-10 (60-Month Extension)||0||
59848875|NCT00112437|75973225|FG013|NOT COMPLETED|Years 6-10 (60-Month Extension)||0||
59848876|NCT00112437|75973226|FG014|NOT COMPLETED|Years 6-10 (60-Month Extension)||0||
59848877|NCT00112437|75973227|FG015|NOT COMPLETED|Years 6-10 (60-Month Extension)||0||
59848878|NCT00112437|75973228|FG016|NOT COMPLETED|Years 6-10 (60-Month Extension)||0||
59848879|NCT00112437|75973229|FG017|NOT COMPLETED|Years 6-10 (60-Month Extension)||0||
59848880|NCT00112437|75973230|FG018|NOT COMPLETED|Years 6-10 (60-Month Extension)||0||
59848881|NCT00112437|75973231|FG019|NOT COMPLETED|Years 6-10 (60-Month Extension)||0||
59848882|NCT00112437|75973232|FG020|NOT COMPLETED|Years 6-10 (60-Month Extension)||0||
59848883|NCT00112437|75973233|FG021|NOT COMPLETED|Years 6-10 (60-Month Extension)||0||
59848884|NCT00112437|75973234|FG022|NOT COMPLETED|Years 6-10 (60-Month Extension)||5||
59848885|NCT00112437|75973235|FG023|NOT COMPLETED|Years 6-10 (60-Month Extension)||12||
59848886|NCT00112437|75973236|FG024|NOT COMPLETED|Years 6-10 (60-Month Extension)||1||
59848887|NCT00112437|75973237|FG025|NOT COMPLETED|Years 6-10 (60-Month Extension)||5||
59848888|NCT03653416|75973293|FG000|STARTED|Overall Study||52||
59848889|NCT03653416|75973294|FG001|STARTED|Overall Study||47||
59848890|NCT03653416|75973293|FG000|COMPLETED|Overall Study||46||
59848891|NCT03653416|75973294|FG001|COMPLETED|Overall Study||46||
59848892|NCT03653416|75973293|FG000|NOT COMPLETED|Overall Study||6||
59720282|NCT00875017|75839384|FG000|COMPLETED|First Intervention||3||
59720283|NCT00875017|75839385|FG001|COMPLETED|First Intervention||5||
59720284|NCT00875017|75839386|FG002|COMPLETED|First Intervention||4||
59720285|NCT00875017|75839387|FG003|COMPLETED|First Intervention||5||
59720286|NCT00875017|75839388|FG004|COMPLETED|First Intervention||4||
59720287|NCT00875017|75839389|FG005|COMPLETED|First Intervention||5||
59720288|NCT00875017|75839384|FG000|NOT COMPLETED|First Intervention||2||
59720289|NCT00875017|75839385|FG001|NOT COMPLETED|First Intervention||0||
59848893|NCT03653416|75973294|FG001|NOT COMPLETED|Overall Study||1||
59848894|NCT00112359|75973302|FG000|STARTED|Overall Study||84||
59848895|NCT00112359|75973303|FG001|STARTED|Overall Study||80||
59848896|NCT00112359|75973302|FG000|COMPLETED|Overall Study||57||
59848897|NCT00112359|75973303|FG001|COMPLETED|Overall Study||67||
59848898|NCT00112359|75973302|FG000|NOT COMPLETED|Overall Study||27||
59848899|NCT00112359|75973303|FG001|NOT COMPLETED|Overall Study||13||
59848900|NCT00119379|75973311|FG000|STARTED|Overall Study||26||
59848901|NCT00119379|75973312|FG001|STARTED|Overall Study||24||
59848902|NCT00119379|75973311|FG000|COMPLETED|Overall Study||22||
59848903|NCT00119379|75973312|FG001|COMPLETED|Overall Study||23||
59848904|NCT00119379|75973311|FG000|NOT COMPLETED|Overall Study||4||
59848905|NCT00119379|75973312|FG001|NOT COMPLETED|Overall Study||1||
59720290|NCT00875017|75839386|FG002|NOT COMPLETED|First Intervention||1||
59720291|NCT00875017|75839387|FG003|NOT COMPLETED|First Intervention||1||
59720292|NCT00875017|75839388|FG004|NOT COMPLETED|First Intervention||1||
59720293|NCT00875017|75839389|FG005|NOT COMPLETED|First Intervention||0||
59568067|NCT01905254|75671022|FG000|COMPLETED|Overall Study||34||
59568068|NCT01905254|75671022|FG000|NOT COMPLETED|Overall Study||0||
59568069|NCT00965055|75671026|FG000|STARTED|Overall Study||2||
59720294|NCT00875017|75839384|FG000|STARTED|Washout||3||
60120571|NCT01691885|76241750|FG001|NOT COMPLETED|Treatment Period 1(7-14 Days)||1||
60120572|NCT01691885|76241749|FG000|STARTED|Washout Period (7-9 Days)||21||
60120573|NCT01691885|76241750|FG001|STARTED|Washout Period (7-9 Days)||22||
60120574|NCT01691885|76241749|FG000|COMPLETED|Washout Period (7-9 Days)||21||
60120575|NCT01691885|76241750|FG001|COMPLETED|Washout Period (7-9 Days)||21||
60120576|NCT01691885|76241749|FG000|NOT COMPLETED|Washout Period (7-9 Days)||0||
59720295|NCT00875017|75839385|FG001|STARTED|Washout||5||
59720296|NCT00875017|75839386|FG002|STARTED|Washout||4||
59720297|NCT00875017|75839387|FG003|STARTED|Washout||5||
59720298|NCT00875017|75839388|FG004|STARTED|Washout||4||
59720299|NCT00875017|75839389|FG005|STARTED|Washout||5||
59720300|NCT00875017|75839384|FG000|COMPLETED|Washout||3||
59720301|NCT00875017|75839385|FG001|COMPLETED|Washout||5||
59720302|NCT00875017|75839386|FG002|COMPLETED|Washout||3||
59720303|NCT00875017|75839387|FG003|COMPLETED|Washout||5||
59720304|NCT00875017|75839388|FG004|COMPLETED|Washout||4||
59720305|NCT00875017|75839389|FG005|COMPLETED|Washout||5||
59720306|NCT00875017|75839384|FG000|NOT COMPLETED|Washout||0||
59720307|NCT00875017|75839385|FG001|NOT COMPLETED|Washout||0||
59720308|NCT00875017|75839386|FG002|NOT COMPLETED|Washout||1||
59720309|NCT00875017|75839387|FG003|NOT COMPLETED|Washout||0||
59720310|NCT00875017|75839388|FG004|NOT COMPLETED|Washout||0||
59720311|NCT00875017|75839389|FG005|NOT COMPLETED|Washout||0||
59720312|NCT00875017|75839384|FG000|STARTED|Second Intervention||3||
59720313|NCT00875017|75839385|FG001|STARTED|Second Intervention||5||
59720314|NCT00875017|75839386|FG002|STARTED|Second Intervention||3||
59720315|NCT00875017|75839387|FG003|STARTED|Second Intervention||5||
59720316|NCT00875017|75839388|FG004|STARTED|Second Intervention||4||
59720317|NCT00875017|75839389|FG005|STARTED|Second Intervention||5||
59720318|NCT00875017|75839384|FG000|COMPLETED|Second Intervention||3||
59720319|NCT00875017|75839385|FG001|COMPLETED|Second Intervention||5||
59720320|NCT00875017|75839386|FG002|COMPLETED|Second Intervention||3||
59720321|NCT00875017|75839387|FG003|COMPLETED|Second Intervention||4||
59720322|NCT00875017|75839388|FG004|COMPLETED|Second Intervention||4||
59720323|NCT00875017|75839389|FG005|COMPLETED|Second Intervention||5||
59720324|NCT00875017|75839384|FG000|NOT COMPLETED|Second Intervention||0||
59720325|NCT00875017|75839385|FG001|NOT COMPLETED|Second Intervention||0||
59720326|NCT00875017|75839386|FG002|NOT COMPLETED|Second Intervention||0||
59720327|NCT00875017|75839387|FG003|NOT COMPLETED|Second Intervention||1||
59568070|NCT00965055|75671026|FG000|COMPLETED|Overall Study||2||
59568071|NCT00965055|75671026|FG000|NOT COMPLETED|Overall Study||0||
59568072|NCT01905956|75671032|FG000|STARTED|Overall Study|Randomized|60||
59568073|NCT01905956|75671033|FG001|STARTED|Overall Study|Randomized|59||
59568074|NCT01905956|75671032|FG000|Intention-to-treat Population|Overall Study|Intention-to-treat population|57||
59568075|NCT01905956|75671033|FG001|Intention-to-treat Population|Overall Study|Intention-to-treat population|54||
59720328|NCT00875017|75839388|FG004|NOT COMPLETED|Second Intervention||0||
59720329|NCT00875017|75839389|FG005|NOT COMPLETED|Second Intervention||0||
59720330|NCT00875017|75839384|FG000|STARTED|Washout||3||
59720331|NCT00875017|75839385|FG001|STARTED|Washout||5||
59720332|NCT00875017|75839386|FG002|STARTED|Washout||3||
59720333|NCT00875017|75839387|FG003|STARTED|Washout||4||
59720334|NCT00875017|75839388|FG004|STARTED|Washout||4||
60120577|NCT01691885|76241750|FG001|NOT COMPLETED|Washout Period (7-9 Days)||1||
60120578|NCT01691885|76241749|FG000|STARTED|Treatment Period 2 (7-14 Days)||21||
60120579|NCT01691885|76241750|FG001|STARTED|Treatment Period 2 (7-14 Days)||21||
60120580|NCT01691885|76241749|FG000|COMPLETED|Treatment Period 2 (7-14 Days)||21||
59568076|NCT01905956|75671032|FG000|COMPLETED|Overall Study|Per-protocol population|54||
59568077|NCT01905956|75671033|FG001|COMPLETED|Overall Study|Per-protocol population|48||
59720335|NCT00875017|75839389|FG005|STARTED|Washout||5||
59720336|NCT00875017|75839384|FG000|COMPLETED|Washout||3||
59720337|NCT00875017|75839385|FG001|COMPLETED|Washout||4||
59848906|NCT00118911|75973320|FG000|STARTED|Overall Study||43||
59848907|NCT00118911|75973321|FG001|STARTED|Overall Study||43||
59848908|NCT00118911|75973320|FG000|Received Intervention as Assigned|Overall Study||41||
59848909|NCT00118911|75973321|FG001|Received Intervention as Assigned|Overall Study||38||
59848910|NCT00118911|75973320|FG000|Completed Post-Treatment Assessment|Overall Study||41||
59848911|NCT00118911|75973321|FG001|Completed Post-Treatment Assessment|Overall Study||37||
59848912|NCT00118911|75973320|FG000|6 Month Follow-up|Overall Study||37||
59848913|NCT00118911|75973321|FG001|6 Month Follow-up|Overall Study||30||
59848914|NCT00118911|75973320|FG000|12 Month Follow-up|Overall Study|1 participant did not complete the 6 month follow-up but did complete the 12 month follow-up|38||
59848915|NCT00118911|75973321|FG001|12 Month Follow-up|Overall Study|2 participants did not complete the 6 month follow-up but did complete the 12 month follow-up|32||
59848916|NCT00118911|75973320|FG000|COMPLETED|Overall Study||41||
59848917|NCT00118911|75973321|FG001|COMPLETED|Overall Study||38||
59848918|NCT00118911|75973320|FG000|NOT COMPLETED|Overall Study||2||
59848919|NCT00118911|75973321|FG001|NOT COMPLETED|Overall Study||5||
59848920|NCT00131937|75973327|FG000|STARTED|Overall Study||14||
59848921|NCT00131937|75973327|FG000|COMPLETED|Overall Study||0||
59848922|NCT00131937|75973327|FG000|NOT COMPLETED|Overall Study||14||
59848923|NCT00131469|75973333|FG000|STARTED|Overall Study||38||
59848924|NCT00131469|75973334|FG001|STARTED|Overall Study||40||
59848925|NCT00131469|75973333|FG000|COMPLETED|Overall Study||29||
59848926|NCT00131469|75973334|FG001|COMPLETED|Overall Study||27||
59848927|NCT00131469|75973333|FG000|NOT COMPLETED|Overall Study||9||
59848928|NCT00131469|75973334|FG001|NOT COMPLETED|Overall Study||13||
59848929|NCT00372593|75973343|FG000|STARTED|Overall Study||531||
59848930|NCT00372593|75973344|FG001|STARTED|Overall Study||532||
59848931|NCT00372593|75973345|FG002|STARTED|Overall Study||7||
59848932|NCT00372593|75973343|FG000|COMPLETED|Overall Study||327||
59848933|NCT00372593|75973344|FG001|COMPLETED|Overall Study||334||
59848934|NCT00372593|75973345|FG002|COMPLETED|Overall Study||3||
59848935|NCT00372593|75973343|FG000|NOT COMPLETED|Overall Study||204||
59848936|NCT00372593|75973344|FG001|NOT COMPLETED|Overall Study||198||
59848937|NCT00372593|75973345|FG002|NOT COMPLETED|Overall Study||4||
59848938|NCT03666988|75973360|FG000|STARTED|Part 1 (Up to 28 Months)||3||
59848939|NCT03666988|75973361|FG001|STARTED|Part 1 (Up to 28 Months)||16||
59848940|NCT03666988|75973362|FG002|STARTED|Part 1 (Up to 28 Months)||12||
59568078|NCT01905956|75671032|FG000|NOT COMPLETED|Overall Study||6||
59568079|NCT01905956|75671033|FG001|NOT COMPLETED|Overall Study||11||
59568080|NCT02266797|75671041|FG000|STARTED|Overall Study||1||
59568081|NCT02266797|75671042|FG001|STARTED|Overall Study||3||
59848941|NCT03666988|75973363|FG003|STARTED|Part 1 (Up to 28 Months)||0||
59848942|NCT03666988|75973364|FG004|STARTED|Part 1 (Up to 28 Months)||0||
59848943|NCT03666988|75973365|FG005|STARTED|Part 1 (Up to 28 Months)||0||
59848944|NCT03666988|75973360|FG000|COMPLETED|Part 1 (Up to 28 Months)||0||
59848945|NCT03666988|75973361|FG001|COMPLETED|Part 1 (Up to 28 Months)||0||
59848946|NCT03666988|75973362|FG002|COMPLETED|Part 1 (Up to 28 Months)||0||
59848947|NCT03666988|75973363|FG003|COMPLETED|Part 1 (Up to 28 Months)||0||
59848948|NCT03666988|75973364|FG004|COMPLETED|Part 1 (Up to 28 Months)||0||
59848949|NCT03666988|75973365|FG005|COMPLETED|Part 1 (Up to 28 Months)||0||
59848950|NCT03666988|75973360|FG000|NOT COMPLETED|Part 1 (Up to 28 Months)||3||
59848951|NCT03666988|75973361|FG001|NOT COMPLETED|Part 1 (Up to 28 Months)||16||
59848952|NCT03666988|75973362|FG002|NOT COMPLETED|Part 1 (Up to 28 Months)||12||
59848953|NCT03666988|75973363|FG003|NOT COMPLETED|Part 1 (Up to 28 Months)||0||
59848954|NCT03666988|75973364|FG004|NOT COMPLETED|Part 1 (Up to 28 Months)||0||
59848955|NCT03666988|75973365|FG005|NOT COMPLETED|Part 1 (Up to 28 Months)||0||
59848956|NCT03666988|75973360|FG000|STARTED|Part 2 (Up to 48 Months)||0||
60120581|NCT01691885|76241750|FG001|COMPLETED|Treatment Period 2 (7-14 Days)||21||
60120582|NCT01691885|76241749|FG000|NOT COMPLETED|Treatment Period 2 (7-14 Days)||0||
60120583|NCT01691885|76241750|FG001|NOT COMPLETED|Treatment Period 2 (7-14 Days)||0||
60120584|NCT02651428|76241758|FG000|STARTED|Overall Study||403||
60120585|NCT02651428|76241759|FG001|STARTED|Overall Study||403||
60120586|NCT02651428|76241758|FG000|COMPLETED|Overall Study||359||
60120587|NCT02651428|76241759|FG001|COMPLETED|Overall Study||359||
59848957|NCT03666988|75973361|FG001|STARTED|Part 2 (Up to 48 Months)||0||
60120588|NCT02651428|76241758|FG000|NOT COMPLETED|Overall Study||44||
59568082|NCT02266797|75671041|FG000|COMPLETED|Overall Study||1||
59568083|NCT02266797|75671042|FG001|COMPLETED|Overall Study||2||
59848958|NCT03666988|75973362|FG002|STARTED|Part 2 (Up to 48 Months)||0||
59848959|NCT03666988|75973363|FG003|STARTED|Part 2 (Up to 48 Months)||0||
59848960|NCT03666988|75973364|FG004|STARTED|Part 2 (Up to 48 Months)||0||
59848961|NCT03666988|75973365|FG005|STARTED|Part 2 (Up to 48 Months)||0||
59848962|NCT03666988|75973360|FG000|COMPLETED|Part 2 (Up to 48 Months)||0||
59848963|NCT03666988|75973361|FG001|COMPLETED|Part 2 (Up to 48 Months)||0||
59848964|NCT03666988|75973362|FG002|COMPLETED|Part 2 (Up to 48 Months)||0||
59848965|NCT03666988|75973363|FG003|COMPLETED|Part 2 (Up to 48 Months)||0||
59848966|NCT03666988|75973364|FG004|COMPLETED|Part 2 (Up to 48 Months)||0||
59848967|NCT03666988|75973365|FG005|COMPLETED|Part 2 (Up to 48 Months)||0||
59848968|NCT03666988|75973360|FG000|NOT COMPLETED|Part 2 (Up to 48 Months)||0||
59848969|NCT03666988|75973361|FG001|NOT COMPLETED|Part 2 (Up to 48 Months)||0||
59848970|NCT03666988|75973362|FG002|NOT COMPLETED|Part 2 (Up to 48 Months)||0||
59848971|NCT03666988|75973363|FG003|NOT COMPLETED|Part 2 (Up to 48 Months)||0||
59848972|NCT03666988|75973364|FG004|NOT COMPLETED|Part 2 (Up to 48 Months)||0||
59848973|NCT03666988|75973365|FG005|NOT COMPLETED|Part 2 (Up to 48 Months)||0||
59848974|NCT00382109|75973385|FG000|STARTED|Overall Study||76||
59848975|NCT00382109|75973386|FG001|STARTED|Overall Study||70||
59848976|NCT00382109|75973385|FG000|COMPLETED|Overall Study||64||
59848977|NCT00382109|75973386|FG001|COMPLETED|Overall Study||66||
59848978|NCT00382109|75973385|FG000|NOT COMPLETED|Overall Study||12||
59848979|NCT00382109|75973386|FG001|NOT COMPLETED|Overall Study||4||
59848980|NCT03651622|75973398|FG000|STARTED|Diet Period 1 (Randomization 1)||23||
59848981|NCT03651622|75973399|FG001|STARTED|Diet Period 1 (Randomization 1)||24||
59848982|NCT03651622|75973400|FG002|STARTED|Diet Period 1 (Randomization 1)||21||
59848983|NCT03651622|75973398|FG000|COMPLETED|Diet Period 1 (Randomization 1)||19||
59848984|NCT03651622|75973399|FG001|COMPLETED|Diet Period 1 (Randomization 1)||17||
59848985|NCT03651622|75973400|FG002|COMPLETED|Diet Period 1 (Randomization 1)||12||
59848986|NCT03651622|75973398|FG000|NOT COMPLETED|Diet Period 1 (Randomization 1)||4||
59848987|NCT03651622|75973399|FG001|NOT COMPLETED|Diet Period 1 (Randomization 1)||7||
59848988|NCT03651622|75973400|FG002|NOT COMPLETED|Diet Period 1 (Randomization 1)||9||
59848989|NCT03651622|75973398|FG000|STARTED|Diet Period 2 (Randomization 2)||19||
59848990|NCT03651622|75973399|FG001|STARTED|Diet Period 2 (Randomization 2)||15||
59848991|NCT03651622|75973400|FG002|STARTED|Diet Period 2 (Randomization 2)||14||
59848992|NCT03651622|75973398|FG000|Number of Participants Rerandomized From Hypocaloric, Low Carbohydrate Diet|Diet Period 2 (Randomization 2)||0||
59848993|NCT03651622|75973399|FG001|Number of Participants Rerandomized From Hypocaloric, Low Carbohydrate Diet|Diet Period 2 (Randomization 2)||5||
59848994|NCT03651622|75973400|FG002|Number of Participants Rerandomized From Hypocaloric, Low Carbohydrate Diet|Diet Period 2 (Randomization 2)||5||
59848995|NCT03651622|75973398|FG000|Number of Participants Rerandomized From Hypocaloric, Moderate Low Fat Diet|Diet Period 2 (Randomization 2)||5||
59848996|NCT03651622|75973399|FG001|Number of Participants Rerandomized From Hypocaloric, Moderate Low Fat Diet|Diet Period 2 (Randomization 2)||0||
59848997|NCT03651622|75973400|FG002|Number of Participants Rerandomized From Hypocaloric, Moderate Low Fat Diet|Diet Period 2 (Randomization 2)||6||
59848998|NCT03651622|75973398|FG000|Number of Participants Rerandomized From Mediterranean, no Caloric Restriction Diet|Diet Period 2 (Randomization 2)||5||
59848999|NCT03651622|75973399|FG001|Number of Participants Rerandomized From Mediterranean, no Caloric Restriction Diet|Diet Period 2 (Randomization 2)||4||
59849000|NCT03651622|75973400|FG002|Number of Participants Rerandomized From Mediterranean, no Caloric Restriction Diet|Diet Period 2 (Randomization 2)||0||
59849001|NCT03651622|75973398|FG000|Number of Participants Not Rerandomized|Diet Period 2 (Randomization 2)||9||
59849002|NCT03651622|75973399|FG001|Number of Participants Not Rerandomized|Diet Period 2 (Randomization 2)||6||
59849003|NCT03651622|75973400|FG002|Number of Participants Not Rerandomized|Diet Period 2 (Randomization 2)||3||
59849004|NCT03651622|75973398|FG000|COMPLETED|Diet Period 2 (Randomization 2)||17||
59849005|NCT03651622|75973399|FG001|COMPLETED|Diet Period 2 (Randomization 2)||13||
59849006|NCT03651622|75973400|FG002|COMPLETED|Diet Period 2 (Randomization 2)||11||
59849007|NCT03651622|75973398|FG000|NOT COMPLETED|Diet Period 2 (Randomization 2)||2||
59849008|NCT03651622|75973399|FG001|NOT COMPLETED|Diet Period 2 (Randomization 2)||2||
59849009|NCT03651622|75973400|FG002|NOT COMPLETED|Diet Period 2 (Randomization 2)||3||
59849010|NCT03651622|75973398|FG000|STARTED|Diet Period 3 (Randomization 3)||14||
59849011|NCT03651622|75973399|FG001|STARTED|Diet Period 3 (Randomization 3)||9||
59849012|NCT03651622|75973400|FG002|STARTED|Diet Period 3 (Randomization 3)||18||
59849013|NCT03651622|75973398|FG000|Number of Participants Rerandomized From Hypocaloric, Low Carbohydrate Diet|Diet Period 3 (Randomization 3)||0||
59849014|NCT03651622|75973399|FG001|Number of Participants Rerandomized From Hypocaloric, Low Carbohydrate Diet|Diet Period 3 (Randomization 3)||2||
59849015|NCT03651622|75973400|FG002|Number of Participants Rerandomized From Hypocaloric, Low Carbohydrate Diet|Diet Period 3 (Randomization 3)||10||
59849016|NCT03651622|75973398|FG000|Number of Participants Rerandomized From Hypocaloric, Moderate Low Fat Diet|Diet Period 3 (Randomization 3)||4||
59849017|NCT03651622|75973399|FG001|Number of Participants Rerandomized From Hypocaloric, Moderate Low Fat Diet|Diet Period 3 (Randomization 3)||0||
59849018|NCT03651622|75973400|FG002|Number of Participants Rerandomized From Hypocaloric, Moderate Low Fat Diet|Diet Period 3 (Randomization 3)||6||
59849019|NCT03651622|75973398|FG000|Number of Participants Rerandomized From Mediterranean|Diet Period 3 (Randomization 3)||6||
59849020|NCT03651622|75973399|FG001|Number of Participants Rerandomized From Mediterranean|Diet Period 3 (Randomization 3)||4||
60120589|NCT02651428|76241759|FG001|NOT COMPLETED|Overall Study||44||
59849021|NCT03651622|75973400|FG002|Number of Participants Rerandomized From Mediterranean|Diet Period 3 (Randomization 3)||0||
59849022|NCT03651622|75973398|FG000|Number of Participants Not Rerandomized|Diet Period 3 (Randomization 3)||4||
59849023|NCT03651622|75973399|FG001|Number of Participants Not Rerandomized|Diet Period 3 (Randomization 3)||3||
59849024|NCT03651622|75973400|FG002|Number of Participants Not Rerandomized|Diet Period 3 (Randomization 3)||2||
59849025|NCT03651622|75973398|FG000|COMPLETED|Diet Period 3 (Randomization 3)||14||
59849026|NCT03651622|75973399|FG001|COMPLETED|Diet Period 3 (Randomization 3)||9||
59849027|NCT03651622|75973400|FG002|COMPLETED|Diet Period 3 (Randomization 3)||17||
59849028|NCT03651622|75973398|FG000|NOT COMPLETED|Diet Period 3 (Randomization 3)||0||
59849029|NCT03651622|75973399|FG001|NOT COMPLETED|Diet Period 3 (Randomization 3)||0||
59849030|NCT03651622|75973400|FG002|NOT COMPLETED|Diet Period 3 (Randomization 3)||1||
59849031|NCT00381797|75973413|FG000|STARTED|Overall Study||18||
59849032|NCT00381797|75973414|FG001|STARTED|Overall Study||17||
59849033|NCT00381797|75973415|FG002|STARTED|Overall Study||10||
59849034|NCT00381797|75973416|FG003|STARTED|Overall Study||15||
59849035|NCT00381797|75973417|FG004|STARTED|Overall Study||37||
59849036|NCT00381797|75973413|FG000|COMPLETED|Overall Study||17||
59849037|NCT00381797|75973414|FG001|COMPLETED|Overall Study||16||
59849038|NCT00381797|75973415|FG002|COMPLETED|Overall Study||10||
59849039|NCT00381797|75973416|FG003|COMPLETED|Overall Study||14||
59849040|NCT00381797|75973417|FG004|COMPLETED|Overall Study||35||
59849041|NCT00381797|75973413|FG000|NOT COMPLETED|Overall Study||1||
59849042|NCT00381797|75973414|FG001|NOT COMPLETED|Overall Study||1||
59849043|NCT00381797|75973415|FG002|NOT COMPLETED|Overall Study||0||
59849044|NCT00381797|75973416|FG003|NOT COMPLETED|Overall Study||1||
59849045|NCT00381797|75973417|FG004|NOT COMPLETED|Overall Study||2||
59849046|NCT03665038|75973453|FG000|STARTED|Overall Study||8||
59849047|NCT03665038|75973454|FG001|STARTED|Overall Study||8||
59849048|NCT03665038|75973455|FG002|STARTED|Overall Study||12||
59849049|NCT03665038|75973453|FG000|COMPLETED|Overall Study||8||
59849050|NCT03665038|75973454|FG001|COMPLETED|Overall Study||8||
59849051|NCT03665038|75973455|FG002|COMPLETED|Overall Study||11||
59849052|NCT03665038|75973453|FG000|NOT COMPLETED|Overall Study||0||
59849053|NCT03665038|75973454|FG001|NOT COMPLETED|Overall Study||0||
59849054|NCT03665038|75973455|FG002|NOT COMPLETED|Overall Study||1||
59849055|NCT03664024|75973465|FG000|STARTED|Overall Study||118||
59849056|NCT03664024|75973465|FG000|Treated|Overall Study||117||
59849057|NCT03664024|75973465|FG000|COMPLETED|Overall Study||0||
59849058|NCT03664024|75973465|FG000|NOT COMPLETED|Overall Study||118||
59849059|NCT00381563|75973474|FG000|STARTED|Overall Study||41||
59849060|NCT00381563|75973475|FG001|STARTED|Overall Study||39||
59849061|NCT00381563|75973474|FG000|COMPLETED|Overall Study||34||
59849062|NCT00381563|75973475|FG001|COMPLETED|Overall Study||33||
59849063|NCT00381563|75973474|FG000|NOT COMPLETED|Overall Study||7||
59849064|NCT00381563|75973475|FG001|NOT COMPLETED|Overall Study||6||
59849065|NCT03624946|75973482|FG000|STARTED|Overall Study||19||
59849066|NCT03624946|75973483|FG001|STARTED|Overall Study||11||
59849067|NCT03624946|75973482|FG000|COMPLETED|Overall Study||19||
59849068|NCT03624946|75973483|FG001|COMPLETED|Overall Study||10||
59849069|NCT03624946|75973482|FG000|NOT COMPLETED|Overall Study||0||
59849070|NCT03624946|75973483|FG001|NOT COMPLETED|Overall Study||1||
59849071|NCT00381095|75973495|FG000|STARTED|Overall Study||72||
59849072|NCT00381095|75973496|FG001|STARTED|Overall Study||80||
59849073|NCT00381095|75973495|FG000|COMPLETED|Overall Study||59||
59849074|NCT00381095|75973496|FG001|COMPLETED|Overall Study||59||
59849075|NCT00381095|75973495|FG000|NOT COMPLETED|Overall Study||13||
59849076|NCT00381095|75973496|FG001|NOT COMPLETED|Overall Study||21||
59849077|NCT03619174|75973504|FG000|STARTED|Overall Study|First subject enrolled 8/8/2018. Last subject, last visit, 7/5/2019|66||
59849078|NCT03619174|75973505|FG001|STARTED|Overall Study|First subject enrolled 8/8/2018. Last subject, last visit, 7/5/2019|33||
59849079|NCT03619174|75973504|FG000|COMPLETED|Overall Study||57||
59849080|NCT03619174|75973505|FG001|COMPLETED|Overall Study||29||
59849081|NCT03619174|75973504|FG000|NOT COMPLETED|Overall Study||9||
59849082|NCT03619174|75973505|FG001|NOT COMPLETED|Overall Study||4||
59849083|NCT00112047|75973513|FG000|STARTED|Randomized Phase|Intention to treat (ITT) population N=255 (2 participants had received prior antiretroviral therapy)|257||
59849084|NCT00112047|75973514|FG001|STARTED|Randomized Phase|ITT analysis population|254||
59849085|NCT00112047|75973513|FG000|COMPLETED|Randomized Phase||187||
59849086|NCT00112047|75973514|FG001|COMPLETED|Randomized Phase||166||
59849087|NCT00112047|75973513|FG000|NOT COMPLETED|Randomized Phase||70||
59849088|NCT00112047|75973514|FG001|NOT COMPLETED|Randomized Phase||88||
59849089|NCT00112047|75973513|FG000|STARTED|Atripla Phase|Number of participants who completed randomized phase and opted to roll over to Atripla at Week 144|160||
59849090|NCT00112047|75973514|FG001|STARTED|Atripla Phase|Number of participants who completed randomized phase and opted to roll over to Atripla at Week 144|126||
59849091|NCT00112047|75973513|FG000|COMPLETED|Atripla Phase||142||
59849092|NCT00112047|75973514|FG001|COMPLETED|Atripla Phase||106||
59849093|NCT00112047|75973513|FG000|NOT COMPLETED|Atripla Phase||18||
59849094|NCT00112047|75973514|FG001|NOT COMPLETED|Atripla Phase||20||
59849095|NCT03658876|75973527|FG000|STARTED|Overall Study||88||
59849096|NCT03658876|75973528|FG001|STARTED|Overall Study||96||
59849097|NCT03658876|75973527|FG000|COMPLETED|Overall Study||76||
59849098|NCT03658876|75973528|FG001|COMPLETED|Overall Study||84||
59849099|NCT03658876|75973527|FG000|NOT COMPLETED|Overall Study||12||
59849100|NCT03658876|75973528|FG001|NOT COMPLETED|Overall Study||12||
59849101|NCT03618628|75973534|FG000|STARTED|Overall Study||3||
59849102|NCT03618628|75973534|FG000|COMPLETED|Overall Study||1||
59849103|NCT03618628|75973534|FG000|NOT COMPLETED|Overall Study||2||
59849104|NCT03617770|75973540|FG000|STARTED|Overall Study|9|9||
59849105|NCT03617770|75973541|FG001|STARTED|Overall Study|5|5||
59849106|NCT03617770|75973540|FG000|COMPLETED|Overall Study|8|8||
59849107|NCT03617770|75973541|FG001|COMPLETED|Overall Study||5||
59849108|NCT03617770|75973540|FG000|NOT COMPLETED|Overall Study||1||
59849109|NCT03617770|75973541|FG001|NOT COMPLETED|Overall Study||0||
59849110|NCT03616600|75973549|FG000|STARTED|Overall Study||16||
59849111|NCT03616600|75973550|FG001|STARTED|Overall Study||15||
59849112|NCT03616600|75973549|FG000|COMPLETED|Overall Study||15||
59849113|NCT03616600|75973550|FG001|COMPLETED|Overall Study||15||
59849114|NCT03616600|75973549|FG000|NOT COMPLETED|Overall Study||1||
59849115|NCT03616600|75973550|FG001|NOT COMPLETED|Overall Study||0||
59849116|NCT00380393|75973559|FG000|STARTED|Month 8 (Cross-sectional Visit)||447||
59849117|NCT00380393|75973560|FG001|STARTED|Month 8 (Cross-sectional Visit)||447||
59849118|NCT00380393|75973559|FG000|COMPLETED|Month 8 (Cross-sectional Visit)||398||
59849119|NCT00380393|75973560|FG001|COMPLETED|Month 8 (Cross-sectional Visit)||407||
59849120|NCT00380393|75973559|FG000|NOT COMPLETED|Month 8 (Cross-sectional Visit)||49||
59849121|NCT00380393|75973560|FG001|NOT COMPLETED|Month 8 (Cross-sectional Visit)||40||
59849122|NCT00380393|75973559|FG000|STARTED|Month 14||447||
59849123|NCT00380393|75973560|FG001|STARTED|Month 14||447||
59849124|NCT00380393|75973559|FG000|COMPLETED|Month 14||390||
59849125|NCT00380393|75973560|FG001|COMPLETED|Month 14||391||
60120590|NCT01587703|76241783|FG000|STARTED|Part1 QD(Median Exposure of 1.38months)||3||
60120591|NCT01587703|76241784|FG001|STARTED|Part1 QD(Median Exposure of 1.38months)||4||
59720338|NCT00875017|75839386|FG002|COMPLETED|Washout||3||
59720339|NCT00875017|75839387|FG003|COMPLETED|Washout||4||
59720340|NCT00875017|75839388|FG004|COMPLETED|Washout||4||
59720341|NCT00875017|75839389|FG005|COMPLETED|Washout||5||
59720342|NCT00875017|75839384|FG000|NOT COMPLETED|Washout||0||
59720343|NCT00875017|75839385|FG001|NOT COMPLETED|Washout||1||
59720344|NCT00875017|75839386|FG002|NOT COMPLETED|Washout||0||
59720345|NCT00875017|75839387|FG003|NOT COMPLETED|Washout||0||
59720346|NCT00875017|75839388|FG004|NOT COMPLETED|Washout||0||
59720347|NCT00875017|75839389|FG005|NOT COMPLETED|Washout||0||
59720348|NCT00875017|75839384|FG000|STARTED|Third Intervention||3||
59720349|NCT00875017|75839385|FG001|STARTED|Third Intervention||4||
59720350|NCT00875017|75839386|FG002|STARTED|Third Intervention||3||
59720351|NCT00875017|75839387|FG003|STARTED|Third Intervention||4||
59720352|NCT00875017|75839388|FG004|STARTED|Third Intervention||4||
59720353|NCT00875017|75839389|FG005|STARTED|Third Intervention||5||
59720354|NCT00875017|75839384|FG000|COMPLETED|Third Intervention||3||
59720355|NCT00875017|75839385|FG001|COMPLETED|Third Intervention||3||
59720356|NCT00875017|75839386|FG002|COMPLETED|Third Intervention||2||
59720357|NCT00875017|75839387|FG003|COMPLETED|Third Intervention||4||
59720358|NCT00875017|75839388|FG004|COMPLETED|Third Intervention||4||
59720359|NCT00875017|75839389|FG005|COMPLETED|Third Intervention||5||
59720360|NCT00875017|75839384|FG000|NOT COMPLETED|Third Intervention||0||
59720361|NCT00875017|75839385|FG001|NOT COMPLETED|Third Intervention||1||
59720362|NCT00875017|75839386|FG002|NOT COMPLETED|Third Intervention||1||
59720363|NCT00875017|75839387|FG003|NOT COMPLETED|Third Intervention||0||
59720364|NCT00875017|75839388|FG004|NOT COMPLETED|Third Intervention||0||
59720365|NCT00875017|75839389|FG005|NOT COMPLETED|Third Intervention||0||
59720366|NCT00875017|75839384|FG000|STARTED|Washout||3||
59720367|NCT00875017|75839385|FG001|STARTED|Washout||3||
59720368|NCT00875017|75839386|FG002|STARTED|Washout||2||
59720369|NCT00875017|75839387|FG003|STARTED|Washout||4||
59720370|NCT00875017|75839388|FG004|STARTED|Washout||4||
59849126|NCT00380393|75973559|FG000|NOT COMPLETED|Month 14||57||
59720371|NCT00875017|75839389|FG005|STARTED|Washout||5||
59720372|NCT00875017|75839384|FG000|COMPLETED|Washout||3||
59720373|NCT00875017|75839385|FG001|COMPLETED|Washout||3||
59720374|NCT00875017|75839386|FG002|COMPLETED|Washout||2||
59720375|NCT00875017|75839387|FG003|COMPLETED|Washout||4||
59720376|NCT00875017|75839388|FG004|COMPLETED|Washout||3||
59720377|NCT00875017|75839389|FG005|COMPLETED|Washout||5||
59720378|NCT00875017|75839384|FG000|NOT COMPLETED|Washout||0||
59849127|NCT00380393|75973560|FG001|NOT COMPLETED|Month 14||56||
59849128|NCT00380081|75973572|FG000|STARTED|Overall Study||14||
59720379|NCT00875017|75839385|FG001|NOT COMPLETED|Washout||0||
59720380|NCT00875017|75839386|FG002|NOT COMPLETED|Washout||0||
59720381|NCT00875017|75839387|FG003|NOT COMPLETED|Washout||0||
59849129|NCT00380081|75973573|FG001|STARTED|Overall Study||13||
59849130|NCT00380081|75973574|FG002|STARTED|Overall Study||13||
59849131|NCT00380081|75973575|FG003|STARTED|Overall Study||15||
59849132|NCT00380081|75973576|FG004|STARTED|Overall Study||13||
59849133|NCT00380081|75973577|FG005|STARTED|Overall Study||14||
59720382|NCT00875017|75839388|FG004|NOT COMPLETED|Washout||1||
59720383|NCT00875017|75839389|FG005|NOT COMPLETED|Washout||0||
59849134|NCT00380081|75973572|FG000|COMPLETED|Overall Study||14||
59849135|NCT00380081|75973573|FG001|COMPLETED|Overall Study||13||
59849136|NCT00380081|75973574|FG002|COMPLETED|Overall Study||13||
59849137|NCT00380081|75973575|FG003|COMPLETED|Overall Study||15||
59849138|NCT00380081|75973576|FG004|COMPLETED|Overall Study||12||
59849139|NCT00380081|75973577|FG005|COMPLETED|Overall Study||13||
59849140|NCT00380081|75973572|FG000|NOT COMPLETED|Overall Study||0||
59849141|NCT00380081|75973573|FG001|NOT COMPLETED|Overall Study||0||
59849142|NCT00380081|75973574|FG002|NOT COMPLETED|Overall Study||0||
59849143|NCT00380081|75973575|FG003|NOT COMPLETED|Overall Study||0||
59849144|NCT00380081|75973576|FG004|NOT COMPLETED|Overall Study||1||
59849145|NCT00380081|75973577|FG005|NOT COMPLETED|Overall Study||1||
59849146|NCT03579940|75973596|FG000|STARTED|Period 1||3||
59849147|NCT03579940|75973597|FG001|STARTED|Period 1||2||
59849148|NCT03579940|75973598|FG002|STARTED|Period 1||2||
59849149|NCT03579940|75973599|FG003|STARTED|Period 1||2||
59849150|NCT03579940|75973600|FG004|STARTED|Period 1||2||
59849151|NCT03579940|75973601|FG005|STARTED|Period 1||2||
59849152|NCT03579940|75973602|FG006|STARTED|Period 1||3||
59849153|NCT03579940|75973603|FG007|STARTED|Period 1||3||
59849154|NCT03579940|75973604|FG008|STARTED|Period 1||3||
59849155|NCT03579940|75973605|FG009|STARTED|Period 1||2||
59849156|NCT03579940|75973606|FG010|STARTED|Period 1||3||
59849157|NCT03579940|75973596|FG000|Received at Least 1 Dose of Study Drug|Period 1||3||
59849158|NCT03579940|75973597|FG001|Received at Least 1 Dose of Study Drug|Period 1||2||
59849159|NCT03579940|75973598|FG002|Received at Least 1 Dose of Study Drug|Period 1||2||
59849160|NCT03579940|75973599|FG003|Received at Least 1 Dose of Study Drug|Period 1||2||
59849161|NCT03579940|75973600|FG004|Received at Least 1 Dose of Study Drug|Period 1||2||
59849162|NCT03579940|75973601|FG005|Received at Least 1 Dose of Study Drug|Period 1||2||
59849163|NCT03579940|75973602|FG006|Received at Least 1 Dose of Study Drug|Period 1||3||
59849164|NCT03579940|75973603|FG007|Received at Least 1 Dose of Study Drug|Period 1||3||
59849165|NCT03579940|75973604|FG008|Received at Least 1 Dose of Study Drug|Period 1||3||
59849166|NCT03579940|75973605|FG009|Received at Least 1 Dose of Study Drug|Period 1||2||
59849167|NCT03579940|75973606|FG010|Received at Least 1 Dose of Study Drug|Period 1||3||
59849168|NCT03579940|75973596|FG000|COMPLETED|Period 1||3||
59849169|NCT03579940|75973597|FG001|COMPLETED|Period 1||2||
59849170|NCT03579940|75973598|FG002|COMPLETED|Period 1||2||
59849171|NCT03579940|75973599|FG003|COMPLETED|Period 1||2||
59849172|NCT03579940|75973600|FG004|COMPLETED|Period 1||2||
59849173|NCT03579940|75973601|FG005|COMPLETED|Period 1||2||
59849174|NCT03579940|75973602|FG006|COMPLETED|Period 1||3||
59849175|NCT03579940|75973603|FG007|COMPLETED|Period 1||3||
59849176|NCT03579940|75973604|FG008|COMPLETED|Period 1||3||
59720384|NCT00875017|75839384|FG000|STARTED|Fourth Intervention||3||
59720385|NCT00875017|75839385|FG001|STARTED|Fourth Intervention||3||
59720386|NCT00875017|75839386|FG002|STARTED|Fourth Intervention||2||
59720387|NCT00875017|75839387|FG003|STARTED|Fourth Intervention||4||
59720388|NCT00875017|75839388|FG004|STARTED|Fourth Intervention||3||
59720389|NCT00875017|75839389|FG005|STARTED|Fourth Intervention||5||
59720390|NCT00875017|75839384|FG000|COMPLETED|Fourth Intervention||3||
59720391|NCT00875017|75839385|FG001|COMPLETED|Fourth Intervention||3||
59720392|NCT00875017|75839386|FG002|COMPLETED|Fourth Intervention||2||
59720393|NCT00875017|75839387|FG003|COMPLETED|Fourth Intervention||4||
59720394|NCT00875017|75839388|FG004|COMPLETED|Fourth Intervention||3||
59720395|NCT00875017|75839389|FG005|COMPLETED|Fourth Intervention||4||
59720396|NCT00875017|75839384|FG000|NOT COMPLETED|Fourth Intervention||0||
59720397|NCT00875017|75839385|FG001|NOT COMPLETED|Fourth Intervention||0||
59720398|NCT00875017|75839386|FG002|NOT COMPLETED|Fourth Intervention||0||
59720399|NCT00875017|75839387|FG003|NOT COMPLETED|Fourth Intervention||0||
59720400|NCT00875017|75839388|FG004|NOT COMPLETED|Fourth Intervention||0||
59720401|NCT00875017|75839389|FG005|NOT COMPLETED|Fourth Intervention||1||
59720402|NCT04206670|75839404|FG000|STARTED|Overall Study||148||
59720403|NCT04206670|75839405|FG001|STARTED|Overall Study||68||
59720404|NCT04206670|75839404|FG000|COMPLETED|Overall Study||124||
59720405|NCT04206670|75839405|FG001|COMPLETED|Overall Study||65||
59720406|NCT04206670|75839404|FG000|NOT COMPLETED|Overall Study||24||
59720407|NCT04206670|75839405|FG001|NOT COMPLETED|Overall Study||3||
59849177|NCT03579940|75973605|FG009|COMPLETED|Period 1||2||
59849178|NCT03579940|75973606|FG010|COMPLETED|Period 1||3||
59849179|NCT03579940|75973596|FG000|NOT COMPLETED|Period 1||0||
59849180|NCT03579940|75973597|FG001|NOT COMPLETED|Period 1||0||
59849181|NCT03579940|75973598|FG002|NOT COMPLETED|Period 1||0||
59849182|NCT03579940|75973599|FG003|NOT COMPLETED|Period 1||0||
59849183|NCT03579940|75973600|FG004|NOT COMPLETED|Period 1||0||
59849184|NCT03579940|75973601|FG005|NOT COMPLETED|Period 1||0||
59849185|NCT03579940|75973602|FG006|NOT COMPLETED|Period 1||0||
59849186|NCT03579940|75973603|FG007|NOT COMPLETED|Period 1||0||
59849187|NCT03579940|75973604|FG008|NOT COMPLETED|Period 1||0||
59849188|NCT03579940|75973605|FG009|NOT COMPLETED|Period 1||0||
59849189|NCT03579940|75973606|FG010|NOT COMPLETED|Period 1||0||
59849190|NCT03579940|75973596|FG000|STARTED|Period 2||3||
59849191|NCT03579940|75973597|FG001|STARTED|Period 2||2||
59849192|NCT03579940|75973598|FG002|STARTED|Period 2||2||
59849193|NCT03579940|75973599|FG003|STARTED|Period 2||2||
59849194|NCT03579940|75973600|FG004|STARTED|Period 2||2||
59849195|NCT03579940|75973601|FG005|STARTED|Period 2||2||
59849196|NCT03579940|75973602|FG006|STARTED|Period 2||3||
59849197|NCT03579940|75973603|FG007|STARTED|Period 2||3||
59720408|NCT00875797|75839414|FG000|STARTED|Overall Study||45||
59849198|NCT03579940|75973604|FG008|STARTED|Period 2||3||
59849199|NCT03579940|75973605|FG009|STARTED|Period 2||2||
59849200|NCT03579940|75973606|FG010|STARTED|Period 2||3||
59849201|NCT03579940|75973596|FG000|COMPLETED|Period 2||3||
59849202|NCT03579940|75973597|FG001|COMPLETED|Period 2||2||
59849203|NCT03579940|75973598|FG002|COMPLETED|Period 2||1||
59849204|NCT03579940|75973599|FG003|COMPLETED|Period 2||2||
59849205|NCT03579940|75973600|FG004|COMPLETED|Period 2||2||
59849206|NCT03579940|75973601|FG005|COMPLETED|Period 2||2||
59849207|NCT03579940|75973602|FG006|COMPLETED|Period 2||3||
59849208|NCT03579940|75973603|FG007|COMPLETED|Period 2||3||
59849209|NCT03579940|75973604|FG008|COMPLETED|Period 2||3||
59849210|NCT03579940|75973605|FG009|COMPLETED|Period 2||2||
59849211|NCT03579940|75973606|FG010|COMPLETED|Period 2||3||
59849212|NCT03579940|75973596|FG000|NOT COMPLETED|Period 2||0||
59849213|NCT03579940|75973597|FG001|NOT COMPLETED|Period 2||0||
59849214|NCT03579940|75973598|FG002|NOT COMPLETED|Period 2||1||
59849215|NCT03579940|75973599|FG003|NOT COMPLETED|Period 2||0||
59849216|NCT03579940|75973600|FG004|NOT COMPLETED|Period 2||0||
59849217|NCT03579940|75973601|FG005|NOT COMPLETED|Period 2||0||
59849218|NCT03579940|75973602|FG006|NOT COMPLETED|Period 2||0||
59849219|NCT03579940|75973603|FG007|NOT COMPLETED|Period 2||0||
59849220|NCT03579940|75973604|FG008|NOT COMPLETED|Period 2||0||
59849221|NCT03579940|75973605|FG009|NOT COMPLETED|Period 2||0||
59849222|NCT03579940|75973606|FG010|NOT COMPLETED|Period 2||0||
59849223|NCT03579940|75973596|FG000|STARTED|Period 3||3||
59849224|NCT03579940|75973597|FG001|STARTED|Period 3||2||
59849225|NCT03579940|75973598|FG002|STARTED|Period 3||1||
59849226|NCT03579940|75973599|FG003|STARTED|Period 3||2||
59849227|NCT03579940|75973600|FG004|STARTED|Period 3||2||
59849228|NCT03579940|75973601|FG005|STARTED|Period 3||2||
59849229|NCT03579940|75973602|FG006|STARTED|Period 3||3||
59849230|NCT03579940|75973603|FG007|STARTED|Period 3||3||
59849231|NCT03579940|75973604|FG008|STARTED|Period 3||3||
59849232|NCT03579940|75973605|FG009|STARTED|Period 3||2||
59849233|NCT03579940|75973606|FG010|STARTED|Period 3||3||
59849234|NCT03579940|75973596|FG000|COMPLETED|Period 3||3||
59849235|NCT03579940|75973597|FG001|COMPLETED|Period 3||2||
59849236|NCT03579940|75973598|FG002|COMPLETED|Period 3||1||
59849237|NCT03579940|75973599|FG003|COMPLETED|Period 3||2||
59849238|NCT03579940|75973600|FG004|COMPLETED|Period 3||2||
59849239|NCT03579940|75973601|FG005|COMPLETED|Period 3||2||
59849240|NCT03579940|75973602|FG006|COMPLETED|Period 3||3||
59849241|NCT03579940|75973603|FG007|COMPLETED|Period 3||3||
59849242|NCT03579940|75973604|FG008|COMPLETED|Period 3||3||
59849243|NCT03579940|75973605|FG009|COMPLETED|Period 3||2||
59720409|NCT00875797|75839415|FG001|STARTED|Overall Study||45||
59720410|NCT00875797|75839414|FG000|COMPLETED|Overall Study||39||
59720411|NCT00875797|75839415|FG001|COMPLETED|Overall Study||42||
59720412|NCT00875797|75839414|FG000|NOT COMPLETED|Overall Study||6||
59720413|NCT00875797|75839415|FG001|NOT COMPLETED|Overall Study||3||
59720414|NCT04329832|75839426|FG000|STARTED|Overall Study||42||
59720415|NCT04329832|75839427|FG001|STARTED|Overall Study||43||
59720416|NCT04329832|75839426|FG000|COMPLETED|Overall Study||42||
59849244|NCT03579940|75973606|FG010|COMPLETED|Period 3||3||
59849245|NCT03579940|75973596|FG000|NOT COMPLETED|Period 3||0||
59849246|NCT03579940|75973597|FG001|NOT COMPLETED|Period 3||0||
59849247|NCT03579940|75973598|FG002|NOT COMPLETED|Period 3||0||
59849248|NCT03579940|75973599|FG003|NOT COMPLETED|Period 3||0||
59849249|NCT03579940|75973600|FG004|NOT COMPLETED|Period 3||0||
59849250|NCT03579940|75973601|FG005|NOT COMPLETED|Period 3||0||
59849251|NCT03579940|75973602|FG006|NOT COMPLETED|Period 3||0||
59849252|NCT03579940|75973603|FG007|NOT COMPLETED|Period 3||0||
59849253|NCT03579940|75973604|FG008|NOT COMPLETED|Period 3||0||
59849254|NCT03579940|75973605|FG009|NOT COMPLETED|Period 3||0||
59849255|NCT03579940|75973606|FG010|NOT COMPLETED|Period 3||0||
59849256|NCT00098306|75973641|FG000|STARTED|Double Blind||241||
59849257|NCT00098306|75973642|FG001|STARTED|Double Blind||240||
59849258|NCT00098306|75973643|FG002|STARTED|Double Blind||120||
59849259|NCT00098306|75973644|FG003|STARTED|Double Blind||0||
59849260|NCT00098306|75973645|FG004|STARTED|Double Blind||0||
59720417|NCT04329832|75839427|FG001|COMPLETED|Overall Study||43||
59849261|NCT00098306|75973646|FG005|STARTED|Double Blind||0||
59849262|NCT00098306|75973647|FG006|STARTED|Double Blind||0||
59849263|NCT00098306|75973641|FG000|Treated|Double Blind||232||
59849264|NCT00098306|75973642|FG001|Treated|Double Blind||235||
59849265|NCT00098306|75973643|FG002|Treated|Double Blind||118||
59849266|NCT00098306|75973644|FG003|Treated|Double Blind||0||
59849267|NCT00098306|75973645|FG004|Treated|Double Blind||0||
59849268|NCT00098306|75973646|FG005|Treated|Double Blind||0||
59849269|NCT00098306|75973647|FG006|Treated|Double Blind||0||
59849270|NCT00098306|75973641|FG000|COMPLETED|Double Blind||0||
59849271|NCT00098306|75973642|FG001|COMPLETED|Double Blind||0||
59849272|NCT00098306|75973643|FG002|COMPLETED|Double Blind||0||
59849273|NCT00098306|75973644|FG003|COMPLETED|Double Blind||0||
59849274|NCT00098306|75973645|FG004|COMPLETED|Double Blind||0||
59849275|NCT00098306|75973646|FG005|COMPLETED|Double Blind||0||
59849276|NCT00098306|75973647|FG006|COMPLETED|Double Blind||0||
59849277|NCT00098306|75973641|FG000|NOT COMPLETED|Double Blind||241||
59849278|NCT00098306|75973642|FG001|NOT COMPLETED|Double Blind||240||
59849279|NCT00098306|75973643|FG002|NOT COMPLETED|Double Blind||120||
59849280|NCT00098306|75973644|FG003|NOT COMPLETED|Double Blind||0||
59849281|NCT00098306|75973645|FG004|NOT COMPLETED|Double Blind||0||
59849282|NCT00098306|75973646|FG005|NOT COMPLETED|Double Blind||0||
59849283|NCT00098306|75973647|FG006|NOT COMPLETED|Double Blind||0||
59849284|NCT00098306|75973641|FG000|STARTED|Open Label||0||
59849285|NCT00098306|75973642|FG001|STARTED|Open Label||0||
59849286|NCT00098306|75973643|FG002|STARTED|Open Label||0||
59849287|NCT00098306|75973644|FG003|STARTED|Open Label||327||
59849288|NCT00098306|75973645|FG004|STARTED|Open Label||62||
59849289|NCT00098306|75973646|FG005|STARTED|Open Label||0||
59849290|NCT00098306|75973647|FG006|STARTED|Open Label||0||
59849291|NCT00098306|75973641|FG000|COMPLETED|Open Label||0||
59849292|NCT00098306|75973642|FG001|COMPLETED|Open Label||0||
59849293|NCT00098306|75973643|FG002|COMPLETED|Open Label||0||
59849294|NCT00098306|75973644|FG003|COMPLETED|Open Label||0||
59849295|NCT00098306|75973645|FG004|COMPLETED|Open Label||0||
59849296|NCT00098306|75973646|FG005|COMPLETED|Open Label||0||
59849297|NCT00098306|75973647|FG006|COMPLETED|Open Label||0||
59849298|NCT00098306|75973641|FG000|NOT COMPLETED|Open Label||0||
59849299|NCT00098306|75973642|FG001|NOT COMPLETED|Open Label||0||
59849300|NCT00098306|75973643|FG002|NOT COMPLETED|Open Label||0||
59849301|NCT00098306|75973644|FG003|NOT COMPLETED|Open Label||327||
59849302|NCT00098306|75973645|FG004|NOT COMPLETED|Open Label||62||
59849303|NCT00098306|75973646|FG005|NOT COMPLETED|Open Label||0||
59849304|NCT00098306|75973647|FG006|NOT COMPLETED|Open Label||0||
59849305|NCT00098306|75973641|FG000|STARTED|Observational Phase||0||
59849306|NCT00098306|75973642|FG001|STARTED|Observational Phase||0||
59849307|NCT00098306|75973643|FG002|STARTED|Observational Phase||0||
59849308|NCT00098306|75973644|FG003|STARTED|Observational Phase||0||
59849309|NCT00098306|75973645|FG004|STARTED|Observational Phase||0||
59849310|NCT00098306|75973646|FG005|STARTED|Observational Phase||250||
59849311|NCT00098306|75973647|FG006|STARTED|Observational Phase||81||
59849312|NCT00098306|75973641|FG000|COMPLETED|Observational Phase||0||
59849313|NCT00098306|75973642|FG001|COMPLETED|Observational Phase||0||
59849314|NCT00098306|75973643|FG002|COMPLETED|Observational Phase||0||
59849315|NCT00098306|75973644|FG003|COMPLETED|Observational Phase||0||
59849316|NCT00098306|75973645|FG004|COMPLETED|Observational Phase||0||
59849317|NCT00098306|75973646|FG005|COMPLETED|Observational Phase||204||
59849318|NCT00098306|75973647|FG006|COMPLETED|Observational Phase||55||
59849319|NCT00098306|75973641|FG000|NOT COMPLETED|Observational Phase||0||
59849320|NCT00098306|75973642|FG001|NOT COMPLETED|Observational Phase||0||
59849321|NCT00098306|75973643|FG002|NOT COMPLETED|Observational Phase||0||
59849322|NCT00098306|75973644|FG003|NOT COMPLETED|Observational Phase||0||
59849323|NCT00098306|75973645|FG004|NOT COMPLETED|Observational Phase||0||
59849324|NCT00098306|75973646|FG005|NOT COMPLETED|Observational Phase||46||
59849325|NCT00098306|75973647|FG006|NOT COMPLETED|Observational Phase||26||
59849326|NCT03615040|75973662|FG000|STARTED|Overall Study||42||
59849327|NCT03615040|75973663|FG001|STARTED|Overall Study||39||
59849328|NCT03615040|75973662|FG000|COMPLETED|Overall Study||36||
59849329|NCT03615040|75973663|FG001|COMPLETED|Overall Study||34||
59849330|NCT03615040|75973662|FG000|NOT COMPLETED|Overall Study||6||
59849331|NCT03615040|75973663|FG001|NOT COMPLETED|Overall Study||5||
59849332|NCT00068822|75973671|FG000|STARTED|First Randomized Intervention||68||
59849333|NCT00068822|75973672|FG001|STARTED|First Randomized Intervention||63||
59849334|NCT00068822|75973671|FG000|COMPLETED|First Randomized Intervention||67||
59849335|NCT00068822|75973672|FG001|COMPLETED|First Randomized Intervention||61||
59849336|NCT00068822|75973671|FG000|NOT COMPLETED|First Randomized Intervention||1||
59849337|NCT00068822|75973672|FG001|NOT COMPLETED|First Randomized Intervention||2||
59849338|NCT00068822|75973671|FG000|STARTED|Optional Crossover Intervention||9||
59849339|NCT00068822|75973672|FG001|STARTED|Optional Crossover Intervention||29||
59849340|NCT00068822|75973671|FG000|Crossover at Month 1|Optional Crossover Intervention||1||
59849341|NCT00068822|75973672|FG001|Crossover at Month 1|Optional Crossover Intervention||2||
59849342|NCT00068822|75973671|FG000|Crossover at Month 3|Optional Crossover Intervention||8||
59849343|NCT00068822|75973672|FG001|Crossover at Month 3|Optional Crossover Intervention||27||
59849344|NCT00068822|75973671|FG000|COMPLETED|Optional Crossover Intervention||9||
59849345|NCT00068822|75973672|FG001|COMPLETED|Optional Crossover Intervention||29||
59849346|NCT00068822|75973671|FG000|NOT COMPLETED|Optional Crossover Intervention||0||
59849347|NCT00068822|75973672|FG001|NOT COMPLETED|Optional Crossover Intervention||0||
59849348|NCT00068588|75973681|FG000|STARTED|Overall Study||0||
59849349|NCT00068588|75973682|FG001|STARTED|Overall Study||3||
59849350|NCT00068588|75973683|FG002|STARTED|Overall Study||21||
59849351|NCT00068588|75973681|FG000|COMPLETED|Overall Study||0||
59849352|NCT00068588|75973682|FG001|COMPLETED|Overall Study||3||
59849353|NCT00068588|75973683|FG002|COMPLETED|Overall Study||17||
59849354|NCT00068588|75973681|FG000|NOT COMPLETED|Overall Study||0||
59849355|NCT00068588|75973682|FG001|NOT COMPLETED|Overall Study||0||
59849356|NCT00068588|75973683|FG002|NOT COMPLETED|Overall Study||4||
59849357|NCT03650452|75973692|FG000|STARTED|Overall Study||70||
59849358|NCT03650452|75973693|FG001|STARTED|Overall Study||71||
59849359|NCT03650452|75973692|FG000|COMPLETED|Overall Study||60||
59849360|NCT03650452|75973693|FG001|COMPLETED|Overall Study||66||
59849361|NCT03650452|75973692|FG000|NOT COMPLETED|Overall Study||10||
59849362|NCT03650452|75973693|FG001|NOT COMPLETED|Overall Study||5||
59849363|NCT03575806|75973701|FG000|STARTED|Overall Study||25||
59849364|NCT03575806|75973702|FG001|STARTED|Overall Study||27||
59849365|NCT03575806|75973701|FG000|COMPLETED|Overall Study||25||
59849366|NCT03575806|75973702|FG001|COMPLETED|Overall Study||23||
59849367|NCT03575806|75973701|FG000|NOT COMPLETED|Overall Study||0||
59849368|NCT03575806|75973702|FG001|NOT COMPLETED|Overall Study||4||
59849369|NCT03610048|75973708|FG000|STARTED|Overall Study||175||
59849370|NCT03610048|75973708|FG000|Completed Treatment|Overall Study||15||
59849371|NCT03610048|75973708|FG000|COMPLETED|Overall Study||14|Completed study|
59849372|NCT03610048|75973708|FG000|NOT COMPLETED|Overall Study||161||
59849373|NCT03608254|75973712|FG000|STARTED|Overall Study||11||
59849374|NCT03608254|75973712|FG000|COMPLETED|Overall Study||8||
59849375|NCT03608254|75973712|FG000|NOT COMPLETED|Overall Study||3||
59849376|NCT03606460|75973718|FG000|STARTED|Overall Study||95||
59849377|NCT03606460|75973719|FG001|STARTED|Overall Study||46||
59849378|NCT03606460|75973718|FG000|COMPLETED|Overall Study||94||
59849379|NCT03606460|75973719|FG001|COMPLETED|Overall Study||38||
59849380|NCT03606460|75973718|FG000|NOT COMPLETED|Overall Study||1||
59849381|NCT03606460|75973719|FG001|NOT COMPLETED|Overall Study||8||
59849382|NCT03605836|75973730|FG000|STARTED|OL Placebo Run-in Period [1 Week]||590||
59849383|NCT03605836|75973731|FG001|STARTED|OL Placebo Run-in Period [1 Week]||0||
59849384|NCT03605836|75973732|FG002|STARTED|OL Placebo Run-in Period [1 Week]||0||
59849385|NCT03605836|75973733|FG003|STARTED|OL Placebo Run-in Period [1 Week]||0||
59849386|NCT03605836|75973730|FG000|Treated|OL Placebo Run-in Period [1 Week]||579||
59849387|NCT03605836|75973731|FG001|Treated|OL Placebo Run-in Period [1 Week]||0||
59849388|NCT03605836|75973732|FG002|Treated|OL Placebo Run-in Period [1 Week]||0||
59849389|NCT03605836|75973733|FG003|Treated|OL Placebo Run-in Period [1 Week]||0||
59849390|NCT03605836|75973730|FG000|COMPLETED|OL Placebo Run-in Period [1 Week]||440||
59849391|NCT03605836|75973731|FG001|COMPLETED|OL Placebo Run-in Period [1 Week]||0||
59849392|NCT03605836|75973732|FG002|COMPLETED|OL Placebo Run-in Period [1 Week]||0||
59849393|NCT03605836|75973733|FG003|COMPLETED|OL Placebo Run-in Period [1 Week]||0||
59849394|NCT03605836|75973730|FG000|NOT COMPLETED|OL Placebo Run-in Period [1 Week]||150||
59849395|NCT03605836|75973731|FG001|NOT COMPLETED|OL Placebo Run-in Period [1 Week]||0||
59849396|NCT03605836|75973732|FG002|NOT COMPLETED|OL Placebo Run-in Period [1 Week]||0||
59849397|NCT03605836|75973733|FG003|NOT COMPLETED|OL Placebo Run-in Period [1 Week]||0||
59849398|NCT03605836|75973730|FG000|STARTED|Double-blind Treatment Period [6 Weeks]||0||
59849399|NCT03605836|75973731|FG001|STARTED|Double-blind Treatment Period [6 Weeks]||147||
59849400|NCT03605836|75973732|FG002|STARTED|Double-blind Treatment Period [6 Weeks]||147||
59849401|NCT03605836|75973733|FG003|STARTED|Double-blind Treatment Period [6 Weeks]||146||
59849402|NCT03605836|75973730|FG000|Treated|Double-blind Treatment Period [6 Weeks]||0||
59849403|NCT03605836|75973731|FG001|Treated|Double-blind Treatment Period [6 Weeks]||145||
59849404|NCT03605836|75973732|FG002|Treated|Double-blind Treatment Period [6 Weeks]||143||
59849405|NCT03605836|75973733|FG003|Treated|Double-blind Treatment Period [6 Weeks]||142||
59849406|NCT03605836|75973730|FG000|COMPLETED|Double-blind Treatment Period [6 Weeks]||0||
59849407|NCT03605836|75973731|FG001|COMPLETED|Double-blind Treatment Period [6 Weeks]||111||
59849408|NCT03605836|75973732|FG002|COMPLETED|Double-blind Treatment Period [6 Weeks]||102||
59849409|NCT03605836|75973733|FG003|COMPLETED|Double-blind Treatment Period [6 Weeks]||123||
59849410|NCT03605836|75973730|FG000|NOT COMPLETED|Double-blind Treatment Period [6 Weeks]||0||
59849411|NCT03605836|75973731|FG001|NOT COMPLETED|Double-blind Treatment Period [6 Weeks]||36||
59849412|NCT03605836|75973732|FG002|NOT COMPLETED|Double-blind Treatment Period [6 Weeks]||45||
59849413|NCT03605836|75973733|FG003|NOT COMPLETED|Double-blind Treatment Period [6 Weeks]||23||
59849414|NCT03605680|75973746|FG000|STARTED|SB Placebo Run-in Period (1 Week)||604||
59849415|NCT03605680|75973747|FG001|STARTED|SB Placebo Run-in Period (1 Week)||0||
59849416|NCT03605680|75973748|FG002|STARTED|SB Placebo Run-in Period (1 Week)||0||
59849417|NCT03605680|75973749|FG003|STARTED|SB Placebo Run-in Period (1 Week)||0||
59849418|NCT03605680|75973746|FG000|Treated|SB Placebo Run-in Period (1 Week)||584||
59849419|NCT03605680|75973747|FG001|Treated|SB Placebo Run-in Period (1 Week)||0||
59849420|NCT03605680|75973748|FG002|Treated|SB Placebo Run-in Period (1 Week)||0||
59849421|NCT03605680|75973749|FG003|Treated|SB Placebo Run-in Period (1 Week)||0||
59849422|NCT03605680|75973746|FG000|COMPLETED|SB Placebo Run-in Period (1 Week)||466||
59849423|NCT03605680|75973747|FG001|COMPLETED|SB Placebo Run-in Period (1 Week)||0||
59849424|NCT03605680|75973748|FG002|COMPLETED|SB Placebo Run-in Period (1 Week)||0||
59849425|NCT03605680|75973749|FG003|COMPLETED|SB Placebo Run-in Period (1 Week)||0||
59849426|NCT03605680|75973746|FG000|NOT COMPLETED|SB Placebo Run-in Period (1 Week)||138||
59849427|NCT03605680|75973747|FG001|NOT COMPLETED|SB Placebo Run-in Period (1 Week)||0||
59849428|NCT03605680|75973748|FG002|NOT COMPLETED|SB Placebo Run-in Period (1 Week)||0||
59849429|NCT03605680|75973749|FG003|NOT COMPLETED|SB Placebo Run-in Period (1 Week)||0||
59849430|NCT03605680|75973746|FG000|STARTED|Double-blind Treatment Period (6 Weeks)||0||
59849431|NCT03605680|75973747|FG001|STARTED|Double-blind Treatment Period (6 Weeks)||154||
59849432|NCT03605680|75973748|FG002|STARTED|Double-blind Treatment Period (6 Weeks)||156||
59849433|NCT03605680|75973749|FG003|STARTED|Double-blind Treatment Period (6 Weeks)||156||
59849434|NCT03605680|75973746|FG000|COMPLETED|Double-blind Treatment Period (6 Weeks)||0||
59849435|NCT03605680|75973747|FG001|COMPLETED|Double-blind Treatment Period (6 Weeks)||110||
59849436|NCT03605680|75973748|FG002|COMPLETED|Double-blind Treatment Period (6 Weeks)||117||
59849437|NCT03605680|75973749|FG003|COMPLETED|Double-blind Treatment Period (6 Weeks)||121||
59849438|NCT03605680|75973746|FG000|NOT COMPLETED|Double-blind Treatment Period (6 Weeks)||0||
59849439|NCT03605680|75973747|FG001|NOT COMPLETED|Double-blind Treatment Period (6 Weeks)||44||
59849440|NCT03605680|75973748|FG002|NOT COMPLETED|Double-blind Treatment Period (6 Weeks)||39||
59849441|NCT03605680|75973749|FG003|NOT COMPLETED|Double-blind Treatment Period (6 Weeks)||35||
59849442|NCT03572218|75973760|FG000|STARTED|Overall Study||36||
59849443|NCT03572218|75973761|FG001|STARTED|Overall Study||36||
59849444|NCT03572218|75973760|FG000|Week 12|Overall Study||30||
59849445|NCT03572218|75973761|FG001|Week 12|Overall Study||31||
59849446|NCT03572218|75973760|FG000|Week 26|Overall Study||30||
59849447|NCT03572218|75973761|FG001|Week 26|Overall Study||31||
59849448|NCT03572218|75973760|FG000|COMPLETED|Overall Study||30||
59849449|NCT03572218|75973761|FG001|COMPLETED|Overall Study||31||
59849450|NCT03572218|75973760|FG000|NOT COMPLETED|Overall Study||6||
59849451|NCT03572218|75973761|FG001|NOT COMPLETED|Overall Study||5||
59849452|NCT00111813|75973767|FG000|STARTED|Overall Study||3||
59849453|NCT00111813|75973768|FG001|STARTED|Overall Study||3||
59849454|NCT00111813|75973769|FG002|STARTED|Overall Study||10||
59849455|NCT00111813|75973770|FG003|STARTED|Overall Study||6||
59849456|NCT00111813|75973771|FG004|STARTED|Overall Study||6||
59849457|NCT00111813|75973772|FG005|STARTED|Overall Study||6||
59849458|NCT00111813|75973767|FG000|COMPLETED|Overall Study||0||
59849459|NCT00111813|75973768|FG001|COMPLETED|Overall Study||0||
59849460|NCT00111813|75973769|FG002|COMPLETED|Overall Study||0||
59849461|NCT00111813|75973770|FG003|COMPLETED|Overall Study||1||
59849462|NCT00111813|75973771|FG004|COMPLETED|Overall Study||0||
59849463|NCT00111813|75973772|FG005|COMPLETED|Overall Study||0||
59849464|NCT00111813|75973767|FG000|NOT COMPLETED|Overall Study||3||
59849465|NCT00111813|75973768|FG001|NOT COMPLETED|Overall Study||3||
59849466|NCT00111813|75973769|FG002|NOT COMPLETED|Overall Study||10||
59849467|NCT00111813|75973770|FG003|NOT COMPLETED|Overall Study||5||
59849468|NCT00111813|75973771|FG004|NOT COMPLETED|Overall Study||6||
59849469|NCT00111813|75973772|FG005|NOT COMPLETED|Overall Study||6||
59849470|NCT00118287|75973787|FG000|STARTED|Overall Study||32||
59849471|NCT00118287|75973787|FG000|COMPLETED|Overall Study||30||
59849472|NCT00118287|75973787|FG000|NOT COMPLETED|Overall Study||2||
59849473|NCT00130689|75973791|FG000|STARTED|Overall Study||43||
59849474|NCT00130689|75973791|FG000|Eligible|Overall Study||37||
59849475|NCT00130689|75973791|FG000|Treated|Overall Study||35||
59849476|NCT00130689|75973791|FG000|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0||
59849477|NCT00130689|75973791|FG000|NOT COMPLETED|Overall Study||43||
59849478|NCT03605212|75973800|FG000|STARTED|Baseline Period||3||
59849479|NCT03605212|75973801|FG001|STARTED|Baseline Period||0||
59849480|NCT03605212|75973802|FG002|STARTED|Baseline Period||3||
59849481|NCT03605212|75973803|FG003|STARTED|Baseline Period||0||
59849482|NCT03605212|75973804|FG004|STARTED|Baseline Period||24||
59849483|NCT03605212|75973800|FG000|COMPLETED|Baseline Period||3||
60120592|NCT01587703|76241785|FG002|STARTED|Part1 QD(Median Exposure of 1.38months)||1||
60120593|NCT01587703|76241786|FG003|STARTED|Part1 QD(Median Exposure of 1.38months)||3||
59849484|NCT03605212|75973801|FG001|COMPLETED|Baseline Period||0||
59849485|NCT03605212|75973802|FG002|COMPLETED|Baseline Period||3||
59849486|NCT03605212|75973803|FG003|COMPLETED|Baseline Period||0||
59849487|NCT03605212|75973804|FG004|COMPLETED|Baseline Period||24||
59849488|NCT03605212|75973800|FG000|NOT COMPLETED|Baseline Period||0||
59849489|NCT03605212|75973801|FG001|NOT COMPLETED|Baseline Period||0||
59849490|NCT03605212|75973802|FG002|NOT COMPLETED|Baseline Period||0||
59849491|NCT03605212|75973803|FG003|NOT COMPLETED|Baseline Period||0||
59849492|NCT03605212|75973804|FG004|NOT COMPLETED|Baseline Period||0||
59849493|NCT03605212|75973800|FG000|STARTED|Treatment Period||3||
59849494|NCT03605212|75973801|FG001|STARTED|Treatment Period||0||
59849495|NCT03605212|75973802|FG002|STARTED|Treatment Period||3||
59849496|NCT03605212|75973803|FG003|STARTED|Treatment Period||0||
59849497|NCT03605212|75973804|FG004|STARTED|Treatment Period||24||
59849498|NCT03605212|75973800|FG000|COMPLETED|Treatment Period||2||
60120594|NCT01587703|76241787|FG004|STARTED|Part1 QD(Median Exposure of 1.38months)||4||
59849499|NCT03605212|75973801|FG001|COMPLETED|Treatment Period||0||
59849500|NCT03605212|75973802|FG002|COMPLETED|Treatment Period||3||
59849501|NCT03605212|75973803|FG003|COMPLETED|Treatment Period||0||
59849502|NCT03605212|75973804|FG004|COMPLETED|Treatment Period||23||
59849503|NCT03605212|75973800|FG000|NOT COMPLETED|Treatment Period||1||
59849504|NCT03605212|75973801|FG001|NOT COMPLETED|Treatment Period||0||
59849505|NCT03605212|75973802|FG002|NOT COMPLETED|Treatment Period||0||
59849506|NCT03605212|75973803|FG003|NOT COMPLETED|Treatment Period||0||
59849507|NCT03605212|75973804|FG004|NOT COMPLETED|Treatment Period||1||
59849508|NCT03603652|75973817|FG000|STARTED|Overall Study||10||
59849509|NCT03603652|75973817|FG000|COMPLETED|Overall Study||8||
59849510|NCT03603652|75973817|FG000|NOT COMPLETED|Overall Study||2||
59849511|NCT00117507|75973821|FG000|STARTED|Overall Study||24||
59849512|NCT00117507|75973821|FG000|COMPLETED|Overall Study||9||
59849513|NCT00117507|75973821|FG000|NOT COMPLETED|Overall Study||15||
59849514|NCT03603496|75973828|FG000|STARTED|Overall Study||706||
59849515|NCT03603496|75973829|FG001|STARTED|Overall Study||703||
59849516|NCT03603496|75973828|FG000|COMPLETED|Overall Study||520||
59849517|NCT03603496|75973829|FG001|COMPLETED|Overall Study||518||
59849518|NCT03603496|75973828|FG000|NOT COMPLETED|Overall Study||186||
59849519|NCT03603496|75973829|FG001|NOT COMPLETED|Overall Study||185||
59849520|NCT03603028|75973835|FG000|STARTED|Overall Study||13||
59849521|NCT03603028|75973835|FG000|COMPLETED|Overall Study||12||
59849522|NCT03603028|75973835|FG000|NOT COMPLETED|Overall Study||1||
59849523|NCT03602482|75973841|FG000|STARTED|Overall Study||50||
59849524|NCT03602482|75973842|FG001|STARTED|Overall Study||50||
59849525|NCT03602482|75973843|FG002|STARTED|Overall Study||20||
59849526|NCT03602482|75973844|FG003|STARTED|Overall Study||19||
59849527|NCT03602482|75973841|FG000|COMPLETED|Overall Study||44||
59849528|NCT03602482|75973842|FG001|COMPLETED|Overall Study||43||
59849529|NCT03602482|75973843|FG002|COMPLETED|Overall Study||20||
59849530|NCT03602482|75973844|FG003|COMPLETED|Overall Study||19||
59849531|NCT03602482|75973841|FG000|NOT COMPLETED|Overall Study||6||
59849532|NCT03602482|75973842|FG001|NOT COMPLETED|Overall Study||7||
59849533|NCT03602482|75973843|FG002|NOT COMPLETED|Overall Study||0||
59849534|NCT03602482|75973844|FG003|NOT COMPLETED|Overall Study||0||
59849535|NCT00096135|75973859|FG000|STARTED|Overall Study||126||
59849536|NCT00096135|75973860|FG001|STARTED|Overall Study||42||
59849537|NCT00096135|75973859|FG000|COMPLETED|Overall Study||63||
59849538|NCT00096135|75973860|FG001|COMPLETED|Overall Study||27||
59849539|NCT00096135|75973859|FG000|NOT COMPLETED|Overall Study||63||
59849540|NCT00096135|75973860|FG001|NOT COMPLETED|Overall Study||15||
59849541|NCT00116805|75973868|FG000|STARTED|Double-blind Period Through Week 48||176||
59849542|NCT00116805|75973869|FG001|STARTED|Double-blind Period Through Week 48||90||
59849543|NCT00116805|75973868|FG000|COMPLETED|Double-blind Period Through Week 48||165||
59849544|NCT00116805|75973869|FG001|COMPLETED|Double-blind Period Through Week 48||85||
59849545|NCT00116805|75973868|FG000|NOT COMPLETED|Double-blind Period Through Week 48||11||
59849546|NCT00116805|75973869|FG001|NOT COMPLETED|Double-blind Period Through Week 48||5||
59720418|NCT04329832|75839426|FG000|NOT COMPLETED|Overall Study||0||
59720419|NCT04329832|75839427|FG001|NOT COMPLETED|Overall Study||0||
59720420|NCT00874939|75839441|FG000|STARTED|Overall Study||4||
59720421|NCT00874939|75839441|FG000|Treated|Overall Study||0||
59720422|NCT00874939|75839441|FG000|COMPLETED|Overall Study||0||
59720423|NCT00874939|75839441|FG000|NOT COMPLETED|Overall Study||4||
59720424|NCT00875563|75839451|FG000|STARTED|Overall Study||42||
59720425|NCT00875563|75839451|FG000|COMPLETED|Overall Study||18||
59720426|NCT00875563|75839451|FG000|NOT COMPLETED|Overall Study||24||
59720427|NCT01155869|75839457|FG000|STARTED|Overall Study||3||
59720428|NCT01155869|75839458|FG001|STARTED|Overall Study||4||
59720429|NCT01155869|75839457|FG000|COMPLETED|Overall Study||0||
59720430|NCT01155869|75839458|FG001|COMPLETED|Overall Study||3||
59720431|NCT01155869|75839457|FG000|NOT COMPLETED|Overall Study||3||
59720432|NCT01155869|75839458|FG001|NOT COMPLETED|Overall Study||1||
59720433|NCT01185353|75839469|FG000|STARTED|Part A (Weeks 0 Through 12)||49||
59720434|NCT01185353|75839470|FG001|STARTED|Part A (Weeks 0 Through 12)||52||
59849547|NCT00116805|75973868|FG000|STARTED|Open-label Period Weeks 49 - 96|11 participants completed 48 weeks but did not continue on study.|154||
59849548|NCT00116805|75973869|FG001|STARTED|Open-label Period Weeks 49 - 96|1 participant completed 48 weeks but did not continue on study.|84||
59720435|NCT01185353|75839471|FG002|STARTED|Part A (Weeks 0 Through 12)||52||
59720436|NCT01185353|75839472|FG003|STARTED|Part A (Weeks 0 Through 12)||50||
59849549|NCT00116805|75973868|FG000|COMPLETED|Open-label Period Weeks 49 - 96||144||
59849550|NCT00116805|75973869|FG001|COMPLETED|Open-label Period Weeks 49 - 96||83||
59849551|NCT00116805|75973868|FG000|NOT COMPLETED|Open-label Period Weeks 49 - 96||10||
59720437|NCT01185353|75839473|FG004|STARTED|Part A (Weeks 0 Through 12)||98||
59720438|NCT01185353|75839474|FG005|STARTED|Part A (Weeks 0 Through 12)||0||
59720439|NCT01185353|75839475|FG006|STARTED|Part A (Weeks 0 Through 12)||0||
59849552|NCT00116805|75973869|FG001|NOT COMPLETED|Open-label Period Weeks 49 - 96||1||
59849553|NCT00116805|75973868|FG000|STARTED|Open-label Period Weeks 97 - 144||144||
59849554|NCT00116805|75973869|FG001|STARTED|Open-label Period Weeks 97 - 144||83||
59849555|NCT00116805|75973868|FG000|COMPLETED|Open-label Period Weeks 97 - 144||133||
59849556|NCT00116805|75973869|FG001|COMPLETED|Open-label Period Weeks 97 - 144||74||
59849557|NCT00116805|75973868|FG000|NOT COMPLETED|Open-label Period Weeks 97 - 144||11||
59849558|NCT00116805|75973869|FG001|NOT COMPLETED|Open-label Period Weeks 97 - 144||9||
59849559|NCT00116805|75973868|FG000|STARTED|Open-label Period Weeks 145 - 192||133||
59849560|NCT00116805|75973869|FG001|STARTED|Open-label Period Weeks 145 - 192||74||
59849561|NCT00116805|75973868|FG000|COMPLETED|Open-label Period Weeks 145 - 192||123||
59849562|NCT00116805|75973869|FG001|COMPLETED|Open-label Period Weeks 145 - 192||68||
59849563|NCT00116805|75973868|FG000|NOT COMPLETED|Open-label Period Weeks 145 - 192||10||
59849564|NCT00116805|75973869|FG001|NOT COMPLETED|Open-label Period Weeks 145 - 192||6||
59849565|NCT00116805|75973868|FG000|STARTED|Open-label Period Weeks 193 - 240||123||
59849566|NCT00116805|75973869|FG001|STARTED|Open-label Period Weeks 193 - 240||68||
59849567|NCT00116805|75973868|FG000|COMPLETED|Open-label Period Weeks 193 - 240||110||
59849568|NCT00116805|75973869|FG001|COMPLETED|Open-label Period Weeks 193 - 240||64||
59849569|NCT00116805|75973868|FG000|NOT COMPLETED|Open-label Period Weeks 193 - 240||13||
59849570|NCT00116805|75973869|FG001|NOT COMPLETED|Open-label Period Weeks 193 - 240||4||
59849571|NCT00116805|75973868|FG000|STARTED|Open-label Period Weeks 241 - 288||110||
59849572|NCT00116805|75973869|FG001|STARTED|Open-label Period Weeks 241 - 288||64||
59849573|NCT00116805|75973868|FG000|COMPLETED|Open-label Period Weeks 241 - 288||104||
59849574|NCT00116805|75973869|FG001|COMPLETED|Open-label Period Weeks 241 - 288||64||
60120595|NCT01587703|76241788|FG005|STARTED|Part1 QD(Median Exposure of 1.38months)||9||
60120596|NCT01587703|76241789|FG006|STARTED|Part1 QD(Median Exposure of 1.38months)||32||
59720440|NCT01185353|75839476|FG007|STARTED|Part A (Weeks 0 Through 12)||0||
59720441|NCT01185353|75839477|FG008|STARTED|Part A (Weeks 0 Through 12)||0||
59720442|NCT01185353|75839478|FG009|STARTED|Part A (Weeks 0 Through 12)||0||
59720443|NCT01185353|75839469|FG000|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||49||
59720444|NCT01185353|75839470|FG001|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||52||
59720445|NCT01185353|75839471|FG002|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||52||
59720446|NCT01185353|75839472|FG003|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||50||
59720447|NCT01185353|75839473|FG004|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||98||
59720448|NCT01185353|75839474|FG005|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0||
59720449|NCT01185353|75839475|FG006|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0||
59720450|NCT01185353|75839476|FG007|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0||
59720451|NCT01185353|75839477|FG008|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0||
59720452|NCT01185353|75839478|FG009|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0||
59720453|NCT01185353|75839469|FG000|COMPLETED|Part A (Weeks 0 Through 12)||44||
59720454|NCT01185353|75839470|FG001|COMPLETED|Part A (Weeks 0 Through 12)||51||
59720455|NCT01185353|75839471|FG002|COMPLETED|Part A (Weeks 0 Through 12)||50||
59720456|NCT01185353|75839472|FG003|COMPLETED|Part A (Weeks 0 Through 12)||49||
59720457|NCT01185353|75839473|FG004|COMPLETED|Part A (Weeks 0 Through 12)||82||
59720458|NCT01185353|75839474|FG005|COMPLETED|Part A (Weeks 0 Through 12)||0||
59720459|NCT01185353|75839475|FG006|COMPLETED|Part A (Weeks 0 Through 12)||0||
59849575|NCT00116805|75973868|FG000|NOT COMPLETED|Open-label Period Weeks 241 - 288||6||
59849576|NCT00116805|75973869|FG001|NOT COMPLETED|Open-label Period Weeks 241 - 288||0||
59849577|NCT00116805|75973868|FG000|STARTED|Open-label Period Weeks 289 - 336||104||
59849578|NCT00116805|75973869|FG001|STARTED|Open-label Period Weeks 289 - 336||64||
59849579|NCT00116805|75973868|FG000|COMPLETED|Open-label Period Weeks 289 - 336||98||
59849580|NCT00116805|75973869|FG001|COMPLETED|Open-label Period Weeks 289 - 336||57||
59849581|NCT00116805|75973868|FG000|NOT COMPLETED|Open-label Period Weeks 289 - 336||6||
59849582|NCT00116805|75973869|FG001|NOT COMPLETED|Open-label Period Weeks 289 - 336||7||
59849583|NCT00116805|75973868|FG000|STARTED|Open-label Period Weeks 337 - 384||98||
59849584|NCT00116805|75973869|FG001|STARTED|Open-label Period Weeks 337 - 384||57||
59849585|NCT00116805|75973868|FG000|COMPLETED|Open-label Period Weeks 337 - 384||90||
59849586|NCT00116805|75973869|FG001|COMPLETED|Open-label Period Weeks 337 - 384||56||
59849587|NCT00116805|75973868|FG000|NOT COMPLETED|Open-label Period Weeks 337 - 384||8||
59849588|NCT00116805|75973869|FG001|NOT COMPLETED|Open-label Period Weeks 337 - 384||1||
59849589|NCT00116805|75973868|FG000|STARTED|Open-label Period Weeks 385 - 432|31 participants completed 384 weeks but did not continue on study.|59||
59849590|NCT00116805|75973869|FG001|STARTED|Open-label Period Weeks 385 - 432|26 participants completed 384 weeks but did not continue on study.|30||
59849591|NCT00116805|75973868|FG000|COMPLETED|Open-label Period Weeks 385 - 432||57||
59849592|NCT00116805|75973869|FG001|COMPLETED|Open-label Period Weeks 385 - 432||30||
59849593|NCT00116805|75973868|FG000|NOT COMPLETED|Open-label Period Weeks 385 - 432||2||
59849594|NCT00116805|75973869|FG001|NOT COMPLETED|Open-label Period Weeks 385 - 432||0||
59849595|NCT00116805|75973868|FG000|STARTED|Open-label Period Weeks 433 - 480||57||
59849596|NCT00116805|75973869|FG001|STARTED|Open-label Period Weeks 433 - 480|1 participant completed 432 weeks but did not continue on study.|29||
59849597|NCT00116805|75973868|FG000|COMPLETED|Open-label Period Weeks 433 - 480||53||
60120597|NCT01587703|76241790|FG007|STARTED|Part1 QD(Median Exposure of 1.38months)||9||
59849598|NCT00116805|75973869|FG001|COMPLETED|Open-label Period Weeks 433 - 480||29||
59849599|NCT00116805|75973868|FG000|NOT COMPLETED|Open-label Period Weeks 433 - 480||4||
59849600|NCT00116805|75973869|FG001|NOT COMPLETED|Open-label Period Weeks 433 - 480||0||
59849601|NCT00116649|75973884|FG000|STARTED|Overall Study|586 screened (34 not eligible) 552 enrolled 551 study population (1 subject not treated)|551||
59849602|NCT00116649|75973884|FG000|COMPLETED|Overall Study||396||
59849603|NCT00116649|75973884|FG000|NOT COMPLETED|Overall Study||155||
59720460|NCT01185353|75839476|FG007|COMPLETED|Part A (Weeks 0 Through 12)||0||
59720461|NCT01185353|75839477|FG008|COMPLETED|Part A (Weeks 0 Through 12)||0||
59720462|NCT01185353|75839478|FG009|COMPLETED|Part A (Weeks 0 Through 12)||0||
59849604|NCT00083889|75973890|FG000|STARTED|Overall Study||375||
59849605|NCT00083889|75973891|FG001|STARTED|Overall Study||375||
59849606|NCT00083889|75973890|FG000|Received Treatment|Overall Study||375||
59849607|NCT00083889|75973891|FG001|Received Treatment|Overall Study|15 subjects randomized to IFN-α discontinued before receiving their first dose of study medication.|360||
59849608|NCT00083889|75973890|FG000|COMPLETED|Overall Study||0||
59849609|NCT00083889|75973891|FG001|COMPLETED|Overall Study|Discontinuation crossover subjects: AEs 5,consent withdrawn 2, lack efficacy 13, sponsor decision 5.|0||
59849610|NCT00083889|75973890|FG000|NOT COMPLETED|Overall Study||375||
59849611|NCT00083889|75973891|FG001|NOT COMPLETED|Overall Study||375||
59849612|NCT03572062|75973910|FG000|STARTED|Overall Study||32||
59849613|NCT03572062|75973911|FG001|STARTED|Overall Study||32||
59849614|NCT03572062|75973912|FG002|STARTED|Overall Study||32||
59849615|NCT03572062|75973913|FG003|STARTED|Overall Study||31||
59849616|NCT03572062|75973914|FG004|STARTED|Overall Study||32||
59849617|NCT03572062|75973915|FG005|STARTED|Overall Study||32||
59849618|NCT03572062|75973916|FG006|STARTED|Overall Study||32||
59849619|NCT03572062|75973917|FG007|STARTED|Overall Study||31||
59849620|NCT03572062|75973918|FG008|STARTED|Overall Study||32||
59849621|NCT03572062|75973919|FG009|STARTED|Overall Study||31||
59849622|NCT03572062|75973910|FG000|Treated|Overall Study||32||
59849623|NCT03572062|75973911|FG001|Treated|Overall Study||32||
59849624|NCT03572062|75973912|FG002|Treated|Overall Study||32||
59849625|NCT03572062|75973913|FG003|Treated|Overall Study||31||
59849626|NCT03572062|75973914|FG004|Treated|Overall Study||31||
59849627|NCT03572062|75973915|FG005|Treated|Overall Study||30||
59849628|NCT03572062|75973916|FG006|Treated|Overall Study||32||
59849629|NCT03572062|75973917|FG007|Treated|Overall Study||30||
59849630|NCT03572062|75973918|FG008|Treated|Overall Study||32||
59849631|NCT03572062|75973919|FG009|Treated|Overall Study||31||
59849632|NCT03572062|75973910|FG000|COMPLETED|Overall Study||32||
59849633|NCT03572062|75973911|FG001|COMPLETED|Overall Study||32||
59849634|NCT03572062|75973912|FG002|COMPLETED|Overall Study||32||
59849635|NCT03572062|75973913|FG003|COMPLETED|Overall Study||31||
59849636|NCT03572062|75973914|FG004|COMPLETED|Overall Study||31||
59849637|NCT03572062|75973915|FG005|COMPLETED|Overall Study||28||
59849638|NCT03572062|75973916|FG006|COMPLETED|Overall Study||31||
59849639|NCT03572062|75973917|FG007|COMPLETED|Overall Study||30||
59849640|NCT03572062|75973918|FG008|COMPLETED|Overall Study||0||
59849641|NCT03572062|75973919|FG009|COMPLETED|Overall Study||0||
59849642|NCT03572062|75973910|FG000|NOT COMPLETED|Overall Study||0||
59849643|NCT03572062|75973911|FG001|NOT COMPLETED|Overall Study||0||
59849644|NCT03572062|75973912|FG002|NOT COMPLETED|Overall Study||0||
59849645|NCT03572062|75973913|FG003|NOT COMPLETED|Overall Study||0||
59849646|NCT03572062|75973914|FG004|NOT COMPLETED|Overall Study||1||
59849647|NCT03572062|75973915|FG005|NOT COMPLETED|Overall Study||4||
59849648|NCT03572062|75973916|FG006|NOT COMPLETED|Overall Study||1||
59849649|NCT03572062|75973917|FG007|NOT COMPLETED|Overall Study||1||
59849650|NCT03572062|75973918|FG008|NOT COMPLETED|Overall Study||32||
59849651|NCT03572062|75973919|FG009|NOT COMPLETED|Overall Study||31||
59849652|NCT03571516|75973941|FG000|STARTED|Overall Study||5||
59849653|NCT03571516|75973942|FG001|STARTED|Overall Study||5||
59849654|NCT03571516|75973941|FG000|COMPLETED|Overall Study||4||
59849655|NCT03571516|75973942|FG001|COMPLETED|Overall Study||4||
59849656|NCT03571516|75973941|FG000|NOT COMPLETED|Overall Study||1||
59849657|NCT03571516|75973942|FG001|NOT COMPLETED|Overall Study||1||
59849658|NCT03600376|75973950|FG000|STARTED|Overall Study||9||
59849659|NCT03600376|75973951|FG001|STARTED|Overall Study||8||
59849660|NCT03600376|75973950|FG000|COMPLETED|Overall Study||7||
59849661|NCT03600376|75973951|FG001|COMPLETED|Overall Study||2||
59849662|NCT03600376|75973950|FG000|NOT COMPLETED|Overall Study||2||
59849663|NCT03600376|75973951|FG001|NOT COMPLETED|Overall Study||6||
59849664|NCT03599362|75973957|FG000|STARTED|Overall Study||7||
59849665|NCT03599362|75973957|FG000|COMPLETED|Overall Study||4||
59849666|NCT03599362|75973957|FG000|NOT COMPLETED|Overall Study||3||
59849667|NCT03598036|75973963|FG000|STARTED|Overall Study||5||
59996699|NCT02714569|76112509|FG006|STARTED|Part B (Overall)|Part B participants randomized to receive 5 mg of LY3202328 + atorvastatin/simvastatin.|8||
59720463|NCT01185353|75839469|FG000|NOT COMPLETED|Part A (Weeks 0 Through 12)||5||
59720464|NCT01185353|75839470|FG001|NOT COMPLETED|Part A (Weeks 0 Through 12)||1||
59720465|NCT01185353|75839471|FG002|NOT COMPLETED|Part A (Weeks 0 Through 12)||2||
59720466|NCT01185353|75839472|FG003|NOT COMPLETED|Part A (Weeks 0 Through 12)||1||
59720467|NCT01185353|75839473|FG004|NOT COMPLETED|Part A (Weeks 0 Through 12)||16||
59720468|NCT01185353|75839474|FG005|NOT COMPLETED|Part A (Weeks 0 Through 12)||0||
59849668|NCT03598036|75973964|FG001|STARTED|Overall Study|Trial ended prematurely before any patients were enrolled into Cohort 2|0||
60120598|NCT01587703|76241791|FG008|STARTED|Part1 QD(Median Exposure of 1.38months)||0||
60120599|NCT01587703|76241792|FG009|STARTED|Part1 QD(Median Exposure of 1.38months)||0||
60120600|NCT01587703|76241793|FG010|STARTED|Part1 QD(Median Exposure of 1.38months)||0||
59720469|NCT01185353|75839475|FG006|NOT COMPLETED|Part A (Weeks 0 Through 12)||0||
59720470|NCT01185353|75839476|FG007|NOT COMPLETED|Part A (Weeks 0 Through 12)||0||
59720471|NCT01185353|75839477|FG008|NOT COMPLETED|Part A (Weeks 0 Through 12)||0||
59720472|NCT01185353|75839478|FG009|NOT COMPLETED|Part A (Weeks 0 Through 12)||0||
59720473|NCT01185353|75839469|FG000|STARTED|Part B (Weeks 12 Through 24)||0||
59720474|NCT01185353|75839470|FG001|STARTED|Part B (Weeks 12 Through 24)||51||
59720475|NCT01185353|75839471|FG002|STARTED|Part B (Weeks 12 Through 24)||50||
59720476|NCT01185353|75839472|FG003|STARTED|Part B (Weeks 12 Through 24)||49||
59720477|NCT01185353|75839473|FG004|STARTED|Part B (Weeks 12 Through 24)||0||
59720478|NCT01185353|75839474|FG005|STARTED|Part B (Weeks 12 Through 24)||63||
59720479|NCT01185353|75839475|FG006|STARTED|Part B (Weeks 12 Through 24)||63||
59720480|NCT01185353|75839476|FG007|STARTED|Part B (Weeks 12 Through 24)||0||
59720481|NCT01185353|75839477|FG008|STARTED|Part B (Weeks 12 Through 24)||0||
59720482|NCT01185353|75839478|FG009|STARTED|Part B (Weeks 12 Through 24)||0||
59720483|NCT01185353|75839469|FG000|COMPLETED|Part B (Weeks 12 Through 24)||0||
59720484|NCT01185353|75839470|FG001|COMPLETED|Part B (Weeks 12 Through 24)||50||
59720485|NCT01185353|75839471|FG002|COMPLETED|Part B (Weeks 12 Through 24)||48||
59720486|NCT01185353|75839472|FG003|COMPLETED|Part B (Weeks 12 Through 24)||45||
59720487|NCT01185353|75839473|FG004|COMPLETED|Part B (Weeks 12 Through 24)||0||
59720488|NCT01185353|75839474|FG005|COMPLETED|Part B (Weeks 12 Through 24)||59||
59720489|NCT01185353|75839475|FG006|COMPLETED|Part B (Weeks 12 Through 24)||57||
59720490|NCT01185353|75839476|FG007|COMPLETED|Part B (Weeks 12 Through 24)||0||
59720491|NCT01185353|75839477|FG008|COMPLETED|Part B (Weeks 12 Through 24)||0||
59720492|NCT01185353|75839478|FG009|COMPLETED|Part B (Weeks 12 Through 24)||0||
59720493|NCT01185353|75839469|FG000|NOT COMPLETED|Part B (Weeks 12 Through 24)||0||
59720494|NCT01185353|75839470|FG001|NOT COMPLETED|Part B (Weeks 12 Through 24)||1||
59720495|NCT01185353|75839471|FG002|NOT COMPLETED|Part B (Weeks 12 Through 24)||2||
59720496|NCT01185353|75839472|FG003|NOT COMPLETED|Part B (Weeks 12 Through 24)||4||
59720497|NCT01185353|75839473|FG004|NOT COMPLETED|Part B (Weeks 12 Through 24)||0||
59720498|NCT01185353|75839474|FG005|NOT COMPLETED|Part B (Weeks 12 Through 24)||4||
59720499|NCT01185353|75839475|FG006|NOT COMPLETED|Part B (Weeks 12 Through 24)||6||
59720500|NCT01185353|75839476|FG007|NOT COMPLETED|Part B (Weeks 12 Through 24)||0||
59720501|NCT01185353|75839477|FG008|NOT COMPLETED|Part B (Weeks 12 Through 24)||0||
59720502|NCT01185353|75839478|FG009|NOT COMPLETED|Part B (Weeks 12 Through 24)||0||
59720503|NCT01185353|75839469|FG000|STARTED|Part C (Weeks 24 Through 76)||0||
59720504|NCT01185353|75839470|FG001|STARTED|Part C (Weeks 24 Through 76)||0||
59720505|NCT01185353|75839471|FG002|STARTED|Part C (Weeks 24 Through 76)||0||
59720506|NCT01185353|75839472|FG003|STARTED|Part C (Weeks 24 Through 76)||0||
59720507|NCT01185353|75839473|FG004|STARTED|Part C (Weeks 24 Through 76)||0||
59720508|NCT01185353|75839474|FG005|STARTED|Part C (Weeks 24 Through 76)||0||
59720509|NCT01185353|75839475|FG006|STARTED|Part C (Weeks 24 Through 76)||0||
59720510|NCT01185353|75839476|FG007|STARTED|Part C (Weeks 24 Through 76)||108||
59720511|NCT01185353|75839477|FG008|STARTED|Part C (Weeks 24 Through 76)||61||
59720512|NCT01185353|75839478|FG009|STARTED|Part C (Weeks 24 Through 76)||32||
59720513|NCT01185353|75839469|FG000|COMPLETED|Part C (Weeks 24 Through 76)||0||
59720514|NCT01185353|75839470|FG001|COMPLETED|Part C (Weeks 24 Through 76)||0||
59720515|NCT01185353|75839471|FG002|COMPLETED|Part C (Weeks 24 Through 76)||0||
59720516|NCT01185353|75839472|FG003|COMPLETED|Part C (Weeks 24 Through 76)||0||
59720517|NCT01185353|75839473|FG004|COMPLETED|Part C (Weeks 24 Through 76)||0||
59720518|NCT01185353|75839474|FG005|COMPLETED|Part C (Weeks 24 Through 76)||0||
59720519|NCT01185353|75839475|FG006|COMPLETED|Part C (Weeks 24 Through 76)||0||
59720520|NCT01185353|75839476|FG007|COMPLETED|Part C (Weeks 24 Through 76)||92||
59720521|NCT01185353|75839477|FG008|COMPLETED|Part C (Weeks 24 Through 76)||53||
59720522|NCT01185353|75839478|FG009|COMPLETED|Part C (Weeks 24 Through 76)||24||
59720523|NCT01185353|75839469|FG000|NOT COMPLETED|Part C (Weeks 24 Through 76)||0||
59720524|NCT01185353|75839470|FG001|NOT COMPLETED|Part C (Weeks 24 Through 76)||0||
59849669|NCT03598036|75973963|FG000|Week 1: 7.9 mg Twice Daily|Overall Study||5||
59849670|NCT03598036|75973964|FG001|Week 1: 7.9 mg Twice Daily|Overall Study||0||
59720525|NCT01185353|75839471|FG002|NOT COMPLETED|Part C (Weeks 24 Through 76)||0||
59720526|NCT01185353|75839472|FG003|NOT COMPLETED|Part C (Weeks 24 Through 76)||0||
59720527|NCT01185353|75839473|FG004|NOT COMPLETED|Part C (Weeks 24 Through 76)||0||
59720528|NCT01185353|75839474|FG005|NOT COMPLETED|Part C (Weeks 24 Through 76)||0||
59720529|NCT01185353|75839475|FG006|NOT COMPLETED|Part C (Weeks 24 Through 76)||0||
59720530|NCT01185353|75839476|FG007|NOT COMPLETED|Part C (Weeks 24 Through 76)||16||
59849671|NCT03598036|75973963|FG000|Week 2: 15.9 mg Twice Daily|Overall Study||5||
59849672|NCT03598036|75973964|FG001|Week 2: 15.9 mg Twice Daily|Overall Study||0||
59849673|NCT03598036|75973963|FG000|Weeks 3 - 24: 23.7 mg Twice Daily|Overall Study|1 subject withdrew at Week 12|5||
59849674|NCT03598036|75973964|FG001|Weeks 3 - 24: 23.7 mg Twice Daily|Overall Study||0||
59849675|NCT03598036|75973963|FG000|COMPLETED|Overall Study||4||
59849676|NCT03598036|75973964|FG001|COMPLETED|Overall Study||0||
59849677|NCT03598036|75973963|FG000|NOT COMPLETED|Overall Study||1||
59849678|NCT03598036|75973964|FG001|NOT COMPLETED|Overall Study||0||
59849679|NCT00082407|75973974|FG000|STARTED|Overall Study||255||
59849680|NCT00082407|75973975|FG001|STARTED|Overall Study||250||
59849681|NCT00082407|75973974|FG000|Received Treatment (Intent to Treat)|Overall Study||253||
59849682|NCT00082407|75973975|FG001|Received Treatment (Intent to Treat)|Overall Study||248||
59849683|NCT00082407|75973974|FG000|COMPLETED|Overall Study||199||
59849684|NCT00082407|75973975|FG001|COMPLETED|Overall Study||223||
59849685|NCT00082407|75973974|FG000|NOT COMPLETED|Overall Study||56||
59849686|NCT00082407|75973975|FG001|NOT COMPLETED|Overall Study||27||
59849687|NCT03643432|75973983|FG000|STARTED|Overall Study||27||
59849688|NCT03643432|75973984|FG001|STARTED|Overall Study||21||
59849689|NCT03643432|75973983|FG000|COMPLETED|Overall Study||26||
59849690|NCT03643432|75973984|FG001|COMPLETED|Overall Study||21||
59849691|NCT03643432|75973983|FG000|NOT COMPLETED|Overall Study||1||
59849692|NCT03643432|75973984|FG001|NOT COMPLETED|Overall Study||0||
59849693|NCT03810183|75973992|FG000|STARTED|Overall Study||6||
59849694|NCT03810183|75973993|FG001|STARTED|Overall Study||3||
59849695|NCT03810183|75973992|FG000|COMPLETED|Overall Study||4||
59849696|NCT03810183|75973993|FG001|COMPLETED|Overall Study||2||
59849697|NCT03810183|75973992|FG000|NOT COMPLETED|Overall Study||2||
59849698|NCT03810183|75973993|FG001|NOT COMPLETED|Overall Study||1||
59849699|NCT03597022|75974003|FG000|STARTED|Overall Study||8||
59849700|NCT03597022|75974004|FG001|STARTED|Overall Study||8||
59849701|NCT03597022|75974005|FG002|STARTED|Overall Study||8||
59849702|NCT03597022|75974003|FG000|COMPLETED|Overall Study||0||
59849703|NCT03597022|75974004|FG001|COMPLETED|Overall Study||0||
59849704|NCT03597022|75974005|FG002|COMPLETED|Overall Study||0||
59849705|NCT03597022|75974003|FG000|NOT COMPLETED|Overall Study||8||
59849706|NCT03597022|75974004|FG001|NOT COMPLETED|Overall Study||8||
59849707|NCT03597022|75974005|FG002|NOT COMPLETED|Overall Study||8||
59849708|NCT03571204|75974016|FG000|STARTED|Overall Study||8||
59849709|NCT03571204|75974017|FG001|STARTED|Overall Study||8||
59849710|NCT03571204|75974018|FG002|STARTED|Overall Study||5||
59849711|NCT03571204|75974016|FG000|COMPLETED|Overall Study||7||
59849712|NCT03571204|75974017|FG001|COMPLETED|Overall Study||6||
59849713|NCT03571204|75974018|FG002|COMPLETED|Overall Study||5||
59849714|NCT03571204|75974016|FG000|NOT COMPLETED|Overall Study||1||
59849715|NCT03571204|75974017|FG001|NOT COMPLETED|Overall Study||2||
59849716|NCT03571204|75974018|FG002|NOT COMPLETED|Overall Study||0||
59849717|NCT03569098|75974030|FG000|STARTED|Double-Blind Treatment Cycle 1||63||
59849718|NCT03569098|75974031|FG001|STARTED|Double-Blind Treatment Cycle 1||63||
59849719|NCT03569098|75974032|FG002|STARTED|Double-Blind Treatment Cycle 1||60||
59849720|NCT03569098|75974030|FG000|Received Study Medication|Double-Blind Treatment Cycle 1||61||
59849721|NCT03569098|75974031|FG001|Received Study Medication|Double-Blind Treatment Cycle 1||63||
59849722|NCT03569098|75974032|FG002|Received Study Medication|Double-Blind Treatment Cycle 1||56||
59849723|NCT03569098|75974030|FG000|COMPLETED|Double-Blind Treatment Cycle 1||55|Completed the double-blind treatment cycle 1.|
59849724|NCT03569098|75974031|FG001|COMPLETED|Double-Blind Treatment Cycle 1||53|Completed the double-blind treatment cycle 1.|
59849725|NCT03569098|75974032|FG002|COMPLETED|Double-Blind Treatment Cycle 1||49|Completed the double-blind treatment cycle 1.|
59849726|NCT03569098|75974030|FG000|NOT COMPLETED|Double-Blind Treatment Cycle 1||8||
59849727|NCT03569098|75974031|FG001|NOT COMPLETED|Double-Blind Treatment Cycle 1||10||
59720531|NCT01185353|75839477|FG008|NOT COMPLETED|Part C (Weeks 24 Through 76)||8||
59720532|NCT01185353|75839478|FG009|NOT COMPLETED|Part C (Weeks 24 Through 76)||8||
59720533|NCT01185353|75839469|FG000|STARTED|Part D (Weeks 76 Through 128)||0||
59720534|NCT01185353|75839470|FG001|STARTED|Part D (Weeks 76 Through 128)||0||
59720535|NCT01185353|75839471|FG002|STARTED|Part D (Weeks 76 Through 128)||0||
59849728|NCT03569098|75974032|FG002|NOT COMPLETED|Double-Blind Treatment Cycle 1||11||
59849729|NCT03569098|75974030|FG000|STARTED|Open-Label Treatment Cycle 2|No participants were treated with placebo during the open-label treatment cycle 2.|0||
59720536|NCT01185353|75839472|FG003|STARTED|Part D (Weeks 76 Through 128)||0||
59720537|NCT01185353|75839473|FG004|STARTED|Part D (Weeks 76 Through 128)||0||
59720538|NCT01185353|75839474|FG005|STARTED|Part D (Weeks 76 Through 128)||0||
59720539|NCT01185353|75839475|FG006|STARTED|Part D (Weeks 76 Through 128)||0||
59849730|NCT03569098|75974031|FG001|STARTED|Open-Label Treatment Cycle 2|All participants who met retreatment criteria were treated with Dysport 300 U during the open-label treatment cycle 2.|146||
59849731|NCT03569098|75974032|FG002|STARTED|Open-Label Treatment Cycle 2|No participants were treated with Dysport 500 U during the open-label treatment cycle 2.|0||
59849732|NCT03569098|75974030|FG000|COMPLETED|Open-Label Treatment Cycle 2||0|Completed the open-label treatment cycle 2.|
59849733|NCT03569098|75974031|FG001|COMPLETED|Open-Label Treatment Cycle 2||111|Completed the open-label treatment cycle 2.|
59849734|NCT03569098|75974032|FG002|COMPLETED|Open-Label Treatment Cycle 2||0|Completed the open-label treatment cycle 2.|
59849735|NCT03569098|75974030|FG000|NOT COMPLETED|Open-Label Treatment Cycle 2||0||
59849736|NCT03569098|75974031|FG001|NOT COMPLETED|Open-Label Treatment Cycle 2||35||
59849737|NCT03569098|75974032|FG002|NOT COMPLETED|Open-Label Treatment Cycle 2||0||
59849738|NCT03569098|75974030|FG000|STARTED|Open-Label Treatment Cycle 3||0||
59849739|NCT03569098|75974031|FG001|STARTED|Open-Label Treatment Cycle 3|Participants were treated with Dysport 300 U during open-label treatment cycle 3 based on investigator judgment following clinical evaluation of the participant at the time of retreatment.|8||
59849740|NCT03569098|75974032|FG002|STARTED|Open-Label Treatment Cycle 3|Participants were treated with Dysport 500 U during open-label treatment cycle 3 based on investigator judgment following clinical evaluation of the participant at the time of retreatment.|56||
59849741|NCT03569098|75974030|FG000|COMPLETED|Open-Label Treatment Cycle 3||0|Completed the open-label treatment cycle 3.|
59849742|NCT03569098|75974031|FG001|COMPLETED|Open-Label Treatment Cycle 3||7|Completed the open-label treatment cycle 3.|
59849743|NCT03569098|75974032|FG002|COMPLETED|Open-Label Treatment Cycle 3||50|Completed the open-label treatment cycle 3.|
59849744|NCT03569098|75974030|FG000|NOT COMPLETED|Open-Label Treatment Cycle 3||0||
59849745|NCT03569098|75974031|FG001|NOT COMPLETED|Open-Label Treatment Cycle 3||1||
59849746|NCT03569098|75974032|FG002|NOT COMPLETED|Open-Label Treatment Cycle 3||6||
59849747|NCT03568942|75974043|FG000|STARTED|Overall Study||22||
59849748|NCT03568942|75974043|FG000|COMPLETED|Overall Study||20||
59849749|NCT03568942|75974043|FG000|NOT COMPLETED|Overall Study||2||
59849750|NCT00110019|75974049|FG000|STARTED|Overall Study||410||
59849751|NCT00110019|75974050|FG001|STARTED|Overall Study||413||
59849752|NCT00110019|75974049|FG000|Eligible|Overall Study||395||
59849753|NCT00110019|75974050|FG001|Eligible|Overall Study||398||
59849754|NCT00110019|75974049|FG000|Treated|Overall Study||393||
59849755|NCT00110019|75974050|FG001|Treated|Overall Study||397||
59849756|NCT00110019|75974049|FG000|COMPLETED|Overall Study||4||
59849757|NCT00110019|75974050|FG001|COMPLETED|Overall Study||0||
59849758|NCT00110019|75974049|FG000|NOT COMPLETED|Overall Study||406||
59849759|NCT00110019|75974050|FG001|NOT COMPLETED|Overall Study||413||
59849760|NCT03595618|75974060|FG000|STARTED|Overall Study||234||
59849761|NCT03595618|75974061|FG001|STARTED|Overall Study||231||
59849762|NCT03595618|75974062|FG002|STARTED|Overall Study||233||
59849763|NCT03595618|75974063|FG003|STARTED|Overall Study||234||
59849764|NCT03595618|75974060|FG000|Treated|Overall Study||234|All participants having taken at least one dose of investigational medicinal product (IMP)|
59849765|NCT03595618|75974061|FG001|Treated|Overall Study||231|All participants having taken at least one dose of investigational medicinal product (IMP)|
59849766|NCT03595618|75974062|FG002|Treated|Overall Study||232|All participants having taken at least one dose of investigational medicinal product (IMP)|
59849767|NCT03595618|75974063|FG003|Treated|Overall Study||234|All participants having taken at least one dose of investigational medicinal product (IMP)|
59849768|NCT03595618|75974060|FG000|COMPLETED|Overall Study||191||
59849769|NCT03595618|75974061|FG001|COMPLETED|Overall Study||191||
59849770|NCT03595618|75974062|FG002|COMPLETED|Overall Study||177||
59849771|NCT03595618|75974063|FG003|COMPLETED|Overall Study||200||
59849772|NCT03595618|75974060|FG000|NOT COMPLETED|Overall Study||43||
59849773|NCT03595618|75974061|FG001|NOT COMPLETED|Overall Study||40||
59849774|NCT03595618|75974062|FG002|NOT COMPLETED|Overall Study||56||
59720540|NCT01185353|75839476|FG007|STARTED|Part D (Weeks 76 Through 128)||79||
59720541|NCT01185353|75839477|FG008|STARTED|Part D (Weeks 76 Through 128)||47||
59720542|NCT01185353|75839478|FG009|STARTED|Part D (Weeks 76 Through 128)||18||
59720543|NCT01185353|75839469|FG000|COMPLETED|Part D (Weeks 76 Through 128)||0||
59720544|NCT01185353|75839470|FG001|COMPLETED|Part D (Weeks 76 Through 128)||0||
59720545|NCT01185353|75839471|FG002|COMPLETED|Part D (Weeks 76 Through 128)||0||
59720546|NCT01185353|75839472|FG003|COMPLETED|Part D (Weeks 76 Through 128)||0||
59720547|NCT01185353|75839473|FG004|COMPLETED|Part D (Weeks 76 Through 128)||0||
59720548|NCT01185353|75839474|FG005|COMPLETED|Part D (Weeks 76 Through 128)||0||
59720549|NCT01185353|75839475|FG006|COMPLETED|Part D (Weeks 76 Through 128)||0||
59720550|NCT01185353|75839476|FG007|COMPLETED|Part D (Weeks 76 Through 128)||76||
59720551|NCT01185353|75839477|FG008|COMPLETED|Part D (Weeks 76 Through 128)||40||
59720552|NCT01185353|75839478|FG009|COMPLETED|Part D (Weeks 76 Through 128)||17||
59720553|NCT01185353|75839469|FG000|NOT COMPLETED|Part D (Weeks 76 Through 128)||0||
59720554|NCT01185353|75839470|FG001|NOT COMPLETED|Part D (Weeks 76 Through 128)||0||
59720555|NCT01185353|75839471|FG002|NOT COMPLETED|Part D (Weeks 76 Through 128)||0||
59720556|NCT01185353|75839472|FG003|NOT COMPLETED|Part D (Weeks 76 Through 128)||0||
59849775|NCT03595618|75974063|FG003|NOT COMPLETED|Overall Study||34||
59849776|NCT02954848|75974075|FG000|STARTED|Overall Study||245||
59720557|NCT01185353|75839473|FG004|NOT COMPLETED|Part D (Weeks 76 Through 128)||0||
59720558|NCT01185353|75839474|FG005|NOT COMPLETED|Part D (Weeks 76 Through 128)||0||
59720559|NCT01185353|75839475|FG006|NOT COMPLETED|Part D (Weeks 76 Through 128)||0||
59720560|NCT01185353|75839476|FG007|NOT COMPLETED|Part D (Weeks 76 Through 128)||3||
59720561|NCT01185353|75839477|FG008|NOT COMPLETED|Part D (Weeks 76 Through 128)||7||
59568084|NCT02266797|75671041|FG000|NOT COMPLETED|Overall Study||0||
59720562|NCT01185353|75839478|FG009|NOT COMPLETED|Part D (Weeks 76 Through 128)||1||
59720563|NCT01098240|75839517|FG000|STARTED|Open-Label Phase||297||
59849777|NCT02954848|75974076|FG001|STARTED|Overall Study||239||
59849778|NCT02954848|75974075|FG000|Treated|Overall Study||245||
59849779|NCT02954848|75974076|FG001|Treated|Overall Study||238||
59849780|NCT02954848|75974075|FG000|COMPLETED|Overall Study||243||
59849781|NCT02954848|75974076|FG001|COMPLETED|Overall Study||234||
59849782|NCT02954848|75974075|FG000|NOT COMPLETED|Overall Study||2||
59849783|NCT02954848|75974076|FG001|NOT COMPLETED|Overall Study||5||
59849784|NCT03642262|75974082|FG000|STARTED|Period 1||12||
59849785|NCT03642262|75974083|FG001|STARTED|Period 1||18||
59849786|NCT03642262|75974082|FG000|COMPLETED|Period 1||11||
59849787|NCT03642262|75974083|FG001|COMPLETED|Period 1||16||
59849788|NCT03642262|75974082|FG000|NOT COMPLETED|Period 1||1||
59849789|NCT03642262|75974083|FG001|NOT COMPLETED|Period 1||2||
59849790|NCT03642262|75974082|FG000|STARTED|Washout: 7 Days||11||
59849791|NCT03642262|75974083|FG001|STARTED|Washout: 7 Days||16||
59849792|NCT03642262|75974082|FG000|COMPLETED|Washout: 7 Days||11||
59849793|NCT03642262|75974083|FG001|COMPLETED|Washout: 7 Days||16||
59849794|NCT03642262|75974082|FG000|NOT COMPLETED|Washout: 7 Days||0||
59849795|NCT03642262|75974083|FG001|NOT COMPLETED|Washout: 7 Days||0||
59849796|NCT03642262|75974082|FG000|STARTED|Period 2||11||
59849797|NCT03642262|75974083|FG001|STARTED|Period 2||16||
59849798|NCT03642262|75974082|FG000|COMPLETED|Period 2||11||
59849799|NCT03642262|75974083|FG001|COMPLETED|Period 2||16||
59849800|NCT03642262|75974082|FG000|NOT COMPLETED|Period 2||0||
59849801|NCT03642262|75974083|FG001|NOT COMPLETED|Period 2||0||
59849802|NCT00109707|75974093|FG000|STARTED|Overall Study||321||
59849803|NCT00109707|75974094|FG001|STARTED|Overall Study||137||
59849804|NCT00109707|75974095|FG002|STARTED|Overall Study||49||
59849805|NCT00109707|75974093|FG000|Entered Extension Study|Overall Study||106||
59849806|NCT00109707|75974094|FG001|Entered Extension Study|Overall Study||15||
59849807|NCT00109707|75974095|FG002|Entered Extension Study|Overall Study||15||
59849808|NCT00109707|75974093|FG000|COMPLETED|Overall Study||67||
59849809|NCT00109707|75974094|FG001|COMPLETED|Overall Study||8||
59849810|NCT00109707|75974095|FG002|COMPLETED|Overall Study||8||
59849811|NCT00109707|75974093|FG000|NOT COMPLETED|Overall Study||254||
59849812|NCT00109707|75974094|FG001|NOT COMPLETED|Overall Study||129||
59849813|NCT00109707|75974095|FG002|NOT COMPLETED|Overall Study||41||
59849814|NCT00095979|75974107|FG000|STARTED|Overall Study||52||
59849815|NCT00095979|75974107|FG000|COMPLETED|Overall Study||50||
59849816|NCT00095979|75974107|FG000|NOT COMPLETED|Overall Study||2||
59849817|NCT00082173|75974118|FG000|STARTED|Overall Study||74||
59849818|NCT00082173|75974119|FG001|STARTED|Overall Study||72||
59849819|NCT00082173|75974118|FG000|COMPLETED|Overall Study||64||
59849820|NCT00082173|75974119|FG001|COMPLETED|Overall Study||61||
59849821|NCT00082173|75974118|FG000|NOT COMPLETED|Overall Study||10||
59849822|NCT00082173|75974119|FG001|NOT COMPLETED|Overall Study||11||
59849823|NCT00108069|75974127|FG000|STARTED|Overall Study||30||
59849824|NCT00108069|75974128|FG001|STARTED|Overall Study||13||
59849825|NCT00108069|75974127|FG000|COMPLETED|Overall Study||0||
59849826|NCT00108069|75974128|FG001|COMPLETED|Overall Study||0||
59849827|NCT00108069|75974127|FG000|NOT COMPLETED|Overall Study||30||
59849828|NCT00108069|75974128|FG001|NOT COMPLETED|Overall Study||13||
59849829|NCT00079274|75974147|FG000|STARTED|Overall Study||1402||
59849830|NCT00079274|75974148|FG001|STARTED|Overall Study||111||
59849831|NCT00079274|75974149|FG002|STARTED|Overall Study||111||
59849832|NCT00079274|75974150|FG003|STARTED|Overall Study||1350||
60120601|NCT01587703|76241794|FG011|STARTED|Part1 QD(Median Exposure of 1.38months)||0||
59849833|NCT00079274|75974151|FG004|STARTED|Overall Study||45||
59849834|NCT00079274|75974152|FG005|STARTED|Overall Study||46||
59849835|NCT00079274|75974153|FG006|STARTED|Overall Study||332||
59849836|NCT00079274|75974147|FG000|COMPLETED|Overall Study||1081||
59849837|NCT00079274|75974148|FG001|COMPLETED|Overall Study||84||
59849838|NCT00079274|75974149|FG002|COMPLETED|Overall Study||84||
59849839|NCT00079274|75974150|FG003|COMPLETED|Overall Study||906||
59849840|NCT00079274|75974151|FG004|COMPLETED|Overall Study||30||
59849841|NCT00079274|75974152|FG005|COMPLETED|Overall Study||26||
59849842|NCT00079274|75974153|FG006|COMPLETED|Overall Study||332||
59849843|NCT00079274|75974147|FG000|NOT COMPLETED|Overall Study||321||
59849844|NCT00079274|75974148|FG001|NOT COMPLETED|Overall Study||27||
59849845|NCT00079274|75974149|FG002|NOT COMPLETED|Overall Study||27||
59849846|NCT00079274|75974150|FG003|NOT COMPLETED|Overall Study||444||
59849847|NCT00079274|75974151|FG004|NOT COMPLETED|Overall Study||15||
59849848|NCT00079274|75974152|FG005|NOT COMPLETED|Overall Study||20||
59849849|NCT00079274|75974153|FG006|NOT COMPLETED|Overall Study||0||
59849850|NCT00079040|75974166|FG000|STARTED|Overall Study||65||
59849851|NCT00079040|75974166|FG000|COMPLETED|Overall Study||63||
59849852|NCT00079040|75974166|FG000|NOT COMPLETED|Overall Study||2||
59849853|NCT00078806|75974170|FG000|STARTED|Part 1A||19||
59849854|NCT00078806|75974171|FG001|STARTED|Part 1A||0||
59849855|NCT00078806|75974172|FG002|STARTED|Part 1A||0||
59849856|NCT00078806|75974173|FG003|STARTED|Part 1A||0||
59849857|NCT00078806|75974170|FG000|COMPLETED|Part 1A||9||
59849858|NCT00078806|75974171|FG001|COMPLETED|Part 1A||0||
59849859|NCT00078806|75974172|FG002|COMPLETED|Part 1A||0||
59849860|NCT00078806|75974173|FG003|COMPLETED|Part 1A||0||
59849861|NCT00078806|75974170|FG000|NOT COMPLETED|Part 1A||10||
59849862|NCT00078806|75974171|FG001|NOT COMPLETED|Part 1A||0||
59849863|NCT00078806|75974172|FG002|NOT COMPLETED|Part 1A||0||
59849864|NCT00078806|75974173|FG003|NOT COMPLETED|Part 1A||0||
59849865|NCT00078806|75974170|FG000|STARTED|Part 1B||10||
59849866|NCT00078806|75974171|FG001|STARTED|Part 1B||0||
59849867|NCT00078806|75974172|FG002|STARTED|Part 1B||0||
59849868|NCT00078806|75974173|FG003|STARTED|Part 1B||0||
59849869|NCT00078806|75974170|FG000|COMPLETED|Part 1B||2||
59849870|NCT00078806|75974171|FG001|COMPLETED|Part 1B||0||
59849871|NCT00078806|75974172|FG002|COMPLETED|Part 1B||0||
59849872|NCT00078806|75974173|FG003|COMPLETED|Part 1B||0||
59849873|NCT00078806|75974170|FG000|NOT COMPLETED|Part 1B||8||
59849874|NCT00078806|75974171|FG001|NOT COMPLETED|Part 1B||0||
59849875|NCT00078806|75974172|FG002|NOT COMPLETED|Part 1B||0||
59849876|NCT00078806|75974173|FG003|NOT COMPLETED|Part 1B||0||
59849877|NCT00078806|75974170|FG000|STARTED|Part 2||0||
59849878|NCT00078806|75974171|FG001|STARTED|Part 2||6||
59849879|NCT00078806|75974172|FG002|STARTED|Part 2||4||
59849880|NCT00078806|75974173|FG003|STARTED|Part 2||0||
59849881|NCT00078806|75974170|FG000|Received Study Drug|Part 2||0||
59849882|NCT00078806|75974171|FG001|Received Study Drug|Part 2||5||
59849883|NCT00078806|75974172|FG002|Received Study Drug|Part 2||4||
59849884|NCT00078806|75974173|FG003|Received Study Drug|Part 2||0||
59849885|NCT00078806|75974170|FG000|COMPLETED|Part 2||0||
59849886|NCT00078806|75974171|FG001|COMPLETED|Part 2||5||
59849887|NCT00078806|75974172|FG002|COMPLETED|Part 2||4||
59849888|NCT00078806|75974173|FG003|COMPLETED|Part 2||0||
59849889|NCT00078806|75974170|FG000|NOT COMPLETED|Part 2||0||
59849890|NCT00078806|75974171|FG001|NOT COMPLETED|Part 2||1||
59849891|NCT00078806|75974172|FG002|NOT COMPLETED|Part 2||0||
59849892|NCT00078806|75974173|FG003|NOT COMPLETED|Part 2||0||
59849893|NCT00078806|75974170|FG000|STARTED|Part 3||0||
59849894|NCT00078806|75974171|FG001|STARTED|Part 3||0||
59849895|NCT00078806|75974172|FG002|STARTED|Part 3||0||
59849896|NCT00078806|75974173|FG003|STARTED|Part 3||9||
59849897|NCT00078806|75974170|FG000|COMPLETED|Part 3||0||
59849898|NCT00078806|75974171|FG001|COMPLETED|Part 3||0||
59849899|NCT00078806|75974172|FG002|COMPLETED|Part 3||0||
59849900|NCT00078806|75974173|FG003|COMPLETED|Part 3||9||
59849901|NCT00078806|75974170|FG000|NOT COMPLETED|Part 3||0||
59849902|NCT00078806|75974171|FG001|NOT COMPLETED|Part 3||0||
59849903|NCT00078806|75974172|FG002|NOT COMPLETED|Part 3||0||
59849904|NCT00078806|75974173|FG003|NOT COMPLETED|Part 3||0||
59849905|NCT00078338|75974190|FG000|STARTED|Overall Study||386||
59849906|NCT00078338|75974191|FG001|STARTED|Overall Study||378||
59849907|NCT00078338|75974190|FG000|Safety Population|Overall Study|Safety population=subjects who received at least 1 dose of treatment and had followup safety data.|381||
59849908|NCT00078338|75974191|FG001|Safety Population|Overall Study|Safety population=subjects who received at least 1 dose of treatment and had followup safety data.|375||
59849909|NCT00078338|75974190|FG000|COMPLETED|Overall Study||301||
59849910|NCT00078338|75974191|FG001|COMPLETED|Overall Study||324||
59849911|NCT00078338|75974190|FG000|NOT COMPLETED|Overall Study||85||
59720564|NCT01098240|75839518|FG001|STARTED|Open-Label Phase||0||
59720565|NCT01098240|75839519|FG002|STARTED|Open-Label Phase||0||
59720566|NCT01098240|75839517|FG000|COMPLETED|Open-Label Phase||162||
59720567|NCT01098240|75839518|FG001|COMPLETED|Open-Label Phase||0||
59720568|NCT01098240|75839519|FG002|COMPLETED|Open-Label Phase||0||
59720569|NCT01098240|75839517|FG000|NOT COMPLETED|Open-Label Phase||135||
59720570|NCT01098240|75839518|FG001|NOT COMPLETED|Open-Label Phase||0||
59849912|NCT00078338|75974191|FG001|NOT COMPLETED|Overall Study||54||
59849913|NCT03808688|75974199|FG000|STARTED|Overall Study||99||
59849914|NCT03808688|75974200|FG001|STARTED|Overall Study||161||
59849915|NCT03808688|75974199|FG000|COMPLETED|Overall Study||81||
59849916|NCT03808688|75974200|FG001|COMPLETED|Overall Study||138||
59849917|NCT03808688|75974199|FG000|NOT COMPLETED|Overall Study||18||
59849918|NCT03808688|75974200|FG001|NOT COMPLETED|Overall Study||23||
59849919|NCT03808298|75974208|FG000|STARTED|Overall Study||57||
59849920|NCT03808298|75974208|FG000|COMPLETED|Overall Study||49||
59849921|NCT03808298|75974208|FG000|NOT COMPLETED|Overall Study||8||
59849922|NCT00077636|75974239|FG000|STARTED|Overall Study||736||
59849923|NCT00077636|75974240|FG001|STARTED|Overall Study||733||
59849924|NCT00077636|75974239|FG000|COMPLETED|Overall Study||692||
59849925|NCT00077636|75974240|FG001|COMPLETED|Overall Study||641||
59849926|NCT00077636|75974239|FG000|NOT COMPLETED|Overall Study||44||
59849927|NCT00077636|75974240|FG001|NOT COMPLETED|Overall Study||92||
59849928|NCT00095199|75974251|FG000|STARTED|Overall Study|1 participant has no data in database; not included in analyses. Data was lost/destroyed at site.|302||
59849929|NCT00095199|75974252|FG001|STARTED|Overall Study||304||
59720571|NCT01098240|75839519|FG002|NOT COMPLETED|Open-Label Phase||0||
59720572|NCT01098240|75839517|FG000|STARTED|Double-Blind Phase||0||
59849930|NCT00095199|75974253|FG002|STARTED|Overall Study||167||
59849931|NCT00095199|75974254|FG003|STARTED|Overall Study||166||
59849932|NCT00095199|75974251|FG000|COMPLETED|Overall Study||6||
59849933|NCT00095199|75974252|FG001|COMPLETED|Overall Study||62||
59849934|NCT00095199|75974253|FG002|COMPLETED|Overall Study||7||
59849935|NCT00095199|75974254|FG003|COMPLETED|Overall Study||23||
59849936|NCT00095199|75974251|FG000|NOT COMPLETED|Overall Study||296||
59849937|NCT00095199|75974252|FG001|NOT COMPLETED|Overall Study||242||
59849938|NCT00095199|75974253|FG002|NOT COMPLETED|Overall Study||160||
59849939|NCT00095199|75974254|FG003|NOT COMPLETED|Overall Study||143||
59849940|NCT00075764|75974271|FG000|STARTED|Overall Study||345||
59849941|NCT00075764|75974272|FG001|STARTED|Overall Study||349||
59849942|NCT00075764|75974271|FG000|COMPLETED|Overall Study||0||
59849943|NCT00075764|75974272|FG001|COMPLETED|Overall Study||0||
59849944|NCT00075764|75974271|FG000|NOT COMPLETED|Overall Study||345||
59849945|NCT00075764|75974272|FG001|NOT COMPLETED|Overall Study||349||
59849946|NCT03568162|75974286|FG000|STARTED|Overall Study||76||
59849947|NCT03568162|75974287|FG001|STARTED|Overall Study||80||
59849948|NCT03568162|75974288|FG002|STARTED|Overall Study||77||
59849949|NCT03568162|75974289|FG003|STARTED|Overall Study||80||
59849950|NCT03568162|75974290|FG004|STARTED|Overall Study||75||
59849951|NCT03568162|75974291|FG005|STARTED|Overall Study||74||
59849952|NCT03568162|75974286|FG000|COMPLETED|Overall Study||54||
59849953|NCT03568162|75974287|FG001|COMPLETED|Overall Study||57||
59849954|NCT03568162|75974288|FG002|COMPLETED|Overall Study||42||
59849955|NCT03568162|75974289|FG003|COMPLETED|Overall Study||50||
59849956|NCT03568162|75974290|FG004|COMPLETED|Overall Study||61||
59849957|NCT03568162|75974291|FG005|COMPLETED|Overall Study||60||
59849958|NCT03568162|75974286|FG000|NOT COMPLETED|Overall Study||22||
59849959|NCT03568162|75974287|FG001|NOT COMPLETED|Overall Study||23||
59849960|NCT03568162|75974288|FG002|NOT COMPLETED|Overall Study||35||
59849961|NCT03568162|75974289|FG003|NOT COMPLETED|Overall Study||30||
59849962|NCT03568162|75974290|FG004|NOT COMPLETED|Overall Study||14||
59849963|NCT03568162|75974291|FG005|NOT COMPLETED|Overall Study||14||
59849964|NCT03567616|75974310|FG000|STARTED|Overall Study||8||
59849965|NCT03567616|75974310|FG000|COMPLETED|Overall Study||0||
59849966|NCT03567616|75974310|FG000|NOT COMPLETED|Overall Study||8||
59849967|NCT03567382|75974319|FG000|STARTED|Overall Study||10||
59849968|NCT03567382|75974320|FG001|STARTED|Overall Study||81||
59849969|NCT03567382|75974321|FG002|STARTED|Overall Study||9||
59849970|NCT03567382|75974322|FG003|STARTED|Overall Study||79||
59849971|NCT03567382|75974319|FG000|Received Tenofovir|Overall Study||9||
59849972|NCT03567382|75974320|FG001|Received Tenofovir|Overall Study||0||
59849973|NCT03567382|75974321|FG002|Received Tenofovir|Overall Study||0||
59849974|NCT03567382|75974322|FG003|Received Tenofovir|Overall Study||0||
59849975|NCT03567382|75974319|FG000|COMPLETED|Overall Study||7||
59849976|NCT03567382|75974320|FG001|COMPLETED|Overall Study||46||
59849977|NCT03567382|75974321|FG002|COMPLETED|Overall Study||7||
59720573|NCT01098240|75839518|FG001|STARTED|Double-Blind Phase||77||
59720574|NCT01098240|75839519|FG002|STARTED|Double-Blind Phase||85||
59720575|NCT01098240|75839517|FG000|COMPLETED|Double-Blind Phase||0||
59720576|NCT01098240|75839518|FG001|COMPLETED|Double-Blind Phase||60||
59720577|NCT01098240|75839519|FG002|COMPLETED|Double-Blind Phase||63||
59720578|NCT01098240|75839517|FG000|NOT COMPLETED|Double-Blind Phase||0||
59720579|NCT01098240|75839518|FG001|NOT COMPLETED|Double-Blind Phase||17||
59720580|NCT01098240|75839519|FG002|NOT COMPLETED|Double-Blind Phase||22||
59720581|NCT01098162|75839526|FG000|STARTED|Overall Study||573||
59720582|NCT01098162|75839526|FG000|COMPLETED|Overall Study||461||
59720583|NCT01098162|75839526|FG000|NOT COMPLETED|Overall Study||112||
59720584|NCT01097694|75839532|FG000|STARTED|Overall Study||32||
59720585|NCT01097694|75839533|FG001|STARTED|Overall Study||30||
59720586|NCT01097694|75839532|FG000|COMPLETED|Overall Study||24||
59720587|NCT01097694|75839533|FG001|COMPLETED|Overall Study||26||
59720588|NCT01097694|75839532|FG000|NOT COMPLETED|Overall Study||8||
59720589|NCT01097694|75839533|FG001|NOT COMPLETED|Overall Study||4||
59720590|NCT01102140|75839541|FG000|STARTED|Overall Study||13||
59720591|NCT01102140|75839542|FG001|STARTED|Overall Study||7||
59720592|NCT01102140|75839541|FG000|COMPLETED|Overall Study||10||
59720593|NCT01102140|75839542|FG001|COMPLETED|Overall Study||5||
59720594|NCT01102140|75839541|FG000|NOT COMPLETED|Overall Study||3||
59720595|NCT01102140|75839542|FG001|NOT COMPLETED|Overall Study||2||
59720596|NCT00874549|75839554|FG000|STARTED|Overall Study||51||
59720597|NCT00874549|75839555|FG001|STARTED|Overall Study||56||
59720598|NCT00874549|75839556|FG002|STARTED|Overall Study||51||
59720599|NCT00874549|75839557|FG003|STARTED|Overall Study||58||
59849978|NCT03567382|75974322|FG003|COMPLETED|Overall Study||46||
60120602|NCT01587703|76241795|FG012|STARTED|Part1 QD(Median Exposure of 1.38months)||0||
60120603|NCT01587703|76241796|FG013|STARTED|Part1 QD(Median Exposure of 1.38months)||0||
59849979|NCT03567382|75974319|FG000|NOT COMPLETED|Overall Study||3||
59720600|NCT00874549|75839554|FG000|COMPLETED|Overall Study||50||
59720601|NCT00874549|75839555|FG001|COMPLETED|Overall Study||55||
59720602|NCT00874549|75839556|FG002|COMPLETED|Overall Study||47||
59720603|NCT00874549|75839557|FG003|COMPLETED|Overall Study||56||
59849980|NCT03567382|75974320|FG001|NOT COMPLETED|Overall Study||35||
59849981|NCT03567382|75974321|FG002|NOT COMPLETED|Overall Study||2||
59849982|NCT03567382|75974322|FG003|NOT COMPLETED|Overall Study||33||
59849983|NCT03595384|75974333|FG000|STARTED|Overall Study||41||
59849984|NCT03595384|75974333|FG000|Completed Week 12 Assessment|Overall Study||37||
59849985|NCT03595384|75974333|FG000|COMPLETED|Overall Study||25|Completed Week 24 Assessment|
60120604|NCT01587703|76241797|FG014|STARTED|Part1 QD(Median Exposure of 1.38months)||0||
59720604|NCT00874549|75839554|FG000|NOT COMPLETED|Overall Study||1||
59720605|NCT00874549|75839555|FG001|NOT COMPLETED|Overall Study||1||
59849986|NCT03595384|75974333|FG000|NOT COMPLETED|Overall Study||16||
59720606|NCT00874549|75839556|FG002|NOT COMPLETED|Overall Study||4||
59720607|NCT00874549|75839557|FG003|NOT COMPLETED|Overall Study||2||
59720608|NCT01155479|75839572|FG000|STARTED|Part I||204||
59720609|NCT01155479|75839573|FG001|STARTED|Part I||204||
59720610|NCT01155479|75839574|FG002|STARTED|Part I||206||
59720611|NCT01155479|75839575|FG003|STARTED|Part I||204||
59720612|NCT01155479|75839576|FG004|STARTED|Part I||204||
59720613|NCT01155479|75839572|FG000|Treated|Part I||200||
59720614|NCT01155479|75839573|FG001|Treated|Part I||202||
59720615|NCT01155479|75839574|FG002|Treated|Part I||204||
59720616|NCT01155479|75839575|FG003|Treated|Part I||198||
59720617|NCT01155479|75839576|FG004|Treated|Part I||203||
59720618|NCT01155479|75839572|FG000|COMPLETED|Part I||166||
59720619|NCT01155479|75839573|FG001|COMPLETED|Part I||177||
59720620|NCT01155479|75839574|FG002|COMPLETED|Part I||167||
59720621|NCT01155479|75839575|FG003|COMPLETED|Part I||177||
59720622|NCT01155479|75839576|FG004|COMPLETED|Part I||181||
59720623|NCT01155479|75839572|FG000|NOT COMPLETED|Part I||38||
59720624|NCT01155479|75839573|FG001|NOT COMPLETED|Part I||27||
59720625|NCT01155479|75839574|FG002|NOT COMPLETED|Part I||39||
59720626|NCT01155479|75839575|FG003|NOT COMPLETED|Part I||27||
59720627|NCT01155479|75839576|FG004|NOT COMPLETED|Part I||23||
59720628|NCT01155479|75839572|FG000|STARTED|Part II||166||
59720629|NCT01155479|75839573|FG001|STARTED|Part II||177||
59720630|NCT01155479|75839574|FG002|STARTED|Part II||167||
59720631|NCT01155479|75839575|FG003|STARTED|Part II||177||
59720632|NCT01155479|75839576|FG004|STARTED|Part II||181||
59720633|NCT01155479|75839572|FG000|COMPLETED|Part II||107||
59720634|NCT01155479|75839573|FG001|COMPLETED|Part II||116||
59720635|NCT01155479|75839574|FG002|COMPLETED|Part II||109||
59720636|NCT01155479|75839575|FG003|COMPLETED|Part II||127||
59720637|NCT01155479|75839576|FG004|COMPLETED|Part II||126||
59720638|NCT01155479|75839572|FG000|NOT COMPLETED|Part II||59||
59720639|NCT01155479|75839573|FG001|NOT COMPLETED|Part II||61||
59720640|NCT01155479|75839574|FG002|NOT COMPLETED|Part II||58||
59720641|NCT01155479|75839575|FG003|NOT COMPLETED|Part II||50||
59720642|NCT01155479|75839576|FG004|NOT COMPLETED|Part II||55||
59720643|NCT01155323|75839604|FG000|STARTED|First Intervention||60||
59720644|NCT01155323|75839605|FG001|STARTED|First Intervention||58||
59720645|NCT01155323|75839604|FG000|COMPLETED|First Intervention||59||
59720646|NCT01155323|75839605|FG001|COMPLETED|First Intervention||57||
59720647|NCT01155323|75839604|FG000|NOT COMPLETED|First Intervention||1||
59720648|NCT01155323|75839605|FG001|NOT COMPLETED|First Intervention||1||
59720649|NCT01155323|75839604|FG000|STARTED|Second Intervention||59||
59720650|NCT01155323|75839605|FG001|STARTED|Second Intervention||57||
59720651|NCT01155323|75839604|FG000|COMPLETED|Second Intervention||58||
59720652|NCT01155323|75839605|FG001|COMPLETED|Second Intervention||56||
59720653|NCT01155323|75839604|FG000|NOT COMPLETED|Second Intervention||1||
59720654|NCT01155323|75839605|FG001|NOT COMPLETED|Second Intervention||1||
59720655|NCT01155167|75839613|FG000|STARTED|Overall Study||43||
59720656|NCT01155167|75839614|FG001|STARTED|Overall Study||43||
59720657|NCT01155167|75839613|FG000|COMPLETED|Overall Study||40||
59720658|NCT01155167|75839614|FG001|COMPLETED|Overall Study||43||
59720659|NCT01155167|75839613|FG000|NOT COMPLETED|Overall Study||3||
59720660|NCT01155167|75839614|FG001|NOT COMPLETED|Overall Study||0||
59720661|NCT01106586|75839622|FG000|STARTED|Overall Study||353||
60120605|NCT01587703|76241798|FG015|STARTED|Part1 QD(Median Exposure of 1.38months)||0||
59720662|NCT01106586|75839623|FG001|STARTED|Overall Study||355||
59720663|NCT01106586|75839622|FG000|COMPLETED|Overall Study||68||
59720664|NCT01106586|75839623|FG001|COMPLETED|Overall Study||70||
59720665|NCT01106586|75839622|FG000|NOT COMPLETED|Overall Study||285||
59720666|NCT01106586|75839623|FG001|NOT COMPLETED|Overall Study||285||
59720667|NCT01155011|75839631|FG000|STARTED|Baseline to 6 Months||151||
59720668|NCT01155011|75839632|FG001|STARTED|Baseline to 6 Months||156||
59720669|NCT01155011|75839631|FG000|COMPLETED|Baseline to 6 Months||129||
59720670|NCT01155011|75839632|FG001|COMPLETED|Baseline to 6 Months||131||
59720671|NCT01155011|75839631|FG000|NOT COMPLETED|Baseline to 6 Months||22||
59720672|NCT01155011|75839632|FG001|NOT COMPLETED|Baseline to 6 Months||25||
59720673|NCT01155011|75839631|FG000|STARTED|6 to 12 Months||129||
59720674|NCT01155011|75839632|FG001|STARTED|6 to 12 Months||131||
59720675|NCT01155011|75839631|FG000|COMPLETED|6 to 12 Months||120||
59720676|NCT01155011|75839632|FG001|COMPLETED|6 to 12 Months||121||
59720677|NCT01155011|75839631|FG000|NOT COMPLETED|6 to 12 Months||9||
59720678|NCT01155011|75839632|FG001|NOT COMPLETED|6 to 12 Months||10||
59720679|NCT01106430|75839644|FG000|STARTED|Overall Study||133||
59720680|NCT01106430|75839645|FG001|STARTED|Overall Study||134||
59720681|NCT01106430|75839644|FG000|COMPLETED|Overall Study||100||
59720682|NCT01106430|75839645|FG001|COMPLETED|Overall Study||101||
59720683|NCT01106430|75839644|FG000|NOT COMPLETED|Overall Study||33||
59720684|NCT01106430|75839645|FG001|NOT COMPLETED|Overall Study||33||
59720685|NCT01154231|75839651|FG000|STARTED|Overall Study||314||
59720686|NCT01154231|75839651|FG000|COMPLETED|Overall Study||312||
59720687|NCT01154231|75839651|FG000|NOT COMPLETED|Overall Study||2||
59720688|NCT01154153|75839657|FG000|STARTED|Overall Study||71||
59720689|NCT01154153|75839658|FG001|STARTED|Overall Study||69||
59720690|NCT01154153|75839657|FG000|COMPLETED|Overall Study||66||
59720691|NCT01154153|75839658|FG001|COMPLETED|Overall Study||66||
59720692|NCT01154153|75839657|FG000|NOT COMPLETED|Overall Study||5||
59720693|NCT01154153|75839658|FG001|NOT COMPLETED|Overall Study||3||
59720694|NCT00874237|75839664|FG000|STARTED|Overall Study||8||
59720695|NCT00874237|75839665|FG001|STARTED|Overall Study||8||
59849987|NCT03591874|75974339|FG000|STARTED|Overall Study||40||
59849988|NCT03591874|75974340|FG001|STARTED|Overall Study||19||
59849989|NCT03591874|75974339|FG000|Received at Least 1 Study Treatment|Overall Study||29||
59720696|NCT00874237|75839666|FG002|STARTED|Overall Study||8||
59720697|NCT00874237|75839667|FG003|STARTED|Overall Study||8||
59720698|NCT00874237|75839668|FG004|STARTED|Overall Study||8||
59720699|NCT00874237|75839669|FG005|STARTED|Overall Study||8||
59720700|NCT00874237|75839664|FG000|COMPLETED|Overall Study||8||
59720701|NCT00874237|75839665|FG001|COMPLETED|Overall Study||7||
59720702|NCT00874237|75839666|FG002|COMPLETED|Overall Study||7||
59720703|NCT00874237|75839667|FG003|COMPLETED|Overall Study||8||
59720704|NCT00874237|75839668|FG004|COMPLETED|Overall Study||8||
59720705|NCT00874237|75839669|FG005|COMPLETED|Overall Study||8||
59720706|NCT00874237|75839664|FG000|NOT COMPLETED|Overall Study||0||
59720707|NCT00874237|75839665|FG001|NOT COMPLETED|Overall Study||1||
59720708|NCT00874237|75839666|FG002|NOT COMPLETED|Overall Study||1||
59720709|NCT00874237|75839667|FG003|NOT COMPLETED|Overall Study||0||
59720710|NCT00874237|75839668|FG004|NOT COMPLETED|Overall Study||0||
59720711|NCT00874237|75839669|FG005|NOT COMPLETED|Overall Study||0||
59720712|NCT01153841|75839681|FG000|STARTED|Overall Study||199||
59720713|NCT01153841|75839682|FG001|STARTED|Overall Study||99||
59720714|NCT01153841|75839681|FG000|COMPLETED|Overall Study||193||
59720715|NCT01153841|75839682|FG001|COMPLETED|Overall Study||99||
59720716|NCT01153841|75839681|FG000|NOT COMPLETED|Overall Study||6||
59720717|NCT01153841|75839682|FG001|NOT COMPLETED|Overall Study||0||
59720718|NCT01153763|75839688|FG000|STARTED|Overall Study||92||
59720719|NCT01153763|75839688|FG000|COMPLETED|Overall Study||71||
59720720|NCT01153763|75839688|FG000|NOT COMPLETED|Overall Study||21||
59720721|NCT00871741|75839694|FG000|STARTED|Overall Study||9||
59720722|NCT00871741|75839695|FG001|STARTED|Overall Study||7||
59720723|NCT00871741|75839694|FG000|COMPLETED|Overall Study||0||
59720724|NCT00871741|75839695|FG001|COMPLETED|Overall Study||0||
59720725|NCT00871741|75839694|FG000|NOT COMPLETED|Overall Study||9||
59720726|NCT00871741|75839695|FG001|NOT COMPLETED|Overall Study||7||
59720727|NCT01152437|75839704|FG000|STARTED|Overall Study|randomised|36||
59720728|NCT01152437|75839705|FG001|STARTED|Overall Study|randomised|15||
59720729|NCT01152437|75839706|FG002|STARTED|Overall Study|entered|43||
59720730|NCT01152437|75839704|FG000|COMPLETED|Overall Study||0||
59849990|NCT03591874|75974340|FG001|Received at Least 1 Study Treatment|Overall Study||16||
59568085|NCT02266797|75671042|FG001|NOT COMPLETED|Overall Study||1||
59568086|NCT00936585|75671048|FG000|STARTED|Overall Study||2||
59568087|NCT00936585|75671048|FG000|COMPLETED|Overall Study||2||
59568088|NCT00936585|75671048|FG000|NOT COMPLETED|Overall Study||0||
59568089|NCT01906658|75671056|FG000|STARTED|Overall Study||11||
59568090|NCT01906658|75671057|FG001|STARTED|Overall Study||11||
59568091|NCT01906658|75671058|FG002|STARTED|Overall Study||10||
59568092|NCT01906658|75671059|FG003|STARTED|Overall Study||11||
59568093|NCT01906658|75671056|FG000|COMPLETED|Overall Study||9||
59568094|NCT01906658|75671057|FG001|COMPLETED|Overall Study||10||
59568095|NCT01906658|75671058|FG002|COMPLETED|Overall Study||7||
59568096|NCT01906658|75671059|FG003|COMPLETED|Overall Study||11||
59568097|NCT01906658|75671056|FG000|NOT COMPLETED|Overall Study||2||
59568098|NCT01906658|75671057|FG001|NOT COMPLETED|Overall Study||1||
59568099|NCT01906658|75671058|FG002|NOT COMPLETED|Overall Study||3||
59568100|NCT01906658|75671059|FG003|NOT COMPLETED|Overall Study||0||
59568101|NCT02192775|75671069|FG000|STARTED|Overall Study||2||
59568102|NCT02192775|75671069|FG000|COMPLETED|Overall Study||0||
59568103|NCT02192775|75671069|FG000|NOT COMPLETED|Overall Study||2||
59568104|NCT00935649|75671073|FG000|STARTED|Overall Study||139||
59568105|NCT00935649|75671073|FG000|COMPLETED|Overall Study||134||
59568106|NCT00935649|75671073|FG000|NOT COMPLETED|Overall Study||5||
59568107|NCT01908062|75671081|FG000|STARTED|Overall Study||26||
59568108|NCT01908062|75671082|FG001|STARTED|Overall Study||25||
59568109|NCT01908062|75671081|FG000|COMPLETED|Overall Study||24||
59568110|NCT01908062|75671082|FG001|COMPLETED|Overall Study||22||
59568111|NCT01908062|75671081|FG000|NOT COMPLETED|Overall Study||2||
59568112|NCT01908062|75671082|FG001|NOT COMPLETED|Overall Study||3||
59568113|NCT00924807|75671091|FG000|STARTED|Overall Study||4||
59568114|NCT00924807|75671091|FG000|COMPLETED|Overall Study||4||
59568115|NCT00924807|75671091|FG000|NOT COMPLETED|Overall Study||0||
59568116|NCT00896025|75671095|FG000|STARTED|Overall Study||8||
59568117|NCT00896025|75671095|FG000|COMPLETED|Overall Study||8||
59568118|NCT00896025|75671095|FG000|NOT COMPLETED|Overall Study||0||
59568119|NCT01908530|75671104|FG000|STARTED|Overall Study||8||
59568120|NCT01908530|75671105|FG001|STARTED|Overall Study||8||
59849991|NCT03591874|75974339|FG000|COMPLETED|Overall Study||21||
59568121|NCT01908530|75671106|FG002|STARTED|Overall Study||10||
59568122|NCT01908530|75671104|FG000|COMPLETED|Overall Study||8||
59568123|NCT01908530|75671105|FG001|COMPLETED|Overall Study||8||
59568124|NCT01908530|75671106|FG002|COMPLETED|Overall Study||10||
59568125|NCT01908530|75671104|FG000|NOT COMPLETED|Overall Study||0||
59568126|NCT01908530|75671105|FG001|NOT COMPLETED|Overall Study||0||
59849992|NCT03591874|75974340|FG001|COMPLETED|Overall Study||12||
59849993|NCT03591874|75974339|FG000|NOT COMPLETED|Overall Study||19||
59849994|NCT03591874|75974340|FG001|NOT COMPLETED|Overall Study||7||
59568127|NCT01908530|75671106|FG002|NOT COMPLETED|Overall Study||0||
59568128|NCT02162979|75671119|FG000|STARTED|Overall Study||0||
59568129|NCT02162979|75671120|FG001|STARTED|Overall Study||0||
59568130|NCT02162979|75671119|FG000|COMPLETED|Overall Study||0||
59568131|NCT02162979|75671120|FG001|COMPLETED|Overall Study||0||
59568132|NCT02162979|75671119|FG000|NOT COMPLETED|Overall Study||0||
59568133|NCT02162979|75671120|FG001|NOT COMPLETED|Overall Study||0||
59720731|NCT01152437|75839705|FG001|COMPLETED|Overall Study||0||
59720732|NCT01152437|75839706|FG002|COMPLETED|Overall Study||0||
59720733|NCT01152437|75839704|FG000|NOT COMPLETED|Overall Study||36||
59720734|NCT01152437|75839705|FG001|NOT COMPLETED|Overall Study||15||
59720735|NCT01152437|75839706|FG002|NOT COMPLETED|Overall Study||43||
59720736|NCT01151579|75839718|FG000|STARTED|Overall Study||58||
59720737|NCT01151579|75839719|FG001|STARTED|Overall Study||31||
59720738|NCT01151579|75839718|FG000|COMPLETED|Overall Study||46||
59720739|NCT01151579|75839719|FG001|COMPLETED|Overall Study||24||
59720740|NCT01151579|75839718|FG000|NOT COMPLETED|Overall Study||12||
59720741|NCT01151579|75839719|FG001|NOT COMPLETED|Overall Study||7||
59720742|NCT01097616|75839728|FG000|STARTED|Double-Blind (DB) Treatment (TRT) Phase||254||
59720743|NCT01097616|75839729|FG001|STARTED|Double-Blind (DB) Treatment (TRT) Phase||383||
59720744|NCT01097616|75839730|FG002|STARTED|Double-Blind (DB) Treatment (TRT) Phase||385||
59720745|NCT01097616|75839731|FG003|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0||
59720746|NCT01097616|75839732|FG004|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0||
59720747|NCT01097616|75839733|FG005|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0||
59720748|NCT01097616|75839734|FG006|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0||
59720749|NCT01097616|75839735|FG007|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0||
59720750|NCT01097616|75839728|FG000|Treated|Double-Blind (DB) Treatment (TRT) Phase||254||
59720751|NCT01097616|75839729|FG001|Treated|Double-Blind (DB) Treatment (TRT) Phase||383||
59720752|NCT01097616|75839730|FG002|Treated|Double-Blind (DB) Treatment (TRT) Phase||384||
59720753|NCT01097616|75839731|FG003|Treated|Double-Blind (DB) Treatment (TRT) Phase||0||
59720754|NCT01097616|75839732|FG004|Treated|Double-Blind (DB) Treatment (TRT) Phase||0||
59720755|NCT01097616|75839733|FG005|Treated|Double-Blind (DB) Treatment (TRT) Phase||0||
59720756|NCT01097616|75839734|FG006|Treated|Double-Blind (DB) Treatment (TRT) Phase||0||
59720757|NCT01097616|75839735|FG007|Treated|Double-Blind (DB) Treatment (TRT) Phase||0||
59720758|NCT01097616|75839728|FG000|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|100 continued into EXT, 128 continued directly into RO, 2 did not continue into either Phase|230||
59720759|NCT01097616|75839729|FG001|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|172 continued into EXT, 172 continued directly into RO, 1 did not continue into either Phase|345||
59720760|NCT01097616|75839730|FG002|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|151 continued into EXT, 186 continued directly into RO, 4 did not continue into either Phase|341||
59720761|NCT01097616|75839731|FG003|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0||
59720762|NCT01097616|75839732|FG004|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0||
59720763|NCT01097616|75839733|FG005|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0||
59720764|NCT01097616|75839734|FG006|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0||
59720765|NCT01097616|75839735|FG007|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0||
59720766|NCT01097616|75839728|FG000|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||24||
59720767|NCT01097616|75839729|FG001|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||38||
59720768|NCT01097616|75839730|FG002|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||44||
59720769|NCT01097616|75839731|FG003|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0||
59720770|NCT01097616|75839732|FG004|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0||
59720771|NCT01097616|75839733|FG005|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0||
59720772|NCT01097616|75839734|FG006|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0||
59720773|NCT01097616|75839735|FG007|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0||
59720774|NCT01097616|75839728|FG000|STARTED|Optional DB EXT Phase||100||
59720775|NCT01097616|75839729|FG001|STARTED|Optional DB EXT Phase||172||
59720776|NCT01097616|75839730|FG002|STARTED|Optional DB EXT Phase||151||
59720777|NCT01097616|75839731|FG003|STARTED|Optional DB EXT Phase||0||
59720778|NCT01097616|75839732|FG004|STARTED|Optional DB EXT Phase||0||
59720779|NCT01097616|75839733|FG005|STARTED|Optional DB EXT Phase||0||
59720780|NCT01097616|75839734|FG006|STARTED|Optional DB EXT Phase||0||
59720781|NCT01097616|75839735|FG007|STARTED|Optional DB EXT Phase||0||
59720782|NCT01097616|75839728|FG000|COMPLETED|Optional DB EXT Phase|All 85 continued into RO|85||
59720783|NCT01097616|75839729|FG001|COMPLETED|Optional DB EXT Phase|All 151 continued into RO|151||
59720784|NCT01097616|75839730|FG002|COMPLETED|Optional DB EXT Phase|All 141 continued into RO|141||
59720785|NCT01097616|75839731|FG003|COMPLETED|Optional DB EXT Phase||0||
59720786|NCT01097616|75839732|FG004|COMPLETED|Optional DB EXT Phase||0||
59720787|NCT01097616|75839733|FG005|COMPLETED|Optional DB EXT Phase||0||
59720788|NCT01097616|75839734|FG006|COMPLETED|Optional DB EXT Phase||0||
59720789|NCT01097616|75839735|FG007|COMPLETED|Optional DB EXT Phase||0||
59720790|NCT01097616|75839728|FG000|NOT COMPLETED|Optional DB EXT Phase||15||
60120606|NCT01587703|76241799|FG016|STARTED|Part1 QD(Median Exposure of 1.38months)||0||
59720791|NCT01097616|75839729|FG001|NOT COMPLETED|Optional DB EXT Phase||21||
59720792|NCT01097616|75839730|FG002|NOT COMPLETED|Optional DB EXT Phase||10||
59720793|NCT01097616|75839731|FG003|NOT COMPLETED|Optional DB EXT Phase||0||
59720794|NCT01097616|75839732|FG004|NOT COMPLETED|Optional DB EXT Phase||0||
59720795|NCT01097616|75839733|FG005|NOT COMPLETED|Optional DB EXT Phase||0||
59720796|NCT01097616|75839734|FG006|NOT COMPLETED|Optional DB EXT Phase||0||
59720797|NCT01097616|75839735|FG007|NOT COMPLETED|Optional DB EXT Phase||0||
59720798|NCT01097616|75839728|FG000|STARTED|DB RO Phase||0||
60120607|NCT01587703|76241800|FG017|STARTED|Part1 QD(Median Exposure of 1.38months)||0||
60120608|NCT01587703|76241801|FG018|STARTED|Part1 QD(Median Exposure of 1.38months)||0||
60120609|NCT01587703|76241783|FG000|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0||
60120610|NCT01587703|76241784|FG001|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0||
60120611|NCT01587703|76241785|FG002|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0||
60120612|NCT01587703|76241786|FG003|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0||
60120613|NCT01587703|76241787|FG004|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0||
60120614|NCT01587703|76241788|FG005|COMPLETED|Part1 QD(Median Exposure of 1.38months)||1||
60120615|NCT01587703|76241789|FG006|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0||
60120616|NCT01587703|76241790|FG007|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0||
60120617|NCT01587703|76241791|FG008|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0||
60120618|NCT01587703|76241792|FG009|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0||
60120619|NCT01587703|76241793|FG010|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0||
60120620|NCT01587703|76241794|FG011|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0||
60120621|NCT01587703|76241795|FG012|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0||
60120622|NCT01587703|76241796|FG013|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0||
60120623|NCT01587703|76241797|FG014|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0||
59568134|NCT01908842|75671128|FG000|STARTED|Induction||383||
59568135|NCT01908842|75671129|FG001|STARTED|Induction||375||
59568136|NCT01908842|75671128|FG000|COMPLETED|Induction||357||
59568137|NCT01908842|75671129|FG001|COMPLETED|Induction||344||
59568138|NCT01908842|75671128|FG000|NOT COMPLETED|Induction||26||
59568139|NCT01908842|75671129|FG001|NOT COMPLETED|Induction||31||
59568140|NCT01908842|75671128|FG000|STARTED|Switch to Other BNX Formulation (Day 15)||357||
59568141|NCT01908842|75671129|FG001|STARTED|Switch to Other BNX Formulation (Day 15)||344||
59568142|NCT01908842|75671128|FG000|COMPLETED|Switch to Other BNX Formulation (Day 15)||287||
59568143|NCT01908842|75671129|FG001|COMPLETED|Switch to Other BNX Formulation (Day 15)||279||
59568144|NCT01908842|75671128|FG000|NOT COMPLETED|Switch to Other BNX Formulation (Day 15)||70||
59568145|NCT01908842|75671129|FG001|NOT COMPLETED|Switch to Other BNX Formulation (Day 15)||65||
59568146|NCT01908842|75671128|FG000|STARTED|Day 22: Film (Col 1); Tablets (Col 2)||287||
59568147|NCT01908842|75671129|FG001|STARTED|Day 22: Film (Col 1); Tablets (Col 2)||279||
59568148|NCT01908842|75671128|FG000|COMPLETED|Day 22: Film (Col 1); Tablets (Col 2)||262||
59568149|NCT01908842|75671129|FG001|COMPLETED|Day 22: Film (Col 1); Tablets (Col 2)||262||
59568150|NCT01908842|75671128|FG000|NOT COMPLETED|Day 22: Film (Col 1); Tablets (Col 2)||25||
59568151|NCT01908842|75671129|FG001|NOT COMPLETED|Day 22: Film (Col 1); Tablets (Col 2)||17||
59568152|NCT03727425|75671135|FG000|STARTED|Overall Study||55||
59568153|NCT03727425|75671135|FG000|COMPLETED|Overall Study||55||
59568154|NCT03727425|75671135|FG000|NOT COMPLETED|Overall Study||0||
59568155|NCT00833859|75671139|FG000|STARTED|Overall Study||2||
59568156|NCT00833859|75671139|FG000|COMPLETED|Overall Study||2||
59568157|NCT00833859|75671139|FG000|NOT COMPLETED|Overall Study||0||
60120624|NCT01587703|76241798|FG015|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0||
60120625|NCT01587703|76241799|FG016|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0||
60120626|NCT01587703|76241800|FG017|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0||
60120627|NCT01587703|76241801|FG018|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0||
60120628|NCT01587703|76241783|FG000|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||3||
60120629|NCT01587703|76241784|FG001|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||4||
60120630|NCT01587703|76241785|FG002|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||1||
60120631|NCT01587703|76241786|FG003|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||3||
60120632|NCT01587703|76241787|FG004|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||4||
60120633|NCT01587703|76241788|FG005|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||8||
60120634|NCT01587703|76241789|FG006|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||32||
60120635|NCT01587703|76241790|FG007|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||9||
60120636|NCT01587703|76241791|FG008|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0||
59568158|NCT00832299|75671143|FG000|STARTED|Overall Study||2||
59568159|NCT00832299|75671143|FG000|COMPLETED|Overall Study||2||
59568160|NCT00832299|75671143|FG000|NOT COMPLETED|Overall Study||0||
59568161|NCT03723603|75671147|FG000|STARTED|Overall Study||8||
59568162|NCT03723603|75671147|FG000|COMPLETED|Overall Study||5||
59568163|NCT03723603|75671147|FG000|NOT COMPLETED|Overall Study||3||
59568164|NCT03723447|75671153|FG000|STARTED|Overall Study||50||
59568165|NCT03723447|75671154|FG001|STARTED|Overall Study||51||
59568166|NCT03723447|75671153|FG000|COMPLETED|Overall Study||50||
59568167|NCT03723447|75671154|FG001|COMPLETED|Overall Study||51||
60120637|NCT01587703|76241792|FG009|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0||
60120638|NCT01587703|76241793|FG010|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0||
60120639|NCT01587703|76241794|FG011|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0||
60120640|NCT01587703|76241795|FG012|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0||
60120641|NCT01587703|76241796|FG013|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0||
60120642|NCT01587703|76241797|FG014|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0||
60120643|NCT01587703|76241798|FG015|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0||
60120644|NCT01587703|76241799|FG016|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0||
60120645|NCT01587703|76241800|FG017|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0||
60120646|NCT01587703|76241801|FG018|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0||
60120647|NCT01587703|76241783|FG000|STARTED|Part1 BID(Median Exposure of 1.41months)||0||
60120648|NCT01587703|76241784|FG001|STARTED|Part1 BID(Median Exposure of 1.41months)||0||
60120649|NCT01587703|76241785|FG002|STARTED|Part1 BID(Median Exposure of 1.41months)||0||
60120650|NCT01587703|76241786|FG003|STARTED|Part1 BID(Median Exposure of 1.41months)||0||
60120651|NCT01587703|76241787|FG004|STARTED|Part1 BID(Median Exposure of 1.41months)||0||
60120652|NCT01587703|76241788|FG005|STARTED|Part1 BID(Median Exposure of 1.41months)||0||
60120653|NCT01587703|76241789|FG006|STARTED|Part1 BID(Median Exposure of 1.41months)||0||
60120654|NCT01587703|76241790|FG007|STARTED|Part1 BID(Median Exposure of 1.41months)||0||
60120655|NCT01587703|76241791|FG008|STARTED|Part1 BID(Median Exposure of 1.41months)||4||
60120656|NCT01587703|76241792|FG009|STARTED|Part1 BID(Median Exposure of 1.41months)||10||
60120657|NCT01587703|76241793|FG010|STARTED|Part1 BID(Median Exposure of 1.41months)||5||
60120658|NCT01587703|76241794|FG011|STARTED|Part1 BID(Median Exposure of 1.41months)||0||
60120659|NCT01587703|76241795|FG012|STARTED|Part1 BID(Median Exposure of 1.41months)||0||
59849995|NCT03566680|75974346|FG000|STARTED|Overall Study||46||
59849996|NCT03566680|75974346|FG000|COMPLETED|Overall Study||29||
59849997|NCT03566680|75974346|FG000|NOT COMPLETED|Overall Study||17||
59849998|NCT00106353|75974352|FG000|STARTED|Part 1||4||
59568168|NCT03723447|75671153|FG000|NOT COMPLETED|Overall Study||0||
60120660|NCT01587703|76241796|FG013|STARTED|Part1 BID(Median Exposure of 1.41months)||0||
59568169|NCT03723447|75671154|FG001|NOT COMPLETED|Overall Study||0||
59568170|NCT03718455|75671160|FG000|STARTED|Overall Study||1||
59568171|NCT03718455|75671160|FG000|COMPLETED|Overall Study||1||
59568172|NCT03718455|75671160|FG000|NOT COMPLETED|Overall Study||0||
59568173|NCT00836355|75671168|FG000|STARTED|Overall Study||0||
59568174|NCT00836355|75671169|FG001|STARTED|Overall Study||4||
59568175|NCT00836355|75671170|FG002|STARTED|Overall Study||0||
59568176|NCT00836355|75671171|FG003|STARTED|Overall Study||2||
59568177|NCT00836355|75671168|FG000|COMPLETED|Overall Study||0||
60120661|NCT01587703|76241797|FG014|STARTED|Part1 BID(Median Exposure of 1.41months)||0||
59568178|NCT00836355|75671169|FG001|COMPLETED|Overall Study||4||
59568179|NCT00836355|75671170|FG002|COMPLETED|Overall Study||0||
59568180|NCT00836355|75671171|FG003|COMPLETED|Overall Study||2||
59849999|NCT00106353|75974353|FG001|STARTED|Part 1||5||
59850000|NCT00106353|75974354|FG002|STARTED|Part 1||3||
59850001|NCT00106353|75974355|FG003|STARTED|Part 1||7||
59850002|NCT00106353|75974356|FG004|STARTED|Part 1||0||
59568181|NCT00836355|75671168|FG000|NOT COMPLETED|Overall Study||0||
59568182|NCT00836355|75671169|FG001|NOT COMPLETED|Overall Study||0||
59850003|NCT00106353|75974357|FG005|STARTED|Part 1||0||
59850004|NCT00106353|75974358|FG006|STARTED|Part 1||0||
59850005|NCT00106353|75974352|FG000|COMPLETED|Part 1||0||
59850006|NCT00106353|75974353|FG001|COMPLETED|Part 1||0||
59568183|NCT00836355|75671170|FG002|NOT COMPLETED|Overall Study||0||
59568184|NCT00836355|75671171|FG003|NOT COMPLETED|Overall Study||0||
59568185|NCT00816777|75671183|FG000|STARTED|Overall Study||2||
59568186|NCT00816777|75671184|FG001|STARTED|Overall Study||2||
59568187|NCT00816777|75671183|FG000|COMPLETED|Overall Study||2||
59568188|NCT00816777|75671184|FG001|COMPLETED|Overall Study||2||
59568189|NCT00816777|75671183|FG000|NOT COMPLETED|Overall Study||0||
59568190|NCT00816777|75671184|FG001|NOT COMPLETED|Overall Study||0||
59568191|NCT00823095|75671190|FG000|STARTED|Overall Study||7||
59568192|NCT00823095|75671190|FG000|COMPLETED|Overall Study||7||
59568193|NCT00823095|75671190|FG000|NOT COMPLETED|Overall Study||0||
59568194|NCT03703791|75671197|FG000|STARTED|Overall Study||0||
59568195|NCT03703791|75671198|FG001|STARTED|Overall Study||1||
59568196|NCT03703791|75671197|FG000|COMPLETED|Overall Study||0||
59568197|NCT03703791|75671198|FG001|COMPLETED|Overall Study||0||
59568198|NCT03703791|75671197|FG000|NOT COMPLETED|Overall Study||0||
59568199|NCT03703791|75671198|FG001|NOT COMPLETED|Overall Study||1||
59568200|NCT00803283|75671206|FG000|STARTED|Overall Study||1||
59568201|NCT00803283|75671207|FG001|STARTED|Overall Study||1||
59568202|NCT00803283|75671206|FG000|COMPLETED|Overall Study||1||
59568203|NCT00803283|75671207|FG001|COMPLETED|Overall Study||1||
59568204|NCT00803283|75671206|FG000|NOT COMPLETED|Overall Study||0||
59568205|NCT00803283|75671207|FG001|NOT COMPLETED|Overall Study||0||
59568206|NCT03697551|75671213|FG000|STARTED|Overall Study||4||
59568207|NCT03697551|75671213|FG000|COMPLETED|Overall Study||4||
59568208|NCT03697551|75671213|FG000|NOT COMPLETED|Overall Study||0||
59568209|NCT00799773|75671219|FG000|STARTED|Overall Study||2||
59568210|NCT00799773|75671220|FG001|STARTED|Overall Study||1||
59568211|NCT00799773|75671219|FG000|COMPLETED|Overall Study||2||
59568212|NCT00799773|75671220|FG001|COMPLETED|Overall Study||1||
59568213|NCT00799773|75671219|FG000|NOT COMPLETED|Overall Study||0||
59568214|NCT00799773|75671220|FG001|NOT COMPLETED|Overall Study||0||
59568215|NCT01975467|75671228|FG000|STARTED|Overall Study|Study terminated before enrollment|0||
59568216|NCT01975467|75671229|FG001|STARTED|Overall Study|Study terminated before enrollment|0||
59568217|NCT01975467|75671228|FG000|COMPLETED|Overall Study||0||
59568218|NCT01975467|75671229|FG001|COMPLETED|Overall Study||0||
59568219|NCT01975467|75671228|FG000|NOT COMPLETED|Overall Study||0||
59720799|NCT01097616|75839729|FG001|STARTED|DB RO Phase||0||
59720800|NCT01097616|75839730|FG002|STARTED|DB RO Phase||0||
59568220|NCT01975467|75671229|FG001|NOT COMPLETED|Overall Study||0||
59568221|NCT00760461|75671235|FG000|STARTED|Overall Study||44||
59568222|NCT00760461|75671235|FG000|COMPLETED|Overall Study||0||
59720801|NCT01097616|75839731|FG003|STARTED|DB RO Phase||101||
59720802|NCT01097616|75839732|FG004|STARTED|DB RO Phase|1 was randomized to this group but actually received suvorexant LD during RO|112||
59568223|NCT00760461|75671235|FG000|NOT COMPLETED|Overall Study||44||
60120662|NCT01587703|76241798|FG015|STARTED|Part1 BID(Median Exposure of 1.41months)||0||
60120663|NCT01587703|76241799|FG016|STARTED|Part1 BID(Median Exposure of 1.41months)||0||
60120664|NCT01587703|76241800|FG017|STARTED|Part1 BID(Median Exposure of 1.41months)||0||
60120665|NCT01587703|76241801|FG018|STARTED|Part1 BID(Median Exposure of 1.41months)||0||
60120666|NCT01587703|76241783|FG000|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0||
60120667|NCT01587703|76241784|FG001|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0||
60120668|NCT01587703|76241785|FG002|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0||
60120669|NCT01587703|76241786|FG003|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0||
60120670|NCT01587703|76241787|FG004|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0||
60120671|NCT01587703|76241788|FG005|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0||
60120672|NCT01587703|76241789|FG006|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0||
60120673|NCT01587703|76241790|FG007|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0||
60120674|NCT01587703|76241791|FG008|COMPLETED|Part1 BID(Median Exposure of 1.41months)||1||
60120675|NCT01587703|76241792|FG009|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0||
60120676|NCT01587703|76241793|FG010|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0||
60120677|NCT01587703|76241794|FG011|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0||
60120678|NCT01587703|76241795|FG012|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0||
60120679|NCT01587703|76241796|FG013|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0||
59568224|NCT00750555|75671239|FG000|STARTED|Overall Study||0||
59568225|NCT00750555|75671239|FG000|COMPLETED|Overall Study||0||
59720803|NCT01097616|75839733|FG005|STARTED|DB RO Phase|1 entered RO but was not treated during RO|161||
59720804|NCT01097616|75839734|FG006|STARTED|DB RO Phase||162||
59568226|NCT00750555|75671239|FG000|NOT COMPLETED|Overall Study||0||
59568227|NCT00754767|75671246|FG000|STARTED|Overall Study||2||
59568228|NCT00754767|75671247|FG001|STARTED|Overall Study||0||
59720805|NCT01097616|75839735|FG007|STARTED|DB RO Phase||327||
59720806|NCT01097616|75839728|FG000|COMPLETED|DB RO Phase||0||
59720807|NCT01097616|75839729|FG001|COMPLETED|DB RO Phase||0||
59720808|NCT01097616|75839730|FG002|COMPLETED|DB RO Phase||0||
59568229|NCT00754767|75671246|FG000|COMPLETED|Overall Study||2||
59568230|NCT00754767|75671247|FG001|COMPLETED|Overall Study||0||
59568231|NCT00754767|75671246|FG000|NOT COMPLETED|Overall Study||0||
59568232|NCT00754767|75671247|FG001|NOT COMPLETED|Overall Study||0||
59568233|NCT00751335|75671255|FG000|STARTED|Overall Study||0||
59568234|NCT00751335|75671256|FG001|STARTED|Overall Study||0||
59568235|NCT00751335|75671255|FG000|COMPLETED|Overall Study||0||
59720809|NCT01097616|75839731|FG003|COMPLETED|DB RO Phase||100||
59720810|NCT01097616|75839732|FG004|COMPLETED|DB RO Phase||111||
59720811|NCT01097616|75839733|FG005|COMPLETED|DB RO Phase||159||
59850007|NCT00106353|75974354|FG002|COMPLETED|Part 1||0||
59568236|NCT00751335|75671256|FG001|COMPLETED|Overall Study||0||
60120680|NCT01587703|76241797|FG014|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0||
60120681|NCT01587703|76241798|FG015|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0||
60120682|NCT01587703|76241799|FG016|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0||
60120683|NCT01587703|76241800|FG017|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0||
60120684|NCT01587703|76241801|FG018|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0||
60120685|NCT01587703|76241783|FG000|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0||
60120686|NCT01587703|76241784|FG001|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0||
60120687|NCT01587703|76241785|FG002|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0||
60120688|NCT01587703|76241786|FG003|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0||
60120689|NCT01587703|76241787|FG004|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0||
60120690|NCT01587703|76241788|FG005|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0||
60120691|NCT01587703|76241789|FG006|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0||
60120692|NCT01587703|76241790|FG007|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0||
60120693|NCT01587703|76241791|FG008|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||3||
60120694|NCT01587703|76241792|FG009|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||10||
59568237|NCT00751335|75671255|FG000|NOT COMPLETED|Overall Study||0||
59568238|NCT00751335|75671256|FG001|NOT COMPLETED|Overall Study||0||
59568239|NCT01962675|75671264|FG000|STARTED|Overall Study||7||
59568240|NCT01962675|75671265|FG001|STARTED|Overall Study||7||
59568241|NCT01962675|75671264|FG000|COMPLETED|Overall Study||7||
59568242|NCT01962675|75671265|FG001|COMPLETED|Overall Study||7||
59568243|NCT01962675|75671264|FG000|NOT COMPLETED|Overall Study||0||
59568244|NCT01962675|75671265|FG001|NOT COMPLETED|Overall Study||0||
59568245|NCT00706329|75671273|FG000|STARTED|Overall Study||25||
59568246|NCT00706329|75671273|FG000|COMPLETED|Overall Study||25||
59568247|NCT00706329|75671273|FG000|NOT COMPLETED|Overall Study||0||
59568248|NCT01941615|75671277|FG000|STARTED|Run in Treatment: Microgynon®||16||
59568249|NCT01941615|75671277|FG000|COMPLETED|Run in Treatment: Microgynon®||16||
59568250|NCT01941615|75671277|FG000|NOT COMPLETED|Run in Treatment: Microgynon®||0||
59568251|NCT01941615|75671277|FG000|STARTED|Reference Treatment: Microgynon®||0||
59568252|NCT01941615|75671277|FG000|COMPLETED|Reference Treatment: Microgynon®||0||
59568253|NCT01941615|75671277|FG000|NOT COMPLETED|Reference Treatment: Microgynon®||0||
59568254|NCT01941615|75671277|FG000|STARTED|Microgynon® Plus Deleobuvir+Faldaprevir||0||
59568255|NCT01941615|75671277|FG000|COMPLETED|Microgynon® Plus Deleobuvir+Faldaprevir||0||
59568256|NCT01941615|75671277|FG000|NOT COMPLETED|Microgynon® Plus Deleobuvir+Faldaprevir||0||
59568257|NCT01901679|75671283|FG000|STARTED|Overall Study||5||
59568258|NCT01901679|75671284|FG001|STARTED|Overall Study||5||
59568259|NCT01901679|75671283|FG000|COMPLETED|Overall Study||5||
59568260|NCT01901679|75671284|FG001|COMPLETED|Overall Study||5||
59568261|NCT01901679|75671283|FG000|NOT COMPLETED|Overall Study||0||
59568262|NCT01901679|75671284|FG001|NOT COMPLETED|Overall Study||0||
59568263|NCT00688935|75671290|FG000|STARTED|Overall Study||0||
59568264|NCT00688935|75671290|FG000|COMPLETED|Overall Study||0||
59568265|NCT00688935|75671290|FG000|NOT COMPLETED|Overall Study||0||
59850008|NCT00106353|75974355|FG003|COMPLETED|Part 1||0||
60120695|NCT01587703|76241793|FG010|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||5||
60120696|NCT01587703|76241794|FG011|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0||
60120697|NCT01587703|76241795|FG012|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0||
60120698|NCT01587703|76241796|FG013|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0||
60120699|NCT01587703|76241797|FG014|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0||
60120700|NCT01587703|76241798|FG015|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0||
60120701|NCT01587703|76241799|FG016|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0||
60120702|NCT01587703|76241800|FG017|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0||
60120703|NCT01587703|76241801|FG018|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0||
60120704|NCT01587703|76241783|FG000|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
60120705|NCT01587703|76241784|FG001|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
60120706|NCT01587703|76241785|FG002|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
60120707|NCT01587703|76241786|FG003|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
60120708|NCT01587703|76241787|FG004|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
60120709|NCT01587703|76241788|FG005|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
60120710|NCT01587703|76241789|FG006|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
60120711|NCT01587703|76241790|FG007|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
60120712|NCT01587703|76241791|FG008|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
60120713|NCT01587703|76241792|FG009|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
59850009|NCT00106353|75974356|FG004|COMPLETED|Part 1||0||
59850010|NCT00106353|75974357|FG005|COMPLETED|Part 1||0||
59850011|NCT00106353|75974358|FG006|COMPLETED|Part 1||0||
59850012|NCT00106353|75974352|FG000|NOT COMPLETED|Part 1||4||
59850013|NCT00106353|75974353|FG001|NOT COMPLETED|Part 1||5||
60120714|NCT01587703|76241793|FG010|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
60120715|NCT01587703|76241794|FG011|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
60120716|NCT01587703|76241795|FG012|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
60120717|NCT01587703|76241796|FG013|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
60120718|NCT01587703|76241797|FG014|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
60120719|NCT01587703|76241798|FG015|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
60120720|NCT01587703|76241799|FG016|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
59568266|NCT00676455|75671294|FG000|STARTED|Overall Study||14||
60120721|NCT01587703|76241800|FG017|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||5||
60120722|NCT01587703|76241801|FG018|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||5||
60120723|NCT01587703|76241783|FG000|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
60120724|NCT01587703|76241784|FG001|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
60120725|NCT01587703|76241785|FG002|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
60120726|NCT01587703|76241786|FG003|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
59720812|NCT01097616|75839734|FG006|COMPLETED|DB RO Phase||161||
59720813|NCT01097616|75839735|FG007|COMPLETED|DB RO Phase||326||
59720814|NCT01097616|75839728|FG000|NOT COMPLETED|DB RO Phase||0||
60120727|NCT01587703|76241787|FG004|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
60120728|NCT01587703|76241788|FG005|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
60120729|NCT01587703|76241789|FG006|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
60120730|NCT01587703|76241790|FG007|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
60120731|NCT01587703|76241791|FG008|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
60120732|NCT01587703|76241792|FG009|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
60120733|NCT01587703|76241793|FG010|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
60120734|NCT01587703|76241794|FG011|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
60120735|NCT01587703|76241795|FG012|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
60120736|NCT01587703|76241796|FG013|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
60120737|NCT01587703|76241797|FG014|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
60120738|NCT01587703|76241798|FG015|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
60120739|NCT01587703|76241799|FG016|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
60120740|NCT01587703|76241800|FG017|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||5||
59568267|NCT00676455|75671294|FG000|COMPLETED|Overall Study||14||
59568268|NCT00676455|75671294|FG000|NOT COMPLETED|Overall Study||0||
60120741|NCT01587703|76241801|FG018|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||5||
60120742|NCT01587703|76241783|FG000|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
60120743|NCT01587703|76241784|FG001|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
60120744|NCT01587703|76241785|FG002|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
60120745|NCT01587703|76241786|FG003|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
59568269|NCT01877343|75671301|FG000|STARTED|Overall Study||2||
59568270|NCT01877343|75671302|FG001|STARTED|Overall Study||3||
59568271|NCT01877343|75671303|FG002|STARTED|Overall Study||0||
59720815|NCT01097616|75839729|FG001|NOT COMPLETED|DB RO Phase||0||
59720816|NCT01097616|75839730|FG002|NOT COMPLETED|DB RO Phase||0||
59720817|NCT01097616|75839731|FG003|NOT COMPLETED|DB RO Phase||1||
59720818|NCT01097616|75839732|FG004|NOT COMPLETED|DB RO Phase||1||
59720819|NCT01097616|75839733|FG005|NOT COMPLETED|DB RO Phase||2||
59720820|NCT01097616|75839734|FG006|NOT COMPLETED|DB RO Phase||1||
59720821|NCT01097616|75839735|FG007|NOT COMPLETED|DB RO Phase||1||
59720822|NCT00871429|75839761|FG000|STARTED|Overall Study||99||
59720823|NCT00871429|75839761|FG000|COMPLETED|Overall Study||75||
59720824|NCT00871429|75839761|FG000|NOT COMPLETED|Overall Study||24||
59720825|NCT01151345|75839769|FG000|STARTED|First Intervention Period||13||
59720826|NCT01151345|75839770|FG001|STARTED|First Intervention Period||13||
59720827|NCT01151345|75839769|FG000|Treated|First Intervention Period||13||
59720828|NCT01151345|75839770|FG001|Treated|First Intervention Period||12||
59720829|NCT01151345|75839769|FG000|COMPLETED|First Intervention Period||13||
59720830|NCT01151345|75839770|FG001|COMPLETED|First Intervention Period||12||
59720831|NCT01151345|75839769|FG000|NOT COMPLETED|First Intervention Period||0||
59720832|NCT01151345|75839770|FG001|NOT COMPLETED|First Intervention Period||1||
59720833|NCT01151345|75839769|FG000|STARTED|Wash-out Period (7 Days)||13||
59720834|NCT01151345|75839770|FG001|STARTED|Wash-out Period (7 Days)||12||
59720835|NCT01151345|75839769|FG000|COMPLETED|Wash-out Period (7 Days)||13||
59720836|NCT01151345|75839770|FG001|COMPLETED|Wash-out Period (7 Days)||12||
59720837|NCT01151345|75839769|FG000|NOT COMPLETED|Wash-out Period (7 Days)||0||
59720838|NCT01151345|75839770|FG001|NOT COMPLETED|Wash-out Period (7 Days)||0||
59720839|NCT01151345|75839769|FG000|STARTED|Second Intervention Period||13||
59720840|NCT01151345|75839770|FG001|STARTED|Second Intervention Period||12||
59720841|NCT01151345|75839769|FG000|COMPLETED|Second Intervention Period||13||
59720842|NCT01151345|75839770|FG001|COMPLETED|Second Intervention Period||12||
59720843|NCT01151345|75839769|FG000|NOT COMPLETED|Second Intervention Period||0||
59720844|NCT01151345|75839770|FG001|NOT COMPLETED|Second Intervention Period||0||
59720845|NCT00593827|75839778|FG000|STARTED|Overall Study|Intent-to-Treat (ITT) Population: Participants who were randomized (eligible and ineligible).|85||
59720846|NCT00593827|75839779|FG001|STARTED|Overall Study|ITT Population: Participants who were randomized (eligible and ineligible).|91||
59720847|NCT00593827|75839778|FG000|Safety Population|Overall Study|Participants (eligible and ineligible) who received at least 1 dose of study drug.|82||
59720848|NCT00593827|75839779|FG001|Safety Population|Overall Study|Participants (eligible and ineligible) who received at least 1 dose of study drug.|89||
59720849|NCT00593827|75839778|FG000|Evaluable Population|Overall Study|Treated participants with CR, PR, SD, PD, or NE response. Refer outcome measure 3 and 4 for details.|79||
59720850|NCT00593827|75839779|FG001|Evaluable Population|Overall Study|Treated participants with CR, PR, SD, PD, or NE response. Refer outcome measure 3 and 4 for details.|89||
59720851|NCT00593827|75839778|FG000|COMPLETED|Overall Study|Completed=off-study (Major reasons: Adverse events (AE)=15; disease progression=76; not treated=3).|85||
59720852|NCT00593827|75839779|FG001|COMPLETED|Overall Study|Completed=off-study (Major reasons: AEs=30; disease progression=55; not treated=2).|89||
59720853|NCT00593827|75839778|FG000|NOT COMPLETED|Overall Study||0||
59568272|NCT01877343|75671304|FG003|STARTED|Overall Study||0||
59568273|NCT01877343|75671305|FG004|STARTED|Overall Study||0||
59720854|NCT00593827|75839779|FG001|NOT COMPLETED|Overall Study||2||
59720855|NCT01150097|75839788|FG000|STARTED|Months 24 to 36 Post-transplantation||106||
59720856|NCT01150097|75839789|FG001|STARTED|Months 24 to 36 Post-transplantation||51||
60120746|NCT01587703|76241787|FG004|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
60120747|NCT01587703|76241788|FG005|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
60120748|NCT01587703|76241789|FG006|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
59720857|NCT01150097|75839790|FG002|STARTED|Months 24 to 36 Post-transplantation||125||
59850014|NCT00106353|75974354|FG002|NOT COMPLETED|Part 1||3||
60120749|NCT01587703|76241790|FG007|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
59720858|NCT01150097|75839788|FG000|COMPLETED|Months 24 to 36 Post-transplantation||96||
59720859|NCT01150097|75839789|FG001|COMPLETED|Months 24 to 36 Post-transplantation||49||
59720860|NCT01150097|75839790|FG002|COMPLETED|Months 24 to 36 Post-transplantation||117||
59850015|NCT00106353|75974355|FG003|NOT COMPLETED|Part 1||7||
59850016|NCT00106353|75974356|FG004|NOT COMPLETED|Part 1||0||
59720861|NCT01150097|75839788|FG000|NOT COMPLETED|Months 24 to 36 Post-transplantation||10||
59720862|NCT01150097|75839789|FG001|NOT COMPLETED|Months 24 to 36 Post-transplantation||2||
59720863|NCT01150097|75839790|FG002|NOT COMPLETED|Months 24 to 36 Post-transplantation||8||
59568274|NCT01877343|75671306|FG005|STARTED|Overall Study||5||
59568275|NCT01877343|75671307|FG006|STARTED|Overall Study||0||
59568276|NCT01877343|75671301|FG000|COMPLETED|Overall Study||2||
59568277|NCT01877343|75671302|FG001|COMPLETED|Overall Study||3||
59568278|NCT01877343|75671303|FG002|COMPLETED|Overall Study||0||
59568279|NCT01877343|75671304|FG003|COMPLETED|Overall Study||0||
59568280|NCT01877343|75671305|FG004|COMPLETED|Overall Study||0||
59568281|NCT01877343|75671306|FG005|COMPLETED|Overall Study||5||
59568282|NCT01877343|75671307|FG006|COMPLETED|Overall Study||0||
59568283|NCT01877343|75671301|FG000|NOT COMPLETED|Overall Study||0||
59568284|NCT01877343|75671302|FG001|NOT COMPLETED|Overall Study||0||
59568285|NCT01877343|75671303|FG002|NOT COMPLETED|Overall Study||0||
59568286|NCT01877343|75671304|FG003|NOT COMPLETED|Overall Study||0||
59568287|NCT01877343|75671305|FG004|NOT COMPLETED|Overall Study||0||
59568288|NCT01877343|75671306|FG005|NOT COMPLETED|Overall Study||0||
59568289|NCT01877343|75671307|FG006|NOT COMPLETED|Overall Study||0||
59568290|NCT00684255|75671311|FG000|STARTED|Overall Study||1||
59568291|NCT00684255|75671311|FG000|COMPLETED|Overall Study||1||
59568292|NCT00684255|75671311|FG000|NOT COMPLETED|Overall Study||0||
59568293|NCT00668265|75671318|FG000|STARTED|Overall Study||9||
59568294|NCT00668265|75671319|FG001|STARTED|Overall Study||5||
59568295|NCT00668265|75671318|FG000|COMPLETED|Overall Study|The PI left, no records avaialable; the number of subjects who completed the study is not known|0||
59568296|NCT00668265|75671319|FG001|COMPLETED|Overall Study|The PI left, no records avaialable; the number of subjects who completed the study is not known|0||
59568297|NCT00668265|75671318|FG000|NOT COMPLETED|Overall Study||9||
59568298|NCT00668265|75671319|FG001|NOT COMPLETED|Overall Study||5||
59568299|NCT01856361|75671329|FG000|STARTED|Overall Study||1||
59850017|NCT00106353|75974357|FG005|NOT COMPLETED|Part 1||0||
60120750|NCT01587703|76241791|FG008|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
60120751|NCT01587703|76241792|FG009|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
60120752|NCT01587703|76241793|FG010|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
60120753|NCT01587703|76241794|FG011|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
59568300|NCT01856361|75671330|FG001|STARTED|Overall Study||1||
59568301|NCT01856361|75671329|FG000|COMPLETED|Overall Study||1||
60120754|NCT01587703|76241795|FG012|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
60120755|NCT01587703|76241796|FG013|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
59568302|NCT01856361|75671330|FG001|COMPLETED|Overall Study||1||
59568303|NCT01856361|75671329|FG000|NOT COMPLETED|Overall Study||0||
59568304|NCT01856361|75671330|FG001|NOT COMPLETED|Overall Study||0||
59568305|NCT00642603|75671338|FG000|STARTED|Overall Study||21||
59568306|NCT00642603|75671339|FG001|STARTED|Overall Study||20||
59720864|NCT01150097|75839788|FG000|STARTED|Months 24 to 48 Post-transplantation||106||
60120756|NCT01587703|76241797|FG014|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
60120757|NCT01587703|76241798|FG015|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
60120758|NCT01587703|76241799|FG016|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
60120759|NCT01587703|76241800|FG017|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
60120760|NCT01587703|76241801|FG018|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0||
60120761|NCT01587703|76241783|FG000|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0||
60120762|NCT01587703|76241784|FG001|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0||
60120763|NCT01587703|76241785|FG002|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0||
60120764|NCT01587703|76241786|FG003|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0||
60120765|NCT01587703|76241787|FG004|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0||
60120766|NCT01587703|76241788|FG005|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0||
60120767|NCT01587703|76241789|FG006|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0||
60120768|NCT01587703|76241790|FG007|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0||
60120769|NCT01587703|76241791|FG008|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0||
60120770|NCT01587703|76241792|FG009|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0||
60120771|NCT01587703|76241793|FG010|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0||
59850018|NCT00106353|75974358|FG006|NOT COMPLETED|Part 1||0||
59720865|NCT01150097|75839789|FG001|STARTED|Months 24 to 48 Post-transplantation||51||
59720866|NCT01150097|75839790|FG002|STARTED|Months 24 to 48 Post-transplantation||0||
59720867|NCT01150097|75839788|FG000|COMPLETED|Months 24 to 48 Post-transplantation||95||
59720868|NCT01150097|75839789|FG001|COMPLETED|Months 24 to 48 Post-transplantation||47||
59720869|NCT01150097|75839790|FG002|COMPLETED|Months 24 to 48 Post-transplantation||0||
59720870|NCT01150097|75839788|FG000|NOT COMPLETED|Months 24 to 48 Post-transplantation||11||
59720871|NCT01150097|75839789|FG001|NOT COMPLETED|Months 24 to 48 Post-transplantation||4||
59850019|NCT00106353|75974352|FG000|STARTED|Part 2||0||
59568307|NCT00642603|75671338|FG000|Safety Population|Overall Study||19||
59720872|NCT01150097|75839790|FG002|NOT COMPLETED|Months 24 to 48 Post-transplantation||0||
59720873|NCT01149863|75839800|FG000|STARTED|Overall Study||34||
60120772|NCT01587703|76241794|FG011|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0||
60120773|NCT01587703|76241795|FG012|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0||
60120774|NCT01587703|76241796|FG013|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0||
60120775|NCT01587703|76241797|FG014|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0||
60120776|NCT01587703|76241798|FG015|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0||
60120777|NCT01587703|76241799|FG016|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0||
60120778|NCT01587703|76241800|FG017|STARTED|Substudy-P2, Week1Day3 to Week2Day1||5||
60120779|NCT01587703|76241801|FG018|STARTED|Substudy-P2, Week1Day3 to Week2Day1||5||
60120780|NCT01587703|76241783|FG000|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0||
60120781|NCT01587703|76241784|FG001|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0||
60120782|NCT01587703|76241785|FG002|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0||
60120783|NCT01587703|76241786|FG003|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0||
60120784|NCT01587703|76241787|FG004|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0||
60120785|NCT01587703|76241788|FG005|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0||
60120786|NCT01587703|76241789|FG006|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0||
60120787|NCT01587703|76241790|FG007|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0||
59720874|NCT01149863|75839800|FG000|COMPLETED|Overall Study||31||
59720875|NCT01149863|75839800|FG000|NOT COMPLETED|Overall Study||3||
59720876|NCT01149473|75839806|FG000|STARTED|First Intervention||40||
59568308|NCT00642603|75671339|FG001|Safety Population|Overall Study||20||
59850020|NCT00106353|75974353|FG001|STARTED|Part 2||0||
59568309|NCT00642603|75671338|FG000|COMPLETED|Overall Study||0||
59720877|NCT01149473|75839807|FG001|STARTED|First Intervention||40||
59720878|NCT01149473|75839806|FG000|COMPLETED|First Intervention||39||
59720879|NCT01149473|75839807|FG001|COMPLETED|First Intervention||39||
59720880|NCT01149473|75839806|FG000|NOT COMPLETED|First Intervention||1||
59720881|NCT01149473|75839807|FG001|NOT COMPLETED|First Intervention||1||
59720882|NCT01149473|75839806|FG000|STARTED|Washout of 7 Days||39||
60120788|NCT01587703|76241791|FG008|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0||
60120789|NCT01587703|76241792|FG009|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0||
60120790|NCT01587703|76241793|FG010|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0||
60120791|NCT01587703|76241794|FG011|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0||
60120792|NCT01587703|76241795|FG012|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0||
60120793|NCT01587703|76241796|FG013|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0||
60120794|NCT01587703|76241797|FG014|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0||
60120795|NCT01587703|76241798|FG015|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0||
59568310|NCT00642603|75671339|FG001|COMPLETED|Overall Study||2||
59568311|NCT00642603|75671338|FG000|NOT COMPLETED|Overall Study||21||
59568312|NCT00642603|75671339|FG001|NOT COMPLETED|Overall Study||18||
59568313|NCT03689192|75671345|FG000|STARTED|Overall Study||13||
59568314|NCT03689192|75671345|FG000|COMPLETED|Overall Study||10||
59568315|NCT03689192|75671345|FG000|NOT COMPLETED|Overall Study||3||
59568316|NCT01841931|75671349|FG000|STARTED|Overall Study||4||
59568317|NCT01841931|75671349|FG000|COMPLETED|Overall Study|As the PI left the institution the study was terminated|0||
59568318|NCT01841931|75671349|FG000|NOT COMPLETED|Overall Study||4||
59568319|NCT00610467|75671355|FG000|STARTED|Overall Study||1||
59568320|NCT00610467|75671356|FG001|STARTED|Overall Study||1||
59568321|NCT00610467|75671355|FG000|COMPLETED|Overall Study||1||
59568322|NCT00610467|75671356|FG001|COMPLETED|Overall Study||1||
59568323|NCT00610467|75671355|FG000|NOT COMPLETED|Overall Study||0||
59568324|NCT00610467|75671356|FG001|NOT COMPLETED|Overall Study||0||
59568325|NCT00597909|75671365|FG000|STARTED|Overall Study||0||
59568326|NCT00597909|75671366|FG001|STARTED|Overall Study||0||
59568327|NCT00597909|75671367|FG002|STARTED|Overall Study||0||
59568328|NCT00597909|75671365|FG000|COMPLETED|Overall Study||0||
59568329|NCT00597909|75671366|FG001|COMPLETED|Overall Study||0||
59568330|NCT00597909|75671367|FG002|COMPLETED|Overall Study||0||
59568331|NCT00597909|75671365|FG000|NOT COMPLETED|Overall Study||0||
59720883|NCT01149473|75839807|FG001|STARTED|Washout of 7 Days||39||
59720884|NCT01149473|75839806|FG000|COMPLETED|Washout of 7 Days||38||
59720885|NCT01149473|75839807|FG001|COMPLETED|Washout of 7 Days||38||
59720886|NCT01149473|75839806|FG000|NOT COMPLETED|Washout of 7 Days||1||
59720887|NCT01149473|75839807|FG001|NOT COMPLETED|Washout of 7 Days||1||
59720888|NCT01149473|75839806|FG000|STARTED|Second Intervention||38||
59720889|NCT01149473|75839807|FG001|STARTED|Second Intervention||38||
59720890|NCT01149473|75839806|FG000|COMPLETED|Second Intervention||38||
59720891|NCT01149473|75839807|FG001|COMPLETED|Second Intervention||38||
59720892|NCT01149473|75839806|FG000|NOT COMPLETED|Second Intervention||0||
59720893|NCT01149473|75839807|FG001|NOT COMPLETED|Second Intervention||0||
59720894|NCT00872989|75839815|FG000|STARTED|Overall Study||66||
59720895|NCT00872989|75839816|FG001|STARTED|Overall Study||63||
59568332|NCT00597909|75671366|FG001|NOT COMPLETED|Overall Study||0||
59568333|NCT00597909|75671367|FG002|NOT COMPLETED|Overall Study||0||
59720896|NCT00872989|75839815|FG000|COMPLETED|Overall Study||1||
59720897|NCT00872989|75839816|FG001|COMPLETED|Overall Study||0||
59568334|NCT00586209|75671377|FG000|STARTED|Overall Study||5||
59568335|NCT00586209|75671378|FG001|STARTED|Overall Study||10||
59568336|NCT00586209|75671377|FG000|COMPLETED|Overall Study||5||
60120796|NCT01587703|76241799|FG016|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0||
60120797|NCT01587703|76241800|FG017|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||5||
59568337|NCT00586209|75671378|FG001|COMPLETED|Overall Study||10||
59720898|NCT00872989|75839815|FG000|NOT COMPLETED|Overall Study||65||
59720899|NCT00872989|75839816|FG001|NOT COMPLETED|Overall Study||63||
59720900|NCT01148771|75839830|FG000|STARTED|First Intervention||6||
59720901|NCT01148771|75839831|FG001|STARTED|First Intervention||6||
59720902|NCT01148771|75839830|FG000|COMPLETED|First Intervention||6||
59720903|NCT01148771|75839831|FG001|COMPLETED|First Intervention||6||
59720904|NCT01148771|75839830|FG000|NOT COMPLETED|First Intervention||0||
59720905|NCT01148771|75839831|FG001|NOT COMPLETED|First Intervention||0||
59720906|NCT01148771|75839830|FG000|STARTED|Washout Period||6||
59720907|NCT01148771|75839831|FG001|STARTED|Washout Period||6||
59850021|NCT00106353|75974354|FG002|STARTED|Part 2||0||
60120798|NCT01587703|76241801|FG018|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||5||
60120799|NCT01587703|76241783|FG000|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0||
60120800|NCT01587703|76241784|FG001|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0||
60120801|NCT01587703|76241785|FG002|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0||
60120802|NCT01587703|76241786|FG003|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0||
60120803|NCT01587703|76241787|FG004|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0||
59720908|NCT01148771|75839830|FG000|COMPLETED|Washout Period||6||
59720909|NCT01148771|75839831|FG001|COMPLETED|Washout Period||5||
59720910|NCT01148771|75839830|FG000|NOT COMPLETED|Washout Period||0||
60120804|NCT01587703|76241788|FG005|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0||
59568338|NCT00586209|75671377|FG000|NOT COMPLETED|Overall Study||0||
59568339|NCT00586209|75671378|FG001|NOT COMPLETED|Overall Study||0||
60120805|NCT01587703|76241789|FG006|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0||
60120806|NCT01587703|76241790|FG007|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0||
60120807|NCT01587703|76241791|FG008|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0||
60120808|NCT01587703|76241792|FG009|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0||
60120809|NCT01587703|76241793|FG010|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0||
60120810|NCT01587703|76241794|FG011|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0||
60120811|NCT01587703|76241795|FG012|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0||
60120812|NCT01587703|76241796|FG013|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0||
60120813|NCT01587703|76241797|FG014|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0||
60120814|NCT01587703|76241798|FG015|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0||
60120815|NCT01587703|76241799|FG016|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0||
60120816|NCT01587703|76241800|FG017|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0||
60120817|NCT01587703|76241801|FG018|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0||
60120818|NCT01587703|76241783|FG000|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0||
60120819|NCT01587703|76241784|FG001|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0||
60120820|NCT01587703|76241785|FG002|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0||
60120821|NCT01587703|76241786|FG003|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0||
60120822|NCT01587703|76241787|FG004|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0||
60120823|NCT01587703|76241788|FG005|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0||
60120824|NCT01587703|76241789|FG006|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0||
60120825|NCT01587703|76241790|FG007|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0||
60120826|NCT01587703|76241791|FG008|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0||
60120827|NCT01587703|76241792|FG009|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0||
60120828|NCT01587703|76241793|FG010|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0||
60120829|NCT01587703|76241794|FG011|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0||
60120830|NCT01587703|76241795|FG012|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0||
60120831|NCT01587703|76241796|FG013|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0||
60120832|NCT01587703|76241797|FG014|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0||
60120833|NCT01587703|76241798|FG015|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0||
60120834|NCT01587703|76241799|FG016|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0||
60120835|NCT01587703|76241800|FG017|STARTED|Substudy-P3, Week2Day1 to Week2Day3||5||
60120836|NCT01587703|76241801|FG018|STARTED|Substudy-P3, Week2Day1 to Week2Day3||5||
60120837|NCT01587703|76241783|FG000|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0||
60120838|NCT01587703|76241784|FG001|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0||
60120839|NCT01587703|76241785|FG002|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0||
60120840|NCT01587703|76241786|FG003|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0||
60120841|NCT01587703|76241787|FG004|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0||
60120842|NCT01587703|76241788|FG005|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0||
60120843|NCT01587703|76241789|FG006|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0||
60120844|NCT01587703|76241790|FG007|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0||
60120845|NCT01587703|76241791|FG008|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0||
60120846|NCT01587703|76241792|FG009|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0||
60120847|NCT01587703|76241793|FG010|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0||
60120848|NCT01587703|76241794|FG011|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0||
60120849|NCT01587703|76241795|FG012|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0||
59568340|NCT00588471|75671386|FG000|STARTED|Overall Study||28||
59720911|NCT01148771|75839831|FG001|NOT COMPLETED|Washout Period||1||
59850022|NCT00106353|75974355|FG003|STARTED|Part 2||0||
59568341|NCT00588471|75671387|FG001|STARTED|Overall Study||29||
59720912|NCT01148771|75839830|FG000|STARTED|Second Intervention||6||
59850023|NCT00106353|75974356|FG004|STARTED|Part 2||17||
59568342|NCT00588471|75671386|FG000|COMPLETED|Overall Study||28||
59568343|NCT00588471|75671387|FG001|COMPLETED|Overall Study||29||
59568344|NCT00588471|75671386|FG000|NOT COMPLETED|Overall Study||0||
59568345|NCT00588471|75671387|FG001|NOT COMPLETED|Overall Study||0||
59568346|NCT01784991|75671395|FG000|STARTED|Overall Study||0||
59568347|NCT01784991|75671396|FG001|STARTED|Overall Study||0||
59568348|NCT01784991|75671395|FG000|COMPLETED|Overall Study||0||
59720913|NCT01148771|75839831|FG001|STARTED|Second Intervention||5||
59720914|NCT01148771|75839830|FG000|COMPLETED|Second Intervention||6||
59568349|NCT01784991|75671396|FG001|COMPLETED|Overall Study||0||
59568350|NCT01784991|75671395|FG000|NOT COMPLETED|Overall Study||0||
59568351|NCT01784991|75671396|FG001|NOT COMPLETED|Overall Study||0||
59568352|NCT01760889|75671405|FG000|STARTED|Overall Study||0||
59568353|NCT01760889|75671406|FG001|STARTED|Overall Study||0||
59568354|NCT01760889|75671407|FG002|STARTED|Overall Study||0||
59568355|NCT01760889|75671405|FG000|COMPLETED|Overall Study||0||
59568356|NCT01760889|75671406|FG001|COMPLETED|Overall Study||0||
59568357|NCT01760889|75671407|FG002|COMPLETED|Overall Study||0||
59568358|NCT01760889|75671405|FG000|NOT COMPLETED|Overall Study||0||
59568359|NCT01760889|75671406|FG001|NOT COMPLETED|Overall Study||0||
59568360|NCT01760889|75671407|FG002|NOT COMPLETED|Overall Study||0||
59568361|NCT01745913|75671417|FG000|STARTED|Overall Study||1||
59568362|NCT01745913|75671418|FG001|STARTED|Overall Study||1||
59568363|NCT01745913|75671417|FG000|COMPLETED|Overall Study||0||
59568364|NCT01745913|75671418|FG001|COMPLETED|Overall Study||0||
59568365|NCT01745913|75671417|FG000|NOT COMPLETED|Overall Study||1||
59568366|NCT01745913|75671418|FG001|NOT COMPLETED|Overall Study||1||
59568367|NCT01693653|75671430|FG000|STARTED|Overall Study||1||
59568368|NCT01693653|75671431|FG001|STARTED|Overall Study||0||
59568369|NCT01693653|75671430|FG000|COMPLETED|Overall Study||1||
59568370|NCT01693653|75671431|FG001|COMPLETED|Overall Study||0||
59720915|NCT01148771|75839831|FG001|COMPLETED|Second Intervention||5||
59720916|NCT01148771|75839830|FG000|NOT COMPLETED|Second Intervention||0||
59720917|NCT01148771|75839831|FG001|NOT COMPLETED|Second Intervention||0||
59720918|NCT01148693|75839843|FG000|STARTED|Overall Study||70||
59720919|NCT01148693|75839844|FG001|STARTED|Overall Study||67||
59568371|NCT01693653|75671430|FG000|NOT COMPLETED|Overall Study||0||
59568372|NCT01693653|75671431|FG001|NOT COMPLETED|Overall Study||0||
59568373|NCT01691079|75671439|FG000|STARTED|Overall Study||0||
59568374|NCT01691079|75671440|FG001|STARTED|Overall Study||0||
59568375|NCT01691079|75671439|FG000|COMPLETED|Overall Study||0||
59568376|NCT01691079|75671440|FG001|COMPLETED|Overall Study||0||
59568377|NCT01691079|75671439|FG000|NOT COMPLETED|Overall Study||0||
59568378|NCT01691079|75671440|FG001|NOT COMPLETED|Overall Study||0||
59568379|NCT01673061|75671448|FG000|STARTED|Overall Study||0||
59568380|NCT01673061|75671449|FG001|STARTED|Overall Study||0||
59568381|NCT01673061|75671448|FG000|COMPLETED|Overall Study||0||
59568382|NCT01673061|75671449|FG001|COMPLETED|Overall Study||0||
59720920|NCT01148693|75839843|FG000|COMPLETED|Overall Study||57||
59720921|NCT01148693|75839844|FG001|COMPLETED|Overall Study||57||
59568383|NCT01673061|75671448|FG000|NOT COMPLETED|Overall Study||0||
59568384|NCT01673061|75671449|FG001|NOT COMPLETED|Overall Study||0||
59568385|NCT01602471|75671455|FG000|STARTED|Overall Study||4||
59568386|NCT01602471|75671455|FG000|COMPLETED|Overall Study||4||
59568387|NCT01602471|75671455|FG000|NOT COMPLETED|Overall Study||0||
59568388|NCT01621737|75671459|FG000|STARTED|Overall Study||0||
59568389|NCT01621737|75671459|FG000|COMPLETED|Overall Study||0||
59568390|NCT01621737|75671459|FG000|NOT COMPLETED|Overall Study||0||
59720922|NCT01148693|75839843|FG000|NOT COMPLETED|Overall Study||13||
59850024|NCT00106353|75974357|FG005|STARTED|Part 2||19||
59850025|NCT00106353|75974358|FG006|STARTED|Part 2||16||
59568391|NCT01598025|75671465|FG000|STARTED|Overall Study||0||
59720923|NCT01148693|75839844|FG001|NOT COMPLETED|Overall Study||10||
59720924|NCT00872599|75839850|FG000|STARTED|First Washout Period After Low Salt||16||
59720925|NCT00872599|75839851|FG001|STARTED|First Washout Period After Low Salt||17||
59720926|NCT00872599|75839850|FG000|COMPLETED|First Washout Period After Low Salt||16||
59720927|NCT00872599|75839851|FG001|COMPLETED|First Washout Period After Low Salt||17||
59720928|NCT00872599|75839850|FG000|NOT COMPLETED|First Washout Period After Low Salt||0||
59720929|NCT00872599|75839851|FG001|NOT COMPLETED|First Washout Period After Low Salt||0||
59720930|NCT00872599|75839850|FG000|STARTED|First Drug During High Salt Intake||16||
59720931|NCT00872599|75839851|FG001|STARTED|First Drug During High Salt Intake||17||
59720932|NCT00872599|75839850|FG000|COMPLETED|First Drug During High Salt Intake||16||
59720933|NCT00872599|75839851|FG001|COMPLETED|First Drug During High Salt Intake||17||
59720934|NCT00872599|75839850|FG000|NOT COMPLETED|First Drug During High Salt Intake||0||
59720935|NCT00872599|75839851|FG001|NOT COMPLETED|First Drug During High Salt Intake||0||
59568392|NCT01598025|75671466|FG001|STARTED|Overall Study||3||
59720936|NCT00872599|75839850|FG000|STARTED|Second Washout Period||16||
59720937|NCT00872599|75839851|FG001|STARTED|Second Washout Period||17||
59720938|NCT00872599|75839850|FG000|COMPLETED|Second Washout Period||15||
59720939|NCT00872599|75839851|FG001|COMPLETED|Second Washout Period||16||
59850026|NCT00106353|75974352|FG000|COMPLETED|Part 2||0||
59850027|NCT00106353|75974353|FG001|COMPLETED|Part 2||0||
60120850|NCT01587703|76241796|FG013|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0||
60120851|NCT01587703|76241797|FG014|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0||
60120852|NCT01587703|76241798|FG015|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0||
60120853|NCT01587703|76241799|FG016|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0||
60120854|NCT01587703|76241800|FG017|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||5||
60120855|NCT01587703|76241801|FG018|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||5||
60120856|NCT01587703|76241783|FG000|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0||
60120857|NCT01587703|76241784|FG001|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0||
60120858|NCT01587703|76241785|FG002|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0||
60120859|NCT01587703|76241786|FG003|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0||
60120860|NCT01587703|76241787|FG004|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0||
60120861|NCT01587703|76241788|FG005|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0||
60120862|NCT01587703|76241789|FG006|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0||
60120863|NCT01587703|76241790|FG007|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0||
60120864|NCT01587703|76241791|FG008|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0||
60120865|NCT01587703|76241792|FG009|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0||
60120866|NCT01587703|76241793|FG010|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0||
60120867|NCT01587703|76241794|FG011|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0||
60120868|NCT01587703|76241795|FG012|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0||
60120869|NCT01587703|76241796|FG013|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0||
60120870|NCT01587703|76241797|FG014|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0||
60120871|NCT01587703|76241798|FG015|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0||
60120872|NCT01587703|76241799|FG016|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0||
60120873|NCT01587703|76241800|FG017|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0||
60120874|NCT01587703|76241801|FG018|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0||
60120875|NCT01587703|76241783|FG000|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0||
60120876|NCT01587703|76241784|FG001|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0||
60120877|NCT01587703|76241785|FG002|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0||
60120878|NCT01587703|76241786|FG003|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0||
60120879|NCT01587703|76241787|FG004|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0||
60120880|NCT01587703|76241788|FG005|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0||
60120881|NCT01587703|76241789|FG006|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0||
60120882|NCT01587703|76241790|FG007|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0||
60120883|NCT01587703|76241791|FG008|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0||
60120884|NCT01587703|76241792|FG009|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0||
60120885|NCT01587703|76241793|FG010|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0||
60120886|NCT01587703|76241794|FG011|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0||
60120887|NCT01587703|76241795|FG012|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0||
60120888|NCT01587703|76241796|FG013|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0||
60120889|NCT01587703|76241797|FG014|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0||
60120890|NCT01587703|76241798|FG015|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0||
60120891|NCT01587703|76241799|FG016|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0||
60120892|NCT01587703|76241800|FG017|STARTED|Substudy-P4,Maximum Exposure of 5.5month||5||
60120893|NCT01587703|76241801|FG018|STARTED|Substudy-P4,Maximum Exposure of 5.5month||5||
60120894|NCT01587703|76241783|FG000|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0||
60120895|NCT01587703|76241784|FG001|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0||
60120896|NCT01587703|76241785|FG002|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0||
60120897|NCT01587703|76241786|FG003|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0||
60120898|NCT01587703|76241787|FG004|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0||
60120899|NCT01587703|76241788|FG005|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0||
60120900|NCT01587703|76241789|FG006|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0||
60120901|NCT01587703|76241790|FG007|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0||
60120902|NCT01587703|76241791|FG008|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0||
60120903|NCT01587703|76241792|FG009|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0||
60120904|NCT01587703|76241793|FG010|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0||
60120905|NCT01587703|76241794|FG011|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0||
60120906|NCT01587703|76241795|FG012|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0||
60120907|NCT01587703|76241796|FG013|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0||
59568393|NCT01598025|75671465|FG000|COMPLETED|Overall Study||0||
59568394|NCT01598025|75671466|FG001|COMPLETED|Overall Study||0||
59568395|NCT01598025|75671465|FG000|NOT COMPLETED|Overall Study||0||
59720940|NCT00872599|75839850|FG000|NOT COMPLETED|Second Washout Period||1||
59720941|NCT00872599|75839851|FG001|NOT COMPLETED|Second Washout Period||1||
59850028|NCT00106353|75974354|FG002|COMPLETED|Part 2||0||
59720942|NCT00872599|75839850|FG000|STARTED|Second Drug During High Salt Intake||15||
59720943|NCT00872599|75839851|FG001|STARTED|Second Drug During High Salt Intake||16||
59720944|NCT00872599|75839850|FG000|COMPLETED|Second Drug During High Salt Intake||15||
59720945|NCT00872599|75839851|FG001|COMPLETED|Second Drug During High Salt Intake||16||
59720946|NCT00872599|75839850|FG000|NOT COMPLETED|Second Drug During High Salt Intake||0||
59720947|NCT00872599|75839851|FG001|NOT COMPLETED|Second Drug During High Salt Intake||0||
59720948|NCT01148537|75839860|FG000|STARTED|Overall Study||44||
59720949|NCT01148537|75839861|FG001|STARTED|Overall Study||44||
59720950|NCT01148537|75839862|FG002|STARTED|Overall Study||44||
59720951|NCT01148537|75839860|FG000|COMPLETED|Overall Study||41||
59720952|NCT01148537|75839861|FG001|COMPLETED|Overall Study||44||
59720953|NCT01148537|75839862|FG002|COMPLETED|Overall Study||41||
59720954|NCT01148537|75839860|FG000|NOT COMPLETED|Overall Study||3||
59720955|NCT01148537|75839861|FG001|NOT COMPLETED|Overall Study||0||
59720956|NCT01148537|75839862|FG002|NOT COMPLETED|Overall Study||3||
59720957|NCT01148459|75839873|FG000|STARTED|Overall Study||99||
59720958|NCT01148459|75839874|FG001|STARTED|Overall Study||101||
59720959|NCT01148459|75839873|FG000|COMPLETED|Overall Study||87||
59720960|NCT01148459|75839874|FG001|COMPLETED|Overall Study||90||
59720961|NCT01148459|75839873|FG000|NOT COMPLETED|Overall Study||12||
59720962|NCT01148459|75839874|FG001|NOT COMPLETED|Overall Study||11||
59720963|NCT00872521|75839883|FG000|STARTED|Completed PAD Induction|Received allocated treatment|26||
59720964|NCT00872521|75839884|FG001|STARTED|Completed PAD Induction|Received allocated treatment|72||
59568396|NCT01598025|75671466|FG001|NOT COMPLETED|Overall Study||3||
59568397|NCT01587963|75671473|FG000|STARTED|Overall Study||7||
59720965|NCT00872521|75839885|FG002|STARTED|Completed PAD Induction|Received allocated treatment|9||
59720966|NCT00872521|75839883|FG000|COMPLETED|Completed PAD Induction|Completed PAD induction|21||
59720967|NCT00872521|75839884|FG001|COMPLETED|Completed PAD Induction|Completed PAD induction|68||
59720968|NCT00872521|75839885|FG002|COMPLETED|Completed PAD Induction|Completed PAD induction|9||
59720969|NCT00872521|75839883|FG000|NOT COMPLETED|Completed PAD Induction||5||
59720970|NCT00872521|75839884|FG001|NOT COMPLETED|Completed PAD Induction||4||
59720971|NCT00872521|75839885|FG002|NOT COMPLETED|Completed PAD Induction||0||
59720972|NCT00872521|75839883|FG000|STARTED|Primary Endpoint Analysis|Completed PAD induction|21||
59720973|NCT00872521|75839884|FG001|STARTED|Primary Endpoint Analysis|Completed PAD induction|68||
59720974|NCT00872521|75839885|FG002|STARTED|Primary Endpoint Analysis|Completed PAD induction|9||
59720975|NCT00872521|75839883|FG000|COMPLETED|Primary Endpoint Analysis|participants analyzed|20||
59720976|NCT00872521|75839884|FG001|COMPLETED|Primary Endpoint Analysis|participants analyzed|63||
59568398|NCT01587963|75671474|FG001|STARTED|Overall Study||4||
59568399|NCT01587963|75671473|FG000|COMPLETED|Overall Study||6||
59568400|NCT01587963|75671474|FG001|COMPLETED|Overall Study||4||
59568401|NCT01587963|75671473|FG000|NOT COMPLETED|Overall Study||1||
59568402|NCT01587963|75671474|FG001|NOT COMPLETED|Overall Study||0||
59568403|NCT01549977|75671482|FG000|STARTED|Overall Study||1||
59568404|NCT01549977|75671483|FG001|STARTED|Overall Study||0||
59568405|NCT01549977|75671482|FG000|COMPLETED|Overall Study||1||
59568406|NCT01549977|75671483|FG001|COMPLETED|Overall Study||0||
59568407|NCT01549977|75671482|FG000|NOT COMPLETED|Overall Study||0||
59568408|NCT01549977|75671483|FG001|NOT COMPLETED|Overall Study||0||
59568409|NCT01548651|75671491|FG000|STARTED|Overall Study||4||
59568410|NCT01548651|75671492|FG001|STARTED|Overall Study||4||
59568411|NCT01548651|75671491|FG000|COMPLETED|Overall Study||3||
59568412|NCT01548651|75671492|FG001|COMPLETED|Overall Study||4||
59568413|NCT01548651|75671491|FG000|NOT COMPLETED|Overall Study||1||
59568414|NCT01548651|75671492|FG001|NOT COMPLETED|Overall Study||0||
59720977|NCT00872521|75839885|FG002|COMPLETED|Primary Endpoint Analysis|participants analyzed|8||
60120908|NCT01587703|76241797|FG014|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0||
60120909|NCT01587703|76241798|FG015|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0||
60120910|NCT01587703|76241799|FG016|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0||
60120911|NCT01587703|76241800|FG017|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0||
59720978|NCT00872521|75839883|FG000|NOT COMPLETED|Primary Endpoint Analysis||1||
59568415|NCT01533753|75671500|FG000|STARTED|Overall Study||2||
59568416|NCT01533753|75671501|FG001|STARTED|Overall Study||3||
59568417|NCT01533753|75671500|FG000|COMPLETED|Overall Study||2||
59568418|NCT01533753|75671501|FG001|COMPLETED|Overall Study||3||
59568419|NCT01533753|75671500|FG000|NOT COMPLETED|Overall Study||0||
59568420|NCT01533753|75671501|FG001|NOT COMPLETED|Overall Study||0||
59720979|NCT00872521|75839884|FG001|NOT COMPLETED|Primary Endpoint Analysis||5||
60120912|NCT01587703|76241801|FG018|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0||
60120913|NCT01587703|76241783|FG000|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0||
60120914|NCT01587703|76241784|FG001|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0||
60120915|NCT01587703|76241785|FG002|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0||
60120916|NCT01587703|76241786|FG003|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0||
60120917|NCT01587703|76241787|FG004|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0||
60120918|NCT01587703|76241788|FG005|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0||
60120919|NCT01587703|76241789|FG006|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0||
60120920|NCT01587703|76241790|FG007|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0||
60120921|NCT01587703|76241791|FG008|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0||
60120922|NCT01587703|76241792|FG009|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0||
60120923|NCT01587703|76241793|FG010|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0||
60120924|NCT01587703|76241794|FG011|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0||
60120925|NCT01587703|76241795|FG012|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0||
60120926|NCT01587703|76241796|FG013|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0||
60120927|NCT01587703|76241797|FG014|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0||
60120928|NCT01587703|76241798|FG015|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0||
60120929|NCT01587703|76241799|FG016|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0||
60120930|NCT01587703|76241800|FG017|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||5||
60120931|NCT01587703|76241801|FG018|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||5||
60120932|NCT01587703|76241783|FG000|STARTED|Part2(Median Exposure of 1.41 Months)||0||
60120933|NCT01587703|76241784|FG001|STARTED|Part2(Median Exposure of 1.41 Months)||0||
60120934|NCT01587703|76241785|FG002|STARTED|Part2(Median Exposure of 1.41 Months)||0||
60120935|NCT01587703|76241786|FG003|STARTED|Part2(Median Exposure of 1.41 Months)||0||
60120936|NCT01587703|76241787|FG004|STARTED|Part2(Median Exposure of 1.41 Months)||0||
60120937|NCT01587703|76241788|FG005|STARTED|Part2(Median Exposure of 1.41 Months)||0||
60120938|NCT01587703|76241789|FG006|STARTED|Part2(Median Exposure of 1.41 Months)||0||
60120939|NCT01587703|76241790|FG007|STARTED|Part2(Median Exposure of 1.41 Months)||0||
60120940|NCT01587703|76241791|FG008|STARTED|Part2(Median Exposure of 1.41 Months)||0||
60120941|NCT01587703|76241792|FG009|STARTED|Part2(Median Exposure of 1.41 Months)||0||
60120942|NCT01587703|76241793|FG010|STARTED|Part2(Median Exposure of 1.41 Months)||0||
60120943|NCT01587703|76241794|FG011|STARTED|Part2(Median Exposure of 1.41 Months)||12||
60120944|NCT01587703|76241795|FG012|STARTED|Part2(Median Exposure of 1.41 Months)||14||
60120945|NCT01587703|76241796|FG013|STARTED|Part2(Median Exposure of 1.41 Months)||23||
60120946|NCT01587703|76241797|FG014|STARTED|Part2(Median Exposure of 1.41 Months)||19||
60120947|NCT01587703|76241798|FG015|STARTED|Part2(Median Exposure of 1.41 Months)||21||
60120948|NCT01587703|76241799|FG016|STARTED|Part2(Median Exposure of 1.41 Months)||13||
60120949|NCT01587703|76241800|FG017|STARTED|Part2(Median Exposure of 1.41 Months)||0||
60120950|NCT01587703|76241801|FG018|STARTED|Part2(Median Exposure of 1.41 Months)||0||
60120951|NCT01587703|76241783|FG000|COMPLETED|Part2(Median Exposure of 1.41 Months)||0||
60120952|NCT01587703|76241784|FG001|COMPLETED|Part2(Median Exposure of 1.41 Months)||0||
60120953|NCT01587703|76241785|FG002|COMPLETED|Part2(Median Exposure of 1.41 Months)||0||
60120954|NCT01587703|76241786|FG003|COMPLETED|Part2(Median Exposure of 1.41 Months)||0||
60120955|NCT01587703|76241787|FG004|COMPLETED|Part2(Median Exposure of 1.41 Months)||0||
60120956|NCT01587703|76241788|FG005|COMPLETED|Part2(Median Exposure of 1.41 Months)||0||
59720980|NCT00872521|75839885|FG002|NOT COMPLETED|Primary Endpoint Analysis||1||
59720981|NCT00872521|75839883|FG000|STARTED|Completed 3-month Follow up|Participants analyzed for primary endpoint|20||
59720982|NCT00872521|75839884|FG001|STARTED|Completed 3-month Follow up|Participants analyzed for primary endpoint|63||
59720983|NCT00872521|75839885|FG002|STARTED|Completed 3-month Follow up|Participants analyzed for primary endpoint|8||
59720984|NCT00872521|75839883|FG000|COMPLETED|Completed 3-month Follow up|Completed 3-month follow-up|20||
59720985|NCT00872521|75839884|FG001|COMPLETED|Completed 3-month Follow up|Completed 3-month follow-up|60||
60120957|NCT01587703|76241789|FG006|COMPLETED|Part2(Median Exposure of 1.41 Months)||0||
60120958|NCT01587703|76241790|FG007|COMPLETED|Part2(Median Exposure of 1.41 Months)||0||
60120959|NCT01587703|76241791|FG008|COMPLETED|Part2(Median Exposure of 1.41 Months)||0||
60120960|NCT01587703|76241792|FG009|COMPLETED|Part2(Median Exposure of 1.41 Months)||0||
60120961|NCT01587703|76241793|FG010|COMPLETED|Part2(Median Exposure of 1.41 Months)||0||
59568421|NCT01534143|75671507|FG000|STARTED|Overall Study||1||
59568422|NCT01534143|75671507|FG000|COMPLETED|Overall Study||1||
59720986|NCT00872521|75839885|FG002|COMPLETED|Completed 3-month Follow up|Completed 3-month follow-up|8||
59720987|NCT00872521|75839883|FG000|NOT COMPLETED|Completed 3-month Follow up||0||
59720988|NCT00872521|75839884|FG001|NOT COMPLETED|Completed 3-month Follow up||3||
59720989|NCT00872521|75839885|FG002|NOT COMPLETED|Completed 3-month Follow up||0||
59720990|NCT00872521|75839883|FG000|STARTED|Secondary Endpoint Analysis|Completed 3-month follow-up|20||
59720991|NCT00872521|75839884|FG001|STARTED|Secondary Endpoint Analysis|Completed 3-month follow-up|60||
59720992|NCT00872521|75839885|FG002|STARTED|Secondary Endpoint Analysis|Completed 3-month follow-up|8||
59720993|NCT00872521|75839883|FG000|COMPLETED|Secondary Endpoint Analysis|Participants analyzed for secondary endpoint|20||
59720994|NCT00872521|75839884|FG001|COMPLETED|Secondary Endpoint Analysis|Participants analyzed for secondary endpoint|58||
59720995|NCT00872521|75839885|FG002|COMPLETED|Secondary Endpoint Analysis|Participants analyzed for secondary endpoint|7||
59720996|NCT00872521|75839883|FG000|NOT COMPLETED|Secondary Endpoint Analysis||0||
59720997|NCT00872521|75839884|FG001|NOT COMPLETED|Secondary Endpoint Analysis||2||
59720998|NCT00872521|75839885|FG002|NOT COMPLETED|Secondary Endpoint Analysis||1||
59720999|NCT01148225|75839904|FG000|STARTED|Overall Study||424||
59721000|NCT01148225|75839904|FG000|COMPLETED|Overall Study||239||
59721001|NCT01148225|75839904|FG000|NOT COMPLETED|Overall Study||185||
59721002|NCT01190891|75839913|FG000|STARTED|Overall Study||52||
59721003|NCT01190891|75839914|FG001|STARTED|Overall Study||52||
59721004|NCT01190891|75839913|FG000|COMPLETED|Overall Study||46||
59721005|NCT01190891|75839914|FG001|COMPLETED|Overall Study||52||
59721006|NCT01190891|75839913|FG000|NOT COMPLETED|Overall Study||6||
59721007|NCT01190891|75839914|FG001|NOT COMPLETED|Overall Study||0||
59721008|NCT00871975|75839920|FG000|STARTED|Overall Study||155||
59721009|NCT00871975|75839920|FG000|COMPLETED|Overall Study||133||
59721010|NCT00871975|75839920|FG000|NOT COMPLETED|Overall Study||22||
59721011|NCT01190813|75839926|FG000|STARTED|Overall Study||90||
59721012|NCT01190813|75839927|FG001|STARTED|Overall Study||49||
59721013|NCT01190813|75839926|FG000|2-week Phone Call|Overall Study|2 missed, 1 dropped|87||
59721014|NCT01190813|75839927|FG001|2-week Phone Call|Overall Study|1 missed, 0 dropped|48||
59721015|NCT01190813|75839926|FG000|4-week Visit|Overall Study|0 missed, 1 dropped|88||
59721016|NCT01190813|75839927|FG001|4-week Visit|Overall Study|1 missed, 1 dropped|47||
59721017|NCT01190813|75839926|FG000|7-week Phone Call|Overall Study|3 missed, 0 dropped|85||
59721018|NCT01190813|75839927|FG001|7-week Phone Call|Overall Study|2 missed, 0 dropped|46||
59721019|NCT01190813|75839926|FG000|10-week Visit|Overall Study|0 missed, 0 dropped|88||
59721020|NCT01190813|75839927|FG001|10-week Visit|Overall Study|0 dropped, 0 missed|48||
60120962|NCT01587703|76241794|FG011|COMPLETED|Part2(Median Exposure of 1.41 Months)||0||
60120963|NCT01587703|76241795|FG012|COMPLETED|Part2(Median Exposure of 1.41 Months)||0||
60120964|NCT01587703|76241796|FG013|COMPLETED|Part2(Median Exposure of 1.41 Months)||1||
59721021|NCT01190813|75839926|FG000|13-week Phone Call|Overall Study|6 missed, 0 dropped|82||
59721022|NCT01190813|75839927|FG001|13-week Phone Call|Overall Study|0 dropped, 0 missed|48||
59721023|NCT01190813|75839926|FG000|16-week Visit|Overall Study|1 dropped|87||
59850029|NCT00106353|75974355|FG003|COMPLETED|Part 2||0||
60120965|NCT01587703|76241797|FG014|COMPLETED|Part2(Median Exposure of 1.41 Months)||0||
60120966|NCT01587703|76241798|FG015|COMPLETED|Part2(Median Exposure of 1.41 Months)||0||
60120967|NCT01587703|76241799|FG016|COMPLETED|Part2(Median Exposure of 1.41 Months)||0||
60120968|NCT01587703|76241800|FG017|COMPLETED|Part2(Median Exposure of 1.41 Months)||0||
60120969|NCT01587703|76241801|FG018|COMPLETED|Part2(Median Exposure of 1.41 Months)||0||
59568423|NCT01534143|75671507|FG000|NOT COMPLETED|Overall Study||0||
59568424|NCT01528293|75671513|FG000|STARTED|Overall Study||1||
59850030|NCT00106353|75974356|FG004|COMPLETED|Part 2||1||
60120970|NCT01587703|76241783|FG000|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0||
60120971|NCT01587703|76241784|FG001|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0||
60120972|NCT01587703|76241785|FG002|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0||
60120973|NCT01587703|76241786|FG003|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0||
60120974|NCT01587703|76241787|FG004|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0||
60120975|NCT01587703|76241788|FG005|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0||
60120976|NCT01587703|76241789|FG006|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0||
60120977|NCT01587703|76241790|FG007|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0||
60120978|NCT01587703|76241791|FG008|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0||
59568425|NCT01528293|75671514|FG001|STARTED|Overall Study||1||
60120979|NCT01587703|76241792|FG009|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0||
60120980|NCT01587703|76241793|FG010|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0||
60120981|NCT01587703|76241794|FG011|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||12||
60120982|NCT01587703|76241795|FG012|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||14||
60120983|NCT01587703|76241796|FG013|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||22||
60120984|NCT01587703|76241797|FG014|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||19||
59568426|NCT01528293|75671513|FG000|COMPLETED|Overall Study||0||
60120985|NCT01587703|76241798|FG015|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||21||
60120986|NCT01587703|76241799|FG016|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||13||
60120987|NCT01587703|76241800|FG017|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0||
60120988|NCT01587703|76241801|FG018|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0||
60120989|NCT01577381|76241864|FG000|STARTED|Overall Study||2||
60120990|NCT01577381|76241865|FG001|STARTED|Overall Study||3||
60120991|NCT01577381|76241866|FG002|STARTED|Overall Study||3||
60120992|NCT01577381|76241867|FG003|STARTED|Overall Study||2||
60120993|NCT01577381|76241864|FG000|COMPLETED|Overall Study||0||
60120994|NCT01577381|76241865|FG001|COMPLETED|Overall Study||0||
60120995|NCT01577381|76241866|FG002|COMPLETED|Overall Study||0||
60120996|NCT01577381|76241867|FG003|COMPLETED|Overall Study||0||
60120997|NCT01577381|76241864|FG000|NOT COMPLETED|Overall Study||2||
60120998|NCT01577381|76241865|FG001|NOT COMPLETED|Overall Study||3||
60120999|NCT01577381|76241866|FG002|NOT COMPLETED|Overall Study||3||
60121000|NCT01577381|76241867|FG003|NOT COMPLETED|Overall Study||2||
60121001|NCT02686164|76241877|FG000|STARTED|Overall Study||30||
59568427|NCT01528293|75671514|FG001|COMPLETED|Overall Study||1||
59568428|NCT01528293|75671513|FG000|NOT COMPLETED|Overall Study||1||
59568429|NCT01528293|75671514|FG001|NOT COMPLETED|Overall Study||0||
59850031|NCT00106353|75974357|FG005|COMPLETED|Part 2||1||
59850032|NCT00106353|75974358|FG006|COMPLETED|Part 2||0||
59568430|NCT03831347|75671520|FG000|STARTED|Overall Study||11||
59568431|NCT03831347|75671520|FG000|COMPLETED|Overall Study||9||
60121002|NCT02686164|76241877|FG000|COMPLETED|Overall Study||27||
60121003|NCT02686164|76241877|FG000|NOT COMPLETED|Overall Study||3||
60121004|NCT02651584|76241886|FG000|STARTED|Overall Study||215||
60121005|NCT02651584|76241887|FG001|STARTED|Overall Study||213||
60121006|NCT02651584|76241886|FG000|COMPLETED|Overall Study||126||
60121007|NCT02651584|76241887|FG001|COMPLETED|Overall Study||121||
60121008|NCT02651584|76241886|FG000|NOT COMPLETED|Overall Study||89||
60121009|NCT02651584|76241887|FG001|NOT COMPLETED|Overall Study||92||
60121010|NCT01691105|76241898|FG000|STARTED|Baseline||477||
59850033|NCT00106353|75974352|FG000|NOT COMPLETED|Part 2||0||
60121011|NCT01691105|76241899|FG001|STARTED|Baseline||567||
60121012|NCT01691105|76241898|FG000|COMPLETED|Baseline||477||
60121013|NCT01691105|76241899|FG001|COMPLETED|Baseline||567||
60121014|NCT01691105|76241898|FG000|NOT COMPLETED|Baseline||0||
60121015|NCT01691105|76241899|FG001|NOT COMPLETED|Baseline||0||
60121016|NCT01691105|76241898|FG000|STARTED|1 Month Follow-up||477||
60121017|NCT01691105|76241899|FG001|STARTED|1 Month Follow-up||567||
60121018|NCT01691105|76241898|FG000|COMPLETED|1 Month Follow-up||434||
60121019|NCT01691105|76241899|FG001|COMPLETED|1 Month Follow-up||526||
60121020|NCT01691105|76241898|FG000|NOT COMPLETED|1 Month Follow-up||43||
60121021|NCT01691105|76241899|FG001|NOT COMPLETED|1 Month Follow-up||41||
60121022|NCT01691105|76241898|FG000|STARTED|6 Month Follow-up||477||
60121023|NCT01691105|76241899|FG001|STARTED|6 Month Follow-up||567||
60121024|NCT01691105|76241898|FG000|COMPLETED|6 Month Follow-up||425||
60121025|NCT01691105|76241899|FG001|COMPLETED|6 Month Follow-up||496||
60121026|NCT01691105|76241898|FG000|NOT COMPLETED|6 Month Follow-up||52||
60121027|NCT01691105|76241899|FG001|NOT COMPLETED|6 Month Follow-up||71||
60121028|NCT01691105|76241898|FG000|STARTED|12 Month Follow-up||477||
60121029|NCT01691105|76241899|FG001|STARTED|12 Month Follow-up||567||
60121030|NCT01691105|76241898|FG000|COMPLETED|12 Month Follow-up||405||
60121031|NCT01691105|76241899|FG001|COMPLETED|12 Month Follow-up||466||
60121032|NCT01691105|76241898|FG000|NOT COMPLETED|12 Month Follow-up||72||
60121033|NCT01691105|76241899|FG001|NOT COMPLETED|12 Month Follow-up||101||
59850034|NCT00106353|75974353|FG001|NOT COMPLETED|Part 2||0||
59721024|NCT01190813|75839927|FG001|16-week Visit|Overall Study|2 dropped|46||
59568432|NCT03831347|75671520|FG000|NOT COMPLETED|Overall Study||2||
59850035|NCT00106353|75974354|FG002|NOT COMPLETED|Part 2||0||
59721025|NCT01190813|75839926|FG000|18-week Visit (Masked Primary)|Overall Study|0 dropped|87||
59721026|NCT01190813|75839927|FG001|18-week Visit (Masked Primary)|Overall Study|1 dropped|45||
60121034|NCT01691105|76241898|FG000|STARTED|12 Month Biochemical Verification||477||
60121035|NCT01691105|76241899|FG001|STARTED|12 Month Biochemical Verification||567||
60121036|NCT01691105|76241898|FG000|COMPLETED|12 Month Biochemical Verification||53||
60121037|NCT01691105|76241899|FG001|COMPLETED|12 Month Biochemical Verification||65||
60121038|NCT01691105|76241898|FG000|NOT COMPLETED|12 Month Biochemical Verification||424||
60121039|NCT01691105|76241899|FG001|NOT COMPLETED|12 Month Biochemical Verification||502||
60121040|NCT02685072|76241907|FG000|STARTED|Treatment Period||33||
60121041|NCT02685072|76241908|FG001|STARTED|Treatment Period||31||
60121042|NCT02685072|76241907|FG000|Completed Week 2 Visit|Treatment Period||23||
60121043|NCT02685072|76241908|FG001|Completed Week 2 Visit|Treatment Period||26||
60121044|NCT02685072|76241907|FG000|Completed Week 3 Visit|Treatment Period||20||
60121045|NCT02685072|76241908|FG001|Completed Week 3 Visit|Treatment Period||23||
59721027|NCT01190813|75839926|FG000|23-week Phone Call|Overall Study|4 missed, 1 dropped|82||
59721028|NCT01190813|75839927|FG001|23-week Phone Call|Overall Study|4 missed, 0 dropped|41||
60121046|NCT02685072|76241907|FG000|Completed Week 4 Visit|Treatment Period||19||
60121047|NCT02685072|76241908|FG001|Completed Week 4 Visit|Treatment Period||23||
60121048|NCT02685072|76241907|FG000|Completed Week 5 Visit|Treatment Period||19||
60121049|NCT02685072|76241908|FG001|Completed Week 5 Visit|Treatment Period||22||
60121050|NCT02685072|76241907|FG000|Completed Week 6 Visit|Treatment Period||18||
60121051|NCT02685072|76241908|FG001|Completed Week 6 Visit|Treatment Period||19||
60121052|NCT02685072|76241907|FG000|Completed Week 7 Visit|Treatment Period||17||
60121053|NCT02685072|76241908|FG001|Completed Week 7 Visit|Treatment Period||18||
60121054|NCT02685072|76241907|FG000|Completed Week 8 Visit|Treatment Period||20|End of study treatment period|
60121055|NCT02685072|76241908|FG001|Completed Week 8 Visit|Treatment Period|Week 8 data were collected at the 1-month follow-up for 1 participant|22|End of study treatment period|
60121056|NCT02685072|76241907|FG000|COMPLETED|Treatment Period||20||
60121057|NCT02685072|76241908|FG001|COMPLETED|Treatment Period||22||
60121058|NCT02685072|76241907|FG000|NOT COMPLETED|Treatment Period||13||
60121059|NCT02685072|76241908|FG001|NOT COMPLETED|Treatment Period||9||
60121060|NCT02685072|76241907|FG000|STARTED|1-Month Follow-Up||20||
60121061|NCT02685072|76241908|FG001|STARTED|1-Month Follow-Up||22||
59568433|NCT00570531|75671524|FG000|STARTED|Overall Study||6||
59721029|NCT01190813|75839926|FG000|26-week Visit|Overall Study|0 missed, 0 dropped|86||
59721030|NCT01190813|75839927|FG001|26-week Visit|Overall Study|0 missed, 0 dropped|45||
59721031|NCT01190813|75839926|FG000|COMPLETED|Overall Study||86||
59721032|NCT01190813|75839927|FG001|COMPLETED|Overall Study||45||
59721033|NCT01190813|75839926|FG000|NOT COMPLETED|Overall Study||4||
59721034|NCT01190813|75839927|FG001|NOT COMPLETED|Overall Study||4||
59721035|NCT03641326|75839935|FG000|STARTED|Overall Study||2||
59721036|NCT03641326|75839936|FG001|STARTED|Overall Study||3||
59568434|NCT00570531|75671524|FG000|COMPLETED|Overall Study||6||
59721037|NCT03641326|75839935|FG000|COMPLETED|Overall Study||2||
59721038|NCT03641326|75839936|FG001|COMPLETED|Overall Study||3||
59721039|NCT03641326|75839935|FG000|NOT COMPLETED|Overall Study||0||
59721040|NCT03641326|75839936|FG001|NOT COMPLETED|Overall Study||0||
59721041|NCT00870727|75839949|FG000|STARTED|Overall Study||17||
60121062|NCT02685072|76241907|FG000|COMPLETED|1-Month Follow-Up||19||
59721042|NCT00870727|75839950|FG001|STARTED|Overall Study||16||
59568435|NCT00570531|75671524|FG000|NOT COMPLETED|Overall Study||0||
59568436|NCT00540969|75671530|FG000|STARTED|Overall Study||2||
59721043|NCT00870727|75839949|FG000|COMPLETED|Overall Study||16||
59721044|NCT00870727|75839950|FG001|COMPLETED|Overall Study||11||
59721045|NCT00870727|75839949|FG000|NOT COMPLETED|Overall Study||1||
59568437|NCT00540969|75671531|FG001|STARTED|Overall Study||1||
59568438|NCT00540969|75671530|FG000|COMPLETED|Overall Study||2||
59568439|NCT00540969|75671531|FG001|COMPLETED|Overall Study||1||
59568440|NCT00540969|75671530|FG000|NOT COMPLETED|Overall Study||0||
59568441|NCT00540969|75671531|FG001|NOT COMPLETED|Overall Study||0||
59568442|NCT00524511|75671539|FG000|STARTED|Overall Study||68||
59568443|NCT00524511|75671540|FG001|STARTED|Overall Study||68||
59568444|NCT00524511|75671539|FG000|COMPLETED|Overall Study||64||
59568445|NCT00524511|75671540|FG001|COMPLETED|Overall Study||61||
59721046|NCT00870727|75839950|FG001|NOT COMPLETED|Overall Study||5||
59850036|NCT00106353|75974355|FG003|NOT COMPLETED|Part 2||0||
59850037|NCT00106353|75974356|FG004|NOT COMPLETED|Part 2||16||
59850038|NCT00106353|75974357|FG005|NOT COMPLETED|Part 2||18||
59850039|NCT00106353|75974358|FG006|NOT COMPLETED|Part 2||16||
59850040|NCT00080301|75974381|FG000|STARTED|Overall Study||375||
59850041|NCT00080301|75974382|FG001|STARTED|Overall Study||377||
59850042|NCT00080301|75974381|FG000|Never Treated|Overall Study||5||
59850043|NCT00080301|75974382|FG001|Never Treated|Overall Study||10||
59850044|NCT00080301|75974381|FG000|Still on Treatment|Overall Study||0||
59850045|NCT00080301|75974382|FG001|Still on Treatment|Overall Study||1||
59850046|NCT00080301|75974381|FG000|COMPLETED|Overall Study|Participants who are off treatment|370||
59850047|NCT00080301|75974382|FG001|COMPLETED|Overall Study|Participants who are off treatment|366||
59850048|NCT00080301|75974381|FG000|NOT COMPLETED|Overall Study||5||
59850049|NCT00080301|75974382|FG001|NOT COMPLETED|Overall Study||11||
59850050|NCT00079677|75974391|FG000|STARTED|Overall Study||131||
59850051|NCT00079677|75974392|FG001|STARTED|Overall Study||132||
59850052|NCT00079677|75974391|FG000|COMPLETED|Overall Study||111||
59850053|NCT00079677|75974392|FG001|COMPLETED|Overall Study||118||
59850054|NCT00079677|75974391|FG000|NOT COMPLETED|Overall Study||20||
59850055|NCT00079677|75974392|FG001|NOT COMPLETED|Overall Study||14||
59850056|NCT00095121|75974400|FG000|STARTED|Double-Blind (Study Weeks 0 Through 48)||115||
59850057|NCT00095121|75974401|FG001|STARTED|Double-Blind (Study Weeks 0 Through 48)||58||
59850058|NCT00095121|75974400|FG000|COMPLETED|Double-Blind (Study Weeks 0 Through 48)||112||
59850059|NCT00095121|75974401|FG001|COMPLETED|Double-Blind (Study Weeks 0 Through 48)||58||
59850060|NCT00095121|75974400|FG000|NOT COMPLETED|Double-Blind (Study Weeks 0 Through 48)||3||
59850061|NCT00095121|75974401|FG001|NOT COMPLETED|Double-Blind (Study Weeks 0 Through 48)||0||
59850062|NCT00095121|75974400|FG000|STARTED|Open-Label (Study Weeks 49 Through 240)||108||
59850063|NCT00095121|75974401|FG001|STARTED|Open-Label (Study Weeks 49 Through 240)||54||
59850064|NCT00095121|75974400|FG000|Received Lamivudine (LAM) After Week 96|Open-Label (Study Weeks 49 Through 240)||21||
59850065|NCT00095121|75974401|FG001|Received Lamivudine (LAM) After Week 96|Open-Label (Study Weeks 49 Through 240)||11||
59850066|NCT00095121|75974400|FG000|COMPLETED|Open-Label (Study Weeks 49 Through 240)|Completed the 240-week study period either on or off treatment at Week 240.|46||
59850067|NCT00095121|75974401|FG001|COMPLETED|Open-Label (Study Weeks 49 Through 240)|Completed the 240-week study period either on or off treatment at Week 240.|35||
59850068|NCT00095121|75974400|FG000|NOT COMPLETED|Open-Label (Study Weeks 49 Through 240)||62||
59850069|NCT00095121|75974401|FG001|NOT COMPLETED|Open-Label (Study Weeks 49 Through 240)||19||
59850070|NCT00094809|75974419|FG000|STARTED|Overall Study||126||
59850071|NCT00094809|75974420|FG001|STARTED|Overall Study||126||
59850072|NCT00094809|75974419|FG000|Received Study Drug|Overall Study||124||
59850073|NCT00094809|75974420|FG001|Received Study Drug|Overall Study||118||
60121063|NCT02685072|76241908|FG001|COMPLETED|1-Month Follow-Up||22||
60121064|NCT02685072|76241907|FG000|NOT COMPLETED|1-Month Follow-Up||1||
59721047|NCT01147055|75839956|FG000|STARTED|First Intervention Period||15||
59721048|NCT01147055|75839957|FG001|STARTED|First Intervention Period||0||
59721049|NCT01147055|75839956|FG000|COMPLETED|First Intervention Period||14||
59721050|NCT01147055|75839957|FG001|COMPLETED|First Intervention Period||0||
59721051|NCT01147055|75839956|FG000|NOT COMPLETED|First Intervention Period||1||
59721052|NCT01147055|75839957|FG001|NOT COMPLETED|First Intervention Period||0||
59721053|NCT01147055|75839956|FG000|STARTED|Washout Period (at Least 14 Days)||14||
59721054|NCT01147055|75839957|FG001|STARTED|Washout Period (at Least 14 Days)||0||
59721055|NCT01147055|75839956|FG000|COMPLETED|Washout Period (at Least 14 Days)||14||
59721056|NCT01147055|75839957|FG001|COMPLETED|Washout Period (at Least 14 Days)||0||
59721057|NCT01147055|75839956|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0||
59721058|NCT01147055|75839957|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0||
59721059|NCT01147055|75839956|FG000|STARTED|Second Intervention Period||0||
59721060|NCT01147055|75839957|FG001|STARTED|Second Intervention Period||14||
59721061|NCT01147055|75839956|FG000|COMPLETED|Second Intervention Period||0||
59721062|NCT01147055|75839957|FG001|COMPLETED|Second Intervention Period||14||
59721063|NCT01147055|75839956|FG000|NOT COMPLETED|Second Intervention Period||0||
59721064|NCT01147055|75839957|FG001|NOT COMPLETED|Second Intervention Period||0||
59721065|NCT01146665|75839965|FG000|STARTED|Overall Study||18||
59721066|NCT01146665|75839966|FG001|STARTED|Overall Study||26||
59721067|NCT01146665|75839965|FG000|1-month Post-ED Discharge (Follow-up)|Overall Study||9||
59721068|NCT01146665|75839966|FG001|1-month Post-ED Discharge (Follow-up)|Overall Study||12||
59721069|NCT01146665|75839965|FG000|3-month Post-ED Discharge (Follow-up)|Overall Study||8||
59721070|NCT01146665|75839966|FG001|3-month Post-ED Discharge (Follow-up)|Overall Study||10||
59850074|NCT00094809|75974419|FG000|Properly Consented; Received Study Drug|Overall Study||123||
59850075|NCT00094809|75974420|FG001|Properly Consented; Received Study Drug|Overall Study||118||
59850076|NCT00094809|75974419|FG000|Completed All 4 Cycles of Treatment|Overall Study||98||
59850077|NCT00094809|75974420|FG001|Completed All 4 Cycles of Treatment|Overall Study||90||
59850078|NCT00094809|75974419|FG000|COMPLETED|Overall Study|Subjects who completed treatment and Long term follow up (LTFU)|74||
60121065|NCT02685072|76241908|FG001|NOT COMPLETED|1-Month Follow-Up||0||
60121066|NCT02685072|76241907|FG000|STARTED|3-Month Follow-Up||19||
59850079|NCT00094809|75974420|FG001|COMPLETED|Overall Study|Subjects who completed treatment and LTFU|61||
60121067|NCT02685072|76241908|FG001|STARTED|3-Month Follow-Up||22||
59850080|NCT00094809|75974419|FG000|NOT COMPLETED|Overall Study||52||
59850081|NCT00094809|75974420|FG001|NOT COMPLETED|Overall Study||65||
59850082|NCT00075218|75974428|FG000|STARTED|Double-Blind Treatment|Intent To Treat Population (ITT)|243||
59850083|NCT00075218|75974429|FG001|STARTED|Double-Blind Treatment|Intent To Treat Population (ITT)|118||
59850084|NCT00075218|75974430|FG002|STARTED|Double-Blind Treatment||0||
59850085|NCT00075218|75974428|FG000|Received Double-Blind Treatment|Double-Blind Treatment|As Treated Population (AT)|228||
59850086|NCT00075218|75974429|FG001|Received Double-Blind Treatment|Double-Blind Treatment|As Treated Population (AT)|114||
59850087|NCT00075218|75974430|FG002|Received Double-Blind Treatment|Double-Blind Treatment||0||
59850088|NCT00075218|75974428|FG000|Crossed Over to Open-Label Treatment|Double-Blind Treatment||152||
59850089|NCT00075218|75974429|FG001|Crossed Over to Open-Label Treatment|Double-Blind Treatment||103||
59850090|NCT00075218|75974430|FG002|Crossed Over to Open-Label Treatment|Double-Blind Treatment||0||
59850091|NCT00075218|75974428|FG000|COMPLETED|Double-Blind Treatment|Defined:subjects completed double-blind treatment phase and/or entered open-label treatment phase.|152||
59850092|NCT00075218|75974429|FG001|COMPLETED|Double-Blind Treatment|Defined:subjects completed double-blind treatment phase and/or entered open-label treatment phase.|103||
59850093|NCT00075218|75974430|FG002|COMPLETED|Double-Blind Treatment||0||
59850094|NCT00075218|75974428|FG000|NOT COMPLETED|Double-Blind Treatment||91||
59850095|NCT00075218|75974429|FG001|NOT COMPLETED|Double-Blind Treatment||15||
59850096|NCT00075218|75974430|FG002|NOT COMPLETED|Double-Blind Treatment||0||
59850097|NCT00075218|75974428|FG000|STARTED|Open-Label Treatment||0||
59850098|NCT00075218|75974429|FG001|STARTED|Open-Label Treatment||0||
59850099|NCT00075218|75974430|FG002|STARTED|Open-Label Treatment||255||
59850100|NCT00075218|75974428|FG000|COMPLETED|Open-Label Treatment||0||
59850101|NCT00075218|75974429|FG001|COMPLETED|Open-Label Treatment||0||
59850102|NCT00075218|75974430|FG002|COMPLETED|Open-Label Treatment||0||
59850103|NCT00075218|75974428|FG000|NOT COMPLETED|Open-Label Treatment||0||
59850104|NCT00075218|75974429|FG001|NOT COMPLETED|Open-Label Treatment||0||
59850105|NCT00075218|75974430|FG002|NOT COMPLETED|Open-Label Treatment||255||
59850106|NCT00094653|75974440|FG000|STARTED|Overall Study||403||
59850107|NCT00094653|75974441|FG001|STARTED|Overall Study||137||
59850108|NCT00094653|75974442|FG002|STARTED|Overall Study||136||
59850109|NCT00094653|75974440|FG000|Treated|Overall Study||381||
59850110|NCT00094653|75974441|FG001|Treated|Overall Study||131||
59850111|NCT00094653|75974442|FG002|Treated|Overall Study||131||
59850112|NCT00094653|75974440|FG000|COMPLETED|Overall Study||82||
59850113|NCT00094653|75974441|FG001|COMPLETED|Overall Study||31||
59850114|NCT00094653|75974442|FG002|COMPLETED|Overall Study||10||
59850115|NCT00094653|75974440|FG000|NOT COMPLETED|Overall Study||321||
59850116|NCT00094653|75974441|FG001|NOT COMPLETED|Overall Study||106||
59850117|NCT00094653|75974442|FG002|NOT COMPLETED|Overall Study||126||
59850118|NCT00104247|75974453|FG000|STARTED|Overall Study||42||
59850119|NCT00104247|75974454|FG001|STARTED|Overall Study||47||
59850120|NCT00104247|75974453|FG000|COMPLETED|Overall Study|Subject withdrew prior to dosing|41||
59850121|NCT00104247|75974454|FG001|COMPLETED|Overall Study|One subject withdrew at Week 4, but is included in the data analysis|46||
59850122|NCT00104247|75974453|FG000|NOT COMPLETED|Overall Study||1||
59850123|NCT00104247|75974454|FG001|NOT COMPLETED|Overall Study||1||
59850124|NCT03591406|75974462|FG000|STARTED|Overall Study||188||
59850125|NCT03591406|75974463|FG001|STARTED|Overall Study||183||
59850126|NCT03591406|75974462|FG000|COMPLETED|Overall Study||181||
59850127|NCT03591406|75974463|FG001|COMPLETED|Overall Study||174||
59850128|NCT03591406|75974462|FG000|NOT COMPLETED|Overall Study||7||
59850129|NCT03591406|75974463|FG001|NOT COMPLETED|Overall Study||9||
59850130|NCT03560986|75974471|FG000|STARTED|Treatment Period A/Follow-up Period 1||48||
59850131|NCT03560986|75974472|FG001|STARTED|Treatment Period A/Follow-up Period 1|One additional participant was allocated to placebo but not treated.|51||
59850132|NCT03560986|75974471|FG000|Treatment Period A Completers|Treatment Period A/Follow-up Period 1||45||
59850133|NCT03560986|75974472|FG001|Treatment Period A Completers|Treatment Period A/Follow-up Period 1||45||
59850134|NCT03560986|75974471|FG000|COMPLETED|Treatment Period A/Follow-up Period 1||12|Participants completing Follow-up Period 1.|
59850135|NCT03560986|75974472|FG001|COMPLETED|Treatment Period A/Follow-up Period 1||13|Participants completing Follow-up Period 1.|
59850136|NCT03560986|75974471|FG000|NOT COMPLETED|Treatment Period A/Follow-up Period 1||36||
59850137|NCT03560986|75974472|FG001|NOT COMPLETED|Treatment Period A/Follow-up Period 1||38||
59850138|NCT03560986|75974471|FG000|STARTED|Treatment Period B/Follow-up Period 2|3 Participants completed Treatment Period A/Follow-up Period 1 but were not allocated in Period B.|9||
59850139|NCT03560986|75974472|FG001|STARTED|Treatment Period B/Follow-up Period 2|5 Part. completed Placebo Treatment Period A/Follow-up Period 1 but were not allocated in Period B.|8||
59850140|NCT03560986|75974471|FG000|Treatment Period B Completers|Treatment Period B/Follow-up Period 2||8||
59850141|NCT03560986|75974472|FG001|Treatment Period B Completers|Treatment Period B/Follow-up Period 2||8||
60121068|NCT02685072|76241907|FG000|COMPLETED|3-Month Follow-Up||19||
60121069|NCT02685072|76241908|FG001|COMPLETED|3-Month Follow-Up||22||
60121070|NCT02685072|76241907|FG000|NOT COMPLETED|3-Month Follow-Up||0||
60121071|NCT02685072|76241908|FG001|NOT COMPLETED|3-Month Follow-Up||0||
59850142|NCT03560986|75974471|FG000|COMPLETED|Treatment Period B/Follow-up Period 2||1|Participants completing Follow-up Period 2.|
59850143|NCT03560986|75974472|FG001|COMPLETED|Treatment Period B/Follow-up Period 2||0|Participants completing Follow-up Period 2.|
59850144|NCT03560986|75974471|FG000|NOT COMPLETED|Treatment Period B/Follow-up Period 2||8||
59850145|NCT03560986|75974472|FG001|NOT COMPLETED|Treatment Period B/Follow-up Period 2||8||
59850146|NCT03560518|75974487|FG000|STARTED|Double Blind Treatment Period||147||
59850147|NCT03560518|75974488|FG001|STARTED|Double Blind Treatment Period||145||
59850148|NCT03560518|75974489|FG002|STARTED|Double Blind Treatment Period||147||
59850149|NCT03560518|75974487|FG000|COMPLETED|Double Blind Treatment Period||122||
59850150|NCT03560518|75974488|FG001|COMPLETED|Double Blind Treatment Period||116||
59850151|NCT03560518|75974489|FG002|COMPLETED|Double Blind Treatment Period||124||
59850152|NCT03560518|75974487|FG000|NOT COMPLETED|Double Blind Treatment Period||25||
59850153|NCT03560518|75974488|FG001|NOT COMPLETED|Double Blind Treatment Period||29||
59850154|NCT03560518|75974489|FG002|NOT COMPLETED|Double Blind Treatment Period||23||
59850155|NCT03560518|75974487|FG000|STARTED|Safety Follow-Up Period||10||
59850156|NCT03560518|75974488|FG001|STARTED|Safety Follow-Up Period||17||
59850157|NCT03560518|75974489|FG002|STARTED|Safety Follow-Up Period||22||
59850158|NCT03560518|75974487|FG000|COMPLETED|Safety Follow-Up Period||10||
59850159|NCT03560518|75974488|FG001|COMPLETED|Safety Follow-Up Period||17||
59850160|NCT03560518|75974489|FG002|COMPLETED|Safety Follow-Up Period||22||
59850161|NCT03560518|75974487|FG000|NOT COMPLETED|Safety Follow-Up Period||0||
59850162|NCT03560518|75974488|FG001|NOT COMPLETED|Safety Follow-Up Period||0||
59850163|NCT03560518|75974489|FG002|NOT COMPLETED|Safety Follow-Up Period||0||
59850164|NCT03560206|75974499|FG000|STARTED|Overall Study||158||
59850165|NCT03560206|75974500|FG001|STARTED|Overall Study||158||
59850166|NCT03560206|75974499|FG000|COMPLETED|Overall Study||108||
59850167|NCT03560206|75974500|FG001|COMPLETED|Overall Study||140||
59850168|NCT03560206|75974499|FG000|NOT COMPLETED|Overall Study||50||
59850169|NCT03560206|75974500|FG001|NOT COMPLETED|Overall Study||18||
59850170|NCT02892760|75974506|FG000|STARTED|Overall Study||17||
59850171|NCT02892760|75974506|FG000|Received Intervention|Overall Study||15||
59850172|NCT02892760|75974506|FG000|COMPLETED|Overall Study||14||
59850173|NCT02892760|75974506|FG000|NOT COMPLETED|Overall Study||3||
59850174|NCT03635086|75974515|FG000|STARTED|Overall Study||12||
59850175|NCT03635086|75974516|FG001|STARTED|Overall Study||12||
59850176|NCT03635086|75974517|FG002|STARTED|Overall Study||12||
59850177|NCT03635086|75974518|FG003|STARTED|Overall Study||12||
59850178|NCT03635086|75974519|FG004|STARTED|Overall Study||12||
59850179|NCT03635086|75974515|FG000|COMPLETED|Overall Study||11||
59850180|NCT03635086|75974516|FG001|COMPLETED|Overall Study||11||
59850181|NCT03635086|75974517|FG002|COMPLETED|Overall Study||11||
59850182|NCT03635086|75974518|FG003|COMPLETED|Overall Study||12||
59850183|NCT03635086|75974519|FG004|COMPLETED|Overall Study||12||
59850184|NCT03635086|75974515|FG000|NOT COMPLETED|Overall Study||1||
59850185|NCT03635086|75974516|FG001|NOT COMPLETED|Overall Study||1||
59850186|NCT03635086|75974517|FG002|NOT COMPLETED|Overall Study||1||
59850187|NCT03635086|75974518|FG003|NOT COMPLETED|Overall Study||0||
59850188|NCT03635086|75974519|FG004|NOT COMPLETED|Overall Study||0||
59850189|NCT03588910|75974534|FG000|STARTED|Overall Study||60||
59850190|NCT03588910|75974535|FG001|STARTED|Overall Study||60||
59850191|NCT03588910|75974534|FG000|Post Op Day 1 Survey|Overall Study||52||
59850192|NCT03588910|75974535|FG001|Post Op Day 1 Survey|Overall Study||47||
59850193|NCT03588910|75974534|FG000|COMPLETED|Overall Study||47|Post Op Day 7 Survey|
59850194|NCT03588910|75974535|FG001|COMPLETED|Overall Study||45|Post Op Day 7 Survey|
59850195|NCT03588910|75974534|FG000|NOT COMPLETED|Overall Study||13||
59850196|NCT03588910|75974535|FG001|NOT COMPLETED|Overall Study||15||
59850197|NCT03587974|75974543|FG000|STARTED|Overall Study||30||
59850198|NCT03587974|75974544|FG001|STARTED|Overall Study||30||
59850199|NCT03587974|75974543|FG000|COMPLETED|Overall Study||25||
59850200|NCT03587974|75974544|FG001|COMPLETED|Overall Study||26||
59850201|NCT03587974|75974543|FG000|NOT COMPLETED|Overall Study||5||
59850202|NCT03587974|75974544|FG001|NOT COMPLETED|Overall Study||4||
59850203|NCT00103857|75974557|FG000|STARTED|54-Week Base Study||179||
59850204|NCT00103857|75974558|FG001|STARTED|54-Week Base Study||182||
59850205|NCT00103857|75974559|FG002|STARTED|54-Week Base Study||182||
59850206|NCT00103857|75974560|FG003|STARTED|54-Week Base Study||190||
59850207|NCT00103857|75974561|FG004|STARTED|54-Week Base Study||182||
59850208|NCT00103857|75974562|FG005|STARTED|54-Week Base Study||176||
59850209|NCT00103857|75974563|FG006|STARTED|54-Week Base Study|Results for the OLC are through Week 24. Results for the 6 randomized groups are through Week 54.|117||
59850210|NCT00103857|75974557|FG000|COMPLETED|54-Week Base Study||122||
59850211|NCT00103857|75974558|FG001|COMPLETED|54-Week Base Study||126||
59850212|NCT00103857|75974559|FG002|COMPLETED|54-Week Base Study||135||
59850213|NCT00103857|75974560|FG003|COMPLETED|54-Week Base Study||148||
59850214|NCT00103857|75974561|FG004|COMPLETED|54-Week Base Study||141||
59850215|NCT00103857|75974562|FG005|COMPLETED|54-Week Base Study||115||
59850216|NCT00103857|75974563|FG006|COMPLETED|54-Week Base Study||79||
59850217|NCT00103857|75974557|FG000|NOT COMPLETED|54-Week Base Study||57||
59721071|NCT01146665|75839965|FG000|COMPLETED|Overall Study||8||
59721072|NCT01146665|75839966|FG001|COMPLETED|Overall Study||10||
59721073|NCT01146665|75839965|FG000|NOT COMPLETED|Overall Study||10||
59721074|NCT01146665|75839966|FG001|NOT COMPLETED|Overall Study||16||
59721075|NCT01145885|75839981|FG000|STARTED|Overall Study||7||
59721076|NCT01145885|75839981|FG000|COMPLETED|Overall Study||0||
59721077|NCT01145885|75839981|FG000|NOT COMPLETED|Overall Study||7||
59721078|NCT01190267|75839993|FG000|STARTED|Overall Study||196||
59721079|NCT01190267|75839994|FG001|STARTED|Overall Study||8||
59721080|NCT01190267|75839993|FG000|COMPLETED|Overall Study||155||
59721081|NCT01190267|75839994|FG001|COMPLETED|Overall Study||4||
59721082|NCT01190267|75839993|FG000|NOT COMPLETED|Overall Study||41||
59721083|NCT01190267|75839994|FG001|NOT COMPLETED|Overall Study||4||
59721084|NCT00869089|75840000|FG000|STARTED|Overall Study||5||
59721085|NCT00869089|75840000|FG000|COMPLETED|Overall Study||2||
59721086|NCT00869089|75840000|FG000|NOT COMPLETED|Overall Study||3||
59721087|NCT01190189|75840004|FG000|STARTED|Overall Study||137||
59721088|NCT01190189|75840004|FG000|COMPLETED|Overall Study||131||
59721089|NCT01190189|75840004|FG000|NOT COMPLETED|Overall Study||6||
59721090|NCT00871117|75840010|FG000|STARTED|Overall Study||239||
59721091|NCT00871117|75840011|FG001|STARTED|Overall Study||237||
59721092|NCT00871117|75840010|FG000|COMPLETED|Overall Study||234||
59721093|NCT00871117|75840011|FG001|COMPLETED|Overall Study||227||
59721094|NCT00871117|75840010|FG000|NOT COMPLETED|Overall Study||5||
59721095|NCT00871117|75840011|FG001|NOT COMPLETED|Overall Study||10||
59721096|NCT00870103|75840018|FG000|STARTED|Overall Study||64||
59850218|NCT00103857|75974558|FG001|NOT COMPLETED|54-Week Base Study||56||
59850219|NCT00103857|75974559|FG002|NOT COMPLETED|54-Week Base Study||47||
59850220|NCT00103857|75974560|FG003|NOT COMPLETED|54-Week Base Study||42||
59721097|NCT00870103|75840018|FG000|COMPLETED|Overall Study||60||
59721098|NCT00870103|75840018|FG000|NOT COMPLETED|Overall Study||4||
59721099|NCT03365752|75840025|FG000|STARTED|Overall Study||13||
59721100|NCT03365752|75840026|FG001|STARTED|Overall Study||13||
59721101|NCT03365752|75840027|FG002|STARTED|Overall Study||13||
59721102|NCT03365752|75840025|FG000|COMPLETED|Overall Study||13||
59850221|NCT00103857|75974561|FG004|NOT COMPLETED|54-Week Base Study||41||
59850222|NCT00103857|75974562|FG005|NOT COMPLETED|54-Week Base Study||61||
59721103|NCT03365752|75840026|FG001|COMPLETED|Overall Study||13||
59721104|NCT03365752|75840027|FG002|COMPLETED|Overall Study||13||
59721105|NCT03365752|75840025|FG000|NOT COMPLETED|Overall Study||0||
59721106|NCT03365752|75840026|FG001|NOT COMPLETED|Overall Study||0||
59568446|NCT00524511|75671539|FG000|NOT COMPLETED|Overall Study||4||
59568447|NCT00524511|75671540|FG001|NOT COMPLETED|Overall Study||7||
59568448|NCT00523809|75671546|FG000|STARTED|Overall Study||5||
59568449|NCT00523809|75671546|FG000|COMPLETED|Overall Study||5||
59568450|NCT00523809|75671546|FG000|NOT COMPLETED|Overall Study||0||
59850223|NCT00103857|75974563|FG006|NOT COMPLETED|54-Week Base Study||38||
59568451|NCT00511329|75671550|FG000|STARTED|Overall Study||0||
59568452|NCT00511329|75671550|FG000|COMPLETED|Overall Study||0||
59568453|NCT00511329|75671550|FG000|NOT COMPLETED|Overall Study||0||
59568454|NCT00501345|75671554|FG000|STARTED|Overall Study||5||
59568455|NCT00501345|75671554|FG000|COMPLETED|Overall Study||5||
59568456|NCT00501345|75671554|FG000|NOT COMPLETED|Overall Study||0||
59568457|NCT00487461|75671561|FG000|STARTED|Overall Study||2||
59568458|NCT00487461|75671562|FG001|STARTED|Overall Study||12||
59568459|NCT00487461|75671563|FG002|STARTED|Overall Study||11||
59568460|NCT00487461|75671561|FG000|COMPLETED|Overall Study||2||
59568461|NCT00487461|75671562|FG001|COMPLETED|Overall Study||10||
59568462|NCT00487461|75671563|FG002|COMPLETED|Overall Study||7||
59568463|NCT00487461|75671561|FG000|NOT COMPLETED|Overall Study||0||
59568464|NCT00487461|75671562|FG001|NOT COMPLETED|Overall Study||2||
59721107|NCT03365752|75840027|FG002|NOT COMPLETED|Overall Study||0||
59721108|NCT01145417|75840037|FG000|STARTED|Overall Study||108||
59721109|NCT01145417|75840038|FG001|STARTED|Overall Study||109||
59721110|NCT01145417|75840037|FG000|COMPLETED|Overall Study||67||
59568465|NCT00487461|75671563|FG002|NOT COMPLETED|Overall Study||4||
59568466|NCT00370695|75671571|FG000|STARTED|Overall Study||15||
59721111|NCT01145417|75840038|FG001|COMPLETED|Overall Study||62||
59568467|NCT00370695|75671571|FG000|12 Weeks Post-activation|Overall Study||2||
59568468|NCT00370695|75671571|FG000|COMPLETED|Overall Study||0||
59568469|NCT00370695|75671571|FG000|NOT COMPLETED|Overall Study||15||
59850224|NCT00103857|75974557|FG000|STARTED|50-Week Extension Study|19 randomized patients completed Period 1 but did not enter Period 2.|103||
59568470|NCT00356187|75671577|FG000|STARTED|Overall Study||0||
59568471|NCT00356187|75671578|FG001|STARTED|Overall Study||0||
59850225|NCT00103857|75974558|FG001|STARTED|50-Week Extension Study|19 randomized patients completed Period 1 but did not enter Period 2.|107||
59721112|NCT01145417|75840037|FG000|NOT COMPLETED|Overall Study||41||
59568472|NCT00356187|75671577|FG000|COMPLETED|Overall Study||0||
59721113|NCT01145417|75840038|FG001|NOT COMPLETED|Overall Study||47||
59721114|NCT01144715|75840046|FG000|STARTED|Overall Study||51||
59850226|NCT00103857|75974559|FG002|STARTED|50-Week Extension Study|14 randomized patients completed Period 1 but did not enter Period 2.|121||
59850227|NCT00103857|75974560|FG003|STARTED|50-Week Extension Study|14 randomized patients completed Period 1 but did not enter Period 2.|134||
59850228|NCT00103857|75974561|FG004|STARTED|50-Week Extension Study|19 randomized patients completed Period 1 but did not enter Period 2.|122||
59568473|NCT00356187|75671578|FG001|COMPLETED|Overall Study||0||
59721115|NCT01144715|75840047|FG001|STARTED|Overall Study||48||
59721116|NCT01144715|75840046|FG000|COMPLETED|Overall Study||47||
59568474|NCT00356187|75671577|FG000|NOT COMPLETED|Overall Study||0||
59721117|NCT01144715|75840047|FG001|COMPLETED|Overall Study||45||
60121072|NCT02652208|76241917|FG000|STARTED|Overall Study||17||
60121073|NCT02652208|76241918|FG001|STARTED|Overall Study||17||
59721118|NCT01144715|75840046|FG000|NOT COMPLETED|Overall Study||4||
59721119|NCT01144715|75840047|FG001|NOT COMPLETED|Overall Study||3||
59721120|NCT01189487|75840053|FG000|STARTED|Overall Study|Treated participants|47||
59568475|NCT00356187|75671578|FG001|NOT COMPLETED|Overall Study||0||
60121074|NCT02652208|76241917|FG000|COMPLETED|Overall Study||13||
59721121|NCT01189487|75840053|FG000|COMPLETED|Overall Study||44||
59721122|NCT01189487|75840053|FG000|NOT COMPLETED|Overall Study||3||
59721123|NCT01106352|75840062|FG000|STARTED|Overall Study||7||
59568476|NCT02224729|75671586|FG000|STARTED|Overall Study||24||
59568477|NCT02224729|75671586|FG000|COMPLETED|Overall Study||24||
59568478|NCT02224729|75671586|FG000|NOT COMPLETED|Overall Study||0||
59568479|NCT00320931|75671590|FG000|STARTED|Overall Study||30||
59568480|NCT00320931|75671590|FG000|COMPLETED|Overall Study||30||
59568481|NCT00320931|75671590|FG000|NOT COMPLETED|Overall Study||0||
59568482|NCT00305643|75671596|FG000|STARTED|Overall Study||6||
59568483|NCT00305643|75671597|FG001|STARTED|Overall Study||5||
59568484|NCT00305643|75671596|FG000|COMPLETED|Overall Study||6||
59568485|NCT00305643|75671597|FG001|COMPLETED|Overall Study||5||
59568486|NCT00305643|75671596|FG000|NOT COMPLETED|Overall Study||0||
59568487|NCT00305643|75671597|FG001|NOT COMPLETED|Overall Study||0||
59568488|NCT00271011|75671604|FG000|STARTED|Overall Study||13||
59568489|NCT00271011|75671604|FG000|COMPLETED|Overall Study||13||
59568490|NCT00271011|75671604|FG000|NOT COMPLETED|Overall Study||0||
59721124|NCT01106352|75840063|FG001|STARTED|Overall Study||3||
59850229|NCT00103857|75974562|FG005|STARTED|50-Week Extension Study|17 randomized patients completed Period 1 but did not enter Period 2.|98||
59568491|NCT00214149|75671608|FG000|STARTED|Overall Study||127||
59568492|NCT00214149|75671608|FG000|COMPLETED|Overall Study|No data are available; study was terminated and PI has left the institution.|0||
59568493|NCT00214149|75671608|FG000|NOT COMPLETED|Overall Study||127||
59568494|NCT03312530|75671617|FG000|STARTED|Overall Study||6||
59568495|NCT03312530|75671618|FG001|STARTED|Overall Study||6||
59568496|NCT03312530|75671619|FG002|STARTED|Overall Study||6||
59568497|NCT03312530|75671620|FG003|STARTED|Overall Study||16||
59568498|NCT03312530|75671621|FG004|STARTED|Overall Study||15||
59568499|NCT03312530|75671617|FG000|COMPLETED|Overall Study||0||
59568500|NCT03312530|75671618|FG001|COMPLETED|Overall Study||0||
59568501|NCT03312530|75671619|FG002|COMPLETED|Overall Study||0||
59568502|NCT03312530|75671620|FG003|COMPLETED|Overall Study||0||
59568503|NCT03312530|75671621|FG004|COMPLETED|Overall Study||0||
59568504|NCT03312530|75671617|FG000|NOT COMPLETED|Overall Study||6||
59568505|NCT03312530|75671618|FG001|NOT COMPLETED|Overall Study||6||
59568506|NCT03312530|75671619|FG002|NOT COMPLETED|Overall Study||6||
59568507|NCT03312530|75671620|FG003|NOT COMPLETED|Overall Study||16||
59721125|NCT01106352|75840064|FG002|STARTED|Overall Study||7||
59568508|NCT03312530|75671621|FG004|NOT COMPLETED|Overall Study||15||
59568509|NCT00179127|75671639|FG000|STARTED|Overall Study||0||
59568510|NCT00179127|75671640|FG001|STARTED|Overall Study||0||
59568511|NCT00179127|75671639|FG000|COMPLETED|Overall Study||0||
59568512|NCT00179127|75671640|FG001|COMPLETED|Overall Study||0||
59721126|NCT01106352|75840065|FG003|STARTED|Overall Study||36||
59721127|NCT01106352|75840066|FG004|STARTED|Overall Study||17||
59568513|NCT00179127|75671639|FG000|NOT COMPLETED|Overall Study||0||
59568514|NCT00179127|75671640|FG001|NOT COMPLETED|Overall Study||0||
59568515|NCT00183963|75671650|FG000|STARTED|Overall Study||1||
59568516|NCT00183963|75671651|FG001|STARTED|Overall Study||1||
59568517|NCT00183963|75671652|FG002|STARTED|Overall Study||1||
59568518|NCT00183963|75671653|FG003|STARTED|Overall Study||1||
59568519|NCT00183963|75671650|FG000|COMPLETED|Overall Study||0||
59568520|NCT00183963|75671651|FG001|COMPLETED|Overall Study||0||
59568521|NCT00183963|75671652|FG002|COMPLETED|Overall Study||0||
59568522|NCT00183963|75671653|FG003|COMPLETED|Overall Study||0||
59568523|NCT00183963|75671650|FG000|NOT COMPLETED|Overall Study||1||
59568524|NCT00183963|75671651|FG001|NOT COMPLETED|Overall Study||1||
59568525|NCT00183963|75671652|FG002|NOT COMPLETED|Overall Study||1||
59568526|NCT00183963|75671653|FG003|NOT COMPLETED|Overall Study||1||
59568527|NCT01930058|75671669|FG000|STARTED|Overall Study||3||
59568528|NCT01930058|75671670|FG001|STARTED|Overall Study||3||
59568529|NCT01930058|75671671|FG002|STARTED|Overall Study||3||
59568530|NCT01930058|75671669|FG000|COMPLETED|Overall Study||3||
59568531|NCT01930058|75671670|FG001|COMPLETED|Overall Study||3||
59568532|NCT01930058|75671671|FG002|COMPLETED|Overall Study||3||
59568533|NCT01930058|75671669|FG000|NOT COMPLETED|Overall Study||0||
59568534|NCT01930058|75671670|FG001|NOT COMPLETED|Overall Study||0||
59568535|NCT01930058|75671671|FG002|NOT COMPLETED|Overall Study||0||
59568536|NCT01909154|75671678|FG000|STARTED|Overall Study||12||
59568537|NCT01909154|75671678|FG000|COMPLETED|Overall Study||12||
59568538|NCT01909154|75671678|FG000|NOT COMPLETED|Overall Study||0||
60121075|NCT02652208|76241918|FG001|COMPLETED|Overall Study||15||
60121076|NCT02652208|76241917|FG000|NOT COMPLETED|Overall Study||4||
60121077|NCT02652208|76241918|FG001|NOT COMPLETED|Overall Study||2||
60121078|NCT02653144|76241927|FG000|STARTED|Overall Study||30||
60121079|NCT02653144|76241928|FG001|STARTED|Overall Study||28||
60121080|NCT02653144|76241929|FG002|STARTED|Overall Study||31||
59568539|NCT01910636|75671684|FG000|STARTED|Overall Study||90||
60121081|NCT02653144|76241927|FG000|COMPLETED|Overall Study||30||
59568540|NCT01910636|75671685|FG001|STARTED|Overall Study||63||
59568541|NCT01910636|75671684|FG000|COMPLETED|Overall Study||90||
59568542|NCT01910636|75671685|FG001|COMPLETED|Overall Study||63||
59568543|NCT01910636|75671684|FG000|NOT COMPLETED|Overall Study||0||
59568544|NCT01910636|75671685|FG001|NOT COMPLETED|Overall Study||0||
59568545|NCT01932164|75671691|FG000|STARTED|Overall Study|It was performed the selection of 5 patients to participate of these study (08/2013)|5||
59568546|NCT01932164|75671691|FG000|Cleft Lip and Palate|Overall Study|It was performed de extraction of deciduous teeth of 5 cleft lip/palate patients (09/2013)|5||
59568547|NCT01932164|75671691|FG000|Cleft Lip and Palate|Overall Study|Dental pulp was obtained from teeth of 5 different patients (09/2013)|5||
59568548|NCT01932164|75671691|FG000|Cleft Lip and Palate|Overall Study|Mesenchymal stem cell obtained from dental pulp of 5patients was obtained, caractherized and frozen|5||
59568549|NCT01932164|75671691|FG000|Cleft Lip and Palate|Overall Study|Alveolar bone graft surgeries were did using their dental pulp stem cells with biomaterial|5||
59568550|NCT01932164|75671691|FG000|Cleft Lip and Palate|Overall Study|The surgeries were performed between december 2013 and june 2014.|5||
59568551|NCT01932164|75671691|FG000|COMPLETED|Overall Study|In all 5 patients we observed bone formation closing the alveolar cleft after 6 months|5||
59568552|NCT01932164|75671691|FG000|NOT COMPLETED|Overall Study||0||
59568553|NCT00118053|75671695|FG000|STARTED|Overall Study||5||
59568554|NCT00118053|75671695|FG000|COMPLETED|Overall Study||5||
59568555|NCT00118053|75671695|FG000|NOT COMPLETED|Overall Study||0||
59568556|NCT01996371|75671702|FG000|STARTED|Overall Study||5||
59568557|NCT01996371|75671703|FG001|STARTED|Overall Study||4||
59568558|NCT01996371|75671704|FG002|STARTED|Overall Study||6||
59568559|NCT01996371|75671702|FG000|COMPLETED|Overall Study||5||
59568560|NCT01996371|75671703|FG001|COMPLETED|Overall Study||4||
59568561|NCT01996371|75671704|FG002|COMPLETED|Overall Study||6||
59568562|NCT01996371|75671702|FG000|NOT COMPLETED|Overall Study||0||
59568563|NCT01996371|75671703|FG001|NOT COMPLETED|Overall Study||0||
59568564|NCT01996371|75671704|FG002|NOT COMPLETED|Overall Study||0||
59568565|NCT00955929|75671718|FG000|STARTED|Overall Study||13||
59568566|NCT00955929|75671719|FG001|STARTED|Overall Study||30||
59568567|NCT00955929|75671720|FG002|STARTED|Overall Study||33||
59568568|NCT00955929|75671718|FG000|COMPLETED|Overall Study||13||
59568569|NCT00955929|75671719|FG001|COMPLETED|Overall Study||30||
59568570|NCT00955929|75671720|FG002|COMPLETED|Overall Study||33||
59568571|NCT00955929|75671718|FG000|NOT COMPLETED|Overall Study||0||
59568572|NCT00955929|75671719|FG001|NOT COMPLETED|Overall Study||0||
59568573|NCT00955929|75671720|FG002|NOT COMPLETED|Overall Study||0||
59568574|NCT03482505|75671728|FG000|STARTED|Overall Study||10||
59568575|NCT03482505|75671728|FG000|COMPLETED|Overall Study||10||
59568576|NCT03482505|75671728|FG000|NOT COMPLETED|Overall Study||0||
59568577|NCT01444209|75671732|FG000|STARTED|Overall Study||2||
59568578|NCT01444209|75671732|FG000|COMPLETED|Overall Study||2||
59568579|NCT01444209|75671732|FG000|NOT COMPLETED|Overall Study||0||
59568580|NCT02296320|75671739|FG000|STARTED|Overall Study||102||
59568581|NCT02296320|75671740|FG001|STARTED|Overall Study||15||
59568582|NCT02296320|75671741|FG002|STARTED|Overall Study||96||
59568583|NCT02296320|75671739|FG000|Treated|Overall Study||100||
59568584|NCT02296320|75671740|FG001|Treated|Overall Study||15||
59568585|NCT02296320|75671741|FG002|Treated|Overall Study||96||
59568586|NCT02296320|75671739|FG000|COMPLETED|Overall Study||67||
59568587|NCT02296320|75671740|FG001|COMPLETED|Overall Study||10||
59568588|NCT02296320|75671741|FG002|COMPLETED|Overall Study||59||
59568589|NCT02296320|75671739|FG000|NOT COMPLETED|Overall Study||35||
59568590|NCT02296320|75671740|FG001|NOT COMPLETED|Overall Study||5||
59568591|NCT02296320|75671741|FG002|NOT COMPLETED|Overall Study||37||
59568592|NCT03632655|75671753|FG000|STARTED|Overall Study||22||
59568593|NCT03632655|75671754|FG001|STARTED|Overall Study||16||
59568594|NCT03632655|75671753|FG000|COMPLETED|Overall Study||0||
59568595|NCT03632655|75671754|FG001|COMPLETED|Overall Study||0||
59568596|NCT03632655|75671753|FG000|NOT COMPLETED|Overall Study||22||
59568597|NCT03632655|75671754|FG001|NOT COMPLETED|Overall Study||16||
59568598|NCT03621657|75671763|FG000|STARTED|Overall Study||0||
59568599|NCT03621657|75671764|FG001|STARTED|Overall Study||0||
59568600|NCT03621657|75671765|FG002|STARTED|Overall Study||1||
59568601|NCT03621657|75671763|FG000|COMPLETED|Overall Study||0||
59568602|NCT03621657|75671764|FG001|COMPLETED|Overall Study||0||
59568603|NCT03621657|75671765|FG002|COMPLETED|Overall Study||1||
59568604|NCT03621657|75671763|FG000|NOT COMPLETED|Overall Study||0||
59568605|NCT03621657|75671764|FG001|NOT COMPLETED|Overall Study||0||
59568606|NCT03621657|75671765|FG002|NOT COMPLETED|Overall Study||0||
59568607|NCT02296242|75671780|FG000|STARTED|Overall Study||5||
59568608|NCT02296242|75671781|FG001|STARTED|Overall Study||6||
59568609|NCT02296242|75671782|FG002|STARTED|Overall Study||7||
59568610|NCT02296242|75671783|FG003|STARTED|Overall Study||14||
59568611|NCT02296242|75671784|FG004|STARTED|Overall Study||21||
59568612|NCT02296242|75671780|FG000|COMPLETED|Overall Study||0||
59568613|NCT02296242|75671781|FG001|COMPLETED|Overall Study||0||
59568614|NCT02296242|75671782|FG002|COMPLETED|Overall Study||0||
59568615|NCT02296242|75671783|FG003|COMPLETED|Overall Study||0||
59568616|NCT02296242|75671784|FG004|COMPLETED|Overall Study||0||
59568617|NCT02296242|75671780|FG000|NOT COMPLETED|Overall Study||5||
59568618|NCT02296242|75671781|FG001|NOT COMPLETED|Overall Study||6||
59568619|NCT02296242|75671782|FG002|NOT COMPLETED|Overall Study||7||
59568620|NCT02296242|75671783|FG003|NOT COMPLETED|Overall Study||14||
59568621|NCT02296242|75671784|FG004|NOT COMPLETED|Overall Study||21||
59568622|NCT02295774|75671804|FG000|STARTED|Overall Study||13||
59568623|NCT02295774|75671804|FG000|COMPLETED|Overall Study||10||
59568624|NCT02295774|75671804|FG000|NOT COMPLETED|Overall Study||3||
59568625|NCT01807611|75671809|FG000|STARTED|Overall Study||82||
59568626|NCT01807611|75671809|FG000|COMPLETED|Overall Study||78||
59568627|NCT01807611|75671809|FG000|NOT COMPLETED|Overall Study||4||
59568628|NCT02294682|75671819|FG000|STARTED|Overall Study||53||
59568629|NCT02294682|75671820|FG001|STARTED|Overall Study||53||
59568630|NCT02294682|75671819|FG000|COMPLETED|Overall Study||52||
59568631|NCT02294682|75671820|FG001|COMPLETED|Overall Study||53||
59568632|NCT02294682|75671819|FG000|NOT COMPLETED|Overall Study||1||
59568633|NCT02294682|75671820|FG001|NOT COMPLETED|Overall Study||0||
59568634|NCT02294604|75671829|FG000|STARTED|Overall Study||80||
59568635|NCT02294604|75671830|FG001|STARTED|Overall Study||80||
59568636|NCT02294604|75671831|FG002|STARTED|Overall Study||80||
59568637|NCT02294604|75671829|FG000|COMPLETED|Overall Study||79||
59568638|NCT02294604|75671830|FG001|COMPLETED|Overall Study||77||
59568639|NCT02294604|75671831|FG002|COMPLETED|Overall Study||80||
59568640|NCT02294604|75671829|FG000|NOT COMPLETED|Overall Study||1||
59568641|NCT02294604|75671830|FG001|NOT COMPLETED|Overall Study||3||
59568642|NCT02294604|75671831|FG002|NOT COMPLETED|Overall Study||0||
59568643|NCT03483051|75671841|FG000|STARTED|First Treatment, Pre Crossover||2||
59568644|NCT03483051|75671842|FG001|STARTED|First Treatment, Pre Crossover||1||
59568645|NCT03483051|75671841|FG000|COMPLETED|First Treatment, Pre Crossover||2||
59568646|NCT03483051|75671842|FG001|COMPLETED|First Treatment, Pre Crossover||1||
59568647|NCT03483051|75671841|FG000|NOT COMPLETED|First Treatment, Pre Crossover||0||
59568648|NCT03483051|75671842|FG001|NOT COMPLETED|First Treatment, Pre Crossover||0||
59568649|NCT03483051|75671841|FG000|STARTED|Second Treatment, After Crossover||2||
59568650|NCT03483051|75671842|FG001|STARTED|Second Treatment, After Crossover||1||
59568651|NCT03483051|75671841|FG000|COMPLETED|Second Treatment, After Crossover||2||
59568652|NCT03483051|75671842|FG001|COMPLETED|Second Treatment, After Crossover||1||
59568653|NCT03483051|75671841|FG000|NOT COMPLETED|Second Treatment, After Crossover||0||
59568654|NCT03483051|75671842|FG001|NOT COMPLETED|Second Treatment, After Crossover||0||
59568655|NCT01645176|75671850|FG000|STARTED|Overall Study||21||21
59568656|NCT01645176|75671850|FG000|COMPLETED|Overall Study||16||16
59568657|NCT01645176|75671850|FG000|NOT COMPLETED|Overall Study||5||5
59568658|NCT03465735|75671856|FG000|STARTED|Overall Study||8||
59568659|NCT03465735|75671857|FG001|STARTED|Overall Study||7||
59568660|NCT03465735|75671856|FG000|COMPLETED|Overall Study||7||
59568661|NCT03465735|75671857|FG001|COMPLETED|Overall Study||5||
59568662|NCT03465735|75671856|FG000|NOT COMPLETED|Overall Study||1||
59568663|NCT03465735|75671857|FG001|NOT COMPLETED|Overall Study||2||
59568664|NCT02322216|75671865|FG000|STARTED|Overall Study||126||
59568665|NCT02322216|75671866|FG001|STARTED|Overall Study||127||
59568666|NCT02322216|75671865|FG000|Treated (Safety Set)|Overall Study||126||
59568667|NCT02322216|75671866|FG001|Treated (Safety Set)|Overall Study||126||
59568668|NCT02322216|75671865|FG000|Per Protocol Set (PPS)|Overall Study||123||
59568669|NCT02322216|75671866|FG001|Per Protocol Set (PPS)|Overall Study||122||
59568670|NCT02322216|75671865|FG000|COMPLETED|Overall Study||124||
59568671|NCT02322216|75671866|FG001|COMPLETED|Overall Study||123||
59568672|NCT02322216|75671865|FG000|NOT COMPLETED|Overall Study||2||
59568673|NCT02322216|75671866|FG001|NOT COMPLETED|Overall Study||4||
59568674|NCT03447639|75671875|FG000|STARTED|Overall Study|No patients were randomized to the Povidone-Iodine irrigation arm|0||
59568675|NCT03447639|75671876|FG001|STARTED|Overall Study|3 patients were randomized to the Standard of Care arm.|3||
59568676|NCT03447639|75671875|FG000|COMPLETED|Overall Study|No patients were randomized to the Povidone-Iodine irrigation arm|0||
59568677|NCT03447639|75671876|FG001|COMPLETED|Overall Study|2 patients were withdrawn because their catheters had to be re-inserted.|1||
59568678|NCT03447639|75671875|FG000|NOT COMPLETED|Overall Study||0||
59568679|NCT03447639|75671876|FG001|NOT COMPLETED|Overall Study||2||
59568680|NCT03425799|75671884|FG000|STARTED|Overall Study|Study terminated due to low recruitment|0||
59850230|NCT00103857|75974563|FG006|STARTED|50-Week Extension Study||0||
59568681|NCT03425799|75671885|FG001|STARTED|Overall Study|Study terminated due to low recruitment|0||
59568682|NCT03425799|75671884|FG000|COMPLETED|Overall Study|Study terminated due to low recruitment|0|Study terminated due to low recruitment|
59568683|NCT03425799|75671885|FG001|COMPLETED|Overall Study|Study terminated due to low recruitment|0|Study terminated due to low recruitment|
59568684|NCT03425799|75671884|FG000|NOT COMPLETED|Overall Study||0||
59568685|NCT03425799|75671885|FG001|NOT COMPLETED|Overall Study||0||
59568686|NCT03363633|75671891|FG000|STARTED|Overall Study||12||
59568687|NCT03363633|75671891|FG000|COMPLETED|Overall Study|See note in Pre-Assignment Details|0||
59568688|NCT03363633|75671891|FG000|NOT COMPLETED|Overall Study||12||
59568689|NCT03360903|75671897|FG000|STARTED|First Intervention||4||
59568690|NCT03360903|75671898|FG001|STARTED|First Intervention||4||
59568691|NCT03360903|75671897|FG000|COMPLETED|First Intervention||4||
59568692|NCT03360903|75671898|FG001|COMPLETED|First Intervention||4||
59568693|NCT03360903|75671897|FG000|NOT COMPLETED|First Intervention||0||
59850231|NCT00103857|75974557|FG000|COMPLETED|50-Week Extension Study||65||
59850232|NCT00103857|75974558|FG001|COMPLETED|50-Week Extension Study||80||
59568694|NCT03360903|75671898|FG001|NOT COMPLETED|First Intervention||0||
59568695|NCT03360903|75671897|FG000|STARTED|Washout (2 Weeks)||4||
59568696|NCT03360903|75671898|FG001|STARTED|Washout (2 Weeks)||4||
59568697|NCT03360903|75671897|FG000|COMPLETED|Washout (2 Weeks)||4||
59568698|NCT03360903|75671898|FG001|COMPLETED|Washout (2 Weeks)||4||
59721128|NCT01106352|75840062|FG000|Started Dose Escalation|Overall Study|Number of subjects for safety analysis set.|7||
59850233|NCT00103857|75974559|FG002|COMPLETED|50-Week Extension Study||95||
59850234|NCT00103857|75974560|FG003|COMPLETED|50-Week Extension Study||98||
59568699|NCT03360903|75671897|FG000|NOT COMPLETED|Washout (2 Weeks)||0||
59568700|NCT03360903|75671898|FG001|NOT COMPLETED|Washout (2 Weeks)||0||
59568701|NCT03360903|75671897|FG000|STARTED|Second Intervention||4||
59568702|NCT03360903|75671898|FG001|STARTED|Second Intervention||4||
59568703|NCT03360903|75671897|FG000|COMPLETED|Second Intervention||4||
59568704|NCT03360903|75671898|FG001|COMPLETED|Second Intervention||4||
59568705|NCT03360903|75671897|FG000|NOT COMPLETED|Second Intervention||0||
59568706|NCT03360903|75671898|FG001|NOT COMPLETED|Second Intervention||0||
59568707|NCT01647516|75671907|FG000|STARTED|Induction Period (IP)||66||
59568708|NCT01647516|75671908|FG001|STARTED|Induction Period (IP)||66||
59568709|NCT01647516|75671909|FG002|STARTED|Induction Period (IP)||67||
59568710|NCT01647516|75671910|FG003|STARTED|Induction Period (IP)||0||
59568711|NCT01647516|75671911|FG004|STARTED|Induction Period (IP)||0||
59568712|NCT01647516|75671912|FG005|STARTED|Induction Period (IP)||0||
59568713|NCT01647516|75671907|FG000|Received Study Drug|Induction Period (IP)||65||
59568714|NCT01647516|75671908|FG001|Received Study Drug|Induction Period (IP)||65||
59568715|NCT01647516|75671909|FG002|Received Study Drug|Induction Period (IP)||67||
59568716|NCT01647516|75671910|FG003|Received Study Drug|Induction Period (IP)||0||
59568717|NCT01647516|75671911|FG004|Received Study Drug|Induction Period (IP)||0||
59568718|NCT01647516|75671912|FG005|Received Study Drug|Induction Period (IP)||0||
59568719|NCT01647516|75671907|FG000|COMPLETED|Induction Period (IP)||60||
59568720|NCT01647516|75671908|FG001|COMPLETED|Induction Period (IP)||63||
59568721|NCT01647516|75671909|FG002|COMPLETED|Induction Period (IP)||63||
59568722|NCT01647516|75671910|FG003|COMPLETED|Induction Period (IP)||0||
59568723|NCT01647516|75671911|FG004|COMPLETED|Induction Period (IP)||0||
59568724|NCT01647516|75671912|FG005|COMPLETED|Induction Period (IP)||0||
59568725|NCT01647516|75671907|FG000|NOT COMPLETED|Induction Period (IP)||6||
59568726|NCT01647516|75671908|FG001|NOT COMPLETED|Induction Period (IP)||3||
59568727|NCT01647516|75671909|FG002|NOT COMPLETED|Induction Period (IP)||4||
59568728|NCT01647516|75671910|FG003|NOT COMPLETED|Induction Period (IP)||0||
59568729|NCT01647516|75671911|FG004|NOT COMPLETED|Induction Period (IP)||0||
59568730|NCT01647516|75671912|FG005|NOT COMPLETED|Induction Period (IP)||0||
59568731|NCT01647516|75671907|FG000|STARTED|Maintenance Period (MP)|The MP includes participants who were responders at week 8.|25||
59568732|NCT01647516|75671908|FG001|STARTED|Maintenance Period (MP)|The MP includes participants who were responders at week 8.|36||
59568733|NCT01647516|75671909|FG002|STARTED|Maintenance Period (MP)|The MP includes participants who were responders at week 8.|42||
59568734|NCT01647516|75671910|FG003|STARTED|Maintenance Period (MP)||0||
59568735|NCT01647516|75671911|FG004|STARTED|Maintenance Period (MP)||0||
59568736|NCT01647516|75671912|FG005|STARTED|Maintenance Period (MP)||0||
59568737|NCT01647516|75671907|FG000|COMPLETED|Maintenance Period (MP)||21||
59568738|NCT01647516|75671908|FG001|COMPLETED|Maintenance Period (MP)||30||
59568739|NCT01647516|75671909|FG002|COMPLETED|Maintenance Period (MP)||40||
59568740|NCT01647516|75671910|FG003|COMPLETED|Maintenance Period (MP)||0||
59568741|NCT01647516|75671911|FG004|COMPLETED|Maintenance Period (MP)||0||
59568742|NCT01647516|75671912|FG005|COMPLETED|Maintenance Period (MP)||0||
59568743|NCT01647516|75671907|FG000|NOT COMPLETED|Maintenance Period (MP)||4||
59568744|NCT01647516|75671908|FG001|NOT COMPLETED|Maintenance Period (MP)||6||
59568745|NCT01647516|75671909|FG002|NOT COMPLETED|Maintenance Period (MP)||2||
59568746|NCT01647516|75671910|FG003|NOT COMPLETED|Maintenance Period (MP)||0||
59568747|NCT01647516|75671911|FG004|NOT COMPLETED|Maintenance Period (MP)||0||
59568748|NCT01647516|75671912|FG005|NOT COMPLETED|Maintenance Period (MP)||0||
59568749|NCT01647516|75671907|FG000|STARTED|Open-Label Period||0||
59568750|NCT01647516|75671908|FG001|STARTED|Open-Label Period||0||
59568751|NCT01647516|75671909|FG002|STARTED|Open-Label Period||0||
59568752|NCT01647516|75671910|FG003|STARTED|Open-Label Period|"The participants were:~non-responders at Week 8,completed the MP or had disease relapse during MP"|55||
59568753|NCT01647516|75671911|FG004|STARTED|Open-Label Period|"The participants were:~non-responders at Week 8,completed the MP or had disease relapse during MP"|56||
59568754|NCT01647516|75671912|FG005|STARTED|Open-Label Period|"The participants were:~non-responders at Week 8,completed the MP or had disease relapse during MP"|59||
59568755|NCT01647516|75671907|FG000|COMPLETED|Open-Label Period||0||
59568756|NCT01647516|75671908|FG001|COMPLETED|Open-Label Period||0||
59568757|NCT01647516|75671909|FG002|COMPLETED|Open-Label Period||0||
59568758|NCT01647516|75671910|FG003|COMPLETED|Open-Label Period||6||
59568759|NCT01647516|75671911|FG004|COMPLETED|Open-Label Period||5||
59568760|NCT01647516|75671912|FG005|COMPLETED|Open-Label Period||3||
59568761|NCT01647516|75671907|FG000|NOT COMPLETED|Open-Label Period||0||
59568762|NCT01647516|75671908|FG001|NOT COMPLETED|Open-Label Period||0||
59568763|NCT01647516|75671909|FG002|NOT COMPLETED|Open-Label Period||0||
59568764|NCT01647516|75671910|FG003|NOT COMPLETED|Open-Label Period||49||
59568765|NCT01647516|75671911|FG004|NOT COMPLETED|Open-Label Period||51||
59568766|NCT01647516|75671912|FG005|NOT COMPLETED|Open-Label Period||56||
59568767|NCT01647282|75671929|FG000|STARTED|Overall Study||30||
59568768|NCT01647282|75671930|FG001|STARTED|Overall Study||30||
59568769|NCT01647282|75671929|FG000|COMPLETED|Overall Study||23||
59568770|NCT01647282|75671930|FG001|COMPLETED|Overall Study||25||
59568771|NCT01647282|75671929|FG000|NOT COMPLETED|Overall Study||7||
59568772|NCT01647282|75671930|FG001|NOT COMPLETED|Overall Study||5||
59568773|NCT02321436|75671938|FG000|STARTED|Overall Study||28||
59568774|NCT02321436|75671939|FG001|STARTED|Overall Study||14||
59850235|NCT00103857|75974561|FG004|COMPLETED|50-Week Extension Study||101||
59568775|NCT02321436|75671938|FG000|COMPLETED|Overall Study||27||
59568776|NCT02321436|75671939|FG001|COMPLETED|Overall Study||13||
59568777|NCT02321436|75671938|FG000|NOT COMPLETED|Overall Study||1||
59568778|NCT02321436|75671939|FG001|NOT COMPLETED|Overall Study||1||
59568779|NCT02319642|75671948|FG000|STARTED|Overall Study||95||
59568780|NCT02319642|75671949|FG001|STARTED|Overall Study||251||
59568781|NCT02319642|75671948|FG000|COMPLETED|Overall Study||91||
59568782|NCT02319642|75671949|FG001|COMPLETED|Overall Study||245||
59568783|NCT02319642|75671948|FG000|NOT COMPLETED|Overall Study||4||
59568784|NCT02319642|75671949|FG001|NOT COMPLETED|Overall Study||6||
59568785|NCT02280096|75671959|FG000|STARTED|Overall Study||13||
59568786|NCT02280096|75671960|FG001|STARTED|Overall Study||11||
59568787|NCT02280096|75671959|FG000|COMPLETED|Overall Study||11||
59568788|NCT02280096|75671960|FG001|COMPLETED|Overall Study||10||
59568789|NCT02280096|75671959|FG000|NOT COMPLETED|Overall Study||2||
59568790|NCT02280096|75671960|FG001|NOT COMPLETED|Overall Study||1||
59568791|NCT02279862|75671977|FG000|STARTED|Overall Study||26||
59568792|NCT02279862|75671978|FG001|STARTED|Overall Study||27||
59568793|NCT02279862|75671977|FG000|Treated|Overall Study||25||
59568794|NCT02279862|75671978|FG001|Treated|Overall Study||26||
59568795|NCT02279862|75671977|FG000|COMPLETED|Overall Study|Completed treatment in induction period|0||
59568796|NCT02279862|75671978|FG001|COMPLETED|Overall Study|Completed treatment in induction period|2||
59568797|NCT02279862|75671977|FG000|NOT COMPLETED|Overall Study||26||
59568798|NCT02279862|75671978|FG001|NOT COMPLETED|Overall Study||25||
59568799|NCT02318940|75671986|FG000|STARTED|Overall Study|in the last patient we lost the record.|50||
59568800|NCT02318940|75671987|FG001|STARTED|Overall Study||50||
59568801|NCT02318940|75671986|FG000|COMPLETED|Overall Study||49||
59568802|NCT02318940|75671987|FG001|COMPLETED|Overall Study||50||
59568803|NCT02318940|75671986|FG000|NOT COMPLETED|Overall Study||1||
59568804|NCT02318940|75671987|FG001|NOT COMPLETED|Overall Study||0||
59568805|NCT02294058|75671996|FG000|STARTED|Overall Study||448||
59568806|NCT02294058|75671997|FG001|STARTED|Overall Study||451||
59568807|NCT02294058|75671998|FG002|STARTED|Overall Study||447||
59568808|NCT02294058|75671996|FG000|Safety Population|Overall Study||445|Three participants randomized to the interferon beta-1a group received ozanimod in error at some visits (2 participants received ozanimod 0.5 mg and 1 participant received ozanimod 1 mg) and are counted in the ozanimod groups in the Safety Population.|
59568809|NCT02294058|75671997|FG001|Safety Population|Overall Study||453|Three participants randomized to the interferon beta-1a group received ozanimod in error at some visits (2 participants received ozanimod 0.5 mg and 1 participant received ozanimod 1 mg) and are counted in the ozanimod groups in the Safety Population.|
59568810|NCT02294058|75671998|FG002|Safety Population|Overall Study||448|Three participants randomized to the interferon beta-1a group received ozanimod in error at some visits (2 participants received ozanimod 0.5 mg and 1 participant received ozanimod 1 mg) and are counted in the ozanimod groups in the Safety Population.|
59568811|NCT02294058|75671996|FG000|COMPLETED|Overall Study||412||
59568812|NCT02294058|75671997|FG001|COMPLETED|Overall Study||425||
59568813|NCT02294058|75671998|FG002|COMPLETED|Overall Study||418||
59568814|NCT02294058|75671996|FG000|NOT COMPLETED|Overall Study||36||
59568815|NCT02294058|75671997|FG001|NOT COMPLETED|Overall Study||26||
59568816|NCT02294058|75671998|FG002|NOT COMPLETED|Overall Study||29||
59568817|NCT02293902|75672010|FG000|STARTED|Double-Blind Period (Up to Week 24)||82||
59568818|NCT02293902|75672011|FG001|STARTED|Double-Blind Period (Up to Week 24)||81||
59568819|NCT02293902|75672012|FG002|STARTED|Double-Blind Period (Up to Week 24)||80||
59568820|NCT02293902|75672013|FG003|STARTED|Double-Blind Period (Up to Week 24)||0||
59568821|NCT02293902|75672014|FG004|STARTED|Double-Blind Period (Up to Week 24)||0||
59568822|NCT02293902|75672010|FG000|Treated|Double-Blind Period (Up to Week 24)||81||
59568823|NCT02293902|75672011|FG001|Treated|Double-Blind Period (Up to Week 24)||81||
59568824|NCT02293902|75672012|FG002|Treated|Double-Blind Period (Up to Week 24)||80||
59568825|NCT02293902|75672013|FG003|Treated|Double-Blind Period (Up to Week 24)||0||
59568826|NCT02293902|75672014|FG004|Treated|Double-Blind Period (Up to Week 24)||0||
59568827|NCT02293902|75672010|FG000|Rescued|Double-Blind Period (Up to Week 24)||44|Included both participants who completed and did not complete the study.|
59568828|NCT02293902|75672011|FG001|Rescued|Double-Blind Period (Up to Week 24)||6|Included both participants who completed and did not complete the study.|
59568829|NCT02293902|75672012|FG002|Rescued|Double-Blind Period (Up to Week 24)||8|Included both participants who completed and did not complete the study.|
59568830|NCT02293902|75672013|FG003|Rescued|Double-Blind Period (Up to Week 24)||0|Included both participants who completed and did not complete the study.|
59568831|NCT02293902|75672014|FG004|Rescued|Double-Blind Period (Up to Week 24)||0|Included both participants who completed and did not complete the study.|
59568832|NCT02293902|75672010|FG000|COMPLETED|Double-Blind Period (Up to Week 24)|42 rescued and 29 not rescued completed.|71||
59568833|NCT02293902|75672011|FG001|COMPLETED|Double-Blind Period (Up to Week 24)|6 rescued and 68 not rescued completed.|74||
59568834|NCT02293902|75672012|FG002|COMPLETED|Double-Blind Period (Up to Week 24)|8 rescued and 62 not rescued completed.|70||
59568835|NCT02293902|75672013|FG003|COMPLETED|Double-Blind Period (Up to Week 24)||0||
59568836|NCT02293902|75672014|FG004|COMPLETED|Double-Blind Period (Up to Week 24)||0||
59568837|NCT02293902|75672010|FG000|NOT COMPLETED|Double-Blind Period (Up to Week 24)||11||
59568838|NCT02293902|75672011|FG001|NOT COMPLETED|Double-Blind Period (Up to Week 24)||7||
59568839|NCT02293902|75672012|FG002|NOT COMPLETED|Double-Blind Period (Up to Week 24)||10||
59568840|NCT02293902|75672013|FG003|NOT COMPLETED|Double-Blind Period (Up to Week 24)||0||
59568841|NCT02293902|75672014|FG004|NOT COMPLETED|Double-Blind Period (Up to Week 24)||0||
59568842|NCT02293902|75672010|FG000|STARTED|Single-Blind Period (Week 25 to Week 52)||0||
59568843|NCT02293902|75672011|FG001|STARTED|Single-Blind Period (Week 25 to Week 52)|68 participants not rescued continued same treatment and 6 rescued continued open label treatment.|74||
59568844|NCT02293902|75672012|FG002|STARTED|Single-Blind Period (Week 25 to Week 52)|62 participants not rescued continued same treatment and 8 rescued continued open label treatment.|70||
59568845|NCT02293902|75672013|FG003|STARTED|Single-Blind Period (Week 25 to Week 52)|14 participants not rescued were switched and 20 rescued continued open label treatment.|34||
59568846|NCT02293902|75672014|FG004|STARTED|Single-Blind Period (Week 25 to Week 52)|15 participants not rescued were switched and 22 rescued continued open label treatment.|37||
59568847|NCT02293902|75672010|FG000|COMPLETED|Single-Blind Period (Week 25 to Week 52)||0||
59568848|NCT02293902|75672011|FG001|COMPLETED|Single-Blind Period (Week 25 to Week 52)|5 rescued and 61 not rescued completed.|66||
59568849|NCT02293902|75672012|FG002|COMPLETED|Single-Blind Period (Week 25 to Week 52)|8 rescued and 60 not rescued completed.|68||
59568850|NCT02293902|75672013|FG003|COMPLETED|Single-Blind Period (Week 25 to Week 52)|20 rescued and 13 not rescued completed.|33||
59568851|NCT02293902|75672014|FG004|COMPLETED|Single-Blind Period (Week 25 to Week 52)|18 rescued and 13 not rescued completed.|31||
59568852|NCT02293902|75672010|FG000|NOT COMPLETED|Single-Blind Period (Week 25 to Week 52)||0||
59568853|NCT02293902|75672011|FG001|NOT COMPLETED|Single-Blind Period (Week 25 to Week 52)||8||
59568854|NCT02293902|75672012|FG002|NOT COMPLETED|Single-Blind Period (Week 25 to Week 52)||2||
59568855|NCT02293902|75672013|FG003|NOT COMPLETED|Single-Blind Period (Week 25 to Week 52)||1||
59568856|NCT02293902|75672014|FG004|NOT COMPLETED|Single-Blind Period (Week 25 to Week 52)||6||
59568857|NCT02278614|75672034|FG000|STARTED|Overall Study||127||
59568858|NCT02278614|75672035|FG001|STARTED|Overall Study||115||
59568859|NCT02278614|75672034|FG000|COMPLETED|Overall Study||122||
59568860|NCT02278614|75672035|FG001|COMPLETED|Overall Study||110||
59568861|NCT02278614|75672034|FG000|NOT COMPLETED|Overall Study||5||
59568862|NCT02278614|75672035|FG001|NOT COMPLETED|Overall Study||5||
59568863|NCT02318706|75672045|FG000|STARTED|Double-blind Phase||334||
59568864|NCT02318706|75672046|FG001|STARTED|Double-blind Phase||166||
59568865|NCT02318706|75672047|FG002|STARTED|Double-blind Phase||168||
59568866|NCT02318706|75672048|FG003|STARTED|Double-blind Phase||166||
59568867|NCT02318706|75672049|FG004|STARTED|Double-blind Phase||0||
59568868|NCT02318706|75672045|FG000|COMPLETED|Double-blind Phase||309||
59568869|NCT02318706|75672046|FG001|COMPLETED|Double-blind Phase||154||
59568870|NCT02318706|75672047|FG002|COMPLETED|Double-blind Phase||150||
59568871|NCT02318706|75672048|FG003|COMPLETED|Double-blind Phase||142||
59568872|NCT02318706|75672049|FG004|COMPLETED|Double-blind Phase||0||
59568873|NCT02318706|75672045|FG000|NOT COMPLETED|Double-blind Phase||25||
59568874|NCT02318706|75672046|FG001|NOT COMPLETED|Double-blind Phase||12||
59568875|NCT02318706|75672047|FG002|NOT COMPLETED|Double-blind Phase||18||
59568876|NCT02318706|75672048|FG003|NOT COMPLETED|Double-blind Phase||24||
59568877|NCT02318706|75672049|FG004|NOT COMPLETED|Double-blind Phase||0||
59568878|NCT02318706|75672045|FG000|STARTED|Open-label Extension Phase||0||
59568879|NCT02318706|75672046|FG001|STARTED|Open-label Extension Phase||0||
59568880|NCT02318706|75672047|FG002|STARTED|Open-label Extension Phase||0||
59568881|NCT02318706|75672048|FG003|STARTED|Open-label Extension Phase||0||
59568882|NCT02318706|75672049|FG004|STARTED|Open-label Extension Phase|A portion of participants who completed the double-blind phase enrolled in the open-label extension.|214||
59568883|NCT02318706|75672045|FG000|COMPLETED|Open-label Extension Phase||0||
59568884|NCT02318706|75672046|FG001|COMPLETED|Open-label Extension Phase||0||
59568885|NCT02318706|75672047|FG002|COMPLETED|Open-label Extension Phase||0||
59568886|NCT02318706|75672048|FG003|COMPLETED|Open-label Extension Phase||0||
59568887|NCT02318706|75672049|FG004|COMPLETED|Open-label Extension Phase||172||
59568888|NCT02318706|75672045|FG000|NOT COMPLETED|Open-label Extension Phase||0||
59568889|NCT02318706|75672046|FG001|NOT COMPLETED|Open-label Extension Phase||0||
59568890|NCT02318706|75672047|FG002|NOT COMPLETED|Open-label Extension Phase||0||
59568891|NCT02318706|75672048|FG003|NOT COMPLETED|Open-label Extension Phase||0||
59568892|NCT02318706|75672049|FG004|NOT COMPLETED|Open-label Extension Phase||42||
59568893|NCT04435769|75672063|FG000|STARTED|Overall Study||42||
59568894|NCT04435769|75672064|FG001|STARTED|Overall Study||67||
59568895|NCT04435769|75672063|FG000|Full Analysis Set (FAS)|Overall Study||42||
59568896|NCT04435769|75672064|FG001|Full Analysis Set (FAS)|Overall Study||67||
59568897|NCT04435769|75672063|FG000|Per Protocol (PP) Population|Overall Study||40||
59568898|NCT04435769|75672064|FG001|Per Protocol (PP) Population|Overall Study||63||
59568899|NCT04435769|75672063|FG000|COMPLETED|Overall Study||42||
59568900|NCT04435769|75672064|FG001|COMPLETED|Overall Study||67||
59568901|NCT04435769|75672063|FG000|NOT COMPLETED|Overall Study||0||
59568902|NCT04435769|75672064|FG001|NOT COMPLETED|Overall Study||0||
59568903|NCT02191111|75672072|FG000|STARTED|Overall Study|Number of participants assigned NA because the unit of analysis was pharmacies not patients.|||5
59568904|NCT02191111|75672073|FG001|STARTED|Overall Study|Number of participants assigned NA because the unit of analysis was pharmacies not patients.|||5
59568905|NCT02191111|75672072|FG000|COMPLETED|Overall Study|Number of participants assigned NA because the unit of analysis was pharmacies not patients.|||5
59568906|NCT02191111|75672073|FG001|COMPLETED|Overall Study|Number of participants assigned NA because the unit of analysis was pharmacies not patients.|||5
59568907|NCT02191111|75672072|FG000|NOT COMPLETED|Overall Study||||0
59568908|NCT02191111|75672073|FG001|NOT COMPLETED|Overall Study||||0
59568909|NCT02223871|75672079|FG000|STARTED|Overall Study||8||
59568910|NCT02223871|75672079|FG000|COMPLETED|Overall Study||8||
59568911|NCT02223871|75672079|FG000|NOT COMPLETED|Overall Study||0||
59568912|NCT04947514|75672083|FG000|STARTED|Overall Study||98||196
59568913|NCT04947514|75672083|FG000|COMPLETED|Overall Study||98||196
59568914|NCT04947514|75672083|FG000|NOT COMPLETED|Overall Study||0||0
59568915|NCT04674761|75672091|FG000|STARTED|Overall Study||35||
59568916|NCT04674761|75672092|FG001|STARTED|Overall Study||17||
59568917|NCT04674761|75672091|FG000|COMPLETED|Overall Study||35||
59568918|NCT04674761|75672092|FG001|COMPLETED|Overall Study||17||
59568919|NCT04674761|75672091|FG000|NOT COMPLETED|Overall Study||0||
59568920|NCT04674761|75672092|FG001|NOT COMPLETED|Overall Study||0||
59568921|NCT04583280|75672100|FG000|STARTED|Overall Study||8||
59568922|NCT04583280|75672101|FG001|STARTED|Overall Study||20||
59568923|NCT04583280|75672100|FG000|COMPLETED|Overall Study||8||
59568924|NCT04583280|75672101|FG001|COMPLETED|Overall Study||19||
59568925|NCT04583280|75672100|FG000|NOT COMPLETED|Overall Study||0||
59568926|NCT04583280|75672101|FG001|NOT COMPLETED|Overall Study||1||
59568927|NCT04557930|75672108|FG000|STARTED|Pre-intervention||39|Physician participants who agreed to enroll in the trial|8
59568928|NCT04557930|75672109|FG001|STARTED|Pre-intervention||30|Physician participants who agreed to enroll in the trial|7
59568929|NCT04557930|75672110|FG002|STARTED|Pre-intervention||25|Physician participants who agreed to enroll in the trial|6
59568930|NCT04557930|75672111|FG003|STARTED|Pre-intervention||41|Physician participants who agreed to enroll in the trial|7
59568931|NCT04557930|75672112|FG004|STARTED|Pre-intervention||28|Physician participants who agreed to enroll in the trial|7
59568932|NCT04557930|75672108|FG000|Patient Participants Treated by Enrolled Physician Participants|Pre-intervention||3203||8
59568933|NCT04557930|75672109|FG001|Patient Participants Treated by Enrolled Physician Participants|Pre-intervention||2677||7
59568934|NCT04557930|75672110|FG002|Patient Participants Treated by Enrolled Physician Participants|Pre-intervention||3303||6
59568935|NCT04557930|75672111|FG003|Patient Participants Treated by Enrolled Physician Participants|Pre-intervention||4976||7
59568936|NCT04557930|75672112|FG004|Patient Participants Treated by Enrolled Physician Participants|Pre-intervention||6615||7
59568937|NCT04557930|75672108|FG000|COMPLETED|Pre-intervention||39|Physician participants who completed study tasks|8
59568938|NCT04557930|75672109|FG001|COMPLETED|Pre-intervention||30|Physician participants who completed study tasks|7
59568939|NCT04557930|75672110|FG002|COMPLETED|Pre-intervention||25|Physician participants who completed study tasks|6
59568940|NCT04557930|75672111|FG003|COMPLETED|Pre-intervention||41|Physician participants who completed study tasks|7
59568941|NCT04557930|75672112|FG004|COMPLETED|Pre-intervention||28|Physician participants who completed study tasks|7
59568942|NCT04557930|75672108|FG000|NOT COMPLETED|Pre-intervention||0||0
59568943|NCT04557930|75672109|FG001|NOT COMPLETED|Pre-intervention||0||0
59568944|NCT04557930|75672110|FG002|NOT COMPLETED|Pre-intervention||0||0
60121082|NCT02653144|76241928|FG001|COMPLETED|Overall Study||28||
60121083|NCT02653144|76241929|FG002|COMPLETED|Overall Study||31||
60121084|NCT02653144|76241927|FG000|NOT COMPLETED|Overall Study||0||
60121085|NCT02653144|76241928|FG001|NOT COMPLETED|Overall Study||0||
60121086|NCT02653144|76241929|FG002|NOT COMPLETED|Overall Study||0||
60121087|NCT00118365|76241939|FG000|STARTED|Overall Study||191||
60121088|NCT00118365|76241940|FG001|STARTED|Overall Study||184||
60121089|NCT00118365|76241939|FG000|COMPLETED|Overall Study||132||
60121090|NCT00118365|76241940|FG001|COMPLETED|Overall Study||124||
60121091|NCT00118365|76241939|FG000|NOT COMPLETED|Overall Study||59||
60121092|NCT00118365|76241940|FG001|NOT COMPLETED|Overall Study||60||
60121093|NCT02695524|76241978|FG000|STARTED|Overall Study||30||
60121094|NCT02695524|76241979|FG001|STARTED|Overall Study||30||
60121095|NCT02695524|76241978|FG000|COMPLETED|Overall Study||27||
60121096|NCT02695524|76241979|FG001|COMPLETED|Overall Study||27||
60121097|NCT02695524|76241978|FG000|NOT COMPLETED|Overall Study||3||
60121098|NCT02695524|76241979|FG001|NOT COMPLETED|Overall Study||3||
60121099|NCT01576367|76241985|FG000|STARTED|Overall Study||17||
60121100|NCT01576367|76241985|FG000|COMPLETED|Overall Study||14||
60121101|NCT01576367|76241985|FG000|NOT COMPLETED|Overall Study||3||
60121102|NCT02653456|76241989|FG000|STARTED|Overall Study||64||
60121103|NCT02653456|76241989|FG000|COMPLETED|Overall Study||59||
60121104|NCT02653456|76241989|FG000|NOT COMPLETED|Overall Study||5||
60121105|NCT01689857|76241996|FG000|STARTED|Overall Study||20||
60121106|NCT01689857|76241997|FG001|STARTED|Overall Study||20||
60121107|NCT01689857|76241996|FG000|COMPLETED|Overall Study||15||
60121108|NCT01689857|76241997|FG001|COMPLETED|Overall Study||18||
60121109|NCT01689857|76241996|FG000|NOT COMPLETED|Overall Study||5||
60121110|NCT01689857|76241997|FG001|NOT COMPLETED|Overall Study||2||
60121111|NCT02653768|76242005|FG000|STARTED|3-Month Follow-Up||230||
60121112|NCT02653768|76242006|FG001|STARTED|3-Month Follow-Up||115||
60121113|NCT02653768|76242005|FG000|COMPLETED|3-Month Follow-Up||164||
60121114|NCT02653768|76242006|FG001|COMPLETED|3-Month Follow-Up||100||
60121115|NCT02653768|76242005|FG000|NOT COMPLETED|3-Month Follow-Up||66||
60121116|NCT02653768|76242006|FG001|NOT COMPLETED|3-Month Follow-Up||15||
60121117|NCT02653768|76242005|FG000|STARTED|6-Month Follow-Up|21 participants withdrew/excluded by 3-months, others missed that assessment but remained in study|209||
60121118|NCT02653768|76242006|FG001|STARTED|6-Month Follow-Up|2 participants withdrew/excluded by 3-months, others missed that assessment but remained in study|113||
60121119|NCT02653768|76242005|FG000|COMPLETED|6-Month Follow-Up||164||
60121120|NCT02653768|76242006|FG001|COMPLETED|6-Month Follow-Up||100||
60121121|NCT02653768|76242005|FG000|NOT COMPLETED|6-Month Follow-Up||45||
60121122|NCT02653768|76242006|FG001|NOT COMPLETED|6-Month Follow-Up||13||
60121123|NCT02653768|76242005|FG000|STARTED|9-Month Follow-Up (Primary)|34 withdrew/excluded before 9 months; others missed prior assessments but remained in study|196||
59568945|NCT04557930|75672111|FG003|NOT COMPLETED|Pre-intervention||0||0
59568946|NCT04557930|75672112|FG004|NOT COMPLETED|Pre-intervention||0||0
59568947|NCT04557930|75672108|FG000|STARTED|Post-intervention||39||8
59568948|NCT04557930|75672109|FG001|STARTED|Post-intervention||30||7
59568949|NCT04557930|75672110|FG002|STARTED|Post-intervention||25||6
59568950|NCT04557930|75672111|FG003|STARTED|Post-intervention||41||7
59568951|NCT04557930|75672112|FG004|STARTED|Post-intervention||28||7
59568952|NCT04557930|75672108|FG000|Patient Participants Treated by Enrolled Physicians|Post-intervention||8076||8
59568953|NCT04557930|75672109|FG001|Patient Participants Treated by Enrolled Physicians|Post-intervention||4691||7
59568954|NCT04557930|75672110|FG002|Patient Participants Treated by Enrolled Physicians|Post-intervention||3706||6
59568955|NCT04557930|75672111|FG003|Patient Participants Treated by Enrolled Physicians|Post-intervention||3949||7
59568956|NCT04557930|75672112|FG004|Patient Participants Treated by Enrolled Physicians|Post-intervention||3030||7
59568957|NCT04557930|75672108|FG000|COMPLETED|Post-intervention||39|We used an intention to treat analysis, so all physician participants enrolled in the trial were deemed to have 'completed' the intervention. There was loss to follow up in only 1 step (Step 2). Two physicians here did not complete all study tasks.|8
59568958|NCT04557930|75672109|FG001|COMPLETED|Post-intervention||30|We used an intention to treat analysis, so all physician participants enrolled in the trial were deemed to have 'completed' the intervention. There was loss to follow up in only 1 step (Step 2). Two physicians here did not complete all study tasks.|7
59568959|NCT04557930|75672110|FG002|COMPLETED|Post-intervention||25|We used an intention to treat analysis, so all physician participants enrolled in the trial were deemed to have 'completed' the intervention. There was loss to follow up in only 1 step (Step 2). Two physicians here did not complete all study tasks.|6
59568960|NCT04557930|75672111|FG003|COMPLETED|Post-intervention||41|We used an intention to treat analysis, so all physician participants enrolled in the trial were deemed to have 'completed' the intervention. There was loss to follow up in only 1 step (Step 2). Two physicians here did not complete all study tasks.|7
59568961|NCT04557930|75672112|FG004|COMPLETED|Post-intervention||28|We used an intention to treat analysis, so all physician participants enrolled in the trial were deemed to have 'completed' the intervention. There was loss to follow up in only 1 step (Step 2). Two physicians here did not complete all study tasks.|7
59568962|NCT04557930|75672108|FG000|NOT COMPLETED|Post-intervention||0||0
59568963|NCT04557930|75672109|FG001|NOT COMPLETED|Post-intervention||0||0
59568964|NCT04557930|75672110|FG002|NOT COMPLETED|Post-intervention||0||0
59568965|NCT04557930|75672111|FG003|NOT COMPLETED|Post-intervention||0||0
59568966|NCT04557930|75672112|FG004|NOT COMPLETED|Post-intervention||0||0
59568967|NCT04489940|75672120|FG000|STARTED|Overall Study||11||
59568968|NCT04489940|75672120|FG000|COMPLETED|Overall Study||1||
59568969|NCT04489940|75672120|FG000|NOT COMPLETED|Overall Study||10||
59568970|NCT04365257|75672126|FG000|STARTED|Overall Study||3||
59568971|NCT04365257|75672127|FG001|STARTED|Overall Study||2||
59568972|NCT04365257|75672126|FG000|COMPLETED|Overall Study||1||
59568973|NCT04365257|75672127|FG001|COMPLETED|Overall Study||1||
59568974|NCT04365257|75672126|FG000|NOT COMPLETED|Overall Study||2||
59568975|NCT04365257|75672127|FG001|NOT COMPLETED|Overall Study||1||
59568976|NCT03844789|75672135|FG000|STARTED|Main Study||78||
59568977|NCT03844789|75672136|FG001|STARTED|Main Study||23||
59568978|NCT03844789|75672135|FG000|16 Week Main Study|Main Study||78||
59568979|NCT03844789|75672136|FG001|16 Week Main Study|Main Study||22||
59568980|NCT03844789|75672135|FG000|COMPLETED|Main Study||78||
59568981|NCT03844789|75672136|FG001|COMPLETED|Main Study||22||
59568982|NCT03844789|75672135|FG000|NOT COMPLETED|Main Study||0||
59568983|NCT03844789|75672136|FG001|NOT COMPLETED|Main Study||1||
59568984|NCT03844789|75672135|FG000|STARTED|Extension Study||78||
59568985|NCT03844789|75672136|FG001|STARTED|Extension Study||22||
59568986|NCT03844789|75672135|FG000|COMPLETED|Extension Study||78||
59568987|NCT03844789|75672136|FG001|COMPLETED|Extension Study||22||
59568988|NCT03844789|75672135|FG000|NOT COMPLETED|Extension Study||0||
59568989|NCT03844789|75672136|FG001|NOT COMPLETED|Extension Study||0||
59568990|NCT03395223|75672159|FG000|STARTED|Overall Study||7||
59568991|NCT03395223|75672159|FG000|Treatment Completed|Overall Study||7||
59568992|NCT03395223|75672159|FG000|COMPLETED|Overall Study||3||
59568993|NCT03395223|75672159|FG000|NOT COMPLETED|Overall Study||4||
59568994|NCT03289650|75672165|FG000|STARTED|Overall Study||14||
59568995|NCT03289650|75672166|FG001|STARTED|Overall Study||15||
59568996|NCT03289650|75672165|FG000|COMPLETED|Overall Study||14||
59568997|NCT03289650|75672166|FG001|COMPLETED|Overall Study||15||
59568998|NCT03289650|75672165|FG000|NOT COMPLETED|Overall Study||0||
59568999|NCT03289650|75672166|FG001|NOT COMPLETED|Overall Study||0||
59569000|NCT02978183|75672180|FG000|STARTED|Overall Study||34||
59569001|NCT02978183|75672181|FG001|STARTED|Overall Study||36||
59569002|NCT02978183|75672180|FG000|COMPLETED|Overall Study||34||
59569003|NCT02978183|75672181|FG001|COMPLETED|Overall Study||36||
59569004|NCT02978183|75672180|FG000|NOT COMPLETED|Overall Study||0||
59569005|NCT02978183|75672181|FG001|NOT COMPLETED|Overall Study||0||
59569006|NCT02864940|75672189|FG000|STARTED|Overall Study||20||
59850236|NCT00103857|75974562|FG005|COMPLETED|50-Week Extension Study||78||
59850237|NCT00103857|75974563|FG006|COMPLETED|50-Week Extension Study||0||
59569007|NCT02864940|75672190|FG001|STARTED|Overall Study||18||
59569008|NCT02864940|75672189|FG000|COMPLETED|Overall Study||7||
59569009|NCT02864940|75672190|FG001|COMPLETED|Overall Study||7||
59569010|NCT02864940|75672189|FG000|NOT COMPLETED|Overall Study||13||
59569011|NCT02864940|75672190|FG001|NOT COMPLETED|Overall Study||11||
59569012|NCT02821832|75672199|FG000|STARTED|Overall Study||251||
59569013|NCT02821832|75672200|FG001|STARTED|Overall Study||154||
59569014|NCT02821832|75672201|FG002|STARTED|Overall Study||141||
59569015|NCT02821832|75672199|FG000|COMPLETED|Overall Study||186||
59569016|NCT02821832|75672200|FG001|COMPLETED|Overall Study||106||
59569017|NCT02821832|75672201|FG002|COMPLETED|Overall Study||109||
59569018|NCT02821832|75672199|FG000|NOT COMPLETED|Overall Study||65||
59569019|NCT02821832|75672200|FG001|NOT COMPLETED|Overall Study||48||
59569020|NCT02821832|75672201|FG002|NOT COMPLETED|Overall Study||32||
59569021|NCT02756611|75672209|FG000|STARTED|Overall Study||258||
59569022|NCT02756611|75672209|FG000|COMPLETED|Overall Study||124|Completed survival follow up period or beyond 108 weeks of treatment|
59569023|NCT02756611|75672209|FG000|NOT COMPLETED|Overall Study||134||
59569024|NCT02624518|75672213|FG000|STARTED|Overall Study||122||
59569025|NCT02624518|75672213|FG000|COMPLETED|Overall Study||121||
59569026|NCT02624518|75672213|FG000|NOT COMPLETED|Overall Study||1||
59569027|NCT02287623|75672219|FG000|STARTED|Overall Study||30||
59569028|NCT02287623|75672220|FG001|STARTED|Overall Study||30||
59569029|NCT02287623|75672219|FG000|COMPLETED|Overall Study||30||
59569030|NCT02287623|75672220|FG001|COMPLETED|Overall Study||29||
59569031|NCT02287623|75672219|FG000|NOT COMPLETED|Overall Study||0||
59569032|NCT02287623|75672220|FG001|NOT COMPLETED|Overall Study||1||
59569033|NCT02195310|75672228|FG000|STARTED|Overall Study||173||
59569034|NCT02195310|75672229|FG001|STARTED|Overall Study||169||
59569035|NCT02195310|75672228|FG000|COMPLETED|Overall Study||153||
59569036|NCT02195310|75672229|FG001|COMPLETED|Overall Study||153||
59569037|NCT02195310|75672228|FG000|NOT COMPLETED|Overall Study||20||
59569038|NCT02195310|75672229|FG001|NOT COMPLETED|Overall Study||16||
59569039|NCT01794520|75672242|FG000|STARTED|Overall Study||6||
59569040|NCT01794520|75672243|FG001|STARTED|Overall Study||9||
59569041|NCT01794520|75672244|FG002|STARTED|Overall Study||6||
59569042|NCT01794520|75672245|FG003|STARTED|Overall Study||9||
59569043|NCT01794520|75672246|FG004|STARTED|Overall Study||36||
59569044|NCT01794520|75672247|FG005|STARTED|Overall Study||20||
59569045|NCT01794520|75672248|FG006|STARTED|Overall Study||31||
59569046|NCT01794520|75672242|FG000|COMPLETED|Overall Study||0||
59569047|NCT01794520|75672243|FG001|COMPLETED|Overall Study||0||
59569048|NCT01794520|75672244|FG002|COMPLETED|Overall Study||0||
59569049|NCT01794520|75672245|FG003|COMPLETED|Overall Study||0||
59569050|NCT01794520|75672246|FG004|COMPLETED|Overall Study||0||
59569051|NCT01794520|75672247|FG005|COMPLETED|Overall Study||0||
59569052|NCT01794520|75672248|FG006|COMPLETED|Overall Study||0||
59569053|NCT01794520|75672242|FG000|NOT COMPLETED|Overall Study||6||
59569054|NCT01794520|75672243|FG001|NOT COMPLETED|Overall Study||9||
59569055|NCT01794520|75672244|FG002|NOT COMPLETED|Overall Study||6||
59569056|NCT01794520|75672245|FG003|NOT COMPLETED|Overall Study||9||
59569057|NCT01794520|75672246|FG004|NOT COMPLETED|Overall Study||36||
59569058|NCT01794520|75672247|FG005|NOT COMPLETED|Overall Study||20||
59569059|NCT01794520|75672248|FG006|NOT COMPLETED|Overall Study||31||
59569060|NCT01774019|75672271|FG000|STARTED|Overall Study||144||
59569061|NCT01774019|75672272|FG001|STARTED|Overall Study||140||
59569062|NCT01774019|75672271|FG000|COMPLETED|Overall Study||138||
59569063|NCT01774019|75672272|FG001|COMPLETED|Overall Study||136||
59569064|NCT01774019|75672271|FG000|NOT COMPLETED|Overall Study||6||
59569065|NCT01774019|75672272|FG001|NOT COMPLETED|Overall Study||4||
59569066|NCT01370811|75672282|FG000|STARTED|First Intervention||6||
59569067|NCT01370811|75672283|FG001|STARTED|First Intervention||6||
59569068|NCT01370811|75672284|FG002|STARTED|First Intervention||6||
59569069|NCT01370811|75672285|FG003|STARTED|First Intervention||6||
59569070|NCT01370811|75672282|FG000|COMPLETED|First Intervention||6||
59569071|NCT01370811|75672283|FG001|COMPLETED|First Intervention||6||
59569072|NCT01370811|75672284|FG002|COMPLETED|First Intervention||6||
59569073|NCT01370811|75672285|FG003|COMPLETED|First Intervention||6||
59569074|NCT01370811|75672282|FG000|NOT COMPLETED|First Intervention||0||
59569075|NCT01370811|75672283|FG001|NOT COMPLETED|First Intervention||0||
59569076|NCT01370811|75672284|FG002|NOT COMPLETED|First Intervention||0||
59569077|NCT01370811|75672285|FG003|NOT COMPLETED|First Intervention||0||
59569078|NCT01370811|75672282|FG000|STARTED|Washout Period of >=5 Days||6||
59569079|NCT01370811|75672283|FG001|STARTED|Washout Period of >=5 Days||6||
59569080|NCT01370811|75672284|FG002|STARTED|Washout Period of >=5 Days||6||
59569081|NCT01370811|75672285|FG003|STARTED|Washout Period of >=5 Days||6||
59569082|NCT01370811|75672282|FG000|COMPLETED|Washout Period of >=5 Days||6||
59569083|NCT01370811|75672283|FG001|COMPLETED|Washout Period of >=5 Days||6||
59569084|NCT01370811|75672284|FG002|COMPLETED|Washout Period of >=5 Days||6||
59569085|NCT01370811|75672285|FG003|COMPLETED|Washout Period of >=5 Days||6||
59569086|NCT01370811|75672282|FG000|NOT COMPLETED|Washout Period of >=5 Days||0||
59569087|NCT01370811|75672283|FG001|NOT COMPLETED|Washout Period of >=5 Days||0||
59569088|NCT01370811|75672284|FG002|NOT COMPLETED|Washout Period of >=5 Days||0||
59569089|NCT01370811|75672285|FG003|NOT COMPLETED|Washout Period of >=5 Days||0||
59569090|NCT01370811|75672282|FG000|STARTED|Second Intervention||6||
59569091|NCT01370811|75672283|FG001|STARTED|Second Intervention||6||
59569092|NCT01370811|75672284|FG002|STARTED|Second Intervention||6||
59569093|NCT01370811|75672285|FG003|STARTED|Second Intervention||6||
59569094|NCT01370811|75672282|FG000|COMPLETED|Second Intervention||6||
59569095|NCT01370811|75672283|FG001|COMPLETED|Second Intervention||6||
59569096|NCT01370811|75672284|FG002|COMPLETED|Second Intervention||6||
59569097|NCT01370811|75672285|FG003|COMPLETED|Second Intervention||6||
59569098|NCT01370811|75672282|FG000|NOT COMPLETED|Second Intervention||0||
59569099|NCT01370811|75672283|FG001|NOT COMPLETED|Second Intervention||0||
59569100|NCT01370811|75672284|FG002|NOT COMPLETED|Second Intervention||0||
59569101|NCT01370811|75672285|FG003|NOT COMPLETED|Second Intervention||0||
59569102|NCT01370811|75672282|FG000|STARTED|Washout Period of >=5 Days||6||
59569103|NCT01370811|75672283|FG001|STARTED|Washout Period of >=5 Days||6||
59569104|NCT01370811|75672284|FG002|STARTED|Washout Period of >=5 Days||6||
59569105|NCT01370811|75672285|FG003|STARTED|Washout Period of >=5 Days||6||
59569106|NCT01370811|75672282|FG000|COMPLETED|Washout Period of >=5 Days||6||
59569107|NCT01370811|75672283|FG001|COMPLETED|Washout Period of >=5 Days||6||
59569108|NCT01370811|75672284|FG002|COMPLETED|Washout Period of >=5 Days||6||
59569109|NCT01370811|75672285|FG003|COMPLETED|Washout Period of >=5 Days||6||
59569110|NCT01370811|75672282|FG000|NOT COMPLETED|Washout Period of >=5 Days||0||
59569111|NCT01370811|75672283|FG001|NOT COMPLETED|Washout Period of >=5 Days||0||
59569112|NCT01370811|75672284|FG002|NOT COMPLETED|Washout Period of >=5 Days||0||
59569113|NCT01370811|75672285|FG003|NOT COMPLETED|Washout Period of >=5 Days||0||
59569114|NCT01370811|75672282|FG000|STARTED|Third Intervention||6||
59569115|NCT01370811|75672283|FG001|STARTED|Third Intervention||6||
59569116|NCT01370811|75672284|FG002|STARTED|Third Intervention||6||
59569117|NCT01370811|75672285|FG003|STARTED|Third Intervention||6||
59569118|NCT01370811|75672282|FG000|COMPLETED|Third Intervention||6||
59569119|NCT01370811|75672283|FG001|COMPLETED|Third Intervention||5||
59569120|NCT01370811|75672284|FG002|COMPLETED|Third Intervention||6||
59569121|NCT01370811|75672285|FG003|COMPLETED|Third Intervention||6||
59569122|NCT01370811|75672282|FG000|NOT COMPLETED|Third Intervention||0||
59569123|NCT01370811|75672283|FG001|NOT COMPLETED|Third Intervention||1||
59569124|NCT01370811|75672284|FG002|NOT COMPLETED|Third Intervention||0||
59569125|NCT01370811|75672285|FG003|NOT COMPLETED|Third Intervention||0||
59569126|NCT01370811|75672282|FG000|STARTED|Washout Period of >=5 Days||6||
59569127|NCT01370811|75672283|FG001|STARTED|Washout Period of >=5 Days||5||
59721129|NCT01106352|75840063|FG001|Started Dose Escalation|Overall Study|Number of subjects for safety analysis set.|3||
59721130|NCT01106352|75840064|FG002|Started Dose Escalation|Overall Study|Number of subjects for safety analysis set.|7||
60121124|NCT02653768|76242006|FG001|STARTED|9-Month Follow-Up (Primary)|4 withdrew/excluded before 9 months; others missed prior assessments but remained in study|111||
60121125|NCT02653768|76242005|FG000|COMPLETED|9-Month Follow-Up (Primary)|13 withdrew/refused before 9 months; others missed prior assessments but remained in study|163||
60121126|NCT02653768|76242006|FG001|COMPLETED|9-Month Follow-Up (Primary)||95||
60121127|NCT02653768|76242005|FG000|NOT COMPLETED|9-Month Follow-Up (Primary)||33||
60121128|NCT02653768|76242006|FG001|NOT COMPLETED|9-Month Follow-Up (Primary)||16||
60121129|NCT01587079|76242012|FG000|STARTED|Overall Study||159||
60121130|NCT01587079|76242012|FG000|COMPLETED|Overall Study||120||
60121131|NCT01587079|76242012|FG000|NOT COMPLETED|Overall Study||39||
60121132|NCT02654860|76242050|FG000|STARTED|First Part||3||
60121133|NCT02654860|76242051|FG001|STARTED|First Part||3||
60121134|NCT02654860|76242052|FG002|STARTED|First Part||3||
60121135|NCT02654860|76242053|FG003|STARTED|First Part||0||
60121136|NCT02654860|76242050|FG000|COMPLETED|First Part||3||
60121137|NCT02654860|76242051|FG001|COMPLETED|First Part||3||
60121138|NCT02654860|76242052|FG002|COMPLETED|First Part||3||
60121139|NCT02654860|76242053|FG003|COMPLETED|First Part||0||
59569128|NCT01370811|75672284|FG002|STARTED|Washout Period of >=5 Days||6||
59569129|NCT01370811|75672285|FG003|STARTED|Washout Period of >=5 Days||6||
59569130|NCT01370811|75672282|FG000|COMPLETED|Washout Period of >=5 Days||6||
59569131|NCT01370811|75672283|FG001|COMPLETED|Washout Period of >=5 Days||5||
59569132|NCT01370811|75672284|FG002|COMPLETED|Washout Period of >=5 Days||6||
59569133|NCT01370811|75672285|FG003|COMPLETED|Washout Period of >=5 Days||6||
59569134|NCT01370811|75672282|FG000|NOT COMPLETED|Washout Period of >=5 Days||0||
59569135|NCT01370811|75672283|FG001|NOT COMPLETED|Washout Period of >=5 Days||0||
59569136|NCT01370811|75672284|FG002|NOT COMPLETED|Washout Period of >=5 Days||0||
59569137|NCT01370811|75672285|FG003|NOT COMPLETED|Washout Period of >=5 Days||0||
59569138|NCT01370811|75672282|FG000|STARTED|Fourth Intervention||6||
59569139|NCT01370811|75672283|FG001|STARTED|Fourth Intervention||5||
59569140|NCT01370811|75672284|FG002|STARTED|Fourth Intervention||6||
59569141|NCT01370811|75672285|FG003|STARTED|Fourth Intervention||6||
59569142|NCT01370811|75672282|FG000|COMPLETED|Fourth Intervention||6||
59569143|NCT01370811|75672283|FG001|COMPLETED|Fourth Intervention||5||
59569144|NCT01370811|75672284|FG002|COMPLETED|Fourth Intervention||6||
59569145|NCT01370811|75672285|FG003|COMPLETED|Fourth Intervention||6||
59721131|NCT01106352|75840065|FG003|Started Dose Escalation|Overall Study||0||
60121140|NCT02654860|76242050|FG000|NOT COMPLETED|First Part||0||
59569146|NCT01370811|75672282|FG000|NOT COMPLETED|Fourth Intervention||0||
59569147|NCT01370811|75672283|FG001|NOT COMPLETED|Fourth Intervention||0||
59569148|NCT01370811|75672284|FG002|NOT COMPLETED|Fourth Intervention||0||
59569149|NCT01370811|75672285|FG003|NOT COMPLETED|Fourth Intervention||0||
59569150|NCT00606138|75672302|FG000|STARTED|Overall Study||6||
59569151|NCT00606138|75672303|FG001|STARTED|Overall Study||2||
59569152|NCT00606138|75672302|FG000|COMPLETED|Overall Study||4||
59569153|NCT00606138|75672303|FG001|COMPLETED|Overall Study||2||
59569154|NCT00606138|75672302|FG000|NOT COMPLETED|Overall Study||2||
59569155|NCT00606138|75672303|FG001|NOT COMPLETED|Overall Study||0||
59569156|NCT01623739|75672313|FG000|STARTED|Overall Study||19||
59569157|NCT01623739|75672314|FG001|STARTED|Overall Study||19||
59569158|NCT01623739|75672313|FG000|COMPLETED|Overall Study||17||
59569159|NCT01623739|75672314|FG001|COMPLETED|Overall Study||15||
59569160|NCT01623739|75672313|FG000|NOT COMPLETED|Overall Study||2||
59569161|NCT01623739|75672314|FG001|NOT COMPLETED|Overall Study||4||
59569162|NCT01624363|75672321|FG000|STARTED|Overall Study||341||
59569163|NCT01624363|75672321|FG000|COMPLETED|Overall Study||341||
59569164|NCT01624363|75672321|FG000|NOT COMPLETED|Overall Study||0||
59569165|NCT01625221|75672325|FG000|STARTED|Overall Study||35||
59569166|NCT01625221|75672325|FG000|COMPLETED|Overall Study||28||
59569167|NCT01625221|75672325|FG000|NOT COMPLETED|Overall Study||7||
59569168|NCT01625455|75672331|FG000|STARTED|Overall Study||2||
59569169|NCT01625455|75672332|FG001|STARTED|Overall Study||3||
59569170|NCT01625455|75672331|FG000|COMPLETED|Overall Study||2||
59569171|NCT01625455|75672332|FG001|COMPLETED|Overall Study||3||
59569172|NCT01625455|75672331|FG000|NOT COMPLETED|Overall Study||0||
59569173|NCT01625455|75672332|FG001|NOT COMPLETED|Overall Study||0||
59569174|NCT01625923|75672338|FG000|STARTED|Overall Study||3||
59569175|NCT01625923|75672338|FG000|COMPLETED|Overall Study||3||
59569176|NCT01625923|75672338|FG000|NOT COMPLETED|Overall Study||0||
59569177|NCT02230579|75672350|FG000|STARTED|Overall Study||6||
59569178|NCT02230579|75672351|FG001|STARTED|Overall Study||6||
59569179|NCT02230579|75672352|FG002|STARTED|Overall Study||6||
59569180|NCT02230579|75672353|FG003|STARTED|Overall Study||6||
59569181|NCT02230579|75672354|FG004|STARTED|Overall Study||6||
59569182|NCT02230579|75672355|FG005|STARTED|Overall Study||6||
59569183|NCT02230579|75672356|FG006|STARTED|Overall Study||12||
59569184|NCT02230579|75672350|FG000|COMPLETED|Overall Study||6||
59569185|NCT02230579|75672351|FG001|COMPLETED|Overall Study||6||
59569186|NCT02230579|75672352|FG002|COMPLETED|Overall Study||6||
59569187|NCT02230579|75672353|FG003|COMPLETED|Overall Study||6||
59569188|NCT02230579|75672354|FG004|COMPLETED|Overall Study||6||
59569189|NCT02230579|75672355|FG005|COMPLETED|Overall Study||6||
59569190|NCT02230579|75672356|FG006|COMPLETED|Overall Study||12||
59569191|NCT02230579|75672350|FG000|NOT COMPLETED|Overall Study||0||
59569192|NCT02230579|75672351|FG001|NOT COMPLETED|Overall Study||0||
59569193|NCT02230579|75672352|FG002|NOT COMPLETED|Overall Study||0||
59569194|NCT02230579|75672353|FG003|NOT COMPLETED|Overall Study||0||
59569195|NCT02230579|75672354|FG004|NOT COMPLETED|Overall Study||0||
59569196|NCT02230579|75672355|FG005|NOT COMPLETED|Overall Study||0||
59569197|NCT02230579|75672356|FG006|NOT COMPLETED|Overall Study||0||
59569198|NCT01631071|75672374|FG000|STARTED|Overall Study||55||
59569199|NCT01631071|75672375|FG001|STARTED|Overall Study||55||
59569200|NCT01631071|75672374|FG000|COMPLETED|Overall Study||55||
59569201|NCT01631071|75672375|FG001|COMPLETED|Overall Study||55||
59569202|NCT01631071|75672374|FG000|NOT COMPLETED|Overall Study||0||
59569203|NCT01631071|75672375|FG001|NOT COMPLETED|Overall Study||0||
59569204|NCT01631149|75672383|FG000|STARTED|Overall Study||12||
59569205|NCT01631149|75672384|FG001|STARTED|Overall Study||12||
59569206|NCT01631149|75672383|FG000|COMPLETED|Overall Study||12||
59569207|NCT01631149|75672384|FG001|COMPLETED|Overall Study||12||
59569208|NCT01631149|75672383|FG000|NOT COMPLETED|Overall Study||0||
59569209|NCT01631149|75672384|FG001|NOT COMPLETED|Overall Study||0||
59569210|NCT01631929|75672392|FG000|STARTED|Overall Study||6||
59569211|NCT01631929|75672393|FG001|STARTED|Overall Study||6||
59569212|NCT01631929|75672392|FG000|COMPLETED|Overall Study||6||
59569213|NCT01631929|75672393|FG001|COMPLETED|Overall Study||6||
59569214|NCT01631929|75672392|FG000|NOT COMPLETED|Overall Study||0||
59569215|NCT01631929|75672393|FG001|NOT COMPLETED|Overall Study||0||
59569216|NCT01632709|75672403|FG000|STARTED|Overall Study||4||
59569217|NCT01632709|75672404|FG001|STARTED|Overall Study||3||
59569218|NCT01632709|75672405|FG002|STARTED|Overall Study||5||
59569219|NCT01632709|75672406|FG003|STARTED|Overall Study||4||
59569220|NCT01632709|75672403|FG000|Completed Visit 2 (Received Injection)|Overall Study||4||
59569221|NCT01632709|75672404|FG001|Completed Visit 2 (Received Injection)|Overall Study||2||
59569222|NCT01632709|75672405|FG002|Completed Visit 2 (Received Injection)|Overall Study||5||
59569223|NCT01632709|75672406|FG003|Completed Visit 2 (Received Injection)|Overall Study||3||
59569224|NCT01632709|75672403|FG000|COMPLETED|Overall Study||2||
59569225|NCT01632709|75672404|FG001|COMPLETED|Overall Study||2||
59569226|NCT01632709|75672405|FG002|COMPLETED|Overall Study||5||
59569227|NCT01632709|75672406|FG003|COMPLETED|Overall Study||3||
59569228|NCT01632709|75672403|FG000|NOT COMPLETED|Overall Study||2||
59569229|NCT01632709|75672404|FG001|NOT COMPLETED|Overall Study||1||
59569230|NCT01632709|75672405|FG002|NOT COMPLETED|Overall Study||0||
59569231|NCT01632709|75672406|FG003|NOT COMPLETED|Overall Study||1||
59569232|NCT01634191|75672418|FG000|STARTED|Overall Study||18||
59569233|NCT01634191|75672419|FG001|STARTED|Overall Study||18||
59569234|NCT01634191|75672418|FG000|COMPLETED|Overall Study||18||
59569235|NCT01634191|75672419|FG001|COMPLETED|Overall Study||18||
59569236|NCT01634191|75672418|FG000|NOT COMPLETED|Overall Study||0||
59569237|NCT01634191|75672419|FG001|NOT COMPLETED|Overall Study||0||
59569238|NCT01634269|75672436|FG000|STARTED|Overall Study||20||
59569239|NCT01634269|75672436|FG000|30 Days|Overall Study||20||
59569240|NCT01634269|75672436|FG000|6 Month|Overall Study||20||
59569241|NCT01634269|75672436|FG000|12 Month|Overall Study||20||
59569242|NCT01634269|75672436|FG000|24 Month|Overall Study||18||
59569243|NCT01634269|75672436|FG000|COMPLETED|Overall Study||18||
59569244|NCT01634269|75672436|FG000|NOT COMPLETED|Overall Study||2||
59569245|NCT01635439|75672448|FG000|STARTED|Overall Study||100||
59569246|NCT01635439|75672449|FG001|STARTED|Overall Study||100||
59569247|NCT01635439|75672448|FG000|COMPLETED|Overall Study||100||
59569248|NCT01635439|75672449|FG001|COMPLETED|Overall Study||100||
59569249|NCT01635439|75672448|FG000|NOT COMPLETED|Overall Study||0||
59569250|NCT01635439|75672449|FG001|NOT COMPLETED|Overall Study||0||
59569251|NCT01636063|75672457|FG000|STARTED|Overall Study||21||
59569252|NCT01636063|75672458|FG001|STARTED|Overall Study||21||
59569253|NCT01636063|75672457|FG000|COMPLETED|Overall Study||21||
59569254|NCT01636063|75672458|FG001|COMPLETED|Overall Study||21||
59569255|NCT01636063|75672457|FG000|NOT COMPLETED|Overall Study||0||
59569256|NCT01636063|75672458|FG001|NOT COMPLETED|Overall Study||0||
59569257|NCT01636297|75672467|FG000|STARTED|Overall Study||40||
59569258|NCT01636297|75672468|FG001|STARTED|Overall Study||40||
59569259|NCT01636297|75672469|FG002|STARTED|Overall Study||20||
59569260|NCT01636297|75672467|FG000|COMPLETED|Overall Study||36||
59569261|NCT01636297|75672468|FG001|COMPLETED|Overall Study||36||
59569262|NCT01636297|75672469|FG002|COMPLETED|Overall Study||19||
59569263|NCT01636297|75672467|FG000|NOT COMPLETED|Overall Study||4||
59569264|NCT01636297|75672468|FG001|NOT COMPLETED|Overall Study||4||
59569265|NCT01636297|75672469|FG002|NOT COMPLETED|Overall Study||1||
59569266|NCT01636453|75672479|FG000|STARTED|Overall Study||120||
59569267|NCT01636453|75672479|FG000|COMPLETED|Overall Study||112||
59569268|NCT01636453|75672479|FG000|NOT COMPLETED|Overall Study||8||
59569269|NCT02227693|75672487|FG000|STARTED|Overall Study||11||
59569270|NCT02227693|75672488|FG001|STARTED|Overall Study||7||
59569271|NCT02227693|75672489|FG002|STARTED|Overall Study||11||
59569272|NCT02227693|75672490|FG003|STARTED|Overall Study||10||
59569273|NCT02227693|75672487|FG000|COMPLETED|Overall Study||11||
59569274|NCT02227693|75672488|FG001|COMPLETED|Overall Study||7||
59569275|NCT02227693|75672489|FG002|COMPLETED|Overall Study||11||
59569276|NCT02227693|75672490|FG003|COMPLETED|Overall Study||10||
59569277|NCT02227693|75672487|FG000|NOT COMPLETED|Overall Study||0||
59569278|NCT02227693|75672488|FG001|NOT COMPLETED|Overall Study||0||
59569279|NCT02227693|75672489|FG002|NOT COMPLETED|Overall Study||0||
59569280|NCT02227693|75672490|FG003|NOT COMPLETED|Overall Study||0||
59569281|NCT01636765|75672504|FG000|STARTED|Overall Study||104||
59569282|NCT01636765|75672504|FG000|COMPLETED|Overall Study||104||
59569283|NCT01636765|75672504|FG000|NOT COMPLETED|Overall Study||0||
59569284|NCT01637935|75672510|FG000|STARTED|Overall Study||34181||
59569285|NCT01637935|75672511|FG001|STARTED|Overall Study||158918||
59569286|NCT01637935|75672510|FG000|COMPLETED|Overall Study||34181||
59569287|NCT01637935|75672511|FG001|COMPLETED|Overall Study||158918||
59569288|NCT01637935|75672510|FG000|NOT COMPLETED|Overall Study||0||
59569289|NCT01637935|75672511|FG001|NOT COMPLETED|Overall Study||0||
59569290|NCT01640197|75672519|FG000|STARTED|Overall Study||30||
59569291|NCT01640197|75672520|FG001|STARTED|Overall Study||30||
59569292|NCT01640197|75672519|FG000|COMPLETED|Overall Study||30||
59569293|NCT01640197|75672520|FG001|COMPLETED|Overall Study||30||
59569294|NCT01640197|75672519|FG000|NOT COMPLETED|Overall Study||0||
59569295|NCT01640197|75672520|FG001|NOT COMPLETED|Overall Study||0||
59569296|NCT01641445|75672528|FG000|STARTED|Overall Study||41||
59569297|NCT01641445|75672529|FG001|STARTED|Overall Study||41||
59569298|NCT01641445|75672528|FG000|COMPLETED|Overall Study||31||
59721132|NCT01106352|75840066|FG004|Started Dose Escalation|Overall Study||0||
59569299|NCT01641445|75672529|FG001|COMPLETED|Overall Study||36||
59569300|NCT01641445|75672528|FG000|NOT COMPLETED|Overall Study||10||
59569301|NCT01641445|75672529|FG001|NOT COMPLETED|Overall Study||5||
59721133|NCT01106352|75840062|FG000|Completed Dose Escalation|Overall Study||6||
59569302|NCT01641835|75672535|FG000|STARTED|Overall Study||303||
59569303|NCT01641835|75672535|FG000|COMPLETED|Overall Study||303||
59569304|NCT01641835|75672535|FG000|NOT COMPLETED|Overall Study||0||
59569305|NCT01642147|75672541|FG000|STARTED|Overall Study||30||
59569306|NCT01642147|75672542|FG001|STARTED|Overall Study||30||
59569307|NCT01642147|75672541|FG000|COMPLETED|Overall Study||30||
59569308|NCT01642147|75672542|FG001|COMPLETED|Overall Study||30||
59569309|NCT01642147|75672541|FG000|NOT COMPLETED|Overall Study||0||
59569310|NCT01642147|75672542|FG001|NOT COMPLETED|Overall Study||0||
59569311|NCT01643707|75672550|FG000|STARTED|Overall Study||858||
59569312|NCT01643707|75672551|FG001|STARTED|Overall Study||484||
59569313|NCT01643707|75672550|FG000|COMPLETED|Overall Study||823||
59569314|NCT01643707|75672551|FG001|COMPLETED|Overall Study||470||
59569315|NCT01643707|75672550|FG000|NOT COMPLETED|Overall Study||35||
59569316|NCT01643707|75672551|FG001|NOT COMPLETED|Overall Study||14||
59569317|NCT01644331|75672562|FG000|STARTED|Overall Study||129||
59569318|NCT01644331|75672563|FG001|STARTED|Overall Study||128||
59569319|NCT01644331|75672562|FG000|COMPLETED|Overall Study||118||
59569320|NCT01644331|75672563|FG001|COMPLETED|Overall Study||118||
59569321|NCT01644331|75672562|FG000|NOT COMPLETED|Overall Study||11||
59569322|NCT01644331|75672563|FG001|NOT COMPLETED|Overall Study||10||
59569323|NCT01646671|75672572|FG000|STARTED|Overall Study||3||
59569324|NCT01646671|75672573|FG001|STARTED|Overall Study||11||
59569325|NCT01646671|75672574|FG002|STARTED|Overall Study||21||
59569326|NCT01646671|75672572|FG000|COMPLETED|Overall Study||3||
59569327|NCT01646671|75672573|FG001|COMPLETED|Overall Study||11||
59569328|NCT01646671|75672574|FG002|COMPLETED|Overall Study||21||
59569329|NCT01646671|75672572|FG000|NOT COMPLETED|Overall Study||0||
59569330|NCT01646671|75672573|FG001|NOT COMPLETED|Overall Study||0||
59569331|NCT01646671|75672574|FG002|NOT COMPLETED|Overall Study||0||
59569332|NCT01647217|75672586|FG000|STARTED|Overall Study||8||
59569333|NCT01647217|75672587|FG001|STARTED|Overall Study||9||
59569334|NCT01647217|75672586|FG000|COMPLETED|Overall Study||7||
59569335|NCT01647217|75672587|FG001|COMPLETED|Overall Study||8||
59569336|NCT01647217|75672586|FG000|NOT COMPLETED|Overall Study||1||
59569337|NCT01647217|75672587|FG001|NOT COMPLETED|Overall Study||1||
59569338|NCT01651195|75672599|FG000|STARTED|Overall Study||284||
59569339|NCT01651195|75672600|FG001|STARTED|Overall Study||284||
59569340|NCT01651195|75672601|FG002|STARTED|Overall Study||204||
59569341|NCT01651195|75672602|FG003|STARTED|Overall Study||211||
59569342|NCT01651195|75672599|FG000|COMPLETED|Overall Study||63||
59569343|NCT01651195|75672600|FG001|COMPLETED|Overall Study||73||
59569344|NCT01651195|75672601|FG002|COMPLETED|Overall Study||121||
59569345|NCT01651195|75672602|FG003|COMPLETED|Overall Study||103||
59569346|NCT01651195|75672599|FG000|NOT COMPLETED|Overall Study||221||
59569347|NCT01651195|75672600|FG001|NOT COMPLETED|Overall Study||211||
59569348|NCT01651195|75672601|FG002|NOT COMPLETED|Overall Study||83||
59569349|NCT01651195|75672602|FG003|NOT COMPLETED|Overall Study||108||
59569350|NCT03251924|75672625|FG000|STARTED|Overall Study||6||
59569351|NCT03251924|75672626|FG001|STARTED|Overall Study||7||
59569352|NCT03251924|75672627|FG002|STARTED|Overall Study||7||
59569353|NCT03251924|75672628|FG003|STARTED|Overall Study||11||
59569354|NCT03251924|75672629|FG004|STARTED|Overall Study||9||
59569355|NCT03251924|75672630|FG005|STARTED|Overall Study||9||
59569356|NCT03251924|75672631|FG006|STARTED|Overall Study||10||
59850238|NCT00103857|75974557|FG000|NOT COMPLETED|50-Week Extension Study||38||
59569357|NCT03251924|75672632|FG007|STARTED|Overall Study||12||
59569358|NCT03251924|75672633|FG008|STARTED|Overall Study||9||
59569359|NCT03251924|75672625|FG000|COMPLETED|Overall Study||0||
59569360|NCT03251924|75672626|FG001|COMPLETED|Overall Study||0||
59569361|NCT03251924|75672627|FG002|COMPLETED|Overall Study||0||
59569362|NCT03251924|75672628|FG003|COMPLETED|Overall Study||0||
59569363|NCT03251924|75672629|FG004|COMPLETED|Overall Study||0||
59569364|NCT03251924|75672630|FG005|COMPLETED|Overall Study||0||
59569365|NCT03251924|75672631|FG006|COMPLETED|Overall Study||3||
59569366|NCT03251924|75672632|FG007|COMPLETED|Overall Study||1||
59569367|NCT03251924|75672633|FG008|COMPLETED|Overall Study||1||
59569368|NCT03251924|75672625|FG000|NOT COMPLETED|Overall Study||6||
59569369|NCT03251924|75672626|FG001|NOT COMPLETED|Overall Study||7||
59569370|NCT03251924|75672627|FG002|NOT COMPLETED|Overall Study||7||
59569371|NCT03251924|75672628|FG003|NOT COMPLETED|Overall Study||11||
59569372|NCT03251924|75672629|FG004|NOT COMPLETED|Overall Study||9||
59569373|NCT03251924|75672630|FG005|NOT COMPLETED|Overall Study||9||
59569374|NCT03251924|75672631|FG006|NOT COMPLETED|Overall Study||7||
59569375|NCT03251924|75672632|FG007|NOT COMPLETED|Overall Study||11||
59569376|NCT03251924|75672633|FG008|NOT COMPLETED|Overall Study||8||
59569377|NCT01651351|75672656|FG000|STARTED|Overall Study||15||
59569378|NCT01651351|75672657|FG001|STARTED|Overall Study||15||
59569379|NCT01651351|75672656|FG000|COMPLETED|Overall Study||15||
59569380|NCT01651351|75672657|FG001|COMPLETED|Overall Study||15||
59569381|NCT01651351|75672656|FG000|NOT COMPLETED|Overall Study||0||
59569382|NCT01651351|75672657|FG001|NOT COMPLETED|Overall Study||0||
59850239|NCT00103857|75974558|FG001|NOT COMPLETED|50-Week Extension Study||27||
59850240|NCT00103857|75974559|FG002|NOT COMPLETED|50-Week Extension Study||26||
59850241|NCT00103857|75974560|FG003|NOT COMPLETED|50-Week Extension Study||36||
59569383|NCT03762317|75672666|FG000|STARTED|Overall Study||5||
59569384|NCT03762317|75672667|FG001|STARTED|Overall Study||5||
59569385|NCT03762317|75672666|FG000|COMPLETED|Overall Study||5||
59569386|NCT03762317|75672667|FG001|COMPLETED|Overall Study||5||
59569387|NCT03762317|75672666|FG000|NOT COMPLETED|Overall Study||0||
59569388|NCT03762317|75672667|FG001|NOT COMPLETED|Overall Study||0||
59569389|NCT01910792|75672675|FG000|STARTED|Overall Study||9||
59569390|NCT01910792|75672676|FG001|STARTED|Overall Study||10||
59569391|NCT01910792|75672675|FG000|COMPLETED|Overall Study||9||
59569392|NCT01910792|75672676|FG001|COMPLETED|Overall Study||10||
59569393|NCT01910792|75672675|FG000|NOT COMPLETED|Overall Study||0||
59569394|NCT01910792|75672676|FG001|NOT COMPLETED|Overall Study||0||
59569395|NCT01932242|75672684|FG000|STARTED|Overall Study||35||
59569396|NCT01932242|75672685|FG001|STARTED|Overall Study||35||
59569397|NCT01932242|75672684|FG000|COMPLETED|Overall Study||30||
59569398|NCT01932242|75672685|FG001|COMPLETED|Overall Study||30||
59569399|NCT01932242|75672684|FG000|NOT COMPLETED|Overall Study||5||
59569400|NCT01932242|75672685|FG001|NOT COMPLETED|Overall Study||5||
59569401|NCT02219581|75672691|FG000|STARTED|Overall Study||0||
59569402|NCT02219581|75672692|FG001|STARTED|Overall Study||0||
59569403|NCT02219581|75672693|FG002|STARTED|Overall Study||1||
59569404|NCT02219581|75672691|FG000|COMPLETED|Overall Study||0||
59569405|NCT02219581|75672692|FG001|COMPLETED|Overall Study||0||
59569406|NCT02219581|75672693|FG002|COMPLETED|Overall Study||1||
59569407|NCT02219581|75672691|FG000|NOT COMPLETED|Overall Study||0||
59569408|NCT02219581|75672692|FG001|NOT COMPLETED|Overall Study||0||
59569409|NCT02219581|75672693|FG002|NOT COMPLETED|Overall Study||0||
59569410|NCT01912274|75672697|FG000|STARTED|Overall Study||50||
59569411|NCT01912274|75672697|FG000|COMPLETED|Overall Study||50||
59569412|NCT01912274|75672697|FG000|NOT COMPLETED|Overall Study||0||
59569413|NCT01654861|75672701|FG000|STARTED|Overall Study||3||
59569414|NCT01654861|75672701|FG000|COMPLETED|Overall Study||3||
59569415|NCT01654861|75672701|FG000|NOT COMPLETED|Overall Study||0||
59569416|NCT01655329|75672705|FG000|STARTED|Overall Study|The same 10 radiologists are interpreting images in both arms.|10||
59569417|NCT01655329|75672705|FG000|COMPLETED|Overall Study||10||
59569418|NCT01655329|75672705|FG000|NOT COMPLETED|Overall Study||0||
59569419|NCT03723707|75672721|FG000|STARTED|Overall Study||191||
59569420|NCT03723707|75672722|FG001|STARTED|Overall Study||164||
59569421|NCT03723707|75672721|FG000|COMPLETED|Overall Study||68||
59569422|NCT03723707|75672722|FG001|COMPLETED|Overall Study||78||
59569423|NCT03723707|75672721|FG000|NOT COMPLETED|Overall Study||123||
59569424|NCT03723707|75672722|FG001|NOT COMPLETED|Overall Study||86||
59569425|NCT03721367|75672728|FG000|STARTED|Overall Study||28||
59569426|NCT03721367|75672728|FG000|COMPLETED|Overall Study||28||
59569427|NCT03721367|75672728|FG000|NOT COMPLETED|Overall Study||0||
59569428|NCT01912352|75672732|FG000|STARTED|Overall Study||83||
59569429|NCT01912352|75672732|FG000|COMPLETED|Overall Study||78||
59569430|NCT01912352|75672732|FG000|NOT COMPLETED|Overall Study||5||
59569431|NCT01655563|75672738|FG000|STARTED|Overall Study||18||
59569432|NCT01655563|75672739|FG001|STARTED|Overall Study||35||
59569433|NCT01655563|75672738|FG000|COMPLETED|Overall Study||18||
59569434|NCT01655563|75672739|FG001|COMPLETED|Overall Study||35||
59569435|NCT01655563|75672738|FG000|NOT COMPLETED|Overall Study||0||
59569436|NCT01655563|75672739|FG001|NOT COMPLETED|Overall Study||0||
59569437|NCT01655719|75672745|FG000|STARTED|Overall Study||1||
59569438|NCT01655719|75672745|FG000|COMPLETED|Overall Study||1||
59569439|NCT01655719|75672745|FG000|NOT COMPLETED|Overall Study||0||
59569440|NCT01913600|75672749|FG000|STARTED|Overall Study||56||
59569441|NCT01913600|75672749|FG000|COMPLETED|Overall Study||55||
59569442|NCT01913600|75672749|FG000|NOT COMPLETED|Overall Study||1||
59569443|NCT01936844|75672755|FG000|STARTED|Overall Study||15||
59569444|NCT01936844|75672756|FG001|STARTED|Overall Study||15||
59569445|NCT01936844|75672755|FG000|COMPLETED|Overall Study||9||
59569446|NCT01936844|75672756|FG001|COMPLETED|Overall Study||8||
59569447|NCT01936844|75672755|FG000|NOT COMPLETED|Overall Study||6||
59569448|NCT01936844|75672756|FG001|NOT COMPLETED|Overall Study||7||
59569449|NCT01917188|75672765|FG000|STARTED|Overall Study||29||
59569450|NCT01917188|75672766|FG001|STARTED|Overall Study||23||
59721134|NCT01106352|75840063|FG001|Completed Dose Escalation|Overall Study||3||
59721135|NCT01106352|75840064|FG002|Completed Dose Escalation|Overall Study||5||
59569451|NCT01917188|75672767|FG002|STARTED|Overall Study||20||
59569452|NCT01917188|75672765|FG000|COMPLETED|Overall Study||17||
59569453|NCT01917188|75672766|FG001|COMPLETED|Overall Study||17||
59569454|NCT01917188|75672767|FG002|COMPLETED|Overall Study||11||
59569455|NCT01917188|75672765|FG000|NOT COMPLETED|Overall Study||12||
59569456|NCT01917188|75672766|FG001|NOT COMPLETED|Overall Study||6||
59569457|NCT01917188|75672767|FG002|NOT COMPLETED|Overall Study||9||
59569458|NCT01937624|75672775|FG000|STARTED|Overall Study||51||
59569459|NCT01937624|75672775|FG000|COMPLETED|Overall Study||51||
59569460|NCT01937624|75672775|FG000|NOT COMPLETED|Overall Study||0||
59569461|NCT01938170|75672779|FG000|STARTED|Overall Study||41||
59569462|NCT01938170|75672779|FG000|COMPLETED|Overall Study||41||
59569463|NCT01938170|75672779|FG000|NOT COMPLETED|Overall Study||0||
59569464|NCT01656031|75672783|FG000|STARTED|Overall Study||39||
59569465|NCT01656031|75672783|FG000|COMPLETED|Overall Study||39||
59569466|NCT01656031|75672783|FG000|NOT COMPLETED|Overall Study||0||
59569467|NCT01917812|75672790|FG000|STARTED|Overall Study||16||
59569468|NCT01917812|75672791|FG001|STARTED|Overall Study||16||
59569469|NCT01917812|75672792|FG002|STARTED|Overall Study||16||
59569470|NCT01917812|75672790|FG000|COMPLETED|Overall Study||15||
59569471|NCT01917812|75672791|FG001|COMPLETED|Overall Study||16||
59569472|NCT01917812|75672792|FG002|COMPLETED|Overall Study||16||
59569473|NCT01917812|75672790|FG000|NOT COMPLETED|Overall Study||1||
59569474|NCT01917812|75672791|FG001|NOT COMPLETED|Overall Study||0||
59569475|NCT01917812|75672792|FG002|NOT COMPLETED|Overall Study||0||
59569476|NCT01656187|75672802|FG000|STARTED|First Intervention (24 Weeks)||20||
59569477|NCT01656187|75672803|FG001|STARTED|First Intervention (24 Weeks)||26||
59569478|NCT01656187|75672802|FG000|COMPLETED|First Intervention (24 Weeks)||14||
59569479|NCT01656187|75672803|FG001|COMPLETED|First Intervention (24 Weeks)||23||
59569480|NCT01656187|75672802|FG000|NOT COMPLETED|First Intervention (24 Weeks)||6||
59569481|NCT01656187|75672803|FG001|NOT COMPLETED|First Intervention (24 Weeks)||3||
59569482|NCT01656187|75672802|FG000|STARTED|Washout (4 Weeks)||14||
59569483|NCT01656187|75672803|FG001|STARTED|Washout (4 Weeks)||23||
59569484|NCT01656187|75672802|FG000|COMPLETED|Washout (4 Weeks)||14||
59569485|NCT01656187|75672803|FG001|COMPLETED|Washout (4 Weeks)||22||
59569486|NCT01656187|75672802|FG000|NOT COMPLETED|Washout (4 Weeks)||0||
59569487|NCT01656187|75672803|FG001|NOT COMPLETED|Washout (4 Weeks)||1||
59569488|NCT01656187|75672802|FG000|STARTED|Second Intervention (24 Weeks)||14||
59569489|NCT01656187|75672803|FG001|STARTED|Second Intervention (24 Weeks)||22||
59569490|NCT01656187|75672802|FG000|COMPLETED|Second Intervention (24 Weeks)||13||
59569491|NCT01656187|75672803|FG001|COMPLETED|Second Intervention (24 Weeks)||19||
59569492|NCT01656187|75672802|FG000|NOT COMPLETED|Second Intervention (24 Weeks)||1||
59569493|NCT01656187|75672803|FG001|NOT COMPLETED|Second Intervention (24 Weeks)||3||
59569494|NCT01658059|75672809|FG000|STARTED|First Intervention- 2 Days||12||
59569495|NCT01658059|75672810|FG001|STARTED|First Intervention- 2 Days||10||
59569496|NCT01658059|75672809|FG000|COMPLETED|First Intervention- 2 Days||6||
59569497|NCT01658059|75672810|FG001|COMPLETED|First Intervention- 2 Days||5||
59569498|NCT01658059|75672809|FG000|NOT COMPLETED|First Intervention- 2 Days||6||
59569499|NCT01658059|75672810|FG001|NOT COMPLETED|First Intervention- 2 Days||5||
59569500|NCT01658059|75672809|FG000|STARTED|Washout Period- 14 Days||6||
59569501|NCT01658059|75672810|FG001|STARTED|Washout Period- 14 Days||5||
59569502|NCT01658059|75672809|FG000|COMPLETED|Washout Period- 14 Days||6||
59569503|NCT01658059|75672810|FG001|COMPLETED|Washout Period- 14 Days||5||
59569504|NCT01658059|75672809|FG000|NOT COMPLETED|Washout Period- 14 Days||0||
59569505|NCT01658059|75672810|FG001|NOT COMPLETED|Washout Period- 14 Days||0||
59569506|NCT01658059|75672809|FG000|STARTED|Second Intervention- 2 Days||6||
59569507|NCT01658059|75672810|FG001|STARTED|Second Intervention- 2 Days||5||
59569508|NCT01658059|75672809|FG000|COMPLETED|Second Intervention- 2 Days||6||
59569509|NCT01658059|75672810|FG001|COMPLETED|Second Intervention- 2 Days||5||
59569510|NCT01658059|75672809|FG000|NOT COMPLETED|Second Intervention- 2 Days||0||
59569511|NCT01658059|75672810|FG001|NOT COMPLETED|Second Intervention- 2 Days||0||
59569512|NCT01658839|75672816|FG000|STARTED|Overall Study||25||
59569513|NCT01658839|75672816|FG000|COMPLETED|Overall Study||25||
59569514|NCT01658839|75672816|FG000|NOT COMPLETED|Overall Study||0||
59569515|NCT01658995|75672822|FG000|STARTED|Overall Study||42||
59569516|NCT01658995|75672823|FG001|STARTED|Overall Study||40||
59569517|NCT01658995|75672822|FG000|COMPLETED|Overall Study||42||
59569518|NCT01658995|75672823|FG001|COMPLETED|Overall Study||40||
59569519|NCT01658995|75672822|FG000|NOT COMPLETED|Overall Study||0||
59569520|NCT01658995|75672823|FG001|NOT COMPLETED|Overall Study||0||
59569521|NCT01350141|75672832|FG000|STARTED|Overall Study||15||
59569522|NCT01350141|75672833|FG001|STARTED|Overall Study||15||
59569523|NCT01350141|75672834|FG002|STARTED|Overall Study||16||
59569524|NCT01350141|75672832|FG000|Treated|Overall Study||14||
59569525|NCT01350141|75672833|FG001|Treated|Overall Study||15||
59569526|NCT01350141|75672834|FG002|Treated|Overall Study||16||
59569527|NCT01350141|75672832|FG000|COMPLETED|Overall Study||12||
59569528|NCT01350141|75672833|FG001|COMPLETED|Overall Study||15||
59569529|NCT01350141|75672834|FG002|COMPLETED|Overall Study||15||
59569530|NCT01350141|75672832|FG000|NOT COMPLETED|Overall Study||3||
59569531|NCT01350141|75672833|FG001|NOT COMPLETED|Overall Study||0||
59569532|NCT01350141|75672834|FG002|NOT COMPLETED|Overall Study||1||
59850242|NCT00103857|75974561|FG004|NOT COMPLETED|50-Week Extension Study||21||
59850243|NCT00103857|75974562|FG005|NOT COMPLETED|50-Week Extension Study||20||
59569533|NCT01660321|75672844|FG000|STARTED|Overall Study||26||
59569534|NCT01660321|75672844|FG000|COMPLETED|Overall Study||26||
59569535|NCT01660321|75672844|FG000|NOT COMPLETED|Overall Study||0||
59569536|NCT01597141|75672850|FG000|STARTED|Overall Study||50||
59569537|NCT01597141|75672851|FG001|STARTED|Overall Study||50||
59569538|NCT01597141|75672850|FG000|COMPLETED|Overall Study||50||
59569539|NCT01597141|75672851|FG001|COMPLETED|Overall Study||50||
59569540|NCT01597141|75672850|FG000|NOT COMPLETED|Overall Study||0||
59569541|NCT01597141|75672851|FG001|NOT COMPLETED|Overall Study||0||
59569542|NCT01597687|75672862|FG000|STARTED|Overall Study||76||
59569543|NCT01597687|75672863|FG001|STARTED|Overall Study||89||
59569544|NCT01597687|75672864|FG002|STARTED|Overall Study||147||
59569545|NCT01597687|75672862|FG000|COMPLETED|Overall Study||76||
59569546|NCT01597687|75672863|FG001|COMPLETED|Overall Study||89||
59569547|NCT01597687|75672864|FG002|COMPLETED|Overall Study||147||
59569548|NCT01597687|75672862|FG000|NOT COMPLETED|Overall Study||0||
59569549|NCT01597687|75672863|FG001|NOT COMPLETED|Overall Study||0||
59850244|NCT00103857|75974563|FG006|NOT COMPLETED|50-Week Extension Study||0||
59569550|NCT01597687|75672864|FG002|NOT COMPLETED|Overall Study||0||
59569551|NCT01597843|75672891|FG000|STARTED|Overall Study||79||
59569552|NCT01597843|75672892|FG001|STARTED|Overall Study||122||
59569553|NCT01597843|75672893|FG002|STARTED|Overall Study||81||
59569554|NCT01597843|75672891|FG000|Survey 1 Responses|Overall Study||45||
59569555|NCT01597843|75672892|FG001|Survey 1 Responses|Overall Study||71||
59569556|NCT01597843|75672893|FG002|Survey 1 Responses|Overall Study||59||
59569557|NCT01597843|75672891|FG000|Survey 2 Responses|Overall Study||52||
59569558|NCT01597843|75672892|FG001|Survey 2 Responses|Overall Study||42||
59569559|NCT01597843|75672893|FG002|Survey 2 Responses|Overall Study||58||
59850245|NCT03587584|75974580|FG000|STARTED|Overall Study||37||
59569560|NCT01597843|75672891|FG000|Survey 3 Responses|Overall Study||65||
59569561|NCT01597843|75672892|FG001|Survey 3 Responses|Overall Study||56||
59569562|NCT01597843|75672893|FG002|Survey 3 Responses|Overall Study||76||
59569563|NCT01597843|75672891|FG000|COMPLETED|Overall Study||79||
59569564|NCT01597843|75672892|FG001|COMPLETED|Overall Study||122||
59569565|NCT01597843|75672893|FG002|COMPLETED|Overall Study||81||
59569566|NCT01597843|75672891|FG000|NOT COMPLETED|Overall Study||0||
59569567|NCT01597843|75672892|FG001|NOT COMPLETED|Overall Study||0||
59569568|NCT01597843|75672893|FG002|NOT COMPLETED|Overall Study||0||
59569569|NCT01662115|75672904|FG000|STARTED|Overall Study||2||
59569570|NCT01662115|75672905|FG001|STARTED|Overall Study||2||
59569571|NCT01662115|75672906|FG002|STARTED|Overall Study||0||
59569572|NCT01662115|75672904|FG000|COMPLETED|Overall Study||2||
59569573|NCT01662115|75672905|FG001|COMPLETED|Overall Study||2||
59569574|NCT01662115|75672906|FG002|COMPLETED|Overall Study||0||
59569575|NCT01662115|75672904|FG000|NOT COMPLETED|Overall Study||0||
59569576|NCT01662115|75672905|FG001|NOT COMPLETED|Overall Study||0||
59569577|NCT01662115|75672906|FG002|NOT COMPLETED|Overall Study||0||
59569578|NCT01662583|75672917|FG000|STARTED|Overall Study||216||
59569579|NCT01662583|75672918|FG001|STARTED|Overall Study||225||
59569580|NCT01662583|75672919|FG002|STARTED|Overall Study||219||
59569581|NCT01662583|75672917|FG000|COMPLETED|Overall Study||216||
59569582|NCT01662583|75672918|FG001|COMPLETED|Overall Study||225||
59569583|NCT01662583|75672919|FG002|COMPLETED|Overall Study||219||
59569584|NCT01662583|75672917|FG000|NOT COMPLETED|Overall Study||0||
59569585|NCT01662583|75672918|FG001|NOT COMPLETED|Overall Study||0||
59569586|NCT01662583|75672919|FG002|NOT COMPLETED|Overall Study||0||
59569587|NCT01598545|75672927|FG000|STARTED|Overall Study||20||
59569588|NCT01598545|75672927|FG000|COMPLETED|Overall Study||20||
59569589|NCT01598545|75672927|FG000|NOT COMPLETED|Overall Study||0||
59569590|NCT01598701|75672933|FG000|STARTED|Overall Study||50||
59569591|NCT01598701|75672934|FG001|STARTED|Overall Study||50||
59569592|NCT01598701|75672933|FG000|COMPLETED|Overall Study||45||
59569593|NCT01598701|75672934|FG001|COMPLETED|Overall Study||41||
59569594|NCT01598701|75672933|FG000|NOT COMPLETED|Overall Study||5||
59569595|NCT01598701|75672934|FG001|NOT COMPLETED|Overall Study||9||
59569596|NCT01598779|75672940|FG000|STARTED|Overall Study||150||
59569597|NCT01598779|75672940|FG000|COMPLETED|Overall Study||150||
59569598|NCT01598779|75672940|FG000|NOT COMPLETED|Overall Study||0||
59569599|NCT01694563|75672944|FG000|STARTED|Overall Study||365||
59569600|NCT01694563|75672944|FG000|COMPLETED|Overall Study||278||
59569601|NCT01694563|75672944|FG000|NOT COMPLETED|Overall Study||87||
59569602|NCT01940276|75672953|FG000|STARTED|Overall Study||50||
59569603|NCT01940276|75672954|FG001|STARTED|Overall Study||50||
59569604|NCT01940276|75672953|FG000|COMPLETED|Overall Study||50||
59569605|NCT01940276|75672954|FG001|COMPLETED|Overall Study||50||
59569606|NCT01940276|75672953|FG000|NOT COMPLETED|Overall Study||0||
59569607|NCT01940276|75672954|FG001|NOT COMPLETED|Overall Study||0||
59569608|NCT01600495|75672962|FG000|STARTED|Overall Study|We start with the prediction of collecting 20 patients in the treated group|23||
59569609|NCT01600495|75672963|FG001|STARTED|Overall Study|We start with the prediction of collecting 20 control patients|23||
59569610|NCT01600495|75672962|FG000|COMPLETED|Overall Study|We finished the job with 23 patients for each group (treated and control)|23||
59569611|NCT01600495|75672963|FG001|COMPLETED|Overall Study|We finished the job with 23 patients for each group (treated and control)|23||
59569612|NCT01600495|75672962|FG000|NOT COMPLETED|Overall Study||0||
59569613|NCT01600495|75672963|FG001|NOT COMPLETED|Overall Study||0||
59569614|NCT01919216|75672973|FG000|STARTED|Overall Study||28||
59569615|NCT01919216|75672974|FG001|STARTED|Overall Study||21||
59569616|NCT01919216|75672975|FG002|STARTED|Overall Study||5||
59569617|NCT01919216|75672973|FG000|COMPLETED|Overall Study||26||
59569618|NCT01919216|75672974|FG001|COMPLETED|Overall Study||20||
59569619|NCT01919216|75672975|FG002|COMPLETED|Overall Study||4||
59569620|NCT01919216|75672973|FG000|NOT COMPLETED|Overall Study||2||
59569621|NCT01919216|75672974|FG001|NOT COMPLETED|Overall Study||1||
59569622|NCT01919216|75672975|FG002|NOT COMPLETED|Overall Study||1||
59850246|NCT03587584|75974581|FG001|STARTED|Overall Study||42||
59850247|NCT03587584|75974580|FG000|COMPLETED|Overall Study||33||
59569623|NCT01600729|75672983|FG000|STARTED|Overall Study||66||
59569624|NCT01600729|75672983|FG000|COMPLETED|Overall Study||65||
59569625|NCT01600729|75672983|FG000|NOT COMPLETED|Overall Study||1||
59569626|NCT01940510|75672987|FG000|STARTED|Overall Study||24||
59569627|NCT01940510|75672987|FG000|COMPLETED|Overall Study||24||
59569628|NCT01940510|75672987|FG000|NOT COMPLETED|Overall Study||0||
59569629|NCT01601431|75672996|FG000|STARTED|Overall Study||223||
59569630|NCT01601431|75672997|FG001|STARTED|Overall Study||217||
59569631|NCT01601431|75672996|FG000|COMPLETED|Overall Study||211||
59569632|NCT01601431|75672997|FG001|COMPLETED|Overall Study||214||
59569633|NCT01601431|75672996|FG000|NOT COMPLETED|Overall Study||12||
59569634|NCT01601431|75672997|FG001|NOT COMPLETED|Overall Study||3||
59850248|NCT03587584|75974581|FG001|COMPLETED|Overall Study||33||
59569635|NCT01601977|75673003|FG000|STARTED|Overall Study|5 patients consented for study participation but did not attend for study assessments.|10||
59569636|NCT01601977|75673003|FG000|COMPLETED|Overall Study||10||
59569637|NCT01601977|75673003|FG000|NOT COMPLETED|Overall Study||0||
59569638|NCT01919450|75673013|FG000|STARTED|Overall Study||20||
59569639|NCT01919450|75673014|FG001|STARTED|Overall Study||20||
59569640|NCT01919450|75673015|FG002|STARTED|Overall Study||20||
59569641|NCT01919450|75673016|FG003|STARTED|Overall Study||20||
59569642|NCT01919450|75673013|FG000|COMPLETED|Overall Study||20||
59569643|NCT01919450|75673014|FG001|COMPLETED|Overall Study||20||
59569644|NCT01919450|75673015|FG002|COMPLETED|Overall Study||20||
59569645|NCT01919450|75673016|FG003|COMPLETED|Overall Study||19||
59569646|NCT01919450|75673013|FG000|NOT COMPLETED|Overall Study||0||
59569647|NCT01919450|75673014|FG001|NOT COMPLETED|Overall Study||0||
59569648|NCT01919450|75673015|FG002|NOT COMPLETED|Overall Study||0||
59569649|NCT01919450|75673016|FG003|NOT COMPLETED|Overall Study||1||
59569650|NCT01602679|75673028|FG000|STARTED|Overall Study||4||
59569651|NCT01602679|75673029|FG001|STARTED|Overall Study||3||
59569652|NCT01602679|75673028|FG000|COMPLETED|Overall Study||4||
59569653|NCT01602679|75673029|FG001|COMPLETED|Overall Study||3||
59569654|NCT01602679|75673028|FG000|NOT COMPLETED|Overall Study||0||
59569655|NCT01602679|75673029|FG001|NOT COMPLETED|Overall Study||0||
59569656|NCT01919606|75673037|FG000|STARTED|Overall Study||1||
59569657|NCT01919606|75673038|FG001|STARTED|Overall Study||0||
59569658|NCT01919606|75673037|FG000|COMPLETED|Overall Study||1||
59569659|NCT01919606|75673038|FG001|COMPLETED|Overall Study||0||
59569660|NCT01919606|75673037|FG000|NOT COMPLETED|Overall Study||0||
59569661|NCT01919606|75673038|FG001|NOT COMPLETED|Overall Study||0||
59569662|NCT01663363|75673044|FG000|STARTED|Overall Study|334 Eyes were treated among 170 participants|170||
59569663|NCT01663363|75673044|FG000|COMPLETED|Overall Study|334 Eyes were treated among 170 participants|170||
59569664|NCT01663363|75673044|FG000|NOT COMPLETED|Overall Study||0||
59569665|NCT01919996|75673048|FG000|STARTED|Overall Study||8||
59569666|NCT01919996|75673048|FG000|COMPLETED|Overall Study||8||
59569667|NCT01919996|75673048|FG000|NOT COMPLETED|Overall Study||0||
59569668|NCT02234713|75673054|FG000|STARTED|Overall Study||31||
59569669|NCT02234713|75673055|FG001|STARTED|Overall Study||32||
59569670|NCT02234713|75673054|FG000|COMPLETED|Overall Study||25||
59569671|NCT02234713|75673055|FG001|COMPLETED|Overall Study||27||
59569672|NCT02234713|75673054|FG000|NOT COMPLETED|Overall Study||6||
59569673|NCT02234713|75673055|FG001|NOT COMPLETED|Overall Study||5||
59569674|NCT01921322|75673064|FG000|STARTED|Overall Study||57||
59569675|NCT01921322|75673065|FG001|STARTED|Overall Study||61||
59569676|NCT01921322|75673064|FG000|COMPLETED|Overall Study||42||
59569677|NCT01921322|75673065|FG001|COMPLETED|Overall Study||44||
59569678|NCT01921322|75673064|FG000|NOT COMPLETED|Overall Study||15||
59569679|NCT01921322|75673065|FG001|NOT COMPLETED|Overall Study||17||
59569680|NCT01665157|75673074|FG000|STARTED|Overall Study||60||
59569681|NCT01665157|75673075|FG001|STARTED|Overall Study||60||
59569682|NCT01665157|75673076|FG002|STARTED|Overall Study||60||
59569683|NCT01665157|75673074|FG000|COMPLETED|Overall Study||60||
59569684|NCT01665157|75673075|FG001|COMPLETED|Overall Study||60||
59569685|NCT01665157|75673076|FG002|COMPLETED|Overall Study||60||
59569686|NCT01665157|75673074|FG000|NOT COMPLETED|Overall Study||0||
59569687|NCT01665157|75673075|FG001|NOT COMPLETED|Overall Study||0||
59569688|NCT01665157|75673076|FG002|NOT COMPLETED|Overall Study||0||
59569689|NCT01943474|75673091|FG000|STARTED|Overall Study||123||
59569690|NCT01943474|75673092|FG001|STARTED|Overall Study||125||
59569691|NCT01943474|75673091|FG000|COMPLETED|Overall Study||123||
59569692|NCT01943474|75673092|FG001|COMPLETED|Overall Study||125||
59569693|NCT01943474|75673091|FG000|NOT COMPLETED|Overall Study||0||
59569694|NCT01943474|75673092|FG001|NOT COMPLETED|Overall Study||0||
59569695|NCT01667029|75673098|FG000|STARTED|Overall Study||4||
59569696|NCT01667029|75673099|FG001|STARTED|Overall Study||4||
59569697|NCT01667029|75673098|FG000|COMPLETED|Overall Study||3||
59569698|NCT01667029|75673099|FG001|COMPLETED|Overall Study||3||
59569699|NCT01667029|75673098|FG000|NOT COMPLETED|Overall Study||1||
59569700|NCT01667029|75673099|FG001|NOT COMPLETED|Overall Study||1||
59569701|NCT01694641|75673107|FG000|STARTED|Overall Study||80||
59569702|NCT01694641|75673108|FG001|STARTED|Overall Study||81||
59569703|NCT01694641|75673107|FG000|COMPLETED|Overall Study||68||
59569704|NCT01694641|75673108|FG001|COMPLETED|Overall Study||71||
59569705|NCT01694641|75673107|FG000|NOT COMPLETED|Overall Study||12||
59569706|NCT01694641|75673108|FG001|NOT COMPLETED|Overall Study||10||
59569707|NCT01669603|75673117|FG000|STARTED|Overall Study||95||
59569708|NCT01669603|75673118|FG001|STARTED|Overall Study||95||
59569709|NCT01669603|75673117|FG000|COMPLETED|Overall Study||58||
59569710|NCT01669603|75673118|FG001|COMPLETED|Overall Study||57||
59569711|NCT01669603|75673117|FG000|NOT COMPLETED|Overall Study||37||
59569712|NCT01669603|75673118|FG001|NOT COMPLETED|Overall Study||38||
59569713|NCT01606735|75673127|FG000|STARTED|Overall Study||58||
59569714|NCT01606735|75673128|FG001|STARTED|Overall Study||56||
59569715|NCT01606735|75673129|FG002|STARTED|Overall Study||58||
59569716|NCT01606735|75673127|FG000|COMPLETED|Overall Study||58||
59569717|NCT01606735|75673128|FG001|COMPLETED|Overall Study||56||
59569718|NCT01606735|75673129|FG002|COMPLETED|Overall Study||58||
59850249|NCT03587584|75974580|FG000|NOT COMPLETED|Overall Study||4||
59569719|NCT01606735|75673127|FG000|NOT COMPLETED|Overall Study||0||
59569720|NCT01606735|75673128|FG001|NOT COMPLETED|Overall Study||0||
59569721|NCT01606735|75673129|FG002|NOT COMPLETED|Overall Study||0||
59569722|NCT01943864|75673137|FG000|STARTED|Overall Study||20||
59569723|NCT01943864|75673137|FG000|COMPLETED|Overall Study|Death or 1 year from randomization after progression was considered completion; 20 participants died|20||
59569724|NCT01943864|75673137|FG000|NOT COMPLETED|Overall Study||0||
59569725|NCT01607203|75673143|FG000|STARTED|Overall Study||59||
59569726|NCT01607203|75673144|FG001|STARTED|Overall Study||61||
59569727|NCT01607203|75673143|FG000|COMPLETED|Overall Study||59||
59569728|NCT01607203|75673144|FG001|COMPLETED|Overall Study||61||
59569729|NCT01607203|75673143|FG000|NOT COMPLETED|Overall Study||0||
59569730|NCT01607203|75673144|FG001|NOT COMPLETED|Overall Study||0||
59569731|NCT01921634|75673151|FG000|STARTED|Overall Study||300||
59569732|NCT01921634|75673151|FG000|COMPLETED|Overall Study||300||
59569733|NCT01921634|75673151|FG000|NOT COMPLETED|Overall Study||0||
59569734|NCT01922024|75673158|FG000|STARTED|Overall Study||1653||
59569735|NCT01922024|75673159|FG001|STARTED|Overall Study||471||
59569736|NCT01922024|75673158|FG000|COMPLETED|Overall Study||1653||
59569737|NCT01922024|75673159|FG001|COMPLETED|Overall Study||471||
59569738|NCT01922024|75673158|FG000|NOT COMPLETED|Overall Study||0||
59569739|NCT01922024|75673159|FG001|NOT COMPLETED|Overall Study||0||
59569740|NCT01922336|75673168|FG000|STARTED|Overall Study||53||
59569741|NCT01922336|75673169|FG001|STARTED|Overall Study||53||
59569742|NCT01922336|75673170|FG002|STARTED|Overall Study||53||
59569743|NCT01922336|75673168|FG000|COMPLETED|Overall Study||53||
59569744|NCT01922336|75673169|FG001|COMPLETED|Overall Study||53||
59569745|NCT01922336|75673170|FG002|COMPLETED|Overall Study||53||
59569746|NCT01922336|75673168|FG000|NOT COMPLETED|Overall Study||0||
59569747|NCT01922336|75673169|FG001|NOT COMPLETED|Overall Study||0||
59569748|NCT01922336|75673170|FG002|NOT COMPLETED|Overall Study||0||
59569749|NCT01608061|75673180|FG000|STARTED|Blinded Period||21||
59569750|NCT01608061|75673181|FG001|STARTED|Blinded Period||21||
59569751|NCT01608061|75673180|FG000|COMPLETED|Blinded Period||21||
59569752|NCT01608061|75673181|FG001|COMPLETED|Blinded Period||21||
59569753|NCT01608061|75673180|FG000|NOT COMPLETED|Blinded Period||0||
59569754|NCT01608061|75673181|FG001|NOT COMPLETED|Blinded Period||0||
59569755|NCT01608061|75673180|FG000|STARTED|Long Term Follow-Up||21||
59569756|NCT01608061|75673181|FG001|STARTED|Long Term Follow-Up||21||
59569757|NCT01608061|75673180|FG000|COMPLETED|Long Term Follow-Up||14||
59569758|NCT01608061|75673181|FG001|COMPLETED|Long Term Follow-Up||16||
59569759|NCT01608061|75673180|FG000|NOT COMPLETED|Long Term Follow-Up||7||
59569760|NCT01608061|75673181|FG001|NOT COMPLETED|Long Term Follow-Up||5||
59569761|NCT01608061|75673180|FG000|STARTED|Extension Period||14||
59569762|NCT01608061|75673181|FG001|STARTED|Extension Period||16||
59569763|NCT01608061|75673180|FG000|COMPLETED|Extension Period||14||
59569764|NCT01608061|75673181|FG001|COMPLETED|Extension Period||14||
59569765|NCT01608061|75673180|FG000|NOT COMPLETED|Extension Period||0||
59569766|NCT01608061|75673181|FG001|NOT COMPLETED|Extension Period||2||
59569767|NCT01924442|75673190|FG000|STARTED|Overall Study||1099||
59569768|NCT01924442|75673191|FG001|STARTED|Overall Study||1104||
59569769|NCT01924442|75673190|FG000|COMPLETED|Overall Study||1059||
59569770|NCT01924442|75673191|FG001|COMPLETED|Overall Study||967||
59569771|NCT01924442|75673190|FG000|NOT COMPLETED|Overall Study||40||
59569772|NCT01924442|75673191|FG001|NOT COMPLETED|Overall Study||137||
59569773|NCT01696357|75673199|FG000|STARTED|Overall Study||42||
59569774|NCT01696357|75673200|FG001|STARTED|Overall Study||42||
59569775|NCT01696357|75673199|FG000|COMPLETED|Overall Study||40||
59569776|NCT01696357|75673200|FG001|COMPLETED|Overall Study||41||
59569777|NCT01696357|75673199|FG000|NOT COMPLETED|Overall Study||2||
59569778|NCT01696357|75673200|FG001|NOT COMPLETED|Overall Study||1||
59569779|NCT01944644|75673208|FG000|STARTED|Overall Study||34||
59569780|NCT01944644|75673209|FG001|STARTED|Overall Study||32||
59569781|NCT01944644|75673208|FG000|COMPLETED|Overall Study||34||
59569782|NCT01944644|75673209|FG001|COMPLETED|Overall Study||32||
59569783|NCT01944644|75673208|FG000|NOT COMPLETED|Overall Study||0||
59569784|NCT01944644|75673209|FG001|NOT COMPLETED|Overall Study||0||
59569785|NCT01608295|75673217|FG000|STARTED|Overall Study||26||
59569786|NCT01608295|75673218|FG001|STARTED|Overall Study||30||
59569787|NCT01608295|75673217|FG000|COMPLETED|Overall Study||20||
59569788|NCT01608295|75673218|FG001|COMPLETED|Overall Study||25||
59569789|NCT01608295|75673217|FG000|NOT COMPLETED|Overall Study||6||
59569790|NCT01608295|75673218|FG001|NOT COMPLETED|Overall Study||5||
59569791|NCT01944878|75673229|FG000|STARTED|Overall Study||127||
59721136|NCT01106352|75840065|FG003|Completed Dose Escalation|Overall Study||0||
59721137|NCT01106352|75840066|FG004|Completed Dose Escalation|Overall Study||0||
59569792|NCT01944878|75673230|FG001|STARTED|Overall Study||328||
59569793|NCT01944878|75673229|FG000|COMPLETED|Overall Study||127||
59569794|NCT01944878|75673230|FG001|COMPLETED|Overall Study||328||
59569795|NCT01944878|75673229|FG000|NOT COMPLETED|Overall Study||0||
59569796|NCT01944878|75673230|FG001|NOT COMPLETED|Overall Study||0||
59569797|NCT01610011|75673240|FG000|STARTED|Overall Study||19||
59569798|NCT01610011|75673241|FG001|STARTED|Overall Study||2||
59569799|NCT01610011|75673240|FG000|COMPLETED|Overall Study||9||
59569800|NCT01610011|75673241|FG001|COMPLETED|Overall Study||2||
59569801|NCT01610011|75673240|FG000|NOT COMPLETED|Overall Study||10||
59569802|NCT01610011|75673241|FG001|NOT COMPLETED|Overall Study||0||
59569803|NCT01945112|75673247|FG000|STARTED|Overall Study|total number of sites where tape was applied|77||153
59569804|NCT01945112|75673248|FG001|STARTED|Overall Study|total number of sites where tape was applied|51||87
59569805|NCT01945112|75673247|FG000|COMPLETED|Overall Study||77||153
59569806|NCT01945112|75673248|FG001|COMPLETED|Overall Study||51||87
59569807|NCT01945112|75673247|FG000|NOT COMPLETED|Overall Study||0||0
59569808|NCT01945112|75673248|FG001|NOT COMPLETED|Overall Study||0||0
59569809|NCT02237989|75673255|FG000|STARTED|Overall Study||19||
59569810|NCT02237989|75673256|FG001|STARTED|Overall Study||20||
59569811|NCT02237989|75673255|FG000|COMPLETED|Overall Study||19||
59569812|NCT02237989|75673256|FG001|COMPLETED|Overall Study||20||
59569813|NCT02237989|75673255|FG000|NOT COMPLETED|Overall Study||0||
59569814|NCT02237989|75673256|FG001|NOT COMPLETED|Overall Study||0||
59569815|NCT01945970|75673262|FG000|STARTED|Overall Study||5||
59569816|NCT01945970|75673263|FG001|STARTED|Overall Study||5||
59569817|NCT01945970|75673264|FG002|STARTED|Overall Study||5||
59569818|NCT01945970|75673265|FG003|STARTED|Overall Study||5||
59569819|NCT01945970|75673266|FG004|STARTED|Overall Study||5||
59569820|NCT01945970|75673267|FG005|STARTED|Overall Study||5||
59569821|NCT01945970|75673262|FG000|COMPLETED|Overall Study||5||
59569822|NCT01945970|75673263|FG001|COMPLETED|Overall Study||5||
59569823|NCT01945970|75673264|FG002|COMPLETED|Overall Study||5||
59569824|NCT01945970|75673265|FG003|COMPLETED|Overall Study||5||
59569825|NCT01945970|75673266|FG004|COMPLETED|Overall Study||5||
59569826|NCT01945970|75673267|FG005|COMPLETED|Overall Study||5||
59569827|NCT01945970|75673262|FG000|NOT COMPLETED|Overall Study||0||
59569828|NCT01945970|75673263|FG001|NOT COMPLETED|Overall Study||0||
59569829|NCT01945970|75673264|FG002|NOT COMPLETED|Overall Study||0||
59569830|NCT01945970|75673265|FG003|NOT COMPLETED|Overall Study||0||
59569831|NCT01945970|75673266|FG004|NOT COMPLETED|Overall Study||0||
59569832|NCT01945970|75673267|FG005|NOT COMPLETED|Overall Study||0||
59569833|NCT02229487|75673279|FG000|STARTED|Overall Study||24||
59569834|NCT02229487|75673280|FG001|STARTED|Overall Study||27||
59569835|NCT02229487|75673279|FG000|COMPLETED|Overall Study||24||
59569836|NCT02229487|75673280|FG001|COMPLETED|Overall Study||27||
59569837|NCT02229487|75673279|FG000|NOT COMPLETED|Overall Study||0||
59569838|NCT02229487|75673280|FG001|NOT COMPLETED|Overall Study||0||
59569839|NCT01946126|75673288|FG000|STARTED|Overall Study||184||
59569840|NCT01946126|75673289|FG001|STARTED|Overall Study||275||
59569841|NCT01946126|75673288|FG000|COMPLETED|Overall Study||184||
59569842|NCT01946126|75673289|FG001|COMPLETED|Overall Study||275||
59569843|NCT01946126|75673288|FG000|NOT COMPLETED|Overall Study||0||
59569844|NCT01946126|75673289|FG001|NOT COMPLETED|Overall Study||0||
59569845|NCT01673113|75673297|FG000|STARTED|Overall Study||11||11
59569846|NCT01673113|75673298|FG001|STARTED|Overall Study||11||11
59569847|NCT01673113|75673297|FG000|COMPLETED|Overall Study||11||11
59569848|NCT01673113|75673298|FG001|COMPLETED|Overall Study||11||11
59569849|NCT01673113|75673297|FG000|NOT COMPLETED|Overall Study||0||0
59569850|NCT01673113|75673298|FG001|NOT COMPLETED|Overall Study||0||0
59569851|NCT01924988|75673305|FG000|STARTED|Overall Study||15||
59569852|NCT01924988|75673305|FG000|COMPLETED|Overall Study||15||
59569853|NCT01924988|75673305|FG000|NOT COMPLETED|Overall Study||0||
59569854|NCT01673191|75673314|FG000|STARTED|Overall Study||26||
59569855|NCT01673191|75673315|FG001|STARTED|Overall Study||11||
59569856|NCT01673191|75673314|FG000|COMPLETED|Overall Study||26||
59569857|NCT01673191|75673315|FG001|COMPLETED|Overall Study||11||
59569858|NCT01673191|75673314|FG000|NOT COMPLETED|Overall Study||0||
59569859|NCT01673191|75673315|FG001|NOT COMPLETED|Overall Study||0||
59569860|NCT01925144|75673321|FG000|STARTED|Period 1 (Day 1 Through Predose Day 3)||30||
59569861|NCT01925144|75673321|FG000|Received Baricitinib|Period 1 (Day 1 Through Predose Day 3)||30||
59569862|NCT01925144|75673321|FG000|COMPLETED|Period 1 (Day 1 Through Predose Day 3)||30||
59569863|NCT01925144|75673321|FG000|NOT COMPLETED|Period 1 (Day 1 Through Predose Day 3)||0||
59569864|NCT01925144|75673321|FG000|STARTED|Period 2 (At Dosing Day 3 Through Day12)||30||
59569865|NCT01925144|75673321|FG000|Received Baricitinib|Period 2 (At Dosing Day 3 Through Day12)||30||
59569866|NCT01925144|75673321|FG000|Received 8 Doses of Omeprazole|Period 2 (At Dosing Day 3 Through Day12)||30||
59569867|NCT01925144|75673321|FG000|COMPLETED|Period 2 (At Dosing Day 3 Through Day12)||30||
59569868|NCT01925144|75673321|FG000|NOT COMPLETED|Period 2 (At Dosing Day 3 Through Day12)||0||
59569869|NCT01673893|75673330|FG000|STARTED|Overall Study||59||
59569870|NCT01673893|75673330|FG000|COMPLETED|Overall Study||59||
59569871|NCT01673893|75673330|FG000|NOT COMPLETED|Overall Study||0||
59569872|NCT01675063|75673336|FG000|STARTED|Overall Study||77||
59569873|NCT01675063|75673336|FG000|COMPLETED|Overall Study||77||
59569874|NCT01675063|75673336|FG000|NOT COMPLETED|Overall Study||0||
59569875|NCT01927718|75673340|FG000|STARTED|Overall Study||10||
59569876|NCT01927718|75673340|FG000|COMPLETED|Overall Study||10||
59569877|NCT01927718|75673340|FG000|NOT COMPLETED|Overall Study||0||
59569878|NCT02238847|75673346|FG000|STARTED|Overall Study||59||
59569879|NCT02238847|75673347|FG001|STARTED|Overall Study||60||
59721138|NCT01106352|75840062|FG000|Started Safety Cohort|Overall Study||0||
59569880|NCT02238847|75673346|FG000|COMPLETED|Overall Study||37||
59569881|NCT02238847|75673347|FG001|COMPLETED|Overall Study||36||
59569882|NCT02238847|75673346|FG000|NOT COMPLETED|Overall Study||22||
59569883|NCT02238847|75673347|FG001|NOT COMPLETED|Overall Study||24||
59569884|NCT01948310|75673355|FG000|STARTED|Overall Study||19||
59569885|NCT01948310|75673356|FG001|STARTED|Overall Study||18||
59569886|NCT01948310|75673355|FG000|COMPLETED|Overall Study||16||
59569887|NCT01948310|75673356|FG001|COMPLETED|Overall Study||13||
59569888|NCT01948310|75673355|FG000|NOT COMPLETED|Overall Study||3||
59569889|NCT01948310|75673356|FG001|NOT COMPLETED|Overall Study||5||
59569890|NCT01948388|75673364|FG000|STARTED|Overall Study||10||
59569891|NCT01948388|75673365|FG001|STARTED|Overall Study||10||
59569892|NCT01948388|75673364|FG000|COMPLETED|Overall Study||8||
59569893|NCT01948388|75673365|FG001|COMPLETED|Overall Study||9||
59569894|NCT01948388|75673364|FG000|NOT COMPLETED|Overall Study||2||
59569895|NCT01948388|75673365|FG001|NOT COMPLETED|Overall Study||1||
59569896|NCT05045625|75673373|FG000|STARTED|Overall Study||12||
59569897|NCT05045625|75673373|FG000|COMPLETED|Overall Study||9||
59569898|NCT05045625|75673373|FG000|NOT COMPLETED|Overall Study||3||
59569899|NCT01928030|75673377|FG000|STARTED|Overall Study||3||
59569900|NCT01928030|75673378|FG001|STARTED|Overall Study||0||
59569901|NCT01928030|75673379|FG002|STARTED|Overall Study||0||
59569902|NCT01928030|75673377|FG000|COMPLETED|Overall Study||3||
59569903|NCT01928030|75673378|FG001|COMPLETED|Overall Study||0||
59569904|NCT01928030|75673379|FG002|COMPLETED|Overall Study||0||
59569905|NCT01928030|75673377|FG000|NOT COMPLETED|Overall Study||0||
59569906|NCT01928030|75673378|FG001|NOT COMPLETED|Overall Study||0||
59569907|NCT01928030|75673379|FG002|NOT COMPLETED|Overall Study||0||
59569908|NCT01675297|75673388|FG000|STARTED|Overall Study||806||
59569909|NCT01675297|75673389|FG001|STARTED|Overall Study||247||
59569910|NCT01675297|75673388|FG000|COMPLETED|Overall Study||642||
59569911|NCT01675297|75673389|FG001|COMPLETED|Overall Study||199||
59569912|NCT01675297|75673388|FG000|NOT COMPLETED|Overall Study||164||
59569913|NCT01675297|75673389|FG001|NOT COMPLETED|Overall Study||48||
59569914|NCT02287376|75673395|FG000|STARTED|Overall Study||25||
59569915|NCT02287376|75673395|FG000|COMPLETED|Overall Study||25||
59569916|NCT02287376|75673395|FG000|NOT COMPLETED|Overall Study||0||
59569917|NCT01675453|75673401|FG000|STARTED|Overall Study||20||
59569918|NCT01675453|75673402|FG001|STARTED|Overall Study||20||
59569919|NCT01675453|75673401|FG000|COMPLETED|Overall Study||20||
59569920|NCT01675453|75673402|FG001|COMPLETED|Overall Study||20||
59569921|NCT01675453|75673401|FG000|NOT COMPLETED|Overall Study||0||
59569922|NCT01675453|75673402|FG001|NOT COMPLETED|Overall Study||0||
59569923|NCT01928186|75673408|FG000|STARTED|Overall Study||28||
59569924|NCT01928186|75673408|FG000|COMPLETED|Overall Study||28||
59569925|NCT01928186|75673408|FG000|NOT COMPLETED|Overall Study||0||
59569926|NCT01611571|75673415|FG000|STARTED|Overall Study||11||
59569927|NCT01611571|75673416|FG001|STARTED|Overall Study||10||
59569928|NCT01611571|75673417|FG002|STARTED|Overall Study||10||
59569929|NCT01611571|75673415|FG000|COMPLETED|Overall Study||10||
59569930|NCT01611571|75673416|FG001|COMPLETED|Overall Study||10||
59569931|NCT01611571|75673417|FG002|COMPLETED|Overall Study||9||
59569932|NCT01611571|75673415|FG000|NOT COMPLETED|Overall Study||1||
59569933|NCT01611571|75673416|FG001|NOT COMPLETED|Overall Study||0||
59569934|NCT01611571|75673417|FG002|NOT COMPLETED|Overall Study||1||
59569935|NCT02238925|75673425|FG000|STARTED|Overall Study||26||
59569936|NCT02238925|75673425|FG000|COMPLETED|Overall Study||1||
59569937|NCT02238925|75673425|FG000|NOT COMPLETED|Overall Study||25||
59569938|NCT01950260|75673431|FG000|STARTED|Overall Study||30||
59569939|NCT01950260|75673432|FG001|STARTED|Overall Study||31||
59569940|NCT01950260|75673431|FG000|COMPLETED|Overall Study||30||
59569941|NCT01950260|75673432|FG001|COMPLETED|Overall Study||31||
59569942|NCT01950260|75673431|FG000|NOT COMPLETED|Overall Study||0||
59569943|NCT01950260|75673432|FG001|NOT COMPLETED|Overall Study||0||
59569944|NCT01676311|75673440|FG000|STARTED|Overall Study||7||
59569945|NCT01676311|75673441|FG001|STARTED|Overall Study||7||
59569946|NCT01676311|75673440|FG000|COMPLETED|Overall Study||7||
59569947|NCT01676311|75673441|FG001|COMPLETED|Overall Study||5||
59569948|NCT01676311|75673440|FG000|NOT COMPLETED|Overall Study||0||
59569949|NCT01676311|75673441|FG001|NOT COMPLETED|Overall Study||2||
59569950|NCT01951118|75673447|FG000|STARTED|Overall Study||121||
59569951|NCT01951118|75673447|FG000|COMPLETED|Overall Study||94||
59569952|NCT01951118|75673447|FG000|NOT COMPLETED|Overall Study||27||
59569953|NCT01698463|75673456|FG000|STARTED|Overall Study||11||
59569954|NCT01698463|75673456|FG000|COMPLETED|Overall Study||11||
60121141|NCT02654860|76242051|FG001|NOT COMPLETED|First Part||0||
59569955|NCT01698463|75673456|FG000|NOT COMPLETED|Overall Study||0||
59569956|NCT01951352|75673460|FG000|STARTED|Overall Study||10||
59569957|NCT01951352|75673460|FG000|COMPLETED|Overall Study||10||
59569958|NCT01951352|75673460|FG000|NOT COMPLETED|Overall Study||0||
59569959|NCT01951820|75673466|FG000|STARTED|Overall Study||34||
59569960|NCT01951820|75673467|FG001|STARTED|Overall Study||30||
59569961|NCT01951820|75673466|FG000|COMPLETED|Overall Study||34||
59569962|NCT01951820|75673467|FG001|COMPLETED|Overall Study||30||
59569963|NCT01951820|75673466|FG000|NOT COMPLETED|Overall Study||0||
59569964|NCT01951820|75673467|FG001|NOT COMPLETED|Overall Study||0||
59569965|NCT01700725|75673476|FG000|STARTED|Overall Study||14||
59569966|NCT01700725|75673477|FG001|STARTED|Overall Study||14||
59569967|NCT01700725|75673478|FG002|STARTED|Overall Study||12||
59569968|NCT01700725|75673476|FG000|COMPLETED|Overall Study||14||
59569969|NCT01700725|75673477|FG001|COMPLETED|Overall Study||14||
59569970|NCT01700725|75673478|FG002|COMPLETED|Overall Study||12||
59569971|NCT01700725|75673476|FG000|NOT COMPLETED|Overall Study||0||
59569972|NCT01700725|75673477|FG001|NOT COMPLETED|Overall Study||0||
59569973|NCT01700725|75673478|FG002|NOT COMPLETED|Overall Study||0||
59569974|NCT01678885|75673488|FG000|STARTED|Phase I; 2 Wks Duration, Both Sub-study||22||
59569975|NCT01678885|75673489|FG001|STARTED|Phase I; 2 Wks Duration, Both Sub-study||18||
59569976|NCT01678885|75673490|FG002|STARTED|Phase I; 2 Wks Duration, Both Sub-study||23||
59569977|NCT01678885|75673491|FG003|STARTED|Phase I; 2 Wks Duration, Both Sub-study||24||
59569978|NCT01678885|75673492|FG004|STARTED|Phase I; 2 Wks Duration, Both Sub-study||0||
59569979|NCT01678885|75673488|FG000|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||22||
59569980|NCT01678885|75673489|FG001|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||15||
59569981|NCT01678885|75673490|FG002|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||22||
59569982|NCT01678885|75673491|FG003|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||21||
59569983|NCT01678885|75673492|FG004|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||0||
59569984|NCT01678885|75673488|FG000|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||0||
59569985|NCT01678885|75673489|FG001|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||3||
59569986|NCT01678885|75673490|FG002|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||1||
59569987|NCT01678885|75673491|FG003|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||3||
59569988|NCT01678885|75673492|FG004|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||0||
59569989|NCT01678885|75673488|FG000|STARTED|Phase II; 8 Week Low Calorie Diet||0||
59569990|NCT01678885|75673489|FG001|STARTED|Phase II; 8 Week Low Calorie Diet||0||
59569991|NCT01678885|75673490|FG002|STARTED|Phase II; 8 Week Low Calorie Diet||0||
59569992|NCT01678885|75673491|FG003|STARTED|Phase II; 8 Week Low Calorie Diet||0||
59569993|NCT01678885|75673492|FG004|STARTED|Phase II; 8 Week Low Calorie Diet||87||
59569994|NCT01678885|75673488|FG000|COMPLETED|Phase II; 8 Week Low Calorie Diet||0||
59569995|NCT01678885|75673489|FG001|COMPLETED|Phase II; 8 Week Low Calorie Diet||0||
59569996|NCT01678885|75673490|FG002|COMPLETED|Phase II; 8 Week Low Calorie Diet||0||
59569997|NCT01678885|75673491|FG003|COMPLETED|Phase II; 8 Week Low Calorie Diet||0||
59569998|NCT01678885|75673492|FG004|COMPLETED|Phase II; 8 Week Low Calorie Diet||70||
59569999|NCT01678885|75673488|FG000|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||0||
59570000|NCT01678885|75673489|FG001|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||0||
59570001|NCT01678885|75673490|FG002|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||0||
59570002|NCT01678885|75673491|FG003|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||0||
59570003|NCT01678885|75673492|FG004|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||17||
59570004|NCT01952444|75673502|FG000|STARTED|Overall Study||20||
59570005|NCT01952444|75673503|FG001|STARTED|Overall Study||20||
59570006|NCT01952444|75673502|FG000|COMPLETED|Overall Study||20||
59570007|NCT01952444|75673503|FG001|COMPLETED|Overall Study||19||
59570008|NCT01952444|75673502|FG000|NOT COMPLETED|Overall Study||0||
59570009|NCT01952444|75673503|FG001|NOT COMPLETED|Overall Study||1||
59570010|NCT01952600|75673517|FG000|STARTED|Overall Study||80||
59570011|NCT01952600|75673518|FG001|STARTED|Overall Study||90||
59570012|NCT01952600|75673519|FG002|STARTED|Overall Study||45||
59570013|NCT01952600|75673517|FG000|COMPLETED|Overall Study||65||
59570014|NCT01952600|75673518|FG001|COMPLETED|Overall Study||77||
59570015|NCT01952600|75673519|FG002|COMPLETED|Overall Study||38||
59570016|NCT01952600|75673517|FG000|NOT COMPLETED|Overall Study||15||
59570017|NCT01952600|75673518|FG001|NOT COMPLETED|Overall Study||13||
59570018|NCT01952600|75673519|FG002|NOT COMPLETED|Overall Study||7||
59570019|NCT01679197|75673527|FG000|STARTED|Overall Study||23||
59570020|NCT01679197|75673527|FG000|COMPLETED|Overall Study||19||
60121142|NCT02654860|76242052|FG002|NOT COMPLETED|First Part||0||
60121143|NCT02654860|76242053|FG003|NOT COMPLETED|First Part||0||
60121144|NCT02654860|76242050|FG000|STARTED|Second Part||15||
60121145|NCT02654860|76242051|FG001|STARTED|Second Part||15||
60121146|NCT02654860|76242052|FG002|STARTED|Second Part||15||
60121147|NCT02654860|76242053|FG003|STARTED|Second Part||15||
60121148|NCT02654860|76242050|FG000|COMPLETED|Second Part||15||
60121149|NCT02654860|76242051|FG001|COMPLETED|Second Part||15||
60121150|NCT02654860|76242052|FG002|COMPLETED|Second Part||15||
60121151|NCT02654860|76242053|FG003|COMPLETED|Second Part||15||
60121152|NCT02654860|76242050|FG000|NOT COMPLETED|Second Part||0||
60121153|NCT02654860|76242051|FG001|NOT COMPLETED|Second Part||0||
59570021|NCT01679197|75673527|FG000|NOT COMPLETED|Overall Study||4||
59570022|NCT01952678|75673539|FG000|STARTED|Overall Study||102||
59570023|NCT01952678|75673540|FG001|STARTED|Overall Study||102||
59570024|NCT01952678|75673539|FG000|COMPLETED|Overall Study||102||
59570025|NCT01952678|75673540|FG001|COMPLETED|Overall Study||102||
59570026|NCT01952678|75673539|FG000|NOT COMPLETED|Overall Study||0||
60121154|NCT02654860|76242052|FG002|NOT COMPLETED|Second Part||0||
60121155|NCT02654860|76242053|FG003|NOT COMPLETED|Second Part||0||
60121156|NCT01587001|76242065|FG000|STARTED|Overall Study||14||
59570027|NCT01952678|75673540|FG001|NOT COMPLETED|Overall Study||0||
59570028|NCT01954628|75673558|FG000|STARTED|Overall Study||200||
59570029|NCT01954628|75673559|FG001|STARTED|Overall Study||200||
59570030|NCT01954628|75673558|FG000|Full Analysis Set (FAS)|Overall Study||200||
59570031|NCT01954628|75673559|FG001|Full Analysis Set (FAS)|Overall Study||198||
59570032|NCT01954628|75673558|FG000|Safety Set|Overall Study||200||
60121157|NCT01587001|76242066|FG001|STARTED|Overall Study||3||
59570033|NCT01954628|75673559|FG001|Safety Set|Overall Study||200||
59570034|NCT01954628|75673558|FG000|Pharmacokinetic Population|Overall Study||181||
59570035|NCT01954628|75673559|FG001|Pharmacokinetic Population|Overall Study||0||
59570036|NCT01954628|75673558|FG000|US 6 Month Ophthalmology Safety Visit|Overall Study||37||
59570037|NCT01954628|75673559|FG001|US 6 Month Ophthalmology Safety Visit|Overall Study||32||
59570038|NCT01954628|75673558|FG000|COMPLETED|Overall Study||169||
59570039|NCT01954628|75673559|FG001|COMPLETED|Overall Study||173||
59570040|NCT01954628|75673558|FG000|NOT COMPLETED|Overall Study||31||
59570041|NCT01954628|75673559|FG001|NOT COMPLETED|Overall Study||27||
59570042|NCT01680835|75673569|FG000|STARTED|Overall Study||108||
59570043|NCT01680835|75673569|FG000|COMPLETED|Overall Study||83||
59570044|NCT01680835|75673569|FG000|NOT COMPLETED|Overall Study||25||
59570045|NCT01614613|75673573|FG000|STARTED|Overall Study||146||
59570046|NCT01614613|75673573|FG000|COMPLETED|Overall Study||146||
59570047|NCT01614613|75673573|FG000|NOT COMPLETED|Overall Study||0||
59570048|NCT01614847|75673580|FG000|STARTED|Day 1|Four subjects chosen at random received Drop A (hyaluronate) during Day 1.|4||
59570049|NCT01614847|75673581|FG001|STARTED|Day 1|The other 4 subjects, not to Group 1, received Drop B (saline) on Day 1.|4||
59570050|NCT01614847|75673580|FG000|COMPLETED|Day 1||4||
59570051|NCT01614847|75673581|FG001|COMPLETED|Day 1|See Arm 1 comments.|4||
59570052|NCT01614847|75673580|FG000|NOT COMPLETED|Day 1||0||
59570053|NCT01614847|75673581|FG001|NOT COMPLETED|Day 1||0||
59570054|NCT01614847|75673580|FG000|STARTED|Day 2 (24 Hours Later)|On Day 2, these subject will received Drop B (normal saline).|4||
59570055|NCT01614847|75673581|FG001|STARTED|Day 2 (24 Hours Later)|On Day 2, these subjects received Drop A (hyaluronate).|4||
59570056|NCT01614847|75673580|FG000|COMPLETED|Day 2 (24 Hours Later)||4||
59570057|NCT01614847|75673581|FG001|COMPLETED|Day 2 (24 Hours Later)||4||
59570058|NCT01614847|75673580|FG000|NOT COMPLETED|Day 2 (24 Hours Later)||0||
59570059|NCT01614847|75673581|FG001|NOT COMPLETED|Day 2 (24 Hours Later)||0||
59570060|NCT01617421|75673592|FG000|STARTED|Overall Study||18||
59570061|NCT01617421|75673592|FG000|COMPLETED|Overall Study||12||
59570062|NCT01617421|75673592|FG000|NOT COMPLETED|Overall Study||6||
59570063|NCT01617577|75673598|FG000|STARTED|Overall Study||5||
59570064|NCT01617577|75673599|FG001|STARTED|Overall Study||3||
59570065|NCT01617577|75673598|FG000|COMPLETED|Overall Study||5||
59570066|NCT01617577|75673599|FG001|COMPLETED|Overall Study||3||
59570067|NCT01617577|75673598|FG000|NOT COMPLETED|Overall Study||0||
59570068|NCT01617577|75673599|FG001|NOT COMPLETED|Overall Study||0||
59570069|NCT02235493|75673606|FG000|STARTED|Overall Study||6||
59570070|NCT02235493|75673606|FG000|COMPLETED|Overall Study||6||
59570071|NCT02235493|75673606|FG000|NOT COMPLETED|Overall Study||0||
59570072|NCT01955564|75673617|FG000|STARTED|Overall Study||18||
59570073|NCT01955564|75673618|FG001|STARTED|Overall Study||6||
59570074|NCT01955564|75673619|FG002|STARTED|Overall Study||6||
59570075|NCT01955564|75673620|FG003|STARTED|Overall Study||6||
59570076|NCT01955564|75673621|FG004|STARTED|Overall Study||6||
59570077|NCT01955564|75673622|FG005|STARTED|Overall Study||6||
59570078|NCT01955564|75673623|FG006|STARTED|Overall Study||6||
59570079|NCT01955564|75673617|FG000|COMPLETED|Overall Study||18||
59570080|NCT01955564|75673618|FG001|COMPLETED|Overall Study||6||
59570081|NCT01955564|75673619|FG002|COMPLETED|Overall Study||6||
59570082|NCT01955564|75673620|FG003|COMPLETED|Overall Study||6||
59570083|NCT01955564|75673621|FG004|COMPLETED|Overall Study||6||
59570084|NCT01955564|75673622|FG005|COMPLETED|Overall Study||6||
59570085|NCT01955564|75673623|FG006|COMPLETED|Overall Study||6||
59721139|NCT01106352|75840063|FG001|Started Safety Cohort|Overall Study||0||
59721140|NCT01106352|75840064|FG002|Started Safety Cohort|Overall Study||0||
59721141|NCT01106352|75840065|FG003|Started Safety Cohort|Overall Study||36||
59721142|NCT01106352|75840066|FG004|Started Safety Cohort|Overall Study||17||
59721143|NCT01106352|75840062|FG000|Treated Safety Cohort|Overall Study||0||
59721144|NCT01106352|75840063|FG001|Treated Safety Cohort|Overall Study||0||
59570086|NCT01955564|75673617|FG000|NOT COMPLETED|Overall Study||0||
59570087|NCT01955564|75673618|FG001|NOT COMPLETED|Overall Study||0||
59570088|NCT01955564|75673619|FG002|NOT COMPLETED|Overall Study||0||
59570089|NCT01955564|75673620|FG003|NOT COMPLETED|Overall Study||0||
59570090|NCT01955564|75673621|FG004|NOT COMPLETED|Overall Study||0||
59721145|NCT01106352|75840064|FG002|Treated Safety Cohort|Overall Study||0||
59721146|NCT01106352|75840065|FG003|Treated Safety Cohort|Overall Study|Number of subjects for safety analysis set.|33||
59721147|NCT01106352|75840066|FG004|Treated Safety Cohort|Overall Study|Number of subjects for safety analysis set.|13||
59721148|NCT01106352|75840062|FG000|Completed Safety Cohort|Overall Study||0||
59850250|NCT03587584|75974581|FG001|NOT COMPLETED|Overall Study||9||
59570091|NCT01955564|75673622|FG005|NOT COMPLETED|Overall Study||0||
59570092|NCT01955564|75673623|FG006|NOT COMPLETED|Overall Study||0||
59570093|NCT01701037|75673645|FG000|STARTED|Overall Study||13||
59570094|NCT01701037|75673645|FG000|COMPLETED|Overall Study||13||
59570095|NCT01701037|75673645|FG000|NOT COMPLETED|Overall Study||0||
59570096|NCT01955720|75673650|FG000|STARTED|Overall Study||13||
59570097|NCT01955720|75673651|FG001|STARTED|Overall Study||13||
59570098|NCT01955720|75673652|FG002|STARTED|Overall Study||3||
59570099|NCT01955720|75673653|FG003|STARTED|Overall Study||3||
59570100|NCT01955720|75673654|FG004|STARTED|Overall Study||7||
59570101|NCT01955720|75673655|FG005|STARTED|Overall Study||7||
59570102|NCT01955720|75673650|FG000|Healthy Subjects Aged 45-64|Overall Study||3||
59570103|NCT01955720|75673651|FG001|Healthy Subjects Aged 45-64|Overall Study||3||
59570104|NCT01955720|75673652|FG002|Healthy Subjects Aged 45-64|Overall Study||3||
59570105|NCT01955720|75673653|FG003|Healthy Subjects Aged 45-64|Overall Study||3||
59570106|NCT01955720|75673654|FG004|Healthy Subjects Aged 45-64|Overall Study||0||
59570107|NCT01955720|75673655|FG005|Healthy Subjects Aged 45-64|Overall Study||0||
59570108|NCT01955720|75673650|FG000|Healthy Subjects Aged 65-80|Overall Study||4||
59570109|NCT01955720|75673651|FG001|Healthy Subjects Aged 65-80|Overall Study||4||
59570110|NCT01955720|75673652|FG002|Healthy Subjects Aged 65-80|Overall Study||0||
59570111|NCT01955720|75673653|FG003|Healthy Subjects Aged 65-80|Overall Study||0||
59570112|NCT01955720|75673654|FG004|Healthy Subjects Aged 65-80|Overall Study||4||
59570113|NCT01955720|75673655|FG005|Healthy Subjects Aged 65-80|Overall Study||4||
59570114|NCT01955720|75673650|FG000|Subjects With Mild Renal Impairment|Overall Study||3||
59570115|NCT01955720|75673651|FG001|Subjects With Mild Renal Impairment|Overall Study||3||
59570116|NCT01955720|75673652|FG002|Subjects With Mild Renal Impairment|Overall Study||0||
59570117|NCT01955720|75673653|FG003|Subjects With Mild Renal Impairment|Overall Study||0||
59570118|NCT01955720|75673654|FG004|Subjects With Mild Renal Impairment|Overall Study||3||
59570119|NCT01955720|75673655|FG005|Subjects With Mild Renal Impairment|Overall Study||3||
59570120|NCT01955720|75673650|FG000|Subjects With Moderate Renal Impairment|Overall Study||3||
59570121|NCT01955720|75673651|FG001|Subjects With Moderate Renal Impairment|Overall Study||3||
59570122|NCT01955720|75673652|FG002|Subjects With Moderate Renal Impairment|Overall Study||0||
59570123|NCT01955720|75673653|FG003|Subjects With Moderate Renal Impairment|Overall Study||0||
59570124|NCT01955720|75673654|FG004|Subjects With Moderate Renal Impairment|Overall Study||0||
59570125|NCT01955720|75673655|FG005|Subjects With Moderate Renal Impairment|Overall Study||0||
59570126|NCT01955720|75673650|FG000|COMPLETED|Overall Study||13||
59570127|NCT01955720|75673651|FG001|COMPLETED|Overall Study||13||
59570128|NCT01955720|75673652|FG002|COMPLETED|Overall Study||3||
59570129|NCT01955720|75673653|FG003|COMPLETED|Overall Study||3||
59570130|NCT01955720|75673654|FG004|COMPLETED|Overall Study||7||
59570131|NCT01955720|75673655|FG005|COMPLETED|Overall Study||7||
59570132|NCT01955720|75673650|FG000|NOT COMPLETED|Overall Study||0||
59570133|NCT01955720|75673651|FG001|NOT COMPLETED|Overall Study||0||
59570134|NCT01955720|75673652|FG002|NOT COMPLETED|Overall Study||0||
59570135|NCT01955720|75673653|FG003|NOT COMPLETED|Overall Study||0||
59570136|NCT01955720|75673654|FG004|NOT COMPLETED|Overall Study||0||
59570137|NCT01955720|75673655|FG005|NOT COMPLETED|Overall Study||0||
59570138|NCT01619839|75673706|FG000|STARTED|Overall Study||48||
59570139|NCT01619839|75673707|FG001|STARTED|Overall Study||31||
59570140|NCT01619839|75673708|FG002|STARTED|Overall Study||18||
59570141|NCT01619839|75673709|FG003|STARTED|Overall Study||10||
59570142|NCT01619839|75673710|FG004|STARTED|Overall Study||106||
59570143|NCT01619839|75673706|FG000|COMPLETED|Overall Study||43||
59570144|NCT01619839|75673707|FG001|COMPLETED|Overall Study||27||
59570145|NCT01619839|75673708|FG002|COMPLETED|Overall Study||17||
59570146|NCT01619839|75673709|FG003|COMPLETED|Overall Study||9||
59570147|NCT01619839|75673710|FG004|COMPLETED|Overall Study||97||
59570148|NCT01619839|75673706|FG000|NOT COMPLETED|Overall Study||5||
59570149|NCT01619839|75673707|FG001|NOT COMPLETED|Overall Study||4||
59570150|NCT01619839|75673708|FG002|NOT COMPLETED|Overall Study||1||
59570151|NCT01619839|75673709|FG003|NOT COMPLETED|Overall Study||1||
59570152|NCT01619839|75673710|FG004|NOT COMPLETED|Overall Study||9||
59570153|NCT01955954|75673719|FG000|STARTED|Overall Study||69||
59570154|NCT01955954|75673719|FG000|Received Treatment|Overall Study||66||
59570155|NCT01955954|75673719|FG000|Completed Treatment|Overall Study||53||
59570156|NCT01955954|75673719|FG000|Completed Post-treatment Assessement|Overall Study||48||
59570157|NCT01955954|75673719|FG000|Completed 2-month Assessment|Overall Study|Primary endpoint|46||
59570158|NCT01955954|75673719|FG000|Completed 6-month Assessement|Overall Study||42||
59570159|NCT01955954|75673719|FG000|COMPLETED|Overall Study|12-months|33||
59570160|NCT01955954|75673719|FG000|NOT COMPLETED|Overall Study||36||
59570161|NCT01701115|75673725|FG000|STARTED|Overall Study||77||
59570162|NCT01701115|75673726|FG001|STARTED|Overall Study||77||
59570163|NCT01701115|75673725|FG000|COMPLETED|Overall Study||75||
59570164|NCT01701115|75673726|FG001|COMPLETED|Overall Study||77||
59570165|NCT01701115|75673725|FG000|NOT COMPLETED|Overall Study||2||
59570166|NCT01701115|75673726|FG001|NOT COMPLETED|Overall Study||0||
59570167|NCT01956032|75673732|FG000|STARTED|Overall Study||15||
59570168|NCT01956032|75673732|FG000|COMPLETED|Overall Study||15||
59570169|NCT01956032|75673732|FG000|NOT COMPLETED|Overall Study||0||
59570170|NCT01621009|75673740|FG000|STARTED|Overall Study||113||
59570171|NCT01621009|75673741|FG001|STARTED|Overall Study||116||
59570172|NCT01621009|75673742|FG002|STARTED|Overall Study||121||
59570173|NCT01621009|75673743|FG003|STARTED|Overall Study||113||
59570174|NCT01621009|75673740|FG000|COMPLETED|Overall Study||70||
59570175|NCT01621009|75673741|FG001|COMPLETED|Overall Study||65||
59570176|NCT01621009|75673742|FG002|COMPLETED|Overall Study||58||
59570177|NCT01621009|75673743|FG003|COMPLETED|Overall Study||60||
59570178|NCT01621009|75673740|FG000|NOT COMPLETED|Overall Study||43||
59570179|NCT01621009|75673741|FG001|NOT COMPLETED|Overall Study||51||
59570180|NCT01621009|75673742|FG002|NOT COMPLETED|Overall Study||63||
59570181|NCT01621009|75673743|FG003|NOT COMPLETED|Overall Study||53||
59570182|NCT04830969|75673755|FG000|STARTED|Overall Study||58||
59570183|NCT04830969|75673756|FG001|STARTED|Overall Study||56||
59570184|NCT04830969|75673755|FG000|COMPLETED|Overall Study||45||
59570185|NCT04830969|75673756|FG001|COMPLETED|Overall Study||41||
59570186|NCT04830969|75673755|FG000|NOT COMPLETED|Overall Study||13||
59570187|NCT04830969|75673756|FG001|NOT COMPLETED|Overall Study||15||
59570188|NCT01683331|75673770|FG000|STARTED|Overall Study||18||
59570189|NCT01683331|75673771|FG001|STARTED|Overall Study||18||
59570190|NCT01683331|75673770|FG000|Began Dosage|Overall Study||18||
59570191|NCT01683331|75673771|FG001|Began Dosage|Overall Study||18||
59570192|NCT01683331|75673770|FG000|12 Months|Overall Study||18||
59570193|NCT01683331|75673771|FG001|12 Months|Overall Study||18||
59570194|NCT01683331|75673770|FG000|24 Months|Overall Study||18||
59570195|NCT01683331|75673771|FG001|24 Months|Overall Study||18||
59570196|NCT01683331|75673770|FG000|COMPLETED|Overall Study||18||
59570197|NCT01683331|75673771|FG001|COMPLETED|Overall Study||18||
59570198|NCT01683331|75673770|FG000|NOT COMPLETED|Overall Study||0||
59570199|NCT01683331|75673771|FG001|NOT COMPLETED|Overall Study||0||
59570200|NCT01701271|75673777|FG000|STARTED|Overall Study||20||
59570201|NCT01701271|75673777|FG000|COMPLETED|Overall Study||20||
59570202|NCT01701271|75673777|FG000|NOT COMPLETED|Overall Study||0||
59570203|NCT02290106|75673784|FG000|STARTED|Overall Study||25||
59570204|NCT02290106|75673785|FG001|STARTED|Overall Study||25||
59570205|NCT02290106|75673784|FG000|COMPLETED|Overall Study||24||
59570206|NCT02290106|75673785|FG001|COMPLETED|Overall Study||23||
59570207|NCT02290106|75673784|FG000|NOT COMPLETED|Overall Study||1||
59570208|NCT02290106|75673785|FG001|NOT COMPLETED|Overall Study||2||
59570209|NCT02287688|75673791|FG000|STARTED|Overall Study||138||
59570210|NCT02287688|75673791|FG000|COMPLETED|Overall Study||138||
59570211|NCT02287688|75673791|FG000|NOT COMPLETED|Overall Study||0||
59570212|NCT01621477|75673795|FG000|STARTED|Overall Study||17||
59570213|NCT01621477|75673795|FG000|COMPLETED|Overall Study||17||
59570214|NCT01621477|75673795|FG000|NOT COMPLETED|Overall Study||0||
59570215|NCT01621633|75673803|FG000|STARTED|Overall Study||8||
59570216|NCT01621633|75673804|FG001|STARTED|Overall Study||8||
59570217|NCT01621633|75673805|FG002|STARTED|Overall Study||8||
59570218|NCT01621633|75673806|FG003|STARTED|Overall Study||8||
59570219|NCT01621633|75673803|FG000|COMPLETED|Overall Study||8||
59570220|NCT01621633|75673804|FG001|COMPLETED|Overall Study||8||
59570221|NCT01621633|75673805|FG002|COMPLETED|Overall Study||8||
59570222|NCT01621633|75673806|FG003|COMPLETED|Overall Study||8||
59570223|NCT01621633|75673803|FG000|NOT COMPLETED|Overall Study||0||
59570224|NCT01621633|75673804|FG001|NOT COMPLETED|Overall Study||0||
59570225|NCT01621633|75673805|FG002|NOT COMPLETED|Overall Study||0||
59570226|NCT01621633|75673806|FG003|NOT COMPLETED|Overall Study||0||
59570227|NCT01958606|75673818|FG000|STARTED|Overall Study||13||
59570228|NCT01958606|75673819|FG001|STARTED|Overall Study||5||
59570229|NCT01958606|75673818|FG000|COMPLETED|Overall Study||11||
59570230|NCT01958606|75673819|FG001|COMPLETED|Overall Study||5||
59570231|NCT01958606|75673818|FG000|NOT COMPLETED|Overall Study||2||
59570232|NCT01958606|75673819|FG001|NOT COMPLETED|Overall Study||0||
59570233|NCT02330588|75673830|FG000|STARTED|Overall Study||44||
59570234|NCT02330588|75673831|FG001|STARTED|Overall Study||43||
59570235|NCT02330588|75673832|FG002|STARTED|Overall Study||46||
59570236|NCT02330588|75673833|FG003|STARTED|Overall Study||46||
59570237|NCT02330588|75673834|FG004|STARTED|Overall Study||47||
59570238|NCT02330588|75673830|FG000|COMPLETED|Overall Study||28||
59570239|NCT02330588|75673831|FG001|COMPLETED|Overall Study||25||
59570240|NCT02330588|75673832|FG002|COMPLETED|Overall Study||31||
59570241|NCT02330588|75673833|FG003|COMPLETED|Overall Study||24||
59570242|NCT02330588|75673834|FG004|COMPLETED|Overall Study||28||
59570243|NCT02330588|75673830|FG000|NOT COMPLETED|Overall Study||16||
59850251|NCT03586726|75974587|FG000|STARTED|Overall Study||16||
59570244|NCT02330588|75673831|FG001|NOT COMPLETED|Overall Study||18||
59570245|NCT02330588|75673832|FG002|NOT COMPLETED|Overall Study||15||
59570246|NCT02330588|75673833|FG003|NOT COMPLETED|Overall Study||22||
59570247|NCT02330588|75673834|FG004|NOT COMPLETED|Overall Study||19||
59570248|NCT01701505|75673860|FG000|STARTED|Overall Study||8||
59570249|NCT01701505|75673861|FG001|STARTED|Overall Study||8||
59570250|NCT01701505|75673862|FG002|STARTED|Overall Study||8||
59570251|NCT01701505|75673863|FG003|STARTED|Overall Study||8||
59850252|NCT03586726|75974587|FG000|COMPLETED|Overall Study||15||
59850253|NCT03586726|75974587|FG000|NOT COMPLETED|Overall Study||1||
59570252|NCT01701505|75673864|FG004|STARTED|Overall Study||8||
59570253|NCT01701505|75673865|FG005|STARTED|Overall Study||8||
59570254|NCT01701505|75673860|FG000|COMPLETED|Overall Study||8||
59570255|NCT01701505|75673861|FG001|COMPLETED|Overall Study||8||
59570256|NCT01701505|75673862|FG002|COMPLETED|Overall Study||8||
59570257|NCT01701505|75673863|FG003|COMPLETED|Overall Study||8||
59570258|NCT01701505|75673864|FG004|COMPLETED|Overall Study||8||
59570259|NCT01701505|75673865|FG005|COMPLETED|Overall Study||8||
59570260|NCT01701505|75673860|FG000|NOT COMPLETED|Overall Study||0||
59570261|NCT01701505|75673861|FG001|NOT COMPLETED|Overall Study||0||
59570262|NCT01701505|75673862|FG002|NOT COMPLETED|Overall Study||0||
59570263|NCT01701505|75673863|FG003|NOT COMPLETED|Overall Study||0||
59570264|NCT01701505|75673864|FG004|NOT COMPLETED|Overall Study||0||
59570265|NCT01701505|75673865|FG005|NOT COMPLETED|Overall Study||0||
59570266|NCT01622257|75673885|FG000|STARTED|Overall Study||66||
59570267|NCT01622257|75673886|FG001|STARTED|Overall Study||66||
59570268|NCT01622257|75673887|FG002|STARTED|Overall Study||66||
59570269|NCT01622257|75673885|FG000|COMPLETED|Overall Study||66||
59570270|NCT01622257|75673886|FG001|COMPLETED|Overall Study||66||
59570271|NCT01622257|75673887|FG002|COMPLETED|Overall Study||66||
59570272|NCT01622257|75673885|FG000|NOT COMPLETED|Overall Study||0||
59570273|NCT01622257|75673886|FG001|NOT COMPLETED|Overall Study||0||
59570274|NCT01622257|75673887|FG002|NOT COMPLETED|Overall Study||0||
59570275|NCT02290184|75673897|FG000|STARTED|Overall Study||22||
59570276|NCT02290184|75673898|FG001|STARTED|Overall Study||23||
59570277|NCT02290184|75673897|FG000|3-month Follow-up|Overall Study|Completed initial 3-month intervention and now transition to a 3-month maintenance phase|22||
59570278|NCT02290184|75673898|FG001|3-month Follow-up|Overall Study|Completed initial 3-month control period and transition to receive the 3-month intervention|23||
59570279|NCT02290184|75673897|FG000|COMPLETED|Overall Study|6-month follow-up visit - completed the 3-month maintenance phase and completed study|22||
59570280|NCT02290184|75673898|FG001|COMPLETED|Overall Study|6-month follow up visit - completed 3-month intervention and competed study|23||
59570281|NCT02290184|75673897|FG000|NOT COMPLETED|Overall Study||0||
59570282|NCT02290184|75673898|FG001|NOT COMPLETED|Overall Study||0||
59570283|NCT02329964|75673912|FG000|STARTED|Overall Study||40||
59570284|NCT02329964|75673913|FG001|STARTED|Overall Study||40||
59570285|NCT02329964|75673912|FG000|COMPLETED|Overall Study||40||
59570286|NCT02329964|75673913|FG001|COMPLETED|Overall Study||40||
59570287|NCT02329964|75673912|FG000|NOT COMPLETED|Overall Study||0||
59570288|NCT02329964|75673913|FG001|NOT COMPLETED|Overall Study||0||
59570289|NCT01704781|75673924|FG000|STARTED|Overall Study||3||
59570290|NCT01704781|75673925|FG001|STARTED|Overall Study||3||
59570291|NCT01704781|75673926|FG002|STARTED|Overall Study||6||
59570292|NCT01704781|75673927|FG003|STARTED|Overall Study||12||
59570293|NCT01704781|75673928|FG004|STARTED|Overall Study||12||
59570294|NCT01704781|75673924|FG000|COMPLETED|Overall Study||3||
59570295|NCT01704781|75673925|FG001|COMPLETED|Overall Study||3||
59570296|NCT01704781|75673926|FG002|COMPLETED|Overall Study||6||
59570297|NCT01704781|75673927|FG003|COMPLETED|Overall Study||12||
59570298|NCT01704781|75673928|FG004|COMPLETED|Overall Study||12||
59570299|NCT01704781|75673924|FG000|NOT COMPLETED|Overall Study||0||
59570300|NCT01704781|75673925|FG001|NOT COMPLETED|Overall Study||0||
59570301|NCT01704781|75673926|FG002|NOT COMPLETED|Overall Study||0||
59570302|NCT01704781|75673927|FG003|NOT COMPLETED|Overall Study||0||
59570303|NCT01704781|75673928|FG004|NOT COMPLETED|Overall Study||0||
59570304|NCT02288156|75673946|FG000|STARTED|Overall Study||20||
59570305|NCT02288156|75673947|FG001|STARTED|Overall Study||20||
59570306|NCT02288156|75673948|FG002|STARTED|Overall Study||20||
59570307|NCT02288156|75673949|FG003|STARTED|Overall Study||20||
59570308|NCT02288156|75673946|FG000|COMPLETED|Overall Study||16||
59570309|NCT02288156|75673947|FG001|COMPLETED|Overall Study||16||
59570310|NCT02288156|75673948|FG002|COMPLETED|Overall Study||18||
59570311|NCT02288156|75673949|FG003|COMPLETED|Overall Study||18||
59570312|NCT02288156|75673946|FG000|NOT COMPLETED|Overall Study||4||
59570313|NCT02288156|75673947|FG001|NOT COMPLETED|Overall Study||4||
59570314|NCT02288156|75673948|FG002|NOT COMPLETED|Overall Study||2||
59570315|NCT02288156|75673949|FG003|NOT COMPLETED|Overall Study||2||
59570316|NCT01623037|75673961|FG000|STARTED|Overall Study||15||
59570317|NCT01623037|75673961|FG000|COMPLETED|Overall Study||15||
59570318|NCT01623037|75673961|FG000|NOT COMPLETED|Overall Study||0||
59570319|NCT04087343|75673969|FG000|STARTED|Overall Study||4||
59570320|NCT04087343|75673970|FG001|STARTED|Overall Study||5||
59570321|NCT04087343|75673969|FG000|COMPLETED|Overall Study||4||
59570322|NCT04087343|75673970|FG001|COMPLETED|Overall Study||5||
59570323|NCT04087343|75673969|FG000|NOT COMPLETED|Overall Study||0||
59570324|NCT04087343|75673970|FG001|NOT COMPLETED|Overall Study||0||
59570325|NCT01686451|75673980|FG000|STARTED|Overall Study||33||
59570326|NCT01686451|75673981|FG001|STARTED|Overall Study||27||
59570327|NCT01686451|75673980|FG000|COMPLETED|Overall Study||33||
59570328|NCT01686451|75673981|FG001|COMPLETED|Overall Study||27||
59570329|NCT01686451|75673980|FG000|NOT COMPLETED|Overall Study||0||
59570330|NCT01686451|75673981|FG001|NOT COMPLETED|Overall Study||0||
59570331|NCT02411357|75673992|FG000|STARTED|Overall Study||48||
59570332|NCT02411357|75673993|FG001|STARTED|Overall Study||48||
60121158|NCT01587001|76242065|FG000|COMPLETED|Overall Study||8||
59570333|NCT02411357|75673994|FG002|STARTED|Overall Study||42||
59570334|NCT02411357|75673992|FG000|COMPLETED|Overall Study||48||
59570335|NCT02411357|75673993|FG001|COMPLETED|Overall Study||48||
59570336|NCT02411357|75673994|FG002|COMPLETED|Overall Study||42||
59570337|NCT02411357|75673992|FG000|NOT COMPLETED|Overall Study||0||
59570338|NCT02411357|75673993|FG001|NOT COMPLETED|Overall Study||0||
59570339|NCT02411357|75673994|FG002|NOT COMPLETED|Overall Study||0||
59570340|NCT01687387|75674005|FG000|STARTED|Overall Study||51||
59570341|NCT01687387|75674006|FG001|STARTED|Overall Study||50||
59570342|NCT01687387|75674007|FG002|STARTED|Overall Study||51||
59570343|NCT01687387|75674005|FG000|COMPLETED|Overall Study||10||
59570344|NCT01687387|75674006|FG001|COMPLETED|Overall Study||12||
59570345|NCT01687387|75674007|FG002|COMPLETED|Overall Study||13||
59570346|NCT01687387|75674005|FG000|NOT COMPLETED|Overall Study||41||
59570347|NCT01687387|75674006|FG001|NOT COMPLETED|Overall Study||38||
59570348|NCT01687387|75674007|FG002|NOT COMPLETED|Overall Study||38||
59570349|NCT01706263|75674015|FG000|STARTED|Overall Study||28||
59570350|NCT01706263|75674015|FG000|COMPLETED|Overall Study||28||
59570351|NCT01706263|75674015|FG000|NOT COMPLETED|Overall Study||0||
59570352|NCT01690117|75674022|FG000|STARTED|Overall Study||47||
59570353|NCT01690117|75674023|FG001|STARTED|Overall Study||45||
59570354|NCT01690117|75674022|FG000|Post-Measurement|Overall Study||41||
59570355|NCT01690117|75674023|FG001|Post-Measurement|Overall Study||40||
59570356|NCT01690117|75674022|FG000|COMPLETED|Overall Study||31||
59570357|NCT01690117|75674023|FG001|COMPLETED|Overall Study||31||
59570358|NCT01690117|75674022|FG000|NOT COMPLETED|Overall Study||16||
59570359|NCT01690117|75674023|FG001|NOT COMPLETED|Overall Study||14||
59570360|NCT02330978|75674031|FG000|STARTED|The First Patient Included at Study||1||
59570361|NCT02330978|75674031|FG000|COMPLETED|The First Patient Included at Study||1||
59570362|NCT02330978|75674031|FG000|NOT COMPLETED|The First Patient Included at Study||0||
59570363|NCT02330978|75674031|FG000|STARTED|The Second Patient Included at Study||1||
59570364|NCT02330978|75674031|FG000|COMPLETED|The Second Patient Included at Study||1||
59570365|NCT02330978|75674031|FG000|NOT COMPLETED|The Second Patient Included at Study||0||
59570366|NCT02330276|75674038|FG000|STARTED|Overall Study||4||
59570367|NCT02330276|75674039|FG001|STARTED|Overall Study||4||
59570368|NCT02330276|75674040|FG002|STARTED|Overall Study||4||
59570369|NCT02330276|75674038|FG000|COMPLETED|Overall Study||4||
59570370|NCT02330276|75674039|FG001|COMPLETED|Overall Study||4||
59570371|NCT02330276|75674040|FG002|COMPLETED|Overall Study||4||
59570372|NCT02330276|75674038|FG000|NOT COMPLETED|Overall Study||0||
59570373|NCT02330276|75674039|FG001|NOT COMPLETED|Overall Study||0||
59570374|NCT02330276|75674040|FG002|NOT COMPLETED|Overall Study||0||
59570375|NCT01690273|75674051|FG000|STARTED|Overall Study||18||
59570376|NCT01690273|75674052|FG001|STARTED|Overall Study||17||
59570377|NCT01690273|75674053|FG002|STARTED|Overall Study||20||
59570378|NCT01690273|75674051|FG000|COMPLETED|Overall Study||18||
59570379|NCT01690273|75674052|FG001|COMPLETED|Overall Study||17||
59570380|NCT01690273|75674053|FG002|COMPLETED|Overall Study||20||
59570381|NCT01690273|75674051|FG000|NOT COMPLETED|Overall Study||0||
59570382|NCT01690273|75674052|FG001|NOT COMPLETED|Overall Study||0||
59570383|NCT01690273|75674053|FG002|NOT COMPLETED|Overall Study||0||
59570384|NCT02384993|75674067|FG000|STARTED|Overall Study||12||
59570385|NCT02384993|75674068|FG001|STARTED|Overall Study||12||
59570386|NCT02384993|75674067|FG000|COMPLETED|Overall Study||12||
59570387|NCT02384993|75674068|FG001|COMPLETED|Overall Study||11||
59570388|NCT02384993|75674067|FG000|NOT COMPLETED|Overall Study||0||
59570389|NCT02384993|75674068|FG001|NOT COMPLETED|Overall Study||1||
59850254|NCT03586648|75974591|FG000|STARTED|Period 1||36||
59850255|NCT03586648|75974592|FG001|STARTED|Period 1||34||
59570390|NCT01690663|75674079|FG000|STARTED|Overall Study||23||
59570391|NCT01690663|75674080|FG001|STARTED|Overall Study||20||
59570392|NCT01690663|75674081|FG002|STARTED|Overall Study||22||
59570393|NCT01690663|75674082|FG003|STARTED|Overall Study||24||
59570394|NCT01690663|75674079|FG000|COMPLETED|Overall Study||20||
59570395|NCT01690663|75674080|FG001|COMPLETED|Overall Study||17||
59570396|NCT01690663|75674081|FG002|COMPLETED|Overall Study||19||
59570397|NCT01690663|75674082|FG003|COMPLETED|Overall Study||20||
59570398|NCT01690663|75674079|FG000|NOT COMPLETED|Overall Study||3||
59570399|NCT01690663|75674080|FG001|NOT COMPLETED|Overall Study||3||
59570400|NCT01690663|75674081|FG002|NOT COMPLETED|Overall Study||3||
59570401|NCT01690663|75674082|FG003|NOT COMPLETED|Overall Study||4||
59570402|NCT02290574|75674092|FG000|STARTED|Overall Study||14||
59570403|NCT02290574|75674092|FG000|COMPLETED|Overall Study||13||
59570404|NCT02290574|75674092|FG000|NOT COMPLETED|Overall Study||1||
59570405|NCT01706497|75674097|FG000|STARTED|Overall Study||177||
59570406|NCT01706497|75674097|FG000|COMPLETED|Overall Study||177||
59570407|NCT01706497|75674097|FG000|NOT COMPLETED|Overall Study||0||
59570408|NCT01706965|75674103|FG000|STARTED|Overall Study||14||
59570409|NCT01706965|75674104|FG001|STARTED|Overall Study||13||
59570410|NCT01706965|75674103|FG000|COMPLETED|Overall Study||13||
59570411|NCT01706965|75674104|FG001|COMPLETED|Overall Study||12||
59570412|NCT01706965|75674103|FG000|NOT COMPLETED|Overall Study||1||
59570413|NCT01706965|75674104|FG001|NOT COMPLETED|Overall Study||1||
59570414|NCT01352117|75674112|FG000|STARTED|Overall Study||96||
59570415|NCT01352117|75674113|FG001|STARTED|Overall Study||96||
59570416|NCT01352117|75674112|FG000|Entered Step 2 to Initiate Delayed ET|Overall Study||32||
59570417|NCT01352117|75674113|FG001|Entered Step 2 to Initiate Delayed ET|Overall Study|Only Arm A participants could enter Step 2 to receive delayed ET.|0||
59850256|NCT03586648|75974591|FG000|COMPLETED|Period 1||32||
59570418|NCT01352117|75674112|FG000|Study Week 48 Data Potential|Overall Study||80|Enrolled >=45 weeks prior to the date when DSMB's recommendation to close the study became public.|
59570419|NCT01352117|75674113|FG001|Study Week 48 Data Potential|Overall Study||83|Enrolled >=45 weeks prior to the date when DSMB's recommendation to close the study became public.|
59570420|NCT01352117|75674112|FG000|Study Week 96 Data Potential|Overall Study||58|Enrolled >=93 weeks prior to the date when DSMB's recommendation to close the study became public.|
59721149|NCT01106352|75840063|FG001|Completed Safety Cohort|Overall Study||0||
59570421|NCT01352117|75674113|FG001|Study Week 96 Data Potential|Overall Study||61|Enrolled >=93 weeks prior to the date when DSMB's recommendation to close the study became public.|
59570422|NCT01352117|75674112|FG000|COMPLETED|Overall Study||75|Completed study, including the long-term safety follow-up in Step 3.|
59570423|NCT01352117|75674113|FG001|COMPLETED|Overall Study||72|Completed study, including the long-term safety follow-up in Step 3.|
59570424|NCT01352117|75674112|FG000|NOT COMPLETED|Overall Study||21||
59570425|NCT01352117|75674113|FG001|NOT COMPLETED|Overall Study||24||
59570426|NCT01707043|75674124|FG000|STARTED|Overall Study||10||
59570427|NCT01707043|75674125|FG001|STARTED|Overall Study||10||
59570428|NCT01707043|75674124|FG000|COMPLETED|Overall Study||10||
59570429|NCT01707043|75674125|FG001|COMPLETED|Overall Study||10||
59570430|NCT01707043|75674124|FG000|NOT COMPLETED|Overall Study||0||
59570431|NCT01707043|75674125|FG001|NOT COMPLETED|Overall Study||0||
59570432|NCT03294499|75674131|FG000|STARTED|Overall Study||94||
59570433|NCT03294499|75674131|FG000|COMPLETED|Overall Study||94||
59570434|NCT03294499|75674131|FG000|NOT COMPLETED|Overall Study||0||
59570435|NCT01708213|75674136|FG000|STARTED|Overall Study||72||
59570436|NCT01708213|75674136|FG000|COMPLETED|Overall Study||71||
59570437|NCT01708213|75674136|FG000|NOT COMPLETED|Overall Study||1||
59570438|NCT01708525|75674140|FG000|STARTED|Overall Study||2||
59570439|NCT01708525|75674140|FG000|COMPLETED|Overall Study||2||
59570440|NCT01708525|75674140|FG000|NOT COMPLETED|Overall Study||0||
59570441|NCT02284880|75674147|FG000|STARTED|Overall Study||11||
59570442|NCT02284880|75674148|FG001|STARTED|Overall Study||9||
59570443|NCT02284880|75674149|FG002|STARTED|Overall Study||10||
59570444|NCT02284880|75674150|FG003|STARTED|Overall Study||10||
59570445|NCT02284880|75674147|FG000|First Period (4 Days)|Overall Study||11||
59570446|NCT02284880|75674148|FG001|First Period (4 Days)|Overall Study||9||
59570447|NCT02284880|75674149|FG002|First Period (4 Days)|Overall Study||10||
59570448|NCT02284880|75674150|FG003|First Period (4 Days)|Overall Study||10||
59570449|NCT02284880|75674147|FG000|Wash-out Period (7 Days)|Overall Study||11||
59570450|NCT02284880|75674148|FG001|Wash-out Period (7 Days)|Overall Study||9||
59570451|NCT02284880|75674149|FG002|Wash-out Period (7 Days)|Overall Study||10||
59570452|NCT02284880|75674150|FG003|Wash-out Period (7 Days)|Overall Study||10||
59570453|NCT02284880|75674147|FG000|Second Period (4 Days)|Overall Study||11||
59570454|NCT02284880|75674148|FG001|Second Period (4 Days)|Overall Study||9||
59570455|NCT02284880|75674149|FG002|Second Period (4 Days)|Overall Study||8||
59570456|NCT02284880|75674150|FG003|Second Period (4 Days)|Overall Study||10||
59570457|NCT02284880|75674147|FG000|COMPLETED|Overall Study||11||
59570458|NCT02284880|75674148|FG001|COMPLETED|Overall Study||9||
59570459|NCT02284880|75674149|FG002|COMPLETED|Overall Study||8||
59570460|NCT02284880|75674150|FG003|COMPLETED|Overall Study||10||
59570461|NCT02284880|75674147|FG000|NOT COMPLETED|Overall Study||0||
59570462|NCT02284880|75674148|FG001|NOT COMPLETED|Overall Study||0||
59570463|NCT02284880|75674149|FG002|NOT COMPLETED|Overall Study||2||
59570464|NCT02284880|75674150|FG003|NOT COMPLETED|Overall Study||0||
59570465|NCT01708603|75674164|FG000|STARTED|Overall Study||612||
59570466|NCT01708603|75674165|FG001|STARTED|Overall Study||610||
59570467|NCT01708603|75674166|FG002|STARTED|Overall Study||300||
59570468|NCT01708603|75674167|FG003|STARTED|Overall Study||309||
59570469|NCT01708603|75674164|FG000|COMPLETED|Overall Study||597||
59570470|NCT01708603|75674165|FG001|COMPLETED|Overall Study||588||
59570471|NCT01708603|75674166|FG002|COMPLETED|Overall Study||291||
59570472|NCT01708603|75674167|FG003|COMPLETED|Overall Study||300||
59570473|NCT01708603|75674164|FG000|NOT COMPLETED|Overall Study||15||
59570474|NCT01708603|75674165|FG001|NOT COMPLETED|Overall Study||22||
59570475|NCT01708603|75674166|FG002|NOT COMPLETED|Overall Study||9||
59850257|NCT03586648|75974592|FG001|COMPLETED|Period 1||30||
60121159|NCT01587001|76242066|FG001|COMPLETED|Overall Study||2||
59570476|NCT01708603|75674167|FG003|NOT COMPLETED|Overall Study||9||
59850258|NCT03586648|75974591|FG000|NOT COMPLETED|Period 1||4||
60121160|NCT01587001|76242065|FG000|NOT COMPLETED|Overall Study||6||
59570477|NCT03578237|75674184|FG000|STARTED|Postoperative Days 0-21||51||
59570478|NCT03578237|75674185|FG001|STARTED|Postoperative Days 0-21||48||
59570479|NCT03578237|75674184|FG000|COMPLETED|Postoperative Days 0-21||51||
59570480|NCT03578237|75674185|FG001|COMPLETED|Postoperative Days 0-21||48||
59570481|NCT03578237|75674184|FG000|NOT COMPLETED|Postoperative Days 0-21||0||
59570482|NCT03578237|75674185|FG001|NOT COMPLETED|Postoperative Days 0-21||0||
59570483|NCT03578237|75674184|FG000|STARTED|Postoperative Day 0 - Month 12||51||
59570484|NCT03578237|75674185|FG001|STARTED|Postoperative Day 0 - Month 12||48||
59570485|NCT03578237|75674184|FG000|COMPLETED|Postoperative Day 0 - Month 12||37||
59570486|NCT03578237|75674185|FG001|COMPLETED|Postoperative Day 0 - Month 12||32||
59570487|NCT03578237|75674184|FG000|NOT COMPLETED|Postoperative Day 0 - Month 12||14||
59570488|NCT03578237|75674185|FG001|NOT COMPLETED|Postoperative Day 0 - Month 12||16||
59570489|NCT02286518|75674205|FG000|STARTED|All Parts (16 Days)||6||
59570490|NCT02286518|75674206|FG001|STARTED|All Parts (16 Days)||6||
59570491|NCT02286518|75674207|FG002|STARTED|All Parts (16 Days)||6||
59570492|NCT02286518|75674208|FG003|STARTED|All Parts (16 Days)||6||
59570493|NCT02286518|75674209|FG004|STARTED|All Parts (16 Days)||6||
59570494|NCT02286518|75674210|FG005|STARTED|All Parts (16 Days)||6||
59570495|NCT02286518|75674211|FG006|STARTED|All Parts (16 Days)||6||
59570496|NCT02286518|75674212|FG007|STARTED|All Parts (16 Days)||6||
59570497|NCT02286518|75674213|FG008|STARTED|All Parts (16 Days)||6||
59570498|NCT02286518|75674214|FG009|STARTED|All Parts (16 Days)||4||
59570499|NCT02286518|75674215|FG010|STARTED|All Parts (16 Days)||6||
59570500|NCT02286518|75674216|FG011|STARTED|All Parts (16 Days)||6||
59570501|NCT02286518|75674217|FG012|STARTED|All Parts (16 Days)||6||
59570502|NCT02286518|75674218|FG013|STARTED|All Parts (16 Days)||6||
59570503|NCT02286518|75674205|FG000|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6||
59570504|NCT02286518|75674206|FG001|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6||
59570505|NCT02286518|75674207|FG002|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6||
59570506|NCT02286518|75674208|FG003|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6||
59570507|NCT02286518|75674209|FG004|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6||
59570508|NCT02286518|75674210|FG005|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6||
59570509|NCT02286518|75674211|FG006|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6||
59570510|NCT02286518|75674212|FG007|COMPLETED|All Parts (16 Days)|Only participants of Part 2 continued in next period.|6||
59570511|NCT02286518|75674213|FG008|COMPLETED|All Parts (16 Days)|Only participants of Part 2 would continue in next period.|6||
59570512|NCT02286518|75674214|FG009|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|4||
59570513|NCT02286518|75674215|FG010|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6||
59570514|NCT02286518|75674216|FG011|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6||
59570515|NCT02286518|75674217|FG012|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6||
59570516|NCT02286518|75674218|FG013|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6||
59570517|NCT02286518|75674205|FG000|NOT COMPLETED|All Parts (16 Days)||0||
59570518|NCT02286518|75674206|FG001|NOT COMPLETED|All Parts (16 Days)||0||
59570519|NCT02286518|75674207|FG002|NOT COMPLETED|All Parts (16 Days)||0||
59570520|NCT02286518|75674208|FG003|NOT COMPLETED|All Parts (16 Days)||0||
59570521|NCT02286518|75674209|FG004|NOT COMPLETED|All Parts (16 Days)||0||
59570522|NCT02286518|75674210|FG005|NOT COMPLETED|All Parts (16 Days)||0||
59570523|NCT02286518|75674211|FG006|NOT COMPLETED|All Parts (16 Days)||0||
59570524|NCT02286518|75674212|FG007|NOT COMPLETED|All Parts (16 Days)||0||
59570525|NCT02286518|75674213|FG008|NOT COMPLETED|All Parts (16 Days)||0||
59570526|NCT02286518|75674214|FG009|NOT COMPLETED|All Parts (16 Days)||0||
59570527|NCT02286518|75674215|FG010|NOT COMPLETED|All Parts (16 Days)||0||
59570528|NCT02286518|75674216|FG011|NOT COMPLETED|All Parts (16 Days)||0||
59570529|NCT02286518|75674217|FG012|NOT COMPLETED|All Parts (16 Days)||0||
59570530|NCT02286518|75674218|FG013|NOT COMPLETED|All Parts (16 Days)||0||
59570531|NCT02286518|75674205|FG000|STARTED|Washout Crossover Period(Part 2:14 Days)||0||
59570532|NCT02286518|75674206|FG001|STARTED|Washout Crossover Period(Part 2:14 Days)||0||
59570533|NCT02286518|75674207|FG002|STARTED|Washout Crossover Period(Part 2:14 Days)||0||
59570534|NCT02286518|75674208|FG003|STARTED|Washout Crossover Period(Part 2:14 Days)||0||
59570535|NCT02286518|75674209|FG004|STARTED|Washout Crossover Period(Part 2:14 Days)||0||
59570536|NCT02286518|75674210|FG005|STARTED|Washout Crossover Period(Part 2:14 Days)||0||
59570537|NCT02286518|75674211|FG006|STARTED|Washout Crossover Period(Part 2:14 Days)||0||
59570538|NCT02286518|75674212|FG007|STARTED|Washout Crossover Period(Part 2:14 Days)||6||
59570539|NCT02286518|75674213|FG008|STARTED|Washout Crossover Period(Part 2:14 Days)||6||
59570540|NCT02286518|75674214|FG009|STARTED|Washout Crossover Period(Part 2:14 Days)||0||
59570541|NCT02286518|75674215|FG010|STARTED|Washout Crossover Period(Part 2:14 Days)||0||
59570542|NCT02286518|75674216|FG011|STARTED|Washout Crossover Period(Part 2:14 Days)||0||
59570543|NCT02286518|75674217|FG012|STARTED|Washout Crossover Period(Part 2:14 Days)||0||
59570544|NCT02286518|75674218|FG013|STARTED|Washout Crossover Period(Part 2:14 Days)||0||
59570545|NCT02286518|75674205|FG000|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0||
59570546|NCT02286518|75674206|FG001|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0||
59570547|NCT02286518|75674207|FG002|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0||
59570548|NCT02286518|75674208|FG003|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0||
59570549|NCT02286518|75674209|FG004|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0||
59570550|NCT02286518|75674210|FG005|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0||
59570551|NCT02286518|75674211|FG006|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0||
59570552|NCT02286518|75674212|FG007|COMPLETED|Washout Crossover Period(Part 2:14 Days)||6||
59570553|NCT02286518|75674213|FG008|COMPLETED|Washout Crossover Period(Part 2:14 Days)||6||
59570554|NCT02286518|75674214|FG009|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0||
59570555|NCT02286518|75674215|FG010|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0||
59570556|NCT02286518|75674216|FG011|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0||
59570557|NCT02286518|75674217|FG012|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0||
59570558|NCT02286518|75674218|FG013|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0||
59570559|NCT02286518|75674205|FG000|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0||
59570560|NCT02286518|75674206|FG001|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0||
59570561|NCT02286518|75674207|FG002|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0||
59570562|NCT02286518|75674208|FG003|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0||
59570563|NCT02286518|75674209|FG004|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0||
59570564|NCT02286518|75674210|FG005|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0||
59570565|NCT02286518|75674211|FG006|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0||
59570566|NCT02286518|75674212|FG007|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0||
59570567|NCT02286518|75674213|FG008|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0||
59570568|NCT02286518|75674214|FG009|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0||
59570569|NCT02286518|75674215|FG010|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0||
59570570|NCT02286518|75674216|FG011|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0||
59570571|NCT02286518|75674217|FG012|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0||
59570572|NCT02286518|75674218|FG013|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0||
59570573|NCT02286518|75674205|FG000|STARTED|Crossover Treatment (Part 2: 3 Days)||0||
59570574|NCT02286518|75674206|FG001|STARTED|Crossover Treatment (Part 2: 3 Days)||0||
59570575|NCT02286518|75674207|FG002|STARTED|Crossover Treatment (Part 2: 3 Days)||0||
59570576|NCT02286518|75674208|FG003|STARTED|Crossover Treatment (Part 2: 3 Days)||0||
59570577|NCT02286518|75674209|FG004|STARTED|Crossover Treatment (Part 2: 3 Days)||0||
59570578|NCT02286518|75674210|FG005|STARTED|Crossover Treatment (Part 2: 3 Days)||0||
59570579|NCT02286518|75674211|FG006|STARTED|Crossover Treatment (Part 2: 3 Days)||0||
59570580|NCT02286518|75674212|FG007|STARTED|Crossover Treatment (Part 2: 3 Days)||6||
59570581|NCT02286518|75674213|FG008|STARTED|Crossover Treatment (Part 2: 3 Days)||6||
59570582|NCT02286518|75674214|FG009|STARTED|Crossover Treatment (Part 2: 3 Days)||0||
59570583|NCT02286518|75674215|FG010|STARTED|Crossover Treatment (Part 2: 3 Days)||0||
59570584|NCT02286518|75674216|FG011|STARTED|Crossover Treatment (Part 2: 3 Days)||0||
59570585|NCT02286518|75674217|FG012|STARTED|Crossover Treatment (Part 2: 3 Days)||0||
59570586|NCT02286518|75674218|FG013|STARTED|Crossover Treatment (Part 2: 3 Days)||0||
59570587|NCT02286518|75674205|FG000|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0||
59570588|NCT02286518|75674206|FG001|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0||
59570589|NCT02286518|75674207|FG002|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0||
59570590|NCT02286518|75674208|FG003|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0||
59570591|NCT02286518|75674209|FG004|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0||
59570592|NCT02286518|75674210|FG005|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0||
59570593|NCT02286518|75674211|FG006|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0||
59570594|NCT02286518|75674212|FG007|COMPLETED|Crossover Treatment (Part 2: 3 Days)||6||
59570595|NCT02286518|75674213|FG008|COMPLETED|Crossover Treatment (Part 2: 3 Days)||6||
59570596|NCT02286518|75674214|FG009|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0||
59570597|NCT02286518|75674215|FG010|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0||
59570598|NCT02286518|75674216|FG011|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0||
59570599|NCT02286518|75674217|FG012|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0||
59570600|NCT02286518|75674218|FG013|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0||
59570601|NCT02286518|75674205|FG000|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0||
59570602|NCT02286518|75674206|FG001|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0||
59570603|NCT02286518|75674207|FG002|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0||
59570604|NCT02286518|75674208|FG003|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0||
59570605|NCT02286518|75674209|FG004|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0||
59570606|NCT02286518|75674210|FG005|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0||
59570607|NCT02286518|75674211|FG006|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0||
59570608|NCT02286518|75674212|FG007|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0||
59570609|NCT02286518|75674213|FG008|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0||
59570610|NCT02286518|75674214|FG009|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0||
59570611|NCT02286518|75674215|FG010|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0||
59570612|NCT02286518|75674216|FG011|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0||
59570613|NCT02286518|75674217|FG012|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0||
59570614|NCT02286518|75674218|FG013|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0||
59570615|NCT02220725|75674268|FG000|STARTED|Overall Study||14||
59570616|NCT02220725|75674269|FG001|STARTED|Overall Study||27||
59570617|NCT02220725|75674270|FG002|STARTED|Overall Study||13||
59570618|NCT02220725|75674271|FG003|STARTED|Overall Study||26||
59570619|NCT02220725|75674268|FG000|COMPLETED|Overall Study||14||
59570620|NCT02220725|75674269|FG001|COMPLETED|Overall Study||27||
59570621|NCT02220725|75674270|FG002|COMPLETED|Overall Study||13||
59570622|NCT02220725|75674271|FG003|COMPLETED|Overall Study||24||
59570623|NCT02220725|75674268|FG000|NOT COMPLETED|Overall Study||0||
59570624|NCT02220725|75674269|FG001|NOT COMPLETED|Overall Study||0||
59570625|NCT02220725|75674270|FG002|NOT COMPLETED|Overall Study||0||
59570626|NCT02220725|75674271|FG003|NOT COMPLETED|Overall Study||2||
59850259|NCT03586648|75974592|FG001|NOT COMPLETED|Period 1||4||
59850260|NCT03586648|75974591|FG000|STARTED|Period 2||32||
59570627|NCT03522077|75674288|FG000|STARTED|Overall Study||49||
59570628|NCT03522077|75674289|FG001|STARTED|Overall Study||51||
59570629|NCT03522077|75674290|FG002|STARTED|Overall Study||100||
59570630|NCT03522077|75674291|FG003|STARTED|Overall Study||100||
59570631|NCT03522077|75674288|FG000|COMPLETED|Overall Study||49||
59570632|NCT03522077|75674289|FG001|COMPLETED|Overall Study||51||
59570633|NCT03522077|75674290|FG002|COMPLETED|Overall Study||100||
59570634|NCT03522077|75674291|FG003|COMPLETED|Overall Study||100||
59570635|NCT03522077|75674288|FG000|NOT COMPLETED|Overall Study||0||
59570636|NCT03522077|75674289|FG001|NOT COMPLETED|Overall Study||0||
59570637|NCT03522077|75674290|FG002|NOT COMPLETED|Overall Study||0||
59570638|NCT03522077|75674291|FG003|NOT COMPLETED|Overall Study||0||
59570639|NCT02249143|75674303|FG000|STARTED|Overall Study||24|randomized|
59570640|NCT02249143|75674304|FG001|STARTED|Overall Study|randomized|26|randomized|
59570641|NCT02249143|75674303|FG000|COMPLETED|Overall Study|with technically acceptable pulmonary function tests in the neonatal intensive care unit|22||
59570642|NCT02249143|75674304|FG001|COMPLETED|Overall Study|with technically acceptable pulmonary function tests in the neonatal intensive care unit|22||
59570643|NCT02249143|75674303|FG000|NOT COMPLETED|Overall Study||2||
59570644|NCT02249143|75674304|FG001|NOT COMPLETED|Overall Study||4||
59570645|NCT02259517|75674313|FG000|STARTED|Overall Study||5||
59570646|NCT02259517|75674314|FG001|STARTED|Overall Study||4||
59570647|NCT02259517|75674315|FG002|STARTED|Overall Study||24||
59570648|NCT02259517|75674313|FG000|COMPLETED|Overall Study||5||
59570649|NCT02259517|75674314|FG001|COMPLETED|Overall Study||4||
59570650|NCT02259517|75674315|FG002|COMPLETED|Overall Study||15||
59570651|NCT02259517|75674313|FG000|NOT COMPLETED|Overall Study||0||
59570652|NCT02259517|75674314|FG001|NOT COMPLETED|Overall Study||0||
59570653|NCT02259517|75674315|FG002|NOT COMPLETED|Overall Study||9||
59570654|NCT02331992|75674321|FG000|STARTED|Overall Study||34||
59570655|NCT02331992|75674321|FG000|COMPLETED|Overall Study||34||
59570656|NCT02331992|75674321|FG000|NOT COMPLETED|Overall Study||0||
59570657|NCT01710787|75674328|FG000|STARTED|Overall Study||44||
59570658|NCT01710787|75674329|FG001|STARTED|Overall Study||44||
59570659|NCT01710787|75674330|FG002|STARTED|Overall Study||22||
59570660|NCT01710787|75674328|FG000|COMPLETED|Overall Study||44||
59570661|NCT01710787|75674329|FG001|COMPLETED|Overall Study||44||
59570662|NCT01710787|75674330|FG002|COMPLETED|Overall Study||22||
59570663|NCT01710787|75674328|FG000|NOT COMPLETED|Overall Study||0||
59570664|NCT01710787|75674329|FG001|NOT COMPLETED|Overall Study||0||
59570665|NCT01710787|75674330|FG002|NOT COMPLETED|Overall Study||0||
59570666|NCT01711177|75674341|FG000|STARTED|Overall Study||10||
59570667|NCT01711177|75674342|FG001|STARTED|Overall Study||3||
59570668|NCT01711177|75674343|FG002|STARTED|Overall Study||3||
59570669|NCT01711177|75674341|FG000|COMPLETED|Overall Study||10||
59570670|NCT01711177|75674342|FG001|COMPLETED|Overall Study||3||
59570671|NCT01711177|75674343|FG002|COMPLETED|Overall Study||3||
59570672|NCT01711177|75674341|FG000|NOT COMPLETED|Overall Study||0||
59570673|NCT01711177|75674342|FG001|NOT COMPLETED|Overall Study||0||
59570674|NCT01711177|75674343|FG002|NOT COMPLETED|Overall Study||0||
59570675|NCT01714921|75674351|FG000|STARTED|Overall Study||504||
59570676|NCT01714921|75674351|FG000|COMPLETED|Overall Study||311||
59570677|NCT01714921|75674351|FG000|NOT COMPLETED|Overall Study||193||
59570678|NCT02277990|75674358|FG000|STARTED|Overall Study||3495|Randomized: Per the study protocol, only randomized subjects are included in the analysis cohort.|
59570679|NCT02277990|75674359|FG001|STARTED|Overall Study||3488|Randomized: Per the study protocol, only randomized subjects are included in the analysis cohort.|
59570680|NCT02277990|75674358|FG000|COMPLETED|Overall Study||3129|Definition of completed is that subject was followed to 12 months|
59570681|NCT02277990|75674359|FG001|COMPLETED|Overall Study||3112|Definition of completed is that subject was followed to 12 months|
59570682|NCT02277990|75674358|FG000|NOT COMPLETED|Overall Study||366||
59570683|NCT02277990|75674359|FG001|NOT COMPLETED|Overall Study||376||
59570684|NCT01715233|75674365|FG000|STARTED|Overall Study||21||
59570685|NCT01715233|75674365|FG000|COMPLETED|Overall Study||21||
59570686|NCT01715233|75674365|FG000|NOT COMPLETED|Overall Study||0||
59570687|NCT01716013|75674372|FG000|STARTED|Overall Study||108||
59570688|NCT01716013|75674373|FG001|STARTED|Overall Study||54||
59570689|NCT01716013|75674372|FG000|COMPLETED|Overall Study||105||
59570690|NCT01716013|75674373|FG001|COMPLETED|Overall Study||54||
59570691|NCT01716013|75674372|FG000|NOT COMPLETED|Overall Study||3||
59570692|NCT01716013|75674373|FG001|NOT COMPLETED|Overall Study||0||
59570693|NCT02317614|75674381|FG000|STARTED|Overall Study||26||
59570694|NCT02317614|75674382|FG001|STARTED|Overall Study||25||
59570695|NCT02317614|75674381|FG000|COMPLETED|Overall Study||23|1 non-complete lost to follow-up prior to accessing intervention (immediately after enrollment)|
59570696|NCT02317614|75674382|FG001|COMPLETED|Overall Study||23|1 non-complete lost to follow-up prior to accessing intervention (immediately after enrollment)|
59570697|NCT02317614|75674381|FG000|NOT COMPLETED|Overall Study||3||
59570698|NCT02317614|75674382|FG001|NOT COMPLETED|Overall Study||2||
59570699|NCT01719367|75674388|FG000|STARTED|Overall Study||19||
59570700|NCT01719367|75674389|FG001|STARTED|Overall Study||19||
59570701|NCT01719367|75674388|FG000|COMPLETED|Overall Study||19||
59570702|NCT01719367|75674389|FG001|COMPLETED|Overall Study||19||
59570703|NCT01719367|75674388|FG000|NOT COMPLETED|Overall Study||0||
59570704|NCT01719367|75674389|FG001|NOT COMPLETED|Overall Study||0||
59721150|NCT01106352|75840064|FG002|Completed Safety Cohort|Overall Study||0||
59570705|NCT02276040|75674395|FG000|STARTED|Overall Study||26||
59570706|NCT02276040|75674395|FG000|COMPLETED|Overall Study||11|Patients with insufficient bleeding to allow for toxicology testing were withdrawn from the study.|
59570707|NCT02276040|75674395|FG000|NOT COMPLETED|Overall Study||15||
59570708|NCT02315664|75674401|FG000|STARTED|Overall Study||30||
59570709|NCT02315664|75674402|FG001|STARTED|Overall Study||31||
59570710|NCT02315664|75674401|FG000|COMPLETED|Overall Study||29||
59570711|NCT02315664|75674402|FG001|COMPLETED|Overall Study||27||
59570712|NCT02315664|75674401|FG000|NOT COMPLETED|Overall Study||1||
59570713|NCT02315664|75674402|FG001|NOT COMPLETED|Overall Study||4||
59570714|NCT02250703|75674410|FG000|STARTED|Overall Study||38||
59570715|NCT02250703|75674411|FG001|STARTED|Overall Study||37||
59570716|NCT02250703|75674410|FG000|COMPLETED|Overall Study||37||
59570717|NCT02250703|75674411|FG001|COMPLETED|Overall Study||36||
59570718|NCT02250703|75674410|FG000|NOT COMPLETED|Overall Study||1||
59570719|NCT02250703|75674411|FG001|NOT COMPLETED|Overall Study||1||
59570720|NCT02298842|75674419|FG000|STARTED|First Platelet Donation (Day 0)||44||
59570721|NCT02298842|75674420|FG001|STARTED|First Platelet Donation (Day 0)||41||
59570722|NCT02298842|75674419|FG000|COMPLETED|First Platelet Donation (Day 0)||38||
59570723|NCT02298842|75674420|FG001|COMPLETED|First Platelet Donation (Day 0)||36||
59570724|NCT02298842|75674419|FG000|NOT COMPLETED|First Platelet Donation (Day 0)||6||
59570725|NCT02298842|75674420|FG001|NOT COMPLETED|First Platelet Donation (Day 0)||5||
59570726|NCT02298842|75674419|FG000|STARTED|Second Platelet Donation (Day 6-8)||38||
59570727|NCT02298842|75674420|FG001|STARTED|Second Platelet Donation (Day 6-8)||36||
59570728|NCT02298842|75674419|FG000|COMPLETED|Second Platelet Donation (Day 6-8)||30||
59570729|NCT02298842|75674420|FG001|COMPLETED|Second Platelet Donation (Day 6-8)||30||
59570730|NCT02298842|75674419|FG000|NOT COMPLETED|Second Platelet Donation (Day 6-8)||8||
59570731|NCT02298842|75674420|FG001|NOT COMPLETED|Second Platelet Donation (Day 6-8)||6||
59570732|NCT02314728|75674430|FG000|STARTED|Overall Study||117||
59570733|NCT02314728|75674431|FG001|STARTED|Overall Study||113||
59570734|NCT02314728|75674430|FG000|COMPLETED|Overall Study||116||
59570735|NCT02314728|75674431|FG001|COMPLETED|Overall Study||112||
59570736|NCT02314728|75674430|FG000|NOT COMPLETED|Overall Study||1||
59570737|NCT02314728|75674431|FG001|NOT COMPLETED|Overall Study||1||
59570738|NCT02326363|75674441|FG000|STARTED|Overall Study||98||
59570739|NCT02326363|75674442|FG001|STARTED|Overall Study||106||
59570740|NCT02326363|75674441|FG000|COMPLETED|Overall Study||47||
59570741|NCT02326363|75674442|FG001|COMPLETED|Overall Study||50||
59570742|NCT02326363|75674441|FG000|NOT COMPLETED|Overall Study||51||
59570743|NCT02326363|75674442|FG001|NOT COMPLETED|Overall Study||56||
59570744|NCT02275338|75674450|FG000|STARTED|Overall Study||52||
59570745|NCT02275338|75674450|FG000|Completed Phase 1|Overall Study||25||
59570746|NCT02275338|75674450|FG000|Started Phase 2|Overall Study||21||
59570747|NCT02275338|75674450|FG000|COMPLETED|Overall Study||19||
59570748|NCT02275338|75674450|FG000|NOT COMPLETED|Overall Study||33||
59570749|NCT02313558|75674457|FG000|STARTED|Overall Study||50||
59570750|NCT02313558|75674458|FG001|STARTED|Overall Study||50||
59570751|NCT02313558|75674457|FG000|COMPLETED|Overall Study||44||
59570752|NCT02313558|75674458|FG001|COMPLETED|Overall Study||46||
59570753|NCT02313558|75674457|FG000|NOT COMPLETED|Overall Study||6||
59570754|NCT02313558|75674458|FG001|NOT COMPLETED|Overall Study||4||
59570755|NCT01721473|75674470|FG000|STARTED|Overall Study||47||
59570756|NCT01721473|75674471|FG001|STARTED|Overall Study||22||
59570757|NCT01721473|75674472|FG002|STARTED|Overall Study||41||
59570758|NCT01721473|75674473|FG003|STARTED|Overall Study||34||
59570759|NCT01721473|75674474|FG004|STARTED|Overall Study||22||
59570760|NCT01721473|75674475|FG005|STARTED|Overall Study||18||
59570761|NCT01721473|75674470|FG000|COMPLETED|Overall Study||47||
59570762|NCT01721473|75674471|FG001|COMPLETED|Overall Study||22||
59570763|NCT01721473|75674472|FG002|COMPLETED|Overall Study||41||
59570764|NCT01721473|75674473|FG003|COMPLETED|Overall Study||34||
59570765|NCT01721473|75674474|FG004|COMPLETED|Overall Study||22||
59570766|NCT01721473|75674475|FG005|COMPLETED|Overall Study||18||
59570767|NCT01721473|75674470|FG000|NOT COMPLETED|Overall Study||0||
59721151|NCT01106352|75840065|FG003|Completed Safety Cohort|Overall Study||23||
59721152|NCT01106352|75840066|FG004|Completed Safety Cohort|Overall Study||9||
59721153|NCT01106352|75840062|FG000|COMPLETED|Overall Study||6||
59721154|NCT01106352|75840063|FG001|COMPLETED|Overall Study||3||
59721155|NCT01106352|75840064|FG002|COMPLETED|Overall Study||5||
59721156|NCT01106352|75840065|FG003|COMPLETED|Overall Study|This group is only applicable for Safety cohort period.|23||
59721157|NCT01106352|75840066|FG004|COMPLETED|Overall Study|This group is only applicable for Safety cohort period.|9||
59721158|NCT01106352|75840062|FG000|NOT COMPLETED|Overall Study||1||
59570768|NCT01721473|75674471|FG001|NOT COMPLETED|Overall Study||0||
59570769|NCT01721473|75674472|FG002|NOT COMPLETED|Overall Study||0||
59850261|NCT03586648|75974592|FG001|STARTED|Period 2||30||
59570770|NCT01721473|75674473|FG003|NOT COMPLETED|Overall Study||0||
59570771|NCT01721473|75674474|FG004|NOT COMPLETED|Overall Study||0||
59570772|NCT01721473|75674475|FG005|NOT COMPLETED|Overall Study||0||
59570773|NCT01646268|75674486|FG000|STARTED|Overall Study||124||
59570774|NCT01646268|75674487|FG001|STARTED|Overall Study||123||
59570775|NCT01646268|75674486|FG000|COMPLETED|Overall Study||113||
59570776|NCT01646268|75674487|FG001|COMPLETED|Overall Study||107||
59570777|NCT01646268|75674486|FG000|NOT COMPLETED|Overall Study||11||
59570778|NCT01646268|75674487|FG001|NOT COMPLETED|Overall Study||16||
59570779|NCT02275026|75674493|FG000|STARTED|Overall Study||104||
59570780|NCT02275026|75674493|FG000|COMPLETED|Overall Study||71||
59570781|NCT02275026|75674493|FG000|NOT COMPLETED|Overall Study||33||
59570782|NCT02294630|75674504|FG000|STARTED|Overall Study||37||
59570783|NCT02294630|75674505|FG001|STARTED|Overall Study||38||
59570784|NCT02294630|75674506|FG002|STARTED|Overall Study||35||
59570785|NCT02294630|75674507|FG003|STARTED|Overall Study||39||
59570786|NCT02294630|75674504|FG000|COMPLETED|Overall Study||37||
59570787|NCT02294630|75674505|FG001|COMPLETED|Overall Study||38||
59570788|NCT02294630|75674506|FG002|COMPLETED|Overall Study||35||
59570789|NCT02294630|75674507|FG003|COMPLETED|Overall Study||39||
59570790|NCT02294630|75674504|FG000|NOT COMPLETED|Overall Study||0||
59570791|NCT02294630|75674505|FG001|NOT COMPLETED|Overall Study||0||
59570792|NCT02294630|75674506|FG002|NOT COMPLETED|Overall Study||0||
59570793|NCT02294630|75674507|FG003|NOT COMPLETED|Overall Study||0||
59570794|NCT01722487|75674519|FG000|STARTED|Overall Study||136||
59570795|NCT01722487|75674520|FG001|STARTED|Overall Study||133||
59570796|NCT01722487|75674519|FG000|COMPLETED|Overall Study|Participants who were still on study or died at study closure|134||
59570797|NCT01722487|75674520|FG001|COMPLETED|Overall Study|Participants who were still on study or died at study closure|126||
59570798|NCT01722487|75674519|FG000|NOT COMPLETED|Overall Study||2||
59570799|NCT01722487|75674520|FG001|NOT COMPLETED|Overall Study||7||
59570800|NCT02730962|75674529|FG000|STARTED|Overall Study||7||
59570801|NCT02730962|75674530|FG001|STARTED|Overall Study||5||
59570802|NCT02730962|75674529|FG000|COMPLETED|Overall Study||7||
59570803|NCT02730962|75674530|FG001|COMPLETED|Overall Study||5||
59570804|NCT02730962|75674529|FG000|NOT COMPLETED|Overall Study||0||
59570805|NCT02730962|75674530|FG001|NOT COMPLETED|Overall Study||0||
59570806|NCT01722643|75674538|FG000|STARTED|Overall Study||30||
59570807|NCT01722643|75674539|FG001|STARTED|Overall Study||31||
59570808|NCT01722643|75674538|FG000|COMPLETED|Overall Study||30||
59570809|NCT01722643|75674539|FG001|COMPLETED|Overall Study||30||
59570810|NCT01722643|75674538|FG000|NOT COMPLETED|Overall Study||0||
59570811|NCT01722643|75674539|FG001|NOT COMPLETED|Overall Study||1||
59570812|NCT02296346|75674547|FG000|STARTED|Overall Study||7||
59570813|NCT02296346|75674548|FG001|STARTED|Overall Study||6||
59570814|NCT02296346|75674547|FG000|COMPLETED|Overall Study||2||
59570815|NCT02296346|75674548|FG001|COMPLETED|Overall Study||0||
59570816|NCT02296346|75674547|FG000|NOT COMPLETED|Overall Study||5||
59570817|NCT02296346|75674548|FG001|NOT COMPLETED|Overall Study||6||
59570818|NCT01726621|75674556|FG000|STARTED|Overall Study||55||
59570819|NCT01726621|75674556|FG000|COMPLETED|Overall Study||51||
59570820|NCT01726621|75674556|FG000|NOT COMPLETED|Overall Study||4||
59570821|NCT02296502|75674564|FG000|STARTED|Overall Study||248||
59570822|NCT02296502|75674565|FG001|STARTED|Overall Study||1||
59570823|NCT02296502|75674566|FG002|STARTED|Overall Study||30||
59570824|NCT02296502|75674567|FG003|STARTED|Overall Study||160||
59570825|NCT02296502|75674564|FG000|COMPLETED|Overall Study||248||
59570826|NCT02296502|75674565|FG001|COMPLETED|Overall Study||1||
59570827|NCT02296502|75674566|FG002|COMPLETED|Overall Study||30||
59570828|NCT02296502|75674567|FG003|COMPLETED|Overall Study||160||
59570829|NCT02296502|75674564|FG000|NOT COMPLETED|Overall Study||0||
59570830|NCT02296502|75674565|FG001|NOT COMPLETED|Overall Study||0||
59570831|NCT02296502|75674566|FG002|NOT COMPLETED|Overall Study||0||
59570832|NCT02296502|75674567|FG003|NOT COMPLETED|Overall Study||0||
59570833|NCT02372630|75674582|FG000|STARTED|Overall Study||20||
59570834|NCT02372630|75674583|FG001|STARTED|Overall Study||20||
59570835|NCT02372630|75674582|FG000|COMPLETED|Overall Study||17||
59570836|NCT02372630|75674583|FG001|COMPLETED|Overall Study||17||
59570837|NCT02372630|75674582|FG000|NOT COMPLETED|Overall Study||3||
59570838|NCT02372630|75674583|FG001|NOT COMPLETED|Overall Study||3||
59570839|NCT02303990|75674589|FG000|STARTED|Overall Study||59||
59570840|NCT02303990|75674589|FG000|COMPLETED|Overall Study||59||
59570841|NCT02303990|75674589|FG000|NOT COMPLETED|Overall Study||0||
59570842|NCT04579250|75674596|FG000|STARTED|Overall Study||3||
59570843|NCT04579250|75674597|FG001|STARTED|Overall Study||14||
59570844|NCT04579250|75674598|FG002|STARTED|Overall Study||8||
59570845|NCT04579250|75674596|FG000|Received First Product Administration|Overall Study||3||
59570846|NCT04579250|75674597|FG001|Received First Product Administration|Overall Study||14||
59570847|NCT04579250|75674598|FG002|Received First Product Administration|Overall Study||8||
59570848|NCT04579250|75674596|FG000|Completed Product Administrations|Overall Study||3||
59570849|NCT04579250|75674597|FG001|Completed Product Administrations|Overall Study||14||
59570850|NCT04579250|75674598|FG002|Completed Product Administrations|Overall Study||8||
59570851|NCT04579250|75674596|FG000|COMPLETED|Overall Study||1||
59570852|NCT04579250|75674597|FG001|COMPLETED|Overall Study||11||
59570853|NCT04579250|75674598|FG002|COMPLETED|Overall Study||6||
59570854|NCT04579250|75674596|FG000|NOT COMPLETED|Overall Study||2||
59570855|NCT04579250|75674597|FG001|NOT COMPLETED|Overall Study||3||
59570856|NCT04579250|75674598|FG002|NOT COMPLETED|Overall Study||2||
59570857|NCT01727089|75674611|FG000|STARTED|Overall Study||29||
59570858|NCT01727089|75674612|FG001|STARTED|Overall Study||30||
59570859|NCT01727089|75674611|FG000|COMPLETED|Overall Study||29||
59570860|NCT01727089|75674612|FG001|COMPLETED|Overall Study||30||
59570861|NCT01727089|75674611|FG000|NOT COMPLETED|Overall Study||0||
59570862|NCT01727089|75674612|FG001|NOT COMPLETED|Overall Study||0||
59570863|NCT03175367|75674625|FG000|STARTED|Double-blind Treatment Period (DBTP)||39||
59570864|NCT03175367|75674626|FG001|STARTED|Double-blind Treatment Period (DBTP)||39||
59570865|NCT03175367|75674627|FG002|STARTED|Double-blind Treatment Period (DBTP)||42||
59570866|NCT03175367|75674628|FG003|STARTED|Double-blind Treatment Period (DBTP)||40||
59570867|NCT03175367|75674629|FG004|STARTED|Double-blind Treatment Period (DBTP)||33||
59570868|NCT03175367|75674630|FG005|STARTED|Double-blind Treatment Period (DBTP)||35||
59570869|NCT03175367|75674631|FG006|STARTED|Double-blind Treatment Period (DBTP)||38||
59570870|NCT03175367|75674625|FG000|COMPLETED|Double-blind Treatment Period (DBTP)||30||
59570871|NCT03175367|75674626|FG001|COMPLETED|Double-blind Treatment Period (DBTP)||31||
59570872|NCT03175367|75674627|FG002|COMPLETED|Double-blind Treatment Period (DBTP)||30||
59570873|NCT03175367|75674628|FG003|COMPLETED|Double-blind Treatment Period (DBTP)||30||
59570874|NCT03175367|75674629|FG004|COMPLETED|Double-blind Treatment Period (DBTP)||31||
59570875|NCT03175367|75674630|FG005|COMPLETED|Double-blind Treatment Period (DBTP)||32||
59570876|NCT03175367|75674631|FG006|COMPLETED|Double-blind Treatment Period (DBTP)||34||
59570877|NCT03175367|75674625|FG000|NOT COMPLETED|Double-blind Treatment Period (DBTP)||9||
59570878|NCT03175367|75674626|FG001|NOT COMPLETED|Double-blind Treatment Period (DBTP)||8||
59570879|NCT03175367|75674627|FG002|NOT COMPLETED|Double-blind Treatment Period (DBTP)||12||
59570880|NCT03175367|75674628|FG003|NOT COMPLETED|Double-blind Treatment Period (DBTP)||10||
59570881|NCT03175367|75674629|FG004|NOT COMPLETED|Double-blind Treatment Period (DBTP)||2||
59570882|NCT03175367|75674630|FG005|NOT COMPLETED|Double-blind Treatment Period (DBTP)||3||
59570883|NCT03175367|75674631|FG006|NOT COMPLETED|Double-blind Treatment Period (DBTP)||4||
59570884|NCT03175367|75674625|FG000|STARTED|Open-Label Treatment Period (OLTP)||0|Treated in OLTP|
59570885|NCT03175367|75674626|FG001|STARTED|Open-Label Treatment Period (OLTP)||0|Treated in OLTP|
59570886|NCT03175367|75674627|FG002|STARTED|Open-Label Treatment Period (OLTP)||0|Treated in OLTP|
59570887|NCT03175367|75674628|FG003|STARTED|Open-Label Treatment Period (OLTP)||0|Treated in OLTP|
59570888|NCT03175367|75674629|FG004|STARTED|Open-Label Treatment Period (OLTP)||31|Treated in OLTP|
59570889|NCT03175367|75674630|FG005|STARTED|Open-Label Treatment Period (OLTP)||32|Treated in OLTP|
59570890|NCT03175367|75674631|FG006|STARTED|Open-Label Treatment Period (OLTP)|One participant completed DBTP, but did not continue to OLTP|33|Treated in OLTP|
59570891|NCT03175367|75674625|FG000|COMPLETED|Open-Label Treatment Period (OLTP)||0|Completed Study|
59570892|NCT03175367|75674626|FG001|COMPLETED|Open-Label Treatment Period (OLTP)||0|Completed Study|
59570893|NCT03175367|75674627|FG002|COMPLETED|Open-Label Treatment Period (OLTP)||0|Completed Study|
59570894|NCT03175367|75674628|FG003|COMPLETED|Open-Label Treatment Period (OLTP)||0|Completed Study|
59570895|NCT03175367|75674629|FG004|COMPLETED|Open-Label Treatment Period (OLTP)||31|Completed Study|
59570896|NCT03175367|75674630|FG005|COMPLETED|Open-Label Treatment Period (OLTP)||30|Completed Study|
59570897|NCT03175367|75674631|FG006|COMPLETED|Open-Label Treatment Period (OLTP)||31|Completed Study|
59570898|NCT03175367|75674625|FG000|NOT COMPLETED|Open-Label Treatment Period (OLTP)||0||
59570899|NCT03175367|75674626|FG001|NOT COMPLETED|Open-Label Treatment Period (OLTP)||0||
59570900|NCT03175367|75674627|FG002|NOT COMPLETED|Open-Label Treatment Period (OLTP)||0||
59570901|NCT03175367|75674628|FG003|NOT COMPLETED|Open-Label Treatment Period (OLTP)||0||
59570902|NCT03175367|75674629|FG004|NOT COMPLETED|Open-Label Treatment Period (OLTP)||0||
59570903|NCT03175367|75674630|FG005|NOT COMPLETED|Open-Label Treatment Period (OLTP)||2||
59570904|NCT03175367|75674631|FG006|NOT COMPLETED|Open-Label Treatment Period (OLTP)||2||
59570905|NCT01727791|75674653|FG000|STARTED|Overall Study||10||
59570906|NCT01727791|75674653|FG000|COMPLETED|Overall Study||10||
59570907|NCT01727791|75674653|FG000|NOT COMPLETED|Overall Study||0||
59570908|NCT01728337|75674657|FG000|STARTED|Overall Study||80||
59570909|NCT01728337|75674657|FG000|COMPLETED|Overall Study||80||
59570910|NCT01728337|75674657|FG000|NOT COMPLETED|Overall Study||0||
59570911|NCT02247193|75674665|FG000|STARTED|Overall Study||15||
59570912|NCT02247193|75674666|FG001|STARTED|Overall Study||15||
59570913|NCT02247193|75674665|FG000|Number Who Underwent Cleft Lip Repair Surgery|Overall Study||15||
59570914|NCT02247193|75674666|FG001|Number Who Underwent Cleft Lip Repair Surgery|Overall Study||15||
59570915|NCT02247193|75674665|FG000|Number Who Received Botox or Placebo|Overall Study||15||
59570916|NCT02247193|75674666|FG001|Number Who Received Botox or Placebo|Overall Study||15||
59570917|NCT02247193|75674665|FG000|Number Who Completed the 6-month Follow up|Overall Study||15||
59570918|NCT02247193|75674666|FG001|Number Who Completed the 6-month Follow up|Overall Study||15||
59570919|NCT02247193|75674665|FG000|Number Who Completed the 12-month Follow up|Overall Study||15||
59570920|NCT02247193|75674666|FG001|Number Who Completed the 12-month Follow up|Overall Study||15||
59570921|NCT02247193|75674665|FG000|COMPLETED|Overall Study||15||
59570922|NCT02247193|75674666|FG001|COMPLETED|Overall Study||15||
59570923|NCT02247193|75674665|FG000|NOT COMPLETED|Overall Study||0||
59570924|NCT02247193|75674666|FG001|NOT COMPLETED|Overall Study||0||
59570925|NCT03174275|75674672|FG000|STARTED|Overall Study (Until End of Surgery)||39||
59570926|NCT03174275|75674672|FG000|COMPLETED|Overall Study (Until End of Surgery)||25||
59570927|NCT03174275|75674672|FG000|NOT COMPLETED|Overall Study (Until End of Surgery)||14||
59721159|NCT01106352|75840063|FG001|NOT COMPLETED|Overall Study||0||
59570928|NCT03174275|75674672|FG000|STARTED|Adjuvant Chemotherapy|The participants were prescribed adjuvant chemotherapy based on the surgical pathology report included.|21||
59570929|NCT03174275|75674672|FG000|COMPLETED|Adjuvant Chemotherapy||13||
59570930|NCT03174275|75674672|FG000|NOT COMPLETED|Adjuvant Chemotherapy||8||
59570931|NCT03174275|75674672|FG000|STARTED|Adjuvant Durvalumab|The participants were prescribed adjuvant durvalumab based on the surgical pathology report included.|35||
59570932|NCT03174275|75674672|FG000|COMPLETED|Adjuvant Durvalumab||25||
59570933|NCT03174275|75674672|FG000|NOT COMPLETED|Adjuvant Durvalumab||10||
59570934|NCT03174275|75674672|FG000|STARTED|Adjuvant Radiotherapy|The participants were prescribed adjuvant radiotherapy based on the surgical pathology report included.|21||
59570935|NCT03174275|75674672|FG000|COMPLETED|Adjuvant Radiotherapy||14||
59570936|NCT03174275|75674672|FG000|NOT COMPLETED|Adjuvant Radiotherapy||7||
59570937|NCT01731691|75674679|FG000|STARTED|Overall Study||3||
59570938|NCT01731691|75674680|FG001|STARTED|Overall Study||5||
59570939|NCT01731691|75674681|FG002|STARTED|Overall Study||4||
59570940|NCT01731691|75674679|FG000|COMPLETED|Overall Study||3||
59570941|NCT01731691|75674680|FG001|COMPLETED|Overall Study||5||
59721160|NCT01106352|75840064|FG002|NOT COMPLETED|Overall Study||2||
59721161|NCT01106352|75840065|FG003|NOT COMPLETED|Overall Study||13||
59721162|NCT01106352|75840066|FG004|NOT COMPLETED|Overall Study||8||
59721163|NCT01144403|75840082|FG000|STARTED|Overall Study||8||
59721164|NCT01144403|75840082|FG000|COMPLETED|Overall Study||3||
59721165|NCT01144403|75840082|FG000|NOT COMPLETED|Overall Study||5||
59721166|NCT01143389|75840089|FG000|STARTED|Overall Study||253||
59721167|NCT01143389|75840090|FG001|STARTED|Overall Study||257||
59721168|NCT01143389|75840089|FG000|COMPLETED|Overall Study||227||
59721169|NCT01143389|75840090|FG001|COMPLETED|Overall Study||232||
59721170|NCT01143389|75840089|FG000|NOT COMPLETED|Overall Study||26||
59721171|NCT01143389|75840090|FG001|NOT COMPLETED|Overall Study||25||
59721172|NCT00868231|75840096|FG000|STARTED|Treatment Period 1||5||
59721173|NCT00868231|75840097|FG001|STARTED|Treatment Period 1||5||
59721174|NCT00868231|75840098|FG002|STARTED|Treatment Period 1||5||
59721175|NCT00868231|75840099|FG003|STARTED|Treatment Period 1||5||
59721176|NCT00868231|75840100|FG004|STARTED|Treatment Period 1||5||
59721177|NCT00868231|75840101|FG005|STARTED|Treatment Period 1||5||
59721178|NCT00868231|75840096|FG000|COMPLETED|Treatment Period 1||5||
59721179|NCT00868231|75840097|FG001|COMPLETED|Treatment Period 1||5||
59721180|NCT00868231|75840098|FG002|COMPLETED|Treatment Period 1||5||
59721181|NCT00868231|75840099|FG003|COMPLETED|Treatment Period 1||5||
59721182|NCT00868231|75840100|FG004|COMPLETED|Treatment Period 1||4||
59721183|NCT00868231|75840101|FG005|COMPLETED|Treatment Period 1||5||
59721184|NCT00868231|75840096|FG000|NOT COMPLETED|Treatment Period 1||0||
59721185|NCT00868231|75840097|FG001|NOT COMPLETED|Treatment Period 1||0||
59721186|NCT00868231|75840098|FG002|NOT COMPLETED|Treatment Period 1||0||
59721187|NCT00868231|75840099|FG003|NOT COMPLETED|Treatment Period 1||0||
59721188|NCT00868231|75840100|FG004|NOT COMPLETED|Treatment Period 1||1||
59721189|NCT00868231|75840101|FG005|NOT COMPLETED|Treatment Period 1||0||
59721190|NCT00868231|75840096|FG000|STARTED|Treatment Period 2||5||
59721191|NCT00868231|75840097|FG001|STARTED|Treatment Period 2||5||
59721192|NCT00868231|75840098|FG002|STARTED|Treatment Period 2||5||
59721193|NCT00868231|75840099|FG003|STARTED|Treatment Period 2||5||
59721194|NCT00868231|75840100|FG004|STARTED|Treatment Period 2||4||
59721195|NCT00868231|75840101|FG005|STARTED|Treatment Period 2||5||
59721196|NCT00868231|75840096|FG000|COMPLETED|Treatment Period 2||4||
59721197|NCT00868231|75840097|FG001|COMPLETED|Treatment Period 2||5||
59721198|NCT00868231|75840098|FG002|COMPLETED|Treatment Period 2||5||
59721199|NCT00868231|75840099|FG003|COMPLETED|Treatment Period 2||5||
59721200|NCT00868231|75840100|FG004|COMPLETED|Treatment Period 2||4||
59721201|NCT00868231|75840101|FG005|COMPLETED|Treatment Period 2||5||
59721202|NCT00868231|75840096|FG000|NOT COMPLETED|Treatment Period 2||1||
59721203|NCT00868231|75840097|FG001|NOT COMPLETED|Treatment Period 2||0||
59721204|NCT00868231|75840098|FG002|NOT COMPLETED|Treatment Period 2||0||
59721205|NCT00868231|75840099|FG003|NOT COMPLETED|Treatment Period 2||0||
59721206|NCT00868231|75840100|FG004|NOT COMPLETED|Treatment Period 2||0||
59721207|NCT00868231|75840101|FG005|NOT COMPLETED|Treatment Period 2||0||
59721208|NCT00868231|75840096|FG000|STARTED|Treatment Period 3||4||
59721209|NCT00868231|75840097|FG001|STARTED|Treatment Period 3||5||
59721210|NCT00868231|75840098|FG002|STARTED|Treatment Period 3||5||
59721211|NCT00868231|75840099|FG003|STARTED|Treatment Period 3||5||
59721212|NCT00868231|75840100|FG004|STARTED|Treatment Period 3||4||
59721213|NCT00868231|75840101|FG005|STARTED|Treatment Period 3||5||
59721214|NCT00868231|75840096|FG000|COMPLETED|Treatment Period 3||4||
59721215|NCT00868231|75840097|FG001|COMPLETED|Treatment Period 3||5||
59721216|NCT00868231|75840098|FG002|COMPLETED|Treatment Period 3||4||
59721217|NCT00868231|75840099|FG003|COMPLETED|Treatment Period 3||5||
59721218|NCT00868231|75840100|FG004|COMPLETED|Treatment Period 3||4||
59721219|NCT00868231|75840101|FG005|COMPLETED|Treatment Period 3||5||
59721220|NCT00868231|75840096|FG000|NOT COMPLETED|Treatment Period 3||0||
59721221|NCT00868231|75840097|FG001|NOT COMPLETED|Treatment Period 3||0||
59721222|NCT00868231|75840098|FG002|NOT COMPLETED|Treatment Period 3||1||
59570942|NCT01731691|75674681|FG002|COMPLETED|Overall Study||4||
59570943|NCT01731691|75674679|FG000|NOT COMPLETED|Overall Study||0||
59570944|NCT01731691|75674680|FG001|NOT COMPLETED|Overall Study||0||
59570945|NCT01731691|75674681|FG002|NOT COMPLETED|Overall Study||0||
59570946|NCT02247739|75674692|FG000|STARTED|Overall Study||5||
59570947|NCT02247739|75674693|FG001|STARTED|Overall Study||6||
59570948|NCT02247739|75674694|FG002|STARTED|Overall Study||5||
59570949|NCT02247739|75674695|FG003|STARTED|Overall Study||5||
59570950|NCT02247739|75674696|FG004|STARTED|Overall Study||6||
59570951|NCT02247739|75674697|FG005|STARTED|Overall Study||5||
59570952|NCT02247739|75674692|FG000|COMPLETED|Overall Study||5||
59570953|NCT02247739|75674693|FG001|COMPLETED|Overall Study||3||
59570954|NCT02247739|75674694|FG002|COMPLETED|Overall Study||4||
59570955|NCT02247739|75674695|FG003|COMPLETED|Overall Study||5||
59570956|NCT02247739|75674696|FG004|COMPLETED|Overall Study||5||
59570957|NCT02247739|75674697|FG005|COMPLETED|Overall Study||4||
59570958|NCT02247739|75674692|FG000|NOT COMPLETED|Overall Study||0||
59570959|NCT02247739|75674693|FG001|NOT COMPLETED|Overall Study||3||
59570960|NCT02247739|75674694|FG002|NOT COMPLETED|Overall Study||1||
59570961|NCT02247739|75674695|FG003|NOT COMPLETED|Overall Study||0||
59570962|NCT02247739|75674696|FG004|NOT COMPLETED|Overall Study||1||
59570963|NCT02247739|75674697|FG005|NOT COMPLETED|Overall Study||1||
59570964|NCT02440451|75674707|FG000|STARTED|Overall Study||15|Started the intervention protocol.|
59570965|NCT02440451|75674707|FG000|COMPLETED|Overall Study||15|Completed the intervention protocol.|
59570966|NCT02440451|75674707|FG000|NOT COMPLETED|Overall Study||0||
59570967|NCT02442869|75674717|FG000|STARTED|Overall Study||18||
59570968|NCT02442869|75674718|FG001|STARTED|Overall Study||29||
59570969|NCT02442869|75674719|FG002|STARTED|Overall Study||6||
59570970|NCT02442869|75674720|FG003|STARTED|Overall Study||2||
59570971|NCT02442869|75674721|FG004|STARTED|Overall Study||5||
59570972|NCT02442869|75674722|FG005|STARTED|Overall Study||2||
59570973|NCT02442869|75674717|FG000|COMPLETED|Overall Study||13||
59570974|NCT02442869|75674718|FG001|COMPLETED|Overall Study||20||
59570975|NCT02442869|75674719|FG002|COMPLETED|Overall Study||6||
59570976|NCT02442869|75674720|FG003|COMPLETED|Overall Study||1||
59570977|NCT02442869|75674721|FG004|COMPLETED|Overall Study||3||
59570978|NCT02442869|75674722|FG005|COMPLETED|Overall Study||2||
59570979|NCT02442869|75674717|FG000|NOT COMPLETED|Overall Study||5||
59570980|NCT02442869|75674718|FG001|NOT COMPLETED|Overall Study||9||
59570981|NCT02442869|75674719|FG002|NOT COMPLETED|Overall Study||0||
59570982|NCT02442869|75674720|FG003|NOT COMPLETED|Overall Study||1||
59570983|NCT02442869|75674721|FG004|NOT COMPLETED|Overall Study||2||
59570984|NCT02442869|75674722|FG005|NOT COMPLETED|Overall Study||0||
59570985|NCT02443571|75674749|FG000|STARTED|Overall Study||596||
59570986|NCT02443571|75674750|FG001|STARTED|Overall Study||95||
59570987|NCT02443571|75674751|FG002|STARTED|Overall Study||23||
59570988|NCT02443571|75674749|FG000|COMPLETED|Overall Study||596||
59570989|NCT02443571|75674750|FG001|COMPLETED|Overall Study||95||
59570990|NCT02443571|75674751|FG002|COMPLETED|Overall Study||23||
59570991|NCT02443571|75674749|FG000|NOT COMPLETED|Overall Study||0||
59570992|NCT02443571|75674750|FG001|NOT COMPLETED|Overall Study||0||
59570993|NCT02443571|75674751|FG002|NOT COMPLETED|Overall Study||0||
59570994|NCT03990363|75674764|FG000|STARTED|Overall Study||172||
59570995|NCT03990363|75674765|FG001|STARTED|Overall Study||172||
59570996|NCT03990363|75674766|FG002|STARTED|Overall Study||173||
59570997|NCT03990363|75674767|FG003|STARTED|Overall Study||171||
59570998|NCT03990363|75674768|FG004|STARTED|Overall Study||173||
59570999|NCT03990363|75674764|FG000|Switch Dose|Overall Study||0|As per Protocol Version 5.0, 37 participants from 3 mg dose (ie, Low Dose group) were switched to 24 mg at Visit 9. Participants received Verinurad 24 mg and Allopurinol 300 mg.|
59571000|NCT03990363|75674765|FG001|Switch Dose|Overall Study||0|As per Protocol Version 5.0, 37 participants from 3 mg dose (ie, Low Dose group) were switched to 24 mg at Visit 9. Participants received Verinurad 24 mg and Allopurinol 300 mg.|
59571001|NCT03990363|75674766|FG002|Switch Dose|Overall Study||37|As per Protocol Version 5.0, 37 participants from 3 mg dose (ie, Low Dose group) were switched to 24 mg at Visit 9. Participants received Verinurad 24 mg and Allopurinol 300 mg.|
59571002|NCT03990363|75674767|FG003|Switch Dose|Overall Study||0|As per Protocol Version 5.0, 37 participants from 3 mg dose (ie, Low Dose group) were switched to 24 mg at Visit 9. Participants received Verinurad 24 mg and Allopurinol 300 mg.|
59571003|NCT03990363|75674768|FG004|Switch Dose|Overall Study||0|As per Protocol Version 5.0, 37 participants from 3 mg dose (ie, Low Dose group) were switched to 24 mg at Visit 9. Participants received Verinurad 24 mg and Allopurinol 300 mg.|
59571004|NCT03990363|75674764|FG000|COMPLETED|Overall Study||137||
59571005|NCT03990363|75674765|FG001|COMPLETED|Overall Study||143||
59571006|NCT03990363|75674766|FG002|COMPLETED|Overall Study||131||
59571007|NCT03990363|75674767|FG003|COMPLETED|Overall Study||145||
59571008|NCT03990363|75674768|FG004|COMPLETED|Overall Study||147||
60121161|NCT01587001|76242066|FG001|NOT COMPLETED|Overall Study||1||
59571009|NCT03990363|75674764|FG000|NOT COMPLETED|Overall Study||35||
59571010|NCT03990363|75674765|FG001|NOT COMPLETED|Overall Study||29||
59571011|NCT03990363|75674766|FG002|NOT COMPLETED|Overall Study||42||
59571012|NCT03990363|75674767|FG003|NOT COMPLETED|Overall Study||26||
59571013|NCT03990363|75674768|FG004|NOT COMPLETED|Overall Study||26||
59571014|NCT02444663|75674798|FG000|STARTED|Clinician Valgus||9||
59571015|NCT02444663|75674798|FG000|COMPLETED|Clinician Valgus||9||
59571016|NCT02444663|75674798|FG000|NOT COMPLETED|Clinician Valgus||0||
59571017|NCT02444663|75674798|FG000|STARTED|Clinician Varus||9||
59571018|NCT02444663|75674798|FG000|COMPLETED|Clinician Varus||9||
59571019|NCT02444663|75674798|FG000|NOT COMPLETED|Clinician Varus||0||
59571020|NCT02444663|75674798|FG000|STARTED|Device Valgus 0N||9||
59571021|NCT02444663|75674798|FG000|COMPLETED|Device Valgus 0N||9||
59571022|NCT02444663|75674798|FG000|NOT COMPLETED|Device Valgus 0N||0||
59571023|NCT02444663|75674798|FG000|STARTED|Device Valgus 10N||9||
59571024|NCT02444663|75674798|FG000|COMPLETED|Device Valgus 10N||9||
60121162|NCT02656420|76242077|FG000|STARTED|Overall Study||55||
60121163|NCT02656420|76242078|FG001|STARTED|Overall Study||25||
60121164|NCT02656420|76242079|FG002|STARTED|Overall Study||35||
60121165|NCT02656420|76242080|FG003|STARTED|Overall Study||55||
60121166|NCT02656420|76242077|FG000|COMPLETED|Overall Study||55||
60121167|NCT02656420|76242078|FG001|COMPLETED|Overall Study||24||
60121168|NCT02656420|76242079|FG002|COMPLETED|Overall Study||35||
60121169|NCT02656420|76242080|FG003|COMPLETED|Overall Study||55||
60121170|NCT02656420|76242077|FG000|NOT COMPLETED|Overall Study||0||
60121171|NCT02656420|76242078|FG001|NOT COMPLETED|Overall Study||1||
60121172|NCT02656420|76242079|FG002|NOT COMPLETED|Overall Study||0||
59571025|NCT02444663|75674798|FG000|NOT COMPLETED|Device Valgus 10N||0||
59571026|NCT02444663|75674798|FG000|STARTED|Device Valgus 20N||9||
59571027|NCT02444663|75674798|FG000|COMPLETED|Device Valgus 20N||9||
59571028|NCT02444663|75674798|FG000|NOT COMPLETED|Device Valgus 20N||0||
59571029|NCT02444663|75674798|FG000|STARTED|Device Valgus 30N||9||
59571030|NCT02444663|75674798|FG000|COMPLETED|Device Valgus 30N||9||
59571031|NCT02444663|75674798|FG000|NOT COMPLETED|Device Valgus 30N||0||
59571032|NCT02444663|75674798|FG000|STARTED|Device Varus 0N||9||
59571033|NCT02444663|75674798|FG000|COMPLETED|Device Varus 0N||9||
59571034|NCT02444663|75674798|FG000|NOT COMPLETED|Device Varus 0N||0||
59571035|NCT02444663|75674798|FG000|STARTED|Device Varus 10N||9||
59571036|NCT02444663|75674798|FG000|COMPLETED|Device Varus 10N||9||
59571037|NCT02444663|75674798|FG000|NOT COMPLETED|Device Varus 10N||0||
59571038|NCT02444663|75674798|FG000|STARTED|Device Varus 20N||9||
59571039|NCT02444663|75674798|FG000|COMPLETED|Device Varus 20N||9||
59571040|NCT02444663|75674798|FG000|NOT COMPLETED|Device Varus 20N||0||
59571041|NCT02444663|75674798|FG000|STARTED|Device Varus 30N||9||
59571042|NCT02444663|75674798|FG000|COMPLETED|Device Varus 30N||9||
59571043|NCT02444663|75674798|FG000|NOT COMPLETED|Device Varus 30N||0||
59571044|NCT02445287|75674822|FG000|STARTED|Overall Study||35||
59571045|NCT02445287|75674823|FG001|STARTED|Overall Study||13||
59571046|NCT02445287|75674822|FG000|COMPLETED|Overall Study||35||
59571047|NCT02445287|75674823|FG001|COMPLETED|Overall Study||13||
59571048|NCT02445287|75674822|FG000|NOT COMPLETED|Overall Study||0||
59571049|NCT02445287|75674823|FG001|NOT COMPLETED|Overall Study||0||
59571050|NCT04661839|75674838|FG000|STARTED|Overall Study||8||
59571051|NCT04661839|75674839|FG001|STARTED|Overall Study||8||
59571052|NCT04661839|75674840|FG002|STARTED|Overall Study||8||
59571053|NCT04661839|75674841|FG003|STARTED|Overall Study||4||
59571054|NCT04661839|75674838|FG000|Safety Population|Overall Study||8||
59571055|NCT04661839|75674839|FG001|Safety Population|Overall Study||8||
59571056|NCT04661839|75674840|FG002|Safety Population|Overall Study||7||
59571057|NCT04661839|75674841|FG003|Safety Population|Overall Study||4||
59571058|NCT04661839|75674838|FG000|COMPLETED|Overall Study||7||
60121173|NCT02656420|76242080|FG003|NOT COMPLETED|Overall Study||0||
60121174|NCT01568047|76242096|FG000|STARTED|Overall Study||10||
59571059|NCT04661839|75674839|FG001|COMPLETED|Overall Study||8||
59571060|NCT04661839|75674840|FG002|COMPLETED|Overall Study||7||
59571061|NCT04661839|75674841|FG003|COMPLETED|Overall Study||3||
59571062|NCT04661839|75674838|FG000|NOT COMPLETED|Overall Study||1||
59571063|NCT04661839|75674839|FG001|NOT COMPLETED|Overall Study||0||
59571064|NCT04661839|75674840|FG002|NOT COMPLETED|Overall Study||1||
59571065|NCT04661839|75674841|FG003|NOT COMPLETED|Overall Study||1||
59571066|NCT02997657|75674853|FG000|STARTED|Overall Study||140||
59571067|NCT02997657|75674854|FG001|STARTED|Overall Study||131||
59571068|NCT02997657|75674853|FG000|COMPLETED|Overall Study||109||
60121175|NCT01568047|76242097|FG001|STARTED|Overall Study||10||
60121176|NCT01568047|76242098|FG002|STARTED|Overall Study||10||
60121177|NCT01568047|76242099|FG003|STARTED|Overall Study||10||
59571069|NCT02997657|75674854|FG001|COMPLETED|Overall Study||97||
59571070|NCT02997657|75674853|FG000|NOT COMPLETED|Overall Study||31||
59571071|NCT02997657|75674854|FG001|NOT COMPLETED|Overall Study||34||
59571072|NCT02445911|75674864|FG000|STARTED|Overall Study||20||
59571073|NCT02445911|75674865|FG001|STARTED|Overall Study||20||
59571074|NCT02445911|75674866|FG002|STARTED|Overall Study||21||
59571075|NCT02445911|75674867|FG003|STARTED|Overall Study||20||
59571076|NCT02445911|75674864|FG000|COMPLETED|Overall Study||20||
59571077|NCT02445911|75674865|FG001|COMPLETED|Overall Study||20||
59571078|NCT02445911|75674866|FG002|COMPLETED|Overall Study||21||
59571079|NCT02445911|75674867|FG003|COMPLETED|Overall Study||20||
59571080|NCT02445911|75674864|FG000|NOT COMPLETED|Overall Study||0||
59571081|NCT02445911|75674865|FG001|NOT COMPLETED|Overall Study||0||
59571082|NCT02445911|75674866|FG002|NOT COMPLETED|Overall Study||0||
59571083|NCT02445911|75674867|FG003|NOT COMPLETED|Overall Study||0||
59571084|NCT02446223|75674877|FG000|STARTED|Overall Study||21||
59571085|NCT02446223|75674877|FG000|COMPLETED|Overall Study||20||
59571086|NCT02446223|75674877|FG000|NOT COMPLETED|Overall Study||1||
59571087|NCT02446613|75674883|FG000|STARTED|Overall Study||6||
59571088|NCT02446613|75674884|FG001|STARTED|Overall Study||10||
59571089|NCT02446613|75674883|FG000|COMPLETED|Overall Study||6||
59571090|NCT02446613|75674884|FG001|COMPLETED|Overall Study||10||
59571091|NCT02446613|75674883|FG000|NOT COMPLETED|Overall Study||0||
59571092|NCT02446613|75674884|FG001|NOT COMPLETED|Overall Study||0||
59571093|NCT02446847|75674896|FG000|STARTED|Overall Study||8||
59571094|NCT02446847|75674897|FG001|STARTED|Overall Study||8||
59571095|NCT02446847|75674896|FG000|COMPLETED|Overall Study||8||
59571096|NCT02446847|75674897|FG001|COMPLETED|Overall Study||6||
59571097|NCT02446847|75674896|FG000|NOT COMPLETED|Overall Study||0||
59571098|NCT02446847|75674897|FG001|NOT COMPLETED|Overall Study||2||
59571099|NCT02448641|75674906|FG000|STARTED|Overall Study||55||
59571100|NCT02448641|75674907|FG001|STARTED|Overall Study||56||
59571101|NCT02448641|75674908|FG002|STARTED|Overall Study||52||
59571102|NCT02448641|75674906|FG000|COMPLETED|Overall Study||54||
59571103|NCT02448641|75674907|FG001|COMPLETED|Overall Study||51||
59571104|NCT02448641|75674908|FG002|COMPLETED|Overall Study||48||
59571105|NCT02448641|75674906|FG000|NOT COMPLETED|Overall Study||1||
59571106|NCT02448641|75674907|FG001|NOT COMPLETED|Overall Study||5||
59571107|NCT02448641|75674908|FG002|NOT COMPLETED|Overall Study||4||
59571108|NCT02450747|75674923|FG000|STARTED|Overall Study||39||
59571109|NCT02450747|75674923|FG000|COMPLETED|Overall Study||39||
59571110|NCT02450747|75674923|FG000|NOT COMPLETED|Overall Study||0||
59571111|NCT02248285|75674933|FG000|STARTED|Overall Study||687||
59571112|NCT02248285|75674934|FG001|STARTED|Overall Study||858||
59571113|NCT02248285|75674933|FG000|COMPLETED|Overall Study||586||
59571114|NCT02248285|75674934|FG001|COMPLETED|Overall Study||571||
59571115|NCT02248285|75674933|FG000|NOT COMPLETED|Overall Study||101||
59571116|NCT02248285|75674934|FG001|NOT COMPLETED|Overall Study||287||
59571117|NCT02240485|75674942|FG000|STARTED|3 Months Post-admission||44||
59571118|NCT02240485|75674943|FG001|STARTED|3 Months Post-admission||36||
59571119|NCT02240485|75674942|FG000|COMPLETED|3 Months Post-admission|Couple modality: 1 couple refused and one gambler refused but his partner continued|41||
59571120|NCT02240485|75674943|FG001|COMPLETED|3 Months Post-admission||30||
59571121|NCT02240485|75674942|FG000|NOT COMPLETED|3 Months Post-admission||3||
60121178|NCT01568047|76242096|FG000|COMPLETED|Overall Study||9||
59571122|NCT02240485|75674943|FG001|NOT COMPLETED|3 Months Post-admission||6||
59571123|NCT02240485|75674942|FG000|STARTED|9 Months Post-admission||41||
59571124|NCT02240485|75674943|FG001|STARTED|9 Months Post-admission||30||
59571125|NCT02240485|75674942|FG000|COMPLETED|9 Months Post-admission||38||
59571126|NCT02240485|75674943|FG001|COMPLETED|9 Months Post-admission|26 couples completed + 1 individual (partner lost)|26||
59571127|NCT02240485|75674942|FG000|NOT COMPLETED|9 Months Post-admission||3||
59571128|NCT02240485|75674943|FG001|NOT COMPLETED|9 Months Post-admission||4||
59571129|NCT02240485|75674942|FG000|STARTED|18 Months Post-admission||38||
59571130|NCT02240485|75674943|FG001|STARTED|18 Months Post-admission||26||
59571131|NCT02240485|75674942|FG000|COMPLETED|18 Months Post-admission||35||
59571132|NCT02240485|75674943|FG001|COMPLETED|18 Months Post-admission||21||
60121179|NCT01568047|76242097|FG001|COMPLETED|Overall Study||9||
59571133|NCT02240485|75674942|FG000|NOT COMPLETED|18 Months Post-admission||3||
59571134|NCT02240485|75674943|FG001|NOT COMPLETED|18 Months Post-admission||5||
59571135|NCT02348385|75674955|FG000|STARTED|Overall Study||24||
59571136|NCT02348385|75674956|FG001|STARTED|Overall Study||25||
59571137|NCT02348385|75674955|FG000|COMPLETED|Overall Study||24||
59571138|NCT02348385|75674956|FG001|COMPLETED|Overall Study||25||
59571139|NCT02348385|75674955|FG000|NOT COMPLETED|Overall Study||0||
59571140|NCT02348385|75674956|FG001|NOT COMPLETED|Overall Study||0||
59571141|NCT04149535|75674966|FG000|STARTED|Overall Study||1501||
59571142|NCT04149535|75674967|FG001|STARTED|Overall Study||1499||
59571143|NCT04149535|75674966|FG000|COMPLETED|Overall Study||1472||
59571144|NCT04149535|75674967|FG001|COMPLETED|Overall Study||1481||
59571145|NCT04149535|75674966|FG000|NOT COMPLETED|Overall Study||29||
59571146|NCT04149535|75674967|FG001|NOT COMPLETED|Overall Study||18||
59571147|NCT02240329|75674973|FG000|STARTED|Overall Study||4||
59571148|NCT02240329|75674973|FG000|Determination of Urge to Cough|Overall Study||4||
59571149|NCT02240329|75674973|FG000|COMPLETED|Overall Study||4||
59571150|NCT02240329|75674973|FG000|NOT COMPLETED|Overall Study||0||
59571151|NCT02251561|75674977|FG000|STARTED|Overall Study||28||
59571152|NCT02251561|75674977|FG000|COMPLETED|Overall Study||28||
59571153|NCT02251561|75674977|FG000|NOT COMPLETED|Overall Study||0||
59571154|NCT02210559|75674985|FG000|STARTED|Overall Study||24||
59571155|NCT02210559|75674986|FG001|STARTED|Overall Study||13||
59571156|NCT02210559|75674985|FG000|Received at Least 1 Dose of Study Drug|Overall Study||24||
59571157|NCT02210559|75674986|FG001|Received at Least 1 Dose of Study Drug|Overall Study||13||
59571158|NCT02210559|75674985|FG000|COMPLETED|Overall Study||18||
59571159|NCT02210559|75674986|FG001|COMPLETED|Overall Study||7||
59571160|NCT02210559|75674985|FG000|NOT COMPLETED|Overall Study||6||
59571161|NCT02210559|75674986|FG001|NOT COMPLETED|Overall Study||6||
59571162|NCT03724357|75674992|FG000|STARTED|Overall Study||3||
59571163|NCT03724357|75674992|FG000|COMPLETED|Overall Study||1||
59571164|NCT03724357|75674992|FG000|NOT COMPLETED|Overall Study||2||
59571165|NCT01738321|75674998|FG000|STARTED|Overall Study||33||
59571166|NCT01738321|75674999|FG001|STARTED|Overall Study||30||
59571167|NCT01738321|75674998|FG000|COMPLETED|Overall Study||33||
59571168|NCT01738321|75674999|FG001|COMPLETED|Overall Study||30||
59571169|NCT01738321|75674998|FG000|NOT COMPLETED|Overall Study||0||
59571170|NCT01738321|75674999|FG001|NOT COMPLETED|Overall Study||0||
59571171|NCT01740817|75675005|FG000|STARTED|First Intervention (48 h)||8||
59571172|NCT01740817|75675006|FG001|STARTED|First Intervention (48 h)||4||
59571173|NCT01740817|75675005|FG000|COMPLETED|First Intervention (48 h)||8||
59571174|NCT01740817|75675006|FG001|COMPLETED|First Intervention (48 h)||4||
59571175|NCT01740817|75675005|FG000|NOT COMPLETED|First Intervention (48 h)||0||
59571176|NCT01740817|75675006|FG001|NOT COMPLETED|First Intervention (48 h)||0||
59571177|NCT01740817|75675005|FG000|STARTED|Washout (4-6 Weeks)||8||
59571178|NCT01740817|75675006|FG001|STARTED|Washout (4-6 Weeks)||4||
59571179|NCT01740817|75675005|FG000|COMPLETED|Washout (4-6 Weeks)||8||
59571180|NCT01740817|75675006|FG001|COMPLETED|Washout (4-6 Weeks)||4||
59571181|NCT01740817|75675005|FG000|NOT COMPLETED|Washout (4-6 Weeks)||0||
59571182|NCT01740817|75675006|FG001|NOT COMPLETED|Washout (4-6 Weeks)||0||
59571183|NCT01740817|75675005|FG000|STARTED|Second Intervention (48 h)||8||
59571184|NCT01740817|75675006|FG001|STARTED|Second Intervention (48 h)||4||
59571185|NCT01740817|75675005|FG000|COMPLETED|Second Intervention (48 h)||8||
59571186|NCT01740817|75675006|FG001|COMPLETED|Second Intervention (48 h)||4||
59571187|NCT01740817|75675005|FG000|NOT COMPLETED|Second Intervention (48 h)||0||
59571188|NCT01740817|75675006|FG001|NOT COMPLETED|Second Intervention (48 h)||0||
59571189|NCT01742065|75675014|FG000|STARTED|Overall Study|20059 patients were analyzed in 13 clinics.|20059||13
59571190|NCT01742065|75675015|FG001|STARTED|Overall Study|21134 patients were analyzed in 13 clinics.|21134||13
59571191|NCT01742065|75675014|FG000|COMPLETED|Overall Study|20059 patients were analyzed in 13 clinics.|20059||13
59571192|NCT01742065|75675015|FG001|COMPLETED|Overall Study|21134 patients were analyzed in 13 clinics.|21134||13
59571193|NCT01742065|75675014|FG000|NOT COMPLETED|Overall Study||0||0
59571194|NCT01742065|75675015|FG001|NOT COMPLETED|Overall Study||0||0
59571195|NCT01743859|75675021|FG000|STARTED|Overall Study||37||
59571196|NCT01743859|75675021|FG000|COMPLETED|Overall Study||28||
59571197|NCT01743859|75675021|FG000|NOT COMPLETED|Overall Study||9||
59571198|NCT01746043|75675029|FG000|STARTED|Overall Study||5||
59571199|NCT01746043|75675030|FG001|STARTED|Overall Study||4||
59571200|NCT01746043|75675031|FG002|STARTED|Overall Study||5||
59571201|NCT01746043|75675032|FG003|STARTED|Overall Study||5||
59571202|NCT01746043|75675029|FG000|COMPLETED|Overall Study||5||
59571203|NCT01746043|75675030|FG001|COMPLETED|Overall Study||4||
59571204|NCT01746043|75675031|FG002|COMPLETED|Overall Study||5||
59571205|NCT01746043|75675032|FG003|COMPLETED|Overall Study||5||
59571206|NCT01746043|75675029|FG000|NOT COMPLETED|Overall Study||0||
59571207|NCT01746043|75675030|FG001|NOT COMPLETED|Overall Study||0||
59571208|NCT01746043|75675031|FG002|NOT COMPLETED|Overall Study||0||
59571209|NCT01746043|75675032|FG003|NOT COMPLETED|Overall Study||0||
59571210|NCT01746511|75675044|FG000|STARTED|Overall Study||40||
59571211|NCT01746511|75675045|FG001|STARTED|Overall Study||39||
59571212|NCT01746511|75675044|FG000|COMPLETED|Overall Study||40||
59571213|NCT01746511|75675045|FG001|COMPLETED|Overall Study||39||
59571214|NCT01746511|75675044|FG000|NOT COMPLETED|Overall Study||0||
59571215|NCT01746511|75675045|FG001|NOT COMPLETED|Overall Study||0||
59571216|NCT01746745|75675051|FG000|STARTED|Overall Study||6||
59571217|NCT01746745|75675051|FG000|Received Study Drug|Overall Study||6||
59571218|NCT01746745|75675051|FG000|COMPLETED|Overall Study||6||
59571219|NCT01746745|75675051|FG000|NOT COMPLETED|Overall Study||0||
59571220|NCT01746979|75675057|FG000|STARTED|Overall Study||346||
59571221|NCT01746979|75675058|FG001|STARTED|Overall Study||347||
59571222|NCT01746979|75675057|FG000|COMPLETED|Overall Study||0||
59571223|NCT01746979|75675058|FG001|COMPLETED|Overall Study||0||
59571224|NCT01746979|75675057|FG000|NOT COMPLETED|Overall Study||346||
59571225|NCT01746979|75675058|FG001|NOT COMPLETED|Overall Study||347||
59571226|NCT01748227|75675064|FG000|STARTED|Overall Study||20||
59571227|NCT01748227|75675064|FG000|COMPLETED|Overall Study||17||
59571228|NCT01748227|75675064|FG000|NOT COMPLETED|Overall Study||3||
59571229|NCT01748695|75675069|FG000|STARTED|First Intervention (4 Weeks)||14||
60121180|NCT01568047|76242098|FG002|COMPLETED|Overall Study||9||
60121181|NCT01568047|76242099|FG003|COMPLETED|Overall Study||9||
60121182|NCT01568047|76242096|FG000|NOT COMPLETED|Overall Study||1||
59571230|NCT01748695|75675070|FG001|STARTED|First Intervention (4 Weeks)||11||
59571231|NCT01748695|75675069|FG000|COMPLETED|First Intervention (4 Weeks)||14||
59571232|NCT01748695|75675070|FG001|COMPLETED|First Intervention (4 Weeks)||11||
59571233|NCT01748695|75675069|FG000|NOT COMPLETED|First Intervention (4 Weeks)||0||
59571234|NCT01748695|75675070|FG001|NOT COMPLETED|First Intervention (4 Weeks)||0||
59571235|NCT01748695|75675069|FG000|STARTED|Second Intervention (4 Weeks)||14||
59571236|NCT01748695|75675070|FG001|STARTED|Second Intervention (4 Weeks)||11||
59571237|NCT01748695|75675069|FG000|COMPLETED|Second Intervention (4 Weeks)||14||
59571238|NCT01748695|75675070|FG001|COMPLETED|Second Intervention (4 Weeks)||11||
59571239|NCT01748695|75675069|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0||
59571240|NCT01748695|75675070|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||0||
59571241|NCT01749631|75675076|FG000|STARTED|Overall Study||97||
59571242|NCT01749631|75675076|FG000|COMPLETED|Overall Study||97||
59571243|NCT01749631|75675076|FG000|NOT COMPLETED|Overall Study||0||
59571244|NCT01750255|75675082|FG000|STARTED|Overall Study||49||
59571245|NCT01750255|75675083|FG001|STARTED|Overall Study||43||
59571246|NCT01750255|75675082|FG000|COMPLETED|Overall Study||43||
59571247|NCT01750255|75675083|FG001|COMPLETED|Overall Study||38||
59571248|NCT01750255|75675082|FG000|NOT COMPLETED|Overall Study||6||
59571249|NCT01750255|75675083|FG001|NOT COMPLETED|Overall Study||5||
59571250|NCT01751971|75675092|FG000|STARTED|Overall Study||22||
59571251|NCT01751971|75675093|FG001|STARTED|Overall Study||25||
59571252|NCT01751971|75675092|FG000|COMPLETED|Overall Study||20||
59571253|NCT01751971|75675093|FG001|COMPLETED|Overall Study||24||
59571254|NCT01751971|75675092|FG000|NOT COMPLETED|Overall Study||2||
59571255|NCT01751971|75675093|FG001|NOT COMPLETED|Overall Study||1||
59571256|NCT01754389|75675108|FG000|STARTED|Overall Study||46||
59571257|NCT01754389|75675109|FG001|STARTED|Overall Study||45||
59571258|NCT01754389|75675110|FG002|STARTED|Overall Study||47||
59571259|NCT01754389|75675108|FG000|COMPLETED|Overall Study||46||
59571260|NCT01754389|75675109|FG001|COMPLETED|Overall Study||45||
59571261|NCT01754389|75675110|FG002|COMPLETED|Overall Study||47||
59571262|NCT01754389|75675108|FG000|NOT COMPLETED|Overall Study||0||
59571263|NCT01754389|75675109|FG001|NOT COMPLETED|Overall Study||0||
59571264|NCT01754389|75675110|FG002|NOT COMPLETED|Overall Study||0||
59571265|NCT01754623|75675118|FG000|STARTED|Overall Study||9||
59571266|NCT01754623|75675118|FG000|COMPLETED|Overall Study||9||
59571267|NCT01754623|75675118|FG000|NOT COMPLETED|Overall Study||0||
59571268|NCT01755169|75675128|FG000|STARTED|Overall Study||2||
59571269|NCT01755169|75675129|FG001|STARTED|Overall Study||1||
60121183|NCT01568047|76242097|FG001|NOT COMPLETED|Overall Study||1||
60121184|NCT01568047|76242098|FG002|NOT COMPLETED|Overall Study||1||
60121185|NCT01568047|76242099|FG003|NOT COMPLETED|Overall Study||1||
60121186|NCT01688999|76242112|FG000|STARTED|Overall Study||50||
59571270|NCT01755169|75675130|FG002|STARTED|Overall Study||0||
59571271|NCT01755169|75675131|FG003|STARTED|Overall Study||1||
59571272|NCT01755169|75675128|FG000|COMPLETED|Overall Study||2||
59571273|NCT01755169|75675129|FG001|COMPLETED|Overall Study||1||
59571274|NCT01755169|75675130|FG002|COMPLETED|Overall Study||0||
59571275|NCT01755169|75675131|FG003|COMPLETED|Overall Study||1||
59571276|NCT01755169|75675128|FG000|NOT COMPLETED|Overall Study||0||
59571277|NCT01755169|75675129|FG001|NOT COMPLETED|Overall Study||0||
59571278|NCT01755169|75675130|FG002|NOT COMPLETED|Overall Study||0||
59571279|NCT01755169|75675131|FG003|NOT COMPLETED|Overall Study||0||
59571280|NCT02073279|75675143|FG000|STARTED|Double-blind Period||32||
59571281|NCT02073279|75675144|FG001|STARTED|Double-blind Period||63||
59571282|NCT02073279|75675143|FG000|COMPLETED|Double-blind Period||28|Double-blind Period|
59571283|NCT02073279|75675144|FG001|COMPLETED|Double-blind Period||56|Double-blind Period|
59571284|NCT02073279|75675143|FG000|NOT COMPLETED|Double-blind Period||4||
59571285|NCT02073279|75675144|FG001|NOT COMPLETED|Double-blind Period||7||
59571286|NCT02073279|75675143|FG000|STARTED|Open-label Extension Period||28||
59571287|NCT02073279|75675144|FG001|STARTED|Open-label Extension Period||56||
59571288|NCT02073279|75675143|FG000|COMPLETED|Open-label Extension Period||21||
59571289|NCT02073279|75675144|FG001|COMPLETED|Open-label Extension Period||41||
59571290|NCT02073279|75675143|FG000|NOT COMPLETED|Open-label Extension Period||7||
59571291|NCT02073279|75675144|FG001|NOT COMPLETED|Open-label Extension Period||15||
59721223|NCT00868231|75840099|FG003|NOT COMPLETED|Treatment Period 3||0||
59571292|NCT01755949|75675159|FG000|STARTED|Overall Study||5||
59571293|NCT01755949|75675160|FG001|STARTED|Overall Study||5||
59571294|NCT01755949|75675161|FG002|STARTED|Overall Study||4||
59571295|NCT01755949|75675162|FG003|STARTED|Overall Study||5||
59571296|NCT01755949|75675163|FG004|STARTED|Overall Study||4||
59571297|NCT01755949|75675164|FG005|STARTED|Overall Study||3||
59571298|NCT01755949|75675159|FG000|COMPLETED|Overall Study||5||
59571299|NCT01755949|75675160|FG001|COMPLETED|Overall Study||5||
59571300|NCT01755949|75675161|FG002|COMPLETED|Overall Study||4||
59571301|NCT01755949|75675162|FG003|COMPLETED|Overall Study||5||
59571302|NCT01755949|75675163|FG004|COMPLETED|Overall Study||4||
60121187|NCT01688999|76242113|FG001|STARTED|Overall Study||6||
60121188|NCT01688999|76242114|FG002|STARTED|Overall Study||13||
59571303|NCT01755949|75675164|FG005|COMPLETED|Overall Study||3||
59571304|NCT01755949|75675159|FG000|NOT COMPLETED|Overall Study||0||
59571305|NCT01755949|75675160|FG001|NOT COMPLETED|Overall Study||0||
59571306|NCT01755949|75675161|FG002|NOT COMPLETED|Overall Study||0||
59571307|NCT01755949|75675162|FG003|NOT COMPLETED|Overall Study||0||
59571308|NCT01755949|75675163|FG004|NOT COMPLETED|Overall Study||0||
59571309|NCT01755949|75675164|FG005|NOT COMPLETED|Overall Study||0||
59571310|NCT01756885|75675180|FG000|STARTED|Overall Study||102||
59571311|NCT01756885|75675181|FG001|STARTED|Overall Study||105||
59571312|NCT01756885|75675180|FG000|COMPLETED|Overall Study||79||
59571313|NCT01756885|75675181|FG001|COMPLETED|Overall Study||79||
59571314|NCT01756885|75675180|FG000|NOT COMPLETED|Overall Study||23||
59571315|NCT01756885|75675181|FG001|NOT COMPLETED|Overall Study||26||
59571316|NCT04172701|75675189|FG000|STARTED|Overall Study||6352||
59571317|NCT04172701|75675190|FG001|STARTED|Overall Study||2932||
59571318|NCT04172701|75675189|FG000|Propensity Score (PS) Matched Population|Overall Study||2444||
59571319|NCT04172701|75675190|FG001|Propensity Score (PS) Matched Population|Overall Study||2444||
59571320|NCT04172701|75675189|FG000|COMPLETED|Overall Study||6352||
59571321|NCT04172701|75675190|FG001|COMPLETED|Overall Study||2932||
59571322|NCT04172701|75675189|FG000|NOT COMPLETED|Overall Study||0||
59571323|NCT04172701|75675190|FG001|NOT COMPLETED|Overall Study||0||
59571324|NCT01760239|75675198|FG000|STARTED|Overall Study||17037||
59571325|NCT01760239|75675199|FG001|STARTED|Overall Study||14542||
59571326|NCT01760239|75675198|FG000|COMPLETED|Overall Study||296||
59571327|NCT01760239|75675199|FG001|COMPLETED|Overall Study||226||
59571328|NCT01760239|75675198|FG000|NOT COMPLETED|Overall Study||16741||
59571329|NCT01760239|75675199|FG001|NOT COMPLETED|Overall Study||14316||
59571330|NCT01760473|75675206|FG000|STARTED|Overall Study||27||
59571331|NCT01760473|75675206|FG000|COMPLETED|Overall Study||12||
59571332|NCT01760473|75675206|FG000|NOT COMPLETED|Overall Study||15||
59571333|NCT01760785|75675220|FG000|STARTED|Overall Study||23||
59571334|NCT01760785|75675221|FG001|STARTED|Overall Study||27||
59571335|NCT01760785|75675220|FG000|COMPLETED|Overall Study||23||
59571336|NCT01760785|75675221|FG001|COMPLETED|Overall Study||27||
59571337|NCT01760785|75675220|FG000|NOT COMPLETED|Overall Study||0||
59571338|NCT01760785|75675221|FG001|NOT COMPLETED|Overall Study||0||
59571339|NCT01761019|75675227|FG000|STARTED|Overall Study||8||
59571340|NCT01761019|75675227|FG000|COMPLETED|Overall Study||8||
59571341|NCT01761019|75675227|FG000|NOT COMPLETED|Overall Study||0||
59571342|NCT01761175|75675233|FG000|STARTED|Overall Study||112||
59571343|NCT01761175|75675234|FG001|STARTED|Overall Study||112||
59571344|NCT01761175|75675233|FG000|COMPLETED|Overall Study||112||
59571345|NCT01761175|75675234|FG001|COMPLETED|Overall Study||112||
59571346|NCT01761175|75675233|FG000|NOT COMPLETED|Overall Study||0||
59571347|NCT01761175|75675234|FG001|NOT COMPLETED|Overall Study||0||
59571348|NCT02241655|75675243|FG000|STARTED|Overall Study||614||
59571349|NCT02241655|75675244|FG001|STARTED|Overall Study||618||
59571350|NCT02241655|75675243|FG000|COMPLETED|Overall Study||614||
59571351|NCT02241655|75675244|FG001|COMPLETED|Overall Study||618||
59571352|NCT02241655|75675243|FG000|NOT COMPLETED|Overall Study||0||
59571353|NCT02241655|75675244|FG001|NOT COMPLETED|Overall Study||0||
59571354|NCT01761643|75675257|FG000|STARTED|Overall Study||198||
59571355|NCT01761643|75675258|FG001|STARTED|Overall Study||200||
59571356|NCT01761643|75675257|FG000|COMPLETED|Overall Study||166||
59571357|NCT01761643|75675258|FG001|COMPLETED|Overall Study||158||
59571358|NCT01761643|75675257|FG000|NOT COMPLETED|Overall Study||32||
59571359|NCT01761643|75675258|FG001|NOT COMPLETED|Overall Study||42||
59571360|NCT01762501|75675266|FG000|STARTED|Overall Study||359||
59571361|NCT01762501|75675267|FG001|STARTED|Overall Study||359||
59571362|NCT01762501|75675266|FG000|COMPLETED|Overall Study||332||
59571363|NCT01762501|75675267|FG001|COMPLETED|Overall Study||336||
59571364|NCT01762501|75675266|FG000|NOT COMPLETED|Overall Study||27||
59571365|NCT01762501|75675267|FG001|NOT COMPLETED|Overall Study||23||
59571366|NCT01764607|75675273|FG000|STARTED|Overall Study||1||
59571367|NCT01764607|75675273|FG000|COMPLETED|Overall Study||1||
59721224|NCT00868231|75840100|FG004|NOT COMPLETED|Treatment Period 3||0||
59721225|NCT00868231|75840101|FG005|NOT COMPLETED|Treatment Period 3||0||
59721226|NCT01143077|75840112|FG000|STARTED|Overall Study||74||
59571368|NCT01764607|75675273|FG000|NOT COMPLETED|Overall Study||0||
59571369|NCT01764685|75675279|FG000|STARTED|Overall Study||0||
59571370|NCT01764685|75675280|FG001|STARTED|Overall Study||4||
59571371|NCT01764685|75675279|FG000|COMPLETED|Overall Study||0||
59571372|NCT01764685|75675280|FG001|COMPLETED|Overall Study||3||
59571373|NCT01764685|75675279|FG000|NOT COMPLETED|Overall Study||0||
59571374|NCT01764685|75675280|FG001|NOT COMPLETED|Overall Study||1||
59571375|NCT01764919|75675286|FG000|STARTED|Overall Study||4||
59571376|NCT01764919|75675286|FG000|COMPLETED|Overall Study||4||
59571377|NCT01764919|75675286|FG000|NOT COMPLETED|Overall Study||0||
59571378|NCT01765465|75675292|FG000|STARTED|Overall Study||71||
59571379|NCT01765465|75675293|FG001|STARTED|Overall Study||67||
59721227|NCT01143077|75840113|FG001|STARTED|Overall Study||88||
59571380|NCT01765465|75675292|FG000|COMPLETED|Overall Study||64||
59571381|NCT01765465|75675293|FG001|COMPLETED|Overall Study||63||
59571382|NCT01765465|75675292|FG000|NOT COMPLETED|Overall Study||7||
59571383|NCT01765465|75675293|FG001|NOT COMPLETED|Overall Study||4||
59571384|NCT01766713|75675303|FG000|STARTED|Overall Study||25||
59571385|NCT01766713|75675304|FG001|STARTED|Overall Study||25||
59571386|NCT01766713|75675303|FG000|COMPLETED|Overall Study||23||
59571387|NCT01766713|75675304|FG001|COMPLETED|Overall Study||22||
59571388|NCT01766713|75675303|FG000|NOT COMPLETED|Overall Study||2||
59571389|NCT01766713|75675304|FG001|NOT COMPLETED|Overall Study||3||
59571390|NCT01767103|75675313|FG000|STARTED|Overall Study||7||
59571391|NCT01767103|75675314|FG001|STARTED|Overall Study||7||
59571392|NCT01767103|75675315|FG002|STARTED|Overall Study||7||
59571393|NCT01767103|75675313|FG000|COMPLETED|Overall Study||7||
59571394|NCT01767103|75675314|FG001|COMPLETED|Overall Study||7||
59571395|NCT01767103|75675315|FG002|COMPLETED|Overall Study||7||
59571396|NCT01767103|75675313|FG000|NOT COMPLETED|Overall Study||0||
59571397|NCT01767103|75675314|FG001|NOT COMPLETED|Overall Study||0||
59571398|NCT01767103|75675315|FG002|NOT COMPLETED|Overall Study||0||
59571399|NCT01767415|75675324|FG000|STARTED|Overall Study||10||
59571400|NCT01767415|75675324|FG000|COMPLETED|Overall Study||10||
59571401|NCT01767415|75675324|FG000|NOT COMPLETED|Overall Study||0||
59571402|NCT01769209|75675328|FG000|STARTED|Overall Study||18||
59571403|NCT01769209|75675328|FG000|COMPLETED|Overall Study||18||
59571404|NCT01769209|75675328|FG000|NOT COMPLETED|Overall Study||0||
59571405|NCT01769365|75675335|FG000|STARTED|Overall Study||102||
59571406|NCT01769365|75675336|FG001|STARTED|Overall Study||102||
59571407|NCT01769365|75675337|FG002|STARTED|Overall Study||103||
59571408|NCT01769365|75675335|FG000|COMPLETED|Overall Study||102||
59571409|NCT01769365|75675336|FG001|COMPLETED|Overall Study||100||
59571410|NCT01769365|75675337|FG002|COMPLETED|Overall Study||101||
59571411|NCT01769365|75675335|FG000|NOT COMPLETED|Overall Study||0||
59571412|NCT01769365|75675336|FG001|NOT COMPLETED|Overall Study||2||
59571413|NCT01769365|75675337|FG002|NOT COMPLETED|Overall Study||2||
59571414|NCT02327143|75675345|FG000|STARTED|Day 1: Time 0 Hrs to 6 Hrs||11||
59571415|NCT02327143|75675346|FG001|STARTED|Day 1: Time 0 Hrs to 6 Hrs||0||
59571416|NCT02327143|75675345|FG000|COMPLETED|Day 1: Time 0 Hrs to 6 Hrs||11||
59571417|NCT02327143|75675346|FG001|COMPLETED|Day 1: Time 0 Hrs to 6 Hrs||0||
59571418|NCT02327143|75675345|FG000|NOT COMPLETED|Day 1: Time 0 Hrs to 6 Hrs||0||
59571419|NCT02327143|75675346|FG001|NOT COMPLETED|Day 1: Time 0 Hrs to 6 Hrs||0||
59571420|NCT02327143|75675345|FG000|STARTED|Day 1: Time 6 Hrs - to Day 9||0||
59571421|NCT02327143|75675346|FG001|STARTED|Day 1: Time 6 Hrs - to Day 9||11||
59571422|NCT02327143|75675345|FG000|COMPLETED|Day 1: Time 6 Hrs - to Day 9||0||
59571423|NCT02327143|75675346|FG001|COMPLETED|Day 1: Time 6 Hrs - to Day 9||11||
59571424|NCT02327143|75675345|FG000|NOT COMPLETED|Day 1: Time 6 Hrs - to Day 9||0||
59571425|NCT02327143|75675346|FG001|NOT COMPLETED|Day 1: Time 6 Hrs - to Day 9||0||
59571426|NCT01770691|75675352|FG000|STARTED|Overall Study||7||
59571427|NCT01770691|75675352|FG000|COMPLETED|Overall Study||7||
59571428|NCT01770691|75675352|FG000|NOT COMPLETED|Overall Study||0||
59571429|NCT01771627|75675361|FG000|STARTED|Overall Study||200||
59571430|NCT01771627|75675362|FG001|STARTED|Overall Study||100||
59571431|NCT01771627|75675361|FG000|COMPLETED|Overall Study||92||
59571432|NCT01771627|75675362|FG001|COMPLETED|Overall Study||50||
59571433|NCT01771627|75675361|FG000|NOT COMPLETED|Overall Study||108||
59571434|NCT01771627|75675362|FG001|NOT COMPLETED|Overall Study||50||
59571435|NCT01773187|75675370|FG000|STARTED|Overall Study||220||
59571436|NCT01773187|75675371|FG001|STARTED|Overall Study||107||
59571437|NCT01773187|75675370|FG000|COMPLETED|Overall Study||167||
59571438|NCT01773187|75675371|FG001|COMPLETED|Overall Study||75||
59571439|NCT01773187|75675370|FG000|NOT COMPLETED|Overall Study||53||
59571440|NCT01773187|75675371|FG001|NOT COMPLETED|Overall Study||32||
59571441|NCT01774045|75675379|FG000|STARTED|Overall Study||23||
59571442|NCT01774045|75675380|FG001|STARTED|Overall Study||7||
59571443|NCT01774045|75675379|FG000|COMPLETED|Overall Study||23||
59571444|NCT01774045|75675380|FG001|COMPLETED|Overall Study||7||
59571445|NCT01774045|75675379|FG000|NOT COMPLETED|Overall Study||0||
59571446|NCT01774045|75675380|FG001|NOT COMPLETED|Overall Study||0||
59571447|NCT01775371|75675389|FG000|STARTED|Overall Study||306||
59571448|NCT01775371|75675390|FG001|STARTED|Overall Study||330||
59571449|NCT01775371|75675389|FG000|COMPLETED|Overall Study||306||
59571450|NCT01775371|75675390|FG001|COMPLETED|Overall Study||330||
59571451|NCT01775371|75675389|FG000|NOT COMPLETED|Overall Study||0||
59571452|NCT01775371|75675390|FG001|NOT COMPLETED|Overall Study||0||
59571453|NCT01673867|75675400|FG000|STARTED|Randomization||292|Started = Randomized|
59571454|NCT01673867|75675401|FG001|STARTED|Randomization||290|Started = Randomized|
59571455|NCT01673867|75675400|FG000|COMPLETED|Randomization||287|Completed = Received treatment|
59571456|NCT01673867|75675401|FG001|COMPLETED|Randomization||268|Completed = Received treatment|
59571457|NCT01673867|75675400|FG000|NOT COMPLETED|Randomization||5||
59571458|NCT01673867|75675401|FG001|NOT COMPLETED|Randomization||22||
59571459|NCT01673867|75675400|FG000|STARTED|Treatment||287|Started = Received treatment|
59571460|NCT01673867|75675401|FG001|STARTED|Treatment||268|Started = Received treatment|
59571461|NCT01673867|75675400|FG000|Participants Who Transitioned to Nivolumab 3 mg/kg|Treatment||0||
59571462|NCT01673867|75675401|FG001|Participants Who Transitioned to Nivolumab 3 mg/kg|Treatment||17||
59571463|NCT01673867|75675400|FG000|Participants Who Transitioned to Nivolumab 480 mg|Treatment||15||
59571464|NCT01673867|75675401|FG001|Participants Who Transitioned to Nivolumab 480 mg|Treatment||1||
59571465|NCT01673867|75675400|FG000|COMPLETED|Treatment||2|Completed = Completed treatment period|
59571466|NCT01673867|75675401|FG001|COMPLETED|Treatment||0|Completed = Completed treatment period|
59571467|NCT01673867|75675400|FG000|NOT COMPLETED|Treatment||285||
59571468|NCT01673867|75675401|FG001|NOT COMPLETED|Treatment||268||
59571469|NCT01777945|75675410|FG000|STARTED|Overall Study||46||
59571470|NCT01777945|75675410|FG000|Evaluable Participants|Overall Study||45||
59571471|NCT01777945|75675410|FG000|COMPLETED|Overall Study||46||
59571472|NCT01777945|75675410|FG000|NOT COMPLETED|Overall Study||0||
59571473|NCT01778179|75675416|FG000|STARTED|Overall Study||25||
59571474|NCT01778179|75675417|FG001|STARTED|Overall Study||25||
59571475|NCT01778179|75675416|FG000|COMPLETED|Overall Study||23||
59571476|NCT01778179|75675417|FG001|COMPLETED|Overall Study||22||
59571477|NCT01778179|75675416|FG000|NOT COMPLETED|Overall Study||2||
59571478|NCT01778179|75675417|FG001|NOT COMPLETED|Overall Study||3||
59571479|NCT02257099|75675423|FG000|STARTED|Overall Study||20||
59571480|NCT02257099|75675423|FG000|COMPLETED|Overall Study||20||
59571481|NCT02257099|75675423|FG000|NOT COMPLETED|Overall Study||0||
59571482|NCT02451839|75675429|FG000|STARTED|Overall Study||72||
59571483|NCT02451839|75675430|FG001|STARTED|Overall Study||59||
59571484|NCT02451839|75675431|FG002|STARTED|Overall Study||37||
59571485|NCT02451839|75675429|FG000|Baseline WHODAS Data Recorded|Overall Study||70||
59571486|NCT02451839|75675430|FG001|Baseline WHODAS Data Recorded|Overall Study||57||
59571487|NCT02451839|75675431|FG002|Baseline WHODAS Data Recorded|Overall Study||37||
59571488|NCT02451839|75675429|FG000|COMPLETED|Overall Study||44||
59571489|NCT02451839|75675430|FG001|COMPLETED|Overall Study||40||
59571490|NCT02451839|75675431|FG002|COMPLETED|Overall Study||30||
59571491|NCT02451839|75675429|FG000|NOT COMPLETED|Overall Study||28||
59571492|NCT02451839|75675430|FG001|NOT COMPLETED|Overall Study||19||
59571493|NCT02451839|75675431|FG002|NOT COMPLETED|Overall Study||7||
59571494|NCT02478775|75675442|FG000|STARTED|Overall Study||6||
59571495|NCT02478775|75675443|FG001|STARTED|Overall Study||27||
59571496|NCT02478775|75675444|FG002|STARTED|Overall Study||27||
59571497|NCT02478775|75675442|FG000|COMPLETED|Overall Study||6||
59571498|NCT02478775|75675443|FG001|COMPLETED|Overall Study||27||
59571499|NCT02478775|75675444|FG002|COMPLETED|Overall Study||27||
59571500|NCT02478775|75675442|FG000|NOT COMPLETED|Overall Study||0||
59571501|NCT02478775|75675443|FG001|NOT COMPLETED|Overall Study||0||
59571502|NCT02478775|75675444|FG002|NOT COMPLETED|Overall Study||0||
59571503|NCT02451995|75675453|FG000|STARTED|Overall Study||42||
59571504|NCT02451995|75675454|FG001|STARTED|Overall Study||41||
59571505|NCT02451995|75675453|FG000|COMPLETED|Overall Study||42||
59571506|NCT02451995|75675454|FG001|COMPLETED|Overall Study||41||
59571507|NCT02451995|75675453|FG000|NOT COMPLETED|Overall Study||0||
59571508|NCT02451995|75675454|FG001|NOT COMPLETED|Overall Study||0||
59571509|NCT01783561|75675462|FG000|STARTED|Overall Study||11||
59571510|NCT01783561|75675463|FG001|STARTED|Overall Study||10||
59571511|NCT01783561|75675462|FG000|COMPLETED|Overall Study||11||
59571512|NCT01783561|75675463|FG001|COMPLETED|Overall Study||10||
59571513|NCT01783561|75675462|FG000|NOT COMPLETED|Overall Study||0||
59571514|NCT01783561|75675463|FG001|NOT COMPLETED|Overall Study||0||
59571515|NCT02452931|75675469|FG000|STARTED|Overall Study||64||
59571516|NCT02452931|75675469|FG000|COMPLETED|Overall Study||60||
59571517|NCT02452931|75675469|FG000|NOT COMPLETED|Overall Study||4||
59571518|NCT01783639|75675473|FG000|STARTED|Overall Study||120||
59571519|NCT01783639|75675473|FG000|COMPLETED|Overall Study||120||
59571520|NCT01783639|75675473|FG000|NOT COMPLETED|Overall Study||0||
59571521|NCT02243527|75675479|FG000|STARTED|Overall Study||12||
59571522|NCT02243527|75675480|FG001|STARTED|Overall Study||13||
59571523|NCT02243527|75675479|FG000|COMPLETED|Overall Study||12||
59571524|NCT02243527|75675480|FG001|COMPLETED|Overall Study||13||
59571525|NCT02243527|75675479|FG000|NOT COMPLETED|Overall Study||0||
59571526|NCT02243527|75675480|FG001|NOT COMPLETED|Overall Study||0||
59571527|NCT02454179|75675488|FG000|STARTED|Overall Study||39||
59571528|NCT02454179|75675489|FG001|STARTED|Overall Study||39||
59571529|NCT02454179|75675488|FG000|Enrolled|Overall Study||39||
59571530|NCT02454179|75675489|FG001|Enrolled|Overall Study||39||
60121189|NCT01688999|76242112|FG000|COMPLETED|Overall Study||42||
60121190|NCT01688999|76242113|FG001|COMPLETED|Overall Study||5||
59721228|NCT01143077|75840114|FG002|STARTED|Overall Study||82||
60121191|NCT01688999|76242114|FG002|COMPLETED|Overall Study||10||
60121192|NCT01688999|76242112|FG000|NOT COMPLETED|Overall Study||8||
60121193|NCT01688999|76242113|FG001|NOT COMPLETED|Overall Study||1||
59571531|NCT02454179|75675488|FG000|Received Study Medication|Overall Study||39||
59571532|NCT02454179|75675489|FG001|Received Study Medication|Overall Study||37||
59571533|NCT02454179|75675488|FG000|Discontinue Study|Overall Study||39||
59571534|NCT02454179|75675489|FG001|Discontinue Study|Overall Study||39||
59571535|NCT02454179|75675488|FG000|COMPLETED|Overall Study||0||
59571536|NCT02454179|75675489|FG001|COMPLETED|Overall Study||0||
59571537|NCT02454179|75675488|FG000|NOT COMPLETED|Overall Study||39||
59571538|NCT02454179|75675489|FG001|NOT COMPLETED|Overall Study||39||
59571539|NCT02041533|75675497|FG000|STARTED|Pre-Treatment Period||271|Started = Participants Randomized|
59721229|NCT01143077|75840112|FG000|COMPLETED|Overall Study||58||
59721230|NCT01143077|75840113|FG001|COMPLETED|Overall Study||73||
59571540|NCT02041533|75675498|FG001|STARTED|Pre-Treatment Period||270|Started = Participants Randomized|
59571541|NCT02041533|75675497|FG000|COMPLETED|Pre-Treatment Period||267|Completed = Participants Treated|
59571542|NCT02041533|75675498|FG001|COMPLETED|Pre-Treatment Period||263|Completed = Participants Treated|
59571543|NCT02041533|75675497|FG000|NOT COMPLETED|Pre-Treatment Period||4||
59571544|NCT02041533|75675498|FG001|NOT COMPLETED|Pre-Treatment Period||7||
59571545|NCT02041533|75675497|FG000|STARTED|Treatment Period||267||
59571546|NCT02041533|75675498|FG001|STARTED|Treatment Period||263||
59571547|NCT02041533|75675497|FG000|Received Optional Nivolumab|Treatment Period||0|Participants in the Investigator Choice Arm who progressed on or after chemotherapy could be eligible to receive optional crossover nivolumab.|
59571548|NCT02041533|75675498|FG001|Received Optional Nivolumab|Treatment Period||159|Participants in the Investigator Choice Arm who progressed on or after chemotherapy could be eligible to receive optional crossover nivolumab.|
59571549|NCT02041533|75675497|FG000|COMPLETED|Treatment Period||0||
59571550|NCT02041533|75675498|FG001|COMPLETED|Treatment Period||28||
59571551|NCT02041533|75675497|FG000|NOT COMPLETED|Treatment Period||267||
59571552|NCT02041533|75675498|FG001|NOT COMPLETED|Treatment Period||235||
59571553|NCT02907203|75675505|FG000|STARTED|Overall Study||52||
59571554|NCT02907203|75675505|FG000|COMPLETED|Overall Study||44||
59571555|NCT02907203|75675505|FG000|NOT COMPLETED|Overall Study||8||
59571556|NCT02260531|75675512|FG000|STARTED|Overall Study||21||
59571557|NCT02260531|75675513|FG001|STARTED|Overall Study||7||
59571558|NCT02260531|75675514|FG002|STARTED|Overall Study||8||
59571559|NCT02260531|75675512|FG000|COMPLETED|Overall Study||21||
59571560|NCT02260531|75675513|FG001|COMPLETED|Overall Study||7||
59571561|NCT02260531|75675514|FG002|COMPLETED|Overall Study||8||
59571562|NCT02260531|75675512|FG000|NOT COMPLETED|Overall Study||0||
59571563|NCT02260531|75675513|FG001|NOT COMPLETED|Overall Study||0||
59571564|NCT02260531|75675514|FG002|NOT COMPLETED|Overall Study||0||
59571565|NCT02458235|75675529|FG000|STARTED|Overall Study||17||
59571566|NCT02458235|75675529|FG000|COMPLETED|Overall Study||17||
59571567|NCT02458235|75675529|FG000|NOT COMPLETED|Overall Study||0||
59571568|NCT01805323|75675533|FG000|STARTED|Overall Study||101||
59571569|NCT01805323|75675533|FG000|COMPLETED|Overall Study||101||
59571570|NCT01805323|75675533|FG000|NOT COMPLETED|Overall Study||0||
59571571|NCT02459795|75675540|FG000|STARTED|Overall Study||187||
59571572|NCT02459795|75675541|FG001|STARTED|Overall Study||189||
59571573|NCT02459795|75675542|FG002|STARTED|Overall Study||93||
59571574|NCT02459795|75675540|FG000|COMPLETED|Overall Study||181||
59571575|NCT02459795|75675541|FG001|COMPLETED|Overall Study||186||
59571576|NCT02459795|75675542|FG002|COMPLETED|Overall Study||92||
59571577|NCT02459795|75675540|FG000|NOT COMPLETED|Overall Study||6||
59571578|NCT02459795|75675541|FG001|NOT COMPLETED|Overall Study||3||
59571579|NCT02459795|75675542|FG002|NOT COMPLETED|Overall Study||1||
59571580|NCT01787383|75675552|FG000|STARTED|Overall Study||101||
59571581|NCT01787383|75675553|FG001|STARTED|Overall Study||98||
59571582|NCT01787383|75675552|FG000|COMPLETED|Overall Study||92||
59571583|NCT01787383|75675553|FG001|COMPLETED|Overall Study||76||
59571584|NCT01787383|75675552|FG000|NOT COMPLETED|Overall Study||9||
59571585|NCT01787383|75675553|FG001|NOT COMPLETED|Overall Study||22||
59571586|NCT02461433|75675569|FG000|STARTED|Overall Study||1||
59571587|NCT02461433|75675570|FG001|STARTED|Overall Study||1||
59571588|NCT02461433|75675569|FG000|COMPLETED|Overall Study||1||
59571589|NCT02461433|75675570|FG001|COMPLETED|Overall Study||1||
59571590|NCT02461433|75675569|FG000|NOT COMPLETED|Overall Study||0||
59571591|NCT02461433|75675570|FG001|NOT COMPLETED|Overall Study||0||
59571592|NCT02462291|75675578|FG000|STARTED|Overall Study||82||
59571593|NCT02462291|75675579|FG001|STARTED|Overall Study||81||
59571594|NCT02462291|75675578|FG000|COMPLETED|Overall Study||77||
59571595|NCT02462291|75675579|FG001|COMPLETED|Overall Study||75||
59571596|NCT02462291|75675578|FG000|NOT COMPLETED|Overall Study||5||
59571597|NCT02462291|75675579|FG001|NOT COMPLETED|Overall Study||6||
59571598|NCT02463227|75675587|FG000|STARTED|Overall Study||14||
59571599|NCT02463227|75675587|FG000|COMPLETED|Overall Study||14||
59571600|NCT02463227|75675587|FG000|NOT COMPLETED|Overall Study||0||
59571601|NCT01788631|75675593|FG000|STARTED|Overall Study||52||
59571602|NCT01788631|75675594|FG001|STARTED|Overall Study||44||
59571603|NCT01788631|75675593|FG000|Randomized|Overall Study||53||
59850262|NCT03586648|75974591|FG000|COMPLETED|Period 2||31||
59571604|NCT01788631|75675594|FG001|Randomized|Overall Study||47||
59571605|NCT01788631|75675593|FG000|COMPLETED|Overall Study||49||
59571606|NCT01788631|75675594|FG001|COMPLETED|Overall Study||43||
59571607|NCT01788631|75675593|FG000|NOT COMPLETED|Overall Study||3||
59571608|NCT01788631|75675594|FG001|NOT COMPLETED|Overall Study||1||
59571609|NCT01789255|75675600|FG000|STARTED|Overall Study||12||
59571610|NCT01789255|75675600|FG000|COMPLETED|Overall Study||12||
59571611|NCT01789255|75675600|FG000|NOT COMPLETED|Overall Study||0||
59571612|NCT02464163|75675608|FG000|STARTED|Overall Study||102||
59571613|NCT02464163|75675609|FG001|STARTED|Overall Study||102||
59571614|NCT02464163|75675610|FG002|STARTED|Overall Study||102||
59571615|NCT02464163|75675611|FG003|STARTED|Overall Study||101||
59571616|NCT02464163|75675608|FG000|COMPLETED|Overall Study||99||
59571617|NCT02464163|75675609|FG001|COMPLETED|Overall Study||94||
59571618|NCT02464163|75675610|FG002|COMPLETED|Overall Study||97||
59571619|NCT02464163|75675611|FG003|COMPLETED|Overall Study||96||
59571620|NCT02464163|75675608|FG000|NOT COMPLETED|Overall Study||3||
59571621|NCT02464163|75675609|FG001|NOT COMPLETED|Overall Study||8||
59571622|NCT02464163|75675610|FG002|NOT COMPLETED|Overall Study||5||
59571623|NCT02464163|75675611|FG003|NOT COMPLETED|Overall Study||5||
59571624|NCT02465099|75675623|FG000|STARTED|Overall Study||45||
59571625|NCT02465099|75675624|FG001|STARTED|Overall Study||19||
59571626|NCT02465099|75675623|FG000|COMPLETED|Overall Study||45||
59571627|NCT02465099|75675624|FG001|COMPLETED|Overall Study||19||
59571628|NCT02465099|75675623|FG000|NOT COMPLETED|Overall Study||0||
59571629|NCT02465099|75675624|FG001|NOT COMPLETED|Overall Study||0||
59571630|NCT01807585|75675633|FG000|STARTED|Overall Study||20|Date of first Baseline Visit|
59571631|NCT01807585|75675634|FG001|STARTED|Overall Study||108|Date of first Baseline Visit|
59571632|NCT01807585|75675635|FG002|STARTED|Overall Study||114|Date of first Baseline Visit|
59571633|NCT01807585|75675633|FG000|3 Mos|Overall Study||20|Primary endpoint|
59571634|NCT01807585|75675634|FG001|3 Mos|Overall Study||108|Primary endpoint|
59571635|NCT01807585|75675635|FG002|3 Mos|Overall Study||113|Primary endpoint|
59571636|NCT01807585|75675633|FG000|COMPLETED|Overall Study||19||
59571637|NCT01807585|75675634|FG001|COMPLETED|Overall Study||104||
59571638|NCT01807585|75675635|FG002|COMPLETED|Overall Study||108||
59571639|NCT01807585|75675633|FG000|NOT COMPLETED|Overall Study||1||
59571640|NCT01807585|75675634|FG001|NOT COMPLETED|Overall Study||4||
59571641|NCT01807585|75675635|FG002|NOT COMPLETED|Overall Study||6||
59571642|NCT01808755|75675646|FG000|STARTED|Overall Study||30||
59571643|NCT01808755|75675647|FG001|STARTED|Overall Study||30||
59571644|NCT01808755|75675646|FG000|COMPLETED|Overall Study||30||
59571645|NCT01808755|75675647|FG001|COMPLETED|Overall Study||30||
59571646|NCT01808755|75675646|FG000|NOT COMPLETED|Overall Study||0||
59571647|NCT01808755|75675647|FG001|NOT COMPLETED|Overall Study||0||
59571648|NCT01790581|75675654|FG000|STARTED|Overall Study||12||
59571649|NCT01790581|75675655|FG001|STARTED|Overall Study||12||
59571650|NCT01790581|75675654|FG000|COMPLETED|Overall Study||12||
59571651|NCT01790581|75675655|FG001|COMPLETED|Overall Study||12||
59571652|NCT01790581|75675654|FG000|NOT COMPLETED|Overall Study||0||
59571653|NCT01790581|75675655|FG001|NOT COMPLETED|Overall Study||0||
59571654|NCT02469389|75675663|FG000|STARTED|Overall Study||53||
59571655|NCT02469389|75675664|FG001|STARTED|Overall Study||52||
59571656|NCT02469389|75675663|FG000|Completed 12-week Assessment|Overall Study|13 lost to contact or refused|40||
59571657|NCT02469389|75675664|FG001|Completed 12-week Assessment|Overall Study|8 lost to contact or refused|44||
59571658|NCT02469389|75675663|FG000|Completed 24-week Assessment|Overall Study|16 lost to contact or refused|37||
59571659|NCT02469389|75675664|FG001|Completed 24-week Assessment|Overall Study|6 lost to contact or refused|46||
59571660|NCT02469389|75675663|FG000|COMPLETED|Overall Study||37||
59571661|NCT02469389|75675664|FG001|COMPLETED|Overall Study||44||
59571662|NCT02469389|75675663|FG000|NOT COMPLETED|Overall Study||16||
59571663|NCT02469389|75675664|FG001|NOT COMPLETED|Overall Study||8||
59571664|NCT01790659|75675672|FG000|STARTED|Overall Study||201||
59571665|NCT01790659|75675673|FG001|STARTED|Overall Study||198||
59571666|NCT01790659|75675672|FG000|COMPLETED|Overall Study||195||
59571667|NCT01790659|75675673|FG001|COMPLETED|Overall Study||192||
59571668|NCT01790659|75675672|FG000|NOT COMPLETED|Overall Study||6||
59571669|NCT01790659|75675673|FG001|NOT COMPLETED|Overall Study||6||
59571670|NCT01811875|75675679|FG000|STARTED|Overall Study||7||
59571671|NCT01811875|75675679|FG000|COMPLETED|Overall Study||5||
59571672|NCT01811875|75675679|FG000|NOT COMPLETED|Overall Study||2||
59571673|NCT02469701|75675683|FG000|STARTED|Overall Study||10||
59571674|NCT02469701|75675683|FG000|COMPLETED|Overall Study||10||
59571675|NCT02469701|75675683|FG000|NOT COMPLETED|Overall Study||0||
59571676|NCT01733407|75675689|FG000|STARTED|Overall Study||9||
59571677|NCT01733407|75675690|FG001|STARTED|Overall Study||9||
59571678|NCT01733407|75675689|FG000|COMPLETED|Overall Study||7||
59571679|NCT01733407|75675690|FG001|COMPLETED|Overall Study||9||
59571680|NCT01733407|75675689|FG000|NOT COMPLETED|Overall Study||2||
59571681|NCT01733407|75675690|FG001|NOT COMPLETED|Overall Study||0||
59571682|NCT01733953|75675698|FG000|STARTED|Overall Study||14||
60121194|NCT01688999|76242114|FG002|NOT COMPLETED|Overall Study||3||
59721231|NCT01143077|75840114|FG002|COMPLETED|Overall Study||67||
59721232|NCT01143077|75840112|FG000|NOT COMPLETED|Overall Study||16||
59721233|NCT01143077|75840113|FG001|NOT COMPLETED|Overall Study||15||
59721234|NCT01143077|75840114|FG002|NOT COMPLETED|Overall Study||15||
59571683|NCT01733953|75675699|FG001|STARTED|Overall Study||13||
59571684|NCT01733953|75675698|FG000|COMPLETED|Overall Study||9||
59571685|NCT01733953|75675699|FG001|COMPLETED|Overall Study||6||
59571686|NCT01733953|75675698|FG000|NOT COMPLETED|Overall Study||5||
59571687|NCT01733953|75675699|FG001|NOT COMPLETED|Overall Study||7||
59571688|NCT01734655|75675705|FG000|STARTED|Overall Study||40||
59571689|NCT01734655|75675705|FG000|COMPLETED|Overall Study||40||
59571690|NCT01734655|75675705|FG000|NOT COMPLETED|Overall Study||0||
59571691|NCT01734889|75675712|FG000|STARTED|Overall Study||18||
59571692|NCT01734889|75675712|FG000|COMPLETED|Overall Study||18||
59571693|NCT01734889|75675712|FG000|NOT COMPLETED|Overall Study||0||
59571694|NCT01735981|75675719|FG000|STARTED|Allocated||13||
59571695|NCT01735981|75675720|FG001|STARTED|Allocated||11||
59571696|NCT01735981|75675719|FG000|COMPLETED|Allocated||11||
59571697|NCT01735981|75675720|FG001|COMPLETED|Allocated||8||
59571698|NCT01735981|75675719|FG000|NOT COMPLETED|Allocated||2||
59571699|NCT01735981|75675720|FG001|NOT COMPLETED|Allocated||3||
59571700|NCT01735981|75675719|FG000|STARTED|Crossed Over||11||
59571701|NCT01735981|75675720|FG001|STARTED|Crossed Over|N=1 lost to cross over before DDR intervention|7||
59571702|NCT01735981|75675719|FG000|COMPLETED|Crossed Over||11||
59571703|NCT01735981|75675720|FG001|COMPLETED|Crossed Over||7||
59571704|NCT01735981|75675719|FG000|NOT COMPLETED|Crossed Over||0||
59571705|NCT01735981|75675720|FG001|NOT COMPLETED|Crossed Over||0||
59571706|NCT01736527|75675728|FG000|STARTED|Overall Study||12||
59571707|NCT01736527|75675728|FG000|COMPLETED|Overall Study||12||
59571708|NCT01736527|75675728|FG000|NOT COMPLETED|Overall Study||0||
59571709|NCT01795105|75675732|FG000|STARTED|Overall Study||692||
59571710|NCT01795105|75675732|FG000|COMPLETED|Overall Study||648||
59571711|NCT01795105|75675732|FG000|NOT COMPLETED|Overall Study||44||
59571712|NCT01796665|75675740|FG000|STARTED|Overall Study||474||
59571713|NCT01796665|75675741|FG001|STARTED|Overall Study||469||
59571714|NCT01796665|75675742|FG002|STARTED|Overall Study||237||
59571715|NCT01796665|75675740|FG000|COMPLETED|Overall Study||416||
59571716|NCT01796665|75675741|FG001|COMPLETED|Overall Study||396||
59571717|NCT01796665|75675742|FG002|COMPLETED|Overall Study||195||
59571718|NCT01796665|75675740|FG000|NOT COMPLETED|Overall Study||58||
59571719|NCT01796665|75675741|FG001|NOT COMPLETED|Overall Study||73||
59571720|NCT01796665|75675742|FG002|NOT COMPLETED|Overall Study||42||
59571721|NCT01796977|75675750|FG000|STARTED|Overall Study||27||
59571722|NCT01796977|75675750|FG000|COMPLETED|Overall Study||27||
59571723|NCT01796977|75675750|FG000|NOT COMPLETED|Overall Study||0||
59571724|NCT01798225|75675761|FG000|STARTED|Overall Study||57||
59571725|NCT01798225|75675762|FG001|STARTED|Overall Study||56||
59571726|NCT01798225|75675761|FG000|COMPLETED|Overall Study||57||
59571727|NCT01798225|75675762|FG001|COMPLETED|Overall Study||53||
59571728|NCT01798225|75675761|FG000|NOT COMPLETED|Overall Study||0||
59571729|NCT01798225|75675762|FG001|NOT COMPLETED|Overall Study||3||
59571730|NCT01800877|75675770|FG000|STARTED|Overall Study||60||
59571731|NCT01800877|75675771|FG001|STARTED|Overall Study||60||
59571732|NCT01800877|75675770|FG000|COMPLETED|Overall Study||58||
59571733|NCT01800877|75675771|FG001|COMPLETED|Overall Study||60||
59571734|NCT01800877|75675770|FG000|NOT COMPLETED|Overall Study||2||
59571735|NCT01800877|75675771|FG001|NOT COMPLETED|Overall Study||0||
59571736|NCT02470949|75675777|FG000|STARTED|First Intervention||4||
59571737|NCT02470949|75675778|FG001|STARTED|First Intervention||5||
59571738|NCT02470949|75675777|FG000|COMPLETED|First Intervention||4||
59571739|NCT02470949|75675778|FG001|COMPLETED|First Intervention||5||
59571740|NCT02470949|75675777|FG000|NOT COMPLETED|First Intervention||0||
59571741|NCT02470949|75675778|FG001|NOT COMPLETED|First Intervention||0||
59571742|NCT02470949|75675777|FG000|STARTED|Washout Period for a Minimum of 4 Weeks||4||
59571743|NCT02470949|75675778|FG001|STARTED|Washout Period for a Minimum of 4 Weeks||5||
59571744|NCT02470949|75675777|FG000|COMPLETED|Washout Period for a Minimum of 4 Weeks||4||
59571745|NCT02470949|75675778|FG001|COMPLETED|Washout Period for a Minimum of 4 Weeks||5||
59571746|NCT02470949|75675777|FG000|NOT COMPLETED|Washout Period for a Minimum of 4 Weeks||0||
59571747|NCT02470949|75675778|FG001|NOT COMPLETED|Washout Period for a Minimum of 4 Weeks||0||
59571748|NCT02470949|75675777|FG000|STARTED|Second Intervention||4||
59571749|NCT02470949|75675778|FG001|STARTED|Second Intervention||2||
59571750|NCT02470949|75675777|FG000|COMPLETED|Second Intervention||4||
59571751|NCT02470949|75675778|FG001|COMPLETED|Second Intervention||2||
59721235|NCT01096446|75840124|FG000|STARTED|Overall Study||12||
59571752|NCT02470949|75675777|FG000|NOT COMPLETED|Second Intervention||0||
59571753|NCT02470949|75675778|FG001|NOT COMPLETED|Second Intervention||0||
59571754|NCT02471651|75675788|FG000|STARTED|Overall Study||20||
59721236|NCT01096446|75840125|FG001|STARTED|Overall Study||10||
59721237|NCT01096446|75840124|FG000|COMPLETED|Overall Study|One infant was SGA; one infant had a congenital anomaly; and one discontinued medical management|9||
59721238|NCT01096446|75840125|FG001|COMPLETED|Overall Study||10||
59721239|NCT01096446|75840124|FG000|NOT COMPLETED|Overall Study||3||
59721240|NCT01096446|75840125|FG001|NOT COMPLETED|Overall Study||0||
59571755|NCT02471651|75675789|FG001|STARTED|Overall Study||20||
59571756|NCT02471651|75675788|FG000|COMPLETED|Overall Study||15||
59721241|NCT00864721|75840130|FG000|STARTED|Overall Study||63||
59721242|NCT00864721|75840130|FG000|COMPLETED|Overall Study||29||
59571757|NCT02471651|75675789|FG001|COMPLETED|Overall Study||15||
59571758|NCT02471651|75675788|FG000|NOT COMPLETED|Overall Study||5||
59571759|NCT02471651|75675789|FG001|NOT COMPLETED|Overall Study||5||
59571760|NCT02473991|75675795|FG000|STARTED|Overall Study||395||
59571761|NCT02473991|75675795|FG000|COMPLETED|Overall Study||395||
59571762|NCT02473991|75675795|FG000|NOT COMPLETED|Overall Study||0||
59571763|NCT02476565|75675801|FG000|STARTED|Overall Study||20||
59571764|NCT02476565|75675802|FG001|STARTED|Overall Study||19||
59571765|NCT02476565|75675801|FG000|COMPLETED|Overall Study||20||
59571766|NCT02476565|75675802|FG001|COMPLETED|Overall Study||19||
59571767|NCT02476565|75675801|FG000|NOT COMPLETED|Overall Study||0||
59571768|NCT02476565|75675802|FG001|NOT COMPLETED|Overall Study||0||
59571769|NCT02477423|75675810|FG000|STARTED|Overall Study||12||
59571770|NCT02477423|75675811|FG001|STARTED|Overall Study||15||
59571771|NCT02477423|75675810|FG000|COMPLETED|Overall Study||11||
59571772|NCT02477423|75675811|FG001|COMPLETED|Overall Study||11||
59571773|NCT02477423|75675810|FG000|NOT COMPLETED|Overall Study||1||
59571774|NCT02477423|75675811|FG001|NOT COMPLETED|Overall Study||4||
59571775|NCT02478671|75675817|FG000|STARTED|Overall Study||4||
59571776|NCT02478671|75675817|FG000|COMPLETED|Overall Study||4||
59571777|NCT02478671|75675817|FG000|NOT COMPLETED|Overall Study||0||
59571778|NCT02479763|75675824|FG000|STARTED|Overall Study||53||
59571779|NCT02479763|75675825|FG001|STARTED|Overall Study||53||
59571780|NCT02479763|75675824|FG000|COMPLETED|Overall Study||50||
59571781|NCT02479763|75675825|FG001|COMPLETED|Overall Study||50||
59571782|NCT02479763|75675824|FG000|NOT COMPLETED|Overall Study||3||
59571783|NCT02479763|75675825|FG001|NOT COMPLETED|Overall Study||3||
59571784|NCT02518997|75675831|FG000|STARTED|Overall Study||18||
59571785|NCT02518997|75675831|FG000|COMPLETED|Overall Study||18||
59571786|NCT02518997|75675831|FG000|NOT COMPLETED|Overall Study||0||
59571787|NCT02519387|75675838|FG000|STARTED|Overall Study||78||
59571788|NCT02519387|75675838|FG000|COMPLETED|Overall Study||56||
59571789|NCT02519387|75675838|FG000|NOT COMPLETED|Overall Study||22||
59571790|NCT02521181|75675845|FG000|STARTED|Overall Study||52||
59571791|NCT02521181|75675846|FG001|STARTED|Overall Study||90||
59571792|NCT02521181|75675847|FG002|STARTED|Overall Study||52||
59571793|NCT02521181|75675845|FG000|COMPLETED|Overall Study|All patients included in primary analysis|52||
59571794|NCT02521181|75675846|FG001|COMPLETED|Overall Study|All patients included in primary analysis|90||
59571795|NCT02521181|75675847|FG002|COMPLETED|Overall Study|All patients included in primary analysis|52||
59571796|NCT02521181|75675845|FG000|NOT COMPLETED|Overall Study||0||
59571797|NCT02521181|75675846|FG001|NOT COMPLETED|Overall Study||0||
59571798|NCT02521181|75675847|FG002|NOT COMPLETED|Overall Study||0||
59571799|NCT02521259|75675857|FG000|STARTED|Overall Study||35||
59571800|NCT02521259|75675858|FG001|STARTED|Overall Study||33||
59571801|NCT02521259|75675857|FG000|COMPLETED|Overall Study||34||
59571802|NCT02521259|75675858|FG001|COMPLETED|Overall Study||28||
59571803|NCT02521259|75675857|FG000|NOT COMPLETED|Overall Study||1||
59571804|NCT02521259|75675858|FG001|NOT COMPLETED|Overall Study||5||
59571805|NCT02257957|75675866|FG000|STARTED|Overall Study||15||
59571806|NCT02257957|75675867|FG001|STARTED|Overall Study||15||
59571807|NCT02257957|75675866|FG000|COMPLETED|Overall Study||15||
59571808|NCT02257957|75675867|FG001|COMPLETED|Overall Study||15||
59571809|NCT02257957|75675866|FG000|NOT COMPLETED|Overall Study||0||
59571810|NCT02257957|75675867|FG001|NOT COMPLETED|Overall Study||0||
59571811|NCT02524769|75675873|FG000|STARTED|Overall Study||27||
59571812|NCT02524769|75675873|FG000|COMPLETED|Overall Study||17||
59571813|NCT02524769|75675873|FG000|NOT COMPLETED|Overall Study||10||
59571814|NCT01815229|75675880|FG000|STARTED|Overall Study||13||
59571815|NCT01815229|75675881|FG001|STARTED|Overall Study||18||
59571816|NCT01815229|75675882|FG002|STARTED|Overall Study||51||
59571817|NCT01815229|75675880|FG000|COMPLETED|Overall Study||13||
59571818|NCT01815229|75675881|FG001|COMPLETED|Overall Study||18||
59571819|NCT01815229|75675882|FG002|COMPLETED|Overall Study||0||
59571820|NCT01815229|75675880|FG000|NOT COMPLETED|Overall Study||0||
59571821|NCT01815229|75675881|FG001|NOT COMPLETED|Overall Study||0||
59571822|NCT01815229|75675882|FG002|NOT COMPLETED|Overall Study||51||
59571823|NCT01877161|75675889|FG000|STARTED|First Session of Stimulation||12||
59571824|NCT01877161|75675889|FG000|COMPLETED|First Session of Stimulation||12||
59571825|NCT01877161|75675889|FG000|NOT COMPLETED|First Session of Stimulation||0||
59571826|NCT01877161|75675889|FG000|STARTED|Washout (at Least 3 Days)||12||
59571827|NCT01877161|75675889|FG000|COMPLETED|Washout (at Least 3 Days)||12||
59571828|NCT01877161|75675889|FG000|NOT COMPLETED|Washout (at Least 3 Days)||0||
59571829|NCT01877161|75675889|FG000|STARTED|Second Session of Stimulation||12||
59571830|NCT01877161|75675889|FG000|COMPLETED|Second Session of Stimulation||12||
59571831|NCT01877161|75675889|FG000|NOT COMPLETED|Second Session of Stimulation||0||
59571832|NCT01877161|75675889|FG000|STARTED|Washout (at Least 3 Days)||12||
59571833|NCT01877161|75675889|FG000|COMPLETED|Washout (at Least 3 Days)||12||
59571834|NCT01877161|75675889|FG000|NOT COMPLETED|Washout (at Least 3 Days)||0||
59571835|NCT01877161|75675889|FG000|STARTED|Third Session of Stimulation||12||
59571836|NCT01877161|75675889|FG000|COMPLETED|Third Session of Stimulation||12||
59571837|NCT01877161|75675889|FG000|NOT COMPLETED|Third Session of Stimulation||0||
59571838|NCT02525549|75675900|FG000|STARTED|Overall Study||365||
59571839|NCT02525549|75675901|FG001|STARTED|Overall Study||360||
59571840|NCT02525549|75675902|FG002|STARTED|Overall Study||178||
59571841|NCT02525549|75675900|FG000|COMPLETED|Overall Study||330||
59571842|NCT02525549|75675901|FG001|COMPLETED|Overall Study||307||
59571843|NCT02525549|75675902|FG002|COMPLETED|Overall Study||159||
59571844|NCT02525549|75675900|FG000|NOT COMPLETED|Overall Study||35||
59571845|NCT02525549|75675901|FG001|NOT COMPLETED|Overall Study||53||
59571846|NCT02525549|75675902|FG002|NOT COMPLETED|Overall Study||19||
59571847|NCT01877941|75675910|FG000|STARTED|Overall Study||39||
59571848|NCT01877941|75675910|FG000|COMPLETED|Overall Study||39||
59571849|NCT01877941|75675910|FG000|NOT COMPLETED|Overall Study||0||
59571850|NCT01878799|75675917|FG000|STARTED|Overall Study||37||
59571851|NCT01878799|75675918|FG001|STARTED|Overall Study||13||
59571852|NCT01878799|75675917|FG000|COMPLETED|Overall Study||36||
59571853|NCT01878799|75675918|FG001|COMPLETED|Overall Study||13||
59571854|NCT01878799|75675917|FG000|NOT COMPLETED|Overall Study||1||
59571855|NCT01878799|75675918|FG001|NOT COMPLETED|Overall Study||0||
59571856|NCT02527265|75675926|FG000|STARTED|Overall Study||15||
59571857|NCT02527265|75675927|FG001|STARTED|Overall Study||15||
59571858|NCT02527265|75675926|FG000|COMPLETED|Overall Study||13||
59571859|NCT02527265|75675927|FG001|COMPLETED|Overall Study||11||
59571860|NCT02527265|75675926|FG000|NOT COMPLETED|Overall Study||2||
59571861|NCT02527265|75675927|FG001|NOT COMPLETED|Overall Study||4||
59571862|NCT01879345|75675936|FG000|STARTED|Single-dose Period||6||
59571863|NCT01879345|75675937|FG001|STARTED|Single-dose Period||6||
59571864|NCT01879345|75675938|FG002|STARTED|Single-dose Period||6||
59571865|NCT01879345|75675936|FG000|COMPLETED|Single-dose Period||6||
59571866|NCT01879345|75675937|FG001|COMPLETED|Single-dose Period||6||
59571867|NCT01879345|75675938|FG002|COMPLETED|Single-dose Period||6||
59571868|NCT01879345|75675936|FG000|NOT COMPLETED|Single-dose Period||0||
59571869|NCT01879345|75675937|FG001|NOT COMPLETED|Single-dose Period||0||
59571870|NCT01879345|75675938|FG002|NOT COMPLETED|Single-dose Period||0||
59571871|NCT01879345|75675936|FG000|STARTED|7-day Multiple-dose Period||6||
59571872|NCT01879345|75675937|FG001|STARTED|7-day Multiple-dose Period||6||
59571873|NCT01879345|75675938|FG002|STARTED|7-day Multiple-dose Period||6||
59571874|NCT01879345|75675936|FG000|COMPLETED|7-day Multiple-dose Period||6||
59571875|NCT01879345|75675937|FG001|COMPLETED|7-day Multiple-dose Period||6||
59571876|NCT01879345|75675938|FG002|COMPLETED|7-day Multiple-dose Period||6||
59571877|NCT01879345|75675936|FG000|NOT COMPLETED|7-day Multiple-dose Period||0||
59571878|NCT01879345|75675937|FG001|NOT COMPLETED|7-day Multiple-dose Period||0||
59571879|NCT01879345|75675938|FG002|NOT COMPLETED|7-day Multiple-dose Period||0||
59571880|NCT01804075|75675950|FG000|STARTED|Overall Study||15||
59571881|NCT01804075|75675951|FG001|STARTED|Overall Study||16||
59571882|NCT01804075|75675950|FG000|COMPLETED|Overall Study||15||
59571883|NCT01804075|75675951|FG001|COMPLETED|Overall Study||16||
59571884|NCT01804075|75675950|FG000|NOT COMPLETED|Overall Study||0||
59571885|NCT01804075|75675951|FG001|NOT COMPLETED|Overall Study||0||
59571886|NCT02416193|75675961|FG000|STARTED|Overall Study||15||
59571887|NCT02416193|75675962|FG001|STARTED|Overall Study||15||
59571888|NCT02416193|75675961|FG000|COMPLETED|Overall Study||15||
59571889|NCT02416193|75675962|FG001|COMPLETED|Overall Study||15||
59571890|NCT02416193|75675961|FG000|NOT COMPLETED|Overall Study||0||
59571891|NCT02416193|75675962|FG001|NOT COMPLETED|Overall Study||0||
59571892|NCT02530151|75675970|FG000|STARTED|Overall Study||37||
59571893|NCT02530151|75675971|FG001|STARTED|Overall Study||33||
59571894|NCT02530151|75675970|FG000|COMPLETED|Overall Study||16||
59571895|NCT02530151|75675971|FG001|COMPLETED|Overall Study||17||
59571896|NCT02530151|75675970|FG000|NOT COMPLETED|Overall Study||21||
59571897|NCT02530151|75675971|FG001|NOT COMPLETED|Overall Study||16||
59571898|NCT02530541|75675977|FG000|STARTED|Overall Study||21||21
59571899|NCT02530541|75675978|FG001|STARTED|Overall Study||23||23
59571900|NCT02530541|75675979|FG002|STARTED|Overall Study||22||22
59571901|NCT02530541|75675980|FG003|STARTED|Overall Study||21||21
59571902|NCT02530541|75675981|FG004|STARTED|Overall Study||20||20
59571903|NCT02530541|75675982|FG005|STARTED|Overall Study||19||19
59571904|NCT02530541|75675977|FG000|COMPLETED|Overall Study||14|33 were treated with both interventions, though interventions differ with application time. 24 subjects completed with passing treatment baseline values|14
59721243|NCT00864721|75840130|FG000|NOT COMPLETED|Overall Study||34||
59571905|NCT02530541|75675978|FG001|COMPLETED|Overall Study||15|33 were treated with both interventions, though interventions differ with application time. 24 subjects completed with passing treatment baseline values|15
59571906|NCT02530541|75675979|FG002|COMPLETED|Overall Study||14|33 were treated with both interventions, though interventions differ with application time. 24 subjects completed with passing treatment baseline values|14
59571907|NCT02530541|75675980|FG003|COMPLETED|Overall Study||15|33 were treated with both interventions, though interventions differ with application time. 24 subjects completed with passing treatment baseline values|15
59571908|NCT02530541|75675981|FG004|COMPLETED|Overall Study||15|33 were treated with both interventions, though interventions differ with application time. 24 subjects completed with passing treatment baseline values|15
59571909|NCT02530541|75675982|FG005|COMPLETED|Overall Study||14|33 were treated with both interventions, though interventions differ with application time. 24 subjects completed with passing treatment baseline values|14
59571910|NCT02530541|75675977|FG000|NOT COMPLETED|Overall Study||7||7
59571911|NCT02530541|75675978|FG001|NOT COMPLETED|Overall Study||8||8
59571912|NCT02530541|75675979|FG002|NOT COMPLETED|Overall Study||8||8
59721244|NCT01095666|75840137|FG000|STARTED|Overall Study||145||
59571913|NCT02530541|75675980|FG003|NOT COMPLETED|Overall Study||6||6
59571914|NCT02530541|75675981|FG004|NOT COMPLETED|Overall Study||5||5
59571915|NCT02530541|75675982|FG005|NOT COMPLETED|Overall Study||5||5
59571916|NCT02416973|75675994|FG000|STARTED|Overall Study||14||
59571917|NCT02416973|75675995|FG001|STARTED|Overall Study||13||
59571918|NCT02416973|75675996|FG002|STARTED|Overall Study||14||
59571919|NCT02416973|75675994|FG000|COMPLETED|Overall Study||13||
59571920|NCT02416973|75675995|FG001|COMPLETED|Overall Study||10||
59571921|NCT02416973|75675996|FG002|COMPLETED|Overall Study||13||
59571922|NCT02416973|75675994|FG000|NOT COMPLETED|Overall Study||1||
59721245|NCT01095666|75840138|FG001|STARTED|Overall Study||147||
59721246|NCT01095666|75840139|FG002|STARTED|Overall Study||152||
59571923|NCT02416973|75675995|FG001|NOT COMPLETED|Overall Study||3||
59571924|NCT02416973|75675996|FG002|NOT COMPLETED|Overall Study||1||
59571925|NCT01804465|75676006|FG000|STARTED|Overall Study||24||
59571926|NCT01804465|75676007|FG001|STARTED|Overall Study||26||
59571927|NCT01804465|75676006|FG000|COMPLETED|Overall Study||24||
59571928|NCT01804465|75676007|FG001|COMPLETED|Overall Study||26||
59571929|NCT01804465|75676006|FG000|NOT COMPLETED|Overall Study||0||
59571930|NCT01804465|75676007|FG001|NOT COMPLETED|Overall Study||0||
59571931|NCT02531321|75676015|FG000|STARTED|Overall Study||7||
59571932|NCT02531321|75676016|FG001|STARTED|Overall Study||10||
59571933|NCT02531321|75676015|FG000|COMPLETED|Overall Study||5||
59571934|NCT02531321|75676016|FG001|COMPLETED|Overall Study||10||
59571935|NCT02531321|75676015|FG000|NOT COMPLETED|Overall Study||2||
59571936|NCT02531321|75676016|FG001|NOT COMPLETED|Overall Study||0||
59571937|NCT02531867|75676022|FG000|STARTED|Overall Study||13||
59571938|NCT02531867|75676022|FG000|COMPLETED|Overall Study||13||
59571939|NCT02531867|75676022|FG000|NOT COMPLETED|Overall Study||0||
59571940|NCT01805089|75676028|FG000|STARTED|Overall Study||48||
59571941|NCT01805089|75676029|FG001|STARTED|Overall Study||47||
59571942|NCT01805089|75676028|FG000|COMPLETED|Overall Study||43||
59571943|NCT01805089|75676029|FG001|COMPLETED|Overall Study||43||
59571944|NCT01805089|75676028|FG000|NOT COMPLETED|Overall Study||5||
59571945|NCT01805089|75676029|FG001|NOT COMPLETED|Overall Study||4||
59571946|NCT02417129|75676035|FG000|STARTED|Overall Study||2||
59571947|NCT02417129|75676036|FG001|STARTED|Overall Study||0||
59571948|NCT02417129|75676035|FG000|COMPLETED|Overall Study||2||
59571949|NCT02417129|75676036|FG001|COMPLETED|Overall Study||0||
59571950|NCT02417129|75676035|FG000|NOT COMPLETED|Overall Study||0||
59571951|NCT02417129|75676036|FG001|NOT COMPLETED|Overall Study||0||
59571952|NCT01816711|75676044|FG000|STARTED|Overall Study||121||
59571953|NCT01816711|75676045|FG001|STARTED|Overall Study||83||
59571954|NCT01816711|75676044|FG000|COMPLETED|Overall Study||121||
59571955|NCT01816711|75676045|FG001|COMPLETED|Overall Study||83||
59571956|NCT01816711|75676044|FG000|NOT COMPLETED|Overall Study||0||
59571957|NCT01816711|75676045|FG001|NOT COMPLETED|Overall Study||0||
59571958|NCT01879735|75676053|FG000|STARTED|Overall Study||6||
59571959|NCT01879735|75676054|FG001|STARTED|Overall Study||16||
59571960|NCT01879735|75676053|FG000|COMPLETED|Overall Study||6||
59571961|NCT01879735|75676054|FG001|COMPLETED|Overall Study||16||
59571962|NCT01879735|75676053|FG000|NOT COMPLETED|Overall Study||0||
59571963|NCT01879735|75676054|FG001|NOT COMPLETED|Overall Study||0||
59571964|NCT02417831|75676060|FG000|STARTED|Period 1: Treatment Period 1 + Washout||17||
59571965|NCT02417831|75676061|FG001|STARTED|Period 1: Treatment Period 1 + Washout||17||
59571966|NCT02417831|75676060|FG000|COMPLETED|Period 1: Treatment Period 1 + Washout||17||
59571967|NCT02417831|75676061|FG001|COMPLETED|Period 1: Treatment Period 1 + Washout||17||
59571968|NCT02417831|75676060|FG000|NOT COMPLETED|Period 1: Treatment Period 1 + Washout||0||
59571969|NCT02417831|75676061|FG001|NOT COMPLETED|Period 1: Treatment Period 1 + Washout||0||
59571970|NCT02417831|75676060|FG000|STARTED|Period 2: Treatment Period 2 + Washout||17||
59571971|NCT02417831|75676061|FG001|STARTED|Period 2: Treatment Period 2 + Washout||17||
59571972|NCT02417831|75676060|FG000|COMPLETED|Period 2: Treatment Period 2 + Washout||17||
59571973|NCT02417831|75676061|FG001|COMPLETED|Period 2: Treatment Period 2 + Washout||17||
59571974|NCT02417831|75676060|FG000|NOT COMPLETED|Period 2: Treatment Period 2 + Washout||0||
59571975|NCT02417831|75676061|FG001|NOT COMPLETED|Period 2: Treatment Period 2 + Washout||0||
59571976|NCT02271451|75676069|FG000|STARTED|Overall Study||7||
59571977|NCT02271451|75676070|FG001|STARTED|Overall Study||8||
59571978|NCT02271451|75676069|FG000|COMPLETED|Overall Study||7||
59571979|NCT02271451|75676070|FG001|COMPLETED|Overall Study|one subject does not have MRI data due to braces|7||
59571980|NCT02271451|75676069|FG000|NOT COMPLETED|Overall Study||0||
59571981|NCT02271451|75676070|FG001|NOT COMPLETED|Overall Study||1||
59571982|NCT02419547|75676076|FG000|STARTED|Overall Study||11||
59571983|NCT02419547|75676076|FG000|COMPLETED|Overall Study||11||
59571984|NCT02419547|75676076|FG000|NOT COMPLETED|Overall Study||0||
59571985|NCT02273323|75676080|FG000|STARTED|Overall Study||15||
59571986|NCT02273323|75676081|FG001|STARTED|Overall Study||15||
59571987|NCT02273323|75676080|FG000|COMPLETED|Overall Study||15||
59571988|NCT02273323|75676081|FG001|COMPLETED|Overall Study||15||
59571989|NCT02273323|75676080|FG000|NOT COMPLETED|Overall Study||0||
59571990|NCT02273323|75676081|FG001|NOT COMPLETED|Overall Study||0||
59571991|NCT02274649|75676089|FG000|STARTED|Overall Study||101||
59571992|NCT02274649|75676090|FG001|STARTED|Overall Study||93||
59571993|NCT02274649|75676089|FG000|COMPLETED|Overall Study||77||
59571994|NCT02274649|75676090|FG001|COMPLETED|Overall Study||81||
59571995|NCT02274649|75676089|FG000|NOT COMPLETED|Overall Study||24||
59571996|NCT02274649|75676090|FG001|NOT COMPLETED|Overall Study||12||
59571997|NCT02533427|75676096|FG000|STARTED|Overall Study||15||
59571998|NCT02533427|75676096|FG000|COMPLETED|Overall Study||15||
59571999|NCT02533427|75676096|FG000|NOT COMPLETED|Overall Study||0||
59572000|NCT01816945|75676105|FG000|STARTED|Overall Study||23||
59572001|NCT01816945|75676106|FG001|STARTED|Overall Study||24||
59572002|NCT01816945|75676105|FG000|COMPLETED|Overall Study||21|Completed 12 months of the intervention|
59572003|NCT01816945|75676106|FG001|COMPLETED|Overall Study||19|Completed 12 months of the intervention|
59572004|NCT01816945|75676105|FG000|NOT COMPLETED|Overall Study||2||
59572005|NCT01816945|75676106|FG001|NOT COMPLETED|Overall Study||5||
59572006|NCT02533505|75676112|FG000|STARTED|Overall Study||26||
59572007|NCT02533505|75676113|FG001|STARTED|Overall Study||25||
59572008|NCT02533505|75676112|FG000|COMPLETED|Overall Study||23||
59572009|NCT02533505|75676113|FG001|COMPLETED|Overall Study||24||
59572010|NCT02533505|75676112|FG000|NOT COMPLETED|Overall Study||3||
59572011|NCT02533505|75676113|FG001|NOT COMPLETED|Overall Study||1||
59572012|NCT01817491|75676121|FG000|STARTED|Overall Study||32||
59572013|NCT01817491|75676122|FG001|STARTED|Overall Study||28||
59572014|NCT01817491|75676121|FG000|COMPLETED|Overall Study||28||
59572015|NCT01817491|75676122|FG001|COMPLETED|Overall Study||28||
59572016|NCT01817491|75676121|FG000|NOT COMPLETED|Overall Study||4||
59572017|NCT01817491|75676122|FG001|NOT COMPLETED|Overall Study||0||
59572018|NCT02481557|75676131|FG000|STARTED|Overall Study||17||
59572019|NCT02481557|75676132|FG001|STARTED|Overall Study||19||
59572020|NCT02481557|75676131|FG000|COMPLETED|Overall Study||17||
59572021|NCT02481557|75676132|FG001|COMPLETED|Overall Study||19||
59572022|NCT02481557|75676131|FG000|NOT COMPLETED|Overall Study||0||
59572023|NCT02481557|75676132|FG001|NOT COMPLETED|Overall Study||0||
59572024|NCT01818427|75676140|FG000|STARTED|Overall Study||239||
59572025|NCT01818427|75676141|FG001|STARTED|Overall Study||284||
59572026|NCT01818427|75676140|FG000|COMPLETED|Overall Study||230||
59572027|NCT01818427|75676141|FG001|COMPLETED|Overall Study||271||
59572028|NCT01818427|75676140|FG000|NOT COMPLETED|Overall Study||9||
59572029|NCT01818427|75676141|FG001|NOT COMPLETED|Overall Study||13||
59572030|NCT02420015|75676149|FG000|STARTED|Overall Study||21||
59572031|NCT02420015|75676150|FG001|STARTED|Overall Study||13||
59572032|NCT02420015|75676149|FG000|COMPLETED|Overall Study||21||
59572033|NCT02420015|75676150|FG001|COMPLETED|Overall Study||13||
59572034|NCT02420015|75676149|FG000|NOT COMPLETED|Overall Study||0||
59572035|NCT02420015|75676150|FG001|NOT COMPLETED|Overall Study||0||
59572036|NCT02481713|75676158|FG000|STARTED|Overall Study||56||
59572037|NCT02481713|75676159|FG001|STARTED|Overall Study||58||
59572038|NCT02481713|75676158|FG000|COMPLETED|Overall Study||40||
59572039|NCT02481713|75676159|FG001|COMPLETED|Overall Study||42||
59572040|NCT02481713|75676158|FG000|NOT COMPLETED|Overall Study||16||
59572041|NCT02481713|75676159|FG001|NOT COMPLETED|Overall Study||16||
59572042|NCT01819597|75676165|FG000|STARTED|Overall Study||52||
59572043|NCT01819597|75676165|FG000|COMPLETED|Overall Study||52||
59572044|NCT01819597|75676165|FG000|NOT COMPLETED|Overall Study||0||
59572045|NCT02482025|75676171|FG000|STARTED|Overall Study||122||
59572046|NCT02482025|75676172|FG001|STARTED|Overall Study||118||
59572047|NCT02482025|75676171|FG000|COMPLETED|Overall Study||122||
59572048|NCT02482025|75676172|FG001|COMPLETED|Overall Study||118||
59572049|NCT02482025|75676171|FG000|NOT COMPLETED|Overall Study||0||
59572050|NCT02482025|75676172|FG001|NOT COMPLETED|Overall Study||0||
59572051|NCT02420639|75676178|FG000|STARTED|Overall Study|Study obtained 12 patients|12||
59572052|NCT02420639|75676178|FG000|COMPLETED|Overall Study|Total of 12 patients enrolled|12||
59572053|NCT02420639|75676178|FG000|NOT COMPLETED|Overall Study||0||
59572054|NCT02420873|75676185|FG000|STARTED|Overall Study||9||
59572055|NCT02420873|75676186|FG001|STARTED|Overall Study||0||
59572056|NCT02420873|75676187|FG002|STARTED|Overall Study||0||
59572057|NCT02420873|75676185|FG000|COMPLETED|Overall Study||9||
59572058|NCT02420873|75676186|FG001|COMPLETED|Overall Study||0||
59572059|NCT02420873|75676187|FG002|COMPLETED|Overall Study||0||
59572060|NCT02420873|75676185|FG000|NOT COMPLETED|Overall Study||0||
59572061|NCT02420873|75676186|FG001|NOT COMPLETED|Overall Study||0||
59572062|NCT02420873|75676187|FG002|NOT COMPLETED|Overall Study||0||
59572063|NCT02534129|75676195|FG000|STARTED|Overall Study||13||13
59572064|NCT02534129|75676196|FG001|STARTED|Overall Study||13||13
59572065|NCT02534129|75676195|FG000|COMPLETED|Overall Study||13||13
59572066|NCT02534129|75676196|FG001|COMPLETED|Overall Study||13||13
59572067|NCT02534129|75676195|FG000|NOT COMPLETED|Overall Study||0||0
59572068|NCT02534129|75676196|FG001|NOT COMPLETED|Overall Study||0||0
59572069|NCT02420951|75676204|FG000|STARTED|Overall Study||25||
59572070|NCT02420951|75676205|FG001|STARTED|Overall Study||25||
59572071|NCT02420951|75676204|FG000|COMPLETED|Overall Study||25||
59572072|NCT02420951|75676205|FG001|COMPLETED|Overall Study||25||
59572073|NCT02420951|75676204|FG000|NOT COMPLETED|Overall Study||0||
59572074|NCT02420951|75676205|FG001|NOT COMPLETED|Overall Study||0||
59572075|NCT02267083|75676211|FG000|STARTED|Overall Study||22||
59572076|NCT02267083|75676211|FG000|COMPLETED|Overall Study||3||
59572077|NCT02267083|75676211|FG000|NOT COMPLETED|Overall Study||19||
59572078|NCT02534285|75676217|FG000|STARTED|Overall Study||50||
59572079|NCT02534285|75676218|FG001|STARTED|Overall Study||50||
59572080|NCT02534285|75676217|FG000|COMPLETED|Overall Study||50||
59572081|NCT02534285|75676218|FG001|COMPLETED|Overall Study||50||
59572082|NCT02534285|75676217|FG000|NOT COMPLETED|Overall Study||0||
59572083|NCT02534285|75676218|FG001|NOT COMPLETED|Overall Study||0||
59572084|NCT02422511|75676232|FG000|STARTED|Overall Study||255|Start is the number of participants (including parents and their newborns) who were randomized. Parents were enrolled with their newborns and at least one parent had to complete a baseline survey to be randomized into the study and considered fully enrolled.|
59721247|NCT01095666|75840137|FG000|COMPLETED|Overall Study||128||
59572085|NCT02422511|75676233|FG001|STARTED|Overall Study||128|Start is the number of participants (including parents and their newborns) who were randomized. Parents were enrolled with their newborns and at least one parent had to complete a baseline survey to be randomized into the study and considered fully enrolled.|
59572086|NCT02422511|75676234|FG002|STARTED|Overall Study||257|Start is the number of participants (including parents and their newborns) who were randomized. Parents were enrolled with their newborns and at least one parent had to complete a baseline survey to be randomized into the study and considered fully enrolled.|
59572087|NCT02422511|75676235|FG003|STARTED|Overall Study||129|Start is the number of participants (including parents and their newborns) who were randomized. Parents were enrolled with their newborns and at least one parent had to complete a baseline survey to be randomized into the study and considered fully enrolled.|
59572088|NCT02422511|75676236|FG004|STARTED|Overall Study||66|Start is the number of participants (including parents and their newborns) who were randomized. Parents were enrolled with their newborns and at least one parent had to complete a baseline survey to be randomized into the study and considered fully enrolled.|
59572089|NCT02422511|75676237|FG005|STARTED|Overall Study||33|Start is the number of participants (including parents and their newborns) who were randomized. Parents were enrolled with their newborns and at least one parent had to complete a baseline survey to be randomized into the study and considered fully enrolled.|
59572090|NCT02422511|75676238|FG006|STARTED|Overall Study||68|Start is the number of participants (including parents and their newborns) who were randomized. Parents were enrolled with their newborns and at least one parent had to complete a baseline survey to be randomized into the study and considered fully enrolled.|
59572091|NCT02422511|75676239|FG007|STARTED|Overall Study||34|Start is the number of participants (including parents and their newborns) who were randomized. Parents were enrolled with their newborns and at least one parent had to complete a baseline survey to be randomized into the study and considered fully enrolled.|
59572092|NCT02422511|75676232|FG000|Received Disclosure|Overall Study||158|Parents received disclosure for their newborns study results and responded to a post-disclosure survey. Either parent could complete or skip the survey.|
59572093|NCT02422511|75676233|FG001|Received Disclosure|Overall Study|Newborns did not receive disclosure|79|Parents received disclosure for their newborns study results and responded to a post-disclosure survey. Either parent could complete or skip the survey.|
59572094|NCT02422511|75676234|FG002|Received Disclosure|Overall Study||194|Parents received disclosure for their newborns study results and responded to a post-disclosure survey. Either parent could complete or skip the survey.|
59572095|NCT02422511|75676235|FG003|Received Disclosure|Overall Study||97|Parents received disclosure for their newborns study results and responded to a post-disclosure survey. Either parent could complete or skip the survey.|
59572096|NCT02422511|75676236|FG004|Received Disclosure|Overall Study||43|Parents received disclosure for their newborns study results and responded to a post-disclosure survey. Either parent could complete or skip the survey.|
59572097|NCT02422511|75676237|FG005|Received Disclosure|Overall Study||21|Parents received disclosure for their newborns study results and responded to a post-disclosure survey. Either parent could complete or skip the survey.|
59572098|NCT02422511|75676238|FG006|Received Disclosure|Overall Study||38|Parents received disclosure for their newborns study results and responded to a post-disclosure survey. Either parent could complete or skip the survey.|
59572099|NCT02422511|75676239|FG007|Received Disclosure|Overall Study||19|Parents received disclosure for their newborns study results and responded to a post-disclosure survey. Either parent could complete or skip the survey.|
59572100|NCT02422511|75676232|FG000|COMPLETED|Overall Study||143|Parents completed 10-month survey for their newborns. Either parent could complete or skip the survey.|
59572101|NCT02422511|75676233|FG001|COMPLETED|Overall Study|Newborns did not complete survey|0|Parents completed 10-month survey for their newborns. Either parent could complete or skip the survey.|
59572102|NCT02422511|75676234|FG002|COMPLETED|Overall Study||168|Parents completed 10-month survey for their newborns. Either parent could complete or skip the survey.|
59572103|NCT02422511|75676235|FG003|COMPLETED|Overall Study|Newborns did not complete survey|0|Parents completed 10-month survey for their newborns. Either parent could complete or skip the survey.|
59572104|NCT02422511|75676236|FG004|COMPLETED|Overall Study||39|Parents completed 10-month survey for their newborns. Either parent could complete or skip the survey.|
59572105|NCT02422511|75676237|FG005|COMPLETED|Overall Study|Newborns did not complete survey|0|Parents completed 10-month survey for their newborns. Either parent could complete or skip the survey.|
59572106|NCT02422511|75676238|FG006|COMPLETED|Overall Study||38|Parents completed 10-month survey for their newborns. Either parent could complete or skip the survey.|
59572107|NCT02422511|75676239|FG007|COMPLETED|Overall Study|Newborns did not complete survey|0|Parents completed 10-month survey for their newborns. Either parent could complete or skip the survey.|
59572108|NCT02422511|75676232|FG000|NOT COMPLETED|Overall Study||112||
59572109|NCT02422511|75676233|FG001|NOT COMPLETED|Overall Study||128||
59572110|NCT02422511|75676234|FG002|NOT COMPLETED|Overall Study||89||
59572111|NCT02422511|75676235|FG003|NOT COMPLETED|Overall Study||129||
59572112|NCT02422511|75676236|FG004|NOT COMPLETED|Overall Study||27||
59572113|NCT02422511|75676237|FG005|NOT COMPLETED|Overall Study||33||
59572114|NCT02422511|75676238|FG006|NOT COMPLETED|Overall Study||30||
59572115|NCT02422511|75676239|FG007|NOT COMPLETED|Overall Study||34||
59572116|NCT02535611|75676259|FG000|STARTED|Overall Study||27||
59572117|NCT02535611|75676260|FG001|STARTED|Overall Study||20||
59572118|NCT02535611|75676259|FG000|COMPLETED|Overall Study||27||
59572119|NCT02535611|75676260|FG001|COMPLETED|Overall Study||20||
59572120|NCT02535611|75676259|FG000|NOT COMPLETED|Overall Study||0||
60121195|NCT02658994|76242124|FG000|STARTED|Enrollment||287||
60121196|NCT02658994|76242125|FG001|STARTED|Enrollment||283||
60121197|NCT02658994|76242126|FG002|STARTED|Enrollment||584||
60121198|NCT02658994|76242124|FG000|COMPLETED|Enrollment||287||
60121199|NCT02658994|76242125|FG001|COMPLETED|Enrollment||283||
60121200|NCT02658994|76242126|FG002|COMPLETED|Enrollment||584||
59572121|NCT02535611|75676260|FG001|NOT COMPLETED|Overall Study||0||
59572122|NCT01823497|75676268|FG000|STARTED|Overall Study||19||
59572123|NCT01823497|75676269|FG001|STARTED|Overall Study||17||
59572124|NCT01823497|75676268|FG000|COMPLETED|Overall Study||16||
59572125|NCT01823497|75676269|FG001|COMPLETED|Overall Study||9||
59572126|NCT01823497|75676268|FG000|NOT COMPLETED|Overall Study||3||
59572127|NCT01823497|75676269|FG001|NOT COMPLETED|Overall Study||8||
59572128|NCT02423447|75676275|FG000|STARTED|Overall Study||13||
59572129|NCT02423447|75676276|FG001|STARTED|Overall Study||12||
59572130|NCT02423447|75676275|FG000|COMPLETED|Overall Study||13||
59572131|NCT02423447|75676276|FG001|COMPLETED|Overall Study||12||
59572132|NCT02423447|75676275|FG000|NOT COMPLETED|Overall Study||0||
59572133|NCT02423447|75676276|FG001|NOT COMPLETED|Overall Study||0||
59572134|NCT02537717|75676285|FG000|STARTED|Overall Study||17||
59572135|NCT02537717|75676285|FG000|COMPLETED|Overall Study||17||
59572136|NCT02537717|75676285|FG000|NOT COMPLETED|Overall Study||0||
59572137|NCT02537873|75676294|FG000|STARTED|Overall Study||17||
59572138|NCT02537873|75676295|FG001|STARTED|Overall Study||8||
59721248|NCT01095666|75840138|FG001|COMPLETED|Overall Study||136||
59721249|NCT01095666|75840139|FG002|COMPLETED|Overall Study||145||
60121201|NCT02658994|76242124|FG000|NOT COMPLETED|Enrollment||0||
60121202|NCT02658994|76242125|FG001|NOT COMPLETED|Enrollment||0||
60121203|NCT02658994|76242126|FG002|NOT COMPLETED|Enrollment||0||
60121204|NCT02658994|76242124|FG000|STARTED|3 Month Follow up||287||
60121205|NCT02658994|76242125|FG001|STARTED|3 Month Follow up||283||
60121206|NCT02658994|76242126|FG002|STARTED|3 Month Follow up||584||
60121207|NCT02658994|76242124|FG000|COMPLETED|3 Month Follow up||221||
60121208|NCT02658994|76242125|FG001|COMPLETED|3 Month Follow up||223||
60121209|NCT02658994|76242126|FG002|COMPLETED|3 Month Follow up||451||
60121210|NCT02658994|76242124|FG000|NOT COMPLETED|3 Month Follow up||66||
60121211|NCT02658994|76242125|FG001|NOT COMPLETED|3 Month Follow up||60||
60121212|NCT02658994|76242126|FG002|NOT COMPLETED|3 Month Follow up||133||
60121213|NCT02658994|76242124|FG000|STARTED|6 Month Follow up|Participants who did not complete 3 month follow up were still eligible for 6 month follow up|287||
60121214|NCT02658994|76242125|FG001|STARTED|6 Month Follow up|Participants who did not complete 3 month follow up were still eligible for 6 month follow up|283||
60121215|NCT02658994|76242126|FG002|STARTED|6 Month Follow up|Participants who did not complete 3 month follow up were still eligible for 6 month follow up|584||
60121216|NCT02658994|76242124|FG000|COMPLETED|6 Month Follow up||228||
60121217|NCT02658994|76242125|FG001|COMPLETED|6 Month Follow up||230||
60121218|NCT02658994|76242126|FG002|COMPLETED|6 Month Follow up||471||
60121219|NCT02658994|76242124|FG000|NOT COMPLETED|6 Month Follow up||59||
60121220|NCT02658994|76242125|FG001|NOT COMPLETED|6 Month Follow up||53||
60121221|NCT02658994|76242126|FG002|NOT COMPLETED|6 Month Follow up||113||
60121222|NCT02658994|76242124|FG000|STARTED|12 Month Follow up|Participants who did not complete 6 month follow up were still eligible for 12 month follow up|287||
60121223|NCT02658994|76242125|FG001|STARTED|12 Month Follow up|Participants who did not complete 6 month follow up were still eligible for 12 month follow up|283||
60121224|NCT02658994|76242126|FG002|STARTED|12 Month Follow up|Participants who did not complete 6 month follow up were still eligible for 12 month follow up|584||
60121225|NCT02658994|76242124|FG000|COMPLETED|12 Month Follow up||228||
60121226|NCT02658994|76242125|FG001|COMPLETED|12 Month Follow up||223||
60121227|NCT02658994|76242126|FG002|COMPLETED|12 Month Follow up||489||
60121228|NCT02658994|76242124|FG000|NOT COMPLETED|12 Month Follow up||59||
60121229|NCT02658994|76242125|FG001|NOT COMPLETED|12 Month Follow up||60||
60121230|NCT02658994|76242126|FG002|NOT COMPLETED|12 Month Follow up||95||
60121231|NCT02658994|76242124|FG000|STARTED|24 Month Follow up|Participants who did not complete 12 month follow up were still eligible for 24 month follow up|287||
60121232|NCT02658994|76242125|FG001|STARTED|24 Month Follow up|Participants who did not complete 12 month follow up were still eligible for 24 month follow up|283||
60121233|NCT02658994|76242126|FG002|STARTED|24 Month Follow up|Participants who did not complete 12 month follow up were still eligible for 24 month follow up|584||
60121234|NCT02658994|76242124|FG000|COMPLETED|24 Month Follow up||220||
60121235|NCT02658994|76242125|FG001|COMPLETED|24 Month Follow up||210||
60121236|NCT02658994|76242126|FG002|COMPLETED|24 Month Follow up||473||
60121237|NCT02658994|76242124|FG000|NOT COMPLETED|24 Month Follow up||67||
60121238|NCT02658994|76242125|FG001|NOT COMPLETED|24 Month Follow up||73||
60121239|NCT02658994|76242126|FG002|NOT COMPLETED|24 Month Follow up||111||
60121240|NCT02658994|76242124|FG000|STARTED|36 Month Follow up|Participants who did not complete 24 month follow up were still eligible for 36 month follow up|287||
60121241|NCT02658994|76242125|FG001|STARTED|36 Month Follow up|Participants who did not complete 24 month follow up were still eligible for 36 month follow up|283||
59572139|NCT02537873|75676294|FG000|COMPLETED|Overall Study||9||
59572140|NCT02537873|75676295|FG001|COMPLETED|Overall Study||4||
59572141|NCT02537873|75676294|FG000|NOT COMPLETED|Overall Study||8||
59572142|NCT02537873|75676295|FG001|NOT COMPLETED|Overall Study||4||
59572143|NCT01823653|75676302|FG000|STARTED|Overall Study||60||
59572144|NCT01823653|75676302|FG000|COMPLETED|Overall Study||60||
59572145|NCT01823653|75676302|FG000|NOT COMPLETED|Overall Study||0||
59572146|NCT02537951|75676309|FG000|STARTED|Overall Study||10||
59721250|NCT01095666|75840137|FG000|NOT COMPLETED|Overall Study||17||
59721251|NCT01095666|75840138|FG001|NOT COMPLETED|Overall Study||11||
59721252|NCT01095666|75840139|FG002|NOT COMPLETED|Overall Study||7||
59572147|NCT02537951|75676309|FG000|COMPLETED|Overall Study||10||
59572148|NCT02537951|75676309|FG000|NOT COMPLETED|Overall Study||0||
59572149|NCT01824589|75676321|FG000|STARTED|Overall Study||1||
59572150|NCT01824589|75676322|FG001|STARTED|Overall Study||0||
59572151|NCT01824589|75676323|FG002|STARTED|Overall Study||0||
59572152|NCT01824589|75676324|FG003|STARTED|Overall Study||0||
59572153|NCT01824589|75676321|FG000|COMPLETED|Overall Study||1||
59572154|NCT01824589|75676322|FG001|COMPLETED|Overall Study||0||
59572155|NCT01824589|75676323|FG002|COMPLETED|Overall Study||0||
59572156|NCT01824589|75676324|FG003|COMPLETED|Overall Study||0||
59572157|NCT01824589|75676321|FG000|NOT COMPLETED|Overall Study||0||
59572158|NCT01824589|75676322|FG001|NOT COMPLETED|Overall Study||0||
59572159|NCT01824589|75676323|FG002|NOT COMPLETED|Overall Study||0||
59572160|NCT01824589|75676324|FG003|NOT COMPLETED|Overall Study||0||
59572161|NCT02486939|75676336|FG000|STARTED|Overall Study||225||
59572162|NCT02486939|75676337|FG001|STARTED|Overall Study||134||
59572163|NCT02486939|75676336|FG000|COMPLETED|Overall Study||224||
59572164|NCT02486939|75676337|FG001|COMPLETED|Overall Study||132||
59572165|NCT02486939|75676336|FG000|NOT COMPLETED|Overall Study||1||
59572166|NCT02486939|75676337|FG001|NOT COMPLETED|Overall Study||2||
59572167|NCT02487485|75676345|FG000|STARTED|Overall Study||12||
59572168|NCT02487485|75676346|FG001|STARTED|Overall Study||11||
59572169|NCT02487485|75676345|FG000|COMPLETED|Overall Study||9||
59572170|NCT02487485|75676346|FG001|COMPLETED|Overall Study||8||
59572171|NCT02487485|75676345|FG000|NOT COMPLETED|Overall Study||3||
59572172|NCT02487485|75676346|FG001|NOT COMPLETED|Overall Study||3||
59572173|NCT02487563|75676355|FG000|STARTED|Overall Study||32||
59572174|NCT02487563|75676356|FG001|STARTED|Overall Study||33||
59572175|NCT02487563|75676357|FG002|STARTED|Overall Study||32||
59572176|NCT02487563|75676355|FG000|COMPLETED|Overall Study||30||
59572177|NCT02487563|75676356|FG001|COMPLETED|Overall Study||30||
59572178|NCT02487563|75676357|FG002|COMPLETED|Overall Study||31||
59572179|NCT02487563|75676355|FG000|NOT COMPLETED|Overall Study||2||
59572180|NCT02487563|75676356|FG001|NOT COMPLETED|Overall Study||3||
59572181|NCT02487563|75676357|FG002|NOT COMPLETED|Overall Study||1||
59572182|NCT02423993|75676372|FG000|STARTED|Overall Study||19||
59572183|NCT02423993|75676373|FG001|STARTED|Overall Study||16||
59572184|NCT02423993|75676374|FG002|STARTED|Overall Study||23||
59572185|NCT02423993|75676375|FG003|STARTED|Overall Study||19||
59572186|NCT02423993|75676372|FG000|COMPLETED|Overall Study||19||
59572187|NCT02423993|75676373|FG001|COMPLETED|Overall Study||16||
59572188|NCT02423993|75676374|FG002|COMPLETED|Overall Study||23||
59572189|NCT02423993|75676375|FG003|COMPLETED|Overall Study||19||
59572190|NCT02423993|75676372|FG000|NOT COMPLETED|Overall Study||0||
59572191|NCT02423993|75676373|FG001|NOT COMPLETED|Overall Study||0||
59572192|NCT02423993|75676374|FG002|NOT COMPLETED|Overall Study||0||
59572193|NCT02423993|75676375|FG003|NOT COMPLETED|Overall Study||0||
59572194|NCT02427737|75676387|FG000|STARTED|OSU Baseline Q4FY15||4158||4754
59572195|NCT02427737|75676388|FG001|STARTED|OSU Baseline Q4FY15||3446||4219
59572196|NCT02427737|75676387|FG000|COMPLETED|OSU Baseline Q4FY15||3940||4754
59572197|NCT02427737|75676388|FG001|COMPLETED|OSU Baseline Q4FY15||3230||4219
59572198|NCT02427737|75676387|FG000|NOT COMPLETED|OSU Baseline Q4FY15||218||0
59572199|NCT02427737|75676388|FG001|NOT COMPLETED|OSU Baseline Q4FY15||216||0
59572200|NCT02427737|75676387|FG000|STARTED|OSU Q1FY16 (First Post-Training Quarter)||4030||4583
59572201|NCT02427737|75676388|FG001|STARTED|OSU Q1FY16 (First Post-Training Quarter)||3246||4144
59572202|NCT02427737|75676387|FG000|COMPLETED|OSU Q1FY16 (First Post-Training Quarter)||3815||4583
59572203|NCT02427737|75676388|FG001|COMPLETED|OSU Q1FY16 (First Post-Training Quarter)||3032||4144
59572204|NCT02427737|75676387|FG000|NOT COMPLETED|OSU Q1FY16 (First Post-Training Quarter)||215||0
59572205|NCT02427737|75676388|FG001|NOT COMPLETED|OSU Q1FY16 (First Post-Training Quarter)||214||0
59572206|NCT02427737|75676387|FG000|STARTED|OSU Q2FY16(Second Post Training Quarter)||4121||4659
59572207|NCT02427737|75676388|FG001|STARTED|OSU Q2FY16(Second Post Training Quarter)||3070||4204
59572208|NCT02427737|75676387|FG000|COMPLETED|OSU Q2FY16(Second Post Training Quarter)||3907||4659
59572209|NCT02427737|75676388|FG001|COMPLETED|OSU Q2FY16(Second Post Training Quarter)||2857||4204
59572210|NCT02427737|75676387|FG000|NOT COMPLETED|OSU Q2FY16(Second Post Training Quarter)||214||0
59572211|NCT02427737|75676388|FG001|NOT COMPLETED|OSU Q2FY16(Second Post Training Quarter)||213||0
59572212|NCT02427737|75676387|FG000|STARTED|OSU Q3FY16 (Third Post Training Quarter)||4148||4647
59572213|NCT02427737|75676388|FG001|STARTED|OSU Q3FY16 (Third Post Training Quarter)||2931||4199
59572214|NCT02427737|75676387|FG000|COMPLETED|OSU Q3FY16 (Third Post Training Quarter)||3928||4647
59572215|NCT02427737|75676388|FG001|COMPLETED|OSU Q3FY16 (Third Post Training Quarter)||2716||4199
59572216|NCT02427737|75676387|FG000|NOT COMPLETED|OSU Q3FY16 (Third Post Training Quarter)||220||0
59572217|NCT02427737|75676388|FG001|NOT COMPLETED|OSU Q3FY16 (Third Post Training Quarter)||215||0
59572218|NCT02427737|75676387|FG000|STARTED|Duke Pre- and Post-Training Groups|Note this is a pre-training to post-training comparison.|9658||9658
59721253|NCT01100658|75840147|FG000|STARTED|Overall Study||1||
59572219|NCT02427737|75676388|FG001|STARTED|Duke Pre- and Post-Training Groups|Note Control=Baseline|4446||4446
59572220|NCT02427737|75676387|FG000|COMPLETED|Duke Pre- and Post-Training Groups||8879||9658
59721254|NCT01100658|75840147|FG000|COMPLETED|Overall Study||0||
59572221|NCT02427737|75676388|FG001|COMPLETED|Duke Pre- and Post-Training Groups||4051||4446
59572222|NCT02427737|75676387|FG000|NOT COMPLETED|Duke Pre- and Post-Training Groups||779||0
59572223|NCT02427737|75676388|FG001|NOT COMPLETED|Duke Pre- and Post-Training Groups||395||0
59572224|NCT02489123|75676402|FG000|STARTED|Overall Study||8||
59572225|NCT02489123|75676402|FG000|COMPLETED|Overall Study||8||
59572226|NCT02489123|75676402|FG000|NOT COMPLETED|Overall Study||0||
59572227|NCT02489357|75676406|FG000|STARTED|Overall Study||12||
59572228|NCT02489357|75676406|FG000|COMPLETED|Overall Study||12||
59572229|NCT02489357|75676406|FG000|NOT COMPLETED|Overall Study||0||
59572230|NCT02490293|75676412|FG000|STARTED|Overall Study||96||
59572231|NCT02490293|75676413|FG001|STARTED|Overall Study||102||
59572232|NCT02490293|75676412|FG000|COMPLETED|Overall Study||94||
59572233|NCT02490293|75676413|FG001|COMPLETED|Overall Study||99||
59572234|NCT02490293|75676412|FG000|NOT COMPLETED|Overall Study||2||
59572235|NCT02490293|75676413|FG001|NOT COMPLETED|Overall Study||3||
59572236|NCT02538419|75676421|FG000|STARTED|Overall Study||20||
59572237|NCT02538419|75676422|FG001|STARTED|Overall Study||20||
59572238|NCT02538419|75676421|FG000|COMPLETED|Overall Study||20||
59572239|NCT02538419|75676422|FG001|COMPLETED|Overall Study||20||
59572240|NCT02538419|75676421|FG000|NOT COMPLETED|Overall Study||0||
59572241|NCT02538419|75676422|FG001|NOT COMPLETED|Overall Study||0||
59572242|NCT02539511|75676430|FG000|STARTED|Overall Study||23||
59572243|NCT02539511|75676431|FG001|STARTED|Overall Study||17||
59572244|NCT02539511|75676430|FG000|COMPLETED|Overall Study||17||
59572245|NCT02539511|75676431|FG001|COMPLETED|Overall Study||17||
59572246|NCT02539511|75676430|FG000|NOT COMPLETED|Overall Study||6||
59572247|NCT02539511|75676431|FG001|NOT COMPLETED|Overall Study||0||
59572248|NCT02540447|75676439|FG000|STARTED|Overall Study||40||
59572249|NCT02540447|75676440|FG001|STARTED|Overall Study||40||
59572250|NCT02540447|75676439|FG000|COMPLETED|Overall Study||40||
59572251|NCT02540447|75676440|FG001|COMPLETED|Overall Study||40||
59572252|NCT02540447|75676439|FG000|NOT COMPLETED|Overall Study||0||
59572253|NCT02540447|75676440|FG001|NOT COMPLETED|Overall Study||0||
59572254|NCT02428595|75676446|FG000|STARTED|Fitting||137||
59572255|NCT02428595|75676446|FG000|COMPLETED|Fitting||73||
59572256|NCT02428595|75676446|FG000|NOT COMPLETED|Fitting||64||
59572257|NCT02428595|75676446|FG000|STARTED|Treatment||73||
59572258|NCT02428595|75676446|FG000|COMPLETED|Treatment||54||
59572259|NCT02428595|75676446|FG000|NOT COMPLETED|Treatment||19||
59572260|NCT02493257|75676461|FG000|STARTED|Overall Study||11||
59572261|NCT02493257|75676462|FG001|STARTED|Overall Study||11||
59572262|NCT02493257|75676461|FG000|4 Week Follow up|Overall Study||11||
59572263|NCT02493257|75676462|FG001|4 Week Follow up|Overall Study||11||
59572264|NCT02493257|75676461|FG000|12 Week Follow up|Overall Study||10||
59572265|NCT02493257|75676462|FG001|12 Week Follow up|Overall Study||10||
59572266|NCT02493257|75676461|FG000|COMPLETED|Overall Study||10||
59572267|NCT02493257|75676462|FG001|COMPLETED|Overall Study||10||
59572268|NCT02493257|75676461|FG000|NOT COMPLETED|Overall Study||1||
59572269|NCT02493257|75676462|FG001|NOT COMPLETED|Overall Study||1||
59572270|NCT02430389|75676470|FG000|STARTED|Overall Study||10||
59572271|NCT02430389|75676471|FG001|STARTED|Overall Study||10||
59572272|NCT02430389|75676470|FG000|COMPLETED|Overall Study||10||
59572273|NCT02430389|75676471|FG001|COMPLETED|Overall Study||10||
59572274|NCT02430389|75676470|FG000|NOT COMPLETED|Overall Study||0||
59572275|NCT02430389|75676471|FG001|NOT COMPLETED|Overall Study||0||
59572276|NCT02431637|75676479|FG000|STARTED|Overall Study||6||
59572277|NCT02431637|75676479|FG000|COMPLETED|Overall Study||6||
59572278|NCT02431637|75676479|FG000|NOT COMPLETED|Overall Study||0||
59572279|NCT02494817|75676485|FG000|STARTED|Overall Study|representing 81 couples|162||
59572280|NCT02494817|75676486|FG001|STARTED|Overall Study|representing 68 couples|136||
59572281|NCT02494817|75676485|FG000|3 Month Assessment|Overall Study|represents 59 couples and 7 partnered men|125||
59572282|NCT02494817|75676486|FG001|3 Month Assessment|Overall Study|represents 44 couples and 4 partnered men|92||
59721255|NCT01100658|75840147|FG000|NOT COMPLETED|Overall Study||1||
59721256|NCT01100502|75840153|FG000|STARTED|Overall Study||165||
59572283|NCT02494817|75676485|FG000|6 Month Assessment|Overall Study|represents 52 couples and 11 partnered men|115||
59572284|NCT02494817|75676486|FG001|6 Month Assessment|Overall Study|represents 45 couples and 8 partnered men|98||
59572285|NCT02494817|75676485|FG000|COMPLETED|Overall Study|49 couples and 9 partnered men completed all 3 assessments (baseline, 3- and 6-month)|107||
59572286|NCT02494817|75676486|FG001|COMPLETED|Overall Study|41 couples and 5 partnered men completed all 3 assessments (baseline, 3- and 6-month)|87||
59572287|NCT02494817|75676485|FG000|NOT COMPLETED|Overall Study||55||
59572288|NCT02494817|75676486|FG001|NOT COMPLETED|Overall Study||49||
59572289|NCT02543723|75676494|FG000|STARTED|Overall Study||65||
59572290|NCT02543723|75676495|FG001|STARTED|Overall Study||63||
59572291|NCT02543723|75676494|FG000|COMPLETED|Overall Study||65||
59572292|NCT02543723|75676495|FG001|COMPLETED|Overall Study||63||
59572293|NCT02543723|75676494|FG000|NOT COMPLETED|Overall Study||0||
59572294|NCT02543723|75676495|FG001|NOT COMPLETED|Overall Study||0||
59572295|NCT02545907|75676505|FG000|STARTED|Overall Study||3||
59572296|NCT02545907|75676506|FG001|STARTED|Overall Study||3||
59572297|NCT02545907|75676507|FG002|STARTED|Overall Study||4||
59721257|NCT01100502|75840154|FG001|STARTED|Overall Study||164||
59572298|NCT02545907|75676505|FG000|COMPLETED|Overall Study||3||
59572299|NCT02545907|75676506|FG001|COMPLETED|Overall Study||3||
59572300|NCT02545907|75676507|FG002|COMPLETED|Overall Study||4||
59572301|NCT02545907|75676505|FG000|NOT COMPLETED|Overall Study||0||
59572302|NCT02545907|75676506|FG001|NOT COMPLETED|Overall Study||0||
59572303|NCT02545907|75676507|FG002|NOT COMPLETED|Overall Study||0||
59572304|NCT02495831|75676516|FG000|STARTED|First Intervention||13||
59572305|NCT02495831|75676517|FG001|STARTED|First Intervention||10||
59572306|NCT02495831|75676516|FG000|COMPLETED|First Intervention||13||
59572307|NCT02495831|75676517|FG001|COMPLETED|First Intervention||10||
59572308|NCT02495831|75676516|FG000|NOT COMPLETED|First Intervention||0||
59572309|NCT02495831|75676517|FG001|NOT COMPLETED|First Intervention||0||
59572310|NCT02495831|75676516|FG000|STARTED|Second Intervention|One participant withdrew at the end of period 1|12||
59572311|NCT02495831|75676517|FG001|STARTED|Second Intervention||10||
59572312|NCT02495831|75676516|FG000|COMPLETED|Second Intervention||12||
59572313|NCT02495831|75676517|FG001|COMPLETED|Second Intervention||10||
59572314|NCT02495831|75676516|FG000|NOT COMPLETED|Second Intervention||0||
59572315|NCT02495831|75676517|FG001|NOT COMPLETED|Second Intervention||0||
59572316|NCT02497235|75676528|FG000|STARTED|Overall Study||2||
59572317|NCT02497235|75676529|FG001|STARTED|Overall Study||2||
59572318|NCT02497235|75676530|FG002|STARTED|Overall Study||2||
59572319|NCT02497235|75676531|FG003|STARTED|Overall Study||2||
59572320|NCT02497235|75676532|FG004|STARTED|Overall Study||3||
59572321|NCT02497235|75676528|FG000|COMPLETED|Overall Study||2||
59572322|NCT02497235|75676529|FG001|COMPLETED|Overall Study||2||
59572323|NCT02497235|75676530|FG002|COMPLETED|Overall Study||2||
59572324|NCT02497235|75676531|FG003|COMPLETED|Overall Study||2||
59572325|NCT02497235|75676532|FG004|COMPLETED|Overall Study||3||
59572326|NCT02497235|75676528|FG000|NOT COMPLETED|Overall Study||0||
59572327|NCT02497235|75676529|FG001|NOT COMPLETED|Overall Study||0||
59572328|NCT02497235|75676530|FG002|NOT COMPLETED|Overall Study||0||
59572329|NCT02497235|75676531|FG003|NOT COMPLETED|Overall Study||0||
59572330|NCT02497235|75676532|FG004|NOT COMPLETED|Overall Study||0||
59572331|NCT02497937|75676547|FG000|STARTED|Period 1 (Up to 7 Days)||6||
59572332|NCT02497937|75676548|FG001|STARTED|Period 1 (Up to 7 Days)||5||
59572333|NCT02497937|75676547|FG000|COMPLETED|Period 1 (Up to 7 Days)||6||
59572334|NCT02497937|75676548|FG001|COMPLETED|Period 1 (Up to 7 Days)||5||
59572335|NCT02497937|75676547|FG000|NOT COMPLETED|Period 1 (Up to 7 Days)||0||
59572336|NCT02497937|75676548|FG001|NOT COMPLETED|Period 1 (Up to 7 Days)||0||
59572337|NCT02497937|75676547|FG000|STARTED|Washout Period (Up to 14 Days)||6||
59572338|NCT02497937|75676548|FG001|STARTED|Washout Period (Up to 14 Days)||5||
59572339|NCT02497937|75676547|FG000|COMPLETED|Washout Period (Up to 14 Days)||6||
59572340|NCT02497937|75676548|FG001|COMPLETED|Washout Period (Up to 14 Days)||5||
59572341|NCT02497937|75676547|FG000|NOT COMPLETED|Washout Period (Up to 14 Days)||0||
59572342|NCT02497937|75676548|FG001|NOT COMPLETED|Washout Period (Up to 14 Days)||0||
59572343|NCT02497937|75676547|FG000|STARTED|Period 2 (Up to 7 Days)||6||
59572344|NCT02497937|75676548|FG001|STARTED|Period 2 (Up to 7 Days)||5||
59572345|NCT02497937|75676547|FG000|COMPLETED|Period 2 (Up to 7 Days)||6||
59572346|NCT02497937|75676548|FG001|COMPLETED|Period 2 (Up to 7 Days)||5||
59572347|NCT02497937|75676547|FG000|NOT COMPLETED|Period 2 (Up to 7 Days)||0||
59572348|NCT02497937|75676548|FG001|NOT COMPLETED|Period 2 (Up to 7 Days)||0||
59572349|NCT02498483|75676557|FG000|STARTED|Overall Study||6||
59572350|NCT02498483|75676558|FG001|STARTED|Overall Study||5||
59572351|NCT02498483|75676557|FG000|COMPLETED|Overall Study||6||
59572352|NCT02498483|75676558|FG001|COMPLETED|Overall Study||5||
59572353|NCT02498483|75676557|FG000|NOT COMPLETED|Overall Study||0||
59572354|NCT02498483|75676558|FG001|NOT COMPLETED|Overall Study||0||
59572355|NCT02547623|75676566|FG000|STARTED|Overall Study||126||
59572356|NCT02547623|75676567|FG001|STARTED|Overall Study||55||
59572357|NCT02547623|75676566|FG000|COMPLETED|Overall Study||122||
59572358|NCT02547623|75676567|FG001|COMPLETED|Overall Study||52||
59572359|NCT02547623|75676566|FG000|NOT COMPLETED|Overall Study||4||
59572360|NCT02547623|75676567|FG001|NOT COMPLETED|Overall Study||3||
59572361|NCT02433665|75676575|FG000|STARTED|Overall Study||77||
59572362|NCT02433665|75676576|FG001|STARTED|Overall Study||79||
59572363|NCT02433665|75676575|FG000|COMPLETED|Overall Study||77||
59572364|NCT02433665|75676576|FG001|COMPLETED|Overall Study||79||
59572365|NCT02433665|75676575|FG000|NOT COMPLETED|Overall Study||0||
59572366|NCT02433665|75676576|FG001|NOT COMPLETED|Overall Study||0||
59572367|NCT02547779|75676584|FG000|STARTED|Overall Study||5214||
59572368|NCT02547779|75676585|FG001|STARTED|Overall Study||5207||
59572369|NCT02547779|75676584|FG000|COMPLETED|Overall Study||5214||
59572370|NCT02547779|75676585|FG001|COMPLETED|Overall Study||5207||
59572371|NCT02547779|75676584|FG000|NOT COMPLETED|Overall Study||0||
59572372|NCT02547779|75676585|FG001|NOT COMPLETED|Overall Study||0||
59572373|NCT02548949|75676591|FG000|STARTED|Overall Study||700||
59572374|NCT02548949|75676591|FG000|COMPLETED|Overall Study||700||
59572375|NCT02548949|75676591|FG000|NOT COMPLETED|Overall Study||0||
59572376|NCT02433977|75676595|FG000|STARTED|Overall Study||6||
59572377|NCT02433977|75676595|FG000|COMPLETED|Overall Study||6||
59572378|NCT02433977|75676595|FG000|NOT COMPLETED|Overall Study||0||
59572379|NCT00559585|75676601|FG000|STARTED|Double Blind ST Period Main Study|Randomized and treated|736||
59572380|NCT00559585|75676602|FG001|STARTED|Double Blind ST Period Main Study|Randomized and treated|721||
59572381|NCT00559585|75676601|FG000|COMPLETED|Double Blind ST Period Main Study||693||
59572382|NCT00559585|75676602|FG001|COMPLETED|Double Blind ST Period Main Study||676||
59572383|NCT00559585|75676601|FG000|NOT COMPLETED|Double Blind ST Period Main Study||43||
59572384|NCT00559585|75676602|FG001|NOT COMPLETED|Double Blind ST Period Main Study||45||
59572385|NCT00559585|75676601|FG000|STARTED|Anti-TNF Sub-Study in ST Period|7 completed Sub-Study ST period and 6 chose to roll over into LT Period.|8||
59572386|NCT00559585|75676602|FG001|STARTED|Anti-TNF Sub-Study in ST Period|9 completed Sub-Study ST Period and 9 chose to over into the LT Period.|10||
59572387|NCT00559585|75676601|FG000|COMPLETED|Anti-TNF Sub-Study in ST Period||7||
59572388|NCT00559585|75676602|FG001|COMPLETED|Anti-TNF Sub-Study in ST Period||9||
59572389|NCT00559585|75676601|FG000|NOT COMPLETED|Anti-TNF Sub-Study in ST Period||1||
59572390|NCT00559585|75676602|FG001|NOT COMPLETED|Anti-TNF Sub-Study in ST Period||1||
59572391|NCT00559585|75676601|FG000|STARTED|Open Label LT Period Main + Sub-Study|1373 includes 15 participants from ST Period Sub-Study who rolled over into LT Period (6 SC + 9 IV).|1373||
59572392|NCT00559585|75676602|FG001|STARTED|Open Label LT Period Main + Sub-Study|IV administration was discontinued and abatacept was only administered SC during LT Period.|0||
59572393|NCT00559585|75676601|FG000|COMPLETED|Open Label LT Period Main + Sub-Study||945||
59572394|NCT00559585|75676602|FG001|COMPLETED|Open Label LT Period Main + Sub-Study||0||
59572395|NCT00559585|75676601|FG000|NOT COMPLETED|Open Label LT Period Main + Sub-Study||428||
59572396|NCT00559585|75676602|FG001|NOT COMPLETED|Open Label LT Period Main + Sub-Study||0||
59572397|NCT01824901|75676619|FG000|STARTED|Overall Study||2||
59572398|NCT01824901|75676620|FG001|STARTED|Overall Study||0||
59572399|NCT01824901|75676621|FG002|STARTED|Overall Study||0||
59572400|NCT01824901|75676622|FG003|STARTED|Overall Study||0||
59572401|NCT01824901|75676619|FG000|COMPLETED|Overall Study||2||
59572402|NCT01824901|75676620|FG001|COMPLETED|Overall Study||0||
59572403|NCT01824901|75676621|FG002|COMPLETED|Overall Study||0||
59572404|NCT01824901|75676622|FG003|COMPLETED|Overall Study||0||
59572405|NCT01824901|75676619|FG000|NOT COMPLETED|Overall Study||0||
59572406|NCT01824901|75676620|FG001|NOT COMPLETED|Overall Study||0||
59572407|NCT01824901|75676621|FG002|NOT COMPLETED|Overall Study||0||
59572408|NCT01824901|75676622|FG003|NOT COMPLETED|Overall Study||0||
59572409|NCT01825057|75676629|FG000|STARTED|Patient Study Flow||336||
59572410|NCT01825057|75676630|FG001|STARTED|Patient Study Flow||379||
59572411|NCT01825057|75676631|FG002|STARTED|Patient Study Flow||458||
59572412|NCT01825057|75676629|FG000|COMPLETED|Patient Study Flow||336||
59572413|NCT01825057|75676630|FG001|COMPLETED|Patient Study Flow||379||
59572414|NCT01825057|75676631|FG002|COMPLETED|Patient Study Flow||458||
59572415|NCT01825057|75676629|FG000|NOT COMPLETED|Patient Study Flow||0||
59572416|NCT01825057|75676630|FG001|NOT COMPLETED|Patient Study Flow||0||
59572417|NCT01825057|75676631|FG002|NOT COMPLETED|Patient Study Flow||0||
59572418|NCT01825057|75676629|FG000|STARTED|Provider Study Flow||13||
59572419|NCT01825057|75676630|FG001|STARTED|Provider Study Flow||12||
59572420|NCT01825057|75676631|FG002|STARTED|Provider Study Flow||13||
59572421|NCT01825057|75676629|FG000|COMPLETED|Provider Study Flow||13||
59572422|NCT01825057|75676630|FG001|COMPLETED|Provider Study Flow||12||
59572423|NCT01825057|75676631|FG002|COMPLETED|Provider Study Flow||13||
59572424|NCT01825057|75676629|FG000|NOT COMPLETED|Provider Study Flow||0||
59572425|NCT01825057|75676630|FG001|NOT COMPLETED|Provider Study Flow||0||
59572426|NCT01825057|75676631|FG002|NOT COMPLETED|Provider Study Flow||0||
59572427|NCT00559507|75676642|FG000|STARTED|Overall Study||12||
59572428|NCT00559507|75676642|FG000|COMPLETED|Overall Study||9||
59572429|NCT00559507|75676642|FG000|NOT COMPLETED|Overall Study||3||
59572430|NCT01826227|75676646|FG000|STARTED|Overall Study||5||
59572431|NCT01826227|75676646|FG000|COMPLETED|Overall Study||5||
59572432|NCT01826227|75676646|FG000|NOT COMPLETED|Overall Study||0||
59572433|NCT01826851|75676652|FG000|STARTED|Overall Study||38||
59572434|NCT01826851|75676653|FG001|STARTED|Overall Study||41||
59572435|NCT01826851|75676652|FG000|COMPLETED|Overall Study||38||
59572436|NCT01826851|75676653|FG001|COMPLETED|Overall Study||41||
59572437|NCT01826851|75676652|FG000|NOT COMPLETED|Overall Study||0||
59572438|NCT01826851|75676653|FG001|NOT COMPLETED|Overall Study||0||
59572439|NCT02499497|75676663|FG000|STARTED|Overall Study||36||
59572440|NCT02499497|75676664|FG001|STARTED|Overall Study||28||
59572441|NCT02499497|75676665|FG002|STARTED|Overall Study||36||
59572442|NCT02499497|75676666|FG003|STARTED|Overall Study||14||
59572443|NCT02499497|75676663|FG000|COMPLETED|Overall Study||32||
59572444|NCT02499497|75676664|FG001|COMPLETED|Overall Study||22||
59572445|NCT02499497|75676665|FG002|COMPLETED|Overall Study||35||
59572446|NCT02499497|75676666|FG003|COMPLETED|Overall Study||13||
59572447|NCT02499497|75676663|FG000|NOT COMPLETED|Overall Study||4||
59572448|NCT02499497|75676664|FG001|NOT COMPLETED|Overall Study||6||
59572449|NCT02499497|75676665|FG002|NOT COMPLETED|Overall Study||1||
59572450|NCT02499497|75676666|FG003|NOT COMPLETED|Overall Study||1||
59572451|NCT01827475|75676679|FG000|STARTED|Overall Study||30||
59572452|NCT01827475|75676680|FG001|STARTED|Overall Study||30||
59572453|NCT01827475|75676681|FG002|STARTED|Overall Study||30||
59572454|NCT01827475|75676679|FG000|COMPLETED|Overall Study||30||
59572455|NCT01827475|75676680|FG001|COMPLETED|Overall Study||30||
59572456|NCT01827475|75676681|FG002|COMPLETED|Overall Study||30||
59572457|NCT01827475|75676679|FG000|NOT COMPLETED|Overall Study||0||
59572458|NCT01827475|75676680|FG001|NOT COMPLETED|Overall Study||0||
59572459|NCT01827475|75676681|FG002|NOT COMPLETED|Overall Study||0||
59572460|NCT02434523|75676691|FG000|STARTED|Overall Study||15||
59572461|NCT02434523|75676692|FG001|STARTED|Overall Study||15||
59572462|NCT02434523|75676691|FG000|COMPLETED|Overall Study||10||
59572463|NCT02434523|75676692|FG001|COMPLETED|Overall Study||9||
59572464|NCT02434523|75676691|FG000|NOT COMPLETED|Overall Study||5||
59572465|NCT02434523|75676692|FG001|NOT COMPLETED|Overall Study||6||
59572466|NCT02501135|75676700|FG000|STARTED|Overall Study||281||
59572467|NCT02501135|75676700|FG000|COMPLETED|Overall Study||281||
59572468|NCT02501135|75676700|FG000|NOT COMPLETED|Overall Study||0||
59572469|NCT02550743|75676714|FG000|STARTED|Overall Study||3||
59572470|NCT02550743|75676715|FG001|STARTED|Overall Study||3||
59572471|NCT02550743|75676716|FG002|STARTED|Overall Study||1||
59572472|NCT02550743|75676717|FG003|STARTED|Overall Study||0||
59572473|NCT02550743|75676714|FG000|COMPLETED|Overall Study||3||
59572474|NCT02550743|75676715|FG001|COMPLETED|Overall Study||3||
59572475|NCT02550743|75676716|FG002|COMPLETED|Overall Study||1||
59572476|NCT02550743|75676717|FG003|COMPLETED|Overall Study||0||
59572477|NCT02550743|75676714|FG000|NOT COMPLETED|Overall Study||0||
59572478|NCT02550743|75676715|FG001|NOT COMPLETED|Overall Study||0||
59572479|NCT02550743|75676716|FG002|NOT COMPLETED|Overall Study||0||
59572480|NCT02550743|75676717|FG003|NOT COMPLETED|Overall Study||0||
59572481|NCT02502461|75676730|FG000|STARTED|Overall Study||46||
59572482|NCT02502461|75676731|FG001|STARTED|Overall Study||44||
59572483|NCT02502461|75676730|FG000|COMPLETED|Overall Study||46||
59572484|NCT02502461|75676731|FG001|COMPLETED|Overall Study||44||
59572485|NCT02502461|75676730|FG000|NOT COMPLETED|Overall Study||0||
59572486|NCT02502461|75676731|FG001|NOT COMPLETED|Overall Study||0||
59572487|NCT02437253|75676739|FG000|STARTED|Overall Study||1||
59572488|NCT02437253|75676740|FG001|STARTED|Overall Study||1||
59572489|NCT02437253|75676739|FG000|COMPLETED|Overall Study||1||
59572490|NCT02437253|75676740|FG001|COMPLETED|Overall Study||1||
59572491|NCT02437253|75676739|FG000|NOT COMPLETED|Overall Study||0||
59572492|NCT02437253|75676740|FG001|NOT COMPLETED|Overall Study||0||
59572493|NCT02551757|75676750|FG000|STARTED|Overall Study||20||
59572494|NCT02551757|75676751|FG001|STARTED|Overall Study||20||
59572495|NCT02551757|75676750|FG000|COMPLETED|Overall Study||13||
59572496|NCT02551757|75676751|FG001|COMPLETED|Overall Study||17||
59572497|NCT02551757|75676750|FG000|NOT COMPLETED|Overall Study||7||
59572498|NCT02551757|75676751|FG001|NOT COMPLETED|Overall Study||3||
59572499|NCT02437487|75676763|FG000|STARTED|Overall Study||59||
59572500|NCT02437487|75676764|FG001|STARTED|Overall Study||30||
59572501|NCT02437487|75676763|FG000|Actual Treatment Received|Overall Study||60||
59572502|NCT02437487|75676764|FG001|Actual Treatment Received|Overall Study||29||
59572503|NCT02437487|75676763|FG000|Intention-to-Treat Population|Overall Study||59||
59572504|NCT02437487|75676764|FG001|Intention-to-Treat Population|Overall Study||30||
59572505|NCT02437487|75676763|FG000|COMPLETED|Overall Study||32||
59572506|NCT02437487|75676764|FG001|COMPLETED|Overall Study||16||
59572507|NCT02437487|75676763|FG000|NOT COMPLETED|Overall Study||27||
59572508|NCT02437487|75676764|FG001|NOT COMPLETED|Overall Study||14||
59572509|NCT01828255|75676772|FG000|STARTED|Overall Study||20||
59572510|NCT01828255|75676773|FG001|STARTED|Overall Study||20||
59572511|NCT01828255|75676772|FG000|COMPLETED|Overall Study||20||
59572512|NCT01828255|75676773|FG001|COMPLETED|Overall Study||20||
59572513|NCT01828255|75676772|FG000|NOT COMPLETED|Overall Study||0||
59721258|NCT01100502|75840153|FG000|COMPLETED|Overall Study|Completed due to study closure by sponsor|89||
59572514|NCT01828255|75676773|FG001|NOT COMPLETED|Overall Study||0||
59572515|NCT02438423|75676785|FG000|STARTED|Overall Study||25||
59572516|NCT02438423|75676786|FG001|STARTED|Overall Study||25||
59572517|NCT02438423|75676787|FG002|STARTED|Overall Study||25||
59572518|NCT02438423|75676788|FG003|STARTED|Overall Study||25||
59572519|NCT02438423|75676785|FG000|COMPLETED|Overall Study||25||
59850263|NCT03586648|75974592|FG001|COMPLETED|Period 2||30||
59572520|NCT02438423|75676786|FG001|COMPLETED|Overall Study||25||
59572521|NCT02438423|75676787|FG002|COMPLETED|Overall Study||25||
59572522|NCT02438423|75676788|FG003|COMPLETED|Overall Study||25||
59572523|NCT02438423|75676785|FG000|NOT COMPLETED|Overall Study||0||
59572524|NCT02438423|75676786|FG001|NOT COMPLETED|Overall Study||0||
59572525|NCT02438423|75676787|FG002|NOT COMPLETED|Overall Study||0||
59572526|NCT02438423|75676788|FG003|NOT COMPLETED|Overall Study||0||
59572527|NCT02553395|75676800|FG000|STARTED|First Intervention||12||
59572528|NCT02553395|75676801|FG001|STARTED|First Intervention||18||
59572529|NCT02553395|75676800|FG000|COMPLETED|First Intervention||12||
59572530|NCT02553395|75676801|FG001|COMPLETED|First Intervention||18||
59572531|NCT02553395|75676800|FG000|NOT COMPLETED|First Intervention||0||
59572532|NCT02553395|75676801|FG001|NOT COMPLETED|First Intervention||0||
59572533|NCT02553395|75676800|FG000|STARTED|Second Intervention||12||
59572534|NCT02553395|75676801|FG001|STARTED|Second Intervention||18||
59572535|NCT02553395|75676800|FG000|COMPLETED|Second Intervention||12||
59850264|NCT03586648|75974591|FG000|NOT COMPLETED|Period 2||1||
59850265|NCT03586648|75974592|FG001|NOT COMPLETED|Period 2||0||
59572536|NCT02553395|75676801|FG001|COMPLETED|Second Intervention||18||
59572537|NCT02553395|75676800|FG000|NOT COMPLETED|Second Intervention||0||
59572538|NCT02553395|75676801|FG001|NOT COMPLETED|Second Intervention||0||
59572539|NCT01829503|75676808|FG000|STARTED|Overall Study||44||
59572540|NCT01829503|75676808|FG000|COMPLETED|Overall Study||44||
59572541|NCT01829503|75676808|FG000|NOT COMPLETED|Overall Study||0||
59572542|NCT02504645|75676816|FG000|STARTED|Overall Study||101||
59572543|NCT02504645|75676817|FG001|STARTED|Overall Study||101||
59572544|NCT02504645|75676816|FG000|COMPLETED|Overall Study||77||
59572545|NCT02504645|75676817|FG001|COMPLETED|Overall Study||76||
59572546|NCT02504645|75676816|FG000|NOT COMPLETED|Overall Study||24||
59572547|NCT02504645|75676817|FG001|NOT COMPLETED|Overall Study||25||
59572548|NCT02267629|75676823|FG000|STARTED|Overall Study||7||
59572549|NCT02267629|75676823|FG000|COMPLETED|Overall Study||7||
59572550|NCT02267629|75676823|FG000|NOT COMPLETED|Overall Study||0||
59572551|NCT02504723|75676829|FG000|STARTED|Overall Study||60||
59572552|NCT02504723|75676830|FG001|STARTED|Overall Study||61||
59572553|NCT02504723|75676829|FG000|COMPLETED|Overall Study||60||
59572554|NCT02504723|75676830|FG001|COMPLETED|Overall Study||61||
59572555|NCT02504723|75676829|FG000|NOT COMPLETED|Overall Study||0||
59572556|NCT02504723|75676830|FG001|NOT COMPLETED|Overall Study||0||
59572557|NCT02439281|75676838|FG000|STARTED|Overall Study||24||
59572558|NCT02439281|75676839|FG001|STARTED|Overall Study||26||
59572559|NCT02439281|75676838|FG000|COMPLETED|Overall Study||24||
59572560|NCT02439281|75676839|FG001|COMPLETED|Overall Study||26||
59572561|NCT02439281|75676838|FG000|NOT COMPLETED|Overall Study||0||
59572562|NCT02439281|75676839|FG001|NOT COMPLETED|Overall Study||0||
59572563|NCT01830205|75676851|FG000|STARTED|Overall Study||12||
59572564|NCT01830205|75676852|FG001|STARTED|Overall Study||6||
59572565|NCT01830205|75676853|FG002|STARTED|Overall Study||6||
59572566|NCT01830205|75676854|FG003|STARTED|Overall Study||12||
59572567|NCT01830205|75676851|FG000|COMPLETED|Overall Study||12||
59572568|NCT01830205|75676852|FG001|COMPLETED|Overall Study||6||
59572569|NCT01830205|75676853|FG002|COMPLETED|Overall Study||6||
59572570|NCT01830205|75676854|FG003|COMPLETED|Overall Study||12||
59572571|NCT01830205|75676851|FG000|NOT COMPLETED|Overall Study||0||
59572572|NCT01830205|75676852|FG001|NOT COMPLETED|Overall Study||0||
59572573|NCT01830205|75676853|FG002|NOT COMPLETED|Overall Study||0||
59572574|NCT01830205|75676854|FG003|NOT COMPLETED|Overall Study||0||
59572575|NCT02505269|75676875|FG000|STARTED|Overall Study||34||
59572576|NCT02505269|75676875|FG000|COMPLETED|Overall Study||34||
59572577|NCT02505269|75676875|FG000|NOT COMPLETED|Overall Study||0||
59572578|NCT02440139|75676879|FG000|STARTED|Overall Study|12 radiologists read 324 CT cases|12|June 2015|324
59572579|NCT02440139|75676879|FG000|COMPLETED|Overall Study|12 radiologists read 324 CT cases|12|August 2016|324
59572580|NCT02440139|75676879|FG000|NOT COMPLETED|Overall Study||0||0
59572581|NCT02554799|75676889|FG000|STARTED|Overall Study||9||
59572582|NCT02554799|75676890|FG001|STARTED|Overall Study||9||
59572583|NCT02554799|75676889|FG000|COMPLETED|Overall Study||9||
59572584|NCT02554799|75676890|FG001|COMPLETED|Overall Study||9||
59572585|NCT02554799|75676889|FG000|NOT COMPLETED|Overall Study||0||
59572586|NCT02554799|75676890|FG001|NOT COMPLETED|Overall Study||0||
59572587|NCT00559273|75676898|FG000|STARTED|Correction Period (20 Weeks)||153||
59572588|NCT00559273|75676899|FG001|STARTED|Correction Period (20 Weeks)||154||
59572589|NCT00559273|75676898|FG000|Treated|Correction Period (20 Weeks)||151||
59572590|NCT00559273|75676899|FG001|Treated|Correction Period (20 Weeks)||154||
59572591|NCT00559273|75676898|FG000|COMPLETED|Correction Period (20 Weeks)||144||
59572592|NCT00559273|75676899|FG001|COMPLETED|Correction Period (20 Weeks)||142||
59572593|NCT00559273|75676898|FG000|NOT COMPLETED|Correction Period (20 Weeks)||9||
59572594|NCT00559273|75676899|FG001|NOT COMPLETED|Correction Period (20 Weeks)||12||
59572595|NCT00559273|75676898|FG000|STARTED|Evaluation Period (8 Weeks)||144||
59572596|NCT00559273|75676899|FG001|STARTED|Evaluation Period (8 Weeks)||142||
60121242|NCT02658994|76242126|FG002|STARTED|36 Month Follow up|Participants who did not complete 24 month follow up were still eligible for 36 month follow up|584||
59572597|NCT00559273|75676898|FG000|COMPLETED|Evaluation Period (8 Weeks)||141||
59572598|NCT00559273|75676899|FG001|COMPLETED|Evaluation Period (8 Weeks)||137||
59572599|NCT00559273|75676898|FG000|NOT COMPLETED|Evaluation Period (8 Weeks)||3||
59572600|NCT00559273|75676899|FG001|NOT COMPLETED|Evaluation Period (8 Weeks)||5||
59572601|NCT02506673|75676907|FG000|STARTED|Overall Study||13||
59572602|NCT02506673|75676908|FG001|STARTED|Overall Study||13||
59572603|NCT02506673|75676907|FG000|COMPLETED|Overall Study||13||
59572604|NCT02506673|75676908|FG001|COMPLETED|Overall Study||13||
59572605|NCT02506673|75676907|FG000|NOT COMPLETED|Overall Study||0||
59572606|NCT02506673|75676908|FG001|NOT COMPLETED|Overall Study||0||
59572607|NCT02508077|75676914|FG000|STARTED|Overall Study||1||
59572608|NCT02508077|75676914|FG000|COMPLETED|Overall Study||1||
59572609|NCT02508077|75676914|FG000|NOT COMPLETED|Overall Study||0||
59572610|NCT02268877|75676920|FG000|STARTED|Overall Study||122|122 patients were randomized to this arm.|
59572611|NCT02268877|75676921|FG001|STARTED|Overall Study|111 patients were randomized to this arm.|111|122 patients were randomized to this arm.|
59572612|NCT02268877|75676920|FG000|COMPLETED|Overall Study||118|118 patients received the intervention|
59572613|NCT02268877|75676921|FG001|COMPLETED|Overall Study|106 patients received the intervention.|106|118 patients received the intervention|
59572614|NCT02268877|75676920|FG000|NOT COMPLETED|Overall Study||4||
59572615|NCT02268877|75676921|FG001|NOT COMPLETED|Overall Study||5||
59572616|NCT01831219|75676929|FG000|STARTED|Overall Study||73||
59572617|NCT01831219|75676930|FG001|STARTED|Overall Study||45||
59572618|NCT01831219|75676929|FG000|COMPLETED|Overall Study||40||
59572619|NCT01831219|75676930|FG001|COMPLETED|Overall Study||21||
59572620|NCT01831219|75676929|FG000|NOT COMPLETED|Overall Study||33||
59572621|NCT01831219|75676930|FG001|NOT COMPLETED|Overall Study||24||
59572622|NCT01831921|75676938|FG000|STARTED|Overall Study||150||
59572623|NCT01831921|75676939|FG001|STARTED|Overall Study||75||
59572624|NCT01831921|75676938|FG000|6 Months|Overall Study||122||
59572625|NCT01831921|75676939|FG001|6 Months|Overall Study||63||
59572626|NCT01831921|75676938|FG000|12 Months|Overall Study|All participants were followed for 12 months to 24 months, depending on date of randomization.|120||
59572627|NCT01831921|75676939|FG001|12 Months|Overall Study||62||
59572628|NCT01831921|75676938|FG000|18 Months|Overall Study|Of 118 eligible for this visit.|90||
59572629|NCT01831921|75676939|FG001|18 Months|Overall Study|Of 59 eligible for this visit.|49||
59572630|NCT01831921|75676938|FG000|COMPLETED|Overall Study|Of 85 eligible for this visit.|66||
59572631|NCT01831921|75676939|FG001|COMPLETED|Overall Study|Of 42 eligible for this visit.|36||
59572632|NCT01831921|75676938|FG000|NOT COMPLETED|Overall Study||84||
59572633|NCT01831921|75676939|FG001|NOT COMPLETED|Overall Study||39||
59572634|NCT01833247|75676948|FG000|STARTED|Overall Study||12||
59572635|NCT01833247|75676948|FG000|COMPLETED|Overall Study||12||
59572636|NCT01833247|75676948|FG000|NOT COMPLETED|Overall Study||0||
59572637|NCT00558259|75676954|FG000|STARTED|Overall Study|Number who started treatment. There were 4 patients randomised to Dabigatran and not treated.|681||
59572638|NCT00558259|75676955|FG001|STARTED|Overall Study|Number who started treatment. There were 6 patients randomised to placebo and not treated.|662||
59572639|NCT00558259|75676954|FG000|COMPLETED|Overall Study|Completed treatment.|610||
59572640|NCT00558259|75676955|FG001|COMPLETED|Overall Study|Completed treatment.|563||
59572641|NCT00558259|75676954|FG000|NOT COMPLETED|Overall Study||71||
59572642|NCT00558259|75676955|FG001|NOT COMPLETED|Overall Study||99||
59572643|NCT02508389|75676964|FG000|STARTED|Overall Study||73||
59572644|NCT02508389|75676965|FG001|STARTED|Overall Study||76||
59572645|NCT02508389|75676966|FG002|STARTED|Overall Study||74||
59572646|NCT02508389|75676964|FG000|COMPLETED|Overall Study||45||
59572647|NCT02508389|75676965|FG001|COMPLETED|Overall Study||45||
59572648|NCT02508389|75676966|FG002|COMPLETED|Overall Study||42||
59572649|NCT02508389|75676964|FG000|NOT COMPLETED|Overall Study||28||
59572650|NCT02508389|75676965|FG001|NOT COMPLETED|Overall Study||31||
59572651|NCT02508389|75676966|FG002|NOT COMPLETED|Overall Study||32||
59572652|NCT02509481|75676976|FG000|STARTED|Overall Study||1265||
59572653|NCT02509481|75676977|FG001|STARTED|Overall Study||1447||
59572654|NCT02509481|75676976|FG000|COMPLETED|Overall Study||1265||
59572655|NCT02509481|75676977|FG001|COMPLETED|Overall Study||1447||
59572656|NCT02509481|75676976|FG000|NOT COMPLETED|Overall Study||0||
59572657|NCT02509481|75676977|FG001|NOT COMPLETED|Overall Study||0||
59572658|NCT02511587|75676985|FG000|STARTED|Overall Study||58||
59572659|NCT02511587|75676986|FG001|STARTED|Overall Study||58||
59572660|NCT02511587|75676985|FG000|COMPLETED|Overall Study||58||
59572661|NCT02511587|75676986|FG001|COMPLETED|Overall Study||58||
59572662|NCT02511587|75676985|FG000|NOT COMPLETED|Overall Study||0||
59572663|NCT02511587|75676986|FG001|NOT COMPLETED|Overall Study||0||
59572664|NCT02560493|75676994|FG000|STARTED|Overall Study||23||
59572665|NCT02560493|75676995|FG001|STARTED|Overall Study||23||
59572666|NCT02560493|75676994|FG000|COMPLETED|Overall Study||22||
59572667|NCT02560493|75676995|FG001|COMPLETED|Overall Study||23||
59572668|NCT02560493|75676994|FG000|NOT COMPLETED|Overall Study||1||
59572669|NCT02560493|75676995|FG001|NOT COMPLETED|Overall Study||0||
59572670|NCT02561585|75677003|FG000|STARTED|Overall Study||20||
59572671|NCT02561585|75677004|FG001|STARTED|Overall Study||11||
59572672|NCT02561585|75677003|FG000|COMPLETED|Overall Study||17||
59572673|NCT02561585|75677004|FG001|COMPLETED|Overall Study||6||
59572674|NCT02561585|75677003|FG000|NOT COMPLETED|Overall Study||3||
59721259|NCT01100502|75840154|FG001|COMPLETED|Overall Study|Completed due to study closure by sponsor|70||
59721260|NCT01100502|75840153|FG000|NOT COMPLETED|Overall Study||76||
59572675|NCT02561585|75677004|FG001|NOT COMPLETED|Overall Study||5||
59572676|NCT02561897|75677016|FG000|STARTED|Overall Study||2||
59572677|NCT02561897|75677017|FG001|STARTED|Overall Study||3||
59572678|NCT02561897|75677016|FG000|COMPLETED|Overall Study||2||
59721261|NCT01100502|75840154|FG001|NOT COMPLETED|Overall Study||94||
59572679|NCT02561897|75677017|FG001|COMPLETED|Overall Study||3||
59572680|NCT02561897|75677016|FG000|NOT COMPLETED|Overall Study||0||
59572681|NCT02561897|75677017|FG001|NOT COMPLETED|Overall Study||0||
59572682|NCT02512679|75677025|FG000|STARTED|Overall Study||20||
59572683|NCT02512679|75677026|FG001|STARTED|Overall Study||0||
59572684|NCT02512679|75677025|FG000|COMPLETED|Overall Study||20||
59572685|NCT02512679|75677026|FG001|COMPLETED|Overall Study||0||
59572686|NCT02512679|75677025|FG000|NOT COMPLETED|Overall Study||0||
59572687|NCT02512679|75677026|FG001|NOT COMPLETED|Overall Study||0||
59572688|NCT02562521|75677032|FG000|STARTED|Overall Study||18||
59572689|NCT02562521|75677033|FG001|STARTED|Overall Study||7||
59572690|NCT02562521|75677032|FG000|COMPLETED|Overall Study||18||
59721262|NCT01094886|75840160|FG000|STARTED|Overall Study||53||
59572691|NCT02562521|75677033|FG001|COMPLETED|Overall Study||7||
59572692|NCT02562521|75677032|FG000|NOT COMPLETED|Overall Study||0||
59572693|NCT02562521|75677033|FG001|NOT COMPLETED|Overall Study||0||
59572694|NCT02562755|75677041|FG000|STARTED|Overall Study||234|Randomized|
59572695|NCT02562755|75677042|FG001|STARTED|Overall Study||225|Randomized|
59572696|NCT02562755|75677041|FG000|Safety Population|Overall Study||218|Patients who received at least one dose of study treatment|
59572697|NCT02562755|75677042|FG001|Safety Population|Overall Study||217|Patients who received at least one dose of study treatment|
59572698|NCT02562755|75677041|FG000|COMPLETED|Overall Study||161||
59572699|NCT02562755|75677042|FG001|COMPLETED|Overall Study||153||
59572700|NCT02562755|75677041|FG000|NOT COMPLETED|Overall Study||73||
59572701|NCT02562755|75677042|FG001|NOT COMPLETED|Overall Study||72||
59572702|NCT02562989|75677051|FG000|STARTED|Overall Study||3||
59572703|NCT02562989|75677052|FG001|STARTED|Overall Study||4||
59572704|NCT02562989|75677053|FG002|STARTED|Overall Study||6||
59572705|NCT02562989|75677051|FG000|COMPLETED|Overall Study||3||
59572706|NCT02562989|75677052|FG001|COMPLETED|Overall Study||4||
59572707|NCT02562989|75677053|FG002|COMPLETED|Overall Study||6||
59572708|NCT02562989|75677051|FG000|NOT COMPLETED|Overall Study||0||
59572709|NCT02562989|75677052|FG001|NOT COMPLETED|Overall Study||0||
59572710|NCT02562989|75677053|FG002|NOT COMPLETED|Overall Study||0||
59572711|NCT02565485|75677063|FG000|STARTED|Overall Study||139||
59572712|NCT02565485|75677064|FG001|STARTED|Overall Study||137||
59572713|NCT02565485|75677063|FG000|COMPLETED|Overall Study||139||
59572714|NCT02565485|75677064|FG001|COMPLETED|Overall Study||137||
59572715|NCT02565485|75677063|FG000|NOT COMPLETED|Overall Study||0||
59572716|NCT02565485|75677064|FG001|NOT COMPLETED|Overall Study||0||
59572717|NCT02515253|75677072|FG000|STARTED|Overall Study||17||
59572718|NCT02515253|75677073|FG001|STARTED|Overall Study||16||
59572719|NCT02515253|75677072|FG000|COMPLETED|Overall Study||10||
59572720|NCT02515253|75677073|FG001|COMPLETED|Overall Study||8||
59572721|NCT02515253|75677072|FG000|NOT COMPLETED|Overall Study||7||
59572722|NCT02515253|75677073|FG001|NOT COMPLETED|Overall Study||8||
59572723|NCT02566265|75677081|FG000|STARTED|Overall Study||81|Initial Vaccine|
59572724|NCT02566265|75677082|FG001|STARTED|Overall Study||41|Initial Vaccine|
59572725|NCT02566265|75677081|FG000|Day 7 (+/- 2 Days) (Optional)|Overall Study||19|Research blood draw only|
59572726|NCT02566265|75677082|FG001|Day 7 (+/- 2 Days) (Optional)|Overall Study||12|Research blood draw only|
59572727|NCT02566265|75677081|FG000|Day of Second Vaccine|Overall Study||74|30 Days After Initial Vaccine|
59572728|NCT02566265|75677082|FG001|Day of Second Vaccine|Overall Study||41|30 Days After Initial Vaccine|
59572729|NCT02566265|75677081|FG000|30 Days Following 2nd Vaccine|Overall Study||72|30 Days After Second Vaccine|
59572730|NCT02566265|75677082|FG001|30 Days Following 2nd Vaccine|Overall Study||35|30 Days After Second Vaccine|
59572731|NCT02566265|75677081|FG000|End of Study Visit (Optional)|Overall Study||38||
59572732|NCT02566265|75677082|FG001|End of Study Visit (Optional)|Overall Study||18||
59572733|NCT02566265|75677081|FG000|COMPLETED|Overall Study||72|All Required Milestones|
59572734|NCT02566265|75677082|FG001|COMPLETED|Overall Study||35|All Required Milestones|
59572735|NCT02566265|75677081|FG000|NOT COMPLETED|Overall Study||9||
59572736|NCT02566265|75677082|FG001|NOT COMPLETED|Overall Study||6||
59572737|NCT02516579|75677088|FG000|STARTED|Overall Study||1906||
59572738|NCT02516579|75677088|FG000|COMPLETED|Overall Study||1906||
59572739|NCT02516579|75677088|FG000|NOT COMPLETED|Overall Study||0||
59572740|NCT02517047|75677092|FG000|STARTED|Overall Study||26||
59572741|NCT02517047|75677092|FG000|COMPLETED|Overall Study||24||
59572742|NCT02517047|75677092|FG000|NOT COMPLETED|Overall Study||2||
59572743|NCT00558103|75677102|FG000|STARTED|Randomized Treatment Phase||38||
59721263|NCT01094886|75840160|FG000|COMPLETED|Overall Study||46||
59721264|NCT01094886|75840160|FG000|NOT COMPLETED|Overall Study||7||
59572744|NCT00558103|75677103|FG001|STARTED|Randomized Treatment Phase||38||
59572745|NCT00558103|75677104|FG002|STARTED|Randomized Treatment Phase||36||
59572746|NCT00558103|75677105|FG003|STARTED|Randomized Treatment Phase||13||
59572747|NCT00558103|75677106|FG004|STARTED|Randomized Treatment Phase||38||
59572748|NCT00558103|75677107|FG005|STARTED|Randomized Treatment Phase||0||
59572749|NCT00558103|75677102|FG000|COMPLETED|Randomized Treatment Phase||33||
59572750|NCT00558103|75677103|FG001|COMPLETED|Randomized Treatment Phase||34||
59572751|NCT00558103|75677104|FG002|COMPLETED|Randomized Treatment Phase||33||
59572752|NCT00558103|75677105|FG003|COMPLETED|Randomized Treatment Phase||11||
59572753|NCT00558103|75677106|FG004|COMPLETED|Randomized Treatment Phase||33||
59572754|NCT00558103|75677107|FG005|COMPLETED|Randomized Treatment Phase||0||
59572755|NCT00558103|75677102|FG000|NOT COMPLETED|Randomized Treatment Phase||5||
59572756|NCT00558103|75677103|FG001|NOT COMPLETED|Randomized Treatment Phase||4||
59572757|NCT00558103|75677104|FG002|NOT COMPLETED|Randomized Treatment Phase||3||
59572758|NCT00558103|75677105|FG003|NOT COMPLETED|Randomized Treatment Phase||2||
59572759|NCT00558103|75677106|FG004|NOT COMPLETED|Randomized Treatment Phase||5||
59572760|NCT00558103|75677107|FG005|NOT COMPLETED|Randomized Treatment Phase||0||
59572761|NCT00558103|75677102|FG000|STARTED|Monotherapy Extension Phase||0||
59572762|NCT00558103|75677103|FG001|STARTED|Monotherapy Extension Phase||0||
59572763|NCT00558103|75677104|FG002|STARTED|Monotherapy Extension Phase||0||
59572764|NCT00558103|75677105|FG003|STARTED|Monotherapy Extension Phase||0||
59721265|NCT01094808|75840167|FG000|STARTED|Overall Study||21||
59572765|NCT00558103|75677106|FG004|STARTED|Monotherapy Extension Phase||0||
59572766|NCT00558103|75677107|FG005|STARTED|Monotherapy Extension Phase|9/11 participants completing pazopanib monotherapy elected to receive lapatinib monotherapy.|9||
59572767|NCT00558103|75677102|FG000|COMPLETED|Monotherapy Extension Phase||0||
59572768|NCT00558103|75677103|FG001|COMPLETED|Monotherapy Extension Phase||0||
59572769|NCT00558103|75677104|FG002|COMPLETED|Monotherapy Extension Phase||0||
59572770|NCT00558103|75677105|FG003|COMPLETED|Monotherapy Extension Phase||0||
59572771|NCT00558103|75677106|FG004|COMPLETED|Monotherapy Extension Phase||0||
59572772|NCT00558103|75677107|FG005|COMPLETED|Monotherapy Extension Phase||0||
59572773|NCT00558103|75677102|FG000|NOT COMPLETED|Monotherapy Extension Phase||0||
59572774|NCT00558103|75677103|FG001|NOT COMPLETED|Monotherapy Extension Phase||0||
59572775|NCT00558103|75677104|FG002|NOT COMPLETED|Monotherapy Extension Phase||0||
59572776|NCT00558103|75677105|FG003|NOT COMPLETED|Monotherapy Extension Phase||0||
59721266|NCT01094808|75840168|FG001|STARTED|Overall Study||20||
59721267|NCT01094808|75840169|FG002|STARTED|Overall Study||21||
59721268|NCT01094808|75840167|FG000|COMPLETED|Overall Study||20||
60121243|NCT02658994|76242124|FG000|COMPLETED|36 Month Follow up||216||
60121244|NCT02658994|76242125|FG001|COMPLETED|36 Month Follow up||206||
59721269|NCT01094808|75840168|FG001|COMPLETED|Overall Study||19||
60121245|NCT02658994|76242126|FG002|COMPLETED|36 Month Follow up||467||
59572777|NCT00558103|75677106|FG004|NOT COMPLETED|Monotherapy Extension Phase||0||
59572778|NCT00558103|75677107|FG005|NOT COMPLETED|Monotherapy Extension Phase||9||
59572779|NCT02569541|75677120|FG000|STARTED|Overall Study||30||
59572780|NCT02569541|75677120|FG000|COMPLETED|Overall Study||9||
59572781|NCT02569541|75677120|FG000|NOT COMPLETED|Overall Study||21||
59572782|NCT01833403|75677124|FG000|STARTED|Overall Study||4||
59572783|NCT01833403|75677124|FG000|COMPLETED|Overall Study||4||
59572784|NCT01833403|75677124|FG000|NOT COMPLETED|Overall Study||0||
59572785|NCT01833481|75677132|FG000|STARTED|Overall Study||10||
59572786|NCT01833481|75677133|FG001|STARTED|Overall Study||10||
59572787|NCT01833481|75677134|FG002|STARTED|Overall Study||10||
59572788|NCT01833481|75677132|FG000|COMPLETED|Overall Study||10||
59572789|NCT01833481|75677133|FG001|COMPLETED|Overall Study||10||
59572790|NCT01833481|75677134|FG002|COMPLETED|Overall Study||10||
59572791|NCT01833481|75677132|FG000|NOT COMPLETED|Overall Study||0||
59572792|NCT01833481|75677133|FG001|NOT COMPLETED|Overall Study||0||
59572793|NCT01833481|75677134|FG002|NOT COMPLETED|Overall Study||0||
59572794|NCT00558025|75677144|FG000|STARTED|Overall Study||104||
59572795|NCT00558025|75677145|FG001|STARTED|Overall Study||52||
59572796|NCT00558025|75677144|FG000|COMPLETED|Overall Study||100||
59572797|NCT00558025|75677145|FG001|COMPLETED|Overall Study||49||
59572798|NCT00558025|75677144|FG000|NOT COMPLETED|Overall Study||4||
59572799|NCT00558025|75677145|FG001|NOT COMPLETED|Overall Study||3||
59572800|NCT01834027|75677153|FG000|STARTED|Overall Study||28||
59572801|NCT01834027|75677154|FG001|STARTED|Overall Study||28||
59572802|NCT01834027|75677153|FG000|COMPLETED|Overall Study||28||
59572803|NCT01834027|75677154|FG001|COMPLETED|Overall Study||28||
59572804|NCT01834027|75677153|FG000|NOT COMPLETED|Overall Study||0||
59572805|NCT01834027|75677154|FG001|NOT COMPLETED|Overall Study||0||
59572806|NCT02576249|75677162|FG000|STARTED|Overall Study||15||
59572807|NCT02576249|75677163|FG001|STARTED|Overall Study||14||
59572808|NCT02576249|75677162|FG000|COMPLETED|Overall Study||15||
59572809|NCT02576249|75677163|FG001|COMPLETED|Overall Study||14||
59572810|NCT02576249|75677162|FG000|NOT COMPLETED|Overall Study||0||
59572811|NCT02576249|75677163|FG001|NOT COMPLETED|Overall Study||0||
59572812|NCT01834261|75677171|FG000|STARTED|MIT fMRI and MEG Resting State Study||11||
59572813|NCT01834261|75677172|FG001|STARTED|MIT fMRI and MEG Resting State Study||10||
59572814|NCT01834261|75677171|FG000|COMPLETED|MIT fMRI and MEG Resting State Study|Enrollment completed in March 2014.|10||
59572815|NCT01834261|75677172|FG001|COMPLETED|MIT fMRI and MEG Resting State Study||9||
59572816|NCT01834261|75677171|FG000|NOT COMPLETED|MIT fMRI and MEG Resting State Study||1||
59572817|NCT01834261|75677172|FG001|NOT COMPLETED|MIT fMRI and MEG Resting State Study||1||
59572818|NCT01834261|75677171|FG000|STARTED|MGH Rest + Nueroeconomic Task fMRI|Subjects who dropped out/were excluded (10), did so before they received either Oxytocin or Placebo.|10||
59572819|NCT01834261|75677172|FG001|STARTED|MGH Rest + Nueroeconomic Task fMRI||10||
59572820|NCT01834261|75677171|FG000|COMPLETED|MGH Rest + Nueroeconomic Task fMRI|Enrollment completed in May 2015.|10||
59572821|NCT01834261|75677172|FG001|COMPLETED|MGH Rest + Nueroeconomic Task fMRI||10||
59572822|NCT01834261|75677171|FG000|NOT COMPLETED|MGH Rest + Nueroeconomic Task fMRI||0||
59572823|NCT01834261|75677172|FG001|NOT COMPLETED|MGH Rest + Nueroeconomic Task fMRI||0||
59572824|NCT02578199|75677178|FG000|STARTED|Overall Study||31||
59572825|NCT02578199|75677178|FG000|COMPLETED|Overall Study||27||
59572826|NCT02578199|75677178|FG000|NOT COMPLETED|Overall Study||4||
59572827|NCT02578745|75677184|FG000|STARTED|Overall Study||60||
59572828|NCT02578745|75677185|FG001|STARTED|Overall Study||60||
59572829|NCT02578745|75677184|FG000|COMPLETED|Overall Study||60||
59572830|NCT02578745|75677185|FG001|COMPLETED|Overall Study||60||
59572831|NCT02578745|75677184|FG000|NOT COMPLETED|Overall Study||0||
59572832|NCT02578745|75677185|FG001|NOT COMPLETED|Overall Study||0||
59572833|NCT01834651|75677192|FG000|STARTED|Overall Study||17||
59572834|NCT01834651|75677192|FG000|COMPLETED|Overall Study|Evaluable for primary outcome assessment at 12 weeks|16||
59572835|NCT01834651|75677192|FG000|NOT COMPLETED|Overall Study||1||
59572836|NCT00557323|75677198|FG000|STARTED|Overall Study||34||
59572837|NCT00557323|75677198|FG000|COMPLETED|Overall Study||27||
59572838|NCT00557323|75677198|FG000|NOT COMPLETED|Overall Study||7||
59572839|NCT02578901|75677204|FG000|STARTED|Overall Study||165||
59572840|NCT02578901|75677205|FG001|STARTED|Overall Study||165||
59572841|NCT02578901|75677204|FG000|COMPLETED|Overall Study||145||
59572842|NCT02578901|75677205|FG001|COMPLETED|Overall Study||144||
59572843|NCT02578901|75677204|FG000|NOT COMPLETED|Overall Study||20||
59572844|NCT02578901|75677205|FG001|NOT COMPLETED|Overall Study||21||
59572845|NCT02579057|75677213|FG000|STARTED|Overall Study||19||
59572846|NCT02579057|75677214|FG001|STARTED|Overall Study||21||
59572847|NCT02579057|75677213|FG000|COMPLETED|Overall Study||19||
59572848|NCT02579057|75677214|FG001|COMPLETED|Overall Study||21||
59572849|NCT02579057|75677213|FG000|NOT COMPLETED|Overall Study||0||
59572850|NCT02579057|75677214|FG001|NOT COMPLETED|Overall Study||0||
59572851|NCT02579135|75677222|FG000|STARTED|Overall Study||107||
59572852|NCT02579135|75677223|FG001|STARTED|Overall Study||115||
59572853|NCT02579135|75677222|FG000|COMPLETED|Overall Study||105||
59572854|NCT02579135|75677223|FG001|COMPLETED|Overall Study||106||
59572855|NCT02579135|75677222|FG000|NOT COMPLETED|Overall Study||2||
59572856|NCT02579135|75677223|FG001|NOT COMPLETED|Overall Study||9||
59572857|NCT00557245|75677232|FG000|STARTED|Overall Study||1589||
59572858|NCT00557245|75677233|FG001|STARTED|Overall Study||1583||
59572859|NCT00557245|75677234|FG002|STARTED|Overall Study||1586||
59572860|NCT00557245|75677232|FG000|COMPLETED|Overall Study||1577||
59572861|NCT00557245|75677233|FG001|COMPLETED|Overall Study||1571||
59572862|NCT00557245|75677234|FG002|COMPLETED|Overall Study||1574||
59572863|NCT00557245|75677232|FG000|NOT COMPLETED|Overall Study||12||
59572864|NCT00557245|75677233|FG001|NOT COMPLETED|Overall Study||12||
59572865|NCT00557245|75677234|FG002|NOT COMPLETED|Overall Study||12||
59572866|NCT01835743|75677247|FG000|STARTED|Overall Study||37||
59572867|NCT01835743|75677248|FG001|STARTED|Overall Study||32||
59721270|NCT01094808|75840169|FG002|COMPLETED|Overall Study||21||
59721271|NCT01094808|75840167|FG000|NOT COMPLETED|Overall Study||1||
59850266|NCT02892448|75974601|FG000|STARTED|Overall Study||12||
60121246|NCT02658994|76242124|FG000|NOT COMPLETED|36 Month Follow up||71||
59572868|NCT01835743|75677247|FG000|COMPLETED|Overall Study||37||
59572869|NCT01835743|75677248|FG001|COMPLETED|Overall Study||32||
59572870|NCT01835743|75677247|FG000|NOT COMPLETED|Overall Study||0||
59572871|NCT01835743|75677248|FG001|NOT COMPLETED|Overall Study||0||
59572872|NCT02579915|75677256|FG000|STARTED|Overall Study||19||
59572873|NCT02579915|75677257|FG001|STARTED|Overall Study||21||
59572874|NCT02579915|75677256|FG000|COMPLETED|Overall Study||9||
59572875|NCT02579915|75677257|FG001|COMPLETED|Overall Study||16||
59572876|NCT02579915|75677256|FG000|NOT COMPLETED|Overall Study||10||
59572877|NCT02579915|75677257|FG001|NOT COMPLETED|Overall Study||5||
59572878|NCT02581475|75677265|FG000|STARTED|Overall Study||193||
59572879|NCT02581475|75677266|FG001|STARTED|Overall Study||193||
59572880|NCT02581475|75677265|FG000|COMPLETED|Overall Study||182||
59572881|NCT02581475|75677266|FG001|COMPLETED|Overall Study||178||
59572882|NCT02581475|75677265|FG000|NOT COMPLETED|Overall Study||11||
59572883|NCT02581475|75677266|FG001|NOT COMPLETED|Overall Study||15||
59721272|NCT01094808|75840168|FG001|NOT COMPLETED|Overall Study||1||
59572884|NCT01836133|75677272|FG000|STARTED|Overall Study||70||
59572885|NCT01836133|75677272|FG000|COMPLETED|Overall Study||70||
59572886|NCT01836133|75677272|FG000|NOT COMPLETED|Overall Study||0||
59572887|NCT02581865|75677279|FG000|STARTED|Overall Study||40||
59572888|NCT02581865|75677280|FG001|STARTED|Overall Study||42||
59572889|NCT02581865|75677281|FG002|STARTED|Overall Study||42||
59572890|NCT02581865|75677279|FG000|COMPLETED|Overall Study||36||
60121247|NCT02658994|76242125|FG001|NOT COMPLETED|36 Month Follow up||77||
59572891|NCT02581865|75677280|FG001|COMPLETED|Overall Study||35||
59572892|NCT02581865|75677281|FG002|COMPLETED|Overall Study||26||
59572893|NCT02581865|75677279|FG000|NOT COMPLETED|Overall Study||4||
59572894|NCT02581865|75677280|FG001|NOT COMPLETED|Overall Study||7||
59572895|NCT02581865|75677281|FG002|NOT COMPLETED|Overall Study||16||
59572896|NCT00556075|75677295|FG000|STARTED|Overall Study||22||
59572897|NCT00556075|75677296|FG001|STARTED|Overall Study||22||
59572898|NCT00556075|75677297|FG002|STARTED|Overall Study||23||
59572899|NCT00556075|75677295|FG000|COMPLETED|Overall Study||9||
59572900|NCT00556075|75677296|FG001|COMPLETED|Overall Study||13||
59572901|NCT00556075|75677297|FG002|COMPLETED|Overall Study||15||
59572902|NCT00556075|75677295|FG000|NOT COMPLETED|Overall Study||13||
59572903|NCT00556075|75677296|FG001|NOT COMPLETED|Overall Study||9||
59572904|NCT00556075|75677297|FG002|NOT COMPLETED|Overall Study||8||
59572905|NCT01837069|75677311|FG000|STARTED|Overall Study||103||
59572906|NCT01837069|75677312|FG001|STARTED|Overall Study||95||
59572907|NCT01837069|75677311|FG000|COMPLETED|Overall Study||103||
59572908|NCT01837069|75677312|FG001|COMPLETED|Overall Study||95||
59572909|NCT01837069|75677311|FG000|NOT COMPLETED|Overall Study||0||
59572910|NCT01837069|75677312|FG001|NOT COMPLETED|Overall Study||0||
59572911|NCT02289690|75677328|FG000|STARTED|Overall Study||4||
59572912|NCT02289690|75677329|FG001|STARTED|Overall Study||3||
59572913|NCT02289690|75677330|FG002|STARTED|Overall Study||4||
59572914|NCT02289690|75677331|FG003|STARTED|Overall Study||3||
59572915|NCT02289690|75677332|FG004|STARTED|Overall Study||8||
59572916|NCT02289690|75677333|FG005|STARTED|Overall Study||14||
59572917|NCT02289690|75677334|FG006|STARTED|Overall Study||4||
59572918|NCT02289690|75677335|FG007|STARTED|Overall Study||61||
59572919|NCT02289690|75677336|FG008|STARTED|Overall Study||59||
59572920|NCT02289690|75677337|FG009|STARTED|Overall Study||61||
59572921|NCT02289690|75677328|FG000|Received Study Drug|Overall Study||4||
59572922|NCT02289690|75677329|FG001|Received Study Drug|Overall Study||3||
59572923|NCT02289690|75677330|FG002|Received Study Drug|Overall Study||4||
59572924|NCT02289690|75677331|FG003|Received Study Drug|Overall Study||3||
59572925|NCT02289690|75677332|FG004|Received Study Drug|Overall Study||8||
59572926|NCT02289690|75677333|FG005|Received Study Drug|Overall Study||14||
59572927|NCT02289690|75677334|FG006|Received Study Drug|Overall Study||4||
59572928|NCT02289690|75677335|FG007|Received Study Drug|Overall Study||60||
59572929|NCT02289690|75677336|FG008|Received Study Drug|Overall Study||58||
59572930|NCT02289690|75677337|FG009|Received Study Drug|Overall Study||60||
59572931|NCT02289690|75677328|FG000|COMPLETED|Overall Study||0|Completed indicates participants remaining on study.|
59572932|NCT02289690|75677329|FG001|COMPLETED|Overall Study||0|Completed indicates participants remaining on study.|
59572933|NCT02289690|75677330|FG002|COMPLETED|Overall Study||0|Completed indicates participants remaining on study.|
59572934|NCT02289690|75677331|FG003|COMPLETED|Overall Study||0|Completed indicates participants remaining on study.|
59572935|NCT02289690|75677332|FG004|COMPLETED|Overall Study||0|Completed indicates participants remaining on study.|
59572936|NCT02289690|75677333|FG005|COMPLETED|Overall Study||0|Completed indicates participants remaining on study.|
59572937|NCT02289690|75677334|FG006|COMPLETED|Overall Study||0|Completed indicates participants remaining on study.|
59572938|NCT02289690|75677335|FG007|COMPLETED|Overall Study||0|Completed indicates participants remaining on study.|
59572939|NCT02289690|75677336|FG008|COMPLETED|Overall Study||0|Completed indicates participants remaining on study.|
59572940|NCT02289690|75677337|FG009|COMPLETED|Overall Study||0|Completed indicates participants remaining on study.|
59572941|NCT02289690|75677328|FG000|NOT COMPLETED|Overall Study||4||
59572942|NCT02289690|75677329|FG001|NOT COMPLETED|Overall Study||3||
59572943|NCT02289690|75677330|FG002|NOT COMPLETED|Overall Study||4||
59572944|NCT02289690|75677331|FG003|NOT COMPLETED|Overall Study||3||
59572945|NCT02289690|75677332|FG004|NOT COMPLETED|Overall Study||8||
59572946|NCT02289690|75677333|FG005|NOT COMPLETED|Overall Study||14||
59572947|NCT02289690|75677334|FG006|NOT COMPLETED|Overall Study||4||
59572948|NCT02289690|75677335|FG007|NOT COMPLETED|Overall Study||61||
59572949|NCT02289690|75677336|FG008|NOT COMPLETED|Overall Study||59||
59572950|NCT02289690|75677337|FG009|NOT COMPLETED|Overall Study||61||
59572951|NCT02584673|75677375|FG000|STARTED|Overall Study||15||
59572952|NCT02584673|75677376|FG001|STARTED|Overall Study||15||
59572953|NCT02584673|75677375|FG000|COMPLETED|Overall Study||15||
59572954|NCT02584673|75677376|FG001|COMPLETED|Overall Study||15||
59572955|NCT02584673|75677375|FG000|NOT COMPLETED|Overall Study||0||
59572956|NCT02584673|75677376|FG001|NOT COMPLETED|Overall Study||0||
59572957|NCT02268955|75677384|FG000|STARTED|Overall Study||11||
59572958|NCT02268955|75677385|FG001|STARTED|Overall Study||11||
59572959|NCT02268955|75677384|FG000|COMPLETED|Overall Study||9||
59572960|NCT02268955|75677385|FG001|COMPLETED|Overall Study||9||
59572961|NCT02268955|75677384|FG000|NOT COMPLETED|Overall Study||2||
59572962|NCT02268955|75677385|FG001|NOT COMPLETED|Overall Study||2||
59572963|NCT02585843|75677393|FG000|STARTED|Overall Study||10||
59572964|NCT02585843|75677394|FG001|STARTED|Overall Study||10||
59572965|NCT02585843|75677393|FG000|COMPLETED|Overall Study||9||
59572966|NCT02585843|75677394|FG001|COMPLETED|Overall Study||10||
59572967|NCT02585843|75677393|FG000|NOT COMPLETED|Overall Study||1||
59572968|NCT02585843|75677394|FG001|NOT COMPLETED|Overall Study||0||
59572969|NCT01837537|75677400|FG000|STARTED|Overall Study||90||
59572970|NCT01837537|75677400|FG000|COMPLETED|Overall Study||90||
59572971|NCT01837537|75677400|FG000|NOT COMPLETED|Overall Study||0||
59572972|NCT01838317|75677406|FG000|STARTED|Overall Study||9||
59572973|NCT01838317|75677407|FG001|STARTED|Overall Study||5||
59572974|NCT01838317|75677406|FG000|COMPLETED|Overall Study||9||
59572975|NCT01838317|75677407|FG001|COMPLETED|Overall Study||5||
59572976|NCT01838317|75677406|FG000|NOT COMPLETED|Overall Study||0||
59572977|NCT01838317|75677407|FG001|NOT COMPLETED|Overall Study||0||
59572978|NCT02271217|75677416|FG000|STARTED|Overall Study||126||
59572979|NCT02271217|75677417|FG001|STARTED|Overall Study||126||
59572980|NCT02271217|75677418|FG002|STARTED|Overall Study||125||
59572981|NCT02271217|75677416|FG000|COMPLETED|Overall Study||115||
59572982|NCT02271217|75677417|FG001|COMPLETED|Overall Study||113||
59572983|NCT02271217|75677418|FG002|COMPLETED|Overall Study||113||
59572984|NCT02271217|75677416|FG000|NOT COMPLETED|Overall Study||11||
59572985|NCT02271217|75677417|FG001|NOT COMPLETED|Overall Study||13||
59572986|NCT02271217|75677418|FG002|NOT COMPLETED|Overall Study||12||
59572987|NCT02429375|75677429|FG000|STARTED|Overall Study||3||
59572988|NCT02429375|75677430|FG001|STARTED|Overall Study||3||
59572989|NCT02429375|75677431|FG002|STARTED|Overall Study||1||
59572990|NCT02429375|75677429|FG000|COMPLETED|Overall Study||3||
59572991|NCT02429375|75677430|FG001|COMPLETED|Overall Study||3||
59572992|NCT02429375|75677431|FG002|COMPLETED|Overall Study||1||
59572993|NCT02429375|75677429|FG000|NOT COMPLETED|Overall Study||0||
59572994|NCT02429375|75677430|FG001|NOT COMPLETED|Overall Study||0||
59572995|NCT02429375|75677431|FG002|NOT COMPLETED|Overall Study||0||
59572996|NCT02289456|75677440|FG000|STARTED|Induction Period||40||
59572997|NCT02289456|75677440|FG000|Treated Population|Induction Period||40||
59572998|NCT02289456|75677440|FG000|COMPLETED|Induction Period||16||
59572999|NCT02289456|75677440|FG000|NOT COMPLETED|Induction Period||24||
59573000|NCT02289456|75677440|FG000|STARTED|Monotherapy Period||16||
59573001|NCT02289456|75677440|FG000|COMPLETED|Monotherapy Period||0||
59573002|NCT02289456|75677440|FG000|NOT COMPLETED|Monotherapy Period||16||
59573003|NCT02588573|75677451|FG000|STARTED|Overall Study||45||90
59573004|NCT02588573|75677452|FG001|STARTED|Overall Study||45||90
59573005|NCT02588573|75677451|FG000|Randomized Eye Etafilcon A|Overall Study||45||45
59573006|NCT02588573|75677452|FG001|Randomized Eye Etafilcon A|Overall Study||45||45
59573007|NCT02588573|75677451|FG000|Randomized Eye Somofilcon A|Overall Study||45||45
59573008|NCT02588573|75677452|FG001|Randomized Eye Somofilcon A|Overall Study||45||45
59573009|NCT02588573|75677451|FG000|COMPLETED|Overall Study||45||90
59573010|NCT02588573|75677452|FG001|COMPLETED|Overall Study||45||90
59573011|NCT02588573|75677451|FG000|NOT COMPLETED|Overall Study||0||0
59573012|NCT02588573|75677452|FG001|NOT COMPLETED|Overall Study||0||0
59573013|NCT01838785|75677470|FG000|STARTED|Overall Study||25||
59573014|NCT01838785|75677470|FG000|COMPLETED|Overall Study||25||
59573015|NCT01838785|75677470|FG000|NOT COMPLETED|Overall Study||0||
59573016|NCT02589977|75677477|FG000|STARTED|Overall Study||23||
59573017|NCT02589977|75677478|FG001|STARTED|Overall Study||20||
59573018|NCT02589977|75677479|FG002|STARTED|Overall Study||12||
59573019|NCT02589977|75677477|FG000|COMPLETED|Overall Study||17||
59721273|NCT01094808|75840169|FG002|NOT COMPLETED|Overall Study||0||
59573020|NCT02589977|75677478|FG001|COMPLETED|Overall Study||15||
59573021|NCT02589977|75677479|FG002|COMPLETED|Overall Study||8||
59573022|NCT02589977|75677477|FG000|NOT COMPLETED|Overall Study||6||
59573023|NCT02589977|75677478|FG001|NOT COMPLETED|Overall Study||5||
59573024|NCT02589977|75677479|FG002|NOT COMPLETED|Overall Study||4||
59573025|NCT02274948|75677489|FG000|STARTED|Overall Study||166||
59573026|NCT02274948|75677490|FG001|STARTED|Overall Study||173||
59573027|NCT02274948|75677489|FG000|COMPLETED|Overall Study||68||
59573028|NCT02274948|75677490|FG001|COMPLETED|Overall Study||82||
59573029|NCT02274948|75677489|FG000|NOT COMPLETED|Overall Study||98||
59573030|NCT02274948|75677490|FG001|NOT COMPLETED|Overall Study||91||
59573031|NCT01838863|75677499|FG000|STARTED|Overall Study||75||
59573032|NCT01838863|75677500|FG001|STARTED|Overall Study||69||
59573033|NCT01838863|75677499|FG000|COMPLETED|Overall Study||65||
59573034|NCT01838863|75677500|FG001|COMPLETED|Overall Study||60||
59721274|NCT00864253|75840179|FG000|STARTED|Overall Study||264||
59573035|NCT01838863|75677499|FG000|NOT COMPLETED|Overall Study||10||
59573036|NCT01838863|75677500|FG001|NOT COMPLETED|Overall Study||9||
59573037|NCT02274792|75677506|FG000|STARTED|Overall Study||132||
59573038|NCT02274792|75677506|FG000|Received Treatment|Overall Study||131||
59573039|NCT02274792|75677506|FG000|COMPLETED|Overall Study||107||
59573040|NCT02274792|75677506|FG000|NOT COMPLETED|Overall Study||25||
59573041|NCT02591537|75677512|FG000|STARTED|Overall Study||8||32
59573042|NCT02591537|75677513|FG001|STARTED|Overall Study||8||32
59573043|NCT02591537|75677512|FG000|COMPLETED|Overall Study||8||32
59573044|NCT02591537|75677513|FG001|COMPLETED|Overall Study||8||32
59573045|NCT02591537|75677512|FG000|NOT COMPLETED|Overall Study||0||0
59573046|NCT02591537|75677513|FG001|NOT COMPLETED|Overall Study||0||0
59573047|NCT02592629|75677523|FG000|STARTED|Overall Study||5||
59573048|NCT02592629|75677524|FG001|STARTED|Overall Study||9||
59573049|NCT02592629|75677525|FG002|STARTED|Overall Study||5||
59573050|NCT02592629|75677523|FG000|COMPLETED|Overall Study||5||
59573051|NCT02592629|75677524|FG001|COMPLETED|Overall Study||9||
59573052|NCT02592629|75677525|FG002|COMPLETED|Overall Study||5||
59573053|NCT02592629|75677523|FG000|NOT COMPLETED|Overall Study||0||
59573054|NCT02592629|75677524|FG001|NOT COMPLETED|Overall Study||0||
59573055|NCT02592629|75677525|FG002|NOT COMPLETED|Overall Study||0||
59573056|NCT02274558|75677536|FG000|STARTED|Overall Study||78||
59573057|NCT02274558|75677537|FG001|STARTED|Overall Study||76||
59573058|NCT02274558|75677538|FG002|STARTED|Overall Study||80||
59573059|NCT02274558|75677536|FG000|Included in the Safety Analysis Set|Overall Study||76||
59573060|NCT02274558|75677537|FG001|Included in the Safety Analysis Set|Overall Study||72||
59573061|NCT02274558|75677538|FG002|Included in the Safety Analysis Set|Overall Study||79||
59573062|NCT02274558|75677536|FG000|COMPLETED|Overall Study||71||
59573063|NCT02274558|75677537|FG001|COMPLETED|Overall Study||63||
59573064|NCT02274558|75677538|FG002|COMPLETED|Overall Study||71||
59573065|NCT02274558|75677536|FG000|NOT COMPLETED|Overall Study||7||
59573066|NCT02274558|75677537|FG001|NOT COMPLETED|Overall Study||13||
59573067|NCT02274558|75677538|FG002|NOT COMPLETED|Overall Study||9||
59573068|NCT02595983|75677548|FG000|STARTED|Overall Study||12||
59573069|NCT02595983|75677548|FG000|COMPLETED|Overall Study||8||
59573070|NCT02595983|75677548|FG000|NOT COMPLETED|Overall Study||4||
59573071|NCT02287896|75677555|FG000|STARTED|Screening Visit V1||36||
59573072|NCT02287896|75677556|FG001|STARTED|Screening Visit V1||26||
59573073|NCT02287896|75677555|FG000|COMPLETED|Screening Visit V1||36||
59573074|NCT02287896|75677556|FG001|COMPLETED|Screening Visit V1||26||
59573075|NCT02287896|75677555|FG000|NOT COMPLETED|Screening Visit V1||0||
59573076|NCT02287896|75677556|FG001|NOT COMPLETED|Screening Visit V1||0||
59573077|NCT02287896|75677555|FG000|STARTED|First Injection Visit||36||
59573078|NCT02287896|75677556|FG001|STARTED|First Injection Visit||26||
59573079|NCT02287896|75677555|FG000|COMPLETED|First Injection Visit||36||
59573080|NCT02287896|75677556|FG001|COMPLETED|First Injection Visit||26||
59573081|NCT02287896|75677555|FG000|NOT COMPLETED|First Injection Visit||0||
59573082|NCT02287896|75677556|FG001|NOT COMPLETED|First Injection Visit||0||
59573083|NCT02287896|75677555|FG000|STARTED|Second Injection Visit||36||
59573084|NCT02287896|75677556|FG001|STARTED|Second Injection Visit||26||
59573085|NCT02287896|75677555|FG000|COMPLETED|Second Injection Visit||36||
59573086|NCT02287896|75677556|FG001|COMPLETED|Second Injection Visit||25||
59573087|NCT02287896|75677555|FG000|NOT COMPLETED|Second Injection Visit||0||
59573088|NCT02287896|75677556|FG001|NOT COMPLETED|Second Injection Visit||1||
59573089|NCT02596451|75677571|FG000|STARTED|Overall Study||385||
59573090|NCT02596451|75677572|FG001|STARTED|Overall Study||392||
59573091|NCT02596451|75677573|FG002|STARTED|Overall Study||387||
59573092|NCT02596451|75677571|FG000|COMPLETED|Overall Study||381||
59573093|NCT02596451|75677572|FG001|COMPLETED|Overall Study||374||
59573094|NCT02596451|75677573|FG002|COMPLETED|Overall Study||373||
59573095|NCT02596451|75677571|FG000|NOT COMPLETED|Overall Study||4||
59573096|NCT02596451|75677572|FG001|NOT COMPLETED|Overall Study||18||
59573097|NCT02596451|75677573|FG002|NOT COMPLETED|Overall Study||14||
59573098|NCT01839799|75677582|FG000|STARTED|Overall Study||17||
59573099|NCT01839799|75677583|FG001|STARTED|Overall Study||15||
59573100|NCT01839799|75677582|FG000|COMPLETED|Overall Study||17||
59573101|NCT01839799|75677583|FG001|COMPLETED|Overall Study||15||
59573102|NCT01839799|75677582|FG000|NOT COMPLETED|Overall Study||0||
59573103|NCT01839799|75677583|FG001|NOT COMPLETED|Overall Study||0||
59573104|NCT02597543|75677591|FG000|STARTED|Overall Study||6||
59573105|NCT02597543|75677592|FG001|STARTED|Overall Study||8||
59573106|NCT02597543|75677591|FG000|COMPLETED|Overall Study||6||
59573107|NCT02597543|75677592|FG001|COMPLETED|Overall Study||8||
59573108|NCT02597543|75677591|FG000|NOT COMPLETED|Overall Study||0||
59573109|NCT02597543|75677592|FG001|NOT COMPLETED|Overall Study||0||
59573110|NCT02598089|75677600|FG000|STARTED|Overall Study||30||
59573111|NCT02598089|75677601|FG001|STARTED|Overall Study||30||
59573112|NCT02598089|75677600|FG000|COMPLETED|Overall Study||30||
59573113|NCT02598089|75677601|FG001|COMPLETED|Overall Study||30||
59573114|NCT02598089|75677600|FG000|NOT COMPLETED|Overall Study||0||
59573115|NCT02598089|75677601|FG001|NOT COMPLETED|Overall Study||0||
59721275|NCT00864253|75840180|FG001|STARTED|Overall Study||265||
59573116|NCT00553501|75677614|FG000|STARTED|Overall Study||59||
59573117|NCT00553501|75677614|FG000|COMPLETED|Overall Study||55||
59573118|NCT00553501|75677614|FG000|NOT COMPLETED|Overall Study||4||
59573119|NCT02599649|75677622|FG000|STARTED|Overall Study||2||
59573120|NCT02599649|75677623|FG001|STARTED|Overall Study||0||
59573121|NCT02599649|75677624|FG002|STARTED|Overall Study||8||
59573122|NCT02599649|75677625|FG003|STARTED|Overall Study||0||
59573123|NCT02599649|75677622|FG000|COMPLETED|Overall Study||2||
59573124|NCT02599649|75677623|FG001|COMPLETED|Overall Study||0||
59573125|NCT02599649|75677624|FG002|COMPLETED|Overall Study||8||
59573126|NCT02599649|75677625|FG003|COMPLETED|Overall Study||0||
59573127|NCT02599649|75677622|FG000|NOT COMPLETED|Overall Study||0||
59573128|NCT02599649|75677623|FG001|NOT COMPLETED|Overall Study||0||
59573129|NCT02599649|75677624|FG002|NOT COMPLETED|Overall Study||0||
59573130|NCT02599649|75677625|FG003|NOT COMPLETED|Overall Study||0||
59573131|NCT01840345|75677635|FG000|STARTED|Overall Study||11||
59573132|NCT01840345|75677635|FG000|COMPLETED|Overall Study||10||
59573133|NCT01840345|75677635|FG000|NOT COMPLETED|Overall Study||1||
59721276|NCT00864253|75840179|FG000|Treated|Overall Study||257||
59573134|NCT02287584|75677642|FG000|STARTED|the Double-blind Phase||190|Subjects treated in the double-blind treatment phase|
59573135|NCT02287584|75677643|FG001|STARTED|the Double-blind Phase||196|Subjects treated in the double-blind treatment phase|
59573136|NCT02287584|75677644|FG002|STARTED|the Double-blind Phase||194|Subjects treated in the double-blind treatment phase|
59573137|NCT02287584|75677645|FG003|STARTED|the Double-blind Phase||0|Subjects treated in the double-blind treatment phase|
59573138|NCT02287584|75677646|FG004|STARTED|the Double-blind Phase||0|Subjects treated in the double-blind treatment phase|
59573139|NCT02287584|75677647|FG005|STARTED|the Double-blind Phase||0|Subjects treated in the double-blind treatment phase|
59573140|NCT02287584|75677642|FG000|COMPLETED|the Double-blind Phase||138||
59573141|NCT02287584|75677643|FG001|COMPLETED|the Double-blind Phase||149||
59573142|NCT02287584|75677644|FG002|COMPLETED|the Double-blind Phase||161||
59573143|NCT02287584|75677645|FG003|COMPLETED|the Double-blind Phase||0||
59573144|NCT02287584|75677646|FG004|COMPLETED|the Double-blind Phase||0||
59573145|NCT02287584|75677647|FG005|COMPLETED|the Double-blind Phase||0||
59573146|NCT02287584|75677642|FG000|NOT COMPLETED|the Double-blind Phase||52||
59573147|NCT02287584|75677643|FG001|NOT COMPLETED|the Double-blind Phase||47||
59573148|NCT02287584|75677644|FG002|NOT COMPLETED|the Double-blind Phase||33||
59573149|NCT02287584|75677645|FG003|NOT COMPLETED|the Double-blind Phase||0||
59573150|NCT02287584|75677646|FG004|NOT COMPLETED|the Double-blind Phase||0||
59573151|NCT02287584|75677647|FG005|NOT COMPLETED|the Double-blind Phase||0||
59573152|NCT02287584|75677642|FG000|STARTED|the Open-label Phase||0|Subjects completed the double-blind treatment phase|
59573153|NCT02287584|75677643|FG001|STARTED|the Open-label Phase||0|Subjects completed the double-blind treatment phase|
59573154|NCT02287584|75677644|FG002|STARTED|the Open-label Phase||0|Subjects completed the double-blind treatment phase|
59573155|NCT02287584|75677645|FG003|STARTED|the Open-label Phase||138|Subjects completed the double-blind treatment phase|
59573156|NCT02287584|75677646|FG004|STARTED|the Open-label Phase||149|Subjects completed the double-blind treatment phase|
59573157|NCT02287584|75677647|FG005|STARTED|the Open-label Phase||161|Subjects completed the double-blind treatment phase|
59573158|NCT02287584|75677642|FG000|Treated|the Open-label Phase||0|Subjects treated in the open-label treatment phase|
59573159|NCT02287584|75677643|FG001|Treated|the Open-label Phase||0|Subjects treated in the open-label treatment phase|
59573160|NCT02287584|75677644|FG002|Treated|the Open-label Phase||0|Subjects treated in the open-label treatment phase|
59573161|NCT02287584|75677645|FG003|Treated|the Open-label Phase||131|Subjects treated in the open-label treatment phase|
59573162|NCT02287584|75677646|FG004|Treated|the Open-label Phase||143|Subjects treated in the open-label treatment phase|
59573163|NCT02287584|75677647|FG005|Treated|the Open-label Phase||157|Subjects treated in the open-label treatment phase|
59573164|NCT02287584|75677642|FG000|COMPLETED|the Open-label Phase||0||
59573165|NCT02287584|75677643|FG001|COMPLETED|the Open-label Phase||0||
59573166|NCT02287584|75677644|FG002|COMPLETED|the Open-label Phase||0||
59573167|NCT02287584|75677645|FG003|COMPLETED|the Open-label Phase||81||
59573168|NCT02287584|75677646|FG004|COMPLETED|the Open-label Phase||87||
59573169|NCT02287584|75677647|FG005|COMPLETED|the Open-label Phase||104||
59573170|NCT02287584|75677642|FG000|NOT COMPLETED|the Open-label Phase||0||
59573171|NCT02287584|75677643|FG001|NOT COMPLETED|the Open-label Phase||0||
59573172|NCT02287584|75677644|FG002|NOT COMPLETED|the Open-label Phase||0||
59573173|NCT02287584|75677645|FG003|NOT COMPLETED|the Open-label Phase||57||
59573174|NCT02287584|75677646|FG004|NOT COMPLETED|the Open-label Phase||62||
59573175|NCT02287584|75677647|FG005|NOT COMPLETED|the Open-label Phase||57||
59573176|NCT01841047|75677661|FG000|STARTED|Overall Study||48||
59573177|NCT01841047|75677661|FG000|COMPLETED|Overall Study||48||
59573178|NCT01841047|75677661|FG000|NOT COMPLETED|Overall Study||0||
59573179|NCT02601833|75677667|FG000|STARTED|Overall Study||56||
59573180|NCT02601833|75677668|FG001|STARTED|Overall Study||42||
59573181|NCT02601833|75677667|FG000|COMPLETED|Overall Study||40||
59573182|NCT02601833|75677668|FG001|COMPLETED|Overall Study||29||
59573183|NCT02601833|75677667|FG000|NOT COMPLETED|Overall Study||16||
59573184|NCT02601833|75677668|FG001|NOT COMPLETED|Overall Study||13||
59573185|NCT00553267|75677680|FG000|STARTED|Overall Study||315||
59573186|NCT00553267|75677681|FG001|STARTED|Overall Study||315||
59573187|NCT00553267|75677682|FG002|STARTED|Overall Study||317||
59573188|NCT00553267|75677680|FG000|COMPLETED|Overall Study||301||
59573189|NCT00553267|75677681|FG001|COMPLETED|Overall Study||297||
59573190|NCT00553267|75677682|FG002|COMPLETED|Overall Study||307||
59573191|NCT00553267|75677680|FG000|NOT COMPLETED|Overall Study||14||
59573192|NCT00553267|75677681|FG001|NOT COMPLETED|Overall Study||18||
59573193|NCT00553267|75677682|FG002|NOT COMPLETED|Overall Study||10||
59573194|NCT02602223|75677690|FG000|STARTED|Overall Study||9||
59573195|NCT02602223|75677690|FG000|COMPLETED|Overall Study||9||
59573196|NCT02602223|75677690|FG000|NOT COMPLETED|Overall Study||0||
59573197|NCT02271984|75677696|FG000|STARTED|First Intervention Period (1 Day)||3||
59573198|NCT02271984|75677697|FG001|STARTED|First Intervention Period (1 Day)||3||
59721277|NCT00864253|75840180|FG001|Treated|Overall Study||258||
59573199|NCT02271984|75677698|FG002|STARTED|First Intervention Period (1 Day)||3||
59573200|NCT02271984|75677699|FG003|STARTED|First Intervention Period (1 Day)||3||
59573201|NCT02271984|75677700|FG004|STARTED|First Intervention Period (1 Day)||3||
59573202|NCT02271984|75677701|FG005|STARTED|First Intervention Period (1 Day)||3||
59573203|NCT02271984|75677702|FG006|STARTED|First Intervention Period (1 Day)||3||
59573204|NCT02271984|75677703|FG007|STARTED|First Intervention Period (1 Day)||3||
59573205|NCT02271984|75677704|FG008|STARTED|First Intervention Period (1 Day)||3||
59573206|NCT02271984|75677705|FG009|STARTED|First Intervention Period (1 Day)||3||
59573207|NCT02271984|75677706|FG010|STARTED|First Intervention Period (1 Day)||3||
59573208|NCT02271984|75677707|FG011|STARTED|First Intervention Period (1 Day)||3||
59573209|NCT02271984|75677696|FG000|COMPLETED|First Intervention Period (1 Day)||3||
59850267|NCT02892448|75974602|FG001|STARTED|Overall Study||12||
59573210|NCT02271984|75677697|FG001|COMPLETED|First Intervention Period (1 Day)||3||
59573211|NCT02271984|75677698|FG002|COMPLETED|First Intervention Period (1 Day)||3||
59573212|NCT02271984|75677699|FG003|COMPLETED|First Intervention Period (1 Day)||3||
59573213|NCT02271984|75677700|FG004|COMPLETED|First Intervention Period (1 Day)||3||
59573214|NCT02271984|75677701|FG005|COMPLETED|First Intervention Period (1 Day)||3||
59573215|NCT02271984|75677702|FG006|COMPLETED|First Intervention Period (1 Day)||3||
59573216|NCT02271984|75677703|FG007|COMPLETED|First Intervention Period (1 Day)||3||
59573217|NCT02271984|75677704|FG008|COMPLETED|First Intervention Period (1 Day)||3||
59573218|NCT02271984|75677705|FG009|COMPLETED|First Intervention Period (1 Day)||3||
59573219|NCT02271984|75677706|FG010|COMPLETED|First Intervention Period (1 Day)||3||
59573220|NCT02271984|75677707|FG011|COMPLETED|First Intervention Period (1 Day)||3||
59573221|NCT02271984|75677696|FG000|NOT COMPLETED|First Intervention Period (1 Day)||0||
59573222|NCT02271984|75677697|FG001|NOT COMPLETED|First Intervention Period (1 Day)||0||
59573223|NCT02271984|75677698|FG002|NOT COMPLETED|First Intervention Period (1 Day)||0||
59573224|NCT02271984|75677699|FG003|NOT COMPLETED|First Intervention Period (1 Day)||0||
59573225|NCT02271984|75677700|FG004|NOT COMPLETED|First Intervention Period (1 Day)||0||
59573226|NCT02271984|75677701|FG005|NOT COMPLETED|First Intervention Period (1 Day)||0||
59573227|NCT02271984|75677702|FG006|NOT COMPLETED|First Intervention Period (1 Day)||0||
59573228|NCT02271984|75677703|FG007|NOT COMPLETED|First Intervention Period (1 Day)||0||
59721278|NCT00864253|75840179|FG000|COMPLETED|Overall Study|Completed = defined as discontinuation due to progressive disease|165||
59721279|NCT00864253|75840180|FG001|COMPLETED|Overall Study|Completed = defined as discontinuation due to progressive disease|207||
59721280|NCT00864253|75840179|FG000|NOT COMPLETED|Overall Study||99||
59721281|NCT00864253|75840180|FG001|NOT COMPLETED|Overall Study||58||
59721282|NCT01094730|75840188|FG000|STARTED|Period 1 (14 Days)||92||
59721283|NCT01094730|75840189|FG001|STARTED|Period 1 (14 Days)||88||
59721284|NCT01094730|75840188|FG000|COMPLETED|Period 1 (14 Days)||90||
59721285|NCT01094730|75840189|FG001|COMPLETED|Period 1 (14 Days)||86||
59721286|NCT01094730|75840188|FG000|NOT COMPLETED|Period 1 (14 Days)||2||
59721287|NCT01094730|75840189|FG001|NOT COMPLETED|Period 1 (14 Days)||2||
59721288|NCT01094730|75840188|FG000|STARTED|Period 2 (14 Days)||90||
59721289|NCT01094730|75840189|FG001|STARTED|Period 2 (14 Days)||86||
59721290|NCT01094730|75840188|FG000|COMPLETED|Period 2 (14 Days)||87||
59721291|NCT01094730|75840189|FG001|COMPLETED|Period 2 (14 Days)||84||
59721292|NCT01094730|75840188|FG000|NOT COMPLETED|Period 2 (14 Days)||3||
59721293|NCT01094730|75840189|FG001|NOT COMPLETED|Period 2 (14 Days)||2||
59721294|NCT01293682|75840196|FG000|STARTED|Overall Study||12||
59721295|NCT01293682|75840196|FG000|COMPLETED|Overall Study||12||
59721296|NCT01293682|75840196|FG000|NOT COMPLETED|Overall Study||0||
59721297|NCT00864097|75840204|FG000|STARTED|Overall Study||154||
59721298|NCT00864097|75840205|FG001|STARTED|Overall Study||157||
59721299|NCT00864097|75840206|FG002|STARTED|Overall Study||151||
59721300|NCT00864097|75840207|FG003|STARTED|Overall Study||145||
59721301|NCT00864097|75840204|FG000|Treated|Overall Study||152||
59721302|NCT00864097|75840205|FG001|Treated|Overall Study||157||
59721303|NCT00864097|75840206|FG002|Treated|Overall Study||150||
59721304|NCT00864097|75840207|FG003|Treated|Overall Study||145||
59721305|NCT00864097|75840204|FG000|COMPLETED|Overall Study||15||
59850268|NCT02892448|75974603|FG002|STARTED|Overall Study||11||
59850269|NCT02892448|75974601|FG000|COMPLETED|Overall Study||10||
59850270|NCT02892448|75974602|FG001|COMPLETED|Overall Study||10||
59850271|NCT02892448|75974603|FG002|COMPLETED|Overall Study||10||
60121248|NCT02658994|76242126|FG002|NOT COMPLETED|36 Month Follow up||117||
60121249|NCT01541917|76242138|FG000|STARTED|Overall Study||144||
60121250|NCT01541917|76242139|FG001|STARTED|Overall Study||145||
60121251|NCT01541917|76242138|FG000|COMPLETED|Overall Study||129||
59573229|NCT02271984|75677704|FG008|NOT COMPLETED|First Intervention Period (1 Day)||0||
59573230|NCT02271984|75677705|FG009|NOT COMPLETED|First Intervention Period (1 Day)||0||
59573231|NCT02271984|75677706|FG010|NOT COMPLETED|First Intervention Period (1 Day)||0||
59573232|NCT02271984|75677707|FG011|NOT COMPLETED|First Intervention Period (1 Day)||0||
59573233|NCT02271984|75677696|FG000|STARTED|Washout Period 1 (7 Days)||3||
59573234|NCT02271984|75677697|FG001|STARTED|Washout Period 1 (7 Days)||3||
59573235|NCT02271984|75677698|FG002|STARTED|Washout Period 1 (7 Days)||3||
59573236|NCT02271984|75677699|FG003|STARTED|Washout Period 1 (7 Days)||3||
59573237|NCT02271984|75677700|FG004|STARTED|Washout Period 1 (7 Days)||3||
59573238|NCT02271984|75677701|FG005|STARTED|Washout Period 1 (7 Days)||3||
59573239|NCT02271984|75677702|FG006|STARTED|Washout Period 1 (7 Days)||3||
59573240|NCT02271984|75677703|FG007|STARTED|Washout Period 1 (7 Days)||3||
59573241|NCT02271984|75677704|FG008|STARTED|Washout Period 1 (7 Days)||3||
59721306|NCT00864097|75840205|FG001|COMPLETED|Overall Study||20||
59850272|NCT02892448|75974601|FG000|NOT COMPLETED|Overall Study||2||
60121252|NCT01541917|76242139|FG001|COMPLETED|Overall Study||136||
60121253|NCT01541917|76242138|FG000|NOT COMPLETED|Overall Study||15||
59573242|NCT02271984|75677705|FG009|STARTED|Washout Period 1 (7 Days)||3||
59573243|NCT02271984|75677706|FG010|STARTED|Washout Period 1 (7 Days)||3||
59573244|NCT02271984|75677707|FG011|STARTED|Washout Period 1 (7 Days)||3||
59573245|NCT02271984|75677696|FG000|COMPLETED|Washout Period 1 (7 Days)||3||
59573246|NCT02271984|75677697|FG001|COMPLETED|Washout Period 1 (7 Days)||3||
59573247|NCT02271984|75677698|FG002|COMPLETED|Washout Period 1 (7 Days)||3||
59573248|NCT02271984|75677699|FG003|COMPLETED|Washout Period 1 (7 Days)||3||
59573249|NCT02271984|75677700|FG004|COMPLETED|Washout Period 1 (7 Days)||3||
59573250|NCT02271984|75677701|FG005|COMPLETED|Washout Period 1 (7 Days)||3||
59573251|NCT02271984|75677702|FG006|COMPLETED|Washout Period 1 (7 Days)||3||
59573252|NCT02271984|75677703|FG007|COMPLETED|Washout Period 1 (7 Days)||3||
59573253|NCT02271984|75677704|FG008|COMPLETED|Washout Period 1 (7 Days)||3||
59573254|NCT02271984|75677705|FG009|COMPLETED|Washout Period 1 (7 Days)||3||
59573255|NCT02271984|75677706|FG010|COMPLETED|Washout Period 1 (7 Days)||3||
59573256|NCT02271984|75677707|FG011|COMPLETED|Washout Period 1 (7 Days)||3||
59573257|NCT02271984|75677696|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0||
59573258|NCT02271984|75677697|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0||
59573259|NCT02271984|75677698|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0||
59573260|NCT02271984|75677699|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0||
59573261|NCT02271984|75677700|FG004|NOT COMPLETED|Washout Period 1 (7 Days)||0||
59573262|NCT02271984|75677701|FG005|NOT COMPLETED|Washout Period 1 (7 Days)||0||
59573263|NCT02271984|75677702|FG006|NOT COMPLETED|Washout Period 1 (7 Days)||0||
59573264|NCT02271984|75677703|FG007|NOT COMPLETED|Washout Period 1 (7 Days)||0||
59573265|NCT02271984|75677704|FG008|NOT COMPLETED|Washout Period 1 (7 Days)||0||
59573266|NCT02271984|75677705|FG009|NOT COMPLETED|Washout Period 1 (7 Days)||0||
59573267|NCT02271984|75677706|FG010|NOT COMPLETED|Washout Period 1 (7 Days)||0||
59573268|NCT02271984|75677707|FG011|NOT COMPLETED|Washout Period 1 (7 Days)||0||
59573269|NCT02271984|75677696|FG000|STARTED|Second Intervention Period (1 Day)||3||
59573270|NCT02271984|75677697|FG001|STARTED|Second Intervention Period (1 Day)||3||
59573271|NCT02271984|75677698|FG002|STARTED|Second Intervention Period (1 Day)||3||
59573272|NCT02271984|75677699|FG003|STARTED|Second Intervention Period (1 Day)||3||
59573273|NCT02271984|75677700|FG004|STARTED|Second Intervention Period (1 Day)||3||
59573274|NCT02271984|75677701|FG005|STARTED|Second Intervention Period (1 Day)||3||
59573275|NCT02271984|75677702|FG006|STARTED|Second Intervention Period (1 Day)||3||
59573276|NCT02271984|75677703|FG007|STARTED|Second Intervention Period (1 Day)||3||
59573277|NCT02271984|75677704|FG008|STARTED|Second Intervention Period (1 Day)||3||
59573278|NCT02271984|75677705|FG009|STARTED|Second Intervention Period (1 Day)||3||
59573279|NCT02271984|75677706|FG010|STARTED|Second Intervention Period (1 Day)||3||
59573280|NCT02271984|75677707|FG011|STARTED|Second Intervention Period (1 Day)||3||
59573281|NCT02271984|75677696|FG000|COMPLETED|Second Intervention Period (1 Day)||3||
59573282|NCT02271984|75677697|FG001|COMPLETED|Second Intervention Period (1 Day)||3||
59573283|NCT02271984|75677698|FG002|COMPLETED|Second Intervention Period (1 Day)||3||
59573284|NCT02271984|75677699|FG003|COMPLETED|Second Intervention Period (1 Day)||3||
59573285|NCT02271984|75677700|FG004|COMPLETED|Second Intervention Period (1 Day)||3||
59573286|NCT02271984|75677701|FG005|COMPLETED|Second Intervention Period (1 Day)||3||
59573287|NCT02271984|75677702|FG006|COMPLETED|Second Intervention Period (1 Day)||3||
60121254|NCT01541917|76242139|FG001|NOT COMPLETED|Overall Study||9||
60121255|NCT02660788|76242150|FG000|STARTED|Overall Study||2749||
59573288|NCT02271984|75677703|FG007|COMPLETED|Second Intervention Period (1 Day)||3||
59573289|NCT02271984|75677704|FG008|COMPLETED|Second Intervention Period (1 Day)||3||
59573290|NCT02271984|75677705|FG009|COMPLETED|Second Intervention Period (1 Day)||3||
59573291|NCT02271984|75677706|FG010|COMPLETED|Second Intervention Period (1 Day)||3||
59573292|NCT02271984|75677707|FG011|COMPLETED|Second Intervention Period (1 Day)||3||
59573293|NCT02271984|75677696|FG000|NOT COMPLETED|Second Intervention Period (1 Day)||0||
59573294|NCT02271984|75677697|FG001|NOT COMPLETED|Second Intervention Period (1 Day)||0||
59573295|NCT02271984|75677698|FG002|NOT COMPLETED|Second Intervention Period (1 Day)||0||
59573296|NCT02271984|75677699|FG003|NOT COMPLETED|Second Intervention Period (1 Day)||0||
59573297|NCT02271984|75677700|FG004|NOT COMPLETED|Second Intervention Period (1 Day)||0||
59573298|NCT02271984|75677701|FG005|NOT COMPLETED|Second Intervention Period (1 Day)||0||
59573299|NCT02271984|75677702|FG006|NOT COMPLETED|Second Intervention Period (1 Day)||0||
59573300|NCT02271984|75677703|FG007|NOT COMPLETED|Second Intervention Period (1 Day)||0||
59573301|NCT02271984|75677704|FG008|NOT COMPLETED|Second Intervention Period (1 Day)||0||
59573302|NCT02271984|75677705|FG009|NOT COMPLETED|Second Intervention Period (1 Day)||0||
59721307|NCT00864097|75840206|FG002|COMPLETED|Overall Study||19||
59573303|NCT02271984|75677706|FG010|NOT COMPLETED|Second Intervention Period (1 Day)||0||
59573304|NCT02271984|75677707|FG011|NOT COMPLETED|Second Intervention Period (1 Day)||0||
59573305|NCT02271984|75677696|FG000|STARTED|Washout Period 2 (7 Days)||3||
59573306|NCT02271984|75677697|FG001|STARTED|Washout Period 2 (7 Days)||3||
59573307|NCT02271984|75677698|FG002|STARTED|Washout Period 2 (7 Days)||3||
59573308|NCT02271984|75677699|FG003|STARTED|Washout Period 2 (7 Days)||3||
59573309|NCT02271984|75677700|FG004|STARTED|Washout Period 2 (7 Days)||3||
59721308|NCT00864097|75840207|FG003|COMPLETED|Overall Study||20||
59721309|NCT00864097|75840204|FG000|NOT COMPLETED|Overall Study||139||
59573310|NCT02271984|75677701|FG005|STARTED|Washout Period 2 (7 Days)||3||
59573311|NCT02271984|75677702|FG006|STARTED|Washout Period 2 (7 Days)||3||
59573312|NCT02271984|75677703|FG007|STARTED|Washout Period 2 (7 Days)||3||
59573313|NCT02271984|75677704|FG008|STARTED|Washout Period 2 (7 Days)||3||
59573314|NCT02271984|75677705|FG009|STARTED|Washout Period 2 (7 Days)||3||
59573315|NCT02271984|75677706|FG010|STARTED|Washout Period 2 (7 Days)||3||
59573316|NCT02271984|75677707|FG011|STARTED|Washout Period 2 (7 Days)||3||
59573317|NCT02271984|75677696|FG000|COMPLETED|Washout Period 2 (7 Days)||3||
59573318|NCT02271984|75677697|FG001|COMPLETED|Washout Period 2 (7 Days)||3||
59573319|NCT02271984|75677698|FG002|COMPLETED|Washout Period 2 (7 Days)||3||
59573320|NCT02271984|75677699|FG003|COMPLETED|Washout Period 2 (7 Days)||3||
59573321|NCT02271984|75677700|FG004|COMPLETED|Washout Period 2 (7 Days)||3||
59573322|NCT02271984|75677701|FG005|COMPLETED|Washout Period 2 (7 Days)||3||
59573323|NCT02271984|75677702|FG006|COMPLETED|Washout Period 2 (7 Days)||3||
59573324|NCT02271984|75677703|FG007|COMPLETED|Washout Period 2 (7 Days)||3||
59573325|NCT02271984|75677704|FG008|COMPLETED|Washout Period 2 (7 Days)||3||
59573326|NCT02271984|75677705|FG009|COMPLETED|Washout Period 2 (7 Days)||3||
59573327|NCT02271984|75677706|FG010|COMPLETED|Washout Period 2 (7 Days)||3||
59573328|NCT02271984|75677707|FG011|COMPLETED|Washout Period 2 (7 Days)||3||
59573329|NCT02271984|75677696|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0||
59573330|NCT02271984|75677697|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0||
59573331|NCT02271984|75677698|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0||
59573332|NCT02271984|75677699|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0||
59573333|NCT02271984|75677700|FG004|NOT COMPLETED|Washout Period 2 (7 Days)||0||
59573334|NCT02271984|75677701|FG005|NOT COMPLETED|Washout Period 2 (7 Days)||0||
59573335|NCT02271984|75677702|FG006|NOT COMPLETED|Washout Period 2 (7 Days)||0||
59573336|NCT02271984|75677703|FG007|NOT COMPLETED|Washout Period 2 (7 Days)||0||
59573337|NCT02271984|75677704|FG008|NOT COMPLETED|Washout Period 2 (7 Days)||0||
60121256|NCT02660788|76242151|FG001|STARTED|Overall Study||2749||
60121257|NCT02660788|76242150|FG000|COMPLETED|Overall Study||2749||
59573338|NCT02271984|75677705|FG009|NOT COMPLETED|Washout Period 2 (7 Days)||0||
59573339|NCT02271984|75677706|FG010|NOT COMPLETED|Washout Period 2 (7 Days)||0||
59573340|NCT02271984|75677707|FG011|NOT COMPLETED|Washout Period 2 (7 Days)||0||
59573341|NCT02271984|75677696|FG000|STARTED|Third Intervention Period (1 Day)||3||
59573342|NCT02271984|75677697|FG001|STARTED|Third Intervention Period (1 Day)||3||
59573343|NCT02271984|75677698|FG002|STARTED|Third Intervention Period (1 Day)||3||
59573344|NCT02271984|75677699|FG003|STARTED|Third Intervention Period (1 Day)||3||
59573345|NCT02271984|75677700|FG004|STARTED|Third Intervention Period (1 Day)||3||
59573346|NCT02271984|75677701|FG005|STARTED|Third Intervention Period (1 Day)||3||
59573347|NCT02271984|75677702|FG006|STARTED|Third Intervention Period (1 Day)||3||
59573348|NCT02271984|75677703|FG007|STARTED|Third Intervention Period (1 Day)||3||
59573349|NCT02271984|75677704|FG008|STARTED|Third Intervention Period (1 Day)||3||
59573350|NCT02271984|75677705|FG009|STARTED|Third Intervention Period (1 Day)||3||
59573351|NCT02271984|75677706|FG010|STARTED|Third Intervention Period (1 Day)||3||
59573352|NCT02271984|75677707|FG011|STARTED|Third Intervention Period (1 Day)||3||
59573353|NCT02271984|75677696|FG000|COMPLETED|Third Intervention Period (1 Day)||3||
59573354|NCT02271984|75677697|FG001|COMPLETED|Third Intervention Period (1 Day)||3||
59573355|NCT02271984|75677698|FG002|COMPLETED|Third Intervention Period (1 Day)||3||
59573356|NCT02271984|75677699|FG003|COMPLETED|Third Intervention Period (1 Day)||3||
59573357|NCT02271984|75677700|FG004|COMPLETED|Third Intervention Period (1 Day)||3||
59573358|NCT02271984|75677701|FG005|COMPLETED|Third Intervention Period (1 Day)||3||
59573359|NCT02271984|75677702|FG006|COMPLETED|Third Intervention Period (1 Day)||3||
59573360|NCT02271984|75677703|FG007|COMPLETED|Third Intervention Period (1 Day)||3||
59573361|NCT02271984|75677704|FG008|COMPLETED|Third Intervention Period (1 Day)||3||
59573362|NCT02271984|75677705|FG009|COMPLETED|Third Intervention Period (1 Day)||3||
59573363|NCT02271984|75677706|FG010|COMPLETED|Third Intervention Period (1 Day)||3||
59573364|NCT02271984|75677707|FG011|COMPLETED|Third Intervention Period (1 Day)||3||
59573365|NCT02271984|75677696|FG000|NOT COMPLETED|Third Intervention Period (1 Day)||0||
59573366|NCT02271984|75677697|FG001|NOT COMPLETED|Third Intervention Period (1 Day)||0||
59573367|NCT02271984|75677698|FG002|NOT COMPLETED|Third Intervention Period (1 Day)||0||
59573368|NCT02271984|75677699|FG003|NOT COMPLETED|Third Intervention Period (1 Day)||0||
59573369|NCT02271984|75677700|FG004|NOT COMPLETED|Third Intervention Period (1 Day)||0||
59573370|NCT02271984|75677701|FG005|NOT COMPLETED|Third Intervention Period (1 Day)||0||
59573371|NCT02271984|75677702|FG006|NOT COMPLETED|Third Intervention Period (1 Day)||0||
59573372|NCT02271984|75677703|FG007|NOT COMPLETED|Third Intervention Period (1 Day)||0||
59573373|NCT02271984|75677704|FG008|NOT COMPLETED|Third Intervention Period (1 Day)||0||
59573374|NCT02271984|75677705|FG009|NOT COMPLETED|Third Intervention Period (1 Day)||0||
59573375|NCT02271984|75677706|FG010|NOT COMPLETED|Third Intervention Period (1 Day)||0||
59573376|NCT02271984|75677707|FG011|NOT COMPLETED|Third Intervention Period (1 Day)||0||
59573377|NCT02271984|75677696|FG000|STARTED|Washout Period 3 (7 Days)||3||
59573378|NCT02271984|75677697|FG001|STARTED|Washout Period 3 (7 Days)||3||
59573379|NCT02271984|75677698|FG002|STARTED|Washout Period 3 (7 Days)||3||
59573380|NCT02271984|75677699|FG003|STARTED|Washout Period 3 (7 Days)||3||
59573381|NCT02271984|75677700|FG004|STARTED|Washout Period 3 (7 Days)||3||
59721310|NCT00864097|75840205|FG001|NOT COMPLETED|Overall Study||137||
59721311|NCT00864097|75840206|FG002|NOT COMPLETED|Overall Study||132||
59573382|NCT02271984|75677701|FG005|STARTED|Washout Period 3 (7 Days)||3||
59573383|NCT02271984|75677702|FG006|STARTED|Washout Period 3 (7 Days)||3||
59573384|NCT02271984|75677703|FG007|STARTED|Washout Period 3 (7 Days)||3||
59573385|NCT02271984|75677704|FG008|STARTED|Washout Period 3 (7 Days)||3||
59573386|NCT02271984|75677705|FG009|STARTED|Washout Period 3 (7 Days)||3||
59573387|NCT02271984|75677706|FG010|STARTED|Washout Period 3 (7 Days)||3||
59573388|NCT02271984|75677707|FG011|STARTED|Washout Period 3 (7 Days)||3||
59573389|NCT02271984|75677696|FG000|COMPLETED|Washout Period 3 (7 Days)||3||
59573390|NCT02271984|75677697|FG001|COMPLETED|Washout Period 3 (7 Days)||3||
59573391|NCT02271984|75677698|FG002|COMPLETED|Washout Period 3 (7 Days)||3||
59573392|NCT02271984|75677699|FG003|COMPLETED|Washout Period 3 (7 Days)||3||
59573393|NCT02271984|75677700|FG004|COMPLETED|Washout Period 3 (7 Days)||3||
59573394|NCT02271984|75677701|FG005|COMPLETED|Washout Period 3 (7 Days)||3||
59573395|NCT02271984|75677702|FG006|COMPLETED|Washout Period 3 (7 Days)||3||
59573396|NCT02271984|75677703|FG007|COMPLETED|Washout Period 3 (7 Days)||3||
59573397|NCT02271984|75677704|FG008|COMPLETED|Washout Period 3 (7 Days)||3||
59573398|NCT02271984|75677705|FG009|COMPLETED|Washout Period 3 (7 Days)||3||
59573399|NCT02271984|75677706|FG010|COMPLETED|Washout Period 3 (7 Days)||3||
59573400|NCT02271984|75677707|FG011|COMPLETED|Washout Period 3 (7 Days)||3||
59573401|NCT02271984|75677696|FG000|NOT COMPLETED|Washout Period 3 (7 Days)||0||
59573402|NCT02271984|75677697|FG001|NOT COMPLETED|Washout Period 3 (7 Days)||0||
59573403|NCT02271984|75677698|FG002|NOT COMPLETED|Washout Period 3 (7 Days)||0||
59573404|NCT02271984|75677699|FG003|NOT COMPLETED|Washout Period 3 (7 Days)||0||
59573405|NCT02271984|75677700|FG004|NOT COMPLETED|Washout Period 3 (7 Days)||0||
59573406|NCT02271984|75677701|FG005|NOT COMPLETED|Washout Period 3 (7 Days)||0||
59573407|NCT02271984|75677702|FG006|NOT COMPLETED|Washout Period 3 (7 Days)||0||
59573408|NCT02271984|75677703|FG007|NOT COMPLETED|Washout Period 3 (7 Days)||0||
59573409|NCT02271984|75677704|FG008|NOT COMPLETED|Washout Period 3 (7 Days)||0||
59573410|NCT02271984|75677705|FG009|NOT COMPLETED|Washout Period 3 (7 Days)||0||
59573411|NCT02271984|75677706|FG010|NOT COMPLETED|Washout Period 3 (7 Days)||0||
59573412|NCT02271984|75677707|FG011|NOT COMPLETED|Washout Period 3 (7 Days)||0||
59573413|NCT02271984|75677696|FG000|STARTED|Fourth Intervention Period (Day 1)||3||
59573414|NCT02271984|75677697|FG001|STARTED|Fourth Intervention Period (Day 1)||3||
59573415|NCT02271984|75677698|FG002|STARTED|Fourth Intervention Period (Day 1)||3||
59573416|NCT02271984|75677699|FG003|STARTED|Fourth Intervention Period (Day 1)||3||
59573417|NCT02271984|75677700|FG004|STARTED|Fourth Intervention Period (Day 1)||3||
59573418|NCT02271984|75677701|FG005|STARTED|Fourth Intervention Period (Day 1)||3||
59573419|NCT02271984|75677702|FG006|STARTED|Fourth Intervention Period (Day 1)||3||
59573420|NCT02271984|75677703|FG007|STARTED|Fourth Intervention Period (Day 1)||3||
59573421|NCT02271984|75677704|FG008|STARTED|Fourth Intervention Period (Day 1)||3||
59573422|NCT02271984|75677705|FG009|STARTED|Fourth Intervention Period (Day 1)||3||
59573423|NCT02271984|75677706|FG010|STARTED|Fourth Intervention Period (Day 1)||3||
59573424|NCT02271984|75677707|FG011|STARTED|Fourth Intervention Period (Day 1)||3||
59573425|NCT02271984|75677696|FG000|COMPLETED|Fourth Intervention Period (Day 1)||3||
59573426|NCT02271984|75677697|FG001|COMPLETED|Fourth Intervention Period (Day 1)||3||
59573427|NCT02271984|75677698|FG002|COMPLETED|Fourth Intervention Period (Day 1)||3||
59573428|NCT02271984|75677699|FG003|COMPLETED|Fourth Intervention Period (Day 1)||3||
59573429|NCT02271984|75677700|FG004|COMPLETED|Fourth Intervention Period (Day 1)||3||
59573430|NCT02271984|75677701|FG005|COMPLETED|Fourth Intervention Period (Day 1)||3||
59573431|NCT02271984|75677702|FG006|COMPLETED|Fourth Intervention Period (Day 1)||3||
59573432|NCT02271984|75677703|FG007|COMPLETED|Fourth Intervention Period (Day 1)||3||
59573433|NCT02271984|75677704|FG008|COMPLETED|Fourth Intervention Period (Day 1)||3||
59573434|NCT02271984|75677705|FG009|COMPLETED|Fourth Intervention Period (Day 1)||3||
59573435|NCT02271984|75677706|FG010|COMPLETED|Fourth Intervention Period (Day 1)||3||
59573436|NCT02271984|75677707|FG011|COMPLETED|Fourth Intervention Period (Day 1)||3||
59573437|NCT02271984|75677696|FG000|NOT COMPLETED|Fourth Intervention Period (Day 1)||0||
59573438|NCT02271984|75677697|FG001|NOT COMPLETED|Fourth Intervention Period (Day 1)||0||
59573439|NCT02271984|75677698|FG002|NOT COMPLETED|Fourth Intervention Period (Day 1)||0||
59573440|NCT02271984|75677699|FG003|NOT COMPLETED|Fourth Intervention Period (Day 1)||0||
59573441|NCT02271984|75677700|FG004|NOT COMPLETED|Fourth Intervention Period (Day 1)||0||
59573442|NCT02271984|75677701|FG005|NOT COMPLETED|Fourth Intervention Period (Day 1)||0||
59573443|NCT02271984|75677702|FG006|NOT COMPLETED|Fourth Intervention Period (Day 1)||0||
59573444|NCT02271984|75677703|FG007|NOT COMPLETED|Fourth Intervention Period (Day 1)||0||
59573445|NCT02271984|75677704|FG008|NOT COMPLETED|Fourth Intervention Period (Day 1)||0||
59573446|NCT02271984|75677705|FG009|NOT COMPLETED|Fourth Intervention Period (Day 1)||0||
59573447|NCT02271984|75677706|FG010|NOT COMPLETED|Fourth Intervention Period (Day 1)||0||
59573448|NCT02271984|75677707|FG011|NOT COMPLETED|Fourth Intervention Period (Day 1)||0||
59573449|NCT02271984|75677696|FG000|STARTED|Washout Period 4 (7 Days)||3||
59573450|NCT02271984|75677697|FG001|STARTED|Washout Period 4 (7 Days)||3||
59573451|NCT02271984|75677698|FG002|STARTED|Washout Period 4 (7 Days)||3||
59573452|NCT02271984|75677699|FG003|STARTED|Washout Period 4 (7 Days)||3||
59573453|NCT02271984|75677700|FG004|STARTED|Washout Period 4 (7 Days)||3||
59573454|NCT02271984|75677701|FG005|STARTED|Washout Period 4 (7 Days)||3||
59573455|NCT02271984|75677702|FG006|STARTED|Washout Period 4 (7 Days)||3||
59573456|NCT02271984|75677703|FG007|STARTED|Washout Period 4 (7 Days)||3||
59573457|NCT02271984|75677704|FG008|STARTED|Washout Period 4 (7 Days)||3||
59573458|NCT02271984|75677705|FG009|STARTED|Washout Period 4 (7 Days)||3||
59573459|NCT02271984|75677706|FG010|STARTED|Washout Period 4 (7 Days)||3||
59573460|NCT02271984|75677707|FG011|STARTED|Washout Period 4 (7 Days)||3||
59573461|NCT02271984|75677696|FG000|COMPLETED|Washout Period 4 (7 Days)||3||
59573462|NCT02271984|75677697|FG001|COMPLETED|Washout Period 4 (7 Days)||3||
59573463|NCT02271984|75677698|FG002|COMPLETED|Washout Period 4 (7 Days)||3||
59573464|NCT02271984|75677699|FG003|COMPLETED|Washout Period 4 (7 Days)||3||
59573465|NCT02271984|75677700|FG004|COMPLETED|Washout Period 4 (7 Days)||3||
59573466|NCT02271984|75677701|FG005|COMPLETED|Washout Period 4 (7 Days)||2||
59573467|NCT02271984|75677702|FG006|COMPLETED|Washout Period 4 (7 Days)||3||
59573468|NCT02271984|75677703|FG007|COMPLETED|Washout Period 4 (7 Days)||2||
59573469|NCT02271984|75677704|FG008|COMPLETED|Washout Period 4 (7 Days)||3||
59573470|NCT02271984|75677705|FG009|COMPLETED|Washout Period 4 (7 Days)||3||
59573471|NCT02271984|75677706|FG010|COMPLETED|Washout Period 4 (7 Days)||3||
59573472|NCT02271984|75677707|FG011|COMPLETED|Washout Period 4 (7 Days)||3||
59573473|NCT02271984|75677696|FG000|NOT COMPLETED|Washout Period 4 (7 Days)||0||
59573474|NCT02271984|75677697|FG001|NOT COMPLETED|Washout Period 4 (7 Days)||0||
59573475|NCT02271984|75677698|FG002|NOT COMPLETED|Washout Period 4 (7 Days)||0||
59573476|NCT02271984|75677699|FG003|NOT COMPLETED|Washout Period 4 (7 Days)||0||
59573477|NCT02271984|75677700|FG004|NOT COMPLETED|Washout Period 4 (7 Days)||0||
59573478|NCT02271984|75677701|FG005|NOT COMPLETED|Washout Period 4 (7 Days)||1||
59573479|NCT02271984|75677702|FG006|NOT COMPLETED|Washout Period 4 (7 Days)||0||
59573480|NCT02271984|75677703|FG007|NOT COMPLETED|Washout Period 4 (7 Days)||1||
59573481|NCT02271984|75677704|FG008|NOT COMPLETED|Washout Period 4 (7 Days)||0||
59573482|NCT02271984|75677705|FG009|NOT COMPLETED|Washout Period 4 (7 Days)||0||
59573483|NCT02271984|75677706|FG010|NOT COMPLETED|Washout Period 4 (7 Days)||0||
59573484|NCT02271984|75677707|FG011|NOT COMPLETED|Washout Period 4 (7 Days)||0||
59573485|NCT02271984|75677696|FG000|STARTED|Fifth Intervention Period (1 Day)||3||
59573486|NCT02271984|75677697|FG001|STARTED|Fifth Intervention Period (1 Day)||3||
59573487|NCT02271984|75677698|FG002|STARTED|Fifth Intervention Period (1 Day)||3||
59573488|NCT02271984|75677699|FG003|STARTED|Fifth Intervention Period (1 Day)||3||
59573489|NCT02271984|75677700|FG004|STARTED|Fifth Intervention Period (1 Day)||3||
59573490|NCT02271984|75677701|FG005|STARTED|Fifth Intervention Period (1 Day)||2||
59573491|NCT02271984|75677702|FG006|STARTED|Fifth Intervention Period (1 Day)||3||
59573492|NCT02271984|75677703|FG007|STARTED|Fifth Intervention Period (1 Day)||2||
59573493|NCT02271984|75677704|FG008|STARTED|Fifth Intervention Period (1 Day)||3||
59573494|NCT02271984|75677705|FG009|STARTED|Fifth Intervention Period (1 Day)||3||
59573495|NCT02271984|75677706|FG010|STARTED|Fifth Intervention Period (1 Day)||3||
59573496|NCT02271984|75677707|FG011|STARTED|Fifth Intervention Period (1 Day)||3||
59573497|NCT02271984|75677696|FG000|COMPLETED|Fifth Intervention Period (1 Day)||3||
59573498|NCT02271984|75677697|FG001|COMPLETED|Fifth Intervention Period (1 Day)||3||
59573499|NCT02271984|75677698|FG002|COMPLETED|Fifth Intervention Period (1 Day)||3||
59573500|NCT02271984|75677699|FG003|COMPLETED|Fifth Intervention Period (1 Day)||3||
59573501|NCT02271984|75677700|FG004|COMPLETED|Fifth Intervention Period (1 Day)||3||
59573502|NCT02271984|75677701|FG005|COMPLETED|Fifth Intervention Period (1 Day)||2||
59573503|NCT02271984|75677702|FG006|COMPLETED|Fifth Intervention Period (1 Day)||3||
59573504|NCT02271984|75677703|FG007|COMPLETED|Fifth Intervention Period (1 Day)||2||
59573505|NCT02271984|75677704|FG008|COMPLETED|Fifth Intervention Period (1 Day)||3||
59573506|NCT02271984|75677705|FG009|COMPLETED|Fifth Intervention Period (1 Day)||3||
59573507|NCT02271984|75677706|FG010|COMPLETED|Fifth Intervention Period (1 Day)||3||
59573508|NCT02271984|75677707|FG011|COMPLETED|Fifth Intervention Period (1 Day)||3||
59573509|NCT02271984|75677696|FG000|NOT COMPLETED|Fifth Intervention Period (1 Day)||0||
59573510|NCT02271984|75677697|FG001|NOT COMPLETED|Fifth Intervention Period (1 Day)||0||
59573511|NCT02271984|75677698|FG002|NOT COMPLETED|Fifth Intervention Period (1 Day)||0||
59573512|NCT02271984|75677699|FG003|NOT COMPLETED|Fifth Intervention Period (1 Day)||0||
59573513|NCT02271984|75677700|FG004|NOT COMPLETED|Fifth Intervention Period (1 Day)||0||
59573514|NCT02271984|75677701|FG005|NOT COMPLETED|Fifth Intervention Period (1 Day)||0||
59573515|NCT02271984|75677702|FG006|NOT COMPLETED|Fifth Intervention Period (1 Day)||0||
59573516|NCT02271984|75677703|FG007|NOT COMPLETED|Fifth Intervention Period (1 Day)||0||
59573517|NCT02271984|75677704|FG008|NOT COMPLETED|Fifth Intervention Period (1 Day)||0||
59573518|NCT02271984|75677705|FG009|NOT COMPLETED|Fifth Intervention Period (1 Day)||0||
59573519|NCT02271984|75677706|FG010|NOT COMPLETED|Fifth Intervention Period (1 Day)||0||
59573520|NCT02271984|75677707|FG011|NOT COMPLETED|Fifth Intervention Period (1 Day)||0||
60121258|NCT02660788|76242151|FG001|COMPLETED|Overall Study||2749||
60121259|NCT02660788|76242150|FG000|NOT COMPLETED|Overall Study||0||
60121260|NCT02660788|76242151|FG001|NOT COMPLETED|Overall Study||0||
59573521|NCT02604173|75677725|FG000|STARTED|Overall Study||33||
59573522|NCT02604173|75677726|FG001|STARTED|Overall Study||35||
59573523|NCT02604173|75677727|FG002|STARTED|Overall Study||35||
59573524|NCT02604173|75677725|FG000|COMPLETED|Overall Study||33||
59573525|NCT02604173|75677726|FG001|COMPLETED|Overall Study||35||
59573526|NCT02604173|75677727|FG002|COMPLETED|Overall Study||35||
60121261|NCT01688921|76242159|FG000|STARTED|Overall Study||627||
59573527|NCT02604173|75677725|FG000|NOT COMPLETED|Overall Study||0||
59573528|NCT02604173|75677726|FG001|NOT COMPLETED|Overall Study||0||
59573529|NCT02604173|75677727|FG002|NOT COMPLETED|Overall Study||0||
59573530|NCT01841281|75677737|FG000|STARTED|First Intervention (12 Weeks)||11||
59573531|NCT01841281|75677738|FG001|STARTED|First Intervention (12 Weeks)||12||
59573532|NCT01841281|75677739|FG002|STARTED|First Intervention (12 Weeks)||13||
59573533|NCT01841281|75677740|FG003|STARTED|First Intervention (12 Weeks)||14||
59573534|NCT01841281|75677737|FG000|COMPLETED|First Intervention (12 Weeks)||11||
59573535|NCT01841281|75677738|FG001|COMPLETED|First Intervention (12 Weeks)||12||
59573536|NCT01841281|75677739|FG002|COMPLETED|First Intervention (12 Weeks)||13||
59573537|NCT01841281|75677740|FG003|COMPLETED|First Intervention (12 Weeks)||14||
59573538|NCT01841281|75677737|FG000|NOT COMPLETED|First Intervention (12 Weeks)||0||
59573539|NCT01841281|75677738|FG001|NOT COMPLETED|First Intervention (12 Weeks)||0||
59573540|NCT01841281|75677739|FG002|NOT COMPLETED|First Intervention (12 Weeks)||0||
59573541|NCT01841281|75677740|FG003|NOT COMPLETED|First Intervention (12 Weeks)||0||
59573542|NCT01841281|75677737|FG000|STARTED|Washout (6 Weeks)||11||
59573543|NCT01841281|75677738|FG001|STARTED|Washout (6 Weeks)||12||
59573544|NCT01841281|75677739|FG002|STARTED|Washout (6 Weeks)||13||
59573545|NCT01841281|75677740|FG003|STARTED|Washout (6 Weeks)||14||
59573546|NCT01841281|75677737|FG000|COMPLETED|Washout (6 Weeks)||9||
59573547|NCT01841281|75677738|FG001|COMPLETED|Washout (6 Weeks)||9||
59573548|NCT01841281|75677739|FG002|COMPLETED|Washout (6 Weeks)||10||
59573549|NCT01841281|75677740|FG003|COMPLETED|Washout (6 Weeks)||13||
59573550|NCT01841281|75677737|FG000|NOT COMPLETED|Washout (6 Weeks)||2||
59573551|NCT01841281|75677738|FG001|NOT COMPLETED|Washout (6 Weeks)||3||
59573552|NCT01841281|75677739|FG002|NOT COMPLETED|Washout (6 Weeks)||3||
59573553|NCT01841281|75677740|FG003|NOT COMPLETED|Washout (6 Weeks)||1||
59573554|NCT01841281|75677737|FG000|STARTED|Second Intervention (12 Weeks)||9||
59573555|NCT01841281|75677738|FG001|STARTED|Second Intervention (12 Weeks)||9||
59573556|NCT01841281|75677739|FG002|STARTED|Second Intervention (12 Weeks)||10||
59573557|NCT01841281|75677740|FG003|STARTED|Second Intervention (12 Weeks)||13||
59573558|NCT01841281|75677737|FG000|COMPLETED|Second Intervention (12 Weeks)||9||
59573559|NCT01841281|75677738|FG001|COMPLETED|Second Intervention (12 Weeks)||6||
59573560|NCT01841281|75677739|FG002|COMPLETED|Second Intervention (12 Weeks)||10||
59573561|NCT01841281|75677740|FG003|COMPLETED|Second Intervention (12 Weeks)||13||
59573562|NCT01841281|75677737|FG000|NOT COMPLETED|Second Intervention (12 Weeks)||0||
59573563|NCT01841281|75677738|FG001|NOT COMPLETED|Second Intervention (12 Weeks)||3||
59573564|NCT01841281|75677739|FG002|NOT COMPLETED|Second Intervention (12 Weeks)||0||
59573565|NCT01841281|75677740|FG003|NOT COMPLETED|Second Intervention (12 Weeks)||0||
59573566|NCT02287038|75677758|FG000|STARTED|Overall Study||23||
59573567|NCT02287038|75677759|FG001|STARTED|Overall Study||21||
59573568|NCT02287038|75677758|FG000|COMPLETED|Overall Study||18||
59573569|NCT02287038|75677759|FG001|COMPLETED|Overall Study||18||
59573570|NCT02287038|75677758|FG000|NOT COMPLETED|Overall Study||5||
59573571|NCT02287038|75677759|FG001|NOT COMPLETED|Overall Study||3||
59573572|NCT02286960|75677769|FG000|STARTED|Overall Study||19||
59573573|NCT02286960|75677770|FG001|STARTED|Overall Study||17||
59573574|NCT02286960|75677769|FG000|COMPLETED|Overall Study||16||
59573575|NCT02286960|75677770|FG001|COMPLETED|Overall Study||14||
59573576|NCT02286960|75677769|FG000|NOT COMPLETED|Overall Study||3||
59573577|NCT02286960|75677770|FG001|NOT COMPLETED|Overall Study||3||
59573578|NCT01842061|75677778|FG000|STARTED|Overall Study||13||
59573579|NCT01842061|75677779|FG001|STARTED|Overall Study||12||
59573580|NCT01842061|75677778|FG000|COMPLETED|Overall Study||12||
59573581|NCT01842061|75677779|FG001|COMPLETED|Overall Study||8||
59573582|NCT01842061|75677778|FG000|NOT COMPLETED|Overall Study||1||
59573583|NCT01842061|75677779|FG001|NOT COMPLETED|Overall Study||4||
59573584|NCT02286102|75677787|FG000|STARTED|Overall Study||36||
59573585|NCT02286102|75677788|FG001|STARTED|Overall Study||34||
59573586|NCT02286102|75677787|FG000|COMPLETED|Overall Study||35||
59573587|NCT02286102|75677788|FG001|COMPLETED|Overall Study||33||
59573588|NCT02286102|75677787|FG000|NOT COMPLETED|Overall Study||1||
59721312|NCT00864097|75840207|FG003|NOT COMPLETED|Overall Study||125||
59721313|NCT01183013|75840224|FG000|STARTED|Overall Study||131||
59721314|NCT01183013|75840225|FG001|STARTED|Overall Study||140||
59721315|NCT01183013|75840226|FG002|STARTED|Overall Study||138||
59573589|NCT02286102|75677788|FG001|NOT COMPLETED|Overall Study||1||
59573590|NCT02285166|75677794|FG000|STARTED|Overall Study||15330||
59721316|NCT01183013|75840227|FG003|STARTED|Overall Study||135||
59573591|NCT02285166|75677794|FG000|COMPLETED|Overall Study||14364||
59721317|NCT01183013|75840228|FG004|STARTED|Overall Study||126||
59721318|NCT01183013|75840229|FG005|STARTED|Overall Study||133||
59721319|NCT01183013|75840230|FG006|STARTED|Overall Study||133||
59721320|NCT01183013|75840224|FG000|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|86||
59573592|NCT02285166|75677794|FG000|NOT COMPLETED|Overall Study||966||
59573593|NCT01842841|75677800|FG000|STARTED|Overall Study||5||
59573594|NCT01842841|75677800|FG000|COMPLETED|Overall Study||5||
59573595|NCT01842841|75677800|FG000|NOT COMPLETED|Overall Study||0||
59573596|NCT02605187|75677808|FG000|STARTED|Overall Study||40||
59573597|NCT02605187|75677809|FG001|STARTED|Overall Study||21||
59573598|NCT02605187|75677810|FG002|STARTED|Overall Study||83||
59573599|NCT02605187|75677811|FG003|STARTED|Overall Study||16||
59573600|NCT02605187|75677808|FG000|COMPLETED|Overall Study||32||
59573601|NCT02605187|75677809|FG001|COMPLETED|Overall Study||19||
59573602|NCT02605187|75677810|FG002|COMPLETED|Overall Study||72||
59573603|NCT02605187|75677811|FG003|COMPLETED|Overall Study||15||
59573604|NCT02605187|75677808|FG000|NOT COMPLETED|Overall Study||8||
59573605|NCT02605187|75677809|FG001|NOT COMPLETED|Overall Study||2||
59573606|NCT02605187|75677810|FG002|NOT COMPLETED|Overall Study||11||
59573607|NCT02605187|75677811|FG003|NOT COMPLETED|Overall Study||1||
59573608|NCT02606903|75677823|FG000|STARTED|Overall Study||35||
59573609|NCT02606903|75677824|FG001|STARTED|Overall Study||36||
59573610|NCT02606903|75677823|FG000|COMPLETED|Overall Study||35||
59573611|NCT02606903|75677824|FG001|COMPLETED|Overall Study||36||
59573612|NCT02606903|75677823|FG000|NOT COMPLETED|Overall Study||0||
59573613|NCT02606903|75677824|FG001|NOT COMPLETED|Overall Study||0||
59573614|NCT01843465|75677830|FG000|STARTED|Overall Study|This study had no follow-up. It focused in the acute setting of cryoballoon ablation.|34||
59573615|NCT01843465|75677830|FG000|COMPLETED|Overall Study||34||
59573616|NCT01843465|75677830|FG000|NOT COMPLETED|Overall Study||0||
59573617|NCT01843621|75677834|FG000|STARTED|Overall Study||7||
59573618|NCT01843621|75677834|FG000|COMPLETED|Overall Study||7||
59573619|NCT01843621|75677834|FG000|NOT COMPLETED|Overall Study||0||
59573620|NCT02608229|75677848|FG000|STARTED|Overall Study||10||
59573621|NCT02608229|75677849|FG001|STARTED|Overall Study||8||
59573622|NCT02608229|75677848|FG000|600 mg BVD-523|Overall Study||10||
59573623|NCT02608229|75677849|FG001|600 mg BVD-523|Overall Study||2||
59573624|NCT02608229|75677848|FG000|450 mg BVD-523|Overall Study||0||
59573625|NCT02608229|75677849|FG001|450 mg BVD-523|Overall Study||6||
59573626|NCT02608229|75677848|FG000|COMPLETED|Overall Study||10||
59573627|NCT02608229|75677849|FG001|COMPLETED|Overall Study||8||
59573628|NCT02608229|75677848|FG000|NOT COMPLETED|Overall Study||0||
59573629|NCT02608229|75677849|FG001|NOT COMPLETED|Overall Study||0||
59573630|NCT00555061|75677857|FG000|STARTED|Overall Study|One participant did not receive study medication and was not included in the analysis population.|87||
59573631|NCT00555061|75677857|FG000|COMPLETED|Overall Study||78||
59573632|NCT00555061|75677857|FG000|NOT COMPLETED|Overall Study||9||
59573633|NCT01844479|75677861|FG000|STARTED|First Intervention up to 30 Minutes||14||
59573634|NCT01844479|75677862|FG001|STARTED|First Intervention up to 30 Minutes||13||
59573635|NCT01844479|75677861|FG000|COMPLETED|First Intervention up to 30 Minutes||14||
59573636|NCT01844479|75677862|FG001|COMPLETED|First Intervention up to 30 Minutes||13||
59573637|NCT01844479|75677861|FG000|NOT COMPLETED|First Intervention up to 30 Minutes||0||
59573638|NCT01844479|75677862|FG001|NOT COMPLETED|First Intervention up to 30 Minutes||0||
59573639|NCT01844479|75677861|FG000|STARTED|Second Intervention up to 30 Minutes||14||
59573640|NCT01844479|75677862|FG001|STARTED|Second Intervention up to 30 Minutes||13||
59573641|NCT01844479|75677861|FG000|COMPLETED|Second Intervention up to 30 Minutes||14||
59573642|NCT01844479|75677862|FG001|COMPLETED|Second Intervention up to 30 Minutes||13||
59573643|NCT01844479|75677861|FG000|NOT COMPLETED|Second Intervention up to 30 Minutes||0||
59573644|NCT01844479|75677862|FG001|NOT COMPLETED|Second Intervention up to 30 Minutes||0||
59573645|NCT01845103|75677869|FG000|STARTED|Overall Study||1||
59573646|NCT01845103|75677869|FG000|COMPLETED|Overall Study||1||
59573647|NCT01845103|75677869|FG000|NOT COMPLETED|Overall Study||0||
59573648|NCT01642212|75677875|FG000|STARTED|Single-blind Baseline||119||
59573649|NCT01642212|75677876|FG001|STARTED|Single-blind Baseline||0||
59573650|NCT01642212|75677877|FG002|STARTED|Single-blind Baseline||0||
59573651|NCT01642212|75677878|FG003|STARTED|Single-blind Baseline||0||
59573652|NCT01642212|75677879|FG004|STARTED|Single-blind Baseline||0||
59573653|NCT01642212|75677875|FG000|COMPLETED|Single-blind Baseline||93||
59573654|NCT01642212|75677876|FG001|COMPLETED|Single-blind Baseline||0||
59573655|NCT01642212|75677877|FG002|COMPLETED|Single-blind Baseline||0||
59573656|NCT01642212|75677878|FG003|COMPLETED|Single-blind Baseline||0||
59573657|NCT01642212|75677879|FG004|COMPLETED|Single-blind Baseline||0||
59573658|NCT01642212|75677875|FG000|NOT COMPLETED|Single-blind Baseline||26||
59573659|NCT01642212|75677876|FG001|NOT COMPLETED|Single-blind Baseline||0||
59573660|NCT01642212|75677877|FG002|NOT COMPLETED|Single-blind Baseline||0||
59573661|NCT01642212|75677878|FG003|NOT COMPLETED|Single-blind Baseline||0||
59573662|NCT01642212|75677879|FG004|NOT COMPLETED|Single-blind Baseline||0||
59573663|NCT01642212|75677875|FG000|STARTED|Double-blind Treatment||0||
59573664|NCT01642212|75677876|FG001|STARTED|Double-blind Treatment||42||
59721321|NCT01183013|75840225|FG001|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|101||
59850273|NCT02892448|75974602|FG001|NOT COMPLETED|Overall Study||2||
59573665|NCT01642212|75677877|FG002|STARTED|Double-blind Treatment||51||
59573666|NCT01642212|75677878|FG003|STARTED|Double-blind Treatment||0||
59573667|NCT01642212|75677879|FG004|STARTED|Double-blind Treatment||0||
59573668|NCT01642212|75677875|FG000|COMPLETED|Double-blind Treatment||0||
59573669|NCT01642212|75677876|FG001|COMPLETED|Double-blind Treatment||39||
59573670|NCT01642212|75677877|FG002|COMPLETED|Double-blind Treatment||49||
59573671|NCT01642212|75677878|FG003|COMPLETED|Double-blind Treatment||0||
59573672|NCT01642212|75677879|FG004|COMPLETED|Double-blind Treatment||0||
59573673|NCT01642212|75677875|FG000|NOT COMPLETED|Double-blind Treatment||0||
59721322|NCT01183013|75840226|FG002|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|97||
59721323|NCT01183013|75840227|FG003|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|105||
59721324|NCT01183013|75840228|FG004|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|90||
59721325|NCT01183013|75840229|FG005|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|88||
59721326|NCT01183013|75840230|FG006|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|96||
59721327|NCT01183013|75840224|FG000|NOT COMPLETED|Overall Study||45||
59721328|NCT01183013|75840225|FG001|NOT COMPLETED|Overall Study||39||
59721329|NCT01183013|75840226|FG002|NOT COMPLETED|Overall Study||41||
59721330|NCT01183013|75840227|FG003|NOT COMPLETED|Overall Study||30||
59721331|NCT01183013|75840228|FG004|NOT COMPLETED|Overall Study||36||
59721332|NCT01183013|75840229|FG005|NOT COMPLETED|Overall Study||45||
59721333|NCT01183013|75840230|FG006|NOT COMPLETED|Overall Study||37||
59721334|NCT05141500|75840247|FG000|STARTED|Overall Study||12||
59721335|NCT05141500|75840247|FG000|COMPLETED|Overall Study||12||
59721336|NCT05141500|75840247|FG000|NOT COMPLETED|Overall Study||0||
59721337|NCT01141283|75840254|FG000|STARTED|Overall Study||290||
59721338|NCT01141283|75840254|FG000|COMPLETED|Overall Study||202||
59721339|NCT01141283|75840254|FG000|NOT COMPLETED|Overall Study||88||
59721340|NCT00863707|75840260|FG000|STARTED|Overall Study||174||
59721341|NCT00863707|75840261|FG001|STARTED|Overall Study||337||
59721342|NCT00863707|75840260|FG000|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|170||
59721343|NCT00863707|75840261|FG001|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|334||
59721344|NCT00863707|75840260|FG000|NOT COMPLETED|Overall Study||4||
59721345|NCT00863707|75840261|FG001|NOT COMPLETED|Overall Study||3||
59721346|NCT01094184|75840269|FG000|STARTED|Overall Study||36||
59721347|NCT01094184|75840270|FG001|STARTED|Overall Study||13||
59721348|NCT01094184|75840269|FG000|COMPLETED|Overall Study||1||
59721349|NCT01094184|75840270|FG001|COMPLETED|Overall Study||2||
59721350|NCT01094184|75840269|FG000|NOT COMPLETED|Overall Study||35||
59721351|NCT01094184|75840270|FG001|NOT COMPLETED|Overall Study||11||
59721352|NCT01134731|75840279|FG000|STARTED|Overall Study||23||
59721353|NCT01134731|75840280|FG001|STARTED|Overall Study||21||
59721354|NCT01134731|75840281|FG002|STARTED|Overall Study||10||
59721355|NCT01134731|75840279|FG000|COMPLETED|Overall Study||10||
59721356|NCT01134731|75840280|FG001|COMPLETED|Overall Study||10||
59721357|NCT01134731|75840281|FG002|COMPLETED|Overall Study||2||
59721358|NCT01134731|75840279|FG000|NOT COMPLETED|Overall Study||13||
59721359|NCT01134731|75840280|FG001|NOT COMPLETED|Overall Study||11||
59721360|NCT01134731|75840281|FG002|NOT COMPLETED|Overall Study||8||
59721361|NCT01141205|75840292|FG000|STARTED|Overall Study||18||
59721362|NCT01141205|75840293|FG001|STARTED|Overall Study||5||
59721363|NCT01141205|75840292|FG000|COMPLETED|Overall Study||15||
59721364|NCT01141205|75840293|FG001|COMPLETED|Overall Study||3||
59721365|NCT01141205|75840292|FG000|NOT COMPLETED|Overall Study||3||
59721366|NCT01141205|75840293|FG001|NOT COMPLETED|Overall Study||2||
59721367|NCT01140503|75840303|FG000|STARTED|Overall Study||5||
59721368|NCT01140503|75840303|FG000|COMPLETED|Overall Study||4||
59721369|NCT01140503|75840303|FG000|NOT COMPLETED|Overall Study||1||
59721370|NCT00863317|75840309|FG000|STARTED|Overall Study||68||
59721371|NCT00863317|75840310|FG001|STARTED|Overall Study||73||
59721372|NCT00863317|75840309|FG000|COMPLETED|Overall Study||60||
59721373|NCT00863317|75840310|FG001|COMPLETED|Overall Study||64||
59721374|NCT00863317|75840309|FG000|NOT COMPLETED|Overall Study||8||
59721375|NCT00863317|75840310|FG001|NOT COMPLETED|Overall Study||9||
59721376|NCT01200368|75840319|FG000|STARTED|Infant Series||183||
59721377|NCT01200368|75840320|FG001|STARTED|Infant Series||184||
59573674|NCT01642212|75677876|FG001|NOT COMPLETED|Double-blind Treatment||3||
59573675|NCT01642212|75677877|FG002|NOT COMPLETED|Double-blind Treatment||2||
59573676|NCT01642212|75677878|FG003|NOT COMPLETED|Double-blind Treatment||0||
59573677|NCT01642212|75677879|FG004|NOT COMPLETED|Double-blind Treatment||0||
59573678|NCT01642212|75677875|FG000|STARTED|Open-label Extension||0||
59573679|NCT01642212|75677876|FG001|STARTED|Open-label Extension||0||
59573680|NCT01642212|75677877|FG002|STARTED|Open-label Extension||0||
59573681|NCT01642212|75677878|FG003|STARTED|Open-label Extension|Two participants completed double-blind treatment but did not enter the open-label extension.|37||
59573682|NCT01642212|75677879|FG004|STARTED|Open-label Extension|Four participants completed double-blind treatment but did not enter the open-label extension.|45||
59573683|NCT01642212|75677875|FG000|COMPLETED|Open-label Extension||0||
59573684|NCT01642212|75677876|FG001|COMPLETED|Open-label Extension||0||
59573685|NCT01642212|75677877|FG002|COMPLETED|Open-label Extension||0||
59573686|NCT01642212|75677878|FG003|COMPLETED|Open-label Extension||27||
59573687|NCT01642212|75677879|FG004|COMPLETED|Open-label Extension||37||
59721378|NCT01200368|75840321|FG002|STARTED|Infant Series||184||
59721379|NCT01200368|75840319|FG000|Vaccinated Dose 1|Infant Series||183||
59721380|NCT01200368|75840320|FG001|Vaccinated Dose 1|Infant Series||183||
59721381|NCT01200368|75840321|FG002|Vaccinated Dose 1|Infant Series||183||
59721382|NCT01200368|75840319|FG000|Vaccinated Dose 2|Infant Series||183||
59721383|NCT01200368|75840320|FG001|Vaccinated Dose 2|Infant Series||182||
59573688|NCT01642212|75677875|FG000|NOT COMPLETED|Open-label Extension||0||
59573689|NCT01642212|75677876|FG001|NOT COMPLETED|Open-label Extension||0||
59573690|NCT01642212|75677877|FG002|NOT COMPLETED|Open-label Extension||0||
59573691|NCT01642212|75677878|FG003|NOT COMPLETED|Open-label Extension||10||
59573692|NCT01642212|75677879|FG004|NOT COMPLETED|Open-label Extension||8||
59573693|NCT02608463|75677890|FG000|STARTED|Overall Study||10||
59573694|NCT02608463|75677891|FG001|STARTED|Overall Study||5||
59573695|NCT02608463|75677892|FG002|STARTED|Overall Study||0||
59573696|NCT02608463|75677893|FG003|STARTED|Overall Study|No study participants were enrolled in Part B.|0||
59573697|NCT02608463|75677890|FG000|COMPLETED|Overall Study||10||
59573698|NCT02608463|75677891|FG001|COMPLETED|Overall Study||5||
59573699|NCT02608463|75677892|FG002|COMPLETED|Overall Study||0||
59573700|NCT02608463|75677893|FG003|COMPLETED|Overall Study||0||
59573701|NCT02608463|75677890|FG000|NOT COMPLETED|Overall Study||0||
59573702|NCT02608463|75677891|FG001|NOT COMPLETED|Overall Study||0||
59573703|NCT02608463|75677892|FG002|NOT COMPLETED|Overall Study||0||
59573704|NCT02608463|75677893|FG003|NOT COMPLETED|Overall Study||0||
59573705|NCT00552175|75677904|FG000|STARTED|Overall Study||167||
59573706|NCT00552175|75677905|FG001|STARTED|Overall Study||86||
59573707|NCT00552175|75677906|FG002|STARTED|Overall Study||86||
59573708|NCT00552175|75677904|FG000|Full Analysis Set Population|Overall Study||167||
59573709|NCT00552175|75677905|FG001|Full Analysis Set Population|Overall Study||85||
59573710|NCT00552175|75677906|FG002|Full Analysis Set Population|Overall Study||86||
59573711|NCT00552175|75677904|FG000|COMPLETED|Overall Study||150||
59573712|NCT00552175|75677905|FG001|COMPLETED|Overall Study||73||
59573713|NCT00552175|75677906|FG002|COMPLETED|Overall Study||72||
59573714|NCT00552175|75677904|FG000|NOT COMPLETED|Overall Study||17||
59573715|NCT00552175|75677905|FG001|NOT COMPLETED|Overall Study||13||
59573716|NCT00552175|75677906|FG002|NOT COMPLETED|Overall Study||14||
59573717|NCT01644474|75677917|FG000|STARTED|Overall Study|Randomized|51||
59573718|NCT01644474|75677918|FG001|STARTED|Overall Study|Randomized|52||
59573719|NCT01644474|75677917|FG000|Treated|Overall Study||51||
59573720|NCT01644474|75677918|FG001|Treated|Overall Study||52||
59573721|NCT01644474|75677917|FG000|COMPLETED|Overall Study||44||
59573722|NCT01644474|75677918|FG001|COMPLETED|Overall Study||44||
59573723|NCT01644474|75677917|FG000|NOT COMPLETED|Overall Study||7||
59573724|NCT01644474|75677918|FG001|NOT COMPLETED|Overall Study||8||
59573725|NCT02614469|75677926|FG000|STARTED|Period 1||9||
59573726|NCT02614469|75677927|FG001|STARTED|Period 1||9||
59573727|NCT02614469|75677926|FG000|COMPLETED|Period 1||9||
59573728|NCT02614469|75677927|FG001|COMPLETED|Period 1||9||
59573729|NCT02614469|75677926|FG000|NOT COMPLETED|Period 1||0||
59573730|NCT02614469|75677927|FG001|NOT COMPLETED|Period 1||0||
59573731|NCT02614469|75677926|FG000|STARTED|Period 2||9||
59573732|NCT02614469|75677927|FG001|STARTED|Period 2||9||
59573733|NCT02614469|75677926|FG000|COMPLETED|Period 2||9||
59573734|NCT02614469|75677927|FG001|COMPLETED|Period 2||9||
59573735|NCT02614469|75677926|FG000|NOT COMPLETED|Period 2||0||
59573736|NCT02614469|75677927|FG001|NOT COMPLETED|Period 2||0||
59573737|NCT02615717|75677935|FG000|STARTED|Overall Study||3||
59573738|NCT02615717|75677936|FG001|STARTED|Overall Study||3||
59573739|NCT02615717|75677935|FG000|COMPLETED|Overall Study||3||
59573740|NCT02615717|75677936|FG001|COMPLETED|Overall Study||3||
59573741|NCT02615717|75677935|FG000|NOT COMPLETED|Overall Study||0||
59573742|NCT02615717|75677936|FG001|NOT COMPLETED|Overall Study||0||
59573743|NCT01847131|75677944|FG000|STARTED|Overall Study||25||
59573744|NCT01847131|75677945|FG001|STARTED|Overall Study||25||
59573745|NCT01847131|75677944|FG000|COMPLETED|Overall Study||25||
59573746|NCT01847131|75677945|FG001|COMPLETED|Overall Study||25||
59573747|NCT01847131|75677944|FG000|NOT COMPLETED|Overall Study||0||
59573748|NCT01847131|75677945|FG001|NOT COMPLETED|Overall Study||0||
59721384|NCT01200368|75840321|FG002|Vaccinated Dose 2|Infant Series||183||
59573749|NCT02285010|75677953|FG000|STARTED|Overall Study||63||
59573750|NCT02285010|75677954|FG001|STARTED|Overall Study||62||
59573751|NCT02285010|75677953|FG000|COMPLETED|Overall Study||58||
59573752|NCT02285010|75677954|FG001|COMPLETED|Overall Study||61||
59573753|NCT02285010|75677953|FG000|NOT COMPLETED|Overall Study||5||
59573754|NCT02285010|75677954|FG001|NOT COMPLETED|Overall Study||1||
59573755|NCT02617667|75677964|FG000|STARTED|Overall Study||51||
59573756|NCT02617667|75677965|FG001|STARTED|Overall Study||51||
59573757|NCT02617667|75677966|FG002|STARTED|Overall Study||52||
59573758|NCT02617667|75677967|FG003|STARTED|Overall Study||53||
59573759|NCT02617667|75677964|FG000|COMPLETED|Overall Study||50||
59573760|NCT02617667|75677965|FG001|COMPLETED|Overall Study||50||
59573761|NCT02617667|75677966|FG002|COMPLETED|Overall Study||48||
59573762|NCT02617667|75677967|FG003|COMPLETED|Overall Study||52||
59573763|NCT02617667|75677964|FG000|NOT COMPLETED|Overall Study||1||
59573764|NCT02617667|75677965|FG001|NOT COMPLETED|Overall Study||1||
59573765|NCT02617667|75677966|FG002|NOT COMPLETED|Overall Study||4||
59573766|NCT02617667|75677967|FG003|NOT COMPLETED|Overall Study||1||
59573767|NCT01848067|75677976|FG000|STARTED|Overall Study||9||
59573768|NCT01848067|75677976|FG000|COMPLETED|Overall Study||9||
59573769|NCT01848067|75677976|FG000|NOT COMPLETED|Overall Study||0||
59573770|NCT01848847|75677982|FG000|STARTED|Overall Study||51||
59573771|NCT01848847|75677983|FG001|STARTED|Overall Study||51||
59573772|NCT01848847|75677982|FG000|COMPLETED|Overall Study||49||
59573773|NCT01848847|75677983|FG001|COMPLETED|Overall Study||48||
59573774|NCT01848847|75677982|FG000|NOT COMPLETED|Overall Study||2||
59573775|NCT01848847|75677983|FG001|NOT COMPLETED|Overall Study||3||
59573776|NCT01850485|75677991|FG000|STARTED|Overall Study||9||
59573777|NCT01850485|75677992|FG001|STARTED|Overall Study||13||
59573778|NCT01850485|75677991|FG000|COMPLETED|Overall Study||9||
59573779|NCT01850485|75677992|FG001|COMPLETED|Overall Study||13||
59573780|NCT01850485|75677991|FG000|NOT COMPLETED|Overall Study||0||
59573781|NCT01850485|75677992|FG001|NOT COMPLETED|Overall Study||0||
59573782|NCT00551161|75677998|FG000|STARTED|Overall Study||12||
59573783|NCT00551161|75677998|FG000|COMPLETED|Overall Study||11||
59573784|NCT00551161|75677998|FG000|NOT COMPLETED|Overall Study||1||
59573785|NCT02277925|75678004|FG000|STARTED|Overall Study||102||
59573786|NCT02277925|75678005|FG001|STARTED|Overall Study||102||
59573787|NCT02277925|75678004|FG000|Surgery|Overall Study||99|Underwent sacral colpopexy|
59573788|NCT02277925|75678005|FG001|Surgery|Overall Study||101|Underwent sacral colpopexy|
59573789|NCT02277925|75678004|FG000|COMPLETED|Overall Study||95|1 year follow-up|
59573790|NCT02277925|75678005|FG001|COMPLETED|Overall Study||87|1 year follow-up|
59573791|NCT02277925|75678004|FG000|NOT COMPLETED|Overall Study||7||
59573792|NCT02277925|75678005|FG001|NOT COMPLETED|Overall Study||15||
59573793|NCT01851655|75678015|FG000|STARTED|Overall Study||12||
59573794|NCT01851655|75678016|FG001|STARTED|Overall Study||12||
59573795|NCT01851655|75678015|FG000|COMPLETED|Overall Study||12||
59573796|NCT01851655|75678016|FG001|COMPLETED|Overall Study||12||
59573797|NCT01851655|75678015|FG000|NOT COMPLETED|Overall Study||0||
59573798|NCT01851655|75678016|FG001|NOT COMPLETED|Overall Study||0||
59573799|NCT01852201|75678024|FG000|STARTED|Overall Study||21||
59573800|NCT01852201|75678025|FG001|STARTED|Overall Study||12||
59573801|NCT01852201|75678024|FG000|COMPLETED|Overall Study||21||
59573802|NCT01852201|75678025|FG001|COMPLETED|Overall Study||12||
59573803|NCT01852201|75678024|FG000|NOT COMPLETED|Overall Study||0||
59573804|NCT01852201|75678025|FG001|NOT COMPLETED|Overall Study||0||
59573805|NCT00550771|75678034|FG000|STARTED|Overall Study||121||
59573806|NCT00550771|75678035|FG001|STARTED|Overall Study||60||
59573807|NCT00550771|75678034|FG000|COMPLETED|Overall Study||104||
59573808|NCT00550771|75678035|FG001|COMPLETED|Overall Study||50||
59573809|NCT00550771|75678034|FG000|NOT COMPLETED|Overall Study||17||
59573810|NCT00550771|75678035|FG001|NOT COMPLETED|Overall Study||10||
59573811|NCT02278237|75678041|FG000|STARTED|Overall Study||90||
59573812|NCT02278237|75678041|FG000|COMPLETED|Overall Study||83||
59573813|NCT02278237|75678041|FG000|NOT COMPLETED|Overall Study||7||
59573814|NCT01852513|75678047|FG000|STARTED|Overall Study||20||
59573815|NCT01852513|75678048|FG001|STARTED|Overall Study||19||
59573816|NCT01852513|75678047|FG000|COMPLETED|Overall Study||20||
59573817|NCT01852513|75678048|FG001|COMPLETED|Overall Study||19||
59573818|NCT01852513|75678047|FG000|NOT COMPLETED|Overall Study||0||
59573819|NCT01852513|75678048|FG001|NOT COMPLETED|Overall Study||0||
59573820|NCT01852669|75678056|FG000|STARTED|Overall Study||71||
59573821|NCT01852669|75678057|FG001|STARTED|Overall Study||69||
59573822|NCT01852669|75678056|FG000|COMPLETED|Overall Study||71||
59573823|NCT01852669|75678057|FG001|COMPLETED|Overall Study|Randomisation error. Patient has protocol violation which necessitated exclusion from analysis|68||
59573824|NCT01852669|75678056|FG000|NOT COMPLETED|Overall Study||0||
59573825|NCT01852669|75678057|FG001|NOT COMPLETED|Overall Study||1||
59573826|NCT01853215|75678063|FG000|STARTED|Overall Study||24||
59573827|NCT01853215|75678063|FG000|COMPLETED|Overall Study||24||
59573828|NCT01853215|75678063|FG000|NOT COMPLETED|Overall Study||0||
59573829|NCT00550537|75678068|FG000|STARTED|Overall Study||116||
59573830|NCT00550537|75678068|FG000|COMPLETED|Overall Study||12||
59573831|NCT00550537|75678068|FG000|NOT COMPLETED|Overall Study||104||
59573832|NCT01853371|75678079|FG000|STARTED|Overall Study||10||
59573833|NCT01853371|75678080|FG001|STARTED|Overall Study||10||
59573834|NCT01853371|75678079|FG000|COMPLETED|Overall Study||10||
59573835|NCT01853371|75678080|FG001|COMPLETED|Overall Study||8||
59573836|NCT01853371|75678079|FG000|NOT COMPLETED|Overall Study||0||
59573837|NCT01853371|75678080|FG001|NOT COMPLETED|Overall Study||2||
59573838|NCT00550147|75678086|FG000|STARTED|OROS Methylphenidate Monotherapy||30||
59573839|NCT00550147|75678086|FG000|COMPLETED|OROS Methylphenidate Monotherapy||24||
59573840|NCT00550147|75678086|FG000|NOT COMPLETED|OROS Methylphenidate Monotherapy||6||
59573841|NCT00550147|75678086|FG000|STARTED|Quetiapine Addition Treatment Period||24||
59573842|NCT00550147|75678086|FG000|COMPLETED|Quetiapine Addition Treatment Period||18||
59573843|NCT00550147|75678086|FG000|NOT COMPLETED|Quetiapine Addition Treatment Period||6||
59573844|NCT01853605|75678103|FG000|STARTED|Overall Study||1939||
59573845|NCT01853605|75678104|FG001|STARTED|Overall Study||693||
59573846|NCT01853605|75678105|FG002|STARTED|Overall Study||751||
59573847|NCT01853605|75678106|FG003|STARTED|Overall Study||428||
59573848|NCT01853605|75678103|FG000|COMPLETED|Overall Study||1939||
59573849|NCT01853605|75678104|FG001|COMPLETED|Overall Study||693||
59573850|NCT01853605|75678105|FG002|COMPLETED|Overall Study||751||
59573851|NCT01853605|75678106|FG003|COMPLETED|Overall Study||428||
59573852|NCT01853605|75678103|FG000|NOT COMPLETED|Overall Study||0||
59573853|NCT01853605|75678104|FG001|NOT COMPLETED|Overall Study||0||
59573854|NCT01853605|75678105|FG002|NOT COMPLETED|Overall Study||0||
59573855|NCT01853605|75678106|FG003|NOT COMPLETED|Overall Study||0||
59573856|NCT01856491|75678116|FG000|STARTED|Overall Study||167||
59573857|NCT01856491|75678116|FG000|COMPLETED|Overall Study||152||
59573858|NCT01856491|75678116|FG000|NOT COMPLETED|Overall Study||15||
59573859|NCT02617901|75678120|FG000|STARTED|Overall Study||20||
59573860|NCT02617901|75678120|FG000|COMPLETED|Overall Study||20||
59573861|NCT02617901|75678120|FG000|NOT COMPLETED|Overall Study||0||
59573862|NCT04685213|75678126|FG000|STARTED|Overall Study||9||
59573863|NCT04685213|75678127|FG001|STARTED|Overall Study||10||
59573864|NCT04685213|75678126|FG000|COMPLETED|Overall Study||8||
59573865|NCT04685213|75678127|FG001|COMPLETED|Overall Study||8||
59573866|NCT04685213|75678126|FG000|NOT COMPLETED|Overall Study||1||
59573867|NCT04685213|75678127|FG001|NOT COMPLETED|Overall Study||2||
59573868|NCT02278783|75678135|FG000|STARTED|Overall Study||1||
59573869|NCT02278783|75678135|FG000|COMPLETED|Overall Study||1||
59573870|NCT02278783|75678135|FG000|NOT COMPLETED|Overall Study||0||
59573871|NCT02618915|75678141|FG000|STARTED|Overall Study||3||
59573872|NCT02618915|75678142|FG001|STARTED|Overall Study||3||
59573873|NCT02618915|75678141|FG000|COMPLETED|Overall Study||3||
59573874|NCT02618915|75678142|FG001|COMPLETED|Overall Study||3||
59573875|NCT02618915|75678141|FG000|NOT COMPLETED|Overall Study||0||
59573876|NCT02618915|75678142|FG001|NOT COMPLETED|Overall Study||0||
59573877|NCT02264353|75678150|FG000|STARTED|Overall Study||20||
59573878|NCT02264353|75678151|FG001|STARTED|Overall Study||24||
59573879|NCT02264353|75678150|FG000|COMPLETED|Overall Study||17||
59573880|NCT02264353|75678151|FG001|COMPLETED|Overall Study||24||
59573881|NCT02264353|75678150|FG000|NOT COMPLETED|Overall Study||3||
59573882|NCT02264353|75678151|FG001|NOT COMPLETED|Overall Study||0||
59573883|NCT02622191|75678159|FG000|STARTED|Overall Study||19||
59573884|NCT02622191|75678160|FG001|STARTED|Overall Study||14||
59573885|NCT02622191|75678159|FG000|COMPLETED|Overall Study||19||
59573886|NCT02622191|75678160|FG001|COMPLETED|Overall Study||14||
59573887|NCT02622191|75678159|FG000|NOT COMPLETED|Overall Study||0||
59573888|NCT02622191|75678160|FG001|NOT COMPLETED|Overall Study||0||
59573889|NCT02265913|75678170|FG000|STARTED|Overall Study||1357||
59573890|NCT02265913|75678171|FG001|STARTED|Overall Study||1361||
59573891|NCT02265913|75678172|FG002|STARTED|Overall Study||1358||
59573892|NCT02265913|75678170|FG000|COMPLETED|Overall Study||793||
59573893|NCT02265913|75678171|FG001|COMPLETED|Overall Study||810||
59573894|NCT02265913|75678172|FG002|COMPLETED|Overall Study||813||
59573895|NCT02265913|75678170|FG000|NOT COMPLETED|Overall Study||564||
59573896|NCT02265913|75678171|FG001|NOT COMPLETED|Overall Study||551||
59721385|NCT01200368|75840319|FG000|Vaccinated Dose 3|Infant Series||181||
59573897|NCT02265913|75678172|FG002|NOT COMPLETED|Overall Study||545||
59573898|NCT02624375|75678180|FG000|STARTED|Overall Study||10||
59573899|NCT02624375|75678180|FG000|COMPLETED|Overall Study||10||
59573900|NCT02624375|75678180|FG000|NOT COMPLETED|Overall Study||0||
59573901|NCT01858753|75678186|FG000|STARTED|Overall Study||5||
59573902|NCT01858753|75678187|FG001|STARTED|Overall Study||0||
59721386|NCT01200368|75840320|FG001|Vaccinated Dose 3|Infant Series||178||
59721387|NCT01200368|75840321|FG002|Vaccinated Dose 3|Infant Series||182||
59721388|NCT01200368|75840319|FG000|COMPLETED|Infant Series||180||
59573903|NCT01858753|75678186|FG000|COMPLETED|Overall Study||0||
59573904|NCT01858753|75678187|FG001|COMPLETED|Overall Study||0||
59573905|NCT01858753|75678186|FG000|NOT COMPLETED|Overall Study||5||
59721389|NCT01200368|75840320|FG001|COMPLETED|Infant Series||178||
59721390|NCT01200368|75840321|FG002|COMPLETED|Infant Series||178||
59573906|NCT01858753|75678187|FG001|NOT COMPLETED|Overall Study||0||
59573907|NCT02624843|75678196|FG000|STARTED|Overall Study||107||
59573908|NCT02624843|75678197|FG001|STARTED|Overall Study||108||
59573909|NCT02624843|75678198|FG002|STARTED|Overall Study||24||
59573910|NCT02624843|75678196|FG000|COMPLETED|Overall Study||70||
59721391|NCT01200368|75840319|FG000|NOT COMPLETED|Infant Series||3||
59850274|NCT02892448|75974603|FG002|NOT COMPLETED|Overall Study||1||
59573911|NCT02624843|75678197|FG001|COMPLETED|Overall Study||72||
59573912|NCT02624843|75678198|FG002|COMPLETED|Overall Study||16||
59573913|NCT02624843|75678196|FG000|NOT COMPLETED|Overall Study||37||
59573914|NCT02624843|75678197|FG001|NOT COMPLETED|Overall Study||36||
59573915|NCT02624843|75678198|FG002|NOT COMPLETED|Overall Study||8||
59573916|NCT02625545|75678206|FG000|STARTED|Overall Study||45||
59573917|NCT02625545|75678206|FG000|3 Month|Overall Study||45||
59573918|NCT02625545|75678206|FG000|6 Month|Overall Study||45||
59573919|NCT02625545|75678206|FG000|12 Month|Overall Study||45||
59573920|NCT02625545|75678206|FG000|COMPLETED|Overall Study||45||
59573921|NCT02625545|75678206|FG000|NOT COMPLETED|Overall Study||0||
59573922|NCT02279641|75678212|FG000|STARTED|Overall Study||6||
59573923|NCT02279641|75678213|FG001|STARTED|Overall Study||6||
59573924|NCT02279641|75678212|FG000|COMPLETED|Overall Study||6||
59573925|NCT02279641|75678213|FG001|COMPLETED|Overall Study||6||
59573926|NCT02279641|75678212|FG000|NOT COMPLETED|Overall Study||0||
59573927|NCT02279641|75678213|FG001|NOT COMPLETED|Overall Study||0||
59573928|NCT01859611|75678229|FG000|STARTED|Overall Study||51||
59573929|NCT01859611|75678229|FG000|COMPLETED|Overall Study||43||
59573930|NCT01859611|75678229|FG000|NOT COMPLETED|Overall Study||8||
59573931|NCT01862419|75678235|FG000|STARTED|Overall Study||1201||
59573932|NCT01862419|75678236|FG001|STARTED|Overall Study||1192||
59573933|NCT01862419|75678235|FG000|COMPLETED|Overall Study||1201||
59573934|NCT01862419|75678236|FG001|COMPLETED|Overall Study||1192||
59573935|NCT01862419|75678235|FG000|NOT COMPLETED|Overall Study||0||
59573936|NCT01862419|75678236|FG001|NOT COMPLETED|Overall Study||0||
59573937|NCT02629991|75678244|FG000|STARTED|Overall Study||11||
59573938|NCT02629991|75678245|FG001|STARTED|Overall Study||12||
59573939|NCT02629991|75678244|FG000|COMPLETED|Overall Study||10||
59573940|NCT02629991|75678245|FG001|COMPLETED|Overall Study||11||
59573941|NCT02629991|75678244|FG000|NOT COMPLETED|Overall Study||1||
59573942|NCT02629991|75678245|FG001|NOT COMPLETED|Overall Study||1||
59573943|NCT02633735|75678256|FG000|STARTED|Pre-implementation Phase||788||
59573944|NCT02633735|75678257|FG001|STARTED|Pre-implementation Phase||1011||
59573945|NCT02633735|75678256|FG000|COMPLETED|Pre-implementation Phase||788||
59573946|NCT02633735|75678257|FG001|COMPLETED|Pre-implementation Phase||1011||
59573947|NCT02633735|75678256|FG000|NOT COMPLETED|Pre-implementation Phase||0||
59573948|NCT02633735|75678257|FG001|NOT COMPLETED|Pre-implementation Phase||0||
59573949|NCT02633735|75678256|FG000|STARTED|Implementation Phase||1991||
59573950|NCT02633735|75678257|FG001|STARTED|Implementation Phase||2150||
59573951|NCT02633735|75678256|FG000|COMPLETED|Implementation Phase||1991||
59573952|NCT02633735|75678257|FG001|COMPLETED|Implementation Phase||2150||
59573953|NCT02633735|75678256|FG000|NOT COMPLETED|Implementation Phase||0||
59573954|NCT02633735|75678257|FG001|NOT COMPLETED|Implementation Phase||0||
59573955|NCT01866163|75678265|FG000|STARTED|Overall Study||323||
59573956|NCT01866163|75678266|FG001|STARTED|Overall Study||103||
59573957|NCT01866163|75678265|FG000|COMPLETED|Overall Study||313||
59573958|NCT01866163|75678266|FG001|COMPLETED|Overall Study||99||
59573959|NCT01866163|75678265|FG000|NOT COMPLETED|Overall Study||10||
59573960|NCT01866163|75678266|FG001|NOT COMPLETED|Overall Study||4||
59573961|NCT01866943|75678272|FG000|STARTED|Overall Study||19||
59573962|NCT01866943|75678273|FG001|STARTED|Overall Study||22||
59573963|NCT01866943|75678272|FG000|COMPLETED|Overall Study|Unknown - the only spreadsheet available is de-identified and blinded.|0||
59573964|NCT01866943|75678273|FG001|COMPLETED|Overall Study|Unknown - the only spreadsheet available is de-identified and blinded.|0||
59573965|NCT01866943|75678272|FG000|NOT COMPLETED|Overall Study||19||
59573966|NCT01866943|75678273|FG001|NOT COMPLETED|Overall Study||22||
59573967|NCT01868425|75678284|FG000|STARTED|Overall Study||55||
59573968|NCT01868425|75678285|FG001|STARTED|Overall Study||57||
59573969|NCT01868425|75678284|FG000|COMPLETED|Overall Study||55||
59573970|NCT01868425|75678285|FG001|COMPLETED|Overall Study||57||
59573971|NCT01868425|75678284|FG000|NOT COMPLETED|Overall Study||0||
59573972|NCT01868425|75678285|FG001|NOT COMPLETED|Overall Study||0||
59573973|NCT01869439|75678291|FG000|STARTED|Overall Study||40||
59573974|NCT01869439|75678291|FG000|COMPLETED|Overall Study||40||
59573975|NCT01869439|75678291|FG000|NOT COMPLETED|Overall Study||0||
59573976|NCT00550459|75678297|FG000|STARTED|Overall Study||28||
59573977|NCT00550459|75678298|FG001|STARTED|Overall Study||29||
59573978|NCT00550459|75678297|FG000|COMPLETED|Overall Study||27||
60121262|NCT01688921|76242160|FG001|STARTED|Overall Study||623||
59573979|NCT00550459|75678298|FG001|COMPLETED|Overall Study||26||
60121263|NCT01688921|76242159|FG000|COMPLETED|Overall Study||611||
59573980|NCT00550459|75678297|FG000|NOT COMPLETED|Overall Study||1||
59573981|NCT00550459|75678298|FG001|NOT COMPLETED|Overall Study||3||
59573982|NCT01871077|75678304|FG000|STARTED|Overall Study||30||60
59573983|NCT01871077|75678304|FG000|COMPLETED|Overall Study||30||60
59573984|NCT01871077|75678304|FG000|NOT COMPLETED|Overall Study||0||0
59573985|NCT01872325|75678310|FG000|STARTED|Overall Study||689||
59573986|NCT01872325|75678311|FG001|STARTED|Overall Study||387||
59573987|NCT01872325|75678310|FG000|COMPLETED|Overall Study||689||
59573988|NCT01872325|75678311|FG001|COMPLETED|Overall Study||387||
59573989|NCT01872325|75678310|FG000|NOT COMPLETED|Overall Study||0||
59573990|NCT01872325|75678311|FG001|NOT COMPLETED|Overall Study||0||
59573991|NCT01874119|75678317|FG000|STARTED|First Intervention (6 Days)||8||
59573992|NCT01874119|75678318|FG001|STARTED|First Intervention (6 Days)||5||
59573993|NCT01874119|75678317|FG000|COMPLETED|First Intervention (6 Days)||7||
59573994|NCT01874119|75678318|FG001|COMPLETED|First Intervention (6 Days)||5||
59573995|NCT01874119|75678317|FG000|NOT COMPLETED|First Intervention (6 Days)||1||
59573996|NCT01874119|75678318|FG001|NOT COMPLETED|First Intervention (6 Days)||0||
59573997|NCT01874119|75678317|FG000|STARTED|Washout (7 Days)||7||
59573998|NCT01874119|75678318|FG001|STARTED|Washout (7 Days)||5||
59573999|NCT01874119|75678317|FG000|COMPLETED|Washout (7 Days)||4||
59574000|NCT01874119|75678318|FG001|COMPLETED|Washout (7 Days)||3||
59574001|NCT01874119|75678317|FG000|NOT COMPLETED|Washout (7 Days)||3||
59574002|NCT01874119|75678318|FG001|NOT COMPLETED|Washout (7 Days)||2||
59574003|NCT01874119|75678317|FG000|STARTED|Second Intervention (6 Days)||4||
59574004|NCT01874119|75678318|FG001|STARTED|Second Intervention (6 Days)||3||
59574005|NCT01874119|75678317|FG000|COMPLETED|Second Intervention (6 Days)||4||
59574006|NCT01874119|75678318|FG001|COMPLETED|Second Intervention (6 Days)||3||
59574007|NCT01874119|75678317|FG000|NOT COMPLETED|Second Intervention (6 Days)||0||
59574008|NCT01874119|75678318|FG001|NOT COMPLETED|Second Intervention (6 Days)||0||
59574009|NCT02280655|75678326|FG000|STARTED|Overall Study||25||
59574010|NCT02280655|75678327|FG001|STARTED|Overall Study||18||
59574011|NCT02280655|75678326|FG000|COMPLETED|Overall Study||25||
59574012|NCT02280655|75678327|FG001|COMPLETED|Overall Study||18||
59574013|NCT02280655|75678326|FG000|NOT COMPLETED|Overall Study||0||
59574014|NCT02280655|75678327|FG001|NOT COMPLETED|Overall Study||0||
59574015|NCT02823145|75678333|FG000|STARTED|Enrollment||1||
59574016|NCT02823145|75678334|FG001|STARTED|Enrollment||374||
59574017|NCT02823145|75678333|FG000|COMPLETED|Enrollment||0||
59574018|NCT02823145|75678334|FG001|COMPLETED|Enrollment||374||
59574019|NCT02823145|75678333|FG000|NOT COMPLETED|Enrollment||1||
59574020|NCT02823145|75678334|FG001|NOT COMPLETED|Enrollment||0||
59574021|NCT02823145|75678333|FG000|STARTED|Treatment||0||
59574022|NCT02823145|75678334|FG001|STARTED|Treatment||374||
59574023|NCT02823145|75678333|FG000|COMPLETED|Treatment||0||
59574024|NCT02823145|75678334|FG001|COMPLETED|Treatment||49||
59574025|NCT02823145|75678333|FG000|NOT COMPLETED|Treatment||0||
59574026|NCT02823145|75678334|FG001|NOT COMPLETED|Treatment||325||
59574027|NCT02280811|75678343|FG000|STARTED|Drug Administration||1||
59574028|NCT02280811|75678344|FG001|STARTED|Drug Administration||2||
59574029|NCT02280811|75678345|FG002|STARTED|Drug Administration||1||
59574030|NCT02280811|75678346|FG003|STARTED|Drug Administration||6||
59574031|NCT02280811|75678347|FG004|STARTED|Drug Administration||2||
59574032|NCT02280811|75678343|FG000|COMPLETED|Drug Administration||1||
59574033|NCT02280811|75678344|FG001|COMPLETED|Drug Administration||2||
59574034|NCT02280811|75678345|FG002|COMPLETED|Drug Administration||1||
59574035|NCT02280811|75678346|FG003|COMPLETED|Drug Administration||6||
59574036|NCT02280811|75678347|FG004|COMPLETED|Drug Administration||2||
59574037|NCT02280811|75678343|FG000|NOT COMPLETED|Drug Administration||0||
59574038|NCT02280811|75678344|FG001|NOT COMPLETED|Drug Administration||0||
59574039|NCT02280811|75678345|FG002|NOT COMPLETED|Drug Administration||0||
59574040|NCT02280811|75678346|FG003|NOT COMPLETED|Drug Administration||0||
59574041|NCT02280811|75678347|FG004|NOT COMPLETED|Drug Administration||0||
59574042|NCT02280811|75678343|FG000|STARTED|Retreated at the MTD||0||
59574043|NCT02280811|75678344|FG001|STARTED|Retreated at the MTD||0||
59574044|NCT02280811|75678345|FG002|STARTED|Retreated at the MTD||0||
59574045|NCT02280811|75678346|FG003|STARTED|Retreated at the MTD||0||
59574046|NCT02280811|75678347|FG004|STARTED|Retreated at the MTD|Patient originally started in Grp1(HPV-16 E6mTCR PBL 1x10^9+HD IL-2) and was retreated at the MTD.|1||
59574047|NCT02280811|75678343|FG000|COMPLETED|Retreated at the MTD||0||
59574048|NCT02280811|75678344|FG001|COMPLETED|Retreated at the MTD||0||
59574049|NCT02280811|75678345|FG002|COMPLETED|Retreated at the MTD||0||
59574050|NCT02280811|75678346|FG003|COMPLETED|Retreated at the MTD||0||
59574051|NCT02280811|75678347|FG004|COMPLETED|Retreated at the MTD||1||
59574052|NCT02280811|75678343|FG000|NOT COMPLETED|Retreated at the MTD||0||
59574053|NCT02280811|75678344|FG001|NOT COMPLETED|Retreated at the MTD||0||
59574054|NCT02280811|75678345|FG002|NOT COMPLETED|Retreated at the MTD||0||
59574055|NCT02280811|75678346|FG003|NOT COMPLETED|Retreated at the MTD||0||
59574056|NCT02280811|75678347|FG004|NOT COMPLETED|Retreated at the MTD||0||
59574057|NCT02263963|75678363|FG000|STARTED|Overall Study||25||
59850275|NCT03585712|75974611|FG000|STARTED|Treatment Period 1||52||
59574058|NCT02263963|75678364|FG001|STARTED|Overall Study||25||
59574059|NCT02263963|75678363|FG000|COMPLETED|Overall Study||25||
59574060|NCT02263963|75678364|FG001|COMPLETED|Overall Study||25||
59574061|NCT02263963|75678363|FG000|NOT COMPLETED|Overall Study||0||
59574062|NCT02263963|75678364|FG001|NOT COMPLETED|Overall Study||0||
59574063|NCT01930435|75678376|FG000|STARTED|Overall Study||20||
59574064|NCT01930435|75678376|FG000|COMPLETED|Overall Study||20||
59574065|NCT01930435|75678376|FG000|NOT COMPLETED|Overall Study||0||
59574066|NCT01930747|75678384|FG000|STARTED|Overall Study||16||
59574067|NCT01930747|75678385|FG001|STARTED|Overall Study||14||
59574068|NCT01930747|75678386|FG002|STARTED|Overall Study||12||
59574069|NCT01930747|75678384|FG000|COMPLETED|Overall Study||16||
59574070|NCT01930747|75678385|FG001|COMPLETED|Overall Study||14||
59574071|NCT01930747|75678386|FG002|COMPLETED|Overall Study||12||
59574072|NCT01930747|75678384|FG000|NOT COMPLETED|Overall Study||0||
59574073|NCT01930747|75678385|FG001|NOT COMPLETED|Overall Study||0||
59574074|NCT01930747|75678386|FG002|NOT COMPLETED|Overall Study||0||
59574075|NCT01931527|75678396|FG000|STARTED|Overall Study||16||
59574076|NCT01931527|75678397|FG001|STARTED|Overall Study||15||
59574077|NCT01931527|75678396|FG000|COMPLETED|Overall Study||16||
59574078|NCT01931527|75678397|FG001|COMPLETED|Overall Study||15||
59574079|NCT01931527|75678396|FG000|NOT COMPLETED|Overall Study||0||
59574080|NCT01931527|75678397|FG001|NOT COMPLETED|Overall Study||0||
59574081|NCT01933243|75678409|FG000|STARTED|Overall Study||12||
59574082|NCT01933243|75678410|FG001|STARTED|Overall Study||12||
59574083|NCT01933243|75678409|FG000|COMPLETED|Overall Study||10||
59574084|NCT01933243|75678410|FG001|COMPLETED|Overall Study||8||
59574085|NCT01933243|75678409|FG000|NOT COMPLETED|Overall Study||2||
59574086|NCT01933243|75678410|FG001|NOT COMPLETED|Overall Study||4||
59574087|NCT01933399|75678419|FG000|STARTED|Overall Study||29||
59574088|NCT01933399|75678420|FG001|STARTED|Overall Study||32||
59574089|NCT01933399|75678421|FG002|STARTED|Overall Study||37||
59574090|NCT01933399|75678419|FG000|COMPLETED|Overall Study||29||
59574091|NCT01933399|75678420|FG001|COMPLETED|Overall Study||32||
59574092|NCT01933399|75678421|FG002|COMPLETED|Overall Study||37||
59574093|NCT01933399|75678419|FG000|NOT COMPLETED|Overall Study||0||
59574094|NCT01933399|75678420|FG001|NOT COMPLETED|Overall Study||0||
59574095|NCT01933399|75678421|FG002|NOT COMPLETED|Overall Study||0||
59574096|NCT02639351|75678434|FG000|STARTED|Overall Study||16||
59574097|NCT02639351|75678435|FG001|STARTED|Overall Study||16||
59574098|NCT02639351|75678436|FG002|STARTED|Overall Study||16||
59574099|NCT02639351|75678437|FG003|STARTED|Overall Study||16||
59574100|NCT02639351|75678438|FG004|STARTED|Overall Study||16||
59574101|NCT02639351|75678434|FG000|COMPLETED|Overall Study||16||
59574102|NCT02639351|75678435|FG001|COMPLETED|Overall Study||16||
59574103|NCT02639351|75678436|FG002|COMPLETED|Overall Study||16||
59574104|NCT02639351|75678437|FG003|COMPLETED|Overall Study||16||
59574105|NCT02639351|75678438|FG004|COMPLETED|Overall Study||16||
59574106|NCT02639351|75678434|FG000|NOT COMPLETED|Overall Study||0||
59574107|NCT02639351|75678435|FG001|NOT COMPLETED|Overall Study||0||
59574108|NCT02639351|75678436|FG002|NOT COMPLETED|Overall Study||0||
59574109|NCT02639351|75678437|FG003|NOT COMPLETED|Overall Study||0||
59574110|NCT02639351|75678438|FG004|NOT COMPLETED|Overall Study||0||
59574111|NCT02639429|75678454|FG000|STARTED|Overall Study||113||
59574112|NCT02639429|75678455|FG001|STARTED|Overall Study||123||
59574113|NCT02639429|75678454|FG000|COMPLETED|Overall Study||113||
59574114|NCT02639429|75678455|FG001|COMPLETED|Overall Study||123||
59574115|NCT02639429|75678454|FG000|NOT COMPLETED|Overall Study||0||
59574116|NCT02639429|75678455|FG001|NOT COMPLETED|Overall Study||0||
59574117|NCT01936363|75678463|FG000|STARTED|Overall Study||32||
59574118|NCT01936363|75678464|FG001|STARTED|Overall Study||33||
59574119|NCT01936363|75678463|FG000|COMPLETED|Overall Study||32||
59574120|NCT01936363|75678464|FG001|COMPLETED|Overall Study||33||
59574121|NCT01936363|75678463|FG000|NOT COMPLETED|Overall Study||0||
59574122|NCT01936363|75678464|FG001|NOT COMPLETED|Overall Study||0||
59574123|NCT01936519|75678472|FG000|STARTED|Overall Study||12||
59574124|NCT01936519|75678473|FG001|STARTED|Overall Study||12||
59574125|NCT01936519|75678472|FG000|COMPLETED|Overall Study||11||
59574126|NCT01936519|75678473|FG001|COMPLETED|Overall Study||8||
59574127|NCT01936519|75678472|FG000|NOT COMPLETED|Overall Study||1||
59574128|NCT01936519|75678473|FG001|NOT COMPLETED|Overall Study||4||
59574129|NCT01936909|75678485|FG000|STARTED|Overall Study||20||
59574130|NCT01936909|75678486|FG001|STARTED|Overall Study||20||
59574131|NCT01936909|75678487|FG002|STARTED|Overall Study||20||
59574132|NCT01936909|75678485|FG000|COMPLETED|Overall Study||10||
59574133|NCT01936909|75678486|FG001|COMPLETED|Overall Study||12||
59574134|NCT01936909|75678487|FG002|COMPLETED|Overall Study||14||
59574135|NCT01936909|75678485|FG000|NOT COMPLETED|Overall Study||10||
59721392|NCT01200368|75840320|FG001|NOT COMPLETED|Infant Series||6||
59574136|NCT01936909|75678486|FG001|NOT COMPLETED|Overall Study||8||
59574137|NCT01936909|75678487|FG002|NOT COMPLETED|Overall Study||6||
59574138|NCT01938079|75678497|FG000|STARTED|Overall Study||10||
59574139|NCT01938079|75678498|FG001|STARTED|Overall Study||10||
59574140|NCT01938079|75678497|FG000|COMPLETED|Overall Study||10||
59721393|NCT01200368|75840321|FG002|NOT COMPLETED|Infant Series||6||
59721394|NCT01200368|75840319|FG000|STARTED|After Infant Series||180||
59574141|NCT01938079|75678498|FG001|COMPLETED|Overall Study||10||
59574142|NCT01938079|75678497|FG000|NOT COMPLETED|Overall Study||0||
59574143|NCT01938079|75678498|FG001|NOT COMPLETED|Overall Study||0||
59574144|NCT02641067|75678506|FG000|STARTED|Overall Study||8||
59574145|NCT02641067|75678507|FG001|STARTED|Overall Study||8||
59574146|NCT02641067|75678506|FG000|COMPLETED|Overall Study||8||
59574147|NCT02641067|75678507|FG001|COMPLETED|Overall Study||8||
59574148|NCT02641067|75678506|FG000|NOT COMPLETED|Overall Study||0||
59574149|NCT02641067|75678507|FG001|NOT COMPLETED|Overall Study||0||
59574150|NCT01939405|75678515|FG000|STARTED|Overall Study||30||
59574151|NCT01939405|75678516|FG001|STARTED|Overall Study||30||
59721395|NCT01200368|75840320|FG001|STARTED|After Infant Series||178||
59574152|NCT01939405|75678515|FG000|COMPLETED|Overall Study||27||
59574153|NCT01939405|75678516|FG001|COMPLETED|Overall Study||28||
59574154|NCT01939405|75678515|FG000|NOT COMPLETED|Overall Study||3||
59574155|NCT01939405|75678516|FG001|NOT COMPLETED|Overall Study||2||
59574156|NCT02329015|75678524|FG000|STARTED|Overall Study||48||
59574157|NCT02329015|75678525|FG001|STARTED|Overall Study||64||
59574158|NCT02329015|75678524|FG000|COMPLETED|Overall Study||48||
59574159|NCT02329015|75678525|FG001|COMPLETED|Overall Study||64||
59574160|NCT02329015|75678524|FG000|NOT COMPLETED|Overall Study||0||
59574161|NCT02329015|75678525|FG001|NOT COMPLETED|Overall Study||0||
59574162|NCT02641691|75678531|FG000|STARTED|Overall Study||20||
59574163|NCT02641691|75678531|FG000|COMPLETED|Overall Study||20||
59574164|NCT02641691|75678531|FG000|NOT COMPLETED|Overall Study||0||
59574165|NCT02642237|75678543|FG000|STARTED|Overall Study||15||
59574166|NCT02642237|75678544|FG001|STARTED|Overall Study||15||
59574167|NCT02642237|75678543|FG000|COMPLETED|Overall Study||15||
59574168|NCT02642237|75678544|FG001|COMPLETED|Overall Study||15||
59574169|NCT02642237|75678543|FG000|NOT COMPLETED|Overall Study||0||
59574170|NCT02642237|75678544|FG001|NOT COMPLETED|Overall Study||0||
59574171|NCT01941745|75678554|FG000|STARTED|Overall Study||22||
59574172|NCT01941745|75678555|FG001|STARTED|Overall Study||22||
59574173|NCT01941745|75678556|FG002|STARTED|Overall Study||21||
59574174|NCT01941745|75678557|FG003|STARTED|Overall Study||23||
59574175|NCT01941745|75678554|FG000|COMPLETED|Overall Study||22||
59574176|NCT01941745|75678555|FG001|COMPLETED|Overall Study||22||
59574177|NCT01941745|75678556|FG002|COMPLETED|Overall Study||21||
59574178|NCT01941745|75678557|FG003|COMPLETED|Overall Study||23||
59574179|NCT01941745|75678554|FG000|NOT COMPLETED|Overall Study||0||
59574180|NCT01941745|75678555|FG001|NOT COMPLETED|Overall Study||0||
59574181|NCT01941745|75678556|FG002|NOT COMPLETED|Overall Study||0||
59574182|NCT01941745|75678557|FG003|NOT COMPLETED|Overall Study||0||
59574183|NCT01943227|75678572|FG000|STARTED|Overall Study||10||
59574184|NCT01943227|75678573|FG001|STARTED|Overall Study||10||
59574185|NCT01943227|75678572|FG000|COMPLETED|Overall Study||10||
59574186|NCT01943227|75678573|FG001|COMPLETED|Overall Study||10||
59574187|NCT01943227|75678572|FG000|NOT COMPLETED|Overall Study||0||
59574188|NCT01943227|75678573|FG001|NOT COMPLETED|Overall Study||0||
59574189|NCT02642393|75678581|FG000|STARTED|Overall Study||149||
59574190|NCT02642393|75678582|FG001|STARTED|Overall Study||149||
59574191|NCT02642393|75678581|FG000|COMPLETED|Overall Study|"Participants who completed the study:~On-drug: 31; In-person off-drug:13; By telephone off-drug: 6"|50||
59574192|NCT02642393|75678582|FG001|COMPLETED|Overall Study|"Participants who completed the study:~On-drug: 40; In-person off-drug: 16; By telephone off-drug: 1"|57||
59574193|NCT02642393|75678581|FG000|NOT COMPLETED|Overall Study||99||
59574194|NCT02642393|75678582|FG001|NOT COMPLETED|Overall Study||92||
59574195|NCT02642627|75678588|FG000|STARTED|Overall Study||42||
59721396|NCT01200368|75840321|FG002|STARTED|After Infant Series||178||
59721397|NCT01200368|75840319|FG000|COMPLETED|After Infant Series||162||
59721398|NCT01200368|75840320|FG001|COMPLETED|After Infant Series||162||
59574196|NCT02642627|75678588|FG000|COMPLETED|Overall Study||39||
59574197|NCT02642627|75678588|FG000|NOT COMPLETED|Overall Study||3||
59574198|NCT01643928|75678598|FG000|STARTED|Overall Study||58||
59574199|NCT01643928|75678599|FG001|STARTED|Overall Study||32||
59574200|NCT01643928|75678600|FG002|STARTED|Overall Study||33||
59574201|NCT01643928|75678601|FG003|STARTED|Overall Study||30||
59574202|NCT01643928|75678602|FG004|STARTED|Overall Study||30||
59574203|NCT01643928|75678598|FG000|COMPLETED|Overall Study||48||
59574204|NCT01643928|75678599|FG001|COMPLETED|Overall Study||30||
59721399|NCT01200368|75840321|FG002|COMPLETED|After Infant Series||169||
59574205|NCT01643928|75678600|FG002|COMPLETED|Overall Study||30||
59574206|NCT01643928|75678601|FG003|COMPLETED|Overall Study||27||
59721400|NCT01200368|75840319|FG000|NOT COMPLETED|After Infant Series||18||
59574207|NCT01643928|75678602|FG004|COMPLETED|Overall Study||28||
59574208|NCT01643928|75678598|FG000|NOT COMPLETED|Overall Study||10||
59574209|NCT01643928|75678599|FG001|NOT COMPLETED|Overall Study||2||
59574210|NCT01643928|75678600|FG002|NOT COMPLETED|Overall Study||3||
59721401|NCT01200368|75840320|FG001|NOT COMPLETED|After Infant Series||16||
59574211|NCT01643928|75678601|FG003|NOT COMPLETED|Overall Study||3||
59574212|NCT01643928|75678602|FG004|NOT COMPLETED|Overall Study||2||
59574213|NCT02303405|75678645|FG000|STARTED|Overall Study|Two subjects failed to provide any data after randomization, and were excluded from analyses.|15||
59574214|NCT02303405|75678646|FG001|STARTED|Overall Study||7||
59574215|NCT02303405|75678645|FG000|COMPLETED|Overall Study|Two subjects failed to provide data at 4 months; last observed data were carried forward.|15||
59574216|NCT02303405|75678646|FG001|COMPLETED|Overall Study||7||
59574217|NCT02303405|75678645|FG000|NOT COMPLETED|Overall Study||0||
59574218|NCT02303405|75678646|FG001|NOT COMPLETED|Overall Study||0||
59574219|NCT01943461|75678656|FG000|STARTED|Overall Study||5||
59574220|NCT01943461|75678657|FG001|STARTED|Overall Study||6||
59574221|NCT01943461|75678658|FG002|STARTED|Overall Study||6||
59574222|NCT01943461|75678659|FG003|STARTED|Overall Study||40||
59574223|NCT01943461|75678656|FG000|COMPLETED|Overall Study||5||
59574224|NCT01943461|75678657|FG001|COMPLETED|Overall Study||6||
59574225|NCT01943461|75678658|FG002|COMPLETED|Overall Study||6||
59721402|NCT01200368|75840321|FG002|NOT COMPLETED|After Infant Series||9||
59574226|NCT01943461|75678659|FG003|COMPLETED|Overall Study||40||
59574227|NCT01943461|75678656|FG000|NOT COMPLETED|Overall Study||0||
59574228|NCT01943461|75678657|FG001|NOT COMPLETED|Overall Study||0||
59574229|NCT01943461|75678658|FG002|NOT COMPLETED|Overall Study||0||
59574230|NCT01943461|75678659|FG003|NOT COMPLETED|Overall Study||0||
59574231|NCT02643875|75678669|FG000|STARTED|Overall Study||36||72
59574232|NCT02643875|75678669|FG000|Received 0.75|Overall Study||36||36
59574233|NCT02643875|75678669|FG000|Received 1.75 D|Overall Study||36||36
59574234|NCT02643875|75678669|FG000|COMPLETED|Overall Study||28||56
59574235|NCT02643875|75678669|FG000|NOT COMPLETED|Overall Study||8||16
59574236|NCT02645123|75678677|FG000|STARTED|Overall Study||25||
59574237|NCT02645123|75678678|FG001|STARTED|Overall Study||25||
59574238|NCT02645123|75678679|FG002|STARTED|Overall Study||25||
59574239|NCT02645123|75678677|FG000|COMPLETED|Overall Study||25||
59574240|NCT02645123|75678678|FG001|COMPLETED|Overall Study||25||
59574241|NCT02645123|75678679|FG002|COMPLETED|Overall Study||25||
59574242|NCT02645123|75678677|FG000|NOT COMPLETED|Overall Study||0||
59574243|NCT02645123|75678678|FG001|NOT COMPLETED|Overall Study||0||
59574244|NCT02645123|75678679|FG002|NOT COMPLETED|Overall Study||0||
59574245|NCT02646371|75678689|FG000|STARTED|Overall Study||34||
59574246|NCT02646371|75678690|FG001|STARTED|Overall Study||33||
59574247|NCT02646371|75678689|FG000|COMPLETED|Overall Study||34||
59574248|NCT02646371|75678690|FG001|COMPLETED|Overall Study||33||
59574249|NCT02646371|75678689|FG000|NOT COMPLETED|Overall Study||0||
59574250|NCT02646371|75678690|FG001|NOT COMPLETED|Overall Study||0||
59574251|NCT02646449|75678698|FG000|STARTED|Overall Study||4||
59574252|NCT02646449|75678699|FG001|STARTED|Overall Study||3||
59574253|NCT02646449|75678698|FG000|COMPLETED|Overall Study||4||
59574254|NCT02646449|75678699|FG001|COMPLETED|Overall Study||3||
59574255|NCT02646449|75678698|FG000|NOT COMPLETED|Overall Study||0||
59574256|NCT02646449|75678699|FG001|NOT COMPLETED|Overall Study||0||
59574257|NCT02646761|75678707|FG000|STARTED|Overall Study||18||
59574258|NCT02646761|75678708|FG001|STARTED|Overall Study||20||
59574259|NCT02646761|75678707|FG000|Subject Withdrew Before Baseline|Overall Study||5||
59574260|NCT02646761|75678708|FG001|Subject Withdrew Before Baseline|Overall Study||8||
59574261|NCT02646761|75678707|FG000|Baseline Assessment|Overall Study||13||
59574262|NCT02646761|75678708|FG001|Baseline Assessment|Overall Study||12||
59574263|NCT02646761|75678707|FG000|5-week Assessment|Overall Study||12||
59574264|NCT02646761|75678708|FG001|5-week Assessment|Overall Study||10||
59574265|NCT02646761|75678707|FG000|COMPLETED|Overall Study||10||
59574266|NCT02646761|75678708|FG001|COMPLETED|Overall Study||10||
59574267|NCT02646761|75678707|FG000|NOT COMPLETED|Overall Study||8||
59574268|NCT02646761|75678708|FG001|NOT COMPLETED|Overall Study||10||
59574269|NCT02646917|75678716|FG000|STARTED|Overall Study||21||
59574270|NCT02646917|75678717|FG001|STARTED|Overall Study||20||
59574271|NCT02646917|75678716|FG000|COMPLETED|Overall Study||21||
59574272|NCT02646917|75678717|FG001|COMPLETED|Overall Study||20||
59574273|NCT02646917|75678716|FG000|NOT COMPLETED|Overall Study||0||
59721403|NCT01200368|75840319|FG000|STARTED|Toddler Dose||162||
59721404|NCT01200368|75840320|FG001|STARTED|Toddler Dose||162||
59721405|NCT01200368|75840321|FG002|STARTED|Toddler Dose||169||
59721406|NCT01200368|75840319|FG000|COMPLETED|Toddler Dose||162||
59721407|NCT01200368|75840320|FG001|COMPLETED|Toddler Dose||159||
59574274|NCT02646917|75678717|FG001|NOT COMPLETED|Overall Study||0||
59574275|NCT02650193|75678731|FG000|STARTED|Overall Study||6||
59574276|NCT02650193|75678732|FG001|STARTED|Overall Study||6||
59574277|NCT02650193|75678733|FG002|STARTED|Overall Study||13||
59574278|NCT02650193|75678731|FG000|COMPLETED|Overall Study||6||
59574279|NCT02650193|75678732|FG001|COMPLETED|Overall Study||6||
59574280|NCT02650193|75678733|FG002|COMPLETED|Overall Study||13||
59574281|NCT02650193|75678731|FG000|NOT COMPLETED|Overall Study||0||
59574282|NCT02650193|75678732|FG001|NOT COMPLETED|Overall Study||0||
59574283|NCT02650193|75678733|FG002|NOT COMPLETED|Overall Study||0||
59574284|NCT02652221|75678742|FG000|STARTED|Overall Study||55||
59574285|NCT02652221|75678742|FG000|COMPLETED|Overall Study||55||
59574286|NCT02652221|75678742|FG000|NOT COMPLETED|Overall Study||0||
59574287|NCT02653391|75678750|FG000|STARTED|Overall Study||18||36
59574288|NCT02653391|75678751|FG001|STARTED|Overall Study||3||6
59574289|NCT02653391|75678752|FG002|STARTED|Overall Study||1||2
59574290|NCT02653391|75678750|FG000|COMPLETED|Overall Study||16||32
59574291|NCT02653391|75678751|FG001|COMPLETED|Overall Study||1||2
59574292|NCT02653391|75678752|FG002|COMPLETED|Overall Study||1||2
59574293|NCT02653391|75678750|FG000|NOT COMPLETED|Overall Study||2||4
59574294|NCT02653391|75678751|FG001|NOT COMPLETED|Overall Study||2||4
59574295|NCT02653391|75678752|FG002|NOT COMPLETED|Overall Study||0||0
59574296|NCT02654483|75678798|FG000|STARTED|Double-blind||7||
59574297|NCT02654483|75678799|FG001|STARTED|Double-blind||7||
59574298|NCT02654483|75678798|FG000|COMPLETED|Double-blind||7||
59574299|NCT02654483|75678799|FG001|COMPLETED|Double-blind||7||
59574300|NCT02654483|75678798|FG000|NOT COMPLETED|Double-blind||0||
59574301|NCT02654483|75678799|FG001|NOT COMPLETED|Double-blind||0||
59574302|NCT02654483|75678798|FG000|STARTED|Open-label|2 participants did not proceed to open-label arm|5|6 participants in total did not continue to the open-label period|
59721408|NCT01200368|75840321|FG002|COMPLETED|Toddler Dose||168||
59574303|NCT02654483|75678799|FG001|STARTED|Open-label|4 participants did not continue to open-label arm|3|6 participants in total did not continue to the open-label period|
59574304|NCT02654483|75678798|FG000|COMPLETED|Open-label||5||
59574305|NCT02654483|75678799|FG001|COMPLETED|Open-label||3||
59574306|NCT02654483|75678798|FG000|NOT COMPLETED|Open-label||0||
59574307|NCT02654483|75678799|FG001|NOT COMPLETED|Open-label||0||
59574308|NCT03237845|75678813|FG000|STARTED|Overall Study||594|Randomized|
59574309|NCT03237845|75678814|FG001|STARTED|Overall Study||592|Randomized|
59574310|NCT03237845|75678813|FG000|Treated|Overall Study||543||
59574311|NCT03237845|75678814|FG001|Treated|Overall Study||543||
59574312|NCT03237845|75678813|FG000|COMPLETED|Overall Study||538||
59574313|NCT03237845|75678814|FG001|COMPLETED|Overall Study||542||
59574314|NCT03237845|75678813|FG000|NOT COMPLETED|Overall Study||56||
59574315|NCT03237845|75678814|FG001|NOT COMPLETED|Overall Study||50||
59574316|NCT02655653|75678822|FG000|STARTED|Overall Study||56||
59574317|NCT02655653|75678823|FG001|STARTED|Overall Study||58||
59574318|NCT02655653|75678822|FG000|COMPLETED|Overall Study||56||
59574319|NCT02655653|75678823|FG001|COMPLETED|Overall Study||58||
59574320|NCT02655653|75678822|FG000|NOT COMPLETED|Overall Study||0||
59574321|NCT02655653|75678823|FG001|NOT COMPLETED|Overall Study||0||
59574322|NCT02656745|75678835|FG000|STARTED|Overall Study||416||
59574323|NCT02656745|75678835|FG000|COMPLETED|Overall Study||416||
59574324|NCT02656745|75678835|FG000|NOT COMPLETED|Overall Study||0||
59574325|NCT02657915|75678844|FG000|STARTED|Overall Study||24||
59574326|NCT02657915|75678845|FG001|STARTED|Overall Study||28||
59574327|NCT02657915|75678844|FG000|Intent-to Treat (ITT) Population|Overall Study||24||
59574328|NCT02657915|75678845|FG001|Intent-to Treat (ITT) Population|Overall Study||28||
59574329|NCT02657915|75678844|FG000|Per-protocol Population|Overall Study||23||
59574330|NCT02657915|75678845|FG001|Per-protocol Population|Overall Study||24||
59574331|NCT02657915|75678844|FG000|COMPLETED|Overall Study||24||
59574332|NCT02657915|75678845|FG001|COMPLETED|Overall Study||28||
59574333|NCT02657915|75678844|FG000|NOT COMPLETED|Overall Study||0||
59574334|NCT02657915|75678845|FG001|NOT COMPLETED|Overall Study||0||
59574335|NCT02658461|75678854|FG000|STARTED|Overall Study|The enrollment reflects episodes of care and not number of actual participants.|12||
59574336|NCT02658461|75678855|FG001|STARTED|Overall Study|The enrollment reflects episodes of care and not number of actual participants.|12||
59574337|NCT02658461|75678856|FG002|STARTED|Overall Study|The enrollment reflects episodes of care and not number of actual participants.|12||
59574338|NCT02658461|75678854|FG000|COMPLETED|Overall Study||12||
59574339|NCT02658461|75678855|FG001|COMPLETED|Overall Study||12||
59574340|NCT02658461|75678856|FG002|COMPLETED|Overall Study||12||
59574341|NCT02658461|75678854|FG000|NOT COMPLETED|Overall Study||0||
59574342|NCT02658461|75678855|FG001|NOT COMPLETED|Overall Study||0||
59574343|NCT02658461|75678856|FG002|NOT COMPLETED|Overall Study||0||
59574344|NCT02658851|75678866|FG000|STARTED|Overall Study||100||
59574345|NCT02658851|75678866|FG000|COMPLETED|Overall Study||100||
59574346|NCT02658851|75678866|FG000|NOT COMPLETED|Overall Study||0||
59574347|NCT02659709|75678870|FG000|STARTED|Overall Study||50||
59574348|NCT02659709|75678870|FG000|COMPLETED|Overall Study||50||
59574349|NCT02659709|75678870|FG000|NOT COMPLETED|Overall Study||0||
59574350|NCT02659787|75678874|FG000|STARTED|First Intervention (1 Day)||19||
59574351|NCT02659787|75678875|FG001|STARTED|First Intervention (1 Day)||19||
59574352|NCT02659787|75678874|FG000|COMPLETED|First Intervention (1 Day)||19||
59574353|NCT02659787|75678875|FG001|COMPLETED|First Intervention (1 Day)||19||
59574354|NCT02659787|75678874|FG000|NOT COMPLETED|First Intervention (1 Day)||0||
59574355|NCT02659787|75678875|FG001|NOT COMPLETED|First Intervention (1 Day)||0||
59574356|NCT02659787|75678874|FG000|STARTED|Washout (3 Days)||19||
59574357|NCT02659787|75678875|FG001|STARTED|Washout (3 Days)||19||
59574358|NCT02659787|75678874|FG000|COMPLETED|Washout (3 Days)||19||
59574359|NCT02659787|75678875|FG001|COMPLETED|Washout (3 Days)||19||
59574360|NCT02659787|75678874|FG000|NOT COMPLETED|Washout (3 Days)||0||
59574361|NCT02659787|75678875|FG001|NOT COMPLETED|Washout (3 Days)||0||
59721409|NCT01200368|75840319|FG000|NOT COMPLETED|Toddler Dose||0||
59721410|NCT01200368|75840320|FG001|NOT COMPLETED|Toddler Dose||3||
59574362|NCT02659787|75678874|FG000|STARTED|Second Intervention (1 Day)||19||
59574363|NCT02659787|75678875|FG001|STARTED|Second Intervention (1 Day)||19||
59574364|NCT02659787|75678874|FG000|COMPLETED|Second Intervention (1 Day)||19||
59574365|NCT02659787|75678875|FG001|COMPLETED|Second Intervention (1 Day)||19||
59721411|NCT01200368|75840321|FG002|NOT COMPLETED|Toddler Dose||1||
59721412|NCT01079130|75840342|FG000|STARTED|Overall Study||85||
59574366|NCT02659787|75678874|FG000|NOT COMPLETED|Second Intervention (1 Day)||0||
59574367|NCT02659787|75678875|FG001|NOT COMPLETED|Second Intervention (1 Day)||0||
59574368|NCT02660801|75678881|FG000|STARTED|Overall Study||11||
59574369|NCT02660801|75678882|FG001|STARTED|Overall Study||15||
59574370|NCT02660801|75678881|FG000|COMPLETED|Overall Study||11||
59574371|NCT02660801|75678882|FG001|COMPLETED|Overall Study||15||
59574372|NCT02660801|75678881|FG000|NOT COMPLETED|Overall Study||0||
59574373|NCT02660801|75678882|FG001|NOT COMPLETED|Overall Study||0||
59574374|NCT02661737|75678888|FG000|STARTED|Overall Study||503||
59574375|NCT02661737|75678888|FG000|COMPLETED|Overall Study||469||
59574376|NCT02661737|75678888|FG000|NOT COMPLETED|Overall Study||34||
59574377|NCT01643850|75678901|FG000|STARTED|Overall Study||5||
59574378|NCT01643850|75678902|FG001|STARTED|Overall Study||2||
59574379|NCT01643850|75678903|FG002|STARTED|Overall Study||8||
59574380|NCT01643850|75678904|FG003|STARTED|Overall Study||3||
59574381|NCT01643850|75678905|FG004|STARTED|Overall Study||3||
59574382|NCT01643850|75678906|FG005|STARTED|Overall Study||3||
59574383|NCT01643850|75678907|FG006|STARTED|Overall Study||4||
59574384|NCT01643850|75678908|FG007|STARTED|Overall Study||4||
59574385|NCT01643850|75678909|FG008|STARTED|Overall Study||4||
59574386|NCT01643850|75678901|FG000|COMPLETED|Overall Study||5||
59574387|NCT01643850|75678902|FG001|COMPLETED|Overall Study||2||
59574388|NCT01643850|75678903|FG002|COMPLETED|Overall Study||7||
59574389|NCT01643850|75678904|FG003|COMPLETED|Overall Study||3||
59574390|NCT01643850|75678905|FG004|COMPLETED|Overall Study||0||
59574391|NCT01643850|75678906|FG005|COMPLETED|Overall Study||3||
59574392|NCT01643850|75678907|FG006|COMPLETED|Overall Study||3||
59574393|NCT01643850|75678908|FG007|COMPLETED|Overall Study||4||
59574394|NCT01643850|75678909|FG008|COMPLETED|Overall Study||3||
59574395|NCT01643850|75678901|FG000|NOT COMPLETED|Overall Study||0||
59574396|NCT01643850|75678902|FG001|NOT COMPLETED|Overall Study||0||
59574397|NCT01643850|75678903|FG002|NOT COMPLETED|Overall Study||1||
59574398|NCT01643850|75678904|FG003|NOT COMPLETED|Overall Study||0||
59574399|NCT01643850|75678905|FG004|NOT COMPLETED|Overall Study||3||
59574400|NCT01643850|75678906|FG005|NOT COMPLETED|Overall Study||0||
59574401|NCT01643850|75678907|FG006|NOT COMPLETED|Overall Study||1||
59574402|NCT01643850|75678908|FG007|NOT COMPLETED|Overall Study||0||
59574403|NCT01643850|75678909|FG008|NOT COMPLETED|Overall Study||1||
59574404|NCT02271594|75678977|FG000|STARTED|Overall Study||19||
59574405|NCT02271594|75678978|FG001|STARTED|Overall Study||12||
59574406|NCT02271594|75678977|FG000|COMPLETED|Overall Study|Study closed down|0||
59574407|NCT02271594|75678978|FG001|COMPLETED|Overall Study|Study closed down|0||
59574408|NCT02271594|75678977|FG000|NOT COMPLETED|Overall Study||19||
59574409|NCT02271594|75678978|FG001|NOT COMPLETED|Overall Study||12||
59574410|NCT02664311|75678988|FG000|STARTED|Overall Study||6||
59574411|NCT02664311|75678989|FG001|STARTED|Overall Study||3||
59574412|NCT02664311|75678988|FG000|COMPLETED|Overall Study||6|Insufficient faculty interest to recruit patients|
59574413|NCT02664311|75678989|FG001|COMPLETED|Overall Study||3|Insufficient faculty interest to recruit patients|
59574414|NCT02664311|75678988|FG000|NOT COMPLETED|Overall Study||0||
59574415|NCT02664311|75678989|FG001|NOT COMPLETED|Overall Study||0||
59574416|NCT02535923|75678997|FG000|STARTED|Overall Study||26||
59574417|NCT02535923|75678998|FG001|STARTED|Overall Study||21||
59574418|NCT02535923|75678997|FG000|Completed Post Assessment|Overall Study|4 lost contact or refused|22||
59574419|NCT02535923|75678998|FG001|Completed Post Assessment|Overall Study|4 lost contact or refused|17||
59574420|NCT02535923|75678997|FG000|Completed Follow Up Assessment|Overall Study|5 lost contact or refused|17||
59574421|NCT02535923|75678998|FG001|Completed Follow Up Assessment|Overall Study|4 lost contact or refused|13||
59574422|NCT02535923|75678997|FG000|COMPLETED|Overall Study||17||
59574423|NCT02535923|75678998|FG001|COMPLETED|Overall Study||13||
59574424|NCT02535923|75678997|FG000|NOT COMPLETED|Overall Study||9||
59574425|NCT02535923|75678998|FG001|NOT COMPLETED|Overall Study||8||
59574426|NCT02270736|75679007|FG000|STARTED|Main Period (MP) (up to 16 Weeks)||72||
59574427|NCT02270736|75679008|FG001|STARTED|Main Period (MP) (up to 16 Weeks)||148||
59574428|NCT02270736|75679009|FG002|STARTED|Main Period (MP) (up to 16 Weeks)||36||
59574429|NCT02270736|75679010|FG003|STARTED|Main Period (MP) (up to 16 Weeks)||0||
59574430|NCT02270736|75679011|FG004|STARTED|Main Period (MP) (up to 16 Weeks)||0||
59574431|NCT02270736|75679007|FG000|Treated|Main Period (MP) (up to 16 Weeks)||72||
59574432|NCT02270736|75679008|FG001|Treated|Main Period (MP) (up to 16 Weeks)||148||
59574433|NCT02270736|75679009|FG002|Treated|Main Period (MP) (up to 16 Weeks)||35||
59574434|NCT02270736|75679010|FG003|Treated|Main Period (MP) (up to 16 Weeks)||0||
59574435|NCT02270736|75679011|FG004|Treated|Main Period (MP) (up to 16 Weeks)||0||
59574436|NCT02270736|75679007|FG000|COMPLETED|Main Period (MP) (up to 16 Weeks)||70||
59574437|NCT02270736|75679008|FG001|COMPLETED|Main Period (MP) (up to 16 Weeks)||146||
59574438|NCT02270736|75679009|FG002|COMPLETED|Main Period (MP) (up to 16 Weeks)||34||
59574439|NCT02270736|75679010|FG003|COMPLETED|Main Period (MP) (up to 16 Weeks)||0||
59574440|NCT02270736|75679011|FG004|COMPLETED|Main Period (MP) (up to 16 Weeks)||0||
59574441|NCT02270736|75679007|FG000|NOT COMPLETED|Main Period (MP) (up to 16 Weeks)||2||
59574442|NCT02270736|75679008|FG001|NOT COMPLETED|Main Period (MP) (up to 16 Weeks)||2||
59574443|NCT02270736|75679009|FG002|NOT COMPLETED|Main Period (MP) (up to 16 Weeks)||2||
59574444|NCT02270736|75679010|FG003|NOT COMPLETED|Main Period (MP) (up to 16 Weeks)||0||
59574445|NCT02270736|75679011|FG004|NOT COMPLETED|Main Period (MP) (up to 16 Weeks)||0||
59574446|NCT02270736|75679007|FG000|STARTED|OLEX Period (up to 48 Weeks)||0||
59574447|NCT02270736|75679008|FG001|STARTED|OLEX Period (up to 48 Weeks)||0||
59574448|NCT02270736|75679009|FG002|STARTED|OLEX Period (up to 48 Weeks)||0||
59574449|NCT02270736|75679010|FG003|STARTED|OLEX Period (up to 48 Weeks)|2 participants from MP did not enter OLEX due to withdrawal of consent.|214||
59574450|NCT02270736|75679011|FG004|STARTED|OLEX Period (up to 48 Weeks)|1 participant from MP did not enter OLEX due to adverse event.|33||
59574451|NCT02270736|75679007|FG000|COMPLETED|OLEX Period (up to 48 Weeks)||0||
59574452|NCT02270736|75679008|FG001|COMPLETED|OLEX Period (up to 48 Weeks)||0||
59574453|NCT02270736|75679009|FG002|COMPLETED|OLEX Period (up to 48 Weeks)||0||
59574454|NCT02270736|75679010|FG003|COMPLETED|OLEX Period (up to 48 Weeks)||189||
59574455|NCT02270736|75679011|FG004|COMPLETED|OLEX Period (up to 48 Weeks)||33||
59574456|NCT02270736|75679007|FG000|NOT COMPLETED|OLEX Period (up to 48 Weeks)||0||
59574457|NCT02270736|75679008|FG001|NOT COMPLETED|OLEX Period (up to 48 Weeks)||0||
59574458|NCT02270736|75679009|FG002|NOT COMPLETED|OLEX Period (up to 48 Weeks)||0||
59574459|NCT02270736|75679010|FG003|NOT COMPLETED|OLEX Period (up to 48 Weeks)||25||
59574460|NCT02270736|75679011|FG004|NOT COMPLETED|OLEX Period (up to 48 Weeks)||0||
59574461|NCT02269098|75679026|FG000|STARTED|Overall Study||51||
59574462|NCT02269098|75679027|FG001|STARTED|Overall Study||50||
59574463|NCT02269098|75679026|FG000|COMPLETED|Overall Study||37||
59574464|NCT02269098|75679027|FG001|COMPLETED|Overall Study||41||
59574465|NCT02269098|75679026|FG000|NOT COMPLETED|Overall Study||14||
59574466|NCT02269098|75679027|FG001|NOT COMPLETED|Overall Study||9||
59574467|NCT04586387|75679034|FG000|STARTED|Overall Study||6||
59574468|NCT04586387|75679035|FG001|STARTED|Overall Study||6||
59574469|NCT04586387|75679034|FG000|Sham Stimulation|Overall Study||6|Will occur over biceps or FDI depending on which area is being stimulated first|
59574470|NCT04586387|75679035|FG001|Sham Stimulation|Overall Study||6|Will occur over biceps or FDI depending on which area is being stimulated first|
59574471|NCT04586387|75679034|FG000|Active Stimulation|Overall Study||6|Will occur over biceps or FDI depending on which area is being stimulated first|
59574472|NCT04586387|75679035|FG001|Active Stimulation|Overall Study||6|Will occur over biceps or FDI depending on which area is being stimulated first|
59574473|NCT04586387|75679034|FG000|3 Day Rest|Overall Study||6||
59574474|NCT04586387|75679035|FG001|3 Day Rest|Overall Study||6||
59574475|NCT04586387|75679034|FG000|Sham Stimulation|Overall Study||6|Will occur over biceps or FDI depending on which area is being stimulated second|
59574476|NCT04586387|75679035|FG001|Sham Stimulation|Overall Study||6|Will occur over biceps or FDI depending on which area is being stimulated second|
59574477|NCT04586387|75679034|FG000|Active Stimulation|Overall Study||6|Will occur over biceps or FDI depending on which area is being stimulated second|
59574478|NCT04586387|75679035|FG001|Active Stimulation|Overall Study||6|Will occur over biceps or FDI depending on which area is being stimulated second|
59574479|NCT04586387|75679034|FG000|COMPLETED|Overall Study||6||
59574480|NCT04586387|75679035|FG001|COMPLETED|Overall Study||6||
59574481|NCT04586387|75679034|FG000|NOT COMPLETED|Overall Study||0||
59574482|NCT04586387|75679035|FG001|NOT COMPLETED|Overall Study||0||
59574483|NCT02667821|75679039|FG000|STARTED|Overall Study||20||
59574484|NCT02667821|75679039|FG000|COMPLETED|Overall Study||20||
59574485|NCT02667821|75679039|FG000|NOT COMPLETED|Overall Study||0||
59574486|NCT02669615|75679044|FG000|STARTED|Overall Study||24||
59574487|NCT02669615|75679044|FG000|COMPLETED|Overall Study||24||
59574488|NCT02669615|75679044|FG000|NOT COMPLETED|Overall Study||0||
59574489|NCT02670629|75679050|FG000|STARTED|Overall Study||29||
59574490|NCT02670629|75679051|FG001|STARTED|Overall Study||29||
59574491|NCT02670629|75679050|FG000|COMPLETED|Overall Study||29||
59574492|NCT02670629|75679051|FG001|COMPLETED|Overall Study||29||
59574493|NCT02670629|75679050|FG000|NOT COMPLETED|Overall Study||0||
59574494|NCT02670629|75679051|FG001|NOT COMPLETED|Overall Study||0||
59574495|NCT02672111|75679059|FG000|STARTED|Overall Study||190||
59574496|NCT02672111|75679060|FG001|STARTED|Overall Study||37||
59574497|NCT02672111|75679059|FG000|Completed Treatment|Overall Study||138||
59574498|NCT02672111|75679060|FG001|Completed Treatment|Overall Study||29||
59574499|NCT02672111|75679059|FG000|COMPLETED|Overall Study||132||
59574500|NCT02672111|75679060|FG001|COMPLETED|Overall Study||25||
59574501|NCT02672111|75679059|FG000|NOT COMPLETED|Overall Study||58||
59574502|NCT02672111|75679060|FG001|NOT COMPLETED|Overall Study||12||
59574503|NCT02675543|75679069|FG000|STARTED|Overall Study||15||
59574504|NCT02675543|75679070|FG001|STARTED|Overall Study||20||
59574505|NCT02675543|75679069|FG000|COMPLETED|Overall Study||15||
59574506|NCT02675543|75679070|FG001|COMPLETED|Overall Study||20||
59574507|NCT02675543|75679069|FG000|NOT COMPLETED|Overall Study||0||
59574508|NCT02675543|75679070|FG001|NOT COMPLETED|Overall Study||0||
59574509|NCT02684435|75679076|FG000|STARTED|Overall Study||63||64
59574510|NCT02684435|75679076|FG000|COMPLETED|Overall Study||63||64
59574511|NCT02684435|75679076|FG000|NOT COMPLETED|Overall Study||0||0
59574512|NCT02684591|75679082|FG000|STARTED|Overall Study||25||
59574513|NCT02684591|75679083|FG001|STARTED|Overall Study||25||
59574514|NCT02684591|75679082|FG000|COMPLETED|Overall Study||24||
59574515|NCT02684591|75679083|FG001|COMPLETED|Overall Study||22||
59574516|NCT02684591|75679082|FG000|NOT COMPLETED|Overall Study||1||
59574517|NCT02684591|75679083|FG001|NOT COMPLETED|Overall Study||3||
59574518|NCT02685293|75679089|FG000|STARTED|Treatment Period 1||1||
59574519|NCT02685293|75679090|FG001|STARTED|Treatment Period 1||3||
59574520|NCT02685293|75679089|FG000|COMPLETED|Treatment Period 1||1||
59574521|NCT02685293|75679090|FG001|COMPLETED|Treatment Period 1||3||
59574522|NCT02685293|75679089|FG000|NOT COMPLETED|Treatment Period 1||0||
59574523|NCT02685293|75679090|FG001|NOT COMPLETED|Treatment Period 1||0||
59574524|NCT02685293|75679089|FG000|STARTED|Washout Period||1||
59574525|NCT02685293|75679090|FG001|STARTED|Washout Period||3||
59574526|NCT02685293|75679089|FG000|COMPLETED|Washout Period||1||
59574527|NCT02685293|75679090|FG001|COMPLETED|Washout Period||3||
59574528|NCT02685293|75679089|FG000|NOT COMPLETED|Washout Period||0||
59574529|NCT02685293|75679090|FG001|NOT COMPLETED|Washout Period||0||
59574530|NCT02685293|75679089|FG000|STARTED|Treatment Period 2||1||
59574531|NCT02685293|75679090|FG001|STARTED|Treatment Period 2||3||
59574532|NCT02685293|75679089|FG000|COMPLETED|Treatment Period 2||1||
59574533|NCT02685293|75679090|FG001|COMPLETED|Treatment Period 2||3||
59574534|NCT02685293|75679089|FG000|NOT COMPLETED|Treatment Period 2||0||
59574535|NCT02685293|75679090|FG001|NOT COMPLETED|Treatment Period 2||0||
59574536|NCT02678039|75679098|FG000|STARTED|Overall Study||53||
59574537|NCT02678039|75679099|FG001|STARTED|Overall Study||47||
59574538|NCT02678039|75679098|FG000|COMPLETED|Overall Study||53||
59574539|NCT02678039|75679099|FG001|COMPLETED|Overall Study||47||
59574540|NCT02678039|75679098|FG000|NOT COMPLETED|Overall Study||0||
59574541|NCT02678039|75679099|FG001|NOT COMPLETED|Overall Study||0||
59574542|NCT02679911|75679105|FG000|STARTED|Overall Study|Intra-individual study|20|This is an intraindividual study so only 20 subjecst are included in total|
59574543|NCT02679911|75679105|FG000|COMPLETED|Overall Study||20||
59574544|NCT02679911|75679105|FG000|NOT COMPLETED|Overall Study||0||
59574545|NCT02680145|75679110|FG000|STARTED|Overall Study||58||
59574546|NCT02680145|75679110|FG000|COMPLETED|Overall Study||47||
59574547|NCT02680145|75679110|FG000|NOT COMPLETED|Overall Study||11||
59574548|NCT02680301|75679116|FG000|STARTED|Overall Study||22||
59574549|NCT02680301|75679117|FG001|STARTED|Overall Study||18||
59574550|NCT02680301|75679116|FG000|COMPLETED|Overall Study||22||
59574551|NCT02680301|75679117|FG001|COMPLETED|Overall Study||17||
59574552|NCT02680301|75679116|FG000|NOT COMPLETED|Overall Study||0||
59574553|NCT02680301|75679117|FG001|NOT COMPLETED|Overall Study||1||
59574554|NCT02680457|75679124|FG000|STARTED|Initial Intervention||6||
59574555|NCT02680457|75679125|FG001|STARTED|Initial Intervention||6||
59574556|NCT02680457|75679124|FG000|COMPLETED|Initial Intervention||6||
59574557|NCT02680457|75679125|FG001|COMPLETED|Initial Intervention||6||
59574558|NCT02680457|75679124|FG000|NOT COMPLETED|Initial Intervention||0||
59574559|NCT02680457|75679125|FG001|NOT COMPLETED|Initial Intervention||0||
59574560|NCT02680457|75679124|FG000|STARTED|Washout Period||6||
59574561|NCT02680457|75679125|FG001|STARTED|Washout Period||6||
59574562|NCT02680457|75679124|FG000|COMPLETED|Washout Period||6||
59574563|NCT02680457|75679125|FG001|COMPLETED|Washout Period||6||
59574564|NCT02680457|75679124|FG000|NOT COMPLETED|Washout Period||0||
59574565|NCT02680457|75679125|FG001|NOT COMPLETED|Washout Period||0||
59574566|NCT02680457|75679124|FG000|STARTED|Cross-over Intervention||6||
59574567|NCT02680457|75679125|FG001|STARTED|Cross-over Intervention||6||
59574568|NCT02680457|75679124|FG000|COMPLETED|Cross-over Intervention||6||
59574569|NCT02680457|75679125|FG001|COMPLETED|Cross-over Intervention||6||
59574570|NCT02680457|75679124|FG000|NOT COMPLETED|Cross-over Intervention||0||
59574571|NCT02680457|75679125|FG001|NOT COMPLETED|Cross-over Intervention||0||
59574572|NCT02689973|75679135|FG000|STARTED|Overall Study||311||
59574573|NCT02689973|75679136|FG001|STARTED|Overall Study||270||
59574574|NCT02689973|75679137|FG002|STARTED|Overall Study||351||
59574575|NCT02689973|75679138|FG003|STARTED|Overall Study||285||
59574576|NCT02689973|75679135|FG000|COMPLETED|Overall Study||257||
59574577|NCT02689973|75679136|FG001|COMPLETED|Overall Study||221||
59574578|NCT02689973|75679137|FG002|COMPLETED|Overall Study||279||
59574579|NCT02689973|75679138|FG003|COMPLETED|Overall Study||232||
59574580|NCT02689973|75679135|FG000|NOT COMPLETED|Overall Study||54||
59574581|NCT02689973|75679136|FG001|NOT COMPLETED|Overall Study||49||
59574582|NCT02689973|75679137|FG002|NOT COMPLETED|Overall Study||72||
59574583|NCT02689973|75679138|FG003|NOT COMPLETED|Overall Study||53||
59574584|NCT02691143|75679151|FG000|STARTED|Overall Study||27||
59574585|NCT02691143|75679152|FG001|STARTED|Overall Study||23||
59574586|NCT02691143|75679151|FG000|COMPLETED|Overall Study||27||
59574587|NCT02691143|75679152|FG001|COMPLETED|Overall Study||23||
59574588|NCT02691143|75679151|FG000|NOT COMPLETED|Overall Study||0||
59574589|NCT02691143|75679152|FG001|NOT COMPLETED|Overall Study||0||
59574590|NCT02283762|75679160|FG000|STARTED|Main Treatment Phase (MT)||60||
59574591|NCT02283762|75679161|FG001|STARTED|Main Treatment Phase (MT)||61||
59574592|NCT02283762|75679160|FG000|COMPLETED|Main Treatment Phase (MT)||42||
59574593|NCT02283762|75679161|FG001|COMPLETED|Main Treatment Phase (MT)||46||
59574594|NCT02283762|75679160|FG000|NOT COMPLETED|Main Treatment Phase (MT)||18||
59574595|NCT02283762|75679161|FG001|NOT COMPLETED|Main Treatment Phase (MT)||15||
59574596|NCT02283762|75679160|FG000|STARTED|Long-term Extension Phase (LTE)||42||
59574597|NCT02283762|75679161|FG001|STARTED|Long-term Extension Phase (LTE)|Of the 46 patients who completed the main treatment phase, 1 patient did not enter the LTE phase|45||
59574598|NCT02283762|75679160|FG000|COMPLETED|Long-term Extension Phase (LTE)||32||
59574599|NCT02283762|75679161|FG001|COMPLETED|Long-term Extension Phase (LTE)||31||
59574600|NCT02283762|75679160|FG000|NOT COMPLETED|Long-term Extension Phase (LTE)||10||
59574601|NCT02283762|75679161|FG001|NOT COMPLETED|Long-term Extension Phase (LTE)||14||
59574602|NCT02692391|75679171|FG000|STARTED|Overall Study||24||
59574603|NCT02692391|75679172|FG001|STARTED|Overall Study||18||
60121264|NCT01688921|76242160|FG001|COMPLETED|Overall Study||608||
59574604|NCT02692391|75679171|FG000|COMPLETED|Overall Study||24||
59574605|NCT02692391|75679172|FG001|COMPLETED|Overall Study||18||
59574606|NCT02692391|75679171|FG000|NOT COMPLETED|Overall Study||0||
59574607|NCT02692391|75679172|FG001|NOT COMPLETED|Overall Study||0||
59574608|NCT02692859|75679180|FG000|STARTED|Overall Study||996||
59574609|NCT02692859|75679181|FG001|STARTED|Overall Study||996||
59574610|NCT02692859|75679180|FG000|COMPLETED|Overall Study||912||
59574611|NCT02692859|75679181|FG001|COMPLETED|Overall Study||901||
59574612|NCT02692859|75679180|FG000|NOT COMPLETED|Overall Study||84||
59574613|NCT02692859|75679181|FG001|NOT COMPLETED|Overall Study||95||
59574614|NCT02694029|75679189|FG000|STARTED|Overall Study||5||
59574615|NCT02694029|75679190|FG001|STARTED|Overall Study||5||
59574616|NCT02694029|75679189|FG000|First Intervention|Overall Study||5||
59574617|NCT02694029|75679190|FG001|First Intervention|Overall Study||5||
59574618|NCT02694029|75679189|FG000|Second Intervention|Overall Study||5||
59574619|NCT02694029|75679190|FG001|Second Intervention|Overall Study||5||
59574620|NCT02694029|75679189|FG000|COMPLETED|Overall Study||5||
59574621|NCT02694029|75679190|FG001|COMPLETED|Overall Study||5||
59574622|NCT02694029|75679189|FG000|NOT COMPLETED|Overall Study||0||
59574623|NCT02694029|75679190|FG001|NOT COMPLETED|Overall Study||0||
59574624|NCT02696291|75679202|FG000|STARTED|Overall Study||5||
59574625|NCT02696291|75679203|FG001|STARTED|Overall Study||2||
59574626|NCT02696291|75679202|FG000|COMPLETED|Overall Study||5||
59574627|NCT02696291|75679203|FG001|COMPLETED|Overall Study||2||
59574628|NCT02696291|75679202|FG000|NOT COMPLETED|Overall Study||0||
59574629|NCT02696291|75679203|FG001|NOT COMPLETED|Overall Study||0||
59574630|NCT02682563|75679211|FG000|STARTED|Overall Study||24||
59574631|NCT02682563|75679212|FG001|STARTED|Overall Study||20||
59574632|NCT02682563|75679211|FG000|COMPLETED|Overall Study||24||
59574633|NCT02682563|75679212|FG001|COMPLETED|Overall Study||20||
59574634|NCT02682563|75679211|FG000|NOT COMPLETED|Overall Study||0||
59574635|NCT02682563|75679212|FG001|NOT COMPLETED|Overall Study||0||
59574636|NCT02697071|75679220|FG000|STARTED|Overall Study||18||
59574637|NCT02697071|75679221|FG001|STARTED|Overall Study||16||
59574638|NCT02697071|75679220|FG000|COMPLETED|Overall Study||18||
59574639|NCT02697071|75679221|FG001|COMPLETED|Overall Study||16||
59574640|NCT02697071|75679220|FG000|NOT COMPLETED|Overall Study||0||
59574641|NCT02697071|75679221|FG001|NOT COMPLETED|Overall Study||0||
59574642|NCT02683421|75679231|FG000|STARTED|Overall Study||5||
59574643|NCT02683421|75679232|FG001|STARTED|Overall Study||4||
59574644|NCT02683421|75679233|FG002|STARTED|Overall Study||4||
59574645|NCT02683421|75679234|FG003|STARTED|Overall Study||5||
59574646|NCT02683421|75679231|FG000|COMPLETED|Overall Study||5||
59574647|NCT02683421|75679232|FG001|COMPLETED|Overall Study||4||
59574648|NCT02683421|75679233|FG002|COMPLETED|Overall Study||4||
59574649|NCT02683421|75679234|FG003|COMPLETED|Overall Study||5||
59574650|NCT02683421|75679231|FG000|NOT COMPLETED|Overall Study||0||
59574651|NCT02683421|75679232|FG001|NOT COMPLETED|Overall Study||0||
59574652|NCT02683421|75679233|FG002|NOT COMPLETED|Overall Study||0||
59574653|NCT02683421|75679234|FG003|NOT COMPLETED|Overall Study||0||
59574654|NCT02683577|75679247|FG000|STARTED|Overall Study||8||
59574655|NCT02683577|75679248|FG001|STARTED|Overall Study||8||
59574656|NCT02683577|75679249|FG002|STARTED|Overall Study||8||
59574657|NCT02683577|75679247|FG000|COMPLETED|Overall Study||8||
59574658|NCT02683577|75679248|FG001|COMPLETED|Overall Study||8||
59574659|NCT02683577|75679249|FG002|COMPLETED|Overall Study||8||
59574660|NCT02683577|75679247|FG000|NOT COMPLETED|Overall Study||0||
59574661|NCT02683577|75679248|FG001|NOT COMPLETED|Overall Study||0||
59574662|NCT02683577|75679249|FG002|NOT COMPLETED|Overall Study||0||
59574663|NCT02283294|75679261|FG000|STARTED|Overall Study||41|Started indicates randomized to medication assignment. This does not necessarily indicate patient started the medication they were randomized to.|
59574664|NCT02283294|75679262|FG001|STARTED|Overall Study||47|Started indicates randomized to medication assignment. This does not necessarily indicate patient started the medication they were randomized to.|
59574665|NCT02283294|75679261|FG000|Received Allocated Treatment Intervention|Overall Study||38||
59574666|NCT02283294|75679262|FG001|Received Allocated Treatment Intervention|Overall Study||31||
59574667|NCT02283294|75679261|FG000|COMPLETED|Overall Study||38||
59574668|NCT02283294|75679262|FG001|COMPLETED|Overall Study||39||
59574669|NCT02283294|75679261|FG000|NOT COMPLETED|Overall Study||3||
59574670|NCT02283294|75679262|FG001|NOT COMPLETED|Overall Study||8||
59574671|NCT02700425|75679271|FG000|STARTED|Overall Study||21||
59574672|NCT02700425|75679272|FG001|STARTED|Overall Study||20||
59574673|NCT02700425|75679271|FG000|COMPLETED|Overall Study||21||
59574674|NCT02700425|75679272|FG001|COMPLETED|Overall Study|1 patient withdrew after randomization|19||
59574675|NCT02700425|75679271|FG000|NOT COMPLETED|Overall Study||0||
59574676|NCT02700425|75679272|FG001|NOT COMPLETED|Overall Study||1||
59574677|NCT02282982|75679278|FG000|STARTED|Overall Study||359||
59574678|NCT02282982|75679278|FG000|Attended Visit 1|Overall Study||359||
59574679|NCT02282982|75679278|FG000|Attended Visit 2|Overall Study||341||
59574680|NCT02282982|75679278|FG000|Attended Visit 3|Overall Study||298||
59574681|NCT02282982|75679278|FG000|Attended Visit 4|Overall Study||194||
59574682|NCT02282982|75679278|FG000|Attended Visit 5|Overall Study||83||
59574683|NCT02282982|75679278|FG000|Attended Follow-up Visit|Overall Study||349||
59574684|NCT02282982|75679278|FG000|COMPLETED|Overall Study||153||
59574685|NCT02282982|75679278|FG000|NOT COMPLETED|Overall Study||206||
59574686|NCT02701049|75679285|FG000|STARTED|Overall Study|Patients who completed a follow-up survey|209||
59574687|NCT02701049|75679286|FG001|STARTED|Overall Study|Patients who completed a follow-up survey|342||
59574688|NCT02701049|75679287|FG002|STARTED|Overall Study|Patients who completed a follow-up survey|198||
59721413|NCT01079130|75840343|FG001|STARTED|Overall Study||85||
59574689|NCT02701049|75679285|FG000|COMPLETED|Overall Study|Total patients included in analysis|209||
59574690|NCT02701049|75679286|FG001|COMPLETED|Overall Study|Total patients included in analysis|342||
59574691|NCT02701049|75679287|FG002|COMPLETED|Overall Study|Total patients included in analysis|198||
59574692|NCT02701049|75679285|FG000|NOT COMPLETED|Overall Study||0||
59574693|NCT02701049|75679286|FG001|NOT COMPLETED|Overall Study||0||
59574694|NCT02701049|75679287|FG002|NOT COMPLETED|Overall Study||0||
59574695|NCT02702921|75679301|FG000|STARTED|Overall Study||98|February 2017|
59574696|NCT02702921|75679302|FG001|STARTED|Overall Study||103|February 2017|
59574697|NCT02702921|75679301|FG000|COMPLETED|Overall Study||84|March 2017|
59574698|NCT02702921|75679302|FG001|COMPLETED|Overall Study||95|March 2017|
59574699|NCT02702921|75679301|FG000|NOT COMPLETED|Overall Study||14||
59574700|NCT02702921|75679302|FG001|NOT COMPLETED|Overall Study||8||
59574701|NCT02702999|75679310|FG000|STARTED|Overall Study||102||
59574702|NCT02702999|75679311|FG001|STARTED|Overall Study||104||
59574703|NCT02702999|75679310|FG000|COMPLETED|Overall Study||102||
59574704|NCT02702999|75679311|FG001|COMPLETED|Overall Study||104||
59574705|NCT02702999|75679310|FG000|NOT COMPLETED|Overall Study||0||
59574706|NCT02702999|75679311|FG001|NOT COMPLETED|Overall Study||0||
59574707|NCT02268864|75679320|FG000|STARTED|Overall Study||17||
59574708|NCT02268864|75679321|FG001|STARTED|Overall Study||25||
59574709|NCT02268864|75679322|FG002|STARTED|Overall Study||64||
59574710|NCT02268864|75679320|FG000|COMPLETED|Overall Study||15||
59574711|NCT02268864|75679321|FG001|COMPLETED|Overall Study||24||
59574712|NCT02268864|75679322|FG002|COMPLETED|Overall Study||64||
59574713|NCT02268864|75679320|FG000|NOT COMPLETED|Overall Study||2||
59574714|NCT02268864|75679321|FG001|NOT COMPLETED|Overall Study||1||
59574715|NCT02268864|75679322|FG002|NOT COMPLETED|Overall Study||0||
59574716|NCT02703467|75679335|FG000|STARTED|Overall Study||20||
59574717|NCT02703467|75679336|FG001|STARTED|Overall Study||5||
59574718|NCT02703467|75679337|FG002|STARTED|Overall Study||45||
59574719|NCT02703467|75679335|FG000|COMPLETED|Overall Study||20||
59574720|NCT02703467|75679336|FG001|COMPLETED|Overall Study||5||
59574721|NCT02703467|75679337|FG002|COMPLETED|Overall Study||45||
59574722|NCT02703467|75679335|FG000|NOT COMPLETED|Overall Study||0||
59574723|NCT02703467|75679336|FG001|NOT COMPLETED|Overall Study||0||
59574724|NCT02703467|75679337|FG002|NOT COMPLETED|Overall Study||0||
59574725|NCT02268786|75679351|FG000|STARTED|Overall Study||330||
59574726|NCT02268786|75679352|FG001|STARTED|Overall Study||331||
59574727|NCT02268786|75679351|FG000|COMPLETED|Overall Study||274||
59574728|NCT02268786|75679352|FG001|COMPLETED|Overall Study||313||
59574729|NCT02268786|75679351|FG000|NOT COMPLETED|Overall Study||56||
59574730|NCT02268786|75679352|FG001|NOT COMPLETED|Overall Study||18||
59721414|NCT01079130|75840344|FG002|STARTED|Overall Study||84||
59721415|NCT01079130|75840345|FG003|STARTED|Overall Study||86||
59574731|NCT02703779|75679360|FG000|STARTED|Overall Study||51||
59574732|NCT02703779|75679361|FG001|STARTED|Overall Study||50||
59574733|NCT02703779|75679360|FG000|COMPLETED|Overall Study||51||
59574734|NCT02703779|75679361|FG001|COMPLETED|Overall Study||50||
59574735|NCT02703779|75679360|FG000|NOT COMPLETED|Overall Study||0||
59574736|NCT02703779|75679361|FG001|NOT COMPLETED|Overall Study||0||
59574737|NCT02268396|75679367|FG000|STARTED|Overall Study||138||
59574738|NCT02268396|75679367|FG000|COMPLETED|Overall Study||126||
59574739|NCT02268396|75679367|FG000|NOT COMPLETED|Overall Study||12||
59574740|NCT02268084|75679373|FG000|STARTED|Overall Study||49||
59574741|NCT02268084|75679374|FG001|STARTED|Overall Study||47||
59574742|NCT02268084|75679373|FG000|COMPLETED|Overall Study||40||
59574743|NCT02268084|75679374|FG001|COMPLETED|Overall Study||40||
59574744|NCT02268084|75679373|FG000|NOT COMPLETED|Overall Study||9||
59574745|NCT02268084|75679374|FG001|NOT COMPLETED|Overall Study||7||
59574746|NCT02705807|75679386|FG000|STARTED|Overall Study||10||
59574747|NCT02705807|75679386|FG000|COMPLETED|Overall Study||10||
59574748|NCT02705807|75679386|FG000|NOT COMPLETED|Overall Study||0||
59574749|NCT02706041|75679392|FG000|STARTED|Overall Study||18||
59574750|NCT02706041|75679393|FG001|STARTED|Overall Study||21||
59574751|NCT02706041|75679392|FG000|Received Allocated Intervention|Overall Study||18||
59574752|NCT02706041|75679393|FG001|Received Allocated Intervention|Overall Study||18||
59574753|NCT02706041|75679392|FG000|COMPLETED|Overall Study||18||
59574754|NCT02706041|75679393|FG001|COMPLETED|Overall Study||18||
59574755|NCT02706041|75679392|FG000|NOT COMPLETED|Overall Study||0||
59574756|NCT02706041|75679393|FG001|NOT COMPLETED|Overall Study||3||
59574757|NCT01643772|75679403|FG000|STARTED|Overall Study||15||
59574758|NCT01643772|75679404|FG001|STARTED|Overall Study||15||
59574759|NCT01643772|75679405|FG002|STARTED|Overall Study||15||
59574760|NCT01643772|75679406|FG003|STARTED|Overall Study||16||
59721416|NCT01079130|75840346|FG004|STARTED|Overall Study||86||
59574761|NCT01643772|75679403|FG000|COMPLETED|Overall Study||15||
59574762|NCT01643772|75679404|FG001|COMPLETED|Overall Study||15||
59574763|NCT01643772|75679405|FG002|COMPLETED|Overall Study||15||
59574764|NCT01643772|75679406|FG003|COMPLETED|Overall Study||14||
59574765|NCT01643772|75679403|FG000|NOT COMPLETED|Overall Study||0||
59574766|NCT01643772|75679404|FG001|NOT COMPLETED|Overall Study||0||
59574767|NCT01643772|75679405|FG002|NOT COMPLETED|Overall Study||0||
59721417|NCT01079130|75840347|FG005|STARTED|Overall Study||85||
59574768|NCT01643772|75679406|FG003|NOT COMPLETED|Overall Study||2||
59574769|NCT02707523|75679421|FG000|STARTED|Overall Study||16||
59574770|NCT02707523|75679422|FG001|STARTED|Overall Study||16||
59574771|NCT02707523|75679423|FG002|STARTED|Overall Study||16||
59574772|NCT02707523|75679421|FG000|COMPLETED|Overall Study||16||
59574773|NCT02707523|75679422|FG001|COMPLETED|Overall Study||16||
59574774|NCT02707523|75679423|FG002|COMPLETED|Overall Study||16||
59574775|NCT02707523|75679421|FG000|NOT COMPLETED|Overall Study||0||
59574776|NCT02707523|75679422|FG001|NOT COMPLETED|Overall Study||0||
59574777|NCT02707523|75679423|FG002|NOT COMPLETED|Overall Study||0||
59574778|NCT02712047|75679431|FG000|STARTED|Treatment Period 1 (35 Days)||14||
59574779|NCT02712047|75679432|FG001|STARTED|Treatment Period 1 (35 Days)||13||
59574780|NCT02712047|75679431|FG000|COMPLETED|Treatment Period 1 (35 Days)||14||
59574781|NCT02712047|75679432|FG001|COMPLETED|Treatment Period 1 (35 Days)||13||
59574782|NCT02712047|75679431|FG000|NOT COMPLETED|Treatment Period 1 (35 Days)||0||
59574783|NCT02712047|75679432|FG001|NOT COMPLETED|Treatment Period 1 (35 Days)||0||
59574784|NCT02712047|75679431|FG000|STARTED|Washout Period (21 Days)||14||
59574785|NCT02712047|75679432|FG001|STARTED|Washout Period (21 Days)||13||
59574786|NCT02712047|75679431|FG000|COMPLETED|Washout Period (21 Days)||14||
59574787|NCT02712047|75679432|FG001|COMPLETED|Washout Period (21 Days)||13||
59574788|NCT02712047|75679431|FG000|NOT COMPLETED|Washout Period (21 Days)||0||
59574789|NCT02712047|75679432|FG001|NOT COMPLETED|Washout Period (21 Days)||0||
59574790|NCT02712047|75679431|FG000|STARTED|Treatment Period 2 (35 Days)||14||
59574791|NCT02712047|75679432|FG001|STARTED|Treatment Period 2 (35 Days)||13||
59574792|NCT02712047|75679431|FG000|COMPLETED|Treatment Period 2 (35 Days)||14||
59574793|NCT02712047|75679432|FG001|COMPLETED|Treatment Period 2 (35 Days)||13||
59574794|NCT02712047|75679431|FG000|NOT COMPLETED|Treatment Period 2 (35 Days)||0||
59574795|NCT02712047|75679432|FG001|NOT COMPLETED|Treatment Period 2 (35 Days)||0||
59574796|NCT02712359|75679442|FG000|STARTED|Epoch 001: Persistence at Year 8||300||
59574797|NCT02712359|75679443|FG001|STARTED|Epoch 001: Persistence at Year 8||300||
59574798|NCT02712359|75679444|FG002|STARTED|Epoch 001: Persistence at Year 8||0||
59574799|NCT02712359|75679445|FG003|STARTED|Epoch 001: Persistence at Year 8||0||
59574800|NCT02712359|75679442|FG000|COMPLETED|Epoch 001: Persistence at Year 8||300||
59574801|NCT02712359|75679443|FG001|COMPLETED|Epoch 001: Persistence at Year 8||300||
59574802|NCT02712359|75679444|FG002|COMPLETED|Epoch 001: Persistence at Year 8||0||
59574803|NCT02712359|75679445|FG003|COMPLETED|Epoch 001: Persistence at Year 8||0||
59574804|NCT02712359|75679442|FG000|NOT COMPLETED|Epoch 001: Persistence at Year 8||0||
59574805|NCT02712359|75679443|FG001|NOT COMPLETED|Epoch 001: Persistence at Year 8||0||
59574806|NCT02712359|75679444|FG002|NOT COMPLETED|Epoch 001: Persistence at Year 8||0||
59574807|NCT02712359|75679445|FG003|NOT COMPLETED|Epoch 001: Persistence at Year 8||0||
59574808|NCT02712359|75679442|FG000|STARTED|Epoch 002: Persistence at Year 10||0||
59574809|NCT02712359|75679443|FG001|STARTED|Epoch 002: Persistence at Year 10||0||
59574810|NCT02712359|75679444|FG002|STARTED|Epoch 002: Persistence at Year 10||299||
59574811|NCT02712359|75679445|FG003|STARTED|Epoch 002: Persistence at Year 10||300||
59574812|NCT02712359|75679442|FG000|COMPLETED|Epoch 002: Persistence at Year 10||0||
59574813|NCT02712359|75679443|FG001|COMPLETED|Epoch 002: Persistence at Year 10||0||
59574814|NCT02712359|75679444|FG002|COMPLETED|Epoch 002: Persistence at Year 10||299||
59574815|NCT02712359|75679445|FG003|COMPLETED|Epoch 002: Persistence at Year 10||300||
59574816|NCT02712359|75679442|FG000|NOT COMPLETED|Epoch 002: Persistence at Year 10||0||
59574817|NCT02712359|75679443|FG001|NOT COMPLETED|Epoch 002: Persistence at Year 10||0||
59574818|NCT02712359|75679444|FG002|NOT COMPLETED|Epoch 002: Persistence at Year 10||0||
59574819|NCT02712359|75679445|FG003|NOT COMPLETED|Epoch 002: Persistence at Year 10||0||
59574820|NCT02716727|75679457|FG000|STARTED|Overall Study||7||
59574821|NCT02716727|75679458|FG001|STARTED|Overall Study||9||
59574822|NCT02716727|75679457|FG000|COMPLETED|Overall Study||7||
59574823|NCT02716727|75679458|FG001|COMPLETED|Overall Study||9||
59574824|NCT02716727|75679457|FG000|NOT COMPLETED|Overall Study||0||
59574825|NCT02716727|75679458|FG001|NOT COMPLETED|Overall Study||0||
59574826|NCT02717273|75679466|FG000|STARTED|Overall Study||52||
59574827|NCT02717273|75679467|FG001|STARTED|Overall Study||50||
59574828|NCT02717273|75679466|FG000|COMPLETED|Overall Study||49||
59574829|NCT02717273|75679467|FG001|COMPLETED|Overall Study||48||
59721418|NCT01079130|75840342|FG000|Safety Set: Received Study Drug|Overall Study||84||
59721419|NCT01079130|75840343|FG001|Safety Set: Received Study Drug|Overall Study||81||
59574830|NCT02717273|75679466|FG000|NOT COMPLETED|Overall Study||3||
59574831|NCT02717273|75679467|FG001|NOT COMPLETED|Overall Study||2||
59574832|NCT02719535|75679473|FG000|STARTED|Overall Study||59||
59574833|NCT02719535|75679473|FG000|COMPLETED|Overall Study||37||
59574834|NCT02719535|75679473|FG000|NOT COMPLETED|Overall Study||22||
59574835|NCT02720627|75679477|FG000|STARTED|Overall Study||27||
59574836|NCT02720627|75679477|FG000|COMPLETED|Overall Study||27||
59574837|NCT02720627|75679477|FG000|NOT COMPLETED|Overall Study||0||
59574838|NCT02721017|75679483|FG000|STARTED|Hospital Stay|Intraoperative Application of Cryoanalgesia started on Date of Surgery (DOS).|10||
59574839|NCT02721017|75679484|FG001|STARTED|Hospital Stay|Thoracic Epidural placed on Date of Surgery (DOS).|10||
59574840|NCT02721017|75679483|FG000|COMPLETED|Hospital Stay|Completed during the course of surgery.|10||
59574841|NCT02721017|75679484|FG001|COMPLETED|Hospital Stay|Removal occurs prior to Hospital Discharge.|10||
59574842|NCT02721017|75679483|FG000|NOT COMPLETED|Hospital Stay||0||
59574843|NCT02721017|75679484|FG001|NOT COMPLETED|Hospital Stay||0||
59574844|NCT02721017|75679483|FG000|STARTED|Participant Follow Up|Assessment of recovery at 2 weeks, 1 month, 3 month and 12 month intervals.|10||
59574845|NCT02721017|75679484|FG001|STARTED|Participant Follow Up|Assessment of recovery at 2 weeks, 1 month, 3 month and 12 month intervals.|10||
59574846|NCT02721017|75679483|FG000|COMPLETED|Participant Follow Up|12 months after Date of Surgery.|10||
59574847|NCT02721017|75679484|FG001|COMPLETED|Participant Follow Up|12 months after Date of Surgery.|10||
59574848|NCT02721017|75679483|FG000|NOT COMPLETED|Participant Follow Up||0||
59574849|NCT02721017|75679484|FG001|NOT COMPLETED|Participant Follow Up||0||
59574850|NCT02721641|75679492|FG000|STARTED|Overall Study||69||
59574851|NCT02721641|75679492|FG000|COMPLETED|Overall Study|In this continued access study, all participants were considered to have completed per protocol.|69||
59574852|NCT02721641|75679492|FG000|NOT COMPLETED|Overall Study||0||
59574853|NCT02722577|75679496|FG000|STARTED|Overall Study||20||
59574854|NCT02722577|75679496|FG000|COMPLETED|Overall Study||20||
59574855|NCT02722577|75679496|FG000|NOT COMPLETED|Overall Study||0||
59574856|NCT02724449|75679500|FG000|STARTED|Overall Study||16||
59574857|NCT02724449|75679500|FG000|COMPLETED|Overall Study||16||
59574858|NCT02724449|75679500|FG000|NOT COMPLETED|Overall Study||0||
59574859|NCT02265744|75679509|FG000|STARTED|Overall Study||69||
59574860|NCT02265744|75679510|FG001|STARTED|Overall Study||68||
59574861|NCT02265744|75679511|FG002|STARTED|Overall Study||68||
59574862|NCT02265744|75679512|FG003|STARTED|Overall Study||70||
59574863|NCT02265744|75679513|FG004|STARTED|Overall Study||71||
59574864|NCT02265744|75679509|FG000|COMPLETED|Overall Study||49||
59574865|NCT02265744|75679510|FG001|COMPLETED|Overall Study||53||
59574866|NCT02265744|75679511|FG002|COMPLETED|Overall Study||51||
59574867|NCT02265744|75679512|FG003|COMPLETED|Overall Study||47||
59574868|NCT02265744|75679513|FG004|COMPLETED|Overall Study||58||
59574869|NCT02265744|75679509|FG000|NOT COMPLETED|Overall Study||20||
59574870|NCT02265744|75679510|FG001|NOT COMPLETED|Overall Study||15||
59574871|NCT02265744|75679511|FG002|NOT COMPLETED|Overall Study||17||
59574872|NCT02265744|75679512|FG003|NOT COMPLETED|Overall Study||23||
59574873|NCT02265744|75679513|FG004|NOT COMPLETED|Overall Study||13||
59574874|NCT03614663|75679527|FG000|STARTED|Overall Study||110||
59574875|NCT03614663|75679528|FG001|STARTED|Overall Study||102||
59574876|NCT03614663|75679527|FG000|COMPLETED|Overall Study||106||
59574877|NCT03614663|75679528|FG001|COMPLETED|Overall Study||99||
59574878|NCT03614663|75679527|FG000|NOT COMPLETED|Overall Study||4||
59574879|NCT03614663|75679528|FG001|NOT COMPLETED|Overall Study||3||
59574880|NCT00085735|75679542|FG000|STARTED|Overall Study||64||
59574881|NCT00085735|75679543|FG001|STARTED|Overall Study||64||
59574882|NCT00085735|75679544|FG002|STARTED|Overall Study||63||
59574883|NCT00085735|75679545|FG003|STARTED|Overall Study||65||
59574884|NCT00085735|75679546|FG004|STARTED|Overall Study||147||
59574885|NCT00085735|75679547|FG005|STARTED|Overall Study||146||
59574886|NCT00085735|75679542|FG000|COMPLETED|Overall Study||52||
59574887|NCT00085735|75679543|FG001|COMPLETED|Overall Study||54||
59574888|NCT00085735|75679544|FG002|COMPLETED|Overall Study||46||
59574889|NCT00085735|75679545|FG003|COMPLETED|Overall Study||46||
59574890|NCT00085735|75679546|FG004|COMPLETED|Overall Study||105||
59574891|NCT00085735|75679547|FG005|COMPLETED|Overall Study||115||
59574892|NCT00085735|75679542|FG000|NOT COMPLETED|Overall Study||12||
59574893|NCT00085735|75679543|FG001|NOT COMPLETED|Overall Study||10||
59574894|NCT00085735|75679544|FG002|NOT COMPLETED|Overall Study||17||
59574895|NCT00085735|75679545|FG003|NOT COMPLETED|Overall Study||19||
59574896|NCT00085735|75679546|FG004|NOT COMPLETED|Overall Study||42||
59574897|NCT00085735|75679547|FG005|NOT COMPLETED|Overall Study||31||
59574898|NCT02726789|75679574|FG000|STARTED|Overall Study||5||
59574899|NCT02726789|75679574|FG000|COMPLETED|Overall Study||5||
59574900|NCT02726789|75679574|FG000|NOT COMPLETED|Overall Study||0||
59574901|NCT02731313|75679579|FG000|STARTED|Overall Study||367||
59574902|NCT02731313|75679579|FG000|COMPLETED|Overall Study||367||
59574903|NCT02731313|75679579|FG000|NOT COMPLETED|Overall Study||0||
59574904|NCT02281591|75679587|FG000|STARTED|Overall Study||8||
59574905|NCT02281591|75679588|FG001|STARTED|Overall Study||8||
59574906|NCT02281591|75679589|FG002|STARTED|Overall Study||8||
59574907|NCT02281591|75679590|FG003|STARTED|Overall Study||8||
59574908|NCT02281591|75679587|FG000|COMPLETED|Overall Study||8||
59574909|NCT02281591|75679588|FG001|COMPLETED|Overall Study||8||
59574910|NCT02281591|75679589|FG002|COMPLETED|Overall Study||8||
59574911|NCT02281591|75679590|FG003|COMPLETED|Overall Study||8||
59574912|NCT02281591|75679587|FG000|NOT COMPLETED|Overall Study||0||
59574913|NCT02281591|75679588|FG001|NOT COMPLETED|Overall Study||0||
59850276|NCT03585712|75974612|FG001|STARTED|Treatment Period 1|Randomization in Treatment Period 2|0||
59850277|NCT03585712|75974613|FG002|STARTED|Treatment Period 1|Randomization in Treatment Period 2|0||
59574914|NCT02281591|75679589|FG002|NOT COMPLETED|Overall Study||0||
59574915|NCT02281591|75679590|FG003|NOT COMPLETED|Overall Study||0||
59574916|NCT01880047|75679604|FG000|STARTED|Weeks 0-2||17||
59850278|NCT03585712|75974611|FG000|COMPLETED|Treatment Period 1||51||
59574917|NCT01880047|75679605|FG001|STARTED|Weeks 0-2||9||
59574918|NCT01880047|75679606|FG002|STARTED|Weeks 0-2||5||
59574919|NCT01880047|75679607|FG003|STARTED|Weeks 0-2||3||
59574920|NCT01880047|75679604|FG000|COMPLETED|Weeks 0-2||17||
59574921|NCT01880047|75679605|FG001|COMPLETED|Weeks 0-2||8||
59574922|NCT01880047|75679606|FG002|COMPLETED|Weeks 0-2||4||
59574923|NCT01880047|75679607|FG003|COMPLETED|Weeks 0-2||2||
59574924|NCT01880047|75679604|FG000|NOT COMPLETED|Weeks 0-2||0||
59574925|NCT01880047|75679605|FG001|NOT COMPLETED|Weeks 0-2||1||
59574926|NCT01880047|75679606|FG002|NOT COMPLETED|Weeks 0-2||1||
59574927|NCT01880047|75679607|FG003|NOT COMPLETED|Weeks 0-2||1||
59574928|NCT01880047|75679604|FG000|STARTED|Weeks 3-4||17||
59574929|NCT01880047|75679605|FG001|STARTED|Weeks 3-4||8||
59574930|NCT01880047|75679606|FG002|STARTED|Weeks 3-4||4||
59574931|NCT01880047|75679607|FG003|STARTED|Weeks 3-4||2||
59574932|NCT01880047|75679604|FG000|COMPLETED|Weeks 3-4||17||
59574933|NCT01880047|75679605|FG001|COMPLETED|Weeks 3-4||7||
59574934|NCT01880047|75679606|FG002|COMPLETED|Weeks 3-4||4||
59574935|NCT01880047|75679607|FG003|COMPLETED|Weeks 3-4||2||
59574936|NCT01880047|75679604|FG000|NOT COMPLETED|Weeks 3-4||0||
59574937|NCT01880047|75679605|FG001|NOT COMPLETED|Weeks 3-4||1||
59574938|NCT01880047|75679606|FG002|NOT COMPLETED|Weeks 3-4||0||
59574939|NCT01880047|75679607|FG003|NOT COMPLETED|Weeks 3-4||0||
59574940|NCT01880047|75679604|FG000|STARTED|Weeks 5-8||17||
59574941|NCT01880047|75679605|FG001|STARTED|Weeks 5-8||7||
59574942|NCT01880047|75679606|FG002|STARTED|Weeks 5-8||4||
59574943|NCT01880047|75679607|FG003|STARTED|Weeks 5-8||2||
59574944|NCT01880047|75679604|FG000|COMPLETED|Weeks 5-8||15||
59574945|NCT01880047|75679605|FG001|COMPLETED|Weeks 5-8||6||
59574946|NCT01880047|75679606|FG002|COMPLETED|Weeks 5-8||4||
59574947|NCT01880047|75679607|FG003|COMPLETED|Weeks 5-8||2||
59574948|NCT01880047|75679604|FG000|NOT COMPLETED|Weeks 5-8||2||
59574949|NCT01880047|75679605|FG001|NOT COMPLETED|Weeks 5-8||1||
59574950|NCT01880047|75679606|FG002|NOT COMPLETED|Weeks 5-8||0||
59574951|NCT01880047|75679607|FG003|NOT COMPLETED|Weeks 5-8||0||
59574952|NCT01880047|75679604|FG000|STARTED|Extension Phase - 18 Months|15 subjects went into extension phase, were followed for variable periods of time|15||
59574953|NCT01880047|75679605|FG001|STARTED|Extension Phase - 18 Months|6 subjects went into extension phase, were followed for variable periods of time|6||
59574954|NCT01880047|75679606|FG002|STARTED|Extension Phase - 18 Months|4 subjects went into extension phase, were followed for variable periods of time|4||
59574955|NCT01880047|75679607|FG003|STARTED|Extension Phase - 18 Months|2 subjects went into extension phase, were followed for variable periods of time|2||
59574956|NCT01880047|75679604|FG000|COMPLETED|Extension Phase - 18 Months||6||
59574957|NCT01880047|75679605|FG001|COMPLETED|Extension Phase - 18 Months||3||
59574958|NCT01880047|75679606|FG002|COMPLETED|Extension Phase - 18 Months||3||
59574959|NCT01880047|75679607|FG003|COMPLETED|Extension Phase - 18 Months||0||
59574960|NCT01880047|75679604|FG000|NOT COMPLETED|Extension Phase - 18 Months||9||
59574961|NCT01880047|75679605|FG001|NOT COMPLETED|Extension Phase - 18 Months||3||
59574962|NCT01880047|75679606|FG002|NOT COMPLETED|Extension Phase - 18 Months||1||
59574963|NCT01880047|75679607|FG003|NOT COMPLETED|Extension Phase - 18 Months||2||
59574964|NCT01881373|75679627|FG000|STARTED|Baseline|Cross-sectional sample|1517|community randomized trial with 2 cross sectional samples at baseline and 24 months.|9
59574965|NCT01881373|75679628|FG001|STARTED|Baseline|Cross-sectional sample|1491|community randomized trial with 2 cross sectional samples at baseline and 24 months.|9
59574966|NCT01881373|75679629|FG002|STARTED|Baseline|Cross-sectional sample|1321|community randomized trial with 2 cross sectional samples at baseline and 24 months.|9
59574967|NCT01881373|75679627|FG000|COMPLETED|Baseline|Cross-sectional sample|1517||9
59574968|NCT01881373|75679628|FG001|COMPLETED|Baseline|Cross-sectional sample|1491||9
59574969|NCT01881373|75679629|FG002|COMPLETED|Baseline|Cross-sectional sample|1321||9
59574970|NCT01881373|75679627|FG000|NOT COMPLETED|Baseline||0||0
59574971|NCT01881373|75679628|FG001|NOT COMPLETED|Baseline||0||0
59574972|NCT01881373|75679629|FG002|NOT COMPLETED|Baseline||0||0
59574973|NCT01881373|75679627|FG000|STARTED|24 Months|Cross-sectional sample, independent of sample at baseline|1342||9
59574974|NCT01881373|75679628|FG001|STARTED|24 Months|Cross-sectional sample, independent of sample at baseline|1295||9
59574975|NCT01881373|75679629|FG002|STARTED|24 Months|Cross-sectional sample, independent of sample at baseline|1405||9
59574976|NCT01881373|75679627|FG000|COMPLETED|24 Months|Cross-sectional sample, independent of sample at baseline|1342||9
59574977|NCT01881373|75679628|FG001|COMPLETED|24 Months|Cross-sectional sample, independent of sample at baseline|1295||9
59574978|NCT01881373|75679629|FG002|COMPLETED|24 Months|Cross-sectional sample, independent of sample at baseline|1405||9
59574979|NCT01881373|75679627|FG000|NOT COMPLETED|24 Months||0||0
59574980|NCT01881373|75679628|FG001|NOT COMPLETED|24 Months||0||0
59574981|NCT01881373|75679629|FG002|NOT COMPLETED|24 Months||0||0
59574982|NCT02731469|75679652|FG000|STARTED|Overall Study||3||
59574983|NCT02731469|75679653|FG001|STARTED|Overall Study||3||
59574984|NCT02731469|75679654|FG002|STARTED|Overall Study||3||
59574985|NCT02731469|75679655|FG003|STARTED|Overall Study||3||
59574986|NCT02731469|75679656|FG004|STARTED|Overall Study||3||
59574987|NCT02731469|75679657|FG005|STARTED|Overall Study||3||
59574988|NCT02731469|75679658|FG006|STARTED|Overall Study||3||
59574989|NCT02731469|75679659|FG007|STARTED|Overall Study||6||
59574990|NCT02731469|75679660|FG008|STARTED|Overall Study||6||
59574991|NCT02731469|75679661|FG009|STARTED|Overall Study||6||
59574992|NCT02731469|75679662|FG010|STARTED|Overall Study||6||
59574993|NCT02731469|75679652|FG000|COMPLETED|Overall Study||3||
59574994|NCT02731469|75679653|FG001|COMPLETED|Overall Study||3||
59574995|NCT02731469|75679654|FG002|COMPLETED|Overall Study||3||
59574996|NCT02731469|75679655|FG003|COMPLETED|Overall Study||3||
59574997|NCT02731469|75679656|FG004|COMPLETED|Overall Study||3||
59574998|NCT02731469|75679657|FG005|COMPLETED|Overall Study||3||
59574999|NCT02731469|75679658|FG006|COMPLETED|Overall Study||3||
59575000|NCT02731469|75679659|FG007|COMPLETED|Overall Study||6||
59575001|NCT02731469|75679660|FG008|COMPLETED|Overall Study||6||
59575002|NCT02731469|75679661|FG009|COMPLETED|Overall Study||6||
59575003|NCT02731469|75679662|FG010|COMPLETED|Overall Study||6||
59575004|NCT02731469|75679652|FG000|NOT COMPLETED|Overall Study||0||
59575005|NCT02731469|75679653|FG001|NOT COMPLETED|Overall Study||0||
59721420|NCT01079130|75840344|FG002|Safety Set: Received Study Drug|Overall Study||84||
59721421|NCT01079130|75840345|FG003|Safety Set: Received Study Drug|Overall Study||85||
59721422|NCT01079130|75840346|FG004|Safety Set: Received Study Drug|Overall Study||84||
59721423|NCT01079130|75840347|FG005|Safety Set: Received Study Drug|Overall Study||84||
59721424|NCT01079130|75840342|FG000|Full Analysis Set (FAS)|Overall Study||84||
59721425|NCT01079130|75840343|FG001|Full Analysis Set (FAS)|Overall Study|2 patients (1 in 37.5 µg;1 in 75 µg group) randomized more than once and were excluded from the FAS.|80||
59721426|NCT01079130|75840344|FG002|Full Analysis Set (FAS)|Overall Study||83||
59721427|NCT01079130|75840345|FG003|Full Analysis Set (FAS)|Overall Study||85||
59721428|NCT01079130|75840346|FG004|Full Analysis Set (FAS)|Overall Study||84||
59721429|NCT01079130|75840347|FG005|Full Analysis Set (FAS)|Overall Study||84||
59721430|NCT01079130|75840342|FG000|COMPLETED|Overall Study||83||
59850279|NCT03585712|75974612|FG001|COMPLETED|Treatment Period 1||0||
59850280|NCT03585712|75974613|FG002|COMPLETED|Treatment Period 1||0||
59850281|NCT03585712|75974611|FG000|NOT COMPLETED|Treatment Period 1||1||
59850282|NCT03585712|75974612|FG001|NOT COMPLETED|Treatment Period 1||0||
59850283|NCT03585712|75974613|FG002|NOT COMPLETED|Treatment Period 1||0||
59850284|NCT03585712|75974611|FG000|STARTED|Treatment Periods 2 and 3|Subjects having completed Treatment Period 1 randomized in Arm A or Arm B|0||
59850285|NCT03585712|75974612|FG001|STARTED|Treatment Periods 2 and 3||26||
59850286|NCT03585712|75974613|FG002|STARTED|Treatment Periods 2 and 3||25||
59850287|NCT03585712|75974611|FG000|COMPLETED|Treatment Periods 2 and 3||0||
59850288|NCT03585712|75974612|FG001|COMPLETED|Treatment Periods 2 and 3||23||
59850289|NCT03585712|75974613|FG002|COMPLETED|Treatment Periods 2 and 3||22||
59850290|NCT03585712|75974611|FG000|NOT COMPLETED|Treatment Periods 2 and 3||0||
59850291|NCT03585712|75974612|FG001|NOT COMPLETED|Treatment Periods 2 and 3||3||
59850292|NCT03585712|75974613|FG002|NOT COMPLETED|Treatment Periods 2 and 3||3||
59850293|NCT03585244|75974630|FG000|STARTED|Overall Study||180||
59850294|NCT03585244|75974630|FG000|COMPLETED|Overall Study||165||
59850295|NCT03585244|75974630|FG000|NOT COMPLETED|Overall Study||15||
59850296|NCT00074984|75974636|FG000|STARTED|Overall Study||31||
59850297|NCT00074984|75974637|FG001|STARTED|Overall Study||51||
59850298|NCT00074984|75974636|FG000|COMPLETED|Overall Study||28||
59996700|NCT02714569|76112510|FG007|STARTED|Part B (Overall)|Part B participants randomized to receive 20 mg of LY3202328 + atorvastatin/simvastatin.|8||
59996701|NCT02714569|76112511|FG008|STARTED|Part B (Overall)|Part B participants randomized to receive 100 mg of LY3202328 + atorvastatin/simvastatin.|8||
59996702|NCT02714569|76112512|FG009|STARTED|Part B (Overall)|Part B participants randomized to receive 300 mg of LY3202328 + atorvastatin/simvastatin.|8||
59996703|NCT02714569|76112513|FG010|STARTED|Part B (Overall)|Part B participants randomized to receive placebo instead of LY3202328 + atorvastatin/simvastatin.|8||
59996704|NCT02714569|76112503|FG000|COMPLETED|Part B (Overall)||0||
59996705|NCT02714569|76112504|FG001|COMPLETED|Part B (Overall)||0||
59996706|NCT02714569|76112505|FG002|COMPLETED|Part B (Overall)||0||
59996707|NCT02714569|76112506|FG003|COMPLETED|Part B (Overall)||0||
59996708|NCT02714569|76112507|FG004|COMPLETED|Part B (Overall)||0||
59996709|NCT02714569|76112508|FG005|COMPLETED|Part B (Overall)||0||
59996710|NCT02714569|76112509|FG006|COMPLETED|Part B (Overall)||7||
59575006|NCT02731469|75679654|FG002|NOT COMPLETED|Overall Study||0||
59575007|NCT02731469|75679655|FG003|NOT COMPLETED|Overall Study||0||
59575008|NCT02731469|75679656|FG004|NOT COMPLETED|Overall Study||0||
59575009|NCT02731469|75679657|FG005|NOT COMPLETED|Overall Study||0||
59575010|NCT02731469|75679658|FG006|NOT COMPLETED|Overall Study||0||
59575011|NCT02731469|75679659|FG007|NOT COMPLETED|Overall Study||0||
59575012|NCT02731469|75679660|FG008|NOT COMPLETED|Overall Study||0||
59575013|NCT02731469|75679661|FG009|NOT COMPLETED|Overall Study||0||
59575014|NCT02731469|75679662|FG010|NOT COMPLETED|Overall Study||0||
59575015|NCT01882543|75679688|FG000|STARTED|Overall Study||37||
59721431|NCT01079130|75840343|FG001|COMPLETED|Overall Study||78||
59721432|NCT01079130|75840344|FG002|COMPLETED|Overall Study||83||
59721433|NCT01079130|75840345|FG003|COMPLETED|Overall Study||81||
59996711|NCT02714569|76112510|FG007|COMPLETED|Part B (Overall)||7||
59996712|NCT02714569|76112511|FG008|COMPLETED|Part B (Overall)||8||
59996713|NCT02714569|76112512|FG009|COMPLETED|Part B (Overall)||6||
59996714|NCT02714569|76112513|FG010|COMPLETED|Part B (Overall)||8||
59996715|NCT02714569|76112503|FG000|NOT COMPLETED|Part B (Overall)||0||
59996716|NCT02714569|76112504|FG001|NOT COMPLETED|Part B (Overall)||0||
59575016|NCT01882543|75679689|FG001|STARTED|Overall Study||32||
59575017|NCT01882543|75679688|FG000|COMPLETED|Overall Study||33||
59575018|NCT01882543|75679689|FG001|COMPLETED|Overall Study||29||
59575019|NCT01882543|75679688|FG000|NOT COMPLETED|Overall Study||4||
59721434|NCT01079130|75840346|FG004|COMPLETED|Overall Study||78||
59575020|NCT01882543|75679689|FG001|NOT COMPLETED|Overall Study||3||
59575021|NCT01944319|75679698|FG000|STARTED|Overall Study||40||
59575022|NCT01944319|75679699|FG001|STARTED|Overall Study||39||
59575023|NCT01944319|75679698|FG000|COMPLETED|Overall Study||40||
59575024|NCT01944319|75679699|FG001|COMPLETED|Overall Study||39||
59575025|NCT01944319|75679698|FG000|NOT COMPLETED|Overall Study||0||
59575026|NCT01944319|75679699|FG001|NOT COMPLETED|Overall Study||0||
59575027|NCT02284165|75679709|FG000|STARTED|Overall Study||36448||
59575028|NCT02284165|75679710|FG001|STARTED|Overall Study||40272||
59575029|NCT02284165|75679711|FG002|STARTED|Overall Study||70996||
59575030|NCT02284165|75679709|FG000|COMPLETED|Overall Study||36448||
59575031|NCT02284165|75679710|FG001|COMPLETED|Overall Study||40272||
59575032|NCT02284165|75679711|FG002|COMPLETED|Overall Study||70996||
59575033|NCT02284165|75679709|FG000|NOT COMPLETED|Overall Study||0||
59575034|NCT02284165|75679710|FG001|NOT COMPLETED|Overall Study||0||
59575035|NCT02284165|75679711|FG002|NOT COMPLETED|Overall Study||0||
59575036|NCT02733653|75679717|FG000|STARTED|Overall Study||50||
59575037|NCT02733653|75679717|FG000|COMPLETED|Overall Study||49||
59575038|NCT02733653|75679717|FG000|NOT COMPLETED|Overall Study||1||
59721435|NCT01079130|75840347|FG005|COMPLETED|Overall Study||80||
59721436|NCT01079130|75840342|FG000|NOT COMPLETED|Overall Study||2||
59721437|NCT01079130|75840343|FG001|NOT COMPLETED|Overall Study||7||
59721438|NCT01079130|75840344|FG002|NOT COMPLETED|Overall Study||1||
59721439|NCT01079130|75840345|FG003|NOT COMPLETED|Overall Study||5||
59721440|NCT01079130|75840346|FG004|NOT COMPLETED|Overall Study||8||
59721441|NCT01079130|75840347|FG005|NOT COMPLETED|Overall Study||5||
59721442|NCT01078974|75840361|FG000|STARTED|Overall Study||7||
59721443|NCT01078974|75840361|FG000|COMPLETED|Overall Study||4||
59721444|NCT01078974|75840361|FG000|NOT COMPLETED|Overall Study||3||
59721445|NCT00869557|75840367|FG000|STARTED|Randomized Phase||48||
59721446|NCT00869557|75840368|FG001|STARTED|Randomized Phase||23||
59721447|NCT00869557|75840367|FG000|COMPLETED|Randomized Phase||45||
59721448|NCT00869557|75840368|FG001|COMPLETED|Randomized Phase||21||
59721449|NCT00869557|75840367|FG000|NOT COMPLETED|Randomized Phase||3||
59721450|NCT00869557|75840368|FG001|NOT COMPLETED|Randomized Phase||2||
59721451|NCT00869557|75840367|FG000|STARTED|Extension Phase||45||
59721452|NCT00869557|75840368|FG001|STARTED|Extension Phase|Seven participants completing randomized Atripla treatment did not enter open-label extension phase.|14||
59721453|NCT00869557|75840367|FG000|COMPLETED|Extension Phase||35||
59721454|NCT00869557|75840368|FG001|COMPLETED|Extension Phase||11||
59721455|NCT00869557|75840367|FG000|NOT COMPLETED|Extension Phase||10||
59721456|NCT00869557|75840368|FG001|NOT COMPLETED|Extension Phase||3||
59721457|NCT01200290|75840375|FG000|STARTED|Treatment Period||18||
59721458|NCT01200290|75840375|FG000|Received at Least 1 Dose of Study Drug|Treatment Period||18||
59721459|NCT01200290|75840375|FG000|COMPLETED|Treatment Period||17||
59850299|NCT00074984|75974637|FG001|COMPLETED|Overall Study||43||
59850300|NCT00074984|75974636|FG000|NOT COMPLETED|Overall Study||3||
59850301|NCT00074984|75974637|FG001|NOT COMPLETED|Overall Study||8||
59850302|NCT03583606|75974647|FG000|STARTED|Overall Study||22||
59575039|NCT02734355|75679723|FG000|STARTED|Overall Study||34||
59575040|NCT02734355|75679724|FG001|STARTED|Overall Study||30||
59575041|NCT02734355|75679723|FG000|COMPLETED|Overall Study||34||
59575042|NCT02734355|75679724|FG001|COMPLETED|Overall Study||30||
59575043|NCT02734355|75679723|FG000|NOT COMPLETED|Overall Study||0||
59575044|NCT02734355|75679724|FG001|NOT COMPLETED|Overall Study||0||
59575045|NCT01947907|75679734|FG000|STARTED|Overall Study||12||
59575046|NCT01947907|75679735|FG001|STARTED|Overall Study||14||
59575047|NCT01947907|75679736|FG002|STARTED|Overall Study||14||
59575048|NCT01947907|75679737|FG003|STARTED|Overall Study||13||
59575049|NCT01947907|75679734|FG000|COMPLETED|Overall Study||12||
59575050|NCT01947907|75679735|FG001|COMPLETED|Overall Study||14||
59575051|NCT01947907|75679736|FG002|COMPLETED|Overall Study||14||
59575052|NCT01947907|75679737|FG003|COMPLETED|Overall Study||13||
59575053|NCT01947907|75679734|FG000|NOT COMPLETED|Overall Study||0||
59575054|NCT01947907|75679735|FG001|NOT COMPLETED|Overall Study||0||
59575055|NCT01947907|75679736|FG002|NOT COMPLETED|Overall Study||0||
59575056|NCT01947907|75679737|FG003|NOT COMPLETED|Overall Study||0||
59575057|NCT02737397|75679747|FG000|STARTED|Overall Study||13||
59575058|NCT02737397|75679747|FG000|JMI-001|Overall Study||13||
59575059|NCT02737397|75679747|FG000|SJP-304|Overall Study||12||
59575060|NCT02737397|75679747|FG000|SJP-223|Overall Study||13||
59575061|NCT02737397|75679747|FG000|Placebo|Overall Study||13||
59575062|NCT02737397|75679747|FG000|COMPLETED|Overall Study||13||
59575063|NCT02737397|75679747|FG000|NOT COMPLETED|Overall Study||0||
59575064|NCT02737631|75679757|FG000|STARTED|Overall Study||222||
59575065|NCT02737631|75679757|FG000|COMPLETED|Overall Study||222||
59575066|NCT02737631|75679757|FG000|NOT COMPLETED|Overall Study||0||
59575067|NCT01948141|75679761|FG000|STARTED|Overall Study||6||
59575068|NCT01948141|75679761|FG000|COMPLETED|Overall Study||6||
59575069|NCT01948141|75679761|FG000|NOT COMPLETED|Overall Study||0||
59575070|NCT01948375|75679767|FG000|STARTED|Overall Study||30||
59575071|NCT01948375|75679768|FG001|STARTED|Overall Study||30||
59575072|NCT01948375|75679767|FG000|COMPLETED|Overall Study||30||
59575073|NCT01948375|75679768|FG001|COMPLETED|Overall Study||30||
59575074|NCT01948375|75679767|FG000|NOT COMPLETED|Overall Study||0||
59575075|NCT01948375|75679768|FG001|NOT COMPLETED|Overall Study||0||
59575076|NCT01885117|75679778|FG000|STARTED|Overall Study||61||
59575077|NCT01885117|75679779|FG001|STARTED|Overall Study||64||
59575078|NCT01885117|75679778|FG000|COMPLETED|Overall Study||61||
59575079|NCT01885117|75679779|FG001|COMPLETED|Overall Study||64||
59575080|NCT01885117|75679778|FG000|NOT COMPLETED|Overall Study||0||
59575081|NCT01885117|75679779|FG001|NOT COMPLETED|Overall Study||0||
59575082|NCT01885897|75679791|FG000|STARTED|Overall Study||6||
59575083|NCT01885897|75679792|FG001|STARTED|Overall Study||3||
59575084|NCT01885897|75679793|FG002|STARTED|Overall Study||4||
59575085|NCT01885897|75679794|FG003|STARTED|Overall Study||3||
59575086|NCT01885897|75679795|FG004|STARTED|Overall Study||8||
59575087|NCT01885897|75679796|FG005|STARTED|Overall Study||9||
59575088|NCT01885897|75679791|FG000|COMPLETED|Overall Study||6||
59575089|NCT01885897|75679792|FG001|COMPLETED|Overall Study||3||
59575090|NCT01885897|75679793|FG002|COMPLETED|Overall Study||4||
59575091|NCT01885897|75679794|FG003|COMPLETED|Overall Study||3||
59575092|NCT01885897|75679795|FG004|COMPLETED|Overall Study||8||
59575093|NCT01885897|75679796|FG005|COMPLETED|Overall Study||9||
59575094|NCT01885897|75679791|FG000|NOT COMPLETED|Overall Study||0||
59575095|NCT01885897|75679792|FG001|NOT COMPLETED|Overall Study||0||
59575096|NCT01885897|75679793|FG002|NOT COMPLETED|Overall Study||0||
59575097|NCT01885897|75679794|FG003|NOT COMPLETED|Overall Study||0||
59575098|NCT01885897|75679795|FG004|NOT COMPLETED|Overall Study||0||
60121265|NCT01688921|76242159|FG000|NOT COMPLETED|Overall Study||16||
60121266|NCT01688921|76242160|FG001|NOT COMPLETED|Overall Study||15||
59575099|NCT01885897|75679796|FG005|NOT COMPLETED|Overall Study||0||
59575100|NCT01889563|75679812|FG000|STARTED|Overall Study||17||
59575101|NCT01889563|75679813|FG001|STARTED|Overall Study||15||
59575102|NCT01889563|75679812|FG000|COMPLETED|Overall Study||10||
59575103|NCT01889563|75679813|FG001|COMPLETED|Overall Study||10||
59575104|NCT01889563|75679812|FG000|NOT COMPLETED|Overall Study||7||
59575105|NCT01889563|75679813|FG001|NOT COMPLETED|Overall Study||5||
59575106|NCT01889797|75679821|FG000|STARTED|Overall Study||16||
59575107|NCT01889797|75679822|FG001|STARTED|Overall Study||16||
59575108|NCT01889797|75679821|FG000|COMPLETED|Overall Study||16||
59575109|NCT01889797|75679822|FG001|COMPLETED|Overall Study||16||
59575110|NCT01889797|75679821|FG000|NOT COMPLETED|Overall Study||0||
59575111|NCT01889797|75679822|FG001|NOT COMPLETED|Overall Study||0||
59575112|NCT01890031|75679833|FG000|STARTED|Overall Study||50||
59575113|NCT01890031|75679834|FG001|STARTED|Overall Study||50||
59575114|NCT01890031|75679835|FG002|STARTED|Overall Study||12||
59575115|NCT01890031|75679836|FG003|STARTED|Overall Study||11||
59575116|NCT01890031|75679837|FG004|STARTED|Overall Study||8||
59575117|NCT01890031|75679833|FG000|COMPLETED|Overall Study||50||
59575118|NCT01890031|75679834|FG001|COMPLETED|Overall Study||50||
59575119|NCT01890031|75679835|FG002|COMPLETED|Overall Study||12||
59575120|NCT01890031|75679836|FG003|COMPLETED|Overall Study||11||
59575121|NCT01890031|75679837|FG004|COMPLETED|Overall Study||8||
59575122|NCT01890031|75679833|FG000|NOT COMPLETED|Overall Study||0||
59575123|NCT01890031|75679834|FG001|NOT COMPLETED|Overall Study||0||
59575124|NCT01890031|75679835|FG002|NOT COMPLETED|Overall Study||0||
59575125|NCT01890031|75679836|FG003|NOT COMPLETED|Overall Study||0||
59575126|NCT01890031|75679837|FG004|NOT COMPLETED|Overall Study||0||
59575127|NCT04537793|75679849|FG000|STARTED|Part A (15 Days)||18||
59575128|NCT04537793|75679850|FG001|STARTED|Part A (15 Days)||0||
59575129|NCT04537793|75679849|FG000|COMPLETED|Part A (15 Days)||18||
59575130|NCT04537793|75679850|FG001|COMPLETED|Part A (15 Days)||0||
59575131|NCT04537793|75679849|FG000|NOT COMPLETED|Part A (15 Days)||0||
59575132|NCT04537793|75679850|FG001|NOT COMPLETED|Part A (15 Days)||0||
59575133|NCT04537793|75679849|FG000|STARTED|Part B (24 Weeks)||0||
59575134|NCT04537793|75679850|FG001|STARTED|Part B (24 Weeks)|Out of the 18 participants from Part A, 10 participants also participated in Part B of the study.|75||
59575135|NCT04537793|75679849|FG000|COMPLETED|Part B (24 Weeks)||0||
59575136|NCT04537793|75679850|FG001|COMPLETED|Part B (24 Weeks)||74||
59575137|NCT04537793|75679849|FG000|NOT COMPLETED|Part B (24 Weeks)||0||
59575138|NCT04537793|75679850|FG001|NOT COMPLETED|Part B (24 Weeks)||1||
59575139|NCT01949389|75679860|FG000|STARTED|Overall Study||51||
59575140|NCT01949389|75679860|FG000|COMPLETED|Overall Study||51||
59575141|NCT01949389|75679860|FG000|NOT COMPLETED|Overall Study||0||
59575142|NCT01949545|75679868|FG000|STARTED|Overall Study||11||
59575143|NCT01949545|75679869|FG001|STARTED|Overall Study||17||
59575144|NCT01949545|75679870|FG002|STARTED|Overall Study||14||
59575145|NCT01949545|75679871|FG003|STARTED|Overall Study||4||
59575146|NCT01949545|75679868|FG000|COMPLETED|Overall Study||11||
59575147|NCT01949545|75679869|FG001|COMPLETED|Overall Study||17||
59575148|NCT01949545|75679870|FG002|COMPLETED|Overall Study||14||
59575149|NCT01949545|75679871|FG003|COMPLETED|Overall Study||4||
59575150|NCT01949545|75679868|FG000|NOT COMPLETED|Overall Study||0||
59575151|NCT01949545|75679869|FG001|NOT COMPLETED|Overall Study||0||
59575152|NCT01949545|75679870|FG002|NOT COMPLETED|Overall Study||0||
59575153|NCT01949545|75679871|FG003|NOT COMPLETED|Overall Study||0||
59575154|NCT01949779|75679881|FG000|STARTED|Overall Study||81||
59575155|NCT01949779|75679881|FG000|COMPLETED|Overall Study||79||
59575156|NCT01949779|75679881|FG000|NOT COMPLETED|Overall Study||2||
59575157|NCT01890343|75679888|FG000|STARTED|Overall Study||8||
59575158|NCT01890343|75679889|FG001|STARTED|Overall Study||10||
59575159|NCT01890343|75679890|FG002|STARTED|Overall Study||10||
59575160|NCT01890343|75679888|FG000|COMPLETED|Overall Study||8||
59575161|NCT01890343|75679889|FG001|COMPLETED|Overall Study||10||
59575162|NCT01890343|75679890|FG002|COMPLETED|Overall Study||10||
59575163|NCT01890343|75679888|FG000|NOT COMPLETED|Overall Study||0||
59575164|NCT01890343|75679889|FG001|NOT COMPLETED|Overall Study||0||
59575165|NCT01890343|75679890|FG002|NOT COMPLETED|Overall Study||0||
59575166|NCT01894087|75679900|FG000|STARTED|Overall Study||102||
59575167|NCT01894087|75679901|FG001|STARTED|Overall Study||102||
59575168|NCT01894087|75679900|FG000|COMPLETED|Overall Study||96||
59575169|NCT01894087|75679901|FG001|COMPLETED|Overall Study||102||
59575170|NCT01894087|75679900|FG000|NOT COMPLETED|Overall Study||6||
59575171|NCT01894087|75679901|FG001|NOT COMPLETED|Overall Study||0||
59575172|NCT01951651|75679909|FG000|STARTED|Overall Study||12||
59575173|NCT01951651|75679910|FG001|STARTED|Overall Study||12||
59721460|NCT01200290|75840375|FG000|NOT COMPLETED|Treatment Period||1||
59721461|NCT01200290|75840375|FG000|STARTED|Post-Treatment Follow-Up Period|Participant who discontinued treatment was included in the post-treatment follow-up period.|18||
59721462|NCT01200290|75840375|FG000|COMPLETED|Post-Treatment Follow-Up Period||16||
59575174|NCT01951651|75679909|FG000|COMPLETED|Overall Study||8||
59721463|NCT01200290|75840375|FG000|NOT COMPLETED|Post-Treatment Follow-Up Period||2||
59721464|NCT01134263|75840384|FG000|STARTED|Overall Study||164||
59721465|NCT01134263|75840385|FG001|STARTED|Overall Study||163||
59721466|NCT01134263|75840386|FG002|STARTED|Overall Study||163||
59721467|NCT01134263|75840387|FG003|STARTED|Overall Study||168||
59721468|NCT01134263|75840388|FG004|STARTED|Overall Study||57||
59721469|NCT01134263|75840384|FG000|Received Vaccination 1|Overall Study||163||
59721470|NCT01134263|75840385|FG001|Received Vaccination 1|Overall Study||162||
59721471|NCT01134263|75840386|FG002|Received Vaccination 1|Overall Study||163||
59575175|NCT01951651|75679910|FG001|COMPLETED|Overall Study||10||
59575176|NCT01951651|75679909|FG000|NOT COMPLETED|Overall Study||4||
59575177|NCT01951651|75679910|FG001|NOT COMPLETED|Overall Study||2||
59575178|NCT01951963|75679918|FG000|STARTED|Overall Study||31||
59575179|NCT01951963|75679919|FG001|STARTED|Overall Study||32||
59575180|NCT01951963|75679918|FG000|COMPLETED|Overall Study||31||
59575181|NCT01951963|75679919|FG001|COMPLETED|Overall Study||32||
59575182|NCT01951963|75679918|FG000|NOT COMPLETED|Overall Study||0||
59575183|NCT01951963|75679919|FG001|NOT COMPLETED|Overall Study||0||
59575184|NCT01894555|75679929|FG000|STARTED|Overall Study||33||
59575185|NCT01894555|75679929|FG000|COMPLETED|Overall Study||33||
59575186|NCT01894555|75679929|FG000|NOT COMPLETED|Overall Study||0||
59575187|NCT01895647|75679936|FG000|STARTED|Overall Study||8||
59575188|NCT01895647|75679937|FG001|STARTED|Overall Study||10||
59575189|NCT01895647|75679938|FG002|STARTED|Overall Study||7||
59575190|NCT01895647|75679936|FG000|COMPLETED|Overall Study||8||
59575191|NCT01895647|75679937|FG001|COMPLETED|Overall Study||10||
59575192|NCT01895647|75679938|FG002|COMPLETED|Overall Study||7||
59575193|NCT01895647|75679936|FG000|NOT COMPLETED|Overall Study||0||
59575194|NCT01895647|75679937|FG001|NOT COMPLETED|Overall Study||0||
59575195|NCT01895647|75679938|FG002|NOT COMPLETED|Overall Study||0||
59575196|NCT01896115|75679948|FG000|STARTED|Overall Study||16||
59575197|NCT01896115|75679949|FG001|STARTED|Overall Study||24||
59575198|NCT01896115|75679948|FG000|Phase 1 Short PW|Overall Study||15||
59575199|NCT01896115|75679949|FG001|Phase 1 Short PW|Overall Study||0||
59575200|NCT01896115|75679948|FG000|Phase 1 Conventional PW|Overall Study||15||
59575201|NCT01896115|75679949|FG001|Phase 1 Conventional PW|Overall Study||0||
59575202|NCT01896115|75679948|FG000|Phase 1 Dorsal Steering|Overall Study||15||
59575203|NCT01896115|75679949|FG001|Phase 1 Dorsal Steering|Overall Study||0||
59575204|NCT01896115|75679948|FG000|Phase 1 Ventral Steering|Overall Study||15||
59575205|NCT01896115|75679949|FG001|Phase 1 Ventral Steering|Overall Study||0||
59575206|NCT01896115|75679948|FG000|Phase 2 Single Contact|Overall Study||0||
59575207|NCT01896115|75679949|FG001|Phase 2 Single Contact|Overall Study||24||
59575208|NCT01896115|75679948|FG000|Phase 2 Steering|Overall Study||0||
59575209|NCT01896115|75679949|FG001|Phase 2 Steering|Overall Study||24||
59575210|NCT01896115|75679948|FG000|COMPLETED|Overall Study||15||
59575211|NCT01896115|75679949|FG001|COMPLETED|Overall Study||24||
59575212|NCT01896115|75679948|FG000|NOT COMPLETED|Overall Study||1||
59575213|NCT01896115|75679949|FG001|NOT COMPLETED|Overall Study||0||
59575214|NCT01953211|75679960|FG000|STARTED|Overall Study|completed prior to clinical trials submission|64||
59575215|NCT01953211|75679960|FG000|COMPLETED|Overall Study|completed prior to clinical trials submission|64||
59575216|NCT01953211|75679960|FG000|NOT COMPLETED|Overall Study||0||
59575217|NCT02028221|75679968|FG000|STARTED|Overall Study||75||
59575218|NCT02028221|75679969|FG001|STARTED|Overall Study||76||
59575219|NCT02028221|75679968|FG000|COMPLETED|Overall Study||62||
59575220|NCT02028221|75679969|FG001|COMPLETED|Overall Study||56||
59575221|NCT02028221|75679968|FG000|NOT COMPLETED|Overall Study||13||
59575222|NCT02028221|75679969|FG001|NOT COMPLETED|Overall Study||20||
59575223|NCT01897285|75679975|FG000|STARTED|Overall Study|All 20 participants received original AND test adhesive dressings on upper arms and lower back.|20||
59575224|NCT01897285|75679975|FG000|COMPLETED|Overall Study||20||
59575225|NCT01897285|75679975|FG000|NOT COMPLETED|Overall Study||0||
59575226|NCT01955473|75679986|FG000|STARTED|Overall Study||3||
59575227|NCT01955473|75679987|FG001|STARTED|Overall Study||6||
59575228|NCT01955473|75679988|FG002|STARTED|Overall Study||6||
59575229|NCT01955473|75679989|FG003|STARTED|Overall Study||6||
59575230|NCT01955473|75679990|FG004|STARTED|Overall Study||30||
59575231|NCT01955473|75679986|FG000|COMPLETED|Overall Study||3||
59575232|NCT01955473|75679987|FG001|COMPLETED|Overall Study||6||
59575233|NCT01955473|75679988|FG002|COMPLETED|Overall Study||6||
59575234|NCT01955473|75679989|FG003|COMPLETED|Overall Study||6||
59575235|NCT01955473|75679990|FG004|COMPLETED|Overall Study||30||
59575236|NCT01955473|75679986|FG000|NOT COMPLETED|Overall Study||0||
59575237|NCT01955473|75679987|FG001|NOT COMPLETED|Overall Study||0||
59575238|NCT01955473|75679988|FG002|NOT COMPLETED|Overall Study||0||
59850303|NCT03583606|75974648|FG001|STARTED|Overall Study||20||
59575239|NCT01955473|75679989|FG003|NOT COMPLETED|Overall Study||0||
59575240|NCT01955473|75679990|FG004|NOT COMPLETED|Overall Study||0||
59575241|NCT01955629|75680006|FG000|STARTED|Overall Study||4||
59575242|NCT01955629|75680006|FG000|COMPLETED|Overall Study|1 participant with DP and 3 with unacceptable toxicity were considered completed as per protocol.|4||
59575243|NCT01955629|75680006|FG000|NOT COMPLETED|Overall Study||0||
59575244|NCT01898611|75680012|FG000|STARTED|Overall Study||5||
59575245|NCT01898611|75680013|FG001|STARTED|Overall Study||11||
59575246|NCT01898611|75680012|FG000|COMPLETED|Overall Study||5||
59575247|NCT01898611|75680013|FG001|COMPLETED|Overall Study||10||
59575248|NCT01898611|75680012|FG000|NOT COMPLETED|Overall Study||0||
59575249|NCT01898611|75680013|FG001|NOT COMPLETED|Overall Study||1||
59575250|NCT01898689|75680021|FG000|STARTED|Overall Study||10||
59575251|NCT01898689|75680022|FG001|STARTED|Overall Study||14||
59575252|NCT01898689|75680021|FG000|COMPLETED|Overall Study||10||
59575253|NCT01898689|75680022|FG001|COMPLETED|Overall Study||14||
59575254|NCT01898689|75680021|FG000|NOT COMPLETED|Overall Study||0||
59575255|NCT01898689|75680022|FG001|NOT COMPLETED|Overall Study||0||
59575256|NCT01956097|75680033|FG000|STARTED|Overall Study||30||
59850304|NCT03583606|75974649|FG002|STARTED|Overall Study||19||
59850305|NCT03583606|75974647|FG000|COMPLETED|Overall Study||21||
59575257|NCT01956097|75680034|FG001|STARTED|Overall Study||30||
59575258|NCT01956097|75680035|FG002|STARTED|Overall Study||15||
59575259|NCT01956097|75680033|FG000|COMPLETED|Overall Study||24||
59575260|NCT01956097|75680034|FG001|COMPLETED|Overall Study||28||
59575261|NCT01956097|75680035|FG002|COMPLETED|Overall Study||15||
59575262|NCT01956097|75680033|FG000|NOT COMPLETED|Overall Study||6||
59575263|NCT01956097|75680034|FG001|NOT COMPLETED|Overall Study||2||
59575264|NCT01956097|75680035|FG002|NOT COMPLETED|Overall Study||0||
59575265|NCT01900249|75680046|FG000|STARTED|Overall Study||67||
59850306|NCT03583606|75974648|FG001|COMPLETED|Overall Study||19||
59575266|NCT01900249|75680047|FG001|STARTED|Overall Study||68||
59575267|NCT01900249|75680048|FG002|STARTED|Overall Study||69||
59575268|NCT01900249|75680046|FG000|COMPLETED|Overall Study||64||
59575269|NCT01900249|75680047|FG001|COMPLETED|Overall Study||63||
59575270|NCT01900249|75680048|FG002|COMPLETED|Overall Study||65||
59575271|NCT01900249|75680046|FG000|NOT COMPLETED|Overall Study||3||
59575272|NCT01900249|75680047|FG001|NOT COMPLETED|Overall Study||5||
59575273|NCT01900249|75680048|FG002|NOT COMPLETED|Overall Study||4||
59575274|NCT01900561|75680058|FG000|STARTED|Overall Study||278||
59575275|NCT01900561|75680059|FG001|STARTED|Overall Study||278||
59575276|NCT01900561|75680058|FG000|COMPLETED|Overall Study||261||
59575277|NCT01900561|75680059|FG001|COMPLETED|Overall Study||269||
59575278|NCT01900561|75680058|FG000|NOT COMPLETED|Overall Study||17||
59575279|NCT01900561|75680059|FG001|NOT COMPLETED|Overall Study||9||
59575280|NCT01957657|75680065|FG000|STARTED|Overall Study||4||
59575281|NCT01957657|75680065|FG000|COMPLETED|Overall Study||4||
59575282|NCT01957657|75680065|FG000|NOT COMPLETED|Overall Study||0||
60121267|NCT00118755|76242169|FG000|STARTED|Overall Study||217||
60121268|NCT00118755|76242170|FG001|STARTED|Overall Study||218||
59575283|NCT01901575|75680069|FG000|STARTED|Overall Study|enrolled patients with PVC's present prior to sedation with remifentanil IVPCA|16||
59575284|NCT01901575|75680069|FG000|COMPLETED|Overall Study||16||
59575285|NCT01901575|75680069|FG000|NOT COMPLETED|Overall Study||0||
59575286|NCT01901809|75680078|FG000|STARTED|Overall Study||19||
59575287|NCT01901809|75680079|FG001|STARTED|Overall Study||23||
59575288|NCT01901809|75680080|FG002|STARTED|Overall Study||24||
59575289|NCT01901809|75680081|FG003|STARTED|Overall Study||24||
59575290|NCT01901809|75680078|FG000|COMPLETED|Overall Study||19||
59575291|NCT01901809|75680079|FG001|COMPLETED|Overall Study||23||
59575292|NCT01901809|75680080|FG002|COMPLETED|Overall Study||21||
59575293|NCT01901809|75680081|FG003|COMPLETED|Overall Study||22||
59575294|NCT01901809|75680078|FG000|NOT COMPLETED|Overall Study||0||
59575295|NCT01901809|75680079|FG001|NOT COMPLETED|Overall Study||0||
59575296|NCT01901809|75680080|FG002|NOT COMPLETED|Overall Study||3||
59575297|NCT01901809|75680081|FG003|NOT COMPLETED|Overall Study||2||
59575298|NCT01902901|75680097|FG000|STARTED|Overall Study||180||
59575299|NCT01902901|75680098|FG001|STARTED|Overall Study||203||
59575300|NCT01902901|75680097|FG000|COMPLETED|Overall Study||180||
59575301|NCT01902901|75680098|FG001|COMPLETED|Overall Study||201||
59575302|NCT01902901|75680097|FG000|NOT COMPLETED|Overall Study||0||
59575303|NCT01902901|75680098|FG001|NOT COMPLETED|Overall Study||2||
59575304|NCT02284399|75680106|FG000|STARTED|Overall Study||1414||
59575305|NCT02284399|75680107|FG001|STARTED|Overall Study||3074||
59575306|NCT02284399|75680106|FG000|COMPLETED|Overall Study||1414||
59575307|NCT02284399|75680107|FG001|COMPLETED|Overall Study||3074||
59575308|NCT02284399|75680106|FG000|NOT COMPLETED|Overall Study||0||
59575309|NCT02284399|75680107|FG001|NOT COMPLETED|Overall Study||0||
59575310|NCT01904071|75680118|FG000|STARTED|Overall Study||24||
59575311|NCT01904071|75680119|FG001|STARTED|Overall Study||20||
59575312|NCT01904071|75680120|FG002|STARTED|Overall Study||20||
59575313|NCT01904071|75680118|FG000|COMPLETED|Overall Study||24||
59575314|NCT01904071|75680119|FG001|COMPLETED|Overall Study||20||
59575315|NCT01904071|75680120|FG002|COMPLETED|Overall Study||20||
59575316|NCT01904071|75680118|FG000|NOT COMPLETED|Overall Study||0||
59575317|NCT01904071|75680119|FG001|NOT COMPLETED|Overall Study||0||
59575318|NCT01904071|75680120|FG002|NOT COMPLETED|Overall Study||0||
59575319|NCT01905241|75680128|FG000|STARTED|Overall Study||20||
59575320|NCT01905241|75680128|FG000|COMPLETED|Overall Study||20||
59575321|NCT01905241|75680128|FG000|NOT COMPLETED|Overall Study||0||
59575322|NCT01907113|75680137|FG000|STARTED|Overall Study||8||
59575323|NCT01907113|75680138|FG001|STARTED|Overall Study||9||
59575324|NCT01907113|75680139|FG002|STARTED|Overall Study||7||
59575325|NCT01907113|75680140|FG003|STARTED|Overall Study||8||
59575326|NCT01907113|75680141|FG004|STARTED|Overall Study||8||
59575327|NCT01907113|75680137|FG000|COMPLETED|Overall Study||8||
59575328|NCT01907113|75680138|FG001|COMPLETED|Overall Study||9||
59575329|NCT01907113|75680139|FG002|COMPLETED|Overall Study||7||
59575330|NCT01907113|75680140|FG003|COMPLETED|Overall Study||8||
59575331|NCT01907113|75680141|FG004|COMPLETED|Overall Study||8||
59575332|NCT01907113|75680137|FG000|NOT COMPLETED|Overall Study||0||
59575333|NCT01907113|75680138|FG001|NOT COMPLETED|Overall Study||0||
59575334|NCT01907113|75680139|FG002|NOT COMPLETED|Overall Study||0||
59575335|NCT01907113|75680140|FG003|NOT COMPLETED|Overall Study||0||
59850307|NCT03583606|75974649|FG002|COMPLETED|Overall Study||19||
59850308|NCT03583606|75974647|FG000|NOT COMPLETED|Overall Study||1||
60121269|NCT00118755|76242169|FG000|Safety Population|Overall Study||208||
60121270|NCT00118755|76242170|FG001|Safety Population|Overall Study||211||
59575336|NCT01907113|75680141|FG004|NOT COMPLETED|Overall Study||0||
59575337|NCT01907269|75680155|FG000|STARTED|6 Month Outcome Measures Post-interventi||1342||
60121271|NCT00118755|76242169|FG000|COMPLETED|Overall Study||7||
59575338|NCT01907269|75680156|FG001|STARTED|6 Month Outcome Measures Post-interventi||1342||
59575339|NCT01907269|75680155|FG000|COMPLETED|6 Month Outcome Measures Post-interventi||953||
59575340|NCT01907269|75680156|FG001|COMPLETED|6 Month Outcome Measures Post-interventi||1053||
59575341|NCT01907269|75680155|FG000|NOT COMPLETED|6 Month Outcome Measures Post-interventi||389||
60121272|NCT00118755|76242170|FG001|COMPLETED|Overall Study||3||
59575342|NCT01907269|75680156|FG001|NOT COMPLETED|6 Month Outcome Measures Post-interventi||289||
59575343|NCT01907269|75680155|FG000|STARTED|18 Month Outcome Measures Post-intervent||1178||
59575344|NCT01907269|75680156|FG001|STARTED|18 Month Outcome Measures Post-intervent||1250||
59575345|NCT01907269|75680155|FG000|COMPLETED|18 Month Outcome Measures Post-intervent||859||
59575346|NCT01907269|75680156|FG001|COMPLETED|18 Month Outcome Measures Post-intervent||970||
59575347|NCT01907269|75680155|FG000|NOT COMPLETED|18 Month Outcome Measures Post-intervent||319||
59575348|NCT01907269|75680156|FG001|NOT COMPLETED|18 Month Outcome Measures Post-intervent||280||
59575349|NCT01908127|75680164|FG000|STARTED|Overall Study||23||
59575350|NCT01908127|75680165|FG001|STARTED|Overall Study||23||
59575351|NCT01908127|75680164|FG000|COMPLETED|Overall Study||22||
59575352|NCT01908127|75680165|FG001|COMPLETED|Overall Study||23||
59575353|NCT01908127|75680164|FG000|NOT COMPLETED|Overall Study||1||
59575354|NCT01908127|75680165|FG001|NOT COMPLETED|Overall Study||0||
59575355|NCT01908751|75680175|FG000|STARTED|Overall Study||22||
59575356|NCT01908751|75680176|FG001|STARTED|Overall Study||23||
59575357|NCT01908751|75680177|FG002|STARTED|Overall Study||21||
59575358|NCT01908751|75680178|FG003|STARTED|Overall Study||20||
59575359|NCT01908751|75680175|FG000|COMPLETED|Overall Study||17||
59575360|NCT01908751|75680176|FG001|COMPLETED|Overall Study||18||
59575361|NCT01908751|75680177|FG002|COMPLETED|Overall Study||16||
59575362|NCT01908751|75680178|FG003|COMPLETED|Overall Study||16||
59575363|NCT01908751|75680175|FG000|NOT COMPLETED|Overall Study||5||
59575364|NCT01908751|75680176|FG001|NOT COMPLETED|Overall Study||5||
59575365|NCT01908751|75680177|FG002|NOT COMPLETED|Overall Study||5||
59575366|NCT01908751|75680178|FG003|NOT COMPLETED|Overall Study||4||
59575367|NCT01909141|75680190|FG000|STARTED|Overall Study||50||
59575368|NCT01909141|75680191|FG001|STARTED|Overall Study||50||
59575369|NCT01909141|75680190|FG000|COMPLETED|Overall Study||50||
59575370|NCT01909141|75680191|FG001|COMPLETED|Overall Study||50||
59575371|NCT01909141|75680190|FG000|NOT COMPLETED|Overall Study||0||
59575372|NCT01909141|75680191|FG001|NOT COMPLETED|Overall Study||0||
59575373|NCT01910311|75680199|FG000|STARTED|Period 1 (Days 1-2)||18||
59575374|NCT01910311|75680199|FG000|Received Baricitinib|Period 1 (Days 1-2)||18||
59575375|NCT01910311|75680199|FG000|COMPLETED|Period 1 (Days 1-2)||18||
59575376|NCT01910311|75680199|FG000|NOT COMPLETED|Period 1 (Days 1-2)||0||
59575377|NCT01910311|75680199|FG000|STARTED|Period 2 (Days 3-32)||18||
59575378|NCT01910311|75680199|FG000|Received Baricitinib|Period 2 (Days 3-32)||18||
59575379|NCT01910311|75680199|FG000|Received At Least 1 Dose of Rifampicin|Period 2 (Days 3-32)||18||
59575380|NCT01910311|75680199|FG000|COMPLETED|Period 2 (Days 3-32)||18||
59575381|NCT01910311|75680199|FG000|NOT COMPLETED|Period 2 (Days 3-32)||0||
59575382|NCT01911169|75680209|FG000|STARTED|Overall Study||6||
59575383|NCT01911169|75680210|FG001|STARTED|Overall Study||3||
59575384|NCT01911169|75680209|FG000|COMPLETED|Overall Study||6||
59575385|NCT01911169|75680210|FG001|COMPLETED|Overall Study||3||
59575386|NCT01911169|75680209|FG000|NOT COMPLETED|Overall Study||0||
59575387|NCT01911169|75680210|FG001|NOT COMPLETED|Overall Study||0||
59575388|NCT03374891|75680218|FG000|STARTED|Overall Study||346||
59575389|NCT03374891|75680219|FG001|STARTED|Overall Study||444||
59575390|NCT03374891|75680218|FG000|COMPLETED|Overall Study||323||
59575391|NCT03374891|75680219|FG001|COMPLETED|Overall Study||437||
59575392|NCT03374891|75680218|FG000|NOT COMPLETED|Overall Study||23||
59575393|NCT03374891|75680219|FG001|NOT COMPLETED|Overall Study||7||
59575394|NCT01911403|75680227|FG000|STARTED|Overall Study||61||
59575395|NCT01911403|75680228|FG001|STARTED|Overall Study||62||
59575396|NCT01911403|75680227|FG000|COMPLETED|Overall Study||52||
59575397|NCT01911403|75680228|FG001|COMPLETED|Overall Study||59||
59575398|NCT01911403|75680227|FG000|NOT COMPLETED|Overall Study||9||
59575399|NCT01911403|75680228|FG001|NOT COMPLETED|Overall Study||3||
59575400|NCT01912495|75680234|FG000|STARTED|Overall Study|8 patients had only screening visit, total enrollment: 65|57||
59575401|NCT01912495|75680234|FG000|COMPLETED|Overall Study||57||
59575402|NCT01912495|75680234|FG000|NOT COMPLETED|Overall Study||0||
59575403|NCT01916629|75680243|FG000|STARTED|Overall Study||7||
59575404|NCT01916629|75680244|FG001|STARTED|Overall Study||5||
59575405|NCT01916629|75680243|FG000|COMPLETED|Overall Study||7||
59575406|NCT01916629|75680244|FG001|COMPLETED|Overall Study||5||
59575407|NCT01916629|75680243|FG000|NOT COMPLETED|Overall Study||0||
59575408|NCT01916629|75680244|FG001|NOT COMPLETED|Overall Study||0||
59575409|NCT01916941|75680252|FG000|STARTED|Overall Study||18||
59575410|NCT01916941|75680253|FG001|STARTED|Overall Study||18||
59575411|NCT01916941|75680252|FG000|COMPLETED|Overall Study||13||
59575412|NCT01916941|75680253|FG001|COMPLETED|Overall Study||14||
59575413|NCT01916941|75680252|FG000|NOT COMPLETED|Overall Study||5||
59575414|NCT01916941|75680253|FG001|NOT COMPLETED|Overall Study||4||
59575415|NCT01918189|75680259|FG000|STARTED|Overall Study||59|59 participants enrolled (i.e., signed informed consent) but 58 completed baseline assessment.|
59575416|NCT01918189|75680259|FG000|Completed Baseline Assessment|Overall Study||58||
59575417|NCT01918189|75680259|FG000|Completed Follow-up Assessment|Overall Study||41||
59575418|NCT01918189|75680259|FG000|COMPLETED|Overall Study||41||
59575419|NCT01918189|75680259|FG000|NOT COMPLETED|Overall Study||18||
59575420|NCT01923805|75680266|FG000|STARTED|Overall Study|early termination|3|early termination|
59575421|NCT01923805|75680267|FG001|STARTED|Overall Study|early termination|5|early termination|
59575422|NCT01923805|75680266|FG000|COMPLETED|Overall Study||0||
59575423|NCT01923805|75680267|FG001|COMPLETED|Overall Study||0||
59575424|NCT01923805|75680266|FG000|NOT COMPLETED|Overall Study||3||
59575425|NCT01923805|75680267|FG001|NOT COMPLETED|Overall Study||5||
59575426|NCT01923961|75680276|FG000|STARTED|First Intervention||3||
59575427|NCT01923961|75680277|FG001|STARTED|First Intervention||3||
59575428|NCT01923961|75680278|FG002|STARTED|First Intervention||2||
59575429|NCT01923961|75680276|FG000|COMPLETED|First Intervention||3||
59575430|NCT01923961|75680277|FG001|COMPLETED|First Intervention||3||
59575431|NCT01923961|75680278|FG002|COMPLETED|First Intervention||2||
59575432|NCT01923961|75680276|FG000|NOT COMPLETED|First Intervention||0||
59575433|NCT01923961|75680277|FG001|NOT COMPLETED|First Intervention||0||
59575434|NCT01923961|75680278|FG002|NOT COMPLETED|First Intervention||0||
59575435|NCT01923961|75680276|FG000|STARTED|Washout (1 Week)||3||
59575436|NCT01923961|75680277|FG001|STARTED|Washout (1 Week)||3||
59575437|NCT01923961|75680278|FG002|STARTED|Washout (1 Week)||2||
59575438|NCT01923961|75680276|FG000|COMPLETED|Washout (1 Week)||3||
59575439|NCT01923961|75680277|FG001|COMPLETED|Washout (1 Week)||3||
59575440|NCT01923961|75680278|FG002|COMPLETED|Washout (1 Week)||2||
59575441|NCT01923961|75680276|FG000|NOT COMPLETED|Washout (1 Week)||0||
59575442|NCT01923961|75680277|FG001|NOT COMPLETED|Washout (1 Week)||0||
59575443|NCT01923961|75680278|FG002|NOT COMPLETED|Washout (1 Week)||0||
59575444|NCT01923961|75680276|FG000|STARTED|Second Intervention||3||
59575445|NCT01923961|75680277|FG001|STARTED|Second Intervention||3||
59575446|NCT01923961|75680278|FG002|STARTED|Second Intervention||2||
59575447|NCT01923961|75680276|FG000|COMPLETED|Second Intervention||3||
59575448|NCT01923961|75680277|FG001|COMPLETED|Second Intervention||3||
59575449|NCT01923961|75680278|FG002|COMPLETED|Second Intervention||2||
59575450|NCT01923961|75680276|FG000|NOT COMPLETED|Second Intervention||0||
59575451|NCT01923961|75680277|FG001|NOT COMPLETED|Second Intervention||0||
59575452|NCT01923961|75680278|FG002|NOT COMPLETED|Second Intervention||0||
59575453|NCT01923961|75680276|FG000|STARTED|Washout (1 Week)||3||
59575454|NCT01923961|75680277|FG001|STARTED|Washout (1 Week)||3||
59575455|NCT01923961|75680278|FG002|STARTED|Washout (1 Week)||2||
59575456|NCT01923961|75680276|FG000|COMPLETED|Washout (1 Week)||3||
59575457|NCT01923961|75680277|FG001|COMPLETED|Washout (1 Week)||3||
59575458|NCT01923961|75680278|FG002|COMPLETED|Washout (1 Week)||2||
59575459|NCT01923961|75680276|FG000|NOT COMPLETED|Washout (1 Week)||0||
59575460|NCT01923961|75680277|FG001|NOT COMPLETED|Washout (1 Week)||0||
59575461|NCT01923961|75680278|FG002|NOT COMPLETED|Washout (1 Week)||0||
59575462|NCT01923961|75680276|FG000|STARTED|Third Intervention||3||
59575463|NCT01923961|75680277|FG001|STARTED|Third Intervention||3||
59575464|NCT01923961|75680278|FG002|STARTED|Third Intervention||2||
59575465|NCT01923961|75680276|FG000|COMPLETED|Third Intervention||3||
59575466|NCT01923961|75680277|FG001|COMPLETED|Third Intervention||3||
59575467|NCT01923961|75680278|FG002|COMPLETED|Third Intervention||2||
59575468|NCT01923961|75680276|FG000|NOT COMPLETED|Third Intervention||0||
59575469|NCT01923961|75680277|FG001|NOT COMPLETED|Third Intervention||0||
59575470|NCT01923961|75680278|FG002|NOT COMPLETED|Third Intervention||0||
59575471|NCT01924975|75680288|FG000|STARTED|Overall Study||51||
59575472|NCT01924975|75680289|FG001|STARTED|Overall Study||51||
59575473|NCT01924975|75680288|FG000|COMPLETED|Overall Study||51||
59575474|NCT01924975|75680289|FG001|COMPLETED|Overall Study||51||
59575475|NCT01924975|75680288|FG000|NOT COMPLETED|Overall Study||0||
59575476|NCT01924975|75680289|FG001|NOT COMPLETED|Overall Study||0||
59575477|NCT01925677|75680295|FG000|STARTED|Overall Study||3||
59575478|NCT01925677|75680295|FG000|COMPLETED|Overall Study||3||
59575479|NCT01925677|75680295|FG000|NOT COMPLETED|Overall Study||0||
59575480|NCT02287675|75680301|FG000|STARTED|Overall Study||22||
59575481|NCT02287675|75680302|FG001|STARTED|Overall Study||18||
59575482|NCT02287675|75680301|FG000|COMPLETED|Overall Study||22||
59575483|NCT02287675|75680302|FG001|COMPLETED|Overall Study||18||
59575484|NCT02287675|75680301|FG000|NOT COMPLETED|Overall Study||0||
59575485|NCT02287675|75680302|FG001|NOT COMPLETED|Overall Study||0||
59575486|NCT01928797|75680310|FG000|STARTED|Overall Study||30||
59575487|NCT01928797|75680311|FG001|STARTED|Overall Study||30||
59575488|NCT01928797|75680310|FG000|COMPLETED|Overall Study||30||
59575489|NCT01928797|75680311|FG001|COMPLETED|Overall Study||30||
59575490|NCT01928797|75680310|FG000|NOT COMPLETED|Overall Study||0||
59575491|NCT01928797|75680311|FG001|NOT COMPLETED|Overall Study||0||
59575492|NCT01929889|75680319|FG000|STARTED|Overall Study|Target enrollment goal was 20 completed subjects.|8||
59575493|NCT01929889|75680319|FG000|COMPLETED|Overall Study|3 subjects completed the study.|3||
59575494|NCT01929889|75680319|FG000|NOT COMPLETED|Overall Study||5||
59575495|NCT03452033|75680327|FG000|STARTED|Overall Study||21||21
59575496|NCT03452033|75680328|FG001|STARTED|Overall Study||22||22
59575497|NCT03452033|75680329|FG002|STARTED|Overall Study||22||22
59575498|NCT03452033|75680330|FG003|STARTED|Overall Study||22||22
59575499|NCT03452033|75680327|FG000|COMPLETED|Overall Study||21||21
59575500|NCT03452033|75680328|FG001|COMPLETED|Overall Study||22||22
59575501|NCT03452033|75680329|FG002|COMPLETED|Overall Study||22||22
59575502|NCT03452033|75680330|FG003|COMPLETED|Overall Study||22||22
59575503|NCT03452033|75680327|FG000|NOT COMPLETED|Overall Study||0||0
59575504|NCT03452033|75680328|FG001|NOT COMPLETED|Overall Study||0||0
59575505|NCT03452033|75680329|FG002|NOT COMPLETED|Overall Study||0||0
59575506|NCT03452033|75680330|FG003|NOT COMPLETED|Overall Study||0||0
59575507|NCT02284555|75680343|FG000|STARTED|Overall Study||12||
59575508|NCT02284555|75680343|FG000|COMPLETED|Overall Study||12||
59575509|NCT02284555|75680343|FG000|NOT COMPLETED|Overall Study||0||
59575510|NCT02753699|75680350|FG000|STARTED|Overall Study||164||
59575511|NCT02753699|75680351|FG001|STARTED|Overall Study||397||
59575512|NCT02753699|75680352|FG002|STARTED|Overall Study||162||
59575513|NCT02753699|75680350|FG000|COMPLETED|Overall Study||150||
59575514|NCT02753699|75680351|FG001|COMPLETED|Overall Study||354||
59575515|NCT02753699|75680352|FG002|COMPLETED|Overall Study||139||
59575516|NCT02753699|75680350|FG000|NOT COMPLETED|Overall Study||14||
59575517|NCT02753699|75680351|FG001|NOT COMPLETED|Overall Study||43||
59575518|NCT02753699|75680352|FG002|NOT COMPLETED|Overall Study||23||
59575519|NCT02287909|75680366|FG000|STARTED|Overall Study||20||
59575520|NCT02287909|75680367|FG001|STARTED|Overall Study||20||
59575521|NCT02287909|75680368|FG002|STARTED|Overall Study||20||
59575522|NCT02287909|75680369|FG003|STARTED|Overall Study||20||
59575523|NCT02287909|75680366|FG000|COMPLETED|Overall Study||18||
59575524|NCT02287909|75680367|FG001|COMPLETED|Overall Study||19||
59575525|NCT02287909|75680368|FG002|COMPLETED|Overall Study||20||
59575526|NCT02287909|75680369|FG003|COMPLETED|Overall Study||19||
59575527|NCT02287909|75680366|FG000|NOT COMPLETED|Overall Study||2||
59575528|NCT02287909|75680367|FG001|NOT COMPLETED|Overall Study||1||
59575529|NCT02287909|75680368|FG002|NOT COMPLETED|Overall Study||0||
59575530|NCT02287909|75680369|FG003|NOT COMPLETED|Overall Study||1||
59575531|NCT02284867|75680381|FG000|STARTED|Overall Study||30||
59575532|NCT02284867|75680382|FG001|STARTED|Overall Study||30||
59575533|NCT02284867|75680381|FG000|COMPLETED|Overall Study||30||
59575534|NCT02284867|75680382|FG001|COMPLETED|Overall Study||30||
59575535|NCT02284867|75680381|FG000|NOT COMPLETED|Overall Study||0||
59575536|NCT02284867|75680382|FG001|NOT COMPLETED|Overall Study||0||
59575537|NCT02833805|75680388|FG000|STARTED|Overall Study||21||
59575538|NCT02833805|75680388|FG000|COMPLETED|Overall Study||21||
59575539|NCT02833805|75680388|FG000|NOT COMPLETED|Overall Study||0||
59575540|NCT02327195|75680394|FG000|STARTED|Overall Study||27||
59575541|NCT02327195|75680395|FG001|STARTED|Overall Study||27||
59575542|NCT02327195|75680394|FG000|COMPLETED|Overall Study||27||
59575543|NCT02327195|75680395|FG001|COMPLETED|Overall Study||27||
59575544|NCT02327195|75680394|FG000|NOT COMPLETED|Overall Study||0||
59575545|NCT02327195|75680395|FG001|NOT COMPLETED|Overall Study||0||
59575546|NCT02756351|75680403|FG000|STARTED|Overall Study||24||
59575547|NCT02756351|75680404|FG001|STARTED|Overall Study||24||
59575548|NCT02756351|75680403|FG000|COMPLETED|Overall Study||24||
59575549|NCT02756351|75680404|FG001|COMPLETED|Overall Study||24||
59575550|NCT02756351|75680403|FG000|NOT COMPLETED|Overall Study||0||
59575551|NCT02756351|75680404|FG001|NOT COMPLETED|Overall Study||0||
59575552|NCT02285023|75680410|FG000|STARTED|Overall Study||166||
59575553|NCT02285023|75680410|FG000|COMPLETED|Overall Study||166||
59575554|NCT02285023|75680410|FG000|NOT COMPLETED|Overall Study||0||
59575555|NCT02330341|75680422|FG000|STARTED|Overall Study||12||
59575556|NCT02330341|75680423|FG001|STARTED|Overall Study||12||
59575557|NCT02330341|75680422|FG000|COMPLETED|Overall Study||12||
59575558|NCT02330341|75680423|FG001|COMPLETED|Overall Study||11||
59575559|NCT02330341|75680422|FG000|NOT COMPLETED|Overall Study||0||
59575560|NCT02330341|75680423|FG001|NOT COMPLETED|Overall Study||1||
59575561|NCT02740517|75680432|FG000|STARTED|Overall Study||19||
59575562|NCT02740517|75680433|FG001|STARTED|Overall Study||11||
59575563|NCT02740517|75680434|FG002|STARTED|Overall Study||18||
59575564|NCT02740517|75680432|FG000|COMPLETED|Overall Study||19||
59575565|NCT02740517|75680433|FG001|COMPLETED|Overall Study||11||
59575566|NCT02740517|75680434|FG002|COMPLETED|Overall Study||18||
59575567|NCT02740517|75680432|FG000|NOT COMPLETED|Overall Study||0||
59575568|NCT02740517|75680433|FG001|NOT COMPLETED|Overall Study||0||
59575569|NCT02740517|75680434|FG002|NOT COMPLETED|Overall Study||0||
59575570|NCT02761967|75680444|FG000|STARTED|Overall Study||70||
59575571|NCT02761967|75680445|FG001|STARTED|Overall Study||70||
59575572|NCT02761967|75680444|FG000|COMPLETED|Overall Study||65||
59575573|NCT02761967|75680445|FG001|COMPLETED|Overall Study||64||
59575574|NCT02761967|75680444|FG000|NOT COMPLETED|Overall Study||5||
59575575|NCT02761967|75680445|FG001|NOT COMPLETED|Overall Study||6||
59575576|NCT02762513|75680454|FG000|STARTED|Overall Study||28|Started study treatment with axitinib|
59575577|NCT02762513|75680454|FG000|COMPLETED|Overall Study||28|Completed at least one 28-day cycle of treatment with axitinib.|
59575578|NCT02762513|75680454|FG000|NOT COMPLETED|Overall Study||0||
59575579|NCT02764385|75680460|FG000|STARTED|Overall Study||9145||
59575580|NCT02764385|75680461|FG001|STARTED|Overall Study||6641||
59575581|NCT02764385|75680460|FG000|COMPLETED|Overall Study||9145||
59575582|NCT02764385|75680461|FG001|COMPLETED|Overall Study||6641||
59575583|NCT02764385|75680460|FG000|NOT COMPLETED|Overall Study||0||
59575584|NCT02764385|75680461|FG001|NOT COMPLETED|Overall Study||0||
59575585|NCT02767271|75680469|FG000|STARTED|Overall Study||15||
59575586|NCT02767271|75680470|FG001|STARTED|Overall Study||15||
59575587|NCT02767271|75680469|FG000|Safety Population|Overall Study||15|Received at least 1 application of study drug.|
59575588|NCT02767271|75680470|FG001|Safety Population|Overall Study||15|Received at least 1 application of study drug.|
59575589|NCT02767271|75680469|FG000|Pharmacokinetic Pedis (PKP) Population|Overall Study||15|Participants with tinea pedis, received ≥1 dose of study drug, had at least 1 PK assessment.|
59575590|NCT02767271|75680470|FG001|Pharmacokinetic Pedis (PKP) Population|Overall Study||0|Participants with tinea pedis, received ≥1 dose of study drug, had at least 1 PK assessment.|
59575591|NCT02767271|75680469|FG000|Pharmacokinetic Cruris (PKC) Population|Overall Study||0|Participants with tinea cruris, received ≥1 dose of study drug, had at least 1 PK assessment.|
59575592|NCT02767271|75680470|FG001|Pharmacokinetic Cruris (PKC) Population|Overall Study||15|Participants with tinea cruris, received ≥1 dose of study drug, had at least 1 PK assessment.|
59575593|NCT02767271|75680469|FG000|COMPLETED|Overall Study||15||
59575594|NCT02767271|75680470|FG001|COMPLETED|Overall Study||15||
59575595|NCT02767271|75680469|FG000|NOT COMPLETED|Overall Study||0||
59575596|NCT02767271|75680470|FG001|NOT COMPLETED|Overall Study||0||
59575597|NCT02741297|75680476|FG000|STARTED|Overall Study||73||
59575598|NCT02741297|75680476|FG000|COMPLETED|Overall Study||59||
59575599|NCT02741297|75680476|FG000|NOT COMPLETED|Overall Study||14||
59575600|NCT02741687|75680482|FG000|STARTED|Overall Study||36||
59575601|NCT02741687|75680483|FG001|STARTED|Overall Study||44||
59575602|NCT02741687|75680482|FG000|COMPLETED|Overall Study||36||
59575603|NCT02741687|75680483|FG001|COMPLETED|Overall Study||44||
59575604|NCT02741687|75680482|FG000|NOT COMPLETED|Overall Study||0||
59575605|NCT02741687|75680483|FG001|NOT COMPLETED|Overall Study||0||
59575606|NCT02742077|75680489|FG000|STARTED|Overall Study||20||
59575607|NCT02742077|75680489|FG000|COMPLETED|Overall Study||20||
59575608|NCT02742077|75680489|FG000|NOT COMPLETED|Overall Study||0||
59575609|NCT02768129|75680495|FG000|STARTED|Overall Study||11||
59575610|NCT02768129|75680496|FG001|STARTED|Overall Study||10||
59575611|NCT02768129|75680495|FG000|COMPLETED|Overall Study||11||
59575612|NCT02768129|75680496|FG001|COMPLETED|Overall Study||10||
59575613|NCT02768129|75680495|FG000|NOT COMPLETED|Overall Study||0||
59575614|NCT02768129|75680496|FG001|NOT COMPLETED|Overall Study||0||
59575615|NCT02768753|75680504|FG000|STARTED|Overall Study||30||
59575616|NCT02768753|75680505|FG001|STARTED|Overall Study||30||
59575617|NCT02768753|75680504|FG000|COMPLETED|Overall Study||30||
59575618|NCT02768753|75680505|FG001|COMPLETED|Overall Study||30||
59575619|NCT02768753|75680504|FG000|NOT COMPLETED|Overall Study||0||
59575620|NCT02768753|75680505|FG001|NOT COMPLETED|Overall Study||0||
59575621|NCT02770625|75680511|FG000|STARTED|Overall Study||8||
59575622|NCT02770625|75680511|FG000|COMPLETED|Overall Study||8||
59575623|NCT02770625|75680511|FG000|NOT COMPLETED|Overall Study||0||
59575624|NCT02774213|75680515|FG000|STARTED|Overall Study||74||
59575625|NCT02774213|75680515|FG000|COMPLETED|Overall Study||55||
59575626|NCT02774213|75680515|FG000|NOT COMPLETED|Overall Study||19||
59575627|NCT02745353|75680521|FG000|STARTED|First Intervention (2 Weeks)||4||
59575628|NCT02745353|75680522|FG001|STARTED|First Intervention (2 Weeks)||3||
59575629|NCT02745353|75680521|FG000|COMPLETED|First Intervention (2 Weeks)||1||
59575630|NCT02745353|75680522|FG001|COMPLETED|First Intervention (2 Weeks)||1||
59575631|NCT02745353|75680521|FG000|NOT COMPLETED|First Intervention (2 Weeks)||3||
59575632|NCT02745353|75680522|FG001|NOT COMPLETED|First Intervention (2 Weeks)||2||
59575633|NCT02745353|75680521|FG000|STARTED|Washout (3 Days)||1||
59575634|NCT02745353|75680522|FG001|STARTED|Washout (3 Days)||1||
59575635|NCT02745353|75680521|FG000|COMPLETED|Washout (3 Days)||1||
59575636|NCT02745353|75680522|FG001|COMPLETED|Washout (3 Days)||1||
59575637|NCT02745353|75680521|FG000|NOT COMPLETED|Washout (3 Days)||0||
59575638|NCT02745353|75680522|FG001|NOT COMPLETED|Washout (3 Days)||0||
59575639|NCT02745353|75680521|FG000|STARTED|Second Intervention (2 Weeks)||1||
59575640|NCT02745353|75680522|FG001|STARTED|Second Intervention (2 Weeks)||1||
59575641|NCT02745353|75680521|FG000|COMPLETED|Second Intervention (2 Weeks)||1||
59575642|NCT02745353|75680522|FG001|COMPLETED|Second Intervention (2 Weeks)||0||
59575643|NCT02745353|75680521|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||0||
59575644|NCT02745353|75680522|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||1||
59575645|NCT02746991|75680530|FG000|STARTED|Overall Study||52||
59575646|NCT02746991|75680531|FG001|STARTED|Overall Study||101||
59575647|NCT02746991|75680530|FG000|COMPLETED|Overall Study||24||
59575648|NCT02746991|75680531|FG001|COMPLETED|Overall Study||67||
59575649|NCT02746991|75680530|FG000|NOT COMPLETED|Overall Study||28||
59575650|NCT02746991|75680531|FG001|NOT COMPLETED|Overall Study||34||
59575651|NCT02289157|75680541|FG000|STARTED|Overall Study||222||
59575652|NCT02289157|75680542|FG001|STARTED|Overall Study||219||
59575653|NCT02289157|75680541|FG000|No Post op Check or Follow up Phone Call|Overall Study||2||
59575654|NCT02289157|75680542|FG001|No Post op Check or Follow up Phone Call|Overall Study||4||
59575655|NCT02289157|75680541|FG000|COMPLETED|Overall Study||222||
59575656|NCT02289157|75680542|FG001|COMPLETED|Overall Study||219||
59575657|NCT02289157|75680541|FG000|NOT COMPLETED|Overall Study||0||
59575658|NCT02289157|75680542|FG001|NOT COMPLETED|Overall Study||0||
59575659|NCT02747615|75680550|FG000|STARTED|Overall Study||30||
59575660|NCT02747615|75680551|FG001|STARTED|Overall Study||30||
59575661|NCT02747615|75680550|FG000|COMPLETED|Overall Study||30||
59575662|NCT02747615|75680551|FG001|COMPLETED|Overall Study||30||
59575663|NCT02747615|75680550|FG000|NOT COMPLETED|Overall Study||0||
59575664|NCT02747615|75680551|FG001|NOT COMPLETED|Overall Study||0||
59575665|NCT02775617|75680559|FG000|STARTED|Overall Study|Participants are seen at via a survey of the community. 92.6% of the resident population|653||
59575666|NCT02775617|75680560|FG001|STARTED|Overall Study|Participants are seen at via a survey of the community. 88.9% of the resident population|638||
59575667|NCT02775617|75680559|FG000|COMPLETED|Overall Study|Participants are seen at via a survey of the community. 96.3% of the resident population|605||
59575668|NCT02775617|75680560|FG001|COMPLETED|Overall Study|Participants are seen at via a survey of the community. 76.2% of the resident population|478||
59575669|NCT02775617|75680559|FG000|NOT COMPLETED|Overall Study||48||
59575670|NCT02775617|75680560|FG001|NOT COMPLETED|Overall Study||160||
59575671|NCT02777021|75680568|FG000|STARTED|Overall Study||60|366 patients were screened for eligibility for Aim 3. 154 patients consented for Aim 3.|
59575672|NCT02777021|75680569|FG001|STARTED|Overall Study||94|366 patients were screened for eligibility for Aim 3. 154 patients consented for Aim 3.|
59575673|NCT02777021|75680568|FG000|COMPLETED|Overall Study||43||
59575674|NCT02777021|75680569|FG001|COMPLETED|Overall Study||77||
59575675|NCT02777021|75680568|FG000|NOT COMPLETED|Overall Study||17||
59575676|NCT02777021|75680569|FG001|NOT COMPLETED|Overall Study||17||
59575677|NCT02748785|75680579|FG000|STARTED|Visit 1- Visit 2||69||
59575678|NCT02748785|75680580|FG001|STARTED|Visit 1- Visit 2||68||
59575679|NCT02748785|75680581|FG002|STARTED|Visit 1- Visit 2||71||
59575680|NCT02748785|75680582|FG003|STARTED|Visit 1- Visit 2||69||
59575681|NCT02748785|75680579|FG000|COMPLETED|Visit 1- Visit 2||59||
59575682|NCT02748785|75680580|FG001|COMPLETED|Visit 1- Visit 2||49||
59575683|NCT02748785|75680581|FG002|COMPLETED|Visit 1- Visit 2||57||
59575684|NCT02748785|75680582|FG003|COMPLETED|Visit 1- Visit 2||63||
59575685|NCT02748785|75680579|FG000|NOT COMPLETED|Visit 1- Visit 2||10||
59575686|NCT02748785|75680580|FG001|NOT COMPLETED|Visit 1- Visit 2||19||
59575687|NCT02748785|75680581|FG002|NOT COMPLETED|Visit 1- Visit 2||14||
59575688|NCT02748785|75680582|FG003|NOT COMPLETED|Visit 1- Visit 2||6||
59575689|NCT02748785|75680579|FG000|STARTED|Visit 2-Visit 3||59||
59575690|NCT02748785|75680580|FG001|STARTED|Visit 2-Visit 3||49||
59575691|NCT02748785|75680581|FG002|STARTED|Visit 2-Visit 3||57||
59575692|NCT02748785|75680582|FG003|STARTED|Visit 2-Visit 3||63||
59575693|NCT02748785|75680579|FG000|COMPLETED|Visit 2-Visit 3||54||
59575694|NCT02748785|75680580|FG001|COMPLETED|Visit 2-Visit 3||44||
59575695|NCT02748785|75680581|FG002|COMPLETED|Visit 2-Visit 3||49||
59575696|NCT02748785|75680582|FG003|COMPLETED|Visit 2-Visit 3||52||
59575697|NCT02748785|75680579|FG000|NOT COMPLETED|Visit 2-Visit 3||5||
59575698|NCT02748785|75680580|FG001|NOT COMPLETED|Visit 2-Visit 3||5||
59575699|NCT02748785|75680581|FG002|NOT COMPLETED|Visit 2-Visit 3||8||
59575700|NCT02748785|75680582|FG003|NOT COMPLETED|Visit 2-Visit 3||11||
59575701|NCT02748785|75680579|FG000|STARTED|Visit 3- Visit 4||54||
59575702|NCT02748785|75680580|FG001|STARTED|Visit 3- Visit 4||44||
59575703|NCT02748785|75680581|FG002|STARTED|Visit 3- Visit 4||49||
59575704|NCT02748785|75680582|FG003|STARTED|Visit 3- Visit 4||52||
59575705|NCT02748785|75680579|FG000|COMPLETED|Visit 3- Visit 4||53||
59575706|NCT02748785|75680580|FG001|COMPLETED|Visit 3- Visit 4||43||
59575707|NCT02748785|75680581|FG002|COMPLETED|Visit 3- Visit 4||47||
59575708|NCT02748785|75680582|FG003|COMPLETED|Visit 3- Visit 4||50||
59575709|NCT02748785|75680579|FG000|NOT COMPLETED|Visit 3- Visit 4||1||
59575710|NCT02748785|75680580|FG001|NOT COMPLETED|Visit 3- Visit 4||1||
59575711|NCT02748785|75680581|FG002|NOT COMPLETED|Visit 3- Visit 4||2||
59575712|NCT02748785|75680582|FG003|NOT COMPLETED|Visit 3- Visit 4||2||
59575713|NCT02750267|75680594|FG000|STARTED|Overall Study||6||
59575714|NCT02750267|75680595|FG001|STARTED|Overall Study||6||
59575715|NCT02750267|75680594|FG000|COMPLETED|Overall Study||6||
59575716|NCT02750267|75680595|FG001|COMPLETED|Overall Study||6||
59575717|NCT02750267|75680594|FG000|NOT COMPLETED|Overall Study||0||
59575718|NCT02750267|75680595|FG001|NOT COMPLETED|Overall Study||0||
59575719|NCT02295553|75680607|FG000|STARTED|Overall Study||14||
59575720|NCT02295553|75680608|FG001|STARTED|Overall Study||14||
59575721|NCT02295553|75680609|FG002|STARTED|Overall Study||14||
59575722|NCT02295553|75680610|FG003|STARTED|Overall Study||14||
59575723|NCT02295553|75680607|FG000|COMPLETED|Overall Study||14||
59575724|NCT02295553|75680608|FG001|COMPLETED|Overall Study||14||
59575725|NCT02295553|75680609|FG002|COMPLETED|Overall Study||13||
59575726|NCT02295553|75680610|FG003|COMPLETED|Overall Study||13||
59575727|NCT02295553|75680607|FG000|NOT COMPLETED|Overall Study||0||
59575728|NCT02295553|75680608|FG001|NOT COMPLETED|Overall Study||0||
59575729|NCT02295553|75680609|FG002|NOT COMPLETED|Overall Study||1||
59575730|NCT02295553|75680610|FG003|NOT COMPLETED|Overall Study||1||
59575731|NCT02296099|75680622|FG000|STARTED|Overall Study||57||
59575732|NCT02296099|75680623|FG001|STARTED|Overall Study||57||
59575733|NCT02296099|75680622|FG000|COMPLETED|Overall Study||54||
59575734|NCT02296099|75680623|FG001|COMPLETED|Overall Study||55||
59575735|NCT02296099|75680622|FG000|NOT COMPLETED|Overall Study||3||
59575736|NCT02296099|75680623|FG001|NOT COMPLETED|Overall Study||2||
59575737|NCT02331589|75680631|FG000|STARTED|Overall Study||39||
59575738|NCT02331589|75680632|FG001|STARTED|Overall Study||36||
59721472|NCT01134263|75840387|FG003|Received Vaccination 1|Overall Study||167||
59575739|NCT02331589|75680631|FG000|COMPLETED|Overall Study||34||
59575740|NCT02331589|75680632|FG001|COMPLETED|Overall Study||31||
59575741|NCT02331589|75680631|FG000|NOT COMPLETED|Overall Study||5||
59575742|NCT02331589|75680632|FG001|NOT COMPLETED|Overall Study||5||
59575743|NCT02292433|75680641|FG000|STARTED|First Intervention Period (7 Days)||4||
59721473|NCT01134263|75840388|FG004|Received Vaccination 1|Overall Study||57||
59575744|NCT02292433|75680642|FG001|STARTED|First Intervention Period (7 Days)||4||
59575745|NCT02292433|75680643|FG002|STARTED|First Intervention Period (7 Days)||4||
59575746|NCT02292433|75680641|FG000|COMPLETED|First Intervention Period (7 Days)||4||
59575747|NCT02292433|75680642|FG001|COMPLETED|First Intervention Period (7 Days)||4||
59575748|NCT02292433|75680643|FG002|COMPLETED|First Intervention Period (7 Days)||4||
59575749|NCT02292433|75680641|FG000|NOT COMPLETED|First Intervention Period (7 Days)||0||
59575750|NCT02292433|75680642|FG001|NOT COMPLETED|First Intervention Period (7 Days)||0||
59575751|NCT02292433|75680643|FG002|NOT COMPLETED|First Intervention Period (7 Days)||0||
59575752|NCT02292433|75680641|FG000|STARTED|First Washout Period (7 to 14 Days)||4||
59575753|NCT02292433|75680642|FG001|STARTED|First Washout Period (7 to 14 Days)||4||
59575754|NCT02292433|75680643|FG002|STARTED|First Washout Period (7 to 14 Days)||4||
59575755|NCT02292433|75680641|FG000|COMPLETED|First Washout Period (7 to 14 Days)||4||
59575756|NCT02292433|75680642|FG001|COMPLETED|First Washout Period (7 to 14 Days)||4||
59575757|NCT02292433|75680643|FG002|COMPLETED|First Washout Period (7 to 14 Days)||4||
59575758|NCT02292433|75680641|FG000|NOT COMPLETED|First Washout Period (7 to 14 Days)||0||
59575759|NCT02292433|75680642|FG001|NOT COMPLETED|First Washout Period (7 to 14 Days)||0||
59575760|NCT02292433|75680643|FG002|NOT COMPLETED|First Washout Period (7 to 14 Days)||0||
59575761|NCT02292433|75680641|FG000|STARTED|Second Intervention Period (7 Days)||4||
59575762|NCT02292433|75680642|FG001|STARTED|Second Intervention Period (7 Days)||4||
59575763|NCT02292433|75680643|FG002|STARTED|Second Intervention Period (7 Days)||4||
59575764|NCT02292433|75680641|FG000|COMPLETED|Second Intervention Period (7 Days)||4||
59575765|NCT02292433|75680642|FG001|COMPLETED|Second Intervention Period (7 Days)||4||
59575766|NCT02292433|75680643|FG002|COMPLETED|Second Intervention Period (7 Days)||4||
59575767|NCT02292433|75680641|FG000|NOT COMPLETED|Second Intervention Period (7 Days)||0||
59575768|NCT02292433|75680642|FG001|NOT COMPLETED|Second Intervention Period (7 Days)||0||
59575769|NCT02292433|75680643|FG002|NOT COMPLETED|Second Intervention Period (7 Days)||0||
59575770|NCT02292433|75680641|FG000|STARTED|Second Washout Period (7 to 14 Days)||4||
59575771|NCT02292433|75680642|FG001|STARTED|Second Washout Period (7 to 14 Days)||4||
59575772|NCT02292433|75680643|FG002|STARTED|Second Washout Period (7 to 14 Days)||4||
59575773|NCT02292433|75680641|FG000|COMPLETED|Second Washout Period (7 to 14 Days)||4||
59575774|NCT02292433|75680642|FG001|COMPLETED|Second Washout Period (7 to 14 Days)||4||
59575775|NCT02292433|75680643|FG002|COMPLETED|Second Washout Period (7 to 14 Days)||4||
59575776|NCT02292433|75680641|FG000|NOT COMPLETED|Second Washout Period (7 to 14 Days)||0||
59575777|NCT02292433|75680642|FG001|NOT COMPLETED|Second Washout Period (7 to 14 Days)||0||
59575778|NCT02292433|75680643|FG002|NOT COMPLETED|Second Washout Period (7 to 14 Days)||0||
59575779|NCT02292433|75680641|FG000|STARTED|Third Intervention Period (7 Days)||4||
59575780|NCT02292433|75680642|FG001|STARTED|Third Intervention Period (7 Days)||4||
59575781|NCT02292433|75680643|FG002|STARTED|Third Intervention Period (7 Days)||4||
59575782|NCT02292433|75680641|FG000|COMPLETED|Third Intervention Period (7 Days)||4||
59575783|NCT02292433|75680642|FG001|COMPLETED|Third Intervention Period (7 Days)||4||
59575784|NCT02292433|75680643|FG002|COMPLETED|Third Intervention Period (7 Days)||4||
59575785|NCT02292433|75680641|FG000|NOT COMPLETED|Third Intervention Period (7 Days)||0||
59575786|NCT02292433|75680642|FG001|NOT COMPLETED|Third Intervention Period (7 Days)||0||
59575787|NCT02292433|75680643|FG002|NOT COMPLETED|Third Intervention Period (7 Days)||0||
59575788|NCT03763175|75680654|FG000|STARTED|Overall Study||20||
59575789|NCT03763175|75680655|FG001|STARTED|Overall Study||19||
59575790|NCT03763175|75680656|FG002|STARTED|Overall Study||20||
59575791|NCT03763175|75680654|FG000|COMPLETED|Overall Study||19||
59575792|NCT03763175|75680655|FG001|COMPLETED|Overall Study||17||
59575793|NCT03763175|75680656|FG002|COMPLETED|Overall Study||19||
59575794|NCT03763175|75680654|FG000|NOT COMPLETED|Overall Study||1||
59575795|NCT03763175|75680655|FG001|NOT COMPLETED|Overall Study||2||
59575796|NCT03763175|75680656|FG002|NOT COMPLETED|Overall Study||1||
59575797|NCT01987219|75680670|FG000|STARTED|Overall Study||2||
59575798|NCT01987219|75680671|FG001|STARTED|Overall Study||2||
59575799|NCT01987219|75680672|FG002|STARTED|Overall Study||7||
59575800|NCT01987219|75680673|FG003|STARTED|Overall Study||2||
59721474|NCT01134263|75840384|FG000|Received Vaccination 2|Overall Study||151||
59721475|NCT01134263|75840385|FG001|Received Vaccination 2|Overall Study||152||
60121273|NCT00118755|76242169|FG000|NOT COMPLETED|Overall Study||210||
59575801|NCT01987219|75680674|FG004|STARTED|Overall Study||1||
59721476|NCT01134263|75840386|FG002|Received Vaccination 2|Overall Study||139||
59721477|NCT01134263|75840387|FG003|Received Vaccination 2|Overall Study||154||
59721478|NCT01134263|75840388|FG004|Received Vaccination 2|Overall Study||53||
59850309|NCT03583606|75974648|FG001|NOT COMPLETED|Overall Study||1||
60121274|NCT00118755|76242170|FG001|NOT COMPLETED|Overall Study||215||
60121275|NCT02661256|76242176|FG000|STARTED|Overall Study|Each participant went through arms in same order: on nCPAP then off nCPAP. 1 participant at a time.|7||
60121276|NCT02661256|76242176|FG000|COMPLETED|Overall Study||7||
60121277|NCT02661256|76242176|FG000|NOT COMPLETED|Overall Study||0||
59575802|NCT01987219|75680675|FG005|STARTED|Overall Study||1||
59575803|NCT01987219|75680670|FG000|COMPLETED|Overall Study||2||
59575804|NCT01987219|75680671|FG001|COMPLETED|Overall Study||2||
59575805|NCT01987219|75680672|FG002|COMPLETED|Overall Study||6||
59575806|NCT01987219|75680673|FG003|COMPLETED|Overall Study||2||
59575807|NCT01987219|75680674|FG004|COMPLETED|Overall Study||1||
59575808|NCT01987219|75680675|FG005|COMPLETED|Overall Study||1||
59575809|NCT01987219|75680670|FG000|NOT COMPLETED|Overall Study||0||
59575810|NCT01987219|75680671|FG001|NOT COMPLETED|Overall Study||0||
59575811|NCT01987219|75680672|FG002|NOT COMPLETED|Overall Study||1||
59575812|NCT01987219|75680673|FG003|NOT COMPLETED|Overall Study||0||
59575813|NCT01987219|75680674|FG004|NOT COMPLETED|Overall Study||0||
59575814|NCT01987219|75680675|FG005|NOT COMPLETED|Overall Study||0||
59575815|NCT01988857|75680683|FG000|STARTED|Overall Study||300||
59575816|NCT01988857|75680683|FG000|COMPLETED|Overall Study||300||
59575817|NCT01988857|75680683|FG000|NOT COMPLETED|Overall Study||0||
59575818|NCT01989793|75680689|FG000|STARTED|Overall Study||18||
59575819|NCT01989793|75680690|FG001|STARTED|Overall Study||19||
59575820|NCT01989793|75680689|FG000|COMPLETED|Overall Study||10||
59575821|NCT01989793|75680690|FG001|COMPLETED|Overall Study||15||
59575822|NCT01989793|75680689|FG000|NOT COMPLETED|Overall Study||8||
59575823|NCT01989793|75680690|FG001|NOT COMPLETED|Overall Study||4||
59575824|NCT01991821|75680698|FG000|STARTED|Overall Study||169||
59575825|NCT01991821|75680699|FG001|STARTED|Overall Study||178||
59575826|NCT01991821|75680698|FG000|COMPLETED|Overall Study||6||
59575827|NCT01991821|75680699|FG001|COMPLETED|Overall Study||11||
59575828|NCT01991821|75680698|FG000|NOT COMPLETED|Overall Study||163||
59575829|NCT01991821|75680699|FG001|NOT COMPLETED|Overall Study||167||
59575830|NCT01992523|75680709|FG000|STARTED|Overall Study||41||
59575831|NCT01992523|75680710|FG001|STARTED|Overall Study||41||
59575832|NCT01992523|75680709|FG000|COMPLETED|Overall Study||41||
59575833|NCT01992523|75680710|FG001|COMPLETED|Overall Study||41||
59575834|NCT01992523|75680709|FG000|NOT COMPLETED|Overall Study||0||
59575835|NCT01992523|75680710|FG001|NOT COMPLETED|Overall Study||0||
59575836|NCT01993849|75680720|FG000|STARTED|Overall Study||12||
59575837|NCT01993849|75680721|FG001|STARTED|Overall Study||11||
59575838|NCT01993849|75680720|FG000|COMPLETED|Overall Study||9||
59575839|NCT01993849|75680721|FG001|COMPLETED|Overall Study||9||
59575840|NCT01993849|75680720|FG000|NOT COMPLETED|Overall Study||3||
59575841|NCT01993849|75680721|FG001|NOT COMPLETED|Overall Study||2||
59575842|NCT02308189|75680731|FG000|STARTED|Overall Study||17||
59575843|NCT02308189|75680732|FG001|STARTED|Overall Study||15||
59575844|NCT02308189|75680731|FG000|COMPLETED|Overall Study||16||
59575845|NCT02308189|75680732|FG001|COMPLETED|Overall Study||14||
59575846|NCT02308189|75680731|FG000|NOT COMPLETED|Overall Study||1||
59575847|NCT02308189|75680732|FG001|NOT COMPLETED|Overall Study||1||
60121278|NCT01541371|76242182|FG000|STARTED|Overall Study||403||
60121279|NCT01541371|76242182|FG000|Full Analysis Set|Overall Study||394||
60121280|NCT01541371|76242182|FG000|COMPLETED|Overall Study||326||
60121281|NCT01541371|76242182|FG000|NOT COMPLETED|Overall Study||77||
60121282|NCT00121173|76242193|FG000|STARTED|Overall Study||4||
60121283|NCT00121173|76242194|FG001|STARTED|Overall Study||3||
60121284|NCT00121173|76242195|FG002|STARTED|Overall Study||9||
60121285|NCT00121173|76242193|FG000|COMPLETED|Overall Study||3||
60121286|NCT00121173|76242194|FG001|COMPLETED|Overall Study||3||
60121287|NCT00121173|76242195|FG002|COMPLETED|Overall Study||9||
60121288|NCT00121173|76242193|FG000|NOT COMPLETED|Overall Study||1||
60121289|NCT00121173|76242194|FG001|NOT COMPLETED|Overall Study||0||
60121290|NCT00121173|76242195|FG002|NOT COMPLETED|Overall Study||0||
60121291|NCT02662036|76242208|FG000|STARTED|Overall Study||35||
60121292|NCT02662036|76242209|FG001|STARTED|Overall Study||35||
60121293|NCT02662036|76242208|FG000|COMPLETED|Overall Study||22||
60121294|NCT02662036|76242209|FG001|COMPLETED|Overall Study||22||
60121295|NCT02662036|76242208|FG000|NOT COMPLETED|Overall Study||13||
60121296|NCT02662036|76242209|FG001|NOT COMPLETED|Overall Study||13||
60121297|NCT01687673|76242215|FG000|STARTED|Overall Study||29||
59575848|NCT02778113|75680738|FG000|STARTED|Study Period One||4||
59575849|NCT02778113|75680739|FG001|STARTED|Study Period One||4||
59575850|NCT02778113|75680740|FG002|STARTED|Study Period One||4||
59575851|NCT02778113|75680741|FG003|STARTED|Study Period One||4||
59575852|NCT02778113|75680738|FG000|Received Study Drug|Study Period One||4||
59575853|NCT02778113|75680739|FG001|Received Study Drug|Study Period One||4||
59575854|NCT02778113|75680740|FG002|Received Study Drug|Study Period One||4||
59575855|NCT02778113|75680741|FG003|Received Study Drug|Study Period One||4||
59575856|NCT02778113|75680738|FG000|COMPLETED|Study Period One||4||
59575857|NCT02778113|75680739|FG001|COMPLETED|Study Period One||4||
59575858|NCT02778113|75680740|FG002|COMPLETED|Study Period One||4||
59575859|NCT02778113|75680741|FG003|COMPLETED|Study Period One||4||
59575860|NCT02778113|75680738|FG000|NOT COMPLETED|Study Period One||0||
59575861|NCT02778113|75680739|FG001|NOT COMPLETED|Study Period One||0||
59575862|NCT02778113|75680740|FG002|NOT COMPLETED|Study Period One||0||
59575863|NCT02778113|75680741|FG003|NOT COMPLETED|Study Period One||0||
59575864|NCT02778113|75680738|FG000|STARTED|Study Period Two||4||
59575865|NCT02778113|75680739|FG001|STARTED|Study Period Two||4||
59575866|NCT02778113|75680740|FG002|STARTED|Study Period Two||4||
59575867|NCT02778113|75680741|FG003|STARTED|Study Period Two||4||
59575868|NCT02778113|75680738|FG000|Received Study Drug|Study Period Two||4||
59575869|NCT02778113|75680739|FG001|Received Study Drug|Study Period Two||4||
59575870|NCT02778113|75680740|FG002|Received Study Drug|Study Period Two||4||
59575871|NCT02778113|75680741|FG003|Received Study Drug|Study Period Two||4||
59575872|NCT02778113|75680738|FG000|COMPLETED|Study Period Two||4||
59575873|NCT02778113|75680739|FG001|COMPLETED|Study Period Two||4||
59575874|NCT02778113|75680740|FG002|COMPLETED|Study Period Two||4||
59575875|NCT02778113|75680741|FG003|COMPLETED|Study Period Two||4||
59575876|NCT02778113|75680738|FG000|NOT COMPLETED|Study Period Two||0||
59575877|NCT02778113|75680739|FG001|NOT COMPLETED|Study Period Two||0||
59575878|NCT02778113|75680740|FG002|NOT COMPLETED|Study Period Two||0||
59575879|NCT02778113|75680741|FG003|NOT COMPLETED|Study Period Two||0||
59575880|NCT02778113|75680738|FG000|STARTED|Study Period Three||4||
59575881|NCT02778113|75680739|FG001|STARTED|Study Period Three||4||
59575882|NCT02778113|75680740|FG002|STARTED|Study Period Three|One participant completed study period two, but did not enter study period three.|3||
59575883|NCT02778113|75680741|FG003|STARTED|Study Period Three||4||
59575884|NCT02778113|75680738|FG000|Received Study Drug|Study Period Three||4||
59575885|NCT02778113|75680739|FG001|Received Study Drug|Study Period Three||4||
59575886|NCT02778113|75680740|FG002|Received Study Drug|Study Period Three||3||
59575887|NCT02778113|75680741|FG003|Received Study Drug|Study Period Three||4||
59575888|NCT02778113|75680738|FG000|COMPLETED|Study Period Three||4||
59575889|NCT02778113|75680739|FG001|COMPLETED|Study Period Three||4||
59575890|NCT02778113|75680740|FG002|COMPLETED|Study Period Three||3||
59575891|NCT02778113|75680741|FG003|COMPLETED|Study Period Three||4||
59575892|NCT02778113|75680738|FG000|NOT COMPLETED|Study Period Three||0||
59575893|NCT02778113|75680739|FG001|NOT COMPLETED|Study Period Three||0||
59575894|NCT02778113|75680740|FG002|NOT COMPLETED|Study Period Three||0||
59575895|NCT02778113|75680741|FG003|NOT COMPLETED|Study Period Three||0||
59575896|NCT02778113|75680738|FG000|STARTED|Study Period Four|One participant completed study period three, but did not enter study period four.|3||
59575897|NCT02778113|75680739|FG001|STARTED|Study Period Four||4||
59575898|NCT02778113|75680740|FG002|STARTED|Study Period Four|One participant completed study period three, but did not enter study period four.|2||
59575899|NCT02778113|75680741|FG003|STARTED|Study Period Four||4||
59575900|NCT02778113|75680738|FG000|Received Study Drug|Study Period Four||3||
59575901|NCT02778113|75680739|FG001|Received Study Drug|Study Period Four||4||
59575902|NCT02778113|75680740|FG002|Received Study Drug|Study Period Four||2||
59575903|NCT02778113|75680741|FG003|Received Study Drug|Study Period Four||4||
59575904|NCT02778113|75680738|FG000|COMPLETED|Study Period Four||3||
59575905|NCT02778113|75680739|FG001|COMPLETED|Study Period Four||4||
59575906|NCT02778113|75680740|FG002|COMPLETED|Study Period Four||2||
59575907|NCT02778113|75680741|FG003|COMPLETED|Study Period Four||4||
59575908|NCT02778113|75680738|FG000|NOT COMPLETED|Study Period Four||0||
59575909|NCT02778113|75680739|FG001|NOT COMPLETED|Study Period Four||0||
59575910|NCT02778113|75680740|FG002|NOT COMPLETED|Study Period Four||0||
59575911|NCT02778113|75680741|FG003|NOT COMPLETED|Study Period Four||0||
59575912|NCT01994785|75680757|FG000|STARTED|Overall Study||109||
59575913|NCT01994785|75680758|FG001|STARTED|Overall Study||109||
59575914|NCT01994785|75680759|FG002|STARTED|Overall Study||117||
59575915|NCT01994785|75680760|FG003|STARTED|Overall Study||117||
59575916|NCT01994785|75680757|FG000|COMPLETED|Overall Study||101||
59575917|NCT01994785|75680758|FG001|COMPLETED|Overall Study||108||
59575918|NCT01994785|75680759|FG002|COMPLETED|Overall Study||117||
59575919|NCT01994785|75680760|FG003|COMPLETED|Overall Study||114||
59575920|NCT01994785|75680757|FG000|NOT COMPLETED|Overall Study||8||
59575921|NCT01994785|75680758|FG001|NOT COMPLETED|Overall Study||1||
59575922|NCT01994785|75680759|FG002|NOT COMPLETED|Overall Study||0||
59575923|NCT01994785|75680760|FG003|NOT COMPLETED|Overall Study||3||
59575924|NCT02780765|75680772|FG000|STARTED|Overall Study||30||
59575925|NCT02780765|75680773|FG001|STARTED|Overall Study||30||
59575926|NCT02780765|75680772|FG000|COMPLETED|Overall Study||30||
59575927|NCT02780765|75680773|FG001|COMPLETED|Overall Study||30||
59575928|NCT02780765|75680772|FG000|NOT COMPLETED|Overall Study||0||
59575929|NCT02780765|75680773|FG001|NOT COMPLETED|Overall Study||0||
59575930|NCT01995487|75680781|FG000|STARTED|Overall Study||958||
59575931|NCT01995487|75680782|FG001|STARTED|Overall Study||961||
59575932|NCT01995487|75680781|FG000|COMPLETED|Overall Study||884||
59575933|NCT01995487|75680782|FG001|COMPLETED|Overall Study||878||
59575934|NCT01995487|75680781|FG000|NOT COMPLETED|Overall Study||74||
59575935|NCT01995487|75680782|FG001|NOT COMPLETED|Overall Study||83||
59575936|NCT02783027|75680790|FG000|STARTED|Overall Study||39||
59575937|NCT02783027|75680791|FG001|STARTED|Overall Study||44||
59575938|NCT02783027|75680790|FG000|COMPLETED|Overall Study||16||
59575939|NCT02783027|75680791|FG001|COMPLETED|Overall Study||27||
59575940|NCT02783027|75680790|FG000|NOT COMPLETED|Overall Study||23||
59575941|NCT02783027|75680791|FG001|NOT COMPLETED|Overall Study||17||
59575942|NCT01996657|75680800|FG000|STARTED|Overall Study||250||
59575943|NCT01996657|75680801|FG001|STARTED|Overall Study||250||
59575944|NCT01996657|75680802|FG002|STARTED|Overall Study||248||
59575945|NCT01996657|75680800|FG000|COMPLETED|Overall Study||237||
59575946|NCT01996657|75680801|FG001|COMPLETED|Overall Study||239||
59721479|NCT01134263|75840384|FG000|Received Vaccination 3|Overall Study||140||
59721480|NCT01134263|75840385|FG001|Received Vaccination 3|Overall Study||145||
59721481|NCT01134263|75840386|FG002|Received Vaccination 3|Overall Study||134||
59721482|NCT01134263|75840387|FG003|Received Vaccination 3|Overall Study||151||
59721483|NCT01134263|75840388|FG004|Received Vaccination 3|Overall Study||49||
59721484|NCT01134263|75840384|FG000|Safety Population|Overall Study||163|Safety Population:All participants who received study drug, analyzed according to treatment received|
59721485|NCT01134263|75840385|FG001|Safety Population|Overall Study||161|Safety Population:All participants who received study drug, analyzed according to treatment received|
59721486|NCT01134263|75840386|FG002|Safety Population|Overall Study|1 participant randomized to the Phase III Lot 2 group, received Phase III Lot 3 vaccination.|164|Safety Population:All participants who received study drug, analyzed according to treatment received|
59721487|NCT01134263|75840387|FG003|Safety Population|Overall Study||167|Safety Population:All participants who received study drug, analyzed according to treatment received|
59721488|NCT01134263|75840388|FG004|Safety Population|Overall Study||57|Safety Population:All participants who received study drug, analyzed according to treatment received|
59721489|NCT01134263|75840384|FG000|COMPLETED|Overall Study||140||
59721490|NCT01134263|75840385|FG001|COMPLETED|Overall Study||143||
59721491|NCT01134263|75840386|FG002|COMPLETED|Overall Study||134||
59721492|NCT01134263|75840387|FG003|COMPLETED|Overall Study||149||
59721493|NCT01134263|75840388|FG004|COMPLETED|Overall Study||48||
59721494|NCT01134263|75840384|FG000|NOT COMPLETED|Overall Study||24||
59721495|NCT01134263|75840385|FG001|NOT COMPLETED|Overall Study||20||
59721496|NCT01134263|75840386|FG002|NOT COMPLETED|Overall Study||29||
59721497|NCT01134263|75840387|FG003|NOT COMPLETED|Overall Study||19||
59721498|NCT01134263|75840388|FG004|NOT COMPLETED|Overall Study||9||
59721499|NCT01199822|75840409|FG000|STARTED|Overall Study||3||
59721500|NCT01199822|75840410|FG001|STARTED|Overall Study||7||
59721501|NCT01199822|75840411|FG002|STARTED|Overall Study||6||
59721502|NCT01199822|75840409|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3||
59721503|NCT01199822|75840410|FG001|Received at Least 1 Dose of Study Drug|Overall Study||7||
59721504|NCT01199822|75840411|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6||
59721505|NCT01199822|75840409|FG000|COMPLETED|Overall Study||3||
59721506|NCT01199822|75840410|FG001|COMPLETED|Overall Study||6||
59721507|NCT01199822|75840411|FG002|COMPLETED|Overall Study||6||
59721508|NCT01199822|75840409|FG000|NOT COMPLETED|Overall Study||0||
59721509|NCT01199822|75840410|FG001|NOT COMPLETED|Overall Study||1||
59721510|NCT01199822|75840411|FG002|NOT COMPLETED|Overall Study||0||
59721511|NCT01096056|75840428|FG000|STARTED|Overall Study||20||
59721512|NCT01096056|75840429|FG001|STARTED|Overall Study||20||
59721513|NCT01096056|75840428|FG000|Completed at Day 42|Overall Study||20||
59721514|NCT01096056|75840429|FG001|Completed at Day 42|Overall Study||20||
59721515|NCT01096056|75840428|FG000|COMPLETED|Overall Study||20||
59721516|NCT01096056|75840429|FG001|COMPLETED|Overall Study||19||
59721517|NCT01096056|75840428|FG000|NOT COMPLETED|Overall Study||0||
59721518|NCT01096056|75840429|FG001|NOT COMPLETED|Overall Study||1||
59721519|NCT00866359|75840437|FG000|STARTED|Treatment Phase (Days 1 to 85)||56||
59721520|NCT00866359|75840438|FG001|STARTED|Treatment Phase (Days 1 to 85)||55||
59721521|NCT00866359|75840439|FG002|STARTED|Treatment Phase (Days 1 to 85)||0||
59575947|NCT01996657|75680802|FG002|COMPLETED|Overall Study||234||
59575948|NCT01996657|75680800|FG000|NOT COMPLETED|Overall Study||13||
59575949|NCT01996657|75680801|FG001|NOT COMPLETED|Overall Study||11||
59575950|NCT01996657|75680802|FG002|NOT COMPLETED|Overall Study||14||
59721522|NCT00866359|75840440|FG003|STARTED|Treatment Phase (Days 1 to 85)||0||
59721523|NCT00866359|75840437|FG000|COMPLETED|Treatment Phase (Days 1 to 85)||45||
59721524|NCT00866359|75840438|FG001|COMPLETED|Treatment Phase (Days 1 to 85)||50||
59721525|NCT00866359|75840439|FG002|COMPLETED|Treatment Phase (Days 1 to 85)||0||
59721526|NCT00866359|75840440|FG003|COMPLETED|Treatment Phase (Days 1 to 85)||0||
59721527|NCT00866359|75840437|FG000|NOT COMPLETED|Treatment Phase (Days 1 to 85)||11||
59721528|NCT00866359|75840438|FG001|NOT COMPLETED|Treatment Phase (Days 1 to 85)||5||
59721529|NCT00866359|75840439|FG002|NOT COMPLETED|Treatment Phase (Days 1 to 85)||0||
59721530|NCT00866359|75840440|FG003|NOT COMPLETED|Treatment Phase (Days 1 to 85)||0||
59721531|NCT00866359|75840437|FG000|STARTED|Extension Phase (Day 86 to 169)||0||
59721532|NCT00866359|75840438|FG001|STARTED|Extension Phase (Day 86 to 169)||0||
59575951|NCT01996813|75680812|FG000|STARTED|Overall Study||23||
59575952|NCT01996813|75680813|FG001|STARTED|Overall Study||24||
59575953|NCT01996813|75680812|FG000|COMPLETED|Overall Study||23||
59575954|NCT01996813|75680813|FG001|COMPLETED|Overall Study||24||
59575955|NCT01996813|75680812|FG000|NOT COMPLETED|Overall Study||0||
59575956|NCT01996813|75680813|FG001|NOT COMPLETED|Overall Study||0||
59575957|NCT02784275|75680823|FG000|STARTED|Overall Study||16||
59575958|NCT02784275|75680824|FG001|STARTED|Overall Study||16||
59575959|NCT02784275|75680825|FG002|STARTED|Overall Study||17||
59575960|NCT02784275|75680826|FG003|STARTED|Overall Study||15||
59575961|NCT02784275|75680823|FG000|COMPLETED|Overall Study||15||
59575962|NCT02784275|75680824|FG001|COMPLETED|Overall Study||16||
59575963|NCT02784275|75680825|FG002|COMPLETED|Overall Study||16||
59575964|NCT02784275|75680826|FG003|COMPLETED|Overall Study||14||
59575965|NCT02784275|75680823|FG000|NOT COMPLETED|Overall Study||1||
59575966|NCT02784275|75680824|FG001|NOT COMPLETED|Overall Study||0||
59575967|NCT02784275|75680825|FG002|NOT COMPLETED|Overall Study||1||
59575968|NCT02784275|75680826|FG003|NOT COMPLETED|Overall Study||1||
59575969|NCT02784587|75680836|FG000|STARTED|Overall Study||25||
59575970|NCT02784587|75680836|FG000|COMPLETED|Overall Study||25||
59575971|NCT02784587|75680836|FG000|NOT COMPLETED|Overall Study||0||
59575972|NCT01997125|75680840|FG000|STARTED|Overall Study||1||
59575973|NCT01997125|75680840|FG000|COMPLETED|Overall Study||1||
59575974|NCT01997125|75680840|FG000|NOT COMPLETED|Overall Study||0||
59575975|NCT01997437|75680844|FG000|STARTED|Overall Study||6||
59575976|NCT01997437|75680844|FG000|COMPLETED|Overall Study||6||
59575977|NCT01997437|75680844|FG000|NOT COMPLETED|Overall Study||0||
59575978|NCT02303743|75680850|FG000|STARTED|Overall Study||108||
59575979|NCT02303743|75680851|FG001|STARTED|Overall Study||152||
59575980|NCT02303743|75680850|FG000|COMPLETED|Overall Study||108||
59575981|NCT02303743|75680851|FG001|COMPLETED|Overall Study||152||
59575982|NCT02303743|75680850|FG000|NOT COMPLETED|Overall Study||0||
59575983|NCT02303743|75680851|FG001|NOT COMPLETED|Overall Study||0||
59575984|NCT02303977|75680857|FG000|STARTED|Overall Study||37||
59575985|NCT02303977|75680857|FG000|COMPLETED|Overall Study||37||
59575986|NCT02303977|75680857|FG000|NOT COMPLETED|Overall Study||0||
59575987|NCT01997515|75680864|FG000|STARTED|Overall Study||40||
59575988|NCT01997515|75680865|FG001|STARTED|Overall Study||40||
59575989|NCT01997515|75680864|FG000|COMPLETED|Overall Study||36||
59575990|NCT01997515|75680865|FG001|COMPLETED|Overall Study||35||
59575991|NCT01997515|75680864|FG000|NOT COMPLETED|Overall Study||4||
59575992|NCT01997515|75680865|FG001|NOT COMPLETED|Overall Study||5||
59575993|NCT02786771|75680873|FG000|STARTED|Overall Study||63||
59575994|NCT02786771|75680874|FG001|STARTED|Overall Study||62||
59575995|NCT02786771|75680873|FG000|COMPLETED|Overall Study||53||
59575996|NCT02786771|75680874|FG001|COMPLETED|Overall Study||56||
59575997|NCT02786771|75680873|FG000|NOT COMPLETED|Overall Study||10||
59575998|NCT02786771|75680874|FG001|NOT COMPLETED|Overall Study||6||
59575999|NCT01997905|75680880|FG000|STARTED|Overall Study||13||
59576000|NCT01997905|75680880|FG000|Baseline Completed|Overall Study||11||
59576001|NCT01997905|75680880|FG000|COMPLETED|Overall Study||10||
59576002|NCT01997905|75680880|FG000|NOT COMPLETED|Overall Study||3||
59576003|NCT02788019|75680886|FG000|STARTED|Overall Study||27||
59576004|NCT02788019|75680887|FG001|STARTED|Overall Study||25||
59576005|NCT02788019|75680886|FG000|COMPLETED|Overall Study||23||
59721533|NCT00866359|75840439|FG002|STARTED|Extension Phase (Day 86 to 169)||45||
60121298|NCT01687673|76242215|FG000|COMPLETED|Overall Study||28|One patient was removed for hepatic decompensation before starting study treatment|
60121299|NCT01687673|76242215|FG000|NOT COMPLETED|Overall Study||1||
60121300|NCT00121251|76242219|FG000|STARTED|Overall Study||17||
60121301|NCT00121251|76242219|FG000|COMPLETED|Overall Study||17||
60121302|NCT00121251|76242219|FG000|NOT COMPLETED|Overall Study||0||
60121303|NCT02664220|76242225|FG000|STARTED|Overall Study||50||
60121304|NCT02664220|76242226|FG001|STARTED|Overall Study||50||
60121305|NCT02664220|76242225|FG000|COMPLETED|Overall Study||50||
59576006|NCT02788019|75680887|FG001|COMPLETED|Overall Study||20||
59576007|NCT02788019|75680886|FG000|NOT COMPLETED|Overall Study||4||
59576008|NCT02788019|75680887|FG001|NOT COMPLETED|Overall Study||5||
59576009|NCT02788097|75680895|FG000|STARTED|Overall Study||61||
60121306|NCT02664220|76242226|FG001|COMPLETED|Overall Study||50||
60121307|NCT02664220|76242225|FG000|NOT COMPLETED|Overall Study||0||
60121308|NCT02664220|76242226|FG001|NOT COMPLETED|Overall Study||0||
60121309|NCT02664532|76242234|FG000|STARTED|Overall Study||75||
60121310|NCT02664532|76242235|FG001|STARTED|Overall Study||75||
60121311|NCT02664532|76242234|FG000|COMPLETED|Overall Study||75||
60121312|NCT02664532|76242235|FG001|COMPLETED|Overall Study||75||
60121313|NCT02664532|76242234|FG000|NOT COMPLETED|Overall Study||0||
59576010|NCT02788097|75680896|FG001|STARTED|Overall Study||69||
59576011|NCT02788097|75680895|FG000|COMPLETED|Overall Study||61||
59576012|NCT02788097|75680896|FG001|COMPLETED|Overall Study||69||
59576013|NCT02788097|75680895|FG000|NOT COMPLETED|Overall Study||0||
59576014|NCT02788097|75680896|FG001|NOT COMPLETED|Overall Study||0||
59576015|NCT01999231|75680906|FG000|STARTED|Overall Study||6||
59576016|NCT01999231|75680907|FG001|STARTED|Overall Study||6||
59576017|NCT01999231|75680908|FG002|STARTED|Overall Study||6||
59576018|NCT01999231|75680909|FG003|STARTED|Overall Study||6||
60121314|NCT02664532|76242235|FG001|NOT COMPLETED|Overall Study||0||
60121315|NCT02664922|76242245|FG000|STARTED|Overall Study||11||
60121316|NCT02664922|76242246|FG001|STARTED|Overall Study||12||
59576019|NCT01999231|75680906|FG000|COMPLETED|Overall Study||6||
59576020|NCT01999231|75680907|FG001|COMPLETED|Overall Study||6||
59576021|NCT01999231|75680908|FG002|COMPLETED|Overall Study||6||
59576022|NCT01999231|75680909|FG003|COMPLETED|Overall Study||6||
59576023|NCT01999231|75680906|FG000|NOT COMPLETED|Overall Study||0||
59576024|NCT01999231|75680907|FG001|NOT COMPLETED|Overall Study||0||
59576025|NCT01999231|75680908|FG002|NOT COMPLETED|Overall Study||0||
59576026|NCT01999231|75680909|FG003|NOT COMPLETED|Overall Study||0||
59576027|NCT02789033|75680925|FG000|STARTED|Overall Study||17||
59576028|NCT02789033|75680926|FG001|STARTED|Overall Study||17||
59576029|NCT02789033|75680927|FG002|STARTED|Overall Study||17||
59576030|NCT02789033|75680928|FG003|STARTED|Overall Study||17||
59576031|NCT02789033|75680925|FG000|COMPLETED|Overall Study||15||
59576032|NCT02789033|75680926|FG001|COMPLETED|Overall Study||15||
59576033|NCT02789033|75680927|FG002|COMPLETED|Overall Study||16||
59576034|NCT02789033|75680928|FG003|COMPLETED|Overall Study||15||
59576035|NCT02789033|75680925|FG000|NOT COMPLETED|Overall Study||2||
59576036|NCT02789033|75680926|FG001|NOT COMPLETED|Overall Study||2||
59576037|NCT02789033|75680927|FG002|NOT COMPLETED|Overall Study||1||
59576038|NCT02789033|75680928|FG003|NOT COMPLETED|Overall Study||2||
59576039|NCT01999777|75680940|FG000|STARTED|Overall Study||31||
59576040|NCT01999777|75680941|FG001|STARTED|Overall Study||31||
59576041|NCT01999777|75680940|FG000|COMPLETED|Overall Study||31||
59576042|NCT01999777|75680941|FG001|COMPLETED|Overall Study||31||
59576043|NCT01999777|75680940|FG000|NOT COMPLETED|Overall Study||0||
59576044|NCT01999777|75680941|FG001|NOT COMPLETED|Overall Study||0||
59576045|NCT02790281|75680947|FG000|STARTED|Overall Study||33||
59576046|NCT02790281|75680947|FG000|COMPLETED|Overall Study||33||
59576047|NCT02790281|75680947|FG000|NOT COMPLETED|Overall Study||0||
59576048|NCT02188147|75680951|FG000|STARTED|Overall Study||39||
59576049|NCT02188147|75680951|FG000|COMPLETED|Overall Study||39||
59576050|NCT02188147|75680951|FG000|NOT COMPLETED|Overall Study||0||
59576051|NCT02794727|75680958|FG000|STARTED|Overall Study||44||
59576052|NCT02794727|75680959|FG001|STARTED|Overall Study||46||
59576053|NCT02794727|75680960|FG002|STARTED|Overall Study||45||
59576054|NCT02794727|75680958|FG000|COMPLETED|Overall Study||44||
59576055|NCT02794727|75680959|FG001|COMPLETED|Overall Study||46||
59576056|NCT02794727|75680960|FG002|COMPLETED|Overall Study||44||
59576057|NCT02794727|75680958|FG000|NOT COMPLETED|Overall Study||0||
59576058|NCT02794727|75680959|FG001|NOT COMPLETED|Overall Study||0||
59576059|NCT02794727|75680960|FG002|NOT COMPLETED|Overall Study||1||
59576060|NCT02795117|75680970|FG000|STARTED|Overall Study||193||
59576061|NCT02795117|75680971|FG001|STARTED|Overall Study||193||
59576062|NCT02795117|75680972|FG002|STARTED|Overall Study||100||
59576063|NCT02795117|75680970|FG000|COMPLETED|Overall Study||175||
59576064|NCT02795117|75680971|FG001|COMPLETED|Overall Study||166||
59576065|NCT02795117|75680972|FG002|COMPLETED|Overall Study||88||
59576066|NCT02795117|75680970|FG000|NOT COMPLETED|Overall Study||18||
59576067|NCT02795117|75680971|FG001|NOT COMPLETED|Overall Study||27||
59576068|NCT02795117|75680972|FG002|NOT COMPLETED|Overall Study||12||
59576069|NCT02333071|75680982|FG000|STARTED|Core Study||326||
59576070|NCT02333071|75680983|FG001|STARTED|Core Study||327||
59576071|NCT02333071|75680982|FG000|Received Intervention|Core Study||319||
59576072|NCT02333071|75680983|FG001|Received Intervention|Core Study||324||
59576073|NCT02333071|75680982|FG000|COMPLETED|Core Study||274||
59576074|NCT02333071|75680983|FG001|COMPLETED|Core Study||190||
59576075|NCT02333071|75680982|FG000|NOT COMPLETED|Core Study||52||
59576076|NCT02333071|75680983|FG001|NOT COMPLETED|Core Study||137||
59576077|NCT02333071|75680982|FG000|STARTED|Open Label Extension||239|"363/464 subjects who completed Core Study continued to this OLE Study (124 BMT-BMT and 239 PBO-BMT.~The OLE study was not reported."|
59576078|NCT02333071|75680983|FG001|STARTED|Open Label Extension||124|"363/464 subjects who completed Core Study continued to this OLE Study (124 BMT-BMT and 239 PBO-BMT.~The OLE study was not reported."|
59850310|NCT03583606|75974649|FG002|NOT COMPLETED|Overall Study||0||
60121317|NCT02664922|76242247|FG002|STARTED|Overall Study||7||
60121318|NCT02664922|76242248|FG003|STARTED|Overall Study||5||
60121319|NCT02664922|76242245|FG000|COMPLETED|Overall Study||10||
60121320|NCT02664922|76242246|FG001|COMPLETED|Overall Study||12||
60121321|NCT02664922|76242247|FG002|COMPLETED|Overall Study||7||
60121322|NCT02664922|76242248|FG003|COMPLETED|Overall Study||5||
60121323|NCT02664922|76242245|FG000|NOT COMPLETED|Overall Study||1||
60121324|NCT02664922|76242246|FG001|NOT COMPLETED|Overall Study||0||
60121325|NCT02664922|76242247|FG002|NOT COMPLETED|Overall Study||0||
60121326|NCT02664922|76242248|FG003|NOT COMPLETED|Overall Study||0||
60121327|NCT02665468|76242260|FG000|STARTED|Overall Study||595||
59576079|NCT02333071|75680982|FG000|COMPLETED|Open Label Extension||95||
59576080|NCT02333071|75680983|FG001|COMPLETED|Open Label Extension||49||
59576081|NCT02333071|75680982|FG000|NOT COMPLETED|Open Label Extension||144||
59576082|NCT02333071|75680983|FG001|NOT COMPLETED|Open Label Extension||75||
59576083|NCT02795819|75680994|FG000|STARTED|Overall Study||0||
60121328|NCT02665468|76242261|FG001|STARTED|Overall Study||601||
60121329|NCT02665468|76242260|FG000|COMPLETED|Overall Study||595||
60121330|NCT02665468|76242261|FG001|COMPLETED|Overall Study||601||
60121331|NCT02665468|76242260|FG000|NOT COMPLETED|Overall Study||0||
59576084|NCT02795819|75680995|FG001|STARTED|Overall Study||6||
59576085|NCT02795819|75680996|FG002|STARTED|Overall Study||0||
59576086|NCT02795819|75680997|FG003|STARTED|Overall Study||0||
59576087|NCT02795819|75680998|FG004|STARTED|Overall Study||0||
59576088|NCT02795819|75680999|FG005|STARTED|Overall Study||0||
59576089|NCT02795819|75681000|FG006|STARTED|Overall Study||0||
59576090|NCT02795819|75680994|FG000|COMPLETED|Overall Study||0||
59576091|NCT02795819|75680995|FG001|COMPLETED|Overall Study||6||
59576092|NCT02795819|75680996|FG002|COMPLETED|Overall Study||0||
59576093|NCT02795819|75680997|FG003|COMPLETED|Overall Study||0||
59721534|NCT00866359|75840440|FG003|STARTED|Extension Phase (Day 86 to 169)||50||
59721535|NCT00866359|75840437|FG000|COMPLETED|Extension Phase (Day 86 to 169)||0||
59721536|NCT00866359|75840438|FG001|COMPLETED|Extension Phase (Day 86 to 169)||0||
59721537|NCT00866359|75840439|FG002|COMPLETED|Extension Phase (Day 86 to 169)||44||
59721538|NCT00866359|75840440|FG003|COMPLETED|Extension Phase (Day 86 to 169)||47||
59721539|NCT00866359|75840437|FG000|NOT COMPLETED|Extension Phase (Day 86 to 169)||0||
59721540|NCT00866359|75840438|FG001|NOT COMPLETED|Extension Phase (Day 86 to 169)||0||
59721541|NCT00866359|75840439|FG002|NOT COMPLETED|Extension Phase (Day 86 to 169)||1||
59721542|NCT00866359|75840440|FG003|NOT COMPLETED|Extension Phase (Day 86 to 169)||3||
59721543|NCT00866359|75840437|FG000|STARTED|Observational Follow-Up Phase||0||
59721544|NCT00866359|75840438|FG001|STARTED|Observational Follow-Up Phase||0||
59721545|NCT00866359|75840439|FG002|STARTED|Observational Follow-Up Phase|Includes those who entered the follow-up phase from both the placebo controlled or extension phase.|54||
59721546|NCT00866359|75840440|FG003|STARTED|Observational Follow-Up Phase|Includes those who entered the follow-up phase from both the placebo controlled or extension phase.|54||
59721547|NCT00866359|75840437|FG000|COMPLETED|Observational Follow-Up Phase||0||
59721548|NCT00866359|75840438|FG001|COMPLETED|Observational Follow-Up Phase||0||
59721549|NCT00866359|75840439|FG002|COMPLETED|Observational Follow-Up Phase||54||
59721550|NCT00866359|75840440|FG003|COMPLETED|Observational Follow-Up Phase||54||
59721551|NCT00866359|75840437|FG000|NOT COMPLETED|Observational Follow-Up Phase||0||
59721552|NCT00866359|75840438|FG001|NOT COMPLETED|Observational Follow-Up Phase||0||
59721553|NCT00866359|75840439|FG002|NOT COMPLETED|Observational Follow-Up Phase||0||
59721554|NCT00866359|75840440|FG003|NOT COMPLETED|Observational Follow-Up Phase||0||
59721555|NCT01199198|75840469|FG000|STARTED|Overall Study||24||
59721556|NCT01199198|75840470|FG001|STARTED|Overall Study||24||
59721557|NCT01199198|75840469|FG000|COMPLETED|Overall Study||17||
59721558|NCT01199198|75840470|FG001|COMPLETED|Overall Study||13||
59721559|NCT01199198|75840469|FG000|NOT COMPLETED|Overall Study||7||
59721560|NCT01199198|75840470|FG001|NOT COMPLETED|Overall Study||11||
59721561|NCT01095978|75840476|FG000|STARTED|Overall Study||2822||
59721562|NCT01095978|75840476|FG000|COMPLETED|Overall Study||2819||
59721563|NCT01095978|75840476|FG000|NOT COMPLETED|Overall Study||3||
59721564|NCT01134107|75840484|FG000|STARTED|Period 1-First Treatment Intervention||67||
59721565|NCT01134107|75840485|FG001|STARTED|Period 1-First Treatment Intervention||66||
59721566|NCT01134107|75840484|FG000|Received at Least One Dose of Study Drug|Period 1-First Treatment Intervention||66||
59721567|NCT01134107|75840485|FG001|Received at Least One Dose of Study Drug|Period 1-First Treatment Intervention||66||
59721568|NCT01134107|75840484|FG000|COMPLETED|Period 1-First Treatment Intervention||61||
59721569|NCT01134107|75840485|FG001|COMPLETED|Period 1-First Treatment Intervention||61||
59721570|NCT01134107|75840484|FG000|NOT COMPLETED|Period 1-First Treatment Intervention||6||
59721571|NCT01134107|75840485|FG001|NOT COMPLETED|Period 1-First Treatment Intervention||5||
59721572|NCT01134107|75840484|FG000|STARTED|Period 2-Second Treatment Intervention||61||
59721573|NCT01134107|75840485|FG001|STARTED|Period 2-Second Treatment Intervention||61||
59721574|NCT01134107|75840484|FG000|COMPLETED|Period 2-Second Treatment Intervention||57||
59721575|NCT01134107|75840485|FG001|COMPLETED|Period 2-Second Treatment Intervention||61||
59721576|NCT01134107|75840484|FG000|NOT COMPLETED|Period 2-Second Treatment Intervention||4||
59721577|NCT01134107|75840485|FG001|NOT COMPLETED|Period 2-Second Treatment Intervention||0||
59721578|NCT01199042|75840491|FG000|STARTED|Sleep Laboratory (3 Nights)||29||
59721579|NCT01199042|75840491|FG000|COMPLETED|Sleep Laboratory (3 Nights)||27||
59721580|NCT01199042|75840491|FG000|NOT COMPLETED|Sleep Laboratory (3 Nights)||2||
59721581|NCT01199042|75840491|FG000|STARTED|At Home (3 Months)||27||
59576094|NCT02795819|75680998|FG004|COMPLETED|Overall Study||0||
59576095|NCT02795819|75680999|FG005|COMPLETED|Overall Study||0||
59576096|NCT02795819|75681000|FG006|COMPLETED|Overall Study||0||
59576097|NCT02795819|75680994|FG000|NOT COMPLETED|Overall Study||0||
59576098|NCT02795819|75680995|FG001|NOT COMPLETED|Overall Study||0||
59576099|NCT02795819|75680996|FG002|NOT COMPLETED|Overall Study||0||
59576100|NCT02795819|75680997|FG003|NOT COMPLETED|Overall Study||0||
59576101|NCT02795819|75680998|FG004|NOT COMPLETED|Overall Study||0||
59576102|NCT02795819|75680999|FG005|NOT COMPLETED|Overall Study||0||
59850311|NCT03583450|75974660|FG000|STARTED|Overall Study||34||
59576103|NCT02795819|75681000|FG006|NOT COMPLETED|Overall Study||0||
59576104|NCT02882633|75681012|FG000|STARTED|Overall Study||25||
59576105|NCT02882633|75681013|FG001|STARTED|Overall Study||25||
59576106|NCT02882633|75681012|FG000|COMPLETED|Overall Study||23||
59576107|NCT02882633|75681013|FG001|COMPLETED|Overall Study||25||
59721582|NCT01199042|75840491|FG000|COMPLETED|At Home (3 Months)||26||
59721583|NCT01199042|75840491|FG000|NOT COMPLETED|At Home (3 Months)||1||
59850312|NCT03583450|75974661|FG001|STARTED|Overall Study||37||
59576108|NCT02882633|75681012|FG000|NOT COMPLETED|Overall Study||2||
59576109|NCT02882633|75681013|FG001|NOT COMPLETED|Overall Study||0||
59576110|NCT02797613|75681021|FG000|STARTED|Overall Study||55||
59576111|NCT02797613|75681022|FG001|STARTED|Overall Study||55||
59576112|NCT02797613|75681021|FG000|COMPLETED|Overall Study||55||
59576113|NCT02797613|75681022|FG001|COMPLETED|Overall Study||55||
59576114|NCT02797613|75681021|FG000|NOT COMPLETED|Overall Study||0||
59576115|NCT02797613|75681022|FG001|NOT COMPLETED|Overall Study||0||
59576116|NCT02882711|75681028|FG000|STARTED|Overall Study||6||
59576117|NCT02882711|75681028|FG000|COMPLETED|Overall Study||2||
59576118|NCT02882711|75681028|FG000|NOT COMPLETED|Overall Study||4||
59576119|NCT02884427|75681035|FG000|STARTED|Overall Study||48||
59576120|NCT02884427|75681036|FG001|STARTED|Overall Study||52||
59576121|NCT02884427|75681037|FG002|STARTED|Overall Study||50||
59576122|NCT02884427|75681035|FG000|COMPLETED|Overall Study||48||
59576123|NCT02884427|75681036|FG001|COMPLETED|Overall Study||52||
59576124|NCT02884427|75681037|FG002|COMPLETED|Overall Study||50||
59576125|NCT02884427|75681035|FG000|NOT COMPLETED|Overall Study||0||
59576126|NCT02884427|75681036|FG001|NOT COMPLETED|Overall Study||0||
59576127|NCT02884427|75681037|FG002|NOT COMPLETED|Overall Study||0||
59576128|NCT02798627|75681047|FG000|STARTED|Overall Study||27||
59576129|NCT02798627|75681048|FG001|STARTED|Overall Study||28||
59576130|NCT02798627|75681047|FG000|COMPLETED|Overall Study||27||
59576131|NCT02798627|75681048|FG001|COMPLETED|Overall Study||28||
59576132|NCT02798627|75681047|FG000|NOT COMPLETED|Overall Study||0||
59576133|NCT02798627|75681048|FG001|NOT COMPLETED|Overall Study||0||
59576134|NCT02886923|75681054|FG000|STARTED|Period 1||12||
59576135|NCT02886923|75681055|FG001|STARTED|Period 1||11||
59576136|NCT02886923|75681054|FG000|COMPLETED|Period 1||12||
59576137|NCT02886923|75681055|FG001|COMPLETED|Period 1||11||
59576138|NCT02886923|75681054|FG000|NOT COMPLETED|Period 1||0||
59576139|NCT02886923|75681055|FG001|NOT COMPLETED|Period 1||0||
59576140|NCT02886923|75681054|FG000|STARTED|Period 2||12||
59576141|NCT02886923|75681055|FG001|STARTED|Period 2||11||
59576142|NCT02886923|75681054|FG000|COMPLETED|Period 2||12||
59576143|NCT02886923|75681055|FG001|COMPLETED|Period 2||11||
59576144|NCT02886923|75681054|FG000|NOT COMPLETED|Period 2||0||
59576145|NCT02886923|75681055|FG001|NOT COMPLETED|Period 2||0||
59576146|NCT02888093|75681063|FG000|STARTED|Overall Study||22||
59576147|NCT02888093|75681064|FG001|STARTED|Overall Study||22||
59576148|NCT02888093|75681063|FG000|COMPLETED|Overall Study||20||
59576149|NCT02888093|75681064|FG001|COMPLETED|Overall Study||20||
59576150|NCT02888093|75681063|FG000|NOT COMPLETED|Overall Study||2||
59576151|NCT02888093|75681064|FG001|NOT COMPLETED|Overall Study||2||
59576152|NCT02895035|75681072|FG000|STARTED|Overall Study||23||
59576153|NCT02895035|75681073|FG001|STARTED|Overall Study||36||
59576154|NCT02895035|75681072|FG000|COMPLETED|Overall Study||18||
59576155|NCT02895035|75681073|FG001|COMPLETED|Overall Study||24||
59576156|NCT02895035|75681072|FG000|NOT COMPLETED|Overall Study||5||
59576157|NCT02895035|75681073|FG001|NOT COMPLETED|Overall Study||12||
59576158|NCT02802449|75681081|FG000|STARTED|Overall Study||111||
59576159|NCT02802449|75681082|FG001|STARTED|Overall Study||219||
59576160|NCT02802449|75681081|FG000|COMPLETED|Overall Study||102||
59576161|NCT02802449|75681082|FG001|COMPLETED|Overall Study||202||
59576162|NCT02802449|75681081|FG000|NOT COMPLETED|Overall Study||9||
59576163|NCT02802449|75681082|FG001|NOT COMPLETED|Overall Study||17||
59576164|NCT02803229|75681090|FG000|STARTED|Overall Study||15|5 participants were not randomized following the placebo lead-in week.|
59576165|NCT02803229|75681091|FG001|STARTED|Overall Study||13|5 participants were not randomized following the placebo lead-in week.|
59576166|NCT02803229|75681090|FG000|COMPLETED|Overall Study||11||
59576167|NCT02803229|75681091|FG001|COMPLETED|Overall Study||7||
59576168|NCT02803229|75681090|FG000|NOT COMPLETED|Overall Study||4||
59576169|NCT02803229|75681091|FG001|NOT COMPLETED|Overall Study||6||
59576170|NCT01938001|75681099|FG000|STARTED|Pre-Treatment||178|Started=randomized|
59850313|NCT03583450|75974660|FG000|COMPLETED|Overall Study||33||
59576171|NCT01938001|75681100|FG001|STARTED|Pre-Treatment||180|Started=randomized|
59576172|NCT01938001|75681099|FG000|COMPLETED|Pre-Treatment||176|Completed=treated|
59576173|NCT01938001|75681100|FG001|COMPLETED|Pre-Treatment||180|Completed=treated|
59576174|NCT01938001|75681099|FG000|NOT COMPLETED|Pre-Treatment||2||
59576175|NCT01938001|75681100|FG001|NOT COMPLETED|Pre-Treatment||0||
59576176|NCT01938001|75681099|FG000|STARTED|Treatment||176|Started=treated|
59576177|NCT01938001|75681100|FG001|STARTED|Treatment||180|Started=treated|
59576178|NCT01938001|75681099|FG000|COMPLETED|Treatment||124|Completed=completed 12 cycles of treatment|
59850314|NCT03583450|75974661|FG001|COMPLETED|Overall Study||37||
59576179|NCT01938001|75681100|FG001|COMPLETED|Treatment||110|Completed=completed 12 cycles of treatment|
59576180|NCT01938001|75681099|FG000|NOT COMPLETED|Treatment||52||
59576181|NCT01938001|75681100|FG001|NOT COMPLETED|Treatment||70||
59576182|NCT02805179|75681106|FG000|STARTED|Overall Study||26||
59576183|NCT02805179|75681106|FG000|Eligible Patients That Started Dose-intensified Chemo-radiation|Overall Study||23||
59576184|NCT02805179|75681106|FG000|Subset of Participants, Boosted to Both High B-value Diffusion and Perfusion|Overall Study||13|Protocol amended to include perfusion|
59576185|NCT02805179|75681106|FG000|COMPLETED|Overall Study||23||
59576186|NCT02805179|75681106|FG000|NOT COMPLETED|Overall Study||3||
59576187|NCT02003053|75681112|FG000|STARTED|Overall Study||4||
59576188|NCT02003053|75681113|FG001|STARTED|Overall Study||3||
59576189|NCT02003053|75681112|FG000|COMPLETED|Overall Study||4||
59576190|NCT02003053|75681113|FG001|COMPLETED|Overall Study||3||
59576191|NCT02003053|75681112|FG000|NOT COMPLETED|Overall Study||0||
59576192|NCT02003053|75681113|FG001|NOT COMPLETED|Overall Study||0||
59576193|NCT02896595|75681121|FG000|STARTED|Overall Study||50||
59576194|NCT02896595|75681122|FG001|STARTED|Overall Study||50||
59576195|NCT02896595|75681121|FG000|COMPLETED|Overall Study||50||
59576196|NCT02896595|75681122|FG001|COMPLETED|Overall Study||50||
59576197|NCT02896595|75681121|FG000|NOT COMPLETED|Overall Study||0||
59576198|NCT02896595|75681122|FG001|NOT COMPLETED|Overall Study||0||
59576199|NCT02003911|75681130|FG000|STARTED|Overall Study||80||
59576200|NCT02003911|75681131|FG001|STARTED|Overall Study||79||
59576201|NCT02003911|75681130|FG000|COMPLETED|Overall Study||78||
59576202|NCT02003911|75681131|FG001|COMPLETED|Overall Study||72||
59576203|NCT02003911|75681130|FG000|NOT COMPLETED|Overall Study||2||
59576204|NCT02003911|75681131|FG001|NOT COMPLETED|Overall Study||7||
59576205|NCT02805647|75681139|FG000|STARTED|Overall Study|at the moment of submision|100||
59576206|NCT02805647|75681140|FG001|STARTED|Overall Study|at the moment of submision|122||
59576207|NCT02805647|75681139|FG000|COMPLETED|Overall Study|after laboratory tests|100||
59576208|NCT02805647|75681140|FG001|COMPLETED|Overall Study|after laboratory tests|122||
59576209|NCT02805647|75681139|FG000|NOT COMPLETED|Overall Study||0||
59576210|NCT02805647|75681140|FG001|NOT COMPLETED|Overall Study||0||
59576211|NCT02004613|75681148|FG000|STARTED|Overall Study||400||
59576212|NCT02004613|75681149|FG001|STARTED|Overall Study||398||
59576213|NCT02004613|75681148|FG000|COMPLETED|Overall Study||398||
59576214|NCT02004613|75681149|FG001|COMPLETED|Overall Study||396||
59576215|NCT02004613|75681148|FG000|NOT COMPLETED|Overall Study||2||
59576216|NCT02004613|75681149|FG001|NOT COMPLETED|Overall Study||2||
59576217|NCT02806895|75681157|FG000|STARTED|Overall Study||17||
59576218|NCT02806895|75681158|FG001|STARTED|Overall Study||17||
59576219|NCT02806895|75681157|FG000|COMPLETED|Overall Study||16||
59576220|NCT02806895|75681158|FG001|COMPLETED|Overall Study||17||
59576221|NCT02806895|75681157|FG000|NOT COMPLETED|Overall Study||1||
59576222|NCT02806895|75681158|FG001|NOT COMPLETED|Overall Study||0||
59576223|NCT02298361|75681168|FG000|STARTED|Overall Study||2240||
59576224|NCT02298361|75681169|FG001|STARTED|Overall Study||12784||
59576225|NCT02298361|75681170|FG002|STARTED|Overall Study||12227||
59576226|NCT02298361|75681168|FG000|COMPLETED|Overall Study||2240||
59576227|NCT02298361|75681169|FG001|COMPLETED|Overall Study||12784||
59576228|NCT02298361|75681170|FG002|COMPLETED|Overall Study||12227||
59576229|NCT02298361|75681168|FG000|NOT COMPLETED|Overall Study||0||
59576230|NCT02298361|75681169|FG001|NOT COMPLETED|Overall Study||0||
59576231|NCT02298361|75681170|FG002|NOT COMPLETED|Overall Study||0||
59576232|NCT02005393|75681178|FG000|STARTED|Overall Study||20||
59576233|NCT02005393|75681178|FG000|COMPLETED|Overall Study||20||
59576234|NCT02005393|75681178|FG000|NOT COMPLETED|Overall Study||0||
59576235|NCT02896907|75681182|FG000|STARTED|Overall Study||8||
59576236|NCT02896907|75681182|FG000|COMPLETED|Overall Study||8||
59576237|NCT02896907|75681182|FG000|NOT COMPLETED|Overall Study||0||
59576238|NCT02005549|75681186|FG000|STARTED|Overall Study||18||
59576239|NCT02005549|75681186|FG000|COMPLETED|Overall Study||18||
59576240|NCT02005549|75681186|FG000|NOT COMPLETED|Overall Study||0||
59576241|NCT02897141|75681192|FG000|STARTED|Overall Study||40||
59576242|NCT02897141|75681193|FG001|STARTED|Overall Study||40||
59576243|NCT02897141|75681192|FG000|COMPLETED|Overall Study||38||
59576244|NCT02897141|75681193|FG001|COMPLETED|Overall Study||39||
59576245|NCT02897141|75681192|FG000|NOT COMPLETED|Overall Study||2||
59576246|NCT02897141|75681193|FG001|NOT COMPLETED|Overall Study||1||
59576247|NCT02809859|75681210|FG000|STARTED|Overall Study||139||
59576248|NCT02809859|75681210|FG000|COMPLETED|Overall Study||125||
59576249|NCT02809859|75681210|FG000|NOT COMPLETED|Overall Study||14||
59576250|NCT02810327|75681216|FG000|STARTED|Overall Study||76||
59576251|NCT02810327|75681217|FG001|STARTED|Overall Study||41||
59576252|NCT02810327|75681216|FG000|COMPLETED|Overall Study||69||
59576253|NCT02810327|75681217|FG001|COMPLETED|Overall Study||34||
59576254|NCT02810327|75681216|FG000|NOT COMPLETED|Overall Study||7||
59576255|NCT02810327|75681217|FG001|NOT COMPLETED|Overall Study||7||
59576256|NCT02810873|75681225|FG000|STARTED|Overall Study||6||
59576257|NCT02810873|75681226|FG001|STARTED|Overall Study||13||
59576258|NCT02810873|75681225|FG000|COMPLETED|Overall Study||6||
59576259|NCT02810873|75681226|FG001|COMPLETED|Overall Study||13||
59576260|NCT02810873|75681225|FG000|NOT COMPLETED|Overall Study||0||
59576261|NCT02810873|75681226|FG001|NOT COMPLETED|Overall Study||0||
59576262|NCT02811419|75681235|FG000|STARTED|Overall Study||369||
59576263|NCT02811419|75681236|FG001|STARTED|Overall Study||371||
59576264|NCT02811419|75681235|FG000|COMPLETED|Overall Study||357||
59576265|NCT02811419|75681236|FG001|COMPLETED|Overall Study||358||
59576266|NCT02811419|75681235|FG000|NOT COMPLETED|Overall Study||12||
59576267|NCT02811419|75681236|FG001|NOT COMPLETED|Overall Study||13||
59576268|NCT02811965|75681242|FG000|STARTED|Overall Study||21||
59576269|NCT02811965|75681242|FG000|COMPLETED|Overall Study||21||
59576270|NCT02811965|75681242|FG000|NOT COMPLETED|Overall Study||0||
59576271|NCT01066663|75681261|FG000|STARTED|Overall Study||3||
59576272|NCT01066663|75681262|FG001|STARTED|Overall Study||3||
59576273|NCT01066663|75681263|FG002|STARTED|Overall Study||10||
59576274|NCT01066663|75681261|FG000|COMPLETED|Overall Study||3||
59576275|NCT01066663|75681262|FG001|COMPLETED|Overall Study||3||
59576276|NCT01066663|75681263|FG002|COMPLETED|Overall Study||9||
59576277|NCT01066663|75681261|FG000|NOT COMPLETED|Overall Study||0||
59576278|NCT01066663|75681262|FG001|NOT COMPLETED|Overall Study||0||
59576279|NCT01066663|75681263|FG002|NOT COMPLETED|Overall Study||1||
59576280|NCT01959685|75681273|FG000|STARTED|Overall Study||9||
59576281|NCT01959685|75681273|FG000|COMPLETED|Overall Study||9||
59576282|NCT01959685|75681273|FG000|NOT COMPLETED|Overall Study||0||
59576283|NCT02901899|75681277|FG000|STARTED|Reached 1st Response Assessment||45||
59576284|NCT02901899|75681277|FG000|Registered|Reached 1st Response Assessment||45||
59576285|NCT02901899|75681277|FG000|Started Treatment|Reached 1st Response Assessment||43||
59576286|NCT02901899|75681277|FG000|Attempted 2 Cycles of Treatment/Reached First Response|Reached 1st Response Assessment||37||
59576287|NCT02901899|75681277|FG000|COMPLETED|Reached 1st Response Assessment||37||
59576288|NCT02901899|75681277|FG000|NOT COMPLETED|Reached 1st Response Assessment||8||
59576289|NCT02901899|75681277|FG000|STARTED|Continued Treatment After 1st Response||37|Treatment may continue in the absence of disease progression, unacceptable toxicity, death and withdrawal from the study.|
59576290|NCT02901899|75681277|FG000|Went on to Start Cycle 3|Continued Treatment After 1st Response||21||
59576291|NCT02901899|75681277|FG000|COMPLETED|Continued Treatment After 1st Response||21||
59576292|NCT02901899|75681277|FG000|NOT COMPLETED|Continued Treatment After 1st Response||16||
59576293|NCT02901899|75681277|FG000|STARTED|Follow up|All patients who receive at least one dose of study drug go into the follow up period.|43|Follow up continues until death, withdrawal of consent or the end of the study, whichever comes first.|
59576294|NCT02901899|75681277|FG000|COMPLETED|Follow up||27||
59576295|NCT02901899|75681277|FG000|NOT COMPLETED|Follow up||16||
59576296|NCT02902913|75681281|FG000|STARTED|Overall Study||9||
59576297|NCT02902913|75681281|FG000|First Intervention (1 Day)|Overall Study||9||
59576298|NCT02902913|75681281|FG000|Washout (7 Days)|Overall Study||9||
59576299|NCT02902913|75681281|FG000|Second Intervention (1 Day)|Overall Study||9||
59576300|NCT02902913|75681281|FG000|Washout (7 Days)|Overall Study||9||
59576301|NCT02902913|75681281|FG000|Third Intervention (1 Day)|Overall Study||9||
59576302|NCT02902913|75681281|FG000|Washout (7 Days)|Overall Study||9||
59576303|NCT02902913|75681281|FG000|Ibuprofen (400mg)|Overall Study||9||
59576304|NCT02902913|75681281|FG000|COMPLETED|Overall Study||9||
59576305|NCT02902913|75681281|FG000|NOT COMPLETED|Overall Study||0||
59576306|NCT03002753|75681291|FG000|STARTED|First Randomization||10||
59576307|NCT03002753|75681292|FG001|STARTED|First Randomization||12||
59576308|NCT03002753|75681293|FG002|STARTED|First Randomization||21||
59576309|NCT03002753|75681291|FG000|COMPLETED|First Randomization||9||
59576310|NCT03002753|75681292|FG001|COMPLETED|First Randomization||11||
59576311|NCT03002753|75681293|FG002|COMPLETED|First Randomization||21||
59576312|NCT03002753|75681291|FG000|NOT COMPLETED|First Randomization||1||
59576313|NCT03002753|75681292|FG001|NOT COMPLETED|First Randomization||1||
59576314|NCT03002753|75681293|FG002|NOT COMPLETED|First Randomization||0||
59576315|NCT03002753|75681291|FG000|STARTED|Second Randomization (Re-randomization)||11||
59576316|NCT03002753|75681292|FG001|STARTED|Second Randomization (Re-randomization)||10||
59576317|NCT03002753|75681293|FG002|STARTED|Second Randomization (Re-randomization)||0||
59576318|NCT03002753|75681291|FG000|COMPLETED|Second Randomization (Re-randomization)||11||
59576319|NCT03002753|75681292|FG001|COMPLETED|Second Randomization (Re-randomization)||9||
59576320|NCT03002753|75681293|FG002|COMPLETED|Second Randomization (Re-randomization)||0||
59576321|NCT03002753|75681291|FG000|NOT COMPLETED|Second Randomization (Re-randomization)||0||
59576322|NCT03002753|75681292|FG001|NOT COMPLETED|Second Randomization (Re-randomization)||1||
59576323|NCT03002753|75681293|FG002|NOT COMPLETED|Second Randomization (Re-randomization)||0||
59576324|NCT02906813|75681304|FG000|STARTED|Intervention Period 1 (3 Days)||3||
59576325|NCT02906813|75681305|FG001|STARTED|Intervention Period 1 (3 Days)||3||
59576326|NCT02906813|75681306|FG002|STARTED|Intervention Period 1 (3 Days)||3||
59576327|NCT02906813|75681304|FG000|COMPLETED|Intervention Period 1 (3 Days)||3||
59576328|NCT02906813|75681305|FG001|COMPLETED|Intervention Period 1 (3 Days)||3||
59576329|NCT02906813|75681306|FG002|COMPLETED|Intervention Period 1 (3 Days)||3||
59576330|NCT02906813|75681304|FG000|NOT COMPLETED|Intervention Period 1 (3 Days)||0||
59576331|NCT02906813|75681305|FG001|NOT COMPLETED|Intervention Period 1 (3 Days)||0||
59576332|NCT02906813|75681306|FG002|NOT COMPLETED|Intervention Period 1 (3 Days)||0||
59576333|NCT02906813|75681304|FG000|STARTED|Washout Period 1 (at Least 3 Days)||3||
59576334|NCT02906813|75681305|FG001|STARTED|Washout Period 1 (at Least 3 Days)||3||
59576335|NCT02906813|75681306|FG002|STARTED|Washout Period 1 (at Least 3 Days)||3||
59576336|NCT02906813|75681304|FG000|COMPLETED|Washout Period 1 (at Least 3 Days)||3||
59576337|NCT02906813|75681305|FG001|COMPLETED|Washout Period 1 (at Least 3 Days)||3||
59576338|NCT02906813|75681306|FG002|COMPLETED|Washout Period 1 (at Least 3 Days)||3||
59576339|NCT02906813|75681304|FG000|NOT COMPLETED|Washout Period 1 (at Least 3 Days)||0||
59576340|NCT02906813|75681305|FG001|NOT COMPLETED|Washout Period 1 (at Least 3 Days)||0||
59576341|NCT02906813|75681306|FG002|NOT COMPLETED|Washout Period 1 (at Least 3 Days)||0||
59576342|NCT02906813|75681304|FG000|STARTED|Intervention Period 2 (3 Days)||3||
59850315|NCT03583450|75974660|FG000|NOT COMPLETED|Overall Study||1||
59850316|NCT03583450|75974661|FG001|NOT COMPLETED|Overall Study||0||
59576343|NCT02906813|75681305|FG001|STARTED|Intervention Period 2 (3 Days)||3||
59576344|NCT02906813|75681306|FG002|STARTED|Intervention Period 2 (3 Days)||3||
59576345|NCT02906813|75681304|FG000|COMPLETED|Intervention Period 2 (3 Days)||3||
59576346|NCT02906813|75681305|FG001|COMPLETED|Intervention Period 2 (3 Days)||3||
59576347|NCT02906813|75681306|FG002|COMPLETED|Intervention Period 2 (3 Days)||3||
59576348|NCT02906813|75681304|FG000|NOT COMPLETED|Intervention Period 2 (3 Days)||0||
59576349|NCT02906813|75681305|FG001|NOT COMPLETED|Intervention Period 2 (3 Days)||0||
59576350|NCT02906813|75681306|FG002|NOT COMPLETED|Intervention Period 2 (3 Days)||0||
59576351|NCT02906813|75681304|FG000|STARTED|Washout Period 2 (at Least 3 Days)||3||
59576352|NCT02906813|75681305|FG001|STARTED|Washout Period 2 (at Least 3 Days)||3||
59576353|NCT02906813|75681306|FG002|STARTED|Washout Period 2 (at Least 3 Days)||3||
59576354|NCT02906813|75681304|FG000|COMPLETED|Washout Period 2 (at Least 3 Days)||3||
59576355|NCT02906813|75681305|FG001|COMPLETED|Washout Period 2 (at Least 3 Days)||3||
59576356|NCT02906813|75681306|FG002|COMPLETED|Washout Period 2 (at Least 3 Days)||3||
59576357|NCT02906813|75681304|FG000|NOT COMPLETED|Washout Period 2 (at Least 3 Days)||0||
59576358|NCT02906813|75681305|FG001|NOT COMPLETED|Washout Period 2 (at Least 3 Days)||0||
59576359|NCT02906813|75681306|FG002|NOT COMPLETED|Washout Period 2 (at Least 3 Days)||0||
59576360|NCT02906813|75681304|FG000|STARTED|Intervention Period 3 (3 Days)||3||
59576361|NCT02906813|75681305|FG001|STARTED|Intervention Period 3 (3 Days)||3||
59576362|NCT02906813|75681306|FG002|STARTED|Intervention Period 3 (3 Days)||3||
59576363|NCT02906813|75681304|FG000|COMPLETED|Intervention Period 3 (3 Days)||3||
59576364|NCT02906813|75681305|FG001|COMPLETED|Intervention Period 3 (3 Days)||3||
59576365|NCT02906813|75681306|FG002|COMPLETED|Intervention Period 3 (3 Days)||3||
59576366|NCT02906813|75681304|FG000|NOT COMPLETED|Intervention Period 3 (3 Days)||0||
59576367|NCT02906813|75681305|FG001|NOT COMPLETED|Intervention Period 3 (3 Days)||0||
59576368|NCT02906813|75681306|FG002|NOT COMPLETED|Intervention Period 3 (3 Days)||0||
59576369|NCT02301416|75681316|FG000|STARTED|Overall Study||25||
59576370|NCT02301416|75681317|FG001|STARTED|Overall Study||40||
59576371|NCT02301416|75681316|FG000|COMPLETED|Overall Study||15||
59576372|NCT02301416|75681317|FG001|COMPLETED|Overall Study||40||
59576373|NCT02301416|75681316|FG000|NOT COMPLETED|Overall Study||10||
59576374|NCT02301416|75681317|FG001|NOT COMPLETED|Overall Study||0||
59576375|NCT02815709|75681328|FG000|STARTED|Overall Study||82||
59576376|NCT02815709|75681329|FG001|STARTED|Overall Study||86||
59576377|NCT02815709|75681330|FG002|STARTED|Overall Study||82||
59576378|NCT02815709|75681331|FG003|STARTED|Overall Study||84||
59576379|NCT02815709|75681332|FG004|STARTED|Overall Study||84||
59576380|NCT02815709|75681328|FG000|Treated With Study Medication|Overall Study||76||
59576381|NCT02815709|75681329|FG001|Treated With Study Medication|Overall Study||79||
59576382|NCT02815709|75681330|FG002|Treated With Study Medication|Overall Study||79||
59576383|NCT02815709|75681331|FG003|Treated With Study Medication|Overall Study||79||
59576384|NCT02815709|75681332|FG004|Treated With Study Medication|Overall Study||76||
59576385|NCT02815709|75681328|FG000|COMPLETED|Overall Study|Completed Study|75||
59576386|NCT02815709|75681329|FG001|COMPLETED|Overall Study|Completed Study|78||
59576387|NCT02815709|75681330|FG002|COMPLETED|Overall Study|Completed Study|75||
59576388|NCT02815709|75681331|FG003|COMPLETED|Overall Study|Completed Study|76||
59576389|NCT02815709|75681332|FG004|COMPLETED|Overall Study|Completed Study|74||
59576390|NCT02815709|75681328|FG000|NOT COMPLETED|Overall Study||7||
59576391|NCT02815709|75681329|FG001|NOT COMPLETED|Overall Study||8||
59576392|NCT02815709|75681330|FG002|NOT COMPLETED|Overall Study||7||
59576393|NCT02815709|75681331|FG003|NOT COMPLETED|Overall Study||8||
59576394|NCT02815709|75681332|FG004|NOT COMPLETED|Overall Study||10||
59576395|NCT02816723|75681347|FG000|STARTED|Overall Study||30||
59576396|NCT02816723|75681348|FG001|STARTED|Overall Study||30||
59576397|NCT02816723|75681347|FG000|COMPLETED|Overall Study||24||
59576398|NCT02816723|75681348|FG001|COMPLETED|Overall Study||28||
59576399|NCT02816723|75681347|FG000|NOT COMPLETED|Overall Study||6||
59576400|NCT02816723|75681348|FG001|NOT COMPLETED|Overall Study||2||
59576401|NCT02912195|75681356|FG000|STARTED|Overall Study||16||
59576402|NCT02912195|75681357|FG001|STARTED|Overall Study||16||
59576403|NCT02912195|75681356|FG000|COMPLETED|Overall Study||16||
59576404|NCT02912195|75681357|FG001|COMPLETED|Overall Study||16||
59576405|NCT02912195|75681356|FG000|NOT COMPLETED|Overall Study||0||
59721584|NCT01198574|75840504|FG000|STARTED|Overall Study||98||
59576406|NCT02912195|75681357|FG001|NOT COMPLETED|Overall Study||0||
59576407|NCT01960075|75681366|FG000|STARTED|Overall Study||149||
59576408|NCT01960075|75681367|FG001|STARTED|Overall Study||149||
59576409|NCT01960075|75681368|FG002|STARTED|Overall Study||180||
59576410|NCT01960075|75681366|FG000|COMPLETED|Overall Study||141||
59576411|NCT01960075|75681367|FG001|COMPLETED|Overall Study||146||
59576412|NCT01960075|75681368|FG002|COMPLETED|Overall Study||173||
59576413|NCT01960075|75681366|FG000|NOT COMPLETED|Overall Study||8||
59576414|NCT01960075|75681367|FG001|NOT COMPLETED|Overall Study||3||
59576415|NCT01960075|75681368|FG002|NOT COMPLETED|Overall Study||7||
59576416|NCT01988246|75681378|FG000|STARTED|Overall Study||15||
59576417|NCT01988246|75681379|FG001|STARTED|Overall Study||15||
59576418|NCT01988246|75681378|FG000|COMPLETED|Overall Study||14||
59576419|NCT01988246|75681379|FG001|COMPLETED|Overall Study||15||
59721585|NCT01198574|75840505|FG001|STARTED|Overall Study||102||
59576420|NCT01988246|75681378|FG000|NOT COMPLETED|Overall Study||1||
59576421|NCT01988246|75681379|FG001|NOT COMPLETED|Overall Study||0||
59576422|NCT02821403|75681387|FG000|STARTED|"First Intervention (1 Month)"||40||
59576423|NCT02821403|75681388|FG001|STARTED|"First Intervention (1 Month)"||40||
59576424|NCT02821403|75681387|FG000|Used Clear Lens|"First Intervention (1 Month)"||13||
59576425|NCT02821403|75681388|FG001|Used Clear Lens|"First Intervention (1 Month)"||13||
59576426|NCT02821403|75681387|FG000|Used Yellow Tinted Lens|"First Intervention (1 Month)"||13||
59576427|NCT02821403|75681388|FG001|Used Yellow Tinted Lens|"First Intervention (1 Month)"||14||
59576428|NCT02821403|75681387|FG000|Used Blue-filtering Coated Lens|"First Intervention (1 Month)"||14||
59576429|NCT02821403|75681388|FG001|Used Blue-filtering Coated Lens|"First Intervention (1 Month)"||13||
59576430|NCT02821403|75681387|FG000|COMPLETED|"First Intervention (1 Month)"||40||
59576431|NCT02821403|75681388|FG001|COMPLETED|"First Intervention (1 Month)"||40||
59576432|NCT02821403|75681387|FG000|NOT COMPLETED|"First Intervention (1 Month)"||0||
59576433|NCT02821403|75681388|FG001|NOT COMPLETED|"First Intervention (1 Month)"||0||
59576434|NCT02821403|75681387|FG000|STARTED|"Second Intervention (1 Month)"||40||
59576435|NCT02821403|75681388|FG001|STARTED|"Second Intervention (1 Month)"||40||
59576436|NCT02821403|75681387|FG000|Used Clear Lens|"Second Intervention (1 Month)"||13||
59576437|NCT02821403|75681388|FG001|Used Clear Lens|"Second Intervention (1 Month)"||14||
59576438|NCT02821403|75681387|FG000|Used Yellow Tinted Lens|"Second Intervention (1 Month)"||14||
59576439|NCT02821403|75681388|FG001|Used Yellow Tinted Lens|"Second Intervention (1 Month)"||13||
59576440|NCT02821403|75681387|FG000|Used Blue-filtering Coated Lens|"Second Intervention (1 Month)"||13||
59576441|NCT02821403|75681388|FG001|Used Blue-filtering Coated Lens|"Second Intervention (1 Month)"||13||
59576442|NCT02821403|75681387|FG000|COMPLETED|"Second Intervention (1 Month)"||40||
59576443|NCT02821403|75681388|FG001|COMPLETED|"Second Intervention (1 Month)"||40||
59576444|NCT02821403|75681387|FG000|NOT COMPLETED|"Second Intervention (1 Month)"||0||
59576445|NCT02821403|75681388|FG001|NOT COMPLETED|"Second Intervention (1 Month)"||0||
59576446|NCT02821403|75681387|FG000|STARTED|"Third Intervention (1 Month)"||40||
59576447|NCT02821403|75681388|FG001|STARTED|"Third Intervention (1 Month)"||40||
59576448|NCT02821403|75681387|FG000|Used Clear Lens|"Third Intervention (1 Month)"||14||
59576449|NCT02821403|75681388|FG001|Used Clear Lens|"Third Intervention (1 Month)"||13||
59576450|NCT02821403|75681387|FG000|Used Yellow Tinted Lens|"Third Intervention (1 Month)"||13||
59576451|NCT02821403|75681388|FG001|Used Yellow Tinted Lens|"Third Intervention (1 Month)"||13||
59576452|NCT02821403|75681387|FG000|Used Blue-filtering Coated Lens|"Third Intervention (1 Month)"||13||
59576453|NCT02821403|75681388|FG001|Used Blue-filtering Coated Lens|"Third Intervention (1 Month)"||14||
59576454|NCT02821403|75681387|FG000|COMPLETED|"Third Intervention (1 Month)"||40||
59576455|NCT02821403|75681388|FG001|COMPLETED|"Third Intervention (1 Month)"||40||
59576456|NCT02821403|75681387|FG000|NOT COMPLETED|"Third Intervention (1 Month)"||0||
59576457|NCT02821403|75681388|FG001|NOT COMPLETED|"Third Intervention (1 Month)"||0||
59576458|NCT01990820|75681402|FG000|STARTED|Overall Study||13||
59576459|NCT01990820|75681403|FG001|STARTED|Overall Study||12||
59721586|NCT01198574|75840506|FG002|STARTED|Overall Study||100||
59576460|NCT01990820|75681402|FG000|COMPLETED|Overall Study||13||
59576461|NCT01990820|75681403|FG001|COMPLETED|Overall Study||12||
59576462|NCT01990820|75681402|FG000|NOT COMPLETED|Overall Study||0||
59576463|NCT01990820|75681403|FG001|NOT COMPLETED|Overall Study||0||
59576464|NCT01990898|75681409|FG000|STARTED|Overall Study||26||
59576465|NCT01990898|75681409|FG000|3 Months|Overall Study||22||
59576466|NCT01990898|75681409|FG000|COMPLETED|Overall Study||22||
59576467|NCT01990898|75681409|FG000|NOT COMPLETED|Overall Study||4||
59576468|NCT02822885|75681413|FG000|STARTED|Overall Study||70||
59576469|NCT02822885|75681413|FG000|COMPLETED|Overall Study||70||
59576470|NCT02822885|75681413|FG000|NOT COMPLETED|Overall Study||0||
59576471|NCT01960387|75681417|FG000|STARTED|Overall Study||2||
59576472|NCT01960387|75681417|FG000|COMPLETED|Overall Study||2||
59576473|NCT01960387|75681417|FG000|NOT COMPLETED|Overall Study||0||
59576474|NCT01991522|75681423|FG000|STARTED|Overall Study||16||
59576475|NCT01991522|75681424|FG001|STARTED|Overall Study||17||
59576476|NCT01991522|75681423|FG000|COMPLETED|Overall Study||16||
59576477|NCT01991522|75681424|FG001|COMPLETED|Overall Study||17||
59576478|NCT01991522|75681423|FG000|NOT COMPLETED|Overall Study||0||
59576479|NCT01991522|75681424|FG001|NOT COMPLETED|Overall Study||0||
59576480|NCT02823431|75681432|FG000|STARTED|Overall Study||11||
59576481|NCT02823431|75681433|FG001|STARTED|Overall Study||12||
59576482|NCT02823431|75681432|FG000|COMPLETED|Overall Study||11||
59576483|NCT02823431|75681433|FG001|COMPLETED|Overall Study||12||
59576484|NCT02823431|75681432|FG000|NOT COMPLETED|Overall Study||0||
59576485|NCT02823431|75681433|FG001|NOT COMPLETED|Overall Study||0||
59576486|NCT01960465|75681441|FG000|STARTED|Overall Study||138||
59576487|NCT01960465|75681442|FG001|STARTED|Overall Study||82||
59576488|NCT01960465|75681441|FG000|COMPLETED|Overall Study||118||
59576489|NCT01960465|75681442|FG001|COMPLETED|Overall Study||73||
59576490|NCT01960465|75681441|FG000|NOT COMPLETED|Overall Study||20||
59576491|NCT01960465|75681442|FG001|NOT COMPLETED|Overall Study||9||
59576492|NCT01991990|75681450|FG000|STARTED|Overall Study||6||
59576493|NCT01991990|75681451|FG001|STARTED|Overall Study||12||
59576494|NCT01991990|75681450|FG000|COMPLETED|Overall Study||6||
59721587|NCT01198574|75840507|FG003|STARTED|Overall Study||102||
59576495|NCT01991990|75681451|FG001|COMPLETED|Overall Study||12||
59576496|NCT01991990|75681450|FG000|NOT COMPLETED|Overall Study||0||
59576497|NCT01991990|75681451|FG001|NOT COMPLETED|Overall Study||0||
59576498|NCT02824913|75681463|FG000|STARTED|First Intervention (1 Day)||1||
59576499|NCT02824913|75681464|FG001|STARTED|First Intervention (1 Day)||0||
59576500|NCT02824913|75681463|FG000|COMPLETED|First Intervention (1 Day)|Only one subject was enrolled in the study and received both study treatments.|1||
59576501|NCT02824913|75681464|FG001|COMPLETED|First Intervention (1 Day)||0||
59576502|NCT02824913|75681463|FG000|NOT COMPLETED|First Intervention (1 Day)||0||
59576503|NCT02824913|75681464|FG001|NOT COMPLETED|First Intervention (1 Day)||0||
59576504|NCT02824913|75681463|FG000|STARTED|Washout (7-14 Days)||1||
59576505|NCT02824913|75681464|FG001|STARTED|Washout (7-14 Days)||0||
59576506|NCT02824913|75681463|FG000|COMPLETED|Washout (7-14 Days)||1||
59576507|NCT02824913|75681464|FG001|COMPLETED|Washout (7-14 Days)||0||
59576508|NCT02824913|75681463|FG000|NOT COMPLETED|Washout (7-14 Days)||0||
59576509|NCT02824913|75681464|FG001|NOT COMPLETED|Washout (7-14 Days)||0||
59576510|NCT02824913|75681463|FG000|STARTED|Second Intervention (1 Day)||1||
59576511|NCT02824913|75681464|FG001|STARTED|Second Intervention (1 Day)||0||
59576512|NCT02824913|75681463|FG000|COMPLETED|Second Intervention (1 Day)||1||
59576513|NCT02824913|75681464|FG001|COMPLETED|Second Intervention (1 Day)||0||
59576514|NCT02824913|75681463|FG000|NOT COMPLETED|Second Intervention (1 Day)||0||
59576515|NCT02824913|75681464|FG001|NOT COMPLETED|Second Intervention (1 Day)||0||
59576516|NCT01961089|75681472|FG000|STARTED|Overall Study||40||
59576517|NCT01961089|75681472|FG000|COMPLETED|Overall Study||40||
59576518|NCT01961089|75681472|FG000|NOT COMPLETED|Overall Study||0||
59576519|NCT02825849|75681478|FG000|STARTED|Overall Study||22||
59576520|NCT02825849|75681479|FG001|STARTED|Overall Study||5||
59576521|NCT02825849|75681478|FG000|COMPLETED|Overall Study||22||
59576522|NCT02825849|75681479|FG001|COMPLETED|Overall Study||5||
59576523|NCT02825849|75681478|FG000|NOT COMPLETED|Overall Study||0||
59576524|NCT02825849|75681479|FG001|NOT COMPLETED|Overall Study||0||
59576525|NCT02057042|75681487|FG000|STARTED|Overall Study||163||
59576526|NCT02057042|75681488|FG001|STARTED|Overall Study||167||
59576527|NCT02057042|75681487|FG000|COMPLETED|Overall Study||118||
59576528|NCT02057042|75681488|FG001|COMPLETED|Overall Study||101||
59576529|NCT02057042|75681487|FG000|NOT COMPLETED|Overall Study||45||
59576530|NCT02057042|75681488|FG001|NOT COMPLETED|Overall Study||66||
59576531|NCT01961167|75681494|FG000|STARTED|Overall Study||27||
59576532|NCT01961167|75681494|FG000|COMPLETED|Overall Study||27|Completion of primary endpoint milestone at 30 days and secondary endpoints at 6 months.|
59576533|NCT01961167|75681494|FG000|NOT COMPLETED|Overall Study||0||
59576534|NCT03008213|75681498|FG000|STARTED|Overall Study||1||
59576535|NCT03008213|75681498|FG000|COMPLETED|Overall Study||1||
59576536|NCT03008213|75681498|FG000|NOT COMPLETED|Overall Study||0||
59576537|NCT01959542|75681502|FG000|STARTED|Overall Study||15|3 patients withdrew after initial consent.|
59576538|NCT01959542|75681502|FG000|Evaluable at Visit 1|Overall Study||12||
59576539|NCT01959542|75681502|FG000|Evaluable at Visit 2|Overall Study||12||
59576540|NCT01959542|75681502|FG000|COMPLETED|Overall Study||12||
59576541|NCT01959542|75681502|FG000|NOT COMPLETED|Overall Study||3||
59576542|NCT03008837|75681509|FG000|STARTED|Overall Study||12||
59576543|NCT03008837|75681510|FG001|STARTED|Overall Study||9||
59576544|NCT03008837|75681509|FG000|COMPLETED|Overall Study||9||
59576545|NCT03008837|75681510|FG001|COMPLETED|Overall Study||5||
59576546|NCT03008837|75681509|FG000|NOT COMPLETED|Overall Study||3||
59576547|NCT03008837|75681510|FG001|NOT COMPLETED|Overall Study||4||
59721588|NCT01198574|75840504|FG000|COMPLETED|Overall Study||94||
59576548|NCT01962025|75681521|FG000|STARTED|Overall Study||8||
59576549|NCT01962025|75681522|FG001|STARTED|Overall Study||6||
59576550|NCT01962025|75681521|FG000|COMPLETED|Overall Study||8||
59576551|NCT01962025|75681522|FG001|COMPLETED|Overall Study||6||
59576552|NCT01962025|75681521|FG000|NOT COMPLETED|Overall Study||0||
59576553|NCT01962025|75681522|FG001|NOT COMPLETED|Overall Study||0||
59576554|NCT01992380|75681533|FG000|STARTED|Overall Study||6||
59721589|NCT01198574|75840505|FG001|COMPLETED|Overall Study||101||
59576555|NCT01992380|75681534|FG001|STARTED|Overall Study||8||
59576556|NCT01992380|75681535|FG002|STARTED|Overall Study||10||
59576557|NCT01992380|75681533|FG000|COMPLETED|Overall Study||6||
59576558|NCT01992380|75681534|FG001|COMPLETED|Overall Study||8||
59576559|NCT01992380|75681535|FG002|COMPLETED|Overall Study||10||
59576560|NCT01992380|75681533|FG000|NOT COMPLETED|Overall Study||0||
59576561|NCT01992380|75681534|FG001|NOT COMPLETED|Overall Study||0||
59576562|NCT01992380|75681535|FG002|NOT COMPLETED|Overall Study||0||
59576563|NCT02059070|75681543|FG000|STARTED|Overall Study||19||
59576564|NCT02059070|75681544|FG001|STARTED|Overall Study||20||
59576565|NCT02059070|75681543|FG000|COMPLETED|Overall Study||14||
59576566|NCT02059070|75681544|FG001|COMPLETED|Overall Study||16||
59850317|NCT03583372|75974673|FG000|STARTED|Overall Study||92||
59576567|NCT02059070|75681543|FG000|NOT COMPLETED|Overall Study||5||
59576568|NCT02059070|75681544|FG001|NOT COMPLETED|Overall Study||4||
59576569|NCT01962961|75681553|FG000|STARTED|Overall Study||9||
59576570|NCT01962961|75681554|FG001|STARTED|Overall Study||8||
59576571|NCT01962961|75681555|FG002|STARTED|Overall Study||7||
59721590|NCT01198574|75840506|FG002|COMPLETED|Overall Study||99||
59576572|NCT01962961|75681553|FG000|COMPLETED|Overall Study||9||
59576573|NCT01962961|75681554|FG001|COMPLETED|Overall Study||7||
59576574|NCT01962961|75681555|FG002|COMPLETED|Overall Study||6||
59576575|NCT01962961|75681553|FG000|NOT COMPLETED|Overall Study||0||
59576576|NCT01962961|75681554|FG001|NOT COMPLETED|Overall Study||1||
59576577|NCT01962961|75681555|FG002|NOT COMPLETED|Overall Study||1||
59576578|NCT03010631|75681567|FG000|STARTED|Cohort 1||18|Participants in Cohort 2 were not included in the first treatment period|
59576579|NCT03010631|75681568|FG001|STARTED|Cohort 1||17|Participants in Cohort 2 were not included in the first treatment period|
59576580|NCT03010631|75681569|FG002|STARTED|Cohort 1||0|Participants in Cohort 2 were not included in the first treatment period|
59576581|NCT03010631|75681570|FG003|STARTED|Cohort 1||0|Participants in Cohort 2 were not included in the first treatment period|
59576582|NCT03010631|75681567|FG000|COMPLETED|Cohort 1||14||
59576583|NCT03010631|75681568|FG001|COMPLETED|Cohort 1||17||
59576584|NCT03010631|75681569|FG002|COMPLETED|Cohort 1||0||
59576585|NCT03010631|75681570|FG003|COMPLETED|Cohort 1||0||
59576586|NCT03010631|75681567|FG000|NOT COMPLETED|Cohort 1||4||
59576587|NCT03010631|75681568|FG001|NOT COMPLETED|Cohort 1||0||
59576588|NCT03010631|75681569|FG002|NOT COMPLETED|Cohort 1||0||
59576589|NCT03010631|75681570|FG003|NOT COMPLETED|Cohort 1||0||
59576590|NCT03010631|75681567|FG000|STARTED|Cohort 2||0|Participants from Cohort 1 were not included in the second treatment period|
59576591|NCT03010631|75681568|FG001|STARTED|Cohort 2||0|Participants from Cohort 1 were not included in the second treatment period|
59576592|NCT03010631|75681569|FG002|STARTED|Cohort 2|New participants were enrolled for Cohort 2|7|Participants from Cohort 1 were not included in the second treatment period|
59576593|NCT03010631|75681570|FG003|STARTED|Cohort 2||7|Participants from Cohort 1 were not included in the second treatment period|
59576594|NCT03010631|75681567|FG000|COMPLETED|Cohort 2||0||
59576595|NCT03010631|75681568|FG001|COMPLETED|Cohort 2||0||
59576596|NCT03010631|75681569|FG002|COMPLETED|Cohort 2||7||
59576597|NCT03010631|75681570|FG003|COMPLETED|Cohort 2||7||
59576598|NCT03010631|75681567|FG000|NOT COMPLETED|Cohort 2||0||
59576599|NCT03010631|75681568|FG001|NOT COMPLETED|Cohort 2||0||
59576600|NCT03010631|75681569|FG002|NOT COMPLETED|Cohort 2||0||
59576601|NCT03010631|75681570|FG003|NOT COMPLETED|Cohort 2||0||
59576602|NCT01993238|75681584|FG000|STARTED|Overall Study||11||
59576603|NCT01993238|75681584|FG000|COMPLETED|Overall Study||11||
59576604|NCT01993238|75681584|FG000|NOT COMPLETED|Overall Study||0||
59576605|NCT01965067|75681590|FG000|STARTED|Overall Study||30||
59576606|NCT01965067|75681591|FG001|STARTED|Overall Study||30||
59576607|NCT01965067|75681590|FG000|COMPLETED|Overall Study||30||
59576608|NCT01965067|75681591|FG001|COMPLETED|Overall Study||30||
59576609|NCT01965067|75681590|FG000|NOT COMPLETED|Overall Study||0||
59576610|NCT01965067|75681591|FG001|NOT COMPLETED|Overall Study||0||
59576611|NCT01960400|75681599|FG000|STARTED|Overall Study||11||
59576612|NCT01960400|75681600|FG001|STARTED|Overall Study||11||
59576613|NCT01960400|75681599|FG000|COMPLETED|Overall Study||11||
59576614|NCT01960400|75681600|FG001|COMPLETED|Overall Study||11||
59576615|NCT01960400|75681599|FG000|NOT COMPLETED|Overall Study||0||
59576616|NCT01960400|75681600|FG001|NOT COMPLETED|Overall Study||0||
59576617|NCT03012191|75681609|FG000|STARTED|Overall Study||2||
59576618|NCT03012191|75681610|FG001|STARTED|Overall Study||2||
59576619|NCT03012191|75681611|FG002|STARTED|Overall Study||2||
59576620|NCT03012191|75681609|FG000|COMPLETED|Overall Study||2||
59576621|NCT03012191|75681610|FG001|COMPLETED|Overall Study||2||
59576622|NCT03012191|75681611|FG002|COMPLETED|Overall Study||2||
59576623|NCT03012191|75681609|FG000|NOT COMPLETED|Overall Study||0||
59576624|NCT03012191|75681610|FG001|NOT COMPLETED|Overall Study||0||
59576625|NCT03012191|75681611|FG002|NOT COMPLETED|Overall Study||0||
59576626|NCT01994486|75681620|FG000|STARTED|Overall Study||20||
59576627|NCT01994486|75681620|FG000|COMPLETED|Overall Study||20||
59576628|NCT01994486|75681620|FG000|NOT COMPLETED|Overall Study||0||
59576629|NCT01997216|75681626|FG000|STARTED|First 9 Hours||18||
59576630|NCT01997216|75681627|FG001|STARTED|First 9 Hours||21||
59576631|NCT01997216|75681626|FG000|COMPLETED|First 9 Hours||18||
59576632|NCT01997216|75681627|FG001|COMPLETED|First 9 Hours||21||
59576633|NCT01997216|75681626|FG000|NOT COMPLETED|First 9 Hours||0||
59576634|NCT01997216|75681627|FG001|NOT COMPLETED|First 9 Hours||0||
59576635|NCT01997216|75681626|FG000|STARTED|Second 9 Hours|One participant was not exposed to Pair 1 due to product unavailability, but was exposed to Pair 2.|19||
59576636|NCT01997216|75681627|FG001|STARTED|Second 9 Hours||21||
59576637|NCT01997216|75681626|FG000|COMPLETED|Second 9 Hours||19||
59576638|NCT01997216|75681627|FG001|COMPLETED|Second 9 Hours||21||
59576639|NCT01997216|75681626|FG000|NOT COMPLETED|Second 9 Hours||0||
59576640|NCT01997216|75681627|FG001|NOT COMPLETED|Second 9 Hours||0||
59850318|NCT03583372|75974674|FG001|STARTED|Overall Study||182||
59850319|NCT03583372|75974675|FG002|STARTED|Overall Study||91||
59576641|NCT02059928|75681633|FG000|STARTED|Overall Study||20||
59576642|NCT02059928|75681633|FG000|COMPLETED|Overall Study||20||
59576643|NCT02059928|75681633|FG000|NOT COMPLETED|Overall Study||0||
59576644|NCT01967641|75681637|FG000|STARTED|Randomized||51||
59576645|NCT01967641|75681637|FG000|COMPLETED|Randomized|Completed week 12|43||
59576646|NCT01967641|75681637|FG000|NOT COMPLETED|Randomized||8||
59576647|NCT01967641|75681637|FG000|STARTED|Admission to Inpatient Phase||43||
59721591|NCT01198574|75840507|FG003|COMPLETED|Overall Study||98||
59576648|NCT01967641|75681637|FG000|COMPLETED|Admission to Inpatient Phase|Completed 7 week inpatient phase|31||
59576649|NCT01967641|75681637|FG000|NOT COMPLETED|Admission to Inpatient Phase||12||
59576650|NCT01967641|75681637|FG000|STARTED|12-week Outpatient Phase||31||
59576651|NCT01967641|75681637|FG000|COMPLETED|12-week Outpatient Phase|Completed week 12 of outpatient phase|18||
59576652|NCT01967641|75681637|FG000|NOT COMPLETED|12-week Outpatient Phase||13||
59576653|NCT03017261|75681642|FG000|STARTED|6 Week Follow up||115||
59576654|NCT03017261|75681642|FG000|COMPLETED|6 Week Follow up||115|8 did not complete the procedure with the device leaving 107 in the per protocol cohort.|
59576655|NCT03017261|75681642|FG000|NOT COMPLETED|6 Week Follow up||0||
59576656|NCT03017261|75681642|FG000|STARTED|3 Month Follow up||115||
59576657|NCT03017261|75681642|FG000|COMPLETED|3 Month Follow up|1 failed to compete 3M imaging so only 114 have 3M data for tibial slope and KSS Objective Score.|115||
59576658|NCT03017261|75681642|FG000|NOT COMPLETED|3 Month Follow up||0||
59576659|NCT03017261|75681642|FG000|STARTED|6 Month Follow up||115||
59576660|NCT03017261|75681642|FG000|COMPLETED|6 Month Follow up||106|2 failed to compete 6M imaging so only 104 have 6M data for KSS Objective Score.|
59576661|NCT03017261|75681642|FG000|NOT COMPLETED|6 Month Follow up||9||
59576662|NCT03017261|75681642|FG000|STARTED|12 Month Follow up||106||
59576663|NCT03017261|75681642|FG000|COMPLETED|12 Month Follow up|1 failed to compete 12M imaging so only 58 have 12M data for KSS Objective Score.|59||
59576664|NCT03017261|75681642|FG000|NOT COMPLETED|12 Month Follow up||47||
59576665|NCT01968421|75681648|FG000|STARTED|Overall Study|March 1, 2015 was the date for recruiting patients|99||
59576666|NCT01968421|75681649|FG001|STARTED|Overall Study|March 1, 2015 was the date for recruiting controls|97||
59576667|NCT01968421|75681648|FG000|Starting Trial|Overall Study||99|starting to recuit first subject|
59576668|NCT01968421|75681649|FG001|Starting Trial|Overall Study||97|starting to recuit first subject|
59576669|NCT01968421|75681648|FG000|COMPLETED|Overall Study|Nov. 23, 2018 is the date for completing the trial|99||
59576670|NCT01968421|75681649|FG001|COMPLETED|Overall Study|Nov. 23, 2018 is the date for completing the trial|97||
59576671|NCT01968421|75681648|FG000|NOT COMPLETED|Overall Study||0||
59576672|NCT01968421|75681649|FG001|NOT COMPLETED|Overall Study||0||
59576673|NCT02314520|75681657|FG000|STARTED|Overall Study||72||
59576674|NCT02314520|75681658|FG001|STARTED|Overall Study||80||
59576675|NCT02314520|75681657|FG000|COMPLETED|Overall Study||72||
59576676|NCT02314520|75681658|FG001|COMPLETED|Overall Study||80||
59576677|NCT02314520|75681657|FG000|NOT COMPLETED|Overall Study||0||
59576678|NCT02314520|75681658|FG001|NOT COMPLETED|Overall Study||0||
59576679|NCT02913521|75681667|FG000|STARTED|Overall Study||316||
59576680|NCT02913521|75681668|FG001|STARTED|Overall Study||312||
59576681|NCT02913521|75681669|FG002|STARTED|Overall Study||306||
59576682|NCT02913521|75681667|FG000|COMPLETED|Overall Study||263||
59576683|NCT02913521|75681668|FG001|COMPLETED|Overall Study||262||
59576684|NCT02913521|75681669|FG002|COMPLETED|Overall Study||261||
59576685|NCT02913521|75681667|FG000|NOT COMPLETED|Overall Study||53||
59576686|NCT02913521|75681668|FG001|NOT COMPLETED|Overall Study||50||
59576687|NCT02913521|75681669|FG002|NOT COMPLETED|Overall Study||45||
60121332|NCT02665468|76242261|FG001|NOT COMPLETED|Overall Study||0||
60121333|NCT02666560|76242267|FG000|STARTED|Condition 1 (1 Day)||8||
60121334|NCT02666560|76242268|FG001|STARTED|Condition 1 (1 Day)||11||
60121335|NCT02666560|76242267|FG000|COMPLETED|Condition 1 (1 Day)||8||
60121336|NCT02666560|76242268|FG001|COMPLETED|Condition 1 (1 Day)||11||
59576688|NCT01969201|75681679|FG000|STARTED|Overall Study||352||
59576689|NCT01969201|75681680|FG001|STARTED|Overall Study||358||
59576690|NCT01969201|75681679|FG000|COMPLETED|Overall Study||307||
59576691|NCT01969201|75681680|FG001|COMPLETED|Overall Study||313||
59576692|NCT01969201|75681679|FG000|NOT COMPLETED|Overall Study||45||
59576693|NCT01969201|75681680|FG001|NOT COMPLETED|Overall Study||45||
59576694|NCT02062502|75681688|FG000|STARTED|Overall Study||306||
59576695|NCT02062502|75681689|FG001|STARTED|Overall Study||305||
59576696|NCT02062502|75681688|FG000|Vaccinated Dose 1|Overall Study||306||
59576697|NCT02062502|75681689|FG001|Vaccinated Dose 1|Overall Study||305||
59576698|NCT02062502|75681688|FG000|COMPLETED|Overall Study||263||
59576699|NCT02062502|75681689|FG001|COMPLETED|Overall Study||270||
59576700|NCT02062502|75681688|FG000|NOT COMPLETED|Overall Study||43||
59576701|NCT02062502|75681689|FG001|NOT COMPLETED|Overall Study||35||
59576702|NCT01962428|75681697|FG000|STARTED|Overall Study||139||
59576703|NCT01962428|75681698|FG001|STARTED|Overall Study||139||
59576704|NCT01962428|75681697|FG000|COMPLETED|Overall Study||129||
59576705|NCT01962428|75681698|FG001|COMPLETED|Overall Study||133||
59576706|NCT01962428|75681697|FG000|NOT COMPLETED|Overall Study||10||
59576707|NCT01962428|75681698|FG001|NOT COMPLETED|Overall Study||6||
59576708|NCT01999400|75681704|FG000|STARTED|First Intervention (1 Day)||6||
59576709|NCT01999400|75681705|FG001|STARTED|First Intervention (1 Day)||6||
59576710|NCT01999400|75681706|FG002|STARTED|First Intervention (1 Day)||5||
59576711|NCT01999400|75681707|FG003|STARTED|First Intervention (1 Day)||5||
59576712|NCT01999400|75681708|FG004|STARTED|First Intervention (1 Day)||4||
59576713|NCT01999400|75681709|FG005|STARTED|First Intervention (1 Day)||4||
59850320|NCT03583372|75974676|FG003|STARTED|Overall Study||141||
60121337|NCT02666560|76242267|FG000|NOT COMPLETED|Condition 1 (1 Day)||0||
59576714|NCT01999400|75681704|FG000|COMPLETED|First Intervention (1 Day)||4||
59576715|NCT01999400|75681705|FG001|COMPLETED|First Intervention (1 Day)||4||
60121338|NCT02666560|76242268|FG001|NOT COMPLETED|Condition 1 (1 Day)||0||
59576716|NCT01999400|75681706|FG002|COMPLETED|First Intervention (1 Day)||3||
59576717|NCT01999400|75681707|FG003|COMPLETED|First Intervention (1 Day)||2||
59576718|NCT01999400|75681708|FG004|COMPLETED|First Intervention (1 Day)||4||
59576719|NCT01999400|75681709|FG005|COMPLETED|First Intervention (1 Day)||3||
59576720|NCT01999400|75681704|FG000|NOT COMPLETED|First Intervention (1 Day)||2||
59576721|NCT01999400|75681705|FG001|NOT COMPLETED|First Intervention (1 Day)||2||
59576722|NCT01999400|75681706|FG002|NOT COMPLETED|First Intervention (1 Day)||2||
59576723|NCT01999400|75681707|FG003|NOT COMPLETED|First Intervention (1 Day)||3||
59576724|NCT01999400|75681708|FG004|NOT COMPLETED|First Intervention (1 Day)||0||
59576725|NCT01999400|75681709|FG005|NOT COMPLETED|First Intervention (1 Day)||1||
59576726|NCT01999400|75681704|FG000|STARTED|Washout (10 Days)||5||
59576727|NCT01999400|75681705|FG001|STARTED|Washout (10 Days)||4||
59576728|NCT01999400|75681706|FG002|STARTED|Washout (10 Days)||3||
59576729|NCT01999400|75681707|FG003|STARTED|Washout (10 Days)||2||
59576730|NCT01999400|75681708|FG004|STARTED|Washout (10 Days)||3||
59576731|NCT01999400|75681709|FG005|STARTED|Washout (10 Days)||3||
59576732|NCT01999400|75681704|FG000|COMPLETED|Washout (10 Days)||5||
59576733|NCT01999400|75681705|FG001|COMPLETED|Washout (10 Days)||4||
59576734|NCT01999400|75681706|FG002|COMPLETED|Washout (10 Days)||3||
59576735|NCT01999400|75681707|FG003|COMPLETED|Washout (10 Days)||2||
59576736|NCT01999400|75681708|FG004|COMPLETED|Washout (10 Days)||3||
59576737|NCT01999400|75681709|FG005|COMPLETED|Washout (10 Days)||3||
59576738|NCT01999400|75681704|FG000|NOT COMPLETED|Washout (10 Days)||0||
59576739|NCT01999400|75681705|FG001|NOT COMPLETED|Washout (10 Days)||0||
59576740|NCT01999400|75681706|FG002|NOT COMPLETED|Washout (10 Days)||0||
59576741|NCT01999400|75681707|FG003|NOT COMPLETED|Washout (10 Days)||0||
59576742|NCT01999400|75681708|FG004|NOT COMPLETED|Washout (10 Days)||0||
59576743|NCT01999400|75681709|FG005|NOT COMPLETED|Washout (10 Days)||0||
59576744|NCT01999400|75681704|FG000|STARTED|Second Intervention (1 Day)||5||
59576745|NCT01999400|75681705|FG001|STARTED|Second Intervention (1 Day)||4||
59576746|NCT01999400|75681706|FG002|STARTED|Second Intervention (1 Day)||3||
59576747|NCT01999400|75681707|FG003|STARTED|Second Intervention (1 Day)||2||
59576748|NCT01999400|75681708|FG004|STARTED|Second Intervention (1 Day)||3||
59576749|NCT01999400|75681709|FG005|STARTED|Second Intervention (1 Day)||3||
59576750|NCT01999400|75681704|FG000|COMPLETED|Second Intervention (1 Day)||5||
59576751|NCT01999400|75681705|FG001|COMPLETED|Second Intervention (1 Day)||4||
59576752|NCT01999400|75681706|FG002|COMPLETED|Second Intervention (1 Day)||3||
59576753|NCT01999400|75681707|FG003|COMPLETED|Second Intervention (1 Day)||2||
59576754|NCT01999400|75681708|FG004|COMPLETED|Second Intervention (1 Day)||3||
59576755|NCT01999400|75681709|FG005|COMPLETED|Second Intervention (1 Day)||3||
59576756|NCT01999400|75681704|FG000|NOT COMPLETED|Second Intervention (1 Day)||0||
59576757|NCT01999400|75681705|FG001|NOT COMPLETED|Second Intervention (1 Day)||0||
59576758|NCT01999400|75681706|FG002|NOT COMPLETED|Second Intervention (1 Day)||0||
59576759|NCT01999400|75681707|FG003|NOT COMPLETED|Second Intervention (1 Day)||0||
59576760|NCT01999400|75681708|FG004|NOT COMPLETED|Second Intervention (1 Day)||0||
59576761|NCT01999400|75681709|FG005|NOT COMPLETED|Second Intervention (1 Day)||0||
59576762|NCT01999400|75681704|FG000|STARTED|Washout (10 Days)||2||
59576763|NCT01999400|75681705|FG001|STARTED|Washout (10 Days)||0||
59576764|NCT01999400|75681706|FG002|STARTED|Washout (10 Days)||1||
59576765|NCT01999400|75681707|FG003|STARTED|Washout (10 Days)||1||
59576766|NCT01999400|75681708|FG004|STARTED|Washout (10 Days)||1||
59576767|NCT01999400|75681709|FG005|STARTED|Washout (10 Days)||1||
59576768|NCT01999400|75681704|FG000|COMPLETED|Washout (10 Days)||2||
59576769|NCT01999400|75681705|FG001|COMPLETED|Washout (10 Days)||0||
59576770|NCT01999400|75681706|FG002|COMPLETED|Washout (10 Days)||1||
59576771|NCT01999400|75681707|FG003|COMPLETED|Washout (10 Days)||1||
59576772|NCT01999400|75681708|FG004|COMPLETED|Washout (10 Days)||1||
59576773|NCT01999400|75681709|FG005|COMPLETED|Washout (10 Days)||1||
59576774|NCT01999400|75681704|FG000|NOT COMPLETED|Washout (10 Days)||0||
59576775|NCT01999400|75681705|FG001|NOT COMPLETED|Washout (10 Days)||0||
59576776|NCT01999400|75681706|FG002|NOT COMPLETED|Washout (10 Days)||0||
59576777|NCT01999400|75681707|FG003|NOT COMPLETED|Washout (10 Days)||0||
59576778|NCT01999400|75681708|FG004|NOT COMPLETED|Washout (10 Days)||0||
59576779|NCT01999400|75681709|FG005|NOT COMPLETED|Washout (10 Days)||0||
59576780|NCT01999400|75681704|FG000|STARTED|Third Intervention (1 Day)||2||
59576781|NCT01999400|75681705|FG001|STARTED|Third Intervention (1 Day)||0||
59576782|NCT01999400|75681706|FG002|STARTED|Third Intervention (1 Day)||1||
59576783|NCT01999400|75681707|FG003|STARTED|Third Intervention (1 Day)||1||
59576784|NCT01999400|75681708|FG004|STARTED|Third Intervention (1 Day)||1||
59576785|NCT01999400|75681709|FG005|STARTED|Third Intervention (1 Day)||1||
59576786|NCT01999400|75681704|FG000|COMPLETED|Third Intervention (1 Day)||2||
59576787|NCT01999400|75681705|FG001|COMPLETED|Third Intervention (1 Day)||0||
59576788|NCT01999400|75681706|FG002|COMPLETED|Third Intervention (1 Day)||1||
59576789|NCT01999400|75681707|FG003|COMPLETED|Third Intervention (1 Day)||1||
59576790|NCT01999400|75681708|FG004|COMPLETED|Third Intervention (1 Day)||1||
59576791|NCT01999400|75681709|FG005|COMPLETED|Third Intervention (1 Day)||0||
59576792|NCT01999400|75681704|FG000|NOT COMPLETED|Third Intervention (1 Day)||0||
59576793|NCT01999400|75681705|FG001|NOT COMPLETED|Third Intervention (1 Day)||0||
59576794|NCT01999400|75681706|FG002|NOT COMPLETED|Third Intervention (1 Day)||0||
59576795|NCT01999400|75681707|FG003|NOT COMPLETED|Third Intervention (1 Day)||0||
59576796|NCT01999400|75681708|FG004|NOT COMPLETED|Third Intervention (1 Day)||0||
59576797|NCT01999400|75681709|FG005|NOT COMPLETED|Third Intervention (1 Day)||1||
59576798|NCT01999400|75681704|FG000|STARTED|Washout (10 Days)||1||
59576799|NCT01999400|75681705|FG001|STARTED|Washout (10 Days)||0||
59576800|NCT01999400|75681706|FG002|STARTED|Washout (10 Days)||1||
59576801|NCT01999400|75681707|FG003|STARTED|Washout (10 Days)||0||
59576802|NCT01999400|75681708|FG004|STARTED|Washout (10 Days)||0||
59576803|NCT01999400|75681709|FG005|STARTED|Washout (10 Days)||0||
59576804|NCT01999400|75681704|FG000|COMPLETED|Washout (10 Days)||1||
59576805|NCT01999400|75681705|FG001|COMPLETED|Washout (10 Days)||0||
59576806|NCT01999400|75681706|FG002|COMPLETED|Washout (10 Days)||1||
59576807|NCT01999400|75681707|FG003|COMPLETED|Washout (10 Days)||0||
59576808|NCT01999400|75681708|FG004|COMPLETED|Washout (10 Days)||0||
59576809|NCT01999400|75681709|FG005|COMPLETED|Washout (10 Days)||0||
59576810|NCT01999400|75681704|FG000|NOT COMPLETED|Washout (10 Days)||0||
59576811|NCT01999400|75681705|FG001|NOT COMPLETED|Washout (10 Days)||0||
59576812|NCT01999400|75681706|FG002|NOT COMPLETED|Washout (10 Days)||0||
59576813|NCT01999400|75681707|FG003|NOT COMPLETED|Washout (10 Days)||0||
59576814|NCT01999400|75681708|FG004|NOT COMPLETED|Washout (10 Days)||0||
59576815|NCT01999400|75681709|FG005|NOT COMPLETED|Washout (10 Days)||0||
59576816|NCT01999400|75681704|FG000|STARTED|Fourth Intervention (1 Day)||1||
59576817|NCT01999400|75681705|FG001|STARTED|Fourth Intervention (1 Day)||0||
59576818|NCT01999400|75681706|FG002|STARTED|Fourth Intervention (1 Day)||1||
59576819|NCT01999400|75681707|FG003|STARTED|Fourth Intervention (1 Day)||0||
59576820|NCT01999400|75681708|FG004|STARTED|Fourth Intervention (1 Day)||0||
59576821|NCT01999400|75681709|FG005|STARTED|Fourth Intervention (1 Day)||0||
59576822|NCT01999400|75681704|FG000|COMPLETED|Fourth Intervention (1 Day)||1||
59576823|NCT01999400|75681705|FG001|COMPLETED|Fourth Intervention (1 Day)||0||
59576824|NCT01999400|75681706|FG002|COMPLETED|Fourth Intervention (1 Day)||1||
59576825|NCT01999400|75681707|FG003|COMPLETED|Fourth Intervention (1 Day)||0||
59576826|NCT01999400|75681708|FG004|COMPLETED|Fourth Intervention (1 Day)||0||
59576827|NCT01999400|75681709|FG005|COMPLETED|Fourth Intervention (1 Day)||0||
59576828|NCT01999400|75681704|FG000|NOT COMPLETED|Fourth Intervention (1 Day)||0||
59576829|NCT01999400|75681705|FG001|NOT COMPLETED|Fourth Intervention (1 Day)||0||
59576830|NCT01999400|75681706|FG002|NOT COMPLETED|Fourth Intervention (1 Day)||0||
59576831|NCT01999400|75681707|FG003|NOT COMPLETED|Fourth Intervention (1 Day)||0||
59576832|NCT01999400|75681708|FG004|NOT COMPLETED|Fourth Intervention (1 Day)||0||
59576833|NCT01999400|75681709|FG005|NOT COMPLETED|Fourth Intervention (1 Day)||0||
59576834|NCT02000180|75681721|FG000|STARTED|Overall Study||18||
59576835|NCT02000180|75681722|FG001|STARTED|Overall Study||19||
59576836|NCT02000180|75681721|FG000|COMPLETED|Overall Study||18||
59576837|NCT02000180|75681722|FG001|COMPLETED|Overall Study||19||
59576838|NCT02000180|75681721|FG000|NOT COMPLETED|Overall Study||0||
59576839|NCT02000180|75681722|FG001|NOT COMPLETED|Overall Study||0||
59576840|NCT01969435|75681728|FG000|STARTED|Overall Study||50||
59576841|NCT01969435|75681728|FG000|COMPLETED|Overall Study||50||
59576842|NCT01969435|75681728|FG000|NOT COMPLETED|Overall Study||0||
59576843|NCT01965002|75681732|FG000|STARTED|Overall Study||5||
59576844|NCT01965002|75681732|FG000|COMPLETED|Overall Study||5||
59576845|NCT01965002|75681732|FG000|NOT COMPLETED|Overall Study||0||
59576846|NCT02304757|75681740|FG000|STARTED|Overall Study||70||
59576847|NCT02304757|75681741|FG001|STARTED|Overall Study||72||
59576848|NCT02304757|75681740|FG000|COMPLETED|Overall Study||70||
59576849|NCT02304757|75681741|FG001|COMPLETED|Overall Study||72||
59576850|NCT02304757|75681740|FG000|NOT COMPLETED|Overall Study||0||
59576851|NCT02304757|75681741|FG001|NOT COMPLETED|Overall Study||0||
59576852|NCT02002208|75681749|FG000|STARTED|Overall Study||69||
59576853|NCT02002208|75681750|FG001|STARTED|Overall Study||70||
59576854|NCT02002208|75681749|FG000|COMPLETED|Overall Study||32||
59576855|NCT02002208|75681750|FG001|COMPLETED|Overall Study||30||
59576856|NCT02002208|75681749|FG000|NOT COMPLETED|Overall Study||37||
59576857|NCT02002208|75681750|FG001|NOT COMPLETED|Overall Study||40||
59576858|NCT01969747|75681760|FG000|STARTED|Overall Study||19||
59576859|NCT01969747|75681761|FG001|STARTED|Overall Study||19||
59576860|NCT01969747|75681762|FG002|STARTED|Overall Study||19||
59576861|NCT01969747|75681763|FG003|STARTED|Overall Study||18||
59576862|NCT01969747|75681760|FG000|COMPLETED|Overall Study||19||
59576863|NCT01969747|75681761|FG001|COMPLETED|Overall Study||19||
59576864|NCT01969747|75681762|FG002|COMPLETED|Overall Study||19||
59576865|NCT01969747|75681763|FG003|COMPLETED|Overall Study||18||
59576866|NCT01969747|75681760|FG000|NOT COMPLETED|Overall Study||0||
59576867|NCT01969747|75681761|FG001|NOT COMPLETED|Overall Study||0||
59576868|NCT01969747|75681762|FG002|NOT COMPLETED|Overall Study||0||
59576869|NCT01969747|75681763|FG003|NOT COMPLETED|Overall Study||0||
59576870|NCT02002832|75681775|FG000|STARTED|Overall Study||194||
59576871|NCT02002832|75681776|FG001|STARTED|Overall Study||194||
59576872|NCT02002832|75681775|FG000|COMPLETED|Overall Study||166||
59576873|NCT02002832|75681776|FG001|COMPLETED|Overall Study||168||
59576874|NCT02002832|75681775|FG000|NOT COMPLETED|Overall Study||28||
59576875|NCT02002832|75681776|FG001|NOT COMPLETED|Overall Study||26||
59576876|NCT02010151|75681785|FG000|STARTED|Overall Study|January 2013 to December 2017|1498||
59576877|NCT02010151|75681786|FG001|STARTED|Overall Study|January 2013 to December 2017|1696||
59576878|NCT02010151|75681785|FG000|COMPLETED|Overall Study|Text message (TM) sent: 0|1498||
59576879|NCT02010151|75681786|FG001|COMPLETED|Overall Study|TM sent: 598|1696||
59576880|NCT02010151|75681785|FG000|NOT COMPLETED|Overall Study||0||
59576881|NCT02010151|75681786|FG001|NOT COMPLETED|Overall Study||0||
59576882|NCT01966718|75681792|FG000|STARTED|Overall Study||8||
59721592|NCT01198574|75840504|FG000|NOT COMPLETED|Overall Study||4||
59721593|NCT01198574|75840505|FG001|NOT COMPLETED|Overall Study||1||
59721594|NCT01198574|75840506|FG002|NOT COMPLETED|Overall Study||1||
59721595|NCT01198574|75840507|FG003|NOT COMPLETED|Overall Study||4||
59576883|NCT01966718|75681792|FG000|COMPLETED|Overall Study||8||
59576884|NCT01966718|75681792|FG000|NOT COMPLETED|Overall Study||0||
59576885|NCT02010697|75681801|FG000|STARTED|Overall Study||1044||
59721596|NCT01198028|75840517|FG000|STARTED|Overall Study||39||
59721597|NCT01198028|75840517|FG000|COMPLETED|Overall Study||29||
59721598|NCT01198028|75840517|FG000|NOT COMPLETED|Overall Study||10||
59721599|NCT01197950|75840524|FG000|STARTED|Overall Study||99||
59721600|NCT01197950|75840525|FG001|STARTED|Overall Study||103||
59721601|NCT01197950|75840526|FG002|STARTED|Overall Study||101||
59721602|NCT01197950|75840524|FG000|COMPLETED|Overall Study|women's request (9), high workload (3), returned home (1), partus in one hour (1), other (2)|83||
59721603|NCT01197950|75840525|FG001|COMPLETED|Overall Study|women's request (11) high workload (4) returned to home (1)|87||
59721604|NCT01197950|75840526|FG002|COMPLETED|Overall Study|woman's request (11) high workload (1) returned to home (2) other (4)|83||
59721605|NCT01197950|75840524|FG000|NOT COMPLETED|Overall Study||16||
59721606|NCT01197950|75840525|FG001|NOT COMPLETED|Overall Study||16||
59721607|NCT01197950|75840526|FG002|NOT COMPLETED|Overall Study||18||
59721608|NCT01092780|75840534|FG000|STARTED|Treatment Period 1||14||
59721609|NCT01092780|75840535|FG001|STARTED|Treatment Period 1||15||
59721610|NCT01092780|75840536|FG002|STARTED|Treatment Period 1||14||
59721611|NCT01092780|75840537|FG003|STARTED|Treatment Period 1||13||
59721612|NCT01092780|75840534|FG000|COMPLETED|Treatment Period 1||14||
59721613|NCT01092780|75840535|FG001|COMPLETED|Treatment Period 1||15||
59721614|NCT01092780|75840536|FG002|COMPLETED|Treatment Period 1||14||
59721615|NCT01092780|75840537|FG003|COMPLETED|Treatment Period 1||13||
59721616|NCT01092780|75840534|FG000|NOT COMPLETED|Treatment Period 1||0||
59721617|NCT01092780|75840535|FG001|NOT COMPLETED|Treatment Period 1||0||
59721618|NCT01092780|75840536|FG002|NOT COMPLETED|Treatment Period 1||0||
59721619|NCT01092780|75840537|FG003|NOT COMPLETED|Treatment Period 1||0||
59721620|NCT01092780|75840534|FG000|STARTED|Washout Period 1||14||
59721621|NCT01092780|75840535|FG001|STARTED|Washout Period 1||15||
59721622|NCT01092780|75840536|FG002|STARTED|Washout Period 1||14||
59721623|NCT01092780|75840537|FG003|STARTED|Washout Period 1||13||
59721624|NCT01092780|75840534|FG000|COMPLETED|Washout Period 1||13||
59721625|NCT01092780|75840535|FG001|COMPLETED|Washout Period 1||14||
59721626|NCT01092780|75840536|FG002|COMPLETED|Washout Period 1||14||
59721627|NCT01092780|75840537|FG003|COMPLETED|Washout Period 1||13||
59721628|NCT01092780|75840534|FG000|NOT COMPLETED|Washout Period 1||1||
59721629|NCT01092780|75840535|FG001|NOT COMPLETED|Washout Period 1||1||
59721630|NCT01092780|75840536|FG002|NOT COMPLETED|Washout Period 1||0||
59721631|NCT01092780|75840537|FG003|NOT COMPLETED|Washout Period 1||0||
59721632|NCT01092780|75840534|FG000|STARTED|Treatment Period 2||13||
59721633|NCT01092780|75840535|FG001|STARTED|Treatment Period 2||14||
59721634|NCT01092780|75840536|FG002|STARTED|Treatment Period 2||14||
59721635|NCT01092780|75840537|FG003|STARTED|Treatment Period 2||13||
59721636|NCT01092780|75840534|FG000|COMPLETED|Treatment Period 2||13||
59721637|NCT01092780|75840535|FG001|COMPLETED|Treatment Period 2||14||
59721638|NCT01092780|75840536|FG002|COMPLETED|Treatment Period 2||14||
59721639|NCT01092780|75840537|FG003|COMPLETED|Treatment Period 2||13||
59576886|NCT02010697|75681802|FG001|STARTED|Overall Study||1038||
59576887|NCT02010697|75681803|FG002|STARTED|Overall Study||1043||
59576888|NCT02010697|75681801|FG000|COMPLETED|Overall Study||1044||
59576889|NCT02010697|75681802|FG001|COMPLETED|Overall Study||1038||
59576890|NCT02010697|75681803|FG002|COMPLETED|Overall Study||1043||
59576891|NCT02010697|75681801|FG000|NOT COMPLETED|Overall Study||0||
59576892|NCT02010697|75681802|FG001|NOT COMPLETED|Overall Study||0||
59576893|NCT02010697|75681803|FG002|NOT COMPLETED|Overall Study||0||
59576894|NCT02004158|75681811|FG000|STARTED|Overall Study||23||
59576895|NCT02004158|75681811|FG000|COMPLETED|Overall Study||20||
59576896|NCT02004158|75681811|FG000|NOT COMPLETED|Overall Study||3||
59721640|NCT01092780|75840534|FG000|NOT COMPLETED|Treatment Period 2||0||
59721641|NCT01092780|75840535|FG001|NOT COMPLETED|Treatment Period 2||0||
59721642|NCT01092780|75840536|FG002|NOT COMPLETED|Treatment Period 2||0||
59721643|NCT01092780|75840537|FG003|NOT COMPLETED|Treatment Period 2||0||
59721644|NCT01092780|75840534|FG000|STARTED|Washout Period 2||13||
59721645|NCT01092780|75840535|FG001|STARTED|Washout Period 2||14||
59721646|NCT01092780|75840536|FG002|STARTED|Washout Period 2||14||
59721647|NCT01092780|75840537|FG003|STARTED|Washout Period 2||13||
59721648|NCT01092780|75840534|FG000|COMPLETED|Washout Period 2||13||
59721649|NCT01092780|75840535|FG001|COMPLETED|Washout Period 2||13||
59721650|NCT01092780|75840536|FG002|COMPLETED|Washout Period 2||13||
59721651|NCT01092780|75840537|FG003|COMPLETED|Washout Period 2||13||
59576897|NCT02308501|75681819|FG000|STARTED|Overall Study|25 participants received one drop of Lastacaft in one eye and Tears Naturale in the other eye.|25||25
59576898|NCT02308501|75681820|FG001|STARTED|Overall Study||25||25
59576899|NCT02308501|75681819|FG000|Randomized Participant Eyes|Overall Study||25||25
59576900|NCT02308501|75681820|FG001|Randomized Participant Eyes|Overall Study||25||25
59576901|NCT02308501|75681819|FG000|COMPLETED|Overall Study||25||25
59576902|NCT02308501|75681820|FG001|COMPLETED|Overall Study||25||25
59576903|NCT02308501|75681819|FG000|NOT COMPLETED|Overall Study||0||0
59576904|NCT02308501|75681820|FG001|NOT COMPLETED|Overall Study||0||0
59576905|NCT02005016|75681830|FG000|STARTED|Overall Study||46||
59576906|NCT02005016|75681830|FG000|COMPLETED|Overall Study||44||
59576907|NCT02005016|75681830|FG000|NOT COMPLETED|Overall Study||2||
59576908|NCT02311309|75681837|FG000|STARTED|Overall Study|There were 863 patients with no peroperative bleeding in the 1439 patients studied|541||
59576909|NCT02311309|75681838|FG001|STARTED|Overall Study|There were 863 patients with no peroperative bleeding in the 1439 patients studied|35||
59576910|NCT02311309|75681839|FG002|STARTED|Overall Study||863||
59576911|NCT02311309|75681837|FG000|COMPLETED|Overall Study||541||
59576912|NCT02311309|75681838|FG001|COMPLETED|Overall Study||35||
59576913|NCT02311309|75681839|FG002|COMPLETED|Overall Study||863||
59576914|NCT02311309|75681837|FG000|NOT COMPLETED|Overall Study||0||
59576915|NCT02311309|75681838|FG001|NOT COMPLETED|Overall Study||0||
59576916|NCT02311309|75681839|FG002|NOT COMPLETED|Overall Study||0||
59576917|NCT01966796|75681851|FG000|STARTED|Overall Study||15||
59576918|NCT01966796|75681852|FG001|STARTED|Overall Study||51||
59576919|NCT01966796|75681853|FG002|STARTED|Overall Study||195||
59576920|NCT01966796|75681854|FG003|STARTED|Overall Study||269||
59576921|NCT01966796|75681851|FG000|COMPLETED|Overall Study||15||
59576922|NCT01966796|75681852|FG001|COMPLETED|Overall Study||51||
59576923|NCT01966796|75681853|FG002|COMPLETED|Overall Study||195||
59576924|NCT01966796|75681854|FG003|COMPLETED|Overall Study||269||
59576925|NCT01966796|75681851|FG000|NOT COMPLETED|Overall Study||0||
59576926|NCT01966796|75681852|FG001|NOT COMPLETED|Overall Study||0||
59576927|NCT01966796|75681853|FG002|NOT COMPLETED|Overall Study||0||
59576928|NCT01966796|75681854|FG003|NOT COMPLETED|Overall Study||0||
59576929|NCT01967342|75681871|FG000|STARTED|Overall Study||98||
59576930|NCT01967342|75681872|FG001|STARTED|Overall Study||95||
59576931|NCT01967342|75681873|FG002|STARTED|Overall Study||97||
59576932|NCT01967342|75681871|FG000|5-week Follow-up|Overall Study||83||
59576933|NCT01967342|75681872|FG001|5-week Follow-up|Overall Study||78||
59576934|NCT01967342|75681873|FG002|5-week Follow-up|Overall Study||76||
59576935|NCT01967342|75681871|FG000|10-week Follow-up|Overall Study||78||
59576936|NCT01967342|75681872|FG001|10-week Follow-up|Overall Study||83||
59576937|NCT01967342|75681873|FG002|10-week Follow-up|Overall Study||80||
59576938|NCT01967342|75681871|FG000|COMPLETED|Overall Study||71|6-month follow-up|
59576939|NCT01967342|75681872|FG001|COMPLETED|Overall Study||70|6-month follow-up|
59576940|NCT01967342|75681873|FG002|COMPLETED|Overall Study||68|6-month follow-up|
59576941|NCT01967342|75681871|FG000|NOT COMPLETED|Overall Study||27||
59576942|NCT01967342|75681872|FG001|NOT COMPLETED|Overall Study||25||
59576943|NCT01967342|75681873|FG002|NOT COMPLETED|Overall Study||29||
59576944|NCT02006108|75681881|FG000|STARTED|Overall Study||21||
59576945|NCT02006108|75681881|FG000|MR Imaging|Overall Study||19||
59576946|NCT02006108|75681881|FG000|COMPLETED|Overall Study||19||
59576947|NCT02006108|75681881|FG000|NOT COMPLETED|Overall Study||2||
59576948|NCT02006264|75681887|FG000|STARTED|Overall Study||15||
59576949|NCT02006264|75681888|FG001|STARTED|Overall Study||15||
59576950|NCT02006264|75681887|FG000|COMPLETED|Overall Study||14||
59576951|NCT02006264|75681888|FG001|COMPLETED|Overall Study||15||
59576952|NCT02006264|75681887|FG000|NOT COMPLETED|Overall Study||1||
59576953|NCT02006264|75681888|FG001|NOT COMPLETED|Overall Study||0||
59576954|NCT02006342|75681896|FG000|STARTED|Overall Study||20||
59721652|NCT01092780|75840534|FG000|NOT COMPLETED|Washout Period 2||0||
59850321|NCT03583372|75974673|FG000|COMPLETED|Overall Study||79||
59576955|NCT02006342|75681897|FG001|STARTED|Overall Study||20||
59576956|NCT02006342|75681896|FG000|COMPLETED|Overall Study||19||
59576957|NCT02006342|75681897|FG001|COMPLETED|Overall Study||20||
59576958|NCT02006342|75681896|FG000|NOT COMPLETED|Overall Study||1||
59576959|NCT02006342|75681897|FG001|NOT COMPLETED|Overall Study||0||
59576960|NCT02006420|75681905|FG000|STARTED|Overall Study||24||
59576961|NCT02006420|75681906|FG001|STARTED|Overall Study||21||
59576962|NCT02006420|75681905|FG000|COMPLETED|Overall Study||24||
59576963|NCT02006420|75681906|FG001|COMPLETED|Overall Study||21||
59576964|NCT02006420|75681905|FG000|NOT COMPLETED|Overall Study||0||
59576965|NCT02006420|75681906|FG001|NOT COMPLETED|Overall Study||0||
59576966|NCT02062580|75681920|FG000|STARTED|Overall Study||71||
59576967|NCT02062580|75681921|FG001|STARTED|Overall Study||78||
59576968|NCT02062580|75681920|FG000|COMPLETED|Overall Study||59||
59576969|NCT02062580|75681921|FG001|COMPLETED|Overall Study||65||
59576970|NCT02062580|75681920|FG000|NOT COMPLETED|Overall Study||12||
59576971|NCT02062580|75681921|FG001|NOT COMPLETED|Overall Study||13||
59576972|NCT01968356|75681935|FG000|STARTED|Overall Study||101||101
59576973|NCT01968356|75681936|FG001|STARTED|Overall Study||93||93
59576974|NCT01968356|75681937|FG002|STARTED|Overall Study||96||96
59576975|NCT01968356|75681938|FG003|STARTED|Overall Study||32||32
59576976|NCT01968356|75681939|FG004|STARTED|Overall Study||97||97
59576977|NCT01968356|75681940|FG005|STARTED|Overall Study||99||99
59576978|NCT01968356|75681941|FG006|STARTED|Overall Study||97||97
59576979|NCT01968356|75681942|FG007|STARTED|Overall Study||31||31
59576980|NCT01968356|75681935|FG000|COMPLETED|Overall Study||101||101
59576981|NCT01968356|75681936|FG001|COMPLETED|Overall Study||93||93
59576982|NCT01968356|75681937|FG002|COMPLETED|Overall Study||96||96
59576983|NCT01968356|75681938|FG003|COMPLETED|Overall Study||32||32
59576984|NCT01968356|75681939|FG004|COMPLETED|Overall Study||97||97
59576985|NCT01968356|75681940|FG005|COMPLETED|Overall Study||99||99
59576986|NCT01968356|75681941|FG006|COMPLETED|Overall Study||97||97
59576987|NCT01968356|75681942|FG007|COMPLETED|Overall Study||31||31
59576988|NCT01968356|75681935|FG000|NOT COMPLETED|Overall Study||0||0
59576989|NCT01968356|75681936|FG001|NOT COMPLETED|Overall Study||0||0
59576990|NCT01968356|75681937|FG002|NOT COMPLETED|Overall Study||0||0
59576991|NCT01968356|75681938|FG003|NOT COMPLETED|Overall Study||0||0
59576992|NCT01968356|75681939|FG004|NOT COMPLETED|Overall Study||0||0
59576993|NCT01968356|75681940|FG005|NOT COMPLETED|Overall Study||0||0
59576994|NCT01968356|75681941|FG006|NOT COMPLETED|Overall Study||0||0
59576995|NCT01968356|75681942|FG007|NOT COMPLETED|Overall Study||0||0
59576996|NCT02063516|75681970|FG000|STARTED|Overall Study||40||
59576997|NCT02063516|75681971|FG001|STARTED|Overall Study||40||
59576998|NCT02063516|75681970|FG000|COMPLETED|Overall Study||40||
59576999|NCT02063516|75681971|FG001|COMPLETED|Overall Study||40||
59577000|NCT02063516|75681970|FG000|NOT COMPLETED|Overall Study||0||
59577001|NCT02063516|75681971|FG001|NOT COMPLETED|Overall Study||0||
59577002|NCT02006888|75681980|FG000|STARTED|Overall Study||158||
59577003|NCT02006888|75681981|FG001|STARTED|Overall Study||156||
59577004|NCT02006888|75681982|FG002|STARTED|Overall Study||80||
59577005|NCT02006888|75681980|FG000|COMPLETED|Overall Study||122||
59577006|NCT02006888|75681981|FG001|COMPLETED|Overall Study||122||
59577007|NCT02006888|75681982|FG002|COMPLETED|Overall Study||58||
59577008|NCT02006888|75681980|FG000|NOT COMPLETED|Overall Study||36||
59577009|NCT02006888|75681981|FG001|NOT COMPLETED|Overall Study||34||
59577010|NCT02006888|75681982|FG002|NOT COMPLETED|Overall Study||22||
59577011|NCT02007200|75681990|FG000|STARTED|Overall Study||55||
59577012|NCT02007200|75681990|FG000|COMPLETED|Overall Study||55||
59577013|NCT02007200|75681990|FG000|NOT COMPLETED|Overall Study||0||
59577014|NCT01969214|75681994|FG000|STARTED|Overall Study||101||
59577015|NCT01969214|75681994|FG000|COMPLETED|Overall Study||86||
59577016|NCT01969214|75681994|FG000|NOT COMPLETED|Overall Study||15||
59577017|NCT02008682|75682000|FG000|STARTED|Overall Study||184||
59577018|NCT02008682|75682001|FG001|STARTED|Overall Study||184||
59577019|NCT02008682|75682000|FG000|Exposed|Overall Study|1 subject withdrawn before exposure to trial product|183||
59577020|NCT02008682|75682001|FG001|Exposed|Overall Study||184||
59577021|NCT02008682|75682000|FG000|COMPLETED|Overall Study|Completed without discontinuation of trial product|157||
59577022|NCT02008682|75682001|FG001|COMPLETED|Overall Study|Completed without discontinuation of trial product|170||
59577023|NCT02008682|75682000|FG000|NOT COMPLETED|Overall Study||27||
59577024|NCT02008682|75682001|FG001|NOT COMPLETED|Overall Study||14||
59577025|NCT01969448|75682010|FG000|STARTED|Overall Study||55||
59577026|NCT01969448|75682011|FG001|STARTED|Overall Study||24||
59577027|NCT01969448|75682012|FG002|STARTED|Overall Study||0||
59577028|NCT01969448|75682010|FG000|COMPLETED|Overall Study||55||
59577029|NCT01969448|75682011|FG001|COMPLETED|Overall Study||24||
59577030|NCT01969448|75682012|FG002|COMPLETED|Overall Study||0||
59577031|NCT01969448|75682010|FG000|NOT COMPLETED|Overall Study||0||
59577032|NCT01969448|75682011|FG001|NOT COMPLETED|Overall Study||0||
59577033|NCT01969448|75682012|FG002|NOT COMPLETED|Overall Study||0||
59577034|NCT01969916|75682020|FG000|STARTED|Overall Study||150||
59577035|NCT01969916|75682020|FG000|COMPLETED|Overall Study||105||
59577036|NCT01969916|75682020|FG000|NOT COMPLETED|Overall Study||45||
59577037|NCT02011490|75682027|FG000|STARTED|Part 1||8||
59577038|NCT02011490|75682028|FG001|STARTED|Part 1||8||
59577039|NCT02011490|75682029|FG002|STARTED|Part 1||8||
59577040|NCT02011490|75682030|FG003|STARTED|Part 1||0||
59577041|NCT02011490|75682031|FG004|STARTED|Part 1||0||
59577042|NCT02011490|75682032|FG005|STARTED|Part 1||0||
59577043|NCT02011490|75682027|FG000|COMPLETED|Part 1||8||
59577044|NCT02011490|75682028|FG001|COMPLETED|Part 1||8||
59577045|NCT02011490|75682029|FG002|COMPLETED|Part 1||8||
59577046|NCT02011490|75682030|FG003|COMPLETED|Part 1||0||
59577047|NCT02011490|75682031|FG004|COMPLETED|Part 1||0||
59577048|NCT02011490|75682032|FG005|COMPLETED|Part 1||0||
59577049|NCT02011490|75682027|FG000|NOT COMPLETED|Part 1||0||
59577050|NCT02011490|75682028|FG001|NOT COMPLETED|Part 1||0||
59577051|NCT02011490|75682029|FG002|NOT COMPLETED|Part 1||0||
59577052|NCT02011490|75682030|FG003|NOT COMPLETED|Part 1||0||
59577053|NCT02011490|75682031|FG004|NOT COMPLETED|Part 1||0||
59577054|NCT02011490|75682032|FG005|NOT COMPLETED|Part 1||0||
59577055|NCT02011490|75682027|FG000|STARTED|Part 2||0||
59577056|NCT02011490|75682028|FG001|STARTED|Part 2||0||
59577057|NCT02011490|75682029|FG002|STARTED|Part 2||0||
59577058|NCT02011490|75682030|FG003|STARTED|Part 2|4 had also participated in Part 1 (all in severe group)|6||
59577059|NCT02011490|75682031|FG004|STARTED|Part 2|3 had also participated in Part 1 (2 in moderate, 1 in severe groups)|6||
59577060|NCT02011490|75682032|FG005|STARTED|Part 2|2 had also participated in Part 1 (both in healthy group)|6||
59577061|NCT02011490|75682027|FG000|COMPLETED|Part 2||0||
59577062|NCT02011490|75682028|FG001|COMPLETED|Part 2||0||
59577063|NCT02011490|75682029|FG002|COMPLETED|Part 2||0||
59577064|NCT02011490|75682030|FG003|COMPLETED|Part 2||6||
59577065|NCT02011490|75682031|FG004|COMPLETED|Part 2||6||
59577066|NCT02011490|75682032|FG005|COMPLETED|Part 2||6||
59577067|NCT02011490|75682027|FG000|NOT COMPLETED|Part 2||0||
59577068|NCT02011490|75682028|FG001|NOT COMPLETED|Part 2||0||
59577069|NCT02011490|75682029|FG002|NOT COMPLETED|Part 2||0||
59577070|NCT02011490|75682030|FG003|NOT COMPLETED|Part 2||0||
59577071|NCT02011490|75682031|FG004|NOT COMPLETED|Part 2||0||
59577072|NCT02011490|75682032|FG005|NOT COMPLETED|Part 2||0||
59577073|NCT02916407|75682048|FG000|STARTED|Overall Study||28||
59577074|NCT02916407|75682049|FG001|STARTED|Overall Study||28||
59577075|NCT02916407|75682048|FG000|COMPLETED|Overall Study||28||
59577076|NCT02916407|75682049|FG001|COMPLETED|Overall Study||28||
59577077|NCT02916407|75682048|FG000|NOT COMPLETED|Overall Study||0||
59577078|NCT02916407|75682049|FG001|NOT COMPLETED|Overall Study||0||
59577079|NCT02916563|75682055|FG000|STARTED|Overall Study||50||
59577080|NCT02916563|75682055|FG000|COMPLETED|Overall Study||50||
59577081|NCT02916563|75682055|FG000|NOT COMPLETED|Overall Study||0||
59577082|NCT02828267|75682063|FG000|STARTED|Overall Study||10||
59577083|NCT02828267|75682064|FG001|STARTED|Overall Study||21||
59577084|NCT02828267|75682065|FG002|STARTED|Overall Study||24||
59577085|NCT02828267|75682066|FG003|STARTED|Overall Study||20||
59577086|NCT02828267|75682063|FG000|COMPLETED|Overall Study||10||
59577087|NCT02828267|75682064|FG001|COMPLETED|Overall Study||21||
59577088|NCT02828267|75682065|FG002|COMPLETED|Overall Study||24||
59577089|NCT02828267|75682066|FG003|COMPLETED|Overall Study||20||
59577090|NCT02828267|75682063|FG000|NOT COMPLETED|Overall Study||0||
59577091|NCT02828267|75682064|FG001|NOT COMPLETED|Overall Study||0||
59577092|NCT02828267|75682065|FG002|NOT COMPLETED|Overall Study||0||
59577093|NCT02828267|75682066|FG003|NOT COMPLETED|Overall Study||0||
59577094|NCT02918357|75682078|FG000|STARTED|Overall Study||385||
59577095|NCT02918357|75682078|FG000|Investigational Drug Administration|Overall Study||385||
59577096|NCT02918357|75682078|FG000|PET/CT Scan|Overall Study||385||
59577097|NCT02918357|75682078|FG000|COMPLETED|Overall Study||385||
59577098|NCT02918357|75682078|FG000|NOT COMPLETED|Overall Study||0||
59577099|NCT02829983|75682102|FG000|STARTED|Overall Study||20||
59577100|NCT02829983|75682103|FG001|STARTED|Overall Study||20||
59577101|NCT02829983|75682102|FG000|COMPLETED|Overall Study||20||
59577102|NCT02829983|75682103|FG001|COMPLETED|Overall Study||20||
59577103|NCT02829983|75682102|FG000|NOT COMPLETED|Overall Study||0||
59577104|NCT02829983|75682103|FG001|NOT COMPLETED|Overall Study||0||
59577105|NCT02014129|75682112|FG000|STARTED|Overall Study||3||
59577106|NCT02014129|75682113|FG001|STARTED|Overall Study||3||
59577107|NCT02014129|75682114|FG002|STARTED|Overall Study||6||
59577108|NCT02014129|75682112|FG000|Received at Least One Dose of Study Drug|Overall Study||3||
59577109|NCT02014129|75682113|FG001|Received at Least One Dose of Study Drug|Overall Study||3||
59577110|NCT02014129|75682114|FG002|Received at Least One Dose of Study Drug|Overall Study||6||
59577111|NCT02014129|75682112|FG000|COMPLETED|Overall Study||3||
59577112|NCT02014129|75682113|FG001|COMPLETED|Overall Study||3||
59577113|NCT02014129|75682114|FG002|COMPLETED|Overall Study||6||
59577114|NCT02014129|75682112|FG000|NOT COMPLETED|Overall Study||0||
59577115|NCT02014129|75682113|FG001|NOT COMPLETED|Overall Study||0||
59577116|NCT02014129|75682114|FG002|NOT COMPLETED|Overall Study||0||
59577117|NCT02918669|75682122|FG000|STARTED|Overall Study||12||
59577118|NCT02918669|75682122|FG000|COMPLETED|Overall Study||8||
59577119|NCT02918669|75682122|FG000|NOT COMPLETED|Overall Study||4||
59577120|NCT02012192|75682128|FG000|STARTED|Overall Study||90||
59577121|NCT02012192|75682129|FG001|STARTED|Overall Study||43||
59577122|NCT02012192|75682128|FG000|COMPLETED|Overall Study||63||
59577123|NCT02012192|75682129|FG001|COMPLETED|Overall Study||43||
59577124|NCT02012192|75682128|FG000|NOT COMPLETED|Overall Study||27||
59577125|NCT02012192|75682129|FG001|NOT COMPLETED|Overall Study||0||
59577126|NCT02066792|75682139|FG000|STARTED|Overall Study||40||
59577127|NCT02066792|75682140|FG001|STARTED|Overall Study||38||
59577128|NCT02066792|75682141|FG002|STARTED|Overall Study||38||
59577129|NCT02066792|75682142|FG003|STARTED|Overall Study||36||
59577130|NCT02066792|75682139|FG000|COMPLETED|Overall Study||33||
59577131|NCT02066792|75682140|FG001|COMPLETED|Overall Study||33||
59577132|NCT02066792|75682141|FG002|COMPLETED|Overall Study||30||
59577133|NCT02066792|75682142|FG003|COMPLETED|Overall Study||27||
59577134|NCT02066792|75682139|FG000|NOT COMPLETED|Overall Study||7||
59577135|NCT02066792|75682140|FG001|NOT COMPLETED|Overall Study||5||
59577136|NCT02066792|75682141|FG002|NOT COMPLETED|Overall Study||8||
59577137|NCT02066792|75682142|FG003|NOT COMPLETED|Overall Study||9||
59577138|NCT02922959|75682154|FG000|STARTED|Overall Study||40||
59577139|NCT02922959|75682155|FG001|STARTED|Overall Study||40||
59577140|NCT02922959|75682154|FG000|3 Weeks|Overall Study|n=38 (95.0%)|38||
59577141|NCT02922959|75682155|FG001|3 Weeks|Overall Study|n=36 (90.0%)|36||
59577142|NCT02922959|75682154|FG000|3 Months|Overall Study|n=35 (87.5%)|35||
59577143|NCT02922959|75682155|FG001|3 Months|Overall Study|n=31 (77.5%)|31||
59577144|NCT02922959|75682154|FG000|6 Months|Overall Study|n=28 (70.0%)|28||
59577145|NCT02922959|75682155|FG001|6 Months|Overall Study|n=30 (75.0%)|30||
59577146|NCT02922959|75682154|FG000|12 Months|Overall Study|n=21 (52.5%)|21||
59577147|NCT02922959|75682155|FG001|12 Months|Overall Study|n=23 (57.5%)|23||
59577148|NCT02922959|75682154|FG000|COMPLETED|Overall Study||21||
59577149|NCT02922959|75682155|FG001|COMPLETED|Overall Study||23||
59577150|NCT02922959|75682154|FG000|NOT COMPLETED|Overall Study||19||
59577151|NCT02922959|75682155|FG001|NOT COMPLETED|Overall Study||17||
59577152|NCT02014363|75682164|FG000|STARTED|Overall Study||55||
59577153|NCT02014363|75682165|FG001|STARTED|Overall Study||54||
59577154|NCT02014363|75682166|FG002|STARTED|Overall Study||55||
59577155|NCT02014363|75682164|FG000|COMPLETED|Overall Study||38||
59577156|NCT02014363|75682165|FG001|COMPLETED|Overall Study||35||
59577157|NCT02014363|75682166|FG002|COMPLETED|Overall Study||31||
59577158|NCT02014363|75682164|FG000|NOT COMPLETED|Overall Study||17||
59577159|NCT02014363|75682165|FG001|NOT COMPLETED|Overall Study||19||
59577160|NCT02014363|75682166|FG002|NOT COMPLETED|Overall Study||24||
59577161|NCT02833337|75682174|FG000|STARTED|Overall Study||180||
59577162|NCT02833337|75682174|FG000|COMPLETED|Overall Study||180|180 completed|
59577163|NCT02833337|75682174|FG000|NOT COMPLETED|Overall Study||0||
59577164|NCT02067806|75682178|FG000|STARTED|Overall Study||394||
59577165|NCT02067806|75682178|FG000|COMPLETED|Overall Study||387||
59577166|NCT02067806|75682178|FG000|NOT COMPLETED|Overall Study||7||
59577167|NCT02833415|75682185|FG000|STARTED|Overall Study||20||
59577168|NCT02833415|75682186|FG001|STARTED|Overall Study||20||
59577169|NCT02833415|75682185|FG000|COMPLETED|Overall Study||18||
59577170|NCT02833415|75682186|FG001|COMPLETED|Overall Study||17||
59577171|NCT02833415|75682185|FG000|NOT COMPLETED|Overall Study||2||
59577172|NCT02833415|75682186|FG001|NOT COMPLETED|Overall Study||3||
59577173|NCT02014519|75682192|FG000|STARTED|Overall Study||2000||
59577174|NCT02014519|75682192|FG000|COMPLETED|Overall Study||2000||
59577175|NCT02014519|75682192|FG000|NOT COMPLETED|Overall Study||0||
59577176|NCT01971086|75682204|FG000|STARTED|Overall Study||300||
59577177|NCT01971086|75682204|FG000|COMPLETED|Overall Study||300||
59577178|NCT01971086|75682204|FG000|NOT COMPLETED|Overall Study||0||
59577179|NCT02012348|75682212|FG000|STARTED|Overall Study||10||
59577180|NCT02012348|75682213|FG001|STARTED|Overall Study||10||
59577181|NCT02012348|75682214|FG002|STARTED|Overall Study||10||
59577182|NCT02012348|75682212|FG000|COMPLETED|Overall Study||10||
59577183|NCT02012348|75682213|FG001|COMPLETED|Overall Study||10||
59577184|NCT02012348|75682214|FG002|COMPLETED|Overall Study||10||
59577185|NCT02012348|75682212|FG000|NOT COMPLETED|Overall Study||0||
59577186|NCT02012348|75682213|FG001|NOT COMPLETED|Overall Study||0||
59577187|NCT02012348|75682214|FG002|NOT COMPLETED|Overall Study||0||
59577188|NCT02016235|75682225|FG000|STARTED|Overall Study||10||
59577189|NCT02016235|75682226|FG001|STARTED|Overall Study||10||
59577190|NCT02016235|75682227|FG002|STARTED|Overall Study||10||
59577191|NCT02016235|75682225|FG000|COMPLETED|Overall Study||10||
59577192|NCT02016235|75682226|FG001|COMPLETED|Overall Study||10||
59577193|NCT02016235|75682227|FG002|COMPLETED|Overall Study||10||
59577194|NCT02016235|75682225|FG000|NOT COMPLETED|Overall Study||0||
59577195|NCT02016235|75682226|FG001|NOT COMPLETED|Overall Study||0||
59577196|NCT02016235|75682227|FG002|NOT COMPLETED|Overall Study||0||
59577197|NCT02834663|75682235|FG000|STARTED|Overall Study|Unit means the eye. One eye was included per patient|25||25
59577198|NCT02834663|75682235|FG000|COMPLETED|Overall Study|Unit means the eye. One eye was included per patient|25||25
59577199|NCT02834663|75682235|FG000|NOT COMPLETED|Overall Study||0||0
59577200|NCT01973036|75682255|FG000|STARTED|Overall Study||108|The group to which the subject was randomized|
59577201|NCT01973036|75682256|FG001|STARTED|Overall Study||93|The group to which the subject was randomized|
59577202|NCT01973036|75682255|FG000|Received Assigned Intervention|Overall Study||113|The intervention completed. (Some subjects rejected arm assignment or required opposite treatment.)|
59577203|NCT01973036|75682256|FG001|Received Assigned Intervention|Overall Study||88|The intervention completed. (Some subjects rejected arm assignment or required opposite treatment.)|
59577204|NCT01973036|75682255|FG000|COMPLETED|Overall Study||108|Data analyzed according to original arm assignment, not treatment completed.|
59577205|NCT01973036|75682256|FG001|COMPLETED|Overall Study||93|Data analyzed according to original arm assignment, not treatment completed.|
59577206|NCT01973036|75682255|FG000|NOT COMPLETED|Overall Study||0||
59577207|NCT01973036|75682256|FG001|NOT COMPLETED|Overall Study||0||
59577208|NCT02017093|75682265|FG000|STARTED|Overall Study||4||
59577209|NCT02017093|75682266|FG001|STARTED|Overall Study||3||
59577210|NCT02017093|75682265|FG000|COMPLETED|Overall Study||4||
59577211|NCT02017093|75682266|FG001|COMPLETED|Overall Study||3||
59577212|NCT02017093|75682265|FG000|NOT COMPLETED|Overall Study||0||
59577213|NCT02017093|75682266|FG001|NOT COMPLETED|Overall Study||0||
59577214|NCT02835677|75682274|FG000|STARTED|Overall Study||25||
59577215|NCT02835677|75682274|FG000|COMPLETED|Overall Study||25||
59577216|NCT02835677|75682274|FG000|NOT COMPLETED|Overall Study||0||
59577217|NCT02310776|75682278|FG000|STARTED|Overall Study||501||
59577218|NCT02310776|75682278|FG000|COMPLETED|Overall Study||501||
59577219|NCT02310776|75682278|FG000|NOT COMPLETED|Overall Study||0||
59577220|NCT02017327|75682285|FG000|STARTED|Overall Study||122||
59577221|NCT02017327|75682286|FG001|STARTED|Overall Study||125||
59577222|NCT02017327|75682287|FG002|STARTED|Overall Study||132||
59577223|NCT02017327|75682285|FG000|COMPLETED|Overall Study||106||
59577224|NCT02017327|75682286|FG001|COMPLETED|Overall Study||113||
59577225|NCT02017327|75682287|FG002|COMPLETED|Overall Study||117||
59577226|NCT02017327|75682285|FG000|NOT COMPLETED|Overall Study||16||
59577227|NCT02017327|75682286|FG001|NOT COMPLETED|Overall Study||12||
59577228|NCT02017327|75682287|FG002|NOT COMPLETED|Overall Study||15||
59577229|NCT02837237|75682295|FG000|STARTED|Overall Study||11||
59577230|NCT02837237|75682295|FG000|COMPLETED|Overall Study||11||
59577231|NCT02837237|75682295|FG000|NOT COMPLETED|Overall Study||0||
59577232|NCT02923271|75682301|FG000|STARTED|Overall Study||18||
59577233|NCT02923271|75682302|FG001|STARTED|Overall Study||16||
59577234|NCT02923271|75682301|FG000|COMPLETED|Overall Study||10||
59577235|NCT02923271|75682302|FG001|COMPLETED|Overall Study||14||
59577236|NCT02923271|75682301|FG000|NOT COMPLETED|Overall Study||8||
59577237|NCT02923271|75682302|FG001|NOT COMPLETED|Overall Study||2||
59577238|NCT02018107|75682308|FG000|STARTED|Overall Study||27||
59577239|NCT02018107|75682308|FG000|COMPLETED|Overall Study||27||
59577240|NCT02018107|75682308|FG000|NOT COMPLETED|Overall Study||0||
59577241|NCT02314598|75682312|FG000|STARTED|Overall Study||46||
59577242|NCT02314598|75682312|FG000|COMPLETED|Overall Study||46||
59577243|NCT02314598|75682312|FG000|NOT COMPLETED|Overall Study||0||
59577244|NCT02018653|75682318|FG000|STARTED|Overall Study||1||
59577245|NCT02018653|75682319|FG001|STARTED|Overall Study||1||
59577246|NCT02018653|75682318|FG000|COMPLETED|Overall Study||1||
59577247|NCT02018653|75682319|FG001|COMPLETED|Overall Study||0||
59577248|NCT02018653|75682318|FG000|NOT COMPLETED|Overall Study||0||
59577249|NCT02018653|75682319|FG001|NOT COMPLETED|Overall Study||1||
59577250|NCT02923895|75682327|FG000|STARTED|Overall Study||97||
59577251|NCT02923895|75682328|FG001|STARTED|Overall Study||95||
59577252|NCT02923895|75682327|FG000|COMPLETED|Overall Study||97||
59577253|NCT02923895|75682328|FG001|COMPLETED|Overall Study||95||
59577254|NCT02923895|75682327|FG000|NOT COMPLETED|Overall Study||0||
59577255|NCT02923895|75682328|FG001|NOT COMPLETED|Overall Study||0||
59577256|NCT01973348|75682338|FG000|STARTED|Overall Study||27||
59577257|NCT01973348|75682339|FG001|STARTED|Overall Study||18||
59577258|NCT01973348|75682340|FG002|STARTED|Overall Study||0||
59577259|NCT01973348|75682341|FG003|STARTED|Overall Study||0||
59577260|NCT01973348|75682338|FG000|COMPLETED|Overall Study||19||
59577261|NCT01973348|75682339|FG001|COMPLETED|Overall Study||15||
59577262|NCT01973348|75682340|FG002|COMPLETED|Overall Study||0||
59577263|NCT01973348|75682341|FG003|COMPLETED|Overall Study||0||
59577264|NCT01973348|75682338|FG000|NOT COMPLETED|Overall Study||8||
59577265|NCT01973348|75682339|FG001|NOT COMPLETED|Overall Study||3||
59577266|NCT01973348|75682340|FG002|NOT COMPLETED|Overall Study||0||
59577267|NCT01973348|75682341|FG003|NOT COMPLETED|Overall Study||0||
59577268|NCT02925143|75682351|FG000|STARTED|Overall Study||6525||
59577269|NCT02925143|75682351|FG000|Participants Receiving Depolarizing Neuromuscular Blocking Agent (NMBA) (Succinylcholine)|Overall Study||3099||
59577270|NCT02925143|75682351|FG000|Participants Receiving Non-depolarizing Neuromuscular Blocking Agent (NMBA)|Overall Study||3426||
59577271|NCT02925143|75682351|FG000|COMPLETED|Overall Study||6525||
59577272|NCT02925143|75682351|FG000|NOT COMPLETED|Overall Study||0||
59577273|NCT02018809|75682359|FG000|STARTED|Overall Study||50||
59577274|NCT02018809|75682360|FG001|STARTED|Overall Study||50||
59577275|NCT02018809|75682361|FG002|STARTED|Overall Study||50||
59577276|NCT02018809|75682362|FG003|STARTED|Overall Study||50||
59577277|NCT02018809|75682359|FG000|COMPLETED|Overall Study||50||
59577278|NCT02018809|75682360|FG001|COMPLETED|Overall Study||50||
59577279|NCT02018809|75682361|FG002|COMPLETED|Overall Study||50||
59577280|NCT02018809|75682362|FG003|COMPLETED|Overall Study||50||
59577281|NCT02018809|75682359|FG000|NOT COMPLETED|Overall Study||0||
59577282|NCT02018809|75682360|FG001|NOT COMPLETED|Overall Study||0||
59577283|NCT02018809|75682361|FG002|NOT COMPLETED|Overall Study||0||
59577284|NCT02018809|75682362|FG003|NOT COMPLETED|Overall Study||0||
59577285|NCT02838407|75682372|FG000|STARTED|Overall Study||197||
59577286|NCT02838407|75682372|FG000|COMPLETED|Overall Study||197||
59577287|NCT02838407|75682372|FG000|NOT COMPLETED|Overall Study||0||
59577288|NCT02020135|75682378|FG000|STARTED|Overall Study||9||
59577289|NCT02020135|75682378|FG000|COMPLETED|Overall Study||0||
59577290|NCT02020135|75682378|FG000|NOT COMPLETED|Overall Study||9||
59577291|NCT02020369|75682386|FG000|STARTED|Overall Study||14||
59577292|NCT02020369|75682387|FG001|STARTED|Overall Study||13||
59577293|NCT02020369|75682386|FG000|COMPLETED|Overall Study||11||
59577294|NCT02020369|75682387|FG001|COMPLETED|Overall Study||11||
59577295|NCT02020369|75682386|FG000|NOT COMPLETED|Overall Study||3||
59577296|NCT02020369|75682387|FG001|NOT COMPLETED|Overall Study||2||
59577297|NCT02839889|75682398|FG000|STARTED|Randomization Period||2||
59577298|NCT02839889|75682399|FG001|STARTED|Randomization Period||3||
59577299|NCT02839889|75682398|FG000|COMPLETED|Randomization Period||2||
59577300|NCT02839889|75682399|FG001|COMPLETED|Randomization Period||3||
59577301|NCT02839889|75682398|FG000|NOT COMPLETED|Randomization Period||0||
59577302|NCT02839889|75682399|FG001|NOT COMPLETED|Randomization Period||0||
59577303|NCT02839889|75682398|FG000|STARTED|Open-Label Period||0||
59577304|NCT02839889|75682399|FG001|STARTED|Open-Label Period||5||
59577305|NCT02839889|75682398|FG000|COMPLETED|Open-Label Period||0||
59577306|NCT02839889|75682399|FG001|COMPLETED|Open-Label Period||4||
59577307|NCT02839889|75682398|FG000|NOT COMPLETED|Open-Label Period||0||
59577308|NCT02839889|75682399|FG001|NOT COMPLETED|Open-Label Period||1||
59577309|NCT02012582|75682409|FG000|STARTED|Overall Study||8||
59577310|NCT02012582|75682410|FG001|STARTED|Overall Study||8||
59577311|NCT02012582|75682411|FG002|STARTED|Overall Study||8||
59577312|NCT02012582|75682412|FG003|STARTED|Overall Study||8||
59577313|NCT02012582|75682409|FG000|COMPLETED|Overall Study||8||
59577314|NCT02012582|75682410|FG001|COMPLETED|Overall Study||8||
59577315|NCT02012582|75682411|FG002|COMPLETED|Overall Study||8||
59577316|NCT02012582|75682412|FG003|COMPLETED|Overall Study||7||
59577317|NCT02012582|75682409|FG000|NOT COMPLETED|Overall Study||0||
59577318|NCT02012582|75682410|FG001|NOT COMPLETED|Overall Study||0||
59577319|NCT02012582|75682411|FG002|NOT COMPLETED|Overall Study||0||
59577320|NCT02012582|75682412|FG003|NOT COMPLETED|Overall Study||1||
59577321|NCT01971385|75682425|FG000|STARTED|Overall Study||17||
59577322|NCT01971385|75682426|FG001|STARTED|Overall Study||18||
59577323|NCT01971385|75682427|FG002|STARTED|Overall Study||19||
59577324|NCT01971385|75682425|FG000|COMPLETED|Overall Study||14||
59577325|NCT01971385|75682426|FG001|COMPLETED|Overall Study||13||
59577326|NCT01971385|75682427|FG002|COMPLETED|Overall Study||15||
59577327|NCT01971385|75682425|FG000|NOT COMPLETED|Overall Study||3||
59577328|NCT01971385|75682426|FG001|NOT COMPLETED|Overall Study||5||
59577329|NCT01971385|75682427|FG002|NOT COMPLETED|Overall Study||4||
59577330|NCT01971463|75682434|FG000|STARTED|Overall Study||81||
59577331|NCT01971463|75682434|FG000|COMPLETED|Overall Study||81||
59577332|NCT01971463|75682434|FG000|NOT COMPLETED|Overall Study||0||
59577333|NCT02925611|75682440|FG000|STARTED|Overall Study||30||
59577334|NCT02925611|75682441|FG001|STARTED|Overall Study||30||
59577335|NCT02925611|75682440|FG000|COMPLETED|Overall Study||30||
59577336|NCT02925611|75682441|FG001|COMPLETED|Overall Study||30||
59577337|NCT02925611|75682440|FG000|NOT COMPLETED|Overall Study||0||
59577338|NCT02925611|75682441|FG001|NOT COMPLETED|Overall Study||0||
59577339|NCT02841449|75682449|FG000|STARTED|Overall Study||7||
59577340|NCT02841449|75682450|FG001|STARTED|Overall Study||9||
59577341|NCT02841449|75682449|FG000|COMPLETED|Overall Study||7||
59577342|NCT02841449|75682450|FG001|COMPLETED|Overall Study||9||
59577343|NCT02841449|75682449|FG000|NOT COMPLETED|Overall Study||0||
59577344|NCT02841449|75682450|FG001|NOT COMPLETED|Overall Study||0||
59577345|NCT01973335|75682460|FG000|STARTED|Overall Study||9||
59577346|NCT01973335|75682461|FG001|STARTED|Overall Study||7||
59577347|NCT01973335|75682462|FG002|STARTED|Overall Study||9||
59577348|NCT01973335|75682463|FG003|STARTED|Overall Study||9||
59577349|NCT01973335|75682460|FG000|COMPLETED|Overall Study||9||
59577350|NCT01973335|75682461|FG001|COMPLETED|Overall Study||7||
59577351|NCT01973335|75682462|FG002|COMPLETED|Overall Study||9||
59577352|NCT01973335|75682463|FG003|COMPLETED|Overall Study||9||
59577353|NCT01973335|75682460|FG000|NOT COMPLETED|Overall Study||0||
59577354|NCT01973335|75682461|FG001|NOT COMPLETED|Overall Study||0||
59577355|NCT01973335|75682462|FG002|NOT COMPLETED|Overall Study||0||
59577356|NCT01973335|75682463|FG003|NOT COMPLETED|Overall Study||0||
59577357|NCT02844569|75682475|FG000|STARTED|Overall Study||12||
59577358|NCT02844569|75682476|FG001|STARTED|Overall Study||12||
59577359|NCT02844569|75682475|FG000|COMPLETED|Overall Study||12||
59577360|NCT02844569|75682476|FG001|COMPLETED|Overall Study||12||
59577361|NCT02844569|75682475|FG000|NOT COMPLETED|Overall Study||0||
59577362|NCT02844569|75682476|FG001|NOT COMPLETED|Overall Study||0||
59577363|NCT01973413|75682484|FG000|STARTED|Overall Study||12||
59577364|NCT01973413|75682485|FG001|STARTED|Overall Study||20||
59577365|NCT01973413|75682484|FG000|COMPLETED|Overall Study||11||
59577366|NCT01973413|75682485|FG001|COMPLETED|Overall Study||20||
59577367|NCT01973413|75682484|FG000|NOT COMPLETED|Overall Study||1||
59577368|NCT01973413|75682485|FG001|NOT COMPLETED|Overall Study||0||
59577369|NCT02927327|75682494|FG000|STARTED|Overall Study||30||
59577370|NCT02927327|75682495|FG001|STARTED|Overall Study||31||
59577371|NCT02927327|75682494|FG000|COMPLETED|Overall Study||30||
59577372|NCT02927327|75682495|FG001|COMPLETED|Overall Study||31||
59577373|NCT02927327|75682494|FG000|NOT COMPLETED|Overall Study||0||
59577374|NCT02927327|75682495|FG001|NOT COMPLETED|Overall Study||0||
59577375|NCT02021461|75682501|FG000|STARTED|Overall Study||38||
59577376|NCT02021461|75682501|FG000|COMPLETED|Overall Study||38||
59577377|NCT02021461|75682501|FG000|NOT COMPLETED|Overall Study||0||
59577378|NCT02927639|75682509|FG000|STARTED|Overall Study||83||
59577379|NCT02927639|75682510|FG001|STARTED|Overall Study|1 subj was inadvertently enrolled in another interventional study just before enrolling so removed.|82||
59577380|NCT02927639|75682509|FG000|COMPLETED|Overall Study||10||
59577381|NCT02927639|75682510|FG001|COMPLETED|Overall Study||13||
59577382|NCT02927639|75682509|FG000|NOT COMPLETED|Overall Study||73||
59577383|NCT02927639|75682510|FG001|NOT COMPLETED|Overall Study||69||
59577384|NCT02929667|75682518|FG000|STARTED|Overall Study||11||
59577385|NCT02929667|75682519|FG001|STARTED|Overall Study||11||
59577386|NCT02929667|75682518|FG000|COMPLETED|Overall Study||11||
59577387|NCT02929667|75682519|FG001|COMPLETED|Overall Study||11||
59721653|NCT01092780|75840535|FG001|NOT COMPLETED|Washout Period 2||1||
59577388|NCT02929667|75682518|FG000|NOT COMPLETED|Overall Study||0||
59577389|NCT02929667|75682519|FG001|NOT COMPLETED|Overall Study||0||
59577390|NCT02021929|75682529|FG000|STARTED|Overall Study||16||
59577391|NCT02021929|75682530|FG001|STARTED|Overall Study||12||
59577392|NCT02021929|75682529|FG000|COMPLETED|Overall Study||14||
59577393|NCT02021929|75682530|FG001|COMPLETED|Overall Study||11||
59577394|NCT02021929|75682529|FG000|NOT COMPLETED|Overall Study||2||
59577395|NCT02021929|75682530|FG001|NOT COMPLETED|Overall Study||1||
59577396|NCT02848079|75682536|FG000|STARTED|Overall Study||41||
59577397|NCT02848079|75682536|FG000|Receieved Study Treatment|Overall Study||41||
59577398|NCT02848079|75682536|FG000|Discontinued|Overall Study||41||
59577399|NCT02848079|75682536|FG000|COMPLETED|Overall Study||41||
59577400|NCT02848079|75682536|FG000|NOT COMPLETED|Overall Study||0||
59577401|NCT02022085|75682540|FG000|STARTED|Overall Study||54||
59577402|NCT02022085|75682540|FG000|COMPLETED|Overall Study||53||
59577403|NCT02022085|75682540|FG000|NOT COMPLETED|Overall Study||1||
59577404|NCT02929823|75682547|FG000|STARTED|Overall Study||42||
59577405|NCT02929823|75682548|FG001|STARTED|Overall Study||46||
59577406|NCT02929823|75682549|FG002|STARTED|Overall Study||42||
59577407|NCT02929823|75682547|FG000|COMPLETED|Overall Study||39||
59577408|NCT02929823|75682548|FG001|COMPLETED|Overall Study||40||
59577409|NCT02929823|75682549|FG002|COMPLETED|Overall Study||38||
59577410|NCT02929823|75682547|FG000|NOT COMPLETED|Overall Study||3||
59577411|NCT02929823|75682548|FG001|NOT COMPLETED|Overall Study||6||
59577412|NCT02929823|75682549|FG002|NOT COMPLETED|Overall Study||4||
59577413|NCT02929979|75682559|FG000|STARTED|Overall Study||52||
59577414|NCT02929979|75682560|FG001|STARTED|Overall Study||38||
59577415|NCT02929979|75682559|FG000|COMPLETED|Overall Study||25||
59577416|NCT02929979|75682560|FG001|COMPLETED|Overall Study||28||
59577417|NCT02929979|75682559|FG000|NOT COMPLETED|Overall Study||27||
59577418|NCT02929979|75682560|FG001|NOT COMPLETED|Overall Study||10||
59577419|NCT02932787|75682569|FG000|STARTED|Overall Study||22||
59577420|NCT02932787|75682570|FG001|STARTED|Overall Study||9||
59577421|NCT02932787|75682569|FG000|COMPLETED|Overall Study||22||
59577422|NCT02932787|75682570|FG001|COMPLETED|Overall Study||9||
59577423|NCT02932787|75682569|FG000|NOT COMPLETED|Overall Study||0||
59577424|NCT02932787|75682570|FG001|NOT COMPLETED|Overall Study||0||
59577425|NCT02023411|75682581|FG000|STARTED|Overall Study||10||
59577426|NCT02023411|75682582|FG001|STARTED|Overall Study||10||
59577427|NCT02023411|75682581|FG000|COMPLETED|Overall Study||10||
59577428|NCT02023411|75682582|FG001|COMPLETED|Overall Study||10||
59577429|NCT02023411|75682581|FG000|NOT COMPLETED|Overall Study||0||
59577430|NCT02023411|75682582|FG001|NOT COMPLETED|Overall Study||0||
59577431|NCT02851823|75682589|FG000|STARTED|Overall Study||25||
59577432|NCT02851823|75682589|FG000|1 Month|Overall Study||25|1 month after therapy|
59577433|NCT02851823|75682589|FG000|3 Months|Overall Study||25|3 months after therapy|
59577434|NCT02851823|75682589|FG000|COMPLETED|Overall Study||25||
59577435|NCT02851823|75682589|FG000|NOT COMPLETED|Overall Study||0||
59577436|NCT02023801|75682595|FG000|STARTED|Overall Study|Treatment Attempted|24||
59577437|NCT02023801|75682595|FG000|Treated|Overall Study|Treatment Completed|24||
59577438|NCT02023801|75682595|FG000|COMPLETED|Overall Study|Completed 12 Month Follow-up|24||
59577439|NCT02023801|75682595|FG000|NOT COMPLETED|Overall Study||0||
59577440|NCT02933879|75682602|FG000|STARTED|Overall Study||64||
59577441|NCT02933879|75682603|FG001|STARTED|Overall Study||62||
59577442|NCT02933879|75682604|FG002|STARTED|Overall Study||58||
59577443|NCT02933879|75682602|FG000|COMPLETED|Overall Study||48||
59577444|NCT02933879|75682603|FG001|COMPLETED|Overall Study||48||
59577445|NCT02933879|75682604|FG002|COMPLETED|Overall Study||41||
59577446|NCT02933879|75682602|FG000|NOT COMPLETED|Overall Study||16||
59577447|NCT02933879|75682603|FG001|NOT COMPLETED|Overall Study||14||
59577448|NCT02933879|75682604|FG002|NOT COMPLETED|Overall Study||17||
59577449|NCT02068820|75682616|FG000|STARTED|Overall Study||20||
59577450|NCT02068820|75682617|FG001|STARTED|Overall Study||180||
59577451|NCT02068820|75682616|FG000|COMPLETED|Overall Study||20||
59577452|NCT02068820|75682617|FG001|COMPLETED|Overall Study||180||
59577453|NCT02068820|75682616|FG000|NOT COMPLETED|Overall Study||0||
59577454|NCT02068820|75682617|FG001|NOT COMPLETED|Overall Study||0||
59721654|NCT01092780|75840536|FG002|NOT COMPLETED|Washout Period 2||1||
59850322|NCT03583372|75974674|FG001|COMPLETED|Overall Study||156||
60121339|NCT02666560|76242267|FG000|STARTED|Condition 2 (1 Day)||8||
60121340|NCT02666560|76242268|FG001|STARTED|Condition 2 (1 Day)||11||
59577455|NCT02855567|75682630|FG000|STARTED|Overall Study||54||
59577456|NCT02855567|75682631|FG001|STARTED|Overall Study||56||
59577457|NCT02855567|75682630|FG000|COMPLETED|Overall Study||54||
59577458|NCT02855567|75682631|FG001|COMPLETED|Overall Study||56||
59577459|NCT02855567|75682630|FG000|NOT COMPLETED|Overall Study||0||
59577460|NCT02855567|75682631|FG001|NOT COMPLETED|Overall Study||0||
59577461|NCT02856035|75682637|FG000|STARTED|Overall Study||4||
59577462|NCT02856035|75682637|FG000|COMPLETED|Overall Study||4||
59577463|NCT02856035|75682637|FG000|NOT COMPLETED|Overall Study||0||
59577464|NCT01975519|75682643|FG000|STARTED|Overall Study||3||
59577465|NCT01975519|75682644|FG001|STARTED|Overall Study||108||
59577466|NCT01975519|75682643|FG000|Phase 1b|Overall Study||3||
59577467|NCT01975519|75682644|FG001|Phase 1b|Overall Study||23||
59577468|NCT01975519|75682643|FG000|Phase 2a Soft Tissue Sarcoma|Overall Study||0||
59577469|NCT01975519|75682644|FG001|Phase 2a Soft Tissue Sarcoma|Overall Study||63||
59577470|NCT01975519|75682643|FG000|Phase 2a Angiosarcoma Cohort|Overall Study||0||
59577471|NCT01975519|75682644|FG001|Phase 2a Angiosarcoma Cohort|Overall Study||22||
59577472|NCT01975519|75682643|FG000|COMPLETED|Overall Study||3||
59577473|NCT01975519|75682644|FG001|COMPLETED|Overall Study||108||
59577474|NCT01975519|75682643|FG000|NOT COMPLETED|Overall Study||0||
59577475|NCT01975519|75682644|FG001|NOT COMPLETED|Overall Study||0||
59577476|NCT02934191|75682660|FG000|STARTED|Overall Study||87||
59577477|NCT02934191|75682661|FG001|STARTED|Overall Study||85||
59577478|NCT02934191|75682660|FG000|COMPLETED|Overall Study||87||
59577479|NCT02934191|75682661|FG001|COMPLETED|Overall Study||85||
59577480|NCT02934191|75682660|FG000|NOT COMPLETED|Overall Study||0||
59577481|NCT02934191|75682661|FG001|NOT COMPLETED|Overall Study||0||
59577482|NCT02934347|75682669|FG000|STARTED|Overall Study||374||
59577483|NCT02934347|75682670|FG001|STARTED|Overall Study||407||
59577484|NCT02934347|75682669|FG000|COMPLETED|Overall Study||374||
59577485|NCT02934347|75682670|FG001|COMPLETED|Overall Study||407||
59577486|NCT02934347|75682669|FG000|NOT COMPLETED|Overall Study||0||
59577487|NCT02934347|75682670|FG001|NOT COMPLETED|Overall Study||0||
59577488|NCT01975909|75682678|FG000|STARTED|Overall Study||10||
59577489|NCT01975909|75682679|FG001|STARTED|Overall Study||10||
59577490|NCT01975909|75682678|FG000|COMPLETED|Overall Study||10||
59577491|NCT01975909|75682679|FG001|COMPLETED|Overall Study||10||
59577492|NCT01975909|75682678|FG000|NOT COMPLETED|Overall Study||0||
59577493|NCT01975909|75682679|FG001|NOT COMPLETED|Overall Study||0||
59577494|NCT02937623|75682687|FG000|STARTED|Overall Study||60||
59577495|NCT02937623|75682688|FG001|STARTED|Overall Study||60||
59577496|NCT02937623|75682687|FG000|COMPLETED|Overall Study||60||
59577497|NCT02937623|75682688|FG001|COMPLETED|Overall Study||60||
59577498|NCT02937623|75682687|FG000|NOT COMPLETED|Overall Study||0||
59577499|NCT02937623|75682688|FG001|NOT COMPLETED|Overall Study||0||
59577500|NCT01977547|75682696|FG000|STARTED|Overall Study||768||
59577501|NCT01977547|75682697|FG001|STARTED|Overall Study||770||
59577502|NCT01977547|75682696|FG000|COMPLETED|Overall Study||728||
59577503|NCT01977547|75682697|FG001|COMPLETED|Overall Study||733||
59577504|NCT01977547|75682696|FG000|NOT COMPLETED|Overall Study||40||
59577505|NCT01977547|75682697|FG001|NOT COMPLETED|Overall Study||37||
59577506|NCT02863289|75682703|FG000|STARTED|Overall Study|Study started on 01/11/2016, with 118 study participants.|118||
59577507|NCT02863289|75682703|FG000|COMPLETED|Overall Study|Study completed on 01/03/2017, 35 study participants have returned the questionnaire.|35||
59577508|NCT02863289|75682703|FG000|NOT COMPLETED|Overall Study||83||
59577509|NCT02864069|75682711|FG000|STARTED|Overall Study||18||
59577510|NCT02864069|75682712|FG001|STARTED|Overall Study||13||
59577511|NCT02864069|75682713|FG002|STARTED|Overall Study||21||
59577512|NCT02864069|75682711|FG000|COMPLETED|Overall Study||12||
59577513|NCT02864069|75682712|FG001|COMPLETED|Overall Study||5||
59577514|NCT02864069|75682713|FG002|COMPLETED|Overall Study||13||
59577515|NCT02864069|75682711|FG000|NOT COMPLETED|Overall Study||6||
59577516|NCT02864069|75682712|FG001|NOT COMPLETED|Overall Study||8||
59577517|NCT02864069|75682713|FG002|NOT COMPLETED|Overall Study||8||
59577518|NCT02013050|75682725|FG000|STARTED|Overall Study||42||
59577519|NCT02013050|75682726|FG001|STARTED|Overall Study||41||
59577520|NCT02013050|75682727|FG002|STARTED|Overall Study||3||
59577521|NCT02013050|75682728|FG003|STARTED|Overall Study||23||
59577522|NCT02013050|75682725|FG000|COMPLETED|Overall Study||38||
59577523|NCT02013050|75682726|FG001|COMPLETED|Overall Study||36||
59577524|NCT02013050|75682727|FG002|COMPLETED|Overall Study||3||
59577525|NCT02013050|75682728|FG003|COMPLETED|Overall Study||19||
59577526|NCT02013050|75682725|FG000|NOT COMPLETED|Overall Study||4||
59577527|NCT02013050|75682726|FG001|NOT COMPLETED|Overall Study||5||
59577528|NCT02013050|75682727|FG002|NOT COMPLETED|Overall Study||0||
59577529|NCT02013050|75682728|FG003|NOT COMPLETED|Overall Study||4||
59577530|NCT01977781|75682740|FG000|STARTED|Overall Study||24||
59577531|NCT01977781|75682741|FG001|STARTED|Overall Study||16||
59577532|NCT01977781|75682740|FG000|COMPLETED|Overall Study||18||
59577533|NCT01977781|75682741|FG001|COMPLETED|Overall Study||15||
59577534|NCT01977781|75682740|FG000|NOT COMPLETED|Overall Study||6||
59577535|NCT01977781|75682741|FG001|NOT COMPLETED|Overall Study||1||
59577536|NCT02938169|75682751|FG000|STARTED|Overall Study||15||
59577537|NCT02938169|75682752|FG001|STARTED|Overall Study||15||
59577538|NCT02938169|75682753|FG002|STARTED|Overall Study||15||
59577539|NCT02938169|75682754|FG003|STARTED|Overall Study||15||
59577540|NCT02938169|75682751|FG000|COMPLETED|Overall Study||13||
59577541|NCT02938169|75682752|FG001|COMPLETED|Overall Study||13||
59850323|NCT03583372|75974675|FG002|COMPLETED|Overall Study||72||
59577542|NCT02938169|75682753|FG002|COMPLETED|Overall Study||10||
59577543|NCT02938169|75682754|FG003|COMPLETED|Overall Study||12||
59577544|NCT02938169|75682751|FG000|NOT COMPLETED|Overall Study||2||
59577545|NCT02938169|75682752|FG001|NOT COMPLETED|Overall Study||2||
59850324|NCT03583372|75974676|FG003|COMPLETED|Overall Study||123||
59577546|NCT02938169|75682753|FG002|NOT COMPLETED|Overall Study||5||
59577547|NCT02938169|75682754|FG003|NOT COMPLETED|Overall Study||3||
59577548|NCT02070302|75682773|FG000|STARTED|Overall Study||5||
59577549|NCT02070302|75682774|FG001|STARTED|Overall Study||5||
59577550|NCT02070302|75682773|FG000|COMPLETED|Overall Study||5||
59577551|NCT02070302|75682774|FG001|COMPLETED|Overall Study||5||
59577552|NCT02070302|75682773|FG000|NOT COMPLETED|Overall Study||0||
59577553|NCT02070302|75682774|FG001|NOT COMPLETED|Overall Study||0||
59577554|NCT02938949|75682782|FG000|STARTED|Overall Study||10||
59577555|NCT02938949|75682783|FG001|STARTED|Overall Study||10||
59577556|NCT02938949|75682782|FG000|COMPLETED|Overall Study||10||
59577557|NCT02938949|75682783|FG001|COMPLETED|Overall Study||10||
59577558|NCT02938949|75682782|FG000|NOT COMPLETED|Overall Study||0||
59577559|NCT02938949|75682783|FG001|NOT COMPLETED|Overall Study||0||
59577560|NCT01979029|75682791|FG000|STARTED|Overall Study||29||
59577561|NCT01979029|75682792|FG001|STARTED|Overall Study||28||
59577562|NCT01979029|75682791|FG000|COMPLETED|Overall Study||29||
59577563|NCT01979029|75682792|FG001|COMPLETED|Overall Study||28||
59577564|NCT01979029|75682791|FG000|NOT COMPLETED|Overall Study||0||
59577565|NCT01979029|75682792|FG001|NOT COMPLETED|Overall Study||0||
59577566|NCT02939105|75682798|FG000|STARTED|Overall Study||15||
59577567|NCT02939105|75682798|FG000|COMPLETED|Overall Study||15||
59577568|NCT02939105|75682798|FG000|NOT COMPLETED|Overall Study||0||
59577569|NCT02025439|75682805|FG000|STARTED|Overall Study||2||
59577570|NCT02025439|75682806|FG001|STARTED|Overall Study||2||
59577571|NCT02025439|75682805|FG000|COMPLETED|Overall Study||2||
59577572|NCT02025439|75682806|FG001|COMPLETED|Overall Study||2||
59577573|NCT02025439|75682805|FG000|NOT COMPLETED|Overall Study||0||
59577574|NCT02025439|75682806|FG001|NOT COMPLETED|Overall Study||0||
59577575|NCT02939651|75682814|FG000|STARTED|Overall Study||21||
59577576|NCT02939651|75682814|FG000|COMPLETED|Overall Study||21||
59577577|NCT02939651|75682814|FG000|NOT COMPLETED|Overall Study||0||
59577578|NCT02025829|75682820|FG000|STARTED|Overall Study||3||
59577579|NCT02025829|75682821|FG001|STARTED|Overall Study||11||
59577580|NCT02025829|75682820|FG000|COMPLETED|Overall Study||3||
59577581|NCT02025829|75682821|FG001|COMPLETED|Overall Study||11||
59577582|NCT02025829|75682820|FG000|NOT COMPLETED|Overall Study||0||
59577583|NCT02025829|75682821|FG001|NOT COMPLETED|Overall Study||0||
59577584|NCT02943941|75682828|FG000|STARTED|Overall Study||16|All participants|
59577585|NCT02943941|75682828|FG000|COMPLETED|Overall Study||16||
59577586|NCT02943941|75682828|FG000|NOT COMPLETED|Overall Study||0||
59577587|NCT02026297|75682835|FG000|STARTED|Overall Study||7||
59577588|NCT02026297|75682836|FG001|STARTED|Overall Study||13||
59577589|NCT02026297|75682835|FG000|COMPLETED|Overall Study||7||
59577590|NCT02026297|75682836|FG001|COMPLETED|Overall Study||13||
59577591|NCT02026297|75682835|FG000|NOT COMPLETED|Overall Study||0||
59577592|NCT02026297|75682836|FG001|NOT COMPLETED|Overall Study||0||
59577593|NCT02070692|75682844|FG000|STARTED|Overall Study||28||
59577594|NCT02070692|75682845|FG001|STARTED|Overall Study||28||
59577595|NCT02070692|75682844|FG000|COMPLETED|Overall Study||18||
59577596|NCT02070692|75682845|FG001|COMPLETED|Overall Study||16||
59577597|NCT02070692|75682844|FG000|NOT COMPLETED|Overall Study||10||
59577598|NCT02070692|75682845|FG001|NOT COMPLETED|Overall Study||12||
59577599|NCT02026453|75682854|FG000|STARTED|Overall Study||101||
59577600|NCT02026453|75682855|FG001|STARTED|Overall Study||103||
59577601|NCT02026453|75682856|FG002|STARTED|Overall Study||102||
59577602|NCT02026453|75682854|FG000|COMPLETED|Overall Study||95||
59577603|NCT02026453|75682855|FG001|COMPLETED|Overall Study||94||
59577604|NCT02026453|75682856|FG002|COMPLETED|Overall Study||89||
59577605|NCT02026453|75682854|FG000|NOT COMPLETED|Overall Study||6||
59577606|NCT02026453|75682855|FG001|NOT COMPLETED|Overall Study||9||
59577607|NCT02026453|75682856|FG002|NOT COMPLETED|Overall Study||13||
59577608|NCT02026687|75682866|FG000|STARTED|Overall Study||40||
59577609|NCT02026687|75682867|FG001|STARTED|Overall Study||40||
59577610|NCT02026687|75682866|FG000|COMPLETED|Overall Study||39||
59577611|NCT02026687|75682867|FG001|COMPLETED|Overall Study||38||
59577612|NCT02026687|75682866|FG000|NOT COMPLETED|Overall Study||1||
59577613|NCT02026687|75682867|FG001|NOT COMPLETED|Overall Study||2||
59577614|NCT02015234|75682875|FG000|STARTED|Overall Study||79||
59577615|NCT02015234|75682876|FG001|STARTED|Overall Study||79||
59577616|NCT02015234|75682875|FG000|COMPLETED|Overall Study||43||
59577617|NCT02015234|75682876|FG001|COMPLETED|Overall Study||54||
59577618|NCT02015234|75682875|FG000|NOT COMPLETED|Overall Study||36||
59577619|NCT02015234|75682876|FG001|NOT COMPLETED|Overall Study||25||
59577620|NCT01974050|75682884|FG000|STARTED|Overall Study||166||
59577621|NCT01974050|75682884|FG000|COMPLETED|Overall Study||141||
59577622|NCT01974050|75682884|FG000|NOT COMPLETED|Overall Study||25||
59577623|NCT02028247|75682891|FG000|STARTED|Overall Study||77||
59577624|NCT02028247|75682892|FG001|STARTED|Overall Study||71||
59577625|NCT02028247|75682893|FG002|STARTED|Overall Study||19||
59577626|NCT02028247|75682891|FG000|COMPLETED|Overall Study||67||
59577627|NCT02028247|75682892|FG001|COMPLETED|Overall Study||59||
59577628|NCT02028247|75682893|FG002|COMPLETED|Overall Study||15||
59577629|NCT02028247|75682891|FG000|NOT COMPLETED|Overall Study||10||
59577630|NCT02028247|75682892|FG001|NOT COMPLETED|Overall Study||12||
59577631|NCT02028247|75682893|FG002|NOT COMPLETED|Overall Study||4||
59577632|NCT01975922|75682903|FG000|STARTED|Overall Study||45||
59577633|NCT01975922|75682904|FG001|STARTED|Overall Study||52||
59577634|NCT01975922|75682903|FG000|COMPLETED|Overall Study||45||
59577635|NCT01975922|75682904|FG001|COMPLETED|Overall Study||43||
59577636|NCT01975922|75682903|FG000|NOT COMPLETED|Overall Study||0||
59577637|NCT01975922|75682904|FG001|NOT COMPLETED|Overall Study||9||
59577638|NCT02028325|75682910|FG000|STARTED|Overall Study||136||
59721655|NCT01092780|75840537|FG003|NOT COMPLETED|Washout Period 2||0||
59721656|NCT01092780|75840534|FG000|STARTED|Treatment Period 3||13||
59721657|NCT01092780|75840535|FG001|STARTED|Treatment Period 3||13||
59721658|NCT01092780|75840536|FG002|STARTED|Treatment Period 3||13||
59721659|NCT01092780|75840537|FG003|STARTED|Treatment Period 3||13||
59721660|NCT01092780|75840534|FG000|COMPLETED|Treatment Period 3||13||
59721661|NCT01092780|75840535|FG001|COMPLETED|Treatment Period 3||13||
59721662|NCT01092780|75840536|FG002|COMPLETED|Treatment Period 3||13||
59721663|NCT01092780|75840537|FG003|COMPLETED|Treatment Period 3||13||
59721664|NCT01092780|75840534|FG000|NOT COMPLETED|Treatment Period 3||0||
59721665|NCT01092780|75840535|FG001|NOT COMPLETED|Treatment Period 3||0||
59721666|NCT01092780|75840536|FG002|NOT COMPLETED|Treatment Period 3||0||
59721667|NCT01092780|75840537|FG003|NOT COMPLETED|Treatment Period 3||0||
59721668|NCT01092780|75840534|FG000|STARTED|Washout Period 3||13||
59721669|NCT01092780|75840535|FG001|STARTED|Washout Period 3||13||
59721670|NCT01092780|75840536|FG002|STARTED|Washout Period 3||13||
59721671|NCT01092780|75840537|FG003|STARTED|Washout Period 3||13||
59721672|NCT01092780|75840534|FG000|COMPLETED|Washout Period 3||13||
59721673|NCT01092780|75840535|FG001|COMPLETED|Washout Period 3||13||
59721674|NCT01092780|75840536|FG002|COMPLETED|Washout Period 3||13||
59721675|NCT01092780|75840537|FG003|COMPLETED|Washout Period 3||13||
59721676|NCT01092780|75840534|FG000|NOT COMPLETED|Washout Period 3||0||
59721677|NCT01092780|75840535|FG001|NOT COMPLETED|Washout Period 3||0||
59721678|NCT01092780|75840536|FG002|NOT COMPLETED|Washout Period 3||0||
59721679|NCT01092780|75840537|FG003|NOT COMPLETED|Washout Period 3||0||
60121341|NCT02666560|76242267|FG000|COMPLETED|Condition 2 (1 Day)||8||
60121342|NCT02666560|76242268|FG001|COMPLETED|Condition 2 (1 Day)||11||
60121343|NCT02666560|76242267|FG000|NOT COMPLETED|Condition 2 (1 Day)||0||
60121344|NCT02666560|76242268|FG001|NOT COMPLETED|Condition 2 (1 Day)||0||
60121345|NCT02666950|76242275|FG000|STARTED|Overall Study||3||
60121346|NCT02666950|76242275|FG000|COMPLETED|Overall Study||3||
60121347|NCT02666950|76242275|FG000|NOT COMPLETED|Overall Study||0||
60121348|NCT02668198|76242279|FG000|STARTED|Overall Study||230||
60121349|NCT02668198|76242279|FG000|COMPLETED|Overall Study||230||
60121350|NCT02668198|76242279|FG000|NOT COMPLETED|Overall Study||0||
59577639|NCT02028325|75682910|FG000|COMPLETED|Overall Study||126||
59577640|NCT02028325|75682910|FG000|NOT COMPLETED|Overall Study||10||
59577641|NCT02016560|75682920|FG000|STARTED|Exploratory Phase||16||
59577642|NCT02016560|75682921|FG001|STARTED|Exploratory Phase||58||
59577643|NCT02016560|75682922|FG002|STARTED|Exploratory Phase||98||
59577644|NCT02016560|75682923|FG003|STARTED|Exploratory Phase||51||
59577645|NCT02016560|75682924|FG004|STARTED|Exploratory Phase||0||
59577646|NCT02016560|75682925|FG005|STARTED|Exploratory Phase||0||
59577647|NCT02016560|75682920|FG000|COMPLETED|Exploratory Phase||16||
59577648|NCT02016560|75682921|FG001|COMPLETED|Exploratory Phase||54||
59721680|NCT01092780|75840534|FG000|STARTED|Treatment Period 4||13||
59721681|NCT01092780|75840535|FG001|STARTED|Treatment Period 4||13||
59721682|NCT01092780|75840536|FG002|STARTED|Treatment Period 4||13||
59721683|NCT01092780|75840537|FG003|STARTED|Treatment Period 4||13||
59721684|NCT01092780|75840534|FG000|COMPLETED|Treatment Period 4||13||
59850325|NCT03583372|75974673|FG000|NOT COMPLETED|Overall Study||13||
59850326|NCT03583372|75974674|FG001|NOT COMPLETED|Overall Study||26||
59577649|NCT02016560|75682922|FG002|COMPLETED|Exploratory Phase||62||
59721685|NCT01092780|75840535|FG001|COMPLETED|Treatment Period 4||13||
59721686|NCT01092780|75840536|FG002|COMPLETED|Treatment Period 4||13||
59721687|NCT01092780|75840537|FG003|COMPLETED|Treatment Period 4||13||
59721688|NCT01092780|75840534|FG000|NOT COMPLETED|Treatment Period 4||0||
59721689|NCT01092780|75840535|FG001|NOT COMPLETED|Treatment Period 4||0||
59721690|NCT01092780|75840536|FG002|NOT COMPLETED|Treatment Period 4||0||
59721691|NCT01092780|75840537|FG003|NOT COMPLETED|Treatment Period 4||0||
60121351|NCT02668432|76242286|FG000|STARTED|Overall Study||5||
60121352|NCT02668432|76242287|FG001|STARTED|Overall Study||4||
60121353|NCT02668432|76242286|FG000|COMPLETED|Overall Study||5||
60121354|NCT02668432|76242287|FG001|COMPLETED|Overall Study||4||
60121355|NCT02668432|76242286|FG000|NOT COMPLETED|Overall Study||0||
60121356|NCT02668432|76242287|FG001|NOT COMPLETED|Overall Study||0||
60121357|NCT01687595|76242295|FG000|STARTED|Overall Study||70||
59577650|NCT02016560|75682923|FG003|COMPLETED|Exploratory Phase||35||
59577651|NCT02016560|75682924|FG004|COMPLETED|Exploratory Phase||0||
59577652|NCT02016560|75682925|FG005|COMPLETED|Exploratory Phase||0||
59577653|NCT02016560|75682920|FG000|NOT COMPLETED|Exploratory Phase||0||
59577654|NCT02016560|75682921|FG001|NOT COMPLETED|Exploratory Phase||4||
59577655|NCT02016560|75682922|FG002|NOT COMPLETED|Exploratory Phase||36||
59577656|NCT02016560|75682923|FG003|NOT COMPLETED|Exploratory Phase||16||
59577657|NCT02016560|75682924|FG004|NOT COMPLETED|Exploratory Phase||0||
59577658|NCT02016560|75682925|FG005|NOT COMPLETED|Exploratory Phase||0||
59577659|NCT02016560|75682920|FG000|STARTED|Confirmatory Phase||0||
59577660|NCT02016560|75682921|FG001|STARTED|Confirmatory Phase||0||
59577661|NCT02016560|75682922|FG002|STARTED|Confirmatory Phase||0||
59577662|NCT02016560|75682923|FG003|STARTED|Confirmatory Phase||0||
59577663|NCT02016560|75682924|FG004|STARTED|Confirmatory Phase||98||
59577664|NCT02016560|75682925|FG005|STARTED|Confirmatory Phase||62||
59577665|NCT02016560|75682920|FG000|COMPLETED|Confirmatory Phase||0||
59577666|NCT02016560|75682921|FG001|COMPLETED|Confirmatory Phase||0||
59577667|NCT02016560|75682922|FG002|COMPLETED|Confirmatory Phase||0||
59577668|NCT02016560|75682923|FG003|COMPLETED|Confirmatory Phase||0||
59577669|NCT02016560|75682924|FG004|COMPLETED|Confirmatory Phase||76||
59577670|NCT02016560|75682925|FG005|COMPLETED|Confirmatory Phase||35||
59577671|NCT02016560|75682920|FG000|NOT COMPLETED|Confirmatory Phase||0||
59577672|NCT02016560|75682921|FG001|NOT COMPLETED|Confirmatory Phase||0||
59577673|NCT02016560|75682922|FG002|NOT COMPLETED|Confirmatory Phase||0||
59577674|NCT02016560|75682923|FG003|NOT COMPLETED|Confirmatory Phase||0||
59577675|NCT02016560|75682924|FG004|NOT COMPLETED|Confirmatory Phase||22||
59577676|NCT02016560|75682925|FG005|NOT COMPLETED|Confirmatory Phase||27||
59577677|NCT02017574|75682949|FG000|STARTED|Overall Study||12||
59577678|NCT02017574|75682950|FG001|STARTED|Overall Study||12||
59577679|NCT02017574|75682949|FG000|COMPLETED|Overall Study||12||
59577680|NCT02017574|75682950|FG001|COMPLETED|Overall Study||12||
59577681|NCT02017574|75682949|FG000|NOT COMPLETED|Overall Study||0||
59577682|NCT02017574|75682950|FG001|NOT COMPLETED|Overall Study||0||
59577683|NCT02869295|75682961|FG000|STARTED|Overall Study||4||
59577684|NCT02869295|75682962|FG001|STARTED|Overall Study||11||
59577685|NCT02869295|75682963|FG002|STARTED|Overall Study||6||
59577686|NCT02869295|75682964|FG003|STARTED|Overall Study||6||
59577687|NCT02869295|75682965|FG004|STARTED|Overall Study||1||
59577688|NCT02869295|75682961|FG000|COMPLETED|Overall Study||0||
59577689|NCT02869295|75682962|FG001|COMPLETED|Overall Study||0||
59577690|NCT02869295|75682963|FG002|COMPLETED|Overall Study||0||
59577691|NCT02869295|75682964|FG003|COMPLETED|Overall Study||0||
59577692|NCT02869295|75682965|FG004|COMPLETED|Overall Study||0||
59577693|NCT02869295|75682961|FG000|NOT COMPLETED|Overall Study||4||
59577694|NCT02869295|75682962|FG001|NOT COMPLETED|Overall Study||11||
59577695|NCT02869295|75682963|FG002|NOT COMPLETED|Overall Study||6||
59577696|NCT02869295|75682964|FG003|NOT COMPLETED|Overall Study||6||
59577697|NCT02869295|75682965|FG004|NOT COMPLETED|Overall Study||1||
59577698|NCT02340104|75682977|FG000|STARTED|Overall Study||8||
59577699|NCT02340104|75682977|FG000|COMPLETED|Overall Study||8||
59577700|NCT02340104|75682977|FG000|NOT COMPLETED|Overall Study||0||
59577701|NCT02869451|75682982|FG000|STARTED|Overall Study||5||
59577702|NCT02869451|75682982|FG000|COMPLETED|Overall Study||5||
59577703|NCT02869451|75682982|FG000|NOT COMPLETED|Overall Study||0||
59577704|NCT02340338|75682993|FG000|STARTED|Overall Study|2 vaccine + 1 placebo|2||
59577705|NCT02340338|75682994|FG001|STARTED|Overall Study|2 vaccine + 1 placebo|2||
59577706|NCT02340338|75682995|FG002|STARTED|Overall Study|3 vaccine + 1 placebo|3||
59577707|NCT02340338|75682996|FG003|STARTED|Overall Study|9 vaccine + 3 placebo|9||
59577708|NCT02340338|75682997|FG004|STARTED|Overall Study|9 vaccine + 3 placebo|9||
59577709|NCT02340338|75682998|FG005|STARTED|Overall Study|9 vaccine + 3 placebo|9||
59577710|NCT02340338|75682999|FG006|STARTED|Overall Study|Placebos were randomly assigned to dose groups 1-6, included in the 46 participants.|12||
59577711|NCT02340338|75682993|FG000|COMPLETED|Overall Study||2||
59577712|NCT02340338|75682994|FG001|COMPLETED|Overall Study||2||
59577713|NCT02340338|75682995|FG002|COMPLETED|Overall Study||3||
59577714|NCT02340338|75682996|FG003|COMPLETED|Overall Study||9||
59577715|NCT02340338|75682997|FG004|COMPLETED|Overall Study||9||
59577716|NCT02340338|75682998|FG005|COMPLETED|Overall Study|1 withdrew voluntarily after the first immunization; safety and serum assessment completed.|9||
59577717|NCT02340338|75682999|FG006|COMPLETED|Overall Study||12||
59577718|NCT02340338|75682993|FG000|NOT COMPLETED|Overall Study||0||
59577719|NCT02340338|75682994|FG001|NOT COMPLETED|Overall Study||0||
59721692|NCT01092546|75840547|FG000|STARTED|Overall Study||16||
59577720|NCT02340338|75682995|FG002|NOT COMPLETED|Overall Study||0||
59577721|NCT02340338|75682996|FG003|NOT COMPLETED|Overall Study||0||
59577722|NCT02340338|75682997|FG004|NOT COMPLETED|Overall Study||0||
59577723|NCT02340338|75682998|FG005|NOT COMPLETED|Overall Study||0||
59577724|NCT02340338|75682999|FG006|NOT COMPLETED|Overall Study||0||
59577725|NCT02305316|75683017|FG000|STARTED|Overall Study||14||
59577726|NCT02305316|75683018|FG001|STARTED|Overall Study||14||
59577727|NCT02305316|75683017|FG000|COMPLETED|Overall Study||14||
59577728|NCT02305316|75683018|FG001|COMPLETED|Overall Study||14||
59721693|NCT01092546|75840547|FG000|COMPLETED|Overall Study||12||
59577729|NCT02305316|75683017|FG000|NOT COMPLETED|Overall Study||0||
59577730|NCT02305316|75683018|FG001|NOT COMPLETED|Overall Study||0||
59577731|NCT02944565|75683024|FG000|STARTED|Overall Study||28||
59577732|NCT02944565|75683024|FG000|COMPLETED|Overall Study||28||
59577733|NCT02944565|75683024|FG000|NOT COMPLETED|Overall Study||0||
59577734|NCT02870309|75683029|FG000|STARTED|Overall Study||4||
59577735|NCT02870309|75683029|FG000|COMPLETED|Overall Study||4||
59577736|NCT02870309|75683029|FG000|NOT COMPLETED|Overall Study||0||
59577737|NCT01979276|75683033|FG000|STARTED|Overall Study||2||
59577738|NCT01979276|75683033|FG000|COMPLETED|Overall Study||2|Completion defined as those removed from treatment due to disease progression (per protocol)|
59577739|NCT01979276|75683033|FG000|NOT COMPLETED|Overall Study||0||
59577740|NCT02871011|75683039|FG000|STARTED|Overall Study||7||
59577741|NCT02871011|75683040|FG001|STARTED|Overall Study||13||
59577742|NCT02871011|75683039|FG000|COMPLETED|Overall Study||7||
59577743|NCT02871011|75683040|FG001|COMPLETED|Overall Study||13||
59577744|NCT02871011|75683039|FG000|NOT COMPLETED|Overall Study||0||
59577745|NCT02871011|75683040|FG001|NOT COMPLETED|Overall Study||0||
59577746|NCT02343380|75683048|FG000|STARTED|Overall Study|Morning test (first week)|10||
59577747|NCT02343380|75683049|FG001|STARTED|Overall Study|Evening test (first week)|10||
59577748|NCT02343380|75683048|FG000|COMPLETED|Overall Study|Evening test (second week)|10||
59577749|NCT02343380|75683049|FG001|COMPLETED|Overall Study|Morning test (second week)|10||
59577750|NCT02343380|75683048|FG000|NOT COMPLETED|Overall Study||0||
59577751|NCT02343380|75683049|FG001|NOT COMPLETED|Overall Study||0||
59577752|NCT02871479|75683068|FG000|STARTED|Overall Study||36||
59577753|NCT02871479|75683069|FG001|STARTED|Overall Study||24||
59577754|NCT02871479|75683070|FG002|STARTED|Overall Study||11||
59577755|NCT02871479|75683068|FG000|COMPLETED|Overall Study||33||
59577756|NCT02871479|75683069|FG001|COMPLETED|Overall Study||21||
59577757|NCT02871479|75683070|FG002|COMPLETED|Overall Study||11||
59577758|NCT02871479|75683068|FG000|NOT COMPLETED|Overall Study||3||
59577759|NCT02871479|75683069|FG001|NOT COMPLETED|Overall Study||3||
59577760|NCT02871479|75683070|FG002|NOT COMPLETED|Overall Study||0||
59577761|NCT02344238|75683081|FG000|STARTED|Overall Study||20||
59577762|NCT02344238|75683082|FG001|STARTED|Overall Study||20||
59577763|NCT02344238|75683083|FG002|STARTED|Overall Study||20||
59577764|NCT02344238|75683081|FG000|COMPLETED|Overall Study||20||
59577765|NCT02344238|75683082|FG001|COMPLETED|Overall Study||20||
59577766|NCT02344238|75683083|FG002|COMPLETED|Overall Study||20||
59577767|NCT02344238|75683081|FG000|NOT COMPLETED|Overall Study||0||
59577768|NCT02344238|75683082|FG001|NOT COMPLETED|Overall Study||0||
59577769|NCT02344238|75683083|FG002|NOT COMPLETED|Overall Study||0||
59577770|NCT02344316|75683094|FG000|STARTED|Overall Study||13||
59577771|NCT02344316|75683095|FG001|STARTED|Overall Study||13||
59577772|NCT02344316|75683094|FG000|COMPLETED|Overall Study||12||
59577773|NCT02344316|75683095|FG001|COMPLETED|Overall Study||11||
59577774|NCT02344316|75683094|FG000|NOT COMPLETED|Overall Study||1||
59577775|NCT02344316|75683095|FG001|NOT COMPLETED|Overall Study||2||
59577776|NCT02872103|75683106|FG000|STARTED|Cycle 1||83||
59577777|NCT02872103|75683107|FG001|STARTED|Cycle 1||39||
59577778|NCT02872103|75683106|FG000|COMPLETED|Cycle 1||83||
59577779|NCT02872103|75683107|FG001|COMPLETED|Cycle 1||38||
59577780|NCT02872103|75683106|FG000|NOT COMPLETED|Cycle 1||0||
59577781|NCT02872103|75683107|FG001|NOT COMPLETED|Cycle 1||1||
59721694|NCT01092546|75840547|FG000|NOT COMPLETED|Overall Study||4||
59721695|NCT01197794|75840558|FG000|STARTED|Overall Study||164||
60121358|NCT01687595|76242296|FG001|STARTED|Overall Study||10||
59577782|NCT02872103|75683106|FG000|STARTED|Cycle 2-4||83||
59721696|NCT01197794|75840559|FG001|STARTED|Overall Study|Two participants did not receive study treatment|161||
59577783|NCT02872103|75683107|FG001|STARTED|Cycle 2-4|1 subject withdrawn in Cycle 1|38||
59577784|NCT02872103|75683106|FG000|COMPLETED|Cycle 2-4||81||
59721697|NCT01197794|75840560|FG002|STARTED|Overall Study|Two participants did not receive study treatment|166||
59577785|NCT02872103|75683107|FG001|COMPLETED|Cycle 2-4||37||
59577786|NCT02872103|75683106|FG000|NOT COMPLETED|Cycle 2-4||2||
59577787|NCT02872103|75683107|FG001|NOT COMPLETED|Cycle 2-4||1||
59577788|NCT02344628|75683117|FG000|STARTED|Overall Study||291||
59577789|NCT02344628|75683118|FG001|STARTED|Overall Study||292||
59721698|NCT01197794|75840561|FG003|STARTED|Overall Study||164||
59850327|NCT03583372|75974675|FG002|NOT COMPLETED|Overall Study||19||
59577790|NCT02344628|75683117|FG000|COMPLETED|Overall Study|4/52 clinical data was available for 283. Serological data 6/12 for 212. Both were available for 200|200||
59577791|NCT02344628|75683118|FG001|COMPLETED|Overall Study|4/52 clinical data was available for 286. Serological data 6/12 for 218. Both were available for 206|206||
59577792|NCT02344628|75683117|FG000|NOT COMPLETED|Overall Study||91||
59577793|NCT02344628|75683118|FG001|NOT COMPLETED|Overall Study||86||
59577794|NCT02345486|75683126|FG000|STARTED|Overall Study||454||
59577795|NCT02345486|75683127|FG001|STARTED|Overall Study||520||
59577796|NCT02345486|75683126|FG000|COMPLETED|Overall Study||454||
59577797|NCT02345486|75683127|FG001|COMPLETED|Overall Study||520||
59577798|NCT02345486|75683126|FG000|NOT COMPLETED|Overall Study||0||
59577799|NCT02345486|75683127|FG001|NOT COMPLETED|Overall Study||0||
59577800|NCT02950025|75683135|FG000|STARTED|Overall Study||2||
59577801|NCT02950025|75683136|FG001|STARTED|Overall Study||3||
59577802|NCT02950025|75683135|FG000|COMPLETED|Overall Study||2||
59577803|NCT02950025|75683136|FG001|COMPLETED|Overall Study||3||
59577804|NCT02950025|75683135|FG000|NOT COMPLETED|Overall Study||0||
59577805|NCT02950025|75683136|FG001|NOT COMPLETED|Overall Study||0||
59577806|NCT02873585|75683142|FG000|STARTED|Overall Study||32||217
59577807|NCT02873585|75683142|FG000|COMPLETED|Overall Study||32||217
59577808|NCT02873585|75683142|FG000|NOT COMPLETED|Overall Study||0||0
59577809|NCT02019758|75683152|FG000|STARTED|Overall Study|64 received intervention; 1 did not receive intervention|65||
59577810|NCT02019758|75683153|FG001|STARTED|Overall Study|63 received intervention; 1 did not receive intervention|64||
59577811|NCT02019758|75683152|FG000|Received Intervention|Overall Study||64||
59577812|NCT02019758|75683153|FG001|Received Intervention|Overall Study||63||
59577813|NCT02019758|75683152|FG000|Did Not Receive Intervention|Overall Study||1||
59577814|NCT02019758|75683153|FG001|Did Not Receive Intervention|Overall Study||1||
59577815|NCT02019758|75683152|FG000|Lost to Follow-up|Overall Study|8 were lost to follow-up and did not undergo week 8 endoscopy or other outcome assessments|8||
59577816|NCT02019758|75683153|FG001|Lost to Follow-up|Overall Study|8 were lost to follow-up and did not undergo week 8 endoscopy or other outcome assessments|8||
59577817|NCT02019758|75683152|FG000|COMPLETED|Overall Study||56||
59577818|NCT02019758|75683153|FG001|COMPLETED|Overall Study|8 were lost to follow-up and did not undergo week 8 endoscopy or other outcome assessments|55||
59577819|NCT02019758|75683152|FG000|NOT COMPLETED|Overall Study||9||
59577820|NCT02019758|75683153|FG001|NOT COMPLETED|Overall Study||9||
59577821|NCT02876159|75683161|FG000|STARTED|Overall Study||10||
59577822|NCT02876159|75683162|FG001|STARTED|Overall Study||10||
59577823|NCT02876159|75683161|FG000|COMPLETED|Overall Study||10||
59577824|NCT02876159|75683162|FG001|COMPLETED|Overall Study||10||
59577825|NCT02876159|75683161|FG000|NOT COMPLETED|Overall Study||0||
59577826|NCT02876159|75683162|FG001|NOT COMPLETED|Overall Study||0||
59577827|NCT02020304|75683173|FG000|STARTED|Overall Study||30||
59577828|NCT02020304|75683174|FG001|STARTED|Overall Study||28||
59577829|NCT02020304|75683173|FG000|COMPLETED|Overall Study||27||
59577830|NCT02020304|75683174|FG001|COMPLETED|Overall Study||26||
59577831|NCT02020304|75683173|FG000|NOT COMPLETED|Overall Study||3||
59577832|NCT02020304|75683174|FG001|NOT COMPLETED|Overall Study||2||
59577833|NCT01980589|75683183|FG000|STARTED|Overall Study||3||
59577834|NCT01980589|75683184|FG001|STARTED|Overall Study||3||
59577835|NCT01980589|75683185|FG002|STARTED|Overall Study||16||
59577836|NCT01980589|75683183|FG000|COMPLETED|Overall Study||3||
59577837|NCT01980589|75683184|FG001|COMPLETED|Overall Study||3||
59577838|NCT01980589|75683185|FG002|COMPLETED|Overall Study||16||
59577839|NCT01980589|75683183|FG000|NOT COMPLETED|Overall Study||0||
59577840|NCT01980589|75683184|FG001|NOT COMPLETED|Overall Study||0||
59577841|NCT01980589|75683185|FG002|NOT COMPLETED|Overall Study||0||
59577842|NCT02021942|75683193|FG000|STARTED|Overall Study||16||
59577843|NCT02021942|75683193|FG000|COMPLETED|Overall Study||16||
59577844|NCT02021942|75683193|FG000|NOT COMPLETED|Overall Study||0||
59577845|NCT01981057|75683199|FG000|STARTED|Overall Study||50||
60121359|NCT01687595|76242295|FG000|Received at Least 1 Dose of Study Drug|Overall Study||70||
60121360|NCT01687595|76242296|FG001|Received at Least 1 Dose of Study Drug|Overall Study||10||
59577846|NCT01981057|75683200|FG001|STARTED|Overall Study||50||
59577847|NCT01981057|75683199|FG000|COMPLETED|Overall Study||50||
59577848|NCT01981057|75683200|FG001|COMPLETED|Overall Study||50||
59577849|NCT01981057|75683199|FG000|NOT COMPLETED|Overall Study||0||
59577850|NCT01981057|75683200|FG001|NOT COMPLETED|Overall Study||0||
59577851|NCT02022020|75683206|FG000|STARTED|Overall Study||220||
59577852|NCT02022020|75683206|FG000|COMPLETED|Overall Study||220||
60121361|NCT01687595|76242295|FG000|COMPLETED|Overall Study||0||
60121362|NCT01687595|76242296|FG001|COMPLETED|Overall Study||0||
59577853|NCT02022020|75683206|FG000|NOT COMPLETED|Overall Study||0||
59577854|NCT02345642|75683212|FG000|STARTED|Overall Study||10||
59577855|NCT02345642|75683213|FG001|STARTED|Overall Study||10||
59577856|NCT02345642|75683212|FG000|COMPLETED|Overall Study||10||
59577857|NCT02345642|75683213|FG001|COMPLETED|Overall Study||10||
59577858|NCT02345642|75683212|FG000|NOT COMPLETED|Overall Study||0||
59577859|NCT02345642|75683213|FG001|NOT COMPLETED|Overall Study||0||
59577860|NCT02345720|75683219|FG000|STARTED|Overall Study||20||
59577861|NCT02345720|75683219|FG000|COMPLETED|Overall Study||20||
59577862|NCT02345720|75683219|FG000|NOT COMPLETED|Overall Study||0||
59577863|NCT01981759|75683225|FG000|STARTED|Overall Study||28|Screened|
59577864|NCT01981759|75683226|FG001|STARTED|Overall Study||30|Screened|
59577865|NCT01981759|75683225|FG000|Baseline (Week 1)|Overall Study||28||
59577866|NCT01981759|75683226|FG001|Baseline (Week 1)|Overall Study||30||
59577867|NCT01981759|75683225|FG000|Randomization (Week 3)|Overall Study||28||
59577868|NCT01981759|75683226|FG001|Randomization (Week 3)|Overall Study||30||
59577869|NCT01981759|75683225|FG000|Completed Week 12|Overall Study||22||
59577870|NCT01981759|75683226|FG001|Completed Week 12|Overall Study||22||
59577871|NCT01981759|75683225|FG000|COMPLETED|Overall Study||21|Week 36/All Follow-Up|
59577872|NCT01981759|75683226|FG001|COMPLETED|Overall Study||19|Week 36/All Follow-Up|
59577873|NCT01981759|75683225|FG000|NOT COMPLETED|Overall Study||7||
59577874|NCT01981759|75683226|FG001|NOT COMPLETED|Overall Study||11||
59577875|NCT01980524|75683232|FG000|STARTED|Study Day 1||4||
59577876|NCT01980524|75683233|FG001|STARTED|Study Day 1||4||
59577877|NCT01980524|75683232|FG000|COMPLETED|Study Day 1||4||
59577878|NCT01980524|75683233|FG001|COMPLETED|Study Day 1||4||
59577879|NCT01980524|75683232|FG000|NOT COMPLETED|Study Day 1||0||
59577880|NCT01980524|75683233|FG001|NOT COMPLETED|Study Day 1||0||
59577881|NCT01980524|75683232|FG000|STARTED|Washout (at Least 2 Weeks)||4||
59577882|NCT01980524|75683233|FG001|STARTED|Washout (at Least 2 Weeks)||4||
59577883|NCT01980524|75683232|FG000|COMPLETED|Washout (at Least 2 Weeks)||4||
59577884|NCT01980524|75683233|FG001|COMPLETED|Washout (at Least 2 Weeks)||4||
59577885|NCT01980524|75683232|FG000|NOT COMPLETED|Washout (at Least 2 Weeks)||0||
59577886|NCT01980524|75683233|FG001|NOT COMPLETED|Washout (at Least 2 Weeks)||0||
59577887|NCT01980524|75683232|FG000|STARTED|Study Day 2||4||
59577888|NCT01980524|75683233|FG001|STARTED|Study Day 2||4||
59577889|NCT01980524|75683232|FG000|COMPLETED|Study Day 2||4||
59577890|NCT01980524|75683233|FG001|COMPLETED|Study Day 2||4||
59577891|NCT01980524|75683232|FG000|NOT COMPLETED|Study Day 2||0||
59577892|NCT01980524|75683233|FG001|NOT COMPLETED|Study Day 2||0||
59577893|NCT01982539|75683239|FG000|STARTED|Overall Study||25||
59577894|NCT01982539|75683239|FG000|COMPLETED|Overall Study||25||
59577895|NCT01982539|75683239|FG000|NOT COMPLETED|Overall Study||0||
59577896|NCT01980914|75683243|FG000|STARTED|Overall Study||11||
59577897|NCT01980914|75683243|FG000|COMPLETED|Overall Study||11||
59577898|NCT01980914|75683243|FG000|NOT COMPLETED|Overall Study||0||
59577899|NCT01982695|75683250|FG000|STARTED|Overall Study||12||
59577900|NCT01982695|75683251|FG001|STARTED|Overall Study||11||
59577901|NCT01982695|75683250|FG000|COMPLETED|Overall Study||12||
59577902|NCT01982695|75683251|FG001|COMPLETED|Overall Study||10||
59577903|NCT01982695|75683250|FG000|NOT COMPLETED|Overall Study||0||
59577904|NCT01982695|75683251|FG001|NOT COMPLETED|Overall Study||1||
59577905|NCT02347124|75683259|FG000|STARTED|Overall Study||360||
59577906|NCT02347124|75683260|FG001|STARTED|Overall Study||358||
59577907|NCT02347124|75683259|FG000|2 Month Follow-up|Overall Study||298||
59577908|NCT02347124|75683260|FG001|2 Month Follow-up|Overall Study||275||
59577909|NCT02347124|75683259|FG000|COMPLETED|Overall Study||267||
59577910|NCT02347124|75683260|FG001|COMPLETED|Overall Study||259||
59577911|NCT02347124|75683259|FG000|NOT COMPLETED|Overall Study||93||
59577912|NCT02347124|75683260|FG001|NOT COMPLETED|Overall Study||99||
59577913|NCT01983787|75683266|FG000|STARTED|Overall Study||10||
59577914|NCT01983787|75683266|FG000|COMPLETED|Overall Study||10||
59577915|NCT01983787|75683266|FG000|NOT COMPLETED|Overall Study||0||
59577916|NCT01981772|75683291|FG000|STARTED|Overall Study||45||
59577917|NCT01981772|75683292|FG001|STARTED|Overall Study||43||
59577918|NCT01981772|75683291|FG000|COMPLETED|Overall Study||45||
59577919|NCT01981772|75683292|FG001|COMPLETED|Overall Study||43||
59577920|NCT01981772|75683291|FG000|NOT COMPLETED|Overall Study||0||
59577921|NCT01981772|75683292|FG001|NOT COMPLETED|Overall Study||0||
59577922|NCT01982240|75683301|FG000|STARTED|Overall Study||452||
59577923|NCT01982240|75683302|FG001|STARTED|Overall Study||453||
59577924|NCT01982240|75683303|FG002|STARTED|Overall Study||441||
59577925|NCT01982240|75683301|FG000|COMPLETED|Overall Study||385||
59577926|NCT01982240|75683302|FG001|COMPLETED|Overall Study||384||
59577927|NCT01982240|75683303|FG002|COMPLETED|Overall Study||371||
59577928|NCT01982240|75683301|FG000|NOT COMPLETED|Overall Study||67||
59577929|NCT01982240|75683302|FG001|NOT COMPLETED|Overall Study||69||
59850328|NCT03583372|75974676|FG003|NOT COMPLETED|Overall Study||18||
59577930|NCT01982240|75683303|FG002|NOT COMPLETED|Overall Study||70||
59577931|NCT02029495|75683318|FG000|STARTED|Overall Study||159||
59577932|NCT02029495|75683319|FG001|STARTED|Overall Study||158||
59577933|NCT02029495|75683320|FG002|STARTED|Overall Study||161||
59577934|NCT02029495|75683318|FG000|COMPLETED|Overall Study||158||
59577935|NCT02029495|75683319|FG001|COMPLETED|Overall Study||158||
59577936|NCT02029495|75683320|FG002|COMPLETED|Overall Study||159||
59577937|NCT02029495|75683318|FG000|NOT COMPLETED|Overall Study||1||
59577938|NCT02029495|75683319|FG001|NOT COMPLETED|Overall Study||0||
59577939|NCT02029495|75683320|FG002|NOT COMPLETED|Overall Study||2||
59577940|NCT02348606|75683333|FG000|STARTED|Overall Study||58||
59577941|NCT02348606|75683334|FG001|STARTED|Overall Study||62||
59577942|NCT02348606|75683335|FG002|STARTED|Overall Study||117||
59577943|NCT02348606|75683336|FG003|STARTED|Overall Study||118||
59577944|NCT02348606|75683337|FG004|STARTED|Overall Study||119||
59577945|NCT02348606|75683333|FG000|COMPLETED|Overall Study||49||
59577946|NCT02348606|75683334|FG001|COMPLETED|Overall Study||54||
59577947|NCT02348606|75683335|FG002|COMPLETED|Overall Study||106||
59577948|NCT02348606|75683336|FG003|COMPLETED|Overall Study||94||
59577949|NCT02348606|75683337|FG004|COMPLETED|Overall Study||101||
59577950|NCT02348606|75683333|FG000|NOT COMPLETED|Overall Study||9||
59577951|NCT02348606|75683334|FG001|NOT COMPLETED|Overall Study||8||
59577952|NCT02348606|75683335|FG002|NOT COMPLETED|Overall Study||11||
59577953|NCT02348606|75683336|FG003|NOT COMPLETED|Overall Study||24||
59577954|NCT02348606|75683337|FG004|NOT COMPLETED|Overall Study||18||
59577955|NCT02348684|75683349|FG000|STARTED|Overall Study||20||
59577956|NCT02348684|75683349|FG000|COMPLETED|Overall Study||20||
59577957|NCT02348684|75683349|FG000|NOT COMPLETED|Overall Study||0||
59577958|NCT02312713|75683356|FG000|STARTED|Overall Study||140||
59577959|NCT02312713|75683357|FG001|STARTED|Overall Study||142||
59577960|NCT02312713|75683358|FG002|STARTED|Overall Study||68||
59577961|NCT02312713|75683356|FG000|COMPLETED|Overall Study||129||
59577962|NCT02312713|75683357|FG001|COMPLETED|Overall Study||112||
59577963|NCT02312713|75683358|FG002|COMPLETED|Overall Study||63||
59577964|NCT02312713|75683356|FG000|NOT COMPLETED|Overall Study||11||
59577965|NCT02312713|75683357|FG001|NOT COMPLETED|Overall Study||30||
59577966|NCT02312713|75683358|FG002|NOT COMPLETED|Overall Study||5||
59577967|NCT02033083|75683368|FG000|STARTED|Overall Study||90||
59577968|NCT02033083|75683369|FG001|STARTED|Overall Study||90||
59577969|NCT02033083|75683368|FG000|COMPLETED|Overall Study||89||
59577970|NCT02033083|75683369|FG001|COMPLETED|Overall Study||89||
59577971|NCT02033083|75683368|FG000|NOT COMPLETED|Overall Study||1||
59577972|NCT02033083|75683369|FG001|NOT COMPLETED|Overall Study||1||
59577973|NCT01985425|75683377|FG000|STARTED|Overall Study||49||
59577974|NCT01985425|75683378|FG001|STARTED|Overall Study||51||
59577975|NCT01985425|75683377|FG000|COMPLETED|Overall Study||49||
59577976|NCT01985425|75683378|FG001|COMPLETED|Overall Study||51||
59577977|NCT01985425|75683377|FG000|NOT COMPLETED|Overall Study||0||
59577978|NCT01985425|75683378|FG001|NOT COMPLETED|Overall Study||0||
59577979|NCT02348918|75683393|FG000|STARTED|Overall Study||39||
59577980|NCT02348918|75683394|FG001|STARTED|Overall Study||33||
59577981|NCT02348918|75683395|FG002|STARTED|Overall Study||42||
59577982|NCT02348918|75683396|FG003|STARTED|Overall Study||24||
59577983|NCT02348918|75683397|FG004|STARTED|Overall Study||19||
59577984|NCT02348918|75683398|FG005|STARTED|Overall Study||17||
59577985|NCT02348918|75683399|FG006|STARTED|Overall Study||13||
59577986|NCT02348918|75683400|FG007|STARTED|Overall Study||16||
59577987|NCT02348918|75683401|FG008|STARTED|Overall Study||15||
59577988|NCT02348918|75683393|FG000|COMPLETED|Overall Study||39||
59577989|NCT02348918|75683394|FG001|COMPLETED|Overall Study||33||
59577990|NCT02348918|75683395|FG002|COMPLETED|Overall Study||42||
59577991|NCT02348918|75683396|FG003|COMPLETED|Overall Study||24||
59577992|NCT02348918|75683397|FG004|COMPLETED|Overall Study||19||
59577993|NCT02348918|75683398|FG005|COMPLETED|Overall Study||17||
59577994|NCT02348918|75683399|FG006|COMPLETED|Overall Study||13||
59577995|NCT02348918|75683400|FG007|COMPLETED|Overall Study||16||
59577996|NCT02348918|75683401|FG008|COMPLETED|Overall Study||15||
59577997|NCT02348918|75683393|FG000|NOT COMPLETED|Overall Study||0||
59577998|NCT02348918|75683394|FG001|NOT COMPLETED|Overall Study||0||
59577999|NCT02348918|75683395|FG002|NOT COMPLETED|Overall Study||0||
59578000|NCT02348918|75683396|FG003|NOT COMPLETED|Overall Study||0||
59578001|NCT02348918|75683397|FG004|NOT COMPLETED|Overall Study||0||
59578002|NCT02348918|75683398|FG005|NOT COMPLETED|Overall Study||0||
59578003|NCT02348918|75683399|FG006|NOT COMPLETED|Overall Study||0||
59578004|NCT02348918|75683400|FG007|NOT COMPLETED|Overall Study||0||
59578005|NCT02348918|75683401|FG008|NOT COMPLETED|Overall Study||0||
59578006|NCT01985581|75683423|FG000|STARTED|First Intervention||25||
59578007|NCT01985581|75683424|FG001|STARTED|First Intervention||25||
59578008|NCT01985581|75683423|FG000|COMPLETED|First Intervention||22||
59578009|NCT01985581|75683424|FG001|COMPLETED|First Intervention||23||
59578010|NCT01985581|75683423|FG000|NOT COMPLETED|First Intervention||3||
59578011|NCT01985581|75683424|FG001|NOT COMPLETED|First Intervention||2||
59578012|NCT01985581|75683423|FG000|STARTED|Second Intervention||22||
59578013|NCT01985581|75683424|FG001|STARTED|Second Intervention||23||
59578014|NCT01985581|75683423|FG000|COMPLETED|Second Intervention||20||
59578015|NCT01985581|75683424|FG001|COMPLETED|Second Intervention||19||
59578016|NCT01985581|75683423|FG000|NOT COMPLETED|Second Intervention||2||
59578017|NCT01985581|75683424|FG001|NOT COMPLETED|Second Intervention||4||
59578018|NCT02024204|75683443|FG000|STARTED|Overall Study||49||
59578019|NCT02024204|75683444|FG001|STARTED|Overall Study||11||
59578020|NCT02024204|75683443|FG000|COMPLETED|Overall Study||49||
59578021|NCT02024204|75683444|FG001|COMPLETED|Overall Study||11||
59578022|NCT02024204|75683443|FG000|NOT COMPLETED|Overall Study||0||
59578023|NCT02024204|75683444|FG001|NOT COMPLETED|Overall Study||0||
59578024|NCT03019055|75683454|FG000|STARTED|Overall Study||0||
59578025|NCT03019055|75683455|FG001|STARTED|Overall Study||3||
59578026|NCT03019055|75683456|FG002|STARTED|Overall Study||3||
59578027|NCT03019055|75683457|FG003|STARTED|Overall Study||20||
59578028|NCT03019055|75683454|FG000|COMPLETED|Overall Study||0||
59578029|NCT03019055|75683455|FG001|COMPLETED|Overall Study||3||
59578030|NCT03019055|75683456|FG002|COMPLETED|Overall Study||3||
59578031|NCT03019055|75683457|FG003|COMPLETED|Overall Study||20||
59578032|NCT03019055|75683454|FG000|NOT COMPLETED|Overall Study||0||
59578033|NCT03019055|75683455|FG001|NOT COMPLETED|Overall Study||0||
59578034|NCT03019055|75683456|FG002|NOT COMPLETED|Overall Study||0||
59578035|NCT03019055|75683457|FG003|NOT COMPLETED|Overall Study||0||
59578036|NCT03930745|75683469|FG000|STARTED|Overall Study||40||
59578037|NCT03930745|75683470|FG001|STARTED|Overall Study||41||
59578038|NCT03930745|75683469|FG000|COMPLETED|Overall Study||24||
59578039|NCT03930745|75683470|FG001|COMPLETED|Overall Study||25||
59578040|NCT03930745|75683469|FG000|NOT COMPLETED|Overall Study||16||
59578041|NCT03930745|75683470|FG001|NOT COMPLETED|Overall Study||16||
59578042|NCT02033317|75683476|FG000|STARTED|Overall Study||6||
59578043|NCT02033317|75683476|FG000|COMPLETED|Overall Study||6||
59578044|NCT02033317|75683476|FG000|NOT COMPLETED|Overall Study||0||
59578045|NCT02034019|75683482|FG000|STARTED|Overall Study||164||
59578046|NCT02034019|75683483|FG001|STARTED|Overall Study||83||
59578047|NCT02034019|75683482|FG000|COMPLETED|Overall Study||163||
59578048|NCT02034019|75683483|FG001|COMPLETED|Overall Study||81||
59578049|NCT02034019|75683482|FG000|NOT COMPLETED|Overall Study||1||
59578050|NCT02034019|75683483|FG001|NOT COMPLETED|Overall Study||2||
59578051|NCT02349152|75683491|FG000|STARTED|Overall Study||60||
59578052|NCT02349152|75683492|FG001|STARTED|Overall Study||56||
59578053|NCT02349152|75683491|FG000|COMPLETED|Overall Study||54||
59578054|NCT02349152|75683492|FG001|COMPLETED|Overall Study||52||
59578055|NCT02349152|75683491|FG000|NOT COMPLETED|Overall Study||6||
59578056|NCT02349152|75683492|FG001|NOT COMPLETED|Overall Study||4||
59578057|NCT02034175|75683498|FG000|STARTED|Overall Study||190||
59578058|NCT02034175|75683498|FG000|COMPLETED|Overall Study||190||
59578059|NCT02034175|75683498|FG000|NOT COMPLETED|Overall Study||0||
59578060|NCT02035345|75683502|FG000|STARTED|Overall Study||15||
59578061|NCT02035345|75683502|FG000|COMPLETED|Overall Study||15||
59578062|NCT02035345|75683502|FG000|NOT COMPLETED|Overall Study||0||
59578063|NCT01985971|75683507|FG000|STARTED|Overall Study||2||
59578064|NCT01985971|75683507|FG000|COMPLETED|Overall Study||1||
59578065|NCT01985971|75683507|FG000|NOT COMPLETED|Overall Study||1||
59578066|NCT01986361|75683513|FG000|STARTED|Overall Study||101||
59578067|NCT01986361|75683514|FG001|STARTED|Overall Study||21||
59578068|NCT01986361|75683513|FG000|COMPLETED|Overall Study||101||
59578069|NCT01986361|75683514|FG001|COMPLETED|Overall Study||21||
59578070|NCT01986361|75683513|FG000|NOT COMPLETED|Overall Study||0||
59578071|NCT01986361|75683514|FG001|NOT COMPLETED|Overall Study||0||
59578072|NCT01983020|75683524|FG000|STARTED|Overall Study||12||
59578073|NCT01983020|75683525|FG001|STARTED|Overall Study||11||
59578074|NCT01983020|75683526|FG002|STARTED|Overall Study||12||
59578075|NCT01983020|75683527|FG003|STARTED|Overall Study||11||
59578076|NCT01983020|75683524|FG000|COMPLETED|Overall Study||12||
59578077|NCT01983020|75683525|FG001|COMPLETED|Overall Study||11||
59578078|NCT01983020|75683526|FG002|COMPLETED|Overall Study||12||
59578079|NCT01983020|75683527|FG003|COMPLETED|Overall Study||11||
59578080|NCT01983020|75683524|FG000|NOT COMPLETED|Overall Study||0||
59578081|NCT01983020|75683525|FG001|NOT COMPLETED|Overall Study||0||
59578082|NCT01983020|75683526|FG002|NOT COMPLETED|Overall Study||0||
59578083|NCT01983020|75683527|FG003|NOT COMPLETED|Overall Study||0||
59578084|NCT02058511|75683537|FG000|STARTED|Overall Study||24||
59578085|NCT02058511|75683537|FG000|COMPLETED|Overall Study||24||
59578086|NCT02058511|75683537|FG000|NOT COMPLETED|Overall Study||0||
59578087|NCT01983566|75683545|FG000|STARTED|Test Period 1||4||
59578088|NCT01983566|75683546|FG001|STARTED|Test Period 1||4||
59578089|NCT01983566|75683547|FG002|STARTED|Test Period 1||4||
59578090|NCT01983566|75683548|FG003|STARTED|Test Period 1||4||
59578091|NCT01983566|75683545|FG000|COMPLETED|Test Period 1||4||
59578092|NCT01983566|75683546|FG001|COMPLETED|Test Period 1||4||
59578093|NCT01983566|75683547|FG002|COMPLETED|Test Period 1||4||
59578094|NCT01983566|75683548|FG003|COMPLETED|Test Period 1||4||
59578095|NCT01983566|75683545|FG000|NOT COMPLETED|Test Period 1||0||
59578096|NCT01983566|75683546|FG001|NOT COMPLETED|Test Period 1||0||
59578097|NCT01983566|75683547|FG002|NOT COMPLETED|Test Period 1||0||
59578098|NCT01983566|75683548|FG003|NOT COMPLETED|Test Period 1||0||
59578099|NCT01983566|75683545|FG000|STARTED|Wash-Out 1||4||
59578100|NCT01983566|75683546|FG001|STARTED|Wash-Out 1||4||
59578101|NCT01983566|75683547|FG002|STARTED|Wash-Out 1||4||
59578102|NCT01983566|75683548|FG003|STARTED|Wash-Out 1||4||
59578103|NCT01983566|75683545|FG000|COMPLETED|Wash-Out 1||4||
59578104|NCT01983566|75683546|FG001|COMPLETED|Wash-Out 1||4||
59578105|NCT01983566|75683547|FG002|COMPLETED|Wash-Out 1||4||
59578106|NCT01983566|75683548|FG003|COMPLETED|Wash-Out 1||4||
59578107|NCT01983566|75683545|FG000|NOT COMPLETED|Wash-Out 1||0||
59578108|NCT01983566|75683546|FG001|NOT COMPLETED|Wash-Out 1||0||
59578109|NCT01983566|75683547|FG002|NOT COMPLETED|Wash-Out 1||0||
59578110|NCT01983566|75683548|FG003|NOT COMPLETED|Wash-Out 1||0||
59578111|NCT01983566|75683545|FG000|STARTED|Test Period 2||4||
59578112|NCT01983566|75683546|FG001|STARTED|Test Period 2||4||
59578113|NCT01983566|75683547|FG002|STARTED|Test Period 2||4||
59578114|NCT01983566|75683548|FG003|STARTED|Test Period 2||4||
59578115|NCT01983566|75683545|FG000|COMPLETED|Test Period 2||4||
59578116|NCT01983566|75683546|FG001|COMPLETED|Test Period 2||4||
59578117|NCT01983566|75683547|FG002|COMPLETED|Test Period 2||4||
59578118|NCT01983566|75683548|FG003|COMPLETED|Test Period 2||4||
59578119|NCT01983566|75683545|FG000|NOT COMPLETED|Test Period 2||0||
59578120|NCT01983566|75683546|FG001|NOT COMPLETED|Test Period 2||0||
59578121|NCT01983566|75683547|FG002|NOT COMPLETED|Test Period 2||0||
59578122|NCT01983566|75683548|FG003|NOT COMPLETED|Test Period 2||0||
59578123|NCT01983566|75683545|FG000|STARTED|Wash-Out 2|Subjects starting may not equal number completing the previous period due to early study termination|2||
59578124|NCT01983566|75683546|FG001|STARTED|Wash-Out 2|Subjects starting may not equal number completing the previous period due to early study termination|3||
59578125|NCT01983566|75683547|FG002|STARTED|Wash-Out 2|Subjects starting may not equal number completing the previous period due to early study termination|2||
59578126|NCT01983566|75683548|FG003|STARTED|Wash-Out 2||4||
59578127|NCT01983566|75683545|FG000|COMPLETED|Wash-Out 2||2||
59578128|NCT01983566|75683546|FG001|COMPLETED|Wash-Out 2||3||
59578129|NCT01983566|75683547|FG002|COMPLETED|Wash-Out 2||2||
59578130|NCT01983566|75683548|FG003|COMPLETED|Wash-Out 2||4||
59578131|NCT01983566|75683545|FG000|NOT COMPLETED|Wash-Out 2||0||
59578132|NCT01983566|75683546|FG001|NOT COMPLETED|Wash-Out 2||0||
59578133|NCT01983566|75683547|FG002|NOT COMPLETED|Wash-Out 2||0||
59578134|NCT01983566|75683548|FG003|NOT COMPLETED|Wash-Out 2||0||
59578135|NCT01983566|75683545|FG000|STARTED|Test Period 3||2||
59578136|NCT01983566|75683546|FG001|STARTED|Test Period 3||3||
59578137|NCT01983566|75683547|FG002|STARTED|Test Period 3||2||
59578138|NCT01983566|75683548|FG003|STARTED|Test Period 3||4||
59578139|NCT01983566|75683545|FG000|COMPLETED|Test Period 3||2||
59578140|NCT01983566|75683546|FG001|COMPLETED|Test Period 3||3||
59578141|NCT01983566|75683547|FG002|COMPLETED|Test Period 3||2||
59578142|NCT01983566|75683548|FG003|COMPLETED|Test Period 3||4||
59578143|NCT01983566|75683545|FG000|NOT COMPLETED|Test Period 3||0||
59578144|NCT01983566|75683546|FG001|NOT COMPLETED|Test Period 3||0||
59578145|NCT01983566|75683547|FG002|NOT COMPLETED|Test Period 3||0||
59578146|NCT01983566|75683548|FG003|NOT COMPLETED|Test Period 3||0||
59578147|NCT01983566|75683545|FG000|STARTED|Wash-Out 3|Subjects starting may not equal number completing the previous period due to early study termination|0||
59578148|NCT01983566|75683546|FG001|STARTED|Wash-Out 3|Subjects starting may not equal number completing the previous period due to early study termination|0||
59578149|NCT01983566|75683547|FG002|STARTED|Wash-Out 3|Subjects starting may not equal number completing the previous period due to early study termination|0||
59578150|NCT01983566|75683548|FG003|STARTED|Wash-Out 3|Subjects starting may not equal number completing the previous period due to early study termination|0||
59578151|NCT01983566|75683545|FG000|COMPLETED|Wash-Out 3||0||
59578152|NCT01983566|75683546|FG001|COMPLETED|Wash-Out 3||0||
59578153|NCT01983566|75683547|FG002|COMPLETED|Wash-Out 3||0||
59578154|NCT01983566|75683548|FG003|COMPLETED|Wash-Out 3||0||
59578155|NCT01983566|75683545|FG000|NOT COMPLETED|Wash-Out 3||0||
59578156|NCT01983566|75683546|FG001|NOT COMPLETED|Wash-Out 3||0||
59578157|NCT01983566|75683547|FG002|NOT COMPLETED|Wash-Out 3||0||
59578158|NCT01983566|75683548|FG003|NOT COMPLETED|Wash-Out 3||0||
59578159|NCT01983566|75683545|FG000|STARTED|Test Period 4||0||
59578160|NCT01983566|75683546|FG001|STARTED|Test Period 4||0||
59578161|NCT01983566|75683547|FG002|STARTED|Test Period 4||0||
59578162|NCT01983566|75683548|FG003|STARTED|Test Period 4||0||
59578163|NCT01983566|75683545|FG000|COMPLETED|Test Period 4||0||
59578164|NCT01983566|75683546|FG001|COMPLETED|Test Period 4||0||
59578165|NCT01983566|75683547|FG002|COMPLETED|Test Period 4||0||
59578166|NCT01983566|75683548|FG003|COMPLETED|Test Period 4||0||
59578167|NCT01983566|75683545|FG000|NOT COMPLETED|Test Period 4||0||
59578168|NCT01983566|75683546|FG001|NOT COMPLETED|Test Period 4||0||
59578169|NCT01983566|75683547|FG002|NOT COMPLETED|Test Period 4||0||
59578170|NCT01983566|75683548|FG003|NOT COMPLETED|Test Period 4||0||
59578171|NCT02059057|75683559|FG000|STARTED|Overall Study||102||
59578172|NCT02059057|75683559|FG000|COMPLETED|Overall Study||87||
59578173|NCT02059057|75683559|FG000|NOT COMPLETED|Overall Study||15||
59578174|NCT01983878|75683564|FG000|STARTED|Overall Study||36||
59578175|NCT01983878|75683564|FG000|Received At Least One Dose of Study Drug|Overall Study||36||
59578176|NCT01983878|75683564|FG000|COMPLETED|Overall Study||36||
59578177|NCT01983878|75683564|FG000|NOT COMPLETED|Overall Study||0||
59578178|NCT01986686|75683571|FG000|STARTED|Overall Study||81||
59578179|NCT01986686|75683572|FG001|STARTED|Overall Study||26||
59578180|NCT01986686|75683571|FG000|COMPLETED|Overall Study||81||
59578181|NCT01986686|75683572|FG001|COMPLETED|Overall Study||26||
59578182|NCT01986686|75683571|FG000|NOT COMPLETED|Overall Study||0||
59578183|NCT01986686|75683572|FG001|NOT COMPLETED|Overall Study||0||
59578184|NCT02351258|75683578|FG000|STARTED|Intervention 1 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|||7
59578185|NCT02351258|75683579|FG001|STARTED|Intervention 1 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|||9
59578186|NCT02351258|75683578|FG000|COMPLETED|Intervention 1 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|||7
59578187|NCT02351258|75683579|FG001|COMPLETED|Intervention 1 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|||9
59578188|NCT02351258|75683578|FG000|NOT COMPLETED|Intervention 1 (12 Months)||||0
59578189|NCT02351258|75683579|FG001|NOT COMPLETED|Intervention 1 (12 Months)||||0
59578190|NCT02351258|75683578|FG000|STARTED|Washout (2-3 Months)|Number of participants is not available for this study, only clinic-level data collected.|||7
59578191|NCT02351258|75683579|FG001|STARTED|Washout (2-3 Months)|Number of participants is not available for this study, only clinic-level data collected.|||9
59578192|NCT02351258|75683578|FG000|COMPLETED|Washout (2-3 Months)|Number of participants is not available for this study, only clinic-level data collected.|||7
59578193|NCT02351258|75683579|FG001|COMPLETED|Washout (2-3 Months)|Number of participants is not available for this study, only clinic-level data collected.|||9
59578194|NCT02351258|75683578|FG000|NOT COMPLETED|Washout (2-3 Months)||||0
59578195|NCT02351258|75683579|FG001|NOT COMPLETED|Washout (2-3 Months)||||0
59578196|NCT02351258|75683578|FG000|STARTED|Intervention 2 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|||7
59578197|NCT02351258|75683579|FG001|STARTED|Intervention 2 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|||9
59578198|NCT02351258|75683578|FG000|COMPLETED|Intervention 2 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|||7
59578199|NCT02351258|75683579|FG001|COMPLETED|Intervention 2 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|||9
59578200|NCT02351258|75683578|FG000|NOT COMPLETED|Intervention 2 (12 Months)||||0
59578201|NCT02351258|75683579|FG001|NOT COMPLETED|Intervention 2 (12 Months)||||0
59578202|NCT02029040|75683586|FG000|STARTED|Overall Study||27||
59578203|NCT02029040|75683587|FG001|STARTED|Overall Study||25||
59578204|NCT02029040|75683586|FG000|COMPLETED|Overall Study||27||
59578205|NCT02029040|75683587|FG001|COMPLETED|Overall Study||25||
59578206|NCT02029040|75683586|FG000|NOT COMPLETED|Overall Study||0||
59578207|NCT02029040|75683587|FG001|NOT COMPLETED|Overall Study||0||
59578208|NCT02029196|75683595|FG000|STARTED|Overall Study||306||
59578209|NCT02029196|75683596|FG001|STARTED|Overall Study||102||
59578210|NCT02029196|75683595|FG000|COMPLETED|Overall Study||286||
59578211|NCT02029196|75683596|FG001|COMPLETED|Overall Study||101||
59578212|NCT02029196|75683595|FG000|NOT COMPLETED|Overall Study||20||
59578213|NCT02029196|75683596|FG001|NOT COMPLETED|Overall Study||1||
59578214|NCT02396732|75683604|FG000|STARTED|Overall Study||14||
59578215|NCT02396732|75683605|FG001|STARTED|Overall Study||17||
59578216|NCT02396732|75683604|FG000|COMPLETED|Overall Study||14||
59578217|NCT02396732|75683605|FG001|COMPLETED|Overall Study||17||
59578218|NCT02396732|75683604|FG000|NOT COMPLETED|Overall Study||0||
59578219|NCT02396732|75683605|FG001|NOT COMPLETED|Overall Study||0||
59578220|NCT02030288|75683613|FG000|STARTED|Overall Study||89||
59578221|NCT02030288|75683614|FG001|STARTED|Overall Study||89||
59578222|NCT02030288|75683613|FG000|COMPLETED|Overall Study||89||
59578223|NCT02030288|75683614|FG001|COMPLETED|Overall Study||89||
59578224|NCT02030288|75683613|FG000|NOT COMPLETED|Overall Study||0||
59578225|NCT02030288|75683614|FG001|NOT COMPLETED|Overall Study||0||
59578226|NCT02031770|75683624|FG000|STARTED|Overall Study||10||
59850329|NCT03582826|75974688|FG000|STARTED|Overall Study||119||
59850330|NCT03582826|75974689|FG001|STARTED|Overall Study||6||
59578227|NCT02031770|75683625|FG001|STARTED|Overall Study||10||
59578228|NCT02031770|75683624|FG000|COMPLETED|Overall Study||9||
59578229|NCT02031770|75683625|FG001|COMPLETED|Overall Study||9||
59578230|NCT02031770|75683624|FG000|NOT COMPLETED|Overall Study||1||
59578231|NCT02031770|75683625|FG001|NOT COMPLETED|Overall Study||1||
59578232|NCT02032550|75683633|FG000|STARTED|Overall Study||371||
59578233|NCT02032550|75683634|FG001|STARTED|Overall Study||372||
59578234|NCT02032550|75683633|FG000|COMPLETED|Overall Study||343||
59578235|NCT02032550|75683634|FG001|COMPLETED|Overall Study||350||
59578236|NCT02032550|75683633|FG000|NOT COMPLETED|Overall Study||28||
59578237|NCT02032550|75683634|FG001|NOT COMPLETED|Overall Study||22||
59578238|NCT02352974|75683640|FG000|STARTED|Main Study||12||
59578239|NCT02352974|75683640|FG000|COMPLETED|Main Study||12||
59578240|NCT02352974|75683640|FG000|NOT COMPLETED|Main Study||0||
59578241|NCT02352974|75683640|FG000|STARTED|Extension|Only 3 out of the 12 patients who completed the main study continued in to the extension period.|3||
59578242|NCT02352974|75683640|FG000|COMPLETED|Extension||3||
59578243|NCT02352974|75683640|FG000|NOT COMPLETED|Extension||0||
59578244|NCT02353754|75683646|FG000|STARTED|Overall Study||12||
59578245|NCT02353754|75683647|FG001|STARTED|Overall Study||0||
59578246|NCT02353754|75683646|FG000|COMPLETED|Overall Study||10||
59578247|NCT02353754|75683647|FG001|COMPLETED|Overall Study||0||
59578248|NCT02353754|75683646|FG000|NOT COMPLETED|Overall Study||2||
59578249|NCT02353754|75683647|FG001|NOT COMPLETED|Overall Study||0||
59578250|NCT02354144|75683655|FG000|STARTED|Overall Study||127||
59578251|NCT02354144|75683656|FG001|STARTED|Overall Study||128||
59578252|NCT02354144|75683655|FG000|COMPLETED|Overall Study|Participants completed all 7 study visits.|48||
59578253|NCT02354144|75683656|FG001|COMPLETED|Overall Study|Participants completed all 7 study visits.|51||
59578254|NCT02354144|75683655|FG000|NOT COMPLETED|Overall Study||79||
59578255|NCT02354144|75683656|FG001|NOT COMPLETED|Overall Study||77||
59721699|NCT01197794|75840562|FG004|STARTED|Overall Study|One participant excluded due to Good Clinical Practice (GCP) violation at centre 4323|163||
59721700|NCT01197794|75840563|FG005|STARTED|Overall Study||163||
59721701|NCT01197794|75840564|FG006|STARTED|Overall Study|Two participants excluded due to Good Clinical Practice (GCP) violation at centre 4323|163||
59721702|NCT01197794|75840558|FG000|COMPLETED|Overall Study||148||
59721703|NCT01197794|75840559|FG001|COMPLETED|Overall Study||146||
59721704|NCT01197794|75840560|FG002|COMPLETED|Overall Study||153||
59721705|NCT01197794|75840561|FG003|COMPLETED|Overall Study||152||
59721706|NCT01197794|75840562|FG004|COMPLETED|Overall Study||149||
59721707|NCT01197794|75840563|FG005|COMPLETED|Overall Study||144||
59721708|NCT01197794|75840564|FG006|COMPLETED|Overall Study||142||
59721709|NCT01197794|75840558|FG000|NOT COMPLETED|Overall Study||16||
59721710|NCT01197794|75840559|FG001|NOT COMPLETED|Overall Study||15||
59721711|NCT01197794|75840560|FG002|NOT COMPLETED|Overall Study||13||
59721712|NCT01197794|75840561|FG003|NOT COMPLETED|Overall Study||12||
59721713|NCT01197794|75840562|FG004|NOT COMPLETED|Overall Study||14||
59721714|NCT01197794|75840563|FG005|NOT COMPLETED|Overall Study||19||
59721715|NCT01197794|75840564|FG006|NOT COMPLETED|Overall Study||21||
59721716|NCT01078662|75840586|FG000|STARTED|Overall Study||62||
59721717|NCT01078662|75840587|FG001|STARTED|Overall Study||193||
59721718|NCT01078662|75840588|FG002|STARTED|Overall Study||23||
59721719|NCT01078662|75840589|FG003|STARTED|Overall Study||8||
59721720|NCT01078662|75840590|FG004|STARTED|Overall Study||12||
59721721|NCT01078662|75840586|FG000|COMPLETED|Overall Study||4||
59721722|NCT01078662|75840587|FG001|COMPLETED|Overall Study||25||
59721723|NCT01078662|75840588|FG002|COMPLETED|Overall Study||2||
59721724|NCT01078662|75840589|FG003|COMPLETED|Overall Study||1||
59721725|NCT01078662|75840590|FG004|COMPLETED|Overall Study||1||
59721726|NCT01078662|75840586|FG000|NOT COMPLETED|Overall Study||58||
59721727|NCT01078662|75840587|FG001|NOT COMPLETED|Overall Study||168||
59721728|NCT01078662|75840588|FG002|NOT COMPLETED|Overall Study||21||
59721729|NCT01078662|75840589|FG003|NOT COMPLETED|Overall Study||7||
59721730|NCT01078662|75840590|FG004|NOT COMPLETED|Overall Study||11||
59721731|NCT01091454|75840599|FG000|STARTED|Overall Study||48||
59721732|NCT01091454|75840599|FG000|COMPLETED|Overall Study||47||
59721733|NCT01091454|75840599|FG000|NOT COMPLETED|Overall Study||1||
59578256|NCT02397122|75683664|FG000|STARTED|Overall Study||20||
59578257|NCT02397122|75683665|FG001|STARTED|Overall Study||20||
59578258|NCT02397122|75683664|FG000|COMPLETED|Overall Study||20||
59578259|NCT02397122|75683665|FG001|COMPLETED|Overall Study||20||
59578260|NCT02397122|75683664|FG000|NOT COMPLETED|Overall Study||0||
59721734|NCT01140347|75840605|FG000|STARTED|Overall Study||283||
59721735|NCT01140347|75840606|FG001|STARTED|Overall Study||282||
59721736|NCT01140347|75840605|FG000|Received at Least 1 Dose of Study Drug|Overall Study||277||
59721737|NCT01140347|75840606|FG001|Received at Least 1 Dose of Study Drug|Overall Study||276||
59721738|NCT01140347|75840605|FG000|COMPLETED|Overall Study||265||
59850331|NCT03582826|75974688|FG000|COMPLETED|Overall Study||78|submitted stool samples|
59721739|NCT01140347|75840606|FG001|COMPLETED|Overall Study||268||
59721740|NCT01140347|75840605|FG000|NOT COMPLETED|Overall Study||18||
59721741|NCT01140347|75840606|FG001|NOT COMPLETED|Overall Study||14||
59721742|NCT01197560|75840614|FG000|STARTED|Overall Study|This is the intent to treat population|54||
59721743|NCT01197560|75840615|FG001|STARTED|Overall Study|This is the intent to treat population|57||
59578261|NCT02397122|75683665|FG001|NOT COMPLETED|Overall Study||0||
59578262|NCT02354378|75683677|FG000|STARTED|Overall Study||64||
59578263|NCT02354378|75683678|FG001|STARTED|Overall Study||20||
59578264|NCT02354378|75683677|FG000|COMPLETED|Overall Study||30||
59578265|NCT02354378|75683678|FG001|COMPLETED|Overall Study||16||
59578266|NCT02354378|75683677|FG000|NOT COMPLETED|Overall Study||34||
59578267|NCT02354378|75683678|FG001|NOT COMPLETED|Overall Study||4||
59578268|NCT02312726|75683684|FG000|STARTED|Overall Study||38||
59578269|NCT02312726|75683685|FG001|STARTED|Overall Study||30||
59578270|NCT02312726|75683686|FG002|STARTED|Overall Study||67||
59578271|NCT02312726|75683684|FG000|COMPLETED|Overall Study||38||
59578272|NCT02312726|75683685|FG001|COMPLETED|Overall Study||30||
59578273|NCT02312726|75683686|FG002|COMPLETED|Overall Study||0||
59578274|NCT02312726|75683684|FG000|NOT COMPLETED|Overall Study||0||
59578275|NCT02312726|75683685|FG001|NOT COMPLETED|Overall Study||0||
59578276|NCT02312726|75683686|FG002|NOT COMPLETED|Overall Study||67||
59578277|NCT02399228|75683693|FG000|STARTED|Overall Study||13||
59578278|NCT02399228|75683693|FG000|COMPLETED|Overall Study||7||
59578279|NCT02399228|75683693|FG000|NOT COMPLETED|Overall Study||6||
59578280|NCT02033174|75683697|FG000|STARTED|First Intervention||8||
59578281|NCT02033174|75683698|FG001|STARTED|First Intervention||8||
59578282|NCT02033174|75683697|FG000|COMPLETED|First Intervention||8||
59578283|NCT02033174|75683698|FG001|COMPLETED|First Intervention||8||
59578284|NCT02033174|75683697|FG000|NOT COMPLETED|First Intervention||0||
59578285|NCT02033174|75683698|FG001|NOT COMPLETED|First Intervention||0||
59578286|NCT02033174|75683697|FG000|STARTED|Washout (1 Week)||8||
59578287|NCT02033174|75683698|FG001|STARTED|Washout (1 Week)||8||
59578288|NCT02033174|75683697|FG000|COMPLETED|Washout (1 Week)||8||
59578289|NCT02033174|75683698|FG001|COMPLETED|Washout (1 Week)||8||
59578290|NCT02033174|75683697|FG000|NOT COMPLETED|Washout (1 Week)||0||
59578291|NCT02033174|75683698|FG001|NOT COMPLETED|Washout (1 Week)||0||
59578292|NCT02033174|75683697|FG000|STARTED|Second Intervention||8||
59578293|NCT02033174|75683698|FG001|STARTED|Second Intervention||8||
59578294|NCT02033174|75683697|FG000|COMPLETED|Second Intervention||8||
59578295|NCT02033174|75683698|FG001|COMPLETED|Second Intervention||8||
59578296|NCT02033174|75683697|FG000|NOT COMPLETED|Second Intervention||0||
59578297|NCT02033174|75683698|FG001|NOT COMPLETED|Second Intervention||0||
59578298|NCT02059213|75683706|FG000|STARTED|Overall Study||20||
59578299|NCT02059213|75683707|FG001|STARTED|Overall Study||42||
59578300|NCT02059213|75683706|FG000|Initiated Treatment|Overall Study||20||
59578301|NCT02059213|75683707|FG001|Initiated Treatment|Overall Study||40||
59578302|NCT02059213|75683706|FG000|COMPLETED|Overall Study||20||
59578303|NCT02059213|75683707|FG001|COMPLETED|Overall Study||40||
59578304|NCT02059213|75683706|FG000|NOT COMPLETED|Overall Study||0||
59578305|NCT02059213|75683707|FG001|NOT COMPLETED|Overall Study||2||
59578306|NCT02037061|75683718|FG000|STARTED|Overall Study||22||
59578307|NCT02037061|75683719|FG001|STARTED|Overall Study||24||
59578308|NCT02037061|75683718|FG000|COMPLETED|Overall Study||22||
59578309|NCT02037061|75683719|FG001|COMPLETED|Overall Study||24||
59578310|NCT02037061|75683718|FG000|NOT COMPLETED|Overall Study||0||
59578311|NCT02037061|75683719|FG001|NOT COMPLETED|Overall Study||0||
59578312|NCT02037607|75683727|FG000|STARTED|Overall Study||100||
59578313|NCT02037607|75683727|FG000|COMPLETED|Overall Study||91||
59578314|NCT02037607|75683727|FG000|NOT COMPLETED|Overall Study||9||
59578315|NCT02354534|75683735|FG000|STARTED|Overall Study||3||
59578316|NCT02354534|75683736|FG001|STARTED|Overall Study||9||
59578317|NCT02354534|75683737|FG002|STARTED|Overall Study||10||
59578318|NCT02354534|75683738|FG003|STARTED|Overall Study||8||
59578319|NCT02354534|75683735|FG000|COMPLETED|Overall Study||3||
59578320|NCT02354534|75683736|FG001|COMPLETED|Overall Study||9||
59578321|NCT02354534|75683737|FG002|COMPLETED|Overall Study||9||
59578322|NCT02354534|75683738|FG003|COMPLETED|Overall Study||8||
59578323|NCT02354534|75683735|FG000|NOT COMPLETED|Overall Study||0||
59578324|NCT02354534|75683736|FG001|NOT COMPLETED|Overall Study||0||
59578325|NCT02354534|75683737|FG002|NOT COMPLETED|Overall Study||1||
59578326|NCT02354534|75683738|FG003|NOT COMPLETED|Overall Study||0||
59578327|NCT02059993|75683750|FG000|STARTED|Overall Study||42||
59578328|NCT02059993|75683751|FG001|STARTED|Overall Study||41||
59578329|NCT02059993|75683750|FG000|COMPLETED|Overall Study||40||
59578330|NCT02059993|75683751|FG001|COMPLETED|Overall Study||37||
59578331|NCT02059993|75683750|FG000|NOT COMPLETED|Overall Study||2||
59578332|NCT02059993|75683751|FG001|NOT COMPLETED|Overall Study||4||
59578333|NCT02060461|75683757|FG000|STARTED|Overall Study||33||
59578334|NCT02060461|75683757|FG000|COMPLETED|Overall Study||33||
59578335|NCT02060461|75683757|FG000|NOT COMPLETED|Overall Study||0||
59578336|NCT02354924|75683765|FG000|STARTED|Overall Study||40||
59578337|NCT02354924|75683766|FG001|STARTED|Overall Study||20||
59578338|NCT02354924|75683765|FG000|COMPLETED|Overall Study||40||
59578339|NCT02354924|75683766|FG001|COMPLETED|Overall Study||20||
59578340|NCT02354924|75683765|FG000|NOT COMPLETED|Overall Study||0||
59578341|NCT02354924|75683766|FG001|NOT COMPLETED|Overall Study||0||
59578342|NCT02060539|75683774|FG000|STARTED|Overall Study||19||
59578343|NCT02060539|75683774|FG000|COMPLETED|Overall Study||19||
59578344|NCT02060539|75683774|FG000|NOT COMPLETED|Overall Study||0||
59578345|NCT02355158|75683778|FG000|STARTED|Overall Study||197||
59578346|NCT02355158|75683778|FG000|COMPLETED|Overall Study||47||
59578347|NCT02355158|75683778|FG000|NOT COMPLETED|Overall Study||150||
59578348|NCT02033876|75683784|FG000|STARTED|Overall Study||12||
59578349|NCT02033876|75683785|FG001|STARTED|Overall Study||12||
59578350|NCT02033876|75683784|FG000|COMPLETED|Overall Study||12||
59578351|NCT02033876|75683785|FG001|COMPLETED|Overall Study||12||
59578352|NCT02033876|75683784|FG000|NOT COMPLETED|Overall Study||0||
59578353|NCT02033876|75683785|FG001|NOT COMPLETED|Overall Study||0||
59578354|NCT02061397|75683791|FG000|STARTED|Simvastatin 20 mg Oral Daily for 2 Month||10||
59578355|NCT02061397|75683791|FG000|COMPLETED|Simvastatin 20 mg Oral Daily for 2 Month||10||
59578356|NCT02061397|75683791|FG000|NOT COMPLETED|Simvastatin 20 mg Oral Daily for 2 Month||0||
59578357|NCT02061397|75683791|FG000|STARTED|Simvastatin 40 mg Oral Daily for 2 Month||10||
59578358|NCT02061397|75683791|FG000|COMPLETED|Simvastatin 40 mg Oral Daily for 2 Month||10||
59578359|NCT02061397|75683791|FG000|NOT COMPLETED|Simvastatin 40 mg Oral Daily for 2 Month||0||
59578360|NCT02400710|75683797|FG000|STARTED|Overall Study||10||
59578361|NCT02400710|75683798|FG001|STARTED|Overall Study||10||
59578362|NCT02400710|75683797|FG000|COMPLETED|Overall Study||10||
59578363|NCT02400710|75683798|FG001|COMPLETED|Overall Study||10||
59578364|NCT02400710|75683797|FG000|NOT COMPLETED|Overall Study||0||
59578365|NCT02400710|75683798|FG001|NOT COMPLETED|Overall Study||0||
59578366|NCT02401022|75683806|FG000|STARTED|Overall Study||104||
59578367|NCT02401022|75683807|FG001|STARTED|Overall Study||110||
59578368|NCT02401022|75683806|FG000|COMPLETED|Overall Study||89||
59578369|NCT02401022|75683807|FG001|COMPLETED|Overall Study||90||
59578370|NCT02401022|75683806|FG000|NOT COMPLETED|Overall Study||15||
59578371|NCT02401022|75683807|FG001|NOT COMPLETED|Overall Study||20||
59578372|NCT02062177|75683815|FG000|STARTED|Overall Study||70||
59578373|NCT02062177|75683816|FG001|STARTED|Overall Study||70||
59578374|NCT02062177|75683815|FG000|COMPLETED|Overall Study||70||
59578375|NCT02062177|75683816|FG001|COMPLETED|Overall Study||70||
59578376|NCT02062177|75683815|FG000|NOT COMPLETED|Overall Study||0||
59578377|NCT02062177|75683816|FG001|NOT COMPLETED|Overall Study||0||
59578378|NCT02034578|75683822|FG000|STARTED|Overall Study||4||
59578379|NCT02034578|75683823|FG001|STARTED|Overall Study||3||
59578380|NCT02034578|75683824|FG002|STARTED|Overall Study||4||
59578381|NCT02034578|75683825|FG003|STARTED|Overall Study||3||
59578382|NCT02034578|75683826|FG004|STARTED|Overall Study||4||
59578383|NCT02034578|75683827|FG005|STARTED|Overall Study||3||
59578384|NCT02034578|75683822|FG000|COMPLETED|Overall Study||4||
59578385|NCT02034578|75683823|FG001|COMPLETED|Overall Study||3||
59578386|NCT02034578|75683824|FG002|COMPLETED|Overall Study||4||
59578387|NCT02034578|75683825|FG003|COMPLETED|Overall Study||3||
59578388|NCT02034578|75683826|FG004|COMPLETED|Overall Study||4||
59578389|NCT02034578|75683827|FG005|COMPLETED|Overall Study||3||
59578390|NCT02034578|75683822|FG000|NOT COMPLETED|Overall Study||0||
59578391|NCT02034578|75683823|FG001|NOT COMPLETED|Overall Study||0||
59578392|NCT02034578|75683824|FG002|NOT COMPLETED|Overall Study||0||
59578393|NCT02034578|75683825|FG003|NOT COMPLETED|Overall Study||0||
59578394|NCT02034578|75683826|FG004|NOT COMPLETED|Overall Study||0||
59578395|NCT02034578|75683827|FG005|NOT COMPLETED|Overall Study||0||
59578396|NCT02403830|75683836|FG000|STARTED|Visit 1||15||
59578397|NCT02403830|75683837|FG001|STARTED|Visit 1||15||
59578398|NCT02403830|75683836|FG000|COMPLETED|Visit 1||15||
59578399|NCT02403830|75683837|FG001|COMPLETED|Visit 1||15||
59578400|NCT02403830|75683836|FG000|NOT COMPLETED|Visit 1||0||
59578401|NCT02403830|75683837|FG001|NOT COMPLETED|Visit 1||0||
59578402|NCT02403830|75683836|FG000|STARTED|Visit 2|One subject completed visit 1 and then withdrew from the study for an adverse event (nausea).|14||
59578403|NCT02403830|75683837|FG001|STARTED|Visit 2||15||
59578404|NCT02403830|75683836|FG000|COMPLETED|Visit 2||14||
59578405|NCT02403830|75683837|FG001|COMPLETED|Visit 2||15||
59578406|NCT02403830|75683836|FG000|NOT COMPLETED|Visit 2||0||
59578407|NCT02403830|75683837|FG001|NOT COMPLETED|Visit 2||0||
59578408|NCT02036840|75683843|FG000|STARTED|Overall Study||513||
59578409|NCT02036840|75683843|FG000|COMPLETED|Overall Study||513||
59578410|NCT02036840|75683843|FG000|NOT COMPLETED|Overall Study||0||
59578411|NCT02951195|75683855|FG000|STARTED|Overall Study||8||
59850332|NCT03582826|75974689|FG001|COMPLETED|Overall Study||6|submitted stool samples|
59850333|NCT03582826|75974688|FG000|NOT COMPLETED|Overall Study||41||
59578412|NCT02951195|75683856|FG001|STARTED|Overall Study||6||
59578413|NCT02951195|75683857|FG002|STARTED|Overall Study||10||
59578414|NCT02951195|75683858|FG003|STARTED|Overall Study||10||
59578415|NCT02951195|75683859|FG004|STARTED|Overall Study||4||
59578416|NCT02951195|75683860|FG005|STARTED|Overall Study||10||
59578417|NCT02951195|75683861|FG006|STARTED|Overall Study||7||
59578418|NCT02951195|75683862|FG007|STARTED|Overall Study||21||
59578419|NCT02951195|75683855|FG000|COMPLETED|Overall Study||8||
59578420|NCT02951195|75683856|FG001|COMPLETED|Overall Study||6||
59578421|NCT02951195|75683857|FG002|COMPLETED|Overall Study||10||
59578422|NCT02951195|75683858|FG003|COMPLETED|Overall Study||10||
59578423|NCT02951195|75683859|FG004|COMPLETED|Overall Study||4||
59578424|NCT02951195|75683860|FG005|COMPLETED|Overall Study||10||
59578425|NCT02951195|75683861|FG006|COMPLETED|Overall Study||7||
59578426|NCT02951195|75683862|FG007|COMPLETED|Overall Study||21||
59850334|NCT03582826|75974689|FG001|NOT COMPLETED|Overall Study||0||
59578427|NCT02951195|75683855|FG000|NOT COMPLETED|Overall Study||0||
59578428|NCT02951195|75683856|FG001|NOT COMPLETED|Overall Study||0||
59578429|NCT02951195|75683857|FG002|NOT COMPLETED|Overall Study||0||
59578430|NCT02951195|75683858|FG003|NOT COMPLETED|Overall Study||0||
59578431|NCT02951195|75683859|FG004|NOT COMPLETED|Overall Study||0||
59578432|NCT02951195|75683860|FG005|NOT COMPLETED|Overall Study||0||
59578433|NCT02951195|75683861|FG006|NOT COMPLETED|Overall Study||0||
59578434|NCT02951195|75683862|FG007|NOT COMPLETED|Overall Study||0||
59578435|NCT02037230|75683894|FG000|STARTED|Overall Study||1||
59578436|NCT02037230|75683895|FG001|STARTED|Overall Study||13||
59578437|NCT02037230|75683896|FG002|STARTED|Overall Study||9||
59578438|NCT02037230|75683897|FG003|STARTED|Overall Study||11||
59578439|NCT02037230|75683894|FG000|Completed 4 Cycles of Treatment|Overall Study||1||
59578440|NCT02037230|75683895|FG001|Completed 4 Cycles of Treatment|Overall Study||9||
59578441|NCT02037230|75683896|FG002|Completed 4 Cycles of Treatment|Overall Study||7||
59578442|NCT02037230|75683897|FG003|Completed 4 Cycles of Treatment|Overall Study||9||
59578443|NCT02037230|75683894|FG000|COMPLETED|Overall Study||0|Completed is defined as finishing 8 cycles of treatment|
59578444|NCT02037230|75683895|FG001|COMPLETED|Overall Study||7|Completed is defined as finishing 8 cycles of treatment|
59578445|NCT02037230|75683896|FG002|COMPLETED|Overall Study||3|Completed is defined as finishing 8 cycles of treatment|
59578446|NCT02037230|75683897|FG003|COMPLETED|Overall Study||5|Completed is defined as finishing 8 cycles of treatment|
59578447|NCT02037230|75683894|FG000|NOT COMPLETED|Overall Study||1||
59578448|NCT02037230|75683895|FG001|NOT COMPLETED|Overall Study||6||
59578449|NCT02037230|75683896|FG002|NOT COMPLETED|Overall Study||6||
59578450|NCT02037230|75683897|FG003|NOT COMPLETED|Overall Study||6||
59721744|NCT01197560|75840614|FG000|Received ≥ One Dose Study Drug|Overall Study||54||
59721745|NCT01197560|75840615|FG001|Received ≥ One Dose Study Drug|Overall Study||55||
59721746|NCT01197560|75840614|FG000|Lenalidomide Crossover|Overall Study||0||
59721747|NCT01197560|75840615|FG001|Lenalidomide Crossover|Overall Study||29||
59721748|NCT01197560|75840614|FG000|Discontinued Treatment After ≥ 6 Cycles|Overall Study||14||
59721749|NCT01197560|75840615|FG001|Discontinued Treatment After ≥ 6 Cycles|Overall Study||0||
59721750|NCT01197560|75840614|FG000|COMPLETED|Overall Study||0|Completed indicates the participates who completed core treatment.|
59721751|NCT01197560|75840615|FG001|COMPLETED|Overall Study||4|Completed indicates the participates who completed core treatment.|
59850335|NCT03518008|75974704|FG000|STARTED|Period 1, First Week of Wear||11||
59850336|NCT03518008|75974705|FG001|STARTED|Period 1, First Week of Wear||11||
59850337|NCT03518008|75974704|FG000|COMPLETED|Period 1, First Week of Wear||11||
59578451|NCT02312882|75683908|FG000|STARTED|Overall Study||40||
59578452|NCT02312882|75683908|FG000|COMPLETED|Overall Study||36||
59578453|NCT02312882|75683908|FG000|NOT COMPLETED|Overall Study||4||
59578454|NCT03020537|75683914|FG000|STARTED|Overall Study||1||
59578455|NCT03020537|75683915|FG001|STARTED|Overall Study||7||
59578456|NCT03020537|75683914|FG000|COMPLETED|Overall Study||1||
59578457|NCT03020537|75683915|FG001|COMPLETED|Overall Study||7||
59578458|NCT03020537|75683914|FG000|NOT COMPLETED|Overall Study||0||
59578459|NCT03020537|75683915|FG001|NOT COMPLETED|Overall Study||0||
59578460|NCT02037776|75683923|FG000|STARTED|Overall Study||61||
59578461|NCT02037776|75683924|FG001|STARTED|Overall Study||64||
59578462|NCT02037776|75683923|FG000|COMPLETED|Overall Study||56||
59578463|NCT02037776|75683924|FG001|COMPLETED|Overall Study||60||
59578464|NCT02037776|75683923|FG000|NOT COMPLETED|Overall Study||5||
59721752|NCT01197560|75840614|FG000|NOT COMPLETED|Overall Study||54||
59721753|NCT01197560|75840615|FG001|NOT COMPLETED|Overall Study||53||
59996717|NCT02714569|76112505|FG002|NOT COMPLETED|Part B (Overall)||0||
59721754|NCT01133405|75840632|FG000|STARTED|Period 1||3||
59721755|NCT01133405|75840633|FG001|STARTED|Period 1||6||
59721756|NCT01133405|75840634|FG002|STARTED|Period 1||5||
59721757|NCT01133405|75840635|FG003|STARTED|Period 1||5||
59721758|NCT01133405|75840636|FG004|STARTED|Period 1||3||
59721759|NCT01133405|75840637|FG005|STARTED|Period 1||5||
59721760|NCT01133405|75840638|FG006|STARTED|Period 1||5||
59721761|NCT01133405|75840639|FG007|STARTED|Period 1||2||
59721762|NCT01133405|75840640|FG008|STARTED|Period 1||4||
59721763|NCT01133405|75840641|FG009|STARTED|Period 1||2||
59721764|NCT01133405|75840632|FG000|Safety Analysis Population|Period 1|One discontinued from study after randomization but before any study procedures.|2||
59721765|NCT01133405|75840633|FG001|Safety Analysis Population|Period 1||6||
59721766|NCT01133405|75840634|FG002|Safety Analysis Population|Period 1||5||
59721767|NCT01133405|75840635|FG003|Safety Analysis Population|Period 1||5||
59721768|NCT01133405|75840636|FG004|Safety Analysis Population|Period 1||3||
60121363|NCT01687595|76242295|FG000|NOT COMPLETED|Overall Study||70||
60121364|NCT01687595|76242296|FG001|NOT COMPLETED|Overall Study||10||
60121365|NCT01687283|76242304|FG000|STARTED|Overall Study||158||
60121366|NCT01687283|76242305|FG001|STARTED|Overall Study||157||
60121367|NCT01687283|76242304|FG000|COMPLETED|Overall Study||123||
60121368|NCT01687283|76242305|FG001|COMPLETED|Overall Study||130||
59578465|NCT02037776|75683924|FG001|NOT COMPLETED|Overall Study||4||
59578466|NCT02877095|75683932|FG000|STARTED|Overall Study|First patient enrolled 1/9/17.|20||
59578467|NCT02877095|75683933|FG001|STARTED|Overall Study||20||
59578468|NCT02877095|75683932|FG000|COMPLETED|Overall Study||20||
59578469|NCT02877095|75683933|FG001|COMPLETED|Overall Study||20||
59578470|NCT02877095|75683932|FG000|NOT COMPLETED|Overall Study||0||
59721769|NCT01133405|75840637|FG005|Safety Analysis Population|Period 1||5||
59721770|NCT01133405|75840638|FG006|Safety Analysis Population|Period 1||5||
59721771|NCT01133405|75840639|FG007|Safety Analysis Population|Period 1||2||
59721772|NCT01133405|75840640|FG008|Safety Analysis Population|Period 1||4||
59721773|NCT01133405|75840641|FG009|Safety Analysis Population|Period 1||2||
59721774|NCT01133405|75840632|FG000|Received at Least 1 Dose of Drug|Period 1||2||
59721775|NCT01133405|75840633|FG001|Received at Least 1 Dose of Drug|Period 1||4||
59721776|NCT01133405|75840634|FG002|Received at Least 1 Dose of Drug|Period 1||4||
59721777|NCT01133405|75840635|FG003|Received at Least 1 Dose of Drug|Period 1||3||
59721778|NCT01133405|75840636|FG004|Received at Least 1 Dose of Drug|Period 1||3||
59721779|NCT01133405|75840637|FG005|Received at Least 1 Dose of Drug|Period 1||4||
59721780|NCT01133405|75840638|FG006|Received at Least 1 Dose of Drug|Period 1||4||
59721781|NCT01133405|75840639|FG007|Received at Least 1 Dose of Drug|Period 1||2||
59721782|NCT01133405|75840640|FG008|Received at Least 1 Dose of Drug|Period 1||4||
59721783|NCT01133405|75840641|FG009|Received at Least 1 Dose of Drug|Period 1||2||
60121369|NCT01687283|76242304|FG000|NOT COMPLETED|Overall Study||35||
59578471|NCT02877095|75683933|FG001|NOT COMPLETED|Overall Study||0||
59578472|NCT02356484|75683939|FG000|STARTED|Overall Study||138||
59578473|NCT02356484|75683939|FG000|COMPLETED|Overall Study||138||
59578474|NCT02356484|75683939|FG000|NOT COMPLETED|Overall Study||0||
59578475|NCT02951273|75683943|FG000|STARTED|Overall Study||30||
59578476|NCT02951273|75683943|FG000|COMPLETED|Overall Study||27||
59578477|NCT02951273|75683943|FG000|NOT COMPLETED|Overall Study||3||
59578478|NCT02357264|75683949|FG000|STARTED|Overall Study||56||
59721784|NCT01133405|75840632|FG000|COMPLETED|Period 1||2||
59721785|NCT01133405|75840633|FG001|COMPLETED|Period 1||3||
59721786|NCT01133405|75840634|FG002|COMPLETED|Period 1||4||
59721787|NCT01133405|75840635|FG003|COMPLETED|Period 1||1||
59721788|NCT01133405|75840636|FG004|COMPLETED|Period 1||3||
59721789|NCT01133405|75840637|FG005|COMPLETED|Period 1||3||
59721790|NCT01133405|75840638|FG006|COMPLETED|Period 1||4||
59721791|NCT01133405|75840639|FG007|COMPLETED|Period 1||2||
59721792|NCT01133405|75840640|FG008|COMPLETED|Period 1||4||
60121370|NCT01687283|76242305|FG001|NOT COMPLETED|Overall Study||27||
60121371|NCT02684370|76242314|FG000|STARTED|Part A||102|Intent-to-treat (ITT) population: All participants who were randomized at Week 0|
60121372|NCT02684370|76242315|FG001|STARTED|Part A||100|Intent-to-treat (ITT) population: All participants who were randomized at Week 0|
60121373|NCT02684370|76242316|FG002|STARTED|Part A||304|Intent-to-treat (ITT) population: All participants who were randomized at Week 0|
60121374|NCT02684370|76242317|FG003|STARTED|Part A||0|Intent-to-treat (ITT) population: All participants who were randomized at Week 0|
59578479|NCT02357264|75683950|FG001|STARTED|Overall Study||130||
59578480|NCT02357264|75683949|FG000|COMPLETED|Overall Study||56||
59721793|NCT01133405|75840641|FG009|COMPLETED|Period 1||2||
59721794|NCT01133405|75840632|FG000|NOT COMPLETED|Period 1||1||
59721795|NCT01133405|75840633|FG001|NOT COMPLETED|Period 1||3||
59721796|NCT01133405|75840634|FG002|NOT COMPLETED|Period 1||1||
59721797|NCT01133405|75840635|FG003|NOT COMPLETED|Period 1||4||
59721798|NCT01133405|75840636|FG004|NOT COMPLETED|Period 1||0||
59721799|NCT01133405|75840637|FG005|NOT COMPLETED|Period 1||2||
59721800|NCT01133405|75840638|FG006|NOT COMPLETED|Period 1||1||
59721801|NCT01133405|75840639|FG007|NOT COMPLETED|Period 1||0||
60121375|NCT02684370|76242318|FG004|STARTED|Part A||0|Intent-to-treat (ITT) population: All participants who were randomized at Week 0|
59578481|NCT02357264|75683950|FG001|COMPLETED|Overall Study||130||
59721802|NCT01133405|75840640|FG008|NOT COMPLETED|Period 1||0||
59721803|NCT01133405|75840641|FG009|NOT COMPLETED|Period 1||0||
59721804|NCT01133405|75840632|FG000|STARTED|Period 2||2||
59721805|NCT01133405|75840633|FG001|STARTED|Period 2|One participant started and received 15 mg LY2886721 only in period 2.|4||
59721806|NCT01133405|75840634|FG002|STARTED|Period 2||4||
59721807|NCT01133405|75840635|FG003|STARTED|Period 2|Two participants started and received 25 mg LY2886721 only in period 2.|3||
59721808|NCT01133405|75840636|FG004|STARTED|Period 2||3||
59721809|NCT01133405|75840637|FG005|STARTED|Period 2|One participant started and received 25 mg LY2886721 only in period 2.|4||
59721810|NCT01133405|75840638|FG006|STARTED|Period 2|Cohort C was planned only for single period.|0||
59721811|NCT01133405|75840639|FG007|STARTED|Period 2|Cohort C was planned only for single period.|0||
59721812|NCT01133405|75840640|FG008|STARTED|Period 2|Cohort D was planned only for single period.|0||
59721813|NCT01133405|75840641|FG009|STARTED|Period 2|Cohort D was planned only for single period.|0||
59721814|NCT01133405|75840632|FG000|Received at Least 1 Dose of Study Drug|Period 2||2||
59721815|NCT01133405|75840633|FG001|Received at Least 1 Dose of Study Drug|Period 2||4||
59578482|NCT02357264|75683949|FG000|NOT COMPLETED|Overall Study||0||
59578483|NCT02357264|75683950|FG001|NOT COMPLETED|Overall Study||0||
59578484|NCT02877485|75683958|FG000|STARTED|Overall Study||22||
59721816|NCT01133405|75840634|FG002|Received at Least 1 Dose of Study Drug|Period 2||4||
59721817|NCT01133405|75840635|FG003|Received at Least 1 Dose of Study Drug|Period 2||3||
59721818|NCT01133405|75840636|FG004|Received at Least 1 Dose of Study Drug|Period 2||3||
59721819|NCT01133405|75840637|FG005|Received at Least 1 Dose of Study Drug|Period 2||4||
59721820|NCT01133405|75840638|FG006|Received at Least 1 Dose of Study Drug|Period 2||0||
59721821|NCT01133405|75840639|FG007|Received at Least 1 Dose of Study Drug|Period 2||0||
59721822|NCT01133405|75840640|FG008|Received at Least 1 Dose of Study Drug|Period 2||0||
59721823|NCT01133405|75840641|FG009|Received at Least 1 Dose of Study Drug|Period 2||0||
59721824|NCT01133405|75840632|FG000|COMPLETED|Period 2||2||
59721825|NCT01133405|75840633|FG001|COMPLETED|Period 2||3||
59721826|NCT01133405|75840634|FG002|COMPLETED|Period 2||3||
59721827|NCT01133405|75840635|FG003|COMPLETED|Period 2||2||
59721828|NCT01133405|75840636|FG004|COMPLETED|Period 2||3||
59721829|NCT01133405|75840637|FG005|COMPLETED|Period 2||2||
59721830|NCT01133405|75840638|FG006|COMPLETED|Period 2||0||
59721831|NCT01133405|75840639|FG007|COMPLETED|Period 2||0||
59721832|NCT01133405|75840640|FG008|COMPLETED|Period 2||0||
59721833|NCT01133405|75840641|FG009|COMPLETED|Period 2||0||
59721834|NCT01133405|75840632|FG000|NOT COMPLETED|Period 2||0||
59721835|NCT01133405|75840633|FG001|NOT COMPLETED|Period 2||1||
59721836|NCT01133405|75840634|FG002|NOT COMPLETED|Period 2||1||
59721837|NCT01133405|75840635|FG003|NOT COMPLETED|Period 2||1||
59721838|NCT01133405|75840636|FG004|NOT COMPLETED|Period 2||0||
59721839|NCT01133405|75840637|FG005|NOT COMPLETED|Period 2||2||
59721840|NCT01133405|75840638|FG006|NOT COMPLETED|Period 2||0||
59721841|NCT01133405|75840639|FG007|NOT COMPLETED|Period 2||0||
59721842|NCT01133405|75840640|FG008|NOT COMPLETED|Period 2||0||
59721843|NCT01133405|75840641|FG009|NOT COMPLETED|Period 2||0||
59721844|NCT01133405|75840632|FG000|STARTED|Period 3||2||
59721845|NCT01133405|75840633|FG001|STARTED|Period 3|One participant started and received placebo only in period 3.|4||
59721846|NCT01133405|75840634|FG002|STARTED|Period 3|One participant started and received 35 mg LY2886721 only in period 3.|4||
59721847|NCT01133405|75840635|FG003|STARTED|Period 3||2||
59721848|NCT01133405|75840636|FG004|STARTED|Period 3||3||
59721849|NCT01133405|75840637|FG005|STARTED|Period 3||2||
59721850|NCT01133405|75840638|FG006|STARTED|Period 3||0||
59721851|NCT01133405|75840639|FG007|STARTED|Period 3||0||
59721852|NCT01133405|75840640|FG008|STARTED|Period 3||0||
59721853|NCT01133405|75840641|FG009|STARTED|Period 3||0||
59721854|NCT01133405|75840632|FG000|Received at Least 1 Dose of Study Drug|Period 3||2||
59721855|NCT01133405|75840633|FG001|Received at Least 1 Dose of Study Drug|Period 3||4||
59721856|NCT01133405|75840634|FG002|Received at Least 1 Dose of Study Drug|Period 3||4||
59721857|NCT01133405|75840635|FG003|Received at Least 1 Dose of Study Drug|Period 3||2||
59721858|NCT01133405|75840636|FG004|Received at Least 1 Dose of Study Drug|Period 3||3||
59721859|NCT01133405|75840637|FG005|Received at Least 1 Dose of Study Drug|Period 3||2||
59721860|NCT01133405|75840638|FG006|Received at Least 1 Dose of Study Drug|Period 3||0||
59721861|NCT01133405|75840639|FG007|Received at Least 1 Dose of Study Drug|Period 3||0||
59721862|NCT01133405|75840640|FG008|Received at Least 1 Dose of Study Drug|Period 3||0||
59578485|NCT02877485|75683959|FG001|STARTED|Overall Study||20||
59578486|NCT02877485|75683958|FG000|COMPLETED|Overall Study||22||
59721863|NCT01133405|75840641|FG009|Received at Least 1 Dose of Study Drug|Period 3||0||
59578487|NCT02877485|75683959|FG001|COMPLETED|Overall Study||20||
59578488|NCT02877485|75683958|FG000|NOT COMPLETED|Overall Study||0||
59578489|NCT02877485|75683959|FG001|NOT COMPLETED|Overall Study||0||
59578490|NCT02404532|75683966|FG000|STARTED|Overall Study||29||
59578491|NCT02404532|75683966|FG000|COMPLETED|Overall Study||29||
59721864|NCT01133405|75840632|FG000|COMPLETED|Period 3||2||
59721865|NCT01133405|75840633|FG001|COMPLETED|Period 3||4||
59721866|NCT01133405|75840634|FG002|COMPLETED|Period 3||4||
59721867|NCT01133405|75840635|FG003|COMPLETED|Period 3||2||
59721868|NCT01133405|75840636|FG004|COMPLETED|Period 3||3||
59578492|NCT02404532|75683966|FG000|NOT COMPLETED|Overall Study||0||
59721869|NCT01133405|75840637|FG005|COMPLETED|Period 3||2||
59721870|NCT01133405|75840638|FG006|COMPLETED|Period 3||0||
59721871|NCT01133405|75840639|FG007|COMPLETED|Period 3||0||
59721872|NCT01133405|75840640|FG008|COMPLETED|Period 3||0||
59721873|NCT01133405|75840641|FG009|COMPLETED|Period 3||0||
59721874|NCT01133405|75840632|FG000|NOT COMPLETED|Period 3||0||
59721875|NCT01133405|75840633|FG001|NOT COMPLETED|Period 3||0||
59721876|NCT01133405|75840634|FG002|NOT COMPLETED|Period 3||0||
59721877|NCT01133405|75840635|FG003|NOT COMPLETED|Period 3||0||
59721878|NCT01133405|75840636|FG004|NOT COMPLETED|Period 3||0||
59721879|NCT01133405|75840637|FG005|NOT COMPLETED|Period 3||0||
59721880|NCT01133405|75840638|FG006|NOT COMPLETED|Period 3||0||
59721881|NCT01133405|75840639|FG007|NOT COMPLETED|Period 3||0||
59721882|NCT01133405|75840640|FG008|NOT COMPLETED|Period 3||0||
59721883|NCT01133405|75840641|FG009|NOT COMPLETED|Period 3||0||
59721884|NCT01196078|75840673|FG000|STARTED|Overall Study||57||
59721885|NCT01196078|75840674|FG001|STARTED|Overall Study||57||
59721886|NCT01196078|75840673|FG000|COMPLETED|Overall Study||24||
59721887|NCT01196078|75840674|FG001|COMPLETED|Overall Study||20||
59721888|NCT01196078|75840673|FG000|NOT COMPLETED|Overall Study||33||
59721889|NCT01196078|75840674|FG001|NOT COMPLETED|Overall Study||37||
59721890|NCT01078584|75840680|FG000|STARTED|Overall Study||7993||
59721891|NCT01078584|75840680|FG000|Participants Conducted Visit 2 (3-month)|Overall Study||7125||
59721892|NCT01078584|75840680|FG000|Participants Conducted Visit 3 (6-month)|Overall Study||5833||
59721893|NCT01078584|75840680|FG000|Participants Conducted Visit 4(12-month)|Overall Study||4983||
59721894|NCT01078584|75840680|FG000|COMPLETED|Overall Study||4983||
59721895|NCT01078584|75840680|FG000|NOT COMPLETED|Overall Study||3010||
59721896|NCT01133171|75840700|FG000|STARTED|Overall Study||25||
59721897|NCT01133171|75840701|FG001|STARTED|Overall Study||27||
59721898|NCT01133171|75840702|FG002|STARTED|Overall Study||25||
59721899|NCT01133171|75840700|FG000|COMPLETED|Overall Study||24||
59721900|NCT01133171|75840701|FG001|COMPLETED|Overall Study||25||
59721901|NCT01133171|75840702|FG002|COMPLETED|Overall Study||25||
59721902|NCT01133171|75840700|FG000|NOT COMPLETED|Overall Study||1||
59721903|NCT01133171|75840701|FG001|NOT COMPLETED|Overall Study||2||
59721904|NCT01133171|75840702|FG002|NOT COMPLETED|Overall Study||0||
59721905|NCT01195844|75840710|FG000|STARTED|Overall Study||230||
59721906|NCT01195844|75840710|FG000|COMPLETED|Overall Study||190||
59721907|NCT01195844|75840710|FG000|NOT COMPLETED|Overall Study||40||
59578493|NCT02879747|75683978|FG000|STARTED|Overall Study||27|observe that 33 more Children were included in the fix-arm (not randomized).|
59578494|NCT02879747|75683979|FG001|STARTED|Overall Study||38|observe that 33 more Children were included in the fix-arm (not randomized).|
59578495|NCT02879747|75683980|FG002|STARTED|Overall Study||33|observe that 33 more Children were included in the fix-arm (not randomized).|
59578496|NCT02879747|75683978|FG000|COMPLETED|Overall Study||23||
59578497|NCT02879747|75683979|FG001|COMPLETED|Overall Study||32||
59578498|NCT02879747|75683980|FG002|COMPLETED|Overall Study||31||
59578499|NCT02879747|75683978|FG000|NOT COMPLETED|Overall Study||4||
59578500|NCT02879747|75683979|FG001|NOT COMPLETED|Overall Study||6||
59578501|NCT02879747|75683980|FG002|NOT COMPLETED|Overall Study||2||
59578502|NCT02880137|75683997|FG000|STARTED|Overall Study||36||
59578503|NCT02880137|75683997|FG000|COMPLETED|Overall Study||36||
59578504|NCT02880137|75683997|FG000|NOT COMPLETED|Overall Study||0||
59578505|NCT03023891|75684001|FG000|STARTED|Overall Study||18||
59578506|NCT03023891|75684001|FG000|COMPLETED|Overall Study||18||
59578507|NCT03023891|75684001|FG000|NOT COMPLETED|Overall Study||0||
59578508|NCT03026777|75684007|FG000|STARTED|Overall Study||168||
59578509|NCT03026777|75684008|FG001|STARTED|Overall Study||169||
59578510|NCT03026777|75684007|FG000|COMPLETED|Overall Study||168||
59578511|NCT03026777|75684008|FG001|COMPLETED|Overall Study||169||
59578512|NCT03026777|75684007|FG000|NOT COMPLETED|Overall Study||0||
59578513|NCT03026777|75684008|FG001|NOT COMPLETED|Overall Study||0||
59578514|NCT03028025|75684016|FG000|STARTED|Overall Study||90||
59578515|NCT03028025|75684017|FG001|STARTED|Overall Study||94||
59578516|NCT03028025|75684016|FG000|COMPLETED|Overall Study||87||
59578517|NCT03028025|75684017|FG001|COMPLETED|Overall Study||93||
59721908|NCT01132547|75840726|FG000|STARTED|Overall Study||9||
59721909|NCT01132547|75840727|FG001|STARTED|Overall Study||13||
59721910|NCT01132547|75840726|FG000|COMPLETED|Overall Study||5||
59721911|NCT01132547|75840727|FG001|COMPLETED|Overall Study||12||
59721912|NCT01132547|75840726|FG000|NOT COMPLETED|Overall Study||4||
59721913|NCT01132547|75840727|FG001|NOT COMPLETED|Overall Study||1||
59721914|NCT01194830|75840735|FG000|STARTED|Overall Study||124||
59721915|NCT01194830|75840736|FG001|STARTED|Overall Study||110||
59721916|NCT01194830|75840735|FG000|COMPLETED|Overall Study||88||
59721917|NCT01194830|75840736|FG001|COMPLETED|Overall Study||83||
59721918|NCT01194830|75840735|FG000|NOT COMPLETED|Overall Study||36||
59721919|NCT01194830|75840736|FG001|NOT COMPLETED|Overall Study||27||
59721920|NCT01194440|75840742|FG000|STARTED|Baseline (First Dose)||59||
59721921|NCT01194440|75840742|FG000|COMPLETED|Baseline (First Dose)||52||
59721922|NCT01194440|75840742|FG000|NOT COMPLETED|Baseline (First Dose)||7||
59721923|NCT01194440|75840742|FG000|STARTED|6-months (2nd Dose)||52||
59721924|NCT01194440|75840742|FG000|COMPLETED|6-months (2nd Dose)||48||
59721925|NCT01194440|75840742|FG000|NOT COMPLETED|6-months (2nd Dose)||4||
59721926|NCT00951015|75840751|FG000|STARTED|Randomization Phase 96 Week||53||
59721927|NCT00951015|75840752|FG001|STARTED|Randomization Phase 96 Week||51||
59721928|NCT00951015|75840753|FG002|STARTED|Randomization Phase 96 Week||51||
59721929|NCT00951015|75840754|FG003|STARTED|Randomization Phase 96 Week||50||
59721930|NCT00951015|75840755|FG004|STARTED|Randomization Phase 96 Week||0||
59721931|NCT00951015|75840751|FG000|COMPLETED|Randomization Phase 96 Week||48||
59721932|NCT00951015|75840752|FG001|COMPLETED|Randomization Phase 96 Week||44||
59721933|NCT00951015|75840753|FG002|COMPLETED|Randomization Phase 96 Week||46||
59721934|NCT00951015|75840754|FG003|COMPLETED|Randomization Phase 96 Week||40||
59721935|NCT00951015|75840755|FG004|COMPLETED|Randomization Phase 96 Week||0||
59721936|NCT00951015|75840751|FG000|NOT COMPLETED|Randomization Phase 96 Week||5||
59721937|NCT00951015|75840752|FG001|NOT COMPLETED|Randomization Phase 96 Week||7||
59721938|NCT00951015|75840753|FG002|NOT COMPLETED|Randomization Phase 96 Week||5||
59721939|NCT00951015|75840754|FG003|NOT COMPLETED|Randomization Phase 96 Week||10||
59721940|NCT00951015|75840755|FG004|NOT COMPLETED|Randomization Phase 96 Week||0||
59721941|NCT00951015|75840751|FG000|STARTED|Open-label Phase||0||
59721942|NCT00951015|75840752|FG001|STARTED|Open-label Phase||0||
59721943|NCT00951015|75840753|FG002|STARTED|Open-label Phase||0||
59721944|NCT00951015|75840754|FG003|STARTED|Open-label Phase||0||
59721945|NCT00951015|75840755|FG004|STARTED|Open-label Phase||138||
59721946|NCT00951015|75840751|FG000|COMPLETED|Open-label Phase||0||
59721947|NCT00951015|75840752|FG001|COMPLETED|Open-label Phase||0||
59721948|NCT00951015|75840753|FG002|COMPLETED|Open-label Phase||0||
59721949|NCT00951015|75840754|FG003|COMPLETED|Open-label Phase||0||
59721950|NCT00951015|75840755|FG004|COMPLETED|Open-label Phase||88||
59721951|NCT00951015|75840751|FG000|NOT COMPLETED|Open-label Phase||0||
59721952|NCT00951015|75840752|FG001|NOT COMPLETED|Open-label Phase||0||
59721953|NCT00951015|75840753|FG002|NOT COMPLETED|Open-label Phase||0||
59721954|NCT00951015|75840754|FG003|NOT COMPLETED|Open-label Phase||0||
59721955|NCT00951015|75840755|FG004|NOT COMPLETED|Open-label Phase||50||
59721956|NCT01139021|75840784|FG000|STARTED|Overall Study||152||
59721957|NCT01139021|75840785|FG001|STARTED|Overall Study||153||
59721958|NCT01139021|75840786|FG002|STARTED|Overall Study||67||
59721959|NCT01139021|75840787|FG003|STARTED|Overall Study||19||
59721960|NCT01139021|75840788|FG004|STARTED|Overall Study||116||
59721961|NCT01139021|75840789|FG005|STARTED|Overall Study||1||
59721962|NCT01139021|75840784|FG000|COMPLETED|Overall Study||151||
59578518|NCT03028025|75684016|FG000|NOT COMPLETED|Overall Study||3||
59578519|NCT03028025|75684017|FG001|NOT COMPLETED|Overall Study||1||
59578520|NCT02955329|75684023|FG000|STARTED|Tobacco Arm||8|Participants vaped tobacco leaves with nicotine out of the PAX device.|
59578521|NCT02955329|75684023|FG000|COMPLETED|Tobacco Arm||8||
59578522|NCT02955329|75684023|FG000|NOT COMPLETED|Tobacco Arm||0||
59578523|NCT02955329|75684023|FG000|STARTED|Cannabis Arm||8|Participants vaped marijuana leaves with Tetrahydrocannabinol (THC) out of the PAX device|
59578524|NCT02955329|75684023|FG000|COMPLETED|Cannabis Arm||8||
59578525|NCT02955329|75684023|FG000|NOT COMPLETED|Cannabis Arm||0||
59578526|NCT02955329|75684023|FG000|STARTED|Combined Cannabis and Tobacco Arm||8|Participants vaped flavorless 6% nicotine e-liquid, followed by THC out of the PAX device.|
59578527|NCT02955329|75684023|FG000|COMPLETED|Combined Cannabis and Tobacco Arm||8||
59578528|NCT02955329|75684023|FG000|NOT COMPLETED|Combined Cannabis and Tobacco Arm||0||
59578529|NCT02359058|75684034|FG000|STARTED|Overall Study||6||
59578530|NCT02359058|75684035|FG001|STARTED|Overall Study||6||
59578531|NCT02359058|75684036|FG002|STARTED|Overall Study||6||
59578532|NCT02359058|75684034|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6||
59578533|NCT02359058|75684035|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6||
59578534|NCT02359058|75684036|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6||
59578535|NCT02359058|75684034|FG000|COMPLETED|Overall Study||6||
59721963|NCT01139021|75840785|FG001|COMPLETED|Overall Study||153||
59850338|NCT03518008|75974705|FG001|COMPLETED|Period 1, First Week of Wear||11||
59721964|NCT01139021|75840786|FG002|COMPLETED|Overall Study||67||
59721965|NCT01139021|75840787|FG003|COMPLETED|Overall Study||18||
59721966|NCT01139021|75840788|FG004|COMPLETED|Overall Study||107||
59721967|NCT01139021|75840789|FG005|COMPLETED|Overall Study||1||
59721968|NCT01139021|75840784|FG000|NOT COMPLETED|Overall Study||1||
59721969|NCT01139021|75840785|FG001|NOT COMPLETED|Overall Study||0||
59721970|NCT01139021|75840786|FG002|NOT COMPLETED|Overall Study||0||
59721971|NCT01139021|75840787|FG003|NOT COMPLETED|Overall Study||1||
59721972|NCT01139021|75840788|FG004|NOT COMPLETED|Overall Study||9||
59721973|NCT01139021|75840789|FG005|NOT COMPLETED|Overall Study||0||
59721974|NCT01193660|75840807|FG000|STARTED|Overall Study||35||
59721975|NCT01193660|75840808|FG001|STARTED|Overall Study||36||
59850339|NCT03518008|75974704|FG000|NOT COMPLETED|Period 1, First Week of Wear||0||
59578536|NCT02359058|75684035|FG001|COMPLETED|Overall Study||6||
59578537|NCT02359058|75684036|FG002|COMPLETED|Overall Study||6||
59721976|NCT01193660|75840809|FG002|STARTED|Overall Study||34||
59721977|NCT01193660|75840807|FG000|COMPLETED|Overall Study||31||
59721978|NCT01193660|75840808|FG001|COMPLETED|Overall Study||33||
59721979|NCT01193660|75840809|FG002|COMPLETED|Overall Study||32||
59721980|NCT01193660|75840807|FG000|NOT COMPLETED|Overall Study||4||
59721981|NCT01193660|75840808|FG001|NOT COMPLETED|Overall Study||3||
59721982|NCT01193660|75840809|FG002|NOT COMPLETED|Overall Study||2||
59721983|NCT01076166|75840817|FG000|STARTED|Overall Study||337||
59721984|NCT01076166|75840817|FG000|COMPLETED|Overall Study||328||
59721985|NCT01076166|75840817|FG000|NOT COMPLETED|Overall Study||9||
59721986|NCT01193582|75840828|FG000|STARTED|Vaccination Series||100||
59721987|NCT01193582|75840829|FG001|STARTED|Vaccination Series||101||
59721988|NCT01193582|75840830|FG002|STARTED|Vaccination Series||125||
59721989|NCT01193582|75840831|FG003|STARTED|Vaccination Series||180||
59721990|NCT01193582|75840828|FG000|Vaccinated Dose 1|Vaccination Series||100||
59721991|NCT01193582|75840829|FG001|Vaccinated Dose 1|Vaccination Series||100||
59721992|NCT01193582|75840830|FG002|Vaccinated Dose 1|Vaccination Series||125||
59721993|NCT01193582|75840831|FG003|Vaccinated Dose 1|Vaccination Series||180||
59721994|NCT01193582|75840828|FG000|Vaccinated Dose 2|Vaccination Series||92||
59721995|NCT01193582|75840829|FG001|Vaccinated Dose 2|Vaccination Series||91||
59721996|NCT01193582|75840830|FG002|Vaccinated Dose 2|Vaccination Series||118||
59721997|NCT01193582|75840831|FG003|Vaccinated Dose 2|Vaccination Series||0||
59721998|NCT01193582|75840828|FG000|Vaccinated Dose 3|Vaccination Series||90||
59721999|NCT01193582|75840829|FG001|Vaccinated Dose 3|Vaccination Series||89||
59722000|NCT01193582|75840830|FG002|Vaccinated Dose 3|Vaccination Series||0||
59722001|NCT01193582|75840831|FG003|Vaccinated Dose 3|Vaccination Series||0||
59722002|NCT01193582|75840828|FG000|Vaccinated Dose 4|Vaccination Series||90||
59722003|NCT01193582|75840829|FG001|Vaccinated Dose 4|Vaccination Series||0||
59722004|NCT01193582|75840830|FG002|Vaccinated Dose 4|Vaccination Series||0||
59722005|NCT01193582|75840831|FG003|Vaccinated Dose 4|Vaccination Series||0||
59722006|NCT01193582|75840828|FG000|COMPLETED|Vaccination Series||89||
59722007|NCT01193582|75840829|FG001|COMPLETED|Vaccination Series||88||
59722008|NCT01193582|75840830|FG002|COMPLETED|Vaccination Series||117||
59722009|NCT01193582|75840831|FG003|COMPLETED|Vaccination Series||177||
59722010|NCT01193582|75840828|FG000|NOT COMPLETED|Vaccination Series||11||
59722011|NCT01193582|75840829|FG001|NOT COMPLETED|Vaccination Series||13||
59722012|NCT01193582|75840830|FG002|NOT COMPLETED|Vaccination Series||8||
59722013|NCT01193582|75840831|FG003|NOT COMPLETED|Vaccination Series||3||
59722014|NCT01193582|75840828|FG000|STARTED|12 Month Follow-up||89||
59722015|NCT01193582|75840829|FG001|STARTED|12 Month Follow-up||88||
59722016|NCT01193582|75840830|FG002|STARTED|12 Month Follow-up||117||
59722017|NCT01193582|75840831|FG003|STARTED|12 Month Follow-up||177||
59722018|NCT01193582|75840828|FG000|COMPLETED|12 Month Follow-up||83||
59578538|NCT02359058|75684034|FG000|NOT COMPLETED|Overall Study||0||
59578539|NCT02359058|75684035|FG001|NOT COMPLETED|Overall Study||0||
59578540|NCT02359058|75684036|FG002|NOT COMPLETED|Overall Study||0||
59578541|NCT02404610|75684047|FG000|STARTED|Overall Study||54||
59578542|NCT02404610|75684048|FG001|STARTED|Overall Study||53||
59578543|NCT02404610|75684047|FG000|COMPLETED|Overall Study||54||
59722019|NCT01193582|75840829|FG001|COMPLETED|12 Month Follow-up||88||
59722020|NCT01193582|75840830|FG002|COMPLETED|12 Month Follow-up||113||
59722021|NCT01193582|75840831|FG003|COMPLETED|12 Month Follow-up||166||
59722022|NCT01193582|75840828|FG000|NOT COMPLETED|12 Month Follow-up||6||
59722023|NCT01193582|75840829|FG001|NOT COMPLETED|12 Month Follow-up||0||
59722024|NCT01193582|75840830|FG002|NOT COMPLETED|12 Month Follow-up||4||
59722025|NCT01193582|75840831|FG003|NOT COMPLETED|12 Month Follow-up||11||
59722026|NCT00945477|75840843|FG000|STARTED|Overall Study||11||
59722027|NCT00945477|75840843|FG000|COMPLETED|Overall Study||5||
59722028|NCT00945477|75840843|FG000|NOT COMPLETED|Overall Study||6||
59722029|NCT01076088|75840854|FG000|STARTED|Overall Study||122||
59722030|NCT01076088|75840855|FG001|STARTED|Overall Study||125||
59722031|NCT01076088|75840856|FG002|STARTED|Overall Study||126||
59722032|NCT01076088|75840857|FG003|STARTED|Overall Study||124||
59578544|NCT02404610|75684048|FG001|COMPLETED|Overall Study||53||
59578545|NCT02404610|75684047|FG000|NOT COMPLETED|Overall Study||0||
59578546|NCT02404610|75684048|FG001|NOT COMPLETED|Overall Study||0||
59578547|NCT02359916|75684061|FG000|STARTED|Overall Study|The number of unique individuals in this study is unknown||"The unit of analysis for this study was vending machine sales (vends)."|5481
59578548|NCT02359916|75684062|FG001|STARTED|Overall Study|The number of unique individuals in this study is unknown||"The unit of analysis for this study was vending machine sales (vends)."|5784
59578549|NCT02359916|75684063|FG002|STARTED|Overall Study|The number of unique individuals in this study is unknown||"The unit of analysis for this study was vending machine sales (vends)."|7473
59578550|NCT02359916|75684064|FG003|STARTED|Overall Study|The number of unique individuals in this study is unknown||"The unit of analysis for this study was vending machine sales (vends)."|1996
59578551|NCT02359916|75684065|FG004|STARTED|Overall Study|The number of unique individuals in this study is unknown||"The unit of analysis for this study was vending machine sales (vends)."|2846
59722033|NCT01076088|75840858|FG004|STARTED|Overall Study||120||
59722034|NCT01076088|75840859|FG005|STARTED|Overall Study||127||
59722035|NCT01076088|75840854|FG000|COMPLETED|Overall Study||111||
59722036|NCT01076088|75840855|FG001|COMPLETED|Overall Study||107||
59722037|NCT01076088|75840856|FG002|COMPLETED|Overall Study||109||
59996718|NCT02714569|76112506|FG003|NOT COMPLETED|Part B (Overall)||0||
59722038|NCT01076088|75840857|FG003|COMPLETED|Overall Study||109||
59722039|NCT01076088|75840858|FG004|COMPLETED|Overall Study||104||
59722040|NCT01076088|75840859|FG005|COMPLETED|Overall Study||104||
59722041|NCT01076088|75840854|FG000|NOT COMPLETED|Overall Study||11||
59996719|NCT02714569|76112507|FG004|NOT COMPLETED|Part B (Overall)||0||
59996720|NCT02714569|76112508|FG005|NOT COMPLETED|Part B (Overall)||0||
59722042|NCT01076088|75840855|FG001|NOT COMPLETED|Overall Study||18||
59722043|NCT01076088|75840856|FG002|NOT COMPLETED|Overall Study||17||
59722044|NCT01076088|75840857|FG003|NOT COMPLETED|Overall Study||15||
59722045|NCT01076088|75840858|FG004|NOT COMPLETED|Overall Study||16||
59722046|NCT01076088|75840859|FG005|NOT COMPLETED|Overall Study||23||
59722047|NCT01193348|75840874|FG000|STARTED|Screening Period||27||
59722048|NCT01193348|75840874|FG000|COMPLETED|Screening Period||22||
59722049|NCT01193348|75840874|FG000|NOT COMPLETED|Screening Period||5||
59722050|NCT01193348|75840874|FG000|STARTED|Treatment Period (26 Weeks)||22||
59722051|NCT01193348|75840874|FG000|COMPLETED|Treatment Period (26 Weeks)||19||
59722052|NCT01193348|75840874|FG000|NOT COMPLETED|Treatment Period (26 Weeks)||3||
59722053|NCT01193348|75840874|FG000|STARTED|Extension Treatment Period||17||
59722054|NCT01193348|75840874|FG000|COMPLETED|Extension Treatment Period||16||
59722055|NCT01193348|75840874|FG000|NOT COMPLETED|Extension Treatment Period||1||
59722056|NCT01193348|75840874|FG000|STARTED|Post Treatment Period (Patients Who Disc||10||
59722057|NCT01193348|75840874|FG000|COMPLETED|Post Treatment Period (Patients Who Disc||8||
59722058|NCT01193348|75840874|FG000|NOT COMPLETED|Post Treatment Period (Patients Who Disc||2||
59722059|NCT00945321|75840883|FG000|STARTED|Period 1||7||
59722060|NCT00945321|75840884|FG001|STARTED|Period 1||7||
59722061|NCT00945321|75840885|FG002|STARTED|Period 1||7||
59722062|NCT00945321|75840886|FG003|STARTED|Period 1||7||
59722063|NCT00945321|75840887|FG004|STARTED|Period 1||7||
59722064|NCT00945321|75840888|FG005|STARTED|Period 1||7||
59722065|NCT00945321|75840883|FG000|COMPLETED|Period 1||7||
59722066|NCT00945321|75840884|FG001|COMPLETED|Period 1||7||
59722067|NCT00945321|75840885|FG002|COMPLETED|Period 1||7||
59722068|NCT00945321|75840886|FG003|COMPLETED|Period 1||7||
59722069|NCT00945321|75840887|FG004|COMPLETED|Period 1||6||
59722070|NCT00945321|75840888|FG005|COMPLETED|Period 1||7||
59722071|NCT00945321|75840883|FG000|NOT COMPLETED|Period 1||0||
59722072|NCT00945321|75840884|FG001|NOT COMPLETED|Period 1||0||
59722073|NCT00945321|75840885|FG002|NOT COMPLETED|Period 1||0||
59722074|NCT00945321|75840886|FG003|NOT COMPLETED|Period 1||0||
59722075|NCT00945321|75840887|FG004|NOT COMPLETED|Period 1||1||
59722076|NCT00945321|75840888|FG005|NOT COMPLETED|Period 1||0||
59722077|NCT00945321|75840883|FG000|STARTED|Period 2||7||
59722078|NCT00945321|75840884|FG001|STARTED|Period 2||7||
59722079|NCT00945321|75840885|FG002|STARTED|Period 2||7||
59722080|NCT00945321|75840886|FG003|STARTED|Period 2||7||
59722081|NCT00945321|75840887|FG004|STARTED|Period 2||6||
59722082|NCT00945321|75840888|FG005|STARTED|Period 2||7||
59722083|NCT00945321|75840883|FG000|COMPLETED|Period 2||7||
59722084|NCT00945321|75840884|FG001|COMPLETED|Period 2||7||
59722085|NCT00945321|75840885|FG002|COMPLETED|Period 2||7||
59722086|NCT00945321|75840886|FG003|COMPLETED|Period 2||7||
59722087|NCT00945321|75840887|FG004|COMPLETED|Period 2||6||
59722088|NCT00945321|75840888|FG005|COMPLETED|Period 2||7||
59722089|NCT00945321|75840883|FG000|NOT COMPLETED|Period 2||0||
59722090|NCT00945321|75840884|FG001|NOT COMPLETED|Period 2||0||
59722091|NCT00945321|75840885|FG002|NOT COMPLETED|Period 2||0||
59722092|NCT00945321|75840886|FG003|NOT COMPLETED|Period 2||0||
59722093|NCT00945321|75840887|FG004|NOT COMPLETED|Period 2||0||
59722094|NCT00945321|75840888|FG005|NOT COMPLETED|Period 2||0||
59722095|NCT00945321|75840883|FG000|STARTED|Period 3||7||
59722096|NCT00945321|75840884|FG001|STARTED|Period 3||7||
59722097|NCT00945321|75840885|FG002|STARTED|Period 3||7||
59722098|NCT00945321|75840886|FG003|STARTED|Period 3||7||
59722099|NCT00945321|75840887|FG004|STARTED|Period 3||6||
59722100|NCT00945321|75840888|FG005|STARTED|Period 3||7||
59722101|NCT00945321|75840883|FG000|COMPLETED|Period 3||7||
59722102|NCT00945321|75840884|FG001|COMPLETED|Period 3||7||
59722103|NCT00945321|75840885|FG002|COMPLETED|Period 3||7||
59722104|NCT00945321|75840886|FG003|COMPLETED|Period 3||7||
59722105|NCT00945321|75840887|FG004|COMPLETED|Period 3||6||
59722106|NCT00945321|75840888|FG005|COMPLETED|Period 3||7||
59722107|NCT00945321|75840883|FG000|NOT COMPLETED|Period 3||0||
59722108|NCT00945321|75840884|FG001|NOT COMPLETED|Period 3||0||
59722109|NCT00945321|75840885|FG002|NOT COMPLETED|Period 3||0||
59722110|NCT00945321|75840886|FG003|NOT COMPLETED|Period 3||0||
59722111|NCT00945321|75840887|FG004|NOT COMPLETED|Period 3||0||
59722112|NCT00945321|75840888|FG005|NOT COMPLETED|Period 3||0||
59722113|NCT00945321|75840883|FG000|STARTED|Period 4||7||
59722114|NCT00945321|75840884|FG001|STARTED|Period 4||7||
59722115|NCT00945321|75840885|FG002|STARTED|Period 4||7||
59722116|NCT00945321|75840886|FG003|STARTED|Period 4||7||
59722117|NCT00945321|75840887|FG004|STARTED|Period 4||6||
59722118|NCT00945321|75840888|FG005|STARTED|Period 4||7||
59722119|NCT00945321|75840883|FG000|COMPLETED|Period 4||7||
59722120|NCT00945321|75840884|FG001|COMPLETED|Period 4||7||
59722121|NCT00945321|75840885|FG002|COMPLETED|Period 4||7||
59722122|NCT00945321|75840886|FG003|COMPLETED|Period 4||7||
59722123|NCT00945321|75840887|FG004|COMPLETED|Period 4||6||
59722124|NCT00945321|75840888|FG005|COMPLETED|Period 4||6||
59722125|NCT00945321|75840883|FG000|NOT COMPLETED|Period 4||0||
59722126|NCT00945321|75840884|FG001|NOT COMPLETED|Period 4||0||
59722127|NCT00945321|75840885|FG002|NOT COMPLETED|Period 4||0||
59722128|NCT00945321|75840886|FG003|NOT COMPLETED|Period 4||0||
59722129|NCT00945321|75840887|FG004|NOT COMPLETED|Period 4||0||
59722130|NCT00945321|75840888|FG005|NOT COMPLETED|Period 4||1||
59722131|NCT00945243|75840906|FG000|STARTED|Overall Study|Enrolled and Treated Per Protocol|11||
59722132|NCT00945243|75840906|FG000|COMPLETED|Overall Study||8||
59722133|NCT00945243|75840906|FG000|NOT COMPLETED|Overall Study||3||
59722134|NCT01192412|75840912|FG000|STARTED|Overall Study||497||
59722135|NCT01192412|75840913|FG001|STARTED|Overall Study||490||
59722136|NCT01192412|75840912|FG000|COMPLETED|Overall Study||493||
59722137|NCT01192412|75840913|FG001|COMPLETED|Overall Study||488||
59722138|NCT01192412|75840912|FG000|NOT COMPLETED|Overall Study||4||
59722139|NCT01192412|75840913|FG001|NOT COMPLETED|Overall Study||2||
59722140|NCT01192178|75840921|FG000|STARTED|Overall Study||171||
59722141|NCT01192178|75840922|FG001|STARTED|Overall Study||168||
59722142|NCT01192178|75840921|FG000|COMPLETED|Overall Study||147||
59722143|NCT01192178|75840922|FG001|COMPLETED|Overall Study||145||
59722144|NCT01192178|75840921|FG000|NOT COMPLETED|Overall Study||24||
59722145|NCT01192178|75840922|FG001|NOT COMPLETED|Overall Study||23||
59722146|NCT01192100|75840930|FG000|STARTED|Overall Study||6||
59722147|NCT01192100|75840931|FG001|STARTED|Overall Study||4||
59722148|NCT01192100|75840932|FG002|STARTED|Overall Study||3||
59722149|NCT01192100|75840933|FG003|STARTED|Overall Study||4||
59722150|NCT01192100|75840934|FG004|STARTED|Overall Study||3||
59722151|NCT01192100|75840935|FG005|STARTED|Overall Study||2||
59722152|NCT01192100|75840930|FG000|Began 1st Intervention Week|Overall Study||6||
59722153|NCT01192100|75840931|FG001|Began 1st Intervention Week|Overall Study||4||
59722154|NCT01192100|75840932|FG002|Began 1st Intervention Week|Overall Study||3||
59722155|NCT01192100|75840933|FG003|Began 1st Intervention Week|Overall Study||4||
59722156|NCT01192100|75840934|FG004|Began 1st Intervention Week|Overall Study||3||
59722157|NCT01192100|75840935|FG005|Began 1st Intervention Week|Overall Study||2||
59722158|NCT01192100|75840930|FG000|Began 2nd Intervention Week|Overall Study||6||
59722159|NCT01192100|75840931|FG001|Began 2nd Intervention Week|Overall Study||4||
59722160|NCT01192100|75840932|FG002|Began 2nd Intervention Week|Overall Study||3||
59722161|NCT01192100|75840933|FG003|Began 2nd Intervention Week|Overall Study||3||
59722162|NCT01192100|75840934|FG004|Began 2nd Intervention Week|Overall Study||2||
59722163|NCT01192100|75840935|FG005|Began 2nd Intervention Week|Overall Study||2||
59722164|NCT01192100|75840930|FG000|Began 3rd Intervention Week|Overall Study||6||
59722165|NCT01192100|75840931|FG001|Began 3rd Intervention Week|Overall Study||4||
59722166|NCT01192100|75840932|FG002|Began 3rd Intervention Week|Overall Study||3||
59722167|NCT01192100|75840933|FG003|Began 3rd Intervention Week|Overall Study||3||
59722168|NCT01192100|75840934|FG004|Began 3rd Intervention Week|Overall Study||2||
59722169|NCT01192100|75840935|FG005|Began 3rd Intervention Week|Overall Study||2||
59722170|NCT01192100|75840930|FG000|COMPLETED|Overall Study||6||
59722171|NCT01192100|75840931|FG001|COMPLETED|Overall Study||4||
59722172|NCT01192100|75840932|FG002|COMPLETED|Overall Study||3||
59722173|NCT01192100|75840933|FG003|COMPLETED|Overall Study||3||
59722174|NCT01192100|75840934|FG004|COMPLETED|Overall Study||2||
59722175|NCT01192100|75840935|FG005|COMPLETED|Overall Study||2||
59722176|NCT01192100|75840930|FG000|NOT COMPLETED|Overall Study||0||
59722177|NCT01192100|75840931|FG001|NOT COMPLETED|Overall Study||0||
59722178|NCT01192100|75840932|FG002|NOT COMPLETED|Overall Study||0||
59722179|NCT01192100|75840933|FG003|NOT COMPLETED|Overall Study||1||
59722180|NCT01192100|75840934|FG004|NOT COMPLETED|Overall Study||1||
59722181|NCT01192100|75840935|FG005|NOT COMPLETED|Overall Study||0||
60121376|NCT02684370|76242319|FG005|STARTED|Part A||0|Intent-to-treat (ITT) population: All participants who were randomized at Week 0|
59578552|NCT02359916|75684066|FG005|STARTED|Overall Study|The number of unique individuals in this study is unknown||"The unit of analysis for this study was vending machine sales (vends)."|3438
59578553|NCT02359916|75684067|FG006|STARTED|Overall Study|The number of unique individuals in this study is unknown||"The unit of analysis for this study was vending machine sales (vends)."|5644
59578554|NCT02359916|75684061|FG000|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|||5481
59578555|NCT02359916|75684062|FG001|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|||5784
59578556|NCT02359916|75684063|FG002|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|||7473
59578557|NCT02359916|75684064|FG003|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|||1996
59578558|NCT02359916|75684065|FG004|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|||2846
59578559|NCT02359916|75684066|FG005|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|||3438
59578560|NCT02359916|75684067|FG006|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|||5644
59578561|NCT02359916|75684061|FG000|NOT COMPLETED|Overall Study||||0
59722182|NCT00869401|75840948|FG000|STARTED|Overall Study||3||
59722183|NCT00869401|75840949|FG001|STARTED|Overall Study||3||
59722184|NCT00869401|75840950|FG002|STARTED|Overall Study||7||
59722185|NCT00869401|75840951|FG003|STARTED|Overall Study||138||
59722186|NCT00869401|75840952|FG004|STARTED|Overall Study||66||
59722187|NCT00869401|75840948|FG000|COMPLETED|Overall Study||3||
59722188|NCT00869401|75840949|FG001|COMPLETED|Overall Study||3||
59722189|NCT00869401|75840950|FG002|COMPLETED|Overall Study||7||
59722190|NCT00869401|75840951|FG003|COMPLETED|Overall Study||133||
59722191|NCT00869401|75840952|FG004|COMPLETED|Overall Study||63||
59722192|NCT00869401|75840948|FG000|NOT COMPLETED|Overall Study||0||
59722193|NCT00869401|75840949|FG001|NOT COMPLETED|Overall Study||0||
59722194|NCT00869401|75840950|FG002|NOT COMPLETED|Overall Study||0||
59722195|NCT00869401|75840951|FG003|NOT COMPLETED|Overall Study||5||
59722196|NCT00869401|75840952|FG004|NOT COMPLETED|Overall Study||3||
59722197|NCT01076010|75840967|FG000|STARTED|Overall Study||161||
59722198|NCT01076010|75840968|FG001|STARTED|Overall Study||88||
59722199|NCT01076010|75840969|FG002|STARTED|Overall Study||28||
59722200|NCT01076010|75840967|FG000|COMPLETED|Overall Study||36||
59722201|NCT01076010|75840968|FG001|COMPLETED|Overall Study||49||
59722202|NCT01076010|75840969|FG002|COMPLETED|Overall Study||26||
59722203|NCT01076010|75840967|FG000|NOT COMPLETED|Overall Study||125||
59722204|NCT01076010|75840968|FG001|NOT COMPLETED|Overall Study||39||
59722205|NCT01076010|75840969|FG002|NOT COMPLETED|Overall Study||2||
59722206|NCT01075152|75840979|FG000|STARTED|Overall Study|randomized|88||
59722207|NCT01075152|75840980|FG001|STARTED|Overall Study|randomized|89||
59722208|NCT01075152|75840979|FG000|COMPLETED|Overall Study||87||
59722209|NCT01075152|75840980|FG001|COMPLETED|Overall Study||89||
59722210|NCT01075152|75840979|FG000|NOT COMPLETED|Overall Study||1||
59722211|NCT01075152|75840980|FG001|NOT COMPLETED|Overall Study||0||
59722212|NCT01078116|75840988|FG000|STARTED|Overall Study|121 participants were included in analysis (3 were excluded due to missing case report form data).|124||
59722213|NCT01078116|75840988|FG000|COMPLETED|Overall Study||76||
59722214|NCT01078116|75840988|FG000|NOT COMPLETED|Overall Study||48||
59722215|NCT00950859|75840994|FG000|STARTED|Overall Study||27||
59722216|NCT00950859|75840995|FG001|STARTED|Overall Study||24||
59722217|NCT00950859|75840994|FG000|COMPLETED|Overall Study||11||
59722218|NCT00950859|75840995|FG001|COMPLETED|Overall Study||14||
59722219|NCT00950859|75840994|FG000|NOT COMPLETED|Overall Study||16||
59722220|NCT00950859|75840995|FG001|NOT COMPLETED|Overall Study||10||
59722221|NCT00862849|75841001|FG000|STARTED|Intervention 1||3||
59722222|NCT00862849|75841002|FG001|STARTED|Intervention 1||5||
59722223|NCT00862849|75841003|FG002|STARTED|Intervention 1||3||
59722224|NCT00862849|75841004|FG003|STARTED|Intervention 1||4||
59722225|NCT00862849|75841005|FG004|STARTED|Intervention 1||4||
59722226|NCT00862849|75841006|FG005|STARTED|Intervention 1||3||
59722227|NCT00862849|75841001|FG000|Received at Least One Dose of Study Drug|Intervention 1||3||
59722228|NCT00862849|75841002|FG001|Received at Least One Dose of Study Drug|Intervention 1||5||
59722229|NCT00862849|75841003|FG002|Received at Least One Dose of Study Drug|Intervention 1||3||
59722230|NCT00862849|75841004|FG003|Received at Least One Dose of Study Drug|Intervention 1||4||
59722231|NCT00862849|75841005|FG004|Received at Least One Dose of Study Drug|Intervention 1||4||
59722232|NCT00862849|75841006|FG005|Received at Least One Dose of Study Drug|Intervention 1||3||
59722233|NCT00862849|75841001|FG000|COMPLETED|Intervention 1||3||
59722234|NCT00862849|75841002|FG001|COMPLETED|Intervention 1||5||
59722235|NCT00862849|75841003|FG002|COMPLETED|Intervention 1||3||
59722236|NCT00862849|75841004|FG003|COMPLETED|Intervention 1||4||
59722237|NCT00862849|75841005|FG004|COMPLETED|Intervention 1||4||
59722238|NCT00862849|75841006|FG005|COMPLETED|Intervention 1||3||
59722239|NCT00862849|75841001|FG000|NOT COMPLETED|Intervention 1||0||
59722240|NCT00862849|75841002|FG001|NOT COMPLETED|Intervention 1||0||
59722241|NCT00862849|75841003|FG002|NOT COMPLETED|Intervention 1||0||
59722242|NCT00862849|75841004|FG003|NOT COMPLETED|Intervention 1||0||
59722243|NCT00862849|75841005|FG004|NOT COMPLETED|Intervention 1||0||
59722244|NCT00862849|75841006|FG005|NOT COMPLETED|Intervention 1||0||
59722245|NCT00862849|75841001|FG000|STARTED|Washout 1 (3 to 14 Days)||3||
59722246|NCT00862849|75841002|FG001|STARTED|Washout 1 (3 to 14 Days)||5||
59722247|NCT00862849|75841003|FG002|STARTED|Washout 1 (3 to 14 Days)||3||
59722248|NCT00862849|75841004|FG003|STARTED|Washout 1 (3 to 14 Days)||4||
59722249|NCT00862849|75841005|FG004|STARTED|Washout 1 (3 to 14 Days)||4||
59722250|NCT00862849|75841006|FG005|STARTED|Washout 1 (3 to 14 Days)||3||
59722251|NCT00862849|75841001|FG000|COMPLETED|Washout 1 (3 to 14 Days)||3||
59722252|NCT00862849|75841002|FG001|COMPLETED|Washout 1 (3 to 14 Days)||4||
59722253|NCT00862849|75841003|FG002|COMPLETED|Washout 1 (3 to 14 Days)||3||
59722254|NCT00862849|75841004|FG003|COMPLETED|Washout 1 (3 to 14 Days)||4||
59722255|NCT00862849|75841005|FG004|COMPLETED|Washout 1 (3 to 14 Days)||4||
59722256|NCT00862849|75841006|FG005|COMPLETED|Washout 1 (3 to 14 Days)||3||
59722257|NCT00862849|75841001|FG000|NOT COMPLETED|Washout 1 (3 to 14 Days)||0||
59722258|NCT00862849|75841002|FG001|NOT COMPLETED|Washout 1 (3 to 14 Days)||1||
59850340|NCT03518008|75974705|FG001|NOT COMPLETED|Period 1, First Week of Wear||0||
59722259|NCT00862849|75841003|FG002|NOT COMPLETED|Washout 1 (3 to 14 Days)||0||
59722260|NCT00862849|75841004|FG003|NOT COMPLETED|Washout 1 (3 to 14 Days)||0||
59722261|NCT00862849|75841005|FG004|NOT COMPLETED|Washout 1 (3 to 14 Days)||0||
59722262|NCT00862849|75841006|FG005|NOT COMPLETED|Washout 1 (3 to 14 Days)||0||
59722263|NCT00862849|75841001|FG000|STARTED|Intervention 2||3||
59722264|NCT00862849|75841002|FG001|STARTED|Intervention 2||4||
59722265|NCT00862849|75841003|FG002|STARTED|Intervention 2||3||
59722266|NCT00862849|75841004|FG003|STARTED|Intervention 2||4||
59722267|NCT00862849|75841005|FG004|STARTED|Intervention 2||4||
59722268|NCT00862849|75841006|FG005|STARTED|Intervention 2||3||
59722269|NCT00862849|75841001|FG000|COMPLETED|Intervention 2||3||
59722270|NCT00862849|75841002|FG001|COMPLETED|Intervention 2||4||
59722271|NCT00862849|75841003|FG002|COMPLETED|Intervention 2||3||
59722272|NCT00862849|75841004|FG003|COMPLETED|Intervention 2||4||
59996721|NCT02714569|76112509|FG006|NOT COMPLETED|Part B (Overall)||1||
59722273|NCT00862849|75841005|FG004|COMPLETED|Intervention 2||4||
59722274|NCT00862849|75841006|FG005|COMPLETED|Intervention 2||3||
59722275|NCT00862849|75841001|FG000|NOT COMPLETED|Intervention 2||0||
59722276|NCT00862849|75841002|FG001|NOT COMPLETED|Intervention 2||0||
59722277|NCT00862849|75841003|FG002|NOT COMPLETED|Intervention 2||0||
59722278|NCT00862849|75841004|FG003|NOT COMPLETED|Intervention 2||0||
59722279|NCT00862849|75841005|FG004|NOT COMPLETED|Intervention 2||0||
59722280|NCT00862849|75841006|FG005|NOT COMPLETED|Intervention 2||0||
59722281|NCT00862849|75841001|FG000|STARTED|Washout 2 (3 to 14 Days)||3||
59722282|NCT00862849|75841002|FG001|STARTED|Washout 2 (3 to 14 Days)||4||
59722283|NCT00862849|75841003|FG002|STARTED|Washout 2 (3 to 14 Days)||3||
59722284|NCT00862849|75841004|FG003|STARTED|Washout 2 (3 to 14 Days)||4||
59722285|NCT00862849|75841005|FG004|STARTED|Washout 2 (3 to 14 Days)||4||
59722286|NCT00862849|75841006|FG005|STARTED|Washout 2 (3 to 14 Days)||3||
59722287|NCT00862849|75841001|FG000|COMPLETED|Washout 2 (3 to 14 Days)||3||
59722288|NCT00862849|75841002|FG001|COMPLETED|Washout 2 (3 to 14 Days)||3||
59722289|NCT00862849|75841003|FG002|COMPLETED|Washout 2 (3 to 14 Days)||3||
59722290|NCT00862849|75841004|FG003|COMPLETED|Washout 2 (3 to 14 Days)||4||
59722291|NCT00862849|75841005|FG004|COMPLETED|Washout 2 (3 to 14 Days)||4||
59722292|NCT00862849|75841006|FG005|COMPLETED|Washout 2 (3 to 14 Days)||3||
59722293|NCT00862849|75841001|FG000|NOT COMPLETED|Washout 2 (3 to 14 Days)||0||
59722294|NCT00862849|75841002|FG001|NOT COMPLETED|Washout 2 (3 to 14 Days)||1||
59722295|NCT00862849|75841003|FG002|NOT COMPLETED|Washout 2 (3 to 14 Days)||0||
59722296|NCT00862849|75841004|FG003|NOT COMPLETED|Washout 2 (3 to 14 Days)||0||
59722297|NCT00862849|75841005|FG004|NOT COMPLETED|Washout 2 (3 to 14 Days)||0||
59722298|NCT00862849|75841006|FG005|NOT COMPLETED|Washout 2 (3 to 14 Days)||0||
59722299|NCT00862849|75841001|FG000|STARTED|Intervention 3||3||
59722300|NCT00862849|75841002|FG001|STARTED|Intervention 3||3||
59722301|NCT00862849|75841003|FG002|STARTED|Intervention 3||3||
59722302|NCT00862849|75841004|FG003|STARTED|Intervention 3||4||
59722303|NCT00862849|75841005|FG004|STARTED|Intervention 3||4||
59722304|NCT00862849|75841006|FG005|STARTED|Intervention 3||3||
59722305|NCT00862849|75841001|FG000|COMPLETED|Intervention 3||3||
59722306|NCT00862849|75841002|FG001|COMPLETED|Intervention 3||3||
59722307|NCT00862849|75841003|FG002|COMPLETED|Intervention 3||3||
59722308|NCT00862849|75841004|FG003|COMPLETED|Intervention 3||4||
59722309|NCT00862849|75841005|FG004|COMPLETED|Intervention 3||4||
59722310|NCT00862849|75841006|FG005|COMPLETED|Intervention 3||3||
59722311|NCT00862849|75841001|FG000|NOT COMPLETED|Intervention 3||0||
59722312|NCT00862849|75841002|FG001|NOT COMPLETED|Intervention 3||0||
59722313|NCT00862849|75841003|FG002|NOT COMPLETED|Intervention 3||0||
59722314|NCT00862849|75841004|FG003|NOT COMPLETED|Intervention 3||0||
59722315|NCT00862849|75841005|FG004|NOT COMPLETED|Intervention 3||0||
59722316|NCT00862849|75841006|FG005|NOT COMPLETED|Intervention 3||0||
59722317|NCT00862849|75841001|FG000|STARTED|Washout 3 (3 to 14 Days)||3||
59722318|NCT00862849|75841002|FG001|STARTED|Washout 3 (3 to 14 Days)||3||
59722319|NCT00862849|75841003|FG002|STARTED|Washout 3 (3 to 14 Days)||3||
59722320|NCT00862849|75841004|FG003|STARTED|Washout 3 (3 to 14 Days)||4||
59722321|NCT00862849|75841005|FG004|STARTED|Washout 3 (3 to 14 Days)||4||
59722322|NCT00862849|75841006|FG005|STARTED|Washout 3 (3 to 14 Days)||3||
59722323|NCT00862849|75841001|FG000|COMPLETED|Washout 3 (3 to 14 Days)||3||
59722324|NCT00862849|75841002|FG001|COMPLETED|Washout 3 (3 to 14 Days)||3||
59722325|NCT00862849|75841003|FG002|COMPLETED|Washout 3 (3 to 14 Days)||3||
59722326|NCT00862849|75841004|FG003|COMPLETED|Washout 3 (3 to 14 Days)||4||
59722327|NCT00862849|75841005|FG004|COMPLETED|Washout 3 (3 to 14 Days)||4||
59722328|NCT00862849|75841006|FG005|COMPLETED|Washout 3 (3 to 14 Days)||3||
59722329|NCT00862849|75841001|FG000|NOT COMPLETED|Washout 3 (3 to 14 Days)||0||
59722330|NCT00862849|75841002|FG001|NOT COMPLETED|Washout 3 (3 to 14 Days)||0||
59722331|NCT00862849|75841003|FG002|NOT COMPLETED|Washout 3 (3 to 14 Days)||0||
59722332|NCT00862849|75841004|FG003|NOT COMPLETED|Washout 3 (3 to 14 Days)||0||
59722333|NCT00862849|75841005|FG004|NOT COMPLETED|Washout 3 (3 to 14 Days)||0||
59722334|NCT00862849|75841006|FG005|NOT COMPLETED|Washout 3 (3 to 14 Days)||0||
59722335|NCT00862849|75841001|FG000|STARTED|Intervention 4||3||
59850341|NCT03518008|75974704|FG000|STARTED|Period 2, Second Week of Wear||11||
59850342|NCT03518008|75974705|FG001|STARTED|Period 2, Second Week of Wear||11||
59850343|NCT03518008|75974704|FG000|COMPLETED|Period 2, Second Week of Wear||11||
59722336|NCT00862849|75841002|FG001|STARTED|Intervention 4||3||
59850344|NCT03518008|75974705|FG001|COMPLETED|Period 2, Second Week of Wear||10||
59722337|NCT00862849|75841003|FG002|STARTED|Intervention 4||3||
59722338|NCT00862849|75841004|FG003|STARTED|Intervention 4||4||
59722339|NCT00862849|75841005|FG004|STARTED|Intervention 4||4||
59722340|NCT00862849|75841006|FG005|STARTED|Intervention 4||3||
59722341|NCT00862849|75841001|FG000|COMPLETED|Intervention 4||3||
59722342|NCT00862849|75841002|FG001|COMPLETED|Intervention 4||3||
59722343|NCT00862849|75841003|FG002|COMPLETED|Intervention 4||3||
59722344|NCT00862849|75841004|FG003|COMPLETED|Intervention 4||4||
59722345|NCT00862849|75841005|FG004|COMPLETED|Intervention 4||4||
59722346|NCT00862849|75841006|FG005|COMPLETED|Intervention 4||3||
59722347|NCT00862849|75841001|FG000|NOT COMPLETED|Intervention 4||0||
59722348|NCT00862849|75841002|FG001|NOT COMPLETED|Intervention 4||0||
59722349|NCT00862849|75841003|FG002|NOT COMPLETED|Intervention 4||0||
59722350|NCT00862849|75841004|FG003|NOT COMPLETED|Intervention 4||0||
59722351|NCT00862849|75841005|FG004|NOT COMPLETED|Intervention 4||0||
59722352|NCT00862849|75841006|FG005|NOT COMPLETED|Intervention 4||0||
59722353|NCT00862849|75841001|FG000|STARTED|Washout 4 (3 to 14 Days)||3||
59722354|NCT00862849|75841002|FG001|STARTED|Washout 4 (3 to 14 Days)||3||
59722355|NCT00862849|75841003|FG002|STARTED|Washout 4 (3 to 14 Days)||3||
59722356|NCT00862849|75841004|FG003|STARTED|Washout 4 (3 to 14 Days)||4||
59722357|NCT00862849|75841005|FG004|STARTED|Washout 4 (3 to 14 Days)||4||
59722358|NCT00862849|75841006|FG005|STARTED|Washout 4 (3 to 14 Days)||3||
59722359|NCT00862849|75841001|FG000|COMPLETED|Washout 4 (3 to 14 Days)||3||
59722360|NCT00862849|75841002|FG001|COMPLETED|Washout 4 (3 to 14 Days)||3||
59722361|NCT00862849|75841003|FG002|COMPLETED|Washout 4 (3 to 14 Days)||3||
59722362|NCT00862849|75841004|FG003|COMPLETED|Washout 4 (3 to 14 Days)||4||
59722363|NCT00862849|75841005|FG004|COMPLETED|Washout 4 (3 to 14 Days)||4||
59722364|NCT00862849|75841006|FG005|COMPLETED|Washout 4 (3 to 14 Days)||3||
59722365|NCT00862849|75841001|FG000|NOT COMPLETED|Washout 4 (3 to 14 Days)||0||
59722366|NCT00862849|75841002|FG001|NOT COMPLETED|Washout 4 (3 to 14 Days)||0||
59722367|NCT00862849|75841003|FG002|NOT COMPLETED|Washout 4 (3 to 14 Days)||0||
59722368|NCT00862849|75841004|FG003|NOT COMPLETED|Washout 4 (3 to 14 Days)||0||
59722369|NCT00862849|75841005|FG004|NOT COMPLETED|Washout 4 (3 to 14 Days)||0||
59722370|NCT00862849|75841006|FG005|NOT COMPLETED|Washout 4 (3 to 14 Days)||0||
59722371|NCT00862849|75841001|FG000|STARTED|Intervention 5||3||
59722372|NCT00862849|75841002|FG001|STARTED|Intervention 5||3||
59722373|NCT00862849|75841003|FG002|STARTED|Intervention 5||3||
59722374|NCT00862849|75841004|FG003|STARTED|Intervention 5||4||
59722375|NCT00862849|75841005|FG004|STARTED|Intervention 5||4||
59722376|NCT00862849|75841006|FG005|STARTED|Intervention 5||3||
59722377|NCT00862849|75841001|FG000|COMPLETED|Intervention 5||3||
59722378|NCT00862849|75841002|FG001|COMPLETED|Intervention 5||3||
59722379|NCT00862849|75841003|FG002|COMPLETED|Intervention 5||3||
59722380|NCT00862849|75841004|FG003|COMPLETED|Intervention 5||4||
59722381|NCT00862849|75841005|FG004|COMPLETED|Intervention 5||4||
59722382|NCT00862849|75841006|FG005|COMPLETED|Intervention 5||3||
59722383|NCT00862849|75841001|FG000|NOT COMPLETED|Intervention 5||0||
59722384|NCT00862849|75841002|FG001|NOT COMPLETED|Intervention 5||0||
59722385|NCT00862849|75841003|FG002|NOT COMPLETED|Intervention 5||0||
59722386|NCT00862849|75841004|FG003|NOT COMPLETED|Intervention 5||0||
59722387|NCT00862849|75841005|FG004|NOT COMPLETED|Intervention 5||0||
59722388|NCT00862849|75841006|FG005|NOT COMPLETED|Intervention 5||0||
59722389|NCT00862849|75841001|FG000|STARTED|Washout 5 (3 to 14 Days)||3||
59722390|NCT00862849|75841002|FG001|STARTED|Washout 5 (3 to 14 Days)||3||
59722391|NCT00862849|75841003|FG002|STARTED|Washout 5 (3 to 14 Days)||3||
59722392|NCT00862849|75841004|FG003|STARTED|Washout 5 (3 to 14 Days)||4||
59722393|NCT00862849|75841005|FG004|STARTED|Washout 5 (3 to 14 Days)||4||
59722394|NCT00862849|75841006|FG005|STARTED|Washout 5 (3 to 14 Days)||3||
59722395|NCT00862849|75841001|FG000|COMPLETED|Washout 5 (3 to 14 Days)||3||
59722396|NCT00862849|75841002|FG001|COMPLETED|Washout 5 (3 to 14 Days)||3||
59722397|NCT00862849|75841003|FG002|COMPLETED|Washout 5 (3 to 14 Days)||3||
59722398|NCT00862849|75841004|FG003|COMPLETED|Washout 5 (3 to 14 Days)||4||
59722399|NCT00862849|75841005|FG004|COMPLETED|Washout 5 (3 to 14 Days)||4||
59722400|NCT00862849|75841006|FG005|COMPLETED|Washout 5 (3 to 14 Days)||3||
59722401|NCT00862849|75841001|FG000|NOT COMPLETED|Washout 5 (3 to 14 Days)||0||
59722402|NCT00862849|75841002|FG001|NOT COMPLETED|Washout 5 (3 to 14 Days)||0||
59722403|NCT00862849|75841003|FG002|NOT COMPLETED|Washout 5 (3 to 14 Days)||0||
59722404|NCT00862849|75841004|FG003|NOT COMPLETED|Washout 5 (3 to 14 Days)||0||
59722405|NCT00862849|75841005|FG004|NOT COMPLETED|Washout 5 (3 to 14 Days)||0||
59722406|NCT00862849|75841006|FG005|NOT COMPLETED|Washout 5 (3 to 14 Days)||0||
59722407|NCT00862849|75841001|FG000|STARTED|Intervention 6||3||
59722408|NCT00862849|75841002|FG001|STARTED|Intervention 6||3||
59722409|NCT00862849|75841003|FG002|STARTED|Intervention 6||3||
59722410|NCT00862849|75841004|FG003|STARTED|Intervention 6||4||
59722411|NCT00862849|75841005|FG004|STARTED|Intervention 6||4||
59722412|NCT00862849|75841006|FG005|STARTED|Intervention 6||3||
59722413|NCT00862849|75841001|FG000|COMPLETED|Intervention 6||3||
59722414|NCT00862849|75841002|FG001|COMPLETED|Intervention 6||3||
59722415|NCT00862849|75841003|FG002|COMPLETED|Intervention 6||3||
59722416|NCT00862849|75841004|FG003|COMPLETED|Intervention 6||4||
59722417|NCT00862849|75841005|FG004|COMPLETED|Intervention 6||4||
59850345|NCT03518008|75974704|FG000|NOT COMPLETED|Period 2, Second Week of Wear||0||
59850346|NCT03518008|75974705|FG001|NOT COMPLETED|Period 2, Second Week of Wear||1||
59722418|NCT00862849|75841006|FG005|COMPLETED|Intervention 6||3||
59722419|NCT00862849|75841001|FG000|NOT COMPLETED|Intervention 6||0||
59722420|NCT00862849|75841002|FG001|NOT COMPLETED|Intervention 6||0||
59722421|NCT00862849|75841003|FG002|NOT COMPLETED|Intervention 6||0||
59722422|NCT00862849|75841004|FG003|NOT COMPLETED|Intervention 6||0||
59722423|NCT00862849|75841005|FG004|NOT COMPLETED|Intervention 6||0||
59722424|NCT00862849|75841006|FG005|NOT COMPLETED|Intervention 6||0||
59722425|NCT01090050|75841016|FG000|STARTED|Overall Study||16||
59722426|NCT01090050|75841017|FG001|STARTED|Overall Study||12||
59722427|NCT01090050|75841016|FG000|COMPLETED|Overall Study||15||
59722428|NCT01090050|75841017|FG001|COMPLETED|Overall Study||5||
59722429|NCT01090050|75841016|FG000|NOT COMPLETED|Overall Study||1||
59722430|NCT01090050|75841017|FG001|NOT COMPLETED|Overall Study||7||
59722431|NCT00944229|75841027|FG000|STARTED|Overall Study||58||
59722432|NCT00944229|75841027|FG000|COMPLETED|Overall Study||33||
59722433|NCT00944229|75841027|FG000|NOT COMPLETED|Overall Study||25||
59722434|NCT01077960|75841031|FG000|STARTED|Overall Study|130 subjects consented to participate, 129 enrolled in the study, and 126 received study drug|126||
59722435|NCT01077960|75841031|FG000|COMPLETED|Overall Study|Modified Intent To Treat (ITT) Population|110||
59722436|NCT01077960|75841031|FG000|NOT COMPLETED|Overall Study||16||
59722437|NCT00944697|75841037|FG000|STARTED|Overall Study||50||
59722438|NCT00944697|75841038|FG001|STARTED|Overall Study||48||
59722439|NCT00944697|75841037|FG000|COMPLETED|Overall Study||48||
59722440|NCT00944697|75841038|FG001|COMPLETED|Overall Study||43||
59722441|NCT00944697|75841037|FG000|NOT COMPLETED|Overall Study||2||
59722442|NCT00944697|75841038|FG001|NOT COMPLETED|Overall Study||5||
59722443|NCT01077804|75841044|FG000|STARTED|Overall Study||7585||
59722444|NCT01077804|75841044|FG000|COMPLETED|Overall Study||7386||
59722445|NCT01077804|75841044|FG000|NOT COMPLETED|Overall Study||199||
59722446|NCT04878172|75841052|FG000|STARTED|Overall Study||2||
59722447|NCT04878172|75841053|FG001|STARTED|Overall Study||2||
59722448|NCT04878172|75841054|FG002|STARTED|Overall Study||2||
59722449|NCT04878172|75841055|FG003|STARTED|Overall Study||3||
59722450|NCT04878172|75841052|FG000|COMPLETED|Overall Study||2||
59722451|NCT04878172|75841053|FG001|COMPLETED|Overall Study||2||
59722452|NCT04878172|75841054|FG002|COMPLETED|Overall Study||2||
59722453|NCT04878172|75841055|FG003|COMPLETED|Overall Study||3||
59722454|NCT04878172|75841052|FG000|NOT COMPLETED|Overall Study||0||
59722455|NCT04878172|75841053|FG001|NOT COMPLETED|Overall Study||0||
59722456|NCT04878172|75841054|FG002|NOT COMPLETED|Overall Study||0||
59722457|NCT04878172|75841055|FG003|NOT COMPLETED|Overall Study||0||
59578562|NCT02359916|75684062|FG001|NOT COMPLETED|Overall Study||||0
59578563|NCT02359916|75684063|FG002|NOT COMPLETED|Overall Study||||0
59578564|NCT02359916|75684064|FG003|NOT COMPLETED|Overall Study||||0
59722458|NCT01075074|75841068|FG000|STARTED|Overall Study||25||
59722459|NCT01075074|75841069|FG001|STARTED|Overall Study||25||
59722460|NCT01075074|75841070|FG002|STARTED|Overall Study||25||
59722461|NCT01075074|75841068|FG000|COMPLETED|Overall Study||24||
59722462|NCT01075074|75841069|FG001|COMPLETED|Overall Study||23||
59722463|NCT01075074|75841070|FG002|COMPLETED|Overall Study||23||
59722464|NCT01075074|75841068|FG000|NOT COMPLETED|Overall Study||1||
59722465|NCT01075074|75841069|FG001|NOT COMPLETED|Overall Study||2||
59722466|NCT01075074|75841070|FG002|NOT COMPLETED|Overall Study||2||
59722467|NCT00866281|75841084|FG000|STARTED|Overall Study||7||
59578565|NCT02359916|75684065|FG004|NOT COMPLETED|Overall Study||||0
59578566|NCT02359916|75684066|FG005|NOT COMPLETED|Overall Study||||0
59578567|NCT02359916|75684067|FG006|NOT COMPLETED|Overall Study||||0
59578568|NCT02405390|75684084|FG000|STARTED|Overall Study||46||
59578569|NCT02405390|75684085|FG001|STARTED|Overall Study||46||
59578570|NCT02405390|75684084|FG000|COMPLETED|Overall Study||46||
59578571|NCT02405390|75684085|FG001|COMPLETED|Overall Study||46||
59578572|NCT02405390|75684084|FG000|NOT COMPLETED|Overall Study||0||
59578573|NCT02405390|75684085|FG001|NOT COMPLETED|Overall Study||0||
59578574|NCT02881775|75684091|FG000|STARTED|Baseline||11||
59578575|NCT02881775|75684092|FG001|STARTED|Baseline||9||
59578576|NCT02881775|75684091|FG000|COMPLETED|Baseline||11||
59578577|NCT02881775|75684092|FG001|COMPLETED|Baseline||9||
59722468|NCT00866281|75841085|FG001|STARTED|Overall Study||15||
59722469|NCT00866281|75841084|FG000|COMPLETED|Overall Study||0||
59722470|NCT00866281|75841085|FG001|COMPLETED|Overall Study||0||
59722471|NCT00866281|75841084|FG000|NOT COMPLETED|Overall Study||7||
59722472|NCT00866281|75841085|FG001|NOT COMPLETED|Overall Study||15||
59722473|NCT01077258|75841094|FG000|STARTED|Overall Study||4208||
59722474|NCT01077258|75841094|FG000|COMPLETED|Overall Study||1640||
59722475|NCT01077258|75841094|FG000|NOT COMPLETED|Overall Study||2568||
59722476|NCT00943917|75841122|FG000|STARTED|Stage I||51||
59722477|NCT00943917|75841123|FG001|STARTED|Stage I||51||
59722478|NCT00943917|75841124|FG002|STARTED|Stage I||53||
59722479|NCT00943917|75841125|FG003|STARTED|Stage I||0||
59722480|NCT00943917|75841126|FG004|STARTED|Stage I||0||
59722481|NCT00943917|75841127|FG005|STARTED|Stage I||0||
59722482|NCT00943917|75841128|FG006|STARTED|Stage I||0||
59722483|NCT00943917|75841129|FG007|STARTED|Stage I||0||
59722484|NCT00943917|75841130|FG008|STARTED|Stage I||0||
59722485|NCT00943917|75841131|FG009|STARTED|Stage I||0||
59722486|NCT00943917|75841132|FG010|STARTED|Stage I||0||
59722487|NCT00943917|75841133|FG011|STARTED|Stage I||0||
59722488|NCT00943917|75841134|FG012|STARTED|Stage I||0||
59722489|NCT00943917|75841135|FG013|STARTED|Stage I||0||
59722490|NCT00943917|75841136|FG014|STARTED|Stage I||0||
59722491|NCT00943917|75841122|FG000|COMPLETED|Stage I||47||
59722492|NCT00943917|75841123|FG001|COMPLETED|Stage I||48||
59722493|NCT00943917|75841124|FG002|COMPLETED|Stage I||47||
59722494|NCT00943917|75841125|FG003|COMPLETED|Stage I||0||
59722495|NCT00943917|75841126|FG004|COMPLETED|Stage I||0||
59722496|NCT00943917|75841127|FG005|COMPLETED|Stage I||0||
59722497|NCT00943917|75841128|FG006|COMPLETED|Stage I||0||
59722498|NCT00943917|75841129|FG007|COMPLETED|Stage I||0||
59722499|NCT00943917|75841130|FG008|COMPLETED|Stage I||0||
59722500|NCT00943917|75841131|FG009|COMPLETED|Stage I||0||
59722501|NCT00943917|75841132|FG010|COMPLETED|Stage I||0||
59722502|NCT00943917|75841133|FG011|COMPLETED|Stage I||0||
59722503|NCT00943917|75841134|FG012|COMPLETED|Stage I||0||
59722504|NCT00943917|75841135|FG013|COMPLETED|Stage I||0||
59722505|NCT00943917|75841136|FG014|COMPLETED|Stage I||0||
59722506|NCT00943917|75841122|FG000|NOT COMPLETED|Stage I||4||
59722507|NCT00943917|75841123|FG001|NOT COMPLETED|Stage I||3||
59722508|NCT00943917|75841124|FG002|NOT COMPLETED|Stage I||6||
59722509|NCT00943917|75841125|FG003|NOT COMPLETED|Stage I||0||
59722510|NCT00943917|75841126|FG004|NOT COMPLETED|Stage I||0||
59722511|NCT00943917|75841127|FG005|NOT COMPLETED|Stage I||0||
59722512|NCT00943917|75841128|FG006|NOT COMPLETED|Stage I||0||
59722513|NCT00943917|75841129|FG007|NOT COMPLETED|Stage I||0||
59722514|NCT00943917|75841130|FG008|NOT COMPLETED|Stage I||0||
59722515|NCT00943917|75841131|FG009|NOT COMPLETED|Stage I||0||
59722516|NCT00943917|75841132|FG010|NOT COMPLETED|Stage I||0||
59722517|NCT00943917|75841133|FG011|NOT COMPLETED|Stage I||0||
59722518|NCT00943917|75841134|FG012|NOT COMPLETED|Stage I||0||
59722519|NCT00943917|75841135|FG013|NOT COMPLETED|Stage I||0||
59722520|NCT00943917|75841136|FG014|NOT COMPLETED|Stage I||0||
59722521|NCT00943917|75841122|FG000|STARTED|Stage II||0||
59722522|NCT00943917|75841123|FG001|STARTED|Stage II||0||
59722523|NCT00943917|75841124|FG002|STARTED|Stage II||0||
59722524|NCT00943917|75841125|FG003|STARTED|Stage II||20||
59722525|NCT00943917|75841126|FG004|STARTED|Stage II||21||
59722526|NCT00943917|75841127|FG005|STARTED|Stage II||23||
59722527|NCT00943917|75841128|FG006|STARTED|Stage II||23||
59722528|NCT00943917|75841129|FG007|STARTED|Stage II||23||
59722529|NCT00943917|75841130|FG008|STARTED|Stage II||21||
59722530|NCT00943917|75841131|FG009|STARTED|Stage II||0||
59722531|NCT00943917|75841132|FG010|STARTED|Stage II||0||
59722532|NCT00943917|75841133|FG011|STARTED|Stage II||0||
59722533|NCT00943917|75841134|FG012|STARTED|Stage II||0||
59722534|NCT00943917|75841135|FG013|STARTED|Stage II||0||
59722535|NCT00943917|75841136|FG014|STARTED|Stage II||0||
59722536|NCT00943917|75841122|FG000|COMPLETED|Stage II||0||
59722537|NCT00943917|75841123|FG001|COMPLETED|Stage II||0||
59722538|NCT00943917|75841124|FG002|COMPLETED|Stage II||0||
59722539|NCT00943917|75841125|FG003|COMPLETED|Stage II||20||
59722540|NCT00943917|75841126|FG004|COMPLETED|Stage II||21||
59722541|NCT00943917|75841127|FG005|COMPLETED|Stage II||20||
59722542|NCT00943917|75841128|FG006|COMPLETED|Stage II||20||
59722543|NCT00943917|75841129|FG007|COMPLETED|Stage II||23||
59722544|NCT00943917|75841130|FG008|COMPLETED|Stage II||20||
59722545|NCT00943917|75841131|FG009|COMPLETED|Stage II||0||
59722546|NCT00943917|75841132|FG010|COMPLETED|Stage II||0||
59722547|NCT00943917|75841133|FG011|COMPLETED|Stage II||0||
59722548|NCT00943917|75841134|FG012|COMPLETED|Stage II||0||
59722549|NCT00943917|75841135|FG013|COMPLETED|Stage II||0||
59722550|NCT00943917|75841136|FG014|COMPLETED|Stage II||0||
59722551|NCT00943917|75841122|FG000|NOT COMPLETED|Stage II||0||
59722552|NCT00943917|75841123|FG001|NOT COMPLETED|Stage II||0||
59722553|NCT00943917|75841124|FG002|NOT COMPLETED|Stage II||0||
59722554|NCT00943917|75841125|FG003|NOT COMPLETED|Stage II||0||
59722555|NCT00943917|75841126|FG004|NOT COMPLETED|Stage II||0||
59722556|NCT00943917|75841127|FG005|NOT COMPLETED|Stage II||3||
59722557|NCT00943917|75841128|FG006|NOT COMPLETED|Stage II||3||
59722558|NCT00943917|75841129|FG007|NOT COMPLETED|Stage II||0||
59722559|NCT00943917|75841130|FG008|NOT COMPLETED|Stage II||1||
59722560|NCT00943917|75841131|FG009|NOT COMPLETED|Stage II||0||
59722561|NCT00943917|75841132|FG010|NOT COMPLETED|Stage II||0||
59722562|NCT00943917|75841133|FG011|NOT COMPLETED|Stage II||0||
59722563|NCT00943917|75841134|FG012|NOT COMPLETED|Stage II||0||
59722564|NCT00943917|75841135|FG013|NOT COMPLETED|Stage II||0||
59722565|NCT00943917|75841136|FG014|NOT COMPLETED|Stage II||0||
59722566|NCT00943917|75841122|FG000|STARTED|Stage II Continuation||0||
59722567|NCT00943917|75841123|FG001|STARTED|Stage II Continuation||0||
59722568|NCT00943917|75841124|FG002|STARTED|Stage II Continuation||0||
59722569|NCT00943917|75841125|FG003|STARTED|Stage II Continuation||0||
59722570|NCT00943917|75841126|FG004|STARTED|Stage II Continuation||0||
59722571|NCT00943917|75841127|FG005|STARTED|Stage II Continuation||0||
59722572|NCT00943917|75841128|FG006|STARTED|Stage II Continuation||0||
59722573|NCT00943917|75841129|FG007|STARTED|Stage II Continuation||0||
59722574|NCT00943917|75841130|FG008|STARTED|Stage II Continuation||0||
59722575|NCT00943917|75841131|FG009|STARTED|Stage II Continuation||15||
59722576|NCT00943917|75841132|FG010|STARTED|Stage II Continuation||15||
59722577|NCT00943917|75841133|FG011|STARTED|Stage II Continuation||13||
59722578|NCT00943917|75841134|FG012|STARTED|Stage II Continuation||16||
59722579|NCT00943917|75841135|FG013|STARTED|Stage II Continuation||15||
59722580|NCT00943917|75841136|FG014|STARTED|Stage II Continuation||12||
59722581|NCT00943917|75841122|FG000|COMPLETED|Stage II Continuation||0||
59722582|NCT00943917|75841123|FG001|COMPLETED|Stage II Continuation||0||
59722583|NCT00943917|75841124|FG002|COMPLETED|Stage II Continuation||0||
59722584|NCT00943917|75841125|FG003|COMPLETED|Stage II Continuation||0||
59722585|NCT00943917|75841126|FG004|COMPLETED|Stage II Continuation||0||
59722586|NCT00943917|75841127|FG005|COMPLETED|Stage II Continuation||0||
59722587|NCT00943917|75841128|FG006|COMPLETED|Stage II Continuation||0||
59722588|NCT00943917|75841129|FG007|COMPLETED|Stage II Continuation||0||
59722589|NCT00943917|75841130|FG008|COMPLETED|Stage II Continuation||0||
59722590|NCT00943917|75841131|FG009|COMPLETED|Stage II Continuation||14||
59722591|NCT00943917|75841132|FG010|COMPLETED|Stage II Continuation||15||
59722592|NCT00943917|75841133|FG011|COMPLETED|Stage II Continuation||11||
59722593|NCT00943917|75841134|FG012|COMPLETED|Stage II Continuation||13||
59722594|NCT00943917|75841135|FG013|COMPLETED|Stage II Continuation||12||
59722595|NCT00943917|75841136|FG014|COMPLETED|Stage II Continuation||8||
59722596|NCT00943917|75841122|FG000|NOT COMPLETED|Stage II Continuation||0||
59722597|NCT00943917|75841123|FG001|NOT COMPLETED|Stage II Continuation||0||
59722598|NCT00943917|75841124|FG002|NOT COMPLETED|Stage II Continuation||0||
59722599|NCT00943917|75841125|FG003|NOT COMPLETED|Stage II Continuation||0||
59722600|NCT00943917|75841126|FG004|NOT COMPLETED|Stage II Continuation||0||
59722601|NCT00943917|75841127|FG005|NOT COMPLETED|Stage II Continuation||0||
59722602|NCT00943917|75841128|FG006|NOT COMPLETED|Stage II Continuation||0||
59722603|NCT00943917|75841129|FG007|NOT COMPLETED|Stage II Continuation||0||
59722604|NCT00943917|75841130|FG008|NOT COMPLETED|Stage II Continuation||0||
59722605|NCT00943917|75841131|FG009|NOT COMPLETED|Stage II Continuation||1||
59722606|NCT00943917|75841132|FG010|NOT COMPLETED|Stage II Continuation||0||
59722607|NCT00943917|75841133|FG011|NOT COMPLETED|Stage II Continuation||2||
59722608|NCT00943917|75841134|FG012|NOT COMPLETED|Stage II Continuation||3||
59722609|NCT00943917|75841135|FG013|NOT COMPLETED|Stage II Continuation||3||
59722610|NCT00943917|75841136|FG014|NOT COMPLETED|Stage II Continuation||4||
59722611|NCT01077024|75841171|FG000|STARTED|Overall Study||267||
59722612|NCT01077024|75841172|FG001|STARTED|Overall Study||271||
59722613|NCT01077024|75841171|FG000|COMPLETED|Overall Study||236||
59722614|NCT01077024|75841172|FG001|COMPLETED|Overall Study||243||
59722615|NCT01077024|75841171|FG000|NOT COMPLETED|Overall Study||31||
59722616|NCT01077024|75841172|FG001|NOT COMPLETED|Overall Study||28||
59722617|NCT01089582|75841178|FG000|STARTED|Overall Study||603||
59722618|NCT01089582|75841178|FG000|COMPLETED|Overall Study|1 subject died during the study; 1 subject died following permanent discontinuation from the study.|573||
59722619|NCT01089582|75841178|FG000|NOT COMPLETED|Overall Study||30||
59722620|NCT00862459|75841185|FG000|STARTED|Overall Study||72||
59722621|NCT00862459|75841186|FG001|STARTED|Overall Study||93||
59722622|NCT00862459|75841187|FG002|STARTED|Overall Study||72||
59722623|NCT00862459|75841185|FG000|Participants Received Treatment|Overall Study|Number reflects all treated participants of whom 67 received Gadobutrol and 70 received OptiMARK|70||
59722624|NCT00862459|75841186|FG001|Participants Received Treatment|Overall Study|Number reflects all treated participants of whom 90 received Gadobutrol and 88 received OptiMARK|90||
59722625|NCT00862459|75841187|FG002|Participants Received Treatment|Overall Study|Number reflects all treated participants of whom 68 received Gadobutrol and 69 received OptiMARK|69||
59722626|NCT00862459|75841185|FG000|COMPLETED|Overall Study||66||
59722627|NCT00862459|75841186|FG001|COMPLETED|Overall Study||85||
59722628|NCT00862459|75841187|FG002|COMPLETED|Overall Study||66||
59722629|NCT00862459|75841185|FG000|NOT COMPLETED|Overall Study||6||
59722630|NCT00862459|75841186|FG001|NOT COMPLETED|Overall Study||8||
59850347|NCT03810014|75974715|FG000|STARTED|Overall Study||215||
59850348|NCT03810014|75974716|FG001|STARTED|Overall Study||204||
59850349|NCT03810014|75974717|FG002|STARTED|Overall Study||210||
59722631|NCT00862459|75841187|FG002|NOT COMPLETED|Overall Study||6||
59722632|NCT01074450|75841198|FG000|STARTED|First Intervention||12||
59722633|NCT01074450|75841199|FG001|STARTED|First Intervention||12||
59722634|NCT01074450|75841198|FG000|COMPLETED|First Intervention||12||
59722635|NCT01074450|75841199|FG001|COMPLETED|First Intervention||10||
59722636|NCT01074450|75841198|FG000|NOT COMPLETED|First Intervention||0||
59722637|NCT01074450|75841199|FG001|NOT COMPLETED|First Intervention||2||
59722638|NCT01074450|75841198|FG000|STARTED|Washout of 7 Days||12||
59722639|NCT01074450|75841199|FG001|STARTED|Washout of 7 Days||10||
59722640|NCT01074450|75841198|FG000|COMPLETED|Washout of 7 Days||12||
59722641|NCT01074450|75841199|FG001|COMPLETED|Washout of 7 Days||10||
59722642|NCT01074450|75841198|FG000|NOT COMPLETED|Washout of 7 Days||0||
59850350|NCT03810014|75974718|FG003|STARTED|Overall Study||213||
59850351|NCT03810014|75974715|FG000|COMPLETED|Overall Study||213||
59722643|NCT01074450|75841199|FG001|NOT COMPLETED|Washout of 7 Days||0||
59722644|NCT01074450|75841198|FG000|STARTED|Second Intervention||12||
59722645|NCT01074450|75841199|FG001|STARTED|Second Intervention||10||
59722646|NCT01074450|75841198|FG000|COMPLETED|Second Intervention|Positive Drug Screen at Check in.|11||
59722647|NCT01074450|75841199|FG001|COMPLETED|Second Intervention|Influenze Symptoms Present at Check in.|9||
59722648|NCT01074450|75841198|FG000|NOT COMPLETED|Second Intervention||1||
59722649|NCT01074450|75841199|FG001|NOT COMPLETED|Second Intervention||1||
59722650|NCT00943761|75841207|FG000|STARTED|Overall Study||21||
59722651|NCT00943761|75841208|FG001|STARTED|Overall Study||24||
59722652|NCT00943761|75841207|FG000|COMPLETED|Overall Study||17||
59722653|NCT00943761|75841208|FG001|COMPLETED|Overall Study||23||
59722654|NCT00943761|75841207|FG000|NOT COMPLETED|Overall Study||4||
59722655|NCT00943761|75841208|FG001|NOT COMPLETED|Overall Study||1||
59722656|NCT00949533|75841216|FG000|STARTED|Overall Study||19||
59722657|NCT00949533|75841217|FG001|STARTED|Overall Study||18||
59722658|NCT00949533|75841216|FG000|COMPLETED|Overall Study||19||
59722659|NCT00949533|75841217|FG001|COMPLETED|Overall Study||17||
59722660|NCT00949533|75841216|FG000|NOT COMPLETED|Overall Study||0||
59722661|NCT00949533|75841217|FG001|NOT COMPLETED|Overall Study||1||
59722662|NCT00866047|75841223|FG000|STARTED|Treatment Period||58||
59722663|NCT00866047|75841223|FG000|COMPLETED|Treatment Period|Number who completed 16 cycles of treatment|10||
59722664|NCT00866047|75841223|FG000|NOT COMPLETED|Treatment Period||48||
59722665|NCT00866047|75841223|FG000|STARTED|Follow-up Period|All participants were to be followed after treatment|58||
59722666|NCT00866047|75841223|FG000|COMPLETED|Follow-up Period|Completed survival follow-up due to death [25] or study completion [28]|53||
59722667|NCT00866047|75841223|FG000|NOT COMPLETED|Follow-up Period||5||
59722668|NCT00869323|75841227|FG000|STARTED|Induction Therapy||3||
59722669|NCT00869323|75841227|FG000|COMPLETED|Induction Therapy||3||
59722670|NCT00869323|75841227|FG000|NOT COMPLETED|Induction Therapy||0||
59722671|NCT00869323|75841227|FG000|STARTED|Maintenance Therapy|One participant removed from study after completing induction therapy due to progressive disease.|2||
59722672|NCT00869323|75841227|FG000|COMPLETED|Maintenance Therapy||1||
59722673|NCT00869323|75841227|FG000|NOT COMPLETED|Maintenance Therapy||1||
59722674|NCT01192022|75841235|FG000|STARTED|Overall Study||114||
59722675|NCT01192022|75841236|FG001|STARTED|Overall Study||110||
59722676|NCT01192022|75841237|FG002|STARTED|Overall Study||8||
59722677|NCT01192022|75841238|FG003|STARTED|Overall Study||9||
59722678|NCT01192022|75841239|FG004|STARTED|Overall Study||12||
59722679|NCT01192022|75841235|FG000|Safety Population-Received Treatment|Overall Study||114||
59722680|NCT01192022|75841236|FG001|Safety Population-Received Treatment|Overall Study||109||
59722681|NCT01192022|75841237|FG002|Safety Population-Received Treatment|Overall Study||8||
59722682|NCT01192022|75841238|FG003|Safety Population-Received Treatment|Overall Study||9||
59722683|NCT01192022|75841239|FG004|Safety Population-Received Treatment|Overall Study||12||
59722684|NCT01192022|75841235|FG000|COMPLETED|Overall Study||101||
59722685|NCT01192022|75841236|FG001|COMPLETED|Overall Study||99||
59722686|NCT01192022|75841237|FG002|COMPLETED|Overall Study||7||
59722687|NCT01192022|75841238|FG003|COMPLETED|Overall Study||7||
59722688|NCT01192022|75841239|FG004|COMPLETED|Overall Study||11||
59722689|NCT01192022|75841235|FG000|NOT COMPLETED|Overall Study||13||
59722690|NCT01192022|75841236|FG001|NOT COMPLETED|Overall Study||11||
59722691|NCT01192022|75841237|FG002|NOT COMPLETED|Overall Study||1||
59722692|NCT01192022|75841238|FG003|NOT COMPLETED|Overall Study||2||
59722693|NCT01192022|75841239|FG004|NOT COMPLETED|Overall Study||1||
59722694|NCT01191944|75841252|FG000|STARTED|Overall Study|Treated titration/maintenance|234||
59722695|NCT01191944|75841253|FG001|STARTED|Overall Study|Treated titration/maintenance|239||
59722696|NCT01191944|75841252|FG000|COMPLETED|Overall Study|Completed titration/maintenance|217||
59722697|NCT01191944|75841253|FG001|COMPLETED|Overall Study|Completed titration/maintenance|220||
59722698|NCT01191944|75841252|FG000|NOT COMPLETED|Overall Study||17||
59722699|NCT01191944|75841253|FG001|NOT COMPLETED|Overall Study||19||
59722700|NCT01191788|75841261|FG000|STARTED|Overall Study||140||
59722701|NCT01191788|75841262|FG001|STARTED|Overall Study||159||
59722702|NCT01191788|75841261|FG000|COMPLETED|Overall Study|Completed 3-month followup|119||
59850352|NCT03810014|75974716|FG001|COMPLETED|Overall Study||202||
59722703|NCT01191788|75841262|FG001|COMPLETED|Overall Study|Completed 3-month followup|137||
59722704|NCT01191788|75841261|FG000|NOT COMPLETED|Overall Study||21||
59722705|NCT01191788|75841262|FG001|NOT COMPLETED|Overall Study||22||
59722706|NCT00940875|75841271|FG000|STARTED|Treatment Phase|Disposition analysis includes 3 participants randomized to G+E but received only gemcitabine|31||
59722707|NCT00940875|75841272|FG001|STARTED|Treatment Phase|3 participants randomized to G+E arm received only gemcitabine and were analyzed in Gemcitabine arm|23||
59722708|NCT00940875|75841271|FG000|COMPLETED|Treatment Phase||5||
59722709|NCT00940875|75841272|FG001|COMPLETED|Treatment Phase||4||
59722710|NCT00940875|75841271|FG000|NOT COMPLETED|Treatment Phase||26||
59722711|NCT00940875|75841272|FG001|NOT COMPLETED|Treatment Phase||19||
59722712|NCT00940875|75841271|FG000|STARTED|Post-Study Treatment||0||
59722713|NCT00940875|75841272|FG001|STARTED|Post-Study Treatment||4||
59722714|NCT00940875|75841271|FG000|COMPLETED|Post-Study Treatment||0||
59850353|NCT03810014|75974717|FG002|COMPLETED|Overall Study||210||
59850354|NCT03810014|75974718|FG003|COMPLETED|Overall Study||211||
59722715|NCT00940875|75841272|FG001|COMPLETED|Post-Study Treatment||1||
59722716|NCT00940875|75841271|FG000|NOT COMPLETED|Post-Study Treatment||0||
59722717|NCT00940875|75841272|FG001|NOT COMPLETED|Post-Study Treatment||3||
59722718|NCT00940485|75841281|FG000|STARTED|Overall Study||97||
59722719|NCT00940485|75841282|FG001|STARTED|Overall Study||100||
59722720|NCT00940485|75841281|FG000|COMPLETED|Overall Study||82||
59722721|NCT00940485|75841282|FG001|COMPLETED|Overall Study||93||
59722722|NCT00940485|75841281|FG000|NOT COMPLETED|Overall Study||15||
59722723|NCT00940485|75841282|FG001|NOT COMPLETED|Overall Study||7||
59722724|NCT00943605|75841290|FG000|STARTED|Overall Study|There were 10 total subjects (5/group) who were retrospectively unenrolled for deviations.|30||
59722725|NCT00943605|75841291|FG001|STARTED|Overall Study|There were 10 total subjects (5/group) who were retrospectively unenrolled for deviations.|30||
59722726|NCT00943605|75841290|FG000|COMPLETED|Overall Study||0||
59722727|NCT00943605|75841291|FG001|COMPLETED|Overall Study||0||
59722728|NCT00943605|75841290|FG000|NOT COMPLETED|Overall Study||30||
59722729|NCT00943605|75841291|FG001|NOT COMPLETED|Overall Study||30||
59722730|NCT01132313|75841309|FG000|STARTED|Overall Study||17||
59722731|NCT01132313|75841310|FG001|STARTED|Overall Study||17||
59722732|NCT01132313|75841311|FG002|STARTED|Overall Study||81||
59722733|NCT01132313|75841312|FG003|STARTED|Overall Study||80||
59722734|NCT01132313|75841313|FG004|STARTED|Overall Study||79||
59722735|NCT01132313|75841314|FG005|STARTED|Overall Study||79||
59722736|NCT01132313|75841315|FG006|STARTED|Overall Study||49||
59722737|NCT01132313|75841316|FG007|STARTED|Overall Study||32||
59722738|NCT01132313|75841317|FG008|STARTED|Overall Study||26||
59722739|NCT01132313|75841318|FG009|STARTED|Overall Study||25||
59722740|NCT01132313|75841319|FG010|STARTED|Overall Study||1||
59722741|NCT01132313|75841320|FG011|STARTED|Overall Study||2||
59722742|NCT01132313|75841309|FG000|COMPLETED|Overall Study||14||
59722743|NCT01132313|75841310|FG001|COMPLETED|Overall Study||17||
59722744|NCT01132313|75841311|FG002|COMPLETED|Overall Study||61||
59722745|NCT01132313|75841312|FG003|COMPLETED|Overall Study||48||
59722746|NCT01132313|75841313|FG004|COMPLETED|Overall Study||34||
59722747|NCT01132313|75841314|FG005|COMPLETED|Overall Study||54||
59722748|NCT01132313|75841315|FG006|COMPLETED|Overall Study||19||
59722749|NCT01132313|75841316|FG007|COMPLETED|Overall Study||24||
59722750|NCT01132313|75841317|FG008|COMPLETED|Overall Study||5||
59722751|NCT01132313|75841318|FG009|COMPLETED|Overall Study||5||
59722752|NCT01132313|75841319|FG010|COMPLETED|Overall Study||0||
59722753|NCT01132313|75841320|FG011|COMPLETED|Overall Study||2||
59722754|NCT01132313|75841309|FG000|NOT COMPLETED|Overall Study||3||
59722755|NCT01132313|75841310|FG001|NOT COMPLETED|Overall Study||0||
59722756|NCT01132313|75841311|FG002|NOT COMPLETED|Overall Study||20||
59722757|NCT01132313|75841312|FG003|NOT COMPLETED|Overall Study||32||
59722758|NCT01132313|75841313|FG004|NOT COMPLETED|Overall Study||45||
59722759|NCT01132313|75841314|FG005|NOT COMPLETED|Overall Study||25||
59722760|NCT01132313|75841315|FG006|NOT COMPLETED|Overall Study||30||
59722761|NCT01132313|75841316|FG007|NOT COMPLETED|Overall Study||8||
59722762|NCT01132313|75841317|FG008|NOT COMPLETED|Overall Study||21||
59722763|NCT01132313|75841318|FG009|NOT COMPLETED|Overall Study||20||
59722764|NCT01132313|75841319|FG010|NOT COMPLETED|Overall Study||1||
59722765|NCT01132313|75841320|FG011|NOT COMPLETED|Overall Study||0||
59722766|NCT00861757|75841355|FG000|STARTED|Overall Study||154||
59722767|NCT00861757|75841356|FG001|STARTED|Overall Study||151||
59722768|NCT00861757|75841357|FG002|STARTED|Overall Study||155||
59722769|NCT00861757|75841358|FG003|STARTED|Overall Study||152||
59722770|NCT00861757|75841355|FG000|COMPLETED|Overall Study||145||
59722771|NCT00861757|75841356|FG001|COMPLETED|Overall Study||136||
59722772|NCT00861757|75841357|FG002|COMPLETED|Overall Study||137||
59850355|NCT03810014|75974715|FG000|NOT COMPLETED|Overall Study||2||
59850356|NCT03810014|75974716|FG001|NOT COMPLETED|Overall Study||2||
59850357|NCT03810014|75974717|FG002|NOT COMPLETED|Overall Study||0||
59850358|NCT03810014|75974718|FG003|NOT COMPLETED|Overall Study||2||
59578578|NCT02881775|75684091|FG000|NOT COMPLETED|Baseline||0||
59722773|NCT00861757|75841358|FG003|COMPLETED|Overall Study||143||
59722774|NCT00861757|75841355|FG000|NOT COMPLETED|Overall Study||9||
59722775|NCT00861757|75841356|FG001|NOT COMPLETED|Overall Study||15||
59722776|NCT00861757|75841357|FG002|NOT COMPLETED|Overall Study||18||
59722777|NCT00861757|75841358|FG003|NOT COMPLETED|Overall Study||9||
59722778|NCT01131455|75841375|FG000|STARTED|Overall Study||6||
59850359|NCT04978363|75974739|FG000|STARTED|Overall Study||2||
60121377|NCT02684370|76242314|FG000|COMPLETED|Part A||98||
59722779|NCT01131455|75841376|FG001|STARTED|Overall Study||4||
59722780|NCT01131455|75841377|FG002|STARTED|Overall Study||0||
59722781|NCT01131455|75841375|FG000|COMPLETED|Overall Study||0||
59722782|NCT01131455|75841376|FG001|COMPLETED|Overall Study||0||
59722783|NCT01131455|75841377|FG002|COMPLETED|Overall Study||0||
59722784|NCT01131455|75841375|FG000|NOT COMPLETED|Overall Study||6||
59722785|NCT01131455|75841376|FG001|NOT COMPLETED|Overall Study||4||
59850360|NCT04978363|75974740|FG001|STARTED|Overall Study||2||
60121378|NCT02684370|76242315|FG001|COMPLETED|Part A||99||
59578579|NCT02881775|75684092|FG001|NOT COMPLETED|Baseline||0||
59722786|NCT01131455|75841377|FG002|NOT COMPLETED|Overall Study||0||
59722787|NCT01138007|75841388|FG000|STARTED|Overall Study||187||
59722788|NCT01138007|75841389|FG001|STARTED|Overall Study||190||
59722789|NCT01138007|75841390|FG002|STARTED|Overall Study||192||
59722790|NCT01138007|75841388|FG000|COMPLETED|Overall Study||165||
59722791|NCT01138007|75841389|FG001|COMPLETED|Overall Study||160||
59722792|NCT01138007|75841390|FG002|COMPLETED|Overall Study||144||
59722793|NCT01138007|75841388|FG000|NOT COMPLETED|Overall Study||22||
59722794|NCT01138007|75841389|FG001|NOT COMPLETED|Overall Study||30||
59722795|NCT01138007|75841390|FG002|NOT COMPLETED|Overall Study||48||
59722796|NCT00865345|75841400|FG000|STARTED|Overall Study||63||
59722797|NCT00865345|75841400|FG000|COMPLETED|Overall Study||61||
59722798|NCT00865345|75841400|FG000|NOT COMPLETED|Overall Study||2||
59722799|NCT01131299|75841404|FG000|STARTED|Overall Study||42||
59722800|NCT01131299|75841405|FG001|STARTED|Overall Study||44||
59722801|NCT01131299|75841404|FG000|COMPLETED|Overall Study||38||
59722802|NCT01131299|75841405|FG001|COMPLETED|Overall Study||37||
59722803|NCT01131299|75841404|FG000|NOT COMPLETED|Overall Study||4||
59722804|NCT01131299|75841405|FG001|NOT COMPLETED|Overall Study||7||
59722805|NCT01130831|75841410|FG000|STARTED|Overall Study||66||
59722806|NCT01130831|75841410|FG000|COMPLETED|Overall Study||52||
59722807|NCT01130831|75841410|FG000|NOT COMPLETED|Overall Study||14||
59722808|NCT01130597|75841426|FG000|STARTED|Overall Study||63||
59722809|NCT01130597|75841426|FG000|COMPLETED|Overall Study||56||
59722810|NCT01130597|75841426|FG000|NOT COMPLETED|Overall Study||7||
59722811|NCT00939003|75841432|FG000|STARTED|Double-blind Treatment Period||97||
59722812|NCT00939003|75841433|FG001|STARTED|Double-blind Treatment Period||95||
59722813|NCT00939003|75841432|FG000|COMPLETED|Double-blind Treatment Period||95||
59722814|NCT00939003|75841433|FG001|COMPLETED|Double-blind Treatment Period||91||
59722815|NCT00939003|75841432|FG000|NOT COMPLETED|Double-blind Treatment Period||2||
59722816|NCT00939003|75841433|FG001|NOT COMPLETED|Double-blind Treatment Period||4||
59722817|NCT00939003|75841432|FG000|STARTED|Open-label Treatment Period||95||
59722818|NCT00939003|75841433|FG001|STARTED|Open-label Treatment Period||91||
59722819|NCT00939003|75841432|FG000|COMPLETED|Open-label Treatment Period||66||
59722820|NCT00939003|75841433|FG001|COMPLETED|Open-label Treatment Period||62||
59722821|NCT00939003|75841432|FG000|NOT COMPLETED|Open-label Treatment Period||29||
59722822|NCT00939003|75841433|FG001|NOT COMPLETED|Open-label Treatment Period||29||
59722823|NCT01188668|75841442|FG000|STARTED|Period 1: ARIP Alone||38||
59722824|NCT01188668|75841442|FG000|COMPLETED|Period 1: ARIP Alone||36||
59722825|NCT01188668|75841442|FG000|NOT COMPLETED|Period 1: ARIP Alone||2||
59722826|NCT01188668|75841442|FG000|STARTED|Period 2: Coadministration ARIP + DVS SR||36||
59722827|NCT01188668|75841442|FG000|COMPLETED|Period 2: Coadministration ARIP + DVS SR||33||
59722828|NCT01188668|75841442|FG000|NOT COMPLETED|Period 2: Coadministration ARIP + DVS SR||3||
59722829|NCT01130051|75841449|FG000|STARTED|Period 1||8||
59722830|NCT01130051|75841450|FG001|STARTED|Period 1||8||
59722831|NCT01130051|75841449|FG000|COMPLETED|Period 1||8||
59722832|NCT01130051|75841450|FG001|COMPLETED|Period 1||8||
59850361|NCT04978363|75974741|FG002|STARTED|Overall Study||2||
59850362|NCT04978363|75974742|FG003|STARTED|Overall Study||1||
59722833|NCT01130051|75841449|FG000|NOT COMPLETED|Period 1||0||
59722834|NCT01130051|75841450|FG001|NOT COMPLETED|Period 1||0||
59722835|NCT01130051|75841449|FG000|STARTED|Washout Period of 14 Days||8||
59722836|NCT01130051|75841450|FG001|STARTED|Washout Period of 14 Days||8||
59722837|NCT01130051|75841449|FG000|COMPLETED|Washout Period of 14 Days||7||
59722838|NCT01130051|75841450|FG001|COMPLETED|Washout Period of 14 Days||6||
59722839|NCT01130051|75841449|FG000|NOT COMPLETED|Washout Period of 14 Days||1||
59722840|NCT01130051|75841450|FG001|NOT COMPLETED|Washout Period of 14 Days||2||
59722841|NCT01130051|75841449|FG000|STARTED|Period 2||7||
59722842|NCT01130051|75841450|FG001|STARTED|Period 2||6||
59722843|NCT01130051|75841449|FG000|COMPLETED|Period 2||7||
59722844|NCT01130051|75841450|FG001|COMPLETED|Period 2||6||
59722845|NCT01130051|75841449|FG000|NOT COMPLETED|Period 2||0||
59722846|NCT01130051|75841450|FG001|NOT COMPLETED|Period 2||0||
59722847|NCT00865189|75841458|FG000|STARTED|Overall Study||46||
59850363|NCT04978363|75974743|FG004|STARTED|Overall Study||3||
59850364|NCT04978363|75974744|FG005|STARTED|Overall Study||1||
59722848|NCT00865189|75841459|FG001|STARTED|Overall Study||45||
59722849|NCT00865189|75841458|FG000|COMPLETED|Overall Study||34||
59722850|NCT00865189|75841459|FG001|COMPLETED|Overall Study||26||
59722851|NCT00865189|75841458|FG000|NOT COMPLETED|Overall Study||12||
59722852|NCT00865189|75841459|FG001|NOT COMPLETED|Overall Study||19||
59722853|NCT01182194|75841467|FG000|STARTED|First Intervention||16||
59722854|NCT01182194|75841468|FG001|STARTED|First Intervention||16||
59722855|NCT01182194|75841467|FG000|COMPLETED|First Intervention||16||
59722856|NCT01182194|75841468|FG001|COMPLETED|First Intervention||16||
59722857|NCT01182194|75841467|FG000|NOT COMPLETED|First Intervention||0||
59722858|NCT01182194|75841468|FG001|NOT COMPLETED|First Intervention||0||
59722859|NCT01182194|75841467|FG000|STARTED|Washout of 28 Days||16||
59722860|NCT01182194|75841468|FG001|STARTED|Washout of 28 Days||16||
59722861|NCT01182194|75841467|FG000|COMPLETED|Washout of 28 Days||15||
59722862|NCT01182194|75841468|FG001|COMPLETED|Washout of 28 Days||16||
59722863|NCT01182194|75841467|FG000|NOT COMPLETED|Washout of 28 Days||1||
59722864|NCT01182194|75841468|FG001|NOT COMPLETED|Washout of 28 Days||0||
59850365|NCT04978363|75974745|FG006|STARTED|Overall Study||2||
59722865|NCT01182194|75841467|FG000|STARTED|Second Intervention||15||
59722866|NCT01182194|75841468|FG001|STARTED|Second Intervention||16||
59722867|NCT01182194|75841467|FG000|COMPLETED|Second Intervention||15||
59722868|NCT01182194|75841468|FG001|COMPLETED|Second Intervention||16||
59722869|NCT01182194|75841467|FG000|NOT COMPLETED|Second Intervention||0||
59722870|NCT01182194|75841468|FG001|NOT COMPLETED|Second Intervention||0||
59722871|NCT01181726|75841476|FG000|STARTED|First Intervention||20||
59722872|NCT01181726|75841477|FG001|STARTED|First Intervention||20||
59722873|NCT01181726|75841476|FG000|COMPLETED|First Intervention||19||
59722874|NCT01181726|75841477|FG001|COMPLETED|First Intervention||20||
59722875|NCT01181726|75841476|FG000|NOT COMPLETED|First Intervention||1||
59722876|NCT01181726|75841477|FG001|NOT COMPLETED|First Intervention||0||
59722877|NCT01181726|75841476|FG000|STARTED|Washout of 28 Days||19||
59722878|NCT01181726|75841477|FG001|STARTED|Washout of 28 Days||20||
59722879|NCT01181726|75841476|FG000|COMPLETED|Washout of 28 Days||19||
59722880|NCT01181726|75841477|FG001|COMPLETED|Washout of 28 Days||20||
59722881|NCT01181726|75841476|FG000|NOT COMPLETED|Washout of 28 Days||0||
59722882|NCT01181726|75841477|FG001|NOT COMPLETED|Washout of 28 Days||0||
59722883|NCT01181726|75841476|FG000|STARTED|Second Intervention||19||
59722884|NCT01181726|75841477|FG001|STARTED|Second Intervention||20||
59722885|NCT01181726|75841476|FG000|COMPLETED|Second Intervention||19||
59722886|NCT01181726|75841477|FG001|COMPLETED|Second Intervention||20||
59722887|NCT01181726|75841476|FG000|NOT COMPLETED|Second Intervention||0||
59722888|NCT01181726|75841477|FG001|NOT COMPLETED|Second Intervention||0||
59722889|NCT01137071|75841483|FG000|STARTED|Overall Study|all patients considered eligible were included on the study|29||
59722890|NCT01137071|75841483|FG000|COMPLETED|Overall Study|Of the eligible patients|15||
59722891|NCT01137071|75841483|FG000|NOT COMPLETED|Overall Study||14||
59722892|NCT00860743|75841498|FG000|STARTED|Overall Study||40||
59722893|NCT00860743|75841499|FG001|STARTED|Overall Study||23||
59722894|NCT00860743|75841498|FG000|COMPLETED|Overall Study||37||
59722895|NCT00860743|75841499|FG001|COMPLETED|Overall Study||23||
59722896|NCT00860743|75841498|FG000|NOT COMPLETED|Overall Study||3||
59722897|NCT00860743|75841499|FG001|NOT COMPLETED|Overall Study||0||
59722898|NCT01186796|75841507|FG000|STARTED|Overall Study||14||
59722899|NCT01186796|75841508|FG001|STARTED|Overall Study|1 subject was randomized but withdrew before study interventions.|16||
59722900|NCT01186796|75841507|FG000|COMPLETED|Overall Study||10||
59722901|NCT01186796|75841508|FG001|COMPLETED|Overall Study||14||
59722902|NCT01186796|75841507|FG000|NOT COMPLETED|Overall Study||4||
59722903|NCT01186796|75841508|FG001|NOT COMPLETED|Overall Study||2||
59722904|NCT01136915|75841516|FG000|STARTED|Overall Study||8||
59722905|NCT01136915|75841517|FG001|STARTED|Overall Study||7||
59722906|NCT01136915|75841516|FG000|COMPLETED|Overall Study||6||
59722907|NCT01136915|75841517|FG001|COMPLETED|Overall Study||6||
59722908|NCT01136915|75841516|FG000|NOT COMPLETED|Overall Study||2||
59722909|NCT01136915|75841517|FG001|NOT COMPLETED|Overall Study||1||
59722910|NCT00940017|75841525|FG000|STARTED|Overall Study||24||
59722911|NCT00940017|75841525|FG000|Subjects Treated|Overall Study||21||
59722912|NCT00940017|75841525|FG000|COMPLETED|Overall Study||20||
59722913|NCT00940017|75841525|FG000|NOT COMPLETED|Overall Study||4||
59722914|NCT01129583|75841531|FG000|STARTED|Overall Study||9||
59722915|NCT01129583|75841532|FG001|STARTED|Overall Study||9||
59722916|NCT01129583|75841531|FG000|COMPLETED|Overall Study||6||
59722917|NCT01129583|75841532|FG001|COMPLETED|Overall Study||7||
59722918|NCT01129583|75841531|FG000|NOT COMPLETED|Overall Study||3||
59722919|NCT01129583|75841532|FG001|NOT COMPLETED|Overall Study||2||
59722920|NCT01186328|75841538|FG000|STARTED|Overall Study||6||
59722921|NCT01186328|75841539|FG001|STARTED|Overall Study||0||
59722922|NCT01186328|75841540|FG002|STARTED|Overall Study||0||
59722923|NCT01186328|75841538|FG000|COMPLETED|Overall Study||5||
59578580|NCT02881775|75684091|FG000|STARTED|First Intervention (1-hr Session)|Two participants dropped out prior to First Intervention (1-hr Session).|9||
59578581|NCT02881775|75684092|FG001|STARTED|First Intervention (1-hr Session)|Two participants dropped out prior to First Intervention (1-hr Session).|7||
59722924|NCT01186328|75841539|FG001|COMPLETED|Overall Study||0||
59850366|NCT04978363|75974746|FG007|STARTED|Overall Study||2||
59578582|NCT02881775|75684091|FG000|COMPLETED|First Intervention (1-hr Session)||9||
59578583|NCT02881775|75684092|FG001|COMPLETED|First Intervention (1-hr Session)||7||
59578584|NCT02881775|75684091|FG000|NOT COMPLETED|First Intervention (1-hr Session)||0||
59578585|NCT02881775|75684092|FG001|NOT COMPLETED|First Intervention (1-hr Session)||0||
59850367|NCT04978363|75974747|FG008|STARTED|Overall Study||2||
59722925|NCT01186328|75841540|FG002|COMPLETED|Overall Study||0||
59722926|NCT01186328|75841538|FG000|NOT COMPLETED|Overall Study||1||
59722927|NCT01186328|75841539|FG001|NOT COMPLETED|Overall Study||0||
59722928|NCT01186328|75841540|FG002|NOT COMPLETED|Overall Study||0||
59722929|NCT00848497|75841547|FG000|STARTED|Overall Study||2||
59722930|NCT00848497|75841548|FG001|STARTED|Overall Study|Completed Visit 4|1||
59722931|NCT00848497|75841547|FG000|COMPLETED|Overall Study||0||
59722932|NCT00848497|75841548|FG001|COMPLETED|Overall Study||0||
59722933|NCT00848497|75841547|FG000|NOT COMPLETED|Overall Study||2||
59722934|NCT00848497|75841548|FG001|NOT COMPLETED|Overall Study||1||
59850368|NCT04978363|75974748|FG009|STARTED|Overall Study||2||
59850369|NCT04978363|75974749|FG010|STARTED|Overall Study||1||
59722935|NCT00857623|75841558|FG000|STARTED|Overall Study||62||
59722936|NCT00857623|75841559|FG001|STARTED|Overall Study||65||
59722937|NCT00857623|75841558|FG000|COMPLETED|Overall Study||48||
59722938|NCT00857623|75841559|FG001|COMPLETED|Overall Study||55||
59722939|NCT00857623|75841558|FG000|NOT COMPLETED|Overall Study||14||
59722940|NCT00857623|75841559|FG001|NOT COMPLETED|Overall Study||10||
59722941|NCT01185782|75841567|FG000|STARTED|Overall Study||129||
59722942|NCT01185782|75841568|FG001|STARTED|Overall Study||136||
59722943|NCT01185782|75841567|FG000|Treated|Overall Study||129||
59722944|NCT01185782|75841568|FG001|Treated|Overall Study||132||
59722945|NCT01185782|75841567|FG000|COMPLETED|Overall Study||123||
59722946|NCT01185782|75841568|FG001|COMPLETED|Overall Study||125||
59722947|NCT01185782|75841567|FG000|NOT COMPLETED|Overall Study||6||
59722948|NCT01185782|75841568|FG001|NOT COMPLETED|Overall Study||11||
59578586|NCT02881775|75684091|FG000|STARTED|Washout (1 Week)||9||
59578587|NCT02881775|75684092|FG001|STARTED|Washout (1 Week)||7||
59722949|NCT01129115|75841578|FG000|STARTED|Overall Study||25||
59722950|NCT01129115|75841579|FG001|STARTED|Overall Study||25||
59722951|NCT01129115|75841580|FG002|STARTED|Overall Study||27||
59722952|NCT01129115|75841581|FG003|STARTED|Overall Study||24||
59722953|NCT01129115|75841578|FG000|COMPLETED|Overall Study||23||
59722954|NCT01129115|75841579|FG001|COMPLETED|Overall Study||18||
59722955|NCT01129115|75841580|FG002|COMPLETED|Overall Study||21||
59722956|NCT01129115|75841581|FG003|COMPLETED|Overall Study||15||
59722957|NCT01129115|75841578|FG000|NOT COMPLETED|Overall Study||2||
59722958|NCT01129115|75841579|FG001|NOT COMPLETED|Overall Study||7||
59722959|NCT01129115|75841580|FG002|NOT COMPLETED|Overall Study||6||
59722960|NCT01129115|75841581|FG003|NOT COMPLETED|Overall Study||9||
59722961|NCT01185704|75841593|FG000|STARTED|Overall Study||68||
59722962|NCT01185704|75841594|FG001|STARTED|Overall Study||68||
59722963|NCT01185704|75841593|FG000|Treated|Overall Study||65||
59722964|NCT01185704|75841594|FG001|Treated|Overall Study||65||
59722965|NCT01185704|75841593|FG000|COMPLETED|Overall Study||55||
59722966|NCT01185704|75841594|FG001|COMPLETED|Overall Study||60||
59722967|NCT01185704|75841593|FG000|NOT COMPLETED|Overall Study||13||
59722968|NCT01185704|75841594|FG001|NOT COMPLETED|Overall Study||8||
59722969|NCT01128959|75841600|FG000|STARTED|Lead in Period||108||
59722970|NCT01128959|75841600|FG000|COMPLETED|Lead in Period||105||
59722971|NCT01128959|75841600|FG000|NOT COMPLETED|Lead in Period||3||
59722972|NCT01128959|75841600|FG000|STARTED|Treatment Period||105||
59722973|NCT01128959|75841600|FG000|COMPLETED|Treatment Period||101||
59722974|NCT01128959|75841600|FG000|NOT COMPLETED|Treatment Period||4||
59722975|NCT00859573|75841608|FG000|STARTED|Overall Study||6||
59722976|NCT00859573|75841609|FG001|STARTED|Overall Study||3||
59722977|NCT00859573|75841608|FG000|COMPLETED|Overall Study||1||
59722978|NCT00859573|75841609|FG001|COMPLETED|Overall Study||1||
59722979|NCT00859573|75841608|FG000|NOT COMPLETED|Overall Study||5||
59722980|NCT00859573|75841609|FG001|NOT COMPLETED|Overall Study||2||
59722981|NCT01136291|75841617|FG000|STARTED|Overall Study||40||
59722982|NCT01136291|75841618|FG001|STARTED|Overall Study||42||
59722983|NCT01136291|75841617|FG000|Follow|Overall Study||40||
59722984|NCT01136291|75841618|FG001|Follow|Overall Study||42||
59722985|NCT01136291|75841617|FG000|COMPLETED|Overall Study||39||
59722986|NCT01136291|75841618|FG001|COMPLETED|Overall Study||41||
59722987|NCT01136291|75841617|FG000|NOT COMPLETED|Overall Study||1||
59722988|NCT01136291|75841618|FG001|NOT COMPLETED|Overall Study||1||
59722989|NCT01185548|75841624|FG000|STARTED|Period 1 : Tolbutamide||4||
59722990|NCT01185548|75841624|FG000|COMPLETED|Period 1 : Tolbutamide||4||
59722991|NCT01185548|75841624|FG000|NOT COMPLETED|Period 1 : Tolbutamide||0||
59722992|NCT01185548|75841624|FG000|STARTED|Period 2: Tasisulam and Tolbutamide||4||
59722993|NCT01185548|75841624|FG000|COMPLETED|Period 2: Tasisulam and Tolbutamide||2||
59722994|NCT01185548|75841624|FG000|NOT COMPLETED|Period 2: Tasisulam and Tolbutamide||2||
59722995|NCT01185548|75841624|FG000|STARTED|Period 3: Tasisulam and Tolbutamide||2||
59722996|NCT01185548|75841624|FG000|COMPLETED|Period 3: Tasisulam and Tolbutamide||2||
59722997|NCT01185548|75841624|FG000|NOT COMPLETED|Period 3: Tasisulam and Tolbutamide||0||
59722998|NCT01128569|75841637|FG000|STARTED|Treatment Period 1||9||
59722999|NCT01128569|75841638|FG001|STARTED|Treatment Period 1||8||
59723000|NCT01128569|75841639|FG002|STARTED|Treatment Period 1||9||
59723001|NCT01128569|75841640|FG003|STARTED|Treatment Period 1||8||
59723002|NCT01128569|75841641|FG004|STARTED|Treatment Period 1||9||
59723003|NCT01128569|75841642|FG005|STARTED|Treatment Period 1||9||
59723004|NCT01128569|75841637|FG000|COMPLETED|Treatment Period 1||9||
59723005|NCT01128569|75841638|FG001|COMPLETED|Treatment Period 1||8||
59723006|NCT01128569|75841639|FG002|COMPLETED|Treatment Period 1||9||
59723007|NCT01128569|75841640|FG003|COMPLETED|Treatment Period 1||8||
59723008|NCT01128569|75841641|FG004|COMPLETED|Treatment Period 1||9||
59723009|NCT01128569|75841642|FG005|COMPLETED|Treatment Period 1||9||
59723010|NCT01128569|75841637|FG000|NOT COMPLETED|Treatment Period 1||0||
59723011|NCT01128569|75841638|FG001|NOT COMPLETED|Treatment Period 1||0||
59723012|NCT01128569|75841639|FG002|NOT COMPLETED|Treatment Period 1||0||
59723013|NCT01128569|75841640|FG003|NOT COMPLETED|Treatment Period 1||0||
59723014|NCT01128569|75841641|FG004|NOT COMPLETED|Treatment Period 1||0||
59723015|NCT01128569|75841642|FG005|NOT COMPLETED|Treatment Period 1||0||
59723016|NCT01128569|75841637|FG000|STARTED|Washout Period 1||9||
59723017|NCT01128569|75841638|FG001|STARTED|Washout Period 1||8||
59723018|NCT01128569|75841639|FG002|STARTED|Washout Period 1||9||
59723019|NCT01128569|75841640|FG003|STARTED|Washout Period 1||8||
59723020|NCT01128569|75841641|FG004|STARTED|Washout Period 1||9||
59723021|NCT01128569|75841642|FG005|STARTED|Washout Period 1||9||
59723022|NCT01128569|75841637|FG000|COMPLETED|Washout Period 1||9||
59723023|NCT01128569|75841638|FG001|COMPLETED|Washout Period 1||8||
59723024|NCT01128569|75841639|FG002|COMPLETED|Washout Period 1||8||
59723025|NCT01128569|75841640|FG003|COMPLETED|Washout Period 1||8||
59723026|NCT01128569|75841641|FG004|COMPLETED|Washout Period 1||9||
59723027|NCT01128569|75841642|FG005|COMPLETED|Washout Period 1||9||
59723028|NCT01128569|75841637|FG000|NOT COMPLETED|Washout Period 1||0||
59723029|NCT01128569|75841638|FG001|NOT COMPLETED|Washout Period 1||0||
59723030|NCT01128569|75841639|FG002|NOT COMPLETED|Washout Period 1||1||
59723031|NCT01128569|75841640|FG003|NOT COMPLETED|Washout Period 1||0||
59723032|NCT01128569|75841641|FG004|NOT COMPLETED|Washout Period 1||0||
59723033|NCT01128569|75841642|FG005|NOT COMPLETED|Washout Period 1||0||
59723034|NCT01128569|75841637|FG000|STARTED|Treatment Period 2||9||
59723035|NCT01128569|75841638|FG001|STARTED|Treatment Period 2||8||
59723036|NCT01128569|75841639|FG002|STARTED|Treatment Period 2||8||
59723037|NCT01128569|75841640|FG003|STARTED|Treatment Period 2||8||
59578588|NCT02881775|75684091|FG000|COMPLETED|Washout (1 Week)||9||
59578589|NCT02881775|75684092|FG001|COMPLETED|Washout (1 Week)||7||
59578590|NCT02881775|75684091|FG000|NOT COMPLETED|Washout (1 Week)||0||
59578591|NCT02881775|75684092|FG001|NOT COMPLETED|Washout (1 Week)||0||
59723038|NCT01128569|75841641|FG004|STARTED|Treatment Period 2||9||
59723039|NCT01128569|75841642|FG005|STARTED|Treatment Period 2||9||
59723040|NCT01128569|75841637|FG000|COMPLETED|Treatment Period 2||9||
59723041|NCT01128569|75841638|FG001|COMPLETED|Treatment Period 2||7||
59723042|NCT01128569|75841639|FG002|COMPLETED|Treatment Period 2||8||
59723043|NCT01128569|75841640|FG003|COMPLETED|Treatment Period 2||8||
59723044|NCT01128569|75841641|FG004|COMPLETED|Treatment Period 2||9||
59723045|NCT01128569|75841642|FG005|COMPLETED|Treatment Period 2||9||
59723046|NCT01128569|75841637|FG000|NOT COMPLETED|Treatment Period 2||0||
59723047|NCT01128569|75841638|FG001|NOT COMPLETED|Treatment Period 2||1||
59723048|NCT01128569|75841639|FG002|NOT COMPLETED|Treatment Period 2||0||
60121379|NCT02684370|76242316|FG002|COMPLETED|Part A||299||
60121380|NCT02684370|76242317|FG003|COMPLETED|Part A||0||
60121381|NCT02684370|76242318|FG004|COMPLETED|Part A||0||
60121382|NCT02684370|76242319|FG005|COMPLETED|Part A||0||
59723049|NCT01128569|75841640|FG003|NOT COMPLETED|Treatment Period 2||0||
59723050|NCT01128569|75841641|FG004|NOT COMPLETED|Treatment Period 2||0||
59723051|NCT01128569|75841642|FG005|NOT COMPLETED|Treatment Period 2||0||
59723052|NCT01128569|75841637|FG000|STARTED|Washout Period 2||9||
59723053|NCT01128569|75841638|FG001|STARTED|Washout Period 2||7||
59723054|NCT01128569|75841639|FG002|STARTED|Washout Period 2||8||
59723055|NCT01128569|75841640|FG003|STARTED|Washout Period 2||8||
59723056|NCT01128569|75841641|FG004|STARTED|Washout Period 2||9||
59723057|NCT01128569|75841642|FG005|STARTED|Washout Period 2||9||
59723058|NCT01128569|75841637|FG000|COMPLETED|Washout Period 2||9||
59723059|NCT01128569|75841638|FG001|COMPLETED|Washout Period 2||7||
59723060|NCT01128569|75841639|FG002|COMPLETED|Washout Period 2||8||
59723061|NCT01128569|75841640|FG003|COMPLETED|Washout Period 2||8||
59723062|NCT01128569|75841641|FG004|COMPLETED|Washout Period 2||9||
59723063|NCT01128569|75841642|FG005|COMPLETED|Washout Period 2||9||
59723064|NCT01128569|75841637|FG000|NOT COMPLETED|Washout Period 2||0||
59723065|NCT01128569|75841638|FG001|NOT COMPLETED|Washout Period 2||0||
59723066|NCT01128569|75841639|FG002|NOT COMPLETED|Washout Period 2||0||
59723067|NCT01128569|75841640|FG003|NOT COMPLETED|Washout Period 2||0||
59723068|NCT01128569|75841641|FG004|NOT COMPLETED|Washout Period 2||0||
59723069|NCT01128569|75841642|FG005|NOT COMPLETED|Washout Period 2||0||
59723070|NCT01128569|75841637|FG000|STARTED|Treatment Period 3||9||
59723071|NCT01128569|75841638|FG001|STARTED|Treatment Period 3||7||
59723072|NCT01128569|75841639|FG002|STARTED|Treatment Period 3||8||
59723073|NCT01128569|75841640|FG003|STARTED|Treatment Period 3||8||
59723074|NCT01128569|75841641|FG004|STARTED|Treatment Period 3||9||
59723075|NCT01128569|75841642|FG005|STARTED|Treatment Period 3||9||
59723076|NCT01128569|75841637|FG000|COMPLETED|Treatment Period 3||9||
59723077|NCT01128569|75841638|FG001|COMPLETED|Treatment Period 3||7||
59723078|NCT01128569|75841639|FG002|COMPLETED|Treatment Period 3||8||
59723079|NCT01128569|75841640|FG003|COMPLETED|Treatment Period 3||8||
59723080|NCT01128569|75841641|FG004|COMPLETED|Treatment Period 3||9||
59723081|NCT01128569|75841642|FG005|COMPLETED|Treatment Period 3||9||
59723082|NCT01128569|75841637|FG000|NOT COMPLETED|Treatment Period 3||0||
59723083|NCT01128569|75841638|FG001|NOT COMPLETED|Treatment Period 3||0||
59723084|NCT01128569|75841639|FG002|NOT COMPLETED|Treatment Period 3||0||
59723085|NCT01128569|75841640|FG003|NOT COMPLETED|Treatment Period 3||0||
59723086|NCT01128569|75841641|FG004|NOT COMPLETED|Treatment Period 3||0||
59723087|NCT01128569|75841642|FG005|NOT COMPLETED|Treatment Period 3||0||
59723088|NCT01128413|75841652|FG000|STARTED|Overall Study||11||
59723089|NCT01128413|75841653|FG001|STARTED|Overall Study||11||
59723090|NCT01128413|75841652|FG000|COMPLETED|Overall Study||7||
59723091|NCT01128413|75841653|FG001|COMPLETED|Overall Study||10||
59723092|NCT01128413|75841652|FG000|NOT COMPLETED|Overall Study||4||
59723093|NCT01128413|75841653|FG001|NOT COMPLETED|Overall Study||1||
59723094|NCT01185080|75841662|FG000|STARTED|Overall Study||50||
59723095|NCT01185080|75841663|FG001|STARTED|Overall Study||16||
59723096|NCT01185080|75841664|FG002|STARTED|Overall Study||17||
59723097|NCT01185080|75841662|FG000|COMPLETED|Overall Study||49||
59723098|NCT01185080|75841663|FG001|COMPLETED|Overall Study||15||
59723099|NCT01185080|75841664|FG002|COMPLETED|Overall Study||16||
59723100|NCT01185080|75841662|FG000|NOT COMPLETED|Overall Study||1||
59723101|NCT01185080|75841663|FG001|NOT COMPLETED|Overall Study||1||
59723102|NCT01185080|75841664|FG002|NOT COMPLETED|Overall Study||1||
59723103|NCT01128179|75841674|FG000|STARTED|Overall Study||23||
59723104|NCT01128179|75841675|FG001|STARTED|Overall Study||12||
59723105|NCT01128179|75841674|FG000|COMPLETED|Overall Study||21||
59850370|NCT04978363|75974739|FG000|Discontinued Intervention|Overall Study||0||
59578592|NCT02881775|75684091|FG000|STARTED|Second Intervention (1-Hour Session)||9||
59723106|NCT01128179|75841675|FG001|COMPLETED|Overall Study||12||
59723107|NCT01128179|75841674|FG000|NOT COMPLETED|Overall Study||2||
59723108|NCT01128179|75841675|FG001|NOT COMPLETED|Overall Study||0||
59850371|NCT04978363|75974740|FG001|Discontinued Intervention|Overall Study||1||
59850372|NCT04978363|75974741|FG002|Discontinued Intervention|Overall Study||1||
59850373|NCT04978363|75974742|FG003|Discontinued Intervention|Overall Study||0||
59723109|NCT01181102|75841683|FG000|STARTED|Overall Study||360||
59723110|NCT01181102|75841684|FG001|STARTED|Overall Study||356||
59723111|NCT01181102|75841683|FG000|Safety Analysis Set|Overall Study||354||
59850374|NCT04978363|75974743|FG004|Discontinued Intervention|Overall Study||1||
59850375|NCT04978363|75974744|FG005|Discontinued Intervention|Overall Study||0||
59723112|NCT01181102|75841684|FG001|Safety Analysis Set|Overall Study||349||
59723113|NCT01181102|75841683|FG000|Efficacy Analysis Population|Overall Study||299||
59723114|NCT01181102|75841684|FG001|Efficacy Analysis Population|Overall Study||295||
59723115|NCT01181102|75841683|FG000|COMPLETED|Overall Study||309||
59723116|NCT01181102|75841684|FG001|COMPLETED|Overall Study||310||
59850376|NCT04978363|75974745|FG006|Discontinued Intervention|Overall Study||0||
59723117|NCT01181102|75841683|FG000|NOT COMPLETED|Overall Study||51||
59723118|NCT01181102|75841684|FG001|NOT COMPLETED|Overall Study||46||
59723119|NCT00858637|75841692|FG000|STARTED|Active Comparison Phase||127||
59723120|NCT00858637|75841693|FG001|STARTED|Active Comparison Phase||0||
59723121|NCT00858637|75841694|FG002|STARTED|Active Comparison Phase||0||
59723122|NCT00858637|75841695|FG003|STARTED|Active Comparison Phase||133||
59723123|NCT00858637|75841696|FG004|STARTED|Active Comparison Phase||0||
59723124|NCT00858637|75841697|FG005|STARTED|Active Comparison Phase||0||
59723125|NCT00858637|75841692|FG000|COMPLETED|Active Comparison Phase||103||
59723126|NCT00858637|75841693|FG001|COMPLETED|Active Comparison Phase||0||
59723127|NCT00858637|75841694|FG002|COMPLETED|Active Comparison Phase||0||
59723128|NCT00858637|75841695|FG003|COMPLETED|Active Comparison Phase||115||
59723129|NCT00858637|75841696|FG004|COMPLETED|Active Comparison Phase||0||
59723130|NCT00858637|75841697|FG005|COMPLETED|Active Comparison Phase||0||
59723131|NCT00858637|75841692|FG000|NOT COMPLETED|Active Comparison Phase||24||
59723132|NCT00858637|75841693|FG001|NOT COMPLETED|Active Comparison Phase||0||
59723133|NCT00858637|75841694|FG002|NOT COMPLETED|Active Comparison Phase||0||
59723134|NCT00858637|75841695|FG003|NOT COMPLETED|Active Comparison Phase||18||
59723135|NCT00858637|75841696|FG004|NOT COMPLETED|Active Comparison Phase||0||
59723136|NCT00858637|75841697|FG005|NOT COMPLETED|Active Comparison Phase||0||
59723137|NCT00858637|75841692|FG000|STARTED|Placebo-controlled Withdrawal Phase||0||
59723138|NCT00858637|75841693|FG001|STARTED|Placebo-controlled Withdrawal Phase||49||
59723139|NCT00858637|75841694|FG002|STARTED|Placebo-controlled Withdrawal Phase||54||
59723140|NCT00858637|75841695|FG003|STARTED|Placebo-controlled Withdrawal Phase||0||
59723141|NCT00858637|75841696|FG004|STARTED|Placebo-controlled Withdrawal Phase||56||
59723142|NCT00858637|75841697|FG005|STARTED|Placebo-controlled Withdrawal Phase||59||
59723143|NCT00858637|75841692|FG000|COMPLETED|Placebo-controlled Withdrawal Phase||0||
59723144|NCT00858637|75841693|FG001|COMPLETED|Placebo-controlled Withdrawal Phase||49||
59723145|NCT00858637|75841694|FG002|COMPLETED|Placebo-controlled Withdrawal Phase||53||
59723146|NCT00858637|75841695|FG003|COMPLETED|Placebo-controlled Withdrawal Phase||0||
59723147|NCT00858637|75841696|FG004|COMPLETED|Placebo-controlled Withdrawal Phase||55||
59723148|NCT00858637|75841697|FG005|COMPLETED|Placebo-controlled Withdrawal Phase||58||
59723149|NCT00858637|75841692|FG000|NOT COMPLETED|Placebo-controlled Withdrawal Phase||0||
59723150|NCT00858637|75841693|FG001|NOT COMPLETED|Placebo-controlled Withdrawal Phase||0||
59723151|NCT00858637|75841694|FG002|NOT COMPLETED|Placebo-controlled Withdrawal Phase||1||
59723152|NCT00858637|75841695|FG003|NOT COMPLETED|Placebo-controlled Withdrawal Phase||0||
59723153|NCT00858637|75841696|FG004|NOT COMPLETED|Placebo-controlled Withdrawal Phase||1||
59723154|NCT00858637|75841697|FG005|NOT COMPLETED|Placebo-controlled Withdrawal Phase||1||
59723155|NCT00858403|75841707|FG000|STARTED|Overall Study||7||
59723156|NCT00858403|75841707|FG000|COMPLETED|Overall Study||2||
59723157|NCT00858403|75841707|FG000|NOT COMPLETED|Overall Study||5||
59723158|NCT00858247|75841713|FG000|STARTED|Baseline Assessment||25||
59723159|NCT00858247|75841714|FG001|STARTED|Baseline Assessment||26||
59723160|NCT00858247|75841713|FG000|COMPLETED|Baseline Assessment||23||
59723161|NCT00858247|75841714|FG001|COMPLETED|Baseline Assessment||24||
59723162|NCT00858247|75841713|FG000|NOT COMPLETED|Baseline Assessment||2||
59723163|NCT00858247|75841714|FG001|NOT COMPLETED|Baseline Assessment||2||
59723164|NCT00858247|75841713|FG000|STARTED|Week 12 Follow-up||23||
59723165|NCT00858247|75841714|FG001|STARTED|Week 12 Follow-up||24||
59723166|NCT00858247|75841713|FG000|COMPLETED|Week 12 Follow-up||23||
59723167|NCT00858247|75841714|FG001|COMPLETED|Week 12 Follow-up||23||
59723168|NCT00858247|75841713|FG000|NOT COMPLETED|Week 12 Follow-up||0||
59723169|NCT00858247|75841714|FG001|NOT COMPLETED|Week 12 Follow-up||1||
59723170|NCT00838435|75841720|FG000|STARTED|Part 1 (4 Weeks)||95||
59723171|NCT00838435|75841720|FG000|COMPLETED|Part 1 (4 Weeks)||95||
59723172|NCT00838435|75841720|FG000|NOT COMPLETED|Part 1 (4 Weeks)||0||
59723173|NCT00838435|75841720|FG000|STARTED|PK Sub-Study 2 (4 Weeks)|1 subject declined participation in the PK Sub-Study.|94||
59723174|NCT00838435|75841720|FG000|COMPLETED|PK Sub-Study 2 (4 Weeks)||93|of the 95 who started Part 1.|
59723175|NCT00838435|75841720|FG000|NOT COMPLETED|PK Sub-Study 2 (4 Weeks)||1||
59723176|NCT00838435|75841720|FG000|STARTED|Safety/Efficacy Sub-Study 1 (6 Months)|65 of 95 subjects in Part 1 were determined responders & eligible for the Safety/Efficacy Sub-study.|65||
59723177|NCT00838435|75841720|FG000|COMPLETED|Safety/Efficacy Sub-Study 1 (6 Months)||63||
59723178|NCT00838435|75841720|FG000|NOT COMPLETED|Safety/Efficacy Sub-Study 1 (6 Months)||2||
59723179|NCT00838435|75841720|FG000|STARTED|Part 2 (7 Years)|65 of 95 subjects in Part 1 were determined responders & eligible for the Part 2 of the study.|65||
59723180|NCT00838435|75841720|FG000|COMPLETED|Part 2 (7 Years)||49||
59723181|NCT00838435|75841720|FG000|NOT COMPLETED|Part 2 (7 Years)||16||
59723182|NCT00838201|75841729|FG000|STARTED|Overall Study||186||
59723183|NCT00838201|75841730|FG001|STARTED|Overall Study||198||
59723184|NCT00838201|75841729|FG000|COMPLETED|Overall Study||144||
59723185|NCT00838201|75841730|FG001|COMPLETED|Overall Study||145||
59723186|NCT00838201|75841729|FG000|NOT COMPLETED|Overall Study||42||
59723187|NCT00838201|75841730|FG001|NOT COMPLETED|Overall Study||53||
59723188|NCT00837967|75841736|FG000|STARTED|First Intervention||13||
59723189|NCT00837967|75841737|FG001|STARTED|First Intervention||12||
59723190|NCT00837967|75841736|FG000|COMPLETED|First Intervention||13||
59723191|NCT00837967|75841737|FG001|COMPLETED|First Intervention||12||
59723192|NCT00837967|75841736|FG000|NOT COMPLETED|First Intervention||0||
59723193|NCT00837967|75841737|FG001|NOT COMPLETED|First Intervention||0||
59723194|NCT00837967|75841736|FG000|STARTED|Washout Period of 7 - 14 Days||13||
59723195|NCT00837967|75841737|FG001|STARTED|Washout Period of 7 - 14 Days||12||
59723196|NCT00837967|75841736|FG000|COMPLETED|Washout Period of 7 - 14 Days||11||
59723197|NCT00837967|75841737|FG001|COMPLETED|Washout Period of 7 - 14 Days||12||
59723198|NCT00837967|75841736|FG000|NOT COMPLETED|Washout Period of 7 - 14 Days||2||
59723199|NCT00837967|75841737|FG001|NOT COMPLETED|Washout Period of 7 - 14 Days||0||
59723200|NCT00837967|75841736|FG000|STARTED|Second Intervention||11||
59723201|NCT00837967|75841737|FG001|STARTED|Second Intervention||12||
59723202|NCT00837967|75841736|FG000|COMPLETED|Second Intervention||11||
59723203|NCT00837967|75841737|FG001|COMPLETED|Second Intervention||12||
59723204|NCT00837967|75841736|FG000|NOT COMPLETED|Second Intervention||0||
59723205|NCT00837967|75841737|FG001|NOT COMPLETED|Second Intervention||0||
59723206|NCT02756806|75841743|FG000|STARTED|Overall Study||7||
59723207|NCT02756806|75841743|FG000|COMPLETED|Overall Study||2||
59723208|NCT02756806|75841743|FG000|NOT COMPLETED|Overall Study||5||
59723209|NCT00942357|75841749|FG000|STARTED|Overall Study||407||
59723210|NCT00942357|75841750|FG001|STARTED|Overall Study||406||
59723211|NCT00942357|75841749|FG000|COMPLETED|Overall Study||370||
59723212|NCT00942357|75841750|FG001|COMPLETED|Overall Study||366||
59723213|NCT00942357|75841749|FG000|NOT COMPLETED|Overall Study||37||
59723214|NCT00942357|75841750|FG001|NOT COMPLETED|Overall Study||40||
59723215|NCT00939783|75841756|FG000|STARTED|Overall Study||649||
59723216|NCT00939783|75841756|FG000|Treated|Overall Study||648||
59723217|NCT00939783|75841756|FG000|COMPLETED|Overall Study||0||
59723218|NCT00939783|75841756|FG000|NOT COMPLETED|Overall Study||649||
59723219|NCT00939627|75841762|FG000|STARTED|Overall Study||27||
59723220|NCT00939627|75841763|FG001|STARTED|Overall Study||28||
59723221|NCT00939627|75841764|FG002|STARTED|Overall Study||0||
59723222|NCT00939627|75841762|FG000|COMPLETED|Overall Study||0||
59723223|NCT00939627|75841763|FG001|COMPLETED|Overall Study||0||
59723224|NCT00939627|75841764|FG002|COMPLETED|Overall Study||0||
59723225|NCT00939627|75841762|FG000|NOT COMPLETED|Overall Study||27||
59723226|NCT00939627|75841763|FG001|NOT COMPLETED|Overall Study||28||
59723227|NCT00939627|75841764|FG002|NOT COMPLETED|Overall Study||0||
59723228|NCT00937833|75841772|FG000|STARTED|Overall Study||73||
59723229|NCT00937833|75841773|FG001|STARTED|Overall Study||77||
59723230|NCT00937833|75841772|FG000|COMPLETED|Overall Study||58||
59723231|NCT00937833|75841773|FG001|COMPLETED|Overall Study||60||
59723232|NCT00937833|75841772|FG000|NOT COMPLETED|Overall Study||15||
59723233|NCT00937833|75841773|FG001|NOT COMPLETED|Overall Study||17||
59723234|NCT01135511|75841788|FG000|STARTED|Overall Study||41||
59723235|NCT01135511|75841789|FG001|STARTED|Overall Study||42||
59723236|NCT01135511|75841790|FG002|STARTED|Overall Study||41||
59723237|NCT01135511|75841791|FG003|STARTED|Overall Study||40||
59723238|NCT01135511|75841792|FG004|STARTED|Overall Study||39||
59723239|NCT01135511|75841793|FG005|STARTED|Overall Study||21||
59850377|NCT04978363|75974746|FG007|Discontinued Intervention|Overall Study||0||
59850378|NCT04978363|75974747|FG008|Discontinued Intervention|Overall Study||0||
59850379|NCT04978363|75974748|FG009|Discontinued Intervention|Overall Study||0||
60121383|NCT02684370|76242314|FG000|NOT COMPLETED|Part A||4||
59723240|NCT01135511|75841794|FG006|STARTED|Overall Study||19||
59723241|NCT01135511|75841795|FG007|STARTED|Overall Study||21||
59723242|NCT01135511|75841796|FG008|STARTED|Overall Study||21||
59723243|NCT01135511|75841788|FG000|COMPLETED|Overall Study||41||
59723244|NCT01135511|75841789|FG001|COMPLETED|Overall Study||39||
59723245|NCT01135511|75841790|FG002|COMPLETED|Overall Study||33||
59723246|NCT01135511|75841791|FG003|COMPLETED|Overall Study||37||
59723247|NCT01135511|75841792|FG004|COMPLETED|Overall Study||38||
59723248|NCT01135511|75841793|FG005|COMPLETED|Overall Study||20||
59723249|NCT01135511|75841794|FG006|COMPLETED|Overall Study||18||
59723250|NCT01135511|75841795|FG007|COMPLETED|Overall Study||20||
59723251|NCT01135511|75841796|FG008|COMPLETED|Overall Study||20||
59723252|NCT01135511|75841788|FG000|NOT COMPLETED|Overall Study||0||
59723253|NCT01135511|75841789|FG001|NOT COMPLETED|Overall Study||3||
59723254|NCT01135511|75841790|FG002|NOT COMPLETED|Overall Study||8||
59723255|NCT01135511|75841791|FG003|NOT COMPLETED|Overall Study||3||
59723256|NCT01135511|75841792|FG004|NOT COMPLETED|Overall Study||1||
59723257|NCT01135511|75841793|FG005|NOT COMPLETED|Overall Study||1||
59723258|NCT01135511|75841794|FG006|NOT COMPLETED|Overall Study||1||
59723259|NCT01135511|75841795|FG007|NOT COMPLETED|Overall Study||1||
59723260|NCT01135511|75841796|FG008|NOT COMPLETED|Overall Study||1||
59723261|NCT04468204|75841818|FG000|STARTED|Overall Study||39||
59850380|NCT04978363|75974749|FG010|Discontinued Intervention|Overall Study||0||
60121384|NCT02684370|76242315|FG001|NOT COMPLETED|Part A||1||
59723262|NCT04468204|75841819|FG001|STARTED|Overall Study||13||
59723263|NCT04468204|75841818|FG000|COMPLETED|Overall Study||39||
59723264|NCT04468204|75841819|FG001|COMPLETED|Overall Study||13||
59723265|NCT04468204|75841818|FG000|NOT COMPLETED|Overall Study||0||
59723266|NCT04468204|75841819|FG001|NOT COMPLETED|Overall Study||0||
59723267|NCT01184846|75841825|FG000|STARTED|Overall Study||28||
60121385|NCT02684370|76242316|FG002|NOT COMPLETED|Part A||5||
59723268|NCT01184846|75841825|FG000|COMPLETED|Overall Study||25||
59723269|NCT01184846|75841825|FG000|NOT COMPLETED|Overall Study||3||
59723270|NCT01180400|75841833|FG000|STARTED|Overall Study||147||
59723271|NCT01180400|75841834|FG001|STARTED|Overall Study||148||
59723272|NCT01180400|75841833|FG000|Received Treatment|Overall Study||147||
59723273|NCT01180400|75841834|FG001|Received Treatment|Overall Study||146||
59723274|NCT01180400|75841833|FG000|COMPLETED|Overall Study||122||
59723275|NCT01180400|75841834|FG001|COMPLETED|Overall Study||121||
59723276|NCT01180400|75841833|FG000|NOT COMPLETED|Overall Study||25||
59723277|NCT01180400|75841834|FG001|NOT COMPLETED|Overall Study||27||
59723278|NCT01180244|75841842|FG000|STARTED|Overall Study|Number of enrolled patients initially randomized to active treatment group|45||
59723279|NCT01180244|75841843|FG001|STARTED|Overall Study|Number of enrolled patients initially randomized to placebo group|46||
59723280|NCT01180244|75841842|FG000|Received Treatment|Overall Study|Number of patients in the active treatment group that received at least one study treatment|40||
59723281|NCT01180244|75841843|FG001|Received Treatment|Overall Study|Number of patients in the placebo group that received at least one sham treatment|45||
59723282|NCT01180244|75841842|FG000|COMPLETED|Overall Study|Number of active treatment patients who completed all study visits and are evaluable|39||
59723283|NCT01180244|75841843|FG001|COMPLETED|Overall Study|Number of placebo group patients who completed all study visits and are evaluable|38||
59723284|NCT01180244|75841842|FG000|NOT COMPLETED|Overall Study||6||
59723285|NCT01180244|75841843|FG001|NOT COMPLETED|Overall Study||8||
59723286|NCT01191086|75841849|FG000|STARTED|Overall Study||210||
59723287|NCT01191086|75841849|FG000|COMPLETED|Overall Study||148||
59723288|NCT01191086|75841849|FG000|NOT COMPLETED|Overall Study||62||
59723289|NCT01088412|75841856|FG000|STARTED|Overall Study||22311||
59723290|NCT01088412|75841857|FG001|STARTED|Overall Study||457||
59723291|NCT01088412|75841858|FG002|STARTED|Overall Study||77||
59723292|NCT01088412|75841856|FG000|Safety Modified Evaluable (SME)|Overall Study||22294||
59723293|NCT01088412|75841857|FG001|Safety Modified Evaluable (SME)|Overall Study||456||
59723294|NCT01088412|75841858|FG002|Safety Modified Evaluable (SME)|Overall Study||0||
59723295|NCT01088412|75841856|FG000|SME With at Least 1 Follow Up (FU)|Overall Study||21178||
59723296|NCT01088412|75841857|FG001|SME With at Least 1 Follow Up (FU)|Overall Study||306||
59723297|NCT01088412|75841858|FG002|SME With at Least 1 Follow Up (FU)|Overall Study||0||
59723298|NCT01088412|75841856|FG000|SME+ >= 1 FU and Unknown Arm|Overall Study||21177||
59850381|NCT04978363|75974739|FG000|COMPLETED|Overall Study||2||
59578593|NCT02881775|75684092|FG001|STARTED|Second Intervention (1-Hour Session)||7||
59578594|NCT02881775|75684091|FG000|COMPLETED|Second Intervention (1-Hour Session)||9||
59723299|NCT01088412|75841857|FG001|SME+ >= 1 FU and Unknown Arm|Overall Study||306||
59723300|NCT01088412|75841858|FG002|SME+ >= 1 FU and Unknown Arm|Overall Study||40||
59723301|NCT01088412|75841856|FG000|SME+ >= 1 FU and No Previous Cancer|Overall Study||20556||
59723302|NCT01088412|75841857|FG001|SME+ >= 1 FU and No Previous Cancer|Overall Study||192||
59723303|NCT01088412|75841858|FG002|SME+ >= 1 FU and No Previous Cancer|Overall Study||0||
59723304|NCT01088412|75841856|FG000|SME+ >= 1 FU and Previous Cancer|Overall Study||622||
59723305|NCT01088412|75841857|FG001|SME+ >= 1 FU and Previous Cancer|Overall Study||114||
59723306|NCT01088412|75841858|FG002|SME+ >= 1 FU and Previous Cancer|Overall Study||0||
59723307|NCT01088412|75841856|FG000|COMPLETED|Overall Study||4294||
59723308|NCT01088412|75841857|FG001|COMPLETED|Overall Study||21||
59723309|NCT01088412|75841858|FG002|COMPLETED|Overall Study||5||
59723310|NCT01088412|75841856|FG000|NOT COMPLETED|Overall Study||18017||
59723311|NCT01088412|75841857|FG001|NOT COMPLETED|Overall Study||436||
59723312|NCT01088412|75841858|FG002|NOT COMPLETED|Overall Study||72||
59723313|NCT01086384|75841871|FG000|STARTED|2-week Run-in Period||2183||
59723314|NCT01086384|75841872|FG001|STARTED|2-week Run-in Period||0||
59723315|NCT01086384|75841873|FG002|STARTED|2-week Run-in Period||0||
59723316|NCT01086384|75841871|FG000|COMPLETED|2-week Run-in Period||2020||
59723317|NCT01086384|75841872|FG001|COMPLETED|2-week Run-in Period||0||
59723318|NCT01086384|75841873|FG002|COMPLETED|2-week Run-in Period||0||
59723319|NCT01086384|75841871|FG000|NOT COMPLETED|2-week Run-in Period||163||
59723320|NCT01086384|75841872|FG001|NOT COMPLETED|2-week Run-in Period||0||
59723321|NCT01086384|75841873|FG002|NOT COMPLETED|2-week Run-in Period||0||
59723322|NCT01086384|75841871|FG000|STARTED|Treatment Period||0||
59723323|NCT01086384|75841872|FG001|STARTED|Treatment Period||1011||
59723324|NCT01086384|75841873|FG002|STARTED|Treatment Period||1009||
59723325|NCT01086384|75841871|FG000|COMPLETED|Treatment Period||0||
59723326|NCT01086384|75841872|FG001|COMPLETED|Treatment Period||863||
59723327|NCT01086384|75841873|FG002|COMPLETED|Treatment Period||885||
59723328|NCT01086384|75841871|FG000|NOT COMPLETED|Treatment Period||0||
59723329|NCT01086384|75841872|FG001|NOT COMPLETED|Treatment Period||148||
59723330|NCT01086384|75841873|FG002|NOT COMPLETED|Treatment Period||124||
59723331|NCT01127633|75841881|FG000|STARTED|Overall Study||723||
59723332|NCT01127633|75841882|FG001|STARTED|Overall Study||734||
59723333|NCT01127633|75841881|FG000|Received at Least 1 Dose of Study Drug|Overall Study||723||
59723334|NCT01127633|75841882|FG001|Received at Least 1 Dose of Study Drug|Overall Study||734||
59723335|NCT01127633|75841881|FG000|COMPLETED|Overall Study||70||
59723336|NCT01127633|75841882|FG001|COMPLETED|Overall Study||61||
59723337|NCT01127633|75841881|FG000|NOT COMPLETED|Overall Study||653||
59723338|NCT01127633|75841882|FG001|NOT COMPLETED|Overall Study||673||
59850382|NCT04978363|75974740|FG001|COMPLETED|Overall Study||1||
59850383|NCT04978363|75974741|FG002|COMPLETED|Overall Study||1||
59578595|NCT02881775|75684092|FG001|COMPLETED|Second Intervention (1-Hour Session)||7||
59723339|NCT01122173|75841888|FG000|STARTED|Overall Study||150||
59723340|NCT01122173|75841888|FG000|COMPLETED|Overall Study||141||
59723341|NCT01122173|75841888|FG000|NOT COMPLETED|Overall Study||9||
59723342|NCT01127165|75841895|FG000|STARTED|Overall Study||65||
59723343|NCT01127165|75841896|FG001|STARTED|Overall Study||60||
59723344|NCT01127165|75841895|FG000|COMPLETED|Overall Study||49||
59723345|NCT01127165|75841896|FG001|COMPLETED|Overall Study||41||
59723346|NCT01127165|75841895|FG000|NOT COMPLETED|Overall Study||16||
59723347|NCT01127165|75841896|FG001|NOT COMPLETED|Overall Study||19||
59723348|NCT01126619|75841902|FG000|STARTED|Overall Study||103||
59723349|NCT01126619|75841902|FG000|COMPLETED|Overall Study|The completed population was used for all effectiveness analyses.|86||
59723350|NCT01126619|75841902|FG000|NOT COMPLETED|Overall Study||17||
59723351|NCT00941733|75841910|FG000|STARTED|Overall Study||239||
59723352|NCT00941733|75841911|FG001|STARTED|Overall Study||119||
59723353|NCT00941733|75841910|FG000|COMPLETED|Overall Study|1 year follow-up|165||
59723354|NCT00941733|75841911|FG001|COMPLETED|Overall Study|1 year follow-up|91||
59723355|NCT00941733|75841910|FG000|NOT COMPLETED|Overall Study||74||
59723356|NCT00941733|75841911|FG001|NOT COMPLETED|Overall Study||28||
59723357|NCT00941655|75841919|FG000|STARTED|Overall Study||8||
59723358|NCT00941655|75841920|FG001|STARTED|Overall Study||7||
59723359|NCT00941655|75841919|FG000|COMPLETED|Overall Study||3||
59723360|NCT00941655|75841920|FG001|COMPLETED|Overall Study||2||
59723361|NCT00941655|75841919|FG000|NOT COMPLETED|Overall Study||5||
59723362|NCT00941655|75841920|FG001|NOT COMPLETED|Overall Study||5||
59723363|NCT00939393|75841929|FG000|STARTED|Overall Study||37||
59723364|NCT00939393|75841930|FG001|STARTED|Overall Study||35||
59723365|NCT00939393|75841929|FG000|COMPLETED|Overall Study||33||
59723366|NCT00939393|75841930|FG001|COMPLETED|Overall Study||35||
59723367|NCT00939393|75841929|FG000|NOT COMPLETED|Overall Study||4||
59723368|NCT00939393|75841930|FG001|NOT COMPLETED|Overall Study||0||
59723369|NCT04441996|75841940|FG000|STARTED|Overall Study||10||
59723370|NCT04441996|75841941|FG001|STARTED|Overall Study||10||
59723371|NCT04441996|75841940|FG000|COMPLETED|Overall Study||10||
59723372|NCT04441996|75841941|FG001|COMPLETED|Overall Study||10||
59723373|NCT04441996|75841940|FG000|NOT COMPLETED|Overall Study||0||
59723374|NCT04441996|75841941|FG001|NOT COMPLETED|Overall Study||0||
59723375|NCT00936117|75841947|FG000|STARTED|Overall Study||20||
59723376|NCT00936117|75841947|FG000|COMPLETED|Overall Study|Completed 42 days on study drug|10||
59723377|NCT00936117|75841947|FG000|NOT COMPLETED|Overall Study||10||
59723378|NCT04088500|75841952|FG000|STARTED|Overall Study||5||
59723379|NCT04088500|75841952|FG000|COMPLETED|Overall Study||0||
59723380|NCT04088500|75841952|FG000|NOT COMPLETED|Overall Study||5||
59723381|NCT01082874|75841960|FG000|STARTED|Overall Study||2499||
59723382|NCT01082874|75841961|FG001|STARTED|Overall Study||2510||
59723383|NCT01082874|75841962|FG002|STARTED|Overall Study||2499||
59723384|NCT01082874|75841963|FG003|STARTED|Overall Study||2502||
59723385|NCT01082874|75841960|FG000|COMPLETED|Overall Study||2488||
59723386|NCT01082874|75841961|FG001|COMPLETED|Overall Study||2498||
59723387|NCT01082874|75841962|FG002|COMPLETED|Overall Study||2488||
59723388|NCT01082874|75841963|FG003|COMPLETED|Overall Study||2489||
59723389|NCT01082874|75841960|FG000|NOT COMPLETED|Overall Study||11||
59723390|NCT01082874|75841961|FG001|NOT COMPLETED|Overall Study||12||
59723391|NCT01082874|75841962|FG002|NOT COMPLETED|Overall Study||11||
59723392|NCT01082874|75841963|FG003|NOT COMPLETED|Overall Study||13||
59723393|NCT00933543|75841975|FG000|STARTED|Overall Study||54||
59723394|NCT00933543|75841976|FG001|STARTED|Overall Study||53||
59723395|NCT00933543|75841975|FG000|COMPLETED|Overall Study||51||
59723396|NCT00933543|75841976|FG001|COMPLETED|Overall Study||46||
59723397|NCT00933543|75841975|FG000|NOT COMPLETED|Overall Study||3||
59723398|NCT00933543|75841976|FG001|NOT COMPLETED|Overall Study||7||
59723399|NCT01082328|75841982|FG000|STARTED|Overall Study||59||
59723400|NCT01082328|75841982|FG000|COMPLETED|Overall Study||58||
59578596|NCT02881775|75684091|FG000|NOT COMPLETED|Second Intervention (1-Hour Session)||0||
59578597|NCT02881775|75684092|FG001|NOT COMPLETED|Second Intervention (1-Hour Session)||0||
59723401|NCT01082328|75841982|FG000|NOT COMPLETED|Overall Study||1||
59723402|NCT01079988|75841991|FG000|STARTED|Overall Study||10||
59723403|NCT01079988|75841992|FG001|STARTED|Overall Study||1||
59723404|NCT01079988|75841993|FG002|STARTED|Overall Study||8||
59723405|NCT01079988|75841994|FG003|STARTED|Overall Study||20||
59723406|NCT01079988|75841995|FG004|STARTED|Overall Study||2||
59850384|NCT04978363|75974742|FG003|COMPLETED|Overall Study||1||
59850385|NCT04978363|75974743|FG004|COMPLETED|Overall Study||2||
59578598|NCT03109769|75684100|FG000|STARTED|Overall Study||22||
59578599|NCT03109769|75684101|FG001|STARTED|Overall Study||22||
59723407|NCT01079988|75841991|FG000|COMPLETED|Overall Study||9||
59723408|NCT01079988|75841992|FG001|COMPLETED|Overall Study||1||
59723409|NCT01079988|75841993|FG002|COMPLETED|Overall Study||8||
59723410|NCT01079988|75841994|FG003|COMPLETED|Overall Study||17||
59723411|NCT01079988|75841995|FG004|COMPLETED|Overall Study||1||
59723412|NCT01079988|75841991|FG000|NOT COMPLETED|Overall Study||1||
59723413|NCT01079988|75841992|FG001|NOT COMPLETED|Overall Study||0||
59723414|NCT01079988|75841993|FG002|NOT COMPLETED|Overall Study||0||
59723415|NCT01079988|75841994|FG003|NOT COMPLETED|Overall Study||3||
59723416|NCT01079988|75841995|FG004|NOT COMPLETED|Overall Study||1||
59723417|NCT01074216|75842007|FG000|STARTED|Overall Study||54||
59723418|NCT01074216|75842007|FG000|COMPLETED|Overall Study||41||
59850386|NCT04978363|75974744|FG005|COMPLETED|Overall Study||1||
59723419|NCT01074216|75842007|FG000|NOT COMPLETED|Overall Study||13||
59723420|NCT01079832|75842011|FG000|STARTED|Overall Study||50||
59723421|NCT01079832|75842011|FG000|COMPLETED|Overall Study||49||
59723422|NCT01079832|75842011|FG000|NOT COMPLETED|Overall Study||1||
59723423|NCT01072344|75842017|FG000|STARTED|Overall Study||46||
59723424|NCT01072344|75842018|FG001|STARTED|Overall Study||47||
59723425|NCT01072344|75842017|FG000|COMPLETED|Overall Study||35||
59723426|NCT01072344|75842018|FG001|COMPLETED|Overall Study||29||
59723427|NCT01072344|75842017|FG000|NOT COMPLETED|Overall Study||11||
59723428|NCT01072344|75842018|FG001|NOT COMPLETED|Overall Study||18||
59723429|NCT01071954|75842024|FG000|STARTED|Overall Study||66||
59723430|NCT01071954|75842024|FG000|Received Treatment|Overall Study||65||
59723431|NCT01071954|75842024|FG000|COMPLETED|Overall Study||39||
59723432|NCT01071954|75842024|FG000|NOT COMPLETED|Overall Study||27||
59723433|NCT00837811|75842031|FG000|STARTED|Overall Study||60||
59723434|NCT00837811|75842032|FG001|STARTED|Overall Study||121||
59723435|NCT00837811|75842033|FG002|STARTED|Overall Study||1||
59723436|NCT00837811|75842031|FG000|Received Any Amount of Study Drug|Overall Study||60||
59723437|NCT00837811|75842032|FG001|Received Any Amount of Study Drug|Overall Study||121||
59723438|NCT00837811|75842033|FG002|Received Any Amount of Study Drug|Overall Study||1||
59723439|NCT00837811|75842031|FG000|Had at Least 1 Efficacy Assessment|Overall Study||59||
59723440|NCT00837811|75842032|FG001|Had at Least 1 Efficacy Assessment|Overall Study||121||
59723441|NCT00837811|75842033|FG002|Had at Least 1 Efficacy Assessment|Overall Study||1||
59723442|NCT00837811|75842031|FG000|Included in Efficacy Analyses|Overall Study||59||
59723443|NCT00837811|75842032|FG001|Included in Efficacy Analyses|Overall Study|Excludes participant from site with Good Clinical Practice (GCP) violations.|120||
59723444|NCT00837811|75842033|FG002|Included in Efficacy Analyses|Overall Study||1||
59723445|NCT00837811|75842031|FG000|COMPLETED|Overall Study||53||
59723446|NCT00837811|75842032|FG001|COMPLETED|Overall Study||87||
59723447|NCT00837811|75842033|FG002|COMPLETED|Overall Study||0||
59723448|NCT00837811|75842031|FG000|NOT COMPLETED|Overall Study||7||
59723449|NCT00837811|75842032|FG001|NOT COMPLETED|Overall Study||34||
59723450|NCT00837811|75842033|FG002|NOT COMPLETED|Overall Study||1||
59723451|NCT00857389|75842050|FG000|STARTED|Overall Study||60||
59723452|NCT00857389|75842050|FG000|COMPLETED|Overall Study||58||
59723453|NCT00857389|75842050|FG000|NOT COMPLETED|Overall Study||2||
59578600|NCT03109769|75684100|FG000|COMPLETED|Overall Study||22||
59578601|NCT03109769|75684101|FG001|COMPLETED|Overall Study||22||
59578602|NCT03109769|75684100|FG000|NOT COMPLETED|Overall Study||0||
59578603|NCT03109769|75684101|FG001|NOT COMPLETED|Overall Study||0||
59578604|NCT02957123|75684107|FG000|STARTED|Overall Study||30||
59723454|NCT01071798|75842054|FG000|STARTED|Participants Who Received One Cycle||1653||
59723455|NCT01071798|75842054|FG000|Baseline and Safety Analysis Set|Participants Who Received One Cycle||1653||
59723456|NCT01071798|75842054|FG000|COMPLETED|Participants Who Received One Cycle||1588||
59723457|NCT01071798|75842054|FG000|NOT COMPLETED|Participants Who Received One Cycle||65||
59723458|NCT01071798|75842054|FG000|STARTED|Subpopulation Who Received Two Cycles||820||
59723459|NCT01071798|75842054|FG000|Baseline and Safety Analysis Set|Subpopulation Who Received Two Cycles||820||
59723460|NCT01071798|75842054|FG000|COMPLETED|Subpopulation Who Received Two Cycles||805||
59723461|NCT01071798|75842054|FG000|NOT COMPLETED|Subpopulation Who Received Two Cycles||15||
59723462|NCT00857311|75842072|FG000|STARTED|Overall Study||9||
59723463|NCT00857311|75842073|FG001|STARTED|Overall Study||0||
59578605|NCT02957123|75684107|FG000|COMPLETED|Overall Study||30||
59578606|NCT02957123|75684107|FG000|NOT COMPLETED|Overall Study||0||
59578607|NCT03110003|75684113|FG000|STARTED|Overall Study||21||
59578608|NCT03110003|75684114|FG001|STARTED|Overall Study||24||
59578609|NCT03110003|75684113|FG000|COMPLETED|Overall Study||21||
59578610|NCT03110003|75684114|FG001|COMPLETED|Overall Study||24||
59578611|NCT03110003|75684113|FG000|NOT COMPLETED|Overall Study||0||
59578612|NCT03110003|75684114|FG001|NOT COMPLETED|Overall Study||0||
59578613|NCT03110471|75684122|FG000|STARTED|Overall Study||30||
59578614|NCT03110471|75684123|FG001|STARTED|Overall Study||30||
59578615|NCT03110471|75684122|FG000|COMPLETED|Overall Study||30||
59578616|NCT03110471|75684123|FG001|COMPLETED|Overall Study||30||
59578617|NCT03110471|75684122|FG000|NOT COMPLETED|Overall Study||0||
59723464|NCT00857311|75842074|FG002|STARTED|Overall Study||8||
59723465|NCT00857311|75842075|FG003|STARTED|Overall Study||0||
59723466|NCT00857311|75842072|FG000|COMPLETED|Overall Study||8||
59723467|NCT00857311|75842073|FG001|COMPLETED|Overall Study||0||
59723468|NCT00857311|75842074|FG002|COMPLETED|Overall Study||8||
60121386|NCT02684370|76242317|FG003|NOT COMPLETED|Part A||0||
59578618|NCT03110471|75684123|FG001|NOT COMPLETED|Overall Study||0||
59578619|NCT02957357|75684129|FG000|STARTED|Overall Study||10479||
59578620|NCT02957357|75684130|FG001|STARTED|Overall Study||835||
59578621|NCT02957357|75684129|FG000|COMPLETED|Overall Study||10479||
59578622|NCT02957357|75684130|FG001|COMPLETED|Overall Study||835||
59723469|NCT00857311|75842075|FG003|COMPLETED|Overall Study||0||
59723470|NCT00857311|75842072|FG000|NOT COMPLETED|Overall Study||1||
59723471|NCT00857311|75842073|FG001|NOT COMPLETED|Overall Study||0||
59723472|NCT00857311|75842074|FG002|NOT COMPLETED|Overall Study||0||
59723473|NCT00857311|75842075|FG003|NOT COMPLETED|Overall Study||0||
59723474|NCT00857233|75842081|FG000|STARTED|Overall Study||297||
59723475|NCT00857233|75842081|FG000|COMPLETED|Overall Study||242||
59723476|NCT00857233|75842081|FG000|NOT COMPLETED|Overall Study||55||
59723477|NCT00856999|75842085|FG000|STARTED|Overall Study||50||
59723478|NCT00856999|75842085|FG000|COMPLETED|Overall Study||45||
59723479|NCT00856999|75842085|FG000|NOT COMPLETED|Overall Study||5||
59723480|NCT01071252|75842095|FG000|STARTED|Overall Study||29||
59723481|NCT01071252|75842096|FG001|STARTED|Overall Study||26||
59723482|NCT01071252|75842097|FG002|STARTED|Overall Study||21||
59723483|NCT01071252|75842098|FG003|STARTED|Overall Study||27||
59723484|NCT01071252|75842099|FG004|STARTED|Overall Study||22||
59723485|NCT01071252|75842095|FG000|COMPLETED|Overall Study||14||
59723486|NCT01071252|75842096|FG001|COMPLETED|Overall Study||16||
59723487|NCT01071252|75842097|FG002|COMPLETED|Overall Study||17||
59723488|NCT01071252|75842098|FG003|COMPLETED|Overall Study||20||
59723489|NCT01071252|75842099|FG004|COMPLETED|Overall Study||11||
59723490|NCT01071252|75842095|FG000|NOT COMPLETED|Overall Study||15||
59723491|NCT01071252|75842096|FG001|NOT COMPLETED|Overall Study||10||
59723492|NCT01071252|75842097|FG002|NOT COMPLETED|Overall Study||4||
59723493|NCT01071252|75842098|FG003|NOT COMPLETED|Overall Study||7||
59723494|NCT01071252|75842099|FG004|NOT COMPLETED|Overall Study||11||
59723495|NCT00856843|75842113|FG000|STARTED|Overall Study||68||
59723496|NCT00856843|75842114|FG001|STARTED|Overall Study||68||
59723497|NCT00856843|75842113|FG000|COMPLETED|Overall Study||66||
59723498|NCT00856843|75842114|FG001|COMPLETED|Overall Study||63||
59723499|NCT00856843|75842113|FG000|NOT COMPLETED|Overall Study||2||
59723500|NCT00856843|75842114|FG001|NOT COMPLETED|Overall Study||5||
59723501|NCT00856609|75842122|FG000|STARTED|Overall Study||41||
59723502|NCT00856609|75842123|FG001|STARTED|Overall Study||39||
59723503|NCT00856609|75842122|FG000|COMPLETED|Overall Study||40||
59723504|NCT00856609|75842123|FG001|COMPLETED|Overall Study||39||
59723505|NCT00856609|75842122|FG000|NOT COMPLETED|Overall Study||1||
59723506|NCT00856609|75842123|FG001|NOT COMPLETED|Overall Study||0||
59723507|NCT01071096|75842129|FG000|STARTED|First Intervention (90 Days)||10||
59723508|NCT01071096|75842130|FG001|STARTED|First Intervention (90 Days)||10||
59723509|NCT01071096|75842129|FG000|COMPLETED|First Intervention (90 Days)||9||
59723510|NCT01071096|75842130|FG001|COMPLETED|First Intervention (90 Days)||10||
59723511|NCT01071096|75842129|FG000|NOT COMPLETED|First Intervention (90 Days)||1||
59723512|NCT01071096|75842130|FG001|NOT COMPLETED|First Intervention (90 Days)||0||
59723513|NCT01071096|75842129|FG000|STARTED|Washout Period (30 Days)||9||
59723514|NCT01071096|75842130|FG001|STARTED|Washout Period (30 Days)||10||
59723515|NCT01071096|75842129|FG000|COMPLETED|Washout Period (30 Days)||9||
59723516|NCT01071096|75842130|FG001|COMPLETED|Washout Period (30 Days)||10||
59723517|NCT01071096|75842129|FG000|NOT COMPLETED|Washout Period (30 Days)||0||
59723518|NCT01071096|75842130|FG001|NOT COMPLETED|Washout Period (30 Days)||0||
59723519|NCT01071096|75842129|FG000|STARTED|Second Intervention (90 Days)||9||
59723520|NCT01071096|75842130|FG001|STARTED|Second Intervention (90 Days)||10||
59723521|NCT01071096|75842129|FG000|COMPLETED|Second Intervention (90 Days)||9||
59723522|NCT01071096|75842130|FG001|COMPLETED|Second Intervention (90 Days)||10||
59723523|NCT01071096|75842129|FG000|NOT COMPLETED|Second Intervention (90 Days)||0||
59723524|NCT01071096|75842130|FG001|NOT COMPLETED|Second Intervention (90 Days)||0||
59723525|NCT00856375|75842149|FG000|STARTED|Overall Study||42||
59723526|NCT00856375|75842150|FG001|STARTED|Overall Study||41||
59723527|NCT00856375|75842149|FG000|COMPLETED|Overall Study||0||
59723528|NCT00856375|75842150|FG001|COMPLETED|Overall Study||0||
59723529|NCT00856375|75842149|FG000|NOT COMPLETED|Overall Study||42||
59723530|NCT00856375|75842150|FG001|NOT COMPLETED|Overall Study||41||
59723531|NCT01070784|75842158|FG000|STARTED|Overall Study||130||
59723532|NCT01070784|75842159|FG001|STARTED|Overall Study||130||
59723533|NCT01070784|75842158|FG000|COMPLETED|Overall Study||110||
60121387|NCT02684370|76242318|FG004|NOT COMPLETED|Part A||0||
59723534|NCT01070784|75842159|FG001|COMPLETED|Overall Study||112||
60121388|NCT02684370|76242319|FG005|NOT COMPLETED|Part A||0||
59723535|NCT01070784|75842158|FG000|NOT COMPLETED|Overall Study||20||
59723536|NCT01070784|75842159|FG001|NOT COMPLETED|Overall Study||18||
59723537|NCT00837577|75842167|FG000|STARTED|Double-blind Period||70||
59723538|NCT00837577|75842168|FG001|STARTED|Double-blind Period||63||
59723539|NCT00837577|75842167|FG000|COMPLETED|Double-blind Period||68||
59723540|NCT00837577|75842168|FG001|COMPLETED|Double-blind Period||63||
59723541|NCT00837577|75842167|FG000|NOT COMPLETED|Double-blind Period||2||
59723542|NCT00837577|75842168|FG001|NOT COMPLETED|Double-blind Period||0||
59723543|NCT00837577|75842167|FG000|STARTED|Open-label Period||68||
59723544|NCT00837577|75842168|FG001|STARTED|Open-label Period||63||
59723545|NCT00837577|75842167|FG000|COMPLETED|Open-label Period||60||
59723546|NCT00837577|75842168|FG001|COMPLETED|Open-label Period||54||
59723547|NCT00837577|75842167|FG000|NOT COMPLETED|Open-label Period||8||
59723548|NCT00837577|75842168|FG001|NOT COMPLETED|Open-label Period||9||
59723549|NCT01070550|75842181|FG000|STARTED|Overall Study||3356||
59723550|NCT01070550|75842182|FG001|STARTED|Overall Study||316||
59723551|NCT01070550|75842183|FG002|STARTED|Overall Study||744||
59723552|NCT01070550|75842184|FG003|STARTED|Overall Study||201||
59723553|NCT01070550|75842185|FG004|STARTED|Overall Study||21||
59723554|NCT01070550|75842186|FG005|STARTED|Overall Study||42||
59723555|NCT01070550|75842181|FG000|COMPLETED|Overall Study||2071||
59723556|NCT01070550|75842182|FG001|COMPLETED|Overall Study||254||
59723557|NCT01070550|75842183|FG002|COMPLETED|Overall Study||528||
59723558|NCT01070550|75842184|FG003|COMPLETED|Overall Study||124||
59723559|NCT01070550|75842185|FG004|COMPLETED|Overall Study||20||
59723560|NCT01070550|75842186|FG005|COMPLETED|Overall Study||35||
59723561|NCT01070550|75842181|FG000|NOT COMPLETED|Overall Study||1285||
59723562|NCT01070550|75842182|FG001|NOT COMPLETED|Overall Study||62||
59723563|NCT01070550|75842183|FG002|NOT COMPLETED|Overall Study||216||
59723564|NCT01070550|75842184|FG003|NOT COMPLETED|Overall Study||77||
59723565|NCT01070550|75842185|FG004|NOT COMPLETED|Overall Study||1||
59723566|NCT01070550|75842186|FG005|NOT COMPLETED|Overall Study||7||
59723567|NCT00848107|75842201|FG000|STARTED|Overall Study||115||
59723568|NCT00848107|75842201|FG000|COMPLETED|Overall Study||94||
59723569|NCT00848107|75842201|FG000|NOT COMPLETED|Overall Study||21||
59723570|NCT00856297|75842210|FG000|STARTED|Overall Study||131||
59723571|NCT00856297|75842211|FG001|STARTED|Overall Study||76||
59723572|NCT00856297|75842212|FG002|STARTED|Overall Study||107||
59723573|NCT00856297|75842213|FG003|STARTED|Overall Study||44||
59723574|NCT00856297|75842214|FG004|STARTED|Overall Study||31||
59723575|NCT00856297|75842210|FG000|COMPLETED|Overall Study||129||
59723576|NCT00856297|75842211|FG001|COMPLETED|Overall Study||76||
59723577|NCT00856297|75842212|FG002|COMPLETED|Overall Study||107||
59723578|NCT00856297|75842213|FG003|COMPLETED|Overall Study||44||
59723579|NCT00856297|75842214|FG004|COMPLETED|Overall Study||31||
59723580|NCT00856297|75842210|FG000|NOT COMPLETED|Overall Study||2||
59723581|NCT00856297|75842211|FG001|NOT COMPLETED|Overall Study||0||
59850387|NCT04978363|75974745|FG006|COMPLETED|Overall Study||2||
60121389|NCT02684370|76242314|FG000|STARTED|Part B||0||
59723582|NCT00856297|75842212|FG002|NOT COMPLETED|Overall Study||0||
59723583|NCT00856297|75842213|FG003|NOT COMPLETED|Overall Study||0||
59723584|NCT00856297|75842214|FG004|NOT COMPLETED|Overall Study||0||
59723585|NCT01046136|75842233|FG000|STARTED|Overall Study||188||
59723586|NCT01046136|75842234|FG001|STARTED|Overall Study||190||
59723587|NCT01046136|75842233|FG000|COMPLETED|Overall Study||184||
59723588|NCT01046136|75842234|FG001|COMPLETED|Overall Study||182||
59723589|NCT01046136|75842233|FG000|NOT COMPLETED|Overall Study||4||
59723590|NCT01046136|75842234|FG001|NOT COMPLETED|Overall Study||8||
59723591|NCT01070394|75842242|FG000|STARTED|Overall Study||40||
59723592|NCT01070394|75842242|FG000|COMPLETED|Overall Study||33||
59723593|NCT01070394|75842242|FG000|NOT COMPLETED|Overall Study||7||
59723594|NCT00836953|75842248|FG000|STARTED|Overall Study||33||
59723595|NCT00836953|75842248|FG000|COMPLETED|Overall Study||31||
59723596|NCT00836953|75842248|FG000|NOT COMPLETED|Overall Study||2||
59723597|NCT01070316|75842252|FG000|STARTED|Main Phase||20||
59723598|NCT01070316|75842252|FG000|COMPLETED|Main Phase||20||
59723599|NCT01070316|75842252|FG000|NOT COMPLETED|Main Phase||0||
59723600|NCT01070316|75842252|FG000|STARTED|Extension Phase|Two participants did not qualify for Extension Phase as defined by protocol|18||
59723601|NCT01070316|75842252|FG000|COMPLETED|Extension Phase||14||
59723602|NCT01070316|75842252|FG000|NOT COMPLETED|Extension Phase||4||
59723603|NCT01126541|75842259|FG000|STARTED|Overall Study||70||
60121390|NCT02684370|76242315|FG001|STARTED|Part B||0||
60121391|NCT02684370|76242316|FG002|STARTED|Part B||0||
60121392|NCT02684370|76242317|FG003|STARTED|Part B|1 participant who received placebo in Part A did not receive a dose of study drug in Part B|97||
60121393|NCT02684370|76242318|FG004|STARTED|Part B|Participants who received ustekinumab in Part A received ustekinumab in Part B|99||
60121394|NCT02684370|76242319|FG005|STARTED|Part B|2 participants who received risankizumab in Part A did not receive a dose of study drug in Part B|297||
60121395|NCT02684370|76242314|FG000|COMPLETED|Part B||0||
59723604|NCT01126541|75842260|FG001|STARTED|Overall Study||73||
59723605|NCT01126541|75842261|FG002|STARTED|Overall Study||81||
59723606|NCT01126541|75842259|FG000|COMPLETED|Overall Study||60||
59723607|NCT01126541|75842260|FG001|COMPLETED|Overall Study||61||
59723608|NCT01126541|75842261|FG002|COMPLETED|Overall Study||55||
59723609|NCT01126541|75842259|FG000|NOT COMPLETED|Overall Study||10||
59723610|NCT01126541|75842260|FG001|NOT COMPLETED|Overall Study||12||
59723611|NCT01126541|75842261|FG002|NOT COMPLETED|Overall Study||26||
59723612|NCT00836875|75842273|FG000|STARTED|Overall Study||11||
59723613|NCT00836875|75842274|FG001|STARTED|Overall Study||20||
59723614|NCT00836875|75842273|FG000|COMPLETED|Overall Study||8||
59723615|NCT00836875|75842274|FG001|COMPLETED|Overall Study||17||
59723616|NCT00836875|75842273|FG000|NOT COMPLETED|Overall Study||3||
59723617|NCT00836875|75842274|FG001|NOT COMPLETED|Overall Study||3||
59723618|NCT01125917|75842280|FG000|STARTED|Overall Study||354||
59723619|NCT01125917|75842280|FG000|COMPLETED|Overall Study||15||
59723620|NCT01125917|75842280|FG000|NOT COMPLETED|Overall Study||339||
59723621|NCT00847561|75842286|FG000|STARTED|Overall Study||70||
59850388|NCT04978363|75974746|FG007|COMPLETED|Overall Study||2||
60121396|NCT02684370|76242315|FG001|COMPLETED|Part B||0||
60121397|NCT02684370|76242316|FG002|COMPLETED|Part B||0||
60121398|NCT02684370|76242317|FG003|COMPLETED|Part B||95||
60121399|NCT02684370|76242318|FG004|COMPLETED|Part B||94||
59723622|NCT00847561|75842287|FG001|STARTED|Overall Study||66||
59723623|NCT00847561|75842286|FG000|COMPLETED|Overall Study||57||
59723624|NCT00847561|75842287|FG001|COMPLETED|Overall Study||62||
59850389|NCT04978363|75974747|FG008|COMPLETED|Overall Study||2||
59723625|NCT00847561|75842286|FG000|NOT COMPLETED|Overall Study||13||
59723626|NCT00847561|75842287|FG001|NOT COMPLETED|Overall Study||4||
59723627|NCT01121549|75842293|FG000|STARTED|Overall Study||378||
59723628|NCT01121549|75842293|FG000|COMPLETED|Overall Study||31||
59723629|NCT01121549|75842293|FG000|NOT COMPLETED|Overall Study||347||
59723630|NCT00847405|75842299|FG000|STARTED|First Intervention||14||
59723631|NCT00847405|75842300|FG001|STARTED|First Intervention||14||
59723632|NCT00847405|75842299|FG000|COMPLETED|First Intervention||14||
59723633|NCT00847405|75842300|FG001|COMPLETED|First Intervention||13||
59723634|NCT00847405|75842299|FG000|NOT COMPLETED|First Intervention||0||
59723635|NCT00847405|75842300|FG001|NOT COMPLETED|First Intervention||1||
59723636|NCT00847405|75842299|FG000|STARTED|Washout of 7 Days||14||
59723637|NCT00847405|75842300|FG001|STARTED|Washout of 7 Days||13||
59723638|NCT00847405|75842299|FG000|COMPLETED|Washout of 7 Days||13||
59723639|NCT00847405|75842300|FG001|COMPLETED|Washout of 7 Days||13||
59723640|NCT00847405|75842299|FG000|NOT COMPLETED|Washout of 7 Days||1||
59723641|NCT00847405|75842300|FG001|NOT COMPLETED|Washout of 7 Days||0||
59723642|NCT00847405|75842299|FG000|STARTED|Second Intervention||13||
59723643|NCT00847405|75842300|FG001|STARTED|Second Intervention||13||
59723644|NCT00847405|75842299|FG000|COMPLETED|Second Intervention||13||
59723645|NCT00847405|75842300|FG001|COMPLETED|Second Intervention||13||
59723646|NCT00847405|75842299|FG000|NOT COMPLETED|Second Intervention||0||
59723647|NCT00847405|75842300|FG001|NOT COMPLETED|Second Intervention||0||
59723648|NCT00836095|75842306|FG000|STARTED|Overall Study||22||
59723649|NCT00836095|75842307|FG001|STARTED|Overall Study||30||
59723650|NCT00836095|75842306|FG000|COMPLETED|Overall Study||22||
59723651|NCT00836095|75842307|FG001|COMPLETED|Overall Study||27||
59723652|NCT00836095|75842306|FG000|NOT COMPLETED|Overall Study||0||
59723653|NCT00836095|75842307|FG001|NOT COMPLETED|Overall Study||3||
59723654|NCT04248712|75842315|FG000|STARTED|Overall Study||1||
59723655|NCT04248712|75842316|FG001|STARTED|Overall Study||0||
59723656|NCT04248712|75842315|FG000|COMPLETED|Overall Study||1||
59723657|NCT04248712|75842316|FG001|COMPLETED|Overall Study||0||
59723658|NCT04248712|75842315|FG000|NOT COMPLETED|Overall Study||0||
59723659|NCT04248712|75842316|FG001|NOT COMPLETED|Overall Study||0||
59723660|NCT00835237|75842324|FG000|STARTED|Overall Study||887||
59723661|NCT00835237|75842325|FG001|STARTED|Overall Study||445||
59723662|NCT00835237|75842324|FG000|COMPLETED|Overall Study||881||
59723663|NCT00835237|75842325|FG001|COMPLETED|Overall Study||445||
59723664|NCT00835237|75842324|FG000|NOT COMPLETED|Overall Study||6||
59723665|NCT00835237|75842325|FG001|NOT COMPLETED|Overall Study||0||
59723666|NCT01072500|75842333|FG000|STARTED|Overall Study||818||
59723667|NCT01072500|75842334|FG001|STARTED|Overall Study||817||
59723668|NCT01072500|75842333|FG000|COMPLETED|Overall Study||794||
59723669|NCT01072500|75842334|FG001|COMPLETED|Overall Study||803||
59723670|NCT01072500|75842333|FG000|NOT COMPLETED|Overall Study||24||
59723671|NCT01072500|75842334|FG001|NOT COMPLETED|Overall Study||14||
59723672|NCT00847015|75842342|FG000|STARTED|Overall Study||18||
59723673|NCT00847015|75842342|FG000|COMPLETED|Overall Study||15||
59723674|NCT00847015|75842342|FG000|NOT COMPLETED|Overall Study||3||
59723675|NCT00855595|75842348|FG000|STARTED|Overall Study||106||
59723676|NCT00855595|75842349|FG001|STARTED|Overall Study||101||
59723677|NCT00855595|75842348|FG000|COMPLETED|Overall Study||100||
59723678|NCT00855595|75842349|FG001|COMPLETED|Overall Study||94||
59723679|NCT00855595|75842348|FG000|NOT COMPLETED|Overall Study||6||
59723680|NCT00855595|75842349|FG001|NOT COMPLETED|Overall Study||7||
59850390|NCT04978363|75974748|FG009|COMPLETED|Overall Study||2||
59850391|NCT04978363|75974749|FG010|COMPLETED|Overall Study||1||
59850392|NCT04978363|75974739|FG000|NOT COMPLETED|Overall Study||0||
59850393|NCT04978363|75974740|FG001|NOT COMPLETED|Overall Study||1||
59850394|NCT04978363|75974741|FG002|NOT COMPLETED|Overall Study||1||
59850395|NCT04978363|75974742|FG003|NOT COMPLETED|Overall Study||0||
59850396|NCT04978363|75974743|FG004|NOT COMPLETED|Overall Study||1||
59850397|NCT04978363|75974744|FG005|NOT COMPLETED|Overall Study||0||
59850398|NCT04978363|75974745|FG006|NOT COMPLETED|Overall Study||0||
59850399|NCT04978363|75974746|FG007|NOT COMPLETED|Overall Study||0||
59723681|NCT00855439|75842357|FG000|STARTED|Overall Study||22||
59723682|NCT00855439|75842358|FG001|STARTED|Overall Study||24||
59723683|NCT00855439|75842357|FG000|COMPLETED|Overall Study||19||
59723684|NCT00855439|75842358|FG001|COMPLETED|Overall Study||24||
59723685|NCT00855439|75842357|FG000|NOT COMPLETED|Overall Study||3||
59723686|NCT00855439|75842358|FG001|NOT COMPLETED|Overall Study||0||
59723687|NCT01064856|75842366|FG000|STARTED|Double-blind (DB) Period||84||
59723688|NCT01064856|75842367|FG001|STARTED|Double-blind (DB) Period||81||
59723689|NCT01064856|75842368|FG002|STARTED|Double-blind (DB) Period|This treatment group is not applicable for this period.|0||
59723690|NCT01064856|75842369|FG003|STARTED|Double-blind (DB) Period|This treatment group is not applicable for this period.|0||
59723691|NCT01064856|75842366|FG000|COMPLETED|Double-blind (DB) Period||82||
59723692|NCT01064856|75842367|FG001|COMPLETED|Double-blind (DB) Period||81||
59723693|NCT01064856|75842368|FG002|COMPLETED|Double-blind (DB) Period||0||
59723694|NCT01064856|75842369|FG003|COMPLETED|Double-blind (DB) Period||0||
59850400|NCT04978363|75974747|FG008|NOT COMPLETED|Overall Study||0||
59850401|NCT04978363|75974748|FG009|NOT COMPLETED|Overall Study||0||
59723695|NCT01064856|75842366|FG000|NOT COMPLETED|Double-blind (DB) Period||2||
59723696|NCT01064856|75842367|FG001|NOT COMPLETED|Double-blind (DB) Period||0||
59723697|NCT01064856|75842368|FG002|NOT COMPLETED|Double-blind (DB) Period||0||
59723698|NCT01064856|75842369|FG003|NOT COMPLETED|Double-blind (DB) Period||0||
59723699|NCT01064856|75842366|FG000|STARTED|Open-label (OL) Period|This treatment group is not applicable for this period.|0||
59723700|NCT01064856|75842367|FG001|STARTED|Open-label (OL) Period|This treatment group is not applicable for this period.|0||
59723701|NCT01064856|75842368|FG002|STARTED|Open-label (OL) Period||82||
59723702|NCT01064856|75842369|FG003|STARTED|Open-label (OL) Period||81||
59723703|NCT01064856|75842366|FG000|COMPLETED|Open-label (OL) Period||0||
59723704|NCT01064856|75842367|FG001|COMPLETED|Open-label (OL) Period||0||
59723705|NCT01064856|75842368|FG002|COMPLETED|Open-label (OL) Period||56||
59723706|NCT01064856|75842369|FG003|COMPLETED|Open-label (OL) Period||61||
59723707|NCT01064856|75842366|FG000|NOT COMPLETED|Open-label (OL) Period||0||
59723708|NCT01064856|75842367|FG001|NOT COMPLETED|Open-label (OL) Period||0||
59723709|NCT01064856|75842368|FG002|NOT COMPLETED|Open-label (OL) Period||26||
59723710|NCT01064856|75842369|FG003|NOT COMPLETED|Open-label (OL) Period||20||
59723711|NCT00846391|75842379|FG000|STARTED|Overall Study||4||
59723712|NCT00846391|75842380|FG001|STARTED|Overall Study||4||
59723713|NCT00846391|75842381|FG002|STARTED|Overall Study||6||
59723714|NCT00846391|75842379|FG000|COMPLETED|Overall Study||3||
59723715|NCT00846391|75842380|FG001|COMPLETED|Overall Study||2||
59723716|NCT00846391|75842381|FG002|COMPLETED|Overall Study||3||
59723717|NCT00846391|75842379|FG000|NOT COMPLETED|Overall Study||1||
59723718|NCT00846391|75842380|FG001|NOT COMPLETED|Overall Study||2||
59723719|NCT00846391|75842381|FG002|NOT COMPLETED|Overall Study||3||
59723720|NCT01042392|75842391|FG000|STARTED|Period II(Randomized,Double Blinded,8wk)||257||
59723721|NCT01042392|75842392|FG001|STARTED|Period II(Randomized,Double Blinded,8wk)|This arm is used only in Period III.|0||
59723722|NCT01042392|75842393|FG002|STARTED|Period II(Randomized,Double Blinded,8wk)||249||
59723723|NCT01042392|75842394|FG003|STARTED|Period II(Randomized,Double Blinded,8wk)|This arm is used only in Period III.|0||
59723724|NCT01042392|75842391|FG000|Intent to Treat (ITT)|Period II(Randomized,Double Blinded,8wk)|ITT excluded patients from centers where 90% of BP measurements were rounded to 5 or 0|222||
59723725|NCT01042392|75842392|FG001|Intent to Treat (ITT)|Period II(Randomized,Double Blinded,8wk)||0||
59723726|NCT01042392|75842393|FG002|Intent to Treat (ITT)|Period II(Randomized,Double Blinded,8wk)||222||
59723727|NCT01042392|75842394|FG003|Intent to Treat (ITT)|Period II(Randomized,Double Blinded,8wk)||0||
59723728|NCT01042392|75842391|FG000|COMPLETED|Period II(Randomized,Double Blinded,8wk)||247||
59723729|NCT01042392|75842392|FG001|COMPLETED|Period II(Randomized,Double Blinded,8wk)||0||
59723730|NCT01042392|75842393|FG002|COMPLETED|Period II(Randomized,Double Blinded,8wk)||241||
59723731|NCT01042392|75842394|FG003|COMPLETED|Period II(Randomized,Double Blinded,8wk)||0||
59723732|NCT01042392|75842391|FG000|NOT COMPLETED|Period II(Randomized,Double Blinded,8wk)||10||
59723733|NCT01042392|75842392|FG001|NOT COMPLETED|Period II(Randomized,Double Blinded,8wk)||0||
59723734|NCT01042392|75842393|FG002|NOT COMPLETED|Period II(Randomized,Double Blinded,8wk)||8||
59723735|NCT01042392|75842394|FG003|NOT COMPLETED|Period II(Randomized,Double Blinded,8wk)||0||
59723736|NCT01042392|75842391|FG000|STARTED|Period III (Unblinded,Controlled, 1 Day)||129||
59723737|NCT01042392|75842392|FG001|STARTED|Period III (Unblinded,Controlled, 1 Day)||118||
59723738|NCT01042392|75842393|FG002|STARTED|Period III (Unblinded,Controlled, 1 Day)||119||
59723739|NCT01042392|75842394|FG003|STARTED|Period III (Unblinded,Controlled, 1 Day)||122||
59723740|NCT01042392|75842391|FG000|Per Protocol Missed-dose (PPMD)|Period III (Unblinded,Controlled, 1 Day)|PPMD excluded patients violated protocol instructions for period 3 (duration and treatment intake)|98||
59723741|NCT01042392|75842392|FG001|Per Protocol Missed-dose (PPMD)|Period III (Unblinded,Controlled, 1 Day)||73||
59723742|NCT01042392|75842393|FG002|Per Protocol Missed-dose (PPMD)|Period III (Unblinded,Controlled, 1 Day)||93||
59723743|NCT01042392|75842394|FG003|Per Protocol Missed-dose (PPMD)|Period III (Unblinded,Controlled, 1 Day)||82||
59723744|NCT01042392|75842391|FG000|COMPLETED|Period III (Unblinded,Controlled, 1 Day)||127||
59723745|NCT01042392|75842392|FG001|COMPLETED|Period III (Unblinded,Controlled, 1 Day)||117||
59723746|NCT01042392|75842393|FG002|COMPLETED|Period III (Unblinded,Controlled, 1 Day)||115||
59723747|NCT01042392|75842394|FG003|COMPLETED|Period III (Unblinded,Controlled, 1 Day)||121||
59723748|NCT01042392|75842391|FG000|NOT COMPLETED|Period III (Unblinded,Controlled, 1 Day)||2||
59723749|NCT01042392|75842392|FG001|NOT COMPLETED|Period III (Unblinded,Controlled, 1 Day)||1||
59723750|NCT01042392|75842393|FG002|NOT COMPLETED|Period III (Unblinded,Controlled, 1 Day)||4||
59723751|NCT01042392|75842394|FG003|NOT COMPLETED|Period III (Unblinded,Controlled, 1 Day)||1||
59723752|NCT01064310|75842408|FG000|STARTED|Period 1||82||
59723753|NCT01064310|75842409|FG001|STARTED|Period 1||86||
59723754|NCT01064310|75842410|FG002|STARTED|Period 1||0||
59723755|NCT01064310|75842408|FG000|COMPLETED|Period 1||68||
59723756|NCT01064310|75842409|FG001|COMPLETED|Period 1||68||
59723757|NCT01064310|75842410|FG002|COMPLETED|Period 1||0||
59723758|NCT01064310|75842408|FG000|NOT COMPLETED|Period 1||14||
59723759|NCT01064310|75842409|FG001|NOT COMPLETED|Period 1||18||
59723760|NCT01064310|75842410|FG002|NOT COMPLETED|Period 1||0||
59723761|NCT01064310|75842408|FG000|STARTED|Period 2||68||
59723762|NCT01064310|75842409|FG001|STARTED|Period 2||68||
59723763|NCT01064310|75842410|FG002|STARTED|Period 2||0||
59723764|NCT01064310|75842408|FG000|COMPLETED|Period 2||64||
59723765|NCT01064310|75842409|FG001|COMPLETED|Period 2||62||
59723766|NCT01064310|75842410|FG002|COMPLETED|Period 2||0||
59723767|NCT01064310|75842408|FG000|NOT COMPLETED|Period 2||4||
59723768|NCT01064310|75842409|FG001|NOT COMPLETED|Period 2||6||
59723769|NCT01064310|75842410|FG002|NOT COMPLETED|Period 2||0||
59723770|NCT01064310|75842408|FG000|STARTED|Open Label Pazopinib||0||
59723771|NCT01064310|75842409|FG001|STARTED|Open Label Pazopinib||0||
59723772|NCT01064310|75842410|FG002|STARTED|Open Label Pazopinib||84||
59723773|NCT01064310|75842408|FG000|COMPLETED|Open Label Pazopinib||0||
59850402|NCT04978363|75974749|FG010|NOT COMPLETED|Overall Study||0||
59850403|NCT04732195|75974772|FG000|STARTED|Overall Study||50||50
59850404|NCT04732195|75974773|FG001|STARTED|Overall Study||50||50
59850405|NCT04732195|75974772|FG000|COMPLETED|Overall Study||50||50
59850406|NCT04732195|75974773|FG001|COMPLETED|Overall Study||50||50
59850407|NCT04732195|75974772|FG000|NOT COMPLETED|Overall Study||0||0
59850408|NCT04732195|75974773|FG001|NOT COMPLETED|Overall Study||0||0
59850409|NCT04681482|75974783|FG000|STARTED|Overall Study||35051||
59850410|NCT04681482|75974784|FG001|STARTED|Overall Study||38756||
59850411|NCT04681482|75974785|FG002|STARTED|Overall Study||12148||
59850412|NCT04681482|75974786|FG003|STARTED|Overall Study||21428||
59850413|NCT04681482|75974783|FG000|COMPLETED|Overall Study||35051||
59850414|NCT04681482|75974784|FG001|COMPLETED|Overall Study||38756||
59850415|NCT04681482|75974785|FG002|COMPLETED|Overall Study||12148||
59850416|NCT04681482|75974786|FG003|COMPLETED|Overall Study||21428||
59850417|NCT04681482|75974783|FG000|NOT COMPLETED|Overall Study||0||
59850418|NCT04681482|75974784|FG001|NOT COMPLETED|Overall Study||0||
59850419|NCT04681482|75974785|FG002|NOT COMPLETED|Overall Study||0||
59850420|NCT04681482|75974786|FG003|NOT COMPLETED|Overall Study||0||
59850421|NCT04493320|75974798|FG000|STARTED|Overall Study||2||
59850422|NCT04493320|75974799|FG001|STARTED|Overall Study||2||
59850423|NCT04493320|75974798|FG000|COMPLETED|Overall Study||1||
59850424|NCT04493320|75974799|FG001|COMPLETED|Overall Study||1||
59850425|NCT04493320|75974798|FG000|NOT COMPLETED|Overall Study||1||
59850426|NCT04493320|75974799|FG001|NOT COMPLETED|Overall Study||1||
59850427|NCT04267380|75974807|FG000|STARTED|Overall Study||149||
59850428|NCT04267380|75974808|FG001|STARTED|Overall Study||149||
59850429|NCT04267380|75974807|FG000|COMPLETED|Overall Study||149||
59850430|NCT04267380|75974808|FG001|COMPLETED|Overall Study||149||
59850431|NCT04267380|75974807|FG000|NOT COMPLETED|Overall Study||0||
59850432|NCT04267380|75974808|FG001|NOT COMPLETED|Overall Study||0||
59850433|NCT04151628|75974816|FG000|STARTED|Overall Study||8||
59850434|NCT04151628|75974817|FG001|STARTED|Overall Study||64||
59850435|NCT04151628|75974816|FG000|COMPLETED|Overall Study||8||
59850436|NCT04151628|75974817|FG001|COMPLETED|Overall Study||64||
59850437|NCT04151628|75974816|FG000|NOT COMPLETED|Overall Study||0||
59850438|NCT04151628|75974817|FG001|NOT COMPLETED|Overall Study||0||
59850439|NCT04101422|75974829|FG000|STARTED|Overall Study||11||
59850440|NCT04101422|75974830|FG001|STARTED|Overall Study||17||
59850441|NCT04101422|75974831|FG002|STARTED|Overall Study||126||
59850442|NCT04101422|75974832|FG003|STARTED|Overall Study||43||
59850443|NCT04101422|75974829|FG000|Extinction Group|Overall Study||0||
59850444|NCT04101422|75974830|FG001|Extinction Group|Overall Study|10 participants were randomized to Session 2: Extincion group after completing Session 1: Cue Reactivity|10||
59850445|NCT04101422|75974831|FG002|Extinction Group|Overall Study|59 participants were randomized and started in the Extinction group and 5 did not complete|59||
59850446|NCT04101422|75974832|FG003|Extinction Group|Overall Study||0||
59850447|NCT04101422|75974829|FG000|Control Group|Overall Study||0||
59850448|NCT04101422|75974830|FG001|Control Group|Overall Study|7 participants were randomized to Session 2: Control group after completing Session 1: Cue Reactivity|7||
59850449|NCT04101422|75974831|FG002|Control Group|Overall Study|67 participants were randomized to the Control group and 9 did not complete.|67||
59850450|NCT04101422|75974832|FG003|Control Group|Overall Study||0||
59850451|NCT04101422|75974829|FG000|COMPLETED|Overall Study||10||
59850452|NCT04101422|75974830|FG001|COMPLETED|Overall Study||17||
59850453|NCT04101422|75974831|FG002|COMPLETED|Overall Study||112||
59850454|NCT04101422|75974832|FG003|COMPLETED|Overall Study||23||
59850455|NCT04101422|75974829|FG000|NOT COMPLETED|Overall Study||1||
59850456|NCT04101422|75974830|FG001|NOT COMPLETED|Overall Study||0||
59850457|NCT04101422|75974831|FG002|NOT COMPLETED|Overall Study||14||
59850458|NCT04101422|75974832|FG003|NOT COMPLETED|Overall Study||20||
59850459|NCT03841604|75974844|FG000|STARTED|Overall Study||46||
59850460|NCT03841604|75974845|FG001|STARTED|Overall Study||25||
59850461|NCT03841604|75974844|FG000|COMPLETED|Overall Study||38||
59850462|NCT03841604|75974845|FG001|COMPLETED|Overall Study||22||
59850463|NCT03841604|75974844|FG000|NOT COMPLETED|Overall Study||8||
59850464|NCT03841604|75974845|FG001|NOT COMPLETED|Overall Study||3||
59850465|NCT03761030|75974853|FG000|STARTED|Overall Study||15||
59850466|NCT03761030|75974854|FG001|STARTED|Overall Study||16||
59850467|NCT03761030|75974853|FG000|COMPLETED|Overall Study||13||
59850468|NCT03761030|75974854|FG001|COMPLETED|Overall Study||12||
59850469|NCT03761030|75974853|FG000|NOT COMPLETED|Overall Study||2||
59850470|NCT03761030|75974854|FG001|NOT COMPLETED|Overall Study||4||
59850471|NCT03541187|75974862|FG000|STARTED|Overall Study||40||
59723774|NCT01064310|75842409|FG001|COMPLETED|Open Label Pazopinib||0||
59723775|NCT01064310|75842410|FG002|COMPLETED|Open Label Pazopinib||0||
59723776|NCT01064310|75842408|FG000|NOT COMPLETED|Open Label Pazopinib||0||
59850472|NCT03541187|75974863|FG001|STARTED|Overall Study||42||
59850473|NCT03541187|75974862|FG000|COMPLETED|Overall Study||28||
59850474|NCT03541187|75974863|FG001|COMPLETED|Overall Study||29||
59850475|NCT03541187|75974862|FG000|NOT COMPLETED|Overall Study||12||
59850476|NCT03541187|75974863|FG001|NOT COMPLETED|Overall Study||13||
59850477|NCT03535675|75974871|FG000|STARTED|Overall Study||29||
59850478|NCT03535675|75974872|FG001|STARTED|Overall Study||30||
59850479|NCT03535675|75974871|FG000|COMPLETED|Overall Study||29||
59850480|NCT03535675|75974872|FG001|COMPLETED|Overall Study||30||
59850481|NCT03535675|75974871|FG000|NOT COMPLETED|Overall Study||0||
59850482|NCT03535675|75974872|FG001|NOT COMPLETED|Overall Study||0||
59850483|NCT03477396|75974878|FG000|STARTED|Overall Study||2||
59850484|NCT03477396|75974878|FG000|COMPLETED|Overall Study||2||
59850485|NCT03477396|75974878|FG000|NOT COMPLETED|Overall Study||0||
59850486|NCT03240081|75974884|FG000|STARTED|Overall Study||25||
59850487|NCT03240081|75974885|FG001|STARTED|Overall Study||25||
59850488|NCT03240081|75974884|FG000|COMPLETED|Overall Study||25||
59850489|NCT03240081|75974885|FG001|COMPLETED|Overall Study||22||
59850490|NCT03240081|75974884|FG000|NOT COMPLETED|Overall Study||0||
59850491|NCT03240081|75974885|FG001|NOT COMPLETED|Overall Study||3||
59850492|NCT03074643|75974894|FG000|STARTED|Overall Study||62||
59850493|NCT03074643|75974895|FG001|STARTED|Overall Study||62||
59850494|NCT03074643|75974896|FG002|STARTED|Overall Study||63||
59850495|NCT03074643|75974894|FG000|COMPLETED|Overall Study||51||
59850496|NCT03074643|75974895|FG001|COMPLETED|Overall Study||50||
59850497|NCT03074643|75974896|FG002|COMPLETED|Overall Study||52||
59850498|NCT03074643|75974894|FG000|NOT COMPLETED|Overall Study||11||
59850499|NCT03074643|75974895|FG001|NOT COMPLETED|Overall Study||12||
59850500|NCT03074643|75974896|FG002|NOT COMPLETED|Overall Study||11||
59850501|NCT03003520|75974906|FG000|STARTED|Overall Study||43||
59850502|NCT03003520|75974907|FG001|STARTED|Overall Study||3||
59850503|NCT03003520|75974906|FG000|Completed Induction Treatment|Overall Study||31||
59850504|NCT03003520|75974907|FG001|Completed Induction Treatment|Overall Study||3||
59850505|NCT03003520|75974906|FG000|Completed Consolidation Treatment|Overall Study||14||
59850506|NCT03003520|75974907|FG001|Completed Consolidation Treatment|Overall Study||2||
59850507|NCT03003520|75974906|FG000|COMPLETED|Overall Study||14||
59850508|NCT03003520|75974907|FG001|COMPLETED|Overall Study||2||
59850509|NCT03003520|75974906|FG000|NOT COMPLETED|Overall Study||29||
59850510|NCT03003520|75974907|FG001|NOT COMPLETED|Overall Study||1||
59850511|NCT02989597|75974923|FG000|STARTED|Overall Study||5||
59850512|NCT02989597|75974924|FG001|STARTED|Overall Study||5||
59850513|NCT02989597|75974923|FG000|COMPLETED|Overall Study||5||
59850514|NCT02989597|75974924|FG001|COMPLETED|Overall Study||5||
59850515|NCT02989597|75974923|FG000|NOT COMPLETED|Overall Study||0||
59850516|NCT02989597|75974924|FG001|NOT COMPLETED|Overall Study||0||
59850517|NCT02958527|75974930|FG000|STARTED|Overall Study||1408||
59850518|NCT02958527|75974930|FG000|COMPLETED|Overall Study||1396||
59850519|NCT02958527|75974930|FG000|NOT COMPLETED|Overall Study||12||
59850520|NCT02768701|75974943|FG000|STARTED|Overall Study||40||
59850521|NCT02768701|75974943|FG000|COMPLETED|Overall Study||32||
59850522|NCT02768701|75974943|FG000|NOT COMPLETED|Overall Study||8||
59850523|NCT02586025|75974952|FG000|STARTED|Neoadjuvant Treatment||219|Intent-to-Treat (ITT) Population|
59850524|NCT02586025|75974953|FG001|STARTED|Neoadjuvant Treatment||110|Intent-to-Treat (ITT) Population|
59850525|NCT02586025|75974952|FG000|Received at Least One Dose of Study Treatment|Neoadjuvant Treatment||218|Safety Evaluable Population|
59850526|NCT02586025|75974953|FG001|Received at Least One Dose of Study Treatment|Neoadjuvant Treatment||110|Safety Evaluable Population|
59850527|NCT02586025|75974952|FG000|Completed Neoadjuvant Treatment|Neoadjuvant Treatment||214||
59850528|NCT02586025|75974953|FG001|Completed Neoadjuvant Treatment|Neoadjuvant Treatment||108||
59850529|NCT02586025|75974952|FG000|Underwent Surgery|Neoadjuvant Treatment||210||
59850530|NCT02586025|75974953|FG001|Underwent Surgery|Neoadjuvant Treatment||105||
59850531|NCT02586025|75974952|FG000|COMPLETED|Neoadjuvant Treatment||208||
59850532|NCT02586025|75974953|FG001|COMPLETED|Neoadjuvant Treatment||103||
59850533|NCT02586025|75974952|FG000|NOT COMPLETED|Neoadjuvant Treatment||11||
59850534|NCT02586025|75974953|FG001|NOT COMPLETED|Neoadjuvant Treatment||7||
59850535|NCT02586025|75974952|FG000|STARTED|Adjuvant Treatment||208||
59850536|NCT02586025|75974953|FG001|STARTED|Adjuvant Treatment||103||
59850537|NCT02586025|75974952|FG000|Started Adjuvant FEC Treatment|Adjuvant Treatment||208||
59850538|NCT02586025|75974953|FG001|Started Adjuvant FEC Treatment|Adjuvant Treatment||103||
59850539|NCT02586025|75974952|FG000|Started Adjuvant Anti-HER2 Treatment|Adjuvant Treatment||204||
59850540|NCT02586025|75974953|FG001|Started Adjuvant Anti-HER2 Treatment|Adjuvant Treatment||99||
59850541|NCT02586025|75974952|FG000|COMPLETED|Adjuvant Treatment||198|Completed Adjuvant anti-HER2 Treatment|
59850542|NCT02586025|75974953|FG001|COMPLETED|Adjuvant Treatment||94|Completed Adjuvant anti-HER2 Treatment|
59850543|NCT02586025|75974952|FG000|NOT COMPLETED|Adjuvant Treatment||10||
59850544|NCT02586025|75974953|FG001|NOT COMPLETED|Adjuvant Treatment||9||
59996722|NCT02714569|76112510|FG007|NOT COMPLETED|Part B (Overall)||1||
59996723|NCT02714569|76112511|FG008|NOT COMPLETED|Part B (Overall)||0||
59996724|NCT02714569|76112512|FG009|NOT COMPLETED|Part B (Overall)||2||
59996725|NCT02714569|76112513|FG010|NOT COMPLETED|Part B (Overall)||0||
59850545|NCT02586025|75974952|FG000|STARTED|Treatment-Free Follow-Up||208|Includes those who had discontinued from neoadjuvant and/or adjuvant treatment but remained in follow-up.|
59850546|NCT02586025|75974953|FG001|STARTED|Treatment-Free Follow-Up||104|Includes those who had discontinued from neoadjuvant and/or adjuvant treatment but remained in follow-up.|
59850547|NCT02586025|75974952|FG000|COMPLETED|Treatment-Free Follow-Up||175||
59850548|NCT02586025|75974953|FG001|COMPLETED|Treatment-Free Follow-Up||82||
59850549|NCT02586025|75974952|FG000|NOT COMPLETED|Treatment-Free Follow-Up||33||
59850550|NCT02586025|75974953|FG001|NOT COMPLETED|Treatment-Free Follow-Up||22||
59850551|NCT02465164|75974962|FG000|STARTED|Overall Study||16||
59850552|NCT02465164|75974963|FG001|STARTED|Overall Study||10||
59850553|NCT02465164|75974962|FG000|COMPLETED|Overall Study||16||
59850554|NCT02465164|75974963|FG001|COMPLETED|Overall Study||10||
59850555|NCT02465164|75974962|FG000|NOT COMPLETED|Overall Study||0||
59850556|NCT02465164|75974963|FG001|NOT COMPLETED|Overall Study||0||
59850557|NCT01721577|75974971|FG000|STARTED|Overall Study||2||
59850558|NCT01721577|75974972|FG001|STARTED|Overall Study||7||
59850559|NCT01721577|75974971|FG000|COMPLETED|Overall Study||0||
59850560|NCT01721577|75974972|FG001|COMPLETED|Overall Study||4||
59850561|NCT01721577|75974971|FG000|NOT COMPLETED|Overall Study||2||
59850562|NCT01721577|75974972|FG001|NOT COMPLETED|Overall Study||3||
59850563|NCT01411332|75974989|FG000|STARTED|Enrollment||9||
59850564|NCT01411332|75974990|FG001|STARTED|Enrollment||9||
59850565|NCT01411332|75974989|FG000|COMPLETED|Enrollment||9||
59850566|NCT01411332|75974990|FG001|COMPLETED|Enrollment||7||
59850567|NCT01411332|75974989|FG000|NOT COMPLETED|Enrollment||0||
59850568|NCT01411332|75974990|FG001|NOT COMPLETED|Enrollment||2||
59850569|NCT01411332|75974989|FG000|STARTED|Treatment||9||
59850570|NCT01411332|75974990|FG001|STARTED|Treatment||7||
59850571|NCT01411332|75974989|FG000|COMPLETED|Treatment||8||
59850572|NCT01411332|75974990|FG001|COMPLETED|Treatment||7||
59850573|NCT01411332|75974989|FG000|NOT COMPLETED|Treatment||1||
59850574|NCT01411332|75974990|FG001|NOT COMPLETED|Treatment||0||
59850575|NCT00227617|75974997|FG000|STARTED|Stage 1||22||
59850576|NCT00227617|75974998|FG001|STARTED|Stage 1||12||
59850577|NCT00227617|75974999|FG002|STARTED|Stage 1||2||
60121400|NCT02684370|76242319|FG005|COMPLETED|Part B||289||
60121401|NCT02684370|76242314|FG000|NOT COMPLETED|Part B||0||
59723777|NCT01064310|75842409|FG001|NOT COMPLETED|Open Label Pazopinib||0||
59723778|NCT01064310|75842410|FG002|NOT COMPLETED|Open Label Pazopinib||84||
59723779|NCT01037244|75842423|FG000|STARTED|Overall Study||154||
59723780|NCT01037244|75842424|FG001|STARTED|Overall Study||152||
59723781|NCT01037244|75842425|FG002|STARTED|Overall Study||158||
59723782|NCT01037244|75842426|FG003|STARTED|Overall Study||154||
59723783|NCT01037244|75842423|FG000|mITT (Modified Intent-to-Treat)|Overall Study||150||
59723784|NCT01037244|75842424|FG001|mITT (Modified Intent-to-Treat)|Overall Study||148||
59723785|NCT01037244|75842425|FG002|mITT (Modified Intent-to-Treat)|Overall Study||154||
59723786|NCT01037244|75842426|FG003|mITT (Modified Intent-to-Treat)|Overall Study||153||
59723787|NCT01037244|75842423|FG000|Safety Population|Overall Study|Two subjects randomized to receive placebo inadvertently received udenafil (1 - 50 mg and 1- 150 mg)|155||
59723788|NCT01037244|75842424|FG001|Safety Population|Overall Study||150||
59723789|NCT01037244|75842425|FG002|Safety Population|Overall Study|Two subjects randomized to receive placebo inadvertently received udenafil (1 - 50 mg and 1- 150 mg)|159||
59723790|NCT01037244|75842426|FG003|Safety Population|Overall Study||152||
59723791|NCT01037244|75842423|FG000|COMPLETED|Overall Study||141||
59723792|NCT01037244|75842424|FG001|COMPLETED|Overall Study||138||
59723793|NCT01037244|75842425|FG002|COMPLETED|Overall Study||144||
59723794|NCT01037244|75842426|FG003|COMPLETED|Overall Study||140||
59723795|NCT01037244|75842423|FG000|NOT COMPLETED|Overall Study||13||
59850578|NCT00227617|75974997|FG000|COMPLETED|Stage 1||22||
59850579|NCT00227617|75974998|FG001|COMPLETED|Stage 1||12||
59850580|NCT00227617|75974999|FG002|COMPLETED|Stage 1||2||
59850581|NCT00227617|75974997|FG000|NOT COMPLETED|Stage 1||0||
59850582|NCT00227617|75974998|FG001|NOT COMPLETED|Stage 1||0||
59850583|NCT00227617|75974999|FG002|NOT COMPLETED|Stage 1||0||
59850584|NCT00227617|75974997|FG000|STARTED|Stage 2||0|Study was terminated due to low accrual|
59850585|NCT00227617|75974998|FG001|STARTED|Stage 2||0|Study was terminated due to low accrual|
59850586|NCT00227617|75974999|FG002|STARTED|Stage 2||0|Study was terminated due to low accrual|
59723796|NCT01037244|75842424|FG001|NOT COMPLETED|Overall Study||14||
59850587|NCT00227617|75974997|FG000|COMPLETED|Stage 2||0||
59850588|NCT00227617|75974998|FG001|COMPLETED|Stage 2||0||
59723797|NCT01037244|75842425|FG002|NOT COMPLETED|Overall Study||14||
59850589|NCT00227617|75974999|FG002|COMPLETED|Stage 2||0||
59850590|NCT00227617|75974997|FG000|NOT COMPLETED|Stage 2||0||
59850591|NCT00227617|75974998|FG001|NOT COMPLETED|Stage 2||0||
59850592|NCT00227617|75974999|FG002|NOT COMPLETED|Stage 2||0||
59850593|NCT04881747|75975017|FG000|STARTED|Period 1||8||
59850594|NCT04881747|75975018|FG001|STARTED|Period 1||8||
59850595|NCT04881747|75975019|FG002|STARTED|Period 1||8||
59850596|NCT04881747|75975020|FG003|STARTED|Period 1||8||
59850597|NCT04881747|75975021|FG004|STARTED|Period 1||8||
59850598|NCT04881747|75975022|FG005|STARTED|Period 1||7||
59850599|NCT04881747|75975017|FG000|Received At Least One Dose of Study Drug|Period 1||8||
59850600|NCT04881747|75975018|FG001|Received At Least One Dose of Study Drug|Period 1||8||
60121402|NCT02684370|76242315|FG001|NOT COMPLETED|Part B||0||
59850601|NCT04881747|75975019|FG002|Received At Least One Dose of Study Drug|Period 1||8||
59850602|NCT04881747|75975020|FG003|Received At Least One Dose of Study Drug|Period 1||8||
59850603|NCT04881747|75975021|FG004|Received At Least One Dose of Study Drug|Period 1||8||
59850604|NCT04881747|75975022|FG005|Received At Least One Dose of Study Drug|Period 1||7||
59850605|NCT04881747|75975017|FG000|COMPLETED|Period 1||8||
59850606|NCT04881747|75975018|FG001|COMPLETED|Period 1||8||
59850607|NCT04881747|75975019|FG002|COMPLETED|Period 1||8||
59850608|NCT04881747|75975020|FG003|COMPLETED|Period 1||8||
59850609|NCT04881747|75975021|FG004|COMPLETED|Period 1||8||
59578623|NCT02957357|75684129|FG000|NOT COMPLETED|Overall Study||0||
59578624|NCT02957357|75684130|FG001|NOT COMPLETED|Overall Study||0||
59578625|NCT03111407|75684145|FG000|STARTED|Overall Study||45||
59578626|NCT03111407|75684146|FG001|STARTED|Overall Study||27||
59578627|NCT03111407|75684145|FG000|COMPLETED|Overall Study||44||
59578628|NCT03111407|75684146|FG001|COMPLETED|Overall Study||26||
59578629|NCT03111407|75684145|FG000|NOT COMPLETED|Overall Study||1||
59578630|NCT03111407|75684146|FG001|NOT COMPLETED|Overall Study||1||
59578631|NCT02958995|75684155|FG000|STARTED|Overall Study||2630666||
59578632|NCT02958995|75684156|FG001|STARTED|Overall Study||107495||
59578633|NCT02958995|75684155|FG000|COMPLETED|Overall Study||2630666||
59578634|NCT02958995|75684156|FG001|COMPLETED|Overall Study||107495||
59578635|NCT02958995|75684155|FG000|NOT COMPLETED|Overall Study||0||
59578636|NCT02958995|75684156|FG001|NOT COMPLETED|Overall Study||0||
59578637|NCT03032393|75684164|FG000|STARTED|Overall Study||15||
59578638|NCT03032393|75684165|FG001|STARTED|Overall Study||15||
59578639|NCT03032393|75684164|FG000|COMPLETED|Overall Study||15||
59578640|NCT03032393|75684165|FG001|COMPLETED|Overall Study||15||
59578641|NCT03032393|75684164|FG000|NOT COMPLETED|Overall Study||0||
59578642|NCT03032393|75684165|FG001|NOT COMPLETED|Overall Study||0||
59578643|NCT03114683|75684171|FG000|STARTED|Overall Study||96||
59578644|NCT03114683|75684171|FG000|COMPLETED|Overall Study||52||
59578645|NCT03114683|75684171|FG000|NOT COMPLETED|Overall Study||44||
59578646|NCT02959307|75684177|FG000|STARTED|Phase 1||18||
59578647|NCT02959307|75684178|FG001|STARTED|Phase 1||31||
59578648|NCT02959307|75684177|FG000|COMPLETED|Phase 1||15||
59578649|NCT02959307|75684178|FG001|COMPLETED|Phase 1||23||
59578650|NCT02959307|75684177|FG000|NOT COMPLETED|Phase 1||3||
59578651|NCT02959307|75684178|FG001|NOT COMPLETED|Phase 1||8||
59578652|NCT02959307|75684177|FG000|STARTED|Phase 2|This group is increased as those in sham were re-randomized to sham or NIR.|28||
59578653|NCT02959307|75684178|FG001|STARTED|Phase 2|This group is decreased as those in sham were re-randomized to sham or NIR.|10||
59578654|NCT02959307|75684177|FG000|COMPLETED|Phase 2||26||
59578655|NCT02959307|75684178|FG001|COMPLETED|Phase 2||10||
59578656|NCT02959307|75684177|FG000|NOT COMPLETED|Phase 2||2||
59578657|NCT02959307|75684178|FG001|NOT COMPLETED|Phase 2||0||
59578658|NCT03114995|75684187|FG000|STARTED|Overall Study||31||
59578659|NCT03114995|75684188|FG001|STARTED|Overall Study||31||
59578660|NCT03114995|75684189|FG002|STARTED|Overall Study||78||
59578661|NCT03114995|75684187|FG000|COMPLETED|Overall Study||30||
59578662|NCT03114995|75684188|FG001|COMPLETED|Overall Study||30||
59578663|NCT03114995|75684189|FG002|COMPLETED|Overall Study||78||
59723798|NCT01037244|75842426|FG003|NOT COMPLETED|Overall Study||14||
59723799|NCT00833989|75842440|FG000|STARTED|Overall Study||17||
59723800|NCT00833989|75842441|FG001|STARTED|Overall Study||8||
59723801|NCT00833989|75842442|FG002|STARTED|Overall Study||9||
59723802|NCT00833989|75842443|FG003|STARTED|Overall Study||8||
59723803|NCT00833989|75842440|FG000|COMPLETED|Overall Study||14||
59723804|NCT00833989|75842441|FG001|COMPLETED|Overall Study||8||
59723805|NCT00833989|75842442|FG002|COMPLETED|Overall Study||8||
59850610|NCT04881747|75975022|FG005|COMPLETED|Period 1||7||
59850611|NCT04881747|75975017|FG000|NOT COMPLETED|Period 1||0||
59850612|NCT04881747|75975018|FG001|NOT COMPLETED|Period 1||0||
59578664|NCT03114995|75684187|FG000|NOT COMPLETED|Overall Study||1||
59578665|NCT03114995|75684188|FG001|NOT COMPLETED|Overall Study||1||
59578666|NCT03114995|75684189|FG002|NOT COMPLETED|Overall Study||0||
59578667|NCT02959853|75684199|FG000|STARTED|Overall Study||11||
59578668|NCT02959853|75684200|FG001|STARTED|Overall Study||12||
59723806|NCT00833989|75842443|FG003|COMPLETED|Overall Study||6||
59723807|NCT00833989|75842440|FG000|NOT COMPLETED|Overall Study||3||
59723808|NCT00833989|75842441|FG001|NOT COMPLETED|Overall Study||0||
59578669|NCT02959853|75684199|FG000|COMPLETED|Overall Study||7||
59578670|NCT02959853|75684200|FG001|COMPLETED|Overall Study||10||
59578671|NCT02959853|75684199|FG000|NOT COMPLETED|Overall Study||4||
59723809|NCT00833989|75842442|FG002|NOT COMPLETED|Overall Study||1||
59723810|NCT00833989|75842443|FG003|NOT COMPLETED|Overall Study||2||
59578672|NCT02959853|75684200|FG001|NOT COMPLETED|Overall Study||2||
59578673|NCT03036215|75684209|FG000|STARTED|Overall Study||41||
59578674|NCT03036215|75684210|FG001|STARTED|Overall Study||39||
59578675|NCT03036215|75684209|FG000|COMPLETED|Overall Study||39||
59723811|NCT01037088|75842456|FG000|STARTED|Overall Study||39||
59578676|NCT03036215|75684210|FG001|COMPLETED|Overall Study||36||
59578677|NCT03036215|75684209|FG000|NOT COMPLETED|Overall Study||2||
59850613|NCT04881747|75975019|FG002|NOT COMPLETED|Period 1||0||
59850614|NCT04881747|75975020|FG003|NOT COMPLETED|Period 1||0||
59850615|NCT04881747|75975021|FG004|NOT COMPLETED|Period 1||0||
59850616|NCT04881747|75975022|FG005|NOT COMPLETED|Period 1||0||
59850617|NCT04881747|75975017|FG000|STARTED|Period 1 Washout||8||
59850618|NCT04881747|75975018|FG001|STARTED|Period 1 Washout||8||
59850619|NCT04881747|75975019|FG002|STARTED|Period 1 Washout||8||
59850620|NCT04881747|75975020|FG003|STARTED|Period 1 Washout||8||
59850621|NCT04881747|75975021|FG004|STARTED|Period 1 Washout||8||
59850622|NCT04881747|75975022|FG005|STARTED|Period 1 Washout||7||
59850623|NCT04881747|75975017|FG000|COMPLETED|Period 1 Washout||8||
59850624|NCT04881747|75975018|FG001|COMPLETED|Period 1 Washout||8||
59850625|NCT04881747|75975019|FG002|COMPLETED|Period 1 Washout||8||
59850626|NCT04881747|75975020|FG003|COMPLETED|Period 1 Washout||8||
59850627|NCT04881747|75975021|FG004|COMPLETED|Period 1 Washout||8||
59850628|NCT04881747|75975022|FG005|COMPLETED|Period 1 Washout||7||
59850629|NCT04881747|75975017|FG000|NOT COMPLETED|Period 1 Washout||0||
59850630|NCT04881747|75975018|FG001|NOT COMPLETED|Period 1 Washout||0||
59850631|NCT04881747|75975019|FG002|NOT COMPLETED|Period 1 Washout||0||
59850632|NCT04881747|75975020|FG003|NOT COMPLETED|Period 1 Washout||0||
59850633|NCT04881747|75975021|FG004|NOT COMPLETED|Period 1 Washout||0||
59850634|NCT04881747|75975022|FG005|NOT COMPLETED|Period 1 Washout||0||
59850635|NCT04881747|75975017|FG000|STARTED|Period 2||8||
59850636|NCT04881747|75975018|FG001|STARTED|Period 2||8||
59850637|NCT04881747|75975019|FG002|STARTED|Period 2||8||
59850638|NCT04881747|75975020|FG003|STARTED|Period 2||8||
59850639|NCT04881747|75975021|FG004|STARTED|Period 2||8||
59850640|NCT04881747|75975022|FG005|STARTED|Period 2||7||
59850641|NCT04881747|75975017|FG000|Received At Least One Dose of Study Drug|Period 2||8||
59850642|NCT04881747|75975018|FG001|Received At Least One Dose of Study Drug|Period 2||8||
59850643|NCT04881747|75975019|FG002|Received At Least One Dose of Study Drug|Period 2||8||
59850644|NCT04881747|75975020|FG003|Received At Least One Dose of Study Drug|Period 2||8||
59850645|NCT04881747|75975021|FG004|Received At Least One Dose of Study Drug|Period 2||8||
59850646|NCT04881747|75975022|FG005|Received At Least One Dose of Study Drug|Period 2||7||
59850647|NCT04881747|75975017|FG000|COMPLETED|Period 2||8||
59850648|NCT04881747|75975018|FG001|COMPLETED|Period 2||8||
59850649|NCT04881747|75975019|FG002|COMPLETED|Period 2||8||
59850650|NCT04881747|75975020|FG003|COMPLETED|Period 2||8||
59850651|NCT04881747|75975021|FG004|COMPLETED|Period 2||8||
59850652|NCT04881747|75975022|FG005|COMPLETED|Period 2||7||
59850653|NCT04881747|75975017|FG000|NOT COMPLETED|Period 2||0||
59850654|NCT04881747|75975018|FG001|NOT COMPLETED|Period 2||0||
59850655|NCT04881747|75975019|FG002|NOT COMPLETED|Period 2||0||
59850656|NCT04881747|75975020|FG003|NOT COMPLETED|Period 2||0||
59850657|NCT04881747|75975021|FG004|NOT COMPLETED|Period 2||0||
59850658|NCT04881747|75975022|FG005|NOT COMPLETED|Period 2||0||
59850659|NCT04881747|75975017|FG000|STARTED|Period 2 Washout||8||
59850660|NCT04881747|75975018|FG001|STARTED|Period 2 Washout||8||
59850661|NCT04881747|75975019|FG002|STARTED|Period 2 Washout||8||
59850662|NCT04881747|75975020|FG003|STARTED|Period 2 Washout||8||
59723812|NCT01037088|75842456|FG000|Received 3.53% THC|Overall Study||36||
59723813|NCT01037088|75842456|FG000|Received 1.29% THC|Overall Study||37||
59723814|NCT01037088|75842456|FG000|Received Placebo|Overall Study||38||
59723815|NCT01037088|75842456|FG000|COMPLETED|Overall Study||36||
59723816|NCT01037088|75842456|FG000|NOT COMPLETED|Overall Study||3||
59723817|NCT01042236|75842465|FG000|STARTED|Treatment Period 1||3||
59723818|NCT01042236|75842466|FG001|STARTED|Treatment Period 1||4||
59723819|NCT01042236|75842467|FG002|STARTED|Treatment Period 1||3||
59723820|NCT01042236|75842468|FG003|STARTED|Treatment Period 1||5||
59723821|NCT01042236|75842469|FG004|STARTED|Treatment Period 1||4||
59723822|NCT01042236|75842470|FG005|STARTED|Treatment Period 1||3||
59723823|NCT01042236|75842465|FG000|COMPLETED|Treatment Period 1||3||
59723824|NCT01042236|75842466|FG001|COMPLETED|Treatment Period 1||3||
59723825|NCT01042236|75842467|FG002|COMPLETED|Treatment Period 1||3||
59723826|NCT01042236|75842468|FG003|COMPLETED|Treatment Period 1||5||
59723827|NCT01042236|75842469|FG004|COMPLETED|Treatment Period 1||3||
59723828|NCT01042236|75842470|FG005|COMPLETED|Treatment Period 1||3||
59723829|NCT01042236|75842465|FG000|NOT COMPLETED|Treatment Period 1||0||
59723830|NCT01042236|75842466|FG001|NOT COMPLETED|Treatment Period 1||1||
59723831|NCT01042236|75842467|FG002|NOT COMPLETED|Treatment Period 1||0||
59850663|NCT04881747|75975021|FG004|STARTED|Period 2 Washout||8||
59723832|NCT01042236|75842468|FG003|NOT COMPLETED|Treatment Period 1||0||
59723833|NCT01042236|75842469|FG004|NOT COMPLETED|Treatment Period 1||1||
59723834|NCT01042236|75842470|FG005|NOT COMPLETED|Treatment Period 1||0||
59723835|NCT01042236|75842465|FG000|STARTED|Treatment Period 2||3||
59850664|NCT04881747|75975022|FG005|STARTED|Period 2 Washout||7||
59850665|NCT04881747|75975017|FG000|COMPLETED|Period 2 Washout||6||
59850666|NCT04881747|75975018|FG001|COMPLETED|Period 2 Washout||8||
59850667|NCT04881747|75975019|FG002|COMPLETED|Period 2 Washout||8||
59850668|NCT04881747|75975020|FG003|COMPLETED|Period 2 Washout||7||
59850669|NCT04881747|75975021|FG004|COMPLETED|Period 2 Washout||7||
59850670|NCT04881747|75975022|FG005|COMPLETED|Period 2 Washout||7||
59850671|NCT04881747|75975017|FG000|NOT COMPLETED|Period 2 Washout||2||
59850672|NCT04881747|75975018|FG001|NOT COMPLETED|Period 2 Washout||0||
59850673|NCT04881747|75975019|FG002|NOT COMPLETED|Period 2 Washout||0||
59850674|NCT04881747|75975020|FG003|NOT COMPLETED|Period 2 Washout||1||
59850675|NCT04881747|75975021|FG004|NOT COMPLETED|Period 2 Washout||1||
59850676|NCT04881747|75975022|FG005|NOT COMPLETED|Period 2 Washout||0||
59850677|NCT04881747|75975017|FG000|STARTED|Period 3||6||
59850678|NCT04881747|75975018|FG001|STARTED|Period 3||8||
59850679|NCT04881747|75975019|FG002|STARTED|Period 3||8||
59850680|NCT04881747|75975020|FG003|STARTED|Period 3||7||
59850681|NCT04881747|75975021|FG004|STARTED|Period 3||7||
59850682|NCT04881747|75975022|FG005|STARTED|Period 3||7||
59850683|NCT04881747|75975017|FG000|Received At Least One Dose of Study Drug|Period 3||6||
59850684|NCT04881747|75975018|FG001|Received At Least One Dose of Study Drug|Period 3||8||
59850685|NCT04881747|75975019|FG002|Received At Least One Dose of Study Drug|Period 3||8||
59850686|NCT04881747|75975020|FG003|Received At Least One Dose of Study Drug|Period 3||7||
59850687|NCT04881747|75975021|FG004|Received At Least One Dose of Study Drug|Period 3||7||
59850688|NCT04881747|75975022|FG005|Received At Least One Dose of Study Drug|Period 3||7||
59850689|NCT04881747|75975017|FG000|COMPLETED|Period 3||6||
59850690|NCT04881747|75975018|FG001|COMPLETED|Period 3||8||
59850691|NCT04881747|75975019|FG002|COMPLETED|Period 3||8||
59850692|NCT04881747|75975020|FG003|COMPLETED|Period 3||7||
59850693|NCT04881747|75975021|FG004|COMPLETED|Period 3||7||
59850694|NCT04881747|75975022|FG005|COMPLETED|Period 3||7||
59850695|NCT04881747|75975017|FG000|NOT COMPLETED|Period 3||0||
59850696|NCT04881747|75975018|FG001|NOT COMPLETED|Period 3||0||
59850697|NCT04881747|75975019|FG002|NOT COMPLETED|Period 3||0||
59850698|NCT04881747|75975020|FG003|NOT COMPLETED|Period 3||0||
59850699|NCT04881747|75975021|FG004|NOT COMPLETED|Period 3||0||
59578678|NCT03036215|75684210|FG001|NOT COMPLETED|Overall Study||3||
59578679|NCT02962427|75684221|FG000|STARTED|Overall Study||3||
59578680|NCT02962427|75684222|FG001|STARTED|Overall Study||1||
59578681|NCT02962427|75684221|FG000|COMPLETED|Overall Study||3||
59578682|NCT02962427|75684222|FG001|COMPLETED|Overall Study||1||
59578683|NCT02962427|75684221|FG000|NOT COMPLETED|Overall Study||0||
59723836|NCT01042236|75842466|FG001|STARTED|Treatment Period 2||3||
59723837|NCT01042236|75842467|FG002|STARTED|Treatment Period 2||3||
59723838|NCT01042236|75842468|FG003|STARTED|Treatment Period 2||5||
59723839|NCT01042236|75842469|FG004|STARTED|Treatment Period 2||3||
59723840|NCT01042236|75842470|FG005|STARTED|Treatment Period 2||3||
59723841|NCT01042236|75842465|FG000|COMPLETED|Treatment Period 2||3||
59723842|NCT01042236|75842466|FG001|COMPLETED|Treatment Period 2||3||
59723843|NCT01042236|75842467|FG002|COMPLETED|Treatment Period 2||3||
59723844|NCT01042236|75842468|FG003|COMPLETED|Treatment Period 2||5||
59723845|NCT01042236|75842469|FG004|COMPLETED|Treatment Period 2||3||
59723846|NCT01042236|75842470|FG005|COMPLETED|Treatment Period 2||3||
59723847|NCT01042236|75842465|FG000|NOT COMPLETED|Treatment Period 2||0||
59723848|NCT01042236|75842466|FG001|NOT COMPLETED|Treatment Period 2||0||
59723849|NCT01042236|75842467|FG002|NOT COMPLETED|Treatment Period 2||0||
59723850|NCT01042236|75842468|FG003|NOT COMPLETED|Treatment Period 2||0||
59723851|NCT01042236|75842469|FG004|NOT COMPLETED|Treatment Period 2||0||
59723852|NCT01042236|75842470|FG005|NOT COMPLETED|Treatment Period 2||0||
59723853|NCT01042236|75842465|FG000|STARTED|Treatment Period 3||3||
59723854|NCT01042236|75842466|FG001|STARTED|Treatment Period 3||3||
59723855|NCT01042236|75842467|FG002|STARTED|Treatment Period 3||3||
59723856|NCT01042236|75842468|FG003|STARTED|Treatment Period 3||5||
59723857|NCT01042236|75842469|FG004|STARTED|Treatment Period 3||3||
59723858|NCT01042236|75842470|FG005|STARTED|Treatment Period 3||3||
59723859|NCT01042236|75842465|FG000|COMPLETED|Treatment Period 3||3||
59723860|NCT01042236|75842466|FG001|COMPLETED|Treatment Period 3||3||
59723861|NCT01042236|75842467|FG002|COMPLETED|Treatment Period 3||3||
59723862|NCT01042236|75842468|FG003|COMPLETED|Treatment Period 3||3||
59723863|NCT01042236|75842469|FG004|COMPLETED|Treatment Period 3||3||
59850700|NCT04881747|75975022|FG005|NOT COMPLETED|Period 3||0||
59850701|NCT04795622|75975032|FG000|STARTED|Overall Study||101||
59850702|NCT04795622|75975033|FG001|STARTED|Overall Study||100||
59850703|NCT04795622|75975032|FG000|Safety Evaluation Set (SES)|Overall Study||97||
59850704|NCT04795622|75975033|FG001|Safety Evaluation Set (SES)|Overall Study||96||
59850705|NCT04795622|75975032|FG000|COMPLETED|Overall Study||88||
59850706|NCT04795622|75975033|FG001|COMPLETED|Overall Study||84||
59850707|NCT04795622|75975032|FG000|NOT COMPLETED|Overall Study||13||
59850708|NCT04795622|75975033|FG001|NOT COMPLETED|Overall Study||16||
59850709|NCT04786691|75975041|FG000|STARTED|First Intervention (2 Hours)||2||
59850710|NCT04786691|75975042|FG001|STARTED|First Intervention (2 Hours)||3||
59850711|NCT04786691|75975043|FG002|STARTED|First Intervention (2 Hours)||2||
59850712|NCT04786691|75975044|FG003|STARTED|First Intervention (2 Hours)||4||
59850713|NCT04786691|75975045|FG004|STARTED|First Intervention (2 Hours)||3||
59850714|NCT04786691|75975046|FG005|STARTED|First Intervention (2 Hours)||4||
59578684|NCT02962427|75684222|FG001|NOT COMPLETED|Overall Study||0||
59723864|NCT01042236|75842470|FG005|COMPLETED|Treatment Period 3||3||
59723865|NCT01042236|75842465|FG000|NOT COMPLETED|Treatment Period 3||0||
59723866|NCT01042236|75842466|FG001|NOT COMPLETED|Treatment Period 3||0||
59723867|NCT01042236|75842467|FG002|NOT COMPLETED|Treatment Period 3||0||
59850715|NCT04786691|75975041|FG000|COMPLETED|First Intervention (2 Hours)||2||
59723868|NCT01042236|75842468|FG003|NOT COMPLETED|Treatment Period 3||2||
59850716|NCT04786691|75975042|FG001|COMPLETED|First Intervention (2 Hours)||3||
59850717|NCT04786691|75975043|FG002|COMPLETED|First Intervention (2 Hours)||2||
59850718|NCT04786691|75975044|FG003|COMPLETED|First Intervention (2 Hours)||4||
59850719|NCT04786691|75975045|FG004|COMPLETED|First Intervention (2 Hours)||3||
59850720|NCT04786691|75975046|FG005|COMPLETED|First Intervention (2 Hours)||4||
59850721|NCT04786691|75975041|FG000|NOT COMPLETED|First Intervention (2 Hours)||0||
59850722|NCT04786691|75975042|FG001|NOT COMPLETED|First Intervention (2 Hours)||0||
59850723|NCT04786691|75975043|FG002|NOT COMPLETED|First Intervention (2 Hours)||0||
59850724|NCT04786691|75975044|FG003|NOT COMPLETED|First Intervention (2 Hours)||0||
59850725|NCT04786691|75975045|FG004|NOT COMPLETED|First Intervention (2 Hours)||0||
59850726|NCT04786691|75975046|FG005|NOT COMPLETED|First Intervention (2 Hours)||0||
59850727|NCT04786691|75975041|FG000|STARTED|Washout Period (2 Days)||2||
59850728|NCT04786691|75975042|FG001|STARTED|Washout Period (2 Days)||3||
59850729|NCT04786691|75975043|FG002|STARTED|Washout Period (2 Days)||2||
59850730|NCT04786691|75975044|FG003|STARTED|Washout Period (2 Days)||4||
59850731|NCT04786691|75975045|FG004|STARTED|Washout Period (2 Days)||3||
59850732|NCT04786691|75975046|FG005|STARTED|Washout Period (2 Days)||4||
59850733|NCT04786691|75975041|FG000|COMPLETED|Washout Period (2 Days)||2||
59850734|NCT04786691|75975042|FG001|COMPLETED|Washout Period (2 Days)||3||
59850735|NCT04786691|75975043|FG002|COMPLETED|Washout Period (2 Days)||2||
59850736|NCT04786691|75975044|FG003|COMPLETED|Washout Period (2 Days)||4||
59850737|NCT04786691|75975045|FG004|COMPLETED|Washout Period (2 Days)||3||
59850738|NCT04786691|75975046|FG005|COMPLETED|Washout Period (2 Days)||4||
59850739|NCT04786691|75975041|FG000|NOT COMPLETED|Washout Period (2 Days)||0||
59850740|NCT04786691|75975042|FG001|NOT COMPLETED|Washout Period (2 Days)||0||
59850741|NCT04786691|75975043|FG002|NOT COMPLETED|Washout Period (2 Days)||0||
59850742|NCT04786691|75975044|FG003|NOT COMPLETED|Washout Period (2 Days)||0||
59850743|NCT04786691|75975045|FG004|NOT COMPLETED|Washout Period (2 Days)||0||
59850744|NCT04786691|75975046|FG005|NOT COMPLETED|Washout Period (2 Days)||0||
59850745|NCT04786691|75975041|FG000|STARTED|Second Intervention (2 Hours)||2||
59850746|NCT04786691|75975042|FG001|STARTED|Second Intervention (2 Hours)||3||
59850747|NCT04786691|75975043|FG002|STARTED|Second Intervention (2 Hours)||2||
59850748|NCT04786691|75975044|FG003|STARTED|Second Intervention (2 Hours)||4||
59850749|NCT04786691|75975045|FG004|STARTED|Second Intervention (2 Hours)||3||
59850750|NCT04786691|75975046|FG005|STARTED|Second Intervention (2 Hours)||4||
59850751|NCT04786691|75975041|FG000|COMPLETED|Second Intervention (2 Hours)||2||
59850752|NCT04786691|75975042|FG001|COMPLETED|Second Intervention (2 Hours)||3||
59850753|NCT04786691|75975043|FG002|COMPLETED|Second Intervention (2 Hours)||2||
59850754|NCT04786691|75975044|FG003|COMPLETED|Second Intervention (2 Hours)||4||
59850755|NCT04786691|75975045|FG004|COMPLETED|Second Intervention (2 Hours)||3||
59850756|NCT04786691|75975046|FG005|COMPLETED|Second Intervention (2 Hours)||4||
59850757|NCT04786691|75975041|FG000|NOT COMPLETED|Second Intervention (2 Hours)||0||
59850758|NCT04786691|75975042|FG001|NOT COMPLETED|Second Intervention (2 Hours)||0||
59850759|NCT04786691|75975043|FG002|NOT COMPLETED|Second Intervention (2 Hours)||0||
59850760|NCT04786691|75975044|FG003|NOT COMPLETED|Second Intervention (2 Hours)||0||
59850761|NCT04786691|75975045|FG004|NOT COMPLETED|Second Intervention (2 Hours)||0||
59850762|NCT04786691|75975046|FG005|NOT COMPLETED|Second Intervention (2 Hours)||0||
59850763|NCT04786691|75975041|FG000|STARTED|Washout Period (2 Days)||2||
59850764|NCT04786691|75975042|FG001|STARTED|Washout Period (2 Days)||3||
59850765|NCT04786691|75975043|FG002|STARTED|Washout Period (2 Days)||2||
59850766|NCT04786691|75975044|FG003|STARTED|Washout Period (2 Days)||4||
59850767|NCT04786691|75975045|FG004|STARTED|Washout Period (2 Days)||3||
59850768|NCT04786691|75975046|FG005|STARTED|Washout Period (2 Days)||4||
59850769|NCT04786691|75975041|FG000|COMPLETED|Washout Period (2 Days)||2||
59850770|NCT04786691|75975042|FG001|COMPLETED|Washout Period (2 Days)||3||
59850771|NCT04786691|75975043|FG002|COMPLETED|Washout Period (2 Days)||2||
59850772|NCT04786691|75975044|FG003|COMPLETED|Washout Period (2 Days)||4||
59850773|NCT04786691|75975045|FG004|COMPLETED|Washout Period (2 Days)||3||
59850774|NCT04786691|75975046|FG005|COMPLETED|Washout Period (2 Days)||4||
59850775|NCT04786691|75975041|FG000|NOT COMPLETED|Washout Period (2 Days)||0||
59850776|NCT04786691|75975042|FG001|NOT COMPLETED|Washout Period (2 Days)||0||
59850777|NCT04786691|75975043|FG002|NOT COMPLETED|Washout Period (2 Days)||0||
59850778|NCT04786691|75975044|FG003|NOT COMPLETED|Washout Period (2 Days)||0||
59850779|NCT04786691|75975045|FG004|NOT COMPLETED|Washout Period (2 Days)||0||
59850780|NCT04786691|75975046|FG005|NOT COMPLETED|Washout Period (2 Days)||0||
59850781|NCT04786691|75975041|FG000|STARTED|Third Intervention (2 Hours)||2||
59850782|NCT04786691|75975042|FG001|STARTED|Third Intervention (2 Hours)||3||
59850783|NCT04786691|75975043|FG002|STARTED|Third Intervention (2 Hours)||2||
59850784|NCT04786691|75975044|FG003|STARTED|Third Intervention (2 Hours)||4||
59850785|NCT04786691|75975045|FG004|STARTED|Third Intervention (2 Hours)||3||
59850786|NCT04786691|75975046|FG005|STARTED|Third Intervention (2 Hours)||4||
59850787|NCT04786691|75975041|FG000|COMPLETED|Third Intervention (2 Hours)||2||
59850788|NCT04786691|75975042|FG001|COMPLETED|Third Intervention (2 Hours)||3||
59850789|NCT04786691|75975043|FG002|COMPLETED|Third Intervention (2 Hours)||2||
59850790|NCT04786691|75975044|FG003|COMPLETED|Third Intervention (2 Hours)||4||
59850791|NCT04786691|75975045|FG004|COMPLETED|Third Intervention (2 Hours)||3||
59850792|NCT04786691|75975046|FG005|COMPLETED|Third Intervention (2 Hours)||4||
59850793|NCT04786691|75975041|FG000|NOT COMPLETED|Third Intervention (2 Hours)||0||
59850794|NCT04786691|75975042|FG001|NOT COMPLETED|Third Intervention (2 Hours)||0||
59850795|NCT04786691|75975043|FG002|NOT COMPLETED|Third Intervention (2 Hours)||0||
59996726|NCT02713789|76112576|FG000|STARTED|Overall Study||8||
59996727|NCT02713789|76112577|FG001|STARTED|Overall Study||10||
59996728|NCT02713789|76112578|FG002|STARTED|Overall Study||8||
60121403|NCT02684370|76242316|FG002|NOT COMPLETED|Part B||0||
60121404|NCT02684370|76242317|FG003|NOT COMPLETED|Part B||2||
60121405|NCT02684370|76242318|FG004|NOT COMPLETED|Part B||5||
60121406|NCT02684370|76242319|FG005|NOT COMPLETED|Part B||8||
60121407|NCT02669914|76242336|FG000|STARTED|Overall Study||4||
60121408|NCT02669914|76242337|FG001|STARTED|Overall Study||0||
60121409|NCT02669914|76242338|FG002|STARTED|Overall Study||0||
60121410|NCT02669914|76242336|FG000|COMPLETED|Overall Study||4||
60121411|NCT02669914|76242337|FG001|COMPLETED|Overall Study||0||
60121412|NCT02669914|76242338|FG002|COMPLETED|Overall Study||0||
60121413|NCT02669914|76242336|FG000|NOT COMPLETED|Overall Study||0||
59723869|NCT01042236|75842469|FG004|NOT COMPLETED|Treatment Period 3||0||
59723870|NCT01042236|75842470|FG005|NOT COMPLETED|Treatment Period 3||0||
59723871|NCT00592501|75842478|FG000|STARTED|Overall Study||25||
59723872|NCT00592501|75842478|FG000|COMPLETED|Overall Study||23||
59723873|NCT00592501|75842478|FG000|NOT COMPLETED|Overall Study||2||
59723874|NCT01040832|75842484|FG000|STARTED|Overall Study|One participant was treated with study drug 'Cetuximab Plus EMD 1201081' but was not randomized|54||
59723875|NCT01040832|75842485|FG001|STARTED|Overall Study||53||
60121414|NCT02669914|76242337|FG001|NOT COMPLETED|Overall Study||0||
60121415|NCT02669914|76242338|FG002|NOT COMPLETED|Overall Study||0||
60121416|NCT01686581|76242346|FG000|STARTED|Overall Study||641||
60121417|NCT01686581|76242346|FG000|Safety Analysis Set; Received Study Drug|Overall Study||633||
60121418|NCT01686581|76242346|FG000|Completed 24 Months|Overall Study||128||
60121419|NCT01686581|76242346|FG000|COMPLETED|Overall Study||464|Completed=Completed Treatment|
60121420|NCT01686581|76242346|FG000|NOT COMPLETED|Overall Study||177||
60121421|NCT02672176|76242352|FG000|STARTED|Overall Study||161||
60121422|NCT02672176|76242353|FG001|STARTED|Overall Study||158||
59578685|NCT02039726|75684232|FG000|STARTED|Overall Study||245||
59578686|NCT02039726|75684233|FG001|STARTED|Overall Study||122||
59578687|NCT02039726|75684232|FG000|Ongoing (as of Data Cutoff)|Overall Study||45||
59578688|NCT02039726|75684233|FG001|Ongoing (as of Data Cutoff)|Overall Study||16||
59578689|NCT02039726|75684232|FG000|Did Not Receive Treatment|Overall Study||4||
59723876|NCT01040832|75842484|FG000|COMPLETED|Overall Study||8||
59723877|NCT01040832|75842485|FG001|COMPLETED|Overall Study||16||
59723878|NCT01040832|75842484|FG000|NOT COMPLETED|Overall Study||46||
59723879|NCT01040832|75842485|FG001|NOT COMPLETED|Overall Study||37||
59723880|NCT00854581|75842491|FG000|STARTED|Induction (Up to Day 21)||13||
59723881|NCT00854581|75842491|FG000|COMPLETED|Induction (Up to Day 21)||7||
59723882|NCT00854581|75842491|FG000|NOT COMPLETED|Induction (Up to Day 21)||6||
59723883|NCT00854581|75842491|FG000|STARTED|Part 1 Maintenance (Up to Day 60)||7||
59723884|NCT00854581|75842491|FG000|COMPLETED|Part 1 Maintenance (Up to Day 60)||5||
59723885|NCT00854581|75842491|FG000|NOT COMPLETED|Part 1 Maintenance (Up to Day 60)||2||
59723886|NCT00854581|75842491|FG000|STARTED|Part 2 Maintenance (Up to 12 Months)||5||
59723887|NCT00854581|75842491|FG000|COMPLETED|Part 2 Maintenance (Up to 12 Months)||2||
59723888|NCT00854581|75842491|FG000|NOT COMPLETED|Part 2 Maintenance (Up to 12 Months)||3||
59723889|NCT00833911|75842500|FG000|STARTED|Titration||392||
59723890|NCT00833911|75842500|FG000|COMPLETED|Titration||371||
59723891|NCT00833911|75842500|FG000|NOT COMPLETED|Titration||21||
59723892|NCT00833911|75842500|FG000|STARTED|Maintenance Phase I||371||
59723893|NCT00833911|75842500|FG000|COMPLETED|Maintenance Phase I||273||
59723894|NCT00833911|75842500|FG000|NOT COMPLETED|Maintenance Phase I||98||
59723895|NCT00833911|75842500|FG000|STARTED|Maintenance Phase II|97 patients chose not to continue into Maintenance Phase II|176||
59723896|NCT00833911|75842500|FG000|COMPLETED|Maintenance Phase II||166||
59723897|NCT00833911|75842500|FG000|NOT COMPLETED|Maintenance Phase II||10||
59723898|NCT01125293|75842514|FG000|STARTED|Overall Study||3||
59850796|NCT04786691|75975044|FG003|NOT COMPLETED|Third Intervention (2 Hours)||0||
59850797|NCT04786691|75975045|FG004|NOT COMPLETED|Third Intervention (2 Hours)||0||
59850798|NCT04786691|75975046|FG005|NOT COMPLETED|Third Intervention (2 Hours)||0||
59850799|NCT04652245|75975054|FG000|STARTED|Treatment Administration Period 1||108||
59850800|NCT04652245|75975055|FG001|STARTED|Treatment Administration Period 1||108||
59850801|NCT04652245|75975054|FG000|COMPLETED|Treatment Administration Period 1||108||
59850802|NCT04652245|75975055|FG001|COMPLETED|Treatment Administration Period 1||108||
59996729|NCT02713789|76112576|FG000|COMPLETED|Overall Study||8||
59996730|NCT02713789|76112577|FG001|COMPLETED|Overall Study||9||
59996731|NCT02713789|76112578|FG002|COMPLETED|Overall Study||7||
59723899|NCT01125293|75842515|FG001|STARTED|Overall Study||3||
59996732|NCT02713789|76112576|FG000|NOT COMPLETED|Overall Study||0||
59996733|NCT02713789|76112577|FG001|NOT COMPLETED|Overall Study||1||
59996734|NCT02713789|76112578|FG002|NOT COMPLETED|Overall Study||1||
59996735|NCT04445051|76112588|FG000|STARTED|Overall Study||5||
59850803|NCT04652245|75975054|FG000|NOT COMPLETED|Treatment Administration Period 1||0||
59850804|NCT04652245|75975055|FG001|NOT COMPLETED|Treatment Administration Period 1||0||
59850805|NCT04652245|75975054|FG000|STARTED|Wash-Out Period||108||
59850806|NCT04652245|75975055|FG001|STARTED|Wash-Out Period||108||
59850807|NCT04652245|75975054|FG000|COMPLETED|Wash-Out Period||108||
59850808|NCT04652245|75975055|FG001|COMPLETED|Wash-Out Period||104||
59850809|NCT04652245|75975054|FG000|NOT COMPLETED|Wash-Out Period||0||
59850810|NCT04652245|75975055|FG001|NOT COMPLETED|Wash-Out Period||4||
59850811|NCT04652245|75975054|FG000|STARTED|Treatment Administration Period 2||108||
59850812|NCT04652245|75975055|FG001|STARTED|Treatment Administration Period 2||104||
59850813|NCT04652245|75975054|FG000|COMPLETED|Treatment Administration Period 2||108||
59850814|NCT04652245|75975055|FG001|COMPLETED|Treatment Administration Period 2||104||
59850815|NCT04652245|75975054|FG000|NOT COMPLETED|Treatment Administration Period 2||0||
59850816|NCT04652245|75975055|FG001|NOT COMPLETED|Treatment Administration Period 2||0||
59850817|NCT04635735|75975064|FG000|STARTED|Overall Study||3||
59850818|NCT04635735|75975064|FG000|COMPLETED|Overall Study||3||
59850819|NCT04635735|75975064|FG000|NOT COMPLETED|Overall Study||0||
59850820|NCT04405739|75975072|FG000|STARTED|Overall Study||4||
59850821|NCT04405739|75975073|FG001|STARTED|Overall Study||18||
59850822|NCT04405739|75975074|FG002|STARTED|Overall Study||25||
59850823|NCT04405739|75975075|FG003|STARTED|Overall Study||24||
59850824|NCT04405739|75975072|FG000|COMPLETED|Overall Study|Molnupiravir 200-mg arm includes 1 participant randomized to molnupiravir 300 mg under protocol version 2|4||
59850825|NCT04405739|75975073|FG001|COMPLETED|Overall Study||13||
59850826|NCT04405739|75975074|FG002|COMPLETED|Overall Study||22||
59850827|NCT04405739|75975075|FG003|COMPLETED|Overall Study||18||
59850828|NCT04405739|75975072|FG000|NOT COMPLETED|Overall Study||0||
59850829|NCT04405739|75975073|FG001|NOT COMPLETED|Overall Study||5||
59850830|NCT04405739|75975074|FG002|NOT COMPLETED|Overall Study||3||
59850831|NCT04405739|75975075|FG003|NOT COMPLETED|Overall Study||6||
59850832|NCT05165121|75975088|FG000|STARTED|Overall Study||20||
59850833|NCT05165121|75975089|FG001|STARTED|Overall Study||36||
59850834|NCT05165121|75975090|FG002|STARTED|Overall Study||35||
59850835|NCT05165121|75975088|FG000|COMPLETED|Overall Study||20||
59850836|NCT05165121|75975089|FG001|COMPLETED|Overall Study||32||
59850837|NCT05165121|75975090|FG002|COMPLETED|Overall Study||32||
59850838|NCT05165121|75975088|FG000|NOT COMPLETED|Overall Study||0||
59850839|NCT05165121|75975089|FG001|NOT COMPLETED|Overall Study||4||
59850840|NCT05165121|75975090|FG002|NOT COMPLETED|Overall Study||3||
59850841|NCT05085392|75975102|FG000|STARTED|Overall Study||20||
59850842|NCT05085392|75975102|FG000|COMPLETED|Overall Study||20||
59850843|NCT05085392|75975102|FG000|NOT COMPLETED|Overall Study||0||
59850844|NCT04954326|75975108|FG000|STARTED|Overall Study||44||
59850845|NCT04954326|75975109|FG001|STARTED|Overall Study||45||
59850846|NCT04954326|75975108|FG000|COMPLETED|Overall Study|One patient randomized into the lyophilizate group received the liquid formulation in error and was classified according to the treatment actually received. They are counted here as the lyophilizate group, as that is what they were initially randomized into. However for the baseline and statistical measures, they are counted in the liquid group, as that is the drug that they received.|44||
59850847|NCT04954326|75975109|FG001|COMPLETED|Overall Study|The reasons for withdrawals were : two deaths, one protocol violation (patient wrongly included with B-cell Burkit ALL and withdrawn before receiving any IMP), and one physician's decision (patient with allergic reaction after starting the infusion with the IMP).|41||
59850848|NCT04954326|75975108|FG000|NOT COMPLETED|Overall Study||0||
59850849|NCT04954326|75975109|FG001|NOT COMPLETED|Overall Study||4||
59850850|NCT04914819|75975117|FG000|STARTED|Overall Study||40||
59850851|NCT04914819|75975118|FG001|STARTED|Overall Study||20||
59850852|NCT04914819|75975117|FG000|COMPLETED|Overall Study||26||
59850853|NCT04914819|75975118|FG001|COMPLETED|Overall Study||18||
59850854|NCT04914819|75975117|FG000|NOT COMPLETED|Overall Study||14||
59850855|NCT04914819|75975118|FG001|NOT COMPLETED|Overall Study||2||
59850856|NCT04818346|75975133|FG000|STARTED|24-Week Placebo-Controlled Period||43||
59850857|NCT04818346|75975134|FG001|STARTED|24-Week Placebo-Controlled Period||43||
59850858|NCT04818346|75975135|FG002|STARTED|24-Week Placebo-Controlled Period||43||
59850859|NCT04818346|75975136|FG003|STARTED|24-Week Placebo-Controlled Period||42||
59996736|NCT04445051|76112589|FG001|STARTED|Overall Study||4||
59850860|NCT04818346|75975133|FG000|COMPLETED|24-Week Placebo-Controlled Period||35||
59850861|NCT04818346|75975134|FG001|COMPLETED|24-Week Placebo-Controlled Period||38||
59850862|NCT04818346|75975135|FG002|COMPLETED|24-Week Placebo-Controlled Period||32||
59850863|NCT04818346|75975136|FG003|COMPLETED|24-Week Placebo-Controlled Period||34||
59850864|NCT04818346|75975133|FG000|NOT COMPLETED|24-Week Placebo-Controlled Period||8||
59850865|NCT04818346|75975134|FG001|NOT COMPLETED|24-Week Placebo-Controlled Period||5||
59850866|NCT04818346|75975135|FG002|NOT COMPLETED|24-Week Placebo-Controlled Period||11||
59850867|NCT04818346|75975136|FG003|NOT COMPLETED|24-Week Placebo-Controlled Period||8||
59850868|NCT04818346|75975133|FG000|STARTED|28-Week Double-Blind Extension Period||0||
59850869|NCT04818346|75975134|FG001|STARTED|28-Week Double-Blind Extension Period||0||
59850870|NCT04818346|75975135|FG002|STARTED|28-Week Double-Blind Extension Period||0||
59850871|NCT04818346|75975136|FG003|STARTED|28-Week Double-Blind Extension Period||0||
59996737|NCT04445051|76112590|FG002|STARTED|Overall Study||5||
59996738|NCT04445051|76112591|FG003|STARTED|Overall Study||6||
59996739|NCT04445051|76112592|FG004|STARTED|Overall Study||5||
59850872|NCT04818346|75975133|FG000|COMPLETED|28-Week Double-Blind Extension Period||0||
59850873|NCT04818346|75975134|FG001|COMPLETED|28-Week Double-Blind Extension Period||0||
59850874|NCT04818346|75975135|FG002|COMPLETED|28-Week Double-Blind Extension Period||0||
59850875|NCT04818346|75975136|FG003|COMPLETED|28-Week Double-Blind Extension Period||0||
59850876|NCT04818346|75975133|FG000|NOT COMPLETED|28-Week Double-Blind Extension Period||0||
59850877|NCT04818346|75975134|FG001|NOT COMPLETED|28-Week Double-Blind Extension Period||0||
59850878|NCT04818346|75975135|FG002|NOT COMPLETED|28-Week Double-Blind Extension Period||0||
59850879|NCT04818346|75975136|FG003|NOT COMPLETED|28-Week Double-Blind Extension Period||0||
59850880|NCT04723394|75975148|FG000|STARTED|Overall Study||456|All Participants Randomized|
59850881|NCT04723394|75975149|FG001|STARTED|Overall Study||454|All Participants Randomized|
59850882|NCT04723394|75975148|FG000|Dosed|Overall Study||452|Full Analysis Set|
59850883|NCT04723394|75975149|FG001|Dosed|Overall Study||451|Full Analysis Set|
59850884|NCT04723394|75975148|FG000|Modified Full Analysis Set|Overall Study||413|Dosed, randomized <=7 days from symptom onset and not hospitalized for isolation purposes at baseline|
59850885|NCT04723394|75975149|FG001|Modified Full Analysis Set|Overall Study||421|Dosed, randomized <=7 days from symptom onset and not hospitalized for isolation purposes at baseline|
59850886|NCT04723394|75975148|FG000|Primary Analysis Population|Overall Study||410|Participants who are included in the modified full analysis set excluding those who did not have an assessment for the primary endpoint|
59850887|NCT04723394|75975149|FG001|Primary Analysis Population|Overall Study||419|Participants who are included in the modified full analysis set excluding those who did not have an assessment for the primary endpoint|
59850888|NCT04723394|75975148|FG000|Key Secondary Analysis Population|Overall Study||404|Participants who are included in the modified full analysis set excluding those who did not have an assessment for the key secondary endpoint|
59850889|NCT04723394|75975149|FG001|Key Secondary Analysis Population|Overall Study||411|Participants who are included in the modified full analysis set excluding those who did not have an assessment for the key secondary endpoint|
59850890|NCT04723394|75975148|FG000|COMPLETED|Overall Study||407||
59850891|NCT04723394|75975149|FG001|COMPLETED|Overall Study||390||
59850892|NCT04723394|75975148|FG000|NOT COMPLETED|Overall Study||49||
59850893|NCT04723394|75975149|FG001|NOT COMPLETED|Overall Study||64||
59850894|NCT04646616|75975155|FG000|STARTED|Overall Study||178||
59850895|NCT04646616|75975155|FG000|COMPLETED|Overall Study||139||
59850896|NCT04646616|75975155|FG000|NOT COMPLETED|Overall Study||39||
59850897|NCT04409002|75975159|FG000|STARTED|Overall Study||18||
59850898|NCT04409002|75975159|FG000|COMPLETED|Overall Study||15||
59850899|NCT04409002|75975159|FG000|NOT COMPLETED|Overall Study||3||
59850900|NCT04289363|75975165|FG000|STARTED|Overall Study||53||
59850901|NCT04289363|75975166|FG001|STARTED|Overall Study||1489||
59850902|NCT04289363|75975165|FG000|COMPLETED|Overall Study||39||
59850903|NCT04289363|75975166|FG001|COMPLETED|Overall Study||1489||
59850904|NCT04289363|75975165|FG000|NOT COMPLETED|Overall Study||14||
59850905|NCT04289363|75975166|FG001|NOT COMPLETED|Overall Study||0||
59850906|NCT04235959|75975175|FG000|STARTED|Overall Study||4||
59850907|NCT04235959|75975176|FG001|STARTED|Overall Study||10||
59850908|NCT04235959|75975177|FG002|STARTED|Overall Study||10||
59850909|NCT04235959|75975175|FG000|Received At Least One Dose of Study Drug|Overall Study||4||
59850910|NCT04235959|75975176|FG001|Received At Least One Dose of Study Drug|Overall Study||10||
59850911|NCT04235959|75975177|FG002|Received At Least One Dose of Study Drug|Overall Study||10||
59850912|NCT04235959|75975175|FG000|COMPLETED|Overall Study||3||
59850913|NCT04235959|75975176|FG001|COMPLETED|Overall Study||9||
59850914|NCT04235959|75975177|FG002|COMPLETED|Overall Study||10||
59850915|NCT04235959|75975175|FG000|NOT COMPLETED|Overall Study||1||
59850916|NCT04235959|75975176|FG001|NOT COMPLETED|Overall Study||1||
59850917|NCT04235959|75975177|FG002|NOT COMPLETED|Overall Study||0||
59850918|NCT04087811|75975187|FG000|STARTED|Overall Study||1674||
59850919|NCT04087811|75975187|FG000|COMPLETED|Overall Study||1594||
59850920|NCT04087811|75975187|FG000|NOT COMPLETED|Overall Study||80||
59850921|NCT03992261|75975191|FG000|STARTED|Overall Study||24||
59850922|NCT03992261|75975191|FG000|COMPLETED|Overall Study||24||
59850923|NCT03992261|75975191|FG000|NOT COMPLETED|Overall Study||0||
59850924|NCT03907501|75975199|FG000|STARTED|Overall Study||7||
59850925|NCT03907501|75975200|FG001|STARTED|Overall Study||6||
59850926|NCT03907501|75975201|FG002|STARTED|Overall Study||5||
59850927|NCT03907501|75975199|FG000|COMPLETED|Overall Study||6||
60121423|NCT02672176|76242352|FG000|COMPLETED|Overall Study||155||
60121424|NCT02672176|76242353|FG001|COMPLETED|Overall Study||132||
60121425|NCT02672176|76242352|FG000|NOT COMPLETED|Overall Study||6||
59723900|NCT01125293|75842516|FG002|STARTED|Overall Study||4||
59723901|NCT01125293|75842517|FG003|STARTED|Overall Study||3||
59723902|NCT01125293|75842518|FG004|STARTED|Overall Study|Per protocol, a 10 patient expansion cohort is used to confirm the MTD determined in Stage B .|10||
59723903|NCT01125293|75842519|FG005|STARTED|Overall Study||23||
59723904|NCT01125293|75842514|FG000|Evaluable for Phase I Dose-Limiting Toxicity|Overall Study||3||
59723905|NCT01125293|75842515|FG001|Evaluable for Phase I Dose-Limiting Toxicity|Overall Study||3||
59723906|NCT01125293|75842516|FG002|Evaluable for Phase I Dose-Limiting Toxicity|Overall Study||3||
59850928|NCT03907501|75975200|FG001|COMPLETED|Overall Study||5||
59850929|NCT03907501|75975201|FG002|COMPLETED|Overall Study||5||
59850930|NCT03907501|75975199|FG000|NOT COMPLETED|Overall Study||1||
59850931|NCT03907501|75975200|FG001|NOT COMPLETED|Overall Study||1||
59850932|NCT03907501|75975201|FG002|NOT COMPLETED|Overall Study||0||
59850933|NCT03525613|75975212|FG000|STARTED|Overall Study||213||
59850934|NCT03525613|75975213|FG001|STARTED|Overall Study||212||
59850935|NCT03525613|75975214|FG002|STARTED|Overall Study||106||
59850936|NCT03525613|75975215|FG003|STARTED|Overall Study||106||
59850937|NCT03525613|75975212|FG000|COMPLETED|Overall Study||144||
59850938|NCT03525613|75975213|FG001|COMPLETED|Overall Study||169||
59850939|NCT03525613|75975214|FG002|COMPLETED|Overall Study||76||
59850940|NCT03525613|75975215|FG003|COMPLETED|Overall Study||82||
59850941|NCT03525613|75975212|FG000|NOT COMPLETED|Overall Study||69||
59850942|NCT03525613|75975213|FG001|NOT COMPLETED|Overall Study||43||
59850943|NCT03525613|75975214|FG002|NOT COMPLETED|Overall Study||30||
59850944|NCT03525613|75975215|FG003|NOT COMPLETED|Overall Study||24||
59850945|NCT03500692|75975229|FG000|STARTED|Overall Study||500||
59850946|NCT03500692|75975229|FG000|COMPLETED|Overall Study||258|3 - year visit complete|
59850947|NCT03500692|75975229|FG000|NOT COMPLETED|Overall Study||242||
59850948|NCT03434028|75975235|FG000|STARTED|Overall Study||782||
59850949|NCT03434028|75975236|FG001|STARTED|Overall Study||781||
59850950|NCT03434028|75975235|FG000|COMPLETED|Overall Study||782||
59850951|NCT03434028|75975236|FG001|COMPLETED|Overall Study||781||
59850952|NCT03434028|75975235|FG000|NOT COMPLETED|Overall Study||0||
59850953|NCT03434028|75975236|FG001|NOT COMPLETED|Overall Study||0||
59850954|NCT03404960|75975244|FG000|STARTED|Overall Study||46||
59850955|NCT03404960|75975245|FG001|STARTED|Overall Study||45||
59850956|NCT03404960|75975244|FG000|COMPLETED|Overall Study||44||
59850957|NCT03404960|75975245|FG001|COMPLETED|Overall Study||40||
59850958|NCT03404960|75975244|FG000|NOT COMPLETED|Overall Study||2||
59850959|NCT03404960|75975245|FG001|NOT COMPLETED|Overall Study||5||
59850960|NCT03264404|75975251|FG000|STARTED|Overall Study||36||
59850961|NCT03264404|75975251|FG000|COMPLETED|Overall Study||2||
59850962|NCT03264404|75975251|FG000|NOT COMPLETED|Overall Study||34||
59850963|NCT03218384|75975257|FG000|STARTED|Overall Study||3||
59850964|NCT03218384|75975258|FG001|STARTED|Overall Study||3||
59850965|NCT03218384|75975257|FG000|COMPLETED|Overall Study||3||
59850966|NCT03218384|75975258|FG001|COMPLETED|Overall Study||3||
59850967|NCT03218384|75975257|FG000|NOT COMPLETED|Overall Study||0||
59850968|NCT03218384|75975258|FG001|NOT COMPLETED|Overall Study||0||
59850969|NCT03118570|75975269|FG000|STARTED|Overall Study||31||
59850970|NCT03118570|75975270|FG001|STARTED|Overall Study||29||
59850971|NCT03118570|75975271|FG002|STARTED|Overall Study||30||
59850972|NCT03118570|75975272|FG003|STARTED|Overall Study||2||
59850973|NCT03118570|75975273|FG004|STARTED|Overall Study||20||
59850974|NCT03118570|75975269|FG000|Reassigned From Placebo to 20 mg/kg Open-Label Setrusumab|Overall Study||0||
59850975|NCT03118570|75975270|FG001|Reassigned From Placebo to 20 mg/kg Open-Label Setrusumab|Overall Study||0||
59850976|NCT03118570|75975271|FG002|Reassigned From Placebo to 20 mg/kg Open-Label Setrusumab|Overall Study||0||
59850977|NCT03118570|75975272|FG003|Reassigned From Placebo to 20 mg/kg Open-Label Setrusumab|Overall Study||0||
59850978|NCT03118570|75975273|FG004|Reassigned From Placebo to 20 mg/kg Open-Label Setrusumab|Overall Study||19||
59850979|NCT03118570|75975269|FG000|COMPLETED|Overall Study||26||
59850980|NCT03118570|75975270|FG001|COMPLETED|Overall Study||22||
59850981|NCT03118570|75975271|FG002|COMPLETED|Overall Study||25||
59850982|NCT03118570|75975272|FG003|COMPLETED|Overall Study||2||
59850983|NCT03118570|75975273|FG004|COMPLETED|Overall Study||15||
59850984|NCT03118570|75975269|FG000|NOT COMPLETED|Overall Study||5||
59850985|NCT03118570|75975270|FG001|NOT COMPLETED|Overall Study||7||
59850986|NCT03118570|75975271|FG002|NOT COMPLETED|Overall Study||5||
59850987|NCT03118570|75975272|FG003|NOT COMPLETED|Overall Study||0||
59850988|NCT03118570|75975273|FG004|NOT COMPLETED|Overall Study||5||
59850989|NCT02971683|75975288|FG000|STARTED|Double-Blind (24 Weeks)||75|All participants who started the Double-Blind period were treated|
59850990|NCT02971683|75975289|FG001|STARTED|Double-Blind (24 Weeks)||73|All participants who started the Double-Blind period were treated|
59850991|NCT02971683|75975288|FG000|COMPLETED|Double-Blind (24 Weeks)||69|Completed Period|
59850992|NCT02971683|75975289|FG001|COMPLETED|Double-Blind (24 Weeks)||65|Completed Period|
59850993|NCT02971683|75975288|FG000|NOT COMPLETED|Double-Blind (24 Weeks)||6||
60121426|NCT02672176|76242353|FG001|NOT COMPLETED|Overall Study||26||
60121427|NCT02691936|76242364|FG000|STARTED|Overall Study||35||
60121428|NCT02691936|76242365|FG001|STARTED|Overall Study||34||
59850994|NCT02971683|75975289|FG001|NOT COMPLETED|Double-Blind (24 Weeks)||8||
60121429|NCT02691936|76242364|FG000|COMPLETED|Overall Study||33||
59850995|NCT02971683|75975288|FG000|STARTED|Open-Label||69|All participants treated in the Open Label Period|
59850996|NCT02971683|75975289|FG001|STARTED|Open-Label||63|All participants treated in the Open Label Period|
59850997|NCT02971683|75975288|FG000|COMPLETED|Open-Label||65|Completed Period|
59850998|NCT02971683|75975289|FG001|COMPLETED|Open-Label||61|Completed Period|
59850999|NCT02971683|75975288|FG000|NOT COMPLETED|Open-Label||4||
59851000|NCT02971683|75975289|FG001|NOT COMPLETED|Open-Label||2||
59851001|NCT02971683|75975288|FG000|STARTED|Long-Term Open Label||25||
59851002|NCT02971683|75975289|FG001|STARTED|Long-Term Open Label||21||
59851003|NCT02971683|75975288|FG000|COMPLETED|Long-Term Open Label||1|Completed Period|
59851004|NCT02971683|75975289|FG001|COMPLETED|Long-Term Open Label||0|Completed Period|
59851005|NCT02971683|75975288|FG000|NOT COMPLETED|Long-Term Open Label||24||
60121430|NCT02691936|76242365|FG001|COMPLETED|Overall Study||29||
59851006|NCT02971683|75975289|FG001|NOT COMPLETED|Long-Term Open Label||21||
59851007|NCT02899299|75975297|FG000|STARTED|Pre-treatment||303|Started = Randomized|
59851008|NCT02899299|75975298|FG001|STARTED|Pre-treatment||302|Started = Randomized|
59851009|NCT02899299|75975297|FG000|COMPLETED|Pre-treatment||300|Completed = Entering treatment|
59851010|NCT02899299|75975298|FG001|COMPLETED|Pre-treatment||284|Completed = Entering treatment|
59851011|NCT02899299|75975297|FG000|NOT COMPLETED|Pre-treatment||3||
59851012|NCT02899299|75975298|FG001|NOT COMPLETED|Pre-treatment||18||
59851013|NCT02899299|75975297|FG000|STARTED|Treatment||300|Started = Entering treatment|
59851014|NCT02899299|75975298|FG001|STARTED|Treatment||284|Started = Entering treatment|
59851015|NCT02899299|75975297|FG000|COMPLETED|Treatment||5|Completed = Continuing treatment|
59851016|NCT02899299|75975298|FG001|COMPLETED|Treatment||0|Completed = Continuing treatment|
59851017|NCT02899299|75975297|FG000|NOT COMPLETED|Treatment||295||
59851018|NCT02899299|75975298|FG001|NOT COMPLETED|Treatment||284||
59851019|NCT02899195|75975304|FG000|STARTED|Concurrent Durvalumab||55||
59851020|NCT02899195|75975304|FG000|COMPLETED|Concurrent Durvalumab||44||
59851021|NCT02899195|75975304|FG000|NOT COMPLETED|Concurrent Durvalumab||11||
59851022|NCT02899195|75975304|FG000|STARTED|Maintenance Durvalumab||44||
59851023|NCT02899195|75975304|FG000|COMPLETED|Maintenance Durvalumab||10||
59851024|NCT02899195|75975304|FG000|NOT COMPLETED|Maintenance Durvalumab||34||
59851025|NCT02804594|75975310|FG000|STARTED|Overall Study||10||
59851026|NCT02804594|75975311|FG001|STARTED|Overall Study||5||
59851027|NCT02804594|75975310|FG000|COMPLETED|Overall Study||10||
59851028|NCT02804594|75975311|FG001|COMPLETED|Overall Study||5||
59851029|NCT02804594|75975310|FG000|NOT COMPLETED|Overall Study||0||
59851030|NCT02804594|75975311|FG001|NOT COMPLETED|Overall Study||0||
59851031|NCT02728050|75975324|FG000|STARTED|Overall Study||6||
59851032|NCT02728050|75975325|FG001|STARTED|Overall Study||6||
59851033|NCT02728050|75975326|FG002|STARTED|Overall Study||11||
59851034|NCT02728050|75975327|FG003|STARTED|Overall Study||8||
59851035|NCT02728050|75975328|FG004|STARTED|Overall Study||9||
59851036|NCT02728050|75975329|FG005|STARTED|Overall Study||7||
59851037|NCT02728050|75975330|FG006|STARTED|Overall Study||37||
59851038|NCT02728050|75975324|FG000|COMPLETED|Overall Study||6||
59851039|NCT02728050|75975325|FG001|COMPLETED|Overall Study||6||
59851040|NCT02728050|75975326|FG002|COMPLETED|Overall Study||11||
59851041|NCT02728050|75975327|FG003|COMPLETED|Overall Study||8||
59851042|NCT02728050|75975328|FG004|COMPLETED|Overall Study||9||
59851043|NCT02728050|75975329|FG005|COMPLETED|Overall Study||7||
59851044|NCT02728050|75975330|FG006|COMPLETED|Overall Study||37||
59851045|NCT02728050|75975324|FG000|NOT COMPLETED|Overall Study||0||
59851046|NCT02728050|75975325|FG001|NOT COMPLETED|Overall Study||0||
59851047|NCT02728050|75975326|FG002|NOT COMPLETED|Overall Study||0||
59851048|NCT02728050|75975327|FG003|NOT COMPLETED|Overall Study||0||
59851049|NCT02728050|75975328|FG004|NOT COMPLETED|Overall Study||0||
59851050|NCT02728050|75975329|FG005|NOT COMPLETED|Overall Study||0||
59851051|NCT02728050|75975330|FG006|NOT COMPLETED|Overall Study||0||
59851052|NCT02711878|75975357|FG000|STARTED|Overall Study||76||
59851053|NCT02711878|75975358|FG001|STARTED|Overall Study||39||
59851054|NCT02711878|75975357|FG000|Completed Visit T1 (13-15 Weeks Post Baseline)|Overall Study||69||
59851055|NCT02711878|75975358|FG001|Completed Visit T1 (13-15 Weeks Post Baseline)|Overall Study||33||
59851056|NCT02711878|75975357|FG000|Completed Visit T2 (28-30 Weeks Post Baseline)|Overall Study||68||
59851057|NCT02711878|75975358|FG001|Completed Visit T2 (28-30 Weeks Post Baseline)|Overall Study||33||
59851058|NCT02711878|75975357|FG000|Completed Visit T3 (56-58 Weeks Post Baseline)|Overall Study||72||
59851059|NCT02711878|75975358|FG001|Completed Visit T3 (56-58 Weeks Post Baseline)|Overall Study||31||
59851060|NCT02711878|75975357|FG000|COMPLETED|Overall Study||68||
59851061|NCT02711878|75975358|FG001|COMPLETED|Overall Study||33||
60121431|NCT02691936|76242364|FG000|NOT COMPLETED|Overall Study||2||
59578690|NCT02039726|75684233|FG001|Did Not Receive Treatment|Overall Study||28||
59578691|NCT02039726|75684232|FG000|COMPLETED|Overall Study||200||
59851062|NCT02711878|75975357|FG000|NOT COMPLETED|Overall Study||8||
59851063|NCT02711878|75975358|FG001|NOT COMPLETED|Overall Study||6||
59851064|NCT02581943|75975373|FG000|STARTED|Overall Study||22||
59851065|NCT02581943|75975374|FG001|STARTED|Overall Study||21||
59851066|NCT02581943|75975373|FG000|COMPLETED|Overall Study||4||
59851067|NCT02581943|75975374|FG001|COMPLETED|Overall Study||2||
59851068|NCT02581943|75975373|FG000|NOT COMPLETED|Overall Study||18||
59851069|NCT02581943|75975374|FG001|NOT COMPLETED|Overall Study||19||
60121432|NCT02691936|76242365|FG001|NOT COMPLETED|Overall Study||5||
59851070|NCT02527200|75975389|FG000|STARTED|Overall Study||20||
59578692|NCT02039726|75684233|FG001|COMPLETED|Overall Study||106||
59578693|NCT02039726|75684232|FG000|NOT COMPLETED|Overall Study||45||
59851071|NCT02527200|75975390|FG001|STARTED|Overall Study||12||
59851072|NCT02527200|75975391|FG002|STARTED|Overall Study||17||
59851073|NCT02527200|75975392|FG003|STARTED|Overall Study||7||
59851074|NCT02527200|75975389|FG000|Safety Analysis Set (SAS)|Overall Study||20||
59851075|NCT02527200|75975390|FG001|Safety Analysis Set (SAS)|Overall Study||12||
59851076|NCT02527200|75975391|FG002|Safety Analysis Set (SAS)|Overall Study||17||
59851077|NCT02527200|75975392|FG003|Safety Analysis Set (SAS)|Overall Study||7||
59851078|NCT02527200|75975389|FG000|Full Analysis Set (FAS)|Overall Study||19||
60121433|NCT02675764|76242373|FG000|STARTED|Overall Study||6||
59851079|NCT02527200|75975390|FG001|Full Analysis Set (FAS)|Overall Study||12||
59851080|NCT02527200|75975391|FG002|Full Analysis Set (FAS)|Overall Study||17||
59851081|NCT02527200|75975392|FG003|Full Analysis Set (FAS)|Overall Study||7||
59851082|NCT02527200|75975389|FG000|COMPLETED|Overall Study||17||
59851083|NCT02527200|75975390|FG001|COMPLETED|Overall Study||9||
59851084|NCT02527200|75975391|FG002|COMPLETED|Overall Study||15||
59851085|NCT02527200|75975392|FG003|COMPLETED|Overall Study||7||
59851086|NCT02527200|75975389|FG000|NOT COMPLETED|Overall Study||3||
59851087|NCT02527200|75975390|FG001|NOT COMPLETED|Overall Study||3||
59851088|NCT02527200|75975391|FG002|NOT COMPLETED|Overall Study||2||
59851089|NCT02527200|75975392|FG003|NOT COMPLETED|Overall Study||0||
59851090|NCT02510040|75975409|FG000|STARTED|Overall Study||81||
59851091|NCT02510040|75975410|FG001|STARTED|Overall Study||114||
59851092|NCT02510040|75975411|FG002|STARTED|Overall Study||22||
59851093|NCT02510040|75975409|FG000|COMPLETED|Overall Study||63||
59851094|NCT02510040|75975410|FG001|COMPLETED|Overall Study||111||
59851095|NCT02510040|75975411|FG002|COMPLETED|Overall Study||21||
59851096|NCT02510040|75975409|FG000|NOT COMPLETED|Overall Study||18||
59851097|NCT02510040|75975410|FG001|NOT COMPLETED|Overall Study||3||
59851098|NCT02510040|75975411|FG002|NOT COMPLETED|Overall Study||1||
59851099|NCT02369354|75975423|FG000|STARTED|Overall Study||100||
59851100|NCT02369354|75975424|FG001|STARTED|Overall Study||100||
59851101|NCT02369354|75975425|FG002|STARTED|Overall Study||100||
59851102|NCT02369354|75975423|FG000|COMPLETED|Overall Study||88||
59851103|NCT02369354|75975424|FG001|COMPLETED|Overall Study||86||
59851104|NCT02369354|75975425|FG002|COMPLETED|Overall Study||86||
59851105|NCT02369354|75975423|FG000|NOT COMPLETED|Overall Study||12||
59851106|NCT02369354|75975424|FG001|NOT COMPLETED|Overall Study||14||
59851107|NCT02369354|75975425|FG002|NOT COMPLETED|Overall Study||14||
59851108|NCT02267603|75975433|FG000|STARTED|Overall Study||50||
59851109|NCT02267603|75975433|FG000|COMPLETED|Overall Study||6||
59851110|NCT02267603|75975433|FG000|NOT COMPLETED|Overall Study||44||
59851111|NCT01935089|75975437|FG000|STARTED|Overall Study||20||
59851112|NCT01935089|75975437|FG000|COMPLETED|Overall Study||17||
59851113|NCT01935089|75975437|FG000|NOT COMPLETED|Overall Study||3||
59851114|NCT01521026|75975443|FG000|STARTED|Overall Study||38||
59851115|NCT01521026|75975444|FG001|STARTED|Overall Study||31||
59851116|NCT01521026|75975443|FG000|COMPLETED|Overall Study||23||
59851117|NCT01521026|75975444|FG001|COMPLETED|Overall Study||28||
59851118|NCT01521026|75975443|FG000|NOT COMPLETED|Overall Study||15||
59851119|NCT01521026|75975444|FG001|NOT COMPLETED|Overall Study||3||
59851120|NCT01334944|75975450|FG000|STARTED|Overall Study||11||
59851121|NCT01334944|75975451|FG001|STARTED|Overall Study||139||
59851122|NCT01334944|75975450|FG000|Received Singel Dose|Overall Study||1||
59578694|NCT02039726|75684233|FG001|NOT COMPLETED|Overall Study||16||
59578695|NCT03036293|75684243|FG000|STARTED|Overall Study||127||
59578696|NCT03036293|75684244|FG001|STARTED|Overall Study||67||
59578697|NCT03036293|75684245|FG002|STARTED|Overall Study||131||
59851123|NCT01334944|75975451|FG001|Received Singel Dose|Overall Study||96||
59851124|NCT01334944|75975450|FG000|Received Multiple Doses|Overall Study||10||
59851125|NCT01334944|75975451|FG001|Received Multiple Doses|Overall Study||43||
59851126|NCT01334944|75975450|FG000|COMPLETED|Overall Study||11||
59851127|NCT01334944|75975451|FG001|COMPLETED|Overall Study||139||
59851128|NCT01334944|75975450|FG000|NOT COMPLETED|Overall Study||0||
59851129|NCT01334944|75975451|FG001|NOT COMPLETED|Overall Study||0||
59851130|NCT00810732|75975460|FG000|STARTED|First Intervention Period (6 Weeks)||5||
59851131|NCT00810732|75975461|FG001|STARTED|First Intervention Period (6 Weeks)||4||
59851132|NCT00810732|75975462|FG002|STARTED|First Intervention Period (6 Weeks)||4||
59851133|NCT00810732|75975463|FG003|STARTED|First Intervention Period (6 Weeks)||5||
59851134|NCT00810732|75975464|FG004|STARTED|First Intervention Period (6 Weeks)||5||
59851135|NCT00810732|75975465|FG005|STARTED|First Intervention Period (6 Weeks)||4||
59851136|NCT00810732|75975460|FG000|COMPLETED|First Intervention Period (6 Weeks)||5||
59851137|NCT00810732|75975461|FG001|COMPLETED|First Intervention Period (6 Weeks)||4||
60121434|NCT02675764|76242374|FG001|STARTED|Overall Study||6||
59851138|NCT00810732|75975462|FG002|COMPLETED|First Intervention Period (6 Weeks)||4||
59851139|NCT00810732|75975463|FG003|COMPLETED|First Intervention Period (6 Weeks)||5||
59851140|NCT00810732|75975464|FG004|COMPLETED|First Intervention Period (6 Weeks)||5||
59851141|NCT00810732|75975465|FG005|COMPLETED|First Intervention Period (6 Weeks)||4||
59851142|NCT00810732|75975460|FG000|NOT COMPLETED|First Intervention Period (6 Weeks)||0||
59851143|NCT00810732|75975461|FG001|NOT COMPLETED|First Intervention Period (6 Weeks)||0||
59851144|NCT00810732|75975462|FG002|NOT COMPLETED|First Intervention Period (6 Weeks)||0||
59851145|NCT00810732|75975463|FG003|NOT COMPLETED|First Intervention Period (6 Weeks)||0||
59851146|NCT00810732|75975464|FG004|NOT COMPLETED|First Intervention Period (6 Weeks)||0||
59851147|NCT00810732|75975465|FG005|NOT COMPLETED|First Intervention Period (6 Weeks)||0||
59851148|NCT00810732|75975460|FG000|STARTED|First Washout Period (at Least 2 Weeks)||5||
59851149|NCT00810732|75975461|FG001|STARTED|First Washout Period (at Least 2 Weeks)||4||
59578698|NCT03036293|75684246|FG003|STARTED|Overall Study||65||
59578699|NCT03036293|75684243|FG000|COMPLETED|Overall Study||126||
59578700|NCT03036293|75684244|FG001|COMPLETED|Overall Study||64||
59578701|NCT03036293|75684245|FG002|COMPLETED|Overall Study||130||
59851150|NCT00810732|75975462|FG002|STARTED|First Washout Period (at Least 2 Weeks)||4||
59851151|NCT00810732|75975463|FG003|STARTED|First Washout Period (at Least 2 Weeks)||5||
59851152|NCT00810732|75975464|FG004|STARTED|First Washout Period (at Least 2 Weeks)||5||
59851153|NCT00810732|75975465|FG005|STARTED|First Washout Period (at Least 2 Weeks)||4||
59851154|NCT00810732|75975460|FG000|COMPLETED|First Washout Period (at Least 2 Weeks)||5||
59851155|NCT00810732|75975461|FG001|COMPLETED|First Washout Period (at Least 2 Weeks)||4||
59851156|NCT00810732|75975462|FG002|COMPLETED|First Washout Period (at Least 2 Weeks)||4||
59851157|NCT00810732|75975463|FG003|COMPLETED|First Washout Period (at Least 2 Weeks)||5||
59851158|NCT00810732|75975464|FG004|COMPLETED|First Washout Period (at Least 2 Weeks)||5||
59851159|NCT00810732|75975465|FG005|COMPLETED|First Washout Period (at Least 2 Weeks)||4||
59851160|NCT00810732|75975460|FG000|NOT COMPLETED|First Washout Period (at Least 2 Weeks)||0||
59851161|NCT00810732|75975461|FG001|NOT COMPLETED|First Washout Period (at Least 2 Weeks)||0||
59851162|NCT00810732|75975462|FG002|NOT COMPLETED|First Washout Period (at Least 2 Weeks)||0||
59851163|NCT00810732|75975463|FG003|NOT COMPLETED|First Washout Period (at Least 2 Weeks)||0||
59851164|NCT00810732|75975464|FG004|NOT COMPLETED|First Washout Period (at Least 2 Weeks)||0||
59851165|NCT00810732|75975465|FG005|NOT COMPLETED|First Washout Period (at Least 2 Weeks)||0||
59851166|NCT00810732|75975460|FG000|STARTED|Second Intervention Period (6 Weeks)||5||
59851167|NCT00810732|75975461|FG001|STARTED|Second Intervention Period (6 Weeks)||4||
59851168|NCT00810732|75975462|FG002|STARTED|Second Intervention Period (6 Weeks)||4||
59851169|NCT00810732|75975463|FG003|STARTED|Second Intervention Period (6 Weeks)||5||
59851170|NCT00810732|75975464|FG004|STARTED|Second Intervention Period (6 Weeks)||5||
59851171|NCT00810732|75975465|FG005|STARTED|Second Intervention Period (6 Weeks)||4||
59851172|NCT00810732|75975460|FG000|COMPLETED|Second Intervention Period (6 Weeks)||5||
59851173|NCT00810732|75975461|FG001|COMPLETED|Second Intervention Period (6 Weeks)||4||
59851174|NCT00810732|75975462|FG002|COMPLETED|Second Intervention Period (6 Weeks)||4||
59851175|NCT00810732|75975463|FG003|COMPLETED|Second Intervention Period (6 Weeks)||5||
59851176|NCT00810732|75975464|FG004|COMPLETED|Second Intervention Period (6 Weeks)||5||
59851177|NCT00810732|75975465|FG005|COMPLETED|Second Intervention Period (6 Weeks)||4||
59851178|NCT00810732|75975460|FG000|NOT COMPLETED|Second Intervention Period (6 Weeks)||0||
59851179|NCT00810732|75975461|FG001|NOT COMPLETED|Second Intervention Period (6 Weeks)||0||
59851180|NCT00810732|75975462|FG002|NOT COMPLETED|Second Intervention Period (6 Weeks)||0||
59851181|NCT00810732|75975463|FG003|NOT COMPLETED|Second Intervention Period (6 Weeks)||0||
59851182|NCT00810732|75975464|FG004|NOT COMPLETED|Second Intervention Period (6 Weeks)||0||
59851183|NCT00810732|75975465|FG005|NOT COMPLETED|Second Intervention Period (6 Weeks)||0||
59851184|NCT00810732|75975460|FG000|STARTED|Second Washout Period (at Least 2 Weeks)||5||
59851185|NCT00810732|75975461|FG001|STARTED|Second Washout Period (at Least 2 Weeks)||4||
59851186|NCT00810732|75975462|FG002|STARTED|Second Washout Period (at Least 2 Weeks)||4||
59851187|NCT00810732|75975463|FG003|STARTED|Second Washout Period (at Least 2 Weeks)||5||
59851188|NCT00810732|75975464|FG004|STARTED|Second Washout Period (at Least 2 Weeks)||5||
59851189|NCT00810732|75975465|FG005|STARTED|Second Washout Period (at Least 2 Weeks)||4||
59851190|NCT00810732|75975460|FG000|COMPLETED|Second Washout Period (at Least 2 Weeks)||5||
59851191|NCT00810732|75975461|FG001|COMPLETED|Second Washout Period (at Least 2 Weeks)||4||
59851192|NCT00810732|75975462|FG002|COMPLETED|Second Washout Period (at Least 2 Weeks)||4||
59851193|NCT00810732|75975463|FG003|COMPLETED|Second Washout Period (at Least 2 Weeks)||5||
59851194|NCT00810732|75975464|FG004|COMPLETED|Second Washout Period (at Least 2 Weeks)||5||
59851195|NCT00810732|75975465|FG005|COMPLETED|Second Washout Period (at Least 2 Weeks)||4||
59851196|NCT00810732|75975460|FG000|NOT COMPLETED|Second Washout Period (at Least 2 Weeks)||0||
59851197|NCT00810732|75975461|FG001|NOT COMPLETED|Second Washout Period (at Least 2 Weeks)||0||
59851198|NCT00810732|75975462|FG002|NOT COMPLETED|Second Washout Period (at Least 2 Weeks)||0||
59851199|NCT00810732|75975463|FG003|NOT COMPLETED|Second Washout Period (at Least 2 Weeks)||0||
59851200|NCT00810732|75975464|FG004|NOT COMPLETED|Second Washout Period (at Least 2 Weeks)||0||
59851201|NCT00810732|75975465|FG005|NOT COMPLETED|Second Washout Period (at Least 2 Weeks)||0||
59578702|NCT03036293|75684246|FG003|COMPLETED|Overall Study||64||
59578703|NCT03036293|75684243|FG000|NOT COMPLETED|Overall Study||1||
59578704|NCT03036293|75684244|FG001|NOT COMPLETED|Overall Study||3||
59578705|NCT03036293|75684245|FG002|NOT COMPLETED|Overall Study||1||
59851202|NCT00810732|75975460|FG000|STARTED|Third Intervention Period (6 Weeks)||5||
59851203|NCT00810732|75975461|FG001|STARTED|Third Intervention Period (6 Weeks)||4||
59851204|NCT00810732|75975462|FG002|STARTED|Third Intervention Period (6 Weeks)||4||
59851205|NCT00810732|75975463|FG003|STARTED|Third Intervention Period (6 Weeks)||5||
59851206|NCT00810732|75975464|FG004|STARTED|Third Intervention Period (6 Weeks)||5||
59851207|NCT00810732|75975465|FG005|STARTED|Third Intervention Period (6 Weeks)||4||
59851208|NCT00810732|75975460|FG000|COMPLETED|Third Intervention Period (6 Weeks)||5||
59851209|NCT00810732|75975461|FG001|COMPLETED|Third Intervention Period (6 Weeks)||4||
59851210|NCT00810732|75975462|FG002|COMPLETED|Third Intervention Period (6 Weeks)||4||
59851211|NCT00810732|75975463|FG003|COMPLETED|Third Intervention Period (6 Weeks)||5||
59578706|NCT03036293|75684246|FG003|NOT COMPLETED|Overall Study||1||
59851212|NCT00810732|75975464|FG004|COMPLETED|Third Intervention Period (6 Weeks)||5||
59851213|NCT00810732|75975465|FG005|COMPLETED|Third Intervention Period (6 Weeks)||4||
59723907|NCT01125293|75842517|FG003|Evaluable for Phase I Dose-Limiting Toxicity|Overall Study||3||
59851214|NCT00810732|75975460|FG000|NOT COMPLETED|Third Intervention Period (6 Weeks)||0||
59851215|NCT00810732|75975461|FG001|NOT COMPLETED|Third Intervention Period (6 Weeks)||0||
59851216|NCT00810732|75975462|FG002|NOT COMPLETED|Third Intervention Period (6 Weeks)||0||
59851217|NCT00810732|75975463|FG003|NOT COMPLETED|Third Intervention Period (6 Weeks)||0||
59851218|NCT00810732|75975464|FG004|NOT COMPLETED|Third Intervention Period (6 Weeks)||0||
59851219|NCT00810732|75975465|FG005|NOT COMPLETED|Third Intervention Period (6 Weeks)||0||
59851220|NCT00571727|75975473|FG000|STARTED|Overall Study||92||
59851221|NCT00571727|75975473|FG000|COMPLETED|Overall Study||26||
59851222|NCT00571727|75975473|FG000|NOT COMPLETED|Overall Study||66||
59851223|NCT00427349|75975477|FG000|STARTED|Overall Study||46||
59851224|NCT00427349|75975477|FG000|Eligible|Overall Study||45||
59851225|NCT00427349|75975477|FG000|Treated|Overall Study||45||
59851226|NCT00427349|75975477|FG000|Eligible and Treated|Overall Study||44||
59851227|NCT00427349|75975477|FG000|COMPLETED|Overall Study|Treatment continued until disease progression or intolerable toxicity|0||
59851228|NCT00427349|75975477|FG000|NOT COMPLETED|Overall Study||46||
59851229|NCT00309985|75975483|FG000|STARTED|Overall Study||397||
59851230|NCT00309985|75975484|FG001|STARTED|Overall Study||393||
59851231|NCT00309985|75975483|FG000|Toxicity Analysis|Overall Study||390||
59851232|NCT00309985|75975484|FG001|Toxicity Analysis|Overall Study||392||
59851233|NCT00309985|75975483|FG000|Both Baseline and 3-month FACT-P Evals|Overall Study||334||
59851234|NCT00309985|75975484|FG001|Both Baseline and 3-month FACT-P Evals|Overall Study||299||
59851235|NCT00309985|75975483|FG000|COMPLETED|Overall Study||335||
59851236|NCT00309985|75975484|FG001|COMPLETED|Overall Study|"Arm B tx info was not collected so only 1 patient w/o follow-up data was considered not completed."|392||
59851237|NCT00309985|75975483|FG000|NOT COMPLETED|Overall Study||62||
59851238|NCT00309985|75975484|FG001|NOT COMPLETED|Overall Study||1||
59851239|NCT00098787|75975493|FG000|STARTED|Overall Study||73||
59851240|NCT00098787|75975494|FG001|STARTED|Overall Study||75||
59851241|NCT00098787|75975495|FG002|STARTED|Overall Study||63||
59851242|NCT00098787|75975493|FG000|Treated|Overall Study||70||
59851243|NCT00098787|75975494|FG001|Treated|Overall Study||73||
59851244|NCT00098787|75975495|FG002|Treated|Overall Study||62||
59851245|NCT00098787|75975493|FG000|Eligible and Treated|Overall Study||61||
59851246|NCT00098787|75975494|FG001|Eligible and Treated|Overall Study||66||
59851247|NCT00098787|75975495|FG002|Eligible and Treated|Overall Study||59||
59851248|NCT00098787|75975493|FG000|COMPLETED|Overall Study||0||
59851249|NCT00098787|75975494|FG001|COMPLETED|Overall Study||0||
59851250|NCT00098787|75975495|FG002|COMPLETED|Overall Study||0||
59851251|NCT00098787|75975493|FG000|NOT COMPLETED|Overall Study||73||
59851252|NCT00098787|75975494|FG001|NOT COMPLETED|Overall Study||75||
59851253|NCT00098787|75975495|FG002|NOT COMPLETED|Overall Study||63||
59851254|NCT00091169|75975505|FG000|STARTED|Overall Study||189||
59851255|NCT00091169|75975506|FG001|STARTED|Overall Study||187||
59851256|NCT00091169|75975505|FG000|Treated|Overall Study||163||
59723908|NCT01125293|75842518|FG004|Evaluable for Phase I Dose-Limiting Toxicity|Overall Study|The Phase I dose expansion cohort was not evaluated for cycle 1 dose-limiting toxicity.|0||
59723909|NCT01125293|75842519|FG005|Evaluable for Phase I Dose-Limiting Toxicity|Overall Study|The Phase II cohort was not evaluated for cycle 1 dose-limiting toxicity.|0||
59723910|NCT01125293|75842514|FG000|COMPLETED|Overall Study||0|Since treatment was not of fixed duration, all participants were considered as 'Not Completed' and reason off-treatment is provided.|
59723911|NCT01125293|75842515|FG001|COMPLETED|Overall Study||0|Since treatment was not of fixed duration, all participants were considered as 'Not Completed' and reason off-treatment is provided.|
59723912|NCT01125293|75842516|FG002|COMPLETED|Overall Study||0|Since treatment was not of fixed duration, all participants were considered as 'Not Completed' and reason off-treatment is provided.|
59723913|NCT01125293|75842517|FG003|COMPLETED|Overall Study||0|Since treatment was not of fixed duration, all participants were considered as 'Not Completed' and reason off-treatment is provided.|
59723914|NCT01125293|75842518|FG004|COMPLETED|Overall Study||0|Since treatment was not of fixed duration, all participants were considered as 'Not Completed' and reason off-treatment is provided.|
59851257|NCT00091169|75975506|FG001|Treated|Overall Study||170||
59851258|NCT00091169|75975505|FG000|COMPLETED|Overall Study||132||
59851259|NCT00091169|75975506|FG001|COMPLETED|Overall Study||134||
59851260|NCT00091169|75975505|FG000|NOT COMPLETED|Overall Study||57||
59851261|NCT00091169|75975506|FG001|NOT COMPLETED|Overall Study||53||
59851262|NCT00075946|75975518|FG000|STARTED|Overall Study||148||
59851263|NCT00075946|75975519|FG001|STARTED|Overall Study||151||
59851264|NCT00075946|75975520|FG002|STARTED|Overall Study||28||
59851265|NCT00075946|75975521|FG003|STARTED|Overall Study||30||
59851266|NCT00075946|75975522|FG004|STARTED|Overall Study||188||
59851267|NCT00075946|75975518|FG000|Treated and With Toxicity Data Available|Overall Study||142||
59851268|NCT00075946|75975519|FG001|Treated and With Toxicity Data Available|Overall Study||148||
59851269|NCT00075946|75975520|FG002|Treated and With Toxicity Data Available|Overall Study||27||
59851270|NCT00075946|75975521|FG003|Treated and With Toxicity Data Available|Overall Study||29||
59851271|NCT00075946|75975522|FG004|Treated and With Toxicity Data Available|Overall Study||154||
59851272|NCT00075946|75975518|FG000|Included in Primary Analysis|Overall Study||143||
59851273|NCT00075946|75975519|FG001|Included in Primary Analysis|Overall Study||146||
59851274|NCT00075946|75975520|FG002|Included in Primary Analysis|Overall Study||23||
59851275|NCT00075946|75975521|FG003|Included in Primary Analysis|Overall Study||29||
59851276|NCT00075946|75975522|FG004|Included in Primary Analysis|Overall Study||0||
59851277|NCT00075946|75975518|FG000|COMPLETED|Overall Study||0||
59851278|NCT00075946|75975519|FG001|COMPLETED|Overall Study||0||
59851279|NCT00075946|75975520|FG002|COMPLETED|Overall Study||0||
59851280|NCT00075946|75975521|FG003|COMPLETED|Overall Study||0||
59851281|NCT00075946|75975522|FG004|COMPLETED|Overall Study||0||
59851282|NCT00075946|75975518|FG000|NOT COMPLETED|Overall Study||148||
59851283|NCT00075946|75975519|FG001|NOT COMPLETED|Overall Study||151||
59851284|NCT00075946|75975520|FG002|NOT COMPLETED|Overall Study||28||
59851285|NCT00075946|75975521|FG003|NOT COMPLETED|Overall Study||30||
59851286|NCT00075946|75975522|FG004|NOT COMPLETED|Overall Study||188||
59851287|NCT00074165|75975533|FG000|STARTED|Overall Study||17||
59851288|NCT00074165|75975533|FG000|COMPLETED|Overall Study||17||
59851289|NCT00074165|75975533|FG000|NOT COMPLETED|Overall Study||0||
59851290|NCT00057876|75975539|FG000|STARTED|Overall Study||38||
59851291|NCT00057876|75975540|FG001|STARTED|Overall Study||36||
59851292|NCT00057876|75975539|FG000|Eligible|Overall Study||37||
59851293|NCT00057876|75975540|FG001|Eligible|Overall Study||34||
59851294|NCT00057876|75975539|FG000|Began Protocol Therapy|Overall Study||35||
59851295|NCT00057876|75975540|FG001|Began Protocol Therapy|Overall Study||34||
59851296|NCT00057876|75975539|FG000|Eligible and Treated|Overall Study||34||
59851297|NCT00057876|75975540|FG001|Eligible and Treated|Overall Study||34||
59851298|NCT00057876|75975539|FG000|COMPLETED|Overall Study||9||
59851299|NCT00057876|75975540|FG001|COMPLETED|Overall Study||9||
59851300|NCT00057876|75975539|FG000|NOT COMPLETED|Overall Study||29||
59851301|NCT00057876|75975540|FG001|NOT COMPLETED|Overall Study||27||
59851302|NCT00057837|75975548|FG000|STARTED|Overall Study||70||
59851303|NCT00057837|75975549|FG001|STARTED|Overall Study||70||
59851304|NCT00057837|75975548|FG000|Treated|Overall Study||69||
59851305|NCT00057837|75975549|FG001|Treated|Overall Study||68||
59851306|NCT00057837|75975548|FG000|Eligible and Treated|Overall Study||66||
59851307|NCT00057837|75975549|FG001|Eligible and Treated|Overall Study||66||
59851308|NCT00057837|75975548|FG000|Patients With Response|Overall Study||46||
59851309|NCT00057837|75975549|FG001|Patients With Response|Overall Study||38||
59851310|NCT00057837|75975548|FG000|COMPLETED|Overall Study||39||
59851311|NCT00057837|75975549|FG001|COMPLETED|Overall Study||31||
59851312|NCT00057837|75975548|FG000|NOT COMPLETED|Overall Study||31||
59851313|NCT00057837|75975549|FG001|NOT COMPLETED|Overall Study||39||
59851314|NCT00046930|75975557|FG000|STARTED|Overall Study||224||
59851315|NCT00046930|75975558|FG001|STARTED|Overall Study||225||
59851316|NCT00046930|75975557|FG000|COMPLETED|Overall Study||212||
59851317|NCT00046930|75975558|FG001|COMPLETED|Overall Study||221||
59851318|NCT00046930|75975557|FG000|NOT COMPLETED|Overall Study||12||
59851319|NCT00046930|75975558|FG001|NOT COMPLETED|Overall Study||4||
60121435|NCT02675764|76242373|FG000|COMPLETED|Overall Study||6||
59723915|NCT01125293|75842519|FG005|COMPLETED|Overall Study||0|Since treatment was not of fixed duration, all participants were considered as 'Not Completed' and reason off-treatment is provided.|
59723916|NCT01125293|75842514|FG000|NOT COMPLETED|Overall Study||3||
59723917|NCT01125293|75842515|FG001|NOT COMPLETED|Overall Study||3||
59723918|NCT01125293|75842516|FG002|NOT COMPLETED|Overall Study||4||
59723919|NCT01125293|75842517|FG003|NOT COMPLETED|Overall Study||3||
59723920|NCT01125293|75842518|FG004|NOT COMPLETED|Overall Study||10||
59723921|NCT01125293|75842519|FG005|NOT COMPLETED|Overall Study||23||
59851320|NCT00042939|75975569|FG000|STARTED|Overall Study||48||
59851321|NCT00042939|75975570|FG001|STARTED|Overall Study||46||
59851322|NCT00042939|75975569|FG000|Treated|Overall Study||46||
59851323|NCT00042939|75975570|FG001|Treated|Overall Study||45||
59851324|NCT00042939|75975569|FG000|Eligible and Began Protocol Therapy|Overall Study||44||
59851325|NCT00042939|75975570|FG001|Eligible and Began Protocol Therapy|Overall Study||43||
59851326|NCT00042939|75975569|FG000|Patients With EGFR Results Available|Overall Study||30||
59851327|NCT00042939|75975570|FG001|Patients With EGFR Results Available|Overall Study||31||
59851328|NCT00042939|75975569|FG000|COMPLETED|Overall Study||24||
59851329|NCT00042939|75975570|FG001|COMPLETED|Overall Study||25||
59851330|NCT00042939|75975569|FG000|NOT COMPLETED|Overall Study||24||
59723922|NCT01121393|75842538|FG000|STARTED|Overall Study|Randomised|242||
59723923|NCT01121393|75842539|FG001|STARTED|Overall Study|Randomised|122||
59723924|NCT01121393|75842538|FG000|Treated|Overall Study|Treated|239||
59723925|NCT01121393|75842539|FG001|Treated|Overall Study|Treated|113||
59723926|NCT01121393|75842538|FG000|COMPLETED|Overall Study|At the time of data cut-off for last-patient out (07 December 2017)|0||
59723927|NCT01121393|75842539|FG001|COMPLETED|Overall Study|Completed 6 courses of chemotherapy|38||
59851331|NCT00042939|75975570|FG001|NOT COMPLETED|Overall Study||21||
59851332|NCT00008385|75975578|FG000|STARTED|Overall Study||521||
59851333|NCT00008385|75975579|FG001|STARTED|Overall Study||1040||
59851334|NCT00008385|75975578|FG000|Treated|Overall Study||477||
59851335|NCT00008385|75975579|FG001|Treated|Overall Study||865||
59851336|NCT00008385|75975578|FG000|Off Treatment Reasons Reported|Overall Study||398||
59851337|NCT00008385|75975579|FG001|Off Treatment Reasons Reported|Overall Study||795||
59851338|NCT00008385|75975578|FG000|COMPLETED|Overall Study||134||
59851339|NCT00008385|75975579|FG001|COMPLETED|Overall Study||238||
59851340|NCT00008385|75975578|FG000|NOT COMPLETED|Overall Study||387||
59851341|NCT00008385|75975579|FG001|NOT COMPLETED|Overall Study||802||
59851342|NCT00003910|75975585|FG000|STARTED|Step 1|Of 59 (step 1), 4 pts were ineligible.|55||
59851343|NCT00003910|75975586|FG001|STARTED|Step 1||0||
59851344|NCT00003910|75975585|FG000|COMPLETED|Step 1||55||
59851345|NCT00003910|75975586|FG001|COMPLETED|Step 1||0||
59851346|NCT00003910|75975585|FG000|NOT COMPLETED|Step 1||0||
59851347|NCT00003910|75975586|FG001|NOT COMPLETED|Step 1||0||
59851348|NCT00003910|75975585|FG000|STARTED|Step 2||0||
59851349|NCT00003910|75975586|FG001|STARTED|Step 2|The 16 includes 2 ineligible pts.|16||
59851350|NCT00003910|75975585|FG000|COMPLETED|Step 2||0||
59851351|NCT00003910|75975586|FG001|COMPLETED|Step 2||16||
59851352|NCT00003910|75975585|FG000|NOT COMPLETED|Step 2||0||
59851353|NCT00003910|75975586|FG001|NOT COMPLETED|Step 2||0||
59851354|NCT00003907|75975594|FG000|STARTED|Overall Study||19||
59851355|NCT00003907|75975595|FG001|STARTED|Overall Study||31||
59851356|NCT00003907|75975594|FG000|Eligible|Overall Study||18||
59851357|NCT00003907|75975595|FG001|Eligible|Overall Study||29||
59851358|NCT00003907|75975594|FG000|Received Protocol Therapy (Treated)|Overall Study||18||
59851359|NCT00003907|75975595|FG001|Received Protocol Therapy (Treated)|Overall Study||31||
59851360|NCT00003907|75975594|FG000|Eligible and Treated|Overall Study||17||
59851361|NCT00003907|75975595|FG001|Eligible and Treated|Overall Study||29||
59851362|NCT00003907|75975594|FG000|COMPLETED|Overall Study||6||
59851363|NCT00003907|75975595|FG001|COMPLETED|Overall Study||8||
59851364|NCT00003907|75975594|FG000|NOT COMPLETED|Overall Study||13||
59851365|NCT00003907|75975595|FG001|NOT COMPLETED|Overall Study||23||
59851366|NCT04241315|75975603|FG000|STARTED|Overall Study||100||
59851367|NCT04241315|75975604|FG001|STARTED|Overall Study||12||
59851368|NCT04241315|75975603|FG000|COMPLETED|Overall Study||100||
59578707|NCT02408198|75684256|FG000|STARTED|Overall Study||13||
59578708|NCT02408198|75684257|FG001|STARTED|Overall Study||5||
59578709|NCT02408198|75684256|FG000|COMPLETED|Overall Study||10||
59578710|NCT02408198|75684257|FG001|COMPLETED|Overall Study||5||
59578711|NCT02408198|75684256|FG000|NOT COMPLETED|Overall Study||3||
59578712|NCT02408198|75684257|FG001|NOT COMPLETED|Overall Study||0||
59578713|NCT02040116|75684263|FG000|STARTED|Overall Study||19||
59578714|NCT02040116|75684263|FG000|COMPLETED|Overall Study||19||
59578715|NCT02040116|75684263|FG000|NOT COMPLETED|Overall Study||0||
59578716|NCT03037541|75684273|FG000|STARTED|Overall Study||30||
59578717|NCT03037541|75684274|FG001|STARTED|Overall Study||30||
59578718|NCT03037541|75684273|FG000|COMPLETED|Overall Study||30||
59578719|NCT03037541|75684274|FG001|COMPLETED|Overall Study||30||
59578720|NCT03037541|75684273|FG000|NOT COMPLETED|Overall Study||0||
59578721|NCT03037541|75684274|FG001|NOT COMPLETED|Overall Study||0||
59578722|NCT02360774|75684282|FG000|STARTED|Overall Study||15||
59578723|NCT02360774|75684283|FG001|STARTED|Overall Study||15||
59578724|NCT02360774|75684282|FG000|COMPLETED|Overall Study||12||
59578725|NCT02360774|75684283|FG001|COMPLETED|Overall Study||13||
59578726|NCT02360774|75684282|FG000|NOT COMPLETED|Overall Study||3||
59578727|NCT02360774|75684283|FG001|NOT COMPLETED|Overall Study||2||
59578728|NCT02361476|75684293|FG000|STARTED|Overall Study||191||
59851369|NCT04241315|75975604|FG001|COMPLETED|Overall Study||11||
59851370|NCT04241315|75975603|FG000|NOT COMPLETED|Overall Study||0||
59851371|NCT04241315|75975604|FG001|NOT COMPLETED|Overall Study||1||
59851372|NCT04225026|75975610|FG000|STARTED|Overall Study||39|Safety analysis Population: This population included all subjects who received at least 1 dose of study medication.|
59851373|NCT04225026|75975610|FG000|Primary Efficacy Population|Overall Study|The Primary Efficacy Population includes all subjects who received at least one dose of GC4419 and either a.)completed their radiation therapy course of treatment or b.)discontinued their radiation therapy course of treatment but are known to have had acute radiation esophagitis.|35||
59851374|NCT04225026|75975610|FG000|Per Protocol Population|Overall Study||29|The Per Protocol Population included those subjects that completed chemoradiotherapy and at least 5 weeks of GC4419|
59851375|NCT04225026|75975610|FG000|COMPLETED|Overall Study||15||
59851376|NCT04225026|75975610|FG000|NOT COMPLETED|Overall Study||24||
59851377|NCT03927703|75975617|FG000|STARTED|Overall Study||237||
59851378|NCT03927703|75975618|FG001|STARTED|Overall Study||118||
59851379|NCT03927703|75975617|FG000|COMPLETED|Overall Study||192||
59851380|NCT03927703|75975618|FG001|COMPLETED|Overall Study||102||
59851381|NCT03927703|75975617|FG000|NOT COMPLETED|Overall Study||45||
59578729|NCT02361476|75684294|FG001|STARTED|Overall Study||188||
59578730|NCT02361476|75684293|FG000|COMPLETED|Overall Study||191||
59578731|NCT02361476|75684294|FG001|COMPLETED|Overall Study||188||
59578732|NCT02361476|75684293|FG000|NOT COMPLETED|Overall Study||0||
59578733|NCT02361476|75684294|FG001|NOT COMPLETED|Overall Study||0||
59578734|NCT02363270|75684302|FG000|STARTED|Overall Study||24||
59851382|NCT03927703|75975618|FG001|NOT COMPLETED|Overall Study||16||
59851383|NCT03918499|75975626|FG000|STARTED|Overall Study||9||
59851384|NCT03918499|75975626|FG000|COMPLETED|Overall Study||9||
59851385|NCT03918499|75975626|FG000|NOT COMPLETED|Overall Study||0||
59851386|NCT03868735|75975632|FG000|STARTED|Overall Study||136||
59996740|NCT04445051|76112593|FG005|STARTED|Overall Study||5||
59578735|NCT02363270|75684303|FG001|STARTED|Overall Study||24||
59578736|NCT02363270|75684302|FG000|COMPLETED|Overall Study||24||
59578737|NCT02363270|75684303|FG001|COMPLETED|Overall Study||24||
59578738|NCT02363270|75684302|FG000|NOT COMPLETED|Overall Study||0||
59851387|NCT03868735|75975633|FG001|STARTED|Overall Study||136||
59578739|NCT02363270|75684303|FG001|NOT COMPLETED|Overall Study||0||
59578740|NCT02042534|75684311|FG000|STARTED|Overall Study||101||
59578741|NCT02042534|75684312|FG001|STARTED|Overall Study||94||
59578742|NCT02042534|75684311|FG000|COMPLETED|Overall Study||101||
59578743|NCT02042534|75684312|FG001|COMPLETED|Overall Study||94||
59578744|NCT02042534|75684311|FG000|NOT COMPLETED|Overall Study||0||
59578745|NCT02042534|75684312|FG001|NOT COMPLETED|Overall Study||0||
59578746|NCT02409914|75684318|FG000|STARTED|Overall Study||7||
59578747|NCT02409914|75684318|FG000|COMPLETED|Overall Study||7||
59578748|NCT02409914|75684318|FG000|NOT COMPLETED|Overall Study||0||
59578749|NCT03038399|75684326|FG000|STARTED|Overall Study||11||
59578750|NCT03038399|75684327|FG001|STARTED|Overall Study||12||
59578751|NCT03038399|75684328|FG002|STARTED|Overall Study||12||
59578752|NCT03038399|75684329|FG003|STARTED|Overall Study||11||
59578753|NCT03038399|75684326|FG000|COMPLETED|Overall Study||10||
59578754|NCT03038399|75684327|FG001|COMPLETED|Overall Study||11||
59578755|NCT03038399|75684328|FG002|COMPLETED|Overall Study||11||
59578756|NCT03038399|75684329|FG003|COMPLETED|Overall Study|Subjects escalated from lower dose groups|9||
59578757|NCT03038399|75684326|FG000|NOT COMPLETED|Overall Study||1||
59578758|NCT03038399|75684327|FG001|NOT COMPLETED|Overall Study||1||
59578759|NCT03038399|75684328|FG002|NOT COMPLETED|Overall Study||1||
59578760|NCT03038399|75684329|FG003|NOT COMPLETED|Overall Study||2||
59578761|NCT02043704|75684343|FG000|STARTED|Overall Study||50||
59578762|NCT02043704|75684344|FG001|STARTED|Overall Study||50||
59578763|NCT02043704|75684343|FG000|COMPLETED|Overall Study||47||
59578764|NCT02043704|75684344|FG001|COMPLETED|Overall Study||43||
59578765|NCT02043704|75684343|FG000|NOT COMPLETED|Overall Study||3||
59578766|NCT02043704|75684344|FG001|NOT COMPLETED|Overall Study||7||
59578767|NCT03117569|75684352|FG000|STARTED|Overall Study||127||
59578768|NCT03117569|75684353|FG001|STARTED|Overall Study||253||
59578769|NCT03117569|75684352|FG000|COMPLETED|Overall Study||123||
59578770|NCT03117569|75684353|FG001|COMPLETED|Overall Study||241||
59578771|NCT03117569|75684352|FG000|NOT COMPLETED|Overall Study||4||
59578772|NCT03117569|75684353|FG001|NOT COMPLETED|Overall Study||12||
59578773|NCT02363972|75684363|FG000|STARTED|Overall Study||103||
59578774|NCT02363972|75684363|FG000|COMPLETED|Overall Study||77||
59578775|NCT02363972|75684363|FG000|NOT COMPLETED|Overall Study||26||
59578776|NCT02963597|75684369|FG000|STARTED|Overall Study||10||
59578777|NCT02963597|75684370|FG001|STARTED|Overall Study||11||
59578778|NCT02963597|75684369|FG000|COMPLETED|Overall Study||10||
59578779|NCT02963597|75684370|FG001|COMPLETED|Overall Study||11||
59578780|NCT02963597|75684369|FG000|NOT COMPLETED|Overall Study||0||
59578781|NCT02963597|75684370|FG001|NOT COMPLETED|Overall Study||0||
59578782|NCT02410382|75684378|FG000|STARTED|Overall Study||0||
59578783|NCT02410382|75684379|FG001|STARTED|Overall Study||0||
59578784|NCT02410382|75684378|FG000|COMPLETED|Overall Study|Study was terminated by IRB - attempts made to obtain info were unsuccessful.|0||
59578785|NCT02410382|75684379|FG001|COMPLETED|Overall Study||0||
59578786|NCT02410382|75684378|FG000|NOT COMPLETED|Overall Study||0||
59578787|NCT02410382|75684379|FG001|NOT COMPLETED|Overall Study||0||
59578788|NCT03038867|75684387|FG000|STARTED|Overall Study||37||
59578789|NCT03038867|75684388|FG001|STARTED|Overall Study||32||
59578790|NCT03038867|75684387|FG000|COMPLETED|Overall Study||37||
59578791|NCT03038867|75684388|FG001|COMPLETED|Overall Study||32||
59578792|NCT03038867|75684387|FG000|NOT COMPLETED|Overall Study||0||
59578793|NCT03038867|75684388|FG001|NOT COMPLETED|Overall Study||0||
59578794|NCT03039179|75684396|FG000|STARTED|Overall Study||38||
59578795|NCT03039179|75684397|FG001|STARTED|Overall Study||42||
59578796|NCT03039179|75684396|FG000|COMPLETED|Overall Study||38||
59578797|NCT03039179|75684397|FG001|COMPLETED|Overall Study||42||
59578798|NCT03039179|75684396|FG000|NOT COMPLETED|Overall Study||0||
59578799|NCT03039179|75684397|FG001|NOT COMPLETED|Overall Study||0||
59578800|NCT02963987|75684403|FG000|STARTED|First Intervention Period||31||
59578801|NCT02963987|75684404|FG001|STARTED|First Intervention Period||19||
59578802|NCT02963987|75684403|FG000|COMPLETED|First Intervention Period||31||
59578803|NCT02963987|75684404|FG001|COMPLETED|First Intervention Period||19||
59578804|NCT02963987|75684403|FG000|NOT COMPLETED|First Intervention Period||0||
59578805|NCT02963987|75684404|FG001|NOT COMPLETED|First Intervention Period||0||
59578806|NCT02963987|75684403|FG000|STARTED|Second Intervention Period||31||
59578807|NCT02963987|75684404|FG001|STARTED|Second Intervention Period||19||
59578808|NCT02963987|75684403|FG000|COMPLETED|Second Intervention Period||31||
59578809|NCT02963987|75684404|FG001|COMPLETED|Second Intervention Period||19||
59578810|NCT02963987|75684403|FG000|NOT COMPLETED|Second Intervention Period||0||
59578811|NCT02963987|75684404|FG001|NOT COMPLETED|Second Intervention Period||0||
59578812|NCT02964767|75684414|FG000|STARTED|Overall Study||171||
59578813|NCT02964767|75684415|FG001|STARTED|Overall Study||48||
59578814|NCT02964767|75684414|FG000|COMPLETED|Overall Study||171||
59578815|NCT02964767|75684415|FG001|COMPLETED|Overall Study||48||
59578816|NCT02964767|75684414|FG000|NOT COMPLETED|Overall Study||0||
59578817|NCT02964767|75684415|FG001|NOT COMPLETED|Overall Study||0||
59578818|NCT03040427|75684425|FG000|STARTED|Overall Study||2||
59578819|NCT03040427|75684426|FG001|STARTED|Overall Study||6||
59578820|NCT03040427|75684427|FG002|STARTED|Overall Study||4||
59578821|NCT03040427|75684425|FG000|COMPLETED|Overall Study||2||
59578822|NCT03040427|75684426|FG001|COMPLETED|Overall Study||6||
59578823|NCT03040427|75684427|FG002|COMPLETED|Overall Study||4||
59578824|NCT03040427|75684425|FG000|NOT COMPLETED|Overall Study||0||
59578825|NCT03040427|75684426|FG001|NOT COMPLETED|Overall Study||0||
59578826|NCT03040427|75684427|FG002|NOT COMPLETED|Overall Study||0||
59578827|NCT03119831|75684438|FG000|STARTED|Overall Study||14||
59723928|NCT01121393|75842538|FG000|NOT COMPLETED|Overall Study||242||
59723929|NCT01121393|75842539|FG001|NOT COMPLETED|Overall Study||84||
59723930|NCT01227616|75842553|FG000|STARTED|Overall Study||196||
59723931|NCT01227616|75842554|FG001|STARTED|Overall Study||97||
59723932|NCT01227616|75842553|FG000|COMPLETED|Overall Study||142||
59723933|NCT01227616|75842554|FG001|COMPLETED|Overall Study||74||
59723934|NCT01227616|75842553|FG000|NOT COMPLETED|Overall Study||54||
59723935|NCT01227616|75842554|FG001|NOT COMPLETED|Overall Study||23||
59723936|NCT00643864|75842560|FG000|STARTED|Pre-test Assessment||3||
59723937|NCT00643864|75842560|FG000|COMPLETED|Pre-test Assessment||3||
59723938|NCT00643864|75842560|FG000|NOT COMPLETED|Pre-test Assessment||0||
59723939|NCT00643864|75842560|FG000|STARTED|Post-test Assessment||3||
59723940|NCT00643864|75842560|FG000|COMPLETED|Post-test Assessment||3||
59723941|NCT00643864|75842560|FG000|NOT COMPLETED|Post-test Assessment||0||
59723942|NCT02710396|75842568|FG000|STARTED|Overall Study||14||
59723943|NCT02710396|75842569|FG001|STARTED|Overall Study||5||
59723944|NCT02710396|75842570|FG002|STARTED|Overall Study||0||
59723945|NCT02710396|75842568|FG000|COMPLETED|Overall Study||14||
59723946|NCT02710396|75842569|FG001|COMPLETED|Overall Study||5||
59723947|NCT02710396|75842570|FG002|COMPLETED|Overall Study||0||
59723948|NCT02710396|75842568|FG000|NOT COMPLETED|Overall Study||0||
59723949|NCT02710396|75842569|FG001|NOT COMPLETED|Overall Study||0||
59723950|NCT02710396|75842570|FG002|NOT COMPLETED|Overall Study||0||
59723951|NCT00937521|75842586|FG000|STARTED|Overall Study - Prior to Booster Dose||188||
59723952|NCT00937521|75842587|FG001|STARTED|Overall Study - Prior to Booster Dose||190||
59723953|NCT00937521|75842588|FG002|STARTED|Overall Study - Prior to Booster Dose||192||
59723954|NCT00937521|75842589|FG003|STARTED|Overall Study - Prior to Booster Dose||188||
59723955|NCT00937521|75842590|FG004|STARTED|Overall Study - Prior to Booster Dose||191||
59723956|NCT00937521|75842591|FG005|STARTED|Overall Study - Prior to Booster Dose||188||
59723957|NCT00937521|75842592|FG006|STARTED|Overall Study - Prior to Booster Dose||186||
59723958|NCT00937521|75842593|FG007|STARTED|Overall Study - Prior to Booster Dose||184||
59723959|NCT00937521|75842586|FG000|Premature Withdrawal|Overall Study - Prior to Booster Dose||3||
59723960|NCT00937521|75842587|FG001|Premature Withdrawal|Overall Study - Prior to Booster Dose||5||
59723961|NCT00937521|75842588|FG002|Premature Withdrawal|Overall Study - Prior to Booster Dose||6||
59723962|NCT00937521|75842589|FG003|Premature Withdrawal|Overall Study - Prior to Booster Dose||1||
59723963|NCT00937521|75842590|FG004|Premature Withdrawal|Overall Study - Prior to Booster Dose||3||
59723964|NCT00937521|75842591|FG005|Premature Withdrawal|Overall Study - Prior to Booster Dose||1||
59723965|NCT00937521|75842592|FG006|Premature Withdrawal|Overall Study - Prior to Booster Dose||5||
59723966|NCT00937521|75842593|FG007|Premature Withdrawal|Overall Study - Prior to Booster Dose||1||
59723967|NCT00937521|75842586|FG000|COMPLETED|Overall Study - Prior to Booster Dose||185||
59723968|NCT00937521|75842587|FG001|COMPLETED|Overall Study - Prior to Booster Dose||185||
59723969|NCT00937521|75842588|FG002|COMPLETED|Overall Study - Prior to Booster Dose||186||
59723970|NCT00937521|75842589|FG003|COMPLETED|Overall Study - Prior to Booster Dose||187||
59723971|NCT00937521|75842590|FG004|COMPLETED|Overall Study - Prior to Booster Dose||188||
59723972|NCT00937521|75842591|FG005|COMPLETED|Overall Study - Prior to Booster Dose||187||
59723973|NCT00937521|75842592|FG006|COMPLETED|Overall Study - Prior to Booster Dose||181||
59723974|NCT00937521|75842593|FG007|COMPLETED|Overall Study - Prior to Booster Dose||183||
59723975|NCT00937521|75842586|FG000|NOT COMPLETED|Overall Study - Prior to Booster Dose||3||
59723976|NCT00937521|75842587|FG001|NOT COMPLETED|Overall Study - Prior to Booster Dose||5||
59723977|NCT00937521|75842588|FG002|NOT COMPLETED|Overall Study - Prior to Booster Dose||6||
59723978|NCT00937521|75842589|FG003|NOT COMPLETED|Overall Study - Prior to Booster Dose||1||
59723979|NCT00937521|75842590|FG004|NOT COMPLETED|Overall Study - Prior to Booster Dose||3||
59578828|NCT03119831|75684439|FG001|STARTED|Overall Study||14||
59578829|NCT03119831|75684440|FG002|STARTED|Overall Study||14||
59578830|NCT03119831|75684438|FG000|COMPLETED|Overall Study||14||
59578831|NCT03119831|75684439|FG001|COMPLETED|Overall Study||14||
59578832|NCT03119831|75684440|FG002|COMPLETED|Overall Study||14||
59578833|NCT03119831|75684438|FG000|NOT COMPLETED|Overall Study||0||
59578834|NCT03119831|75684439|FG001|NOT COMPLETED|Overall Study||0||
59578835|NCT03119831|75684440|FG002|NOT COMPLETED|Overall Study||0||
59578836|NCT02965781|75684454|FG000|STARTED|Overall Study||46||
59578837|NCT02965781|75684455|FG001|STARTED|Overall Study||46||
59578838|NCT02965781|75684456|FG002|STARTED|Overall Study||47||
59578839|NCT02965781|75684454|FG000|COMPLETED|Overall Study||46||
59723980|NCT00937521|75842591|FG005|NOT COMPLETED|Overall Study - Prior to Booster Dose||1||
59723981|NCT00937521|75842592|FG006|NOT COMPLETED|Overall Study - Prior to Booster Dose||5||
59723982|NCT00937521|75842593|FG007|NOT COMPLETED|Overall Study - Prior to Booster Dose||1||
59578840|NCT02965781|75684455|FG001|COMPLETED|Overall Study||46||
59578841|NCT02965781|75684456|FG002|COMPLETED|Overall Study||47||
59578842|NCT02965781|75684454|FG000|NOT COMPLETED|Overall Study||0||
59578843|NCT02965781|75684455|FG001|NOT COMPLETED|Overall Study||0||
59578844|NCT02965781|75684456|FG002|NOT COMPLETED|Overall Study||0||
59578845|NCT02968277|75684467|FG000|STARTED|Overall Study||10||
59578846|NCT02968277|75684468|FG001|STARTED|Overall Study||7||
59578847|NCT02968277|75684469|FG002|STARTED|Overall Study||13||
59578848|NCT02968277|75684467|FG000|COMPLETED|Overall Study||10||
59578849|NCT02968277|75684468|FG001|COMPLETED|Overall Study||7||
59578850|NCT02968277|75684469|FG002|COMPLETED|Overall Study||13||
59578851|NCT02968277|75684467|FG000|NOT COMPLETED|Overall Study||0||
59578852|NCT02968277|75684468|FG001|NOT COMPLETED|Overall Study||0||
59578853|NCT02968277|75684469|FG002|NOT COMPLETED|Overall Study||0||
59578854|NCT03123263|75684481|FG000|STARTED|Overall Study||60||
59578855|NCT03123263|75684481|FG000|COMPLETED|Overall Study||60||
59578856|NCT03123263|75684481|FG000|NOT COMPLETED|Overall Study||0||
59578857|NCT03124121|75684490|FG000|STARTED|Overall Study||42||
59578858|NCT03124121|75684491|FG001|STARTED|Overall Study||70||
59578859|NCT03124121|75684490|FG000|COMPLETED|Overall Study||39||
59578860|NCT03124121|75684491|FG001|COMPLETED|Overall Study||67||
59578861|NCT03124121|75684490|FG000|NOT COMPLETED|Overall Study||3||
59578862|NCT03124121|75684491|FG001|NOT COMPLETED|Overall Study||3||
59578863|NCT03041441|75684499|FG000|STARTED|Overall Study||5||
59578864|NCT03041441|75684499|FG000|COMPLETED|Overall Study||3||
59578865|NCT03041441|75684499|FG000|NOT COMPLETED|Overall Study||2||
59578866|NCT03041909|75684507|FG000|STARTED|Overall Study||3||
59578867|NCT03041909|75684508|FG001|STARTED|Overall Study||1||
59578868|NCT03041909|75684509|FG002|STARTED|Overall Study||1||
59578869|NCT03041909|75684507|FG000|COMPLETED|Overall Study||3||
59578870|NCT03041909|75684508|FG001|COMPLETED|Overall Study||1||
59578871|NCT03041909|75684509|FG002|COMPLETED|Overall Study||1||
59578872|NCT03041909|75684507|FG000|NOT COMPLETED|Overall Study||0||
59578873|NCT03041909|75684508|FG001|NOT COMPLETED|Overall Study||0||
59578874|NCT03041909|75684509|FG002|NOT COMPLETED|Overall Study||0||
59578875|NCT03042299|75684519|FG000|STARTED|Intervention Period 1 (6 Days)||7||
59578876|NCT03042299|75684520|FG001|STARTED|Intervention Period 1 (6 Days)||7||
59578877|NCT03042299|75684519|FG000|COMPLETED|Intervention Period 1 (6 Days)||7||
59578878|NCT03042299|75684520|FG001|COMPLETED|Intervention Period 1 (6 Days)||7||
59578879|NCT03042299|75684519|FG000|NOT COMPLETED|Intervention Period 1 (6 Days)||0||
59578880|NCT03042299|75684520|FG001|NOT COMPLETED|Intervention Period 1 (6 Days)||0||
59578881|NCT03042299|75684519|FG000|STARTED|Washout Period (at Least 6 Days)||7||
59578882|NCT03042299|75684520|FG001|STARTED|Washout Period (at Least 6 Days)||7||
59578883|NCT03042299|75684519|FG000|COMPLETED|Washout Period (at Least 6 Days)||7||
59578884|NCT03042299|75684520|FG001|COMPLETED|Washout Period (at Least 6 Days)||7||
59578885|NCT03042299|75684519|FG000|NOT COMPLETED|Washout Period (at Least 6 Days)||0||
59578886|NCT03042299|75684520|FG001|NOT COMPLETED|Washout Period (at Least 6 Days)||0||
59578887|NCT03042299|75684519|FG000|STARTED|Intervention Period 2 (6 Days)||7||
59578888|NCT03042299|75684520|FG001|STARTED|Intervention Period 2 (6 Days)||7||
59578889|NCT03042299|75684519|FG000|COMPLETED|Intervention Period 2 (6 Days)||7||
59578890|NCT03042299|75684520|FG001|COMPLETED|Intervention Period 2 (6 Days)||7||
59578891|NCT03042299|75684519|FG000|NOT COMPLETED|Intervention Period 2 (6 Days)||0||
59578892|NCT03042299|75684520|FG001|NOT COMPLETED|Intervention Period 2 (6 Days)||0||
59578893|NCT03043079|75684529|FG000|STARTED|Overall Study||21|We originally wanted 25 healthy/active volunteers. We divided that up into 15 healthy and 10 active.|
59578894|NCT03043079|75684530|FG001|STARTED|Overall Study||14|We originally wanted 25 healthy/active volunteers. We divided that up into 15 healthy and 10 active.|
59578895|NCT03043079|75684531|FG002|STARTED|Overall Study||10|We originally wanted 25 healthy/active volunteers. We divided that up into 15 healthy and 10 active.|
59578896|NCT03043079|75684529|FG000|COMPLETED|Overall Study||21||
59578897|NCT03043079|75684530|FG001|COMPLETED|Overall Study||14||
59578898|NCT03043079|75684531|FG002|COMPLETED|Overall Study||10||
59578899|NCT03043079|75684529|FG000|NOT COMPLETED|Overall Study||0||
59578900|NCT03043079|75684530|FG001|NOT COMPLETED|Overall Study||0||
59578901|NCT03043079|75684531|FG002|NOT COMPLETED|Overall Study||0||
59578902|NCT02971631|75684540|FG000|STARTED|First Intervention - One Day||3||
59578903|NCT02971631|75684541|FG001|STARTED|First Intervention - One Day||2||
59578904|NCT02971631|75684540|FG000|COMPLETED|First Intervention - One Day||3||
59578905|NCT02971631|75684541|FG001|COMPLETED|First Intervention - One Day||2||
59578906|NCT02971631|75684540|FG000|NOT COMPLETED|First Intervention - One Day||0||
59578907|NCT02971631|75684541|FG001|NOT COMPLETED|First Intervention - One Day||0||
59578908|NCT02971631|75684540|FG000|STARTED|Second Intervention - One Day||3||
59578909|NCT02971631|75684541|FG001|STARTED|Second Intervention - One Day||2||
59578910|NCT02971631|75684540|FG000|COMPLETED|Second Intervention - One Day||3||
59578911|NCT02971631|75684541|FG001|COMPLETED|Second Intervention - One Day||2||
59578912|NCT02971631|75684540|FG000|NOT COMPLETED|Second Intervention - One Day||0||
59578913|NCT02971631|75684541|FG001|NOT COMPLETED|Second Intervention - One Day||0||
59578914|NCT03045809|75684548|FG000|STARTED|Overall Study||705||
59578915|NCT03045809|75684548|FG000|Attended an Additional Visit (if Needed)|Overall Study|(only if needed, for medical follow-up, to complete study procedures, or to report adverse events).|51||
59578916|NCT03045809|75684548|FG000|COMPLETED|Overall Study||705||
59578917|NCT03045809|75684548|FG000|NOT COMPLETED|Overall Study||0||
59578918|NCT02044796|75684556|FG000|STARTED|Overall Study||9||
59578919|NCT02044796|75684557|FG001|STARTED|Overall Study||9||
59578920|NCT02044796|75684558|FG002|STARTED|Overall Study||9||
59578921|NCT02044796|75684559|FG003|STARTED|Overall Study||6||
59723983|NCT00937521|75842586|FG000|STARTED|Booster Phase||155||
60121436|NCT02675764|76242374|FG001|COMPLETED|Overall Study||6||
60121437|NCT02675764|76242373|FG000|NOT COMPLETED|Overall Study||0||
60121438|NCT02675764|76242374|FG001|NOT COMPLETED|Overall Study||0||
60121439|NCT02679976|76242380|FG000|STARTED|Overall Study||30||
60121440|NCT02679976|76242380|FG000|Hyperopes|Overall Study||16||
60121441|NCT02679976|76242380|FG000|Myopes|Overall Study||14||
60121442|NCT02679976|76242380|FG000|COMPLETED|Overall Study||30||
60121443|NCT02679976|76242380|FG000|NOT COMPLETED|Overall Study||0||
60121444|NCT02680054|76242385|FG000|STARTED|Overall Study||38||
60121445|NCT02680054|76242385|FG000|COMPLETED|Overall Study||27||
60121446|NCT02680054|76242385|FG000|NOT COMPLETED|Overall Study||11||
60121447|NCT02681458|76242396|FG000|STARTED|Overall Study||718||
60121448|NCT02681458|76242397|FG001|STARTED|Overall Study||718||
60121449|NCT02681458|76242396|FG000|COMPLETED|Overall Study||73||
60121450|NCT02681458|76242397|FG001|COMPLETED|Overall Study||62||
60121451|NCT02681458|76242396|FG000|NOT COMPLETED|Overall Study||645||
60121452|NCT02681458|76242397|FG001|NOT COMPLETED|Overall Study||656||
60121453|NCT02683174|76242403|FG000|STARTED|Overall Study||86||
60121454|NCT02683174|76242403|FG000|COMPLETED|Overall Study||86||
60121455|NCT02683174|76242403|FG000|NOT COMPLETED|Overall Study||0||
60121456|NCT01685801|76242412|FG000|STARTED|Cycle 1 Period 1 (2 Weeks)||5||
60121457|NCT01685801|76242413|FG001|STARTED|Cycle 1 Period 1 (2 Weeks)||6||
60121458|NCT01685801|76242414|FG002|STARTED|Cycle 1 Period 1 (2 Weeks)||7||
60121459|NCT01685801|76242415|FG003|STARTED|Cycle 1 Period 1 (2 Weeks)||6||
60121460|NCT01685801|76242412|FG000|COMPLETED|Cycle 1 Period 1 (2 Weeks)||5||
60121461|NCT01685801|76242413|FG001|COMPLETED|Cycle 1 Period 1 (2 Weeks)||6||
60121462|NCT01685801|76242414|FG002|COMPLETED|Cycle 1 Period 1 (2 Weeks)||7||
60121463|NCT01685801|76242415|FG003|COMPLETED|Cycle 1 Period 1 (2 Weeks)||6||
60121464|NCT01685801|76242412|FG000|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0||
60121465|NCT01685801|76242413|FG001|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0||
60121466|NCT01685801|76242414|FG002|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0||
60121467|NCT01685801|76242415|FG003|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0||
60121468|NCT01685801|76242412|FG000|STARTED|Cycle 1 Period 2 (2 Weeks)||5||
60121469|NCT01685801|76242413|FG001|STARTED|Cycle 1 Period 2 (2 Weeks)||6||
60121470|NCT01685801|76242414|FG002|STARTED|Cycle 1 Period 2 (2 Weeks)||7||
60121471|NCT01685801|76242415|FG003|STARTED|Cycle 1 Period 2 (2 Weeks)||6||
60121472|NCT01685801|76242412|FG000|COMPLETED|Cycle 1 Period 2 (2 Weeks)||5||
60121473|NCT01685801|76242413|FG001|COMPLETED|Cycle 1 Period 2 (2 Weeks)||6||
60121474|NCT01685801|76242414|FG002|COMPLETED|Cycle 1 Period 2 (2 Weeks)||7||
60121475|NCT01685801|76242415|FG003|COMPLETED|Cycle 1 Period 2 (2 Weeks)||5||
60121476|NCT01685801|76242412|FG000|NOT COMPLETED|Cycle 1 Period 2 (2 Weeks)||0||
60121477|NCT01685801|76242413|FG001|NOT COMPLETED|Cycle 1 Period 2 (2 Weeks)||0||
60121478|NCT01685801|76242414|FG002|NOT COMPLETED|Cycle 1 Period 2 (2 Weeks)||0||
60121479|NCT01685801|76242415|FG003|NOT COMPLETED|Cycle 1 Period 2 (2 Weeks)||1||
60121480|NCT01685801|76242412|FG000|STARTED|Washout Period 1 (4 Weeks)||5||
60121481|NCT01685801|76242413|FG001|STARTED|Washout Period 1 (4 Weeks)||6||
60121482|NCT01685801|76242414|FG002|STARTED|Washout Period 1 (4 Weeks)||7||
60121483|NCT01685801|76242415|FG003|STARTED|Washout Period 1 (4 Weeks)||5||
60121484|NCT01685801|76242412|FG000|COMPLETED|Washout Period 1 (4 Weeks)||5||
60121485|NCT01685801|76242413|FG001|COMPLETED|Washout Period 1 (4 Weeks)||6||
60121486|NCT01685801|76242414|FG002|COMPLETED|Washout Period 1 (4 Weeks)||7||
60121487|NCT01685801|76242415|FG003|COMPLETED|Washout Period 1 (4 Weeks)||5||
60121488|NCT01685801|76242412|FG000|NOT COMPLETED|Washout Period 1 (4 Weeks)||0||
60121489|NCT01685801|76242413|FG001|NOT COMPLETED|Washout Period 1 (4 Weeks)||0||
60121490|NCT01685801|76242414|FG002|NOT COMPLETED|Washout Period 1 (4 Weeks)||0||
60121491|NCT01685801|76242415|FG003|NOT COMPLETED|Washout Period 1 (4 Weeks)||0||
60121492|NCT01685801|76242412|FG000|STARTED|Cycle 2 Period 1 (2 Weeks)||5||
60121493|NCT01685801|76242413|FG001|STARTED|Cycle 2 Period 1 (2 Weeks)||6||
60121494|NCT01685801|76242414|FG002|STARTED|Cycle 2 Period 1 (2 Weeks)||7||
60121495|NCT01685801|76242415|FG003|STARTED|Cycle 2 Period 1 (2 Weeks)||5||
60121496|NCT01685801|76242412|FG000|COMPLETED|Cycle 2 Period 1 (2 Weeks)||5||
60121497|NCT01685801|76242413|FG001|COMPLETED|Cycle 2 Period 1 (2 Weeks)||6||
60121498|NCT01685801|76242414|FG002|COMPLETED|Cycle 2 Period 1 (2 Weeks)||7||
59723984|NCT00937521|75842587|FG001|STARTED|Booster Phase||163||
59578922|NCT02044796|75684560|FG004|STARTED|Overall Study||10||
59578923|NCT02044796|75684561|FG005|STARTED|Overall Study||6||
59578924|NCT02044796|75684562|FG006|STARTED|Overall Study||6||
59578925|NCT02044796|75684563|FG007|STARTED|Overall Study||4||
59578926|NCT02044796|75684564|FG008|STARTED|Overall Study||106||
59578927|NCT02044796|75684565|FG009|STARTED|Overall Study||34||
59578928|NCT02044796|75684556|FG000|COMPLETED|Overall Study||9||
59578929|NCT02044796|75684557|FG001|COMPLETED|Overall Study||9||
59578930|NCT02044796|75684558|FG002|COMPLETED|Overall Study||9||
59578931|NCT02044796|75684559|FG003|COMPLETED|Overall Study||6||
59578932|NCT02044796|75684560|FG004|COMPLETED|Overall Study||10||
59578933|NCT02044796|75684561|FG005|COMPLETED|Overall Study||6||
59578934|NCT02044796|75684562|FG006|COMPLETED|Overall Study||6||
59578935|NCT02044796|75684563|FG007|COMPLETED|Overall Study||4||
59578936|NCT02044796|75684564|FG008|COMPLETED|Overall Study||106||
59578937|NCT02044796|75684565|FG009|COMPLETED|Overall Study||34||
59578938|NCT02044796|75684556|FG000|NOT COMPLETED|Overall Study||0||
59578939|NCT02044796|75684557|FG001|NOT COMPLETED|Overall Study||0||
59578940|NCT02044796|75684558|FG002|NOT COMPLETED|Overall Study||0||
59578941|NCT02044796|75684559|FG003|NOT COMPLETED|Overall Study||0||
59578942|NCT02044796|75684560|FG004|NOT COMPLETED|Overall Study||0||
59578943|NCT02044796|75684561|FG005|NOT COMPLETED|Overall Study||0||
59578944|NCT02044796|75684562|FG006|NOT COMPLETED|Overall Study||0||
59578945|NCT02044796|75684563|FG007|NOT COMPLETED|Overall Study||0||
59578946|NCT02044796|75684564|FG008|NOT COMPLETED|Overall Study||0||
59578947|NCT02044796|75684565|FG009|NOT COMPLETED|Overall Study||0||
59578948|NCT03124823|75684583|FG000|STARTED|Overall Study||11||
59578949|NCT03124823|75684583|FG000|COMPLETED|Overall Study||11||
59578950|NCT03124823|75684583|FG000|NOT COMPLETED|Overall Study||0||
59578951|NCT03124901|75684587|FG000|STARTED|Overall Study||147||
59578952|NCT03124901|75684587|FG000|COMPLETED|Overall Study||147||
59578953|NCT03124901|75684587|FG000|NOT COMPLETED|Overall Study||0||
59578954|NCT03124979|75684591|FG000|STARTED|Overall Study||13||
59578955|NCT03124979|75684591|FG000|COMPLETED|Overall Study||13||
59578956|NCT03124979|75684591|FG000|NOT COMPLETED|Overall Study||0||
59578957|NCT02045108|75684599|FG000|STARTED|Overall Study||22||
59578958|NCT02045108|75684600|FG001|STARTED|Overall Study||15||
59578959|NCT02045108|75684601|FG002|STARTED|Overall Study||20||
59578960|NCT02045108|75684602|FG003|STARTED|Overall Study||20||
59578961|NCT02045108|75684599|FG000|COMPLETED|Overall Study||21||
59578962|NCT02045108|75684600|FG001|COMPLETED|Overall Study||12||
59578963|NCT02045108|75684601|FG002|COMPLETED|Overall Study||18||
59578964|NCT02045108|75684602|FG003|COMPLETED|Overall Study||19||
59578965|NCT02045108|75684599|FG000|NOT COMPLETED|Overall Study||1||
59578966|NCT02045108|75684600|FG001|NOT COMPLETED|Overall Study||3||
59578967|NCT02045108|75684601|FG002|NOT COMPLETED|Overall Study||2||
59578968|NCT02045108|75684602|FG003|NOT COMPLETED|Overall Study||1||
59578969|NCT02973503|75684612|FG000|STARTED|Overall Study||117||
59578970|NCT02973503|75684612|FG000|COMPLETED|Overall Study||117||
59578971|NCT02973503|75684612|FG000|NOT COMPLETED|Overall Study||0||
59578972|NCT03127943|75684621|FG000|STARTED|First Intervention||12||
59578973|NCT03127943|75684622|FG001|STARTED|First Intervention||12||
59578974|NCT03127943|75684621|FG000|COMPLETED|First Intervention||12||
59578975|NCT03127943|75684622|FG001|COMPLETED|First Intervention||12||
59578976|NCT03127943|75684621|FG000|NOT COMPLETED|First Intervention||0||
59578977|NCT03127943|75684622|FG001|NOT COMPLETED|First Intervention||0||
59578978|NCT03127943|75684621|FG000|STARTED|Washout (1 Week)||12||
59578979|NCT03127943|75684622|FG001|STARTED|Washout (1 Week)||12||
59578980|NCT03127943|75684621|FG000|COMPLETED|Washout (1 Week)||12||
59578981|NCT03127943|75684622|FG001|COMPLETED|Washout (1 Week)||12||
59578982|NCT03127943|75684621|FG000|NOT COMPLETED|Washout (1 Week)||0||
59578983|NCT03127943|75684622|FG001|NOT COMPLETED|Washout (1 Week)||0||
59578984|NCT03127943|75684621|FG000|STARTED|Second Intervention||12||
59578985|NCT03127943|75684622|FG001|STARTED|Second Intervention||12||
59578986|NCT03127943|75684621|FG000|COMPLETED|Second Intervention||12||
59578987|NCT03127943|75684622|FG001|COMPLETED|Second Intervention||12||
59578988|NCT03127943|75684621|FG000|NOT COMPLETED|Second Intervention||0||
59578989|NCT03127943|75684622|FG001|NOT COMPLETED|Second Intervention||0||
59578990|NCT03047447|75684631|FG000|STARTED|Overall Study||10||
59578991|NCT03047447|75684632|FG001|STARTED|Overall Study||10||
59578992|NCT03047447|75684633|FG002|STARTED|Overall Study||10||
59578993|NCT03047447|75684631|FG000|COMPLETED|Overall Study||10||
59578994|NCT03047447|75684632|FG001|COMPLETED|Overall Study||10||
59578995|NCT03047447|75684633|FG002|COMPLETED|Overall Study||10||
59578996|NCT03047447|75684631|FG000|NOT COMPLETED|Overall Study||0||
59578997|NCT03047447|75684632|FG001|NOT COMPLETED|Overall Study||0||
59578998|NCT03047447|75684633|FG002|NOT COMPLETED|Overall Study||0||
59578999|NCT02412098|75684647|FG000|STARTED|Overall Study||14||
59579000|NCT02412098|75684648|FG001|STARTED|Overall Study||14||
59579001|NCT02412098|75684649|FG002|STARTED|Overall Study||21||
59579002|NCT02412098|75684647|FG000|COMPLETED|Overall Study||14||
59579003|NCT02412098|75684648|FG001|COMPLETED|Overall Study||14||
59579004|NCT02412098|75684649|FG002|COMPLETED|Overall Study||21||
59579005|NCT02412098|75684647|FG000|NOT COMPLETED|Overall Study||0||
59579006|NCT02412098|75684648|FG001|NOT COMPLETED|Overall Study||0||
59579007|NCT02412098|75684649|FG002|NOT COMPLETED|Overall Study||0||
59579008|NCT03048383|75684664|FG000|STARTED|Overall Study||28||
59579009|NCT03048383|75684665|FG001|STARTED|Overall Study||21||
59579010|NCT03048383|75684666|FG002|STARTED|Overall Study||22||
59579011|NCT03048383|75684664|FG000|COMPLETED|Overall Study||15||
59579012|NCT03048383|75684665|FG001|COMPLETED|Overall Study||13||
59579013|NCT03048383|75684666|FG002|COMPLETED|Overall Study||10||
59579014|NCT03048383|75684664|FG000|NOT COMPLETED|Overall Study||13||
59579015|NCT03048383|75684665|FG001|NOT COMPLETED|Overall Study||8||
59579016|NCT03048383|75684666|FG002|NOT COMPLETED|Overall Study||12||
59579017|NCT02045264|75684674|FG000|STARTED|Overall Study||12||
59579018|NCT02045264|75684674|FG000|COMPLETED|Overall Study||12||
59579019|NCT02045264|75684674|FG000|NOT COMPLETED|Overall Study||0||
59579020|NCT02975297|75684680|FG000|STARTED|Overall Study||41||
59579021|NCT02975297|75684681|FG001|STARTED|Overall Study||41||
59579022|NCT02975297|75684680|FG000|COMPLETED|Overall Study||34||
59579023|NCT02975297|75684681|FG001|COMPLETED|Overall Study||35||
59579024|NCT02975297|75684680|FG000|NOT COMPLETED|Overall Study||7||
59579025|NCT02975297|75684681|FG001|NOT COMPLETED|Overall Study||6||
59579026|NCT02046200|75684687|FG000|STARTED|First Intervention (1 Day)||5||
59579027|NCT02046200|75684688|FG001|STARTED|First Intervention (1 Day)||6||
59579028|NCT02046200|75684687|FG000|COMPLETED|First Intervention (1 Day)||5||
59579029|NCT02046200|75684688|FG001|COMPLETED|First Intervention (1 Day)||6||
59579030|NCT02046200|75684687|FG000|NOT COMPLETED|First Intervention (1 Day)||0||
59579031|NCT02046200|75684688|FG001|NOT COMPLETED|First Intervention (1 Day)||0||
59579032|NCT02046200|75684687|FG000|STARTED|Second Intervention (1 Day)||5||
59579033|NCT02046200|75684688|FG001|STARTED|Second Intervention (1 Day)||6||
59579034|NCT02046200|75684687|FG000|COMPLETED|Second Intervention (1 Day)||5||
59579035|NCT02046200|75684688|FG001|COMPLETED|Second Intervention (1 Day)||6||
59579036|NCT02046200|75684687|FG000|NOT COMPLETED|Second Intervention (1 Day)||0||
59579037|NCT02046200|75684688|FG001|NOT COMPLETED|Second Intervention (1 Day)||0||
59579038|NCT02978339|75684702|FG000|STARTED|Overall Study||15||
59579039|NCT02978339|75684702|FG000|COMPLETED|Overall Study||15||
59579040|NCT02978339|75684702|FG000|NOT COMPLETED|Overall Study||0||
59579041|NCT02367014|75684710|FG000|STARTED|Overall Study||9||
59579042|NCT02367014|75684711|FG001|STARTED|Overall Study||9||
59579043|NCT02367014|75684712|FG002|STARTED|Overall Study||9||
59579044|NCT02367014|75684713|FG003|STARTED|Overall Study||9||
59579045|NCT02367014|75684710|FG000|COMPLETED|Overall Study||9||
59579046|NCT02367014|75684711|FG001|COMPLETED|Overall Study||9||
59579047|NCT02367014|75684712|FG002|COMPLETED|Overall Study||9||
59579048|NCT02367014|75684713|FG003|COMPLETED|Overall Study||9||
59579049|NCT02367014|75684710|FG000|NOT COMPLETED|Overall Study||0||
59579050|NCT02367014|75684711|FG001|NOT COMPLETED|Overall Study||0||
59579051|NCT02367014|75684712|FG002|NOT COMPLETED|Overall Study||0||
59579052|NCT02367014|75684713|FG003|NOT COMPLETED|Overall Study||0||
59579053|NCT02367872|75684733|FG000|STARTED|Overall Study||6||
59579054|NCT02367872|75684734|FG001|STARTED|Overall Study||6||
59579055|NCT02367872|75684735|FG002|STARTED|Overall Study||6||
59579056|NCT02367872|75684736|FG003|STARTED|Overall Study||6||
59579057|NCT02367872|75684737|FG004|STARTED|Overall Study||6||
59579058|NCT02367872|75684738|FG005|STARTED|Overall Study||6||
59579059|NCT02367872|75684739|FG006|STARTED|Overall Study||6||
59579060|NCT02367872|75684740|FG007|STARTED|Overall Study||6||
59579061|NCT02367872|75684733|FG000|COMPLETED|Overall Study||6||
59579062|NCT02367872|75684734|FG001|COMPLETED|Overall Study||6||
60121499|NCT01685801|76242415|FG003|COMPLETED|Cycle 2 Period 1 (2 Weeks)||5||
59579063|NCT02367872|75684735|FG002|COMPLETED|Overall Study||6||
59579064|NCT02367872|75684736|FG003|COMPLETED|Overall Study||6||
59579065|NCT02367872|75684737|FG004|COMPLETED|Overall Study||6||
59579066|NCT02367872|75684738|FG005|COMPLETED|Overall Study||6||
59579067|NCT02367872|75684739|FG006|COMPLETED|Overall Study||6||
59579068|NCT02367872|75684740|FG007|COMPLETED|Overall Study||6||
59579069|NCT02367872|75684733|FG000|NOT COMPLETED|Overall Study||0||
59579070|NCT02367872|75684734|FG001|NOT COMPLETED|Overall Study||0||
59579071|NCT02367872|75684735|FG002|NOT COMPLETED|Overall Study||0||
59579072|NCT02367872|75684736|FG003|NOT COMPLETED|Overall Study||0||
59579073|NCT02367872|75684737|FG004|NOT COMPLETED|Overall Study||0||
59579074|NCT02367872|75684738|FG005|NOT COMPLETED|Overall Study||0||
59579075|NCT02367872|75684739|FG006|NOT COMPLETED|Overall Study||0||
59579076|NCT02367872|75684740|FG007|NOT COMPLETED|Overall Study||0||
59579077|NCT02979899|75684769|FG000|STARTED|Overall Study||64||
59579078|NCT02979899|75684770|FG001|STARTED|Overall Study||64||
59579079|NCT02979899|75684769|FG000|COMPLETED|Overall Study||64||
59579080|NCT02979899|75684770|FG001|COMPLETED|Overall Study||64||
59579081|NCT02979899|75684769|FG000|NOT COMPLETED|Overall Study||0||
59579082|NCT02979899|75684770|FG001|NOT COMPLETED|Overall Study||0||
59579083|NCT02412644|75684778|FG000|STARTED|Overall Study||21||
59579084|NCT02412644|75684779|FG001|STARTED|Overall Study||8||
59579085|NCT02412644|75684778|FG000|COMPLETED|Overall Study||6||
60121500|NCT01685801|76242412|FG000|NOT COMPLETED|Cycle 2 Period 1 (2 Weeks)||0||
59579086|NCT02412644|75684779|FG001|COMPLETED|Overall Study||4||
59579087|NCT02412644|75684778|FG000|NOT COMPLETED|Overall Study||15||
59579088|NCT02412644|75684779|FG001|NOT COMPLETED|Overall Study||4||
59579089|NCT03134963|75684793|FG000|STARTED|Overall Study||12||
59579090|NCT03134963|75684794|FG001|STARTED|Overall Study||13||
59579091|NCT03134963|75684795|FG002|STARTED|Overall Study||3||
59579092|NCT03134963|75684796|FG003|STARTED|Overall Study||14||
59579093|NCT03134963|75684793|FG000|COMPLETED|Overall Study||12||
59579094|NCT03134963|75684794|FG001|COMPLETED|Overall Study||13||
59579095|NCT03134963|75684795|FG002|COMPLETED|Overall Study||3||
59579096|NCT03134963|75684796|FG003|COMPLETED|Overall Study||14||
59579097|NCT03134963|75684793|FG000|NOT COMPLETED|Overall Study||0||
59579098|NCT03134963|75684794|FG001|NOT COMPLETED|Overall Study||0||
59579099|NCT03134963|75684795|FG002|NOT COMPLETED|Overall Study||0||
59579100|NCT03134963|75684796|FG003|NOT COMPLETED|Overall Study||0||
59579101|NCT02046902|75684809|FG000|STARTED|Overall Study||336||
59579102|NCT02046902|75684810|FG001|STARTED|Overall Study||113||
59579103|NCT02046902|75684811|FG002|STARTED|Overall Study||137||
59579104|NCT02046902|75684809|FG000|COMPLETED|Overall Study||336||
59579105|NCT02046902|75684810|FG001|COMPLETED|Overall Study||113||
59579106|NCT02046902|75684811|FG002|COMPLETED|Overall Study||137||
59579107|NCT02046902|75684809|FG000|NOT COMPLETED|Overall Study||0||
59579108|NCT02046902|75684810|FG001|NOT COMPLETED|Overall Study||0||
59579109|NCT02046902|75684811|FG002|NOT COMPLETED|Overall Study||0||
59579110|NCT02980211|75684819|FG000|STARTED|Overall Study||17||
59579111|NCT02980211|75684819|FG000|COMPLETED|Overall Study||17||
59579112|NCT02980211|75684819|FG000|NOT COMPLETED|Overall Study||0||
59579113|NCT02412956|75684825|FG000|STARTED|Overall Study||44||
59579114|NCT02412956|75684826|FG001|STARTED|Overall Study||47||
59579115|NCT02412956|75684827|FG002|STARTED|Overall Study||8||
59579116|NCT02412956|75684825|FG000|COMPLETED|Overall Study||35||
59579117|NCT02412956|75684826|FG001|COMPLETED|Overall Study||30||
59579118|NCT02412956|75684827|FG002|COMPLETED|Overall Study||8||
59579119|NCT02412956|75684825|FG000|NOT COMPLETED|Overall Study||9||
59579120|NCT02412956|75684826|FG001|NOT COMPLETED|Overall Study||17||
59579121|NCT02412956|75684827|FG002|NOT COMPLETED|Overall Study||0||
59579122|NCT03054077|75684835|FG000|STARTED|Overall Study||12||
59579123|NCT03054077|75684836|FG001|STARTED|Overall Study||12||
59579124|NCT03054077|75684835|FG000|COMPLETED|Overall Study||12||
59579125|NCT03054077|75684836|FG001|COMPLETED|Overall Study||12||
59579126|NCT03054077|75684835|FG000|NOT COMPLETED|Overall Study||0||
59579127|NCT03054077|75684836|FG001|NOT COMPLETED|Overall Study||0||
59579128|NCT02046980|75684845|FG000|STARTED|Overall Study||72||
59579129|NCT02046980|75684846|FG001|STARTED|Overall Study||72||
59579130|NCT02046980|75684847|FG002|STARTED|Overall Study||73||
59579131|NCT02046980|75684845|FG000|COMPLETED|Overall Study||70||
59579132|NCT02046980|75684846|FG001|COMPLETED|Overall Study||67||
59579133|NCT02046980|75684847|FG002|COMPLETED|Overall Study||72||
59579134|NCT02046980|75684845|FG000|NOT COMPLETED|Overall Study||2||
59579135|NCT02046980|75684846|FG001|NOT COMPLETED|Overall Study||5||
59579136|NCT02046980|75684847|FG002|NOT COMPLETED|Overall Study||1||
59579137|NCT02983877|75684855|FG000|STARTED|Overall Study||38||
59579138|NCT02983877|75684855|FG000|COMPLETED|Overall Study||38||
59579139|NCT02983877|75684855|FG000|NOT COMPLETED|Overall Study||0||
59579140|NCT02413034|75684862|FG000|STARTED|Overall Study||14||
59579141|NCT02413034|75684863|FG001|STARTED|Overall Study||14||
59579142|NCT02413034|75684862|FG000|COMPLETED|Overall Study||14||
59579143|NCT02413034|75684863|FG001|COMPLETED|Overall Study||14||
59579144|NCT02413034|75684862|FG000|NOT COMPLETED|Overall Study||0||
59579145|NCT02413034|75684863|FG001|NOT COMPLETED|Overall Study||0||
59579146|NCT03136913|75684869|FG000|STARTED|Overall Study||13||
59579147|NCT03136913|75684869|FG000|Subjects Received Both Intervention|Overall Study|10 subjects with 10 OFT and 10 CFT sites received clinical measurement before implant surgery|10||
59579148|NCT03136913|75684869|FG000|COMPLETED|Overall Study|8 subjects with 8 OFT and 8 CFT sites received implant surgery|8||
59579149|NCT03136913|75684869|FG000|NOT COMPLETED|Overall Study||5||
59579150|NCT02413190|75684876|FG000|STARTED|Overall Study||94||
59579151|NCT02413190|75684876|FG000|COMPLETED|Overall Study||94||
59579152|NCT02413190|75684876|FG000|NOT COMPLETED|Overall Study||0||
59579153|NCT02413580|75684880|FG000|STARTED|Overall Study||49||
59579154|NCT02413580|75684880|FG000|COMPLETED|Overall Study||46||
59579155|NCT02413580|75684880|FG000|NOT COMPLETED|Overall Study||3||
59579156|NCT02985827|75684886|FG000|STARTED|Overall Study||33||
59579157|NCT02985827|75684887|FG001|STARTED|Overall Study||15||
59579158|NCT02985827|75684886|FG000|COMPLETED|Overall Study||33||
59579159|NCT02985827|75684887|FG001|COMPLETED|Overall Study||15||
59579160|NCT02985827|75684886|FG000|NOT COMPLETED|Overall Study||0||
59579161|NCT02985827|75684887|FG001|NOT COMPLETED|Overall Study||0||
59579162|NCT02369900|75684895|FG000|STARTED|Overall Study||18||
59579163|NCT02369900|75684896|FG001|STARTED|Overall Study||22||
59579164|NCT02369900|75684895|FG000|COMPLETED|Overall Study||18||
59579165|NCT02369900|75684896|FG001|COMPLETED|Overall Study||22||
59579166|NCT02369900|75684895|FG000|NOT COMPLETED|Overall Study||0||
59579167|NCT02369900|75684896|FG001|NOT COMPLETED|Overall Study||0||
59579168|NCT03054857|75684904|FG000|STARTED|Overall Study||50||
59579169|NCT03054857|75684905|FG001|STARTED|Overall Study||50||
59579170|NCT03054857|75684904|FG000|COMPLETED|Overall Study||49||
59579171|NCT03054857|75684905|FG001|COMPLETED|Overall Study||50||
59579172|NCT03054857|75684904|FG000|NOT COMPLETED|Overall Study||1||
59579173|NCT03054857|75684905|FG001|NOT COMPLETED|Overall Study||0||
59579174|NCT02370056|75684917|FG000|STARTED|Overall Study||27||
59579175|NCT02370056|75684918|FG001|STARTED|Overall Study||26||
59579176|NCT02370056|75684917|FG000|COMPLETED|Overall Study||27||
59579177|NCT02370056|75684918|FG001|COMPLETED|Overall Study||26||
59579178|NCT02370056|75684917|FG000|NOT COMPLETED|Overall Study||0||
59579179|NCT02370056|75684918|FG001|NOT COMPLETED|Overall Study||0||
59579180|NCT02987231|75684926|FG000|STARTED|Overall Study||30||
59579181|NCT02987231|75684927|FG001|STARTED|Overall Study||30||
59579182|NCT02987231|75684926|FG000|COMPLETED|Overall Study||30||
59579183|NCT02987231|75684927|FG001|COMPLETED|Overall Study||30||
59579184|NCT02987231|75684926|FG000|NOT COMPLETED|Overall Study||0||
59579185|NCT02987231|75684927|FG001|NOT COMPLETED|Overall Study||0||
59579186|NCT02414204|75684935|FG000|STARTED|Overall Study||2||
59579187|NCT02414204|75684936|FG001|STARTED|Overall Study||2||
59579188|NCT02414204|75684935|FG000|COMPLETED|Overall Study||2||
59579189|NCT02414204|75684936|FG001|COMPLETED|Overall Study||2||
59579190|NCT02414204|75684935|FG000|NOT COMPLETED|Overall Study||0||
59579191|NCT02414204|75684936|FG001|NOT COMPLETED|Overall Study||0||
59579192|NCT02987621|75684942|FG000|STARTED|Overall Study||7||
59579193|NCT02987621|75684943|FG001|STARTED|Overall Study||7||
59579194|NCT02987621|75684942|FG000|COMPLETED|Overall Study||7||
59579195|NCT02987621|75684943|FG001|COMPLETED|Overall Study||7||
59579196|NCT02987621|75684942|FG000|NOT COMPLETED|Overall Study||0||
59579197|NCT02987621|75684943|FG001|NOT COMPLETED|Overall Study||0||
59579198|NCT02989493|75684953|FG000|STARTED|Overall Study||29||
59579199|NCT02989493|75684954|FG001|STARTED|Overall Study||32||
59579200|NCT02989493|75684953|FG000|COMPLETED|Overall Study||29||
59579201|NCT02989493|75684954|FG001|COMPLETED|Overall Study||32||
59579202|NCT02989493|75684953|FG000|NOT COMPLETED|Overall Study||0||
59579203|NCT02989493|75684954|FG001|NOT COMPLETED|Overall Study||0||
59579204|NCT02050334|75684962|FG000|STARTED|Overall Study||9||
59579205|NCT02050334|75684963|FG001|STARTED|Overall Study||9||
59579206|NCT02050334|75684962|FG000|COMPLETED|Overall Study||9||
59579207|NCT02050334|75684963|FG001|COMPLETED|Overall Study||9||
59579208|NCT02050334|75684962|FG000|NOT COMPLETED|Overall Study||0||
59579209|NCT02050334|75684963|FG001|NOT COMPLETED|Overall Study||0||
59579210|NCT03062267|75684972|FG000|STARTED|Overall Study||12||
59579211|NCT03062267|75684973|FG001|STARTED|Overall Study||37||
59579212|NCT03062267|75684972|FG000|COMPLETED|Overall Study||10||
59579213|NCT03062267|75684973|FG001|COMPLETED|Overall Study||32||
59579214|NCT03062267|75684972|FG000|NOT COMPLETED|Overall Study||2||
59579215|NCT03062267|75684973|FG001|NOT COMPLETED|Overall Study||5||
59579216|NCT03063125|75684979|FG000|STARTED|Overall Study||25||
59579217|NCT03063125|75684979|FG000|COMPLETED|Overall Study||23||
59579218|NCT03063125|75684979|FG000|NOT COMPLETED|Overall Study||2||
59579219|NCT02371850|75684983|FG000|STARTED|Overall Study||10||
59579220|NCT02371850|75684983|FG000|COMPLETED|Overall Study||10||
59579221|NCT02371850|75684983|FG000|NOT COMPLETED|Overall Study||0||
59579222|NCT03141281|75684998|FG000|STARTED|Overall Study||57||
59579223|NCT03141281|75684999|FG001|STARTED|Overall Study||59||
59579224|NCT03141281|75685000|FG002|STARTED|Overall Study||56||
59579225|NCT03141281|75685001|FG003|STARTED|Overall Study||58||
59579226|NCT03141281|75684998|FG000|Post-Test|Overall Study||50||
59579227|NCT03141281|75684999|FG001|Post-Test|Overall Study||47||
59579228|NCT03141281|75685000|FG002|Post-Test|Overall Study||50||
59579229|NCT03141281|75685001|FG003|Post-Test|Overall Study||56||
59579230|NCT03141281|75684998|FG000|COMPLETED|Overall Study||45||
59579231|NCT03141281|75684999|FG001|COMPLETED|Overall Study||38||
59579232|NCT03141281|75685000|FG002|COMPLETED|Overall Study||42||
59579233|NCT03141281|75685001|FG003|COMPLETED|Overall Study||47||
59579234|NCT03141281|75684998|FG000|NOT COMPLETED|Overall Study||12||
59579235|NCT03141281|75684999|FG001|NOT COMPLETED|Overall Study||21||
59579236|NCT03141281|75685000|FG002|NOT COMPLETED|Overall Study||14||
59579237|NCT03141281|75685001|FG003|NOT COMPLETED|Overall Study||11||
59579238|NCT02415608|75685013|FG000|STARTED|Overall Study||3||
59579239|NCT02415608|75685014|FG001|STARTED|Overall Study||1||
59579240|NCT02415608|75685013|FG000|COMPLETED|Overall Study||3||
59579241|NCT02415608|75685014|FG001|COMPLETED|Overall Study||1||
59579242|NCT02415608|75685013|FG000|NOT COMPLETED|Overall Study||0||
59579243|NCT02415608|75685014|FG001|NOT COMPLETED|Overall Study||0||
59579244|NCT03144089|75685022|FG000|STARTED|Overall Study||28||
59579245|NCT03144089|75685023|FG001|STARTED|Overall Study||28||
59579246|NCT03144089|75685022|FG000|COMPLETED|Overall Study||28||
59579247|NCT03144089|75685023|FG001|COMPLETED|Overall Study||28||
59579248|NCT03144089|75685022|FG000|NOT COMPLETED|Overall Study||0||
59579249|NCT03144089|75685023|FG001|NOT COMPLETED|Overall Study||0||
59579250|NCT02051426|75685033|FG000|STARTED|First Intervention||16||
59579251|NCT02051426|75685034|FG001|STARTED|First Intervention||19||
59579252|NCT02051426|75685033|FG000|COMPLETED|First Intervention||16||
59579253|NCT02051426|75685034|FG001|COMPLETED|First Intervention||19||
59579254|NCT02051426|75685033|FG000|NOT COMPLETED|First Intervention||0||
59579255|NCT02051426|75685034|FG001|NOT COMPLETED|First Intervention||0||
59579256|NCT02051426|75685033|FG000|STARTED|Washout Period of 1 Month||16||
59579257|NCT02051426|75685034|FG001|STARTED|Washout Period of 1 Month||19||
59579258|NCT02051426|75685033|FG000|COMPLETED|Washout Period of 1 Month||16||
59579259|NCT02051426|75685034|FG001|COMPLETED|Washout Period of 1 Month||19||
59579260|NCT02051426|75685033|FG000|NOT COMPLETED|Washout Period of 1 Month||0||
59579261|NCT02051426|75685034|FG001|NOT COMPLETED|Washout Period of 1 Month||0||
59579262|NCT02051426|75685033|FG000|STARTED|Second Intervention||16||
59579263|NCT02051426|75685034|FG001|STARTED|Second Intervention||19||
59579264|NCT02051426|75685033|FG000|COMPLETED|Second Intervention||16||
59579265|NCT02051426|75685034|FG001|COMPLETED|Second Intervention||19||
59579266|NCT02051426|75685033|FG000|NOT COMPLETED|Second Intervention||0||
59579267|NCT02051426|75685034|FG001|NOT COMPLETED|Second Intervention||0||
59579268|NCT03144635|75685040|FG000|STARTED|Overall Study||80||
59579269|NCT03144635|75685040|FG000|COMPLETED|Overall Study||0||
59579270|NCT03144635|75685040|FG000|NOT COMPLETED|Overall Study||80||
59579271|NCT02313506|75685048|FG000|STARTED|Overall Study||17||
59579272|NCT02313506|75685049|FG001|STARTED|Overall Study||17||
59579273|NCT02313506|75685048|FG000|COMPLETED|Overall Study||17||
59579274|NCT02313506|75685049|FG001|COMPLETED|Overall Study||17||
59579275|NCT02313506|75685048|FG000|NOT COMPLETED|Overall Study||0||
59579276|NCT02313506|75685049|FG001|NOT COMPLETED|Overall Study||0||
59579277|NCT03145259|75685056|FG000|STARTED|Overall Study||12||
59579278|NCT03145259|75685056|FG000|COMPLETED|Overall Study||12||
59579279|NCT03145259|75685056|FG000|NOT COMPLETED|Overall Study||0||
59579280|NCT03146585|75685066|FG000|STARTED|Overall Study||25||
59579281|NCT03146585|75685067|FG001|STARTED|Overall Study||10||
59579282|NCT03146585|75685068|FG002|STARTED|Overall Study||5||
59579283|NCT03146585|75685066|FG000|COMPLETED|Overall Study||25||
59579284|NCT03146585|75685067|FG001|COMPLETED|Overall Study||10||
59579285|NCT03146585|75685068|FG002|COMPLETED|Overall Study||5||
59579286|NCT03146585|75685066|FG000|NOT COMPLETED|Overall Study||0||
59579287|NCT03146585|75685067|FG001|NOT COMPLETED|Overall Study||0||
59579288|NCT03146585|75685068|FG002|NOT COMPLETED|Overall Study||0||
59579289|NCT02375984|75685076|FG000|STARTED|Overall Study||1||
59579290|NCT02375984|75685076|FG000|COMPLETED|Overall Study||1||
59579291|NCT02375984|75685076|FG000|NOT COMPLETED|Overall Study||0||
59579292|NCT02989727|75685084|FG000|STARTED|Overall Study||46|We only analyzed data from treatment completers (n=150) in the original study (n=221), NCT00274677.|
59579293|NCT02989727|75685085|FG001|STARTED|Overall Study||44|We only analyzed data from treatment completers (n=150) in the original study (n=221), NCT00274677.|
59579294|NCT02989727|75685086|FG002|STARTED|Overall Study||30|We only analyzed data from treatment completers (n=150) in the original study (n=221), NCT00274677.|
59579295|NCT02989727|75685087|FG003|STARTED|Overall Study||30|We only analyzed data from treatment completers (n=150) in the original study (n=221), NCT00274677.|
59579296|NCT02989727|75685084|FG000|COMPLETED|Overall Study||46||
59579297|NCT02989727|75685085|FG001|COMPLETED|Overall Study||44||
59579298|NCT02989727|75685086|FG002|COMPLETED|Overall Study||30||
59579299|NCT02989727|75685087|FG003|COMPLETED|Overall Study||30||
59579300|NCT02989727|75685084|FG000|NOT COMPLETED|Overall Study||0||
59579301|NCT02989727|75685085|FG001|NOT COMPLETED|Overall Study||0||
59579302|NCT02989727|75685086|FG002|NOT COMPLETED|Overall Study||0||
59579303|NCT02989727|75685087|FG003|NOT COMPLETED|Overall Study||0||
59579304|NCT02051816|75685099|FG000|STARTED|Overall Study||37||
59579305|NCT02051816|75685100|FG001|STARTED|Overall Study||40||
59579306|NCT02051816|75685101|FG002|STARTED|Overall Study||37||
59579307|NCT02051816|75685102|FG003|STARTED|Overall Study||36||
59579308|NCT02051816|75685099|FG000|COMPLETED|Overall Study||37||
59579309|NCT02051816|75685100|FG001|COMPLETED|Overall Study||40||
59579310|NCT02051816|75685101|FG002|COMPLETED|Overall Study||37||
59579311|NCT02051816|75685102|FG003|COMPLETED|Overall Study||36||
59579312|NCT02051816|75685099|FG000|NOT COMPLETED|Overall Study||0||
59579313|NCT02051816|75685100|FG001|NOT COMPLETED|Overall Study||0||
59579314|NCT02051816|75685101|FG002|NOT COMPLETED|Overall Study||0||
59579315|NCT02051816|75685102|FG003|NOT COMPLETED|Overall Study||0||
59579316|NCT02039947|75685120|FG000|STARTED|Overall Study||76||
59579317|NCT02039947|75685121|FG001|STARTED|Overall Study||16||
59579318|NCT02039947|75685122|FG002|STARTED|Overall Study||16||
59579319|NCT02039947|75685123|FG003|STARTED|Overall Study||17||
59579320|NCT02039947|75685120|FG000|COMPLETED|Overall Study||76||
59579321|NCT02039947|75685121|FG001|COMPLETED|Overall Study||16||
59579322|NCT02039947|75685122|FG002|COMPLETED|Overall Study||16||
59579323|NCT02039947|75685123|FG003|COMPLETED|Overall Study||17||
59579324|NCT02039947|75685120|FG000|NOT COMPLETED|Overall Study||0||
59579325|NCT02039947|75685121|FG001|NOT COMPLETED|Overall Study||0||
59579326|NCT02039947|75685122|FG002|NOT COMPLETED|Overall Study||0||
59579327|NCT02039947|75685123|FG003|NOT COMPLETED|Overall Study||0||
59579328|NCT02052752|75685140|FG000|STARTED|Overall Study||30||
59579329|NCT02052752|75685141|FG001|STARTED|Overall Study||30||
59579330|NCT02052752|75685142|FG002|STARTED|Overall Study||30||
59579331|NCT02052752|75685140|FG000|COMPLETED|Overall Study||30||
59579332|NCT02052752|75685141|FG001|COMPLETED|Overall Study||30||
59579333|NCT02052752|75685142|FG002|COMPLETED|Overall Study||30||
59579334|NCT02052752|75685140|FG000|NOT COMPLETED|Overall Study||0||
59579335|NCT02052752|75685141|FG001|NOT COMPLETED|Overall Study||0||
59579336|NCT02052752|75685142|FG002|NOT COMPLETED|Overall Study||0||
59579337|NCT02992067|75685151|FG000|STARTED|Overall Study||359||
59579338|NCT02992067|75685151|FG000|COMPLETED|Overall Study||359||
59579339|NCT02992067|75685151|FG000|NOT COMPLETED|Overall Study||0||
59579340|NCT03063437|75685157|FG000|STARTED|Overall Study||4||
59579341|NCT03063437|75685158|FG001|STARTED|Overall Study||5||
59579342|NCT03063437|75685157|FG000|COMPLETED|Overall Study||4||
59579343|NCT03063437|75685158|FG001|COMPLETED|Overall Study||5||
59579344|NCT03063437|75685157|FG000|NOT COMPLETED|Overall Study||0||
59579345|NCT03063437|75685158|FG001|NOT COMPLETED|Overall Study||0||
59579346|NCT02042131|75685167|FG000|STARTED|Overall Study||32||
59579347|NCT02042131|75685168|FG001|STARTED|Overall Study||32||
59579348|NCT02042131|75685169|FG002|STARTED|Overall Study||33||
59579349|NCT02042131|75685167|FG000|COMPLETED|Overall Study||32||
59579350|NCT02042131|75685168|FG001|COMPLETED|Overall Study||32||
59579351|NCT02042131|75685169|FG002|COMPLETED|Overall Study||33||
59579352|NCT02042131|75685167|FG000|NOT COMPLETED|Overall Study||0||
59579353|NCT02042131|75685168|FG001|NOT COMPLETED|Overall Study||0||
59579354|NCT02042131|75685169|FG002|NOT COMPLETED|Overall Study||0||
59579355|NCT02996591|75685181|FG000|STARTED|Overall Study||18||
59579356|NCT02996591|75685182|FG001|STARTED|Overall Study||18||
59579357|NCT02996591|75685181|FG000|COMPLETED|Overall Study||18||
59579358|NCT02996591|75685182|FG001|COMPLETED|Overall Study||18||
59579359|NCT02996591|75685181|FG000|NOT COMPLETED|Overall Study||0||
59579360|NCT02996591|75685182|FG001|NOT COMPLETED|Overall Study||0||
59579361|NCT02053376|75685188|FG000|STARTED|Overall Study||43||
59579362|NCT02053376|75685188|FG000|COMPLETED|Overall Study||43||
59579363|NCT02053376|75685188|FG000|NOT COMPLETED|Overall Study||0||
59579364|NCT03065075|75685194|FG000|STARTED|Overall Study||76||
59579365|NCT03065075|75685195|FG001|STARTED|Overall Study||76||
59579366|NCT03065075|75685194|FG000|Intent-to-treat Analysis|Overall Study||72||
59579367|NCT03065075|75685195|FG001|Intent-to-treat Analysis|Overall Study||74||
59579368|NCT03065075|75685194|FG000|As-treated Analysis|Overall Study||69||
59579369|NCT03065075|75685195|FG001|As-treated Analysis|Overall Study||77||
59579370|NCT03065075|75685194|FG000|COMPLETED|Overall Study||76||
59579371|NCT03065075|75685195|FG001|COMPLETED|Overall Study||76||
59579372|NCT03065075|75685194|FG000|NOT COMPLETED|Overall Study||0||
59579373|NCT03065075|75685195|FG001|NOT COMPLETED|Overall Study||0||
59579374|NCT03066947|75685201|FG000|STARTED|Overall Study||24||
59579375|NCT03066947|75685201|FG000|COMPLETED|Overall Study||14||
59579376|NCT03066947|75685201|FG000|NOT COMPLETED|Overall Study||10||
59579377|NCT02042911|75685206|FG000|STARTED|Overall Study||10||
59579378|NCT02042911|75685206|FG000|COMPLETED|Overall Study||9||
59579379|NCT02042911|75685206|FG000|NOT COMPLETED|Overall Study||1||
59579380|NCT02043145|75685213|FG000|STARTED|Overall Study||55||
59579381|NCT02043145|75685214|FG001|STARTED|Overall Study||247||
59579382|NCT02043145|75685215|FG002|STARTED|Overall Study||425||
59579383|NCT02043145|75685213|FG000|COMPLETED|Overall Study||55||
59579384|NCT02043145|75685214|FG001|COMPLETED|Overall Study||247||
59579385|NCT02043145|75685215|FG002|COMPLETED|Overall Study||425||
59579386|NCT02043145|75685213|FG000|NOT COMPLETED|Overall Study||0||
59579387|NCT02043145|75685214|FG001|NOT COMPLETED|Overall Study||0||
59579388|NCT02043145|75685215|FG002|NOT COMPLETED|Overall Study||0||
60121501|NCT01685801|76242413|FG001|NOT COMPLETED|Cycle 2 Period 1 (2 Weeks)||0||
60121502|NCT01685801|76242414|FG002|NOT COMPLETED|Cycle 2 Period 1 (2 Weeks)||0||
60121503|NCT01685801|76242415|FG003|NOT COMPLETED|Cycle 2 Period 1 (2 Weeks)||0||
59579389|NCT02062801|75685227|FG000|STARTED|Overall Study||301||
59579390|NCT02062801|75685228|FG001|STARTED|Overall Study||301||
59579391|NCT02062801|75685227|FG000|COMPLETED|Overall Study||299||
59579392|NCT02062801|75685228|FG001|COMPLETED|Overall Study||297||
59579393|NCT02062801|75685227|FG000|NOT COMPLETED|Overall Study||2||
59579394|NCT02062801|75685228|FG001|NOT COMPLETED|Overall Study||4||
59579395|NCT03152591|75685236|FG000|STARTED|Overall Study||15|All randomized patients were included in the Full Analysis Set (FAS) and Safety Analysis Set (SAF).|
59579396|NCT03152591|75685237|FG001|STARTED|Overall Study||14|All randomized patients were included in the Full Analysis Set (FAS) and Safety Analysis Set (SAF).|
59579397|NCT03152591|75685236|FG000|Pharmacokinetic (PK) Analysis Set|Overall Study||14|At least one dose of study drug and one evaluable PK concentration measurement|
59579398|NCT03152591|75685237|FG001|Pharmacokinetic (PK) Analysis Set|Overall Study||0|At least one dose of study drug and one evaluable PK concentration measurement|
59579399|NCT03152591|75685236|FG000|Pharmacodynamic (PD) Analysis Set|Overall Study||15|At least one dose of study drug and one evaluable PD assessment|
59579400|NCT03152591|75685237|FG001|Pharmacodynamic (PD) Analysis Set|Overall Study||14|At least one dose of study drug and one evaluable PD assessment|
59579401|NCT03152591|75685236|FG000|COMPLETED|Overall Study||15||
59579402|NCT03152591|75685237|FG001|COMPLETED|Overall Study||14||
60121504|NCT01685801|76242412|FG000|STARTED|Cycle 2 Period 2 (2 Weeks)||5||
59579403|NCT03152591|75685236|FG000|NOT COMPLETED|Overall Study||0||
59579404|NCT03152591|75685237|FG001|NOT COMPLETED|Overall Study||0||
59579405|NCT02063035|75685245|FG000|STARTED|Overall Study||12||
59579406|NCT02063035|75685246|FG001|STARTED|Overall Study||17||
59579407|NCT02063035|75685245|FG000|COMPLETED|Overall Study||12||
59579408|NCT02063035|75685246|FG001|COMPLETED|Overall Study||17||
59579409|NCT02063035|75685245|FG000|NOT COMPLETED|Overall Study||0||
59579410|NCT02063035|75685246|FG001|NOT COMPLETED|Overall Study||0||
59579411|NCT02043379|75685254|FG000|STARTED|Overall Study||30||
59579412|NCT02043379|75685255|FG001|STARTED|Overall Study||20||
59579413|NCT02043379|75685254|FG000|COMPLETED|Overall Study||30||
59579414|NCT02043379|75685255|FG001|COMPLETED|Overall Study||20||
59579415|NCT02043379|75685254|FG000|NOT COMPLETED|Overall Study||0||
59579416|NCT02043379|75685255|FG001|NOT COMPLETED|Overall Study||0||
59579417|NCT02054156|75685263|FG000|STARTED|Overall Study||110||
59579418|NCT02054156|75685264|FG001|STARTED|Overall Study||111||
59579419|NCT02054156|75685263|FG000|COMPLETED|Overall Study||35||
59579420|NCT02054156|75685264|FG001|COMPLETED|Overall Study||30||
59579421|NCT02054156|75685263|FG000|NOT COMPLETED|Overall Study||75||
59579422|NCT02054156|75685264|FG001|NOT COMPLETED|Overall Study||81||
59579423|NCT03159143|75685270|FG000|STARTED|Overall Study||22||
59579424|NCT03159143|75685270|FG000|COMPLETED|Overall Study||22||
59579425|NCT03159143|75685270|FG000|NOT COMPLETED|Overall Study||0||
59579426|NCT03159299|75685276|FG000|STARTED|Overall Study||26||
59579427|NCT03159299|75685277|FG001|STARTED|Overall Study||21||
59579428|NCT03159299|75685276|FG000|COMPLETED|Overall Study||24||
59579429|NCT03159299|75685277|FG001|COMPLETED|Overall Study||20||
59723985|NCT00937521|75842588|FG002|STARTED|Booster Phase||169||
59723986|NCT00937521|75842589|FG003|STARTED|Booster Phase||170||
59723987|NCT00937521|75842590|FG004|STARTED|Booster Phase||168||
59723988|NCT00937521|75842591|FG005|STARTED|Booster Phase||165||
59723989|NCT00937521|75842592|FG006|STARTED|Booster Phase||165||
59723990|NCT00937521|75842593|FG007|STARTED|Booster Phase||161||
59723991|NCT00937521|75842586|FG000|Premature Withdrawal|Booster Phase||3||
59723992|NCT00937521|75842587|FG001|Premature Withdrawal|Booster Phase||2||
59723993|NCT00937521|75842588|FG002|Premature Withdrawal|Booster Phase||5||
59723994|NCT00937521|75842589|FG003|Premature Withdrawal|Booster Phase||3||
59723995|NCT00937521|75842590|FG004|Premature Withdrawal|Booster Phase||5||
59723996|NCT00937521|75842591|FG005|Premature Withdrawal|Booster Phase||5||
59723997|NCT00937521|75842592|FG006|Premature Withdrawal|Booster Phase||5||
59723998|NCT00937521|75842593|FG007|Premature Withdrawal|Booster Phase||2||
59723999|NCT00937521|75842586|FG000|COMPLETED|Booster Phase||152||
59724000|NCT00937521|75842587|FG001|COMPLETED|Booster Phase||161||
59724001|NCT00937521|75842588|FG002|COMPLETED|Booster Phase||164||
59724002|NCT00937521|75842589|FG003|COMPLETED|Booster Phase||167||
59724003|NCT00937521|75842590|FG004|COMPLETED|Booster Phase||163||
59724004|NCT00937521|75842591|FG005|COMPLETED|Booster Phase||160||
59724005|NCT00937521|75842592|FG006|COMPLETED|Booster Phase||160||
59724006|NCT00937521|75842593|FG007|COMPLETED|Booster Phase||159||
59724007|NCT00937521|75842586|FG000|NOT COMPLETED|Booster Phase||3||
59724008|NCT00937521|75842587|FG001|NOT COMPLETED|Booster Phase||2||
59724009|NCT00937521|75842588|FG002|NOT COMPLETED|Booster Phase||5||
59724010|NCT00937521|75842589|FG003|NOT COMPLETED|Booster Phase||3||
59724011|NCT00937521|75842590|FG004|NOT COMPLETED|Booster Phase||5||
59851388|NCT03868735|75975632|FG000|COMPLETED|Overall Study||136||
59851389|NCT03868735|75975633|FG001|COMPLETED|Overall Study||136||
59851390|NCT03868735|75975632|FG000|NOT COMPLETED|Overall Study||0||
59851391|NCT03868735|75975633|FG001|NOT COMPLETED|Overall Study||0||
59579430|NCT03159299|75685276|FG000|NOT COMPLETED|Overall Study||2||
59579431|NCT03159299|75685277|FG001|NOT COMPLETED|Overall Study||1||
59579432|NCT02376530|75685287|FG000|STARTED|Overall Study||196||
59579433|NCT02376530|75685288|FG001|STARTED|Overall Study||198||
59579434|NCT02376530|75685289|FG002|STARTED|Overall Study||197||
59579435|NCT02376530|75685290|FG003|STARTED|Overall Study||197||
59579436|NCT02376530|75685287|FG000|COMPLETED|Overall Study||196||
59579437|NCT02376530|75685288|FG001|COMPLETED|Overall Study||198||
59579438|NCT02376530|75685289|FG002|COMPLETED|Overall Study||197||
59579439|NCT02376530|75685290|FG003|COMPLETED|Overall Study||197||
59579440|NCT02376530|75685287|FG000|NOT COMPLETED|Overall Study||0||
59579441|NCT02376530|75685288|FG001|NOT COMPLETED|Overall Study||0||
59579442|NCT02376530|75685289|FG002|NOT COMPLETED|Overall Study||0||
59579443|NCT02376530|75685290|FG003|NOT COMPLETED|Overall Study||0||
59579444|NCT02376998|75685300|FG000|STARTED|Overall Study||20||
59579445|NCT02376998|75685300|FG000|COMPLETED|Overall Study||11||
59579446|NCT02376998|75685300|FG000|NOT COMPLETED|Overall Study||9||
59579447|NCT03161327|75685304|FG000|STARTED|Overall Study||238||
59579448|NCT03161327|75685304|FG000|COMPLETED|Overall Study||238||
59579449|NCT03161327|75685304|FG000|NOT COMPLETED|Overall Study||0||
59579450|NCT02377700|75685309|FG000|STARTED|Overall Study||5||
59724012|NCT00937521|75842591|FG005|NOT COMPLETED|Booster Phase||5||
59724013|NCT00937521|75842592|FG006|NOT COMPLETED|Booster Phase||5||
59724014|NCT00937521|75842593|FG007|NOT COMPLETED|Booster Phase||2||
59724015|NCT00935883|75842628|FG000|STARTED|Treatment Period||20||
59724016|NCT00935883|75842629|FG001|STARTED|Treatment Period||40||
59724017|NCT00935883|75842628|FG000|COMPLETED|Treatment Period||19||
59724018|NCT00935883|75842629|FG001|COMPLETED|Treatment Period||38||
59724019|NCT00935883|75842628|FG000|NOT COMPLETED|Treatment Period||1||
59724020|NCT00935883|75842629|FG001|NOT COMPLETED|Treatment Period||2||
59724021|NCT00935883|75842628|FG000|STARTED|Follow-Up Period||19||
59724022|NCT00935883|75842629|FG001|STARTED|Follow-Up Period||38||
59724023|NCT00935883|75842628|FG000|COMPLETED|Follow-Up Period||19||
59724024|NCT00935883|75842629|FG001|COMPLETED|Follow-Up Period||38||
59851392|NCT03786952|75975647|FG000|STARTED|Overall Study||56||
59724025|NCT00935883|75842628|FG000|NOT COMPLETED|Follow-Up Period||0||
59724026|NCT00935883|75842629|FG001|NOT COMPLETED|Follow-Up Period||0||
59579451|NCT02377700|75685309|FG000|COMPLETED|Overall Study||5||
59579452|NCT02377700|75685309|FG000|NOT COMPLETED|Overall Study||0||
59579453|NCT03068897|75685317|FG000|STARTED|Overall Study||80||
59579454|NCT03068897|75685318|FG001|STARTED|Overall Study||80||
59579455|NCT03068897|75685319|FG002|STARTED|Overall Study||80||
59579456|NCT03068897|75685320|FG003|STARTED|Overall Study||80||
59579457|NCT03068897|75685317|FG000|COMPLETED|Overall Study||76||
59579458|NCT03068897|75685318|FG001|COMPLETED|Overall Study||76||
59579459|NCT03068897|75685319|FG002|COMPLETED|Overall Study||79||
59579460|NCT03068897|75685320|FG003|COMPLETED|Overall Study||74||
59579461|NCT03068897|75685317|FG000|NOT COMPLETED|Overall Study||4||
59579462|NCT03068897|75685318|FG001|NOT COMPLETED|Overall Study||4||
59579463|NCT03068897|75685319|FG002|NOT COMPLETED|Overall Study||1||
59579464|NCT03068897|75685320|FG003|NOT COMPLETED|Overall Study||6||
59579465|NCT02049476|75685330|FG000|STARTED|Overall Study|First patient enrolled on 1/31/2014|20||28
59579466|NCT02049476|75685330|FG000|COMPLETED|Overall Study|20th patient completed the study|20||28
59579467|NCT02049476|75685330|FG000|NOT COMPLETED|Overall Study||0||0
59579468|NCT02299297|75685334|FG000|STARTED|Overall Study||12||
59579469|NCT02299297|75685334|FG000|COMPLETED|Overall Study||11||
59579470|NCT02299297|75685334|FG000|NOT COMPLETED|Overall Study||1||
59579471|NCT02055404|75685338|FG000|STARTED|Overall Study||3||
59579472|NCT02055404|75685338|FG000|COMPLETED|Overall Study||3||
59579473|NCT02055404|75685338|FG000|NOT COMPLETED|Overall Study||0||
59579474|NCT03069677|75685353|FG000|STARTED|Overall Study||80||
59579475|NCT03069677|75685354|FG001|STARTED|Overall Study||80||
59579476|NCT03069677|75685353|FG000|COMPLETED|Overall Study||77||
59579477|NCT03069677|75685354|FG001|COMPLETED|Overall Study||77||
59579478|NCT03069677|75685353|FG000|NOT COMPLETED|Overall Study||3||
59579479|NCT03069677|75685354|FG001|NOT COMPLETED|Overall Study||3||
59579480|NCT03072953|75685360|FG000|STARTED|Overall Study||2||
59579481|NCT03072953|75685360|FG000|COMPLETED|Overall Study||2||
59579482|NCT03072953|75685360|FG000|NOT COMPLETED|Overall Study||0||
59579483|NCT02044393|75685366|FG000|STARTED|Period 1||10||
59579484|NCT02044393|75685367|FG001|STARTED|Period 1||10||
59579485|NCT02044393|75685366|FG000|COMPLETED|Period 1||10||
59579486|NCT02044393|75685367|FG001|COMPLETED|Period 1||10||
59579487|NCT02044393|75685366|FG000|NOT COMPLETED|Period 1||0||
59579488|NCT02044393|75685367|FG001|NOT COMPLETED|Period 1||0||
59579489|NCT02044393|75685366|FG000|STARTED|Period 2||10||
59579490|NCT02044393|75685367|FG001|STARTED|Period 2||10||
59579491|NCT02044393|75685366|FG000|COMPLETED|Period 2||10||
59579492|NCT02044393|75685367|FG001|COMPLETED|Period 2||10||
59579493|NCT02044393|75685366|FG000|NOT COMPLETED|Period 2||0||
59579494|NCT02044393|75685367|FG001|NOT COMPLETED|Period 2||0||
59579495|NCT02378402|75685380|FG000|STARTED|Overall Study||25||
59579496|NCT02378402|75685381|FG001|STARTED|Overall Study||25||
59579497|NCT02378402|75685382|FG002|STARTED|Overall Study||21||
59579498|NCT02378402|75685380|FG000|COMPLETED|Overall Study||25||
59579499|NCT02378402|75685381|FG001|COMPLETED|Overall Study||23||
59579500|NCT02378402|75685382|FG002|COMPLETED|Overall Study||21||
59579501|NCT02378402|75685380|FG000|NOT COMPLETED|Overall Study||0||
59579502|NCT02378402|75685381|FG001|NOT COMPLETED|Overall Study||2||
59579503|NCT02378402|75685382|FG002|NOT COMPLETED|Overall Study||0||
59579504|NCT02046265|75685394|FG000|STARTED|Overall Study||17||
59579505|NCT02046265|75685395|FG001|STARTED|Overall Study||17||
59579506|NCT02046265|75685396|FG002|STARTED|Overall Study||12||
59579507|NCT02046265|75685397|FG003|STARTED|Overall Study||14||
59579508|NCT02046265|75685394|FG000|COMPLETED|Overall Study||16||
59579509|NCT02046265|75685395|FG001|COMPLETED|Overall Study||15||
59579510|NCT02046265|75685396|FG002|COMPLETED|Overall Study||10||
59579511|NCT02046265|75685397|FG003|COMPLETED|Overall Study||12||
59579512|NCT02046265|75685394|FG000|NOT COMPLETED|Overall Study||1||
59579513|NCT02046265|75685395|FG001|NOT COMPLETED|Overall Study||2||
59579514|NCT02046265|75685396|FG002|NOT COMPLETED|Overall Study||2||
59579515|NCT02046265|75685397|FG003|NOT COMPLETED|Overall Study||2||
59579516|NCT02064907|75685409|FG000|STARTED|Period 1||26||
59579517|NCT02064907|75685410|FG001|STARTED|Period 1||26||
59579518|NCT02064907|75685409|FG000|COMPLETED|Period 1||26||
59724027|NCT00936975|75842635|FG000|STARTED|Overall Study||18||
59579519|NCT02064907|75685410|FG001|COMPLETED|Period 1||26||
59579520|NCT02064907|75685409|FG000|NOT COMPLETED|Period 1||0||
59579521|NCT02064907|75685410|FG001|NOT COMPLETED|Period 1||0||
59579522|NCT02064907|75685409|FG000|STARTED|Period 2||26||
59579523|NCT02064907|75685410|FG001|STARTED|Period 2||26||
59579524|NCT02064907|75685409|FG000|COMPLETED|Period 2||26||
59724028|NCT00936975|75842635|FG000|COMPLETED|Overall Study||12||
59996741|NCT04445051|76112588|FG000|COMPLETED|Overall Study||5||
59579525|NCT02064907|75685410|FG001|COMPLETED|Period 2||26||
59579526|NCT02064907|75685409|FG000|NOT COMPLETED|Period 2||0||
59579527|NCT02064907|75685410|FG001|NOT COMPLETED|Period 2||0||
59579528|NCT03165617|75685418|FG000|STARTED|Overall Study||2258||
59579529|NCT03165617|75685419|FG001|STARTED|Overall Study||2256||
59579530|NCT03165617|75685418|FG000|COMPLETED|Overall Study||2249||
59579531|NCT03165617|75685419|FG001|COMPLETED|Overall Study||2247||
59579532|NCT03165617|75685418|FG000|NOT COMPLETED|Overall Study||9||
59579533|NCT03165617|75685419|FG001|NOT COMPLETED|Overall Study||9||
59579534|NCT02064985|75685446|FG000|STARTED|Overall Study||12||
59579535|NCT02064985|75685447|FG001|STARTED|Overall Study||12||
59579536|NCT02064985|75685448|FG002|STARTED|Overall Study||12||
59579537|NCT02064985|75685446|FG000|COMPLETED|Overall Study||12||
59579538|NCT02064985|75685447|FG001|COMPLETED|Overall Study||12||
59579539|NCT02064985|75685448|FG002|COMPLETED|Overall Study||12||
59579540|NCT02064985|75685446|FG000|NOT COMPLETED|Overall Study||0||
59579541|NCT02064985|75685447|FG001|NOT COMPLETED|Overall Study||0||
59579542|NCT02064985|75685448|FG002|NOT COMPLETED|Overall Study||0||
59579543|NCT03075449|75685456|FG000|STARTED|Overall Study||170||
59579544|NCT03075449|75685456|FG000|COMPLETED|Overall Study||170||
59579545|NCT03075449|75685456|FG000|NOT COMPLETED|Overall Study||0||
59579546|NCT02065453|75685462|FG000|STARTED|Overall Study||27||
59579547|NCT02065453|75685463|FG001|STARTED|Overall Study||25||
59579548|NCT02065453|75685462|FG000|COMPLETED|Overall Study||24||
59579549|NCT02065453|75685463|FG001|COMPLETED|Overall Study||21||
59579550|NCT02065453|75685462|FG000|NOT COMPLETED|Overall Study||3||
59579551|NCT02065453|75685463|FG001|NOT COMPLETED|Overall Study||4||
59579552|NCT03077165|75685474|FG000|STARTED|Overall Study||21||
59579553|NCT03077165|75685475|FG001|STARTED|Overall Study||22||
59579554|NCT03077165|75685476|FG002|STARTED|Overall Study||20||
59724029|NCT00936975|75842635|FG000|NOT COMPLETED|Overall Study||6||
59724030|NCT00936897|75842642|FG000|STARTED|Overall Study|Randomized|417||
59724031|NCT00936897|75842643|FG001|STARTED|Overall Study|Randomized|416||
59724032|NCT00936897|75842642|FG000|COMPLETED|Overall Study||398||
59724033|NCT00936897|75842643|FG001|COMPLETED|Overall Study||356||
59724034|NCT00936897|75842642|FG000|NOT COMPLETED|Overall Study||19||
59851393|NCT03786952|75975648|FG001|STARTED|Overall Study||59||
59851394|NCT03786952|75975649|FG002|STARTED|Overall Study||58||
59851395|NCT03786952|75975650|FG003|STARTED|Overall Study||57||
59851396|NCT03786952|75975651|FG004|STARTED|Overall Study||97||
59851397|NCT03786952|75975652|FG005|STARTED|Overall Study||87||
59851398|NCT03786952|75975653|FG006|STARTED|Overall Study||94||
59851399|NCT03786952|75975654|FG007|STARTED|Overall Study||98||
59851400|NCT03786952|75975647|FG000|COMPLETED|Overall Study||56||
59851401|NCT03786952|75975648|FG001|COMPLETED|Overall Study||59||
59851402|NCT03786952|75975649|FG002|COMPLETED|Overall Study||58||
59851403|NCT03786952|75975650|FG003|COMPLETED|Overall Study||57||
59851404|NCT03786952|75975651|FG004|COMPLETED|Overall Study||97||
59851405|NCT03786952|75975652|FG005|COMPLETED|Overall Study||87||
59851406|NCT03786952|75975653|FG006|COMPLETED|Overall Study||94||
59851407|NCT03786952|75975654|FG007|COMPLETED|Overall Study||98||
59851408|NCT03786952|75975647|FG000|NOT COMPLETED|Overall Study||0||
59851409|NCT03786952|75975648|FG001|NOT COMPLETED|Overall Study||0||
59851410|NCT03786952|75975649|FG002|NOT COMPLETED|Overall Study||0||
59851411|NCT03786952|75975650|FG003|NOT COMPLETED|Overall Study||0||
59851412|NCT03786952|75975651|FG004|NOT COMPLETED|Overall Study||0||
59851413|NCT03786952|75975652|FG005|NOT COMPLETED|Overall Study||0||
59579555|NCT03077165|75685477|FG003|STARTED|Overall Study||19||
59579556|NCT03077165|75685478|FG004|STARTED|Overall Study||19||
59579557|NCT03077165|75685479|FG005|STARTED|Overall Study||20||
59579558|NCT03077165|75685474|FG000|COMPLETED|Overall Study||20||
59579559|NCT03077165|75685475|FG001|COMPLETED|Overall Study||22||
59579560|NCT03077165|75685476|FG002|COMPLETED|Overall Study||20||
59579561|NCT03077165|75685477|FG003|COMPLETED|Overall Study||19||
59579562|NCT03077165|75685478|FG004|COMPLETED|Overall Study||16||
59579563|NCT03077165|75685479|FG005|COMPLETED|Overall Study||20||
59579564|NCT03077165|75685474|FG000|NOT COMPLETED|Overall Study||1||
59579565|NCT03077165|75685475|FG001|NOT COMPLETED|Overall Study||0||
59579566|NCT03077165|75685476|FG002|NOT COMPLETED|Overall Study||0||
59579567|NCT03077165|75685477|FG003|NOT COMPLETED|Overall Study||0||
59579568|NCT03077165|75685478|FG004|NOT COMPLETED|Overall Study||3||
59579569|NCT03077165|75685479|FG005|NOT COMPLETED|Overall Study||0||
59724035|NCT00936897|75842643|FG001|NOT COMPLETED|Overall Study||60||
59724036|NCT01120691|75842652|FG000|STARTED|Overall Study||741||
59724037|NCT01120691|75842653|FG001|STARTED|Overall Study||741||
59724038|NCT01120691|75842654|FG002|STARTED|Overall Study||742||
59724039|NCT01120691|75842652|FG000|Full Analysis Set (FAS)|Overall Study||736||
59724040|NCT01120691|75842653|FG001|Full Analysis Set (FAS)|Overall Study||739||
59851414|NCT03786952|75975653|FG006|NOT COMPLETED|Overall Study||0||
59851415|NCT03786952|75975654|FG007|NOT COMPLETED|Overall Study||0||
59851416|NCT03493958|75976016|FG000|STARTED|Overall Study||25||
59851417|NCT03493958|75976016|FG000|COMPLETED|Overall Study||10||
59851418|NCT03493958|75976016|FG000|NOT COMPLETED|Overall Study||15||
59851419|NCT03486223|75976022|FG000|STARTED|Intervention 1||8||
59579570|NCT03170219|75685495|FG000|STARTED|Overall Study||7||
59579571|NCT03170219|75685496|FG001|STARTED|Overall Study||4||
59579572|NCT03170219|75685495|FG000|COMPLETED|Overall Study||7||
59851420|NCT03486223|75976023|FG001|STARTED|Intervention 1||8||
59851421|NCT03486223|75976022|FG000|COMPLETED|Intervention 1||8||
59851422|NCT03486223|75976023|FG001|COMPLETED|Intervention 1||7||
59851423|NCT03486223|75976022|FG000|NOT COMPLETED|Intervention 1||0||
59851424|NCT03486223|75976023|FG001|NOT COMPLETED|Intervention 1||1||
59851425|NCT03486223|75976022|FG000|STARTED|Washout||8||
59851426|NCT03486223|75976023|FG001|STARTED|Washout||7||
59851427|NCT03486223|75976022|FG000|COMPLETED|Washout||8||
59851428|NCT03486223|75976023|FG001|COMPLETED|Washout||7||
59851429|NCT03486223|75976022|FG000|NOT COMPLETED|Washout||0||
59579573|NCT03170219|75685496|FG001|COMPLETED|Overall Study||4||
59579574|NCT03170219|75685495|FG000|NOT COMPLETED|Overall Study||0||
59579575|NCT03170219|75685496|FG001|NOT COMPLETED|Overall Study||0||
59579576|NCT03177395|75685506|FG000|STARTED|Overall Study||6||
59579577|NCT03177395|75685507|FG001|STARTED|Overall Study||6||
59579578|NCT03177395|75685508|FG002|STARTED|Overall Study||6||
59579579|NCT03177395|75685509|FG003|STARTED|Overall Study||6||
59579580|NCT03177395|75685506|FG000|COMPLETED|Overall Study||6||
59579581|NCT03177395|75685507|FG001|COMPLETED|Overall Study||6||
59579582|NCT03177395|75685508|FG002|COMPLETED|Overall Study||6||
59579583|NCT03177395|75685509|FG003|COMPLETED|Overall Study||6||
59579584|NCT03177395|75685506|FG000|NOT COMPLETED|Overall Study||0||
59579585|NCT03177395|75685507|FG001|NOT COMPLETED|Overall Study||0||
59579586|NCT03177395|75685508|FG002|NOT COMPLETED|Overall Study||0||
59579587|NCT03177395|75685509|FG003|NOT COMPLETED|Overall Study||0||
59579588|NCT03078647|75685524|FG000|STARTED|Overall Study||17||
59579589|NCT03078647|75685525|FG001|STARTED|Overall Study||11||
59579590|NCT03078647|75685526|FG002|STARTED|Overall Study||3||
59579591|NCT03078647|75685524|FG000|COMPLETED|Overall Study||17||
59579592|NCT03078647|75685525|FG001|COMPLETED|Overall Study||10||
59579593|NCT03078647|75685526|FG002|COMPLETED|Overall Study||3||
59579594|NCT03078647|75685524|FG000|NOT COMPLETED|Overall Study||0||
59579595|NCT03078647|75685525|FG001|NOT COMPLETED|Overall Study||1||
59579596|NCT03078647|75685526|FG002|NOT COMPLETED|Overall Study||0||
59579597|NCT03083093|75685536|FG000|STARTED|Overall Study||50||
59579598|NCT03083093|75685537|FG001|STARTED|Overall Study||50||
59579599|NCT03083093|75685536|FG000|COMPLETED|Overall Study||50||
59579600|NCT03083093|75685537|FG001|COMPLETED|Overall Study||50||
59579601|NCT03083093|75685536|FG000|NOT COMPLETED|Overall Study||0||
59579602|NCT03083093|75685537|FG001|NOT COMPLETED|Overall Study||0||
59579603|NCT03179345|75685547|FG000|STARTED|Overall Study||8||
59579604|NCT03179345|75685548|FG001|STARTED|Overall Study||8||
59579605|NCT03179345|75685549|FG002|STARTED|Overall Study||8||
59579606|NCT03179345|75685550|FG003|STARTED|Overall Study||8||
59579607|NCT03179345|75685547|FG000|Received Gralise®|Overall Study||8||
59579608|NCT03179345|75685548|FG001|Received Gralise®|Overall Study||7||
59579609|NCT03179345|75685549|FG002|Received Gralise®|Overall Study||7||
59579610|NCT03179345|75685550|FG003|Received Gralise®|Overall Study||6||
59579611|NCT03179345|75685547|FG000|Received Neurontin®|Overall Study||8||
59579612|NCT03179345|75685548|FG001|Received Neurontin®|Overall Study||8||
59579613|NCT03179345|75685549|FG002|Received Neurontin®|Overall Study||7||
59579614|NCT03179345|75685550|FG003|Received Neurontin®|Overall Study||8||
59579615|NCT03179345|75685547|FG000|Received Lyrica®|Overall Study||8||
59851430|NCT03486223|75976023|FG001|NOT COMPLETED|Washout||0||
59851431|NCT03486223|75976022|FG000|STARTED|Intervention 2||8||
59851432|NCT03486223|75976023|FG001|STARTED|Intervention 2||7||
59851433|NCT03486223|75976022|FG000|COMPLETED|Intervention 2||8||
59579616|NCT03179345|75685548|FG001|Received Lyrica®|Overall Study||7||
59579617|NCT03179345|75685549|FG002|Received Lyrica®|Overall Study||8||
59579618|NCT03179345|75685550|FG003|Received Lyrica®|Overall Study||8||
59579619|NCT03179345|75685547|FG000|Received Placebo|Overall Study||8||
59579620|NCT03179345|75685548|FG001|Received Placebo|Overall Study||7||
59579621|NCT03179345|75685549|FG002|Received Placebo|Overall Study||7||
59579622|NCT03179345|75685550|FG003|Received Placebo|Overall Study||8||
59579623|NCT03179345|75685547|FG000|COMPLETED|Overall Study||8||
59579624|NCT03179345|75685548|FG001|COMPLETED|Overall Study||7||
59579625|NCT03179345|75685549|FG002|COMPLETED|Overall Study||7||
59579626|NCT03179345|75685550|FG003|COMPLETED|Overall Study||6||
59579627|NCT03179345|75685547|FG000|NOT COMPLETED|Overall Study||0||
59579628|NCT03179345|75685548|FG001|NOT COMPLETED|Overall Study||1||
59579629|NCT03179345|75685549|FG002|NOT COMPLETED|Overall Study||1||
59851434|NCT03486223|75976023|FG001|COMPLETED|Intervention 2||7||
59851435|NCT03486223|75976022|FG000|NOT COMPLETED|Intervention 2||0||
59579630|NCT03179345|75685550|FG003|NOT COMPLETED|Overall Study||2||
59579631|NCT03180515|75685566|FG000|STARTED|Aim 1||12||
59579632|NCT03180515|75685566|FG000|COMPLETED|Aim 1||12||
59579633|NCT03180515|75685566|FG000|NOT COMPLETED|Aim 1||0||
59579634|NCT03180515|75685566|FG000|STARTED|Aim 2||12||
59579635|NCT03180515|75685566|FG000|COMPLETED|Aim 2||12||
59579636|NCT03180515|75685566|FG000|NOT COMPLETED|Aim 2||0||
59579637|NCT03180515|75685566|FG000|STARTED|Aim 3||1||
59579638|NCT03180515|75685566|FG000|COMPLETED|Aim 3||1||
59579639|NCT03180515|75685566|FG000|NOT COMPLETED|Aim 3||0||
59851436|NCT03486223|75976023|FG001|NOT COMPLETED|Intervention 2||0||
59851437|NCT03482024|75976034|FG000|STARTED|Overall Study||14||
59579640|NCT03086213|75685582|FG000|STARTED|Overall Study||24||
59579641|NCT03086213|75685583|FG001|STARTED|Overall Study||24||
59579642|NCT03086213|75685582|FG000|COMPLETED|Overall Study||24||
59579643|NCT03086213|75685583|FG001|COMPLETED|Overall Study||24||
59579644|NCT03086213|75685582|FG000|NOT COMPLETED|Overall Study||0||
59851438|NCT03482024|75976035|FG001|STARTED|Overall Study||8||
59851439|NCT03482024|75976036|FG002|STARTED|Overall Study||8||
59579645|NCT03086213|75685583|FG001|NOT COMPLETED|Overall Study||0||
59851440|NCT03482024|75976037|FG003|STARTED|Overall Study||7||
59579646|NCT03089879|75685592|FG000|STARTED|Overall Study||7||
59579647|NCT03089879|75685593|FG001|STARTED|Overall Study||2||
59579648|NCT03089879|75685594|FG002|STARTED|Overall Study||26||
59579649|NCT03089879|75685592|FG000|COMPLETED|Overall Study||7||
59579650|NCT03089879|75685593|FG001|COMPLETED|Overall Study||2||
59579651|NCT03089879|75685594|FG002|COMPLETED|Overall Study||26||
59579652|NCT03089879|75685592|FG000|NOT COMPLETED|Overall Study||0||
59579653|NCT03089879|75685593|FG001|NOT COMPLETED|Overall Study||0||
59579654|NCT03089879|75685594|FG002|NOT COMPLETED|Overall Study||0||
59579655|NCT02378714|75685607|FG000|STARTED|Overall Study||68||
59579656|NCT02378714|75685608|FG001|STARTED|Overall Study||68||
59579657|NCT02378714|75685609|FG002|STARTED|Overall Study||81||
59579658|NCT02378714|75685610|FG003|STARTED|Overall Study||83||
59579659|NCT02378714|75685607|FG000|COMPLETED|Overall Study||39||
59579660|NCT02378714|75685608|FG001|COMPLETED|Overall Study||29||
59579661|NCT02378714|75685609|FG002|COMPLETED|Overall Study||51||
59579662|NCT02378714|75685610|FG003|COMPLETED|Overall Study||51||
59579663|NCT02378714|75685607|FG000|NOT COMPLETED|Overall Study||29||
59579664|NCT02378714|75685608|FG001|NOT COMPLETED|Overall Study||39||
59579665|NCT02378714|75685609|FG002|NOT COMPLETED|Overall Study||30||
59579666|NCT02378714|75685610|FG003|NOT COMPLETED|Overall Study||32||
59579667|NCT03091361|75685642|FG000|STARTED|Overall Study||30||
59579668|NCT03091361|75685642|FG000|COMPLETED|Overall Study||30||
59579669|NCT03091361|75685642|FG000|NOT COMPLETED|Overall Study||0||
59579670|NCT05091047|75685646|FG000|STARTED|Overall Study||8||
59579671|NCT05091047|75685646|FG000|COMPLETED|Overall Study||8||
59579672|NCT05091047|75685646|FG000|NOT COMPLETED|Overall Study||0||
59579673|NCT03091673|75685653|FG000|STARTED|First Dose||31||
59579674|NCT03091673|75685654|FG001|STARTED|First Dose|All 31 subjects received the 0.5 mg dose during period 1.|0||
59579675|NCT03091673|75685653|FG000|COMPLETED|First Dose||31||
59579676|NCT03091673|75685654|FG001|COMPLETED|First Dose||0||
59579677|NCT03091673|75685653|FG000|NOT COMPLETED|First Dose||0||
59579678|NCT03091673|75685654|FG001|NOT COMPLETED|First Dose||0||
59579679|NCT03091673|75685653|FG000|STARTED|Second Dose|No subjects received the 0.5 mg dose during period 2.|0||
59579680|NCT03091673|75685654|FG001|STARTED|Second Dose|Only the 11 study subjects ages 12-<18 years were assigned the 1 mg dose during period 2.|11||
59579681|NCT03091673|75685653|FG000|COMPLETED|Second Dose||0||
59579682|NCT03091673|75685654|FG001|COMPLETED|Second Dose||11||
59579683|NCT03091673|75685653|FG000|NOT COMPLETED|Second Dose||0||
59579684|NCT03091673|75685654|FG001|NOT COMPLETED|Second Dose||0||
59579685|NCT03091751|75685665|FG000|STARTED|Overall Study||22||
59579686|NCT03091751|75685665|FG000|COMPLETED|Overall Study||22||
59579687|NCT03091751|75685665|FG000|NOT COMPLETED|Overall Study||0||
59579688|NCT02381288|75685673|FG000|STARTED|Overall Study||5||
59579689|NCT02381288|75685674|FG001|STARTED|Overall Study||2||
59579690|NCT02381288|75685675|FG002|STARTED|Overall Study||5||
59579691|NCT02381288|75685676|FG003|STARTED|Overall Study||5||
59579692|NCT02381288|75685673|FG000|COMPLETED|Overall Study||5||
59579693|NCT02381288|75685674|FG001|COMPLETED|Overall Study||2||
59579694|NCT02381288|75685675|FG002|COMPLETED|Overall Study||5||
59579695|NCT02381288|75685676|FG003|COMPLETED|Overall Study||5||
59579696|NCT02381288|75685673|FG000|NOT COMPLETED|Overall Study||0||
59579697|NCT02381288|75685674|FG001|NOT COMPLETED|Overall Study||0||
59579698|NCT02381288|75685675|FG002|NOT COMPLETED|Overall Study||0||
59579699|NCT02381288|75685676|FG003|NOT COMPLETED|Overall Study||0||
59579700|NCT02381678|75685689|FG000|STARTED|Overall Study||54||
59579701|NCT02381678|75685690|FG001|STARTED|Overall Study||139||
59579702|NCT02381678|75685691|FG002|STARTED|Overall Study||32||
59579703|NCT02381678|75685689|FG000|COMPLETED|Overall Study||54||
59579704|NCT02381678|75685690|FG001|COMPLETED|Overall Study||139||
59579705|NCT02381678|75685691|FG002|COMPLETED|Overall Study||32||
59579706|NCT02381678|75685689|FG000|NOT COMPLETED|Overall Study||0||
59579707|NCT02381678|75685690|FG001|NOT COMPLETED|Overall Study||0||
59579708|NCT02381678|75685691|FG002|NOT COMPLETED|Overall Study||0||
59579709|NCT02382848|75685697|FG000|STARTED|First Intervention (3 Weeks)||3||
59579710|NCT02382848|75685698|FG001|STARTED|First Intervention (3 Weeks)||5||
59851441|NCT03482024|75976038|FG004|STARTED|Overall Study||8||
59579711|NCT02382848|75685697|FG000|COMPLETED|First Intervention (3 Weeks)||3||
59851442|NCT03482024|75976034|FG000|Received At Least One Dose of Study Drug|Overall Study||14||
59579712|NCT02382848|75685698|FG001|COMPLETED|First Intervention (3 Weeks)||5||
59579713|NCT02382848|75685697|FG000|NOT COMPLETED|First Intervention (3 Weeks)||0||
59579714|NCT02382848|75685698|FG001|NOT COMPLETED|First Intervention (3 Weeks)||0||
59579715|NCT02382848|75685697|FG000|STARTED|Washout (1 Week)||3||
59579716|NCT02382848|75685698|FG001|STARTED|Washout (1 Week)||5||
59579717|NCT02382848|75685697|FG000|COMPLETED|Washout (1 Week)||3||
59579718|NCT02382848|75685698|FG001|COMPLETED|Washout (1 Week)||5||
59851443|NCT03482024|75976035|FG001|Received At Least One Dose of Study Drug|Overall Study||8||
59579719|NCT02382848|75685697|FG000|NOT COMPLETED|Washout (1 Week)||0||
59579720|NCT02382848|75685698|FG001|NOT COMPLETED|Washout (1 Week)||0||
59579721|NCT02382848|75685697|FG000|STARTED|Second Intervention (3 Weeks)||3||
59579722|NCT02382848|75685698|FG001|STARTED|Second Intervention (3 Weeks)||5||
59579723|NCT02382848|75685697|FG000|COMPLETED|Second Intervention (3 Weeks)||3||
59579724|NCT02382848|75685698|FG001|COMPLETED|Second Intervention (3 Weeks)||5||
59579725|NCT02382848|75685697|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||0||
59579726|NCT02382848|75685698|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0||
59579727|NCT03094325|75685704|FG000|STARTED|Overall Study||10||
59579728|NCT03094325|75685704|FG000|TEE Before Cardiopulmonary Bypass|Overall Study||10||
59579729|NCT03094325|75685704|FG000|OPIE Before Cardiopulmonary Bypass|Overall Study||10||
59579730|NCT03094325|75685704|FG000|TEE After Cardiopulmonary Bypass|Overall Study||10||
59579731|NCT03094325|75685704|FG000|OPIE After Cardiopulmonary Bypass|Overall Study||10||
59579732|NCT03094325|75685704|FG000|COMPLETED|Overall Study||10||
59579733|NCT03094325|75685704|FG000|NOT COMPLETED|Overall Study||0||
59579734|NCT02065687|75685712|FG000|STARTED|Overall Study||234||
59579735|NCT02065687|75685713|FG001|STARTED|Overall Study||235||
59579736|NCT02065687|75685712|FG000|COMPLETED|Overall Study||234||
59579737|NCT02065687|75685713|FG001|COMPLETED|Overall Study||235||
59579738|NCT02065687|75685712|FG000|NOT COMPLETED|Overall Study||0||
59579739|NCT02065687|75685713|FG001|NOT COMPLETED|Overall Study||0||
59579740|NCT03095885|75685719|FG000|STARTED|Overall Study||22||
59579741|NCT03095885|75685719|FG000|COMPLETED|Overall Study||22||
59579742|NCT03095885|75685719|FG000|NOT COMPLETED|Overall Study||0||
59579743|NCT02383706|75685723|FG000|STARTED|Overall Study||108||
59579744|NCT02383706|75685723|FG000|COMPLETED|Overall Study||80||
59579745|NCT02383706|75685723|FG000|NOT COMPLETED|Overall Study||28||
59579746|NCT03096353|75685730|FG000|STARTED|Period 1||15||
59579747|NCT03096353|75685731|FG001|STARTED|Period 1||13||
59579748|NCT03096353|75685730|FG000|COMPLETED|Period 1||12||
59579749|NCT03096353|75685731|FG001|COMPLETED|Period 1||12||
59579750|NCT03096353|75685730|FG000|NOT COMPLETED|Period 1||3||
59579751|NCT03096353|75685731|FG001|NOT COMPLETED|Period 1||1||
59579752|NCT03096353|75685730|FG000|STARTED|Period 2||12||
59579753|NCT03096353|75685731|FG001|STARTED|Period 2||12||
59579754|NCT03096353|75685730|FG000|COMPLETED|Period 2||12||
59579755|NCT03096353|75685731|FG001|COMPLETED|Period 2||12||
59579756|NCT03096353|75685730|FG000|NOT COMPLETED|Period 2||0||
59579757|NCT03096353|75685731|FG001|NOT COMPLETED|Period 2||0||
59579758|NCT02384096|75685739|FG000|STARTED|First Intervention (7 Days)||5||
59579759|NCT02384096|75685740|FG001|STARTED|First Intervention (7 Days)||7||
59579760|NCT02384096|75685739|FG000|COMPLETED|First Intervention (7 Days)||4||
59579761|NCT02384096|75685740|FG001|COMPLETED|First Intervention (7 Days)||7||
59579762|NCT02384096|75685739|FG000|NOT COMPLETED|First Intervention (7 Days)||1||
59579763|NCT02384096|75685740|FG001|NOT COMPLETED|First Intervention (7 Days)||0||
59579764|NCT02384096|75685739|FG000|STARTED|Second Intervention (7 Days)||4||
59579765|NCT02384096|75685740|FG001|STARTED|Second Intervention (7 Days)||7||
59579766|NCT02384096|75685739|FG000|COMPLETED|Second Intervention (7 Days)||4||
59579767|NCT02384096|75685740|FG001|COMPLETED|Second Intervention (7 Days)||6||
59579768|NCT02384096|75685739|FG000|NOT COMPLETED|Second Intervention (7 Days)||0||
59579769|NCT02384096|75685740|FG001|NOT COMPLETED|Second Intervention (7 Days)||1||
59579770|NCT03098615|75685745|FG000|STARTED|Overall Study||19||
59579771|NCT03098615|75685745|FG000|COMPLETED|Overall Study||17||
59579772|NCT03098615|75685745|FG000|NOT COMPLETED|Overall Study||2||
59579773|NCT02387294|75685752|FG000|STARTED|Overall Study||60||
59579774|NCT02387294|75685753|FG001|STARTED|Overall Study||60||
59579775|NCT02387294|75685752|FG000|COMPLETED|Overall Study||60||
59579776|NCT02387294|75685753|FG001|COMPLETED|Overall Study||60||
59579777|NCT02387294|75685752|FG000|NOT COMPLETED|Overall Study||0||
59579778|NCT02387294|75685753|FG001|NOT COMPLETED|Overall Study||0||
59851444|NCT03482024|75976036|FG002|Received At Least One Dose of Study Drug|Overall Study||8||
59579779|NCT02066857|75685762|FG000|STARTED|Overall Study||1||
59579780|NCT02066857|75685763|FG001|STARTED|Overall Study||4||
59579781|NCT02066857|75685762|FG000|COMPLETED|Overall Study||0||
59579782|NCT02066857|75685763|FG001|COMPLETED|Overall Study||3||
59579783|NCT02066857|75685762|FG000|NOT COMPLETED|Overall Study||1||
59579784|NCT02066857|75685763|FG001|NOT COMPLETED|Overall Study||1||
59579785|NCT02388386|75685770|FG000|STARTED|Overall Study||10||
59579786|NCT02388386|75685770|FG000|COMPLETED|Overall Study||10||
59579787|NCT02388386|75685770|FG000|NOT COMPLETED|Overall Study||0||
59579788|NCT03810703|75685781|FG000|STARTED|Overall Study||31||
59579789|NCT03810703|75685782|FG001|STARTED|Overall Study||31||
59579790|NCT03810703|75685783|FG002|STARTED|Overall Study||31||
59579791|NCT03810703|75685781|FG000|COMPLETED|Overall Study||31||
59579792|NCT03810703|75685782|FG001|COMPLETED|Overall Study||31||
59579793|NCT03810703|75685783|FG002|COMPLETED|Overall Study||31||
59579794|NCT03810703|75685781|FG000|NOT COMPLETED|Overall Study||0||
59579795|NCT03810703|75685782|FG001|NOT COMPLETED|Overall Study||0||
59579796|NCT03810703|75685783|FG002|NOT COMPLETED|Overall Study||0||
59579797|NCT02389088|75685791|FG000|STARTED|Overall Study - Phase I||9||
59579798|NCT02389088|75685791|FG000|COMPLETED|Overall Study - Phase I||9||
59579799|NCT02389088|75685791|FG000|NOT COMPLETED|Overall Study - Phase I||0||
59579800|NCT02389088|75685791|FG000|STARTED|Phase II - All Study Participants||9||
59579801|NCT02389088|75685791|FG000|COMPLETED|Phase II - All Study Participants||9||
59579802|NCT02389088|75685791|FG000|NOT COMPLETED|Phase II - All Study Participants||0||
59579803|NCT02068027|75685807|FG000|STARTED|Overall Study||130||
59579804|NCT02068027|75685808|FG001|STARTED|Overall Study||130||
59579805|NCT02068027|75685807|FG000|COMPLETED|Overall Study||117||
59579806|NCT02068027|75685808|FG001|COMPLETED|Overall Study||114||
59579807|NCT02068027|75685807|FG000|NOT COMPLETED|Overall Study||13||
59579808|NCT02068027|75685808|FG001|NOT COMPLETED|Overall Study||16||
59579809|NCT02391350|75685816|FG000|STARTED|Overall Study||110||
59579810|NCT02391350|75685817|FG001|STARTED|Overall Study||110||
59579811|NCT02391350|75685816|FG000|4-week Follow-up|Overall Study||106||
59579812|NCT02391350|75685817|FG001|4-week Follow-up|Overall Study||105||
59579813|NCT02391350|75685816|FG000|6-month Follow-up|Overall Study||100||
59579814|NCT02391350|75685817|FG001|6-month Follow-up|Overall Study||96||
59579815|NCT02391350|75685816|FG000|COMPLETED|Overall Study||98|One-year follow-up|
59579816|NCT02391350|75685817|FG001|COMPLETED|Overall Study||93|One-year follow-up|
59579817|NCT02391350|75685816|FG000|NOT COMPLETED|Overall Study||12||
59579818|NCT02391350|75685817|FG001|NOT COMPLETED|Overall Study||17||
59579819|NCT02392208|75685823|FG000|STARTED|Telavancin Before Hemodialysis||8||
59579820|NCT02392208|75685823|FG000|COMPLETED|Telavancin Before Hemodialysis||8||
59579821|NCT02392208|75685823|FG000|NOT COMPLETED|Telavancin Before Hemodialysis||0||
59579822|NCT02392208|75685823|FG000|STARTED|Telavancin After Hemodialysis||8||
59579823|NCT02392208|75685823|FG000|COMPLETED|Telavancin After Hemodialysis||8||
59579824|NCT02392208|75685823|FG000|NOT COMPLETED|Telavancin After Hemodialysis||0||
59579825|NCT02392286|75685830|FG000|STARTED|Overall Study||7||
59579826|NCT02392286|75685831|FG001|STARTED|Overall Study||8||
59579827|NCT02392286|75685830|FG000|COMPLETED|Overall Study||4||
59579828|NCT02392286|75685831|FG001|COMPLETED|Overall Study||6||
59579829|NCT02392286|75685830|FG000|NOT COMPLETED|Overall Study||3||
59579830|NCT02392286|75685831|FG001|NOT COMPLETED|Overall Study||2||
59579831|NCT02393378|75685839|FG000|STARTED|Overall Study||3||
59579832|NCT02393378|75685840|FG001|STARTED|Overall Study||4||
59579833|NCT02393378|75685839|FG000|COMPLETED|Overall Study||3||
59579834|NCT02393378|75685840|FG001|COMPLETED|Overall Study||4||
59579835|NCT02393378|75685839|FG000|NOT COMPLETED|Overall Study||0||
59579836|NCT02393378|75685840|FG001|NOT COMPLETED|Overall Study||0||
59579837|NCT02068729|75685846|FG000|STARTED|Overall Study||131||
59579838|NCT02068729|75685846|FG000|COMPLETED|Overall Study||56||
59579839|NCT02068729|75685846|FG000|NOT COMPLETED|Overall Study||75||
59579840|NCT03101033|75685907|FG000|STARTED|Overall Study||32||
59579841|NCT03101033|75685908|FG001|STARTED|Overall Study||60||
59579842|NCT03101033|75685907|FG000|COMPLETED|Overall Study||27||
59579843|NCT03101033|75685908|FG001|COMPLETED|Overall Study||51||
59579844|NCT03101033|75685907|FG000|NOT COMPLETED|Overall Study||5||
59579845|NCT03101033|75685908|FG001|NOT COMPLETED|Overall Study||9||
59579846|NCT02069041|75685914|FG000|STARTED|Overall Study||8||
59579847|NCT02069041|75685914|FG000|Received at Least One Dose of Study Drug|Overall Study||8||
59579848|NCT02069041|75685914|FG000|COMPLETED|Overall Study||8||
59579849|NCT02069041|75685914|FG000|NOT COMPLETED|Overall Study||0||
59579850|NCT03101111|75685920|FG000|STARTED|Overall Study|First subject signed ICF (MV-CHIK group)|26||
59579851|NCT03101111|75685921|FG001|STARTED|Overall Study|First subject signed ICF (MMR group)|8||
59579852|NCT03101111|75685920|FG000|COMPLETED|Overall Study|End of Study Visit|23||
59579853|NCT03101111|75685921|FG001|COMPLETED|Overall Study|End of Study Visit|7||
59579854|NCT03101111|75685920|FG000|NOT COMPLETED|Overall Study||3||
59579855|NCT03101111|75685921|FG001|NOT COMPLETED|Overall Study||1||
59579856|NCT03102437|75685933|FG000|STARTED|Overall Study||70||
59579857|NCT03102437|75685934|FG001|STARTED|Overall Study||36||
59579858|NCT03102437|75685933|FG000|COMPLETED|Overall Study||65||
59579859|NCT03102437|75685934|FG001|COMPLETED|Overall Study||36||
59579860|NCT03102437|75685933|FG000|NOT COMPLETED|Overall Study||5||
59579861|NCT03102437|75685934|FG001|NOT COMPLETED|Overall Study||0||
59579862|NCT02069119|75685944|FG000|STARTED|Overall Study||20||
59579863|NCT02069119|75685945|FG001|STARTED|Overall Study||4||
59579864|NCT02069119|75685946|FG002|STARTED|Overall Study||20||
59579865|NCT02069119|75685947|FG003|STARTED|Overall Study||4||
59579866|NCT02069119|75685944|FG000|COMPLETED|Overall Study||20||
59579867|NCT02069119|75685945|FG001|COMPLETED|Overall Study||4||
59579868|NCT02069119|75685946|FG002|COMPLETED|Overall Study||20||
59579869|NCT02069119|75685947|FG003|COMPLETED|Overall Study||4||
59579870|NCT02069119|75685944|FG000|NOT COMPLETED|Overall Study||0||
59579871|NCT02069119|75685945|FG001|NOT COMPLETED|Overall Study||0||
59579872|NCT02069119|75685946|FG002|NOT COMPLETED|Overall Study||0||
59579873|NCT02069119|75685947|FG003|NOT COMPLETED|Overall Study||0||
59579874|NCT02069353|75685959|FG000|STARTED|Overall Study||4||
59579875|NCT02069353|75685959|FG000|COMPLETED|Overall Study||4||
59579876|NCT02069353|75685959|FG000|NOT COMPLETED|Overall Study||0||
59579877|NCT03103061|75685963|FG000|STARTED|Overall Study||24||
59579878|NCT03103061|75685963|FG000|COMPLETED|Overall Study||24||
59579879|NCT03103061|75685963|FG000|NOT COMPLETED|Overall Study||0||
59579880|NCT03105479|75685967|FG000|STARTED|Overall Study||1||
59579881|NCT03105479|75685968|FG001|STARTED|Overall Study||0||
59579882|NCT03105479|75685969|FG002|STARTED|Overall Study||0||
59579883|NCT03105479|75685970|FG003|STARTED|Overall Study||0||
59579884|NCT03105479|75685971|FG004|STARTED|Overall Study||0||
59579885|NCT03105479|75685972|FG005|STARTED|Overall Study||0||
59579886|NCT03105479|75685973|FG006|STARTED|Overall Study||0||
59579887|NCT03105479|75685967|FG000|COMPLETED|Overall Study||1||
59579888|NCT03105479|75685968|FG001|COMPLETED|Overall Study||0||
59579889|NCT03105479|75685969|FG002|COMPLETED|Overall Study||0||
59579890|NCT03105479|75685970|FG003|COMPLETED|Overall Study||0||
59579891|NCT03105479|75685971|FG004|COMPLETED|Overall Study||0||
59579892|NCT03105479|75685972|FG005|COMPLETED|Overall Study||0||
59579893|NCT03105479|75685973|FG006|COMPLETED|Overall Study||0||
59579894|NCT03105479|75685967|FG000|NOT COMPLETED|Overall Study||0||
59579895|NCT03105479|75685968|FG001|NOT COMPLETED|Overall Study||0||
59851445|NCT03482024|75976037|FG003|Received At Least One Dose of Study Drug|Overall Study||7||
59851446|NCT03482024|75976038|FG004|Received At Least One Dose of Study Drug|Overall Study||8||
59851447|NCT03482024|75976034|FG000|COMPLETED|Overall Study||13||
59851448|NCT03482024|75976035|FG001|COMPLETED|Overall Study||8||
59851449|NCT03482024|75976036|FG002|COMPLETED|Overall Study||8||
59851450|NCT03482024|75976037|FG003|COMPLETED|Overall Study||7||
59579896|NCT03105479|75685969|FG002|NOT COMPLETED|Overall Study||0||
59579897|NCT03105479|75685970|FG003|NOT COMPLETED|Overall Study||0||
59579898|NCT03105479|75685971|FG004|NOT COMPLETED|Overall Study||0||
59579899|NCT03105479|75685972|FG005|NOT COMPLETED|Overall Study||0||
59579900|NCT03105479|75685973|FG006|NOT COMPLETED|Overall Study||0||
59579901|NCT03106337|75685980|FG000|STARTED|Overall Study||35||
59579902|NCT03106337|75685980|FG000|COMPLETED|Overall Study||35||
59579903|NCT03106337|75685980|FG000|NOT COMPLETED|Overall Study||0||
59579904|NCT02049151|75685987|FG000|STARTED|Overall Study|2 subjects did not receive treatment|15||
59579905|NCT02049151|75685988|FG001|STARTED|Overall Study|1 subject did not receive treatment|17||
59579906|NCT02049151|75685987|FG000|COMPLETED|Overall Study||15||
59579907|NCT02049151|75685988|FG001|COMPLETED|Overall Study||17||
59579908|NCT02049151|75685987|FG000|NOT COMPLETED|Overall Study||0||
59579909|NCT02049151|75685988|FG001|NOT COMPLETED|Overall Study||0||
59579910|NCT02049307|75685996|FG000|STARTED|Overall Study||52||
59579911|NCT02049307|75685997|FG001|STARTED|Overall Study||56||
59579912|NCT02049307|75685996|FG000|COMPLETED|Overall Study||50||
59579913|NCT02049307|75685997|FG001|COMPLETED|Overall Study||55||
59579914|NCT02049307|75685996|FG000|NOT COMPLETED|Overall Study||2||
59579915|NCT02049307|75685997|FG001|NOT COMPLETED|Overall Study||1||
59579916|NCT02049385|75686005|FG000|STARTED|First Intervention||4||
59579917|NCT02049385|75686006|FG001|STARTED|First Intervention||2||
59579918|NCT02049385|75686005|FG000|COMPLETED|First Intervention||1||
59579919|NCT02049385|75686006|FG001|COMPLETED|First Intervention||2||
59579920|NCT02049385|75686005|FG000|NOT COMPLETED|First Intervention||3||
59579921|NCT02049385|75686006|FG001|NOT COMPLETED|First Intervention||0||
59579922|NCT02049385|75686005|FG000|STARTED|Second Intervention||1||
59579923|NCT02049385|75686006|FG001|STARTED|Second Intervention||2||
59579924|NCT02049385|75686005|FG000|COMPLETED|Second Intervention||1||
59579925|NCT02049385|75686006|FG001|COMPLETED|Second Intervention||0||
59579926|NCT02049385|75686005|FG000|NOT COMPLETED|Second Intervention||0||
59579927|NCT02049385|75686006|FG001|NOT COMPLETED|Second Intervention||2||
59579928|NCT03717155|75686012|FG000|STARTED|Overall Study||43||
59579929|NCT03717155|75686012|FG000|COMPLETED|Overall Study||43||
59579930|NCT03717155|75686012|FG000|NOT COMPLETED|Overall Study||0||
59579931|NCT02049931|75686019|FG000|STARTED|Overall Study||20||
59579932|NCT02049931|75686020|FG001|STARTED|Overall Study||20||
59579933|NCT02049931|75686021|FG002|STARTED|Overall Study||20||
59579934|NCT02049931|75686019|FG000|COMPLETED|Overall Study||17||
59579935|NCT02049931|75686020|FG001|COMPLETED|Overall Study||15||
59579936|NCT02049931|75686021|FG002|COMPLETED|Overall Study||17||
59579937|NCT02049931|75686019|FG000|NOT COMPLETED|Overall Study||3||
59579938|NCT02049931|75686020|FG001|NOT COMPLETED|Overall Study||5||
59579939|NCT02049931|75686021|FG002|NOT COMPLETED|Overall Study||3||
59579940|NCT03286829|75686033|FG000|STARTED|Overall Study||15||
59579941|NCT03286829|75686034|FG001|STARTED|Overall Study||15||
59579942|NCT03286829|75686035|FG002|STARTED|Overall Study||15||
59579943|NCT03286829|75686036|FG003|STARTED|Overall Study||15||
59579944|NCT03286829|75686033|FG000|COMPLETED|Overall Study||15||
59579945|NCT03286829|75686034|FG001|COMPLETED|Overall Study||15||
59579946|NCT03286829|75686035|FG002|COMPLETED|Overall Study||15||
59579947|NCT03286829|75686036|FG003|COMPLETED|Overall Study||15||
59724041|NCT01120691|75842654|FG002|Full Analysis Set (FAS)|Overall Study||739||
59724042|NCT01120691|75842652|FG000|Safety Set (SAF)|Overall Study||736||
59724043|NCT01120691|75842653|FG001|Safety Set (SAF)|Overall Study||740||
59724044|NCT01120691|75842654|FG002|Safety Set (SAF)|Overall Study||739||
59724045|NCT01120691|75842652|FG000|Modified Safety Set (mSAF)|Overall Study||729||
59579948|NCT03286829|75686033|FG000|NOT COMPLETED|Overall Study||0||
59579949|NCT03286829|75686034|FG001|NOT COMPLETED|Overall Study||0||
59724046|NCT01120691|75842653|FG001|Modified Safety Set (mSAF)|Overall Study||740||
59724047|NCT01120691|75842654|FG002|Modified Safety Set (mSAF)|Overall Study||737||
59724048|NCT01120691|75842652|FG000|Modified Full Analysis Set (mFAS)|Overall Study||729||
59724049|NCT01120691|75842653|FG001|Modified Full Analysis Set (mFAS)|Overall Study||739||
59724050|NCT01120691|75842654|FG002|Modified Full Analysis Set (mFAS)|Overall Study||737||
59724051|NCT01120691|75842652|FG000|COMPLETED|Overall Study||570||
59851451|NCT03482024|75976038|FG004|COMPLETED|Overall Study||8||
59579950|NCT03286829|75686035|FG002|NOT COMPLETED|Overall Study||0||
59579951|NCT03286829|75686036|FG003|NOT COMPLETED|Overall Study||0||
59579952|NCT02051335|75686052|FG000|STARTED|Period 1||7||
59579953|NCT02051335|75686053|FG001|STARTED|Period 1||7||
59579954|NCT02051335|75686054|FG002|STARTED|Period 1||7||
59579955|NCT02051335|75686055|FG003|STARTED|Period 1||6||
59724052|NCT01120691|75842653|FG001|COMPLETED|Overall Study||538||
59724053|NCT01120691|75842654|FG002|COMPLETED|Overall Study||559||
59724054|NCT01120691|75842652|FG000|NOT COMPLETED|Overall Study||171||
59724055|NCT01120691|75842653|FG001|NOT COMPLETED|Overall Study||203||
59851452|NCT03482024|75976034|FG000|NOT COMPLETED|Overall Study||1||
59851453|NCT03482024|75976035|FG001|NOT COMPLETED|Overall Study||0||
59851454|NCT03482024|75976036|FG002|NOT COMPLETED|Overall Study||0||
59579956|NCT02051335|75686052|FG000|COMPLETED|Period 1||7||
59579957|NCT02051335|75686053|FG001|COMPLETED|Period 1||7||
59579958|NCT02051335|75686054|FG002|COMPLETED|Period 1||7||
59724056|NCT01120691|75842654|FG002|NOT COMPLETED|Overall Study||183||
59724057|NCT00935493|75842669|FG000|STARTED|Overall Study||41||
59724058|NCT00935493|75842670|FG001|STARTED|Overall Study||41||
59724059|NCT00935493|75842671|FG002|STARTED|Overall Study||41||
59724060|NCT00935493|75842669|FG000|COMPLETED|Overall Study||40||
59724061|NCT00935493|75842670|FG001|COMPLETED|Overall Study||39||
59724062|NCT00935493|75842671|FG002|COMPLETED|Overall Study||40||
59724063|NCT00935493|75842669|FG000|NOT COMPLETED|Overall Study||1||
59724064|NCT00935493|75842670|FG001|NOT COMPLETED|Overall Study||2||
59724065|NCT00935493|75842671|FG002|NOT COMPLETED|Overall Study||1||
59579959|NCT02051335|75686055|FG003|COMPLETED|Period 1||6||
59579960|NCT02051335|75686052|FG000|NOT COMPLETED|Period 1||0||
59579961|NCT02051335|75686053|FG001|NOT COMPLETED|Period 1||0||
59579962|NCT02051335|75686054|FG002|NOT COMPLETED|Period 1||0||
59579963|NCT02051335|75686055|FG003|NOT COMPLETED|Period 1||0||
59579964|NCT02051335|75686052|FG000|STARTED|Period 2||7||
59724066|NCT03856996|75842681|FG000|STARTED|Overall Study||15||
59724067|NCT03856996|75842682|FG001|STARTED|Overall Study||15||
59724068|NCT03856996|75842681|FG000|COMPLETED|Overall Study||12||
59724069|NCT03856996|75842682|FG001|COMPLETED|Overall Study||13||
59724070|NCT03856996|75842681|FG000|NOT COMPLETED|Overall Study||3||
59724071|NCT03856996|75842682|FG001|NOT COMPLETED|Overall Study||2||
59724072|NCT00935259|75842688|FG000|STARTED|Period 1||16||
59724073|NCT00935259|75842689|FG001|STARTED|Period 1||15||
59724074|NCT00935259|75842688|FG000|COMPLETED|Period 1||15||
59724075|NCT00935259|75842689|FG001|COMPLETED|Period 1||14||
59724076|NCT00935259|75842688|FG000|NOT COMPLETED|Period 1||1||
59724077|NCT00935259|75842689|FG001|NOT COMPLETED|Period 1||1||
59724078|NCT00935259|75842688|FG000|STARTED|Period 2||15||
59724079|NCT00935259|75842689|FG001|STARTED|Period 2||14||
59724080|NCT00935259|75842688|FG000|COMPLETED|Period 2||15||
59724081|NCT00935259|75842689|FG001|COMPLETED|Period 2||14||
59724082|NCT00935259|75842688|FG000|NOT COMPLETED|Period 2||0||
59724083|NCT00935259|75842689|FG001|NOT COMPLETED|Period 2||0||
59724084|NCT02937766|75842699|FG000|STARTED|Overall Study||30||
59724085|NCT02937766|75842700|FG001|STARTED|Overall Study||30||
59724086|NCT02937766|75842699|FG000|COMPLETED|Overall Study||23||
59579965|NCT02051335|75686053|FG001|STARTED|Period 2||7||
59579966|NCT02051335|75686054|FG002|STARTED|Period 2||7||
59579967|NCT02051335|75686055|FG003|STARTED|Period 2|2 Participants received treatment in Period 1 but discontinued prior to Period 2.|4||
59579968|NCT02051335|75686052|FG000|COMPLETED|Period 2||7||
59579969|NCT02051335|75686053|FG001|COMPLETED|Period 2||7||
59724087|NCT02937766|75842700|FG001|COMPLETED|Overall Study||30||
59579970|NCT02051335|75686054|FG002|COMPLETED|Period 2||7||
59579971|NCT02051335|75686055|FG003|COMPLETED|Period 2||4||
59579972|NCT02051335|75686052|FG000|NOT COMPLETED|Period 2||0||
59579973|NCT02051335|75686053|FG001|NOT COMPLETED|Period 2||0||
59579974|NCT02051335|75686054|FG002|NOT COMPLETED|Period 2||0||
59579975|NCT02051335|75686055|FG003|NOT COMPLETED|Period 2||0||
59579976|NCT02051335|75686052|FG000|STARTED|Period 3||7||
59579977|NCT02051335|75686053|FG001|STARTED|Period 3||7||
59579978|NCT02051335|75686054|FG002|STARTED|Period 3|2 Participants received treatment in Period 2 but discontinued prior to Period 3.|5||
59579979|NCT02051335|75686055|FG003|STARTED|Period 3||4||
59579980|NCT02051335|75686052|FG000|COMPLETED|Period 3||7||
59579981|NCT02051335|75686053|FG001|COMPLETED|Period 3||7||
59579982|NCT02051335|75686054|FG002|COMPLETED|Period 3||5||
59724088|NCT02937766|75842699|FG000|NOT COMPLETED|Overall Study||7||
59724089|NCT02937766|75842700|FG001|NOT COMPLETED|Overall Study||0||
59724090|NCT01120379|75842706|FG000|STARTED|One Year Timepoint||5020||
59579983|NCT02051335|75686055|FG003|COMPLETED|Period 3||4||
59579984|NCT02051335|75686052|FG000|NOT COMPLETED|Period 3||0||
59579985|NCT02051335|75686053|FG001|NOT COMPLETED|Period 3||0||
59724091|NCT01120379|75842706|FG000|COMPLETED|One Year Timepoint||4742||
59724092|NCT01120379|75842706|FG000|NOT COMPLETED|One Year Timepoint||278||
59724093|NCT01120379|75842706|FG000|STARTED|Two Year Timepoint||4742||
59724094|NCT01120379|75842706|FG000|COMPLETED|Two Year Timepoint||4505||
59724095|NCT01120379|75842706|FG000|NOT COMPLETED|Two Year Timepoint||237||
59724096|NCT01120379|75842706|FG000|STARTED|Three Year Timepoint||4505||
59724097|NCT01120379|75842706|FG000|COMPLETED|Three Year Timepoint||4291||
59724098|NCT01120379|75842706|FG000|NOT COMPLETED|Three Year Timepoint||214||
59724099|NCT01120379|75842706|FG000|STARTED|Four Year Timepoint||4291||
59724100|NCT01120379|75842706|FG000|COMPLETED|Four Year Timepoint||3923||
59579986|NCT02051335|75686054|FG002|NOT COMPLETED|Period 3||0||
59579987|NCT02051335|75686055|FG003|NOT COMPLETED|Period 3||0||
59579988|NCT02051335|75686052|FG000|STARTED|Period 4||7||
59579989|NCT02051335|75686053|FG001|STARTED|Period 4||7||
59579990|NCT02051335|75686054|FG002|STARTED|Period 4||5||
59579991|NCT02051335|75686055|FG003|STARTED|Period 4||4||
59579992|NCT02051335|75686052|FG000|COMPLETED|Period 4||7||
59579993|NCT02051335|75686053|FG001|COMPLETED|Period 4||7||
59579994|NCT02051335|75686054|FG002|COMPLETED|Period 4||5||
59579995|NCT02051335|75686055|FG003|COMPLETED|Period 4||4||
59579996|NCT02051335|75686052|FG000|NOT COMPLETED|Period 4||0||
59579997|NCT02051335|75686053|FG001|NOT COMPLETED|Period 4||0||
59579998|NCT02051335|75686054|FG002|NOT COMPLETED|Period 4||0||
59579999|NCT02051335|75686055|FG003|NOT COMPLETED|Period 4||0||
59580000|NCT03289481|75686067|FG000|STARTED|Overall Study||6||
59580001|NCT03289481|75686068|FG001|STARTED|Overall Study||7||
59580002|NCT03289481|75686067|FG000|COMPLETED|Overall Study||4||
59580003|NCT03289481|75686068|FG001|COMPLETED|Overall Study||5||
59580004|NCT03289481|75686067|FG000|NOT COMPLETED|Overall Study||2||
59580005|NCT03289481|75686068|FG001|NOT COMPLETED|Overall Study||2||
59580006|NCT03290027|75686077|FG000|STARTED|Overall Study||277||
59580007|NCT03290027|75686078|FG001|STARTED|Overall Study||273||
59580008|NCT03290027|75686077|FG000|COMPLETED|Overall Study||219||
59580009|NCT03290027|75686078|FG001|COMPLETED|Overall Study||228||
59580010|NCT03290027|75686077|FG000|NOT COMPLETED|Overall Study||58||
59580011|NCT03290027|75686078|FG001|NOT COMPLETED|Overall Study||45||
59580012|NCT02300077|75686087|FG000|STARTED|Overall Study||21||
59580013|NCT02300077|75686088|FG001|STARTED|Overall Study||18||
59580014|NCT02300077|75686089|FG002|STARTED|Overall Study||21||
59580015|NCT02300077|75686087|FG000|COMPLETED|Overall Study||21||
59580016|NCT02300077|75686088|FG001|COMPLETED|Overall Study||18||
59580017|NCT02300077|75686089|FG002|COMPLETED|Overall Study||21||
59580018|NCT02300077|75686087|FG000|NOT COMPLETED|Overall Study||0||
59580019|NCT02300077|75686088|FG001|NOT COMPLETED|Overall Study||0||
59580020|NCT02300077|75686089|FG002|NOT COMPLETED|Overall Study||0||
59580021|NCT03291041|75686099|FG000|STARTED|Overall Study||13||
59580022|NCT03291041|75686100|FG001|STARTED|Overall Study||12||
59580023|NCT03291041|75686099|FG000|COMPLETED|Overall Study||13||
59580024|NCT03291041|75686100|FG001|COMPLETED|Overall Study||12||
59580025|NCT03291041|75686099|FG000|NOT COMPLETED|Overall Study||0||
59580026|NCT03291041|75686100|FG001|NOT COMPLETED|Overall Study||0||
59580027|NCT02052661|75686106|FG000|STARTED|Overall Study||300||
59580028|NCT02052661|75686106|FG000|COMPLETED|Overall Study||300||
59580029|NCT02052661|75686106|FG000|NOT COMPLETED|Overall Study||0||
59580030|NCT02052895|75686113|FG000|STARTED|Overall Study||196||
59580031|NCT02052895|75686114|FG001|STARTED|Overall Study||15||
59580032|NCT02052895|75686115|FG002|STARTED|Overall Study||15||
59580033|NCT02052895|75686113|FG000|COMPLETED|Overall Study||196||
59580034|NCT02052895|75686114|FG001|COMPLETED|Overall Study||15||
59580035|NCT02052895|75686115|FG002|COMPLETED|Overall Study||15||
59580036|NCT02052895|75686113|FG000|NOT COMPLETED|Overall Study||0||
59580037|NCT02052895|75686114|FG001|NOT COMPLETED|Overall Study||0||
59580038|NCT02052895|75686115|FG002|NOT COMPLETED|Overall Study||0||
59580039|NCT03291197|75686122|FG000|STARTED|Overall Study||5||
59580040|NCT03291197|75686122|FG000|COMPLETED|Overall Study||5||
59580041|NCT03291197|75686122|FG000|NOT COMPLETED|Overall Study||0||
59580042|NCT03294629|75686132|FG000|STARTED|First Intervention (2 Weeks)||16||
59580043|NCT03294629|75686133|FG001|STARTED|First Intervention (2 Weeks)||19||
59580044|NCT03294629|75686132|FG000|COMPLETED|First Intervention (2 Weeks)||14||
59580045|NCT03294629|75686133|FG001|COMPLETED|First Intervention (2 Weeks)||15||
59580046|NCT03294629|75686132|FG000|NOT COMPLETED|First Intervention (2 Weeks)||2||
59580047|NCT03294629|75686133|FG001|NOT COMPLETED|First Intervention (2 Weeks)||4||
59996742|NCT04445051|76112589|FG001|COMPLETED|Overall Study||4||
59996743|NCT04445051|76112590|FG002|COMPLETED|Overall Study||4||
59580048|NCT03294629|75686132|FG000|STARTED|Second Intervention (2 Weeks)||14||
59580049|NCT03294629|75686133|FG001|STARTED|Second Intervention (2 Weeks)||15||
59580050|NCT03294629|75686132|FG000|COMPLETED|Second Intervention (2 Weeks)||12||
59580051|NCT03294629|75686133|FG001|COMPLETED|Second Intervention (2 Weeks)||13||
59580052|NCT03294629|75686132|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||2||
59580053|NCT03294629|75686133|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||2||
59580054|NCT03296345|75686139|FG000|STARTED|Overall Study||62||
59580055|NCT03296345|75686139|FG000|COMPLETED|Overall Study||62||
59580056|NCT03296345|75686139|FG000|NOT COMPLETED|Overall Study||0||
59580057|NCT04736069|75686147|FG000|STARTED|Overall Study||30||
59580058|NCT04736069|75686148|FG001|STARTED|Overall Study||30||
59580059|NCT04736069|75686147|FG000|COMPLETED|Overall Study||30||
59580060|NCT04736069|75686148|FG001|COMPLETED|Overall Study||22||
59580061|NCT04736069|75686147|FG000|NOT COMPLETED|Overall Study||0||
59580062|NCT04736069|75686148|FG001|NOT COMPLETED|Overall Study||8||
59580063|NCT03298841|75686162|FG000|STARTED|Overall Study||25||
59580064|NCT03298841|75686163|FG001|STARTED|Overall Study||25||
59580065|NCT03298841|75686162|FG000|COMPLETED|Overall Study||25||
59580066|NCT03298841|75686163|FG001|COMPLETED|Overall Study||25||
59580067|NCT03298841|75686162|FG000|NOT COMPLETED|Overall Study||0||
59580068|NCT03298841|75686163|FG001|NOT COMPLETED|Overall Study||0||
59580069|NCT03302741|75686172|FG000|STARTED|Overall Study||8||
59580070|NCT03302741|75686173|FG001|STARTED|Overall Study||9||
59580071|NCT03302741|75686172|FG000|COMPLETED|Overall Study||7||
59580072|NCT03302741|75686173|FG001|COMPLETED|Overall Study||8||
59580073|NCT03302741|75686172|FG000|NOT COMPLETED|Overall Study||1||
59580074|NCT03302741|75686173|FG001|NOT COMPLETED|Overall Study||1||
59580075|NCT02803307|75686181|FG000|STARTED|Overall Study||20||
59580076|NCT02803307|75686182|FG001|STARTED|Overall Study||20||
59580077|NCT02803307|75686181|FG000|COMPLETED|Overall Study||20||
59580078|NCT02803307|75686182|FG001|COMPLETED|Overall Study||20||
59580079|NCT02803307|75686181|FG000|NOT COMPLETED|Overall Study||0||
59580080|NCT02803307|75686182|FG001|NOT COMPLETED|Overall Study||0||
59580081|NCT03303911|75686190|FG000|STARTED|Overall Study||13||
59580082|NCT03303911|75686191|FG001|STARTED|Overall Study||13||
59580083|NCT03303911|75686190|FG000|COMPLETED|Overall Study||13||
59580084|NCT03303911|75686191|FG001|COMPLETED|Overall Study||13||
59580085|NCT03303911|75686190|FG000|NOT COMPLETED|Overall Study||0||
59580086|NCT03303911|75686191|FG001|NOT COMPLETED|Overall Study||0||
59580087|NCT03305159|75686199|FG000|STARTED|Overall Study||66||
59580088|NCT03305159|75686200|FG001|STARTED|Overall Study||68||
59580089|NCT03305159|75686199|FG000|COMPLETED|Overall Study||63||
59580090|NCT03305159|75686200|FG001|COMPLETED|Overall Study||60||
59580091|NCT03305159|75686199|FG000|NOT COMPLETED|Overall Study||3||
59580092|NCT03305159|75686200|FG001|NOT COMPLETED|Overall Study||8||
59580093|NCT03306641|75686206|FG000|STARTED|First Intervention||23||
59580094|NCT03306641|75686207|FG001|STARTED|First Intervention||22||
59580095|NCT03306641|75686206|FG000|COMPLETED|First Intervention||23||
59580096|NCT03306641|75686207|FG001|COMPLETED|First Intervention||22||
59580097|NCT03306641|75686206|FG000|NOT COMPLETED|First Intervention||0||
59580098|NCT03306641|75686207|FG001|NOT COMPLETED|First Intervention||0||
59580099|NCT03306641|75686206|FG000|STARTED|Second Intervention||23||
59580100|NCT03306641|75686207|FG001|STARTED|Second Intervention||22||
59580101|NCT03306641|75686206|FG000|COMPLETED|Second Intervention||23||
59580102|NCT03306641|75686207|FG001|COMPLETED|Second Intervention||22||
59580103|NCT03306641|75686206|FG000|NOT COMPLETED|Second Intervention||0||
59580104|NCT03306641|75686207|FG001|NOT COMPLETED|Second Intervention||0||
59580105|NCT04473326|75686215|FG000|STARTED|Overall Study||29||
59580106|NCT04473326|75686216|FG001|STARTED|Overall Study||31||
59580107|NCT04473326|75686215|FG000|COMPLETED|Overall Study||28||
59580108|NCT04473326|75686216|FG001|COMPLETED|Overall Study||28||
59580109|NCT04473326|75686215|FG000|NOT COMPLETED|Overall Study||1||
59580110|NCT04473326|75686216|FG001|NOT COMPLETED|Overall Study||3||
59580111|NCT03308669|75686224|FG000|STARTED|Overall Study||10||
59580112|NCT03308669|75686225|FG001|STARTED|Overall Study||20||
59580113|NCT03308669|75686224|FG000|Received at Least One Dose of Study Drug|Overall Study||10||
59580114|NCT03308669|75686225|FG001|Received at Least One Dose of Study Drug|Overall Study||20||
59580115|NCT03308669|75686224|FG000|COMPLETED|Overall Study||10||
59580116|NCT03308669|75686225|FG001|COMPLETED|Overall Study||20||
59580117|NCT03308669|75686224|FG000|NOT COMPLETED|Overall Study||0||
59580118|NCT03308669|75686225|FG001|NOT COMPLETED|Overall Study||0||
59580119|NCT02055781|75686246|FG000|STARTED|Overall Study||104||
59580120|NCT02055781|75686247|FG001|STARTED|Overall Study||107||
59580121|NCT02055781|75686248|FG002|STARTED|Overall Study||100||
59580122|NCT02055781|75686246|FG000|COMPLETED|Overall Study||62||
59580123|NCT02055781|75686247|FG001|COMPLETED|Overall Study||79||
59580124|NCT02055781|75686248|FG002|COMPLETED|Overall Study||63||
59580125|NCT02055781|75686246|FG000|NOT COMPLETED|Overall Study||42||
59580126|NCT02055781|75686247|FG001|NOT COMPLETED|Overall Study||28||
59580127|NCT02055781|75686248|FG002|NOT COMPLETED|Overall Study||37||
59580128|NCT03309449|75686259|FG000|STARTED|Overall Study||46||
59580129|NCT03309449|75686260|FG001|STARTED|Overall Study||46||
59580130|NCT03309449|75686261|FG002|STARTED|Overall Study||46||
59580131|NCT03309449|75686259|FG000|COMPLETED|Overall Study||46||
59580132|NCT03309449|75686260|FG001|COMPLETED|Overall Study||46||
59580133|NCT03309449|75686261|FG002|COMPLETED|Overall Study||46||
59580134|NCT03309449|75686259|FG000|NOT COMPLETED|Overall Study||0||
59724101|NCT01120379|75842706|FG000|NOT COMPLETED|Four Year Timepoint||368||
59724102|NCT01120067|75842712|FG000|STARTED|Overall Study||12||
59724103|NCT01120067|75842713|FG001|STARTED|Overall Study||11||
59724104|NCT01120067|75842712|FG000|COMPLETED|Overall Study||7||
59580135|NCT03309449|75686260|FG001|NOT COMPLETED|Overall Study||0||
59580136|NCT03309449|75686261|FG002|NOT COMPLETED|Overall Study||0||
59580137|NCT02056171|75686271|FG000|STARTED|Overall Study||3||
59580138|NCT02056171|75686272|FG001|STARTED|Overall Study||3||
59580139|NCT02056171|75686271|FG000|COMPLETED|Overall Study||3||
59580140|NCT02056171|75686272|FG001|COMPLETED|Overall Study||3||
59580141|NCT02056171|75686271|FG000|NOT COMPLETED|Overall Study||0||
59580142|NCT02056171|75686272|FG001|NOT COMPLETED|Overall Study||0||
59580143|NCT03312023|75686282|FG000|STARTED|Overall Study||8||
59580144|NCT03312023|75686283|FG001|STARTED|Overall Study||5||
59580145|NCT03312023|75686284|FG002|STARTED|Overall Study||4||
59580146|NCT03312023|75686285|FG003|STARTED|Overall Study||4||
59580147|NCT03312023|75686282|FG000|Completed Week 12|Overall Study||8|(end of treatment)|
59580148|NCT03312023|75686283|FG001|Completed Week 12|Overall Study||5|(end of treatment)|
59580149|NCT03312023|75686284|FG002|Completed Week 12|Overall Study||4|(end of treatment)|
59580150|NCT03312023|75686285|FG003|Completed Week 12|Overall Study||4|(end of treatment)|
59580151|NCT03312023|75686282|FG000|COMPLETED|Overall Study||8||
59580152|NCT03312023|75686283|FG001|COMPLETED|Overall Study||5||
59580153|NCT03312023|75686284|FG002|COMPLETED|Overall Study||4||
59580154|NCT03312023|75686285|FG003|COMPLETED|Overall Study||4||
59580155|NCT03312023|75686282|FG000|NOT COMPLETED|Overall Study||0||
59580156|NCT03312023|75686283|FG001|NOT COMPLETED|Overall Study||0||
59580157|NCT03312023|75686284|FG002|NOT COMPLETED|Overall Study||0||
59580158|NCT03312023|75686285|FG003|NOT COMPLETED|Overall Study||0||
59580159|NCT02056639|75686298|FG000|STARTED|Overall Study||23||
59580160|NCT02056639|75686299|FG001|STARTED|Overall Study||23||
59580161|NCT02056639|75686298|FG000|COMPLETED|Overall Study||23||
59580162|NCT02056639|75686299|FG001|COMPLETED|Overall Study||23||
59580163|NCT02056639|75686298|FG000|NOT COMPLETED|Overall Study||0||
59580164|NCT02056639|75686299|FG001|NOT COMPLETED|Overall Study||0||
59580165|NCT02340091|75686307|FG000|STARTED|Overall Study|All Study Participants|62||
59580166|NCT02340091|75686307|FG000|COMPLETED|Overall Study||60||
59580167|NCT02340091|75686307|FG000|NOT COMPLETED|Overall Study||2||
59580168|NCT02340715|75686312|FG000|STARTED|Overall Study|158|158||
59580169|NCT02340715|75686312|FG000|COMPLETED|Overall Study|158|158||
59580170|NCT02340715|75686312|FG000|NOT COMPLETED|Overall Study||0||
59580171|NCT02342197|75686318|FG000|STARTED|Overall Study||30||
59580172|NCT02342197|75686319|FG001|STARTED|Overall Study||30||
59580173|NCT02342197|75686318|FG000|COMPLETED|Overall Study||27||
59580174|NCT02342197|75686319|FG001|COMPLETED|Overall Study||28||
59580175|NCT02342197|75686318|FG000|NOT COMPLETED|Overall Study||3||
59580176|NCT02342197|75686319|FG001|NOT COMPLETED|Overall Study||2||
59580177|NCT03182933|75686327|FG000|STARTED|Overall Study||32||
59580178|NCT03182933|75686328|FG001|STARTED|Overall Study||32||
59580179|NCT03182933|75686327|FG000|COMPLETED|Overall Study||31||
59580180|NCT03182933|75686328|FG001|COMPLETED|Overall Study||32||
59580181|NCT03182933|75686327|FG000|NOT COMPLETED|Overall Study||1||
59580182|NCT03182933|75686328|FG001|NOT COMPLETED|Overall Study||0||
59580183|NCT03183869|75686336|FG000|STARTED|Overall Study||4||
59580184|NCT03183869|75686337|FG001|STARTED|Overall Study||7||
59580185|NCT03183869|75686336|FG000|COMPLETED|Overall Study||0||
59580186|NCT03183869|75686337|FG001|COMPLETED|Overall Study||2||
59580187|NCT03183869|75686336|FG000|NOT COMPLETED|Overall Study||4||
59580188|NCT03183869|75686337|FG001|NOT COMPLETED|Overall Study||5||
59580189|NCT02344225|75686346|FG000|STARTED|Overall Study||6||
59580190|NCT02344225|75686347|FG001|STARTED|Overall Study||3||
59580191|NCT02344225|75686348|FG002|STARTED|Overall Study||5||
59580192|NCT02344225|75686346|FG000|COMPLETED|Overall Study||6||
59851455|NCT03482024|75976037|FG003|NOT COMPLETED|Overall Study||0||
59851456|NCT03482024|75976038|FG004|NOT COMPLETED|Overall Study||0||
59851457|NCT03468309|75976050|FG000|STARTED|Overall Study||53||
59580193|NCT02344225|75686347|FG001|COMPLETED|Overall Study||3||
59580194|NCT02344225|75686348|FG002|COMPLETED|Overall Study||5||
59580195|NCT02344225|75686346|FG000|NOT COMPLETED|Overall Study||0||
59580196|NCT02344225|75686347|FG001|NOT COMPLETED|Overall Study||0||
59580197|NCT02344225|75686348|FG002|NOT COMPLETED|Overall Study||0||
59580198|NCT03314753|75686358|FG000|STARTED|Overall Study||53||
60121505|NCT01685801|76242413|FG001|STARTED|Cycle 2 Period 2 (2 Weeks)||6||
60121506|NCT01685801|76242414|FG002|STARTED|Cycle 2 Period 2 (2 Weeks)||7||
60121507|NCT01685801|76242415|FG003|STARTED|Cycle 2 Period 2 (2 Weeks)||5||
59580199|NCT03314753|75686359|FG001|STARTED|Overall Study||36||
59580200|NCT03314753|75686358|FG000|COMPLETED|Overall Study||53||
59580201|NCT03314753|75686359|FG001|COMPLETED|Overall Study||36||
59580202|NCT03314753|75686358|FG000|NOT COMPLETED|Overall Study||0||
59580203|NCT03314753|75686359|FG001|NOT COMPLETED|Overall Study||0||
59580204|NCT03318341|75686367|FG000|STARTED|Month 1||13||
59580205|NCT03318341|75686368|FG001|STARTED|Month 1||13||
59580206|NCT03318341|75686367|FG000|COMPLETED|Month 1||13||
59580207|NCT03318341|75686368|FG001|COMPLETED|Month 1||12||
59580208|NCT03318341|75686367|FG000|NOT COMPLETED|Month 1||0||
59580209|NCT03318341|75686368|FG001|NOT COMPLETED|Month 1||1||
59580210|NCT03318341|75686367|FG000|STARTED|Month 2||13||
59851458|NCT03468309|75976050|FG000|COMPLETED|Overall Study||47||
59851459|NCT03468309|75976050|FG000|NOT COMPLETED|Overall Study||6||
59580211|NCT03318341|75686368|FG001|STARTED|Month 2||12||
59580212|NCT03318341|75686367|FG000|COMPLETED|Month 2||13||
59580213|NCT03318341|75686368|FG001|COMPLETED|Month 2||12||
59580214|NCT03318341|75686367|FG000|NOT COMPLETED|Month 2||0||
59580215|NCT03318341|75686368|FG001|NOT COMPLETED|Month 2||0||
59580216|NCT02300545|75686376|FG000|STARTED|Overall Study||56||
59580217|NCT02300545|75686376|FG000|COMPLETED|Overall Study||56||
59580218|NCT02300545|75686376|FG000|NOT COMPLETED|Overall Study||0||
59580219|NCT02346643|75686380|FG000|STARTED|Overall Study||41||
59851460|NCT03423147|75976056|FG000|STARTED|Overall Study||160||
59580220|NCT02346643|75686380|FG000|Received Trial System|Overall Study||29||
59580221|NCT02346643|75686380|FG000|Received Permanent System|Overall Study||31|Two cases were trials on the table (all-in-one procedures)|
59580222|NCT02346643|75686380|FG000|COMPLETED|Overall Study||6||
59580223|NCT02346643|75686380|FG000|NOT COMPLETED|Overall Study||35||
59580224|NCT03186677|75686389|FG000|STARTED|Period 1||3||
59580225|NCT03186677|75686390|FG001|STARTED|Period 1||3||
59580226|NCT03186677|75686391|FG002|STARTED|Period 1||3||
59580227|NCT03186677|75686392|FG003|STARTED|Period 1||0||
59580228|NCT03186677|75686393|FG004|STARTED|Period 1||0||
59580229|NCT03186677|75686389|FG000|COMPLETED|Period 1||3||
59580230|NCT03186677|75686390|FG001|COMPLETED|Period 1||3||
59580231|NCT03186677|75686391|FG002|COMPLETED|Period 1||3||
59580232|NCT03186677|75686392|FG003|COMPLETED|Period 1||0||
59580233|NCT03186677|75686393|FG004|COMPLETED|Period 1||0||
59580234|NCT03186677|75686389|FG000|NOT COMPLETED|Period 1||0||
59580235|NCT03186677|75686390|FG001|NOT COMPLETED|Period 1||0||
59580236|NCT03186677|75686391|FG002|NOT COMPLETED|Period 1||0||
59580237|NCT03186677|75686392|FG003|NOT COMPLETED|Period 1||0||
59580238|NCT03186677|75686393|FG004|NOT COMPLETED|Period 1||0||
59580239|NCT03186677|75686389|FG000|STARTED|Period 2||0||
59580240|NCT03186677|75686390|FG001|STARTED|Period 2||0||
59580241|NCT03186677|75686391|FG002|STARTED|Period 2||0||
59580242|NCT03186677|75686392|FG003|STARTED|Period 2||5||
59580243|NCT03186677|75686393|FG004|STARTED|Period 2||2||
59580244|NCT03186677|75686389|FG000|COMPLETED|Period 2||0||
59580245|NCT03186677|75686390|FG001|COMPLETED|Period 2||0||
59580246|NCT03186677|75686391|FG002|COMPLETED|Period 2||0||
59580247|NCT03186677|75686392|FG003|COMPLETED|Period 2||5||
59580248|NCT03186677|75686393|FG004|COMPLETED|Period 2||2||
59580249|NCT03186677|75686389|FG000|NOT COMPLETED|Period 2||0||
59580250|NCT03186677|75686390|FG001|NOT COMPLETED|Period 2||0||
59580251|NCT03186677|75686391|FG002|NOT COMPLETED|Period 2||0||
59580252|NCT03186677|75686392|FG003|NOT COMPLETED|Period 2||0||
59580253|NCT03186677|75686393|FG004|NOT COMPLETED|Period 2||0||
59580254|NCT02347345|75686408|FG000|STARTED|Overall Study||10||
59580255|NCT02347345|75686409|FG001|STARTED|Overall Study||12||
59580256|NCT02347345|75686410|FG002|STARTED|Overall Study||12||
59580257|NCT02347345|75686408|FG000|COMPLETED|Overall Study||10||
59580258|NCT02347345|75686409|FG001|COMPLETED|Overall Study||12||
59580259|NCT02347345|75686410|FG002|COMPLETED|Overall Study||12||
59580260|NCT02347345|75686408|FG000|NOT COMPLETED|Overall Study||0||
59580261|NCT02347345|75686409|FG001|NOT COMPLETED|Overall Study||0||
59580262|NCT02347345|75686410|FG002|NOT COMPLETED|Overall Study||0||
59580263|NCT03319277|75686423|FG000|STARTED|Overall Study||59||
59580264|NCT03319277|75686424|FG001|STARTED|Overall Study||59||
59580265|NCT03319277|75686423|FG000|COMPLETED|Overall Study||59||
59580266|NCT03319277|75686424|FG001|COMPLETED|Overall Study||59||
59580267|NCT03319277|75686423|FG000|NOT COMPLETED|Overall Study||0||
59580268|NCT03319277|75686424|FG001|NOT COMPLETED|Overall Study||0||
59580269|NCT03323723|75686430|FG000|STARTED|Screening||73||
59580270|NCT03323723|75686430|FG000|COMPLETED|Screening||64||
59580271|NCT03323723|75686430|FG000|NOT COMPLETED|Screening||9||
59580272|NCT03323723|75686430|FG000|STARTED|Baseline Phase||64||
59580273|NCT03323723|75686430|FG000|COMPLETED|Baseline Phase||60||
59580274|NCT03323723|75686430|FG000|NOT COMPLETED|Baseline Phase||4||
59580275|NCT03323723|75686430|FG000|STARTED|Treatment Phase||60||
59580276|NCT03323723|75686430|FG000|COMPLETED|Treatment Phase||51||
59580277|NCT03323723|75686430|FG000|NOT COMPLETED|Treatment Phase||9||
59580278|NCT02348593|75686439|FG000|STARTED|Overall Study||59||
59580279|NCT02348593|75686440|FG001|STARTED|Overall Study||59||
59580280|NCT02348593|75686441|FG002|STARTED|Overall Study||59||
59851461|NCT03423147|75976057|FG001|STARTED|Overall Study||159||
59851462|NCT03423147|75976056|FG000|COMPLETED|Overall Study||152||
59851463|NCT03423147|75976057|FG001|COMPLETED|Overall Study||150||
59851464|NCT03423147|75976056|FG000|NOT COMPLETED|Overall Study||8||
59851465|NCT03423147|75976057|FG001|NOT COMPLETED|Overall Study||9||
59580281|NCT02348593|75686442|FG003|STARTED|Overall Study||59||
59580282|NCT02348593|75686439|FG000|COMPLETED|Overall Study||49||
59580283|NCT02348593|75686440|FG001|COMPLETED|Overall Study||51||
59580284|NCT02348593|75686441|FG002|COMPLETED|Overall Study||43||
59580285|NCT02348593|75686442|FG003|COMPLETED|Overall Study||52||
59580286|NCT02348593|75686439|FG000|NOT COMPLETED|Overall Study||10||
59580287|NCT02348593|75686440|FG001|NOT COMPLETED|Overall Study||8||
59580288|NCT02348593|75686441|FG002|NOT COMPLETED|Overall Study||16||
59580289|NCT02348593|75686442|FG003|NOT COMPLETED|Overall Study||7||
59580290|NCT03323801|75686452|FG000|STARTED|Overall Study||10||
59580291|NCT03323801|75686452|FG000|COMPLETED|Overall Study||10||
59580292|NCT03323801|75686452|FG000|NOT COMPLETED|Overall Study||0||
59580293|NCT02349685|75686460|FG000|STARTED|Overall Study||89||
59580294|NCT02349685|75686461|FG001|STARTED|Overall Study||89||
59580295|NCT02349685|75686462|FG002|STARTED|Overall Study||41||
59580296|NCT02349685|75686460|FG000|COMPLETED|Overall Study||84||
59580297|NCT02349685|75686461|FG001|COMPLETED|Overall Study||87||
59580298|NCT02349685|75686462|FG002|COMPLETED|Overall Study||37||
59580299|NCT02349685|75686460|FG000|NOT COMPLETED|Overall Study||5||
59580300|NCT02349685|75686461|FG001|NOT COMPLETED|Overall Study||2||
59580301|NCT02349685|75686462|FG002|NOT COMPLETED|Overall Study||4||
59580302|NCT03676010|75686476|FG000|STARTED|Overall Study||32||
59851466|NCT03322631|75976067|FG000|STARTED|Overall Study||9||
59851467|NCT03322631|75976068|FG001|STARTED|Overall Study||12||
59580303|NCT03676010|75686477|FG001|STARTED|Overall Study||35||
59580304|NCT03676010|75686478|FG002|STARTED|Overall Study||33||
59580305|NCT03676010|75686479|FG003|STARTED|Overall Study||36||
59580306|NCT03676010|75686480|FG004|STARTED|Overall Study||24||
59580307|NCT03676010|75686481|FG005|STARTED|Overall Study||36||
59580308|NCT03676010|75686476|FG000|COMPLETED|Overall Study|Of the 32 experts who filled in the first questionnaire, 28 (87%) also participated in the second round of rating.|28||
59580309|NCT03676010|75686477|FG001|COMPLETED|Overall Study|Of the 35 experts who filled-in the first questionnaire, 31 (89%) also answered the second questionnaire.|31||
59580310|NCT03676010|75686478|FG002|COMPLETED|Overall Study|Of the 33 experts who filled-in the first questionnaire, 30 (91%) also answered the second questionnaire.|30||
59580311|NCT03676010|75686479|FG003|COMPLETED|Overall Study|Of the 36 experts who filled-in the first questionnaire, 31 (86%) also answered the second questionnaire.|31||
59580312|NCT03676010|75686480|FG004|COMPLETED|Overall Study|Of the 24 experts who completed the first questionnaire, 24 (100%) also answered the second round.|24||
59580313|NCT03676010|75686481|FG005|COMPLETED|Overall Study|Of the 36 experts who completed the first questionnaire, 24 (67%) also answered the second round.|24||
59580314|NCT03676010|75686476|FG000|NOT COMPLETED|Overall Study||4||
59580315|NCT03676010|75686477|FG001|NOT COMPLETED|Overall Study||4||
59580316|NCT03676010|75686478|FG002|NOT COMPLETED|Overall Study||3||
59580317|NCT03676010|75686479|FG003|NOT COMPLETED|Overall Study||5||
59580318|NCT03676010|75686480|FG004|NOT COMPLETED|Overall Study||0||
59580319|NCT03676010|75686481|FG005|NOT COMPLETED|Overall Study||12||
59580320|NCT03326843|75686495|FG000|STARTED|Overall Study||4||
59580321|NCT03326843|75686495|FG000|COMPLETED|Overall Study||4||
59580322|NCT03326843|75686495|FG000|NOT COMPLETED|Overall Study||0||
59580323|NCT02352259|75686499|FG000|STARTED|Overall Study||23||
59580324|NCT02352259|75686499|FG000|COMPLETED|Overall Study||23||
59580325|NCT02352259|75686499|FG000|NOT COMPLETED|Overall Study||0||
59580326|NCT02354443|75686503|FG000|STARTED|Overall Study||1||
59580327|NCT02354443|75686503|FG000|COMPLETED|Overall Study||1||
59580328|NCT02354443|75686503|FG000|NOT COMPLETED|Overall Study||0||
59580329|NCT03326999|75686509|FG000|STARTED|Overall Study||30||
59580330|NCT03326999|75686510|FG001|STARTED|Overall Study||30||
59851468|NCT03322631|75976069|FG002|STARTED|Overall Study||16||
59851469|NCT03322631|75976070|FG003|STARTED|Overall Study||11||
59580331|NCT03326999|75686509|FG000|COMPLETED|Overall Study||30||
59580332|NCT03326999|75686510|FG001|COMPLETED|Overall Study||30||
59580333|NCT03326999|75686509|FG000|NOT COMPLETED|Overall Study||0||
59580334|NCT03326999|75686510|FG001|NOT COMPLETED|Overall Study||0||
59580335|NCT02397265|75686516|FG000|STARTED|First Intervention of Three||2||
59580336|NCT02397265|75686517|FG001|STARTED|First Intervention of Three||2||
59580337|NCT02397265|75686518|FG002|STARTED|First Intervention of Three||2||
59580338|NCT02397265|75686516|FG000|COMPLETED|First Intervention of Three||2||
59580339|NCT02397265|75686517|FG001|COMPLETED|First Intervention of Three||2||
59580340|NCT02397265|75686518|FG002|COMPLETED|First Intervention of Three||2||
59580341|NCT02397265|75686516|FG000|NOT COMPLETED|First Intervention of Three||0||
59580342|NCT02397265|75686517|FG001|NOT COMPLETED|First Intervention of Three||0||
59580343|NCT02397265|75686518|FG002|NOT COMPLETED|First Intervention of Three||0||
59580344|NCT02397265|75686516|FG000|STARTED|Second Intervention of Three||2||
59580345|NCT02397265|75686517|FG001|STARTED|Second Intervention of Three||2||
59580346|NCT02397265|75686518|FG002|STARTED|Second Intervention of Three||2||
59580347|NCT02397265|75686516|FG000|COMPLETED|Second Intervention of Three||2||
59580348|NCT02397265|75686517|FG001|COMPLETED|Second Intervention of Three||2||
59580349|NCT02397265|75686518|FG002|COMPLETED|Second Intervention of Three||2||
59580350|NCT02397265|75686516|FG000|NOT COMPLETED|Second Intervention of Three||0||
59580351|NCT02397265|75686517|FG001|NOT COMPLETED|Second Intervention of Three||0||
59580352|NCT02397265|75686518|FG002|NOT COMPLETED|Second Intervention of Three||0||
59580353|NCT02397265|75686516|FG000|STARTED|Third Intervention of Three||2||
59580354|NCT02397265|75686517|FG001|STARTED|Third Intervention of Three||2||
59580355|NCT02397265|75686518|FG002|STARTED|Third Intervention of Three||2||
59580356|NCT02397265|75686516|FG000|COMPLETED|Third Intervention of Three||2||
59580357|NCT02397265|75686517|FG001|COMPLETED|Third Intervention of Three||2||
59580358|NCT02397265|75686518|FG002|COMPLETED|Third Intervention of Three||2||
59580359|NCT02397265|75686516|FG000|NOT COMPLETED|Third Intervention of Three||0||
59580360|NCT02397265|75686517|FG001|NOT COMPLETED|Third Intervention of Three||0||
59580361|NCT02397265|75686518|FG002|NOT COMPLETED|Third Intervention of Three||0||
59580362|NCT03328949|75686526|FG000|STARTED|Overall Study||120||
59580363|NCT03328949|75686526|FG000|COMPLETED|Overall Study||120||
59580364|NCT03328949|75686526|FG000|NOT COMPLETED|Overall Study||0||
59580365|NCT03330041|75686531|FG000|STARTED|Overall Study||50||
59580366|NCT03330041|75686531|FG000|COMPLETED|Overall Study||48||
59580367|NCT03330041|75686531|FG000|NOT COMPLETED|Overall Study||2||
59580368|NCT03198221|75686541|FG000|STARTED|Overall Study||3||
59580369|NCT03198221|75686542|FG001|STARTED|Overall Study||2||
59580370|NCT03198221|75686543|FG002|STARTED|Overall Study||7||
59580371|NCT03198221|75686544|FG003|STARTED|Overall Study||2||
59580372|NCT03198221|75686541|FG000|COMPLETED|Overall Study||3||
59580373|NCT03198221|75686542|FG001|COMPLETED|Overall Study||2||
59580374|NCT03198221|75686543|FG002|COMPLETED|Overall Study||7||
59580375|NCT03198221|75686544|FG003|COMPLETED|Overall Study||2||
59580376|NCT03198221|75686541|FG000|NOT COMPLETED|Overall Study||0||
59851470|NCT03322631|75976067|FG000|Received at Least 1 Dose of Study Drug|Overall Study||9||
59580377|NCT03198221|75686542|FG001|NOT COMPLETED|Overall Study||0||
59580378|NCT03198221|75686543|FG002|NOT COMPLETED|Overall Study||0||
59580379|NCT03198221|75686544|FG003|NOT COMPLETED|Overall Study||0||
59580380|NCT03203681|75686554|FG000|STARTED|Overall Study||60||
59580381|NCT03203681|75686554|FG000|3 Month|Overall Study||44||
59580382|NCT03203681|75686554|FG000|6 Months|Overall Study||33||
59580383|NCT03203681|75686554|FG000|COMPLETED|Overall Study||33||
59580384|NCT03203681|75686554|FG000|NOT COMPLETED|Overall Study||27||
59580385|NCT03207035|75686560|FG000|STARTED|Overall Study||10||
59580386|NCT03207035|75686561|FG001|STARTED|Overall Study||10||
59580387|NCT03207035|75686560|FG000|COMPLETED|Overall Study||10||
59580388|NCT03207035|75686561|FG001|COMPLETED|Overall Study||10||
59580389|NCT03207035|75686560|FG000|NOT COMPLETED|Overall Study||0||
59580390|NCT03207035|75686561|FG001|NOT COMPLETED|Overall Study||0||
59580391|NCT05993299|75686567|FG000|STARTED|Overall Study||7||
59580392|NCT05993299|75686567|FG000|Received T Cell Infusion|Overall Study||5||
59580393|NCT05993299|75686567|FG000|COMPLETED|Overall Study||1||
59580394|NCT05993299|75686567|FG000|NOT COMPLETED|Overall Study||6||
59580395|NCT05359666|75686573|FG000|STARTED|Overall Study|"Of the 636 subjects within the ITT population, a total of 44 subjects had data that could not be verified. Their data was considered non-evaluable and excluded from the analysis. The randomization groups (i.e., Irrisept or SoC) for these 44 subjects could not be verified and is unknown. There were 294 subjects randomized to Irrisept in the mITT population."|294||
59580396|NCT05359666|75686574|FG001|STARTED|Overall Study|"Of the 636 subjects within the ITT population, a total of 44 subjects had data that could not be verified. Their data was considered non-evaluable and excluded from the analysis. The randomization groups (i.e., Irrisept or SoC) for these 44 subjects could not be verified and is unknown. There were 298 subjects randomized to SoC in the mITT population."|298||
59580397|NCT05359666|75686573|FG000|COMPLETED|Overall Study||294||
59580398|NCT05359666|75686574|FG001|COMPLETED|Overall Study||298||
59580399|NCT05359666|75686573|FG000|NOT COMPLETED|Overall Study||0||
59580400|NCT05359666|75686574|FG001|NOT COMPLETED|Overall Study||0||
59580401|NCT05319756|75686580|FG000|STARTED|Overall Study||9||
59724105|NCT01120067|75842713|FG001|COMPLETED|Overall Study||10||
59724106|NCT01120067|75842712|FG000|NOT COMPLETED|Overall Study||5||
59724107|NCT01120067|75842713|FG001|NOT COMPLETED|Overall Study||1||
59724108|NCT01124045|75842721|FG000|STARTED|Overall Study||39||
59724109|NCT01124045|75842722|FG001|STARTED|Overall Study||40||
59724110|NCT01124045|75842721|FG000|COMPLETED|Overall Study||39||
59724111|NCT01124045|75842722|FG001|COMPLETED|Overall Study||37||
59724112|NCT01124045|75842721|FG000|NOT COMPLETED|Overall Study||0||
59724113|NCT01124045|75842722|FG001|NOT COMPLETED|Overall Study||3||
59724114|NCT01123889|75842730|FG000|STARTED|Overall Study||5||
59724115|NCT01123889|75842731|FG001|STARTED|Overall Study||7||
59724116|NCT01123889|75842730|FG000|COMPLETED|Overall Study||2||
59724117|NCT01123889|75842731|FG001|COMPLETED|Overall Study||6||
59724118|NCT01123889|75842730|FG000|NOT COMPLETED|Overall Study||3||
59724119|NCT01123889|75842731|FG001|NOT COMPLETED|Overall Study||1||
59724120|NCT00934947|75842739|FG000|STARTED|Overall Study||23||
59724121|NCT00934947|75842740|FG001|STARTED|Overall Study||22||
59724122|NCT00934947|75842739|FG000|COMPLETED|Overall Study||23||
59724123|NCT00934947|75842740|FG001|COMPLETED|Overall Study||20||
59724124|NCT00934947|75842739|FG000|NOT COMPLETED|Overall Study||0||
59724125|NCT00934947|75842740|FG001|NOT COMPLETED|Overall Study||2||
59724126|NCT01123655|75842750|FG000|STARTED|Overall Study||10||
59724127|NCT01123655|75842751|FG001|STARTED|Overall Study||4||
59724128|NCT01123655|75842752|FG002|STARTED|Overall Study||8||
59724129|NCT01123655|75842750|FG000|COMPLETED|Overall Study||9||
59724130|NCT01123655|75842751|FG001|COMPLETED|Overall Study||3||
59724131|NCT01123655|75842752|FG002|COMPLETED|Overall Study||7||
59724132|NCT01123655|75842750|FG000|NOT COMPLETED|Overall Study||1||
59724133|NCT01123655|75842751|FG001|NOT COMPLETED|Overall Study||1||
59724134|NCT01123655|75842752|FG002|NOT COMPLETED|Overall Study||1||
59724135|NCT00934791|75842760|FG000|STARTED|Overall Study||1||
59724136|NCT00934791|75842761|FG001|STARTED|Overall Study||0||
59724137|NCT00934791|75842760|FG000|COMPLETED|Overall Study||0||
59724138|NCT00934791|75842761|FG001|COMPLETED|Overall Study||0||
60121508|NCT01685801|76242412|FG000|COMPLETED|Cycle 2 Period 2 (2 Weeks)||5||
60121509|NCT01685801|76242413|FG001|COMPLETED|Cycle 2 Period 2 (2 Weeks)||5||
60121510|NCT01685801|76242414|FG002|COMPLETED|Cycle 2 Period 2 (2 Weeks)||7||
60121511|NCT01685801|76242415|FG003|COMPLETED|Cycle 2 Period 2 (2 Weeks)||4||
60121512|NCT01685801|76242412|FG000|NOT COMPLETED|Cycle 2 Period 2 (2 Weeks)||0||
60121513|NCT01685801|76242413|FG001|NOT COMPLETED|Cycle 2 Period 2 (2 Weeks)||1||
60121514|NCT01685801|76242414|FG002|NOT COMPLETED|Cycle 2 Period 2 (2 Weeks)||0||
60121515|NCT01685801|76242415|FG003|NOT COMPLETED|Cycle 2 Period 2 (2 Weeks)||1||
60121516|NCT01685801|76242412|FG000|STARTED|Washout Period 2 (4 Weeks)||5||
59724139|NCT00934791|75842760|FG000|NOT COMPLETED|Overall Study||1||
59724140|NCT00934791|75842761|FG001|NOT COMPLETED|Overall Study||0||
59724141|NCT01119443|75842769|FG000|STARTED|Up-titration Period (10 Days)||14||
59724142|NCT01119443|75842770|FG001|STARTED|Up-titration Period (10 Days)||14||
59724143|NCT01119443|75842769|FG000|COMPLETED|Up-titration Period (10 Days)||14||
59724144|NCT01119443|75842770|FG001|COMPLETED|Up-titration Period (10 Days)||14||
60121517|NCT01685801|76242413|FG001|STARTED|Washout Period 2 (4 Weeks)||5||
59724145|NCT01119443|75842769|FG000|NOT COMPLETED|Up-titration Period (10 Days)||0||
59580402|NCT05319756|75686581|FG001|STARTED|Overall Study||9||
59580403|NCT05319756|75686582|FG002|STARTED|Overall Study||9||
59580404|NCT05319756|75686583|FG003|STARTED|Overall Study||9||
59580405|NCT05319756|75686584|FG004|STARTED|Overall Study||9||
59580406|NCT05319756|75686585|FG005|STARTED|Overall Study||9||
59580407|NCT05319756|75686580|FG000|COMPLETED|Overall Study||8||
59580408|NCT05319756|75686581|FG001|COMPLETED|Overall Study||8||
59580409|NCT05319756|75686582|FG002|COMPLETED|Overall Study||9||
59580410|NCT05319756|75686583|FG003|COMPLETED|Overall Study||9||
59580411|NCT05319756|75686584|FG004|COMPLETED|Overall Study||8||
59580412|NCT05319756|75686585|FG005|COMPLETED|Overall Study||8||
59580413|NCT05319756|75686580|FG000|NOT COMPLETED|Overall Study||1||
59580414|NCT05319756|75686581|FG001|NOT COMPLETED|Overall Study||1||
59580415|NCT05319756|75686582|FG002|NOT COMPLETED|Overall Study||0||
59580416|NCT05319756|75686583|FG003|NOT COMPLETED|Overall Study||0||
59580417|NCT05319756|75686584|FG004|NOT COMPLETED|Overall Study||1||
59580418|NCT05319756|75686585|FG005|NOT COMPLETED|Overall Study||1||
59580419|NCT05254210|75686618|FG000|STARTED|Overall Study||10||
59580420|NCT05254210|75686618|FG000|COMPLETED|Overall Study||8||
59580421|NCT05254210|75686618|FG000|NOT COMPLETED|Overall Study||2||
59580422|NCT05239598|75686624|FG000|STARTED|Phase I||21||
59580423|NCT05239598|75686625|FG001|STARTED|Phase I||19||
59580424|NCT05239598|75686624|FG000|COMPLETED|Phase I||21||
59580425|NCT05239598|75686625|FG001|COMPLETED|Phase I||19||
59580426|NCT05239598|75686624|FG000|NOT COMPLETED|Phase I||0||
59580427|NCT05239598|75686625|FG001|NOT COMPLETED|Phase I||0||
59580428|NCT05239598|75686624|FG000|STARTED|Phase II (Open Label)||37||
59580429|NCT05239598|75686625|FG001|STARTED|Phase II (Open Label)||0||
59580430|NCT05239598|75686624|FG000|COMPLETED|Phase II (Open Label)||35||
59580431|NCT05239598|75686625|FG001|COMPLETED|Phase II (Open Label)||0||
59580432|NCT05239598|75686624|FG000|NOT COMPLETED|Phase II (Open Label)||2||
59580433|NCT05239598|75686625|FG001|NOT COMPLETED|Phase II (Open Label)||0||
59580434|NCT05216380|75686636|FG000|STARTED|Overall Study||54||
59580435|NCT05216380|75686636|FG000|COMPLETED|Overall Study||54||
59580436|NCT05216380|75686636|FG000|NOT COMPLETED|Overall Study||0||
59580437|NCT05053126|75686640|FG000|STARTED|Overall Study||10||
59580438|NCT05053126|75686641|FG001|STARTED|Overall Study||10||
59580439|NCT05053126|75686642|FG002|STARTED|Overall Study||10||
59580440|NCT05053126|75686643|FG003|STARTED|Overall Study||10||
59580441|NCT05053126|75686644|FG004|STARTED|Overall Study||10||
59580442|NCT05053126|75686645|FG005|STARTED|Overall Study||10||
59580443|NCT05053126|75686640|FG000|COMPLETED|Overall Study||10||
59580444|NCT05053126|75686641|FG001|COMPLETED|Overall Study||10||
59580445|NCT05053126|75686642|FG002|COMPLETED|Overall Study||10||
59580446|NCT05053126|75686643|FG003|COMPLETED|Overall Study||9||
59580447|NCT05053126|75686644|FG004|COMPLETED|Overall Study||10||
59580448|NCT05053126|75686645|FG005|COMPLETED|Overall Study||9||
59580449|NCT05053126|75686640|FG000|NOT COMPLETED|Overall Study||0||
59580450|NCT05053126|75686641|FG001|NOT COMPLETED|Overall Study||0||
59580451|NCT05053126|75686642|FG002|NOT COMPLETED|Overall Study||0||
59580452|NCT05053126|75686643|FG003|NOT COMPLETED|Overall Study||1||
59580453|NCT05053126|75686644|FG004|NOT COMPLETED|Overall Study||0||
59580454|NCT05053126|75686645|FG005|NOT COMPLETED|Overall Study||1||
59580455|NCT05049616|75686661|FG000|STARTED|Overall Study||34||
59580456|NCT05049616|75686662|FG001|STARTED|Overall Study||36||
59580457|NCT05049616|75686661|FG000|COMPLETED|Overall Study||31||
59580458|NCT05049616|75686662|FG001|COMPLETED|Overall Study||36||
59580459|NCT05049616|75686661|FG000|NOT COMPLETED|Overall Study||3||
59580460|NCT05049616|75686662|FG001|NOT COMPLETED|Overall Study||0||
59724146|NCT01119443|75842770|FG001|NOT COMPLETED|Up-titration Period (10 Days)||0||
59851471|NCT03322631|75976068|FG001|Received at Least 1 Dose of Study Drug|Overall Study||12||
60121518|NCT01685801|76242414|FG002|STARTED|Washout Period 2 (4 Weeks)||7||
60121519|NCT01685801|76242415|FG003|STARTED|Washout Period 2 (4 Weeks)||4||
59580461|NCT05010070|75686668|FG000|STARTED|Overall Study||11||
59580462|NCT05010070|75686668|FG000|COMPLETED|Overall Study||9||
59580463|NCT05010070|75686668|FG000|NOT COMPLETED|Overall Study||2||
59580464|NCT04792645|75686674|FG000|STARTED|Overall Study||45||
59580465|NCT04792645|75686675|FG001|STARTED|Overall Study||55||
59580466|NCT04792645|75686674|FG000|COMPLETED|Overall Study||36||
59580467|NCT04792645|75686675|FG001|COMPLETED|Overall Study||43||
59580468|NCT04792645|75686674|FG000|NOT COMPLETED|Overall Study||9||
59580469|NCT04792645|75686675|FG001|NOT COMPLETED|Overall Study||12||
59580470|NCT04621734|75686683|FG000|STARTED|Overall Study||17||
59580471|NCT04621734|75686684|FG001|STARTED|Overall Study||18||
59724147|NCT01119443|75842769|FG000|STARTED|Crossover Period 1 (5 Days)||14||
59580472|NCT04621734|75686683|FG000|COMPLETED|Overall Study||16||
59580473|NCT04621734|75686684|FG001|COMPLETED|Overall Study||17||
59580474|NCT04621734|75686683|FG000|NOT COMPLETED|Overall Study||1||
59580475|NCT04621734|75686684|FG001|NOT COMPLETED|Overall Study||1||
59580476|NCT04523480|75686693|FG000|STARTED|Overall Study||33||
59580477|NCT04523480|75686694|FG001|STARTED|Overall Study||42||
59580478|NCT04523480|75686695|FG002|STARTED|Overall Study||0||
59580479|NCT04523480|75686693|FG000|COMPLETED|Overall Study||3||
59580480|NCT04523480|75686694|FG001|COMPLETED|Overall Study||7||
59580481|NCT04523480|75686695|FG002|COMPLETED|Overall Study||0||
59580482|NCT04523480|75686693|FG000|NOT COMPLETED|Overall Study||30||
59580483|NCT04523480|75686694|FG001|NOT COMPLETED|Overall Study||35||
59580484|NCT04523480|75686695|FG002|NOT COMPLETED|Overall Study||0||
59580485|NCT04454125|75686705|FG000|STARTED|Overall Study||20||
59580486|NCT04454125|75686706|FG001|STARTED|Overall Study||20||
59580487|NCT04454125|75686705|FG000|COMPLETED|Overall Study||20||
59580488|NCT04454125|75686706|FG001|COMPLETED|Overall Study||19||
59580489|NCT04454125|75686705|FG000|NOT COMPLETED|Overall Study||0||
59580490|NCT04454125|75686706|FG001|NOT COMPLETED|Overall Study||1||
59580491|NCT04313296|75686712|FG000|STARTED|Overall Study||209||
59580492|NCT04313296|75686712|FG000|COMPLETED|Overall Study||209||
59580493|NCT04313296|75686712|FG000|NOT COMPLETED|Overall Study||0||
59580494|NCT04307446|75686718|FG000|STARTED|Overall Study||12||
59580495|NCT04307446|75686719|FG001|STARTED|Overall Study||11||
59580496|NCT04307446|75686718|FG000|COMPLETED|Overall Study||10||
59580497|NCT04307446|75686719|FG001|COMPLETED|Overall Study||11||
59580498|NCT04307446|75686718|FG000|NOT COMPLETED|Overall Study||2||
59580499|NCT04307446|75686719|FG001|NOT COMPLETED|Overall Study||0||
59580500|NCT04207801|75686728|FG000|STARTED|Overall Study||30||
59580501|NCT04207801|75686729|FG001|STARTED|Overall Study||30||
59580502|NCT04207801|75686730|FG002|STARTED|Overall Study||30||
59580503|NCT04207801|75686728|FG000|COMPLETED|Overall Study||26||
59580504|NCT04207801|75686729|FG001|COMPLETED|Overall Study||26||
59580505|NCT04207801|75686730|FG002|COMPLETED|Overall Study||23||
59580506|NCT04207801|75686728|FG000|NOT COMPLETED|Overall Study||4||
59580507|NCT04207801|75686729|FG001|NOT COMPLETED|Overall Study||4||
59580508|NCT04207801|75686730|FG002|NOT COMPLETED|Overall Study||7||
59580509|NCT04143009|75686741|FG000|STARTED|Pre-pilot||5||
59580510|NCT04143009|75686742|FG001|STARTED|Pre-pilot||3||
59580511|NCT04143009|75686743|FG002|STARTED|Pre-pilot||4||
59580512|NCT04143009|75686741|FG000|COMPLETED|Pre-pilot||5||
59580513|NCT04143009|75686742|FG001|COMPLETED|Pre-pilot||3||
59580514|NCT04143009|75686743|FG002|COMPLETED|Pre-pilot||4||
59580515|NCT04143009|75686741|FG000|NOT COMPLETED|Pre-pilot||0||
59580516|NCT04143009|75686742|FG001|NOT COMPLETED|Pre-pilot||0||
59580517|NCT04143009|75686743|FG002|NOT COMPLETED|Pre-pilot||0||
59580518|NCT04143009|75686741|FG000|STARTED|Pilot Trial|The AFB arm was removed in study period 2 (Pilot trial phase), and thus 0 participants started the trial in the AFB arm.|0||
59580519|NCT04143009|75686742|FG001|STARTED|Pilot Trial|The study protocol was modified to 2 arms with randomization at the individual level. 40 participants started in the EFB arm for study period 2 (Pilot Trial Phase).|40||
59580520|NCT04143009|75686743|FG002|STARTED|Pilot Trial|The study protocol was modified to 2 arms with randomization at the individual level. 40 participants started in the Enhanced Standard Care (ESC) arm for study period 2 (Pilot Trial Phase).|40||
59580521|NCT04143009|75686741|FG000|COMPLETED|Pilot Trial||0||
59580522|NCT04143009|75686742|FG001|COMPLETED|Pilot Trial||39||
59580523|NCT04143009|75686743|FG002|COMPLETED|Pilot Trial||39||
59580524|NCT04143009|75686741|FG000|NOT COMPLETED|Pilot Trial||0||
59580525|NCT04143009|75686742|FG001|NOT COMPLETED|Pilot Trial||1||
59580526|NCT04143009|75686743|FG002|NOT COMPLETED|Pilot Trial||1||
59580527|NCT04126317|75686753|FG000|STARTED|Overall Study||53||
59580528|NCT04126317|75686754|FG001|STARTED|Overall Study||53||
59580529|NCT04126317|75686753|FG000|COMPLETED|Overall Study||49||
59580530|NCT04126317|75686754|FG001|COMPLETED|Overall Study||51||
59580531|NCT04126317|75686753|FG000|NOT COMPLETED|Overall Study||4||
59580532|NCT04126317|75686754|FG001|NOT COMPLETED|Overall Study||2||
59580533|NCT04066894|75686760|FG000|STARTED|Overall Study||3||
59580534|NCT04066894|75686760|FG000|COMPLETED|Overall Study||1||
59580535|NCT04066894|75686760|FG000|NOT COMPLETED|Overall Study||2||
59580536|NCT04005053|75686767|FG000|STARTED|Overall Study||16||
59580537|NCT04005053|75686768|FG001|STARTED|Overall Study||13||
59580538|NCT04005053|75686769|FG002|STARTED|Overall Study||15||
59580539|NCT04005053|75686767|FG000|COMPLETED|Overall Study||14||
59580540|NCT04005053|75686768|FG001|COMPLETED|Overall Study||11||
59580541|NCT04005053|75686769|FG002|COMPLETED|Overall Study||14||
59580542|NCT04005053|75686767|FG000|NOT COMPLETED|Overall Study||2||
59580543|NCT04005053|75686768|FG001|NOT COMPLETED|Overall Study||2||
59580544|NCT04005053|75686769|FG002|NOT COMPLETED|Overall Study||1||
59580545|NCT03971578|75686779|FG000|STARTED|Overall Study||25||
59580546|NCT03971578|75686780|FG001|STARTED|Overall Study||56||
59580547|NCT03971578|75686779|FG000|COMPLETED|Overall Study||14||
59580548|NCT03971578|75686780|FG001|COMPLETED|Overall Study||37||
59580549|NCT03971578|75686779|FG000|NOT COMPLETED|Overall Study||11||
59580550|NCT03971578|75686780|FG001|NOT COMPLETED|Overall Study||19||
59580551|NCT03929913|75686786|FG000|STARTED|Overall Study||19||
59580552|NCT03929913|75686786|FG000|COMPLETED|Overall Study||12||
59580553|NCT03929913|75686786|FG000|NOT COMPLETED|Overall Study||7||
59580554|NCT03872700|75686792|FG000|STARTED|Overall Study||24||
59580555|NCT03872700|75686793|FG001|STARTED|Overall Study||25||
59580556|NCT03872700|75686792|FG000|COMPLETED|Overall Study||24||
59580557|NCT03872700|75686793|FG001|COMPLETED|Overall Study||25||
59580558|NCT03872700|75686792|FG000|NOT COMPLETED|Overall Study||0||
59580559|NCT03872700|75686793|FG001|NOT COMPLETED|Overall Study||0||
59580560|NCT03832192|75686801|FG000|STARTED|Overall Study||152||
59580561|NCT03832192|75686802|FG001|STARTED|Overall Study||149||
59580562|NCT03832192|75686801|FG000|COMPLETED|Overall Study||0||
59580563|NCT03832192|75686802|FG001|COMPLETED|Overall Study||0||
59580564|NCT03832192|75686801|FG000|NOT COMPLETED|Overall Study||152||
59580565|NCT03832192|75686802|FG001|NOT COMPLETED|Overall Study||149||
59580566|NCT03776461|75686808|FG000|STARTED|Overall Study||25||
59580567|NCT03776461|75686808|FG000|COMPLETED|Overall Study||18||
59580568|NCT03776461|75686808|FG000|NOT COMPLETED|Overall Study||7||
59580569|NCT03738800|75686818|FG000|STARTED|Double-blind Treatment Period||23||
59580570|NCT03738800|75686819|FG001|STARTED|Double-blind Treatment Period||21||
59580571|NCT03738800|75686820|FG002|STARTED|Double-blind Treatment Period||21||
59580572|NCT03738800|75686818|FG000|COMPLETED|Double-blind Treatment Period||14||
59580573|NCT03738800|75686819|FG001|COMPLETED|Double-blind Treatment Period||18||
59580574|NCT03738800|75686820|FG002|COMPLETED|Double-blind Treatment Period||17||
59580575|NCT03738800|75686818|FG000|NOT COMPLETED|Double-blind Treatment Period||9||
59580576|NCT03738800|75686819|FG001|NOT COMPLETED|Double-blind Treatment Period||3||
59580577|NCT03738800|75686820|FG002|NOT COMPLETED|Double-blind Treatment Period||4||
59580578|NCT03738800|75686818|FG000|STARTED|Open Label Extension||49||
59580579|NCT03738800|75686819|FG001|STARTED|Open Label Extension|Open-label Extemsion (OLE) received trifarotene cream HE1 200 mcg/g twice weekly for 90 days.|0||
59580580|NCT03738800|75686820|FG002|STARTED|Open Label Extension|Open-label Extemsion (OLE) received trifarotene cream HE1 200 mcg/g twice weekly for 90 days.|0||
59580581|NCT03738800|75686818|FG000|COMPLETED|Open Label Extension||39||
59580582|NCT03738800|75686819|FG001|COMPLETED|Open Label Extension||0||
59580583|NCT03738800|75686820|FG002|COMPLETED|Open Label Extension||0||
59580584|NCT03738800|75686818|FG000|NOT COMPLETED|Open Label Extension||10||
59580585|NCT03738800|75686819|FG001|NOT COMPLETED|Open Label Extension||0||
59580586|NCT03738800|75686820|FG002|NOT COMPLETED|Open Label Extension||0||
59580587|NCT03682055|75686839|FG000|STARTED|Overall Study||1||
59580588|NCT03682055|75686840|FG001|STARTED|Overall Study||2||
59580589|NCT03682055|75686841|FG002|STARTED|Overall Study||1||
59580590|NCT03682055|75686842|FG003|STARTED|Overall Study||2||
59580591|NCT03682055|75686843|FG004|STARTED|Overall Study||1||
59580592|NCT03682055|75686844|FG005|STARTED|Overall Study||7||
59580593|NCT03682055|75686839|FG000|COMPLETED|Overall Study||0||
59580594|NCT03682055|75686840|FG001|COMPLETED|Overall Study||0||
59580595|NCT03682055|75686841|FG002|COMPLETED|Overall Study||0||
59580596|NCT03682055|75686842|FG003|COMPLETED|Overall Study||0||
59580597|NCT03682055|75686843|FG004|COMPLETED|Overall Study||0||
59580598|NCT03682055|75686844|FG005|COMPLETED|Overall Study||0||
59580599|NCT03682055|75686839|FG000|NOT COMPLETED|Overall Study||1||
59580600|NCT03682055|75686840|FG001|NOT COMPLETED|Overall Study||2||
59580601|NCT03682055|75686841|FG002|NOT COMPLETED|Overall Study||1||
59580602|NCT03682055|75686842|FG003|NOT COMPLETED|Overall Study||2||
59580603|NCT03682055|75686843|FG004|NOT COMPLETED|Overall Study||1||
59580604|NCT03682055|75686844|FG005|NOT COMPLETED|Overall Study||7||
59580605|NCT03547518|75686860|FG000|STARTED|Overall Study||13||
59580606|NCT03547518|75686861|FG001|STARTED|Overall Study||12||
59580607|NCT03547518|75686860|FG000|COMPLETED|Overall Study||11||
59580608|NCT03547518|75686861|FG001|COMPLETED|Overall Study||12||
59580609|NCT03547518|75686860|FG000|NOT COMPLETED|Overall Study||2||
59580610|NCT03547518|75686861|FG001|NOT COMPLETED|Overall Study||0||
59580611|NCT03519347|75686872|FG000|STARTED|Baseline Observation Period||5||
59580612|NCT03519347|75686873|FG001|STARTED|Baseline Observation Period||4||
59580613|NCT03519347|75686874|FG002|STARTED|Baseline Observation Period||4||
59580614|NCT03519347|75686875|FG003|STARTED|Baseline Observation Period||6||
59580615|NCT03519347|75686872|FG000|COMPLETED|Baseline Observation Period||5||
59580616|NCT03519347|75686873|FG001|COMPLETED|Baseline Observation Period||4||
59580617|NCT03519347|75686874|FG002|COMPLETED|Baseline Observation Period||4||
59580618|NCT03519347|75686875|FG003|COMPLETED|Baseline Observation Period||6||
59580619|NCT03519347|75686872|FG000|NOT COMPLETED|Baseline Observation Period||0||
59580620|NCT03519347|75686873|FG001|NOT COMPLETED|Baseline Observation Period||0||
59580621|NCT03519347|75686874|FG002|NOT COMPLETED|Baseline Observation Period||0||
59580622|NCT03519347|75686875|FG003|NOT COMPLETED|Baseline Observation Period||0||
59580623|NCT03519347|75686872|FG000|STARTED|Interventional Crossover Period 1||5||
59580624|NCT03519347|75686873|FG001|STARTED|Interventional Crossover Period 1||4||
59580625|NCT03519347|75686874|FG002|STARTED|Interventional Crossover Period 1||4||
59580626|NCT03519347|75686875|FG003|STARTED|Interventional Crossover Period 1||6||
59580627|NCT03519347|75686872|FG000|COMPLETED|Interventional Crossover Period 1||5||
59580628|NCT03519347|75686873|FG001|COMPLETED|Interventional Crossover Period 1||4||
59580629|NCT03519347|75686874|FG002|COMPLETED|Interventional Crossover Period 1||4||
59580630|NCT03519347|75686875|FG003|COMPLETED|Interventional Crossover Period 1||5||
59580631|NCT03519347|75686872|FG000|NOT COMPLETED|Interventional Crossover Period 1||0||
59580632|NCT03519347|75686873|FG001|NOT COMPLETED|Interventional Crossover Period 1||0||
59580633|NCT03519347|75686874|FG002|NOT COMPLETED|Interventional Crossover Period 1||0||
59580634|NCT03519347|75686875|FG003|NOT COMPLETED|Interventional Crossover Period 1||1||
59580635|NCT03519347|75686872|FG000|STARTED|Interventional Crossover Period 2|1 participant in the B1B2K1K2 experienced Death after completing the Interventional Crossover Period 1 and before starting Interventional Crossover Period 2, decreasing the number of participants who started the period from n = 5 to n = 4.|4||
59580636|NCT03519347|75686873|FG001|STARTED|Interventional Crossover Period 2||4||
59580637|NCT03519347|75686874|FG002|STARTED|Interventional Crossover Period 2||4||
59580638|NCT03519347|75686875|FG003|STARTED|Interventional Crossover Period 2||5||
59580639|NCT03519347|75686872|FG000|COMPLETED|Interventional Crossover Period 2||4||
59580640|NCT03519347|75686873|FG001|COMPLETED|Interventional Crossover Period 2||4||
59580641|NCT03519347|75686874|FG002|COMPLETED|Interventional Crossover Period 2||4||
59580642|NCT03519347|75686875|FG003|COMPLETED|Interventional Crossover Period 2||5||
59580643|NCT03519347|75686872|FG000|NOT COMPLETED|Interventional Crossover Period 2||0||
59580644|NCT03519347|75686873|FG001|NOT COMPLETED|Interventional Crossover Period 2||0||
59580645|NCT03519347|75686874|FG002|NOT COMPLETED|Interventional Crossover Period 2||0||
59580646|NCT03519347|75686875|FG003|NOT COMPLETED|Interventional Crossover Period 2||0||
59580647|NCT03519347|75686872|FG000|STARTED|Interventional Crossover Period 3|1 participant in the B1B2K1K2 arm experienced Death after completing the Interventional Crossover Period 2 and before starting Interventional Crossover Period 3, decreasing the number of participants who started the period from n = 4 to n = 3.|3||
59580648|NCT03519347|75686873|FG001|STARTED|Interventional Crossover Period 3||4||
59580649|NCT03519347|75686874|FG002|STARTED|Interventional Crossover Period 3||4||
59580650|NCT03519347|75686875|FG003|STARTED|Interventional Crossover Period 3||5||
59580651|NCT03519347|75686872|FG000|COMPLETED|Interventional Crossover Period 3||3||
59580652|NCT03519347|75686873|FG001|COMPLETED|Interventional Crossover Period 3||4||
59580653|NCT03519347|75686874|FG002|COMPLETED|Interventional Crossover Period 3||4||
59580654|NCT03519347|75686875|FG003|COMPLETED|Interventional Crossover Period 3||5||
59580655|NCT03519347|75686872|FG000|NOT COMPLETED|Interventional Crossover Period 3||0||
59580656|NCT03519347|75686873|FG001|NOT COMPLETED|Interventional Crossover Period 3||0||
59580657|NCT03519347|75686874|FG002|NOT COMPLETED|Interventional Crossover Period 3||0||
59580658|NCT03519347|75686875|FG003|NOT COMPLETED|Interventional Crossover Period 3||0||
59580659|NCT03519347|75686872|FG000|STARTED|Interventional Crossover Period 4||3||
59580660|NCT03519347|75686873|FG001|STARTED|Interventional Crossover Period 4||4||
59580661|NCT03519347|75686874|FG002|STARTED|Interventional Crossover Period 4|1 participant in the K1K2B1B2 arm experienced Death after completing Interventional Crossover Period 3 and before starting Interventional Crossover Period 4, decreasing the number of participants who started the period from n = 4 to n = 3.|3||
59580662|NCT03519347|75686875|FG003|STARTED|Interventional Crossover Period 4||5||
59580663|NCT03519347|75686872|FG000|COMPLETED|Interventional Crossover Period 4||3||
59580664|NCT03519347|75686873|FG001|COMPLETED|Interventional Crossover Period 4||4||
59580665|NCT03519347|75686874|FG002|COMPLETED|Interventional Crossover Period 4||3||
59580666|NCT03519347|75686875|FG003|COMPLETED|Interventional Crossover Period 4||5||
59580667|NCT03519347|75686872|FG000|NOT COMPLETED|Interventional Crossover Period 4||0||
59580668|NCT03519347|75686873|FG001|NOT COMPLETED|Interventional Crossover Period 4||0||
59580669|NCT03519347|75686874|FG002|NOT COMPLETED|Interventional Crossover Period 4||0||
59580670|NCT03519347|75686875|FG003|NOT COMPLETED|Interventional Crossover Period 4||0||
59580671|NCT03457129|75686891|FG000|STARTED|Overall Study||10||
59580672|NCT03457129|75686892|FG001|STARTED|Overall Study||10||
59580673|NCT03457129|75686891|FG000|COMPLETED|Overall Study||7||
59580674|NCT03457129|75686892|FG001|COMPLETED|Overall Study||8||
59580675|NCT03457129|75686891|FG000|NOT COMPLETED|Overall Study||3||
59580676|NCT03457129|75686892|FG001|NOT COMPLETED|Overall Study||2||
59580677|NCT03244644|75686900|FG000|STARTED|Overall Study||87||
59580678|NCT03244644|75686901|FG001|STARTED|Overall Study||180||
59580679|NCT03244644|75686900|FG000|COMPLETED|Overall Study||75||
59580680|NCT03244644|75686901|FG001|COMPLETED|Overall Study||159||
59580681|NCT03244644|75686900|FG000|NOT COMPLETED|Overall Study||12||
59580682|NCT03244644|75686901|FG001|NOT COMPLETED|Overall Study||21||
59580683|NCT03199638|75686913|FG000|STARTED|Overall Study||7||
59580684|NCT03199638|75686914|FG001|STARTED|Overall Study||7||
59580685|NCT03199638|75686913|FG000|COMPLETED|Overall Study||7||
59580686|NCT03199638|75686914|FG001|COMPLETED|Overall Study||5||
59580687|NCT03199638|75686913|FG000|NOT COMPLETED|Overall Study||0||
59580688|NCT03199638|75686914|FG001|NOT COMPLETED|Overall Study||2||
59580689|NCT03192995|75686922|FG000|STARTED|Overall Study||16||
59580690|NCT03192995|75686923|FG001|STARTED|Overall Study||6||
59580691|NCT03192995|75686922|FG000|COMPLETED|Overall Study||16||
59580692|NCT03192995|75686923|FG001|COMPLETED|Overall Study||6||
59580693|NCT03192995|75686922|FG000|NOT COMPLETED|Overall Study||0||
59580694|NCT03192995|75686923|FG001|NOT COMPLETED|Overall Study||0||
60121520|NCT01685801|76242412|FG000|COMPLETED|Washout Period 2 (4 Weeks)||5||
59580695|NCT03015194|75686933|FG000|STARTED|Overall Study||30||
59580696|NCT03015194|75686933|FG000|COMPLETED|Overall Study||18||
59580697|NCT03015194|75686933|FG000|NOT COMPLETED|Overall Study||12||
60121521|NCT01685801|76242413|FG001|COMPLETED|Washout Period 2 (4 Weeks)||5||
60121522|NCT01685801|76242414|FG002|COMPLETED|Washout Period 2 (4 Weeks)||7||
59580698|NCT02888626|75686938|FG000|STARTED|Overall Study||7||
59580699|NCT02888626|75686938|FG000|COMPLETED|Overall Study||7||
59580700|NCT02888626|75686938|FG000|NOT COMPLETED|Overall Study||0||
59580701|NCT02873715|75686944|FG000|STARTED|Overall Study||504||226
59580702|NCT02873715|75686945|FG001|STARTED|Overall Study||506||226
59580703|NCT02873715|75686944|FG000|6-month Follow-up|Overall Study||403||199
59580704|NCT02873715|75686945|FG001|6-month Follow-up|Overall Study||405||201
59580705|NCT02873715|75686944|FG000|12-month Follow-up|Overall Study||380||195
59580706|NCT02873715|75686945|FG001|12-month Follow-up|Overall Study||386||199
59580707|NCT02873715|75686944|FG000|18-month Follow-up|Overall Study||380||189
59580708|NCT02873715|75686945|FG001|18-month Follow-up|Overall Study||364||189
59580709|NCT02873715|75686944|FG000|24-month Follow-up|Overall Study||413||205
59580710|NCT02873715|75686945|FG001|24-month Follow-up|Overall Study||386||198
59580711|NCT02873715|75686944|FG000|COMPLETED|Overall Study||413||205
59580712|NCT02873715|75686945|FG001|COMPLETED|Overall Study||386||198
59580713|NCT02873715|75686944|FG000|NOT COMPLETED|Overall Study||91||21
59580714|NCT02873715|75686945|FG001|NOT COMPLETED|Overall Study||120||28
59580715|NCT02623972|75686953|FG000|STARTED|Overall Study||16||
59580716|NCT02623972|75686954|FG001|STARTED|Overall Study||6||
59580717|NCT02623972|75686953|FG000|COMPLETED|Overall Study||16||
59580718|NCT02623972|75686954|FG001|COMPLETED|Overall Study||6||
59580719|NCT02623972|75686953|FG000|NOT COMPLETED|Overall Study||0||
59580720|NCT02623972|75686954|FG001|NOT COMPLETED|Overall Study||0||
59580721|NCT02536300|75686963|FG000|STARTED|Overall Study||47||
59580722|NCT02536300|75686964|FG001|STARTED|Overall Study||27||
59580723|NCT02536300|75686965|FG002|STARTED|Overall Study||22||
59580724|NCT02536300|75686963|FG000|COMPLETED|Overall Study||0||
59580725|NCT02536300|75686964|FG001|COMPLETED|Overall Study||0||
59580726|NCT02536300|75686965|FG002|COMPLETED|Overall Study||0||
59580727|NCT02536300|75686963|FG000|NOT COMPLETED|Overall Study||47||
59580728|NCT02536300|75686964|FG001|NOT COMPLETED|Overall Study||27||
59580729|NCT02536300|75686965|FG002|NOT COMPLETED|Overall Study||22||
59580730|NCT02522715|75686975|FG000|STARTED|Overall Study||3||
59580731|NCT02522715|75686976|FG001|STARTED|Overall Study|+1 early withdrawal|33||
59580732|NCT02522715|75686975|FG000|COMPLETED|Overall Study||3||
59580733|NCT02522715|75686976|FG001|COMPLETED|Overall Study||33||
59580734|NCT02522715|75686975|FG000|NOT COMPLETED|Overall Study||0||
59580735|NCT02522715|75686976|FG001|NOT COMPLETED|Overall Study||0||
59580742|NCT01949662|75686993|FG000|STARTED|Overall Study||47||
59580743|NCT01949662|75686994|FG001|STARTED|Overall Study||43||
59580744|NCT01949662|75686993|FG000|COMPLETED|Overall Study||29||
59580745|NCT01949662|75686994|FG001|COMPLETED|Overall Study||29||
59580746|NCT01949662|75686993|FG000|NOT COMPLETED|Overall Study||18||
59580747|NCT01949662|75686994|FG001|NOT COMPLETED|Overall Study||14||
59580748|NCT01856686|75687002|FG000|STARTED|Overall Study||31||
59580749|NCT01856686|75687003|FG001|STARTED|Overall Study||33||
59724148|NCT01119443|75842770|FG001|STARTED|Crossover Period 1 (5 Days)||14||
59724149|NCT01119443|75842769|FG000|COMPLETED|Crossover Period 1 (5 Days)||14||
59580750|NCT01856686|75687002|FG000|COMPLETED|Overall Study||26||
59724150|NCT01119443|75842770|FG001|COMPLETED|Crossover Period 1 (5 Days)||13||
59724151|NCT01119443|75842769|FG000|NOT COMPLETED|Crossover Period 1 (5 Days)||0||
59851472|NCT03322631|75976069|FG002|Received at Least 1 Dose of Study Drug|Overall Study||16||
59580751|NCT01856686|75687003|FG001|COMPLETED|Overall Study||22||
59580752|NCT01856686|75687002|FG000|NOT COMPLETED|Overall Study||5||
59580753|NCT01856686|75687003|FG001|NOT COMPLETED|Overall Study||11||
59580754|NCT01770145|75687009|FG000|STARTED|Baseline||127||
59580755|NCT01770145|75687009|FG000|COMPLETED|Baseline||101||
59580756|NCT01770145|75687009|FG000|NOT COMPLETED|Baseline||26||
59580757|NCT01770145|75687009|FG000|STARTED|Treatment||101||
59580758|NCT01770145|75687009|FG000|COMPLETED|Treatment||97||
59580759|NCT01770145|75687009|FG000|NOT COMPLETED|Treatment||4||
59580760|NCT01749137|75687015|FG000|STARTED|Overall Study||37||
59580761|NCT01749137|75687016|FG001|STARTED|Overall Study||37||
59580762|NCT01749137|75687015|FG000|COMPLETED|Overall Study||22||
59580763|NCT01749137|75687016|FG001|COMPLETED|Overall Study||26||
59580764|NCT01749137|75687015|FG000|NOT COMPLETED|Overall Study||15||
59580765|NCT01749137|75687016|FG001|NOT COMPLETED|Overall Study||11||
59580766|NCT01726582|75687022|FG000|STARTED|Overall Study||229||
59580767|NCT01726582|75687022|FG000|Treated|Overall Study||130||
59580768|NCT01726582|75687022|FG000|COMPLETED|Overall Study||45||
59580769|NCT01726582|75687022|FG000|NOT COMPLETED|Overall Study||184||
59580770|NCT01373489|75687030|FG000|STARTED|Overall Study||59||
59724152|NCT01119443|75842770|FG001|NOT COMPLETED|Crossover Period 1 (5 Days)||1||
59996744|NCT04445051|76112591|FG003|COMPLETED|Overall Study||6||
59580771|NCT01373489|75687031|FG001|STARTED|Overall Study||54||
59580772|NCT01373489|75687030|FG000|COMPLETED|Overall Study||44||
59580773|NCT01373489|75687031|FG001|COMPLETED|Overall Study||41||
59580774|NCT01373489|75687030|FG000|NOT COMPLETED|Overall Study||15||
59580775|NCT01373489|75687031|FG001|NOT COMPLETED|Overall Study||13||
59580776|NCT00794339|75687037|FG000|STARTED|Overall Study||73||
59580777|NCT00794339|75687037|FG000|Eligible|Overall Study||69||
59580778|NCT00794339|75687037|FG000|Evaluable|Overall Study||59||
59580779|NCT00794339|75687037|FG000|COMPLETED|Overall Study||59||
59580780|NCT00794339|75687037|FG000|NOT COMPLETED|Overall Study||14||
59580781|NCT00786682|75687058|FG000|STARTED|Overall Study||11||
59580782|NCT00786682|75687058|FG000|COMPLETED|Overall Study||11||
59580783|NCT00786682|75687058|FG000|NOT COMPLETED|Overall Study||0||
59580784|NCT00506662|75687064|FG000|STARTED|Overall Study||38||
59580785|NCT00506662|75687065|FG001|STARTED|Overall Study||48||
59580786|NCT00506662|75687064|FG000|COMPLETED|Overall Study||21||
59580787|NCT00506662|75687065|FG001|COMPLETED|Overall Study||20||
59580788|NCT00506662|75687064|FG000|NOT COMPLETED|Overall Study||17||
59580789|NCT00506662|75687065|FG001|NOT COMPLETED|Overall Study||28||
59580790|NCT00161213|75687071|FG000|STARTED|Overall Study||44||
59580791|NCT00161213|75687071|FG000|COMPLETED|Overall Study||42||
59580792|NCT00161213|75687071|FG000|NOT COMPLETED|Overall Study||2||
59580793|NCT00118131|75687075|FG000|STARTED|Overall Study||49||
59580794|NCT00118131|75687075|FG000|COMPLETED|Overall Study||49||
59580795|NCT00118131|75687075|FG000|NOT COMPLETED|Overall Study||0||
59580796|NCT00006436|75687079|FG000|STARTED|Overall Study||68||
59580797|NCT00006436|75687079|FG000|COMPLETED|Overall Study||65||
59580798|NCT00006436|75687079|FG000|NOT COMPLETED|Overall Study||3||
59580799|NCT03208673|75687086|FG000|STARTED|Overall Study||32||
59580800|NCT03208673|75687086|FG000|COMPLETED|Overall Study||32||
59580801|NCT03208673|75687086|FG000|NOT COMPLETED|Overall Study||0||
59580802|NCT02399917|75687093|FG000|STARTED|Overall Study||6||
59580803|NCT02399917|75687094|FG001|STARTED|Overall Study||6||
59580804|NCT02399917|75687095|FG002|STARTED|Overall Study||24||
59580805|NCT02399917|75687093|FG000|COMPLETED|Overall Study||6||
59580806|NCT02399917|75687094|FG001|COMPLETED|Overall Study||6||
59580807|NCT02399917|75687095|FG002|COMPLETED|Overall Study||24||
59580808|NCT02399917|75687093|FG000|NOT COMPLETED|Overall Study||0||
59580809|NCT02399917|75687094|FG001|NOT COMPLETED|Overall Study||0||
59580810|NCT02399917|75687095|FG002|NOT COMPLETED|Overall Study||0||
59580811|NCT02400073|75687104|FG000|STARTED|Overall Study||122||
59580812|NCT02400073|75687104|FG000|COMPLETED|Overall Study||111||
59580813|NCT02400073|75687104|FG000|NOT COMPLETED|Overall Study||11||
59580814|NCT02400463|75687108|FG000|STARTED|Overall Study||6||
59580815|NCT02400463|75687108|FG000|COMPLETED|Overall Study||6||
59580816|NCT02400463|75687108|FG000|NOT COMPLETED|Overall Study||0||
59580817|NCT03331835|75687114|FG000|STARTED|Overall Study||105||
59580818|NCT03331835|75687115|FG001|STARTED|Overall Study||105||
59580819|NCT03331835|75687114|FG000|COMPLETED|Overall Study||91||
59580820|NCT03331835|75687115|FG001|COMPLETED|Overall Study||58||
59580821|NCT03331835|75687114|FG000|NOT COMPLETED|Overall Study||14||
59580822|NCT03331835|75687115|FG001|NOT COMPLETED|Overall Study||47||
59580823|NCT02401555|75687124|FG000|STARTED|Overall Study||87||
59580824|NCT02401555|75687125|FG001|STARTED|Overall Study||212||
59580825|NCT02401555|75687126|FG002|STARTED|Overall Study||120||
59580826|NCT02401555|75687124|FG000|COMPLETED|Overall Study||87||
59580827|NCT02401555|75687125|FG001|COMPLETED|Overall Study||212||
59580828|NCT02401555|75687126|FG002|COMPLETED|Overall Study||120||
59580829|NCT02401555|75687124|FG000|NOT COMPLETED|Overall Study||0||
59580830|NCT02401555|75687125|FG001|NOT COMPLETED|Overall Study||0||
59580831|NCT02401555|75687126|FG002|NOT COMPLETED|Overall Study||0||
59580832|NCT02402881|75687136|FG000|STARTED|Pre-Intervention Study Period||2222||
59580833|NCT02402881|75687137|FG001|STARTED|Pre-Intervention Study Period||5657||
59580834|NCT02402881|75687136|FG000|COMPLETED|Pre-Intervention Study Period||2222||
59580835|NCT02402881|75687137|FG001|COMPLETED|Pre-Intervention Study Period||5657||
59580836|NCT02402881|75687136|FG000|NOT COMPLETED|Pre-Intervention Study Period||0||
59580837|NCT02402881|75687137|FG001|NOT COMPLETED|Pre-Intervention Study Period||0||
59580838|NCT02402881|75687136|FG000|STARTED|Post-Intervention Study Period||3111||
59580839|NCT02402881|75687137|FG001|STARTED|Post-Intervention Study Period||8662||
59580840|NCT02402881|75687136|FG000|COMPLETED|Post-Intervention Study Period||3111||
59580841|NCT02402881|75687137|FG001|COMPLETED|Post-Intervention Study Period||8662||
59580842|NCT02402881|75687136|FG000|NOT COMPLETED|Post-Intervention Study Period||0||
59996745|NCT04445051|76112592|FG004|COMPLETED|Overall Study||5||
59580843|NCT02402881|75687137|FG001|NOT COMPLETED|Post-Intervention Study Period||0||
59580844|NCT03332459|75687146|FG000|STARTED|Overall Study||3||
59580845|NCT03332459|75687147|FG001|STARTED|Overall Study||1||
59580846|NCT03332459|75687148|FG002|STARTED|Overall Study||3||
59580847|NCT03332459|75687146|FG000|COMPLETED|Overall Study||3||
59580848|NCT03332459|75687147|FG001|COMPLETED|Overall Study||1||
59580849|NCT03332459|75687148|FG002|COMPLETED|Overall Study||3||
59580850|NCT03332459|75687146|FG000|NOT COMPLETED|Overall Study||0||
59580851|NCT03332459|75687147|FG001|NOT COMPLETED|Overall Study||0||
59580852|NCT03332459|75687148|FG002|NOT COMPLETED|Overall Study||0||
59580853|NCT02403895|75687156|FG000|STARTED|Overall Study||11||
59580854|NCT02403895|75687156|FG000|COMPLETED|Overall Study||11||
59580855|NCT02403895|75687156|FG000|NOT COMPLETED|Overall Study||0||
59580856|NCT03333317|75687163|FG000|STARTED|Overall Study||3||
59580857|NCT03333317|75687164|FG001|STARTED|Overall Study||1||
59580858|NCT03333317|75687165|FG002|STARTED|Overall Study||3||
59580859|NCT03333317|75687163|FG000|COMPLETED|Overall Study||3||
59580860|NCT03333317|75687164|FG001|COMPLETED|Overall Study||1||
59580861|NCT03333317|75687165|FG002|COMPLETED|Overall Study||3||
59580862|NCT03333317|75687163|FG000|NOT COMPLETED|Overall Study||0||
59580863|NCT03333317|75687164|FG001|NOT COMPLETED|Overall Study||0||
59580864|NCT03333317|75687165|FG002|NOT COMPLETED|Overall Study||0||
59580865|NCT02406859|75687178|FG000|STARTED|Part 1 - Manometric Parameters||15||
59580866|NCT02406859|75687179|FG001|STARTED|Part 1 - Manometric Parameters||14||
59580867|NCT02406859|75687180|FG002|STARTED|Part 1 - Manometric Parameters||21||
59580868|NCT02406859|75687178|FG000|COMPLETED|Part 1 - Manometric Parameters||12||
59580869|NCT02406859|75687179|FG001|COMPLETED|Part 1 - Manometric Parameters||13||
59580870|NCT02406859|75687180|FG002|COMPLETED|Part 1 - Manometric Parameters||17||
59580871|NCT02406859|75687178|FG000|NOT COMPLETED|Part 1 - Manometric Parameters||3||
59580872|NCT02406859|75687179|FG001|NOT COMPLETED|Part 1 - Manometric Parameters||1||
59580873|NCT02406859|75687180|FG002|NOT COMPLETED|Part 1 - Manometric Parameters||4||
59580874|NCT02406859|75687178|FG000|STARTED|Part 2 - Biofeedback Training||12||
59580875|NCT02406859|75687179|FG001|STARTED|Part 2 - Biofeedback Training||13||
59580876|NCT02406859|75687180|FG002|STARTED|Part 2 - Biofeedback Training||17||
59580877|NCT02406859|75687178|FG000|COMPLETED|Part 2 - Biofeedback Training||12||
59580878|NCT02406859|75687179|FG001|COMPLETED|Part 2 - Biofeedback Training||13||
59580879|NCT02406859|75687180|FG002|COMPLETED|Part 2 - Biofeedback Training||17||
59580880|NCT02406859|75687178|FG000|NOT COMPLETED|Part 2 - Biofeedback Training||0||
59580881|NCT02406859|75687179|FG001|NOT COMPLETED|Part 2 - Biofeedback Training||0||
59580882|NCT02406859|75687180|FG002|NOT COMPLETED|Part 2 - Biofeedback Training||0||
59580883|NCT02406937|75687200|FG000|STARTED|Overall Study||60||
59580884|NCT02406937|75687201|FG001|STARTED|Overall Study||60||
59580885|NCT02406937|75687202|FG002|STARTED|Overall Study||60||
59580886|NCT02406937|75687200|FG000|COMPLETED|Overall Study||59||
59580887|NCT02406937|75687201|FG001|COMPLETED|Overall Study||59||
59580888|NCT02406937|75687202|FG002|COMPLETED|Overall Study||58||
59580889|NCT02406937|75687200|FG000|NOT COMPLETED|Overall Study||1||
59580890|NCT02406937|75687201|FG001|NOT COMPLETED|Overall Study||1||
59580891|NCT02406937|75687202|FG002|NOT COMPLETED|Overall Study||2||
59580892|NCT03210155|75687215|FG000|STARTED|Overall Study||0||
59580893|NCT03210155|75687216|FG001|STARTED|Overall Study||1||
59580894|NCT03210155|75687215|FG000|COMPLETED|Overall Study||0||
59580895|NCT03210155|75687216|FG001|COMPLETED|Overall Study||1||
59580896|NCT03210155|75687215|FG000|NOT COMPLETED|Overall Study||0||
59580897|NCT03210155|75687216|FG001|NOT COMPLETED|Overall Study||0||
59580898|NCT02408263|75687222|FG000|STARTED|Overall Study||25||
59580899|NCT02408263|75687223|FG001|STARTED|Overall Study||25||
59580900|NCT02408263|75687222|FG000|COMPLETED|Overall Study||25||
59580901|NCT02408263|75687223|FG001|COMPLETED|Overall Study||25||
59580902|NCT02408263|75687222|FG000|NOT COMPLETED|Overall Study||0||
59580903|NCT02408263|75687223|FG001|NOT COMPLETED|Overall Study||0||
59580904|NCT03210701|75687228|FG000|STARTED|Overall Study||123||
59580905|NCT03210701|75687228|FG000|COMPLETED|Overall Study||123||
59580906|NCT03210701|75687228|FG000|NOT COMPLETED|Overall Study||0||
59580907|NCT02354833|75687234|FG000|STARTED|Overall Study||38||
59580908|NCT02354833|75687235|FG001|STARTED|Overall Study||43||
59580909|NCT02354833|75687234|FG000|COMPLETED|Overall Study||38||
59580910|NCT02354833|75687235|FG001|COMPLETED|Overall Study||43||
59580911|NCT02354833|75687234|FG000|NOT COMPLETED|Overall Study||0||
59580912|NCT02354833|75687235|FG001|NOT COMPLETED|Overall Study||0||
59580913|NCT02355067|75687245|FG000|STARTED|Overall Study||20||
59580914|NCT02355067|75687246|FG001|STARTED|Overall Study||20||
59580915|NCT02355067|75687245|FG000|COMPLETED|Overall Study||12||
59580916|NCT02355067|75687246|FG001|COMPLETED|Overall Study||12||
59580917|NCT02355067|75687245|FG000|NOT COMPLETED|Overall Study||8||
59580918|NCT02355067|75687246|FG001|NOT COMPLETED|Overall Study||8||
59580919|NCT03340337|75687252|FG000|STARTED|Overall Study||30||
59580920|NCT03340337|75687252|FG000|Received Neo-Russian|Overall Study||30|All the participants received this type of electrical stimulation, in a randomized order.|
59580921|NCT03340337|75687252|FG000|Received Aussie|Overall Study||30|All the participants received this type of electrical stimulation, in a randomized order.|
59580922|NCT03340337|75687252|FG000|Received RBS|Overall Study||30|All the participants received this type of electrical stimulation, in a randomized order.|
59580923|NCT03340337|75687252|FG000|COMPLETED|Overall Study||30||
59580924|NCT03340337|75687252|FG000|NOT COMPLETED|Overall Study||0||
59580925|NCT03340415|75687269|FG000|STARTED|Overall Study||29||
59580926|NCT03340415|75687270|FG001|STARTED|Overall Study||24||
59580927|NCT03340415|75687269|FG000|COMPLETED|Overall Study||29||
59996746|NCT04445051|76112593|FG005|COMPLETED|Overall Study||5||
59580928|NCT03340415|75687270|FG001|COMPLETED|Overall Study||21||
59580929|NCT03340415|75687269|FG000|NOT COMPLETED|Overall Study||0||
59580930|NCT03340415|75687270|FG001|NOT COMPLETED|Overall Study||3||
59580931|NCT02356003|75687278|FG000|STARTED|Overall Study||10||
59580932|NCT02356003|75687278|FG000|COMPLETED|Overall Study||10||
59580933|NCT02356003|75687278|FG000|NOT COMPLETED|Overall Study||0||
59580934|NCT02356471|75687283|FG000|STARTED|Overall Study||34||
59580935|NCT02356471|75687283|FG000|COMPLETED|Overall Study||28||
59580936|NCT02356471|75687283|FG000|NOT COMPLETED|Overall Study||6||
59580937|NCT03340805|75687289|FG000|STARTED|Overall Study||24||
59580938|NCT03340805|75687290|FG001|STARTED|Overall Study||26||
59580939|NCT03340805|75687289|FG000|COMPLETED|Overall Study|1 subject withdrew early from study fluid administration but stayed in trial for outcome assessment|24||
59580940|NCT03340805|75687290|FG001|COMPLETED|Overall Study||26||
59580941|NCT03340805|75687289|FG000|NOT COMPLETED|Overall Study||0||
59580942|NCT03340805|75687290|FG001|NOT COMPLETED|Overall Study||0||
59580943|NCT03838484|75687302|FG000|STARTED|Overall Study||5||
59580944|NCT03838484|75687303|FG001|STARTED|Overall Study||5||
59580945|NCT03838484|75687304|FG002|STARTED|Overall Study||4||
59580946|NCT03838484|75687305|FG003|STARTED|Overall Study||4||
59580947|NCT03838484|75687302|FG000|COMPLETED|Overall Study||5||
59580948|NCT03838484|75687303|FG001|COMPLETED|Overall Study||4||
59580949|NCT03838484|75687304|FG002|COMPLETED|Overall Study||4||
59580950|NCT03838484|75687305|FG003|COMPLETED|Overall Study||4||
59580951|NCT03838484|75687302|FG000|NOT COMPLETED|Overall Study||0||
59580952|NCT03838484|75687303|FG001|NOT COMPLETED|Overall Study||1||
59580953|NCT03838484|75687304|FG002|NOT COMPLETED|Overall Study||0||
59580954|NCT03838484|75687305|FG003|NOT COMPLETED|Overall Study||0||
59580955|NCT02357173|75687324|FG000|STARTED|Overall Study||25||
59580956|NCT02357173|75687325|FG001|STARTED|Overall Study||21||
59580957|NCT02357173|75687326|FG002|STARTED|Overall Study||22||
59580958|NCT02357173|75687324|FG000|COMPLETED|Overall Study||19||
59580959|NCT02357173|75687325|FG001|COMPLETED|Overall Study||15||
59580960|NCT02357173|75687326|FG002|COMPLETED|Overall Study||16||
59580961|NCT02357173|75687324|FG000|NOT COMPLETED|Overall Study||6||
59580962|NCT02357173|75687325|FG001|NOT COMPLETED|Overall Study||6||
59580963|NCT02357173|75687326|FG002|NOT COMPLETED|Overall Study||6||
59580964|NCT02357485|75687334|FG000|STARTED|Overall Study|6 subjects, 8 knees ( 2 bilateral & 4 unilateral)|6||
59580965|NCT02357485|75687334|FG000|COMPLETED|Overall Study||6||
59580966|NCT02357485|75687334|FG000|NOT COMPLETED|Overall Study||0||
59580967|NCT02408965|75687341|FG000|STARTED|Overall Study||140||
59580968|NCT02408965|75687342|FG001|STARTED|Overall Study||144||
59580969|NCT02408965|75687341|FG000|COMPLETED|Overall Study||140||
59580970|NCT02408965|75687342|FG001|COMPLETED|Overall Study||144||
59580971|NCT02408965|75687341|FG000|NOT COMPLETED|Overall Study||0||
59580972|NCT02408965|75687342|FG001|NOT COMPLETED|Overall Study||0||
59580973|NCT02409277|75687351|FG000|STARTED|Overall Study||267||
59580974|NCT02409277|75687352|FG001|STARTED|Overall Study||60||
59580975|NCT02409277|75687353|FG002|STARTED|Overall Study||599||
59580976|NCT02409277|75687351|FG000|3 Months Follow-up|Overall Study||178||
59580977|NCT02409277|75687352|FG001|3 Months Follow-up|Overall Study||40||
59580978|NCT02409277|75687353|FG002|3 Months Follow-up|Overall Study||599||
59580979|NCT02409277|75687351|FG000|6 Months Follow-up|Overall Study||182||
59580980|NCT02409277|75687352|FG001|6 Months Follow-up|Overall Study||42||
59580981|NCT02409277|75687353|FG002|6 Months Follow-up|Overall Study||599||
59580982|NCT02409277|75687351|FG000|12 Months Follow-up|Overall Study||167||
59580983|NCT02409277|75687352|FG001|12 Months Follow-up|Overall Study||43||
59580984|NCT02409277|75687353|FG002|12 Months Follow-up|Overall Study||599||
59580985|NCT02409277|75687351|FG000|COMPLETED|Overall Study||167||
59580986|NCT02409277|75687352|FG001|COMPLETED|Overall Study||43||
59580987|NCT02409277|75687353|FG002|COMPLETED|Overall Study||599||
59580988|NCT02409277|75687351|FG000|NOT COMPLETED|Overall Study||100||
59580989|NCT02409277|75687352|FG001|NOT COMPLETED|Overall Study||17||
59580990|NCT02409277|75687353|FG002|NOT COMPLETED|Overall Study||0||
59580991|NCT02410291|75687380|FG000|STARTED|Overall Study||29||
59580992|NCT02410291|75687381|FG001|STARTED|Overall Study||29||
59580993|NCT02410291|75687380|FG000|COMPLETED|Overall Study||29||
59580994|NCT02410291|75687381|FG001|COMPLETED|Overall Study||29||
59580995|NCT02410291|75687380|FG000|NOT COMPLETED|Overall Study||0||
59580996|NCT02410291|75687381|FG001|NOT COMPLETED|Overall Study||0||
59580997|NCT02411461|75687390|FG000|STARTED|Overall Study||16||
59580998|NCT02411461|75687391|FG001|STARTED|Overall Study||8||
59580999|NCT02411461|75687392|FG002|STARTED|Overall Study||15||
59581000|NCT02411461|75687390|FG000|COMPLETED|Overall Study||16||
59581001|NCT02411461|75687391|FG001|COMPLETED|Overall Study||8||
59581002|NCT02411461|75687392|FG002|COMPLETED|Overall Study||15||
59581003|NCT02411461|75687390|FG000|NOT COMPLETED|Overall Study||0||
59581004|NCT02411461|75687391|FG001|NOT COMPLETED|Overall Study||0||
59581005|NCT02411461|75687392|FG002|NOT COMPLETED|Overall Study||0||
59581006|NCT03330275|75687400|FG000|STARTED|Visit 1 - Period 1||6||
59581007|NCT03330275|75687401|FG001|STARTED|Visit 1 - Period 1||6||
59581008|NCT03330275|75687402|FG002|STARTED|Visit 1 - Period 1||6||
59581009|NCT03330275|75687403|FG003|STARTED|Visit 1 - Period 1||6||
59581010|NCT03330275|75687404|FG004|STARTED|Visit 1 - Period 1||0||
59581011|NCT03330275|75687405|FG005|STARTED|Visit 1 - Period 1||0||
59581012|NCT03330275|75687406|FG006|STARTED|Visit 1 - Period 1||0||
59581013|NCT03330275|75687407|FG007|STARTED|Visit 1 - Period 1||0||
59581014|NCT03330275|75687408|FG008|STARTED|Visit 1 - Period 1||0||
59581015|NCT03330275|75687409|FG009|STARTED|Visit 1 - Period 1||0||
59581016|NCT03330275|75687400|FG000|COMPLETED|Visit 1 - Period 1||6||
59581017|NCT03330275|75687401|FG001|COMPLETED|Visit 1 - Period 1||6||
59581018|NCT03330275|75687402|FG002|COMPLETED|Visit 1 - Period 1||6||
59581019|NCT03330275|75687403|FG003|COMPLETED|Visit 1 - Period 1||6||
59581020|NCT03330275|75687404|FG004|COMPLETED|Visit 1 - Period 1||0||
59581021|NCT03330275|75687405|FG005|COMPLETED|Visit 1 - Period 1||0||
59581022|NCT03330275|75687406|FG006|COMPLETED|Visit 1 - Period 1||0||
59581023|NCT03330275|75687407|FG007|COMPLETED|Visit 1 - Period 1||0||
59581024|NCT03330275|75687408|FG008|COMPLETED|Visit 1 - Period 1||0||
59581025|NCT03330275|75687409|FG009|COMPLETED|Visit 1 - Period 1||0||
59581026|NCT03330275|75687400|FG000|NOT COMPLETED|Visit 1 - Period 1||0||
59581027|NCT03330275|75687401|FG001|NOT COMPLETED|Visit 1 - Period 1||0||
59581028|NCT03330275|75687402|FG002|NOT COMPLETED|Visit 1 - Period 1||0||
59581029|NCT03330275|75687403|FG003|NOT COMPLETED|Visit 1 - Period 1||0||
59581030|NCT03330275|75687404|FG004|NOT COMPLETED|Visit 1 - Period 1||0||
59581031|NCT03330275|75687405|FG005|NOT COMPLETED|Visit 1 - Period 1||0||
59581032|NCT03330275|75687406|FG006|NOT COMPLETED|Visit 1 - Period 1||0||
59581033|NCT03330275|75687407|FG007|NOT COMPLETED|Visit 1 - Period 1||0||
59581034|NCT03330275|75687408|FG008|NOT COMPLETED|Visit 1 - Period 1||0||
59581035|NCT03330275|75687409|FG009|NOT COMPLETED|Visit 1 - Period 1||0||
59581036|NCT03330275|75687400|FG000|STARTED|Visit 1 - Period 2||6||
59581037|NCT03330275|75687401|FG001|STARTED|Visit 1 - Period 2||6||
59581038|NCT03330275|75687402|FG002|STARTED|Visit 1 - Period 2||6||
59581039|NCT03330275|75687403|FG003|STARTED|Visit 1 - Period 2||6||
59581040|NCT03330275|75687404|FG004|STARTED|Visit 1 - Period 2||0||
59581041|NCT03330275|75687405|FG005|STARTED|Visit 1 - Period 2||0||
59581042|NCT03330275|75687406|FG006|STARTED|Visit 1 - Period 2||0||
59581043|NCT03330275|75687407|FG007|STARTED|Visit 1 - Period 2||0||
59581044|NCT03330275|75687408|FG008|STARTED|Visit 1 - Period 2||0||
59581045|NCT03330275|75687409|FG009|STARTED|Visit 1 - Period 2||0||
59581046|NCT03330275|75687400|FG000|COMPLETED|Visit 1 - Period 2||6||
59581047|NCT03330275|75687401|FG001|COMPLETED|Visit 1 - Period 2||6||
59581048|NCT03330275|75687402|FG002|COMPLETED|Visit 1 - Period 2||6||
59581049|NCT03330275|75687403|FG003|COMPLETED|Visit 1 - Period 2||6||
59581050|NCT03330275|75687404|FG004|COMPLETED|Visit 1 - Period 2||0||
59581051|NCT03330275|75687405|FG005|COMPLETED|Visit 1 - Period 2||0||
59581052|NCT03330275|75687406|FG006|COMPLETED|Visit 1 - Period 2||0||
59581053|NCT03330275|75687407|FG007|COMPLETED|Visit 1 - Period 2||0||
59581054|NCT03330275|75687408|FG008|COMPLETED|Visit 1 - Period 2||0||
59581055|NCT03330275|75687409|FG009|COMPLETED|Visit 1 - Period 2||0||
59581056|NCT03330275|75687400|FG000|NOT COMPLETED|Visit 1 - Period 2||0||
59581057|NCT03330275|75687401|FG001|NOT COMPLETED|Visit 1 - Period 2||0||
59581058|NCT03330275|75687402|FG002|NOT COMPLETED|Visit 1 - Period 2||0||
59581059|NCT03330275|75687403|FG003|NOT COMPLETED|Visit 1 - Period 2||0||
59581060|NCT03330275|75687404|FG004|NOT COMPLETED|Visit 1 - Period 2||0||
59581061|NCT03330275|75687405|FG005|NOT COMPLETED|Visit 1 - Period 2||0||
59581062|NCT03330275|75687406|FG006|NOT COMPLETED|Visit 1 - Period 2||0||
59581063|NCT03330275|75687407|FG007|NOT COMPLETED|Visit 1 - Period 2||0||
59581064|NCT03330275|75687408|FG008|NOT COMPLETED|Visit 1 - Period 2||0||
59581065|NCT03330275|75687409|FG009|NOT COMPLETED|Visit 1 - Period 2||0||
59581066|NCT03330275|75687400|FG000|STARTED|Visits 2, 3 and 4 - Period 1||0||
59581067|NCT03330275|75687401|FG001|STARTED|Visits 2, 3 and 4 - Period 1||0||
59581068|NCT03330275|75687402|FG002|STARTED|Visits 2, 3 and 4 - Period 1||0||
59581069|NCT03330275|75687403|FG003|STARTED|Visits 2, 3 and 4 - Period 1||0||
59581070|NCT03330275|75687404|FG004|STARTED|Visits 2, 3 and 4 - Period 1||4||
59581071|NCT03330275|75687405|FG005|STARTED|Visits 2, 3 and 4 - Period 1||4||
59581072|NCT03330275|75687406|FG006|STARTED|Visits 2, 3 and 4 - Period 1||4||
59581073|NCT03330275|75687407|FG007|STARTED|Visits 2, 3 and 4 - Period 1||4||
59581074|NCT03330275|75687408|FG008|STARTED|Visits 2, 3 and 4 - Period 1||4||
59581075|NCT03330275|75687409|FG009|STARTED|Visits 2, 3 and 4 - Period 1||4||
59581076|NCT03330275|75687400|FG000|COMPLETED|Visits 2, 3 and 4 - Period 1||0||
59581077|NCT03330275|75687401|FG001|COMPLETED|Visits 2, 3 and 4 - Period 1||0||
59581078|NCT03330275|75687402|FG002|COMPLETED|Visits 2, 3 and 4 - Period 1||0||
59581079|NCT03330275|75687403|FG003|COMPLETED|Visits 2, 3 and 4 - Period 1||0||
59581080|NCT03330275|75687404|FG004|COMPLETED|Visits 2, 3 and 4 - Period 1||4||
59581081|NCT03330275|75687405|FG005|COMPLETED|Visits 2, 3 and 4 - Period 1||4||
59581082|NCT03330275|75687406|FG006|COMPLETED|Visits 2, 3 and 4 - Period 1||4||
59581083|NCT03330275|75687407|FG007|COMPLETED|Visits 2, 3 and 4 - Period 1||4||
59581084|NCT03330275|75687408|FG008|COMPLETED|Visits 2, 3 and 4 - Period 1||4||
59996747|NCT04445051|76112588|FG000|NOT COMPLETED|Overall Study||0||
59581085|NCT03330275|75687409|FG009|COMPLETED|Visits 2, 3 and 4 - Period 1||4||
59581086|NCT03330275|75687400|FG000|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0||
59581087|NCT03330275|75687401|FG001|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0||
59581088|NCT03330275|75687402|FG002|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0||
59581089|NCT03330275|75687403|FG003|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0||
59581090|NCT03330275|75687404|FG004|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0||
59581091|NCT03330275|75687405|FG005|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0||
59581092|NCT03330275|75687406|FG006|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0||
59581093|NCT03330275|75687407|FG007|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0||
59581094|NCT03330275|75687408|FG008|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0||
59724153|NCT01119443|75842769|FG000|STARTED|Crossover Period 2 (5 Days)||14||
59996748|NCT04445051|76112589|FG001|NOT COMPLETED|Overall Study||0||
59581095|NCT03330275|75687409|FG009|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0||
59581096|NCT03330275|75687400|FG000|STARTED|Visits 2, 3 and 4 - Period 2||0||
59581097|NCT03330275|75687401|FG001|STARTED|Visits 2, 3 and 4 - Period 2||0||
59581098|NCT03330275|75687402|FG002|STARTED|Visits 2, 3 and 4 - Period 2||0||
59581099|NCT03330275|75687403|FG003|STARTED|Visits 2, 3 and 4 - Period 2||0||
59581100|NCT03330275|75687404|FG004|STARTED|Visits 2, 3 and 4 - Period 2||4||
59581101|NCT03330275|75687405|FG005|STARTED|Visits 2, 3 and 4 - Period 2||4||
59581102|NCT03330275|75687406|FG006|STARTED|Visits 2, 3 and 4 - Period 2||4||
59581103|NCT03330275|75687407|FG007|STARTED|Visits 2, 3 and 4 - Period 2||4||
59581104|NCT03330275|75687408|FG008|STARTED|Visits 2, 3 and 4 - Period 2||4||
59581105|NCT03330275|75687409|FG009|STARTED|Visits 2, 3 and 4 - Period 2||4||
59581106|NCT03330275|75687400|FG000|COMPLETED|Visits 2, 3 and 4 - Period 2||0||
59581107|NCT03330275|75687401|FG001|COMPLETED|Visits 2, 3 and 4 - Period 2||0||
59581108|NCT03330275|75687402|FG002|COMPLETED|Visits 2, 3 and 4 - Period 2||0||
59581109|NCT03330275|75687403|FG003|COMPLETED|Visits 2, 3 and 4 - Period 2||0||
59581110|NCT03330275|75687404|FG004|COMPLETED|Visits 2, 3 and 4 - Period 2||4||
59581111|NCT03330275|75687405|FG005|COMPLETED|Visits 2, 3 and 4 - Period 2||4||
59581112|NCT03330275|75687406|FG006|COMPLETED|Visits 2, 3 and 4 - Period 2||4||
59581113|NCT03330275|75687407|FG007|COMPLETED|Visits 2, 3 and 4 - Period 2||4||
59581114|NCT03330275|75687408|FG008|COMPLETED|Visits 2, 3 and 4 - Period 2||4||
59581115|NCT03330275|75687409|FG009|COMPLETED|Visits 2, 3 and 4 - Period 2||4||
59581116|NCT03330275|75687400|FG000|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0||
59581117|NCT03330275|75687401|FG001|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0||
59581118|NCT03330275|75687402|FG002|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0||
59581119|NCT03330275|75687403|FG003|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0||
59581120|NCT03330275|75687404|FG004|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0||
59581121|NCT03330275|75687405|FG005|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0||
59581122|NCT03330275|75687406|FG006|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0||
59581123|NCT03330275|75687407|FG007|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0||
59581124|NCT03330275|75687408|FG008|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0||
59581125|NCT03330275|75687409|FG009|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0||
59581126|NCT03330275|75687400|FG000|STARTED|Visits 2, 3 and 4 - Period 3||0||
59581127|NCT03330275|75687401|FG001|STARTED|Visits 2, 3 and 4 - Period 3||0||
59581128|NCT03330275|75687402|FG002|STARTED|Visits 2, 3 and 4 - Period 3||0||
59581129|NCT03330275|75687403|FG003|STARTED|Visits 2, 3 and 4 - Period 3||0||
59581130|NCT03330275|75687404|FG004|STARTED|Visits 2, 3 and 4 - Period 3||4||
59581131|NCT03330275|75687405|FG005|STARTED|Visits 2, 3 and 4 - Period 3||4||
59581132|NCT03330275|75687406|FG006|STARTED|Visits 2, 3 and 4 - Period 3||4||
59581133|NCT03330275|75687407|FG007|STARTED|Visits 2, 3 and 4 - Period 3||4||
59581134|NCT03330275|75687408|FG008|STARTED|Visits 2, 3 and 4 - Period 3||4||
59581135|NCT03330275|75687409|FG009|STARTED|Visits 2, 3 and 4 - Period 3||4||
59581136|NCT03330275|75687400|FG000|COMPLETED|Visits 2, 3 and 4 - Period 3||0||
59581137|NCT03330275|75687401|FG001|COMPLETED|Visits 2, 3 and 4 - Period 3||0||
59581138|NCT03330275|75687402|FG002|COMPLETED|Visits 2, 3 and 4 - Period 3||0||
59581139|NCT03330275|75687403|FG003|COMPLETED|Visits 2, 3 and 4 - Period 3||0||
59581140|NCT03330275|75687404|FG004|COMPLETED|Visits 2, 3 and 4 - Period 3||4||
59581141|NCT03330275|75687405|FG005|COMPLETED|Visits 2, 3 and 4 - Period 3||4||
59581142|NCT03330275|75687406|FG006|COMPLETED|Visits 2, 3 and 4 - Period 3||4||
59581143|NCT03330275|75687407|FG007|COMPLETED|Visits 2, 3 and 4 - Period 3||4||
59581144|NCT03330275|75687408|FG008|COMPLETED|Visits 2, 3 and 4 - Period 3||4||
59581145|NCT03330275|75687409|FG009|COMPLETED|Visits 2, 3 and 4 - Period 3||4||
59581146|NCT03330275|75687400|FG000|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0||
59581147|NCT03330275|75687401|FG001|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0||
59581148|NCT03330275|75687402|FG002|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0||
59581149|NCT03330275|75687403|FG003|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0||
59581150|NCT03330275|75687404|FG004|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0||
59581151|NCT03330275|75687405|FG005|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0||
59581152|NCT03330275|75687406|FG006|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0||
59581153|NCT03330275|75687407|FG007|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0||
59581154|NCT03330275|75687408|FG008|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0||
59581155|NCT03330275|75687409|FG009|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0||
59581156|NCT02411929|75687417|FG000|STARTED|Period 1||8||
59581157|NCT02411929|75687417|FG000|COMPLETED|Period 1||8||
59581158|NCT02411929|75687417|FG000|NOT COMPLETED|Period 1||0||
59581159|NCT02411929|75687417|FG000|STARTED|Washout Period||8||
59581160|NCT02411929|75687417|FG000|COMPLETED|Washout Period||8||
59581161|NCT02411929|75687417|FG000|NOT COMPLETED|Washout Period||0||
59581162|NCT02411929|75687417|FG000|STARTED|Period 2||8||
59581163|NCT02411929|75687417|FG000|COMPLETED|Period 2||8||
59581164|NCT02411929|75687417|FG000|NOT COMPLETED|Period 2||0||
59581165|NCT02358889|75687429|FG000|STARTED|Overall Study||30||
59581166|NCT02358889|75687430|FG001|STARTED|Overall Study||30||
59581167|NCT02358889|75687431|FG002|STARTED|Overall Study||28||
59581168|NCT02358889|75687429|FG000|COMPLETED|Overall Study||30||
59581169|NCT02358889|75687430|FG001|COMPLETED|Overall Study||28||
59581170|NCT02358889|75687431|FG002|COMPLETED|Overall Study||27||
59581171|NCT02358889|75687429|FG000|NOT COMPLETED|Overall Study||0||
59581172|NCT02358889|75687430|FG001|NOT COMPLETED|Overall Study||2||
59581173|NCT02358889|75687431|FG002|NOT COMPLETED|Overall Study||1||
59581174|NCT03340883|75687439|FG000|STARTED|Overall Study||4||
59581175|NCT03340883|75687440|FG001|STARTED|Overall Study||3||
59581176|NCT03340883|75687441|FG002|STARTED|Overall Study||4||
59581177|NCT03340883|75687442|FG003|STARTED|Overall Study||4||
59581178|NCT03340883|75687443|FG004|STARTED|Overall Study||3||
59581179|NCT03340883|75687444|FG005|STARTED|Overall Study||3||
59724154|NCT01119443|75842770|FG001|STARTED|Crossover Period 2 (5 Days)||13||
59724155|NCT01119443|75842769|FG000|COMPLETED|Crossover Period 2 (5 Days)||14||
59724156|NCT01119443|75842770|FG001|COMPLETED|Crossover Period 2 (5 Days)||13||
59724157|NCT01119443|75842769|FG000|NOT COMPLETED|Crossover Period 2 (5 Days)||0||
59724158|NCT01119443|75842770|FG001|NOT COMPLETED|Crossover Period 2 (5 Days)||0||
59724159|NCT01119443|75842769|FG000|STARTED|Crossover Period 3 (5 Days)||14||
59724160|NCT01119443|75842770|FG001|STARTED|Crossover Period 3 (5 Days)||13||
59724161|NCT01119443|75842769|FG000|COMPLETED|Crossover Period 3 (5 Days)||14||
59724162|NCT01119443|75842770|FG001|COMPLETED|Crossover Period 3 (5 Days)||13||
59724163|NCT01119443|75842769|FG000|NOT COMPLETED|Crossover Period 3 (5 Days)||0||
59724164|NCT01119443|75842770|FG001|NOT COMPLETED|Crossover Period 3 (5 Days)||0||
59724165|NCT01119443|75842769|FG000|STARTED|Crossover Period 4 (5 Days)||14||
59724166|NCT01119443|75842770|FG001|STARTED|Crossover Period 4 (5 Days)||13||
59724167|NCT01119443|75842769|FG000|COMPLETED|Crossover Period 4 (5 Days)||14||
59724168|NCT01119443|75842770|FG001|COMPLETED|Crossover Period 4 (5 Days)||13||
59724169|NCT01119443|75842769|FG000|NOT COMPLETED|Crossover Period 4 (5 Days)||0||
59724170|NCT01119443|75842770|FG001|NOT COMPLETED|Crossover Period 4 (5 Days)||0||
59724171|NCT01119443|75842769|FG000|STARTED|Down-titration Period (1 Day)||14||
59724172|NCT01119443|75842770|FG001|STARTED|Down-titration Period (1 Day)||13||
59724173|NCT01119443|75842769|FG000|COMPLETED|Down-titration Period (1 Day)||14||
59724174|NCT01119443|75842770|FG001|COMPLETED|Down-titration Period (1 Day)||13||
59724175|NCT01119443|75842769|FG000|NOT COMPLETED|Down-titration Period (1 Day)||0||
59724176|NCT01119443|75842770|FG001|NOT COMPLETED|Down-titration Period (1 Day)||0||
59724177|NCT01119443|75842769|FG000|STARTED|End of Study (All Patients)||14||
59724178|NCT01119443|75842770|FG001|STARTED|End of Study (All Patients)||14||
59724179|NCT01119443|75842769|FG000|COMPLETED|End of Study (All Patients)||14||
59724180|NCT01119443|75842770|FG001|COMPLETED|End of Study (All Patients)||14||
59724181|NCT01119443|75842769|FG000|NOT COMPLETED|End of Study (All Patients)||0||
59724182|NCT01119443|75842770|FG001|NOT COMPLETED|End of Study (All Patients)||0||
59724183|NCT01111019|75842779|FG000|STARTED|Overall Study||19||
59724184|NCT01111019|75842779|FG000|COMPLETED|Overall Study||16||
59724185|NCT01111019|75842779|FG000|NOT COMPLETED|Overall Study||3||
59724186|NCT02883400|75842785|FG000|STARTED|Overall Study||22||
59724187|NCT02883400|75842786|FG001|STARTED|Overall Study||8||
59724188|NCT02883400|75842785|FG000|COMPLETED|Overall Study||22||
59724189|NCT02883400|75842786|FG001|COMPLETED|Overall Study||8||
59724190|NCT02883400|75842785|FG000|NOT COMPLETED|Overall Study||0||
59724191|NCT02883400|75842786|FG001|NOT COMPLETED|Overall Study||0||
59724192|NCT01119287|75842798|FG000|STARTED|Overall Study||26||
59724193|NCT01119287|75842799|FG001|STARTED|Overall Study||24||
59724194|NCT01119287|75842800|FG002|STARTED|Overall Study||26||
59724195|NCT01119287|75842801|FG003|STARTED|Overall Study||31||
59724196|NCT01119287|75842802|FG004|STARTED|Overall Study||31||
59724197|NCT01119287|75842803|FG005|STARTED|Overall Study||32||
59724198|NCT01119287|75842798|FG000|COMPLETED|Overall Study||26||
59724199|NCT01119287|75842799|FG001|COMPLETED|Overall Study||24||
59724200|NCT01119287|75842800|FG002|COMPLETED|Overall Study||24||
59724201|NCT01119287|75842801|FG003|COMPLETED|Overall Study||29||
59724202|NCT01119287|75842802|FG004|COMPLETED|Overall Study||30||
59724203|NCT01119287|75842803|FG005|COMPLETED|Overall Study||32||
59724204|NCT01119287|75842798|FG000|NOT COMPLETED|Overall Study||0||
59724205|NCT01119287|75842799|FG001|NOT COMPLETED|Overall Study||0||
59724206|NCT01119287|75842800|FG002|NOT COMPLETED|Overall Study||2||
59724207|NCT01119287|75842801|FG003|NOT COMPLETED|Overall Study||2||
59724208|NCT01119287|75842802|FG004|NOT COMPLETED|Overall Study||1||
59724209|NCT01119287|75842803|FG005|NOT COMPLETED|Overall Study||0||
59724210|NCT01110707|75842817|FG000|STARTED|Overall Study||63||
59724211|NCT01110707|75842818|FG001|STARTED|Overall Study||68||
59724212|NCT01110707|75842817|FG000|COMPLETED|Overall Study||63||
59724213|NCT01110707|75842818|FG001|COMPLETED|Overall Study||65||
59724214|NCT01110707|75842817|FG000|NOT COMPLETED|Overall Study||0||
59724215|NCT01110707|75842818|FG001|NOT COMPLETED|Overall Study||3||
59581180|NCT03340883|75687439|FG000|COMPLETED|Overall Study||4||
59581181|NCT03340883|75687440|FG001|COMPLETED|Overall Study||3||
59581182|NCT03340883|75687441|FG002|COMPLETED|Overall Study||4||
59581183|NCT03340883|75687442|FG003|COMPLETED|Overall Study||4||
59581184|NCT03340883|75687443|FG004|COMPLETED|Overall Study||3||
59581185|NCT03340883|75687444|FG005|COMPLETED|Overall Study||3||
59581186|NCT03340883|75687439|FG000|NOT COMPLETED|Overall Study||0||
59581187|NCT03340883|75687440|FG001|NOT COMPLETED|Overall Study||0||
59581188|NCT03340883|75687441|FG002|NOT COMPLETED|Overall Study||0||
59581189|NCT03340883|75687442|FG003|NOT COMPLETED|Overall Study||0||
59581190|NCT03340883|75687443|FG004|NOT COMPLETED|Overall Study||0||
59581191|NCT03340883|75687444|FG005|NOT COMPLETED|Overall Study||0||
59581192|NCT03341975|75687460|FG000|STARTED|Overall Study||44||
59581193|NCT03341975|75687461|FG001|STARTED|Overall Study||47||
59581194|NCT03341975|75687460|FG000|COMPLETED|Overall Study||44||
59581195|NCT03341975|75687461|FG001|COMPLETED|Overall Study||47||
59581196|NCT03341975|75687460|FG000|NOT COMPLETED|Overall Study||0||
59581197|NCT03341975|75687461|FG001|NOT COMPLETED|Overall Study||0||
59581198|NCT03344861|75687467|FG000|STARTED|Overall Study||10||
59581199|NCT03344861|75687467|FG000|COMPLETED|Overall Study||10||
59581200|NCT03344861|75687467|FG000|NOT COMPLETED|Overall Study||0||
59581201|NCT03348683|75687473|FG000|STARTED|Overall Study||121||
59581202|NCT03348683|75687474|FG001|STARTED|Overall Study||119||
59581203|NCT03348683|75687473|FG000|COMPLETED|Overall Study||121||
59581204|NCT03348683|75687474|FG001|COMPLETED|Overall Study||119||
59581205|NCT03348683|75687473|FG000|NOT COMPLETED|Overall Study||0||
59581206|NCT03348683|75687474|FG001|NOT COMPLETED|Overall Study||0||
59581207|NCT03351101|75687482|FG000|STARTED|Overall Study||136||
59581208|NCT03351101|75687483|FG001|STARTED|Overall Study||132||
59581209|NCT03351101|75687482|FG000|COMPLETED|Overall Study||135||
59581210|NCT03351101|75687483|FG001|COMPLETED|Overall Study||129||
59581211|NCT03351101|75687482|FG000|NOT COMPLETED|Overall Study||1||
59581212|NCT03351101|75687483|FG001|NOT COMPLETED|Overall Study||3||
59581213|NCT03223337|75687493|FG000|STARTED|Part 1 (Up to 16 Days)||8||
59581214|NCT03223337|75687494|FG001|STARTED|Part 1 (Up to 16 Days)||8||
59581215|NCT03223337|75687495|FG002|STARTED|Part 1 (Up to 16 Days)||0||
59581216|NCT03223337|75687496|FG003|STARTED|Part 1 (Up to 16 Days)||0||
59581217|NCT03223337|75687493|FG000|COMPLETED|Part 1 (Up to 16 Days)||8||
59581218|NCT03223337|75687494|FG001|COMPLETED|Part 1 (Up to 16 Days)||8||
59581219|NCT03223337|75687495|FG002|COMPLETED|Part 1 (Up to 16 Days)||0||
59581220|NCT03223337|75687496|FG003|COMPLETED|Part 1 (Up to 16 Days)||0||
59581221|NCT03223337|75687493|FG000|NOT COMPLETED|Part 1 (Up to 16 Days)||0||
59581222|NCT03223337|75687494|FG001|NOT COMPLETED|Part 1 (Up to 16 Days)||0||
59581223|NCT03223337|75687495|FG002|NOT COMPLETED|Part 1 (Up to 16 Days)||0||
59581224|NCT03223337|75687496|FG003|NOT COMPLETED|Part 1 (Up to 16 Days)||0||
59581225|NCT03223337|75687493|FG000|STARTED|Part 2 (Up to 16 Days)||0||
59581226|NCT03223337|75687494|FG001|STARTED|Part 2 (Up to 16 Days)||0||
59581227|NCT03223337|75687495|FG002|STARTED|Part 2 (Up to 16 Days)||12||
59581228|NCT03223337|75687496|FG003|STARTED|Part 2 (Up to 16 Days)||9||
59581229|NCT03223337|75687493|FG000|COMPLETED|Part 2 (Up to 16 Days)||0||
59581230|NCT03223337|75687494|FG001|COMPLETED|Part 2 (Up to 16 Days)||0||
59581231|NCT03223337|75687495|FG002|COMPLETED|Part 2 (Up to 16 Days)||12||
59581232|NCT03223337|75687496|FG003|COMPLETED|Part 2 (Up to 16 Days)||9||
59581233|NCT03223337|75687493|FG000|NOT COMPLETED|Part 2 (Up to 16 Days)||0||
59581234|NCT03223337|75687494|FG001|NOT COMPLETED|Part 2 (Up to 16 Days)||0||
59581235|NCT03223337|75687495|FG002|NOT COMPLETED|Part 2 (Up to 16 Days)||0||
59581236|NCT03223337|75687496|FG003|NOT COMPLETED|Part 2 (Up to 16 Days)||0||
59581237|NCT03834974|75687508|FG000|STARTED|Overall Study||34||
59581238|NCT03834974|75687509|FG001|STARTED|Overall Study||32||
59581239|NCT03834974|75687508|FG000|COMPLETED|Overall Study||34||
59581240|NCT03834974|75687509|FG001|COMPLETED|Overall Study||32||
59581241|NCT03834974|75687508|FG000|NOT COMPLETED|Overall Study||0||
59581242|NCT03834974|75687509|FG001|NOT COMPLETED|Overall Study||0||
59581243|NCT03223649|75687518|FG000|STARTED|Overall Study||52||
59581244|NCT03223649|75687519|FG001|STARTED|Overall Study||57||
59581245|NCT03223649|75687518|FG000|COMPLETED|Overall Study||42||
59581246|NCT03223649|75687519|FG001|COMPLETED|Overall Study||51||
59581247|NCT03223649|75687518|FG000|NOT COMPLETED|Overall Study||10||
59581248|NCT03223649|75687519|FG001|NOT COMPLETED|Overall Study||6||
59581249|NCT02360215|75687527|FG000|STARTED|Overall Study||257||
59581250|NCT02360215|75687528|FG001|STARTED|Overall Study||261||
59581251|NCT02360215|75687527|FG000|All Randomized Participants|Overall Study||257||
59581252|NCT02360215|75687528|FG001|All Randomized Participants|Overall Study||261||
59851473|NCT03322631|75976070|FG003|Received at Least 1 Dose of Study Drug|Overall Study||11||
59581253|NCT02360215|75687527|FG000|Started Protocol Treatment|Overall Study||232||
59581254|NCT02360215|75687528|FG001|Started Protocol Treatment|Overall Study||223||
59581255|NCT02360215|75687527|FG000|MDASI-BT Symptom Score|Overall Study||249|M.D. Anderson Symptom Inventory-Brain Module (MDASI-BT) baseline symptom severity subscale completed|
59581256|NCT02360215|75687528|FG001|MDASI-BT Symptom Score|Overall Study||251|M.D. Anderson Symptom Inventory-Brain Module (MDASI-BT) baseline symptom severity subscale completed|
59851474|NCT03322631|75976067|FG000|COMPLETED|Overall Study||9||
60121523|NCT01685801|76242415|FG003|COMPLETED|Washout Period 2 (4 Weeks)||4||
59581257|NCT02360215|75687527|FG000|MDASI-BT Intererence Score|Overall Study||248|MDSAI-BT symptom interference subscale completed at baseline|
59581258|NCT02360215|75687528|FG001|MDASI-BT Intererence Score|Overall Study||251|MDSAI-BT symptom interference subscale completed at baseline|
59581259|NCT02360215|75687527|FG000|MDASI-BT Cognitive Factor Score|Overall Study||249|MDSAI-BT cognifitive factor subscale completed at baseline|
59581260|NCT02360215|75687528|FG001|MDASI-BT Cognitive Factor Score|Overall Study||251|MDSAI-BT cognifitive factor subscale completed at baseline|
59581261|NCT02360215|75687527|FG000|MDASI-BT Neurologic Factor Score|Overall Study||249|MDSAI-BT neurologic factor subscale completed at baseline|
59581262|NCT02360215|75687528|FG001|MDASI-BT Neurologic Factor Score|Overall Study||251|MDSAI-BT neurologic factor subscale completed at baseline|
59581263|NCT02360215|75687527|FG000|HVLT-R Total Recall|Overall Study||256|Has standardized baseline Hopkins Verbal Learning Test - Revised (HVLT-R) Total Recall score|
59581264|NCT02360215|75687528|FG001|HVLT-R Total Recall|Overall Study||259|Has standardized baseline Hopkins Verbal Learning Test - Revised (HVLT-R) Total Recall score|
59581265|NCT02360215|75687527|FG000|HVLT-R Delayed Recall|Overall Study||256|Has standardized baseline HVLT-R Delayed Recall score|
59581266|NCT02360215|75687528|FG001|HVLT-R Delayed Recall|Overall Study||259|Has standardized baseline HVLT-R Delayed Recall score|
59581267|NCT02360215|75687527|FG000|HVLT-R Recognition|Overall Study||255|Has standardized baseline HVLT-R Recognition score|
59581268|NCT02360215|75687528|FG001|HVLT-R Recognition|Overall Study||259|Has standardized baseline HVLT-R Recognition score|
59581269|NCT02360215|75687527|FG000|Trail Making Test (TMT) Part A|Overall Study||256|Has standardized baseline TMT Part A score|
59581270|NCT02360215|75687528|FG001|Trail Making Test (TMT) Part A|Overall Study||260|Has standardized baseline TMT Part A score|
59581271|NCT02360215|75687527|FG000|TMT Part B|Overall Study||250|Has standardized baseline TMT Part B score|
59581272|NCT02360215|75687528|FG001|TMT Part B|Overall Study||257|Has standardized baseline TMT Part B score|
59581273|NCT02360215|75687527|FG000|Controlled Oral Word Association (COWA)|Overall Study||257|Has standardized baseline COWA score|
59581274|NCT02360215|75687528|FG001|Controlled Oral Word Association (COWA)|Overall Study||261|Has standardized baseline COWA score|
59581275|NCT02360215|75687527|FG000|Clinical Trial Battery Composite Score|Overall Study||255|Has standarized baseline Clinical Trial Battery Composite (CTB COMP) score|
59581276|NCT02360215|75687528|FG001|Clinical Trial Battery Composite Score|Overall Study||259|Has standarized baseline Clinical Trial Battery Composite (CTB COMP) score|
59581277|NCT02360215|75687527|FG000|EQ-5D-5L Index at 2 Months|Overall Study||142|EQ-5D-5L index score completed at baseline and 2 months from treatment start|
59581278|NCT02360215|75687528|FG001|EQ-5D-5L Index at 2 Months|Overall Study||125|EQ-5D-5L index score completed at baseline and 2 months from treatment start|
59581279|NCT02360215|75687527|FG000|EQ-5D-5L Index at 4 Months|Overall Study||110|EQ-5D-5L index score completed at baseline and 4 months from treatment start|
59581280|NCT02360215|75687528|FG001|EQ-5D-5L Index at 4 Months|Overall Study||96|EQ-5D-5L index score completed at baseline and 4 months from treatment start|
59581281|NCT02360215|75687527|FG000|EQ-5D-5L Index at 6 Months|Overall Study||79|EQ-5D-5L index score completed at baseline and 6 months from treatment start|
59581282|NCT02360215|75687528|FG001|EQ-5D-5L Index at 6 Months|Overall Study||70|EQ-5D-5L index score completed at baseline and 6 months from treatment start|
59581283|NCT02360215|75687527|FG000|EQ-5D-5L Index at 12 Months|Overall Study||56|EQ-5D-5L index score completed at baseline and 12 months from treatment start|
59581284|NCT02360215|75687528|FG001|EQ-5D-5L Index at 12 Months|Overall Study||45|EQ-5D-5L index score completed at baseline and 12 months from treatment start|
59581285|NCT02360215|75687527|FG000|EQ-5D-5L VAS at 2 Months|Overall Study||139|EQ-5D-5L visual analogue scale (VAS) completed at baseline and 2 months from treatment start|
59581286|NCT02360215|75687528|FG001|EQ-5D-5L VAS at 2 Months|Overall Study||123|EQ-5D-5L visual analogue scale (VAS) completed at baseline and 2 months from treatment start|
59581287|NCT02360215|75687527|FG000|EQ-5D-5L VAS at 4 Months|Overall Study||104|EQ-5D-5L visual analogue scale (VAS) completed at baseline and 4 months from treatment start|
59581288|NCT02360215|75687528|FG001|EQ-5D-5L VAS at 4 Months|Overall Study||193|EQ-5D-5L visual analogue scale (VAS) completed at baseline and 4 months from treatment start|
59724216|NCT01119131|75842828|FG000|STARTED|Overall Study||10||
59724217|NCT01119131|75842829|FG001|STARTED|Overall Study||28||
59724218|NCT01119131|75842830|FG002|STARTED|Overall Study||30||
59724219|NCT01119131|75842828|FG000|COMPLETED|Overall Study||8||
59724220|NCT01119131|75842829|FG001|COMPLETED|Overall Study||27||
59724221|NCT01119131|75842830|FG002|COMPLETED|Overall Study||24||
59724222|NCT01119131|75842828|FG000|NOT COMPLETED|Overall Study||2||
59724223|NCT01119131|75842829|FG001|NOT COMPLETED|Overall Study||1||
59724224|NCT01119131|75842830|FG002|NOT COMPLETED|Overall Study||6||
59724225|NCT01118975|75842840|FG000|STARTED|Overall Study||9||
59724226|NCT01118975|75842841|FG001|STARTED|Overall Study||3||
59724227|NCT01118975|75842840|FG000|COMPLETED|Overall Study||9||
59851475|NCT03322631|75976068|FG001|COMPLETED|Overall Study||11||
59851476|NCT03322631|75976069|FG002|COMPLETED|Overall Study||15||
59851477|NCT03322631|75976070|FG003|COMPLETED|Overall Study||11||
59851478|NCT03322631|75976067|FG000|NOT COMPLETED|Overall Study||0||
59851479|NCT03322631|75976068|FG001|NOT COMPLETED|Overall Study||1||
59851480|NCT03322631|75976069|FG002|NOT COMPLETED|Overall Study||1||
59851481|NCT03322631|75976070|FG003|NOT COMPLETED|Overall Study||0||
59851482|NCT03057795|75976083|FG000|STARTED|Overall Study||59||
60121524|NCT01685801|76242412|FG000|NOT COMPLETED|Washout Period 2 (4 Weeks)||0||
60121525|NCT01685801|76242413|FG001|NOT COMPLETED|Washout Period 2 (4 Weeks)||0||
60121526|NCT01685801|76242414|FG002|NOT COMPLETED|Washout Period 2 (4 Weeks)||0||
60121527|NCT01685801|76242415|FG003|NOT COMPLETED|Washout Period 2 (4 Weeks)||0||
60121528|NCT01685801|76242412|FG000|STARTED|Open-label Period (8 Weeks)||5||
59581289|NCT02360215|75687527|FG000|EQ-5D-5L VAS at 6 Months|Overall Study||76|EQ-5D-5L visual analogue scale (VAS) completed at baseline and 6 months from treatment start|
59581290|NCT02360215|75687528|FG001|EQ-5D-5L VAS at 6 Months|Overall Study||69|EQ-5D-5L visual analogue scale (VAS) completed at baseline and 6 months from treatment start|
59581291|NCT02360215|75687527|FG000|EQ-5D-5L VAS at 12 Months|Overall Study||57|EQ-5D-5L visual analogue scale (VAS) completed at baseline and 12 months from treatment start|
59581292|NCT02360215|75687528|FG001|EQ-5D-5L VAS at 12 Months|Overall Study||48|EQ-5D-5L visual analogue scale (VAS) completed at baseline and 12 months from treatment start|
59581293|NCT02360215|75687527|FG000|COMPLETED|Overall Study||257|Subjects contributing data to results are considered to have completed the study.|
59581294|NCT02360215|75687528|FG001|COMPLETED|Overall Study||261|Subjects contributing data to results are considered to have completed the study.|
59581295|NCT02360215|75687527|FG000|NOT COMPLETED|Overall Study||0||
59581296|NCT02360215|75687528|FG001|NOT COMPLETED|Overall Study||0||
59581297|NCT01349192|75687537|FG000|STARTED|Overall Study||24||
59581298|NCT01349192|75687538|FG001|STARTED|Overall Study||23||
59581299|NCT01349192|75687537|FG000|Evaluable for Primary Endpoint|Overall Study||22||
59581300|NCT01349192|75687538|FG001|Evaluable for Primary Endpoint|Overall Study||19||
59581301|NCT01349192|75687537|FG000|Withdrawals|Overall Study||3||
59581302|NCT01349192|75687538|FG001|Withdrawals|Overall Study||6||
59581303|NCT01349192|75687537|FG000|COMPLETED|Overall Study||21||
59581304|NCT01349192|75687538|FG001|COMPLETED|Overall Study||17||
59581305|NCT01349192|75687537|FG000|NOT COMPLETED|Overall Study||3||
59581306|NCT01349192|75687538|FG001|NOT COMPLETED|Overall Study||6||
59581307|NCT02360371|75687548|FG000|STARTED|Overall Study||13||
59581308|NCT02360371|75687549|FG001|STARTED|Overall Study||84||
59581309|NCT02360371|75687548|FG000|Placebo (Oral)|Overall Study||13||
59581310|NCT02360371|75687549|FG001|Placebo (Oral)|Overall Study||69||
59581311|NCT02360371|75687548|FG000|Hydromorphone (Oral) 2mg|Overall Study||13||
59581312|NCT02360371|75687549|FG001|Hydromorphone (Oral) 2mg|Overall Study||69||
59581313|NCT02360371|75687548|FG000|Hydromorphone (Oral) 4mg|Overall Study||13||
59581314|NCT02360371|75687549|FG001|Hydromorphone (Oral) 4mg|Overall Study||69||
59581315|NCT02360371|75687548|FG000|Hydromorphone (Oral) 8mg|Overall Study||13||
59581316|NCT02360371|75687549|FG001|Hydromorphone (Oral) 8mg|Overall Study||69||
59581317|NCT02360371|75687548|FG000|COMPLETED|Overall Study||13||
59581318|NCT02360371|75687549|FG001|COMPLETED|Overall Study||69||
59581319|NCT02360371|75687548|FG000|NOT COMPLETED|Overall Study||0||
59581320|NCT02360371|75687549|FG001|NOT COMPLETED|Overall Study||15||
59581321|NCT02362321|75687561|FG000|STARTED|Overall Study||10||
59581322|NCT02362321|75687562|FG001|STARTED|Overall Study||10||
59581323|NCT02362321|75687561|FG000|COMPLETED|Overall Study||6||
59581324|NCT02362321|75687562|FG001|COMPLETED|Overall Study||10||
59581325|NCT02362321|75687561|FG000|NOT COMPLETED|Overall Study||4||
59581326|NCT02362321|75687562|FG001|NOT COMPLETED|Overall Study||0||
59581327|NCT02413879|75687568|FG000|STARTED|Overall Study||86||
59581328|NCT02413879|75687568|FG000|COMPLETED|Overall Study||86||
59581329|NCT02413879|75687568|FG000|NOT COMPLETED|Overall Study||0||
59581330|NCT02415439|75687585|FG000|STARTED|Overall Study||6||
59581331|NCT02415439|75687586|FG001|STARTED|Overall Study||6||
59581332|NCT02415439|75687587|FG002|STARTED|Overall Study||6||
59581333|NCT02415439|75687588|FG003|STARTED|Overall Study||6||
59581334|NCT02415439|75687589|FG004|STARTED|Overall Study||6||
59581335|NCT02415439|75687590|FG005|STARTED|Overall Study||6||
59581336|NCT02415439|75687591|FG006|STARTED|Overall Study||6||
59581337|NCT02415439|75687592|FG007|STARTED|Overall Study||12||
59581338|NCT02415439|75687593|FG008|STARTED|Overall Study||6||
59581339|NCT02415439|75687594|FG009|STARTED|Overall Study||6||
59581340|NCT02415439|75687595|FG010|STARTED|Overall Study||6||
59581341|NCT02415439|75687596|FG011|STARTED|Overall Study||6||
59581342|NCT02415439|75687597|FG012|STARTED|Overall Study||8||
59581343|NCT02415439|75687585|FG000|COMPLETED|Overall Study||6||
59581344|NCT02415439|75687586|FG001|COMPLETED|Overall Study||6||
59581345|NCT02415439|75687587|FG002|COMPLETED|Overall Study||6||
59581346|NCT02415439|75687588|FG003|COMPLETED|Overall Study||6||
59581347|NCT02415439|75687589|FG004|COMPLETED|Overall Study||6||
59581348|NCT02415439|75687590|FG005|COMPLETED|Overall Study||6||
59581349|NCT02415439|75687591|FG006|COMPLETED|Overall Study||6||
59581350|NCT02415439|75687592|FG007|COMPLETED|Overall Study||12||
59581351|NCT02415439|75687593|FG008|COMPLETED|Overall Study||5||
59581352|NCT02415439|75687594|FG009|COMPLETED|Overall Study||6||
59581353|NCT02415439|75687595|FG010|COMPLETED|Overall Study||6||
59581354|NCT02415439|75687596|FG011|COMPLETED|Overall Study||6||
59581355|NCT02415439|75687597|FG012|COMPLETED|Overall Study||8||
59581356|NCT02415439|75687585|FG000|NOT COMPLETED|Overall Study||0||
59581357|NCT02415439|75687586|FG001|NOT COMPLETED|Overall Study||0||
59581358|NCT02415439|75687587|FG002|NOT COMPLETED|Overall Study||0||
59581359|NCT02415439|75687588|FG003|NOT COMPLETED|Overall Study||0||
59581360|NCT02415439|75687589|FG004|NOT COMPLETED|Overall Study||0||
59581361|NCT02415439|75687590|FG005|NOT COMPLETED|Overall Study||0||
59581362|NCT02415439|75687591|FG006|NOT COMPLETED|Overall Study||0||
59581363|NCT02415439|75687592|FG007|NOT COMPLETED|Overall Study||0||
59581364|NCT02415439|75687593|FG008|NOT COMPLETED|Overall Study||1||
59581365|NCT02415439|75687594|FG009|NOT COMPLETED|Overall Study||0||
59581366|NCT02415439|75687595|FG010|NOT COMPLETED|Overall Study||0||
59581367|NCT02415439|75687596|FG011|NOT COMPLETED|Overall Study||0||
59581368|NCT02415439|75687597|FG012|NOT COMPLETED|Overall Study||0||
59581369|NCT02363803|75687629|FG000|STARTED|Period 1||17||
59581370|NCT02363803|75687630|FG001|STARTED|Period 1||17||
59581371|NCT02363803|75687629|FG000|COMPLETED|Period 1||17||
59581372|NCT02363803|75687630|FG001|COMPLETED|Period 1||17||
59581373|NCT02363803|75687629|FG000|NOT COMPLETED|Period 1||0||
59581374|NCT02363803|75687630|FG001|NOT COMPLETED|Period 1||0||
59581375|NCT02363803|75687629|FG000|STARTED|Period 2||17||
59581376|NCT02363803|75687630|FG001|STARTED|Period 2|One participant did not return for Period 2 treatment|16||
59581377|NCT02363803|75687629|FG000|COMPLETED|Period 2||17||
59581378|NCT02363803|75687630|FG001|COMPLETED|Period 2||16||
59581379|NCT02363803|75687629|FG000|NOT COMPLETED|Period 2||0||
59581380|NCT02363803|75687630|FG001|NOT COMPLETED|Period 2||0||
59581381|NCT02364271|75687644|FG000|STARTED|Overall Study||479||
59581382|NCT02364271|75687645|FG001|STARTED|Overall Study||123||
59581383|NCT02364271|75687644|FG000|COMPLETED|Overall Study||479||
59581384|NCT02364271|75687645|FG001|COMPLETED|Overall Study||123||
59581385|NCT02364271|75687644|FG000|NOT COMPLETED|Overall Study||0||
59581386|NCT02364271|75687645|FG001|NOT COMPLETED|Overall Study||0||
59581387|NCT02366611|75687654|FG000|STARTED|Overall Study||10||
59581388|NCT02366611|75687655|FG001|STARTED|Overall Study||1||
59581389|NCT02366611|75687654|FG000|COMPLETED|Overall Study||8||
59581390|NCT02366611|75687655|FG001|COMPLETED|Overall Study||1||
59581391|NCT02366611|75687654|FG000|NOT COMPLETED|Overall Study||2||
59581392|NCT02366611|75687655|FG001|NOT COMPLETED|Overall Study||0||
59581393|NCT02366845|75687664|FG000|STARTED|Overall Study||25||
59581394|NCT02366845|75687665|FG001|STARTED|Overall Study||25||
59581395|NCT02366845|75687664|FG000|COMPLETED|Overall Study||25||
59581396|NCT02366845|75687665|FG001|COMPLETED|Overall Study||25||
59581397|NCT02366845|75687664|FG000|NOT COMPLETED|Overall Study||0||
59581398|NCT02366845|75687665|FG001|NOT COMPLETED|Overall Study||0||
59581399|NCT02367391|75687673|FG000|STARTED|Overall Study||76||
59581400|NCT02367391|75687674|FG001|STARTED|Overall Study||76||
59581401|NCT02367391|75687673|FG000|COMPLETED|Overall Study||74||
59581402|NCT02367391|75687674|FG001|COMPLETED|Overall Study||76||
59581403|NCT02367391|75687673|FG000|NOT COMPLETED|Overall Study||2||
59581404|NCT02367391|75687674|FG001|NOT COMPLETED|Overall Study||0||
59581408|NCT02368093|75687686|FG000|STARTED|Overall Study||24||
59581409|NCT02368093|75687687|FG001|STARTED|Overall Study||24||
59581410|NCT02368093|75687686|FG000|COMPLETED|Overall Study||24||
59581411|NCT02368093|75687687|FG001|COMPLETED|Overall Study||24||
59581412|NCT02368093|75687686|FG000|NOT COMPLETED|Overall Study||0||
59581413|NCT02368093|75687687|FG001|NOT COMPLETED|Overall Study||0||
59581414|NCT02376283|75687696|FG000|STARTED|Overall Study||27||
59581415|NCT02376283|75687697|FG001|STARTED|Overall Study||30||
59581416|NCT02376283|75687698|FG002|STARTED|Overall Study||30||
59581417|NCT02376283|75687696|FG000|COMPLETED|Overall Study||27||
59581418|NCT02376283|75687697|FG001|COMPLETED|Overall Study||30||
59581419|NCT02376283|75687698|FG002|COMPLETED|Overall Study||30||
59581420|NCT02376283|75687696|FG000|NOT COMPLETED|Overall Study||0||
59581421|NCT02376283|75687697|FG001|NOT COMPLETED|Overall Study||0||
59581422|NCT02376283|75687698|FG002|NOT COMPLETED|Overall Study||0||
59581423|NCT02376361|75687709|FG000|STARTED|Overall Study||229||
59581424|NCT02376361|75687710|FG001|STARTED|Overall Study||207||
59581425|NCT02376361|75687709|FG000|COMPLETED|Overall Study||58||
59581426|NCT02376361|75687710|FG001|COMPLETED|Overall Study||90||
59581427|NCT02376361|75687709|FG000|NOT COMPLETED|Overall Study||171||
59581428|NCT02376361|75687710|FG001|NOT COMPLETED|Overall Study||117||
59581429|NCT02301793|75687718|FG000|STARTED|Pre Education Study Period|Nurses had not been randomized|||2722
59581430|NCT02301793|75687719|FG001|STARTED|Pre Education Study Period|Nurses had not been randomized|||2603
59581431|NCT02301793|75687718|FG000|COMPLETED|Pre Education Study Period|Nurses had not been randomized|||2722
59581432|NCT02301793|75687719|FG001|COMPLETED|Pre Education Study Period|Nurses had not been randomized|||2603
59581433|NCT02301793|75687718|FG000|NOT COMPLETED|Pre Education Study Period||||0
59581434|NCT02301793|75687719|FG001|NOT COMPLETED|Pre Education Study Period||||0
59581435|NCT02301793|75687718|FG000|STARTED|During and Post Education Study Period||488||6566
59724228|NCT01118975|75842841|FG001|COMPLETED|Overall Study||2||
59581436|NCT02301793|75687719|FG001|STARTED|During and Post Education Study Period||445||5355
59581437|NCT02301793|75687718|FG000|COMPLETED|During and Post Education Study Period||405||6566
59581438|NCT02301793|75687719|FG001|COMPLETED|During and Post Education Study Period||396||5355
59581439|NCT02301793|75687718|FG000|NOT COMPLETED|During and Post Education Study Period||83||0
59581440|NCT02301793|75687719|FG001|NOT COMPLETED|During and Post Education Study Period||49||0
59581441|NCT02380183|75687727|FG000|STARTED|Overall Study||36||
59581442|NCT02380183|75687728|FG001|STARTED|Overall Study||34||
59581443|NCT02380183|75687727|FG000|COMPLETED|Overall Study||36||
59581444|NCT02380183|75687728|FG001|COMPLETED|Overall Study||34||
59581445|NCT02380183|75687727|FG000|NOT COMPLETED|Overall Study||0||
59581446|NCT02380183|75687728|FG001|NOT COMPLETED|Overall Study||0||
59581447|NCT02380261|75687734|FG000|STARTED|Overall Study||35||
59581448|NCT02380261|75687734|FG000|COMPLETED|Overall Study||35||
59581449|NCT02380261|75687734|FG000|NOT COMPLETED|Overall Study||0||
59581450|NCT02382913|75687748|FG000|STARTED|Overall Study||27||
59581451|NCT02382913|75687749|FG001|STARTED|Overall Study||36||
59581452|NCT02382913|75687750|FG002|STARTED|Overall Study||32||
59581453|NCT02382913|75687751|FG003|STARTED|Overall Study||27||
59581454|NCT02382913|75687752|FG004|STARTED|Overall Study||33||
59581455|NCT02382913|75687753|FG005|STARTED|Overall Study||30||
59581456|NCT02382913|75687754|FG006|STARTED|Overall Study||37||
59581457|NCT02382913|75687755|FG007|STARTED|Overall Study||30||
59581458|NCT02382913|75687756|FG008|STARTED|Overall Study||30||
59581459|NCT02382913|75687757|FG009|STARTED|Overall Study||33||
59581460|NCT02382913|75687748|FG000|COMPLETED|Overall Study||27||
59581461|NCT02382913|75687749|FG001|COMPLETED|Overall Study||36||
59581462|NCT02382913|75687750|FG002|COMPLETED|Overall Study||32||
59851483|NCT03057795|75976083|FG000|COMPLETED|Overall Study||59||
59851484|NCT03057795|75976083|FG000|NOT COMPLETED|Overall Study||0||
59851485|NCT03018704|75976089|FG000|STARTED|Overall Study||19||
59851486|NCT03018704|75976090|FG001|STARTED|Overall Study||18||
59581463|NCT02382913|75687751|FG003|COMPLETED|Overall Study||27||
59581464|NCT02382913|75687752|FG004|COMPLETED|Overall Study||33||
59581465|NCT02382913|75687753|FG005|COMPLETED|Overall Study||30||
59581466|NCT02382913|75687754|FG006|COMPLETED|Overall Study||37||
59581467|NCT02382913|75687755|FG007|COMPLETED|Overall Study||30||
59581468|NCT02382913|75687756|FG008|COMPLETED|Overall Study||30||
59581469|NCT02382913|75687757|FG009|COMPLETED|Overall Study||33||
59581470|NCT02382913|75687748|FG000|NOT COMPLETED|Overall Study||0||
59581471|NCT02382913|75687749|FG001|NOT COMPLETED|Overall Study||0||
59581472|NCT02382913|75687750|FG002|NOT COMPLETED|Overall Study||0||
59581473|NCT02382913|75687751|FG003|NOT COMPLETED|Overall Study||0||
59581474|NCT02382913|75687752|FG004|NOT COMPLETED|Overall Study||0||
59581475|NCT02382913|75687753|FG005|NOT COMPLETED|Overall Study||0||
59581476|NCT02382913|75687754|FG006|NOT COMPLETED|Overall Study||0||
59581477|NCT02382913|75687755|FG007|NOT COMPLETED|Overall Study||0||
59581478|NCT02382913|75687756|FG008|NOT COMPLETED|Overall Study||0||
59581479|NCT02382913|75687757|FG009|NOT COMPLETED|Overall Study||0||
59581480|NCT02385097|75687781|FG000|STARTED|Overall Study||106||
59581481|NCT02385097|75687782|FG001|STARTED|Overall Study||105||
59581482|NCT02385097|75687781|FG000|COMPLETED|Overall Study||106||
59581483|NCT02385097|75687782|FG001|COMPLETED|Overall Study||105||
59581484|NCT02385097|75687781|FG000|NOT COMPLETED|Overall Study||0||
59581485|NCT02385097|75687782|FG001|NOT COMPLETED|Overall Study||0||
59581486|NCT02385721|75687788|FG000|STARTED|Overall Study||601||
59581487|NCT02385721|75687788|FG000|COMPLETED|Overall Study||371||
59581488|NCT02385721|75687788|FG000|NOT COMPLETED|Overall Study||230||
59581489|NCT02387359|75687795|FG000|STARTED|Overall Study||354||
59581490|NCT02387359|75687796|FG001|STARTED|Overall Study||351||
59581491|NCT02387359|75687797|FG002|STARTED|Overall Study||349||
59581492|NCT02387359|75687795|FG000|COMPLETED|Overall Study||295||
59581493|NCT02387359|75687796|FG001|COMPLETED|Overall Study||309||
59581494|NCT02387359|75687797|FG002|COMPLETED|Overall Study||293||
59581495|NCT02387359|75687795|FG000|NOT COMPLETED|Overall Study||59||
59581496|NCT02387359|75687796|FG001|NOT COMPLETED|Overall Study||42||
59581497|NCT02387359|75687797|FG002|NOT COMPLETED|Overall Study||56||
59581498|NCT02387749|75687805|FG000|STARTED|Overall Study||10||
59581499|NCT02387749|75687805|FG000|COMPLETED|Overall Study||10||
59581500|NCT02387749|75687805|FG000|NOT COMPLETED|Overall Study||0||
59581501|NCT02390791|75687816|FG000|STARTED|Overall Study||40||
59581502|NCT02390791|75687817|FG001|STARTED|Overall Study||45||
59581503|NCT02390791|75687816|FG000|COMPLETED|Overall Study||40||
59581504|NCT02390791|75687817|FG001|COMPLETED|Overall Study||45||
59581505|NCT02390791|75687816|FG000|NOT COMPLETED|Overall Study||0||
59581506|NCT02390791|75687817|FG001|NOT COMPLETED|Overall Study||0||
59581507|NCT02392351|75687825|FG000|STARTED|Overall Study||34||
59581508|NCT02392351|75687826|FG001|STARTED|Overall Study||17||
59581509|NCT02392351|75687825|FG000|COMPLETED|Overall Study|Primary endpoint: only observational results available.|0||
59581510|NCT02392351|75687826|FG001|COMPLETED|Overall Study|Primary endpoint: only observational results available.|0||
59851487|NCT03018704|75976089|FG000|COMPLETED|Overall Study||18||
59581511|NCT02392351|75687825|FG000|NOT COMPLETED|Overall Study||34||
59581512|NCT02392351|75687826|FG001|NOT COMPLETED|Overall Study||17||
59581513|NCT02393677|75687834|FG000|STARTED|Overall Study||40||
59581514|NCT02393677|75687835|FG001|STARTED|Overall Study||40||
59581515|NCT02393677|75687834|FG000|COMPLETED|Overall Study||40||
59581516|NCT02393677|75687835|FG001|COMPLETED|Overall Study||40||
59581517|NCT02393677|75687834|FG000|NOT COMPLETED|Overall Study||0||
59581518|NCT02393677|75687835|FG001|NOT COMPLETED|Overall Study||0||
59581519|NCT02394457|75687843|FG000|STARTED|Overall Study||15||
59581520|NCT02394457|75687844|FG001|STARTED|Overall Study||13||
59581521|NCT02394457|75687843|FG000|COMPLETED|Overall Study||15||
59581522|NCT02394457|75687844|FG001|COMPLETED|Overall Study||13||
59581523|NCT02394457|75687843|FG000|NOT COMPLETED|Overall Study||0||
59581524|NCT02394457|75687844|FG001|NOT COMPLETED|Overall Study||0||
59851488|NCT03018704|75976090|FG001|COMPLETED|Overall Study||17||
59851489|NCT03018704|75976089|FG000|NOT COMPLETED|Overall Study||1||
59851490|NCT03018704|75976090|FG001|NOT COMPLETED|Overall Study||1||
59581525|NCT03224351|75687858|FG000|STARTED|Overall Study||10||
59581526|NCT03224351|75687859|FG001|STARTED|Overall Study||11||
59581527|NCT03224351|75687860|FG002|STARTED|Overall Study||20||
59581528|NCT03224351|75687861|FG003|STARTED|Overall Study||22||
59581529|NCT03224351|75687862|FG004|STARTED|Overall Study||11||
59581530|NCT03224351|75687863|FG005|STARTED|Overall Study||18||
59581531|NCT03224351|75687864|FG006|STARTED|Overall Study||6||
59581532|NCT03224351|75687865|FG007|STARTED|Overall Study||19||
59581533|NCT03224351|75687858|FG000|COMPLETED|Overall Study||10||
59581534|NCT03224351|75687859|FG001|COMPLETED|Overall Study||11||
59581535|NCT03224351|75687860|FG002|COMPLETED|Overall Study||20||
59581536|NCT03224351|75687861|FG003|COMPLETED|Overall Study||22||
59581537|NCT03224351|75687862|FG004|COMPLETED|Overall Study||11||
59581538|NCT03224351|75687863|FG005|COMPLETED|Overall Study||18||
59581539|NCT03224351|75687864|FG006|COMPLETED|Overall Study||6||
59581540|NCT03224351|75687865|FG007|COMPLETED|Overall Study||19||
59581541|NCT03224351|75687858|FG000|NOT COMPLETED|Overall Study||0||
59581542|NCT03224351|75687859|FG001|NOT COMPLETED|Overall Study||0||
59581543|NCT03224351|75687860|FG002|NOT COMPLETED|Overall Study||0||
59581544|NCT03224351|75687861|FG003|NOT COMPLETED|Overall Study||0||
59581545|NCT03224351|75687862|FG004|NOT COMPLETED|Overall Study||0||
59581546|NCT03224351|75687863|FG005|NOT COMPLETED|Overall Study||0||
59581547|NCT03224351|75687864|FG006|NOT COMPLETED|Overall Study||0||
59581548|NCT03224351|75687865|FG007|NOT COMPLETED|Overall Study||0||
59581549|NCT01721876|75687893|FG000|STARTED|Overall Study||222||
59581550|NCT01721876|75687894|FG001|STARTED|Overall Study||444||
59581551|NCT01721876|75687893|FG000|Treated|Overall Study||221||
59581552|NCT01721876|75687894|FG001|Treated|Overall Study||440||
59581553|NCT01721876|75687893|FG000|COMPLETED|Overall Study||0||
59581554|NCT01721876|75687894|FG001|COMPLETED|Overall Study||0||
59581555|NCT01721876|75687893|FG000|NOT COMPLETED|Overall Study||222||
59581556|NCT01721876|75687894|FG001|NOT COMPLETED|Overall Study||444||
59581557|NCT03224585|75687902|FG000|STARTED|Overall Study||2||
59581558|NCT03224585|75687903|FG001|STARTED|Overall Study||3||
59581559|NCT03224585|75687902|FG000|COMPLETED|Overall Study||2||
59581560|NCT03224585|75687903|FG001|COMPLETED|Overall Study||3||
59581561|NCT03224585|75687902|FG000|NOT COMPLETED|Overall Study||0||
59581562|NCT03224585|75687903|FG001|NOT COMPLETED|Overall Study||0||
59581563|NCT03423641|75687910|FG000|STARTED|Overall Study||15524||
59581564|NCT03423641|75687911|FG001|STARTED|Overall Study||18284||
59581565|NCT03423641|75687910|FG000|COMPLETED|Overall Study||15193||
59581566|NCT03423641|75687911|FG001|COMPLETED|Overall Study||10210||
59581567|NCT03423641|75687910|FG000|NOT COMPLETED|Overall Study||331||
59581568|NCT03423641|75687911|FG001|NOT COMPLETED|Overall Study||8074||
59581569|NCT03225599|75687917|FG000|STARTED|Overall Study||9||
59581570|NCT03225599|75687917|FG000|COMPLETED|Overall Study||7||
59581571|NCT03225599|75687917|FG000|NOT COMPLETED|Overall Study||2||
59581572|NCT03226223|75687923|FG000|STARTED|Overall Study||10||
59581573|NCT03226223|75687924|FG001|STARTED|Overall Study||8||
59581574|NCT03226223|75687923|FG000|COMPLETED|Overall Study||8||
59581575|NCT03226223|75687924|FG001|COMPLETED|Overall Study||6||
59581576|NCT03226223|75687923|FG000|NOT COMPLETED|Overall Study||2||
59581577|NCT03226223|75687924|FG001|NOT COMPLETED|Overall Study||2||
59581578|NCT03226457|75687930|FG000|STARTED|Treatment 1: 6 Weeks||12||
59581579|NCT03226457|75687931|FG001|STARTED|Treatment 1: 6 Weeks||11||
59581580|NCT03226457|75687930|FG000|COMPLETED|Treatment 1: 6 Weeks||12||
59581581|NCT03226457|75687931|FG001|COMPLETED|Treatment 1: 6 Weeks||11||
59581582|NCT03226457|75687930|FG000|NOT COMPLETED|Treatment 1: 6 Weeks||0||
59581583|NCT03226457|75687931|FG001|NOT COMPLETED|Treatment 1: 6 Weeks||0||
59581584|NCT03226457|75687930|FG000|STARTED|Washout Period: Minimum 2 Weeks||12||
59581585|NCT03226457|75687931|FG001|STARTED|Washout Period: Minimum 2 Weeks||11||
59581586|NCT03226457|75687930|FG000|COMPLETED|Washout Period: Minimum 2 Weeks||12||
59724229|NCT01118975|75842840|FG000|NOT COMPLETED|Overall Study||0||
59724230|NCT01118975|75842841|FG001|NOT COMPLETED|Overall Study||1||
59724231|NCT01110239|75842851|FG000|STARTED|Sham Preconditioning||7||
59724232|NCT01110239|75842852|FG001|STARTED|Sham Preconditioning||14||
59581587|NCT03226457|75687931|FG001|COMPLETED|Washout Period: Minimum 2 Weeks||11||
59581588|NCT03226457|75687930|FG000|NOT COMPLETED|Washout Period: Minimum 2 Weeks||0||
59581589|NCT03226457|75687931|FG001|NOT COMPLETED|Washout Period: Minimum 2 Weeks||0||
59581590|NCT03226457|75687930|FG000|STARTED|Treatment 2: 6 Weeks||12||
59724233|NCT01110239|75842853|FG002|STARTED|Sham Preconditioning||7||
59581591|NCT03226457|75687931|FG001|STARTED|Treatment 2: 6 Weeks||11||
59581592|NCT03226457|75687930|FG000|COMPLETED|Treatment 2: 6 Weeks||12||
59581593|NCT03226457|75687931|FG001|COMPLETED|Treatment 2: 6 Weeks||11||
59581594|NCT03226457|75687930|FG000|NOT COMPLETED|Treatment 2: 6 Weeks||0||
59581595|NCT03226457|75687931|FG001|NOT COMPLETED|Treatment 2: 6 Weeks||0||
59581596|NCT03228017|75687939|FG000|STARTED|Overall Study||45||
59581597|NCT03228017|75687940|FG001|STARTED|Overall Study||18||
59581598|NCT03228017|75687939|FG000|COMPLETED|Overall Study||45||
59581599|NCT03228017|75687940|FG001|COMPLETED|Overall Study||18||
59581600|NCT03228017|75687939|FG000|NOT COMPLETED|Overall Study||0||
59581601|NCT03228017|75687940|FG001|NOT COMPLETED|Overall Study||0||
59581602|NCT03358355|75687946|FG000|STARTED|Overall Study||9||
59581603|NCT03358355|75687946|FG000|COMPLETED|Overall Study||9||
59581604|NCT03358355|75687946|FG000|NOT COMPLETED|Overall Study||0||
59581605|NCT03424187|75687961|FG000|STARTED|Overall Study||2||
59581606|NCT03424187|75687962|FG001|STARTED|Overall Study||3||
59581607|NCT03424187|75687963|FG002|STARTED|Overall Study||2||
59581608|NCT03424187|75687964|FG003|STARTED|Overall Study||3||
59581609|NCT03424187|75687965|FG004|STARTED|Overall Study||2||
59581610|NCT03424187|75687966|FG005|STARTED|Overall Study||3||
59581611|NCT03424187|75687961|FG000|COMPLETED|Overall Study||2||
59581612|NCT03424187|75687962|FG001|COMPLETED|Overall Study||3||
59581613|NCT03424187|75687963|FG002|COMPLETED|Overall Study||2||
59581614|NCT03424187|75687964|FG003|COMPLETED|Overall Study||3||
59581615|NCT03424187|75687965|FG004|COMPLETED|Overall Study||2||
59581616|NCT03424187|75687966|FG005|COMPLETED|Overall Study||3||
59581617|NCT03424187|75687961|FG000|NOT COMPLETED|Overall Study||0||
59581618|NCT03424187|75687962|FG001|NOT COMPLETED|Overall Study||0||
59581619|NCT03424187|75687963|FG002|NOT COMPLETED|Overall Study||0||
59581620|NCT03424187|75687964|FG003|NOT COMPLETED|Overall Study||0||
59581621|NCT03424187|75687965|FG004|NOT COMPLETED|Overall Study||0||
59581622|NCT03424187|75687966|FG005|NOT COMPLETED|Overall Study||0||
59581623|NCT03427931|75687979|FG000|STARTED|Overall Study||7||
59581624|NCT03427931|75687979|FG000|COMPLETED|Overall Study||5||
59581625|NCT03427931|75687979|FG000|NOT COMPLETED|Overall Study||2||
59581626|NCT03362879|75687983|FG000|STARTED|Overall Study||409||
59581627|NCT03362879|75687983|FG000|COMPLETED|Overall Study||409||
59581628|NCT03362879|75687983|FG000|NOT COMPLETED|Overall Study||0||
59581629|NCT03231917|75687990|FG000|STARTED|Overall Study||60||
59581630|NCT03231917|75687991|FG001|STARTED|Overall Study||61||
59581631|NCT03231917|75687990|FG000|COMPLETED|Overall Study||60||
59581632|NCT03231917|75687991|FG001|COMPLETED|Overall Study||61||
59581633|NCT03231917|75687990|FG000|NOT COMPLETED|Overall Study||0||
59581634|NCT03231917|75687991|FG001|NOT COMPLETED|Overall Study||0||
59581635|NCT03362957|75687999|FG000|STARTED|Overall Study||14||
59581636|NCT03362957|75688000|FG001|STARTED|Overall Study||7||
59581637|NCT03362957|75687999|FG000|Crossover to Receive GAE Procedure|Overall Study||0||
59581638|NCT03362957|75688000|FG001|Crossover to Receive GAE Procedure|Overall Study||7||
59581639|NCT03362957|75687999|FG000|COMPLETED|Overall Study||14||
59581640|NCT03362957|75688000|FG001|COMPLETED|Overall Study||7||
59581641|NCT03362957|75687999|FG000|NOT COMPLETED|Overall Study||0||
59581642|NCT03362957|75688000|FG001|NOT COMPLETED|Overall Study||0||
59581643|NCT03430349|75688010|FG000|STARTED|Overall Study||15||
59581644|NCT03430349|75688011|FG001|STARTED|Overall Study||15||
59581645|NCT03430349|75688010|FG000|Received nOPV Vaccination|Overall Study||15||
59581646|NCT03430349|75688011|FG001|Received nOPV Vaccination|Overall Study||15||
59581647|NCT03430349|75688010|FG000|COMPLETED|Overall Study||15||
59581648|NCT03430349|75688011|FG001|COMPLETED|Overall Study||15||
59581649|NCT03430349|75688010|FG000|NOT COMPLETED|Overall Study||0||
59581650|NCT03430349|75688011|FG001|NOT COMPLETED|Overall Study||0||
59581651|NCT03376061|75688020|FG000|STARTED|Overall Study||49||
59581652|NCT03376061|75688021|FG001|STARTED|Overall Study||48||
59581653|NCT03376061|75688020|FG000|COMPLETED|Overall Study||49||
59581654|NCT03376061|75688021|FG001|COMPLETED|Overall Study||48||
59581655|NCT03376061|75688020|FG000|NOT COMPLETED|Overall Study||0||
59581656|NCT03376061|75688021|FG001|NOT COMPLETED|Overall Study||0||
59581657|NCT03376295|75688030|FG000|STARTED|Overall Study||1977||
59581658|NCT03376295|75688031|FG001|STARTED|Overall Study||1977||
59581659|NCT03376295|75688030|FG000|COMPLETED|Overall Study||1977||
59581660|NCT03376295|75688031|FG001|COMPLETED|Overall Study||1977||
59581661|NCT03376295|75688030|FG000|NOT COMPLETED|Overall Study||0||
59581662|NCT03376295|75688031|FG001|NOT COMPLETED|Overall Study||0||
59581663|NCT03381989|75688037|FG000|STARTED|Overall Study||30||
59581664|NCT03381989|75688037|FG000|COMPLETED|Overall Study||22||
59581665|NCT03381989|75688037|FG000|NOT COMPLETED|Overall Study||8||
59581666|NCT03244865|75688042|FG000|STARTED|Overall Study||35||
59581667|NCT03244865|75688042|FG000|COMPLETED|Overall Study||35||
59581668|NCT03244865|75688042|FG000|NOT COMPLETED|Overall Study||0||
59581669|NCT03247985|75688048|FG000|STARTED|Overall Study||19||
59581670|NCT03247985|75688049|FG001|STARTED|Overall Study||19||
59581671|NCT03247985|75688048|FG000|COMPLETED|Overall Study||19||
59581672|NCT03247985|75688049|FG001|COMPLETED|Overall Study||19||
59581673|NCT03247985|75688048|FG000|NOT COMPLETED|Overall Study||0||
59581674|NCT03247985|75688049|FG001|NOT COMPLETED|Overall Study||0||
59581675|NCT03249779|75688055|FG000|STARTED|Overall Study||8||
59581676|NCT03249779|75688055|FG000|COMPLETED|Overall Study||8||
59581677|NCT03249779|75688055|FG000|NOT COMPLETED|Overall Study||0||
59581678|NCT03382847|75688059|FG000|STARTED|Overall Study||25||
59581679|NCT03382847|75688059|FG000|COMPLETED|Overall Study||25||
59581680|NCT03382847|75688059|FG000|NOT COMPLETED|Overall Study||0||
59581681|NCT03440723|75688065|FG000|STARTED|Overall Study||21||
59581682|NCT03440723|75688066|FG001|STARTED|Overall Study||21||
59581683|NCT03440723|75688065|FG000|COMPLETED|Overall Study||21||
59581684|NCT03440723|75688066|FG001|COMPLETED|Overall Study||21||
59581685|NCT03440723|75688065|FG000|NOT COMPLETED|Overall Study||0||
59581686|NCT03440723|75688066|FG001|NOT COMPLETED|Overall Study||0||
59581687|NCT03441269|75688076|FG000|STARTED|Overall Study||75||
59581688|NCT03441269|75688077|FG001|STARTED|Overall Study||75||
59581689|NCT03441269|75688078|FG002|STARTED|Overall Study||75||
59581690|NCT03441269|75688076|FG000|COMPLETED|Overall Study||75||
59581691|NCT03441269|75688077|FG001|COMPLETED|Overall Study||74||
59581692|NCT03441269|75688078|FG002|COMPLETED|Overall Study||74||
59581693|NCT03441269|75688076|FG000|NOT COMPLETED|Overall Study||0||
59581694|NCT03441269|75688077|FG001|NOT COMPLETED|Overall Study||1||
59581695|NCT03441269|75688078|FG002|NOT COMPLETED|Overall Study||1||
59581696|NCT03383627|75688086|FG000|STARTED|Overall Study||80||
59581697|NCT03383627|75688086|FG000|COMPLETED|Overall Study||80||
59581698|NCT03383627|75688086|FG000|NOT COMPLETED|Overall Study||0||
59581699|NCT03252353|75688092|FG000|STARTED|Overall Study||28||
59581700|NCT03252353|75688093|FG001|STARTED|Overall Study||28||
59581701|NCT03252353|75688092|FG000|COMPLETED|Overall Study||28||
59581702|NCT03252353|75688093|FG001|COMPLETED|Overall Study||28||
59581703|NCT03252353|75688092|FG000|NOT COMPLETED|Overall Study||0||
59581704|NCT03252353|75688093|FG001|NOT COMPLETED|Overall Study||0||
59581705|NCT03441581|75688104|FG000|STARTED|Overall Study||12||
59581706|NCT03441581|75688105|FG001|STARTED|Overall Study||12||
59581707|NCT03441581|75688104|FG000|COMPLETED|Overall Study||12||
59581708|NCT03441581|75688105|FG001|COMPLETED|Overall Study||12||
59581709|NCT03441581|75688104|FG000|NOT COMPLETED|Overall Study||0||
59581710|NCT03441581|75688105|FG001|NOT COMPLETED|Overall Study||0||
59581711|NCT02265510|75688125|FG000|STARTED|Overall Study||3||
59581712|NCT02265510|75688126|FG001|STARTED|Overall Study||3||
59581713|NCT02265510|75688127|FG002|STARTED|Overall Study||6||
59581714|NCT02265510|75688128|FG003|STARTED|Overall Study||4||
59581715|NCT02265510|75688129|FG004|STARTED|Overall Study||3||
59581716|NCT02265510|75688130|FG005|STARTED|Overall Study||6||
59581717|NCT02265510|75688131|FG006|STARTED|Overall Study||3||
59581718|NCT02265510|75688132|FG007|STARTED|Overall Study||4||
59581719|NCT02265510|75688133|FG008|STARTED|Overall Study||4||
59581720|NCT02265510|75688134|FG009|STARTED|Overall Study||7||
59581721|NCT02265510|75688135|FG010|STARTED|Overall Study||5||
59581722|NCT02265510|75688136|FG011|STARTED|Overall Study||16||
59581723|NCT02265510|75688137|FG012|STARTED|Overall Study||9||
59581724|NCT02265510|75688138|FG013|STARTED|Overall Study||10||
59581725|NCT02265510|75688125|FG000|COMPLETED|Overall Study||0||
59581726|NCT02265510|75688126|FG001|COMPLETED|Overall Study||0||
59581727|NCT02265510|75688127|FG002|COMPLETED|Overall Study||0||
59581728|NCT02265510|75688128|FG003|COMPLETED|Overall Study||0||
59581729|NCT02265510|75688129|FG004|COMPLETED|Overall Study||0||
59581730|NCT02265510|75688130|FG005|COMPLETED|Overall Study||0||
59581731|NCT02265510|75688131|FG006|COMPLETED|Overall Study||0||
59581732|NCT02265510|75688132|FG007|COMPLETED|Overall Study||0||
59581733|NCT02265510|75688133|FG008|COMPLETED|Overall Study||0||
59581734|NCT02265510|75688134|FG009|COMPLETED|Overall Study||0||
59581735|NCT02265510|75688135|FG010|COMPLETED|Overall Study||0||
59581736|NCT02265510|75688136|FG011|COMPLETED|Overall Study||0||
59581737|NCT02265510|75688137|FG012|COMPLETED|Overall Study||0||
59581738|NCT02265510|75688138|FG013|COMPLETED|Overall Study||0||
59581739|NCT02265510|75688125|FG000|NOT COMPLETED|Overall Study||3||
59581740|NCT02265510|75688126|FG001|NOT COMPLETED|Overall Study||3||
59581741|NCT02265510|75688127|FG002|NOT COMPLETED|Overall Study||6||
59581742|NCT02265510|75688128|FG003|NOT COMPLETED|Overall Study||4||
59581743|NCT02265510|75688129|FG004|NOT COMPLETED|Overall Study||3||
59581744|NCT02265510|75688130|FG005|NOT COMPLETED|Overall Study||6||
59581745|NCT02265510|75688131|FG006|NOT COMPLETED|Overall Study||3||
59581746|NCT02265510|75688132|FG007|NOT COMPLETED|Overall Study||4||
59581747|NCT02265510|75688133|FG008|NOT COMPLETED|Overall Study||4||
59581748|NCT02265510|75688134|FG009|NOT COMPLETED|Overall Study||7||
59581749|NCT02265510|75688135|FG010|NOT COMPLETED|Overall Study||5||
59581750|NCT02265510|75688136|FG011|NOT COMPLETED|Overall Study||16||
59581751|NCT02265510|75688137|FG012|NOT COMPLETED|Overall Study||9||
59581752|NCT02265510|75688138|FG013|NOT COMPLETED|Overall Study||10||
59581753|NCT03254147|75688194|FG000|STARTED|Overall Study|The number of patients meeting the inclusion and exclusion criteria|53969||
59581754|NCT03254147|75688194|FG000|COMPLETED|Overall Study||53969||
59581755|NCT03254147|75688194|FG000|NOT COMPLETED|Overall Study||0||
59581756|NCT03384329|75688200|FG000|STARTED|Overall Study||11||
59581757|NCT03384329|75688201|FG001|STARTED|Overall Study||11||
59581758|NCT03384329|75688200|FG000|COMPLETED|Overall Study||11||
59581759|NCT03384329|75688201|FG001|COMPLETED|Overall Study||11||
59581760|NCT03384329|75688200|FG000|NOT COMPLETED|Overall Study||0||
59581761|NCT03384329|75688201|FG001|NOT COMPLETED|Overall Study||0||
59724234|NCT01110239|75842854|FG003|STARTED|Sham Preconditioning||6||
59581762|NCT03384953|75688209|FG000|STARTED|Overall Study||91||
59581763|NCT03384953|75688210|FG001|STARTED|Overall Study||12||
59581764|NCT03384953|75688209|FG000|Completed Treatment|Overall Study||68||
59581765|NCT03384953|75688210|FG001|Completed Treatment|Overall Study||6||
59581766|NCT03384953|75688209|FG000|COMPLETED|Overall Study||51||
59581767|NCT03384953|75688210|FG001|COMPLETED|Overall Study||4||
59581768|NCT03384953|75688209|FG000|NOT COMPLETED|Overall Study||40||
59581769|NCT03384953|75688210|FG001|NOT COMPLETED|Overall Study||8||
59581770|NCT03443063|75688218|FG000|STARTED|Overall Study||8||
59581771|NCT03443063|75688219|FG001|STARTED|Overall Study||8||
59581772|NCT03443063|75688218|FG000|COMPLETED|Overall Study||8||
59581773|NCT03443063|75688219|FG001|COMPLETED|Overall Study||8||
59581774|NCT03443063|75688218|FG000|NOT COMPLETED|Overall Study||0||
59581775|NCT03443063|75688219|FG001|NOT COMPLETED|Overall Study||0||
59581776|NCT03256253|75688227|FG000|STARTED|Overall Study||18||
59581777|NCT03256253|75688227|FG000|COMPLETED|Overall Study||6||
59581778|NCT03256253|75688227|FG000|NOT COMPLETED|Overall Study||12||
59581779|NCT03256799|75688231|FG000|STARTED|Overall Study||1||
59581780|NCT03256799|75688231|FG000|COMPLETED|Overall Study||1||
59581781|NCT03256799|75688231|FG000|NOT COMPLETED|Overall Study||0||
59581782|NCT03257189|75688235|FG000|STARTED|Overall Study||30||
59581783|NCT03257189|75688235|FG000|COMPLETED|Overall Study||30||
59581784|NCT03257189|75688235|FG000|NOT COMPLETED|Overall Study||0||
59581785|NCT01238211|75688239|FG000|STARTED|Overall Study||61||
59581786|NCT01238211|75688239|FG000|COMPLETED|Overall Study||3||
59581787|NCT01238211|75688239|FG000|NOT COMPLETED|Overall Study||58||
59581788|NCT03259139|75688249|FG000|STARTED|Overall Study||42||
59581789|NCT03259139|75688250|FG001|STARTED|Overall Study||42||
59581790|NCT03259139|75688251|FG002|STARTED|Overall Study||42||
59581791|NCT03259139|75688252|FG003|STARTED|Overall Study||42||
59581792|NCT03259139|75688253|FG004|STARTED|Overall Study||41||
59581793|NCT03259139|75688254|FG005|STARTED|Overall Study||41||
59581794|NCT03259139|75688249|FG000|Eligible|Overall Study||41||
59581795|NCT03259139|75688250|FG001|Eligible|Overall Study||41||
59581796|NCT03259139|75688251|FG002|Eligible|Overall Study||41||
59581797|NCT03259139|75688252|FG003|Eligible|Overall Study||41||
59581798|NCT03259139|75688253|FG004|Eligible|Overall Study||41||
59581799|NCT03259139|75688254|FG005|Eligible|Overall Study||41||
59581800|NCT03259139|75688249|FG000|Outlier Elimination|Overall Study||41||
59581801|NCT03259139|75688250|FG001|Outlier Elimination|Overall Study||41||
59581802|NCT03259139|75688251|FG002|Outlier Elimination|Overall Study||41||
59581803|NCT03259139|75688252|FG003|Outlier Elimination|Overall Study||41||
59581804|NCT03259139|75688253|FG004|Outlier Elimination|Overall Study||39||
59581805|NCT03259139|75688254|FG005|Outlier Elimination|Overall Study||39||
59581806|NCT03259139|75688249|FG000|Found Handgun|Overall Study||38||
59581807|NCT03259139|75688250|FG001|Found Handgun|Overall Study||38||
59581808|NCT03259139|75688251|FG002|Found Handgun|Overall Study||37||
59581809|NCT03259139|75688252|FG003|Found Handgun|Overall Study||37||
59581810|NCT03259139|75688253|FG004|Found Handgun|Overall Study||35||
59581811|NCT03259139|75688254|FG005|Found Handgun|Overall Study||35||
59581812|NCT03259139|75688249|FG000|COMPLETED|Overall Study||38||
59581813|NCT03259139|75688250|FG001|COMPLETED|Overall Study||38||
59581814|NCT03259139|75688251|FG002|COMPLETED|Overall Study||37||
59581815|NCT03259139|75688252|FG003|COMPLETED|Overall Study||37||
59581816|NCT03259139|75688253|FG004|COMPLETED|Overall Study||35||
59581817|NCT03259139|75688254|FG005|COMPLETED|Overall Study||35||
59581818|NCT03259139|75688249|FG000|NOT COMPLETED|Overall Study||4||
59581819|NCT03259139|75688250|FG001|NOT COMPLETED|Overall Study||4||
59581820|NCT03259139|75688251|FG002|NOT COMPLETED|Overall Study||5||
59581821|NCT03259139|75688252|FG003|NOT COMPLETED|Overall Study||5||
59581822|NCT03259139|75688253|FG004|NOT COMPLETED|Overall Study||6||
59581823|NCT03259139|75688254|FG005|NOT COMPLETED|Overall Study||6||
59581824|NCT03260699|75688273|FG000|STARTED|Overall Study||5||
59581825|NCT03260699|75688274|FG001|STARTED|Overall Study||4||
59581826|NCT03260699|75688273|FG000|COMPLETED|Overall Study||5||
59581827|NCT03260699|75688274|FG001|COMPLETED|Overall Study||2||
59581828|NCT03260699|75688273|FG000|NOT COMPLETED|Overall Study||0||
59581829|NCT03260699|75688274|FG001|NOT COMPLETED|Overall Study||2||
59581830|NCT03268343|75688280|FG000|STARTED|Overall Study||12||
59581831|NCT03268343|75688281|FG001|STARTED|Overall Study||12||
59581832|NCT03268343|75688280|FG000|COMPLETED|Overall Study||12||
59581833|NCT03268343|75688281|FG001|COMPLETED|Overall Study||12||
59581834|NCT03268343|75688280|FG000|NOT COMPLETED|Overall Study||0||
59581835|NCT03268343|75688281|FG001|NOT COMPLETED|Overall Study||0||
59581836|NCT03744637|75688298|FG000|STARTED|Overall Study||2||
59581837|NCT03744637|75688299|FG001|STARTED|Overall Study||2||
59581838|NCT03744637|75688300|FG002|STARTED|Overall Study||2||
59581839|NCT03744637|75688301|FG003|STARTED|Overall Study||1||
59581840|NCT03744637|75688302|FG004|STARTED|Overall Study||1||
59581841|NCT03744637|75688303|FG005|STARTED|Overall Study||1||
59581842|NCT03744637|75688304|FG006|STARTED|Overall Study||8||
59581843|NCT03744637|75688305|FG007|STARTED|Overall Study||4||
59581844|NCT03744637|75688306|FG008|STARTED|Overall Study||3||
59581845|NCT03744637|75688307|FG009|STARTED|Overall Study||1||
59581846|NCT03744637|75688298|FG000|COMPLETED|Overall Study||2||
59581847|NCT03744637|75688299|FG001|COMPLETED|Overall Study||2||
59581848|NCT03744637|75688300|FG002|COMPLETED|Overall Study||2||
59581849|NCT03744637|75688301|FG003|COMPLETED|Overall Study||1||
59581850|NCT03744637|75688302|FG004|COMPLETED|Overall Study|Participant did not receive MK-5475 240 ug in Part 2 as planned.|1||
59581851|NCT03744637|75688303|FG005|COMPLETED|Overall Study|Participant received 165 ug in Part 2 Periods 2 and 3, instead of planned 360 ug.|1||
59581852|NCT03744637|75688304|FG006|COMPLETED|Overall Study||8||
59581853|NCT03744637|75688305|FG007|COMPLETED|Overall Study|Participants received 120 ug in Part 2 Periods 2 and 3, instead of planned 360 ug.|4||
59581854|NCT03744637|75688306|FG008|COMPLETED|Overall Study||3||
59581855|NCT03744637|75688307|FG009|COMPLETED|Overall Study|Participant did not receive 120 ug in Part 2 Period 3 as planned.|1||
59581856|NCT03744637|75688298|FG000|NOT COMPLETED|Overall Study||0||
59581857|NCT03744637|75688299|FG001|NOT COMPLETED|Overall Study||0||
59581858|NCT03744637|75688300|FG002|NOT COMPLETED|Overall Study||0||
59581859|NCT03744637|75688301|FG003|NOT COMPLETED|Overall Study||0||
59581860|NCT03744637|75688302|FG004|NOT COMPLETED|Overall Study||0||
59581861|NCT03744637|75688303|FG005|NOT COMPLETED|Overall Study||0||
59581862|NCT03744637|75688304|FG006|NOT COMPLETED|Overall Study||0||
59581863|NCT03744637|75688305|FG007|NOT COMPLETED|Overall Study||0||
59581864|NCT03744637|75688306|FG008|NOT COMPLETED|Overall Study||0||
59581865|NCT03744637|75688307|FG009|NOT COMPLETED|Overall Study||0||
59581866|NCT03269435|75688370|FG000|STARTED|Overall Study||51||
59581867|NCT03269435|75688371|FG001|STARTED|Overall Study||48||
59581868|NCT03269435|75688370|FG000|COMPLETED|Overall Study||51||
59581869|NCT03269435|75688371|FG001|COMPLETED|Overall Study||48||
59581870|NCT03269435|75688370|FG000|NOT COMPLETED|Overall Study||0||
59581871|NCT03269435|75688371|FG001|NOT COMPLETED|Overall Study||0||
59581872|NCT03279731|75688379|FG000|STARTED|Overall Study||19||
59581873|NCT03279731|75688380|FG001|STARTED|Overall Study||17||
59581874|NCT03279731|75688379|FG000|COMPLETED|Overall Study||13||
59581875|NCT03279731|75688380|FG001|COMPLETED|Overall Study||14||
59581876|NCT03279731|75688379|FG000|NOT COMPLETED|Overall Study||6||
59581877|NCT03279731|75688380|FG001|NOT COMPLETED|Overall Study||3||
59581878|NCT03390257|75688388|FG000|STARTED|Overall Study||14||
59581879|NCT03390257|75688388|FG000|COMPLETED|Overall Study||14||
59581880|NCT03390257|75688388|FG000|NOT COMPLETED|Overall Study||0||
59581881|NCT03391115|75688396|FG000|STARTED|Overall Study||20||
59581882|NCT03391115|75688397|FG001|STARTED|Overall Study||18||
59581883|NCT03391115|75688396|FG000|COMPLETED|Overall Study||20||
59581884|NCT03391115|75688397|FG001|COMPLETED|Overall Study|Two Nurse participants in the dyadic patient-nurse enrollment were not successfully recruited.|18||
59581885|NCT03391115|75688396|FG000|NOT COMPLETED|Overall Study||0||
59581886|NCT03391115|75688397|FG001|NOT COMPLETED|Overall Study||0||
59581887|NCT03397121|75688405|FG000|STARTED|Overall Study||242||
59581888|NCT03397121|75688406|FG001|STARTED|Overall Study||240||
59581889|NCT03397121|75688405|FG000|COMPLETED|Overall Study||235||
59581890|NCT03397121|75688406|FG001|COMPLETED|Overall Study||231||
59581891|NCT03397121|75688405|FG000|NOT COMPLETED|Overall Study||7||
59581892|NCT03397121|75688406|FG001|NOT COMPLETED|Overall Study||9||
59581893|NCT02264574|75688415|FG000|STARTED|Overall Study||113||
59581894|NCT02264574|75688416|FG001|STARTED|Overall Study||116||
59581895|NCT02264574|75688415|FG000|COMPLETED|Overall Study||84|On-study until study termination by sponsor.|
59581896|NCT02264574|75688416|FG001|COMPLETED|Overall Study||86|On-study until study termination by sponsor.|
59581897|NCT02264574|75688415|FG000|NOT COMPLETED|Overall Study||29||
59581898|NCT02264574|75688416|FG001|NOT COMPLETED|Overall Study||30||
59581899|NCT03398213|75688425|FG000|STARTED|Overall Study||26||
59581900|NCT03398213|75688426|FG001|STARTED|Overall Study||24||
59581901|NCT03398213|75688427|FG002|STARTED|Overall Study||22||
59581902|NCT03398213|75688425|FG000|COMPLETED|Overall Study||26||
59581903|NCT03398213|75688426|FG001|COMPLETED|Overall Study||24||
59581904|NCT03398213|75688427|FG002|COMPLETED|Overall Study||22||
59581905|NCT03398213|75688425|FG000|NOT COMPLETED|Overall Study||0||
59581906|NCT03398213|75688426|FG001|NOT COMPLETED|Overall Study||0||
59581907|NCT03398213|75688427|FG002|NOT COMPLETED|Overall Study||0||
59581908|NCT03400163|75688437|FG000|STARTED|Treatment Period||1||
59581909|NCT03400163|75688438|FG001|STARTED|Treatment Period||2||
59581910|NCT03400163|75688437|FG000|COMPLETED|Treatment Period||1||
59581911|NCT03400163|75688438|FG001|COMPLETED|Treatment Period||2||
59581912|NCT03400163|75688437|FG000|NOT COMPLETED|Treatment Period||0||
59581913|NCT03400163|75688438|FG001|NOT COMPLETED|Treatment Period||0||
59581914|NCT03400163|75688437|FG000|STARTED|Follow-up Period||1||
59581915|NCT03400163|75688438|FG001|STARTED|Follow-up Period||2||
59581916|NCT03400163|75688437|FG000|COMPLETED|Follow-up Period||1||
59581917|NCT03400163|75688438|FG001|COMPLETED|Follow-up Period||2||
59581918|NCT03400163|75688437|FG000|NOT COMPLETED|Follow-up Period||0||
59581919|NCT03400163|75688438|FG001|NOT COMPLETED|Follow-up Period||0||
59581920|NCT03400475|75688446|FG000|STARTED|Overall Study||24||
59581921|NCT03400475|75688447|FG001|STARTED|Overall Study||22||
59581922|NCT03400475|75688446|FG000|COMPLETED|Overall Study||24||
59581923|NCT03400475|75688447|FG001|COMPLETED|Overall Study||22||
59581924|NCT03400475|75688446|FG000|NOT COMPLETED|Overall Study||0||
59581925|NCT03400475|75688447|FG001|NOT COMPLETED|Overall Study||0||
59581926|NCT01641900|75688456|FG000|STARTED|Overall Study||28||
59581927|NCT01641900|75688457|FG001|STARTED|Overall Study||31||
59581928|NCT01641900|75688456|FG000|Completed Placebo Intervention|Overall Study|n=1,assigned to placebo intervention first, completed the session and dropped out of the study.|27||
59581929|NCT01641900|75688457|FG001|Completed Placebo Intervention|Overall Study|n=2,both assigned to placebo intervention first, completed the session and dropped out of the study.|29||
59581930|NCT01641900|75688456|FG000|Completed Drug Intervention|Overall Study|n=1,assigned to drug intervention first, completed the session and dropped out of the study.|26||
59581931|NCT01641900|75688457|FG001|Completed Drug Intervention|Overall Study||29||
59581932|NCT01641900|75688456|FG000|COMPLETED|Overall Study||26||
59581933|NCT01641900|75688457|FG001|COMPLETED|Overall Study||29||
59581934|NCT01641900|75688456|FG000|NOT COMPLETED|Overall Study||2||
59581935|NCT01641900|75688457|FG001|NOT COMPLETED|Overall Study||2||
59581936|NCT03402659|75688467|FG000|STARTED|Overall Study||83||
59581937|NCT03402659|75688468|FG001|STARTED|Overall Study||78||
59581938|NCT03402659|75688467|FG000|COMPLETED|Overall Study||78||
59581939|NCT03402659|75688468|FG001|COMPLETED|Overall Study||73||
59581940|NCT03402659|75688467|FG000|NOT COMPLETED|Overall Study||5||
59581941|NCT03402659|75688468|FG001|NOT COMPLETED|Overall Study||5||
59581942|NCT03282071|75688476|FG000|STARTED|Overall Study||75||2
59581943|NCT03282071|75688477|FG001|STARTED|Overall Study||69||2
59581944|NCT03282071|75688476|FG000|COMPLETED|Overall Study||65||2
59581945|NCT03282071|75688477|FG001|COMPLETED|Overall Study||60||2
59581946|NCT03282071|75688476|FG000|NOT COMPLETED|Overall Study||10||0
59581947|NCT03282071|75688477|FG001|NOT COMPLETED|Overall Study||9||0
59581948|NCT03283787|75688488|FG000|STARTED|Overall Study||20||
59581949|NCT03283787|75688489|FG001|STARTED|Overall Study||20||
59581950|NCT03283787|75688490|FG002|STARTED|Overall Study||20||
59581951|NCT03283787|75688488|FG000|COMPLETED|Overall Study||17||
59581952|NCT03283787|75688489|FG001|COMPLETED|Overall Study||13||
59581953|NCT03283787|75688490|FG002|COMPLETED|Overall Study||13||
59581954|NCT03283787|75688488|FG000|NOT COMPLETED|Overall Study||3||
59581955|NCT03283787|75688489|FG001|NOT COMPLETED|Overall Study||7||
59581956|NCT03283787|75688490|FG002|NOT COMPLETED|Overall Study||7||
59581957|NCT03284411|75688501|FG000|STARTED|Overall Study||30||
59581958|NCT03284411|75688501|FG000|COMPLETED|Overall Study||30||
59581959|NCT03284411|75688501|FG000|NOT COMPLETED|Overall Study||0||
59581960|NCT03403517|75688508|FG000|STARTED|Overall Study||88||
59581961|NCT03403517|75688509|FG001|STARTED|Overall Study||86||
59581962|NCT03403517|75688508|FG000|COMPLETED|Overall Study||88||
59581963|NCT03403517|75688509|FG001|COMPLETED|Overall Study||86||
59581964|NCT03403517|75688508|FG000|NOT COMPLETED|Overall Study||0||
59581965|NCT03403517|75688509|FG001|NOT COMPLETED|Overall Study||0||
59581966|NCT03404219|75688515|FG000|STARTED|Overall Study||31||
59581967|NCT03404219|75688515|FG000|COMPLETED|Overall Study||31||
59581968|NCT03404219|75688515|FG000|NOT COMPLETED|Overall Study||0||
59581969|NCT01640808|75688522|FG000|STARTED|Overall Study||309||
59581970|NCT01640808|75688523|FG001|STARTED|Overall Study||307||
59581971|NCT01640808|75688522|FG000|Subjects Received Treatment|Overall Study||305||
59581972|NCT01640808|75688523|FG001|Subjects Received Treatment|Overall Study||305||
59581973|NCT01640808|75688522|FG000|COMPLETED|Overall Study||251||
59581974|NCT01640808|75688523|FG001|COMPLETED|Overall Study||291||
59581975|NCT01640808|75688522|FG000|NOT COMPLETED|Overall Study||58||
59581976|NCT01640808|75688523|FG001|NOT COMPLETED|Overall Study||16||
59581977|NCT03404375|75688531|FG000|STARTED|Overall Study||70||
59581978|NCT03404375|75688532|FG001|STARTED|Overall Study||172||
59581979|NCT03404375|75688531|FG000|COMPLETED|Overall Study||70||
59581980|NCT03404375|75688532|FG001|COMPLETED|Overall Study||172||
59581981|NCT03404375|75688531|FG000|NOT COMPLETED|Overall Study||0||
59581982|NCT03404375|75688532|FG001|NOT COMPLETED|Overall Study||0||
59581983|NCT03404609|75688538|FG000|STARTED|Overall Study||7||
59581984|NCT03404609|75688538|FG000|COMPLETED|Overall Study||7||
59581985|NCT03404609|75688538|FG000|NOT COMPLETED|Overall Study||0||
59581986|NCT02263326|75688544|FG000|STARTED|Overall Study||44||
59581987|NCT02263326|75688545|FG001|STARTED|Overall Study||45||
59581988|NCT02263326|75688544|FG000|COMPLETED|Overall Study||43||
59581989|NCT02263326|75688545|FG001|COMPLETED|Overall Study||44||
59581990|NCT02263326|75688544|FG000|NOT COMPLETED|Overall Study||1||
59581991|NCT02263326|75688545|FG001|NOT COMPLETED|Overall Study||1||
59581992|NCT03406325|75688559|FG000|STARTED|Overall Study||12||
59581993|NCT03406325|75688560|FG001|STARTED|Overall Study||1||
59581994|NCT03406325|75688561|FG002|STARTED|Overall Study||1||
59581995|NCT03406325|75688562|FG003|STARTED|Overall Study||1||
59581996|NCT03406325|75688563|FG004|STARTED|Overall Study||1||
59581997|NCT03406325|75688564|FG005|STARTED|Overall Study||1||
59581998|NCT03406325|75688565|FG006|STARTED|Overall Study||1||
59581999|NCT03406325|75688566|FG007|STARTED|Overall Study||1||
59582000|NCT03406325|75688559|FG000|COMPLETED|Overall Study||12||
59582001|NCT03406325|75688560|FG001|COMPLETED|Overall Study||1||
59582002|NCT03406325|75688561|FG002|COMPLETED|Overall Study||1||
59582003|NCT03406325|75688562|FG003|COMPLETED|Overall Study||1||
59582004|NCT03406325|75688563|FG004|COMPLETED|Overall Study||1||
59582005|NCT03406325|75688564|FG005|COMPLETED|Overall Study||1||
59582006|NCT03406325|75688565|FG006|COMPLETED|Overall Study||1||
59582007|NCT03406325|75688566|FG007|COMPLETED|Overall Study||1||
59582008|NCT03406325|75688559|FG000|NOT COMPLETED|Overall Study||0||
59582009|NCT03406325|75688560|FG001|NOT COMPLETED|Overall Study||0||
59582010|NCT03406325|75688561|FG002|NOT COMPLETED|Overall Study||0||
59582011|NCT03406325|75688562|FG003|NOT COMPLETED|Overall Study||0||
59582012|NCT03406325|75688563|FG004|NOT COMPLETED|Overall Study||0||
59582013|NCT03406325|75688564|FG005|NOT COMPLETED|Overall Study||0||
59582014|NCT03406325|75688565|FG006|NOT COMPLETED|Overall Study||0||
59582015|NCT03406325|75688566|FG007|NOT COMPLETED|Overall Study||0||
59582016|NCT03407651|75688598|FG000|STARTED|Period 1: Part 1a||11||
59582017|NCT03407651|75688598|FG000|COMPLETED|Period 1: Part 1a||10||
59582018|NCT03407651|75688598|FG000|NOT COMPLETED|Period 1: Part 1a||1||
59724235|NCT01110239|75842851|FG000|COMPLETED|Sham Preconditioning||7||
59582019|NCT03407651|75688598|FG000|STARTED|Period 2: Part 1b||9|One subject completed Part 1a of the study and opted to enter into Part 2 of the study and did not enter Part 1b, making the number of subjects in Part 1b smaller than the number of subjects in Part 1a. That subject withdrew consent after 1 SC dose in Part 2 but is counted as a discontinuation in Part 1 as no additional assessments were performed and the subject did not enter Part 1b. One subject had poor IV access and skipped Part 1b of the study.|
59582020|NCT03407651|75688598|FG000|COMPLETED|Period 2: Part 1b||9||
59582021|NCT03407651|75688598|FG000|NOT COMPLETED|Period 2: Part 1b||0||
59582022|NCT03407651|75688598|FG000|STARTED|Period 3: Part 2|The subject who discontinued after 44 daily SC doses in Part 2 elected to participate in Period 3.|11||
59582023|NCT03407651|75688598|FG000|COMPLETED|Period 3: Part 2||8||
59582024|NCT03407651|75688598|FG000|NOT COMPLETED|Period 3: Part 2||3||
59582025|NCT03450083|75688620|FG000|STARTED|Overall Study||12||
59582026|NCT03450083|75688621|FG001|STARTED|Overall Study||12||
59582027|NCT03450083|75688620|FG000|COMPLETED|Overall Study||12||
59582028|NCT03450083|75688621|FG001|COMPLETED|Overall Study||12||
59582029|NCT03450083|75688620|FG000|NOT COMPLETED|Overall Study||0||
59582030|NCT03450083|75688621|FG001|NOT COMPLETED|Overall Study||0||
59582031|NCT03578549|75688627|FG000|STARTED|Overall Study||30||
59582032|NCT03578549|75688627|FG000|COMPLETED|Overall Study||29||
59582033|NCT03578549|75688627|FG000|NOT COMPLETED|Overall Study||1||
59582034|NCT03580343|75688631|FG000|STARTED|Overall Study||5||
59582035|NCT03580343|75688631|FG000|COMPLETED|Overall Study||4||
59582036|NCT03580343|75688631|FG000|NOT COMPLETED|Overall Study||1||
59582037|NCT03453515|75688637|FG000|STARTED|Overall Study||113||
59582038|NCT03453515|75688638|FG001|STARTED|Overall Study||113||
59582039|NCT03453515|75688637|FG000|COMPLETED|Overall Study||107||
59582040|NCT03453515|75688638|FG001|COMPLETED|Overall Study||100||
59582041|NCT03453515|75688637|FG000|NOT COMPLETED|Overall Study||6||
59582042|NCT03453515|75688638|FG001|NOT COMPLETED|Overall Study||13||
59582043|NCT03456245|75688644|FG000|STARTED|Overall Study||205||
59582044|NCT03456245|75688644|FG000|COMPLETED|Overall Study||190||
59582045|NCT03456245|75688644|FG000|NOT COMPLETED|Overall Study||15||
59582046|NCT02260986|75688651|FG000|STARTED|Overall Study||315||
59582047|NCT02260986|75688652|FG001|STARTED|Overall Study||106||
59582048|NCT02260986|75688653|FG002|STARTED|Overall Study||319||
59582049|NCT02260986|75688651|FG000|Safety Population|Overall Study||315||
59582050|NCT02260986|75688652|FG001|Safety Population|Overall Study|4 participants from Dupilumab 300 mg qw arm analyzed in Dupilumab 300 mg q2w arm|110||
59582051|NCT02260986|75688653|FG002|Safety Population|Overall Study|4 participants received fewer injections of Dupilumab 300 mg (analyzed in Dupilumab 300 mg q2w arm)|315||
59582052|NCT02260986|75688651|FG000|COMPLETED|Overall Study||225||
59582053|NCT02260986|75688652|FG001|COMPLETED|Overall Study||93||
59582054|NCT02260986|75688653|FG002|COMPLETED|Overall Study||278||
59582055|NCT02260986|75688651|FG000|NOT COMPLETED|Overall Study||90||
59582056|NCT02260986|75688652|FG001|NOT COMPLETED|Overall Study||13||
59582057|NCT02260986|75688653|FG002|NOT COMPLETED|Overall Study||41||
59582058|NCT02259582|75688669|FG000|STARTED|Overall Study||25||
59582059|NCT02259582|75688670|FG001|STARTED|Overall Study||28||
59582060|NCT02259582|75688671|FG002|STARTED|Overall Study||29||
59582061|NCT02259582|75688669|FG000|COMPLETED|Overall Study||9||
59582062|NCT02259582|75688670|FG001|COMPLETED|Overall Study||11||
59582063|NCT02259582|75688671|FG002|COMPLETED|Overall Study||8||
59582064|NCT02259582|75688669|FG000|NOT COMPLETED|Overall Study||16||
59582065|NCT02259582|75688670|FG001|NOT COMPLETED|Overall Study||17||
59582066|NCT02259582|75688671|FG002|NOT COMPLETED|Overall Study||21||
59582067|NCT03238651|75688684|FG000|STARTED|Overall Study||3||
59582068|NCT03238651|75688685|FG001|STARTED|Overall Study||6||
59582069|NCT03238651|75688686|FG002|STARTED|Overall Study||4||
59582070|NCT03238651|75688687|FG003|STARTED|Overall Study||3||
59582071|NCT03238651|75688688|FG004|STARTED|Overall Study||1||
59582072|NCT03238651|75688684|FG000|COMPLETED|Overall Study||0||
59582073|NCT03238651|75688685|FG001|COMPLETED|Overall Study||0||
59582074|NCT03238651|75688686|FG002|COMPLETED|Overall Study||0||
59582075|NCT03238651|75688687|FG003|COMPLETED|Overall Study||0||
59582076|NCT03238651|75688688|FG004|COMPLETED|Overall Study||0||
59582077|NCT03238651|75688684|FG000|NOT COMPLETED|Overall Study||3||
59582078|NCT03238651|75688685|FG001|NOT COMPLETED|Overall Study||6||
59582079|NCT03238651|75688686|FG002|NOT COMPLETED|Overall Study||4||
59582080|NCT03238651|75688687|FG003|NOT COMPLETED|Overall Study||3||
59582081|NCT03238651|75688688|FG004|NOT COMPLETED|Overall Study||1||
59582082|NCT05838456|75688703|FG000|STARTED|Step 1: Months 1-3||38||1
59582083|NCT05838456|75688704|FG001|STARTED|Step 1: Months 1-3||8||1
59582084|NCT05838456|75688705|FG002|STARTED|Step 1: Months 1-3||11||1
59582085|NCT05838456|75688706|FG003|STARTED|Step 1: Months 1-3||23||1
59582086|NCT05838456|75688703|FG000|COMPLETED|Step 1: Months 1-3||38||1
59582087|NCT05838456|75688704|FG001|COMPLETED|Step 1: Months 1-3||8||1
59582088|NCT05838456|75688705|FG002|COMPLETED|Step 1: Months 1-3||11||1
59582089|NCT05838456|75688706|FG003|COMPLETED|Step 1: Months 1-3||23||1
59582090|NCT05838456|75688703|FG000|NOT COMPLETED|Step 1: Months 1-3||0||0
59582091|NCT05838456|75688704|FG001|NOT COMPLETED|Step 1: Months 1-3||0||0
59582092|NCT05838456|75688705|FG002|NOT COMPLETED|Step 1: Months 1-3||0||0
59582093|NCT05838456|75688706|FG003|NOT COMPLETED|Step 1: Months 1-3||0||0
59582094|NCT05838456|75688703|FG000|STARTED|Step 2: Months 4-6||9||1
59582095|NCT05838456|75688704|FG001|STARTED|Step 2: Months 4-6||3||1
59582096|NCT05838456|75688705|FG002|STARTED|Step 2: Months 4-6||4||1
59582097|NCT05838456|75688706|FG003|STARTED|Step 2: Months 4-6||20||1
59582098|NCT05838456|75688703|FG000|COMPLETED|Step 2: Months 4-6||9||1
59582099|NCT05838456|75688704|FG001|COMPLETED|Step 2: Months 4-6||3||1
59582100|NCT05838456|75688705|FG002|COMPLETED|Step 2: Months 4-6||4||1
59582101|NCT05838456|75688706|FG003|COMPLETED|Step 2: Months 4-6||20||1
59582102|NCT05838456|75688703|FG000|NOT COMPLETED|Step 2: Months 4-6||0||0
59582103|NCT05838456|75688704|FG001|NOT COMPLETED|Step 2: Months 4-6||0||0
59582104|NCT05838456|75688705|FG002|NOT COMPLETED|Step 2: Months 4-6||0||0
59582105|NCT05838456|75688706|FG003|NOT COMPLETED|Step 2: Months 4-6||0||0
59582106|NCT05838456|75688703|FG000|STARTED|Step 3: Months 7-9||11||1
59582107|NCT05838456|75688704|FG001|STARTED|Step 3: Months 7-9||2||1
59582108|NCT05838456|75688705|FG002|STARTED|Step 3: Months 7-9||5||1
59582109|NCT05838456|75688706|FG003|STARTED|Step 3: Months 7-9||19||1
59582110|NCT05838456|75688703|FG000|COMPLETED|Step 3: Months 7-9||11||1
59582111|NCT05838456|75688704|FG001|COMPLETED|Step 3: Months 7-9||2||1
59582112|NCT05838456|75688705|FG002|COMPLETED|Step 3: Months 7-9||5||1
59582113|NCT05838456|75688706|FG003|COMPLETED|Step 3: Months 7-9||19||1
59582114|NCT05838456|75688703|FG000|NOT COMPLETED|Step 3: Months 7-9||0||0
59582115|NCT05838456|75688704|FG001|NOT COMPLETED|Step 3: Months 7-9||0||0
59582116|NCT05838456|75688705|FG002|NOT COMPLETED|Step 3: Months 7-9||0||0
59582117|NCT05838456|75688706|FG003|NOT COMPLETED|Step 3: Months 7-9||0||0
59582118|NCT05838456|75688703|FG000|STARTED|Step 4: Months 10-12||7||1
59582119|NCT05838456|75688704|FG001|STARTED|Step 4: Months 10-12||2||1
59582120|NCT05838456|75688705|FG002|STARTED|Step 4: Months 10-12||5||1
59582121|NCT05838456|75688706|FG003|STARTED|Step 4: Months 10-12||9||1
59582122|NCT05838456|75688703|FG000|COMPLETED|Step 4: Months 10-12||7||1
59582123|NCT05838456|75688704|FG001|COMPLETED|Step 4: Months 10-12||2||1
59582124|NCT05838456|75688705|FG002|COMPLETED|Step 4: Months 10-12||5||1
59582125|NCT05838456|75688706|FG003|COMPLETED|Step 4: Months 10-12||9||1
59582126|NCT05838456|75688703|FG000|NOT COMPLETED|Step 4: Months 10-12||0||0
59582127|NCT05838456|75688704|FG001|NOT COMPLETED|Step 4: Months 10-12||0||0
59582128|NCT05838456|75688705|FG002|NOT COMPLETED|Step 4: Months 10-12||0||0
59582129|NCT05838456|75688706|FG003|NOT COMPLETED|Step 4: Months 10-12||0||0
59582130|NCT05838456|75688703|FG000|STARTED|Step 4: Months 13-15||16||1
59582131|NCT05838456|75688704|FG001|STARTED|Step 4: Months 13-15||7||1
59582132|NCT05838456|75688705|FG002|STARTED|Step 4: Months 13-15||10||1
59582133|NCT05838456|75688706|FG003|STARTED|Step 4: Months 13-15||34||1
59582134|NCT05838456|75688703|FG000|COMPLETED|Step 4: Months 13-15||16||1
59582135|NCT05838456|75688704|FG001|COMPLETED|Step 4: Months 13-15||7||1
59582136|NCT05838456|75688705|FG002|COMPLETED|Step 4: Months 13-15||10||1
59582137|NCT05838456|75688706|FG003|COMPLETED|Step 4: Months 13-15||34||1
59582138|NCT05838456|75688703|FG000|NOT COMPLETED|Step 4: Months 13-15||0||0
59582139|NCT05838456|75688704|FG001|NOT COMPLETED|Step 4: Months 13-15||0||0
59582140|NCT05838456|75688705|FG002|NOT COMPLETED|Step 4: Months 13-15||0||0
59582141|NCT05838456|75688706|FG003|NOT COMPLETED|Step 4: Months 13-15||0||0
59582142|NCT05346055|75688712|FG000|STARTED|Overall Study||8||
59582143|NCT05346055|75688712|FG000|COMPLETED|Overall Study||5||
59582144|NCT05346055|75688712|FG000|NOT COMPLETED|Overall Study||3||
59996749|NCT04445051|76112590|FG002|NOT COMPLETED|Overall Study||1||
59582145|NCT05216952|75688716|FG000|STARTED|Overall Study||3||
59582146|NCT05216952|75688716|FG000|COMPLETED|Overall Study||3||
59582147|NCT05216952|75688716|FG000|NOT COMPLETED|Overall Study||0||
59582148|NCT05211739|75688722|FG000|STARTED|First Wear Period (Approx 30 Days)||36||72
59582149|NCT05211739|75688723|FG001|STARTED|First Wear Period (Approx 30 Days)||38||76
59582150|NCT05211739|75688722|FG000|Exposed to Study Lenses|First Wear Period (Approx 30 Days)||35||70
59582151|NCT05211739|75688723|FG001|Exposed to Study Lenses|First Wear Period (Approx 30 Days)||38||76
59582152|NCT05211739|75688722|FG000|COMPLETED|First Wear Period (Approx 30 Days)||35||70
59582153|NCT05211739|75688723|FG001|COMPLETED|First Wear Period (Approx 30 Days)||36||72
59582154|NCT05211739|75688722|FG000|NOT COMPLETED|First Wear Period (Approx 30 Days)||1||2
59582155|NCT05211739|75688723|FG001|NOT COMPLETED|First Wear Period (Approx 30 Days)||2||4
59582156|NCT05211739|75688722|FG000|STARTED|Second Wear Period (Approx 30 Days)||35||70
59582157|NCT05211739|75688723|FG001|STARTED|Second Wear Period (Approx 30 Days)||36||72
59582158|NCT05211739|75688722|FG000|COMPLETED|Second Wear Period (Approx 30 Days)||34||68
59582159|NCT05211739|75688723|FG001|COMPLETED|Second Wear Period (Approx 30 Days)||36||72
59582160|NCT05211739|75688722|FG000|NOT COMPLETED|Second Wear Period (Approx 30 Days)||1||2
59582161|NCT05211739|75688723|FG001|NOT COMPLETED|Second Wear Period (Approx 30 Days)||0||0
59582162|NCT05194839|75688735|FG000|STARTED|Overall Study||27||
59582163|NCT05194839|75688736|FG001|STARTED|Overall Study||26||
59582164|NCT05194839|75688737|FG002|STARTED|Overall Study||26||
59582165|NCT05194839|75688735|FG000|COMPLETED|Overall Study||12||
59582166|NCT05194839|75688736|FG001|COMPLETED|Overall Study||13||
59724236|NCT01110239|75842852|FG001|COMPLETED|Sham Preconditioning||14||
59582167|NCT05194839|75688737|FG002|COMPLETED|Overall Study||12||
59582168|NCT05194839|75688735|FG000|NOT COMPLETED|Overall Study||15||
59582169|NCT05194839|75688736|FG001|NOT COMPLETED|Overall Study||13||
59582170|NCT05194839|75688737|FG002|NOT COMPLETED|Overall Study||14||
59582171|NCT05085405|75688751|FG000|STARTED|Overall Study||13||
59582172|NCT05085405|75688752|FG001|STARTED|Overall Study||13||
59582173|NCT05085405|75688753|FG002|STARTED|Overall Study||12||
59582174|NCT05085405|75688754|FG003|STARTED|Overall Study||13||
59582175|NCT05085405|75688755|FG004|STARTED|Overall Study||6||
59582176|NCT05085405|75688756|FG005|STARTED|Overall Study||6||
59582177|NCT05085405|75688751|FG000|COMPLETED|Overall Study||13|"Patients were considered to have completed the overall study if they continued to meet all eligibility criteria at the time of study entry (e.g., not screen failures), and if they were still enrolled in the Anticoagulation Monitoring Service 5 weeks after study entry and eligible for the week 5 patient phone assessment per study protocol.~Clinicians were considered to have completed the overall study if they received the clinician-level intervention for any of their eligible patients."|
59582178|NCT05085405|75688752|FG001|COMPLETED|Overall Study||13|"Patients were considered to have completed the overall study if they continued to meet all eligibility criteria at the time of study entry (e.g., not screen failures), and if they were still enrolled in the Anticoagulation Monitoring Service 5 weeks after study entry and eligible for the week 5 patient phone assessment per study protocol.~Clinicians were considered to have completed the overall study if they received the clinician-level intervention for any of their eligible patients."|
59582179|NCT05085405|75688753|FG002|COMPLETED|Overall Study||11|"Patients were considered to have completed the overall study if they continued to meet all eligibility criteria at the time of study entry (e.g., not screen failures), and if they were still enrolled in the Anticoagulation Monitoring Service 5 weeks after study entry and eligible for the week 5 patient phone assessment per study protocol.~Clinicians were considered to have completed the overall study if they received the clinician-level intervention for any of their eligible patients."|
59582180|NCT05085405|75688754|FG003|COMPLETED|Overall Study||10|"Patients were considered to have completed the overall study if they continued to meet all eligibility criteria at the time of study entry (e.g., not screen failures), and if they were still enrolled in the Anticoagulation Monitoring Service 5 weeks after study entry and eligible for the week 5 patient phone assessment per study protocol.~Clinicians were considered to have completed the overall study if they received the clinician-level intervention for any of their eligible patients."|
59582181|NCT05085405|75688755|FG004|COMPLETED|Overall Study||6|"Patients were considered to have completed the overall study if they continued to meet all eligibility criteria at the time of study entry (e.g., not screen failures), and if they were still enrolled in the Anticoagulation Monitoring Service 5 weeks after study entry and eligible for the week 5 patient phone assessment per study protocol.~Clinicians were considered to have completed the overall study if they received the clinician-level intervention for any of their eligible patients."|
59582182|NCT05085405|75688756|FG005|COMPLETED|Overall Study||6|"Patients were considered to have completed the overall study if they continued to meet all eligibility criteria at the time of study entry (e.g., not screen failures), and if they were still enrolled in the Anticoagulation Monitoring Service 5 weeks after study entry and eligible for the week 5 patient phone assessment per study protocol.~Clinicians were considered to have completed the overall study if they received the clinician-level intervention for any of their eligible patients."|
59582183|NCT05085405|75688751|FG000|NOT COMPLETED|Overall Study||0||
59582184|NCT05085405|75688752|FG001|NOT COMPLETED|Overall Study||0||
59582185|NCT05085405|75688753|FG002|NOT COMPLETED|Overall Study||1||
59582186|NCT05085405|75688754|FG003|NOT COMPLETED|Overall Study||3||
59582187|NCT05085405|75688755|FG004|NOT COMPLETED|Overall Study||0||
59582188|NCT05085405|75688756|FG005|NOT COMPLETED|Overall Study||0||
59582189|NCT04932941|75688768|FG000|STARTED|Overall Study||87||
59582190|NCT04932941|75688769|FG001|STARTED|Overall Study||45||
59582191|NCT04932941|75688768|FG000|Intention-to-Treat Set (ITT)|Overall Study||87|The ITT Set corresponded with the randomized set and included all randomized participants, irrespective of any deviation from the protocol or premature discontinuation from the study drug or withdrawal from study.|
59582192|NCT04932941|75688769|FG001|Intention-to-Treat Set (ITT)|Overall Study||45|The ITT Set corresponded with the randomized set and included all randomized participants, irrespective of any deviation from the protocol or premature discontinuation from the study drug or withdrawal from study.|
59582193|NCT04932941|75688768|FG000|Pharmacokinetic Analysis Set|Overall Study||4|The Pharmacokinetic Analysis Set included all the participants who were administered active study drug and had at least 1 post-dose evaluable plasma concentration after Day 1 dose.|
59582194|NCT04932941|75688769|FG001|Pharmacokinetic Analysis Set|Overall Study||0|The Pharmacokinetic Analysis Set included all the participants who were administered active study drug and had at least 1 post-dose evaluable plasma concentration after Day 1 dose.|
59582195|NCT04932941|75688768|FG000|Safety Set|Overall Study||86|The Safety Set included all randomized participants who received at least 1 dose of study drug.|
59582196|NCT04932941|75688769|FG001|Safety Set|Overall Study||45|The Safety Set included all randomized participants who received at least 1 dose of study drug.|
59582197|NCT04932941|75688768|FG000|COMPLETED|Overall Study||73||
59582198|NCT04932941|75688769|FG001|COMPLETED|Overall Study||38||
59582199|NCT04932941|75688768|FG000|NOT COMPLETED|Overall Study||14||
59582200|NCT04932941|75688769|FG001|NOT COMPLETED|Overall Study||7||
59582201|NCT04881058|75688778|FG000|STARTED|Overall Study||10||
59582202|NCT04881058|75688778|FG000|COMPLETED|Overall Study||10||
59582203|NCT04881058|75688778|FG000|NOT COMPLETED|Overall Study||0||
59582204|NCT04865029|75688784|FG000|STARTED|Overall Study||5||
59851491|NCT02663349|75976096|FG000|STARTED|Overall Study||22||
59851492|NCT02663349|75976096|FG000|Attended First Treatment Session|Overall Study||18||
59851493|NCT02663349|75976096|FG000|Completed Intervention|Overall Study||16||
60121529|NCT01685801|76242413|FG001|STARTED|Open-label Period (8 Weeks)||5||
60121530|NCT01685801|76242414|FG002|STARTED|Open-label Period (8 Weeks)||7||
60121531|NCT01685801|76242415|FG003|STARTED|Open-label Period (8 Weeks)||4||
60121532|NCT01685801|76242412|FG000|COMPLETED|Open-label Period (8 Weeks)||5||
59582205|NCT04865029|75688785|FG001|STARTED|Overall Study||5||
59582206|NCT04865029|75688784|FG000|COMPLETED|Overall Study||5||
59582207|NCT04865029|75688785|FG001|COMPLETED|Overall Study||5||
59582208|NCT04865029|75688784|FG000|NOT COMPLETED|Overall Study||0||
59582209|NCT04865029|75688785|FG001|NOT COMPLETED|Overall Study||0||
59582210|NCT04805892|75688792|FG000|STARTED|Overall Study||84||
59582211|NCT04805892|75688792|FG000|COMPLETED|Overall Study||84||
59582212|NCT04805892|75688792|FG000|NOT COMPLETED|Overall Study||0||
59582213|NCT04804579|75688798|FG000|STARTED|Overall Study||12||
59582214|NCT04804579|75688799|FG001|STARTED|Overall Study||11||
59582215|NCT04804579|75688798|FG000|COMPLETED|Overall Study||11||
59582216|NCT04804579|75688799|FG001|COMPLETED|Overall Study||11||
59582217|NCT04804579|75688798|FG000|NOT COMPLETED|Overall Study||1||
59582218|NCT04804579|75688799|FG001|NOT COMPLETED|Overall Study||0||
59582219|NCT04796779|75688807|FG000|STARTED|Overall Study||68||
59582220|NCT04796779|75688808|FG001|STARTED|Overall Study||34||
59582221|NCT04796779|75688807|FG000|COMPLETED|Overall Study||67||
59582222|NCT04796779|75688808|FG001|COMPLETED|Overall Study||34||
59582223|NCT04796779|75688807|FG000|NOT COMPLETED|Overall Study||1||
59582224|NCT04796779|75688808|FG001|NOT COMPLETED|Overall Study||0||
59582225|NCT04662086|75688817|FG000|STARTED|Overall Study||60||
59582226|NCT04662086|75688818|FG001|STARTED|Overall Study||60||
59582227|NCT04662086|75688819|FG002|STARTED|Overall Study||2||
59582228|NCT04662086|75688817|FG000|Received Allocated Treatment|Overall Study||59||
59582229|NCT04662086|75688818|FG001|Received Allocated Treatment|Overall Study||59||
59582230|NCT04662086|75688819|FG002|Received Allocated Treatment|Overall Study||2||
59582231|NCT04662086|75688817|FG000|COMPLETED|Overall Study||55||
59582232|NCT04662086|75688818|FG001|COMPLETED|Overall Study||56||
59582233|NCT04662086|75688819|FG002|COMPLETED|Overall Study||1||
59582234|NCT04662086|75688817|FG000|NOT COMPLETED|Overall Study||5||
59582235|NCT04662086|75688818|FG001|NOT COMPLETED|Overall Study||4||
59582236|NCT04662086|75688819|FG002|NOT COMPLETED|Overall Study||1||
59582237|NCT04662073|75688829|FG000|STARTED|Overall Study||2||
59582238|NCT04662073|75688830|FG001|STARTED|Overall Study||0||
59582239|NCT04662073|75688829|FG000|COMPLETED|Overall Study||1||
59582240|NCT04662073|75688830|FG001|COMPLETED|Overall Study||0||
59582241|NCT04662073|75688829|FG000|NOT COMPLETED|Overall Study||1||
59582242|NCT04662073|75688830|FG001|NOT COMPLETED|Overall Study||0||
59582243|NCT04656418|75688838|FG000|STARTED|Overall Study||39||
59582244|NCT04656418|75688839|FG001|STARTED|Overall Study||25||
59582245|NCT04656418|75688838|FG000|Intention-to-treat (ITT) Analysis Set|Overall Study||39|ITT analysis set included all the randomized participants who provided written informed consent and underwent study screening procedures.|
59582246|NCT04656418|75688839|FG001|Intention-to-treat (ITT) Analysis Set|Overall Study||25|ITT analysis set included all the randomized participants who provided written informed consent and underwent study screening procedures.|
59582247|NCT04656418|75688838|FG000|Safety Analysis Set|Overall Study||39|Safety analysis set included all the randomized participants who provided written informed consent, underwent study screening procedures and received at least 1 dose of the investigational product.|
59582248|NCT04656418|75688839|FG001|Safety Analysis Set|Overall Study||25|Safety analysis set included all the randomized participants who provided written informed consent, underwent study screening procedures and received at least 1 dose of the investigational product.|
59582249|NCT04656418|75688838|FG000|COMPLETED|Overall Study||38||
59582250|NCT04656418|75688839|FG001|COMPLETED|Overall Study||22||
59582251|NCT04656418|75688838|FG000|NOT COMPLETED|Overall Study||1||
59582252|NCT04656418|75688839|FG001|NOT COMPLETED|Overall Study||3||
59582253|NCT04622306|75688846|FG000|STARTED|Couples Used First Assigned Condom Set||48||
59582254|NCT04622306|75688847|FG001|STARTED|Couples Used First Assigned Condom Set||50||
59582255|NCT04622306|75688848|FG002|STARTED|Couples Used First Assigned Condom Set||48||
59582256|NCT04622306|75688849|FG003|STARTED|Couples Used First Assigned Condom Set||51||
59582257|NCT04622306|75688850|FG004|STARTED|Couples Used First Assigned Condom Set||53||
59582258|NCT04622306|75688851|FG005|STARTED|Couples Used First Assigned Condom Set||50||
59582259|NCT04622306|75688846|FG000|COMPLETED|Couples Used First Assigned Condom Set|Condoms remaining at the end of the period were not used or were used in violation of the protocol.|46||
59582260|NCT04622306|75688847|FG001|COMPLETED|Couples Used First Assigned Condom Set||48||
59582261|NCT04622306|75688848|FG002|COMPLETED|Couples Used First Assigned Condom Set||48||
59582262|NCT04622306|75688849|FG003|COMPLETED|Couples Used First Assigned Condom Set||51||
59582263|NCT04622306|75688850|FG004|COMPLETED|Couples Used First Assigned Condom Set||51||
59582264|NCT04622306|75688851|FG005|COMPLETED|Couples Used First Assigned Condom Set||45||
59582265|NCT04622306|75688846|FG000|NOT COMPLETED|Couples Used First Assigned Condom Set||2||
59582266|NCT04622306|75688847|FG001|NOT COMPLETED|Couples Used First Assigned Condom Set||2||
59582267|NCT04622306|75688848|FG002|NOT COMPLETED|Couples Used First Assigned Condom Set||0||
59582268|NCT04622306|75688849|FG003|NOT COMPLETED|Couples Used First Assigned Condom Set||0||
59582269|NCT04622306|75688850|FG004|NOT COMPLETED|Couples Used First Assigned Condom Set||2||
59582270|NCT04622306|75688851|FG005|NOT COMPLETED|Couples Used First Assigned Condom Set||5||
59582271|NCT04622306|75688846|FG000|STARTED|Couples Used Second Assigned Condom Set||46|Couples received their second randomly assigned set of 5 condoms along with 5 blank report forms.|
59582272|NCT04622306|75688847|FG001|STARTED|Couples Used Second Assigned Condom Set||48|Couples received their second randomly assigned set of 5 condoms along with 5 blank report forms.|
59724237|NCT01110239|75842853|FG002|COMPLETED|Sham Preconditioning||6||
59582273|NCT04622306|75688848|FG002|STARTED|Couples Used Second Assigned Condom Set||48|Couples received their second randomly assigned set of 5 condoms along with 5 blank report forms.|
59582274|NCT04622306|75688849|FG003|STARTED|Couples Used Second Assigned Condom Set||51|Couples received their second randomly assigned set of 5 condoms along with 5 blank report forms.|
59582275|NCT04622306|75688850|FG004|STARTED|Couples Used Second Assigned Condom Set||51|Couples received their second randomly assigned set of 5 condoms along with 5 blank report forms.|
59582276|NCT04622306|75688851|FG005|STARTED|Couples Used Second Assigned Condom Set||45|Couples received their second randomly assigned set of 5 condoms along with 5 blank report forms.|
59582277|NCT04622306|75688846|FG000|COMPLETED|Couples Used Second Assigned Condom Set|Condoms remaining at the end of the period were not used or were used in violation of the protocol.|46||
59582278|NCT04622306|75688847|FG001|COMPLETED|Couples Used Second Assigned Condom Set||48||
59582279|NCT04622306|75688848|FG002|COMPLETED|Couples Used Second Assigned Condom Set||48||
59582280|NCT04622306|75688849|FG003|COMPLETED|Couples Used Second Assigned Condom Set||51||
59582281|NCT04622306|75688850|FG004|COMPLETED|Couples Used Second Assigned Condom Set||51||
59582282|NCT04622306|75688851|FG005|COMPLETED|Couples Used Second Assigned Condom Set||45||
59582283|NCT04622306|75688846|FG000|NOT COMPLETED|Couples Used Second Assigned Condom Set||0||
59582284|NCT04622306|75688847|FG001|NOT COMPLETED|Couples Used Second Assigned Condom Set||0||
59582285|NCT04622306|75688848|FG002|NOT COMPLETED|Couples Used Second Assigned Condom Set||0||
59582286|NCT04622306|75688849|FG003|NOT COMPLETED|Couples Used Second Assigned Condom Set||0||
59582287|NCT04622306|75688850|FG004|NOT COMPLETED|Couples Used Second Assigned Condom Set||0||
59582288|NCT04622306|75688851|FG005|NOT COMPLETED|Couples Used Second Assigned Condom Set||0||
59582289|NCT04622306|75688846|FG000|STARTED|Couples Used Third Assigned Condom Set||46|Couples received their third set of randomly assigned set of 5 condoms and blank report forms.|
59582290|NCT04622306|75688847|FG001|STARTED|Couples Used Third Assigned Condom Set||48|Couples received their third set of randomly assigned set of 5 condoms and blank report forms.|
59582291|NCT04622306|75688848|FG002|STARTED|Couples Used Third Assigned Condom Set||48|Couples received their third set of randomly assigned set of 5 condoms and blank report forms.|
59582292|NCT04622306|75688849|FG003|STARTED|Couples Used Third Assigned Condom Set||51|Couples received their third set of randomly assigned set of 5 condoms and blank report forms.|
59582293|NCT04622306|75688850|FG004|STARTED|Couples Used Third Assigned Condom Set||51|Couples received their third set of randomly assigned set of 5 condoms and blank report forms.|
59582294|NCT04622306|75688851|FG005|STARTED|Couples Used Third Assigned Condom Set||45|Couples received their third set of randomly assigned set of 5 condoms and blank report forms.|
59582295|NCT04622306|75688846|FG000|COMPLETED|Couples Used Third Assigned Condom Set|Condoms remaining at the end of the period were not used or were used in violation of the protocol.|46||
59582296|NCT04622306|75688847|FG001|COMPLETED|Couples Used Third Assigned Condom Set||48||
59582297|NCT04622306|75688848|FG002|COMPLETED|Couples Used Third Assigned Condom Set||46||
59582298|NCT04622306|75688849|FG003|COMPLETED|Couples Used Third Assigned Condom Set||48||
59582299|NCT04622306|75688850|FG004|COMPLETED|Couples Used Third Assigned Condom Set||51||
59582300|NCT04622306|75688851|FG005|COMPLETED|Couples Used Third Assigned Condom Set||45||
59582301|NCT04622306|75688846|FG000|NOT COMPLETED|Couples Used Third Assigned Condom Set||0||
59582302|NCT04622306|75688847|FG001|NOT COMPLETED|Couples Used Third Assigned Condom Set||0||
59582303|NCT04622306|75688848|FG002|NOT COMPLETED|Couples Used Third Assigned Condom Set||2||
59582304|NCT04622306|75688849|FG003|NOT COMPLETED|Couples Used Third Assigned Condom Set||3||
59582305|NCT04622306|75688850|FG004|NOT COMPLETED|Couples Used Third Assigned Condom Set||0||
59582306|NCT04622306|75688851|FG005|NOT COMPLETED|Couples Used Third Assigned Condom Set||0||
59582307|NCT04601103|75688863|FG000|STARTED|Overall Study||18||
59582308|NCT04601103|75688864|FG001|STARTED|Overall Study||18||
59582309|NCT04601103|75688865|FG002|STARTED|Overall Study||17||
59582310|NCT04601103|75688863|FG000|COMPLETED|Overall Study||0||
59582311|NCT04601103|75688864|FG001|COMPLETED|Overall Study||0||
59582312|NCT04601103|75688865|FG002|COMPLETED|Overall Study||0||
59582313|NCT04601103|75688863|FG000|NOT COMPLETED|Overall Study||18||
59582314|NCT04601103|75688864|FG001|NOT COMPLETED|Overall Study||18||
59582315|NCT04601103|75688865|FG002|NOT COMPLETED|Overall Study||17||
59582316|NCT04575597|75688879|FG000|STARTED|Overall Study||75||
59582317|NCT04575597|75688880|FG001|STARTED|Overall Study||77||
59582318|NCT04575597|75688881|FG002|STARTED|Overall Study||76||
59582319|NCT04575597|75688882|FG003|STARTED|Overall Study||74||
59582320|NCT04575597|75688883|FG004|STARTED|Overall Study||716||
59582321|NCT04575597|75688884|FG005|STARTED|Overall Study||717||
59582322|NCT04575597|75688879|FG000|Treated|Overall Study||74||
59582323|NCT04575597|75688880|FG001|Treated|Overall Study||77||
59582324|NCT04575597|75688881|FG002|Treated|Overall Study||74||
59582325|NCT04575597|75688882|FG003|Treated|Overall Study||74||
59582326|NCT04575597|75688883|FG004|Treated|Overall Study||710||
59582327|NCT04575597|75688884|FG005|Treated|Overall Study||701||
59582328|NCT04575597|75688879|FG000|COMPLETED|Overall Study||71||
59582329|NCT04575597|75688880|FG001|COMPLETED|Overall Study||74||
59582330|NCT04575597|75688881|FG002|COMPLETED|Overall Study||71||
59582331|NCT04575597|75688882|FG003|COMPLETED|Overall Study||69||
59582332|NCT04575597|75688883|FG004|COMPLETED|Overall Study||675||
59582333|NCT04575597|75688884|FG005|COMPLETED|Overall Study||663||
59582334|NCT04575597|75688879|FG000|NOT COMPLETED|Overall Study||4||
59582335|NCT04575597|75688880|FG001|NOT COMPLETED|Overall Study||3||
59724238|NCT01110239|75842854|FG003|COMPLETED|Sham Preconditioning||6||
59724239|NCT01110239|75842851|FG000|NOT COMPLETED|Sham Preconditioning||0||
59582336|NCT04575597|75688881|FG002|NOT COMPLETED|Overall Study||5||
59582337|NCT04575597|75688882|FG003|NOT COMPLETED|Overall Study||5||
59582338|NCT04575597|75688883|FG004|NOT COMPLETED|Overall Study||41||
59582339|NCT04575597|75688884|FG005|NOT COMPLETED|Overall Study||54||
59582340|NCT04562792|75688900|FG000|STARTED|Overall Study||1||
59582341|NCT04562792|75688900|FG000|COMPLETED|Overall Study||1||
59582342|NCT04562792|75688900|FG000|NOT COMPLETED|Overall Study||0||
59582343|NCT04546724|75688906|FG000|STARTED|Overall Study||3082|In total, 4,128 subjects were randomized, of whom 3,093 subjects were randomized in the VLA1553 arm and 1,035 subjects in the placebo arm. Ten subjects in VLA1553 arm and 1 in placebo arm did not receive their vaccination. All vaccinated subjects were included in the Safety population, except for 1 subject that was vaccinated twice.|
59582344|NCT04546724|75688907|FG001|STARTED|Overall Study||1033|In total, 4,128 subjects were randomized, of whom 3,093 subjects were randomized in the VLA1553 arm and 1,035 subjects in the placebo arm. Ten subjects in VLA1553 arm and 1 in placebo arm did not receive their vaccination. All vaccinated subjects were included in the Safety population, except for 1 subject that was vaccinated twice.|
59582345|NCT04546724|75688906|FG000|COMPLETED|Overall Study||2724||
59582346|NCT04546724|75688907|FG001|COMPLETED|Overall Study||920||
59582347|NCT04546724|75688906|FG000|NOT COMPLETED|Overall Study||358||
59582348|NCT04546724|75688907|FG001|NOT COMPLETED|Overall Study||113||
59582349|NCT04485546|75688917|FG000|STARTED|Overall Study||37||
59582350|NCT04485546|75688917|FG000|COMPLETED|Overall Study||29||
59582351|NCT04485546|75688917|FG000|NOT COMPLETED|Overall Study||8||
59582352|NCT04391842|75688923|FG000|STARTED|Overall Study||34||
59582353|NCT04391842|75688923|FG000|COMPLETED|Overall Study||32||
59582354|NCT04391842|75688923|FG000|NOT COMPLETED|Overall Study||2||
59582355|NCT04337203|75688927|FG000|STARTED|Overall Study||40||
59582356|NCT04337203|75688927|FG000|COMPLETED|Overall Study||40||
59582357|NCT04337203|75688927|FG000|NOT COMPLETED|Overall Study||0||
59582358|NCT04327024|75688946|FG000|STARTED|Overall Study||53||
59582359|NCT04327024|75688947|FG001|STARTED|Overall Study||53||
59582360|NCT04327024|75688948|FG002|STARTED|Overall Study||53||
59582361|NCT04327024|75688946|FG000|COMPLETED|Overall Study||51||
59582362|NCT04327024|75688947|FG001|COMPLETED|Overall Study||49||
59582363|NCT04327024|75688948|FG002|COMPLETED|Overall Study||50||
59582364|NCT04327024|75688946|FG000|NOT COMPLETED|Overall Study||2||
59582365|NCT04327024|75688947|FG001|NOT COMPLETED|Overall Study||4||
59582366|NCT04327024|75688948|FG002|NOT COMPLETED|Overall Study||3||
59582367|NCT04322149|75688961|FG000|STARTED|Overall Study||9||
59582368|NCT04322149|75688962|FG001|STARTED|Overall Study||9||
59582369|NCT04322149|75688963|FG002|STARTED|Overall Study||18||
59582370|NCT04322149|75688964|FG003|STARTED|Overall Study||18||
59582371|NCT04322149|75688961|FG000|COMPLETED|Overall Study||8||
59582372|NCT04322149|75688962|FG001|COMPLETED|Overall Study||7||
59582373|NCT04322149|75688963|FG002|COMPLETED|Overall Study||18||
59582374|NCT04322149|75688964|FG003|COMPLETED|Overall Study||16||
59582375|NCT04322149|75688961|FG000|NOT COMPLETED|Overall Study||1||
59582376|NCT04322149|75688962|FG001|NOT COMPLETED|Overall Study||2||
59582377|NCT04322149|75688963|FG002|NOT COMPLETED|Overall Study||0||
59582378|NCT04322149|75688964|FG003|NOT COMPLETED|Overall Study||2||
59582379|NCT04315272|75688976|FG000|STARTED|Overall Study||221||
59582380|NCT04315272|75688977|FG001|STARTED|Overall Study||228||
59582381|NCT04315272|75688976|FG000|COMPLETED|Overall Study||220||
59582382|NCT04315272|75688977|FG001|COMPLETED|Overall Study||227||
59582383|NCT04315272|75688976|FG000|NOT COMPLETED|Overall Study||1||
59582384|NCT04315272|75688977|FG001|NOT COMPLETED|Overall Study||1||
59582385|NCT04294459|75688985|FG000|STARTED|Overall Study||12||
59582386|NCT04294459|75688986|FG001|STARTED|Overall Study||11||
59582387|NCT04294459|75688985|FG000|COMPLETED|Overall Study||12||
59582388|NCT04294459|75688986|FG001|COMPLETED|Overall Study||10||
59582389|NCT04294459|75688985|FG000|NOT COMPLETED|Overall Study||0||
59582390|NCT04294459|75688986|FG001|NOT COMPLETED|Overall Study||1||
59582391|NCT04226742|75688995|FG000|STARTED|Overall Study||56||
59582392|NCT04226742|75688996|FG001|STARTED|Overall Study||51||
59582393|NCT04226742|75688995|FG000|COMPLETED|Overall Study||35||
59582394|NCT04226742|75688996|FG001|COMPLETED|Overall Study||35||
59582395|NCT04226742|75688995|FG000|NOT COMPLETED|Overall Study||21||
59582396|NCT04226742|75688996|FG001|NOT COMPLETED|Overall Study||16||
59582397|NCT04194528|75689002|FG000|STARTED|Overall Study||2||
59851494|NCT02663349|75976096|FG000|Completed Follow-up Assessment 3 Months Post-intervention|Overall Study||16||
59851495|NCT02663349|75976096|FG000|COMPLETED|Overall Study||16||
59582398|NCT04194528|75689002|FG000|COMPLETED|Overall Study||1||
59582399|NCT04194528|75689002|FG000|NOT COMPLETED|Overall Study||1||
59582400|NCT04181632|75689010|FG000|STARTED|Overall Study||12||
59582401|NCT04181632|75689011|FG001|STARTED|Overall Study||9||
59582402|NCT04181632|75689012|FG002|STARTED|Overall Study||8||
59582403|NCT04181632|75689013|FG003|STARTED|Overall Study||11||
59582404|NCT04181632|75689010|FG000|COMPLETED|Overall Study||12||
59851496|NCT02663349|75976096|FG000|NOT COMPLETED|Overall Study||6||
59851497|NCT02558491|75976100|FG000|STARTED|First Invention||19||
60121533|NCT01685801|76242413|FG001|COMPLETED|Open-label Period (8 Weeks)||5||
59582405|NCT04181632|75689011|FG001|COMPLETED|Overall Study||9||
59582406|NCT04181632|75689012|FG002|COMPLETED|Overall Study||8||
59582407|NCT04181632|75689013|FG003|COMPLETED|Overall Study||11||
59582408|NCT04181632|75689010|FG000|NOT COMPLETED|Overall Study||0||
59582409|NCT04181632|75689011|FG001|NOT COMPLETED|Overall Study||0||
59582410|NCT04181632|75689012|FG002|NOT COMPLETED|Overall Study||0||
59582411|NCT04181632|75689013|FG003|NOT COMPLETED|Overall Study||0||
59582412|NCT04179396|75689025|FG000|STARTED|Overall Study||8||
59582413|NCT04179396|75689026|FG001|STARTED|Overall Study||0||
59582414|NCT04179396|75689025|FG000|COMPLETED|Overall Study||8||
59582415|NCT04179396|75689026|FG001|COMPLETED|Overall Study||0||
59582416|NCT04179396|75689025|FG000|NOT COMPLETED|Overall Study||0||
59582417|NCT04179396|75689026|FG001|NOT COMPLETED|Overall Study||0||
59582418|NCT04146012|75689034|FG000|STARTED|Overall Study||33||
59582419|NCT04146012|75689035|FG001|STARTED|Overall Study||17||
59582420|NCT04146012|75689034|FG000|COMPLETED|Overall Study||3||
59582421|NCT04146012|75689035|FG001|COMPLETED|Overall Study||2||
59582422|NCT04146012|75689034|FG000|NOT COMPLETED|Overall Study||30||
59582423|NCT04146012|75689035|FG001|NOT COMPLETED|Overall Study||15||
59582424|NCT04085458|75689041|FG000|STARTED|Overall Study||32||
59582425|NCT04085458|75689041|FG000|COMPLETED|Overall Study||27||
59582426|NCT04085458|75689041|FG000|NOT COMPLETED|Overall Study||5||
59582427|NCT04033159|75689047|FG000|STARTED|Single Ascending Dose (Day 1)||6||
59582428|NCT04033159|75689048|FG001|STARTED|Single Ascending Dose (Day 1)||8||
59582429|NCT04033159|75689049|FG002|STARTED|Single Ascending Dose (Day 1)||0||
59582430|NCT04033159|75689047|FG000|COMPLETED|Single Ascending Dose (Day 1)||6||
59582431|NCT04033159|75689048|FG001|COMPLETED|Single Ascending Dose (Day 1)||8||
59582432|NCT04033159|75689049|FG002|COMPLETED|Single Ascending Dose (Day 1)||0||
59582433|NCT04033159|75689047|FG000|NOT COMPLETED|Single Ascending Dose (Day 1)||0||
59582434|NCT04033159|75689048|FG001|NOT COMPLETED|Single Ascending Dose (Day 1)||0||
59582435|NCT04033159|75689049|FG002|NOT COMPLETED|Single Ascending Dose (Day 1)||0||
59582436|NCT04033159|75689047|FG000|STARTED|Washout Period||6||
59582437|NCT04033159|75689048|FG001|STARTED|Washout Period||8||
59582438|NCT04033159|75689049|FG002|STARTED|Washout Period||0||
59582439|NCT04033159|75689047|FG000|COMPLETED|Washout Period||6||
59582440|NCT04033159|75689048|FG001|COMPLETED|Washout Period||0||
59582441|NCT04033159|75689049|FG002|COMPLETED|Washout Period||0||
59582442|NCT04033159|75689047|FG000|NOT COMPLETED|Washout Period||0||
59582443|NCT04033159|75689048|FG001|NOT COMPLETED|Washout Period||8||
59582444|NCT04033159|75689049|FG002|NOT COMPLETED|Washout Period||0||
59582445|NCT04033159|75689047|FG000|STARTED|Multiple Ascending Dose Period||6||
59582446|NCT04033159|75689048|FG001|STARTED|Multiple Ascending Dose Period||0||
59582447|NCT04033159|75689049|FG002|STARTED|Multiple Ascending Dose Period||0||
59582448|NCT04033159|75689047|FG000|COMPLETED|Multiple Ascending Dose Period||0||
59582449|NCT04033159|75689048|FG001|COMPLETED|Multiple Ascending Dose Period||0||
59582450|NCT04033159|75689049|FG002|COMPLETED|Multiple Ascending Dose Period||0||
59582451|NCT04033159|75689047|FG000|NOT COMPLETED|Multiple Ascending Dose Period||6||
59582452|NCT04033159|75689048|FG001|NOT COMPLETED|Multiple Ascending Dose Period||0||
59582453|NCT04033159|75689049|FG002|NOT COMPLETED|Multiple Ascending Dose Period||0||
59582454|NCT03969888|75689065|FG000|STARTED|Overall Study||6||
59582455|NCT03969888|75689066|FG001|STARTED|Overall Study||7||
59582456|NCT03969888|75689067|FG002|STARTED|Overall Study||5||
59582457|NCT03969888|75689068|FG003|STARTED|Overall Study||12||
59582458|NCT03969888|75689069|FG004|STARTED|Overall Study||11||
59582459|NCT03969888|75689070|FG005|STARTED|Overall Study||12||
59582460|NCT03969888|75689071|FG006|STARTED|Overall Study||14||
59582461|NCT03969888|75689072|FG007|STARTED|Overall Study||11||
59582462|NCT03969888|75689065|FG000|COMPLETED|Overall Study||6||
59582463|NCT03969888|75689066|FG001|COMPLETED|Overall Study||7||
59582464|NCT03969888|75689067|FG002|COMPLETED|Overall Study||4||
59582465|NCT03969888|75689068|FG003|COMPLETED|Overall Study||12||
59582466|NCT03969888|75689069|FG004|COMPLETED|Overall Study||11||
59582467|NCT03969888|75689070|FG005|COMPLETED|Overall Study||12||
59582468|NCT03969888|75689071|FG006|COMPLETED|Overall Study||13||
59582469|NCT03969888|75689072|FG007|COMPLETED|Overall Study||10||
59582470|NCT03969888|75689065|FG000|NOT COMPLETED|Overall Study||0||
59582471|NCT03969888|75689066|FG001|NOT COMPLETED|Overall Study||0||
59582472|NCT03969888|75689067|FG002|NOT COMPLETED|Overall Study||1||
59582473|NCT03969888|75689068|FG003|NOT COMPLETED|Overall Study||0||
59582474|NCT03969888|75689069|FG004|NOT COMPLETED|Overall Study||0||
59582475|NCT03969888|75689070|FG005|NOT COMPLETED|Overall Study||0||
59582476|NCT03969888|75689071|FG006|NOT COMPLETED|Overall Study||1||
59582477|NCT03969888|75689072|FG007|NOT COMPLETED|Overall Study||1||
59582478|NCT03952559|75689096|FG000|STARTED|High Dose Open Label - PK Lead-in||33||
59582479|NCT03952559|75689097|FG001|STARTED|High Dose Open Label - PK Lead-in||0||
59582480|NCT03952559|75689098|FG002|STARTED|High Dose Open Label - PK Lead-in||0||
59582481|NCT03952559|75689099|FG003|STARTED|High Dose Open Label - PK Lead-in||0||
59582482|NCT03952559|75689100|FG004|STARTED|High Dose Open Label - PK Lead-in||0||
59582483|NCT03952559|75689096|FG000|Received at Least One Dose of Study Drug|High Dose Open Label - PK Lead-in||33||
59582484|NCT03952559|75689097|FG001|Received at Least One Dose of Study Drug|High Dose Open Label - PK Lead-in||0||
59582485|NCT03952559|75689098|FG002|Received at Least One Dose of Study Drug|High Dose Open Label - PK Lead-in||0||
59582486|NCT03952559|75689099|FG003|Received at Least One Dose of Study Drug|High Dose Open Label - PK Lead-in||0||
59582487|NCT03952559|75689100|FG004|Received at Least One Dose of Study Drug|High Dose Open Label - PK Lead-in||0||
59582488|NCT03952559|75689096|FG000|COMPLETED|High Dose Open Label - PK Lead-in||33||
59582489|NCT03952559|75689097|FG001|COMPLETED|High Dose Open Label - PK Lead-in||0||
59582490|NCT03952559|75689098|FG002|COMPLETED|High Dose Open Label - PK Lead-in||0||
59582491|NCT03952559|75689099|FG003|COMPLETED|High Dose Open Label - PK Lead-in||0||
59582492|NCT03952559|75689100|FG004|COMPLETED|High Dose Open Label - PK Lead-in||0||
59582493|NCT03952559|75689096|FG000|NOT COMPLETED|High Dose Open Label - PK Lead-in||0||
59582494|NCT03952559|75689097|FG001|NOT COMPLETED|High Dose Open Label - PK Lead-in||0||
59582495|NCT03952559|75689098|FG002|NOT COMPLETED|High Dose Open Label - PK Lead-in||0||
59582496|NCT03952559|75689099|FG003|NOT COMPLETED|High Dose Open Label - PK Lead-in||0||
59582497|NCT03952559|75689100|FG004|NOT COMPLETED|High Dose Open Label - PK Lead-in||0||
59582498|NCT03952559|75689096|FG000|STARTED|Double Blind Treatment Period|Participants who completed the Open-label PK Lead-in (Week 2) continued into the long-term extension study.|0||
59582499|NCT03952559|75689097|FG001|STARTED|Double Blind Treatment Period|Participants were assigned to this arm during double blind treatment period.|122||
59582500|NCT03952559|75689098|FG002|STARTED|Double Blind Treatment Period|Participants were assigned to this arm during double blind treatment period.|121||
59582501|NCT03952559|75689099|FG003|STARTED|Double Blind Treatment Period|Participants were assigned to this arm during double blind treatment period.|120||
59582502|NCT03952559|75689100|FG004|STARTED|Double Blind Treatment Period|Participants were assigned to this arm during double blind treatment period.|120||
59582503|NCT03952559|75689096|FG000|Received at Least One Dose of Study Drug|Double Blind Treatment Period||0||
59582504|NCT03952559|75689097|FG001|Received at Least One Dose of Study Drug|Double Blind Treatment Period||122||
59582505|NCT03952559|75689098|FG002|Received at Least One Dose of Study Drug|Double Blind Treatment Period||120||
59582506|NCT03952559|75689099|FG003|Received at Least One Dose of Study Drug|Double Blind Treatment Period||120||
59582507|NCT03952559|75689100|FG004|Received at Least One Dose of Study Drug|Double Blind Treatment Period||120||
59582508|NCT03952559|75689096|FG000|COMPLETED|Double Blind Treatment Period||0||
59582509|NCT03952559|75689097|FG001|COMPLETED|Double Blind Treatment Period||115||
59582510|NCT03952559|75689098|FG002|COMPLETED|Double Blind Treatment Period||116||
59582511|NCT03952559|75689099|FG003|COMPLETED|Double Blind Treatment Period||117||
59582512|NCT03952559|75689100|FG004|COMPLETED|Double Blind Treatment Period||119||
59582513|NCT03952559|75689096|FG000|NOT COMPLETED|Double Blind Treatment Period||0||
59582514|NCT03952559|75689097|FG001|NOT COMPLETED|Double Blind Treatment Period||7||
59582515|NCT03952559|75689098|FG002|NOT COMPLETED|Double Blind Treatment Period||5||
59582516|NCT03952559|75689099|FG003|NOT COMPLETED|Double Blind Treatment Period||3||
59582517|NCT03952559|75689100|FG004|NOT COMPLETED|Double Blind Treatment Period||1||
59582518|NCT03945175|75689136|FG000|STARTED|Overall Study||52|Participants Assessed for Eligibility|
59582519|NCT03945175|75689136|FG000|Participants Who Met Inclusion Criteria|Overall Study||21||
59582520|NCT03945175|75689136|FG000|Participants Allocated to Single-Blind Placebo Treatment|Overall Study||21||
59582521|NCT03945175|75689136|FG000|Participants Who Completed Single-Blind Placebo Treatment|Overall Study||20||
59582522|NCT03945175|75689136|FG000|Participants Allocated to Mydayis Treatment|Overall Study||18||
59582523|NCT03945175|75689136|FG000|Participants Included in Analysis of Outcome Measures|Overall Study||18||
59582524|NCT03945175|75689136|FG000|COMPLETED|Overall Study||17||
59582525|NCT03945175|75689136|FG000|NOT COMPLETED|Overall Study||35||
59582526|NCT03942406|75689147|FG000|STARTED|Overall Study||92||
59582527|NCT03942406|75689148|FG001|STARTED|Overall Study||92||
59582528|NCT03942406|75689149|FG002|STARTED|Overall Study||46||
59582529|NCT03942406|75689150|FG003|STARTED|Overall Study||50||
59582530|NCT03942406|75689151|FG004|STARTED|Overall Study||8||
59582531|NCT03942406|75689152|FG005|STARTED|Overall Study||8||
59582532|NCT03942406|75689153|FG006|STARTED|Overall Study||4||
59582533|NCT03942406|75689147|FG000|COMPLETED|Overall Study||81||
59582534|NCT03942406|75689148|FG001|COMPLETED|Overall Study||85||
59582535|NCT03942406|75689149|FG002|COMPLETED|Overall Study||41||
59582536|NCT03942406|75689150|FG003|COMPLETED|Overall Study||40||
59582537|NCT03942406|75689151|FG004|COMPLETED|Overall Study||6||
59582538|NCT03942406|75689152|FG005|COMPLETED|Overall Study||7||
59582539|NCT03942406|75689153|FG006|COMPLETED|Overall Study||4||
59582540|NCT03942406|75689147|FG000|NOT COMPLETED|Overall Study||11||
59582541|NCT03942406|75689148|FG001|NOT COMPLETED|Overall Study||7||
59582542|NCT03942406|75689149|FG002|NOT COMPLETED|Overall Study||5||
59582543|NCT03942406|75689150|FG003|NOT COMPLETED|Overall Study||10||
59582544|NCT03942406|75689151|FG004|NOT COMPLETED|Overall Study||2||
59582545|NCT03942406|75689152|FG005|NOT COMPLETED|Overall Study||1||
59582546|NCT03942406|75689153|FG006|NOT COMPLETED|Overall Study||0||
59582547|NCT03927612|75689171|FG000|STARTED|Overall Study||24||
59582548|NCT03927612|75689172|FG001|STARTED|Overall Study||24||
59582549|NCT03927612|75689171|FG000|COMPLETED|Overall Study||24||
59582550|NCT03927612|75689172|FG001|COMPLETED|Overall Study||24||
59582551|NCT03927612|75689171|FG000|NOT COMPLETED|Overall Study||0||
59582552|NCT03927612|75689172|FG001|NOT COMPLETED|Overall Study||0||
59582553|NCT03915587|75689180|FG000|STARTED|Overall Study||7||
59582554|NCT03915587|75689181|FG001|STARTED|Overall Study||16||
59582555|NCT03915587|75689180|FG000|COMPLETED|Overall Study||7||
59582556|NCT03915587|75689181|FG001|COMPLETED|Overall Study||16||
59582557|NCT03915587|75689180|FG000|NOT COMPLETED|Overall Study||0||
59582558|NCT03915587|75689181|FG001|NOT COMPLETED|Overall Study||0||
59582559|NCT03909100|75689187|FG000|STARTED|Overall Study||120||
59582560|NCT03909100|75689187|FG000|Safety Population|Overall Study||112|All participants who had at least 1 of the treatment procedures conducted.|
59582561|NCT03909100|75689187|FG000|Received Treatment in Session 2|Overall Study||107||
59582562|NCT03909100|75689187|FG000|Evaluable Population|Overall Study||106|Evaluable Population included all participants who signed the informed consent form (ICF), had at least 1 of the procedures conducted, and also reported the Cryolipolysis Satisfaction Questionnaire (CSQ) Item 1 at 12 weeks after the final treatment (measured at Week 12 for participants who received 1 treatment session and at Week 20 for participants who received 2 treatment sessions).|
59582563|NCT03909100|75689187|FG000|COMPLETED|Overall Study||105||
59582564|NCT03909100|75689187|FG000|NOT COMPLETED|Overall Study||15||
59582565|NCT03901482|75689197|FG000|STARTED|Overall Study||399||
59582566|NCT03901482|75689198|FG001|STARTED|Overall Study||400||
59582567|NCT03901482|75689199|FG002|STARTED|Overall Study||402||
59582568|NCT03901482|75689197|FG000|COMPLETED|Overall Study||363||
59582569|NCT03901482|75689198|FG001|COMPLETED|Overall Study||368||
59582570|NCT03901482|75689199|FG002|COMPLETED|Overall Study||364||
59582571|NCT03901482|75689197|FG000|NOT COMPLETED|Overall Study||36||
59582572|NCT03901482|75689198|FG001|NOT COMPLETED|Overall Study||32||
59582573|NCT03901482|75689199|FG002|NOT COMPLETED|Overall Study||38||
59582574|NCT03896295|75689209|FG000|STARTED|Overall Study||7||
59582575|NCT03896295|75689210|FG001|STARTED|Overall Study||30||
59582576|NCT03896295|75689209|FG000|COMPLETED|Overall Study||0||
59582577|NCT03896295|75689210|FG001|COMPLETED|Overall Study||0||
59582578|NCT03896295|75689209|FG000|NOT COMPLETED|Overall Study||7||
59582579|NCT03896295|75689210|FG001|NOT COMPLETED|Overall Study||30||
59582580|NCT03882723|75689221|FG000|STARTED|Overall Study||8||
59582581|NCT03882723|75689221|FG000|BiTrac Max Shield|Overall Study||8||
59582582|NCT03882723|75689221|FG000|BiTrac™ Full Face|Overall Study||8||
59582583|NCT03882723|75689221|FG000|Respironics PerforMax|Overall Study||8||
59582584|NCT03882723|75689221|FG000|Respironics AF531|Overall Study||8||
59582585|NCT03882723|75689221|FG000|COMPLETED|Overall Study||8||
59582586|NCT03882723|75689221|FG000|NOT COMPLETED|Overall Study||0||
59582587|NCT03861143|75689235|FG000|STARTED|Overall Study||66||
59582588|NCT03861143|75689236|FG001|STARTED|Overall Study||66||
59582589|NCT03861143|75689237|FG002|STARTED|Overall Study||66||
59582590|NCT03861143|75689235|FG000|COMPLETED|Overall Study||62||
59582591|NCT03861143|75689236|FG001|COMPLETED|Overall Study||59||
59582592|NCT03861143|75689237|FG002|COMPLETED|Overall Study||58||
59582593|NCT03861143|75689235|FG000|NOT COMPLETED|Overall Study||4||
59582594|NCT03861143|75689236|FG001|NOT COMPLETED|Overall Study||7||
59582595|NCT03861143|75689237|FG002|NOT COMPLETED|Overall Study||8||
59582596|NCT03783975|75689245|FG000|STARTED|Overall Study||131||
59582597|NCT03783975|75689245|FG000|COMPLETED|Overall Study||131||
59582598|NCT03783975|75689245|FG000|NOT COMPLETED|Overall Study||0||
59582599|NCT03734666|75689251|FG000|STARTED|Overall Study||35||
59582600|NCT03734666|75689252|FG001|STARTED|Overall Study||32||
59582601|NCT03734666|75689251|FG000|COMPLETED|Overall Study||16||
59582602|NCT03734666|75689252|FG001|COMPLETED|Overall Study||16||
59582603|NCT03734666|75689251|FG000|NOT COMPLETED|Overall Study||19||
59582604|NCT03734666|75689252|FG001|NOT COMPLETED|Overall Study||16||
59582605|NCT03690921|75689259|FG000|STARTED|Overall Study||8||
59582606|NCT03690921|75689259|FG000|COMPLETED|Overall Study||8||
59582607|NCT03690921|75689259|FG000|NOT COMPLETED|Overall Study||0||
59582608|NCT03635489|75689265|FG000|STARTED|Overall Study||49||
59582609|NCT03635489|75689266|FG001|STARTED|Overall Study||51||
59582610|NCT03635489|75689265|FG000|COMPLETED|Overall Study||42||
59582611|NCT03635489|75689266|FG001|COMPLETED|Overall Study||45||
59582612|NCT03635489|75689265|FG000|NOT COMPLETED|Overall Study||7||
59582613|NCT03635489|75689266|FG001|NOT COMPLETED|Overall Study||6||
59582614|NCT03633617|75689277|FG000|STARTED|Part A||39|Started Part A|
59582615|NCT03633617|75689278|FG001|STARTED|Part A||42|Started Part A|
59582616|NCT03633617|75689279|FG002|STARTED|Part A||0|Started Part A|
59582617|NCT03633617|75689280|FG003|STARTED|Part A||0|Started Part A|
59582618|NCT03633617|75689281|FG004|STARTED|Part A||0|Started Part A|
59724240|NCT01110239|75842852|FG001|NOT COMPLETED|Sham Preconditioning||0||
59724241|NCT01110239|75842853|FG002|NOT COMPLETED|Sham Preconditioning||1||
59724242|NCT01110239|75842854|FG003|NOT COMPLETED|Sham Preconditioning||0||
59582619|NCT03633617|75689282|FG005|STARTED|Part A||0|Started Part A|
59582620|NCT03633617|75689283|FG006|STARTED|Part A||0|Started Part A|
59582621|NCT03633617|75689284|FG007|STARTED|Part A||0|Started Part A|
59582622|NCT03633617|75689285|FG008|STARTED|Part A||0|Started Part A|
59582623|NCT03633617|75689286|FG009|STARTED|Part A||0|Started Part A|
59582624|NCT03633617|75689287|FG010|STARTED|Part A||0|Started Part A|
59582625|NCT03633617|75689277|FG000|COMPLETED|Part A||36|Completed week 24 visit for Part A|
59724243|NCT01110239|75842851|FG000|STARTED|5 Min Ischemia||0||
59724244|NCT01110239|75842852|FG001|STARTED|5 Min Ischemia||14||
59724245|NCT01110239|75842853|FG002|STARTED|5 Min Ischemia||0||
59582626|NCT03633617|75689278|FG001|COMPLETED|Part A||37|Completed week 24 visit for Part A|
59582627|NCT03633617|75689279|FG002|COMPLETED|Part A||0|Completed week 24 visit for Part A|
59582628|NCT03633617|75689280|FG003|COMPLETED|Part A||0|Completed week 24 visit for Part A|
59582629|NCT03633617|75689281|FG004|COMPLETED|Part A||0|Completed week 24 visit for Part A|
59582630|NCT03633617|75689282|FG005|COMPLETED|Part A||0|Completed week 24 visit for Part A|
59582631|NCT03633617|75689283|FG006|COMPLETED|Part A||0|Completed week 24 visit for Part A|
59582632|NCT03633617|75689284|FG007|COMPLETED|Part A||0|Completed week 24 visit for Part A|
59582633|NCT03633617|75689285|FG008|COMPLETED|Part A||0|Completed week 24 visit for Part A|
59582634|NCT03633617|75689286|FG009|COMPLETED|Part A||0|Completed week 24 visit for Part A|
59582635|NCT03633617|75689287|FG010|COMPLETED|Part A||0|Completed week 24 visit for Part A|
59582636|NCT03633617|75689277|FG000|NOT COMPLETED|Part A||3||
59582637|NCT03633617|75689278|FG001|NOT COMPLETED|Part A||5||
59582638|NCT03633617|75689279|FG002|NOT COMPLETED|Part A||0||
59582639|NCT03633617|75689280|FG003|NOT COMPLETED|Part A||0||
59582640|NCT03633617|75689281|FG004|NOT COMPLETED|Part A||0||
59582641|NCT03633617|75689282|FG005|NOT COMPLETED|Part A||0||
59582642|NCT03633617|75689283|FG006|NOT COMPLETED|Part A||0||
59582643|NCT03633617|75689284|FG007|NOT COMPLETED|Part A||0||
59582644|NCT03633617|75689285|FG008|NOT COMPLETED|Part A||0||
59582645|NCT03633617|75689286|FG009|NOT COMPLETED|Part A||0||
59582646|NCT03633617|75689287|FG010|NOT COMPLETED|Part A||0||
59582647|NCT03633617|75689277|FG000|STARTED|Part B||0|Started Part B (Participants from Part A were not eligible for Part B)|
59582648|NCT03633617|75689278|FG001|STARTED|Part B||0|Started Part B (Participants from Part A were not eligible for Part B)|
59582649|NCT03633617|75689279|FG002|STARTED|Part B||79|Started Part B (Participants from Part A were not eligible for Part B)|
59582650|NCT03633617|75689280|FG003|STARTED|Part B||81|Started Part B (Participants from Part A were not eligible for Part B)|
59582651|NCT03633617|75689281|FG004|STARTED|Part B||80|Started Part B (Participants from Part A were not eligible for Part B)|
59582652|NCT03633617|75689282|FG005|STARTED|Part B||0|Started Part B (Participants from Part A were not eligible for Part B)|
59582653|NCT03633617|75689283|FG006|STARTED|Part B||0|Started Part B (Participants from Part A were not eligible for Part B)|
59582654|NCT03633617|75689284|FG007|STARTED|Part B||0|Started Part B (Participants from Part A were not eligible for Part B)|
59582655|NCT03633617|75689285|FG008|STARTED|Part B||0|Started Part B (Participants from Part A were not eligible for Part B)|
59582656|NCT03633617|75689286|FG009|STARTED|Part B||0|Started Part B (Participants from Part A were not eligible for Part B)|
59582657|NCT03633617|75689287|FG010|STARTED|Part B||0|Started Part B (Participants from Part A were not eligible for Part B)|
59582658|NCT03633617|75689277|FG000|COMPLETED|Part B||0|Completed week 24 visit for Part B|
59582659|NCT03633617|75689278|FG001|COMPLETED|Part B||0|Completed week 24 visit for Part B|
59582660|NCT03633617|75689279|FG002|COMPLETED|Part B||74|Completed week 24 visit for Part B|
59582661|NCT03633617|75689280|FG003|COMPLETED|Part B||79|Completed week 24 visit for Part B|
59582662|NCT03633617|75689281|FG004|COMPLETED|Part B||75|Completed week 24 visit for Part B|
59582663|NCT03633617|75689282|FG005|COMPLETED|Part B||0|Completed week 24 visit for Part B|
59582664|NCT03633617|75689283|FG006|COMPLETED|Part B||0|Completed week 24 visit for Part B|
59582665|NCT03633617|75689284|FG007|COMPLETED|Part B||0|Completed week 24 visit for Part B|
59582666|NCT03633617|75689285|FG008|COMPLETED|Part B||0|Completed week 24 visit for Part B|
59582667|NCT03633617|75689286|FG009|COMPLETED|Part B||0|Completed week 24 visit for Part B|
59582668|NCT03633617|75689287|FG010|COMPLETED|Part B||0|Completed week 24 visit for Part B|
59582669|NCT03633617|75689277|FG000|NOT COMPLETED|Part B||0||
59582670|NCT03633617|75689278|FG001|NOT COMPLETED|Part B||0||
59582671|NCT03633617|75689279|FG002|NOT COMPLETED|Part B||5||
59582672|NCT03633617|75689280|FG003|NOT COMPLETED|Part B||2||
59582673|NCT03633617|75689281|FG004|NOT COMPLETED|Part B||5||
59582674|NCT03633617|75689282|FG005|NOT COMPLETED|Part B||0||
59582675|NCT03633617|75689283|FG006|NOT COMPLETED|Part B||0||
59582676|NCT03633617|75689284|FG007|NOT COMPLETED|Part B||0||
59582677|NCT03633617|75689285|FG008|NOT COMPLETED|Part B||0||
59582678|NCT03633617|75689286|FG009|NOT COMPLETED|Part B||0||
59582679|NCT03633617|75689287|FG010|NOT COMPLETED|Part B||0||
59582680|NCT03633617|75689277|FG000|STARTED|Part C (& Follow-up)||0||
59582681|NCT03633617|75689278|FG001|STARTED|Part C (& Follow-up)||0||
59582682|NCT03633617|75689279|FG002|STARTED|Part C (& Follow-up)||0||
59582683|NCT03633617|75689280|FG003|STARTED|Part C (& Follow-up)||0||
59582684|NCT03633617|75689281|FG004|STARTED|Part C (& Follow-up)||0||
59582685|NCT03633617|75689282|FG005|STARTED|Part C (& Follow-up)||37||
59582686|NCT03633617|75689283|FG006|STARTED|Part C (& Follow-up)||40||
59582687|NCT03633617|75689284|FG007|STARTED|Part C (& Follow-up)||37||
59582688|NCT03633617|75689285|FG008|STARTED|Part C (& Follow-up)||37||
59582689|NCT03633617|75689286|FG009|STARTED|Part C (& Follow-up)||79||
59851498|NCT02558491|75976101|FG001|STARTED|First Invention||14||
59851499|NCT02558491|75976100|FG000|COMPLETED|First Invention||14||
59851500|NCT02558491|75976101|FG001|COMPLETED|First Invention||12||
59851501|NCT02558491|75976100|FG000|NOT COMPLETED|First Invention||5||
59582690|NCT03633617|75689287|FG010|STARTED|Part C (& Follow-up)||74||
59582691|NCT03633617|75689277|FG000|Completed Week 52 (End of Treatment)|Part C (& Follow-up)||0||
59582692|NCT03633617|75689278|FG001|Completed Week 52 (End of Treatment)|Part C (& Follow-up)||0||
59582693|NCT03633617|75689279|FG002|Completed Week 52 (End of Treatment)|Part C (& Follow-up)||0||
59582694|NCT03633617|75689280|FG003|Completed Week 52 (End of Treatment)|Part C (& Follow-up)||0||
59582695|NCT03633617|75689281|FG004|Completed Week 52 (End of Treatment)|Part C (& Follow-up)||0||
59582696|NCT03633617|75689282|FG005|Completed Week 52 (End of Treatment)|Part C (& Follow-up)||32||
59851502|NCT02558491|75976101|FG001|NOT COMPLETED|First Invention||2||
59851503|NCT02558491|75976100|FG000|STARTED|Second Intervention||14||
59582697|NCT03633617|75689283|FG006|Completed Week 52 (End of Treatment)|Part C (& Follow-up)||38||
59582698|NCT03633617|75689284|FG007|Completed Week 52 (End of Treatment)|Part C (& Follow-up)||34||
59582699|NCT03633617|75689285|FG008|Completed Week 52 (End of Treatment)|Part C (& Follow-up)||36||
59582700|NCT03633617|75689286|FG009|Completed Week 52 (End of Treatment)|Part C (& Follow-up)||74||
59582701|NCT03633617|75689287|FG010|Completed Week 52 (End of Treatment)|Part C (& Follow-up)||65||
59582702|NCT03633617|75689277|FG000|COMPLETED|Part C (& Follow-up)||0|Completed follow-up (end of study)|
59582703|NCT03633617|75689278|FG001|COMPLETED|Part C (& Follow-up)||0|Completed follow-up (end of study)|
59582704|NCT03633617|75689279|FG002|COMPLETED|Part C (& Follow-up)||0|Completed follow-up (end of study)|
59582705|NCT03633617|75689280|FG003|COMPLETED|Part C (& Follow-up)||0|Completed follow-up (end of study)|
59582706|NCT03633617|75689281|FG004|COMPLETED|Part C (& Follow-up)||0|Completed follow-up (end of study)|
59582707|NCT03633617|75689282|FG005|COMPLETED|Part C (& Follow-up)||30|Completed follow-up (end of study)|
59582708|NCT03633617|75689283|FG006|COMPLETED|Part C (& Follow-up)||35|Completed follow-up (end of study)|
59582709|NCT03633617|75689284|FG007|COMPLETED|Part C (& Follow-up)||33|Completed follow-up (end of study)|
59582710|NCT03633617|75689285|FG008|COMPLETED|Part C (& Follow-up)||36|Completed follow-up (end of study)|
59582711|NCT03633617|75689286|FG009|COMPLETED|Part C (& Follow-up)||67|Completed follow-up (end of study)|
59582712|NCT03633617|75689287|FG010|COMPLETED|Part C (& Follow-up)||64|Completed follow-up (end of study)|
59582713|NCT03633617|75689277|FG000|NOT COMPLETED|Part C (& Follow-up)||0||
59582714|NCT03633617|75689278|FG001|NOT COMPLETED|Part C (& Follow-up)||0||
59582715|NCT03633617|75689279|FG002|NOT COMPLETED|Part C (& Follow-up)||0||
59582716|NCT03633617|75689280|FG003|NOT COMPLETED|Part C (& Follow-up)||0||
59582717|NCT03633617|75689281|FG004|NOT COMPLETED|Part C (& Follow-up)||0||
59582718|NCT03633617|75689282|FG005|NOT COMPLETED|Part C (& Follow-up)||7||
59582719|NCT03633617|75689283|FG006|NOT COMPLETED|Part C (& Follow-up)||5||
59582720|NCT03633617|75689284|FG007|NOT COMPLETED|Part C (& Follow-up)||4||
59582721|NCT03633617|75689285|FG008|NOT COMPLETED|Part C (& Follow-up)||1||
59582722|NCT03633617|75689286|FG009|NOT COMPLETED|Part C (& Follow-up)||12||
59582723|NCT03633617|75689287|FG010|NOT COMPLETED|Part C (& Follow-up)||10||
59582724|NCT03631784|75689317|FG000|STARTED|Overall Study||112||
59582725|NCT03631784|75689318|FG001|STARTED|Overall Study||102||
59582726|NCT03631784|75689317|FG000|COMPLETED|Overall Study||0||
59582727|NCT03631784|75689318|FG001|COMPLETED|Overall Study||0||
59582728|NCT03631784|75689317|FG000|NOT COMPLETED|Overall Study||112||
59582729|NCT03631784|75689318|FG001|NOT COMPLETED|Overall Study||102||
59582730|NCT03617705|75689324|FG000|STARTED|Overall Study||49||
59582731|NCT03617705|75689324|FG000|COMPLETED|Overall Study||40||
59582732|NCT03617705|75689324|FG000|NOT COMPLETED|Overall Study||9||
59582733|NCT03607422|75689334|FG000|STARTED|Overall Study||242|Randomized into study|
59582734|NCT03607422|75689335|FG001|STARTED|Overall Study||243|Randomized into study|
59582735|NCT03607422|75689336|FG002|STARTED|Overall Study||247|Randomized into study|
59582736|NCT03607422|75689337|FG003|STARTED|Overall Study||60|Randomized into study|
59582737|NCT03607422|75689338|FG004|STARTED|Overall Study||58|Randomized into study|
59582738|NCT03607422|75689339|FG005|STARTED|Overall Study||62|Randomized into study|
59582739|NCT03607422|75689334|FG000|COMPLETED|Overall Study||204|Completed Week 16|
59582740|NCT03607422|75689335|FG001|COMPLETED|Overall Study||233|Completed Week 16|
59582741|NCT03607422|75689336|FG002|COMPLETED|Overall Study||235|Completed Week 16|
59582742|NCT03607422|75689337|FG003|COMPLETED|Overall Study||55|Completed Week 16|
59582743|NCT03607422|75689338|FG004|COMPLETED|Overall Study||55|Completed Week 16|
59582744|NCT03607422|75689339|FG005|COMPLETED|Overall Study||59|Completed Week 16|
59582745|NCT03607422|75689334|FG000|NOT COMPLETED|Overall Study||38||
59582746|NCT03607422|75689335|FG001|NOT COMPLETED|Overall Study||10||
59582747|NCT03607422|75689336|FG002|NOT COMPLETED|Overall Study||12||
59582748|NCT03607422|75689337|FG003|NOT COMPLETED|Overall Study||5||
59582749|NCT03607422|75689338|FG004|NOT COMPLETED|Overall Study||3||
59582750|NCT03607422|75689339|FG005|NOT COMPLETED|Overall Study||3||
59582751|NCT03574038|75689355|FG000|STARTED|Overall Study|Patients|3||
59582752|NCT03574038|75689356|FG001|STARTED|Overall Study|Patients|4||
59582753|NCT03574038|75689357|FG002|STARTED|Overall Study|Patients|3||
59582754|NCT03574038|75689355|FG000|COMPLETED|Overall Study|Patients|3||
59582755|NCT03574038|75689356|FG001|COMPLETED|Overall Study|Patients|4||
59582756|NCT03574038|75689357|FG002|COMPLETED|Overall Study|Patients|3||
59582757|NCT03574038|75689355|FG000|NOT COMPLETED|Overall Study||0||
59582758|NCT03574038|75689356|FG001|NOT COMPLETED|Overall Study||0||
59582759|NCT03574038|75689357|FG002|NOT COMPLETED|Overall Study||0||
59582760|NCT03568318|75689377|FG000|STARTED|Overall Study||264|Randomized into study|
59582761|NCT03568318|75689378|FG001|STARTED|Overall Study||261|Randomized into study|
59582762|NCT03568318|75689379|FG002|STARTED|Overall Study||260|Randomized into study|
59582763|NCT03568318|75689380|FG003|STARTED|Overall Study||63|Randomized into study|
59582764|NCT03568318|75689381|FG004|STARTED|Overall Study||60|Randomized into study|
59582765|NCT03568318|75689382|FG005|STARTED|Overall Study||60|Randomized into study|
59582766|NCT03568318|75689377|FG000|Received Study Drug|Overall Study||264||
59582767|NCT03568318|75689378|FG001|Received Study Drug|Overall Study||261||
59582768|NCT03568318|75689379|FG002|Received Study Drug|Overall Study||260||
59582769|NCT03568318|75689380|FG003|Received Study Drug|Overall Study||62||
59582770|NCT03568318|75689381|FG004|Received Study Drug|Overall Study||60||
59582771|NCT03568318|75689382|FG005|Received Study Drug|Overall Study||60||
59582772|NCT03568318|75689377|FG000|COMPLETED|Overall Study||244|Completed Week 16|
59582773|NCT03568318|75689378|FG001|COMPLETED|Overall Study||249|Completed Week 16|
59582774|NCT03568318|75689379|FG002|COMPLETED|Overall Study||250|Completed Week 16|
59582775|NCT03568318|75689380|FG003|COMPLETED|Overall Study||59|Completed Week 16|
59582776|NCT03568318|75689381|FG004|COMPLETED|Overall Study||58|Completed Week 16|
59582777|NCT03568318|75689382|FG005|COMPLETED|Overall Study||60|Completed Week 16|
59582778|NCT03568318|75689377|FG000|NOT COMPLETED|Overall Study||20||
59582779|NCT03568318|75689378|FG001|NOT COMPLETED|Overall Study||12||
59582780|NCT03568318|75689379|FG002|NOT COMPLETED|Overall Study||10||
59582781|NCT03568318|75689380|FG003|NOT COMPLETED|Overall Study||4||
59582782|NCT03568318|75689381|FG004|NOT COMPLETED|Overall Study||2||
59582783|NCT03568318|75689382|FG005|NOT COMPLETED|Overall Study||0||
59582784|NCT03550794|75689398|FG000|STARTED|Overall Study||46||
59582785|NCT03550794|75689399|FG001|STARTED|Overall Study||49||
59582786|NCT03550794|75689398|FG000|COMPLETED|Overall Study||42||
59582787|NCT03550794|75689399|FG001|COMPLETED|Overall Study||46||
59582788|NCT03550794|75689398|FG000|NOT COMPLETED|Overall Study||4||
59582789|NCT03550794|75689399|FG001|NOT COMPLETED|Overall Study||3||
59582790|NCT03506880|75689408|FG000|STARTED|Overall Study||393|The start of study enrollment included 1,176 parent-teen dyads. This means there were 1,176 enrolled in the study with 1,176 teens who completed the baseline survey.|
59582791|NCT03506880|75689409|FG001|STARTED|Overall Study||393|The start of study enrollment included 1,176 parent-teen dyads. This means there were 1,176 enrolled in the study with 1,176 teens who completed the baseline survey.|
59582792|NCT03506880|75689410|FG002|STARTED|Overall Study||390|The start of study enrollment included 1,176 parent-teen dyads. This means there were 1,176 enrolled in the study with 1,176 teens who completed the baseline survey.|
59582793|NCT03506880|75689408|FG000|T2 (30 -Days Post-baseline)|Overall Study||331|Only teen participants received the T2 baseline survey. 1,001 teen participants completed this survey.|
59582794|NCT03506880|75689409|FG001|T2 (30 -Days Post-baseline)|Overall Study||328|Only teen participants received the T2 baseline survey. 1,001 teen participants completed this survey.|
59582795|NCT03506880|75689410|FG002|T2 (30 -Days Post-baseline)|Overall Study||342|Only teen participants received the T2 baseline survey. 1,001 teen participants completed this survey.|
59582796|NCT03506880|75689408|FG000|T3 (6-months Post-baseline)|Overall Study||315|Parents and teens received the T3 survey. This means there were 952 parents and 952 teens who completed this survey.|
59582797|NCT03506880|75689409|FG001|T3 (6-months Post-baseline)|Overall Study||318|Parents and teens received the T3 survey. This means there were 952 parents and 952 teens who completed this survey.|
59851504|NCT02558491|75976101|FG001|STARTED|Second Intervention||12||
60121534|NCT01685801|76242414|FG002|COMPLETED|Open-label Period (8 Weeks)||7||
60121535|NCT01685801|76242415|FG003|COMPLETED|Open-label Period (8 Weeks)||4||
60121536|NCT01685801|76242412|FG000|NOT COMPLETED|Open-label Period (8 Weeks)||0||
60121537|NCT01685801|76242413|FG001|NOT COMPLETED|Open-label Period (8 Weeks)||0||
60121538|NCT01685801|76242414|FG002|NOT COMPLETED|Open-label Period (8 Weeks)||0||
59582798|NCT03506880|75689410|FG002|T3 (6-months Post-baseline)|Overall Study||319|Parents and teens received the T3 survey. This means there were 952 parents and 952 teens who completed this survey.|
59582799|NCT03506880|75689408|FG000|T4 (12-months Post-baseline)|Overall Study||296|Parents and teens received the T4 survey. This means there were 906 parents and 906 teens who completed this survey.|
59582800|NCT03506880|75689409|FG001|T4 (12-months Post-baseline)|Overall Study||305|Parents and teens received the T4 survey. This means there were 906 parents and 906 teens who completed this survey.|
59582801|NCT03506880|75689410|FG002|T4 (12-months Post-baseline)|Overall Study||305|Parents and teens received the T4 survey. This means there were 906 parents and 906 teens who completed this survey.|
59582802|NCT03506880|75689408|FG000|COMPLETED|Overall Study||296|The completed number reflects the number of parent-teen dyads who completed the study. There were 906 parents and 906 teens who completed this study.|
59724246|NCT01110239|75842854|FG003|STARTED|5 Min Ischemia||0||
59724247|NCT01110239|75842851|FG000|COMPLETED|5 Min Ischemia||0||
59724248|NCT01110239|75842852|FG001|COMPLETED|5 Min Ischemia||0||
59851505|NCT02558491|75976100|FG000|COMPLETED|Second Intervention||12||
59851506|NCT02558491|75976101|FG001|COMPLETED|Second Intervention||12||
60121539|NCT01685801|76242415|FG003|NOT COMPLETED|Open-label Period (8 Weeks)||0||
60121540|NCT01353222|76242434|FG000|STARTED|Overall Study||70||
60121541|NCT01353222|76242435|FG001|STARTED|Overall Study||72||
60121542|NCT01353222|76242434|FG000|DN24-02 Arm ≥1 Leukapheresis|Overall Study||67|Safety population for the DN24-02 arm.|
60121543|NCT01353222|76242435|FG001|DN24-02 Arm ≥1 Leukapheresis|Overall Study||0|Safety population for the DN24-02 arm.|
60121544|NCT01353222|76242434|FG000|Standard Care Arm ≥1 Post-baseline Visit|Overall Study||0|Safety population for the Standard of Care arm.|
60121545|NCT01353222|76242435|FG001|Standard Care Arm ≥1 Post-baseline Visit|Overall Study||72|Safety population for the Standard of Care arm.|
60121546|NCT01353222|76242434|FG000|COMPLETED|Overall Study||0||
60121547|NCT01353222|76242435|FG001|COMPLETED|Overall Study||0||
60121548|NCT01353222|76242434|FG000|NOT COMPLETED|Overall Study||70||
60121549|NCT01353222|76242435|FG001|NOT COMPLETED|Overall Study||72||
60121550|NCT02683954|76242443|FG000|STARTED|Overall Study||30||
60121551|NCT02683954|76242444|FG001|STARTED|Overall Study||30||
60121552|NCT02683954|76242443|FG000|COMPLETED|Overall Study||30||
60121553|NCT02683954|76242444|FG001|COMPLETED|Overall Study||30||
60121554|NCT02683954|76242443|FG000|NOT COMPLETED|Overall Study||0||
59582803|NCT03506880|75689409|FG001|COMPLETED|Overall Study||305|The completed number reflects the number of parent-teen dyads who completed the study. There were 906 parents and 906 teens who completed this study.|
59582804|NCT03506880|75689410|FG002|COMPLETED|Overall Study||305|The completed number reflects the number of parent-teen dyads who completed the study. There were 906 parents and 906 teens who completed this study.|
59582805|NCT03506880|75689408|FG000|NOT COMPLETED|Overall Study||97||
59582806|NCT03506880|75689409|FG001|NOT COMPLETED|Overall Study||88||
59582807|NCT03506880|75689410|FG002|NOT COMPLETED|Overall Study||85||
59582808|NCT03456102|75689422|FG000|STARTED|Overall Study||10||
59582809|NCT03456102|75689423|FG001|STARTED|Overall Study||6||
59582810|NCT03456102|75689424|FG002|STARTED|Overall Study||0||
59582811|NCT03456102|75689425|FG003|STARTED|Overall Study||0||
59582812|NCT03456102|75689422|FG000|COMPLETED|Overall Study||10||
59582813|NCT03456102|75689423|FG001|COMPLETED|Overall Study||6||
59582814|NCT03456102|75689424|FG002|COMPLETED|Overall Study||0||
59582815|NCT03456102|75689425|FG003|COMPLETED|Overall Study||0||
59582816|NCT03456102|75689422|FG000|NOT COMPLETED|Overall Study||0||
59582817|NCT03456102|75689423|FG001|NOT COMPLETED|Overall Study||0||
59582818|NCT03456102|75689424|FG002|NOT COMPLETED|Overall Study||0||
59582819|NCT03456102|75689425|FG003|NOT COMPLETED|Overall Study||0||
59582820|NCT03427125|75689438|FG000|STARTED|2 to 4 Week Washout Period|No patients received study drug during this period|0|All patients were washed off of existing phosphate lowering medication. No patient received study drug during this period|
59582821|NCT03427125|75689439|FG001|STARTED|2 to 4 Week Washout Period||1559|All patients were washed off of existing phosphate lowering medication. No patient received study drug during this period|
59582822|NCT03427125|75689440|FG002|STARTED|2 to 4 Week Washout Period|No patients received study drug during this period|0|All patients were washed off of existing phosphate lowering medication. No patient received study drug during this period|
59582823|NCT03427125|75689438|FG000|COMPLETED|2 to 4 Week Washout Period||0||
59582824|NCT03427125|75689439|FG001|COMPLETED|2 to 4 Week Washout Period||564||
59582825|NCT03427125|75689440|FG002|COMPLETED|2 to 4 Week Washout Period||0||
59582826|NCT03427125|75689438|FG000|NOT COMPLETED|2 to 4 Week Washout Period||0||
59582827|NCT03427125|75689439|FG001|NOT COMPLETED|2 to 4 Week Washout Period||995||
59582828|NCT03427125|75689440|FG002|NOT COMPLETED|2 to 4 Week Washout Period||0||
59582829|NCT03427125|75689438|FG000|STARTED|26-Week Treatment Period|Patients were randomized 3:1 to receive tenapanor:sevelamer. The total number of participants receiving tenapanor (423) and sevelamer (141) equal the total number randomized (564).|423||
59582830|NCT03427125|75689439|FG001|STARTED|26-Week Treatment Period|No study participants received placebo during this period|0||
59582831|NCT03427125|75689440|FG002|STARTED|26-Week Treatment Period|Patients were randomized 3:1 to receive tenapanor:sevelamer. The total number of participants receiving tenapanor (423) and sevelamer (141) equal the total number randomized (564).|141||
59582832|NCT03427125|75689438|FG000|COMPLETED|26-Week Treatment Period||256||
59582833|NCT03427125|75689439|FG001|COMPLETED|26-Week Treatment Period||0||
59582834|NCT03427125|75689440|FG002|COMPLETED|26-Week Treatment Period||117||
59582835|NCT03427125|75689438|FG000|NOT COMPLETED|26-Week Treatment Period||167||
59582836|NCT03427125|75689439|FG001|NOT COMPLETED|26-Week Treatment Period||0||
59582837|NCT03427125|75689440|FG002|NOT COMPLETED|26-Week Treatment Period||24||
59582838|NCT03427125|75689438|FG000|STARTED|12-Week Randomized Withdrawal Period|The 256 participants from the tenapanor group that completed the previous study period were randomized in a double bind manner 1:1 to either stay on tenapanor or placebo.|129||
59582839|NCT03427125|75689439|FG001|STARTED|12-Week Randomized Withdrawal Period|The 256 participants from the tenapanor group that completed the previous study period were randomized in a double bind manner 1:1 to either stay on tenapanor or placebo.|127||
59582840|NCT03427125|75689440|FG002|STARTED|12-Week Randomized Withdrawal Period|Participants that received sevelamer did not participate in this period of the study they continued receiving drug per standard of care.|117||
59582841|NCT03427125|75689438|FG000|COMPLETED|12-Week Randomized Withdrawal Period||99||
59582842|NCT03427125|75689439|FG001|COMPLETED|12-Week Randomized Withdrawal Period||99||
59582843|NCT03427125|75689440|FG002|COMPLETED|12-Week Randomized Withdrawal Period||112||
59582844|NCT03427125|75689438|FG000|NOT COMPLETED|12-Week Randomized Withdrawal Period||30||
59582845|NCT03427125|75689439|FG001|NOT COMPLETED|12-Week Randomized Withdrawal Period||28||
59582846|NCT03427125|75689440|FG002|NOT COMPLETED|12-Week Randomized Withdrawal Period||5||
59582847|NCT03427125|75689438|FG000|STARTED|14-Week Safety Extension|Participants that dropped out of the previous period due to elevated serum phosphorus could enroll into this safety extension period; that is why the number (222) is higher than the number of participants that completed the previous period|222||
59582848|NCT03427125|75689439|FG001|STARTED|14-Week Safety Extension|There was no placebo group in this period. All participants that received placebo in the previous study period when into the tenapanor group.|0||
59582849|NCT03427125|75689440|FG002|STARTED|14-Week Safety Extension||112||
59582850|NCT03427125|75689438|FG000|COMPLETED|14-Week Safety Extension||205||
59582851|NCT03427125|75689439|FG001|COMPLETED|14-Week Safety Extension||0||
59582852|NCT03427125|75689440|FG002|COMPLETED|14-Week Safety Extension||109||
59582853|NCT03427125|75689438|FG000|NOT COMPLETED|14-Week Safety Extension||17||
59582854|NCT03427125|75689439|FG001|NOT COMPLETED|14-Week Safety Extension||0||
59582855|NCT03427125|75689440|FG002|NOT COMPLETED|14-Week Safety Extension||3||
59582856|NCT03359863|75689449|FG000|STARTED|Overall Study||10||
59582857|NCT03359863|75689449|FG000|COMPLETED|Overall Study||5||
59582858|NCT03359863|75689449|FG000|NOT COMPLETED|Overall Study||5||
59582859|NCT03341273|75689455|FG000|STARTED|Overall Study||249||
59582860|NCT03341273|75689456|FG001|STARTED|Overall Study||250||
59582861|NCT03341273|75689455|FG000|COMPLETED|Overall Study||229||
59582862|NCT03341273|75689456|FG001|COMPLETED|Overall Study||238||
59582863|NCT03341273|75689455|FG000|NOT COMPLETED|Overall Study||20||
59582864|NCT03341273|75689456|FG001|NOT COMPLETED|Overall Study||12||
59582865|NCT03284710|75689466|FG000|STARTED|Overall Study||36||
59582866|NCT03284710|75689467|FG001|STARTED|Overall Study||36||
59582867|NCT03284710|75689468|FG002|STARTED|Overall Study||36||
59582868|NCT03284710|75689469|FG003|STARTED|Overall Study||24||
59582869|NCT03284710|75689466|FG000|Month 6.5 Immunogenicity Timepoint|Overall Study||31||
59582870|NCT03284710|75689467|FG001|Month 6.5 Immunogenicity Timepoint|Overall Study||31||
59582871|NCT03284710|75689468|FG002|Month 6.5 Immunogenicity Timepoint|Overall Study||31||
59582872|NCT03284710|75689469|FG003|Month 6.5 Immunogenicity Timepoint|Overall Study||18||
59582873|NCT03284710|75689466|FG000|Month 12 Immunogenicity Timepoint|Overall Study||30||
59582874|NCT03284710|75689467|FG001|Month 12 Immunogenicity Timepoint|Overall Study||31||
59582875|NCT03284710|75689468|FG002|Month 12 Immunogenicity Timepoint|Overall Study||31||
59582876|NCT03284710|75689469|FG003|Month 12 Immunogenicity Timepoint|Overall Study||17||
59582877|NCT03284710|75689466|FG000|Month 12.5 Immunogenicity Timepoint|Overall Study||0||
59582878|NCT03284710|75689467|FG001|Month 12.5 Immunogenicity Timepoint|Overall Study||0||
59582879|NCT03284710|75689468|FG002|Month 12.5 Immunogenicity Timepoint|Overall Study||0||
59582880|NCT03284710|75689469|FG003|Month 12.5 Immunogenicity Timepoint|Overall Study||0||
59582881|NCT03284710|75689466|FG000|Month 18 Immunogenicity Timepoint|Overall Study||0||
59582882|NCT03284710|75689467|FG001|Month 18 Immunogenicity Timepoint|Overall Study||0||
59582883|NCT03284710|75689468|FG002|Month 18 Immunogenicity Timepoint|Overall Study||0||
59582884|NCT03284710|75689469|FG003|Month 18 Immunogenicity Timepoint|Overall Study||0||
59582885|NCT03284710|75689466|FG000|COMPLETED|Overall Study||30||
59582886|NCT03284710|75689467|FG001|COMPLETED|Overall Study||31||
59582887|NCT03284710|75689468|FG002|COMPLETED|Overall Study||32||
59582888|NCT03284710|75689469|FG003|COMPLETED|Overall Study||16||
59582889|NCT03284710|75689466|FG000|NOT COMPLETED|Overall Study||6||
59582890|NCT03284710|75689467|FG001|NOT COMPLETED|Overall Study||5||
59582891|NCT03284710|75689468|FG002|NOT COMPLETED|Overall Study||4||
59582892|NCT03284710|75689469|FG003|NOT COMPLETED|Overall Study||8||
59582893|NCT03248167|75689488|FG000|STARTED|Overall Study||17||
59582894|NCT03248167|75689489|FG001|STARTED|Overall Study||13||
59582895|NCT03248167|75689488|FG000|COMPLETED|Overall Study||12||
59582896|NCT03248167|75689489|FG001|COMPLETED|Overall Study||9||
59582897|NCT03248167|75689488|FG000|NOT COMPLETED|Overall Study||5||
59582898|NCT03248167|75689489|FG001|NOT COMPLETED|Overall Study||4||
59582899|NCT03220737|75689503|FG000|STARTED|Main Study (Day 1 - 181)||163||
59582900|NCT03220737|75689504|FG001|STARTED|Main Study (Day 1 - 181)||26||
59582901|NCT03220737|75689505|FG002|STARTED|Main Study (Day 1 - 181)||158||
59582902|NCT03220737|75689506|FG003|STARTED|Main Study (Day 1 - 181)||27||
59582903|NCT03220737|75689507|FG004|STARTED|Main Study (Day 1 - 181)||150||
59582904|NCT03220737|75689508|FG005|STARTED|Main Study (Day 1 - 181)||26||
59582905|NCT03220737|75689509|FG006|STARTED|Main Study (Day 1 - 181)||2688||
59582906|NCT03220737|75689503|FG000|COMPLETED|Main Study (Day 1 - 181)||157||
59582907|NCT03220737|75689504|FG001|COMPLETED|Main Study (Day 1 - 181)||24||
59582908|NCT03220737|75689505|FG002|COMPLETED|Main Study (Day 1 - 181)||146||
59582909|NCT03220737|75689506|FG003|COMPLETED|Main Study (Day 1 - 181)||24||
59582910|NCT03220737|75689507|FG004|COMPLETED|Main Study (Day 1 - 181)||130||
59582911|NCT03220737|75689508|FG005|COMPLETED|Main Study (Day 1 - 181)||25||
59582912|NCT03220737|75689509|FG006|COMPLETED|Main Study (Day 1 - 181)||2687||
59582913|NCT03220737|75689503|FG000|NOT COMPLETED|Main Study (Day 1 - 181)||6||
59582914|NCT03220737|75689504|FG001|NOT COMPLETED|Main Study (Day 1 - 181)||2||
59582915|NCT03220737|75689505|FG002|NOT COMPLETED|Main Study (Day 1 - 181)||12||
59582916|NCT03220737|75689506|FG003|NOT COMPLETED|Main Study (Day 1 - 181)||3||
59582917|NCT03220737|75689507|FG004|NOT COMPLETED|Main Study (Day 1 - 181)||20||
59582918|NCT03220737|75689508|FG005|NOT COMPLETED|Main Study (Day 1 - 181)||1||
59582919|NCT03220737|75689509|FG006|NOT COMPLETED|Main Study (Day 1 - 181)||1||
59582920|NCT03220737|75689503|FG000|STARTED|Placebo Crossover (Day 181-365)|Only placebo subjects who opted to receive Vaxchora were included in the crossover group.|13||
59582921|NCT03220737|75689504|FG001|STARTED|Placebo Crossover (Day 181-365)|Placebo subjects from Main study opted to cross over to the active group to receive Vaxchora.|0||
59582922|NCT03220737|75689505|FG002|STARTED|Placebo Crossover (Day 181-365)|Only placebo subjects who opted to receive Vaxchora were included in the crossover group.|11||
59582923|NCT03220737|75689506|FG003|STARTED|Placebo Crossover (Day 181-365)|Placebo subjects from Main study opted to cross over to the active group to receive Vaxchora|0||
59582924|NCT03220737|75689507|FG004|STARTED|Placebo Crossover (Day 181-365)|Only placebo subjects who opted to receive Vaxchora were included in the crossover group.|7||
59582925|NCT03220737|75689508|FG005|STARTED|Placebo Crossover (Day 181-365)|Placebo subjects from Main study opted to cross over to the active group to receive Vaxchora|0||
59582926|NCT03220737|75689509|FG006|STARTED|Placebo Crossover (Day 181-365)||0||
59582927|NCT03220737|75689503|FG000|COMPLETED|Placebo Crossover (Day 181-365)||13||
59724249|NCT01110239|75842853|FG002|COMPLETED|5 Min Ischemia||0||
59851507|NCT02558491|75976100|FG000|NOT COMPLETED|Second Intervention||2||
59851508|NCT02558491|75976101|FG001|NOT COMPLETED|Second Intervention||0||
59724250|NCT01110239|75842854|FG003|COMPLETED|5 Min Ischemia||0||
59851509|NCT02558491|75976100|FG000|STARTED|Third Intervention||12||
59851510|NCT02558491|75976101|FG001|STARTED|Third Intervention||12||
59582928|NCT03220737|75689504|FG001|COMPLETED|Placebo Crossover (Day 181-365)||0||
59582929|NCT03220737|75689505|FG002|COMPLETED|Placebo Crossover (Day 181-365)||11||
59582930|NCT03220737|75689506|FG003|COMPLETED|Placebo Crossover (Day 181-365)||0||
59582931|NCT03220737|75689507|FG004|COMPLETED|Placebo Crossover (Day 181-365)||5||
59582932|NCT03220737|75689508|FG005|COMPLETED|Placebo Crossover (Day 181-365)||0||
59582933|NCT03220737|75689509|FG006|COMPLETED|Placebo Crossover (Day 181-365)||0||
59582934|NCT03220737|75689503|FG000|NOT COMPLETED|Placebo Crossover (Day 181-365)||0||
59582935|NCT03220737|75689504|FG001|NOT COMPLETED|Placebo Crossover (Day 181-365)||0||
59582936|NCT03220737|75689505|FG002|NOT COMPLETED|Placebo Crossover (Day 181-365)||0||
59582937|NCT03220737|75689506|FG003|NOT COMPLETED|Placebo Crossover (Day 181-365)||0||
59582938|NCT03220737|75689507|FG004|NOT COMPLETED|Placebo Crossover (Day 181-365)||2||
59582939|NCT03220737|75689508|FG005|NOT COMPLETED|Placebo Crossover (Day 181-365)||0||
59582940|NCT03220737|75689509|FG006|NOT COMPLETED|Placebo Crossover (Day 181-365)||0||
59582941|NCT03220737|75689503|FG000|STARTED|Long-term Follow-up (Day 365-730)|Cohort 1 subjects from the main study had to opt to be included in the Long-term follow-up study.|73||
59582942|NCT03220737|75689504|FG001|STARTED|Long-term Follow-up (Day 365-730)||0||
59582943|NCT03220737|75689505|FG002|STARTED|Long-term Follow-up (Day 365-730)|Cohort 2 subjects were not eligible for the Long-term follow-up study.|0||
59582944|NCT03220737|75689506|FG003|STARTED|Long-term Follow-up (Day 365-730)||0||
59582945|NCT03220737|75689507|FG004|STARTED|Long-term Follow-up (Day 365-730)|Cohort 3 subjects were not eligible for the Long-term follow-up study.|0||
59582946|NCT03220737|75689508|FG005|STARTED|Long-term Follow-up (Day 365-730)||0||
59582947|NCT03220737|75689509|FG006|STARTED|Long-term Follow-up (Day 365-730)||0||
59582948|NCT03220737|75689503|FG000|COMPLETED|Long-term Follow-up (Day 365-730)||62||
59582949|NCT03220737|75689504|FG001|COMPLETED|Long-term Follow-up (Day 365-730)||0||
59582950|NCT03220737|75689505|FG002|COMPLETED|Long-term Follow-up (Day 365-730)||0||
59582951|NCT03220737|75689506|FG003|COMPLETED|Long-term Follow-up (Day 365-730)||0||
59582952|NCT03220737|75689507|FG004|COMPLETED|Long-term Follow-up (Day 365-730)||0||
59582953|NCT03220737|75689508|FG005|COMPLETED|Long-term Follow-up (Day 365-730)||0||
59582954|NCT03220737|75689509|FG006|COMPLETED|Long-term Follow-up (Day 365-730)||0||
59582955|NCT03220737|75689503|FG000|NOT COMPLETED|Long-term Follow-up (Day 365-730)||11||
59582956|NCT03220737|75689504|FG001|NOT COMPLETED|Long-term Follow-up (Day 365-730)||0||
59582957|NCT03220737|75689505|FG002|NOT COMPLETED|Long-term Follow-up (Day 365-730)||0||
59582958|NCT03220737|75689506|FG003|NOT COMPLETED|Long-term Follow-up (Day 365-730)||0||
59582959|NCT03220737|75689507|FG004|NOT COMPLETED|Long-term Follow-up (Day 365-730)||0||
59582960|NCT03220737|75689508|FG005|NOT COMPLETED|Long-term Follow-up (Day 365-730)||0||
59582961|NCT03220737|75689509|FG006|NOT COMPLETED|Long-term Follow-up (Day 365-730)||0||
59582962|NCT03198728|75689533|FG000|STARTED|Overall Study||214||
59582963|NCT03198728|75689534|FG001|STARTED|Overall Study||100||
59582964|NCT03198728|75689533|FG000|COMPLETED|Overall Study||162|Day 365. Five subjects withdrew from treatment or were lost to follow up after Day 365|
59582965|NCT03198728|75689534|FG001|COMPLETED|Overall Study||76|Day 365. Five subjects withdrew from treatment or were lost to follow up after Day 365|
59582966|NCT03198728|75689533|FG000|NOT COMPLETED|Overall Study||52||
59582967|NCT03198728|75689534|FG001|NOT COMPLETED|Overall Study||24||
59582968|NCT03159624|75689550|FG000|STARTED|Overall Study||21||
59582969|NCT03159624|75689551|FG001|STARTED|Overall Study||26||
59582970|NCT03159624|75689550|FG000|COMPLETED|Overall Study||21||
59582971|NCT03159624|75689551|FG001|COMPLETED|Overall Study||25||
59582972|NCT03159624|75689550|FG000|NOT COMPLETED|Overall Study||0||
59582973|NCT03159624|75689551|FG001|NOT COMPLETED|Overall Study||1||
59582980|NCT03144804|75689566|FG000|STARTED|Overall Study||36||
59582981|NCT03144804|75689566|FG000|COMPLETED|Overall Study||32||
59582982|NCT03144804|75689566|FG000|NOT COMPLETED|Overall Study||4||
59582983|NCT03142334|75689572|FG000|STARTED|Overall Study||496||
59582984|NCT03142334|75689573|FG001|STARTED|Overall Study||498||
59582985|NCT03142334|75689572|FG000|Treated|Overall Study||488||
59582986|NCT03142334|75689573|FG001|Treated|Overall Study||496||
59582987|NCT03142334|75689572|FG000|Continuing Study Treatment|Overall Study||0||
59582988|NCT03142334|75689573|FG001|Continuing Study Treatment|Overall Study||1||
59582989|NCT03142334|75689572|FG000|Completed Study Treatment|Overall Study||298||
59582990|NCT03142334|75689573|FG001|Completed Study Treatment|Overall Study||365||
59582991|NCT03142334|75689572|FG000|Discontinued Study Treatment|Overall Study||190||
59582992|NCT03142334|75689573|FG001|Discontinued Study Treatment|Overall Study||130||
59582993|NCT03142334|75689572|FG000|COMPLETED|Overall Study||0|Completed Trial|
59582994|NCT03142334|75689573|FG001|COMPLETED|Overall Study||0|Completed Trial|
59582995|NCT03142334|75689572|FG000|NOT COMPLETED|Overall Study||496||
59582996|NCT03142334|75689573|FG001|NOT COMPLETED|Overall Study||498||
59582997|NCT03126539|75689581|FG000|STARTED|Overall Study||9||9
59582998|NCT03126539|75689582|FG001|STARTED|Overall Study||9||9
59582999|NCT03126539|75689583|FG002|STARTED|Overall Study||9||27
59583000|NCT03126539|75689584|FG003|STARTED|Overall Study|Group B was not done|0||0
59583001|NCT03126539|75689585|FG004|STARTED|Overall Study||0||0
59583002|NCT03126539|75689581|FG000|COMPLETED|Overall Study||8||8
59583003|NCT03126539|75689582|FG001|COMPLETED|Overall Study||8||8
59583004|NCT03126539|75689583|FG002|COMPLETED|Overall Study||8||24
59583005|NCT03126539|75689584|FG003|COMPLETED|Overall Study||0||0
59583006|NCT03126539|75689585|FG004|COMPLETED|Overall Study||0||0
59583007|NCT03126539|75689581|FG000|NOT COMPLETED|Overall Study||1||1
59583008|NCT03126539|75689582|FG001|NOT COMPLETED|Overall Study||1||1
59583009|NCT03126539|75689583|FG002|NOT COMPLETED|Overall Study||1||3
59583010|NCT03126539|75689584|FG003|NOT COMPLETED|Overall Study||0||0
59583011|NCT03126539|75689585|FG004|NOT COMPLETED|Overall Study||0||0
59583012|NCT03123250|75689598|FG000|STARTED|Treatment||101||
59583013|NCT03123250|75689598|FG000|COMPLETED|Treatment||101||
59583014|NCT03123250|75689598|FG000|NOT COMPLETED|Treatment||0||
59724251|NCT01110239|75842851|FG000|NOT COMPLETED|5 Min Ischemia||0||
59724252|NCT01110239|75842852|FG001|NOT COMPLETED|5 Min Ischemia||14||
59724253|NCT01110239|75842853|FG002|NOT COMPLETED|5 Min Ischemia||0||
59724254|NCT01110239|75842854|FG003|NOT COMPLETED|5 Min Ischemia||0||
59724255|NCT01110239|75842851|FG000|STARTED|7.5 Min Ischemia||0||
59724256|NCT01110239|75842852|FG001|STARTED|7.5 Min Ischemia||0||
59724257|NCT01110239|75842853|FG002|STARTED|7.5 Min Ischemia||7||
59724258|NCT01110239|75842854|FG003|STARTED|7.5 Min Ischemia||0||
59724259|NCT01110239|75842851|FG000|COMPLETED|7.5 Min Ischemia||0||
59724260|NCT01110239|75842852|FG001|COMPLETED|7.5 Min Ischemia||0||
59724261|NCT01110239|75842853|FG002|COMPLETED|7.5 Min Ischemia||6||
59724262|NCT01110239|75842854|FG003|COMPLETED|7.5 Min Ischemia||0||
59724263|NCT01110239|75842851|FG000|NOT COMPLETED|7.5 Min Ischemia||0||
59724264|NCT01110239|75842852|FG001|NOT COMPLETED|7.5 Min Ischemia||0||
59724265|NCT01110239|75842853|FG002|NOT COMPLETED|7.5 Min Ischemia||1||
59724266|NCT01110239|75842854|FG003|NOT COMPLETED|7.5 Min Ischemia||0||
59724267|NCT01110239|75842851|FG000|STARTED|10 Min Ischemia||0||
59724268|NCT01110239|75842852|FG001|STARTED|10 Min Ischemia||0||
59724269|NCT01110239|75842853|FG002|STARTED|10 Min Ischemia||0||
59724270|NCT01110239|75842854|FG003|STARTED|10 Min Ischemia||6||
59724271|NCT01110239|75842851|FG000|COMPLETED|10 Min Ischemia||0||
59724272|NCT01110239|75842852|FG001|COMPLETED|10 Min Ischemia||0||
59724273|NCT01110239|75842853|FG002|COMPLETED|10 Min Ischemia||0||
59724274|NCT01110239|75842854|FG003|COMPLETED|10 Min Ischemia||6||
59724275|NCT01110239|75842851|FG000|NOT COMPLETED|10 Min Ischemia||0||
59724276|NCT01110239|75842852|FG001|NOT COMPLETED|10 Min Ischemia||0||
59724277|NCT01110239|75842853|FG002|NOT COMPLETED|10 Min Ischemia||0||
59724278|NCT01110239|75842854|FG003|NOT COMPLETED|10 Min Ischemia||0||
59724279|NCT01118663|75842867|FG000|STARTED|Overall Study||7||
59724280|NCT01118663|75842868|FG001|STARTED|Overall Study||10||
59724281|NCT01118663|75842867|FG000|COMPLETED|Overall Study||5||
59724282|NCT01118663|75842868|FG001|COMPLETED|Overall Study||8||
59724283|NCT01118663|75842867|FG000|NOT COMPLETED|Overall Study||2||
59724284|NCT01118663|75842868|FG001|NOT COMPLETED|Overall Study||2||
59724285|NCT01118351|75842874|FG000|STARTED|Overall Study||19||
59724286|NCT01118351|75842874|FG000|COMPLETED|Overall Study||15||
59724287|NCT01118351|75842874|FG000|NOT COMPLETED|Overall Study||4||
59724288|NCT03712852|75842881|FG000|STARTED|Overall Study||20||
59724289|NCT03712852|75842882|FG001|STARTED|Overall Study||20||
59724290|NCT03712852|75842883|FG002|STARTED|Overall Study||20||
59724291|NCT03712852|75842881|FG000|COMPLETED|Overall Study||20||
59724292|NCT03712852|75842882|FG001|COMPLETED|Overall Study||20||
59724293|NCT03712852|75842883|FG002|COMPLETED|Overall Study||20||
59724294|NCT03712852|75842881|FG000|NOT COMPLETED|Overall Study||0||
59724295|NCT03712852|75842882|FG001|NOT COMPLETED|Overall Study||0||
59724296|NCT03712852|75842883|FG002|NOT COMPLETED|Overall Study||0||
59724297|NCT01118117|75842895|FG000|STARTED|Overall Study||261||
59724298|NCT01118117|75842896|FG001|STARTED|Overall Study||15||
59724299|NCT01118117|75842895|FG000|COMPLETED|Overall Study||240||
59724300|NCT01118117|75842896|FG001|COMPLETED|Overall Study||15||
59724301|NCT01118117|75842895|FG000|NOT COMPLETED|Overall Study||21||
59583015|NCT03123250|75689598|FG000|STARTED|1 Month Follow-Up||101||
59724302|NCT01118117|75842896|FG001|NOT COMPLETED|Overall Study||0||
59724303|NCT01109849|75842904|FG000|STARTED|Initial Randomization: ADHD Treatment||50||
59724304|NCT01109849|75842905|FG001|STARTED|Initial Randomization: ADHD Treatment||180||
59724305|NCT01109849|75842906|FG002|STARTED|Initial Randomization: ADHD Treatment||0||
59724306|NCT01109849|75842907|FG003|STARTED|Initial Randomization: ADHD Treatment||0||
59724307|NCT01109849|75842908|FG004|STARTED|Initial Randomization: ADHD Treatment||0||
59724308|NCT01109849|75842904|FG000|COMPLETED|Initial Randomization: ADHD Treatment||32||
59724309|NCT01109849|75842905|FG001|COMPLETED|Initial Randomization: ADHD Treatment||131||
59724310|NCT01109849|75842906|FG002|COMPLETED|Initial Randomization: ADHD Treatment||0||
59724311|NCT01109849|75842907|FG003|COMPLETED|Initial Randomization: ADHD Treatment||0||
59724312|NCT01109849|75842908|FG004|COMPLETED|Initial Randomization: ADHD Treatment||0||
59724313|NCT01109849|75842904|FG000|NOT COMPLETED|Initial Randomization: ADHD Treatment||18||
59583016|NCT03123250|75689598|FG000|COMPLETED|1 Month Follow-Up||101||
59583017|NCT03123250|75689598|FG000|NOT COMPLETED|1 Month Follow-Up||0||
59583018|NCT03123250|75689598|FG000|STARTED|3 Months Follow-Up|2 subjects exited the study since the previous follow-up.|99||
59583019|NCT03123250|75689598|FG000|COMPLETED|3 Months Follow-Up||99||
59583020|NCT03123250|75689598|FG000|NOT COMPLETED|3 Months Follow-Up||0||
59583021|NCT03123250|75689598|FG000|STARTED|6 Months Follow-Up|Since the previous follow-up, 1 subject who had exited the study was re-enrolled prior to the 6 months follow-up.|100||
59583022|NCT03123250|75689598|FG000|COMPLETED|6 Months Follow-Up||100||
59583023|NCT03123250|75689598|FG000|NOT COMPLETED|6 Months Follow-Up||0||
59583024|NCT03123250|75689598|FG000|STARTED|12 Months Follow-Up|4 subjects exited the study since the previous follow-up.|96||
59583025|NCT03123250|75689598|FG000|COMPLETED|12 Months Follow-Up||96||
59583026|NCT03123250|75689598|FG000|NOT COMPLETED|12 Months Follow-Up||0||
59583027|NCT03123250|75689598|FG000|STARTED|24 Months Follow-Up|Since the previous follow-up, 10 subjects did not reconsent to additional long-term follow-ups.|86||
59583028|NCT03123250|75689598|FG000|COMPLETED|24 Months Follow-Up||86||
59583029|NCT03123250|75689598|FG000|NOT COMPLETED|24 Months Follow-Up||0||
59583030|NCT03123250|75689598|FG000|STARTED|36 Months Follow-Up|4 subjects exited the study since the previous follow-up.|82||
59583031|NCT03123250|75689598|FG000|COMPLETED|36 Months Follow-Up||82||
59583032|NCT03123250|75689598|FG000|NOT COMPLETED|36 Months Follow-Up||0||
59583033|NCT03123250|75689598|FG000|STARTED|48 Months Follow-Up|Since the previous follow-up, 16 subjects did not reconsent to additional long-term follow-ups.|66||
59583034|NCT03123250|75689598|FG000|COMPLETED|48 Months Follow-Up||66||
59583035|NCT03123250|75689598|FG000|NOT COMPLETED|48 Months Follow-Up||0||
59583036|NCT03123250|75689598|FG000|STARTED|60 Months Follow Up|4 subjects exited the study since the previous follow-up.|62||
59583037|NCT03123250|75689598|FG000|COMPLETED|60 Months Follow Up||60||
59583038|NCT03123250|75689598|FG000|NOT COMPLETED|60 Months Follow Up||2||
59583039|NCT03099096|75689602|FG000|STARTED|Overall Study||159||
59583040|NCT03099096|75689602|FG000|COMPLETED|Overall Study||157||
59583041|NCT03099096|75689602|FG000|NOT COMPLETED|Overall Study||2||
59583042|NCT03043664|75689606|FG000|STARTED|Overall Study||22||
59583043|NCT03043664|75689606|FG000|COMPLETED|Overall Study||21||
59583044|NCT03043664|75689606|FG000|NOT COMPLETED|Overall Study||1||
59583045|NCT03041467|75689612|FG000|STARTED|Overall Study||170||
59583046|NCT03041467|75689613|FG001|STARTED|Overall Study||160||
59583047|NCT03041467|75689612|FG000|30 Days|Overall Study||159||
59583048|NCT03041467|75689613|FG001|30 Days|Overall Study||154||
59583049|NCT03041467|75689612|FG000|3 Months|Overall Study||158||
59583050|NCT03041467|75689613|FG001|3 Months|Overall Study||151||
59583051|NCT03041467|75689612|FG000|6 Months|Overall Study||145||
59583052|NCT03041467|75689613|FG001|6 Months|Overall Study||144||
59583053|NCT03041467|75689612|FG000|9 Months|Overall Study||138||
59583054|NCT03041467|75689613|FG001|9 Months|Overall Study||138||
59583055|NCT03041467|75689612|FG000|12 Months|Overall Study||131||
59583056|NCT03041467|75689613|FG001|12 Months|Overall Study||121||
59583057|NCT03041467|75689612|FG000|18 Months|Overall Study||123||
59583058|NCT03041467|75689613|FG001|18 Months|Overall Study||113||
59583059|NCT03041467|75689612|FG000|24 Months|Overall Study||110||
59583060|NCT03041467|75689613|FG001|24 Months|Overall Study||101||
59583061|NCT03041467|75689612|FG000|36 Months|Overall Study||75||
59583062|NCT03041467|75689613|FG001|36 Months|Overall Study||58||
59583063|NCT03041467|75689612|FG000|48 Months|Overall Study||54||
59583064|NCT03041467|75689613|FG001|48 Months|Overall Study||41||
59583065|NCT03041467|75689612|FG000|COMPLETED|Overall Study||54||
59583066|NCT03041467|75689613|FG001|COMPLETED|Overall Study||41||
59583067|NCT03041467|75689612|FG000|NOT COMPLETED|Overall Study||116||
59583068|NCT03041467|75689613|FG001|NOT COMPLETED|Overall Study||119||
59583069|NCT03019406|75689625|FG000|STARTED|PAP: up to 25 Weeks||6||
59583070|NCT03019406|75689626|FG001|STARTED|PAP: up to 25 Weeks||5||
59583071|NCT03019406|75689627|FG002|STARTED|PAP: up to 25 Weeks||5||
59583072|NCT03019406|75689628|FG003|STARTED|PAP: up to 25 Weeks||6||
59583073|NCT03019406|75689625|FG000|Treated|PAP: up to 25 Weeks||6||
59583074|NCT03019406|75689626|FG001|Treated|PAP: up to 25 Weeks||5||
59583075|NCT03019406|75689627|FG002|Treated|PAP: up to 25 Weeks||5||
59583076|NCT03019406|75689628|FG003|Treated|PAP: up to 25 Weeks||6||
59583077|NCT03019406|75689625|FG000|COMPLETED|PAP: up to 25 Weeks||6||
59583078|NCT03019406|75689626|FG001|COMPLETED|PAP: up to 25 Weeks||5||
59583079|NCT03019406|75689627|FG002|COMPLETED|PAP: up to 25 Weeks||5||
59583080|NCT03019406|75689628|FG003|COMPLETED|PAP: up to 25 Weeks||6||
59583081|NCT03019406|75689625|FG000|NOT COMPLETED|PAP: up to 25 Weeks||0||
59583082|NCT03019406|75689626|FG001|NOT COMPLETED|PAP: up to 25 Weeks||0||
59583083|NCT03019406|75689627|FG002|NOT COMPLETED|PAP: up to 25 Weeks||0||
59583084|NCT03019406|75689628|FG003|NOT COMPLETED|PAP: up to 25 Weeks||0||
59583085|NCT03019406|75689625|FG000|STARTED|ETP: Ongoing From Week 26||6||
59583086|NCT03019406|75689626|FG001|STARTED|ETP: Ongoing From Week 26||5||
59583087|NCT03019406|75689627|FG002|STARTED|ETP: Ongoing From Week 26||5||
59583088|NCT03019406|75689628|FG003|STARTED|ETP: Ongoing From Week 26|Participants who completed PAP and accepted to receive avalglucosidase alfa treatment in ETP.|3||
59583089|NCT03019406|75689625|FG000|COMPLETED|ETP: Ongoing From Week 26||0||
59583090|NCT03019406|75689626|FG001|COMPLETED|ETP: Ongoing From Week 26||0||
59583091|NCT03019406|75689627|FG002|COMPLETED|ETP: Ongoing From Week 26||0||
59583092|NCT03019406|75689628|FG003|COMPLETED|ETP: Ongoing From Week 26||0||
59724314|NCT01109849|75842905|FG001|NOT COMPLETED|Initial Randomization: ADHD Treatment||49||
59851511|NCT02558491|75976100|FG000|COMPLETED|Third Intervention||12||
59851512|NCT02558491|75976101|FG001|COMPLETED|Third Intervention||12||
59851513|NCT02558491|75976100|FG000|NOT COMPLETED|Third Intervention||0||
59851514|NCT02558491|75976101|FG001|NOT COMPLETED|Third Intervention||0||
59851515|NCT02490878|75976110|FG000|STARTED|Overall Study||10||
59851516|NCT02490878|75976111|FG001|STARTED|Overall Study||9||
59851517|NCT02490878|75976110|FG000|Eligible Participants|Overall Study||10||
59851518|NCT02490878|75976111|FG001|Eligible Participants|Overall Study||8||
59851519|NCT02490878|75976110|FG000|COMPLETED|Overall Study||10||
59851520|NCT02490878|75976111|FG001|COMPLETED|Overall Study||6||
59851521|NCT02490878|75976110|FG000|NOT COMPLETED|Overall Study||0||
59851522|NCT02490878|75976111|FG001|NOT COMPLETED|Overall Study||3||
59851523|NCT02421601|75976117|FG000|STARTED|Overall Study||991||
59851524|NCT02421601|75976117|FG000|COMPLETED|Overall Study||909||
59851525|NCT02421601|75976117|FG000|NOT COMPLETED|Overall Study||82||
59851526|NCT01934218|75976123|FG000|STARTED|Double-blind Phase||404||
59851527|NCT01934218|75976124|FG001|STARTED|Double-blind Phase||410||
59851528|NCT01934218|75976123|FG000|Analyzed Participants|Double-blind Phase||402|5 subjects removed from ITT analyses because of no post treatment data. (Pre-defined)|
59851529|NCT01934218|75976124|FG001|Analyzed Participants|Double-blind Phase||407|5 subjects removed from ITT analyses because of no post treatment data. (Pre-defined)|
59851530|NCT01934218|75976123|FG000|COMPLETED|Double-blind Phase||356||
59851531|NCT01934218|75976124|FG001|COMPLETED|Double-blind Phase||356||
59851532|NCT01934218|75976123|FG000|NOT COMPLETED|Double-blind Phase||48||
59851533|NCT01934218|75976124|FG001|NOT COMPLETED|Double-blind Phase||54||
59851534|NCT01934218|75976123|FG000|STARTED|Open-Label Phase||316||
59851535|NCT01934218|75976124|FG001|STARTED|Open-Label Phase||328||
59851536|NCT01934218|75976123|FG000|COMPLETED|Open-Label Phase||290||
59851537|NCT01934218|75976124|FG001|COMPLETED|Open-Label Phase||304||
59851538|NCT01934218|75976123|FG000|NOT COMPLETED|Open-Label Phase||26||
59851539|NCT01934218|75976124|FG001|NOT COMPLETED|Open-Label Phase||24||
60121555|NCT02683954|76242444|FG001|NOT COMPLETED|Overall Study||0||
60121556|NCT02684188|76242452|FG000|STARTED|Overall Study||77||
60121557|NCT02684188|76242453|FG001|STARTED|Overall Study||50||
60121558|NCT02684188|76242452|FG000|COMPLETED|Overall Study||75||
60121559|NCT02684188|76242453|FG001|COMPLETED|Overall Study||47||
60121560|NCT02684188|76242452|FG000|NOT COMPLETED|Overall Study||2||
60121561|NCT02684188|76242453|FG001|NOT COMPLETED|Overall Study||3||
60121562|NCT01684943|76242465|FG000|STARTED|Overall Study||29||
60121563|NCT01684943|76242466|FG001|STARTED|Overall Study||3||
60121564|NCT01684943|76242467|FG002|STARTED|Overall Study||1||
60121565|NCT01684943|76242465|FG000|COMPLETED|Overall Study||20||
60121566|NCT01684943|76242466|FG001|COMPLETED|Overall Study||2||
59583093|NCT03019406|75689625|FG000|NOT COMPLETED|ETP: Ongoing From Week 26||6||
59583094|NCT03019406|75689626|FG001|NOT COMPLETED|ETP: Ongoing From Week 26||5||
59583095|NCT03019406|75689627|FG002|NOT COMPLETED|ETP: Ongoing From Week 26||5||
59583096|NCT03019406|75689628|FG003|NOT COMPLETED|ETP: Ongoing From Week 26||3||
59583097|NCT02972593|75689643|FG000|STARTED|Overall Study||50||
59583098|NCT02972593|75689644|FG001|STARTED|Overall Study||50||
59583099|NCT02972593|75689643|FG000|COMPLETED|Overall Study||30||
59583100|NCT02972593|75689644|FG001|COMPLETED|Overall Study||35||
59583101|NCT02972593|75689643|FG000|NOT COMPLETED|Overall Study||20||
59583102|NCT02972593|75689644|FG001|NOT COMPLETED|Overall Study||15||
59583103|NCT02949700|75689656|FG000|STARTED|Phase I||9||
59583104|NCT02949700|75689657|FG001|STARTED|Phase I||3||
59851540|NCT01702805|75976132|FG000|STARTED|Overall Study||911||
59851541|NCT01702805|75976133|FG001|STARTED|Overall Study||913||
59851542|NCT01702805|75976132|FG000|Completed Assessment for Neurodevelopmental Impairment|Overall Study||699||
59851543|NCT01702805|75976133|FG001|Completed Assessment for Neurodevelopmental Impairment|Overall Study||712||
59851544|NCT01702805|75976132|FG000|Died After Discharge|Overall Study||19||
59851545|NCT01702805|75976133|FG001|Died After Discharge|Overall Study||10||
59851546|NCT01702805|75976132|FG000|Died Before Discharge|Overall Study||127||
59851547|NCT01702805|75976133|FG001|Died Before Discharge|Overall Study||125||
59851548|NCT01702805|75976132|FG000|Survived to Discharge|Overall Study||781||
59851549|NCT01702805|75976133|FG001|Survived to Discharge|Overall Study||781||
59851550|NCT01702805|75976132|FG000|COMPLETED|Overall Study||845|Complete data for Primary Outcome, Death or Neurodevelopmental Impairment|
59851551|NCT01702805|75976133|FG001|COMPLETED|Overall Study||847|Complete data for Primary Outcome, Death or Neurodevelopmental Impairment|
59851552|NCT01702805|75976132|FG000|NOT COMPLETED|Overall Study||66||
59851553|NCT01702805|75976133|FG001|NOT COMPLETED|Overall Study||66||
59851554|NCT01168921|75976139|FG000|STARTED|Overall Study||23||
59851555|NCT01168921|75976139|FG000|COMPLETED|Overall Study||23||
59851556|NCT01168921|75976139|FG000|NOT COMPLETED|Overall Study||0||
59851557|NCT00097370|75976143|FG000|STARTED|Stage 1|Participants entered from study MHE100185.|37||
59851558|NCT00097370|75976143|FG000|COMPLETED|Stage 1||31||
59851559|NCT00097370|75976143|FG000|NOT COMPLETED|Stage 1||6||
59851560|NCT00097370|75976143|FG000|STARTED|Stage 2|41 participants entered from study MHE100185 and 31 participants continued from Stage 1.|72||
59851561|NCT00097370|75976143|FG000|COMPLETED|Stage 2||59||
60121567|NCT01684943|76242467|FG002|COMPLETED|Overall Study||0||
60121568|NCT01684943|76242465|FG000|NOT COMPLETED|Overall Study||9||
59583105|NCT02949700|75689658|FG002|STARTED|Phase I||0||
59583106|NCT02949700|75689659|FG003|STARTED|Phase I||0||
59583107|NCT02949700|75689656|FG000|COMPLETED|Phase I||7||
59583108|NCT02949700|75689657|FG001|COMPLETED|Phase I||2||
59583109|NCT02949700|75689658|FG002|COMPLETED|Phase I||0||
59583110|NCT02949700|75689659|FG003|COMPLETED|Phase I||0||
59583111|NCT02949700|75689656|FG000|NOT COMPLETED|Phase I||2||
59583112|NCT02949700|75689657|FG001|NOT COMPLETED|Phase I||1||
59583113|NCT02949700|75689658|FG002|NOT COMPLETED|Phase I||0||
59583114|NCT02949700|75689659|FG003|NOT COMPLETED|Phase I||0||
59583115|NCT02949700|75689656|FG000|STARTED|Phase II||0||
59583116|NCT02949700|75689657|FG001|STARTED|Phase II||0||
59583117|NCT02949700|75689658|FG002|STARTED|Phase II|"All patients underwent a 2 week lead-in period in order to decrease the gastrointestinal toxicity associated with metformin. During this lead-in period, all patients started metformin at the dose of 500mg PO BID and increased to their assigned dose levels at the end of the lead-in period.~One patient, however, did not complete the lead-in period and was taken off study due to protocol violation, hence the assignment of this patient to the lead-in dose, or DL-1."|1||
59583118|NCT02949700|75689659|FG003|STARTED|Phase II||12||
59583119|NCT02949700|75689656|FG000|COMPLETED|Phase II||0||
59583120|NCT02949700|75689657|FG001|COMPLETED|Phase II||0||
59583121|NCT02949700|75689658|FG002|COMPLETED|Phase II||0||
59583122|NCT02949700|75689659|FG003|COMPLETED|Phase II||7||
59583123|NCT02949700|75689656|FG000|NOT COMPLETED|Phase II||0||
59583124|NCT02949700|75689657|FG001|NOT COMPLETED|Phase II||0||
59583125|NCT02949700|75689658|FG002|NOT COMPLETED|Phase II||1||
59583126|NCT02949700|75689659|FG003|NOT COMPLETED|Phase II||5||
59583127|NCT02947087|75689670|FG000|STARTED|Overall Study||32||
59583128|NCT02947087|75689671|FG001|STARTED|Overall Study||16||
59583129|NCT02947087|75689670|FG000|COMPLETED|Overall Study||29||
59583130|NCT02947087|75689671|FG001|COMPLETED|Overall Study||14||
59583131|NCT02947087|75689670|FG000|NOT COMPLETED|Overall Study||3||
59583132|NCT02947087|75689671|FG001|NOT COMPLETED|Overall Study||2||
59583133|NCT02868216|75689679|FG000|STARTED|Overall Study||43||
59583134|NCT02868216|75689680|FG001|STARTED|Overall Study||47||
59583135|NCT02868216|75689679|FG000|COMPLETED|Overall Study||35||
59583136|NCT02868216|75689680|FG001|COMPLETED|Overall Study||41||
59583137|NCT02868216|75689679|FG000|NOT COMPLETED|Overall Study||8||
59583138|NCT02868216|75689680|FG001|NOT COMPLETED|Overall Study||6||
59583139|NCT02841995|75689689|FG000|STARTED|Overall Study||17||
59583140|NCT02841995|75689690|FG001|STARTED|Overall Study||16||
59583141|NCT02841995|75689691|FG002|STARTED|Overall Study||21||
59583142|NCT02841995|75689689|FG000|COMPLETED|Overall Study||0||
59583143|NCT02841995|75689690|FG001|COMPLETED|Overall Study||0||
59583144|NCT02841995|75689691|FG002|COMPLETED|Overall Study||0||
59583145|NCT02841995|75689689|FG000|NOT COMPLETED|Overall Study||17||
59583146|NCT02841995|75689690|FG001|NOT COMPLETED|Overall Study||16||
59583147|NCT02841995|75689691|FG002|NOT COMPLETED|Overall Study||21||
59583148|NCT02771977|75689701|FG000|STARTED|Overall Study||2528||
59583149|NCT02771977|75689702|FG001|STARTED|Overall Study||2532||
59583150|NCT02771977|75689701|FG000|COMPLETED|Overall Study||2528||
59583151|NCT02771977|75689702|FG001|COMPLETED|Overall Study||2532||
59583152|NCT02771977|75689701|FG000|NOT COMPLETED|Overall Study||0||
59583153|NCT02771977|75689702|FG001|NOT COMPLETED|Overall Study||0||
59583154|NCT02643966|75689708|FG000|STARTED|First Screening Round||6266||
59583155|NCT02643966|75689708|FG000|COMPLETED|First Screening Round||6178||
59583156|NCT02643966|75689708|FG000|NOT COMPLETED|First Screening Round||88||
59583157|NCT02643966|75689708|FG000|STARTED|Between First and Second Screening||6178||
59583158|NCT02643966|75689708|FG000|COMPLETED|Between First and Second Screening||6020||
59583159|NCT02643966|75689708|FG000|NOT COMPLETED|Between First and Second Screening||158||
59583160|NCT02643966|75689708|FG000|STARTED|Second Screening Round||6020||
59583161|NCT02643966|75689708|FG000|COMPLETED|Second Screening Round||5937||
59583162|NCT02643966|75689708|FG000|NOT COMPLETED|Second Screening Round||83||
59583163|NCT02643966|75689708|FG000|STARTED|Between Second and Third Screening||5937||
59583164|NCT02643966|75689708|FG000|COMPLETED|Between Second and Third Screening||5680||
59583165|NCT02643966|75689708|FG000|NOT COMPLETED|Between Second and Third Screening||257||
59583166|NCT02643966|75689708|FG000|STARTED|Third Screening Round||5680||
59583167|NCT02643966|75689708|FG000|COMPLETED|Third Screening Round||5437||
59583168|NCT02643966|75689708|FG000|NOT COMPLETED|Third Screening Round||243||
59583169|NCT02579811|75689720|FG000|STARTED|Overall Study||40||
59583170|NCT02579811|75689720|FG000|COMPLETED|Overall Study||40||
59583171|NCT02579811|75689720|FG000|NOT COMPLETED|Overall Study||0||
59583172|NCT02577549|75689726|FG000|STARTED|Overall Study||414||
59583173|NCT02577549|75689727|FG001|STARTED|Overall Study||409||
59583174|NCT02577549|75689726|FG000|COMPLETED|Overall Study||336||
59583175|NCT02577549|75689727|FG001|COMPLETED|Overall Study||332||
59583176|NCT02577549|75689726|FG000|NOT COMPLETED|Overall Study||78||
59583177|NCT02577549|75689727|FG001|NOT COMPLETED|Overall Study||77||
59583178|NCT02554383|75689737|FG000|STARTED|Overall Study||257|Randomized to the treatment group|
59583179|NCT02554383|75689738|FG001|STARTED|Overall Study||258|Randomized to the treatment group|
59583180|NCT02554383|75689737|FG000|COMPLETED|Overall Study||234|Parent completed >=2 diaries Days 2-4 and >= 3 diaries Days 5-11, where Day 1 is day of enrollment|
59583181|NCT02554383|75689738|FG001|COMPLETED|Overall Study||239|Parent completed >=2 diaries Days 2-4 and >= 3 diaries Days 5-11, where Day 1 is day of enrollment|
59583182|NCT02554383|75689737|FG000|NOT COMPLETED|Overall Study||23||
59583183|NCT02554383|75689738|FG001|NOT COMPLETED|Overall Study||19||
59583184|NCT02522871|75689746|FG000|STARTED|Overall Study||153|Enrolled and received liver allograft|
59583185|NCT02522871|75689747|FG001|STARTED|Overall Study||147|Enrolled and received liver allograft|
59583186|NCT02522871|75689746|FG000|As-Treated and Safety Population|Overall Study||153||
59583187|NCT02522871|75689747|FG001|As-Treated and Safety Population|Overall Study||146||
59583188|NCT02522871|75689746|FG000|Modified Intent to Treat Population|Overall Study||152||
59583189|NCT02522871|75689747|FG001|Modified Intent to Treat Population|Overall Study||146||
59583190|NCT02522871|75689746|FG000|Per Protocol Population|Overall Study||151||
59583191|NCT02522871|75689747|FG001|Per Protocol Population|Overall Study||142||
59583192|NCT02522871|75689746|FG000|COMPLETED|Overall Study||142|Completing the 12 month visit.|
59583193|NCT02522871|75689747|FG001|COMPLETED|Overall Study||133|Completing the 12 month visit.|
59583194|NCT02522871|75689746|FG000|NOT COMPLETED|Overall Study||11||
59583195|NCT02522871|75689747|FG001|NOT COMPLETED|Overall Study||14||
59583196|NCT02519439|75689762|FG000|STARTED|Overall Study||26||
59583197|NCT02519439|75689762|FG000|COMPLETED|Overall Study||5||
59583198|NCT02519439|75689762|FG000|NOT COMPLETED|Overall Study||21||
59583199|NCT02378038|75689766|FG000|STARTED|Overall Study||5||
59583200|NCT02378038|75689766|FG000|COMPLETED|Overall Study||0||
59583201|NCT02378038|75689766|FG000|NOT COMPLETED|Overall Study||5||
59583202|NCT02147184|75689772|FG000|STARTED|Overall Study||127||
59583203|NCT02147184|75689773|FG001|STARTED|Overall Study||137||
59583204|NCT02147184|75689772|FG000|COMPLETED|Overall Study||78||
59583205|NCT02147184|75689773|FG001|COMPLETED|Overall Study||110||
59583206|NCT02147184|75689772|FG000|NOT COMPLETED|Overall Study||49||
59583207|NCT02147184|75689773|FG001|NOT COMPLETED|Overall Study||27||
59583208|NCT02101021|75689784|FG000|STARTED|Overall Study||7||
59583209|NCT02101021|75689785|FG001|STARTED|Overall Study||4||
59583210|NCT02101021|75689786|FG002|STARTED|Overall Study||7||
59583211|NCT02101021|75689787|FG003|STARTED|Overall Study||3||
59583212|NCT02101021|75689788|FG004|STARTED|Overall Study||4||
59583213|NCT02101021|75689784|FG000|COMPLETED|Overall Study||0||
59583214|NCT02101021|75689785|FG001|COMPLETED|Overall Study||0||
59583215|NCT02101021|75689786|FG002|COMPLETED|Overall Study||0||
59583216|NCT02101021|75689787|FG003|COMPLETED|Overall Study||0||
59583217|NCT02101021|75689788|FG004|COMPLETED|Overall Study||0||
59583218|NCT02101021|75689784|FG000|NOT COMPLETED|Overall Study||7||
59583219|NCT02101021|75689785|FG001|NOT COMPLETED|Overall Study||4||
59583220|NCT02101021|75689786|FG002|NOT COMPLETED|Overall Study||7||
59583221|NCT02101021|75689787|FG003|NOT COMPLETED|Overall Study||3||
59583222|NCT02101021|75689788|FG004|NOT COMPLETED|Overall Study||4||
59583223|NCT02088632|75689802|FG000|STARTED|Overall Study||3||
59583224|NCT02088632|75689803|FG001|STARTED|Overall Study||3||
59583225|NCT02088632|75689802|FG000|COMPLETED|Overall Study||3||
59583226|NCT02088632|75689803|FG001|COMPLETED|Overall Study||3||
59583227|NCT02088632|75689802|FG000|NOT COMPLETED|Overall Study||0||
59583228|NCT02088632|75689803|FG001|NOT COMPLETED|Overall Study||0||
59583229|NCT02031536|75689813|FG000|STARTED|Overall Study||2||
59583230|NCT02031536|75689814|FG001|STARTED|Overall Study||0||
59583231|NCT02031536|75689813|FG000|COMPLETED|Overall Study||1||
59583232|NCT02031536|75689814|FG001|COMPLETED|Overall Study||0||
59583233|NCT02031536|75689813|FG000|NOT COMPLETED|Overall Study||1||
59583234|NCT02031536|75689814|FG001|NOT COMPLETED|Overall Study||0||
59583235|NCT02028455|75689828|FG000|STARTED|Enrollment and Preliminary Assessments||7||
59583236|NCT02028455|75689829|FG001|STARTED|Enrollment and Preliminary Assessments||12||
59583237|NCT02028455|75689830|FG002|STARTED|Enrollment and Preliminary Assessments||7||
59583238|NCT02028455|75689831|FG003|STARTED|Enrollment and Preliminary Assessments||5||
59583239|NCT02028455|75689832|FG004|STARTED|Enrollment and Preliminary Assessments||6||
59583240|NCT02028455|75689833|FG005|STARTED|Enrollment and Preliminary Assessments||6||
59583241|NCT02028455|75689834|FG006|STARTED|Enrollment and Preliminary Assessments||4||
59583242|NCT02028455|75689835|FG007|STARTED|Enrollment and Preliminary Assessments||120||
59583243|NCT02028455|75689828|FG000|COMPLETED|Enrollment and Preliminary Assessments||7||
59583244|NCT02028455|75689829|FG001|COMPLETED|Enrollment and Preliminary Assessments||12||
59583245|NCT02028455|75689830|FG002|COMPLETED|Enrollment and Preliminary Assessments||7||
59583246|NCT02028455|75689831|FG003|COMPLETED|Enrollment and Preliminary Assessments||5||
59583247|NCT02028455|75689832|FG004|COMPLETED|Enrollment and Preliminary Assessments||6||
59724315|NCT01109849|75842906|FG002|NOT COMPLETED|Initial Randomization: ADHD Treatment||0||
59724316|NCT01109849|75842907|FG003|NOT COMPLETED|Initial Randomization: ADHD Treatment||0||
59724317|NCT01109849|75842908|FG004|NOT COMPLETED|Initial Randomization: ADHD Treatment||0||
59583248|NCT02028455|75689833|FG005|COMPLETED|Enrollment and Preliminary Assessments||6||
59583249|NCT02028455|75689834|FG006|COMPLETED|Enrollment and Preliminary Assessments||0||
59583250|NCT02028455|75689835|FG007|COMPLETED|Enrollment and Preliminary Assessments||103||
59583251|NCT02028455|75689828|FG000|NOT COMPLETED|Enrollment and Preliminary Assessments||0||
59583252|NCT02028455|75689829|FG001|NOT COMPLETED|Enrollment and Preliminary Assessments||0||
59583253|NCT02028455|75689830|FG002|NOT COMPLETED|Enrollment and Preliminary Assessments||0||
59583254|NCT02028455|75689831|FG003|NOT COMPLETED|Enrollment and Preliminary Assessments||0||
59583255|NCT02028455|75689832|FG004|NOT COMPLETED|Enrollment and Preliminary Assessments||0||
59724318|NCT01109849|75842904|FG000|STARTED|Adaptive Randomization: Weight Recovery||0||
59583256|NCT02028455|75689833|FG005|NOT COMPLETED|Enrollment and Preliminary Assessments||0||
59583257|NCT02028455|75689834|FG006|NOT COMPLETED|Enrollment and Preliminary Assessments||4||
59583258|NCT02028455|75689835|FG007|NOT COMPLETED|Enrollment and Preliminary Assessments||17||
59583259|NCT02028455|75689828|FG000|STARTED|Treatment(T Cell Infusion) and Follow up||7||
59583260|NCT02028455|75689829|FG001|STARTED|Treatment(T Cell Infusion) and Follow up||12||
59583261|NCT02028455|75689830|FG002|STARTED|Treatment(T Cell Infusion) and Follow up||7||
59583262|NCT02028455|75689831|FG003|STARTED|Treatment(T Cell Infusion) and Follow up||5||
59583263|NCT02028455|75689832|FG004|STARTED|Treatment(T Cell Infusion) and Follow up||6||
59583264|NCT02028455|75689833|FG005|STARTED|Treatment(T Cell Infusion) and Follow up||6||
59583265|NCT02028455|75689834|FG006|STARTED|Treatment(T Cell Infusion) and Follow up||0||
59583266|NCT02028455|75689835|FG007|STARTED|Treatment(T Cell Infusion) and Follow up||103||
59583267|NCT02028455|75689828|FG000|COMPLETED|Treatment(T Cell Infusion) and Follow up||0||
59583268|NCT02028455|75689829|FG001|COMPLETED|Treatment(T Cell Infusion) and Follow up||0||
59583269|NCT02028455|75689830|FG002|COMPLETED|Treatment(T Cell Infusion) and Follow up||0||
59583270|NCT02028455|75689831|FG003|COMPLETED|Treatment(T Cell Infusion) and Follow up||0||
59583271|NCT02028455|75689832|FG004|COMPLETED|Treatment(T Cell Infusion) and Follow up||0||
59583272|NCT02028455|75689833|FG005|COMPLETED|Treatment(T Cell Infusion) and Follow up||0||
59583273|NCT02028455|75689834|FG006|COMPLETED|Treatment(T Cell Infusion) and Follow up||0||
59583274|NCT02028455|75689835|FG007|COMPLETED|Treatment(T Cell Infusion) and Follow up||0||
59583275|NCT02028455|75689828|FG000|NOT COMPLETED|Treatment(T Cell Infusion) and Follow up||7||
59583276|NCT02028455|75689829|FG001|NOT COMPLETED|Treatment(T Cell Infusion) and Follow up||12||
59583277|NCT02028455|75689830|FG002|NOT COMPLETED|Treatment(T Cell Infusion) and Follow up||7||
59583278|NCT02028455|75689831|FG003|NOT COMPLETED|Treatment(T Cell Infusion) and Follow up||5||
59583279|NCT02028455|75689832|FG004|NOT COMPLETED|Treatment(T Cell Infusion) and Follow up||6||
59583280|NCT02028455|75689833|FG005|NOT COMPLETED|Treatment(T Cell Infusion) and Follow up||6||
59583281|NCT02028455|75689834|FG006|NOT COMPLETED|Treatment(T Cell Infusion) and Follow up||0||
59583282|NCT02028455|75689835|FG007|NOT COMPLETED|Treatment(T Cell Infusion) and Follow up||103||
59583283|NCT02019641|75689859|FG000|STARTED|10-Week Follow up||17||
59583284|NCT02019641|75689860|FG001|STARTED|10-Week Follow up||17||
59583285|NCT02019641|75689861|FG002|STARTED|10-Week Follow up||0||
59583286|NCT02019641|75689859|FG000|COMPLETED|10-Week Follow up||14||
59583287|NCT02019641|75689860|FG001|COMPLETED|10-Week Follow up||16||
59583288|NCT02019641|75689861|FG002|COMPLETED|10-Week Follow up||0||
59583289|NCT02019641|75689859|FG000|NOT COMPLETED|10-Week Follow up||3||
59583290|NCT02019641|75689860|FG001|NOT COMPLETED|10-Week Follow up||1||
59583291|NCT02019641|75689861|FG002|NOT COMPLETED|10-Week Follow up||0||
59583292|NCT02019641|75689859|FG000|STARTED|20-Week Follow up||0||
59583293|NCT02019641|75689860|FG001|STARTED|20-Week Follow up||0||
59583294|NCT02019641|75689861|FG002|STARTED|20-Week Follow up||15||
59583295|NCT02019641|75689859|FG000|COMPLETED|20-Week Follow up||0||
59583296|NCT02019641|75689860|FG001|COMPLETED|20-Week Follow up||0||
59583297|NCT02019641|75689861|FG002|COMPLETED|20-Week Follow up||14||
59583298|NCT02019641|75689859|FG000|NOT COMPLETED|20-Week Follow up||0||
59583299|NCT02019641|75689860|FG001|NOT COMPLETED|20-Week Follow up||0||
59583300|NCT02019641|75689861|FG002|NOT COMPLETED|20-Week Follow up||1||
59583301|NCT01964430|75689870|FG000|STARTED|Pre-Treatment (Randomization) Period||432||
59583302|NCT01964430|75689871|FG001|STARTED|Pre-Treatment (Randomization) Period||434||
59583303|NCT01964430|75689870|FG000|COMPLETED|Pre-Treatment (Randomization) Period||429|Participants continuing to Treatment|
59583304|NCT01964430|75689871|FG001|COMPLETED|Pre-Treatment (Randomization) Period||423|Participants continuing to Treatment|
59583305|NCT01964430|75689870|FG000|NOT COMPLETED|Pre-Treatment (Randomization) Period||3||
59583306|NCT01964430|75689871|FG001|NOT COMPLETED|Pre-Treatment (Randomization) Period||11||
59583307|NCT01964430|75689870|FG000|STARTED|Treatment Period||429||
59583308|NCT01964430|75689871|FG001|STARTED|Treatment Period||423||
59583309|NCT01964430|75689870|FG000|COMPLETED|Treatment Period||287||
59583310|NCT01964430|75689871|FG001|COMPLETED|Treatment Period||310||
59583311|NCT01964430|75689870|FG000|NOT COMPLETED|Treatment Period||142||
59583312|NCT01964430|75689871|FG001|NOT COMPLETED|Treatment Period||113||
59583313|NCT01898494|75689881|FG000|STARTED|Step 1 (Arm S - Transoral Surgery)||49||
59583314|NCT01898494|75689882|FG001|STARTED|Step 1 (Arm S - Transoral Surgery)||126||
59583315|NCT01898494|75689883|FG002|STARTED|Step 1 (Arm S - Transoral Surgery)||132||
59583316|NCT01898494|75689884|FG003|STARTED|Step 1 (Arm S - Transoral Surgery)||138||
59583317|NCT01898494|75689885|FG004|STARTED|Step 1 (Arm S - Transoral Surgery)||74||
59583318|NCT01898494|75689881|FG000|COMPLETED|Step 1 (Arm S - Transoral Surgery)||49||
59583319|NCT01898494|75689882|FG001|COMPLETED|Step 1 (Arm S - Transoral Surgery)||126||
59583320|NCT01898494|75689883|FG002|COMPLETED|Step 1 (Arm S - Transoral Surgery)||132||
59583321|NCT01898494|75689884|FG003|COMPLETED|Step 1 (Arm S - Transoral Surgery)||138||
59583322|NCT01898494|75689885|FG004|COMPLETED|Step 1 (Arm S - Transoral Surgery)||50||
59583323|NCT01898494|75689881|FG000|NOT COMPLETED|Step 1 (Arm S - Transoral Surgery)||0||
59583324|NCT01898494|75689882|FG001|NOT COMPLETED|Step 1 (Arm S - Transoral Surgery)||0||
59583325|NCT01898494|75689883|FG002|NOT COMPLETED|Step 1 (Arm S - Transoral Surgery)||0||
59583326|NCT01898494|75689884|FG003|NOT COMPLETED|Step 1 (Arm S - Transoral Surgery)||0||
59583327|NCT01898494|75689885|FG004|NOT COMPLETED|Step 1 (Arm S - Transoral Surgery)||24||
59583328|NCT01898494|75689881|FG000|STARTED|Step 2 (Adjuvant Treatment)||49||
59583329|NCT01898494|75689882|FG001|STARTED|Step 2 (Adjuvant Treatment)||126||
59583330|NCT01898494|75689883|FG002|STARTED|Step 2 (Adjuvant Treatment)||132||
59583331|NCT01898494|75689884|FG003|STARTED|Step 2 (Adjuvant Treatment)||138||
59583332|NCT01898494|75689885|FG004|STARTED|Step 2 (Adjuvant Treatment)|This group of patients did not proceed to adjuvant treatment on this study. They either received surgery but did not proceed to adjuvant treatment or did not receive surgery in Step 1.|0||
59583333|NCT01898494|75689881|FG000|Treated|Step 2 (Adjuvant Treatment)||49||
59583334|NCT01898494|75689882|FG001|Treated|Step 2 (Adjuvant Treatment)||120||
59583335|NCT01898494|75689883|FG002|Treated|Step 2 (Adjuvant Treatment)||127||
59583336|NCT01898494|75689884|FG003|Treated|Step 2 (Adjuvant Treatment)||134||
59851562|NCT00097370|75976143|FG000|NOT COMPLETED|Stage 2||13||
59851563|NCT00097370|75976143|FG000|STARTED|Stage 3|Participants continued from Stage 2.|59||
59583337|NCT01898494|75689885|FG004|Treated|Step 2 (Adjuvant Treatment)||0||
59583338|NCT01898494|75689881|FG000|Eligible and Treated|Step 2 (Adjuvant Treatment)||38||
59583339|NCT01898494|75689882|FG001|Eligible and Treated|Step 2 (Adjuvant Treatment)||100||
59583340|NCT01898494|75689883|FG002|Eligible and Treated|Step 2 (Adjuvant Treatment)||108||
59583341|NCT01898494|75689884|FG003|Eligible and Treated|Step 2 (Adjuvant Treatment)||113||
59583342|NCT01898494|75689885|FG004|Eligible and Treated|Step 2 (Adjuvant Treatment)||0||
59583343|NCT01898494|75689881|FG000|Eligible and Treated Patients With Baseline MDADI Assessed|Step 2 (Adjuvant Treatment)||35||
59583344|NCT01898494|75689882|FG001|Eligible and Treated Patients With Baseline MDADI Assessed|Step 2 (Adjuvant Treatment)||91||
59583345|NCT01898494|75689883|FG002|Eligible and Treated Patients With Baseline MDADI Assessed|Step 2 (Adjuvant Treatment)||99||
59583346|NCT01898494|75689884|FG003|Eligible and Treated Patients With Baseline MDADI Assessed|Step 2 (Adjuvant Treatment)||102||
59583347|NCT01898494|75689885|FG004|Eligible and Treated Patients With Baseline MDADI Assessed|Step 2 (Adjuvant Treatment)||0||
59583348|NCT01898494|75689881|FG000|Eligible and Treated Patients With Post-surgery MDADI Assessed|Step 2 (Adjuvant Treatment)||31||
59583349|NCT01898494|75689882|FG001|Eligible and Treated Patients With Post-surgery MDADI Assessed|Step 2 (Adjuvant Treatment)||83||
59583350|NCT01898494|75689883|FG002|Eligible and Treated Patients With Post-surgery MDADI Assessed|Step 2 (Adjuvant Treatment)||88||
59583351|NCT01898494|75689884|FG003|Eligible and Treated Patients With Post-surgery MDADI Assessed|Step 2 (Adjuvant Treatment)||94||
59583352|NCT01898494|75689885|FG004|Eligible and Treated Patients With Post-surgery MDADI Assessed|Step 2 (Adjuvant Treatment)||0||
59583353|NCT01898494|75689881|FG000|Eligible and Treated Patients With FACT-H&N Assessed at 6 Months|Step 2 (Adjuvant Treatment)||21||
59583354|NCT01898494|75689882|FG001|Eligible and Treated Patients With FACT-H&N Assessed at 6 Months|Step 2 (Adjuvant Treatment)||75||
59583355|NCT01898494|75689883|FG002|Eligible and Treated Patients With FACT-H&N Assessed at 6 Months|Step 2 (Adjuvant Treatment)||80||
59583356|NCT01898494|75689884|FG003|Eligible and Treated Patients With FACT-H&N Assessed at 6 Months|Step 2 (Adjuvant Treatment)||77||
59583357|NCT01898494|75689885|FG004|Eligible and Treated Patients With FACT-H&N Assessed at 6 Months|Step 2 (Adjuvant Treatment)||0||
59583358|NCT01898494|75689881|FG000|COMPLETED|Step 2 (Adjuvant Treatment)||49||
59583359|NCT01898494|75689882|FG001|COMPLETED|Step 2 (Adjuvant Treatment)||119||
59583360|NCT01898494|75689883|FG002|COMPLETED|Step 2 (Adjuvant Treatment)||118||
59583361|NCT01898494|75689884|FG003|COMPLETED|Step 2 (Adjuvant Treatment)||127||
59583362|NCT01898494|75689885|FG004|COMPLETED|Step 2 (Adjuvant Treatment)||0||
59583363|NCT01898494|75689881|FG000|NOT COMPLETED|Step 2 (Adjuvant Treatment)||0||
59583364|NCT01898494|75689882|FG001|NOT COMPLETED|Step 2 (Adjuvant Treatment)||7||
59583365|NCT01898494|75689883|FG002|NOT COMPLETED|Step 2 (Adjuvant Treatment)||14||
59583366|NCT01898494|75689884|FG003|NOT COMPLETED|Step 2 (Adjuvant Treatment)||11||
59583367|NCT01898494|75689885|FG004|NOT COMPLETED|Step 2 (Adjuvant Treatment)||0||
59583368|NCT01863043|75689899|FG000|STARTED|Overall Study||74||
59583369|NCT01863043|75689900|FG001|STARTED|Overall Study||72||
59583370|NCT01863043|75689899|FG000|COMPLETED|Overall Study||61||
59583371|NCT01863043|75689900|FG001|COMPLETED|Overall Study||60||
59583372|NCT01863043|75689899|FG000|NOT COMPLETED|Overall Study||13||
59583373|NCT01863043|75689900|FG001|NOT COMPLETED|Overall Study||12||
59583374|NCT01841359|75689906|FG000|STARTED|Overall Study||22||
59583375|NCT01841359|75689906|FG000|COMPLETED|Overall Study||14||
59583376|NCT01841359|75689906|FG000|NOT COMPLETED|Overall Study||8||
59583377|NCT01660451|75689916|FG000|STARTED|Overall Study||33||
59583378|NCT01660451|75689917|FG001|STARTED|Overall Study||51||
59583379|NCT01660451|75689918|FG002|STARTED|Overall Study||142||
59583380|NCT01660451|75689916|FG000|COMPLETED|Overall Study||16||
59583381|NCT01660451|75689917|FG001|COMPLETED|Overall Study||34||
59583382|NCT01660451|75689918|FG002|COMPLETED|Overall Study||37||
59583383|NCT01660451|75689916|FG000|NOT COMPLETED|Overall Study||17||
59583384|NCT01660451|75689917|FG001|NOT COMPLETED|Overall Study||17||
59583385|NCT01660451|75689918|FG002|NOT COMPLETED|Overall Study||105||
59583386|NCT01586065|75689927|FG000|STARTED|Overall Study||10||
59583387|NCT01586065|75689927|FG000|COMPLETED|Overall Study||10||
59583388|NCT01586065|75689927|FG000|NOT COMPLETED|Overall Study||0||
59583389|NCT01390584|75689937|FG000|STARTED|Step 1: Induction Tx (ABVD Then PET/CT)||4||
59583390|NCT01390584|75689938|FG001|STARTED|Step 1: Induction Tx (ABVD Then PET/CT)||1||
59583391|NCT01390584|75689939|FG002|STARTED|Step 1: Induction Tx (ABVD Then PET/CT)||1||
59583392|NCT01390584|75689937|FG000|COMPLETED|Step 1: Induction Tx (ABVD Then PET/CT)||4||
60121569|NCT01684943|76242466|FG001|NOT COMPLETED|Overall Study||1||
59583393|NCT01390584|75689938|FG001|COMPLETED|Step 1: Induction Tx (ABVD Then PET/CT)||1||
59583394|NCT01390584|75689939|FG002|COMPLETED|Step 1: Induction Tx (ABVD Then PET/CT)||0||
59583395|NCT01390584|75689937|FG000|NOT COMPLETED|Step 1: Induction Tx (ABVD Then PET/CT)||0||
59583396|NCT01390584|75689938|FG001|NOT COMPLETED|Step 1: Induction Tx (ABVD Then PET/CT)||0||
59583397|NCT01390584|75689939|FG002|NOT COMPLETED|Step 1: Induction Tx (ABVD Then PET/CT)||1||
59583398|NCT01390584|75689937|FG000|STARTED|Step 2: ABVD or BEACOPP Then INRT||4||
59583399|NCT01390584|75689938|FG001|STARTED|Step 2: ABVD or BEACOPP Then INRT||1||
59583400|NCT01390584|75689939|FG002|STARTED|Step 2: ABVD or BEACOPP Then INRT||0||
59583401|NCT01390584|75689937|FG000|COMPLETED|Step 2: ABVD or BEACOPP Then INRT||4||
59583402|NCT01390584|75689938|FG001|COMPLETED|Step 2: ABVD or BEACOPP Then INRT||1||
59583403|NCT01390584|75689939|FG002|COMPLETED|Step 2: ABVD or BEACOPP Then INRT||0||
59583404|NCT01390584|75689937|FG000|NOT COMPLETED|Step 2: ABVD or BEACOPP Then INRT||0||
59583405|NCT01390584|75689938|FG001|NOT COMPLETED|Step 2: ABVD or BEACOPP Then INRT||0||
59583406|NCT01390584|75689939|FG002|NOT COMPLETED|Step 2: ABVD or BEACOPP Then INRT||0||
59583407|NCT01242800|75689950|FG000|STARTED|Overall Study||131||
59583408|NCT01242800|75689951|FG001|STARTED|Overall Study||125||
59583409|NCT01242800|75689950|FG000|COMPLETED|Overall Study|Patient continued their systemic therapy after randomization per their treating physician's discretion.|131||
59583410|NCT01242800|75689951|FG001|COMPLETED|Overall Study|Protocol therapy was early surgery and/or radiation therapy in this trial.|106||
59583411|NCT01242800|75689950|FG000|NOT COMPLETED|Overall Study||0||
59583412|NCT01242800|75689951|FG001|NOT COMPLETED|Overall Study||19||
59583413|NCT01216683|75689960|FG000|STARTED|Induction||65||
59583414|NCT01216683|75689961|FG001|STARTED|Induction||99||
59583415|NCT01216683|75689962|FG002|STARTED|Induction||125||
59583416|NCT01216683|75689960|FG000|Received Treatment and Assessed for Toxicities|Induction||65||
59583417|NCT01216683|75689961|FG001|Received Treatment and Assessed for Toxicities|Induction||93||
59583418|NCT01216683|75689962|FG002|Received Treatment and Assessed for Toxicities|Induction||122||
59583419|NCT01216683|75689960|FG000|Eligible and Treated|Induction||59||
59583420|NCT01216683|75689961|FG001|Eligible and Treated|Induction||85||
59583421|NCT01216683|75689962|FG002|Eligible and Treated|Induction||114||
59583422|NCT01216683|75689960|FG000|Included in the Primary Analysis of Complete Remission Rate During Induction Treatment|Induction||48||
59583423|NCT01216683|75689961|FG001|Included in the Primary Analysis of Complete Remission Rate During Induction Treatment|Induction||85||
59583424|NCT01216683|75689962|FG002|Included in the Primary Analysis of Complete Remission Rate During Induction Treatment|Induction||89||
59583425|NCT01216683|75689960|FG000|COMPLETED|Induction||61||
59583426|NCT01216683|75689961|FG001|COMPLETED|Induction||80||
59583427|NCT01216683|75689962|FG002|COMPLETED|Induction||104||
59583428|NCT01216683|75689960|FG000|NOT COMPLETED|Induction||4||
59583429|NCT01216683|75689961|FG001|NOT COMPLETED|Induction||19||
59583430|NCT01216683|75689962|FG002|NOT COMPLETED|Induction||21||
59583431|NCT01216683|75689960|FG000|STARTED|Continuation||59||
59583432|NCT01216683|75689961|FG001|STARTED|Continuation||71||
59583433|NCT01216683|75689962|FG002|STARTED|Continuation||94||
59583434|NCT01216683|75689960|FG000|Received Continuation Treatment|Continuation||59||
59583435|NCT01216683|75689961|FG001|Received Continuation Treatment|Continuation||70||
59583436|NCT01216683|75689962|FG002|Received Continuation Treatment|Continuation||89||
59583437|NCT01216683|75689960|FG000|COMPLETED|Continuation||44||
59583438|NCT01216683|75689961|FG001|COMPLETED|Continuation||56||
59583439|NCT01216683|75689962|FG002|COMPLETED|Continuation||51||
59583440|NCT01216683|75689960|FG000|NOT COMPLETED|Continuation||15||
59583441|NCT01216683|75689961|FG001|NOT COMPLETED|Continuation||15||
59583442|NCT01216683|75689962|FG002|NOT COMPLETED|Continuation||43||
59583443|NCT01145495|75689983|FG000|STARTED|Overall Study||65||
59583444|NCT01145495|75689983|FG000|COMPLETED|Overall Study||51||
59583445|NCT01145495|75689983|FG000|NOT COMPLETED|Overall Study||14||
59583446|NCT01124695|75689989|FG000|STARTED|Overall Study||124||
59583447|NCT01124695|75689989|FG000|Treated|Overall Study||122||
59583448|NCT01124695|75689989|FG000|Eligible and Treated|Overall Study||113||
59583449|NCT01124695|75689989|FG000|Eligible and Treated and Had CYP2D6 Score|Overall Study||85||
59583450|NCT01124695|75689989|FG000|Eligible and Treated and Had Cycle 3 Edoxifen Evaluation|Overall Study||63||
59583451|NCT01124695|75689989|FG000|Eligible and Treated Patients With 3-month Endoxifen and Were Progression-free and Alive at 3 Months|Overall Study||43||
59583452|NCT01124695|75689989|FG000|COMPLETED|Overall Study||1||
59851564|NCT00097370|75976143|FG000|COMPLETED|Stage 3||0||
59851565|NCT00097370|75976143|FG000|NOT COMPLETED|Stage 3||59||
59851566|NCT03515824|75976150|FG000|STARTED|Overall Study||3||
60121570|NCT01684943|76242467|FG002|NOT COMPLETED|Overall Study||1||
59851567|NCT03515824|75976151|FG001|STARTED|Overall Study||4||
60121571|NCT01683383|76242482|FG000|STARTED|Overall Study||50||
59583453|NCT01124695|75689989|FG000|NOT COMPLETED|Overall Study||123||
59583454|NCT01084083|75690000|FG000|STARTED|Overall Study||90||
59583455|NCT01084083|75690000|FG000|Treated|Overall Study|This is the all treated patients for toxicity analysis|89||
59583456|NCT01084083|75690000|FG000|Eligible|Overall Study||81||
59583457|NCT01084083|75690000|FG000|Eligible and Treated|Overall Study|This is the eligible and treated patients for secondary efficacy endpoints|80||
59583458|NCT01084083|75690000|FG000|CR to Induction Therapy|Overall Study||56||
59851568|NCT03515824|75976152|FG002|STARTED|Overall Study||15||
60121572|NCT01683383|76242483|FG001|STARTED|Overall Study||51||
59583459|NCT01084083|75690000|FG000|CR and Treated With 5400 cGy IMRT|Overall Study|This is the primary study population for the primary endpoint (24-month PFS).|44||
59583460|NCT01084083|75690000|FG000|COMPLETED|Overall Study||78||
59583461|NCT01084083|75690000|FG000|NOT COMPLETED|Overall Study||12||
59583462|NCT01079780|75690008|FG000|STARTED|Overall Study||70||
59583463|NCT01079780|75690009|FG001|STARTED|Overall Study||16||
59583464|NCT01079780|75690010|FG002|STARTED|Overall Study||50||
59583465|NCT01079780|75690008|FG000|Started Protocol Therapy|Overall Study||69||
59583466|NCT01079780|75690009|FG001|Started Protocol Therapy|Overall Study||16||
59583467|NCT01079780|75690010|FG002|Started Protocol Therapy|Overall Study||48||
59583468|NCT01079780|75690008|FG000|Treated Patients With Toxicity Data Available|Overall Study||68||
59583469|NCT01079780|75690009|FG001|Treated Patients With Toxicity Data Available|Overall Study||16||
59583470|NCT01079780|75690010|FG002|Treated Patients With Toxicity Data Available|Overall Study||48||
59583471|NCT01079780|75690008|FG000|Eligible and Treated|Overall Study||62||
59583472|NCT01079780|75690009|FG001|Eligible and Treated|Overall Study||16||
59583473|NCT01079780|75690010|FG002|Eligible and Treated|Overall Study||45||
59583474|NCT01079780|75690008|FG000|Analyzable Patients for Efficacy Analysis|Overall Study||44||
59583475|NCT01079780|75690009|FG001|Analyzable Patients for Efficacy Analysis|Overall Study||0||
59583476|NCT01079780|75690010|FG002|Analyzable Patients for Efficacy Analysis|Overall Study||45||
59583477|NCT01079780|75690008|FG000|COMPLETED|Overall Study||0||
59583478|NCT01079780|75690009|FG001|COMPLETED|Overall Study||0||
59583479|NCT01079780|75690010|FG002|COMPLETED|Overall Study||0||
59583480|NCT01079780|75690008|FG000|NOT COMPLETED|Overall Study||70||
59583481|NCT01079780|75690009|FG001|NOT COMPLETED|Overall Study||16||
59583482|NCT01079780|75690010|FG002|NOT COMPLETED|Overall Study||50||
59583483|NCT01013961|75690020|FG000|STARTED|Overall Study||16||
59583484|NCT01013961|75690021|FG001|STARTED|Overall Study||15||
59583485|NCT01013961|75690020|FG000|COMPLETED|Overall Study||13||
59583486|NCT01013961|75690021|FG001|COMPLETED|Overall Study||12||
59583487|NCT01013961|75690020|FG000|NOT COMPLETED|Overall Study||3||
59583488|NCT01013961|75690021|FG001|NOT COMPLETED|Overall Study||3||
59583489|NCT00980590|75690029|FG000|STARTED|Overall Study||50||
59583490|NCT00980590|75690030|FG001|STARTED|Overall Study||50||
59583491|NCT00980590|75690029|FG000|COMPLETED|Overall Study||50||
59583492|NCT00980590|75690030|FG001|COMPLETED|Overall Study||50||
59583493|NCT00980590|75690029|FG000|NOT COMPLETED|Overall Study||0||
59583494|NCT00980590|75690030|FG001|NOT COMPLETED|Overall Study||0||
59583495|NCT00834093|75690036|FG000|STARTED|Overall Study||18||
59583496|NCT00834093|75690036|FG000|Eligible and Treated|Overall Study||13||
59583497|NCT00834093|75690036|FG000|COMPLETED|Overall Study||10||
59583498|NCT00834093|75690036|FG000|NOT COMPLETED|Overall Study||8||
59583499|NCT00606294|75690042|FG000|STARTED|Overall Study||197||
59583500|NCT00606294|75690043|FG001|STARTED|Overall Study||19||
59583501|NCT00606294|75690042|FG000|COMPLETED|Overall Study||161||
59583502|NCT00606294|75690043|FG001|COMPLETED|Overall Study||19||
59583503|NCT00606294|75690042|FG000|NOT COMPLETED|Overall Study||36||
59583504|NCT00606294|75690043|FG001|NOT COMPLETED|Overall Study||0||
59583505|NCT00583596|75690049|FG000|STARTED|Overall Study|Subjects in Phase 2 clinical trial who received the AMPLATZER Duct Occluder.|436||
59583506|NCT00583596|75690049|FG000|COMPLETED|Overall Study||152||
59583507|NCT00583596|75690049|FG000|NOT COMPLETED|Overall Study||284||
59583508|NCT00330564|75690054|FG000|STARTED|Overall Study||15||
59583509|NCT00330564|75690054|FG000|COMPLETED|Overall Study||15||
59583510|NCT00330564|75690054|FG000|NOT COMPLETED|Overall Study||0||
59583511|NCT00316888|75690060|FG000|STARTED|Overall Study||28||
59583512|NCT00316888|75690061|FG001|STARTED|Overall Study||35||
59583513|NCT00316888|75690060|FG000|Eligible|Overall Study||28||
59583514|NCT00316888|75690061|FG001|Eligible|Overall Study||35||
59583515|NCT00316888|75690060|FG000|Treated|Overall Study|Received induction and/or chemo+radiation therapy|28||
59583516|NCT00316888|75690061|FG001|Treated|Overall Study||34||
59583517|NCT00316888|75690060|FG000|Started Induction Chemotherapy|Overall Study||28||
59583518|NCT00316888|75690061|FG001|Started Induction Chemotherapy|Overall Study|Induction chemotherapy was removed for patients on this arm|0||
59583519|NCT00316888|75690060|FG000|Started Chemo+Radiation+Cetuximab|Overall Study|One patient did not start chemo+radiation therapy after completing induction therapy|27||
59583520|NCT00316888|75690061|FG001|Started Chemo+Radiation+Cetuximab|Overall Study||34||
59583521|NCT00316888|75690060|FG000|COMPLETED|Overall Study||22||
59583522|NCT00316888|75690061|FG001|COMPLETED|Overall Study||27||
59583523|NCT00316888|75690060|FG000|NOT COMPLETED|Overall Study||6||
59583524|NCT00316888|75690061|FG001|NOT COMPLETED|Overall Study||8||
59583525|NCT00274924|75690070|FG000|STARTED|Step 1 (R-CHOP X 3 Cycles)||17||
59583526|NCT00274924|75690071|FG001|STARTED|Step 1 (R-CHOP X 3 Cycles)||77||
59724319|NCT01109849|75842905|FG001|STARTED|Adaptive Randomization: Weight Recovery||0||
59583527|NCT00274924|75690072|FG002|STARTED|Step 1 (R-CHOP X 3 Cycles)||6||
59583528|NCT00274924|75690070|FG000|Treated|Step 1 (R-CHOP X 3 Cycles)||17||
59583529|NCT00274924|75690071|FG001|Treated|Step 1 (R-CHOP X 3 Cycles)||77||
59583530|NCT00274924|75690072|FG002|Treated|Step 1 (R-CHOP X 3 Cycles)||5||
59583531|NCT00274924|75690070|FG000|Eligible and Treated|Step 1 (R-CHOP X 3 Cycles)||13||
59583532|NCT00274924|75690071|FG001|Eligible and Treated|Step 1 (R-CHOP X 3 Cycles)||63||
59583533|NCT00274924|75690072|FG002|Eligible and Treated|Step 1 (R-CHOP X 3 Cycles)||4||
59583534|NCT00274924|75690070|FG000|COMPLETED|Step 1 (R-CHOP X 3 Cycles)||13||
59583535|NCT00274924|75690071|FG001|COMPLETED|Step 1 (R-CHOP X 3 Cycles)||63||
59583536|NCT00274924|75690072|FG002|COMPLETED|Step 1 (R-CHOP X 3 Cycles)||0||
59583537|NCT00274924|75690070|FG000|NOT COMPLETED|Step 1 (R-CHOP X 3 Cycles)||4||
59583538|NCT00274924|75690071|FG001|NOT COMPLETED|Step 1 (R-CHOP X 3 Cycles)||14||
59583539|NCT00274924|75690072|FG002|NOT COMPLETED|Step 1 (R-CHOP X 3 Cycles)||6||
59583540|NCT00274924|75690070|FG000|STARTED|Step 2 (Tx Based on Mid-treatment PET)|All patients who started step 2 therapy were included regardless of eligibility.|17||
59583541|NCT00274924|75690071|FG001|STARTED|Step 2 (Tx Based on Mid-treatment PET)|One patient withdrew from the study after step 1 treatment.|76||
59583542|NCT00274924|75690072|FG002|STARTED|Step 2 (Tx Based on Mid-treatment PET)||0||
59583543|NCT00274924|75690070|FG000|Eligible and Treated|Step 2 (Tx Based on Mid-treatment PET)||13||
59583544|NCT00274924|75690071|FG001|Eligible and Treated|Step 2 (Tx Based on Mid-treatment PET)||61||
59583545|NCT00274924|75690072|FG002|Eligible and Treated|Step 2 (Tx Based on Mid-treatment PET)||0||
59583546|NCT00274924|75690070|FG000|COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||10||
59583547|NCT00274924|75690071|FG001|COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||58||
59583548|NCT00274924|75690072|FG002|COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||0||
59583549|NCT00274924|75690070|FG000|NOT COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||7||
59583550|NCT00274924|75690071|FG001|NOT COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||18||
59583551|NCT00274924|75690072|FG002|NOT COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||0||
59583552|NCT00104884|75690079|FG000|STARTED|Overall Study||4||
59583553|NCT00104884|75690079|FG000|COMPLETED|Overall Study||0||
59583554|NCT00104884|75690079|FG000|NOT COMPLETED|Overall Study||4||
59583555|NCT00096174|75690083|FG000|STARTED|Overall Study||69||
59583556|NCT00096174|75690083|FG000|Began Protocol Therapy|Overall Study|3 patients never started treatment|66||
59583557|NCT00096174|75690083|FG000|Eligible and Treated|Overall Study|6 treated patients were ineligible|60||
59583558|NCT00096174|75690083|FG000|COMPLETED|Overall Study||7||
59583559|NCT00096174|75690083|FG000|NOT COMPLETED|Overall Study||62||
59583560|NCT00080938|75690087|FG000|STARTED|Overall Study||26||
59583561|NCT00080938|75690087|FG000|Began Protocol Therapy|Overall Study||25||
59583562|NCT00080938|75690087|FG000|Eligible and Treated|Overall Study||21||
59583563|NCT00080938|75690087|FG000|COMPLETED|Overall Study||2||
59583564|NCT00080938|75690087|FG000|NOT COMPLETED|Overall Study||24||
59583565|NCT00074282|75690091|FG000|STARTED|Step 1||102||
59583566|NCT00074282|75690092|FG001|STARTED|Step 1||0||
59583567|NCT00074282|75690093|FG002|STARTED|Step 1||0||
59583568|NCT00074282|75690091|FG000|Eligible|Step 1||98||
59583569|NCT00074282|75690092|FG001|Eligible|Step 1||0||
59583570|NCT00074282|75690093|FG002|Eligible|Step 1||0||
59583571|NCT00074282|75690091|FG000|Started Treatment|Step 1||96||
59583572|NCT00074282|75690092|FG001|Started Treatment|Step 1||0||
59583573|NCT00074282|75690093|FG002|Started Treatment|Step 1||0||
59583574|NCT00074282|75690091|FG000|COMPLETED|Step 1||44||
59583575|NCT00074282|75690092|FG001|COMPLETED|Step 1||0||
59583576|NCT00074282|75690093|FG002|COMPLETED|Step 1||0||
59583577|NCT00074282|75690091|FG000|NOT COMPLETED|Step 1||58||
59583578|NCT00074282|75690092|FG001|NOT COMPLETED|Step 1||0||
59583579|NCT00074282|75690093|FG002|NOT COMPLETED|Step 1||0||
59583580|NCT00074282|75690091|FG000|STARTED|Step 2||0||
59583581|NCT00074282|75690092|FG001|STARTED|Step 2||9||
59583582|NCT00074282|75690093|FG002|STARTED|Step 2||31||
59583583|NCT00074282|75690091|FG000|COMPLETED|Step 2||0||
59583584|NCT00074282|75690092|FG001|COMPLETED|Step 2||7||
59583585|NCT00074282|75690093|FG002|COMPLETED|Step 2||7||
59583586|NCT00074282|75690091|FG000|NOT COMPLETED|Step 2||0||
59583587|NCT00074282|75690092|FG001|NOT COMPLETED|Step 2||2||
59583588|NCT00074282|75690093|FG002|NOT COMPLETED|Step 2||24||
59583589|NCT00071981|75690105|FG000|STARTED|Overall Study||47||
60121573|NCT01683383|76242482|FG000|Transported and Treated|Overall Study||49||
59583590|NCT00071981|75690106|FG001|STARTED|Overall Study||43||
59583591|NCT00071981|75690107|FG002|STARTED|Overall Study||37||
59583592|NCT00071981|75690108|FG003|STARTED|Overall Study||48||
59583593|NCT00071981|75690105|FG000|Eligible|Overall Study||43||
59583594|NCT00071981|75690106|FG001|Eligible|Overall Study||36||
59583595|NCT00071981|75690107|FG002|Eligible|Overall Study||33||
59583596|NCT00071981|75690108|FG003|Eligible|Overall Study||42||
59583597|NCT00071981|75690105|FG000|Treated|Overall Study||45||
59583598|NCT00071981|75690106|FG001|Treated|Overall Study||38||
59583599|NCT00071981|75690107|FG002|Treated|Overall Study||36||
59583600|NCT00071981|75690108|FG003|Treated|Overall Study||48||
59583601|NCT00071981|75690105|FG000|Eligible and Treated|Overall Study||41||
59583602|NCT00071981|75690106|FG001|Eligible and Treated|Overall Study||33||
59583603|NCT00071981|75690107|FG002|Eligible and Treated|Overall Study||32||
59583604|NCT00071981|75690108|FG003|Eligible and Treated|Overall Study||42||
59583605|NCT00071981|75690105|FG000|Have CTL Response Data|Overall Study||40||
59583606|NCT00071981|75690106|FG001|Have CTL Response Data|Overall Study||30||
59583607|NCT00071981|75690107|FG002|Have CTL Response Data|Overall Study||29||
59583608|NCT00071981|75690108|FG003|Have CTL Response Data|Overall Study||41||
59724320|NCT01109849|75842906|FG002|STARTED|Adaptive Randomization: Weight Recovery||24||
59583609|NCT00071981|75690105|FG000|Have Helper T Cell Response Data|Overall Study||37||
59583610|NCT00071981|75690106|FG001|Have Helper T Cell Response Data|Overall Study||27||
59583611|NCT00071981|75690107|FG002|Have Helper T Cell Response Data|Overall Study||25||
59583612|NCT00071981|75690108|FG003|Have Helper T Cell Response Data|Overall Study||39||
59583613|NCT00071981|75690105|FG000|COMPLETED|Overall Study||1||
59583614|NCT00071981|75690106|FG001|COMPLETED|Overall Study||2||
59583615|NCT00071981|75690107|FG002|COMPLETED|Overall Study||0||
59583616|NCT00071981|75690108|FG003|COMPLETED|Overall Study||3||
59583617|NCT00071981|75690105|FG000|NOT COMPLETED|Overall Study||46||
59583618|NCT00071981|75690106|FG001|NOT COMPLETED|Overall Study||41||
59583619|NCT00071981|75690107|FG002|NOT COMPLETED|Overall Study||37||
59583620|NCT00071981|75690108|FG003|NOT COMPLETED|Overall Study||45||
59583621|NCT00070291|75690118|FG000|STARTED|Step 1||4||
59583622|NCT00070291|75690118|FG000|Treated|Step 1||3||
59583623|NCT00070291|75690118|FG000|COMPLETED|Step 1||2||
59583624|NCT00070291|75690118|FG000|NOT COMPLETED|Step 1||2||
59583625|NCT00070291|75690118|FG000|STARTED|Step 2|One patient completed step 1, but opted to get alternative therapy. One patient entered step 2.|1||
59583626|NCT00070291|75690118|FG000|COMPLETED|Step 2||0||
59583627|NCT00070291|75690118|FG000|NOT COMPLETED|Step 2||1||
59583628|NCT00064350|75690125|FG000|STARTED|Induction Treatment||59||
59583629|NCT00064350|75690126|FG001|STARTED|Induction Treatment||46||
59583630|NCT00064350|75690127|FG002|STARTED|Induction Treatment||237||
59583631|NCT00064350|75690125|FG000|Treated|Induction Treatment||59||
59583632|NCT00064350|75690126|FG001|Treated|Induction Treatment||46||
59583633|NCT00064350|75690127|FG002|Treated|Induction Treatment||228||
59583634|NCT00064350|75690125|FG000|Eligible and Treated|Induction Treatment||59||
59583635|NCT00064350|75690126|FG001|Eligible and Treated|Induction Treatment||46||
59583636|NCT00064350|75690127|FG002|Eligible and Treated|Induction Treatment||194||
59583637|NCT00064350|75690125|FG000|COMPLETED|Induction Treatment||51||
59583638|NCT00064350|75690126|FG001|COMPLETED|Induction Treatment||37||
59583639|NCT00064350|75690127|FG002|COMPLETED|Induction Treatment||1||
59583640|NCT00064350|75690125|FG000|NOT COMPLETED|Induction Treatment||8||
59583641|NCT00064350|75690126|FG001|NOT COMPLETED|Induction Treatment||9||
59583642|NCT00064350|75690127|FG002|NOT COMPLETED|Induction Treatment||236||
59583643|NCT00064350|75690125|FG000|STARTED|Randomization||59||
59583644|NCT00064350|75690126|FG001|STARTED|Randomization||46||
59583645|NCT00064350|75690127|FG002|STARTED|Randomization||0||
59724321|NCT01109849|75842907|FG003|STARTED|Adaptive Randomization: Weight Recovery||23||
59583646|NCT00064350|75690125|FG000|Treated|Randomization||55||
59583647|NCT00064350|75690126|FG001|Treated|Randomization||40||
59583648|NCT00064350|75690127|FG002|Treated|Randomization||0||
59583649|NCT00064350|75690125|FG000|Eligible and Treated|Randomization||50||
59583650|NCT00064350|75690126|FG001|Eligible and Treated|Randomization||31||
59724322|NCT01109849|75842908|FG004|STARTED|Adaptive Randomization: Weight Recovery||25||
59724323|NCT01109849|75842904|FG000|COMPLETED|Adaptive Randomization: Weight Recovery||0||
59724324|NCT01109849|75842905|FG001|COMPLETED|Adaptive Randomization: Weight Recovery||0||
59724325|NCT01109849|75842906|FG002|COMPLETED|Adaptive Randomization: Weight Recovery||23||
59724326|NCT01109849|75842907|FG003|COMPLETED|Adaptive Randomization: Weight Recovery||20||
59724327|NCT01109849|75842908|FG004|COMPLETED|Adaptive Randomization: Weight Recovery||24||
59724328|NCT01109849|75842904|FG000|NOT COMPLETED|Adaptive Randomization: Weight Recovery||0||
59724329|NCT01109849|75842905|FG001|NOT COMPLETED|Adaptive Randomization: Weight Recovery||0||
59724330|NCT01109849|75842906|FG002|NOT COMPLETED|Adaptive Randomization: Weight Recovery||1||
59724331|NCT01109849|75842907|FG003|NOT COMPLETED|Adaptive Randomization: Weight Recovery||3||
59724332|NCT01109849|75842908|FG004|NOT COMPLETED|Adaptive Randomization: Weight Recovery||1||
59724333|NCT01061736|75842938|FG000|STARTED|Overall Study||50||
60121574|NCT01683383|76242483|FG001|Transported and Treated|Overall Study||51||
59583651|NCT00064350|75690127|FG002|Eligible and Treated|Randomization||0||
59583652|NCT00064350|75690125|FG000|COMPLETED|Randomization||33||
59583653|NCT00064350|75690126|FG001|COMPLETED|Randomization||28||
59583654|NCT00064350|75690127|FG002|COMPLETED|Randomization||0||
59583655|NCT00064350|75690125|FG000|NOT COMPLETED|Randomization||26||
59583656|NCT00064350|75690126|FG001|NOT COMPLETED|Randomization||18||
59583657|NCT00064350|75690127|FG002|NOT COMPLETED|Randomization||0||
59583658|NCT00064350|75690125|FG000|STARTED|Cross-Over||10||
59583659|NCT00064350|75690126|FG001|STARTED|Cross-Over||27||
59583660|NCT00064350|75690127|FG002|STARTED|Cross-Over||0||
59583661|NCT00064350|75690125|FG000|Treated|Cross-Over||9||
59583662|NCT00064350|75690126|FG001|Treated|Cross-Over||26||
59583663|NCT00064350|75690127|FG002|Treated|Cross-Over||0||
59583664|NCT00064350|75690125|FG000|Eligible and Treated|Cross-Over||7||
59583665|NCT00064350|75690126|FG001|Eligible and Treated|Cross-Over||21||
59583666|NCT00064350|75690127|FG002|Eligible and Treated|Cross-Over||0||
59583667|NCT00064350|75690125|FG000|COMPLETED|Cross-Over||4||
59583668|NCT00064350|75690126|FG001|COMPLETED|Cross-Over||13||
59583669|NCT00064350|75690127|FG002|COMPLETED|Cross-Over||0||
59583670|NCT00064350|75690125|FG000|NOT COMPLETED|Cross-Over||6||
59583671|NCT00064350|75690126|FG001|NOT COMPLETED|Cross-Over||14||
59583672|NCT00064350|75690127|FG002|NOT COMPLETED|Cross-Over||0||
59583673|NCT00063986|75690136|FG000|STARTED|Overall Study||110||
59583674|NCT00063986|75690136|FG000|Treated|Overall Study||105||
59583675|NCT00063986|75690136|FG000|Eligible and Treated|Overall Study||104||
59583676|NCT00063986|75690136|FG000|COMPLETED|Overall Study||104||
59583677|NCT00063986|75690136|FG000|NOT COMPLETED|Overall Study||6||
59583678|NCT00060346|75690140|FG000|STARTED|Overall Study||16||
59583679|NCT00060346|75690140|FG000|Eligible and Treated|Overall Study||16||
59583680|NCT00060346|75690140|FG000|COMPLETED|Overall Study||16||
59583681|NCT00060346|75690140|FG000|NOT COMPLETED|Overall Study||0||
59583682|NCT00057954|75690144|FG000|STARTED|Overall Study||6||
59583683|NCT00057954|75690144|FG000|COMPLETED|Overall Study||4||
59583684|NCT00057954|75690144|FG000|NOT COMPLETED|Overall Study||2||
59583685|NCT00049530|75690148|FG000|STARTED|Overall Study||32||
59583686|NCT00049530|75690148|FG000|Eligible and Treated|Overall Study||29||
59583687|NCT00049530|75690148|FG000|COMPLETED|Overall Study||0||
59583688|NCT00049530|75690148|FG000|NOT COMPLETED|Overall Study||32||
59583689|NCT00045305|75690152|FG000|STARTED|Overall Study||17||
59583690|NCT00045305|75690152|FG000|Eligible and Treated|Overall Study||17||
59583691|NCT00045305|75690152|FG000|COMPLETED|Overall Study||3||
59583692|NCT00045305|75690152|FG000|NOT COMPLETED|Overall Study||14||
59583693|NCT00033657|75690158|FG000|STARTED|Neoadjuvant Chemotherapy||50||
59583694|NCT00033657|75690159|FG001|STARTED|Neoadjuvant Chemotherapy||47||
59583695|NCT00033657|75690158|FG000|Eligible|Neoadjuvant Chemotherapy||42||
59583696|NCT00033657|75690159|FG001|Eligible|Neoadjuvant Chemotherapy||43||
59583697|NCT00033657|75690158|FG000|Eligible and Treated|Neoadjuvant Chemotherapy||39||
59583698|NCT00033657|75690159|FG001|Eligible and Treated|Neoadjuvant Chemotherapy||42||
59583699|NCT00033657|75690158|FG000|COMPLETED|Neoadjuvant Chemotherapy||36||
59583700|NCT00033657|75690159|FG001|COMPLETED|Neoadjuvant Chemotherapy||36||
59583701|NCT00033657|75690158|FG000|NOT COMPLETED|Neoadjuvant Chemotherapy||14||
59583702|NCT00033657|75690159|FG001|NOT COMPLETED|Neoadjuvant Chemotherapy||11||
59583703|NCT00033657|75690158|FG000|STARTED|Surgical Resection||36||
59583704|NCT00033657|75690159|FG001|STARTED|Surgical Resection||36||
59583705|NCT00033657|75690158|FG000|COMPLETED|Surgical Resection||36||
59583706|NCT00033657|75690159|FG001|COMPLETED|Surgical Resection||33||
59583707|NCT00033657|75690158|FG000|NOT COMPLETED|Surgical Resection||0||
59583708|NCT00033657|75690159|FG001|NOT COMPLETED|Surgical Resection||3||
59583709|NCT00033657|75690158|FG000|STARTED|Adjuvant Chemotherapy||36||
59583710|NCT00033657|75690159|FG001|STARTED|Adjuvant Chemotherapy||33||
59583711|NCT00033657|75690158|FG000|COMPLETED|Adjuvant Chemotherapy||18||
59583712|NCT00033657|75690159|FG001|COMPLETED|Adjuvant Chemotherapy||16||
59583713|NCT00033657|75690158|FG000|NOT COMPLETED|Adjuvant Chemotherapy||18||
59583714|NCT00033657|75690159|FG001|NOT COMPLETED|Adjuvant Chemotherapy||17||
59583715|NCT00003389|75690169|FG000|STARTED|Overall Study||428||
59583716|NCT00003389|75690170|FG001|STARTED|Overall Study||426||
59583717|NCT00003389|75690169|FG000|Treated Pts w/ Toxicity Data Available|Overall Study||414||
59583718|NCT00003389|75690170|FG001|Treated Pts w/ Toxicity Data Available|Overall Study||422||
59583719|NCT00003389|75690169|FG000|Eligible Patients|Overall Study||395||
59583720|NCT00003389|75690170|FG001|Eligible Patients|Overall Study||399||
59583721|NCT00003389|75690169|FG000|COMPLETED|Overall Study||330||
59583722|NCT00003389|75690170|FG001|COMPLETED|Overall Study||366||
59583723|NCT00003389|75690169|FG000|NOT COMPLETED|Overall Study||98||
59583724|NCT00003389|75690170|FG001|NOT COMPLETED|Overall Study||60||
59583725|NCT00003138|75690178|FG000|STARTED|Step 1||61||
59583726|NCT00003138|75690179|FG001|STARTED|Step 1||57||
59583727|NCT00003138|75690178|FG000|Patients With Complete Data|Step 1||57||
59583728|NCT00003138|75690179|FG001|Patients With Complete Data|Step 1||53||
59724334|NCT01061736|75842939|FG001|STARTED|Overall Study||50||
59724335|NCT01061736|75842940|FG002|STARTED|Overall Study||51||
60121575|NCT01683383|76242482|FG000|COMPLETED|Overall Study||49||
60121576|NCT01683383|76242483|FG001|COMPLETED|Overall Study||51||
60121577|NCT01683383|76242482|FG000|NOT COMPLETED|Overall Study||1||
60121578|NCT01683383|76242483|FG001|NOT COMPLETED|Overall Study||0||
60121579|NCT02694744|76242491|FG000|STARTED|Overall Study||57||
60121580|NCT02694744|76242492|FG001|STARTED|Overall Study||57||
60121581|NCT02694744|76242491|FG000|Safety Population|Overall Study||57|Safety Population: All subjects who have taken at least one dose of patiromer.|
60121582|NCT02694744|76242492|FG001|Safety Population|Overall Study||56|Safety Population: All subjects who have taken at least one dose of patiromer.|
60121583|NCT02694744|76242491|FG000|ITT|Overall Study||57|Two randomized participates from Group 2 were excluded from the analyses for the ITT population.|
60121584|NCT02694744|76242492|FG001|ITT|Overall Study||55|Two randomized participates from Group 2 were excluded from the analyses for the ITT population.|
60121585|NCT02694744|76242491|FG000|COMPLETED|Overall Study||51||
60121586|NCT02694744|76242492|FG001|COMPLETED|Overall Study||52||
59583729|NCT00003138|75690178|FG000|Treated|Step 1||56||
59583730|NCT00003138|75690179|FG001|Treated|Step 1||53||
59583731|NCT00003138|75690178|FG000|Eligible and Treated|Step 1||52||
59583732|NCT00003138|75690179|FG001|Eligible and Treated|Step 1||50||
59583733|NCT00003138|75690178|FG000|Patients With QOL Data at 4 Months|Step 1||42||
59583734|NCT00003138|75690179|FG001|Patients With QOL Data at 4 Months|Step 1||42||
59583735|NCT00003138|75690178|FG000|Patients With Transfusion Data|Step 1||37||
59583736|NCT00003138|75690179|FG001|Patients With Transfusion Data|Step 1||42||
59583737|NCT00003138|75690178|FG000|COMPLETED|Step 1||0||
59583738|NCT00003138|75690179|FG001|COMPLETED|Step 1||0||
59583739|NCT00003138|75690178|FG000|NOT COMPLETED|Step 1||61||
59583740|NCT00003138|75690179|FG001|NOT COMPLETED|Step 1||57||
59583741|NCT00003138|75690178|FG000|STARTED|Step 2 (Cross Over)||26||
59583742|NCT00003138|75690179|FG001|STARTED|Step 2 (Cross Over)|Only patients in the supportive care arm are eligible to cross over to the Erythropoietin arm.|0||
59583743|NCT00003138|75690178|FG000|COMPLETED|Step 2 (Cross Over)||0||
59583744|NCT00003138|75690179|FG001|COMPLETED|Step 2 (Cross Over)||0||
59583745|NCT00003138|75690178|FG000|NOT COMPLETED|Step 2 (Cross Over)||26||
59583746|NCT00003138|75690179|FG001|NOT COMPLETED|Step 2 (Cross Over)||0||
59583747|NCT00003138|75690178|FG000|STARTED|Step 3 (EPO 150 Units/kg and G-CSF)||12||
59583748|NCT00003138|75690179|FG001|STARTED|Step 3 (EPO 150 Units/kg and G-CSF)||20||
59583749|NCT00003138|75690178|FG000|Treated|Step 3 (EPO 150 Units/kg and G-CSF)||12||
59583750|NCT00003138|75690179|FG001|Treated|Step 3 (EPO 150 Units/kg and G-CSF)||19||
59583751|NCT00003138|75690178|FG000|COMPLETED|Step 3 (EPO 150 Units/kg and G-CSF)||0||
59583752|NCT00003138|75690179|FG001|COMPLETED|Step 3 (EPO 150 Units/kg and G-CSF)||0||
59583753|NCT00003138|75690178|FG000|NOT COMPLETED|Step 3 (EPO 150 Units/kg and G-CSF)||12||
59583754|NCT00003138|75690179|FG001|NOT COMPLETED|Step 3 (EPO 150 Units/kg and G-CSF)||20||
59583755|NCT00003138|75690178|FG000|STARTED|Step 4 (EPO 300 Units/kg and G-CSF)||6||
59583756|NCT00003138|75690179|FG001|STARTED|Step 4 (EPO 300 Units/kg and G-CSF)||7||
59583757|NCT00003138|75690178|FG000|COMPLETED|Step 4 (EPO 300 Units/kg and G-CSF)||0||
59583758|NCT00003138|75690179|FG001|COMPLETED|Step 4 (EPO 300 Units/kg and G-CSF)||0||
59583759|NCT00003138|75690178|FG000|NOT COMPLETED|Step 4 (EPO 300 Units/kg and G-CSF)||6||
59583760|NCT00003138|75690179|FG001|NOT COMPLETED|Step 4 (EPO 300 Units/kg and G-CSF)||7||
59583761|NCT00002525|75690190|FG000|STARTED|Overall Study|859 patients were enrolled to the study, but 4 patients were not randomized to any treatment arm|427||
59583762|NCT00002525|75690191|FG001|STARTED|Overall Study||428||
59583763|NCT00002525|75690190|FG000|Treated|Overall Study||419||
59583764|NCT00002525|75690191|FG001|Treated|Overall Study|"Patients on No perioperative 5-FU arm received no perioperative chemotherapy"|0||
59583765|NCT00002525|75690190|FG000|Dukes' B3 or C Stage|Overall Study|"Primary population: pts with Duke's B3, C disease. 158 such pts on No perioperative 5-FU arm"|156||
59583766|NCT00002525|75690191|FG001|Dukes' B3 or C Stage|Overall Study||158||
59583767|NCT00002525|75690190|FG000|Dukes' B2 Stage|Overall Study||150||
59583768|NCT00002525|75690191|FG001|Dukes' B2 Stage|Overall Study||139||
59583769|NCT00002525|75690190|FG000|COMPLETED|Overall Study||241||
59583770|NCT00002525|75690191|FG001|COMPLETED|Overall Study|"Patients on No perioperative 5-FU arm received no perioperative chemotherapy"|428||
59583771|NCT00002525|75690190|FG000|NOT COMPLETED|Overall Study||186||
59583772|NCT00002525|75690191|FG001|NOT COMPLETED|Overall Study||0||
59583773|NCT02259348|75690199|FG000|STARTED|Overall Study||12||
59583774|NCT02259348|75690199|FG000|One Year Post-transplant|Overall Study||2||
59583775|NCT02259348|75690199|FG000|COMPLETED|Overall Study||2||
59583776|NCT02259348|75690199|FG000|NOT COMPLETED|Overall Study||10||
59583777|NCT03960541|75690205|FG000|STARTED|Overall Study||4||
59583778|NCT03960541|75690206|FG001|STARTED|Overall Study||4||
59583779|NCT03960541|75690205|FG000|COMPLETED|Overall Study||4||
59583780|NCT03960541|75690206|FG001|COMPLETED|Overall Study||4||
59583781|NCT03960541|75690205|FG000|NOT COMPLETED|Overall Study||0||
59583782|NCT03960541|75690206|FG001|NOT COMPLETED|Overall Study||0||
59583783|NCT03587207|75690217|FG000|STARTED|Overall Study||100||
59583784|NCT03587207|75690218|FG001|STARTED|Overall Study||104||
59583785|NCT03587207|75690219|FG002|STARTED|Overall Study||100||
59583786|NCT03587207|75690220|FG003|STARTED|Overall Study||94||
59583787|NCT03587207|75690221|FG004|STARTED|Overall Study||102||
59583788|NCT03587207|75690217|FG000|COMPLETED|Overall Study||100||
59583789|NCT03587207|75690218|FG001|COMPLETED|Overall Study||104||
59583790|NCT03587207|75690219|FG002|COMPLETED|Overall Study||100||
59583791|NCT03587207|75690220|FG003|COMPLETED|Overall Study||94||
59583792|NCT03587207|75690221|FG004|COMPLETED|Overall Study||102||
59724336|NCT01061736|75842941|FG003|STARTED|Overall Study||51||
59583793|NCT03587207|75690217|FG000|NOT COMPLETED|Overall Study||0||
59583794|NCT03587207|75690218|FG001|NOT COMPLETED|Overall Study||0||
59583795|NCT03587207|75690219|FG002|NOT COMPLETED|Overall Study||0||
59583796|NCT03587207|75690220|FG003|NOT COMPLETED|Overall Study||0||
59583797|NCT03587207|75690221|FG004|NOT COMPLETED|Overall Study||0||
59583798|NCT03416621|75690236|FG000|STARTED|Overall Study||13||
59583799|NCT03416621|75690237|FG001|STARTED|Overall Study||12||
59583800|NCT03416621|75690238|FG002|STARTED|Overall Study||6||
59583801|NCT03416621|75690236|FG000|COMPLETED|Overall Study||13||
59583802|NCT03416621|75690237|FG001|COMPLETED|Overall Study||11||
59583803|NCT03416621|75690238|FG002|COMPLETED|Overall Study||1||
59583804|NCT03416621|75690236|FG000|NOT COMPLETED|Overall Study||0||
59583805|NCT03416621|75690237|FG001|NOT COMPLETED|Overall Study||1||
59583806|NCT03416621|75690238|FG002|NOT COMPLETED|Overall Study||5||
59724337|NCT01061736|75842942|FG004|STARTED|Overall Study||52||
59724338|NCT01061736|75842943|FG005|STARTED|Overall Study||52||
59583807|NCT03417557|75690248|FG000|STARTED|1st Intervention (3 Hours)||8||
59583808|NCT03417557|75690249|FG001|STARTED|1st Intervention (3 Hours)||9||
59583809|NCT03417557|75690248|FG000|COMPLETED|1st Intervention (3 Hours)||8||
59583810|NCT03417557|75690249|FG001|COMPLETED|1st Intervention (3 Hours)||9||
59583811|NCT03417557|75690248|FG000|NOT COMPLETED|1st Intervention (3 Hours)||0||
59583812|NCT03417557|75690249|FG001|NOT COMPLETED|1st Intervention (3 Hours)||0||
59583813|NCT03417557|75690248|FG000|STARTED|2nd Intervention (3 Hours)||9||
59583814|NCT03417557|75690249|FG001|STARTED|2nd Intervention (3 Hours)||8||
59583815|NCT03417557|75690248|FG000|COMPLETED|2nd Intervention (3 Hours)||9||
59583816|NCT03417557|75690249|FG001|COMPLETED|2nd Intervention (3 Hours)||8||
59583817|NCT03417557|75690248|FG000|NOT COMPLETED|2nd Intervention (3 Hours)||0||
59583818|NCT03417557|75690249|FG001|NOT COMPLETED|2nd Intervention (3 Hours)||0||
59583819|NCT03459131|75690255|FG000|STARTED|Period 1, First 7 Days of Wear||7||
59583820|NCT03459131|75690256|FG001|STARTED|Period 1, First 7 Days of Wear||8||
59583821|NCT03459131|75690255|FG000|COMPLETED|Period 1, First 7 Days of Wear||7||
59583822|NCT03459131|75690256|FG001|COMPLETED|Period 1, First 7 Days of Wear||8||
59583823|NCT03459131|75690255|FG000|NOT COMPLETED|Period 1, First 7 Days of Wear||0||
59583824|NCT03459131|75690256|FG001|NOT COMPLETED|Period 1, First 7 Days of Wear||0||
59583825|NCT03459131|75690255|FG000|STARTED|Period 2, Second 7 Days of Wear||7||
59583826|NCT03459131|75690256|FG001|STARTED|Period 2, Second 7 Days of Wear||8||
59583827|NCT03459131|75690255|FG000|COMPLETED|Period 2, Second 7 Days of Wear||7||
59583828|NCT03459131|75690256|FG001|COMPLETED|Period 2, Second 7 Days of Wear||8||
59583829|NCT03459131|75690255|FG000|NOT COMPLETED|Period 2, Second 7 Days of Wear||0||
59583830|NCT03459131|75690256|FG001|NOT COMPLETED|Period 2, Second 7 Days of Wear||0||
59583831|NCT03417713|75690262|FG000|STARTED|Overall Study||33||
59583832|NCT03417713|75690262|FG000|COMPLETED|Overall Study||30||
59583833|NCT03417713|75690262|FG000|NOT COMPLETED|Overall Study||3||
59583834|NCT03592121|75690268|FG000|STARTED|Overall Study||3||
59583835|NCT03592121|75690269|FG001|STARTED|Overall Study||0||
59583836|NCT03592121|75690268|FG000|COMPLETED|Overall Study||3||
59583837|NCT03592121|75690269|FG001|COMPLETED|Overall Study||0||
59583838|NCT03592121|75690268|FG000|NOT COMPLETED|Overall Study||0||
59583839|NCT03592121|75690269|FG001|NOT COMPLETED|Overall Study||0||
59583840|NCT03596723|75690277|FG000|STARTED|Overall Study||1||
59583841|NCT03596723|75690278|FG001|STARTED|Overall Study||1||
59583842|NCT03596723|75690277|FG000|COMPLETED|Overall Study||1||
59583843|NCT03596723|75690278|FG001|COMPLETED|Overall Study||1||
59583844|NCT03596723|75690277|FG000|NOT COMPLETED|Overall Study||0||
59583845|NCT03596723|75690278|FG001|NOT COMPLETED|Overall Study||0||
59583846|NCT04355117|75690284|FG000|STARTED|Overall Study||71||
59583847|NCT04355117|75690284|FG000|COMPLETED|Overall Study||71||
59583848|NCT04355117|75690284|FG000|NOT COMPLETED|Overall Study||0||
59583849|NCT04357379|75690290|FG000|STARTED|Overall Study||10||
59583850|NCT04357379|75690290|FG000|COMPLETED|Overall Study||10||
59583851|NCT04357379|75690290|FG000|NOT COMPLETED|Overall Study||0||
59583852|NCT03463889|75690294|FG000|STARTED|Overall Study||12||
59583853|NCT03463889|75690294|FG000|COMPLETED|Overall Study||12||
59583854|NCT03463889|75690294|FG000|NOT COMPLETED|Overall Study||0||
59583855|NCT04484207|75690301|FG000|STARTED|Overall Study||86||
59583856|NCT04484207|75690302|FG001|STARTED|Overall Study||44||
59583857|NCT04484207|75690303|FG002|STARTED|Overall Study||42||
59583858|NCT04484207|75690301|FG000|14-Day Follow-Up|Overall Study||69||
59583859|NCT04484207|75690302|FG001|14-Day Follow-Up|Overall Study||40||
59851569|NCT03515824|75976153|FG003|STARTED|Overall Study||0||
59851570|NCT03515824|75976150|FG000|COMPLETED|Overall Study||0||
59583860|NCT04484207|75690303|FG002|14-Day Follow-Up|Overall Study||33||
59583861|NCT04484207|75690301|FG000|30-Day Follow-Up|Overall Study||65||
59583862|NCT04484207|75690302|FG001|30-Day Follow-Up|Overall Study||34||
59583863|NCT04484207|75690303|FG002|30-Day Follow-Up|Overall Study||31||
59583864|NCT04484207|75690301|FG000|COMPLETED|Overall Study||65||
59583865|NCT04484207|75690302|FG001|COMPLETED|Overall Study||34||
59583866|NCT04484207|75690303|FG002|COMPLETED|Overall Study||31||
59583867|NCT04484207|75690301|FG000|NOT COMPLETED|Overall Study||21||
59583868|NCT04484207|75690302|FG001|NOT COMPLETED|Overall Study||10||
59583869|NCT04484207|75690303|FG002|NOT COMPLETED|Overall Study||11||
59583870|NCT04485455|75690314|FG000|STARTED|Overall Study||5||
59583871|NCT04485455|75690314|FG000|COMPLETED|Overall Study||5||
59583872|NCT04485455|75690314|FG000|NOT COMPLETED|Overall Study||0||
59583873|NCT04525079|75690323|FG000|STARTED|Overall Study||6||
59583874|NCT04525079|75690324|FG001|STARTED|Overall Study||6||
59583875|NCT04525079|75690325|FG002|STARTED|Overall Study||6||
59583876|NCT04525079|75690326|FG003|STARTED|Overall Study||6||
59583877|NCT04525079|75690327|FG004|STARTED|Overall Study||8||
59583878|NCT04525079|75690323|FG000|COMPLETED|Overall Study||6||
59583879|NCT04525079|75690324|FG001|COMPLETED|Overall Study||6||
59583880|NCT04525079|75690325|FG002|COMPLETED|Overall Study||6||
59583881|NCT04525079|75690326|FG003|COMPLETED|Overall Study||6||
59583882|NCT04525079|75690327|FG004|COMPLETED|Overall Study||8||
59583883|NCT04525079|75690323|FG000|NOT COMPLETED|Overall Study||0||
59583884|NCT04525079|75690324|FG001|NOT COMPLETED|Overall Study||0||
59583885|NCT04525079|75690325|FG002|NOT COMPLETED|Overall Study||0||
59851571|NCT03515824|75976151|FG001|COMPLETED|Overall Study||0||
59583886|NCT04525079|75690326|FG003|NOT COMPLETED|Overall Study||0||
59583887|NCT04525079|75690327|FG004|NOT COMPLETED|Overall Study||0||
59583888|NCT03599687|75690341|FG000|STARTED|Overall Study||82||
59583889|NCT03599687|75690342|FG001|STARTED|Overall Study||82||
59583890|NCT03599687|75690341|FG000|COMPLETED|Overall Study||82||
59583891|NCT03599687|75690342|FG001|COMPLETED|Overall Study||82||
59583892|NCT03599687|75690341|FG000|NOT COMPLETED|Overall Study||0||
59583893|NCT03599687|75690342|FG001|NOT COMPLETED|Overall Study||0||
59583894|NCT03467477|75690348|FG000|STARTED|Overall Study||161||
59583895|NCT03467477|75690348|FG000|COMPLETED|Overall Study||161||
59583896|NCT03467477|75690348|FG000|NOT COMPLETED|Overall Study||0||
59583897|NCT04555031|75690355|FG000|STARTED|Overall Study||10||
59583898|NCT04555031|75690355|FG000|COMPLETED|Overall Study||10||
59583899|NCT04555031|75690355|FG000|NOT COMPLETED|Overall Study||0||
59583900|NCT04574297|75690366|FG000|STARTED|Overall Study||180||
59583901|NCT04574297|75690367|FG001|STARTED|Overall Study||263||
59583902|NCT04574297|75690368|FG002|STARTED|Overall Study||230||
59583903|NCT04574297|75690369|FG003|STARTED|Overall Study||125||
59583904|NCT04574297|75690366|FG000|COMPLETED|Overall Study||180||
59583905|NCT04574297|75690367|FG001|COMPLETED|Overall Study||263||
59583906|NCT04574297|75690368|FG002|COMPLETED|Overall Study||230||
59583907|NCT04574297|75690369|FG003|COMPLETED|Overall Study||125||
59583908|NCT04574297|75690366|FG000|NOT COMPLETED|Overall Study||0||
59583909|NCT04574297|75690367|FG001|NOT COMPLETED|Overall Study||0||
59583910|NCT04574297|75690368|FG002|NOT COMPLETED|Overall Study||0||
59583911|NCT04574297|75690369|FG003|NOT COMPLETED|Overall Study||0||
59583912|NCT03468179|75690379|FG000|STARTED|Overall Study||10||
59583913|NCT03468179|75690379|FG000|COMPLETED|Overall Study||10||
59583914|NCT03468179|75690379|FG000|NOT COMPLETED|Overall Study||0||
59583915|NCT03472469|75690385|FG000|STARTED|Overall Study||787||
59583916|NCT03472469|75690386|FG001|STARTED|Overall Study||774||
59583917|NCT03472469|75690385|FG000|COMPLETED|Overall Study||787||
59583918|NCT03472469|75690386|FG001|COMPLETED|Overall Study||774||
59583919|NCT03472469|75690385|FG000|NOT COMPLETED|Overall Study||0||
59583920|NCT03472469|75690386|FG001|NOT COMPLETED|Overall Study||0||
59583921|NCT04926233|75690394|FG000|STARTED|Overall Study||1280486||
59583922|NCT04926233|75690395|FG001|STARTED|Overall Study||90660||
59583923|NCT04926233|75690394|FG000|COMPLETED|Overall Study||1280486||
59583924|NCT04926233|75690395|FG001|COMPLETED|Overall Study||90660||
59583925|NCT04926233|75690394|FG000|NOT COMPLETED|Overall Study||0||
59583926|NCT04926233|75690395|FG001|NOT COMPLETED|Overall Study||0||
59583927|NCT04943159|75690447|FG000|STARTED|Overall Study||3||
59583928|NCT04943159|75690447|FG000|COMPLETED|Overall Study||3||
59583929|NCT04943159|75690447|FG000|NOT COMPLETED|Overall Study||0||
59583930|NCT02259114|75690456|FG000|STARTED|Overall Study||21||
59583931|NCT02259114|75690457|FG001|STARTED|Overall Study||4||
59583932|NCT02259114|75690458|FG002|STARTED|Overall Study||13||
59583933|NCT02259114|75690459|FG003|STARTED|Overall Study||3||
59583934|NCT02259114|75690460|FG004|STARTED|Overall Study||6||
59583935|NCT02259114|75690456|FG000|Treated|Overall Study|One participant was randomized but did not receive treatment due to a protocol violation.|20||
59583936|NCT02259114|75690457|FG001|Treated|Overall Study||4||
59583937|NCT02259114|75690458|FG002|Treated|Overall Study||13||
59583938|NCT02259114|75690459|FG003|Treated|Overall Study||3||
59583939|NCT02259114|75690460|FG004|Treated|Overall Study||6||
59583940|NCT02259114|75690456|FG000|COMPLETED|Overall Study||0||
59583941|NCT02259114|75690457|FG001|COMPLETED|Overall Study||0||
59583942|NCT02259114|75690458|FG002|COMPLETED|Overall Study||0||
59583943|NCT02259114|75690459|FG003|COMPLETED|Overall Study||0||
59583944|NCT02259114|75690460|FG004|COMPLETED|Overall Study||0||
59583945|NCT02259114|75690456|FG000|NOT COMPLETED|Overall Study||21||
59583946|NCT02259114|75690457|FG001|NOT COMPLETED|Overall Study||4||
59583947|NCT02259114|75690458|FG002|NOT COMPLETED|Overall Study||13||
59583948|NCT02259114|75690459|FG003|NOT COMPLETED|Overall Study||3||
59583949|NCT02259114|75690460|FG004|NOT COMPLETED|Overall Study||6||
59583950|NCT03611777|75690474|FG000|STARTED|Overall Study||432||
59583951|NCT03611777|75690475|FG001|STARTED|Overall Study||469||
59583952|NCT03611777|75690474|FG000|COMPLETED|Overall Study||432||
59583953|NCT03611777|75690475|FG001|COMPLETED|Overall Study||469||
59583954|NCT03611777|75690474|FG000|NOT COMPLETED|Overall Study||0||
59583955|NCT03611777|75690475|FG001|NOT COMPLETED|Overall Study||0||
59583956|NCT03473171|75690484|FG000|STARTED|Overall Study||5||
59583957|NCT03473171|75690484|FG000|COMPLETED|Overall Study||5||
59583958|NCT03473171|75690484|FG000|NOT COMPLETED|Overall Study||0||
59583959|NCT03613493|75690492|FG000|STARTED|Overall Study||10||
59583960|NCT03613493|75690493|FG001|STARTED|Overall Study||75||
59583961|NCT03613493|75690494|FG002|STARTED|Overall Study||0||
59583962|NCT03613493|75690495|FG003|STARTED|Overall Study||90||
59583963|NCT03613493|75690492|FG000|Enrollment Criteria Met|Overall Study||10||
59583964|NCT03613493|75690493|FG001|Enrollment Criteria Met|Overall Study||74||
59583965|NCT03613493|75690494|FG002|Enrollment Criteria Met|Overall Study||0||
59583966|NCT03613493|75690495|FG003|Enrollment Criteria Met|Overall Study||89||
59583967|NCT03613493|75690492|FG000|COMPLETED|Overall Study||10||
59583968|NCT03613493|75690493|FG001|COMPLETED|Overall Study||73||
59583969|NCT03613493|75690494|FG002|COMPLETED|Overall Study||0||
59583970|NCT03613493|75690495|FG003|COMPLETED|Overall Study||83||
59583971|NCT03613493|75690492|FG000|NOT COMPLETED|Overall Study||0||
59583972|NCT03613493|75690493|FG001|NOT COMPLETED|Overall Study||2||
59583973|NCT03613493|75690494|FG002|NOT COMPLETED|Overall Study||0||
59583974|NCT03613493|75690495|FG003|NOT COMPLETED|Overall Study||7||
59583975|NCT04492397|75690504|FG000|STARTED|First Intervention||17||
59583976|NCT04492397|75690505|FG001|STARTED|First Intervention||18||
59583977|NCT04492397|75690504|FG000|COMPLETED|First Intervention||17||
59583978|NCT04492397|75690505|FG001|COMPLETED|First Intervention||18||
59583979|NCT04492397|75690504|FG000|NOT COMPLETED|First Intervention||0||
59583980|NCT04492397|75690505|FG001|NOT COMPLETED|First Intervention||0||
59583981|NCT04492397|75690504|FG000|STARTED|Second Intervention||17||
59583982|NCT04492397|75690505|FG001|STARTED|Second Intervention||18||
59583983|NCT04492397|75690504|FG000|COMPLETED|Second Intervention||17||
59583984|NCT04492397|75690505|FG001|COMPLETED|Second Intervention||18||
59583985|NCT04492397|75690504|FG000|NOT COMPLETED|Second Intervention||0||
59583986|NCT04492397|75690505|FG001|NOT COMPLETED|Second Intervention||0||
59583987|NCT02258334|75690515|FG000|STARTED|Overall Study||50||
59583988|NCT02258334|75690516|FG001|STARTED|Overall Study||54||
59583989|NCT02258334|75690517|FG002|STARTED|Overall Study||52||
59583990|NCT02258334|75690518|FG003|STARTED|Overall Study||52||
59583991|NCT02258334|75690515|FG000|COMPLETED|Overall Study||49||
59583992|NCT02258334|75690516|FG001|COMPLETED|Overall Study||54||
59583993|NCT02258334|75690517|FG002|COMPLETED|Overall Study||52||
59583994|NCT02258334|75690518|FG003|COMPLETED|Overall Study||52||
59583995|NCT02258334|75690515|FG000|NOT COMPLETED|Overall Study||1||
59583996|NCT02258334|75690516|FG001|NOT COMPLETED|Overall Study||0||
59583997|NCT02258334|75690517|FG002|NOT COMPLETED|Overall Study||0||
59583998|NCT02258334|75690518|FG003|NOT COMPLETED|Overall Study||0||
59583999|NCT03478163|75690532|FG000|STARTED|Overall Study||5||
59584000|NCT03478163|75690533|FG001|STARTED|Overall Study||6||
59584001|NCT03478163|75690532|FG000|COMPLETED|Overall Study||5||
59584002|NCT03478163|75690533|FG001|COMPLETED|Overall Study||6||
59584003|NCT03478163|75690532|FG000|NOT COMPLETED|Overall Study||0||
59584004|NCT03478163|75690533|FG001|NOT COMPLETED|Overall Study||0||
59584005|NCT04449263|75690539|FG000|STARTED|First Intervention||29||
59584006|NCT04449263|75690540|FG001|STARTED|First Intervention||30||
59584007|NCT04449263|75690539|FG000|COMPLETED|First Intervention||29||
59584008|NCT04449263|75690540|FG001|COMPLETED|First Intervention||30||
59584009|NCT04449263|75690539|FG000|NOT COMPLETED|First Intervention||0||
59584010|NCT04449263|75690540|FG001|NOT COMPLETED|First Intervention||0||
59584011|NCT04449263|75690539|FG000|STARTED|Second Intervention||29||
59584012|NCT04449263|75690540|FG001|STARTED|Second Intervention||30||
59584013|NCT04449263|75690539|FG000|COMPLETED|Second Intervention||29||
59584014|NCT04449263|75690540|FG001|COMPLETED|Second Intervention||30||
59584015|NCT04449263|75690539|FG000|NOT COMPLETED|Second Intervention||0||
59584016|NCT04449263|75690540|FG001|NOT COMPLETED|Second Intervention||0||
59584017|NCT04449263|75690539|FG000|STARTED|Third Intervention||29||
59584018|NCT04449263|75690540|FG001|STARTED|Third Intervention||30||
59584019|NCT04449263|75690539|FG000|COMPLETED|Third Intervention||29||
59584020|NCT04449263|75690540|FG001|COMPLETED|Third Intervention||30||
59584021|NCT04449263|75690539|FG000|NOT COMPLETED|Third Intervention||0||
59584022|NCT04449263|75690540|FG001|NOT COMPLETED|Third Intervention||0||
59584023|NCT04413929|75690548|FG000|STARTED|Overall Study||8411||
59584024|NCT04413929|75690548|FG000|COMPLETED|Overall Study||8411||
59584025|NCT04413929|75690548|FG000|NOT COMPLETED|Overall Study||0||
59584026|NCT04960202|75690555|FG000|STARTED|Overall Study||1120||
59584027|NCT04960202|75690556|FG001|STARTED|Overall Study||1126||
59584028|NCT04960202|75690555|FG000|Treated|Overall Study||1109||
59584029|NCT04960202|75690556|FG001|Treated|Overall Study||1115||
59584030|NCT04960202|75690555|FG000|COMPLETED|Overall Study||1045||
59584031|NCT04960202|75690556|FG001|COMPLETED|Overall Study||1039||
59584032|NCT04960202|75690555|FG000|NOT COMPLETED|Overall Study||75||
59584033|NCT04960202|75690556|FG001|NOT COMPLETED|Overall Study||87||
59584034|NCT03615911|75690564|FG000|STARTED|Overall Study||14||
59584035|NCT03615911|75690565|FG001|STARTED|Overall Study||12||
59584036|NCT03615911|75690564|FG000|Received Late Booster Immunization|Overall Study||3||
59851572|NCT03515824|75976152|FG002|COMPLETED|Overall Study||0||
59584037|NCT03615911|75690565|FG001|Received Late Booster Immunization|Overall Study||7||
59584038|NCT03615911|75690564|FG000|COMPLETED|Overall Study|A subgroup received an additional booster of 1x10^8 PFU MVA-MERS-S 12 (+/-4) months after prime.|12||
59584039|NCT03615911|75690565|FG001|COMPLETED|Overall Study|A subgroup received an additional booster of 1x10^8 PFU MVA-MERS-S 12 (+/-4) months after prime.|11||
59584040|NCT03615911|75690564|FG000|NOT COMPLETED|Overall Study||2||
59584041|NCT03615911|75690565|FG001|NOT COMPLETED|Overall Study||1||
59584042|NCT03618017|75690575|FG000|STARTED|Overall Study||33|Enrolled|
59584043|NCT03618017|75690576|FG001|STARTED|Overall Study||33|Enrolled|
59584044|NCT03618017|75690575|FG000|COMPLETED|Overall Study||26|Completed the 3-month follow-up survey.|
59584045|NCT03618017|75690576|FG001|COMPLETED|Overall Study||28|Completed the 3-month follow-up survey.|
59584046|NCT03618017|75690575|FG000|NOT COMPLETED|Overall Study||7||
59584047|NCT03618017|75690576|FG001|NOT COMPLETED|Overall Study||5||
59584048|NCT03619811|75690584|FG000|STARTED|Overall Study||43||
59584049|NCT03619811|75690584|FG000|COMPLETED|Overall Study||31||
59851573|NCT03515824|75976153|FG003|COMPLETED|Overall Study||0||
59584050|NCT03619811|75690584|FG000|NOT COMPLETED|Overall Study||12||
59584051|NCT03619889|75690590|FG000|STARTED|Overall Study||37||
59584052|NCT03619889|75690591|FG001|STARTED|Overall Study||37||
59584053|NCT03619889|75690590|FG000|COMPLETED|Overall Study||35||
59584054|NCT03619889|75690591|FG001|COMPLETED|Overall Study||37||
59584055|NCT03619889|75690590|FG000|NOT COMPLETED|Overall Study||2||
59584056|NCT03619889|75690591|FG001|NOT COMPLETED|Overall Study||0||
59584057|NCT03481595|75690599|FG000|STARTED|Overall Study||146||
59584058|NCT03481595|75690600|FG001|STARTED|Overall Study||148||
59584059|NCT03481595|75690599|FG000|COMPLETED|Overall Study||143||
59584060|NCT03481595|75690600|FG001|COMPLETED|Overall Study||127||
59584061|NCT03481595|75690599|FG000|NOT COMPLETED|Overall Study||3||
59584062|NCT03481595|75690600|FG001|NOT COMPLETED|Overall Study||21||
59584063|NCT03622619|75690608|FG000|STARTED|Overall Study||23||
59584064|NCT03622619|75690609|FG001|STARTED|Overall Study||23||
59584065|NCT03622619|75690608|FG000|COMPLETED|Overall Study||21||
59584066|NCT03622619|75690609|FG001|COMPLETED|Overall Study||21||
59584067|NCT03622619|75690608|FG000|NOT COMPLETED|Overall Study||2||
59584068|NCT03622619|75690609|FG001|NOT COMPLETED|Overall Study||2||
59584069|NCT04428359|75690617|FG000|STARTED|Overall Study||33||
59584070|NCT04428359|75690618|FG001|STARTED|Overall Study||33||
59584071|NCT04428359|75690617|FG000|COMPLETED|Overall Study||31||
59584072|NCT04428359|75690618|FG001|COMPLETED|Overall Study||30||
59584073|NCT04428359|75690617|FG000|NOT COMPLETED|Overall Study||2||
59584074|NCT04428359|75690618|FG001|NOT COMPLETED|Overall Study||3||
59584075|NCT02257632|75690626|FG000|STARTED|Overall Study||19|All randomized patients|
59584076|NCT02257632|75690627|FG001|STARTED|Overall Study||22|All randomized patients|
59584077|NCT02257632|75690626|FG000|Full Analysis Set (FAS)|Overall Study||19|all randomized patients who received study treatment and had ≥ 1 primary efficacy assessment|
59584078|NCT02257632|75690627|FG001|Full Analysis Set (FAS)|Overall Study||21|all randomized patients who received study treatment and had ≥ 1 primary efficacy assessment|
59584079|NCT02257632|75690626|FG000|Safety Set (SAF)|Overall Study||19|all patients who received study treatment and had ≥ 1 post-baseline safety assessment.|
59584080|NCT02257632|75690627|FG001|Safety Set (SAF)|Overall Study||21|all patients who received study treatment and had ≥ 1 post-baseline safety assessment.|
59584081|NCT02257632|75690626|FG000|Per-Protocol Set (PPS)|Overall Study||17|all patients in the FAS who did not have any major protocol deviations|
59584082|NCT02257632|75690627|FG001|Per-Protocol Set (PPS)|Overall Study||20|all patients in the FAS who did not have any major protocol deviations|
59584083|NCT02257632|75690626|FG000|COMPLETED|Overall Study||18||
59584084|NCT02257632|75690627|FG001|COMPLETED|Overall Study||19||
59584085|NCT02257632|75690626|FG000|NOT COMPLETED|Overall Study||1||
59584086|NCT02257632|75690627|FG001|NOT COMPLETED|Overall Study||3||
59584087|NCT04415489|75690637|FG000|STARTED|Overall Study||50||
59584088|NCT04415489|75690638|FG001|STARTED|Overall Study||50||
59584089|NCT04415489|75690637|FG000|COMPLETED|Overall Study||50||
59584090|NCT04415489|75690638|FG001|COMPLETED|Overall Study||50||
59584091|NCT04415489|75690637|FG000|NOT COMPLETED|Overall Study||0||
59584092|NCT04415489|75690638|FG001|NOT COMPLETED|Overall Study||0||
59584093|NCT04383665|75690645|FG000|STARTED|Overall Study||2||
59584094|NCT04383665|75690646|FG001|STARTED|Overall Study||2||
59584095|NCT04383665|75690647|FG002|STARTED|Overall Study||2||
59584096|NCT04383665|75690648|FG003|STARTED|Overall Study||2||
59584097|NCT04383665|75690649|FG004|STARTED|Overall Study||2||
59584098|NCT04383665|75690650|FG005|STARTED|Overall Study||2||
59584099|NCT04383665|75690645|FG000|COMPLETED|Overall Study||2||
59584100|NCT04383665|75690646|FG001|COMPLETED|Overall Study||2||
59584101|NCT04383665|75690647|FG002|COMPLETED|Overall Study||2||
59584102|NCT04383665|75690648|FG003|COMPLETED|Overall Study||2||
59584103|NCT04383665|75690649|FG004|COMPLETED|Overall Study||2||
59584104|NCT04383665|75690650|FG005|COMPLETED|Overall Study||2||
59584105|NCT04383665|75690645|FG000|NOT COMPLETED|Overall Study||0||
59584106|NCT04383665|75690646|FG001|NOT COMPLETED|Overall Study||0||
59584107|NCT04383665|75690647|FG002|NOT COMPLETED|Overall Study||0||
59584108|NCT04383665|75690648|FG003|NOT COMPLETED|Overall Study||0||
59584109|NCT04383665|75690649|FG004|NOT COMPLETED|Overall Study||0||
59584110|NCT04383665|75690650|FG005|NOT COMPLETED|Overall Study||0||
59584111|NCT01642914|75690661|FG000|STARTED|Overall Study||173||
59584112|NCT01642914|75690662|FG001|STARTED|Overall Study||154||
59584113|NCT01642914|75690663|FG002|STARTED|Overall Study||160||
59584114|NCT01642914|75690661|FG000|COMPLETED|Overall Study||127||
59584115|NCT01642914|75690662|FG001|COMPLETED|Overall Study||122||
60121587|NCT02694744|76242491|FG000|NOT COMPLETED|Overall Study||6||
60121588|NCT02694744|76242492|FG001|NOT COMPLETED|Overall Study||5||
60121589|NCT01683071|76242506|FG000|STARTED|Part 1||25||
59584116|NCT01642914|75690663|FG002|COMPLETED|Overall Study||120||
59584117|NCT01642914|75690661|FG000|NOT COMPLETED|Overall Study||46||
59584118|NCT01642914|75690662|FG001|NOT COMPLETED|Overall Study||32||
59584119|NCT01642914|75690663|FG002|NOT COMPLETED|Overall Study||40||
59584120|NCT04381481|75690685|FG000|STARTED|Overall Study||200||
59584121|NCT04381481|75690686|FG001|STARTED|Overall Study||205||
59584122|NCT04381481|75690687|FG002|STARTED|Overall Study||199||
59584123|NCT04381481|75690688|FG003|STARTED|Overall Study||197||
59584124|NCT04381481|75690689|FG004|STARTED|Overall Study||199||
59584125|NCT04381481|75690690|FG005|STARTED|Overall Study||195||
59584126|NCT04381481|75690691|FG006|STARTED|Overall Study||194||
59584127|NCT04381481|75690692|FG007|STARTED|Overall Study||193||
59584128|NCT04381481|75690693|FG008|STARTED|Overall Study||214||
59584129|NCT04381481|75690694|FG009|STARTED|Overall Study||198||
59584130|NCT04381481|75690695|FG010|STARTED|Overall Study||192||
59584131|NCT04381481|75690696|FG011|STARTED|Overall Study||188||
59584132|NCT04381481|75690685|FG000|COMPLETED|Overall Study||185||
59584133|NCT04381481|75690686|FG001|COMPLETED|Overall Study||190||
59584134|NCT04381481|75690687|FG002|COMPLETED|Overall Study||190||
59584135|NCT04381481|75690688|FG003|COMPLETED|Overall Study||183||
59584136|NCT04381481|75690689|FG004|COMPLETED|Overall Study||191||
59584137|NCT04381481|75690690|FG005|COMPLETED|Overall Study||180||
59584138|NCT04381481|75690691|FG006|COMPLETED|Overall Study||184||
59584139|NCT04381481|75690692|FG007|COMPLETED|Overall Study||177||
59584140|NCT04381481|75690693|FG008|COMPLETED|Overall Study||195||
59584141|NCT04381481|75690694|FG009|COMPLETED|Overall Study||188||
59584142|NCT04381481|75690695|FG010|COMPLETED|Overall Study||183||
59584143|NCT04381481|75690696|FG011|COMPLETED|Overall Study||173||
59584144|NCT04381481|75690685|FG000|NOT COMPLETED|Overall Study||15||
59584145|NCT04381481|75690686|FG001|NOT COMPLETED|Overall Study||15||
59584146|NCT04381481|75690687|FG002|NOT COMPLETED|Overall Study||9||
59584147|NCT04381481|75690688|FG003|NOT COMPLETED|Overall Study||14||
59584148|NCT04381481|75690689|FG004|NOT COMPLETED|Overall Study||8||
59584149|NCT04381481|75690690|FG005|NOT COMPLETED|Overall Study||15||
59584150|NCT04381481|75690691|FG006|NOT COMPLETED|Overall Study||10||
59584151|NCT04381481|75690692|FG007|NOT COMPLETED|Overall Study||16||
59584152|NCT04381481|75690693|FG008|NOT COMPLETED|Overall Study||19||
59584153|NCT04381481|75690694|FG009|NOT COMPLETED|Overall Study||10||
59584154|NCT04381481|75690695|FG010|NOT COMPLETED|Overall Study||9||
59584155|NCT04381481|75690696|FG011|NOT COMPLETED|Overall Study||15||
59584156|NCT01642602|75690722|FG000|STARTED|Overall Study||104||
59584157|NCT01642602|75690722|FG000|COMPLETED|Overall Study||102||
59584158|NCT01642602|75690722|FG000|NOT COMPLETED|Overall Study||2||
59584159|NCT03488849|75690729|FG000|STARTED|Overall Study||10||
59584160|NCT03488849|75690730|FG001|STARTED|Overall Study||8||
59584161|NCT03488849|75690731|FG002|STARTED|Overall Study||6||
59584162|NCT03488849|75690729|FG000|COMPLETED|Overall Study||10||
59584163|NCT03488849|75690730|FG001|COMPLETED|Overall Study||8||
59584164|NCT03488849|75690731|FG002|COMPLETED|Overall Study||6||
59584165|NCT03488849|75690729|FG000|NOT COMPLETED|Overall Study||0||
59584166|NCT03488849|75690730|FG001|NOT COMPLETED|Overall Study||0||
59584167|NCT03488849|75690731|FG002|NOT COMPLETED|Overall Study||0||
59584168|NCT04371419|75690741|FG000|STARTED|Overall Study||784||
59584169|NCT04371419|75690742|FG001|STARTED|Overall Study||791||
59584170|NCT04371419|75690743|FG002|STARTED|Overall Study||780||
59584171|NCT04371419|75690744|FG003|STARTED|Overall Study||778||
59584172|NCT04371419|75690745|FG004|STARTED|Overall Study||777||
59584173|NCT04371419|75690746|FG005|STARTED|Overall Study||788||
59584174|NCT04371419|75690747|FG006|STARTED|Overall Study||783||
59584175|NCT04371419|75690748|FG007|STARTED|Overall Study||788||
59584176|NCT04371419|75690749|FG008|STARTED|Overall Study||779||
59584177|NCT04371419|75690750|FG009|STARTED|Overall Study||780||
59584178|NCT04371419|75690751|FG010|STARTED|Overall Study||782||
59584179|NCT04371419|75690752|FG011|STARTED|Overall Study||790||
59584180|NCT04371419|75690753|FG012|STARTED|Overall Study||779||
59584181|NCT04371419|75690754|FG013|STARTED|Overall Study||786||
59584182|NCT04371419|75690755|FG014|STARTED|Overall Study||781||
59584183|NCT04371419|75690756|FG015|STARTED|Overall Study||781||
59584184|NCT04371419|75690757|FG016|STARTED|Overall Study||1617||
59584185|NCT04371419|75690741|FG000|Completed the Knowledge Questions|Overall Study||663|Participants who completed the knowledge questions and were included in the knowledge outcome analysis questions|
59584186|NCT04371419|75690742|FG001|Completed the Knowledge Questions|Overall Study||669|Participants who completed the knowledge questions and were included in the knowledge outcome analysis questions|
59584187|NCT04371419|75690743|FG002|Completed the Knowledge Questions|Overall Study||673|Participants who completed the knowledge questions and were included in the knowledge outcome analysis questions|
59584188|NCT04371419|75690744|FG003|Completed the Knowledge Questions|Overall Study||664|Participants who completed the knowledge questions and were included in the knowledge outcome analysis questions|
59584189|NCT04371419|75690745|FG004|Completed the Knowledge Questions|Overall Study||666|Participants who completed the knowledge questions and were included in the knowledge outcome analysis questions|
59584190|NCT04371419|75690746|FG005|Completed the Knowledge Questions|Overall Study||683|Participants who completed the knowledge questions and were included in the knowledge outcome analysis questions|
59584191|NCT04371419|75690747|FG006|Completed the Knowledge Questions|Overall Study||664|Participants who completed the knowledge questions and were included in the knowledge outcome analysis questions|
59584192|NCT04371419|75690748|FG007|Completed the Knowledge Questions|Overall Study||679|Participants who completed the knowledge questions and were included in the knowledge outcome analysis questions|
59584193|NCT04371419|75690749|FG008|Completed the Knowledge Questions|Overall Study||670|Participants who completed the knowledge questions and were included in the knowledge outcome analysis questions|
59584194|NCT04371419|75690750|FG009|Completed the Knowledge Questions|Overall Study||655|Participants who completed the knowledge questions and were included in the knowledge outcome analysis questions|
59584195|NCT04371419|75690751|FG010|Completed the Knowledge Questions|Overall Study||656|Participants who completed the knowledge questions and were included in the knowledge outcome analysis questions|
59584196|NCT04371419|75690752|FG011|Completed the Knowledge Questions|Overall Study||692|Participants who completed the knowledge questions and were included in the knowledge outcome analysis questions|
59584197|NCT04371419|75690753|FG012|Completed the Knowledge Questions|Overall Study||664|Participants who completed the knowledge questions and were included in the knowledge outcome analysis questions|
59584198|NCT04371419|75690754|FG013|Completed the Knowledge Questions|Overall Study||687|Participants who completed the knowledge questions and were included in the knowledge outcome analysis questions|
59584199|NCT04371419|75690755|FG014|Completed the Knowledge Questions|Overall Study||652|Participants who completed the knowledge questions and were included in the knowledge outcome analysis questions|
59584200|NCT04371419|75690756|FG015|Completed the Knowledge Questions|Overall Study||652|Participants who completed the knowledge questions and were included in the knowledge outcome analysis questions|
59584201|NCT04371419|75690757|FG016|Completed the Knowledge Questions|Overall Study||1526|Participants who completed the knowledge questions and were included in the knowledge outcome analysis questions|
59584202|NCT04371419|75690741|FG000|COMPLETED|Overall Study||641|Participants completed the survey and were included in all analyses.|
59584203|NCT04371419|75690742|FG001|COMPLETED|Overall Study||636|Participants completed the survey and were included in all analyses.|
59584204|NCT04371419|75690743|FG002|COMPLETED|Overall Study||639|Participants completed the survey and were included in all analyses.|
59584205|NCT04371419|75690744|FG003|COMPLETED|Overall Study||631|Participants completed the survey and were included in all analyses.|
59584206|NCT04371419|75690745|FG004|COMPLETED|Overall Study||644|Participants completed the survey and were included in all analyses.|
59584207|NCT04371419|75690746|FG005|COMPLETED|Overall Study||654|Participants completed the survey and were included in all analyses.|
59584208|NCT04371419|75690747|FG006|COMPLETED|Overall Study||639|Participants completed the survey and were included in all analyses.|
59584209|NCT04371419|75690748|FG007|COMPLETED|Overall Study||658|Participants completed the survey and were included in all analyses.|
59584210|NCT04371419|75690749|FG008|COMPLETED|Overall Study||649|Participants completed the survey and were included in all analyses.|
59584211|NCT04371419|75690750|FG009|COMPLETED|Overall Study||621|Participants completed the survey and were included in all analyses.|
59584212|NCT04371419|75690751|FG010|COMPLETED|Overall Study||626|Participants completed the survey and were included in all analyses.|
59584213|NCT04371419|75690752|FG011|COMPLETED|Overall Study||662|Participants completed the survey and were included in all analyses.|
59584214|NCT04371419|75690753|FG012|COMPLETED|Overall Study||633|Participants completed the survey and were included in all analyses.|
59584215|NCT04371419|75690754|FG013|COMPLETED|Overall Study||660|Participants completed the survey and were included in all analyses.|
59584216|NCT04371419|75690755|FG014|COMPLETED|Overall Study||626|Participants completed the survey and were included in all analyses.|
59584217|NCT04371419|75690756|FG015|COMPLETED|Overall Study||625|Participants completed the survey and were included in all analyses.|
59584218|NCT04371419|75690757|FG016|COMPLETED|Overall Study||1450|Participants completed the survey and were included in all analyses.|
59584219|NCT04371419|75690741|FG000|NOT COMPLETED|Overall Study||143||
59584220|NCT04371419|75690742|FG001|NOT COMPLETED|Overall Study||155||
59584221|NCT04371419|75690743|FG002|NOT COMPLETED|Overall Study||141||
59584222|NCT04371419|75690744|FG003|NOT COMPLETED|Overall Study||147||
59584223|NCT04371419|75690745|FG004|NOT COMPLETED|Overall Study||133||
59584224|NCT04371419|75690746|FG005|NOT COMPLETED|Overall Study||134||
59584225|NCT04371419|75690747|FG006|NOT COMPLETED|Overall Study||144||
59584226|NCT04371419|75690748|FG007|NOT COMPLETED|Overall Study||130||
59584227|NCT04371419|75690749|FG008|NOT COMPLETED|Overall Study||130||
59584228|NCT04371419|75690750|FG009|NOT COMPLETED|Overall Study||159||
59584229|NCT04371419|75690751|FG010|NOT COMPLETED|Overall Study||156||
59851574|NCT03515824|75976150|FG000|NOT COMPLETED|Overall Study||3||
59851575|NCT03515824|75976151|FG001|NOT COMPLETED|Overall Study||4||
59851576|NCT03515824|75976152|FG002|NOT COMPLETED|Overall Study||15||
59851577|NCT03515824|75976153|FG003|NOT COMPLETED|Overall Study||0||
59851578|NCT01089374|75976163|FG000|STARTED|Overall Study||11||
59851579|NCT01089374|75976164|FG001|STARTED|Overall Study||46||
59851580|NCT01089374|75976163|FG000|COMPLETED|Overall Study||1||
59851581|NCT01089374|75976164|FG001|COMPLETED|Overall Study||46||
59851582|NCT01089374|75976163|FG000|NOT COMPLETED|Overall Study||10||
59851583|NCT01089374|75976164|FG001|NOT COMPLETED|Overall Study||0||
59851584|NCT03511378|75976171|FG000|STARTED|Overall Study||70||
59851585|NCT03511378|75976172|FG001|STARTED|Overall Study||68||
59851586|NCT03511378|75976171|FG000|COMPLETED|Overall Study||67||
59851587|NCT03511378|75976172|FG001|COMPLETED|Overall Study||66||
59851588|NCT03511378|75976171|FG000|NOT COMPLETED|Overall Study||3||
59851589|NCT03511378|75976172|FG001|NOT COMPLETED|Overall Study||2||
59851590|NCT03511066|75976181|FG000|STARTED|Overall Study||88||
59851591|NCT03511066|75976182|FG001|STARTED|Overall Study||90||
59851592|NCT03511066|75976183|FG002|STARTED|Overall Study||50||
59851593|NCT03511066|75976181|FG000|COMPLETED|Overall Study||85||
59851594|NCT03511066|75976182|FG001|COMPLETED|Overall Study||85||
59851595|NCT03511066|75976183|FG002|COMPLETED|Overall Study||47||
59851596|NCT03511066|75976181|FG000|NOT COMPLETED|Overall Study||3||
59851597|NCT03511066|75976182|FG001|NOT COMPLETED|Overall Study||5||
59851598|NCT03511066|75976183|FG002|NOT COMPLETED|Overall Study||3||
59851599|NCT03510910|75976193|FG000|STARTED|Overall Study||42||
59851600|NCT03510910|75976194|FG001|STARTED|Overall Study||43||
59851601|NCT03510910|75976193|FG000|COMPLETED|Overall Study||40||
59851602|NCT03510910|75976194|FG001|COMPLETED|Overall Study||40||
59851603|NCT03510910|75976193|FG000|NOT COMPLETED|Overall Study||2||
59584230|NCT04371419|75690752|FG011|NOT COMPLETED|Overall Study||128||
59584231|NCT04371419|75690753|FG012|NOT COMPLETED|Overall Study||146||
59584232|NCT04371419|75690754|FG013|NOT COMPLETED|Overall Study||126||
59584233|NCT04371419|75690755|FG014|NOT COMPLETED|Overall Study||155||
59584234|NCT04371419|75690756|FG015|NOT COMPLETED|Overall Study||156||
59584235|NCT04371419|75690757|FG016|NOT COMPLETED|Overall Study||167||
59584236|NCT02256540|75690788|FG000|STARTED|Overall Study||6||
59584237|NCT02256540|75690789|FG001|STARTED|Overall Study||6||
59584238|NCT02256540|75690790|FG002|STARTED|Overall Study||6||
59584239|NCT02256540|75690788|FG000|COMPLETED|Overall Study||6||
59584240|NCT02256540|75690789|FG001|COMPLETED|Overall Study||5||
59584241|NCT02256540|75690790|FG002|COMPLETED|Overall Study||4||
59584242|NCT02256540|75690788|FG000|NOT COMPLETED|Overall Study||0||
59584243|NCT02256540|75690789|FG001|NOT COMPLETED|Overall Study||1||
59584244|NCT02256540|75690790|FG002|NOT COMPLETED|Overall Study||2||
59584245|NCT04366583|75690800|FG000|STARTED|Overall Study||82||
59584246|NCT04366583|75690801|FG001|STARTED|Overall Study||84||
59584247|NCT04366583|75690800|FG000|COMPLETED|Overall Study||82||
59584248|NCT04366583|75690801|FG001|COMPLETED|Overall Study||84||
59584249|NCT04366583|75690800|FG000|NOT COMPLETED|Overall Study||0||
59584250|NCT04366583|75690801|FG001|NOT COMPLETED|Overall Study||0||
59584251|NCT03627299|75690807|FG000|STARTED|Overall Study||10||
59584252|NCT03627299|75690807|FG000|COMPLETED|Overall Study||10||
59584253|NCT03627299|75690807|FG000|NOT COMPLETED|Overall Study||0||
59584254|NCT01640184|75690814|FG000|STARTED|Overall Study||34||
59584255|NCT01640184|75690815|FG001|STARTED|Overall Study||23||
59584256|NCT01640184|75690816|FG002|STARTED|Overall Study||22||
59584257|NCT01640184|75690814|FG000|COMPLETED|Overall Study||26||
59584258|NCT01640184|75690815|FG001|COMPLETED|Overall Study||21||
59584259|NCT01640184|75690816|FG002|COMPLETED|Overall Study||20||
59584260|NCT01640184|75690814|FG000|NOT COMPLETED|Overall Study||8||
59584261|NCT01640184|75690815|FG001|NOT COMPLETED|Overall Study||2||
59584262|NCT01640184|75690816|FG002|NOT COMPLETED|Overall Study||2||
59584263|NCT03630185|75690829|FG000|STARTED|Overall Study||4||
59584264|NCT03630185|75690830|FG001|STARTED|Overall Study||4||
59584265|NCT03630185|75690829|FG000|30 Day Follow up|Overall Study||1||
59584266|NCT03630185|75690830|FG001|30 Day Follow up|Overall Study||1||
59584267|NCT03630185|75690829|FG000|90 Day Follow up|Overall Study||0||
59584268|NCT03630185|75690830|FG001|90 Day Follow up|Overall Study||1||
59584269|NCT03630185|75690829|FG000|6 Month Follow up|Overall Study||0||
59584270|NCT03630185|75690830|FG001|6 Month Follow up|Overall Study||0||
59584271|NCT03630185|75690829|FG000|COMPLETED|Overall Study||0||
59584272|NCT03630185|75690830|FG001|COMPLETED|Overall Study||0||
59584273|NCT03630185|75690829|FG000|NOT COMPLETED|Overall Study||4||
59584274|NCT03630185|75690830|FG001|NOT COMPLETED|Overall Study||4||
59584275|NCT02256384|75690836|FG000|STARTED|Overall Study||76||
59584276|NCT02256384|75690836|FG000|COMPLETED|Overall Study||62||
59584277|NCT02256384|75690836|FG000|NOT COMPLETED|Overall Study||14||
59584278|NCT03631433|75690846|FG000|STARTED|Overall Study||49||
59584279|NCT03631433|75690847|FG001|STARTED|Overall Study||53||
59584280|NCT03631433|75690846|FG000|COMPLETED|Overall Study||49||
59584281|NCT03631433|75690847|FG001|COMPLETED|Overall Study||53||
59584282|NCT03631433|75690846|FG000|NOT COMPLETED|Overall Study||0||
59584283|NCT03631433|75690847|FG001|NOT COMPLETED|Overall Study||0||
59584284|NCT03489941|75690853|FG000|STARTED|Overall Study||51||51
59584285|NCT03489941|75690854|FG001|STARTED|Overall Study||52||52
59584286|NCT03489941|75690855|FG002|STARTED|Overall Study||27||27
59584287|NCT03489941|75690853|FG000|COMPLETED|Overall Study||51||51
59584288|NCT03489941|75690854|FG001|COMPLETED|Overall Study||52||52
59584289|NCT03489941|75690855|FG002|COMPLETED|Overall Study||27||27
59584290|NCT03489941|75690853|FG000|NOT COMPLETED|Overall Study||0||0
59584291|NCT03489941|75690854|FG001|NOT COMPLETED|Overall Study||0||0
59584292|NCT03489941|75690855|FG002|NOT COMPLETED|Overall Study||0||0
59584293|NCT03491891|75690863|FG000|STARTED|Overall Study||6038||
59584294|NCT03491891|75690864|FG001|STARTED|Overall Study||2438||
59584295|NCT03491891|75690863|FG000|COMPLETED|Overall Study||5185||
59584296|NCT03491891|75690864|FG001|COMPLETED|Overall Study||2058||
59584297|NCT03491891|75690863|FG000|NOT COMPLETED|Overall Study||853||
59584298|NCT03491891|75690864|FG001|NOT COMPLETED|Overall Study||380||
59584299|NCT03493607|75690870|FG000|STARTED|Overall Study||6||
59584300|NCT03493607|75690870|FG000|COMPLETED|Overall Study||6||
59584301|NCT03493607|75690870|FG000|NOT COMPLETED|Overall Study||0||
59584302|NCT02255760|75690879|FG000|STARTED|Overall Study||14||
59584303|NCT02255760|75690880|FG001|STARTED|Overall Study||3||
59584304|NCT02255760|75690881|FG002|STARTED|Overall Study||15||
59584305|NCT02255760|75690882|FG003|STARTED|Overall Study||15||
59584306|NCT02255760|75690883|FG004|STARTED|Overall Study||9||
59584307|NCT02255760|75690879|FG000|COMPLETED|Overall Study||14||
59584308|NCT02255760|75690880|FG001|COMPLETED|Overall Study||2||
59584309|NCT02255760|75690881|FG002|COMPLETED|Overall Study||15||
59584310|NCT02255760|75690882|FG003|COMPLETED|Overall Study||15||
59584311|NCT02255760|75690883|FG004|COMPLETED|Overall Study||9||
59584312|NCT02255760|75690879|FG000|NOT COMPLETED|Overall Study||0||
59584313|NCT02255760|75690880|FG001|NOT COMPLETED|Overall Study||1||
59584314|NCT02255760|75690881|FG002|NOT COMPLETED|Overall Study||0||
59584315|NCT02255760|75690882|FG003|NOT COMPLETED|Overall Study||0||
59584316|NCT02255760|75690883|FG004|NOT COMPLETED|Overall Study||0||
59584317|NCT03497585|75690899|FG000|STARTED|Overall Study|112 participants were recruited: 107 patients, plus 5 HCPs for the acceptability interviews.|112||
59584318|NCT03497585|75690899|FG000|COMPLETED|Overall Study||57||
59584319|NCT03497585|75690899|FG000|NOT COMPLETED|Overall Study||55||
59584320|NCT03637517|75690906|FG000|STARTED|Overall Study||14||
59584321|NCT03637517|75690907|FG001|STARTED|Overall Study||14||
59584322|NCT03637517|75690908|FG002|STARTED|Overall Study||14||
59584323|NCT03637517|75690906|FG000|COMPLETED|Overall Study||14||
59584324|NCT03637517|75690907|FG001|COMPLETED|Overall Study||14||
59584325|NCT03637517|75690908|FG002|COMPLETED|Overall Study||14||
59584326|NCT03637517|75690906|FG000|NOT COMPLETED|Overall Study||0||
59584327|NCT03637517|75690907|FG001|NOT COMPLETED|Overall Study||0||
59584328|NCT03637517|75690908|FG002|NOT COMPLETED|Overall Study||0||
59584329|NCT04297631|75690916|FG000|STARTED|Overall Study||20||
59584330|NCT04297631|75690916|FG000|COMPLETED|Overall Study||20||
59584331|NCT04297631|75690916|FG000|NOT COMPLETED|Overall Study||0||
59584332|NCT04296227|75690921|FG000|STARTED|Overall Study||85||
59584333|NCT04296227|75690921|FG000|COMPLETED|Overall Study||85||
59584334|NCT04296227|75690921|FG000|NOT COMPLETED|Overall Study||0||
59584335|NCT04292639|75690925|FG000|STARTED|Overall Study||20||
59584336|NCT04292639|75690925|FG000|COMPLETED|Overall Study||20||
59584337|NCT04292639|75690925|FG000|NOT COMPLETED|Overall Study||0||
59584338|NCT03502265|75690929|FG000|STARTED|Overall Study||4||
59584339|NCT03502265|75690929|FG000|COMPLETED|Overall Study||4||
59584340|NCT03502265|75690929|FG000|NOT COMPLETED|Overall Study||0||
59584341|NCT04274075|75690939|FG000|STARTED|Overall Study||3||
59584342|NCT04274075|75690940|FG001|STARTED|Overall Study||3||
59584343|NCT04274075|75690941|FG002|STARTED|Overall Study||3||
59584344|NCT04274075|75690942|FG003|STARTED|Overall Study||3||
59584345|NCT04274075|75690943|FG004|STARTED|Overall Study||3||
59584346|NCT04274075|75690944|FG005|STARTED|Overall Study||3||
59584347|NCT04274075|75690939|FG000|Completed Treatment Period 1 (9 Days)|Overall Study||3||
59584348|NCT04274075|75690940|FG001|Completed Treatment Period 1 (9 Days)|Overall Study||3||
59584349|NCT04274075|75690941|FG002|Completed Treatment Period 1 (9 Days)|Overall Study||3||
59584350|NCT04274075|75690942|FG003|Completed Treatment Period 1 (9 Days)|Overall Study||3||
59584351|NCT04274075|75690943|FG004|Completed Treatment Period 1 (9 Days)|Overall Study||3||
59584352|NCT04274075|75690944|FG005|Completed Treatment Period 1 (9 Days)|Overall Study||3||
59584353|NCT04274075|75690939|FG000|Completed Treatment Period 2 (9 Days)|Overall Study||3||
59584354|NCT04274075|75690940|FG001|Completed Treatment Period 2 (9 Days)|Overall Study||3||
59584355|NCT04274075|75690941|FG002|Completed Treatment Period 2 (9 Days)|Overall Study||3||
59584356|NCT04274075|75690942|FG003|Completed Treatment Period 2 (9 Days)|Overall Study||3||
59584357|NCT04274075|75690943|FG004|Completed Treatment Period 2 (9 Days)|Overall Study||3||
59584358|NCT04274075|75690944|FG005|Completed Treatment Period 2 (9 Days)|Overall Study||3||
59584359|NCT04274075|75690939|FG000|Completed Treatment Period 3 (9 Days)|Overall Study||3||
59584360|NCT04274075|75690940|FG001|Completed Treatment Period 3 (9 Days)|Overall Study||3||
59584361|NCT04274075|75690941|FG002|Completed Treatment Period 3 (9 Days)|Overall Study||3||
59584362|NCT04274075|75690942|FG003|Completed Treatment Period 3 (9 Days)|Overall Study||3||
59584363|NCT04274075|75690943|FG004|Completed Treatment Period 3 (9 Days)|Overall Study||3||
59584364|NCT04274075|75690944|FG005|Completed Treatment Period 3 (9 Days)|Overall Study||3||
59584365|NCT04274075|75690939|FG000|Completed Follow-up Visit|Overall Study||3|The follow-up visit took place 12 to 14 days after the last dose of study drug.|
59584366|NCT04274075|75690940|FG001|Completed Follow-up Visit|Overall Study||3|The follow-up visit took place 12 to 14 days after the last dose of study drug.|
59584367|NCT04274075|75690941|FG002|Completed Follow-up Visit|Overall Study||3|The follow-up visit took place 12 to 14 days after the last dose of study drug.|
59584368|NCT04274075|75690942|FG003|Completed Follow-up Visit|Overall Study||3|The follow-up visit took place 12 to 14 days after the last dose of study drug.|
59584369|NCT04274075|75690943|FG004|Completed Follow-up Visit|Overall Study||3|The follow-up visit took place 12 to 14 days after the last dose of study drug.|
59584370|NCT04274075|75690944|FG005|Completed Follow-up Visit|Overall Study||3|The follow-up visit took place 12 to 14 days after the last dose of study drug.|
59584371|NCT04274075|75690939|FG000|COMPLETED|Overall Study||3||
59584372|NCT04274075|75690940|FG001|COMPLETED|Overall Study||3||
59584373|NCT04274075|75690941|FG002|COMPLETED|Overall Study||3||
59584374|NCT04274075|75690942|FG003|COMPLETED|Overall Study||3||
59584375|NCT04274075|75690943|FG004|COMPLETED|Overall Study||3||
59584376|NCT04274075|75690944|FG005|COMPLETED|Overall Study||3||
59584377|NCT04274075|75690939|FG000|NOT COMPLETED|Overall Study||0||
59584378|NCT04274075|75690940|FG001|NOT COMPLETED|Overall Study||0||
59584379|NCT04274075|75690941|FG002|NOT COMPLETED|Overall Study||0||
59584380|NCT04274075|75690942|FG003|NOT COMPLETED|Overall Study||0||
59584381|NCT04274075|75690943|FG004|NOT COMPLETED|Overall Study||0||
59584382|NCT04274075|75690944|FG005|NOT COMPLETED|Overall Study||0||
59584383|NCT03639857|75690955|FG000|STARTED|Overall Study||1||1
59584384|NCT03639857|75690956|FG001|STARTED|Overall Study||3||3
59584385|NCT03639857|75690957|FG002|STARTED|Overall Study||3||3
59584386|NCT03639857|75690955|FG000|COMPLETED|Overall Study||1||1
59584387|NCT03639857|75690956|FG001|COMPLETED|Overall Study||3||3
59584388|NCT03639857|75690957|FG002|COMPLETED|Overall Study||3||3
59584389|NCT03639857|75690955|FG000|NOT COMPLETED|Overall Study||0||0
59584390|NCT03639857|75690956|FG001|NOT COMPLETED|Overall Study||0||0
59584391|NCT03639857|75690957|FG002|NOT COMPLETED|Overall Study||0||0
59584392|NCT03504839|75690965|FG000|STARTED|Overall Study||53||
59584393|NCT03504839|75690965|FG000|COMPLETED|Overall Study||49||
59584394|NCT03504839|75690965|FG000|NOT COMPLETED|Overall Study||4||
59584395|NCT04269629|75690969|FG000|STARTED|Overall Study|1425 patients were included in the study (=Visit 1)|1425||
59584396|NCT04269629|75690969|FG000|Number of Patients Who Performed VIT|Overall Study|Visit 2 was performed with 1342 patients|1342||
59584397|NCT04269629|75690969|FG000|COMPLETED|Overall Study|Visit 3 was performed with 1186 patients|1186||
59584398|NCT04269629|75690969|FG000|NOT COMPLETED|Overall Study||239||
59584399|NCT01641822|75690979|FG000|STARTED|Run-in Phase||107||
59584400|NCT01641822|75690980|FG001|STARTED|Run-in Phase||0||
59584401|NCT01641822|75690981|FG002|STARTED|Run-in Phase||0||
59584402|NCT01641822|75690979|FG000|COMPLETED|Run-in Phase|3 participants who completed the TIS Run-In Phase did not continue to the Comparative Phase.|93||
59584403|NCT01641822|75690980|FG001|COMPLETED|Run-in Phase||0||
59584404|NCT01641822|75690981|FG002|COMPLETED|Run-in Phase||0||
59584405|NCT01641822|75690979|FG000|NOT COMPLETED|Run-in Phase||14||
59584406|NCT01641822|75690980|FG001|NOT COMPLETED|Run-in Phase||0||
59584407|NCT01641822|75690981|FG002|NOT COMPLETED|Run-in Phase||0||
59584408|NCT01641822|75690979|FG000|STARTED|Comparative Phase|Participants continuing into the Comparative Phase were randomized to the AZLI or Placebo group.|0||
59584409|NCT01641822|75690980|FG001|STARTED|Comparative Phase||43||
59584410|NCT01641822|75690981|FG002|STARTED|Comparative Phase||47||
59584411|NCT01641822|75690979|FG000|Received Randomized Study Drug Treatment|Comparative Phase||0||
59584412|NCT01641822|75690980|FG001|Received Randomized Study Drug Treatment|Comparative Phase||42||
59584413|NCT01641822|75690981|FG002|Received Randomized Study Drug Treatment|Comparative Phase||46||
59584414|NCT01641822|75690979|FG000|COMPLETED|Comparative Phase||0||
59584415|NCT01641822|75690980|FG001|COMPLETED|Comparative Phase||37||
59584416|NCT01641822|75690981|FG002|COMPLETED|Comparative Phase||37||
59584417|NCT01641822|75690979|FG000|NOT COMPLETED|Comparative Phase||0||
59584418|NCT01641822|75690980|FG001|NOT COMPLETED|Comparative Phase||6||
59584419|NCT01641822|75690981|FG002|NOT COMPLETED|Comparative Phase||10||
59584420|NCT04250987|75690988|FG000|STARTED|Overall Study||12||
59584421|NCT04250987|75690988|FG000|COMPLETED|Overall Study||12||
59584422|NCT04250987|75690988|FG000|NOT COMPLETED|Overall Study||0||
59584423|NCT03507569|75690996|FG000|STARTED|Overall Study||2||
59584424|NCT03507569|75690997|FG001|STARTED|Overall Study||1||
59584425|NCT03507569|75690998|FG002|STARTED|Overall Study||2||
59584426|NCT03507569|75690999|FG003|STARTED|Overall Study||1||
59584427|NCT03507569|75690996|FG000|COMPLETED|Overall Study||2||
59584428|NCT03507569|75690997|FG001|COMPLETED|Overall Study||1||
59584429|NCT03507569|75690998|FG002|COMPLETED|Overall Study||2||
59584430|NCT03507569|75690999|FG003|COMPLETED|Overall Study||1||
59584431|NCT03507569|75690996|FG000|NOT COMPLETED|Overall Study||0||
59584432|NCT03507569|75690997|FG001|NOT COMPLETED|Overall Study||0||
59584433|NCT03507569|75690998|FG002|NOT COMPLETED|Overall Study||0||
59584434|NCT03507569|75690999|FG003|NOT COMPLETED|Overall Study||0||
59584435|NCT03508661|75691009|FG000|STARTED|Overall Study||10||
59584436|NCT03508661|75691009|FG000|COMPLETED|Overall Study||10||
59584437|NCT03508661|75691009|FG000|NOT COMPLETED|Overall Study||0||
59584438|NCT03645785|75691013|FG000|STARTED|Day 1 (Normal Fluid Intake and Diet)||23||
59584439|NCT03645785|75691013|FG000|COMPLETED|Day 1 (Normal Fluid Intake and Diet)||23||
59584440|NCT03645785|75691013|FG000|NOT COMPLETED|Day 1 (Normal Fluid Intake and Diet)||0||
59584441|NCT03645785|75691013|FG000|STARTED|Day 2-4 (Double Fluid and Add Citrate)||23||
59584442|NCT03645785|75691013|FG000|COMPLETED|Day 2-4 (Double Fluid and Add Citrate)||23||
59584443|NCT03645785|75691013|FG000|NOT COMPLETED|Day 2-4 (Double Fluid and Add Citrate)||0||
59584444|NCT03511001|75691031|FG000|STARTED|Overall Study||126||
59584445|NCT03511001|75691032|FG001|STARTED|Overall Study||61||
59584446|NCT03511001|75691031|FG000|Completers Analyzed|Overall Study|1 participant was excluded post-randomization due to not meeting race/ethnicity inclusion criteria.|114||
59584447|NCT03511001|75691032|FG001|Completers Analyzed|Overall Study||61||
59584448|NCT03511001|75691031|FG000|COMPLETED|Overall Study||115||
59584449|NCT03511001|75691032|FG001|COMPLETED|Overall Study||54||
59584450|NCT03511001|75691031|FG000|NOT COMPLETED|Overall Study||11||
59584451|NCT03511001|75691032|FG001|NOT COMPLETED|Overall Study||7||
59584452|NCT03647033|75691040|FG000|STARTED|Overall Study||16||
59584453|NCT03647033|75691041|FG001|STARTED|Overall Study||16||
59584454|NCT03647033|75691040|FG000|COMPLETED|Overall Study||16||
59584455|NCT03647033|75691041|FG001|COMPLETED|Overall Study||16||
59584456|NCT03647033|75691040|FG000|NOT COMPLETED|Overall Study||0||
59584457|NCT03647033|75691041|FG001|NOT COMPLETED|Overall Study||0||
59584458|NCT03511937|75691049|FG000|STARTED|Overall Study||200||
59584459|NCT03511937|75691050|FG001|STARTED|Overall Study||200||
59584460|NCT03511937|75691049|FG000|COMPLETED|Overall Study||200||
59584461|NCT03511937|75691050|FG001|COMPLETED|Overall Study||200||
59584462|NCT03511937|75691049|FG000|NOT COMPLETED|Overall Study||0||
59584463|NCT03511937|75691050|FG001|NOT COMPLETED|Overall Study||0||
59584464|NCT01641198|75691061|FG000|STARTED|After 12 Months of Function||20||100
59584465|NCT01641198|75691062|FG001|STARTED|After 12 Months of Function||19||95
59584466|NCT01641198|75691063|FG002|STARTED|After 12 Months of Function||19||95
59584467|NCT01641198|75691061|FG000|COMPLETED|After 12 Months of Function|Participants: 3 interval violation, 1 protocol violation. Implants: 13 bone loss not measurable|16||67
59584468|NCT01641198|75691062|FG001|COMPLETED|After 12 Months of Function|Participants: 2 interval violation, 1 adverse event. Implants: 3 bone loss not measurable|16||77
59584469|NCT01641198|75691063|FG002|COMPLETED|After 12 Months of Function|Participants: 2 interval violation. Implants: 3 bone loss not measurable|17||82
59584470|NCT01641198|75691061|FG000|NOT COMPLETED|After 12 Months of Function||4||33
59584471|NCT01641198|75691062|FG001|NOT COMPLETED|After 12 Months of Function||3||18
59584472|NCT01641198|75691063|FG002|NOT COMPLETED|After 12 Months of Function||2||13
59584473|NCT01641198|75691061|FG000|STARTED|After 24 Months of Function||16||67
59584474|NCT01641198|75691062|FG001|STARTED|After 24 Months of Function||16||77
59584475|NCT01641198|75691063|FG002|STARTED|After 24 Months of Function||17||82
59584476|NCT01641198|75691061|FG000|COMPLETED|After 24 Months of Function|Participants: 4 interval violation. Implants: 3 bone loss not measurable|12||57
59584477|NCT01641198|75691062|FG001|COMPLETED|After 24 Months of Function|Participants: 9 interval violation|7||35
59584478|NCT01641198|75691063|FG002|COMPLETED|After 24 Months of Function|Participants: 6 interval violation. Implants: 2 bone loss not measurable|11||53
59584479|NCT01641198|75691061|FG000|NOT COMPLETED|After 24 Months of Function||4||10
59584480|NCT01641198|75691062|FG001|NOT COMPLETED|After 24 Months of Function||9||42
59851604|NCT03510910|75976194|FG001|NOT COMPLETED|Overall Study||3||
59851605|NCT03509350|75976202|FG000|STARTED|Overall Study||252||
59851606|NCT03509350|75976203|FG001|STARTED|Overall Study||249||
59851607|NCT03509350|75976202|FG000|COMPLETED|Overall Study||252||
59851608|NCT03509350|75976203|FG001|COMPLETED|Overall Study||247||
59851609|NCT03509350|75976202|FG000|NOT COMPLETED|Overall Study||0||
59851610|NCT03509350|75976203|FG001|NOT COMPLETED|Overall Study||2||
59851611|NCT03478696|75976211|FG000|STARTED|Overall Study||366||
59851612|NCT03478696|75976212|FG001|STARTED|Overall Study||366||
59851613|NCT03478696|75976211|FG000|COMPLETED|Overall Study||349||
59851614|NCT03478696|75976212|FG001|COMPLETED|Overall Study||354||
59851615|NCT03478696|75976211|FG000|NOT COMPLETED|Overall Study||17||
59851616|NCT03478696|75976212|FG001|NOT COMPLETED|Overall Study||12||
59851617|NCT03477838|75976218|FG000|STARTED|Overall Study||28||
59851618|NCT03477838|75976218|FG000|COMPLETED|Overall Study||14||
59851619|NCT03477838|75976218|FG000|NOT COMPLETED|Overall Study||14||
59851620|NCT00072176|75976224|FG000|STARTED|Overall Study||34||
59851621|NCT00072176|75976225|FG001|STARTED|Overall Study||28||
59851622|NCT00072176|75976224|FG000|COMPLETED|Overall Study||33||
59851623|NCT00072176|75976225|FG001|COMPLETED|Overall Study||27||
59851624|NCT00072176|75976224|FG000|NOT COMPLETED|Overall Study||1||
59851625|NCT00072176|75976225|FG001|NOT COMPLETED|Overall Study||1||
59851626|NCT00071396|75976231|FG000|STARTED|Overall Study||44||
59851627|NCT00071396|75976231|FG000|COMPLETED|Overall Study|Evaluable for response.|41||
59584481|NCT01641198|75691063|FG002|NOT COMPLETED|After 24 Months of Function||6||29
59584482|NCT01641198|75691061|FG000|STARTED|At 15-20 Years of Function||12||57
59584483|NCT01641198|75691062|FG001|STARTED|At 15-20 Years of Function||7||35
59584484|NCT01641198|75691063|FG002|STARTED|At 15-20 Years of Function||11||53
59584485|NCT01641198|75691061|FG000|COMPLETED|At 15-20 Years of Function|Participants: 5 interval violation, 1 death|6||30
59584486|NCT01641198|75691062|FG001|COMPLETED|At 15-20 Years of Function|Participants: 1 interval violation|6||30
59584487|NCT01641198|75691063|FG002|COMPLETED|At 15-20 Years of Function|Participants: 1 interval violation, 1 death|9||45
59584488|NCT01641198|75691061|FG000|NOT COMPLETED|At 15-20 Years of Function||6||27
59584489|NCT01641198|75691062|FG001|NOT COMPLETED|At 15-20 Years of Function||1||5
59584490|NCT01641198|75691063|FG002|NOT COMPLETED|At 15-20 Years of Function||2||8
59851628|NCT00071396|75976231|FG000|NOT COMPLETED|Overall Study||3||
59851629|NCT03473236|75976245|FG000|STARTED|Overall Study||10||
59851630|NCT03473236|75976246|FG001|STARTED|Overall Study||6||
59851631|NCT03473236|75976247|FG002|STARTED|Overall Study||6||
59851632|NCT03473236|75976248|FG003|STARTED|Overall Study||6||
59851633|NCT03473236|75976249|FG004|STARTED|Overall Study||6||
59851634|NCT03473236|75976250|FG005|STARTED|Overall Study||7||
59851635|NCT03473236|75976251|FG006|STARTED|Overall Study||6||
59851636|NCT03473236|75976252|FG007|STARTED|Overall Study||6||
59851637|NCT03473236|75976253|FG008|STARTED|Overall Study||7||
59851638|NCT03473236|75976254|FG009|STARTED|Overall Study||6||
59851639|NCT03473236|75976245|FG000|COMPLETED|Overall Study||10||
59851640|NCT03473236|75976246|FG001|COMPLETED|Overall Study||6||
59851641|NCT03473236|75976247|FG002|COMPLETED|Overall Study||6||
59851642|NCT03473236|75976248|FG003|COMPLETED|Overall Study||6||
59851643|NCT03473236|75976249|FG004|COMPLETED|Overall Study||6||
59851644|NCT03473236|75976250|FG005|COMPLETED|Overall Study||6||
59851645|NCT03473236|75976251|FG006|COMPLETED|Overall Study||6||
59851646|NCT03473236|75976252|FG007|COMPLETED|Overall Study||6||
59851647|NCT03473236|75976253|FG008|COMPLETED|Overall Study||6||
59851648|NCT03473236|75976254|FG009|COMPLETED|Overall Study||6||
59851649|NCT03473236|75976245|FG000|NOT COMPLETED|Overall Study||0||
59851650|NCT03473236|75976246|FG001|NOT COMPLETED|Overall Study||0||
59851651|NCT03473236|75976247|FG002|NOT COMPLETED|Overall Study||0||
59851652|NCT03473236|75976248|FG003|NOT COMPLETED|Overall Study||0||
59851653|NCT03473236|75976249|FG004|NOT COMPLETED|Overall Study||0||
59851654|NCT03473236|75976250|FG005|NOT COMPLETED|Overall Study||1||
59851655|NCT03473236|75976251|FG006|NOT COMPLETED|Overall Study||0||
59851656|NCT03473236|75976252|FG007|NOT COMPLETED|Overall Study||0||
59851657|NCT03473236|75976253|FG008|NOT COMPLETED|Overall Study||1||
59851658|NCT03473236|75976254|FG009|NOT COMPLETED|Overall Study||0||
59851659|NCT03550378|75976286|FG000|STARTED|Overall Study||20||
59851660|NCT03550378|75976287|FG001|STARTED|Overall Study||21||
59851661|NCT03550378|75976286|FG000|COMPLETED|Overall Study||20||
59851662|NCT03550378|75976287|FG001|COMPLETED|Overall Study||20||
59851663|NCT03550378|75976286|FG000|NOT COMPLETED|Overall Study||0||
59851664|NCT03550378|75976287|FG001|NOT COMPLETED|Overall Study||1||
59851665|NCT03472534|75976294|FG000|STARTED|Overall Study|Each participant receives all 4 unit interventions.|46||184
59851666|NCT03472534|75976294|FG000|Diacerein 1% Ointment|Overall Study||46||46
59851667|NCT03472534|75976294|FG000|Vehicle Ointment|Overall Study||46||46
59851668|NCT03472534|75976294|FG000|0.2% Sodium Lauryl Sulfate (SLS)|Overall Study||46||46
59851669|NCT03472534|75976294|FG000|0.9% Saline|Overall Study||46||46
59851670|NCT03472534|75976294|FG000|COMPLETED|Overall Study||35||140
59851671|NCT03472534|75976294|FG000|NOT COMPLETED|Overall Study||11||44
59851672|NCT03549130|75976300|FG000|STARTED|Overall Study||64||
59851673|NCT03549130|75976301|FG001|STARTED|Overall Study||66||
59851674|NCT03549130|75976300|FG000|COMPLETED|Overall Study||64||
59851675|NCT03549130|75976301|FG001|COMPLETED|Overall Study||64||
59851676|NCT03549130|75976300|FG000|NOT COMPLETED|Overall Study||0||
59851677|NCT03549130|75976301|FG001|NOT COMPLETED|Overall Study||2||
59851678|NCT03470194|75976311|FG000|STARTED|Overall Study||49||
59851679|NCT03470194|75976312|FG001|STARTED|Overall Study||57||
59851680|NCT03470194|75976311|FG000|COMPLETED|Overall Study||38||
59851681|NCT03470194|75976312|FG001|COMPLETED|Overall Study||40||
59851682|NCT03470194|75976311|FG000|NOT COMPLETED|Overall Study||11||
59851683|NCT03470194|75976312|FG001|NOT COMPLETED|Overall Study||17||
59851684|NCT03469336|75976318|FG000|STARTED|Overall Study||18||
59851685|NCT03469336|75976318|FG000|COMPLETED|Overall Study||17||
59851686|NCT03469336|75976318|FG000|NOT COMPLETED|Overall Study||1||
59851687|NCT03469258|75976328|FG000|STARTED|Overall Study||4||
59851688|NCT03469258|75976328|FG000|COMPLETED|Overall Study||0||
59851689|NCT03469258|75976328|FG000|NOT COMPLETED|Overall Study||4||
59851690|NCT03503188|75976334|FG000|STARTED|Overall Study||128|Started are enrolled in entire study|
59851691|NCT03503188|75976335|FG001|STARTED|Overall Study||146|Started are enrolled in entire study|
59851692|NCT03503188|75976334|FG000|Entered in the Entire Study|Overall Study||128||
59851693|NCT03503188|75976335|FG001|Entered in the Entire Study|Overall Study||145||
59851694|NCT03503188|75976334|FG000|Main Study|Overall Study||99|Only eligible participants|
59851695|NCT03503188|75976335|FG001|Main Study|Overall Study||101|Only eligible participants|
59851696|NCT03503188|75976334|FG000|Sub-study|Overall Study||29|Only eligible participants|
59851697|NCT03503188|75976335|FG001|Sub-study|Overall Study||44|Only eligible participants|
59851698|NCT03503188|75976334|FG000|COMPLETED|Overall Study||128||
59851699|NCT03503188|75976335|FG001|COMPLETED|Overall Study||145||
59851700|NCT03503188|75976334|FG000|NOT COMPLETED|Overall Study||0||
59851701|NCT03503188|75976335|FG001|NOT COMPLETED|Overall Study||1||
59851702|NCT03502798|75976343|FG000|STARTED|Overall Study||5||
59851703|NCT03502798|75976344|FG001|STARTED|Overall Study||40||
59851704|NCT03502798|75976343|FG000|COMPLETED|Overall Study||5||
59851705|NCT03502798|75976344|FG001|COMPLETED|Overall Study||33||
59851706|NCT03502798|75976343|FG000|NOT COMPLETED|Overall Study||0||
59851707|NCT03502798|75976344|FG001|NOT COMPLETED|Overall Study||7||
59851708|NCT00066170|75976354|FG000|STARTED|Overall Study||56||
59851709|NCT00066170|75976355|FG001|STARTED|Overall Study||55||
59851710|NCT00066170|75976356|FG002|STARTED|Overall Study||63||
59851711|NCT00066170|75976357|FG003|STARTED|Overall Study||57||
59851712|NCT00066170|75976354|FG000|Intent to Treat|Overall Study||55||
59584491|NCT04214951|75691074|FG000|STARTED|Overall Study||50||
59851713|NCT00066170|75976355|FG001|Intent to Treat|Overall Study||50||
59851714|NCT00066170|75976356|FG002|Intent to Treat|Overall Study||63||
59851715|NCT00066170|75976357|FG003|Intent to Treat|Overall Study||54||
59851716|NCT00066170|75976354|FG000|COMPLETED|Overall Study||49||
59851717|NCT00066170|75976355|FG001|COMPLETED|Overall Study||45||
59851718|NCT00066170|75976356|FG002|COMPLETED|Overall Study||59||
59851719|NCT00066170|75976357|FG003|COMPLETED|Overall Study||48||
59851720|NCT00066170|75976354|FG000|NOT COMPLETED|Overall Study||7||
59851721|NCT00066170|75976355|FG001|NOT COMPLETED|Overall Study||10||
59851722|NCT00066170|75976356|FG002|NOT COMPLETED|Overall Study||4||
59851723|NCT00066170|75976357|FG003|NOT COMPLETED|Overall Study||9||
59851724|NCT00065468|75976370|FG000|STARTED|Overall Study||207||
59851725|NCT00065468|75976371|FG001|STARTED|Overall Study||209||
59851726|NCT00065468|75976372|FG002|STARTED|Overall Study||210||
59851727|NCT00065468|75976370|FG000|Received Treatment|Overall Study||200||
59851728|NCT00065468|75976371|FG001|Received Treatment|Overall Study||208||
59851729|NCT00065468|75976372|FG002|Received Treatment|Overall Study||208||
59851730|NCT00065468|75976370|FG000|COMPLETED|Overall Study||0||
59851731|NCT00065468|75976371|FG001|COMPLETED|Overall Study||0||
59851732|NCT00065468|75976372|FG002|COMPLETED|Overall Study||0||
59851733|NCT00065468|75976370|FG000|NOT COMPLETED|Overall Study||207||
59851734|NCT00065468|75976371|FG001|NOT COMPLETED|Overall Study||209||
59851735|NCT00065468|75976372|FG002|NOT COMPLETED|Overall Study||210||
59851736|NCT00071006|75976380|FG000|STARTED|Overall Study||12||
59851737|NCT00071006|75976380|FG000|COMPLETED|Overall Study||0||
59851738|NCT00071006|75976380|FG000|NOT COMPLETED|Overall Study||12||
59851739|NCT00094575|75976386|FG000|STARTED|Overall Study||444||
59851740|NCT00094575|75976387|FG001|STARTED|Overall Study||437||
59851741|NCT00094575|75976386|FG000|COMPLETED|Overall Study||298||
59851742|NCT00094575|75976387|FG001|COMPLETED|Overall Study||291||
59851743|NCT00094575|75976386|FG000|NOT COMPLETED|Overall Study||146||
59851744|NCT00094575|75976387|FG001|NOT COMPLETED|Overall Study||146||
59851745|NCT00057746|75976398|FG000|STARTED|Overall Study||131||
59851746|NCT00057746|75976399|FG001|STARTED|Overall Study||67||
59851747|NCT00057746|75976400|FG002|STARTED|Overall Study||67||
59851748|NCT00057746|75976398|FG000|COMPLETED|Overall Study||131||
59851749|NCT00057746|75976399|FG001|COMPLETED|Overall Study||67||
59851750|NCT00057746|75976400|FG002|COMPLETED|Overall Study||66||
59851751|NCT00057746|75976398|FG000|NOT COMPLETED|Overall Study||0||
59851752|NCT00057746|75976399|FG001|NOT COMPLETED|Overall Study||0||
59851753|NCT00057746|75976400|FG002|NOT COMPLETED|Overall Study||1||
59851754|NCT00094107|75976408|FG000|STARTED|Overall Study||32||
59851755|NCT00094107|75976408|FG000|COMPLETED|Overall Study||0||
59851756|NCT00094107|75976408|FG000|NOT COMPLETED|Overall Study||32||
59851757|NCT00102063|75976415|FG000|STARTED|Overall Study||100||
59851758|NCT00102063|75976416|FG001|STARTED|Overall Study||102||
59851759|NCT00102063|75976417|FG002|STARTED|Overall Study||100||
59851760|NCT00102063|75976415|FG000|COMPLETED|Overall Study||84||
59851761|NCT00102063|75976416|FG001|COMPLETED|Overall Study||84||
59851762|NCT00102063|75976417|FG002|COMPLETED|Overall Study||90||
59851763|NCT00102063|75976415|FG000|NOT COMPLETED|Overall Study||16||
59851764|NCT00102063|75976416|FG001|NOT COMPLETED|Overall Study||18||
59851765|NCT00102063|75976417|FG002|NOT COMPLETED|Overall Study||10||
59851766|NCT00065156|75976425|FG000|STARTED|Overall Study||148||
59851767|NCT00065156|75976425|FG000|Modified Intent to Treat Population|Overall Study||94||
59851768|NCT00065156|75976425|FG000|COMPLETED|Overall Study|24 patients rolled over to free drug due to sponsor closure of study.|24||
59851769|NCT00065156|75976425|FG000|NOT COMPLETED|Overall Study||124||
59851770|NCT00064298|75976431|FG000|STARTED|Overall Study||72||
59851771|NCT00064298|75976432|FG001|STARTED|Overall Study||62||
59851772|NCT00064298|75976431|FG000|COMPLETED|Overall Study||66||
59851773|NCT00064298|75976432|FG001|COMPLETED|Overall Study||57||
59851774|NCT00064298|75976431|FG000|NOT COMPLETED|Overall Study||6||
59851775|NCT00064298|75976432|FG001|NOT COMPLETED|Overall Study||5||
59851776|NCT00078819|75976440|FG000|STARTED|Double-blind Treatment Period: Week 1-12||105||
59851777|NCT00078819|75976441|FG001|STARTED|Double-blind Treatment Period: Week 1-12||106||
59851778|NCT00078819|75976442|FG002|STARTED|Double-blind Treatment Period: Week 1-12||0||
59851779|NCT00078819|75976443|FG003|STARTED|Double-blind Treatment Period: Week 1-12||0||
59851780|NCT00078819|75976440|FG000|Entered Escape|Double-blind Treatment Period: Week 1-12||27||
59851781|NCT00078819|75976441|FG001|Entered Escape|Double-blind Treatment Period: Week 1-12||5||
59851782|NCT00078819|75976442|FG002|Entered Escape|Double-blind Treatment Period: Week 1-12||0||
59851783|NCT00078819|75976443|FG003|Entered Escape|Double-blind Treatment Period: Week 1-12||0||
59851784|NCT00078819|75976440|FG000|COMPLETED|Double-blind Treatment Period: Week 1-12||104|Includes participants who escaped early|
59851785|NCT00078819|75976441|FG001|COMPLETED|Double-blind Treatment Period: Week 1-12||105|Includes participants who escaped early|
59851786|NCT00078819|75976442|FG002|COMPLETED|Double-blind Treatment Period: Week 1-12||0|Includes participants who escaped early|
59851787|NCT00078819|75976443|FG003|COMPLETED|Double-blind Treatment Period: Week 1-12||0|Includes participants who escaped early|
59851788|NCT00078819|75976440|FG000|NOT COMPLETED|Double-blind Treatment Period: Week 1-12||1||
59851789|NCT00078819|75976441|FG001|NOT COMPLETED|Double-blind Treatment Period: Week 1-12||1||
59851790|NCT00078819|75976442|FG002|NOT COMPLETED|Double-blind Treatment Period: Week 1-12||0||
59851791|NCT00078819|75976443|FG003|NOT COMPLETED|Double-blind Treatment Period: Week 1-12||0||
59851792|NCT00078819|75976440|FG000|STARTED|Open-label Treatment Period: Weeks 13-36|One participant discontinued before starting the open-label period|103||
59851793|NCT00078819|75976441|FG001|STARTED|Open-label Treatment Period: Weeks 13-36||105||
59851794|NCT00078819|75976442|FG002|STARTED|Open-label Treatment Period: Weeks 13-36||0||
59851795|NCT00078819|75976443|FG003|STARTED|Open-label Treatment Period: Weeks 13-36||0||
59851796|NCT00078819|75976440|FG000|COMPLETED|Open-label Treatment Period: Weeks 13-36||63|Includes participants who completed week 36 with a PASI response|
59851797|NCT00078819|75976441|FG001|COMPLETED|Open-label Treatment Period: Weeks 13-36||75|Includes participants who completed week 36 with a PASI response|
59851798|NCT00078819|75976442|FG002|COMPLETED|Open-label Treatment Period: Weeks 13-36||0|Includes participants who completed week 36 with a PASI response|
59851799|NCT00078819|75976443|FG003|COMPLETED|Open-label Treatment Period: Weeks 13-36||0|Includes participants who completed week 36 with a PASI response|
59851800|NCT00078819|75976440|FG000|NOT COMPLETED|Open-label Treatment Period: Weeks 13-36||40||
59851801|NCT00078819|75976441|FG001|NOT COMPLETED|Open-label Treatment Period: Weeks 13-36||30||
59851802|NCT00078819|75976442|FG002|NOT COMPLETED|Open-label Treatment Period: Weeks 13-36||0||
59851803|NCT00078819|75976443|FG003|NOT COMPLETED|Open-label Treatment Period: Weeks 13-36||0||
59851804|NCT00078819|75976440|FG000|STARTED|Withdrawal Period: Weeks 37-48||0||
59851805|NCT00078819|75976441|FG001|STARTED|Withdrawal Period: Weeks 37-48||0||
59851806|NCT00078819|75976442|FG002|STARTED|Withdrawal Period: Weeks 37-48|Participants who completed week 36 with a PASI response|69||
59851807|NCT00078819|75976443|FG003|STARTED|Withdrawal Period: Weeks 37-48|Participants who completed week 36 with a PASI response|69||
59851808|NCT00078819|75976440|FG000|Received Study Drug|Withdrawal Period: Weeks 37-48||0||
59851809|NCT00078819|75976441|FG001|Received Study Drug|Withdrawal Period: Weeks 37-48||0||
59851810|NCT00078819|75976442|FG002|Received Study Drug|Withdrawal Period: Weeks 37-48||69||
59851811|NCT00078819|75976443|FG003|Received Study Drug|Withdrawal Period: Weeks 37-48||68||
59851812|NCT00078819|75976440|FG000|COMPLETED|Withdrawal Period: Weeks 37-48||0||
59851813|NCT00078819|75976441|FG001|COMPLETED|Withdrawal Period: Weeks 37-48||0||
59851814|NCT00078819|75976442|FG002|COMPLETED|Withdrawal Period: Weeks 37-48|Defined as continuing to receive blinded study drug through week 48|40||
59851815|NCT00078819|75976443|FG003|COMPLETED|Withdrawal Period: Weeks 37-48|Defined as continuing to receive blinded study drug through week 48|55||
59851816|NCT00078819|75976440|FG000|NOT COMPLETED|Withdrawal Period: Weeks 37-48||0||
59851817|NCT00078819|75976441|FG001|NOT COMPLETED|Withdrawal Period: Weeks 37-48||0||
59851818|NCT00078819|75976442|FG002|NOT COMPLETED|Withdrawal Period: Weeks 37-48||29||
59851819|NCT00078819|75976443|FG003|NOT COMPLETED|Withdrawal Period: Weeks 37-48||14||
59851820|NCT00078819|75976440|FG000|STARTED|Re-treatment Period||0||
59851821|NCT00078819|75976441|FG001|STARTED|Re-treatment Period||0||
59851822|NCT00078819|75976442|FG002|STARTED|Re-treatment Period||29||
59851823|NCT00078819|75976443|FG003|STARTED|Re-treatment Period||13||
59851824|NCT00078819|75976440|FG000|Received Study Drug|Re-treatment Period||0||
59851825|NCT00078819|75976441|FG001|Received Study Drug|Re-treatment Period||0||
59851826|NCT00078819|75976442|FG002|Received Study Drug|Re-treatment Period|One additional participant received re-treatment without having disease relapse|30||
59851827|NCT00078819|75976443|FG003|Received Study Drug|Re-treatment Period||12||
59851828|NCT00078819|75976440|FG000|COMPLETED|Re-treatment Period||0||
59851829|NCT00078819|75976441|FG001|COMPLETED|Re-treatment Period||0||
59851830|NCT00078819|75976442|FG002|COMPLETED|Re-treatment Period||29||
59851831|NCT00078819|75976443|FG003|COMPLETED|Re-treatment Period||13||
59851832|NCT00078819|75976440|FG000|NOT COMPLETED|Re-treatment Period||0||
59584492|NCT04214951|75691075|FG001|STARTED|Overall Study||50||
59584493|NCT04214951|75691074|FG000|COMPLETED|Overall Study||10||
59584494|NCT04214951|75691075|FG001|COMPLETED|Overall Study||10||
59584495|NCT04214951|75691074|FG000|NOT COMPLETED|Overall Study||40||
59584496|NCT04214951|75691075|FG001|NOT COMPLETED|Overall Study||40||
59584497|NCT03514277|75691084|FG000|STARTED|Overall Study||11||
59584498|NCT03514277|75691085|FG001|STARTED|Overall Study||4||
59584499|NCT03514277|75691086|FG002|STARTED|Overall Study||4||
59584500|NCT03514277|75691084|FG000|COMPLETED|Overall Study||11||
59584501|NCT03514277|75691085|FG001|COMPLETED|Overall Study||4||
59584502|NCT03514277|75691086|FG002|COMPLETED|Overall Study||4||
59584503|NCT03514277|75691084|FG000|NOT COMPLETED|Overall Study||0||
59584504|NCT03514277|75691085|FG001|NOT COMPLETED|Overall Study||0||
59584505|NCT03514277|75691086|FG002|NOT COMPLETED|Overall Study||0||
59724339|NCT01061736|75842944|FG006|STARTED|Overall Study||84||
59724340|NCT01061736|75842945|FG007|STARTED|Overall Study||430||
59724341|NCT01061736|75842946|FG008|STARTED|Overall Study||427||
59724342|NCT01061736|75842947|FG009|STARTED|Overall Study||428||
59724343|NCT01061736|75842938|FG000|Treated|Overall Study||50||
59724344|NCT01061736|75842939|FG001|Treated|Overall Study||50||
59724345|NCT01061736|75842940|FG002|Treated|Overall Study||51||
59724346|NCT01061736|75842941|FG003|Treated|Overall Study||51||
59724347|NCT01061736|75842942|FG004|Treated|Overall Study||51||
59724348|NCT01061736|75842943|FG005|Treated|Overall Study||52||
59724349|NCT01061736|75842944|FG006|Treated|Overall Study||84||
59724350|NCT01061736|75842945|FG007|Treated|Overall Study||428||
59724351|NCT01061736|75842946|FG008|Treated|Overall Study||426||
59851833|NCT00078819|75976441|FG001|NOT COMPLETED|Re-treatment Period||0||
59851834|NCT00078819|75976442|FG002|NOT COMPLETED|Re-treatment Period||0||
59851835|NCT00078819|75976443|FG003|NOT COMPLETED|Re-treatment Period||0||
59851836|NCT00098865|75976460|FG000|STARTED|Overall Study||15||
59851837|NCT00098865|75976460|FG000|COMPLETED|Overall Study||6||
59851838|NCT00098865|75976460|FG000|NOT COMPLETED|Overall Study||9||
59851839|NCT02954458|75976468|FG000|STARTED|Overall Study||7||
59851840|NCT02954458|75976469|FG001|STARTED|Overall Study||3||
59851841|NCT02954458|75976470|FG002|STARTED|Overall Study||1||
59851842|NCT02954458|75976471|FG003|STARTED|Overall Study||50||
59851843|NCT02954458|75976468|FG000|COMPLETED|Overall Study||6||
59851844|NCT02954458|75976469|FG001|COMPLETED|Overall Study||3||
59851845|NCT02954458|75976470|FG002|COMPLETED|Overall Study||0||
59851846|NCT02954458|75976471|FG003|COMPLETED|Overall Study||38||
59851847|NCT02954458|75976468|FG000|NOT COMPLETED|Overall Study||1||
59584506|NCT04227119|75691094|FG000|STARTED|Overall Study||11||
59724352|NCT01061736|75842947|FG009|Treated|Overall Study||428||
59724353|NCT01061736|75842938|FG000|Rescued|Overall Study||0||
59724354|NCT01061736|75842939|FG001|Rescued|Overall Study||0||
59724355|NCT01061736|75842940|FG002|Rescued|Overall Study||0||
59724356|NCT01061736|75842941|FG003|Rescued|Overall Study||0||
59724357|NCT01061736|75842942|FG004|Rescued|Overall Study||0||
59724358|NCT01061736|75842943|FG005|Rescued|Overall Study||0||
59724359|NCT01061736|75842944|FG006|Rescued|Overall Study||0||
59851848|NCT02954458|75976469|FG001|NOT COMPLETED|Overall Study||0||
59851849|NCT02954458|75976470|FG002|NOT COMPLETED|Overall Study||1||
59851850|NCT02954458|75976471|FG003|NOT COMPLETED|Overall Study||12||
59851851|NCT03500224|75976485|FG000|STARTED|Overall Study||6||
59851852|NCT03500224|75976485|FG000|COMPLETED|Overall Study||4||
59851853|NCT03500224|75976485|FG000|NOT COMPLETED|Overall Study||2||
59851854|NCT00077649|75976493|FG000|STARTED|Overall Study||47||
59851855|NCT00077649|75976494|FG001|STARTED|Overall Study||47||
59851856|NCT00077649|75976495|FG002|STARTED|Overall Study||47||
59851857|NCT00077649|75976496|FG003|STARTED|Overall Study||47||
59851858|NCT00077649|75976493|FG000|Completed 24 Weeks of Follow-up|Overall Study||36||
59851859|NCT00077649|75976494|FG001|Completed 24 Weeks of Follow-up|Overall Study||40||
59851860|NCT00077649|75976495|FG002|Completed 24 Weeks of Follow-up|Overall Study||36||
59851861|NCT00077649|75976496|FG003|Completed 24 Weeks of Follow-up|Overall Study||31||
59851862|NCT00077649|75976493|FG000|COMPLETED|Overall Study||33||
59851863|NCT00077649|75976494|FG001|COMPLETED|Overall Study||38||
59851864|NCT00077649|75976495|FG002|COMPLETED|Overall Study||32||
59851865|NCT00077649|75976496|FG003|COMPLETED|Overall Study||30||
59851866|NCT00077649|75976493|FG000|NOT COMPLETED|Overall Study||14||
59851867|NCT00077649|75976494|FG001|NOT COMPLETED|Overall Study||9||
59851868|NCT00077649|75976495|FG002|NOT COMPLETED|Overall Study||15||
59851869|NCT00077649|75976496|FG003|NOT COMPLETED|Overall Study||17||
59851870|NCT00038948|75976512|FG000|STARTED|Overall Study||555||
59851871|NCT00038948|75976513|FG001|STARTED|Overall Study||275||
59851872|NCT00038948|75976512|FG000|COMPLETED|Overall Study||386||
59851873|NCT00038948|75976513|FG001|COMPLETED|Overall Study||198||
59851874|NCT00038948|75976512|FG000|NOT COMPLETED|Overall Study||169||
59851875|NCT00038948|75976513|FG001|NOT COMPLETED|Overall Study||77||
59851876|NCT00054704|75976527|FG000|STARTED|Overall Study||8||
59851877|NCT00054704|75976528|FG001|STARTED|Overall Study||11||
59851878|NCT00054704|75976527|FG000|COMPLETED|Overall Study||3||
59851879|NCT00054704|75976528|FG001|COMPLETED|Overall Study||6||
59851880|NCT00054704|75976527|FG000|NOT COMPLETED|Overall Study||5||
59851881|NCT00054704|75976528|FG001|NOT COMPLETED|Overall Study||5||
59851882|NCT00031694|75976534|FG000|STARTED|Overall Study||19||
59851883|NCT00031694|75976534|FG000|COMPLETED|Overall Study||0||
59851884|NCT00031694|75976534|FG000|NOT COMPLETED|Overall Study||19||
59851885|NCT00093795|75976542|FG000|STARTED|Overall Study||1630||
59851886|NCT00093795|75976543|FG001|STARTED|Overall Study||1634||
59851887|NCT00093795|75976544|FG002|STARTED|Overall Study||1630||
59851888|NCT00093795|75976542|FG000|COMPLETED|Overall Study||1610||
59851889|NCT00093795|75976543|FG001|COMPLETED|Overall Study||1618||
59851890|NCT00093795|75976544|FG002|COMPLETED|Overall Study||1613||
59851891|NCT00093795|75976542|FG000|NOT COMPLETED|Overall Study||20||
59584507|NCT04227119|75691094|FG000|COMPLETED|Overall Study||11||
59584508|NCT04227119|75691094|FG000|NOT COMPLETED|Overall Study||0||
59584509|NCT03651479|75691102|FG000|STARTED|Overall Study||20||
59584510|NCT03651479|75691103|FG001|STARTED|Overall Study||20||
59851892|NCT00093795|75976543|FG001|NOT COMPLETED|Overall Study||16||
59851893|NCT00093795|75976544|FG002|NOT COMPLETED|Overall Study||17||
59851894|NCT03467152|75976554|FG000|STARTED|Overall Study||100||
59851895|NCT03467152|75976555|FG001|STARTED|Overall Study||100||
59851896|NCT03467152|75976556|FG002|STARTED|Overall Study|The treatment arms to which these 6 participants were randomized is unknown.|6||
59851897|NCT03467152|75976554|FG000|Treated|Overall Study||97||
59851898|NCT03467152|75976555|FG001|Treated|Overall Study||99||
59584511|NCT03651479|75691102|FG000|COMPLETED|Overall Study||20||
59584512|NCT03651479|75691103|FG001|COMPLETED|Overall Study||20||
59851899|NCT03467152|75976556|FG002|Treated|Overall Study||0||
59851900|NCT03467152|75976554|FG000|COMPLETED|Overall Study||84||
59851901|NCT03467152|75976555|FG001|COMPLETED|Overall Study||89||
59851902|NCT03467152|75976556|FG002|COMPLETED|Overall Study||0||
59851903|NCT03467152|75976554|FG000|NOT COMPLETED|Overall Study||16||
59851904|NCT03467152|75976555|FG001|NOT COMPLETED|Overall Study||11||
59851905|NCT03467152|75976556|FG002|NOT COMPLETED|Overall Study||6||
59851906|NCT03466060|75976565|FG000|STARTED|Period 1||19||
59851907|NCT03466060|75976566|FG001|STARTED|Period 1||18||
59851908|NCT03466060|75976567|FG002|STARTED|Period 1||20||
59851909|NCT03466060|75976568|FG003|STARTED|Period 1||18||
59851910|NCT03466060|75976569|FG004|STARTED|Period 1||20||
59851911|NCT03466060|75976570|FG005|STARTED|Period 1||18||
59851912|NCT03466060|75976565|FG000|COMPLETED|Period 1||19||
59851913|NCT03466060|75976566|FG001|COMPLETED|Period 1||16||
59851914|NCT03466060|75976567|FG002|COMPLETED|Period 1||17||
59851915|NCT03466060|75976568|FG003|COMPLETED|Period 1||17||
59851916|NCT03466060|75976569|FG004|COMPLETED|Period 1||20||
59851917|NCT03466060|75976570|FG005|COMPLETED|Period 1||18||
59851918|NCT03466060|75976565|FG000|NOT COMPLETED|Period 1||0||
59851919|NCT03466060|75976566|FG001|NOT COMPLETED|Period 1||2||
59996750|NCT04445051|76112591|FG003|NOT COMPLETED|Overall Study||0||
59584513|NCT03651479|75691102|FG000|NOT COMPLETED|Overall Study||0||
59851920|NCT03466060|75976567|FG002|NOT COMPLETED|Period 1||3||
59851921|NCT03466060|75976568|FG003|NOT COMPLETED|Period 1||1||
59851922|NCT03466060|75976569|FG004|NOT COMPLETED|Period 1||0||
59851923|NCT03466060|75976570|FG005|NOT COMPLETED|Period 1||0||
59851924|NCT03466060|75976565|FG000|STARTED|Period 2||19||
59851925|NCT03466060|75976566|FG001|STARTED|Period 2||16||
59851926|NCT03466060|75976567|FG002|STARTED|Period 2||17||
59851927|NCT03466060|75976568|FG003|STARTED|Period 2||17||
59851928|NCT03466060|75976569|FG004|STARTED|Period 2||20||
59851929|NCT03466060|75976570|FG005|STARTED|Period 2||18||
59851930|NCT03466060|75976565|FG000|COMPLETED|Period 2||19||
59851931|NCT03466060|75976566|FG001|COMPLETED|Period 2||16||
59851932|NCT03466060|75976567|FG002|COMPLETED|Period 2||16||
59851933|NCT03466060|75976568|FG003|COMPLETED|Period 2||17||
59851934|NCT03466060|75976569|FG004|COMPLETED|Period 2||20||
59851935|NCT03466060|75976570|FG005|COMPLETED|Period 2||18||
59851936|NCT03466060|75976565|FG000|NOT COMPLETED|Period 2||0||
59851937|NCT03466060|75976566|FG001|NOT COMPLETED|Period 2||0||
59851938|NCT03466060|75976567|FG002|NOT COMPLETED|Period 2||1||
59851939|NCT03466060|75976568|FG003|NOT COMPLETED|Period 2||0||
59851940|NCT03466060|75976569|FG004|NOT COMPLETED|Period 2||0||
59851941|NCT03466060|75976570|FG005|NOT COMPLETED|Period 2||0||
59851942|NCT00092547|75976586|FG000|STARTED|Base Vaccine Phase (Day 1 to Month 7)||1184||
59851943|NCT00092547|75976587|FG001|STARTED|Base Vaccine Phase (Day 1 to Month 7)||597||
59851944|NCT00092547|75976588|FG002|STARTED|Base Vaccine Phase (Day 1 to Month 7)||0||
59851945|NCT00092547|75976586|FG000|Vaccinated|Base Vaccine Phase (Day 1 to Month 7)||1179||
59851946|NCT00092547|75976587|FG001|Vaccinated|Base Vaccine Phase (Day 1 to Month 7)||596||
59851947|NCT00092547|75976588|FG002|Vaccinated|Base Vaccine Phase (Day 1 to Month 7)||0||
59851948|NCT00092547|75976586|FG000|COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||1121||
59851949|NCT00092547|75976587|FG001|COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||561||
59851950|NCT00092547|75976588|FG002|COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||0||
59851951|NCT00092547|75976586|FG000|NOT COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||63||
59851952|NCT00092547|75976587|FG001|NOT COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||36||
59851953|NCT00092547|75976588|FG002|NOT COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||0||
59851954|NCT00092547|75976586|FG000|STARTED|Base Follow-up Phase (Month 7 to 18)|Includes participants continuing and who previously discontinued who re-entered the study|1128||
59851955|NCT00092547|75976587|FG001|STARTED|Base Follow-up Phase (Month 7 to 18)|Includes participants continuing and who previously discontinued who re-entered the study|565||
59851956|NCT00092547|75976588|FG002|STARTED|Base Follow-up Phase (Month 7 to 18)||0||
59851957|NCT00092547|75976586|FG000|COMPLETED|Base Follow-up Phase (Month 7 to 18)||1108||
59851958|NCT00092547|75976587|FG001|COMPLETED|Base Follow-up Phase (Month 7 to 18)||551||
59851959|NCT00092547|75976588|FG002|COMPLETED|Base Follow-up Phase (Month 7 to 18)||0||
59851960|NCT00092547|75976586|FG000|NOT COMPLETED|Base Follow-up Phase (Month 7 to 18)||20||
59851961|NCT00092547|75976587|FG001|NOT COMPLETED|Base Follow-up Phase (Month 7 to 18)||14||
59851962|NCT00092547|75976588|FG002|NOT COMPLETED|Base Follow-up Phase (Month 7 to 18)||0||
59851963|NCT00092547|75976586|FG000|STARTED|Base Follow-up Phase (Month 18 to 30)|Includes participants continuing and who previously discontinued who re-entered the study|964||
59851964|NCT00092547|75976587|FG001|STARTED|Base Follow-up Phase (Month 18 to 30)|Includes participants continuing and who previously discontinued who re-entered the study|490||
59851965|NCT00092547|75976588|FG002|STARTED|Base Follow-up Phase (Month 18 to 30)||0||
59851966|NCT00092547|75976586|FG000|COMPLETED|Base Follow-up Phase (Month 18 to 30)||956||
59851967|NCT00092547|75976587|FG001|COMPLETED|Base Follow-up Phase (Month 18 to 30)||485||
59851968|NCT00092547|75976588|FG002|COMPLETED|Base Follow-up Phase (Month 18 to 30)||0||
59851969|NCT00092547|75976586|FG000|NOT COMPLETED|Base Follow-up Phase (Month 18 to 30)||8||
59851970|NCT00092547|75976587|FG001|NOT COMPLETED|Base Follow-up Phase (Month 18 to 30)||5||
59851971|NCT00092547|75976588|FG002|NOT COMPLETED|Base Follow-up Phase (Month 18 to 30)||0||
59851972|NCT00092547|75976586|FG000|STARTED|Extension Vaccine Phase (Month 30 to 37)|Includes participants continuing and who previously discontinued who re-entered the study|956||
59851973|NCT00092547|75976587|FG001|STARTED|Extension Vaccine Phase (Month 30 to 37)||0||
59851974|NCT00092547|75976588|FG002|STARTED|Extension Vaccine Phase (Month 30 to 37)|Includes participants continuing and who previously discontinued who re-entered the study|485||
59851975|NCT00092547|75976586|FG000|Vaccinated in Extension Study|Extension Vaccine Phase (Month 30 to 37)||0||
59851976|NCT00092547|75976587|FG001|Vaccinated in Extension Study|Extension Vaccine Phase (Month 30 to 37)||0||
59851977|NCT00092547|75976588|FG002|Vaccinated in Extension Study|Extension Vaccine Phase (Month 30 to 37)||482||
59851978|NCT00092547|75976586|FG000|COMPLETED|Extension Vaccine Phase (Month 30 to 37)||933||
59851979|NCT00092547|75976587|FG001|COMPLETED|Extension Vaccine Phase (Month 30 to 37)||0||
59851980|NCT00092547|75976588|FG002|COMPLETED|Extension Vaccine Phase (Month 30 to 37)||469||
59851981|NCT00092547|75976586|FG000|NOT COMPLETED|Extension Vaccine Phase (Month 30 to 37)||23||
59851982|NCT00092547|75976587|FG001|NOT COMPLETED|Extension Vaccine Phase (Month 30 to 37)||0||
59851983|NCT00092547|75976588|FG002|NOT COMPLETED|Extension Vaccine Phase (Month 30 to 37)||16||
59851984|NCT00092547|75976586|FG000|STARTED|Long-term Follow-up (Month 42 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|612||
59851985|NCT00092547|75976587|FG001|STARTED|Long-term Follow-up (Month 42 Visit)||0||
59851986|NCT00092547|75976588|FG002|STARTED|Long-term Follow-up (Month 42 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|308||
59851987|NCT00092547|75976586|FG000|COMPLETED|Long-term Follow-up (Month 42 Visit)||611||
59851988|NCT00092547|75976587|FG001|COMPLETED|Long-term Follow-up (Month 42 Visit)||0||
59851989|NCT00092547|75976588|FG002|COMPLETED|Long-term Follow-up (Month 42 Visit)||308||
59851990|NCT00092547|75976586|FG000|NOT COMPLETED|Long-term Follow-up (Month 42 Visit)||1||
59851991|NCT00092547|75976587|FG001|NOT COMPLETED|Long-term Follow-up (Month 42 Visit)||0||
59851992|NCT00092547|75976588|FG002|NOT COMPLETED|Long-term Follow-up (Month 42 Visit)||0||
59851993|NCT00092547|75976586|FG000|STARTED|Long-term Follow-up (Month 72 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|550||
59851994|NCT00092547|75976587|FG001|STARTED|Long-term Follow-up (Month 72 Visit)||0||
59851995|NCT00092547|75976588|FG002|STARTED|Long-term Follow-up (Month 72 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|276||
59851996|NCT00092547|75976586|FG000|COMPLETED|Long-term Follow-up (Month 72 Visit)||550||
59851997|NCT00092547|75976587|FG001|COMPLETED|Long-term Follow-up (Month 72 Visit)||0||
59851998|NCT00092547|75976588|FG002|COMPLETED|Long-term Follow-up (Month 72 Visit)||276||
59851999|NCT00092547|75976586|FG000|NOT COMPLETED|Long-term Follow-up (Month 72 Visit)||0||
59852000|NCT00092547|75976587|FG001|NOT COMPLETED|Long-term Follow-up (Month 72 Visit)||0||
59852001|NCT00092547|75976588|FG002|NOT COMPLETED|Long-term Follow-up (Month 72 Visit)||0||
59852002|NCT00092547|75976586|FG000|STARTED|Long-term Follow-up (Month 96 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|508||
59852003|NCT00092547|75976587|FG001|STARTED|Long-term Follow-up (Month 96 Visit)||0||
59852004|NCT00092547|75976588|FG002|STARTED|Long-term Follow-up (Month 96 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|267||
59852005|NCT00092547|75976586|FG000|COMPLETED|Long-term Follow-up (Month 96 Visit)||508||
59852006|NCT00092547|75976587|FG001|COMPLETED|Long-term Follow-up (Month 96 Visit)||0||
59852007|NCT00092547|75976588|FG002|COMPLETED|Long-term Follow-up (Month 96 Visit)||267||
59852008|NCT00092547|75976586|FG000|NOT COMPLETED|Long-term Follow-up (Month 96 Visit)||0||
59852009|NCT00092547|75976587|FG001|NOT COMPLETED|Long-term Follow-up (Month 96 Visit)||0||
59852010|NCT00092547|75976588|FG002|NOT COMPLETED|Long-term Follow-up (Month 96 Visit)||0||
59852011|NCT00092547|75976586|FG000|STARTED|Long-term Follow-up (Month 126 Visit)||454||
59852012|NCT00092547|75976587|FG001|STARTED|Long-term Follow-up (Month 126 Visit)||0||
59852013|NCT00092547|75976588|FG002|STARTED|Long-term Follow-up (Month 126 Visit)||211||
59852014|NCT00092547|75976586|FG000|COMPLETED|Long-term Follow-up (Month 126 Visit)||454||
59852015|NCT00092547|75976587|FG001|COMPLETED|Long-term Follow-up (Month 126 Visit)||0||
59852016|NCT00092547|75976588|FG002|COMPLETED|Long-term Follow-up (Month 126 Visit)||211||
59852017|NCT00092547|75976586|FG000|NOT COMPLETED|Long-term Follow-up (Month 126 Visit)||0||
59852018|NCT00092547|75976587|FG001|NOT COMPLETED|Long-term Follow-up (Month 126 Visit)||0||
59852019|NCT00092547|75976588|FG002|NOT COMPLETED|Long-term Follow-up (Month 126 Visit)||0||
59852020|NCT03802994|75976604|FG000|STARTED|Overall Study||9||9
59852021|NCT03802994|75976605|FG001|STARTED|Overall Study||12||12
59852022|NCT03802994|75976606|FG002|STARTED|Overall Study||15||15
59852023|NCT03802994|75976607|FG003|STARTED|Overall Study||11||11
59852024|NCT03802994|75976608|FG004|STARTED|Overall Study||10||10
59852025|NCT03802994|75976604|FG000|COMPLETED|Overall Study||9||9
59852026|NCT03802994|75976605|FG001|COMPLETED|Overall Study||10||10
59852027|NCT03802994|75976606|FG002|COMPLETED|Overall Study||12||12
59852028|NCT03802994|75976607|FG003|COMPLETED|Overall Study||9||9
59852029|NCT03802994|75976608|FG004|COMPLETED|Overall Study||8||8
59852030|NCT03802994|75976604|FG000|NOT COMPLETED|Overall Study||0||0
59584514|NCT03651479|75691103|FG001|NOT COMPLETED|Overall Study||0||
59584515|NCT03653351|75691111|FG000|STARTED|Overall Study||14||
59584516|NCT03653351|75691112|FG001|STARTED|Overall Study||12||
59584517|NCT03653351|75691111|FG000|COMPLETED|Overall Study||13||
59584518|NCT03653351|75691112|FG001|COMPLETED|Overall Study||10||
59584519|NCT03653351|75691111|FG000|NOT COMPLETED|Overall Study||1||
59584520|NCT03653351|75691112|FG001|NOT COMPLETED|Overall Study||2||
59584521|NCT03515681|75691120|FG000|STARTED|Overall Study||70||
59584522|NCT03515681|75691121|FG001|STARTED|Overall Study||70||
59584523|NCT03515681|75691120|FG000|Randomized|Overall Study||70||
59584524|NCT03515681|75691121|FG001|Randomized|Overall Study||70||
59584525|NCT03515681|75691120|FG000|Completed at 6 Months|Overall Study||61||
59584526|NCT03515681|75691121|FG001|Completed at 6 Months|Overall Study||62||
59584527|NCT03515681|75691120|FG000|COMPLETED|Overall Study||37|Completed at 12 months|
59584528|NCT03515681|75691121|FG001|COMPLETED|Overall Study||25|Completed at 12 months|
59584529|NCT03515681|75691120|FG000|NOT COMPLETED|Overall Study||33||
59852031|NCT03802994|75976605|FG001|NOT COMPLETED|Overall Study||2||2
59852032|NCT03802994|75976606|FG002|NOT COMPLETED|Overall Study||3||3
59852033|NCT03802994|75976607|FG003|NOT COMPLETED|Overall Study||2||2
59996751|NCT04445051|76112592|FG004|NOT COMPLETED|Overall Study||0||
59584530|NCT03515681|75691121|FG001|NOT COMPLETED|Overall Study||45||
59584531|NCT03655301|75691127|FG000|STARTED|Overall Study||13||
59584532|NCT03655301|75691127|FG000|COMPLETED|Overall Study||13||
59584533|NCT03655301|75691127|FG000|NOT COMPLETED|Overall Study||0||
59584534|NCT03656939|75691131|FG000|STARTED|Overall Study||21240||
59584535|NCT03656939|75691131|FG000|Main Study Cohort|Overall Study||21240||
59584536|NCT03656939|75691131|FG000|Main Study Cohort: Participants Who Received Dose 1|Overall Study||20318||
59852034|NCT03802994|75976608|FG004|NOT COMPLETED|Overall Study||2||2
59852035|NCT03465904|75976633|FG000|STARTED|Overall Study||298||
59852036|NCT03465904|75976634|FG001|STARTED|Overall Study||303||
59852037|NCT03465904|75976633|FG000|COMPLETED|Overall Study||209||
59852038|NCT03465904|75976634|FG001|COMPLETED|Overall Study||237||
59852039|NCT03465904|75976633|FG000|NOT COMPLETED|Overall Study||89||
59852040|NCT03465904|75976634|FG001|NOT COMPLETED|Overall Study||66||
59852041|NCT03802916|75976642|FG000|STARTED|Overall Study||15||
59852042|NCT03802916|75976643|FG001|STARTED|Overall Study||15||
59852043|NCT03802916|75976642|FG000|COMPLETED|Overall Study||15||
59852044|NCT03802916|75976643|FG001|COMPLETED|Overall Study||13||
59852045|NCT03802916|75976642|FG000|NOT COMPLETED|Overall Study||0||
59852046|NCT03802916|75976643|FG001|NOT COMPLETED|Overall Study||2||
59852047|NCT00076011|75976651|FG000|STARTED|Overall Study||52||
59852048|NCT00076011|75976651|FG000|COMPLETED|Overall Study||0||
59852049|NCT00076011|75976651|FG000|NOT COMPLETED|Overall Study||52||
59852050|NCT03465436|75976659|FG000|STARTED|Period 1||14||
59852051|NCT03465436|75976660|FG001|STARTED|Period 1||14||
59852052|NCT03465436|75976661|FG002|STARTED|Period 1||14||
59852053|NCT03465436|75976662|FG003|STARTED|Period 1||14||
59852054|NCT03465436|75976659|FG000|Received at Least 1 Dose of Study Drug|Period 1||14||
59852055|NCT03465436|75976660|FG001|Received at Least 1 Dose of Study Drug|Period 1||14||
59852056|NCT03465436|75976661|FG002|Received at Least 1 Dose of Study Drug|Period 1||14||
59852057|NCT03465436|75976662|FG003|Received at Least 1 Dose of Study Drug|Period 1||14||
59852058|NCT03465436|75976659|FG000|COMPLETED|Period 1||14||
59852059|NCT03465436|75976660|FG001|COMPLETED|Period 1||14||
59852060|NCT03465436|75976661|FG002|COMPLETED|Period 1||13||
59852061|NCT03465436|75976662|FG003|COMPLETED|Period 1||14||
59852062|NCT03465436|75976659|FG000|NOT COMPLETED|Period 1||0||
59852063|NCT03465436|75976660|FG001|NOT COMPLETED|Period 1||0||
59852064|NCT03465436|75976661|FG002|NOT COMPLETED|Period 1||1||
59852065|NCT03465436|75976662|FG003|NOT COMPLETED|Period 1||0||
59852066|NCT03465436|75976659|FG000|STARTED|Period 2||14||
59852067|NCT03465436|75976660|FG001|STARTED|Period 2||14||
59852068|NCT03465436|75976661|FG002|STARTED|Period 2||13||
59852069|NCT03465436|75976662|FG003|STARTED|Period 2||14||
59852070|NCT03465436|75976659|FG000|Received at Least 1 Dose of Study Drug|Period 2||14||
59852071|NCT03465436|75976660|FG001|Received at Least 1 Dose of Study Drug|Period 2||13||
59852072|NCT03465436|75976661|FG002|Received at Least 1 Dose of Study Drug|Period 2||13||
59852073|NCT03465436|75976662|FG003|Received at Least 1 Dose of Study Drug|Period 2||14||
59852074|NCT03465436|75976659|FG000|COMPLETED|Period 2||14||
59852075|NCT03465436|75976660|FG001|COMPLETED|Period 2||13||
59852076|NCT03465436|75976661|FG002|COMPLETED|Period 2||13||
59852077|NCT03465436|75976662|FG003|COMPLETED|Period 2||14||
59852078|NCT03465436|75976659|FG000|NOT COMPLETED|Period 2||0||
59852079|NCT03465436|75976660|FG001|NOT COMPLETED|Period 2||1||
59852080|NCT03465436|75976661|FG002|NOT COMPLETED|Period 2||0||
59852081|NCT03465436|75976662|FG003|NOT COMPLETED|Period 2||0||
59852082|NCT03465436|75976659|FG000|STARTED|Period 3||14||
59852083|NCT03465436|75976660|FG001|STARTED|Period 3||13||
59852084|NCT03465436|75976661|FG002|STARTED|Period 3||13||
59852085|NCT03465436|75976662|FG003|STARTED|Period 3||14||
59852086|NCT03465436|75976659|FG000|Received at Least One Dose of Study Drug|Period 3||13||
59852087|NCT03465436|75976660|FG001|Received at Least One Dose of Study Drug|Period 3||12||
59852088|NCT03465436|75976661|FG002|Received at Least One Dose of Study Drug|Period 3||13||
59852089|NCT03465436|75976662|FG003|Received at Least One Dose of Study Drug|Period 3||14||
59852090|NCT03465436|75976659|FG000|COMPLETED|Period 3||13||
59852091|NCT03465436|75976660|FG001|COMPLETED|Period 3||12||
59852092|NCT03465436|75976661|FG002|COMPLETED|Period 3||13||
59852093|NCT03465436|75976662|FG003|COMPLETED|Period 3||14||
59852094|NCT03465436|75976659|FG000|NOT COMPLETED|Period 3||1||
59852095|NCT03465436|75976660|FG001|NOT COMPLETED|Period 3||1||
59852096|NCT03465436|75976661|FG002|NOT COMPLETED|Period 3||0||
59852097|NCT03465436|75976662|FG003|NOT COMPLETED|Period 3||0||
59852098|NCT03465436|75976659|FG000|STARTED|Period 4||13||
59852099|NCT03465436|75976660|FG001|STARTED|Period 4||12||
59852100|NCT03465436|75976661|FG002|STARTED|Period 4||13||
59852101|NCT03465436|75976662|FG003|STARTED|Period 4||14||
59852102|NCT03465436|75976659|FG000|Received at Least 1 Dose of Study Drug|Period 4||13||
59852103|NCT03465436|75976660|FG001|Received at Least 1 Dose of Study Drug|Period 4||12||
59996752|NCT04445051|76112593|FG005|NOT COMPLETED|Overall Study||0||
59584537|NCT03656939|75691131|FG000|Main Study Cohort: Participants Who Received Dose 2|Overall Study||19387||
59584538|NCT03656939|75691131|FG000|Main Study Cohort: Participants Who Received Dose 3|Overall Study||18415||
59584539|NCT03656939|75691131|FG000|Main Study Cohort: Participants Who Received Dose 4|Overall Study||12944||
59852104|NCT03465436|75976661|FG002|Received at Least 1 Dose of Study Drug|Period 4||13||
59852105|NCT03465436|75976662|FG003|Received at Least 1 Dose of Study Drug|Period 4||14||
59852106|NCT03465436|75976659|FG000|COMPLETED|Period 4||13||
59852107|NCT03465436|75976660|FG001|COMPLETED|Period 4||12||
59852108|NCT03465436|75976661|FG002|COMPLETED|Period 4||12||
59852109|NCT03465436|75976662|FG003|COMPLETED|Period 4||14||
59852110|NCT03465436|75976659|FG000|NOT COMPLETED|Period 4||0||
59852111|NCT03465436|75976660|FG001|NOT COMPLETED|Period 4||0||
59852112|NCT03465436|75976661|FG002|NOT COMPLETED|Period 4||1||
59852113|NCT03465436|75976662|FG003|NOT COMPLETED|Period 4||0||
59852114|NCT00053846|75976676|FG000|STARTED|Overall Study||213||
59852115|NCT00053846|75976677|FG001|STARTED|Overall Study||219||
59852116|NCT00053846|75976676|FG000|COMPLETED|Overall Study||187||
59852117|NCT00053846|75976677|FG001|COMPLETED|Overall Study||192||
59852118|NCT00053846|75976676|FG000|NOT COMPLETED|Overall Study||26||
59996753|NCT04086121|76112607|FG000|STARTED|Overall Study||14||
59852119|NCT00053846|75976677|FG001|NOT COMPLETED|Overall Study||27||
59852120|NCT00090987|75976683|FG000|STARTED|Overall Study||30||
59852121|NCT00090987|75976683|FG000|COMPLETED|Overall Study||9||
59852122|NCT00090987|75976683|FG000|NOT COMPLETED|Overall Study||21||
59852123|NCT03464422|75976687|FG000|STARTED|Overall Study||21||
59852124|NCT03464422|75976687|FG000|COMPLETED|Overall Study||17||
59852125|NCT03464422|75976687|FG000|NOT COMPLETED|Overall Study||4||
59852126|NCT03489304|75976693|FG000|STARTED|Overall Study||20||
59852127|NCT03489304|75976693|FG000|COMPLETED|Overall Study||16||
59852128|NCT03489304|75976693|FG000|NOT COMPLETED|Overall Study||4||
59852129|NCT03543358|75976697|FG000|STARTED|Overall Study||3||
59852130|NCT03543358|75976698|FG001|STARTED|Overall Study||0||
59852131|NCT03543358|75976697|FG000|Received Treatment or Retreatment|Overall Study||0||
59852132|NCT03543358|75976698|FG001|Received Treatment or Retreatment|Overall Study||0||
59852133|NCT03543358|75976697|FG000|COMPLETED|Overall Study||0||
59852134|NCT03543358|75976698|FG001|COMPLETED|Overall Study||0||
59852135|NCT03543358|75976697|FG000|NOT COMPLETED|Overall Study||3||
59852136|NCT03543358|75976698|FG001|NOT COMPLETED|Overall Study||0||
59852137|NCT03485950|75976704|FG000|STARTED|Overall Study||50||
59852138|NCT03485950|75976705|FG001|STARTED|Overall Study||50||
59852139|NCT03485950|75976704|FG000|COMPLETED|Overall Study||43||
59852140|NCT03485950|75976705|FG001|COMPLETED|Overall Study||48||
59852141|NCT03485950|75976704|FG000|NOT COMPLETED|Overall Study||7||
59852142|NCT03485950|75976705|FG001|NOT COMPLETED|Overall Study||2||
59852143|NCT00060944|75976713|FG000|STARTED|Overall Study||136||
59852144|NCT00060944|75976714|FG001|STARTED|Overall Study||134||
59852145|NCT00060944|75976713|FG000|Treated|Overall Study||130||
59852146|NCT00060944|75976714|FG001|Treated|Overall Study||130||
59852147|NCT00060944|75976713|FG000|COMPLETED|Overall Study||0||
59852148|NCT00060944|75976714|FG001|COMPLETED|Overall Study||0||
59852149|NCT00060944|75976713|FG000|NOT COMPLETED|Overall Study||136||
59852150|NCT00060944|75976714|FG001|NOT COMPLETED|Overall Study||134||
59852151|NCT03462082|75976720|FG000|STARTED|Study Phase (Randomized, Blinded Period)||3||
59852152|NCT03462082|75976721|FG001|STARTED|Study Phase (Randomized, Blinded Period)||4||
59852153|NCT03462082|75976722|FG002|STARTED|Study Phase (Randomized, Blinded Period)||4||
59852154|NCT03462082|75976723|FG003|STARTED|Study Phase (Randomized, Blinded Period)||3||
59852155|NCT03462082|75976724|FG004|STARTED|Study Phase (Randomized, Blinded Period)||3||
59852156|NCT03462082|75976725|FG005|STARTED|Study Phase (Randomized, Blinded Period)||5||
59852157|NCT03462082|75976726|FG006|STARTED|Study Phase (Randomized, Blinded Period)||0||
59852158|NCT03462082|75976727|FG007|STARTED|Study Phase (Randomized, Blinded Period)||0||
59852159|NCT03462082|75976720|FG000|COMPLETED|Study Phase (Randomized, Blinded Period)||3||
59852160|NCT03462082|75976721|FG001|COMPLETED|Study Phase (Randomized, Blinded Period)||4||
59852161|NCT03462082|75976722|FG002|COMPLETED|Study Phase (Randomized, Blinded Period)||4||
59852162|NCT03462082|75976723|FG003|COMPLETED|Study Phase (Randomized, Blinded Period)||3||
59852163|NCT03462082|75976724|FG004|COMPLETED|Study Phase (Randomized, Blinded Period)||3||
59852164|NCT03462082|75976725|FG005|COMPLETED|Study Phase (Randomized, Blinded Period)||5||
59852165|NCT03462082|75976726|FG006|COMPLETED|Study Phase (Randomized, Blinded Period)||0||
59852166|NCT03462082|75976727|FG007|COMPLETED|Study Phase (Randomized, Blinded Period)||0||
59852167|NCT03462082|75976720|FG000|NOT COMPLETED|Study Phase (Randomized, Blinded Period)||0||
59852168|NCT03462082|75976721|FG001|NOT COMPLETED|Study Phase (Randomized, Blinded Period)||0||
59584540|NCT03656939|75691131|FG000|Prospective Study Cohort|Overall Study||2300||
59584541|NCT03656939|75691131|FG000|Prospective Study Cohort: Participants Who Received Dose 1|Overall Study||2300||
59584542|NCT03656939|75691131|FG000|Prospective Study Cohort: Participants Who Received Dose 2|Overall Study||2203||
59852169|NCT03462082|75976722|FG002|NOT COMPLETED|Study Phase (Randomized, Blinded Period)||0||
59852170|NCT03462082|75976723|FG003|NOT COMPLETED|Study Phase (Randomized, Blinded Period)||0||
59852171|NCT03462082|75976724|FG004|NOT COMPLETED|Study Phase (Randomized, Blinded Period)||0||
59852172|NCT03462082|75976725|FG005|NOT COMPLETED|Study Phase (Randomized, Blinded Period)||0||
59852173|NCT03462082|75976726|FG006|NOT COMPLETED|Study Phase (Randomized, Blinded Period)||0||
59852174|NCT03462082|75976727|FG007|NOT COMPLETED|Study Phase (Randomized, Blinded Period)||0||
59852175|NCT03462082|75976720|FG000|STARTED|Open Label Phase||0||
59852176|NCT03462082|75976721|FG001|STARTED|Open Label Phase||0||
59852177|NCT03462082|75976722|FG002|STARTED|Open Label Phase||0||
59852178|NCT03462082|75976723|FG003|STARTED|Open Label Phase||0||
59852179|NCT03462082|75976724|FG004|STARTED|Open Label Phase||0||
59852180|NCT03462082|75976725|FG005|STARTED|Open Label Phase||0||
59852181|NCT03462082|75976726|FG006|STARTED|Open Label Phase||7||
59852182|NCT03462082|75976727|FG007|STARTED|Open Label Phase||10||
59852183|NCT03462082|75976720|FG000|COMPLETED|Open Label Phase||0||
59852184|NCT03462082|75976721|FG001|COMPLETED|Open Label Phase||0||
59852185|NCT03462082|75976722|FG002|COMPLETED|Open Label Phase||0||
59852186|NCT03462082|75976723|FG003|COMPLETED|Open Label Phase||0||
59852187|NCT03462082|75976724|FG004|COMPLETED|Open Label Phase||0||
59852188|NCT03462082|75976725|FG005|COMPLETED|Open Label Phase||0||
59584543|NCT03656939|75691131|FG000|Prospective Study Cohort: Participants Who Received Dose 3|Overall Study||2047||
59852189|NCT03462082|75976726|FG006|COMPLETED|Open Label Phase||6||
59852190|NCT03462082|75976727|FG007|COMPLETED|Open Label Phase||8||
59852191|NCT03462082|75976720|FG000|NOT COMPLETED|Open Label Phase||0||
59852192|NCT03462082|75976721|FG001|NOT COMPLETED|Open Label Phase||0||
59852193|NCT03462082|75976722|FG002|NOT COMPLETED|Open Label Phase||0||
59852194|NCT03462082|75976723|FG003|NOT COMPLETED|Open Label Phase||0||
59852195|NCT03462082|75976724|FG004|NOT COMPLETED|Open Label Phase||0||
59852196|NCT03462082|75976725|FG005|NOT COMPLETED|Open Label Phase||0||
59852197|NCT03462082|75976726|FG006|NOT COMPLETED|Open Label Phase||1||
59852198|NCT03462082|75976727|FG007|NOT COMPLETED|Open Label Phase||2||
59852199|NCT03541252|75976737|FG000|STARTED|Overall Study||20||
59852200|NCT03541252|75976737|FG000|COMPLETED|Overall Study||19||
59852201|NCT03541252|75976737|FG000|NOT COMPLETED|Overall Study||1||
59852202|NCT00031460|75976743|FG000|STARTED|Overall Study||24||
59852203|NCT00031460|75976744|FG001|STARTED|Overall Study||22||
59852204|NCT00031460|75976743|FG000|COMPLETED|Overall Study||15||
59852205|NCT00031460|75976744|FG001|COMPLETED|Overall Study||8||
59852206|NCT00031460|75976743|FG000|NOT COMPLETED|Overall Study||9||
59852207|NCT00031460|75976744|FG001|NOT COMPLETED|Overall Study||14||
59852208|NCT03540160|75976750|FG000|STARTED|Overall Study||558||
59852209|NCT03540160|75976750|FG000|COMPLETED|Overall Study||179||
59852210|NCT03540160|75976750|FG000|NOT COMPLETED|Overall Study||379||
59852211|NCT03459196|75976754|FG000|STARTED|Overall Study||54|Subjects who signed the informed consent form are considered as enrolled and started the study.|
59852212|NCT03459196|75976754|FG000|COMPLETED|Overall Study||52||
59852213|NCT03459196|75976754|FG000|NOT COMPLETED|Overall Study||2||
59852214|NCT03459040|75976758|FG000|STARTED|Overall Study||30||
59852215|NCT03459040|75976758|FG000|COMPLETED|Overall Study||21||
59852216|NCT03459040|75976758|FG000|NOT COMPLETED|Overall Study||9||
59852217|NCT03457636|75976763|FG000|STARTED|Overall Study||22||
59852218|NCT03457636|75976763|FG000|COMPLETED|Overall Study||20||
59852219|NCT03457636|75976763|FG000|NOT COMPLETED|Overall Study||2||
59852220|NCT03481816|75976769|FG000|STARTED|Starting Dose||6||
59852221|NCT03481816|75976770|FG001|STARTED|Starting Dose||0||
59852222|NCT03481816|75976769|FG000|COMPLETED|Starting Dose||5||
59852223|NCT03481816|75976770|FG001|COMPLETED|Starting Dose||0||
59852224|NCT03481816|75976769|FG000|NOT COMPLETED|Starting Dose||1||
59852225|NCT03481816|75976770|FG001|NOT COMPLETED|Starting Dose||0||
59852226|NCT03481816|75976769|FG000|STARTED|Dose Expansion||0||
59852227|NCT03481816|75976770|FG001|STARTED|Dose Expansion||12||
59852228|NCT03481816|75976769|FG000|COMPLETED|Dose Expansion||0||
59852229|NCT03481816|75976770|FG001|COMPLETED|Dose Expansion||0||
59852230|NCT03481816|75976769|FG000|NOT COMPLETED|Dose Expansion||0||
59852231|NCT03481816|75976770|FG001|NOT COMPLETED|Dose Expansion||12||
59852232|NCT03538054|75976778|FG000|STARTED|Baseline Phase (2 Weeks)||19||
59852233|NCT03538054|75976778|FG000|COMPLETED|Baseline Phase (2 Weeks)||18||
59852234|NCT03538054|75976778|FG000|NOT COMPLETED|Baseline Phase (2 Weeks)||1||
59852235|NCT03538054|75976778|FG000|STARTED|Placebo Phase (5 Weeks)||18||
59584544|NCT03656939|75691131|FG000|Prospective Study Cohort: Participants Who Received Dose 4|Overall Study||1291||
59584545|NCT03656939|75691131|FG000|COMPLETED|Overall Study||21240||
59724360|NCT01061736|75842945|FG007|Rescued|Overall Study|Included both participants who completed and did not complete the study.|61||
59724361|NCT01061736|75842946|FG008|Rescued|Overall Study|Included both participants who completed and did not complete the study.|55||
59724362|NCT01061736|75842947|FG009|Rescued|Overall Study|Included both participants who completed and did not complete the study.|168||
59724363|NCT01061736|75842938|FG000|COMPLETED|Overall Study||37||
59724364|NCT01061736|75842939|FG001|COMPLETED|Overall Study||46||
59724365|NCT01061736|75842940|FG002|COMPLETED|Overall Study||45||
59724366|NCT01061736|75842941|FG003|COMPLETED|Overall Study||48||
59724367|NCT01061736|75842942|FG004|COMPLETED|Overall Study||45||
59724368|NCT01061736|75842943|FG005|COMPLETED|Overall Study||49||
59724369|NCT01061736|75842944|FG006|COMPLETED|Overall Study||0||
59724370|NCT01061736|75842945|FG007|COMPLETED|Overall Study||336||
59724371|NCT01061736|75842946|FG008|COMPLETED|Overall Study||330||
59852236|NCT03538054|75976778|FG000|COMPLETED|Placebo Phase (5 Weeks)||16||
59852237|NCT03538054|75976778|FG000|NOT COMPLETED|Placebo Phase (5 Weeks)||2||
59584546|NCT03656939|75691131|FG000|NOT COMPLETED|Overall Study||0||
59584547|NCT03657407|75691139|FG000|STARTED|Overall Study||29||
59584548|NCT03657407|75691140|FG001|STARTED|Overall Study||27||
59724372|NCT01061736|75842947|FG009|COMPLETED|Overall Study||354||
59724373|NCT01061736|75842938|FG000|NOT COMPLETED|Overall Study||13||
59724374|NCT01061736|75842939|FG001|NOT COMPLETED|Overall Study||4||
59724375|NCT01061736|75842940|FG002|NOT COMPLETED|Overall Study||6||
59724376|NCT01061736|75842941|FG003|NOT COMPLETED|Overall Study||3||
59724377|NCT01061736|75842942|FG004|NOT COMPLETED|Overall Study||7||
59724378|NCT01061736|75842943|FG005|NOT COMPLETED|Overall Study||3||
59852238|NCT03538054|75976778|FG000|STARTED|Dextromethorphan Phase (10 Weeks)||16||
59852239|NCT03538054|75976778|FG000|COMPLETED|Dextromethorphan Phase (10 Weeks)||14||
59852240|NCT03538054|75976778|FG000|NOT COMPLETED|Dextromethorphan Phase (10 Weeks)||2||
59852241|NCT03480802|75976786|FG000|STARTED|Overall Study||152|Vaccinated on Day 1|
59852242|NCT03480802|75976787|FG001|STARTED|Overall Study||150|Vaccinated on Day 1|
59852243|NCT03480802|75976786|FG000|Week 8|Overall Study||150|Vaccinated with PNEUMOVAX™23|
59852244|NCT03480802|75976787|FG001|Week 8|Overall Study||148|Vaccinated with PNEUMOVAX™23|
59852245|NCT03480802|75976786|FG000|COMPLETED|Overall Study||145||
59852246|NCT03480802|75976787|FG001|COMPLETED|Overall Study||147||
59852247|NCT03480802|75976786|FG000|NOT COMPLETED|Overall Study||7||
59852248|NCT03480802|75976787|FG001|NOT COMPLETED|Overall Study||3||
59852249|NCT00050960|75976797|FG000|STARTED|Overall Study||306||
59852250|NCT00050960|75976798|FG001|STARTED|Overall Study||306||
59852251|NCT00050960|75976797|FG000|COMPLETED|Overall Study|Represents number of patients with no primary reason for termination|4||
59852252|NCT00050960|75976798|FG001|COMPLETED|Overall Study|Represents number of patients with no primary reason for termination|2||
59852253|NCT00050960|75976797|FG000|NOT COMPLETED|Overall Study||302||
59852254|NCT00050960|75976798|FG001|NOT COMPLETED|Overall Study||304||
59852255|NCT03456856|75976804|FG000|STARTED|Overall Study||30||
59852256|NCT03456856|75976804|FG000|COMPLETED|Overall Study||27||
59852257|NCT03456856|75976804|FG000|NOT COMPLETED|Overall Study||3||
59852258|NCT00058214|75976808|FG000|STARTED|Overall Study||25||
59852259|NCT00058214|75976808|FG000|COMPLETED|Overall Study||24||
59852260|NCT00058214|75976808|FG000|NOT COMPLETED|Overall Study||1||
59852261|NCT00097773|75976816|FG000|STARTED|Overall Study||76||
59852262|NCT00097773|75976817|FG001|STARTED|Overall Study||76||
59852263|NCT00097773|75976818|FG002|STARTED|Overall Study||76||
59852264|NCT00097773|75976819|FG003|STARTED|Overall Study||76||
59852265|NCT00097773|75976816|FG000|COMPLETED|Overall Study||68||
59852266|NCT00097773|75976817|FG001|COMPLETED|Overall Study||68||
59852267|NCT00097773|75976818|FG002|COMPLETED|Overall Study||68||
59852268|NCT00097773|75976819|FG003|COMPLETED|Overall Study||73||
59852269|NCT00097773|75976816|FG000|NOT COMPLETED|Overall Study||8||
59852270|NCT00097773|75976817|FG001|NOT COMPLETED|Overall Study||8||
59852271|NCT00097773|75976818|FG002|NOT COMPLETED|Overall Study||8||
59852272|NCT00097773|75976819|FG003|NOT COMPLETED|Overall Study||3||
59852273|NCT03480022|75976836|FG000|STARTED|Overall Study||55||
59852274|NCT03480022|75976837|FG001|STARTED|Overall Study||27||
59852275|NCT03480022|75976836|FG000|COMPLETED|Overall Study||44||
59852276|NCT03480022|75976837|FG001|COMPLETED|Overall Study||23||
59852277|NCT03480022|75976836|FG000|NOT COMPLETED|Overall Study||11||
59852278|NCT03480022|75976837|FG001|NOT COMPLETED|Overall Study||4||
59852279|NCT03533608|75976843|FG000|STARTED|Overall Study||39||
59852280|NCT03533608|75976843|FG000|COMPLETED|Overall Study||34||
59852281|NCT03533608|75976843|FG000|NOT COMPLETED|Overall Study||5||
59852282|NCT00049322|75976850|FG000|STARTED|Overall Study||15||
59584549|NCT03657407|75691139|FG000|COMPLETED|Overall Study||29||
59584550|NCT03657407|75691140|FG001|COMPLETED|Overall Study||27||
59724379|NCT01061736|75842944|FG006|NOT COMPLETED|Overall Study||84||
59852283|NCT00049322|75976851|FG001|STARTED|Overall Study||15||
59852284|NCT00049322|75976850|FG000|COMPLETED|Overall Study||14||
59852285|NCT00049322|75976851|FG001|COMPLETED|Overall Study||9||
59852286|NCT00049322|75976850|FG000|NOT COMPLETED|Overall Study||1||
59852287|NCT00049322|75976851|FG001|NOT COMPLETED|Overall Study||6||
59852288|NCT03437512|75976861|FG000|STARTED|Randomized||12||
59852289|NCT03437512|75976862|FG001|STARTED|Randomized||13||
59852290|NCT03437512|75976861|FG000|COMPLETED|Randomized||12||
59852291|NCT03437512|75976862|FG001|COMPLETED|Randomized||11||
59852292|NCT03437512|75976861|FG000|NOT COMPLETED|Randomized||0||
59852293|NCT03437512|75976862|FG001|NOT COMPLETED|Randomized||2||
59724380|NCT01061736|75842945|FG007|NOT COMPLETED|Overall Study||94||
59724381|NCT01061736|75842946|FG008|NOT COMPLETED|Overall Study||97||
59724382|NCT01061736|75842947|FG009|NOT COMPLETED|Overall Study||74||
59724383|NCT01117337|75842974|FG000|STARTED|Overall Study|52 pateints on inguinal hernia were randomized to mesh fixation group|52||
59724384|NCT01117337|75842975|FG001|STARTED|Overall Study||52||
59724385|NCT01117337|75842974|FG000|Underwent Surgery|Overall Study|52 patients underwent surgery|52||
59724386|NCT01117337|75842975|FG001|Underwent Surgery|Overall Study||52||
59724387|NCT01117337|75842974|FG000|COMPLETED|Overall Study|48 completed one year follow-up. 4 lost to follow-up.|48||
59724388|NCT01117337|75842975|FG001|COMPLETED|Overall Study||52||
59724389|NCT01117337|75842974|FG000|NOT COMPLETED|Overall Study||4||
59724390|NCT01117337|75842975|FG001|NOT COMPLETED|Overall Study||0||
59724391|NCT04465162|75842981|FG000|STARTED|Overall Study||73||
59724392|NCT04465162|75842981|FG000|COMPLETED|Overall Study||73||
59852294|NCT03437512|75976861|FG000|STARTED|Received First tDCS Session||12||
59852295|NCT03437512|75976862|FG001|STARTED|Received First tDCS Session||11||
59852296|NCT03437512|75976861|FG000|COMPLETED|Received First tDCS Session||12||
59852297|NCT03437512|75976862|FG001|COMPLETED|Received First tDCS Session||11||
59852298|NCT03437512|75976861|FG000|NOT COMPLETED|Received First tDCS Session||0||
59852299|NCT03437512|75976862|FG001|NOT COMPLETED|Received First tDCS Session||0||
59852300|NCT03437512|75976861|FG000|STARTED|Received Final tDCS Session||12||
59852301|NCT03437512|75976862|FG001|STARTED|Received Final tDCS Session||11||
59852302|NCT03437512|75976861|FG000|COMPLETED|Received Final tDCS Session||12||
59852303|NCT03437512|75976862|FG001|COMPLETED|Received Final tDCS Session||11||
59852304|NCT03437512|75976861|FG000|NOT COMPLETED|Received Final tDCS Session||0||
59852305|NCT03437512|75976862|FG001|NOT COMPLETED|Received Final tDCS Session||0||
59852306|NCT03437512|75976861|FG000|STARTED|Completed Study Follow up||12||
59996754|NCT04086121|76112607|FG000|COMPLETED|Overall Study||0||
59724393|NCT04465162|75842981|FG000|NOT COMPLETED|Overall Study||0||
59852307|NCT03437512|75976862|FG001|STARTED|Completed Study Follow up||11||
59852308|NCT03437512|75976861|FG000|COMPLETED|Completed Study Follow up||10||
59852309|NCT03437512|75976862|FG001|COMPLETED|Completed Study Follow up||10||
59852310|NCT03437512|75976861|FG000|NOT COMPLETED|Completed Study Follow up||2||
59852311|NCT03437512|75976862|FG001|NOT COMPLETED|Completed Study Follow up||1||
59852312|NCT00058058|75976868|FG000|STARTED|Overall Study||1007|Enrolled|
59852313|NCT00058058|75976868|FG000|COMPLETED|Overall Study||969|Completed MRI|
59852314|NCT00058058|75976868|FG000|NOT COMPLETED|Overall Study||38||
59852315|NCT03532048|75976875|FG000|STARTED|Overall Study|68 individuals (19 fathers, 31 children & 18 mothers)|68||19
59852316|NCT03532048|75976876|FG001|STARTED|Overall Study|67 individuals (17 fathers, 33 children & 17 mothers)|67||17
59852317|NCT03532048|75976875|FG000|COMPLETED|Overall Study|49 individuals (14 fathers, 22 children, 13 mothers). 1 father only took part in interview|49||14
59852318|NCT03532048|75976876|FG001|COMPLETED|Overall Study|50 individuals (13 fathers, 24 children & 13 mothers)|50||13
59852319|NCT03532048|75976875|FG000|NOT COMPLETED|Overall Study||19||5
59852320|NCT03532048|75976876|FG001|NOT COMPLETED|Overall Study||17||4
59852321|NCT00008138|75976882|FG000|STARTED|Neoadjuvant Chemotherapy||58||
59852322|NCT00008138|75976882|FG000|Eligible|Neoadjuvant Chemotherapy||58||
59852323|NCT00008138|75976882|FG000|COMPLETED|Neoadjuvant Chemotherapy||38||
59852324|NCT00008138|75976882|FG000|NOT COMPLETED|Neoadjuvant Chemotherapy||20||
59852325|NCT00008138|75976882|FG000|STARTED|Interval Debulking||38||
59852326|NCT00008138|75976882|FG000|Received Protocol Surgery|Interval Debulking||36||
59852327|NCT00008138|75976882|FG000|COMPLETED|Interval Debulking||36||
59852328|NCT00008138|75976882|FG000|NOT COMPLETED|Interval Debulking||2||
59852329|NCT00008138|75976882|FG000|STARTED|Post-Cytoreduction Chemotherapy|Among 36 patients from previous period, 5 patients rejected and 5 patients are ineligible.|26||
59852330|NCT00008138|75976882|FG000|COMPLETED|Post-Cytoreduction Chemotherapy||18||
59852331|NCT00008138|75976882|FG000|NOT COMPLETED|Post-Cytoreduction Chemotherapy||8||
59852332|NCT03436732|75976889|FG000|STARTED|Overall Study||4||
59852333|NCT03436732|75976890|FG001|STARTED|Overall Study||1||
59852334|NCT03436732|75976889|FG000|COMPLETED|Overall Study||0||
59852335|NCT03436732|75976890|FG001|COMPLETED|Overall Study||0||
59852336|NCT03436732|75976889|FG000|NOT COMPLETED|Overall Study||4||
59852337|NCT03436732|75976890|FG001|NOT COMPLETED|Overall Study||1||
59724394|NCT01108523|75842985|FG000|STARTED|Overall Study||7||
59724395|NCT01108523|75842985|FG000|COMPLETED|Overall Study||3||
59724396|NCT01108523|75842985|FG000|NOT COMPLETED|Overall Study||4||
59724397|NCT01035606|75842992|FG000|STARTED|Overall Study||19||
59724398|NCT01035606|75842993|FG001|STARTED|Overall Study||19||
59724399|NCT01035606|75842994|FG002|STARTED|Overall Study||11||
59724400|NCT01035606|75842992|FG000|COMPLETED|Overall Study||16||
59724401|NCT01035606|75842993|FG001|COMPLETED|Overall Study||16||
59724402|NCT01035606|75842994|FG002|COMPLETED|Overall Study||7||
59724403|NCT01035606|75842992|FG000|NOT COMPLETED|Overall Study||3||
59724404|NCT01035606|75842993|FG001|NOT COMPLETED|Overall Study||3||
59724405|NCT01035606|75842994|FG002|NOT COMPLETED|Overall Study||4||
59724406|NCT01117181|75843004|FG000|STARTED|Overall Study||29||
59724407|NCT01117181|75843005|FG001|STARTED|Overall Study||31||
59724408|NCT01117181|75843004|FG000|COMPLETED|Overall Study||28||
59724409|NCT01117181|75843005|FG001|COMPLETED|Overall Study||29||
59724410|NCT01117181|75843004|FG000|NOT COMPLETED|Overall Study||1||
59724411|NCT01117181|75843005|FG001|NOT COMPLETED|Overall Study||2||
59724412|NCT01040130|75843013|FG000|STARTED|Overall Study|Number of patients entered and treated|25||
59724413|NCT01040130|75843014|FG001|STARTED|Overall Study||25||
59724414|NCT01040130|75843015|FG002|STARTED|Overall Study||25||
59724415|NCT01040130|75843016|FG003|STARTED|Overall Study||25||
59724416|NCT01040130|75843017|FG004|STARTED|Overall Study||25||
59724417|NCT01040130|75843018|FG005|STARTED|Overall Study||26||
59724418|NCT01040130|75843013|FG000|COMPLETED|Overall Study|Number of patients who did not discontinue from the trial.|22||
59724419|NCT01040130|75843014|FG001|COMPLETED|Overall Study||22||
59724420|NCT01040130|75843015|FG002|COMPLETED|Overall Study||23||
59724421|NCT01040130|75843016|FG003|COMPLETED|Overall Study||20||
59852338|NCT03436420|75976897|FG000|STARTED|Overall Study||6||
59852339|NCT03436420|75976897|FG000|COMPLETED|Overall Study||3||
59852340|NCT03436420|75976897|FG000|NOT COMPLETED|Overall Study||3||
59852341|NCT00027560|75976901|FG000|STARTED|Overall Study||51||
59852342|NCT00027560|75976901|FG000|COMPLETED|Overall Study||50||
59852343|NCT00027560|75976901|FG000|NOT COMPLETED|Overall Study||1||
59852344|NCT03451084|75976911|FG000|STARTED|Overall Study||6||
59852345|NCT03451084|75976912|FG001|STARTED|Overall Study||6||
59852346|NCT03451084|75976913|FG002|STARTED|Overall Study||6||
59852347|NCT03451084|75976914|FG003|STARTED|Overall Study||6||
59852348|NCT03451084|75976911|FG000|COMPLETED|Overall Study||0||
59852349|NCT03451084|75976912|FG001|COMPLETED|Overall Study||0||
59852350|NCT03451084|75976913|FG002|COMPLETED|Overall Study||0||
59852351|NCT03451084|75976914|FG003|COMPLETED|Overall Study||0||
59852352|NCT03451084|75976911|FG000|NOT COMPLETED|Overall Study||6||
59852353|NCT03451084|75976912|FG001|NOT COMPLETED|Overall Study||6||
59852354|NCT03451084|75976913|FG002|NOT COMPLETED|Overall Study||6||
59852355|NCT03451084|75976914|FG003|NOT COMPLETED|Overall Study||6||
59852356|NCT03451006|75976926|FG000|STARTED|Overall Study||4||
59852357|NCT03451006|75976927|FG001|STARTED|Overall Study||3||
59852358|NCT03451006|75976926|FG000|COMPLETED|Overall Study||2||
59852359|NCT03451006|75976927|FG001|COMPLETED|Overall Study||1||
59724422|NCT01040130|75843017|FG004|COMPLETED|Overall Study||25||
59852360|NCT03451006|75976926|FG000|NOT COMPLETED|Overall Study||2||
59852361|NCT03451006|75976927|FG001|NOT COMPLETED|Overall Study||2||
59852362|NCT03450070|75976933|FG000|STARTED|Overall Study||118||
59852363|NCT03450070|75976933|FG000|COMPLETED|Overall Study||110||
59852364|NCT03450070|75976933|FG000|NOT COMPLETED|Overall Study||8||
59852365|NCT03449758|75976937|FG000|STARTED|Overall Study||84|Enrolled and treated.|
59852366|NCT03449758|75976937|FG000|COMPLETED|Overall Study||65||
59852367|NCT03449758|75976937|FG000|NOT COMPLETED|Overall Study||19||
59852368|NCT03449446|75976949|FG000|STARTED|Overall Study||39||
59852369|NCT03449446|75976950|FG001|STARTED|Overall Study||40||
59852370|NCT03449446|75976951|FG002|STARTED|Overall Study||41||
59852371|NCT03449446|75976952|FG003|STARTED|Overall Study||80||
59852372|NCT03449446|75976953|FG004|STARTED|Overall Study||78||
59852373|NCT03449446|75976954|FG005|STARTED|Overall Study||78||
59852374|NCT03449446|75976955|FG006|STARTED|Overall Study||39||
59852375|NCT03449446|75976949|FG000|COMPLETED|Overall Study||3||
59852376|NCT03449446|75976950|FG001|COMPLETED|Overall Study||33||
59852377|NCT03449446|75976951|FG002|COMPLETED|Overall Study||34||
59852378|NCT03449446|75976952|FG003|COMPLETED|Overall Study||71||
59852379|NCT03449446|75976953|FG004|COMPLETED|Overall Study||66||
59852380|NCT03449446|75976954|FG005|COMPLETED|Overall Study||69||
59852381|NCT03449446|75976955|FG006|COMPLETED|Overall Study||38||
59852382|NCT03449446|75976949|FG000|NOT COMPLETED|Overall Study||36||
59852383|NCT03449446|75976950|FG001|NOT COMPLETED|Overall Study||7||
59852384|NCT03449446|75976951|FG002|NOT COMPLETED|Overall Study||7||
59852385|NCT03449446|75976952|FG003|NOT COMPLETED|Overall Study||9||
59852386|NCT03449446|75976953|FG004|NOT COMPLETED|Overall Study||12||
59852387|NCT03449446|75976954|FG005|NOT COMPLETED|Overall Study||9||
59852388|NCT03449446|75976955|FG006|NOT COMPLETED|Overall Study||1||
59852389|NCT03449134|75976974|FG000|STARTED|52-Week Treatment Period||244||
59852390|NCT03449134|75976975|FG001|STARTED|52-Week Treatment Period||244||
59852391|NCT03449134|75976976|FG002|STARTED|52-Week Treatment Period||244||
59852392|NCT03449134|75976974|FG000|Treated|52-Week Treatment Period||243||
59852393|NCT03449134|75976975|FG001|Treated|52-Week Treatment Period||244||
59852394|NCT03449134|75976976|FG002|Treated|52-Week Treatment Period||243||
59852395|NCT03449134|75976974|FG000|COMPLETED|52-Week Treatment Period||199||
59852396|NCT03449134|75976975|FG001|COMPLETED|52-Week Treatment Period||200||
59852397|NCT03449134|75976976|FG002|COMPLETED|52-Week Treatment Period||184||
59852398|NCT03449134|75976974|FG000|NOT COMPLETED|52-Week Treatment Period||45||
59852399|NCT03449134|75976975|FG001|NOT COMPLETED|52-Week Treatment Period||44||
59852400|NCT03449134|75976976|FG002|NOT COMPLETED|52-Week Treatment Period||60||
59852401|NCT03449134|75976974|FG000|STARTED|12-Week Off-Treatment Durability Period|Not all participants continued in the optional Off-Treatment Period.|10||
59852402|NCT03449134|75976975|FG001|STARTED|12-Week Off-Treatment Durability Period|Not all participants continued in the optional Off-Treatment Period.|18||
59852403|NCT03449134|75976976|FG002|STARTED|12-Week Off-Treatment Durability Period|Not all participants continued in the optional Off-Treatment Period.|13||
59852404|NCT03449134|75976974|FG000|COMPLETED|12-Week Off-Treatment Durability Period||10||
59852405|NCT03449134|75976975|FG001|COMPLETED|12-Week Off-Treatment Durability Period||18||
59852406|NCT03449134|75976976|FG002|COMPLETED|12-Week Off-Treatment Durability Period||13||
59852407|NCT03449134|75976974|FG000|NOT COMPLETED|12-Week Off-Treatment Durability Period||0||
59852408|NCT03449134|75976975|FG001|NOT COMPLETED|12-Week Off-Treatment Durability Period||0||
59852409|NCT03449134|75976976|FG002|NOT COMPLETED|12-Week Off-Treatment Durability Period||0||
59852410|NCT03529162|75976989|FG000|STARTED|Overall Study||2||
59852411|NCT03529162|75976990|FG001|STARTED|Overall Study||2||
59852412|NCT03529162|75976989|FG000|COMPLETED|Overall Study||0||
59852413|NCT03529162|75976990|FG001|COMPLETED|Overall Study||0||
59852414|NCT03529162|75976989|FG000|NOT COMPLETED|Overall Study||2||
59852415|NCT03529162|75976990|FG001|NOT COMPLETED|Overall Study||2||
59852416|NCT03447730|75977001|FG000|STARTED|Overall Study||6||
59852417|NCT03447730|75977002|FG001|STARTED|Overall Study||9||
59852418|NCT03447730|75977003|FG002|STARTED|Overall Study||8||
59852419|NCT03447730|75977001|FG000|COMPLETED|Overall Study||6|Completed all 6 days of TID dosing|
59852420|NCT03447730|75977002|FG001|COMPLETED|Overall Study||7|Completed all 6 days of TID dosing|
59852421|NCT03447730|75977003|FG002|COMPLETED|Overall Study||8|Completed all 6 days of TID dosing|
60121590|NCT01683071|76242507|FG001|STARTED|Part 1||26||
60121591|NCT01683071|76242508|FG002|STARTED|Part 1||25||
60121592|NCT01683071|76242509|FG003|STARTED|Part 1||25||
60121593|NCT01683071|76242510|FG004|STARTED|Part 1||0||
59724423|NCT01040130|75843018|FG005|COMPLETED|Overall Study||22||
59724424|NCT01040130|75843013|FG000|NOT COMPLETED|Overall Study||3||
59724425|NCT01040130|75843014|FG001|NOT COMPLETED|Overall Study||3||
59724426|NCT01040130|75843015|FG002|NOT COMPLETED|Overall Study||2||
59724427|NCT01040130|75843016|FG003|NOT COMPLETED|Overall Study||5||
59724428|NCT01040130|75843017|FG004|NOT COMPLETED|Overall Study||0||
59724429|NCT01040130|75843018|FG005|NOT COMPLETED|Overall Study||4||
59724430|NCT00932451|75843028|FG000|STARTED|Overall Study||1066||
59724431|NCT00932451|75843028|FG000|COMPLETED|Overall Study||244||
59724432|NCT00932451|75843028|FG000|NOT COMPLETED|Overall Study||822||
59852422|NCT03447730|75977001|FG000|NOT COMPLETED|Overall Study||0||
59852423|NCT03447730|75977002|FG001|NOT COMPLETED|Overall Study||2||
60121594|NCT01683071|76242511|FG005|STARTED|Part 1||0||
59852424|NCT03447730|75977003|FG002|NOT COMPLETED|Overall Study||0||
59852425|NCT03429556|75977015|FG000|STARTED|Overall Study||12||
59852426|NCT03429556|75977016|FG001|STARTED|Overall Study||4||
59852427|NCT03429556|75977017|FG002|STARTED|Overall Study||4||
59852428|NCT03429556|75977018|FG003|STARTED|Overall Study||3||
59852429|NCT03429556|75977015|FG000|COMPLETED|Overall Study||12||
59852430|NCT03429556|75977016|FG001|COMPLETED|Overall Study||3||
59852431|NCT03429556|75977017|FG002|COMPLETED|Overall Study||4||
59852432|NCT03429556|75977018|FG003|COMPLETED|Overall Study||3||
59852433|NCT03429556|75977015|FG000|NOT COMPLETED|Overall Study||0||
59852434|NCT03429556|75977016|FG001|NOT COMPLETED|Overall Study||1||
59852435|NCT03429556|75977017|FG002|NOT COMPLETED|Overall Study||0||
59852436|NCT03429556|75977018|FG003|NOT COMPLETED|Overall Study||0||
59852437|NCT03428152|75977030|FG000|STARTED|Overall Study||37||
59852438|NCT03428152|75977031|FG001|STARTED|Overall Study||41||
59852439|NCT03428152|75977030|FG000|COMPLETED|Overall Study||30||
59852440|NCT03428152|75977031|FG001|COMPLETED|Overall Study|exclusions: epidural / TAP / wound infiltration malignity retroperitone was opened age >65|30||
59852441|NCT03428152|75977030|FG000|NOT COMPLETED|Overall Study||7||
59852442|NCT03428152|75977031|FG001|NOT COMPLETED|Overall Study||11||
59852443|NCT03444766|75977037|FG000|STARTED|Overall Study||100|Started Treatment Period|
59852444|NCT03444766|75977037|FG000|COMPLETED|Overall Study||34|Completed Treatment Period|
59852445|NCT03444766|75977037|FG000|NOT COMPLETED|Overall Study||66||
59852446|NCT03426436|75977041|FG000|STARTED|Overall Study||314||
59852447|NCT03426436|75977041|FG000|COMPLETED|Overall Study||295|16 subjects excluded from analysis|
59852448|NCT03426436|75977041|FG000|NOT COMPLETED|Overall Study||19||
59852449|NCT03425188|75977045|FG000|STARTED|Overall Study||53||
59852450|NCT03425188|75977045|FG000|COMPLETED|Overall Study||52||
59852451|NCT03425188|75977045|FG000|NOT COMPLETED|Overall Study||1||
59852452|NCT03423238|75977052|FG000|STARTED|Overall Study||19||
59852453|NCT03423238|75977053|FG001|STARTED|Overall Study||19||
59852454|NCT03423238|75977052|FG000|COMPLETED|Overall Study||17||
59852455|NCT03423238|75977053|FG001|COMPLETED|Overall Study||19||
59852456|NCT03423238|75977052|FG000|NOT COMPLETED|Overall Study||2||
59852457|NCT03423238|75977053|FG001|NOT COMPLETED|Overall Study||0||
59852458|NCT02953678|75977060|FG000|STARTED|Overall Study||71||
59852459|NCT02953678|75977060|FG000|COMPLETED|Overall Study||0||
59852460|NCT02953678|75977060|FG000|NOT COMPLETED|Overall Study||71||
59852461|NCT03412084|75977067|FG000|STARTED|Overall Study||48||
59852462|NCT03412084|75977068|FG001|STARTED|Overall Study||36||
59852463|NCT03412084|75977067|FG000|COMPLETED|Overall Study||44||
59852464|NCT03412084|75977068|FG001|COMPLETED|Overall Study||35||
59852465|NCT03412084|75977067|FG000|NOT COMPLETED|Overall Study||4||
59852466|NCT03412084|75977068|FG001|NOT COMPLETED|Overall Study||1||
59852467|NCT00090753|75977076|FG000|STARTED|First Treatment Period||748||
59852468|NCT00090753|75977077|FG001|STARTED|First Treatment Period||480||
59852469|NCT00090753|75977076|FG000|COMPLETED|First Treatment Period||492||
59852470|NCT00090753|75977077|FG001|COMPLETED|First Treatment Period||302||
59852471|NCT00090753|75977076|FG000|NOT COMPLETED|First Treatment Period||256||
59852472|NCT00090753|75977077|FG001|NOT COMPLETED|First Treatment Period||178||
59852473|NCT00090753|75977076|FG000|STARTED|Extended Treatment Period|39 patients who completed the first treatment period refused to enter the extended treatment period.|453||
59852474|NCT00090753|75977077|FG001|STARTED|Extended Treatment Period|52 patients who completed the first treatment period refused to enter the extended treatment period.|250||
59852475|NCT00090753|75977076|FG000|COMPLETED|Extended Treatment Period||94||
59852476|NCT00090753|75977077|FG001|COMPLETED|Extended Treatment Period||59||
59852477|NCT00090753|75977076|FG000|NOT COMPLETED|Extended Treatment Period||359||
59852478|NCT00090753|75977077|FG001|NOT COMPLETED|Extended Treatment Period||191||
59852479|NCT00048932|75977085|FG000|STARTED|Double Blind Period (DB)|Number Treated|959||
59852480|NCT00048932|75977086|FG001|STARTED|Double Blind Period (DB)|Number Treated|482||
59852481|NCT00048932|75977087|FG002|STARTED|Double Blind Period (DB)||0||
59852482|NCT00048932|75977085|FG000|COMPLETED|Double Blind Period (DB)||836||
59852483|NCT00048932|75977086|FG001|COMPLETED|Double Blind Period (DB)||395||
59852484|NCT00048932|75977087|FG002|COMPLETED|Double Blind Period (DB)||0||
59852485|NCT00048932|75977085|FG000|NOT COMPLETED|Double Blind Period (DB)||123||
59852486|NCT00048932|75977086|FG001|NOT COMPLETED|Double Blind Period (DB)||87||
59852487|NCT00048932|75977087|FG002|NOT COMPLETED|Double Blind Period (DB)||0||
59852488|NCT00048932|75977085|FG000|STARTED|Open Label Period (OL)||0||
59852489|NCT00048932|75977086|FG001|STARTED|Open Label Period (OL)||0||
59852490|NCT00048932|75977087|FG002|STARTED|Open Label Period (OL)|47 participants who completed the double-blind did not enter the open-label|1184||
59584551|NCT03657407|75691139|FG000|NOT COMPLETED|Overall Study||0||
59584552|NCT03657407|75691140|FG001|NOT COMPLETED|Overall Study||0||
59584553|NCT01639560|75691148|FG000|STARTED|Overall Study||45||
59584554|NCT01639560|75691149|FG001|STARTED|Overall Study||48||
59584555|NCT01639560|75691148|FG000|End of Treatment|Overall Study||28||
59852491|NCT00048932|75977085|FG000|COMPLETED|Open Label Period (OL)||0||
59852492|NCT00048932|75977086|FG001|COMPLETED|Open Label Period (OL)||0||
59852493|NCT00048932|75977087|FG002|COMPLETED|Open Label Period (OL)||743||
59584556|NCT01639560|75691149|FG001|End of Treatment|Overall Study||20||
59584557|NCT01639560|75691148|FG000|COMPLETED|Overall Study||26||
59584558|NCT01639560|75691149|FG001|COMPLETED|Overall Study||19||
59852494|NCT00048932|75977085|FG000|NOT COMPLETED|Open Label Period (OL)||0||
59852495|NCT00048932|75977086|FG001|NOT COMPLETED|Open Label Period (OL)||0||
59852496|NCT00048932|75977087|FG002|NOT COMPLETED|Open Label Period (OL)||441||
59852497|NCT00073983|75977096|FG000|STARTED|Overall Study||54||
59852498|NCT00073983|75977096|FG000|COMPLETED|Overall Study|One patient in the chondrosarcoma subtype was not evaluable.|53||
59852499|NCT00073983|75977096|FG000|NOT COMPLETED|Overall Study||1||
59852500|NCT03812679|75977102|FG000|STARTED|Overall Study||22||
59852501|NCT03812679|75977102|FG000|COMPLETED|Overall Study||14||
59852502|NCT03812679|75977102|FG000|NOT COMPLETED|Overall Study||8||
59852503|NCT02952820|75977109|FG000|STARTED|Placebo-Controlled Treatment (6 Months)||325||
59852504|NCT02952820|75977110|FG001|STARTED|Placebo-Controlled Treatment (6 Months)||323||
59852505|NCT02952820|75977111|FG002|STARTED|Placebo-Controlled Treatment (6 Months)||323||
59852506|NCT02952820|75977109|FG000|Treated|Placebo-Controlled Treatment (6 Months)||321||
59852507|NCT02952820|75977110|FG001|Treated|Placebo-Controlled Treatment (6 Months)||319||
59852508|NCT02952820|75977111|FG002|Treated|Placebo-Controlled Treatment (6 Months)||319||
59852509|NCT02952820|75977109|FG000|Safety Analysis Set|Placebo-Controlled Treatment (6 Months)||319||
59852510|NCT02952820|75977110|FG001|Safety Analysis Set|Placebo-Controlled Treatment (6 Months)||314||
59852511|NCT02952820|75977111|FG002|Safety Analysis Set|Placebo-Controlled Treatment (6 Months)||314||
59852512|NCT02952820|75977109|FG000|COMPLETED|Placebo-Controlled Treatment (6 Months)||261||
59852513|NCT02952820|75977110|FG001|COMPLETED|Placebo-Controlled Treatment (6 Months)||254||
59852514|NCT02952820|75977111|FG002|COMPLETED|Placebo-Controlled Treatment (6 Months)||235||
59852515|NCT02952820|75977109|FG000|NOT COMPLETED|Placebo-Controlled Treatment (6 Months)||64||
59852516|NCT02952820|75977110|FG001|NOT COMPLETED|Placebo-Controlled Treatment (6 Months)||69||
59852517|NCT02952820|75977111|FG002|NOT COMPLETED|Placebo-Controlled Treatment (6 Months)||88||
59852518|NCT02952820|75977109|FG000|STARTED|Active Treatment Period (6 Months)|Participants from Placebo were re-randomized to Lemborexant 5 mg and Lemborexant 10 mg.|0||
59852519|NCT02952820|75977110|FG001|STARTED|Active Treatment Period (6 Months)||384||
59852520|NCT02952820|75977111|FG002|STARTED|Active Treatment Period (6 Months)||352||
59852521|NCT02952820|75977109|FG000|COMPLETED|Active Treatment Period (6 Months)||0||
59852522|NCT02952820|75977110|FG001|COMPLETED|Active Treatment Period (6 Months)||346||
59852523|NCT02952820|75977111|FG002|COMPLETED|Active Treatment Period (6 Months)||321||
59852524|NCT02952820|75977109|FG000|NOT COMPLETED|Active Treatment Period (6 Months)||0||
59852525|NCT02952820|75977110|FG001|NOT COMPLETED|Active Treatment Period (6 Months)||38||
59852526|NCT02952820|75977111|FG002|NOT COMPLETED|Active Treatment Period (6 Months)||31||
59852527|NCT00006392|75977126|FG000|STARTED|Overall Study||8904||
59852528|NCT00006392|75977127|FG001|STARTED|Overall Study||8910||
59852529|NCT00006392|75977128|FG002|STARTED|Overall Study||8863||
59852530|NCT00006392|75977129|FG003|STARTED|Overall Study||8856||
59852531|NCT00006392|75977126|FG000|COMPLETED|Overall Study||8737||
59852532|NCT00006392|75977127|FG001|COMPLETED|Overall Study||8752||
59852533|NCT00006392|75977128|FG002|COMPLETED|Overall Study||8703||
59852534|NCT00006392|75977129|FG003|COMPLETED|Overall Study||8696||
59852535|NCT00006392|75977126|FG000|NOT COMPLETED|Overall Study||167||
59852536|NCT00006392|75977127|FG001|NOT COMPLETED|Overall Study||158||
59852537|NCT00006392|75977128|FG002|NOT COMPLETED|Overall Study||160||
59852538|NCT00006392|75977129|FG003|NOT COMPLETED|Overall Study||160||
59852539|NCT00379769|75977143|FG000|STARTED|Main Study||1117||
59852540|NCT00379769|75977144|FG001|STARTED|Main Study||1105||
59852541|NCT00379769|75977145|FG002|STARTED|Main Study||1103||
59852542|NCT00379769|75977146|FG003|STARTED|Main Study||1122||
59852543|NCT00379769|75977147|FG004|STARTED|Main Study||0||
59852544|NCT00379769|75977148|FG005|STARTED|Main Study||0||
59852545|NCT00379769|75977143|FG000|COMPLETED|Main Study||939||
59852546|NCT00379769|75977144|FG001|COMPLETED|Main Study||906||
59852547|NCT00379769|75977145|FG002|COMPLETED|Main Study||896||
59852548|NCT00379769|75977146|FG003|COMPLETED|Main Study||892||
59852549|NCT00379769|75977147|FG004|COMPLETED|Main Study||0||
59852550|NCT00379769|75977148|FG005|COMPLETED|Main Study||0||
59852551|NCT00379769|75977143|FG000|NOT COMPLETED|Main Study||178||
59852552|NCT00379769|75977144|FG001|NOT COMPLETED|Main Study||199||
59852553|NCT00379769|75977145|FG002|NOT COMPLETED|Main Study||207||
59852554|NCT00379769|75977146|FG003|NOT COMPLETED|Main Study||230||
59852555|NCT00379769|75977147|FG004|NOT COMPLETED|Main Study||0||
59852556|NCT00379769|75977148|FG005|NOT COMPLETED|Main Study||0||
59852557|NCT00379769|75977143|FG000|STARTED|Observational Follow-up||0||
59852558|NCT00379769|75977144|FG001|STARTED|Observational Follow-up||0||
59852559|NCT00379769|75977145|FG002|STARTED|Observational Follow-up||0||
59852560|NCT00379769|75977146|FG003|STARTED|Observational Follow-up||0||
59852561|NCT00379769|75977147|FG004|STARTED|Observational Follow-up|"665 from RSG in Addition to Background MET arm; 615 from RGS in Addition to Background SU arm."|1280||
59584559|NCT01639560|75691148|FG000|NOT COMPLETED|Overall Study||19||
59852562|NCT00379769|75977148|FG005|STARTED|Observational Follow-up|"647 from SU in Addition to Background MET arm; 603 from MET in Addition to Background SU arm."|1250||
59852563|NCT00379769|75977143|FG000|COMPLETED|Observational Follow-up||0||
59852564|NCT00379769|75977144|FG001|COMPLETED|Observational Follow-up||0||
59852565|NCT00379769|75977145|FG002|COMPLETED|Observational Follow-up||0||
59852566|NCT00379769|75977146|FG003|COMPLETED|Observational Follow-up||0||
59584560|NCT01639560|75691149|FG001|NOT COMPLETED|Overall Study||29||
59724433|NCT01108055|75843036|FG000|STARTED|Overall Study||43||
59724434|NCT01108055|75843036|FG000|Eligible and Started Treatment|Overall Study||32||
59724435|NCT01108055|75843036|FG000|COMPLETED|Overall Study||28||
59724436|NCT01108055|75843036|FG000|NOT COMPLETED|Overall Study||15||
59724437|NCT01107899|75843043|FG000|STARTED|Overall Study||10||
59724438|NCT01107899|75843044|FG001|STARTED|Overall Study||10||
59724439|NCT01107899|75843045|FG002|STARTED|Overall Study||9||
59724440|NCT01107899|75843043|FG000|Received at Least One Dose of Study Drug|Overall Study||10||
59724441|NCT01107899|75843044|FG001|Received at Least One Dose of Study Drug|Overall Study||10||
59724442|NCT01107899|75843045|FG002|Received at Least One Dose of Study Drug|Overall Study||8||
59724443|NCT01107899|75843043|FG000|Loading Dose (LD) Intent to Treat (ITT)|Overall Study|Received LD and had evaluable pharmacodynamic (PD) measurements 24-hours post-LD.|5||
59724444|NCT01107899|75843044|FG001|Loading Dose (LD) Intent to Treat (ITT)|Overall Study|Received LD and had evaluable pharmacodynamic (PD) measurements 24-hours post-LD.|10||
59724445|NCT01107899|75843045|FG002|Loading Dose (LD) Intent to Treat (ITT)|Overall Study|Received LD and had evaluable pharmacodynamic (PD) measurements 24-hours post-LD.|6||
59724446|NCT01107899|75843043|FG000|ITT Washout Population|Overall Study|ITT Washout Population (WP): Received LD, had evaluable baseline PD data (pre-LD) and post-LD.|5||
59724447|NCT01107899|75843044|FG001|ITT Washout Population|Overall Study|ITT Washout Population (WP): Received LD, had evaluable baseline PD data (pre-LD) and post-LD.|10||
59724448|NCT01107899|75843045|FG002|ITT Washout Population|Overall Study|ITT Washout Population (WP): Received LD, had evaluable baseline PD data (pre-LD) and post-LD.|6||
59724449|NCT01107899|75843043|FG000|Primary Washout Population|Overall Study|Primary WP: Completed study with no missed visits, had evaluable PD data through Day 11.|5||
59724450|NCT01107899|75843044|FG001|Primary Washout Population|Overall Study|Primary WP: Completed study with no missed visits, had evaluable PD data through Day 11.|10||
59724451|NCT01107899|75843045|FG002|Primary Washout Population|Overall Study|Primary WP: Completed study with no missed visits, had evaluable PD data through Day 11.|4||
59724452|NCT01107899|75843043|FG000|COMPLETED|Overall Study||5||
59724453|NCT01107899|75843044|FG001|COMPLETED|Overall Study||10||
59724454|NCT01107899|75843045|FG002|COMPLETED|Overall Study||5||
59724455|NCT01107899|75843043|FG000|NOT COMPLETED|Overall Study||5||
59724456|NCT01107899|75843044|FG001|NOT COMPLETED|Overall Study||0||
59724457|NCT01107899|75843045|FG002|NOT COMPLETED|Overall Study||4||
59724458|NCT01115933|75843056|FG000|STARTED|Overall Study||65||
59724459|NCT01115933|75843056|FG000|COMPLETED|Overall Study||64||
59724460|NCT01115933|75843056|FG000|NOT COMPLETED|Overall Study||1||
59724461|NCT01107743|75843113|FG000|STARTED|Overall Study||1291||
59724462|NCT01107743|75843113|FG000|COMPLETED|Overall Study||1245||
59724463|NCT01107743|75843113|FG000|NOT COMPLETED|Overall Study||46||
59724464|NCT01059864|75843162|FG000|STARTED|Open-Label Run-In Phase||111||
59724465|NCT01059864|75843163|FG001|STARTED|Open-Label Run-In Phase||0||
59724466|NCT01059864|75843164|FG002|STARTED|Open-Label Run-In Phase||0||
59724467|NCT01059864|75843162|FG000|COMPLETED|Open-Label Run-In Phase||98||
59724468|NCT01059864|75843163|FG001|COMPLETED|Open-Label Run-In Phase||0||
59724469|NCT01059864|75843164|FG002|COMPLETED|Open-Label Run-In Phase||0||
59724470|NCT01059864|75843162|FG000|NOT COMPLETED|Open-Label Run-In Phase||13||
59724471|NCT01059864|75843163|FG001|NOT COMPLETED|Open-Label Run-In Phase||0||
59724472|NCT01059864|75843164|FG002|NOT COMPLETED|Open-Label Run-In Phase||0||
59724473|NCT01059864|75843162|FG000|STARTED|Double-Blind Treatment Phase||0||
59724474|NCT01059864|75843163|FG001|STARTED|Double-Blind Treatment Phase||50||
59724475|NCT01059864|75843164|FG002|STARTED|Double-Blind Treatment Phase||48||
59724476|NCT01059864|75843162|FG000|Treated|Double-Blind Treatment Phase||0||
59724477|NCT01059864|75843163|FG001|Treated|Double-Blind Treatment Phase||50||
59724478|NCT01059864|75843164|FG002|Treated|Double-Blind Treatment Phase||47||
59724479|NCT01059864|75843162|FG000|COMPLETED|Double-Blind Treatment Phase||0||
59724480|NCT01059864|75843163|FG001|COMPLETED|Double-Blind Treatment Phase||47||
59724481|NCT01059864|75843164|FG002|COMPLETED|Double-Blind Treatment Phase||45||
59724482|NCT01059864|75843162|FG000|NOT COMPLETED|Double-Blind Treatment Phase||0||
59724483|NCT01059864|75843163|FG001|NOT COMPLETED|Double-Blind Treatment Phase||3||
59724484|NCT01059864|75843164|FG002|NOT COMPLETED|Double-Blind Treatment Phase||3||
59724485|NCT01035138|75843174|FG000|STARTED|Overall Study||73||
59724486|NCT01035138|75843175|FG001|STARTED|Overall Study||60||
59724487|NCT01035138|75843176|FG002|STARTED|Overall Study||47||
59724488|NCT01035138|75843174|FG000|COMPLETED|Overall Study||0||
59724489|NCT01035138|75843175|FG001|COMPLETED|Overall Study||0||
59724490|NCT01035138|75843176|FG002|COMPLETED|Overall Study||0||
59724491|NCT01035138|75843174|FG000|NOT COMPLETED|Overall Study||73||
59724492|NCT01035138|75843175|FG001|NOT COMPLETED|Overall Study||60||
59724493|NCT01035138|75843176|FG002|NOT COMPLETED|Overall Study||47||
59724494|NCT03739840|75843190|FG000|STARTED|Treatment Period: Wk0-16||56||
59724495|NCT03739840|75843191|FG001|STARTED|Treatment Period: Wk0-16||60||
59724496|NCT03739840|75843192|FG002|STARTED|Treatment Period: Wk0-16||57||
59724497|NCT03739840|75843193|FG003|STARTED|Treatment Period: Wk0-16||59||
59724498|NCT03739840|75843190|FG000|Completed Titration and Stabilization|Treatment Period: Wk0-16||54||
59724499|NCT03739840|75843191|FG001|Completed Titration and Stabilization|Treatment Period: Wk0-16||58||
59724500|NCT03739840|75843192|FG002|Completed Titration and Stabilization|Treatment Period: Wk0-16||51||
59724501|NCT03739840|75843193|FG003|Completed Titration and Stabilization|Treatment Period: Wk0-16||54||
59724502|NCT03739840|75843190|FG000|Completed Maintenance Period|Treatment Period: Wk0-16||46||
59852567|NCT00379769|75977147|FG004|COMPLETED|Observational Follow-up||1131||
59852568|NCT00379769|75977148|FG005|COMPLETED|Observational Follow-up||1102||
59852569|NCT00379769|75977143|FG000|NOT COMPLETED|Observational Follow-up||0||
59852570|NCT00379769|75977144|FG001|NOT COMPLETED|Observational Follow-up||0||
59724503|NCT03739840|75843191|FG001|Completed Maintenance Period|Treatment Period: Wk0-16||44||
59724504|NCT03739840|75843192|FG002|Completed Maintenance Period|Treatment Period: Wk0-16||44||
59724505|NCT03739840|75843193|FG003|Completed Maintenance Period|Treatment Period: Wk0-16||36||
59724506|NCT03739840|75843190|FG000|COMPLETED|Treatment Period: Wk0-16||46||
59724507|NCT03739840|75843191|FG001|COMPLETED|Treatment Period: Wk0-16||44||
59724508|NCT03739840|75843192|FG002|COMPLETED|Treatment Period: Wk0-16||44||
59724509|NCT03739840|75843193|FG003|COMPLETED|Treatment Period: Wk0-16||36||
59724510|NCT03739840|75843190|FG000|NOT COMPLETED|Treatment Period: Wk0-16||10||
59852571|NCT00379769|75977145|FG002|NOT COMPLETED|Observational Follow-up||0||
59852572|NCT00379769|75977146|FG003|NOT COMPLETED|Observational Follow-up||0||
59852573|NCT00379769|75977147|FG004|NOT COMPLETED|Observational Follow-up||149||
59852574|NCT00379769|75977148|FG005|NOT COMPLETED|Observational Follow-up||148||
59852575|NCT00006164|75977177|FG000|STARTED|Overall Study||517||
60121595|NCT01683071|76242506|FG000|COMPLETED|Part 1||21||
60121596|NCT01683071|76242507|FG001|COMPLETED|Part 1||22||
60121597|NCT01683071|76242508|FG002|COMPLETED|Part 1||22||
59852576|NCT00006164|75977178|FG001|STARTED|Overall Study||533||
59852577|NCT00006164|75977177|FG000|COMPLETED|Overall Study|70 Withdrew or were lost to followup; 158 Discontinued peginterferon but were followed|447||
59852578|NCT00006164|75977178|FG001|COMPLETED|Overall Study|81 Withdrew or were lost to followup; 9 took peginterferon outside of protocol|452||
59852579|NCT00006164|75977177|FG000|NOT COMPLETED|Overall Study||70||
59852580|NCT00006164|75977178|FG001|NOT COMPLETED|Overall Study||81||
59852581|NCT00378599|75977184|FG000|STARTED|Overall Study||125||
59852582|NCT00378599|75977184|FG000|COMPLETED|Overall Study||73||
59852583|NCT00378599|75977184|FG000|NOT COMPLETED|Overall Study||52||
59852584|NCT00378209|75977188|FG000|STARTED|Overall Study|1 patient who never started treatment was excluded in the analysis.|64||
59852585|NCT00378209|75977188|FG000|COMPLETED|Overall Study|This included patients who completed at least 8 cycles of combination therapy with all drugs.|42||
59852586|NCT00378209|75977188|FG000|NOT COMPLETED|Overall Study||22||
59852587|NCT00377819|75977195|FG000|STARTED|Overall Study||251||
59852588|NCT00377819|75977196|FG001|STARTED|Overall Study||253||
59852589|NCT00377819|75977195|FG000|Received Study Medication|Overall Study||249||
59852590|NCT00377819|75977196|FG001|Received Study Medication|Overall Study||253||
59852591|NCT00377819|75977195|FG000|COMPLETED|Overall Study||238||
60121598|NCT01683071|76242509|FG003|COMPLETED|Part 1||20||
60121599|NCT01683071|76242510|FG004|COMPLETED|Part 1||0||
59584561|NCT04209335|75691155|FG000|STARTED|Overall Study||48||
59852592|NCT00377819|75977196|FG001|COMPLETED|Overall Study||243||
59852593|NCT00377819|75977195|FG000|NOT COMPLETED|Overall Study||13||
59852594|NCT00377819|75977196|FG001|NOT COMPLETED|Overall Study||10||
59852595|NCT03419962|75977202|FG000|STARTED|Overall Study||1359||
59852596|NCT03419962|75977202|FG000|COMPLETED|Overall Study||1322||
59852597|NCT03419962|75977202|FG000|NOT COMPLETED|Overall Study||37||
59852598|NCT00377429|75977206|FG000|STARTED|Overall Study|Treated|47||
59852599|NCT00377429|75977206|FG000|COMPLETED|Overall Study|Completed main study|32||
59852600|NCT00377429|75977206|FG000|NOT COMPLETED|Overall Study||15||
59852601|NCT00376961|75977210|FG000|STARTED|Initial Registration||68||
59852602|NCT00376961|75977211|FG001|STARTED|Initial Registration||0||
59852603|NCT00376961|75977210|FG000|Eligible|Initial Registration||65||
59852604|NCT00376961|75977211|FG001|Eligible|Initial Registration||0||
59852605|NCT00376961|75977210|FG000|COMPLETED|Initial Registration||61||
59852606|NCT00376961|75977211|FG001|COMPLETED|Initial Registration||0||
59852607|NCT00376961|75977210|FG000|NOT COMPLETED|Initial Registration||7||
59852608|NCT00376961|75977211|FG001|NOT COMPLETED|Initial Registration||0||
59852609|NCT00376961|75977210|FG000|STARTED|Maintenance||0||
59852610|NCT00376961|75977211|FG001|STARTED|Maintenance||50||
59852611|NCT00376961|75977210|FG000|Eligible|Maintenance||0||
59852612|NCT00376961|75977211|FG001|Eligible|Maintenance||47||
59852613|NCT00376961|75977210|FG000|COMPLETED|Maintenance||0||
59852614|NCT00376961|75977211|FG001|COMPLETED|Maintenance||27||
60121600|NCT01683071|76242511|FG005|COMPLETED|Part 1||0||
60121601|NCT01683071|76242506|FG000|NOT COMPLETED|Part 1||4||
59584562|NCT04209335|75691155|FG000|COMPLETED|Overall Study||48||
59584563|NCT04209335|75691155|FG000|NOT COMPLETED|Overall Study||0||
59724511|NCT03739840|75843191|FG001|NOT COMPLETED|Treatment Period: Wk0-16||16||
59724512|NCT03739840|75843192|FG002|NOT COMPLETED|Treatment Period: Wk0-16||13||
59724513|NCT03739840|75843193|FG003|NOT COMPLETED|Treatment Period: Wk0-16||23||
59724514|NCT03739840|75843190|FG000|STARTED|Post-Treatment Period: Wk16-23||46||
59852615|NCT00376961|75977210|FG000|NOT COMPLETED|Maintenance||0||
59852616|NCT00376961|75977211|FG001|NOT COMPLETED|Maintenance||23||
59852617|NCT03418324|75977221|FG000|STARTED|Overall Study||3||
59852618|NCT03418324|75977222|FG001|STARTED|Overall Study||8||
59852619|NCT03418324|75977221|FG000|COMPLETED|Overall Study||2||
59852620|NCT03418324|75977222|FG001|COMPLETED|Overall Study||6||
60121602|NCT01683071|76242507|FG001|NOT COMPLETED|Part 1||4||
59584564|NCT04205669|75691164|FG000|STARTED|Overall Study||47||
59584565|NCT04205669|75691165|FG001|STARTED|Overall Study||57||
59852621|NCT03418324|75977221|FG000|NOT COMPLETED|Overall Study||1||
59852622|NCT03418324|75977222|FG001|NOT COMPLETED|Overall Study||2||
59852623|NCT00376259|75977230|FG000|STARTED|Overall Study||22||
59852624|NCT00376259|75977231|FG001|STARTED|Overall Study||21||
59852625|NCT00376259|75977230|FG000|Received Study Drug|Overall Study||21||
59852626|NCT00376259|75977231|FG001|Received Study Drug|Overall Study||21||
59852627|NCT00376259|75977230|FG000|COMPLETED|Overall Study||0||
59852628|NCT00376259|75977231|FG001|COMPLETED|Overall Study||0||
59852629|NCT00376259|75977230|FG000|NOT COMPLETED|Overall Study||22||
59852630|NCT00376259|75977231|FG001|NOT COMPLETED|Overall Study||21||
59852631|NCT03410056|75977241|FG000|STARTED|Overall Study||8||
59852632|NCT03410056|75977242|FG001|STARTED|Overall Study||6||
59852633|NCT03410056|75977243|FG002|STARTED|Overall Study||11||
59852634|NCT03410056|75977244|FG003|STARTED|Overall Study||11||
59852635|NCT03410056|75977245|FG004|STARTED|Overall Study||0||
59852636|NCT03410056|75977246|FG005|STARTED|Overall Study||0||
59852637|NCT03410056|75977247|FG006|STARTED|Overall Study||0||
59852638|NCT03410056|75977241|FG000|Received Treatment|Overall Study||8||
59852639|NCT03410056|75977242|FG001|Received Treatment|Overall Study||6||
59852640|NCT03410056|75977243|FG002|Received Treatment|Overall Study||11||
59852641|NCT03410056|75977244|FG003|Received Treatment|Overall Study||11||
59852642|NCT03410056|75977245|FG004|Received Treatment|Overall Study||0||
59852643|NCT03410056|75977246|FG005|Received Treatment|Overall Study||0||
59852644|NCT03410056|75977247|FG006|Received Treatment|Overall Study||0||
59852645|NCT03410056|75977241|FG000|COMPLETED|Overall Study||8||
59852646|NCT03410056|75977242|FG001|COMPLETED|Overall Study||4||
59852647|NCT03410056|75977243|FG002|COMPLETED|Overall Study||3||
59852648|NCT03410056|75977244|FG003|COMPLETED|Overall Study||6||
59852649|NCT03410056|75977245|FG004|COMPLETED|Overall Study||0||
59852650|NCT03410056|75977246|FG005|COMPLETED|Overall Study||0||
59852651|NCT03410056|75977247|FG006|COMPLETED|Overall Study||0||
59852652|NCT03410056|75977241|FG000|NOT COMPLETED|Overall Study||0||
59852653|NCT03410056|75977242|FG001|NOT COMPLETED|Overall Study||2||
59852654|NCT03410056|75977243|FG002|NOT COMPLETED|Overall Study||8||
59852655|NCT03410056|75977244|FG003|NOT COMPLETED|Overall Study||5||
59852656|NCT03410056|75977245|FG004|NOT COMPLETED|Overall Study||0||
59852657|NCT03410056|75977246|FG005|NOT COMPLETED|Overall Study||0||
59852658|NCT03410056|75977247|FG006|NOT COMPLETED|Overall Study||0||
59852659|NCT03409666|75977265|FG000|STARTED|Overall Study||25||
59852660|NCT03409666|75977266|FG001|STARTED|Overall Study||25||
59852661|NCT03409666|75977265|FG000|COMPLETED|Overall Study||25||
59852662|NCT03409666|75977266|FG001|COMPLETED|Overall Study||21||
59852663|NCT03409666|75977265|FG000|NOT COMPLETED|Overall Study||0||
59852664|NCT03409666|75977266|FG001|NOT COMPLETED|Overall Study||4||
59852665|NCT03440944|75977274|FG000|STARTED|Overall Study||9||
59852666|NCT03440944|75977275|FG001|STARTED|Overall Study||9||
59852667|NCT03440944|75977274|FG000|COMPLETED|Overall Study||8||
59852668|NCT03440944|75977275|FG001|COMPLETED|Overall Study||8||
59852669|NCT03440944|75977274|FG000|NOT COMPLETED|Overall Study||1||
59852670|NCT03440944|75977275|FG001|NOT COMPLETED|Overall Study||1||
59852671|NCT00365105|75977284|FG000|STARTED|Overall Study||129||
59852672|NCT00365105|75977285|FG001|STARTED|Overall Study||132||
59852673|NCT00365105|75977284|FG000|Eligible|Overall Study||124||
59852674|NCT00365105|75977285|FG001|Eligible|Overall Study||124||
59852675|NCT00365105|75977284|FG000|Eligible With Adverse Event Data|Overall Study||123||
59852676|NCT00365105|75977285|FG001|Eligible With Adverse Event Data|Overall Study||124||
59852677|NCT00365105|75977284|FG000|COMPLETED|Overall Study||124|Subjects contributing any data to analysis are considered to have completed the study|
59852678|NCT00365105|75977285|FG001|COMPLETED|Overall Study||124|Subjects contributing any data to analysis are considered to have completed the study|
59852679|NCT00365105|75977284|FG000|NOT COMPLETED|Overall Study||5||
59852680|NCT00365105|75977285|FG001|NOT COMPLETED|Overall Study||8||
59852681|NCT00399893|75977293|FG000|STARTED|Overall Study||2||
59852682|NCT00399893|75977294|FG001|STARTED|Overall Study||3||
59852683|NCT00399893|75977293|FG000|COMPLETED|Overall Study|Participant withdrew after 3 months but was included in results|1||
59852684|NCT00399893|75977294|FG001|COMPLETED|Overall Study||3||
59852685|NCT00399893|75977293|FG000|NOT COMPLETED|Overall Study||1||
59852686|NCT00399893|75977294|FG001|NOT COMPLETED|Overall Study||0||
59852687|NCT00048542|75977304|FG000|STARTED|Double-Blind Phase|For all groups, started indicates when the subjects entered the double-blind treatment phase.|38||
59852688|NCT00048542|75977305|FG001|STARTED|Double-Blind Phase||37||
59852689|NCT00048542|75977306|FG002|STARTED|Double-Blind Phase||30||
59852690|NCT00048542|75977307|FG003|STARTED|Double-Blind Phase||28||
59852691|NCT00048542|75977308|FG004|STARTED|Double-Blind Phase||0||
59852692|NCT00048542|75977309|FG005|STARTED|Double-Blind Phase||0||
59852693|NCT00048542|75977310|FG006|STARTED|Double-Blind Phase||0||
59852694|NCT00048542|75977311|FG007|STARTED|Double-Blind Phase||0||
59852695|NCT00048542|75977304|FG000|COMPLETED|Double-Blind Phase||35||
59852696|NCT00048542|75977305|FG001|COMPLETED|Double-Blind Phase||36||
59852697|NCT00048542|75977306|FG002|COMPLETED|Double-Blind Phase||29||
59852698|NCT00048542|75977307|FG003|COMPLETED|Double-Blind Phase||28||
59852699|NCT00048542|75977308|FG004|COMPLETED|Double-Blind Phase||0||
59852700|NCT00048542|75977309|FG005|COMPLETED|Double-Blind Phase||0||
59852701|NCT00048542|75977310|FG006|COMPLETED|Double-Blind Phase||0||
59852702|NCT00048542|75977311|FG007|COMPLETED|Double-Blind Phase||0||
59852703|NCT00048542|75977304|FG000|NOT COMPLETED|Double-Blind Phase||3||
59852704|NCT00048542|75977305|FG001|NOT COMPLETED|Double-Blind Phase||1||
59852705|NCT00048542|75977306|FG002|NOT COMPLETED|Double-Blind Phase||1||
59852706|NCT00048542|75977307|FG003|NOT COMPLETED|Double-Blind Phase||0||
59584566|NCT04205669|75691164|FG000|COMPLETED|Overall Study||34||
59724515|NCT03739840|75843191|FG001|STARTED|Post-Treatment Period: Wk16-23||44||
59724516|NCT03739840|75843192|FG002|STARTED|Post-Treatment Period: Wk16-23||44||
59724517|NCT03739840|75843193|FG003|STARTED|Post-Treatment Period: Wk16-23||36||
59724518|NCT03739840|75843190|FG000|Started Conversion Period|Post-Treatment Period: Wk16-23||33||
59724519|NCT03739840|75843191|FG001|Started Conversion Period|Post-Treatment Period: Wk16-23||31||
59724520|NCT03739840|75843192|FG002|Started Conversion Period|Post-Treatment Period: Wk16-23||29||
59724521|NCT03739840|75843193|FG003|Started Conversion Period|Post-Treatment Period: Wk16-23||28||
59724522|NCT03739840|75843190|FG000|Completed Conversion Period|Post-Treatment Period: Wk16-23||33||
59724523|NCT03739840|75843191|FG001|Completed Conversion Period|Post-Treatment Period: Wk16-23||31||
59724524|NCT03739840|75843192|FG002|Completed Conversion Period|Post-Treatment Period: Wk16-23||29||
59724525|NCT03739840|75843193|FG003|Completed Conversion Period|Post-Treatment Period: Wk16-23||28||
59724526|NCT03739840|75843190|FG000|Started Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||19||
59724527|NCT03739840|75843191|FG001|Started Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||18||
59724528|NCT03739840|75843192|FG002|Started Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||21||
59724529|NCT03739840|75843193|FG003|Started Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||13||
59724530|NCT03739840|75843190|FG000|Completed Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||15||
59724531|NCT03739840|75843191|FG001|Completed Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||16||
59724532|NCT03739840|75843192|FG002|Completed Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||18||
59724533|NCT03739840|75843193|FG003|Completed Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||12||
59724534|NCT03739840|75843190|FG000|Enrolled in EP0093|Post-Treatment Period: Wk16-23||27||
59724535|NCT03739840|75843191|FG001|Enrolled in EP0093|Post-Treatment Period: Wk16-23||26||
59724536|NCT03739840|75843192|FG002|Enrolled in EP0093|Post-Treatment Period: Wk16-23||23||
59724537|NCT03739840|75843193|FG003|Enrolled in EP0093|Post-Treatment Period: Wk16-23||23||
59724538|NCT03739840|75843190|FG000|COMPLETED|Post-Treatment Period: Wk16-23||42||
59724539|NCT03739840|75843191|FG001|COMPLETED|Post-Treatment Period: Wk16-23||42||
59724540|NCT03739840|75843192|FG002|COMPLETED|Post-Treatment Period: Wk16-23||41||
59724541|NCT03739840|75843193|FG003|COMPLETED|Post-Treatment Period: Wk16-23||35||
59724542|NCT03739840|75843190|FG000|NOT COMPLETED|Post-Treatment Period: Wk16-23||4||
59724543|NCT03739840|75843191|FG001|NOT COMPLETED|Post-Treatment Period: Wk16-23||2||
59724544|NCT03739840|75843192|FG002|NOT COMPLETED|Post-Treatment Period: Wk16-23||3||
59724545|NCT03739840|75843193|FG003|NOT COMPLETED|Post-Treatment Period: Wk16-23||1||
59724546|NCT01035060|75843217|FG000|STARTED|Overall Study||39||
59724547|NCT01035060|75843218|FG001|STARTED|Overall Study||29||
59724548|NCT01035060|75843217|FG000|COMPLETED|Overall Study||15||
59724549|NCT01035060|75843218|FG001|COMPLETED|Overall Study||15||
59724550|NCT01035060|75843217|FG000|NOT COMPLETED|Overall Study||24||
59724551|NCT01035060|75843218|FG001|NOT COMPLETED|Overall Study||14||
59724552|NCT01039428|75843226|FG000|STARTED|Overall Study||35||
59724553|NCT01039428|75843227|FG001|STARTED|Overall Study||28||
59724554|NCT01039428|75843226|FG000|COMPLETED|Overall Study||33||
59724555|NCT01039428|75843227|FG001|COMPLETED|Overall Study||28||
59724556|NCT01039428|75843226|FG000|NOT COMPLETED|Overall Study||2||
59724557|NCT01039428|75843227|FG001|NOT COMPLETED|Overall Study||0||
59724558|NCT01034358|75843233|FG000|STARTED|Overall Study||15||
59724559|NCT01034358|75843233|FG000|COMPLETED|Overall Study|One patient was found after enrollment to have already received one prior dose of the HPV vaccine.|13||
59724560|NCT01034358|75843233|FG000|NOT COMPLETED|Overall Study||2||
59724561|NCT03398824|75843237|FG000|STARTED|Overall Study||14||
59724562|NCT03398824|75843237|FG000|COMPLETED|Overall Study||12||
59724563|NCT03398824|75843237|FG000|NOT COMPLETED|Overall Study||2||
59724564|NCT01033734|75843241|FG000|STARTED|Overall Study||8||
59724565|NCT01033734|75843241|FG000|COMPLETED|Overall Study||7||
59724566|NCT01033734|75843241|FG000|NOT COMPLETED|Overall Study||1||
59724567|NCT01115855|75843256|FG000|STARTED|Overall Study||111||
59724568|NCT01115855|75843257|FG001|STARTED|Overall Study||110||
59724569|NCT01115855|75843256|FG000|COMPLETED|Overall Study||75||
59724570|NCT01115855|75843257|FG001|COMPLETED|Overall Study||74||
59724571|NCT01115855|75843256|FG000|NOT COMPLETED|Overall Study||36||
59724572|NCT01115855|75843257|FG001|NOT COMPLETED|Overall Study||36||
59724573|NCT03615508|75843263|FG000|STARTED|Overall Study||1||
59852707|NCT00048542|75977308|FG004|NOT COMPLETED|Double-Blind Phase||0||
59852708|NCT00048542|75977309|FG005|NOT COMPLETED|Double-Blind Phase||0||
59852709|NCT00048542|75977310|FG006|NOT COMPLETED|Double-Blind Phase||0||
59852710|NCT00048542|75977311|FG007|NOT COMPLETED|Double-Blind Phase||0||
59996755|NCT04086121|76112607|FG000|NOT COMPLETED|Overall Study||14||
59584567|NCT04205669|75691165|FG001|COMPLETED|Overall Study||45||
59724574|NCT03615508|75843263|FG000|COMPLETED|Overall Study||1||
59724575|NCT03615508|75843263|FG000|NOT COMPLETED|Overall Study||0||
59852711|NCT00048542|75977304|FG000|STARTED|Open-Label Extension BSA Phase||0||
59852712|NCT00048542|75977305|FG001|STARTED|Open-Label Extension BSA Phase||0||
59852713|NCT00048542|75977306|FG002|STARTED|Open-Label Extension BSA Phase||0||
59852714|NCT00048542|75977307|FG003|STARTED|Open-Label Extension BSA Phase||0||
59852715|NCT00048542|75977308|FG004|STARTED|Open-Label Extension BSA Phase||71||
59852716|NCT00048542|75977309|FG005|STARTED|Open-Label Extension BSA Phase||57||
59852717|NCT00048542|75977310|FG006|STARTED|Open-Label Extension BSA Phase||0||
59852718|NCT00048542|75977311|FG007|STARTED|Open-Label Extension BSA Phase||0||
59852719|NCT00048542|75977304|FG000|COMPLETED|Open-Label Extension BSA Phase||0||
59852720|NCT00048542|75977305|FG001|COMPLETED|Open-Label Extension BSA Phase||0||
59852721|NCT00048542|75977306|FG002|COMPLETED|Open-Label Extension BSA Phase||0||
59852722|NCT00048542|75977307|FG003|COMPLETED|Open-Label Extension BSA Phase||0||
59852723|NCT00048542|75977308|FG004|COMPLETED|Open-Label Extension BSA Phase||59||
59852724|NCT00048542|75977309|FG005|COMPLETED|Open-Label Extension BSA Phase||47||
59852725|NCT00048542|75977310|FG006|COMPLETED|Open-Label Extension BSA Phase||0||
59852726|NCT00048542|75977311|FG007|COMPLETED|Open-Label Extension BSA Phase||0||
59852727|NCT00048542|75977304|FG000|NOT COMPLETED|Open-Label Extension BSA Phase||0||
59852728|NCT00048542|75977305|FG001|NOT COMPLETED|Open-Label Extension BSA Phase||0||
59852729|NCT00048542|75977306|FG002|NOT COMPLETED|Open-Label Extension BSA Phase||0||
59852730|NCT00048542|75977307|FG003|NOT COMPLETED|Open-Label Extension BSA Phase||0||
59852731|NCT00048542|75977308|FG004|NOT COMPLETED|Open-Label Extension BSA Phase||12||
59852732|NCT00048542|75977309|FG005|NOT COMPLETED|Open-Label Extension BSA Phase||10||
59852733|NCT00048542|75977310|FG006|NOT COMPLETED|Open-Label Extension BSA Phase||0||
59852734|NCT00048542|75977311|FG007|NOT COMPLETED|Open-Label Extension BSA Phase||0||
59852735|NCT00048542|75977304|FG000|STARTED|Open-Label Extension Fixed Dose Phase||0||
59852736|NCT00048542|75977305|FG001|STARTED|Open-Label Extension Fixed Dose Phase||0||
59852737|NCT00048542|75977306|FG002|STARTED|Open-Label Extension Fixed Dose Phase||0||
59852738|NCT00048542|75977307|FG003|STARTED|Open-Label Extension Fixed Dose Phase||0||
59852739|NCT00048542|75977308|FG004|STARTED|Open-Label Extension Fixed Dose Phase||0||
59852740|NCT00048542|75977309|FG005|STARTED|Open-Label Extension Fixed Dose Phase||0||
59852741|NCT00048542|75977310|FG006|STARTED|Open-Label Extension Fixed Dose Phase||59||
59852742|NCT00048542|75977311|FG007|STARTED|Open-Label Extension Fixed Dose Phase||47||
59852743|NCT00048542|75977304|FG000|COMPLETED|Open-Label Extension Fixed Dose Phase||0||
59852744|NCT00048542|75977305|FG001|COMPLETED|Open-Label Extension Fixed Dose Phase||0||
59852745|NCT00048542|75977306|FG002|COMPLETED|Open-Label Extension Fixed Dose Phase||0||
59852746|NCT00048542|75977307|FG003|COMPLETED|Open-Label Extension Fixed Dose Phase||0||
59852747|NCT00048542|75977308|FG004|COMPLETED|Open-Label Extension Fixed Dose Phase||0||
59852748|NCT00048542|75977309|FG005|COMPLETED|Open-Label Extension Fixed Dose Phase||0||
59852749|NCT00048542|75977310|FG006|COMPLETED|Open-Label Extension Fixed Dose Phase||37||
59852750|NCT00048542|75977311|FG007|COMPLETED|Open-Label Extension Fixed Dose Phase||25||
59852751|NCT00048542|75977304|FG000|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0||
59852752|NCT00048542|75977305|FG001|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0||
59852753|NCT00048542|75977306|FG002|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0||
59852754|NCT00048542|75977307|FG003|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0||
59852755|NCT00048542|75977308|FG004|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0||
59852756|NCT00048542|75977309|FG005|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0||
59852757|NCT00048542|75977310|FG006|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||22||
59852758|NCT00048542|75977311|FG007|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||22||
59852759|NCT03814590|75977354|FG000|STARTED|Overall Study||12||
59852760|NCT03814590|75977355|FG001|STARTED|Overall Study||12||
59852761|NCT03814590|75977356|FG002|STARTED|Overall Study||12||
59852762|NCT03814590|75977357|FG003|STARTED|Overall Study||12||
59852763|NCT03814590|75977358|FG004|STARTED|Overall Study||101||
59852764|NCT03814590|75977359|FG005|STARTED|Overall Study||97||
59852765|NCT03814590|75977360|FG006|STARTED|Overall Study||100||
59852766|NCT03814590|75977361|FG007|STARTED|Overall Study||101||
59852767|NCT03814590|75977362|FG008|STARTED|Overall Study||101||
59852768|NCT03814590|75977363|FG009|STARTED|Overall Study||100||
59852769|NCT03814590|75977364|FG010|STARTED|Overall Study||103||
59852770|NCT03814590|75977365|FG011|STARTED|Overall Study||100||
59852771|NCT03814590|75977366|FG012|STARTED|Overall Study||101||
59852772|NCT03814590|75977367|FG013|STARTED|Overall Study||101||
59852773|NCT03814590|75977354|FG000|COMPLETED|Overall Study||12||
59852774|NCT03814590|75977355|FG001|COMPLETED|Overall Study||10||
59852775|NCT03814590|75977356|FG002|COMPLETED|Overall Study||11||
59852776|NCT03814590|75977357|FG003|COMPLETED|Overall Study||12||
59852777|NCT03814590|75977358|FG004|COMPLETED|Overall Study||100||
59852778|NCT03814590|75977359|FG005|COMPLETED|Overall Study||92||
59852779|NCT03814590|75977360|FG006|COMPLETED|Overall Study||97||
59852780|NCT03814590|75977361|FG007|COMPLETED|Overall Study||95||
59852781|NCT03814590|75977362|FG008|COMPLETED|Overall Study||101||
59852782|NCT03814590|75977363|FG009|COMPLETED|Overall Study||95||
59852783|NCT03814590|75977364|FG010|COMPLETED|Overall Study||100||
59852784|NCT03814590|75977365|FG011|COMPLETED|Overall Study||100||
59852785|NCT03814590|75977366|FG012|COMPLETED|Overall Study||97||
59852786|NCT03814590|75977367|FG013|COMPLETED|Overall Study||98||
59852787|NCT03814590|75977354|FG000|NOT COMPLETED|Overall Study||0||
59852788|NCT03814590|75977355|FG001|NOT COMPLETED|Overall Study||2||
59852789|NCT03814590|75977356|FG002|NOT COMPLETED|Overall Study||1||
59852790|NCT03814590|75977357|FG003|NOT COMPLETED|Overall Study||0||
59852791|NCT03814590|75977358|FG004|NOT COMPLETED|Overall Study||1||
59852792|NCT03814590|75977359|FG005|NOT COMPLETED|Overall Study||5||
59852793|NCT03814590|75977360|FG006|NOT COMPLETED|Overall Study||3||
59852794|NCT03814590|75977361|FG007|NOT COMPLETED|Overall Study||6||
59852795|NCT03814590|75977362|FG008|NOT COMPLETED|Overall Study||0||
59852796|NCT03814590|75977363|FG009|NOT COMPLETED|Overall Study||5||
59852797|NCT03814590|75977364|FG010|NOT COMPLETED|Overall Study||3||
59852798|NCT03814590|75977365|FG011|NOT COMPLETED|Overall Study||0||
59852799|NCT03814590|75977366|FG012|NOT COMPLETED|Overall Study||4||
59852800|NCT03814590|75977367|FG013|NOT COMPLETED|Overall Study||3||
59852801|NCT00048074|75977410|FG000|STARTED|Overall Study||465||
59852802|NCT00048074|75977411|FG001|STARTED|Overall Study||448||
59852803|NCT00048074|75977412|FG002|STARTED|Overall Study||469||
59852804|NCT00048074|75977410|FG000|COMPLETED|Overall Study||384||
59852805|NCT00048074|75977411|FG001|COMPLETED|Overall Study||361||
59852806|NCT00048074|75977412|FG002|COMPLETED|Overall Study||372||
59852807|NCT00048074|75977410|FG000|NOT COMPLETED|Overall Study||81||
59852808|NCT00048074|75977411|FG001|NOT COMPLETED|Overall Study||87||
59852809|NCT00048074|75977412|FG002|NOT COMPLETED|Overall Study||97||
59852810|NCT03831191|75977424|FG000|STARTED|Induction Period (16 Weeks)||33||
59852811|NCT03831191|75977425|FG001|STARTED|Induction Period (16 Weeks)||35||
59852812|NCT03831191|75977426|FG002|STARTED|Induction Period (16 Weeks)||34||
59852813|NCT03831191|75977427|FG003|STARTED|Induction Period (16 Weeks)||34||
59852814|NCT03831191|75977428|FG004|STARTED|Induction Period (16 Weeks)||0||
59852815|NCT03831191|75977429|FG005|STARTED|Induction Period (16 Weeks)||0||
59852816|NCT03831191|75977430|FG006|STARTED|Induction Period (16 Weeks)||0||
59852817|NCT03831191|75977431|FG007|STARTED|Induction Period (16 Weeks)||0||
59852818|NCT03831191|75977432|FG008|STARTED|Induction Period (16 Weeks)||0||
59852819|NCT03831191|75977433|FG009|STARTED|Induction Period (16 Weeks)||0||
59852820|NCT03831191|75977434|FG010|STARTED|Induction Period (16 Weeks)||0||
59852821|NCT03831191|75977435|FG011|STARTED|Induction Period (16 Weeks)||0||
59852822|NCT03831191|75977436|FG012|STARTED|Induction Period (16 Weeks)||0||
59852823|NCT03831191|75977437|FG013|STARTED|Induction Period (16 Weeks)||0||
59852824|NCT03831191|75977438|FG014|STARTED|Induction Period (16 Weeks)||0||
59852825|NCT03831191|75977424|FG000|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||33||
59852826|NCT03831191|75977425|FG001|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||35||
59852827|NCT03831191|75977426|FG002|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||34||
59852828|NCT03831191|75977427|FG003|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||33||
59852829|NCT03831191|75977428|FG004|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0||
59852830|NCT03831191|75977429|FG005|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0||
59852831|NCT03831191|75977430|FG006|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0||
59852832|NCT03831191|75977431|FG007|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0||
59852833|NCT03831191|75977432|FG008|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0||
59852834|NCT03831191|75977433|FG009|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0||
59852835|NCT03831191|75977434|FG010|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0||
59852836|NCT03831191|75977435|FG011|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0||
59852837|NCT03831191|75977436|FG012|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0||
59852838|NCT03831191|75977437|FG013|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0||
59852839|NCT03831191|75977438|FG014|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0||
59852840|NCT03831191|75977424|FG000|COMPLETED|Induction Period (16 Weeks)||10||
59852841|NCT03831191|75977425|FG001|COMPLETED|Induction Period (16 Weeks)||14||
59852842|NCT03831191|75977426|FG002|COMPLETED|Induction Period (16 Weeks)||13||
59852843|NCT03831191|75977427|FG003|COMPLETED|Induction Period (16 Weeks)||11||
59852844|NCT03831191|75977428|FG004|COMPLETED|Induction Period (16 Weeks)||0||
59852845|NCT03831191|75977429|FG005|COMPLETED|Induction Period (16 Weeks)||0||
59852846|NCT03831191|75977430|FG006|COMPLETED|Induction Period (16 Weeks)||0||
59852847|NCT03831191|75977431|FG007|COMPLETED|Induction Period (16 Weeks)||0||
59852848|NCT03831191|75977432|FG008|COMPLETED|Induction Period (16 Weeks)||0||
59852849|NCT03831191|75977433|FG009|COMPLETED|Induction Period (16 Weeks)||0||
59852850|NCT03831191|75977434|FG010|COMPLETED|Induction Period (16 Weeks)||0||
59852851|NCT03831191|75977435|FG011|COMPLETED|Induction Period (16 Weeks)||0||
59852852|NCT03831191|75977436|FG012|COMPLETED|Induction Period (16 Weeks)||0||
59852853|NCT03831191|75977437|FG013|COMPLETED|Induction Period (16 Weeks)||0||
60121603|NCT01683071|76242508|FG002|NOT COMPLETED|Part 1||3||
60121604|NCT01683071|76242509|FG003|NOT COMPLETED|Part 1||5||
60121605|NCT01683071|76242510|FG004|NOT COMPLETED|Part 1||0||
59852854|NCT03831191|75977438|FG014|COMPLETED|Induction Period (16 Weeks)||0||
60121606|NCT01683071|76242511|FG005|NOT COMPLETED|Part 1||0||
59852855|NCT03831191|75977424|FG000|NOT COMPLETED|Induction Period (16 Weeks)||23||
59852856|NCT03831191|75977425|FG001|NOT COMPLETED|Induction Period (16 Weeks)||21||
60121607|NCT01683071|76242506|FG000|STARTED|Part 2||0||
59852857|NCT03831191|75977426|FG002|NOT COMPLETED|Induction Period (16 Weeks)||21||
59852858|NCT03831191|75977427|FG003|NOT COMPLETED|Induction Period (16 Weeks)||23||
59852859|NCT03831191|75977428|FG004|NOT COMPLETED|Induction Period (16 Weeks)||0||
59852860|NCT03831191|75977429|FG005|NOT COMPLETED|Induction Period (16 Weeks)||0||
59852861|NCT03831191|75977430|FG006|NOT COMPLETED|Induction Period (16 Weeks)||0||
59852862|NCT03831191|75977431|FG007|NOT COMPLETED|Induction Period (16 Weeks)||0||
59852863|NCT03831191|75977432|FG008|NOT COMPLETED|Induction Period (16 Weeks)||0||
59852864|NCT03831191|75977433|FG009|NOT COMPLETED|Induction Period (16 Weeks)||0||
59852865|NCT03831191|75977434|FG010|NOT COMPLETED|Induction Period (16 Weeks)||0||
59852866|NCT03831191|75977435|FG011|NOT COMPLETED|Induction Period (16 Weeks)||0||
59852867|NCT03831191|75977436|FG012|NOT COMPLETED|Induction Period (16 Weeks)||0||
59852868|NCT03831191|75977437|FG013|NOT COMPLETED|Induction Period (16 Weeks)||0||
59852869|NCT03831191|75977438|FG014|NOT COMPLETED|Induction Period (16 Weeks)||0||
59852870|NCT03831191|75977424|FG000|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during induction period.|0||
59852871|NCT03831191|75977425|FG001|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during induction period.|0||
59852872|NCT03831191|75977426|FG002|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during induction period.|0||
59852873|NCT03831191|75977427|FG003|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during induction period.|0||
59852874|NCT03831191|75977428|FG004|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|4||
59852875|NCT03831191|75977429|FG005|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|5||
59852876|NCT03831191|75977430|FG006|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|2||
59852877|NCT03831191|75977431|FG007|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|4||
59852878|NCT03831191|75977432|FG008|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|8||
59852879|NCT03831191|75977433|FG009|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|1||
59852880|NCT03831191|75977434|FG010|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|4||
59852881|NCT03831191|75977435|FG011|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|8||
59852882|NCT03831191|75977436|FG012|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|1||
59852883|NCT03831191|75977437|FG013|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|1||
59852884|NCT03831191|75977438|FG014|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|9||
59852885|NCT03831191|75977424|FG000|COMPLETED|Maintenance Period (36 Weeks)||0||
59852886|NCT03831191|75977425|FG001|COMPLETED|Maintenance Period (36 Weeks)||0||
59852887|NCT03831191|75977426|FG002|COMPLETED|Maintenance Period (36 Weeks)||0||
59852888|NCT03831191|75977427|FG003|COMPLETED|Maintenance Period (36 Weeks)||0||
59852889|NCT03831191|75977428|FG004|COMPLETED|Maintenance Period (36 Weeks)||0||
59852890|NCT03831191|75977429|FG005|COMPLETED|Maintenance Period (36 Weeks)||0||
59852891|NCT03831191|75977430|FG006|COMPLETED|Maintenance Period (36 Weeks)||0||
59852892|NCT03831191|75977431|FG007|COMPLETED|Maintenance Period (36 Weeks)||0||
59852893|NCT03831191|75977432|FG008|COMPLETED|Maintenance Period (36 Weeks)||0||
59852894|NCT03831191|75977433|FG009|COMPLETED|Maintenance Period (36 Weeks)||0||
59852895|NCT03831191|75977434|FG010|COMPLETED|Maintenance Period (36 Weeks)||0||
59852896|NCT03831191|75977435|FG011|COMPLETED|Maintenance Period (36 Weeks)||1||
59852897|NCT03831191|75977436|FG012|COMPLETED|Maintenance Period (36 Weeks)||0||
59852898|NCT03831191|75977437|FG013|COMPLETED|Maintenance Period (36 Weeks)||0||
59852899|NCT03831191|75977438|FG014|COMPLETED|Maintenance Period (36 Weeks)||0||
59852900|NCT03831191|75977424|FG000|NOT COMPLETED|Maintenance Period (36 Weeks)||0||
59852901|NCT03831191|75977425|FG001|NOT COMPLETED|Maintenance Period (36 Weeks)||0||
59852902|NCT03831191|75977426|FG002|NOT COMPLETED|Maintenance Period (36 Weeks)||0||
59852903|NCT03831191|75977427|FG003|NOT COMPLETED|Maintenance Period (36 Weeks)||0||
59852904|NCT03831191|75977428|FG004|NOT COMPLETED|Maintenance Period (36 Weeks)||4||
59852905|NCT03831191|75977429|FG005|NOT COMPLETED|Maintenance Period (36 Weeks)||5||
59852906|NCT03831191|75977430|FG006|NOT COMPLETED|Maintenance Period (36 Weeks)||2||
59852907|NCT03831191|75977431|FG007|NOT COMPLETED|Maintenance Period (36 Weeks)||4||
59852908|NCT03831191|75977432|FG008|NOT COMPLETED|Maintenance Period (36 Weeks)||8||
59852909|NCT03831191|75977433|FG009|NOT COMPLETED|Maintenance Period (36 Weeks)||1||
59852910|NCT03831191|75977434|FG010|NOT COMPLETED|Maintenance Period (36 Weeks)||4||
59852911|NCT03831191|75977435|FG011|NOT COMPLETED|Maintenance Period (36 Weeks)||7||
59852912|NCT03831191|75977436|FG012|NOT COMPLETED|Maintenance Period (36 Weeks)||1||
59852913|NCT03831191|75977437|FG013|NOT COMPLETED|Maintenance Period (36 Weeks)||1||
59852914|NCT03831191|75977438|FG014|NOT COMPLETED|Maintenance Period (36 Weeks)||9||
59852915|NCT03831191|75977424|FG000|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0||
59852916|NCT03831191|75977425|FG001|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0||
59852917|NCT03831191|75977426|FG002|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0||
59852918|NCT03831191|75977427|FG003|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0||
59852919|NCT03831191|75977428|FG004|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0||
59852920|NCT03831191|75977429|FG005|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0||
59852921|NCT03831191|75977430|FG006|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0||
59852922|NCT03831191|75977431|FG007|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0||
59852923|NCT03831191|75977432|FG008|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0||
59852924|NCT03831191|75977433|FG009|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0||
59852925|NCT03831191|75977434|FG010|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0||
59852926|NCT03831191|75977435|FG011|STARTED|Post-Treatment Follow-Up Period(8 Weeks)|No participant entered the post follow-up period.|0||
59852927|NCT03831191|75977436|FG012|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0||
59852928|NCT03831191|75977437|FG013|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0||
59852929|NCT03831191|75977438|FG014|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0||
59852930|NCT03831191|75977424|FG000|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0||
59852931|NCT03831191|75977425|FG001|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0||
59852932|NCT03831191|75977426|FG002|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0||
59852933|NCT03831191|75977427|FG003|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0||
59852934|NCT03831191|75977428|FG004|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0||
59852935|NCT03831191|75977429|FG005|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0||
59852936|NCT03831191|75977430|FG006|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0||
59852937|NCT03831191|75977431|FG007|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0||
59852938|NCT03831191|75977432|FG008|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0||
59852939|NCT03831191|75977433|FG009|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0||
59852940|NCT03831191|75977434|FG010|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0||
59852941|NCT03831191|75977435|FG011|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0||
59852942|NCT03831191|75977436|FG012|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0||
59852943|NCT03831191|75977437|FG013|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0||
59852944|NCT03831191|75977438|FG014|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0||
59852945|NCT03831191|75977424|FG000|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0||
59852946|NCT03831191|75977425|FG001|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0||
59852947|NCT03831191|75977426|FG002|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0||
59852948|NCT03831191|75977427|FG003|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0||
59852949|NCT03831191|75977428|FG004|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0||
59852950|NCT03831191|75977429|FG005|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0||
59852951|NCT03831191|75977430|FG006|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0||
59852952|NCT03831191|75977431|FG007|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0||
59852953|NCT03831191|75977432|FG008|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0||
59852954|NCT03831191|75977433|FG009|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0||
59852955|NCT03831191|75977434|FG010|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0||
59852956|NCT03831191|75977435|FG011|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0||
59852957|NCT03831191|75977436|FG012|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0||
59852958|NCT03831191|75977437|FG013|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0||
59852959|NCT03831191|75977438|FG014|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0||
59852960|NCT00005906|75977471|FG000|STARTED|Overall Study||4||
59852961|NCT00005906|75977471|FG000|COMPLETED|Overall Study||1||
59852962|NCT00005906|75977471|FG000|NOT COMPLETED|Overall Study||3||
59996756|NCT02729909|76112614|FG000|STARTED|Overall Study||105||
59996757|NCT02729909|76112615|FG001|STARTED|Overall Study||106||
59996758|NCT02729909|76112614|FG000|COMPLETED|Overall Study||104||
59996759|NCT02729909|76112615|FG001|COMPLETED|Overall Study||101||
59996760|NCT02729909|76112614|FG000|NOT COMPLETED|Overall Study||1||
59996761|NCT02729909|76112615|FG001|NOT COMPLETED|Overall Study||5||
59996762|NCT02713243|76112623|FG000|STARTED|Overall Study||10||
59996763|NCT02713243|76112624|FG001|STARTED|Overall Study||10||
59996764|NCT02713243|76112623|FG000|PD Analysis Set|Overall Study||9||
59996765|NCT02713243|76112624|FG001|PD Analysis Set|Overall Study||10||
59724576|NCT01115309|75843267|FG000|STARTED|Procedure Safety (1-Month)||175||
59724577|NCT01115309|75843267|FG000|COMPLETED|Procedure Safety (1-Month)||172||
59724578|NCT01115309|75843267|FG000|NOT COMPLETED|Procedure Safety (1-Month)||3||
59724579|NCT01115309|75843267|FG000|STARTED|Long-term Follow-up||50||
59724580|NCT01115309|75843267|FG000|6-Month Follow-up|Long-term Follow-up||46||
59724581|NCT01115309|75843267|FG000|12-Month Follow-up|Long-term Follow-up||44||
59996766|NCT02713243|76112623|FG000|PK Analysis Set|Overall Study||8||
59996767|NCT02713243|76112624|FG001|PK Analysis Set|Overall Study||9||
59996768|NCT02713243|76112623|FG000|COMPLETED|Overall Study||9||
59996769|NCT02713243|76112624|FG001|COMPLETED|Overall Study||8||
59996770|NCT02713243|76112623|FG000|NOT COMPLETED|Overall Study||1||
59996771|NCT02713243|76112624|FG001|NOT COMPLETED|Overall Study||2||
59996772|NCT03434041|76112632|FG000|STARTED|Double Blind Treatment Phase (4 Weeks)||126||
59996773|NCT03434041|76112633|FG001|STARTED|Double Blind Treatment Phase (4 Weeks)||126||
59724582|NCT01115309|75843267|FG000|COMPLETED|Long-term Follow-up||44||
59724583|NCT01115309|75843267|FG000|NOT COMPLETED|Long-term Follow-up||6||
59724584|NCT03638128|75843275|FG000|STARTED|Overall Study||21||
59724585|NCT03638128|75843276|FG001|STARTED|Overall Study||27||
59724586|NCT03638128|75843277|FG002|STARTED|Overall Study||27||
59724587|NCT03638128|75843275|FG000|COMPLETED|Overall Study||5||
59724588|NCT03638128|75843276|FG001|COMPLETED|Overall Study||8||
59852963|NCT03409276|75977480|FG000|STARTED|Overall Study||2||
59852964|NCT03409276|75977481|FG001|STARTED|Overall Study||10||
59852965|NCT03409276|75977482|FG002|STARTED|Overall Study||6||
59852966|NCT03409276|75977483|FG003|STARTED|Overall Study||21||
59852967|NCT03409276|75977484|FG004|STARTED|Overall Study||21||
59852968|NCT03409276|75977480|FG000|Month 2.5 Immunogenicity Cohort|Overall Study||2||
59852969|NCT03409276|75977481|FG001|Month 2.5 Immunogenicity Cohort|Overall Study||10||
59852970|NCT03409276|75977482|FG002|Month 2.5 Immunogenicity Cohort|Overall Study||0||
59852971|NCT03409276|75977483|FG003|Month 2.5 Immunogenicity Cohort|Overall Study||0||
59852972|NCT03409276|75977484|FG004|Month 2.5 Immunogenicity Cohort|Overall Study||0||
59852973|NCT03409276|75977480|FG000|Month 8.5 Immunogenicity Cohort|Overall Study||0||
59852974|NCT03409276|75977481|FG001|Month 8.5 Immunogenicity Cohort|Overall Study||0||
59852975|NCT03409276|75977482|FG002|Month 8.5 Immunogenicity Cohort|Overall Study||6||
59852976|NCT03409276|75977483|FG003|Month 8.5 Immunogenicity Cohort|Overall Study||19||
59852977|NCT03409276|75977484|FG004|Month 8.5 Immunogenicity Cohort|Overall Study||16||
59852978|NCT03409276|75977480|FG000|COMPLETED|Overall Study||2||
59852979|NCT03409276|75977481|FG001|COMPLETED|Overall Study||10||
59852980|NCT03409276|75977482|FG002|COMPLETED|Overall Study||6||
59852981|NCT03409276|75977483|FG003|COMPLETED|Overall Study||19||
59852982|NCT03409276|75977484|FG004|COMPLETED|Overall Study||18||
59852983|NCT03409276|75977480|FG000|NOT COMPLETED|Overall Study||0||
59852984|NCT03409276|75977481|FG001|NOT COMPLETED|Overall Study||0||
59852985|NCT03409276|75977482|FG002|NOT COMPLETED|Overall Study||0||
59852986|NCT03409276|75977483|FG003|NOT COMPLETED|Overall Study||2||
59852987|NCT03409276|75977484|FG004|NOT COMPLETED|Overall Study||3||
59852988|NCT00004562|75977502|FG000|STARTED|Overall Study||1101||
59852989|NCT00004562|75977503|FG001|STARTED|Overall Study||1100||
59852990|NCT00004562|75977502|FG000|COMPLETED|Overall Study||999||
59852991|NCT00004562|75977503|FG001|COMPLETED|Overall Study||1009||
59852992|NCT00004562|75977502|FG000|NOT COMPLETED|Overall Study||102||
59852993|NCT00004562|75977503|FG001|NOT COMPLETED|Overall Study||91||
59852994|NCT00004412|75977512|FG000|STARTED|Randomized Period||11||
59852995|NCT00004412|75977513|FG001|STARTED|Randomized Period||12||
59852996|NCT00004412|75977514|FG002|STARTED|Randomized Period||0||
59852997|NCT00004412|75977512|FG000|COMPLETED|Randomized Period||8||
59852998|NCT00004412|75977513|FG001|COMPLETED|Randomized Period||12||
59852999|NCT00004412|75977514|FG002|COMPLETED|Randomized Period||0||
59853000|NCT00004412|75977512|FG000|NOT COMPLETED|Randomized Period||3||
59853001|NCT00004412|75977513|FG001|NOT COMPLETED|Randomized Period||0||
59853002|NCT00004412|75977514|FG002|NOT COMPLETED|Randomized Period||0||
59853003|NCT00004412|75977512|FG000|STARTED|Crossover Period|Eight subjects were randomized to Standard of Care dressing Arm|8||
59853004|NCT00004412|75977513|FG001|STARTED|Crossover Period|Twelve patients were randomized to the Arginine Butyrate plus Standard local care dressing Arm|12||
59853005|NCT00004412|75977514|FG002|STARTED|Crossover Period|Three of Randomized Period's Arm I elected to move to Crossover Period's Crossover Arm.|3||
59853006|NCT00004412|75977512|FG000|COMPLETED|Crossover Period|Eight subjects in this arm completed study without crossing over.|8||
59853007|NCT00004412|75977513|FG001|COMPLETED|Crossover Period|Twelve subjects in this arm completed the study.|12||
59853008|NCT00004412|75977514|FG002|COMPLETED|Crossover Period|Three subjects, from Arm I, who crossed- over to Arm II completed the study.|3||
59853009|NCT00004412|75977512|FG000|NOT COMPLETED|Crossover Period||0||
59853010|NCT00004412|75977513|FG001|NOT COMPLETED|Crossover Period||0||
59853011|NCT00004412|75977514|FG002|NOT COMPLETED|Crossover Period||0||
59853012|NCT03440320|75977524|FG000|STARTED|Overall Study||18||
59853013|NCT03440320|75977525|FG001|STARTED|Overall Study||14||
59853014|NCT03440320|75977524|FG000|COMPLETED|Overall Study||18||
59853015|NCT03440320|75977525|FG001|COMPLETED|Overall Study||13||
59853016|NCT03440320|75977524|FG000|NOT COMPLETED|Overall Study||0||
59853017|NCT03440320|75977525|FG001|NOT COMPLETED|Overall Study||1||
59853018|NCT00004088|75977533|FG000|STARTED|Overall Study||77||
59853019|NCT00004088|75977533|FG000|COMPLETED|Overall Study||68||
59853020|NCT00004088|75977533|FG000|NOT COMPLETED|Overall Study||9||
59853021|NCT03439072|75977537|FG000|STARTED|Overall Study||41||
59853022|NCT03439072|75977538|FG001|STARTED|Overall Study||40||
59853023|NCT03439072|75977537|FG000|COMPLETED|Overall Study|1 subject dropped before G-Pen; another after G-Pen (n=40 G-Pen; N=39 Lilly Glucagon)|39||
59853024|NCT03439072|75977538|FG001|COMPLETED|Overall Study|1 subject dropped before Lilly Glucagon; 3 others after Lilly Glucagon (N=39 Lilly; N=36 G-Pen)|36||
59853025|NCT03439072|75977537|FG000|NOT COMPLETED|Overall Study||2||
59853026|NCT03439072|75977538|FG001|NOT COMPLETED|Overall Study||4||
59853027|NCT00078312|75977544|FG000|STARTED|Overall Study||328||
59853028|NCT00078312|75977544|FG000|COMPLETED|Overall Study||151||
59853029|NCT00078312|75977544|FG000|NOT COMPLETED|Overall Study||177||
59853030|NCT00003896|75977548|FG000|STARTED|Overall Study||68||
59853031|NCT00003896|75977548|FG000|Eligible|Overall Study|2 eligible patients did not have any toxicity assessments reported.|63||
59853032|NCT00003896|75977548|FG000|COMPLETED|Overall Study||39||
59853033|NCT00003896|75977548|FG000|NOT COMPLETED|Overall Study||29||
59853034|NCT00003830|75977555|FG000|STARTED|Overall Study||2807||
59853035|NCT00003830|75977556|FG001|STARTED|Overall Study||2804||
59853036|NCT00003830|75977555|FG000|COMPLETED|Overall Study||1975||
59853037|NCT00003830|75977556|FG001|COMPLETED|Overall Study||2011||
59853038|NCT00003830|75977555|FG000|NOT COMPLETED|Overall Study||832||
59853039|NCT00003830|75977556|FG001|NOT COMPLETED|Overall Study||793||
59853040|NCT03407482|75977564|FG000|STARTED|Overall Study||160||
59853041|NCT03407482|75977564|FG000|COMPLETED|Overall Study||29||
59853042|NCT03407482|75977564|FG000|NOT COMPLETED|Overall Study||131||
59853043|NCT00003782|75977571|FG000|STARTED|Overall Study||1783||
59853044|NCT00003782|75977572|FG001|STARTED|Overall Study||1784||
59853045|NCT00003782|75977573|FG002|STARTED|Overall Study||1784||
59853046|NCT00003782|75977571|FG000|COMPLETED|Overall Study||1753||
59853047|NCT00003782|75977572|FG001|COMPLETED|Overall Study||1753||
59853048|NCT00003782|75977573|FG002|COMPLETED|Overall Study||1758||
59853049|NCT00003782|75977571|FG000|NOT COMPLETED|Overall Study||30||
59853050|NCT00003782|75977572|FG001|NOT COMPLETED|Overall Study||31||
59853051|NCT00003782|75977573|FG002|NOT COMPLETED|Overall Study||26||
59853052|NCT03389308|75977581|FG000|STARTED|Overall Study||51||
59853053|NCT03389308|75977581|FG000|COMPLETED|Overall Study||39||
59853054|NCT03389308|75977581|FG000|NOT COMPLETED|Overall Study||12||
59853055|NCT03407170|75977585|FG000|STARTED|Overall Study||1||
59853056|NCT03407170|75977585|FG000|COMPLETED|Overall Study||0||
59853057|NCT03407170|75977585|FG000|NOT COMPLETED|Overall Study||1||
59853058|NCT03406858|75977589|FG000|STARTED|Overall Study||15||
59853059|NCT03406858|75977589|FG000|COMPLETED|Overall Study||13||
59853060|NCT03406858|75977589|FG000|NOT COMPLETED|Overall Study||2||
59853061|NCT03406702|75977593|FG000|STARTED|Overall Study||7||
59853062|NCT03406702|75977593|FG000|COMPLETED|Overall Study||6||
59853063|NCT03406702|75977593|FG000|NOT COMPLETED|Overall Study||1||
59853064|NCT00003656|75977611|FG000|STARTED|Overall Study||12||
59853065|NCT00003656|75977612|FG001|STARTED|Overall Study||14||
59853066|NCT00003656|75977611|FG000|COMPLETED|Overall Study||12||
59853067|NCT00003656|75977612|FG001|COMPLETED|Overall Study||13||
59853068|NCT00003656|75977611|FG000|NOT COMPLETED|Overall Study||0||
59853069|NCT00003656|75977612|FG001|NOT COMPLETED|Overall Study||1||
59853070|NCT00003590|75977619|FG000|STARTED|Overall Study||29||
59853071|NCT00003590|75977619|FG000|Eligible|Overall Study||28||
59853072|NCT00003590|75977619|FG000|Eligible and Began Protocol Therapy|Overall Study||28||
59853073|NCT00003590|75977619|FG000|COMPLETED|Overall Study|Patients were to receive Hydroxyurea up to 2 years in absence of progressive disease.|7||
59853074|NCT00003590|75977619|FG000|NOT COMPLETED|Overall Study||22||
59853075|NCT03416374|75977625|FG000|STARTED|Treatment Period I||6||
59853076|NCT03416374|75977626|FG001|STARTED|Treatment Period I||39||
59853077|NCT03416374|75977625|FG000|COMPLETED|Treatment Period I||0||
59853078|NCT03416374|75977626|FG001|COMPLETED|Treatment Period I||0||
59853079|NCT03416374|75977625|FG000|NOT COMPLETED|Treatment Period I||6||
59853080|NCT03416374|75977626|FG001|NOT COMPLETED|Treatment Period I||39||
59853081|NCT03416374|75977625|FG000|STARTED|Between Treatment Period I and II||6||
59853082|NCT03416374|75977626|FG001|STARTED|Between Treatment Period I and II||39||
59853083|NCT03416374|75977625|FG000|COMPLETED|Between Treatment Period I and II||6||
59853084|NCT03416374|75977626|FG001|COMPLETED|Between Treatment Period I and II||30||
59853085|NCT03416374|75977625|FG000|NOT COMPLETED|Between Treatment Period I and II||0||
59584568|NCT04205669|75691164|FG000|NOT COMPLETED|Overall Study||13||
59584569|NCT04205669|75691165|FG001|NOT COMPLETED|Overall Study||12||
59584570|NCT01601652|75691171|FG000|STARTED|Overall Study||12|"12 started omegaven~1 Died of complications unrelated to omegaven 6 DC home on PN (3M still on PN; 2M & 1F weaned from PN) 5 Weaned from PN prior to DC (2F, 3M)"|
59724589|NCT03638128|75843277|FG002|COMPLETED|Overall Study||1||
59724590|NCT03638128|75843275|FG000|NOT COMPLETED|Overall Study||16||
59724591|NCT03638128|75843276|FG001|NOT COMPLETED|Overall Study||19||
59724592|NCT03638128|75843277|FG002|NOT COMPLETED|Overall Study||26||
59724593|NCT01059630|75843290|FG000|STARTED|Overall Study||209||
59724594|NCT01059630|75843291|FG001|STARTED|Overall Study||204||
59724595|NCT01059630|75843290|FG000|COMPLETED|Overall Study||82||
59724596|NCT01059630|75843291|FG001|COMPLETED|Overall Study||101||
59724597|NCT01059630|75843290|FG000|NOT COMPLETED|Overall Study||127||
59724598|NCT01059630|75843291|FG001|NOT COMPLETED|Overall Study||103||
59724599|NCT00932373|75843308|FG000|STARTED|Overall Study||3||
59724600|NCT00932373|75843309|FG001|STARTED|Overall Study||1||
59724601|NCT00932373|75843310|FG002|STARTED|Overall Study||1||
59724602|NCT00932373|75843311|FG003|STARTED|Overall Study||1||
59724603|NCT00932373|75843312|FG004|STARTED|Overall Study||15||
59724604|NCT00932373|75843313|FG005|STARTED|Overall Study||3||
59853086|NCT03416374|75977626|FG001|NOT COMPLETED|Between Treatment Period I and II||9||
59853087|NCT03416374|75977625|FG000|STARTED|Treatment Period II||6||
59853088|NCT03416374|75977626|FG001|STARTED|Treatment Period II||30||
59853089|NCT03416374|75977625|FG000|COMPLETED|Treatment Period II||2||
59853090|NCT03416374|75977626|FG001|COMPLETED|Treatment Period II||12||
59853091|NCT03416374|75977625|FG000|NOT COMPLETED|Treatment Period II||4||
59853092|NCT03416374|75977626|FG001|NOT COMPLETED|Treatment Period II||18||
59853093|NCT03799952|75977637|FG000|STARTED|Overall Study||31||
59853094|NCT03799952|75977638|FG001|STARTED|Overall Study||31||
59853095|NCT03799952|75977637|FG000|COMPLETED|Overall Study||30||
59853096|NCT03799952|75977638|FG001|COMPLETED|Overall Study||29||
59853097|NCT03799952|75977637|FG000|NOT COMPLETED|Overall Study||1||
59853098|NCT03799952|75977638|FG001|NOT COMPLETED|Overall Study||2||
59853099|NCT00077766|75977646|FG000|STARTED|Overall Study||157||
59853100|NCT00077766|75977647|FG001|STARTED|Overall Study||156||
59853101|NCT00077766|75977646|FG000|COMPLETED|Overall Study||118||
59853102|NCT00077766|75977647|FG001|COMPLETED|Overall Study||131||
59853103|NCT00077766|75977646|FG000|NOT COMPLETED|Overall Study||39||
59853104|NCT00077766|75977647|FG001|NOT COMPLETED|Overall Study||25||
59853105|NCT03388138|75977656|FG000|STARTED|Overall Study||94||
59853106|NCT03388138|75977657|FG001|STARTED|Overall Study||47||
59853107|NCT03388138|75977656|FG000|COMPLETED|Overall Study||93||
59853108|NCT03388138|75977657|FG001|COMPLETED|Overall Study||47||
59853109|NCT03388138|75977656|FG000|NOT COMPLETED|Overall Study||1||
59853110|NCT03388138|75977657|FG001|NOT COMPLETED|Overall Study||0||
59853111|NCT02952898|75977666|FG000|STARTED|Overall Study||220||
59853112|NCT02952898|75977667|FG001|STARTED|Overall Study||221||
59853113|NCT02952898|75977668|FG002|STARTED|Overall Study||224||
59853114|NCT02952898|75977666|FG000|COMPLETED|Overall Study||198||
59853115|NCT02952898|75977667|FG001|COMPLETED|Overall Study||202||
59853116|NCT02952898|75977668|FG002|COMPLETED|Overall Study||209||
59853117|NCT02952898|75977666|FG000|NOT COMPLETED|Overall Study||22||
59853118|NCT02952898|75977667|FG001|NOT COMPLETED|Overall Study||19||
59853119|NCT02952898|75977668|FG002|NOT COMPLETED|Overall Study||15||
59853120|NCT00045734|75977676|FG000|STARTED|Overall Study||23||
59853121|NCT00045734|75977676|FG000|COMPLETED|Overall Study||22||
59853122|NCT00045734|75977676|FG000|NOT COMPLETED|Overall Study||1||
59853123|NCT03387046|75977682|FG000|STARTED|Overall Study||5||
59853124|NCT03387046|75977683|FG001|STARTED|Overall Study||2||
59853125|NCT03387046|75977682|FG000|COMPLETED|Overall Study||4||
59853126|NCT03387046|75977683|FG001|COMPLETED|Overall Study||1||
59853127|NCT03387046|75977682|FG000|NOT COMPLETED|Overall Study||1||
59853128|NCT03387046|75977683|FG001|NOT COMPLETED|Overall Study||1||
59853129|NCT00045110|75977692|FG000|STARTED|100mg Phase 1 Dose Escalalation||6||
59853130|NCT00045110|75977693|FG001|STARTED|100mg Phase 1 Dose Escalalation||59||
59853131|NCT00045110|75977694|FG002|STARTED|100mg Phase 1 Dose Escalalation||45||
59853132|NCT00045110|75977692|FG000|COMPLETED|100mg Phase 1 Dose Escalalation||6||
59853133|NCT00045110|75977693|FG001|COMPLETED|100mg Phase 1 Dose Escalalation||53||
59853134|NCT00045110|75977694|FG002|COMPLETED|100mg Phase 1 Dose Escalalation||43||
59853135|NCT00045110|75977692|FG000|NOT COMPLETED|100mg Phase 1 Dose Escalalation||0||
59853136|NCT00045110|75977693|FG001|NOT COMPLETED|100mg Phase 1 Dose Escalalation||6||
59853137|NCT00045110|75977694|FG002|NOT COMPLETED|100mg Phase 1 Dose Escalalation||2||
59853138|NCT00045110|75977692|FG000|STARTED|200mg Phase 1 Dose Escalation||4||
59853139|NCT00045110|75977693|FG001|STARTED|200mg Phase 1 Dose Escalation||0||
59853140|NCT00045110|75977694|FG002|STARTED|200mg Phase 1 Dose Escalation||0||
59853141|NCT00045110|75977692|FG000|COMPLETED|200mg Phase 1 Dose Escalation||4||
59853142|NCT00045110|75977693|FG001|COMPLETED|200mg Phase 1 Dose Escalation||0||
59853143|NCT00045110|75977694|FG002|COMPLETED|200mg Phase 1 Dose Escalation||0||
59853144|NCT00045110|75977692|FG000|NOT COMPLETED|200mg Phase 1 Dose Escalation||0||
59853145|NCT00045110|75977693|FG001|NOT COMPLETED|200mg Phase 1 Dose Escalation||0||
59853146|NCT00045110|75977694|FG002|NOT COMPLETED|200mg Phase 1 Dose Escalation||0||
59853147|NCT00045110|75977692|FG000|STARTED|275mg Phase 1 Dose Escalation||3||
59853148|NCT00045110|75977693|FG001|STARTED|275mg Phase 1 Dose Escalation||0||
59853149|NCT00045110|75977694|FG002|STARTED|275mg Phase 1 Dose Escalation||0||
59853150|NCT00045110|75977692|FG000|COMPLETED|275mg Phase 1 Dose Escalation||3||
59853151|NCT00045110|75977693|FG001|COMPLETED|275mg Phase 1 Dose Escalation||0||
59853152|NCT00045110|75977694|FG002|COMPLETED|275mg Phase 1 Dose Escalation||0||
59853153|NCT00045110|75977692|FG000|NOT COMPLETED|275mg Phase 1 Dose Escalation||0||
59853154|NCT00045110|75977693|FG001|NOT COMPLETED|275mg Phase 1 Dose Escalation||0||
59853155|NCT00045110|75977694|FG002|NOT COMPLETED|275mg Phase 1 Dose Escalation||0||
59584571|NCT01601652|75691171|FG000|COMPLETED|Overall Study||11|Last patient admitted to study on 2/18/2017 and data collection ended a month later.|
59584572|NCT01601652|75691171|FG000|NOT COMPLETED|Overall Study||1||
59584573|NCT03516227|75691177|FG000|STARTED|Overall Study||20||
59584574|NCT03516227|75691178|FG001|STARTED|Overall Study||20||
59584575|NCT03516227|75691177|FG000|COMPLETED|Overall Study||19||
59584576|NCT03516227|75691178|FG001|COMPLETED|Overall Study||16||
59584577|NCT03516227|75691177|FG000|NOT COMPLETED|Overall Study||1||
59584578|NCT03516227|75691178|FG001|NOT COMPLETED|Overall Study||4||
59584579|NCT03520283|75691187|FG000|STARTED|Overall Study||24||
59584580|NCT03520283|75691188|FG001|STARTED|Overall Study||42||
59584581|NCT03520283|75691187|FG000|COMPLETED|Overall Study||24||
59584582|NCT03520283|75691188|FG001|COMPLETED|Overall Study||42||
59584583|NCT03520283|75691187|FG000|NOT COMPLETED|Overall Study||0||
59584584|NCT03520283|75691188|FG001|NOT COMPLETED|Overall Study||0||
59584585|NCT04186481|75691203|FG000|STARTED|Overall Study||32||
59584586|NCT04186481|75691203|FG000|Completed 6 Month Visit|Overall Study||31||
59584587|NCT04186481|75691203|FG000|Completed 12 Month Visit|Overall Study||4||
59584588|NCT04186481|75691203|FG000|COMPLETED|Overall Study||32||
59584589|NCT04186481|75691203|FG000|NOT COMPLETED|Overall Study||0||
59584590|NCT03952130|75691209|FG000|STARTED|Overall Study||178||
59584591|NCT03952130|75691210|FG001|STARTED|Overall Study||176||
59584592|NCT03952130|75691209|FG000|Received at Least One Dose of Study Drug|Overall Study||178||
59853156|NCT00045110|75977692|FG000|STARTED|400mg Phase 1 Dose Escalation||3||
59584593|NCT03952130|75691210|FG001|Received at Least One Dose of Study Drug|Overall Study||176||
59724605|NCT00932373|75843314|FG006|STARTED|Overall Study||3||
59724606|NCT00932373|75843315|FG007|STARTED|Overall Study||3||
59724607|NCT00932373|75843316|FG008|STARTED|Overall Study||3||
59724608|NCT00932373|75843317|FG009|STARTED|Overall Study||16||
59724609|NCT00932373|75843318|FG010|STARTED|Overall Study||3||
59724610|NCT00932373|75843308|FG000|COMPLETED|Overall Study||0||
59853157|NCT00045110|75977693|FG001|STARTED|400mg Phase 1 Dose Escalation||0||
59853158|NCT00045110|75977694|FG002|STARTED|400mg Phase 1 Dose Escalation||0||
59853159|NCT00045110|75977692|FG000|COMPLETED|400mg Phase 1 Dose Escalation||3||
59853160|NCT00045110|75977693|FG001|COMPLETED|400mg Phase 1 Dose Escalation||0||
59853161|NCT00045110|75977694|FG002|COMPLETED|400mg Phase 1 Dose Escalation||0||
59853162|NCT00045110|75977692|FG000|NOT COMPLETED|400mg Phase 1 Dose Escalation||0||
59853163|NCT00045110|75977693|FG001|NOT COMPLETED|400mg Phase 1 Dose Escalation||0||
59853164|NCT00045110|75977694|FG002|NOT COMPLETED|400mg Phase 1 Dose Escalation||0||
59853165|NCT00045110|75977692|FG000|STARTED|525mg Phase 1 Dose Escalation||3||
59853166|NCT00045110|75977693|FG001|STARTED|525mg Phase 1 Dose Escalation||0||
59853167|NCT00045110|75977694|FG002|STARTED|525mg Phase 1 Dose Escalation||0||
59853168|NCT00045110|75977692|FG000|COMPLETED|525mg Phase 1 Dose Escalation||3||
59853169|NCT00045110|75977693|FG001|COMPLETED|525mg Phase 1 Dose Escalation||0||
59853170|NCT00045110|75977694|FG002|COMPLETED|525mg Phase 1 Dose Escalation||0||
59853171|NCT00045110|75977692|FG000|NOT COMPLETED|525mg Phase 1 Dose Escalation||0||
59853172|NCT00045110|75977693|FG001|NOT COMPLETED|525mg Phase 1 Dose Escalation||0||
59853173|NCT00045110|75977694|FG002|NOT COMPLETED|525mg Phase 1 Dose Escalation||0||
59853174|NCT00045110|75977692|FG000|STARTED|650mg Phase 1 Dose Escalation||6||
59853175|NCT00045110|75977693|FG001|STARTED|650mg Phase 1 Dose Escalation||0||
59853176|NCT00045110|75977694|FG002|STARTED|650mg Phase 1 Dose Escalation||0||
59853177|NCT00045110|75977692|FG000|COMPLETED|650mg Phase 1 Dose Escalation||6||
59853178|NCT00045110|75977693|FG001|COMPLETED|650mg Phase 1 Dose Escalation||0||
59853179|NCT00045110|75977694|FG002|COMPLETED|650mg Phase 1 Dose Escalation||0||
59853180|NCT00045110|75977692|FG000|NOT COMPLETED|650mg Phase 1 Dose Escalation||0||
59853181|NCT00045110|75977693|FG001|NOT COMPLETED|650mg Phase 1 Dose Escalation||0||
59853182|NCT00045110|75977694|FG002|NOT COMPLETED|650mg Phase 1 Dose Escalation||0||
59853183|NCT00045110|75977692|FG000|STARTED|775mg Dose Escalation||7||
59853184|NCT00045110|75977693|FG001|STARTED|775mg Dose Escalation||0||
59853185|NCT00045110|75977694|FG002|STARTED|775mg Dose Escalation||0||
59853186|NCT00045110|75977692|FG000|COMPLETED|775mg Dose Escalation||7||
59853187|NCT00045110|75977693|FG001|COMPLETED|775mg Dose Escalation||0||
59853188|NCT00045110|75977694|FG002|COMPLETED|775mg Dose Escalation||0||
59853189|NCT00045110|75977692|FG000|NOT COMPLETED|775mg Dose Escalation||0||
59853190|NCT00045110|75977693|FG001|NOT COMPLETED|775mg Dose Escalation||0||
59584594|NCT03952130|75691209|FG000|COMPLETED|Overall Study||176||
59584595|NCT03952130|75691210|FG001|COMPLETED|Overall Study||170||
59584596|NCT03952130|75691209|FG000|NOT COMPLETED|Overall Study||2||
59584597|NCT03952130|75691210|FG001|NOT COMPLETED|Overall Study||6||
59584598|NCT03661541|75691219|FG000|STARTED|Overall Study||12||
59584599|NCT03661541|75691220|FG001|STARTED|Overall Study||12||
59584600|NCT03661541|75691221|FG002|STARTED|Overall Study||12||
59584601|NCT03661541|75691219|FG000|COMPLETED|Overall Study||10||
59584602|NCT03661541|75691220|FG001|COMPLETED|Overall Study||10||
59853191|NCT00045110|75977694|FG002|NOT COMPLETED|775mg Dose Escalation||0||
59853192|NCT03353740|75977711|FG000|STARTED|Overall Study||346||
59853193|NCT03353740|75977711|FG000|COMPLETED|Overall Study||294||
59853194|NCT03353740|75977711|FG000|NOT COMPLETED|Overall Study||52||
59853195|NCT00003476|75977715|FG000|STARTED|Overall Study||8||
59853196|NCT00003476|75977715|FG000|COMPLETED|Overall Study||7||
59584603|NCT03661541|75691221|FG002|COMPLETED|Overall Study||10||
59584604|NCT03661541|75691219|FG000|NOT COMPLETED|Overall Study||2||
59584605|NCT03661541|75691220|FG001|NOT COMPLETED|Overall Study||2||
59584606|NCT03661541|75691221|FG002|NOT COMPLETED|Overall Study||2||
59584607|NCT03661697|75691235|FG000|STARTED|Overall Study||7||
59724611|NCT00932373|75843309|FG001|COMPLETED|Overall Study||0||
59724612|NCT00932373|75843310|FG002|COMPLETED|Overall Study||0||
59724613|NCT00932373|75843311|FG003|COMPLETED|Overall Study||1||
59724614|NCT00932373|75843312|FG004|COMPLETED|Overall Study||1||
59724615|NCT00932373|75843313|FG005|COMPLETED|Overall Study||0||
59724616|NCT00932373|75843314|FG006|COMPLETED|Overall Study||2||
59724617|NCT00932373|75843315|FG007|COMPLETED|Overall Study||0||
59724618|NCT00932373|75843316|FG008|COMPLETED|Overall Study||1||
59724619|NCT00932373|75843317|FG009|COMPLETED|Overall Study||3||
59724620|NCT00932373|75843318|FG010|COMPLETED|Overall Study||0||
59724621|NCT00932373|75843308|FG000|NOT COMPLETED|Overall Study||3||
59724622|NCT00932373|75843309|FG001|NOT COMPLETED|Overall Study||1||
59584608|NCT03661697|75691236|FG001|STARTED|Overall Study||7||
59724623|NCT00932373|75843310|FG002|NOT COMPLETED|Overall Study||1||
59724624|NCT00932373|75843311|FG003|NOT COMPLETED|Overall Study||0||
59724625|NCT00932373|75843312|FG004|NOT COMPLETED|Overall Study||14||
59724626|NCT00932373|75843313|FG005|NOT COMPLETED|Overall Study||3||
59584609|NCT03661697|75691235|FG000|COMPLETED|Overall Study||7||
59584610|NCT03661697|75691236|FG001|COMPLETED|Overall Study||7||
59584611|NCT03661697|75691235|FG000|NOT COMPLETED|Overall Study||0||
59724627|NCT00932373|75843314|FG006|NOT COMPLETED|Overall Study||1||
59584612|NCT03661697|75691236|FG001|NOT COMPLETED|Overall Study||0||
59584613|NCT03922490|75691244|FG000|STARTED|Overall Study||2||
59584614|NCT03922490|75691245|FG001|STARTED|Overall Study||0||
59584615|NCT03922490|75691244|FG000|COMPLETED|Overall Study|Due to COVID, recruiting patients was difficult and thus the study has been suspended. To add to that difficulty, RAs have not been permanent and have been leaving prior the agreed time when hired. The target number of participants was never obtained and thus the data set is incomplete.|0||
59584616|NCT03922490|75691245|FG001|COMPLETED|Overall Study||0||
59584617|NCT03922490|75691244|FG000|NOT COMPLETED|Overall Study||2||
59584618|NCT03922490|75691245|FG001|NOT COMPLETED|Overall Study||0||
59584619|NCT01640964|75691254|FG000|STARTED|Overall Study||20||
59584620|NCT01640964|75691255|FG001|STARTED|Overall Study||20||
59584621|NCT01640964|75691256|FG002|STARTED|Overall Study||6||
59584622|NCT01640964|75691254|FG000|COMPLETED|Overall Study||19||
59584623|NCT01640964|75691255|FG001|COMPLETED|Overall Study||19||
59584624|NCT01640964|75691256|FG002|COMPLETED|Overall Study||3||
59584625|NCT01640964|75691254|FG000|NOT COMPLETED|Overall Study||1||
59584626|NCT01640964|75691255|FG001|NOT COMPLETED|Overall Study||1||
59584627|NCT01640964|75691256|FG002|NOT COMPLETED|Overall Study||3||
59584628|NCT03663101|75691269|FG000|STARTED|Overall Study||4||
59584629|NCT03663101|75691270|FG001|STARTED|Overall Study||3||
59584630|NCT03663101|75691271|FG002|STARTED|Overall Study||5||
59584631|NCT03663101|75691272|FG003|STARTED|Overall Study||4||
59584632|NCT03663101|75691269|FG000|COMPLETED|Overall Study||4||
59584633|NCT03663101|75691270|FG001|COMPLETED|Overall Study||3||
59584634|NCT03663101|75691271|FG002|COMPLETED|Overall Study||5||
59584635|NCT03663101|75691272|FG003|COMPLETED|Overall Study||4||
59584636|NCT03663101|75691269|FG000|NOT COMPLETED|Overall Study||0||
59584637|NCT03663101|75691270|FG001|NOT COMPLETED|Overall Study||0||
59584638|NCT03663101|75691271|FG002|NOT COMPLETED|Overall Study||0||
59584639|NCT03663101|75691272|FG003|NOT COMPLETED|Overall Study||0||
59584640|NCT03524339|75691284|FG000|STARTED|Overall Study||66||
59584641|NCT03524339|75691285|FG001|STARTED|Overall Study||66||
59584642|NCT03524339|75691284|FG000|COMPLETED|Overall Study||57||
59584643|NCT03524339|75691285|FG001|COMPLETED|Overall Study||62||
59584644|NCT03524339|75691284|FG000|NOT COMPLETED|Overall Study||9||
59584645|NCT03524339|75691285|FG001|NOT COMPLETED|Overall Study||4||
59584646|NCT04174313|75691293|FG000|STARTED|Overall Study||15||
59584647|NCT04174313|75691294|FG001|STARTED|Overall Study||50||
59584648|NCT04174313|75691293|FG000|COMPLETED|Overall Study||15||
59584649|NCT04174313|75691294|FG001|COMPLETED|Overall Study||50||
59584650|NCT04174313|75691293|FG000|NOT COMPLETED|Overall Study||0||
59584651|NCT04174313|75691294|FG001|NOT COMPLETED|Overall Study||0||
59584652|NCT03664193|75691304|FG000|STARTED|Overall Study||30||
59584653|NCT03664193|75691304|FG000|COMPLETED|Overall Study||30||
59584654|NCT03664193|75691304|FG000|NOT COMPLETED|Overall Study||0||
59584655|NCT04668248|75691310|FG000|STARTED|Overall Study||24||
59584656|NCT04668248|75691311|FG001|STARTED|Overall Study||23||
59584657|NCT04668248|75691310|FG000|Sick|Overall Study||1||
59584658|NCT04668248|75691311|FG001|Sick|Overall Study||0||
59584659|NCT04668248|75691310|FG000|Schedule Change|Overall Study||4||
59584660|NCT04668248|75691311|FG001|Schedule Change|Overall Study||0||
59584661|NCT04668248|75691310|FG000|Did Not Complete Training in Time|Overall Study||0||
59584662|NCT04668248|75691311|FG001|Did Not Complete Training in Time|Overall Study||2||
59584663|NCT04668248|75691310|FG000|COMPLETED|Overall Study||19||
59584664|NCT04668248|75691311|FG001|COMPLETED|Overall Study||21||
59584665|NCT04668248|75691310|FG000|NOT COMPLETED|Overall Study||5||
59724628|NCT00932373|75843315|FG007|NOT COMPLETED|Overall Study||3||
59584666|NCT04668248|75691311|FG001|NOT COMPLETED|Overall Study||2||
59584667|NCT03526055|75691322|FG000|STARTED|Initial Program||5||
59584668|NCT03526055|75691323|FG001|STARTED|Initial Program||5||
59584669|NCT03526055|75691322|FG000|COMPLETED|Initial Program||5||
59584670|NCT03526055|75691323|FG001|COMPLETED|Initial Program||5||
59584671|NCT03526055|75691322|FG000|NOT COMPLETED|Initial Program||0||
59584672|NCT03526055|75691323|FG001|NOT COMPLETED|Initial Program||0||
59584673|NCT03526055|75691322|FG000|STARTED|Second Program||5||
59584674|NCT03526055|75691323|FG001|STARTED|Second Program||5||
59584675|NCT03526055|75691322|FG000|COMPLETED|Second Program||5||
59584676|NCT03526055|75691323|FG001|COMPLETED|Second Program||5||
59584677|NCT03526055|75691322|FG000|NOT COMPLETED|Second Program||0||
59584678|NCT03526055|75691323|FG001|NOT COMPLETED|Second Program||0||
59584679|NCT03667547|75691330|FG000|STARTED|Overall Study||12||
59584680|NCT03667547|75691330|FG000|COMPLETED|Overall Study||12||
59584681|NCT03667547|75691330|FG000|NOT COMPLETED|Overall Study||0||
59584682|NCT04160975|75691340|FG000|STARTED|Overall Study||479||
59584683|NCT04160975|75691341|FG001|STARTED|Overall Study||496||
59584684|NCT04160975|75691342|FG002|STARTED|Overall Study||478||
59584685|NCT04160975|75691343|FG003|STARTED|Overall Study||485||
59584686|NCT04160975|75691344|FG004|STARTED|Overall Study||649||
59584687|NCT04160975|75691345|FG005|STARTED|Overall Study||658||
59584688|NCT04160975|75691340|FG000|COMPLETED|Overall Study||415||
59584689|NCT04160975|75691341|FG001|COMPLETED|Overall Study||430||
59584690|NCT04160975|75691342|FG002|COMPLETED|Overall Study||417||
59584691|NCT04160975|75691343|FG003|COMPLETED|Overall Study||410||
59584692|NCT04160975|75691344|FG004|COMPLETED|Overall Study||614||
59584693|NCT04160975|75691345|FG005|COMPLETED|Overall Study||607||
59724629|NCT00932373|75843316|FG008|NOT COMPLETED|Overall Study||2||
59724630|NCT00932373|75843317|FG009|NOT COMPLETED|Overall Study||13||
59724631|NCT00932373|75843318|FG010|NOT COMPLETED|Overall Study||3||
59724632|NCT01055496|75843352|FG000|STARTED|Overall Study||48||
59724633|NCT01055496|75843353|FG001|STARTED|Overall Study||55||
59724634|NCT01055496|75843352|FG000|COMPLETED|Overall Study||33||
59853197|NCT00003476|75977715|FG000|NOT COMPLETED|Overall Study||1||
59853198|NCT00003470|75977719|FG000|STARTED|Overall Study||27||
59853199|NCT00003470|75977719|FG000|COMPLETED|Overall Study||21||
59853200|NCT00003470|75977719|FG000|NOT COMPLETED|Overall Study||6||
59853201|NCT03386344|75977726|FG000|STARTED|Overall Study||126||
59853202|NCT03386344|75977727|FG001|STARTED|Overall Study||125||
59853203|NCT03386344|75977728|FG002|STARTED|Overall Study||125||
59853204|NCT03386344|75977726|FG000|COMPLETED|Overall Study||9||
59853205|NCT03386344|75977727|FG001|COMPLETED|Overall Study||9||
59853206|NCT03386344|75977728|FG002|COMPLETED|Overall Study||9||
59853207|NCT03386344|75977726|FG000|NOT COMPLETED|Overall Study||117||
59853208|NCT03386344|75977727|FG001|NOT COMPLETED|Overall Study||116||
59853209|NCT03386344|75977728|FG002|NOT COMPLETED|Overall Study||116||
59853210|NCT00399035|75977739|FG000|STARTED|Overall Study||502||
59853211|NCT00399035|75977740|FG001|STARTED|Overall Study||216||
59853212|NCT00399035|75977741|FG002|STARTED|Overall Study||358||
59853213|NCT00399035|75977739|FG000|COMPLETED|Overall Study||189||
59853214|NCT00399035|75977740|FG001|COMPLETED|Overall Study||58||
59853215|NCT00399035|75977741|FG002|COMPLETED|Overall Study||106||
59853216|NCT00399035|75977739|FG000|NOT COMPLETED|Overall Study||313||
59853217|NCT00399035|75977740|FG001|NOT COMPLETED|Overall Study||158||
59853218|NCT00399035|75977741|FG002|NOT COMPLETED|Overall Study||252||
59853219|NCT00073749|75977755|FG000|STARTED|Overall Study||2||
59853220|NCT00073749|75977756|FG001|STARTED|Overall Study||5||
59853221|NCT00073749|75977757|FG002|STARTED|Overall Study||11||
59853222|NCT00073749|75977758|FG003|STARTED|Overall Study||6||
59853223|NCT00073749|75977759|FG004|STARTED|Overall Study||6||
59853224|NCT00073749|75977760|FG005|STARTED|Overall Study||6||
59853225|NCT00073749|75977761|FG006|STARTED|Overall Study||43||
59853226|NCT00073749|75977755|FG000|COMPLETED|Overall Study||0||
59853227|NCT00073749|75977756|FG001|COMPLETED|Overall Study||0||
59853228|NCT00073749|75977757|FG002|COMPLETED|Overall Study||0||
59853229|NCT00073749|75977758|FG003|COMPLETED|Overall Study||0||
59853230|NCT00073749|75977759|FG004|COMPLETED|Overall Study||0||
59584694|NCT04160975|75691340|FG000|NOT COMPLETED|Overall Study||64||
59584695|NCT04160975|75691341|FG001|NOT COMPLETED|Overall Study||66||
59584696|NCT04160975|75691342|FG002|NOT COMPLETED|Overall Study||61||
59584697|NCT04160975|75691343|FG003|NOT COMPLETED|Overall Study||75||
59584698|NCT04160975|75691344|FG004|NOT COMPLETED|Overall Study||35||
59584699|NCT04160975|75691345|FG005|NOT COMPLETED|Overall Study||51||
59584700|NCT04153409|75691360|FG000|STARTED|Overall Study||10||
59584701|NCT04153409|75691361|FG001|STARTED|Overall Study||11||
59584702|NCT04153409|75691360|FG000|COMPLETED|Overall Study||8||
59584703|NCT04153409|75691361|FG001|COMPLETED|Overall Study||9||
59584704|NCT04153409|75691360|FG000|NOT COMPLETED|Overall Study||2||
59584705|NCT04153409|75691361|FG001|NOT COMPLETED|Overall Study||2||
59584706|NCT01638390|75691367|FG000|STARTED|Overall Study|enrolled|357||
59584707|NCT01638390|75691367|FG000|COMPLETED|Overall Study|treated eyes|336||
59584708|NCT01638390|75691367|FG000|NOT COMPLETED|Overall Study||21||
59584709|NCT03535571|75691378|FG000|STARTED|Overall Study||20||
59584710|NCT03535571|75691378|FG000|COMPLETED|Overall Study||19||
59724635|NCT01055496|75843353|FG001|COMPLETED|Overall Study||25||
59724636|NCT01055496|75843352|FG000|NOT COMPLETED|Overall Study||15||
59853231|NCT00073749|75977760|FG005|COMPLETED|Overall Study||0||
59853232|NCT00073749|75977761|FG006|COMPLETED|Overall Study||3||
59853233|NCT00073749|75977755|FG000|NOT COMPLETED|Overall Study||2||
59853234|NCT00073749|75977756|FG001|NOT COMPLETED|Overall Study||5||
59853235|NCT00073749|75977757|FG002|NOT COMPLETED|Overall Study||11||
59853236|NCT00073749|75977758|FG003|NOT COMPLETED|Overall Study||6||
59853237|NCT00073749|75977759|FG004|NOT COMPLETED|Overall Study||6||
59584711|NCT03535571|75691378|FG000|NOT COMPLETED|Overall Study||1||
59724637|NCT01055496|75843353|FG001|NOT COMPLETED|Overall Study||30||
59724638|NCT01055262|75843380|FG000|STARTED|Overall Study||169||
59724639|NCT01055262|75843380|FG000|COMPLETED|Overall Study||160||
59724640|NCT01055262|75843380|FG000|NOT COMPLETED|Overall Study||9||
59724641|NCT01052844|75843386|FG000|STARTED|Overall Study||40||
59724642|NCT01052844|75843387|FG001|STARTED|Overall Study||40||
59724643|NCT01052844|75843386|FG000|COMPLETED|Overall Study||40||
59724644|NCT01052844|75843387|FG001|COMPLETED|Overall Study||39||
59724645|NCT01052844|75843386|FG000|NOT COMPLETED|Overall Study||0||
59724646|NCT01052844|75843387|FG001|NOT COMPLETED|Overall Study||1||
59724647|NCT01049412|75843395|FG000|STARTED|Period I||70||
59853238|NCT00073749|75977760|FG005|NOT COMPLETED|Overall Study||6||
59853239|NCT00073749|75977761|FG006|NOT COMPLETED|Overall Study||40||
59853240|NCT00398567|75977783|FG000|STARTED|Overall Study||4||
59853241|NCT00398567|75977784|FG001|STARTED|Overall Study||4||
59853242|NCT00398567|75977785|FG002|STARTED|Overall Study||37||
59853243|NCT00398567|75977783|FG000|COMPLETED|Overall Study||0||
59853244|NCT00398567|75977784|FG001|COMPLETED|Overall Study||0||
59853245|NCT00398567|75977785|FG002|COMPLETED|Overall Study||3||
59853246|NCT00398567|75977783|FG000|NOT COMPLETED|Overall Study||4||
59853247|NCT00398567|75977784|FG001|NOT COMPLETED|Overall Study||4||
59853248|NCT00398567|75977785|FG002|NOT COMPLETED|Overall Study||34||
59853249|NCT05249569|75977791|FG000|STARTED|Overall Study||1||
59853250|NCT05249569|75977791|FG000|COMPLETED|Overall Study||0||
59853251|NCT05249569|75977791|FG000|NOT COMPLETED|Overall Study||1||
59853252|NCT04855240|75977798|FG000|STARTED|Overall Study||81||
59853253|NCT04855240|75977799|FG001|STARTED|Overall Study||78||
59853254|NCT04855240|75977800|FG002|STARTED|Overall Study||80||
59853255|NCT04855240|75977798|FG000|COMPLETED|Overall Study||77||
59853256|NCT04855240|75977799|FG001|COMPLETED|Overall Study||73||
59853257|NCT04855240|75977800|FG002|COMPLETED|Overall Study||75||
59853258|NCT04855240|75977798|FG000|NOT COMPLETED|Overall Study||4||
59853259|NCT04855240|75977799|FG001|NOT COMPLETED|Overall Study||5||
59853260|NCT04855240|75977800|FG002|NOT COMPLETED|Overall Study||5||
59853261|NCT04779879|75977814|FG000|STARTED|Part A: Up to Week 24||8||
59853262|NCT04779879|75977815|FG001|STARTED|Part A: Up to Week 24||22||
59853263|NCT04779879|75977816|FG002|STARTED|Part A: Up to Week 24||0||
59853264|NCT04779879|75977817|FG003|STARTED|Part A: Up to Week 24||0||
59853265|NCT04779879|75977818|FG004|STARTED|Part A: Up to Week 24||0||
59853266|NCT04779879|75977819|FG005|STARTED|Part A: Up to Week 24||0||
59853267|NCT04779879|75977814|FG000|Treatment Received|Part A: Up to Week 24||8||
59853268|NCT04779879|75977815|FG001|Treatment Received|Part A: Up to Week 24||22||
59853269|NCT04779879|75977816|FG002|Treatment Received|Part A: Up to Week 24||0||
60121608|NCT01683071|76242507|FG001|STARTED|Part 2||0||
60121609|NCT01683071|76242508|FG002|STARTED|Part 2||0||
60121610|NCT01683071|76242509|FG003|STARTED|Part 2||0||
60121611|NCT01683071|76242510|FG004|STARTED|Part 2||99||
60121612|NCT01683071|76242511|FG005|STARTED|Part 2||97||
60121613|NCT01683071|76242506|FG000|COMPLETED|Part 2||0||
60121614|NCT01683071|76242507|FG001|COMPLETED|Part 2||0||
60121615|NCT01683071|76242508|FG002|COMPLETED|Part 2||0||
60121616|NCT01683071|76242509|FG003|COMPLETED|Part 2||0||
60121617|NCT01683071|76242510|FG004|COMPLETED|Part 2||82||
60121618|NCT01683071|76242511|FG005|COMPLETED|Part 2||82||
60121619|NCT01683071|76242506|FG000|NOT COMPLETED|Part 2||0||
60121620|NCT01683071|76242507|FG001|NOT COMPLETED|Part 2||0||
60121621|NCT01683071|76242508|FG002|NOT COMPLETED|Part 2||0||
59584712|NCT03675581|75691384|FG000|STARTED|Period 1: Microgynon Alone||17||
59584713|NCT03675581|75691384|FG000|COMPLETED|Period 1: Microgynon Alone||17||
59584714|NCT03675581|75691384|FG000|NOT COMPLETED|Period 1: Microgynon Alone||0||
59584715|NCT03675581|75691384|FG000|STARTED|Period 2: Microgynon + Nintedanib||17||
59584716|NCT03675581|75691384|FG000|COMPLETED|Period 2: Microgynon + Nintedanib||17||
59584717|NCT03675581|75691384|FG000|NOT COMPLETED|Period 2: Microgynon + Nintedanib||0||
59584718|NCT03678311|75691392|FG000|STARTED|Overall Study||9||
59584719|NCT03678311|75691392|FG000|COMPLETED|Overall Study||9||
59584720|NCT03678311|75691392|FG000|NOT COMPLETED|Overall Study||0||
59724648|NCT01049412|75843396|FG001|STARTED|Period I||68||
59724649|NCT01049412|75843395|FG000|Took at Least One Dose of Study Drug|Period I||69||
59724650|NCT01049412|75843396|FG001|Took at Least One Dose of Study Drug|Period I||68||
59724651|NCT01049412|75843395|FG000|COMPLETED|Period I||62||
59724652|NCT01049412|75843396|FG001|COMPLETED|Period I||55||
59724653|NCT01049412|75843395|FG000|NOT COMPLETED|Period I||8||
59724654|NCT01049412|75843396|FG001|NOT COMPLETED|Period I||13||
59724655|NCT01049412|75843395|FG000|STARTED|Period II||62||
60121622|NCT01683071|76242509|FG003|NOT COMPLETED|Part 2||0||
60121623|NCT01683071|76242510|FG004|NOT COMPLETED|Part 2||17||
60121624|NCT01683071|76242511|FG005|NOT COMPLETED|Part 2||15||
60121625|NCT01567865|76242535|FG000|STARTED|Enrolled and Vaccinated (Day 0)||163||
60121626|NCT01567865|76242536|FG001|STARTED|Enrolled and Vaccinated (Day 0)||220||
60121627|NCT01567865|76242537|FG002|STARTED|Enrolled and Vaccinated (Day 0)||211||
60121628|NCT01567865|76242538|FG003|STARTED|Enrolled and Vaccinated (Day 0)||224||
60121629|NCT01567865|76242535|FG000|COMPLETED|Enrolled and Vaccinated (Day 0)||163||
60121630|NCT01567865|76242536|FG001|COMPLETED|Enrolled and Vaccinated (Day 0)||220||
60121631|NCT01567865|76242537|FG002|COMPLETED|Enrolled and Vaccinated (Day 0)||211||
59584721|NCT01600716|75691398|FG000|STARTED|Overall Study||66||
59584722|NCT01600716|75691399|FG001|STARTED|Overall Study||78||
59584723|NCT01600716|75691398|FG000|COMPLETED|Overall Study||59||
59724656|NCT01049412|75843396|FG001|STARTED|Period II||55||
59724657|NCT01049412|75843395|FG000|COMPLETED|Period II||58||
59853270|NCT04779879|75977817|FG003|Treatment Received|Part A: Up to Week 24||0||
59853271|NCT04779879|75977818|FG004|Treatment Received|Part A: Up to Week 24||0||
59853272|NCT04779879|75977819|FG005|Treatment Received|Part A: Up to Week 24||0||
60121632|NCT01567865|76242538|FG003|COMPLETED|Enrolled and Vaccinated (Day 0)||224||
60121633|NCT01567865|76242535|FG000|NOT COMPLETED|Enrolled and Vaccinated (Day 0)||0||
60121634|NCT01567865|76242536|FG001|NOT COMPLETED|Enrolled and Vaccinated (Day 0)||0||
60121635|NCT01567865|76242537|FG002|NOT COMPLETED|Enrolled and Vaccinated (Day 0)||0||
60121636|NCT01567865|76242538|FG003|NOT COMPLETED|Enrolled and Vaccinated (Day 0)||0||
60121637|NCT01567865|76242535|FG000|STARTED|Evaluated for Immunogenicity||163||
60121638|NCT01567865|76242536|FG001|STARTED|Evaluated for Immunogenicity||220||
60121639|NCT01567865|76242537|FG002|STARTED|Evaluated for Immunogenicity||211||
59853273|NCT04779879|75977814|FG000|COMPLETED|Part A: Up to Week 24||8||
59853274|NCT04779879|75977815|FG001|COMPLETED|Part A: Up to Week 24||22||
59853275|NCT04779879|75977816|FG002|COMPLETED|Part A: Up to Week 24||0||
59853276|NCT04779879|75977817|FG003|COMPLETED|Part A: Up to Week 24||0||
59853277|NCT04779879|75977818|FG004|COMPLETED|Part A: Up to Week 24||0||
59853278|NCT04779879|75977819|FG005|COMPLETED|Part A: Up to Week 24||0||
59853279|NCT04779879|75977814|FG000|NOT COMPLETED|Part A: Up to Week 24||0||
59853280|NCT04779879|75977815|FG001|NOT COMPLETED|Part A: Up to Week 24||0||
59853281|NCT04779879|75977816|FG002|NOT COMPLETED|Part A: Up to Week 24||0||
59853282|NCT04779879|75977817|FG003|NOT COMPLETED|Part A: Up to Week 24||0||
59853283|NCT04779879|75977818|FG004|NOT COMPLETED|Part A: Up to Week 24||0||
59853284|NCT04779879|75977819|FG005|NOT COMPLETED|Part A: Up to Week 24||0||
59853285|NCT04779879|75977814|FG000|STARTED|Part B: Up to Week 36||0||
59853286|NCT04779879|75977815|FG001|STARTED|Part B: Up to Week 36||0||
59584724|NCT01600716|75691399|FG001|COMPLETED|Overall Study||71||
59584725|NCT01600716|75691398|FG000|NOT COMPLETED|Overall Study||7||
59584726|NCT01600716|75691399|FG001|NOT COMPLETED|Overall Study||7||
59584727|NCT03680105|75691416|FG000|STARTED|Overall Study||8||
59584728|NCT03680105|75691417|FG001|STARTED|Overall Study||8||
59584729|NCT03680105|75691418|FG002|STARTED|Overall Study||8||
59584730|NCT03680105|75691419|FG003|STARTED|Overall Study||8||
59584731|NCT03680105|75691420|FG004|STARTED|Overall Study||8||
59584732|NCT03680105|75691421|FG005|STARTED|Overall Study||12||
59584733|NCT03680105|75691422|FG006|STARTED|Overall Study||8||
59584734|NCT03680105|75691423|FG007|STARTED|Overall Study||8||
59584735|NCT03680105|75691424|FG008|STARTED|Overall Study||8||
59584736|NCT03680105|75691416|FG000|COMPLETED|Overall Study||8||
59584737|NCT03680105|75691417|FG001|COMPLETED|Overall Study||8||
59584738|NCT03680105|75691418|FG002|COMPLETED|Overall Study||8||
59584739|NCT03680105|75691419|FG003|COMPLETED|Overall Study||8||
59584740|NCT03680105|75691420|FG004|COMPLETED|Overall Study||8||
59584741|NCT03680105|75691421|FG005|COMPLETED|Overall Study||12||
59584742|NCT03680105|75691422|FG006|COMPLETED|Overall Study||8||
59584743|NCT03680105|75691423|FG007|COMPLETED|Overall Study||8||
59584744|NCT03680105|75691424|FG008|COMPLETED|Overall Study||8||
59584745|NCT03680105|75691416|FG000|NOT COMPLETED|Overall Study||0||
59584746|NCT03680105|75691417|FG001|NOT COMPLETED|Overall Study||0||
59584747|NCT03680105|75691418|FG002|NOT COMPLETED|Overall Study||0||
59584748|NCT03680105|75691419|FG003|NOT COMPLETED|Overall Study||0||
59584749|NCT03680105|75691420|FG004|NOT COMPLETED|Overall Study||0||
59584750|NCT03680105|75691421|FG005|NOT COMPLETED|Overall Study||0||
59584751|NCT03680105|75691422|FG006|NOT COMPLETED|Overall Study||0||
59584752|NCT03680105|75691423|FG007|NOT COMPLETED|Overall Study||0||
59584753|NCT03680105|75691424|FG008|NOT COMPLETED|Overall Study||0||
59584754|NCT03535649|75691448|FG000|STARTED|Overall Study||105||
59584755|NCT03535649|75691448|FG000|COMPLETED|Overall Study||105||
59584756|NCT03535649|75691448|FG000|NOT COMPLETED|Overall Study||0||
59584757|NCT03536819|75691452|FG000|STARTED|Overall Study||20||
59584758|NCT03536819|75691452|FG000|COMPLETED|Overall Study||15||
59584759|NCT03536819|75691452|FG000|NOT COMPLETED|Overall Study||5||
59584760|NCT03796442|75691458|FG000|STARTED|Overall Study||70||
59584761|NCT03796442|75691459|FG001|STARTED|Overall Study||70||
59584762|NCT03796442|75691458|FG000|COMPLETED|Overall Study||66||
59584763|NCT03796442|75691459|FG001|COMPLETED|Overall Study||63||
59584764|NCT03796442|75691458|FG000|NOT COMPLETED|Overall Study||4||
59584765|NCT03796442|75691459|FG001|NOT COMPLETED|Overall Study||7||
59584766|NCT03688685|75691465|FG000|STARTED|Overall Study||25||
59584767|NCT03688685|75691465|FG000|COMPLETED|Overall Study||21||
59584768|NCT03688685|75691465|FG000|NOT COMPLETED|Overall Study||4||
59584769|NCT04113785|75691469|FG000|STARTED|Overall Study||21||
59584770|NCT04113785|75691469|FG000|COMPLETED|Overall Study||21||
59584771|NCT04113785|75691469|FG000|NOT COMPLETED|Overall Study||0||
59584772|NCT04112069|75691473|FG000|STARTED|Overall Study||10||
59853287|NCT04779879|75977816|FG002|STARTED|Part B: Up to Week 36||84||
59584773|NCT04112069|75691474|FG001|STARTED|Overall Study||10||
59853288|NCT04779879|75977817|FG003|STARTED|Part B: Up to Week 36||83||
59853289|NCT04779879|75977818|FG004|STARTED|Part B: Up to Week 36||0||
59853290|NCT04779879|75977819|FG005|STARTED|Part B: Up to Week 36||0||
59853291|NCT04779879|75977814|FG000|Treatment Received|Part B: Up to Week 36||0||
59853292|NCT04779879|75977815|FG001|Treatment Received|Part B: Up to Week 36||0||
59853293|NCT04779879|75977816|FG002|Treatment Received|Part B: Up to Week 36||84||
59853294|NCT04779879|75977817|FG003|Treatment Received|Part B: Up to Week 36||82||
59853295|NCT04779879|75977818|FG004|Treatment Received|Part B: Up to Week 36||0||
59584774|NCT04112069|75691473|FG000|COMPLETED|Overall Study||10||
59584775|NCT04112069|75691474|FG001|COMPLETED|Overall Study||10||
59584776|NCT04112069|75691473|FG000|NOT COMPLETED|Overall Study||0||
59584777|NCT04112069|75691474|FG001|NOT COMPLETED|Overall Study||0||
59584778|NCT03544307|75691482|FG000|STARTED|Overall Study||10||
59584779|NCT03544307|75691483|FG001|STARTED|Overall Study||10||
59584780|NCT03544307|75691482|FG000|COMPLETED|Overall Study||10||
59584781|NCT03544307|75691483|FG001|COMPLETED|Overall Study||10||
59584782|NCT03544307|75691482|FG000|NOT COMPLETED|Overall Study||0||
59584783|NCT03544307|75691483|FG001|NOT COMPLETED|Overall Study||0||
59853296|NCT04779879|75977819|FG005|Treatment Received|Part B: Up to Week 36||0||
59853297|NCT04779879|75977814|FG000|COMPLETED|Part B: Up to Week 36||0||
59853298|NCT04779879|75977815|FG001|COMPLETED|Part B: Up to Week 36||0||
59853299|NCT04779879|75977816|FG002|COMPLETED|Part B: Up to Week 36||84||
59853300|NCT04779879|75977817|FG003|COMPLETED|Part B: Up to Week 36||81||
59853301|NCT04779879|75977818|FG004|COMPLETED|Part B: Up to Week 36||0||
59853302|NCT04779879|75977819|FG005|COMPLETED|Part B: Up to Week 36||0||
59853303|NCT04779879|75977814|FG000|NOT COMPLETED|Part B: Up to Week 36||0||
59853304|NCT04779879|75977815|FG001|NOT COMPLETED|Part B: Up to Week 36||0||
59853305|NCT04779879|75977816|FG002|NOT COMPLETED|Part B: Up to Week 36||0||
59853306|NCT04779879|75977817|FG003|NOT COMPLETED|Part B: Up to Week 36||2||
59853307|NCT04779879|75977818|FG004|NOT COMPLETED|Part B: Up to Week 36||0||
59853308|NCT04779879|75977819|FG005|NOT COMPLETED|Part B: Up to Week 36||0||
59853309|NCT04779879|75977814|FG000|STARTED|Part C: Up to Week 36||0||
59853310|NCT04779879|75977815|FG001|STARTED|Part C: Up to Week 36||0||
59853311|NCT04779879|75977816|FG002|STARTED|Part C: Up to Week 36||0||
59853312|NCT04779879|75977817|FG003|STARTED|Part C: Up to Week 36||0||
59853313|NCT04779879|75977818|FG004|STARTED|Part C: Up to Week 36||79||
59853314|NCT04779879|75977819|FG005|STARTED|Part C: Up to Week 36||78||
59853315|NCT04779879|75977814|FG000|Treatment Received|Part C: Up to Week 36||0||
59853316|NCT04779879|75977815|FG001|Treatment Received|Part C: Up to Week 36||0||
59853317|NCT04779879|75977816|FG002|Treatment Received|Part C: Up to Week 36||0||
59853318|NCT04779879|75977817|FG003|Treatment Received|Part C: Up to Week 36||0||
59853319|NCT04779879|75977818|FG004|Treatment Received|Part C: Up to Week 36||79||
59853320|NCT04779879|75977819|FG005|Treatment Received|Part C: Up to Week 36||78||
59853321|NCT04779879|75977814|FG000|COMPLETED|Part C: Up to Week 36||0||
59853322|NCT04779879|75977815|FG001|COMPLETED|Part C: Up to Week 36||0||
59853323|NCT04779879|75977816|FG002|COMPLETED|Part C: Up to Week 36||0||
59853324|NCT04779879|75977817|FG003|COMPLETED|Part C: Up to Week 36||0||
59853325|NCT04779879|75977818|FG004|COMPLETED|Part C: Up to Week 36||75||
59853326|NCT04779879|75977819|FG005|COMPLETED|Part C: Up to Week 36||75||
59853327|NCT04779879|75977814|FG000|NOT COMPLETED|Part C: Up to Week 36||0||
59853328|NCT04779879|75977815|FG001|NOT COMPLETED|Part C: Up to Week 36||0||
59853329|NCT04779879|75977816|FG002|NOT COMPLETED|Part C: Up to Week 36||0||
59853330|NCT04779879|75977817|FG003|NOT COMPLETED|Part C: Up to Week 36||0||
59853331|NCT04779879|75977818|FG004|NOT COMPLETED|Part C: Up to Week 36||4||
59853332|NCT04779879|75977819|FG005|NOT COMPLETED|Part C: Up to Week 36||3||
59853333|NCT04574583|75977839|FG000|STARTED|Overall Study||3||
59853334|NCT04574583|75977840|FG001|STARTED|Overall Study||6||
59853335|NCT04574583|75977841|FG002|STARTED|Overall Study||3||
59853336|NCT04574583|75977839|FG000|COMPLETED|Overall Study||3||
59853337|NCT04574583|75977840|FG001|COMPLETED|Overall Study||6||
59853338|NCT04574583|75977841|FG002|COMPLETED|Overall Study||3||
59853339|NCT04574583|75977839|FG000|NOT COMPLETED|Overall Study||0||
59853340|NCT04574583|75977840|FG001|NOT COMPLETED|Overall Study||0||
59853341|NCT04574583|75977841|FG002|NOT COMPLETED|Overall Study||0||
59853342|NCT04535167|75977860|FG000|STARTED|Treatment||2||
59853343|NCT04535167|75977861|FG001|STARTED|Treatment||2||
59853344|NCT04535167|75977862|FG002|STARTED|Treatment||2||
59853345|NCT04535167|75977863|FG003|STARTED|Treatment||2||
59853346|NCT04535167|75977864|FG004|STARTED|Treatment||6||
59853347|NCT04535167|75977865|FG005|STARTED|Treatment||7||
59853348|NCT04535167|75977866|FG006|STARTED|Treatment||4||
59853349|NCT04535167|75977860|FG000|COMPLETED|Treatment||2||
59853350|NCT04535167|75977861|FG001|COMPLETED|Treatment||2||
59853351|NCT04535167|75977862|FG002|COMPLETED|Treatment||2||
59853352|NCT04535167|75977863|FG003|COMPLETED|Treatment||2||
59853353|NCT04535167|75977864|FG004|COMPLETED|Treatment||6||
59853354|NCT04535167|75977865|FG005|COMPLETED|Treatment||7||
59853355|NCT04535167|75977866|FG006|COMPLETED|Treatment||3||
59853356|NCT04535167|75977860|FG000|NOT COMPLETED|Treatment||0||
59853357|NCT04535167|75977861|FG001|NOT COMPLETED|Treatment||0||
59853358|NCT04535167|75977862|FG002|NOT COMPLETED|Treatment||0||
59853359|NCT04535167|75977863|FG003|NOT COMPLETED|Treatment||0||
59853360|NCT04535167|75977864|FG004|NOT COMPLETED|Treatment||0||
59584784|NCT04086407|75691489|FG000|STARTED|Overall Study||8||
59584785|NCT04086407|75691489|FG000|COMPLETED|Overall Study||8||
59853361|NCT04535167|75977865|FG005|NOT COMPLETED|Treatment||0||
59853362|NCT04535167|75977866|FG006|NOT COMPLETED|Treatment||1||
59853363|NCT04535167|75977860|FG000|STARTED|Follow-Up||2||
59853364|NCT04535167|75977861|FG001|STARTED|Follow-Up||2||
59853365|NCT04535167|75977862|FG002|STARTED|Follow-Up||2||
59853366|NCT04535167|75977863|FG003|STARTED|Follow-Up||2||
59853367|NCT04535167|75977864|FG004|STARTED|Follow-Up||6||
59853368|NCT04535167|75977865|FG005|STARTED|Follow-Up||7||
59853369|NCT04535167|75977866|FG006|STARTED|Follow-Up|Participant may or may not continued in follow-up period after discontinuing from the treatment period.|4||
59853370|NCT04535167|75977860|FG000|COMPLETED|Follow-Up||2||
59853371|NCT04535167|75977861|FG001|COMPLETED|Follow-Up||2||
59853372|NCT04535167|75977862|FG002|COMPLETED|Follow-Up||2||
59853373|NCT04535167|75977863|FG003|COMPLETED|Follow-Up||1||
59853374|NCT04535167|75977864|FG004|COMPLETED|Follow-Up||6||
59853375|NCT04535167|75977865|FG005|COMPLETED|Follow-Up||7||
59853376|NCT04535167|75977866|FG006|COMPLETED|Follow-Up||3||
59853377|NCT04535167|75977860|FG000|NOT COMPLETED|Follow-Up||0||
59853378|NCT04535167|75977861|FG001|NOT COMPLETED|Follow-Up||0||
59853379|NCT04535167|75977862|FG002|NOT COMPLETED|Follow-Up||0||
59853380|NCT04535167|75977863|FG003|NOT COMPLETED|Follow-Up||1||
59853381|NCT04535167|75977864|FG004|NOT COMPLETED|Follow-Up||0||
59853382|NCT04535167|75977865|FG005|NOT COMPLETED|Follow-Up||0||
59853383|NCT04535167|75977866|FG006|NOT COMPLETED|Follow-Up||1||
59853384|NCT04223791|75977884|FG000|STARTED|Overall Study||322||
59853385|NCT04223791|75977885|FG001|STARTED|Overall Study||321||
59853386|NCT04223791|75977884|FG000|Treated|Overall Study||322||
59853387|NCT04223791|75977885|FG001|Treated|Overall Study||319||
59853388|NCT04223791|75977884|FG000|COMPLETED|Overall Study||0||
59853389|NCT04223791|75977885|FG001|COMPLETED|Overall Study||0||
59853390|NCT04223791|75977884|FG000|NOT COMPLETED|Overall Study||322||
59853391|NCT04223791|75977885|FG001|NOT COMPLETED|Overall Study||321||
59853392|NCT04115293|75977893|FG000|STARTED|Overall Study||88||
59853393|NCT04115293|75977894|FG001|STARTED|Overall Study||86||
59853394|NCT04115293|75977893|FG000|COMPLETED|Overall Study||84||
59853395|NCT04115293|75977894|FG001|COMPLETED|Overall Study||82||
59853396|NCT04115293|75977893|FG000|NOT COMPLETED|Overall Study||4||
59853397|NCT04115293|75977894|FG001|NOT COMPLETED|Overall Study||4||
59853398|NCT04035499|75977900|FG000|STARTED|Overall Study||25||
59853399|NCT04035499|75977900|FG000|COMPLETED|Overall Study||22||
59853400|NCT04035499|75977900|FG000|NOT COMPLETED|Overall Study||3||
59853401|NCT03915067|75977907|FG000|STARTED|Overall Study||57||
59853402|NCT03915067|75977908|FG001|STARTED|Overall Study||59||
59853403|NCT03915067|75977909|FG002|STARTED|Overall Study||55||
59853404|NCT03915067|75977907|FG000|Modified Intent-to-treat (mITT) Population|Overall Study||53|mITT population included all randomized participants who had at least 1 post-baseline assessment of the primary efficacy parameter, the C-APPS, as described in the protocol.|
59853405|NCT03915067|75977908|FG001|Modified Intent-to-treat (mITT) Population|Overall Study||58|mITT population included all randomized participants who had at least 1 post-baseline assessment of the primary efficacy parameter, the C-APPS, as described in the protocol.|
59853406|NCT03915067|75977909|FG002|Modified Intent-to-treat (mITT) Population|Overall Study||53|mITT population included all randomized participants who had at least 1 post-baseline assessment of the primary efficacy parameter, the C-APPS, as described in the protocol.|
59853407|NCT03915067|75977907|FG000|Safety Population|Overall Study||56|Safety population included all participants who were administered study intervention.|
59853408|NCT03915067|75977908|FG001|Safety Population|Overall Study||59|Safety population included all participants who were administered study intervention.|
59853409|NCT03915067|75977909|FG002|Safety Population|Overall Study||54|Safety population included all participants who were administered study intervention.|
59853410|NCT03915067|75977907|FG000|COMPLETED|Overall Study||47||
59853411|NCT03915067|75977908|FG001|COMPLETED|Overall Study||50||
59853412|NCT03915067|75977909|FG002|COMPLETED|Overall Study||49||
59853413|NCT03915067|75977907|FG000|NOT COMPLETED|Overall Study||10||
59853414|NCT03915067|75977908|FG001|NOT COMPLETED|Overall Study||9||
59853415|NCT03915067|75977909|FG002|NOT COMPLETED|Overall Study||6||
59853416|NCT03654404|75977917|FG000|STARTED|Overall Study||20||
59853417|NCT03654404|75977917|FG000|COMPLETED|Overall Study||12||
59853418|NCT03654404|75977917|FG000|NOT COMPLETED|Overall Study||8||
59853419|NCT03550118|75977929|FG000|STARTED|Overall Study||15||
59853420|NCT03550118|75977930|FG001|STARTED|Overall Study||13||
59853421|NCT03550118|75977931|FG002|STARTED|Overall Study||12||
59853422|NCT03550118|75977932|FG003|STARTED|Overall Study||13||
59853423|NCT03550118|75977933|FG004|STARTED|Overall Study||7||
59853424|NCT03550118|75977934|FG005|STARTED|Overall Study||14||
59853425|NCT03550118|75977935|FG006|STARTED|Overall Study||12||
59853426|NCT03550118|75977936|FG007|STARTED|Overall Study||18||
60121640|NCT01567865|76242538|FG003|STARTED|Evaluated for Immunogenicity||224||
59853427|NCT03550118|75977929|FG000|COMPLETED|Overall Study||10||
59853428|NCT03550118|75977930|FG001|COMPLETED|Overall Study||12||
59853429|NCT03550118|75977931|FG002|COMPLETED|Overall Study||10||
59853430|NCT03550118|75977932|FG003|COMPLETED|Overall Study||12||
60121641|NCT01567865|76242535|FG000|COMPLETED|Evaluated for Immunogenicity||146||
60121642|NCT01567865|76242536|FG001|COMPLETED|Evaluated for Immunogenicity||195||
60121643|NCT01567865|76242537|FG002|COMPLETED|Evaluated for Immunogenicity||192||
59853431|NCT03550118|75977933|FG004|COMPLETED|Overall Study||6||
59853432|NCT03550118|75977934|FG005|COMPLETED|Overall Study||12||
59853433|NCT03550118|75977935|FG006|COMPLETED|Overall Study||12||
59853434|NCT03550118|75977936|FG007|COMPLETED|Overall Study||12||
59853435|NCT03550118|75977929|FG000|NOT COMPLETED|Overall Study||5||
59853436|NCT03550118|75977930|FG001|NOT COMPLETED|Overall Study||1||
59853437|NCT03550118|75977931|FG002|NOT COMPLETED|Overall Study||2||
59853438|NCT03550118|75977932|FG003|NOT COMPLETED|Overall Study||1||
59853439|NCT03550118|75977933|FG004|NOT COMPLETED|Overall Study||1||
59853440|NCT03550118|75977934|FG005|NOT COMPLETED|Overall Study||2||
59853441|NCT03550118|75977935|FG006|NOT COMPLETED|Overall Study||0||
59853442|NCT03550118|75977936|FG007|NOT COMPLETED|Overall Study||6||
59853443|NCT03503396|75977957|FG000|STARTED|Overall Study||24||
59853444|NCT03503396|75977958|FG001|STARTED|Overall Study||24||
59853445|NCT03503396|75977957|FG000|COMPLETED|Overall Study||22||
59853446|NCT03503396|75977958|FG001|COMPLETED|Overall Study||24||
60121644|NCT01567865|76242538|FG003|COMPLETED|Evaluated for Immunogenicity||194||
60121645|NCT01567865|76242535|FG000|NOT COMPLETED|Evaluated for Immunogenicity||17||
59853447|NCT03503396|75977957|FG000|NOT COMPLETED|Overall Study||2||
59853448|NCT03503396|75977958|FG001|NOT COMPLETED|Overall Study||0||
59853449|NCT03447314|75977982|FG000|STARTED|Part 1 (Up to 47 Months and 13 Days)||9||
59853450|NCT03447314|75977983|FG001|STARTED|Part 1 (Up to 47 Months and 13 Days)||6||
59853451|NCT03447314|75977984|FG002|STARTED|Part 1 (Up to 47 Months and 13 Days)||9||
59853452|NCT03447314|75977985|FG003|STARTED|Part 1 (Up to 47 Months and 13 Days)||4||
59853453|NCT03447314|75977986|FG004|STARTED|Part 1 (Up to 47 Months and 13 Days)||2||
59853454|NCT03447314|75977987|FG005|STARTED|Part 1 (Up to 47 Months and 13 Days)||6||
59853455|NCT03447314|75977988|FG006|STARTED|Part 1 (Up to 47 Months and 13 Days)||5||
59853456|NCT03447314|75977989|FG007|STARTED|Part 1 (Up to 47 Months and 13 Days)||0||
59853457|NCT03447314|75977990|FG008|STARTED|Part 1 (Up to 47 Months and 13 Days)||0||
59853458|NCT03447314|75977991|FG009|STARTED|Part 1 (Up to 47 Months and 13 Days)||0||
59853459|NCT03447314|75977992|FG010|STARTED|Part 1 (Up to 47 Months and 13 Days)||7||
59853460|NCT03447314|75977993|FG011|STARTED|Part 1 (Up to 47 Months and 13 Days)||6||
59853461|NCT03447314|75977994|FG012|STARTED|Part 1 (Up to 47 Months and 13 Days)||0||
59853462|NCT03447314|75977995|FG013|STARTED|Part 1 (Up to 47 Months and 13 Days)||0||
59853463|NCT03447314|75977996|FG014|STARTED|Part 1 (Up to 47 Months and 13 Days)||0||
59853464|NCT03447314|75977997|FG015|STARTED|Part 1 (Up to 47 Months and 13 Days)||0||
59853465|NCT03447314|75977998|FG016|STARTED|Part 1 (Up to 47 Months and 13 Days)||0||
59853466|NCT03447314|75977999|FG017|STARTED|Part 1 (Up to 47 Months and 13 Days)||0||
59853467|NCT03447314|75977982|FG000|COMPLETED|Part 1 (Up to 47 Months and 13 Days)||2||
59853468|NCT03447314|75977983|FG001|COMPLETED|Part 1 (Up to 47 Months and 13 Days)||1||
59853469|NCT03447314|75977984|FG002|COMPLETED|Part 1 (Up to 47 Months and 13 Days)||2||
59853470|NCT03447314|75977985|FG003|COMPLETED|Part 1 (Up to 47 Months and 13 Days)||0||
59853471|NCT03447314|75977986|FG004|COMPLETED|Part 1 (Up to 47 Months and 13 Days)||1||
59853472|NCT03447314|75977987|FG005|COMPLETED|Part 1 (Up to 47 Months and 13 Days)||0||
59853473|NCT03447314|75977988|FG006|COMPLETED|Part 1 (Up to 47 Months and 13 Days)||2||
59853474|NCT03447314|75977989|FG007|COMPLETED|Part 1 (Up to 47 Months and 13 Days)||0||
59853475|NCT03447314|75977990|FG008|COMPLETED|Part 1 (Up to 47 Months and 13 Days)||0||
59853476|NCT03447314|75977991|FG009|COMPLETED|Part 1 (Up to 47 Months and 13 Days)||0||
59853477|NCT03447314|75977992|FG010|COMPLETED|Part 1 (Up to 47 Months and 13 Days)||2||
59853478|NCT03447314|75977993|FG011|COMPLETED|Part 1 (Up to 47 Months and 13 Days)||3||
59853479|NCT03447314|75977994|FG012|COMPLETED|Part 1 (Up to 47 Months and 13 Days)||0||
59853480|NCT03447314|75977995|FG013|COMPLETED|Part 1 (Up to 47 Months and 13 Days)||0||
59853481|NCT03447314|75977996|FG014|COMPLETED|Part 1 (Up to 47 Months and 13 Days)||0||
59853482|NCT03447314|75977997|FG015|COMPLETED|Part 1 (Up to 47 Months and 13 Days)||0||
59853483|NCT03447314|75977998|FG016|COMPLETED|Part 1 (Up to 47 Months and 13 Days)||0||
59853484|NCT03447314|75977999|FG017|COMPLETED|Part 1 (Up to 47 Months and 13 Days)||0||
59853485|NCT03447314|75977982|FG000|NOT COMPLETED|Part 1 (Up to 47 Months and 13 Days)||7||
59853486|NCT03447314|75977983|FG001|NOT COMPLETED|Part 1 (Up to 47 Months and 13 Days)||5||
59853487|NCT03447314|75977984|FG002|NOT COMPLETED|Part 1 (Up to 47 Months and 13 Days)||7||
59853488|NCT03447314|75977985|FG003|NOT COMPLETED|Part 1 (Up to 47 Months and 13 Days)||4||
59853489|NCT03447314|75977986|FG004|NOT COMPLETED|Part 1 (Up to 47 Months and 13 Days)||1||
59853490|NCT03447314|75977987|FG005|NOT COMPLETED|Part 1 (Up to 47 Months and 13 Days)||6||
59853491|NCT03447314|75977988|FG006|NOT COMPLETED|Part 1 (Up to 47 Months and 13 Days)||3||
59853492|NCT03447314|75977989|FG007|NOT COMPLETED|Part 1 (Up to 47 Months and 13 Days)||0||
59853493|NCT03447314|75977990|FG008|NOT COMPLETED|Part 1 (Up to 47 Months and 13 Days)||0||
59853494|NCT03447314|75977991|FG009|NOT COMPLETED|Part 1 (Up to 47 Months and 13 Days)||0||
59853495|NCT03447314|75977992|FG010|NOT COMPLETED|Part 1 (Up to 47 Months and 13 Days)||5||
59853496|NCT03447314|75977993|FG011|NOT COMPLETED|Part 1 (Up to 47 Months and 13 Days)||3||
59853497|NCT03447314|75977994|FG012|NOT COMPLETED|Part 1 (Up to 47 Months and 13 Days)||0||
59853498|NCT03447314|75977995|FG013|NOT COMPLETED|Part 1 (Up to 47 Months and 13 Days)||0||
59853499|NCT03447314|75977996|FG014|NOT COMPLETED|Part 1 (Up to 47 Months and 13 Days)||0||
59853500|NCT03447314|75977997|FG015|NOT COMPLETED|Part 1 (Up to 47 Months and 13 Days)||0||
59853501|NCT03447314|75977998|FG016|NOT COMPLETED|Part 1 (Up to 47 Months and 13 Days)||0||
59853502|NCT03447314|75977999|FG017|NOT COMPLETED|Part 1 (Up to 47 Months and 13 Days)||0||
59853503|NCT03447314|75977982|FG000|STARTED|Part 2 (Up to 47 Months and 13 Days)||0||
59853504|NCT03447314|75977983|FG001|STARTED|Part 2 (Up to 47 Months and 13 Days)||0||
59853505|NCT03447314|75977984|FG002|STARTED|Part 2 (Up to 47 Months and 13 Days)||0||
59853506|NCT03447314|75977985|FG003|STARTED|Part 2 (Up to 47 Months and 13 Days)||0||
59853507|NCT03447314|75977986|FG004|STARTED|Part 2 (Up to 47 Months and 13 Days)||0||
59853508|NCT03447314|75977987|FG005|STARTED|Part 2 (Up to 47 Months and 13 Days)||0||
59853509|NCT03447314|75977988|FG006|STARTED|Part 2 (Up to 47 Months and 13 Days)||0||
59853510|NCT03447314|75977989|FG007|STARTED|Part 2 (Up to 47 Months and 13 Days)||0||
59853511|NCT03447314|75977990|FG008|STARTED|Part 2 (Up to 47 Months and 13 Days)||0||
59853512|NCT03447314|75977991|FG009|STARTED|Part 2 (Up to 47 Months and 13 Days)||0||
59853513|NCT03447314|75977992|FG010|STARTED|Part 2 (Up to 47 Months and 13 Days)||0||
59853514|NCT03447314|75977993|FG011|STARTED|Part 2 (Up to 47 Months and 13 Days)||0||
59853515|NCT03447314|75977994|FG012|STARTED|Part 2 (Up to 47 Months and 13 Days)||0||
59853516|NCT03447314|75977995|FG013|STARTED|Part 2 (Up to 47 Months and 13 Days)||0||
59853517|NCT03447314|75977996|FG014|STARTED|Part 2 (Up to 47 Months and 13 Days)||0||
59853518|NCT03447314|75977997|FG015|STARTED|Part 2 (Up to 47 Months and 13 Days)||0||
59853519|NCT03447314|75977998|FG016|STARTED|Part 2 (Up to 47 Months and 13 Days)||0||
59853520|NCT03447314|75977999|FG017|STARTED|Part 2 (Up to 47 Months and 13 Days)||0||
59853521|NCT03447314|75977982|FG000|COMPLETED|Part 2 (Up to 47 Months and 13 Days)||0||
59853522|NCT03447314|75977983|FG001|COMPLETED|Part 2 (Up to 47 Months and 13 Days)||0||
59853523|NCT03447314|75977984|FG002|COMPLETED|Part 2 (Up to 47 Months and 13 Days)||0||
59853524|NCT03447314|75977985|FG003|COMPLETED|Part 2 (Up to 47 Months and 13 Days)||0||
59853525|NCT03447314|75977986|FG004|COMPLETED|Part 2 (Up to 47 Months and 13 Days)||0||
59853526|NCT03447314|75977987|FG005|COMPLETED|Part 2 (Up to 47 Months and 13 Days)||0||
59853527|NCT03447314|75977988|FG006|COMPLETED|Part 2 (Up to 47 Months and 13 Days)||0||
59853528|NCT03447314|75977989|FG007|COMPLETED|Part 2 (Up to 47 Months and 13 Days)||0||
59853529|NCT03447314|75977990|FG008|COMPLETED|Part 2 (Up to 47 Months and 13 Days)||0||
59853530|NCT03447314|75977991|FG009|COMPLETED|Part 2 (Up to 47 Months and 13 Days)||0||
59853531|NCT03447314|75977992|FG010|COMPLETED|Part 2 (Up to 47 Months and 13 Days)||0||
59853532|NCT03447314|75977993|FG011|COMPLETED|Part 2 (Up to 47 Months and 13 Days)||0||
59853533|NCT03447314|75977994|FG012|COMPLETED|Part 2 (Up to 47 Months and 13 Days)||0||
59853534|NCT03447314|75977995|FG013|COMPLETED|Part 2 (Up to 47 Months and 13 Days)||0||
59853535|NCT03447314|75977996|FG014|COMPLETED|Part 2 (Up to 47 Months and 13 Days)||0||
59853536|NCT03447314|75977997|FG015|COMPLETED|Part 2 (Up to 47 Months and 13 Days)||0||
59853537|NCT03447314|75977998|FG016|COMPLETED|Part 2 (Up to 47 Months and 13 Days)||0||
59853538|NCT03447314|75977999|FG017|COMPLETED|Part 2 (Up to 47 Months and 13 Days)||0||
59853539|NCT03447314|75977982|FG000|NOT COMPLETED|Part 2 (Up to 47 Months and 13 Days)||0||
59853540|NCT03447314|75977983|FG001|NOT COMPLETED|Part 2 (Up to 47 Months and 13 Days)||0||
59853541|NCT03447314|75977984|FG002|NOT COMPLETED|Part 2 (Up to 47 Months and 13 Days)||0||
59853542|NCT03447314|75977985|FG003|NOT COMPLETED|Part 2 (Up to 47 Months and 13 Days)||0||
59853543|NCT03447314|75977986|FG004|NOT COMPLETED|Part 2 (Up to 47 Months and 13 Days)||0||
59853544|NCT03447314|75977987|FG005|NOT COMPLETED|Part 2 (Up to 47 Months and 13 Days)||0||
59853545|NCT03447314|75977988|FG006|NOT COMPLETED|Part 2 (Up to 47 Months and 13 Days)||0||
59853546|NCT03447314|75977989|FG007|NOT COMPLETED|Part 2 (Up to 47 Months and 13 Days)||0||
59853547|NCT03447314|75977990|FG008|NOT COMPLETED|Part 2 (Up to 47 Months and 13 Days)||0||
59853548|NCT03447314|75977991|FG009|NOT COMPLETED|Part 2 (Up to 47 Months and 13 Days)||0||
59853549|NCT03447314|75977992|FG010|NOT COMPLETED|Part 2 (Up to 47 Months and 13 Days)||0||
59853550|NCT03447314|75977993|FG011|NOT COMPLETED|Part 2 (Up to 47 Months and 13 Days)||0||
59853551|NCT03447314|75977994|FG012|NOT COMPLETED|Part 2 (Up to 47 Months and 13 Days)||0||
59853552|NCT03447314|75977995|FG013|NOT COMPLETED|Part 2 (Up to 47 Months and 13 Days)||0||
59853553|NCT03447314|75977996|FG014|NOT COMPLETED|Part 2 (Up to 47 Months and 13 Days)||0||
59853554|NCT03447314|75977997|FG015|NOT COMPLETED|Part 2 (Up to 47 Months and 13 Days)||0||
59853555|NCT03447314|75977998|FG016|NOT COMPLETED|Part 2 (Up to 47 Months and 13 Days)||0||
59853556|NCT03447314|75977999|FG017|NOT COMPLETED|Part 2 (Up to 47 Months and 13 Days)||0||
59853557|NCT03423121|75978042|FG000|STARTED|Overall Study||28||
59853558|NCT03423121|75978043|FG001|STARTED|Overall Study||26||
59853559|NCT03423121|75978042|FG000|COMPLETED|Overall Study||25||
59853560|NCT03423121|75978043|FG001|COMPLETED|Overall Study||20||
59853561|NCT03423121|75978042|FG000|NOT COMPLETED|Overall Study||3||
59853562|NCT03423121|75978043|FG001|NOT COMPLETED|Overall Study||6||
59853563|NCT03335475|75978051|FG000|STARTED|Overall Study||29||
59853564|NCT03335475|75978052|FG001|STARTED|Overall Study||31||
59853565|NCT03335475|75978051|FG000|COMPLETED|Overall Study||25||
59853566|NCT03335475|75978052|FG001|COMPLETED|Overall Study||30||
59853567|NCT03335475|75978051|FG000|NOT COMPLETED|Overall Study||4||
59853568|NCT03335475|75978052|FG001|NOT COMPLETED|Overall Study||1||
59853569|NCT03252756|75978060|FG000|STARTED|Overall Study||13||
59853570|NCT03252756|75978061|FG001|STARTED|Overall Study||14||
59584786|NCT04086407|75691489|FG000|NOT COMPLETED|Overall Study||0||
59853571|NCT03252756|75978060|FG000|COMPLETED|Overall Study||10||
59853572|NCT03252756|75978061|FG001|COMPLETED|Overall Study||8||
59853573|NCT03252756|75978060|FG000|NOT COMPLETED|Overall Study||3||
59853574|NCT03252756|75978061|FG001|NOT COMPLETED|Overall Study||6||
59853575|NCT03164356|75978073|FG000|STARTED|Overall Study||19||
59853576|NCT03164356|75978074|FG001|STARTED|Overall Study||15||
59853577|NCT03164356|75978075|FG002|STARTED|Overall Study||17||
59853578|NCT03164356|75978076|FG003|STARTED|Overall Study||17||
59853579|NCT03164356|75978073|FG000|COMPLETED|Overall Study||14||
59853580|NCT03164356|75978074|FG001|COMPLETED|Overall Study||10||
59853581|NCT03164356|75978075|FG002|COMPLETED|Overall Study||11||
59853582|NCT03164356|75978076|FG003|COMPLETED|Overall Study||15||
59584787|NCT04098575|75691499|FG000|STARTED|Overall Study||505||
59853583|NCT03164356|75978073|FG000|NOT COMPLETED|Overall Study||5||
59853584|NCT03164356|75978074|FG001|NOT COMPLETED|Overall Study||5||
59853585|NCT03164356|75978075|FG002|NOT COMPLETED|Overall Study||6||
59853586|NCT03164356|75978076|FG003|NOT COMPLETED|Overall Study||2||
59853587|NCT03089541|75978096|FG000|STARTED|Overall Study||29||
59853588|NCT03089541|75978096|FG000|COMPLETED|Overall Study||29||
59853589|NCT03089541|75978096|FG000|NOT COMPLETED|Overall Study||0||
59853590|NCT02923232|75978101|FG000|STARTED|Overall Study||52||
59853591|NCT02923232|75978101|FG000|COMPLETED|Overall Study|The study was not completed due to the withdraw of research funding.|52||
59853592|NCT02923232|75978101|FG000|NOT COMPLETED|Overall Study||0||
59853593|NCT01925131|75978111|FG000|STARTED|Overall Study||5||
59853594|NCT01925131|75978112|FG001|STARTED|Overall Study||4||
59853595|NCT01925131|75978113|FG002|STARTED|Overall Study||10||
59853596|NCT01925131|75978114|FG003|STARTED|Overall Study||5||
59853597|NCT01925131|75978115|FG004|STARTED|Overall Study||11||
59853598|NCT01925131|75978116|FG005|STARTED|Overall Study||13||
59853599|NCT01925131|75978111|FG000|COMPLETED|Overall Study||0||
59853600|NCT01925131|75978112|FG001|COMPLETED|Overall Study||2||
59853601|NCT01925131|75978113|FG002|COMPLETED|Overall Study||1||
59853602|NCT01925131|75978114|FG003|COMPLETED|Overall Study||0||
59853603|NCT01925131|75978115|FG004|COMPLETED|Overall Study||0||
59853604|NCT01925131|75978116|FG005|COMPLETED|Overall Study||3||
59853605|NCT01925131|75978111|FG000|NOT COMPLETED|Overall Study||5||
59853606|NCT01925131|75978112|FG001|NOT COMPLETED|Overall Study||2||
59853607|NCT01925131|75978113|FG002|NOT COMPLETED|Overall Study||9||
59853608|NCT01925131|75978114|FG003|NOT COMPLETED|Overall Study||5||
59853609|NCT01925131|75978115|FG004|NOT COMPLETED|Overall Study||11||
59853610|NCT01925131|75978116|FG005|NOT COMPLETED|Overall Study||10||
59853611|NCT01698918|75978132|FG000|STARTED|First Line Treatment (Core+Extension)||202||
59853612|NCT01698918|75978132|FG000|Dexamethasone Randomized Set (Stomatitis Sub-study)|First Line Treatment (Core+Extension)||11|Participants experiencing stomatitis (in countries where the alcohol-free 0.5 mg/5 mL dexamethasone oral solution was commercially available) randomized to take 0.5 mg/5 mL dexamethasone mouth rinse.|
59724658|NCT01049412|75843396|FG001|COMPLETED|Period II||52||
59724659|NCT01049412|75843395|FG000|NOT COMPLETED|Period II||4||
59724660|NCT01049412|75843396|FG001|NOT COMPLETED|Period II||3||
59724661|NCT00934089|75843406|FG000|STARTED|First Intervention Period (14 Days)||15||
59724662|NCT00934089|75843407|FG001|STARTED|First Intervention Period (14 Days)||16||
59853613|NCT01698918|75978132|FG000|Standard of Care Randomized Set (Stomatitis Sub-study)|First Line Treatment (Core+Extension)||13|Participants experiencing stomatitis (in countries where the alcohol-free 0.5 mg/5 mL dexamethasone oral solution was commercially available) randomized to take standard of care to treat stomatitis|
59853614|NCT01698918|75978132|FG000|COMPLETED|First Line Treatment (Core+Extension)||29||
59853615|NCT01698918|75978132|FG000|NOT COMPLETED|First Line Treatment (Core+Extension)||173||
59853616|NCT01698918|75978132|FG000|STARTED|Second Line Treatment (Core+Extension)||53||
59853617|NCT01698918|75978132|FG000|COMPLETED|Second Line Treatment (Core+Extension)||7||
59853618|NCT01698918|75978132|FG000|NOT COMPLETED|Second Line Treatment (Core+Extension)||46||
59853619|NCT01208974|75978145|FG000|STARTED|NAC-Sparing Mastectomy||21||
59853620|NCT01208974|75978146|FG001|STARTED|NAC-Sparing Mastectomy||0||
59853621|NCT01208974|75978147|FG002|STARTED|NAC-Sparing Mastectomy||0||
59853622|NCT01208974|75978148|FG003|STARTED|NAC-Sparing Mastectomy||0||
59584788|NCT04098575|75691500|FG001|STARTED|Overall Study||2961||
59584789|NCT04098575|75691501|FG002|STARTED|Overall Study||6105||
59584790|NCT04098575|75691499|FG000|COMPLETED|Overall Study||505||
59584791|NCT04098575|75691500|FG001|COMPLETED|Overall Study||2961||
59853623|NCT01208974|75978145|FG000|COMPLETED|NAC-Sparing Mastectomy||21||
59853624|NCT01208974|75978146|FG001|COMPLETED|NAC-Sparing Mastectomy||0||
59853625|NCT01208974|75978147|FG002|COMPLETED|NAC-Sparing Mastectomy||0||
59853626|NCT01208974|75978148|FG003|COMPLETED|NAC-Sparing Mastectomy||0||
59853627|NCT01208974|75978145|FG000|NOT COMPLETED|NAC-Sparing Mastectomy||0||
59853628|NCT01208974|75978146|FG001|NOT COMPLETED|NAC-Sparing Mastectomy||0||
59853629|NCT01208974|75978147|FG002|NOT COMPLETED|NAC-Sparing Mastectomy||0||
59853630|NCT01208974|75978148|FG003|NOT COMPLETED|NAC-Sparing Mastectomy||0||
59853631|NCT01208974|75978145|FG000|STARTED|Post-Mastectomy Period (Weeks 1 to 4)||21||
59853632|NCT01208974|75978146|FG001|STARTED|Post-Mastectomy Period (Weeks 1 to 4)||0||
59853633|NCT01208974|75978147|FG002|STARTED|Post-Mastectomy Period (Weeks 1 to 4)||0||
59853634|NCT01208974|75978148|FG003|STARTED|Post-Mastectomy Period (Weeks 1 to 4)||0||
59853635|NCT01208974|75978145|FG000|COMPLETED|Post-Mastectomy Period (Weeks 1 to 4)||18||
59853636|NCT01208974|75978146|FG001|COMPLETED|Post-Mastectomy Period (Weeks 1 to 4)||0||
59853637|NCT01208974|75978147|FG002|COMPLETED|Post-Mastectomy Period (Weeks 1 to 4)||0||
59853638|NCT01208974|75978148|FG003|COMPLETED|Post-Mastectomy Period (Weeks 1 to 4)||0||
59584792|NCT04098575|75691501|FG002|COMPLETED|Overall Study||6105||
59584793|NCT04098575|75691499|FG000|NOT COMPLETED|Overall Study||0||
59584794|NCT04098575|75691500|FG001|NOT COMPLETED|Overall Study||0||
59724663|NCT00934089|75843406|FG000|Treated|First Intervention Period (14 Days)||14||
59724664|NCT00934089|75843407|FG001|Treated|First Intervention Period (14 Days)||16||
59724665|NCT00934089|75843406|FG000|COMPLETED|First Intervention Period (14 Days)||13||
59724666|NCT00934089|75843407|FG001|COMPLETED|First Intervention Period (14 Days)||16||
59724667|NCT00934089|75843406|FG000|NOT COMPLETED|First Intervention Period (14 Days)||2||
59724668|NCT00934089|75843407|FG001|NOT COMPLETED|First Intervention Period (14 Days)||0||
59724669|NCT00934089|75843406|FG000|STARTED|Washout Period (28 Days)||13||
59584795|NCT04098575|75691501|FG002|NOT COMPLETED|Overall Study||0||
59584796|NCT01600326|75691511|FG000|STARTED|Overall Study||15||
59724670|NCT00934089|75843407|FG001|STARTED|Washout Period (28 Days)||16||
59853639|NCT01208974|75978145|FG000|NOT COMPLETED|Post-Mastectomy Period (Weeks 1 to 4)||3||
59853640|NCT01208974|75978146|FG001|NOT COMPLETED|Post-Mastectomy Period (Weeks 1 to 4)||0||
59853641|NCT01208974|75978147|FG002|NOT COMPLETED|Post-Mastectomy Period (Weeks 1 to 4)||0||
59853642|NCT01208974|75978148|FG003|NOT COMPLETED|Post-Mastectomy Period (Weeks 1 to 4)||0||
59853643|NCT01208974|75978145|FG000|STARTED|Prophylactic NAC RT (Weeks 5 to 8)||0||
59853644|NCT01208974|75978146|FG001|STARTED|Prophylactic NAC RT (Weeks 5 to 8)||6||
59853645|NCT01208974|75978147|FG002|STARTED|Prophylactic NAC RT (Weeks 5 to 8)||6||
59853646|NCT01208974|75978148|FG003|STARTED|Prophylactic NAC RT (Weeks 5 to 8)||6||
59853647|NCT01208974|75978145|FG000|Cohort 1: Starting Dose|Prophylactic NAC RT (Weeks 5 to 8)||0||
59853648|NCT01208974|75978146|FG001|Cohort 1: Starting Dose|Prophylactic NAC RT (Weeks 5 to 8)||6||
59853649|NCT01208974|75978147|FG002|Cohort 1: Starting Dose|Prophylactic NAC RT (Weeks 5 to 8)||0||
59853650|NCT01208974|75978148|FG003|Cohort 1: Starting Dose|Prophylactic NAC RT (Weeks 5 to 8)||0||
59853651|NCT01208974|75978145|FG000|Cohort 2: 1st Dose Escalation|Prophylactic NAC RT (Weeks 5 to 8)||0||
59853652|NCT01208974|75978146|FG001|Cohort 2: 1st Dose Escalation|Prophylactic NAC RT (Weeks 5 to 8)||0||
59853653|NCT01208974|75978147|FG002|Cohort 2: 1st Dose Escalation|Prophylactic NAC RT (Weeks 5 to 8)||6||
59853654|NCT01208974|75978148|FG003|Cohort 2: 1st Dose Escalation|Prophylactic NAC RT (Weeks 5 to 8)||0||
59853655|NCT01208974|75978145|FG000|Cohort 3: 2nd Dose Escalation|Prophylactic NAC RT (Weeks 5 to 8)||0||
59853656|NCT01208974|75978146|FG001|Cohort 3: 2nd Dose Escalation|Prophylactic NAC RT (Weeks 5 to 8)||0||
59853657|NCT01208974|75978147|FG002|Cohort 3: 2nd Dose Escalation|Prophylactic NAC RT (Weeks 5 to 8)||0||
59853658|NCT01208974|75978148|FG003|Cohort 3: 2nd Dose Escalation|Prophylactic NAC RT (Weeks 5 to 8)||6||
59853659|NCT01208974|75978145|FG000|COMPLETED|Prophylactic NAC RT (Weeks 5 to 8)||0||
59853660|NCT01208974|75978146|FG001|COMPLETED|Prophylactic NAC RT (Weeks 5 to 8)||6||
59853661|NCT01208974|75978147|FG002|COMPLETED|Prophylactic NAC RT (Weeks 5 to 8)||6||
59853662|NCT01208974|75978148|FG003|COMPLETED|Prophylactic NAC RT (Weeks 5 to 8)||6||
59853663|NCT01208974|75978145|FG000|NOT COMPLETED|Prophylactic NAC RT (Weeks 5 to 8)||0||
59853664|NCT01208974|75978146|FG001|NOT COMPLETED|Prophylactic NAC RT (Weeks 5 to 8)||0||
59853665|NCT01208974|75978147|FG002|NOT COMPLETED|Prophylactic NAC RT (Weeks 5 to 8)||0||
59853666|NCT01208974|75978148|FG003|NOT COMPLETED|Prophylactic NAC RT (Weeks 5 to 8)||0||
59853667|NCT00840177|75978158|FG000|STARTED|Overall Study||36||
59853668|NCT00840177|75978159|FG001|STARTED|Overall Study||29||
59853669|NCT00840177|75978160|FG002|STARTED|Overall Study||50||
59853670|NCT00840177|75978158|FG000|Treated|Overall Study||36||
59853671|NCT00840177|75978159|FG001|Treated|Overall Study||29||
59853672|NCT00840177|75978160|FG002|Treated|Overall Study||46||
59853673|NCT00840177|75978158|FG000|Assessed for AEs|Overall Study||35||
59853674|NCT00840177|75978159|FG001|Assessed for AEs|Overall Study||29||
59853675|NCT00840177|75978160|FG002|Assessed for AEs|Overall Study||46||
59853676|NCT00840177|75978158|FG000|COMPLETED|Overall Study||18||
59853677|NCT00840177|75978159|FG001|COMPLETED|Overall Study||20||
59853678|NCT00840177|75978160|FG002|COMPLETED|Overall Study||39||
59853679|NCT00840177|75978158|FG000|NOT COMPLETED|Overall Study||18||
59853680|NCT00840177|75978159|FG001|NOT COMPLETED|Overall Study||9||
59853681|NCT00840177|75978160|FG002|NOT COMPLETED|Overall Study||11||
59853682|NCT01347580|75978170|FG000|STARTED|Overall Study|based on randomized treatment|909||
59853683|NCT01347580|75978171|FG001|STARTED|Overall Study|based on randomized treatment|953||
59853684|NCT01347580|75978170|FG000|Modified Intent to Treat Population|Overall Study|based on randomized treatment|906||
59853685|NCT01347580|75978171|FG001|Modified Intent to Treat Population|Overall Study|based on randomized treatment|952||
59853686|NCT01347580|75978170|FG000|Safety Population|Overall Study|based on actual treatment|908||
59853687|NCT01347580|75978171|FG001|Safety Population|Overall Study|based on actual treatment|950||
59853688|NCT01347580|75978170|FG000|COMPLETED|Overall Study|based on randomized treatment|844||
59853689|NCT01347580|75978171|FG001|COMPLETED|Overall Study|based on randomized treatment|897||
59853690|NCT01347580|75978170|FG000|NOT COMPLETED|Overall Study||65||
59853691|NCT01347580|75978171|FG001|NOT COMPLETED|Overall Study||56||
59853692|NCT00398411|75978179|FG000|STARTED|Overall Study||34||
59853693|NCT00398411|75978180|FG001|STARTED|Overall Study||32||
59853694|NCT00398411|75978179|FG000|COMPLETED|Overall Study||34||
59853695|NCT00398411|75978180|FG001|COMPLETED|Overall Study||31||
59853696|NCT00398411|75978179|FG000|NOT COMPLETED|Overall Study||0||
59853697|NCT00398411|75978180|FG001|NOT COMPLETED|Overall Study||1||
59853698|NCT03352414|75978188|FG000|STARTED|Overall Study||42|Is the Randomized population meeting preoperative eligibility criteria (also called the Safety Population)|
59853699|NCT03352414|75978189|FG001|STARTED|Overall Study||42|Is the Randomized population meeting preoperative eligibility criteria (also called the Safety Population)|
59853700|NCT03352414|75978188|FG000|Allocated|Overall Study||30|Eligible by operative criteria (received additional postoperative study drug)|
59853701|NCT03352414|75978189|FG001|Allocated|Overall Study||32|Eligible by operative criteria (received additional postoperative study drug)|
59996774|NCT03434041|76112632|FG000|Full Analysis Set|Double Blind Treatment Phase (4 Weeks)||124||
59584797|NCT01600326|75691512|FG001|STARTED|Overall Study||15||
59584798|NCT01600326|75691511|FG000|Primary Outcome Measure Data Collection|Overall Study||15||
59584799|NCT01600326|75691512|FG001|Primary Outcome Measure Data Collection|Overall Study||15||
59584800|NCT01600326|75691511|FG000|COMPLETED|Overall Study||14||
59584801|NCT01600326|75691512|FG001|COMPLETED|Overall Study||14||
59853702|NCT03352414|75978188|FG000|COMPLETED|Overall Study||30||
59853703|NCT03352414|75978189|FG001|COMPLETED|Overall Study||32||
59853704|NCT03352414|75978188|FG000|NOT COMPLETED|Overall Study||12||
59853705|NCT03352414|75978189|FG001|NOT COMPLETED|Overall Study||10||
59853706|NCT00364793|75978201|FG000|STARTED|Overall Study||15||
59853707|NCT00364793|75978202|FG001|STARTED|Overall Study||10||
59853708|NCT00364793|75978203|FG002|STARTED|Overall Study||4||
59853709|NCT00364793|75978204|FG003|STARTED|Overall Study||8||
59853710|NCT00364793|75978201|FG000|COMPLETED|Overall Study||7||
59853711|NCT00364793|75978202|FG001|COMPLETED|Overall Study||5||
59853712|NCT00364793|75978203|FG002|COMPLETED|Overall Study||0||
59853713|NCT00364793|75978204|FG003|COMPLETED|Overall Study||5||
59853714|NCT00364793|75978201|FG000|NOT COMPLETED|Overall Study||8||
59853715|NCT00364793|75978202|FG001|NOT COMPLETED|Overall Study||5||
59853716|NCT00364793|75978203|FG002|NOT COMPLETED|Overall Study||4||
59853717|NCT00364793|75978204|FG003|NOT COMPLETED|Overall Study||3||
59853718|NCT03351478|75978220|FG000|STARTED|Overall Study||307||
59853719|NCT03351478|75978221|FG001|STARTED|Overall Study||309||
59853720|NCT03351478|75978222|FG002|STARTED|Overall Study||154||
59853721|NCT03351478|75978220|FG000|COMPLETED|Overall Study||293||
59853722|NCT03351478|75978221|FG001|COMPLETED|Overall Study||292||
59853723|NCT03351478|75978222|FG002|COMPLETED|Overall Study||147||
59853724|NCT03351478|75978220|FG000|NOT COMPLETED|Overall Study||14||
59853725|NCT03351478|75978221|FG001|NOT COMPLETED|Overall Study||17||
59584802|NCT01600326|75691511|FG000|NOT COMPLETED|Overall Study||1||
59584803|NCT01600326|75691512|FG001|NOT COMPLETED|Overall Study||1||
59584804|NCT04082819|75691521|FG000|STARTED|Overall Study||37||
59724671|NCT00934089|75843406|FG000|COMPLETED|Washout Period (28 Days)||13||
59724672|NCT00934089|75843407|FG001|COMPLETED|Washout Period (28 Days)||16||
59724673|NCT00934089|75843406|FG000|NOT COMPLETED|Washout Period (28 Days)||0||
59724674|NCT00934089|75843407|FG001|NOT COMPLETED|Washout Period (28 Days)||0||
59724675|NCT00934089|75843406|FG000|STARTED|Second Intervention Period (14 Days)||13||
59724676|NCT00934089|75843407|FG001|STARTED|Second Intervention Period (14 Days)||16||
59724677|NCT00934089|75843406|FG000|COMPLETED|Second Intervention Period (14 Days)||13||
59724678|NCT00934089|75843407|FG001|COMPLETED|Second Intervention Period (14 Days)||16||
59724679|NCT00934089|75843406|FG000|NOT COMPLETED|Second Intervention Period (14 Days)||0||
59724680|NCT00934089|75843407|FG001|NOT COMPLETED|Second Intervention Period (14 Days)||0||
59724681|NCT01032174|75843415|FG000|STARTED|Overall Study||63||
59724682|NCT01032174|75843416|FG001|STARTED|Overall Study||60||
59724683|NCT01032174|75843415|FG000|COMPLETED|Overall Study||63||
59724684|NCT01032174|75843416|FG001|COMPLETED|Overall Study||59||
59724685|NCT01032174|75843415|FG000|NOT COMPLETED|Overall Study||0||
59724686|NCT01032174|75843416|FG001|NOT COMPLETED|Overall Study||1||
59724687|NCT00933933|75843427|FG000|STARTED|General Population From 16 to 89 Years||6164||
59724688|NCT00933933|75843428|FG001|STARTED|General Population From 16 to 89 Years||1287||
59724689|NCT00933933|75843429|FG002|STARTED|General Population From 16 to 89 Years||1206||
59724690|NCT00933933|75843427|FG000|COMPLETED|General Population From 16 to 89 Years||6164||
59724691|NCT00933933|75843428|FG001|COMPLETED|General Population From 16 to 89 Years||1267||
59724692|NCT00933933|75843429|FG002|COMPLETED|General Population From 16 to 89 Years||1206||
59724693|NCT00933933|75843427|FG000|NOT COMPLETED|General Population From 16 to 89 Years||0||
59724694|NCT00933933|75843428|FG001|NOT COMPLETED|General Population From 16 to 89 Years||20||
59724695|NCT00933933|75843429|FG002|NOT COMPLETED|General Population From 16 to 89 Years||0||
59724696|NCT00933933|75843427|FG000|STARTED|Pregnant Females Between 16-44 Years||448||
59724697|NCT00933933|75843428|FG001|STARTED|Pregnant Females Between 16-44 Years||67||
59724698|NCT00933933|75843429|FG002|STARTED|Pregnant Females Between 16-44 Years||203||
59724699|NCT00933933|75843427|FG000|COMPLETED|Pregnant Females Between 16-44 Years||448||
59724700|NCT00933933|75843428|FG001|COMPLETED|Pregnant Females Between 16-44 Years||65||
59724701|NCT00933933|75843429|FG002|COMPLETED|Pregnant Females Between 16-44 Years||203||
59724702|NCT00933933|75843427|FG000|NOT COMPLETED|Pregnant Females Between 16-44 Years||0||
59724703|NCT00933933|75843428|FG001|NOT COMPLETED|Pregnant Females Between 16-44 Years||2||
59724704|NCT00933933|75843429|FG002|NOT COMPLETED|Pregnant Females Between 16-44 Years||0||
59724705|NCT00933933|75843427|FG000|STARTED|Pediatric From 2 to 21 Years||588||
59724706|NCT00933933|75843428|FG001|STARTED|Pediatric From 2 to 21 Years||64||
59853726|NCT03351478|75978222|FG002|NOT COMPLETED|Overall Study||7||
59853727|NCT00363545|75978232|FG000|STARTED|Overall Study||636||
59853728|NCT00363545|75978233|FG001|STARTED|Overall Study||638||
59853729|NCT00363545|75978232|FG000|COMPLETED|Overall Study||592||
59853730|NCT00363545|75978233|FG001|COMPLETED|Overall Study||581||
59853731|NCT00363545|75978232|FG000|NOT COMPLETED|Overall Study||44||
59853732|NCT00363545|75978233|FG001|NOT COMPLETED|Overall Study||57||
59853733|NCT03351244|75978242|FG000|STARTED|Overall Study||89||
59853734|NCT03351244|75978243|FG001|STARTED|Overall Study||88||
59853735|NCT03351244|75978244|FG002|STARTED|Overall Study||87||
59853736|NCT03351244|75978242|FG000|COMPLETED|Overall Study||62||
59853737|NCT03351244|75978243|FG001|COMPLETED|Overall Study||48||
59584805|NCT04082819|75691522|FG001|STARTED|Overall Study||54||
59853738|NCT03351244|75978244|FG002|COMPLETED|Overall Study||53||
59853739|NCT03351244|75978242|FG000|NOT COMPLETED|Overall Study||27||
59584806|NCT04082819|75691523|FG002|STARTED|Overall Study||3||
59853740|NCT03351244|75978243|FG001|NOT COMPLETED|Overall Study||40||
59853741|NCT03351244|75978244|FG002|NOT COMPLETED|Overall Study||34||
59853742|NCT03386032|75978257|FG000|STARTED|Overall Study||36||
59853743|NCT03386032|75978258|FG001|STARTED|Overall Study||18||
59853744|NCT03386032|75978259|FG002|STARTED|Overall Study||11||
59853745|NCT03386032|75978257|FG000|COMPLETED|Overall Study||18||
59853746|NCT03386032|75978258|FG001|COMPLETED|Overall Study||11||
59853747|NCT03386032|75978259|FG002|COMPLETED|Overall Study||11||
59853748|NCT03386032|75978257|FG000|NOT COMPLETED|Overall Study||18||
59853749|NCT03386032|75978258|FG001|NOT COMPLETED|Overall Study||7||
59853750|NCT03386032|75978259|FG002|NOT COMPLETED|Overall Study||0||
59853751|NCT00077610|75978270|FG000|STARTED|Overall Study||223||
59853752|NCT00077610|75978271|FG001|STARTED|Overall Study||224||
59853753|NCT00077610|75978272|FG002|STARTED|Overall Study||226||
59853754|NCT00077610|75978270|FG000|Started Treatment|Overall Study||221||
59853755|NCT00077610|75978271|FG001|Started Treatment|Overall Study||220||
59853756|NCT00077610|75978272|FG002|Started Treatment|Overall Study||225||
59853757|NCT00077610|75978270|FG000|COMPLETED|Overall Study||169||
59853758|NCT00077610|75978271|FG001|COMPLETED|Overall Study||168||
59853759|NCT00077610|75978272|FG002|COMPLETED|Overall Study||180||
59853760|NCT00077610|75978270|FG000|NOT COMPLETED|Overall Study||54||
59853761|NCT00077610|75978271|FG001|NOT COMPLETED|Overall Study||56||
59853762|NCT00077610|75978272|FG002|NOT COMPLETED|Overall Study||46||
59853763|NCT03385564|75978289|FG000|STARTED|Overall Study||7||
59853764|NCT03385564|75978290|FG001|STARTED|Overall Study||15||
59853765|NCT03385564|75978291|FG002|STARTED|Overall Study||21||
59853766|NCT03385564|75978292|FG003|STARTED|Overall Study||26||
59853767|NCT03385564|75978289|FG000|Intent to Treat Set|Overall Study||7||
59853768|NCT03385564|75978290|FG001|Intent to Treat Set|Overall Study||15||
59853769|NCT03385564|75978291|FG002|Intent to Treat Set|Overall Study||21||
59853770|NCT03385564|75978292|FG003|Intent to Treat Set|Overall Study||26||
59853771|NCT03385564|75978289|FG000|COMPLETED|Overall Study||7|Completed trial medication|
59853772|NCT03385564|75978290|FG001|COMPLETED|Overall Study||14|Completed trial medication|
59853773|NCT03385564|75978291|FG002|COMPLETED|Overall Study||16|Completed trial medication|
59853774|NCT03385564|75978292|FG003|COMPLETED|Overall Study||17|Completed trial medication|
59853775|NCT03385564|75978289|FG000|NOT COMPLETED|Overall Study||0||
59853776|NCT03385564|75978290|FG001|NOT COMPLETED|Overall Study||1||
59853777|NCT03385564|75978291|FG002|NOT COMPLETED|Overall Study||5||
59853778|NCT03385564|75978292|FG003|NOT COMPLETED|Overall Study||9||
59853779|NCT00066222|75978302|FG000|STARTED|Overall Study||72||
59853780|NCT00066222|75978302|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|71||
59853781|NCT00066222|75978302|FG000|NOT COMPLETED|Overall Study||1||
59853782|NCT00397943|75978311|FG000|STARTED|Overall Study||40||
59853783|NCT00397943|75978312|FG001|STARTED|Overall Study||40||
59853784|NCT00397943|75978313|FG002|STARTED|Overall Study||10||
59853785|NCT00397943|75978314|FG003|STARTED|Overall Study||10||
59853786|NCT00397943|75978315|FG004|STARTED|Overall Study||10||
59853787|NCT00397943|75978311|FG000|COMPLETED|Overall Study||28||
59853788|NCT00397943|75978312|FG001|COMPLETED|Overall Study||31||
59853789|NCT00397943|75978313|FG002|COMPLETED|Overall Study||10||
59853790|NCT00397943|75978314|FG003|COMPLETED|Overall Study||10||
59853791|NCT00397943|75978315|FG004|COMPLETED|Overall Study||10||
59853792|NCT00397943|75978311|FG000|NOT COMPLETED|Overall Study||12||
59853793|NCT00397943|75978312|FG001|NOT COMPLETED|Overall Study||9||
59853794|NCT00397943|75978313|FG002|NOT COMPLETED|Overall Study||0||
59853795|NCT00397943|75978314|FG003|NOT COMPLETED|Overall Study||0||
59853796|NCT00397943|75978315|FG004|NOT COMPLETED|Overall Study||0||
59853797|NCT00066066|75978330|FG000|STARTED|Overall Study||27||
59853798|NCT00066066|75978331|FG001|STARTED|Overall Study||22||
59853799|NCT00066066|75978332|FG002|STARTED|Overall Study||30||
59853800|NCT00066066|75978333|FG003|STARTED|Overall Study||20||
60121646|NCT01567865|76242536|FG001|NOT COMPLETED|Evaluated for Immunogenicity||25||
60121647|NCT01567865|76242537|FG002|NOT COMPLETED|Evaluated for Immunogenicity||19||
59584807|NCT04082819|75691521|FG000|COMPLETED|Overall Study||37||
59584808|NCT04082819|75691522|FG001|COMPLETED|Overall Study||54||
59853801|NCT00066066|75978334|FG004|STARTED|Overall Study||27||
59853802|NCT00066066|75978335|FG005|STARTED|Overall Study||20||
59853803|NCT00066066|75978330|FG000|Baseline|Overall Study||27||
59853804|NCT00066066|75978331|FG001|Baseline|Overall Study||22||
59853805|NCT00066066|75978332|FG002|Baseline|Overall Study||30||
59853806|NCT00066066|75978333|FG003|Baseline|Overall Study||20||
59853807|NCT00066066|75978334|FG004|Baseline|Overall Study||27||
59853808|NCT00066066|75978335|FG005|Baseline|Overall Study||20||
59853809|NCT00066066|75978330|FG000|3 Month|Overall Study||21||
59584809|NCT04082819|75691523|FG002|COMPLETED|Overall Study||3||
59853810|NCT00066066|75978331|FG001|3 Month|Overall Study||17||
59853811|NCT00066066|75978332|FG002|3 Month|Overall Study||23||
59853812|NCT00066066|75978333|FG003|3 Month|Overall Study||16||
59853813|NCT00066066|75978334|FG004|3 Month|Overall Study||22||
59853814|NCT00066066|75978335|FG005|3 Month|Overall Study||15||
59853815|NCT00066066|75978330|FG000|6 Month|Overall Study||19||
60121648|NCT01567865|76242538|FG003|NOT COMPLETED|Evaluated for Immunogenicity||30||
59853816|NCT00066066|75978331|FG001|6 Month|Overall Study||13||
59853817|NCT00066066|75978332|FG002|6 Month|Overall Study||23||
59853818|NCT00066066|75978333|FG003|6 Month|Overall Study||13||
59853819|NCT00066066|75978334|FG004|6 Month|Overall Study||21||
59853820|NCT00066066|75978335|FG005|6 Month|Overall Study||14||
59853821|NCT00066066|75978330|FG000|12 Month|Overall Study||18||
59853822|NCT00066066|75978331|FG001|12 Month|Overall Study||11||
59853823|NCT00066066|75978332|FG002|12 Month|Overall Study||21||
59853824|NCT00066066|75978333|FG003|12 Month|Overall Study||11||
59853825|NCT00066066|75978334|FG004|12 Month|Overall Study||19||
59853826|NCT00066066|75978335|FG005|12 Month|Overall Study||9||
59853827|NCT00066066|75978330|FG000|COMPLETED|Overall Study|27 enrolled, 21 analyzed,18 subjects had complete data,3 subjects had data carried forward.|21||
59853828|NCT00066066|75978331|FG001|COMPLETED|Overall Study|22 enrolled, 18 analyzed,11 subjects had complete data,7 subjects had data carried forward.|18||
59853829|NCT00066066|75978332|FG002|COMPLETED|Overall Study|30 enrolled, 23 analyzed,21 subjects had complete data,2 subjects had data carried forward.|23||
59853830|NCT00066066|75978333|FG003|COMPLETED|Overall Study|20 enrolled, 16 analyzed,11 subjects had complete data,5 subjects had data carried forward.|16||
59853831|NCT00066066|75978334|FG004|COMPLETED|Overall Study|27 enrolled, 24 analyzed,19 subjects had complete data,5 subjects had data carried forward.|24||
59853832|NCT00066066|75978335|FG005|COMPLETED|Overall Study|20 enrolled, 15 analyzed,9 subjects had complete data,6 subjects had data carried forward.|15||
59853833|NCT00066066|75978330|FG000|NOT COMPLETED|Overall Study||6||
59853834|NCT00066066|75978331|FG001|NOT COMPLETED|Overall Study||4||
59853835|NCT00066066|75978332|FG002|NOT COMPLETED|Overall Study||7||
59853836|NCT00066066|75978333|FG003|NOT COMPLETED|Overall Study||4||
59853837|NCT00066066|75978334|FG004|NOT COMPLETED|Overall Study||3||
59853838|NCT00066066|75978335|FG005|NOT COMPLETED|Overall Study||5||
59853839|NCT00363467|75978349|FG000|STARTED|Overall Study||3||
59853840|NCT00363467|75978349|FG000|COMPLETED|Overall Study||2||
59853841|NCT00363467|75978349|FG000|NOT COMPLETED|Overall Study||1||
59853842|NCT00397631|75978355|FG000|STARTED|Overall Study|Randomization ratio was 1:1|261||
59853843|NCT00397631|75978356|FG001|STARTED|Overall Study||259||
59724707|NCT00933933|75843429|FG002|STARTED|Pediatric From 2 to 21 Years|Specimens from individuals 16-21 years included reactivity for general population or pregnant women.|0||
59724708|NCT00933933|75843427|FG000|COMPLETED|Pediatric From 2 to 21 Years||588||
59724709|NCT00933933|75843428|FG001|COMPLETED|Pediatric From 2 to 21 Years||64||
59724710|NCT00933933|75843429|FG002|COMPLETED|Pediatric From 2 to 21 Years|Specimens from individuals 16-21 years included reactivity for general population or pregnant women|0||
59724711|NCT00933933|75843427|FG000|NOT COMPLETED|Pediatric From 2 to 21 Years||0||
59724712|NCT00933933|75843428|FG001|NOT COMPLETED|Pediatric From 2 to 21 Years||0||
59853844|NCT00397631|75978355|FG000|COMPLETED|Overall Study||231||
59853845|NCT00397631|75978356|FG001|COMPLETED|Overall Study||215||
59853846|NCT00397631|75978355|FG000|NOT COMPLETED|Overall Study||30||
59853847|NCT00397631|75978356|FG001|NOT COMPLETED|Overall Study||44||
59853848|NCT00077376|75978362|FG000|STARTED|Overall Study||61||
59853849|NCT00077376|75978362|FG000|Treated|Overall Study||59||
59853850|NCT00077376|75978362|FG000|HER2+ in Central Testing|Overall Study||39||
59853851|NCT00077376|75978362|FG000|COMPLETED|Overall Study||39||
59853852|NCT00077376|75978362|FG000|NOT COMPLETED|Overall Study||22||
59853853|NCT00363311|75978368|FG000|STARTED|Overall Study||155||
59853854|NCT00363311|75978369|FG001|STARTED|Overall Study||147||
59853855|NCT00363311|75978368|FG000|COMPLETED|Overall Study||79||
59853856|NCT00363311|75978369|FG001|COMPLETED|Overall Study||102||
59853857|NCT00363311|75978368|FG000|NOT COMPLETED|Overall Study||76||
59853858|NCT00363311|75978369|FG001|NOT COMPLETED|Overall Study||45||
60121649|NCT01567163|76242549|FG000|STARTED|Overall Study||22||
60121650|NCT01567163|76242549|FG000|Received at Least 1 Dose of Study Drug|Overall Study||22||
59724713|NCT00933933|75843429|FG002|NOT COMPLETED|Pediatric From 2 to 21 Years||0||
59724714|NCT01032018|75843447|FG000|STARTED|Overall Study||77||
59724715|NCT01032018|75843448|FG001|STARTED|Overall Study||73||
59724716|NCT01032018|75843447|FG000|COMPLETED|Overall Study||71||
59724717|NCT01032018|75843448|FG001|COMPLETED|Overall Study||67||
59724718|NCT01032018|75843447|FG000|NOT COMPLETED|Overall Study||6||
59724719|NCT01032018|75843448|FG001|NOT COMPLETED|Overall Study||6||
59724720|NCT01031706|75843456|FG000|STARTED|Overall Study||14||
59724721|NCT01031706|75843457|FG001|STARTED|Overall Study||9||
59724722|NCT01031706|75843456|FG000|COMPLETED|Overall Study||12||
59724723|NCT01031706|75843457|FG001|COMPLETED|Overall Study||8||
59724724|NCT01031706|75843456|FG000|NOT COMPLETED|Overall Study||2||
59724725|NCT01031706|75843457|FG001|NOT COMPLETED|Overall Study||1||
59724726|NCT00927069|75843465|FG000|STARTED|Week 0 to Week 12||50||
59724727|NCT00927069|75843466|FG001|STARTED|Week 0 to Week 12||35||
59724728|NCT00927069|75843467|FG002|STARTED|Week 0 to Week 12||0||
59853859|NCT00362609|75978377|FG000|STARTED|Overall Study||19||
59853860|NCT00362609|75978378|FG001|STARTED|Overall Study||40||
59853861|NCT00362609|75978377|FG000|COMPLETED|Overall Study||19||
59853862|NCT00362609|75978378|FG001|COMPLETED|Overall Study||38||
59853863|NCT00362609|75978377|FG000|NOT COMPLETED|Overall Study||0||
59853864|NCT00362609|75978378|FG001|NOT COMPLETED|Overall Study||2||
60121651|NCT01567163|76242549|FG000|Drug-Drug Interaction Population|Overall Study|Completed Cycle 1, Day 1 and Cycle 2, Day 1 treatment with required assessments.|18||
60121652|NCT01567163|76242549|FG000|COMPLETED|Overall Study||18||
59853865|NCT00362375|75978386|FG000|STARTED|Overall Study|Number eligible and randomized|161||
59853866|NCT00362375|75978387|FG001|STARTED|Overall Study|Number eligible and randomized|152||
59853867|NCT00362375|75978386|FG000|COMPLETED|Overall Study|Number completed 6-month follow-up assessment|121||
59853868|NCT00362375|75978387|FG001|COMPLETED|Overall Study|Number completed 6-month follow-up assessment|117||
59853869|NCT00362375|75978386|FG000|NOT COMPLETED|Overall Study||40||
59853870|NCT00362375|75978387|FG001|NOT COMPLETED|Overall Study||35||
59853871|NCT00362297|75978395|FG000|STARTED|Treatment 1 (Initial Drug Assignment)||16||
59853872|NCT00362297|75978396|FG001|STARTED|Treatment 1 (Initial Drug Assignment)||15||
59853873|NCT00362297|75978395|FG000|COMPLETED|Treatment 1 (Initial Drug Assignment)||16||
59853874|NCT00362297|75978396|FG001|COMPLETED|Treatment 1 (Initial Drug Assignment)||11||
59584810|NCT04082819|75691521|FG000|NOT COMPLETED|Overall Study||0||
59584811|NCT04082819|75691522|FG001|NOT COMPLETED|Overall Study||0||
59584812|NCT04082819|75691523|FG002|NOT COMPLETED|Overall Study||0||
59584813|NCT04081961|75691537|FG000|STARTED|Overall Study||9||
59584814|NCT04081961|75691538|FG001|STARTED|Overall Study||9||
59584815|NCT04081961|75691539|FG002|STARTED|Overall Study||9||
59724729|NCT00927069|75843468|FG003|STARTED|Week 0 to Week 12||0||
59724730|NCT00927069|75843465|FG000|COMPLETED|Week 0 to Week 12||49||
59724731|NCT00927069|75843466|FG001|COMPLETED|Week 0 to Week 12||34||
59853875|NCT00362297|75978395|FG000|NOT COMPLETED|Treatment 1 (Initial Drug Assignment)||0||
59853876|NCT00362297|75978396|FG001|NOT COMPLETED|Treatment 1 (Initial Drug Assignment)||4||
59853877|NCT00362297|75978395|FG000|STARTED|Treatment 2||16||
59853878|NCT00362297|75978396|FG001|STARTED|Treatment 2||11||
59853879|NCT00362297|75978395|FG000|COMPLETED|Treatment 2||16||
59853880|NCT00362297|75978396|FG001|COMPLETED|Treatment 2||11||
59853881|NCT00362297|75978395|FG000|NOT COMPLETED|Treatment 2||0||
59853882|NCT00362297|75978396|FG001|NOT COMPLETED|Treatment 2||0||
59853883|NCT00065442|75978404|FG000|STARTED|Overall Study||171||
59853884|NCT00065442|75978405|FG001|STARTED|Overall Study||341||
59853885|NCT00065442|75978404|FG000|COMPLETED|Overall Study||46||
59853886|NCT00065442|75978405|FG001|COMPLETED|Overall Study||121||
59853887|NCT00065442|75978404|FG000|NOT COMPLETED|Overall Study||125||
59853888|NCT00065442|75978405|FG001|NOT COMPLETED|Overall Study||220||
59853889|NCT00090402|75978414|FG000|STARTED|Overall Study||13||
59853890|NCT00090402|75978415|FG001|STARTED|Overall Study||13||
59853891|NCT00090402|75978416|FG002|STARTED|Overall Study||13||
59853892|NCT00090402|75978414|FG000|COMPLETED|Overall Study||11||
59853893|NCT00090402|75978415|FG001|COMPLETED|Overall Study||11||
59853894|NCT00090402|75978416|FG002|COMPLETED|Overall Study||12||
59853895|NCT00090402|75978414|FG000|NOT COMPLETED|Overall Study||2||
59853896|NCT00090402|75978415|FG001|NOT COMPLETED|Overall Study||2||
59853897|NCT00090402|75978416|FG002|NOT COMPLETED|Overall Study||1||
59853898|NCT00361283|75978427|FG000|STARTED|Overall Study||108||
59853899|NCT00361283|75978427|FG000|COMPLETED|Overall Study||81||
59853900|NCT00361283|75978427|FG000|NOT COMPLETED|Overall Study||27||
59853901|NCT00077064|75978433|FG000|STARTED|Overall Study||17||
59853902|NCT00077064|75978434|FG001|STARTED|Overall Study||16||
59853903|NCT00077064|75978433|FG000|COMPLETED|Overall Study|Randomized eligible subjects are considered to have completed the study.|17||
59853904|NCT00077064|75978434|FG001|COMPLETED|Overall Study|Randomized eligible subjects are considered to have completed the study.|10||
59853905|NCT00077064|75978433|FG000|NOT COMPLETED|Overall Study||0||
59853906|NCT00077064|75978434|FG001|NOT COMPLETED|Overall Study||6||
59853907|NCT00396383|75978441|FG000|STARTED|Overall Study||9||
59853908|NCT00396383|75978441|FG000|COMPLETED|Overall Study||6||
59853909|NCT00396383|75978441|FG000|NOT COMPLETED|Overall Study||3||
59853910|NCT00395447|75978447|FG000|STARTED|Overall Study||1031||
59853911|NCT00395447|75978448|FG001|STARTED|Overall Study||713||
59853912|NCT00395447|75978447|FG000|COMPLETED|Overall Study||910||
59853913|NCT00395447|75978448|FG001|COMPLETED|Overall Study||602||
59853914|NCT00395447|75978447|FG000|NOT COMPLETED|Overall Study||121||
59724732|NCT00927069|75843467|FG002|COMPLETED|Week 0 to Week 12||0||
59724733|NCT00927069|75843468|FG003|COMPLETED|Week 0 to Week 12||0||
59724734|NCT00927069|75843465|FG000|NOT COMPLETED|Week 0 to Week 12||1||
59724735|NCT00927069|75843466|FG001|NOT COMPLETED|Week 0 to Week 12||1||
59724736|NCT00927069|75843467|FG002|NOT COMPLETED|Week 0 to Week 12||0||
59724737|NCT00927069|75843468|FG003|NOT COMPLETED|Week 0 to Week 12||0||
59724738|NCT00927069|75843465|FG000|STARTED|Week 12 to Week 24|17 patients stayed at the same dose. One patient withdrew at Week 12 and also had no dose increase|18||
59853915|NCT00395447|75978448|FG001|NOT COMPLETED|Overall Study||111||
59853916|NCT03404674|75978460|FG000|STARTED|Overall Study||5|Enrolled and received Dose 1|
59853917|NCT03404674|75978461|FG001|STARTED|Overall Study||5|Enrolled and received Dose 1|
59853918|NCT03404674|75978462|FG002|STARTED|Overall Study||10|Enrolled and received Dose 1|
59853919|NCT03404674|75978463|FG003|STARTED|Overall Study||10|Enrolled and received Dose 1|
59853920|NCT03404674|75978464|FG004|STARTED|Overall Study||10|Enrolled and received Dose 1|
59853921|NCT03404674|75978465|FG005|STARTED|Overall Study||10|Enrolled and received Dose 1|
59584816|NCT04081961|75691537|FG000|COMPLETED|Overall Study||9||
59584817|NCT04081961|75691538|FG001|COMPLETED|Overall Study||9||
59584818|NCT04081961|75691539|FG002|COMPLETED|Overall Study||9||
59584819|NCT04081961|75691537|FG000|NOT COMPLETED|Overall Study||0||
59853922|NCT03404674|75978460|FG000|Received Dose 2|Overall Study||5||
59853923|NCT03404674|75978461|FG001|Received Dose 2|Overall Study||4||
59853924|NCT03404674|75978462|FG002|Received Dose 2|Overall Study||10||
59853925|NCT03404674|75978463|FG003|Received Dose 2|Overall Study||9||
59853926|NCT03404674|75978464|FG004|Received Dose 2|Overall Study||10||
59853927|NCT03404674|75978465|FG005|Received Dose 2|Overall Study||10||
59853928|NCT03404674|75978460|FG000|Received Dose 3|Overall Study||5||
59853929|NCT03404674|75978461|FG001|Received Dose 3|Overall Study||4||
59853930|NCT03404674|75978462|FG002|Received Dose 3|Overall Study||9||
59853931|NCT03404674|75978463|FG003|Received Dose 3|Overall Study||9||
59853932|NCT03404674|75978464|FG004|Received Dose 3|Overall Study||10||
59853933|NCT03404674|75978465|FG005|Received Dose 3|Overall Study||9||
59853934|NCT03404674|75978460|FG000|COMPLETED|Overall Study||5||
59853935|NCT03404674|75978461|FG001|COMPLETED|Overall Study||4||
59853936|NCT03404674|75978462|FG002|COMPLETED|Overall Study||8||
59853937|NCT03404674|75978463|FG003|COMPLETED|Overall Study||9||
59853938|NCT03404674|75978464|FG004|COMPLETED|Overall Study||10||
59853939|NCT03404674|75978465|FG005|COMPLETED|Overall Study||9||
59853940|NCT03404674|75978460|FG000|NOT COMPLETED|Overall Study||0||
59853941|NCT03404674|75978461|FG001|NOT COMPLETED|Overall Study||1||
59853942|NCT03404674|75978462|FG002|NOT COMPLETED|Overall Study||2||
59853943|NCT03404674|75978463|FG003|NOT COMPLETED|Overall Study||1||
59853944|NCT03404674|75978464|FG004|NOT COMPLETED|Overall Study||0||
59853945|NCT03404674|75978465|FG005|NOT COMPLETED|Overall Study||1||
59853946|NCT00064662|75978482|FG000|STARTED|Overall Study||329||
59853947|NCT00064662|75978483|FG001|STARTED|Overall Study||326||
59853948|NCT00064662|75978482|FG000|COMPLETED|Overall Study||255||
59853949|NCT00064662|75978483|FG001|COMPLETED|Overall Study||265||
59853950|NCT00064662|75978482|FG000|NOT COMPLETED|Overall Study||74||
59853951|NCT00064662|75978483|FG001|NOT COMPLETED|Overall Study||61||
59853952|NCT03404518|75978491|FG000|STARTED|Overall Study||97||
59853953|NCT03404518|75978492|FG001|STARTED|Overall Study||88||
59853954|NCT03404518|75978491|FG000|COMPLETED|Overall Study||56||
59853955|NCT03404518|75978492|FG001|COMPLETED|Overall Study||52||
59853956|NCT03404518|75978491|FG000|NOT COMPLETED|Overall Study||41||
59853957|NCT03404518|75978492|FG001|NOT COMPLETED|Overall Study||36||
59853958|NCT03404206|75978501|FG000|STARTED|Overall Study||166||
59853959|NCT03404206|75978502|FG001|STARTED|Overall Study||166||
59853960|NCT03404206|75978503|FG002|STARTED|Overall Study||55||
59853961|NCT03404206|75978501|FG000|COMPLETED|Overall Study||162||
59853962|NCT03404206|75978502|FG001|COMPLETED|Overall Study||164||
59853963|NCT03404206|75978503|FG002|COMPLETED|Overall Study||55||
59853964|NCT03404206|75978501|FG000|NOT COMPLETED|Overall Study||4||
59853965|NCT03404206|75978502|FG001|NOT COMPLETED|Overall Study||2||
59853966|NCT03404206|75978503|FG002|NOT COMPLETED|Overall Study||0||
59853967|NCT03403426|75978511|FG000|STARTED|Overall Study||85||
59853968|NCT03403426|75978511|FG000|COMPLETED|Overall Study||82||
59853969|NCT03403426|75978511|FG000|NOT COMPLETED|Overall Study||3||
59584820|NCT04081961|75691538|FG001|NOT COMPLETED|Overall Study||0||
59584821|NCT04081961|75691539|FG002|NOT COMPLETED|Overall Study||0||
59724739|NCT00927069|75843466|FG001|STARTED|Week 12 to Week 24|11 patients stayed at the same dose of 40 mg Adalimumab every other week|11||
59724740|NCT00927069|75843467|FG002|STARTED|Week 12 to Week 24|31 Pts. from Group A had a dose incr. since they did not respond to 40mg adalimumab every other week|31||
59724741|NCT00927069|75843468|FG003|STARTED|Week 12 to Week 24|23 Pts. from Group B had a dose incr. since they did not respond to 40mg adalimumab every other week|23||
59724742|NCT00927069|75843465|FG000|COMPLETED|Week 12 to Week 24||16||
59724743|NCT00927069|75843466|FG001|COMPLETED|Week 12 to Week 24||11||
59724744|NCT00927069|75843467|FG002|COMPLETED|Week 12 to Week 24||28||
59724745|NCT00927069|75843468|FG003|COMPLETED|Week 12 to Week 24||20||
59724746|NCT00927069|75843465|FG000|NOT COMPLETED|Week 12 to Week 24||2||
59724747|NCT00927069|75843466|FG001|NOT COMPLETED|Week 12 to Week 24||0||
59853970|NCT00394901|75978519|FG000|STARTED|Baseline Phase|Subjects randomized|98||
59853971|NCT00394901|75978520|FG001|STARTED|Baseline Phase|Subjects randomized|87||
59853972|NCT00394901|75978521|FG002|STARTED|Baseline Phase|Subjects randomized|90||
59853973|NCT00394901|75978522|FG003|STARTED|Baseline Phase|Subjects randomized|97||
59853974|NCT00394901|75978519|FG000|COMPLETED|Baseline Phase||98||
59853975|NCT00394901|75978520|FG001|COMPLETED|Baseline Phase||87||
59853976|NCT00394901|75978521|FG002|COMPLETED|Baseline Phase||89||
59853977|NCT00394901|75978522|FG003|COMPLETED|Baseline Phase||97||
59853978|NCT00394901|75978519|FG000|NOT COMPLETED|Baseline Phase||0||
59853979|NCT00394901|75978520|FG001|NOT COMPLETED|Baseline Phase||0||
59853980|NCT00394901|75978521|FG002|NOT COMPLETED|Baseline Phase||1||
59853981|NCT00394901|75978522|FG003|NOT COMPLETED|Baseline Phase||0||
59853982|NCT00394901|75978519|FG000|STARTED|Double-blind Phase|Subjects treated with the study drug.|98||
59853983|NCT00394901|75978520|FG001|STARTED|Double-blind Phase|Subjects treated with the study drug.|87||
59853984|NCT00394901|75978521|FG002|STARTED|Double-blind Phase|Subjects treated with the study drug.|89||
59584822|NCT04075409|75691550|FG000|STARTED|Overall Study||13||
59584823|NCT04075409|75691551|FG001|STARTED|Overall Study||13||
59853985|NCT00394901|75978522|FG003|STARTED|Double-blind Phase|Subjects treated with the study drug.|97||
59853986|NCT00394901|75978519|FG000|COMPLETED|Double-blind Phase||83||
59853987|NCT00394901|75978520|FG001|COMPLETED|Double-blind Phase||73||
59853988|NCT00394901|75978521|FG002|COMPLETED|Double-blind Phase||71||
59853989|NCT00394901|75978522|FG003|COMPLETED|Double-blind Phase||70||
59853990|NCT00394901|75978519|FG000|NOT COMPLETED|Double-blind Phase||15||
59853991|NCT00394901|75978520|FG001|NOT COMPLETED|Double-blind Phase||14||
59853992|NCT00394901|75978521|FG002|NOT COMPLETED|Double-blind Phase||18||
59853993|NCT00394901|75978522|FG003|NOT COMPLETED|Double-blind Phase||27||
59853994|NCT03349060|75978538|FG000|STARTED|Overall Study||156||
59853995|NCT03349060|75978539|FG001|STARTED|Overall Study||154||
59853996|NCT03349060|75978540|FG002|STARTED|Overall Study||77||
59853997|NCT03349060|75978538|FG000|COMPLETED|Overall Study||135||
59853998|NCT03349060|75978539|FG001|COMPLETED|Overall Study||137||
59853999|NCT03349060|75978540|FG002|COMPLETED|Overall Study||61||
59854000|NCT03349060|75978538|FG000|NOT COMPLETED|Overall Study||21||
59854001|NCT03349060|75978539|FG001|NOT COMPLETED|Overall Study||17||
59854002|NCT03349060|75978540|FG002|NOT COMPLETED|Overall Study||16||
59854003|NCT03348904|75978551|FG000|STARTED|Overall Study||0||
59854004|NCT03348904|75978552|FG001|STARTED|Overall Study||2||
59854005|NCT03348904|75978553|FG002|STARTED|Overall Study||0||
59854006|NCT03348904|75978551|FG000|COMPLETED|Overall Study||0||
59854007|NCT03348904|75978552|FG001|COMPLETED|Overall Study||1||
59854008|NCT03348904|75978553|FG002|COMPLETED|Overall Study||0||
59854009|NCT03348904|75978551|FG000|NOT COMPLETED|Overall Study||0||
59854010|NCT03348904|75978552|FG001|NOT COMPLETED|Overall Study||1||
59854011|NCT03348904|75978553|FG002|NOT COMPLETED|Overall Study||0||
59854012|NCT00359021|75978563|FG000|STARTED|Overall Study||256||
59854013|NCT00359021|75978564|FG001|STARTED|Overall Study||247||
59854014|NCT00359021|75978563|FG000|COMPLETED|Overall Study||175||
59854015|NCT00359021|75978564|FG001|COMPLETED|Overall Study||195||
59854016|NCT00359021|75978563|FG000|NOT COMPLETED|Overall Study||81||
59854017|NCT00359021|75978564|FG001|NOT COMPLETED|Overall Study||52||
59854018|NCT00360269|75978574|FG000|STARTED|Overall Study||19||
59854019|NCT00360269|75978575|FG001|STARTED|Overall Study||19||
59854020|NCT00360269|75978574|FG000|COMPLETED|Overall Study||9||
59854021|NCT00360269|75978575|FG001|COMPLETED|Overall Study||7||
59854022|NCT00360269|75978574|FG000|NOT COMPLETED|Overall Study||10||
59854023|NCT00360269|75978575|FG001|NOT COMPLETED|Overall Study||12||
59854024|NCT00076752|75978581|FG000|STARTED|Overall Study||9||
59854025|NCT00076752|75978581|FG000|COMPLETED|Overall Study||6||
59854026|NCT00076752|75978581|FG000|NOT COMPLETED|Overall Study||3||
59854027|NCT03384940|75978589|FG000|STARTED|Overall Study||53||
59854028|NCT03384940|75978590|FG001|STARTED|Overall Study||15||
59854029|NCT03384940|75978591|FG002|STARTED|Overall Study||18||
59854030|NCT03384940|75978589|FG000|COMPLETED|Overall Study||0|As of database lock for final analysis on 28 Dec 2020|
59854031|NCT03384940|75978590|FG001|COMPLETED|Overall Study||0|As of database lock for final analysis on 28 Dec 2020|
59854032|NCT03384940|75978591|FG002|COMPLETED|Overall Study||0|As of database lock for final analysis on 28 Dec 2020|
59854033|NCT03384940|75978589|FG000|NOT COMPLETED|Overall Study||53||
59854034|NCT03384940|75978590|FG001|NOT COMPLETED|Overall Study||15||
59854035|NCT03384940|75978591|FG002|NOT COMPLETED|Overall Study||18||
59854036|NCT00075582|75978601|FG000|STARTED|Overall Study||305||
59854037|NCT00075582|75978602|FG001|STARTED|Overall Study||85||
59854038|NCT00075582|75978601|FG000|COMPLETED|Overall Study||255||
59854039|NCT00075582|75978602|FG001|COMPLETED|Overall Study||50||
59854040|NCT00075582|75978601|FG000|NOT COMPLETED|Overall Study||50||
59854041|NCT00075582|75978602|FG001|NOT COMPLETED|Overall Study||35||
59854042|NCT00063258|75978614|FG000|STARTED|Overall Study||5||
59854043|NCT00063258|75978615|FG001|STARTED|Overall Study||0||
59854044|NCT00063258|75978614|FG000|COMPLETED|Overall Study||1||
59854045|NCT00063258|75978615|FG001|COMPLETED|Overall Study||0||
59854046|NCT00063258|75978614|FG000|NOT COMPLETED|Overall Study||4||
59854047|NCT00063258|75978615|FG001|NOT COMPLETED|Overall Study||0||
59854048|NCT00088530|75978623|FG000|STARTED|Overall Study||70||
59854049|NCT00088530|75978624|FG001|STARTED|Overall Study||70||
59854050|NCT00088530|75978623|FG000|COMPLETED|Overall Study||20||
59854051|NCT00088530|75978624|FG001|COMPLETED|Overall Study||16||
59854052|NCT00088530|75978623|FG000|NOT COMPLETED|Overall Study||50||
59854053|NCT00088530|75978624|FG001|NOT COMPLETED|Overall Study||54||
59854054|NCT00359801|75978632|FG000|STARTED|Overall Study||987||
59854055|NCT00359801|75978633|FG001|STARTED|Overall Study||989||
59854056|NCT00359801|75978632|FG000|COMPLETED|Overall Study|7 additional subjects had missing data and final status (completed/discontinued) is unknown.|682||
59854057|NCT00359801|75978633|FG001|COMPLETED|Overall Study|4 additional subjects had missing data and final status (completed/discontinued) is unknown.|769||
59854058|NCT00359801|75978632|FG000|NOT COMPLETED|Overall Study||305||
59854059|NCT00359801|75978633|FG001|NOT COMPLETED|Overall Study||220||
59854060|NCT00045032|75978642|FG000|STARTED|Overall Study|Included all participants with available signed Informed Consent Form.|1697||
59854061|NCT00045032|75978643|FG001|STARTED|Overall Study|Included all participants with available signed Informed Consent Form.|1702||
59854062|NCT00045032|75978644|FG002|STARTED|Overall Study|Included all participants with available signed Informed Consent Form.|1700||
59854063|NCT00045032|75978642|FG000|Crossover to Adjuvant Herceptin|Overall Study||888||
59854064|NCT00045032|75978643|FG001|Crossover to Adjuvant Herceptin|Overall Study|This milestone is not applicable to participants who were already randomized to Herceptin.|0||
59996775|NCT03434041|76112633|FG001|Full Analysis Set|Double Blind Treatment Phase (4 Weeks)||126||
59854065|NCT00045032|75978644|FG002|Crossover to Adjuvant Herceptin|Overall Study|This milestone is not applicable to participants who were already randomized to Herceptin.|0||
59854066|NCT00045032|75978642|FG000|COMPLETED|Overall Study||834||
59854067|NCT00045032|75978643|FG001|COMPLETED|Overall Study||994||
59854068|NCT00045032|75978644|FG002|COMPLETED|Overall Study||974||
59854069|NCT00045032|75978642|FG000|NOT COMPLETED|Overall Study||863||
59854070|NCT00045032|75978643|FG001|NOT COMPLETED|Overall Study||708||
59854071|NCT00045032|75978644|FG002|NOT COMPLETED|Overall Study||726||
59854072|NCT00356915|75978657|FG000|STARTED|Overall Study||593||
59854073|NCT00356915|75978658|FG001|STARTED|Overall Study||590||
59854074|NCT00356915|75978659|FG002|STARTED|Overall Study||198||
59854075|NCT00356915|75978657|FG000|COMPLETED|Overall Study||517||
59854076|NCT00356915|75978658|FG001|COMPLETED|Overall Study||496||
59854077|NCT00356915|75978659|FG002|COMPLETED|Overall Study||156||
59854078|NCT00356915|75978657|FG000|NOT COMPLETED|Overall Study||76||
59854079|NCT00356915|75978658|FG001|NOT COMPLETED|Overall Study||94||
59854080|NCT00356915|75978659|FG002|NOT COMPLETED|Overall Study||42||
59854081|NCT00356759|75978675|FG000|STARTED|Overall Study||126||
59854082|NCT00356759|75978676|FG001|STARTED|Overall Study||124||
59854083|NCT00356759|75978675|FG000|COMPLETED|Overall Study||112||
59854084|NCT00356759|75978676|FG001|COMPLETED|Overall Study||114||
59854085|NCT00356759|75978675|FG000|NOT COMPLETED|Overall Study||14||
59854086|NCT00356759|75978676|FG001|NOT COMPLETED|Overall Study||10||
59854087|NCT03804710|75978684|FG000|STARTED|Overall Study||75||
59854088|NCT03804710|75978685|FG001|STARTED|Overall Study||74||
59854089|NCT03804710|75978684|FG000|COMPLETED|Overall Study||73||
59854090|NCT03804710|75978685|FG001|COMPLETED|Overall Study||69||
59854091|NCT03804710|75978684|FG000|NOT COMPLETED|Overall Study||2||
59854092|NCT03804710|75978685|FG001|NOT COMPLETED|Overall Study||5||
60121653|NCT01567163|76242549|FG000|NOT COMPLETED|Overall Study||4||
60121654|NCT01567085|76242558|FG000|STARTED|Overall Study||80||
59584824|NCT04075409|75691552|FG002|STARTED|Overall Study||13||
59584825|NCT04075409|75691550|FG000|COMPLETED|Overall Study||13||
59584826|NCT04075409|75691551|FG001|COMPLETED|Overall Study||13||
59584827|NCT04075409|75691552|FG002|COMPLETED|Overall Study||13||
59584828|NCT04075409|75691550|FG000|NOT COMPLETED|Overall Study||0||
59584829|NCT04075409|75691551|FG001|NOT COMPLETED|Overall Study||0||
59584830|NCT04075409|75691552|FG002|NOT COMPLETED|Overall Study||0||
59584831|NCT04074941|75691573|FG000|STARTED|Overall Study||11||
59584832|NCT04074941|75691574|FG001|STARTED|Overall Study||9||
59584833|NCT04074941|75691573|FG000|COMPLETED|Overall Study||11||
59584834|NCT04074941|75691574|FG001|COMPLETED|Overall Study||9||
59584835|NCT04074941|75691573|FG000|NOT COMPLETED|Overall Study||0||
59724748|NCT00927069|75843467|FG002|NOT COMPLETED|Week 12 to Week 24||3||
59724749|NCT00927069|75843468|FG003|NOT COMPLETED|Week 12 to Week 24||3||
59724750|NCT01031628|75843482|FG000|STARTED|Overall Study||0||
59724751|NCT01031628|75843483|FG001|STARTED|Overall Study||1||
59724752|NCT01031628|75843484|FG002|STARTED|Overall Study||3||
59724753|NCT01031628|75843485|FG003|STARTED|Overall Study||0||
59724754|NCT01031628|75843482|FG000|COMPLETED|Overall Study||0||
59724755|NCT01031628|75843483|FG001|COMPLETED|Overall Study||0||
59724756|NCT01031628|75843484|FG002|COMPLETED|Overall Study||0||
59584836|NCT04074941|75691574|FG001|NOT COMPLETED|Overall Study||0||
59584837|NCT03694613|75691580|FG000|STARTED|Overall Study||65||
59584838|NCT03694613|75691580|FG000|COMPLETED|Overall Study|65 samples were collected and analyzed. at least 3 ml were collected.|65||
59584839|NCT03694613|75691580|FG000|NOT COMPLETED|Overall Study||0||
59584840|NCT03706313|75691595|FG000|STARTED|Overall Study||20||
59584841|NCT03706313|75691596|FG001|STARTED|Overall Study||20||
59584842|NCT03706313|75691595|FG000|COMPLETED|Overall Study||20||
59584843|NCT03706313|75691596|FG001|COMPLETED|Overall Study||20||
59584844|NCT03706313|75691595|FG000|NOT COMPLETED|Overall Study||0||
59584845|NCT03706313|75691596|FG001|NOT COMPLETED|Overall Study||0||
59584846|NCT03421106|75691604|FG000|STARTED|Sample A (Followed for 1 Year)||158||
59584847|NCT03421106|75691605|FG001|STARTED|Sample A (Followed for 1 Year)||159||
59584848|NCT03421106|75691604|FG000|COMPLETED|Sample A (Followed for 1 Year)||102||
59584849|NCT03421106|75691605|FG001|COMPLETED|Sample A (Followed for 1 Year)||105||
59724757|NCT01031628|75843485|FG003|COMPLETED|Overall Study||0||
59724758|NCT01031628|75843482|FG000|NOT COMPLETED|Overall Study||0||
59724759|NCT01031628|75843483|FG001|NOT COMPLETED|Overall Study||1||
59724760|NCT01031628|75843484|FG002|NOT COMPLETED|Overall Study||3||
59854093|NCT00356603|75978697|FG000|STARTED|Overall Study||39||
59854094|NCT00356603|75978698|FG001|STARTED|Overall Study||36||
59854095|NCT00356603|75978697|FG000|COMPLETED|Overall Study||33||
59854096|NCT00356603|75978698|FG001|COMPLETED|Overall Study||33||
59854097|NCT00356603|75978697|FG000|NOT COMPLETED|Overall Study||6||
59854098|NCT00356603|75978698|FG001|NOT COMPLETED|Overall Study||3||
59854099|NCT00002558|75978708|FG000|STARTED|Overall Study||92||
59854100|NCT00002558|75978709|FG001|STARTED|Overall Study||16||
59854101|NCT00002558|75978708|FG000|COMPLETED|Overall Study||92||
59854102|NCT00002558|75978709|FG001|COMPLETED|Overall Study||15||
59854103|NCT00002558|75978708|FG000|NOT COMPLETED|Overall Study||0||
59854104|NCT00002558|75978709|FG001|NOT COMPLETED|Overall Study||1||
60121655|NCT01567085|76242558|FG000|Received at Least 1 Dose of Study Drug|Overall Study||80||
60121656|NCT01567085|76242558|FG000|COMPLETED|Overall Study||60||
59854105|NCT00001880|75978715|FG000|STARTED|Overall Study||42||
59854106|NCT00001880|75978715|FG000|COMPLETED|Overall Study||28||
59854107|NCT00001880|75978715|FG000|NOT COMPLETED|Overall Study||14||
59854108|NCT00043550|75978722|FG000|STARTED|Overall Study||55||
59854109|NCT00043550|75978723|FG001|STARTED|Overall Study||51||
59854110|NCT00043550|75978724|FG002|STARTED|Overall Study||50||
59854111|NCT00043550|75978722|FG000|Week 8 Completed|Overall Study||35||
59854112|NCT00043550|75978723|FG001|Week 8 Completed|Overall Study||40||
59854113|NCT00043550|75978724|FG002|Week 8 Completed|Overall Study||35||
59854114|NCT00043550|75978722|FG000|COMPLETED|Overall Study||33||
59854115|NCT00043550|75978723|FG001|COMPLETED|Overall Study||39||
59854116|NCT00043550|75978724|FG002|COMPLETED|Overall Study||30||
59854117|NCT00043550|75978722|FG000|NOT COMPLETED|Overall Study||22||
59854118|NCT00043550|75978723|FG001|NOT COMPLETED|Overall Study||12||
59854119|NCT00043550|75978724|FG002|NOT COMPLETED|Overall Study||20||
59854120|NCT00041756|75978737|FG000|STARTED|Overall Study||77||
59854121|NCT00041756|75978738|FG001|STARTED|Overall Study||80||
59854122|NCT00041756|75978739|FG002|STARTED|Overall Study||79||
59854123|NCT00041756|75978740|FG003|STARTED|Overall Study||80||
59854124|NCT00041756|75978741|FG004|STARTED|Overall Study||79||
59854125|NCT00041756|75978737|FG000|COMPLETED|Overall Study||69||
59854126|NCT00041756|75978738|FG001|COMPLETED|Overall Study||65||
59854127|NCT00041756|75978739|FG002|COMPLETED|Overall Study||66||
59854128|NCT00041756|75978740|FG003|COMPLETED|Overall Study||64||
59854129|NCT00041756|75978741|FG004|COMPLETED|Overall Study||19||
59854130|NCT00041756|75978737|FG000|NOT COMPLETED|Overall Study||8||
59854131|NCT00041756|75978738|FG001|NOT COMPLETED|Overall Study||15||
59854132|NCT00041756|75978739|FG002|NOT COMPLETED|Overall Study||13||
59854133|NCT00041756|75978740|FG003|NOT COMPLETED|Overall Study||16||
59854134|NCT00041756|75978741|FG004|NOT COMPLETED|Overall Study||60||
59854135|NCT00041132|75978753|FG000|STARTED|Overall Study||56||
59854136|NCT00041132|75978753|FG000|Eligible|Overall Study||49||
59854137|NCT00041132|75978753|FG000|Eligible and Began Protocol Therapy|Overall Study||49||
59854138|NCT00041132|75978753|FG000|COMPLETED|Overall Study||26||
59854139|NCT00041132|75978753|FG000|NOT COMPLETED|Overall Study||30||
59854140|NCT00040742|75978761|FG000|STARTED|Overall Study||188||
59854141|NCT00040742|75978762|FG001|STARTED|Overall Study||183||
59854142|NCT00040742|75978763|FG002|STARTED|Overall Study||187||
59854143|NCT00040742|75978764|FG003|STARTED|Overall Study|One subject found to be ineligible after randomization. No baseline data collected.|186||
59854144|NCT00040742|75978761|FG000|COMPLETED|Overall Study||149||
59854145|NCT00040742|75978762|FG001|COMPLETED|Overall Study||134||
59854146|NCT00040742|75978763|FG002|COMPLETED|Overall Study||141||
59854147|NCT00040742|75978764|FG003|COMPLETED|Overall Study||152||
59854148|NCT00040742|75978761|FG000|NOT COMPLETED|Overall Study||39||
59854149|NCT00040742|75978762|FG001|NOT COMPLETED|Overall Study||49||
59854150|NCT00040742|75978763|FG002|NOT COMPLETED|Overall Study||46||
59854151|NCT00040742|75978764|FG003|NOT COMPLETED|Overall Study||34||
59854152|NCT00040664|75978774|FG000|STARTED|Overall Study|All (69) enrolled on QD; 10 switched to twice daily. Participant flow not collected for this group.|69||
59854153|NCT00040664|75978775|FG001|STARTED|Overall Study||17||
59854154|NCT00040664|75978776|FG002|STARTED|Overall Study||17||
59854155|NCT00040664|75978777|FG003|STARTED|Overall Study||35||
59854156|NCT00040664|75978774|FG000|COMPLETED|Overall Study||16||
59854157|NCT00040664|75978775|FG001|COMPLETED|Overall Study||4||
59854158|NCT00040664|75978776|FG002|COMPLETED|Overall Study||4||
59854159|NCT00040664|75978777|FG003|COMPLETED|Overall Study||8||
59854160|NCT00040664|75978774|FG000|NOT COMPLETED|Overall Study||53||
59854161|NCT00040664|75978775|FG001|NOT COMPLETED|Overall Study||13||
59854162|NCT00040664|75978776|FG002|NOT COMPLETED|Overall Study||13||
59854163|NCT00040664|75978777|FG003|NOT COMPLETED|Overall Study||27||
59854164|NCT02952586|75978797|FG000|STARTED|Lead-In Phase (7 Days)||350||
59854165|NCT02952586|75978798|FG001|STARTED|Lead-In Phase (7 Days)||347||
59854166|NCT02952586|75978797|FG000|Safety Analysis Set|Lead-In Phase (7 Days)||348||
59854167|NCT02952586|75978798|FG001|Safety Analysis Set|Lead-In Phase (7 Days)||344||
59584850|NCT03421106|75691604|FG000|NOT COMPLETED|Sample A (Followed for 1 Year)||56||
59724761|NCT01031628|75843485|FG003|NOT COMPLETED|Overall Study||0||
59724762|NCT01031004|75843497|FG000|STARTED|Overall Study||25||
59724763|NCT01031004|75843498|FG001|STARTED|Overall Study||25||
59724764|NCT01031004|75843497|FG000|COMPLETED|Overall Study||24||
59724765|NCT01031004|75843498|FG001|COMPLETED|Overall Study||24||
59724766|NCT01031004|75843497|FG000|NOT COMPLETED|Overall Study||1||
59724767|NCT01031004|75843498|FG001|NOT COMPLETED|Overall Study||1||
59724768|NCT00931515|75843506|FG000|STARTED|Overall Study||15||
59724769|NCT00931515|75843507|FG001|STARTED|Overall Study||15||
59724770|NCT00931515|75843506|FG000|COMPLETED|Overall Study||13||
59724771|NCT00931515|75843507|FG001|COMPLETED|Overall Study||10||
59724772|NCT00931515|75843506|FG000|NOT COMPLETED|Overall Study||2||
59854168|NCT02952586|75978797|FG000|COMPLETED|Lead-In Phase (7 Days)||345||
59854169|NCT02952586|75978798|FG001|COMPLETED|Lead-In Phase (7 Days)||343||
59854170|NCT02952586|75978797|FG000|NOT COMPLETED|Lead-In Phase (7 Days)||5||
59854171|NCT02952586|75978798|FG001|NOT COMPLETED|Lead-In Phase (7 Days)||4||
59854172|NCT02952586|75978797|FG000|STARTED|CRT for Avelumab or Placebo (63 Days)||345||
59996776|NCT03434041|76112632|FG000|COMPLETED|Double Blind Treatment Phase (4 Weeks)||108||
59854173|NCT02952586|75978798|FG001|STARTED|CRT for Avelumab or Placebo (63 Days)|All participants who did not withdraw from study after Lead-In phase, entered into CRT phase.|340||
59854174|NCT02952586|75978797|FG000|COMPLETED|CRT for Avelumab or Placebo (63 Days)||312||
59854175|NCT02952586|75978798|FG001|COMPLETED|CRT for Avelumab or Placebo (63 Days)||313||
59854176|NCT02952586|75978797|FG000|NOT COMPLETED|CRT for Avelumab or Placebo (63 Days)||33||
59854177|NCT02952586|75978798|FG001|NOT COMPLETED|CRT for Avelumab or Placebo (63 Days)||27||
59854178|NCT02952586|75978797|FG000|STARTED|CRT for Cisplatin (63 Days)|Avelumab, Cisplatin, and IMRT were treatments in CRT phase.|345||
59854179|NCT02952586|75978798|FG001|STARTED|CRT for Cisplatin (63 Days)|Placebo, Cisplatin, and IMRT were treatments in CRT phase.|340||
59854180|NCT02952586|75978797|FG000|COMPLETED|CRT for Cisplatin (63 Days)||234||
59854181|NCT02952586|75978798|FG001|COMPLETED|CRT for Cisplatin (63 Days)||236||
59854182|NCT02952586|75978797|FG000|NOT COMPLETED|CRT for Cisplatin (63 Days)||111||
59854183|NCT02952586|75978798|FG001|NOT COMPLETED|CRT for Cisplatin (63 Days)||104||
59854184|NCT02952586|75978797|FG000|STARTED|CRT for IMRT (63 Days)|Avelumab, Cisplatin, and IMRT were treatments in CRT phase.|345||
59854185|NCT02952586|75978798|FG001|STARTED|CRT for IMRT (63 Days)|Placebo, Cisplatin, and IMRT were treatments in CRT phase.|340||
59854186|NCT02952586|75978797|FG000|COMPLETED|CRT for IMRT (63 Days)||322||
59854187|NCT02952586|75978798|FG001|COMPLETED|CRT for IMRT (63 Days)||320||
59854188|NCT02952586|75978797|FG000|NOT COMPLETED|CRT for IMRT (63 Days)||23||
59854189|NCT02952586|75978798|FG001|NOT COMPLETED|CRT for IMRT (63 Days)||20||
59854190|NCT02952586|75978797|FG000|STARTED|Maintenance Phase (12 Months)|All participants who did not withdraw from study after CRT phases, entered into maintenance phase.|291||
59854191|NCT02952586|75978798|FG001|STARTED|Maintenance Phase (12 Months)|All participants who did not withdraw from study after CRT phases, entered into maintenance phase.|304||
59854192|NCT02952586|75978797|FG000|COMPLETED|Maintenance Phase (12 Months)||139||
59854193|NCT02952586|75978798|FG001|COMPLETED|Maintenance Phase (12 Months)||177||
59854194|NCT02952586|75978797|FG000|NOT COMPLETED|Maintenance Phase (12 Months)||152||
59854195|NCT02952586|75978798|FG001|NOT COMPLETED|Maintenance Phase (12 Months)||127||
59854196|NCT02952586|75978797|FG000|STARTED|Follow-Up Phase (90 Days)|Participants who did not withdraw study after previous phases, entered in short-term follow up phase.|266||
59854197|NCT02952586|75978798|FG001|STARTED|Follow-Up Phase (90 Days)|Participants who did not withdraw study after previous phases, entered in short-term follow up phase.|284||
59854198|NCT02952586|75978797|FG000|COMPLETED|Follow-Up Phase (90 Days)||208||
59854199|NCT02952586|75978798|FG001|COMPLETED|Follow-Up Phase (90 Days)||216||
59854200|NCT02952586|75978797|FG000|NOT COMPLETED|Follow-Up Phase (90 Days)||58||
59854201|NCT02952586|75978798|FG001|NOT COMPLETED|Follow-Up Phase (90 Days)||68||
59854202|NCT02952586|75978797|FG000|STARTED|LT Follow-up (up to 45 Months)|Participants who did not withdraw study after previous phases, entered in long-term follow up phase.|247||
59854203|NCT02952586|75978798|FG001|STARTED|LT Follow-up (up to 45 Months)|Participants who did not withdraw study after previous phases, entered in long-term follow up phase.|237||
59854204|NCT02952586|75978797|FG000|COMPLETED|LT Follow-up (up to 45 Months)||0||
59854205|NCT02952586|75978798|FG001|COMPLETED|LT Follow-up (up to 45 Months)||0||
59854206|NCT02952586|75978797|FG000|NOT COMPLETED|LT Follow-up (up to 45 Months)||247||
59854207|NCT02952586|75978798|FG001|NOT COMPLETED|LT Follow-up (up to 45 Months)||237||
59854208|NCT03384316|75978807|FG000|STARTED|Overall Study||6||
59854209|NCT03384316|75978808|FG001|STARTED|Overall Study||5||
59854210|NCT03384316|75978807|FG000|COMPLETED|Overall Study||6||
59854211|NCT03384316|75978808|FG001|COMPLETED|Overall Study||4||
59584851|NCT03421106|75691605|FG001|NOT COMPLETED|Sample A (Followed for 1 Year)||54||
59584852|NCT03421106|75691604|FG000|STARTED|Sample B (Evaluated at Post Only)||85||
59584853|NCT03421106|75691605|FG001|STARTED|Sample B (Evaluated at Post Only)||102||
59584854|NCT03421106|75691604|FG000|COMPLETED|Sample B (Evaluated at Post Only)||85||
59584855|NCT03421106|75691605|FG001|COMPLETED|Sample B (Evaluated at Post Only)||102||
59584856|NCT03421106|75691604|FG000|NOT COMPLETED|Sample B (Evaluated at Post Only)||0||
59584857|NCT03421106|75691605|FG001|NOT COMPLETED|Sample B (Evaluated at Post Only)||0||
59584858|NCT03706469|75691615|FG000|STARTED|Overall Study||4||
59584859|NCT03706469|75691616|FG001|STARTED|Overall Study||4||
59584860|NCT03706469|75691617|FG002|STARTED|Overall Study||4||
59584861|NCT03706469|75691618|FG003|STARTED|Overall Study||4||
59584862|NCT03706469|75691615|FG000|COMPLETED|Overall Study||4||
59584863|NCT03706469|75691616|FG001|COMPLETED|Overall Study||4||
59584864|NCT03706469|75691617|FG002|COMPLETED|Overall Study||4||
59854212|NCT03384316|75978807|FG000|NOT COMPLETED|Overall Study||0||
59854213|NCT03384316|75978808|FG001|NOT COMPLETED|Overall Study||1||
59854214|NCT03403192|75978820|FG000|STARTED|Overall Study||41||
59854215|NCT03403192|75978821|FG001|STARTED|Overall Study||40||
59854216|NCT03403192|75978822|FG002|STARTED|Overall Study||40||
59854217|NCT03403192|75978823|FG003|STARTED|Overall Study||42||
60121657|NCT01567085|76242558|FG000|NOT COMPLETED|Overall Study||20||
60121658|NCT01566773|76242562|FG000|STARTED|Overall Study||140||
60121659|NCT01566773|76242562|FG000|GP MDI 18 µg BID|Overall Study||64||
59584865|NCT03706469|75691618|FG003|COMPLETED|Overall Study||4||
59584866|NCT03706469|75691615|FG000|NOT COMPLETED|Overall Study||0||
59584867|NCT03706469|75691616|FG001|NOT COMPLETED|Overall Study||0||
59584868|NCT03706469|75691617|FG002|NOT COMPLETED|Overall Study||0||
59584869|NCT03706469|75691618|FG003|NOT COMPLETED|Overall Study||0||
59584870|NCT03545165|75691630|FG000|STARTED|Overall Study||6||
59584871|NCT03545165|75691630|FG000|COMPLETED|Overall Study||6||
59584872|NCT03545165|75691630|FG000|NOT COMPLETED|Overall Study||0||
59584873|NCT03546491|75691634|FG000|STARTED|Overall Study||32||
59584874|NCT03546491|75691634|FG000|Recieved Test Product 1|Overall Study||32|This was a 2 treatment, 3 period crossover design, each subject saw one treatment twice.|
59584875|NCT03546491|75691634|FG000|Received Test Product 2|Overall Study||32|This was a 2 treatment, 3 period crossover design, each subject saw one treatment twice.|
59584876|NCT03546491|75691634|FG000|COMPLETED|Overall Study||30||
59584877|NCT03546491|75691634|FG000|NOT COMPLETED|Overall Study||2||
59584878|NCT03714659|75691644|FG000|STARTED|Overall Study||20||
59584879|NCT03714659|75691644|FG000|COMPLETED|Overall Study||19||
59584880|NCT03714659|75691644|FG000|NOT COMPLETED|Overall Study||1||
59584881|NCT01637142|75691648|FG000|STARTED|Treatment Period 1||18||
59584882|NCT01637142|75691648|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 1||18||
59584883|NCT01637142|75691648|FG000|COMPLETED|Treatment Period 1||18||
59584884|NCT01637142|75691648|FG000|NOT COMPLETED|Treatment Period 1||0||
59584885|NCT01637142|75691648|FG000|STARTED|Washout Period (at Least 3 Days)||18||
59584886|NCT01637142|75691648|FG000|COMPLETED|Washout Period (at Least 3 Days)||17||
59584887|NCT01637142|75691648|FG000|NOT COMPLETED|Washout Period (at Least 3 Days)||1||
59584888|NCT01637142|75691648|FG000|STARTED|Treatment Period 2||17||
59584889|NCT01637142|75691648|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 2||17||
59584890|NCT01637142|75691648|FG000|COMPLETED|Treatment Period 2||17||
59584891|NCT01637142|75691648|FG000|NOT COMPLETED|Treatment Period 2||0||
59584892|NCT04055519|75691654|FG000|STARTED|First Wear Period (30 Days)||16||32
59584893|NCT04055519|75691655|FG001|STARTED|First Wear Period (30 Days)||20||40
59584894|NCT04055519|75691654|FG000|COMPLETED|First Wear Period (30 Days)||16||32
59584895|NCT04055519|75691655|FG001|COMPLETED|First Wear Period (30 Days)||20||40
59584896|NCT04055519|75691654|FG000|NOT COMPLETED|First Wear Period (30 Days)||0||0
59584897|NCT04055519|75691655|FG001|NOT COMPLETED|First Wear Period (30 Days)||0||0
59584898|NCT04055519|75691654|FG000|STARTED|Second Wear Period (30 Days)||16||32
59584899|NCT04055519|75691655|FG001|STARTED|Second Wear Period (30 Days)||20||40
59584900|NCT04055519|75691654|FG000|COMPLETED|Second Wear Period (30 Days)||16||32
59584901|NCT04055519|75691655|FG001|COMPLETED|Second Wear Period (30 Days)||20||40
59584902|NCT04055519|75691654|FG000|NOT COMPLETED|Second Wear Period (30 Days)||0||0
59584903|NCT04055519|75691655|FG001|NOT COMPLETED|Second Wear Period (30 Days)||0||0
59584904|NCT01636986|75691666|FG000|STARTED|Overall Study||30||
59584905|NCT01636986|75691667|FG001|STARTED|Overall Study||32||
59584906|NCT01636986|75691666|FG000|COMPLETED|Overall Study||30||
59584907|NCT01636986|75691667|FG001|COMPLETED|Overall Study||30||
59584908|NCT01636986|75691666|FG000|NOT COMPLETED|Overall Study||0||
59584909|NCT01636986|75691667|FG001|NOT COMPLETED|Overall Study||2||
59584910|NCT04055675|75691675|FG000|STARTED|Overall Study||96||
59584911|NCT04055675|75691676|FG001|STARTED|Overall Study||104||
59584912|NCT04055675|75691675|FG000|COMPLETED|Overall Study||96||
59584913|NCT04055675|75691676|FG001|COMPLETED|Overall Study||104||
59584914|NCT04055675|75691675|FG000|NOT COMPLETED|Overall Study||0||
59584915|NCT04055675|75691676|FG001|NOT COMPLETED|Overall Study||0||
59584916|NCT04523142|75691682|FG000|STARTED|Overall Study|202 participants were enrolled. Two participants were lost to follow-up directly after Visit 1. The safety population comprised 200 participants.|202||
59584917|NCT04523142|75691682|FG000|COMPLETED|Overall Study||175||
59584918|NCT04523142|75691682|FG000|NOT COMPLETED|Overall Study||27||
59584919|NCT03557333|75691686|FG000|STARTED|Overall Study||354||
59584920|NCT03557333|75691686|FG000|COMPLETED|Overall Study||262||
59584921|NCT03557333|75691686|FG000|NOT COMPLETED|Overall Study||92||
59584922|NCT04050605|75691692|FG000|STARTED|Overall Study||40||
59584923|NCT04050605|75691692|FG000|COMPLETED|Overall Study||40||
59584924|NCT04050605|75691692|FG000|NOT COMPLETED|Overall Study||0||
59584925|NCT04035161|75691702|FG000|STARTED|Overall Study||1121||
59584926|NCT04035161|75691702|FG000|Treated With Investigational Product|Overall Study||609||
59584927|NCT04035161|75691702|FG000|Treated With Reference Standard|Overall Study||419||
59724773|NCT00931515|75843507|FG001|NOT COMPLETED|Overall Study||5||
59724774|NCT01028352|75843513|FG000|STARTED|Overall Study||35||
59724775|NCT01028352|75843513|FG000|COMPLETED|Overall Study||29||
59724776|NCT01028352|75843513|FG000|NOT COMPLETED|Overall Study||6||
59724777|NCT03172780|75843520|FG000|STARTED|Overall Study||406||
59724778|NCT03172780|75843521|FG001|STARTED|Overall Study||409||
59724779|NCT03172780|75843522|FG002|STARTED|Overall Study||405||
59724780|NCT03172780|75843520|FG000|COMPLETED|Overall Study||388||
59724781|NCT03172780|75843521|FG001|COMPLETED|Overall Study||389||
59724782|NCT03172780|75843522|FG002|COMPLETED|Overall Study||389||
59584928|NCT04035161|75691702|FG000|Treated With Active Control|Overall Study||609||
59584929|NCT04035161|75691702|FG000|Treated With Negative Control|Overall Study||605||
59584930|NCT04035161|75691702|FG000|COMPLETED|Overall Study||1121||
59584931|NCT04035161|75691702|FG000|NOT COMPLETED|Overall Study||0||
59584932|NCT04037969|75691714|FG000|STARTED|Overall Study||10||
59584933|NCT04037969|75691715|FG001|STARTED|Overall Study||10||
59584934|NCT04037969|75691714|FG000|COMPLETED|Overall Study||10||
59584935|NCT04037969|75691715|FG001|COMPLETED|Overall Study||10||
59584936|NCT04037969|75691714|FG000|NOT COMPLETED|Overall Study||0||
59584937|NCT04037969|75691715|FG001|NOT COMPLETED|Overall Study||0||
59584938|NCT03718871|75691722|FG000|STARTED|Overall Study||250||8
59584939|NCT03718871|75691723|FG001|STARTED|Overall Study||250||9
59584940|NCT03718871|75691722|FG000|COMPLETED|Overall Study||250||8
59584941|NCT03718871|75691723|FG001|COMPLETED|Overall Study||250||9
59584942|NCT03718871|75691722|FG000|NOT COMPLETED|Overall Study||0||0
59584943|NCT03718871|75691723|FG001|NOT COMPLETED|Overall Study||0||0
59584944|NCT04471194|75691732|FG000|STARTED|Overall Study||24||
59584945|NCT04471194|75691733|FG001|STARTED|Overall Study||24||
59584946|NCT04471194|75691732|FG000|COMPLETED|Overall Study||21||
59584947|NCT04471194|75691733|FG001|COMPLETED|Overall Study||21||
59584948|NCT04471194|75691732|FG000|NOT COMPLETED|Overall Study||3||
59584949|NCT04471194|75691733|FG001|NOT COMPLETED|Overall Study||3||
59584950|NCT03752177|75691743|FG000|STARTED|Overall Study||3||
59584951|NCT03752177|75691744|FG001|STARTED|Overall Study||3||
59584952|NCT03752177|75691745|FG002|STARTED|Overall Study||3||
59584953|NCT03752177|75691746|FG003|STARTED|Overall Study||3||
59584954|NCT03752177|75691743|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3||
59584955|NCT03752177|75691744|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3||
59584956|NCT03752177|75691745|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3||
59584957|NCT03752177|75691746|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3||
59584958|NCT03752177|75691743|FG000|COMPLETED|Overall Study||3||
59584959|NCT03752177|75691744|FG001|COMPLETED|Overall Study||3||
59584960|NCT03752177|75691745|FG002|COMPLETED|Overall Study||3||
59584961|NCT03752177|75691746|FG003|COMPLETED|Overall Study||3||
59584962|NCT03752177|75691743|FG000|NOT COMPLETED|Overall Study||0||
59584963|NCT03752177|75691744|FG001|NOT COMPLETED|Overall Study||0||
59584964|NCT03752177|75691745|FG002|NOT COMPLETED|Overall Study||0||
59584965|NCT03752177|75691746|FG003|NOT COMPLETED|Overall Study||0||
59584966|NCT01601496|75691757|FG000|STARTED|Overall Study|Enrolled|117||
59584967|NCT01601496|75691757|FG000|COMPLETED|Overall Study|Completed 12-M F/up|102||
59584968|NCT01601496|75691757|FG000|NOT COMPLETED|Overall Study||15||
59584969|NCT03211832|75691763|FG000|STARTED|Overall Study|In Group 1, 78 health department employees agreed to participate and completed the baseline survey.|78|Baseline Survey. All participants were employees at participating local health departments.|4
59584970|NCT03211832|75691764|FG001|STARTED|Overall Study|In Group 2, 85 health department employees agreed to participate and completed the baseline survey.|85|Baseline Survey. All participants were employees at participating local health departments.|4
59584971|NCT03211832|75691765|FG002|STARTED|Overall Study|In Group 3, 66 health department employees agreed to participate and completed the baseline survey.|66|Baseline Survey. All participants were employees at participating local health departments.|4
59584972|NCT03211832|75691763|FG000|Survey Time 2|Overall Study|Group 1 was in intervention status at Survey Time 2 and so Group 1 participant surveys were analyzed as intervention. At Survey Time 2, 8 health department employees were added to replace those no longer working at the health department. In Group 1, 83 unique individuals completed the Time 2 survey.|83|At Survey Time 2, 37 health department employees were added to replace those no longer working at the agency.|4
59584973|NCT03211832|75691764|FG001|Survey Time 2|Overall Study|At Survey Time 2, Group 2 was still in control status. At Survey Time 2, 19 health department employees were added to replace those no longer working at the health department. A total of 87 unique individual health department employees in Group 2 completed the Time 2 survey.|87|At Survey Time 2, 37 health department employees were added to replace those no longer working at the agency.|4
59584974|NCT03211832|75691765|FG002|Survey Time 2|Overall Study|At Survey Time 2, Group 3 was still in control status. Ten health department employees were added to replace those no longer at the agency. In Group 3, 63 unique individuals completed the survey at Time 2.|63|At Survey Time 2, 37 health department employees were added to replace those no longer working at the agency.|4
59584975|NCT03211832|75691763|FG000|Survey Time 3|Overall Study|In Group 1, 6 health department employees were added to replace employees no longer at the health department. At Survey Time 3, 70 unique individuals completed the survey.|70|More unique health department employee participants were again added (27 due to employee turnover and 15 to better reflect Group 2 health department units involved in the intervention).|4
59584976|NCT03211832|75691764|FG001|Survey Time 3|Overall Study|Groups 1 and 2 were in intervention status at Survey Time 3 and so their employee participant surveys were analyzed as intervention. Ten health department employees were added at Survey Time 3 to replace those no longer with the agency and 15 more were added to better reflect participating units within the health departments. At Survey Time 3, 112 unique individuals completed the survey in Group 2.|112|More unique health department employee participants were again added (27 due to employee turnover and 15 to better reflect Group 2 health department units involved in the intervention).|4
59584977|NCT03211832|75691765|FG002|Survey Time 3|Overall Study|Group 3 was still in control status at Survey Time 3. Eleven health department employees were added at Survey Time 3 to replace those no longer working at the agency.|55|More unique health department employee participants were again added (27 due to employee turnover and 15 to better reflect Group 2 health department units involved in the intervention).|4
59724783|NCT03172780|75843520|FG000|NOT COMPLETED|Overall Study||18||
59724784|NCT03172780|75843521|FG001|NOT COMPLETED|Overall Study||20||
59724785|NCT03172780|75843522|FG002|NOT COMPLETED|Overall Study||16||
59584978|NCT03211832|75691763|FG000|Survey Time 4|Overall Study|At Survey Time 4, 7 health department employees were added to replace those no longer with the health departments.70 unique individuals completed the Time 4 survey.|70|At Survey Time 4, all groups were in Intervention status. At Survey Time 4, 23 health department employees were added to replace those no longer working at the health departments.|4
59584979|NCT03211832|75691764|FG001|Survey Time 4|Overall Study|At Survey Time 4, 10 health department employees were added to replace some of those no longer with the health departments.|97|At Survey Time 4, all groups were in Intervention status. At Survey Time 4, 23 health department employees were added to replace those no longer working at the health departments.|4
59584980|NCT03211832|75691765|FG002|Survey Time 4|Overall Study|At Survey Time 4, 6 health department employees were added to replace those no longer with the agency.|60|At Survey Time 4, all groups were in Intervention status. At Survey Time 4, 23 health department employees were added to replace those no longer working at the health departments.|4
59584981|NCT03211832|75691763|FG000|COMPLETED|Overall Study|In the stepped wedge design, all groups were in intervention at the last data collection. 227 unique individuals completed self-report surveys at the end of the study, but only a portion of these had completed the baseline survey. A total of 331 unique individuals completed the survey at one or more time points.|42||4
59584982|NCT03211832|75691764|FG001|COMPLETED|Overall Study||33||4
59584983|NCT03211832|75691765|FG002|COMPLETED|Overall Study||32||4
59584984|NCT03211832|75691763|FG000|NOT COMPLETED|Overall Study||36||0
59584985|NCT03211832|75691764|FG001|NOT COMPLETED|Overall Study||52||0
59584986|NCT03211832|75691765|FG002|NOT COMPLETED|Overall Study||34||0
59584987|NCT04887948|75691774|FG000|STARTED|Overall Study||190||
59584988|NCT04887948|75691775|FG001|STARTED|Overall Study||191||
59584989|NCT04887948|75691776|FG002|STARTED|Overall Study||189||
59584990|NCT04887948|75691774|FG000|Vaccinated|Overall Study||187||
59584991|NCT04887948|75691775|FG001|Vaccinated|Overall Study||187||
59584992|NCT04887948|75691776|FG002|Vaccinated|Overall Study||185||
59584993|NCT04887948|75691774|FG000|COMPLETED|Overall Study||184||
59584994|NCT04887948|75691775|FG001|COMPLETED|Overall Study||177||
59584995|NCT04887948|75691776|FG002|COMPLETED|Overall Study||182||
59584996|NCT04887948|75691774|FG000|NOT COMPLETED|Overall Study||6||
59584997|NCT04887948|75691775|FG001|NOT COMPLETED|Overall Study||14||
59584998|NCT04887948|75691776|FG002|NOT COMPLETED|Overall Study||7||
59584999|NCT04882800|75691791|FG000|STARTED|Device A Right Ear/Device B Left Ear||15||
59585000|NCT04882800|75691791|FG000|COMPLETED|Device A Right Ear/Device B Left Ear||15||
59585001|NCT04882800|75691791|FG000|NOT COMPLETED|Device A Right Ear/Device B Left Ear||0||
59585002|NCT04882800|75691791|FG000|STARTED|Device B Right Ear/Device A Left Ear||15||
59585003|NCT04882800|75691791|FG000|COMPLETED|Device B Right Ear/Device A Left Ear||15||
59585004|NCT04882800|75691791|FG000|NOT COMPLETED|Device B Right Ear/Device A Left Ear||0||
59585005|NCT03799289|75691799|FG000|STARTED|Initial Weight Loss Program (Weeks 1-12)||30||
59585006|NCT03799289|75691800|FG001|STARTED|Initial Weight Loss Program (Weeks 1-12)||30||
59585007|NCT03799289|75691799|FG000|COMPLETED|Initial Weight Loss Program (Weeks 1-12)||24||
59585008|NCT03799289|75691800|FG001|COMPLETED|Initial Weight Loss Program (Weeks 1-12)||27||
59585009|NCT03799289|75691799|FG000|NOT COMPLETED|Initial Weight Loss Program (Weeks 1-12)||6||
59585010|NCT03799289|75691800|FG001|NOT COMPLETED|Initial Weight Loss Program (Weeks 1-12)||3||
59585011|NCT03799289|75691799|FG000|STARTED|Maintenance Intervention (Weeks 13-24)||24||
59585012|NCT03799289|75691800|FG001|STARTED|Maintenance Intervention (Weeks 13-24)||27||
59585013|NCT03799289|75691799|FG000|COMPLETED|Maintenance Intervention (Weeks 13-24)||24||
59585014|NCT03799289|75691800|FG001|COMPLETED|Maintenance Intervention (Weeks 13-24)||27||
59585015|NCT03799289|75691799|FG000|NOT COMPLETED|Maintenance Intervention (Weeks 13-24)||0||
59585016|NCT03799289|75691800|FG001|NOT COMPLETED|Maintenance Intervention (Weeks 13-24)||0||
59585017|NCT03810053|75691806|FG000|STARTED|Overall Study||290||
59585018|NCT03810053|75691806|FG000|COMPLETED|Overall Study||290||
59585019|NCT03810053|75691806|FG000|NOT COMPLETED|Overall Study||0||
59585020|NCT03883607|75691812|FG000|STARTED|Overall Study||5|Randomized and treated participants.|
59585021|NCT03883607|75691813|FG001|STARTED|Overall Study||5|Randomized and treated participants.|
59585022|NCT03883607|75691812|FG000|COMPLETED|Overall Study||5||
59585023|NCT03883607|75691813|FG001|COMPLETED|Overall Study||5||
59585024|NCT03883607|75691812|FG000|NOT COMPLETED|Overall Study||0||
59585025|NCT03883607|75691813|FG001|NOT COMPLETED|Overall Study||0||
59585026|NCT03926039|75691821|FG000|STARTED|Overall Study||35||
59585027|NCT03926039|75691822|FG001|STARTED|Overall Study||35||
59585028|NCT03926039|75691821|FG000|COMPLETED|Overall Study||35||
59585029|NCT03926039|75691822|FG001|COMPLETED|Overall Study||34||
59585030|NCT03926039|75691821|FG000|NOT COMPLETED|Overall Study||0||
59585031|NCT03926039|75691822|FG001|NOT COMPLETED|Overall Study||1||
59585032|NCT04000373|75691828|FG000|STARTED|Overall Study||5||
59585033|NCT04000373|75691828|FG000|COMPLETED|Overall Study||5||
59585034|NCT04000373|75691828|FG000|NOT COMPLETED|Overall Study||0||
59585035|NCT04049123|75691832|FG000|STARTED|Period 1||5||
59585036|NCT04049123|75691833|FG001|STARTED|Period 1||5||
59585037|NCT04049123|75691834|FG002|STARTED|Period 1||5||
59585038|NCT04049123|75691832|FG000|Received at Least One Dose of Study Drug|Period 1||5||
59585039|NCT04049123|75691833|FG001|Received at Least One Dose of Study Drug|Period 1||5||
59585040|NCT04049123|75691834|FG002|Received at Least One Dose of Study Drug|Period 1||5||
59585041|NCT04049123|75691832|FG000|COMPLETED|Period 1||5||
60121660|NCT01566773|76242562|FG000|GP MDI 9 µg BID|Overall Study||64||
60121661|NCT01566773|76242562|FG000|GP MDI 4.6 µg BID|Overall Study||62||
59585042|NCT04049123|75691833|FG001|COMPLETED|Period 1||5||
59585043|NCT04049123|75691834|FG002|COMPLETED|Period 1||5||
59585044|NCT04049123|75691832|FG000|NOT COMPLETED|Period 1||0||
59585045|NCT04049123|75691833|FG001|NOT COMPLETED|Period 1||0||
59585046|NCT04049123|75691834|FG002|NOT COMPLETED|Period 1||0||
59585047|NCT04049123|75691832|FG000|STARTED|Period 2||5||
59585048|NCT04049123|75691833|FG001|STARTED|Period 2||5||
59585049|NCT04049123|75691834|FG002|STARTED|Period 2||5||
59585050|NCT04049123|75691832|FG000|COMPLETED|Period 2||5||
59585051|NCT04049123|75691833|FG001|COMPLETED|Period 2||5||
59585052|NCT04049123|75691834|FG002|COMPLETED|Period 2||5||
59585053|NCT04049123|75691832|FG000|NOT COMPLETED|Period 2||0||
59585054|NCT04049123|75691833|FG001|NOT COMPLETED|Period 2||0||
59585055|NCT04049123|75691834|FG002|NOT COMPLETED|Period 2||0||
59585056|NCT04049123|75691832|FG000|STARTED|Period 3||5||
59585057|NCT04049123|75691833|FG001|STARTED|Period 3||5||
59585058|NCT04049123|75691834|FG002|STARTED|Period 3||5||
59585059|NCT04049123|75691832|FG000|COMPLETED|Period 3||5||
59585060|NCT04049123|75691833|FG001|COMPLETED|Period 3||5||
59585061|NCT04049123|75691834|FG002|COMPLETED|Period 3||5||
59585062|NCT04049123|75691832|FG000|NOT COMPLETED|Period 3||0||
59585063|NCT04049123|75691833|FG001|NOT COMPLETED|Period 3||0||
59585064|NCT04049123|75691834|FG002|NOT COMPLETED|Period 3||0||
59585065|NCT04051463|75691844|FG000|STARTED|Overall Study||15||
59585066|NCT04051463|75691845|FG001|STARTED|Overall Study||14||
59585067|NCT04051463|75691844|FG000|COMPLETED|Overall Study||13||
59585068|NCT04051463|75691845|FG001|COMPLETED|Overall Study||13||
59585069|NCT04051463|75691844|FG000|NOT COMPLETED|Overall Study||2||
59585070|NCT04051463|75691845|FG001|NOT COMPLETED|Overall Study||1||
59585071|NCT04054661|75691851|FG000|STARTED|Overall Study||229||
59585072|NCT04054661|75691851|FG000|Enrolled in Repeatability Sub-study|Overall Study||15||
59585073|NCT04054661|75691851|FG000|Enrolled in Sample Stability Sub-study|Overall Study||3||
59585074|NCT04054661|75691851|FG000|COMPLETED|Overall Study||229||
59585075|NCT04054661|75691851|FG000|NOT COMPLETED|Overall Study||0||
59585076|NCT04128527|75691864|FG000|STARTED|Overall Study||16||
59585077|NCT04128527|75691864|FG000|COMPLETED|Overall Study||16||
59585078|NCT04128527|75691864|FG000|NOT COMPLETED|Overall Study||0||
59585079|NCT04132973|75691868|FG000|STARTED|Overall Study||34||
59585080|NCT04132973|75691868|FG000|Completed Intervention|Overall Study||11||
59585081|NCT04132973|75691868|FG000|COMPLETED|Overall Study||8||
59585082|NCT04132973|75691868|FG000|NOT COMPLETED|Overall Study||26||
59585083|NCT04184297|75691874|FG000|STARTED|Overall Study||2864||
59585084|NCT04184297|75691875|FG001|STARTED|Overall Study||24326||
59585085|NCT04184297|75691874|FG000|COMPLETED|Overall Study||2864||
59585086|NCT04184297|75691875|FG001|COMPLETED|Overall Study||24326||
59585087|NCT04184297|75691874|FG000|NOT COMPLETED|Overall Study||0||
59585088|NCT04184297|75691875|FG001|NOT COMPLETED|Overall Study||0||
59585089|NCT04031885|75691883|FG000|STARTED|Overall Study||1||
59585090|NCT04031885|75691884|FG001|STARTED|Overall Study||3||
59585091|NCT04031885|75691883|FG000|Received Any Quantity of Study Treatment|Overall Study||1||
59585092|NCT04031885|75691884|FG001|Received Any Quantity of Study Treatment|Overall Study||1||
59585093|NCT04031885|75691883|FG000|COMPLETED|Overall Study||1||
59585094|NCT04031885|75691884|FG001|COMPLETED|Overall Study||3||
59585095|NCT04031885|75691883|FG000|NOT COMPLETED|Overall Study||0||
59585096|NCT04031885|75691884|FG001|NOT COMPLETED|Overall Study||0||
59585097|NCT04029545|75691893|FG000|STARTED|Overall Study||2||
59585098|NCT04029545|75691894|FG001|STARTED|Overall Study||1||
59585099|NCT04029545|75691895|FG002|STARTED|Overall Study||2||
59585100|NCT04029545|75691893|FG000|COMPLETED|Overall Study||2||
59585101|NCT04029545|75691894|FG001|COMPLETED|Overall Study||1||
59585102|NCT04029545|75691895|FG002|COMPLETED|Overall Study||2||
59585103|NCT04029545|75691893|FG000|NOT COMPLETED|Overall Study||0||
59585104|NCT04029545|75691894|FG001|NOT COMPLETED|Overall Study||0||
59724786|NCT00929643|75843530|FG000|STARTED|Overall Study||203||
59585105|NCT04029545|75691895|FG002|NOT COMPLETED|Overall Study||0||
59585106|NCT04029311|75691905|FG000|STARTED|Overall Study||15||
59585107|NCT04029311|75691906|FG001|STARTED|Overall Study||13||
59585108|NCT04029311|75691905|FG000|COMPLETED|Overall Study||12||
59724787|NCT00929643|75843530|FG000|COMPLETED|Overall Study||201||
59724788|NCT00929643|75843530|FG000|NOT COMPLETED|Overall Study||2||
59724789|NCT00926367|75843536|FG000|STARTED|Overall Study||25||
59724790|NCT00926367|75843537|FG001|STARTED|Overall Study||27||
59724791|NCT00926367|75843536|FG000|COMPLETED|Overall Study||23||
59724792|NCT00926367|75843537|FG001|COMPLETED|Overall Study||24||
59585109|NCT04029311|75691906|FG001|COMPLETED|Overall Study||13||
59585110|NCT04029311|75691905|FG000|NOT COMPLETED|Overall Study||3||
59585111|NCT04029311|75691906|FG001|NOT COMPLETED|Overall Study||0||
59585112|NCT01638000|75691914|FG000|STARTED|Overall Study||943||
59585113|NCT01638000|75691915|FG001|STARTED|Overall Study||944||
59585114|NCT01638000|75691914|FG000|Received at Least 1 Double-Blind Dose|Overall Study||936||
59585115|NCT01638000|75691915|FG001|Received at Least 1 Double-Blind Dose|Overall Study||934||
59585116|NCT01638000|75691914|FG000|COMPLETED|Overall Study||883||
59585117|NCT01638000|75691915|FG001|COMPLETED|Overall Study||873||
59585118|NCT01638000|75691914|FG000|NOT COMPLETED|Overall Study||60||
59585119|NCT01638000|75691915|FG001|NOT COMPLETED|Overall Study||71||
59585120|NCT04023695|75691923|FG000|STARTED|Overall Study||57||
59585121|NCT04023695|75691924|FG001|STARTED|Overall Study||53||
59585122|NCT04023695|75691923|FG000|COMPLETED|Overall Study||57||
59585123|NCT04023695|75691924|FG001|COMPLETED|Overall Study||53||
59585124|NCT04023695|75691923|FG000|NOT COMPLETED|Overall Study||0||
59585125|NCT04023695|75691924|FG001|NOT COMPLETED|Overall Study||0||
59585126|NCT04013789|75691930|FG000|STARTED|First Wear Period (1 Week)||33||
59585127|NCT04013789|75691931|FG001|STARTED|First Wear Period (1 Week)||34||
59585128|NCT04013789|75691930|FG000|COMPLETED|First Wear Period (1 Week)||33||
59585129|NCT04013789|75691931|FG001|COMPLETED|First Wear Period (1 Week)||34||
59585130|NCT04013789|75691930|FG000|NOT COMPLETED|First Wear Period (1 Week)||0||
59585131|NCT04013789|75691931|FG001|NOT COMPLETED|First Wear Period (1 Week)||0||
59585132|NCT04013789|75691930|FG000|STARTED|Second Wear Period (1 Week)|One subject withdrew from the study between the first wear period and the second wear period.|32||
59585133|NCT04013789|75691931|FG001|STARTED|Second Wear Period (1 Week)||34||
59585134|NCT04013789|75691930|FG000|COMPLETED|Second Wear Period (1 Week)||32||
59585135|NCT04013789|75691931|FG001|COMPLETED|Second Wear Period (1 Week)||34||
59585136|NCT04013789|75691930|FG000|NOT COMPLETED|Second Wear Period (1 Week)||0||
59585137|NCT04013789|75691931|FG001|NOT COMPLETED|Second Wear Period (1 Week)||0||
59585138|NCT04211909|75691941|FG000|STARTED|Overall Study||54||
59585139|NCT04211909|75691942|FG001|STARTED|Overall Study||33||
59585140|NCT04211909|75691941|FG000|COMPLETED|Overall Study||54||
59585141|NCT04211909|75691942|FG001|COMPLETED|Overall Study||33||
59585142|NCT04211909|75691941|FG000|NOT COMPLETED|Overall Study||0||
59585143|NCT04211909|75691942|FG001|NOT COMPLETED|Overall Study||0||
59585144|NCT03559205|75691950|FG000|STARTED|Overall Study||177||
59585145|NCT03559205|75691951|FG001|STARTED|Overall Study||144||
59585146|NCT03559205|75691950|FG000|Baseline Data|Overall Study||141||
59585147|NCT03559205|75691951|FG001|Baseline Data|Overall Study||132||
59585148|NCT03559205|75691950|FG000|COMPLETED|Overall Study||65||
59585149|NCT03559205|75691951|FG001|COMPLETED|Overall Study||57||
59585150|NCT03559205|75691950|FG000|NOT COMPLETED|Overall Study||112||
59585151|NCT03559205|75691951|FG001|NOT COMPLETED|Overall Study||87||
59585152|NCT04223843|75691961|FG000|STARTED|Overall Study||55||
59585153|NCT04223843|75691962|FG001|STARTED|Overall Study||55||
59585154|NCT04223843|75691963|FG002|STARTED|Overall Study||51||
59585155|NCT04223843|75691964|FG003|STARTED|Overall Study||52||
60121662|NCT01566773|76242562|FG000|GP MDI 2.4 µg BID|Overall Study||64||
60121663|NCT01566773|76242562|FG000|GP MDI 1.2 µg BID|Overall Study||57||
59585156|NCT04223843|75691961|FG000|COMPLETED|Overall Study||55||
59585157|NCT04223843|75691962|FG001|COMPLETED|Overall Study||55||
59585158|NCT04223843|75691963|FG002|COMPLETED|Overall Study||51||
59585159|NCT04223843|75691964|FG003|COMPLETED|Overall Study||52||
59585160|NCT04223843|75691961|FG000|NOT COMPLETED|Overall Study||0||
59585161|NCT04223843|75691962|FG001|NOT COMPLETED|Overall Study||0||
59585162|NCT04223843|75691963|FG002|NOT COMPLETED|Overall Study||0||
59585163|NCT04223843|75691964|FG003|NOT COMPLETED|Overall Study||0||
59585164|NCT01637922|75691974|FG000|STARTED|Overall Study||15||
59585165|NCT01637922|75691975|FG001|STARTED|Overall Study||19||
59585166|NCT01637922|75691974|FG000|COMPLETED|Overall Study||13||
59585167|NCT01637922|75691975|FG001|COMPLETED|Overall Study||14||
59585168|NCT01637922|75691974|FG000|NOT COMPLETED|Overall Study||2||
59585169|NCT01637922|75691975|FG001|NOT COMPLETED|Overall Study||5||
59585170|NCT02767531|75691982|FG000|STARTED|Period 1|Orlistat therapy|1||
59585171|NCT02767531|75691983|FG001|STARTED|Period 1|Off Orlistat|1||
59585172|NCT02767531|75691982|FG000|COMPLETED|Period 1||1||
59585173|NCT02767531|75691983|FG001|COMPLETED|Period 1||1||
59585174|NCT02767531|75691982|FG000|NOT COMPLETED|Period 1||0||
59585175|NCT02767531|75691983|FG001|NOT COMPLETED|Period 1||0||
59585176|NCT02767531|75691982|FG000|STARTED|Period 2|Off Orlistat|1||
59585177|NCT02767531|75691983|FG001|STARTED|Period 2|Orlistat Therapy|1||
59585178|NCT02767531|75691982|FG000|COMPLETED|Period 2||1||
59585179|NCT02767531|75691983|FG001|COMPLETED|Period 2||1||
59585180|NCT02767531|75691982|FG000|NOT COMPLETED|Period 2||0||
59585181|NCT02767531|75691983|FG001|NOT COMPLETED|Period 2||0||
59585182|NCT02767531|75691982|FG000|STARTED|Period 3|Orlistat Therapy|1||
59585183|NCT02767531|75691983|FG001|STARTED|Period 3|Off Orlistat|1||
59585184|NCT02767531|75691982|FG000|COMPLETED|Period 3||1||
59585185|NCT02767531|75691983|FG001|COMPLETED|Period 3||1||
59585186|NCT02767531|75691982|FG000|NOT COMPLETED|Period 3||0||
59585187|NCT02767531|75691983|FG001|NOT COMPLETED|Period 3||0||
59585188|NCT02767531|75691982|FG000|STARTED|Period 4|Off Orlistat|1||
59585189|NCT02767531|75691983|FG001|STARTED|Period 4|Orlistat Therapy|1||
59585190|NCT02767531|75691982|FG000|COMPLETED|Period 4||1||
59585191|NCT02767531|75691983|FG001|COMPLETED|Period 4||1||
59585192|NCT02767531|75691982|FG000|NOT COMPLETED|Period 4||0||
59585193|NCT02767531|75691983|FG001|NOT COMPLETED|Period 4||0||
59585194|NCT04229303|75691998|FG000|STARTED|Overall Study||6||
59585195|NCT04229303|75691999|FG001|STARTED|Overall Study||6||
59585196|NCT04229303|75692000|FG002|STARTED|Overall Study||6||
59585197|NCT04229303|75692001|FG003|STARTED|Overall Study||6||
59585198|NCT04229303|75692002|FG004|STARTED|Overall Study||6||
59585199|NCT04229303|75692003|FG005|STARTED|Overall Study||6||
59585200|NCT04229303|75692004|FG006|STARTED|Overall Study||6||
59585201|NCT04229303|75692005|FG007|STARTED|Overall Study||8||
60121664|NCT01566773|76242562|FG000|GP MDI 0.6 µg BID|Overall Study||59||
59585202|NCT04229303|75692006|FG008|STARTED|Overall Study||8||
59585203|NCT04229303|75691998|FG000|COMPLETED|Overall Study||6||
59585204|NCT04229303|75691999|FG001|COMPLETED|Overall Study||6||
59585205|NCT04229303|75692000|FG002|COMPLETED|Overall Study||6||
59585206|NCT04229303|75692001|FG003|COMPLETED|Overall Study||6||
59585207|NCT04229303|75692002|FG004|COMPLETED|Overall Study||6||
59585208|NCT04229303|75692003|FG005|COMPLETED|Overall Study||6||
59585209|NCT04229303|75692004|FG006|COMPLETED|Overall Study||6||
59585210|NCT04229303|75692005|FG007|COMPLETED|Overall Study||8||
59585211|NCT04229303|75692006|FG008|COMPLETED|Overall Study||8||
59585212|NCT04229303|75691998|FG000|NOT COMPLETED|Overall Study||0||
59585213|NCT04229303|75691999|FG001|NOT COMPLETED|Overall Study||0||
59585214|NCT04229303|75692000|FG002|NOT COMPLETED|Overall Study||0||
59585215|NCT04229303|75692001|FG003|NOT COMPLETED|Overall Study||0||
59585216|NCT04229303|75692002|FG004|NOT COMPLETED|Overall Study||0||
59585217|NCT04229303|75692003|FG005|NOT COMPLETED|Overall Study||0||
59585218|NCT04229303|75692004|FG006|NOT COMPLETED|Overall Study||0||
59585219|NCT04229303|75692005|FG007|NOT COMPLETED|Overall Study||0||
59585220|NCT04229303|75692006|FG008|NOT COMPLETED|Overall Study||0||
59585221|NCT03504410|75692036|FG000|STARTED|Overall Study||98||
59585222|NCT03504410|75692037|FG001|STARTED|Overall Study||102||
59585223|NCT03504410|75692036|FG000|COMPLETED|Overall Study||11||
59585224|NCT03504410|75692037|FG001|COMPLETED|Overall Study||11||
59585225|NCT03504410|75692036|FG000|NOT COMPLETED|Overall Study||87||
59585226|NCT03504410|75692037|FG001|NOT COMPLETED|Overall Study||91||
59585227|NCT04243421|75692043|FG000|STARTED|Overall Study||30||
59585228|NCT04243421|75692043|FG000|COMPLETED|Overall Study||30||
59585229|NCT04243421|75692043|FG000|NOT COMPLETED|Overall Study||0||
59585230|NCT03559829|75692048|FG000|STARTED|Overall Study||20||
59585231|NCT03559829|75692048|FG000|COMPLETED|Overall Study||20||
59585232|NCT03559829|75692048|FG000|NOT COMPLETED|Overall Study||0||
59585233|NCT04256603|75692054|FG000|STARTED|Overall Study||21||
59585234|NCT04256603|75692055|FG001|STARTED|Overall Study||6||
59585235|NCT04256603|75692054|FG000|COMPLETED|Overall Study||21||
59585236|NCT04256603|75692055|FG001|COMPLETED|Overall Study||6||
59585237|NCT04256603|75692054|FG000|NOT COMPLETED|Overall Study||0||
59585238|NCT04256603|75692055|FG001|NOT COMPLETED|Overall Study||0||
59585239|NCT03560141|75692063|FG000|STARTED|Overall Study||6||12
59585240|NCT03560141|75692064|FG001|STARTED|Overall Study||5||10
59585241|NCT03560141|75692063|FG000|COMPLETED|Overall Study||6||12
59585242|NCT03560141|75692064|FG001|COMPLETED|Overall Study||5||10
59585243|NCT03560141|75692063|FG000|NOT COMPLETED|Overall Study||0||0
59585244|NCT03560141|75692064|FG001|NOT COMPLETED|Overall Study||0||0
59585245|NCT03562559|75692072|FG000|STARTED|Overall Study||40||
59585246|NCT03562559|75692072|FG000|COMPLETED|Overall Study||40||
59585247|NCT03562559|75692072|FG000|NOT COMPLETED|Overall Study||0||
59585248|NCT03563027|75692079|FG000|STARTED|Overall Study||60||
59585249|NCT03563027|75692080|FG001|STARTED|Overall Study||60||
59585250|NCT03563027|75692081|FG002|STARTED|Overall Study||60||
59585251|NCT03563027|75692079|FG000|COMPLETED|Overall Study||60||
59585252|NCT03563027|75692080|FG001|COMPLETED|Overall Study||60||
59585253|NCT03563027|75692081|FG002|COMPLETED|Overall Study||58||
59585254|NCT03563027|75692079|FG000|NOT COMPLETED|Overall Study||0||
59585255|NCT03563027|75692080|FG001|NOT COMPLETED|Overall Study||0||
59585256|NCT03563027|75692081|FG002|NOT COMPLETED|Overall Study||2||
59585257|NCT02440334|75692089|FG000|STARTED|Overall Study||53||
59585258|NCT02440334|75692089|FG000|COMPLETED|Overall Study||53||
59585259|NCT02440334|75692089|FG000|NOT COMPLETED|Overall Study||0||
59585260|NCT02444234|75692093|FG000|STARTED|First Intervention (3 Days)||6||
59585261|NCT02444234|75692094|FG001|STARTED|First Intervention (3 Days)||5||
59585262|NCT02444234|75692093|FG000|COMPLETED|First Intervention (3 Days)||6||
59585263|NCT02444234|75692094|FG001|COMPLETED|First Intervention (3 Days)||5||
59585264|NCT02444234|75692093|FG000|NOT COMPLETED|First Intervention (3 Days)||0||
59585265|NCT02444234|75692094|FG001|NOT COMPLETED|First Intervention (3 Days)||0||
59585266|NCT02444234|75692093|FG000|STARTED|Washout (2 Day Minimum)||6||
59585267|NCT02444234|75692094|FG001|STARTED|Washout (2 Day Minimum)||5||
59585268|NCT02444234|75692093|FG000|COMPLETED|Washout (2 Day Minimum)||6||
59585269|NCT02444234|75692094|FG001|COMPLETED|Washout (2 Day Minimum)||5||
59585270|NCT02444234|75692093|FG000|NOT COMPLETED|Washout (2 Day Minimum)||0||
60121665|NCT01566773|76242562|FG000|Placebo MDI|Overall Study||62||
59585271|NCT02444234|75692094|FG001|NOT COMPLETED|Washout (2 Day Minimum)||0||
59585272|NCT02444234|75692093|FG000|STARTED|Second Intervention (3 Days)||6||
59585273|NCT02444234|75692094|FG001|STARTED|Second Intervention (3 Days)||5||
59585274|NCT02444234|75692093|FG000|COMPLETED|Second Intervention (3 Days)||6||
59585275|NCT02444234|75692094|FG001|COMPLETED|Second Intervention (3 Days)||5||
59585276|NCT02444234|75692093|FG000|NOT COMPLETED|Second Intervention (3 Days)||0||
59585277|NCT02444234|75692094|FG001|NOT COMPLETED|Second Intervention (3 Days)||0||
60121666|NCT01566773|76242562|FG000|Spiriva® Handihaler®|Overall Study||62||
59585278|NCT02444936|75692104|FG000|STARTED|Overall Study||10||
59585279|NCT02444936|75692105|FG001|STARTED|Overall Study||12||
59585280|NCT02444936|75692104|FG000|COMPLETED|Overall Study||10||
59585281|NCT02444936|75692105|FG001|COMPLETED|Overall Study||12||
59585282|NCT02444936|75692104|FG000|NOT COMPLETED|Overall Study||0||
59585283|NCT02444936|75692105|FG001|NOT COMPLETED|Overall Study||0||
59585284|NCT02445014|75692111|FG000|STARTED|Overall Study||3||
59585285|NCT02445014|75692111|FG000|COMPLETED|Overall Study||3||
59585286|NCT02445014|75692111|FG000|NOT COMPLETED|Overall Study||0||
59585287|NCT02445326|75692117|FG000|STARTED|Overall Study||35||
59585288|NCT02445326|75692118|FG001|STARTED|Overall Study||38||
59585289|NCT02445326|75692117|FG000|COMPLETED|Overall Study||33||
59585290|NCT02445326|75692118|FG001|COMPLETED|Overall Study||37||
59585291|NCT02445326|75692117|FG000|NOT COMPLETED|Overall Study||2||
59585292|NCT02445326|75692118|FG001|NOT COMPLETED|Overall Study||1||
59585293|NCT02446496|75692124|FG000|STARTED|Overall Study||24||
59585294|NCT02446496|75692124|FG000|COMPLETED|Overall Study||24||
59585295|NCT02446496|75692124|FG000|NOT COMPLETED|Overall Study||0||
59724793|NCT00926367|75843536|FG000|NOT COMPLETED|Overall Study||2||
59724794|NCT00926367|75843537|FG001|NOT COMPLETED|Overall Study||3||
59724795|NCT01114529|75843548|FG000|STARTED|Completed Study Medication at Month 24|Randomized set - 360 Full analysis set - 353 Safety analysis set -346*|353||
59724796|NCT01114529|75843549|FG001|STARTED|Completed Study Medication at Month 24|Randomized set -231 Full analysis set -231 Safety analysis set -238**|231||
59724797|NCT01114529|75843550|FG002|STARTED|Completed Study Medication at Month 24|Randomized set-125 Full analysis set -125 Safety analysis set -121***|125||
59724798|NCT01114529|75843548|FG000|COMPLETED|Completed Study Medication at Month 24|completed at month 24|229||
59724799|NCT01114529|75843549|FG001|COMPLETED|Completed Study Medication at Month 24|completed at month 24|190||
59724800|NCT01114529|75843550|FG002|COMPLETED|Completed Study Medication at Month 24|completed at month 24|93||
59724801|NCT01114529|75843548|FG000|NOT COMPLETED|Completed Study Medication at Month 24||124||
59724802|NCT01114529|75843549|FG001|NOT COMPLETED|Completed Study Medication at Month 24||41||
59724803|NCT01114529|75843550|FG002|NOT COMPLETED|Completed Study Medication at Month 24||32||
59724804|NCT01114529|75843548|FG000|STARTED|Completed Study Phase at Month 24|It includes those discontinued treatment|353||
59724805|NCT01114529|75843549|FG001|STARTED|Completed Study Phase at Month 24|It includes those discontinued treatment|231||
59724806|NCT01114529|75843550|FG002|STARTED|Completed Study Phase at Month 24|It includes those discontinued treatment|125||
59724807|NCT01114529|75843548|FG000|COMPLETED|Completed Study Phase at Month 24|at month 24|313||
59724808|NCT01114529|75843549|FG001|COMPLETED|Completed Study Phase at Month 24|at month 24|215||
59854218|NCT03403192|75978820|FG000|COMPLETED|Overall Study||37||
59854219|NCT03403192|75978821|FG001|COMPLETED|Overall Study||36||
59854220|NCT03403192|75978822|FG002|COMPLETED|Overall Study||37||
60121667|NCT01566773|76242562|FG000|COMPLETED|Overall Study||110||
60121668|NCT01566773|76242562|FG000|NOT COMPLETED|Overall Study||30||
60121669|NCT01566149|76242584|FG000|STARTED|Overall Study||24||
60121670|NCT01566149|76242585|FG001|STARTED|Overall Study||25||
59585296|NCT02448368|75692132|FG000|STARTED|Overall Study||2||
59585297|NCT02448368|75692133|FG001|STARTED|Overall Study||2||
59585298|NCT02448368|75692134|FG002|STARTED|Overall Study||2||
59585299|NCT02448368|75692135|FG003|STARTED|Overall Study||2||
59585300|NCT02448368|75692136|FG004|STARTED|Overall Study||2||
59585301|NCT02448368|75692137|FG005|STARTED|Overall Study||2||
59585302|NCT02448368|75692138|FG006|STARTED|Overall Study||2||
59854221|NCT03403192|75978823|FG003|COMPLETED|Overall Study||36||
59854222|NCT03403192|75978820|FG000|NOT COMPLETED|Overall Study||4||
59854223|NCT03403192|75978821|FG001|NOT COMPLETED|Overall Study||4||
59854224|NCT03403192|75978822|FG002|NOT COMPLETED|Overall Study||3||
59854225|NCT03403192|75978823|FG003|NOT COMPLETED|Overall Study||6||
59854226|NCT00356525|75978837|FG000|STARTED|Overall Study||14||
59854227|NCT00356525|75978838|FG001|STARTED|Overall Study||11||
59854228|NCT00356525|75978839|FG002|STARTED|Overall Study||7||
60121671|NCT01566149|76242584|FG000|COMPLETED|Overall Study||21||
60121672|NCT01566149|76242585|FG001|COMPLETED|Overall Study||23||
60121673|NCT01566149|76242584|FG000|NOT COMPLETED|Overall Study||3||
59585303|NCT02448368|75692139|FG007|STARTED|Overall Study||2||
59585304|NCT02448368|75692140|FG008|STARTED|Overall Study||2||
59585305|NCT02448368|75692141|FG009|STARTED|Overall Study||2||
59585306|NCT02448368|75692142|FG010|STARTED|Overall Study||5||
59585307|NCT02448368|75692143|FG011|STARTED|Overall Study||5||
59585308|NCT02448368|75692144|FG012|STARTED|Overall Study||5||
59585309|NCT02448368|75692132|FG000|COMPLETED|Overall Study||2||
59585310|NCT02448368|75692133|FG001|COMPLETED|Overall Study||2||
59585311|NCT02448368|75692134|FG002|COMPLETED|Overall Study||2||
59585312|NCT02448368|75692135|FG003|COMPLETED|Overall Study||2||
59585313|NCT02448368|75692136|FG004|COMPLETED|Overall Study||2||
59585314|NCT02448368|75692137|FG005|COMPLETED|Overall Study||2||
59585315|NCT02448368|75692138|FG006|COMPLETED|Overall Study||2||
59585316|NCT02448368|75692139|FG007|COMPLETED|Overall Study||2||
59585317|NCT02448368|75692140|FG008|COMPLETED|Overall Study||2||
59585318|NCT02448368|75692141|FG009|COMPLETED|Overall Study||2||
59585319|NCT02448368|75692142|FG010|COMPLETED|Overall Study||5||
59585320|NCT02448368|75692143|FG011|COMPLETED|Overall Study||5||
59585321|NCT02448368|75692144|FG012|COMPLETED|Overall Study||5||
59585322|NCT02448368|75692132|FG000|NOT COMPLETED|Overall Study||0||
59585323|NCT02448368|75692133|FG001|NOT COMPLETED|Overall Study||0||
59585324|NCT02448368|75692134|FG002|NOT COMPLETED|Overall Study||0||
59854229|NCT00356525|75978840|FG003|STARTED|Overall Study||9||
59854230|NCT00356525|75978837|FG000|COMPLETED|Overall Study||0||
59854231|NCT00356525|75978838|FG001|COMPLETED|Overall Study||0||
59854232|NCT00356525|75978839|FG002|COMPLETED|Overall Study||0||
59854233|NCT00356525|75978840|FG003|COMPLETED|Overall Study||0||
59854234|NCT00356525|75978837|FG000|NOT COMPLETED|Overall Study||14||
59854235|NCT00356525|75978838|FG001|NOT COMPLETED|Overall Study||11||
59854236|NCT00356525|75978839|FG002|NOT COMPLETED|Overall Study||7||
59854237|NCT00356525|75978840|FG003|NOT COMPLETED|Overall Study||9||
59854238|NCT00356369|75978852|FG000|STARTED|Active Phase||374||
59854239|NCT00356369|75978853|FG001|STARTED|Active Phase||126||
59854240|NCT00356369|75978852|FG000|COMPLETED|Active Phase||372||
59854241|NCT00356369|75978853|FG001|COMPLETED|Active Phase||125||
59854242|NCT00356369|75978852|FG000|NOT COMPLETED|Active Phase||2||
59854243|NCT00356369|75978853|FG001|NOT COMPLETED|Active Phase||1||
59854244|NCT00356369|75978852|FG000|STARTED|Year 1||364||
59854245|NCT00356369|75978853|FG001|STARTED|Year 1||121||
59854246|NCT00356369|75978852|FG000|COMPLETED|Year 1||364||
59854247|NCT00356369|75978853|FG001|COMPLETED|Year 1||121||
59854248|NCT00356369|75978852|FG000|NOT COMPLETED|Year 1||0||
59854249|NCT00356369|75978853|FG001|NOT COMPLETED|Year 1||0||
59854250|NCT00356369|75978852|FG000|STARTED|Year 2||354||
59854251|NCT00356369|75978853|FG001|STARTED|Year 2||117||
59854252|NCT00356369|75978852|FG000|COMPLETED|Year 2||354||
59854253|NCT00356369|75978853|FG001|COMPLETED|Year 2||117||
59854254|NCT00356369|75978852|FG000|NOT COMPLETED|Year 2||0||
59854255|NCT00356369|75978853|FG001|NOT COMPLETED|Year 2||0||
59854256|NCT00356369|75978852|FG000|STARTED|Year 3||344||
59854257|NCT00356369|75978853|FG001|STARTED|Year 3||116||
59854258|NCT00356369|75978852|FG000|COMPLETED|Year 3||344||
59854259|NCT00356369|75978853|FG001|COMPLETED|Year 3||116||
59854260|NCT00356369|75978852|FG000|NOT COMPLETED|Year 3||0||
59854261|NCT00356369|75978853|FG001|NOT COMPLETED|Year 3||0||
59854262|NCT00356369|75978852|FG000|STARTED|Year 4||317||
59854263|NCT00356369|75978853|FG001|STARTED|Year 4||109||
59854264|NCT00356369|75978852|FG000|COMPLETED|Year 4||317||
59854265|NCT00356369|75978853|FG001|COMPLETED|Year 4||109||
59854266|NCT00356369|75978852|FG000|NOT COMPLETED|Year 4||0||
59854267|NCT00356369|75978853|FG001|NOT COMPLETED|Year 4||0||
59854268|NCT00356369|75978852|FG000|STARTED|Year 5||299||
60121674|NCT01566149|76242585|FG001|NOT COMPLETED|Overall Study||2||
60121675|NCT01565993|76242593|FG000|STARTED|Overall Study||66||
59585325|NCT02448368|75692135|FG003|NOT COMPLETED|Overall Study||0||
59585326|NCT02448368|75692136|FG004|NOT COMPLETED|Overall Study||0||
59585327|NCT02448368|75692137|FG005|NOT COMPLETED|Overall Study||0||
59585328|NCT02448368|75692138|FG006|NOT COMPLETED|Overall Study||0||
59585329|NCT02448368|75692139|FG007|NOT COMPLETED|Overall Study||0||
59724809|NCT01114529|75843550|FG002|COMPLETED|Completed Study Phase at Month 24|at month 24|111||
59724810|NCT01114529|75843548|FG000|NOT COMPLETED|Completed Study Phase at Month 24||40||
59724811|NCT01114529|75843549|FG001|NOT COMPLETED|Completed Study Phase at Month 24||16||
59724812|NCT01114529|75843550|FG002|NOT COMPLETED|Completed Study Phase at Month 24||14||
59724813|NCT00926289|75843562|FG000|STARTED|Overall Study|Number of treated patients|294||
59724814|NCT00926289|75843563|FG001|STARTED|Overall Study|Number of treated patients|594||
59724815|NCT00926289|75843562|FG000|COMPLETED|Overall Study||269||
59724816|NCT00926289|75843563|FG001|COMPLETED|Overall Study||558||
59724817|NCT00926289|75843562|FG000|NOT COMPLETED|Overall Study||25||
59724818|NCT00926289|75843563|FG001|NOT COMPLETED|Overall Study||36||
59724819|NCT02707276|75843573|FG000|STARTED|Overall Study||3||
59724820|NCT02707276|75843574|FG001|STARTED|Overall Study||5||
59724821|NCT02707276|75843575|FG002|STARTED|Overall Study||3||
59724822|NCT02707276|75843576|FG003|STARTED|Overall Study||2||
59724823|NCT02707276|75843573|FG000|COMPLETED|Overall Study||3||
59724824|NCT02707276|75843574|FG001|COMPLETED|Overall Study||5||
59724825|NCT02707276|75843575|FG002|COMPLETED|Overall Study||3||
59724826|NCT02707276|75843576|FG003|COMPLETED|Overall Study||2||
59724827|NCT02707276|75843573|FG000|NOT COMPLETED|Overall Study||0||
59724828|NCT02707276|75843574|FG001|NOT COMPLETED|Overall Study||0||
59724829|NCT02707276|75843575|FG002|NOT COMPLETED|Overall Study||0||
59724830|NCT02707276|75843576|FG003|NOT COMPLETED|Overall Study||0||
59724831|NCT03208036|75843588|FG000|STARTED|Baseline Assessment||11||
59854269|NCT00356369|75978853|FG001|STARTED|Year 5||105||
59854270|NCT00356369|75978852|FG000|COMPLETED|Year 5||299||
60121676|NCT01565993|76242594|FG001|STARTED|Overall Study|3 patients were excluded for failing to meet the inclusion criteria|42||
59585330|NCT02448368|75692140|FG008|NOT COMPLETED|Overall Study||0||
59724832|NCT03208036|75843589|FG001|STARTED|Baseline Assessment||11||
59724833|NCT03208036|75843588|FG000|COMPLETED|Baseline Assessment||10||
59724834|NCT03208036|75843589|FG001|COMPLETED|Baseline Assessment||10||
59724835|NCT03208036|75843588|FG000|NOT COMPLETED|Baseline Assessment||1||
59854271|NCT00356369|75978853|FG001|COMPLETED|Year 5||105||
59854272|NCT00356369|75978852|FG000|NOT COMPLETED|Year 5||0||
59854273|NCT00356369|75978853|FG001|NOT COMPLETED|Year 5||0||
59854274|NCT03383614|75978863|FG000|STARTED|Overall Study||6||
59854275|NCT03383614|75978864|FG001|STARTED|Overall Study||6||
59854276|NCT03383614|75978865|FG002|STARTED|Overall Study||6||
59854277|NCT03383614|75978866|FG003|STARTED|Overall Study||6||
59854278|NCT03383614|75978863|FG000|COMPLETED|Overall Study||6||
59854279|NCT03383614|75978864|FG001|COMPLETED|Overall Study||5||
59854280|NCT03383614|75978865|FG002|COMPLETED|Overall Study||6||
59854281|NCT03383614|75978866|FG003|COMPLETED|Overall Study||6||
59854282|NCT03383614|75978863|FG000|NOT COMPLETED|Overall Study||0||
59854283|NCT03383614|75978864|FG001|NOT COMPLETED|Overall Study||1||
59854284|NCT03383614|75978865|FG002|NOT COMPLETED|Overall Study||0||
59854285|NCT03383614|75978866|FG003|NOT COMPLETED|Overall Study||0||
59854286|NCT03403036|75978881|FG000|STARTED|Overall Study||39||
59854287|NCT03403036|75978881|FG000|COMPLETED|Overall Study||34||
59854288|NCT03403036|75978881|FG000|NOT COMPLETED|Overall Study||5||
59854289|NCT00356135|75978888|FG000|STARTED|Overall Study||47||
59854290|NCT00356135|75978889|FG001|STARTED|Overall Study||48||
59854291|NCT00356135|75978890|FG002|STARTED|Overall Study||44||
59854292|NCT00356135|75978888|FG000|COMPLETED|Overall Study||43||
59854293|NCT00356135|75978889|FG001|COMPLETED|Overall Study||46||
59854294|NCT00356135|75978890|FG002|COMPLETED|Overall Study||39||
59854295|NCT00356135|75978888|FG000|NOT COMPLETED|Overall Study||4||
59854296|NCT00356135|75978889|FG001|NOT COMPLETED|Overall Study||2||
59854297|NCT00356135|75978890|FG002|NOT COMPLETED|Overall Study||5||
59854298|NCT03383146|75978902|FG000|STARTED|Overall Study||148||
59854299|NCT03383146|75978903|FG001|STARTED|Overall Study||302||
59854300|NCT03383146|75978902|FG000|Safety Population|Overall Study||145|Safety Population included all participants who received ≥1 administration of study treatment.|
59854301|NCT03383146|75978903|FG001|Safety Population|Overall Study||299|Safety Population included all participants who received ≥1 administration of study treatment.|
59854302|NCT03383146|75978902|FG000|Run-in Period|Overall Study||91|Run-in Period included rollover participants from previous relamorelin study RLM-MD-01 or RLM-MD-02 who met all the inclusion and exclusion criteria.|
59854303|NCT03383146|75978903|FG001|Run-in Period|Overall Study||207|Run-in Period included rollover participants from previous relamorelin study RLM-MD-01 or RLM-MD-02 who met all the inclusion and exclusion criteria.|
59854304|NCT03383146|75978902|FG000|COMPLETED|Overall Study||63||
59854305|NCT03383146|75978903|FG001|COMPLETED|Overall Study||118||
59854306|NCT03383146|75978902|FG000|NOT COMPLETED|Overall Study||85||
59854307|NCT03383146|75978903|FG001|NOT COMPLETED|Overall Study||184||
59854308|NCT03616964|75978913|FG000|STARTED|Overall Study||257||
59854309|NCT03616964|75978914|FG001|STARTED|Overall Study||262||
59854310|NCT03616964|75978915|FG002|STARTED|Overall Study||259||
59854311|NCT03616964|75978913|FG000|Received at Least One Dose of Study Drug|Overall Study||256||
59854312|NCT03616964|75978914|FG001|Received at Least One Dose of Study Drug|Overall Study||261||
59854313|NCT03616964|75978915|FG002|Received at Least One Dose of Study Drug|Overall Study||258||
59854314|NCT03616964|75978913|FG000|Safety Population|Overall Study||256|All randomized participants who received at least one dose of study drug and who did not discontinue from the study for the reason 'Lost to Follow-up' at the first postbaseline visit.|
59854315|NCT03616964|75978914|FG001|Safety Population|Overall Study||261|All randomized participants who received at least one dose of study drug and who did not discontinue from the study for the reason 'Lost to Follow-up' at the first postbaseline visit.|
59854316|NCT03616964|75978915|FG002|Safety Population|Overall Study||258|All randomized participants who received at least one dose of study drug and who did not discontinue from the study for the reason 'Lost to Follow-up' at the first postbaseline visit.|
59854317|NCT03616964|75978913|FG000|Pharmacokinetic (PK) Population|Overall Study||0|Participants with estimated glomerular filtration rate less than (<) 60 milliliter/minute (mL/min)/1.73 square meter (m2) at screening randomized to the 4 mg dose received a dose of 2 mg QD.|
59854318|NCT03616964|75978914|FG001|Pharmacokinetic (PK) Population|Overall Study||277|Participants with estimated glomerular filtration rate less than (<) 60 milliliter/minute (mL/min)/1.73 square meter (m2) at screening randomized to the 4 mg dose received a dose of 2 mg QD.|
59854319|NCT03616964|75978915|FG002|Pharmacokinetic (PK) Population|Overall Study||241|Participants with estimated glomerular filtration rate less than (<) 60 milliliter/minute (mL/min)/1.73 square meter (m2) at screening randomized to the 4 mg dose received a dose of 2 mg QD.|
59854320|NCT03616964|75978913|FG000|COMPLETED|Overall Study||212||
59854321|NCT03616964|75978914|FG001|COMPLETED|Overall Study||222||
59854322|NCT03616964|75978915|FG002|COMPLETED|Overall Study||205||
59854323|NCT03616964|75978913|FG000|NOT COMPLETED|Overall Study||45||
59854324|NCT03616964|75978914|FG001|NOT COMPLETED|Overall Study||40||
59585331|NCT02448368|75692141|FG009|NOT COMPLETED|Overall Study||0||
59585332|NCT02448368|75692142|FG010|NOT COMPLETED|Overall Study||0||
59854325|NCT03616964|75978915|FG002|NOT COMPLETED|Overall Study||54||
59854326|NCT00350519|75978927|FG000|STARTED|Overall Study||18||
59854327|NCT00350519|75978928|FG001|STARTED|Overall Study||19||
59854328|NCT00350519|75978927|FG000|COMPLETED|Overall Study||14||
59854329|NCT00350519|75978928|FG001|COMPLETED|Overall Study||13||
59854330|NCT00350519|75978927|FG000|NOT COMPLETED|Overall Study||4||
59854331|NCT00350519|75978928|FG001|NOT COMPLETED|Overall Study||6||
59585333|NCT02448368|75692143|FG011|NOT COMPLETED|Overall Study||0||
59585334|NCT02448368|75692144|FG012|NOT COMPLETED|Overall Study||0||
59585335|NCT02448914|75692169|FG000|STARTED|First Intervention (1 Day)||6||
59585336|NCT02448914|75692170|FG001|STARTED|First Intervention (1 Day)||5||
59585337|NCT02448914|75692169|FG000|COMPLETED|First Intervention (1 Day)||6||
59585338|NCT02448914|75692170|FG001|COMPLETED|First Intervention (1 Day)||5||
59585339|NCT02448914|75692169|FG000|NOT COMPLETED|First Intervention (1 Day)||0||
59585340|NCT02448914|75692170|FG001|NOT COMPLETED|First Intervention (1 Day)||0||
59585341|NCT02448914|75692169|FG000|STARTED|Second Intervention (1 Day)||6||
59854332|NCT03382912|75978936|FG000|STARTED|Overall Study||27||
59854333|NCT03382912|75978937|FG001|STARTED|Overall Study||25||
59854334|NCT03382912|75978936|FG000|Received at Least 1 Dose of Study Drug|Overall Study||27||
59854335|NCT03382912|75978937|FG001|Received at Least 1 Dose of Study Drug|Overall Study||24||
59854336|NCT03382912|75978936|FG000|COMPLETED|Overall Study||21||
59854337|NCT03382912|75978937|FG001|COMPLETED|Overall Study||13||
59854338|NCT03382912|75978936|FG000|NOT COMPLETED|Overall Study||6||
59854339|NCT03382912|75978937|FG001|NOT COMPLETED|Overall Study||12||
59854340|NCT00350207|75978946|FG000|STARTED|Overall Study||128||
59854341|NCT00350207|75978947|FG001|STARTED|Overall Study||134||
59854342|NCT00350207|75978948|FG002|STARTED|Overall Study||126||
59854343|NCT00350207|75978946|FG000|COMPLETED|Overall Study||120||
59854344|NCT00350207|75978947|FG001|COMPLETED|Overall Study||128||
59854345|NCT00350207|75978948|FG002|COMPLETED|Overall Study||119||
59854346|NCT00350207|75978946|FG000|NOT COMPLETED|Overall Study||8||
59854347|NCT00350207|75978947|FG001|NOT COMPLETED|Overall Study||6||
59854348|NCT00350207|75978948|FG002|NOT COMPLETED|Overall Study||7||
59854349|NCT00349973|75978958|FG000|STARTED|Overall Study||12||
59854350|NCT00349973|75978959|FG001|STARTED|Overall Study||8||
59854351|NCT00349973|75978958|FG000|COMPLETED|Overall Study||8||
59854352|NCT00349973|75978959|FG001|COMPLETED|Overall Study||5||
59854353|NCT00349973|75978958|FG000|NOT COMPLETED|Overall Study||4||
59854354|NCT00349973|75978959|FG001|NOT COMPLETED|Overall Study||3||
59854355|NCT03187262|75978965|FG000|STARTED|Induction||13||
59854356|NCT03187262|75978965|FG000|COMPLETED|Induction||7||
59854357|NCT03187262|75978965|FG000|NOT COMPLETED|Induction||6||
59854358|NCT03187262|75978965|FG000|STARTED|Consolidation||7||
59854359|NCT03187262|75978965|FG000|COMPLETED|Consolidation||2||
59854360|NCT03187262|75978965|FG000|NOT COMPLETED|Consolidation||5||
59854361|NCT03187262|75978965|FG000|STARTED|Maintenance||2||
59854362|NCT03187262|75978965|FG000|COMPLETED|Maintenance||2||
59854363|NCT03187262|75978965|FG000|NOT COMPLETED|Maintenance||0||
59854364|NCT03381196|75978971|FG000|STARTED|Overall Study||276||
59854365|NCT03381196|75978972|FG001|STARTED|Overall Study||277||
59854366|NCT03381196|75978971|FG000|Treated|Overall Study||273||
59854367|NCT03381196|75978972|FG001|Treated|Overall Study||271||
59854368|NCT03381196|75978971|FG000|COMPLETED|Overall Study||260||
59854369|NCT03381196|75978972|FG001|COMPLETED|Overall Study||258||
59854370|NCT03381196|75978971|FG000|NOT COMPLETED|Overall Study||16||
59854371|NCT03381196|75978972|FG001|NOT COMPLETED|Overall Study||19||
59854372|NCT02950558|75978980|FG000|STARTED|Overall Study||8||
59854373|NCT02950558|75978981|FG001|STARTED|Overall Study||6||
59854374|NCT02950558|75978980|FG000|12 Month Pain Questionnaire|Overall Study||6||
59854375|NCT02950558|75978981|FG001|12 Month Pain Questionnaire|Overall Study||6||
59854376|NCT02950558|75978980|FG000|COMPLETED|Overall Study||6||
59854377|NCT02950558|75978981|FG001|COMPLETED|Overall Study||6||
59854378|NCT02950558|75978980|FG000|NOT COMPLETED|Overall Study||2||
59854379|NCT02950558|75978981|FG001|NOT COMPLETED|Overall Study||0||
59854380|NCT03345472|75978988|FG000|STARTED|Implant to 3 Months||103||
59854381|NCT03345472|75978988|FG000|COMPLETED|Implant to 3 Months||99||
59854382|NCT03345472|75978988|FG000|NOT COMPLETED|Implant to 3 Months||4||
59854383|NCT03345472|75978988|FG000|STARTED|3 Months to 12 Months||99||
59854384|NCT03345472|75978988|FG000|COMPLETED|3 Months to 12 Months||91||
59854385|NCT03345472|75978988|FG000|NOT COMPLETED|3 Months to 12 Months||8||
59854386|NCT00349349|75978995|FG000|STARTED|Overall Study||95||
59854387|NCT00349349|75978996|FG001|STARTED|Overall Study||112||
59854388|NCT00349349|75978997|FG002|STARTED|Overall Study||16||
59854389|NCT00349349|75978995|FG000|COMPLETED|Overall Study||42||
59854390|NCT00349349|75978996|FG001|COMPLETED|Overall Study||50||
59854391|NCT00349349|75978997|FG002|COMPLETED|Overall Study||10||
59854392|NCT00349349|75978995|FG000|NOT COMPLETED|Overall Study||53||
59854393|NCT00349349|75978996|FG001|NOT COMPLETED|Overall Study||62||
59854394|NCT00349349|75978997|FG002|NOT COMPLETED|Overall Study||6||
59854395|NCT02950480|75979009|FG000|STARTED|Overall Study||2||
59854396|NCT02950480|75979010|FG001|STARTED|Overall Study||2||
59854397|NCT02950480|75979009|FG000|COMPLETED|Overall Study||1||
59854398|NCT02950480|75979010|FG001|COMPLETED|Overall Study||2||
59854399|NCT02950480|75979009|FG000|NOT COMPLETED|Overall Study||1||
59854400|NCT02950480|75979010|FG001|NOT COMPLETED|Overall Study||0||
59854401|NCT00348881|75979018|FG000|STARTED|Overall Study||1424||
59854402|NCT00348881|75979019|FG001|STARTED|Overall Study||709||
59854403|NCT00348881|75979018|FG000|COMPLETED|Overall Study||1407||
59854404|NCT00348881|75979019|FG001|COMPLETED|Overall Study||697||
59854405|NCT00348881|75979018|FG000|NOT COMPLETED|Overall Study||17||
59854406|NCT00348881|75979019|FG001|NOT COMPLETED|Overall Study||12||
59854407|NCT03376516|75979029|FG000|STARTED|Overall Study||11||
59854408|NCT03376516|75979029|FG000|Received Treatment|Overall Study||10||
59854409|NCT03376516|75979029|FG000|SAF Population|Overall Study||10|SAF population = study population of patients in safety analysis|
59854410|NCT03376516|75979029|FG000|FAS Population|Overall Study||10|FAS population = full analysis population|
59854411|NCT03376516|75979029|FG000|PK Population|Overall Study||10|PK population = study population of patients who underwent pharmacokinetic analysis|
59854412|NCT03376516|75979029|FG000|PP Population|Overall Study||9|PP population = per-protocol population|
59996777|NCT03434041|76112633|FG001|COMPLETED|Double Blind Treatment Phase (4 Weeks)||106||
59854413|NCT03376516|75979029|FG000|SURG Population|Overall Study||2|SURG population = study population of patients undergoing surgery treated with Wilate|
59854414|NCT03376516|75979029|FG000|COMPLETED|Overall Study||9||
59854415|NCT03376516|75979029|FG000|NOT COMPLETED|Overall Study||2||
59854416|NCT02257580|75979046|FG000|STARTED|Overall Study||16||
59854417|NCT02257580|75979047|FG001|STARTED|Overall Study||12||
59854418|NCT02257580|75979046|FG000|COMPLETED|Overall Study||16||
59854419|NCT02257580|75979047|FG001|COMPLETED|Overall Study||12||
59854420|NCT02257580|75979046|FG000|NOT COMPLETED|Overall Study||0||
59854421|NCT02257580|75979047|FG001|NOT COMPLETED|Overall Study||0||
59854422|NCT03797144|75979055|FG000|STARTED|Enrollment||16||
59854423|NCT03797144|75979056|FG001|STARTED|Enrollment||11||
59854424|NCT03797144|75979055|FG000|COMPLETED|Enrollment||12||
59854425|NCT03797144|75979056|FG001|COMPLETED|Enrollment||10||
59854426|NCT03797144|75979055|FG000|NOT COMPLETED|Enrollment||4||
59854427|NCT03797144|75979056|FG001|NOT COMPLETED|Enrollment||1||
59854428|NCT03797144|75979055|FG000|STARTED|Surgery||12||
59854429|NCT03797144|75979056|FG001|STARTED|Surgery||10||
59854430|NCT03797144|75979055|FG000|COMPLETED|Surgery||11||
59854431|NCT03797144|75979056|FG001|COMPLETED|Surgery||10||
59854432|NCT03797144|75979055|FG000|NOT COMPLETED|Surgery||1||
59854433|NCT03797144|75979056|FG001|NOT COMPLETED|Surgery||0||
59854434|NCT03797144|75979055|FG000|STARTED|3 Month||11||
59854435|NCT03797144|75979056|FG001|STARTED|3 Month||10||
59585342|NCT02448914|75692170|FG001|STARTED|Second Intervention (1 Day)||5||
59585343|NCT02448914|75692169|FG000|COMPLETED|Second Intervention (1 Day)||6||
59585344|NCT02448914|75692170|FG001|COMPLETED|Second Intervention (1 Day)||5||
59585345|NCT02448914|75692169|FG000|NOT COMPLETED|Second Intervention (1 Day)||0||
59585346|NCT02448914|75692170|FG001|NOT COMPLETED|Second Intervention (1 Day)||0||
59724836|NCT03208036|75843589|FG001|NOT COMPLETED|Baseline Assessment||1||
59724837|NCT03208036|75843588|FG000|STARTED|2nd Baseline Assessment||10||
59724838|NCT03208036|75843589|FG001|STARTED|2nd Baseline Assessment||10||
59724839|NCT03208036|75843588|FG000|COMPLETED|2nd Baseline Assessment||9||
59724840|NCT03208036|75843589|FG001|COMPLETED|2nd Baseline Assessment||8||
59724841|NCT03208036|75843588|FG000|NOT COMPLETED|2nd Baseline Assessment||1||
59724842|NCT03208036|75843589|FG001|NOT COMPLETED|2nd Baseline Assessment||2||
59724843|NCT03208036|75843588|FG000|STARTED|Intervention||9||
59724844|NCT03208036|75843589|FG001|STARTED|Intervention||8||
59724845|NCT03208036|75843588|FG000|COMPLETED|Intervention||6||
59724846|NCT03208036|75843589|FG001|COMPLETED|Intervention||6||
59724847|NCT03208036|75843588|FG000|NOT COMPLETED|Intervention||3||
59724848|NCT03208036|75843589|FG001|NOT COMPLETED|Intervention||2||
59724849|NCT03208036|75843588|FG000|STARTED|4-month Assessment||6||
59724850|NCT03208036|75843589|FG001|STARTED|4-month Assessment||6||
59724851|NCT03208036|75843588|FG000|COMPLETED|4-month Assessment||6||
59724852|NCT03208036|75843589|FG001|COMPLETED|4-month Assessment||6||
59724853|NCT03208036|75843588|FG000|NOT COMPLETED|4-month Assessment||0||
59724854|NCT03208036|75843589|FG001|NOT COMPLETED|4-month Assessment||0||
59724855|NCT03208036|75843588|FG000|STARTED|5.5 Month Assessment||6||
59724856|NCT03208036|75843589|FG001|STARTED|5.5 Month Assessment||6||
59724857|NCT03208036|75843588|FG000|COMPLETED|5.5 Month Assessment||5||
59724858|NCT03208036|75843589|FG001|COMPLETED|5.5 Month Assessment||4||
59724859|NCT03208036|75843588|FG000|NOT COMPLETED|5.5 Month Assessment||1||
59724860|NCT03208036|75843589|FG001|NOT COMPLETED|5.5 Month Assessment||2||
59854436|NCT03797144|75979055|FG000|COMPLETED|3 Month||9||
59854437|NCT03797144|75979056|FG001|COMPLETED|3 Month||10||
59854438|NCT03797144|75979055|FG000|NOT COMPLETED|3 Month||2||
59854439|NCT03797144|75979056|FG001|NOT COMPLETED|3 Month||0||
59854440|NCT03797144|75979055|FG000|STARTED|12 Month||9||
59854441|NCT03797144|75979056|FG001|STARTED|12 Month||10||
59854442|NCT03797144|75979055|FG000|COMPLETED|12 Month||1||
59854443|NCT03797144|75979056|FG001|COMPLETED|12 Month||1||
59854444|NCT03797144|75979055|FG000|NOT COMPLETED|12 Month||8||
59854445|NCT03797144|75979056|FG001|NOT COMPLETED|12 Month||9||
59854446|NCT03797144|75979055|FG000|STARTED|24 Month||1||
59854447|NCT03797144|75979056|FG001|STARTED|24 Month||1||
59854448|NCT03797144|75979055|FG000|COMPLETED|24 Month||0||
59854449|NCT03797144|75979056|FG001|COMPLETED|24 Month||0||
59854450|NCT03797144|75979055|FG000|NOT COMPLETED|24 Month||1||
59724861|NCT00926211|75843595|FG000|STARTED|Overall Study|One additional subject was not randomized and did not receive the treatment procedure.|36||
59724862|NCT00926211|75843595|FG000|COMPLETED|Overall Study||35||
59724863|NCT00926211|75843595|FG000|NOT COMPLETED|Overall Study||1||
59724864|NCT01114373|75843600|FG000|STARTED|Intervention 1 (4 Weeks)||21||
59724865|NCT01114373|75843601|FG001|STARTED|Intervention 1 (4 Weeks)||19||
59724866|NCT01114373|75843600|FG000|COMPLETED|Intervention 1 (4 Weeks)||18||
59724867|NCT01114373|75843601|FG001|COMPLETED|Intervention 1 (4 Weeks)||19||
59724868|NCT01114373|75843600|FG000|NOT COMPLETED|Intervention 1 (4 Weeks)||3||
59724869|NCT01114373|75843601|FG001|NOT COMPLETED|Intervention 1 (4 Weeks)||0||
59724870|NCT01114373|75843600|FG000|STARTED|Intervention 2 (4 Weeks)||18||
59854451|NCT03797144|75979056|FG001|NOT COMPLETED|24 Month||1||
59854452|NCT00347009|75979063|FG000|STARTED|Overall Study||155||
59854453|NCT00347009|75979063|FG000|COMPLETED|Overall Study||128||
59854454|NCT00347009|75979063|FG000|NOT COMPLETED|Overall Study||27||
59854455|NCT01845116|75979067|FG000|STARTED|Overall Study||11||
59854456|NCT01845116|75979067|FG000|COMPLETED|Overall Study||11||
59854457|NCT01845116|75979067|FG000|NOT COMPLETED|Overall Study||0||
59854458|NCT00346775|75979071|FG000|STARTED|Period 1: Intervention Period 1||49||
59854459|NCT00346775|75979072|FG001|STARTED|Period 1: Intervention Period 1||48||
59854460|NCT00346775|75979071|FG000|COMPLETED|Period 1: Intervention Period 1||44||
59854461|NCT00346775|75979072|FG001|COMPLETED|Period 1: Intervention Period 1||45||
59854462|NCT00346775|75979071|FG000|NOT COMPLETED|Period 1: Intervention Period 1||5||
59854463|NCT00346775|75979072|FG001|NOT COMPLETED|Period 1: Intervention Period 1||3||
59854464|NCT00346775|75979071|FG000|STARTED|Period 2: Washout Period (7 Days)||44||
59854465|NCT00346775|75979072|FG001|STARTED|Period 2: Washout Period (7 Days)||45||
59854466|NCT00346775|75979071|FG000|COMPLETED|Period 2: Washout Period (7 Days)||44||
59854467|NCT00346775|75979072|FG001|COMPLETED|Period 2: Washout Period (7 Days)||45||
59854468|NCT00346775|75979071|FG000|NOT COMPLETED|Period 2: Washout Period (7 Days)||0||
59854469|NCT00346775|75979072|FG001|NOT COMPLETED|Period 2: Washout Period (7 Days)||0||
59854470|NCT00346775|75979071|FG000|STARTED|Period 3: Intervention Period 2||44||
59854471|NCT00346775|75979072|FG001|STARTED|Period 3: Intervention Period 2||45||
59854472|NCT00346775|75979071|FG000|COMPLETED|Period 3: Intervention Period 2||44||
59854473|NCT00346775|75979072|FG001|COMPLETED|Period 3: Intervention Period 2||45||
59854474|NCT00346775|75979071|FG000|NOT COMPLETED|Period 3: Intervention Period 2||0||
59854475|NCT00346775|75979072|FG001|NOT COMPLETED|Period 3: Intervention Period 2||0||
59854476|NCT00346697|75979084|FG000|STARTED|Overall Study||24||
59854477|NCT00346697|75979085|FG001|STARTED|Overall Study||24||
59854478|NCT00346697|75979084|FG000|COMPLETED|Overall Study||24||
59854479|NCT00346697|75979085|FG001|COMPLETED|Overall Study||23||
59854480|NCT00346697|75979084|FG000|NOT COMPLETED|Overall Study||0||
59854481|NCT00346697|75979085|FG001|NOT COMPLETED|Overall Study||1||
59854482|NCT03400852|75979095|FG000|STARTED|Blinded Treatment Period||29|Period 2 arm not included in Period 1|
59854483|NCT03400852|75979096|FG001|STARTED|Blinded Treatment Period||15|Period 2 arm not included in Period 1|
59854484|NCT03400852|75979097|FG002|STARTED|Blinded Treatment Period||0|Period 2 arm not included in Period 1|
59854485|NCT03400852|75979095|FG000|COMPLETED|Blinded Treatment Period||20||
59854486|NCT03400852|75979096|FG001|COMPLETED|Blinded Treatment Period||9||
59854487|NCT03400852|75979097|FG002|COMPLETED|Blinded Treatment Period||0||
59854488|NCT03400852|75979095|FG000|NOT COMPLETED|Blinded Treatment Period||9||
59854489|NCT03400852|75979096|FG001|NOT COMPLETED|Blinded Treatment Period||6||
59854490|NCT03400852|75979097|FG002|NOT COMPLETED|Blinded Treatment Period||0||
59854491|NCT03400852|75979095|FG000|STARTED|Open Label Period||0|Period 1 arms not included in Period 2|
59854492|NCT03400852|75979096|FG001|STARTED|Open Label Period||0|Period 1 arms not included in Period 2|
59854493|NCT03400852|75979097|FG002|STARTED|Open Label Period||24|Period 1 arms not included in Period 2|
59854494|NCT03400852|75979095|FG000|COMPLETED|Open Label Period||0||
59854495|NCT03400852|75979096|FG001|COMPLETED|Open Label Period||0||
59854496|NCT03400852|75979097|FG002|COMPLETED|Open Label Period||2||
59854497|NCT03400852|75979095|FG000|NOT COMPLETED|Open Label Period||0||
59854498|NCT03400852|75979096|FG001|NOT COMPLETED|Open Label Period||0||
59854499|NCT03400852|75979097|FG002|NOT COMPLETED|Open Label Period||22||
59854500|NCT03398356|75979108|FG000|STARTED|Before Treatment||15||
59854501|NCT03398356|75979109|FG001|STARTED|Before Treatment||21||
59854502|NCT03398356|75979110|FG002|STARTED|Before Treatment||11||
59854503|NCT03398356|75979108|FG000|COMPLETED|Before Treatment||12||
59854504|NCT03398356|75979109|FG001|COMPLETED|Before Treatment||13||
59854505|NCT03398356|75979110|FG002|COMPLETED|Before Treatment|only baseline parameters were taken, this group did not participate in the further part of the study|0||
59854506|NCT03398356|75979108|FG000|NOT COMPLETED|Before Treatment||3||
59854507|NCT03398356|75979109|FG001|NOT COMPLETED|Before Treatment||8||
59854508|NCT03398356|75979110|FG002|NOT COMPLETED|Before Treatment||11||
59724871|NCT01114373|75843601|FG001|STARTED|Intervention 2 (4 Weeks)||19||
59724872|NCT01114373|75843600|FG000|COMPLETED|Intervention 2 (4 Weeks)||18||
59724873|NCT01114373|75843601|FG001|COMPLETED|Intervention 2 (4 Weeks)||18||
59724874|NCT01114373|75843600|FG000|NOT COMPLETED|Intervention 2 (4 Weeks)||0||
59724875|NCT01114373|75843601|FG001|NOT COMPLETED|Intervention 2 (4 Weeks)||1||
59724876|NCT00925899|75843613|FG000|STARTED|Part 1||34||
59724877|NCT00925899|75843614|FG001|STARTED|Part 1||38||
59724878|NCT00925899|75843613|FG000|COMPLETED|Part 1||23||
59724879|NCT00925899|75843614|FG001|COMPLETED|Part 1||27||
59854509|NCT03398356|75979108|FG000|STARTED|After 6 Weeks of Treatment||12||
59854510|NCT03398356|75979109|FG001|STARTED|After 6 Weeks of Treatment||13||
59724880|NCT00925899|75843613|FG000|NOT COMPLETED|Part 1||11||
59724881|NCT00925899|75843614|FG001|NOT COMPLETED|Part 1||11||
59724882|NCT00925899|75843613|FG000|STARTED|Part 2|All patients received the same intervention in the second part of the study (20 mg melatonin)|15|Nine patients withdrew before part two because they did not wish to continue in the study|
59724883|NCT00925899|75843614|FG001|STARTED|Part 2|Nine patients withdrew because they did not wish to continue in the study|21|Nine patients withdrew before part two because they did not wish to continue in the study|
59854511|NCT03398356|75979110|FG002|STARTED|After 6 Weeks of Treatment|control group- only initial parameters were assessed to compare, no follow-up|0||
59854512|NCT03398356|75979108|FG000|COMPLETED|After 6 Weeks of Treatment||12||
59854513|NCT03398356|75979109|FG001|COMPLETED|After 6 Weeks of Treatment||11||
59996778|NCT03434041|76112632|FG000|NOT COMPLETED|Double Blind Treatment Phase (4 Weeks)||18||
60121677|NCT01565993|76242593|FG000|COMPLETED|Overall Study|A total of 105 polypectomies were performed on 98 patients|66||
60121678|NCT01565993|76242594|FG001|COMPLETED|Overall Study||39||
60121679|NCT01565993|76242593|FG000|NOT COMPLETED|Overall Study||0||
59724884|NCT00925899|75843613|FG000|COMPLETED|Part 2||9||
59724885|NCT00925899|75843614|FG001|COMPLETED|Part 2||9||
59724886|NCT00925899|75843613|FG000|NOT COMPLETED|Part 2||6||
59724887|NCT00925899|75843614|FG001|NOT COMPLETED|Part 2||12||
59724888|NCT01114217|75843623|FG000|STARTED|Overall Study||337||
59724889|NCT01114217|75843624|FG001|STARTED|Overall Study||297||
59724890|NCT01114217|75843623|FG000|Received at Least 1 Dose of Ferumoxytol|Overall Study||337||
59724891|NCT01114217|75843624|FG001|Received at Least 1 Dose of Ferumoxytol|Overall Study||0||
59724892|NCT01114217|75843623|FG000|COMPLETED|Overall Study|Two participants lacked study completion data: one site stopped communicating during the study.|262|Completed Study is defined as had study drug and Week 5 visit.|
59724893|NCT01114217|75843624|FG001|COMPLETED|Overall Study||199|Completed Study is defined as had study drug and Week 5 visit.|
59724894|NCT01114217|75843623|FG000|NOT COMPLETED|Overall Study||75||
59724895|NCT01114217|75843624|FG001|NOT COMPLETED|Overall Study||98||
59724896|NCT01030536|75843633|FG000|STARTED|Overall Study||7||
59724897|NCT01030536|75843634|FG001|STARTED|Overall Study||6||
59724898|NCT01030536|75843635|FG002|STARTED|Overall Study||6||
59724899|NCT01030536|75843636|FG003|STARTED|Overall Study||3||
59724900|NCT01030536|75843637|FG004|STARTED|Overall Study||1||
59724901|NCT01030536|75843633|FG000|COMPLETED|Overall Study||0||
59724902|NCT01030536|75843634|FG001|COMPLETED|Overall Study||0||
59724903|NCT01030536|75843635|FG002|COMPLETED|Overall Study||0||
59724904|NCT01030536|75843636|FG003|COMPLETED|Overall Study||0||
59724905|NCT01030536|75843637|FG004|COMPLETED|Overall Study||0||
59724906|NCT01030536|75843633|FG000|NOT COMPLETED|Overall Study||7||
59724907|NCT01030536|75843634|FG001|NOT COMPLETED|Overall Study||6||
59724908|NCT01030536|75843635|FG002|NOT COMPLETED|Overall Study||6||
59724909|NCT01030536|75843636|FG003|NOT COMPLETED|Overall Study||3||
59724910|NCT01030536|75843637|FG004|NOT COMPLETED|Overall Study||1||
59724911|NCT01030458|75843655|FG000|STARTED|Overall Study||94||
59724912|NCT01030458|75843656|FG001|STARTED|Overall Study||89||
59724913|NCT01030458|75843655|FG000|COMPLETED|Overall Study||67||
59724914|NCT01030458|75843656|FG001|COMPLETED|Overall Study||57||
59724915|NCT01030458|75843655|FG000|NOT COMPLETED|Overall Study||27||
59724916|NCT01030458|75843656|FG001|NOT COMPLETED|Overall Study||32||
59724917|NCT00930969|75843662|FG000|STARTED|Overall Study||175||
59724918|NCT00930969|75843662|FG000|COMPLETED|Overall Study||137||
59724919|NCT00930969|75843662|FG000|NOT COMPLETED|Overall Study||38||
59724920|NCT01114139|75843668|FG000|STARTED|Overall Study||609||
59724921|NCT01114139|75843669|FG001|STARTED|Overall Study||203||
59724922|NCT01114139|75843668|FG000|Received at Least 1 Dose of Study Drug|Overall Study||608||
59724923|NCT01114139|75843669|FG001|Received at Least 1 Dose of Study Drug|Overall Study||200||
59724924|NCT01114139|75843668|FG000|COMPLETED|Overall Study||569|Completed is defined as had study drug and Week 5 visit.|
59724925|NCT01114139|75843669|FG001|COMPLETED|Overall Study||187|Completed is defined as had study drug and Week 5 visit.|
59724926|NCT01114139|75843668|FG000|NOT COMPLETED|Overall Study||40||
59724927|NCT01114139|75843669|FG001|NOT COMPLETED|Overall Study||16||
59724928|NCT01027884|75843677|FG000|STARTED|Overall Study||34||
59724929|NCT01027884|75843678|FG001|STARTED|Overall Study||32||
59724930|NCT01027884|75843677|FG000|COMPLETED|Overall Study||30||
59724931|NCT01027884|75843678|FG001|COMPLETED|Overall Study||25||
59724932|NCT01027884|75843677|FG000|NOT COMPLETED|Overall Study||4||
59724933|NCT01027884|75843678|FG001|NOT COMPLETED|Overall Study||7||
59724934|NCT03387514|75843686|FG000|STARTED|Overall Study||5||
59724935|NCT03387514|75843686|FG000|PET 1|Overall Study||5||
59724936|NCT03387514|75843686|FG000|Tissue Samples|Overall Study||4||
59724937|NCT03387514|75843686|FG000|PET 2A|Overall Study|Due to change in standard of care system therapy to immune therapy during the course of this trial, patients did not proceed to anti-angiogenesis therapy or combined anti-angiogenesis therapy with immune therapy to allow for PET imaging 2A or further PET imaging timepoints during the follow-up period of this trial.|0||
59724938|NCT03387514|75843686|FG000|PET 2B|Overall Study|Due to change in standard of care system therapy to immune therapy during the course of this trial, patients did not proceed to anti-angiogenesis therapy or combined anti-angiogenesis therapy with immune therapy to allow for PET imaging 2A or further PET imaging timepoints during the follow-up period of this trial.|0||
59724939|NCT03387514|75843686|FG000|PET 3A|Overall Study|Due to change in standard of care system therapy to immune therapy during the course of this trial, patients did not proceed to anti-angiogenesis therapy or combined anti-angiogenesis therapy with immune therapy to allow for PET imaging 2A or further PET imaging timepoints during the follow-up period of this trial.|0||
59724940|NCT03387514|75843686|FG000|PET 3B|Overall Study|Due to change in standard of care system therapy to immune therapy during the course of this trial, patients did not proceed to anti-angiogenesis therapy or combined anti-angiogenesis therapy with immune therapy to allow for PET imaging 2A or further PET imaging timepoints during the follow-up period of this trial.|0||
59854514|NCT03398356|75979110|FG002|COMPLETED|After 6 Weeks of Treatment|control group- only initial parameters were assessed to compare, no follow-up|0||
59854515|NCT03398356|75979108|FG000|NOT COMPLETED|After 6 Weeks of Treatment||0||
60121680|NCT01565993|76242594|FG001|NOT COMPLETED|Overall Study||3||
60121681|NCT01565291|76242602|FG000|STARTED|Overall Study||16||
60121682|NCT01565291|76242603|FG001|STARTED|Overall Study||16||
60121683|NCT01565291|76242602|FG000|COMPLETED|Overall Study||15||
59854516|NCT03398356|75979109|FG001|NOT COMPLETED|After 6 Weeks of Treatment||2||
59854517|NCT03398356|75979110|FG002|NOT COMPLETED|After 6 Weeks of Treatment||0||
59854518|NCT03398356|75979108|FG000|STARTED|Post 6 Week Period Initial Evaluation|two of the patients were moved from group B, because of intolerance of the higher dose of the drug|14||
59854519|NCT03398356|75979109|FG001|STARTED|Post 6 Week Period Initial Evaluation||11||
59854520|NCT03398356|75979110|FG002|STARTED|Post 6 Week Period Initial Evaluation||0||
59854521|NCT03398356|75979108|FG000|COMPLETED|Post 6 Week Period Initial Evaluation||14||
59854522|NCT03398356|75979109|FG001|COMPLETED|Post 6 Week Period Initial Evaluation||11||
59854523|NCT03398356|75979110|FG002|COMPLETED|Post 6 Week Period Initial Evaluation||0||
59854524|NCT03398356|75979108|FG000|NOT COMPLETED|Post 6 Week Period Initial Evaluation||0||
59854525|NCT03398356|75979109|FG001|NOT COMPLETED|Post 6 Week Period Initial Evaluation||0||
59854526|NCT03398356|75979110|FG002|NOT COMPLETED|Post 6 Week Period Initial Evaluation||0||
59854527|NCT03398356|75979108|FG000|STARTED|After 12 Weeks of Treatment||14||
59854528|NCT03398356|75979109|FG001|STARTED|After 12 Weeks of Treatment||11||
59854529|NCT03398356|75979110|FG002|STARTED|After 12 Weeks of Treatment|control group- only initial parameters were assessed to compare, no follow-up|0||
59854530|NCT03398356|75979108|FG000|COMPLETED|After 12 Weeks of Treatment||14|two of the patients were moved from group B, because of intolerance of the higher dose of the drug|
59854531|NCT03398356|75979109|FG001|COMPLETED|After 12 Weeks of Treatment||11|two of the patients were moved from group B, because of intolerance of the higher dose of the drug|
59854532|NCT03398356|75979110|FG002|COMPLETED|After 12 Weeks of Treatment|control group- only initial parameters were assessed to compare, no follow-up|0|two of the patients were moved from group B, because of intolerance of the higher dose of the drug|
59854533|NCT03398356|75979108|FG000|NOT COMPLETED|After 12 Weeks of Treatment||0||
59854534|NCT03398356|75979109|FG001|NOT COMPLETED|After 12 Weeks of Treatment||0||
59854535|NCT03398356|75979110|FG002|NOT COMPLETED|After 12 Weeks of Treatment||0||
59854536|NCT03398356|75979108|FG000|STARTED|After 15 Weeks of Treatment||14||
59854537|NCT03398356|75979109|FG001|STARTED|After 15 Weeks of Treatment||11||
59854538|NCT03398356|75979110|FG002|STARTED|After 15 Weeks of Treatment|control group- only initial parameters were assessed to compare, no follow-up|0||
59854539|NCT03398356|75979108|FG000|COMPLETED|After 15 Weeks of Treatment||14||
59854540|NCT03398356|75979109|FG001|COMPLETED|After 15 Weeks of Treatment||11||
59854541|NCT03398356|75979110|FG002|COMPLETED|After 15 Weeks of Treatment|control group- only initial parameters were assessed to compare, no follow-up|0||
59854542|NCT03398356|75979108|FG000|NOT COMPLETED|After 15 Weeks of Treatment||0||
59854543|NCT03398356|75979109|FG001|NOT COMPLETED|After 15 Weeks of Treatment||0||
59854544|NCT03398356|75979110|FG002|NOT COMPLETED|After 15 Weeks of Treatment||0||
59854545|NCT00346151|75979118|FG000|STARTED|Overall Study||5||
59854546|NCT00346151|75979118|FG000|COMPLETED|Overall Study||2||
59854547|NCT00346151|75979118|FG000|NOT COMPLETED|Overall Study||3||
59854548|NCT00130286|75979126|FG000|STARTED|Overall Study||22||
59854549|NCT00130286|75979127|FG001|STARTED|Overall Study||19||
59854550|NCT00130286|75979128|FG002|STARTED|Overall Study||17||
59854551|NCT00130286|75979129|FG003|STARTED|Overall Study||19||
59854552|NCT00130286|75979126|FG000|COMPLETED|Overall Study||22||
59854553|NCT00130286|75979127|FG001|COMPLETED|Overall Study||16||
59854554|NCT00130286|75979128|FG002|COMPLETED|Overall Study||13||
59854555|NCT00130286|75979129|FG003|COMPLETED|Overall Study||17||
59854556|NCT00130286|75979126|FG000|NOT COMPLETED|Overall Study||0||
59854557|NCT00130286|75979127|FG001|NOT COMPLETED|Overall Study||3||
59854558|NCT00130286|75979128|FG002|NOT COMPLETED|Overall Study||4||
59854559|NCT00130286|75979129|FG003|NOT COMPLETED|Overall Study||2||
59854560|NCT00346073|75979141|FG000|STARTED|Overall Study||1522||
59854561|NCT00346073|75979142|FG001|STARTED|Overall Study||762||
59585347|NCT01638546|75692179|FG000|STARTED|Overall Study||52||
59585348|NCT01638546|75692180|FG001|STARTED|Overall Study||45||
59724941|NCT03387514|75843686|FG000|PET 4|Overall Study|Due to change in standard of care system therapy to immune therapy during the course of this trial, patients did not proceed to anti-angiogenesis therapy or combined anti-angiogenesis therapy with immune therapy to allow for PET imaging 2A or further PET imaging timepoints during the follow-up period of this trial.|0||
59724942|NCT03387514|75843686|FG000|COMPLETED|Overall Study|Due to change in standard of care system therapy to immune therapy during the course of this trial, patients did not proceed to anti-angiogenesis therapy or combined anti-angiogenesis therapy with immune therapy to allow for PET imaging 2A or further PET imaging timepoints during the follow-up period of this trial.|0||
59724943|NCT03387514|75843686|FG000|NOT COMPLETED|Overall Study||5||
59724944|NCT01022580|75843701|FG000|STARTED|Overall Study||252||
59724945|NCT01022580|75843702|FG001|STARTED|Overall Study||259||
59724946|NCT01022580|75843701|FG000|COMPLETED|Overall Study|Survived to discharge|234||
59724947|NCT01022580|75843702|FG001|COMPLETED|Overall Study|Survived to discharge.|237||
59724948|NCT01022580|75843701|FG000|NOT COMPLETED|Overall Study||18||
59724949|NCT01022580|75843702|FG001|NOT COMPLETED|Overall Study||22||
59724950|NCT01107353|75843716|FG000|STARTED|Overall Study||20||
59854562|NCT00346073|75979141|FG000|COMPLETED|Overall Study||1481||
59854563|NCT00346073|75979142|FG001|COMPLETED|Overall Study||738||
59854564|NCT00346073|75979141|FG000|NOT COMPLETED|Overall Study||41||
59854565|NCT00346073|75979142|FG001|NOT COMPLETED|Overall Study||24||
59854566|NCT03374488|75979150|FG000|STARTED|Overall Study||42||
59854567|NCT03374488|75979151|FG001|STARTED|Overall Study||42||
59854568|NCT03374488|75979150|FG000|Intention-to-Treat (ITT)|Overall Study||42||
59585349|NCT01638546|75692179|FG000|COMPLETED|Overall Study||51||
59854569|NCT03374488|75979151|FG001|Intention-to-Treat (ITT)|Overall Study||42||
59854570|NCT03374488|75979150|FG000|All Participants as Treated (APaT)|Overall Study||42||
59854571|NCT03374488|75979151|FG001|All Participants as Treated (APaT)|Overall Study||41||
59854572|NCT03374488|75979150|FG000|COMPLETED|Overall Study||23|Refers to participants that discontinued study with amendment 4, and didn't require follow-up.|
59854573|NCT03374488|75979151|FG001|COMPLETED|Overall Study||28|Refers to participants that discontinued study with amendment 4, and didn't require follow-up.|
59854574|NCT03374488|75979150|FG000|NOT COMPLETED|Overall Study||19||
59854575|NCT03374488|75979151|FG001|NOT COMPLETED|Overall Study||14||
59854576|NCT00345683|75979160|FG000|STARTED|Overall Study||3010||
59854577|NCT00345683|75979161|FG001|STARTED|Overall Study||1010||
59854578|NCT00345683|75979160|FG000|COMPLETED|Overall Study||2985||
59854579|NCT00345683|75979161|FG001|COMPLETED|Overall Study||1001||
59854580|NCT00345683|75979160|FG000|NOT COMPLETED|Overall Study||25||
59854581|NCT00345683|75979161|FG001|NOT COMPLETED|Overall Study||9||
59854582|NCT03828383|75979169|FG000|STARTED|Overall Study||41||
59854583|NCT03828383|75979170|FG001|STARTED|Overall Study||37||
59854584|NCT03828383|75979169|FG000|COMPLETED|Overall Study||34||
59854585|NCT03828383|75979170|FG001|COMPLETED|Overall Study||30||
59854586|NCT03828383|75979169|FG000|NOT COMPLETED|Overall Study||7||
59854587|NCT03828383|75979170|FG001|NOT COMPLETED|Overall Study||7||
59854588|NCT00345605|75979176|FG000|STARTED|Initial Washout||6||
59854589|NCT00345605|75979177|FG001|STARTED|Initial Washout||6||
59854590|NCT00345605|75979176|FG000|COMPLETED|Initial Washout||6||
59854591|NCT00345605|75979177|FG001|COMPLETED|Initial Washout||6||
59854592|NCT00345605|75979176|FG000|NOT COMPLETED|Initial Washout||0||
59585350|NCT01638546|75692180|FG001|COMPLETED|Overall Study||42||
59585351|NCT01638546|75692179|FG000|NOT COMPLETED|Overall Study||1||
59585352|NCT01638546|75692180|FG001|NOT COMPLETED|Overall Study||3||
59854593|NCT00345605|75979177|FG001|NOT COMPLETED|Initial Washout||0||
59854594|NCT00345605|75979176|FG000|STARTED|Arm 1||6||
59854595|NCT00345605|75979177|FG001|STARTED|Arm 1||6||
59854596|NCT00345605|75979176|FG000|COMPLETED|Arm 1||6||
59854597|NCT00345605|75979177|FG001|COMPLETED|Arm 1||5||
59854598|NCT00345605|75979176|FG000|NOT COMPLETED|Arm 1||0||
59854599|NCT00345605|75979177|FG001|NOT COMPLETED|Arm 1||1||
59854600|NCT00345605|75979176|FG000|STARTED|Interval||6||
59585353|NCT02451488|75692190|FG000|STARTED|Overall Study||4||
59585354|NCT02451488|75692191|FG001|STARTED|Overall Study||4||
59585355|NCT02451488|75692190|FG000|COMPLETED|Overall Study||4||
59585356|NCT02451488|75692191|FG001|COMPLETED|Overall Study||4||
59585357|NCT02451488|75692190|FG000|NOT COMPLETED|Overall Study||0||
59724951|NCT01107353|75843717|FG001|STARTED|Overall Study||20||
59585358|NCT02451488|75692191|FG001|NOT COMPLETED|Overall Study||0||
59585359|NCT03172494|75692200|FG000|STARTED|Overall Study||361||
59585360|NCT03172494|75692201|FG001|STARTED|Overall Study||179||
59585361|NCT03172494|75692202|FG002|STARTED|Overall Study||180||
59585362|NCT03172494|75692200|FG000|Full Analysis Set (FAS)|Overall Study||361||
59585363|NCT03172494|75692201|FG001|Full Analysis Set (FAS)|Overall Study||179||
59724952|NCT01107353|75843716|FG000|COMPLETED|Overall Study||19||
59724953|NCT01107353|75843717|FG001|COMPLETED|Overall Study||20||
59724954|NCT01107353|75843716|FG000|NOT COMPLETED|Overall Study||1||
59724955|NCT01107353|75843717|FG001|NOT COMPLETED|Overall Study||0||
59724956|NCT01107197|75843725|FG000|STARTED|Overall Study||99||
59724957|NCT01107197|75843726|FG001|STARTED|Overall Study||101||
59724958|NCT01107197|75843725|FG000|COMPLETED|Overall Study|Included in intention-to-treat efficacy analyses (per-protocol analyses were based on 67 patients )|79||
59724959|NCT01107197|75843726|FG001|COMPLETED|Overall Study|Included in intention-to-treat efficacy analyses (per-protocol analyses were based on 64 patients )|78||
59724960|NCT01107197|75843725|FG000|NOT COMPLETED|Overall Study||20||
59724961|NCT01107197|75843726|FG001|NOT COMPLETED|Overall Study||23||
59854601|NCT00345605|75979177|FG001|STARTED|Interval||6||
59854602|NCT00345605|75979176|FG000|COMPLETED|Interval||6||
59585364|NCT03172494|75692202|FG002|Full Analysis Set (FAS)|Overall Study||180||
59585365|NCT03172494|75692200|FG000|Safety Analysis Set (SAS)|Overall Study||358||
59585366|NCT03172494|75692201|FG001|Safety Analysis Set (SAS)|Overall Study||175||
59585367|NCT03172494|75692202|FG002|Safety Analysis Set (SAS)|Overall Study||180||
59585368|NCT03172494|75692200|FG000|Exposed|Overall Study||358||
59585369|NCT03172494|75692201|FG001|Exposed|Overall Study||175||
59854603|NCT00345605|75979177|FG001|COMPLETED|Interval||6||
59854604|NCT00345605|75979176|FG000|NOT COMPLETED|Interval||0||
59854605|NCT00345605|75979177|FG001|NOT COMPLETED|Interval||0||
59854606|NCT00345605|75979176|FG000|STARTED|Crossover Wash-out||6||
59854607|NCT00345605|75979177|FG001|STARTED|Crossover Wash-out||6||
59854608|NCT00345605|75979176|FG000|COMPLETED|Crossover Wash-out||6||
59585370|NCT03172494|75692202|FG002|Exposed|Overall Study||180||
59585371|NCT03172494|75692200|FG000|COMPLETED|Overall Study||341||
59854609|NCT00345605|75979177|FG001|COMPLETED|Crossover Wash-out||6||
59854610|NCT00345605|75979176|FG000|NOT COMPLETED|Crossover Wash-out||0||
59854611|NCT00345605|75979177|FG001|NOT COMPLETED|Crossover Wash-out||0||
59854612|NCT00345605|75979176|FG000|STARTED|Arm 2, Opposite Treatment||6||
59854613|NCT00345605|75979177|FG001|STARTED|Arm 2, Opposite Treatment||6||
59585372|NCT03172494|75692201|FG001|COMPLETED|Overall Study||167||
59585373|NCT03172494|75692202|FG002|COMPLETED|Overall Study||151||
59585374|NCT03172494|75692200|FG000|NOT COMPLETED|Overall Study||20||
59585375|NCT03172494|75692201|FG001|NOT COMPLETED|Overall Study||12||
59585376|NCT03172494|75692202|FG002|NOT COMPLETED|Overall Study||29||
59585377|NCT02452346|75692211|FG000|STARTED|Overall Study||12||
59585378|NCT02452346|75692211|FG000|COMPLETED|Overall Study||3||
59585379|NCT02452346|75692211|FG000|NOT COMPLETED|Overall Study||9||
59585380|NCT03171168|75692217|FG000|STARTED|Overall Study||17||
59585381|NCT03171168|75692218|FG001|STARTED|Overall Study||37||
59585382|NCT03171168|75692217|FG000|COMPLETED|Overall Study||10||
59585383|NCT03171168|75692218|FG001|COMPLETED|Overall Study||19||
59585384|NCT03171168|75692217|FG000|NOT COMPLETED|Overall Study||7||
59585385|NCT03171168|75692218|FG001|NOT COMPLETED|Overall Study||18||
59585386|NCT02453360|75692227|FG000|STARTED|Overall Study||20||
59585387|NCT02453360|75692228|FG001|STARTED|Overall Study||20||
59585388|NCT02453360|75692229|FG002|STARTED|Overall Study||20||
59585389|NCT02453360|75692227|FG000|COMPLETED|Overall Study||20||
59585390|NCT02453360|75692228|FG001|COMPLETED|Overall Study||20||
59585391|NCT02453360|75692229|FG002|COMPLETED|Overall Study||20||
59585392|NCT02453360|75692227|FG000|NOT COMPLETED|Overall Study||0||
59585393|NCT02453360|75692228|FG001|NOT COMPLETED|Overall Study||0||
59585394|NCT02453360|75692229|FG002|NOT COMPLETED|Overall Study||0||
59585395|NCT02453672|75692240|FG000|STARTED|Overall Study||40||
59585396|NCT02453672|75692241|FG001|STARTED|Overall Study||40||
59585397|NCT02453672|75692242|FG002|STARTED|Overall Study||39||
59585398|NCT02453672|75692240|FG000|COMPLETED|Overall Study||37||
59585399|NCT02453672|75692241|FG001|COMPLETED|Overall Study||38||
59585400|NCT02453672|75692242|FG002|COMPLETED|Overall Study||38||
59585401|NCT02453672|75692240|FG000|NOT COMPLETED|Overall Study||3||
59585402|NCT02453672|75692241|FG001|NOT COMPLETED|Overall Study||2||
59585403|NCT02453672|75692242|FG002|NOT COMPLETED|Overall Study||1||
59585404|NCT03119064|75692252|FG000|STARTED|Overall Study||9||
59585405|NCT03119064|75692253|FG001|STARTED|Overall Study||3||
59585406|NCT03119064|75692254|FG002|STARTED|Overall Study||0||
59585407|NCT03119064|75692252|FG000|COMPLETED|Overall Study||9||
59585408|NCT03119064|75692253|FG001|COMPLETED|Overall Study||3||
59585409|NCT03119064|75692254|FG002|COMPLETED|Overall Study||0||
59585410|NCT03119064|75692252|FG000|NOT COMPLETED|Overall Study||0||
59585411|NCT03119064|75692253|FG001|NOT COMPLETED|Overall Study||0||
59585412|NCT03119064|75692254|FG002|NOT COMPLETED|Overall Study||0||
59585413|NCT02453750|75692261|FG000|STARTED|Overall Study||21||
59585414|NCT02453750|75692261|FG000|COMPLETED|Overall Study||21||
59585415|NCT02453750|75692261|FG000|NOT COMPLETED|Overall Study||0||
59585416|NCT02454296|75692270|FG000|STARTED|Overall Study||20||
59585417|NCT02454296|75692271|FG001|STARTED|Overall Study||21||
59585418|NCT02454296|75692270|FG000|COMPLETED|Overall Study||20||
59585419|NCT02454296|75692271|FG001|COMPLETED|Overall Study||21||
59585420|NCT02454296|75692270|FG000|NOT COMPLETED|Overall Study||0||
59585421|NCT02454296|75692271|FG001|NOT COMPLETED|Overall Study||0||
59585422|NCT02457260|75692282|FG000|STARTED|Overall Study||12||
59585423|NCT02457260|75692283|FG001|STARTED|Overall Study||7||
59585424|NCT02457260|75692284|FG002|STARTED|Overall Study||2||
59585425|NCT02457260|75692282|FG000|COMPLETED|Overall Study||10||
59585426|NCT02457260|75692283|FG001|COMPLETED|Overall Study||4||
59585427|NCT02457260|75692284|FG002|COMPLETED|Overall Study||1||
59585428|NCT02457260|75692282|FG000|NOT COMPLETED|Overall Study||2||
59585429|NCT02457260|75692283|FG001|NOT COMPLETED|Overall Study||3||
59585430|NCT02457260|75692284|FG002|NOT COMPLETED|Overall Study||1||
59585431|NCT02457728|75692293|FG000|STARTED|Overall Study||34||
59585432|NCT02457728|75692293|FG000|COMPLETED|Overall Study||34||
59585433|NCT02457728|75692293|FG000|NOT COMPLETED|Overall Study||0||
59585434|NCT02458352|75692297|FG000|STARTED|Overall Study||105||
59585435|NCT02458352|75692297|FG000|COMPLETED|Overall Study||105||
59585436|NCT02458352|75692297|FG000|NOT COMPLETED|Overall Study||0||
59585437|NCT01636362|75692303|FG000|STARTED|Overall Study||45||
59585438|NCT01636362|75692303|FG000|COMPLETED|Overall Study||37||
59585439|NCT01636362|75692303|FG000|NOT COMPLETED|Overall Study||8||
59585440|NCT02896712|75692309|FG000|STARTED|Phase 1||18||
59585441|NCT02896712|75692310|FG001|STARTED|Phase 1||17||
59585442|NCT02896712|75692311|FG002|STARTED|Phase 1||19||
59585443|NCT02896712|75692312|FG003|STARTED|Phase 1||21||
59585444|NCT02896712|75692313|FG004|STARTED|Phase 1||23||
59585445|NCT02896712|75692314|FG005|STARTED|Phase 1||20||
59585446|NCT02896712|75692309|FG000|COMPLETED|Phase 1||14||
59585447|NCT02896712|75692310|FG001|COMPLETED|Phase 1||17||
59585448|NCT02896712|75692311|FG002|COMPLETED|Phase 1||19||
59585449|NCT02896712|75692312|FG003|COMPLETED|Phase 1||10||
59854614|NCT00345605|75979176|FG000|COMPLETED|Arm 2, Opposite Treatment||5||
59585450|NCT02896712|75692313|FG004|COMPLETED|Phase 1||23||
59585451|NCT02896712|75692314|FG005|COMPLETED|Phase 1||20||
59854615|NCT00345605|75979177|FG001|COMPLETED|Arm 2, Opposite Treatment||6||
59585452|NCT02896712|75692309|FG000|NOT COMPLETED|Phase 1||4||
59585453|NCT02896712|75692310|FG001|NOT COMPLETED|Phase 1||0||
59585454|NCT02896712|75692311|FG002|NOT COMPLETED|Phase 1||0||
59585455|NCT02896712|75692312|FG003|NOT COMPLETED|Phase 1||11||
59585456|NCT02896712|75692313|FG004|NOT COMPLETED|Phase 1||0||
59585457|NCT02896712|75692314|FG005|NOT COMPLETED|Phase 1||0||
59585458|NCT02896712|75692309|FG000|STARTED|Phase 2||14||
59585459|NCT02896712|75692310|FG001|STARTED|Phase 2||17||
59585460|NCT02896712|75692311|FG002|STARTED|Phase 2||19||
59585461|NCT02896712|75692312|FG003|STARTED|Phase 2||10||
59585462|NCT02896712|75692313|FG004|STARTED|Phase 2||23||
59585463|NCT02896712|75692314|FG005|STARTED|Phase 2||20||
59585464|NCT02896712|75692309|FG000|COMPLETED|Phase 2||8||
59585465|NCT02896712|75692310|FG001|COMPLETED|Phase 2||11||
59585466|NCT02896712|75692311|FG002|COMPLETED|Phase 2||10||
59585467|NCT02896712|75692312|FG003|COMPLETED|Phase 2||9||
59585468|NCT02896712|75692313|FG004|COMPLETED|Phase 2||13||
59585469|NCT02896712|75692314|FG005|COMPLETED|Phase 2||13||
59585470|NCT02896712|75692309|FG000|NOT COMPLETED|Phase 2||6||
59585471|NCT02896712|75692310|FG001|NOT COMPLETED|Phase 2||6||
59585472|NCT02896712|75692311|FG002|NOT COMPLETED|Phase 2||9||
59585473|NCT02896712|75692312|FG003|NOT COMPLETED|Phase 2||1||
59585474|NCT02896712|75692313|FG004|NOT COMPLETED|Phase 2||10||
59585475|NCT02896712|75692314|FG005|NOT COMPLETED|Phase 2||7||
59585476|NCT02797184|75692332|FG000|STARTED|Overall Study||21||
59585477|NCT02797184|75692333|FG001|STARTED|Overall Study||21||
59585478|NCT02797184|75692332|FG000|COMPLETED|Overall Study||3||
59585479|NCT02797184|75692333|FG001|COMPLETED|Overall Study||3||
59585480|NCT02797184|75692332|FG000|NOT COMPLETED|Overall Study||18||
59585481|NCT02797184|75692333|FG001|NOT COMPLETED|Overall Study||18||
59585482|NCT02465216|75692344|FG000|STARTED|Overall Study||15||
59585483|NCT02465216|75692345|FG001|STARTED|Overall Study||5||
59585484|NCT02465216|75692346|FG002|STARTED|Overall Study||14||
59585485|NCT02465216|75692347|FG003|STARTED|Overall Study||14||
59585486|NCT02465216|75692348|FG004|STARTED|Overall Study||12||
59585487|NCT02465216|75692344|FG000|COMPLETED|Overall Study||12||
59585488|NCT02465216|75692345|FG001|COMPLETED|Overall Study||5||
59585489|NCT02465216|75692346|FG002|COMPLETED|Overall Study||13||
59585490|NCT02465216|75692347|FG003|COMPLETED|Overall Study||12||
59585491|NCT02465216|75692348|FG004|COMPLETED|Overall Study||9||
59585492|NCT02465216|75692344|FG000|NOT COMPLETED|Overall Study||3||
59585493|NCT02465216|75692345|FG001|NOT COMPLETED|Overall Study||0||
59585494|NCT02465216|75692346|FG002|NOT COMPLETED|Overall Study||1||
59585495|NCT02465216|75692347|FG003|NOT COMPLETED|Overall Study||2||
59585496|NCT02465216|75692348|FG004|NOT COMPLETED|Overall Study||3||
59585497|NCT02465372|75692362|FG000|STARTED|Overall Study||349||3
59585498|NCT02465372|75692363|FG001|STARTED|Overall Study||250||2
59585499|NCT02465372|75692362|FG000|COMPLETED|Overall Study||227||3
59585500|NCT02465372|75692363|FG001|COMPLETED|Overall Study||153||2
59585501|NCT02465372|75692362|FG000|NOT COMPLETED|Overall Study||122||0
59585502|NCT02465372|75692363|FG001|NOT COMPLETED|Overall Study||97||0
59585503|NCT03042468|75692375|FG000|STARTED|Overall Study||6||
59585504|NCT03042468|75692376|FG001|STARTED|Overall Study||6||
59585505|NCT03042468|75692377|FG002|STARTED|Overall Study||5||
59585506|NCT03042468|75692378|FG003|STARTED|Overall Study||6||
59585507|NCT03042468|75692379|FG004|STARTED|Overall Study||6||
59585508|NCT03042468|75692380|FG005|STARTED|Overall Study||21||
59585509|NCT03042468|75692375|FG000|COMPLETED|Overall Study||6||
59585510|NCT03042468|75692376|FG001|COMPLETED|Overall Study||5||
59585511|NCT03042468|75692377|FG002|COMPLETED|Overall Study||4||
59585512|NCT03042468|75692378|FG003|COMPLETED|Overall Study||6||
59585513|NCT03042468|75692379|FG004|COMPLETED|Overall Study||5||
59585514|NCT03042468|75692380|FG005|COMPLETED|Overall Study||19||
59585515|NCT03042468|75692375|FG000|NOT COMPLETED|Overall Study||0||
59585516|NCT03042468|75692376|FG001|NOT COMPLETED|Overall Study||1||
59585517|NCT03042468|75692377|FG002|NOT COMPLETED|Overall Study||1||
59585518|NCT03042468|75692378|FG003|NOT COMPLETED|Overall Study||0||
59585519|NCT03042468|75692379|FG004|NOT COMPLETED|Overall Study||1||
59585520|NCT03042468|75692380|FG005|NOT COMPLETED|Overall Study||2||
59724962|NCT01989598|75843732|FG000|STARTED|Overall Study|Includes pts receiving Single agent Trametinib and pts who are receiving Trametinib with AKT Inhibitor GSK2141795|25||
60121684|NCT01565291|76242603|FG001|COMPLETED|Overall Study||16||
59585521|NCT01634178|75692398|FG000|STARTED|Treatment Period 1||23||
59585522|NCT01634178|75692399|FG001|STARTED|Treatment Period 1||23||
59585523|NCT01634178|75692398|FG000|COMPLETED|Treatment Period 1||23||
59585524|NCT01634178|75692399|FG001|COMPLETED|Treatment Period 1||22||
59585525|NCT01634178|75692398|FG000|NOT COMPLETED|Treatment Period 1||0||
59585526|NCT01634178|75692399|FG001|NOT COMPLETED|Treatment Period 1||1||
59585527|NCT01634178|75692398|FG000|STARTED|Treatment Period 2||23||
59585528|NCT01634178|75692399|FG001|STARTED|Treatment Period 2||22||
59585529|NCT01634178|75692398|FG000|COMPLETED|Treatment Period 2||22||
59585530|NCT01634178|75692399|FG001|COMPLETED|Treatment Period 2||22||
59585531|NCT01634178|75692398|FG000|NOT COMPLETED|Treatment Period 2||1||
59585532|NCT01634178|75692399|FG001|NOT COMPLETED|Treatment Period 2||0||
59585533|NCT02465450|75692409|FG000|STARTED|Treatment Period 1||26||
59585534|NCT02465450|75692410|FG001|STARTED|Treatment Period 1||24||
59585535|NCT02465450|75692411|FG002|STARTED|Treatment Period 1||35||
59585536|NCT02465450|75692412|FG003|STARTED|Treatment Period 1||0||
59585537|NCT02465450|75692413|FG004|STARTED|Treatment Period 1||0||
59585538|NCT02465450|75692414|FG005|STARTED|Treatment Period 1||0||
59585539|NCT02465450|75692409|FG000|COMPLETED|Treatment Period 1||24||
59585540|NCT02465450|75692410|FG001|COMPLETED|Treatment Period 1||23||
59585541|NCT02465450|75692411|FG002|COMPLETED|Treatment Period 1||34||
59585542|NCT02465450|75692412|FG003|COMPLETED|Treatment Period 1||0||
59585543|NCT02465450|75692413|FG004|COMPLETED|Treatment Period 1||0||
59585544|NCT02465450|75692414|FG005|COMPLETED|Treatment Period 1||0||
59585545|NCT02465450|75692409|FG000|NOT COMPLETED|Treatment Period 1||2||
59585546|NCT02465450|75692410|FG001|NOT COMPLETED|Treatment Period 1||1||
59585547|NCT02465450|75692411|FG002|NOT COMPLETED|Treatment Period 1||1||
59585548|NCT02465450|75692412|FG003|NOT COMPLETED|Treatment Period 1||0||
59585549|NCT02465450|75692413|FG004|NOT COMPLETED|Treatment Period 1||0||
59585550|NCT02465450|75692414|FG005|NOT COMPLETED|Treatment Period 1||0||
59585551|NCT02465450|75692409|FG000|STARTED|Treatment Period 2||0||
59585552|NCT02465450|75692410|FG001|STARTED|Treatment Period 2||0||
59585553|NCT02465450|75692411|FG002|STARTED|Treatment Period 2||0||
59585554|NCT02465450|75692412|FG003|STARTED|Treatment Period 2||30||
59585555|NCT02465450|75692413|FG004|STARTED|Treatment Period 2||28||
59585556|NCT02465450|75692414|FG005|STARTED|Treatment Period 2||23||
59585557|NCT02465450|75692409|FG000|COMPLETED|Treatment Period 2||0||
59585558|NCT02465450|75692410|FG001|COMPLETED|Treatment Period 2||0||
59585559|NCT02465450|75692411|FG002|COMPLETED|Treatment Period 2||0||
59585560|NCT02465450|75692412|FG003|COMPLETED|Treatment Period 2||27||
59585561|NCT02465450|75692413|FG004|COMPLETED|Treatment Period 2||24||
59585562|NCT02465450|75692414|FG005|COMPLETED|Treatment Period 2||23||
59585563|NCT02465450|75692409|FG000|NOT COMPLETED|Treatment Period 2||0||
59585564|NCT02465450|75692410|FG001|NOT COMPLETED|Treatment Period 2||0||
59585565|NCT02465450|75692411|FG002|NOT COMPLETED|Treatment Period 2||0||
59585566|NCT02465450|75692412|FG003|NOT COMPLETED|Treatment Period 2||3||
59585567|NCT02465450|75692413|FG004|NOT COMPLETED|Treatment Period 2||4||
59585568|NCT02465450|75692414|FG005|NOT COMPLETED|Treatment Period 2||0||
59585569|NCT00608972|75692432|FG000|STARTED|Overall Study||31||
59585570|NCT00608972|75692432|FG000|COMPLETED|Overall Study||2||
59585571|NCT00608972|75692432|FG000|NOT COMPLETED|Overall Study||29||
59585572|NCT02412306|75692441|FG000|STARTED|Overall Study||5||
59585573|NCT02412306|75692442|FG001|STARTED|Overall Study||9||
59585574|NCT02412306|75692443|FG002|STARTED|Overall Study||21||
59585575|NCT02412306|75692444|FG003|STARTED|Overall Study||14||
59585576|NCT02412306|75692445|FG004|STARTED|Overall Study||17||
59585577|NCT02412306|75692441|FG000|COMPLETED|Overall Study||0||
59585578|NCT02412306|75692442|FG001|COMPLETED|Overall Study||1||
59585579|NCT02412306|75692443|FG002|COMPLETED|Overall Study||5||
59585580|NCT02412306|75692444|FG003|COMPLETED|Overall Study||14||
59585581|NCT02412306|75692445|FG004|COMPLETED|Overall Study||15||
59585582|NCT02412306|75692441|FG000|NOT COMPLETED|Overall Study||5||
59585583|NCT02412306|75692442|FG001|NOT COMPLETED|Overall Study||8||
59585584|NCT02412306|75692443|FG002|NOT COMPLETED|Overall Study||16||
59585585|NCT02412306|75692444|FG003|NOT COMPLETED|Overall Study||0||
59585586|NCT02412306|75692445|FG004|NOT COMPLETED|Overall Study||2||
59585587|NCT04285723|75692468|FG000|STARTED|Overall Study||39|Ful study population|
59585588|NCT04285723|75692469|FG001|STARTED|Overall Study||18|Ful study population|
59585589|NCT04285723|75692468|FG000|COMPLETED|Overall Study||36||
59585590|NCT04285723|75692469|FG001|COMPLETED|Overall Study||16||
59585591|NCT04285723|75692468|FG000|NOT COMPLETED|Overall Study||3||
59585592|NCT04285723|75692469|FG001|NOT COMPLETED|Overall Study||2||
59585593|NCT01352221|75692483|FG000|STARTED|Double-blind Phase||64||
59585594|NCT01352221|75692484|FG001|STARTED|Double-blind Phase||64||
59585595|NCT01352221|75692485|FG002|STARTED|Double-blind Phase|Not Applicable to double-blind phase|0||
59585596|NCT01352221|75692486|FG003|STARTED|Double-blind Phase|Not Applicable to double-blind phase|0||
59585597|NCT01352221|75692483|FG000|COMPLETED|Double-blind Phase||55||
59585598|NCT01352221|75692484|FG001|COMPLETED|Double-blind Phase||53||
59585599|NCT01352221|75692485|FG002|COMPLETED|Double-blind Phase|Not Applicable to double-blind phase|0||
59585600|NCT01352221|75692486|FG003|COMPLETED|Double-blind Phase|Not Applicable to double-blind phase|0||
59585601|NCT01352221|75692483|FG000|NOT COMPLETED|Double-blind Phase||9||
59585602|NCT01352221|75692484|FG001|NOT COMPLETED|Double-blind Phase||11||
59585603|NCT01352221|75692485|FG002|NOT COMPLETED|Double-blind Phase||0||
59585604|NCT01352221|75692486|FG003|NOT COMPLETED|Double-blind Phase||0||
59585605|NCT01352221|75692483|FG000|STARTED|Open-label Phase|Not Applicable to open-label phase|0||
59585606|NCT01352221|75692484|FG001|STARTED|Open-label Phase|Not Applicable to open-label phase|0||
59585607|NCT01352221|75692485|FG002|STARTED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|50||
59585608|NCT01352221|75692486|FG003|STARTED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|47||
59585609|NCT01352221|75692483|FG000|COMPLETED|Open-label Phase|Not Applicable to open-label phase|0||
59585610|NCT01352221|75692484|FG001|COMPLETED|Open-label Phase|Not Applicable to open-label phase|0||
59585611|NCT01352221|75692485|FG002|COMPLETED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|37||
59585612|NCT01352221|75692486|FG003|COMPLETED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|36||
59585613|NCT01352221|75692483|FG000|NOT COMPLETED|Open-label Phase||0||
59585614|NCT01352221|75692484|FG001|NOT COMPLETED|Open-label Phase||0||
59585615|NCT01352221|75692485|FG002|NOT COMPLETED|Open-label Phase||13||
59585616|NCT01352221|75692486|FG003|NOT COMPLETED|Open-label Phase||11||
59585617|NCT03681769|75692500|FG000|STARTED|Overall Study||11||
59585618|NCT03681769|75692501|FG001|STARTED|Overall Study||11||
59585619|NCT03681769|75692500|FG000|COMPLETED|Overall Study||10||
59585620|NCT03681769|75692501|FG001|COMPLETED|Overall Study||10||
59585621|NCT03681769|75692500|FG000|NOT COMPLETED|Overall Study||1||
59585622|NCT03681769|75692501|FG001|NOT COMPLETED|Overall Study||1||
59585623|NCT01953120|75692508|FG000|STARTED|Overall Study||20||
59585624|NCT01953120|75692508|FG000|COMPLETED|Overall Study||19||
59585625|NCT01953120|75692508|FG000|NOT COMPLETED|Overall Study||1||
59585626|NCT01634100|75692512|FG000|STARTED|Overall Study||3||
59585627|NCT01634100|75692513|FG001|STARTED|Overall Study||3||
59585628|NCT01634100|75692514|FG002|STARTED|Overall Study||3||
59585629|NCT01634100|75692515|FG003|STARTED|Overall Study||3||
59585630|NCT01634100|75692516|FG004|STARTED|Overall Study||3||
59585631|NCT01634100|75692517|FG005|STARTED|Overall Study||3||
59585632|NCT01634100|75692512|FG000|Received Empa Alone|Overall Study||3||
59585633|NCT01634100|75692513|FG001|Received Empa Alone|Overall Study||3||
59585634|NCT01634100|75692514|FG002|Received Empa Alone|Overall Study||3||
59585635|NCT01634100|75692515|FG003|Received Empa Alone|Overall Study||3||
59585636|NCT01634100|75692516|FG004|Received Empa Alone|Overall Study||3||
59585637|NCT01634100|75692517|FG005|Received Empa Alone|Overall Study||3||
59585638|NCT01634100|75692512|FG000|Received Empa + Rifampicin|Overall Study||3||
59585639|NCT01634100|75692513|FG001|Received Empa + Rifampicin|Overall Study||3||
59585640|NCT01634100|75692514|FG002|Received Empa + Rifampicin|Overall Study||3||
59585641|NCT01634100|75692515|FG003|Received Empa + Rifampicin|Overall Study||3||
59585642|NCT01634100|75692516|FG004|Received Empa + Rifampicin|Overall Study||3||
59585643|NCT01634100|75692517|FG005|Received Empa + Rifampicin|Overall Study||3||
59585644|NCT01634100|75692512|FG000|Received Empa + Probenecid|Overall Study||2||
59585645|NCT01634100|75692513|FG001|Received Empa + Probenecid|Overall Study||3||
59585646|NCT01634100|75692514|FG002|Received Empa + Probenecid|Overall Study||2||
59585647|NCT01634100|75692515|FG003|Received Empa + Probenecid|Overall Study||3||
59585648|NCT01634100|75692516|FG004|Received Empa + Probenecid|Overall Study||3||
59585649|NCT01634100|75692517|FG005|Received Empa + Probenecid|Overall Study||3||
59585650|NCT01634100|75692512|FG000|COMPLETED|Overall Study||2||
59585651|NCT01634100|75692513|FG001|COMPLETED|Overall Study||3||
59585652|NCT01634100|75692514|FG002|COMPLETED|Overall Study||2||
59585653|NCT01634100|75692515|FG003|COMPLETED|Overall Study||3||
59585654|NCT01634100|75692516|FG004|COMPLETED|Overall Study||3||
59585655|NCT01634100|75692517|FG005|COMPLETED|Overall Study||3||
59585656|NCT01634100|75692512|FG000|NOT COMPLETED|Overall Study||1||
59585657|NCT01634100|75692513|FG001|NOT COMPLETED|Overall Study||0||
59585658|NCT01634100|75692514|FG002|NOT COMPLETED|Overall Study||1||
59585659|NCT01634100|75692515|FG003|NOT COMPLETED|Overall Study||0||
59585660|NCT01634100|75692516|FG004|NOT COMPLETED|Overall Study||0||
59585661|NCT01634100|75692517|FG005|NOT COMPLETED|Overall Study||0||
59585662|NCT01633944|75692527|FG000|STARTED|Open-label Titration Phase||752||
59585663|NCT01633944|75692528|FG001|STARTED|Open-label Titration Phase||0||
59585664|NCT01633944|75692529|FG002|STARTED|Open-label Titration Phase||0||
59585665|NCT01633944|75692527|FG000|COMPLETED|Open-label Titration Phase||462||
59585666|NCT01633944|75692528|FG001|COMPLETED|Open-label Titration Phase||0||
59585667|NCT01633944|75692529|FG002|COMPLETED|Open-label Titration Phase||0||
59585668|NCT01633944|75692527|FG000|NOT COMPLETED|Open-label Titration Phase||290||
59585669|NCT01633944|75692528|FG001|NOT COMPLETED|Open-label Titration Phase||0||
59585670|NCT01633944|75692529|FG002|NOT COMPLETED|Open-label Titration Phase||0||
59585671|NCT01633944|75692527|FG000|STARTED|Double-blind Treatment Phase|All subjects completing OL titration in the previous period were randomized to a DB treatment.|0||
59585672|NCT01633944|75692528|FG001|STARTED|Double-blind Treatment Phase|Subjects were randomized to DB treatment after completing OL titration in the previous period.|230||
59585673|NCT01633944|75692529|FG002|STARTED|Double-blind Treatment Phase|Subjects were randomized to DB treatment after completing OL titration in the previous period.|232||
59585674|NCT01633944|75692527|FG000|COMPLETED|Double-blind Treatment Phase||0||
59585675|NCT01633944|75692528|FG001|COMPLETED|Double-blind Treatment Phase||176||
59585676|NCT01633944|75692529|FG002|COMPLETED|Double-blind Treatment Phase||174||
59585677|NCT01633944|75692527|FG000|NOT COMPLETED|Double-blind Treatment Phase||0||
59585678|NCT01633944|75692528|FG001|NOT COMPLETED|Double-blind Treatment Phase||54||
59585679|NCT01633944|75692529|FG002|NOT COMPLETED|Double-blind Treatment Phase||58||
59585680|NCT00589316|75692545|FG000|STARTED|Overall Study||1||
59585681|NCT00589316|75692546|FG001|STARTED|Overall Study||1||
59585682|NCT00589316|75692547|FG002|STARTED|Overall Study||5||
59854616|NCT00345605|75979176|FG000|NOT COMPLETED|Arm 2, Opposite Treatment||1||
59854617|NCT00345605|75979177|FG001|NOT COMPLETED|Arm 2, Opposite Treatment||0||
59585683|NCT00589316|75692548|FG003|STARTED|Overall Study||1||
59585684|NCT00589316|75692549|FG004|STARTED|Overall Study||1||
59585685|NCT00589316|75692550|FG005|STARTED|Overall Study||2||
59585686|NCT00589316|75692551|FG006|STARTED|Overall Study||7||
59585687|NCT00589316|75692552|FG007|STARTED|Overall Study||7||
59585688|NCT00589316|75692545|FG000|COMPLETED|Overall Study||1||
59585689|NCT00589316|75692546|FG001|COMPLETED|Overall Study||1||
59585690|NCT00589316|75692547|FG002|COMPLETED|Overall Study||5||
59585691|NCT00589316|75692548|FG003|COMPLETED|Overall Study||1||
59585692|NCT00589316|75692549|FG004|COMPLETED|Overall Study||1||
59585693|NCT00589316|75692550|FG005|COMPLETED|Overall Study||2||
59585694|NCT00589316|75692551|FG006|COMPLETED|Overall Study||7||
59585695|NCT00589316|75692552|FG007|COMPLETED|Overall Study||7||
59585696|NCT00589316|75692545|FG000|NOT COMPLETED|Overall Study||0||
59585697|NCT00589316|75692546|FG001|NOT COMPLETED|Overall Study||0||
59585698|NCT00589316|75692547|FG002|NOT COMPLETED|Overall Study||0||
59585699|NCT00589316|75692548|FG003|NOT COMPLETED|Overall Study||0||
59585700|NCT00589316|75692549|FG004|NOT COMPLETED|Overall Study||0||
59585701|NCT00589316|75692550|FG005|NOT COMPLETED|Overall Study||0||
59585702|NCT00589316|75692551|FG006|NOT COMPLETED|Overall Study||0||
59585703|NCT00589316|75692552|FG007|NOT COMPLETED|Overall Study||0||
59585704|NCT01633788|75692574|FG000|STARTED|Overall Study||57||
59585705|NCT01633788|75692575|FG001|STARTED|Overall Study||58||
59585706|NCT01633788|75692576|FG002|STARTED|Overall Study||59||
59585707|NCT01633788|75692577|FG003|STARTED|Overall Study||58||
59585708|NCT01633788|75692574|FG000|COMPLETED|Overall Study||50||
59585709|NCT01633788|75692575|FG001|COMPLETED|Overall Study||50||
59585710|NCT01633788|75692576|FG002|COMPLETED|Overall Study||49||
59585711|NCT01633788|75692577|FG003|COMPLETED|Overall Study||45||
59585712|NCT01633788|75692574|FG000|NOT COMPLETED|Overall Study||7||
59585713|NCT01633788|75692575|FG001|NOT COMPLETED|Overall Study||8||
59585714|NCT01633788|75692576|FG002|NOT COMPLETED|Overall Study||10||
59585715|NCT01633788|75692577|FG003|NOT COMPLETED|Overall Study||13||
59585716|NCT04154943|75692587|FG000|STARTED|Overall Study||79||
59585717|NCT04154943|75692587|FG000|COMPLETED|Overall Study||0||
59585718|NCT04154943|75692587|FG000|NOT COMPLETED|Overall Study||79||
59585719|NCT03492463|75692595|FG000|STARTED|Overall Study||37||
59585720|NCT03492463|75692596|FG001|STARTED|Overall Study||33||
59585721|NCT03492463|75692597|FG002|STARTED|Overall Study||11||
59585722|NCT03492463|75692598|FG003|STARTED|Overall Study||13||
59585723|NCT03492463|75692595|FG000|COMPLETED|Overall Study||26||
59585724|NCT03492463|75692596|FG001|COMPLETED|Overall Study||19||
59585725|NCT03492463|75692597|FG002|COMPLETED|Overall Study||7||
59585726|NCT03492463|75692598|FG003|COMPLETED|Overall Study||10||
59585727|NCT03492463|75692595|FG000|NOT COMPLETED|Overall Study||11||
59585728|NCT03492463|75692596|FG001|NOT COMPLETED|Overall Study||14||
59585729|NCT03492463|75692597|FG002|NOT COMPLETED|Overall Study||4||
59585730|NCT03492463|75692598|FG003|NOT COMPLETED|Overall Study||3||
59585731|NCT03476239|75692608|FG000|STARTED|Overall Study||121||
59585732|NCT03476239|75692608|FG000|Received Blinatumomab|Overall Study||120||
59585733|NCT03476239|75692608|FG000|Interim Analysis Set|Overall Study||90|Protocol-specified number of dosed subjects with the opportunity for 2 cycles of treatment|
59585734|NCT03476239|75692608|FG000|COMPLETED|Overall Study||23||
59585735|NCT03476239|75692608|FG000|NOT COMPLETED|Overall Study||98||
59585736|NCT02678312|75692617|FG000|STARTED|Part 1 Open Label Epoch- Period 1||17|Out of 26 participants enrolled in the Part 1 of the study, 17 were dosed based on their age to receive LCZ696 0.8 mg or 0.4 mg in Period 1.|
59585737|NCT02678312|75692618|FG001|STARTED|Part 1 Open Label Epoch- Period 1||0|Out of 26 participants enrolled in the Part 1 of the study, 17 were dosed based on their age to receive LCZ696 0.8 mg or 0.4 mg in Period 1.|
59585738|NCT02678312|75692619|FG002|STARTED|Part 1 Open Label Epoch- Period 1||0|Out of 26 participants enrolled in the Part 1 of the study, 17 were dosed based on their age to receive LCZ696 0.8 mg or 0.4 mg in Period 1.|
59585739|NCT02678312|75692620|FG003|STARTED|Part 1 Open Label Epoch- Period 1||0|Out of 26 participants enrolled in the Part 1 of the study, 17 were dosed based on their age to receive LCZ696 0.8 mg or 0.4 mg in Period 1.|
59585740|NCT02678312|75692621|FG004|STARTED|Part 1 Open Label Epoch- Period 1||0|Out of 26 participants enrolled in the Part 1 of the study, 17 were dosed based on their age to receive LCZ696 0.8 mg or 0.4 mg in Period 1.|
59585741|NCT02678312|75692617|FG000|COMPLETED|Part 1 Open Label Epoch- Period 1||14||
59585742|NCT02678312|75692618|FG001|COMPLETED|Part 1 Open Label Epoch- Period 1||0||
59585743|NCT02678312|75692619|FG002|COMPLETED|Part 1 Open Label Epoch- Period 1||0||
59585744|NCT02678312|75692620|FG003|COMPLETED|Part 1 Open Label Epoch- Period 1||0||
59585745|NCT02678312|75692621|FG004|COMPLETED|Part 1 Open Label Epoch- Period 1||0||
59585746|NCT02678312|75692617|FG000|NOT COMPLETED|Part 1 Open Label Epoch- Period 1||3||
59585747|NCT02678312|75692618|FG001|NOT COMPLETED|Part 1 Open Label Epoch- Period 1||0||
59585748|NCT02678312|75692619|FG002|NOT COMPLETED|Part 1 Open Label Epoch- Period 1||0||
59585749|NCT02678312|75692620|FG003|NOT COMPLETED|Part 1 Open Label Epoch- Period 1||0||
59585750|NCT02678312|75692621|FG004|NOT COMPLETED|Part 1 Open Label Epoch- Period 1||0||
59585751|NCT02678312|75692617|FG000|STARTED|Part 1 Open Label Epoch- Period 2||0||
59585752|NCT02678312|75692618|FG001|STARTED|Part 1 Open Label Epoch- Period 2|Out of 26 participants enrolled in Part 1, 18 participants were dosed in dose cohort 2 to receive LCZ696 1.6 mg or 3.1 mg dose in Period 2. A total of 9 participants who received LCZ696 in Dose cohort 1, received drug further in dose cohort 2 and 9 others received drug directly in Period 2 were included in Dose cohort 2.|18||
59585753|NCT02678312|75692619|FG002|STARTED|Part 1 Open Label Epoch- Period 2|2 participants who were dosed in Dose Cohort 2 at dose level 3.1 mg/kg were then prescribed one dose of study drug at dose level 0.8 mg/kg within period 2 and were therefore grouped under Dose cohort S.|2||
59585754|NCT02678312|75692620|FG003|STARTED|Part 1 Open Label Epoch- Period 2||0||
59585755|NCT02678312|75692621|FG004|STARTED|Part 1 Open Label Epoch- Period 2||0||
59585756|NCT02678312|75692617|FG000|COMPLETED|Part 1 Open Label Epoch- Period 2||0||
59585757|NCT02678312|75692618|FG001|COMPLETED|Part 1 Open Label Epoch- Period 2||18||
59585758|NCT02678312|75692619|FG002|COMPLETED|Part 1 Open Label Epoch- Period 2||2||
59854618|NCT03394924|75979188|FG000|STARTED|Overall Study||31||
59854619|NCT03394924|75979189|FG001|STARTED|Overall Study||28||
59585759|NCT02678312|75692620|FG003|COMPLETED|Part 1 Open Label Epoch- Period 2||0||
59585760|NCT02678312|75692621|FG004|COMPLETED|Part 1 Open Label Epoch- Period 2||0||
59585761|NCT02678312|75692617|FG000|NOT COMPLETED|Part 1 Open Label Epoch- Period 2||0||
59585762|NCT02678312|75692618|FG001|NOT COMPLETED|Part 1 Open Label Epoch- Period 2||0||
59585763|NCT02678312|75692619|FG002|NOT COMPLETED|Part 1 Open Label Epoch- Period 2||0||
59585764|NCT02678312|75692620|FG003|NOT COMPLETED|Part 1 Open Label Epoch- Period 2||0||
59585765|NCT02678312|75692621|FG004|NOT COMPLETED|Part 1 Open Label Epoch- Period 2||0||
59585766|NCT02678312|75692617|FG000|STARTED|Part 2 Double Blind Epoch||0|Out of 377 participants enrolled in Part 2 of the study, 2 participants in the enalapril arm were randomized in error and did not receive the study medication. Therefore, 375 of 377 randomized participants received study medication.|
59585767|NCT02678312|75692618|FG001|STARTED|Part 2 Double Blind Epoch||0|Out of 377 participants enrolled in Part 2 of the study, 2 participants in the enalapril arm were randomized in error and did not receive the study medication. Therefore, 375 of 377 randomized participants received study medication.|
59585768|NCT02678312|75692619|FG002|STARTED|Part 2 Double Blind Epoch||0|Out of 377 participants enrolled in Part 2 of the study, 2 participants in the enalapril arm were randomized in error and did not receive the study medication. Therefore, 375 of 377 randomized participants received study medication.|
59585769|NCT02678312|75692620|FG003|STARTED|Part 2 Double Blind Epoch||187|Out of 377 participants enrolled in Part 2 of the study, 2 participants in the enalapril arm were randomized in error and did not receive the study medication. Therefore, 375 of 377 randomized participants received study medication.|
59585770|NCT02678312|75692621|FG004|STARTED|Part 2 Double Blind Epoch||188|Out of 377 participants enrolled in Part 2 of the study, 2 participants in the enalapril arm were randomized in error and did not receive the study medication. Therefore, 375 of 377 randomized participants received study medication.|
59585771|NCT02678312|75692617|FG000|COMPLETED|Part 2 Double Blind Epoch||0||
59585772|NCT02678312|75692618|FG001|COMPLETED|Part 2 Double Blind Epoch||0||
59585773|NCT02678312|75692619|FG002|COMPLETED|Part 2 Double Blind Epoch||0||
59585774|NCT02678312|75692620|FG003|COMPLETED|Part 2 Double Blind Epoch||169||
59585775|NCT02678312|75692621|FG004|COMPLETED|Part 2 Double Blind Epoch||164||
59585776|NCT02678312|75692617|FG000|NOT COMPLETED|Part 2 Double Blind Epoch||0||
59585777|NCT02678312|75692618|FG001|NOT COMPLETED|Part 2 Double Blind Epoch||0||
59585778|NCT02678312|75692619|FG002|NOT COMPLETED|Part 2 Double Blind Epoch||0||
59585779|NCT02678312|75692620|FG003|NOT COMPLETED|Part 2 Double Blind Epoch||18||
59585780|NCT02678312|75692621|FG004|NOT COMPLETED|Part 2 Double Blind Epoch||24||
59585781|NCT02466230|75692642|FG000|STARTED|Overall Study||28||
59585782|NCT02466230|75692642|FG000|COMPLETED|Overall Study||28||
59585783|NCT02466230|75692642|FG000|NOT COMPLETED|Overall Study||0||
59585784|NCT02467166|75692646|FG000|STARTED|Overall Study||36||
59585785|NCT02467166|75692646|FG000|COMPLETED|Overall Study||36||
59585786|NCT02467166|75692646|FG000|NOT COMPLETED|Overall Study||0||
59585787|NCT02468570|75692652|FG000|STARTED|Overall Study||6||
59585788|NCT02468570|75692653|FG001|STARTED|Overall Study||3||
59585789|NCT02468570|75692652|FG000|COMPLETED|Overall Study||6||
59585790|NCT02468570|75692653|FG001|COMPLETED|Overall Study||3||
59585791|NCT02468570|75692652|FG000|NOT COMPLETED|Overall Study||0||
59585792|NCT02468570|75692653|FG001|NOT COMPLETED|Overall Study||0||
59585793|NCT02468804|75692661|FG000|STARTED|Overall Study||37||
59585794|NCT02468804|75692662|FG001|STARTED|Overall Study||58||
59585795|NCT02468804|75692661|FG000|COMPLETED|Overall Study||36||
59585796|NCT02468804|75692662|FG001|COMPLETED|Overall Study||50||
59585797|NCT02468804|75692661|FG000|NOT COMPLETED|Overall Study||1||
59585798|NCT02468804|75692662|FG001|NOT COMPLETED|Overall Study||8||
59585799|NCT02469116|75692668|FG000|STARTED|Overall Study||18||
59585800|NCT02469116|75692668|FG000|COMPLETED|Overall Study||18||
59585801|NCT02469116|75692668|FG000|NOT COMPLETED|Overall Study||0||
59585802|NCT02470910|75692672|FG000|STARTED|Overall Study||15||
59585803|NCT02470910|75692672|FG000|COMPLETED|Overall Study||15||
59585804|NCT02470910|75692672|FG000|NOT COMPLETED|Overall Study||0||
59585805|NCT02473718|75692681|FG000|STARTED|Overall Study||41||
59585806|NCT02473718|75692682|FG001|STARTED|Overall Study||41||
59585807|NCT02473718|75692681|FG000|COMPLETED|Overall Study||41||
59585808|NCT02473718|75692682|FG001|COMPLETED|Overall Study||41||
59585809|NCT02473718|75692681|FG000|NOT COMPLETED|Overall Study||0||
59585810|NCT02473718|75692682|FG001|NOT COMPLETED|Overall Study||0||
59585811|NCT02474498|75692691|FG000|STARTED|Overall Study||13||
59585812|NCT02474498|75692692|FG001|STARTED|Overall Study||14||
59585813|NCT02474498|75692693|FG002|STARTED|Overall Study||14||
59585814|NCT02474498|75692691|FG000|COMPLETED|Overall Study||13||
59585815|NCT02474498|75692692|FG001|COMPLETED|Overall Study||14||
59585816|NCT02474498|75692693|FG002|COMPLETED|Overall Study||14||
59585817|NCT02474498|75692691|FG000|NOT COMPLETED|Overall Study||0||
59585818|NCT02474498|75692692|FG001|NOT COMPLETED|Overall Study||0||
59585819|NCT02474498|75692693|FG002|NOT COMPLETED|Overall Study||0||
59585820|NCT02476448|75692709|FG000|STARTED|Overall Study|one given phenazopyridine pre-op and was analyzed in her randomization group per intention to treat|44||
59585821|NCT02476448|75692710|FG001|STARTED|Overall Study||44||
59585822|NCT02476448|75692711|FG002|STARTED|Overall Study||44||
59585823|NCT02476448|75692712|FG003|STARTED|Overall Study||44||
59585824|NCT02476448|75692709|FG000|COMPLETED|Overall Study||44||
59585825|NCT02476448|75692710|FG001|COMPLETED|Overall Study||44||
59585826|NCT02476448|75692711|FG002|COMPLETED|Overall Study||44||
59585827|NCT02476448|75692712|FG003|COMPLETED|Overall Study||44||
59585828|NCT02476448|75692709|FG000|NOT COMPLETED|Overall Study||0||
59585829|NCT02476448|75692710|FG001|NOT COMPLETED|Overall Study||0||
59585830|NCT02476448|75692711|FG002|NOT COMPLETED|Overall Study||0||
59585831|NCT02476448|75692712|FG003|NOT COMPLETED|Overall Study||0||
59585832|NCT02483468|75692724|FG000|STARTED|Overall Study||65||
59585833|NCT02483468|75692725|FG001|STARTED|Overall Study||51||
59585834|NCT02483468|75692724|FG000|COMPLETED|Overall Study||46|completed defined as followed up to 3 months|
59585835|NCT02483468|75692725|FG001|COMPLETED|Overall Study||30|completed defined as followed up to 3 months|
59585836|NCT02483468|75692724|FG000|NOT COMPLETED|Overall Study||19||
59585837|NCT02483468|75692725|FG001|NOT COMPLETED|Overall Study||21||
59585838|NCT02480582|75692732|FG000|STARTED|Overall Study||7||
59585839|NCT02480582|75692733|FG001|STARTED|Overall Study||7||
59585840|NCT02480582|75692734|FG002|STARTED|Overall Study||7||
59585841|NCT02480582|75692735|FG003|STARTED|Overall Study||7||
59585842|NCT02480582|75692736|FG004|STARTED|Overall Study||7||
59585843|NCT02480582|75692737|FG005|STARTED|Overall Study||7||
59585844|NCT02480582|75692732|FG000|COMPLETED|Overall Study||7||
59585845|NCT02480582|75692733|FG001|COMPLETED|Overall Study||7||
59585846|NCT02480582|75692734|FG002|COMPLETED|Overall Study||7||
59585847|NCT02480582|75692735|FG003|COMPLETED|Overall Study||7||
59585848|NCT02480582|75692736|FG004|COMPLETED|Overall Study||7||
59585849|NCT02480582|75692737|FG005|COMPLETED|Overall Study||7||
59585850|NCT02480582|75692732|FG000|NOT COMPLETED|Overall Study||0||
59585851|NCT02480582|75692733|FG001|NOT COMPLETED|Overall Study||0||
59585852|NCT02480582|75692734|FG002|NOT COMPLETED|Overall Study||0||
59585853|NCT02480582|75692735|FG003|NOT COMPLETED|Overall Study||0||
59585854|NCT02480582|75692736|FG004|NOT COMPLETED|Overall Study||0||
59585855|NCT02480582|75692737|FG005|NOT COMPLETED|Overall Study||0||
59585856|NCT02415842|75692763|FG000|STARTED|Overall Study||29||
59585857|NCT02415842|75692764|FG001|STARTED|Overall Study||29||
59585858|NCT02415842|75692765|FG002|STARTED|Overall Study||29||
59585859|NCT02415842|75692766|FG003|STARTED|Overall Study||27||
59585860|NCT02415842|75692767|FG004|STARTED|Overall Study||30||
59585861|NCT02415842|75692768|FG005|STARTED|Overall Study||30||
59585862|NCT02415842|75692769|FG006|STARTED|Overall Study||30||
59585863|NCT02415842|75692770|FG007|STARTED|Overall Study||26||
59585864|NCT02415842|75692771|FG008|STARTED|Overall Study||29||
59585865|NCT02415842|75692772|FG009|STARTED|Overall Study||53||
59585866|NCT02415842|75692773|FG010|STARTED|Overall Study||49||
59585867|NCT02415842|75692774|FG011|STARTED|Overall Study||33||
59585868|NCT02415842|75692775|FG012|STARTED|Overall Study||20||
59585869|NCT02415842|75692763|FG000|COMPLETED|Overall Study||29||
59585870|NCT02415842|75692764|FG001|COMPLETED|Overall Study||29||
59585871|NCT02415842|75692765|FG002|COMPLETED|Overall Study||29||
59585872|NCT02415842|75692766|FG003|COMPLETED|Overall Study||27||
59585873|NCT02415842|75692767|FG004|COMPLETED|Overall Study||30||
59854620|NCT03394924|75979190|FG002|STARTED|Overall Study||9||
59854621|NCT03394924|75979188|FG000|COMPLETED|Overall Study||28||
59854622|NCT03394924|75979189|FG001|COMPLETED|Overall Study||22||
59854623|NCT03394924|75979190|FG002|COMPLETED|Overall Study||9||
59854624|NCT03394924|75979188|FG000|NOT COMPLETED|Overall Study||3||
59585874|NCT02415842|75692768|FG005|COMPLETED|Overall Study||30||
59585875|NCT02415842|75692769|FG006|COMPLETED|Overall Study||30||
59585876|NCT02415842|75692770|FG007|COMPLETED|Overall Study||26||
59585877|NCT02415842|75692771|FG008|COMPLETED|Overall Study||29||
59585878|NCT02415842|75692772|FG009|COMPLETED|Overall Study||53||
59585879|NCT02415842|75692773|FG010|COMPLETED|Overall Study||49||
59585880|NCT02415842|75692774|FG011|COMPLETED|Overall Study||33||
59585881|NCT02415842|75692775|FG012|COMPLETED|Overall Study||20||
59724963|NCT01989598|75843732|FG000|Dual Therapy With Trametinib and GSK2141795|Overall Study|Patients with progressive disease or who achieve less than PR after 4 courses also received Akt inhibitor GSK2141795 PO daily on days 1-28 along with Tremetinib|12||
59724964|NCT01989598|75843732|FG000|COMPLETED|Overall Study|Note: 25 patients enrolled, however, one patient unevaluable was not included in analysis|25||
59724965|NCT01989598|75843732|FG000|NOT COMPLETED|Overall Study||0||
59724966|NCT01112579|75843743|FG000|STARTED|Overall Study||42||
59724967|NCT01112579|75843744|FG001|STARTED|Overall Study||24||
59585882|NCT02415842|75692763|FG000|NOT COMPLETED|Overall Study||0||
59724968|NCT01112579|75843743|FG000|COMPLETED|Overall Study||41||
59724969|NCT01112579|75843744|FG001|COMPLETED|Overall Study||21||
59724970|NCT01112579|75843743|FG000|NOT COMPLETED|Overall Study||1||
59854625|NCT03394924|75979189|FG001|NOT COMPLETED|Overall Study||6||
59854626|NCT03394924|75979190|FG002|NOT COMPLETED|Overall Study||0||
59854627|NCT00345293|75979200|FG000|STARTED|Overall Study||10||
59585883|NCT02415842|75692764|FG001|NOT COMPLETED|Overall Study||0||
59585884|NCT02415842|75692765|FG002|NOT COMPLETED|Overall Study||0||
59585885|NCT02415842|75692766|FG003|NOT COMPLETED|Overall Study||0||
59585886|NCT02415842|75692767|FG004|NOT COMPLETED|Overall Study||0||
59585887|NCT02415842|75692768|FG005|NOT COMPLETED|Overall Study||0||
59585888|NCT02415842|75692769|FG006|NOT COMPLETED|Overall Study||0||
59585889|NCT02415842|75692770|FG007|NOT COMPLETED|Overall Study||0||
59585890|NCT02415842|75692771|FG008|NOT COMPLETED|Overall Study||0||
59585891|NCT02415842|75692772|FG009|NOT COMPLETED|Overall Study||0||
59585892|NCT02415842|75692773|FG010|NOT COMPLETED|Overall Study||0||
59585893|NCT02415842|75692774|FG011|NOT COMPLETED|Overall Study||0||
59585894|NCT02415842|75692775|FG012|NOT COMPLETED|Overall Study||0||
59585895|NCT02481206|75692822|FG000|STARTED|Overall Study||34||
59585896|NCT02481206|75692823|FG001|STARTED|Overall Study||32||
59585897|NCT02481206|75692822|FG000|COMPLETED|Overall Study||29||
59585898|NCT02481206|75692823|FG001|COMPLETED|Overall Study||31||
59585899|NCT02481206|75692822|FG000|NOT COMPLETED|Overall Study||5||
59585900|NCT02481206|75692823|FG001|NOT COMPLETED|Overall Study||1||
59585901|NCT02415998|75692831|FG000|STARTED|Overall Study||25||
59585902|NCT02415998|75692831|FG000|COMPLETED|Overall Study||20||
59585903|NCT02415998|75692831|FG000|NOT COMPLETED|Overall Study||5||
59585904|NCT02481440|75692835|FG000|STARTED|Overall Study||102||
59585905|NCT02481440|75692835|FG000|COMPLETED|Overall Study||41||
59585906|NCT02481440|75692835|FG000|NOT COMPLETED|Overall Study||61||
59585907|NCT02481596|75692842|FG000|STARTED|Overall Study||126||
59585908|NCT02481596|75692843|FG001|STARTED|Overall Study||127||
59585909|NCT02481596|75692844|FG002|STARTED|Overall Study||253||
59585910|NCT02481596|75692842|FG000|COMPLETED|Overall Study||123||
59585911|NCT02481596|75692843|FG001|COMPLETED|Overall Study||126||
59585912|NCT02481596|75692844|FG002|COMPLETED|Overall Study||245||
59585913|NCT02481596|75692842|FG000|NOT COMPLETED|Overall Study||3||
59585914|NCT02481596|75692843|FG001|NOT COMPLETED|Overall Study||1||
59585915|NCT02481596|75692844|FG002|NOT COMPLETED|Overall Study||8||
59585916|NCT02256631|75692859|FG000|STARTED|Overall Study||13||
59585917|NCT02256631|75692860|FG001|STARTED|Overall Study||14||
59585918|NCT02256631|75692861|FG002|STARTED|Overall Study||13||
59585919|NCT02256631|75692862|FG003|STARTED|Overall Study||10||
59585920|NCT02256631|75692863|FG004|STARTED|Overall Study||11||
59585921|NCT02256631|75692864|FG005|STARTED|Overall Study||11||
59585922|NCT02256631|75692865|FG006|STARTED|Overall Study||11||
59585923|NCT02256631|75692859|FG000|COMPLETED|Overall Study||12||
59585924|NCT02256631|75692860|FG001|COMPLETED|Overall Study||11||
59585925|NCT02256631|75692861|FG002|COMPLETED|Overall Study||13||
59585926|NCT02256631|75692862|FG003|COMPLETED|Overall Study||6||
59585927|NCT02256631|75692863|FG004|COMPLETED|Overall Study||10||
59585928|NCT02256631|75692864|FG005|COMPLETED|Overall Study||6||
59585929|NCT02256631|75692865|FG006|COMPLETED|Overall Study||7||
59585930|NCT02256631|75692859|FG000|NOT COMPLETED|Overall Study||1||
59585931|NCT02256631|75692860|FG001|NOT COMPLETED|Overall Study||3||
59585932|NCT02256631|75692861|FG002|NOT COMPLETED|Overall Study||0||
59585933|NCT02256631|75692862|FG003|NOT COMPLETED|Overall Study||4||
59585934|NCT02256631|75692863|FG004|NOT COMPLETED|Overall Study||1||
59585935|NCT02256631|75692864|FG005|NOT COMPLETED|Overall Study||5||
59585936|NCT02256631|75692865|FG006|NOT COMPLETED|Overall Study||4||
59724971|NCT01112579|75843744|FG001|NOT COMPLETED|Overall Study||3||
59724972|NCT01112267|75843752|FG000|STARTED|Overall Study||126||
59724973|NCT01112267|75843753|FG001|STARTED|Overall Study||122||
59724974|NCT01112267|75843752|FG000|Treated|Overall Study||125||
59724975|NCT01112267|75843753|FG001|Treated|Overall Study||120||
59724976|NCT01112267|75843752|FG000|COMPLETED|Overall Study||92||
59724977|NCT01112267|75843753|FG001|COMPLETED|Overall Study||104||
59724978|NCT01112267|75843752|FG000|NOT COMPLETED|Overall Study||34||
59724979|NCT01112267|75843753|FG001|NOT COMPLETED|Overall Study||18||
59724980|NCT00925587|75843761|FG000|STARTED|Overall Study||178||
59724981|NCT00925587|75843762|FG001|STARTED|Overall Study||180||
59724982|NCT00925587|75843761|FG000|COMPLETED|Overall Study||142||
59724983|NCT00925587|75843762|FG001|COMPLETED|Overall Study||155||
59724984|NCT00925587|75843761|FG000|NOT COMPLETED|Overall Study||36||
59724985|NCT00925587|75843762|FG001|NOT COMPLETED|Overall Study||25||
59724986|NCT00193414|75843768|FG000|STARTED|Overall Study||72||
59724987|NCT00193414|75843768|FG000|COMPLETED|Overall Study||14||
59724988|NCT00193414|75843768|FG000|NOT COMPLETED|Overall Study||58||
59724989|NCT00928707|75843774|FG000|STARTED|Overall Study||23||
59724990|NCT00928707|75843775|FG001|STARTED|Overall Study||22||
59724991|NCT00928707|75843774|FG000|COMPLETED|Overall Study||22||
59724992|NCT00928707|75843775|FG001|COMPLETED|Overall Study||22||
59724993|NCT00928707|75843774|FG000|NOT COMPLETED|Overall Study||1||
59724994|NCT00928707|75843775|FG001|NOT COMPLETED|Overall Study||0||
59724995|NCT00930813|75843783|FG000|STARTED|Overall Study||49||
59724996|NCT00930813|75843784|FG001|STARTED|Overall Study||52||
59724997|NCT00930813|75843783|FG000|COMPLETED|Overall Study||41||
59724998|NCT00930813|75843784|FG001|COMPLETED|Overall Study||38||
59724999|NCT00930813|75843783|FG000|NOT COMPLETED|Overall Study||8||
59725000|NCT00930813|75843784|FG001|NOT COMPLETED|Overall Study||14||
59725001|NCT00930579|75843792|FG000|STARTED|Overall Study||35||
59725002|NCT00930579|75843792|FG000|COMPLETED|Overall Study||33||
59725003|NCT00930579|75843792|FG000|NOT COMPLETED|Overall Study||2||
59725004|NCT00925353|75843796|FG000|STARTED|Overall Study||13||
59725005|NCT00925353|75843796|FG000|COMPLETED|Overall Study||10||
59725006|NCT00925353|75843796|FG000|NOT COMPLETED|Overall Study||3||
59725007|NCT03140488|75843804|FG000|STARTED|Overall Study||35||
59725008|NCT03140488|75843805|FG001|STARTED|Overall Study||35||
59725009|NCT03140488|75843806|FG002|STARTED|Overall Study||35||
59725010|NCT03140488|75843807|FG003|STARTED|Overall Study||35||
59725011|NCT03140488|75843804|FG000|COMPLETED|Overall Study||35||
59725012|NCT03140488|75843805|FG001|COMPLETED|Overall Study||35||
59725013|NCT03140488|75843806|FG002|COMPLETED|Overall Study||35||
59585937|NCT02519036|75692889|FG000|STARTED|Overall Study||12||
59585938|NCT02519036|75692890|FG001|STARTED|Overall Study||3||
59585939|NCT02519036|75692891|FG002|STARTED|Overall Study||6||
59585940|NCT02519036|75692892|FG003|STARTED|Overall Study||6||
59585941|NCT02519036|75692893|FG004|STARTED|Overall Study||9||
59585942|NCT02519036|75692894|FG005|STARTED|Overall Study||10||
59585943|NCT02519036|75692889|FG000|COMPLETED|Overall Study||12||
59585944|NCT02519036|75692890|FG001|COMPLETED|Overall Study||3||
59585945|NCT02519036|75692891|FG002|COMPLETED|Overall Study||6||
59585946|NCT02519036|75692892|FG003|COMPLETED|Overall Study||6||
59585947|NCT02519036|75692893|FG004|COMPLETED|Overall Study||9||
59585948|NCT02519036|75692894|FG005|COMPLETED|Overall Study||10||
59585949|NCT02519036|75692889|FG000|NOT COMPLETED|Overall Study||0||
59585950|NCT02519036|75692890|FG001|NOT COMPLETED|Overall Study||0||
59585951|NCT02519036|75692891|FG002|NOT COMPLETED|Overall Study||0||
59585952|NCT02519036|75692892|FG003|NOT COMPLETED|Overall Study||0||
59585953|NCT02519036|75692893|FG004|NOT COMPLETED|Overall Study||0||
59585954|NCT02519036|75692894|FG005|NOT COMPLETED|Overall Study||0||
59585955|NCT02520518|75692917|FG000|STARTED|Overall Study||3||
59585956|NCT02520518|75692918|FG001|STARTED|Overall Study||1||
59585957|NCT02520518|75692919|FG002|STARTED|Overall Study||3||
59585958|NCT02520518|75692920|FG003|STARTED|Overall Study||2||
59585959|NCT02520518|75692917|FG000|COMPLETED|Overall Study||3||
59585960|NCT02520518|75692918|FG001|COMPLETED|Overall Study||1||
59585961|NCT02520518|75692919|FG002|COMPLETED|Overall Study||1||
59585962|NCT02520518|75692920|FG003|COMPLETED|Overall Study||1||
59585963|NCT02520518|75692917|FG000|NOT COMPLETED|Overall Study||0||
59585964|NCT02520518|75692918|FG001|NOT COMPLETED|Overall Study||0||
59585965|NCT02520518|75692919|FG002|NOT COMPLETED|Overall Study||2||
59585966|NCT02520518|75692920|FG003|NOT COMPLETED|Overall Study||1||
59585967|NCT02521766|75692934|FG000|STARTED|Overall Study||49||
59585968|NCT02521766|75692935|FG001|STARTED|Overall Study||65||
59585969|NCT02521766|75692934|FG000|Per Protocol|Overall Study||47|Successful HMIOL implantation without a major protocol deviation|
59585970|NCT02521766|75692935|FG001|Per Protocol|Overall Study||65|Successful HMIOL implantation without a major protocol deviation|
59585971|NCT02521766|75692934|FG000|COMPLETED|Overall Study||44||
59585972|NCT02521766|75692935|FG001|COMPLETED|Overall Study||62||
59585973|NCT02521766|75692934|FG000|NOT COMPLETED|Overall Study||5||
59585974|NCT02521766|75692935|FG001|NOT COMPLETED|Overall Study||3||
59585975|NCT02482610|75692952|FG000|STARTED|Overall Study||4||
59585976|NCT02482610|75692953|FG001|STARTED|Overall Study||5||
59585977|NCT02482610|75692954|FG002|STARTED|Overall Study||2||
59585978|NCT02482610|75692955|FG003|STARTED|Overall Study||3||
59585979|NCT02482610|75692956|FG004|STARTED|Overall Study||3||
59585980|NCT02482610|75692957|FG005|STARTED|Overall Study||5||
59585981|NCT02482610|75692952|FG000|COMPLETED|Overall Study||4||
59585982|NCT02482610|75692953|FG001|COMPLETED|Overall Study||5||
59585983|NCT02482610|75692954|FG002|COMPLETED|Overall Study||2||
59585984|NCT02482610|75692955|FG003|COMPLETED|Overall Study||3||
59585985|NCT02482610|75692956|FG004|COMPLETED|Overall Study||3||
59585986|NCT02482610|75692957|FG005|COMPLETED|Overall Study||5||
59585987|NCT02482610|75692952|FG000|NOT COMPLETED|Overall Study||0||
59585988|NCT02482610|75692953|FG001|NOT COMPLETED|Overall Study||0||
59585989|NCT02482610|75692954|FG002|NOT COMPLETED|Overall Study||0||
59585990|NCT02482610|75692955|FG003|NOT COMPLETED|Overall Study||0||
59585991|NCT02482610|75692956|FG004|NOT COMPLETED|Overall Study||0||
59585992|NCT02482610|75692957|FG005|NOT COMPLETED|Overall Study||0||
59585993|NCT02483000|75692968|FG000|STARTED|Overall Study||3||
59585994|NCT02483000|75692968|FG000|COMPLETED|Overall Study||3||
59585995|NCT02483000|75692968|FG000|NOT COMPLETED|Overall Study||0||
59585996|NCT02279745|75692975|FG000|STARTED|Overall Study||45||
59585997|NCT02279745|75692975|FG000|COMPLETED|Overall Study||25||
59585998|NCT02279745|75692975|FG000|NOT COMPLETED|Overall Study||20||
59585999|NCT02484092|75692979|FG000|STARTED|Overall Study||15||
59586000|NCT02484092|75692979|FG000|COMPLETED|Overall Study||15||
59586001|NCT02484092|75692979|FG000|NOT COMPLETED|Overall Study||0||
59586002|NCT02420210|75692983|FG000|STARTED|Overall Study||2||
59586003|NCT02420210|75692983|FG000|COMPLETED|Overall Study||2||
59586004|NCT02420210|75692983|FG000|NOT COMPLETED|Overall Study||0||
59586005|NCT02485964|75692987|FG000|STARTED|Overall Study||10||
59586006|NCT02485964|75692987|FG000|COMPLETED|Overall Study||10||
59586007|NCT02485964|75692987|FG000|NOT COMPLETED|Overall Study||0||
59586008|NCT02487056|75692991|FG000|STARTED|Overall Study||1622||
59586009|NCT02487056|75692991|FG000|COMPLETED|Overall Study||1606||
59586010|NCT02487056|75692991|FG000|NOT COMPLETED|Overall Study||16||
59586011|NCT02524106|75692998|FG000|STARTED|Overall Study||6||
59586012|NCT02524106|75692999|FG001|STARTED|Overall Study||5||
59586013|NCT02524106|75692998|FG000|COMPLETED|Overall Study||6||
59586014|NCT02524106|75692999|FG001|COMPLETED|Overall Study||5||
59586015|NCT02524106|75692998|FG000|NOT COMPLETED|Overall Study||0||
59586016|NCT02524106|75692999|FG001|NOT COMPLETED|Overall Study||0||
59586017|NCT02524418|75693005|FG000|STARTED|Overall Study||88||
59586018|NCT02524418|75693005|FG000|COMPLETED|Overall Study||75||
59586019|NCT02524418|75693005|FG000|NOT COMPLETED|Overall Study||13||
59725014|NCT03140488|75843807|FG003|COMPLETED|Overall Study||35||
59586020|NCT01761877|75693014|FG000|STARTED|Overall Study||58|A total of 58 patients enrolled and initiated a 4-month NSAID washout, of which 50 started sulindac treatment and 43 completed to 12 months.|
59586021|NCT01761877|75693015|FG001|STARTED|Overall Study|A total of 56 patients enrolled to observation but 6 withdrew or became ineligible before their baseline MRI.|56|A total of 58 patients enrolled and initiated a 4-month NSAID washout, of which 50 started sulindac treatment and 43 completed to 12 months.|
59586022|NCT01761877|75693014|FG000|COMPLETED|Overall Study||43||
59586023|NCT01761877|75693015|FG001|COMPLETED|Overall Study||40||
59586024|NCT01761877|75693014|FG000|NOT COMPLETED|Overall Study||15||
59586025|NCT01761877|75693015|FG001|NOT COMPLETED|Overall Study||16||
59586026|NCT02421146|75693026|FG000|STARTED|Overall Study||2||
59586027|NCT02421146|75693027|FG001|STARTED|Overall Study||4||
59586028|NCT02421146|75693028|FG002|STARTED|Overall Study||3||
59586029|NCT02421146|75693029|FG003|STARTED|Overall Study||3||
59586030|NCT02421146|75693026|FG000|COMPLETED|Overall Study||2||
59586031|NCT02421146|75693027|FG001|COMPLETED|Overall Study||4||
59586032|NCT02421146|75693028|FG002|COMPLETED|Overall Study||3||
59586033|NCT02421146|75693029|FG003|COMPLETED|Overall Study||3||
59586034|NCT02421146|75693026|FG000|NOT COMPLETED|Overall Study||0||
59586035|NCT02421146|75693027|FG001|NOT COMPLETED|Overall Study||0||
59586036|NCT02421146|75693028|FG002|NOT COMPLETED|Overall Study||0||
59586037|NCT02421146|75693029|FG003|NOT COMPLETED|Overall Study||0||
59586038|NCT02488070|75693039|FG000|STARTED|Overall Study||10||
59586039|NCT02488070|75693039|FG000|COMPLETED|Overall Study||10||
59586040|NCT02488070|75693039|FG000|NOT COMPLETED|Overall Study||0||
59586041|NCT02421224|75693053|FG000|STARTED|Overall Study||444||12
59586042|NCT02421224|75693054|FG001|STARTED|Overall Study||397||11
59586043|NCT02421224|75693055|FG002|STARTED|Overall Study||508||11
59586044|NCT02421224|75693056|FG003|STARTED|Overall Study||482||11
59586045|NCT02421224|75693057|FG004|STARTED|Overall Study||495||11
59586046|NCT02421224|75693058|FG005|STARTED|Overall Study||515||11
59586047|NCT02421224|75693059|FG006|STARTED|Overall Study||489||11
59586048|NCT02421224|75693060|FG007|STARTED|Overall Study||364||11
59586049|NCT02421224|75693061|FG008|STARTED|Overall Study||496||12
59586050|NCT02421224|75693053|FG000|COMPLETED|Overall Study||442||12
59586051|NCT02421224|75693054|FG001|COMPLETED|Overall Study||394||11
59586052|NCT02421224|75693055|FG002|COMPLETED|Overall Study||507||11
59586053|NCT02421224|75693056|FG003|COMPLETED|Overall Study||479||11
59586054|NCT02421224|75693057|FG004|COMPLETED|Overall Study||491||11
59586055|NCT02421224|75693058|FG005|COMPLETED|Overall Study||513||11
59586056|NCT02421224|75693059|FG006|COMPLETED|Overall Study||489||11
59586057|NCT02421224|75693060|FG007|COMPLETED|Overall Study||362||11
59586058|NCT02421224|75693061|FG008|COMPLETED|Overall Study||495||12
59586059|NCT02421224|75693053|FG000|NOT COMPLETED|Overall Study||2||0
59586060|NCT02421224|75693054|FG001|NOT COMPLETED|Overall Study||3||0
59586061|NCT02421224|75693055|FG002|NOT COMPLETED|Overall Study||1||0
59586062|NCT02421224|75693056|FG003|NOT COMPLETED|Overall Study||3||0
59586063|NCT02421224|75693057|FG004|NOT COMPLETED|Overall Study||4||0
59586064|NCT02421224|75693058|FG005|NOT COMPLETED|Overall Study||2||0
59586065|NCT02421224|75693059|FG006|NOT COMPLETED|Overall Study||0||0
59586066|NCT02421224|75693060|FG007|NOT COMPLETED|Overall Study||2||0
59586067|NCT02421224|75693061|FG008|NOT COMPLETED|Overall Study||1||0
59586068|NCT02422940|75693083|FG000|STARTED|Overall Study||152||
59586069|NCT02422940|75693084|FG001|STARTED|Overall Study||142||
59586070|NCT02422940|75693083|FG000|COMPLETED|Overall Study||31||
59586071|NCT02422940|75693084|FG001|COMPLETED|Overall Study||21||
59586072|NCT02422940|75693083|FG000|NOT COMPLETED|Overall Study||121||
59586073|NCT02422940|75693084|FG001|NOT COMPLETED|Overall Study||121||
59586074|NCT02526680|75693090|FG000|STARTED|Overall Study||27||
59586075|NCT02526680|75693090|FG000|COMPLETED|Overall Study||27||
59586076|NCT02526680|75693090|FG000|NOT COMPLETED|Overall Study||0||
59586077|NCT00588523|75693095|FG000|STARTED|Overall Study||60||
59586078|NCT00588523|75693095|FG000|COMPLETED|Overall Study||57||
59586079|NCT00588523|75693095|FG000|NOT COMPLETED|Overall Study||3||
59586080|NCT02527694|75693101|FG000|STARTED|Overall Study||20||
59586081|NCT02527694|75693102|FG001|STARTED|Overall Study||29||
59586082|NCT02527694|75693101|FG000|COMPLETED|Overall Study||10||
59586083|NCT02527694|75693102|FG001|COMPLETED|Overall Study||21||
59586084|NCT02527694|75693101|FG000|NOT COMPLETED|Overall Study||10||
59586085|NCT02527694|75693102|FG001|NOT COMPLETED|Overall Study||8||
59586086|NCT02440633|75693110|FG000|STARTED|Overall Study||8||
59586087|NCT02440633|75693110|FG000|COMPLETED|Overall Study||8||
59586088|NCT02440633|75693110|FG000|NOT COMPLETED|Overall Study||0||
59586089|NCT00534703|75693120|FG000|STARTED|Overall Study||4||
59586090|NCT00534703|75693121|FG001|STARTED|Overall Study||1||
59586091|NCT00534703|75693120|FG000|COMPLETED|Overall Study||4||
59586092|NCT00534703|75693121|FG001|COMPLETED|Overall Study||1||
59586093|NCT00534703|75693120|FG000|NOT COMPLETED|Overall Study||0||
59586094|NCT00534703|75693121|FG001|NOT COMPLETED|Overall Study||0||
59586095|NCT00430183|75693131|FG000|STARTED|Overall Study||391||
59586096|NCT00430183|75693132|FG001|STARTED|Overall Study||397||
59586097|NCT00430183|75693131|FG000|COMPLETED|Overall Study||391||
59586098|NCT00430183|75693132|FG001|COMPLETED|Overall Study||397||
59586099|NCT00430183|75693131|FG000|NOT COMPLETED|Overall Study||0||
59586100|NCT00430183|75693132|FG001|NOT COMPLETED|Overall Study||0||
59586101|NCT02443519|75693142|FG000|STARTED|Overall Study||31||
59586102|NCT02443519|75693143|FG001|STARTED|Overall Study||29||
59586103|NCT02443519|75693142|FG000|COMPLETED|Overall Study||29||
59586104|NCT02443519|75693143|FG001|COMPLETED|Overall Study||26||
59586105|NCT02443519|75693142|FG000|NOT COMPLETED|Overall Study||2||
59586106|NCT02443519|75693143|FG001|NOT COMPLETED|Overall Study||3||
59586107|NCT02444143|75693151|FG000|STARTED|Overall Study||10||
59586108|NCT02444143|75693152|FG001|STARTED|Overall Study||10||
59586109|NCT02444143|75693151|FG000|COMPLETED|Overall Study||10||
59586110|NCT02444143|75693152|FG001|COMPLETED|Overall Study|1 patient withdrawal|9||
59586111|NCT02444143|75693151|FG000|NOT COMPLETED|Overall Study||0||
59586112|NCT02444143|75693152|FG001|NOT COMPLETED|Overall Study||1||
59586113|NCT02445625|75693160|FG000|STARTED|Overall Study||15||
59586114|NCT02445625|75693160|FG000|COMPLETED|Overall Study||15||
59586115|NCT02445625|75693160|FG000|NOT COMPLETED|Overall Study||0||
59586116|NCT02445859|75693167|FG000|STARTED|Overall Study||45||
59586117|NCT02445859|75693168|FG001|STARTED|Overall Study||45||
59586118|NCT02445859|75693167|FG000|COMPLETED|Overall Study||43||
59586119|NCT02445859|75693168|FG001|COMPLETED|Overall Study||42||
59586120|NCT02445859|75693167|FG000|NOT COMPLETED|Overall Study||2||
59586121|NCT02445859|75693168|FG001|NOT COMPLETED|Overall Study||3||
59586122|NCT02446483|75693174|FG000|STARTED|Period 1: Intervention Period 1||30||
59586123|NCT02446483|75693175|FG001|STARTED|Period 1: Intervention Period 1||30||
59586124|NCT02446483|75693174|FG000|COMPLETED|Period 1: Intervention Period 1||30||
59586125|NCT02446483|75693175|FG001|COMPLETED|Period 1: Intervention Period 1||30||
59586126|NCT02446483|75693174|FG000|NOT COMPLETED|Period 1: Intervention Period 1||0||
59586127|NCT02446483|75693175|FG001|NOT COMPLETED|Period 1: Intervention Period 1||0||
59586128|NCT02446483|75693174|FG000|STARTED|Period 2: Washout Period (7 Days)||30||
59586129|NCT02446483|75693175|FG001|STARTED|Period 2: Washout Period (7 Days)||30||
59586130|NCT02446483|75693174|FG000|COMPLETED|Period 2: Washout Period (7 Days)||30||
59586131|NCT02446483|75693175|FG001|COMPLETED|Period 2: Washout Period (7 Days)||30||
59586132|NCT02446483|75693174|FG000|NOT COMPLETED|Period 2: Washout Period (7 Days)||0||
59586133|NCT02446483|75693175|FG001|NOT COMPLETED|Period 2: Washout Period (7 Days)||0||
59586134|NCT02446483|75693174|FG000|STARTED|Period 3: Intervention Period 2||30||
59586135|NCT02446483|75693175|FG001|STARTED|Period 3: Intervention Period 2||30||
59586136|NCT02446483|75693174|FG000|COMPLETED|Period 3: Intervention Period 2||30||
59586137|NCT02446483|75693175|FG001|COMPLETED|Period 3: Intervention Period 2||30||
59586138|NCT02446483|75693174|FG000|NOT COMPLETED|Period 3: Intervention Period 2||0||
59586139|NCT02446483|75693175|FG001|NOT COMPLETED|Period 3: Intervention Period 2||0||
59586140|NCT02447575|75693181|FG000|STARTED|Overall Study|23 subjects were enrolled in the study: http://dx.doi.org/10.1016/j.chest.2016.08.017|23||
59586141|NCT02447575|75693181|FG000|COMPLETED|Overall Study||23||
59586142|NCT02447575|75693181|FG000|NOT COMPLETED|Overall Study||0||
59586143|NCT02449291|75693188|FG000|STARTED|Overall Study||191||
59725015|NCT03140488|75843804|FG000|NOT COMPLETED|Overall Study||0||
59725016|NCT03140488|75843805|FG001|NOT COMPLETED|Overall Study||0||
59725017|NCT03140488|75843806|FG002|NOT COMPLETED|Overall Study||0||
59725018|NCT03140488|75843807|FG003|NOT COMPLETED|Overall Study||0||
59725019|NCT01106651|75843820|FG000|STARTED|Overall Study||237||
59725020|NCT01106651|75843821|FG001|STARTED|Overall Study||241||
59725021|NCT01106651|75843822|FG002|STARTED|Overall Study||236||
59725022|NCT01106651|75843820|FG000|COMPLETED|Overall Study||158||
59725023|NCT01106651|75843821|FG001|COMPLETED|Overall Study||184||
59854628|NCT00345293|75979201|FG001|STARTED|Overall Study||3||
59854629|NCT00345293|75979200|FG000|COMPLETED|Overall Study||8||
59854630|NCT00345293|75979201|FG001|COMPLETED|Overall Study||3||
59586144|NCT02449291|75693189|FG001|STARTED|Overall Study||188||
59586145|NCT02449291|75693190|FG002|STARTED|Overall Study||181||
59586146|NCT02449291|75693188|FG000|COMPLETED|Overall Study||186||
59586147|NCT02449291|75693189|FG001|COMPLETED|Overall Study||186||
59586148|NCT02449291|75693190|FG002|COMPLETED|Overall Study||180||
59586149|NCT02449291|75693188|FG000|NOT COMPLETED|Overall Study||5||
59586150|NCT02449291|75693189|FG001|NOT COMPLETED|Overall Study||2||
59586151|NCT02449291|75693190|FG002|NOT COMPLETED|Overall Study||1||
59586152|NCT02420041|75693203|FG000|STARTED|Overall Study||14||
59586153|NCT02420041|75693204|FG001|STARTED|Overall Study||14||
59586154|NCT02420041|75693203|FG000|COMPLETED|Overall Study||14||
59586155|NCT02420041|75693204|FG001|COMPLETED|Overall Study||14||
59586156|NCT02420041|75693203|FG000|NOT COMPLETED|Overall Study||0||
59586157|NCT02420041|75693204|FG001|NOT COMPLETED|Overall Study||0||
59586158|NCT02421055|75693212|FG000|STARTED|Overall Study||34||
59586159|NCT02421055|75693213|FG001|STARTED|Overall Study||50||
59586160|NCT02421055|75693214|FG002|STARTED|Overall Study||74||
59586161|NCT02421055|75693212|FG000|Pre-operative Serum Sample (Minimum)|Overall Study||34||
59586162|NCT02421055|75693213|FG001|Pre-operative Serum Sample (Minimum)|Overall Study||50||
59586163|NCT02421055|75693214|FG002|Pre-operative Serum Sample (Minimum)|Overall Study||74||
59586164|NCT02421055|75693212|FG000|Pre-operative Complete Sample Set|Overall Study||23|Complete sample set of serum, 24-hour urine and stool|
59854631|NCT00345293|75979200|FG000|NOT COMPLETED|Overall Study||2||
59586165|NCT02421055|75693213|FG001|Pre-operative Complete Sample Set|Overall Study||22|Complete sample set of serum, 24-hour urine and stool|
59725024|NCT01106651|75843822|FG002|COMPLETED|Overall Study||178||
59586166|NCT02421055|75693214|FG002|Pre-operative Complete Sample Set|Overall Study||36|Complete sample set of serum, 24-hour urine and stool|
59586167|NCT02421055|75693212|FG000|Post-operative Serum Sample (Minimum)|Overall Study||0||
59586168|NCT02421055|75693213|FG001|Post-operative Serum Sample (Minimum)|Overall Study||23||
59586169|NCT02421055|75693214|FG002|Post-operative Serum Sample (Minimum)|Overall Study||26||
59586170|NCT02421055|75693212|FG000|Post-operative Complete Sample Set|Overall Study||0|Complete sample set of serum, 24-hour urine and stool|
59586171|NCT02421055|75693213|FG001|Post-operative Complete Sample Set|Overall Study||13|Complete sample set of serum, 24-hour urine and stool|
59586172|NCT02421055|75693214|FG002|Post-operative Complete Sample Set|Overall Study||14|Complete sample set of serum, 24-hour urine and stool|
59586173|NCT02421055|75693212|FG000|COMPLETED|Overall Study||0|Clinical data collected at pre-operative and post-operative time points|
59586174|NCT02421055|75693213|FG001|COMPLETED|Overall Study||50|Clinical data collected at pre-operative and post-operative time points|
59586175|NCT02421055|75693214|FG002|COMPLETED|Overall Study||74|Clinical data collected at pre-operative and post-operative time points|
59586176|NCT02421055|75693212|FG000|NOT COMPLETED|Overall Study||34||
59586177|NCT02421055|75693213|FG001|NOT COMPLETED|Overall Study||0||
59586178|NCT02421055|75693214|FG002|NOT COMPLETED|Overall Study||0||
59586179|NCT02450383|75693225|FG000|STARTED|Overall Study||10||
59586180|NCT02450383|75693226|FG001|STARTED|Overall Study||10||
59586181|NCT02450383|75693225|FG000|COMPLETED|Overall Study||10||
59586182|NCT02450383|75693226|FG001|COMPLETED|Overall Study||10||
59586183|NCT02450383|75693225|FG000|NOT COMPLETED|Overall Study||0||
59586184|NCT02450383|75693226|FG001|NOT COMPLETED|Overall Study||0||
59586185|NCT02421211|75693234|FG000|STARTED|Overall Study||20||
60121685|NCT01565291|76242602|FG000|NOT COMPLETED|Overall Study||1||
60121686|NCT01565291|76242603|FG001|NOT COMPLETED|Overall Study||0||
60121687|NCT02691702|76242620|FG000|STARTED|Overall Study||10||
59586186|NCT02421211|75693235|FG001|STARTED|Overall Study||20||
59586187|NCT02421211|75693234|FG000|COMPLETED|Overall Study||20||
59586188|NCT02421211|75693235|FG001|COMPLETED|Overall Study||20||
59586189|NCT02421211|75693234|FG000|NOT COMPLETED|Overall Study||0||
59586190|NCT02421211|75693235|FG001|NOT COMPLETED|Overall Study||0||
59586191|NCT02421757|75693247|FG000|STARTED|Overall Study||11||
59586192|NCT02421757|75693248|FG001|STARTED|Overall Study||9||
59586193|NCT02421757|75693247|FG000|COMPLETED|Overall Study||11||
59586194|NCT02421757|75693248|FG001|COMPLETED|Overall Study||9||
59586195|NCT02421757|75693247|FG000|NOT COMPLETED|Overall Study||0||
59586196|NCT02421757|75693248|FG001|NOT COMPLETED|Overall Study||0||
59586197|NCT02423317|75693256|FG000|STARTED|Overall Study||30||
59586198|NCT02423317|75693257|FG001|STARTED|Overall Study||30||
59586199|NCT02423317|75693256|FG000|COMPLETED|Overall Study||30||
59586200|NCT02423317|75693257|FG001|COMPLETED|Overall Study||30||
59586201|NCT02423317|75693256|FG000|NOT COMPLETED|Overall Study||0||
59586202|NCT02423317|75693257|FG001|NOT COMPLETED|Overall Study||0||
59586203|NCT02424175|75693263|FG000|STARTED|Overall Study||10||
59586204|NCT02424175|75693263|FG000|COMPLETED|Overall Study||10||
59586205|NCT02424175|75693263|FG000|NOT COMPLETED|Overall Study||0||
59586206|NCT03093259|75693269|FG000|STARTED|Overall Study||23||
59586207|NCT03093259|75693270|FG001|STARTED|Overall Study||9||
59586208|NCT03093259|75693269|FG000|COMPLETED|Overall Study||21||
59586209|NCT03093259|75693270|FG001|COMPLETED|Overall Study||9||
59586210|NCT03093259|75693269|FG000|NOT COMPLETED|Overall Study||2||
59586211|NCT03093259|75693270|FG001|NOT COMPLETED|Overall Study||0||
59586212|NCT02528318|75693283|FG000|STARTED|Overall Study||8||
59586213|NCT02528318|75693284|FG001|STARTED|Overall Study||8||
59586214|NCT02528318|75693285|FG002|STARTED|Overall Study||8||
59586215|NCT02528318|75693286|FG003|STARTED|Overall Study|Study was terminated prior to initiation of this intervention|0||
59586216|NCT02528318|75693287|FG004|STARTED|Overall Study||24||
59586217|NCT02528318|75693283|FG000|COMPLETED|Overall Study||8||
59586218|NCT02528318|75693284|FG001|COMPLETED|Overall Study||8||
59586219|NCT02528318|75693285|FG002|COMPLETED|Overall Study||8||
59586220|NCT02528318|75693286|FG003|COMPLETED|Overall Study||0||
59586221|NCT02528318|75693287|FG004|COMPLETED|Overall Study||24||
59586222|NCT02528318|75693283|FG000|NOT COMPLETED|Overall Study||0||
59586223|NCT02528318|75693284|FG001|NOT COMPLETED|Overall Study||0||
59586224|NCT02528318|75693285|FG002|NOT COMPLETED|Overall Study||0||
59586225|NCT02528318|75693286|FG003|NOT COMPLETED|Overall Study||0||
59586226|NCT02528318|75693287|FG004|NOT COMPLETED|Overall Study||0||
59586227|NCT02423408|75693301|FG000|STARTED|Overall Study||83||
59586228|NCT02423408|75693302|FG001|STARTED|Overall Study||82||
59586229|NCT02423408|75693301|FG000|COMPLETED|Overall Study||82||
59586230|NCT02423408|75693302|FG001|COMPLETED|Overall Study||80||
60121688|NCT02691702|76242621|FG001|STARTED|Overall Study||11||
60121689|NCT02691702|76242622|FG002|STARTED|Overall Study||8||
60121690|NCT02691702|76242623|FG003|STARTED|Overall Study||8||
59586231|NCT02423408|75693301|FG000|NOT COMPLETED|Overall Study||1||
59586232|NCT02423408|75693302|FG001|NOT COMPLETED|Overall Study||2||
59586233|NCT02528786|75693308|FG000|STARTED|Overall Study||8||
59586234|NCT02528786|75693308|FG000|COMPLETED|Overall Study||8||
59586235|NCT02528786|75693308|FG000|NOT COMPLETED|Overall Study||0||
59586236|NCT02424968|75693312|FG000|STARTED|Overall Study||18||
59586237|NCT02424968|75693312|FG000|COMPLETED|Overall Study||18||
60121691|NCT02691702|76242624|FG004|STARTED|Overall Study||8||
59586238|NCT02424968|75693312|FG000|NOT COMPLETED|Overall Study||0||
59586239|NCT02424799|75693322|FG000|STARTED|Part A (Up to Day 11)||9||
59586240|NCT02424799|75693323|FG001|STARTED|Part A (Up to Day 11)||8||
59586241|NCT02424799|75693324|FG002|STARTED|Part A (Up to Day 11)||0||
59586242|NCT02424799|75693325|FG003|STARTED|Part A (Up to Day 11)||0||
59586243|NCT02424799|75693326|FG004|STARTED|Part A (Up to Day 11)||0||
59586244|NCT02424799|75693327|FG005|STARTED|Part A (Up to Day 11)||0||
59586245|NCT02424799|75693322|FG000|COMPLETED|Part A (Up to Day 11)||9||
59586246|NCT02424799|75693323|FG001|COMPLETED|Part A (Up to Day 11)||8||
59586247|NCT02424799|75693324|FG002|COMPLETED|Part A (Up to Day 11)||0||
59586248|NCT02424799|75693325|FG003|COMPLETED|Part A (Up to Day 11)||0||
59586249|NCT02424799|75693326|FG004|COMPLETED|Part A (Up to Day 11)||0||
59586250|NCT02424799|75693327|FG005|COMPLETED|Part A (Up to Day 11)||0||
59586251|NCT02424799|75693322|FG000|NOT COMPLETED|Part A (Up to Day 11)||0||
59586252|NCT02424799|75693323|FG001|NOT COMPLETED|Part A (Up to Day 11)||0||
59586253|NCT02424799|75693324|FG002|NOT COMPLETED|Part A (Up to Day 11)||0||
59586254|NCT02424799|75693325|FG003|NOT COMPLETED|Part A (Up to Day 11)||0||
59586255|NCT02424799|75693326|FG004|NOT COMPLETED|Part A (Up to Day 11)||0||
59586256|NCT02424799|75693327|FG005|NOT COMPLETED|Part A (Up to Day 11)||0||
59586257|NCT02424799|75693322|FG000|STARTED|Part B (Up to Day 19)||0||
59586258|NCT02424799|75693323|FG001|STARTED|Part B (Up to Day 19)||0||
59586259|NCT02424799|75693324|FG002|STARTED|Part B (Up to Day 19)||3||
59586260|NCT02424799|75693325|FG003|STARTED|Part B (Up to Day 19)||9||
59586261|NCT02424799|75693326|FG004|STARTED|Part B (Up to Day 19)||0||
59586262|NCT02424799|75693327|FG005|STARTED|Part B (Up to Day 19)||0||
59586263|NCT02424799|75693322|FG000|COMPLETED|Part B (Up to Day 19)||0||
59586264|NCT02424799|75693323|FG001|COMPLETED|Part B (Up to Day 19)||0||
59586265|NCT02424799|75693324|FG002|COMPLETED|Part B (Up to Day 19)||3||
59586266|NCT02424799|75693325|FG003|COMPLETED|Part B (Up to Day 19)||9||
59586267|NCT02424799|75693326|FG004|COMPLETED|Part B (Up to Day 19)||0||
59586268|NCT02424799|75693327|FG005|COMPLETED|Part B (Up to Day 19)||0||
59586269|NCT02424799|75693322|FG000|NOT COMPLETED|Part B (Up to Day 19)||0||
59586270|NCT02424799|75693323|FG001|NOT COMPLETED|Part B (Up to Day 19)||0||
59586271|NCT02424799|75693324|FG002|NOT COMPLETED|Part B (Up to Day 19)||0||
59586272|NCT02424799|75693325|FG003|NOT COMPLETED|Part B (Up to Day 19)||0||
59586273|NCT02424799|75693326|FG004|NOT COMPLETED|Part B (Up to Day 19)||0||
59586274|NCT02424799|75693327|FG005|NOT COMPLETED|Part B (Up to Day 19)||0||
59586275|NCT02424799|75693322|FG000|STARTED|Part C (Up to Day 23)||0||
59586276|NCT02424799|75693323|FG001|STARTED|Part C (Up to Day 23)||0||
59586277|NCT02424799|75693324|FG002|STARTED|Part C (Up to Day 23)||0||
59586278|NCT02424799|75693325|FG003|STARTED|Part C (Up to Day 23)||0||
59586279|NCT02424799|75693326|FG004|STARTED|Part C (Up to Day 23)||1||
59586280|NCT02424799|75693327|FG005|STARTED|Part C (Up to Day 23)||4||
59586281|NCT02424799|75693322|FG000|COMPLETED|Part C (Up to Day 23)||0||
59586282|NCT02424799|75693323|FG001|COMPLETED|Part C (Up to Day 23)||0||
59586283|NCT02424799|75693324|FG002|COMPLETED|Part C (Up to Day 23)||0||
59586284|NCT02424799|75693325|FG003|COMPLETED|Part C (Up to Day 23)||0||
59586285|NCT02424799|75693326|FG004|COMPLETED|Part C (Up to Day 23)||1||
59586286|NCT02424799|75693327|FG005|COMPLETED|Part C (Up to Day 23)||4||
59586287|NCT02424799|75693322|FG000|NOT COMPLETED|Part C (Up to Day 23)||0||
59586288|NCT02424799|75693323|FG001|NOT COMPLETED|Part C (Up to Day 23)||0||
59586289|NCT02424799|75693324|FG002|NOT COMPLETED|Part C (Up to Day 23)||0||
59586290|NCT02424799|75693325|FG003|NOT COMPLETED|Part C (Up to Day 23)||0||
59586291|NCT02424799|75693326|FG004|NOT COMPLETED|Part C (Up to Day 23)||0||
59586292|NCT02424799|75693327|FG005|NOT COMPLETED|Part C (Up to Day 23)||0||
59586293|NCT02492750|75693362|FG000|STARTED|Overall Study||4||
59586294|NCT02492750|75693363|FG001|STARTED|Overall Study||4||
59586295|NCT02492750|75693364|FG002|STARTED|Overall Study||6||
59586296|NCT02492750|75693362|FG000|COMPLETED|Overall Study||4||
59586297|NCT02492750|75693363|FG001|COMPLETED|Overall Study||4||
59586298|NCT02492750|75693364|FG002|COMPLETED|Overall Study||6||
59586299|NCT02492750|75693362|FG000|NOT COMPLETED|Overall Study||0||
59586300|NCT02492750|75693363|FG001|NOT COMPLETED|Overall Study||0||
59586301|NCT02492750|75693364|FG002|NOT COMPLETED|Overall Study||0||
59586302|NCT02453347|75693372|FG000|STARTED|Overall Study||6||
59586303|NCT02453347|75693372|FG000|COMPLETED|Overall Study||6||
59586304|NCT02453347|75693372|FG000|NOT COMPLETED|Overall Study||0||
59586305|NCT02493452|75693379|FG000|STARTED|Overall Study||379||
59586306|NCT02493452|75693380|FG001|STARTED|Overall Study||377||
59586307|NCT02493452|75693381|FG002|STARTED|Overall Study||379||
59586308|NCT02493452|75693379|FG000|COMPLETED|Overall Study||329||
59586309|NCT02493452|75693380|FG001|COMPLETED|Overall Study||328||
59586310|NCT02493452|75693381|FG002|COMPLETED|Overall Study||325||
59586311|NCT02493452|75693379|FG000|NOT COMPLETED|Overall Study||50||
59586312|NCT02493452|75693380|FG001|NOT COMPLETED|Overall Study||49||
59586313|NCT02493452|75693381|FG002|NOT COMPLETED|Overall Study||54||
59586314|NCT02428309|75693389|FG000|STARTED|Overall Study||1||
59586315|NCT02428309|75693389|FG000|COMPLETED|Overall Study|The enrolled participant completed treatment and was followed through week 152, per protocol.|1||
59586316|NCT02428309|75693389|FG000|NOT COMPLETED|Overall Study||0||
59586317|NCT02429869|75693394|FG000|STARTED|Overall Study||10||
59586318|NCT02429869|75693394|FG000|COMPLETED|Overall Study||10||
59586319|NCT02429869|75693394|FG000|NOT COMPLETED|Overall Study||0||
59586320|NCT02430337|75693400|FG000|STARTED|Overall Study||11||
59586321|NCT02430337|75693401|FG001|STARTED|Overall Study||20||
59586322|NCT02430337|75693400|FG000|COMPLETED|Overall Study||11||
59586323|NCT02430337|75693401|FG001|COMPLETED|Overall Study||20||
59586324|NCT02430337|75693400|FG000|NOT COMPLETED|Overall Study||0||
59586325|NCT02430337|75693401|FG001|NOT COMPLETED|Overall Study||0||
59586326|NCT02493608|75693411|FG000|STARTED|Overall Study||48||
59586327|NCT02493608|75693412|FG001|STARTED|Overall Study||48||
59586328|NCT02493608|75693411|FG000|COMPLETED|Overall Study||48||
59586329|NCT02493608|75693412|FG001|COMPLETED|Overall Study||48||
59586330|NCT02493608|75693411|FG000|NOT COMPLETED|Overall Study||0||
59586331|NCT02493608|75693412|FG001|NOT COMPLETED|Overall Study||0||
59586332|NCT02494076|75693420|FG000|STARTED|Overall Study||26||
59586333|NCT02494076|75693421|FG001|STARTED|Overall Study||26||
59586334|NCT02494076|75693420|FG000|COMPLETED|Overall Study||26||
59586335|NCT02494076|75693421|FG001|COMPLETED|Overall Study||26||
59586336|NCT02494076|75693420|FG000|NOT COMPLETED|Overall Study||0||
59586337|NCT02494076|75693421|FG001|NOT COMPLETED|Overall Study||0||
59586338|NCT02431273|75693427|FG000|STARTED|TDF (Single IVR)||6||
59586339|NCT02431273|75693427|FG000|COMPLETED|TDF (Single IVR)||6|All 6 participants that completed Period 1 (TDF IVR) screened for Period 2 (TDF-FTC IVR)|
59586340|NCT02431273|75693427|FG000|NOT COMPLETED|TDF (Single IVR)||0||
59586341|NCT02431273|75693427|FG000|STARTED|TDF-FTC (Dual IVR)||6||
59586342|NCT02431273|75693427|FG000|COMPLETED|TDF-FTC (Dual IVR)||6|2 of 6 participants that completed Period 2 (TDF-FTC IVR) screened for Period 3 (TDF-FTC-MVC IVR)|
59586343|NCT02431273|75693427|FG000|NOT COMPLETED|TDF-FTC (Dual IVR)||0||
59586344|NCT02431273|75693427|FG000|STARTED|TDF-FTC-MVC (Triple IVR)||6||
59586345|NCT02431273|75693427|FG000|COMPLETED|TDF-FTC-MVC (Triple IVR)||6|2 participants that completed Periods 1 and 2, along with 4 new subjects participated in Period 3|
59586346|NCT02431273|75693427|FG000|NOT COMPLETED|TDF-FTC-MVC (Triple IVR)||0||
59586347|NCT02428478|75693435|FG000|STARTED|First Study Night||9||
59586348|NCT02428478|75693436|FG001|STARTED|First Study Night||8||
59586349|NCT02428478|75693435|FG000|COMPLETED|First Study Night||9||
59586350|NCT02428478|75693436|FG001|COMPLETED|First Study Night||8||
59586351|NCT02428478|75693435|FG000|NOT COMPLETED|First Study Night||0||
59586352|NCT02428478|75693436|FG001|NOT COMPLETED|First Study Night||0||
59586353|NCT02428478|75693435|FG000|STARTED|Second Study Night|1 participant did not return for the second study night|8||
59586354|NCT02428478|75693436|FG001|STARTED|Second Study Night|2 participants did not return for the second study night|6||
59586355|NCT02428478|75693435|FG000|COMPLETED|Second Study Night||8||
59586356|NCT02428478|75693436|FG001|COMPLETED|Second Study Night||6||
59586357|NCT02428478|75693435|FG000|NOT COMPLETED|Second Study Night||0||
59586358|NCT02428478|75693436|FG001|NOT COMPLETED|Second Study Night||0||
59586359|NCT02431741|75693442|FG000|STARTED|Overall Study||14||
59586360|NCT02431741|75693442|FG000|COMPLETED|Overall Study||14||
59586361|NCT02431741|75693442|FG000|NOT COMPLETED|Overall Study||0||
59586362|NCT02432287|75693448|FG000|STARTED|First Intervention||8||
59586363|NCT02432287|75693449|FG001|STARTED|First Intervention||8||
59586364|NCT02432287|75693448|FG000|COMPLETED|First Intervention||8||
59586365|NCT02432287|75693449|FG001|COMPLETED|First Intervention||7||
59586366|NCT02432287|75693448|FG000|NOT COMPLETED|First Intervention||0||
59586367|NCT02432287|75693449|FG001|NOT COMPLETED|First Intervention||1||
59586368|NCT02432287|75693448|FG000|STARTED|Washout Period||7||
59586369|NCT02432287|75693449|FG001|STARTED|Washout Period||7||
59586370|NCT02432287|75693448|FG000|COMPLETED|Washout Period||7||
59586371|NCT02432287|75693449|FG001|COMPLETED|Washout Period||7||
59586372|NCT02432287|75693448|FG000|NOT COMPLETED|Washout Period||0||
59586373|NCT02432287|75693449|FG001|NOT COMPLETED|Washout Period||0||
59586374|NCT02432287|75693448|FG000|STARTED|Second Intervention||7||
59586375|NCT02432287|75693449|FG001|STARTED|Second Intervention||7||
59586376|NCT02432287|75693448|FG000|COMPLETED|Second Intervention||7||
59586377|NCT02432287|75693449|FG001|COMPLETED|Second Intervention||7||
59586378|NCT02432287|75693448|FG000|NOT COMPLETED|Second Intervention||0||
59586379|NCT02432287|75693449|FG001|NOT COMPLETED|Second Intervention||0||
59586380|NCT02433613|75693457|FG000|STARTED|Overall Study||1071||
59586381|NCT02433613|75693457|FG000|COMPLETED|Overall Study||1054||
59586382|NCT02433613|75693457|FG000|NOT COMPLETED|Overall Study||17||
59586383|NCT02532998|75693461|FG000|STARTED|Overall Study||23||
59586384|NCT02532998|75693461|FG000|COMPLETED|Overall Study||23||
59586385|NCT02532998|75693461|FG000|NOT COMPLETED|Overall Study||0||
59586386|NCT02453581|75693475|FG000|STARTED|Overall Study||8||
59586387|NCT02453581|75693476|FG001|STARTED|Overall Study||8||
59586388|NCT02453581|75693477|FG002|STARTED|Overall Study||8||
59586389|NCT02453581|75693475|FG000|COMPLETED|Overall Study||8||
59586390|NCT02453581|75693476|FG001|COMPLETED|Overall Study||8||
59586391|NCT02453581|75693477|FG002|COMPLETED|Overall Study||8||
59586392|NCT02453581|75693475|FG000|NOT COMPLETED|Overall Study||0||
59586393|NCT02453581|75693476|FG001|NOT COMPLETED|Overall Study||0||
59586394|NCT02453581|75693477|FG002|NOT COMPLETED|Overall Study||0||
59725025|NCT01106651|75843820|FG000|NOT COMPLETED|Overall Study||79||
59586395|NCT02533466|75693496|FG000|STARTED|Overall Study||16||
59586396|NCT02533466|75693497|FG001|STARTED|Overall Study||14||
59586397|NCT02533466|75693496|FG000|COMPLETED|Overall Study||16||
59586398|NCT02533466|75693497|FG001|COMPLETED|Overall Study||14||
59586399|NCT02533466|75693496|FG000|NOT COMPLETED|Overall Study||0||
59586400|NCT02533466|75693497|FG001|NOT COMPLETED|Overall Study||0||
59586401|NCT02454127|75693509|FG000|STARTED|Overall Study||40||
59586402|NCT02454127|75693510|FG001|STARTED|Overall Study||40||
59586403|NCT02454127|75693511|FG002|STARTED|Overall Study||40||
59586404|NCT02454127|75693512|FG003|STARTED|Overall Study||40||
59586405|NCT02454127|75693509|FG000|COMPLETED|Overall Study||21||
59586406|NCT02454127|75693510|FG001|COMPLETED|Overall Study||26||
59586407|NCT02454127|75693511|FG002|COMPLETED|Overall Study||26||
59586408|NCT02454127|75693512|FG003|COMPLETED|Overall Study||20||
59586409|NCT02454127|75693509|FG000|NOT COMPLETED|Overall Study||19||
59586410|NCT02454127|75693510|FG001|NOT COMPLETED|Overall Study||14||
59586411|NCT02454127|75693511|FG002|NOT COMPLETED|Overall Study||14||
59586412|NCT02454127|75693512|FG003|NOT COMPLETED|Overall Study||20||
59586413|NCT02436031|75693522|FG000|STARTED|First Study Night||8||
59586414|NCT02436031|75693523|FG001|STARTED|First Study Night||8||
59586415|NCT02436031|75693522|FG000|COMPLETED|First Study Night||8||
59586416|NCT02436031|75693523|FG001|COMPLETED|First Study Night||8||
59586417|NCT02436031|75693522|FG000|NOT COMPLETED|First Study Night||0||
59586418|NCT02436031|75693523|FG001|NOT COMPLETED|First Study Night||0||
59586419|NCT02436031|75693522|FG000|STARTED|Second Study Night|1 participant did not tolerate the study setup so did not participate in the second study night|7||
59586420|NCT02436031|75693523|FG001|STARTED|Second Study Night||8||
59586421|NCT02436031|75693522|FG000|COMPLETED|Second Study Night||7||
59586422|NCT02436031|75693523|FG001|COMPLETED|Second Study Night||8||
59586423|NCT02436031|75693522|FG000|NOT COMPLETED|Second Study Night||0||
59586424|NCT02436031|75693523|FG001|NOT COMPLETED|Second Study Night||0||
59586425|NCT02454283|75693531|FG000|STARTED|Overall Study||26||
59586426|NCT02454283|75693532|FG001|STARTED|Overall Study||15||
59586427|NCT02454283|75693531|FG000|COMPLETED|Overall Study||26||
59586428|NCT02454283|75693532|FG001|COMPLETED|Overall Study||15||
59586429|NCT02454283|75693531|FG000|NOT COMPLETED|Overall Study||0||
59586430|NCT02454283|75693532|FG001|NOT COMPLETED|Overall Study||0||
59586431|NCT02437669|75693538|FG000|STARTED|Overall Study||35||
59586432|NCT02437669|75693538|FG000|COMPLETED|Overall Study||35||
59586433|NCT02437669|75693538|FG000|NOT COMPLETED|Overall Study||0||
59586434|NCT02430818|75693545|FG000|STARTED|Overall Study||7||
59586435|NCT02430818|75693546|FG001|STARTED|Overall Study||6||
59586436|NCT02430818|75693545|FG000|COMPLETED|Overall Study||7||
59586437|NCT02430818|75693546|FG001|COMPLETED|Overall Study||6||
59586438|NCT02430818|75693545|FG000|NOT COMPLETED|Overall Study||0||
59586439|NCT02430818|75693546|FG001|NOT COMPLETED|Overall Study||0||
59586440|NCT02455453|75693556|FG000|STARTED|Overall Study||47||
59586441|NCT02455453|75693556|FG000|COMPLETED|Overall Study||47||
59586442|NCT02455453|75693556|FG000|NOT COMPLETED|Overall Study||0||
59586443|NCT02997865|75693562|FG000|STARTED|Overall Study||69||
59725026|NCT01106651|75843821|FG001|NOT COMPLETED|Overall Study||57||
59586444|NCT02997865|75693563|FG001|STARTED|Overall Study||70||
59586445|NCT02997865|75693562|FG000|COMPLETED|Overall Study|Number of participants who completed the Week 32 outcome assessments.|56||
59725027|NCT01106651|75843822|FG002|NOT COMPLETED|Overall Study||58||
59725028|NCT01027650|75843841|FG000|STARTED|Overall Study||6||
59725029|NCT01027650|75843842|FG001|STARTED|Overall Study||6||
59725030|NCT01027650|75843843|FG002|STARTED|Overall Study||6||
59725031|NCT01027650|75843844|FG003|STARTED|Overall Study||3||
59854632|NCT00345293|75979201|FG001|NOT COMPLETED|Overall Study||0||
59854633|NCT00355121|75979210|FG000|STARTED|Overall Study||353||
59586446|NCT02997865|75693563|FG001|COMPLETED|Overall Study|Number of participants who completed the Week 32 outcome assessments.|66||
59586447|NCT02997865|75693562|FG000|NOT COMPLETED|Overall Study||13||
59586448|NCT02997865|75693563|FG001|NOT COMPLETED|Overall Study||4||
59586449|NCT02457403|75693573|FG000|STARTED|Overall Study|34 participants|34||
59586450|NCT02457403|75693574|FG001|STARTED|Overall Study|34 historic controls|34||
59586451|NCT02457403|75693573|FG000|COMPLETED|Overall Study||34||
59586452|NCT02457403|75693574|FG001|COMPLETED|Overall Study||34||
59586453|NCT02457403|75693573|FG000|NOT COMPLETED|Overall Study||0||
59586454|NCT02457403|75693574|FG001|NOT COMPLETED|Overall Study||0||
59586455|NCT02533934|75693584|FG000|STARTED|Overall Study||42||
59586456|NCT02533934|75693585|FG001|STARTED|Overall Study||26||
59586457|NCT02533934|75693584|FG000|COMPLETED|Overall Study||42||
59586458|NCT02533934|75693585|FG001|COMPLETED|Overall Study||26||
59586459|NCT02533934|75693584|FG000|NOT COMPLETED|Overall Study||0||
59586460|NCT02533934|75693585|FG001|NOT COMPLETED|Overall Study||0||
59586461|NCT02459119|75693591|FG000|STARTED|Overall Study||17||
59586462|NCT02459119|75693591|FG000|COMPLETED|Overall Study||17||
59586463|NCT02459119|75693591|FG000|NOT COMPLETED|Overall Study||0||
59586464|NCT02535026|75693595|FG000|STARTED|Overall Study||580||
59586465|NCT02535026|75693595|FG000|COMPLETED|Overall Study||580||
59586466|NCT02535026|75693595|FG000|NOT COMPLETED|Overall Study||0||
59586467|NCT02519023|75693611|FG000|STARTED|Overall Study||49||
59586468|NCT02519023|75693612|FG001|STARTED|Overall Study||38||
59586469|NCT02519023|75693611|FG000|COMPLETED|Overall Study||31||
59586470|NCT02519023|75693612|FG001|COMPLETED|Overall Study||31||
59586471|NCT02519023|75693611|FG000|NOT COMPLETED|Overall Study||18||
59586472|NCT02519023|75693612|FG001|NOT COMPLETED|Overall Study||7||
59586473|NCT02535572|75693620|FG000|STARTED|Overall Study||21||
59586474|NCT02535572|75693621|FG001|STARTED|Overall Study||20||
59586475|NCT02535572|75693620|FG000|COMPLETED|Overall Study||17||
59586476|NCT02535572|75693621|FG001|COMPLETED|Overall Study||17||
59586477|NCT02535572|75693620|FG000|NOT COMPLETED|Overall Study||4||
59586478|NCT02535572|75693621|FG001|NOT COMPLETED|Overall Study||3||
59586479|NCT02497040|75693631|FG000|STARTED|Overall Study||30||
59586480|NCT02497040|75693632|FG001|STARTED|Overall Study||30||
59586481|NCT02497040|75693633|FG002|STARTED|Overall Study||30||
59586482|NCT02497040|75693631|FG000|COMPLETED|Overall Study||30||
59586483|NCT02497040|75693632|FG001|COMPLETED|Overall Study||30||
59586484|NCT02497040|75693633|FG002|COMPLETED|Overall Study||30||
59586485|NCT02497040|75693631|FG000|NOT COMPLETED|Overall Study||0||
59586486|NCT02497040|75693632|FG001|NOT COMPLETED|Overall Study||0||
59586487|NCT02497040|75693633|FG002|NOT COMPLETED|Overall Study||0||
59586488|NCT02523235|75693643|FG000|STARTED|Overall Study||56||
59586489|NCT02523235|75693644|FG001|STARTED|Overall Study||58||
59586490|NCT02523235|75693643|FG000|COMPLETED|Overall Study||56||
59586491|NCT02523235|75693644|FG001|COMPLETED|Overall Study||58||
59586492|NCT02523235|75693643|FG000|NOT COMPLETED|Overall Study||0||
59586493|NCT02523235|75693644|FG001|NOT COMPLETED|Overall Study||0||
59586494|NCT02498522|75693653|FG000|STARTED|Overall Study||85||
59586495|NCT02498522|75693654|FG001|STARTED|Overall Study||85||
59586496|NCT02498522|75693653|FG000|COMPLETED|Overall Study||83||
59586497|NCT02498522|75693654|FG001|COMPLETED|Overall Study||83||
59586498|NCT02498522|75693653|FG000|NOT COMPLETED|Overall Study||2||
59586499|NCT02498522|75693654|FG001|NOT COMPLETED|Overall Study||2||
59586500|NCT02459197|75693662|FG000|STARTED|Overall Study||58||
59586501|NCT02459197|75693663|FG001|STARTED|Overall Study||56||
59586502|NCT02459197|75693662|FG000|COMPLETED|Overall Study||58||
59586503|NCT02459197|75693663|FG001|COMPLETED|Overall Study||55||
59586504|NCT02459197|75693662|FG000|NOT COMPLETED|Overall Study||0||
59586505|NCT02459197|75693663|FG001|NOT COMPLETED|Overall Study||1||
59586506|NCT02431052|75693674|FG000|STARTED|Overall Study||53||
59586507|NCT02431052|75693675|FG001|STARTED|Overall Study||50||
59586508|NCT02431052|75693676|FG002|STARTED|Overall Study||106||
59586509|NCT02431052|75693677|FG003|STARTED|Overall Study||110||
59586510|NCT02431052|75693678|FG004|STARTED|Overall Study||101||
59586511|NCT02431052|75693674|FG000|COMPLETED|Overall Study||42||
59586512|NCT02431052|75693675|FG001|COMPLETED|Overall Study||46||
59586513|NCT02431052|75693676|FG002|COMPLETED|Overall Study||94||
59586514|NCT02431052|75693677|FG003|COMPLETED|Overall Study||94||
59586515|NCT02431052|75693678|FG004|COMPLETED|Overall Study||86||
59586516|NCT02431052|75693674|FG000|NOT COMPLETED|Overall Study||11||
59586517|NCT02431052|75693675|FG001|NOT COMPLETED|Overall Study||4||
59586518|NCT02431052|75693676|FG002|NOT COMPLETED|Overall Study||12||
59586519|NCT02431052|75693677|FG003|NOT COMPLETED|Overall Study||16||
59586520|NCT02431052|75693678|FG004|NOT COMPLETED|Overall Study||15||
59586521|NCT02459275|75693697|FG000|STARTED|Overall Study||19||
59586522|NCT02459275|75693698|FG001|STARTED|Overall Study||17||
59586523|NCT02459275|75693697|FG000|COMPLETED|Overall Study||19||
59586524|NCT02459275|75693698|FG001|COMPLETED|Overall Study||17||
59586525|NCT02459275|75693697|FG000|NOT COMPLETED|Overall Study||0||
59586526|NCT02459275|75693698|FG001|NOT COMPLETED|Overall Study||0||
59586527|NCT02498834|75693706|FG000|STARTED|Overall Study||185||
59586528|NCT02498834|75693707|FG001|STARTED|Overall Study||174||
59586529|NCT02498834|75693706|FG000|COMPLETED|Overall Study||175||
59586530|NCT02498834|75693707|FG001|COMPLETED|Overall Study||164||
59586531|NCT02498834|75693706|FG000|NOT COMPLETED|Overall Study||10||
59586532|NCT02498834|75693707|FG001|NOT COMPLETED|Overall Study||10||
59586533|NCT02524561|75693716|FG000|STARTED|Baseline: Pre-randomization Mammogram|Consented to MDBHAS|168||
59586534|NCT02524561|75693717|FG001|STARTED|Baseline: Pre-randomization Mammogram|Consented to MDBHAS|162||
59586535|NCT02524561|75693718|FG002|STARTED|Baseline: Pre-randomization Mammogram|Consented to MDBHAS.|187||
59725032|NCT01027650|75843845|FG004|STARTED|Overall Study||25||
59854634|NCT00355121|75979211|FG001|STARTED|Overall Study||353||
59854635|NCT00355121|75979212|FG002|STARTED|Overall Study||175||
59586536|NCT02524561|75693716|FG000|Obtained Baseline Mammogram|Baseline: Pre-randomization Mammogram||137||
59586537|NCT02524561|75693717|FG001|Obtained Baseline Mammogram|Baseline: Pre-randomization Mammogram||133||
59586538|NCT02524561|75693718|FG002|Obtained Baseline Mammogram|Baseline: Pre-randomization Mammogram||151||
59586539|NCT02524561|75693716|FG000|COMPLETED|Baseline: Pre-randomization Mammogram||168||
59586540|NCT02524561|75693717|FG001|COMPLETED|Baseline: Pre-randomization Mammogram||162||
59586541|NCT02524561|75693718|FG002|COMPLETED|Baseline: Pre-randomization Mammogram||187||
59586542|NCT02524561|75693716|FG000|NOT COMPLETED|Baseline: Pre-randomization Mammogram||0||
59725033|NCT01027650|75843846|FG005|STARTED|Overall Study||26||
59725034|NCT01027650|75843847|FG006|STARTED|Overall Study||25||
59586543|NCT02524561|75693717|FG001|NOT COMPLETED|Baseline: Pre-randomization Mammogram||0||
59725035|NCT01027650|75843848|FG007|STARTED|Overall Study||24||
59586544|NCT02524561|75693718|FG002|NOT COMPLETED|Baseline: Pre-randomization Mammogram||0||
59586545|NCT02524561|75693716|FG000|STARTED|Year 1: Post Randomization Mammograms|Consented to MDBHAS|168||
59586546|NCT02524561|75693717|FG001|STARTED|Year 1: Post Randomization Mammograms|Consented to MDBHAS|162||
59586547|NCT02524561|75693718|FG002|STARTED|Year 1: Post Randomization Mammograms|Consented to MDBHAS|187||
59586548|NCT02524561|75693716|FG000|Obtained Mammogam|Year 1: Post Randomization Mammograms|Obtained post-randomization mammogram|136||
59586549|NCT02524561|75693717|FG001|Obtained Mammogam|Year 1: Post Randomization Mammograms|Obtained post randomization mammogram|123||
59586550|NCT02524561|75693718|FG002|Obtained Mammogam|Year 1: Post Randomization Mammograms|Obtained post randomization mammogram|148||
59586551|NCT02524561|75693716|FG000|COMPLETED|Year 1: Post Randomization Mammograms||168||
59586552|NCT02524561|75693717|FG001|COMPLETED|Year 1: Post Randomization Mammograms||162||
59586553|NCT02524561|75693718|FG002|COMPLETED|Year 1: Post Randomization Mammograms||187||
59586554|NCT02524561|75693716|FG000|NOT COMPLETED|Year 1: Post Randomization Mammograms||0||
59586555|NCT02524561|75693717|FG001|NOT COMPLETED|Year 1: Post Randomization Mammograms||0||
59586556|NCT02524561|75693718|FG002|NOT COMPLETED|Year 1: Post Randomization Mammograms||0||
59586557|NCT02524561|75693716|FG000|STARTED|Final: Year 3 or 4 Post-randomization|Consented to MDBHAS|168||
59586558|NCT02524561|75693717|FG001|STARTED|Final: Year 3 or 4 Post-randomization|Consented to MDBHAS|162||
59586559|NCT02524561|75693718|FG002|STARTED|Final: Year 3 or 4 Post-randomization|Consented to MDBHAS|187||
59586560|NCT02524561|75693716|FG000|Obtained Year 3 or 4 Mammogram|Final: Year 3 or 4 Post-randomization||143||
59586561|NCT02524561|75693717|FG001|Obtained Year 3 or 4 Mammogram|Final: Year 3 or 4 Post-randomization||139||
59586562|NCT02524561|75693718|FG002|Obtained Year 3 or 4 Mammogram|Final: Year 3 or 4 Post-randomization||151||
59586563|NCT02524561|75693716|FG000|COMPLETED|Final: Year 3 or 4 Post-randomization||168||
59586564|NCT02524561|75693717|FG001|COMPLETED|Final: Year 3 or 4 Post-randomization||162||
59586565|NCT02524561|75693718|FG002|COMPLETED|Final: Year 3 or 4 Post-randomization||187||
59586566|NCT02524561|75693716|FG000|NOT COMPLETED|Final: Year 3 or 4 Post-randomization||0||
59586567|NCT02524561|75693717|FG001|NOT COMPLETED|Final: Year 3 or 4 Post-randomization||0||
59586568|NCT02524561|75693718|FG002|NOT COMPLETED|Final: Year 3 or 4 Post-randomization||0||
59586569|NCT02431598|75693726|FG000|STARTED|Overall Study||6||
59586570|NCT02431598|75693727|FG001|STARTED|Overall Study||9||
59586571|NCT02431598|75693728|FG002|STARTED|Overall Study||9||
59586572|NCT02431598|75693729|FG003|STARTED|Overall Study||7||
59586573|NCT02431598|75693730|FG004|STARTED|Overall Study||7||
59586574|NCT02431598|75693731|FG005|STARTED|Overall Study||6||
59586575|NCT02431598|75693726|FG000|COMPLETED|Overall Study||6||
59586576|NCT02431598|75693727|FG001|COMPLETED|Overall Study||9||
59586577|NCT02431598|75693728|FG002|COMPLETED|Overall Study||9||
59586578|NCT02431598|75693729|FG003|COMPLETED|Overall Study||7||
59586579|NCT02431598|75693730|FG004|COMPLETED|Overall Study||7||
59586580|NCT02431598|75693731|FG005|COMPLETED|Overall Study||6||
59586581|NCT02431598|75693726|FG000|NOT COMPLETED|Overall Study||0||
59586582|NCT02431598|75693727|FG001|NOT COMPLETED|Overall Study||0||
59586583|NCT02431598|75693728|FG002|NOT COMPLETED|Overall Study||0||
59586584|NCT02431598|75693729|FG003|NOT COMPLETED|Overall Study||0||
59586585|NCT02431598|75693730|FG004|NOT COMPLETED|Overall Study||0||
59586586|NCT02431598|75693731|FG005|NOT COMPLETED|Overall Study||0||
59586587|NCT02499380|75693748|FG000|STARTED|Overall Study||20||
59586588|NCT02499380|75693748|FG000|COMPLETED|Overall Study||17||
59586589|NCT02499380|75693748|FG000|NOT COMPLETED|Overall Study||3||
59586590|NCT02461693|75693754|FG000|STARTED|Overall Study||103||
59586591|NCT02461693|75693755|FG001|STARTED|Overall Study||102||
59586592|NCT02461693|75693754|FG000|COMPLETED|Overall Study||103||
59586593|NCT02461693|75693755|FG001|COMPLETED|Overall Study||102||
59586594|NCT02461693|75693754|FG000|NOT COMPLETED|Overall Study||0||
59586595|NCT02461693|75693755|FG001|NOT COMPLETED|Overall Study||0||
59586596|NCT02525263|75693761|FG000|STARTED|Overall Study|The single patient in this trial was enrolled on 18 July 2016.|1||
59586597|NCT02525263|75693761|FG000|COMPLETED|Overall Study|The trial was completed when the patient reached the specified endpoint of starting hemodialysis.|1||
59586598|NCT02525263|75693761|FG000|NOT COMPLETED|Overall Study||0||
59586599|NCT02525575|75693767|FG000|STARTED|Overall Study||37||
59586600|NCT02525575|75693767|FG000|COMPLETED|Overall Study||22||
59586601|NCT02525575|75693767|FG000|NOT COMPLETED|Overall Study||15||
59586602|NCT02525653|75693771|FG000|STARTED|Overall Study||40||
59586603|NCT02525653|75693771|FG000|COMPLETED|Overall Study||40||
59586604|NCT02525653|75693771|FG000|NOT COMPLETED|Overall Study||0||
59586605|NCT02431754|75693777|FG000|STARTED|Period 1 (8 Weeks)||85||
59586606|NCT02431754|75693778|FG001|STARTED|Period 1 (8 Weeks)||86||
59586607|NCT02431754|75693777|FG000|Received at Least One Dose of Study Drug|Period 1 (8 Weeks)||85||
59586608|NCT02431754|75693778|FG001|Received at Least One Dose of Study Drug|Period 1 (8 Weeks)||86||
59586609|NCT02431754|75693777|FG000|COMPLETED|Period 1 (8 Weeks)||79||
59586610|NCT02431754|75693778|FG001|COMPLETED|Period 1 (8 Weeks)||82||
59586611|NCT02431754|75693777|FG000|NOT COMPLETED|Period 1 (8 Weeks)||6||
59586612|NCT02431754|75693778|FG001|NOT COMPLETED|Period 1 (8 Weeks)||4||
59586613|NCT02431754|75693777|FG000|STARTED|Wash-out Period (4 Weeks)||79||
59586614|NCT02431754|75693778|FG001|STARTED|Wash-out Period (4 Weeks)||82||
59586615|NCT02431754|75693777|FG000|COMPLETED|Wash-out Period (4 Weeks)||75||
59586616|NCT02431754|75693778|FG001|COMPLETED|Wash-out Period (4 Weeks)||82||
59586617|NCT02431754|75693777|FG000|NOT COMPLETED|Wash-out Period (4 Weeks)||4||
59725036|NCT01027650|75843841|FG000|COMPLETED|Overall Study||6||
59725037|NCT01027650|75843842|FG001|COMPLETED|Overall Study||6||
59586618|NCT02431754|75693778|FG001|NOT COMPLETED|Wash-out Period (4 Weeks)||0||
59586619|NCT02431754|75693777|FG000|STARTED|Period 2 (8 Weeks)||75||
59586620|NCT02431754|75693778|FG001|STARTED|Period 2 (8 Weeks)||82||
59586621|NCT02431754|75693777|FG000|COMPLETED|Period 2 (8 Weeks)||74||
59586622|NCT02431754|75693778|FG001|COMPLETED|Period 2 (8 Weeks)||78||
59586623|NCT02431754|75693777|FG000|NOT COMPLETED|Period 2 (8 Weeks)||1||
59586624|NCT02431754|75693778|FG001|NOT COMPLETED|Period 2 (8 Weeks)||4||
59586625|NCT02499692|75693786|FG000|STARTED|Overall Study||103||
59586626|NCT02499692|75693786|FG000|COMPLETED|Overall Study||103||
59586627|NCT02499692|75693786|FG000|NOT COMPLETED|Overall Study||0||
59586628|NCT02526277|75693794|FG000|STARTED|Overall Study||8||
59586629|NCT02526277|75693795|FG001|STARTED|Overall Study||6||
59586630|NCT02526277|75693796|FG002|STARTED|Overall Study||7||
59586631|NCT02526277|75693797|FG003|STARTED|Overall Study||7||
59586632|NCT02526277|75693794|FG000|COMPLETED|Overall Study||8||
59586633|NCT02526277|75693795|FG001|COMPLETED|Overall Study||6||
59586634|NCT02526277|75693796|FG002|COMPLETED|Overall Study||7||
59586635|NCT02526277|75693797|FG003|COMPLETED|Overall Study||7||
59586636|NCT02526277|75693794|FG000|NOT COMPLETED|Overall Study||0||
59586637|NCT02526277|75693795|FG001|NOT COMPLETED|Overall Study||0||
59586638|NCT02526277|75693796|FG002|NOT COMPLETED|Overall Study||0||
59586639|NCT02526277|75693797|FG003|NOT COMPLETED|Overall Study||0||
59586640|NCT02500628|75693812|FG000|STARTED|Overall Study||38||
59586641|NCT02500628|75693813|FG001|STARTED|Overall Study||23||
59586642|NCT02500628|75693812|FG000|COMPLETED|Overall Study||38||
59586643|NCT02500628|75693813|FG001|COMPLETED|Overall Study||23||
59586644|NCT02500628|75693812|FG000|NOT COMPLETED|Overall Study||0||
59586645|NCT02500628|75693813|FG001|NOT COMPLETED|Overall Study||0||
59586646|NCT02526667|75693821|FG000|STARTED|Abdomen||284||568
59586647|NCT02526667|75693822|FG001|STARTED|Abdomen||56||112
59586648|NCT02526667|75693823|FG002|STARTED|Abdomen||281||562
59586649|NCT02526667|75693821|FG000|COMPLETED|Abdomen||284||307
59586650|NCT02526667|75693822|FG001|COMPLETED|Abdomen||56||59
59586651|NCT02526667|75693823|FG002|COMPLETED|Abdomen||281||314
59586652|NCT02526667|75693821|FG000|NOT COMPLETED|Abdomen||0||261
59586653|NCT02526667|75693822|FG001|NOT COMPLETED|Abdomen||0||53
59586654|NCT02526667|75693823|FG002|NOT COMPLETED|Abdomen||0||248
59586655|NCT02526667|75693821|FG000|STARTED|Groin||290||580
59586656|NCT02526667|75693822|FG001|STARTED|Groin||56||112
59586657|NCT02526667|75693823|FG002|STARTED|Groin||294||588
59586658|NCT02526667|75693821|FG000|COMPLETED|Groin||290||291
59586659|NCT02526667|75693822|FG001|COMPLETED|Groin||56||55
59586660|NCT02526667|75693823|FG002|COMPLETED|Groin||294||294
59586661|NCT02526667|75693821|FG000|NOT COMPLETED|Groin||0||289
59586662|NCT02526667|75693822|FG001|NOT COMPLETED|Groin||0||57
59586663|NCT02526667|75693823|FG002|NOT COMPLETED|Groin||0||294
59586664|NCT02535806|75693837|FG000|STARTED|Overall Study||2||
59586665|NCT02535806|75693837|FG000|COMPLETED|Overall Study||2||
59586666|NCT02535806|75693837|FG000|NOT COMPLETED|Overall Study||0||
59586667|NCT02865343|75693843|FG000|STARTED|Overall Study||6||
59586668|NCT02865343|75693844|FG001|STARTED|Overall Study||5||
59586669|NCT02865343|75693843|FG000|COMPLETED|Overall Study||6||
59586670|NCT02865343|75693844|FG001|COMPLETED|Overall Study||3||
59586671|NCT02865343|75693843|FG000|NOT COMPLETED|Overall Study||0||
59586672|NCT02865343|75693844|FG001|NOT COMPLETED|Overall Study||2||
59586673|NCT02536040|75693854|FG000|STARTED|Overall Study||30||
59586674|NCT02536040|75693855|FG001|STARTED|Overall Study||36||
59586675|NCT02536040|75693854|FG000|COMPLETED|Overall Study||29||
59586676|NCT02536040|75693855|FG001|COMPLETED|Overall Study||35||
59586677|NCT02536040|75693854|FG000|NOT COMPLETED|Overall Study||1||
59586678|NCT02536040|75693855|FG001|NOT COMPLETED|Overall Study||1||
59586679|NCT02536196|75693864|FG000|STARTED|Overall Study||262||
59586680|NCT02536196|75693865|FG001|STARTED|Overall Study||121||
59586681|NCT02536196|75693866|FG002|STARTED|Overall Study||95||
59725038|NCT01027650|75843843|FG002|COMPLETED|Overall Study||6||
59725039|NCT01027650|75843844|FG003|COMPLETED|Overall Study||3||
59725040|NCT01027650|75843845|FG004|COMPLETED|Overall Study||23||
59725041|NCT01027650|75843846|FG005|COMPLETED|Overall Study||24||
59725042|NCT01027650|75843847|FG006|COMPLETED|Overall Study||24||
59725043|NCT01027650|75843848|FG007|COMPLETED|Overall Study||24||
59725044|NCT01027650|75843841|FG000|NOT COMPLETED|Overall Study||0||
59725045|NCT01027650|75843842|FG001|NOT COMPLETED|Overall Study||0||
59725046|NCT01027650|75843843|FG002|NOT COMPLETED|Overall Study||0||
59725047|NCT01027650|75843844|FG003|NOT COMPLETED|Overall Study||0||
59725048|NCT01027650|75843845|FG004|NOT COMPLETED|Overall Study||2||
59725049|NCT01027650|75843846|FG005|NOT COMPLETED|Overall Study||2||
59725050|NCT01027650|75843847|FG006|NOT COMPLETED|Overall Study||1||
59725051|NCT01027650|75843848|FG007|NOT COMPLETED|Overall Study||0||
59725052|NCT01106027|75843866|FG000|STARTED|Overall Study||2||
59586682|NCT02536196|75693864|FG000|COMPLETED|Overall Study||233||
59586683|NCT02536196|75693865|FG001|COMPLETED|Overall Study||107||
59586684|NCT02536196|75693866|FG002|COMPLETED|Overall Study||95||
59725053|NCT01106027|75843866|FG000|COMPLETED|Overall Study||1||
59725054|NCT01106027|75843866|FG000|NOT COMPLETED|Overall Study||1||
59725055|NCT00927927|75843885|FG000|STARTED|Overall Study||3||
59725056|NCT00927927|75843886|FG001|STARTED|Overall Study||3||
59586685|NCT02536196|75693864|FG000|NOT COMPLETED|Overall Study||29||
59586686|NCT02536196|75693865|FG001|NOT COMPLETED|Overall Study||14||
59586687|NCT02536196|75693866|FG002|NOT COMPLETED|Overall Study||0||
59586688|NCT02461771|75693876|FG000|STARTED|Overall Study||3||
59586689|NCT02461771|75693877|FG001|STARTED|Overall Study||3||
59586690|NCT02461771|75693878|FG002|STARTED|Overall Study||7||
59586691|NCT02461771|75693876|FG000|COMPLETED|Overall Study||3|Completed acute safety observation period (up to Day 15) and follow-up visits up to Day 113.|
59586692|NCT02461771|75693877|FG001|COMPLETED|Overall Study||3|Completed acute safety observation period (up to Day 15) and follow-up visits up to Day 113.|
59586693|NCT02461771|75693878|FG002|COMPLETED|Overall Study||7|Completed acute safety observation period (up to Day 15) and follow-up visits up to Day 113.|
59586694|NCT02461771|75693876|FG000|NOT COMPLETED|Overall Study||0||
59586695|NCT02461771|75693877|FG001|NOT COMPLETED|Overall Study||0||
59586696|NCT02461771|75693878|FG002|NOT COMPLETED|Overall Study||0||
59586697|NCT02463799|75693888|FG000|STARTED|Overall Study||16||
59586698|NCT02463799|75693889|FG001|STARTED|Overall Study||16||
59586699|NCT02463799|75693888|FG000|COMPLETED|Overall Study||16||
59586700|NCT02463799|75693889|FG001|COMPLETED|Overall Study||16||
59586701|NCT02463799|75693888|FG000|NOT COMPLETED|Overall Study||0||
59586702|NCT02463799|75693889|FG001|NOT COMPLETED|Overall Study||0||
59586703|NCT02537444|75693897|FG000|STARTED|Overall Study||39||
59586704|NCT02537444|75693898|FG001|STARTED|Overall Study||39||
59586705|NCT02537444|75693897|FG000|Enrolled|Overall Study||39||
59586706|NCT02537444|75693898|FG001|Enrolled|Overall Study||39||
59586707|NCT02537444|75693897|FG000|Received Study Medication|Overall Study||38||
59586708|NCT02537444|75693898|FG001|Received Study Medication|Overall Study||39||
59586709|NCT02537444|75693897|FG000|Discontinued Study|Overall Study||39||
59586710|NCT02537444|75693898|FG001|Discontinued Study|Overall Study||39||
59586711|NCT02537444|75693897|FG000|COMPLETED|Overall Study||0||
59586712|NCT02537444|75693898|FG001|COMPLETED|Overall Study||0||
59586713|NCT02537444|75693897|FG000|NOT COMPLETED|Overall Study||39||
59586714|NCT02537444|75693898|FG001|NOT COMPLETED|Overall Study||39||
59586715|NCT02464033|75693904|FG000|STARTED|Overall Study||20||
59586716|NCT02464033|75693904|FG000|COMPLETED|Overall Study||20||
59586717|NCT02464033|75693904|FG000|NOT COMPLETED|Overall Study||0||
59586718|NCT02432300|75693909|FG000|STARTED|Overall Study||17||
59586719|NCT02432300|75693909|FG000|COMPLETED|Overall Study||13||
59586720|NCT02432300|75693909|FG000|NOT COMPLETED|Overall Study||4||
59586721|NCT02432456|75693915|FG000|STARTED|Overall Study||75||
59586722|NCT02432456|75693916|FG001|STARTED|Overall Study||75||
59586723|NCT02432456|75693915|FG000|COMPLETED|Overall Study||75||
59586724|NCT02432456|75693916|FG001|COMPLETED|Overall Study||75||
59586725|NCT02432456|75693915|FG000|NOT COMPLETED|Overall Study||0||
59586726|NCT02432456|75693916|FG001|NOT COMPLETED|Overall Study||0||
59586727|NCT02531971|75693924|FG000|STARTED|Overall Study||11||
59586728|NCT02531971|75693925|FG001|STARTED|Overall Study||13||
59586729|NCT02531971|75693924|FG000|COMPLETED|Overall Study||11||
59586730|NCT02531971|75693925|FG001|COMPLETED|Overall Study||13||
59586731|NCT02531971|75693924|FG000|NOT COMPLETED|Overall Study||0||
59586732|NCT02531971|75693925|FG001|NOT COMPLETED|Overall Study||0||
59586733|NCT02464657|75693935|FG000|STARTED|Overall Study||3||
59586734|NCT02464657|75693936|FG001|STARTED|Overall Study||2||
59586735|NCT02464657|75693937|FG002|STARTED|Overall Study||39||
59586736|NCT02464657|75693935|FG000|COMPLETED|Overall Study||3||
59586737|NCT02464657|75693936|FG001|COMPLETED|Overall Study||2||
59586738|NCT02464657|75693937|FG002|COMPLETED|Overall Study||39||
59586739|NCT02464657|75693935|FG000|NOT COMPLETED|Overall Study||0||
59586740|NCT02464657|75693936|FG001|NOT COMPLETED|Overall Study||0||
59586741|NCT02464657|75693937|FG002|NOT COMPLETED|Overall Study||0||
59586742|NCT02533063|75693948|FG000|STARTED|Intervention 1 (8 Weeks)||16||
59725057|NCT00927927|75843887|FG002|STARTED|Overall Study||3||
59854636|NCT00355121|75979210|FG000|COMPLETED|Overall Study||332||
59586743|NCT02533063|75693949|FG001|STARTED|Intervention 1 (8 Weeks)||16||
59586744|NCT02533063|75693948|FG000|COMPLETED|Intervention 1 (8 Weeks)||14||
59586745|NCT02533063|75693949|FG001|COMPLETED|Intervention 1 (8 Weeks)||11||
59586746|NCT02533063|75693948|FG000|NOT COMPLETED|Intervention 1 (8 Weeks)||2||
59586747|NCT02533063|75693949|FG001|NOT COMPLETED|Intervention 1 (8 Weeks)||5||
59586748|NCT02533063|75693948|FG000|STARTED|Washout (4 Weeks)||14||
59586749|NCT02533063|75693949|FG001|STARTED|Washout (4 Weeks)||11||
59586750|NCT02533063|75693948|FG000|COMPLETED|Washout (4 Weeks)||14||
59586751|NCT02533063|75693949|FG001|COMPLETED|Washout (4 Weeks)||11||
59586752|NCT02533063|75693948|FG000|NOT COMPLETED|Washout (4 Weeks)||0||
59586753|NCT02533063|75693949|FG001|NOT COMPLETED|Washout (4 Weeks)||0||
59586754|NCT02533063|75693948|FG000|STARTED|Intervention 2 (8 Weeks)||14||
59586755|NCT02533063|75693949|FG001|STARTED|Intervention 2 (8 Weeks)||11||
59586756|NCT02533063|75693948|FG000|COMPLETED|Intervention 2 (8 Weeks)||14||
59586757|NCT02533063|75693949|FG001|COMPLETED|Intervention 2 (8 Weeks)||11||
59586758|NCT02533063|75693948|FG000|NOT COMPLETED|Intervention 2 (8 Weeks)||0||
59586759|NCT02533063|75693949|FG001|NOT COMPLETED|Intervention 2 (8 Weeks)||0||
59586760|NCT02467075|75693958|FG000|STARTED|Initial CT Scan||0||
59586761|NCT02467075|75693959|FG001|STARTED|Initial CT Scan||1||
59586762|NCT02467075|75693958|FG000|COMPLETED|Initial CT Scan||0||
59586763|NCT02467075|75693959|FG001|COMPLETED|Initial CT Scan||1||
59586764|NCT02467075|75693958|FG000|NOT COMPLETED|Initial CT Scan||0||
59586765|NCT02467075|75693959|FG001|NOT COMPLETED|Initial CT Scan||0||
59586766|NCT02467075|75693958|FG000|STARTED|48 Hour Follow-up||0||
59586767|NCT02467075|75693959|FG001|STARTED|48 Hour Follow-up||1||
59586768|NCT02467075|75693958|FG000|COMPLETED|48 Hour Follow-up||0||
59586769|NCT02467075|75693959|FG001|COMPLETED|48 Hour Follow-up||1||
59586770|NCT02467075|75693958|FG000|NOT COMPLETED|48 Hour Follow-up||0||
59586771|NCT02467075|75693959|FG001|NOT COMPLETED|48 Hour Follow-up||0||
59586772|NCT02467075|75693958|FG000|STARTED|72 Hour Follow-up||0||
59586773|NCT02467075|75693959|FG001|STARTED|72 Hour Follow-up||1||
59586774|NCT02467075|75693958|FG000|COMPLETED|72 Hour Follow-up||0||
59586775|NCT02467075|75693959|FG001|COMPLETED|72 Hour Follow-up||1||
59586776|NCT02467075|75693958|FG000|NOT COMPLETED|72 Hour Follow-up||0||
59586777|NCT02467075|75693959|FG001|NOT COMPLETED|72 Hour Follow-up||0||
59586778|NCT02467075|75693958|FG000|STARTED|30 Day Follow-up||0||
59586779|NCT02467075|75693959|FG001|STARTED|30 Day Follow-up||1||
59586780|NCT02467075|75693958|FG000|COMPLETED|30 Day Follow-up||0||
59586781|NCT02467075|75693959|FG001|COMPLETED|30 Day Follow-up||1||
59586782|NCT02467075|75693958|FG000|NOT COMPLETED|30 Day Follow-up||0||
59586783|NCT02467075|75693959|FG001|NOT COMPLETED|30 Day Follow-up||0||
59586784|NCT02533921|75693969|FG000|STARTED|Overall Study||104||
59586785|NCT02533921|75693970|FG001|STARTED|Overall Study||106||
59586786|NCT02533921|75693969|FG000|COMPLETED|Overall Study||88||
59586787|NCT02533921|75693970|FG001|COMPLETED|Overall Study||95||
59586788|NCT02533921|75693969|FG000|NOT COMPLETED|Overall Study||16||
59586789|NCT02533921|75693970|FG001|NOT COMPLETED|Overall Study||11||
59586790|NCT02535481|75693978|FG000|STARTED|Overall Study||22||
59586791|NCT02535481|75693979|FG001|STARTED|Overall Study||22||
59586792|NCT02535481|75693978|FG000|COMPLETED|Overall Study||22||
59586793|NCT02535481|75693979|FG001|COMPLETED|Overall Study||22||
59586794|NCT02535481|75693978|FG000|NOT COMPLETED|Overall Study||0||
59586795|NCT02535481|75693979|FG001|NOT COMPLETED|Overall Study||0||
59586796|NCT02535949|75693988|FG000|STARTED|Overall Study||50||
59586797|NCT02535949|75693989|FG001|STARTED|Overall Study||50||
59586798|NCT02535949|75693990|FG002|STARTED|Overall Study||50||
59586799|NCT02535949|75693988|FG000|COMPLETED|Overall Study||49||
59586800|NCT02535949|75693989|FG001|COMPLETED|Overall Study||50||
59586801|NCT02535949|75693990|FG002|COMPLETED|Overall Study||50||
59586802|NCT02535949|75693988|FG000|NOT COMPLETED|Overall Study||1||
59586803|NCT02535949|75693989|FG001|NOT COMPLETED|Overall Study||0||
59586804|NCT02535949|75693990|FG002|NOT COMPLETED|Overall Study||0||
59586805|NCT02536105|75693999|FG000|STARTED|Concerta Open Label||80||
59586806|NCT02536105|75693999|FG000|Completion of Phase|Concerta Open Label||76||
59586807|NCT02536105|75693999|FG000|COMPLETED|Concerta Open Label||72|Number of participants who completed the entire study.|
59586808|NCT02536105|75693999|FG000|NOT COMPLETED|Concerta Open Label||8||
59586809|NCT02536105|75693999|FG000|STARTED|Placebo||74||
59586810|NCT02536105|75693999|FG000|Completion of Placebo Day|Placebo||74||
59586811|NCT02536105|75693999|FG000|COMPLETED|Placebo||72|Number of participants who completed the entire study.|
59586812|NCT02536105|75693999|FG000|NOT COMPLETED|Placebo||2||
59586813|NCT02536105|75693999|FG000|STARTED|Methylphenidate HCl ER Tablet 1||72||
59586814|NCT02536105|75693999|FG000|Completion of MPH HCl ER Tab 1 Day|Methylphenidate HCl ER Tablet 1||72||
59586815|NCT02536105|75693999|FG000|COMPLETED|Methylphenidate HCl ER Tablet 1||72|Number of participants who completed the entire study.|
59586816|NCT02536105|75693999|FG000|NOT COMPLETED|Methylphenidate HCl ER Tablet 1||0||
59586817|NCT02536105|75693999|FG000|STARTED|Methylphenidate HCl ER Tablet 2||73||
59586818|NCT02536105|75693999|FG000|Completion of MPH HCl ER Tablet 2 Phase|Methylphenidate HCl ER Tablet 2||73||
59586819|NCT02536105|75693999|FG000|COMPLETED|Methylphenidate HCl ER Tablet 2||72|Number of participants who completed the entire study.|
59586820|NCT02536105|75693999|FG000|NOT COMPLETED|Methylphenidate HCl ER Tablet 2||1||
59586821|NCT02536105|75693999|FG000|STARTED|Methylphenidate HCl ER Suspension||74||
59586822|NCT02536105|75693999|FG000|Completion of MPH HCl ER Susp Phase|Methylphenidate HCl ER Suspension||74||
59586823|NCT02536105|75693999|FG000|COMPLETED|Methylphenidate HCl ER Suspension||72|Number of participants who completed the entire study.|
59586824|NCT02536105|75693999|FG000|NOT COMPLETED|Methylphenidate HCl ER Suspension||2||
59586825|NCT02436668|75694011|FG000|STARTED|Overall Study||213||
59586826|NCT02436668|75694012|FG001|STARTED|Overall Study||211||
59586827|NCT02436668|75694011|FG000|COMPLETED|Overall Study||212||
59586828|NCT02436668|75694012|FG001|COMPLETED|Overall Study||207||
59586829|NCT02436668|75694011|FG000|NOT COMPLETED|Overall Study||1||
59586830|NCT02436668|75694012|FG001|NOT COMPLETED|Overall Study||4||
59586831|NCT02503982|75694021|FG000|STARTED|Overall Study||13||
59586832|NCT02503982|75694021|FG000|COMPLETED|Overall Study||13||
59586833|NCT02503982|75694021|FG000|NOT COMPLETED|Overall Study||0||
59586834|NCT02438540|75694027|FG000|STARTED|Overall Study||19||
59586835|NCT02438540|75694028|FG001|STARTED|Overall Study||20||
59586836|NCT02438540|75694027|FG000|COMPLETED|Overall Study||19||
59586837|NCT02438540|75694028|FG001|COMPLETED|Overall Study||20||
59586838|NCT02438540|75694027|FG000|NOT COMPLETED|Overall Study||0||
59586839|NCT02438540|75694028|FG001|NOT COMPLETED|Overall Study||0||
59586840|NCT02506634|75694043|FG000|STARTED|Overall Study||374||
59586841|NCT02506634|75694043|FG000|Participants Who Were Diagnosed as GERD|Overall Study||154||
59725058|NCT00927927|75843888|FG003|STARTED|Overall Study||3||
59586842|NCT02506634|75694043|FG000|Participants Who Received PPI Treatment|Overall Study||357||
59586843|NCT02506634|75694043|FG000|Participants Who Finished GERDQ|Overall Study||342||
59586844|NCT02506634|75694043|FG000|COMPLETED|Overall Study||357||
59586845|NCT02506634|75694043|FG000|NOT COMPLETED|Overall Study||17||
59586846|NCT02506868|75694083|FG000|STARTED|Main Period of Study (24 Weeks)||98||
59586847|NCT02506868|75694084|FG001|STARTED|Main Period of Study (24 Weeks)||98||
59586848|NCT02506868|75694083|FG000|mITT Population|Main Period of Study (24 Weeks)||98|The analysis included all patients who received at least one injection of BCD-066 or Aranesp.|
59586849|NCT02506868|75694084|FG001|mITT Population|Main Period of Study (24 Weeks)|One patient from Aranesp group was excluded prior to the first administration|97|The analysis included all patients who received at least one injection of BCD-066 or Aranesp.|
59586850|NCT02506868|75694083|FG000|Per Protocol Population|Main Period of Study (24 Weeks)||86|The analysis included all patients who completed 24 weeks of study|
59586851|NCT02506868|75694084|FG001|Per Protocol Population|Main Period of Study (24 Weeks)||90|The analysis included all patients who completed 24 weeks of study|
59586852|NCT02506868|75694083|FG000|COMPLETED|Main Period of Study (24 Weeks)||86||
59586853|NCT02506868|75694084|FG001|COMPLETED|Main Period of Study (24 Weeks)||90||
59586854|NCT02506868|75694083|FG000|NOT COMPLETED|Main Period of Study (24 Weeks)||12||
59586855|NCT02506868|75694084|FG001|NOT COMPLETED|Main Period of Study (24 Weeks)||8||
59586856|NCT02506868|75694083|FG000|STARTED|Additional Period of Study (Until 52W)||86||
59586857|NCT02506868|75694084|FG001|STARTED|Additional Period of Study (Until 52W)||90||
59586858|NCT02506868|75694083|FG000|COMPLETED|Additional Period of Study (Until 52W)||83||
59586859|NCT02506868|75694084|FG001|COMPLETED|Additional Period of Study (Until 52W)||85||
59586860|NCT02506868|75694083|FG000|NOT COMPLETED|Additional Period of Study (Until 52W)||3||
59586861|NCT02506868|75694084|FG001|NOT COMPLETED|Additional Period of Study (Until 52W)||5||
59586862|NCT02541422|75694094|FG000|STARTED|First Intervention||23||
59586863|NCT02541422|75694095|FG001|STARTED|First Intervention||26||
59586864|NCT02541422|75694094|FG000|COMPLETED|First Intervention||23||
59586865|NCT02541422|75694095|FG001|COMPLETED|First Intervention||26||
59586866|NCT02541422|75694094|FG000|NOT COMPLETED|First Intervention||0||
59586867|NCT02541422|75694095|FG001|NOT COMPLETED|First Intervention||0||
59586868|NCT02541422|75694094|FG000|STARTED|Second Intervention||23||
59586869|NCT02541422|75694095|FG001|STARTED|Second Intervention||26||
59586870|NCT02541422|75694094|FG000|COMPLETED|Second Intervention||23||
59586871|NCT02541422|75694095|FG001|COMPLETED|Second Intervention||26||
59586872|NCT02541422|75694094|FG000|NOT COMPLETED|Second Intervention||0||
59586873|NCT02541422|75694095|FG001|NOT COMPLETED|Second Intervention||0||
59586874|NCT02541812|75694103|FG000|STARTED|Overall Study||10||
59586875|NCT02541812|75694104|FG001|STARTED|Overall Study||10||
59586876|NCT02541812|75694103|FG000|COMPLETED|Overall Study||10||
59586877|NCT02541812|75694104|FG001|COMPLETED|Overall Study||10||
59586878|NCT02541812|75694103|FG000|NOT COMPLETED|Overall Study||0||
59586879|NCT02541812|75694104|FG001|NOT COMPLETED|Overall Study||0||
59586880|NCT02542046|75694114|FG000|STARTED|Overall Study||300||
59586881|NCT02542046|75694115|FG001|STARTED|Overall Study||300||
59586882|NCT02542046|75694116|FG002|STARTED|Overall Study||300||
59586883|NCT02542046|75694114|FG000|COMPLETED|Overall Study||300||
59586884|NCT02542046|75694115|FG001|COMPLETED|Overall Study||300||
59586885|NCT02542046|75694116|FG002|COMPLETED|Overall Study||300||
59586886|NCT02542046|75694114|FG000|NOT COMPLETED|Overall Study||0||
59586887|NCT02542046|75694115|FG001|NOT COMPLETED|Overall Study||0||
59586888|NCT02542046|75694116|FG002|NOT COMPLETED|Overall Study||0||
59586889|NCT02439164|75694126|FG000|STARTED|Overall Study||18||
59586890|NCT02439164|75694127|FG001|STARTED|Overall Study||18||
59586891|NCT02439164|75694126|FG000|COMPLETED|Overall Study||18||
59586892|NCT02439164|75694127|FG001|COMPLETED|Overall Study||18||
59586893|NCT02439164|75694126|FG000|NOT COMPLETED|Overall Study||0||
59586894|NCT02439164|75694127|FG001|NOT COMPLETED|Overall Study||0||
59586895|NCT02542280|75694136|FG000|STARTED|Overall Study||174||
59586896|NCT02542280|75694137|FG001|STARTED|Overall Study||175||
59586897|NCT02542280|75694136|FG000|COMPLETED|Overall Study||162||
59586898|NCT02542280|75694137|FG001|COMPLETED|Overall Study||167||
59586899|NCT02542280|75694136|FG000|NOT COMPLETED|Overall Study||12||
59586900|NCT02542280|75694137|FG001|NOT COMPLETED|Overall Study||8||
59586901|NCT02439710|75694143|FG000|STARTED|Overall Study||656||
59586902|NCT02439710|75694143|FG000|COMPLETED|Overall Study||656||
59586903|NCT02439710|75694143|FG000|NOT COMPLETED|Overall Study||0||
59586904|NCT02440022|75694149|FG000|STARTED|Overall Study||141||
59586905|NCT02440022|75694150|FG001|STARTED|Overall Study||144||
59586906|NCT02440022|75694149|FG000|COMPLETED|Overall Study||114||
59854637|NCT00355121|75979211|FG001|COMPLETED|Overall Study||324||
59586907|NCT02440022|75694150|FG001|COMPLETED|Overall Study||131||
59586908|NCT02440022|75694149|FG000|NOT COMPLETED|Overall Study||27||
59586909|NCT02440022|75694150|FG001|NOT COMPLETED|Overall Study||13||
59586910|NCT02440178|75694156|FG000|STARTED|Overall Study||66||
59586911|NCT02440178|75694156|FG000|COMPLETED|Overall Study||46||
59586912|NCT02440178|75694156|FG000|NOT COMPLETED|Overall Study||20||
59586913|NCT02543840|75694164|FG000|STARTED|Overall Study|This is a quasi-experimental design, not a RCT. 1050 veterans did 1436 interviews at 3 time points.|1050||
59586914|NCT02543840|75694165|FG001|STARTED|Overall Study||62||
59586915|NCT02543840|75694164|FG000|0 Month Timepoint (t0)|Overall Study||593||
59586916|NCT02543840|75694165|FG001|0 Month Timepoint (t0)|Overall Study||40||
59586917|NCT02543840|75694164|FG000|6 Month Timepoint (t6)|Overall Study|593 participants started at 0 months; 188 repeated and 66 participants added at 6 months timepoint.|66||
59586918|NCT02543840|75694165|FG001|6 Month Timepoint (t6)|Overall Study||0||
59586919|NCT02543840|75694164|FG000|12 Month Timepoint (t12)|Overall Study|91 continued from 0 months (t0), 16 from 6 months (t6), 91 from t0 & t6; 391 added at 12 months.|391||
59586920|NCT02543840|75694165|FG001|12 Month Timepoint (t12)|Overall Study|22 new providers completed at 12 months; 21 completed at both 0 and 12 months. 19 completed only T0.|22||
59586921|NCT02543840|75694164|FG000|COMPLETED|Overall Study||1050||
59586922|NCT02543840|75694165|FG001|COMPLETED|Overall Study||62||
59586923|NCT02543840|75694164|FG000|NOT COMPLETED|Overall Study||0||
59586924|NCT02543840|75694165|FG001|NOT COMPLETED|Overall Study||0||
59586925|NCT02546570|75694174|FG000|STARTED|Overall Study||9||
59586926|NCT02546570|75694175|FG001|STARTED|Overall Study||2||
59586927|NCT02546570|75694174|FG000|Crossover Order: Oxytocin, Placebo|Overall Study||6||
59586928|NCT02546570|75694175|FG001|Crossover Order: Oxytocin, Placebo|Overall Study||2||
59586929|NCT02546570|75694174|FG000|Crossover Order: Placebo, Oxytocin|Overall Study||3||
59586930|NCT02546570|75694175|FG001|Crossover Order: Placebo, Oxytocin|Overall Study||0||
59586931|NCT02546570|75694174|FG000|COMPLETED|Overall Study||9||
59586932|NCT02546570|75694175|FG001|COMPLETED|Overall Study||2||
59586933|NCT02546570|75694174|FG000|NOT COMPLETED|Overall Study||0||
59586934|NCT02546570|75694175|FG001|NOT COMPLETED|Overall Study||0||
59586935|NCT02743351|75694188|FG000|STARTED|Overall Study||7||
59586936|NCT02743351|75694189|FG001|STARTED|Overall Study||45||
59586937|NCT02743351|75694190|FG002|STARTED|Overall Study||44||
59586938|NCT02743351|75694188|FG000|COMPLETED|Overall Study||7|Patients who completed study through day +100|
59586939|NCT02743351|75694189|FG001|COMPLETED|Overall Study||35|Patients who completed study through day +100|
59586940|NCT02743351|75694190|FG002|COMPLETED|Overall Study||36|Patients who completed study through day +100|
59586941|NCT02743351|75694188|FG000|NOT COMPLETED|Overall Study||0||
59586942|NCT02743351|75694189|FG001|NOT COMPLETED|Overall Study||10||
59586943|NCT02743351|75694190|FG002|NOT COMPLETED|Overall Study||8||
59586944|NCT02548910|75694204|FG000|STARTED|Overall Study||31||
59586945|NCT02548910|75694205|FG001|STARTED|Overall Study||31||
59586946|NCT02548910|75694204|FG000|COMPLETED|Overall Study||31||
59586947|NCT02548910|75694205|FG001|COMPLETED|Overall Study||31||
59586948|NCT02548910|75694204|FG000|NOT COMPLETED|Overall Study||0||
59586949|NCT02548910|75694205|FG001|NOT COMPLETED|Overall Study||0||
59586950|NCT02538523|75694214|FG000|STARTED|Overall Study||29||
59586951|NCT02538523|75694215|FG001|STARTED|Overall Study||29||
59586952|NCT02538523|75694214|FG000|COMPLETED|Overall Study||29||
59586953|NCT02538523|75694215|FG001|COMPLETED|Overall Study||29||
59586954|NCT02538523|75694214|FG000|NOT COMPLETED|Overall Study||0||
59586955|NCT02538523|75694215|FG001|NOT COMPLETED|Overall Study||0||
59586956|NCT02510144|75694223|FG000|STARTED|Overall Study||39||
59586957|NCT02510144|75694224|FG001|STARTED|Overall Study||41||
59586958|NCT02510144|75694223|FG000|COMPLETED|Overall Study||39||
59586959|NCT02510144|75694224|FG001|COMPLETED|Overall Study||41||
59586960|NCT02510144|75694223|FG000|NOT COMPLETED|Overall Study||0||
59586961|NCT02510144|75694224|FG001|NOT COMPLETED|Overall Study||0||
59586962|NCT02538679|75694233|FG000|STARTED|Overall Study||24||
59586963|NCT02538679|75694234|FG001|STARTED|Overall Study||54||
59586964|NCT02538679|75694235|FG002|STARTED|Overall Study||49||
59586965|NCT02538679|75694233|FG000|COMPLETED|Overall Study||21||
59586966|NCT02538679|75694234|FG001|COMPLETED|Overall Study||45||
59586967|NCT02538679|75694235|FG002|COMPLETED|Overall Study||41||
59586968|NCT02538679|75694233|FG000|NOT COMPLETED|Overall Study||3||
59586969|NCT02538679|75694234|FG001|NOT COMPLETED|Overall Study||9||
59586970|NCT02538679|75694235|FG002|NOT COMPLETED|Overall Study||8||
59586971|NCT02511236|75694245|FG000|STARTED|Overall Study||165||
59586972|NCT02511236|75694246|FG001|STARTED|Overall Study||191||
59586973|NCT02511236|75694245|FG000|COMPLETED|Overall Study||125||
59586974|NCT02511236|75694246|FG001|COMPLETED|Overall Study||146||
59586975|NCT02511236|75694245|FG000|NOT COMPLETED|Overall Study||40||
59586976|NCT02511236|75694246|FG001|NOT COMPLETED|Overall Study||45||
59586977|NCT02467387|75694252|FG000|STARTED|First Intervention||11||
59586978|NCT02467387|75694253|FG001|STARTED|First Intervention||12||
59586979|NCT02467387|75694252|FG000|Received Treatment as Randomized|First Intervention||10||
59586980|NCT02467387|75694253|FG001|Received Treatment as Randomized|First Intervention||12||
59586981|NCT02467387|75694252|FG000|COMPLETED|First Intervention||10||
59586982|NCT02467387|75694253|FG001|COMPLETED|First Intervention||12||
59586983|NCT02467387|75694252|FG000|NOT COMPLETED|First Intervention||1||
59586984|NCT02467387|75694253|FG001|NOT COMPLETED|First Intervention||0||
59586985|NCT02467387|75694252|FG000|STARTED|Second Intervention||10||
59854638|NCT00355121|75979212|FG002|COMPLETED|Overall Study||170||
59854639|NCT00355121|75979210|FG000|NOT COMPLETED|Overall Study||21||
59586986|NCT02467387|75694253|FG001|STARTED|Second Intervention||12||
59586987|NCT02467387|75694252|FG000|COMPLETED|Second Intervention||7||
59586988|NCT02467387|75694253|FG001|COMPLETED|Second Intervention||12||
59586989|NCT02467387|75694252|FG000|NOT COMPLETED|Second Intervention||3||
59586990|NCT02467387|75694253|FG001|NOT COMPLETED|Second Intervention||0||
59725059|NCT00927927|75843889|FG004|STARTED|Overall Study||3||
59586991|NCT02512094|75694261|FG000|STARTED|Overall Study||53||
59586992|NCT02512094|75694261|FG000|COMPLETED|Overall Study||53||
59586993|NCT02512094|75694261|FG000|NOT COMPLETED|Overall Study||0||
59586994|NCT02512874|75694265|FG000|STARTED|Overall Study||65||
59586995|NCT02512874|75694265|FG000|COMPLETED|Overall Study||63||
59586996|NCT02512874|75694265|FG000|NOT COMPLETED|Overall Study||2||
59586997|NCT02721979|75694269|FG000|STARTED|Overall Study||23||
59586998|NCT02721979|75694269|FG000|COMPLETED|Overall Study||22||
59586999|NCT02721979|75694269|FG000|NOT COMPLETED|Overall Study||1||
59587000|NCT02551094|75694276|FG000|STARTED|Overall Study||2366||
59587001|NCT02551094|75694277|FG001|STARTED|Overall Study||2379||
59587002|NCT02551094|75694276|FG000|COMPLETED|Overall Study||2226||
59587003|NCT02551094|75694277|FG001|COMPLETED|Overall Study||2232||
59587004|NCT02551094|75694276|FG000|NOT COMPLETED|Overall Study||140||
59587005|NCT02551094|75694277|FG001|NOT COMPLETED|Overall Study||147||
59587006|NCT02513498|75694283|FG000|STARTED|Overall Study||50||
59587007|NCT02513498|75694283|FG000|COMPLETED|Overall Study||26||
59587008|NCT02513498|75694283|FG000|NOT COMPLETED|Overall Study||24||
59587009|NCT02514044|75694289|FG000|STARTED|Dexedrine+tDCS+Speech Therapy (1 Day)||10||
59587010|NCT02514044|75694289|FG000|COMPLETED|Dexedrine+tDCS+Speech Therapy (1 Day)||10||
59587011|NCT02514044|75694289|FG000|NOT COMPLETED|Dexedrine+tDCS+Speech Therapy (1 Day)||0||
59587012|NCT02514044|75694289|FG000|STARTED|Washout (1 Week)||10||
59587013|NCT02514044|75694289|FG000|COMPLETED|Washout (1 Week)||10||
59587014|NCT02514044|75694289|FG000|NOT COMPLETED|Washout (1 Week)||0||
59587015|NCT02514044|75694289|FG000|STARTED|Placebo+tDCS+Speech Therapy (1 Day)||10||
59587016|NCT02514044|75694289|FG000|COMPLETED|Placebo+tDCS+Speech Therapy (1 Day)||10||
59587017|NCT02514044|75694289|FG000|NOT COMPLETED|Placebo+tDCS+Speech Therapy (1 Day)||0||
59587018|NCT02515058|75694299|FG000|STARTED|Overall Study||21||
59587019|NCT02515058|75694300|FG001|STARTED|Overall Study||22||
59587020|NCT02515058|75694299|FG000|COMPLETED|Overall Study||18||
59587021|NCT02515058|75694300|FG001|COMPLETED|Overall Study||20||
59587022|NCT02515058|75694299|FG000|NOT COMPLETED|Overall Study||3||
59587023|NCT02515058|75694300|FG001|NOT COMPLETED|Overall Study||2||
59587024|NCT02552810|75694308|FG000|STARTED|Overall Study||15||
59587025|NCT02552810|75694309|FG001|STARTED|Overall Study||15||
59587026|NCT02552810|75694308|FG000|COMPLETED|Overall Study||15||
59587027|NCT02552810|75694309|FG001|COMPLETED|Overall Study||15||
59587028|NCT02552810|75694308|FG000|NOT COMPLETED|Overall Study||0||
59587029|NCT02552810|75694309|FG001|NOT COMPLETED|Overall Study||0||
59587030|NCT02553512|75694315|FG000|STARTED|Overall Study||167||
59587031|NCT02553512|75694315|FG000|COMPLETED|Overall Study||144||
59587032|NCT02553512|75694315|FG000|NOT COMPLETED|Overall Study||23||
59587033|NCT02553746|75694321|FG000|STARTED|Overall Study||80||
59587034|NCT02553746|75694322|FG001|STARTED|Overall Study||66||
59587035|NCT02553746|75694321|FG000|COMPLETED|Overall Study||77||
59587036|NCT02553746|75694322|FG001|COMPLETED|Overall Study||64||
59587037|NCT02553746|75694321|FG000|NOT COMPLETED|Overall Study||3||
59587038|NCT02553746|75694322|FG001|NOT COMPLETED|Overall Study||2||
59587039|NCT02554760|75694328|FG000|STARTED|Overall Study||9||
59587040|NCT02554760|75694329|FG001|STARTED|Overall Study||10||
59587041|NCT02554760|75694328|FG000|COMPLETED|Overall Study||9||
59587042|NCT02554760|75694329|FG001|COMPLETED|Overall Study||10||
59587043|NCT02554760|75694328|FG000|NOT COMPLETED|Overall Study||0||
59587044|NCT02554760|75694329|FG001|NOT COMPLETED|Overall Study||0||
59587045|NCT02555228|75694340|FG000|STARTED|Overall Study|20th August 2015|27||
59587046|NCT02555228|75694341|FG001|STARTED|Overall Study|14th August 2015|27||
59587047|NCT02555228|75694340|FG000|COMPLETED|Overall Study|19th November 2015|27||
59587048|NCT02555228|75694341|FG001|COMPLETED|Overall Study|29th October 2015|27||
59587049|NCT02555228|75694340|FG000|NOT COMPLETED|Overall Study||0||
59587050|NCT02555228|75694341|FG001|NOT COMPLETED|Overall Study||0||
59587051|NCT02555306|75694351|FG000|STARTED|Overall Study||3||
59587052|NCT02555306|75694352|FG001|STARTED|Overall Study||3||
59587053|NCT02555306|75694353|FG002|STARTED|Overall Study||3||
59587054|NCT02555306|75694354|FG003|STARTED|Overall Study||3||
59587055|NCT02555306|75694351|FG000|COMPLETED|Overall Study||3||
59854640|NCT00355121|75979211|FG001|NOT COMPLETED|Overall Study||29||
59587056|NCT02555306|75694352|FG001|COMPLETED|Overall Study||3||
59587057|NCT02555306|75694353|FG002|COMPLETED|Overall Study||3||
59587058|NCT02555306|75694354|FG003|COMPLETED|Overall Study||3||
59587059|NCT02555306|75694351|FG000|NOT COMPLETED|Overall Study||0||
59587060|NCT02555306|75694352|FG001|NOT COMPLETED|Overall Study||0||
59587061|NCT02555306|75694353|FG002|NOT COMPLETED|Overall Study||0||
59587062|NCT02555306|75694354|FG003|NOT COMPLETED|Overall Study||0||
59587063|NCT02555930|75694364|FG000|STARTED|Overall Study||148||
59587064|NCT02555930|75694364|FG000|COMPLETED|Overall Study||148||
59587065|NCT02555930|75694364|FG000|NOT COMPLETED|Overall Study||0||
59587066|NCT02556554|75694372|FG000|STARTED|Overall Study||8||
59587067|NCT02556554|75694373|FG001|STARTED|Overall Study||14||
59587068|NCT02556554|75694374|FG002|STARTED|Overall Study||19||
59587069|NCT02556554|75694375|FG003|STARTED|Overall Study||12||
59587070|NCT02556554|75694376|FG004|STARTED|Overall Study||14||
59587071|NCT02556554|75694372|FG000|COMPLETED|Overall Study||8||
59587072|NCT02556554|75694373|FG001|COMPLETED|Overall Study||13||
59587073|NCT02556554|75694374|FG002|COMPLETED|Overall Study||15||
59587074|NCT02556554|75694375|FG003|COMPLETED|Overall Study||12||
59587075|NCT02556554|75694376|FG004|COMPLETED|Overall Study||14||
59587076|NCT02556554|75694372|FG000|NOT COMPLETED|Overall Study||0||
59587077|NCT02556554|75694373|FG001|NOT COMPLETED|Overall Study||1||
59587078|NCT02556554|75694374|FG002|NOT COMPLETED|Overall Study||4||
59587079|NCT02556554|75694375|FG003|NOT COMPLETED|Overall Study||0||
59587080|NCT02556554|75694376|FG004|NOT COMPLETED|Overall Study||0||
59587081|NCT02556788|75694389|FG000|STARTED|Overall Study||602||
59587082|NCT02556788|75694390|FG001|STARTED|Overall Study||610||
59587083|NCT02556788|75694389|FG000|COMPLETED|Overall Study||558||
59587084|NCT02556788|75694390|FG001|COMPLETED|Overall Study||573||
59587085|NCT02556788|75694389|FG000|NOT COMPLETED|Overall Study||44||
59587086|NCT02556788|75694390|FG001|NOT COMPLETED|Overall Study||37||
59587087|NCT02516150|75694396|FG000|STARTED|Overall Study||15||
59587088|NCT02516150|75694396|FG000|COMPLETED|Overall Study||15||
59587089|NCT02516150|75694396|FG000|NOT COMPLETED|Overall Study||0||
59587090|NCT02557178|75694404|FG000|STARTED|Overall Study||72||
59587091|NCT02557178|75694405|FG001|STARTED|Overall Study||74||
59587092|NCT02557178|75694404|FG000|COMPLETED|Overall Study||56||
59587093|NCT02557178|75694405|FG001|COMPLETED|Overall Study||63||
59587094|NCT02557178|75694404|FG000|NOT COMPLETED|Overall Study||16||
59587095|NCT02557178|75694405|FG001|NOT COMPLETED|Overall Study||11||
59587096|NCT02560922|75694413|FG000|STARTED|Overall Study||124||
59587097|NCT02560922|75694414|FG001|STARTED|Overall Study||124||
59587098|NCT02560922|75694413|FG000|COMPLETED|Overall Study||98||
59587099|NCT02560922|75694414|FG001|COMPLETED|Overall Study||112||
59587100|NCT02560922|75694413|FG000|NOT COMPLETED|Overall Study||26||
59587101|NCT02560922|75694414|FG001|NOT COMPLETED|Overall Study||12||
59587102|NCT02561702|75694420|FG000|STARTED|First Intervention||2||
59587103|NCT02561702|75694421|FG001|STARTED|First Intervention||2||
59587104|NCT02561702|75694420|FG000|COMPLETED|First Intervention||2||
59587105|NCT02561702|75694421|FG001|COMPLETED|First Intervention||2||
59587106|NCT02561702|75694420|FG000|NOT COMPLETED|First Intervention||0||
59587107|NCT02561702|75694421|FG001|NOT COMPLETED|First Intervention||0||
59587108|NCT02561702|75694420|FG000|STARTED|Washout||2||
59587109|NCT02561702|75694421|FG001|STARTED|Washout||2||
59587110|NCT02561702|75694420|FG000|COMPLETED|Washout||2||
59587111|NCT02561702|75694421|FG001|COMPLETED|Washout||2||
59587112|NCT02561702|75694420|FG000|NOT COMPLETED|Washout||0||
59587113|NCT02561702|75694421|FG001|NOT COMPLETED|Washout||0||
59587114|NCT02561702|75694420|FG000|STARTED|Second Intervention||2||
59587115|NCT02561702|75694421|FG001|STARTED|Second Intervention||2||
59587116|NCT02561702|75694420|FG000|COMPLETED|Second Intervention||2||
59587117|NCT02561702|75694421|FG001|COMPLETED|Second Intervention||2||
59587118|NCT02561702|75694420|FG000|NOT COMPLETED|Second Intervention||0||
59587119|NCT02561702|75694421|FG001|NOT COMPLETED|Second Intervention||0||
59587120|NCT02563496|75694432|FG000|STARTED|Overall Study|No participants were enrolled since they didn't meet inclusion/exclusion criteria.|0||
59587121|NCT02563496|75694433|FG001|STARTED|Overall Study||14||
59587122|NCT02563496|75694434|FG002|STARTED|Overall Study||5||
59587123|NCT02563496|75694435|FG003|STARTED|Overall Study||22||
59587124|NCT02563496|75694436|FG004|STARTED|Overall Study||19||
59587125|NCT02563496|75694432|FG000|COMPLETED|Overall Study||0||
59587126|NCT02563496|75694433|FG001|COMPLETED|Overall Study||14||
59587127|NCT02563496|75694434|FG002|COMPLETED|Overall Study||5||
59587128|NCT02563496|75694435|FG003|COMPLETED|Overall Study||22||
59587129|NCT02563496|75694436|FG004|COMPLETED|Overall Study||19||
59587130|NCT02563496|75694432|FG000|NOT COMPLETED|Overall Study||0||
59587131|NCT02563496|75694433|FG001|NOT COMPLETED|Overall Study||0||
59587132|NCT02563496|75694434|FG002|NOT COMPLETED|Overall Study||0||
59587133|NCT02563496|75694435|FG003|NOT COMPLETED|Overall Study||0||
59587134|NCT02563496|75694436|FG004|NOT COMPLETED|Overall Study||0||
59587135|NCT02563808|75694450|FG000|STARTED|Overall Study||96|A total of 5 participants enrolled were not included in final data due to data collection error|
59587136|NCT02563808|75694451|FG001|STARTED|Overall Study|A total of 5 participants enrolled were not included in final data due to data collection error|88|A total of 5 participants enrolled were not included in final data due to data collection error|
59587137|NCT02563808|75694450|FG000|COMPLETED|Overall Study||96||
59587138|NCT02563808|75694451|FG001|COMPLETED|Overall Study||88||
59587139|NCT02563808|75694450|FG000|NOT COMPLETED|Overall Study||0||
59587140|NCT02563808|75694451|FG001|NOT COMPLETED|Overall Study||0||
59587141|NCT02540161|75694461|FG000|STARTED|Overall Study||20||
59587142|NCT02540161|75694462|FG001|STARTED|Overall Study||7||
59587143|NCT02540161|75694463|FG002|STARTED|Overall Study||5||
59587144|NCT02540161|75694464|FG003|STARTED|Overall Study||7||
59587145|NCT02540161|75694461|FG000|COMPLETED|Overall Study||20||
59587146|NCT02540161|75694462|FG001|COMPLETED|Overall Study||7||
59587147|NCT02540161|75694463|FG002|COMPLETED|Overall Study||5||
59587148|NCT02540161|75694464|FG003|COMPLETED|Overall Study||7||
59587149|NCT02540161|75694461|FG000|NOT COMPLETED|Overall Study||0||
59587150|NCT02540161|75694462|FG001|NOT COMPLETED|Overall Study||0||
59587151|NCT02540161|75694463|FG002|NOT COMPLETED|Overall Study||0||
59587152|NCT02540161|75694464|FG003|NOT COMPLETED|Overall Study||0||
59587153|NCT02467465|75694476|FG000|STARTED|Overall Study||15||
59587154|NCT02467465|75694477|FG001|STARTED|Overall Study||15||
59587155|NCT02467465|75694476|FG000|COMPLETED|Overall Study||15||
59587156|NCT02467465|75694477|FG001|COMPLETED|Overall Study||15||
59587157|NCT02467465|75694476|FG000|NOT COMPLETED|Overall Study||0||
59587158|NCT02467465|75694477|FG001|NOT COMPLETED|Overall Study||0||
59587159|NCT02564354|75694487|FG000|STARTED|Overall Study||10||
59587160|NCT02564354|75694488|FG001|STARTED|Overall Study||8||
59587161|NCT02564354|75694487|FG000|COMPLETED|Overall Study||10||
59587162|NCT02564354|75694488|FG001|COMPLETED|Overall Study||8||
59587163|NCT02564354|75694487|FG000|NOT COMPLETED|Overall Study||0||
59587164|NCT02564354|75694488|FG001|NOT COMPLETED|Overall Study||0||
59587165|NCT02467777|75694496|FG000|STARTED|Overall Study||23||
59587166|NCT02467777|75694497|FG001|STARTED|Overall Study||27||
59587167|NCT02467777|75694496|FG000|COMPLETED|Overall Study||23||
59587168|NCT02467777|75694497|FG001|COMPLETED|Overall Study||27||
59587169|NCT02467777|75694496|FG000|NOT COMPLETED|Overall Study||0||
59587170|NCT02467777|75694497|FG001|NOT COMPLETED|Overall Study||0||
59587171|NCT02564432|75694503|FG000|STARTED|Overall Study||10||
59587172|NCT02564432|75694503|FG000|COMPLETED|Overall Study|1 patient suffered periprosthetic fracture at 8 months; 1 failed to osseointegrate|8||
59587173|NCT02564432|75694503|FG000|NOT COMPLETED|Overall Study||2||
59587174|NCT02540629|75694511|FG000|STARTED|Overall Study||6201||
59587175|NCT02540629|75694512|FG001|STARTED|Overall Study||6469||
59587176|NCT02540629|75694511|FG000|COMPLETED|Overall Study||6201||
59587177|NCT02540629|75694512|FG001|COMPLETED|Overall Study||6469||
59587178|NCT02540629|75694511|FG000|NOT COMPLETED|Overall Study||0||
59587179|NCT02540629|75694512|FG001|NOT COMPLETED|Overall Study||0||
59587180|NCT02568644|75694521|FG000|STARTED|Overall Study||30||
59587181|NCT02568644|75694522|FG001|STARTED|Overall Study||30||
59587182|NCT02568644|75694521|FG000|COMPLETED|Overall Study||30||
59587183|NCT02568644|75694522|FG001|COMPLETED|Overall Study||30||
59587184|NCT02568644|75694521|FG000|NOT COMPLETED|Overall Study||0||
59587185|NCT02568644|75694522|FG001|NOT COMPLETED|Overall Study||0||
59587186|NCT02541409|75694532|FG000|STARTED|Overall Study||25||
59587187|NCT02541409|75694533|FG001|STARTED|Overall Study||25||
59587188|NCT02541409|75694532|FG000|COMPLETED|Overall Study||22||
59587189|NCT02541409|75694533|FG001|COMPLETED|Overall Study||22||
59587190|NCT02541409|75694532|FG000|NOT COMPLETED|Overall Study||3||
59587191|NCT02541409|75694533|FG001|NOT COMPLETED|Overall Study||3||
59587192|NCT02569112|75694539|FG000|STARTED|Overall Study||10||20
59587193|NCT02569112|75694540|FG001|STARTED|Overall Study||10||10
59587194|NCT02569112|75694539|FG000|COMPLETED|Overall Study||10|Each subject received a single cryolipolysis treatment on both sides of their body.|20
59587195|NCT02569112|75694540|FG001|COMPLETED|Overall Study|Each subject received multipolar RF with varipulse technology to only one side of their body.|10|Each subject received a single cryolipolysis treatment on both sides of their body.|10
59587196|NCT02569112|75694539|FG000|NOT COMPLETED|Overall Study||0||0
59587197|NCT02569112|75694540|FG001|NOT COMPLETED|Overall Study||0||0
59587198|NCT02569658|75694547|FG000|STARTED|Overall Study||53||
59587199|NCT02569658|75694548|FG001|STARTED|Overall Study||57||
59587200|NCT02569658|75694547|FG000|COMPLETED|Overall Study||52||
59587201|NCT02569658|75694548|FG001|COMPLETED|Overall Study||56||
59587202|NCT02569658|75694547|FG000|NOT COMPLETED|Overall Study||1||
59587203|NCT02569658|75694548|FG001|NOT COMPLETED|Overall Study||1||
59587204|NCT02541565|75694554|FG000|STARTED|Overall Study||30||
59587205|NCT02541565|75694554|FG000|COMPLETED|Overall Study||27||
59587206|NCT02541565|75694554|FG000|NOT COMPLETED|Overall Study||3||
59587207|NCT02569892|75694558|FG000|STARTED|Overall Study||10||10
59587208|NCT02569892|75694559|FG001|STARTED|Overall Study||9||9
59587209|NCT02569892|75694558|FG000|COMPLETED|Overall Study||10||10
59587210|NCT02569892|75694559|FG001|COMPLETED|Overall Study||8||8
59587211|NCT02569892|75694558|FG000|NOT COMPLETED|Overall Study||0||0
59587212|NCT02569892|75694559|FG001|NOT COMPLETED|Overall Study||1||1
59587213|NCT02571218|75694567|FG000|STARTED|Overall Study||40||
59587214|NCT02571218|75694568|FG001|STARTED|Overall Study||41||
59587215|NCT02571218|75694567|FG000|COMPLETED|Overall Study||40||
59587216|NCT02571218|75694568|FG001|COMPLETED|Overall Study||41||
59587217|NCT02571218|75694567|FG000|NOT COMPLETED|Overall Study||0||
59587218|NCT02571218|75694568|FG001|NOT COMPLETED|Overall Study||0||
59587219|NCT02573402|75694576|FG000|STARTED|Overall Study||12||
59587220|NCT02573402|75694577|FG001|STARTED|Overall Study||7||
60121692|NCT02691702|76242625|FG005|STARTED|Overall Study||8||
59587221|NCT02573402|75694576|FG000|COMPLETED|Overall Study||12||
59587222|NCT02573402|75694577|FG001|COMPLETED|Overall Study||7||
59587223|NCT02573402|75694576|FG000|NOT COMPLETED|Overall Study||0||
59587224|NCT02573402|75694577|FG001|NOT COMPLETED|Overall Study||0||
59587225|NCT02578238|75694583|FG000|STARTED|Overall Study||143||
59587226|NCT02578238|75694583|FG000|COMPLETED|Overall Study||143||
59587227|NCT02578238|75694583|FG000|NOT COMPLETED|Overall Study||0||
59587228|NCT02579876|75694589|FG000|STARTED|Overall Study||15||
59587229|NCT02579876|75694590|FG001|STARTED|Overall Study||5||
59587230|NCT02579876|75694589|FG000|COMPLETED|Overall Study||14||
59587231|NCT02579876|75694590|FG001|COMPLETED|Overall Study||5||
59587232|NCT02579876|75694589|FG000|NOT COMPLETED|Overall Study||1||
59587233|NCT02579876|75694590|FG001|NOT COMPLETED|Overall Study||0||
59587234|NCT02582216|75694596|FG000|STARTED|Overall Study||22||
59587235|NCT02582216|75694596|FG000|COMPLETED|Overall Study||22||
59587236|NCT02582216|75694596|FG000|NOT COMPLETED|Overall Study||0||
59587237|NCT02582840|75694604|FG000|STARTED|Overall Study||14||
59587238|NCT02582840|75694605|FG001|STARTED|Overall Study||14||
59587239|NCT02582840|75694606|FG002|STARTED|Overall Study||14||
59587240|NCT02582840|75694604|FG000|COMPLETED|Overall Study||14||
59587241|NCT02582840|75694605|FG001|COMPLETED|Overall Study||14||
59587242|NCT02582840|75694606|FG002|COMPLETED|Overall Study||14||
59587243|NCT02582840|75694604|FG000|NOT COMPLETED|Overall Study||0||
59587244|NCT02582840|75694605|FG001|NOT COMPLETED|Overall Study||0||
59587245|NCT02582840|75694606|FG002|NOT COMPLETED|Overall Study||0||
59587246|NCT02583230|75694616|FG000|STARTED|Overall Study||11||
59587247|NCT02583230|75694616|FG000|COMPLETED|Overall Study||11||
59587248|NCT02583230|75694616|FG000|NOT COMPLETED|Overall Study||0||
59587249|NCT02580188|75694622|FG000|STARTED|Overall Study||35||
59587250|NCT02580188|75694623|FG001|STARTED|Overall Study||35||
59587251|NCT02580188|75694622|FG000|COMPLETED|Overall Study||32||
59587252|NCT02580188|75694623|FG001|COMPLETED|Overall Study||32||
59587253|NCT02580188|75694622|FG000|NOT COMPLETED|Overall Study||3||
59587254|NCT02580188|75694623|FG001|NOT COMPLETED|Overall Study||3||
59587255|NCT02584790|75694630|FG000|STARTED|Overall Study||55||
59587256|NCT02584790|75694630|FG000|COMPLETED|Overall Study||40||
59587257|NCT02584790|75694630|FG000|NOT COMPLETED|Overall Study||15||
59587258|NCT02584868|75694636|FG000|STARTED|Overall Study||44||
59587259|NCT02584868|75694637|FG001|STARTED|Overall Study||44||
59587260|NCT02584868|75694636|FG000|COMPLETED|Overall Study||44||
59587261|NCT02584868|75694637|FG001|COMPLETED|Overall Study||44||
59587262|NCT02584868|75694636|FG000|NOT COMPLETED|Overall Study||0||
59587263|NCT02584868|75694637|FG001|NOT COMPLETED|Overall Study||0||
59587264|NCT02586896|75694645|FG000|STARTED|Overall Study||150||
59587265|NCT02586896|75694646|FG001|STARTED|Overall Study||150||
59587266|NCT02586896|75694645|FG000|3-Month Follow-up|Overall Study||126||
59587267|NCT02586896|75694646|FG001|3-Month Follow-up|Overall Study||123||
59587268|NCT02586896|75694645|FG000|COMPLETED|Overall Study||131|6-Month Follow-Up|
59587269|NCT02586896|75694646|FG001|COMPLETED|Overall Study||133|6-Month Follow-Up|
59587270|NCT02586896|75694645|FG000|NOT COMPLETED|Overall Study||19||
59587271|NCT02586896|75694646|FG001|NOT COMPLETED|Overall Study||17||
59587272|NCT02586974|75694654|FG000|STARTED|Overall Study||32||
59587273|NCT02586974|75694655|FG001|STARTED|Overall Study||32||
59587274|NCT02586974|75694654|FG000|COMPLETED|Overall Study||32||
59587275|NCT02586974|75694655|FG001|COMPLETED|Overall Study||32||
59587276|NCT02586974|75694654|FG000|NOT COMPLETED|Overall Study||0||
59587277|NCT02586974|75694655|FG001|NOT COMPLETED|Overall Study||0||
59587278|NCT02596022|75694665|FG000|STARTED|Overall Study||10||
59587279|NCT02596022|75694666|FG001|STARTED|Overall Study||8||
59587280|NCT02596022|75694665|FG000|COMPLETED|Overall Study||10||
59587281|NCT02596022|75694666|FG001|COMPLETED|Overall Study||8||
59587282|NCT02596022|75694665|FG000|NOT COMPLETED|Overall Study||0||
59587283|NCT02596022|75694666|FG001|NOT COMPLETED|Overall Study||0||
59587284|NCT02597582|75694674|FG000|STARTED|Overall Study||21||
59587285|NCT02597582|75694675|FG001|STARTED|Overall Study||20||
59587286|NCT02597582|75694674|FG000|COMPLETED|Overall Study||21||
59587287|NCT02597582|75694675|FG001|COMPLETED|Overall Study||20||
59587288|NCT02597582|75694674|FG000|NOT COMPLETED|Overall Study||0||
59587289|NCT02597582|75694675|FG001|NOT COMPLETED|Overall Study||0||
59587290|NCT02599766|75694683|FG000|STARTED|Overall Study||22||
59587291|NCT02599766|75694683|FG000|COMPLETED|Overall Study||19||
59587292|NCT02599766|75694683|FG000|NOT COMPLETED|Overall Study||3||
59587293|NCT02601170|75694693|FG000|STARTED|Overall Study||11||
59587294|NCT02601170|75694694|FG001|STARTED|Overall Study||11||
59587295|NCT02601170|75694693|FG000|COMPLETED|Overall Study||11||
59587296|NCT02601170|75694694|FG001|COMPLETED|Overall Study||11||
59587297|NCT02601170|75694693|FG000|NOT COMPLETED|Overall Study||0||
59587298|NCT02601170|75694694|FG001|NOT COMPLETED|Overall Study||0||
59587299|NCT02602496|75694703|FG000|STARTED|Overall Study||15||
59587300|NCT02602496|75694704|FG001|STARTED|Overall Study||20||
59587301|NCT02602496|75694705|FG002|STARTED|Overall Study||17||
59587302|NCT02602496|75694703|FG000|COMPLETED|Overall Study||14||
59587303|NCT02602496|75694704|FG001|COMPLETED|Overall Study||18||
59587304|NCT02602496|75694705|FG002|COMPLETED|Overall Study||17||
59587305|NCT02602496|75694703|FG000|NOT COMPLETED|Overall Study||1||
59587306|NCT02602496|75694704|FG001|NOT COMPLETED|Overall Study||2||
59587307|NCT02602496|75694705|FG002|NOT COMPLETED|Overall Study||0||
59587308|NCT02603666|75694713|FG000|STARTED|Overall Study||130||
59587309|NCT02603666|75694713|FG000|COMPLETED|Overall Study||130||
59587310|NCT02603666|75694713|FG000|NOT COMPLETED|Overall Study||0||
59587311|NCT02605304|75694719|FG000|STARTED|Overall Study||4||
59587312|NCT02605304|75694720|FG001|STARTED|Overall Study||3||
59587313|NCT02605304|75694719|FG000|COMPLETED|Overall Study||4||
59587314|NCT02605304|75694720|FG001|COMPLETED|Overall Study||3||
59587315|NCT02605304|75694719|FG000|NOT COMPLETED|Overall Study||0||
59587316|NCT02605304|75694720|FG001|NOT COMPLETED|Overall Study||0||
59587317|NCT02606708|75694726|FG000|STARTED|Overall Study||314||
59587318|NCT02606708|75694726|FG000|COMPLETED|Overall Study||314||
59587319|NCT02606708|75694726|FG000|NOT COMPLETED|Overall Study||0||
59587320|NCT02607254|75694733|FG000|STARTED|Overall Study||3||
59587321|NCT02607254|75694734|FG001|STARTED|Overall Study||3||
59587322|NCT02607254|75694735|FG002|STARTED|Overall Study||5||
59587323|NCT02607254|75694733|FG000|COMPLETED|Overall Study||3||
59587324|NCT02607254|75694734|FG001|COMPLETED|Overall Study||3||
59587325|NCT02607254|75694735|FG002|COMPLETED|Overall Study||5||
59587326|NCT02607254|75694733|FG000|NOT COMPLETED|Overall Study||0||
59587327|NCT02607254|75694734|FG001|NOT COMPLETED|Overall Study||0||
59587328|NCT02607254|75694735|FG002|NOT COMPLETED|Overall Study||0||
59587329|NCT02609204|75694749|FG000|STARTED|Overall Study||51||
59587330|NCT02609204|75694749|FG000|COMPLETED|Overall Study||51||
59587331|NCT02609204|75694749|FG000|NOT COMPLETED|Overall Study||0||
59587332|NCT02611154|75694754|FG000|STARTED|Overall Study||5||
59587333|NCT02611154|75694754|FG000|COMPLETED|Overall Study||5||
59587334|NCT02611154|75694754|FG000|NOT COMPLETED|Overall Study||0||
59587335|NCT02613338|75694773|FG000|STARTED|Overall Study||30||
59587336|NCT02613338|75694773|FG000|COMPLETED|Overall Study||30||
59587337|NCT02613338|75694773|FG000|NOT COMPLETED|Overall Study||0||
59587338|NCT02614274|75694777|FG000|STARTED|Overall Study||9||
59587339|NCT02614274|75694777|FG000|COMPLETED|Overall Study||5||
59587340|NCT02614274|75694777|FG000|NOT COMPLETED|Overall Study||4||
59587341|NCT02617784|75694783|FG000|STARTED|Overall Study|None were prematurely withdrawn; 1 switched to CAPD mid-study and was excluded from second analysis.|12||
59587342|NCT02617784|75694784|FG001|STARTED|Overall Study||12||
59587343|NCT02617784|75694783|FG000|First Dose Assessment Period|Overall Study||12||
59587344|NCT02617784|75694784|FG001|First Dose Assessment Period|Overall Study||12||
59587345|NCT02617784|75694783|FG000|Second Dose Assessment Period|Overall Study||11||
59587346|NCT02617784|75694784|FG001|Second Dose Assessment Period|Overall Study||12||
59587347|NCT02617784|75694783|FG000|COMPLETED|Overall Study||12||
59587348|NCT02617784|75694784|FG001|COMPLETED|Overall Study||12||
59587349|NCT02617784|75694783|FG000|NOT COMPLETED|Overall Study||0||
59587350|NCT02617784|75694784|FG001|NOT COMPLETED|Overall Study||0||
59587351|NCT01575834|75694792|FG000|STARTED|Overall Study||3591||
59587352|NCT01575834|75694793|FG001|STARTED|Overall Study||3589||
59587353|NCT01575834|75694792|FG000|Received Double-blind Treatment|Overall Study|Six participants received a dose of romosozumab in error during the double-blind period.|3582||
59587354|NCT01575834|75694793|FG001|Received Double-blind Treatment|Overall Study||3575||
59587355|NCT01575834|75694792|FG000|Completed Double-blind Period|Overall Study||3205||
59587356|NCT01575834|75694793|FG001|Completed Double-blind Period|Overall Study||3185||
60121693|NCT02691702|76242626|FG006|STARTED|Overall Study||8||
60121694|NCT02691702|76242627|FG007|STARTED|Overall Study||12||
60121695|NCT02691702|76242628|FG008|STARTED|Overall Study||8||
60121696|NCT02691702|76242629|FG009|STARTED|Overall Study||8||
60121697|NCT02691702|76242630|FG010|STARTED|Overall Study||8||
60121698|NCT02691702|76242620|FG000|COMPLETED|Overall Study||8||
60121699|NCT02691702|76242621|FG001|COMPLETED|Overall Study||10||
59587357|NCT01575834|75694792|FG000|Completed 24-month Study Period|Overall Study||3032||
59587358|NCT01575834|75694793|FG001|Completed 24-month Study Period|Overall Study||2994||
59587359|NCT01575834|75694792|FG000|COMPLETED|Overall Study|Completed 36-month study period|2892||
59587360|NCT01575834|75694793|FG001|COMPLETED|Overall Study|Completed 36-month study period|2851||
59587361|NCT01575834|75694792|FG000|NOT COMPLETED|Overall Study||699||
59587362|NCT01575834|75694793|FG001|NOT COMPLETED|Overall Study||738||
59587363|NCT02618642|75694807|FG000|STARTED|Before 10 PILER Irradiation Treatments||15||
59587364|NCT02618642|75694808|FG001|STARTED|Before 10 PILER Irradiation Treatments||15||
59587365|NCT02618642|75694809|FG002|STARTED|Before 10 PILER Irradiation Treatments||15||
59587366|NCT02618642|75694810|FG003|STARTED|Before 10 PILER Irradiation Treatments||15||
59587367|NCT02618642|75694807|FG000|COMPLETED|Before 10 PILER Irradiation Treatments||15||
59587368|NCT02618642|75694808|FG001|COMPLETED|Before 10 PILER Irradiation Treatments||15||
59587369|NCT02618642|75694809|FG002|COMPLETED|Before 10 PILER Irradiation Treatments||15||
59587370|NCT02618642|75694810|FG003|COMPLETED|Before 10 PILER Irradiation Treatments||15||
59587371|NCT02618642|75694807|FG000|NOT COMPLETED|Before 10 PILER Irradiation Treatments||0||
59725060|NCT00927927|75843890|FG005|STARTED|Overall Study||3||
60121700|NCT02691702|76242622|FG002|COMPLETED|Overall Study||7||
60121701|NCT02691702|76242623|FG003|COMPLETED|Overall Study||8||
60121702|NCT02691702|76242624|FG004|COMPLETED|Overall Study||8||
59587372|NCT02618642|75694808|FG001|NOT COMPLETED|Before 10 PILER Irradiation Treatments||0||
59587373|NCT02618642|75694809|FG002|NOT COMPLETED|Before 10 PILER Irradiation Treatments||0||
59587374|NCT02618642|75694810|FG003|NOT COMPLETED|Before 10 PILER Irradiation Treatments||0||
59587375|NCT02618642|75694807|FG000|STARTED|After 10 PILER Irradiation Treatments||15||
59587376|NCT02618642|75694808|FG001|STARTED|After 10 PILER Irradiation Treatments||15||
59587377|NCT02618642|75694809|FG002|STARTED|After 10 PILER Irradiation Treatments||15||
59587378|NCT02618642|75694810|FG003|STARTED|After 10 PILER Irradiation Treatments||15||
59587379|NCT02618642|75694807|FG000|COMPLETED|After 10 PILER Irradiation Treatments||15||
59587380|NCT02618642|75694808|FG001|COMPLETED|After 10 PILER Irradiation Treatments||15||
59587381|NCT02618642|75694809|FG002|COMPLETED|After 10 PILER Irradiation Treatments||15||
59587382|NCT02618642|75694810|FG003|COMPLETED|After 10 PILER Irradiation Treatments||15||
59587383|NCT02618642|75694807|FG000|NOT COMPLETED|After 10 PILER Irradiation Treatments||0||
59587384|NCT02618642|75694808|FG001|NOT COMPLETED|After 10 PILER Irradiation Treatments||0||
60121703|NCT02691702|76242625|FG005|COMPLETED|Overall Study||5||
59587385|NCT02618642|75694809|FG002|NOT COMPLETED|After 10 PILER Irradiation Treatments||0||
59587386|NCT02618642|75694810|FG003|NOT COMPLETED|After 10 PILER Irradiation Treatments||0||
59587387|NCT02620904|75694829|FG000|STARTED|Overall Study||4||
59587388|NCT02620904|75694830|FG001|STARTED|Overall Study||5||
59587389|NCT02620904|75694829|FG000|COMPLETED|Overall Study||4||
59587390|NCT02620904|75694830|FG001|COMPLETED|Overall Study||5||
59587391|NCT02620904|75694829|FG000|NOT COMPLETED|Overall Study||0||
59587392|NCT02620904|75694830|FG001|NOT COMPLETED|Overall Study||0||
59587393|NCT02621060|75694838|FG000|STARTED|Overall Study||15||
59587394|NCT02621060|75694839|FG001|STARTED|Overall Study||15||
59587395|NCT02621060|75694838|FG000|COMPLETED|Overall Study||12||
59587396|NCT02621060|75694839|FG001|COMPLETED|Overall Study||14||
59587397|NCT02621060|75694838|FG000|NOT COMPLETED|Overall Study||3||
59587398|NCT02621060|75694839|FG001|NOT COMPLETED|Overall Study||1||
59587399|NCT02624180|75694847|FG000|STARTED|Overall Study||43||
59587400|NCT02624180|75694848|FG001|STARTED|Overall Study||38||
59587401|NCT02624180|75694847|FG000|COMPLETED|Overall Study||37|Participants completing primary endpoint at 8 weeks|
59587402|NCT02624180|75694848|FG001|COMPLETED|Overall Study||34|Participants completing primary endpoint at 8 weeks|
59587403|NCT02624180|75694847|FG000|NOT COMPLETED|Overall Study||6||
59587404|NCT02624180|75694848|FG001|NOT COMPLETED|Overall Study||4||
59587405|NCT02625428|75694856|FG000|STARTED|Overall Study||20||
59587406|NCT02625428|75694857|FG001|STARTED|Overall Study||20||
59587407|NCT02625428|75694856|FG000|COMPLETED|Overall Study||20||
59587408|NCT02625428|75694857|FG001|COMPLETED|Overall Study||20||
59587409|NCT02625428|75694856|FG000|NOT COMPLETED|Overall Study||0||
59587410|NCT02625428|75694857|FG001|NOT COMPLETED|Overall Study||0||
59587411|NCT02626910|75694867|FG000|STARTED|Overall Study||23||
59587412|NCT02626910|75694868|FG001|STARTED|Overall Study||10||
59587413|NCT02626910|75694869|FG002|STARTED|Overall Study||6||
59587414|NCT02626910|75694870|FG003|STARTED|Overall Study||10||
59587415|NCT02626910|75694867|FG000|COMPLETED|Overall Study||23||
59587416|NCT02626910|75694868|FG001|COMPLETED|Overall Study||10||
59587417|NCT02626910|75694869|FG002|COMPLETED|Overall Study||6||
59587418|NCT02626910|75694870|FG003|COMPLETED|Overall Study||10||
59587419|NCT02626910|75694867|FG000|NOT COMPLETED|Overall Study||0||
59587420|NCT02626910|75694868|FG001|NOT COMPLETED|Overall Study||0||
59587421|NCT02626910|75694869|FG002|NOT COMPLETED|Overall Study||0||
59587422|NCT02626910|75694870|FG003|NOT COMPLETED|Overall Study||0||
59587423|NCT02627924|75694880|FG000|STARTED|Overall Study||91||
59587424|NCT02627924|75694880|FG000|COMPLETED|Overall Study||79||
59587425|NCT02627924|75694880|FG000|NOT COMPLETED|Overall Study||12||
59587426|NCT02628236|75694887|FG000|STARTED|Overall Study||14||
59587427|NCT02628236|75694887|FG000|COMPLETED|Overall Study||14||
59587428|NCT02628236|75694887|FG000|NOT COMPLETED|Overall Study||0||
59587429|NCT02629094|75694891|FG000|STARTED|Overall Study||5||
59587430|NCT02629094|75694891|FG000|COMPLETED|Overall Study||5||
59587431|NCT02629094|75694891|FG000|NOT COMPLETED|Overall Study||0||
59587432|NCT02630030|75694895|FG000|STARTED|Overall Study||3||
59587433|NCT02630030|75694895|FG000|COMPLETED|Overall Study||3||
59587434|NCT02630030|75694895|FG000|NOT COMPLETED|Overall Study||0||
59587435|NCT02631590|75694899|FG000|STARTED|Overall Study||24||
59587436|NCT02631590|75694899|FG000|COMPLETED|Overall Study||24||
59587437|NCT02631590|75694899|FG000|NOT COMPLETED|Overall Study||0||
59587438|NCT02253654|75694905|FG000|STARTED|Overall Study||108||
59587439|NCT02253654|75694906|FG001|STARTED|Overall Study||108||
59587440|NCT02253654|75694905|FG000|Received Treatment|Overall Study||104||
59587441|NCT02253654|75694906|FG001|Received Treatment|Overall Study||107||
59587442|NCT02253654|75694905|FG000|COMPLETED|Overall Study||85||
59587443|NCT02253654|75694906|FG001|COMPLETED|Overall Study||90||
59587444|NCT02253654|75694905|FG000|NOT COMPLETED|Overall Study||23||
59587445|NCT02253654|75694906|FG001|NOT COMPLETED|Overall Study||18||
59587446|NCT02252406|75694914|FG000|STARTED|Starting Dose Ranolazine 500 mg BID||16||
59587447|NCT02252406|75694915|FG001|STARTED|Starting Dose Ranolazine 500 mg BID||17||
59587448|NCT02252406|75694914|FG000|COMPLETED|Starting Dose Ranolazine 500 mg BID||12||
59587449|NCT02252406|75694915|FG001|COMPLETED|Starting Dose Ranolazine 500 mg BID||14||
59587450|NCT02252406|75694914|FG000|NOT COMPLETED|Starting Dose Ranolazine 500 mg BID||4||
59587451|NCT02252406|75694915|FG001|NOT COMPLETED|Starting Dose Ranolazine 500 mg BID||3||
59587452|NCT02252406|75694914|FG000|STARTED|Titrated to Ranolazine 1000mg BID||12||
59587453|NCT02252406|75694915|FG001|STARTED|Titrated to Ranolazine 1000mg BID||14||
59587454|NCT02252406|75694914|FG000|COMPLETED|Titrated to Ranolazine 1000mg BID||9||
59587455|NCT02252406|75694915|FG001|COMPLETED|Titrated to Ranolazine 1000mg BID||13||
59587456|NCT02252406|75694914|FG000|NOT COMPLETED|Titrated to Ranolazine 1000mg BID||3||
59587457|NCT02252406|75694915|FG001|NOT COMPLETED|Titrated to Ranolazine 1000mg BID||1||
59587458|NCT02246478|75694925|FG000|STARTED|Single-dose Phase||6||
59587459|NCT02246478|75694926|FG001|STARTED|Single-dose Phase||5||
59587460|NCT02246478|75694927|FG002|STARTED|Single-dose Phase||5||
59587461|NCT02246478|75694928|FG003|STARTED|Single-dose Phase||5||
59587462|NCT02246478|75694925|FG000|COMPLETED|Single-dose Phase||6||
59587463|NCT02246478|75694926|FG001|COMPLETED|Single-dose Phase||5||
59587464|NCT02246478|75694927|FG002|COMPLETED|Single-dose Phase||5||
59587465|NCT02246478|75694928|FG003|COMPLETED|Single-dose Phase||5||
59587466|NCT02246478|75694925|FG000|NOT COMPLETED|Single-dose Phase||0||
59587467|NCT02246478|75694926|FG001|NOT COMPLETED|Single-dose Phase||0||
59587468|NCT02246478|75694927|FG002|NOT COMPLETED|Single-dose Phase||0||
59587469|NCT02246478|75694928|FG003|NOT COMPLETED|Single-dose Phase||0||
59587470|NCT02246478|75694925|FG000|STARTED|Multiple-dose Phase||6||
59587471|NCT02246478|75694926|FG001|STARTED|Multiple-dose Phase||5||
59587472|NCT02246478|75694927|FG002|STARTED|Multiple-dose Phase||5||
59587473|NCT02246478|75694928|FG003|STARTED|Multiple-dose Phase||5||
59587474|NCT02246478|75694925|FG000|COMPLETED|Multiple-dose Phase||5||
59587475|NCT02246478|75694926|FG001|COMPLETED|Multiple-dose Phase||5||
59587476|NCT02246478|75694927|FG002|COMPLETED|Multiple-dose Phase||5||
59587477|NCT02246478|75694928|FG003|COMPLETED|Multiple-dose Phase||4||
59587478|NCT02246478|75694925|FG000|NOT COMPLETED|Multiple-dose Phase||1||
59587479|NCT02246478|75694926|FG001|NOT COMPLETED|Multiple-dose Phase||0||
59587480|NCT02246478|75694927|FG002|NOT COMPLETED|Multiple-dose Phase||0||
59587481|NCT02246478|75694928|FG003|NOT COMPLETED|Multiple-dose Phase||1||
59587482|NCT02252016|75694947|FG000|STARTED|Overall Study||107||
59587483|NCT02252016|75694948|FG001|STARTED|Overall Study||52||
59587484|NCT02252016|75694947|FG000|COMPLETED|Overall Study|Completed = completed 24 weeks of follow-up|104||
59587485|NCT02252016|75694948|FG001|COMPLETED|Overall Study|Completed = completed 24 weeks of follow-up|49||
59587486|NCT02252016|75694947|FG000|NOT COMPLETED|Overall Study||3||
59587487|NCT02252016|75694948|FG001|NOT COMPLETED|Overall Study||3||
59587488|NCT02249832|75694954|FG000|STARTED|Overall Study||55||
59587489|NCT02249832|75694954|FG000|COMPLETED|Overall Study||42||
59587490|NCT02249832|75694954|FG000|NOT COMPLETED|Overall Study||13||
59587491|NCT02248974|75694965|FG000|STARTED|Baseline||47||
59587492|NCT02248974|75694966|FG001|STARTED|Baseline||51||
59587493|NCT02248974|75694965|FG000|COMPLETED|Baseline||47||
59587494|NCT02248974|75694966|FG001|COMPLETED|Baseline||51||
59587495|NCT02248974|75694965|FG000|NOT COMPLETED|Baseline||0||
59587496|NCT02248974|75694966|FG001|NOT COMPLETED|Baseline||0||
59587497|NCT02248974|75694965|FG000|STARTED|1-Day Follow-Up||47||
59587498|NCT02248974|75694966|FG001|STARTED|1-Day Follow-Up|"No DA group did not receive 1-Day Follow-up survey."|0||
59587499|NCT02248974|75694965|FG000|COMPLETED|1-Day Follow-Up||37||
59587500|NCT02248974|75694966|FG001|COMPLETED|1-Day Follow-Up|"No DA group did not receive 1-Day Follow-up survey."|0||
59587501|NCT02248974|75694965|FG000|NOT COMPLETED|1-Day Follow-Up||10||
59587502|NCT02248974|75694966|FG001|NOT COMPLETED|1-Day Follow-Up||0||
59587503|NCT02248974|75694965|FG000|STARTED|1-Week Follow-Up||37||
59587504|NCT02248974|75694966|FG001|STARTED|1-Week Follow-Up||51||
59587505|NCT02248974|75694965|FG000|COMPLETED|1-Week Follow-Up||29||
59587506|NCT02248974|75694966|FG001|COMPLETED|1-Week Follow-Up||34||
59587507|NCT02248974|75694965|FG000|NOT COMPLETED|1-Week Follow-Up||8||
59587508|NCT02248974|75694966|FG001|NOT COMPLETED|1-Week Follow-Up||17||
59587509|NCT02248974|75694965|FG000|STARTED|1-Month Follow-Up||29||
59587510|NCT02248974|75694966|FG001|STARTED|1-Month Follow-Up||34||
59587511|NCT02248974|75694965|FG000|COMPLETED|1-Month Follow-Up||27||
59587512|NCT02248974|75694966|FG001|COMPLETED|1-Month Follow-Up||31||
59587513|NCT02248974|75694965|FG000|NOT COMPLETED|1-Month Follow-Up||2||
59587514|NCT02248974|75694966|FG001|NOT COMPLETED|1-Month Follow-Up||3||
59587515|NCT02246166|75694974|FG000|STARTED|Overall Study||26||
59587516|NCT02246166|75694975|FG001|STARTED|Overall Study||27||
59587517|NCT02246166|75694974|FG000|COMPLETED|Overall Study||25||
59587518|NCT02246166|75694975|FG001|COMPLETED|Overall Study||27||
59587519|NCT02246166|75694974|FG000|NOT COMPLETED|Overall Study||1||
59587520|NCT02246166|75694975|FG001|NOT COMPLETED|Overall Study||0||
59587521|NCT02706847|75694984|FG000|STARTED|Period 1: Day 1 to Week 12||85||
59587522|NCT02706847|75694985|FG001|STARTED|Period 1: Day 1 to Week 12||84||
59587523|NCT02706847|75694986|FG002|STARTED|Period 1: Day 1 to Week 12||165||
59587524|NCT02706847|75694987|FG003|STARTED|Period 1: Day 1 to Week 12||165||
59587525|NCT02706847|75694984|FG000|Received Study Treatment|Period 1: Day 1 to Week 12||85||
59587526|NCT02706847|75694985|FG001|Received Study Treatment|Period 1: Day 1 to Week 12||84||
59587527|NCT02706847|75694986|FG002|Received Study Treatment|Period 1: Day 1 to Week 12||164||
59587528|NCT02706847|75694987|FG003|Received Study Treatment|Period 1: Day 1 to Week 12||165||
59587529|NCT02706847|75694984|FG000|COMPLETED|Period 1: Day 1 to Week 12||75||
59587530|NCT02706847|75694985|FG001|COMPLETED|Period 1: Day 1 to Week 12||76||
59725061|NCT00927927|75843891|FG006|STARTED|Overall Study||3||
59587531|NCT02706847|75694986|FG002|COMPLETED|Period 1: Day 1 to Week 12||157||
59587532|NCT02706847|75694987|FG003|COMPLETED|Period 1: Day 1 to Week 12||149||
59587533|NCT02706847|75694984|FG000|NOT COMPLETED|Period 1: Day 1 to Week 12||10||
59587534|NCT02706847|75694985|FG001|NOT COMPLETED|Period 1: Day 1 to Week 12||8||
59587535|NCT02706847|75694986|FG002|NOT COMPLETED|Period 1: Day 1 to Week 12||8||
59587536|NCT02706847|75694987|FG003|NOT COMPLETED|Period 1: Day 1 to Week 12||16||
59587537|NCT02706847|75694984|FG000|STARTED|Period 1: Week 12 to Week 24||75||
59587538|NCT02706847|75694985|FG001|STARTED|Period 1: Week 12 to Week 24||76||
59587539|NCT02706847|75694986|FG002|STARTED|Period 1: Week 12 to Week 24||157||
59587540|NCT02706847|75694987|FG003|STARTED|Period 1: Week 12 to Week 24||149||
59587541|NCT02706847|75694984|FG000|Received Study Treatment|Period 1: Week 12 to Week 24||72||
59587542|NCT02706847|75694985|FG001|Received Study Treatment|Period 1: Week 12 to Week 24||75||
59725062|NCT00927927|75843892|FG007|STARTED|Overall Study||3||
59587543|NCT02706847|75694986|FG002|Received Study Treatment|Period 1: Week 12 to Week 24||156||
59587544|NCT02706847|75694987|FG003|Received Study Treatment|Period 1: Week 12 to Week 24||148||
59587545|NCT02706847|75694984|FG000|COMPLETED|Period 1: Week 12 to Week 24||72||
59587546|NCT02706847|75694985|FG001|COMPLETED|Period 1: Week 12 to Week 24||74||
59587547|NCT02706847|75694986|FG002|COMPLETED|Period 1: Week 12 to Week 24||153||
59587548|NCT02706847|75694987|FG003|COMPLETED|Period 1: Week 12 to Week 24||135||
59587549|NCT02706847|75694984|FG000|NOT COMPLETED|Period 1: Week 12 to Week 24||3||
59587550|NCT02706847|75694985|FG001|NOT COMPLETED|Period 1: Week 12 to Week 24||2||
59587551|NCT02706847|75694986|FG002|NOT COMPLETED|Period 1: Week 12 to Week 24||4||
59587552|NCT02706847|75694987|FG003|NOT COMPLETED|Period 1: Week 12 to Week 24||14||
59587553|NCT02706847|75694984|FG000|STARTED|Period 2: Week 24 to Week 260||71|Six participants completed the Week 24 visit but did not continue into Period 2.|
59587554|NCT02706847|75694985|FG001|STARTED|Period 2: Week 24 to Week 260||73|Six participants completed the Week 24 visit but did not continue into Period 2.|
59587555|NCT02706847|75694986|FG002|STARTED|Period 2: Week 24 to Week 260||152|Six participants completed the Week 24 visit but did not continue into Period 2.|
59587556|NCT02706847|75694987|FG003|STARTED|Period 2: Week 24 to Week 260||132|Six participants completed the Week 24 visit but did not continue into Period 2.|
59587557|NCT02706847|75694984|FG000|Switched to Upadacitinib 15 mg After Protocol Amendment 4|Period 2: Week 24 to Week 260||0||
59587558|NCT02706847|75694985|FG001|Switched to Upadacitinib 15 mg After Protocol Amendment 4|Period 2: Week 24 to Week 260||44||
59587559|NCT02706847|75694986|FG002|Switched to Upadacitinib 15 mg After Protocol Amendment 4|Period 2: Week 24 to Week 260||0||
59587560|NCT02706847|75694987|FG003|Switched to Upadacitinib 15 mg After Protocol Amendment 4|Period 2: Week 24 to Week 260||94||
59587561|NCT02706847|75694984|FG000|COMPLETED|Period 2: Week 24 to Week 260||35||
59587562|NCT02706847|75694985|FG001|COMPLETED|Period 2: Week 24 to Week 260||41||
59587563|NCT02706847|75694986|FG002|COMPLETED|Period 2: Week 24 to Week 260||81||
59587564|NCT02706847|75694987|FG003|COMPLETED|Period 2: Week 24 to Week 260||82||
59587565|NCT02706847|75694984|FG000|NOT COMPLETED|Period 2: Week 24 to Week 260||36||
59587566|NCT02706847|75694985|FG001|NOT COMPLETED|Period 2: Week 24 to Week 260||32||
59587567|NCT02706847|75694986|FG002|NOT COMPLETED|Period 2: Week 24 to Week 260||71||
59587568|NCT02706847|75694987|FG003|NOT COMPLETED|Period 2: Week 24 to Week 260||50||
59587569|NCT02245620|75695000|FG000|STARTED|Overall Study||20||
59587570|NCT02245620|75695001|FG001|STARTED|Overall Study||21||
59587571|NCT02245620|75695000|FG000|COMPLETED|Overall Study||19||
59587572|NCT02245620|75695001|FG001|COMPLETED|Overall Study||20||
59587573|NCT02245620|75695000|FG000|NOT COMPLETED|Overall Study||1||
59587574|NCT02245620|75695001|FG001|NOT COMPLETED|Overall Study||1||
59587575|NCT02244996|75695009|FG000|STARTED|Overall Study||25||
59587576|NCT02244996|75695010|FG001|STARTED|Overall Study||25||
59587577|NCT02244996|75695009|FG000|COMPLETED|Overall Study||23||
59587578|NCT02244996|75695010|FG001|COMPLETED|Overall Study||19||
59587579|NCT02244996|75695009|FG000|NOT COMPLETED|Overall Study||2||
59587580|NCT02244996|75695010|FG001|NOT COMPLETED|Overall Study||6||
59587581|NCT02470741|75695018|FG000|STARTED|Overall Study||6||
59587582|NCT02470741|75695019|FG001|STARTED|Overall Study||6||
59587583|NCT02470741|75695018|FG000|COMPLETED|Overall Study||3||
59587584|NCT02470741|75695019|FG001|COMPLETED|Overall Study||4||
59587585|NCT02470741|75695018|FG000|NOT COMPLETED|Overall Study||3||
59587586|NCT02470741|75695019|FG001|NOT COMPLETED|Overall Study||2||
59587587|NCT02543437|75695025|FG000|STARTED|Overall Study||117||
59587588|NCT02543437|75695025|FG000|COMPLETED|Overall Study||117||
59587589|NCT02543437|75695025|FG000|NOT COMPLETED|Overall Study||0||
59587590|NCT02544607|75695029|FG000|STARTED|Overall Study||16||
59854641|NCT00355121|75979212|FG002|NOT COMPLETED|Overall Study||5||
59587591|NCT02544607|75695029|FG000|COMPLETED|Overall Study||16||
59587592|NCT02544607|75695029|FG000|NOT COMPLETED|Overall Study||0||
59587593|NCT02243280|75695045|FG000|STARTED|Enrolled||40||
59587594|NCT02243280|75695046|FG001|STARTED|Enrolled||39||
59587595|NCT02243280|75695047|FG002|STARTED|Enrolled||0||
59587596|NCT02243280|75695048|FG003|STARTED|Enrolled||0||
59587597|NCT02243280|75695049|FG004|STARTED|Enrolled||0||
59587598|NCT02243280|75695050|FG005|STARTED|Enrolled||27||
59587599|NCT02243280|75695051|FG006|STARTED|Enrolled||0||
59587600|NCT02243280|75695052|FG007|STARTED|Enrolled||0||
59587601|NCT02243280|75695053|FG008|STARTED|Enrolled||34||
59587602|NCT02243280|75695054|FG009|STARTED|Enrolled||0||
59587603|NCT02243280|75695055|FG010|STARTED|Enrolled||34||
59587604|NCT02243280|75695045|FG000|COMPLETED|Enrolled||40||
59587605|NCT02243280|75695046|FG001|COMPLETED|Enrolled||39||
59587606|NCT02243280|75695047|FG002|COMPLETED|Enrolled||0||
59587607|NCT02243280|75695048|FG003|COMPLETED|Enrolled||0||
59854642|NCT00343889|75979225|FG000|STARTED|Overall Study||190||
59587608|NCT02243280|75695049|FG004|COMPLETED|Enrolled||0||
59587609|NCT02243280|75695050|FG005|COMPLETED|Enrolled||27||
59587610|NCT02243280|75695051|FG006|COMPLETED|Enrolled||0||
59587611|NCT02243280|75695052|FG007|COMPLETED|Enrolled||0||
59587612|NCT02243280|75695053|FG008|COMPLETED|Enrolled||34||
59587613|NCT02243280|75695054|FG009|COMPLETED|Enrolled||0||
59587614|NCT02243280|75695055|FG010|COMPLETED|Enrolled||34||
59587615|NCT02243280|75695045|FG000|NOT COMPLETED|Enrolled||0||
59587616|NCT02243280|75695046|FG001|NOT COMPLETED|Enrolled||0||
59587617|NCT02243280|75695047|FG002|NOT COMPLETED|Enrolled||0||
59587618|NCT02243280|75695048|FG003|NOT COMPLETED|Enrolled||0||
59587619|NCT02243280|75695049|FG004|NOT COMPLETED|Enrolled||0||
59587620|NCT02243280|75695050|FG005|NOT COMPLETED|Enrolled||0||
59587621|NCT02243280|75695051|FG006|NOT COMPLETED|Enrolled||0||
59587622|NCT02243280|75695052|FG007|NOT COMPLETED|Enrolled||0||
59587623|NCT02243280|75695053|FG008|NOT COMPLETED|Enrolled||0||
59587624|NCT02243280|75695054|FG009|NOT COMPLETED|Enrolled||0||
59587625|NCT02243280|75695055|FG010|NOT COMPLETED|Enrolled||0||
59587626|NCT02243280|75695045|FG000|STARTED|Treated|Two Arm I participants received ABT-493 doses of 200 mg instead of 300 mg and are included in Arm A|42||
59587627|NCT02243280|75695046|FG001|STARTED|Treated||39||
59587628|NCT02243280|75695047|FG002|STARTED|Treated||0||
59587629|NCT02243280|75695048|FG003|STARTED|Treated||0||
59587630|NCT02243280|75695049|FG004|STARTED|Treated||0||
59587631|NCT02243280|75695050|FG005|STARTED|Treated||27||
59587632|NCT02243280|75695051|FG006|STARTED|Treated||0||
59587633|NCT02243280|75695052|FG007|STARTED|Treated||0||
59587634|NCT02243280|75695053|FG008|STARTED|Treated|Two Arm I participants received ABT-493 doses of 200 mg instead of 300 mg and are included in Arm A|32||
59587635|NCT02243280|75695054|FG009|STARTED|Treated||0||
59587636|NCT02243280|75695055|FG010|STARTED|Treated||34||
59587637|NCT02243280|75695045|FG000|Completed Treatment|Treated||42||
59587638|NCT02243280|75695046|FG001|Completed Treatment|Treated||38||
59587639|NCT02243280|75695047|FG002|Completed Treatment|Treated||0||
59587640|NCT02243280|75695048|FG003|Completed Treatment|Treated||0||
59587641|NCT02243280|75695049|FG004|Completed Treatment|Treated||0||
59587642|NCT02243280|75695050|FG005|Completed Treatment|Treated||27||
59587643|NCT02243280|75695051|FG006|Completed Treatment|Treated||0||
59587644|NCT02243280|75695052|FG007|Completed Treatment|Treated||0||
59587645|NCT02243280|75695053|FG008|Completed Treatment|Treated||32||
59587646|NCT02243280|75695054|FG009|Completed Treatment|Treated||0||
59587647|NCT02243280|75695055|FG010|Completed Treatment|Treated||33||
59587648|NCT02243280|75695045|FG000|COMPLETED|Treated||41||
59587649|NCT02243280|75695046|FG001|COMPLETED|Treated||39||
59587650|NCT02243280|75695047|FG002|COMPLETED|Treated||0||
59587651|NCT02243280|75695048|FG003|COMPLETED|Treated||0||
59587652|NCT02243280|75695049|FG004|COMPLETED|Treated||0||
59587653|NCT02243280|75695050|FG005|COMPLETED|Treated||27||
59587654|NCT02243280|75695051|FG006|COMPLETED|Treated||0||
59587655|NCT02243280|75695052|FG007|COMPLETED|Treated||0||
59587656|NCT02243280|75695053|FG008|COMPLETED|Treated||31||
59587657|NCT02243280|75695054|FG009|COMPLETED|Treated||0||
59587658|NCT02243280|75695055|FG010|COMPLETED|Treated||31||
59587659|NCT02243280|75695045|FG000|NOT COMPLETED|Treated||1||
59587660|NCT02243280|75695046|FG001|NOT COMPLETED|Treated||0||
59587661|NCT02243280|75695047|FG002|NOT COMPLETED|Treated||0||
59587662|NCT02243280|75695048|FG003|NOT COMPLETED|Treated||0||
59587663|NCT02243280|75695049|FG004|NOT COMPLETED|Treated||0||
59587664|NCT02243280|75695050|FG005|NOT COMPLETED|Treated||0||
59587665|NCT02243280|75695051|FG006|NOT COMPLETED|Treated||0||
59587666|NCT02243280|75695052|FG007|NOT COMPLETED|Treated||0||
59587667|NCT02243280|75695053|FG008|NOT COMPLETED|Treated||1||
59587668|NCT02243280|75695054|FG009|NOT COMPLETED|Treated||0||
59587669|NCT02243280|75695055|FG010|NOT COMPLETED|Treated||3||
59587670|NCT02549365|75695075|FG000|STARTED|Overall Study||164||
59587671|NCT02549365|75695076|FG001|STARTED|Overall Study||112||
59587672|NCT02549365|75695075|FG000|COMPLETED|Overall Study||164||
59587673|NCT02549365|75695076|FG001|COMPLETED|Overall Study||112||
59587674|NCT02549365|75695075|FG000|NOT COMPLETED|Overall Study||0||
59587675|NCT02549365|75695076|FG001|NOT COMPLETED|Overall Study||0||
59854643|NCT00343889|75979226|FG001|STARTED|Overall Study||189||
59854644|NCT00343889|75979225|FG000|COMPLETED|Overall Study||187||
60121704|NCT02691702|76242626|FG006|COMPLETED|Overall Study||5||
60121705|NCT02691702|76242627|FG007|COMPLETED|Overall Study||12||
59587676|NCT02471521|75695084|FG000|STARTED|Overall Study||60||
59587677|NCT02471521|75695085|FG001|STARTED|Overall Study||60||
59587678|NCT02471521|75695084|FG000|COMPLETED|Overall Study||60||
59587679|NCT02471521|75695085|FG001|COMPLETED|Overall Study||52||
59587680|NCT02471521|75695084|FG000|NOT COMPLETED|Overall Study||0||
59587681|NCT02471521|75695085|FG001|NOT COMPLETED|Overall Study||8||
59587682|NCT02554435|75695093|FG000|STARTED|Overall Study||20||
59587683|NCT02554435|75695094|FG001|STARTED|Overall Study||20||
59587684|NCT02554435|75695093|FG000|COMPLETED|Overall Study||14||
59854645|NCT00343889|75979226|FG001|COMPLETED|Overall Study||188||
60121706|NCT02691702|76242628|FG008|COMPLETED|Overall Study||6||
59587685|NCT02554435|75695094|FG001|COMPLETED|Overall Study||19||
59587686|NCT02554435|75695093|FG000|NOT COMPLETED|Overall Study||6||
59587687|NCT02554435|75695094|FG001|NOT COMPLETED|Overall Study||1||
59587688|NCT02555449|75695101|FG000|STARTED|Overall Study||6||
59587689|NCT02555449|75695101|FG000|COMPLETED|Overall Study||6||
59587690|NCT02555449|75695101|FG000|NOT COMPLETED|Overall Study||0||
59587691|NCT02248818|75695113|FG000|STARTED|Screening||0||
59587692|NCT02248818|75695114|FG001|STARTED|Screening||0||
59587693|NCT02248818|75695115|FG002|STARTED|Screening||0||
59587694|NCT02248818|75695116|FG003|STARTED|Screening||0||
59587695|NCT02248818|75695117|FG004|STARTED|Screening||0||
59587696|NCT02248818|75695118|FG005|STARTED|Screening||0||
59587697|NCT02248818|75695119|FG006|STARTED|Screening||0||
59854646|NCT00343889|75979225|FG000|NOT COMPLETED|Overall Study||3||
60121707|NCT02691702|76242629|FG009|COMPLETED|Overall Study||6||
60121708|NCT02691702|76242630|FG010|COMPLETED|Overall Study||6||
60121709|NCT02691702|76242620|FG000|NOT COMPLETED|Overall Study||2||
60121710|NCT02691702|76242621|FG001|NOT COMPLETED|Overall Study||1||
60121711|NCT02691702|76242622|FG002|NOT COMPLETED|Overall Study||1||
60121712|NCT02691702|76242623|FG003|NOT COMPLETED|Overall Study||0||
60121713|NCT02691702|76242624|FG004|NOT COMPLETED|Overall Study||0||
60121714|NCT02691702|76242625|FG005|NOT COMPLETED|Overall Study||3||
60121715|NCT02691702|76242626|FG006|NOT COMPLETED|Overall Study||3||
59587698|NCT02248818|75695120|FG007|STARTED|Screening||0||
59587699|NCT02248818|75695121|FG008|STARTED|Screening||155||
59587700|NCT02248818|75695113|FG000|COMPLETED|Screening||0||
59587701|NCT02248818|75695114|FG001|COMPLETED|Screening||0||
59587702|NCT02248818|75695115|FG002|COMPLETED|Screening||0||
59587703|NCT02248818|75695116|FG003|COMPLETED|Screening||0||
59587704|NCT02248818|75695117|FG004|COMPLETED|Screening||0||
59587705|NCT02248818|75695118|FG005|COMPLETED|Screening||0||
59587706|NCT02248818|75695119|FG006|COMPLETED|Screening||0||
59587707|NCT02248818|75695120|FG007|COMPLETED|Screening||0||
59587708|NCT02248818|75695121|FG008|COMPLETED|Screening||48||
59587709|NCT02248818|75695113|FG000|NOT COMPLETED|Screening||0||
59587710|NCT02248818|75695114|FG001|NOT COMPLETED|Screening||0||
59587711|NCT02248818|75695115|FG002|NOT COMPLETED|Screening||0||
59587712|NCT02248818|75695116|FG003|NOT COMPLETED|Screening||0||
59587713|NCT02248818|75695117|FG004|NOT COMPLETED|Screening||0||
59587714|NCT02248818|75695118|FG005|NOT COMPLETED|Screening||0||
59587715|NCT02248818|75695119|FG006|NOT COMPLETED|Screening||0||
59587716|NCT02248818|75695120|FG007|NOT COMPLETED|Screening||0||
59587717|NCT02248818|75695121|FG008|NOT COMPLETED|Screening||107||
59587718|NCT02248818|75695113|FG000|STARTED|Randomised Study||6||
59587719|NCT02248818|75695114|FG001|STARTED|Randomised Study||6||
59587720|NCT02248818|75695115|FG002|STARTED|Randomised Study||6||
59587721|NCT02248818|75695116|FG003|STARTED|Randomised Study||6||
59725063|NCT00927927|75843893|FG008|STARTED|Overall Study||8||
59725064|NCT00927927|75843894|FG009|STARTED|Overall Study||3||
59725065|NCT00927927|75843895|FG010|STARTED|Overall Study||5||
59725066|NCT00927927|75843896|FG011|STARTED|Overall Study||6||
59725067|NCT00927927|75843897|FG012|STARTED|Overall Study||5||
59725068|NCT00927927|75843898|FG013|STARTED|Overall Study||5||
59725069|NCT00927927|75843899|FG014|STARTED|Overall Study||9||
59725070|NCT00927927|75843885|FG000|Exposed|Overall Study||3||
59725071|NCT00927927|75843886|FG001|Exposed|Overall Study||3||
59725072|NCT00927927|75843887|FG002|Exposed|Overall Study||3||
59725073|NCT00927927|75843888|FG003|Exposed|Overall Study||3||
59725074|NCT00927927|75843889|FG004|Exposed|Overall Study||3||
59725075|NCT00927927|75843890|FG005|Exposed|Overall Study||3||
59725076|NCT00927927|75843891|FG006|Exposed|Overall Study||3||
59725077|NCT00927927|75843892|FG007|Exposed|Overall Study||3||
59725078|NCT00927927|75843893|FG008|Exposed|Overall Study||8||
59725079|NCT00927927|75843894|FG009|Exposed|Overall Study||3||
59725080|NCT00927927|75843895|FG010|Exposed|Overall Study||5||
59725081|NCT00927927|75843896|FG011|Exposed|Overall Study||5||
59725082|NCT00927927|75843897|FG012|Exposed|Overall Study||5||
59725083|NCT00927927|75843898|FG013|Exposed|Overall Study||5||
59725084|NCT00927927|75843899|FG014|Exposed|Overall Study||9||
59725085|NCT00927927|75843885|FG000|COMPLETED|Overall Study||3||
59725086|NCT00927927|75843886|FG001|COMPLETED|Overall Study||3||
59725087|NCT00927927|75843887|FG002|COMPLETED|Overall Study||3||
59725088|NCT00927927|75843888|FG003|COMPLETED|Overall Study||3||
59725089|NCT00927927|75843889|FG004|COMPLETED|Overall Study||3||
59725090|NCT00927927|75843890|FG005|COMPLETED|Overall Study||3||
59725091|NCT00927927|75843891|FG006|COMPLETED|Overall Study||3||
59725092|NCT00927927|75843892|FG007|COMPLETED|Overall Study||1||
59725093|NCT00927927|75843893|FG008|COMPLETED|Overall Study||8||
59725094|NCT00927927|75843894|FG009|COMPLETED|Overall Study||3||
59725095|NCT00927927|75843895|FG010|COMPLETED|Overall Study||5||
59725096|NCT00927927|75843896|FG011|COMPLETED|Overall Study|One subject withdrew consent after being randomised but before receiving any trial product.|4||
60121716|NCT02691702|76242627|FG007|NOT COMPLETED|Overall Study||0||
60121717|NCT02691702|76242628|FG008|NOT COMPLETED|Overall Study||2||
60121718|NCT02691702|76242629|FG009|NOT COMPLETED|Overall Study||2||
60121719|NCT02691702|76242630|FG010|NOT COMPLETED|Overall Study||2||
60121720|NCT01564277|76242664|FG000|STARTED|Overall Study||12||
59587722|NCT02248818|75695117|FG004|STARTED|Randomised Study||6||
59587723|NCT02248818|75695118|FG005|STARTED|Randomised Study||8||
59587724|NCT02248818|75695119|FG006|STARTED|Randomised Study||6||
59587725|NCT02248818|75695120|FG007|STARTED|Randomised Study||4||
59587726|NCT02248818|75695121|FG008|STARTED|Randomised Study||0||
59587727|NCT02248818|75695113|FG000|COMPLETED|Randomised Study||6||
59587728|NCT02248818|75695114|FG001|COMPLETED|Randomised Study||6||
59587729|NCT02248818|75695115|FG002|COMPLETED|Randomised Study||6||
59587730|NCT02248818|75695116|FG003|COMPLETED|Randomised Study||6||
59587731|NCT02248818|75695117|FG004|COMPLETED|Randomised Study||6||
59587732|NCT02248818|75695118|FG005|COMPLETED|Randomised Study||0||
59587733|NCT02248818|75695119|FG006|COMPLETED|Randomised Study||6||
59587734|NCT02248818|75695120|FG007|COMPLETED|Randomised Study||4||
59725097|NCT00927927|75843897|FG012|COMPLETED|Overall Study||5||
59587735|NCT02248818|75695121|FG008|COMPLETED|Randomised Study||0||
59587736|NCT02248818|75695113|FG000|NOT COMPLETED|Randomised Study||0||
59587737|NCT02248818|75695114|FG001|NOT COMPLETED|Randomised Study||0||
59587738|NCT02248818|75695115|FG002|NOT COMPLETED|Randomised Study||0||
59587739|NCT02248818|75695116|FG003|NOT COMPLETED|Randomised Study||0||
59587740|NCT02248818|75695117|FG004|NOT COMPLETED|Randomised Study||0||
59587741|NCT02248818|75695118|FG005|NOT COMPLETED|Randomised Study||8||
59587742|NCT02248818|75695119|FG006|NOT COMPLETED|Randomised Study||0||
59587743|NCT02248818|75695120|FG007|NOT COMPLETED|Randomised Study||0||
59587744|NCT02248818|75695121|FG008|NOT COMPLETED|Randomised Study||0||
59587745|NCT02472223|75695141|FG000|STARTED|Overall Study||16||
59587746|NCT02472223|75695142|FG001|STARTED|Overall Study||12||
59587747|NCT02472223|75695141|FG000|COMPLETED|Overall Study||10||
59587748|NCT02472223|75695142|FG001|COMPLETED|Overall Study||7||
59587749|NCT02472223|75695141|FG000|NOT COMPLETED|Overall Study||6||
59587750|NCT02472223|75695142|FG001|NOT COMPLETED|Overall Study||5||
59587751|NCT02247960|75695150|FG000|STARTED|Patient Consent and Randomization||85||
59587752|NCT02247960|75695151|FG001|STARTED|Patient Consent and Randomization||90||
59587753|NCT02247960|75695150|FG000|COMPLETED|Patient Consent and Randomization||83||
59587754|NCT02247960|75695151|FG001|COMPLETED|Patient Consent and Randomization||84||
59587755|NCT02247960|75695150|FG000|NOT COMPLETED|Patient Consent and Randomization||2||
59587756|NCT02247960|75695151|FG001|NOT COMPLETED|Patient Consent and Randomization||6||
59587757|NCT02247960|75695150|FG000|STARTED|Catheter Removed||83||
59587758|NCT02247960|75695151|FG001|STARTED|Catheter Removed||84||
59587759|NCT02247960|75695150|FG000|COMPLETED|Catheter Removed||76||
59587760|NCT02247960|75695151|FG001|COMPLETED|Catheter Removed||74||
59587761|NCT02247960|75695150|FG000|NOT COMPLETED|Catheter Removed||7||
59587762|NCT02247960|75695151|FG001|NOT COMPLETED|Catheter Removed||10||
59587763|NCT02472457|75695159|FG000|STARTED|Overall Study|1 subject followed the Specific Carbohydrate Diet|8||
59587764|NCT02472457|75695160|FG001|STARTED|Overall Study||11||
59587765|NCT02472457|75695159|FG000|COMPLETED|Overall Study||8||
59587766|NCT02472457|75695160|FG001|COMPLETED|Overall Study||10||
59587767|NCT02472457|75695159|FG000|NOT COMPLETED|Overall Study||0||
59587768|NCT02472457|75695160|FG001|NOT COMPLETED|Overall Study||1||
59587769|NCT02473783|75695168|FG000|STARTED|Overall Study||20||
59587770|NCT02473783|75695169|FG001|STARTED|Overall Study||17||
59587771|NCT02473783|75695168|FG000|COMPLETED|Overall Study||20||
59587772|NCT02473783|75695169|FG001|COMPLETED|Overall Study||17||
59587773|NCT02473783|75695168|FG000|NOT COMPLETED|Overall Study||0||
59587774|NCT02473783|75695169|FG001|NOT COMPLETED|Overall Study||0||
59587775|NCT02557555|75695176|FG000|STARTED|Overall Study||100||
59587776|NCT02557555|75695176|FG000|COMPLETED|Overall Study||100||
59587777|NCT02557555|75695176|FG000|NOT COMPLETED|Overall Study||0||
59587778|NCT02632526|75695187|FG000|STARTED|Overall Study||36||
59587779|NCT02632526|75695188|FG001|STARTED|Overall Study||12||
59587780|NCT02632526|75695189|FG002|STARTED|Overall Study||24||
59587781|NCT02632526|75695190|FG003|STARTED|Overall Study||12||
59587782|NCT02632526|75695191|FG004|STARTED|Overall Study||4||
59587783|NCT02632526|75695192|FG005|STARTED|Overall Study||8||
59587784|NCT02632526|75695187|FG000|COMPLETED|Overall Study||36||
59587785|NCT02632526|75695188|FG001|COMPLETED|Overall Study||12||
59587786|NCT02632526|75695189|FG002|COMPLETED|Overall Study||24||
59587787|NCT02632526|75695190|FG003|COMPLETED|Overall Study||12||
59587788|NCT02632526|75695191|FG004|COMPLETED|Overall Study||4||
59587789|NCT02632526|75695192|FG005|COMPLETED|Overall Study||8||
59587790|NCT02632526|75695187|FG000|NOT COMPLETED|Overall Study||0||
59587791|NCT02632526|75695188|FG001|NOT COMPLETED|Overall Study||0||
59587792|NCT02632526|75695189|FG002|NOT COMPLETED|Overall Study||0||
59587793|NCT02632526|75695190|FG003|NOT COMPLETED|Overall Study||0||
59587794|NCT02632526|75695191|FG004|NOT COMPLETED|Overall Study||0||
59587795|NCT02632526|75695192|FG005|NOT COMPLETED|Overall Study||0||
59587796|NCT02247804|75695240|FG000|STARTED|Treatment Period 1||198||
59587797|NCT02247804|75695241|FG001|STARTED|Treatment Period 1||198||
59587798|NCT02247804|75695242|FG002|STARTED|Treatment Period 1||198||
59587799|NCT02247804|75695240|FG000|Received (Sham or Bimatoprost SR)|Treatment Period 1||193||
59587800|NCT02247804|75695241|FG001|Received (Sham or Bimatoprost SR)|Treatment Period 1||197||
59587801|NCT02247804|75695242|FG002|Received (Sham or Bimatoprost SR)|Treatment Period 1||197||
59587802|NCT02247804|75695240|FG000|COMPLETED|Treatment Period 1||176||
59587803|NCT02247804|75695241|FG001|COMPLETED|Treatment Period 1||194||
59587804|NCT02247804|75695242|FG002|COMPLETED|Treatment Period 1||190||
59587805|NCT02247804|75695240|FG000|NOT COMPLETED|Treatment Period 1||22||
59587806|NCT02247804|75695241|FG001|NOT COMPLETED|Treatment Period 1||4||
59587807|NCT02247804|75695242|FG002|NOT COMPLETED|Treatment Period 1||8||
59587808|NCT02247804|75695240|FG000|STARTED|Treatment Period 2||172|Started=received administration (Sham or Bimatoprost SR) in the cycle|
59587809|NCT02247804|75695241|FG001|STARTED|Treatment Period 2||191|Started=received administration (Sham or Bimatoprost SR) in the cycle|
59587810|NCT02247804|75695242|FG002|STARTED|Treatment Period 2||187|Started=received administration (Sham or Bimatoprost SR) in the cycle|
59587811|NCT02247804|75695240|FG000|COMPLETED|Treatment Period 2||164||
59587812|NCT02247804|75695241|FG001|COMPLETED|Treatment Period 2||186||
59587813|NCT02247804|75695242|FG002|COMPLETED|Treatment Period 2||179||
59587814|NCT02247804|75695240|FG000|NOT COMPLETED|Treatment Period 2||8||
59587815|NCT02247804|75695241|FG001|NOT COMPLETED|Treatment Period 2||5||
59587816|NCT02247804|75695242|FG002|NOT COMPLETED|Treatment Period 2||8||
59587817|NCT02247804|75695240|FG000|STARTED|Treatment Period 3||158|Started=received administration (Sham or Bimatoprost SR) in the cycle|
59587818|NCT02247804|75695241|FG001|STARTED|Treatment Period 3||183|Started=received administration (Sham or Bimatoprost SR) in the cycle|
59587819|NCT02247804|75695242|FG002|STARTED|Treatment Period 3||177|Started=received administration (Sham or Bimatoprost SR) in the cycle|
59587820|NCT02247804|75695240|FG000|COMPLETED|Treatment Period 3||147||
59587821|NCT02247804|75695241|FG001|COMPLETED|Treatment Period 3||173||
59587822|NCT02247804|75695242|FG002|COMPLETED|Treatment Period 3||167||
59587823|NCT02247804|75695240|FG000|NOT COMPLETED|Treatment Period 3||11||
59587824|NCT02247804|75695241|FG001|NOT COMPLETED|Treatment Period 3||10||
59587825|NCT02247804|75695242|FG002|NOT COMPLETED|Treatment Period 3||10||
59587826|NCT02635880|75695250|FG000|STARTED|Overall Study||32||
59587827|NCT02635880|75695250|FG000|COMPLETED|Overall Study||32||
59587828|NCT02635880|75695250|FG000|NOT COMPLETED|Overall Study||0||
59587829|NCT02640716|75695256|FG000|STARTED|Overall Study||30|Completed baseline assessments and randomized|
59587830|NCT02640716|75695257|FG001|STARTED|Overall Study||30|Completed baseline assessments and randomized|
59587831|NCT02640716|75695256|FG000|Training Completion|Overall Study||27|Training completion|
59587832|NCT02640716|75695257|FG001|Training Completion|Overall Study||27|Training completion|
59587833|NCT02640716|75695256|FG000|COMPLETED|Overall Study||23|6-month follow-up|
59587834|NCT02640716|75695257|FG001|COMPLETED|Overall Study||21|6-month follow-up|
59587835|NCT02640716|75695256|FG000|NOT COMPLETED|Overall Study||7||
59587836|NCT02640716|75695257|FG001|NOT COMPLETED|Overall Study||9||
59587837|NCT02243202|75695267|FG000|STARTED|Overall Study||82||
59587838|NCT02243202|75695268|FG001|STARTED|Overall Study||85||
59587839|NCT02243202|75695269|FG002|STARTED|Overall Study||84||
59587840|NCT02243202|75695270|FG003|STARTED|Overall Study||84||
59587841|NCT02243202|75695267|FG000|Treated|Overall Study||82||
59587842|NCT02243202|75695268|FG001|Treated|Overall Study||85||
59587843|NCT02243202|75695269|FG002|Treated|Overall Study||84||
59587844|NCT02243202|75695270|FG003|Treated|Overall Study||83||
59587845|NCT02243202|75695267|FG000|COMPLETED|Overall Study||57||
59587846|NCT02243202|75695268|FG001|COMPLETED|Overall Study||60||
59587847|NCT02243202|75695269|FG002|COMPLETED|Overall Study||53||
59587848|NCT02243202|75695270|FG003|COMPLETED|Overall Study||61||
59587849|NCT02243202|75695267|FG000|NOT COMPLETED|Overall Study||25||
59587850|NCT02243202|75695268|FG001|NOT COMPLETED|Overall Study||25||
59587851|NCT02243202|75695269|FG002|NOT COMPLETED|Overall Study||31||
59587852|NCT02243202|75695270|FG003|NOT COMPLETED|Overall Study||23||
59587853|NCT02243046|75695283|FG000|STARTED|Overall Study||55||
59587854|NCT02243046|75695284|FG001|STARTED|Overall Study||54||
59587855|NCT02243046|75695285|FG002|STARTED|Overall Study||53||
59587856|NCT02243046|75695283|FG000|3 Month|Overall Study|1 subject didn't return for 3 month clinic visit|54||
59587857|NCT02243046|75695284|FG001|3 Month|Overall Study|1 subject didn't return for 3 month clinic visit|53||
59587858|NCT02243046|75695285|FG002|3 Month|Overall Study|2 subjects didn't return for 3 month clinic visit|51||
59587859|NCT02243046|75695283|FG000|6 Month|Overall Study||54||
59587860|NCT02243046|75695284|FG001|6 Month|Overall Study||53||
59587861|NCT02243046|75695285|FG002|6 Month|Overall Study|2 subjects didn't return for 6 month clinic visit|49||
59725098|NCT00927927|75843898|FG013|COMPLETED|Overall Study||5||
59725099|NCT00927927|75843899|FG014|COMPLETED|Overall Study||9||
59587862|NCT02243046|75695283|FG000|COMPLETED|Overall Study||54||
59587863|NCT02243046|75695284|FG001|COMPLETED|Overall Study||53||
59587864|NCT02243046|75695285|FG002|COMPLETED|Overall Study||49||
59587865|NCT02243046|75695283|FG000|NOT COMPLETED|Overall Study||1||
59587866|NCT02243046|75695284|FG001|NOT COMPLETED|Overall Study||1||
59587867|NCT02243046|75695285|FG002|NOT COMPLETED|Overall Study||4||
59587868|NCT02207946|75695295|FG000|STARTED|Overall Study||19||
59587869|NCT02207946|75695296|FG001|STARTED|Overall Study||11||
59587870|NCT02207946|75695295|FG000|COMPLETED|Overall Study||18||
59587871|NCT02207946|75695296|FG001|COMPLETED|Overall Study||10||
59587872|NCT02207946|75695295|FG000|NOT COMPLETED|Overall Study||1||
59725100|NCT00927927|75843885|FG000|NOT COMPLETED|Overall Study||0||
59587873|NCT02207946|75695296|FG001|NOT COMPLETED|Overall Study||1||
59587874|NCT03976076|75695303|FG000|STARTED|Overall Study||12||
59587875|NCT03976076|75695303|FG000|COMPLETED|Overall Study||10||
59587876|NCT03976076|75695303|FG000|NOT COMPLETED|Overall Study||2||
59587877|NCT02560051|75695315|FG000|STARTED|Overall Study||6||
59587878|NCT02560051|75695316|FG001|STARTED|Overall Study||8||
59587879|NCT02560051|75695317|FG002|STARTED|Overall Study||5||
59587880|NCT02560051|75695315|FG000|COMPLETED|Overall Study||3||
59587881|NCT02560051|75695316|FG001|COMPLETED|Overall Study||4||
59587882|NCT02560051|75695317|FG002|COMPLETED|Overall Study||4||
59587883|NCT02560051|75695315|FG000|NOT COMPLETED|Overall Study||3||
59587884|NCT02560051|75695316|FG001|NOT COMPLETED|Overall Study||4||
59587885|NCT02560051|75695317|FG002|NOT COMPLETED|Overall Study||1||
59587886|NCT03786770|75695329|FG000|STARTED|Overall Study||14||
59725101|NCT00927927|75843886|FG001|NOT COMPLETED|Overall Study||0||
59725102|NCT00927927|75843887|FG002|NOT COMPLETED|Overall Study||0||
59725103|NCT00927927|75843888|FG003|NOT COMPLETED|Overall Study||0||
59587887|NCT03786770|75695330|FG001|STARTED|Overall Study||15||
59587888|NCT03786770|75695331|FG002|STARTED|Overall Study||16||
59587889|NCT03786770|75695332|FG003|STARTED|Overall Study||16||
59587890|NCT03786770|75695329|FG000|COMPLETED|Overall Study||13||
59587891|NCT03786770|75695330|FG001|COMPLETED|Overall Study||15||
59587892|NCT03786770|75695331|FG002|COMPLETED|Overall Study||16||
59587893|NCT03786770|75695332|FG003|COMPLETED|Overall Study||16||
59587894|NCT03786770|75695329|FG000|NOT COMPLETED|Overall Study||1||
59587895|NCT03786770|75695330|FG001|NOT COMPLETED|Overall Study||0||
59587896|NCT03786770|75695331|FG002|NOT COMPLETED|Overall Study||0||
59587897|NCT03786770|75695332|FG003|NOT COMPLETED|Overall Study||0||
59587898|NCT02474407|75695342|FG000|STARTED|First Intervention (14 Days)||39||
59587899|NCT02474407|75695343|FG001|STARTED|First Intervention (14 Days)||39||
59587900|NCT02474407|75695342|FG000|COMPLETED|First Intervention (14 Days)||39||
59587901|NCT02474407|75695343|FG001|COMPLETED|First Intervention (14 Days)||39||
59587902|NCT02474407|75695342|FG000|NOT COMPLETED|First Intervention (14 Days)||0||
59587903|NCT02474407|75695343|FG001|NOT COMPLETED|First Intervention (14 Days)||0||
59587904|NCT02474407|75695342|FG000|STARTED|Washout (14 Days)||39||
59587905|NCT02474407|75695343|FG001|STARTED|Washout (14 Days)||39||
59587906|NCT02474407|75695342|FG000|COMPLETED|Washout (14 Days)||39||
59587907|NCT02474407|75695343|FG001|COMPLETED|Washout (14 Days)||39||
59587908|NCT02474407|75695342|FG000|NOT COMPLETED|Washout (14 Days)||0||
59587909|NCT02474407|75695343|FG001|NOT COMPLETED|Washout (14 Days)||0||
59587910|NCT02474407|75695342|FG000|STARTED|Second Intervention (14 Days)||39||
59587911|NCT02474407|75695343|FG001|STARTED|Second Intervention (14 Days)||39||
59587912|NCT02474407|75695342|FG000|COMPLETED|Second Intervention (14 Days)||39||
59587913|NCT02474407|75695343|FG001|COMPLETED|Second Intervention (14 Days)||39||
59587914|NCT02474407|75695342|FG000|NOT COMPLETED|Second Intervention (14 Days)||0||
59587915|NCT02474407|75695343|FG001|NOT COMPLETED|Second Intervention (14 Days)||0||
59587916|NCT02475031|75695371|FG000|STARTED|Overall Study||35||
59587917|NCT02475031|75695372|FG001|STARTED|Overall Study||35||
59587918|NCT02475031|75695371|FG000|COMPLETED|Overall Study||35||
59587919|NCT02475031|75695372|FG001|COMPLETED|Overall Study||35||
59587920|NCT02475031|75695371|FG000|NOT COMPLETED|Overall Study||0||
59587921|NCT02475031|75695372|FG001|NOT COMPLETED|Overall Study||0||
59587922|NCT02476357|75695382|FG000|STARTED|Overall Study||40||
59587923|NCT02476357|75695383|FG001|STARTED|Overall Study||40||
59587924|NCT02476357|75695382|FG000|COMPLETED|Overall Study||40||
59587925|NCT02476357|75695383|FG001|COMPLETED|Overall Study||40||
59587926|NCT02476357|75695382|FG000|NOT COMPLETED|Overall Study||0||
59587927|NCT02476357|75695383|FG001|NOT COMPLETED|Overall Study||0||
59587928|NCT02519491|75695393|FG000|STARTED|Overall Study||219||
59587929|NCT02519491|75695394|FG001|STARTED|Overall Study||219||
59587930|NCT02519491|75695393|FG000|COMPLETED|Overall Study||219||
59587931|NCT02519491|75695394|FG001|COMPLETED|Overall Study||219||
59587932|NCT02519491|75695393|FG000|NOT COMPLETED|Overall Study||0||
59587933|NCT02519491|75695394|FG001|NOT COMPLETED|Overall Study||0||
59587934|NCT02560753|75695404|FG000|STARTED|Overall Study||9||
59587935|NCT02560753|75695405|FG001|STARTED|Overall Study||9||
59587936|NCT02560753|75695406|FG002|STARTED|Overall Study||10||
59587937|NCT02560753|75695407|FG003|STARTED|Overall Study||8||
59587938|NCT02560753|75695404|FG000|COMPLETED|Overall Study||8||
59587939|NCT02560753|75695405|FG001|COMPLETED|Overall Study||9||
59587940|NCT02560753|75695406|FG002|COMPLETED|Overall Study||9||
59587941|NCT02560753|75695407|FG003|COMPLETED|Overall Study||8||
59587942|NCT02560753|75695404|FG000|NOT COMPLETED|Overall Study||1||
59587943|NCT02560753|75695405|FG001|NOT COMPLETED|Overall Study||0||
59587944|NCT02560753|75695406|FG002|NOT COMPLETED|Overall Study||1||
59587945|NCT02560753|75695407|FG003|NOT COMPLETED|Overall Study||0||
59854647|NCT00343889|75979226|FG001|NOT COMPLETED|Overall Study||1||
59854648|NCT00354341|75979234|FG000|STARTED|Overall Study||88||
59854649|NCT00354341|75979235|FG001|STARTED|Overall Study||82||
59587946|NCT02481505|75695420|FG000|STARTED|Overall Study||15||
59587947|NCT02481505|75695421|FG001|STARTED|Overall Study||15||
59587948|NCT02481505|75695422|FG002|STARTED|Overall Study||15||
59587949|NCT02481505|75695420|FG000|COMPLETED|Overall Study||15||
59587950|NCT02481505|75695421|FG001|COMPLETED|Overall Study||15||
59854650|NCT00354341|75979234|FG000|COMPLETED|Overall Study||85||
59854651|NCT00354341|75979235|FG001|COMPLETED|Overall Study||75||
59854652|NCT00354341|75979234|FG000|NOT COMPLETED|Overall Study||3||
59587951|NCT02481505|75695422|FG002|COMPLETED|Overall Study||15||
59587952|NCT02481505|75695420|FG000|NOT COMPLETED|Overall Study||0||
59587953|NCT02481505|75695421|FG001|NOT COMPLETED|Overall Study||0||
59587954|NCT02481505|75695422|FG002|NOT COMPLETED|Overall Study||0||
59587955|NCT02563093|75695434|FG000|STARTED|Overall Study||52||
59854653|NCT00354341|75979235|FG001|NOT COMPLETED|Overall Study||7||
59587956|NCT02563093|75695435|FG001|STARTED|Overall Study||52||
59587957|NCT02563093|75695436|FG002|STARTED|Overall Study||53||
59587958|NCT02563093|75695437|FG003|STARTED|Overall Study||51||
59587959|NCT02563093|75695434|FG000|COMPLETED|Overall Study||52||
59587960|NCT02563093|75695435|FG001|COMPLETED|Overall Study||52||
59587961|NCT02563093|75695436|FG002|COMPLETED|Overall Study||53||
59854654|NCT00354107|75979241|FG000|STARTED|Overall Study||5||
59854655|NCT00354107|75979241|FG000|COMPLETED|Overall Study||0||
59587962|NCT02563093|75695437|FG003|COMPLETED|Overall Study||51||
59587963|NCT02563093|75695434|FG000|NOT COMPLETED|Overall Study||0||
59587964|NCT02563093|75695435|FG001|NOT COMPLETED|Overall Study||0||
59587965|NCT02563093|75695436|FG002|NOT COMPLETED|Overall Study||0||
59587966|NCT02563093|75695437|FG003|NOT COMPLETED|Overall Study||0||
59587967|NCT02564029|75695448|FG000|STARTED|Overall Study||7||
59587968|NCT02564029|75695448|FG000|COMPLETED|Overall Study||7||
59587969|NCT02564029|75695448|FG000|NOT COMPLETED|Overall Study||0||
59587970|NCT02564497|75695461|FG000|STARTED|Overall Study||74||
59587971|NCT02564497|75695462|FG001|STARTED|Overall Study||72||
59587972|NCT02564497|75695461|FG000|COMPLETED|Overall Study||74||
59587973|NCT02564497|75695462|FG001|COMPLETED|Overall Study||72||
59587974|NCT02564497|75695461|FG000|NOT COMPLETED|Overall Study||0||
59587975|NCT02564497|75695462|FG001|NOT COMPLETED|Overall Study||0||
59587976|NCT02565901|75695471|FG000|STARTED|Overall Study||11||
59587977|NCT02565901|75695472|FG001|STARTED|Overall Study||11||
59587978|NCT02565901|75695473|FG002|STARTED|Overall Study||6||
59587979|NCT02565901|75695471|FG000|COMPLETED|Overall Study||11||
59587980|NCT02565901|75695472|FG001|COMPLETED|Overall Study||11||
59587981|NCT02565901|75695473|FG002|COMPLETED|Overall Study||6||
59587982|NCT02565901|75695471|FG000|NOT COMPLETED|Overall Study||0||
59587983|NCT02565901|75695472|FG001|NOT COMPLETED|Overall Study||0||
59587984|NCT02565901|75695473|FG002|NOT COMPLETED|Overall Study||0||
59587985|NCT02566135|75695484|FG000|STARTED|Overall Study||29||
59587986|NCT02566135|75695485|FG001|STARTED|Overall Study||29||
59587987|NCT02566135|75695484|FG000|COMPLETED|Overall Study||29||
59587988|NCT02566135|75695485|FG001|COMPLETED|Overall Study||29||
59587989|NCT02566135|75695484|FG000|NOT COMPLETED|Overall Study||0||
59587990|NCT02566135|75695485|FG001|NOT COMPLETED|Overall Study||0||
59587991|NCT03565640|75695493|FG000|STARTED|Overall Study||23||
59587992|NCT03565640|75695494|FG001|STARTED|Overall Study||24||
59854656|NCT00354107|75979241|FG000|NOT COMPLETED|Overall Study||5||
59854657|NCT00354029|75979247|FG000|STARTED|Overall Study||43||
59854658|NCT00354029|75979248|FG001|STARTED|Overall Study||40||
59854659|NCT00354029|75979247|FG000|COMPLETED|Overall Study||39||
59854660|NCT00354029|75979248|FG001|COMPLETED|Overall Study||38||
59854661|NCT00354029|75979247|FG000|NOT COMPLETED|Overall Study||4||
59854662|NCT00354029|75979248|FG001|NOT COMPLETED|Overall Study||2||
59854663|NCT00353873|75979256|FG000|STARTED|Overall Study||153||
59854664|NCT00353873|75979257|FG001|STARTED|Overall Study||150||
59854665|NCT00353873|75979256|FG000|COMPLETED|Overall Study||147||
59854666|NCT00353873|75979257|FG001|COMPLETED|Overall Study||147||
59854667|NCT00353873|75979256|FG000|NOT COMPLETED|Overall Study||6||
59854668|NCT00353873|75979257|FG001|NOT COMPLETED|Overall Study||3||
59854669|NCT03796676|75979266|FG000|STARTED|Overall Study||96||
59587993|NCT03565640|75695493|FG000|COMPLETED|Overall Study||22||
59587994|NCT03565640|75695494|FG001|COMPLETED|Overall Study||21||
59587995|NCT03565640|75695493|FG000|NOT COMPLETED|Overall Study||1||
59587996|NCT03565640|75695494|FG001|NOT COMPLETED|Overall Study||3||
59587997|NCT03551210|75695502|FG000|STARTED|Overall Study||171||
59725104|NCT00927927|75843889|FG004|NOT COMPLETED|Overall Study||0||
59725105|NCT00927927|75843890|FG005|NOT COMPLETED|Overall Study||0||
59725106|NCT00927927|75843891|FG006|NOT COMPLETED|Overall Study||0||
59725107|NCT00927927|75843892|FG007|NOT COMPLETED|Overall Study||2||
59725108|NCT00927927|75843893|FG008|NOT COMPLETED|Overall Study||0||
59725109|NCT00927927|75843894|FG009|NOT COMPLETED|Overall Study||0||
59725110|NCT00927927|75843895|FG010|NOT COMPLETED|Overall Study||0||
59725111|NCT00927927|75843896|FG011|NOT COMPLETED|Overall Study||2||
59725112|NCT00927927|75843897|FG012|NOT COMPLETED|Overall Study||0||
59854670|NCT03796676|75979267|FG001|STARTED|Overall Study||95||
59854671|NCT03796676|75979268|FG002|STARTED|Overall Study||94||
59854672|NCT03796676|75979266|FG000|COMPLETED|Overall Study||90||
59854673|NCT03796676|75979267|FG001|COMPLETED|Overall Study||92||
59854674|NCT03796676|75979268|FG002|COMPLETED|Overall Study||91||
59854675|NCT03796676|75979266|FG000|NOT COMPLETED|Overall Study||6||
59854676|NCT03796676|75979267|FG001|NOT COMPLETED|Overall Study||3||
60121721|NCT01564277|76242665|FG001|STARTED|Overall Study||12||
60121722|NCT01564277|76242664|FG000|COMPLETED|Overall Study||11||
59587998|NCT03551210|75695503|FG001|STARTED|Overall Study||171||
59587999|NCT03551210|75695502|FG000|COMPLETED|Overall Study||161||
59588000|NCT03551210|75695503|FG001|COMPLETED|Overall Study||151||
59725113|NCT00927927|75843898|FG013|NOT COMPLETED|Overall Study||0||
59854677|NCT03796676|75979268|FG002|NOT COMPLETED|Overall Study||3||
59854678|NCT03342898|75979282|FG000|STARTED|Overall Study||300||
59854679|NCT03342898|75979283|FG001|STARTED|Overall Study||300||
59588001|NCT03551210|75695502|FG000|NOT COMPLETED|Overall Study||10||
59588002|NCT03551210|75695503|FG001|NOT COMPLETED|Overall Study||20||
59588003|NCT02482675|75695510|FG000|STARTED|Overall Study||1||
59588004|NCT02482675|75695511|FG001|STARTED|Overall Study||1||
59588005|NCT02482675|75695512|FG002|STARTED|Overall Study||1||
59588006|NCT02482675|75695513|FG003|STARTED|Overall Study||1||
59588007|NCT02482675|75695514|FG004|STARTED|Overall Study||1||
59725114|NCT00927927|75843899|FG014|NOT COMPLETED|Overall Study||0||
59588008|NCT02482675|75695515|FG005|STARTED|Overall Study||1||
59854680|NCT03342898|75979284|FG002|STARTED|Overall Study||300||
59854681|NCT03342898|75979282|FG000|COMPLETED|Overall Study||246||
59854682|NCT03342898|75979283|FG001|COMPLETED|Overall Study||247||
59854683|NCT03342898|75979284|FG002|COMPLETED|Overall Study||246||
59854684|NCT03342898|75979282|FG000|NOT COMPLETED|Overall Study||54||
59854685|NCT03342898|75979283|FG001|NOT COMPLETED|Overall Study||53||
59854686|NCT03342898|75979284|FG002|NOT COMPLETED|Overall Study||54||
59854687|NCT00339833|75979294|FG000|STARTED|Overall Study||28||
59854688|NCT00339833|75979295|FG001|STARTED|Overall Study||26||
59854689|NCT00339833|75979294|FG000|COMPLETED|Overall Study||22||
59854690|NCT00339833|75979295|FG001|COMPLETED|Overall Study||18||
59854691|NCT00339833|75979294|FG000|NOT COMPLETED|Overall Study||6||
59854692|NCT00339833|75979295|FG001|NOT COMPLETED|Overall Study||8||
59854693|NCT03793556|75979303|FG000|STARTED|Overall Study||35||
59854694|NCT03793556|75979304|FG001|STARTED|Overall Study||36||
59854695|NCT03793556|75979303|FG000|COMPLETED|Overall Study||22||
59854696|NCT03793556|75979304|FG001|COMPLETED|Overall Study||34||
59854697|NCT03793556|75979303|FG000|NOT COMPLETED|Overall Study||13||
59854698|NCT03793556|75979304|FG001|NOT COMPLETED|Overall Study||2||
59854699|NCT03392194|75979315|FG000|STARTED|Overall Study||16||
59854700|NCT03392194|75979316|FG001|STARTED|Overall Study||17||
59854701|NCT03392194|75979315|FG000|COMPLETED|Overall Study||14||
59854702|NCT03392194|75979316|FG001|COMPLETED|Overall Study||15||
59854703|NCT03392194|75979315|FG000|NOT COMPLETED|Overall Study||2||
59854704|NCT03392194|75979316|FG001|NOT COMPLETED|Overall Study||2||
59854705|NCT03828617|75979326|FG000|STARTED|Overall Study||489||
59854706|NCT03828617|75979327|FG001|STARTED|Overall Study||490||
59854707|NCT03828617|75979328|FG002|STARTED|Overall Study||486||
59854708|NCT03828617|75979329|FG003|STARTED|Overall Study||245||
59854709|NCT03828617|75979326|FG000|Vaccinated|Overall Study||488||
59854710|NCT03828617|75979327|FG001|Vaccinated|Overall Study||489||
59854711|NCT03828617|75979328|FG002|Vaccinated|Overall Study||486||
59854712|NCT03828617|75979329|FG003|Vaccinated|Overall Study||245||
59854713|NCT03828617|75979326|FG000|Safety Population|Overall Study||488||
59854714|NCT03828617|75979327|FG001|Safety Population|Overall Study||489||
59854715|NCT03828617|75979328|FG002|Safety Population|Overall Study||486||
59854716|NCT03828617|75979329|FG003|Safety Population|Overall Study||245||
59854717|NCT03828617|75979326|FG000|Evaluable Immunogenicity Population(EIP)|Overall Study||463||
59854718|NCT03828617|75979327|FG001|Evaluable Immunogenicity Population(EIP)|Overall Study||473||
59854719|NCT03828617|75979328|FG002|Evaluable Immunogenicity Population(EIP)|Overall Study||456||
59854720|NCT03828617|75979329|FG003|Evaluable Immunogenicity Population(EIP)|Overall Study||232||
59854721|NCT03828617|75979326|FG000|COMPLETED|Overall Study||465||
59854722|NCT03828617|75979327|FG001|COMPLETED|Overall Study||475||
59854723|NCT03828617|75979328|FG002|COMPLETED|Overall Study||460||
59854724|NCT03828617|75979329|FG003|COMPLETED|Overall Study||235||
59854725|NCT03828617|75979326|FG000|NOT COMPLETED|Overall Study||24||
59854726|NCT03828617|75979327|FG001|NOT COMPLETED|Overall Study||15||
59854727|NCT03828617|75979328|FG002|NOT COMPLETED|Overall Study||26||
59854728|NCT03828617|75979329|FG003|NOT COMPLETED|Overall Study||10||
59854729|NCT03391960|75979338|FG000|STARTED|Overall Study|Units were not assessed for this Arm/Group. Data was collected from the health care worker surveys for the retrospective study to monitor compliance with the scrub-the-hub protocol (signed informed consent and were enrolled)|165||0
59854730|NCT03391960|75979339|FG001|STARTED|Overall Study|No individual patient was recruited into the study. Data was collected from the compliance audits to monitor compliance with the disinfecting barrier cap protocol.|||156
59854731|NCT03391960|75979338|FG000|COMPLETED|Overall Study||165||0
59854732|NCT03391960|75979339|FG001|COMPLETED|Overall Study|No individual patient was recruited into the study. Data was collected from the compliance audits to monitor compliance with the disinfecting barrier cap protocol.|||156
59854733|NCT03391960|75979338|FG000|NOT COMPLETED|Overall Study||0||0
59854734|NCT03391960|75979339|FG001|NOT COMPLETED|Overall Study||||0
59854735|NCT05489146|75979356|FG000|STARTED|Overall Study||8||
59854736|NCT05489146|75979357|FG001|STARTED|Overall Study||6||
59854737|NCT05489146|75979356|FG000|COMPLETED|Overall Study||8||
59854738|NCT05489146|75979357|FG001|COMPLETED|Overall Study||6||
59854739|NCT05489146|75979356|FG000|NOT COMPLETED|Overall Study||0||
60121723|NCT01564277|76242665|FG001|COMPLETED|Overall Study||11||
60121724|NCT01564277|76242664|FG000|NOT COMPLETED|Overall Study||1||
60121725|NCT01564277|76242665|FG001|NOT COMPLETED|Overall Study||1||
59588009|NCT02482675|75695516|FG006|STARTED|Overall Study||1||
59588010|NCT02482675|75695517|FG007|STARTED|Overall Study||1||
59725115|NCT01027416|75843933|FG000|STARTED|Overall Study||31||
59725116|NCT01027416|75843934|FG001|STARTED|Overall Study||28||
59725117|NCT01027416|75843933|FG000|COMPLETED|Overall Study||30||
59725118|NCT01027416|75843934|FG001|COMPLETED|Overall Study||23||
59725119|NCT01027416|75843933|FG000|NOT COMPLETED|Overall Study||1||
59725120|NCT01027416|75843934|FG001|NOT COMPLETED|Overall Study||5||
59725121|NCT00923559|75843942|FG000|STARTED|Overall Study||40||
59725122|NCT00923559|75843943|FG001|STARTED|Overall Study||40||
59725123|NCT00923559|75843942|FG000|COMPLETED|Overall Study||38||
59725124|NCT00923559|75843943|FG001|COMPLETED|Overall Study||37||
59854740|NCT05489146|75979357|FG001|NOT COMPLETED|Overall Study||0||
59854741|NCT03390166|75979365|FG000|STARTED|Overall Study||630||
59854742|NCT03390166|75979366|FG001|STARTED|Overall Study||315||
59854743|NCT03390166|75979365|FG000|COMPLETED|Overall Study||618||
59854744|NCT03390166|75979366|FG001|COMPLETED|Overall Study||305||
59854745|NCT03390166|75979365|FG000|NOT COMPLETED|Overall Study||12||
59854746|NCT03390166|75979366|FG001|NOT COMPLETED|Overall Study||10||
59854747|NCT03828539|75979374|FG000|STARTED|Overall Study||389|All patients who received a randomization number, regardless of receiving study medication were included in the Randomized Set|
59854748|NCT03828539|75979375|FG001|STARTED|Overall Study||388|All patients who received a randomization number, regardless of receiving study medication were included in the Randomized Set|
59854749|NCT03828539|75979374|FG000|Full Analysis Set (FAS)|Overall Study||388|All patients who received at least one dose of active study medication. In FAS, patients were analyzed according to randomized treatment, regardless of the actual treatment received.|
59854750|NCT03828539|75979375|FG001|Full Analysis Set (FAS)|Overall Study||388|All patients who received at least one dose of active study medication. In FAS, patients were analyzed according to randomized treatment, regardless of the actual treatment received.|
59854751|NCT03828539|75979374|FG000|Safety Analysis Set (SAF)|Overall Study||388|All randomized patients who received at least one dose of active study medication. In the SAF, patients were analyzed based on actual treatment received.|
59854752|NCT03828539|75979375|FG001|Safety Analysis Set (SAF)|Overall Study||388|All randomized patients who received at least one dose of active study medication. In the SAF, patients were analyzed based on actual treatment received.|
59854753|NCT03828539|75979374|FG000|COMPLETED|Overall Study||373||
59854754|NCT03828539|75979375|FG001|COMPLETED|Overall Study||366||
59854755|NCT03828539|75979374|FG000|NOT COMPLETED|Overall Study||16||
59854756|NCT03828539|75979375|FG001|NOT COMPLETED|Overall Study||22||
59854757|NCT03336502|75979383|FG000|STARTED|Overall Study||30|70|
59854758|NCT03336502|75979384|FG001|STARTED|Overall Study||40|70|
59854759|NCT03336502|75979383|FG000|COMPLETED|Overall Study||26|57|
59854760|NCT03336502|75979384|FG001|COMPLETED|Overall Study||31|57|
59854761|NCT03336502|75979383|FG000|NOT COMPLETED|Overall Study||4||
59854762|NCT03336502|75979384|FG001|NOT COMPLETED|Overall Study||9||
59854763|NCT00338741|75979392|FG000|STARTED|Overall Study|2 subjects signed a consent form but no data were received for either subject|34||
59854764|NCT00338741|75979393|FG001|STARTED|Overall Study||2||
59854765|NCT00338741|75979392|FG000|COMPLETED|Overall Study||32||
59854766|NCT00338741|75979393|FG001|COMPLETED|Overall Study||2||
59854767|NCT00338741|75979392|FG000|NOT COMPLETED|Overall Study||2||
59854768|NCT00338741|75979393|FG001|NOT COMPLETED|Overall Study||0||
59854769|NCT03370510|75979401|FG000|STARTED|Overall Study||3||
59854770|NCT03370510|75979402|FG001|STARTED|Overall Study||2||
59854771|NCT03370510|75979401|FG000|COMPLETED|Overall Study||1||
59854772|NCT03370510|75979402|FG001|COMPLETED|Overall Study||2||
59854773|NCT03370510|75979401|FG000|NOT COMPLETED|Overall Study||2||
59854774|NCT03370510|75979402|FG001|NOT COMPLETED|Overall Study||0||
59854775|NCT00351611|75979410|FG000|STARTED|Overall Study||89||
59854776|NCT00351611|75979411|FG001|STARTED|Overall Study||98||
59854777|NCT00351611|75979410|FG000|Treated|Overall Study||89||
59854778|NCT00351611|75979411|FG001|Treated|Overall Study||98||
59854779|NCT00351611|75979410|FG000|COMPLETED|Overall Study||75||
59854780|NCT00351611|75979411|FG001|COMPLETED|Overall Study||88||
59854781|NCT00351611|75979410|FG000|NOT COMPLETED|Overall Study||14||
59854782|NCT00351611|75979411|FG001|NOT COMPLETED|Overall Study||10||
59854783|NCT00351533|75979419|FG000|STARTED|Overall Study||41||
59854784|NCT00351533|75979420|FG001|STARTED|Overall Study||49||
59854785|NCT00351533|75979419|FG000|COMPLETED|Overall Study|Pts did not undergo BALs if not intubated|39||
59854786|NCT00351533|75979420|FG001|COMPLETED|Overall Study|Pts did not undergo BALs if not intubated|44||
59854787|NCT00351533|75979419|FG000|NOT COMPLETED|Overall Study||2||
59854788|NCT00351533|75979420|FG001|NOT COMPLETED|Overall Study||5||
59854789|NCT00351377|75979426|FG000|STARTED|Overall Study||111||
59854790|NCT00351377|75979426|FG000|COMPLETED|Overall Study||104||
59854791|NCT00351377|75979426|FG000|NOT COMPLETED|Overall Study||7||
59588011|NCT02482675|75695518|FG008|STARTED|Overall Study||1||
59725125|NCT00923559|75843942|FG000|NOT COMPLETED|Overall Study||2||
59854792|NCT00337727|75979432|FG000|STARTED|Overall Study||430||
59725126|NCT00923559|75843943|FG001|NOT COMPLETED|Overall Study||3||
59725127|NCT01015638|75843953|FG000|STARTED|Overall Study||17||
59725128|NCT01015638|75843954|FG001|STARTED|Overall Study||19||
59725129|NCT01015638|75843953|FG000|COMPLETED|Overall Study||16||
59725130|NCT01015638|75843954|FG001|COMPLETED|Overall Study||19||
59725131|NCT01015638|75843953|FG000|NOT COMPLETED|Overall Study||1||
59725132|NCT01015638|75843954|FG001|NOT COMPLETED|Overall Study||0||
59725133|NCT01022502|75843960|FG000|STARTED|Overall Study|19 used the refined ointment on the right site, 19 used the crude ointment on the left site.|38||
59725134|NCT01022502|75843960|FG000|COMPLETED|Overall Study|3 participants withdrew at week 4,5,6,respectively.|35||
59725135|NCT01022502|75843960|FG000|NOT COMPLETED|Overall Study||3||
59725136|NCT01105091|75843968|FG000|STARTED|Overall Study||20||
59725137|NCT01105091|75843969|FG001|STARTED|Overall Study||10||
59854793|NCT00337727|75979433|FG001|STARTED|Overall Study||418||
59854794|NCT00337727|75979432|FG000|COMPLETED|Overall Study||412||
59854795|NCT00337727|75979433|FG001|COMPLETED|Overall Study||406||
59854796|NCT00337727|75979432|FG000|NOT COMPLETED|Overall Study||18||
59854797|NCT00337727|75979433|FG001|NOT COMPLETED|Overall Study||12||
60121726|NCT02679222|76242671|FG000|STARTED|Overall Study||10||
59588012|NCT02482675|75695519|FG009|STARTED|Overall Study||1||
59725138|NCT01105091|75843968|FG000|COMPLETED|Overall Study||18||
59725139|NCT01105091|75843969|FG001|COMPLETED|Overall Study||10||
59725140|NCT01105091|75843968|FG000|NOT COMPLETED|Overall Study||2||
59854798|NCT00324233|75979441|FG000|STARTED|First Period||18||
59854799|NCT00324233|75979442|FG001|STARTED|First Period||18||
59854800|NCT00324233|75979441|FG000|COMPLETED|First Period||17||
59854801|NCT00324233|75979442|FG001|COMPLETED|First Period||18||
59854802|NCT00324233|75979441|FG000|NOT COMPLETED|First Period||1||
59854803|NCT00324233|75979442|FG001|NOT COMPLETED|First Period||0||
59854804|NCT00324233|75979441|FG000|STARTED|Second Period||17||
59854805|NCT00324233|75979442|FG001|STARTED|Second Period||18||
59854806|NCT00324233|75979441|FG000|COMPLETED|Second Period||12||
59854807|NCT00324233|75979442|FG001|COMPLETED|Second Period||11||
60121727|NCT02679222|76242671|FG000|COMPLETED|Overall Study||9||
59588013|NCT02482675|75695520|FG010|STARTED|Overall Study||1||
59588014|NCT02482675|75695521|FG011|STARTED|Overall Study||1||
59588015|NCT02482675|75695522|FG012|STARTED|Overall Study||1||
59588016|NCT02482675|75695523|FG013|STARTED|Overall Study||1||
59588017|NCT02482675|75695524|FG014|STARTED|Overall Study||1||
59588018|NCT02482675|75695525|FG015|STARTED|Overall Study||1||
59588019|NCT02482675|75695526|FG016|STARTED|Overall Study||1||
59588020|NCT02482675|75695527|FG017|STARTED|Overall Study||1||
59588021|NCT02482675|75695528|FG018|STARTED|Overall Study||1||
59588022|NCT02482675|75695529|FG019|STARTED|Overall Study||1||
59588023|NCT02482675|75695530|FG020|STARTED|Overall Study||1||
59588024|NCT02482675|75695531|FG021|STARTED|Overall Study||1||
59588025|NCT02482675|75695532|FG022|STARTED|Overall Study||1||
59588026|NCT02482675|75695510|FG000|COMPLETED|Overall Study||1||
59588027|NCT02482675|75695511|FG001|COMPLETED|Overall Study||1||
59588028|NCT02482675|75695512|FG002|COMPLETED|Overall Study||1||
59588029|NCT02482675|75695513|FG003|COMPLETED|Overall Study||1||
59588030|NCT02482675|75695514|FG004|COMPLETED|Overall Study||1||
59588031|NCT02482675|75695515|FG005|COMPLETED|Overall Study||1||
59588032|NCT02482675|75695516|FG006|COMPLETED|Overall Study||1||
59588033|NCT02482675|75695517|FG007|COMPLETED|Overall Study||1||
59588034|NCT02482675|75695518|FG008|COMPLETED|Overall Study||1||
59588035|NCT02482675|75695519|FG009|COMPLETED|Overall Study||1||
59854808|NCT00324233|75979441|FG000|NOT COMPLETED|Second Period||5||
59854809|NCT00324233|75979442|FG001|NOT COMPLETED|Second Period||7||
60121728|NCT02679222|76242671|FG000|NOT COMPLETED|Overall Study||1||
60121729|NCT01563185|76242683|FG000|STARTED|Overall Study||12||
60121730|NCT01563185|76242683|FG000|COMPLETED|Overall Study||10||
60121731|NCT01563185|76242683|FG000|NOT COMPLETED|Overall Study||2||
60121732|NCT03305848|76242687|FG000|STARTED|Overall Study||20||
59588036|NCT02482675|75695520|FG010|COMPLETED|Overall Study||1||
59588037|NCT02482675|75695521|FG011|COMPLETED|Overall Study||1||
59588038|NCT02482675|75695522|FG012|COMPLETED|Overall Study||1||
59588039|NCT02482675|75695523|FG013|COMPLETED|Overall Study||1||
59588040|NCT02482675|75695524|FG014|COMPLETED|Overall Study||1||
59588041|NCT02482675|75695525|FG015|COMPLETED|Overall Study||1||
59588042|NCT02482675|75695526|FG016|COMPLETED|Overall Study||1||
59588043|NCT02482675|75695527|FG017|COMPLETED|Overall Study||1||
59588044|NCT02482675|75695528|FG018|COMPLETED|Overall Study||1||
59588045|NCT02482675|75695529|FG019|COMPLETED|Overall Study||1||
59588046|NCT02482675|75695530|FG020|COMPLETED|Overall Study||1||
59588047|NCT02482675|75695531|FG021|COMPLETED|Overall Study||1||
59588048|NCT02482675|75695532|FG022|COMPLETED|Overall Study||1||
59588049|NCT02482675|75695510|FG000|NOT COMPLETED|Overall Study||0||
59588050|NCT02482675|75695511|FG001|NOT COMPLETED|Overall Study||0||
59588051|NCT02482675|75695512|FG002|NOT COMPLETED|Overall Study||0||
59588052|NCT02482675|75695513|FG003|NOT COMPLETED|Overall Study||0||
59588053|NCT02482675|75695514|FG004|NOT COMPLETED|Overall Study||0||
59588054|NCT02482675|75695515|FG005|NOT COMPLETED|Overall Study||0||
59588055|NCT02482675|75695516|FG006|NOT COMPLETED|Overall Study||0||
59588056|NCT02482675|75695517|FG007|NOT COMPLETED|Overall Study||0||
59588057|NCT02482675|75695518|FG008|NOT COMPLETED|Overall Study||0||
59588058|NCT02482675|75695519|FG009|NOT COMPLETED|Overall Study||0||
59588059|NCT02482675|75695520|FG010|NOT COMPLETED|Overall Study||0||
59588060|NCT02482675|75695521|FG011|NOT COMPLETED|Overall Study||0||
59588061|NCT02482675|75695522|FG012|NOT COMPLETED|Overall Study||0||
59588062|NCT02482675|75695523|FG013|NOT COMPLETED|Overall Study||0||
59588063|NCT02482675|75695524|FG014|NOT COMPLETED|Overall Study||0||
59588064|NCT02482675|75695525|FG015|NOT COMPLETED|Overall Study||0||
59588065|NCT02482675|75695526|FG016|NOT COMPLETED|Overall Study||0||
59588066|NCT02482675|75695527|FG017|NOT COMPLETED|Overall Study||0||
59588067|NCT02482675|75695528|FG018|NOT COMPLETED|Overall Study||0||
59588068|NCT02482675|75695529|FG019|NOT COMPLETED|Overall Study||0||
59588069|NCT02482675|75695530|FG020|NOT COMPLETED|Overall Study||0||
59588070|NCT02482675|75695531|FG021|NOT COMPLETED|Overall Study||0||
59588071|NCT02482675|75695532|FG022|NOT COMPLETED|Overall Study||0||
59588072|NCT02566369|75695544|FG000|STARTED|Overall Study||612||
59588073|NCT02566369|75695545|FG001|STARTED|Overall Study||596||
59588074|NCT02566369|75695544|FG000|COMPLETED|Overall Study||540||
59588075|NCT02566369|75695545|FG001|COMPLETED|Overall Study||535||
59588076|NCT02566369|75695544|FG000|NOT COMPLETED|Overall Study||72||
59588077|NCT02566369|75695545|FG001|NOT COMPLETED|Overall Study||61||
59854810|NCT03335566|75979450|FG000|STARTED|Overall Study||218||
59854811|NCT03335566|75979451|FG001|STARTED|Overall Study||206||
60121733|NCT03305848|76242687|FG000|COMPLETED|Overall Study||17||
59588078|NCT02569411|75695553|FG000|STARTED|Overall Study||65|Authors were contacted in either arm to share complete individual patient data during the study|
59588079|NCT02569411|75695554|FG001|STARTED|Overall Study||64|Authors were contacted in either arm to share complete individual patient data during the study|
59588080|NCT02569411|75695553|FG000|COMPLETED|Overall Study||0|None of the authors contacted in either arm shared complete individual patient data during the study|
59588081|NCT02569411|75695554|FG001|COMPLETED|Overall Study||0|None of the authors contacted in either arm shared complete individual patient data during the study|
59588082|NCT02569411|75695553|FG000|NOT COMPLETED|Overall Study||65||
59588083|NCT02569411|75695554|FG001|NOT COMPLETED|Overall Study||64||
59588084|NCT02569723|75695560|FG000|STARTED|Overall Study||6||
59588085|NCT02569723|75695560|FG000|COMPLETED|Overall Study||6||
59588086|NCT02569723|75695560|FG000|NOT COMPLETED|Overall Study||0||
59588087|NCT02570425|75695566|FG000|STARTED|Visit 1||274||
59588088|NCT02570425|75695567|FG001|STARTED|Visit 1||242||
59588089|NCT02570425|75695566|FG000|COMPLETED|Visit 1||274||
59588090|NCT02570425|75695567|FG001|COMPLETED|Visit 1||242||
59588091|NCT02570425|75695566|FG000|NOT COMPLETED|Visit 1||0||
59588092|NCT02570425|75695567|FG001|NOT COMPLETED|Visit 1||0||
59588093|NCT02570425|75695566|FG000|STARTED|Visit 2|In total 18 patients who completed Visit 1, did not attend Visit 2.|251||
59588094|NCT02570425|75695567|FG001|STARTED|Visit 2|In total 18 patients who completed Visit 1, did not attend Visit 2.|247||
59588095|NCT02570425|75695566|FG000|COMPLETED|Visit 2||251||
59588096|NCT02570425|75695567|FG001|COMPLETED|Visit 2||247||
59588097|NCT02570425|75695566|FG000|NOT COMPLETED|Visit 2||0||
59588098|NCT02570425|75695567|FG001|NOT COMPLETED|Visit 2||0||
59588099|NCT02570425|75695566|FG000|STARTED|Visit 3|In total 38 patients who completed Visit 2, did not attend Visit 3.|229||
59588100|NCT02570425|75695567|FG001|STARTED|Visit 3|In total 38 patients who completed Visit 2, did not attend Visit 3.|231||
59588101|NCT02570425|75695566|FG000|COMPLETED|Visit 3||229||
59588102|NCT02570425|75695567|FG001|COMPLETED|Visit 3||231||
59588103|NCT02570425|75695566|FG000|NOT COMPLETED|Visit 3||0||
59588104|NCT02570425|75695567|FG001|NOT COMPLETED|Visit 3||0||
59588105|NCT02571439|75695578|FG000|STARTED|Overall Study||20||
59588106|NCT02571439|75695579|FG001|STARTED|Overall Study||21||
59588107|NCT02571439|75695578|FG000|COMPLETED|Overall Study||20||
59588108|NCT02571439|75695579|FG001|COMPLETED|Overall Study||21||
59588109|NCT02571439|75695578|FG000|NOT COMPLETED|Overall Study||0||
59588110|NCT02571439|75695579|FG001|NOT COMPLETED|Overall Study||0||
59588111|NCT02573857|75695587|FG000|STARTED|Overall Study||8||
59588112|NCT02573857|75695588|FG001|STARTED|Overall Study||8||
59588113|NCT02573857|75695587|FG000|COMPLETED|Overall Study||8||
59588114|NCT02573857|75695588|FG001|COMPLETED|Overall Study||8||
59588115|NCT02573857|75695587|FG000|NOT COMPLETED|Overall Study||0||
59588116|NCT02573857|75695588|FG001|NOT COMPLETED|Overall Study||0||
59588117|NCT02576041|75695594|FG000|STARTED|Placebo (run-in)||18||
59588118|NCT02576041|75695594|FG000|COMPLETED|Placebo (run-in)||18||
59588119|NCT02576041|75695594|FG000|NOT COMPLETED|Placebo (run-in)||0||
59588120|NCT02576041|75695594|FG000|STARTED|Bilastine (Active Treatement)||18||
59588121|NCT02576041|75695594|FG000|COMPLETED|Bilastine (Active Treatement)||18||
59588122|NCT02576041|75695594|FG000|NOT COMPLETED|Bilastine (Active Treatement)||0||
59588123|NCT02576899|75695600|FG000|STARTED|Overall Study||16||
59588124|NCT02576899|75695601|FG001|STARTED|Overall Study||20||
59588125|NCT02576899|75695600|FG000|COMPLETED|Overall Study||5||
59588126|NCT02576899|75695601|FG001|COMPLETED|Overall Study||7||
59588127|NCT02576899|75695600|FG000|NOT COMPLETED|Overall Study||11||
59588128|NCT02576899|75695601|FG001|NOT COMPLETED|Overall Study||13||
59588129|NCT02577445|75695610|FG000|STARTED|Overall Study||14||
59588130|NCT02577445|75695611|FG001|STARTED|Overall Study||17||
59588131|NCT02577445|75695610|FG000|COMPLETED|Overall Study|study terminated prematurely|0||
59588132|NCT02577445|75695611|FG001|COMPLETED|Overall Study|study terminated prematurely|0||
59588133|NCT02577445|75695610|FG000|NOT COMPLETED|Overall Study||14||
59588134|NCT02577445|75695611|FG001|NOT COMPLETED|Overall Study||17||
59588135|NCT02577601|75695618|FG000|STARTED|UPA Only (1 Month)||36||
59588136|NCT02577601|75695618|FG000|COMPLETED|UPA Only (1 Month)||36||
59588137|NCT02577601|75695618|FG000|NOT COMPLETED|UPA Only (1 Month)||0||
59588138|NCT02577601|75695618|FG000|STARTED|Washout (1 Month)||33||
59588139|NCT02577601|75695618|FG000|COMPLETED|Washout (1 Month)||33||
59588140|NCT02577601|75695618|FG000|NOT COMPLETED|Washout (1 Month)||0||
59725141|NCT01105091|75843969|FG001|NOT COMPLETED|Overall Study||0||
59588141|NCT02577601|75695618|FG000|STARTED|UPA+COC (1 Month)||33||
59588142|NCT02577601|75695618|FG000|COMPLETED|UPA+COC (1 Month)||33||
59588143|NCT02577601|75695618|FG000|NOT COMPLETED|UPA+COC (1 Month)||0||
59588144|NCT02577991|75695628|FG000|STARTED|Overall Study||24||
59588145|NCT02577991|75695629|FG001|STARTED|Overall Study||27||
59588146|NCT02577991|75695630|FG002|STARTED|Overall Study||29||
59588147|NCT02577991|75695628|FG000|COMPLETED|Overall Study||21||
59588148|NCT02577991|75695629|FG001|COMPLETED|Overall Study||25||
59588149|NCT02577991|75695630|FG002|COMPLETED|Overall Study||29||
59588150|NCT02577991|75695628|FG000|NOT COMPLETED|Overall Study||3||
59588151|NCT02577991|75695629|FG001|NOT COMPLETED|Overall Study||2||
59588152|NCT02577991|75695630|FG002|NOT COMPLETED|Overall Study||0||
59588153|NCT02207634|75695640|FG000|STARTED|Overall Study||990||
59588154|NCT02207634|75695641|FG001|STARTED|Overall Study||984||
59588155|NCT02207634|75695640|FG000|Received Treatment|Overall Study||990||
59588156|NCT02207634|75695641|FG001|Received Treatment|Overall Study||983||
59588157|NCT02207634|75695640|FG000|COMPLETED|Overall Study||968||
59588158|NCT02207634|75695641|FG001|COMPLETED|Overall Study||953||
59588159|NCT02207634|75695640|FG000|NOT COMPLETED|Overall Study||22||
59588160|NCT02207634|75695641|FG001|NOT COMPLETED|Overall Study||31||
59588161|NCT02485561|75695650|FG000|STARTED|Overall Study||161||
59588162|NCT02485561|75695651|FG001|STARTED|Overall Study||157||
59588163|NCT02485561|75695652|FG002|STARTED|Overall Study||159||
59588164|NCT02485561|75695650|FG000|Completed 1 mo Survey|Overall Study||145||
59588165|NCT02485561|75695651|FG001|Completed 1 mo Survey|Overall Study||138||
59588166|NCT02485561|75695652|FG002|Completed 1 mo Survey|Overall Study||144||
59588167|NCT02485561|75695650|FG000|COMPLETED|Overall Study||133|Completed 12 month follow up survey (final time point)|
59588168|NCT02485561|75695651|FG001|COMPLETED|Overall Study||118|Completed 12 month follow up survey (final time point)|
59588169|NCT02485561|75695652|FG002|COMPLETED|Overall Study||136|Completed 12 month follow up survey (final time point)|
59588170|NCT02485561|75695650|FG000|NOT COMPLETED|Overall Study||28||
59588171|NCT02485561|75695651|FG001|NOT COMPLETED|Overall Study||39||
59588172|NCT02485561|75695652|FG002|NOT COMPLETED|Overall Study||23||
59588173|NCT02486263|75695662|FG000|STARTED|Overall Study||40||
59588174|NCT02486263|75695663|FG001|STARTED|Overall Study||36||
59588175|NCT02486263|75695662|FG000|COMPLETED|Overall Study||37||
59588176|NCT02486263|75695663|FG001|COMPLETED|Overall Study||35||
59588177|NCT02486263|75695662|FG000|NOT COMPLETED|Overall Study||3||
59588178|NCT02486263|75695663|FG001|NOT COMPLETED|Overall Study||1||
59588179|NCT03452228|75695673|FG000|STARTED|Double-Blind Treatment Period (12 Weeks)||17|Randomized|
59588180|NCT03452228|75695674|FG001|STARTED|Double-Blind Treatment Period (12 Weeks)||35|Randomized|
59588181|NCT03452228|75695675|FG002|STARTED|Double-Blind Treatment Period (12 Weeks)||0|Randomized|
59588182|NCT03452228|75695673|FG000|Treated|Double-Blind Treatment Period (12 Weeks)||16|Randomized and Treated|
59588183|NCT03452228|75695674|FG001|Treated|Double-Blind Treatment Period (12 Weeks)||35|Randomized and Treated|
59588184|NCT03452228|75695675|FG002|Treated|Double-Blind Treatment Period (12 Weeks)||0|Randomized and Treated|
59588185|NCT03452228|75695673|FG000|Actual Cohort 1|Double-Blind Treatment Period (12 Weeks)||5|Actual Cohort 1 included participants with homozygous or compound heterozygous loss-of-function (LOF) mutations in genes in the lipoprotein lipase (LPL) pathway as was determined based on genotype data.|
59588186|NCT03452228|75695674|FG001|Actual Cohort 1|Double-Blind Treatment Period (12 Weeks)||12|Actual Cohort 1 included participants with homozygous or compound heterozygous loss-of-function (LOF) mutations in genes in the lipoprotein lipase (LPL) pathway as was determined based on genotype data.|
59588187|NCT03452228|75695675|FG002|Actual Cohort 1|Double-Blind Treatment Period (12 Weeks)||0|Actual Cohort 1 included participants with homozygous or compound heterozygous loss-of-function (LOF) mutations in genes in the lipoprotein lipase (LPL) pathway as was determined based on genotype data.|
59588188|NCT03452228|75695673|FG000|Actual Cohort 2|Double-Blind Treatment Period (12 Weeks)||6|Actual Cohort 2 included participants with heterozygous LOF mutations in genes in the LPL pathway as was determined based on genotype data.|
59588189|NCT03452228|75695674|FG001|Actual Cohort 2|Double-Blind Treatment Period (12 Weeks)||9|Actual Cohort 2 included participants with heterozygous LOF mutations in genes in the LPL pathway as was determined based on genotype data.|
59588190|NCT03452228|75695675|FG002|Actual Cohort 2|Double-Blind Treatment Period (12 Weeks)||0|Actual Cohort 2 included participants with heterozygous LOF mutations in genes in the LPL pathway as was determined based on genotype data.|
59588191|NCT03452228|75695673|FG000|Actual Cohort 3|Double-Blind Treatment Period (12 Weeks)||5|Actual Cohort 3 included participants without LOF mutations in genes in the LPL pathway as was determined based on genotype data.|
59588192|NCT03452228|75695674|FG001|Actual Cohort 3|Double-Blind Treatment Period (12 Weeks)||14|Actual Cohort 3 included participants without LOF mutations in genes in the LPL pathway as was determined based on genotype data.|
59588193|NCT03452228|75695675|FG002|Actual Cohort 3|Double-Blind Treatment Period (12 Weeks)||0|Actual Cohort 3 included participants without LOF mutations in genes in the LPL pathway as was determined based on genotype data.|
59588194|NCT03452228|75695673|FG000|COMPLETED|Double-Blind Treatment Period (12 Weeks)||15||
59588195|NCT03452228|75695674|FG001|COMPLETED|Double-Blind Treatment Period (12 Weeks)||32||
59588196|NCT03452228|75695675|FG002|COMPLETED|Double-Blind Treatment Period (12 Weeks)||0||
59588197|NCT03452228|75695673|FG000|NOT COMPLETED|Double-Blind Treatment Period (12 Weeks)||2||
59588198|NCT03452228|75695674|FG001|NOT COMPLETED|Double-Blind Treatment Period (12 Weeks)||3||
59588199|NCT03452228|75695675|FG002|NOT COMPLETED|Double-Blind Treatment Period (12 Weeks)||0||
59588200|NCT03452228|75695673|FG000|STARTED|Single-Blind Treatment Period (12 Weeks)||0||
59588201|NCT03452228|75695674|FG001|STARTED|Single-Blind Treatment Period (12 Weeks)||0||
59588202|NCT03452228|75695675|FG002|STARTED|Single-Blind Treatment Period (12 Weeks)|Participants were moved from DBTP to SBTP.|47||
59588203|NCT03452228|75695673|FG000|Treated|Single-Blind Treatment Period (12 Weeks)||0||
59588204|NCT03452228|75695674|FG001|Treated|Single-Blind Treatment Period (12 Weeks)||0||
59588205|NCT03452228|75695675|FG002|Treated|Single-Blind Treatment Period (12 Weeks)||47||
59588206|NCT03452228|75695673|FG000|Actual Cohort 1: DB Placebo to SB Evinacumab|Single-Blind Treatment Period (12 Weeks)||0|Actual Cohort 1 included participants with homozygous or compound heterozygous LOF mutations in genes in the LPL pathway as was determined based on genotype data. Those actual cohort 1 participants who received placebo in DBTP were shifted into single blind (SB) evinacumab group.|
59725142|NCT00924729|75843979|FG000|STARTED|Overall Study||25||
59725143|NCT00924729|75843980|FG001|STARTED|Overall Study||25||
59725144|NCT00924729|75843979|FG000|COMPLETED|Overall Study||23||
59588207|NCT03452228|75695674|FG001|Actual Cohort 1: DB Placebo to SB Evinacumab|Single-Blind Treatment Period (12 Weeks)||0|Actual Cohort 1 included participants with homozygous or compound heterozygous LOF mutations in genes in the LPL pathway as was determined based on genotype data. Those actual cohort 1 participants who received placebo in DBTP were shifted into single blind (SB) evinacumab group.|
59588208|NCT03452228|75695675|FG002|Actual Cohort 1: DB Placebo to SB Evinacumab|Single-Blind Treatment Period (12 Weeks)||4|Actual Cohort 1 included participants with homozygous or compound heterozygous LOF mutations in genes in the LPL pathway as was determined based on genotype data. Those actual cohort 1 participants who received placebo in DBTP were shifted into single blind (SB) evinacumab group.|
59588209|NCT03452228|75695673|FG000|Actual Cohort 1: DB Evinacumab to SB Evinacumab|Single-Blind Treatment Period (12 Weeks)||0|Actual Cohort 1 included participants with homozygous or compound heterozygous LOF mutations in genes in the LPL pathway as was determined based on genotype data. Those actual cohort 1 participants who received evinacumab in DBTP were shifted into SB evinacumab group.|
59588210|NCT03452228|75695674|FG001|Actual Cohort 1: DB Evinacumab to SB Evinacumab|Single-Blind Treatment Period (12 Weeks)||0|Actual Cohort 1 included participants with homozygous or compound heterozygous LOF mutations in genes in the LPL pathway as was determined based on genotype data. Those actual cohort 1 participants who received evinacumab in DBTP were shifted into SB evinacumab group.|
59588211|NCT03452228|75695675|FG002|Actual Cohort 1: DB Evinacumab to SB Evinacumab|Single-Blind Treatment Period (12 Weeks)||11|Actual Cohort 1 included participants with homozygous or compound heterozygous LOF mutations in genes in the LPL pathway as was determined based on genotype data. Those actual cohort 1 participants who received evinacumab in DBTP were shifted into SB evinacumab group.|
59588212|NCT03452228|75695673|FG000|Actual Cohort 2: DB Placebo to SB Evinacumab|Single-Blind Treatment Period (12 Weeks)||0|Actual Cohort 2 included participants with heterozygous LOF mutations in genes in the LPL pathway as was determined based on genotype data. Those actual cohort 2 participants who received placebo in DBTP were shifted into SB evinacumab group.|
59588213|NCT03452228|75695674|FG001|Actual Cohort 2: DB Placebo to SB Evinacumab|Single-Blind Treatment Period (12 Weeks)||0|Actual Cohort 2 included participants with heterozygous LOF mutations in genes in the LPL pathway as was determined based on genotype data. Those actual cohort 2 participants who received placebo in DBTP were shifted into SB evinacumab group.|
59588214|NCT03452228|75695675|FG002|Actual Cohort 2: DB Placebo to SB Evinacumab|Single-Blind Treatment Period (12 Weeks)||6|Actual Cohort 2 included participants with heterozygous LOF mutations in genes in the LPL pathway as was determined based on genotype data. Those actual cohort 2 participants who received placebo in DBTP were shifted into SB evinacumab group.|
59588215|NCT03452228|75695673|FG000|Actual Cohort 2: DB Evinacumab to SB Evinacumab|Single-Blind Treatment Period (12 Weeks)||0|Actual Cohort 2 included participants with heterozygous LOF mutations in genes in the LPL pathway as was determined based on genotype data. Those actual cohort 2 participants who received evinacumab in DBTP were shifted into SB evinacumab group.|
59588216|NCT03452228|75695674|FG001|Actual Cohort 2: DB Evinacumab to SB Evinacumab|Single-Blind Treatment Period (12 Weeks)||0|Actual Cohort 2 included participants with heterozygous LOF mutations in genes in the LPL pathway as was determined based on genotype data. Those actual cohort 2 participants who received evinacumab in DBTP were shifted into SB evinacumab group.|
59588217|NCT03452228|75695675|FG002|Actual Cohort 2: DB Evinacumab to SB Evinacumab|Single-Blind Treatment Period (12 Weeks)||9|Actual Cohort 2 included participants with heterozygous LOF mutations in genes in the LPL pathway as was determined based on genotype data. Those actual cohort 2 participants who received evinacumab in DBTP were shifted into SB evinacumab group.|
59588218|NCT03452228|75695673|FG000|Actual Cohort 3: DB Placebo to SB Evinacumab|Single-Blind Treatment Period (12 Weeks)||0|Actual Cohort 3 included participants without LOF mutations in genes in the LPL pathway as was determined based on genotype data. Those actual cohort 3 participants who received placebo in DBTP were shifted into SB evinacumab group.|
59588219|NCT03452228|75695674|FG001|Actual Cohort 3: DB Placebo to SB Evinacumab|Single-Blind Treatment Period (12 Weeks)||0|Actual Cohort 3 included participants without LOF mutations in genes in the LPL pathway as was determined based on genotype data. Those actual cohort 3 participants who received placebo in DBTP were shifted into SB evinacumab group.|
59588220|NCT03452228|75695675|FG002|Actual Cohort 3: DB Placebo to SB Evinacumab|Single-Blind Treatment Period (12 Weeks)||5|Actual Cohort 3 included participants without LOF mutations in genes in the LPL pathway as was determined based on genotype data. Those actual cohort 3 participants who received placebo in DBTP were shifted into SB evinacumab group.|
59588221|NCT03452228|75695673|FG000|Actual Cohort 3: DB Evinacumab to SB Evinacumab|Single-Blind Treatment Period (12 Weeks)||0|Actual Cohort 3 included participants without LOF mutations in genes in the LPL pathway as was determined based on genotype data. Those actual cohort 3 participants who received evinacumab in DBTP were shifted into SB evinacumab group.|
59588222|NCT03452228|75695674|FG001|Actual Cohort 3: DB Evinacumab to SB Evinacumab|Single-Blind Treatment Period (12 Weeks)||0|Actual Cohort 3 included participants without LOF mutations in genes in the LPL pathway as was determined based on genotype data. Those actual cohort 3 participants who received evinacumab in DBTP were shifted into SB evinacumab group.|
59725145|NCT00924729|75843980|FG001|COMPLETED|Overall Study||25||
59725146|NCT00924729|75843979|FG000|NOT COMPLETED|Overall Study||2||
59725147|NCT00924729|75843980|FG001|NOT COMPLETED|Overall Study||0||
59725148|NCT01099709|75843988|FG000|STARTED|Period 1||42||
59725149|NCT01099709|75843989|FG001|STARTED|Period 1||43||
59854812|NCT03335566|75979450|FG000|COMPLETED|Overall Study||214||
59854813|NCT03335566|75979451|FG001|COMPLETED|Overall Study||203||
59854814|NCT03335566|75979450|FG000|NOT COMPLETED|Overall Study||4||
59854815|NCT03335566|75979451|FG001|NOT COMPLETED|Overall Study||3||
59854816|NCT03369418|75979459|FG000|STARTED|Overall Study||16||
59854817|NCT03369418|75979460|FG001|STARTED|Overall Study||14||
59854818|NCT03369418|75979459|FG000|COMPLETED|Overall Study||13||
59854819|NCT03369418|75979460|FG001|COMPLETED|Overall Study||11||
59854820|NCT03369418|75979459|FG000|NOT COMPLETED|Overall Study||3||
60121734|NCT03305848|76242687|FG000|NOT COMPLETED|Overall Study||3||
60121735|NCT01563029|76242696|FG000|STARTED|Overall Study||119||
60121736|NCT01563029|76242697|FG001|STARTED|Overall Study||118||
59588223|NCT03452228|75695675|FG002|Actual Cohort 3: DB Evinacumab to SB Evinacumab|Single-Blind Treatment Period (12 Weeks)||12|Actual Cohort 3 included participants without LOF mutations in genes in the LPL pathway as was determined based on genotype data. Those actual cohort 3 participants who received evinacumab in DBTP were shifted into SB evinacumab group.|
59588224|NCT03452228|75695673|FG000|COMPLETED|Single-Blind Treatment Period (12 Weeks)||0||
59588225|NCT03452228|75695674|FG001|COMPLETED|Single-Blind Treatment Period (12 Weeks)||0||
59588226|NCT03452228|75695675|FG002|COMPLETED|Single-Blind Treatment Period (12 Weeks)||43||
59588227|NCT03452228|75695673|FG000|NOT COMPLETED|Single-Blind Treatment Period (12 Weeks)||0||
59588228|NCT03452228|75695674|FG001|NOT COMPLETED|Single-Blind Treatment Period (12 Weeks)||0||
59588229|NCT03452228|75695675|FG002|NOT COMPLETED|Single-Blind Treatment Period (12 Weeks)||4||
59588230|NCT02580799|75695699|FG000|STARTED|Overall Study||30||
59588231|NCT02580799|75695699|FG000|COMPLETED|Overall Study||30||
59588232|NCT02580799|75695699|FG000|NOT COMPLETED|Overall Study||0||
59588233|NCT02581111|75695705|FG000|STARTED|Overall Study||98||
59588234|NCT02581111|75695706|FG001|STARTED|Overall Study||101||
59588235|NCT02581111|75695705|FG000|COMPLETED|Overall Study||96||
59588236|NCT02581111|75695706|FG001|COMPLETED|Overall Study||94||
59588237|NCT02581111|75695705|FG000|NOT COMPLETED|Overall Study||2||
59588238|NCT02581111|75695706|FG001|NOT COMPLETED|Overall Study||7||
59588239|NCT02489227|75695715|FG000|STARTED|Overall Study||274||
59588240|NCT02489227|75695716|FG001|STARTED|Overall Study||135||
59588241|NCT02489227|75695717|FG002|STARTED|Overall Study||136||
59588242|NCT02489227|75695715|FG000|COMPLETED|Overall Study||220||
59588243|NCT02489227|75695716|FG001|COMPLETED|Overall Study||101||
59588244|NCT02489227|75695717|FG002|COMPLETED|Overall Study||117||
59588245|NCT02489227|75695715|FG000|NOT COMPLETED|Overall Study||54||
59588246|NCT02489227|75695716|FG001|NOT COMPLETED|Overall Study||34||
59588247|NCT02489227|75695717|FG002|NOT COMPLETED|Overall Study||19||
59588248|NCT02490631|75695729|FG000|STARTED|Overall Study||79||
59588249|NCT02490631|75695730|FG001|STARTED|Overall Study||78||
59588250|NCT02490631|75695729|FG000|COMPLETED|Overall Study||76||
59588251|NCT02490631|75695730|FG001|COMPLETED|Overall Study||75||
59588252|NCT02490631|75695729|FG000|NOT COMPLETED|Overall Study||3||
59588253|NCT02490631|75695730|FG001|NOT COMPLETED|Overall Study||3||
59588254|NCT02207556|75695738|FG000|STARTED|Overall Study||7||
59588255|NCT02207556|75695739|FG001|STARTED|Overall Study||25||
59588256|NCT02207556|75695738|FG000|COMPLETED|Overall Study||5||
59588257|NCT02207556|75695739|FG001|COMPLETED|Overall Study||20||
59588258|NCT02207556|75695738|FG000|NOT COMPLETED|Overall Study||2||
59588259|NCT02207556|75695739|FG001|NOT COMPLETED|Overall Study||5||
59588260|NCT02494297|75695748|FG000|STARTED|Overall Study||1597|1,698 patients were recruited 101 patients were excluded due to protocol violations.|
59588261|NCT02494297|75695748|FG000|COMPLETED|Overall Study|As there was no Follow-Up in this study, participation equals completion|1597||
59588262|NCT02494297|75695748|FG000|NOT COMPLETED|Overall Study||0||
59588263|NCT03732638|75695754|FG000|STARTED|DBT Phase (Weeks 1 to 12)||370||
59588264|NCT03732638|75695755|FG001|STARTED|DBT Phase (Weeks 1 to 12)||371||
59588265|NCT03732638|75695754|FG000|COMPLETED|DBT Phase (Weeks 1 to 12)||316||
59588266|NCT03732638|75695755|FG001|COMPLETED|DBT Phase (Weeks 1 to 12)||310||
59588267|NCT03732638|75695754|FG000|NOT COMPLETED|DBT Phase (Weeks 1 to 12)||54||
59588268|NCT03732638|75695755|FG001|NOT COMPLETED|DBT Phase (Weeks 1 to 12)||61||
59588269|NCT03732638|75695754|FG000|STARTED|OLE Phase (Weeks 13 to 64)|Participants who completed DBT phase and entered the OLE phase|302||
59588270|NCT03732638|75695755|FG001|STARTED|OLE Phase (Weeks 13 to 64)|Participants who completed DBT phase and entered the OLE phase|301||
59588271|NCT03732638|75695754|FG000|COMPLETED|OLE Phase (Weeks 13 to 64)||209||
59588272|NCT03732638|75695755|FG001|COMPLETED|OLE Phase (Weeks 13 to 64)||219||
59588273|NCT03732638|75695754|FG000|NOT COMPLETED|OLE Phase (Weeks 13 to 64)||93||
59588274|NCT03732638|75695755|FG001|NOT COMPLETED|OLE Phase (Weeks 13 to 64)||82||
59588275|NCT03732638|75695754|FG000|STARTED|Follow-up Phase (up to 72 Weeks)|Participants who entered follow-up phase either directly from DBT phase or after OLE phase|332||
59588276|NCT03732638|75695755|FG001|STARTED|Follow-up Phase (up to 72 Weeks)|Participants who entered follow-up phase either directly from DBT phase or after OLE phase|336||
59588277|NCT03732638|75695754|FG000|COMPLETED|Follow-up Phase (up to 72 Weeks)||267||
59588278|NCT03732638|75695755|FG001|COMPLETED|Follow-up Phase (up to 72 Weeks)||274||
59854821|NCT03369418|75979460|FG001|NOT COMPLETED|Overall Study||3||
59588279|NCT03732638|75695754|FG000|NOT COMPLETED|Follow-up Phase (up to 72 Weeks)||65||
59588280|NCT03732638|75695755|FG001|NOT COMPLETED|Follow-up Phase (up to 72 Weeks)||62||
59588281|NCT02572609|75695770|FG000|STARTED|Period 1: Treatment Period 1 + Washout||18||
59854822|NCT03334630|75979468|FG000|STARTED|Overall Study||239||
59854823|NCT03334630|75979469|FG001|STARTED|Overall Study||243||
59854824|NCT03334630|75979468|FG000|COMPLETED|Overall Study||225||
59854825|NCT03334630|75979469|FG001|COMPLETED|Overall Study||230||
59854826|NCT03334630|75979468|FG000|NOT COMPLETED|Overall Study||14||
59854827|NCT03334630|75979469|FG001|NOT COMPLETED|Overall Study||13||
59854828|NCT03368170|75979477|FG000|STARTED|Overall Study||39||
59588282|NCT02572609|75695771|FG001|STARTED|Period 1: Treatment Period 1 + Washout||18||
59588283|NCT02572609|75695770|FG000|COMPLETED|Period 1: Treatment Period 1 + Washout||18||
59588284|NCT02572609|75695771|FG001|COMPLETED|Period 1: Treatment Period 1 + Washout||18||
59588285|NCT02572609|75695770|FG000|NOT COMPLETED|Period 1: Treatment Period 1 + Washout||0||
59588286|NCT02572609|75695771|FG001|NOT COMPLETED|Period 1: Treatment Period 1 + Washout||0||
59588287|NCT02572609|75695770|FG000|STARTED|Period 2: Treatment Period 2||18||
59588288|NCT02572609|75695771|FG001|STARTED|Period 2: Treatment Period 2||18||
59588289|NCT02572609|75695770|FG000|COMPLETED|Period 2: Treatment Period 2||18||
59588290|NCT02572609|75695771|FG001|COMPLETED|Period 2: Treatment Period 2||18||
59588291|NCT02572609|75695770|FG000|NOT COMPLETED|Period 2: Treatment Period 2||0||
59588292|NCT02572609|75695771|FG001|NOT COMPLETED|Period 2: Treatment Period 2||0||
59588293|NCT02585245|75695777|FG000|STARTED|Overall Study||607||
59588294|NCT02585245|75695777|FG000|COMPLETED|Overall Study||594||
59588295|NCT02585245|75695777|FG000|NOT COMPLETED|Overall Study||13||
59588296|NCT02587117|75695784|FG000|STARTED|Overall Study||13||
59588297|NCT02587117|75695785|FG001|STARTED|Overall Study||15||
59588298|NCT02587117|75695784|FG000|COMPLETED|Overall Study||13||
59588299|NCT02587117|75695785|FG001|COMPLETED|Overall Study||15||
59588300|NCT02587117|75695784|FG000|NOT COMPLETED|Overall Study||0||
59588301|NCT02587117|75695785|FG001|NOT COMPLETED|Overall Study||0||
59588302|NCT03266588|75695794|FG000|STARTED|Observational Period||1605|Number includes participants who entered the Observation Period.|
59588303|NCT03266588|75695795|FG001|STARTED|Observational Period||786|Number includes participants who entered the Observation Period.|
59588304|NCT03266588|75695796|FG002|STARTED|Observational Period||476|Number includes participants who entered the Observation Period.|
59588305|NCT03266588|75695794|FG000|COMPLETED|Observational Period||1089||
59588306|NCT03266588|75695795|FG001|COMPLETED|Observational Period||511||
59588307|NCT03266588|75695796|FG002|COMPLETED|Observational Period||308||
59588308|NCT03266588|75695794|FG000|NOT COMPLETED|Observational Period||516||
59588309|NCT03266588|75695795|FG001|NOT COMPLETED|Observational Period||275||
59588310|NCT03266588|75695796|FG002|NOT COMPLETED|Observational Period||168||
59588311|NCT03266588|75695794|FG000|STARTED|Long-term Treatment Period||1089||
59588312|NCT03266588|75695795|FG001|STARTED|Long-term Treatment Period||511||
59588313|NCT03266588|75695796|FG002|STARTED|Long-term Treatment Period||308||
59588314|NCT03266588|75695794|FG000|Treated|Long-term Treatment Period||1033||
59588315|NCT03266588|75695795|FG001|Treated|Long-term Treatment Period||481||
59588316|NCT03266588|75695796|FG002|Treated|Long-term Treatment Period||286||
59588317|NCT03266588|75695794|FG000|COMPLETED|Long-term Treatment Period||683||
59588318|NCT03266588|75695795|FG001|COMPLETED|Long-term Treatment Period||271||
59588319|NCT03266588|75695796|FG002|COMPLETED|Long-term Treatment Period||243||
59588320|NCT03266588|75695794|FG000|NOT COMPLETED|Long-term Treatment Period||406||
59588321|NCT03266588|75695795|FG001|NOT COMPLETED|Long-term Treatment Period||240||
59588322|NCT03266588|75695796|FG002|NOT COMPLETED|Long-term Treatment Period||65||
59588323|NCT02587351|75695806|FG000|STARTED|Overall Study||268||
59588324|NCT02587351|75695807|FG001|STARTED|Overall Study||264||
59588325|NCT02587351|75695806|FG000|COMPLETED|Overall Study||268||
59588326|NCT02587351|75695807|FG001|COMPLETED|Overall Study||264||
59588327|NCT02587351|75695806|FG000|NOT COMPLETED|Overall Study||0||
59588328|NCT02587351|75695807|FG001|NOT COMPLETED|Overall Study||0||
59588329|NCT02495467|75695815|FG000|STARTED|First Intervention (4 Weeks)||114||
59588330|NCT02495467|75695816|FG001|STARTED|First Intervention (4 Weeks)||118||
59588331|NCT02495467|75695815|FG000|COMPLETED|First Intervention (4 Weeks)||114||
59588332|NCT02495467|75695816|FG001|COMPLETED|First Intervention (4 Weeks)|One subject completed visits in treatment Period 1 but never used treatment|118||
59588333|NCT02495467|75695815|FG000|NOT COMPLETED|First Intervention (4 Weeks)||0||
59588334|NCT02495467|75695816|FG001|NOT COMPLETED|First Intervention (4 Weeks)||0||
59588335|NCT02495467|75695815|FG000|STARTED|Washout (1 Week)||114||
59588336|NCT02495467|75695816|FG001|STARTED|Washout (1 Week)||118||
59588337|NCT02495467|75695815|FG000|COMPLETED|Washout (1 Week)||112||
59588338|NCT02495467|75695816|FG001|COMPLETED|Washout (1 Week)||116||
59588339|NCT02495467|75695815|FG000|NOT COMPLETED|Washout (1 Week)||2||
59588340|NCT02495467|75695816|FG001|NOT COMPLETED|Washout (1 Week)||2||
59588341|NCT02495467|75695815|FG000|STARTED|Second Intervention (4 Weeks)||112||
59588342|NCT02495467|75695816|FG001|STARTED|Second Intervention (4 Weeks)||116||
59588343|NCT02495467|75695815|FG000|COMPLETED|Second Intervention (4 Weeks)||112||
59588344|NCT02495467|75695816|FG001|COMPLETED|Second Intervention (4 Weeks)||113||
59588345|NCT02495467|75695815|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0||
59588346|NCT02495467|75695816|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||3||
59588347|NCT02495623|75695825|FG000|STARTED|Overall Study||25||
59588348|NCT02495623|75695826|FG001|STARTED|Overall Study||26||
59588349|NCT02495623|75695827|FG002|STARTED|Overall Study||28||
59588350|NCT02495623|75695825|FG000|Dosed|Overall Study||22||
59588351|NCT02495623|75695826|FG001|Dosed|Overall Study||19||
59588352|NCT02495623|75695827|FG002|Dosed|Overall Study||22||
59588353|NCT02495623|75695825|FG000|COMPLETED|Overall Study||20||
59588354|NCT02495623|75695826|FG001|COMPLETED|Overall Study||17||
59588355|NCT02495623|75695827|FG002|COMPLETED|Overall Study||20||
59588356|NCT02495623|75695825|FG000|NOT COMPLETED|Overall Study||5||
59588357|NCT02495623|75695826|FG001|NOT COMPLETED|Overall Study||9||
59588358|NCT02495623|75695827|FG002|NOT COMPLETED|Overall Study||8||
59588359|NCT02495779|75695835|FG000|STARTED|Overall Study||54||
59588360|NCT02495779|75695835|FG000|COMPLETED|Overall Study||48||
59588361|NCT02495779|75695835|FG000|NOT COMPLETED|Overall Study||6||
59588362|NCT02502019|75695839|FG000|STARTED|Overall Study||27||
59588363|NCT02502019|75695839|FG000|COMPLETED|Overall Study||27||
59588364|NCT02502019|75695839|FG000|NOT COMPLETED|Overall Study||0||
59588365|NCT02502487|75695846|FG000|STARTED|Overall Study||86||
59588366|NCT02502487|75695847|FG001|STARTED|Overall Study||86||
59588367|NCT02502487|75695848|FG002|STARTED|Overall Study||86||
59588368|NCT02502487|75695846|FG000|COMPLETED|Overall Study||86||
59588369|NCT02502487|75695847|FG001|COMPLETED|Overall Study||86||
59588370|NCT02502487|75695848|FG002|COMPLETED|Overall Study||86||
59854829|NCT03368170|75979478|FG001|STARTED|Overall Study||36||
59854830|NCT03368170|75979477|FG000|COMPLETED|Overall Study||37||
59854831|NCT03368170|75979478|FG001|COMPLETED|Overall Study||35||
59854832|NCT03368170|75979477|FG000|NOT COMPLETED|Overall Study||2||
59854833|NCT03368170|75979478|FG001|NOT COMPLETED|Overall Study||1||
59854834|NCT00324155|75979486|FG000|STARTED|Enrolled and Randomized||250||
59854835|NCT00324155|75979487|FG001|STARTED|Enrolled and Randomized||252||
59854836|NCT00324155|75979486|FG000|COMPLETED|Enrolled and Randomized|3 randomized but who did not receive treatment (no longer met study criteria).|247||
59854837|NCT00324155|75979487|FG001|COMPLETED|Enrolled and Randomized|1 randomized but who did not receive treatment (lost to follow-up).|251||
59854838|NCT00324155|75979486|FG000|NOT COMPLETED|Enrolled and Randomized||3||
59854839|NCT00324155|75979487|FG001|NOT COMPLETED|Enrolled and Randomized||1||
59854840|NCT00324155|75979486|FG000|STARTED|Received Treatment in Induction Phase||247||
59854841|NCT00324155|75979487|FG001|STARTED|Received Treatment in Induction Phase||251||
59854842|NCT00324155|75979486|FG000|COMPLETED|Received Treatment in Induction Phase|45 participants on treatment at end of Induction Phase. Study undergoing closure.|45||
59854843|NCT00324155|75979487|FG001|COMPLETED|Received Treatment in Induction Phase|54 participants on treatment at end of Induction Phase. Study undergoing closure.|54||
59854844|NCT00324155|75979486|FG000|NOT COMPLETED|Received Treatment in Induction Phase||202||
59854845|NCT00324155|75979487|FG001|NOT COMPLETED|Received Treatment in Induction Phase||197||
59854846|NCT00324155|75979486|FG000|STARTED|Received Treatment in Maintenance Phase|2 completed Induction Phase but did not enter Maintenance Phase|43||
59854847|NCT00324155|75979487|FG001|STARTED|Received Treatment in Maintenance Phase|1 completed Induction Phase but did not enter Maintenance Phase|53||
59854848|NCT00324155|75979486|FG000|COMPLETED|Received Treatment in Maintenance Phase|Study is in closure at this time. 11 in Maintenance Phase not yet summarized.|11||
59854849|NCT00324155|75979487|FG001|COMPLETED|Received Treatment in Maintenance Phase|Study is in closure. 6 participants in Maintenance Phase not yet summarized.|6||
59854850|NCT00324155|75979486|FG000|NOT COMPLETED|Received Treatment in Maintenance Phase||32||
59854851|NCT00324155|75979487|FG001|NOT COMPLETED|Received Treatment in Maintenance Phase||47||
59854852|NCT00324155|75979486|FG000|STARTED|Follow-up Phase|All participants received study drug. Follow-up was performed for those leaving earlier phases.|247||
59854853|NCT00324155|75979487|FG001|STARTED|Follow-up Phase|All participants received study drug. Follow-up was performed for those leaving earlier phases.|251||
59854854|NCT00324155|75979486|FG000|COMPLETED|Follow-up Phase||236||
59854855|NCT00324155|75979487|FG001|COMPLETED|Follow-up Phase||245||
59854856|NCT00324155|75979486|FG000|NOT COMPLETED|Follow-up Phase||11||
59725150|NCT01099709|75843988|FG000|COMPLETED|Period 1||41||
59725151|NCT01099709|75843989|FG001|COMPLETED|Period 1||41||
59725152|NCT01099709|75843988|FG000|NOT COMPLETED|Period 1||1||
59725153|NCT01099709|75843989|FG001|NOT COMPLETED|Period 1||2||
59725154|NCT01099709|75843988|FG000|STARTED|Period 2||41||
59725155|NCT01099709|75843989|FG001|STARTED|Period 2||41||
59725156|NCT01099709|75843988|FG000|COMPLETED|Period 2||41||
59725157|NCT01099709|75843989|FG001|COMPLETED|Period 2||41||
59725158|NCT01099709|75843988|FG000|NOT COMPLETED|Period 2||0||
59725159|NCT01099709|75843989|FG001|NOT COMPLETED|Period 2||0||
59725160|NCT01099397|75843996|FG000|STARTED|Overall Study||39||
59854857|NCT00324155|75979487|FG001|NOT COMPLETED|Follow-up Phase||6||
59854858|NCT03334396|75979514|FG000|STARTED|Overall Study||249||
59854859|NCT03334396|75979515|FG001|STARTED|Overall Study||127||
59854860|NCT03334396|75979516|FG002|STARTED|Overall Study||123||
59854861|NCT03334396|75979517|FG003|STARTED|Overall Study||125||
59854862|NCT03334396|75979518|FG004|STARTED|Overall Study||15||
59854863|NCT03334396|75979519|FG005|STARTED|Overall Study||5||
59854864|NCT03334396|75979520|FG006|STARTED|Overall Study||8||
59854865|NCT03334396|75979521|FG007|STARTED|Overall Study||8||
59854866|NCT03334396|75979514|FG000|Received at Least One Dose of Study Drug|Overall Study||249||
59854867|NCT03334396|75979515|FG001|Received at Least One Dose of Study Drug|Overall Study||127||
59854868|NCT03334396|75979516|FG002|Received at Least One Dose of Study Drug|Overall Study||123||
59854869|NCT03334396|75979517|FG003|Received at Least One Dose of Study Drug|Overall Study||125||
59854870|NCT03334396|75979518|FG004|Received at Least One Dose of Study Drug|Overall Study||15||
59854871|NCT03334396|75979519|FG005|Received at Least One Dose of Study Drug|Overall Study||5||
59854872|NCT03334396|75979520|FG006|Received at Least One Dose of Study Drug|Overall Study||8||
59854873|NCT03334396|75979521|FG007|Received at Least One Dose of Study Drug|Overall Study||8||
59725161|NCT01099397|75843996|FG000|COMPLETED|Overall Study||26||
59725162|NCT01099397|75843996|FG000|NOT COMPLETED|Overall Study||13||
59725163|NCT01022424|75844001|FG000|STARTED|Overall Study||13||
59588371|NCT02502487|75695846|FG000|NOT COMPLETED|Overall Study||0||
59588372|NCT02502487|75695847|FG001|NOT COMPLETED|Overall Study||0||
59588373|NCT02502487|75695848|FG002|NOT COMPLETED|Overall Study||0||
59588374|NCT03238196|75695860|FG000|STARTED|Overall Study||22||
59725164|NCT01022424|75844001|FG000|COMPLETED|Overall Study||9||
59725165|NCT01022424|75844001|FG000|NOT COMPLETED|Overall Study||4||
59854874|NCT03334396|75979514|FG000|COMPLETED|Overall Study||226||
59854875|NCT03334396|75979515|FG001|COMPLETED|Overall Study||116||
59854876|NCT03334396|75979516|FG002|COMPLETED|Overall Study||113||
59854877|NCT03334396|75979517|FG003|COMPLETED|Overall Study||120||
59854878|NCT03334396|75979518|FG004|COMPLETED|Overall Study||12||
59854879|NCT03334396|75979519|FG005|COMPLETED|Overall Study||4||
59854880|NCT03334396|75979520|FG006|COMPLETED|Overall Study||5||
59854881|NCT03334396|75979521|FG007|COMPLETED|Overall Study||7||
59854882|NCT03334396|75979514|FG000|NOT COMPLETED|Overall Study||23||
59854883|NCT03334396|75979515|FG001|NOT COMPLETED|Overall Study||11||
59854884|NCT03334396|75979516|FG002|NOT COMPLETED|Overall Study||10||
59854885|NCT03334396|75979517|FG003|NOT COMPLETED|Overall Study||5||
59854886|NCT03334396|75979518|FG004|NOT COMPLETED|Overall Study||3||
59854887|NCT03334396|75979519|FG005|NOT COMPLETED|Overall Study||1||
59854888|NCT03334396|75979520|FG006|NOT COMPLETED|Overall Study||3||
59854889|NCT03334396|75979521|FG007|NOT COMPLETED|Overall Study||1||
59854890|NCT03338998|75979540|FG000|STARTED|Treatment Period||16||
59854891|NCT03338998|75979541|FG001|STARTED|Treatment Period||13||
59854892|NCT03338998|75979540|FG000|COMPLETED|Treatment Period||8||
59854893|NCT03338998|75979541|FG001|COMPLETED|Treatment Period||10||
59854894|NCT03338998|75979540|FG000|NOT COMPLETED|Treatment Period||8||
59854895|NCT03338998|75979541|FG001|NOT COMPLETED|Treatment Period||3||
59854896|NCT03338998|75979540|FG000|STARTED|Safety Follow-Up Period||16||
59854897|NCT03338998|75979541|FG001|STARTED|Safety Follow-Up Period||13||
59854898|NCT03338998|75979540|FG000|COMPLETED|Safety Follow-Up Period||14||
59854899|NCT03338998|75979541|FG001|COMPLETED|Safety Follow-Up Period||12||
59854900|NCT03338998|75979540|FG000|NOT COMPLETED|Safety Follow-Up Period||2||
59854901|NCT03338998|75979541|FG001|NOT COMPLETED|Safety Follow-Up Period||1||
59854902|NCT03338296|75979550|FG000|STARTED|Overall Study||139||
59854903|NCT03338296|75979551|FG001|STARTED|Overall Study||139||
59854904|NCT03338296|75979550|FG000|Safety Analysis Set|Overall Study||139||
59854905|NCT03338296|75979551|FG001|Safety Analysis Set|Overall Study||136||
59854906|NCT03338296|75979550|FG000|COMPLETED|Overall Study||36||
59854907|NCT03338296|75979551|FG001|COMPLETED|Overall Study||31||
59854908|NCT03338296|75979550|FG000|NOT COMPLETED|Overall Study||103||
59854909|NCT03338296|75979551|FG001|NOT COMPLETED|Overall Study||108||
59854910|NCT03338062|75979559|FG000|STARTED|Overall Study||10||
59854911|NCT03338062|75979560|FG001|STARTED|Overall Study||5||
59854912|NCT03338062|75979559|FG000|COMPLETED|Overall Study||9||
59854913|NCT03338062|75979560|FG001|COMPLETED|Overall Study||5||
59854914|NCT03338062|75979559|FG000|NOT COMPLETED|Overall Study||1||
59854915|NCT03338062|75979560|FG001|NOT COMPLETED|Overall Study||0||
59854916|NCT03364192|75979567|FG000|STARTED|Overall Study||28||
59854917|NCT03364192|75979567|FG000|COMPLETED|Overall Study||12||
59854918|NCT03364192|75979567|FG000|NOT COMPLETED|Overall Study||16||
59854919|NCT03783962|75979574|FG000|STARTED|Overall Study||28||
59854920|NCT03783962|75979575|FG001|STARTED|Overall Study||28||
59854921|NCT03783962|75979574|FG000|COMPLETED|Overall Study||25||
59854922|NCT03783962|75979575|FG001|COMPLETED|Overall Study||21||
59854923|NCT03783962|75979574|FG000|NOT COMPLETED|Overall Study||3||
59854924|NCT03783962|75979575|FG001|NOT COMPLETED|Overall Study||7||
59854925|NCT03361228|75979583|FG000|STARTED|Overall Study||4||
59854926|NCT03361228|75979584|FG001|STARTED|Overall Study||1||
59854927|NCT03361228|75979583|FG000|COMPLETED|Overall Study||0||
59854928|NCT03361228|75979584|FG001|COMPLETED|Overall Study||0||
59854929|NCT03361228|75979583|FG000|NOT COMPLETED|Overall Study||4||
59854930|NCT03361228|75979584|FG001|NOT COMPLETED|Overall Study||1||
59854931|NCT03359590|75979590|FG000|STARTED|First Intervention||10||
59854932|NCT03359590|75979591|FG001|STARTED|First Intervention||10||
59854933|NCT03359590|75979590|FG000|Exposed|First Intervention||9||
59854934|NCT03359590|75979591|FG001|Exposed|First Intervention||10||
59854935|NCT03359590|75979590|FG000|Discontinued|First Intervention||1||
59854936|NCT03359590|75979591|FG001|Discontinued|First Intervention||2||
59854937|NCT03359590|75979590|FG000|COMPLETED|First Intervention||9||
59854938|NCT03359590|75979591|FG001|COMPLETED|First Intervention||8||
59854939|NCT03359590|75979590|FG000|NOT COMPLETED|First Intervention||1||
59588375|NCT03238196|75695861|FG001|STARTED|Overall Study||3||
59725166|NCT01098851|75844011|FG000|STARTED|Overall Study||11||
59725167|NCT01098851|75844012|FG001|STARTED|Overall Study||10||
59725168|NCT01098851|75844011|FG000|COMPLETED|Overall Study||10||
59725169|NCT01098851|75844012|FG001|COMPLETED|Overall Study||10||
59725170|NCT01098851|75844011|FG000|NOT COMPLETED|Overall Study||1||
59725171|NCT01098851|75844012|FG001|NOT COMPLETED|Overall Study||0||
59725172|NCT01026948|75844018|FG000|STARTED|Overall Study||70||
59725173|NCT01026948|75844018|FG000|COMPLETED|Overall Study|8 Women were recalled because of signal loss|62||
59725174|NCT01026948|75844018|FG000|NOT COMPLETED|Overall Study||8||
59854940|NCT03359590|75979591|FG001|NOT COMPLETED|First Intervention||2||
59854941|NCT03359590|75979590|FG000|STARTED|Second Intervention||9||
59854942|NCT03359590|75979591|FG001|STARTED|Second Intervention||8||
59854943|NCT03359590|75979590|FG000|Exposed|Second Intervention||9||
59854944|NCT03359590|75979591|FG001|Exposed|Second Intervention||8||
59588376|NCT03238196|75695862|FG002|STARTED|Overall Study||6||
59854945|NCT03359590|75979590|FG000|Discontinued|Second Intervention||0||
59854946|NCT03359590|75979591|FG001|Discontinued|Second Intervention||0||
59854947|NCT03359590|75979590|FG000|COMPLETED|Second Intervention||9||
60121737|NCT01563029|76242698|FG002|STARTED|Overall Study||120||
59588377|NCT03238196|75695863|FG003|STARTED|Overall Study||4||
59588378|NCT03238196|75695860|FG000|COMPLETED|Overall Study||0||
59588379|NCT03238196|75695861|FG001|COMPLETED|Overall Study||0||
59588380|NCT03238196|75695862|FG002|COMPLETED|Overall Study||0||
59588381|NCT03238196|75695863|FG003|COMPLETED|Overall Study||0||
59588382|NCT03238196|75695860|FG000|NOT COMPLETED|Overall Study||22||
59588383|NCT03238196|75695861|FG001|NOT COMPLETED|Overall Study||3||
59588384|NCT03238196|75695862|FG002|NOT COMPLETED|Overall Study||6||
59588385|NCT03238196|75695863|FG003|NOT COMPLETED|Overall Study||4||
59588386|NCT02503735|75695872|FG000|STARTED|Overall Study||10|10/14 consented patients started treatment with Sofosbuvir/Ledipasvir (4 screen failures)|
59588387|NCT02503735|75695872|FG000|SVR 12 (12week Post Treatment RNA Neg)|Overall Study||8||
59588388|NCT02503735|75695872|FG000|COMPLETED|Overall Study||10|All 10 subjects who initiated treatment completed treatment|
59588389|NCT02503735|75695872|FG000|NOT COMPLETED|Overall Study||0||
59588390|NCT03019640|75695882|FG000|STARTED|Overall Study||22||
59588391|NCT03019640|75695882|FG000|COMPLETED|Overall Study||14||
59588392|NCT03019640|75695882|FG000|NOT COMPLETED|Overall Study||8||
59588393|NCT02506309|75695888|FG000|STARTED|Overall Study||84||
59588394|NCT02506309|75695889|FG001|STARTED|Overall Study||84||
59588395|NCT02506309|75695888|FG000|COMPLETED|Overall Study||66||
59725175|NCT01104779|75844026|FG000|STARTED|Overall Study||147||
59725176|NCT01104779|75844027|FG001|STARTED|Overall Study||151||
59725177|NCT01104779|75844028|FG002|STARTED|Overall Study||148||
59725178|NCT01104779|75844026|FG000|COMPLETED|Overall Study||88||
59725179|NCT01104779|75844027|FG001|COMPLETED|Overall Study||96||
59725180|NCT01104779|75844028|FG002|COMPLETED|Overall Study||86||
59725181|NCT01104779|75844026|FG000|NOT COMPLETED|Overall Study||59||
59725182|NCT01104779|75844027|FG001|NOT COMPLETED|Overall Study||55||
59725183|NCT01104779|75844028|FG002|NOT COMPLETED|Overall Study||62||
59725184|NCT00918957|75844038|FG000|STARTED|Overall Study||32||
59725185|NCT00918957|75844039|FG001|STARTED|Overall Study||30||
59725186|NCT00918957|75844038|FG000|COMPLETED|Overall Study||29||
59725187|NCT00918957|75844039|FG001|COMPLETED|Overall Study||30||
59725188|NCT00918957|75844038|FG000|NOT COMPLETED|Overall Study||3||
59725189|NCT00918957|75844039|FG001|NOT COMPLETED|Overall Study||0||
59725190|NCT01022268|75844047|FG000|STARTED|Overall Study||818||
59725191|NCT01022268|75844048|FG001|STARTED|Overall Study||84||
59725192|NCT01022268|75844047|FG000|COMPLETED|Overall Study||816||
59725193|NCT01022268|75844048|FG001|COMPLETED|Overall Study||84||
59725194|NCT01022268|75844047|FG000|NOT COMPLETED|Overall Study||2||
59725195|NCT01022268|75844048|FG001|NOT COMPLETED|Overall Study||0||
59725196|NCT01015560|75844054|FG000|STARTED|Overall Study||44||
59725197|NCT01015560|75844054|FG000|Eligible and Analyzable|Overall Study||43||
59725198|NCT01015560|75844054|FG000|COMPLETED|Overall Study||41||
59725199|NCT01015560|75844054|FG000|NOT COMPLETED|Overall Study||3||
59725200|NCT00918879|75844060|FG000|STARTED|Overall Study|Randomized and treated|107||
59725201|NCT00918879|75844061|FG001|STARTED|Overall Study|Randomized and treated|106||
59725202|NCT00918879|75844060|FG000|COMPLETED|Overall Study|Completed 24 weeks of treatment|101||
59725203|NCT00918879|75844061|FG001|COMPLETED|Overall Study|Completed 24 weeks of treatment|100||
59725204|NCT00918879|75844060|FG000|NOT COMPLETED|Overall Study||6||
59725205|NCT00918879|75844061|FG001|NOT COMPLETED|Overall Study||6||
59725206|NCT01026792|75844067|FG000|STARTED|Overall Study||38||
59725207|NCT01026792|75844067|FG000|COMPLETED|Overall Study||37||
59725208|NCT01026792|75844067|FG000|NOT COMPLETED|Overall Study||1||
59725209|NCT01026324|75844074|FG000|STARTED|Treatment Allocation||5||
59725210|NCT01026324|75844075|FG001|STARTED|Treatment Allocation||3||
59725211|NCT01026324|75844076|FG002|STARTED|Treatment Allocation||4||
59725212|NCT01026324|75844074|FG000|Discontinued Intervention (Toxicity)|Treatment Allocation||1||
59725213|NCT01026324|75844075|FG001|Discontinued Intervention (Toxicity)|Treatment Allocation||0||
59725214|NCT01026324|75844076|FG002|Discontinued Intervention (Toxicity)|Treatment Allocation||0||
59725215|NCT01026324|75844074|FG000|Discontinuted Intervention (Progression)|Treatment Allocation||3||
59725216|NCT01026324|75844075|FG001|Discontinuted Intervention (Progression)|Treatment Allocation||3||
59725217|NCT01026324|75844076|FG002|Discontinuted Intervention (Progression)|Treatment Allocation||4||
59725218|NCT01026324|75844074|FG000|Discontinued Intervention (Withdrew)|Treatment Allocation||1||
59854948|NCT03359590|75979591|FG001|COMPLETED|Second Intervention||8||
60121738|NCT01563029|76242699|FG003|STARTED|Overall Study||118||
59588396|NCT02506309|75695889|FG001|COMPLETED|Overall Study||64||
59588397|NCT02506309|75695888|FG000|NOT COMPLETED|Overall Study||18||
59588398|NCT02506309|75695889|FG001|NOT COMPLETED|Overall Study||20||
59588399|NCT02507011|75695895|FG000|STARTED|First Intervention||1||
59588400|NCT02507011|75695896|FG001|STARTED|First Intervention||1||
59588401|NCT02507011|75695895|FG000|COMPLETED|First Intervention||1||
59725219|NCT01026324|75844075|FG001|Discontinued Intervention (Withdrew)|Treatment Allocation||0||
59725220|NCT01026324|75844076|FG002|Discontinued Intervention (Withdrew)|Treatment Allocation||0||
59725221|NCT01026324|75844074|FG000|COMPLETED|Treatment Allocation||5||
59725222|NCT01026324|75844075|FG001|COMPLETED|Treatment Allocation||3||
59725223|NCT01026324|75844076|FG002|COMPLETED|Treatment Allocation||4||
59854949|NCT03359590|75979590|FG000|NOT COMPLETED|Second Intervention||0||
59854950|NCT03359590|75979591|FG001|NOT COMPLETED|Second Intervention||0||
59854951|NCT05085964|75979599|FG000|STARTED|Overall Study||21||
59854952|NCT05085964|75979600|FG001|STARTED|Overall Study||0||
59854953|NCT05085964|75979599|FG000|COMPLETED|Overall Study||0||
59854954|NCT05085964|75979600|FG001|COMPLETED|Overall Study||0||
59854955|NCT05085964|75979599|FG000|NOT COMPLETED|Overall Study||21||
59854956|NCT05085964|75979600|FG001|NOT COMPLETED|Overall Study||0||
59854957|NCT02891200|75979609|FG000|STARTED|Overall Study||145||
59854958|NCT02891200|75979610|FG001|STARTED|Overall Study||147||
59854959|NCT02891200|75979609|FG000|COMPLETED|Overall Study||103||
59854960|NCT02891200|75979610|FG001|COMPLETED|Overall Study||98||
59854961|NCT02891200|75979609|FG000|NOT COMPLETED|Overall Study||42||
59854962|NCT02891200|75979610|FG001|NOT COMPLETED|Overall Study||49||
59854963|NCT02946580|75979618|FG000|STARTED|Overall Study||28||
59854964|NCT02946580|75979619|FG001|STARTED|Overall Study||25||
59854965|NCT02946580|75979618|FG000|COMPLETED|Overall Study||27||
59854966|NCT02946580|75979619|FG001|COMPLETED|Overall Study||20||
59854967|NCT02946580|75979618|FG000|NOT COMPLETED|Overall Study||1||
59854968|NCT02946580|75979619|FG001|NOT COMPLETED|Overall Study||5||
59854969|NCT00323609|75979627|FG000|STARTED|Overall Study||191||
59854970|NCT00323609|75979628|FG001|STARTED|Overall Study||190||
59854971|NCT00323609|75979629|FG002|STARTED|Overall Study||8||
59854972|NCT00323609|75979630|FG003|STARTED|Overall Study||15||
59854973|NCT00323609|75979627|FG000|COMPLETED|Overall Study|Revision retains subjects with follow-up data in a visit window when terminated in same visit window|100||
59854974|NCT00323609|75979628|FG001|COMPLETED|Overall Study|Revision retains subjects with follow-up data in a visit window when terminated in same visit window|91||
59854975|NCT00323609|75979629|FG002|COMPLETED|Overall Study||0||
59854976|NCT00323609|75979630|FG003|COMPLETED|Overall Study||0||
59854977|NCT00323609|75979627|FG000|NOT COMPLETED|Overall Study||91||
59854978|NCT00323609|75979628|FG001|NOT COMPLETED|Overall Study||99||
59854979|NCT00323609|75979629|FG002|NOT COMPLETED|Overall Study||8||
59854980|NCT00323609|75979630|FG003|NOT COMPLETED|Overall Study||15||
59854981|NCT04598152|75979636|FG000|STARTED|Overall Study||3||
59854982|NCT04598152|75979637|FG001|STARTED|Overall Study||1||
59854983|NCT04598152|75979636|FG000|COMPLETED|Overall Study||3||
59854984|NCT04598152|75979637|FG001|COMPLETED|Overall Study||0||
59854985|NCT04598152|75979636|FG000|NOT COMPLETED|Overall Study||0||
59854986|NCT04598152|75979637|FG001|NOT COMPLETED|Overall Study||1||
59854987|NCT00323297|75979645|FG000|STARTED|Part A (Double Blind Randomized)||53||
59854988|NCT00323297|75979646|FG001|STARTED|Part A (Double Blind Randomized)||50||
59854989|NCT00323297|75979645|FG000|COMPLETED|Part A (Double Blind Randomized)||48||
59854990|NCT00323297|75979646|FG001|COMPLETED|Part A (Double Blind Randomized)||43||
59854991|NCT00323297|75979645|FG000|NOT COMPLETED|Part A (Double Blind Randomized)||5||
59854992|NCT00323297|75979646|FG001|NOT COMPLETED|Part A (Double Blind Randomized)||7||
59854993|NCT00323297|75979645|FG000|STARTED|Part B (Open-label)||48||
59854994|NCT00323297|75979646|FG001|STARTED|Part B (Open-label)||43||
59854995|NCT00323297|75979645|FG000|COMPLETED|Part B (Open-label)||39||
59854996|NCT00323297|75979646|FG001|COMPLETED|Part B (Open-label)||31||
59854997|NCT00323297|75979645|FG000|NOT COMPLETED|Part B (Open-label)||9||
59854998|NCT00323297|75979646|FG001|NOT COMPLETED|Part B (Open-label)||12||
59854999|NCT00323063|75979654|FG000|STARTED|Overall Study||26||
59855000|NCT00323063|75979655|FG001|STARTED|Overall Study||23||
59855001|NCT00323063|75979654|FG000|COMPLETED|Overall Study||24||
59855002|NCT00323063|75979655|FG001|COMPLETED|Overall Study||23||
59855003|NCT00323063|75979654|FG000|NOT COMPLETED|Overall Study||2||
59855004|NCT00323063|75979655|FG001|NOT COMPLETED|Overall Study||0||
59855005|NCT00322049|75979665|FG000|STARTED|Overall Study||4||
59855006|NCT00322049|75979666|FG001|STARTED|Overall Study||10||
59855007|NCT00322049|75979667|FG002|STARTED|Overall Study||20||
59855008|NCT00322049|75979668|FG003|STARTED|Overall Study||17||
59855009|NCT00322049|75979665|FG000|COMPLETED|Overall Study||4||
59855010|NCT00322049|75979666|FG001|COMPLETED|Overall Study||9||
59855011|NCT00322049|75979667|FG002|COMPLETED|Overall Study||20||
59855012|NCT00322049|75979668|FG003|COMPLETED|Overall Study||16||
59855013|NCT00322049|75979665|FG000|NOT COMPLETED|Overall Study||0||
59855014|NCT00322049|75979666|FG001|NOT COMPLETED|Overall Study||1||
59855015|NCT00322049|75979667|FG002|NOT COMPLETED|Overall Study||0||
59855016|NCT00322049|75979668|FG003|NOT COMPLETED|Overall Study||1||
59855017|NCT00321893|75979689|FG000|STARTED|Overall Study||101||
59855018|NCT00321893|75979690|FG001|STARTED|Overall Study||101||
59855019|NCT00321893|75979689|FG000|COMPLETED|Overall Study||77||
59855020|NCT00321893|75979690|FG001|COMPLETED|Overall Study||87||
59855021|NCT00321893|75979689|FG000|NOT COMPLETED|Overall Study||24||
59855022|NCT00321893|75979690|FG001|NOT COMPLETED|Overall Study||14||
59855023|NCT00371345|75979698|FG000|STARTED|Overall Study||24||
59855024|NCT00371345|75979699|FG001|STARTED|Overall Study||46||
59855025|NCT00371345|75979698|FG000|COMPLETED|Overall Study||0||
59855026|NCT00371345|75979699|FG001|COMPLETED|Overall Study||0||
59996779|NCT03434041|76112633|FG001|NOT COMPLETED|Double Blind Treatment Phase (4 Weeks)||20||
59855027|NCT00371345|75979698|FG000|NOT COMPLETED|Overall Study||24||
59855028|NCT00371345|75979699|FG001|NOT COMPLETED|Overall Study||46||
59855029|NCT00321737|75979722|FG000|STARTED|Overall Study||147||
59855030|NCT00321737|75979723|FG001|STARTED|Overall Study||140||
59855031|NCT00321737|75979724|FG002|STARTED|Overall Study||158||
59855032|NCT00321737|75979722|FG000|COMPLETED|Overall Study||25||
59855033|NCT00321737|75979723|FG001|COMPLETED|Overall Study||92||
59855034|NCT00321737|75979724|FG002|COMPLETED|Overall Study||104||
59855035|NCT00321737|75979722|FG000|NOT COMPLETED|Overall Study||122||
59855036|NCT00321737|75979723|FG001|NOT COMPLETED|Overall Study||48||
59855037|NCT00321737|75979724|FG002|NOT COMPLETED|Overall Study||54||
59855038|NCT00320801|75979734|FG000|STARTED|Open-label Run-in Period||188||
59855039|NCT00320801|75979735|FG001|STARTED|Open-label Run-in Period||0||
59855040|NCT00320801|75979736|FG002|STARTED|Open-label Run-in Period||0||
59855041|NCT00320801|75979737|FG003|STARTED|Open-label Run-in Period||0||
59855042|NCT00320801|75979734|FG000|COMPLETED|Open-label Run-in Period||96||
59855043|NCT00320801|75979735|FG001|COMPLETED|Open-label Run-in Period||0||
59855044|NCT00320801|75979736|FG002|COMPLETED|Open-label Run-in Period||0||
59855045|NCT00320801|75979737|FG003|COMPLETED|Open-label Run-in Period||0||
59855046|NCT00320801|75979734|FG000|NOT COMPLETED|Open-label Run-in Period||92||
59855047|NCT00320801|75979735|FG001|NOT COMPLETED|Open-label Run-in Period||0||
59855048|NCT00320801|75979736|FG002|NOT COMPLETED|Open-label Run-in Period||0||
59855049|NCT00320801|75979737|FG003|NOT COMPLETED|Open-label Run-in Period||0||
59855050|NCT00320801|75979734|FG000|STARTED|Double-blind Phase||0||
59855051|NCT00320801|75979735|FG001|STARTED|Double-blind Phase||47||
59855052|NCT00320801|75979736|FG002|STARTED|Double-blind Phase||49||
59855053|NCT00320801|75979737|FG003|STARTED|Double-blind Phase||0||
59855054|NCT00320801|75979734|FG000|COMPLETED|Double-blind Phase||0||
59855055|NCT00320801|75979735|FG001|COMPLETED|Double-blind Phase||36||
59855056|NCT00320801|75979736|FG002|COMPLETED|Double-blind Phase||35||
59855057|NCT00320801|75979737|FG003|COMPLETED|Double-blind Phase||0||
59855058|NCT00320801|75979734|FG000|NOT COMPLETED|Double-blind Phase||0||
59855059|NCT00320801|75979735|FG001|NOT COMPLETED|Double-blind Phase||11||
59855060|NCT00320801|75979736|FG002|NOT COMPLETED|Double-blind Phase||14||
59855061|NCT00320801|75979737|FG003|NOT COMPLETED|Double-blind Phase||0||
59855062|NCT00320801|75979734|FG000|STARTED|Extension Phase||0||
59855063|NCT00320801|75979735|FG001|STARTED|Extension Phase||0||
59855064|NCT00320801|75979736|FG002|STARTED|Extension Phase||0||
59855065|NCT00320801|75979737|FG003|STARTED|Extension Phase||55||
59855066|NCT00320801|75979734|FG000|COMPLETED|Extension Phase||0||
59855067|NCT00320801|75979735|FG001|COMPLETED|Extension Phase||0||
59855068|NCT00320801|75979736|FG002|COMPLETED|Extension Phase||0||
59855069|NCT00320801|75979737|FG003|COMPLETED|Extension Phase||7||
59855070|NCT00320801|75979734|FG000|NOT COMPLETED|Extension Phase||0||
59855071|NCT00320801|75979735|FG001|NOT COMPLETED|Extension Phase||0||
59855072|NCT00320801|75979736|FG002|NOT COMPLETED|Extension Phase||0||
59855073|NCT00320801|75979737|FG003|NOT COMPLETED|Extension Phase||48||
59855074|NCT00320489|75979749|FG000|STARTED|Overall Study||264||
59855075|NCT00320489|75979750|FG001|STARTED|Overall Study||260||
59855076|NCT00320489|75979749|FG000|COMPLETED|Overall Study||119||
59855077|NCT00320489|75979750|FG001|COMPLETED|Overall Study||124||
59855078|NCT00320489|75979749|FG000|NOT COMPLETED|Overall Study||145||
59855079|NCT00320489|75979750|FG001|NOT COMPLETED|Overall Study||136||
59855080|NCT03928028|75979759|FG000|STARTED|Overall Study||63||21
59855081|NCT03928028|75979760|FG001|STARTED|Overall Study||57||19
60121739|NCT01563029|76242700|FG004|STARTED|Overall Study||118||
60121740|NCT01563029|76242696|FG000|COMPLETED|Overall Study||66||
60121741|NCT01563029|76242697|FG001|COMPLETED|Overall Study||94||
59588402|NCT02507011|75695896|FG001|COMPLETED|First Intervention||1||
59855082|NCT03928028|75979761|FG002|STARTED|Overall Study||57||19
59855083|NCT03928028|75979759|FG000|Mother|Overall Study||21||21
59855084|NCT03928028|75979760|FG001|Mother|Overall Study||19||19
59855085|NCT03928028|75979761|FG002|Mother|Overall Study||19||19
59855086|NCT03928028|75979759|FG000|Father|Overall Study||21||21
59855087|NCT03928028|75979760|FG001|Father|Overall Study||19||19
59855088|NCT03928028|75979761|FG002|Father|Overall Study||19||19
59855089|NCT03928028|75979759|FG000|Adolescent|Overall Study||21||21
59855090|NCT03928028|75979760|FG001|Adolescent|Overall Study||19||19
59855091|NCT03928028|75979761|FG002|Adolescent|Overall Study||19||19
59855092|NCT03928028|75979759|FG000|COMPLETED|Overall Study||42||14
59855093|NCT03928028|75979760|FG001|COMPLETED|Overall Study||48||16
59855094|NCT03928028|75979761|FG002|COMPLETED|Overall Study||51||17
59855095|NCT03928028|75979759|FG000|NOT COMPLETED|Overall Study||21||7
59855096|NCT03928028|75979760|FG001|NOT COMPLETED|Overall Study||9||3
59855097|NCT03928028|75979761|FG002|NOT COMPLETED|Overall Study||6||2
59855098|NCT00320411|75979769|FG000|STARTED|Overall Study||62||
60121742|NCT01563029|76242698|FG002|COMPLETED|Overall Study||87||
59855099|NCT00320411|75979769|FG000|COMPLETED|Overall Study||58||
59855100|NCT00320411|75979769|FG000|NOT COMPLETED|Overall Study||4||
59855101|NCT00320255|75979779|FG000|STARTED|Overall Study||30||
59855102|NCT00320255|75979780|FG001|STARTED|Overall Study||32||
59855103|NCT00320255|75979781|FG002|STARTED|Overall Study||30||
59855104|NCT00320255|75979782|FG003|STARTED|Overall Study||33||
59855105|NCT00320255|75979783|FG004|STARTED|Overall Study||2||
59855106|NCT00320255|75979784|FG005|STARTED|Overall Study||3||
59855107|NCT00320255|75979779|FG000|Received Treatment|Overall Study||29||
59855108|NCT00320255|75979780|FG001|Received Treatment|Overall Study||32||
59588403|NCT02507011|75695895|FG000|NOT COMPLETED|First Intervention||0||
59588404|NCT02507011|75695896|FG001|NOT COMPLETED|First Intervention||0||
59588405|NCT02507011|75695895|FG000|STARTED|Second Intervention||1||
59588406|NCT02507011|75695896|FG001|STARTED|Second Intervention||1||
59588407|NCT02507011|75695895|FG000|COMPLETED|Second Intervention||1||
59588408|NCT02507011|75695896|FG001|COMPLETED|Second Intervention||1||
59588409|NCT02507011|75695895|FG000|NOT COMPLETED|Second Intervention||0||
59588410|NCT02507011|75695896|FG001|NOT COMPLETED|Second Intervention||0||
59588411|NCT02977286|75695904|FG000|STARTED|Overall Study||6||
59588412|NCT02977286|75695905|FG001|STARTED|Overall Study||6||
59588413|NCT02977286|75695904|FG000|COMPLETED|Overall Study||6||
59588414|NCT02977286|75695905|FG001|COMPLETED|Overall Study||6||
59588415|NCT02977286|75695904|FG000|NOT COMPLETED|Overall Study||0||
59588416|NCT02977286|75695905|FG001|NOT COMPLETED|Overall Study||0||
59588417|NCT01810705|75695915|FG000|STARTED|Overall Study||83||
59588418|NCT01810705|75695916|FG001|STARTED|Overall Study||40||
59588419|NCT01810705|75695915|FG000|COMPLETED|Overall Study||10||
59588420|NCT01810705|75695916|FG001|COMPLETED|Overall Study||5||
59588421|NCT01810705|75695915|FG000|NOT COMPLETED|Overall Study||73||
59588422|NCT01810705|75695916|FG001|NOT COMPLETED|Overall Study||35||
59588423|NCT02508103|75695924|FG000|STARTED|Overall Study||5||
59588424|NCT02508103|75695925|FG001|STARTED|Overall Study||5||
59588425|NCT02508103|75695924|FG000|COMPLETED|Overall Study||5||
59588426|NCT02508103|75695925|FG001|COMPLETED|Overall Study||5||
59588427|NCT02508103|75695924|FG000|NOT COMPLETED|Overall Study||0||
59588428|NCT02508103|75695925|FG001|NOT COMPLETED|Overall Study||0||
59588429|NCT02508259|75695933|FG000|STARTED|Overall Study||5||
59588430|NCT02508259|75695934|FG001|STARTED|Overall Study||5||
59588431|NCT02508259|75695933|FG000|COMPLETED|Overall Study||5||
59588432|NCT02508259|75695934|FG001|COMPLETED|Overall Study||5||
59588433|NCT02508259|75695933|FG000|NOT COMPLETED|Overall Study||0||
59588434|NCT02508259|75695934|FG001|NOT COMPLETED|Overall Study||0||
59588435|NCT02509585|75695940|FG000|STARTED|Overall Study||18||
59588436|NCT02509585|75695940|FG000|COMPLETED|Overall Study||18||
59588437|NCT02509585|75695940|FG000|NOT COMPLETED|Overall Study||0||
59588438|NCT02240706|75695950|FG000|STARTED|Overall Study||3||
59588439|NCT02240706|75695951|FG001|STARTED|Overall Study||3||
59588440|NCT02240706|75695952|FG002|STARTED|Overall Study||6||
59588441|NCT02240706|75695953|FG003|STARTED|Overall Study||4||
59588442|NCT02240706|75695954|FG004|STARTED|Overall Study||11||
59588443|NCT02240706|75695955|FG005|STARTED|Overall Study|No patients were enrolled in the Phase II part due to strategic reasons.|0||
59588444|NCT02240706|75695956|FG006|STARTED|Overall Study|No patients were enrolled in the Phase II part due to strategic reasons.|0||
59588445|NCT02240706|75695950|FG000|COMPLETED|Overall Study||0||
59588446|NCT02240706|75695951|FG001|COMPLETED|Overall Study||0||
59588447|NCT02240706|75695952|FG002|COMPLETED|Overall Study||0||
59588448|NCT02240706|75695953|FG003|COMPLETED|Overall Study||0||
59588449|NCT02240706|75695954|FG004|COMPLETED|Overall Study||0||
59588450|NCT02240706|75695955|FG005|COMPLETED|Overall Study||0||
59588451|NCT02240706|75695956|FG006|COMPLETED|Overall Study||0||
59588452|NCT02240706|75695950|FG000|NOT COMPLETED|Overall Study||3||
59588453|NCT02240706|75695951|FG001|NOT COMPLETED|Overall Study||3||
59588454|NCT02240706|75695952|FG002|NOT COMPLETED|Overall Study||6||
59588455|NCT02240706|75695953|FG003|NOT COMPLETED|Overall Study||4||
59588456|NCT02240706|75695954|FG004|NOT COMPLETED|Overall Study||11||
59725224|NCT01026324|75844074|FG000|NOT COMPLETED|Treatment Allocation||0||
59725225|NCT01026324|75844075|FG001|NOT COMPLETED|Treatment Allocation||0||
59725226|NCT01026324|75844076|FG002|NOT COMPLETED|Treatment Allocation||0||
59725227|NCT01026324|75844074|FG000|STARTED|Follow up/Survival||5||
59725228|NCT01026324|75844075|FG001|STARTED|Follow up/Survival||3||
59725229|NCT01026324|75844076|FG002|STARTED|Follow up/Survival||4||
59725230|NCT01026324|75844074|FG000|Follow up Discontinuation (Death)|Follow up/Survival||4||
59588457|NCT02240706|75695955|FG005|NOT COMPLETED|Overall Study||0||
59588458|NCT02240706|75695956|FG006|NOT COMPLETED|Overall Study||0||
59588459|NCT00534469|75695971|FG000|STARTED|Overall Study||52||
59588460|NCT00534469|75695971|FG000|COMPLETED|Overall Study||52||
59588461|NCT00534469|75695971|FG000|NOT COMPLETED|Overall Study||0||
59588462|NCT01600092|75695981|FG000|STARTED|Overall Study||513||
59588463|NCT01600092|75695982|FG001|STARTED|Overall Study||507||
59588464|NCT01600092|75695981|FG000|Received at Least 1 Vaccination|Overall Study|1 participant received RotaTeq™ existing formulation as their first vaccination|510||
59588465|NCT01600092|75695982|FG001|Received at Least 1 Vaccination|Overall Study||504||
59588466|NCT01600092|75695981|FG000|Received All 3 Vaccinations|Overall Study||500||
59588467|NCT01600092|75695982|FG001|Received All 3 Vaccinations|Overall Study||494||
59588468|NCT01600092|75695981|FG000|COMPLETED|Overall Study||495||
59588469|NCT01600092|75695982|FG001|COMPLETED|Overall Study||491||
59588470|NCT01600092|75695981|FG000|NOT COMPLETED|Overall Study||18||
59588471|NCT01600092|75695982|FG001|NOT COMPLETED|Overall Study||16||
59588472|NCT02588599|75695988|FG000|STARTED|Overall Study||54||
59588473|NCT02588599|75695988|FG000|COMPLETED|Overall Study||54||
59725231|NCT01026324|75844075|FG001|Follow up Discontinuation (Death)|Follow up/Survival||3||
59725232|NCT01026324|75844076|FG002|Follow up Discontinuation (Death)|Follow up/Survival||4||
59725233|NCT01026324|75844074|FG000|COMPLETED|Follow up/Survival||4||
59588474|NCT02588599|75695988|FG000|NOT COMPLETED|Overall Study||0||
59588475|NCT02240628|75695994|FG000|STARTED|Overall Study||38||
59588476|NCT02240628|75695995|FG001|STARTED|Overall Study||38||
59588477|NCT02240628|75695994|FG000|COMPLETED|Overall Study||32||
59588478|NCT02240628|75695995|FG001|COMPLETED|Overall Study||33||
59588479|NCT02240628|75695994|FG000|NOT COMPLETED|Overall Study||6||
59588480|NCT02240628|75695995|FG001|NOT COMPLETED|Overall Study||5||
59588481|NCT02589067|75696003|FG000|STARTED|Overall Study||33||
59588482|NCT02589067|75696004|FG001|STARTED|Overall Study||34||
59588483|NCT02589067|75696003|FG000|COMPLETED|Overall Study||28||
59588484|NCT02589067|75696004|FG001|COMPLETED|Overall Study||28||
59588485|NCT02589067|75696003|FG000|NOT COMPLETED|Overall Study||5||
59588486|NCT02589067|75696004|FG001|NOT COMPLETED|Overall Study||6||
59588487|NCT02511379|75696011|FG000|STARTED|Overall Study||14||
59588488|NCT02511379|75696011|FG000|COMPLETED|Overall Study||14||
59588489|NCT02511379|75696011|FG000|NOT COMPLETED|Overall Study||0||
59588490|NCT02207400|75696017|FG000|STARTED|Overall Study||123||
59588491|NCT02207400|75696018|FG001|STARTED|Overall Study||123||
59588492|NCT02207400|75696017|FG000|COMPLETED|Overall Study||107||
59588493|NCT02207400|75696018|FG001|COMPLETED|Overall Study||109||
59588494|NCT02207400|75696017|FG000|NOT COMPLETED|Overall Study||16||
59588495|NCT02207400|75696018|FG001|NOT COMPLETED|Overall Study||14||
59588496|NCT02511535|75696030|FG000|STARTED|Overall Study||49||
59588497|NCT02511535|75696031|FG001|STARTED|Overall Study||21||
59588498|NCT02511535|75696032|FG002|STARTED|Overall Study||49||
59588499|NCT02511535|75696030|FG000|COMPLETED|Overall Study||49||
59588500|NCT02511535|75696031|FG001|COMPLETED|Overall Study||21||
59588501|NCT02511535|75696032|FG002|COMPLETED|Overall Study||49||
59588502|NCT02511535|75696030|FG000|NOT COMPLETED|Overall Study||0||
59588503|NCT02511535|75696031|FG001|NOT COMPLETED|Overall Study||0||
59588504|NCT02511535|75696032|FG002|NOT COMPLETED|Overall Study||0||
59588505|NCT02589847|75696042|FG000|STARTED|Overall Study||162||
59588506|NCT02589847|75696043|FG001|STARTED|Overall Study||110||
59588507|NCT02589847|75696042|FG000|Safety Population|Overall Study||149||
59588508|NCT02589847|75696043|FG001|Safety Population|Overall Study||0||
59588509|NCT02589847|75696042|FG000|Full Analysis Set (FAS)|Overall Study||149||
59588510|NCT02589847|75696043|FG001|Full Analysis Set (FAS)|Overall Study||104||
59588511|NCT02589847|75696042|FG000|Evaluable|Overall Study||142||
59588512|NCT02589847|75696043|FG001|Evaluable|Overall Study||75||
59588513|NCT02589847|75696042|FG000|COMPLETED|Overall Study||107||
59588514|NCT02589847|75696043|FG001|COMPLETED|Overall Study||39||
59588515|NCT02589847|75696042|FG000|NOT COMPLETED|Overall Study||55||
59588516|NCT02589847|75696043|FG001|NOT COMPLETED|Overall Study||71||
59588517|NCT02512393|75696052|FG000|STARTED|Overall Study||21||
59588518|NCT02512393|75696053|FG001|STARTED|Overall Study||20||
59588519|NCT02512393|75696052|FG000|COMPLETED|Overall Study||20||
59588520|NCT02512393|75696053|FG001|COMPLETED|Overall Study||20||
59588521|NCT02512393|75696052|FG000|NOT COMPLETED|Overall Study||1||
59588522|NCT02512393|75696053|FG001|NOT COMPLETED|Overall Study||0||
59588523|NCT02592421|75696061|FG000|STARTED|Study 1||20||
59588524|NCT02592421|75696062|FG001|STARTED|Study 1||10||
59588525|NCT02592421|75696061|FG000|COMPLETED|Study 1||20||
59588526|NCT02592421|75696062|FG001|COMPLETED|Study 1||10||
59588527|NCT02592421|75696061|FG000|NOT COMPLETED|Study 1||0||
59588528|NCT02592421|75696062|FG001|NOT COMPLETED|Study 1||0||
59588529|NCT02592421|75696061|FG000|STARTED|Study 2: Glucose Clamp Conditions||20||
59588530|NCT02592421|75696062|FG001|STARTED|Study 2: Glucose Clamp Conditions||10||
59588531|NCT02592421|75696061|FG000|COMPLETED|Study 2: Glucose Clamp Conditions||20||
59588532|NCT02592421|75696062|FG001|COMPLETED|Study 2: Glucose Clamp Conditions||10||
59588533|NCT02592421|75696061|FG000|NOT COMPLETED|Study 2: Glucose Clamp Conditions||0||
59588534|NCT02592421|75696062|FG001|NOT COMPLETED|Study 2: Glucose Clamp Conditions||0||
59588535|NCT02592421|75696061|FG000|STARTED|Study 3: Pancreatic Clamp Conditions||20||
59588536|NCT02592421|75696062|FG001|STARTED|Study 3: Pancreatic Clamp Conditions||10||
59588537|NCT02592421|75696061|FG000|COMPLETED|Study 3: Pancreatic Clamp Conditions||20||
59588538|NCT02592421|75696062|FG001|COMPLETED|Study 3: Pancreatic Clamp Conditions||10||
59588539|NCT02592421|75696061|FG000|NOT COMPLETED|Study 3: Pancreatic Clamp Conditions||0||
59588540|NCT02592421|75696062|FG001|NOT COMPLETED|Study 3: Pancreatic Clamp Conditions||0||
59588541|NCT02512783|75696070|FG000|STARTED|Overall Study||96||
59588542|NCT02512783|75696071|FG001|STARTED|Overall Study||75||
59588543|NCT02512783|75696070|FG000|COMPLETED|Overall Study||96||
59588544|NCT02512783|75696071|FG001|COMPLETED|Overall Study||75||
59588545|NCT02512783|75696070|FG000|NOT COMPLETED|Overall Study||0||
59588546|NCT02512783|75696071|FG001|NOT COMPLETED|Overall Study||0||
59588547|NCT02513095|75696079|FG000|STARTED|Overall Study||17||
59588548|NCT02513095|75696080|FG001|STARTED|Overall Study||17||
59588549|NCT02513095|75696079|FG000|Treatment Phase - Up to 120 Minutes|Overall Study||17||
59588550|NCT02513095|75696080|FG001|Treatment Phase - Up to 120 Minutes|Overall Study||17||
59588551|NCT02513095|75696079|FG000|COMPLETED|Overall Study||17||
59855109|NCT00320255|75979781|FG002|Received Treatment|Overall Study||29||
59588552|NCT02513095|75696080|FG001|COMPLETED|Overall Study||17||
59588553|NCT02513095|75696079|FG000|NOT COMPLETED|Overall Study||0||
59588554|NCT02513095|75696080|FG001|NOT COMPLETED|Overall Study||0||
59588555|NCT02592655|75696088|FG000|STARTED|First Tourniquet, Left Thigh.||19||
59588556|NCT02592655|75696088|FG000|ATS (Pneumatic)|First Tourniquet, Left Thigh.||5||
59588557|NCT02592655|75696088|FG000|Windlass Tourniquet|First Tourniquet, Left Thigh.||7||
59588558|NCT02592655|75696088|FG000|Tourniquet Tape 10 cm Width|First Tourniquet, Left Thigh.||5||
59588559|NCT02592655|75696088|FG000|Tourniquet Tape 5 cm Width|First Tourniquet, Left Thigh.||2||
59588560|NCT02592655|75696088|FG000|COMPLETED|First Tourniquet, Left Thigh.||19||
59588561|NCT02592655|75696088|FG000|NOT COMPLETED|First Tourniquet, Left Thigh.||0||
59588562|NCT02592655|75696088|FG000|STARTED|Second Tourniquet Right Thigh.||19|Participants switch to different interventions each period.|
59588563|NCT02592655|75696088|FG000|ATS (Pneumatic)|Second Tourniquet Right Thigh.||5||
59588564|NCT02592655|75696088|FG000|Windlass Tourniquet|Second Tourniquet Right Thigh.||8||
59588565|NCT02592655|75696088|FG000|Tourniquet Tape 10 cm Width|Second Tourniquet Right Thigh.||5||
59588566|NCT02592655|75696088|FG000|Tourniquet Tape 5 cm Width|Second Tourniquet Right Thigh.||1||
59588567|NCT02592655|75696088|FG000|COMPLETED|Second Tourniquet Right Thigh.||19||
59588568|NCT02592655|75696088|FG000|NOT COMPLETED|Second Tourniquet Right Thigh.||0||
59588569|NCT02592655|75696088|FG000|STARTED|Third Tourniquet, Left Thigh.||19|Participants switch to different interventions each period.|
59588570|NCT02592655|75696088|FG000|ATS (Pneumatic)|Third Tourniquet, Left Thigh.||8||
59588571|NCT02592655|75696088|FG000|Windlass Tourniquet|Third Tourniquet, Left Thigh.||4||
59588572|NCT02592655|75696088|FG000|Tourniquet Tape 10 cm Width|Third Tourniquet, Left Thigh.||6||
59588573|NCT02592655|75696088|FG000|Tourniquet Tape 5 cm Width|Third Tourniquet, Left Thigh.||1||
59588574|NCT02592655|75696088|FG000|COMPLETED|Third Tourniquet, Left Thigh.||19||
59588575|NCT02592655|75696088|FG000|NOT COMPLETED|Third Tourniquet, Left Thigh.||0||
59588576|NCT02592655|75696088|FG000|STARTED|Fourth Tourniquet Right Thigh.|Only the first 4 participants received all four interventions.|4|Investigator decided to discontinue the 5 cm Tourniquet Tape after the 4th participant.|
59588577|NCT02592655|75696088|FG000|ATS (Pneumatic)|Fourth Tourniquet Right Thigh.||1||
59588578|NCT02592655|75696088|FG000|Windlass Tourniquet|Fourth Tourniquet Right Thigh.||0||
59588579|NCT02592655|75696088|FG000|Tourniquet Tape 10 cm Width|Fourth Tourniquet Right Thigh.||3||
59588580|NCT02592655|75696088|FG000|Tourniquet Tape 5 cm Width|Fourth Tourniquet Right Thigh.||0||
59588581|NCT02592655|75696088|FG000|COMPLETED|Fourth Tourniquet Right Thigh.||4||
59588582|NCT02592655|75696088|FG000|NOT COMPLETED|Fourth Tourniquet Right Thigh.||0||
59588583|NCT02513641|75696103|FG000|STARTED|Overall Study||8||
59588584|NCT02513641|75696103|FG000|COMPLETED|Overall Study||8||
59588585|NCT02513641|75696103|FG000|NOT COMPLETED|Overall Study||0||
59588586|NCT02513719|75696107|FG000|STARTED|At 8 Months Clinical Follow-up||312||
59588587|NCT02513719|75696107|FG000|COMPLETED|At 8 Months Clinical Follow-up||312||
59588588|NCT02513719|75696107|FG000|NOT COMPLETED|At 8 Months Clinical Follow-up||0||
59588589|NCT02513719|75696107|FG000|STARTED|At 1 Year Clinical Follow-up||312||
59588590|NCT02513719|75696107|FG000|COMPLETED|At 1 Year Clinical Follow-up||305||
59588591|NCT02513719|75696107|FG000|NOT COMPLETED|At 1 Year Clinical Follow-up||7||
59588592|NCT02513719|75696107|FG000|STARTED|At 2 Years Clinical Follow-up||305||
59588593|NCT02513719|75696107|FG000|COMPLETED|At 2 Years Clinical Follow-up||300||
59588594|NCT02513719|75696107|FG000|NOT COMPLETED|At 2 Years Clinical Follow-up||5||
59588595|NCT02513719|75696107|FG000|STARTED|At 3 Years Clinical Follow-up||300||
59588596|NCT02513719|75696107|FG000|COMPLETED|At 3 Years Clinical Follow-up||289||
59588597|NCT02513719|75696107|FG000|NOT COMPLETED|At 3 Years Clinical Follow-up||11||
59588598|NCT02513719|75696107|FG000|STARTED|At 4 Years Clinical Follow-up||289||
59588599|NCT02513719|75696107|FG000|COMPLETED|At 4 Years Clinical Follow-up||273||
59588600|NCT02513719|75696107|FG000|NOT COMPLETED|At 4 Years Clinical Follow-up||16||
59588601|NCT02513719|75696107|FG000|STARTED|At 5 Years Clinical Follow-up||273||
59588602|NCT02513719|75696107|FG000|COMPLETED|At 5 Years Clinical Follow-up||254||
59588603|NCT02513719|75696107|FG000|NOT COMPLETED|At 5 Years Clinical Follow-up||19||
59588604|NCT02514889|75696113|FG000|STARTED|Randomization/Allocation to Condition||131||
59588605|NCT02514889|75696114|FG001|STARTED|Randomization/Allocation to Condition||130||
59588606|NCT02514889|75696113|FG000|COMPLETED|Randomization/Allocation to Condition||111||
59588607|NCT02514889|75696114|FG001|COMPLETED|Randomization/Allocation to Condition||106||
59588608|NCT02514889|75696113|FG000|NOT COMPLETED|Randomization/Allocation to Condition||20||
59588609|NCT02514889|75696114|FG001|NOT COMPLETED|Randomization/Allocation to Condition||24||
59588610|NCT02514889|75696113|FG000|STARTED|Intervention Participation||111||
59588611|NCT02514889|75696114|FG001|STARTED|Intervention Participation||106||
59588612|NCT02514889|75696113|FG000|COMPLETED|Intervention Participation||102||
59588613|NCT02514889|75696114|FG001|COMPLETED|Intervention Participation||98||
59588614|NCT02514889|75696113|FG000|NOT COMPLETED|Intervention Participation||9||
59588615|NCT02514889|75696114|FG001|NOT COMPLETED|Intervention Participation||8||
59588616|NCT02514889|75696113|FG000|STARTED|Follow-up Assessment Participation||102|179 participants provided survey data via in-person interviews; 21 provided survey data via phone|
59588617|NCT02514889|75696114|FG001|STARTED|Follow-up Assessment Participation||98|179 participants provided survey data via in-person interviews; 21 provided survey data via phone|
59588618|NCT02514889|75696113|FG000|COMPLETED|Follow-up Assessment Participation||92|179 participants completed in-person follow-up but 1 in-person visit did not include waist measure|
59588619|NCT02514889|75696114|FG001|COMPLETED|Follow-up Assessment Participation||86|179 participants completed in-person follow-up but 1 in-person visit did not include waist measure|
59588620|NCT02514889|75696113|FG000|NOT COMPLETED|Follow-up Assessment Participation||10||
59588621|NCT02514889|75696114|FG001|NOT COMPLETED|Follow-up Assessment Participation||12||
59588622|NCT02515825|75696122|FG000|STARTED|Overall Study||70||
59588623|NCT02515825|75696123|FG001|STARTED|Overall Study||31||
59588624|NCT02515825|75696122|FG000|COMPLETED|Overall Study||70||
59588625|NCT02515825|75696123|FG001|COMPLETED|Overall Study||31||
59588626|NCT02515825|75696122|FG000|NOT COMPLETED|Overall Study||0||
59588627|NCT02515825|75696123|FG001|NOT COMPLETED|Overall Study||0||
59588628|NCT02593903|75696132|FG000|STARTED|Overall Study||35||
59588629|NCT02593903|75696133|FG001|STARTED|Overall Study||32||
59588630|NCT02593903|75696132|FG000|COMPLETED|Overall Study||35||
59588631|NCT02593903|75696133|FG001|COMPLETED|Overall Study||31||
59588632|NCT02593903|75696132|FG000|NOT COMPLETED|Overall Study||0||
59588633|NCT02593903|75696133|FG001|NOT COMPLETED|Overall Study||1||
59588634|NCT02596321|75696141|FG000|STARTED|Overall Study||56||
59588635|NCT02596321|75696142|FG001|STARTED|Overall Study||56||
59588636|NCT02596321|75696141|FG000|COMPLETED|Overall Study||53||
59588637|NCT02596321|75696142|FG001|COMPLETED|Overall Study||56||
59588638|NCT02596321|75696141|FG000|NOT COMPLETED|Overall Study||3||
59588639|NCT02596321|75696142|FG001|NOT COMPLETED|Overall Study||0||
59588640|NCT02596867|75696148|FG000|STARTED|Overall Study||2||
59588641|NCT02596867|75696148|FG000|2 Patients Prospectively Recruited|Overall Study||2||
59588642|NCT02596867|75696148|FG000|COMPLETED|Overall Study||2||
59588643|NCT02596867|75696148|FG000|NOT COMPLETED|Overall Study||0||
59588644|NCT02597101|75696155|FG000|STARTED|Overall Study||4||
59588645|NCT02597101|75696156|FG001|STARTED|Overall Study||5||
59588646|NCT02597101|75696155|FG000|COMPLETED|Overall Study||4||
59588647|NCT02597101|75696156|FG001|COMPLETED|Overall Study||5||
59588648|NCT02597101|75696155|FG000|NOT COMPLETED|Overall Study||0||
59588649|NCT02597101|75696156|FG001|NOT COMPLETED|Overall Study||0||
59588650|NCT02599441|75696162|FG000|STARTED|Overall Study||9|Enrolled in the study|
59588651|NCT02599441|75696162|FG000|COMPLETED|Overall Study||9|Completed the study|
59588652|NCT02599441|75696162|FG000|NOT COMPLETED|Overall Study||0||
59588653|NCT02600611|75696168|FG000|STARTED|Overall Study||300||
59588654|NCT02600611|75696169|FG001|STARTED|Overall Study||300||
59588655|NCT02600611|75696168|FG000|COMPLETED|Overall Study||298||
59588656|NCT02600611|75696169|FG001|COMPLETED|Overall Study||300||
59588657|NCT02600611|75696168|FG000|NOT COMPLETED|Overall Study||2||
59588658|NCT02600611|75696169|FG001|NOT COMPLETED|Overall Study||0||
59588659|NCT02600767|75696175|FG000|STARTED|Overall Study||79||
59588660|NCT02600767|75696175|FG000|COMPLETED|Overall Study||74||
59588661|NCT02600767|75696175|FG000|NOT COMPLETED|Overall Study||5||
59588662|NCT02608177|75696181|FG000|STARTED|Overall Study||2||
59588663|NCT02608177|75696182|FG001|STARTED|Overall Study||1||
59588664|NCT02608177|75696181|FG000|COMPLETED|Overall Study||2||
59588665|NCT02608177|75696182|FG001|COMPLETED|Overall Study||1||
59855110|NCT00320255|75979782|FG003|Received Treatment|Overall Study||32||
59588666|NCT02608177|75696181|FG000|NOT COMPLETED|Overall Study||0||
59588667|NCT02608177|75696182|FG001|NOT COMPLETED|Overall Study||0||
59588668|NCT02608489|75696192|FG000|STARTED|Overall Study||43||
59588669|NCT02608489|75696193|FG001|STARTED|Overall Study||43||
59588670|NCT02608489|75696192|FG000|COMPLETED|Overall Study||30||
59588671|NCT02608489|75696193|FG001|COMPLETED|Overall Study||33||
59588672|NCT02608489|75696192|FG000|NOT COMPLETED|Overall Study||13||
59588673|NCT02608489|75696193|FG001|NOT COMPLETED|Overall Study||10||
59588674|NCT02609113|75696201|FG000|STARTED|Overall Study||11||
59588675|NCT02609113|75696202|FG001|STARTED|Overall Study||11||
59588676|NCT02609113|75696201|FG000|COMPLETED|Overall Study||9||
59588677|NCT02609113|75696202|FG001|COMPLETED|Overall Study||9||
59588678|NCT02609113|75696201|FG000|NOT COMPLETED|Overall Study||2||
59588679|NCT02609113|75696202|FG001|NOT COMPLETED|Overall Study||2||
59588680|NCT02611765|75696210|FG000|STARTED|Overall Study||29||
59588681|NCT02611765|75696211|FG001|STARTED|Overall Study||35||
59588682|NCT02611765|75696210|FG000|COMPLETED|Overall Study||27||
59588683|NCT02611765|75696211|FG001|COMPLETED|Overall Study||29||
59588684|NCT02611765|75696210|FG000|NOT COMPLETED|Overall Study||2||
59588685|NCT02611765|75696211|FG001|NOT COMPLETED|Overall Study||6||
59588686|NCT02612857|75696220|FG000|STARTED|Overall Study||11||
59588687|NCT02612857|75696221|FG001|STARTED|Overall Study||9||
59588688|NCT02612857|75696222|FG002|STARTED|Overall Study||10||
59588689|NCT02612857|75696220|FG000|COMPLETED|Overall Study||8||
59588690|NCT02612857|75696221|FG001|COMPLETED|Overall Study||5||
59588691|NCT02612857|75696222|FG002|COMPLETED|Overall Study||6||
59588692|NCT02612857|75696220|FG000|NOT COMPLETED|Overall Study||3||
59588693|NCT02612857|75696221|FG001|NOT COMPLETED|Overall Study||4||
59588694|NCT02612857|75696222|FG002|NOT COMPLETED|Overall Study||4||
59588695|NCT02615743|75696232|FG000|STARTED|Overall Study||21||
59588696|NCT02615743|75696233|FG001|STARTED|Overall Study||20||
59588697|NCT02615743|75696232|FG000|COMPLETED|Overall Study||15||
59588698|NCT02615743|75696233|FG001|COMPLETED|Overall Study||17||
59588699|NCT02615743|75696232|FG000|NOT COMPLETED|Overall Study||6||
59855111|NCT00320255|75979783|FG004|Received Treatment|Overall Study||2||
59588700|NCT02615743|75696233|FG001|NOT COMPLETED|Overall Study||3||
59588701|NCT02616523|75696242|FG000|STARTED|Overall Study|June 2014|20||
59588702|NCT02616523|75696243|FG001|STARTED|Overall Study|June 2014|20||
59588703|NCT02616523|75696244|FG002|STARTED|Overall Study|June 2014|20||
59588704|NCT02616523|75696242|FG000|COMPLETED|Overall Study|April 2015|19||
59588705|NCT02616523|75696243|FG001|COMPLETED|Overall Study|April 2015|20||
59588706|NCT02616523|75696244|FG002|COMPLETED|Overall Study|April 2015|20||
59588707|NCT02616523|75696242|FG000|NOT COMPLETED|Overall Study||1||
59588708|NCT02616523|75696243|FG001|NOT COMPLETED|Overall Study||0||
59588709|NCT02616523|75696244|FG002|NOT COMPLETED|Overall Study||0||
59588710|NCT02619799|75696257|FG000|STARTED|Overall Study||25||
59588711|NCT02619799|75696258|FG001|STARTED|Overall Study||25||
59588712|NCT02619799|75696257|FG000|COMPLETED|Overall Study||25||
59588713|NCT02619799|75696258|FG001|COMPLETED|Overall Study||25||
59588714|NCT02619799|75696257|FG000|NOT COMPLETED|Overall Study||0||
59588715|NCT02619799|75696258|FG001|NOT COMPLETED|Overall Study||0||
59588716|NCT02621983|75696266|FG000|STARTED|Overall Study||21||
59588717|NCT02621983|75696267|FG001|STARTED|Overall Study||17||
59588718|NCT02621983|75696266|FG000|COMPLETED|Overall Study||9||
59588719|NCT02621983|75696267|FG001|COMPLETED|Overall Study||6||
59588720|NCT02621983|75696266|FG000|NOT COMPLETED|Overall Study||12||
59588721|NCT02621983|75696267|FG001|NOT COMPLETED|Overall Study||11||
59588722|NCT02623855|75696275|FG000|STARTED|Overall Study||56||
59588723|NCT02623855|75696276|FG001|STARTED|Overall Study||100||
59588724|NCT02623855|75696275|FG000|COMPLETED|Overall Study||46||
59588725|NCT02623855|75696276|FG001|COMPLETED|Overall Study||84||
59588726|NCT02623855|75696275|FG000|NOT COMPLETED|Overall Study||10||
59588727|NCT02623855|75696276|FG001|NOT COMPLETED|Overall Study||16||
59588728|NCT02625181|75696285|FG000|STARTED|Overall Study||1518|Baseline measurement period|
59588729|NCT02625181|75696286|FG001|STARTED|Overall Study||12809|Baseline measurement period|
59588730|NCT02625181|75696287|FG002|STARTED|Overall Study||12707|Baseline measurement period|
59588731|NCT02625181|75696285|FG000|COMPLETED|Overall Study||1518||
59588732|NCT02625181|75696286|FG001|COMPLETED|Overall Study||12809||
59588733|NCT02625181|75696287|FG002|COMPLETED|Overall Study||12707||
59588734|NCT02625181|75696285|FG000|NOT COMPLETED|Overall Study||0||
59588735|NCT02625181|75696286|FG001|NOT COMPLETED|Overall Study||0||
59588736|NCT02625181|75696287|FG002|NOT COMPLETED|Overall Study||0||
59588737|NCT02625571|75696293|FG000|STARTED|Overall Study||13||
59588738|NCT02625571|75696293|FG000|COMPLETED|Overall Study||10||
59588739|NCT02625571|75696293|FG000|NOT COMPLETED|Overall Study||3||
59588740|NCT02628223|75696299|FG000|STARTED|Overall Study||38||
59588741|NCT02628223|75696300|FG001|STARTED|Overall Study||38||
59588742|NCT02628223|75696299|FG000|COMPLETED|Overall Study||38||
59588743|NCT02628223|75696300|FG001|COMPLETED|Overall Study||36||
59588744|NCT02628223|75696299|FG000|NOT COMPLETED|Overall Study||0||
59588745|NCT02628223|75696300|FG001|NOT COMPLETED|Overall Study||2||
59588746|NCT02630017|75696308|FG000|STARTED|Overall Study||13||
59588747|NCT02630017|75696309|FG001|STARTED|Overall Study||12||
59588748|NCT02630017|75696310|FG002|STARTED|Overall Study||13||
59588749|NCT02630017|75696311|FG003|STARTED|Overall Study||13||
59588750|NCT02630017|75696308|FG000|COMPLETED|Overall Study||12||
59588751|NCT02630017|75696309|FG001|COMPLETED|Overall Study||11||
59588752|NCT02630017|75696310|FG002|COMPLETED|Overall Study||11||
59588753|NCT02630017|75696311|FG003|COMPLETED|Overall Study||12||
59588754|NCT02630017|75696308|FG000|NOT COMPLETED|Overall Study||1||
59588755|NCT02630017|75696309|FG001|NOT COMPLETED|Overall Study||1||
59588756|NCT02630017|75696310|FG002|NOT COMPLETED|Overall Study||2||
59588757|NCT02630017|75696311|FG003|NOT COMPLETED|Overall Study||1||
59588758|NCT02630719|75696323|FG000|STARTED|Overall Study||4||
59588759|NCT02630719|75696324|FG001|STARTED|Overall Study||6||
59588760|NCT02630719|75696323|FG000|COMPLETED|Overall Study||4||
59588761|NCT02630719|75696324|FG001|COMPLETED|Overall Study||6||
59588762|NCT02630719|75696323|FG000|NOT COMPLETED|Overall Study||0||
59588763|NCT02630719|75696324|FG001|NOT COMPLETED|Overall Study||0||
59588764|NCT02630953|75696332|FG000|STARTED|6 Month Assessment||97||
59588765|NCT02630953|75696333|FG001|STARTED|6 Month Assessment||102||
59588766|NCT02630953|75696332|FG000|COMPLETED|6 Month Assessment||83||
59588767|NCT02630953|75696333|FG001|COMPLETED|6 Month Assessment||70||
59588768|NCT02630953|75696332|FG000|NOT COMPLETED|6 Month Assessment||14||
59725234|NCT01026324|75844075|FG001|COMPLETED|Follow up/Survival||3||
60121743|NCT01563029|76242699|FG003|COMPLETED|Overall Study||85||
60121744|NCT01563029|76242700|FG004|COMPLETED|Overall Study||89||
59588769|NCT02630953|75696333|FG001|NOT COMPLETED|6 Month Assessment||32||
59588770|NCT02630953|75696332|FG000|STARTED|12 Month Assessment||97||
59588771|NCT02630953|75696333|FG001|STARTED|12 Month Assessment||102||
59588772|NCT02630953|75696332|FG000|COMPLETED|12 Month Assessment||73||
59588773|NCT02630953|75696333|FG001|COMPLETED|12 Month Assessment||64||
59588774|NCT02630953|75696332|FG000|NOT COMPLETED|12 Month Assessment||24||
59588775|NCT02630953|75696333|FG001|NOT COMPLETED|12 Month Assessment||38||
59588776|NCT02633371|75696339|FG000|STARTED|Overall Study||10||
59588777|NCT02633371|75696339|FG000|COMPLETED|Overall Study||7||
59588778|NCT02633371|75696339|FG000|NOT COMPLETED|Overall Study||3||
59588779|NCT02634073|75696343|FG000|STARTED|Overall Study||4||
59588780|NCT02634073|75696344|FG001|STARTED|Overall Study||4||
59588781|NCT02634073|75696345|FG002|STARTED|Overall Study||4||
59588782|NCT02634073|75696346|FG003|STARTED|Overall Study||4||
59588783|NCT02634073|75696343|FG000|COMPLETED|Overall Study||4||
59588784|NCT02634073|75696344|FG001|COMPLETED|Overall Study||4||
59725235|NCT01026324|75844076|FG002|COMPLETED|Follow up/Survival||4||
59588785|NCT02634073|75696345|FG002|COMPLETED|Overall Study||4||
59588786|NCT02634073|75696346|FG003|COMPLETED|Overall Study||4||
59588787|NCT02634073|75696343|FG000|NOT COMPLETED|Overall Study||0||
59588788|NCT02634073|75696344|FG001|NOT COMPLETED|Overall Study||0||
59588789|NCT02634073|75696345|FG002|NOT COMPLETED|Overall Study||0||
59588790|NCT02634073|75696346|FG003|NOT COMPLETED|Overall Study||0||
59588791|NCT02637427|75696358|FG000|STARTED|Overall Study||27||
59588792|NCT02637427|75696359|FG001|STARTED|Overall Study||30||
59588793|NCT02637427|75696358|FG000|COMPLETED|Overall Study||27||
59588794|NCT02637427|75696359|FG001|COMPLETED|Overall Study||30||
59588795|NCT02637427|75696358|FG000|NOT COMPLETED|Overall Study||0||
59588796|NCT02637427|75696359|FG001|NOT COMPLETED|Overall Study||0||
59588797|NCT02638051|75696367|FG000|STARTED|Overall Study||130||
59588798|NCT02638051|75696368|FG001|STARTED|Overall Study||130||
59588799|NCT02638051|75696367|FG000|COMPLETED|Overall Study||130||
59588800|NCT02638051|75696368|FG001|COMPLETED|Overall Study||130||
59588801|NCT02638051|75696367|FG000|NOT COMPLETED|Overall Study||0||
59588802|NCT02638051|75696368|FG001|NOT COMPLETED|Overall Study||0||
59588803|NCT02207244|75696377|FG000|STARTED|Placebo Controlled Period: Week 0-16||248||
59588804|NCT02207244|75696378|FG001|STARTED|Placebo Controlled Period: Week 0-16||496||
59588805|NCT02207244|75696379|FG002|STARTED|Placebo Controlled Period: Week 0-16||248||
59588806|NCT02207244|75696380|FG003|STARTED|Placebo Controlled Period: Week 0-16||0||
59588807|NCT02207244|75696381|FG004|STARTED|Placebo Controlled Period: Week 0-16||0||
59588808|NCT02207244|75696382|FG005|STARTED|Placebo Controlled Period: Week 0-16||0||
59588809|NCT02207244|75696383|FG006|STARTED|Placebo Controlled Period: Week 0-16||0||
59588810|NCT02207244|75696384|FG007|STARTED|Placebo Controlled Period: Week 0-16||0||
59588811|NCT02207244|75696385|FG008|STARTED|Placebo Controlled Period: Week 0-16||0||
59588812|NCT02207244|75696386|FG009|STARTED|Placebo Controlled Period: Week 0-16||0||
59588813|NCT02207244|75696387|FG010|STARTED|Placebo Controlled Period: Week 0-16||0||
59588814|NCT02207244|75696377|FG000|Treated|Placebo Controlled Period: Week 0-16||248||
59588815|NCT02207244|75696378|FG001|Treated|Placebo Controlled Period: Week 0-16||494||
59588816|NCT02207244|75696379|FG002|Treated|Placebo Controlled Period: Week 0-16||248||
59725236|NCT01026324|75844074|FG000|NOT COMPLETED|Follow up/Survival||1||
59725237|NCT01026324|75844075|FG001|NOT COMPLETED|Follow up/Survival||0||
59725238|NCT01026324|75844076|FG002|NOT COMPLETED|Follow up/Survival||0||
59725239|NCT01098539|75844087|FG000|STARTED|Overall Study||249||
59725240|NCT01098539|75844088|FG001|STARTED|Overall Study||246||
59725241|NCT01098539|75844087|FG000|COMPLETED|Overall Study||198||
59725242|NCT01098539|75844088|FG001|COMPLETED|Overall Study||178||
59725243|NCT01098539|75844087|FG000|NOT COMPLETED|Overall Study||51||
59725244|NCT01098539|75844088|FG001|NOT COMPLETED|Overall Study||68||
59725245|NCT01098461|75844098|FG000|STARTED|Treatment Period (TP) (16 Weeks)||53||
59725246|NCT01098461|75844099|FG001|STARTED|Treatment Period (TP) (16 Weeks)||52||
59855112|NCT00320255|75979784|FG005|Received Treatment|Overall Study||3||
59588817|NCT02207244|75696380|FG003|Treated|Placebo Controlled Period: Week 0-16||0||
59588818|NCT02207244|75696381|FG004|Treated|Placebo Controlled Period: Week 0-16||0||
59588819|NCT02207244|75696382|FG005|Treated|Placebo Controlled Period: Week 0-16||0||
59588820|NCT02207244|75696383|FG006|Treated|Placebo Controlled Period: Week 0-16||0||
59588821|NCT02207244|75696384|FG007|Treated|Placebo Controlled Period: Week 0-16||0||
59588822|NCT02207244|75696385|FG008|Treated|Placebo Controlled Period: Week 0-16||0||
59588823|NCT02207244|75696386|FG009|Treated|Placebo Controlled Period: Week 0-16||0||
59588824|NCT02207244|75696387|FG010|Treated|Placebo Controlled Period: Week 0-16||0||
59588825|NCT02207244|75696377|FG000|COMPLETED|Placebo Controlled Period: Week 0-16||233||
59588826|NCT02207244|75696378|FG001|COMPLETED|Placebo Controlled Period: Week 0-16||478||
59588827|NCT02207244|75696379|FG002|COMPLETED|Placebo Controlled Period: Week 0-16||237||
59588828|NCT02207244|75696380|FG003|COMPLETED|Placebo Controlled Period: Week 0-16||0||
59588829|NCT02207244|75696381|FG004|COMPLETED|Placebo Controlled Period: Week 0-16||0||
59588830|NCT02207244|75696382|FG005|COMPLETED|Placebo Controlled Period: Week 0-16||0||
59588831|NCT02207244|75696383|FG006|COMPLETED|Placebo Controlled Period: Week 0-16||0||
59588832|NCT02207244|75696384|FG007|COMPLETED|Placebo Controlled Period: Week 0-16||0||
59588833|NCT02207244|75696385|FG008|COMPLETED|Placebo Controlled Period: Week 0-16||0||
59588834|NCT02207244|75696386|FG009|COMPLETED|Placebo Controlled Period: Week 0-16||0||
59588835|NCT02207244|75696387|FG010|COMPLETED|Placebo Controlled Period: Week 0-16||0||
59588836|NCT02207244|75696377|FG000|NOT COMPLETED|Placebo Controlled Period: Week 0-16||15||
59588837|NCT02207244|75696378|FG001|NOT COMPLETED|Placebo Controlled Period: Week 0-16||18||
59588838|NCT02207244|75696379|FG002|NOT COMPLETED|Placebo Controlled Period: Week 0-16||11||
59588839|NCT02207244|75696380|FG003|NOT COMPLETED|Placebo Controlled Period: Week 0-16||0||
59588840|NCT02207244|75696381|FG004|NOT COMPLETED|Placebo Controlled Period: Week 0-16||0||
59588841|NCT02207244|75696382|FG005|NOT COMPLETED|Placebo Controlled Period: Week 0-16||0||
59588842|NCT02207244|75696383|FG006|NOT COMPLETED|Placebo Controlled Period: Week 0-16||0||
59725247|NCT01098461|75844100|FG002|STARTED|Treatment Period (TP) (16 Weeks)||54||
59725248|NCT01098461|75844101|FG003|STARTED|Treatment Period (TP) (16 Weeks)||53||
59725249|NCT01098461|75844098|FG000|COMPLETED|Treatment Period (TP) (16 Weeks)||41||
59725250|NCT01098461|75844099|FG001|COMPLETED|Treatment Period (TP) (16 Weeks)||45||
59855113|NCT00320255|75979779|FG000|COMPLETED|Overall Study||19||
59588843|NCT02207244|75696384|FG007|NOT COMPLETED|Placebo Controlled Period: Week 0-16||0||
59588844|NCT02207244|75696385|FG008|NOT COMPLETED|Placebo Controlled Period: Week 0-16||0||
59588845|NCT02207244|75696386|FG009|NOT COMPLETED|Placebo Controlled Period: Week 0-16||0||
59588846|NCT02207244|75696387|FG010|NOT COMPLETED|Placebo Controlled Period: Week 0-16||0||
59588847|NCT02207244|75696377|FG000|STARTED|Placebo Crossover and ACP: Week 16-28||0||
59588848|NCT02207244|75696378|FG001|STARTED|Placebo Crossover and ACP: Week 16-28||0||
59588849|NCT02207244|75696379|FG002|STARTED|Placebo Crossover and ACP: Week 16-28||0||
59588850|NCT02207244|75696380|FG003|STARTED|Placebo Crossover and ACP: Week 16-28||233||
59588851|NCT02207244|75696381|FG004|STARTED|Placebo Crossover and ACP: Week 16-28||478||
59588852|NCT02207244|75696382|FG005|STARTED|Placebo Crossover and ACP: Week 16-28||237||
59588853|NCT02207244|75696383|FG006|STARTED|Placebo Crossover and ACP: Week 16-28||0||
59588854|NCT02207244|75696384|FG007|STARTED|Placebo Crossover and ACP: Week 16-28||0||
59588855|NCT02207244|75696385|FG008|STARTED|Placebo Crossover and ACP: Week 16-28||0||
59588856|NCT02207244|75696386|FG009|STARTED|Placebo Crossover and ACP: Week 16-28||0||
59588857|NCT02207244|75696387|FG010|STARTED|Placebo Crossover and ACP: Week 16-28||0||
59588858|NCT02207244|75696377|FG000|COMPLETED|Placebo Crossover and ACP: Week 16-28||0||
59588859|NCT02207244|75696378|FG001|COMPLETED|Placebo Crossover and ACP: Week 16-28||0||
59588860|NCT02207244|75696379|FG002|COMPLETED|Placebo Crossover and ACP: Week 16-28||0||
59588861|NCT02207244|75696380|FG003|COMPLETED|Placebo Crossover and ACP: Week 16-28||227||
59588862|NCT02207244|75696381|FG004|COMPLETED|Placebo Crossover and ACP: Week 16-28||470||
59588863|NCT02207244|75696382|FG005|COMPLETED|Placebo Crossover and ACP: Week 16-28||228||
59588864|NCT02207244|75696383|FG006|COMPLETED|Placebo Crossover and ACP: Week 16-28||0||
59588865|NCT02207244|75696384|FG007|COMPLETED|Placebo Crossover and ACP: Week 16-28||0||
59588866|NCT02207244|75696385|FG008|COMPLETED|Placebo Crossover and ACP: Week 16-28||0||
59588867|NCT02207244|75696386|FG009|COMPLETED|Placebo Crossover and ACP: Week 16-28||0||
59588868|NCT02207244|75696387|FG010|COMPLETED|Placebo Crossover and ACP: Week 16-28||0||
59588869|NCT02207244|75696377|FG000|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||0||
59588870|NCT02207244|75696378|FG001|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||0||
59588871|NCT02207244|75696379|FG002|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||0||
59588872|NCT02207244|75696380|FG003|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||6||
59588873|NCT02207244|75696381|FG004|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||8||
59588874|NCT02207244|75696382|FG005|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||9||
59588875|NCT02207244|75696383|FG006|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||0||
59588876|NCT02207244|75696384|FG007|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||0||
59588877|NCT02207244|75696385|FG008|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||0||
59588878|NCT02207244|75696386|FG009|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||0||
59588879|NCT02207244|75696387|FG010|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||0||
59588880|NCT02207244|75696377|FG000|STARTED|Withdrawal and Re-treatment: Week 28-72||0||
59588881|NCT02207244|75696378|FG001|STARTED|Withdrawal and Re-treatment: Week 28-72||0||
59588882|NCT02207244|75696379|FG002|STARTED|Withdrawal and Re-treatment: Week 28-72||0||
59588883|NCT02207244|75696380|FG003|STARTED|Withdrawal and Re-treatment: Week 28-72||0||
59588884|NCT02207244|75696381|FG004|STARTED|Withdrawal and Re-treatment: Week 28-72||0||
59588885|NCT02207244|75696382|FG005|STARTED|Withdrawal and Re-treatment: Week 28-72||0||
59588886|NCT02207244|75696383|FG006|STARTED|Withdrawal and Re-treatment: Week 28-72||227||
59588887|NCT02207244|75696384|FG007|STARTED|Withdrawal and Re-treatment: Week 28-72||470||
59588888|NCT02207244|75696385|FG008|STARTED|Withdrawal and Re-treatment: Week 28-72||220||
59588889|NCT02207244|75696386|FG009|STARTED|Withdrawal and Re-treatment: Week 28-72||8||
59588890|NCT02207244|75696387|FG010|STARTED|Withdrawal and Re-treatment: Week 28-72||0||
59588891|NCT02207244|75696377|FG000|Nonresponders|Withdrawal and Re-treatment: Week 28-72||0||
59588892|NCT02207244|75696378|FG001|Nonresponders|Withdrawal and Re-treatment: Week 28-72||0||
59588893|NCT02207244|75696379|FG002|Nonresponders|Withdrawal and Re-treatment: Week 28-72||0||
59588894|NCT02207244|75696380|FG003|Nonresponders|Withdrawal and Re-treatment: Week 28-72||0||
59588895|NCT02207244|75696381|FG004|Nonresponders|Withdrawal and Re-treatment: Week 28-72||0||
59725251|NCT01098461|75844100|FG002|COMPLETED|Treatment Period (TP) (16 Weeks)||53||
59588896|NCT02207244|75696382|FG005|Nonresponders|Withdrawal and Re-treatment: Week 28-72||0||
59588897|NCT02207244|75696383|FG006|Nonresponders|Withdrawal and Re-treatment: Week 28-72||80||
59588898|NCT02207244|75696384|FG007|Nonresponders|Withdrawal and Re-treatment: Week 28-72||95||
59588899|NCT02207244|75696385|FG008|Nonresponders|Withdrawal and Re-treatment: Week 28-72||112||
59588900|NCT02207244|75696386|FG009|Nonresponders|Withdrawal and Re-treatment: Week 28-72||0||
59588901|NCT02207244|75696387|FG010|Nonresponders|Withdrawal and Re-treatment: Week 28-72||0||
59588902|NCT02207244|75696377|FG000|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0||
59588903|NCT02207244|75696378|FG001|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0||
59588904|NCT02207244|75696379|FG002|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0||
59588905|NCT02207244|75696380|FG003|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0||
59588906|NCT02207244|75696381|FG004|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0||
59588907|NCT02207244|75696382|FG005|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0||
59588908|NCT02207244|75696383|FG006|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0||
59588909|NCT02207244|75696384|FG007|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72|Participants randomized to withdrawal=182 and maintenance= 193|375||
59588910|NCT02207244|75696385|FG008|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0||
59588911|NCT02207244|75696386|FG009|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0||
59588912|NCT02207244|75696387|FG010|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0||
59588913|NCT02207244|75696377|FG000|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||0|These participants were re-treated with guselkumab at or before Week 72.|
59588914|NCT02207244|75696378|FG001|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||0|These participants were re-treated with guselkumab at or before Week 72.|
59588915|NCT02207244|75696379|FG002|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||0|These participants were re-treated with guselkumab at or before Week 72.|
59588916|NCT02207244|75696380|FG003|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||0|These participants were re-treated with guselkumab at or before Week 72.|
59588917|NCT02207244|75696381|FG004|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||0|These participants were re-treated with guselkumab at or before Week 72.|
59588918|NCT02207244|75696382|FG005|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||0|These participants were re-treated with guselkumab at or before Week 72.|
59588919|NCT02207244|75696383|FG006|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||147|These participants were re-treated with guselkumab at or before Week 72.|
59588920|NCT02207244|75696384|FG007|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||0|These participants were re-treated with guselkumab at or before Week 72.|
59588921|NCT02207244|75696385|FG008|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||108|These participants were re-treated with guselkumab at or before Week 72.|
59588922|NCT02207244|75696386|FG009|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||0|These participants were re-treated with guselkumab at or before Week 72.|
59588923|NCT02207244|75696387|FG010|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||0|These participants were re-treated with guselkumab at or before Week 72.|
59588924|NCT02207244|75696377|FG000|COMPLETED|Withdrawal and Re-treatment: Week 28-72||0||
59588925|NCT02207244|75696378|FG001|COMPLETED|Withdrawal and Re-treatment: Week 28-72||0||
59588926|NCT02207244|75696379|FG002|COMPLETED|Withdrawal and Re-treatment: Week 28-72||0||
59588927|NCT02207244|75696380|FG003|COMPLETED|Withdrawal and Re-treatment: Week 28-72||0||
59588928|NCT02207244|75696381|FG004|COMPLETED|Withdrawal and Re-treatment: Week 28-72||0||
59588929|NCT02207244|75696382|FG005|COMPLETED|Withdrawal and Re-treatment: Week 28-72||0||
59588930|NCT02207244|75696383|FG006|COMPLETED|Withdrawal and Re-treatment: Week 28-72||213||
59588931|NCT02207244|75696384|FG007|COMPLETED|Withdrawal and Re-treatment: Week 28-72||443||
59588932|NCT02207244|75696385|FG008|COMPLETED|Withdrawal and Re-treatment: Week 28-72||211||
59588933|NCT02207244|75696386|FG009|COMPLETED|Withdrawal and Re-treatment: Week 28-72||0||
59588934|NCT02207244|75696387|FG010|COMPLETED|Withdrawal and Re-treatment: Week 28-72||0||
59588935|NCT02207244|75696377|FG000|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||0||
59588936|NCT02207244|75696378|FG001|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||0||
59588937|NCT02207244|75696379|FG002|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||0||
59588938|NCT02207244|75696380|FG003|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||0||
59588939|NCT02207244|75696381|FG004|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||0||
59588940|NCT02207244|75696382|FG005|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||0||
59588941|NCT02207244|75696383|FG006|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||14||
59588942|NCT02207244|75696384|FG007|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||27||
59588943|NCT02207244|75696385|FG008|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||9||
59588944|NCT02207244|75696386|FG009|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||8||
59588945|NCT02207244|75696387|FG010|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||0||
59588946|NCT02207244|75696377|FG000|STARTED|Open-label Guselkumab: Week 72-264||0||
59588947|NCT02207244|75696378|FG001|STARTED|Open-label Guselkumab: Week 72-264||0||
59588948|NCT02207244|75696379|FG002|STARTED|Open-label Guselkumab: Week 72-264||0||
59588949|NCT02207244|75696380|FG003|STARTED|Open-label Guselkumab: Week 72-264||0||
59588950|NCT02207244|75696381|FG004|STARTED|Open-label Guselkumab: Week 72-264||0||
59588951|NCT02207244|75696382|FG005|STARTED|Open-label Guselkumab: Week 72-264||0||
59588952|NCT02207244|75696383|FG006|STARTED|Open-label Guselkumab: Week 72-264||0||
59588953|NCT02207244|75696384|FG007|STARTED|Open-label Guselkumab: Week 72-264||0||
59588954|NCT02207244|75696385|FG008|STARTED|Open-label Guselkumab: Week 72-264||211||
59588955|NCT02207244|75696386|FG009|STARTED|Open-label Guselkumab: Week 72-264||0||
59588956|NCT02207244|75696387|FG010|STARTED|Open-label Guselkumab: Week 72-264||656||
59588957|NCT02207244|75696377|FG000|COMPLETED|Open-label Guselkumab: Week 72-264||0||
59588958|NCT02207244|75696378|FG001|COMPLETED|Open-label Guselkumab: Week 72-264||0||
59588959|NCT02207244|75696379|FG002|COMPLETED|Open-label Guselkumab: Week 72-264||0||
59588960|NCT02207244|75696380|FG003|COMPLETED|Open-label Guselkumab: Week 72-264||0||
59588961|NCT02207244|75696381|FG004|COMPLETED|Open-label Guselkumab: Week 72-264||0||
59588962|NCT02207244|75696382|FG005|COMPLETED|Open-label Guselkumab: Week 72-264||0||
59588963|NCT02207244|75696383|FG006|COMPLETED|Open-label Guselkumab: Week 72-264||0||
59588964|NCT02207244|75696384|FG007|COMPLETED|Open-label Guselkumab: Week 72-264||0||
59588965|NCT02207244|75696385|FG008|COMPLETED|Open-label Guselkumab: Week 72-264||173||
59588966|NCT02207244|75696386|FG009|COMPLETED|Open-label Guselkumab: Week 72-264||0||
59588967|NCT02207244|75696387|FG010|COMPLETED|Open-label Guselkumab: Week 72-264||554||
59588968|NCT02207244|75696377|FG000|NOT COMPLETED|Open-label Guselkumab: Week 72-264||0||
59588969|NCT02207244|75696378|FG001|NOT COMPLETED|Open-label Guselkumab: Week 72-264||0||
59588970|NCT02207244|75696379|FG002|NOT COMPLETED|Open-label Guselkumab: Week 72-264||0||
59588971|NCT02207244|75696380|FG003|NOT COMPLETED|Open-label Guselkumab: Week 72-264||0||
59588972|NCT02207244|75696381|FG004|NOT COMPLETED|Open-label Guselkumab: Week 72-264||0||
59588973|NCT02207244|75696382|FG005|NOT COMPLETED|Open-label Guselkumab: Week 72-264||0||
59588974|NCT02207244|75696383|FG006|NOT COMPLETED|Open-label Guselkumab: Week 72-264||0||
59588975|NCT02207244|75696384|FG007|NOT COMPLETED|Open-label Guselkumab: Week 72-264||0||
59588976|NCT02207244|75696385|FG008|NOT COMPLETED|Open-label Guselkumab: Week 72-264||38||
59588977|NCT02207244|75696386|FG009|NOT COMPLETED|Open-label Guselkumab: Week 72-264||0||
59588978|NCT02207244|75696387|FG010|NOT COMPLETED|Open-label Guselkumab: Week 72-264||102||
59588979|NCT02638207|75696419|FG000|STARTED|Overall Study||35||
59588980|NCT02638207|75696420|FG001|STARTED|Overall Study||69||
59588981|NCT02638207|75696421|FG002|STARTED|Overall Study||38||
59588982|NCT02638207|75696419|FG000|COMPLETED|Overall Study||28||
59588983|NCT02638207|75696420|FG001|COMPLETED|Overall Study||61||
59588984|NCT02638207|75696421|FG002|COMPLETED|Overall Study||34||
59588985|NCT02638207|75696419|FG000|NOT COMPLETED|Overall Study||7||
59588986|NCT02638207|75696420|FG001|NOT COMPLETED|Overall Study||8||
59588987|NCT02638207|75696421|FG002|NOT COMPLETED|Overall Study||4||
59588988|NCT04363879|75696433|FG000|STARTED|Overall Study||78||
59588989|NCT04363879|75696434|FG001|STARTED|Overall Study||92||
59588990|NCT04363879|75696433|FG000|COMPLETED|Overall Study||78||
59588991|NCT04363879|75696434|FG001|COMPLETED|Overall Study||92||
59588992|NCT04363879|75696433|FG000|NOT COMPLETED|Overall Study||0||
59588993|NCT04363879|75696434|FG001|NOT COMPLETED|Overall Study||0||
59588994|NCT02207088|75696440|FG000|STARTED|Overall Study||68||
59588995|NCT02207088|75696440|FG000|COMPLETED|Overall Study||66||
59588996|NCT02207088|75696440|FG000|NOT COMPLETED|Overall Study||2||
59588997|NCT02638597|75696446|FG000|STARTED|Overall Study||8||
59588998|NCT02638597|75696447|FG001|STARTED|Overall Study||8||
59588999|NCT02638597|75696446|FG000|COMPLETED|Overall Study||4||
59589000|NCT02638597|75696447|FG001|COMPLETED|Overall Study||3||
59589001|NCT02638597|75696446|FG000|NOT COMPLETED|Overall Study||4||
59589002|NCT02638597|75696447|FG001|NOT COMPLETED|Overall Study||5||
59589003|NCT02206620|75696455|FG000|STARTED|Phase I - First Intervention (6 Weeks)||22||
59589004|NCT02206620|75696456|FG001|STARTED|Phase I - First Intervention (6 Weeks)||27||
59589005|NCT02206620|75696455|FG000|COMPLETED|Phase I - First Intervention (6 Weeks)||21||
59589006|NCT02206620|75696456|FG001|COMPLETED|Phase I - First Intervention (6 Weeks)||26||
59589007|NCT02206620|75696455|FG000|NOT COMPLETED|Phase I - First Intervention (6 Weeks)||1||
59589008|NCT02206620|75696456|FG001|NOT COMPLETED|Phase I - First Intervention (6 Weeks)||1||
59589009|NCT02206620|75696455|FG000|STARTED|Washout (6 Weeks)||21||
59855114|NCT00320255|75979780|FG001|COMPLETED|Overall Study||25||
59589010|NCT02206620|75696456|FG001|STARTED|Washout (6 Weeks)||26||
59589011|NCT02206620|75696455|FG000|COMPLETED|Washout (6 Weeks)||21||
59589012|NCT02206620|75696456|FG001|COMPLETED|Washout (6 Weeks)||26||
59589013|NCT02206620|75696455|FG000|NOT COMPLETED|Washout (6 Weeks)||0||
59589014|NCT02206620|75696456|FG001|NOT COMPLETED|Washout (6 Weeks)||0||
59589015|NCT02206620|75696455|FG000|STARTED|Phase II - Second Intervention (6 Weeks)||21||
59589016|NCT02206620|75696456|FG001|STARTED|Phase II - Second Intervention (6 Weeks)||26||
59589017|NCT02206620|75696455|FG000|COMPLETED|Phase II - Second Intervention (6 Weeks)||21||
59589018|NCT02206620|75696456|FG001|COMPLETED|Phase II - Second Intervention (6 Weeks)||24||
59589019|NCT02206620|75696455|FG000|NOT COMPLETED|Phase II - Second Intervention (6 Weeks)||0||
59589020|NCT02206620|75696456|FG001|NOT COMPLETED|Phase II - Second Intervention (6 Weeks)||2||
59589021|NCT02239926|75696470|FG000|STARTED|Overall Study||0||
59589022|NCT02239926|75696471|FG001|STARTED|Overall Study||2||
59589023|NCT02239926|75696470|FG000|COMPLETED|Overall Study||0||
59589024|NCT02239926|75696471|FG001|COMPLETED|Overall Study||1||
59589025|NCT02239926|75696470|FG000|NOT COMPLETED|Overall Study||0||
59589026|NCT02239926|75696471|FG001|NOT COMPLETED|Overall Study||1||
60121745|NCT01563029|76242696|FG000|NOT COMPLETED|Overall Study||53||
60121746|NCT01563029|76242697|FG001|NOT COMPLETED|Overall Study||24||
59589027|NCT02239692|75696479|FG000|STARTED|Overall Study||73||
59589028|NCT02239692|75696480|FG001|STARTED|Overall Study||131||
59589029|NCT02239692|75696479|FG000|Intention-to-treat Analysis Set|Overall Study||73||
59589030|NCT02239692|75696480|FG001|Intention-to-treat Analysis Set|Overall Study||131||
59855115|NCT00320255|75979781|FG002|COMPLETED|Overall Study||24||
59589031|NCT02239692|75696479|FG000|Per-protocol Analysis Set|Overall Study||66||
59589032|NCT02239692|75696480|FG001|Per-protocol Analysis Set|Overall Study||120||
59589033|NCT02239692|75696479|FG000|Safety Analysis Set|Overall Study||70||
59589034|NCT02239692|75696480|FG001|Safety Analysis Set|Overall Study||125||
59589035|NCT02239692|75696479|FG000|COMPLETED|Overall Study||67||
59589036|NCT02239692|75696480|FG001|COMPLETED|Overall Study||118||
59589037|NCT02239692|75696479|FG000|NOT COMPLETED|Overall Study||6||
59589038|NCT02239692|75696480|FG001|NOT COMPLETED|Overall Study||13||
59855116|NCT00320255|75979782|FG003|COMPLETED|Overall Study||25||
59855117|NCT00320255|75979783|FG004|COMPLETED|Overall Study||2||
59589039|NCT02641249|75696486|FG000|STARTED|Overall Study||19||
59589040|NCT02641249|75696486|FG000|COMPLETED|Overall Study||15||
59589041|NCT02641249|75696486|FG000|NOT COMPLETED|Overall Study||4||
59589042|NCT02641561|75696495|FG000|STARTED|Overall Study||48||
59589043|NCT02641561|75696496|FG001|STARTED|Overall Study||48||
59589044|NCT02641561|75696497|FG002|STARTED|Overall Study||48||
59589045|NCT02641561|75696498|FG003|STARTED|Overall Study||48||
59589046|NCT02641561|75696495|FG000|COMPLETED|Overall Study||48||
59589047|NCT02641561|75696496|FG001|COMPLETED|Overall Study||48||
59589048|NCT02641561|75696497|FG002|COMPLETED|Overall Study||48||
59589049|NCT02641561|75696498|FG003|COMPLETED|Overall Study||48||
59589050|NCT02641561|75696495|FG000|NOT COMPLETED|Overall Study||0||
59589051|NCT02641561|75696496|FG001|NOT COMPLETED|Overall Study||0||
59589052|NCT02641561|75696497|FG002|NOT COMPLETED|Overall Study||0||
59589053|NCT02641561|75696498|FG003|NOT COMPLETED|Overall Study||0||
59589054|NCT02206152|75696508|FG000|STARTED|Pre-Randomization||22||
59589055|NCT02206152|75696508|FG000|COMPLETED|Pre-Randomization||20||
59589056|NCT02206152|75696508|FG000|NOT COMPLETED|Pre-Randomization||2||
59589057|NCT02206152|75696508|FG000|STARTED|Placebo, Then NAC||10||
59589058|NCT02206152|75696508|FG000|COMPLETED|Placebo, Then NAC||10||
59589059|NCT02206152|75696508|FG000|NOT COMPLETED|Placebo, Then NAC||0||
59589060|NCT02206152|75696508|FG000|STARTED|NAC, Then Placebo||10||
59589061|NCT02206152|75696508|FG000|COMPLETED|NAC, Then Placebo||10||
59589062|NCT02206152|75696508|FG000|NOT COMPLETED|NAC, Then Placebo||0||
59589063|NCT02239536|75696516|FG000|STARTED|Overall Study||190||
59589064|NCT02239536|75696517|FG001|STARTED|Overall Study||172||
59589065|NCT02239536|75696516|FG000|COMPLETED|Overall Study||167||
59589066|NCT02239536|75696517|FG001|COMPLETED|Overall Study||155||
59589067|NCT02239536|75696516|FG000|NOT COMPLETED|Overall Study||23||
59589068|NCT02239536|75696517|FG001|NOT COMPLETED|Overall Study||17||
59589069|NCT02239224|75696527|FG000|STARTED|Overall Study||3||
59589070|NCT02239224|75696528|FG001|STARTED|Overall Study||6||
59589071|NCT02239224|75696529|FG002|STARTED|Overall Study||6||
59589072|NCT02239224|75696530|FG003|STARTED|Overall Study||5||
59589073|NCT02239224|75696527|FG000|Received at Least One Dose of Study Drug|Overall Study||3||
59589074|NCT02239224|75696528|FG001|Received at Least One Dose of Study Drug|Overall Study||6||
59589075|NCT02239224|75696529|FG002|Received at Least One Dose of Study Drug|Overall Study||6||
59589076|NCT02239224|75696530|FG003|Received at Least One Dose of Study Drug|Overall Study||5||
59589077|NCT02239224|75696527|FG000|COMPLETED|Overall Study||3||
59589078|NCT02239224|75696528|FG001|COMPLETED|Overall Study||6||
59589079|NCT02239224|75696529|FG002|COMPLETED|Overall Study||3||
59589080|NCT02239224|75696530|FG003|COMPLETED|Overall Study||4||
59589081|NCT02239224|75696527|FG000|NOT COMPLETED|Overall Study||0||
59589082|NCT02239224|75696528|FG001|NOT COMPLETED|Overall Study||0||
59589083|NCT02239224|75696529|FG002|NOT COMPLETED|Overall Study||3||
59589084|NCT02239224|75696530|FG003|NOT COMPLETED|Overall Study||1||
59589085|NCT01600014|75696540|FG000|STARTED|1. Cycle & Observation Period D1 to W52|Subjects completing W52 without having been administered a 2nd cycle are counted as completers.|450||
59589086|NCT01600014|75696541|FG001|STARTED|1. Cycle & Observation Period D1 to W52||0||
59589087|NCT01600014|75696540|FG000|COMPLETED|1. Cycle & Observation Period D1 to W52||162||
59589088|NCT01600014|75696541|FG001|COMPLETED|1. Cycle & Observation Period D1 to W52||0||
59589089|NCT01600014|75696540|FG000|NOT COMPLETED|1. Cycle & Observation Period D1 to W52||288||
59589090|NCT01600014|75696541|FG001|NOT COMPLETED|1. Cycle & Observation Period D1 to W52||0||
59589091|NCT01600014|75696540|FG000|STARTED|2. Cycle Recalcitrant Subgroup W8 to W52||92||
59589092|NCT01600014|75696541|FG001|STARTED|2. Cycle Recalcitrant Subgroup W8 to W52||49||
59589093|NCT01600014|75696540|FG000|COMPLETED|2. Cycle Recalcitrant Subgroup W8 to W52||80||
59589094|NCT01600014|75696541|FG001|COMPLETED|2. Cycle Recalcitrant Subgroup W8 to W52||39||
59589095|NCT01600014|75696540|FG000|NOT COMPLETED|2. Cycle Recalcitrant Subgroup W8 to W52||12||
59589096|NCT01600014|75696541|FG001|NOT COMPLETED|2. Cycle Recalcitrant Subgroup W8 to W52||10||
59589097|NCT01600014|75696540|FG000|STARTED|2. Cycl Recurrent Subgroup W26/44 to W52||42||
59589098|NCT01600014|75696541|FG001|STARTED|2. Cycl Recurrent Subgroup W26/44 to W52||20||
59589099|NCT01600014|75696540|FG000|COMPLETED|2. Cycl Recurrent Subgroup W26/44 to W52||39||
59589100|NCT01600014|75696541|FG001|COMPLETED|2. Cycl Recurrent Subgroup W26/44 to W52||20||
59589101|NCT01600014|75696540|FG000|NOT COMPLETED|2. Cycl Recurrent Subgroup W26/44 to W52||3||
59589102|NCT01600014|75696541|FG001|NOT COMPLETED|2. Cycl Recurrent Subgroup W26/44 to W52||0||
59589103|NCT02237196|75696563|FG000|STARTED|Overall Study||32||
59589104|NCT02237196|75696564|FG001|STARTED|Overall Study||31||
59589105|NCT02237196|75696565|FG002|STARTED|Overall Study||30||
59589106|NCT02237196|75696566|FG003|STARTED|Overall Study||28||
59589107|NCT02237196|75696563|FG000|COMPLETED|Overall Study||24||
59589108|NCT02237196|75696564|FG001|COMPLETED|Overall Study||25||
59589109|NCT02237196|75696565|FG002|COMPLETED|Overall Study||20||
59725252|NCT01098461|75844101|FG003|COMPLETED|Treatment Period (TP) (16 Weeks)||50||
59589110|NCT02237196|75696566|FG003|COMPLETED|Overall Study||17||
59589111|NCT02237196|75696563|FG000|NOT COMPLETED|Overall Study||8||
59589112|NCT02237196|75696564|FG001|NOT COMPLETED|Overall Study||6||
59589113|NCT02237196|75696565|FG002|NOT COMPLETED|Overall Study||10||
59589114|NCT02237196|75696566|FG003|NOT COMPLETED|Overall Study||11||
59589115|NCT02642575|75696576|FG000|STARTED|Overall Study||67||
59589116|NCT02642575|75696576|FG000|COMPLETED|Overall Study||67||
59589117|NCT02642575|75696576|FG000|NOT COMPLETED|Overall Study||0||
59589118|NCT02237118|75696582|FG000|STARTED|Overall Study||60||
59589119|NCT02237118|75696583|FG001|STARTED|Overall Study||63||
59589120|NCT02237118|75696582|FG000|COMPLETED|Overall Study||59||
59589121|NCT02237118|75696583|FG001|COMPLETED|Overall Study||62||
59589122|NCT02237118|75696582|FG000|NOT COMPLETED|Overall Study||1||
59589123|NCT02237118|75696583|FG001|NOT COMPLETED|Overall Study||1||
59589124|NCT02234622|75696599|FG000|STARTED|Overall Study||108||
59589125|NCT02234622|75696600|FG001|STARTED|Overall Study||104||
59589126|NCT02234622|75696599|FG000|COMPLETED|Overall Study||65||
59589127|NCT02234622|75696600|FG001|COMPLETED|Overall Study||68||
59589128|NCT02234622|75696599|FG000|NOT COMPLETED|Overall Study||43||
59589129|NCT02234622|75696600|FG001|NOT COMPLETED|Overall Study||36||
59589130|NCT02203032|75696608|FG000|STARTED|Open Label Run-in (Week 0 to Week 16)||872||
59589131|NCT02203032|75696609|FG001|STARTED|Open Label Run-in (Week 0 to Week 16)||0||
59589132|NCT02203032|75696610|FG002|STARTED|Open Label Run-in (Week 0 to Week 16)||0||
59589133|NCT02203032|75696611|FG003|STARTED|Open Label Run-in (Week 0 to Week 16)||0||
59589134|NCT02203032|75696608|FG000|Treated|Open Label Run-in (Week 0 to Week 16)||871||
59589135|NCT02203032|75696609|FG001|Treated|Open Label Run-in (Week 0 to Week 16)||0||
59589136|NCT02203032|75696610|FG002|Treated|Open Label Run-in (Week 0 to Week 16)||0||
59589137|NCT02203032|75696611|FG003|Treated|Open Label Run-in (Week 0 to Week 16)||0||
59589138|NCT02203032|75696608|FG000|COMPLETED|Open Label Run-in (Week 0 to Week 16)||853||
59589139|NCT02203032|75696609|FG001|COMPLETED|Open Label Run-in (Week 0 to Week 16)||0||
59589140|NCT02203032|75696610|FG002|COMPLETED|Open Label Run-in (Week 0 to Week 16)||0||
59589141|NCT02203032|75696611|FG003|COMPLETED|Open Label Run-in (Week 0 to Week 16)||0||
59589142|NCT02203032|75696608|FG000|NOT COMPLETED|Open Label Run-in (Week 0 to Week 16)||19||
59589143|NCT02203032|75696609|FG001|NOT COMPLETED|Open Label Run-in (Week 0 to Week 16)||0||
59589144|NCT02203032|75696610|FG002|NOT COMPLETED|Open Label Run-in (Week 0 to Week 16)||0||
59589145|NCT02203032|75696611|FG003|NOT COMPLETED|Open Label Run-in (Week 0 to Week 16)||0||
59589146|NCT02203032|75696608|FG000|STARTED|Blinded Phase (Week 16 to Week 44)||0||
59589147|NCT02203032|75696609|FG001|STARTED|Blinded Phase (Week 16 to Week 44)||135||
59589148|NCT02203032|75696610|FG002|STARTED|Blinded Phase (Week 16 to Week 44)||133||
59589149|NCT02203032|75696611|FG003|STARTED|Blinded Phase (Week 16 to Week 44)||585||
59589150|NCT02203032|75696608|FG000|COMPLETED|Blinded Phase (Week 16 to Week 44)||0||
59589151|NCT02203032|75696609|FG001|COMPLETED|Blinded Phase (Week 16 to Week 44)||120||
59589152|NCT02203032|75696610|FG002|COMPLETED|Blinded Phase (Week 16 to Week 44)||107||
59589153|NCT02203032|75696611|FG003|COMPLETED|Blinded Phase (Week 16 to Week 44)||539||
59589154|NCT02203032|75696608|FG000|NOT COMPLETED|Blinded Phase (Week 16 to Week 44)||0||
59589155|NCT02203032|75696609|FG001|NOT COMPLETED|Blinded Phase (Week 16 to Week 44)||15||
59589156|NCT02203032|75696610|FG002|NOT COMPLETED|Blinded Phase (Week 16 to Week 44)||26||
59589157|NCT02203032|75696611|FG003|NOT COMPLETED|Blinded Phase (Week 16 to Week 44)||46||
59589158|NCT02169414|75696623|FG000|STARTED|Overall Study||19||
59725253|NCT01098461|75844098|FG000|NOT COMPLETED|Treatment Period (TP) (16 Weeks)||12||
59725254|NCT01098461|75844099|FG001|NOT COMPLETED|Treatment Period (TP) (16 Weeks)||7||
59725255|NCT01098461|75844100|FG002|NOT COMPLETED|Treatment Period (TP) (16 Weeks)||1||
59725256|NCT01098461|75844101|FG003|NOT COMPLETED|Treatment Period (TP) (16 Weeks)||3||
59725257|NCT01098461|75844098|FG000|STARTED|Follow-up (FU) Period (8 Weeks)|Par. withdrawing from the TP could enter the FU Period. One par. did not participate in the FU.|52||
59725258|NCT01098461|75844099|FG001|STARTED|Follow-up (FU) Period (8 Weeks)||52||
59725259|NCT01098461|75844100|FG002|STARTED|Follow-up (FU) Period (8 Weeks)|Par. withdrawing from the TP could enter the FU Period. One par. did not participate in the FU.|53||
59725260|NCT01098461|75844101|FG003|STARTED|Follow-up (FU) Period (8 Weeks)|Par. withdrawing from the TP could enter the FU Period. One par. did not participate in the FU.|52||
60121747|NCT01563029|76242698|FG002|NOT COMPLETED|Overall Study||33||
60121748|NCT01563029|76242699|FG003|NOT COMPLETED|Overall Study||33||
59589159|NCT02169414|75696624|FG001|STARTED|Overall Study||19||
59589160|NCT02169414|75696625|FG002|STARTED|Overall Study||18||
59589161|NCT02169414|75696626|FG003|STARTED|Overall Study||18||
59589162|NCT02169414|75696623|FG000|BIA 9-1067 + Levodopa/Carbidopa|Overall Study||18||
59589163|NCT02169414|75696624|FG001|BIA 9-1067 + Levodopa/Carbidopa|Overall Study||19||
59589164|NCT02169414|75696625|FG002|BIA 9-1067 + Levodopa/Carbidopa|Overall Study||18||
59589165|NCT02169414|75696626|FG003|BIA 9-1067 + Levodopa/Carbidopa|Overall Study||18||
59589166|NCT02169414|75696623|FG000|BIA 9-1067 + Levodopa/Benserazide|Overall Study||18||
59589167|NCT02169414|75696624|FG001|BIA 9-1067 + Levodopa/Benserazide|Overall Study||18||
59589168|NCT02169414|75696625|FG002|BIA 9-1067 + Levodopa/Benserazide|Overall Study||18||
59589169|NCT02169414|75696626|FG003|BIA 9-1067 + Levodopa/Benserazide|Overall Study||18||
59589170|NCT02169414|75696623|FG000|COMPLETED|Overall Study||18||
59589171|NCT02169414|75696624|FG001|COMPLETED|Overall Study||18||
59589172|NCT02169414|75696625|FG002|COMPLETED|Overall Study||18||
59589173|NCT02169414|75696626|FG003|COMPLETED|Overall Study||18||
59725261|NCT01098461|75844098|FG000|COMPLETED|Follow-up (FU) Period (8 Weeks)||52||
59725262|NCT01098461|75844099|FG001|COMPLETED|Follow-up (FU) Period (8 Weeks)||49||
59589174|NCT02169414|75696623|FG000|NOT COMPLETED|Overall Study||1||
59589175|NCT02169414|75696624|FG001|NOT COMPLETED|Overall Study||1||
59589176|NCT02169414|75696625|FG002|NOT COMPLETED|Overall Study||0||
59589177|NCT02169414|75696626|FG003|NOT COMPLETED|Overall Study||0||
59589178|NCT02201940|75696642|FG000|STARTED|Overall Study||625||
59589179|NCT02201940|75696643|FG001|STARTED|Overall Study||116||
59589180|NCT02201940|75696642|FG000|COMPLETED|Overall Study||613||
59589181|NCT02201940|75696643|FG001|COMPLETED|Overall Study||0||
59589182|NCT02201940|75696642|FG000|NOT COMPLETED|Overall Study||12||
59589183|NCT02201940|75696643|FG001|NOT COMPLETED|Overall Study||116||
59589184|NCT02232984|75696649|FG000|STARTED|Overall Study|Enrolled subjects|749||
59589185|NCT02232984|75696649|FG000|Successfully Implanted|Overall Study|Successfully implanted subjects|675||
59589186|NCT02232984|75696649|FG000|COMPLETED|Overall Study|Total number of subjects who completed study|672||
59589187|NCT02232984|75696649|FG000|NOT COMPLETED|Overall Study||77||
59589188|NCT02169336|75696659|FG000|STARTED|Overall Study||31||
59589189|NCT02169336|75696660|FG001|STARTED|Overall Study||32||
59589190|NCT02169336|75696661|FG002|STARTED|Overall Study||32||
59589191|NCT02169336|75696659|FG000|COMPLETED|Overall Study||27||
59589192|NCT02169336|75696660|FG001|COMPLETED|Overall Study||28||
59589193|NCT02169336|75696661|FG002|COMPLETED|Overall Study||29||
59589194|NCT02169336|75696659|FG000|NOT COMPLETED|Overall Study||4||
59589195|NCT02169336|75696660|FG001|NOT COMPLETED|Overall Study||4||
59589196|NCT02169336|75696661|FG002|NOT COMPLETED|Overall Study||3||
59589197|NCT03043807|75696669|FG000|STARTED|Overall Study||26||
59589198|NCT03043807|75696669|FG000|COMPLETED|Overall Study||25||
59589199|NCT03043807|75696669|FG000|NOT COMPLETED|Overall Study||1||
59589200|NCT02609828|75696677|FG000|STARTED|Overall Study||74||
59589201|NCT02609828|75696678|FG001|STARTED|Overall Study|A total of 10 participants were initially randomized to this arm. This arm was discontinued per protocol amendment 3. At time of amendment, out of 10 participants, 1 participant was still in treatment with tanezumab 10 mg. Post-amendment, this participant continued treatment with tanezumab 20 mg and was included in tanezumab 10/20 mg arm.|9||
59589202|NCT02609828|75696679|FG002|STARTED|Overall Study|The participant switched to this arm from tanezumab 10 mg post protocol amendment 3 implementation for remaining doses.|1||
59589203|NCT02609828|75696680|FG003|STARTED|Overall Study||72||
59589204|NCT02609828|75696677|FG000|Treated|Overall Study||73||
59589205|NCT02609828|75696678|FG001|Treated|Overall Study||9||
59589206|NCT02609828|75696679|FG002|Treated|Overall Study||1||
59589207|NCT02609828|75696680|FG003|Treated|Overall Study||72||
59589208|NCT02609828|75696677|FG000|COMPLETED|Overall Study||31||
59589209|NCT02609828|75696678|FG001|COMPLETED|Overall Study||5||
59589210|NCT02609828|75696679|FG002|COMPLETED|Overall Study||0||
59589211|NCT02609828|75696680|FG003|COMPLETED|Overall Study||29||
59589212|NCT02609828|75696677|FG000|NOT COMPLETED|Overall Study||43||
59589213|NCT02609828|75696678|FG001|NOT COMPLETED|Overall Study||4||
59589214|NCT02609828|75696679|FG002|NOT COMPLETED|Overall Study||1||
59589215|NCT02609828|75696680|FG003|NOT COMPLETED|Overall Study||43||
59589216|NCT01632306|75696696|FG000|STARTED|Overall Study||3||
59589217|NCT01632306|75696697|FG001|STARTED|Overall Study||10||
59589218|NCT01632306|75696698|FG002|STARTED|Overall Study||0||
59589219|NCT01632306|75696696|FG000|Received at Least One Dose of Study Drug|Overall Study||3||
59589220|NCT01632306|75696697|FG001|Received at Least One Dose of Study Drug|Overall Study||10||
59589221|NCT01632306|75696698|FG002|Received at Least One Dose of Study Drug|Overall Study||0||
59589222|NCT01632306|75696696|FG000|COMPLETED|Overall Study||2||
59589223|NCT01632306|75696697|FG001|COMPLETED|Overall Study||10||
59589224|NCT01632306|75696698|FG002|COMPLETED|Overall Study||0||
59589225|NCT01632306|75696696|FG000|NOT COMPLETED|Overall Study||1||
59589226|NCT01632306|75696697|FG001|NOT COMPLETED|Overall Study||0||
59589227|NCT01632306|75696698|FG002|NOT COMPLETED|Overall Study||0||
59589228|NCT02201784|75696706|FG000|STARTED|Overall Study||30||
59589229|NCT02201784|75696707|FG001|STARTED|Overall Study||30||
59589230|NCT02201784|75696706|FG000|COMPLETED|Overall Study||28||
59589231|NCT02201784|75696707|FG001|COMPLETED|Overall Study||30||
59589232|NCT02201784|75696706|FG000|NOT COMPLETED|Overall Study||2||
59855118|NCT00320255|75979784|FG005|COMPLETED|Overall Study||3||
59855119|NCT00320255|75979779|FG000|NOT COMPLETED|Overall Study||11||
59589233|NCT02201784|75696707|FG001|NOT COMPLETED|Overall Study||0||
59589234|NCT02201472|75696713|FG000|STARTED|Overall Study||2||
59589235|NCT02201472|75696713|FG000|COMPLETED|Overall Study||0||
59589236|NCT02201472|75696713|FG000|NOT COMPLETED|Overall Study||2||
59589237|NCT02647346|75696717|FG000|STARTED|Overall Study||132||
59589238|NCT02647346|75696717|FG000|COMPLETED|Overall Study||129||
59589239|NCT02647346|75696717|FG000|NOT COMPLETED|Overall Study||3||
59589240|NCT02649608|75696721|FG000|STARTED|Overall Study||2||
59855120|NCT00320255|75979780|FG001|NOT COMPLETED|Overall Study||7||
59855121|NCT00320255|75979781|FG002|NOT COMPLETED|Overall Study||6||
59855122|NCT00320255|75979782|FG003|NOT COMPLETED|Overall Study||8||
59589241|NCT02649608|75696722|FG001|STARTED|Overall Study||1||
59589242|NCT02649608|75696723|FG002|STARTED|Overall Study||3||
59589243|NCT02649608|75696724|FG003|STARTED|Overall Study||3||
59589244|NCT02649608|75696725|FG004|STARTED|Overall Study||3||
59589245|NCT02649608|75696726|FG005|STARTED|Overall Study||2||
59589246|NCT02649608|75696727|FG006|STARTED|Overall Study||1||
59589247|NCT02649608|75696721|FG000|COMPLETED|Overall Study||2||
59589248|NCT02649608|75696722|FG001|COMPLETED|Overall Study||1||
59589249|NCT02649608|75696723|FG002|COMPLETED|Overall Study||3||
59589250|NCT02649608|75696724|FG003|COMPLETED|Overall Study||3||
59589251|NCT02649608|75696725|FG004|COMPLETED|Overall Study||3||
59589252|NCT02649608|75696726|FG005|COMPLETED|Overall Study||2||
59589253|NCT02649608|75696727|FG006|COMPLETED|Overall Study||1||
59589254|NCT02649608|75696721|FG000|NOT COMPLETED|Overall Study||0||
59589255|NCT02649608|75696722|FG001|NOT COMPLETED|Overall Study||0||
59589256|NCT02649608|75696723|FG002|NOT COMPLETED|Overall Study||0||
59589257|NCT02649608|75696724|FG003|NOT COMPLETED|Overall Study||0||
59589258|NCT02649608|75696725|FG004|NOT COMPLETED|Overall Study||0||
59589259|NCT02649608|75696726|FG005|NOT COMPLETED|Overall Study||0||
59589260|NCT02649608|75696727|FG006|NOT COMPLETED|Overall Study||0||
59589261|NCT02168946|75696758|FG000|STARTED|Overall Study|2 additional subjects were randomized to Vabomere but did not receive study drug|50||
59589262|NCT02168946|75696759|FG001|STARTED|Overall Study||25||
59589263|NCT02168946|75696758|FG000|COMPLETED|Overall Study||38||
59589264|NCT02168946|75696759|FG001|COMPLETED|Overall Study||20||
59589265|NCT02168946|75696758|FG000|NOT COMPLETED|Overall Study||12||
59589266|NCT02168946|75696759|FG001|NOT COMPLETED|Overall Study||5||
59589267|NCT02649842|75696765|FG000|STARTED|Overall Study||101||
59589268|NCT02649842|75696765|FG000|COMPLETED|Overall Study||101||
59589269|NCT02649842|75696765|FG000|NOT COMPLETED|Overall Study||0||
59589270|NCT02650856|75696773|FG000|STARTED|Overall Study||19||
59589271|NCT02650856|75696774|FG001|STARTED|Overall Study||21||
59589272|NCT02650856|75696773|FG000|Baseline|Overall Study||19||
59589273|NCT02650856|75696774|FG001|Baseline|Overall Study||21||
59589274|NCT02650856|75696773|FG000|24 Hours|Overall Study||19||
59589275|NCT02650856|75696774|FG001|24 Hours|Overall Study||21||
59589276|NCT02650856|75696773|FG000|48 Hours|Overall Study||19||
59589277|NCT02650856|75696774|FG001|48 Hours|Overall Study||21||
59589278|NCT02650856|75696773|FG000|72 Hours|Overall Study||19||
59589279|NCT02650856|75696774|FG001|72 Hours|Overall Study||21||
59589280|NCT02650856|75696773|FG000|COMPLETED|Overall Study||19||
59589281|NCT02650856|75696774|FG001|COMPLETED|Overall Study||21||
59589282|NCT02650856|75696773|FG000|NOT COMPLETED|Overall Study||0||
59589283|NCT02650856|75696774|FG001|NOT COMPLETED|Overall Study||0||
59589284|NCT02168478|75696780|FG000|STARTED|Overall Study||206||
59589285|NCT02168478|75696780|FG000|COMPLETED|Overall Study||202||
59589286|NCT02168478|75696780|FG000|NOT COMPLETED|Overall Study||4||
59589287|NCT02152670|75696784|FG000|STARTED|Overall Study||1||
60121749|NCT01563029|76242700|FG004|NOT COMPLETED|Overall Study||29||
59589288|NCT02152670|75696784|FG000|COMPLETED|Overall Study||1||
59589289|NCT02152670|75696784|FG000|NOT COMPLETED|Overall Study||0||
59589290|NCT02652416|75696792|FG000|STARTED|Overall Study||18||
59589291|NCT02652416|75696793|FG001|STARTED|Overall Study||18||
59589292|NCT02652416|75696794|FG002|STARTED|Overall Study||18||
59589293|NCT02652416|75696795|FG003|STARTED|Overall Study||18||
59589294|NCT02652416|75696792|FG000|Subjects Who Participated in MD Part|Overall Study||6|All subjects who participated in the 100 mg dose group of SRD part continued in the MD part|
59589295|NCT02652416|75696793|FG001|Subjects Who Participated in MD Part|Overall Study||0|All subjects who participated in the 100 mg dose group of SRD part continued in the MD part|
59589296|NCT02652416|75696794|FG002|Subjects Who Participated in MD Part|Overall Study||0|All subjects who participated in the 100 mg dose group of SRD part continued in the MD part|
59589297|NCT02652416|75696795|FG003|Subjects Who Participated in MD Part|Overall Study||18|All subjects who participated in the 100 mg dose group of SRD part continued in the MD part|
59589298|NCT02652416|75696792|FG000|COMPLETED|Overall Study||18||
59589299|NCT02652416|75696793|FG001|COMPLETED|Overall Study||18||
59589300|NCT02652416|75696794|FG002|COMPLETED|Overall Study||18||
59589301|NCT02652416|75696795|FG003|COMPLETED|Overall Study||18||
59589302|NCT02652416|75696792|FG000|NOT COMPLETED|Overall Study||0||
59589303|NCT02652416|75696793|FG001|NOT COMPLETED|Overall Study||0||
59589304|NCT02652416|75696794|FG002|NOT COMPLETED|Overall Study||0||
59589305|NCT02652416|75696795|FG003|NOT COMPLETED|Overall Study||0||
59589306|NCT02656160|75696809|FG000|STARTED|First Study Night||7||
59589307|NCT02656160|75696810|FG001|STARTED|First Study Night||6||
59589308|NCT02656160|75696809|FG000|COMPLETED|First Study Night||7||
59589309|NCT02656160|75696810|FG001|COMPLETED|First Study Night||6||
59589310|NCT02656160|75696809|FG000|NOT COMPLETED|First Study Night||0||
59589311|NCT02656160|75696810|FG001|NOT COMPLETED|First Study Night||0||
59589312|NCT02656160|75696809|FG000|STARTED|Second Study Night|3 subjects did not return for the second study night|4||
59589313|NCT02656160|75696810|FG001|STARTED|Second Study Night||6||
59589314|NCT02656160|75696809|FG000|COMPLETED|Second Study Night||4||
60121750|NCT01562873|76242713|FG000|STARTED|Overall Study||21||
59589315|NCT02656160|75696810|FG001|COMPLETED|Second Study Night||6||
59589316|NCT02656160|75696809|FG000|NOT COMPLETED|Second Study Night||0||
59725263|NCT01098461|75844100|FG002|COMPLETED|Follow-up (FU) Period (8 Weeks)||52||
59589317|NCT02656160|75696810|FG001|NOT COMPLETED|Second Study Night||0||
59589318|NCT02684396|75696822|FG000|STARTED|Overall Study||6||
59589319|NCT02684396|75696823|FG001|STARTED|Overall Study||6||
59589320|NCT02684396|75696824|FG002|STARTED|Overall Study||6||
59589321|NCT02684396|75696825|FG003|STARTED|Overall Study||6||
59589322|NCT02684396|75696826|FG004|STARTED|Overall Study||5||
59589323|NCT02684396|75696827|FG005|STARTED|Overall Study||10||
59589324|NCT02684396|75696822|FG000|COMPLETED|Overall Study||6||
59589325|NCT02684396|75696823|FG001|COMPLETED|Overall Study||6||
59589326|NCT02684396|75696824|FG002|COMPLETED|Overall Study||6||
59589327|NCT02684396|75696825|FG003|COMPLETED|Overall Study||6||
59589328|NCT02684396|75696826|FG004|COMPLETED|Overall Study||5||
59589329|NCT02684396|75696827|FG005|COMPLETED|Overall Study||10||
59589330|NCT02684396|75696822|FG000|NOT COMPLETED|Overall Study||0||
59589331|NCT02684396|75696823|FG001|NOT COMPLETED|Overall Study||0||
59589332|NCT02684396|75696824|FG002|NOT COMPLETED|Overall Study||0||
59589333|NCT02684396|75696825|FG003|NOT COMPLETED|Overall Study||0||
59589334|NCT02684396|75696826|FG004|NOT COMPLETED|Overall Study||0||
59589335|NCT02684396|75696827|FG005|NOT COMPLETED|Overall Study||0||
59589336|NCT02657252|75696843|FG000|STARTED|Overall Study||57||57
59589337|NCT02657252|75696844|FG001|STARTED|Overall Study||58||58
59589338|NCT02657252|75696843|FG000|COMPLETED|Overall Study||47||47
59589339|NCT02657252|75696844|FG001|COMPLETED|Overall Study||51||51
59589340|NCT02657252|75696843|FG000|NOT COMPLETED|Overall Study||10||10
59589341|NCT02657252|75696844|FG001|NOT COMPLETED|Overall Study||7||7
59589342|NCT02657564|75696850|FG000|STARTED|Overall Study||1237||
59589343|NCT02657564|75696850|FG000|COMPLETED|Overall Study||1163||
59589344|NCT02657564|75696850|FG000|NOT COMPLETED|Overall Study||74||
59589345|NCT02684630|75696857|FG000|STARTED|Overall Study||65||
59589346|NCT02684630|75696858|FG001|STARTED|Overall Study||63||
59589347|NCT02684630|75696857|FG000|COMPLETED|Overall Study||60||
59589348|NCT02684630|75696858|FG001|COMPLETED|Overall Study||60||
59589349|NCT02684630|75696857|FG000|NOT COMPLETED|Overall Study||5||
59589350|NCT02684630|75696858|FG001|NOT COMPLETED|Overall Study||3||
59589351|NCT02684942|75696866|FG000|STARTED|Overall Study||7||
59589352|NCT02684942|75696867|FG001|STARTED|Overall Study||7||
59589353|NCT02684942|75696868|FG002|STARTED|Overall Study||7||
59589354|NCT02684942|75696869|FG003|STARTED|Overall Study||7||
59589355|NCT02684942|75696870|FG004|STARTED|Overall Study||6||
59589356|NCT02684942|75696871|FG005|STARTED|Overall Study||6||
59589357|NCT02684942|75696866|FG000|COMPLETED|Overall Study||7||
59589358|NCT02684942|75696867|FG001|COMPLETED|Overall Study||7||
59589359|NCT02684942|75696868|FG002|COMPLETED|Overall Study||7||
59589360|NCT02684942|75696869|FG003|COMPLETED|Overall Study||7||
59589361|NCT02684942|75696870|FG004|COMPLETED|Overall Study||6||
59589362|NCT02684942|75696871|FG005|COMPLETED|Overall Study||6||
59589363|NCT02684942|75696866|FG000|NOT COMPLETED|Overall Study||0||
59589364|NCT02684942|75696867|FG001|NOT COMPLETED|Overall Study||0||
59589365|NCT02684942|75696868|FG002|NOT COMPLETED|Overall Study||0||
59725264|NCT01098461|75844101|FG003|COMPLETED|Follow-up (FU) Period (8 Weeks)||52||
59725265|NCT01098461|75844098|FG000|NOT COMPLETED|Follow-up (FU) Period (8 Weeks)||0||
59725266|NCT01098461|75844099|FG001|NOT COMPLETED|Follow-up (FU) Period (8 Weeks)||3||
59725267|NCT01098461|75844100|FG002|NOT COMPLETED|Follow-up (FU) Period (8 Weeks)||1||
59855123|NCT00320255|75979783|FG004|NOT COMPLETED|Overall Study||0||
59589366|NCT02684942|75696869|FG003|NOT COMPLETED|Overall Study||0||
59589367|NCT02684942|75696870|FG004|NOT COMPLETED|Overall Study||0||
59589368|NCT02684942|75696871|FG005|NOT COMPLETED|Overall Study||0||
59589369|NCT02685956|75696884|FG000|STARTED|Overall Study||317||
59589370|NCT02685956|75696885|FG001|STARTED|Overall Study||1978||
59589371|NCT02685956|75696884|FG000|COMPLETED|Overall Study||317||
59589372|NCT02685956|75696885|FG001|COMPLETED|Overall Study||1978||
59589373|NCT02685956|75696884|FG000|NOT COMPLETED|Overall Study||0||
59589374|NCT02685956|75696885|FG001|NOT COMPLETED|Overall Study||0||
59725268|NCT01098461|75844101|FG003|NOT COMPLETED|Follow-up (FU) Period (8 Weeks)||0||
59725269|NCT01098305|75844114|FG000|STARTED|Overall Study||119||
59725270|NCT01098305|75844115|FG001|STARTED|Overall Study||118||
59725271|NCT01098305|75844114|FG000|COMPLETED|Overall Study||88||
59725272|NCT01098305|75844115|FG001|COMPLETED|Overall Study||85||
59589375|NCT02660918|75696895|FG000|STARTED|Overall Study||42||
59589376|NCT02660918|75696896|FG001|STARTED|Overall Study||42||
59725273|NCT01098305|75844114|FG000|NOT COMPLETED|Overall Study||31||
59589377|NCT02660918|75696895|FG000|COMPLETED|Overall Study|Age ineligible|41||
59589378|NCT02660918|75696896|FG001|COMPLETED|Overall Study|Age ineligible|41||
59589379|NCT02660918|75696895|FG000|NOT COMPLETED|Overall Study||1||
59589380|NCT02660918|75696896|FG001|NOT COMPLETED|Overall Study||1||
59589381|NCT02687126|75696903|FG000|STARTED|Data Collection||106||
59589382|NCT02687126|75696903|FG000|COMPLETED|Data Collection||106||
59855124|NCT00320255|75979784|FG005|NOT COMPLETED|Overall Study||0||
59589383|NCT02687126|75696903|FG000|NOT COMPLETED|Data Collection||0||
59589384|NCT02687126|75696903|FG000|STARTED|Data Analysis||106||
59589385|NCT02687126|75696903|FG000|COMPLETED|Data Analysis||106||
59589386|NCT02687126|75696903|FG000|NOT COMPLETED|Data Analysis||0||
59589387|NCT02688218|75696912|FG000|STARTED|First Exercise Intervention (2 Hours)||24||
59589388|NCT02688218|75696913|FG001|STARTED|First Exercise Intervention (2 Hours)||6||
59589389|NCT02688218|75696912|FG000|COMPLETED|First Exercise Intervention (2 Hours)||24||
59589390|NCT02688218|75696913|FG001|COMPLETED|First Exercise Intervention (2 Hours)||6||
59589391|NCT02688218|75696912|FG000|NOT COMPLETED|First Exercise Intervention (2 Hours)||0||
59589392|NCT02688218|75696913|FG001|NOT COMPLETED|First Exercise Intervention (2 Hours)||0||
59589393|NCT02688218|75696912|FG000|STARTED|Washout (30 Minutes)||24||
59589394|NCT02688218|75696913|FG001|STARTED|Washout (30 Minutes)||6||
59589395|NCT02688218|75696912|FG000|COMPLETED|Washout (30 Minutes)||24||
59589396|NCT02688218|75696913|FG001|COMPLETED|Washout (30 Minutes)||6||
59589397|NCT02688218|75696912|FG000|NOT COMPLETED|Washout (30 Minutes)||0||
59589398|NCT02688218|75696913|FG001|NOT COMPLETED|Washout (30 Minutes)||0||
59589399|NCT02688218|75696912|FG000|STARTED|Second Exercise Intervention (2 Hours)||24||
59589400|NCT02688218|75696913|FG001|STARTED|Second Exercise Intervention (2 Hours)||6||
59589401|NCT02688218|75696912|FG000|COMPLETED|Second Exercise Intervention (2 Hours)||24||
59589402|NCT02688218|75696913|FG001|COMPLETED|Second Exercise Intervention (2 Hours)||6||
59589403|NCT02688218|75696912|FG000|NOT COMPLETED|Second Exercise Intervention (2 Hours)||0||
59589404|NCT02688218|75696913|FG001|NOT COMPLETED|Second Exercise Intervention (2 Hours)||0||
59589405|NCT02662244|75696919|FG000|STARTED|Overall Study||33||
59589406|NCT02662244|75696919|FG000|COMPLETED|Overall Study||31||
59589407|NCT02662244|75696919|FG000|NOT COMPLETED|Overall Study||2||
59589408|NCT01328587|75696925|FG000|STARTED|Overall Study||34||
59589409|NCT01328587|75696925|FG000|COMPLETED|Overall Study||34||
59589410|NCT01328587|75696925|FG000|NOT COMPLETED|Overall Study||0||
59589411|NCT02685007|75696929|FG000|STARTED|Overall Study||131||
59589412|NCT02685007|75696929|FG000|COMPLETED|Overall Study||131||
59589413|NCT02685007|75696929|FG000|NOT COMPLETED|Overall Study||0||
59589414|NCT02665364|75696935|FG000|STARTED|Overall Study||91||
59589415|NCT02665364|75696936|FG001|STARTED|Overall Study||93||
59589416|NCT02665364|75696935|FG000|COMPLETED|Overall Study||85||
59589417|NCT02665364|75696936|FG001|COMPLETED|Overall Study||84||
59589418|NCT02665364|75696935|FG000|NOT COMPLETED|Overall Study||6||
59589419|NCT02665364|75696936|FG001|NOT COMPLETED|Overall Study||9||
59589420|NCT02688829|75696942|FG000|STARTED|Overall Study||21||
59589421|NCT02688829|75696942|FG000|COMPLETED|Overall Study||19||
59589422|NCT02688829|75696942|FG000|NOT COMPLETED|Overall Study||2||
59589423|NCT02689063|75696950|FG000|STARTED|Overall Study||75||
59589424|NCT02689063|75696951|FG001|STARTED|Overall Study||75||
59589425|NCT02689063|75696952|FG002|STARTED|Overall Study||76||
59589426|NCT02689063|75696953|FG003|STARTED|Overall Study||50||
59589427|NCT02689063|75696950|FG000|COMPLETED|Overall Study||75||
59589428|NCT02689063|75696951|FG001|COMPLETED|Overall Study||73||
59589429|NCT02689063|75696952|FG002|COMPLETED|Overall Study||73||
59589430|NCT02689063|75696953|FG003|COMPLETED|Overall Study||50||
59589431|NCT02689063|75696950|FG000|NOT COMPLETED|Overall Study||0||
59589432|NCT02689063|75696951|FG001|NOT COMPLETED|Overall Study||2||
59589433|NCT02689063|75696952|FG002|NOT COMPLETED|Overall Study||3||
59589434|NCT02689063|75696953|FG003|NOT COMPLETED|Overall Study||0||
59589435|NCT02643199|75696963|FG000|STARTED|Overall Study||90||
59589436|NCT02643199|75696963|FG000|COMPLETED|Overall Study||90||
59589437|NCT02643199|75696963|FG000|NOT COMPLETED|Overall Study||0||
59589438|NCT02690935|75696969|FG000|STARTED|Overall Study|Count of participants|51||
59589439|NCT02690935|75696970|FG001|STARTED|Overall Study|Count of participants|51||
59589440|NCT02690935|75696969|FG000|COMPLETED|Overall Study|Count of participants|51||
59589441|NCT02690935|75696970|FG001|COMPLETED|Overall Study|Count of participants|51||
59589442|NCT02690935|75696969|FG000|NOT COMPLETED|Overall Study||0||
59589443|NCT02690935|75696970|FG001|NOT COMPLETED|Overall Study||0||
59589444|NCT02666846|75696979|FG000|STARTED|Overall Study||20||
59589445|NCT02666846|75696980|FG001|STARTED|Overall Study||20||
59589446|NCT02666846|75696981|FG002|STARTED|Overall Study||20||
59589447|NCT02666846|75696979|FG000|COMPLETED|Overall Study||20||
59589448|NCT02666846|75696980|FG001|COMPLETED|Overall Study||20||
59589449|NCT02666846|75696981|FG002|COMPLETED|Overall Study||20||
59589450|NCT02666846|75696979|FG000|NOT COMPLETED|Overall Study||0||
59589451|NCT02666846|75696980|FG001|NOT COMPLETED|Overall Study||0||
59589452|NCT02666846|75696981|FG002|NOT COMPLETED|Overall Study||0||
59589453|NCT02643979|75697013|FG000|STARTED|Overall Study||11||
59589454|NCT02643979|75697014|FG001|STARTED|Overall Study||11||
59589455|NCT02643979|75697013|FG000|COMPLETED|Overall Study||11||
59589456|NCT02643979|75697014|FG001|COMPLETED|Overall Study||11||
59589457|NCT02643979|75697013|FG000|NOT COMPLETED|Overall Study||0||
59589458|NCT02643979|75697014|FG001|NOT COMPLETED|Overall Study||0||
59589459|NCT02667392|75697020|FG000|STARTED|Overall Study||11||
59589460|NCT02667392|75697020|FG000|COMPLETED|Overall Study||11||
59589461|NCT02667392|75697020|FG000|NOT COMPLETED|Overall Study||0||
59589462|NCT02692495|75697026|FG000|STARTED|Overall Study||12||
59589463|NCT02692495|75697027|FG001|STARTED|Overall Study||4||
59589464|NCT02692495|75697026|FG000|COMPLETED|Overall Study||12||
59589465|NCT02692495|75697027|FG001|COMPLETED|Overall Study||4||
59589466|NCT02692495|75697026|FG000|NOT COMPLETED|Overall Study||0||
59589467|NCT02692495|75697027|FG001|NOT COMPLETED|Overall Study||0||
59589468|NCT02667704|75697037|FG000|STARTED|Treatment Period 1||13||
59589469|NCT02667704|75697037|FG000|COMPLETED|Treatment Period 1||13||
59589470|NCT02667704|75697037|FG000|NOT COMPLETED|Treatment Period 1||0||
59589471|NCT02667704|75697037|FG000|STARTED|Treatment Period 2||13||
59589472|NCT02667704|75697037|FG000|COMPLETED|Treatment Period 2||13||
59589473|NCT02667704|75697037|FG000|NOT COMPLETED|Treatment Period 2||0||
59589474|NCT02645617|75697044|FG000|STARTED|Overall Study||12||
59589475|NCT02645617|75697044|FG000|COMPLETED|Overall Study||12||
59589476|NCT02645617|75697044|FG000|NOT COMPLETED|Overall Study||0||
59589477|NCT02668952|75697050|FG000|STARTED|Overall Study||16||
59589478|NCT02668952|75697051|FG001|STARTED|Overall Study||14||
59589479|NCT02668952|75697050|FG000|COMPLETED|Overall Study||16||
59589480|NCT02668952|75697051|FG001|COMPLETED|Overall Study||14||
59589481|NCT02668952|75697050|FG000|NOT COMPLETED|Overall Study||0||
59589482|NCT02668952|75697051|FG001|NOT COMPLETED|Overall Study||0||
59589483|NCT02648971|75697059|FG000|STARTED|Overall Study||18||
59589484|NCT02648971|75697060|FG001|STARTED|Overall Study||18||
59589485|NCT02648971|75697059|FG000|COMPLETED|Overall Study||18||
59589486|NCT02648971|75697060|FG001|COMPLETED|Overall Study||18||
59589487|NCT02648971|75697059|FG000|NOT COMPLETED|Overall Study||0||
59589488|NCT02648971|75697060|FG001|NOT COMPLETED|Overall Study||0||
59589489|NCT02689154|75697066|FG000|STARTED|Overall Study||18||
59589490|NCT02689154|75697066|FG000|COMPLETED|Overall Study||18||
59589491|NCT02689154|75697066|FG000|NOT COMPLETED|Overall Study||0||
59589492|NCT02694445|75697070|FG000|STARTED|Overall Study||3098||
59589493|NCT02694445|75697070|FG000|COMPLETED|Overall Study||3046||
59589494|NCT02694445|75697070|FG000|NOT COMPLETED|Overall Study||52||
59589495|NCT02690168|75697074|FG000|STARTED|Overall Study||6||
59589496|NCT02690168|75697074|FG000|COMPLETED|Overall Study||6||
59589497|NCT02690168|75697074|FG000|NOT COMPLETED|Overall Study||0||
59589498|NCT02694601|75697079|FG000|STARTED|Overall Study||10||
59589499|NCT02694601|75697079|FG000|COMPLETED|Overall Study||10||
59589500|NCT02694601|75697079|FG000|NOT COMPLETED|Overall Study||0||
59589501|NCT02694835|75697087|FG000|STARTED|Overall Study||41|Randomized and Treated|
59589502|NCT02694835|75697088|FG001|STARTED|Overall Study||39|Randomized and Treated|
59589503|NCT02694835|75697087|FG000|COMPLETED|Overall Study||41||
59589504|NCT02694835|75697088|FG001|COMPLETED|Overall Study||39||
59589505|NCT02694835|75697087|FG000|NOT COMPLETED|Overall Study||0||
59589506|NCT02694835|75697088|FG001|NOT COMPLETED|Overall Study||0||
59589507|NCT02696083|75697094|FG000|STARTED|Overall Study||19||
59589508|NCT02696083|75697094|FG000|COMPLETED|Overall Study||13||
59589509|NCT02696083|75697094|FG000|NOT COMPLETED|Overall Study||6||
59589510|NCT02650219|75697105|FG000|STARTED|Overall Study||40||
59589511|NCT02650219|75697106|FG001|STARTED|Overall Study||20||
59589512|NCT02650219|75697105|FG000|COMPLETED|Overall Study||40||
59589513|NCT02650219|75697106|FG001|COMPLETED|Overall Study||20||
59589514|NCT02650219|75697105|FG000|NOT COMPLETED|Overall Study||0||
59855125|NCT00370331|75979801|FG000|STARTED|Overall Study||62||
59855126|NCT00370331|75979802|FG001|STARTED|Overall Study||135||
59855127|NCT00370331|75979801|FG000|COMPLETED|Overall Study||55||
60121751|NCT01562873|76242714|FG001|STARTED|Overall Study|The observed number of objective responses in Cohort A was not sufficient for Cohort B to open.|0||
60121752|NCT01562873|76242713|FG000|COMPLETED|Overall Study||0||
59855128|NCT00370331|75979802|FG001|COMPLETED|Overall Study||112||
59855129|NCT00370331|75979801|FG000|NOT COMPLETED|Overall Study||7||
59855130|NCT00370331|75979802|FG001|NOT COMPLETED|Overall Study||23||
59855131|NCT02962960|75979811|FG000|STARTED|Overall Study||14||
59855132|NCT02962960|75979812|FG001|STARTED|Overall Study||13||
59855133|NCT02962960|75979813|FG002|STARTED|Overall Study||9||
59855134|NCT02962960|75979811|FG000|COMPLETED|Overall Study||11|Subjects who completed study up to Week 52|
59855135|NCT02962960|75979812|FG001|COMPLETED|Overall Study||11|Subjects who completed study up to Week 52|
59855136|NCT02962960|75979813|FG002|COMPLETED|Overall Study||9|Subjects who completed study up to Week 52|
59855137|NCT02962960|75979811|FG000|NOT COMPLETED|Overall Study||3||
59855138|NCT02962960|75979812|FG001|NOT COMPLETED|Overall Study||2||
59855139|NCT02962960|75979813|FG002|NOT COMPLETED|Overall Study||0||
59855140|NCT00369941|75979825|FG000|STARTED|Overall Study||282||
59855141|NCT00369941|75979826|FG001|STARTED|Overall Study||284||
59855142|NCT00369941|75979825|FG000|Treated|Overall Study||281||
59855143|NCT00369941|75979826|FG001|Treated|Overall Study||282||
59855144|NCT00369941|75979825|FG000|COMPLETED|Overall Study||210||
59855145|NCT00369941|75979826|FG001|COMPLETED|Overall Study||184||
59855146|NCT00369941|75979825|FG000|NOT COMPLETED|Overall Study||72||
59589515|NCT02650219|75697106|FG001|NOT COMPLETED|Overall Study||0||
59589516|NCT02698033|75697112|FG000|STARTED|Overall Study||7||
59589517|NCT02698033|75697112|FG000|COMPLETED|Overall Study||6||
59589518|NCT02698033|75697112|FG000|NOT COMPLETED|Overall Study||1||
59589519|NCT02690948|75697118|FG000|STARTED|Overall Study||9||
59589520|NCT02690948|75697119|FG001|STARTED|Overall Study||7||
59589521|NCT02690948|75697118|FG000|COMPLETED|Overall Study||9||
59589522|NCT02690948|75697119|FG001|COMPLETED|Overall Study||7||
59589523|NCT02690948|75697118|FG000|NOT COMPLETED|Overall Study||0||
59589524|NCT02690948|75697119|FG001|NOT COMPLETED|Overall Study||0||
59589525|NCT02698735|75697125|FG000|STARTED|Overall Study||5||20
59589526|NCT02698735|75697125|FG000|COMPLETED|Overall Study|There are only 18 out of 20 samples because one patient declined intradermal injection intervention.|5|One patient was enrolled but declined the intradermal injections. Patient completed all followups.|18
59855147|NCT00369941|75979826|FG001|NOT COMPLETED|Overall Study||100||
59855148|NCT00319553|75979835|FG000|STARTED|Overall Study||323||
59855149|NCT00319553|75979836|FG001|STARTED|Overall Study||321||
59855150|NCT00319553|75979835|FG000|COMPLETED|Overall Study||319||
59855151|NCT00319553|75979836|FG001|COMPLETED|Overall Study||317||
59855152|NCT00319553|75979835|FG000|NOT COMPLETED|Overall Study||4||
59855153|NCT00319553|75979836|FG001|NOT COMPLETED|Overall Study||4||
59855154|NCT00369785|75979844|FG000|STARTED|Overall Study||99||
59855155|NCT00369785|75979845|FG001|STARTED|Overall Study||99||
59855156|NCT00369785|75979844|FG000|COMPLETED|Overall Study||72||
59855157|NCT00369785|75979845|FG001|COMPLETED|Overall Study||74||
59855158|NCT00369785|75979844|FG000|NOT COMPLETED|Overall Study||27||
59855159|NCT00369785|75979845|FG001|NOT COMPLETED|Overall Study||25||
59855160|NCT00369707|75979851|FG000|STARTED|Induction Part A (1 Cycle -35 Days)||42||
59855161|NCT00369707|75979851|FG000|COMPLETED|Induction Part A (1 Cycle -35 Days)||42||
59855162|NCT00369707|75979851|FG000|NOT COMPLETED|Induction Part A (1 Cycle -35 Days)||0||
59855163|NCT00369707|75979851|FG000|STARTED|Induction Part B (2 Cycles)||42||
59855164|NCT00369707|75979851|FG000|COMPLETED|Induction Part B (2 Cycles)||35||
59855165|NCT00369707|75979851|FG000|NOT COMPLETED|Induction Part B (2 Cycles)||7||
59855166|NCT00369707|75979851|FG000|STARTED|Maintenance Period (up to 4 Cycles)||35||
59855167|NCT00369707|75979851|FG000|COMPLETED|Maintenance Period (up to 4 Cycles)||27||
59855168|NCT00369707|75979851|FG000|NOT COMPLETED|Maintenance Period (up to 4 Cycles)||8||
59855169|NCT00369707|75979851|FG000|STARTED|Follow up for 2 Years After Treatment||41|All patients that receive treatment go into follow up at completion of study treatment.|
59855170|NCT00369707|75979851|FG000|COMPLETED|Follow up for 2 Years After Treatment||38||
59855171|NCT00369707|75979851|FG000|NOT COMPLETED|Follow up for 2 Years After Treatment||3||
59855172|NCT02943460|75979858|FG000|STARTED|Blinded Study Phase||22||
59855173|NCT02943460|75979859|FG001|STARTED|Blinded Study Phase||20||
59855174|NCT02943460|75979860|FG002|STARTED|Blinded Study Phase||10||
59855175|NCT02943460|75979858|FG000|COMPLETED|Blinded Study Phase||19||
59855176|NCT02943460|75979859|FG001|COMPLETED|Blinded Study Phase||19||
59855177|NCT02943460|75979860|FG002|COMPLETED|Blinded Study Phase||10||
59855178|NCT02943460|75979858|FG000|NOT COMPLETED|Blinded Study Phase||3||
59855179|NCT02943460|75979859|FG001|NOT COMPLETED|Blinded Study Phase||1||
59855180|NCT02943460|75979860|FG002|NOT COMPLETED|Blinded Study Phase||0||
59855181|NCT02943460|75979858|FG000|STARTED|Open Label Extension (OLE) Phase||19||
59855182|NCT02943460|75979859|FG001|STARTED|Open Label Extension (OLE) Phase|1 participant completed the Blinded Study Phase, but did not continue in the OLE Phase.|18||
59855183|NCT02943460|75979860|FG002|STARTED|Open Label Extension (OLE) Phase||10||
59855184|NCT02943460|75979858|FG000|COMPLETED|Open Label Extension (OLE) Phase||14||
59855185|NCT02943460|75979859|FG001|COMPLETED|Open Label Extension (OLE) Phase||11||
59855186|NCT02943460|75979860|FG002|COMPLETED|Open Label Extension (OLE) Phase||8||
59855187|NCT02943460|75979858|FG000|NOT COMPLETED|Open Label Extension (OLE) Phase||5||
59855188|NCT02943460|75979859|FG001|NOT COMPLETED|Open Label Extension (OLE) Phase||7||
59855189|NCT02943460|75979860|FG002|NOT COMPLETED|Open Label Extension (OLE) Phase||2||
59855190|NCT03768206|75979871|FG000|STARTED|Overall Study||24||
59855191|NCT03768206|75979872|FG001|STARTED|Overall Study||21||
59855192|NCT03768206|75979871|FG000|COMPLETED|Overall Study||22||
59855193|NCT03768206|75979872|FG001|COMPLETED|Overall Study||19||
59855194|NCT03768206|75979871|FG000|NOT COMPLETED|Overall Study||2||
59855195|NCT03768206|75979872|FG001|NOT COMPLETED|Overall Study||2||
59855196|NCT03767894|75979879|FG000|STARTED|Overall Study||12||
59855197|NCT03767894|75979879|FG000|COMPLETED|Overall Study||11||
59855198|NCT03767894|75979879|FG000|NOT COMPLETED|Overall Study||1||
59855199|NCT03766646|75979885|FG000|STARTED|Overall Study||19||
59855200|NCT03766646|75979886|FG001|STARTED|Overall Study||15||
59855201|NCT03766646|75979885|FG000|COMPLETED|Overall Study||18||
59855202|NCT03766646|75979886|FG001|COMPLETED|Overall Study||12||
59855203|NCT03766646|75979885|FG000|NOT COMPLETED|Overall Study||1||
59855204|NCT03766646|75979886|FG001|NOT COMPLETED|Overall Study||3||
59855205|NCT03765164|75979894|FG000|STARTED|Pre-intervention||78||
59855206|NCT03765164|75979895|FG001|STARTED|Pre-intervention||78||
59855207|NCT03765164|75979894|FG000|COMPLETED|Pre-intervention||73||
59855208|NCT03765164|75979895|FG001|COMPLETED|Pre-intervention||72||
59855209|NCT03765164|75979894|FG000|NOT COMPLETED|Pre-intervention||5||
59855210|NCT03765164|75979895|FG001|NOT COMPLETED|Pre-intervention||6||
59855211|NCT03765164|75979894|FG000|STARTED|Post-intervention||73||
59855212|NCT03765164|75979895|FG001|STARTED|Post-intervention||72||
59855213|NCT03765164|75979894|FG000|COMPLETED|Post-intervention||0||
59855214|NCT03765164|75979895|FG001|COMPLETED|Post-intervention||0||
60121753|NCT01562873|76242714|FG001|COMPLETED|Overall Study||0||
60121754|NCT01562873|76242713|FG000|NOT COMPLETED|Overall Study||21||
60121755|NCT01562873|76242714|FG001|NOT COMPLETED|Overall Study||0||
59855215|NCT03765164|75979894|FG000|NOT COMPLETED|Post-intervention||73||
59855216|NCT03765164|75979895|FG001|NOT COMPLETED|Post-intervention||72||
59855217|NCT00369629|75979901|FG000|STARTED|Treated 2 Cycles/Reached First Response||6||
59855218|NCT00369629|75979902|FG001|STARTED|Treated 2 Cycles/Reached First Response||3||
59855219|NCT00369629|75979903|FG002|STARTED|Treated 2 Cycles/Reached First Response||5||
59855220|NCT00369629|75979904|FG003|STARTED|Treated 2 Cycles/Reached First Response|No patients were enrolled at this dose level as the study closed early due to lack of funding.|0||
59855221|NCT00369629|75979901|FG000|COMPLETED|Treated 2 Cycles/Reached First Response||4||
59855222|NCT00369629|75979902|FG001|COMPLETED|Treated 2 Cycles/Reached First Response||2||
59855223|NCT00369629|75979903|FG002|COMPLETED|Treated 2 Cycles/Reached First Response||3||
59855224|NCT00369629|75979904|FG003|COMPLETED|Treated 2 Cycles/Reached First Response||0||
59855225|NCT00369629|75979901|FG000|NOT COMPLETED|Treated 2 Cycles/Reached First Response||2||
59855226|NCT00369629|75979902|FG001|NOT COMPLETED|Treated 2 Cycles/Reached First Response||1||
59855227|NCT00369629|75979903|FG002|NOT COMPLETED|Treated 2 Cycles/Reached First Response||2||
59589527|NCT02698735|75697125|FG000|NOT COMPLETED|Overall Study||0||2
59589528|NCT02691260|75697139|FG000|STARTED|Overall Study||26||
59589529|NCT02691260|75697140|FG001|STARTED|Overall Study||26||
59589530|NCT02691260|75697141|FG002|STARTED|Overall Study||27||
59589531|NCT02691260|75697142|FG003|STARTED|Overall Study||26||
59589532|NCT02691260|75697139|FG000|COMPLETED|Overall Study||24||
59589533|NCT02691260|75697140|FG001|COMPLETED|Overall Study||24||
59589534|NCT02691260|75697141|FG002|COMPLETED|Overall Study||25||
59589535|NCT02691260|75697142|FG003|COMPLETED|Overall Study||23||
59589536|NCT02691260|75697139|FG000|NOT COMPLETED|Overall Study||2||
59589537|NCT02691260|75697140|FG001|NOT COMPLETED|Overall Study||2||
59589538|NCT02691260|75697141|FG002|NOT COMPLETED|Overall Study||2||
59589539|NCT02691260|75697142|FG003|NOT COMPLETED|Overall Study||3||
59589540|NCT02691416|75697154|FG000|STARTED|Overall Study||30||
59589541|NCT02691416|75697155|FG001|STARTED|Overall Study||30||
59589542|NCT02691416|75697154|FG000|COMPLETED|Overall Study||30||
59589543|NCT02691416|75697155|FG001|COMPLETED|Overall Study||30||
59589544|NCT02691416|75697154|FG000|NOT COMPLETED|Overall Study||0||
59589545|NCT02691416|75697155|FG001|NOT COMPLETED|Overall Study||0||
59589546|NCT02650999|75697165|FG000|STARTED|Overall Study||12||
59589547|NCT02650999|75697165|FG000|COMPLETED|Overall Study||12||
59589548|NCT02650999|75697165|FG000|NOT COMPLETED|Overall Study||0||
59589549|NCT02651545|75697171|FG000|STARTED|Overall Study||30||
59589550|NCT02651545|75697172|FG001|STARTED|Overall Study||30||
59589551|NCT02651545|75697171|FG000|COMPLETED|Overall Study||7||
59589552|NCT02651545|75697172|FG001|COMPLETED|Overall Study||17||
59589553|NCT02651545|75697171|FG000|NOT COMPLETED|Overall Study||23||
59589554|NCT02651545|75697172|FG001|NOT COMPLETED|Overall Study||13||
59589555|NCT02691962|75697178|FG000|STARTED|Overall Study||75||
59589556|NCT02691962|75697178|FG000|COMPLETED|Overall Study||59||
59589557|NCT02691962|75697178|FG000|NOT COMPLETED|Overall Study||16||
59589558|NCT02701387|75697183|FG000|STARTED|Overall Study||7||
59589559|NCT02701387|75697183|FG000|COMPLETED|Overall Study||7||
59589560|NCT02701387|75697183|FG000|NOT COMPLETED|Overall Study||0||
59589561|NCT02693132|75697191|FG000|STARTED|Overall Study||17||
59589562|NCT02693132|75697192|FG001|STARTED|Overall Study||17||
59589563|NCT02693132|75697193|FG002|STARTED|Overall Study||18||
59725274|NCT01098305|75844115|FG001|NOT COMPLETED|Overall Study||33||
59725275|NCT00833833|75844127|FG000|STARTED|Phase 1 (as of 01 April 2011)||6||
59725276|NCT00833833|75844128|FG001|STARTED|Phase 1 (as of 01 April 2011)||8||
59725277|NCT00833833|75844129|FG002|STARTED|Phase 1 (as of 01 April 2011)||14||
59725278|NCT00833833|75844130|FG003|STARTED|Phase 1 (as of 01 April 2011)||10||
59725279|NCT00833833|75844131|FG004|STARTED|Phase 1 (as of 01 April 2011)||0||
59725280|NCT00833833|75844132|FG005|STARTED|Phase 1 (as of 01 April 2011)||0||
59725281|NCT00833833|75844127|FG000|COMPLETED|Phase 1 (as of 01 April 2011)|Confirmed progressive disease|2||
59855228|NCT00369629|75979904|FG003|NOT COMPLETED|Treated 2 Cycles/Reached First Response||0||
59589564|NCT02693132|75697191|FG000|COMPLETED|Overall Study||16||
59589565|NCT02693132|75697192|FG001|COMPLETED|Overall Study||16||
59589566|NCT02693132|75697193|FG002|COMPLETED|Overall Study||17||
59589567|NCT02693132|75697191|FG000|NOT COMPLETED|Overall Study||1||
59589568|NCT02693132|75697192|FG001|NOT COMPLETED|Overall Study||1||
59589569|NCT02693132|75697193|FG002|NOT COMPLETED|Overall Study||1||
59589570|NCT02673944|75697201|FG000|STARTED|Overall Study||10||
59589571|NCT02673944|75697201|FG000|COMPLETED|Overall Study||10||
59589572|NCT02673944|75697201|FG000|NOT COMPLETED|Overall Study||0||
59589573|NCT02674412|75697206|FG000|STARTED|Overall Study||5||
59589574|NCT02674412|75697207|FG001|STARTED|Overall Study||5||
59589575|NCT02674412|75697206|FG000|COMPLETED|Overall Study||5||
59589576|NCT02674412|75697207|FG001|COMPLETED|Overall Study||5||
59725282|NCT00833833|75844128|FG001|COMPLETED|Phase 1 (as of 01 April 2011)|Confirmed progressive disease|3||
59725283|NCT00833833|75844129|FG002|COMPLETED|Phase 1 (as of 01 April 2011)|Confirmed progressive disease|5||
59725284|NCT00833833|75844130|FG003|COMPLETED|Phase 1 (as of 01 April 2011)|Confirmed progressive disease|4||
59725285|NCT00833833|75844131|FG004|COMPLETED|Phase 1 (as of 01 April 2011)||0||
59725286|NCT00833833|75844132|FG005|COMPLETED|Phase 1 (as of 01 April 2011)||0||
59589577|NCT02674412|75697206|FG000|NOT COMPLETED|Overall Study||0||
59589578|NCT02674412|75697207|FG001|NOT COMPLETED|Overall Study||0||
59589579|NCT02697188|75697214|FG000|STARTED|TE Period 1 - 400 mg QD||12||
59589580|NCT02697188|75697214|FG000|COMPLETED|TE Period 1 - 400 mg QD||12||
59589581|NCT02697188|75697214|FG000|NOT COMPLETED|TE Period 1 - 400 mg QD||0||
59589582|NCT02697188|75697214|FG000|STARTED|TU Period 2 - 200 mg QD||12||
59589583|NCT02697188|75697214|FG000|COMPLETED|TU Period 2 - 200 mg QD||12||
59589584|NCT02697188|75697214|FG000|NOT COMPLETED|TU Period 2 - 200 mg QD||0||
59589585|NCT02697188|75697214|FG000|STARTED|TU Period 3 - 200 mg BID||12||
59589586|NCT02697188|75697214|FG000|COMPLETED|TU Period 3 - 200 mg BID||12||
59589587|NCT02697188|75697214|FG000|NOT COMPLETED|TU Period 3 - 200 mg BID||0||
59589588|NCT02697188|75697214|FG000|STARTED|TU Period 4 - 400 BID||12||
59589589|NCT02697188|75697214|FG000|COMPLETED|TU Period 4 - 400 BID||12||
59589590|NCT02697188|75697214|FG000|NOT COMPLETED|TU Period 4 - 400 BID||0||
59589591|NCT02697188|75697214|FG000|STARTED|TE Period 5 - 800 mg BID||12||
59589592|NCT02697188|75697214|FG000|COMPLETED|TE Period 5 - 800 mg BID||12||
59589593|NCT02697188|75697214|FG000|NOT COMPLETED|TE Period 5 - 800 mg BID||0||
59589594|NCT02652481|75697222|FG000|STARTED|Phase 1||239||
59589595|NCT02652481|75697222|FG000|COMPLETED|Phase 1||141||
59589596|NCT02652481|75697222|FG000|NOT COMPLETED|Phase 1||98||
59589597|NCT02652481|75697222|FG000|STARTED|Phase 2||261||
59589598|NCT02652481|75697222|FG000|COMPLETED|Phase 2||243||
59589599|NCT02652481|75697222|FG000|NOT COMPLETED|Phase 2||18||
59589600|NCT02697890|75697228|FG000|STARTED|Overall Study||14||
59589601|NCT02697890|75697229|FG001|STARTED|Overall Study||14||
59589602|NCT02697890|75697228|FG000|COMPLETED|Overall Study||14||
59589603|NCT02697890|75697229|FG001|COMPLETED|Overall Study||14||
59589604|NCT02697890|75697228|FG000|NOT COMPLETED|Overall Study||0||
59589605|NCT02697890|75697229|FG001|NOT COMPLETED|Overall Study||0||
59589606|NCT02653183|75697237|FG000|STARTED|Overall Study||53||
59589607|NCT02653183|75697238|FG001|STARTED|Overall Study||50||
59589608|NCT02653183|75697237|FG000|COMPLETED|Overall Study||49||
59589609|NCT02653183|75697238|FG001|COMPLETED|Overall Study||46||
59589610|NCT02653183|75697237|FG000|NOT COMPLETED|Overall Study||4||
59589611|NCT02653183|75697238|FG001|NOT COMPLETED|Overall Study||4||
59589612|NCT02701400|75697246|FG000|STARTED|Overall Study||9||
59589613|NCT02701400|75697247|FG001|STARTED|Overall Study||9||
59589614|NCT02701400|75697246|FG000|COMPLETED|Overall Study||9||
59589615|NCT02701400|75697247|FG001|COMPLETED|Overall Study||9||
59589616|NCT02701400|75697246|FG000|NOT COMPLETED|Overall Study||0||
59589617|NCT02701400|75697247|FG001|NOT COMPLETED|Overall Study||0||
59589618|NCT02653417|75697258|FG000|STARTED|Overall Study||38||
59589619|NCT02653417|75697259|FG001|STARTED|Overall Study||34||
59589620|NCT02653417|75697260|FG002|STARTED|Overall Study||29||
59589621|NCT02653417|75697261|FG003|STARTED|Overall Study||38||
59589622|NCT02653417|75697258|FG000|COMPLETED|Overall Study||37||
59589623|NCT02653417|75697259|FG001|COMPLETED|Overall Study||32||
59589624|NCT02653417|75697260|FG002|COMPLETED|Overall Study||26||
59589625|NCT02653417|75697261|FG003|COMPLETED|Overall Study||33||
59589626|NCT02653417|75697258|FG000|NOT COMPLETED|Overall Study||1||
59589627|NCT02653417|75697259|FG001|NOT COMPLETED|Overall Study||2||
59589628|NCT02653417|75697260|FG002|NOT COMPLETED|Overall Study||3||
59589629|NCT02653417|75697261|FG003|NOT COMPLETED|Overall Study||5||
59589630|NCT02677766|75697277|FG000|STARTED|Overall Study||20||
59589631|NCT02677766|75697278|FG001|STARTED|Overall Study||20||
59589632|NCT02677766|75697277|FG000|COMPLETED|Overall Study||15||
59589633|NCT02677766|75697278|FG001|COMPLETED|Overall Study||17||
59589634|NCT02677766|75697277|FG000|NOT COMPLETED|Overall Study||5||
59589635|NCT02677766|75697278|FG001|NOT COMPLETED|Overall Study||3||
59589636|NCT02701868|75697287|FG000|STARTED|Overall Study||21||
59589637|NCT02701868|75697288|FG001|STARTED|Overall Study||75||
59589638|NCT02701868|75697289|FG002|STARTED|Overall Study||75||
59589639|NCT02701868|75697287|FG000|COMPLETED|Overall Study||21||
59589640|NCT02701868|75697288|FG001|COMPLETED|Overall Study||75||
59589641|NCT02701868|75697289|FG002|COMPLETED|Overall Study||75||
59589642|NCT02701868|75697287|FG000|NOT COMPLETED|Overall Study||0||
59589643|NCT02701868|75697288|FG001|NOT COMPLETED|Overall Study||0||
59589644|NCT02701868|75697289|FG002|NOT COMPLETED|Overall Study||0||
59589645|NCT02705365|75697300|FG000|STARTED|Overall Study||400||
59589646|NCT02705365|75697301|FG001|STARTED|Overall Study||800||
59589647|NCT02705365|75697300|FG000|COMPLETED|Overall Study||400||
59589648|NCT02705365|75697301|FG001|COMPLETED|Overall Study||800||
59589649|NCT02705365|75697300|FG000|NOT COMPLETED|Overall Study||0||
59589650|NCT02705365|75697301|FG001|NOT COMPLETED|Overall Study||0||
59589651|NCT02703350|75697307|FG000|STARTED|Period One (Part A)||5||
59589652|NCT02703350|75697308|FG001|STARTED|Period One (Part A)||5||
59589653|NCT02703350|75697309|FG002|STARTED|Period One (Part A)||5||
59589654|NCT02703350|75697310|FG003|STARTED|Period One (Part A)||5||
59589655|NCT02703350|75697311|FG004|STARTED|Period One (Part A)||5||
59589656|NCT02703350|75697312|FG005|STARTED|Period One (Part A)||5||
59589657|NCT02703350|75697313|FG006|STARTED|Period One (Part A)||0||
59589658|NCT02703350|75697314|FG007|STARTED|Period One (Part A)||0||
59589659|NCT02703350|75697307|FG000|Received Study Drug|Period One (Part A)||5||
59589660|NCT02703350|75697308|FG001|Received Study Drug|Period One (Part A)||5||
59589661|NCT02703350|75697309|FG002|Received Study Drug|Period One (Part A)||5||
59589662|NCT02703350|75697310|FG003|Received Study Drug|Period One (Part A)||5||
59589663|NCT02703350|75697311|FG004|Received Study Drug|Period One (Part A)||5||
59589664|NCT02703350|75697312|FG005|Received Study Drug|Period One (Part A)||5||
59589665|NCT02703350|75697313|FG006|Received Study Drug|Period One (Part A)||0||
59589666|NCT02703350|75697314|FG007|Received Study Drug|Period One (Part A)||0||
59589667|NCT02703350|75697307|FG000|COMPLETED|Period One (Part A)||5||
59589668|NCT02703350|75697308|FG001|COMPLETED|Period One (Part A)||5||
59589669|NCT02703350|75697309|FG002|COMPLETED|Period One (Part A)||5||
59589670|NCT02703350|75697310|FG003|COMPLETED|Period One (Part A)||5||
59589671|NCT02703350|75697311|FG004|COMPLETED|Period One (Part A)||5||
59589672|NCT02703350|75697312|FG005|COMPLETED|Period One (Part A)||5||
59589673|NCT02703350|75697313|FG006|COMPLETED|Period One (Part A)||0||
59589674|NCT02703350|75697314|FG007|COMPLETED|Period One (Part A)||0||
59589675|NCT02703350|75697307|FG000|NOT COMPLETED|Period One (Part A)||0||
59589676|NCT02703350|75697308|FG001|NOT COMPLETED|Period One (Part A)||0||
59589677|NCT02703350|75697309|FG002|NOT COMPLETED|Period One (Part A)||0||
59589678|NCT02703350|75697310|FG003|NOT COMPLETED|Period One (Part A)||0||
59589679|NCT02703350|75697311|FG004|NOT COMPLETED|Period One (Part A)||0||
59589680|NCT02703350|75697312|FG005|NOT COMPLETED|Period One (Part A)||0||
59589681|NCT02703350|75697313|FG006|NOT COMPLETED|Period One (Part A)||0||
59589682|NCT02703350|75697314|FG007|NOT COMPLETED|Period One (Part A)||0||
59589683|NCT02703350|75697307|FG000|STARTED|Period Two (Part A)||5||
59589684|NCT02703350|75697308|FG001|STARTED|Period Two (Part A)||5||
59589685|NCT02703350|75697309|FG002|STARTED|Period Two (Part A)||5||
59589686|NCT02703350|75697310|FG003|STARTED|Period Two (Part A)||5||
59589687|NCT02703350|75697311|FG004|STARTED|Period Two (Part A)||5||
59589688|NCT02703350|75697312|FG005|STARTED|Period Two (Part A)||5||
59589689|NCT02703350|75697313|FG006|STARTED|Period Two (Part A)||0||
59589690|NCT02703350|75697314|FG007|STARTED|Period Two (Part A)||0||
59589691|NCT02703350|75697307|FG000|Received Study Drug|Period Two (Part A)||5||
59589692|NCT02703350|75697308|FG001|Received Study Drug|Period Two (Part A)||5||
59589693|NCT02703350|75697309|FG002|Received Study Drug|Period Two (Part A)||5||
59589694|NCT02703350|75697310|FG003|Received Study Drug|Period Two (Part A)||5||
59589695|NCT02703350|75697311|FG004|Received Study Drug|Period Two (Part A)||5||
59589696|NCT02703350|75697312|FG005|Received Study Drug|Period Two (Part A)||5||
59589697|NCT02703350|75697313|FG006|Received Study Drug|Period Two (Part A)||0||
59589698|NCT02703350|75697314|FG007|Received Study Drug|Period Two (Part A)||0||
59589699|NCT02703350|75697307|FG000|COMPLETED|Period Two (Part A)||5||
59589700|NCT02703350|75697308|FG001|COMPLETED|Period Two (Part A)||5||
59589701|NCT02703350|75697309|FG002|COMPLETED|Period Two (Part A)||5||
59589702|NCT02703350|75697310|FG003|COMPLETED|Period Two (Part A)||5||
59589703|NCT02703350|75697311|FG004|COMPLETED|Period Two (Part A)||5||
59589704|NCT02703350|75697312|FG005|COMPLETED|Period Two (Part A)||5||
59589705|NCT02703350|75697313|FG006|COMPLETED|Period Two (Part A)||0||
59589706|NCT02703350|75697314|FG007|COMPLETED|Period Two (Part A)||0||
59589707|NCT02703350|75697307|FG000|NOT COMPLETED|Period Two (Part A)||0||
59589708|NCT02703350|75697308|FG001|NOT COMPLETED|Period Two (Part A)||0||
59589709|NCT02703350|75697309|FG002|NOT COMPLETED|Period Two (Part A)||0||
59589710|NCT02703350|75697310|FG003|NOT COMPLETED|Period Two (Part A)||0||
59589711|NCT02703350|75697311|FG004|NOT COMPLETED|Period Two (Part A)||0||
59589712|NCT02703350|75697312|FG005|NOT COMPLETED|Period Two (Part A)||0||
59589713|NCT02703350|75697313|FG006|NOT COMPLETED|Period Two (Part A)||0||
59589714|NCT02703350|75697314|FG007|NOT COMPLETED|Period Two (Part A)||0||
59589715|NCT02703350|75697307|FG000|STARTED|Period Three (Part A)||5||
59589716|NCT02703350|75697308|FG001|STARTED|Period Three (Part A)||5||
59589717|NCT02703350|75697309|FG002|STARTED|Period Three (Part A)||5||
59589718|NCT02703350|75697310|FG003|STARTED|Period Three (Part A)||5||
59589719|NCT02703350|75697311|FG004|STARTED|Period Three (Part A)||5||
59589720|NCT02703350|75697312|FG005|STARTED|Period Three (Part A)||5||
59589721|NCT02703350|75697313|FG006|STARTED|Period Three (Part A)||0||
59589722|NCT02703350|75697314|FG007|STARTED|Period Three (Part A)||0||
59589723|NCT02703350|75697307|FG000|Received Study Drug|Period Three (Part A)||5||
59589724|NCT02703350|75697308|FG001|Received Study Drug|Period Three (Part A)||5||
59589725|NCT02703350|75697309|FG002|Received Study Drug|Period Three (Part A)||5||
59589726|NCT02703350|75697310|FG003|Received Study Drug|Period Three (Part A)||5||
59589727|NCT02703350|75697311|FG004|Received Study Drug|Period Three (Part A)||5||
59589728|NCT02703350|75697312|FG005|Received Study Drug|Period Three (Part A)||5||
59589729|NCT02703350|75697313|FG006|Received Study Drug|Period Three (Part A)||0||
59589730|NCT02703350|75697314|FG007|Received Study Drug|Period Three (Part A)||0||
59589731|NCT02703350|75697307|FG000|COMPLETED|Period Three (Part A)||5||
59589732|NCT02703350|75697308|FG001|COMPLETED|Period Three (Part A)||5||
59589733|NCT02703350|75697309|FG002|COMPLETED|Period Three (Part A)||5||
59589734|NCT02703350|75697310|FG003|COMPLETED|Period Three (Part A)||5||
59589735|NCT02703350|75697311|FG004|COMPLETED|Period Three (Part A)||5||
59589736|NCT02703350|75697312|FG005|COMPLETED|Period Three (Part A)||5||
59589737|NCT02703350|75697313|FG006|COMPLETED|Period Three (Part A)||0||
59589738|NCT02703350|75697314|FG007|COMPLETED|Period Three (Part A)||0||
59589739|NCT02703350|75697307|FG000|NOT COMPLETED|Period Three (Part A)||0||
59589740|NCT02703350|75697308|FG001|NOT COMPLETED|Period Three (Part A)||0||
59589741|NCT02703350|75697309|FG002|NOT COMPLETED|Period Three (Part A)||0||
59589742|NCT02703350|75697310|FG003|NOT COMPLETED|Period Three (Part A)||0||
59589743|NCT02703350|75697311|FG004|NOT COMPLETED|Period Three (Part A)||0||
59589744|NCT02703350|75697312|FG005|NOT COMPLETED|Period Three (Part A)||0||
59589745|NCT02703350|75697313|FG006|NOT COMPLETED|Period Three (Part A)||0||
59589746|NCT02703350|75697314|FG007|NOT COMPLETED|Period Three (Part A)||0||
59589747|NCT02703350|75697307|FG000|STARTED|Period Four (Part A)||5||
59589748|NCT02703350|75697308|FG001|STARTED|Period Four (Part A)||5||
59589749|NCT02703350|75697309|FG002|STARTED|Period Four (Part A)||5||
59589750|NCT02703350|75697310|FG003|STARTED|Period Four (Part A)||5||
59589751|NCT02703350|75697311|FG004|STARTED|Period Four (Part A)||5||
59589752|NCT02703350|75697312|FG005|STARTED|Period Four (Part A)||5||
59589753|NCT02703350|75697313|FG006|STARTED|Period Four (Part A)||0||
59589754|NCT02703350|75697314|FG007|STARTED|Period Four (Part A)||0||
59589755|NCT02703350|75697307|FG000|Received Study Drug|Period Four (Part A)||5||
59589756|NCT02703350|75697308|FG001|Received Study Drug|Period Four (Part A)||5||
59589757|NCT02703350|75697309|FG002|Received Study Drug|Period Four (Part A)||5||
59589758|NCT02703350|75697310|FG003|Received Study Drug|Period Four (Part A)||5||
59589759|NCT02703350|75697311|FG004|Received Study Drug|Period Four (Part A)||5||
59589760|NCT02703350|75697312|FG005|Received Study Drug|Period Four (Part A)||5||
59589761|NCT02703350|75697313|FG006|Received Study Drug|Period Four (Part A)||0||
59589762|NCT02703350|75697314|FG007|Received Study Drug|Period Four (Part A)||0||
59589763|NCT02703350|75697307|FG000|COMPLETED|Period Four (Part A)||5||
59589764|NCT02703350|75697308|FG001|COMPLETED|Period Four (Part A)||5||
59589765|NCT02703350|75697309|FG002|COMPLETED|Period Four (Part A)||5||
59589766|NCT02703350|75697310|FG003|COMPLETED|Period Four (Part A)||5||
59589767|NCT02703350|75697311|FG004|COMPLETED|Period Four (Part A)||5||
59589768|NCT02703350|75697312|FG005|COMPLETED|Period Four (Part A)||5||
59589769|NCT02703350|75697313|FG006|COMPLETED|Period Four (Part A)||0||
59589770|NCT02703350|75697314|FG007|COMPLETED|Period Four (Part A)||0||
59589771|NCT02703350|75697307|FG000|NOT COMPLETED|Period Four (Part A)||0||
59589772|NCT02703350|75697308|FG001|NOT COMPLETED|Period Four (Part A)||0||
59589773|NCT02703350|75697309|FG002|NOT COMPLETED|Period Four (Part A)||0||
59589774|NCT02703350|75697310|FG003|NOT COMPLETED|Period Four (Part A)||0||
59589775|NCT02703350|75697311|FG004|NOT COMPLETED|Period Four (Part A)||0||
59589776|NCT02703350|75697312|FG005|NOT COMPLETED|Period Four (Part A)||0||
59589777|NCT02703350|75697313|FG006|NOT COMPLETED|Period Four (Part A)||0||
59589778|NCT02703350|75697314|FG007|NOT COMPLETED|Period Four (Part A)||0||
59589779|NCT02703350|75697307|FG000|STARTED|Period Five (Part A)||5||
59589780|NCT02703350|75697308|FG001|STARTED|Period Five (Part A)||5||
59589781|NCT02703350|75697309|FG002|STARTED|Period Five (Part A)||5||
59589782|NCT02703350|75697310|FG003|STARTED|Period Five (Part A)||5||
59589783|NCT02703350|75697311|FG004|STARTED|Period Five (Part A)||5||
59589784|NCT02703350|75697312|FG005|STARTED|Period Five (Part A)||5||
59589785|NCT02703350|75697313|FG006|STARTED|Period Five (Part A)||0||
59589786|NCT02703350|75697314|FG007|STARTED|Period Five (Part A)||0||
59589787|NCT02703350|75697307|FG000|Received Study Drug|Period Five (Part A)||5||
59589788|NCT02703350|75697308|FG001|Received Study Drug|Period Five (Part A)||5||
59589789|NCT02703350|75697309|FG002|Received Study Drug|Period Five (Part A)||5||
59589790|NCT02703350|75697310|FG003|Received Study Drug|Period Five (Part A)||5||
59589791|NCT02703350|75697311|FG004|Received Study Drug|Period Five (Part A)||5||
59589792|NCT02703350|75697312|FG005|Received Study Drug|Period Five (Part A)||5||
59589793|NCT02703350|75697313|FG006|Received Study Drug|Period Five (Part A)||0||
59589794|NCT02703350|75697314|FG007|Received Study Drug|Period Five (Part A)||0||
59589795|NCT02703350|75697307|FG000|COMPLETED|Period Five (Part A)||5||
59589796|NCT02703350|75697308|FG001|COMPLETED|Period Five (Part A)||5||
59589797|NCT02703350|75697309|FG002|COMPLETED|Period Five (Part A)||5||
59589798|NCT02703350|75697310|FG003|COMPLETED|Period Five (Part A)||5||
59589799|NCT02703350|75697311|FG004|COMPLETED|Period Five (Part A)||5||
59589800|NCT02703350|75697312|FG005|COMPLETED|Period Five (Part A)||5||
59589801|NCT02703350|75697313|FG006|COMPLETED|Period Five (Part A)||0||
59589802|NCT02703350|75697314|FG007|COMPLETED|Period Five (Part A)||0||
59589803|NCT02703350|75697307|FG000|NOT COMPLETED|Period Five (Part A)||0||
59589804|NCT02703350|75697308|FG001|NOT COMPLETED|Period Five (Part A)||0||
59589805|NCT02703350|75697309|FG002|NOT COMPLETED|Period Five (Part A)||0||
59589806|NCT02703350|75697310|FG003|NOT COMPLETED|Period Five (Part A)||0||
59589807|NCT02703350|75697311|FG004|NOT COMPLETED|Period Five (Part A)||0||
59589808|NCT02703350|75697312|FG005|NOT COMPLETED|Period Five (Part A)||0||
59589809|NCT02703350|75697313|FG006|NOT COMPLETED|Period Five (Part A)||0||
59589810|NCT02703350|75697314|FG007|NOT COMPLETED|Period Five (Part A)||0||
59589811|NCT02703350|75697307|FG000|STARTED|Period Six (Part A)||5||
59589812|NCT02703350|75697308|FG001|STARTED|Period Six (Part A)||5||
59589813|NCT02703350|75697309|FG002|STARTED|Period Six (Part A)||5||
59589814|NCT02703350|75697310|FG003|STARTED|Period Six (Part A)||5||
59589815|NCT02703350|75697311|FG004|STARTED|Period Six (Part A)||5||
59589816|NCT02703350|75697312|FG005|STARTED|Period Six (Part A)||5||
59589817|NCT02703350|75697313|FG006|STARTED|Period Six (Part A)||0||
59589818|NCT02703350|75697314|FG007|STARTED|Period Six (Part A)||0||
59589819|NCT02703350|75697307|FG000|Received Study Drug|Period Six (Part A)||5||
59589820|NCT02703350|75697308|FG001|Received Study Drug|Period Six (Part A)||5||
59589821|NCT02703350|75697309|FG002|Received Study Drug|Period Six (Part A)||5||
59589822|NCT02703350|75697310|FG003|Received Study Drug|Period Six (Part A)||5||
59589823|NCT02703350|75697311|FG004|Received Study Drug|Period Six (Part A)||5||
59589824|NCT02703350|75697312|FG005|Received Study Drug|Period Six (Part A)||5||
59589825|NCT02703350|75697313|FG006|Received Study Drug|Period Six (Part A)||0||
59589826|NCT02703350|75697314|FG007|Received Study Drug|Period Six (Part A)||0||
59855229|NCT00369629|75979901|FG000|STARTED|Moved on to 4 More Cycles||4||
59855230|NCT00369629|75979902|FG001|STARTED|Moved on to 4 More Cycles||2||
59855231|NCT00369629|75979903|FG002|STARTED|Moved on to 4 More Cycles||3||
59855232|NCT00369629|75979904|FG003|STARTED|Moved on to 4 More Cycles||0||
59855233|NCT00369629|75979901|FG000|COMPLETED|Moved on to 4 More Cycles||4||
59855234|NCT00369629|75979902|FG001|COMPLETED|Moved on to 4 More Cycles||2||
59855235|NCT00369629|75979903|FG002|COMPLETED|Moved on to 4 More Cycles||2||
59589827|NCT02703350|75697307|FG000|COMPLETED|Period Six (Part A)||5||
59589828|NCT02703350|75697308|FG001|COMPLETED|Period Six (Part A)||5||
59589829|NCT02703350|75697309|FG002|COMPLETED|Period Six (Part A)||5||
59589830|NCT02703350|75697310|FG003|COMPLETED|Period Six (Part A)||5||
59589831|NCT02703350|75697311|FG004|COMPLETED|Period Six (Part A)||5||
59589832|NCT02703350|75697312|FG005|COMPLETED|Period Six (Part A)||5||
59589833|NCT02703350|75697313|FG006|COMPLETED|Period Six (Part A)||0||
59589834|NCT02703350|75697314|FG007|COMPLETED|Period Six (Part A)||0||
59589835|NCT02703350|75697307|FG000|NOT COMPLETED|Period Six (Part A)||0||
59589836|NCT02703350|75697308|FG001|NOT COMPLETED|Period Six (Part A)||0||
59589837|NCT02703350|75697309|FG002|NOT COMPLETED|Period Six (Part A)||0||
59589838|NCT02703350|75697310|FG003|NOT COMPLETED|Period Six (Part A)||0||
59589839|NCT02703350|75697311|FG004|NOT COMPLETED|Period Six (Part A)||0||
59589840|NCT02703350|75697312|FG005|NOT COMPLETED|Period Six (Part A)||0||
59589841|NCT02703350|75697313|FG006|NOT COMPLETED|Period Six (Part A)||0||
59589842|NCT02703350|75697314|FG007|NOT COMPLETED|Period Six (Part A)||0||
59589843|NCT02703350|75697307|FG000|STARTED|Part B||0|Participants who completed all six periods in Part A were eligible for Part B.|
59589844|NCT02703350|75697308|FG001|STARTED|Part B||0|Participants who completed all six periods in Part A were eligible for Part B.|
59589845|NCT02703350|75697309|FG002|STARTED|Part B||0|Participants who completed all six periods in Part A were eligible for Part B.|
59589846|NCT02703350|75697310|FG003|STARTED|Part B||0|Participants who completed all six periods in Part A were eligible for Part B.|
59589847|NCT02703350|75697311|FG004|STARTED|Part B||0|Participants who completed all six periods in Part A were eligible for Part B.|
59589848|NCT02703350|75697312|FG005|STARTED|Part B||0|Participants who completed all six periods in Part A were eligible for Part B.|
59589849|NCT02703350|75697313|FG006|STARTED|Part B||15|Participants who completed all six periods in Part A were eligible for Part B.|
59589850|NCT02703350|75697314|FG007|STARTED|Part B||15|Participants who completed all six periods in Part A were eligible for Part B.|
59589851|NCT02703350|75697307|FG000|Received Study Drug|Part B||0||
59589852|NCT02703350|75697308|FG001|Received Study Drug|Part B||0||
59589853|NCT02703350|75697309|FG002|Received Study Drug|Part B||0||
59589854|NCT02703350|75697310|FG003|Received Study Drug|Part B||0||
59589855|NCT02703350|75697311|FG004|Received Study Drug|Part B||0||
59589856|NCT02703350|75697312|FG005|Received Study Drug|Part B||0||
59589857|NCT02703350|75697313|FG006|Received Study Drug|Part B||15||
59589858|NCT02703350|75697314|FG007|Received Study Drug|Part B||15||
59589859|NCT02703350|75697307|FG000|COMPLETED|Part B||0||
59589860|NCT02703350|75697308|FG001|COMPLETED|Part B||0||
59589861|NCT02703350|75697309|FG002|COMPLETED|Part B||0||
59589862|NCT02703350|75697310|FG003|COMPLETED|Part B||0||
59589863|NCT02703350|75697311|FG004|COMPLETED|Part B||0||
59589864|NCT02703350|75697312|FG005|COMPLETED|Part B||0||
59589865|NCT02703350|75697313|FG006|COMPLETED|Part B||15||
59589866|NCT02703350|75697314|FG007|COMPLETED|Part B||15||
59589867|NCT02703350|75697307|FG000|NOT COMPLETED|Part B||0||
59589868|NCT02703350|75697308|FG001|NOT COMPLETED|Part B||0||
59589869|NCT02703350|75697309|FG002|NOT COMPLETED|Part B||0||
59589870|NCT02703350|75697310|FG003|NOT COMPLETED|Part B||0||
59589871|NCT02703350|75697311|FG004|NOT COMPLETED|Part B||0||
59589872|NCT02703350|75697312|FG005|NOT COMPLETED|Part B||0||
59589873|NCT02703350|75697313|FG006|NOT COMPLETED|Part B||0||
59589874|NCT02703350|75697314|FG007|NOT COMPLETED|Part B||0||
59589875|NCT02682056|75697332|FG000|STARTED|Overall Study||15||
59589876|NCT02682056|75697332|FG000|COMPLETED|Overall Study||15||
59589877|NCT02682056|75697332|FG000|NOT COMPLETED|Overall Study||0||
59589878|NCT02706925|75697349|FG000|STARTED|Overall Study||16||
59589879|NCT02706925|75697350|FG001|STARTED|Overall Study||6||
59589880|NCT02706925|75697351|FG002|STARTED|Overall Study||6||
59589881|NCT02706925|75697352|FG003|STARTED|Overall Study||6||
59589882|NCT02706925|75697353|FG004|STARTED|Overall Study||6||
59589883|NCT02706925|75697354|FG005|STARTED|Overall Study||5||
59589884|NCT02706925|75697355|FG006|STARTED|Overall Study||6||
59589885|NCT02706925|75697356|FG007|STARTED|Overall Study||6||
59589886|NCT02706925|75697357|FG008|STARTED|Overall Study||6||
59589887|NCT02706925|75697349|FG000|COMPLETED|Overall Study||16||
60121756|NCT03273712|76242718|FG000|STARTED|Overall Study||39||
60121757|NCT03273712|76242718|FG000|COMPLETED|Overall Study||32||
60121758|NCT03273712|76242718|FG000|NOT COMPLETED|Overall Study||7||
60121759|NCT01562327|76242723|FG000|STARTED|Overall Study||50||
59589888|NCT02706925|75697350|FG001|COMPLETED|Overall Study||6||
59589889|NCT02706925|75697351|FG002|COMPLETED|Overall Study||6||
59589890|NCT02706925|75697352|FG003|COMPLETED|Overall Study||6||
59589891|NCT02706925|75697353|FG004|COMPLETED|Overall Study||6||
59589892|NCT02706925|75697354|FG005|COMPLETED|Overall Study||5||
59589893|NCT02706925|75697355|FG006|COMPLETED|Overall Study||6||
59589894|NCT02706925|75697356|FG007|COMPLETED|Overall Study||6||
59589895|NCT02706925|75697357|FG008|COMPLETED|Overall Study||6||
60121760|NCT01562327|76242723|FG000|COMPLETED|Overall Study||42||
60121761|NCT01562327|76242723|FG000|NOT COMPLETED|Overall Study||8||
60121762|NCT01561313|76242730|FG000|STARTED|Overall Study||33||
60121763|NCT01561313|76242731|FG001|STARTED|Overall Study||31||
59589896|NCT02706925|75697349|FG000|NOT COMPLETED|Overall Study||0||
59589897|NCT02706925|75697350|FG001|NOT COMPLETED|Overall Study||0||
59589898|NCT02706925|75697351|FG002|NOT COMPLETED|Overall Study||0||
59589899|NCT02706925|75697352|FG003|NOT COMPLETED|Overall Study||0||
59589900|NCT02706925|75697353|FG004|NOT COMPLETED|Overall Study||0||
59589901|NCT02706925|75697354|FG005|NOT COMPLETED|Overall Study||0||
59589902|NCT02706925|75697355|FG006|NOT COMPLETED|Overall Study||0||
59589903|NCT02706925|75697356|FG007|NOT COMPLETED|Overall Study||0||
59589904|NCT02706925|75697357|FG008|NOT COMPLETED|Overall Study||0||
59589905|NCT02656069|75697387|FG000|STARTED|First Intervention||44||
59589906|NCT02656069|75697388|FG001|STARTED|First Intervention||36||
59589907|NCT02656069|75697387|FG000|COMPLETED|First Intervention||44||
59589908|NCT02656069|75697388|FG001|COMPLETED|First Intervention||36||
59589909|NCT02656069|75697387|FG000|NOT COMPLETED|First Intervention||0||
59589910|NCT02656069|75697388|FG001|NOT COMPLETED|First Intervention||0||
59589911|NCT02656069|75697387|FG000|STARTED|Second Intervention||44||
59589912|NCT02656069|75697388|FG001|STARTED|Second Intervention||36||
59589913|NCT02656069|75697387|FG000|COMPLETED|Second Intervention||43||
59589914|NCT02656069|75697388|FG001|COMPLETED|Second Intervention||35||
59589915|NCT02656069|75697387|FG000|NOT COMPLETED|Second Intervention||1||
59589916|NCT02656069|75697388|FG001|NOT COMPLETED|Second Intervention||1||
59589917|NCT02707172|75697394|FG000|STARTED|1st Set of Experiment||28||
59589918|NCT02707172|75697394|FG000|COMPLETED|1st Set of Experiment||28||
59589919|NCT02707172|75697394|FG000|NOT COMPLETED|1st Set of Experiment||0||
59589920|NCT02707172|75697394|FG000|STARTED|Wash Out||28||
59589921|NCT02707172|75697394|FG000|COMPLETED|Wash Out||28||
59589922|NCT02707172|75697394|FG000|NOT COMPLETED|Wash Out||0||
59589923|NCT02707172|75697394|FG000|STARTED|2nd Set of Experiment||28||
59589924|NCT02707172|75697394|FG000|COMPLETED|2nd Set of Experiment||28||
59589925|NCT02707172|75697394|FG000|NOT COMPLETED|2nd Set of Experiment||0||
59589926|NCT02683772|75697399|FG000|STARTED|Overall Study||15||
59589927|NCT02683772|75697400|FG001|STARTED|Overall Study||23||
59589928|NCT02683772|75697399|FG000|COMPLETED|Overall Study||15||
59589929|NCT02683772|75697400|FG001|COMPLETED|Overall Study||23||
59589930|NCT02683772|75697399|FG000|NOT COMPLETED|Overall Study||0||
59589931|NCT02683772|75697400|FG001|NOT COMPLETED|Overall Study||0||
59589932|NCT02708641|75697410|FG000|STARTED|Overall Study||12||
59589933|NCT02708641|75697410|FG000|COMPLETED|Overall Study||12||
59589934|NCT02708641|75697410|FG000|NOT COMPLETED|Overall Study||0||
59589935|NCT02657629|75697416|FG000|STARTED|Overall Study||14||
59589936|NCT02657629|75697417|FG001|STARTED|Overall Study||14||
59589937|NCT02657629|75697416|FG000|COMPLETED|Overall Study||12||
59589938|NCT02657629|75697417|FG001|COMPLETED|Overall Study||14||
59589939|NCT02657629|75697416|FG000|NOT COMPLETED|Overall Study||2||
59589940|NCT02657629|75697417|FG001|NOT COMPLETED|Overall Study||0||
59589941|NCT02683928|75697425|FG000|STARTED|Overall Study||48||
59589942|NCT02683928|75697426|FG001|STARTED|Overall Study||16||
59589943|NCT02683928|75697425|FG000|COMPLETED|Overall Study||26||
59589944|NCT02683928|75697426|FG001|COMPLETED|Overall Study||8||
59589945|NCT02683928|75697425|FG000|NOT COMPLETED|Overall Study||22||
59589946|NCT02683928|75697426|FG001|NOT COMPLETED|Overall Study||8||
59589947|NCT02708186|75697434|FG000|STARTED|Overall Study||16||
59589948|NCT02708186|75697435|FG001|STARTED|Overall Study||18||
59589949|NCT02708186|75697434|FG000|COMPLETED|Overall Study||14||
59589950|NCT02708186|75697435|FG001|COMPLETED|Overall Study||16||
59589951|NCT02708186|75697434|FG000|NOT COMPLETED|Overall Study||2||
59589952|NCT02708186|75697435|FG001|NOT COMPLETED|Overall Study||2||
59589953|NCT02710591|75697445|FG000|STARTED|Overall Study||5||
59589954|NCT02710591|75697446|FG001|STARTED|Overall Study||5||
59589955|NCT02710591|75697447|FG002|STARTED|Overall Study||5||
59589956|NCT02710591|75697448|FG003|STARTED|Overall Study||5||
59589957|NCT02710591|75697445|FG000|COMPLETED|Overall Study||5||
59589958|NCT02710591|75697446|FG001|COMPLETED|Overall Study||5||
59589959|NCT02710591|75697447|FG002|COMPLETED|Overall Study||5||
59589960|NCT02710591|75697448|FG003|COMPLETED|Overall Study||5||
59589961|NCT02710591|75697445|FG000|NOT COMPLETED|Overall Study||0||
59589962|NCT02710591|75697446|FG001|NOT COMPLETED|Overall Study||0||
59589963|NCT02710591|75697447|FG002|NOT COMPLETED|Overall Study||0||
59589964|NCT02710591|75697448|FG003|NOT COMPLETED|Overall Study||0||
59589965|NCT02710981|75697458|FG000|STARTED|6th Ovulation Induction Cycle (5 Days)||42||
59589966|NCT02710981|75697459|FG001|STARTED|6th Ovulation Induction Cycle (5 Days)||0||
59589967|NCT02710981|75697458|FG000|COMPLETED|6th Ovulation Induction Cycle (5 Days)||41||
59589968|NCT02710981|75697459|FG001|COMPLETED|6th Ovulation Induction Cycle (5 Days)||0||
59589969|NCT02710981|75697458|FG000|NOT COMPLETED|6th Ovulation Induction Cycle (5 Days)||1||
59589970|NCT02710981|75697459|FG001|NOT COMPLETED|6th Ovulation Induction Cycle (5 Days)||0||
59589971|NCT02710981|75697458|FG000|STARTED|7th Ovulation Induction Cycle (5 Days)||0||
59589972|NCT02710981|75697459|FG001|STARTED|7th Ovulation Induction Cycle (5 Days)||41||
59589973|NCT02710981|75697458|FG000|COMPLETED|7th Ovulation Induction Cycle (5 Days)||0||
59589974|NCT02710981|75697459|FG001|COMPLETED|7th Ovulation Induction Cycle (5 Days)||36||
59589975|NCT02710981|75697458|FG000|NOT COMPLETED|7th Ovulation Induction Cycle (5 Days)||0||
59589976|NCT02710981|75697459|FG001|NOT COMPLETED|7th Ovulation Induction Cycle (5 Days)||5||
59589977|NCT02711839|75697469|FG000|STARTED|Overall Study||20||
59589978|NCT02711839|75697470|FG001|STARTED|Overall Study||34||
59589979|NCT02711839|75697469|FG000|COMPLETED|Overall Study||16||
59589980|NCT02711839|75697470|FG001|COMPLETED|Overall Study||24||
59589981|NCT02711839|75697469|FG000|NOT COMPLETED|Overall Study||4||
59589982|NCT02711839|75697470|FG001|NOT COMPLETED|Overall Study||10||
59589983|NCT02713711|75697476|FG000|STARTED|Overall Study||9|14 participants and 58 total psoriatic plaques divided in the 4 groups.|14
59589984|NCT02713711|75697477|FG001|STARTED|Overall Study||6|14 participants and 58 total psoriatic plaques divided in the 4 groups.|15
59589985|NCT02713711|75697478|FG002|STARTED|Overall Study||6|14 participants and 58 total psoriatic plaques divided in the 4 groups.|14
59589986|NCT02713711|75697479|FG003|STARTED|Overall Study||10|14 participants and 58 total psoriatic plaques divided in the 4 groups.|15
59589987|NCT02713711|75697476|FG000|COMPLETED|Overall Study||9||14
59589988|NCT02713711|75697477|FG001|COMPLETED|Overall Study||6||15
59589989|NCT02713711|75697478|FG002|COMPLETED|Overall Study||6||14
59589990|NCT02713711|75697479|FG003|COMPLETED|Overall Study||10||15
59589991|NCT02713711|75697476|FG000|NOT COMPLETED|Overall Study||0||0
59589992|NCT02713711|75697477|FG001|NOT COMPLETED|Overall Study||0||0
59589993|NCT02713711|75697478|FG002|NOT COMPLETED|Overall Study||0||0
59589994|NCT02713711|75697479|FG003|NOT COMPLETED|Overall Study||0||0
59589995|NCT02659501|75697494|FG000|STARTED|Overall Study||12||
59589996|NCT02659501|75697495|FG001|STARTED|Overall Study||12||
59589997|NCT02659501|75697494|FG000|COMPLETED|Overall Study||12||
59589998|NCT02659501|75697495|FG001|COMPLETED|Overall Study||12||
59589999|NCT02659501|75697494|FG000|NOT COMPLETED|Overall Study||0||
59590000|NCT02659501|75697495|FG001|NOT COMPLETED|Overall Study||0||
59590001|NCT02718157|75697501|FG000|STARTED|Overall Study||771||
59590002|NCT02718157|75697501|FG000|COMPLETED|Overall Study||609||
59590003|NCT02718157|75697501|FG000|NOT COMPLETED|Overall Study||162||
59590004|NCT02719639|75697505|FG000|STARTED|Overall Study||7443||
59590005|NCT02719639|75697505|FG000|COMPLETED|Overall Study||7443||
59590006|NCT02719639|75697505|FG000|NOT COMPLETED|Overall Study||0||
59590007|NCT02720107|75697509|FG000|STARTED|Overall Study||130||
59590008|NCT02720107|75697509|FG000|COMPLETED|Overall Study||130||
59590009|NCT02720107|75697509|FG000|NOT COMPLETED|Overall Study||0||
59590010|NCT02662387|75697515|FG000|STARTED|Overall Study||27||
59590011|NCT02662387|75697516|FG001|STARTED|Overall Study||28||
59590012|NCT02662387|75697515|FG000|COMPLETED|Overall Study||27||
59590013|NCT02662387|75697516|FG001|COMPLETED|Overall Study||28||
59590014|NCT02662387|75697515|FG000|NOT COMPLETED|Overall Study||0||
59590015|NCT02662387|75697516|FG001|NOT COMPLETED|Overall Study||0||
59590016|NCT02722837|75697524|FG000|STARTED|Overall Study||119||
59590017|NCT02722837|75697524|FG000|COMPLETED|Overall Study||119||
59590018|NCT02722837|75697524|FG000|NOT COMPLETED|Overall Study||0||
59590019|NCT02710526|75697531|FG000|STARTED|Treatment Phase||28||
59590020|NCT02710526|75697532|FG001|STARTED|Treatment Phase||20||
59590021|NCT02710526|75697533|FG002|STARTED|Treatment Phase||18||
59590022|NCT02710526|75697531|FG000|COMPLETED|Treatment Phase||22||
59590023|NCT02710526|75697532|FG001|COMPLETED|Treatment Phase||16||
59590024|NCT02710526|75697533|FG002|COMPLETED|Treatment Phase||12||
59590025|NCT02710526|75697531|FG000|NOT COMPLETED|Treatment Phase||6||
59590026|NCT02710526|75697532|FG001|NOT COMPLETED|Treatment Phase||4||
59590027|NCT02710526|75697533|FG002|NOT COMPLETED|Treatment Phase||6||
59590028|NCT02710526|75697531|FG000|STARTED|Safety Extension||15||
59590029|NCT02710526|75697532|FG001|STARTED|Safety Extension||12||
59590030|NCT02710526|75697533|FG002|STARTED|Safety Extension||0||
59590031|NCT02710526|75697531|FG000|COMPLETED|Safety Extension||14||
59590032|NCT02710526|75697532|FG001|COMPLETED|Safety Extension||12||
59590033|NCT02710526|75697533|FG002|COMPLETED|Safety Extension||0||
59590034|NCT02710526|75697531|FG000|NOT COMPLETED|Safety Extension||1||
59590035|NCT02710526|75697532|FG001|NOT COMPLETED|Safety Extension||0||
59590036|NCT02710526|75697533|FG002|NOT COMPLETED|Safety Extension||0||
59590037|NCT02724787|75697551|FG000|STARTED|Overall Study||24||
59725287|NCT00833833|75844127|FG000|NOT COMPLETED|Phase 1 (as of 01 April 2011)||4||
59725288|NCT00833833|75844128|FG001|NOT COMPLETED|Phase 1 (as of 01 April 2011)||5||
59725289|NCT00833833|75844129|FG002|NOT COMPLETED|Phase 1 (as of 01 April 2011)||9||
59590038|NCT02724787|75697551|FG000|COMPLETED|Overall Study|22 completed treatment. 20 participants returned for post-treatment assessment.|22||
59590039|NCT02724787|75697551|FG000|NOT COMPLETED|Overall Study||2||
59590040|NCT02725645|75697555|FG000|STARTED|Overall Study||14||
59590041|NCT02725645|75697555|FG000|COMPLETED|Overall Study||14||
59590042|NCT02725645|75697555|FG000|NOT COMPLETED|Overall Study||0||
59590043|NCT02664961|75697559|FG000|STARTED|Overall Study||3||
59590044|NCT02664961|75697559|FG000|COMPLETED|Overall Study||3||
59590045|NCT02664961|75697559|FG000|NOT COMPLETED|Overall Study||0||
59590046|NCT02725801|75697565|FG000|STARTED|Overall Study||8||
59590047|NCT02725801|75697566|FG001|STARTED|Overall Study||12||
59590048|NCT02725801|75697565|FG000|COMPLETED|Overall Study||8||
59590049|NCT02725801|75697566|FG001|COMPLETED|Overall Study||12||
59725290|NCT00833833|75844130|FG003|NOT COMPLETED|Phase 1 (as of 01 April 2011)||6||
59590050|NCT02725801|75697565|FG000|NOT COMPLETED|Overall Study||0||
59590051|NCT02725801|75697566|FG001|NOT COMPLETED|Overall Study||0||
59590052|NCT02665273|75697574|FG000|STARTED|Overall Study||13||
59590053|NCT02665273|75697575|FG001|STARTED|Overall Study||15||
59590054|NCT02665273|75697574|FG000|COMPLETED|Overall Study||13||
59590055|NCT02665273|75697575|FG001|COMPLETED|Overall Study||15||
59590056|NCT02665273|75697574|FG000|NOT COMPLETED|Overall Study||0||
59590057|NCT02665273|75697575|FG001|NOT COMPLETED|Overall Study||0||
59590058|NCT02713178|75697584|FG000|STARTED|Overall Study||76||
59590059|NCT02713178|75697585|FG001|STARTED|Overall Study||77||
59590060|NCT02713178|75697586|FG002|STARTED|Overall Study||79||
59590061|NCT02713178|75697584|FG000|COMPLETED|Overall Study||75||
59590062|NCT02713178|75697585|FG001|COMPLETED|Overall Study||73||
59590063|NCT02713178|75697586|FG002|COMPLETED|Overall Study||74||
59590064|NCT02713178|75697584|FG000|NOT COMPLETED|Overall Study||1||
59590065|NCT02713178|75697585|FG001|NOT COMPLETED|Overall Study||4||
59590066|NCT02713178|75697586|FG002|NOT COMPLETED|Overall Study||5||
59590067|NCT02665741|75697597|FG000|STARTED|Overall Study||42||
59590068|NCT02665741|75697598|FG001|STARTED|Overall Study||42||
59590069|NCT02665741|75697599|FG002|STARTED|Overall Study||42||
59590070|NCT02665741|75697597|FG000|COMPLETED|Overall Study||42||
59590071|NCT02665741|75697598|FG001|COMPLETED|Overall Study||42||
59590072|NCT02665741|75697599|FG002|COMPLETED|Overall Study||42||
59590073|NCT02665741|75697597|FG000|NOT COMPLETED|Overall Study||0||
59590074|NCT02665741|75697598|FG001|NOT COMPLETED|Overall Study||0||
59590075|NCT02665741|75697599|FG002|NOT COMPLETED|Overall Study||0||
59590076|NCT02726971|75697609|FG000|STARTED|Overall Study||70||
59590077|NCT02726971|75697610|FG001|STARTED|Overall Study||71||
59590078|NCT02726971|75697609|FG000|COMPLETED|Overall Study||59||
59590079|NCT02726971|75697610|FG001|COMPLETED|Overall Study||62||
59590080|NCT02726971|75697609|FG000|NOT COMPLETED|Overall Study||11||
59590081|NCT02726971|75697610|FG001|NOT COMPLETED|Overall Study||9||
59590082|NCT02727751|75697616|FG000|STARTED|Overall Study||312||
59590083|NCT02727751|75697616|FG000|COMPLETED|Overall Study||262||
59590084|NCT02727751|75697616|FG000|NOT COMPLETED|Overall Study||50||
59590085|NCT02713256|75697620|FG000|STARTED|Overall Study||15||
59590086|NCT02713256|75697620|FG000|COMPLETED|Overall Study||15||
59590087|NCT02713256|75697620|FG000|NOT COMPLETED|Overall Study||0||
59590088|NCT02714504|75697626|FG000|STARTED|Overall Study||61||
59590089|NCT02714504|75697627|FG001|STARTED|Overall Study||178||
59590090|NCT02714504|75697626|FG000|COMPLETED|Overall Study||61||
60121764|NCT01561313|76242730|FG000|COMPLETED|Overall Study||31||
60121765|NCT01561313|76242731|FG001|COMPLETED|Overall Study||31||
60121766|NCT01561313|76242730|FG000|NOT COMPLETED|Overall Study||2||
59590091|NCT02714504|75697627|FG001|COMPLETED|Overall Study||178||
59590092|NCT02714504|75697626|FG000|NOT COMPLETED|Overall Study||0||
59590093|NCT02714504|75697627|FG001|NOT COMPLETED|Overall Study||0||
59590094|NCT02665975|75697635|FG000|STARTED|Overall Study||46||
59590095|NCT02665975|75697636|FG001|STARTED|Overall Study||46||
59590096|NCT02665975|75697635|FG000|COMPLETED|Overall Study||37||
59590097|NCT02665975|75697636|FG001|COMPLETED|Overall Study||37||
59590098|NCT02665975|75697635|FG000|NOT COMPLETED|Overall Study||9||
59590099|NCT02665975|75697636|FG001|NOT COMPLETED|Overall Study||9||
59590100|NCT02718248|75697642|FG000|STARTED|Overall Study||7||
59590101|NCT02718248|75697642|FG000|COMPLETED|Overall Study||7||
59590102|NCT02718248|75697642|FG000|NOT COMPLETED|Overall Study||0||
59590103|NCT02668003|75697648|FG000|STARTED|Overall Study||501||
59590104|NCT02668003|75697649|FG001|STARTED|Overall Study||501||
59590105|NCT02668003|75697648|FG000|COMPLETED|Overall Study||500||
59590106|NCT02668003|75697649|FG001|COMPLETED|Overall Study||496||
59590107|NCT02668003|75697648|FG000|NOT COMPLETED|Overall Study||1||
59590108|NCT02668003|75697649|FG001|NOT COMPLETED|Overall Study||5||
59590109|NCT02724800|75697657|FG000|STARTED|Overall Study||32||
59590110|NCT02724800|75697658|FG001|STARTED|Overall Study||31||
59590111|NCT02724800|75697657|FG000|COMPLETED|Overall Study||15||
59590112|NCT02724800|75697658|FG001|COMPLETED|Overall Study||22||
59590113|NCT02724800|75697657|FG000|NOT COMPLETED|Overall Study||17||
59725291|NCT00833833|75844131|FG004|NOT COMPLETED|Phase 1 (as of 01 April 2011)||0||
59855236|NCT00369629|75979904|FG003|COMPLETED|Moved on to 4 More Cycles||0||
59590114|NCT02724800|75697658|FG001|NOT COMPLETED|Overall Study||9||
59590115|NCT02730247|75697664|FG000|STARTED|Overall Study||7||
59590116|NCT02730247|75697664|FG000|COMPLETED|Overall Study||7||
59590117|NCT02730247|75697664|FG000|NOT COMPLETED|Overall Study||0||
59590118|NCT02730403|75697668|FG000|STARTED|Overall Study||211||
59590119|NCT02730403|75697668|FG000|COMPLETED|Overall Study||157||
59590120|NCT02730403|75697668|FG000|NOT COMPLETED|Overall Study||54||
59590121|NCT02669329|75697673|FG000|STARTED|Overall Study||30||60
59590122|NCT02669329|75697673|FG000|COMPLETED|Overall Study||30||60
59590123|NCT02669329|75697673|FG000|NOT COMPLETED|Overall Study||0||0
59590124|NCT02727842|75697677|FG000|STARTED|Overall Study||30||1
59590125|NCT02727842|75697677|FG000|COMPLETED|Overall Study||30||1
59590126|NCT02727842|75697677|FG000|NOT COMPLETED|Overall Study||0||0
59590127|NCT02670343|75697681|FG000|STARTED|Overall Study||8||
59590128|NCT02670343|75697681|FG000|COMPLETED|Overall Study||8||
59590129|NCT02670343|75697681|FG000|NOT COMPLETED|Overall Study||0||
59590130|NCT02730260|75697687|FG000|STARTED|Overall Study||258||
59590131|NCT02730260|75697688|FG001|STARTED|Overall Study||260||
59590132|NCT02730260|75697687|FG000|COMPLETED|Overall Study||176||
59590133|NCT02730260|75697688|FG001|COMPLETED|Overall Study||185||
59590134|NCT02730260|75697687|FG000|NOT COMPLETED|Overall Study||82||
59590135|NCT02730260|75697688|FG001|NOT COMPLETED|Overall Study||75||
59590136|NCT02730884|75697694|FG000|STARTED|Overall Study||3||
59590137|NCT02730884|75697694|FG000|COMPLETED|Overall Study||3||
59590138|NCT02730884|75697694|FG000|NOT COMPLETED|Overall Study||0||
59590139|NCT02732587|75697698|FG000|STARTED|Overall Study||5||
59590140|NCT02732587|75697698|FG000|COMPLETED|Overall Study||5||
59590141|NCT02732587|75697698|FG000|NOT COMPLETED|Overall Study||0||
59590142|NCT02731820|75697704|FG000|STARTED|Overall Study||20||
59590143|NCT02731820|75697705|FG001|STARTED|Overall Study||20||
59590144|NCT02731820|75697704|FG000|COMPLETED|Overall Study||17||
59590145|NCT02731820|75697705|FG001|COMPLETED|Overall Study||18||
59590146|NCT02731820|75697704|FG000|NOT COMPLETED|Overall Study||3||
59590147|NCT02731820|75697705|FG001|NOT COMPLETED|Overall Study||2||
59590148|NCT02732899|75697713|FG000|STARTED|Overall Study||10||
59590149|NCT02732899|75697714|FG001|STARTED|Overall Study||10||
59590150|NCT02732899|75697713|FG000|COMPLETED|Overall Study||10||
59590151|NCT02732899|75697714|FG001|COMPLETED|Overall Study||10||
59590152|NCT02732899|75697713|FG000|NOT COMPLETED|Overall Study||0||
59590153|NCT02732899|75697714|FG001|NOT COMPLETED|Overall Study||0||
59590154|NCT02733757|75697724|FG000|STARTED|Overall Study||20||
59590155|NCT02733757|75697725|FG001|STARTED|Overall Study||20||
59590156|NCT02733757|75697726|FG002|STARTED|Overall Study||20||
59590157|NCT02733757|75697727|FG003|STARTED|Overall Study||20||
59590158|NCT02733757|75697724|FG000|COMPLETED|Overall Study||20||
59590159|NCT02733757|75697725|FG001|COMPLETED|Overall Study||20||
59590160|NCT02733757|75697726|FG002|COMPLETED|Overall Study||20||
59590161|NCT02733757|75697727|FG003|COMPLETED|Overall Study||20||
59590162|NCT02733757|75697724|FG000|NOT COMPLETED|Overall Study||0||
59590163|NCT02733757|75697725|FG001|NOT COMPLETED|Overall Study||0||
59590164|NCT02733757|75697726|FG002|NOT COMPLETED|Overall Study||0||
59590165|NCT02733757|75697727|FG003|NOT COMPLETED|Overall Study||0||
59590166|NCT02734147|75697739|FG000|STARTED|Overall Study||12||
59590167|NCT02734147|75697740|FG001|STARTED|Overall Study||12||
59590168|NCT02734147|75697739|FG000|COMPLETED|Overall Study||9||
59590169|NCT02734147|75697740|FG001|COMPLETED|Overall Study||11||
59590170|NCT02734147|75697739|FG000|NOT COMPLETED|Overall Study||3||
59590171|NCT02734147|75697740|FG001|NOT COMPLETED|Overall Study||1||
59590172|NCT02673541|75697748|FG000|STARTED|Overall Study||3||
59590173|NCT02673541|75697749|FG001|STARTED|Overall Study||2||
59590174|NCT02673541|75697748|FG000|COMPLETED|Overall Study||3||
59590175|NCT02673541|75697749|FG001|COMPLETED|Overall Study||2||
59590176|NCT02673541|75697748|FG000|NOT COMPLETED|Overall Study||0||
59590177|NCT02673541|75697749|FG001|NOT COMPLETED|Overall Study||0||
59590178|NCT02732366|75697757|FG000|STARTED|Overall Study||23||
59590179|NCT02732366|75697758|FG001|STARTED|Overall Study||23||
59590180|NCT02732366|75697757|FG000|Withdrawal by Participant|Overall Study||5||
59590181|NCT02732366|75697758|FG001|Withdrawal by Participant|Overall Study||2||
59590182|NCT02732366|75697757|FG000|COMPLETED|Overall Study||18||
59590183|NCT02732366|75697758|FG001|COMPLETED|Overall Study||21||
59590184|NCT02732366|75697757|FG000|NOT COMPLETED|Overall Study||5||
59590185|NCT02732366|75697758|FG001|NOT COMPLETED|Overall Study||2||
59590186|NCT02732600|75697769|FG000|STARTED|Overall Study||3525||13
59590187|NCT02732600|75697770|FG001|STARTED|Overall Study||2091||12
59590188|NCT02732600|75697769|FG000|Sub-set of Sites Newly Delivering PS Services|Overall Study||899||12
59590189|NCT02732600|75697770|FG001|Sub-set of Sites Newly Delivering PS Services|Overall Study||1484||11
59590190|NCT02732600|75697769|FG000|Veteran Baseline Veteran (Sub-set of 23 Sites)|Overall Study||118||12
59590191|NCT02732600|75697770|FG001|Veteran Baseline Veteran (Sub-set of 23 Sites)|Overall Study||145||11
59590192|NCT02732600|75697769|FG000|Veteran 6-months (Sub-set 23 Sites)|Overall Study||70||12
59590193|NCT02732600|75697770|FG001|Veteran 6-months (Sub-set 23 Sites)|Overall Study||84||11
59590194|NCT02732600|75697769|FG000|Veteran 1-year (Sub-set 23 Sites)|Overall Study||54||12
59590195|NCT02732600|75697770|FG001|Veteran 1-year (Sub-set 23 Sites)|Overall Study||71||11
59590196|NCT02732600|75697769|FG000|Peer Specialist Responses at 6-months (All 25 Sites)|Overall Study||12||13
59590197|NCT02732600|75697770|FG001|Peer Specialist Responses at 6-months (All 25 Sites)|Overall Study||14||12
59590198|NCT02732600|75697769|FG000|Peer Specialist Responses at 1-year (All 25 Sites)|Overall Study||5||13
59590199|NCT02732600|75697770|FG001|Peer Specialist Responses at 1-year (All 25 Sites)|Overall Study||12||12
59590200|NCT02732600|75697769|FG000|Supervisor Responses 6-months (All 25 Sites)|Overall Study||10||13
59590201|NCT02732600|75697770|FG001|Supervisor Responses 6-months (All 25 Sites)|Overall Study||21||12
59590202|NCT02732600|75697769|FG000|Supervisor 1-year (All 25 Sites)|Overall Study||6||13
59590203|NCT02732600|75697770|FG001|Supervisor 1-year (All 25 Sites)|Overall Study||10||12
59590204|NCT02732600|75697769|FG000|COMPLETED|Overall Study||100|These are the number of Veterans (across all 25 sites) who completed surveys|13
59590205|NCT02732600|75697770|FG001|COMPLETED|Overall Study||113|These are the number of Veterans (across all 25 sites) who completed surveys|12
59590206|NCT02732600|75697769|FG000|NOT COMPLETED|Overall Study||3425||0
59590207|NCT02732600|75697770|FG001|NOT COMPLETED|Overall Study||1978||0
59590208|NCT02734238|75697779|FG000|STARTED|Overall Study||26||
59590209|NCT02734238|75697780|FG001|STARTED|Overall Study||24||
59590210|NCT02734238|75697779|FG000|COMPLETED|Overall Study||26||
59590211|NCT02734238|75697780|FG001|COMPLETED|Overall Study||24||
59590212|NCT02734238|75697779|FG000|NOT COMPLETED|Overall Study||0||
59590213|NCT02734238|75697780|FG001|NOT COMPLETED|Overall Study||0||
59590214|NCT02734849|75697789|FG000|STARTED|Overall Study|One patient was randomized but never received study treatment and excluded from all analysis sets.|16||
59590215|NCT02734849|75697790|FG001|STARTED|Overall Study||14||
59590216|NCT02734849|75697791|FG002|STARTED|Overall Study||10||
59590217|NCT02734849|75697789|FG000|COMPLETED|Overall Study||12||
59590218|NCT02734849|75697790|FG001|COMPLETED|Overall Study||14||
59590219|NCT02734849|75697791|FG002|COMPLETED|Overall Study||9||
59590220|NCT02734849|75697789|FG000|NOT COMPLETED|Overall Study||4||
59590221|NCT02734849|75697790|FG001|NOT COMPLETED|Overall Study||0||
59590222|NCT02734849|75697791|FG002|NOT COMPLETED|Overall Study||1||
59590223|NCT02735551|75697802|FG000|STARTED|Overall Study||3||
59590224|NCT02735551|75697803|FG001|STARTED|Overall Study||0||
59590225|NCT02735551|75697804|FG002|STARTED|Overall Study||0||
59590226|NCT02735551|75697802|FG000|COMPLETED|Overall Study||3||
59590227|NCT02735551|75697803|FG001|COMPLETED|Overall Study||0||
59590228|NCT02735551|75697804|FG002|COMPLETED|Overall Study||0||
59590229|NCT02735551|75697802|FG000|NOT COMPLETED|Overall Study||0||
59590230|NCT02735551|75697803|FG001|NOT COMPLETED|Overall Study||0||
59590231|NCT02735551|75697804|FG002|NOT COMPLETED|Overall Study||0||
59590232|NCT02736175|75697814|FG000|STARTED|Overall Study||216||
59590233|NCT02736175|75697815|FG001|STARTED|Overall Study||222||
59590234|NCT02736175|75697814|FG000|COMPLETED|Overall Study||214||
59590235|NCT02736175|75697815|FG001|COMPLETED|Overall Study||221||
59590236|NCT02736175|75697814|FG000|NOT COMPLETED|Overall Study||2||
59590237|NCT02736175|75697815|FG001|NOT COMPLETED|Overall Study||1||
59590238|NCT02735174|75697821|FG000|STARTED|Overall Study||21||
59590239|NCT02735174|75697821|FG000|COMPLETED|Overall Study||21||
59590240|NCT02735174|75697821|FG000|NOT COMPLETED|Overall Study||0||
59590241|NCT02735642|75697827|FG000|STARTED|Overall Study||1046||
59590242|NCT02735642|75697828|FG001|STARTED|Overall Study||152||
59590243|NCT02735642|75697827|FG000|COMPLETED|Overall Study||1046||
59590244|NCT02735642|75697828|FG001|COMPLETED|Overall Study||152||
59590245|NCT02735642|75697827|FG000|NOT COMPLETED|Overall Study||0||
59590246|NCT02735642|75697828|FG001|NOT COMPLETED|Overall Study||0||
59590247|NCT02736955|75697841|FG000|STARTED|Overall Study||36||
59590248|NCT02736955|75697842|FG001|STARTED|Overall Study||117||
59590249|NCT02736955|75697843|FG002|STARTED|Overall Study||8||
59590250|NCT02736955|75697841|FG000|COMPLETED|Overall Study||29||
59590251|NCT02736955|75697842|FG001|COMPLETED|Overall Study||103||
59590252|NCT02736955|75697843|FG002|COMPLETED|Overall Study||6||
59590253|NCT02736955|75697841|FG000|NOT COMPLETED|Overall Study||7||
59590254|NCT02736955|75697842|FG001|NOT COMPLETED|Overall Study||14||
59590255|NCT02736955|75697843|FG002|NOT COMPLETED|Overall Study||2||
59590256|NCT02677753|75697854|FG000|STARTED|Overall Study||37||
59590257|NCT02677753|75697855|FG001|STARTED|Overall Study||38||
59590258|NCT02677753|75697854|FG000|COMPLETED|Overall Study||36||
59590259|NCT02677753|75697855|FG001|COMPLETED|Overall Study||38||
59590260|NCT02677753|75697854|FG000|NOT COMPLETED|Overall Study||1||
59590261|NCT02677753|75697855|FG001|NOT COMPLETED|Overall Study||0||
59590262|NCT02679469|75697861|FG000|STARTED|Overall Study||7||
59590263|NCT02679469|75697861|FG000|COMPLETED|Overall Study||7||
59590264|NCT02679469|75697861|FG000|NOT COMPLETED|Overall Study||0||
59590265|NCT02681809|75697868|FG000|STARTED|Overall Study||20||
59590266|NCT02681809|75697869|FG001|STARTED|Overall Study||19||
59590267|NCT02681809|75697870|FG002|STARTED|Overall Study||9||
59590268|NCT02681809|75697868|FG000|COMPLETED|Overall Study||15||
59590269|NCT02681809|75697869|FG001|COMPLETED|Overall Study||15||
59590270|NCT02681809|75697870|FG002|COMPLETED|Overall Study||8||
59590271|NCT02681809|75697868|FG000|NOT COMPLETED|Overall Study||5||
59590272|NCT02681809|75697869|FG001|NOT COMPLETED|Overall Study||4||
59590273|NCT02681809|75697870|FG002|NOT COMPLETED|Overall Study||1||
59590274|NCT04003987|75697880|FG000|STARTED|Overall Study||39||
59725292|NCT00833833|75844132|FG005|NOT COMPLETED|Phase 1 (as of 01 April 2011)||0||
59855237|NCT00369629|75979901|FG000|NOT COMPLETED|Moved on to 4 More Cycles||0||
59855238|NCT00369629|75979902|FG001|NOT COMPLETED|Moved on to 4 More Cycles||0||
59590275|NCT04003987|75697881|FG001|STARTED|Overall Study||39||
59590276|NCT04003987|75697880|FG000|COMPLETED|Overall Study||39||
59590277|NCT04003987|75697881|FG001|COMPLETED|Overall Study||39||
59590278|NCT04003987|75697880|FG000|NOT COMPLETED|Overall Study||0||
59590279|NCT04003987|75697881|FG001|NOT COMPLETED|Overall Study||0||
59590280|NCT03105128|75697890|FG000|STARTED|Period 1||373|Randomized|
59590281|NCT03105128|75697891|FG001|STARTED|Period 1||372|Randomized|
59590282|NCT03105128|75697892|FG002|STARTED|Period 1||186|Randomized|
59590283|NCT03105128|75697893|FG003|STARTED|Period 1||0|Randomized|
59590284|NCT03105128|75697894|FG004|STARTED|Period 1||0|Randomized|
59590285|NCT03105128|75697895|FG005|STARTED|Period 1||0|Randomized|
59590286|NCT03105128|75697896|FG006|STARTED|Period 1||0|Randomized|
59590287|NCT03105128|75697890|FG000|COMPLETED|Period 1||365|Completed Period 1|
59590288|NCT03105128|75697891|FG001|COMPLETED|Period 1||366|Completed Period 1|
59590289|NCT03105128|75697892|FG002|COMPLETED|Period 1||163|Completed Period 1|
59590290|NCT03105128|75697893|FG003|COMPLETED|Period 1||0|Completed Period 1|
59590291|NCT03105128|75697894|FG004|COMPLETED|Period 1||0|Completed Period 1|
59590292|NCT03105128|75697895|FG005|COMPLETED|Period 1||0|Completed Period 1|
59590293|NCT03105128|75697896|FG006|COMPLETED|Period 1||0|Completed Period 1|
59590294|NCT03105128|75697890|FG000|NOT COMPLETED|Period 1||8||
59590295|NCT03105128|75697891|FG001|NOT COMPLETED|Period 1||6||
59590296|NCT03105128|75697892|FG002|NOT COMPLETED|Period 1||23||
59590297|NCT03105128|75697893|FG003|NOT COMPLETED|Period 1||0||
59590298|NCT03105128|75697894|FG004|NOT COMPLETED|Period 1||0||
59590299|NCT03105128|75697895|FG005|NOT COMPLETED|Period 1||0||
59590300|NCT03105128|75697896|FG006|NOT COMPLETED|Period 1||0||
59590301|NCT03105128|75697890|FG000|STARTED|Period 2||0||
59590302|NCT03105128|75697891|FG001|STARTED|Period 2||0||
59590303|NCT03105128|75697892|FG002|STARTED|Period 2||0||
59590304|NCT03105128|75697893|FG003|STARTED|Period 2||67||
59590305|NCT03105128|75697894|FG004|STARTED|Period 2||68||
59590306|NCT03105128|75697895|FG005|STARTED|Period 2||67||
59590307|NCT03105128|75697896|FG006|STARTED|Period 2||76||
59590308|NCT03105128|75697890|FG000|COMPLETED|Period 2||0|Completed study|
59590309|NCT03105128|75697891|FG001|COMPLETED|Period 2||0|Completed study|
59590310|NCT03105128|75697892|FG002|COMPLETED|Period 2||0|Completed study|
59590311|NCT03105128|75697893|FG003|COMPLETED|Period 2||62|Completed study|
59590312|NCT03105128|75697894|FG004|COMPLETED|Period 2||65|Completed study|
59590313|NCT03105128|75697895|FG005|COMPLETED|Period 2||64|Completed study|
59590314|NCT03105128|75697896|FG006|COMPLETED|Period 2||74|Completed study|
59590315|NCT03105128|75697890|FG000|NOT COMPLETED|Period 2||0||
59590316|NCT03105128|75697891|FG001|NOT COMPLETED|Period 2||0||
59590317|NCT03105128|75697892|FG002|NOT COMPLETED|Period 2||0||
59590318|NCT03105128|75697893|FG003|NOT COMPLETED|Period 2||5||
59590319|NCT03105128|75697894|FG004|NOT COMPLETED|Period 2||3||
59590320|NCT03105128|75697895|FG005|NOT COMPLETED|Period 2||3||
59590321|NCT03105128|75697896|FG006|NOT COMPLETED|Period 2||2||
59590322|NCT03122509|75697912|FG000|STARTED|Overall Study||25||
59590323|NCT03122509|75697913|FG001|STARTED|Overall Study||0||
59590324|NCT03122509|75697912|FG000|COMPLETED|Overall Study||25||
59590325|NCT03122509|75697913|FG001|COMPLETED|Overall Study||0||
59590326|NCT03122509|75697912|FG000|NOT COMPLETED|Overall Study||0||
59590327|NCT03122509|75697913|FG001|NOT COMPLETED|Overall Study||0||
59590328|NCT04658888|75697920|FG000|STARTED|Overall Study||333||
59590329|NCT04658888|75697921|FG001|STARTED|Overall Study||631||
59590330|NCT04658888|75697920|FG000|COMPLETED|Overall Study||333||
59590331|NCT04658888|75697921|FG001|COMPLETED|Overall Study||631||
59590332|NCT04658888|75697920|FG000|NOT COMPLETED|Overall Study||0||
59590333|NCT04658888|75697921|FG001|NOT COMPLETED|Overall Study||0||
59590334|NCT02200614|75697931|FG000|STARTED|Double Blind Treatment||955|Randomized|
59590335|NCT02200614|75697932|FG001|STARTED|Double Blind Treatment||554|Randomized|
59590336|NCT02200614|75697931|FG000|COMPLETED|Double Blind Treatment||591|Ongoing with treatment|
59590337|NCT02200614|75697932|FG001|COMPLETED|Double Blind Treatment||170|Ongoing with treatment|
59590338|NCT02200614|75697931|FG000|NOT COMPLETED|Double Blind Treatment||364||
59590339|NCT02200614|75697932|FG001|NOT COMPLETED|Double Blind Treatment||384||
59590340|NCT02200614|75697931|FG000|STARTED|Open Label|Not all participants from treatment period entered follow-up|591||
59590341|NCT02200614|75697932|FG001|STARTED|Open Label|Not all participants from treatment period entered follow-up|170||
59590342|NCT02200614|75697931|FG000|COMPLETED|Open Label||295|Moving to roll-over study|
59590343|NCT02200614|75697932|FG001|COMPLETED|Open Label||114|Moving to roll-over study|
59590344|NCT02200614|75697931|FG000|NOT COMPLETED|Open Label||296||
59590345|NCT02200614|75697932|FG001|NOT COMPLETED|Open Label||56||
59590346|NCT02231892|75697943|FG000|STARTED|Overall Study||17||
59590347|NCT02231892|75697944|FG001|STARTED|Overall Study||17||
59590348|NCT02231892|75697945|FG002|STARTED|Overall Study||70||
59590349|NCT02231892|75697943|FG000|Sham|Overall Study||8|All participants were randomly assigned to sham, 100% MT, or 110% MT on each of 3 Study Days.|
59590350|NCT02231892|75697944|FG001|Sham|Overall Study||5|All participants were randomly assigned to sham, 100% MT, or 110% MT on each of 3 Study Days.|
59590351|NCT02231892|75697945|FG002|Sham|Overall Study||26|All participants were randomly assigned to sham, 100% MT, or 110% MT on each of 3 Study Days.|
59590352|NCT02231892|75697943|FG000|100% MT|Overall Study||7|All participants were randomly assigned to sham, 100% MT, or 110% MT on each of 3 Study Days.|
59590353|NCT02231892|75697944|FG001|100% MT|Overall Study||6|All participants were randomly assigned to sham, 100% MT, or 110% MT on each of 3 Study Days.|
59590354|NCT02231892|75697945|FG002|100% MT|Overall Study||25|All participants were randomly assigned to sham, 100% MT, or 110% MT on each of 3 Study Days.|
59590355|NCT02231892|75697943|FG000|110% MT|Overall Study||7|All participants were randomly assigned to sham, 100% MT, or 110% MT on each of 3 Study Days.|
59590356|NCT02231892|75697944|FG001|110% MT|Overall Study||5|All participants were randomly assigned to sham, 100% MT, or 110% MT on each of 3 Study Days.|
59590357|NCT02231892|75697945|FG002|110% MT|Overall Study||27|All participants were randomly assigned to sham, 100% MT, or 110% MT on each of 3 Study Days.|
59590358|NCT02231892|75697943|FG000|COMPLETED|Overall Study||6||
59590359|NCT02231892|75697944|FG001|COMPLETED|Overall Study|3 participants completed this phase and Hi Frequency MRI phase, but are only counted in Hi Freq MRI.|5||
59590360|NCT02231892|75697945|FG002|COMPLETED|Overall Study|3 participants completed this phase and Hi Frequency Beh phase, but are only counted in Hi Freq MRI.|25||
59590361|NCT02231892|75697943|FG000|NOT COMPLETED|Overall Study||11||
59590362|NCT02231892|75697944|FG001|NOT COMPLETED|Overall Study||12||
59590363|NCT02231892|75697945|FG002|NOT COMPLETED|Overall Study||45||
59590364|NCT02231580|75697961|FG000|STARTED|Overall Study||14||
59590365|NCT02231580|75697962|FG001|STARTED|Overall Study||3||
59590366|NCT02231580|75697961|FG000|Cohort 1|Overall Study||8||
59590367|NCT02231580|75697962|FG001|Cohort 1|Overall Study||2||
59590368|NCT02231580|75697961|FG000|Cohort 2|Overall Study||6||
59590369|NCT02231580|75697962|FG001|Cohort 2|Overall Study||1||
59590370|NCT02231580|75697961|FG000|COMPLETED|Overall Study||9||
59590371|NCT02231580|75697962|FG001|COMPLETED|Overall Study||3||
59590372|NCT02231580|75697961|FG000|NOT COMPLETED|Overall Study||5||
59590373|NCT02231580|75697962|FG001|NOT COMPLETED|Overall Study||0||
59590374|NCT02166606|75697970|FG000|STARTED|Overall Study||1184||
59590375|NCT02166606|75697970|FG000|Actively Enrolled|Overall Study||1180||
59590376|NCT02166606|75697970|FG000|Consent Eligible|Overall Study||1174||
59590377|NCT02166606|75697970|FG000|COMPLETED|Overall Study||1106||
59590378|NCT02166606|75697970|FG000|NOT COMPLETED|Overall Study||78||
59590379|NCT02230956|75697977|FG000|STARTED|Overall Study||44||
59590380|NCT02230956|75697978|FG001|STARTED|Overall Study||43||
59590381|NCT02230956|75697979|FG002|STARTED|Overall Study||89||
59590382|NCT02230956|75697977|FG000|COMPLETED|Overall Study||39||
59590383|NCT02230956|75697978|FG001|COMPLETED|Overall Study||37||
59590384|NCT02230956|75697979|FG002|COMPLETED|Overall Study||82||
59590385|NCT02230956|75697977|FG000|NOT COMPLETED|Overall Study||5||
59590386|NCT02230956|75697978|FG001|NOT COMPLETED|Overall Study||6||
59590387|NCT02230956|75697979|FG002|NOT COMPLETED|Overall Study||7||
59590388|NCT02230410|75697987|FG000|STARTED|Overall Study||18||
59590389|NCT02230410|75697987|FG000|COMPLETED|Overall Study||15||
59590390|NCT02230410|75697987|FG000|NOT COMPLETED|Overall Study||3||
59590391|NCT02230332|75697993|FG000|STARTED|Overall Study||38||
59590392|NCT02230332|75697994|FG001|STARTED|Overall Study||40||
59590393|NCT02230332|75697993|FG000|COMPLETED|Overall Study||34||
59590394|NCT02230332|75697994|FG001|COMPLETED|Overall Study||39||
59590395|NCT02230332|75697993|FG000|NOT COMPLETED|Overall Study||4||
59590396|NCT02230332|75697994|FG001|NOT COMPLETED|Overall Study||1||
59590397|NCT02230254|75698000|FG000|STARTED|Overall Study||101||
59590398|NCT02230254|75698000|FG000|COMPLETED|Overall Study||98||
59590399|NCT02230254|75698000|FG000|NOT COMPLETED|Overall Study||3||
59590400|NCT02198664|75698006|FG000|STARTED|Overall Study||26||
59590401|NCT02198664|75698007|FG001|STARTED|Overall Study||21||
59590402|NCT02198664|75698006|FG000|COMPLETED|Overall Study||10||
59590403|NCT02198664|75698007|FG001|COMPLETED|Overall Study||13||
59590404|NCT02198664|75698006|FG000|NOT COMPLETED|Overall Study||16||
59590405|NCT02198664|75698007|FG001|NOT COMPLETED|Overall Study||8||
59590406|NCT02165826|75698018|FG000|STARTED|Main Treatment Period||441||
59590407|NCT02165826|75698019|FG001|STARTED|Main Treatment Period||439||
59590408|NCT02165826|75698020|FG002|STARTED|Main Treatment Period||443||
59590409|NCT02165826|75698018|FG000|Safety Analysis Set: Received Study Drug|Main Treatment Period||441||
59590410|NCT02165826|75698019|FG001|Safety Analysis Set: Received Study Drug|Main Treatment Period||437||
59590411|NCT02165826|75698020|FG002|Safety Analysis Set: Received Study Drug|Main Treatment Period||443||
59590412|NCT02165826|75698018|FG000|COMPLETED|Main Treatment Period||360||
59590413|NCT02165826|75698019|FG001|COMPLETED|Main Treatment Period||349||
59590414|NCT02165826|75698020|FG002|COMPLETED|Main Treatment Period||334||
59590415|NCT02165826|75698018|FG000|NOT COMPLETED|Main Treatment Period||81||
59590416|NCT02165826|75698019|FG001|NOT COMPLETED|Main Treatment Period||90||
59590417|NCT02165826|75698020|FG002|NOT COMPLETED|Main Treatment Period||109||
59590418|NCT02165826|75698018|FG000|STARTED|Down-Titration Period||27||
59590419|NCT02165826|75698019|FG001|STARTED|Down-Titration Period||39||
59590420|NCT02165826|75698020|FG002|STARTED|Down-Titration Period||38||
59590421|NCT02165826|75698018|FG000|Safety Analysis Set: Received Study Drug|Down-Titration Period||27||
59590422|NCT02165826|75698019|FG001|Safety Analysis Set: Received Study Drug|Down-Titration Period||39||
59590423|NCT02165826|75698020|FG002|Safety Analysis Set: Received Study Drug|Down-Titration Period||38||
59590424|NCT02165826|75698018|FG000|COMPLETED|Down-Titration Period||20||
59590425|NCT02165826|75698019|FG001|COMPLETED|Down-Titration Period||28||
59590426|NCT02165826|75698020|FG002|COMPLETED|Down-Titration Period||31||
59590427|NCT02165826|75698018|FG000|NOT COMPLETED|Down-Titration Period||7||
59590428|NCT02165826|75698019|FG001|NOT COMPLETED|Down-Titration Period||11||
59590429|NCT02165826|75698020|FG002|NOT COMPLETED|Down-Titration Period||7||
59590430|NCT02535247|75698047|FG000|STARTED|Overall Study||17||
59590431|NCT02535247|75698048|FG001|STARTED|Overall Study||0||
59590432|NCT02535247|75698047|FG000|COMPLETED|Overall Study||13||
59590433|NCT02535247|75698048|FG001|COMPLETED|Overall Study||0||
59590434|NCT02535247|75698047|FG000|NOT COMPLETED|Overall Study||4||
59590435|NCT02535247|75698048|FG001|NOT COMPLETED|Overall Study||0||
59590436|NCT02198040|75698057|FG000|STARTED|Overall Study||9||
59590437|NCT02198040|75698058|FG001|STARTED|Overall Study||9||
59590438|NCT02198040|75698059|FG002|STARTED|Overall Study||9||
59590439|NCT02198040|75698057|FG000|COMPLETED|Overall Study||9||
59590440|NCT02198040|75698058|FG001|COMPLETED|Overall Study||8||
59590441|NCT02198040|75698059|FG002|COMPLETED|Overall Study||8||
59590442|NCT02198040|75698057|FG000|NOT COMPLETED|Overall Study||0||
59590443|NCT02198040|75698058|FG001|NOT COMPLETED|Overall Study||1||
59590444|NCT02198040|75698059|FG002|NOT COMPLETED|Overall Study||1||
59590445|NCT02197806|75698073|FG000|STARTED|Overall Study||15||
59590446|NCT02197806|75698074|FG001|STARTED|Overall Study||17||
59590447|NCT02197806|75698075|FG002|STARTED|Overall Study||16||
59590448|NCT02197806|75698076|FG003|STARTED|Overall Study||17||
59590449|NCT02197806|75698073|FG000|COMPLETED|Overall Study||15||
59590450|NCT02197806|75698074|FG001|COMPLETED|Overall Study||16||
59590451|NCT02197806|75698075|FG002|COMPLETED|Overall Study||16||
59590452|NCT02197806|75698076|FG003|COMPLETED|Overall Study||16||
59590453|NCT02197806|75698073|FG000|NOT COMPLETED|Overall Study||0||
59590454|NCT02197806|75698074|FG001|NOT COMPLETED|Overall Study||1||
59590455|NCT02197806|75698075|FG002|NOT COMPLETED|Overall Study||0||
59590456|NCT02197806|75698076|FG003|NOT COMPLETED|Overall Study||1||
59590457|NCT04109599|75698095|FG000|STARTED|Overall Study||3||
59590458|NCT04109599|75698096|FG001|STARTED|Overall Study||4||
59590459|NCT04109599|75698097|FG002|STARTED|Overall Study||4||
59590460|NCT04109599|75698098|FG003|STARTED|Overall Study||4||
59590461|NCT04109599|75698099|FG004|STARTED|Overall Study||4||
59590462|NCT04109599|75698100|FG005|STARTED|Overall Study||4||
59590463|NCT04109599|75698101|FG006|STARTED|Overall Study||4||
59590464|NCT04109599|75698102|FG007|STARTED|Overall Study||3||
59590465|NCT04109599|75698103|FG008|STARTED|Overall Study||3||
59590466|NCT04109599|75698095|FG000|COMPLETED|Overall Study||3||
59590467|NCT04109599|75698096|FG001|COMPLETED|Overall Study||4||
59590468|NCT04109599|75698097|FG002|COMPLETED|Overall Study||4||
59590469|NCT04109599|75698098|FG003|COMPLETED|Overall Study||4||
59590470|NCT04109599|75698099|FG004|COMPLETED|Overall Study||4||
59590471|NCT04109599|75698100|FG005|COMPLETED|Overall Study||4||
59590472|NCT04109599|75698101|FG006|COMPLETED|Overall Study||4||
59590473|NCT04109599|75698102|FG007|COMPLETED|Overall Study||3||
59590474|NCT04109599|75698103|FG008|COMPLETED|Overall Study||3||
59590475|NCT04109599|75698095|FG000|NOT COMPLETED|Overall Study||0||
59590476|NCT04109599|75698096|FG001|NOT COMPLETED|Overall Study||0||
59590477|NCT04109599|75698097|FG002|NOT COMPLETED|Overall Study||0||
59590478|NCT04109599|75698098|FG003|NOT COMPLETED|Overall Study||0||
59590479|NCT04109599|75698099|FG004|NOT COMPLETED|Overall Study||0||
59590480|NCT04109599|75698100|FG005|NOT COMPLETED|Overall Study||0||
59590481|NCT04109599|75698101|FG006|NOT COMPLETED|Overall Study||0||
59590482|NCT04109599|75698102|FG007|NOT COMPLETED|Overall Study||0||
59590483|NCT04109599|75698103|FG008|NOT COMPLETED|Overall Study||0||
59590484|NCT02229864|75698123|FG000|STARTED|Overall Study||12||
59590485|NCT02229864|75698123|FG000|COMPLETED|Overall Study||9||
59590486|NCT02229864|75698123|FG000|NOT COMPLETED|Overall Study||3||
59590487|NCT02229552|75698127|FG000|STARTED|Baseline||237||
59590488|NCT02229552|75698127|FG000|COMPLETED|Baseline||231||
59590489|NCT02229552|75698127|FG000|NOT COMPLETED|Baseline||6||
59590490|NCT02229552|75698127|FG000|STARTED|1-year Follow up||231||
59590491|NCT02229552|75698127|FG000|COMPLETED|1-year Follow up||206||
59590492|NCT02229552|75698127|FG000|NOT COMPLETED|1-year Follow up||25||
59590493|NCT02229552|75698127|FG000|STARTED|2-Year Follow up|All baseline participants were eligible for year 2 follow up, regardless of completion of year 1.|231||
59590494|NCT02229552|75698127|FG000|COMPLETED|2-Year Follow up||205||
59590495|NCT02229552|75698127|FG000|NOT COMPLETED|2-Year Follow up||26||
59590496|NCT02229396|75698134|FG000|STARTED|Overall Study||233||
59590497|NCT02229396|75698135|FG001|STARTED|Overall Study||231||
59590498|NCT02229396|75698136|FG002|STARTED|Overall Study||231||
59590499|NCT02229396|75698134|FG000|Randomization Code Allocated|Overall Study||233||
59590500|NCT02229396|75698135|FG001|Randomization Code Allocated|Overall Study||231||
59590501|NCT02229396|75698136|FG002|Randomization Code Allocated|Overall Study||231||
59590502|NCT02229396|75698134|FG000|Safety Analysis Set|Overall Study||233||
59590503|NCT02229396|75698135|FG001|Safety Analysis Set|Overall Study||231||
59590504|NCT02229396|75698136|FG002|Safety Analysis Set|Overall Study||230||
59590505|NCT02229396|75698134|FG000|Intent-to-Treat (ITT) Analysis Set|Overall Study||230||
59590506|NCT02229396|75698135|FG001|Intent-to-Treat (ITT) Analysis Set|Overall Study||228||
59590507|NCT02229396|75698136|FG002|Intent-to-Treat (ITT) Analysis Set|Overall Study||227||
59590508|NCT02229396|75698134|FG000|Completed 28-Week Study Period|Overall Study||208||
59590509|NCT02229396|75698135|FG001|Completed 28-Week Study Period|Overall Study||202||
59590510|NCT02229396|75698136|FG002|Completed 28-Week Study Period|Overall Study||193||
59590511|NCT02229396|75698134|FG000|Completed 52-Week Study Period|Overall Study||194||
59590512|NCT02229396|75698135|FG001|Completed 52-Week Study Period|Overall Study||193||
59590513|NCT02229396|75698136|FG002|Completed 52-Week Study Period|Overall Study||177||
59590514|NCT02229396|75698134|FG000|COMPLETED|Overall Study||155|Completed 104-Week Study Period|
59590515|NCT02229396|75698135|FG001|COMPLETED|Overall Study||154|Completed 104-Week Study Period|
59590516|NCT02229396|75698136|FG002|COMPLETED|Overall Study||136|Completed 104-Week Study Period|
59590517|NCT02229396|75698134|FG000|NOT COMPLETED|Overall Study||78||
59590518|NCT02229396|75698135|FG001|NOT COMPLETED|Overall Study||77||
59590519|NCT02229396|75698136|FG002|NOT COMPLETED|Overall Study||95||
59590520|NCT01452854|75698144|FG000|STARTED|Overall Study||2||
59590521|NCT01452854|75698144|FG000|COMPLETED|Overall Study||2||
59590522|NCT01452854|75698144|FG000|NOT COMPLETED|Overall Study||0||
59590523|NCT02197416|75698151|FG000|STARTED|Overall Study||9||
59590524|NCT02197416|75698152|FG001|STARTED|Overall Study||43||
59590525|NCT02197416|75698153|FG002|STARTED|Overall Study||161||
59590526|NCT02197416|75698151|FG000|COMPLETED|Overall Study||8||
59590527|NCT02197416|75698152|FG001|COMPLETED|Overall Study||39||
59590528|NCT02197416|75698153|FG002|COMPLETED|Overall Study||153||
59590529|NCT02197416|75698151|FG000|NOT COMPLETED|Overall Study||1||
59590530|NCT02197416|75698152|FG001|NOT COMPLETED|Overall Study||4||
59590531|NCT02197416|75698153|FG002|NOT COMPLETED|Overall Study||8||
59590532|NCT02165202|75698161|FG000|STARTED|Oral Phase|Participants Enrolled in the study|91||
59590533|NCT02165202|75698162|FG001|STARTED|Oral Phase|Participants Enrolled in the study|45||
59725293|NCT00833833|75844127|FG000|STARTED|Phase 2 (as of 01 April 2011)||0||
59725294|NCT00833833|75844128|FG001|STARTED|Phase 2 (as of 01 April 2011)||0||
59725295|NCT00833833|75844129|FG002|STARTED|Phase 2 (as of 01 April 2011)||0||
59725296|NCT00833833|75844130|FG003|STARTED|Phase 2 (as of 01 April 2011)||0||
59725297|NCT00833833|75844131|FG004|STARTED|Phase 2 (as of 01 April 2011)||113||
59725298|NCT00833833|75844132|FG005|STARTED|Phase 2 (as of 01 April 2011)||108||
59725299|NCT00833833|75844127|FG000|Safety Population|Phase 2 (as of 01 April 2011)||0||
59725300|NCT00833833|75844128|FG001|Safety Population|Phase 2 (as of 01 April 2011)||0||
59725301|NCT00833833|75844129|FG002|Safety Population|Phase 2 (as of 01 April 2011)||0||
59725302|NCT00833833|75844130|FG003|Safety Population|Phase 2 (as of 01 April 2011)||0||
59725303|NCT00833833|75844131|FG004|Safety Population|Phase 2 (as of 01 April 2011)||112||
59725304|NCT00833833|75844132|FG005|Safety Population|Phase 2 (as of 01 April 2011)||107||
59725305|NCT00833833|75844127|FG000|COMPLETED|Phase 2 (as of 01 April 2011)||0||
59725306|NCT00833833|75844128|FG001|COMPLETED|Phase 2 (as of 01 April 2011)||0||
59725307|NCT00833833|75844129|FG002|COMPLETED|Phase 2 (as of 01 April 2011)||0||
59725308|NCT00833833|75844130|FG003|COMPLETED|Phase 2 (as of 01 April 2011)||0||
59725309|NCT00833833|75844131|FG004|COMPLETED|Phase 2 (as of 01 April 2011)|Confirmed progressive disease|58||
59725310|NCT00833833|75844132|FG005|COMPLETED|Phase 2 (as of 01 April 2011)|Confirmed progressive disease|47||
59725311|NCT00833833|75844127|FG000|NOT COMPLETED|Phase 2 (as of 01 April 2011)||0||
59725312|NCT00833833|75844128|FG001|NOT COMPLETED|Phase 2 (as of 01 April 2011)||0||
59725313|NCT00833833|75844129|FG002|NOT COMPLETED|Phase 2 (as of 01 April 2011)||0||
59725314|NCT00833833|75844130|FG003|NOT COMPLETED|Phase 2 (as of 01 April 2011)||0||
59725315|NCT00833833|75844131|FG004|NOT COMPLETED|Phase 2 (as of 01 April 2011)||55||
59725316|NCT00833833|75844132|FG005|NOT COMPLETED|Phase 2 (as of 01 April 2011)||61||
59725317|NCT01098071|75844152|FG000|STARTED|Overall Study||34||
59725318|NCT01098071|75844152|FG000|COMPLETED|Overall Study||19||
59590534|NCT02165202|75698161|FG000|COMPLETED|Oral Phase||80|Participants who completed oral run in phase (0-week 4) and received at least 1 injection.|
59590535|NCT02165202|75698162|FG001|COMPLETED|Oral Phase||42|Participants who completed oral run in phase (0-week 4) and received at least 1 injection.|
59590536|NCT02165202|75698161|FG000|NOT COMPLETED|Oral Phase||11||
59590537|NCT02165202|75698162|FG001|NOT COMPLETED|Oral Phase||3||
59590538|NCT02165202|75698161|FG000|STARTED|Injection Phase|Participants who received at least one injection.|80||
59590539|NCT02165202|75698162|FG001|STARTED|Injection Phase|Participants who received at least one injection.|42||
59590540|NCT02165202|75698161|FG000|COMPLETED|Injection Phase||70|Ppts who received at least 1 injection but were not discontinued or terminated till the end of study|
59725319|NCT01098071|75844152|FG000|NOT COMPLETED|Overall Study||15||
59725320|NCT01097057|75844156|FG000|STARTED|Overall Study||20||
59725321|NCT01097057|75844156|FG000|COMPLETED|Overall Study||17||
59725322|NCT01097057|75844156|FG000|NOT COMPLETED|Overall Study||3||
59725323|NCT01022112|75844165|FG000|STARTED|Overall Study||82||
59725324|NCT01022112|75844166|FG001|STARTED|Overall Study||74||
59725325|NCT01022112|75844167|FG002|STARTED|Overall Study||77||
59725326|NCT01022112|75844168|FG003|STARTED|Overall Study||75||
59725327|NCT01022112|75844169|FG004|STARTED|Overall Study||75||
59725328|NCT01022112|75844165|FG000|COMPLETED|Overall Study||79||
59725329|NCT01022112|75844166|FG001|COMPLETED|Overall Study||71||
59725330|NCT01022112|75844167|FG002|COMPLETED|Overall Study||74||
59725331|NCT01022112|75844168|FG003|COMPLETED|Overall Study||72||
59725332|NCT01022112|75844169|FG004|COMPLETED|Overall Study||65||
59725333|NCT01022112|75844165|FG000|NOT COMPLETED|Overall Study||3||
59725334|NCT01022112|75844166|FG001|NOT COMPLETED|Overall Study||3||
59725335|NCT01022112|75844167|FG002|NOT COMPLETED|Overall Study||3||
59725336|NCT01022112|75844168|FG003|NOT COMPLETED|Overall Study||3||
59725337|NCT01022112|75844169|FG004|NOT COMPLETED|Overall Study||10||
59725338|NCT01096667|75844186|FG000|STARTED|Overall Study||39||
59725339|NCT01096667|75844187|FG001|STARTED|Overall Study||39||
59725340|NCT01096667|75844188|FG002|STARTED|Overall Study||38||
59725341|NCT01096667|75844189|FG003|STARTED|Overall Study||39||
59590541|NCT02165202|75698162|FG001|COMPLETED|Injection Phase||36|Ppts who received at least 1 injection but were not discontinued or terminated till the end of study|
59725342|NCT01096667|75844190|FG004|STARTED|Overall Study||39||
59725343|NCT01096667|75844186|FG000|Treated|Overall Study||38||
59725344|NCT01096667|75844187|FG001|Treated|Overall Study||39||
59725345|NCT01096667|75844188|FG002|Treated|Overall Study||38||
59725346|NCT01096667|75844189|FG003|Treated|Overall Study||39||
59725347|NCT01096667|75844190|FG004|Treated|Overall Study||39||
59725348|NCT01096667|75844186|FG000|COMPLETED|Overall Study||36||
59725349|NCT01096667|75844187|FG001|COMPLETED|Overall Study||37||
59725350|NCT01096667|75844188|FG002|COMPLETED|Overall Study||36||
59590542|NCT02165202|75698161|FG000|NOT COMPLETED|Injection Phase||10||
59590543|NCT02165202|75698162|FG001|NOT COMPLETED|Injection Phase||6||
59855239|NCT00369629|75979903|FG002|NOT COMPLETED|Moved on to 4 More Cycles||1||
59855240|NCT00369629|75979904|FG003|NOT COMPLETED|Moved on to 4 More Cycles||0||
59855241|NCT00369629|75979901|FG000|STARTED|Completed 4 More Cycles||4||
59855242|NCT00369629|75979902|FG001|STARTED|Completed 4 More Cycles||2||
59855243|NCT00369629|75979903|FG002|STARTED|Completed 4 More Cycles||2||
59855244|NCT00369629|75979904|FG003|STARTED|Completed 4 More Cycles||0||
59855245|NCT00369629|75979901|FG000|COMPLETED|Completed 4 More Cycles||0||
59855246|NCT00369629|75979902|FG001|COMPLETED|Completed 4 More Cycles||0||
59855247|NCT00369629|75979903|FG002|COMPLETED|Completed 4 More Cycles||0||
59855248|NCT00369629|75979904|FG003|COMPLETED|Completed 4 More Cycles||0||
59590544|NCT01628874|75698170|FG000|STARTED|Overall Study||34||
59590545|NCT01628874|75698171|FG001|STARTED|Overall Study||32||
59590546|NCT01628874|75698170|FG000|COMPLETED|Overall Study||29||
59590547|NCT01628874|75698171|FG001|COMPLETED|Overall Study||29||
59590548|NCT01628874|75698170|FG000|NOT COMPLETED|Overall Study||5||
59590549|NCT01628874|75698171|FG001|NOT COMPLETED|Overall Study||3||
59590550|NCT03770689|75698181|FG000|STARTED|Overall Study||1||
59590551|NCT03770689|75698182|FG001|STARTED|Overall Study||6||
59590552|NCT03770689|75698183|FG002|STARTED|Overall Study||6||
59590553|NCT03770689|75698184|FG003|STARTED|Overall Study||6||
59590554|NCT03770689|75698181|FG000|Pharmacokinetic Analysis Set|Overall Study|Number of participants analyzed in 50 mg group for PK outcome is different than PK analysis set. Because 1 participant from peposertib 100 mg took peposertib 50 mg from Fraction Day (FD) 1 through FD 10. PK results for this participant was summarized by actual dose received (50 mg) whereas non-PK results are summarized by planned dose (100 mg). Number of participants analyzed for 50 mg dose level in PK outputs that is 2 was therefore higher than non-PK outputs that is 1.|1||
59590555|NCT03770689|75698182|FG001|Pharmacokinetic Analysis Set|Overall Study|Number of participants analyzed in 100 mg group for PK outcome is different than PK analysis set. Because 1 participant from peposertib 100 mg took peposertib 50 mg from Fraction Day (FD) 1 through FD 10. PK results for this participant was summarized by actual dose received (50 mg) whereas non-PK results are summarized by planned dose (100 mg). Number of participants analyzed for 100 mg dose level in PK outputs that is 5 was therefore lesser than non-PK outputs that is 6.|6||
59590556|NCT03770689|75698183|FG002|Pharmacokinetic Analysis Set|Overall Study||6||
59590557|NCT03770689|75698184|FG003|Pharmacokinetic Analysis Set|Overall Study||6||
59590558|NCT03770689|75698181|FG000|Full Analysis Set (FAS)|Overall Study||1||
59590559|NCT03770689|75698182|FG001|Full Analysis Set (FAS)|Overall Study||6||
59590560|NCT03770689|75698183|FG002|Full Analysis Set (FAS)|Overall Study||6||
59590561|NCT03770689|75698184|FG003|Full Analysis Set (FAS)|Overall Study||6||
59590562|NCT03770689|75698181|FG000|Safety Analysis Set (SAF)|Overall Study||1||
59590563|NCT03770689|75698182|FG001|Safety Analysis Set (SAF)|Overall Study||6||
59590564|NCT03770689|75698183|FG002|Safety Analysis Set (SAF)|Overall Study||6||
59590565|NCT03770689|75698184|FG003|Safety Analysis Set (SAF)|Overall Study||6||
59590566|NCT03770689|75698181|FG000|COMPLETED|Overall Study||1||
59590567|NCT03770689|75698182|FG001|COMPLETED|Overall Study||6||
59590568|NCT03770689|75698183|FG002|COMPLETED|Overall Study||6||
59590569|NCT03770689|75698184|FG003|COMPLETED|Overall Study||6||
59590570|NCT03770689|75698181|FG000|NOT COMPLETED|Overall Study||0||
59590571|NCT03770689|75698182|FG001|NOT COMPLETED|Overall Study||0||
59590572|NCT03770689|75698183|FG002|NOT COMPLETED|Overall Study||0||
59590573|NCT03770689|75698184|FG003|NOT COMPLETED|Overall Study||0||
59590574|NCT02196714|75698196|FG000|STARTED|Overall Study||24||
59590575|NCT02196714|75698197|FG001|STARTED|Overall Study||23||
59590576|NCT02196714|75698198|FG002|STARTED|Overall Study||24||
59590577|NCT02196714|75698199|FG003|STARTED|Overall Study||24||
59590578|NCT02196714|75698196|FG000|COMPLETED|Overall Study||24||
59725351|NCT01096667|75844189|FG003|COMPLETED|Overall Study||36||
59725352|NCT01096667|75844190|FG004|COMPLETED|Overall Study||39||
59725353|NCT01096667|75844186|FG000|NOT COMPLETED|Overall Study||3||
59725354|NCT01096667|75844187|FG001|NOT COMPLETED|Overall Study||2||
59725355|NCT01096667|75844188|FG002|NOT COMPLETED|Overall Study||2||
59725356|NCT01096667|75844189|FG003|NOT COMPLETED|Overall Study||3||
59725357|NCT01096667|75844190|FG004|NOT COMPLETED|Overall Study||0||
59725358|NCT01014624|75844205|FG000|STARTED|Overall Study||29||
59725359|NCT01014624|75844206|FG001|STARTED|Overall Study||27||
59725360|NCT01014624|75844205|FG000|COMPLETED|Overall Study||27||
59725361|NCT01014624|75844206|FG001|COMPLETED|Overall Study||26||
59725362|NCT01014624|75844205|FG000|NOT COMPLETED|Overall Study||2||
59725363|NCT01014624|75844206|FG001|NOT COMPLETED|Overall Study||1||
59725364|NCT01021878|75844216|FG000|STARTED|Overall Study||33||
59725365|NCT01021878|75844217|FG001|STARTED|Overall Study||27||
59725366|NCT01021878|75844216|FG000|Completed Follow-up|Overall Study||17||
59725367|NCT01021878|75844217|FG001|Completed Follow-up|Overall Study||17||
59725368|NCT01021878|75844216|FG000|COMPLETED|Overall Study||17||
59725369|NCT01021878|75844217|FG001|COMPLETED|Overall Study||17||
59725370|NCT01021878|75844216|FG000|NOT COMPLETED|Overall Study||16||
59725371|NCT01021878|75844217|FG001|NOT COMPLETED|Overall Study||10||
59855249|NCT00369629|75979901|FG000|NOT COMPLETED|Completed 4 More Cycles||4||
59855250|NCT00369629|75979902|FG001|NOT COMPLETED|Completed 4 More Cycles||2||
59725372|NCT00854113|75844237|FG000|STARTED|Overall Study||6||
59855251|NCT00369629|75979903|FG002|NOT COMPLETED|Completed 4 More Cycles||2||
59855252|NCT00369629|75979904|FG003|NOT COMPLETED|Completed 4 More Cycles||0||
59855253|NCT00369629|75979901|FG000|STARTED|Follow up for 1 Year|All patients treated on study go into the follow up period|6||
59855254|NCT00369629|75979902|FG001|STARTED|Follow up for 1 Year||3||
59855255|NCT00369629|75979903|FG002|STARTED|Follow up for 1 Year||5||
59855256|NCT00369629|75979904|FG003|STARTED|Follow up for 1 Year||0||
59855257|NCT00369629|75979901|FG000|COMPLETED|Follow up for 1 Year||4||
59855258|NCT00369629|75979902|FG001|COMPLETED|Follow up for 1 Year||1||
59855259|NCT00369629|75979903|FG002|COMPLETED|Follow up for 1 Year||2||
59855260|NCT00369629|75979904|FG003|COMPLETED|Follow up for 1 Year||0||
59855261|NCT00369629|75979901|FG000|NOT COMPLETED|Follow up for 1 Year||2||
59855262|NCT00369629|75979902|FG001|NOT COMPLETED|Follow up for 1 Year||2||
59855263|NCT00369629|75979903|FG002|NOT COMPLETED|Follow up for 1 Year||3||
59855264|NCT00369629|75979904|FG003|NOT COMPLETED|Follow up for 1 Year||0||
59855265|NCT02469064|75979916|FG000|STARTED|Overall Study||64||
59855266|NCT02469064|75979917|FG001|STARTED|Overall Study||62||
59855267|NCT02469064|75979916|FG000|COMPLETED|Overall Study||63||
59855268|NCT02469064|75979917|FG001|COMPLETED|Overall Study||59||
59855269|NCT02469064|75979916|FG000|NOT COMPLETED|Overall Study||1||
59855270|NCT02469064|75979917|FG001|NOT COMPLETED|Overall Study||3||
59855271|NCT02446912|75979926|FG000|STARTED|Overall Study||93||
59855272|NCT02446912|75979927|FG001|STARTED|Overall Study||180||
59855273|NCT02446912|75979928|FG002|STARTED|Overall Study||184||
59855274|NCT02446912|75979926|FG000|Participants Who Completed Week 52|Overall Study||80||
59855275|NCT02446912|75979927|FG001|Participants Who Completed Week 52|Overall Study||153||
59855276|NCT02446912|75979928|FG002|Participants Who Completed Week 52|Overall Study||157||
59855277|NCT02446912|75979926|FG000|COMPLETED|Overall Study||75||
59855278|NCT02446912|75979927|FG001|COMPLETED|Overall Study||145||
59855279|NCT02446912|75979928|FG002|COMPLETED|Overall Study||149||
59855280|NCT02446912|75979926|FG000|NOT COMPLETED|Overall Study||18||
59855281|NCT02446912|75979927|FG001|NOT COMPLETED|Overall Study||35||
59855282|NCT02446912|75979928|FG002|NOT COMPLETED|Overall Study||35||
59855283|NCT00736840|75979936|FG000|STARTED|Overall Study||414||
59590579|NCT02196714|75698197|FG001|COMPLETED|Overall Study||23||
59590580|NCT02196714|75698198|FG002|COMPLETED|Overall Study||23||
59590581|NCT02196714|75698199|FG003|COMPLETED|Overall Study||24||
59590582|NCT02196714|75698196|FG000|NOT COMPLETED|Overall Study||0||
59590583|NCT02196714|75698197|FG001|NOT COMPLETED|Overall Study||0||
59590584|NCT02196714|75698198|FG002|NOT COMPLETED|Overall Study||1||
59590585|NCT02196714|75698199|FG003|NOT COMPLETED|Overall Study||0||
59590586|NCT02737891|75698213|FG000|STARTED|Overall Study||30||
59590587|NCT02737891|75698214|FG001|STARTED|Overall Study||30||
59590588|NCT02737891|75698213|FG000|COMPLETED|Overall Study||30||
59590589|NCT02737891|75698214|FG001|COMPLETED|Overall Study||28||
59590590|NCT02737891|75698213|FG000|NOT COMPLETED|Overall Study||0||
59590591|NCT02737891|75698214|FG001|NOT COMPLETED|Overall Study||2||
59725373|NCT00854113|75844238|FG001|STARTED|Overall Study||6||
59725374|NCT00854113|75844239|FG002|STARTED|Overall Study||6||
59725375|NCT00854113|75844240|FG003|STARTED|Overall Study||6||
59725376|NCT00854113|75844241|FG004|STARTED|Overall Study||6||
59725377|NCT00854113|75844242|FG005|STARTED|Overall Study||6||
59725378|NCT00854113|75844243|FG006|STARTED|Overall Study||12||
59725379|NCT00854113|75844244|FG007|STARTED|Overall Study||8||
59725380|NCT00854113|75844245|FG008|STARTED|Overall Study||8||
59725381|NCT00854113|75844246|FG009|STARTED|Overall Study||8||
59725382|NCT00854113|75844247|FG010|STARTED|Overall Study||6||
59725383|NCT00854113|75844237|FG000|COMPLETED|Overall Study||6||
59725384|NCT00854113|75844238|FG001|COMPLETED|Overall Study||6||
59725385|NCT00854113|75844239|FG002|COMPLETED|Overall Study||6||
59725386|NCT00854113|75844240|FG003|COMPLETED|Overall Study||6||
59725387|NCT00854113|75844241|FG004|COMPLETED|Overall Study||6||
59725388|NCT00854113|75844242|FG005|COMPLETED|Overall Study||6||
59725389|NCT00854113|75844243|FG006|COMPLETED|Overall Study||12||
59725390|NCT00854113|75844244|FG007|COMPLETED|Overall Study||5||
59725391|NCT00854113|75844245|FG008|COMPLETED|Overall Study||7||
59725392|NCT00854113|75844246|FG009|COMPLETED|Overall Study||8||
59725393|NCT00854113|75844247|FG010|COMPLETED|Overall Study||6||
59725394|NCT00854113|75844237|FG000|NOT COMPLETED|Overall Study||0||
59855284|NCT00736840|75979936|FG000|COMPLETED|Overall Study|9 subjects-no biopsy results, 2-no breath test, 2 no biopsy results and no complete breath test|401||
59855285|NCT00736840|75979936|FG000|NOT COMPLETED|Overall Study||13||
60121767|NCT01561313|76242731|FG001|NOT COMPLETED|Overall Study||0||
59590592|NCT02196558|75698223|FG000|STARTED|Treatment Phase (12 Weeks)||12||
59590593|NCT02196558|75698224|FG001|STARTED|Treatment Phase (12 Weeks)||15||
59725395|NCT00854113|75844238|FG001|NOT COMPLETED|Overall Study||0||
59725396|NCT00854113|75844239|FG002|NOT COMPLETED|Overall Study||0||
59725397|NCT00854113|75844240|FG003|NOT COMPLETED|Overall Study||0||
59855286|NCT00318461|75979945|FG000|STARTED|Double-Blind, 6 Months|Randomised|242||
59855287|NCT00318461|75979946|FG001|STARTED|Double-Blind, 6 Months|Randomised|241||
59590594|NCT02196558|75698225|FG002|STARTED|Treatment Phase (12 Weeks)||10||
59590595|NCT02196558|75698223|FG000|COMPLETED|Treatment Phase (12 Weeks)||12||
59725398|NCT00854113|75844241|FG004|NOT COMPLETED|Overall Study||0||
59725399|NCT00854113|75844242|FG005|NOT COMPLETED|Overall Study||0||
59855288|NCT00318461|75979947|FG002|STARTED|Double-Blind, 6 Months|Randomised|242||
59855289|NCT00318461|75979948|FG003|STARTED|Double-Blind, 6 Months|Randomised|122||
59855290|NCT00318461|75979949|FG004|STARTED|Double-Blind, 6 Months|Randomised|244||
59855291|NCT00318461|75979945|FG000|Exposed to Study Drug|Double-Blind, 6 Months||242||
59855292|NCT00318461|75979946|FG001|Exposed to Study Drug|Double-Blind, 6 Months|Subject withdrew before exposure to drug, and thus not included in the safety and ITT analysis sets|240||
59855293|NCT00318461|75979947|FG002|Exposed to Study Drug|Double-Blind, 6 Months||242||
59855294|NCT00318461|75979948|FG003|Exposed to Study Drug|Double-Blind, 6 Months|Subject withdrew before exposure to drug, and thus not included in the safety and ITT analysis sets|121||
59855295|NCT00318461|75979949|FG004|Exposed to Study Drug|Double-Blind, 6 Months|Subjects withdrew before exposure to drug, and thus not included in the safety and ITT analysis sets|242||
59855296|NCT00318461|75979945|FG000|COMPLETED|Double-Blind, 6 Months||208||
59855297|NCT00318461|75979946|FG001|COMPLETED|Double-Blind, 6 Months||197||
59855298|NCT00318461|75979947|FG002|COMPLETED|Double-Blind, 6 Months||191||
59855299|NCT00318461|75979948|FG003|COMPLETED|Double-Blind, 6 Months||74||
59855300|NCT00318461|75979949|FG004|COMPLETED|Double-Blind, 6 Months||210||
59855301|NCT00318461|75979945|FG000|NOT COMPLETED|Double-Blind, 6 Months||34||
59855302|NCT00318461|75979946|FG001|NOT COMPLETED|Double-Blind, 6 Months||44||
59855303|NCT00318461|75979947|FG002|NOT COMPLETED|Double-Blind, 6 Months||51||
59855304|NCT00318461|75979948|FG003|NOT COMPLETED|Double-Blind, 6 Months||48||
60121768|NCT01561079|76242737|FG000|STARTED|Overall Study||127||
59855305|NCT00318461|75979949|FG004|NOT COMPLETED|Double-Blind, 6 Months||34||
59855306|NCT00318461|75979945|FG000|STARTED|Open-Label Extension, 18 Months||208||
59855307|NCT00318461|75979946|FG001|STARTED|Open-Label Extension, 18 Months||197||
59855308|NCT00318461|75979947|FG002|STARTED|Open-Label Extension, 18 Months||191||
59855309|NCT00318461|75979948|FG003|STARTED|Open-Label Extension, 18 Months||74||
59855310|NCT00318461|75979949|FG004|STARTED|Open-Label Extension, 18 Months||210||
59855311|NCT00318461|75979945|FG000|COMPLETED|Open-Label Extension, 18 Months||130||
59855312|NCT00318461|75979946|FG001|COMPLETED|Open-Label Extension, 18 Months||137||
59855313|NCT00318461|75979947|FG002|COMPLETED|Open-Label Extension, 18 Months||118||
59855314|NCT00318461|75979948|FG003|COMPLETED|Open-Label Extension, 18 Months||31||
59855315|NCT00318461|75979949|FG004|COMPLETED|Open-Label Extension, 18 Months||113||
59855316|NCT00318461|75979945|FG000|NOT COMPLETED|Open-Label Extension, 18 Months||78||
59855317|NCT00318461|75979946|FG001|NOT COMPLETED|Open-Label Extension, 18 Months||60||
59855318|NCT00318461|75979947|FG002|NOT COMPLETED|Open-Label Extension, 18 Months||73||
59855319|NCT00318461|75979948|FG003|NOT COMPLETED|Open-Label Extension, 18 Months||43||
59855320|NCT00318461|75979949|FG004|NOT COMPLETED|Open-Label Extension, 18 Months||97||
59855321|NCT04043312|75979963|FG000|STARTED|Overall Study||12||
59855322|NCT04043312|75979964|FG001|STARTED|Overall Study||14||
59855323|NCT04043312|75979963|FG000|COMPLETED|Overall Study||12||
59855324|NCT04043312|75979964|FG001|COMPLETED|Overall Study||14||
59855325|NCT04043312|75979963|FG000|NOT COMPLETED|Overall Study||0||
59855326|NCT04043312|75979964|FG001|NOT COMPLETED|Overall Study||0||
59855327|NCT03764072|75979976|FG000|STARTED|Overall Study||46||
59855328|NCT03764072|75979977|FG001|STARTED|Overall Study||42||
59855329|NCT03764072|75979978|FG002|STARTED|Overall Study||44||
59855330|NCT03764072|75979979|FG003|STARTED|Overall Study||45||
59855331|NCT03764072|75979980|FG004|STARTED|Overall Study||46||
59855332|NCT03764072|75979981|FG005|STARTED|Overall Study||27||
59855333|NCT03764072|75979976|FG000|COMPLETED|Overall Study||46||
59855334|NCT03764072|75979977|FG001|COMPLETED|Overall Study||42||
59855335|NCT03764072|75979978|FG002|COMPLETED|Overall Study||43||
59855336|NCT03764072|75979979|FG003|COMPLETED|Overall Study||45||
59855337|NCT03764072|75979980|FG004|COMPLETED|Overall Study||45||
59855338|NCT03764072|75979981|FG005|COMPLETED|Overall Study||26||
59855339|NCT03764072|75979976|FG000|NOT COMPLETED|Overall Study||0||
59855340|NCT03764072|75979977|FG001|NOT COMPLETED|Overall Study||0||
59855341|NCT03764072|75979978|FG002|NOT COMPLETED|Overall Study||1||
59855342|NCT03764072|75979979|FG003|NOT COMPLETED|Overall Study||0||
59855343|NCT03764072|75979980|FG004|NOT COMPLETED|Overall Study||1||
59855344|NCT03764072|75979981|FG005|NOT COMPLETED|Overall Study||1||
59855345|NCT03333928|75980003|FG000|STARTED|Initial Dosing Period (Period 1)||16||
59855346|NCT03333928|75980004|FG001|STARTED|Initial Dosing Period (Period 1)||25||
59855347|NCT03333928|75980005|FG002|STARTED|Initial Dosing Period (Period 1)||18||
59855348|NCT03333928|75980003|FG000|COMPLETED|Initial Dosing Period (Period 1)||15||
59855349|NCT03333928|75980004|FG001|COMPLETED|Initial Dosing Period (Period 1)||21||
59855350|NCT03333928|75980005|FG002|COMPLETED|Initial Dosing Period (Period 1)||14||
59855351|NCT03333928|75980003|FG000|NOT COMPLETED|Initial Dosing Period (Period 1)||1||
59855352|NCT03333928|75980004|FG001|NOT COMPLETED|Initial Dosing Period (Period 1)||4||
59855353|NCT03333928|75980005|FG002|NOT COMPLETED|Initial Dosing Period (Period 1)||4||
59855354|NCT03333928|75980003|FG000|STARTED|Dose-controlled Extension (Period 2)||22|Subjects randomized to active treatment remained on their Period 1 dose. Subjects who had been randomized to Placebo during Period 1 were randomized 1:1 to either HTD1801 500 mg BID or HTD1801 1000 mg BID.|
59996780|NCT03434041|76112632|FG000|STARTED|Follow-up Phase (Up to 8 Weeks)||106||
59996781|NCT03434041|76112633|FG001|STARTED|Follow-up Phase (Up to 8 Weeks)||103||
60121769|NCT01561079|76242737|FG000|COMPLETED|Overall Study||49||
59996782|NCT03434041|76112632|FG000|COMPLETED|Follow-up Phase (Up to 8 Weeks)||99||
59996783|NCT03434041|76112633|FG001|COMPLETED|Follow-up Phase (Up to 8 Weeks)||100||
59855355|NCT03333928|75980004|FG001|STARTED|Dose-controlled Extension (Period 2)||29|Subjects randomized to active treatment remained on their Period 1 dose. Subjects who had been randomized to Placebo during Period 1 were randomized 1:1 to either HTD1801 500 mg BID or HTD1801 1000 mg BID.|
59855356|NCT03333928|75980005|FG002|STARTED|Dose-controlled Extension (Period 2)||0|Subjects randomized to active treatment remained on their Period 1 dose. Subjects who had been randomized to Placebo during Period 1 were randomized 1:1 to either HTD1801 500 mg BID or HTD1801 1000 mg BID.|
59855357|NCT03333928|75980003|FG000|COMPLETED|Dose-controlled Extension (Period 2)||19||
59855358|NCT03333928|75980004|FG001|COMPLETED|Dose-controlled Extension (Period 2)||28||
59855359|NCT03333928|75980005|FG002|COMPLETED|Dose-controlled Extension (Period 2)||0||
59855360|NCT03333928|75980003|FG000|NOT COMPLETED|Dose-controlled Extension (Period 2)||3||
59855361|NCT03333928|75980004|FG001|NOT COMPLETED|Dose-controlled Extension (Period 2)||1||
59855362|NCT03333928|75980005|FG002|NOT COMPLETED|Dose-controlled Extension (Period 2)||0||
59855363|NCT03333928|75980003|FG000|STARTED|Randomized Withdrawal (Period 3)||10|Active subjects from Period 2 were re-randomized in Period 3 to receive either Placebo, HTD1801 500 mg BID or HTD 1000 mg BID.|
59855364|NCT03333928|75980004|FG001|STARTED|Randomized Withdrawal (Period 3)||14|Active subjects from Period 2 were re-randomized in Period 3 to receive either Placebo, HTD1801 500 mg BID or HTD 1000 mg BID.|
59855365|NCT03333928|75980005|FG002|STARTED|Randomized Withdrawal (Period 3)||26|Active subjects from Period 2 were re-randomized in Period 3 to receive either Placebo, HTD1801 500 mg BID or HTD 1000 mg BID.|
59855366|NCT03333928|75980003|FG000|COMPLETED|Randomized Withdrawal (Period 3)||8||
59855367|NCT03333928|75980004|FG001|COMPLETED|Randomized Withdrawal (Period 3)||14||
59855368|NCT03333928|75980005|FG002|COMPLETED|Randomized Withdrawal (Period 3)||25||
59855369|NCT03333928|75980003|FG000|NOT COMPLETED|Randomized Withdrawal (Period 3)||2||
59855370|NCT03333928|75980004|FG001|NOT COMPLETED|Randomized Withdrawal (Period 3)||0||
59855371|NCT03333928|75980005|FG002|NOT COMPLETED|Randomized Withdrawal (Period 3)||1||
59855372|NCT02945410|75980027|FG000|STARTED|Intervention 1 (5 Days)||3||
59855373|NCT02945410|75980028|FG001|STARTED|Intervention 1 (5 Days)||4||
59855374|NCT02945410|75980029|FG002|STARTED|Intervention 1 (5 Days)||2||
59855375|NCT02945410|75980030|FG003|STARTED|Intervention 1 (5 Days)||3||
59855376|NCT02945410|75980031|FG004|STARTED|Intervention 1 (5 Days)||2||
59855377|NCT02945410|75980032|FG005|STARTED|Intervention 1 (5 Days)||1||
59855378|NCT02945410|75980027|FG000|COMPLETED|Intervention 1 (5 Days)||2||
59855379|NCT02945410|75980028|FG001|COMPLETED|Intervention 1 (5 Days)||1||
59855380|NCT02945410|75980029|FG002|COMPLETED|Intervention 1 (5 Days)||2||
59855381|NCT02945410|75980030|FG003|COMPLETED|Intervention 1 (5 Days)||3||
59855382|NCT02945410|75980031|FG004|COMPLETED|Intervention 1 (5 Days)||2||
59855383|NCT02945410|75980032|FG005|COMPLETED|Intervention 1 (5 Days)||0||
59855384|NCT02945410|75980027|FG000|NOT COMPLETED|Intervention 1 (5 Days)||1||
59855385|NCT02945410|75980028|FG001|NOT COMPLETED|Intervention 1 (5 Days)||3||
59855386|NCT02945410|75980029|FG002|NOT COMPLETED|Intervention 1 (5 Days)||0||
59855387|NCT02945410|75980030|FG003|NOT COMPLETED|Intervention 1 (5 Days)||0||
59855388|NCT02945410|75980031|FG004|NOT COMPLETED|Intervention 1 (5 Days)||0||
60121770|NCT01561079|76242737|FG000|NOT COMPLETED|Overall Study||78||
60121771|NCT01559675|76242782|FG000|STARTED|Overall Study||58||
59855389|NCT02945410|75980032|FG005|NOT COMPLETED|Intervention 1 (5 Days)||1||
59855390|NCT02945410|75980027|FG000|STARTED|Washout 1 (14 Days)||2||
59855391|NCT02945410|75980028|FG001|STARTED|Washout 1 (14 Days)||1||
59855392|NCT02945410|75980029|FG002|STARTED|Washout 1 (14 Days)||2||
59855393|NCT02945410|75980030|FG003|STARTED|Washout 1 (14 Days)||3||
59855394|NCT02945410|75980031|FG004|STARTED|Washout 1 (14 Days)||2||
59855395|NCT02945410|75980032|FG005|STARTED|Washout 1 (14 Days)||0||
59855396|NCT02945410|75980027|FG000|COMPLETED|Washout 1 (14 Days)||2||
59855397|NCT02945410|75980028|FG001|COMPLETED|Washout 1 (14 Days)||1||
59855398|NCT02945410|75980029|FG002|COMPLETED|Washout 1 (14 Days)||0||
59855399|NCT02945410|75980030|FG003|COMPLETED|Washout 1 (14 Days)||3||
59855400|NCT02945410|75980031|FG004|COMPLETED|Washout 1 (14 Days)||1||
59855401|NCT02945410|75980032|FG005|COMPLETED|Washout 1 (14 Days)||0||
59855402|NCT02945410|75980027|FG000|NOT COMPLETED|Washout 1 (14 Days)||0||
59855403|NCT02945410|75980028|FG001|NOT COMPLETED|Washout 1 (14 Days)||0||
59855404|NCT02945410|75980029|FG002|NOT COMPLETED|Washout 1 (14 Days)||2||
59855405|NCT02945410|75980030|FG003|NOT COMPLETED|Washout 1 (14 Days)||0||
59855406|NCT02945410|75980031|FG004|NOT COMPLETED|Washout 1 (14 Days)||1||
59855407|NCT02945410|75980032|FG005|NOT COMPLETED|Washout 1 (14 Days)||0||
59855408|NCT02945410|75980027|FG000|STARTED|Intervention 2 (5 Days)||2||
59855409|NCT02945410|75980028|FG001|STARTED|Intervention 2 (5 Days)||1||
59855410|NCT02945410|75980029|FG002|STARTED|Intervention 2 (5 Days)||0||
59855411|NCT02945410|75980030|FG003|STARTED|Intervention 2 (5 Days)||3||
59855412|NCT02945410|75980031|FG004|STARTED|Intervention 2 (5 Days)||1||
60121772|NCT01559675|76242783|FG001|STARTED|Overall Study||63||
59725400|NCT00854113|75844243|FG006|NOT COMPLETED|Overall Study||0||
59725401|NCT00854113|75844244|FG007|NOT COMPLETED|Overall Study||3||
59725402|NCT00854113|75844245|FG008|NOT COMPLETED|Overall Study||1||
59725403|NCT00854113|75844246|FG009|NOT COMPLETED|Overall Study||0||
59725404|NCT00854113|75844247|FG010|NOT COMPLETED|Overall Study||0||
59725405|NCT00845845|75844273|FG000|STARTED|Overall Study||3||
59725406|NCT00845845|75844274|FG001|STARTED|Overall Study||6||
59725407|NCT00845845|75844273|FG000|COMPLETED|Overall Study||3||
59725408|NCT00845845|75844274|FG001|COMPLETED|Overall Study||2||
59855413|NCT02945410|75980032|FG005|STARTED|Intervention 2 (5 Days)||0||
59855414|NCT02945410|75980027|FG000|COMPLETED|Intervention 2 (5 Days)||2||
59855415|NCT02945410|75980028|FG001|COMPLETED|Intervention 2 (5 Days)||1||
59855416|NCT02945410|75980029|FG002|COMPLETED|Intervention 2 (5 Days)||0||
59855417|NCT02945410|75980030|FG003|COMPLETED|Intervention 2 (5 Days)||3||
59855418|NCT02945410|75980031|FG004|COMPLETED|Intervention 2 (5 Days)||1||
59855419|NCT02945410|75980032|FG005|COMPLETED|Intervention 2 (5 Days)||0||
59855420|NCT02945410|75980027|FG000|NOT COMPLETED|Intervention 2 (5 Days)||0||
59855421|NCT02945410|75980028|FG001|NOT COMPLETED|Intervention 2 (5 Days)||0||
59855422|NCT02945410|75980029|FG002|NOT COMPLETED|Intervention 2 (5 Days)||0||
59855423|NCT02945410|75980030|FG003|NOT COMPLETED|Intervention 2 (5 Days)||0||
59855424|NCT02945410|75980031|FG004|NOT COMPLETED|Intervention 2 (5 Days)||0||
59855425|NCT02945410|75980032|FG005|NOT COMPLETED|Intervention 2 (5 Days)||0||
59855426|NCT02945410|75980027|FG000|STARTED|Washout 2 (14 Days)||2||
59855427|NCT02945410|75980028|FG001|STARTED|Washout 2 (14 Days)||1||
59855428|NCT02945410|75980029|FG002|STARTED|Washout 2 (14 Days)||0||
59855429|NCT02945410|75980030|FG003|STARTED|Washout 2 (14 Days)||3||
59855430|NCT02945410|75980031|FG004|STARTED|Washout 2 (14 Days)||1||
59855431|NCT02945410|75980032|FG005|STARTED|Washout 2 (14 Days)||0||
59855432|NCT02945410|75980027|FG000|COMPLETED|Washout 2 (14 Days)||2||
59855433|NCT02945410|75980028|FG001|COMPLETED|Washout 2 (14 Days)||1||
59855434|NCT02945410|75980029|FG002|COMPLETED|Washout 2 (14 Days)||0||
59855435|NCT02945410|75980030|FG003|COMPLETED|Washout 2 (14 Days)||3||
59855436|NCT02945410|75980031|FG004|COMPLETED|Washout 2 (14 Days)||1||
59855437|NCT02945410|75980032|FG005|COMPLETED|Washout 2 (14 Days)||0||
59855438|NCT02945410|75980027|FG000|NOT COMPLETED|Washout 2 (14 Days)||0||
59855439|NCT02945410|75980028|FG001|NOT COMPLETED|Washout 2 (14 Days)||0||
59855440|NCT02945410|75980029|FG002|NOT COMPLETED|Washout 2 (14 Days)||0||
59855441|NCT02945410|75980030|FG003|NOT COMPLETED|Washout 2 (14 Days)||0||
59855442|NCT02945410|75980031|FG004|NOT COMPLETED|Washout 2 (14 Days)||0||
59855443|NCT02945410|75980032|FG005|NOT COMPLETED|Washout 2 (14 Days)||0||
59855444|NCT02945410|75980027|FG000|STARTED|Intervention 3 (5 Days)||2||
59855445|NCT02945410|75980028|FG001|STARTED|Intervention 3 (5 Days)||1||
59855446|NCT02945410|75980029|FG002|STARTED|Intervention 3 (5 Days)||0||
59855447|NCT02945410|75980030|FG003|STARTED|Intervention 3 (5 Days)||3||
59855448|NCT02945410|75980031|FG004|STARTED|Intervention 3 (5 Days)||1||
59855449|NCT02945410|75980032|FG005|STARTED|Intervention 3 (5 Days)||0||
59855450|NCT02945410|75980027|FG000|COMPLETED|Intervention 3 (5 Days)||2||
59855451|NCT02945410|75980028|FG001|COMPLETED|Intervention 3 (5 Days)||1||
59855452|NCT02945410|75980029|FG002|COMPLETED|Intervention 3 (5 Days)||0||
59855453|NCT02945410|75980030|FG003|COMPLETED|Intervention 3 (5 Days)||3||
59855454|NCT02945410|75980031|FG004|COMPLETED|Intervention 3 (5 Days)||1||
59855455|NCT02945410|75980032|FG005|COMPLETED|Intervention 3 (5 Days)||0||
59855456|NCT02945410|75980027|FG000|NOT COMPLETED|Intervention 3 (5 Days)||0||
59855457|NCT02945410|75980028|FG001|NOT COMPLETED|Intervention 3 (5 Days)||0||
59855458|NCT02945410|75980029|FG002|NOT COMPLETED|Intervention 3 (5 Days)||0||
59855459|NCT02945410|75980030|FG003|NOT COMPLETED|Intervention 3 (5 Days)||0||
59855460|NCT02945410|75980031|FG004|NOT COMPLETED|Intervention 3 (5 Days)||0||
59855461|NCT02945410|75980032|FG005|NOT COMPLETED|Intervention 3 (5 Days)||0||
59855462|NCT02945254|75980042|FG000|STARTED|Overall Study||10||
59855463|NCT02945254|75980043|FG001|STARTED|Overall Study||10||
59855464|NCT02945254|75980042|FG000|COMPLETED|Overall Study||8||
59855465|NCT02945254|75980043|FG001|COMPLETED|Overall Study||10||
59855466|NCT02945254|75980042|FG000|NOT COMPLETED|Overall Study||2||
59855467|NCT02945254|75980043|FG001|NOT COMPLETED|Overall Study||0||
59855468|NCT05010512|75980051|FG000|STARTED|Period 1, 8 (-0/+3) Days||55||
59855469|NCT05010512|75980052|FG001|STARTED|Period 1, 8 (-0/+3) Days||56||
59855470|NCT05010512|75980051|FG000|COMPLETED|Period 1, 8 (-0/+3) Days||55||
59855471|NCT05010512|75980052|FG001|COMPLETED|Period 1, 8 (-0/+3) Days||56||
59855472|NCT05010512|75980051|FG000|NOT COMPLETED|Period 1, 8 (-0/+3) Days||0||
59855473|NCT05010512|75980052|FG001|NOT COMPLETED|Period 1, 8 (-0/+3) Days||0||
59855474|NCT05010512|75980051|FG000|STARTED|Period 2, 8 (-0/+3) Days||55||
59855475|NCT05010512|75980052|FG001|STARTED|Period 2, 8 (-0/+3) Days||56||
59855476|NCT05010512|75980051|FG000|COMPLETED|Period 2, 8 (-0/+3) Days||55||
59855477|NCT05010512|75980052|FG001|COMPLETED|Period 2, 8 (-0/+3) Days||56||
59855478|NCT05010512|75980051|FG000|NOT COMPLETED|Period 2, 8 (-0/+3) Days||0||
59855479|NCT05010512|75980052|FG001|NOT COMPLETED|Period 2, 8 (-0/+3) Days||0||
59855480|NCT02943070|75980061|FG000|STARTED|Overall Study||50||
59855481|NCT02943070|75980061|FG000|COMPLETED|Overall Study||7||
59855482|NCT02943070|75980061|FG000|NOT COMPLETED|Overall Study||43||
59855483|NCT02143726|75980074|FG000|STARTED|Overall Study||18||
59855484|NCT02143726|75980075|FG001|STARTED|Overall Study||17||
59855485|NCT02143726|75980074|FG000|Received Everolimus After Disease Progression|Overall Study||11||
59855486|NCT02143726|75980075|FG001|Received Everolimus After Disease Progression|Overall Study||0||
59855487|NCT02143726|75980074|FG000|COMPLETED|Overall Study||16||
59855488|NCT02143726|75980075|FG001|COMPLETED|Overall Study||17||
59855489|NCT02143726|75980074|FG000|NOT COMPLETED|Overall Study||2||
59855490|NCT02143726|75980075|FG001|NOT COMPLETED|Overall Study||0||
59855491|NCT03332212|75980085|FG000|STARTED|Overall Study||19||
59855492|NCT03332212|75980086|FG001|STARTED|Overall Study||18||
59855493|NCT03332212|75980087|FG002|STARTED|Overall Study||17||
59855494|NCT03332212|75980088|FG003|STARTED|Overall Study||18||
59855495|NCT03332212|75980085|FG000|Treated|Overall Study||19||
59855496|NCT03332212|75980086|FG001|Treated|Overall Study||17||
59855497|NCT03332212|75980087|FG002|Treated|Overall Study||17||
59855498|NCT03332212|75980088|FG003|Treated|Overall Study||18||
59855499|NCT03332212|75980085|FG000|COMPLETED|Overall Study||18||
59855500|NCT03332212|75980086|FG001|COMPLETED|Overall Study||16||
59855501|NCT03332212|75980087|FG002|COMPLETED|Overall Study||17||
59855502|NCT03332212|75980088|FG003|COMPLETED|Overall Study||17||
59855503|NCT03332212|75980085|FG000|NOT COMPLETED|Overall Study||1||
59855504|NCT03332212|75980086|FG001|NOT COMPLETED|Overall Study||2||
59855505|NCT03332212|75980087|FG002|NOT COMPLETED|Overall Study||0||
59855506|NCT03332212|75980088|FG003|NOT COMPLETED|Overall Study||1||
59855507|NCT03331666|75980098|FG000|STARTED|Overall Study||2||
59855508|NCT03331666|75980099|FG001|STARTED|Overall Study||2||
59855509|NCT03331666|75980098|FG000|COMPLETED|Overall Study||0||
59855510|NCT03331666|75980099|FG001|COMPLETED|Overall Study||0||
59855511|NCT03331666|75980098|FG000|NOT COMPLETED|Overall Study||2||
59855512|NCT03331666|75980099|FG001|NOT COMPLETED|Overall Study||2||
59855513|NCT03331042|75980109|FG000|STARTED|Overall Study||22||
59855514|NCT03331042|75980110|FG001|STARTED|Overall Study||21||
59855515|NCT03331042|75980111|FG002|STARTED|Overall Study||21||
59855516|NCT03331042|75980112|FG003|STARTED|Overall Study||21||
59855517|NCT03331042|75980109|FG000|COMPLETED|Overall Study||21||
59855518|NCT03331042|75980110|FG001|COMPLETED|Overall Study||21||
59855519|NCT03331042|75980111|FG002|COMPLETED|Overall Study||20||
59855520|NCT03331042|75980112|FG003|COMPLETED|Overall Study||20||
59855521|NCT03331042|75980109|FG000|NOT COMPLETED|Overall Study||1||
59855522|NCT03331042|75980110|FG001|NOT COMPLETED|Overall Study||0||
59855523|NCT03331042|75980111|FG002|NOT COMPLETED|Overall Study||1||
59855524|NCT03331042|75980112|FG003|NOT COMPLETED|Overall Study||1||
59855525|NCT03762668|75980130|FG000|STARTED|Period 1, First Week of Wear||30||
59855526|NCT03762668|75980131|FG001|STARTED|Period 1, First Week of Wear||30||
60121773|NCT01559675|76242782|FG000|COMPLETED|Overall Study||43||
60121774|NCT01559675|76242783|FG001|COMPLETED|Overall Study||49||
60121775|NCT01559675|76242782|FG000|NOT COMPLETED|Overall Study||15||
59590596|NCT02196558|75698224|FG001|COMPLETED|Treatment Phase (12 Weeks)||12||
59590597|NCT02196558|75698225|FG002|COMPLETED|Treatment Phase (12 Weeks)||8||
59590598|NCT02196558|75698223|FG000|NOT COMPLETED|Treatment Phase (12 Weeks)||0||
59590599|NCT02196558|75698224|FG001|NOT COMPLETED|Treatment Phase (12 Weeks)||3||
59590600|NCT02196558|75698225|FG002|NOT COMPLETED|Treatment Phase (12 Weeks)||2||
59590601|NCT02196558|75698223|FG000|STARTED|Extension Phase (40 Weeks)|Participants who wished to continue, had no safety issues, and had>=20% improvement in joint counts.|11||
59590602|NCT02196558|75698224|FG001|STARTED|Extension Phase (40 Weeks)|Participants who wished to continue, had no safety issues, and had>=20% improvement in joint counts.|11||
59590603|NCT02196558|75698225|FG002|STARTED|Extension Phase (40 Weeks)|Participants who wished to continue, had no safety issues, and had>=20% improvement in joint counts.|6||
59590604|NCT02196558|75698223|FG000|COMPLETED|Extension Phase (40 Weeks)||9||
59590605|NCT02196558|75698224|FG001|COMPLETED|Extension Phase (40 Weeks)||8||
59590606|NCT02196558|75698225|FG002|COMPLETED|Extension Phase (40 Weeks)||5||
59725409|NCT00845845|75844273|FG000|NOT COMPLETED|Overall Study||0||
59725410|NCT00845845|75844274|FG001|NOT COMPLETED|Overall Study||4||
59725411|NCT01104701|75844284|FG000|STARTED|Overall Study||30||
59725412|NCT01104701|75844285|FG001|STARTED|Overall Study||30||
59725413|NCT01104701|75844286|FG002|STARTED|Overall Study||31||
59725414|NCT01104701|75844287|FG003|STARTED|Overall Study||30||
59855527|NCT03762668|75980130|FG000|COMPLETED|Period 1, First Week of Wear||30||
59855528|NCT03762668|75980131|FG001|COMPLETED|Period 1, First Week of Wear||29||
59855529|NCT03762668|75980130|FG000|NOT COMPLETED|Period 1, First Week of Wear||0||
59855530|NCT03762668|75980131|FG001|NOT COMPLETED|Period 1, First Week of Wear||1||
59855531|NCT03762668|75980130|FG000|STARTED|Period 2, Second Week of Wear||30||
59855532|NCT03762668|75980131|FG001|STARTED|Period 2, Second Week of Wear||29||
59855533|NCT03762668|75980130|FG000|COMPLETED|Period 2, Second Week of Wear||30||
59855534|NCT03762668|75980131|FG001|COMPLETED|Period 2, Second Week of Wear||29||
59855535|NCT03762668|75980130|FG000|NOT COMPLETED|Period 2, Second Week of Wear||0||
59855536|NCT03762668|75980131|FG001|NOT COMPLETED|Period 2, Second Week of Wear||0||
59855537|NCT03762200|75980137|FG000|STARTED|Overall Study||103||
59855538|NCT03762200|75980137|FG000|COMPLETED|Overall Study||101||
59855539|NCT03762200|75980137|FG000|NOT COMPLETED|Overall Study||2||
59855540|NCT03711370|75980143|FG000|STARTED|Overall Study|38 mother-infant dyads (38 mothers + 38 infants = 76 participants total) were randomized to the Clear Bottle Group|76||
59855541|NCT03711370|75980144|FG001|STARTED|Overall Study|38 mother-infant dyads (38 mothers + 38 infants = 76 participants total) were randomized to the Opaque Bottle Group|76||
59855542|NCT03711370|75980143|FG000|Pre-Test: Clear Bottle Feeding Condition|Overall Study|38 mother-infant dyads (38 mothers + 38 infants = 76 participants total)|76||
59855543|NCT03711370|75980144|FG001|Pre-Test: Clear Bottle Feeding Condition|Overall Study|38 mother-infant dyads (38 mothers + 38 infants = 76 participants total)|76||
60121776|NCT01559675|76242783|FG001|NOT COMPLETED|Overall Study||14||
59725415|NCT01104701|75844284|FG000|COMPLETED|Overall Study||30||
59725416|NCT01104701|75844285|FG001|COMPLETED|Overall Study||27||
59725417|NCT01104701|75844286|FG002|COMPLETED|Overall Study||29||
59855544|NCT03711370|75980143|FG000|Pre-Test: Opaque Bottle Feeding Condition|Overall Study|38 mother-infant dyads (38 mothers + 38 infants = 76 participants total)|76||
59855545|NCT03711370|75980144|FG001|Pre-Test: Opaque Bottle Feeding Condition|Overall Study|38 mother-infant dyads (38 mothers + 38 infants = 76 participants total)|76||
59855546|NCT03711370|75980143|FG000|Post-test: Clear Bottle Feeding Condition|Overall Study|30 mother-infant dyads (30 mothers + 30 infants = 60 participants total)|60||
59855547|NCT03711370|75980144|FG001|Post-test: Clear Bottle Feeding Condition|Overall Study|33 mother-infant dyads (33 mothers + 33 infants = 66 participants total)|66||
59855548|NCT03711370|75980143|FG000|Post-test: Opaque Bottle Feeding Condition|Overall Study|30 mother-infant dyads (30 mothers + 30 infants = 60 participants total)|60||
59855549|NCT03711370|75980144|FG001|Post-test: Opaque Bottle Feeding Condition|Overall Study|33 mother-infant dyads (33 mothers + 33 infants = 66 participants total)|66||
59855550|NCT03711370|75980143|FG000|COMPLETED|Overall Study|30 mother-infant dyads (30 mothers + 30 infants = 60 participants total) in the Clear Bottle Group were included in data analysis|60||
59855551|NCT03711370|75980144|FG001|COMPLETED|Overall Study|30 mother-infant dyads (30 mothers + 30 infants = 60 participants total) in the Opaque Bottle Group were included in data analysis|60||
59855552|NCT03711370|75980143|FG000|NOT COMPLETED|Overall Study||16||
59855553|NCT03711370|75980144|FG001|NOT COMPLETED|Overall Study||16||
59855554|NCT03329404|75980160|FG000|STARTED|Overall Study||4||
59855555|NCT03329404|75980161|FG001|STARTED|Overall Study||5||
59855556|NCT03329404|75980160|FG000|COMPLETED|Overall Study||3|"4 subjects were randomized to the MIR/REF RBC treatment sequence, 3 of the 4 subjects completed the first arm of the study and 1 subject did not complete the first arm of the study.~5 subjects were randomized to the REF/MIR RBC treatment sequence, 1 of the 5 subjects completed the first arm of the study and 4 subjects did not complete the first arm of the study.~In summary- no subjects completed the entire study and 4 subjects completed one arm of the study."|
59855557|NCT03329404|75980161|FG001|COMPLETED|Overall Study||1|"4 subjects were randomized to the MIR/REF RBC treatment sequence, 3 of the 4 subjects completed the first arm of the study and 1 subject did not complete the first arm of the study.~5 subjects were randomized to the REF/MIR RBC treatment sequence, 1 of the 5 subjects completed the first arm of the study and 4 subjects did not complete the first arm of the study.~In summary- no subjects completed the entire study and 4 subjects completed one arm of the study."|
59855558|NCT03329404|75980160|FG000|NOT COMPLETED|Overall Study||1||
59855559|NCT03329404|75980161|FG001|NOT COMPLETED|Overall Study||4||
59855560|NCT03478930|75980169|FG000|STARTED|Overall Study||126||
59590607|NCT02196558|75698223|FG000|NOT COMPLETED|Extension Phase (40 Weeks)||2||
59590608|NCT02196558|75698224|FG001|NOT COMPLETED|Extension Phase (40 Weeks)||3||
59590609|NCT02196558|75698225|FG002|NOT COMPLETED|Extension Phase (40 Weeks)||1||
59590610|NCT02740153|75698235|FG000|STARTED|Overall Study||101||
59590611|NCT02740153|75698236|FG001|STARTED|Overall Study||86||
59590612|NCT02740153|75698235|FG000|COMPLETED|Overall Study||101||
59590613|NCT02740153|75698236|FG001|COMPLETED|Overall Study||86||
59590614|NCT02740153|75698235|FG000|NOT COMPLETED|Overall Study||0||
59590615|NCT02740153|75698236|FG001|NOT COMPLETED|Overall Study||0||
59590616|NCT02196324|75698246|FG000|STARTED|Overall Study||63||
59590617|NCT02196324|75698247|FG001|STARTED|Overall Study||65||
59590618|NCT02196324|75698246|FG000|COMPLETED|Overall Study||48||
59590619|NCT02196324|75698247|FG001|COMPLETED|Overall Study||57||
59590620|NCT02196324|75698246|FG000|NOT COMPLETED|Overall Study||15||
59725418|NCT01104701|75844287|FG003|COMPLETED|Overall Study||28||
59725419|NCT01104701|75844284|FG000|NOT COMPLETED|Overall Study||0||
59725420|NCT01104701|75844285|FG001|NOT COMPLETED|Overall Study||3||
59725421|NCT01104701|75844286|FG002|NOT COMPLETED|Overall Study||2||
59725422|NCT01104701|75844287|FG003|NOT COMPLETED|Overall Study||2||
59725423|NCT00833755|75844301|FG000|STARTED|Overall Study||16||
59725424|NCT00833755|75844302|FG001|STARTED|Overall Study||18||
59725425|NCT00833755|75844303|FG002|STARTED|Overall Study||22||
59725426|NCT00833755|75844304|FG003|STARTED|Overall Study||23||
59725427|NCT00833755|75844301|FG000|COMPLETED|Overall Study||12||
59725428|NCT00833755|75844302|FG001|COMPLETED|Overall Study||13||
59725429|NCT00833755|75844303|FG002|COMPLETED|Overall Study||20||
59725430|NCT00833755|75844304|FG003|COMPLETED|Overall Study||17||
59725431|NCT00833755|75844301|FG000|NOT COMPLETED|Overall Study||4||
59725432|NCT00833755|75844302|FG001|NOT COMPLETED|Overall Study||5||
59725433|NCT00833755|75844303|FG002|NOT COMPLETED|Overall Study||2||
59725434|NCT00833755|75844304|FG003|NOT COMPLETED|Overall Study||6||
59725435|NCT01021332|75844315|FG000|STARTED|Overall Study|Took ≥ 1 dose of FDC open-label study drug|1066||
59725436|NCT01021332|75844315|FG000|Safety Analysis Set (SAF)|Overall Study||1066||
59725437|NCT01021332|75844315|FG000|Full Analysis Set (FAS)|Overall Study||1009||
59725438|NCT01021332|75844315|FG000|COMPLETED|Overall Study||960||
59725439|NCT01021332|75844315|FG000|NOT COMPLETED|Overall Study||106||
59725440|NCT00923091|75844329|FG000|STARTED|PeriodI-II (Randomized, Double-Blind)||335||
59725441|NCT00923091|75844330|FG001|STARTED|PeriodI-II (Randomized, Double-Blind)||336||
59725442|NCT00923091|75844331|FG002|STARTED|PeriodI-II (Randomized, Double-Blind)||336||
59590621|NCT02196324|75698247|FG001|NOT COMPLETED|Overall Study||8||
59590622|NCT02195700|75698255|FG000|STARTED|Overall Study||58||
59590623|NCT02195700|75698256|FG001|STARTED|Overall Study||59||
59590624|NCT02195700|75698255|FG000|Safety and ITT Populations|Overall Study||58||
59590625|NCT02195700|75698256|FG001|Safety and ITT Populations|Overall Study||59||
59590626|NCT02195700|75698255|FG000|Modified ITT Population|Overall Study|ITT who received study drug and >=1 centrally read post-baseline AIMS from weeks 2, 4, 6, 9, or 12|56||
59590627|NCT02195700|75698256|FG001|Modified ITT Population|Overall Study|ITT who received study drug and >=1 centrally read post-baseline AIMS from weeks 2, 4, 6, 9, or 12|57||
59590628|NCT02195700|75698255|FG000|Maintenance Period|Overall Study||53||
59590629|NCT02195700|75698256|FG001|Maintenance Period|Overall Study||54||
59590630|NCT02195700|75698255|FG000|COMPLETED|Overall Study||52||
59590631|NCT02195700|75698256|FG001|COMPLETED|Overall Study||52||
59590632|NCT02195700|75698255|FG000|NOT COMPLETED|Overall Study||6||
59590633|NCT02195700|75698256|FG001|NOT COMPLETED|Overall Study||7||
59590634|NCT02740543|75698264|FG000|STARTED|Overall Study||9||
59590635|NCT02740543|75698265|FG001|STARTED|Overall Study||9||
59590636|NCT02740543|75698264|FG000|COMPLETED|Overall Study||9||
59590637|NCT02740543|75698265|FG001|COMPLETED|Overall Study||9||
59590638|NCT02740543|75698264|FG000|NOT COMPLETED|Overall Study||0||
59590639|NCT02740543|75698265|FG001|NOT COMPLETED|Overall Study||0||
59590640|NCT02228460|75698271|FG000|STARTED|Overall Study||11||
59590641|NCT02228460|75698271|FG000|COMPLETED|Overall Study||9||
59590642|NCT02228460|75698271|FG000|NOT COMPLETED|Overall Study||2||
59590643|NCT02752256|75698278|FG000|STARTED|Overall Study||35||
59590644|NCT02752256|75698279|FG001|STARTED|Overall Study||41||
59590645|NCT02752256|75698278|FG000|COMPLETED|Overall Study||35||
59590646|NCT02752256|75698279|FG001|COMPLETED|Overall Study||41||
59590647|NCT02752256|75698278|FG000|NOT COMPLETED|Overall Study||0||
59590648|NCT02752256|75698279|FG001|NOT COMPLETED|Overall Study||0||
59590649|NCT02227446|75698287|FG000|STARTED|Overall Study||521||
59590650|NCT02227446|75698288|FG001|STARTED|Overall Study||515||
59590651|NCT02227446|75698287|FG000|COMPLETED|Overall Study||499||
59590652|NCT02227446|75698288|FG001|COMPLETED|Overall Study||481||
59590653|NCT02227446|75698287|FG000|NOT COMPLETED|Overall Study||22||
59590654|NCT02227446|75698288|FG001|NOT COMPLETED|Overall Study||34||
59590655|NCT02227368|75698296|FG000|STARTED|Overall Study||16||
59590656|NCT02227368|75698297|FG001|STARTED|Overall Study||24||
59590657|NCT02227368|75698296|FG000|Sujects Who Received Treatment|Overall Study||16||
59590658|NCT02227368|75698297|FG001|Sujects Who Received Treatment|Overall Study||24||
59590659|NCT02227368|75698296|FG000|Sujects Who Completed Treatment|Overall Study||10||
59590660|NCT02227368|75698297|FG001|Sujects Who Completed Treatment|Overall Study||17||
59590661|NCT02227368|75698296|FG000|COMPLETED|Overall Study|Subjects who discontinued treatment were encouraged to remain in the study.|14||
59590662|NCT02227368|75698297|FG001|COMPLETED|Overall Study|Subjects who discontinued treatment were encouraged to remain in the study.|20||
59590663|NCT02227368|75698296|FG000|NOT COMPLETED|Overall Study||2||
59590664|NCT02227368|75698297|FG001|NOT COMPLETED|Overall Study||4||
59590665|NCT02162862|75698306|FG000|STARTED|Overall Study||31||
59590666|NCT02162862|75698307|FG001|STARTED|Overall Study||35||
59590667|NCT02162862|75698308|FG002|STARTED|Overall Study||33||
59590668|NCT02162862|75698306|FG000|COMPLETED|Overall Study||31||
59590669|NCT02162862|75698307|FG001|COMPLETED|Overall Study||24||
59590670|NCT02162862|75698308|FG002|COMPLETED|Overall Study||29||
59590671|NCT02162862|75698306|FG000|NOT COMPLETED|Overall Study||0||
59590672|NCT02162862|75698307|FG001|NOT COMPLETED|Overall Study||11||
59590673|NCT02162862|75698308|FG002|NOT COMPLETED|Overall Study||4||
59590674|NCT02752490|75698320|FG000|STARTED|Overall Study||409||
59590675|NCT02752490|75698321|FG001|STARTED|Overall Study||435||
59590676|NCT02752490|75698320|FG000|COMPLETED|Overall Study||409||
59590677|NCT02752490|75698321|FG001|COMPLETED|Overall Study||435||
59590678|NCT02752490|75698320|FG000|NOT COMPLETED|Overall Study||0||
59590679|NCT02752490|75698321|FG001|NOT COMPLETED|Overall Study||0||
59590680|NCT03402607|75698329|FG000|STARTED|Overall Study||6||
59590681|NCT03402607|75698330|FG001|STARTED|Overall Study||6||
59590682|NCT03402607|75698329|FG000|COMPLETED|Overall Study||6||
59590683|NCT03402607|75698330|FG001|COMPLETED|Overall Study||6||
59590684|NCT03402607|75698329|FG000|NOT COMPLETED|Overall Study||0||
59590685|NCT03402607|75698330|FG001|NOT COMPLETED|Overall Study||0||
59590686|NCT02752880|75698338|FG000|STARTED|Overall Study||23||
59590687|NCT02752880|75698339|FG001|STARTED|Overall Study||23||
59590688|NCT02752880|75698338|FG000|COMPLETED|Overall Study||21||
59725443|NCT00923091|75844332|FG003|STARTED|PeriodI-II (Randomized, Double-Blind)||336||
60121777|NCT01374906|76242791|FG000|STARTED|Overall Study||74||
59590689|NCT02752880|75698339|FG001|COMPLETED|Overall Study||20||
59590690|NCT02752880|75698338|FG000|NOT COMPLETED|Overall Study||2||
59590691|NCT02752880|75698339|FG001|NOT COMPLETED|Overall Study||3||
59590692|NCT02226198|75698346|FG000|STARTED|Lead-in Phase||11||
59590693|NCT02226198|75698347|FG001|STARTED|Lead-in Phase||0||
59590694|NCT02226198|75698348|FG002|STARTED|Lead-in Phase||0||
59590695|NCT02226198|75698346|FG000|COMPLETED|Lead-in Phase||10||
59590696|NCT02226198|75698347|FG001|COMPLETED|Lead-in Phase||0||
59590697|NCT02226198|75698348|FG002|COMPLETED|Lead-in Phase||0||
59590698|NCT02226198|75698346|FG000|NOT COMPLETED|Lead-in Phase||1||
59590699|NCT02226198|75698347|FG001|NOT COMPLETED|Lead-in Phase||0||
59590700|NCT02226198|75698348|FG002|NOT COMPLETED|Lead-in Phase||0||
59590701|NCT02226198|75698346|FG000|STARTED|Cross-Over: First Intervention (6 Weeks)||0||
59590702|NCT02226198|75698347|FG001|STARTED|Cross-Over: First Intervention (6 Weeks)||7||
59590703|NCT02226198|75698348|FG002|STARTED|Cross-Over: First Intervention (6 Weeks)||7||
59590704|NCT02226198|75698346|FG000|COMPLETED|Cross-Over: First Intervention (6 Weeks)||0||
59855561|NCT03478930|75980170|FG001|STARTED|Overall Study||123||
59590705|NCT02226198|75698347|FG001|COMPLETED|Cross-Over: First Intervention (6 Weeks)||6||
59590706|NCT02226198|75698348|FG002|COMPLETED|Cross-Over: First Intervention (6 Weeks)||7||
59590707|NCT02226198|75698346|FG000|NOT COMPLETED|Cross-Over: First Intervention (6 Weeks)||0||
59590708|NCT02226198|75698347|FG001|NOT COMPLETED|Cross-Over: First Intervention (6 Weeks)||1||
59590709|NCT02226198|75698348|FG002|NOT COMPLETED|Cross-Over: First Intervention (6 Weeks)||0||
59590710|NCT02226198|75698346|FG000|STARTED|Cross-Over: Second Interv. (6 Weeks)||0||
59590711|NCT02226198|75698347|FG001|STARTED|Cross-Over: Second Interv. (6 Weeks)||6||
59590712|NCT02226198|75698348|FG002|STARTED|Cross-Over: Second Interv. (6 Weeks)||7||
59590713|NCT02226198|75698346|FG000|COMPLETED|Cross-Over: Second Interv. (6 Weeks)||0||
59590714|NCT02226198|75698347|FG001|COMPLETED|Cross-Over: Second Interv. (6 Weeks)||6||
59590715|NCT02226198|75698348|FG002|COMPLETED|Cross-Over: Second Interv. (6 Weeks)||7||
59590716|NCT02226198|75698346|FG000|NOT COMPLETED|Cross-Over: Second Interv. (6 Weeks)||0||
59590717|NCT02226198|75698347|FG001|NOT COMPLETED|Cross-Over: Second Interv. (6 Weeks)||0||
59590718|NCT02226198|75698348|FG002|NOT COMPLETED|Cross-Over: Second Interv. (6 Weeks)||0||
59590719|NCT02226198|75698346|FG000|STARTED|Maintenance Phase (12 Weeks)||13||
59590720|NCT02226198|75698347|FG001|STARTED|Maintenance Phase (12 Weeks)||0||
59590721|NCT02226198|75698348|FG002|STARTED|Maintenance Phase (12 Weeks)||0||
59590722|NCT02226198|75698346|FG000|COMPLETED|Maintenance Phase (12 Weeks)||13||
59590723|NCT02226198|75698347|FG001|COMPLETED|Maintenance Phase (12 Weeks)||0||
59590724|NCT02226198|75698348|FG002|COMPLETED|Maintenance Phase (12 Weeks)||0||
59590725|NCT02226198|75698346|FG000|NOT COMPLETED|Maintenance Phase (12 Weeks)||0||
59590726|NCT02226198|75698347|FG001|NOT COMPLETED|Maintenance Phase (12 Weeks)||0||
59590727|NCT02226198|75698348|FG002|NOT COMPLETED|Maintenance Phase (12 Weeks)||0||
59590728|NCT02754518|75698374|FG000|STARTED|Overall Study||40||
59590729|NCT02754518|75698374|FG000|COMPLETED|Overall Study||40||
59590730|NCT02754518|75698374|FG000|NOT COMPLETED|Overall Study||0||
59590731|NCT02751385|75698378|FG000|STARTED|Period 1||2||
59590732|NCT02751385|75698379|FG001|STARTED|Period 1||0||
59590733|NCT02751385|75698378|FG000|COMPLETED|Period 1||2||
59590734|NCT02751385|75698379|FG001|COMPLETED|Period 1||0||
59590735|NCT02751385|75698378|FG000|NOT COMPLETED|Period 1||0||
59590736|NCT02751385|75698379|FG001|NOT COMPLETED|Period 1||0||
59590737|NCT02751385|75698378|FG000|STARTED|Period 2||0||
59590738|NCT02751385|75698379|FG001|STARTED|Period 2||2||
59590739|NCT02751385|75698378|FG000|COMPLETED|Period 2||0||
59590740|NCT02751385|75698379|FG001|COMPLETED|Period 2||2||
59590741|NCT02751385|75698378|FG000|NOT COMPLETED|Period 2||0||
59590742|NCT02751385|75698379|FG001|NOT COMPLETED|Period 2||0||
59590743|NCT02754674|75698389|FG000|STARTED|Overall Study||34||
59590744|NCT02754674|75698390|FG001|STARTED|Overall Study||33||
59590745|NCT02754674|75698389|FG000|COMPLETED|Overall Study||28||
59590746|NCT02754674|75698390|FG001|COMPLETED|Overall Study||26||
59590747|NCT02754674|75698389|FG000|NOT COMPLETED|Overall Study||6||
59590748|NCT02754674|75698390|FG001|NOT COMPLETED|Overall Study||7||
59590749|NCT02756624|75698398|FG000|STARTED|Overall Study||343||
59590750|NCT02756624|75698399|FG001|STARTED|Overall Study||173||
59590751|NCT02756624|75698398|FG000|COMPLETED|Overall Study||327||
59590752|NCT02756624|75698399|FG001|COMPLETED|Overall Study||166||
59590753|NCT02756624|75698398|FG000|NOT COMPLETED|Overall Study||16||
59590754|NCT02756624|75698399|FG001|NOT COMPLETED|Overall Study||7||
59590755|NCT02753413|75698407|FG000|STARTED|Overall Study||49||
59590756|NCT02753413|75698408|FG001|STARTED|Overall Study||51||
59590757|NCT02753413|75698407|FG000|COMPLETED|Overall Study||49||
59590758|NCT02753413|75698408|FG001|COMPLETED|Overall Study||51||
59590759|NCT02753413|75698407|FG000|NOT COMPLETED|Overall Study||0||
59590760|NCT02753413|75698408|FG001|NOT COMPLETED|Overall Study||0||
59590761|NCT03380000|75698414|FG000|STARTED|First Intervention (1day)||8||
59590762|NCT03380000|75698415|FG001|STARTED|First Intervention (1day)||8||
59590763|NCT03380000|75698414|FG000|COMPLETED|First Intervention (1day)||8||
59590764|NCT03380000|75698415|FG001|COMPLETED|First Intervention (1day)||8||
59590765|NCT03380000|75698414|FG000|NOT COMPLETED|First Intervention (1day)||0||
59590766|NCT03380000|75698415|FG001|NOT COMPLETED|First Intervention (1day)||0||
59590767|NCT03380000|75698414|FG000|STARTED|Washout (>7days)||8||
59590768|NCT03380000|75698415|FG001|STARTED|Washout (>7days)||8||
59590769|NCT03380000|75698414|FG000|COMPLETED|Washout (>7days)||8||
59725444|NCT00923091|75844333|FG004|STARTED|PeriodI-II (Randomized, Double-Blind)||336||
59855562|NCT03478930|75980169|FG000|COMPLETED|Overall Study||117||
59855563|NCT03478930|75980170|FG001|COMPLETED|Overall Study||114||
59855564|NCT03478930|75980169|FG000|NOT COMPLETED|Overall Study||9||
59590770|NCT03380000|75698415|FG001|COMPLETED|Washout (>7days)||8||
59590771|NCT03380000|75698414|FG000|NOT COMPLETED|Washout (>7days)||0||
59590772|NCT03380000|75698415|FG001|NOT COMPLETED|Washout (>7days)||0||
59590773|NCT03380000|75698414|FG000|STARTED|Second Intervention (1day)||8||
59590774|NCT03380000|75698415|FG001|STARTED|Second Intervention (1day)||8||
59590775|NCT03380000|75698414|FG000|COMPLETED|Second Intervention (1day)||8||
59590776|NCT03380000|75698415|FG001|COMPLETED|Second Intervention (1day)||8||
59590777|NCT03380000|75698414|FG000|NOT COMPLETED|Second Intervention (1day)||0||
59590778|NCT03380000|75698415|FG001|NOT COMPLETED|Second Intervention (1day)||0||
59725445|NCT00923091|75844334|FG005|STARTED|PeriodI-II (Randomized, Double-Blind)||337||
59590779|NCT02754427|75698423|FG000|STARTED|Overall Study||21||
59590780|NCT02754427|75698424|FG001|STARTED|Overall Study||20||
59590781|NCT02754427|75698423|FG000|COMPLETED|Overall Study||21||
59590782|NCT02754427|75698424|FG001|COMPLETED|Overall Study||19||
59590783|NCT02754427|75698423|FG000|NOT COMPLETED|Overall Study||0||
59590784|NCT02754427|75698424|FG001|NOT COMPLETED|Overall Study||1||
59590785|NCT02754661|75698432|FG000|STARTED|Overall Study||160||
59590786|NCT02754661|75698433|FG001|STARTED|Overall Study||160||
59590787|NCT02754661|75698432|FG000|COMPLETED|Overall Study||145||
59590788|NCT02754661|75698433|FG001|COMPLETED|Overall Study||141||
59590789|NCT02754661|75698432|FG000|NOT COMPLETED|Overall Study||15||
59590790|NCT02754661|75698433|FG001|NOT COMPLETED|Overall Study||19||
59590791|NCT02757092|75698443|FG000|STARTED|Overall Study|Random assignment was to encode subjects from opaque envelopes and sealed, on the day of discharge|18||
59590792|NCT02757092|75698444|FG001|STARTED|Overall Study|Random assignment was to encode subjects from opaque envelopes and sealed, on the day of discharge|18||
59590793|NCT02757092|75698443|FG000|COMPLETED|Overall Study|All subjects completed the study|18||
59590794|NCT02757092|75698444|FG001|COMPLETED|Overall Study|All subjects completed the study|18||
59590795|NCT02757092|75698443|FG000|NOT COMPLETED|Overall Study||0||
59590796|NCT02757092|75698444|FG001|NOT COMPLETED|Overall Study||0||
59590797|NCT02755129|75698508|FG000|STARTED|Overall Study||15||
59590798|NCT02755129|75698508|FG000|COMPLETED|Overall Study||15||
59590799|NCT02755129|75698508|FG000|NOT COMPLETED|Overall Study||0||
59590800|NCT02755285|75698515|FG000|STARTED|Overall Study||20||
59590801|NCT02755285|75698515|FG000|COMPLETED|Overall Study||20||
59590802|NCT02755285|75698515|FG000|NOT COMPLETED|Overall Study||0||
59590803|NCT02226120|75698519|FG000|STARTED|Overall Study||1980|All enrolled patients who received at least one dose of study medication (Safety Analysis Set (SAF))|
59590804|NCT02226120|75698519|FG000|COMPLETED|Overall Study||1660|Completed open-label treatment|
59590805|NCT02226120|75698519|FG000|NOT COMPLETED|Overall Study||320||
59590806|NCT02756689|75698525|FG000|STARTED|Overall Study||64||
59590807|NCT02756689|75698526|FG001|STARTED|Overall Study||65||
59590808|NCT02756689|75698525|FG000|COMPLETED|Overall Study||64||
59590809|NCT02756689|75698526|FG001|COMPLETED|Overall Study||65||
59590810|NCT02756689|75698525|FG000|NOT COMPLETED|Overall Study||0||
59590811|NCT02756689|75698526|FG001|NOT COMPLETED|Overall Study||0||
59590812|NCT02757326|75698569|FG000|STARTED|Overall Study||3||
59590813|NCT02757326|75698570|FG001|STARTED|Overall Study||4||
59590814|NCT02757326|75698571|FG002|STARTED|Overall Study||6||
59590815|NCT02757326|75698569|FG000|COMPLETED|Overall Study||3||
59590816|NCT02757326|75698570|FG001|COMPLETED|Overall Study||4||
59590817|NCT02757326|75698571|FG002|COMPLETED|Overall Study||6||
59590818|NCT02757326|75698569|FG000|NOT COMPLETED|Overall Study||0||
59590819|NCT02757326|75698570|FG001|NOT COMPLETED|Overall Study||0||
59590820|NCT02757326|75698571|FG002|NOT COMPLETED|Overall Study||0||
59590821|NCT02757950|75698585|FG000|STARTED|Overall Study||1203||
59590822|NCT02757950|75698586|FG001|STARTED|Overall Study||1259||
59590823|NCT02757950|75698585|FG000|COMPLETED|Overall Study||1199||
59590824|NCT02757950|75698586|FG001|COMPLETED|Overall Study||1248||
59590825|NCT02757950|75698585|FG000|NOT COMPLETED|Overall Study||4||
59590826|NCT02757950|75698586|FG001|NOT COMPLETED|Overall Study||11||
59590827|NCT02753881|75698596|FG000|STARTED|Overall Study||10||
59590828|NCT02753881|75698597|FG001|STARTED|Overall Study||10||
59590829|NCT02753881|75698598|FG002|STARTED|Overall Study||10||
59590830|NCT02753881|75698596|FG000|COMPLETED|Overall Study||10||
59590831|NCT02753881|75698597|FG001|COMPLETED|Overall Study||10||
59590832|NCT02753881|75698598|FG002|COMPLETED|Overall Study||10||
59590833|NCT02753881|75698596|FG000|NOT COMPLETED|Overall Study||0||
59590834|NCT02753881|75698597|FG001|NOT COMPLETED|Overall Study||0||
59590835|NCT02753881|75698598|FG002|NOT COMPLETED|Overall Study||0||
59590836|NCT02759354|75698610|FG000|STARTED|Overall Study||192||
59590837|NCT02759354|75698611|FG001|STARTED|Overall Study||190||
59590838|NCT02759354|75698612|FG002|STARTED|Overall Study||181||
59590839|NCT02759354|75698613|FG003|STARTED|Overall Study||191||
59590840|NCT02759354|75698610|FG000|COMPLETED|Overall Study||192||
59590841|NCT02759354|75698611|FG001|COMPLETED|Overall Study||190||
59590842|NCT02759354|75698612|FG002|COMPLETED|Overall Study||181||
59590843|NCT02759354|75698613|FG003|COMPLETED|Overall Study||191||
59590844|NCT02759354|75698610|FG000|NOT COMPLETED|Overall Study||0||
59590845|NCT02759354|75698611|FG001|NOT COMPLETED|Overall Study||0||
59590846|NCT02759354|75698612|FG002|NOT COMPLETED|Overall Study||0||
59590847|NCT02759354|75698613|FG003|NOT COMPLETED|Overall Study||0||
59725446|NCT00923091|75844335|FG006|STARTED|PeriodI-II (Randomized, Double-Blind)||337||
59590848|NCT01190306|75698627|FG000|STARTED|Overall Study||61||
59590849|NCT01190306|75698628|FG001|STARTED|Overall Study||66||
59590850|NCT01190306|75698627|FG000|COMPLETED|Overall Study||61||
59590851|NCT01190306|75698628|FG001|COMPLETED|Overall Study||66||
59590852|NCT01190306|75698627|FG000|NOT COMPLETED|Overall Study||0||
59590853|NCT01190306|75698628|FG001|NOT COMPLETED|Overall Study||0||
59590854|NCT02759575|75698634|FG000|STARTED|Overall Study||9||
59590855|NCT02759575|75698634|FG000|COMPLETED|Overall Study||9||
59590856|NCT02759575|75698634|FG000|NOT COMPLETED|Overall Study||0||
59590857|NCT02760056|75698640|FG000|STARTED|Overall Study||10||
59590858|NCT02760056|75698641|FG001|STARTED|Overall Study||5||
59590859|NCT02760056|75698640|FG000|COMPLETED|Overall Study||10||
59590860|NCT02760056|75698641|FG001|COMPLETED|Overall Study||5||
59590861|NCT02760056|75698640|FG000|NOT COMPLETED|Overall Study||0||
59590862|NCT02760056|75698641|FG001|NOT COMPLETED|Overall Study||0||
59590863|NCT02764970|75698650|FG000|STARTED|Overall Study||65||
59590864|NCT02764970|75698651|FG001|STARTED|Overall Study||47||
59590865|NCT02764970|75698650|FG000|COMPLETED|Overall Study||65||
59590866|NCT02764970|75698651|FG001|COMPLETED|Overall Study||47||
59590867|NCT02764970|75698650|FG000|NOT COMPLETED|Overall Study||0||
59590868|NCT02764970|75698651|FG001|NOT COMPLETED|Overall Study||0||
59590869|NCT02739698|75698659|FG000|STARTED|Overall Study||22||
59590870|NCT02739698|75698660|FG001|STARTED|Overall Study||21||
59590871|NCT02739698|75698659|FG000|COMPLETED|Overall Study||16||
59590872|NCT02739698|75698660|FG001|COMPLETED|Overall Study||16||
59590873|NCT02739698|75698659|FG000|NOT COMPLETED|Overall Study||6||
59590874|NCT02739698|75698660|FG001|NOT COMPLETED|Overall Study||5||
59590875|NCT02766374|75698668|FG000|STARTED|Overall Study||35||
59590876|NCT02766374|75698669|FG001|STARTED|Overall Study||33||
59590877|NCT02766374|75698668|FG000|COMPLETED|Overall Study||25||
59590878|NCT02766374|75698669|FG001|COMPLETED|Overall Study||30||
59590879|NCT02766374|75698668|FG000|NOT COMPLETED|Overall Study||10||
59590880|NCT02766374|75698669|FG001|NOT COMPLETED|Overall Study||3||
59590881|NCT02767934|75698675|FG000|STARTED|Overall Study||12||
59590882|NCT02767934|75698675|FG000|COMPLETED|Overall Study||12||
59590883|NCT02767934|75698675|FG000|NOT COMPLETED|Overall Study||0||
59590884|NCT02194998|75698684|FG000|STARTED|On-HCV Treatment||21||
59590885|NCT02194998|75698685|FG001|STARTED|On-HCV Treatment||6||
59590886|NCT02194998|75698686|FG002|STARTED|On-HCV Treatment||15||
59590887|NCT02194998|75698687|FG003|STARTED|On-HCV Treatment||4||
59590888|NCT02194998|75698684|FG000|COMPLETED|On-HCV Treatment||21||
59590889|NCT02194998|75698685|FG001|COMPLETED|On-HCV Treatment||5||
59590890|NCT02194998|75698686|FG002|COMPLETED|On-HCV Treatment||15||
59590891|NCT02194998|75698687|FG003|COMPLETED|On-HCV Treatment||4||
59590892|NCT02194998|75698684|FG000|NOT COMPLETED|On-HCV Treatment||0||
59590893|NCT02194998|75698685|FG001|NOT COMPLETED|On-HCV Treatment||1||
59590894|NCT02194998|75698686|FG002|NOT COMPLETED|On-HCV Treatment||0||
59590895|NCT02194998|75698687|FG003|NOT COMPLETED|On-HCV Treatment||0||
59590896|NCT02194998|75698684|FG000|STARTED|Post-HCV Treatment Follow-Up||21||
59590897|NCT02194998|75698685|FG001|STARTED|Post-HCV Treatment Follow-Up||5||
59590898|NCT02194998|75698686|FG002|STARTED|Post-HCV Treatment Follow-Up||15||
59590899|NCT02194998|75698687|FG003|STARTED|Post-HCV Treatment Follow-Up||4||
59590900|NCT02194998|75698684|FG000|COMPLETED|Post-HCV Treatment Follow-Up||20||
59590901|NCT02194998|75698685|FG001|COMPLETED|Post-HCV Treatment Follow-Up||5||
59590902|NCT02194998|75698686|FG002|COMPLETED|Post-HCV Treatment Follow-Up||14||
59590903|NCT02194998|75698687|FG003|COMPLETED|Post-HCV Treatment Follow-Up||4||
59590904|NCT02194998|75698684|FG000|NOT COMPLETED|Post-HCV Treatment Follow-Up||1||
59590905|NCT02194998|75698685|FG001|NOT COMPLETED|Post-HCV Treatment Follow-Up||0||
59590906|NCT02194998|75698686|FG002|NOT COMPLETED|Post-HCV Treatment Follow-Up||1||
59590907|NCT02194998|75698687|FG003|NOT COMPLETED|Post-HCV Treatment Follow-Up||0||
59590908|NCT02194062|75698700|FG000|STARTED|Overall Study||10||
59590909|NCT02194062|75698701|FG001|STARTED|Overall Study||10||
59590910|NCT02194062|75698702|FG002|STARTED|Overall Study||12||
59590911|NCT02194062|75698700|FG000|COMPLETED|Overall Study||8||
59590912|NCT02194062|75698701|FG001|COMPLETED|Overall Study||8||
59590913|NCT02194062|75698702|FG002|COMPLETED|Overall Study||7||
59590914|NCT02194062|75698700|FG000|NOT COMPLETED|Overall Study||2||
59590915|NCT02194062|75698701|FG001|NOT COMPLETED|Overall Study||2||
59590916|NCT02194062|75698702|FG002|NOT COMPLETED|Overall Study||5||
59590917|NCT02768558|75698712|FG000|STARTED|Overall Study||3||
59590918|NCT02768558|75698713|FG001|STARTED|Overall Study||5||
59590919|NCT02768558|75698712|FG000|Eligible|Overall Study||3|Participants contributing data to results are considered to have completed the study|
59590920|NCT02768558|75698713|FG001|Eligible|Overall Study||5|Participants contributing data to results are considered to have completed the study|
59590921|NCT02768558|75698712|FG000|COMPLETED|Overall Study||3||
59590922|NCT02768558|75698713|FG001|COMPLETED|Overall Study||5||
59590923|NCT02768558|75698712|FG000|NOT COMPLETED|Overall Study||0||
59725447|NCT00923091|75844336|FG007|STARTED|PeriodI-II (Randomized, Double-Blind)||336||
59725448|NCT00923091|75844337|FG008|STARTED|PeriodI-II (Randomized, Double-Blind)||0||
59590924|NCT02768558|75698713|FG001|NOT COMPLETED|Overall Study||0||
59590925|NCT02193828|75698723|FG000|STARTED|Overall Study||18||
59590926|NCT02193828|75698724|FG001|STARTED|Overall Study||18||
59590927|NCT02193828|75698725|FG002|STARTED|Overall Study||23||
59590928|NCT02193828|75698726|FG003|STARTED|Overall Study||17||
59590929|NCT02193828|75698723|FG000|COMPLETED|Overall Study||18||
59590930|NCT02193828|75698724|FG001|COMPLETED|Overall Study||18||
59590931|NCT02193828|75698725|FG002|COMPLETED|Overall Study||22||
59590932|NCT02193828|75698726|FG003|COMPLETED|Overall Study||16||
59590933|NCT02193828|75698723|FG000|NOT COMPLETED|Overall Study||0||
59590934|NCT02193828|75698724|FG001|NOT COMPLETED|Overall Study||0||
59590935|NCT02193828|75698725|FG002|NOT COMPLETED|Overall Study||1||
59725449|NCT00923091|75844338|FG009|STARTED|PeriodI-II (Randomized, Double-Blind)||0||
59725450|NCT00923091|75844339|FG010|STARTED|PeriodI-II (Randomized, Double-Blind)||0||
59590936|NCT02193828|75698726|FG003|NOT COMPLETED|Overall Study||1||
59590937|NCT02772302|75698738|FG000|STARTED|Overall Study||10||
59590938|NCT02772302|75698739|FG001|STARTED|Overall Study||10||
59590939|NCT02772302|75698738|FG000|COMPLETED|Overall Study||10||
59590940|NCT02772302|75698739|FG001|COMPLETED|Overall Study||10||
59590941|NCT02772302|75698738|FG000|NOT COMPLETED|Overall Study||0||
59590942|NCT02772302|75698739|FG001|NOT COMPLETED|Overall Study||0||
59590943|NCT02192970|75698747|FG000|STARTED|Overall Study||101||
59590944|NCT02192970|75698748|FG001|STARTED|Overall Study||195||
59590945|NCT02192970|75698747|FG000|COMPLETED|Overall Study||95||
59590946|NCT02192970|75698748|FG001|COMPLETED|Overall Study||195||
59590947|NCT02192970|75698747|FG000|NOT COMPLETED|Overall Study||6||
59590948|NCT02192970|75698748|FG001|NOT COMPLETED|Overall Study||0||
59590949|NCT02774798|75698757|FG000|STARTED|Overall Study||7||
59590950|NCT02774798|75698758|FG001|STARTED|Overall Study||17||
59590951|NCT02774798|75698759|FG002|STARTED|Overall Study||7||
59590952|NCT02774798|75698757|FG000|COMPLETED|Overall Study||7||
59590953|NCT02774798|75698758|FG001|COMPLETED|Overall Study||17||
59590954|NCT02774798|75698759|FG002|COMPLETED|Overall Study||7||
59590955|NCT02774798|75698757|FG000|NOT COMPLETED|Overall Study||0||
59590956|NCT02774798|75698758|FG001|NOT COMPLETED|Overall Study||0||
59590957|NCT02774798|75698759|FG002|NOT COMPLETED|Overall Study||0||
59590958|NCT02743442|75698767|FG000|STARTED|Overall Study||8||
59590959|NCT02743442|75698767|FG000|COMPLETED|Overall Study||8||
59590960|NCT02743442|75698767|FG000|NOT COMPLETED|Overall Study||0||
59590961|NCT02760277|75698775|FG000|STARTED|Vamorolone 0.25 mg/kg/Day||12||
59590962|NCT02760277|75698776|FG001|STARTED|Vamorolone 0.25 mg/kg/Day||0||
59590963|NCT02760277|75698777|FG002|STARTED|Vamorolone 0.25 mg/kg/Day||0||
59590964|NCT02760277|75698778|FG003|STARTED|Vamorolone 0.25 mg/kg/Day||0||
59590965|NCT02760277|75698775|FG000|COMPLETED|Vamorolone 0.25 mg/kg/Day||12||
59590966|NCT02760277|75698776|FG001|COMPLETED|Vamorolone 0.25 mg/kg/Day||0||
59590967|NCT02760277|75698777|FG002|COMPLETED|Vamorolone 0.25 mg/kg/Day||0||
59590968|NCT02760277|75698778|FG003|COMPLETED|Vamorolone 0.25 mg/kg/Day||0||
59590969|NCT02760277|75698775|FG000|NOT COMPLETED|Vamorolone 0.25 mg/kg/Day||0||
59590970|NCT02760277|75698776|FG001|NOT COMPLETED|Vamorolone 0.25 mg/kg/Day||0||
59590971|NCT02760277|75698777|FG002|NOT COMPLETED|Vamorolone 0.25 mg/kg/Day||0||
59590972|NCT02760277|75698778|FG003|NOT COMPLETED|Vamorolone 0.25 mg/kg/Day||0||
59725451|NCT00923091|75844340|FG011|STARTED|PeriodI-II (Randomized, Double-Blind)||0||
59725452|NCT00923091|75844341|FG012|STARTED|PeriodI-II (Randomized, Double-Blind)||0||
59725453|NCT00923091|75844329|FG000|COMPLETED|PeriodI-II (Randomized, Double-Blind)||319||
59725454|NCT00923091|75844330|FG001|COMPLETED|PeriodI-II (Randomized, Double-Blind)||325||
59725455|NCT00923091|75844331|FG002|COMPLETED|PeriodI-II (Randomized, Double-Blind)||323||
59725456|NCT00923091|75844332|FG003|COMPLETED|PeriodI-II (Randomized, Double-Blind)||309||
59725457|NCT00923091|75844333|FG004|COMPLETED|PeriodI-II (Randomized, Double-Blind)||315||
59725458|NCT00923091|75844334|FG005|COMPLETED|PeriodI-II (Randomized, Double-Blind)||322||
59725459|NCT00923091|75844335|FG006|COMPLETED|PeriodI-II (Randomized, Double-Blind)||319||
59725460|NCT00923091|75844336|FG007|COMPLETED|PeriodI-II (Randomized, Double-Blind)||311||
59725461|NCT00923091|75844337|FG008|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0||
59725462|NCT00923091|75844338|FG009|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0||
59725463|NCT00923091|75844339|FG010|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0||
59725464|NCT00923091|75844340|FG011|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0||
59725465|NCT00923091|75844341|FG012|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0||
59725466|NCT00923091|75844329|FG000|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||16||
59725467|NCT00923091|75844330|FG001|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||11||
59725468|NCT00923091|75844331|FG002|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||13||
59725469|NCT00923091|75844332|FG003|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||27||
59725470|NCT00923091|75844333|FG004|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||21||
59725471|NCT00923091|75844334|FG005|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||15||
59725472|NCT00923091|75844335|FG006|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||18||
59725473|NCT00923091|75844336|FG007|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||25||
59725474|NCT00923091|75844337|FG008|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0||
59590973|NCT02760277|75698775|FG000|STARTED|0.75 mg/kg/Day||0||
59590974|NCT02760277|75698776|FG001|STARTED|0.75 mg/kg/Day||12||
59590975|NCT02760277|75698777|FG002|STARTED|0.75 mg/kg/Day||0||
59590976|NCT02760277|75698778|FG003|STARTED|0.75 mg/kg/Day||0||
59590977|NCT02760277|75698775|FG000|COMPLETED|0.75 mg/kg/Day||0||
59590978|NCT02760277|75698776|FG001|COMPLETED|0.75 mg/kg/Day||12||
59590979|NCT02760277|75698777|FG002|COMPLETED|0.75 mg/kg/Day||0||
59590980|NCT02760277|75698778|FG003|COMPLETED|0.75 mg/kg/Day||0||
59590981|NCT02760277|75698775|FG000|NOT COMPLETED|0.75 mg/kg/Day||0||
59590982|NCT02760277|75698776|FG001|NOT COMPLETED|0.75 mg/kg/Day||0||
59590983|NCT02760277|75698777|FG002|NOT COMPLETED|0.75 mg/kg/Day||0||
59590984|NCT02760277|75698778|FG003|NOT COMPLETED|0.75 mg/kg/Day||0||
59590985|NCT02760277|75698775|FG000|STARTED|2.0 mg/kg/Day||0||
59590986|NCT02760277|75698776|FG001|STARTED|2.0 mg/kg/Day||0||
59590987|NCT02760277|75698777|FG002|STARTED|2.0 mg/kg/Day||12||
59590988|NCT02760277|75698778|FG003|STARTED|2.0 mg/kg/Day||0||
59590989|NCT02760277|75698775|FG000|COMPLETED|2.0 mg/kg/Day||0||
59725475|NCT00923091|75844338|FG009|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0||
59725476|NCT00923091|75844339|FG010|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0||
59725477|NCT00923091|75844340|FG011|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0||
59725478|NCT00923091|75844341|FG012|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0||
59725479|NCT00923091|75844329|FG000|STARTED|Period III (Single-Blind)|2543 completed Period 2. Three decided not to continue in the study=2540.|2540||
59725480|NCT00923091|75844330|FG001|STARTED|Period III (Single-Blind)||0||
59725481|NCT00923091|75844331|FG002|STARTED|Period III (Single-Blind)||0||
59725482|NCT00923091|75844332|FG003|STARTED|Period III (Single-Blind)||0||
59725483|NCT00923091|75844333|FG004|STARTED|Period III (Single-Blind)||0||
59725484|NCT00923091|75844334|FG005|STARTED|Period III (Single-Blind)||0||
59725485|NCT00923091|75844335|FG006|STARTED|Period III (Single-Blind)||0||
59725486|NCT00923091|75844336|FG007|STARTED|Period III (Single-Blind)||0||
59725487|NCT00923091|75844337|FG008|STARTED|Period III (Single-Blind)||0||
59725488|NCT00923091|75844338|FG009|STARTED|Period III (Single-Blind)||0||
59725489|NCT00923091|75844339|FG010|STARTED|Period III (Single-Blind)||0||
59725490|NCT00923091|75844340|FG011|STARTED|Period III (Single-Blind)||0||
59725491|NCT00923091|75844341|FG012|STARTED|Period III (Single-Blind)||0||
59725492|NCT00923091|75844329|FG000|COMPLETED|Period III (Single-Blind)||2520||
59725493|NCT00923091|75844330|FG001|COMPLETED|Period III (Single-Blind)||0||
59725494|NCT00923091|75844331|FG002|COMPLETED|Period III (Single-Blind)||0||
59725495|NCT00923091|75844332|FG003|COMPLETED|Period III (Single-Blind)||0||
59725496|NCT00923091|75844333|FG004|COMPLETED|Period III (Single-Blind)||0||
59725497|NCT00923091|75844334|FG005|COMPLETED|Period III (Single-Blind)||0||
59725498|NCT00923091|75844335|FG006|COMPLETED|Period III (Single-Blind)||0||
59725499|NCT00923091|75844336|FG007|COMPLETED|Period III (Single-Blind)||0||
59725500|NCT00923091|75844337|FG008|COMPLETED|Period III (Single-Blind)||0||
59725501|NCT00923091|75844338|FG009|COMPLETED|Period III (Single-Blind)||0||
59725502|NCT00923091|75844339|FG010|COMPLETED|Period III (Single-Blind)||0||
59725503|NCT00923091|75844340|FG011|COMPLETED|Period III (Single-Blind)||0||
59725504|NCT00923091|75844341|FG012|COMPLETED|Period III (Single-Blind)||0||
59725505|NCT00923091|75844329|FG000|NOT COMPLETED|Period III (Single-Blind)||20||
59725506|NCT00923091|75844330|FG001|NOT COMPLETED|Period III (Single-Blind)||0||
59725507|NCT00923091|75844331|FG002|NOT COMPLETED|Period III (Single-Blind)||0||
59725508|NCT00923091|75844332|FG003|NOT COMPLETED|Period III (Single-Blind)||0||
59725509|NCT00923091|75844333|FG004|NOT COMPLETED|Period III (Single-Blind)||0||
59725510|NCT00923091|75844334|FG005|NOT COMPLETED|Period III (Single-Blind)||0||
59725511|NCT00923091|75844335|FG006|NOT COMPLETED|Period III (Single-Blind)||0||
59725512|NCT00923091|75844336|FG007|NOT COMPLETED|Period III (Single-Blind)||0||
59725513|NCT00923091|75844337|FG008|NOT COMPLETED|Period III (Single-Blind)||0||
59725514|NCT00923091|75844338|FG009|NOT COMPLETED|Period III (Single-Blind)||0||
59725515|NCT00923091|75844339|FG010|NOT COMPLETED|Period III (Single-Blind)||0||
59725516|NCT00923091|75844340|FG011|NOT COMPLETED|Period III (Single-Blind)||0||
59725517|NCT00923091|75844341|FG012|NOT COMPLETED|Period III (Single-Blind)||0||
59725518|NCT00923091|75844329|FG000|STARTED|Period IV (Double-Blind)|2 did not continue in the study and 1837 responders went directly to Period VI. 228+453+2+1837=2520|228||
59725519|NCT00923091|75844330|FG001|STARTED|Period IV (Double-Blind)||453||
59725520|NCT00923091|75844331|FG002|STARTED|Period IV (Double-Blind)||0||
59725521|NCT00923091|75844332|FG003|STARTED|Period IV (Double-Blind)||0||
59725522|NCT00923091|75844333|FG004|STARTED|Period IV (Double-Blind)||0||
59725523|NCT00923091|75844334|FG005|STARTED|Period IV (Double-Blind)||0||
59725524|NCT00923091|75844335|FG006|STARTED|Period IV (Double-Blind)||0||
59725525|NCT00923091|75844336|FG007|STARTED|Period IV (Double-Blind)||0||
59725526|NCT00923091|75844337|FG008|STARTED|Period IV (Double-Blind)||0||
59725527|NCT00923091|75844338|FG009|STARTED|Period IV (Double-Blind)||0||
59725528|NCT00923091|75844339|FG010|STARTED|Period IV (Double-Blind)||0||
59725529|NCT00923091|75844340|FG011|STARTED|Period IV (Double-Blind)||0||
59725530|NCT00923091|75844341|FG012|STARTED|Period IV (Double-Blind)||0||
59725531|NCT00923091|75844329|FG000|COMPLETED|Period IV (Double-Blind)||226||
59725532|NCT00923091|75844330|FG001|COMPLETED|Period IV (Double-Blind)||451||
59725533|NCT00923091|75844331|FG002|COMPLETED|Period IV (Double-Blind)||0||
59725534|NCT00923091|75844332|FG003|COMPLETED|Period IV (Double-Blind)||0||
60121778|NCT01374906|76242792|FG001|STARTED|Overall Study||76||
59590990|NCT02760277|75698776|FG001|COMPLETED|2.0 mg/kg/Day||0||
59590991|NCT02760277|75698777|FG002|COMPLETED|2.0 mg/kg/Day||12||
59725535|NCT00923091|75844333|FG004|COMPLETED|Period IV (Double-Blind)||0||
59725536|NCT00923091|75844334|FG005|COMPLETED|Period IV (Double-Blind)||0||
59725537|NCT00923091|75844335|FG006|COMPLETED|Period IV (Double-Blind)||0||
59725538|NCT00923091|75844336|FG007|COMPLETED|Period IV (Double-Blind)||0||
59725539|NCT00923091|75844337|FG008|COMPLETED|Period IV (Double-Blind)||0||
59725540|NCT00923091|75844338|FG009|COMPLETED|Period IV (Double-Blind)||0||
59725541|NCT00923091|75844339|FG010|COMPLETED|Period IV (Double-Blind)||0||
59725542|NCT00923091|75844340|FG011|COMPLETED|Period IV (Double-Blind)||0||
59590992|NCT02760277|75698778|FG003|COMPLETED|2.0 mg/kg/Day||0||
59725543|NCT00923091|75844341|FG012|COMPLETED|Period IV (Double-Blind)||0||
59725544|NCT00923091|75844329|FG000|NOT COMPLETED|Period IV (Double-Blind)||2||
59725545|NCT00923091|75844330|FG001|NOT COMPLETED|Period IV (Double-Blind)||2||
60121779|NCT01374906|76242791|FG000|DC Dur Core Phs at/Prior to Data Cutoff|Overall Study||24||
59590993|NCT02760277|75698775|FG000|NOT COMPLETED|2.0 mg/kg/Day||0||
59590994|NCT02760277|75698776|FG001|NOT COMPLETED|2.0 mg/kg/Day||0||
59725546|NCT00923091|75844331|FG002|NOT COMPLETED|Period IV (Double-Blind)||0||
59725547|NCT00923091|75844332|FG003|NOT COMPLETED|Period IV (Double-Blind)||0||
59725548|NCT00923091|75844333|FG004|NOT COMPLETED|Period IV (Double-Blind)||0||
59725549|NCT00923091|75844334|FG005|NOT COMPLETED|Period IV (Double-Blind)||0||
59725550|NCT00923091|75844335|FG006|NOT COMPLETED|Period IV (Double-Blind)||0||
59725551|NCT00923091|75844336|FG007|NOT COMPLETED|Period IV (Double-Blind)||0||
59725552|NCT00923091|75844337|FG008|NOT COMPLETED|Period IV (Double-Blind)||0||
59725553|NCT00923091|75844338|FG009|NOT COMPLETED|Period IV (Double-Blind)||0||
59725554|NCT00923091|75844339|FG010|NOT COMPLETED|Period IV (Double-Blind)||0||
59725555|NCT00923091|75844340|FG011|NOT COMPLETED|Period IV (Double-Blind)||0||
59725556|NCT00923091|75844341|FG012|NOT COMPLETED|Period IV (Double-Blind)||0||
59725557|NCT00923091|75844329|FG000|STARTED|Period V (Double -Blind)|677 completed Period 4. 1 did not continue and 2 erroneously responders were not counted = 674|0||
59725558|NCT00923091|75844330|FG001|STARTED|Period V (Double -Blind)||0||
59725559|NCT00923091|75844331|FG002|STARTED|Period V (Double -Blind)||0||
59725560|NCT00923091|75844332|FG003|STARTED|Period V (Double -Blind)||0||
59725561|NCT00923091|75844333|FG004|STARTED|Period V (Double -Blind)||0||
59725562|NCT00923091|75844334|FG005|STARTED|Period V (Double -Blind)||0||
59725563|NCT00923091|75844335|FG006|STARTED|Period V (Double -Blind)||0||
59725564|NCT00923091|75844336|FG007|STARTED|Period V (Double -Blind)||0||
59725565|NCT00923091|75844337|FG008|STARTED|Period V (Double -Blind)||135||
59725566|NCT00923091|75844338|FG009|STARTED|Period V (Double -Blind)||119||
59725567|NCT00923091|75844339|FG010|STARTED|Period V (Double -Blind)||194||
59725568|NCT00923091|75844340|FG011|STARTED|Period V (Double -Blind)||151||
59725569|NCT00923091|75844341|FG012|STARTED|Period V (Double -Blind)||75||
59725570|NCT00923091|75844329|FG000|COMPLETED|Period V (Double -Blind)||0||
59725571|NCT00923091|75844330|FG001|COMPLETED|Period V (Double -Blind)||0||
59725572|NCT00923091|75844331|FG002|COMPLETED|Period V (Double -Blind)||0||
59725573|NCT00923091|75844332|FG003|COMPLETED|Period V (Double -Blind)||0||
59725574|NCT00923091|75844333|FG004|COMPLETED|Period V (Double -Blind)||0||
59725575|NCT00923091|75844334|FG005|COMPLETED|Period V (Double -Blind)||0||
59725576|NCT00923091|75844335|FG006|COMPLETED|Period V (Double -Blind)||0||
59725577|NCT00923091|75844336|FG007|COMPLETED|Period V (Double -Blind)||0||
59725578|NCT00923091|75844337|FG008|COMPLETED|Period V (Double -Blind)||134||
59725579|NCT00923091|75844338|FG009|COMPLETED|Period V (Double -Blind)||119||
59725580|NCT00923091|75844339|FG010|COMPLETED|Period V (Double -Blind)||193||
59590995|NCT02760277|75698777|FG002|NOT COMPLETED|2.0 mg/kg/Day||0||
59590996|NCT02760277|75698778|FG003|NOT COMPLETED|2.0 mg/kg/Day||0||
59590997|NCT02760277|75698775|FG000|STARTED|6.0 mg/kg/Day||0||
59725581|NCT00923091|75844340|FG011|COMPLETED|Period V (Double -Blind)||151||
59725582|NCT00923091|75844341|FG012|COMPLETED|Period V (Double -Blind)||73||
59725583|NCT00923091|75844329|FG000|NOT COMPLETED|Period V (Double -Blind)||0||
59725584|NCT00923091|75844330|FG001|NOT COMPLETED|Period V (Double -Blind)||0||
59725585|NCT00923091|75844331|FG002|NOT COMPLETED|Period V (Double -Blind)||0||
59725586|NCT00923091|75844332|FG003|NOT COMPLETED|Period V (Double -Blind)||0||
59725587|NCT00923091|75844333|FG004|NOT COMPLETED|Period V (Double -Blind)||0||
59725588|NCT00923091|75844334|FG005|NOT COMPLETED|Period V (Double -Blind)||0||
59725589|NCT00923091|75844335|FG006|NOT COMPLETED|Period V (Double -Blind)||0||
59725590|NCT00923091|75844336|FG007|NOT COMPLETED|Period V (Double -Blind)||0||
59725591|NCT00923091|75844337|FG008|NOT COMPLETED|Period V (Double -Blind)||1||
59725592|NCT00923091|75844338|FG009|NOT COMPLETED|Period V (Double -Blind)||0||
59725593|NCT00923091|75844339|FG010|NOT COMPLETED|Period V (Double -Blind)||1||
59725594|NCT00923091|75844340|FG011|NOT COMPLETED|Period V (Double -Blind)||0||
59725595|NCT00923091|75844341|FG012|NOT COMPLETED|Period V (Double -Blind)||2||
59725596|NCT00923091|75844329|FG000|STARTED|Period VI (Open-Label)|1837 from Period III+2 from Period IV + 670 from Period 5 = 2509|1447||
59725597|NCT00923091|75844330|FG001|STARTED|Period VI (Open-Label)||272||
59725598|NCT00923091|75844331|FG002|STARTED|Period VI (Open-Label)||480||
59590998|NCT02760277|75698776|FG001|STARTED|6.0 mg/kg/Day||0||
59590999|NCT02760277|75698777|FG002|STARTED|6.0 mg/kg/Day||0||
59591000|NCT02760277|75698778|FG003|STARTED|6.0 mg/kg/Day||12||
59591001|NCT02760277|75698775|FG000|COMPLETED|6.0 mg/kg/Day||0||
59591002|NCT02760277|75698776|FG001|COMPLETED|6.0 mg/kg/Day||0||
59591003|NCT02760277|75698777|FG002|COMPLETED|6.0 mg/kg/Day||0||
59591004|NCT02760277|75698778|FG003|COMPLETED|6.0 mg/kg/Day||12||
59591005|NCT02760277|75698775|FG000|NOT COMPLETED|6.0 mg/kg/Day||0||
59725599|NCT00923091|75844332|FG003|STARTED|Period VI (Open-Label)||146||
59725600|NCT00923091|75844333|FG004|STARTED|Period VI (Open-Label)||164||
59725601|NCT00923091|75844334|FG005|STARTED|Period VI (Open-Label)||0||
59725602|NCT00923091|75844335|FG006|STARTED|Period VI (Open-Label)||0||
59725603|NCT00923091|75844336|FG007|STARTED|Period VI (Open-Label)||0||
59725604|NCT00923091|75844337|FG008|STARTED|Period VI (Open-Label)||0||
59725605|NCT00923091|75844338|FG009|STARTED|Period VI (Open-Label)||0||
60121780|NCT01374906|76242792|FG001|DC Dur Core Phs at/Prior to Data Cutoff|Overall Study||22||
60121781|NCT01374906|76242791|FG000|Completed Core Phase|Overall Study||50||
59591006|NCT02760277|75698776|FG001|NOT COMPLETED|6.0 mg/kg/Day||0||
59725606|NCT00923091|75844339|FG010|STARTED|Period VI (Open-Label)||0||
59725607|NCT00923091|75844340|FG011|STARTED|Period VI (Open-Label)||0||
59725608|NCT00923091|75844341|FG012|STARTED|Period VI (Open-Label)||0||
59725609|NCT00923091|75844329|FG000|COMPLETED|Period VI (Open-Label)||1408||
59725610|NCT00923091|75844330|FG001|COMPLETED|Period VI (Open-Label)||264||
59725611|NCT00923091|75844331|FG002|COMPLETED|Period VI (Open-Label)||467||
59725612|NCT00923091|75844332|FG003|COMPLETED|Period VI (Open-Label)||143||
59725613|NCT00923091|75844333|FG004|COMPLETED|Period VI (Open-Label)||157||
59725614|NCT00923091|75844334|FG005|COMPLETED|Period VI (Open-Label)||0||
59725615|NCT00923091|75844335|FG006|COMPLETED|Period VI (Open-Label)||0||
59725616|NCT00923091|75844336|FG007|COMPLETED|Period VI (Open-Label)||0||
59725617|NCT00923091|75844337|FG008|COMPLETED|Period VI (Open-Label)||0||
59725618|NCT00923091|75844338|FG009|COMPLETED|Period VI (Open-Label)||0||
59725619|NCT00923091|75844339|FG010|COMPLETED|Period VI (Open-Label)||0||
59725620|NCT00923091|75844340|FG011|COMPLETED|Period VI (Open-Label)||0||
59725621|NCT00923091|75844341|FG012|COMPLETED|Period VI (Open-Label)||0||
59725622|NCT00923091|75844329|FG000|NOT COMPLETED|Period VI (Open-Label)||39||
59725623|NCT00923091|75844330|FG001|NOT COMPLETED|Period VI (Open-Label)||8||
59725624|NCT00923091|75844331|FG002|NOT COMPLETED|Period VI (Open-Label)||13||
59725625|NCT00923091|75844332|FG003|NOT COMPLETED|Period VI (Open-Label)||3||
59725626|NCT00923091|75844333|FG004|NOT COMPLETED|Period VI (Open-Label)||7||
59725627|NCT00923091|75844334|FG005|NOT COMPLETED|Period VI (Open-Label)||0||
59725628|NCT00923091|75844335|FG006|NOT COMPLETED|Period VI (Open-Label)||0||
59725629|NCT00923091|75844336|FG007|NOT COMPLETED|Period VI (Open-Label)||0||
59725630|NCT00923091|75844337|FG008|NOT COMPLETED|Period VI (Open-Label)||0||
59725631|NCT00923091|75844338|FG009|NOT COMPLETED|Period VI (Open-Label)||0||
59725632|NCT00923091|75844339|FG010|NOT COMPLETED|Period VI (Open-Label)||0||
59725633|NCT00923091|75844340|FG011|NOT COMPLETED|Period VI (Open-Label)||0||
59725634|NCT00923091|75844341|FG012|NOT COMPLETED|Period VI (Open-Label)||0||
59725635|NCT00853957|75844368|FG000|STARTED|Overall Study||220||
59725636|NCT00853957|75844369|FG001|STARTED|Overall Study||223||
59725637|NCT00853957|75844368|FG000|COMPLETED|Overall Study||206||
59725638|NCT00853957|75844369|FG001|COMPLETED|Overall Study||204||
59725639|NCT00853957|75844368|FG000|NOT COMPLETED|Overall Study||14||
59725640|NCT00853957|75844369|FG001|NOT COMPLETED|Overall Study||19||
59725641|NCT01021020|75844375|FG000|STARTED|Period I||28||
59725642|NCT01021020|75844375|FG000|COMPLETED|Period I|Colchicine(fasted)-subject took Claritin-D 12hour.Colchicine(fed)arm-subject had schedule conflict.|26||
59725643|NCT01021020|75844375|FG000|NOT COMPLETED|Period I||2||
59725644|NCT01021020|75844375|FG000|STARTED|14 Day Washout Period A||26||
59725645|NCT01021020|75844375|FG000|COMPLETED|14 Day Washout Period A|Colchicine/Probenecid-medical investigator dropped due to abnormal check-in lab results.|25||
59725646|NCT01021020|75844375|FG000|NOT COMPLETED|14 Day Washout Period A||1||
59725647|NCT01021020|75844375|FG000|STARTED|Period II||25||
59725648|NCT01021020|75844375|FG000|COMPLETED|Period II||25||
59725649|NCT01021020|75844375|FG000|NOT COMPLETED|Period II||0||
59725650|NCT01021020|75844375|FG000|STARTED|14 Day Washout Period B||25||
59855565|NCT03478930|75980170|FG001|NOT COMPLETED|Overall Study||9||
59591007|NCT02760277|75698777|FG002|NOT COMPLETED|6.0 mg/kg/Day||0||
59725651|NCT01021020|75844375|FG000|COMPLETED|14 Day Washout Period B||25||
59725652|NCT01021020|75844375|FG000|NOT COMPLETED|14 Day Washout Period B||0||
59725653|NCT01021020|75844375|FG000|STARTED|Period III||25||
59725654|NCT01021020|75844375|FG000|COMPLETED|Period III||25||
59725655|NCT01021020|75844375|FG000|NOT COMPLETED|Period III||0||
59725656|NCT00833053|75844389|FG000|STARTED|Overall Study||19||
59725657|NCT00833053|75844390|FG001|STARTED|Overall Study||20||
59725658|NCT00833053|75844389|FG000|COMPLETED|Overall Study||10||
59725659|NCT00833053|75844390|FG001|COMPLETED|Overall Study||17||
59725660|NCT00833053|75844389|FG000|NOT COMPLETED|Overall Study||9||
59725661|NCT00833053|75844390|FG001|NOT COMPLETED|Overall Study||3||
59725662|NCT00832975|75844396|FG000|STARTED|Overall Study||157||
59725663|NCT00832975|75844396|FG000|COMPLETED|Overall Study||118||
59725664|NCT00832975|75844396|FG000|NOT COMPLETED|Overall Study||39||
59591008|NCT02760277|75698778|FG003|NOT COMPLETED|6.0 mg/kg/Day||0||
59591009|NCT02776904|75698790|FG000|STARTED|Overall Study||281||
59591010|NCT02776904|75698791|FG001|STARTED|Overall Study||46||
59591011|NCT02776904|75698790|FG000|Gait Assessment|Overall Study||178||
59591012|NCT02776904|75698791|FG001|Gait Assessment|Overall Study||32||
59725665|NCT01020786|75844400|FG000|STARTED|Induction Period||109||
59725666|NCT01020786|75844400|FG000|COMPLETED|Induction Period|Completed induction therapy. Completed=starting the maintenance therapy.|60||
59725667|NCT01020786|75844400|FG000|NOT COMPLETED|Induction Period||49||
59725668|NCT01020786|75844400|FG000|STARTED|Maintenance Period||60||
59725669|NCT01020786|75844400|FG000|COMPLETED|Maintenance Period||0||
59725670|NCT01020786|75844400|FG000|NOT COMPLETED|Maintenance Period||60||
59725671|NCT00918645|75844405|FG000|STARTED|Overall Study||13||
59725672|NCT00918645|75844405|FG000|COMPLETED|Overall Study||12||
59725673|NCT00918645|75844405|FG000|NOT COMPLETED|Overall Study||1||
59725674|NCT00922935|75844412|FG000|STARTED|Overall Study||10||
59855566|NCT03038438|75980176|FG000|STARTED|Overall Study||200||
59855567|NCT03038438|75980176|FG000|30-Day Follow-Up|Overall Study||198||
59591013|NCT02776904|75698790|FG000|ImPACT|Overall Study||21||
59725675|NCT00922935|75844413|FG001|STARTED|Overall Study||16||
59725676|NCT00922935|75844414|FG002|STARTED|Overall Study||10||
59725677|NCT00922935|75844412|FG000|COMPLETED|Overall Study||9||
59725678|NCT00922935|75844413|FG001|COMPLETED|Overall Study||11||
59725679|NCT00922935|75844414|FG002|COMPLETED|Overall Study||10||
59725680|NCT00922935|75844412|FG000|NOT COMPLETED|Overall Study||1||
59725681|NCT00922935|75844413|FG001|NOT COMPLETED|Overall Study||5||
59725682|NCT00922935|75844414|FG002|NOT COMPLETED|Overall Study||0||
59725683|NCT01020474|75844424|FG000|STARTED|Overall Study||54||
59725684|NCT01020474|75844425|FG001|STARTED|Overall Study||53||
59725685|NCT01020474|75844424|FG000|COMPLETED|Overall Study||44||
59725686|NCT01020474|75844425|FG001|COMPLETED|Overall Study||36||
59725687|NCT01020474|75844424|FG000|NOT COMPLETED|Overall Study||10||
59725688|NCT01020474|75844425|FG001|NOT COMPLETED|Overall Study||17||
59725689|NCT00922779|75844431|FG000|STARTED|Overall Study||6661||
59725690|NCT00922779|75844431|FG000|COMPLETED|Overall Study||4334||
59725691|NCT00922779|75844431|FG000|NOT COMPLETED|Overall Study||2327||
59725692|NCT00924651|75844437|FG000|STARTED|Overall Study||356||
59725693|NCT00924651|75844438|FG001|STARTED|Overall Study||337||
59725694|NCT00924651|75844437|FG000|COMPLETED|Overall Study||331||
59725695|NCT00924651|75844438|FG001|COMPLETED|Overall Study||312||
59725696|NCT00924651|75844437|FG000|NOT COMPLETED|Overall Study||25||
59725697|NCT00924651|75844438|FG001|NOT COMPLETED|Overall Study||25||
59725698|NCT00922623|75844444|FG000|STARTED|Overall Study||93||
59725699|NCT00922623|75844444|FG000|COMPLETED|Overall Study||88||
59725700|NCT00922623|75844444|FG000|NOT COMPLETED|Overall Study||5||
59725701|NCT01025232|75844452|FG000|STARTED|Overall Study||46||
59725702|NCT01025232|75844453|FG001|STARTED|Overall Study||42||
59725703|NCT01025232|75844452|FG000|COMPLETED|Overall Study||43||
59725704|NCT01025232|75844453|FG001|COMPLETED|Overall Study||36||
59725705|NCT01025232|75844452|FG000|NOT COMPLETED|Overall Study||3||
59725706|NCT01025232|75844453|FG001|NOT COMPLETED|Overall Study||6||
59725707|NCT01025154|75844459|FG000|STARTED|Overall Study||59||
59725708|NCT01025154|75844459|FG000|COMPLETED|Overall Study||57||
59725709|NCT01025154|75844459|FG000|NOT COMPLETED|Overall Study||2||
59725710|NCT00832819|75844466|FG000|STARTED|Overall Study||6||
59725711|NCT00832819|75844467|FG001|STARTED|Overall Study||6||
59725712|NCT00832819|75844468|FG002|STARTED|Overall Study||16||
59725713|NCT00832819|75844466|FG000|COMPLETED|Overall Study||6||
59725714|NCT00832819|75844467|FG001|COMPLETED|Overall Study||5||
59725715|NCT00832819|75844468|FG002|COMPLETED|Overall Study||15||
59725716|NCT00832819|75844466|FG000|NOT COMPLETED|Overall Study||0||
59725717|NCT00832819|75844467|FG001|NOT COMPLETED|Overall Study||1||
60121782|NCT01374906|76242792|FG001|Completed Core Phase|Overall Study||54||
59591014|NCT02776904|75698791|FG001|ImPACT|Overall Study|ImPACT testing for the concussed subjects was completed for the clinical assessment (not research).|46||
59725718|NCT00832819|75844468|FG002|NOT COMPLETED|Overall Study||1||
59725719|NCT00853723|75844477|FG000|STARTED|Overall Study||35||
59725720|NCT00853723|75844478|FG001|STARTED|Overall Study||35||
59725721|NCT00853723|75844479|FG002|STARTED|Overall Study||35||
59725722|NCT00853723|75844477|FG000|COMPLETED|Overall Study||29||
59725723|NCT00853723|75844478|FG001|COMPLETED|Overall Study||28||
59725724|NCT00853723|75844479|FG002|COMPLETED|Overall Study||33||
59725725|NCT00853723|75844477|FG000|NOT COMPLETED|Overall Study||6||
59725726|NCT00853723|75844478|FG001|NOT COMPLETED|Overall Study||7||
59855568|NCT03038438|75980176|FG000|6-Month Follow-up|Overall Study||193||
59855569|NCT03038438|75980176|FG000|12-Month Follow-up|Overall Study||191||
60121783|NCT01374906|76242791|FG000|Completed Core/Did Not Enter Ext. Phase|Overall Study||10||
60121784|NCT01374906|76242792|FG001|Completed Core/Did Not Enter Ext. Phase|Overall Study||13||
60121785|NCT01374906|76242791|FG000|Completed Core Phase/Entered Ext. Phase|Overall Study||40||
59591015|NCT02776904|75698790|FG000|COMPLETED|Overall Study||281||
59591016|NCT02776904|75698791|FG001|COMPLETED|Overall Study||46||
59591017|NCT02776904|75698790|FG000|NOT COMPLETED|Overall Study||0||
59591018|NCT02776904|75698791|FG001|NOT COMPLETED|Overall Study||0||
59591019|NCT02744534|75698804|FG000|STARTED|Overall Study||21||
59591020|NCT02744534|75698804|FG000|COMPLETED|Overall Study||21||
59591021|NCT02744534|75698804|FG000|NOT COMPLETED|Overall Study||0||
59591022|NCT02744846|75698810|FG000|STARTED|5 Year Outcome Assessment||681739||
59591023|NCT02744846|75698810|FG000|Excluded Ineligible Patients|5 Year Outcome Assessment|Includes lost to follow-up and patients that had not reached age 4 years by end of study period|319189||
59591024|NCT02744846|75698810|FG000|COMPLETED|5 Year Outcome Assessment|Number of patients that meet eligibility criteria|362550||
59591025|NCT02744846|75698810|FG000|NOT COMPLETED|5 Year Outcome Assessment||319189||
59591026|NCT02744846|75698810|FG000|STARTED|10 Year Outcome Assessment||362550||
59591027|NCT02744846|75698810|FG000|Exclude Ineligible Patients|10 Year Outcome Assessment|Loss to follow-up, patients not yet 9 years, or systems that only had data from 2009 to 2016 or less|305820||
59591028|NCT02744846|75698810|FG000|COMPLETED|10 Year Outcome Assessment||56730||
59591029|NCT02744846|75698810|FG000|NOT COMPLETED|10 Year Outcome Assessment||305820||
59591030|NCT02762071|75698820|FG000|STARTED|Overall Study||54||
59591031|NCT02762071|75698821|FG001|STARTED|Overall Study||54||
59725727|NCT00853723|75844479|FG002|NOT COMPLETED|Overall Study||2||
59725728|NCT01104545|75844493|FG000|STARTED|Overall Study||8||
59725729|NCT01104545|75844494|FG001|STARTED|Overall Study||8||
59725730|NCT01104545|75844495|FG002|STARTED|Overall Study|1 participant received 0.50 mg of MK-3614 or placebo in Periods 3 and 4 instead of planned 0.75 mg|8||
59725731|NCT01104545|75844493|FG000|COMPLETED|Overall Study||8||
59725732|NCT01104545|75844494|FG001|COMPLETED|Overall Study|Participant discontinued after receiving 0.75 mg MK-3614 in Period 1|7||
59725733|NCT01104545|75844495|FG002|COMPLETED|Overall Study|Participants discontinued after receiving MK-3614 0.75 mg (Period 1)and placebo (Period 2)|6||
59725734|NCT01104545|75844493|FG000|NOT COMPLETED|Overall Study||0||
59725735|NCT01104545|75844494|FG001|NOT COMPLETED|Overall Study||1||
59725736|NCT01104545|75844495|FG002|NOT COMPLETED|Overall Study||2||
59725737|NCT00918255|75844543|FG000|STARTED|Overall Study||51||
59725738|NCT00918255|75844544|FG001|STARTED|Overall Study||52||
59725739|NCT00918255|75844545|FG002|STARTED|Overall Study||51||
59725740|NCT00918255|75844543|FG000|COMPLETED|Overall Study||45||
59725741|NCT00918255|75844544|FG001|COMPLETED|Overall Study||52||
59725742|NCT00918255|75844545|FG002|COMPLETED|Overall Study||46||
59725743|NCT00918255|75844543|FG000|NOT COMPLETED|Overall Study||6||
59725744|NCT00918255|75844544|FG001|NOT COMPLETED|Overall Study||0||
59725745|NCT00918255|75844545|FG002|NOT COMPLETED|Overall Study||5||
59725746|NCT01096589|75844557|FG000|STARTED|Overall Study||22||
59725747|NCT01096589|75844558|FG001|STARTED|Overall Study||20||
59725748|NCT01096589|75844559|FG002|STARTED|Overall Study||22||
59725749|NCT01096589|75844560|FG003|STARTED|Overall Study||18||
59725750|NCT01096589|75844557|FG000|COMPLETED|Overall Study||18||
59725751|NCT01096589|75844558|FG001|COMPLETED|Overall Study||18||
59725752|NCT01096589|75844559|FG002|COMPLETED|Overall Study||18||
59725753|NCT01096589|75844560|FG003|COMPLETED|Overall Study||15||
59725754|NCT01096589|75844557|FG000|NOT COMPLETED|Overall Study||4||
59725755|NCT01096589|75844558|FG001|NOT COMPLETED|Overall Study||2||
59725756|NCT01096589|75844559|FG002|NOT COMPLETED|Overall Study||4||
59725757|NCT01096589|75844560|FG003|NOT COMPLETED|Overall Study||3||
59725758|NCT00845065|75844576|FG000|STARTED|Overall Study||67||
59725759|NCT00845065|75844577|FG001|STARTED|Overall Study||134||
59725760|NCT00845065|75844576|FG000|COMPLETED|Overall Study||20||
59725761|NCT00845065|75844577|FG001|COMPLETED|Overall Study||79||
59725762|NCT00845065|75844576|FG000|NOT COMPLETED|Overall Study||47||
59725763|NCT00845065|75844577|FG001|NOT COMPLETED|Overall Study||55||
59725764|NCT00832585|75844583|FG000|STARTED|Overall Study|Eight subjects were screened but only 5 started the study and received study drug.|5||
59725765|NCT00832585|75844583|FG000|COMPLETED|Overall Study|Only three subjects completed all of the visits for the study as per protocol.|3||
59725766|NCT00832585|75844583|FG000|NOT COMPLETED|Overall Study||2||
59725767|NCT00918567|75844589|FG000|STARTED|Overall Study||29||
59725768|NCT00918567|75844590|FG001|STARTED|Overall Study||27||
59725769|NCT00918567|75844589|FG000|COMPLETED|Overall Study||24||
59725770|NCT00918567|75844590|FG001|COMPLETED|Overall Study||25||
59725771|NCT00918567|75844589|FG000|NOT COMPLETED|Overall Study||5||
59725772|NCT00918567|75844590|FG001|NOT COMPLETED|Overall Study||2||
59725773|NCT01024920|75844598|FG000|STARTED|Overall Study||67||
59725774|NCT01024920|75844599|FG001|STARTED|Overall Study||32||
59725775|NCT01024920|75844598|FG000|Treated|Overall Study||64||
59725776|NCT01024920|75844599|FG001|Treated|Overall Study||32||
59725777|NCT01024920|75844598|FG000|COMPLETED|Overall Study||0||
59725778|NCT01024920|75844599|FG001|COMPLETED|Overall Study||0||
59725779|NCT01024920|75844598|FG000|NOT COMPLETED|Overall Study||67||
59725780|NCT01024920|75844599|FG001|NOT COMPLETED|Overall Study||32||
59725781|NCT00832117|75844607|FG000|STARTED|Overall Study||29||
59725782|NCT00832117|75844607|FG000|COMPLETED|Overall Study||17||
59725783|NCT00832117|75844607|FG000|NOT COMPLETED|Overall Study||12||
59725784|NCT01104311|75844616|FG000|STARTED|Overall Study||66||
59725785|NCT01104311|75844617|FG001|STARTED|Overall Study||66||
59725786|NCT01104311|75844616|FG000|COMPLETED|Overall Study||56||
59855570|NCT03038438|75980176|FG000|24-Month Follow-up|Overall Study||148||
59855571|NCT03038438|75980176|FG000|36-Month Follow-up|Overall Study||162||
60121786|NCT01374906|76242792|FG001|Completed Core Phase/Entered Ext. Phase|Overall Study||41||
60121787|NCT01374906|76242791|FG000|DC Dur Ext Phs at/Prior to Data Cutoff|Overall Study||16||
59725787|NCT01104311|75844617|FG001|COMPLETED|Overall Study||54||
59725788|NCT01104311|75844616|FG000|NOT COMPLETED|Overall Study||10||
60121788|NCT01374906|76242792|FG001|DC Dur Ext Phs at/Prior to Data Cutoff|Overall Study||26||
59725789|NCT01104311|75844617|FG001|NOT COMPLETED|Overall Study||12||
59725790|NCT00831493|75844627|FG000|STARTED|Overall Study||3||
59725791|NCT00831493|75844627|FG000|COMPLETED|Overall Study||2||
59725792|NCT00831493|75844627|FG000|NOT COMPLETED|Overall Study||1||
59725793|NCT00853567|75844634|FG000|STARTED|Overall Study||71||
59725794|NCT00853567|75844634|FG000|COMPLETED|Overall Study||0||
59725795|NCT00853567|75844634|FG000|NOT COMPLETED|Overall Study||71||
59725796|NCT00853489|75844644|FG000|STARTED|Overall Study||16||
59725797|NCT00853489|75844645|FG001|STARTED|Overall Study||14||
59725798|NCT00853489|75844644|FG000|COMPLETED|Overall Study||11||
59725799|NCT00853489|75844645|FG001|COMPLETED|Overall Study||12||
59725800|NCT00853489|75844644|FG000|NOT COMPLETED|Overall Study||5||
59725801|NCT00853489|75844645|FG001|NOT COMPLETED|Overall Study||2||
59725802|NCT01019694|75844654|FG000|STARTED|Overall Study|2 pats. in Comb. Inh. Aero. and 3 pats. in Atro+Alb not treated and excluded from the Treated Set|157||
59855572|NCT03038438|75980176|FG000|COMPLETED|Overall Study||162||
59725803|NCT01019694|75844655|FG001|STARTED|Overall Study|2 pats. in Comb. Inh. Aero. and 3 pats. in Atro+Alb not treated and excluded from the Treated Set|156||
59725804|NCT01019694|75844656|FG002|STARTED|Overall Study|2 pats. in Comb. Inh. Aero. and 3 pats. in Atro+Alb not treated and excluded from the Treated Set|157||
59725805|NCT01019694|75844654|FG000|COMPLETED|Overall Study||133||
59725806|NCT01019694|75844655|FG001|COMPLETED|Overall Study||118||
59725807|NCT01019694|75844656|FG002|COMPLETED|Overall Study||110||
59725808|NCT01019694|75844654|FG000|NOT COMPLETED|Overall Study||24||
59725809|NCT01019694|75844655|FG001|NOT COMPLETED|Overall Study||38||
59725810|NCT01019694|75844656|FG002|NOT COMPLETED|Overall Study||47||
59725811|NCT00831415|75844664|FG000|STARTED|Overall Study||304||
59725812|NCT00831415|75844664|FG000|"Completers for Exposure"|Overall Study|Participants with ≥ 301 days of exposure to study drug and completed study day 308 evaluations.|227||
59725813|NCT00831415|75844664|FG000|"Study Completers"|Overall Study|"Defined as participants whose conclusion of study participation status was study completed."|227||
59725814|NCT00831415|75844664|FG000|COMPLETED|Overall Study|In addition to Completers for Study includes 2 participants who discontinued after on-therapy period|229||
59725815|NCT00831415|75844664|FG000|NOT COMPLETED|Overall Study||75||
59725816|NCT01095653|75844671|FG000|STARTED|Overall Study||132||
59725817|NCT01095653|75844672|FG001|STARTED|Overall Study||128||
59725818|NCT01095653|75844673|FG002|STARTED|Overall Study||133||
59725819|NCT01095653|75844671|FG000|COMPLETED|Overall Study||113||
59725820|NCT01095653|75844672|FG001|COMPLETED|Overall Study||113||
59725821|NCT01095653|75844673|FG002|COMPLETED|Overall Study||117||
59725822|NCT01095653|75844671|FG000|NOT COMPLETED|Overall Study||19||
59725823|NCT01095653|75844672|FG001|NOT COMPLETED|Overall Study||15||
59725824|NCT01095653|75844673|FG002|NOT COMPLETED|Overall Study||16||
59725825|NCT00920907|75844683|FG000|STARTED|Induction Period||37||
59725826|NCT00920907|75844684|FG001|STARTED|Induction Period||38||
59725827|NCT00920907|75844683|FG000|COMPLETED|Induction Period||15||
59725828|NCT00920907|75844684|FG001|COMPLETED|Induction Period||16||
59725829|NCT00920907|75844683|FG000|NOT COMPLETED|Induction Period||22||
59725830|NCT00920907|75844684|FG001|NOT COMPLETED|Induction Period||22||
59725831|NCT00920907|75844683|FG000|STARTED|Maintenance Period||15||
59725832|NCT00920907|75844684|FG001|STARTED|Maintenance Period|1 patient completed Induction phase but discontinued the study prior to start of maintenance phase.|15||
59725833|NCT00920907|75844683|FG000|COMPLETED|Maintenance Period|All participants who entered Maintenance were treated with study drug.|3||
59725834|NCT00920907|75844684|FG001|COMPLETED|Maintenance Period|2 participants who entered Maintenance Period did not receive study drug during the period.|2||
59725835|NCT00920907|75844683|FG000|NOT COMPLETED|Maintenance Period||12||
59725836|NCT00920907|75844684|FG001|NOT COMPLETED|Maintenance Period||13||
59725837|NCT01103141|75844694|FG000|STARTED|Overall Study||67||
59725838|NCT01103141|75844695|FG001|STARTED|Overall Study||76||
59725839|NCT01103141|75844694|FG000|COMPLETED|Overall Study||65||
59725840|NCT01103141|75844695|FG001|COMPLETED|Overall Study||74||
59725841|NCT01103141|75844694|FG000|NOT COMPLETED|Overall Study||2||
59725842|NCT01103141|75844695|FG001|NOT COMPLETED|Overall Study||2||
59725843|NCT00844831|75844701|FG000|STARTED|Overall Study||25||
59725844|NCT00844831|75844701|FG000|COMPLETED|Overall Study||19||
59725845|NCT00844831|75844701|FG000|NOT COMPLETED|Overall Study||6||
59725846|NCT00920829|75844713|FG000|STARTED|Allocation||38||
59725847|NCT00920829|75844714|FG001|STARTED|Allocation||39||
59725848|NCT00920829|75844715|FG002|STARTED|Allocation||38||
59725849|NCT00920829|75844716|FG003|STARTED|Allocation||37||
59725850|NCT00920829|75844713|FG000|COMPLETED|Allocation||35||
59725851|NCT00920829|75844714|FG001|COMPLETED|Allocation||38||
59725852|NCT00920829|75844715|FG002|COMPLETED|Allocation||38||
59725853|NCT00920829|75844716|FG003|COMPLETED|Allocation||35||
59725854|NCT00920829|75844713|FG000|NOT COMPLETED|Allocation||3||
59725855|NCT00920829|75844714|FG001|NOT COMPLETED|Allocation||1||
59725856|NCT00920829|75844715|FG002|NOT COMPLETED|Allocation||0||
59725857|NCT00920829|75844716|FG003|NOT COMPLETED|Allocation||2||
59725858|NCT00920829|75844713|FG000|STARTED|Available for Analysis||35||
59725859|NCT00920829|75844714|FG001|STARTED|Available for Analysis||38||
59725860|NCT00920829|75844715|FG002|STARTED|Available for Analysis||38||
59725861|NCT00920829|75844716|FG003|STARTED|Available for Analysis||35||
59725862|NCT00920829|75844713|FG000|COMPLETED|Available for Analysis||27||
59725863|NCT00920829|75844714|FG001|COMPLETED|Available for Analysis||27||
59725864|NCT00920829|75844715|FG002|COMPLETED|Available for Analysis||28||
59725865|NCT00920829|75844716|FG003|COMPLETED|Available for Analysis||24||
59725866|NCT00920829|75844713|FG000|NOT COMPLETED|Available for Analysis||8||
59725867|NCT00920829|75844714|FG001|NOT COMPLETED|Available for Analysis||11||
59725868|NCT00920829|75844715|FG002|NOT COMPLETED|Available for Analysis||10||
59725869|NCT00920829|75844716|FG003|NOT COMPLETED|Available for Analysis||11||
59725870|NCT00831181|75844726|FG000|STARTED|Overall Study||27||
59591032|NCT02762071|75698820|FG000|COMPLETED|Overall Study||54||
59725871|NCT00831181|75844726|FG000|COMPLETED|Overall Study||15||
59725872|NCT00831181|75844726|FG000|NOT COMPLETED|Overall Study||12||
59725873|NCT01023672|75844731|FG000|STARTED|Overall Study||20||
59591033|NCT02762071|75698821|FG001|COMPLETED|Overall Study||54||
59725874|NCT01023672|75844731|FG000|COMPLETED|Overall Study||17||
59725875|NCT01023672|75844731|FG000|NOT COMPLETED|Overall Study||3||
59725876|NCT01094171|75844735|FG000|STARTED|Overall Study||400||
59725877|NCT01094171|75844735|FG000|COMPLETED|Overall Study||390||
59725878|NCT01094171|75844735|FG000|NOT COMPLETED|Overall Study||10||
59725879|NCT01093625|75844741|FG000|STARTED|Baseline and Dispensed||49||
59725880|NCT01093625|75844742|FG001|STARTED|Baseline and Dispensed||49||
59725881|NCT01093625|75844741|FG000|COMPLETED|Baseline and Dispensed||47||
59725882|NCT01093625|75844742|FG001|COMPLETED|Baseline and Dispensed||49||
59725883|NCT01093625|75844741|FG000|NOT COMPLETED|Baseline and Dispensed||2||
59725884|NCT01093625|75844742|FG001|NOT COMPLETED|Baseline and Dispensed||0||
59725885|NCT01093625|75844741|FG000|STARTED|2-Week Visit||47||
59725886|NCT01093625|75844742|FG001|STARTED|2-Week Visit||49||
59725887|NCT01093625|75844741|FG000|COMPLETED|2-Week Visit||46||
59725888|NCT01093625|75844742|FG001|COMPLETED|2-Week Visit||49||
59725889|NCT01093625|75844741|FG000|NOT COMPLETED|2-Week Visit||1||
59725890|NCT01093625|75844742|FG001|NOT COMPLETED|2-Week Visit||0||
59725891|NCT01093625|75844741|FG000|STARTED|1-Month Visit||46||
59725892|NCT01093625|75844742|FG001|STARTED|1-Month Visit||49||
59725893|NCT01093625|75844741|FG000|COMPLETED|1-Month Visit||44||
59725894|NCT01093625|75844742|FG001|COMPLETED|1-Month Visit||49||
59725895|NCT01093625|75844741|FG000|NOT COMPLETED|1-Month Visit||2||
59725896|NCT01093625|75844742|FG001|NOT COMPLETED|1-Month Visit||0||
59725897|NCT01093625|75844741|FG000|STARTED|3-Month Visit||44||
59725898|NCT01093625|75844742|FG001|STARTED|3-Month Visit||49||
59725899|NCT01093625|75844741|FG000|COMPLETED|3-Month Visit||42||
59725900|NCT01093625|75844742|FG001|COMPLETED|3-Month Visit||49||
59725901|NCT01093625|75844741|FG000|NOT COMPLETED|3-Month Visit||2||
59725902|NCT01093625|75844742|FG001|NOT COMPLETED|3-Month Visit||0||
59725903|NCT01093625|75844741|FG000|STARTED|6-Month Visit||42||
59725904|NCT01093625|75844742|FG001|STARTED|6-Month Visit||49||
59725905|NCT01093625|75844741|FG000|COMPLETED|6-Month Visit||34||
59725906|NCT01093625|75844742|FG001|COMPLETED|6-Month Visit||40||
59725907|NCT01093625|75844741|FG000|NOT COMPLETED|6-Month Visit||8||
59725908|NCT01093625|75844742|FG001|NOT COMPLETED|6-Month Visit||9||
59725909|NCT01093625|75844741|FG000|STARTED|1-Year Visit||34||
59725910|NCT01093625|75844742|FG001|STARTED|1-Year Visit||40||
59725911|NCT01093625|75844741|FG000|COMPLETED|1-Year Visit||29||
59725912|NCT01093625|75844742|FG001|COMPLETED|1-Year Visit||37||
59725913|NCT01093625|75844741|FG000|NOT COMPLETED|1-Year Visit||5||
59725914|NCT01093625|75844742|FG001|NOT COMPLETED|1-Year Visit||3||
59725915|NCT01023516|75844750|FG000|STARTED|Overall Study||313||
59725916|NCT01023516|75844751|FG001|STARTED|Overall Study||302||
59725917|NCT01023516|75844750|FG000|COMPLETED|Overall Study||289||
59725918|NCT01023516|75844751|FG001|COMPLETED|Overall Study||284||
59725919|NCT01023516|75844750|FG000|NOT COMPLETED|Overall Study||24||
59725920|NCT01023516|75844751|FG001|NOT COMPLETED|Overall Study||18||
59725921|NCT00844753|75844761|FG000|STARTED|Overall Study||32||
59725922|NCT00844753|75844762|FG001|STARTED|Overall Study||32||
59725923|NCT00844753|75844763|FG002|STARTED|Overall Study||32||
59725924|NCT00844753|75844764|FG003|STARTED|Overall Study||32||
59725925|NCT00844753|75844761|FG000|COMPLETED|Overall Study||24||
59725926|NCT00844753|75844762|FG001|COMPLETED|Overall Study||29||
59725927|NCT00844753|75844763|FG002|COMPLETED|Overall Study||25||
59725928|NCT00844753|75844764|FG003|COMPLETED|Overall Study||21||
59725929|NCT00844753|75844761|FG000|NOT COMPLETED|Overall Study||8||
59725930|NCT00844753|75844762|FG001|NOT COMPLETED|Overall Study||3||
59725931|NCT00844753|75844763|FG002|NOT COMPLETED|Overall Study||7||
59725932|NCT00844753|75844764|FG003|NOT COMPLETED|Overall Study||11||
59725933|NCT00830947|75844774|FG000|STARTED|Overall Study||23||
60121789|NCT01374906|76242791|FG000|Completed Extension Phase|Overall Study||24||
59725934|NCT00830947|75844775|FG001|STARTED|Overall Study||22||
59725935|NCT00830947|75844774|FG000|COMPLETED|Overall Study||19||
59725936|NCT00830947|75844775|FG001|COMPLETED|Overall Study||18||
59725937|NCT00830947|75844774|FG000|NOT COMPLETED|Overall Study||4||
59725938|NCT00830947|75844775|FG001|NOT COMPLETED|Overall Study||4||
59725939|NCT01018992|75844783|FG000|STARTED|Overall Study||63||
59725940|NCT01018992|75844784|FG001|STARTED|Overall Study||65||
59725941|NCT01018992|75844783|FG000|COMPLETED|Overall Study||47||
59725942|NCT01018992|75844784|FG001|COMPLETED|Overall Study||49||
59725943|NCT01018992|75844783|FG000|NOT COMPLETED|Overall Study||16||
60121790|NCT01374906|76242792|FG001|Completed Extension Phase|Overall Study||15||
60121791|NCT01374906|76242791|FG000|COMPLETED|Overall Study||34||
59725944|NCT01018992|75844784|FG001|NOT COMPLETED|Overall Study||16||
59725945|NCT00917553|75844792|FG000|STARTED|Overall Study||17||
59725946|NCT00917553|75844793|FG001|STARTED|Overall Study||16||
59725947|NCT00917553|75844792|FG000|COMPLETED|Overall Study||15||
59725948|NCT00917553|75844793|FG001|COMPLETED|Overall Study||15||
59725949|NCT00917553|75844792|FG000|NOT COMPLETED|Overall Study||2||
59725950|NCT00917553|75844793|FG001|NOT COMPLETED|Overall Study||1||
59725951|NCT01018680|75844801|FG000|STARTED|Overall Study||260||
59725952|NCT01018680|75844802|FG001|STARTED|Overall Study||264||
59725953|NCT01018680|75844801|FG000|COMPLETED|Overall Study||199||
59725954|NCT01018680|75844802|FG001|COMPLETED|Overall Study||189||
59725955|NCT01018680|75844801|FG000|NOT COMPLETED|Overall Study||61||
59725956|NCT01018680|75844802|FG001|NOT COMPLETED|Overall Study||75||
59725957|NCT01012440|75844808|FG000|STARTED|Overall Study||5||
59725958|NCT01012440|75844808|FG000|COMPLETED|Overall Study||3||
59725959|NCT01012440|75844808|FG000|NOT COMPLETED|Overall Study||2||
59725960|NCT00916929|75844814|FG000|STARTED|Overall Study||80||
59725961|NCT00916929|75844815|FG001|STARTED|Overall Study||82||
59725962|NCT00916929|75844814|FG000|COMPLETED|Overall Study||70||
59725963|NCT00916929|75844815|FG001|COMPLETED|Overall Study||53||
59725964|NCT00916929|75844814|FG000|NOT COMPLETED|Overall Study||10||
59725965|NCT00916929|75844815|FG001|NOT COMPLETED|Overall Study||29||
59725966|NCT00844597|75844829|FG000|STARTED|Overall Study||4||
59725967|NCT00844597|75844830|FG001|STARTED|Overall Study||2||
59725968|NCT00844597|75844831|FG002|STARTED|Overall Study||2||
59725969|NCT00844597|75844832|FG003|STARTED|Overall Study||3||
59725970|NCT00844597|75844833|FG004|STARTED|Overall Study||4||
59725971|NCT00844597|75844834|FG005|STARTED|Overall Study||4||
59725972|NCT00844597|75844829|FG000|COMPLETED|Overall Study||4||
59725973|NCT00844597|75844830|FG001|COMPLETED|Overall Study||2||
59725974|NCT00844597|75844831|FG002|COMPLETED|Overall Study||2||
59725975|NCT00844597|75844832|FG003|COMPLETED|Overall Study||2||
59725976|NCT00844597|75844833|FG004|COMPLETED|Overall Study||4||
59855573|NCT03038438|75980176|FG000|NOT COMPLETED|Overall Study||38||
59855574|NCT03523000|75980180|FG000|STARTED|Overall Study||20||
59855575|NCT03523000|75980181|FG001|STARTED|Overall Study||16||
59591034|NCT02762071|75698820|FG000|NOT COMPLETED|Overall Study||0||
59591035|NCT02762071|75698821|FG001|NOT COMPLETED|Overall Study||0||
59591036|NCT02745626|75698831|FG000|STARTED|Overall Study||24||
59591037|NCT02745626|75698832|FG001|STARTED|Overall Study||22||
59591038|NCT02745626|75698833|FG002|STARTED|Overall Study||22||
59591039|NCT02745626|75698831|FG000|COMPLETED|Overall Study||21||
59591040|NCT02745626|75698832|FG001|COMPLETED|Overall Study||16||
59591041|NCT02745626|75698833|FG002|COMPLETED|Overall Study||19||
59591042|NCT02745626|75698831|FG000|NOT COMPLETED|Overall Study||3||
59591043|NCT02745626|75698832|FG001|NOT COMPLETED|Overall Study||6||
59591044|NCT02745626|75698833|FG002|NOT COMPLETED|Overall Study||3||
59591045|NCT02763865|75698843|FG000|STARTED|Overall Study||5||
59591046|NCT02763865|75698844|FG001|STARTED|Overall Study||5||
59591047|NCT02763865|75698843|FG000|COMPLETED|Overall Study||5||
59591048|NCT02763865|75698844|FG001|COMPLETED|Overall Study||5||
59591049|NCT02763865|75698843|FG000|NOT COMPLETED|Overall Study||0||
59591050|NCT02763865|75698844|FG001|NOT COMPLETED|Overall Study||0||
59591051|NCT02746406|75698852|FG000|STARTED|Overall Study||5||
59591052|NCT02746406|75698852|FG000|COMPLETED|Overall Study||5||
59591053|NCT02746406|75698852|FG000|NOT COMPLETED|Overall Study||0||
59591054|NCT02765269|75698858|FG000|STARTED|Overall Study||25||
59591055|NCT02765269|75698859|FG001|STARTED|Overall Study||21||
59591056|NCT02765269|75698858|FG000|COMPLETED|Overall Study||25||
59725977|NCT00844597|75844834|FG005|COMPLETED|Overall Study||4||
59725978|NCT00844597|75844829|FG000|NOT COMPLETED|Overall Study||0||
59725979|NCT00844597|75844830|FG001|NOT COMPLETED|Overall Study||0||
59725980|NCT00844597|75844831|FG002|NOT COMPLETED|Overall Study||0||
59725981|NCT00844597|75844832|FG003|NOT COMPLETED|Overall Study||1||
59725982|NCT00844597|75844833|FG004|NOT COMPLETED|Overall Study||0||
59725983|NCT00844597|75844834|FG005|NOT COMPLETED|Overall Study||0||
59725984|NCT01017120|75844852|FG000|STARTED|Overall Study||373||
59725985|NCT01017120|75844853|FG001|STARTED|Overall Study||369||
59725986|NCT01017120|75844852|FG000|COMPLETED|Overall Study||307||
59725987|NCT01017120|75844853|FG001|COMPLETED|Overall Study||334||
59725988|NCT01017120|75844852|FG000|NOT COMPLETED|Overall Study||66||
59725989|NCT01017120|75844853|FG001|NOT COMPLETED|Overall Study||35||
59725990|NCT01016964|75844861|FG000|STARTED|Overall Study||21||
59725991|NCT01016964|75844862|FG001|STARTED|Overall Study||42||
59725992|NCT01016964|75844861|FG000|COMPLETED|Overall Study||18||
59725993|NCT01016964|75844862|FG001|COMPLETED|Overall Study||39||
59725994|NCT01016964|75844861|FG000|NOT COMPLETED|Overall Study||3||
59725995|NCT01016964|75844862|FG001|NOT COMPLETED|Overall Study||3||
59725996|NCT02996110|75844873|FG000|STARTED|Pre-Treatment||65|Initial Randomization|
59725997|NCT02996110|75844874|FG001|STARTED|Pre-Treatment||56|Initial Randomization|
59725998|NCT02996110|75844875|FG002|STARTED|Pre-Treatment||26|Initial Randomization|
59725999|NCT02996110|75844876|FG003|STARTED|Pre-Treatment||17|Initial Randomization|
59726000|NCT02996110|75844877|FG004|STARTED|Pre-Treatment||18|Initial Randomization|
59591057|NCT02765269|75698859|FG001|COMPLETED|Overall Study||21||
59591058|NCT02765269|75698858|FG000|NOT COMPLETED|Overall Study||0||
59726001|NCT02996110|75844873|FG000|COMPLETED|Pre-Treatment||65|Continuing Into Treatment Period|
59726002|NCT02996110|75844874|FG001|COMPLETED|Pre-Treatment||55|Continuing Into Treatment Period|
59726003|NCT02996110|75844875|FG002|COMPLETED|Pre-Treatment||25|Continuing Into Treatment Period|
59726004|NCT02996110|75844876|FG003|COMPLETED|Pre-Treatment||17|Continuing Into Treatment Period|
59726005|NCT02996110|75844877|FG004|COMPLETED|Pre-Treatment||16|Continuing Into Treatment Period|
59726006|NCT02996110|75844873|FG000|NOT COMPLETED|Pre-Treatment||0||
59726007|NCT02996110|75844874|FG001|NOT COMPLETED|Pre-Treatment||1||
59855576|NCT03523000|75980180|FG000|COMPLETED|Overall Study||15||
59591059|NCT02765269|75698859|FG001|NOT COMPLETED|Overall Study||0||
59591060|NCT02747186|75698865|FG000|STARTED|First Intervention||12||
59591061|NCT02747186|75698866|FG001|STARTED|First Intervention||12||
59591062|NCT02747186|75698865|FG000|COMPLETED|First Intervention||12||
59591063|NCT02747186|75698866|FG001|COMPLETED|First Intervention||12||
59591064|NCT02747186|75698865|FG000|NOT COMPLETED|First Intervention||0||
59726008|NCT02996110|75844875|FG002|NOT COMPLETED|Pre-Treatment||1||
59726009|NCT02996110|75844876|FG003|NOT COMPLETED|Pre-Treatment||0||
59726010|NCT02996110|75844877|FG004|NOT COMPLETED|Pre-Treatment||2||
59726011|NCT02996110|75844873|FG000|STARTED|Track 1||30||
59726012|NCT02996110|75844874|FG001|STARTED|Track 1||30||
59855577|NCT03523000|75980181|FG001|COMPLETED|Overall Study||16||
59855578|NCT03523000|75980180|FG000|NOT COMPLETED|Overall Study||5||
59855579|NCT03523000|75980181|FG001|NOT COMPLETED|Overall Study||0||
59855580|NCT03327220|75980192|FG000|STARTED|Overall Study||62||
59855581|NCT03327220|75980193|FG001|STARTED|Overall Study||62||
59855582|NCT03327220|75980192|FG000|Safety Population: Received Study Treatment|Overall Study||59||
59855583|NCT03327220|75980193|FG001|Safety Population: Received Study Treatment|Overall Study||60||
59855584|NCT03327220|75980192|FG000|COMPLETED|Overall Study||57||
59855585|NCT03327220|75980193|FG001|COMPLETED|Overall Study||58||
59855586|NCT03327220|75980192|FG000|NOT COMPLETED|Overall Study||5||
59855587|NCT03327220|75980193|FG001|NOT COMPLETED|Overall Study||4||
60121792|NCT01374906|76242792|FG001|COMPLETED|Overall Study||28||
59591065|NCT02747186|75698866|FG001|NOT COMPLETED|First Intervention||0||
59591066|NCT02747186|75698865|FG000|STARTED|Washout (1 Week)||12||
59591067|NCT02747186|75698866|FG001|STARTED|Washout (1 Week)||12||
59591068|NCT02747186|75698865|FG000|COMPLETED|Washout (1 Week)||12||
59591069|NCT02747186|75698866|FG001|COMPLETED|Washout (1 Week)||12||
59591070|NCT02747186|75698865|FG000|NOT COMPLETED|Washout (1 Week)||0||
59591071|NCT02747186|75698866|FG001|NOT COMPLETED|Washout (1 Week)||0||
59591072|NCT02747186|75698865|FG000|STARTED|Second Intervention||12||
59591073|NCT02747186|75698866|FG001|STARTED|Second Intervention||12||
59591074|NCT02747186|75698865|FG000|COMPLETED|Second Intervention||12||
59591075|NCT02747186|75698866|FG001|COMPLETED|Second Intervention||12||
59591076|NCT02747186|75698865|FG000|NOT COMPLETED|Second Intervention||0||
59591077|NCT02747186|75698866|FG001|NOT COMPLETED|Second Intervention||0||
59591078|NCT02766517|75698875|FG000|STARTED|Overall Study||19||
59591079|NCT02766517|75698876|FG001|STARTED|Overall Study||9||
59591080|NCT02766517|75698877|FG002|STARTED|Overall Study||9||
59591081|NCT02766517|75698875|FG000|COMPLETED|Overall Study||19||
59591082|NCT02766517|75698876|FG001|COMPLETED|Overall Study||9||
59591083|NCT02766517|75698877|FG002|COMPLETED|Overall Study||9||
59591084|NCT02766517|75698875|FG000|NOT COMPLETED|Overall Study||0||
59591085|NCT02766517|75698876|FG001|NOT COMPLETED|Overall Study||0||
59591086|NCT02766517|75698877|FG002|NOT COMPLETED|Overall Study||0||
59591087|NCT02766673|75698885|FG000|STARTED|Overall Study||4||
59591088|NCT02766673|75698886|FG001|STARTED|Overall Study||4||
59591089|NCT02766673|75698887|FG002|STARTED|Overall Study||4||
59591090|NCT02766673|75698888|FG003|STARTED|Overall Study||4||
59591091|NCT02766673|75698889|FG004|STARTED|Overall Study||4||
59591092|NCT02766673|75698890|FG005|STARTED|Overall Study||4||
59726013|NCT02996110|75844875|FG002|STARTED|Track 1||0||
59726014|NCT02996110|75844876|FG003|STARTED|Track 1||0||
59726015|NCT02996110|75844877|FG004|STARTED|Track 1||0||
59726016|NCT02996110|75844873|FG000|Re-Randomized to Track 2|Track 1||5||
59726017|NCT02996110|75844874|FG001|Re-Randomized to Track 2|Track 1||6||
59591093|NCT02766673|75698885|FG000|COMPLETED|Overall Study||3||
59591094|NCT02766673|75698886|FG001|COMPLETED|Overall Study||4||
59591095|NCT02766673|75698887|FG002|COMPLETED|Overall Study||4||
59591096|NCT02766673|75698888|FG003|COMPLETED|Overall Study||4||
59591097|NCT02766673|75698889|FG004|COMPLETED|Overall Study||4||
59591098|NCT02766673|75698890|FG005|COMPLETED|Overall Study||3||
59591099|NCT02766673|75698885|FG000|NOT COMPLETED|Overall Study||1||
59591100|NCT02766673|75698886|FG001|NOT COMPLETED|Overall Study||0||
59591101|NCT02766673|75698887|FG002|NOT COMPLETED|Overall Study||0||
59591102|NCT02766673|75698888|FG003|NOT COMPLETED|Overall Study||0||
59591103|NCT02766673|75698889|FG004|NOT COMPLETED|Overall Study||0||
59591104|NCT02766673|75698890|FG005|NOT COMPLETED|Overall Study||1||
59591105|NCT02766907|75698900|FG000|STARTED|Overall Study||10||
59726018|NCT02996110|75844875|FG002|Re-Randomized to Track 2|Track 1||0||
59726019|NCT02996110|75844876|FG003|Re-Randomized to Track 2|Track 1||0||
59726020|NCT02996110|75844877|FG004|Re-Randomized to Track 2|Track 1||0||
59726021|NCT02996110|75844873|FG000|COMPLETED|Track 1||7||
59726022|NCT02996110|75844874|FG001|COMPLETED|Track 1||8||
59855588|NCT00318149|75980205|FG000|STARTED|Overall Study||75||
59855589|NCT00318149|75980206|FG001|STARTED|Overall Study||50||
59855590|NCT00318149|75980207|FG002|STARTED|Overall Study||75||
59855591|NCT00318149|75980208|FG003|STARTED|Overall Study||75||
59591106|NCT02766907|75698901|FG001|STARTED|Overall Study||10||
59591107|NCT02766907|75698900|FG000|COMPLETED|Overall Study||9||
59591108|NCT02766907|75698901|FG001|COMPLETED|Overall Study||9||
59591109|NCT02766907|75698900|FG000|NOT COMPLETED|Overall Study||1||
59591110|NCT02766907|75698901|FG001|NOT COMPLETED|Overall Study||1||
59591111|NCT02767609|75698907|FG000|STARTED|Overall Study||1||
59591112|NCT02767609|75698907|FG000|COMPLETED|Overall Study||1||
59591113|NCT02767609|75698907|FG000|NOT COMPLETED|Overall Study||0||
59591114|NCT02767843|75698911|FG000|STARTED|Overall Study||4||
59591115|NCT02767843|75698911|FG000|COMPLETED|Overall Study||4||
59726023|NCT02996110|75844875|FG002|COMPLETED|Track 1||0||
59726024|NCT02996110|75844876|FG003|COMPLETED|Track 1||0||
59591116|NCT02767843|75698911|FG000|NOT COMPLETED|Overall Study||0||
59591117|NCT04064684|75698919|FG000|STARTED|Overall Study||1||
59591118|NCT04064684|75698920|FG001|STARTED|Overall Study||1||
59591119|NCT04064684|75698919|FG000|COMPLETED|Overall Study||1||
59591120|NCT04064684|75698920|FG001|COMPLETED|Overall Study||1||
59591121|NCT04064684|75698919|FG000|NOT COMPLETED|Overall Study||0||
59591122|NCT04064684|75698920|FG001|NOT COMPLETED|Overall Study||0||
59591123|NCT02192190|75698932|FG000|STARTED|Overall Study||76||
59591124|NCT02192190|75698933|FG001|STARTED|Overall Study||39||
59591125|NCT02192190|75698934|FG002|STARTED|Overall Study||38||
59591126|NCT02192190|75698935|FG003|STARTED|Overall Study||38||
59591127|NCT02192190|75698936|FG004|STARTED|Overall Study||39||
59591128|NCT02192190|75698937|FG005|STARTED|Overall Study||38||
59591129|NCT02192190|75698932|FG000|Received at Least 1 Dose of Study Drug|Overall Study||76||
59591130|NCT02192190|75698933|FG001|Received at Least 1 Dose of Study Drug|Overall Study||39||
59591131|NCT02192190|75698934|FG002|Received at Least 1 Dose of Study Drug|Overall Study||38||
59591132|NCT02192190|75698935|FG003|Received at Least 1 Dose of Study Drug|Overall Study||38||
59591133|NCT02192190|75698936|FG004|Received at Least 1 Dose of Study Drug|Overall Study||38||
59591134|NCT02192190|75698937|FG005|Received at Least 1 Dose of Study Drug|Overall Study||37||
59591135|NCT02192190|75698932|FG000|COMPLETED|Overall Study||22||
59591136|NCT02192190|75698933|FG001|COMPLETED|Overall Study||10||
59591137|NCT02192190|75698934|FG002|COMPLETED|Overall Study||13||
59591138|NCT02192190|75698935|FG003|COMPLETED|Overall Study||12||
59591139|NCT02192190|75698936|FG004|COMPLETED|Overall Study||9||
59591140|NCT02192190|75698937|FG005|COMPLETED|Overall Study||9||
59591141|NCT02192190|75698932|FG000|NOT COMPLETED|Overall Study||54||
59591142|NCT02192190|75698933|FG001|NOT COMPLETED|Overall Study||29||
59591143|NCT02192190|75698934|FG002|NOT COMPLETED|Overall Study||25||
59591144|NCT02192190|75698935|FG003|NOT COMPLETED|Overall Study||26||
59591145|NCT02192190|75698936|FG004|NOT COMPLETED|Overall Study||30||
59591146|NCT02192190|75698937|FG005|NOT COMPLETED|Overall Study||29||
59591147|NCT02748889|75698954|FG000|STARTED|Overall Study||0||
59591148|NCT02748889|75698955|FG001|STARTED|Overall Study||1||
59591149|NCT02748889|75698954|FG000|COMPLETED|Overall Study||0||
59591150|NCT02748889|75698955|FG001|COMPLETED|Overall Study||1||
59591151|NCT02748889|75698954|FG000|NOT COMPLETED|Overall Study||0||
59591152|NCT02748889|75698955|FG001|NOT COMPLETED|Overall Study||0||
59591153|NCT02749201|75698959|FG000|STARTED|Overall Study||10||
59591154|NCT02749201|75698959|FG000|COMPLETED|Overall Study||10||
59591155|NCT02749201|75698959|FG000|NOT COMPLETED|Overall Study||0||
59591156|NCT02224638|75698965|FG000|STARTED|Overall Study||11||
59591157|NCT02224638|75698966|FG001|STARTED|Overall Study||10||
59591158|NCT02224638|75698965|FG000|COMPLETED|Overall Study||10||
59591159|NCT02224638|75698966|FG001|COMPLETED|Overall Study||9||
59591160|NCT02224638|75698965|FG000|NOT COMPLETED|Overall Study||1||
59591161|NCT02224638|75698966|FG001|NOT COMPLETED|Overall Study||1||
59591162|NCT02749903|75698974|FG000|STARTED|Overall Study||46||
59591163|NCT02749903|75698974|FG000|COMPLETED|Overall Study||46||
59591164|NCT02749903|75698974|FG000|NOT COMPLETED|Overall Study||0||
59591165|NCT02224560|75698981|FG000|STARTED|Overall Study||76||
59591166|NCT02224560|75698982|FG001|STARTED|Overall Study||73||
59591167|NCT02224560|75698983|FG002|STARTED|Overall Study||76||
59591168|NCT02224560|75698981|FG000|Safety Analysis Set|Overall Study|Six participants assigned to the 10 mg/kg/day dose were included in the 20 mg/kg/day group.|82|Received at least 1 dose of IMP; analyzed as per actual treatment received.|
59591169|NCT02224560|75698982|FG001|Safety Analysis Set|Overall Study|Six participants assigned to the 10 mg/kg/day dose were included in the 20 mg/kg/day group.|67|Received at least 1 dose of IMP; analyzed as per actual treatment received.|
59591170|NCT02224560|75698983|FG002|Safety Analysis Set|Overall Study||76|Received at least 1 dose of IMP; analyzed as per actual treatment received.|
59591171|NCT02224560|75698981|FG000|Intent to Treat (ITT) Analysis Set|Overall Study||76|Received at least 1 dose of IMP with at least 1 post-baseline efficacy endpoint measurement.|
59591172|NCT02224560|75698982|FG001|Intent to Treat (ITT) Analysis Set|Overall Study||73|Received at least 1 dose of IMP with at least 1 post-baseline efficacy endpoint measurement.|
59591173|NCT02224560|75698983|FG002|Intent to Treat (ITT) Analysis Set|Overall Study||76|Received at least 1 dose of IMP with at least 1 post-baseline efficacy endpoint measurement.|
59591174|NCT02224560|75698981|FG000|COMPLETED|Overall Study||67||
59591175|NCT02224560|75698982|FG001|COMPLETED|Overall Study||71||
59591176|NCT02224560|75698983|FG002|COMPLETED|Overall Study||74||
59591177|NCT02224560|75698981|FG000|NOT COMPLETED|Overall Study||9||
59855592|NCT00318149|75980209|FG004|STARTED|Overall Study||75||
59855593|NCT00318149|75980210|FG005|STARTED|Overall Study||75||
59591178|NCT02224560|75698982|FG001|NOT COMPLETED|Overall Study||2||
59591179|NCT02224560|75698983|FG002|NOT COMPLETED|Overall Study||2||
59591180|NCT02161458|75698995|FG000|STARTED|Overall Study||22||
59591181|NCT02161458|75698996|FG001|STARTED|Overall Study||35||
59591182|NCT02161458|75698997|FG002|STARTED|Overall Study||33||
59591183|NCT02161458|75698998|FG003|STARTED|Overall Study||8||
59726025|NCT02996110|75844877|FG004|COMPLETED|Track 1||0||
59855594|NCT00318149|75980205|FG000|COMPLETED|Overall Study||75||
59591184|NCT02161458|75698995|FG000|COMPLETED|Overall Study||22||
59591185|NCT02161458|75698996|FG001|COMPLETED|Overall Study||29||
59591186|NCT02161458|75698997|FG002|COMPLETED|Overall Study||28||
59591187|NCT02161458|75698998|FG003|COMPLETED|Overall Study||8||
59591188|NCT02161458|75698995|FG000|NOT COMPLETED|Overall Study||0||
59591189|NCT02161458|75698996|FG001|NOT COMPLETED|Overall Study||6||
59591190|NCT02161458|75698997|FG002|NOT COMPLETED|Overall Study||5||
59591191|NCT02161458|75698998|FG003|NOT COMPLETED|Overall Study||0||
59591192|NCT02223858|75699010|FG000|STARTED|Overall Study||180||
59591193|NCT02223858|75699011|FG001|STARTED|Overall Study||180||
59591194|NCT02223858|75699010|FG000|1-month Follow-up|Overall Study||156||
59591195|NCT02223858|75699011|FG001|1-month Follow-up|Overall Study||150||
59591196|NCT02223858|75699010|FG000|3-month Follow-up|Overall Study||155||
59591197|NCT02223858|75699011|FG001|3-month Follow-up|Overall Study||154||
59591198|NCT02223858|75699010|FG000|6-month Follow-up|Overall Study||156||
59591199|NCT02223858|75699011|FG001|6-month Follow-up|Overall Study||154||
59591200|NCT02223858|75699010|FG000|COMPLETED|Overall Study||156||
59591201|NCT02223858|75699011|FG001|COMPLETED|Overall Study||154||
59591202|NCT02223858|75699010|FG000|NOT COMPLETED|Overall Study||24||
59591203|NCT02223858|75699011|FG001|NOT COMPLETED|Overall Study||26||
59591204|NCT02223390|75699019|FG000|STARTED|Overall Study||32||
59591205|NCT02223390|75699020|FG001|STARTED|Overall Study||32||
59591206|NCT02223390|75699019|FG000|COMPLETED|Overall Study||23||
59591207|NCT02223390|75699020|FG001|COMPLETED|Overall Study||28||
59591208|NCT02223390|75699019|FG000|NOT COMPLETED|Overall Study||9||
59591209|NCT02223390|75699020|FG001|NOT COMPLETED|Overall Study||4||
59591210|NCT02774941|75699028|FG000|STARTED|Overall Study||110||
59591211|NCT02774941|75699029|FG001|STARTED|Overall Study||110||
59591212|NCT02774941|75699028|FG000|Subjects Excluded|Overall Study||1||
59591213|NCT02774941|75699029|FG001|Subjects Excluded|Overall Study||2||
59591214|NCT02774941|75699028|FG000|COMPLETED|Overall Study||109||
59591215|NCT02774941|75699029|FG001|COMPLETED|Overall Study||108||
59591216|NCT02774941|75699028|FG000|NOT COMPLETED|Overall Study||1||
59591217|NCT02774941|75699029|FG001|NOT COMPLETED|Overall Study||2||
59591218|NCT02590640|75699035|FG000|STARTED|Overall Study||40||
59591219|NCT02590640|75699035|FG000|COMPLETED|Overall Study||37||
59591220|NCT02590640|75699035|FG000|NOT COMPLETED|Overall Study||3||
59591221|NCT04647110|75699042|FG000|STARTED|Overall Study||345||
59591222|NCT04647110|75699043|FG001|STARTED|Overall Study||204||
59591223|NCT04647110|75699042|FG000|COMPLETED|Overall Study||345||
59591224|NCT04647110|75699043|FG001|COMPLETED|Overall Study||204||
59591225|NCT04647110|75699042|FG000|NOT COMPLETED|Overall Study||0||
59591226|NCT04647110|75699043|FG001|NOT COMPLETED|Overall Study||0||
59591227|NCT02241967|75699118|FG000|STARTED|Overall Study||30||
59591228|NCT02241967|75699119|FG001|STARTED|Overall Study||30||
59591229|NCT02241967|75699120|FG002|STARTED|Overall Study||30||
59591230|NCT02241967|75699121|FG003|STARTED|Overall Study||29||
59591231|NCT02241967|75699118|FG000|COMPLETED|Overall Study||30||
59591232|NCT02241967|75699119|FG001|COMPLETED|Overall Study||30||
59591233|NCT02241967|75699120|FG002|COMPLETED|Overall Study||30||
59591234|NCT02241967|75699121|FG003|COMPLETED|Overall Study||29||
59591235|NCT02241967|75699118|FG000|NOT COMPLETED|Overall Study||0||
59591236|NCT02241967|75699119|FG001|NOT COMPLETED|Overall Study||0||
59591237|NCT02241967|75699120|FG002|NOT COMPLETED|Overall Study||0||
59591238|NCT02241967|75699121|FG003|NOT COMPLETED|Overall Study||0||
59591239|NCT02885012|75699137|FG000|STARTED|Overall Study||1||
59591240|NCT02885012|75699138|FG001|STARTED|Overall Study||2||
59591241|NCT02885012|75699137|FG000|COMPLETED|Overall Study||1||
59591242|NCT02885012|75699138|FG001|COMPLETED|Overall Study||2||
59591243|NCT02885012|75699137|FG000|NOT COMPLETED|Overall Study||0||
59591244|NCT02885012|75699138|FG001|NOT COMPLETED|Overall Study||0||
59591245|NCT02885246|75699144|FG000|STARTED|Overall Study||1839||
59591246|NCT02885246|75699144|FG000|COMPLETED|Overall Study||1839||
59591247|NCT02885246|75699144|FG000|NOT COMPLETED|Overall Study||0||
59591248|NCT02885636|75699150|FG000|STARTED|Overall Study||15||
59591249|NCT02885636|75699151|FG001|STARTED|Overall Study||15||
59591250|NCT02885636|75699150|FG000|COMPLETED|Overall Study||15||
59591251|NCT02885636|75699151|FG001|COMPLETED|Overall Study||15||
59591252|NCT02885636|75699150|FG000|NOT COMPLETED|Overall Study||0||
59591253|NCT02885636|75699151|FG001|NOT COMPLETED|Overall Study||0||
59591254|NCT02892110|75699159|FG000|STARTED|Overall Study||35||
59591255|NCT02892110|75699160|FG001|STARTED|Overall Study||37||
59591256|NCT02892110|75699159|FG000|COMPLETED|Overall Study||22||
59591257|NCT02892110|75699160|FG001|COMPLETED|Overall Study||25||
59591258|NCT02892110|75699159|FG000|NOT COMPLETED|Overall Study||13||
59591259|NCT02892110|75699160|FG001|NOT COMPLETED|Overall Study||12||
59591260|NCT02778152|75699166|FG000|STARTED|Overall Study||13||
59591261|NCT02778152|75699166|FG000|COMPLETED|Overall Study||13||
59591262|NCT02778152|75699166|FG000|NOT COMPLETED|Overall Study||0||
59591263|NCT02778932|75699172|FG000|STARTED|Overall Study||74||
59591264|NCT02778932|75699173|FG001|STARTED|Overall Study||74||
59591265|NCT02778932|75699172|FG000|COMPLETED|Overall Study||74||
59591266|NCT02778932|75699173|FG001|COMPLETED|Overall Study||74||
59591267|NCT02778932|75699172|FG000|NOT COMPLETED|Overall Study||0||
59591268|NCT02778932|75699173|FG001|NOT COMPLETED|Overall Study||0||
59591269|NCT02779166|75699183|FG000|STARTED|Overall Study||50||
59591270|NCT02779166|75699184|FG001|STARTED|Overall Study||48||
59591271|NCT02779166|75699183|FG000|COMPLETED|Overall Study||50||
59591272|NCT02779166|75699184|FG001|COMPLETED|Overall Study||48||
59591273|NCT02779166|75699183|FG000|NOT COMPLETED|Overall Study||0||
59591274|NCT02779166|75699184|FG001|NOT COMPLETED|Overall Study||0||
59591275|NCT02898740|75699192|FG000|STARTED|Overall Study||21||
59591276|NCT02898740|75699193|FG001|STARTED|Overall Study||19||
59591277|NCT02898740|75699192|FG000|COMPLETED|Overall Study||21||
59591278|NCT02898740|75699193|FG001|COMPLETED|Overall Study||19||
59591279|NCT02898740|75699192|FG000|NOT COMPLETED|Overall Study||0||
59591280|NCT02898740|75699193|FG001|NOT COMPLETED|Overall Study||0||
59591281|NCT02898974|75699201|FG000|STARTED|Overall Study||13||
59591282|NCT02898974|75699202|FG001|STARTED|Overall Study||9||
59591283|NCT02898974|75699201|FG000|COMPLETED|Overall Study||13||
59591284|NCT02898974|75699202|FG001|COMPLETED|Overall Study||9||
59591285|NCT02898974|75699201|FG000|NOT COMPLETED|Overall Study||0||
59591286|NCT02898974|75699202|FG001|NOT COMPLETED|Overall Study||0||
59591287|NCT02901080|75699208|FG000|STARTED|Overall Study||161||
59591288|NCT02901080|75699208|FG000|COMPLETED|Overall Study||112||
59591289|NCT02901080|75699208|FG000|NOT COMPLETED|Overall Study||49||
59591290|NCT02758184|75699216|FG000|STARTED|Overall Study||11||
59591291|NCT02758184|75699217|FG001|STARTED|Overall Study||10||
59591292|NCT02758184|75699216|FG000|COMPLETED|Overall Study||11||
59591293|NCT02758184|75699217|FG001|COMPLETED|Overall Study||10||
59591294|NCT02758184|75699216|FG000|NOT COMPLETED|Overall Study||0||
59591295|NCT02758184|75699217|FG001|NOT COMPLETED|Overall Study||0||
59591296|NCT02782364|75699223|FG000|STARTED|Overall Study||18||
59591297|NCT02782364|75699224|FG001|STARTED|Overall Study||18||
59855595|NCT00318149|75980206|FG001|COMPLETED|Overall Study||50||
59855596|NCT00318149|75980207|FG002|COMPLETED|Overall Study||75||
59855597|NCT00318149|75980208|FG003|COMPLETED|Overall Study||75||
60121793|NCT01374906|76242791|FG000|NOT COMPLETED|Overall Study||40||
59591298|NCT02782364|75699223|FG000|COMPLETED|Overall Study||18||
59591299|NCT02782364|75699224|FG001|COMPLETED|Overall Study||18||
59591300|NCT02782364|75699223|FG000|NOT COMPLETED|Overall Study||0||
59591301|NCT02782364|75699224|FG001|NOT COMPLETED|Overall Study||0||
59591302|NCT02902172|75699233|FG000|STARTED|Overall Study||16||
59591303|NCT02902172|75699234|FG001|STARTED|Overall Study||20||
59591304|NCT02902172|75699233|FG000|COMPLETED|Overall Study||16||
59591305|NCT02902172|75699234|FG001|COMPLETED|Overall Study||20||
59591306|NCT02902172|75699233|FG000|NOT COMPLETED|Overall Study||0||
59591307|NCT02902172|75699234|FG001|NOT COMPLETED|Overall Study||0||
59591308|NCT02784548|75699241|FG000|STARTED|Overall Study||15||
59591309|NCT02784548|75699241|FG000|COMPLETED|Overall Study||15||
59591310|NCT02784548|75699241|FG000|NOT COMPLETED|Overall Study||0||
59591311|NCT02777749|75699249|FG000|STARTED|Overall Study||53||
59591312|NCT02777749|75699250|FG001|STARTED|Overall Study||51||
59591313|NCT02777749|75699251|FG002|STARTED|Overall Study||51||
59591314|NCT02777749|75699249|FG000|COMPLETED|Overall Study||53||
59591315|NCT02777749|75699250|FG001|COMPLETED|Overall Study||51||
59591316|NCT02777749|75699251|FG002|COMPLETED|Overall Study||51||
59591317|NCT02777749|75699249|FG000|NOT COMPLETED|Overall Study||0||
59591318|NCT02777749|75699250|FG001|NOT COMPLETED|Overall Study||0||
59591319|NCT02777749|75699251|FG002|NOT COMPLETED|Overall Study||0||
60121794|NCT01374906|76242792|FG001|NOT COMPLETED|Overall Study||48||
59591320|NCT02785172|75699267|FG000|STARTED|Overall Study||61||
59591321|NCT02785172|75699268|FG001|STARTED|Overall Study||63||
59591322|NCT02785172|75699269|FG002|STARTED|Overall Study||16||
59591323|NCT02785172|75699270|FG003|STARTED|Overall Study||14||
59591324|NCT02785172|75699267|FG000|COMPLETED|Overall Study||61||
59591325|NCT02785172|75699268|FG001|COMPLETED|Overall Study||62||
59591326|NCT02785172|75699269|FG002|COMPLETED|Overall Study||15||
59591327|NCT02785172|75699270|FG003|COMPLETED|Overall Study||14||
59591328|NCT02785172|75699267|FG000|NOT COMPLETED|Overall Study||0||
59591329|NCT02785172|75699268|FG001|NOT COMPLETED|Overall Study||1||
59591330|NCT02785172|75699269|FG002|NOT COMPLETED|Overall Study||1||
59591331|NCT02785172|75699270|FG003|NOT COMPLETED|Overall Study||0||
59591332|NCT02906696|75699280|FG000|STARTED|Overall Study||8||
59591333|NCT02906696|75699280|FG000|COMPLETED|Overall Study||8||
59591334|NCT02906696|75699280|FG000|NOT COMPLETED|Overall Study||0||
59591335|NCT02779543|75699286|FG000|STARTED|Overall Study||100||
59855598|NCT00318149|75980209|FG004|COMPLETED|Overall Study||75||
60121795|NCT03028948|76242804|FG000|STARTED|8 Week Follow-up||224||
59591336|NCT02779543|75699287|FG001|STARTED|Overall Study||100||
59591337|NCT02779543|75699286|FG000|COMPLETED|Overall Study||100||
59591338|NCT02779543|75699287|FG001|COMPLETED|Overall Study||100||
59591339|NCT02779543|75699286|FG000|NOT COMPLETED|Overall Study||0||
59591340|NCT02779543|75699287|FG001|NOT COMPLETED|Overall Study||0||
59591341|NCT02785406|75699296|FG000|STARTED|Overall Study||10||
59591342|NCT02785406|75699297|FG001|STARTED|Overall Study||10||
59591343|NCT02785406|75699296|FG000|Completed First Week|Overall Study||10||
59591344|NCT02785406|75699297|FG001|Completed First Week|Overall Study||10||
59591345|NCT02785406|75699296|FG000|Completed Second Week|Overall Study||10||
59591346|NCT02785406|75699297|FG001|Completed Second Week|Overall Study||10||
59591347|NCT02785406|75699296|FG000|COMPLETED|Overall Study||10||
59591348|NCT02785406|75699297|FG001|COMPLETED|Overall Study||10||
59591349|NCT02785406|75699296|FG000|NOT COMPLETED|Overall Study||0||
59591350|NCT02785406|75699297|FG001|NOT COMPLETED|Overall Study||0||
59591351|NCT02786810|75699303|FG000|STARTED|Overall Study||10||
59591352|NCT02786810|75699303|FG000|COMPLETED|Overall Study||10||
59591353|NCT02786810|75699303|FG000|NOT COMPLETED|Overall Study||0||
59591354|NCT02908178|75699311|FG000|STARTED|Overall Study|The sample prior to Mahalanobis matching.|2409||
59591355|NCT02908178|75699312|FG001|STARTED|Overall Study|The sample prior to Mahalanobis matching.|13106||
59591356|NCT02908178|75699313|FG002|STARTED|Overall Study|The sample prior to Mahalanobis matching.|1992||
59591357|NCT02908178|75699314|FG003|STARTED|Overall Study|The sample prior to Mahalanobis matching.|10784||
59591358|NCT02908178|75699311|FG000|COMPLETED|Overall Study|The sample after Mahalanobis matching; that is, the number in the main analyses.|2409||
59591359|NCT02908178|75699312|FG001|COMPLETED|Overall Study|The sample after Mahalanobis matching; that is, the number in the main analyses.|4718||
59591360|NCT02908178|75699313|FG002|COMPLETED|Overall Study|The sample after Mahalanobis matching; that is, the number in the main analyses.|1992||
59591361|NCT02908178|75699314|FG003|COMPLETED|Overall Study|The sample after Mahalanobis matching; that is, the number in the main analyses.|3965||
59591362|NCT02908178|75699311|FG000|NOT COMPLETED|Overall Study||0||
59591363|NCT02908178|75699312|FG001|NOT COMPLETED|Overall Study||8388||
59591364|NCT02908178|75699313|FG002|NOT COMPLETED|Overall Study||0||
59591365|NCT02908178|75699314|FG003|NOT COMPLETED|Overall Study||6819||
59591366|NCT02780869|75699325|FG000|STARTED|Overall Study||175||
59591367|NCT02780869|75699326|FG001|STARTED|Overall Study||83||
59591368|NCT02780869|75699325|FG000|COMPLETED|Overall Study||162||
59591369|NCT02780869|75699326|FG001|COMPLETED|Overall Study||74||
59591370|NCT02780869|75699325|FG000|NOT COMPLETED|Overall Study||13||
59591371|NCT02780869|75699326|FG001|NOT COMPLETED|Overall Study||9||
59591372|NCT02908490|75699334|FG000|STARTED|Overall Study||12||
59591373|NCT02908490|75699335|FG001|STARTED|Overall Study||13||
59591374|NCT02908490|75699334|FG000|COMPLETED|Overall Study||10||
59591375|NCT02908490|75699335|FG001|COMPLETED|Overall Study||11||
59591376|NCT02908490|75699334|FG000|NOT COMPLETED|Overall Study||2||
59591377|NCT02908490|75699335|FG001|NOT COMPLETED|Overall Study||2||
59591378|NCT02910362|75699343|FG000|STARTED|Overall Study||8||16
59591379|NCT02910362|75699344|FG001|STARTED|Overall Study||7||14
59591380|NCT02910362|75699343|FG000|COMPLETED|Overall Study||8||16
59591381|NCT02910362|75699344|FG001|COMPLETED|Overall Study||7||14
59591382|NCT02910362|75699343|FG000|NOT COMPLETED|Overall Study||0||0
59591383|NCT02910362|75699344|FG001|NOT COMPLETED|Overall Study||0||0
59591384|NCT02910674|75699350|FG000|STARTED|Overall Study||102||
59591385|NCT02910674|75699350|FG000|COMPLETED|Overall Study||102||
59591386|NCT02910674|75699350|FG000|NOT COMPLETED|Overall Study||0||
59591387|NCT02911844|75699355|FG000|STARTED|Overall Study||5||
59591388|NCT02911844|75699355|FG000|COMPLETED|Overall Study||5||
59591389|NCT02911844|75699355|FG000|NOT COMPLETED|Overall Study||0||
59591390|NCT02911922|75699361|FG000|STARTED|Overall Study||1||
59591391|NCT02911922|75699362|FG001|STARTED|Overall Study||0||
59591392|NCT02911922|75699361|FG000|COMPLETED|Overall Study||1||
59591393|NCT02911922|75699362|FG001|COMPLETED|Overall Study||0||
59591394|NCT02911922|75699361|FG000|NOT COMPLETED|Overall Study||0||
59591395|NCT02911922|75699362|FG001|NOT COMPLETED|Overall Study||0||
59591396|NCT02790788|75699372|FG000|STARTED|Overall Study||46||
59591397|NCT02790788|75699373|FG001|STARTED|Overall Study||54||
59591398|NCT02790788|75699372|FG000|COMPLETED|Overall Study||46||
59591399|NCT02790788|75699373|FG001|COMPLETED|Overall Study||54||
59591400|NCT02790788|75699372|FG000|NOT COMPLETED|Overall Study||0||
59591401|NCT02790788|75699373|FG001|NOT COMPLETED|Overall Study||0||
59591402|NCT02793674|75699383|FG000|STARTED|Overall Study||9||
59591403|NCT02793674|75699384|FG001|STARTED|Overall Study||12||
59591404|NCT02793674|75699383|FG000|COMPLETED|Overall Study||9||
59591405|NCT02793674|75699384|FG001|COMPLETED|Overall Study||12||
59591406|NCT02793674|75699383|FG000|NOT COMPLETED|Overall Study||0||
59591407|NCT02793674|75699384|FG001|NOT COMPLETED|Overall Study||0||
59591408|NCT03001778|75699398|FG000|STARTED|Overall Study||21||
59591409|NCT03001778|75699399|FG001|STARTED|Overall Study||46||
59591410|NCT03001778|75699398|FG000|COMPLETED|Overall Study||21||
59591411|NCT03001778|75699399|FG001|COMPLETED|Overall Study||46||
59591412|NCT03001778|75699398|FG000|NOT COMPLETED|Overall Study||0||
59591413|NCT03001778|75699399|FG001|NOT COMPLETED|Overall Study||0||
59591414|NCT02888665|75699408|FG000|STARTED|Overall Study||3||
59591415|NCT02888665|75699409|FG001|STARTED|Overall Study||3||
59591416|NCT02888665|75699410|FG002|STARTED|Overall Study||31||
59591417|NCT02888665|75699408|FG000|COMPLETED|Overall Study||3||
59591418|NCT02888665|75699409|FG001|COMPLETED|Overall Study||3||
59591419|NCT02888665|75699410|FG002|COMPLETED|Overall Study||31||
59591420|NCT02888665|75699408|FG000|NOT COMPLETED|Overall Study||0||
59591421|NCT02888665|75699409|FG001|NOT COMPLETED|Overall Study||0||
59591422|NCT02888665|75699410|FG002|NOT COMPLETED|Overall Study||0||
59591423|NCT02918396|75699422|FG000|STARTED|Overall Study||2||
59591424|NCT02918396|75699423|FG001|STARTED|Overall Study||1||
59591425|NCT02918396|75699424|FG002|STARTED|Overall Study||2||
59591426|NCT02918396|75699422|FG000|COMPLETED|Overall Study||2||
59591427|NCT02918396|75699423|FG001|COMPLETED|Overall Study||1||
59591428|NCT02918396|75699424|FG002|COMPLETED|Overall Study||2||
59591429|NCT02918396|75699422|FG000|NOT COMPLETED|Overall Study||0||
59591430|NCT02918396|75699423|FG001|NOT COMPLETED|Overall Study||0||
59591431|NCT02918396|75699424|FG002|NOT COMPLETED|Overall Study||0||
59591432|NCT02781571|75699432|FG000|STARTED|Overall Study||79||
59591433|NCT02781571|75699432|FG000|COMPLETED|Overall Study||79||
59591434|NCT02781571|75699432|FG000|NOT COMPLETED|Overall Study||0||
59591435|NCT02918630|75699438|FG000|STARTED|Overall Study||4||
59591436|NCT02918630|75699439|FG001|STARTED|Overall Study||3||
59591437|NCT02918630|75699438|FG000|COMPLETED|Overall Study||4||
59591438|NCT02918630|75699439|FG001|COMPLETED|Overall Study||3||
59591439|NCT02918630|75699438|FG000|NOT COMPLETED|Overall Study||0||
59591440|NCT02918630|75699439|FG001|NOT COMPLETED|Overall Study||0||
59591441|NCT02781649|75699448|FG000|STARTED|Overall Study|4 in this group had insufficient viral RNA for genotyping. They were treated as 1a|7||
59591442|NCT02781649|75699449|FG001|STARTED|Overall Study||0||
59591443|NCT02781649|75699450|FG002|STARTED|Overall Study||3||
59591444|NCT02781649|75699448|FG000|COMPLETED|Overall Study||7||
59591445|NCT02781649|75699449|FG001|COMPLETED|Overall Study||0||
59591446|NCT02781649|75699450|FG002|COMPLETED|Overall Study||3||
59591447|NCT02781649|75699448|FG000|NOT COMPLETED|Overall Study||0||
59591448|NCT02781649|75699449|FG001|NOT COMPLETED|Overall Study||0||
59591449|NCT02781649|75699450|FG002|NOT COMPLETED|Overall Study||0||
59591450|NCT02794766|75699461|FG000|STARTED|Overall Study||15||
59591451|NCT02794766|75699462|FG001|STARTED|Overall Study||15||
59591452|NCT02794766|75699463|FG002|STARTED|Overall Study||15||
59591453|NCT02794766|75699461|FG000|COMPLETED|Overall Study||15||
59591454|NCT02794766|75699462|FG001|COMPLETED|Overall Study||15||
59591455|NCT02794766|75699463|FG002|COMPLETED|Overall Study||14||
59591456|NCT02794766|75699461|FG000|NOT COMPLETED|Overall Study||0||
59591457|NCT02794766|75699462|FG001|NOT COMPLETED|Overall Study||0||
59591458|NCT02794766|75699463|FG002|NOT COMPLETED|Overall Study||1||
59591459|NCT02794844|75699471|FG000|STARTED|Overall Study||28||
59591460|NCT02794844|75699471|FG000|COMPLETED|Overall Study||23||
59591461|NCT02794844|75699471|FG000|NOT COMPLETED|Overall Study||5||
59591462|NCT02795780|75699477|FG000|STARTED|Overall Study||25||
59591463|NCT02795780|75699478|FG001|STARTED|Overall Study||54||
59591464|NCT02795780|75699477|FG000|COMPLETED|Overall Study||25||
59591465|NCT02795780|75699478|FG001|COMPLETED|Overall Study||54||
59591466|NCT02795780|75699477|FG000|NOT COMPLETED|Overall Study||0||
59591467|NCT02795780|75699478|FG001|NOT COMPLETED|Overall Study||0||
59591468|NCT02783443|75699488|FG000|STARTED|Overall Study||30||
59591469|NCT02783443|75699489|FG001|STARTED|Overall Study||30||
59591470|NCT02783443|75699488|FG000|COMPLETED|Overall Study||30||
59591471|NCT02783443|75699489|FG001|COMPLETED|Overall Study||30||
59591472|NCT02783443|75699488|FG000|NOT COMPLETED|Overall Study||0||
59591473|NCT02783443|75699489|FG001|NOT COMPLETED|Overall Study||0||
59591474|NCT02796092|75699497|FG000|STARTED|Overall Study||50||
59591475|NCT02796092|75699498|FG001|STARTED|Overall Study||50||
59591476|NCT02796092|75699497|FG000|COMPLETED|Overall Study||50||
59591477|NCT02796092|75699498|FG001|COMPLETED|Overall Study||50||
59591478|NCT02796092|75699497|FG000|NOT COMPLETED|Overall Study||0||
59591479|NCT02796092|75699498|FG001|NOT COMPLETED|Overall Study||0||
59591480|NCT02889289|75699504|FG000|STARTED|Overall Study||1||
59591481|NCT02889289|75699504|FG000|COMPLETED|Overall Study||1||
59591482|NCT02889289|75699504|FG000|NOT COMPLETED|Overall Study||0||
59591483|NCT02784613|75699508|FG000|STARTED|Overall Study||10||
59591484|NCT02784613|75699508|FG000|COMPLETED|Overall Study||8||
59591485|NCT02784613|75699508|FG000|NOT COMPLETED|Overall Study||2||
59591486|NCT02890303|75699512|FG000|STARTED|Overall Study||100||
59591487|NCT02890303|75699512|FG000|COMPLETED|Overall Study||100||
59591488|NCT02890303|75699512|FG000|NOT COMPLETED|Overall Study||0||
59591489|NCT03002012|75699518|FG000|STARTED|Overall Study||11||
59591490|NCT03002012|75699519|FG001|STARTED|Overall Study||11||
59591491|NCT03002012|75699518|FG000|COMPLETED|Overall Study||11||
59855599|NCT00318149|75980210|FG005|COMPLETED|Overall Study||73||
59855600|NCT00318149|75980205|FG000|NOT COMPLETED|Overall Study||0||
59591492|NCT03002012|75699519|FG001|COMPLETED|Overall Study||11||
59591493|NCT03002012|75699518|FG000|NOT COMPLETED|Overall Study||0||
59591494|NCT03002012|75699519|FG001|NOT COMPLETED|Overall Study||0||
59591495|NCT02798354|75699528|FG000|STARTED|First Intervention Period||1184|Clinic attrition occurred after enrollment due to data collection burden|14
59591496|NCT02798354|75699529|FG001|STARTED|First Intervention Period||2176|Clinic attrition occurred after enrollment due to data collection burden|16
59591497|NCT02798354|75699530|FG002|STARTED|First Intervention Period||990|Clinic attrition occurred after enrollment due to data collection burden|13
59591498|NCT02798354|75699528|FG000|Control Data Error 1|First Intervention Period||440||11
59855601|NCT00318149|75980206|FG001|NOT COMPLETED|Overall Study||0||
59591499|NCT02798354|75699529|FG001|Control Data Error 1|First Intervention Period||549||10
59591500|NCT02798354|75699530|FG002|Control Data Error 1|First Intervention Period||345||10
59591501|NCT02798354|75699528|FG000|Intervention Data Error 1|First Intervention Period||744||11
59591502|NCT02798354|75699529|FG001|Intervention Data Error 1|First Intervention Period||1627||10
59591503|NCT02798354|75699530|FG002|Intervention Data Error 1|First Intervention Period||645||10
59591504|NCT02798354|75699528|FG000|COMPLETED|First Intervention Period||1184||11
59591505|NCT02798354|75699529|FG001|COMPLETED|First Intervention Period||2176||10
59591506|NCT02798354|75699530|FG002|COMPLETED|First Intervention Period||990||10
59855602|NCT00318149|75980207|FG002|NOT COMPLETED|Overall Study||0||
59855603|NCT00318149|75980208|FG003|NOT COMPLETED|Overall Study||0||
59591507|NCT02798354|75699528|FG000|NOT COMPLETED|First Intervention Period||0||3
59591508|NCT02798354|75699529|FG001|NOT COMPLETED|First Intervention Period||0||6
59591509|NCT02798354|75699530|FG002|NOT COMPLETED|First Intervention Period||0||3
59591510|NCT02798354|75699528|FG000|STARTED|Second Intervention Period||2617||11
59591511|NCT02798354|75699529|FG001|STARTED|Second Intervention Period||1047||10
59591512|NCT02798354|75699530|FG002|STARTED|Second Intervention Period||1368||10
59591513|NCT02798354|75699528|FG000|Control Data Error 2|Second Intervention Period||1378||11
59591514|NCT02798354|75699529|FG001|Control Data Error 2|Second Intervention Period||593||10
59591515|NCT02798354|75699530|FG002|Control Data Error 2|Second Intervention Period||668||9
59591516|NCT02798354|75699528|FG000|Intervention Data Error 2|Second Intervention Period||1239||11
59591517|NCT02798354|75699529|FG001|Intervention Data Error 2|Second Intervention Period||454||9
59591518|NCT02798354|75699530|FG002|Intervention Data Error 2|Second Intervention Period||700||10
59591519|NCT02798354|75699528|FG000|COMPLETED|Second Intervention Period||2617||11
59591520|NCT02798354|75699529|FG001|COMPLETED|Second Intervention Period||1047||9
59591521|NCT02798354|75699530|FG002|COMPLETED|Second Intervention Period||1368||10
59591522|NCT02798354|75699528|FG000|NOT COMPLETED|Second Intervention Period||0||0
59591523|NCT02798354|75699529|FG001|NOT COMPLETED|Second Intervention Period||0||1
59591524|NCT02798354|75699530|FG002|NOT COMPLETED|Second Intervention Period||0||0
59591525|NCT02798354|75699528|FG000|STARTED|Third Intervention Period||746||11
59591526|NCT02798354|75699529|FG001|STARTED|Third Intervention Period||1010||9
59591527|NCT02798354|75699530|FG002|STARTED|Third Intervention Period||2715||10
59591528|NCT02798354|75699528|FG000|Control Data Error 3|Third Intervention Period||419||11
59591529|NCT02798354|75699529|FG001|Control Data Error 3|Third Intervention Period||620||9
59591530|NCT02798354|75699530|FG002|Control Data Error 3|Third Intervention Period||1467||10
59591531|NCT02798354|75699528|FG000|Intervention Data Error 3|Third Intervention Period||327||11
59591532|NCT02798354|75699529|FG001|Intervention Data Error 3|Third Intervention Period||390||9
59591533|NCT02798354|75699530|FG002|Intervention Data Error 3|Third Intervention Period||1248||10
59591534|NCT02798354|75699528|FG000|COMPLETED|Third Intervention Period||746||11
59591535|NCT02798354|75699529|FG001|COMPLETED|Third Intervention Period||1010||9
59591536|NCT02798354|75699530|FG002|COMPLETED|Third Intervention Period||2715||10
59591537|NCT02798354|75699528|FG000|NOT COMPLETED|Third Intervention Period||0||0
59591538|NCT02798354|75699529|FG001|NOT COMPLETED|Third Intervention Period||0||0
59591539|NCT02798354|75699530|FG002|NOT COMPLETED|Third Intervention Period||0||0
59591540|NCT02890381|75699546|FG000|STARTED|Overall Study||11||
59591541|NCT02890381|75699547|FG001|STARTED|Overall Study||6||
59591542|NCT02890381|75699546|FG000|COMPLETED|Overall Study||11||
59591543|NCT02890381|75699547|FG001|COMPLETED|Overall Study||6||
59591544|NCT02890381|75699546|FG000|NOT COMPLETED|Overall Study||0||
59591545|NCT02890381|75699547|FG001|NOT COMPLETED|Overall Study||0||
59591546|NCT03005054|75699553|FG000|STARTED|Overall Study||3||
59591547|NCT03005054|75699553|FG000|COMPLETED|Overall Study||3||
59591548|NCT03005054|75699553|FG000|NOT COMPLETED|Overall Study||0||
59591549|NCT02891629|75699559|FG000|STARTED|Overall Study||10||
59591550|NCT02891629|75699560|FG001|STARTED|Overall Study||5||
59591551|NCT02891629|75699559|FG000|COMPLETED|Overall Study||10||
59591552|NCT02891629|75699560|FG001|COMPLETED|Overall Study||4||
59591553|NCT02891629|75699559|FG000|NOT COMPLETED|Overall Study||0||
59591554|NCT02891629|75699560|FG001|NOT COMPLETED|Overall Study||1||
59591555|NCT02891863|75699566|FG000|STARTED|Overall Study||9||
59591556|NCT02891863|75699566|FG000|COMPLETED|Overall Study||9||
59591557|NCT02891863|75699566|FG000|NOT COMPLETED|Overall Study||0||
59591558|NCT03001453|75699572|FG000|STARTED|Overall Study||50||
59591559|NCT03001453|75699573|FG001|STARTED|Overall Study||57||
59591560|NCT03001453|75699572|FG000|COMPLETED|Overall Study||50||
59591561|NCT03001453|75699573|FG001|COMPLETED|Overall Study||57||
59591562|NCT03001453|75699572|FG000|NOT COMPLETED|Overall Study||0||
59591563|NCT03001453|75699573|FG001|NOT COMPLETED|Overall Study||0||
59591564|NCT03001843|75699581|FG000|STARTED|Overall Study||27||
59591565|NCT03001843|75699582|FG001|STARTED|Overall Study||27||
59591566|NCT03001843|75699581|FG000|COMPLETED|Overall Study||27||
59591567|NCT03001843|75699582|FG001|COMPLETED|Overall Study||27||
59591568|NCT03001843|75699581|FG000|NOT COMPLETED|Overall Study||0||
59591569|NCT03001843|75699582|FG001|NOT COMPLETED|Overall Study||0||
59591570|NCT03003793|75699590|FG000|STARTED|Overall Study||16||
59591571|NCT03003793|75699591|FG001|STARTED|Overall Study||16||
59591572|NCT03003793|75699590|FG000|COMPLETED|Overall Study||16||
59855604|NCT00318149|75980209|FG004|NOT COMPLETED|Overall Study||0||
59591573|NCT03003793|75699591|FG001|COMPLETED|Overall Study||16||
59591574|NCT03003793|75699590|FG000|NOT COMPLETED|Overall Study||0||
59591575|NCT03003793|75699591|FG001|NOT COMPLETED|Overall Study||0||
59591576|NCT02784925|75699597|FG000|STARTED|Overall Study||30||
59591577|NCT02784925|75699597|FG000|COMPLETED|Overall Study||30||
59591578|NCT02784925|75699597|FG000|NOT COMPLETED|Overall Study||0||
59591579|NCT02785159|75699605|FG000|STARTED|Overall Study||62||
59591580|NCT02785159|75699606|FG001|STARTED|Overall Study||58||
59591581|NCT02785159|75699607|FG002|STARTED|Overall Study||15||
59591582|NCT02785159|75699608|FG003|STARTED|Overall Study||17||
59591583|NCT02785159|75699605|FG000|COMPLETED|Overall Study||51||
59591584|NCT02785159|75699606|FG001|COMPLETED|Overall Study||45||
59591585|NCT02785159|75699607|FG002|COMPLETED|Overall Study||12||
59591586|NCT02785159|75699608|FG003|COMPLETED|Overall Study||14||
59591587|NCT02785159|75699605|FG000|NOT COMPLETED|Overall Study||11||
59591588|NCT02785159|75699606|FG001|NOT COMPLETED|Overall Study||13||
59591589|NCT02785159|75699607|FG002|NOT COMPLETED|Overall Study||3||
59591590|NCT02785159|75699608|FG003|NOT COMPLETED|Overall Study||3||
59591591|NCT02786719|75699618|FG000|STARTED|Overall Study||13||
59591592|NCT02786719|75699618|FG000|COMPLETED|Overall Study||12||
59591593|NCT02786719|75699618|FG000|NOT COMPLETED|Overall Study||1||
59591594|NCT03003949|75699624|FG000|STARTED|Overall Study||40||
59591595|NCT03003949|75699625|FG001|STARTED|Overall Study||42||
59591596|NCT03003949|75699624|FG000|Week 8|Overall Study||40||
59591597|NCT03003949|75699625|FG001|Week 8|Overall Study||42||
59591598|NCT03003949|75699624|FG000|Week 16|Overall Study||38||
59591599|NCT03003949|75699625|FG001|Week 16|Overall Study||35||
59591600|NCT03003949|75699624|FG000|Week 20|Overall Study||35||
59591601|NCT03003949|75699625|FG001|Week 20|Overall Study||33||
59591602|NCT03003949|75699624|FG000|Week 24|Overall Study||35||
59591603|NCT03003949|75699625|FG001|Week 24|Overall Study||32||
59591604|NCT03003949|75699624|FG000|COMPLETED|Overall Study||35||
59591605|NCT03003949|75699625|FG001|COMPLETED|Overall Study||32||
59591606|NCT03003949|75699624|FG000|NOT COMPLETED|Overall Study||5||
59591607|NCT03003949|75699625|FG001|NOT COMPLETED|Overall Study||10||
59591608|NCT02896075|75699631|FG000|STARTED|Overall Study||40||
59591609|NCT02896075|75699631|FG000|Leg Soreness|Overall Study||40||
59726026|NCT02996110|75844873|FG000|NOT COMPLETED|Track 1||23||
59726027|NCT02996110|75844874|FG001|NOT COMPLETED|Track 1||22||
59726028|NCT02996110|75844875|FG002|NOT COMPLETED|Track 1||0||
59726029|NCT02996110|75844876|FG003|NOT COMPLETED|Track 1||0||
59726030|NCT02996110|75844877|FG004|NOT COMPLETED|Track 1||0||
59726031|NCT02996110|75844873|FG000|STARTED|Track 2||46||
59726032|NCT02996110|75844874|FG001|STARTED|Track 2||32||
59726033|NCT02996110|75844875|FG002|STARTED|Track 2||31||
59726034|NCT02996110|75844876|FG003|STARTED|Track 2||21||
59726035|NCT02996110|75844877|FG004|STARTED|Track 2||22||
59726036|NCT02996110|75844873|FG000|No Pre-Randomization|Track 2||35||
59726037|NCT02996110|75844874|FG001|No Pre-Randomization|Track 2||25||
59855605|NCT00318149|75980210|FG005|NOT COMPLETED|Overall Study||2||
59591610|NCT02896075|75699631|FG000|COMPLETED|Overall Study||40||
59591611|NCT02896075|75699631|FG000|NOT COMPLETED|Overall Study||0||
59591612|NCT02787655|75699640|FG000|STARTED|Overall Study||40||
59591613|NCT02787655|75699641|FG001|STARTED|Overall Study||38||
59726038|NCT02996110|75844875|FG002|No Pre-Randomization|Track 2||25||
59726039|NCT02996110|75844876|FG003|No Pre-Randomization|Track 2||17||
59726040|NCT02996110|75844877|FG004|No Pre-Randomization|Track 2||16||
59726041|NCT02996110|75844873|FG000|Re-Randomized From Track 1 Nivolumab + Relatlimab|Track 2||2||
59726042|NCT02996110|75844874|FG001|Re-Randomized From Track 1 Nivolumab + Relatlimab|Track 2||0||
59726043|NCT02996110|75844875|FG002|Re-Randomized From Track 1 Nivolumab + Relatlimab|Track 2||2||
59726044|NCT02996110|75844876|FG003|Re-Randomized From Track 1 Nivolumab + Relatlimab|Track 2||1||
59591614|NCT02787655|75699640|FG000|COMPLETED|Overall Study||29||
59591615|NCT02787655|75699641|FG001|COMPLETED|Overall Study||26||
59591616|NCT02787655|75699640|FG000|NOT COMPLETED|Overall Study||11||
59591617|NCT02787655|75699641|FG001|NOT COMPLETED|Overall Study||12||
59591618|NCT02798978|75699654|FG000|STARTED|Part 1 (30 Days)||10||
59591619|NCT02798978|75699655|FG001|STARTED|Part 1 (30 Days)||6||
59591620|NCT02798978|75699656|FG002|STARTED|Part 1 (30 Days)||6||
59591621|NCT02798978|75699657|FG003|STARTED|Part 1 (30 Days)||6||
59591622|NCT02798978|75699658|FG004|STARTED|Part 1 (30 Days)||6||
59591623|NCT02798978|75699659|FG005|STARTED|Part 1 (30 Days)||6||
59591624|NCT02798978|75699660|FG006|STARTED|Part 1 (30 Days)||0||
59591625|NCT02798978|75699654|FG000|COMPLETED|Part 1 (30 Days)||10||
59591626|NCT02798978|75699655|FG001|COMPLETED|Part 1 (30 Days)||6||
59726045|NCT02996110|75844877|FG004|Re-Randomized From Track 1 Nivolumab + Relatlimab|Track 2||1||
59726046|NCT02996110|75844873|FG000|Re-Randomized From Track 1 Nivolumab + Ipilimumab|Track 2||0||
59726047|NCT02996110|75844874|FG001|Re-Randomized From Track 1 Nivolumab + Ipilimumab|Track 2||3||
59726048|NCT02996110|75844875|FG002|Re-Randomized From Track 1 Nivolumab + Ipilimumab|Track 2||1||
59726049|NCT02996110|75844876|FG003|Re-Randomized From Track 1 Nivolumab + Ipilimumab|Track 2||1||
59726050|NCT02996110|75844877|FG004|Re-Randomized From Track 1 Nivolumab + Ipilimumab|Track 2||0||
59855606|NCT00317603|75980226|FG000|STARTED|Overall Study||15||
59591627|NCT02798978|75699656|FG002|COMPLETED|Part 1 (30 Days)||6||
59591628|NCT02798978|75699657|FG003|COMPLETED|Part 1 (30 Days)||6||
59591629|NCT02798978|75699658|FG004|COMPLETED|Part 1 (30 Days)||6||
59591630|NCT02798978|75699659|FG005|COMPLETED|Part 1 (30 Days)||6||
59591631|NCT02798978|75699660|FG006|COMPLETED|Part 1 (30 Days)||0||
59591632|NCT02798978|75699654|FG000|NOT COMPLETED|Part 1 (30 Days)||0||
59591633|NCT02798978|75699655|FG001|NOT COMPLETED|Part 1 (30 Days)||0||
59591634|NCT02798978|75699656|FG002|NOT COMPLETED|Part 1 (30 Days)||0||
59591635|NCT02798978|75699657|FG003|NOT COMPLETED|Part 1 (30 Days)||0||
59591636|NCT02798978|75699658|FG004|NOT COMPLETED|Part 1 (30 Days)||0||
59591637|NCT02798978|75699659|FG005|NOT COMPLETED|Part 1 (30 Days)||0||
59591638|NCT02798978|75699660|FG006|NOT COMPLETED|Part 1 (30 Days)||0||
59591639|NCT02798978|75699654|FG000|STARTED|Part 2 (45 Days)||0||
59855607|NCT00317603|75980226|FG000|Treated|Overall Study||12||
59855608|NCT00317603|75980226|FG000|COMPLETED|Overall Study||12||
59855609|NCT00317603|75980226|FG000|NOT COMPLETED|Overall Study||3||
59855610|NCT03326518|75980233|FG000|STARTED|Overall Study||19||
59855611|NCT03326518|75980234|FG001|STARTED|Overall Study||12||
59855612|NCT03326518|75980235|FG002|STARTED|Overall Study||14||
59855613|NCT03326518|75980233|FG000|COMPLETED|Overall Study||16||
59855614|NCT03326518|75980234|FG001|COMPLETED|Overall Study||12||
59855615|NCT03326518|75980235|FG002|COMPLETED|Overall Study||13||
59855616|NCT03326518|75980233|FG000|NOT COMPLETED|Overall Study||3||
59591640|NCT02798978|75699655|FG001|STARTED|Part 2 (45 Days)||0||
59591641|NCT02798978|75699656|FG002|STARTED|Part 2 (45 Days)||0||
59591642|NCT02798978|75699657|FG003|STARTED|Part 2 (45 Days)||0||
59591643|NCT02798978|75699658|FG004|STARTED|Part 2 (45 Days)||0||
59591644|NCT02798978|75699659|FG005|STARTED|Part 2 (45 Days)||0||
59591645|NCT02798978|75699660|FG006|STARTED|Part 2 (45 Days)||0||
59591646|NCT02798978|75699654|FG000|COMPLETED|Part 2 (45 Days)||0||
59591647|NCT02798978|75699655|FG001|COMPLETED|Part 2 (45 Days)||0||
59591648|NCT02798978|75699656|FG002|COMPLETED|Part 2 (45 Days)||0||
59591649|NCT02798978|75699657|FG003|COMPLETED|Part 2 (45 Days)||0||
59726051|NCT02996110|75844873|FG000|Re-Randomized From Track 2 Nivolumab + Relatlimab|Track 2||7||
59726052|NCT02996110|75844874|FG001|Re-Randomized From Track 2 Nivolumab + Relatlimab|Track 2||0||
59726053|NCT02996110|75844875|FG002|Re-Randomized From Track 2 Nivolumab + Relatlimab|Track 2||2||
59726054|NCT02996110|75844876|FG003|Re-Randomized From Track 2 Nivolumab + Relatlimab|Track 2||0||
59726055|NCT02996110|75844877|FG004|Re-Randomized From Track 2 Nivolumab + Relatlimab|Track 2||1||
59855617|NCT03326518|75980234|FG001|NOT COMPLETED|Overall Study||0||
59855618|NCT03326518|75980235|FG002|NOT COMPLETED|Overall Study||1||
59855619|NCT00317369|75980246|FG000|STARTED|Overall Study||10||
59855620|NCT00317369|75980247|FG001|STARTED|Overall Study||9||
59855621|NCT00317369|75980248|FG002|STARTED|Overall Study||10||
59855622|NCT00317369|75980246|FG000|COMPLETED|Overall Study||8||
59855623|NCT00317369|75980247|FG001|COMPLETED|Overall Study||7||
59855624|NCT00317369|75980248|FG002|COMPLETED|Overall Study||8||
59855625|NCT00317369|75980246|FG000|NOT COMPLETED|Overall Study||2||
59855626|NCT00317369|75980247|FG001|NOT COMPLETED|Overall Study||2||
59855627|NCT00317369|75980248|FG002|NOT COMPLETED|Overall Study||2||
59855628|NCT03325894|75980258|FG000|STARTED|Overall Study||64||
59855629|NCT03325894|75980259|FG001|STARTED|Overall Study||77||
59855630|NCT03325894|75980258|FG000|COMPLETED|Overall Study||0||
59855631|NCT03325894|75980259|FG001|COMPLETED|Overall Study||0||
59855632|NCT03325894|75980258|FG000|NOT COMPLETED|Overall Study||64||
59855633|NCT03325894|75980259|FG001|NOT COMPLETED|Overall Study||77||
59855634|NCT01239368|75980278|FG000|STARTED|Overall Study||2||
59855635|NCT01239368|75980279|FG001|STARTED|Overall Study||1||
59855636|NCT01239368|75980280|FG002|STARTED|Overall Study||1||
59855637|NCT01239368|75980281|FG003|STARTED|Overall Study||2||
59855638|NCT01239368|75980282|FG004|STARTED|Overall Study||7||
59855639|NCT01239368|75980283|FG005|STARTED|Overall Study||5||
59855640|NCT01239368|75980284|FG006|STARTED|Overall Study||7||
59855641|NCT01239368|75980285|FG007|STARTED|Overall Study||0||
59855642|NCT01239368|75980286|FG008|STARTED|Overall Study||1||
59726056|NCT02996110|75844873|FG000|Re-Randomized From Track 2 Nivolumab + BMS986205|Track 2||2||
59726057|NCT02996110|75844874|FG001|Re-Randomized From Track 2 Nivolumab + BMS986205|Track 2||2||
59726058|NCT02996110|75844875|FG002|Re-Randomized From Track 2 Nivolumab + BMS986205|Track 2||0||
59726059|NCT02996110|75844876|FG003|Re-Randomized From Track 2 Nivolumab + BMS986205|Track 2||1||
59726060|NCT02996110|75844877|FG004|Re-Randomized From Track 2 Nivolumab + BMS986205|Track 2||2||
59726061|NCT02996110|75844873|FG000|Previously Un-Treated But Re-Randomized|Track 2||0||
59726062|NCT02996110|75844874|FG001|Previously Un-Treated But Re-Randomized|Track 2||0||
59726063|NCT02996110|75844875|FG002|Previously Un-Treated But Re-Randomized|Track 2||0||
59726064|NCT02996110|75844876|FG003|Previously Un-Treated But Re-Randomized|Track 2||1||
59855643|NCT01239368|75980287|FG009|STARTED|Overall Study||5||
59855644|NCT01239368|75980278|FG000|COMPLETED|Overall Study||0||
59855645|NCT01239368|75980279|FG001|COMPLETED|Overall Study||0||
59855646|NCT01239368|75980280|FG002|COMPLETED|Overall Study||0||
59855647|NCT01239368|75980281|FG003|COMPLETED|Overall Study||1||
59855648|NCT01239368|75980282|FG004|COMPLETED|Overall Study||2||
59855649|NCT01239368|75980283|FG005|COMPLETED|Overall Study||1||
59855650|NCT01239368|75980284|FG006|COMPLETED|Overall Study||1||
59855651|NCT01239368|75980285|FG007|COMPLETED|Overall Study||0||
59855652|NCT01239368|75980286|FG008|COMPLETED|Overall Study||1||
59855653|NCT01239368|75980287|FG009|COMPLETED|Overall Study||1||
59855654|NCT01239368|75980278|FG000|NOT COMPLETED|Overall Study||2||
59855655|NCT01239368|75980279|FG001|NOT COMPLETED|Overall Study||1||
59855656|NCT01239368|75980280|FG002|NOT COMPLETED|Overall Study||1||
59855657|NCT01239368|75980281|FG003|NOT COMPLETED|Overall Study||1||
59855658|NCT01239368|75980282|FG004|NOT COMPLETED|Overall Study||5||
59855659|NCT01239368|75980283|FG005|NOT COMPLETED|Overall Study||4||
59855660|NCT01239368|75980284|FG006|NOT COMPLETED|Overall Study||6||
59855661|NCT01239368|75980285|FG007|NOT COMPLETED|Overall Study||0||
59855662|NCT01239368|75980286|FG008|NOT COMPLETED|Overall Study||0||
59855663|NCT01239368|75980287|FG009|NOT COMPLETED|Overall Study||4||
59855664|NCT02924324|75980322|FG000|STARTED|Overall Study||28||
59855665|NCT02924324|75980323|FG001|STARTED|Overall Study||28||
59855666|NCT02924324|75980322|FG000|COMPLETED|Overall Study||28||
59855667|NCT02924324|75980323|FG001|COMPLETED|Overall Study||28||
59855668|NCT02924324|75980322|FG000|NOT COMPLETED|Overall Study||0||
59855669|NCT02924324|75980323|FG001|NOT COMPLETED|Overall Study||0||
59855670|NCT02852330|75980329|FG000|STARTED|Overall Study||20||
59855671|NCT02852330|75980329|FG000|COMPLETED|Overall Study||20||
59855672|NCT02852330|75980329|FG000|NOT COMPLETED|Overall Study||0||
59855673|NCT00369161|75980335|FG000|STARTED|Overall Study|"Started indicates randomized and safety population."|109||
59855674|NCT00369161|75980336|FG001|STARTED|Overall Study||119||
59855675|NCT00369161|75980335|FG000|Intention to Treat (ITT)|Overall Study||107||
59855676|NCT00369161|75980336|FG001|Intention to Treat (ITT)|Overall Study||117||
59855677|NCT00369161|75980335|FG000|COMPLETED|Overall Study||82||
59855678|NCT00369161|75980336|FG001|COMPLETED|Overall Study||95||
59855679|NCT00369161|75980335|FG000|NOT COMPLETED|Overall Study||27||
59855680|NCT00369161|75980336|FG001|NOT COMPLETED|Overall Study||24||
59855681|NCT00337571|75980346|FG000|STARTED|Overall Study||52||
59855682|NCT00337571|75980347|FG001|STARTED|Overall Study||53||
59855683|NCT00337571|75980348|FG002|STARTED|Overall Study||59||
59855684|NCT00337571|75980349|FG003|STARTED|Overall Study||54||
59855685|NCT00337571|75980346|FG000|COMPLETED|Overall Study||38||
59855686|NCT00337571|75980347|FG001|COMPLETED|Overall Study||44||
59855687|NCT00337571|75980348|FG002|COMPLETED|Overall Study||49||
59855688|NCT00337571|75980349|FG003|COMPLETED|Overall Study||47||
59855689|NCT00337571|75980346|FG000|NOT COMPLETED|Overall Study||14||
59855690|NCT00337571|75980347|FG001|NOT COMPLETED|Overall Study||9||
59855691|NCT00337571|75980348|FG002|NOT COMPLETED|Overall Study||10||
59855692|NCT00337571|75980349|FG003|NOT COMPLETED|Overall Study||7||
59726065|NCT02996110|75844877|FG004|Previously Un-Treated But Re-Randomized|Track 2||0||
59726066|NCT02996110|75844873|FG000|Re-Randomized From Track 2 Nivolumab + Ipilimumab|Track 2||0||
59726067|NCT02996110|75844874|FG001|Re-Randomized From Track 2 Nivolumab + Ipilimumab|Track 2||2||
59726068|NCT02996110|75844875|FG002|Re-Randomized From Track 2 Nivolumab + Ipilimumab|Track 2||1||
59726069|NCT02996110|75844876|FG003|Re-Randomized From Track 2 Nivolumab + Ipilimumab|Track 2||0||
59726070|NCT02996110|75844877|FG004|Re-Randomized From Track 2 Nivolumab + Ipilimumab|Track 2||2||
59726071|NCT02996110|75844873|FG000|COMPLETED|Track 2||4||
59726072|NCT02996110|75844874|FG001|COMPLETED|Track 2||3||
59726073|NCT02996110|75844875|FG002|COMPLETED|Track 2||1||
59726074|NCT02996110|75844876|FG003|COMPLETED|Track 2||1||
59726075|NCT02996110|75844877|FG004|COMPLETED|Track 2||1||
59726076|NCT02996110|75844873|FG000|NOT COMPLETED|Track 2||42||
59726077|NCT02996110|75844874|FG001|NOT COMPLETED|Track 2||29||
59726078|NCT02996110|75844875|FG002|NOT COMPLETED|Track 2||30||
59726079|NCT02996110|75844876|FG003|NOT COMPLETED|Track 2||20||
59726080|NCT02996110|75844877|FG004|NOT COMPLETED|Track 2||21||
59726081|NCT00916617|75844895|FG000|STARTED|Overall Study||24||
59855693|NCT00368927|75980361|FG000|STARTED|Overall Study||31||
59855694|NCT00368927|75980362|FG001|STARTED|Overall Study||30||
59855695|NCT00368927|75980361|FG000|COMPLETED|Overall Study||26||
59855696|NCT00368927|75980362|FG001|COMPLETED|Overall Study||27||
59855697|NCT00368927|75980361|FG000|NOT COMPLETED|Overall Study||5||
59855698|NCT00368927|75980362|FG001|NOT COMPLETED|Overall Study||3||
59855699|NCT02655692|75980371|FG000|STARTED|Overall Study||55||
59855700|NCT02655692|75980372|FG001|STARTED|Overall Study||55||
59855701|NCT02655692|75980373|FG002|STARTED|Overall Study||53||
59855702|NCT02655692|75980371|FG000|COMPLETED|Overall Study||36||
59855703|NCT02655692|75980372|FG001|COMPLETED|Overall Study||41||
59726082|NCT00916617|75844896|FG001|STARTED|Overall Study||21||
59726083|NCT00916617|75844897|FG002|STARTED|Overall Study||10||
59855704|NCT02655692|75980373|FG002|COMPLETED|Overall Study||40||
59855705|NCT02655692|75980371|FG000|NOT COMPLETED|Overall Study||19||
59855706|NCT02655692|75980372|FG001|NOT COMPLETED|Overall Study||14||
59855707|NCT02655692|75980373|FG002|NOT COMPLETED|Overall Study||13||
59855708|NCT00316589|75980385|FG000|STARTED|Overall Study||88|Vaccinated|
59855709|NCT00316589|75980386|FG001|STARTED|Overall Study||352|Vaccinated|
59855710|NCT00316589|75980387|FG002|STARTED|Overall Study||9|Vaccinated|
59855711|NCT00316589|75980388|FG003|STARTED|Overall Study||132|Vaccinated|
59855712|NCT00316589|75980385|FG000|COMPLETED|Overall Study||87|active study period|
59855713|NCT00316589|75980386|FG001|COMPLETED|Overall Study||328|active study period|
59855714|NCT00316589|75980387|FG002|COMPLETED|Overall Study||8|active study period|
59855715|NCT00316589|75980388|FG003|COMPLETED|Overall Study||127|active study period|
59855716|NCT00316589|75980385|FG000|NOT COMPLETED|Overall Study||1||
59855717|NCT00316589|75980386|FG001|NOT COMPLETED|Overall Study||24||
59855718|NCT00316589|75980387|FG002|NOT COMPLETED|Overall Study||1||
59855719|NCT00316589|75980388|FG003|NOT COMPLETED|Overall Study||5||
59855720|NCT00316277|75980402|FG000|STARTED|Phase 1 (12 Weeks)||329||
59855721|NCT00316277|75980403|FG001|STARTED|Phase 1 (12 Weeks)||324||
59855722|NCT00316277|75980402|FG000|COMPLETED|Phase 1 (12 Weeks)||19||
59855723|NCT00316277|75980403|FG001|COMPLETED|Phase 1 (12 Weeks)||24||
59855724|NCT00316277|75980402|FG000|NOT COMPLETED|Phase 1 (12 Weeks)||310||
59855725|NCT00316277|75980403|FG001|NOT COMPLETED|Phase 1 (12 Weeks)||300||
59855726|NCT00316277|75980402|FG000|STARTED|Phase 2 (24 Weeks)||180||
59855727|NCT00316277|75980403|FG001|STARTED|Phase 2 (24 Weeks)||180||
59855728|NCT00316277|75980402|FG000|COMPLETED|Phase 2 (24 Weeks)||161||
59855729|NCT00316277|75980403|FG001|COMPLETED|Phase 2 (24 Weeks)||161||
59855730|NCT00316277|75980402|FG000|NOT COMPLETED|Phase 2 (24 Weeks)||19||
59855731|NCT00316277|75980403|FG001|NOT COMPLETED|Phase 2 (24 Weeks)||19||
59855732|NCT00368849|75980417|FG000|STARTED|Overall Study||10||
59855733|NCT00368849|75980418|FG001|STARTED|Overall Study||10||
59855734|NCT00368849|75980417|FG000|COMPLETED|Overall Study||10||
59855735|NCT00368849|75980418|FG001|COMPLETED|Overall Study||8||
59855736|NCT00368849|75980417|FG000|NOT COMPLETED|Overall Study||0||
59855737|NCT00368849|75980418|FG001|NOT COMPLETED|Overall Study||2||
59855738|NCT00316199|75980425|FG000|STARTED|Overall Study||60||
59855739|NCT00316199|75980425|FG000|COMPLETED|Overall Study||48||
59855740|NCT00316199|75980425|FG000|NOT COMPLETED|Overall Study||12||
59855741|NCT00316121|75980431|FG000|STARTED|Overall Study||92||
59855742|NCT00316121|75980432|FG001|STARTED|Overall Study||46||
59855743|NCT00316121|75980431|FG000|COMPLETED|Overall Study||70||
59855744|NCT00316121|75980432|FG001|COMPLETED|Overall Study||37||
59855745|NCT00316121|75980431|FG000|NOT COMPLETED|Overall Study||22||
59855746|NCT00316121|75980432|FG001|NOT COMPLETED|Overall Study||9||
59855747|NCT00915902|75980440|FG000|STARTED|1st Treatment Period||20||
59855748|NCT00915902|75980441|FG001|STARTED|1st Treatment Period||22||
59855749|NCT00915902|75980440|FG000|COMPLETED|1st Treatment Period||19||
59855750|NCT00915902|75980441|FG001|COMPLETED|1st Treatment Period||22||
59855751|NCT00915902|75980440|FG000|NOT COMPLETED|1st Treatment Period||1||
59855752|NCT00915902|75980441|FG001|NOT COMPLETED|1st Treatment Period||0||
59855753|NCT00915902|75980440|FG000|STARTED|Washout (4 Weeks)||19||
59855754|NCT00915902|75980441|FG001|STARTED|Washout (4 Weeks)||22||
59855755|NCT00915902|75980440|FG000|COMPLETED|Washout (4 Weeks)||19||
59855756|NCT00915902|75980441|FG001|COMPLETED|Washout (4 Weeks)||21||
59855757|NCT00915902|75980440|FG000|NOT COMPLETED|Washout (4 Weeks)||0||
59855758|NCT00915902|75980441|FG001|NOT COMPLETED|Washout (4 Weeks)||1||
59855759|NCT00915902|75980440|FG000|STARTED|2nd Treatment Period||19||
59855760|NCT00915902|75980441|FG001|STARTED|2nd Treatment Period||21||
59855761|NCT00915902|75980440|FG000|COMPLETED|2nd Treatment Period||19||
59855762|NCT00915902|75980441|FG001|COMPLETED|2nd Treatment Period||20||
59855763|NCT00915902|75980440|FG000|NOT COMPLETED|2nd Treatment Period||0||
59855764|NCT00915902|75980441|FG001|NOT COMPLETED|2nd Treatment Period||1||
59855765|NCT00337103|75980451|FG000|STARTED|Overall Study||554||
59855766|NCT00337103|75980452|FG001|STARTED|Overall Study||548||
59855767|NCT00337103|75980451|FG000|Treated (Safety Population)|Overall Study||544||
59855768|NCT00337103|75980452|FG001|Treated (Safety Population)|Overall Study||546||
59855769|NCT00337103|75980451|FG000|COMPLETED|Overall Study||0||
59855770|NCT00337103|75980452|FG001|COMPLETED|Overall Study||0||
59855771|NCT00337103|75980451|FG000|NOT COMPLETED|Overall Study||554||
59855772|NCT00337103|75980452|FG001|NOT COMPLETED|Overall Study||548||
59855773|NCT00415532|75980461|FG000|STARTED|Treatment Period||77||
59855774|NCT00415532|75980462|FG001|STARTED|Treatment Period||157||
59855775|NCT00415532|75980461|FG000|Received Treatment|Treatment Period||75||
59855776|NCT00415532|75980462|FG001|Received Treatment|Treatment Period||154||
59855777|NCT00415532|75980461|FG000|Switched to Romiplostim Group|Treatment Period||2||
59855778|NCT00415532|75980462|FG001|Switched to Romiplostim Group|Treatment Period||0||
59855779|NCT00415532|75980461|FG000|COMPLETED|Treatment Period||60||
59855780|NCT00415532|75980462|FG001|COMPLETED|Treatment Period||142||
59855781|NCT00415532|75980461|FG000|NOT COMPLETED|Treatment Period||17||
59855782|NCT00415532|75980462|FG001|NOT COMPLETED|Treatment Period||15||
59855783|NCT00415532|75980461|FG000|STARTED|Safety Follow Up Period|Participants who completed the treatment period were not required to participate in this follow-up|43||
59855784|NCT00415532|75980462|FG001|STARTED|Safety Follow Up Period|Participants who completed the treatment period were not required to participate in this follow-up|30||
59996784|NCT03434041|76112632|FG000|NOT COMPLETED|Follow-up Phase (Up to 8 Weeks)||7||
59855785|NCT00415532|75980461|FG000|COMPLETED|Safety Follow Up Period||34||
59855786|NCT00415532|75980462|FG001|COMPLETED|Safety Follow Up Period||18||
59855787|NCT00415532|75980461|FG000|NOT COMPLETED|Safety Follow Up Period||9||
59855788|NCT00415532|75980462|FG001|NOT COMPLETED|Safety Follow Up Period||12||
59855789|NCT00315731|75980468|FG000|STARTED|Overall Study||15||
59855790|NCT00315731|75980468|FG000|COMPLETED|Overall Study||9||
59855791|NCT00315731|75980468|FG000|NOT COMPLETED|Overall Study||6||
59855792|NCT00062868|75980495|FG000|STARTED|Dose Level 1||3||
59855793|NCT00062868|75980496|FG001|STARTED|Dose Level 1||0||
59855794|NCT00062868|75980497|FG002|STARTED|Dose Level 1||0||
59855795|NCT00062868|75980498|FG003|STARTED|Dose Level 1||3||
59855796|NCT00062868|75980499|FG004|STARTED|Dose Level 1||0||
59855797|NCT00062868|75980500|FG005|STARTED|Dose Level 1||0||
59855798|NCT00062868|75980501|FG006|STARTED|Dose Level 1||4||
59855799|NCT00062868|75980502|FG007|STARTED|Dose Level 1||0||
59855800|NCT00062868|75980503|FG008|STARTED|Dose Level 1||0||
59855801|NCT00062868|75980504|FG009|STARTED|Dose Level 1||3||
59855802|NCT00062868|75980505|FG010|STARTED|Dose Level 1||0||
59855803|NCT00062868|75980506|FG011|STARTED|Dose Level 1||0||
59855804|NCT00062868|75980507|FG012|STARTED|Dose Level 1||3||
59855805|NCT00062868|75980508|FG013|STARTED|Dose Level 1||0||
59855806|NCT00062868|75980509|FG014|STARTED|Dose Level 1||0||
59855807|NCT00062868|75980510|FG015|STARTED|Dose Level 1||3||
59855808|NCT00062868|75980511|FG016|STARTED|Dose Level 1||0||
59855809|NCT00062868|75980512|FG017|STARTED|Dose Level 1||0||
59855810|NCT00062868|75980513|FG018|STARTED|Dose Level 1||16||
59855811|NCT00062868|75980514|FG019|STARTED|Dose Level 1||2||
59855812|NCT00062868|75980515|FG020|STARTED|Dose Level 1||3||
59855813|NCT00062868|75980495|FG000|COMPLETED|Dose Level 1||1||
59855814|NCT00062868|75980496|FG001|COMPLETED|Dose Level 1||0||
59855815|NCT00062868|75980497|FG002|COMPLETED|Dose Level 1||0||
59855816|NCT00062868|75980498|FG003|COMPLETED|Dose Level 1||1||
59855817|NCT00062868|75980499|FG004|COMPLETED|Dose Level 1||0||
59855818|NCT00062868|75980500|FG005|COMPLETED|Dose Level 1||0||
59855819|NCT00062868|75980501|FG006|COMPLETED|Dose Level 1||1||
59855820|NCT00062868|75980502|FG007|COMPLETED|Dose Level 1||0||
59855821|NCT00062868|75980503|FG008|COMPLETED|Dose Level 1||0||
59855822|NCT00062868|75980504|FG009|COMPLETED|Dose Level 1||3||
59855823|NCT00062868|75980505|FG010|COMPLETED|Dose Level 1||0||
59855824|NCT00062868|75980506|FG011|COMPLETED|Dose Level 1||0||
59855825|NCT00062868|75980507|FG012|COMPLETED|Dose Level 1||2||
59855826|NCT00062868|75980508|FG013|COMPLETED|Dose Level 1||0||
59855827|NCT00062868|75980509|FG014|COMPLETED|Dose Level 1||0||
59855828|NCT00062868|75980510|FG015|COMPLETED|Dose Level 1||3||
59855829|NCT00062868|75980511|FG016|COMPLETED|Dose Level 1||0||
59855830|NCT00062868|75980512|FG017|COMPLETED|Dose Level 1||0||
59855831|NCT00062868|75980513|FG018|COMPLETED|Dose Level 1||7||
59855832|NCT00062868|75980514|FG019|COMPLETED|Dose Level 1||2||
59855833|NCT00062868|75980515|FG020|COMPLETED|Dose Level 1||1||
59855834|NCT00062868|75980495|FG000|NOT COMPLETED|Dose Level 1||2||
59855835|NCT00062868|75980496|FG001|NOT COMPLETED|Dose Level 1||0||
59855836|NCT00062868|75980497|FG002|NOT COMPLETED|Dose Level 1||0||
59855837|NCT00062868|75980498|FG003|NOT COMPLETED|Dose Level 1||2||
59855838|NCT00062868|75980499|FG004|NOT COMPLETED|Dose Level 1||0||
59855839|NCT00062868|75980500|FG005|NOT COMPLETED|Dose Level 1||0||
59855840|NCT00062868|75980501|FG006|NOT COMPLETED|Dose Level 1||3||
59855841|NCT00062868|75980502|FG007|NOT COMPLETED|Dose Level 1||0||
59855842|NCT00062868|75980503|FG008|NOT COMPLETED|Dose Level 1||0||
59855843|NCT00062868|75980504|FG009|NOT COMPLETED|Dose Level 1||0||
59855844|NCT00062868|75980505|FG010|NOT COMPLETED|Dose Level 1||0||
59855845|NCT00062868|75980506|FG011|NOT COMPLETED|Dose Level 1||0||
59855846|NCT00062868|75980507|FG012|NOT COMPLETED|Dose Level 1||1||
59855847|NCT00062868|75980508|FG013|NOT COMPLETED|Dose Level 1||0||
59855848|NCT00062868|75980509|FG014|NOT COMPLETED|Dose Level 1||0||
59855849|NCT00062868|75980510|FG015|NOT COMPLETED|Dose Level 1||0||
59855850|NCT00062868|75980511|FG016|NOT COMPLETED|Dose Level 1||0||
59855851|NCT00062868|75980512|FG017|NOT COMPLETED|Dose Level 1||0||
59855852|NCT00062868|75980513|FG018|NOT COMPLETED|Dose Level 1||9||
59855853|NCT00062868|75980514|FG019|NOT COMPLETED|Dose Level 1||0||
59855854|NCT00062868|75980515|FG020|NOT COMPLETED|Dose Level 1||2||
59855855|NCT00062868|75980495|FG000|STARTED|Dose Level 2||0||
59855856|NCT00062868|75980496|FG001|STARTED|Dose Level 2||6||
59855857|NCT00062868|75980497|FG002|STARTED|Dose Level 2||0||
59855858|NCT00062868|75980498|FG003|STARTED|Dose Level 2||0||
59855859|NCT00062868|75980499|FG004|STARTED|Dose Level 2||3||
59855860|NCT00062868|75980500|FG005|STARTED|Dose Level 2||0||
59855861|NCT00062868|75980501|FG006|STARTED|Dose Level 2||0||
59855862|NCT00062868|75980502|FG007|STARTED|Dose Level 2||0||
59855863|NCT00062868|75980503|FG008|STARTED|Dose Level 2||0||
59855864|NCT00062868|75980504|FG009|STARTED|Dose Level 2||0||
59855865|NCT00062868|75980505|FG010|STARTED|Dose Level 2||4||
59855866|NCT00062868|75980506|FG011|STARTED|Dose Level 2||0||
59855867|NCT00062868|75980507|FG012|STARTED|Dose Level 2||0||
59855868|NCT00062868|75980508|FG013|STARTED|Dose Level 2||3||
59855869|NCT00062868|75980509|FG014|STARTED|Dose Level 2||0||
59855870|NCT00062868|75980510|FG015|STARTED|Dose Level 2||0||
59855871|NCT00062868|75980511|FG016|STARTED|Dose Level 2||3||
59855872|NCT00062868|75980512|FG017|STARTED|Dose Level 2||0||
59855873|NCT00062868|75980513|FG018|STARTED|Dose Level 2||0||
59855874|NCT00062868|75980514|FG019|STARTED|Dose Level 2||0||
59855875|NCT00062868|75980515|FG020|STARTED|Dose Level 2||0||
59855876|NCT00062868|75980495|FG000|COMPLETED|Dose Level 2||0||
59855877|NCT00062868|75980496|FG001|COMPLETED|Dose Level 2||3||
59855878|NCT00062868|75980497|FG002|COMPLETED|Dose Level 2||0||
59855879|NCT00062868|75980498|FG003|COMPLETED|Dose Level 2||0||
59855880|NCT00062868|75980499|FG004|COMPLETED|Dose Level 2||1||
59855881|NCT00062868|75980500|FG005|COMPLETED|Dose Level 2||0||
59855882|NCT00062868|75980501|FG006|COMPLETED|Dose Level 2||0||
59855883|NCT00062868|75980502|FG007|COMPLETED|Dose Level 2||0||
59855884|NCT00062868|75980503|FG008|COMPLETED|Dose Level 2||0||
59855885|NCT00062868|75980504|FG009|COMPLETED|Dose Level 2||0||
59855886|NCT00062868|75980505|FG010|COMPLETED|Dose Level 2||3||
59855887|NCT00062868|75980506|FG011|COMPLETED|Dose Level 2||0||
59855888|NCT00062868|75980507|FG012|COMPLETED|Dose Level 2||0||
59855889|NCT00062868|75980508|FG013|COMPLETED|Dose Level 2||2||
59855890|NCT00062868|75980509|FG014|COMPLETED|Dose Level 2||0||
59855891|NCT00062868|75980510|FG015|COMPLETED|Dose Level 2||0||
59855892|NCT00062868|75980511|FG016|COMPLETED|Dose Level 2||0||
59855893|NCT00062868|75980512|FG017|COMPLETED|Dose Level 2||0||
59855894|NCT00062868|75980513|FG018|COMPLETED|Dose Level 2||0||
59855895|NCT00062868|75980514|FG019|COMPLETED|Dose Level 2||0||
59855896|NCT00062868|75980515|FG020|COMPLETED|Dose Level 2||0||
59855897|NCT00062868|75980495|FG000|NOT COMPLETED|Dose Level 2||0||
59855898|NCT00062868|75980496|FG001|NOT COMPLETED|Dose Level 2||3||
59855899|NCT00062868|75980497|FG002|NOT COMPLETED|Dose Level 2||0||
59855900|NCT00062868|75980498|FG003|NOT COMPLETED|Dose Level 2||0||
59855901|NCT00062868|75980499|FG004|NOT COMPLETED|Dose Level 2||2||
59855902|NCT00062868|75980500|FG005|NOT COMPLETED|Dose Level 2||0||
59855903|NCT00062868|75980501|FG006|NOT COMPLETED|Dose Level 2||0||
59855904|NCT00062868|75980502|FG007|NOT COMPLETED|Dose Level 2||0||
59855905|NCT00062868|75980503|FG008|NOT COMPLETED|Dose Level 2||0||
59855906|NCT00062868|75980504|FG009|NOT COMPLETED|Dose Level 2||0||
59855907|NCT00062868|75980505|FG010|NOT COMPLETED|Dose Level 2||1||
59855908|NCT00062868|75980506|FG011|NOT COMPLETED|Dose Level 2||0||
59855909|NCT00062868|75980507|FG012|NOT COMPLETED|Dose Level 2||0||
59855910|NCT00062868|75980508|FG013|NOT COMPLETED|Dose Level 2||1||
59855911|NCT00062868|75980509|FG014|NOT COMPLETED|Dose Level 2||0||
59855912|NCT00062868|75980510|FG015|NOT COMPLETED|Dose Level 2||0||
59855913|NCT00062868|75980511|FG016|NOT COMPLETED|Dose Level 2||3||
59855914|NCT00062868|75980512|FG017|NOT COMPLETED|Dose Level 2||0||
59855915|NCT00062868|75980513|FG018|NOT COMPLETED|Dose Level 2||0||
59855916|NCT00062868|75980514|FG019|NOT COMPLETED|Dose Level 2||0||
59855917|NCT00062868|75980515|FG020|NOT COMPLETED|Dose Level 2||0||
59855918|NCT00062868|75980495|FG000|STARTED|Dose Level 3||0||
59855919|NCT00062868|75980496|FG001|STARTED|Dose Level 3||0||
59855920|NCT00062868|75980497|FG002|STARTED|Dose Level 3||3||
59855921|NCT00062868|75980498|FG003|STARTED|Dose Level 3||0||
59855922|NCT00062868|75980499|FG004|STARTED|Dose Level 3||0||
59855923|NCT00062868|75980500|FG005|STARTED|Dose Level 3||0||
59855924|NCT00062868|75980501|FG006|STARTED|Dose Level 3||0||
59855925|NCT00062868|75980502|FG007|STARTED|Dose Level 3||0||
59855926|NCT00062868|75980503|FG008|STARTED|Dose Level 3||0||
59855927|NCT00062868|75980504|FG009|STARTED|Dose Level 3||0||
59855928|NCT00062868|75980505|FG010|STARTED|Dose Level 3||0||
59855929|NCT00062868|75980506|FG011|STARTED|Dose Level 3||5||
59855930|NCT00062868|75980507|FG012|STARTED|Dose Level 3||0||
59855931|NCT00062868|75980508|FG013|STARTED|Dose Level 3||0||
59855932|NCT00062868|75980509|FG014|STARTED|Dose Level 3||3||
59726084|NCT00916617|75844898|FG003|STARTED|Overall Study||7||
59726085|NCT00916617|75844895|FG000|COMPLETED|Overall Study||1||
59726086|NCT00916617|75844896|FG001|COMPLETED|Overall Study||0||
59726087|NCT00916617|75844897|FG002|COMPLETED|Overall Study||0||
59726088|NCT00916617|75844898|FG003|COMPLETED|Overall Study||0||
59726089|NCT00916617|75844895|FG000|NOT COMPLETED|Overall Study||23||
59726090|NCT00916617|75844896|FG001|NOT COMPLETED|Overall Study||21||
59726091|NCT00916617|75844897|FG002|NOT COMPLETED|Overall Study||10||
59726092|NCT00916617|75844898|FG003|NOT COMPLETED|Overall Study||7||
59726093|NCT01103063|75844910|FG000|STARTED|Overall Study||1446||
59855933|NCT00062868|75980510|FG015|STARTED|Dose Level 3||0||
59855934|NCT00062868|75980511|FG016|STARTED|Dose Level 3||0||
59855935|NCT00062868|75980512|FG017|STARTED|Dose Level 3||4||
59855936|NCT00062868|75980513|FG018|STARTED|Dose Level 3||0||
59855937|NCT00062868|75980514|FG019|STARTED|Dose Level 3||0||
59855938|NCT00062868|75980515|FG020|STARTED|Dose Level 3||0||
59855939|NCT00062868|75980495|FG000|COMPLETED|Dose Level 3||0||
59855940|NCT00062868|75980496|FG001|COMPLETED|Dose Level 3||0||
59855941|NCT00062868|75980497|FG002|COMPLETED|Dose Level 3||1||
59855942|NCT00062868|75980498|FG003|COMPLETED|Dose Level 3||0||
59855943|NCT00062868|75980499|FG004|COMPLETED|Dose Level 3||0||
59855944|NCT00062868|75980500|FG005|COMPLETED|Dose Level 3||0||
59855945|NCT00062868|75980501|FG006|COMPLETED|Dose Level 3||0||
59855946|NCT00062868|75980502|FG007|COMPLETED|Dose Level 3||0||
59855947|NCT00062868|75980503|FG008|COMPLETED|Dose Level 3||0||
59855948|NCT00062868|75980504|FG009|COMPLETED|Dose Level 3||0||
59855949|NCT00062868|75980505|FG010|COMPLETED|Dose Level 3||0||
59855950|NCT00062868|75980506|FG011|COMPLETED|Dose Level 3||4||
59855951|NCT00062868|75980507|FG012|COMPLETED|Dose Level 3||0||
59855952|NCT00062868|75980508|FG013|COMPLETED|Dose Level 3||0||
59855953|NCT00062868|75980509|FG014|COMPLETED|Dose Level 3||2||
59855954|NCT00062868|75980510|FG015|COMPLETED|Dose Level 3||0||
59855955|NCT00062868|75980511|FG016|COMPLETED|Dose Level 3||0||
59855956|NCT00062868|75980512|FG017|COMPLETED|Dose Level 3||3||
59855957|NCT00062868|75980513|FG018|COMPLETED|Dose Level 3||0||
59855958|NCT00062868|75980514|FG019|COMPLETED|Dose Level 3||0||
59855959|NCT00062868|75980515|FG020|COMPLETED|Dose Level 3||0||
59855960|NCT00062868|75980495|FG000|NOT COMPLETED|Dose Level 3||0||
59855961|NCT00062868|75980496|FG001|NOT COMPLETED|Dose Level 3||0||
59855962|NCT00062868|75980497|FG002|NOT COMPLETED|Dose Level 3||2||
59855963|NCT00062868|75980498|FG003|NOT COMPLETED|Dose Level 3||0||
59855964|NCT00062868|75980499|FG004|NOT COMPLETED|Dose Level 3||0||
59855965|NCT00062868|75980500|FG005|NOT COMPLETED|Dose Level 3||0||
59855966|NCT00062868|75980501|FG006|NOT COMPLETED|Dose Level 3||0||
59855967|NCT00062868|75980502|FG007|NOT COMPLETED|Dose Level 3||0||
59855968|NCT00062868|75980503|FG008|NOT COMPLETED|Dose Level 3||0||
59855969|NCT00062868|75980504|FG009|NOT COMPLETED|Dose Level 3||0||
59855970|NCT00062868|75980505|FG010|NOT COMPLETED|Dose Level 3||0||
59855971|NCT00062868|75980506|FG011|NOT COMPLETED|Dose Level 3||1||
59855972|NCT00062868|75980507|FG012|NOT COMPLETED|Dose Level 3||0||
59855973|NCT00062868|75980508|FG013|NOT COMPLETED|Dose Level 3||0||
59855974|NCT00062868|75980509|FG014|NOT COMPLETED|Dose Level 3||1||
59591650|NCT02798978|75699658|FG004|COMPLETED|Part 2 (45 Days)||0||
59726094|NCT01103063|75844911|FG001|STARTED|Overall Study||1445||
59726095|NCT01103063|75844910|FG000|COMPLETED|Overall Study||969||
59726096|NCT01103063|75844911|FG001|COMPLETED|Overall Study||1024||
59726097|NCT01103063|75844910|FG000|NOT COMPLETED|Overall Study||477||
59726098|NCT01103063|75844911|FG001|NOT COMPLETED|Overall Study||421||
59726099|NCT01091675|75844919|FG000|STARTED|Overall Study|7 patients leave the study due to hypertension, 27 patients withdrew due to lack of efficacy|57||
59726100|NCT01091675|75844919|FG000|COMPLETED|Overall Study||23||
59726101|NCT01091675|75844919|FG000|NOT COMPLETED|Overall Study||34||
59726102|NCT01091519|75844925|FG000|STARTED|Overall Study||346||
59726103|NCT01091519|75844926|FG001|STARTED|Overall Study||435||
59726104|NCT01091519|75844925|FG000|Treated|Overall Study||342||
59726105|NCT01091519|75844926|FG001|Treated|Overall Study||431||
59726106|NCT01091519|75844925|FG000|COMPLETED|Overall Study||291||
59726107|NCT01091519|75844926|FG001|COMPLETED|Overall Study||362||
59726108|NCT01091519|75844925|FG000|NOT COMPLETED|Overall Study||55||
59726109|NCT01091519|75844926|FG001|NOT COMPLETED|Overall Study||73||
59726110|NCT01011738|75844935|FG000|STARTED|Overall Study||877||
59726111|NCT01011738|75844936|FG001|STARTED|Overall Study||912||
59726112|NCT01011738|75844937|FG002|STARTED|Overall Study||53||
59726113|NCT01011738|75844935|FG000|COMPLETED|Overall Study||553||
59726114|NCT01011738|75844936|FG001|COMPLETED|Overall Study||618||
59726115|NCT01011738|75844937|FG002|COMPLETED|Overall Study||36||
59726116|NCT01011738|75844935|FG000|NOT COMPLETED|Overall Study||324||
59726117|NCT01011738|75844936|FG001|NOT COMPLETED|Overall Study||294||
59726118|NCT01011738|75844937|FG002|NOT COMPLETED|Overall Study||17||
59726119|NCT00918333|75844948|FG000|STARTED|Overall Study||26||
59726120|NCT00918333|75844949|FG001|STARTED|Overall Study||98||
59726121|NCT00918333|75844948|FG000|COMPLETED|Overall Study||23||
59726122|NCT00918333|75844949|FG001|COMPLETED|Overall Study||93||
59726123|NCT00918333|75844948|FG000|NOT COMPLETED|Overall Study||3||
59726124|NCT00918333|75844949|FG001|NOT COMPLETED|Overall Study||5||
59726125|NCT01091363|75844960|FG000|STARTED|Overall Study||55||
59726126|NCT01091363|75844961|FG001|STARTED|Overall Study||54||
59726127|NCT01091363|75844960|FG000|COMPLETED|Overall Study||42||
59855975|NCT00062868|75980510|FG015|NOT COMPLETED|Dose Level 3||0||
59855976|NCT00062868|75980511|FG016|NOT COMPLETED|Dose Level 3||0||
59855977|NCT00062868|75980512|FG017|NOT COMPLETED|Dose Level 3||1||
59855978|NCT00062868|75980513|FG018|NOT COMPLETED|Dose Level 3||0||
59855979|NCT00062868|75980514|FG019|NOT COMPLETED|Dose Level 3||0||
59855980|NCT00062868|75980515|FG020|NOT COMPLETED|Dose Level 3||0||
59855981|NCT00075504|75980561|FG000|STARTED|Overall Study||23||
59726128|NCT01091363|75844961|FG001|COMPLETED|Overall Study||37||
59726129|NCT01091363|75844960|FG000|NOT COMPLETED|Overall Study||13||
59726130|NCT01091363|75844961|FG001|NOT COMPLETED|Overall Study||17||
59726131|NCT01090973|75844967|FG000|STARTED|Overall Study||1||
59726132|NCT01090973|75844967|FG000|COMPLETED|Overall Study||0||
59726133|NCT01090973|75844967|FG000|NOT COMPLETED|Overall Study||1||
59726134|NCT01090739|75844971|FG000|STARTED|Enrollment|Subject enrollment = signed informed consent form|207||
59726135|NCT01090739|75844971|FG000|COMPLETED|Enrollment||152||
59726136|NCT01090739|75844971|FG000|NOT COMPLETED|Enrollment||55||
59726137|NCT01090739|75844971|FG000|STARTED|12 Month Follow-up||152||
59726138|NCT01090739|75844971|FG000|COMPLETED|12 Month Follow-up||147||
59726139|NCT01090739|75844971|FG000|NOT COMPLETED|12 Month Follow-up||5||
59855982|NCT00075504|75980562|FG001|STARTED|Overall Study||10||
59855983|NCT00075504|75980561|FG000|COMPLETED|Overall Study||14||
59855984|NCT00075504|75980562|FG001|COMPLETED|Overall Study||3||
59855985|NCT00075504|75980561|FG000|NOT COMPLETED|Overall Study||9||
59855986|NCT00075504|75980562|FG001|NOT COMPLETED|Overall Study||7||
59855987|NCT00062166|75980568|FG000|STARTED|Overall Study||340||
59855988|NCT00062166|75980568|FG000|COMPLETED|Overall Study||334||
59855989|NCT00062166|75980568|FG000|NOT COMPLETED|Overall Study||6||
59855990|NCT00087438|75980573|FG000|STARTED|Overall Study||59||
59855991|NCT00087438|75980573|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|55||
59855992|NCT00087438|75980573|FG000|NOT COMPLETED|Overall Study||4||
59855993|NCT00321464|75980581|FG000|STARTED|Overall Study||1020||
59855994|NCT00321464|75980582|FG001|STARTED|Overall Study||1026||
59855995|NCT00321464|75980581|FG000|Received Investigational Product|Overall Study||1014||
59855996|NCT00321464|75980582|FG001|Received Investigational Product|Overall Study||1019||
59855997|NCT00321464|75980581|FG000|COMPLETED|Overall Study||461||
59855998|NCT00321464|75980582|FG001|COMPLETED|Overall Study||468||
59855999|NCT00321464|75980581|FG000|NOT COMPLETED|Overall Study||559||
59856000|NCT00321464|75980582|FG001|NOT COMPLETED|Overall Study||558||
59856001|NCT02889796|75980592|FG000|STARTED|Overall Study||477||
59856002|NCT02889796|75980593|FG001|STARTED|Overall Study||480||
59856003|NCT02889796|75980594|FG002|STARTED|Overall Study||325||
59856004|NCT02889796|75980595|FG003|STARTED|Overall Study||190||
59856005|NCT02889796|75980596|FG004|STARTED|Overall Study||191||
59856006|NCT02889796|75980597|FG005|STARTED|Overall Study||96||
59856007|NCT02889796|75980592|FG000|COMPLETED|Overall Study||424||
59856008|NCT02889796|75980593|FG001|COMPLETED|Overall Study||422||
59856009|NCT02889796|75980594|FG002|COMPLETED|Overall Study||281||
59856010|NCT02889796|75980595|FG003|COMPLETED|Overall Study||181||
59856011|NCT02889796|75980596|FG004|COMPLETED|Overall Study||185||
59856012|NCT02889796|75980597|FG005|COMPLETED|Overall Study|Completed 24 weeks of placebo treatment and not rerandomized to Filgotinib 200 mg or 100 mg groups|24||
59856013|NCT02889796|75980592|FG000|NOT COMPLETED|Overall Study||53||
59856014|NCT02889796|75980593|FG001|NOT COMPLETED|Overall Study||58||
59856015|NCT02889796|75980594|FG002|NOT COMPLETED|Overall Study||44||
59856016|NCT02889796|75980595|FG003|NOT COMPLETED|Overall Study||9||
59856017|NCT02889796|75980596|FG004|NOT COMPLETED|Overall Study||6||
59856018|NCT02889796|75980597|FG005|NOT COMPLETED|Overall Study||72||
59856019|NCT02889562|75980622|FG000|STARTED|Overall Study||28||
59856020|NCT02889562|75980623|FG001|STARTED|Overall Study||28||
59856021|NCT02889562|75980622|FG000|COMPLETED|Overall Study||28||
59856022|NCT02889562|75980623|FG001|COMPLETED|Overall Study||26||
59856023|NCT02889562|75980622|FG000|NOT COMPLETED|Overall Study||0||
59856024|NCT02889562|75980623|FG001|NOT COMPLETED|Overall Study||2||
59856025|NCT03323164|75980631|FG000|STARTED|Overall Study||18||
59856026|NCT03323164|75980632|FG001|STARTED|Overall Study||17||
59856027|NCT03323164|75980631|FG000|COMPLETED|Overall Study||16||
59856028|NCT03323164|75980632|FG001|COMPLETED|Overall Study||15||
59726140|NCT01090739|75844971|FG000|STARTED|24 Month Follow-up||147||
59726141|NCT01090739|75844971|FG000|COMPLETED|24 Month Follow-up||138||
59726142|NCT01090739|75844971|FG000|NOT COMPLETED|24 Month Follow-up||9||
59726143|NCT01090739|75844971|FG000|STARTED|36 Month Follow-up||138||
59726144|NCT01090739|75844971|FG000|COMPLETED|36 Month Follow-up||115||
59726145|NCT01090739|75844971|FG000|NOT COMPLETED|36 Month Follow-up||23||
59726146|NCT02497300|75844978|FG000|STARTED|First Intervention (6 Weeks)||13||
59726147|NCT02497300|75844979|FG001|STARTED|First Intervention (6 Weeks)||6||
59726148|NCT02497300|75844978|FG000|COMPLETED|First Intervention (6 Weeks)||12||
59726149|NCT02497300|75844979|FG001|COMPLETED|First Intervention (6 Weeks)||6||
59726150|NCT02497300|75844978|FG000|NOT COMPLETED|First Intervention (6 Weeks)||1||
59726151|NCT02497300|75844979|FG001|NOT COMPLETED|First Intervention (6 Weeks)||0||
59726152|NCT02497300|75844978|FG000|STARTED|Washout (1 Month)||12||
59726153|NCT02497300|75844979|FG001|STARTED|Washout (1 Month)||6||
59726154|NCT02497300|75844978|FG000|COMPLETED|Washout (1 Month)||12||
59726155|NCT02497300|75844979|FG001|COMPLETED|Washout (1 Month)||6||
59726156|NCT02497300|75844978|FG000|NOT COMPLETED|Washout (1 Month)||0||
59726157|NCT02497300|75844979|FG001|NOT COMPLETED|Washout (1 Month)||0||
59726158|NCT02497300|75844978|FG000|STARTED|Second Intervention (6 Weeks)||12||
59726159|NCT02497300|75844979|FG001|STARTED|Second Intervention (6 Weeks)||6||
59726160|NCT02497300|75844978|FG000|COMPLETED|Second Intervention (6 Weeks)||10||
59856029|NCT03323164|75980631|FG000|NOT COMPLETED|Overall Study||2||
59856030|NCT03323164|75980632|FG001|NOT COMPLETED|Overall Study||2||
59856031|NCT03323086|75980644|FG000|STARTED|Overall Study||26||
59726161|NCT02497300|75844979|FG001|COMPLETED|Second Intervention (6 Weeks)||5||
59726162|NCT02497300|75844978|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||2||
59856032|NCT03323086|75980645|FG001|STARTED|Overall Study||22||
59856033|NCT03323086|75980644|FG000|COMPLETED|Overall Study||23||
59856034|NCT03323086|75980645|FG001|COMPLETED|Overall Study||20||
59856035|NCT03323086|75980644|FG000|NOT COMPLETED|Overall Study||3||
59856036|NCT03323086|75980645|FG001|NOT COMPLETED|Overall Study||2||
59856037|NCT02888080|75980653|FG000|STARTED|Overall Study||20||
59726163|NCT02497300|75844979|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||1||
59726164|NCT00916383|75844989|FG000|STARTED|Overall Study||49||
59856038|NCT02888080|75980654|FG001|STARTED|Overall Study||20||
59856039|NCT02888080|75980653|FG000|COMPLETED|Overall Study||18||
59856040|NCT02888080|75980654|FG001|COMPLETED|Overall Study||15||
59856041|NCT02888080|75980653|FG000|NOT COMPLETED|Overall Study||2||
59856042|NCT02888080|75980654|FG001|NOT COMPLETED|Overall Study||5||
59856043|NCT03322462|75980660|FG000|STARTED|Overall Study||155||
59726165|NCT00916383|75844989|FG000|COMPLETED|Overall Study||46||
59856044|NCT03322462|75980660|FG000|Flortaucipir PET Scan|Overall Study||155||
59856045|NCT03322462|75980660|FG000|COMPLETED|Overall Study||152||
59856046|NCT03322462|75980660|FG000|NOT COMPLETED|Overall Study||3||
59856047|NCT00086580|75980668|FG000|STARTED|Treatment Period||168||
59591651|NCT02798978|75699659|FG005|COMPLETED|Part 2 (45 Days)||0||
59591652|NCT02798978|75699660|FG006|COMPLETED|Part 2 (45 Days)||0||
59591653|NCT02798978|75699654|FG000|NOT COMPLETED|Part 2 (45 Days)||0||
59726166|NCT00916383|75844989|FG000|NOT COMPLETED|Overall Study||3||
59726167|NCT00916305|75844999|FG000|STARTED|Overall Study||28||
59726168|NCT00916305|75845000|FG001|STARTED|Overall Study||37||
59726169|NCT00916305|75844999|FG000|COMPLETED|Overall Study||7||
59726170|NCT00916305|75845000|FG001|COMPLETED|Overall Study||9||
59726171|NCT00916305|75844999|FG000|NOT COMPLETED|Overall Study||21||
59726172|NCT00916305|75845000|FG001|NOT COMPLETED|Overall Study||28||
59726173|NCT00916149|75845009|FG000|STARTED|Overall Study||16||
59856048|NCT00086580|75980669|FG001|STARTED|Treatment Period||167||
59856049|NCT00086580|75980668|FG000|Safety Population|Treatment Period|Four participants did not receive treatment|164||
59856050|NCT00086580|75980669|FG001|Safety Population|Treatment Period|Two participants did not receive treatment|165||
59856051|NCT00086580|75980668|FG000|COMPLETED|Treatment Period|Finished 6 cycles of study drugs|103||
59591654|NCT02798978|75699655|FG001|NOT COMPLETED|Part 2 (45 Days)||0||
59591655|NCT02798978|75699656|FG002|NOT COMPLETED|Part 2 (45 Days)||0||
59591656|NCT02798978|75699657|FG003|NOT COMPLETED|Part 2 (45 Days)||0||
59591657|NCT02798978|75699658|FG004|NOT COMPLETED|Part 2 (45 Days)||0||
59591658|NCT02798978|75699659|FG005|NOT COMPLETED|Part 2 (45 Days)||0||
59591659|NCT02798978|75699660|FG006|NOT COMPLETED|Part 2 (45 Days)||0||
59591660|NCT02898103|75699684|FG000|STARTED|Overall Study||4||
59591661|NCT02898103|75699685|FG001|STARTED|Overall Study||3||
59591662|NCT02898103|75699684|FG000|COMPLETED|Overall Study||4||
59591663|NCT02898103|75699685|FG001|COMPLETED|Overall Study||3||
59591664|NCT02898103|75699684|FG000|NOT COMPLETED|Overall Study||0||
59591665|NCT02898103|75699685|FG001|NOT COMPLETED|Overall Study||0||
59591666|NCT03005041|75699695|FG000|STARTED|Period 1||28||
59591667|NCT03005041|75699696|FG001|STARTED|Period 1||27||
59591668|NCT03005041|75699695|FG000|COMPLETED|Period 1||28||
59591669|NCT03005041|75699696|FG001|COMPLETED|Period 1||27||
59591670|NCT03005041|75699695|FG000|NOT COMPLETED|Period 1||0||
59591671|NCT03005041|75699696|FG001|NOT COMPLETED|Period 1||0||
59591672|NCT03005041|75699695|FG000|STARTED|Washout Period 1||28||
59591673|NCT03005041|75699696|FG001|STARTED|Washout Period 1||27||
59591674|NCT03005041|75699695|FG000|COMPLETED|Washout Period 1||28||
59591675|NCT03005041|75699696|FG001|COMPLETED|Washout Period 1||27||
59591676|NCT03005041|75699695|FG000|NOT COMPLETED|Washout Period 1||0||
59591677|NCT03005041|75699696|FG001|NOT COMPLETED|Washout Period 1||0||
59591678|NCT03005041|75699695|FG000|STARTED|Period 2||28||
59591679|NCT03005041|75699696|FG001|STARTED|Period 2||27||
59591680|NCT03005041|75699695|FG000|COMPLETED|Period 2||28||
59591681|NCT03005041|75699696|FG001|COMPLETED|Period 2||27||
59591682|NCT03005041|75699695|FG000|NOT COMPLETED|Period 2||0||
59591683|NCT03005041|75699696|FG001|NOT COMPLETED|Period 2||0||
59591684|NCT03007225|75699704|FG000|STARTED|Overall Study|Followed up for at least 6 months after DEB TACE|25|Study completed|
59591685|NCT03007225|75699705|FG001|STARTED|Overall Study|followed up for at least 6 months after TACE|25|Study completed|
59591686|NCT03007225|75699704|FG000|COMPLETED|Overall Study||25|Study completed|
59591687|NCT03007225|75699705|FG001|COMPLETED|Overall Study||25|Study completed|
59591688|NCT03007225|75699704|FG000|NOT COMPLETED|Overall Study||0||
59591689|NCT03007225|75699705|FG001|NOT COMPLETED|Overall Study||0||
59591690|NCT02799290|75699714|FG000|STARTED|Overall Study||24||28
59726174|NCT00916149|75845010|FG001|STARTED|Overall Study||10||
59726175|NCT00916149|75845011|FG002|STARTED|Overall Study||5||
59726176|NCT00916149|75845009|FG000|COMPLETED|Overall Study||12||
59726177|NCT00916149|75845010|FG001|COMPLETED|Overall Study||8||
59726178|NCT00916149|75845011|FG002|COMPLETED|Overall Study||5||
59726179|NCT00916149|75845009|FG000|NOT COMPLETED|Overall Study||4||
59726180|NCT00916149|75845010|FG001|NOT COMPLETED|Overall Study||2||
59856052|NCT00086580|75980669|FG001|COMPLETED|Treatment Period|Finished 6 cycles of study drug|107||
59856053|NCT00086580|75980668|FG000|NOT COMPLETED|Treatment Period||65||
59856054|NCT00086580|75980669|FG001|NOT COMPLETED|Treatment Period||60||
59856055|NCT00086580|75980668|FG000|STARTED|Follow-up Period||141||
59856056|NCT00086580|75980669|FG001|STARTED|Follow-up Period||137||
59856057|NCT00086580|75980668|FG000|COMPLETED|Follow-up Period||37||
59856058|NCT00086580|75980669|FG001|COMPLETED|Follow-up Period||18||
59856059|NCT00086580|75980668|FG000|NOT COMPLETED|Follow-up Period||104||
59856060|NCT00086580|75980669|FG001|NOT COMPLETED|Follow-up Period||119||
59856061|NCT00086580|75980668|FG000|STARTED|Observation Period||95||
59856062|NCT00086580|75980669|FG001|STARTED|Observation Period||121||
59856063|NCT00086580|75980668|FG000|COMPLETED|Observation Period||49||
59856064|NCT00086580|75980669|FG001|COMPLETED|Observation Period||56||
59856065|NCT00086580|75980668|FG000|NOT COMPLETED|Observation Period||46||
59856066|NCT00086580|75980669|FG001|NOT COMPLETED|Observation Period||65||
59856067|NCT00086502|75980677|FG000|STARTED|Overall Study||175||
59856068|NCT00086502|75980678|FG001|STARTED|Overall Study||178||
59856069|NCT00086502|75980677|FG000|COMPLETED|Overall Study||149||
59856070|NCT00086502|75980678|FG001|COMPLETED|Overall Study||158||
59856071|NCT00086502|75980677|FG000|NOT COMPLETED|Overall Study||26||
59856072|NCT00086502|75980678|FG001|NOT COMPLETED|Overall Study||20||
59856073|NCT03826667|75980684|FG000|STARTED|Overall Study||464||467
59856074|NCT03826667|75980684|FG000|HEALICOIL™ PK Preloaded Suture Anchors|Overall Study||193|Type of suture anchor received at start|193
59856075|NCT03826667|75980684|FG000|BIORAPTOR™ 2.3 PK Suture Anchors/BIORAPTOR™ Curved 2.3 PK Suture Anchors|Overall Study||41|Type of suture anchor received at start|41
59856076|NCT03826667|75980684|FG000|MULTIFIX™ S Ultra Knotless Fixation System|Overall Study||78|Type of suture anchor received at start|78
59726181|NCT00916149|75845011|FG002|NOT COMPLETED|Overall Study||0||
59726182|NCT01090427|75845021|FG000|STARTED|Controlled Period||37||
59726183|NCT01090427|75845022|FG001|STARTED|Controlled Period||37||
59726184|NCT01090427|75845023|FG002|STARTED|Controlled Period||36||
59726185|NCT01090427|75845024|FG003|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0||
59726186|NCT01090427|75845025|FG004|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0||
59856077|NCT03826667|75980684|FG000|FOOTPRINT™ Ultra PK Suture Anchors|Overall Study||136|Type of suture anchor received at start|138
59856078|NCT03826667|75980684|FG000|TWINFIX™ Ultra PK Suture Anchors/TWINFIX™ Ultra Preloaded and With Needles|Overall Study||57|Type of suture anchor received at start|57
59856079|NCT03826667|75980684|FG000|SPEEDSCREW™ Knotless Fixation System|Overall Study||59|Type of suture anchor received at start|59
59856080|NCT03826667|75980684|FG000|SpeedLock Knotless Fixation Device|Overall Study||18|Type of suture anchor received at start|18
59856081|NCT03826667|75980684|FG000|COMPLETED|Overall Study||443||446
59856082|NCT03826667|75980684|FG000|NOT COMPLETED|Overall Study||21||21
59856083|NCT03636542|75980696|FG000|STARTED|Overall Study||12||
59856084|NCT03636542|75980697|FG001|STARTED|Overall Study||14||
59856085|NCT03636542|75980696|FG000|COMPLETED|Overall Study||10||
59856086|NCT03636542|75980697|FG001|COMPLETED|Overall Study||12||
59856087|NCT03636542|75980696|FG000|NOT COMPLETED|Overall Study||2||
59856088|NCT03636542|75980697|FG001|NOT COMPLETED|Overall Study||2||
59856089|NCT03305770|75980705|FG000|STARTED|Overall Study||70|All randomized subjects|140
59856090|NCT03305770|75980706|FG001|STARTED|Overall Study||37|All randomized subjects|74
59856091|NCT03305770|75980705|FG000|Enrolled Dispensed Analysis Set|Overall Study||70|Enrolled subjects/eyes exposed to study lenses|140
59856092|NCT03305770|75980706|FG001|Enrolled Dispensed Analysis Set|Overall Study||36|Enrolled subjects/eyes exposed to study lenses|72
59856093|NCT03305770|75980705|FG000|Completed Analysis Set|Overall Study||69|Subjects/eyes in the Enrolled Dispensed set that completed the study|138
59856094|NCT03305770|75980706|FG001|Completed Analysis Set|Overall Study||36|Subjects/eyes in the Enrolled Dispensed set that completed the study|72
60121796|NCT03028948|76242805|FG001|STARTED|8 Week Follow-up||217||
60121797|NCT03028948|76242804|FG000|COMPLETED|8 Week Follow-up||198||
60121798|NCT03028948|76242805|FG001|COMPLETED|8 Week Follow-up||215||
59726187|NCT01090427|75845026|FG005|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0||
59726188|NCT01090427|75845027|FG006|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0||
59726189|NCT01090427|75845021|FG000|COMPLETED|Controlled Period||37||
59726190|NCT01090427|75845022|FG001|COMPLETED|Controlled Period||37||
59726191|NCT01090427|75845023|FG002|COMPLETED|Controlled Period||36||
59726192|NCT01090427|75845024|FG003|COMPLETED|Controlled Period||0||
59726193|NCT01090427|75845025|FG004|COMPLETED|Controlled Period||0||
59856095|NCT03305770|75980705|FG000|COMPLETED|Overall Study||69||138
59856096|NCT03305770|75980706|FG001|COMPLETED|Overall Study||36||72
59856097|NCT03305770|75980705|FG000|NOT COMPLETED|Overall Study||1||2
59856098|NCT03305770|75980706|FG001|NOT COMPLETED|Overall Study||1||2
59856099|NCT00086190|75980717|FG000|STARTED|Overall Study||42||
59856100|NCT00086190|75980718|FG001|STARTED|Overall Study||34||
59856101|NCT00086190|75980719|FG002|STARTED|Overall Study||39||
59856102|NCT00086190|75980717|FG000|COMPLETED|Overall Study||34||
60121799|NCT03028948|76242804|FG000|NOT COMPLETED|8 Week Follow-up||26||
60121800|NCT03028948|76242805|FG001|NOT COMPLETED|8 Week Follow-up||2||
59726194|NCT01090427|75845026|FG005|COMPLETED|Controlled Period||0||
59726195|NCT01090427|75845027|FG006|COMPLETED|Controlled Period||0||
60121801|NCT03028948|76242804|FG000|STARTED|24 Week Follow-up||224||
60121802|NCT03028948|76242805|FG001|STARTED|24 Week Follow-up||217||
59856103|NCT00086190|75980718|FG001|COMPLETED|Overall Study||30||
59856104|NCT00086190|75980719|FG002|COMPLETED|Overall Study||33||
59856105|NCT00086190|75980717|FG000|NOT COMPLETED|Overall Study||8||
59856106|NCT00086190|75980718|FG001|NOT COMPLETED|Overall Study||4||
59856107|NCT00086190|75980719|FG002|NOT COMPLETED|Overall Study||6||
59856108|NCT03320824|75980729|FG000|STARTED|Overall Study||184||
59856109|NCT03320824|75980730|FG001|STARTED|Overall Study||89||
59856110|NCT03320824|75980729|FG000|COMPLETED|Overall Study||166||
59856111|NCT03320824|75980730|FG001|COMPLETED|Overall Study||85||
59856112|NCT03320824|75980729|FG000|NOT COMPLETED|Overall Study||18||
59856113|NCT03320824|75980730|FG001|NOT COMPLETED|Overall Study||4||
59856114|NCT01760291|75980736|FG000|STARTED|Overall Study||576||
59856115|NCT01760291|75980736|FG000|COMPLETED|Overall Study||340||
59856116|NCT01760291|75980736|FG000|NOT COMPLETED|Overall Study||236||
59856117|NCT03275350|75980742|FG000|STARTED|Overall Study||55||
59856118|NCT03275350|75980743|FG001|STARTED|Overall Study||59||
59856119|NCT03275350|75980742|FG000|COMPLETED|Overall Study||47||
59856120|NCT03275350|75980743|FG001|COMPLETED|Overall Study||51||
59856121|NCT03275350|75980742|FG000|NOT COMPLETED|Overall Study||8||
59856122|NCT03275350|75980743|FG001|NOT COMPLETED|Overall Study||8||
59856123|NCT03319732|75980750|FG000|STARTED|Overall Study||323||
59856124|NCT03319732|75980750|FG000|COMPLETED|Overall Study||218||
59856125|NCT03319732|75980750|FG000|NOT COMPLETED|Overall Study||105||
59856126|NCT03304522|75980757|FG000|STARTED|Overall Study||46||
59856127|NCT03304522|75980758|FG001|STARTED|Overall Study||43||
59856128|NCT03304522|75980757|FG000|COMPLETED|Overall Study||45||
59856129|NCT03304522|75980758|FG001|COMPLETED|Overall Study||35||
59856130|NCT03304522|75980757|FG000|NOT COMPLETED|Overall Study||1||
59856131|NCT03304522|75980758|FG001|NOT COMPLETED|Overall Study||8||
59856132|NCT03315286|75980766|FG000|STARTED|Overall Study||50||
59856133|NCT03315286|75980767|FG001|STARTED|Overall Study||47||
59856134|NCT03315286|75980766|FG000|COMPLETED|Overall Study||49||
59856135|NCT03315286|75980767|FG001|COMPLETED|Overall Study||43||
59856136|NCT03315286|75980766|FG000|NOT COMPLETED|Overall Study||1||
59856137|NCT03315286|75980767|FG001|NOT COMPLETED|Overall Study||4||
59856138|NCT03273946|75980773|FG000|STARTED|Overall Study||158||
59856139|NCT03273946|75980773|FG000|COMPLETED|Overall Study||149||
59856140|NCT03273946|75980773|FG000|NOT COMPLETED|Overall Study||9||
59856141|NCT00314951|75980779|FG000|STARTED|Enrollment||323||
59856142|NCT00314951|75980780|FG001|STARTED|Enrollment||306||
59856143|NCT00314951|75980779|FG000|COMPLETED|Enrollment|6 subjects took incorrect treatment assignment, 6 subjects didn't take drug|323||
59856144|NCT00314951|75980780|FG001|COMPLETED|Enrollment|6 subjects took incorrect treatment assignment, 6 subjects didn't take drug|300||
59856145|NCT00314951|75980779|FG000|NOT COMPLETED|Enrollment||0||
59856146|NCT00314951|75980780|FG001|NOT COMPLETED|Enrollment||6||
59856147|NCT00314951|75980779|FG000|STARTED|Treatment||323||
59856148|NCT00314951|75980780|FG001|STARTED|Treatment||300||
59856149|NCT00314951|75980779|FG000|COMPLETED|Treatment||307||
59856150|NCT00314951|75980780|FG001|COMPLETED|Treatment||289||
59856151|NCT00314951|75980779|FG000|NOT COMPLETED|Treatment||16||
59856152|NCT00314951|75980780|FG001|NOT COMPLETED|Treatment||11||
59856153|NCT00314951|75980779|FG000|STARTED|Follow-up||307||
59856154|NCT00314951|75980780|FG001|STARTED|Follow-up||289||
59856155|NCT00314951|75980779|FG000|COMPLETED|Follow-up||263||
59856156|NCT00314951|75980780|FG001|COMPLETED|Follow-up||255||
59856157|NCT00314951|75980779|FG000|NOT COMPLETED|Follow-up||44||
59856158|NCT00314951|75980780|FG001|NOT COMPLETED|Follow-up||34||
59856159|NCT00085644|75980788|FG000|STARTED|Double-Blind Period||208||
59856160|NCT00085644|75980789|FG001|STARTED|Double-Blind Period||107||
59856161|NCT00085644|75980790|FG002|STARTED|Double-Blind Period|This treatment group is not applicable to the Double-Blind Period.|0||
59856162|NCT00085644|75980788|FG000|COMPLETED|Double-Blind Period||195||
59856163|NCT00085644|75980789|FG001|COMPLETED|Double-Blind Period||101||
59856164|NCT00085644|75980790|FG002|COMPLETED|Double-Blind Period||0||
59856165|NCT00085644|75980788|FG000|NOT COMPLETED|Double-Blind Period||13||
59856166|NCT00085644|75980789|FG001|NOT COMPLETED|Double-Blind Period||6||
59856167|NCT00085644|75980790|FG002|NOT COMPLETED|Double-Blind Period||0||
59856168|NCT00085644|75980788|FG000|STARTED|Open-Label Period|This treatment group is not applicable to the Open-Label Period.|0||
59856169|NCT00085644|75980789|FG001|STARTED|Open-Label Period|This treatment group is not applicable to the Open-Label Period.|0||
59856170|NCT00085644|75980790|FG002|STARTED|Open-Label Period|1 subject who discontinued for personal reasons subsequently died 450 days after last dose.|311||
59856171|NCT00085644|75980788|FG000|COMPLETED|Open-Label Period||0||
59856172|NCT00085644|75980789|FG001|COMPLETED|Open-Label Period||0||
59856173|NCT00085644|75980790|FG002|COMPLETED|Open-Label Period||202||
59856174|NCT00085644|75980788|FG000|NOT COMPLETED|Open-Label Period||0||
59856175|NCT00085644|75980789|FG001|NOT COMPLETED|Open-Label Period||0||
59856176|NCT00085644|75980790|FG002|NOT COMPLETED|Open-Label Period||109||
59856177|NCT03315208|75980799|FG000|STARTED|Overall Study||29||
59856178|NCT03315208|75980800|FG001|STARTED|Overall Study||18||
59856179|NCT03315208|75980799|FG000|COMPLETED|Overall Study||16||
59856180|NCT03315208|75980800|FG001|COMPLETED|Overall Study||12||
59856181|NCT03315208|75980799|FG000|NOT COMPLETED|Overall Study||13||
59856182|NCT03315208|75980800|FG001|NOT COMPLETED|Overall Study||6||
59856183|NCT00314795|75980807|FG000|STARTED|Overall Study||22||
59856184|NCT00314795|75980807|FG000|COMPLETED|Overall Study||2||
59856185|NCT00314795|75980807|FG000|NOT COMPLETED|Overall Study||20||
59856186|NCT00314327|75980811|FG000|STARTED|Overall Study||1||
59856187|NCT00314327|75980811|FG000|COMPLETED|Overall Study||0||
59856188|NCT00314327|75980811|FG000|NOT COMPLETED|Overall Study||1||
59856189|NCT00336479|75980819|FG000|STARTED|Overall Study||75||
59856190|NCT00336479|75980820|FG001|STARTED|Overall Study||79||
59856191|NCT00336479|75980821|FG002|STARTED|Overall Study||79||
59856192|NCT00336479|75980822|FG003|STARTED|Overall Study||17||
59856193|NCT00336479|75980819|FG000|COMPLETED|Overall Study||38||
59856194|NCT00336479|75980820|FG001|COMPLETED|Overall Study||54||
59856195|NCT00336479|75980821|FG002|COMPLETED|Overall Study||53||
59856196|NCT00336479|75980822|FG003|COMPLETED|Overall Study||13||
59856197|NCT00336479|75980819|FG000|NOT COMPLETED|Overall Study||37||
59856198|NCT00336479|75980820|FG001|NOT COMPLETED|Overall Study||25||
59856199|NCT00336479|75980821|FG002|NOT COMPLETED|Overall Study||26||
59856200|NCT00336479|75980822|FG003|NOT COMPLETED|Overall Study||4||
59856201|NCT00314249|75980835|FG000|STARTED|Overall Study||509||
59856202|NCT00314249|75980836|FG001|STARTED|Overall Study||516||
59856203|NCT00314249|75980835|FG000|COMPLETED|Overall Study||357||
59856204|NCT00314249|75980836|FG001|COMPLETED|Overall Study||353||
59856205|NCT00314249|75980835|FG000|NOT COMPLETED|Overall Study||152||
59856206|NCT00314249|75980836|FG001|NOT COMPLETED|Overall Study||163||
59856207|NCT03315130|75980845|FG000|STARTED|Main Portion (12 Weeks)||15||
59856208|NCT03315130|75980846|FG001|STARTED|Main Portion (12 Weeks)||15||
59856209|NCT03315130|75980847|FG002|STARTED|Main Portion (12 Weeks)||15||
59856210|NCT03315130|75980848|FG003|STARTED|Main Portion (12 Weeks)||0||
59856211|NCT03315130|75980845|FG000|COMPLETED|Main Portion (12 Weeks)||15||
59856212|NCT03315130|75980846|FG001|COMPLETED|Main Portion (12 Weeks)||13||
59856213|NCT03315130|75980847|FG002|COMPLETED|Main Portion (12 Weeks)||15||
59856214|NCT03315130|75980848|FG003|COMPLETED|Main Portion (12 Weeks)||0||
59856215|NCT03315130|75980845|FG000|NOT COMPLETED|Main Portion (12 Weeks)||0||
59856216|NCT03315130|75980846|FG001|NOT COMPLETED|Main Portion (12 Weeks)||2||
59856217|NCT03315130|75980847|FG002|NOT COMPLETED|Main Portion (12 Weeks)||0||
59856218|NCT03315130|75980848|FG003|NOT COMPLETED|Main Portion (12 Weeks)||0||
59856219|NCT03315130|75980845|FG000|STARTED|EP:Before Switch to 0.3 mg/kg(Week13-48)|(15 [who received RA101495 0.1 mg/kg] + 7 [crossover from placebo])|22||
59856220|NCT03315130|75980846|FG001|STARTED|EP:Before Switch to 0.3 mg/kg(Week13-48)|(14 [who received RA101495 0.3 mg/kg + 7 [crossover from placebo] + 1 [Subject who withdrew consent in Main Portion rejoined])|21||
59856221|NCT03315130|75980847|FG002|STARTED|EP:Before Switch to 0.3 mg/kg(Week13-48)||0||
59856222|NCT03315130|75980848|FG003|STARTED|EP:Before Switch to 0.3 mg/kg(Week13-48)||0||
59856223|NCT03315130|75980845|FG000|COMPLETED|EP:Before Switch to 0.3 mg/kg(Week13-48)||21||
59856224|NCT03315130|75980846|FG001|COMPLETED|EP:Before Switch to 0.3 mg/kg(Week13-48)||21||
59856225|NCT03315130|75980847|FG002|COMPLETED|EP:Before Switch to 0.3 mg/kg(Week13-48)||0||
59856226|NCT03315130|75980848|FG003|COMPLETED|EP:Before Switch to 0.3 mg/kg(Week13-48)||0||
59856227|NCT03315130|75980845|FG000|NOT COMPLETED|EP:Before Switch to 0.3 mg/kg(Week13-48)||1||
59856228|NCT03315130|75980846|FG001|NOT COMPLETED|EP:Before Switch to 0.3 mg/kg(Week13-48)||0||
59856229|NCT03315130|75980847|FG002|NOT COMPLETED|EP:Before Switch to 0.3 mg/kg(Week13-48)||0||
59856230|NCT03315130|75980848|FG003|NOT COMPLETED|EP:Before Switch to 0.3 mg/kg(Week13-48)||0||
59856231|NCT03315130|75980845|FG000|STARTED|EP:After Switch to 0.3 mg/kg(Week48-122)||0||
59856232|NCT03315130|75980846|FG001|STARTED|EP:After Switch to 0.3 mg/kg(Week48-122)||21||
59591691|NCT02799290|75699715|FG001|STARTED|Overall Study||13||15
59591692|NCT02799290|75699716|FG002|STARTED|Overall Study||11||13
59591693|NCT02799290|75699714|FG000|COMPLETED|Overall Study||24||28
59726196|NCT01090427|75845021|FG000|NOT COMPLETED|Controlled Period||0||
59591694|NCT02799290|75699715|FG001|COMPLETED|Overall Study||13||15
59591695|NCT02799290|75699716|FG002|COMPLETED|Overall Study||11||13
59591696|NCT02799290|75699714|FG000|NOT COMPLETED|Overall Study||0||0
59591697|NCT02799290|75699715|FG001|NOT COMPLETED|Overall Study||0||0
59591698|NCT02799290|75699716|FG002|NOT COMPLETED|Overall Study||0||0
59591699|NCT02800148|75699731|FG000|STARTED|Overall Study||224||
59591700|NCT02800148|75699732|FG001|STARTED|Overall Study||224||
59591701|NCT02800148|75699733|FG002|STARTED|Overall Study||219||
59591702|NCT02800148|75699731|FG000|COMPLETED|Overall Study||199||
59591703|NCT02800148|75699732|FG001|COMPLETED|Overall Study||204||
59591704|NCT02800148|75699733|FG002|COMPLETED|Overall Study||194||
59591705|NCT02800148|75699731|FG000|NOT COMPLETED|Overall Study||25||
59591706|NCT02800148|75699732|FG001|NOT COMPLETED|Overall Study||20||
59591707|NCT02800148|75699733|FG002|NOT COMPLETED|Overall Study||25||
59591708|NCT03008707|75699743|FG000|STARTED|Overall Study||28||
59591709|NCT03008707|75699744|FG001|STARTED|Overall Study||38||
59591710|NCT03008707|75699743|FG000|COMPLETED|Overall Study||28||
59726197|NCT01090427|75845022|FG001|NOT COMPLETED|Controlled Period||0||
59726198|NCT01090427|75845023|FG002|NOT COMPLETED|Controlled Period||0||
59726199|NCT01090427|75845024|FG003|NOT COMPLETED|Controlled Period||0||
59726200|NCT01090427|75845025|FG004|NOT COMPLETED|Controlled Period||0||
59726201|NCT01090427|75845026|FG005|NOT COMPLETED|Controlled Period||0||
59726202|NCT01090427|75845027|FG006|NOT COMPLETED|Controlled Period||0||
59726203|NCT01090427|75845021|FG000|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0||
59856233|NCT03315130|75980847|FG002|STARTED|EP:After Switch to 0.3 mg/kg(Week48-122)||0||
59856234|NCT03315130|75980848|FG003|STARTED|EP:After Switch to 0.3 mg/kg(Week48-122)||21||
59856235|NCT03315130|75980845|FG000|COMPLETED|EP:After Switch to 0.3 mg/kg(Week48-122)||0||
59856236|NCT03315130|75980846|FG001|COMPLETED|EP:After Switch to 0.3 mg/kg(Week48-122)||17||
59856237|NCT03315130|75980847|FG002|COMPLETED|EP:After Switch to 0.3 mg/kg(Week48-122)||0||
59856238|NCT03315130|75980848|FG003|COMPLETED|EP:After Switch to 0.3 mg/kg(Week48-122)||20||
59856239|NCT03315130|75980845|FG000|NOT COMPLETED|EP:After Switch to 0.3 mg/kg(Week48-122)||0||
59856240|NCT03315130|75980846|FG001|NOT COMPLETED|EP:After Switch to 0.3 mg/kg(Week48-122)||4||
59856241|NCT03315130|75980847|FG002|NOT COMPLETED|EP:After Switch to 0.3 mg/kg(Week48-122)||0||
59856242|NCT03315130|75980848|FG003|NOT COMPLETED|EP:After Switch to 0.3 mg/kg(Week48-122)||1||
59856243|NCT03273166|75980868|FG000|STARTED|Overall Study||82||
59856244|NCT03273166|75980868|FG000|COMPLETED|Overall Study||51||
59856245|NCT03273166|75980868|FG000|NOT COMPLETED|Overall Study||31||
59856246|NCT03314662|75980876|FG000|STARTED|Overall Study||889||
59856247|NCT03314662|75980877|FG001|STARTED|Overall Study||445||
59856248|NCT03314662|75980878|FG002|STARTED|Overall Study||444||
59856249|NCT03314662|75980876|FG000|Treated|Overall Study||888||
59856250|NCT03314662|75980877|FG001|Treated|Overall Study||444||
59856251|NCT03314662|75980878|FG002|Treated|Overall Study||444||
59856252|NCT03314662|75980876|FG000|COMPLETED|Overall Study||881||
59856253|NCT03314662|75980877|FG001|COMPLETED|Overall Study||440||
59856254|NCT03314662|75980878|FG002|COMPLETED|Overall Study||439||
59856255|NCT03314662|75980876|FG000|NOT COMPLETED|Overall Study||8||
59856256|NCT03314662|75980877|FG001|NOT COMPLETED|Overall Study||5||
59856257|NCT03314662|75980878|FG002|NOT COMPLETED|Overall Study||5||
59856258|NCT03271528|75980896|FG000|STARTED|Medication Dispense/Exposure Period 1||13||
59856259|NCT03271528|75980897|FG001|STARTED|Medication Dispense/Exposure Period 1||14||
59856260|NCT03271528|75980896|FG000|COMPLETED|Medication Dispense/Exposure Period 1||11||
59856261|NCT03271528|75980897|FG001|COMPLETED|Medication Dispense/Exposure Period 1||12||
59856262|NCT03271528|75980896|FG000|NOT COMPLETED|Medication Dispense/Exposure Period 1||2||
59856263|NCT03271528|75980897|FG001|NOT COMPLETED|Medication Dispense/Exposure Period 1||2||
59856264|NCT03271528|75980896|FG000|STARTED|Alcohol Trial 1, Washout Period 1||11||
59856265|NCT03271528|75980897|FG001|STARTED|Alcohol Trial 1, Washout Period 1||12||
59856266|NCT03271528|75980896|FG000|COMPLETED|Alcohol Trial 1, Washout Period 1||9||
59856267|NCT03271528|75980897|FG001|COMPLETED|Alcohol Trial 1, Washout Period 1||11||
59856268|NCT03271528|75980896|FG000|NOT COMPLETED|Alcohol Trial 1, Washout Period 1||2||
59856269|NCT03271528|75980897|FG001|NOT COMPLETED|Alcohol Trial 1, Washout Period 1||1||
59856270|NCT03271528|75980896|FG000|STARTED|Medication Dispense/Exposure Period 2||9||
59856271|NCT03271528|75980897|FG001|STARTED|Medication Dispense/Exposure Period 2||11||
59856272|NCT03271528|75980896|FG000|COMPLETED|Medication Dispense/Exposure Period 2||8||
59856273|NCT03271528|75980897|FG001|COMPLETED|Medication Dispense/Exposure Period 2||11||
59856274|NCT03271528|75980896|FG000|NOT COMPLETED|Medication Dispense/Exposure Period 2||1||
59856275|NCT03271528|75980897|FG001|NOT COMPLETED|Medication Dispense/Exposure Period 2||0||
59856276|NCT03271528|75980896|FG000|STARTED|Alcohol Self-Administration Trial 2||8||
59856277|NCT03271528|75980897|FG001|STARTED|Alcohol Self-Administration Trial 2||11||
59856278|NCT03271528|75980896|FG000|COMPLETED|Alcohol Self-Administration Trial 2||8||
59856279|NCT03271528|75980897|FG001|COMPLETED|Alcohol Self-Administration Trial 2||11||
59856280|NCT03271528|75980896|FG000|NOT COMPLETED|Alcohol Self-Administration Trial 2||0||
59856281|NCT03271528|75980897|FG001|NOT COMPLETED|Alcohol Self-Administration Trial 2||0||
59856282|NCT03301714|75980906|FG000|STARTED|Overall Study||60||
59856283|NCT03301714|75980907|FG001|STARTED|Overall Study||60||
59856284|NCT03301714|75980908|FG002|STARTED|Overall Study||60||
59856285|NCT03301714|75980906|FG000|COMPLETED|Overall Study||50||
59856286|NCT03301714|75980907|FG001|COMPLETED|Overall Study||54||
59856287|NCT03301714|75980908|FG002|COMPLETED|Overall Study||53||
59856288|NCT03301714|75980906|FG000|NOT COMPLETED|Overall Study||10||
59856289|NCT03301714|75980907|FG001|NOT COMPLETED|Overall Study||6||
59856290|NCT03301714|75980908|FG002|NOT COMPLETED|Overall Study||7||
59856291|NCT03299686|75980921|FG000|STARTED|Treatment Epoch||70||
59856292|NCT03299686|75980922|FG001|STARTED|Treatment Epoch||48||
59856293|NCT03299686|75980921|FG000|PD (Pharmacodynamics) Analysis Set|Treatment Epoch||69|All subjects with available PD data, who received any study drug, and no major protocol deviations|
59856294|NCT03299686|75980922|FG001|PD (Pharmacodynamics) Analysis Set|Treatment Epoch||48|All subjects with available PD data, who received any study drug, and no major protocol deviations|
59856295|NCT03299686|75980921|FG000|COMPLETED|Treatment Epoch||59||
59856296|NCT03299686|75980922|FG001|COMPLETED|Treatment Epoch||44||
59856297|NCT03299686|75980921|FG000|NOT COMPLETED|Treatment Epoch||11||
59856298|NCT03299686|75980922|FG001|NOT COMPLETED|Treatment Epoch||4||
60121803|NCT03028948|76242804|FG000|COMPLETED|24 Week Follow-up||189||
60121804|NCT03028948|76242805|FG001|COMPLETED|24 Week Follow-up||207||
59856299|NCT03299686|75980921|FG000|STARTED|Follow-up Epoch||59||
59856300|NCT03299686|75980922|FG001|STARTED|Follow-up Epoch||44||
59856301|NCT03299686|75980921|FG000|COMPLETED|Follow-up Epoch||59||
59856302|NCT03299686|75980922|FG001|COMPLETED|Follow-up Epoch||43||
59856303|NCT03299686|75980921|FG000|NOT COMPLETED|Follow-up Epoch||0||
59856304|NCT03299686|75980922|FG001|NOT COMPLETED|Follow-up Epoch||1||
59856305|NCT03462758|75980930|FG000|STARTED|Overall Study||201||
59856306|NCT03462758|75980931|FG001|STARTED|Overall Study||203||
59856307|NCT03462758|75980930|FG000|COMPLETED|Overall Study||145||
59856308|NCT03462758|75980931|FG001|COMPLETED|Overall Study||149||
59856309|NCT03462758|75980930|FG000|NOT COMPLETED|Overall Study||56||
59856310|NCT03462758|75980931|FG001|NOT COMPLETED|Overall Study||54||
59856311|NCT00075270|75980939|FG000|STARTED|Overall Study||291||
59856312|NCT00075270|75980940|FG001|STARTED|Overall Study||288||
59856313|NCT00075270|75980939|FG000|Missing|Overall Study|These participants have no completion status information recorded on the case report forms.|26||
59856314|NCT00075270|75980940|FG001|Missing|Overall Study|These participants have no completion status information recorded on the case report forms.|13||
59856315|NCT00075270|75980939|FG000|COMPLETED|Overall Study||5||
59856316|NCT00075270|75980940|FG001|COMPLETED|Overall Study||4||
59856317|NCT00075270|75980939|FG000|NOT COMPLETED|Overall Study||286||
59856318|NCT00075270|75980940|FG001|NOT COMPLETED|Overall Study||284||
59856319|NCT00074958|75980947|FG000|STARTED|Overall Study||16||
59856320|NCT00074958|75980947|FG000|COMPLETED|Overall Study||15||
59856321|NCT00074958|75980947|FG000|NOT COMPLETED|Overall Study||1||
59856322|NCT02940574|75980953|FG000|STARTED|From Study Start to 1-month Follow-up||22||
59856323|NCT02940574|75980954|FG001|STARTED|From Study Start to 1-month Follow-up||18||
59856324|NCT02940574|75980953|FG000|COMPLETED|From Study Start to 1-month Follow-up|Discontinued intervention (N=1): self-termination unrelated to treatment|21||
59856325|NCT02940574|75980954|FG001|COMPLETED|From Study Start to 1-month Follow-up|All participants completed, but data from 1 participant was not included in analyses.|18||
59856326|NCT02940574|75980953|FG000|NOT COMPLETED|From Study Start to 1-month Follow-up||1||
59856327|NCT02940574|75980954|FG001|NOT COMPLETED|From Study Start to 1-month Follow-up||0||
59856328|NCT02940574|75980953|FG000|STARTED|1-year Follow-up||21||
59856329|NCT02940574|75980954|FG001|STARTED|1-year Follow-up||18||
59856330|NCT02940574|75980953|FG000|COMPLETED|1-year Follow-up||18||
59856331|NCT02940574|75980954|FG001|COMPLETED|1-year Follow-up||14||
59856332|NCT02940574|75980953|FG000|NOT COMPLETED|1-year Follow-up||3||
59856333|NCT02940574|75980954|FG001|NOT COMPLETED|1-year Follow-up||4||
59856334|NCT03882788|75980966|FG000|STARTED|Overall Study||44||
59856335|NCT03882788|75980967|FG001|STARTED|Overall Study||45||
59856336|NCT03882788|75980966|FG000|COMPLETED|Overall Study||44||
59856337|NCT03882788|75980967|FG001|COMPLETED|Overall Study||45||
59856338|NCT03882788|75980966|FG000|NOT COMPLETED|Overall Study||0||
59856339|NCT03882788|75980967|FG001|NOT COMPLETED|Overall Study||0||
59856340|NCT03760250|75980973|FG000|STARTED|Overall Study||6||
59856341|NCT03760250|75980973|FG000|COMPLETED|Overall Study||4||
59856342|NCT03760250|75980973|FG000|NOT COMPLETED|Overall Study||2||
59856343|NCT03757988|75980977|FG000|STARTED|Overall Study||17||
59856344|NCT03757988|75980977|FG000|COMPLETED|Overall Study||16||
59856345|NCT03757988|75980977|FG000|NOT COMPLETED|Overall Study||1||
59856346|NCT00313781|75980984|FG000|STARTED|Before Crossover||102||
59856347|NCT00313781|75980985|FG001|STARTED|Before Crossover||102||
59856348|NCT00313781|75980986|FG002|STARTED|Before Crossover||0||
59856349|NCT00313781|75980984|FG000|Treated|Before Crossover||97||
59856350|NCT00313781|75980985|FG001|Treated|Before Crossover||102||
59856351|NCT00313781|75980986|FG002|Treated|Before Crossover||0||
59856352|NCT00313781|75980984|FG000|COMPLETED|Before Crossover||27||
59856353|NCT00313781|75980985|FG001|COMPLETED|Before Crossover||23||
59856354|NCT00313781|75980986|FG002|COMPLETED|Before Crossover||0||
59856355|NCT00313781|75980984|FG000|NOT COMPLETED|Before Crossover||75||
59856356|NCT00313781|75980985|FG001|NOT COMPLETED|Before Crossover||79||
59856357|NCT00313781|75980986|FG002|NOT COMPLETED|Before Crossover||0||
59856358|NCT00313781|75980984|FG000|STARTED|After Crossover||0||
59856359|NCT00313781|75980985|FG001|STARTED|After Crossover||0||
59856360|NCT00313781|75980986|FG002|STARTED|After Crossover||37||
59856361|NCT00313781|75980984|FG000|COMPLETED|After Crossover||0||
59856362|NCT00313781|75980985|FG001|COMPLETED|After Crossover||0||
59856363|NCT00313781|75980986|FG002|COMPLETED|After Crossover||10||
59726204|NCT01090427|75845022|FG001|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0||
59856364|NCT00313781|75980984|FG000|NOT COMPLETED|After Crossover||0||
59856365|NCT00313781|75980985|FG001|NOT COMPLETED|After Crossover||0||
59856366|NCT00313781|75980986|FG002|NOT COMPLETED|After Crossover||27||
59726205|NCT01090427|75845023|FG002|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0||
59726206|NCT01090427|75845024|FG003|STARTED|After Controlled Period||19||
59726207|NCT01090427|75845025|FG004|STARTED|After Controlled Period||18||
59726208|NCT01090427|75845026|FG005|STARTED|After Controlled Period||37||
59726209|NCT01090427|75845027|FG006|STARTED|After Controlled Period||36||
59726210|NCT01090427|75845021|FG000|COMPLETED|After Controlled Period||0||
59856367|NCT00368537|75980997|FG000|STARTED|Randomization||281||
59856368|NCT00368537|75980998|FG001|STARTED|Randomization||269||
59856369|NCT00368537|75980997|FG000|COMPLETED|Randomization||268||
59856370|NCT00368537|75980998|FG001|COMPLETED|Randomization||263||
59856371|NCT00368537|75980997|FG000|NOT COMPLETED|Randomization||13||
59856372|NCT00368537|75980998|FG001|NOT COMPLETED|Randomization||6||
59856373|NCT00368537|75980997|FG000|STARTED|Baseline Participants||268||
59856374|NCT00368537|75980998|FG001|STARTED|Baseline Participants||263||
59856375|NCT00368537|75980997|FG000|COMPLETED|Baseline Participants||244||
59856376|NCT00368537|75980998|FG001|COMPLETED|Baseline Participants||239||
59856377|NCT00368537|75980997|FG000|NOT COMPLETED|Baseline Participants||24||
59856378|NCT00368537|75980998|FG001|NOT COMPLETED|Baseline Participants||24||
59856379|NCT00313703|75981008|FG000|STARTED|Overall Study||186||
59856380|NCT00313703|75981009|FG001|STARTED|Overall Study||34||
59856381|NCT00313703|75981010|FG002|STARTED|Overall Study||77||
59856382|NCT00313703|75981011|FG003|STARTED|Overall Study||12||
59856383|NCT00313703|75981008|FG000|COMPLETED|Overall Study|Some subjects lost to follow-up|175||
59856384|NCT00313703|75981009|FG001|COMPLETED|Overall Study|Some subjects lost-to follow-up|32||
59856385|NCT00313703|75981010|FG002|COMPLETED|Overall Study|Some subjects lost-to-follow-up|72||
59856386|NCT00313703|75981011|FG003|COMPLETED|Overall Study|Outcomes not reported due to heterogeneity of this group|0||
59856387|NCT00313703|75981008|FG000|NOT COMPLETED|Overall Study||11||
59856388|NCT00313703|75981009|FG001|NOT COMPLETED|Overall Study||2||
59856389|NCT00313703|75981010|FG002|NOT COMPLETED|Overall Study||5||
59856390|NCT00313703|75981011|FG003|NOT COMPLETED|Overall Study||12||
59856391|NCT00313313|75981024|FG000|STARTED|Overall Study||248||
59856392|NCT00313313|75981025|FG001|STARTED|Overall Study||253||
59856393|NCT00313313|75981026|FG002|STARTED|Overall Study||267||
59856394|NCT00313313|75981024|FG000|COMPLETED|Overall Study|61 subjects completed the study without being rescued|185||
59856395|NCT00313313|75981025|FG001|COMPLETED|Overall Study|55 subjects completed the study without being rescued|187||
59856396|NCT00313313|75981026|FG002|COMPLETED|Overall Study|26 subjects completed the study without being rescued|185||
59856397|NCT00313313|75981024|FG000|NOT COMPLETED|Overall Study||63||
59856398|NCT00313313|75981025|FG001|NOT COMPLETED|Overall Study||66||
59856399|NCT00313313|75981026|FG002|NOT COMPLETED|Overall Study||82||
59856400|NCT00312845|75981036|FG000|STARTED|Overall Study||336||
59856401|NCT00312845|75981037|FG001|STARTED|Overall Study||340||
59856402|NCT00312845|75981036|FG000|COMPLETED|Overall Study||237||
59856403|NCT00312845|75981037|FG001|COMPLETED|Overall Study||245||
59856404|NCT00312845|75981036|FG000|NOT COMPLETED|Overall Study||99||
59856405|NCT00312845|75981037|FG001|NOT COMPLETED|Overall Study||95||
59856406|NCT00368069|75981045|FG000|STARTED|Overall Study||79||
59856407|NCT00368069|75981046|FG001|STARTED|Overall Study||79||
59856408|NCT00368069|75981045|FG000|COMPLETED|Overall Study||71||
59856409|NCT00368069|75981046|FG001|COMPLETED|Overall Study||72||
59856410|NCT00368069|75981045|FG000|NOT COMPLETED|Overall Study||8||
59856411|NCT00368069|75981046|FG001|NOT COMPLETED|Overall Study||7||
59856412|NCT00367991|75981054|FG000|STARTED|Overall Study||29||
59856413|NCT00367991|75981055|FG001|STARTED|Overall Study||15||
59856414|NCT00367991|75981054|FG000|COMPLETED|Overall Study||27||
59856415|NCT00367991|75981055|FG001|COMPLETED|Overall Study||13||
59856416|NCT00367991|75981054|FG000|NOT COMPLETED|Overall Study||2||
59856417|NCT00367991|75981055|FG001|NOT COMPLETED|Overall Study||2||
59856418|NCT00367835|75981063|FG000|STARTED|Overall Study||138||
59856419|NCT00367835|75981064|FG001|STARTED|Overall Study||79||
59856420|NCT00367835|75981063|FG000|COMPLETED|Overall Study||109||
59856421|NCT00367835|75981064|FG001|COMPLETED|Overall Study||48||
59856422|NCT00367835|75981063|FG000|NOT COMPLETED|Overall Study||29||
59856423|NCT00367835|75981064|FG001|NOT COMPLETED|Overall Study||31||
59856424|NCT03267940|75981076|FG000|STARTED|Run-in Portion (Max. Exposure: 508 Days)||9||
59856425|NCT03267940|75981077|FG001|STARTED|Run-in Portion (Max. Exposure: 508 Days)||9||
59856426|NCT03267940|75981078|FG002|STARTED|Run-in Portion (Max. Exposure: 508 Days)||0||
59856427|NCT03267940|75981079|FG003|STARTED|Run-in Portion (Max. Exposure: 508 Days)||0||
59856428|NCT03267940|75981080|FG004|STARTED|Run-in Portion (Max. Exposure: 508 Days)||0||
59856429|NCT03267940|75981081|FG005|STARTED|Run-in Portion (Max. Exposure: 508 Days)||0||
59856430|NCT03267940|75981076|FG000|Received at Least 1 Dose of Study Drug|Run-in Portion (Max. Exposure: 508 Days)||9||
59856431|NCT03267940|75981077|FG001|Received at Least 1 Dose of Study Drug|Run-in Portion (Max. Exposure: 508 Days)||9||
59856432|NCT03267940|75981078|FG002|Received at Least 1 Dose of Study Drug|Run-in Portion (Max. Exposure: 508 Days)||0||
59856433|NCT03267940|75981079|FG003|Received at Least 1 Dose of Study Drug|Run-in Portion (Max. Exposure: 508 Days)||0||
59856434|NCT03267940|75981080|FG004|Received at Least 1 Dose of Study Drug|Run-in Portion (Max. Exposure: 508 Days)||0||
59856435|NCT03267940|75981081|FG005|Received at Least 1 Dose of Study Drug|Run-in Portion (Max. Exposure: 508 Days)||0||
59856436|NCT03267940|75981076|FG000|COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||1||
59856437|NCT03267940|75981077|FG001|COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||2||
59856438|NCT03267940|75981078|FG002|COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0||
59856439|NCT03267940|75981079|FG003|COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0||
59856440|NCT03267940|75981080|FG004|COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0||
59856441|NCT03267940|75981081|FG005|COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0||
59856442|NCT03267940|75981076|FG000|NOT COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||8||
59856443|NCT03267940|75981077|FG001|NOT COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||7||
59856444|NCT03267940|75981078|FG002|NOT COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0||
59856445|NCT03267940|75981079|FG003|NOT COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0||
59856446|NCT03267940|75981080|FG004|NOT COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0||
59856447|NCT03267940|75981081|FG005|NOT COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0||
59856448|NCT03267940|75981076|FG000|STARTED|Expansion (Maximum Exposure: 421 Days)||0||
59856449|NCT03267940|75981077|FG001|STARTED|Expansion (Maximum Exposure: 421 Days)||0||
60121805|NCT03028948|76242804|FG000|NOT COMPLETED|24 Week Follow-up||35||
60121806|NCT03028948|76242805|FG001|NOT COMPLETED|24 Week Follow-up||10||
60121807|NCT03028948|76242804|FG000|STARTED|48 Week Follow-up||224||
59591711|NCT03008707|75699744|FG001|COMPLETED|Overall Study||38||
59591712|NCT03008707|75699743|FG000|NOT COMPLETED|Overall Study||0||
59591713|NCT03008707|75699744|FG001|NOT COMPLETED|Overall Study||0||
59591714|NCT02801006|75699750|FG000|STARTED|Lens 1||22||44
59591715|NCT02801006|75699751|FG001|STARTED|Lens 1||19||38
59591716|NCT02801006|75699750|FG000|COMPLETED|Lens 1||22||44
59591717|NCT02801006|75699751|FG001|COMPLETED|Lens 1||19||38
59591718|NCT02801006|75699750|FG000|NOT COMPLETED|Lens 1||0||0
59591719|NCT02801006|75699751|FG001|NOT COMPLETED|Lens 1||0||0
59591720|NCT02801006|75699750|FG000|STARTED|Lens 2||22||44
59591721|NCT02801006|75699751|FG001|STARTED|Lens 2||19||38
59591722|NCT02801006|75699750|FG000|COMPLETED|Lens 2||22||44
59591723|NCT02801006|75699751|FG001|COMPLETED|Lens 2||19||38
59591724|NCT02801006|75699750|FG000|NOT COMPLETED|Lens 2||0||0
59591725|NCT02801006|75699751|FG001|NOT COMPLETED|Lens 2||0||0
59591726|NCT02790463|75699761|FG000|STARTED|Overall Study||782||
59591727|NCT02790463|75699762|FG001|STARTED|Overall Study||681||
59591728|NCT02790463|75699761|FG000|COMPLETED|Overall Study||782||
59591729|NCT02790463|75699762|FG001|COMPLETED|Overall Study||372||
59591730|NCT02790463|75699761|FG000|NOT COMPLETED|Overall Study||0||
59591731|NCT02790463|75699762|FG001|NOT COMPLETED|Overall Study||309||
59591732|NCT02791399|75699770|FG000|STARTED|Overall Study||136||
59591733|NCT02791399|75699771|FG001|STARTED|Overall Study||150||
59591734|NCT02791399|75699770|FG000|COMPLETED|Overall Study||123||
59591735|NCT02791399|75699771|FG001|COMPLETED|Overall Study||135||
59591736|NCT02791399|75699770|FG000|NOT COMPLETED|Overall Study||13||
59591737|NCT02791399|75699771|FG001|NOT COMPLETED|Overall Study||15||
59591738|NCT02902081|75699777|FG000|STARTED|Overall Study||38||
59591739|NCT02902081|75699777|FG000|COMPLETED|Overall Study||38||
59591740|NCT02902081|75699777|FG000|NOT COMPLETED|Overall Study||0||
59591741|NCT02801942|75699787|FG000|STARTED|Overall Study||12||
59591742|NCT02801942|75699788|FG001|STARTED|Overall Study||10||
59591743|NCT02801942|75699787|FG000|COMPLETED|Overall Study||12||
59591744|NCT02801942|75699788|FG001|COMPLETED|Overall Study||10||
59591745|NCT02801942|75699787|FG000|NOT COMPLETED|Overall Study||0||
59591746|NCT02801942|75699788|FG001|NOT COMPLETED|Overall Study||0||
59591747|NCT02791945|75699796|FG000|STARTED|Overall Study||14||
59591748|NCT02791945|75699797|FG001|STARTED|Overall Study||16||
59591749|NCT02791945|75699796|FG000|COMPLETED|Overall Study||12||
59591750|NCT02791945|75699797|FG001|COMPLETED|Overall Study||14||
59591751|NCT02791945|75699796|FG000|NOT COMPLETED|Overall Study||2||
59591752|NCT02791945|75699797|FG001|NOT COMPLETED|Overall Study||2||
59591753|NCT02793817|75699805|FG000|STARTED|Overall Study||261||
59591754|NCT02793817|75699806|FG001|STARTED|Overall Study||259||
59591755|NCT02793817|75699805|FG000|COMPLETED|Overall Study||258||
59591756|NCT02793817|75699806|FG001|COMPLETED|Overall Study||254||
59726211|NCT01090427|75845022|FG001|COMPLETED|After Controlled Period||0||
59726212|NCT01090427|75845023|FG002|COMPLETED|After Controlled Period||0||
59726213|NCT01090427|75845024|FG003|COMPLETED|After Controlled Period||17||
59726214|NCT01090427|75845025|FG004|COMPLETED|After Controlled Period||18||
59726215|NCT01090427|75845026|FG005|COMPLETED|After Controlled Period||32||
59726216|NCT01090427|75845027|FG006|COMPLETED|After Controlled Period||34||
59726217|NCT01090427|75845021|FG000|NOT COMPLETED|After Controlled Period||0||
59726218|NCT01090427|75845022|FG001|NOT COMPLETED|After Controlled Period||0||
59726219|NCT01090427|75845023|FG002|NOT COMPLETED|After Controlled Period||0||
59726220|NCT01090427|75845024|FG003|NOT COMPLETED|After Controlled Period||2||
59726221|NCT01090427|75845025|FG004|NOT COMPLETED|After Controlled Period||0||
59591757|NCT02793817|75699805|FG000|NOT COMPLETED|Overall Study||3||
59591758|NCT02793817|75699806|FG001|NOT COMPLETED|Overall Study||5||
59591759|NCT03007394|75699814|FG000|STARTED|Overall Study||118||
59591760|NCT03007394|75699815|FG001|STARTED|Overall Study||154||
59591761|NCT03007394|75699814|FG000|COMPLETED|Overall Study||91||
59591762|NCT03007394|75699815|FG001|COMPLETED|Overall Study||91||
59591763|NCT03007394|75699814|FG000|NOT COMPLETED|Overall Study||27||
59591764|NCT03007394|75699815|FG001|NOT COMPLETED|Overall Study||63||
59591765|NCT02806544|75699821|FG000|STARTED|Overall Study||35||
59591766|NCT02806544|75699821|FG000|COMPLETED|Overall Study||31||
59591767|NCT02806544|75699821|FG000|NOT COMPLETED|Overall Study||4||
59726222|NCT01090427|75845026|FG005|NOT COMPLETED|After Controlled Period||5||
59726223|NCT01090427|75845027|FG006|NOT COMPLETED|After Controlled Period||2||
59726224|NCT02299414|75845041|FG000|STARTED|Overall Study||1208||
59726225|NCT02299414|75845042|FG001|STARTED|Overall Study||1200||
59591768|NCT03008174|75699827|FG000|STARTED|Overall Study||10||
59591769|NCT03008174|75699828|FG001|STARTED|Overall Study||10||
59591770|NCT03008174|75699827|FG000|COMPLETED|Overall Study||7||
59591771|NCT03008174|75699828|FG001|COMPLETED|Overall Study||6||
59591772|NCT03008174|75699827|FG000|NOT COMPLETED|Overall Study||3||
59591773|NCT03008174|75699828|FG001|NOT COMPLETED|Overall Study||4||
59591774|NCT02809430|75699834|FG000|STARTED|Overall Study||90||
59591775|NCT02809430|75699834|FG000|Failed 3-night run-in Because no Evidence of Obstructive Sleep Apnea|Overall Study|14 with CPAP < 3 hours, 5 without evidence of OSA, 9 with evidence of central or complex sleep apnea|28||
59856450|NCT03267940|75981078|FG002|STARTED|Expansion (Maximum Exposure: 421 Days)||24||
59856451|NCT03267940|75981079|FG003|STARTED|Expansion (Maximum Exposure: 421 Days)||22||
59856452|NCT03267940|75981080|FG004|STARTED|Expansion (Maximum Exposure: 421 Days)||11||
59591776|NCT02809430|75699834|FG000|Stopped CPAP During Inpatient Rehabilitation|Overall Study|10 of 62 participants stopped CPAP after the run-in and prior to discharge from IPR|10||
59591777|NCT02809430|75699834|FG000|COMPLETED|Overall Study||52||
59591778|NCT02809430|75699834|FG000|NOT COMPLETED|Overall Study||38||
59591779|NCT03014492|75699843|FG000|STARTED|Overall Study||44||
59591780|NCT03014492|75699844|FG001|STARTED|Overall Study||28||
59591781|NCT03014492|75699843|FG000|COMPLETED|Overall Study||44||
59591782|NCT03014492|75699844|FG001|COMPLETED|Overall Study||28||
59591783|NCT03014492|75699843|FG000|NOT COMPLETED|Overall Study||0||
59591784|NCT03014492|75699844|FG001|NOT COMPLETED|Overall Study||0||
59591785|NCT02928380|75699850|FG000|STARTED|Period 1||13||
59591786|NCT02928380|75699851|FG001|STARTED|Period 1||14||
59591787|NCT02928380|75699852|FG002|STARTED|Period 1||14||
59591788|NCT02928380|75699853|FG003|STARTED|Period 1||14||
59591789|NCT02928380|75699854|FG004|STARTED|Period 1||14||
59591790|NCT02928380|75699855|FG005|STARTED|Period 1||14||
59591791|NCT02928380|75699850|FG000|COMPLETED|Period 1||13||
59591792|NCT02928380|75699851|FG001|COMPLETED|Period 1||14||
59591793|NCT02928380|75699852|FG002|COMPLETED|Period 1||14||
59591794|NCT02928380|75699853|FG003|COMPLETED|Period 1||14||
59591795|NCT02928380|75699854|FG004|COMPLETED|Period 1||14||
59591796|NCT02928380|75699855|FG005|COMPLETED|Period 1||14||
59591797|NCT02928380|75699850|FG000|NOT COMPLETED|Period 1||0||
59591798|NCT02928380|75699851|FG001|NOT COMPLETED|Period 1||0||
59591799|NCT02928380|75699852|FG002|NOT COMPLETED|Period 1||0||
59591800|NCT02928380|75699853|FG003|NOT COMPLETED|Period 1||0||
59591801|NCT02928380|75699854|FG004|NOT COMPLETED|Period 1||0||
59591802|NCT02928380|75699855|FG005|NOT COMPLETED|Period 1||0||
59591803|NCT02928380|75699850|FG000|STARTED|Wash Out Period 1||13||
59591804|NCT02928380|75699851|FG001|STARTED|Wash Out Period 1||14||
59591805|NCT02928380|75699852|FG002|STARTED|Wash Out Period 1||14||
59591806|NCT02928380|75699853|FG003|STARTED|Wash Out Period 1||14||
59591807|NCT02928380|75699854|FG004|STARTED|Wash Out Period 1||14||
59591808|NCT02928380|75699855|FG005|STARTED|Wash Out Period 1||14||
59591809|NCT02928380|75699850|FG000|COMPLETED|Wash Out Period 1||13||
59591810|NCT02928380|75699851|FG001|COMPLETED|Wash Out Period 1||14||
59591811|NCT02928380|75699852|FG002|COMPLETED|Wash Out Period 1||14||
59591812|NCT02928380|75699853|FG003|COMPLETED|Wash Out Period 1||14||
59591813|NCT02928380|75699854|FG004|COMPLETED|Wash Out Period 1||14||
59591814|NCT02928380|75699855|FG005|COMPLETED|Wash Out Period 1||14||
59591815|NCT02928380|75699850|FG000|NOT COMPLETED|Wash Out Period 1||0||
59591816|NCT02928380|75699851|FG001|NOT COMPLETED|Wash Out Period 1||0||
59591817|NCT02928380|75699852|FG002|NOT COMPLETED|Wash Out Period 1||0||
59591818|NCT02928380|75699853|FG003|NOT COMPLETED|Wash Out Period 1||0||
59591819|NCT02928380|75699854|FG004|NOT COMPLETED|Wash Out Period 1||0||
59591820|NCT02928380|75699855|FG005|NOT COMPLETED|Wash Out Period 1||0||
59591821|NCT02928380|75699850|FG000|STARTED|Period 2||13||
59591822|NCT02928380|75699851|FG001|STARTED|Period 2||14||
59591823|NCT02928380|75699852|FG002|STARTED|Period 2||14||
59591824|NCT02928380|75699853|FG003|STARTED|Period 2||14||
59591825|NCT02928380|75699854|FG004|STARTED|Period 2||14||
59591826|NCT02928380|75699855|FG005|STARTED|Period 2||14||
59591827|NCT02928380|75699850|FG000|COMPLETED|Period 2||13||
59591828|NCT02928380|75699851|FG001|COMPLETED|Period 2||14||
59591829|NCT02928380|75699852|FG002|COMPLETED|Period 2||14||
59726226|NCT02299414|75845041|FG000|COMPLETED|Overall Study||1208||
59726227|NCT02299414|75845042|FG001|COMPLETED|Overall Study||1200||
59726228|NCT02299414|75845041|FG000|NOT COMPLETED|Overall Study||0||
59726229|NCT02299414|75845042|FG001|NOT COMPLETED|Overall Study||0||
59726230|NCT01016262|75845051|FG000|STARTED|Double-blind Phase||41||
59726231|NCT01016262|75845052|FG001|STARTED|Double-blind Phase||39||
59726232|NCT01016262|75845053|FG002|STARTED|Double-blind Phase||39||
59726233|NCT01016262|75845054|FG003|STARTED|Double-blind Phase||0||
59856453|NCT03267940|75981081|FG005|STARTED|Expansion (Maximum Exposure: 421 Days)||10||
60121808|NCT03028948|76242805|FG001|STARTED|48 Week Follow-up||217||
59591830|NCT02928380|75699853|FG003|COMPLETED|Period 2||14||
59591831|NCT02928380|75699854|FG004|COMPLETED|Period 2||14||
59726234|NCT01016262|75845055|FG004|STARTED|Double-blind Phase||0||
59591832|NCT02928380|75699855|FG005|COMPLETED|Period 2||14||
59726235|NCT01016262|75845056|FG005|STARTED|Double-blind Phase||0||
59591833|NCT02928380|75699850|FG000|NOT COMPLETED|Period 2||0||
59591834|NCT02928380|75699851|FG001|NOT COMPLETED|Period 2||0||
59591835|NCT02928380|75699852|FG002|NOT COMPLETED|Period 2||0||
59591836|NCT02928380|75699853|FG003|NOT COMPLETED|Period 2||0||
59591837|NCT02928380|75699854|FG004|NOT COMPLETED|Period 2||0||
59591838|NCT02928380|75699855|FG005|NOT COMPLETED|Period 2||0||
59591839|NCT02928380|75699850|FG000|STARTED|Wash Out Period 2||13||
59591840|NCT02928380|75699851|FG001|STARTED|Wash Out Period 2||14||
59591841|NCT02928380|75699852|FG002|STARTED|Wash Out Period 2||14||
59726236|NCT01016262|75845051|FG000|COMPLETED|Double-blind Phase||40||
59591842|NCT02928380|75699853|FG003|STARTED|Wash Out Period 2||14||
59591843|NCT02928380|75699854|FG004|STARTED|Wash Out Period 2||14||
59591844|NCT02928380|75699855|FG005|STARTED|Wash Out Period 2||14||
59591845|NCT02928380|75699850|FG000|COMPLETED|Wash Out Period 2||13||
59591846|NCT02928380|75699851|FG001|COMPLETED|Wash Out Period 2||14||
59591847|NCT02928380|75699852|FG002|COMPLETED|Wash Out Period 2||14||
59591848|NCT02928380|75699853|FG003|COMPLETED|Wash Out Period 2||14||
59591849|NCT02928380|75699854|FG004|COMPLETED|Wash Out Period 2||14||
59591850|NCT02928380|75699855|FG005|COMPLETED|Wash Out Period 2||14||
59591851|NCT02928380|75699850|FG000|NOT COMPLETED|Wash Out Period 2||0||
59591852|NCT02928380|75699851|FG001|NOT COMPLETED|Wash Out Period 2||0||
59591853|NCT02928380|75699852|FG002|NOT COMPLETED|Wash Out Period 2||0||
59591854|NCT02928380|75699853|FG003|NOT COMPLETED|Wash Out Period 2||0||
59591855|NCT02928380|75699854|FG004|NOT COMPLETED|Wash Out Period 2||0||
59591856|NCT02928380|75699855|FG005|NOT COMPLETED|Wash Out Period 2||0||
59591857|NCT02928380|75699850|FG000|STARTED|Period 3||13||
59591858|NCT02928380|75699851|FG001|STARTED|Period 3||14||
59591859|NCT02928380|75699852|FG002|STARTED|Period 3||14||
59591860|NCT02928380|75699853|FG003|STARTED|Period 3||14||
59591861|NCT02928380|75699854|FG004|STARTED|Period 3||14||
59591862|NCT02928380|75699855|FG005|STARTED|Period 3||14||
59591863|NCT02928380|75699850|FG000|COMPLETED|Period 3||13||
59591864|NCT02928380|75699851|FG001|COMPLETED|Period 3||14||
59591865|NCT02928380|75699852|FG002|COMPLETED|Period 3||14||
59591866|NCT02928380|75699853|FG003|COMPLETED|Period 3||14||
59591867|NCT02928380|75699854|FG004|COMPLETED|Period 3||14||
59591868|NCT02928380|75699855|FG005|COMPLETED|Period 3||14||
59591869|NCT02928380|75699850|FG000|NOT COMPLETED|Period 3||0||
59591870|NCT02928380|75699851|FG001|NOT COMPLETED|Period 3||0||
59591871|NCT02928380|75699852|FG002|NOT COMPLETED|Period 3||0||
59591872|NCT02928380|75699853|FG003|NOT COMPLETED|Period 3||0||
59591873|NCT02928380|75699854|FG004|NOT COMPLETED|Period 3||0||
59591874|NCT02928380|75699855|FG005|NOT COMPLETED|Period 3||0||
59591875|NCT02928536|75699866|FG000|STARTED|Overall Study||11902||
59591876|NCT02928536|75699866|FG000|COMPLETED|Overall Study||11902||
59591877|NCT02928536|75699866|FG000|NOT COMPLETED|Overall Study||0||
59591878|NCT02930174|75699872|FG000|STARTED|Overall Study||12||
59591879|NCT02930174|75699873|FG001|STARTED|Overall Study||8||
59591880|NCT02930174|75699872|FG000|COMPLETED|Overall Study||12||
59591881|NCT02930174|75699873|FG001|COMPLETED|Overall Study||8||
59591882|NCT02930174|75699872|FG000|NOT COMPLETED|Overall Study||0||
59591883|NCT02930174|75699873|FG001|NOT COMPLETED|Overall Study||0||
59591884|NCT02933372|75699883|FG000|STARTED|Overall Study||15||
59591885|NCT02933372|75699884|FG001|STARTED|Overall Study||10||
59591886|NCT02933372|75699883|FG000|COMPLETED|Overall Study||15||
59591887|NCT02933372|75699884|FG001|COMPLETED|Overall Study||10||
59591888|NCT02933372|75699883|FG000|NOT COMPLETED|Overall Study||0||
59591889|NCT02933372|75699884|FG001|NOT COMPLETED|Overall Study||0||
59591890|NCT02933450|75699892|FG000|STARTED|Overall Study||20||
59591891|NCT02933450|75699893|FG001|STARTED|Overall Study||23||
59591892|NCT02933450|75699892|FG000|COMPLETED|Overall Study||15||
59591893|NCT02933450|75699893|FG001|COMPLETED|Overall Study||15||
59591894|NCT02933450|75699892|FG000|NOT COMPLETED|Overall Study||5||
59591895|NCT02933450|75699893|FG001|NOT COMPLETED|Overall Study||8||
59591896|NCT02902237|75699899|FG000|STARTED|Overall Study||17||
59591897|NCT02902237|75699899|FG000|COMPLETED|Overall Study|STUDY INITIATION: 2017 03 29, 1st Patient In, STUDY COMPLETION: 2019 11 05, Date of Study End|17||
59591898|NCT02902237|75699899|FG000|NOT COMPLETED|Overall Study||0||
59591899|NCT02903407|75699912|FG000|STARTED|Overall Study||4||
59591900|NCT02903407|75699913|FG001|STARTED|Overall Study||3||
59591901|NCT02903407|75699912|FG000|COMPLETED|Overall Study||4||
59591902|NCT02903407|75699913|FG001|COMPLETED|Overall Study||3||
59591903|NCT02903407|75699912|FG000|NOT COMPLETED|Overall Study||0||
59591904|NCT02903407|75699913|FG001|NOT COMPLETED|Overall Study||0||
59591905|NCT02811302|75699919|FG000|STARTED|Overall Study||1495||
59591906|NCT02811302|75699919|FG000|COMPLETED|Overall Study||1282||
59591907|NCT02811302|75699919|FG000|NOT COMPLETED|Overall Study||213||
59591908|NCT02905981|75699924|FG000|STARTED|Overall Study||1||
59591909|NCT02905981|75699924|FG000|COMPLETED|Overall Study||0||
59591910|NCT02905981|75699924|FG000|NOT COMPLETED|Overall Study||1||
59591911|NCT02907073|75699931|FG000|STARTED|Overall Study||8||
59591912|NCT02907073|75699932|FG001|STARTED|Overall Study||0||
59591913|NCT02907073|75699933|FG002|STARTED|Overall Study||0||
59591914|NCT02907073|75699931|FG000|COMPLETED|Overall Study||8||
59591915|NCT02907073|75699932|FG001|COMPLETED|Overall Study||0||
59591916|NCT02907073|75699933|FG002|COMPLETED|Overall Study||0||
59591917|NCT02907073|75699931|FG000|NOT COMPLETED|Overall Study||0||
59591918|NCT02907073|75699932|FG001|NOT COMPLETED|Overall Study||0||
59591919|NCT02907073|75699933|FG002|NOT COMPLETED|Overall Study||0||
59591920|NCT02812160|75699943|FG000|STARTED|Overall Study||187||
59591921|NCT02812160|75699944|FG001|STARTED|Overall Study||101||
59591922|NCT02812160|75699943|FG000|COMPLETED|Overall Study||187||
59591923|NCT02812160|75699944|FG001|COMPLETED|Overall Study||101||
59591924|NCT02812160|75699943|FG000|NOT COMPLETED|Overall Study||0||
59591925|NCT02812160|75699944|FG001|NOT COMPLETED|Overall Study||0||
59591926|NCT02812238|75699950|FG000|STARTED|First Intervention||19||
59591927|NCT02812238|75699951|FG001|STARTED|First Intervention||19||
59591928|NCT02812238|75699950|FG000|COMPLETED|First Intervention||18||
59591929|NCT02812238|75699951|FG001|COMPLETED|First Intervention||19||
59591930|NCT02812238|75699950|FG000|NOT COMPLETED|First Intervention||1||
59591931|NCT02812238|75699951|FG001|NOT COMPLETED|First Intervention||0||
59591932|NCT02812238|75699950|FG000|STARTED|Second Intervention||18||
59591933|NCT02812238|75699951|FG001|STARTED|Second Intervention||19||
59591934|NCT02812238|75699950|FG000|COMPLETED|Second Intervention||18||
59591935|NCT02812238|75699951|FG001|COMPLETED|Second Intervention||18||
59591936|NCT02812238|75699950|FG000|NOT COMPLETED|Second Intervention||0||
59591937|NCT02812238|75699951|FG001|NOT COMPLETED|Second Intervention||1||
59591938|NCT03015649|75699957|FG000|STARTED|Overall Study||34||
59591939|NCT03015649|75699957|FG000|COMPLETED|Overall Study||34||
59591940|NCT03015649|75699957|FG000|NOT COMPLETED|Overall Study||0||
59591941|NCT03015961|75699963|FG000|STARTED|Overall Study||18||
59591942|NCT03015961|75699964|FG001|STARTED|Overall Study||20||
59591943|NCT03015961|75699963|FG000|COMPLETED|Overall Study||18||
59591944|NCT03015961|75699964|FG001|COMPLETED|Overall Study||18||
59591945|NCT03015961|75699963|FG000|NOT COMPLETED|Overall Study||0||
59591946|NCT03015961|75699964|FG001|NOT COMPLETED|Overall Study||2||
59591947|NCT02814656|75699974|FG000|STARTED|Overall Study||6||
59591948|NCT02814656|75699975|FG001|STARTED|Overall Study||6||
59591949|NCT02814656|75699976|FG002|STARTED|Overall Study||6||
59591950|NCT02814656|75699977|FG003|STARTED|Overall Study||6||
59591951|NCT02814656|75699974|FG000|COMPLETED|Overall Study||6||
59591952|NCT02814656|75699975|FG001|COMPLETED|Overall Study||6||
59591953|NCT02814656|75699976|FG002|COMPLETED|Overall Study||6||
59591954|NCT02814656|75699977|FG003|COMPLETED|Overall Study||6||
59591955|NCT02814656|75699974|FG000|NOT COMPLETED|Overall Study||0||
59591956|NCT02814656|75699975|FG001|NOT COMPLETED|Overall Study||0||
59591957|NCT02814656|75699976|FG002|NOT COMPLETED|Overall Study||0||
59591958|NCT02814656|75699977|FG003|NOT COMPLETED|Overall Study||0||
59591959|NCT03018223|75699987|FG000|STARTED|Overall Study||32||
59591960|NCT03018223|75699987|FG000|COMPLETED|Overall Study||32||
59591961|NCT03018223|75699987|FG000|NOT COMPLETED|Overall Study||0||
59591962|NCT03018925|75699991|FG000|STARTED|Overall Study||15||
59591963|NCT03018925|75699991|FG000|COMPLETED|Overall Study||15||
59591964|NCT03018925|75699991|FG000|NOT COMPLETED|Overall Study||0||
59591965|NCT02814890|75700018|FG000|STARTED|Overall Study||33||
59591966|NCT02814890|75700019|FG001|STARTED|Overall Study||32||
59591967|NCT02814890|75700018|FG000|COMPLETED|Overall Study||30||
59591968|NCT02814890|75700019|FG001|COMPLETED|Overall Study||30||
59591969|NCT02814890|75700018|FG000|NOT COMPLETED|Overall Study||3||
59591970|NCT02814890|75700019|FG001|NOT COMPLETED|Overall Study||2||
59591971|NCT03019783|75700033|FG000|STARTED|Overall Study||29||
59591972|NCT03019783|75700034|FG001|STARTED|Overall Study||31||
59591973|NCT03019783|75700033|FG000|COMPLETED|Overall Study||29||
59591974|NCT03019783|75700034|FG001|COMPLETED|Overall Study||31||
59591975|NCT03019783|75700033|FG000|NOT COMPLETED|Overall Study||0||
59591976|NCT03019783|75700034|FG001|NOT COMPLETED|Overall Study||0||
59591977|NCT02815982|75700044|FG000|STARTED|Overall Study||27||
59591978|NCT02815982|75700045|FG001|STARTED|Overall Study||26||
59591979|NCT02815982|75700046|FG002|STARTED|Overall Study||27||
59591980|NCT02815982|75700047|FG003|STARTED|Overall Study||26||
59591981|NCT02815982|75700044|FG000|COMPLETED|Overall Study||27|All participants completed at least baseline measurements|
59591982|NCT02815982|75700045|FG001|COMPLETED|Overall Study||26|All participants completed at least baseline measurements|
59591983|NCT02815982|75700046|FG002|COMPLETED|Overall Study||27|All participants completed at least baseline measurements|
59591984|NCT02815982|75700047|FG003|COMPLETED|Overall Study||26|All participants completed at least baseline measurements|
59591985|NCT02815982|75700044|FG000|NOT COMPLETED|Overall Study||0||
59591986|NCT02815982|75700045|FG001|NOT COMPLETED|Overall Study||0||
59591987|NCT02815982|75700046|FG002|NOT COMPLETED|Overall Study||0||
59591988|NCT02815982|75700047|FG003|NOT COMPLETED|Overall Study||0||
59726237|NCT01016262|75845052|FG001|COMPLETED|Double-blind Phase||38||
59591989|NCT03019939|75700059|FG000|STARTED|Overall Study||65||
59591990|NCT03019939|75700059|FG000|COMPLETED|Overall Study||65||
59591991|NCT03019939|75700059|FG000|NOT COMPLETED|Overall Study||0||
59591992|NCT03017924|75700065|FG000|STARTED|Overall Study||12||
59591993|NCT03017924|75700066|FG001|STARTED|Overall Study||11||
59591994|NCT03017924|75700065|FG000|COMPLETED|Overall Study||10||
59591995|NCT03017924|75700066|FG001|COMPLETED|Overall Study||8||
59591996|NCT03017924|75700065|FG000|NOT COMPLETED|Overall Study||2||
59591997|NCT03017924|75700066|FG001|NOT COMPLETED|Overall Study||3||
59591998|NCT03020095|75700074|FG000|STARTED|Overall Study||38||
59591999|NCT03020095|75700074|FG000|COMPLETED|Overall Study||37||
59592000|NCT03020095|75700074|FG000|NOT COMPLETED|Overall Study||1||
59592001|NCT02818244|75700082|FG000|STARTED|Overall Study||25||25
59592002|NCT02818244|75700083|FG001|STARTED|Overall Study||25||25
59592003|NCT02818244|75700084|FG002|STARTED|Overall Study||25||25
59592004|NCT02818244|75700085|FG003|STARTED|Overall Study||25||25
59592005|NCT02818244|75700082|FG000|COMPLETED|Overall Study||25||25
59592006|NCT02818244|75700083|FG001|COMPLETED|Overall Study||25||25
59592007|NCT02818244|75700084|FG002|COMPLETED|Overall Study||25||25
59592008|NCT02818244|75700085|FG003|COMPLETED|Overall Study||25||25
59592009|NCT02818244|75700082|FG000|NOT COMPLETED|Overall Study||0||0
59592010|NCT02818244|75700083|FG001|NOT COMPLETED|Overall Study||0||0
59592011|NCT02818244|75700084|FG002|NOT COMPLETED|Overall Study||0||0
59592012|NCT02818244|75700085|FG003|NOT COMPLETED|Overall Study||0||0
59592013|NCT02934698|75700095|FG000|STARTED|Overall Study||2||
59592014|NCT02934698|75700095|FG000|COMPLETED|Overall Study||2||
59592015|NCT02934698|75700095|FG000|NOT COMPLETED|Overall Study||0||
59592016|NCT03019796|75700099|FG000|STARTED|First Intervention Drug Tests||20||
59592017|NCT03019796|75700100|FG001|STARTED|First Intervention Drug Tests||20||
59592018|NCT03019796|75700099|FG000|COMPLETED|First Intervention Drug Tests||20||
59592019|NCT03019796|75700100|FG001|COMPLETED|First Intervention Drug Tests||20||
59592020|NCT03019796|75700099|FG000|NOT COMPLETED|First Intervention Drug Tests||0||
59592021|NCT03019796|75700100|FG001|NOT COMPLETED|First Intervention Drug Tests||0||
59592022|NCT03019796|75700099|FG000|STARTED|Second Intervention Training (4 Months)||20||
59592023|NCT03019796|75700100|FG001|STARTED|Second Intervention Training (4 Months)||20||
59592024|NCT03019796|75700099|FG000|COMPLETED|Second Intervention Training (4 Months)||19||
59592025|NCT03019796|75700100|FG001|COMPLETED|Second Intervention Training (4 Months)||19||
59592026|NCT03019796|75700099|FG000|NOT COMPLETED|Second Intervention Training (4 Months)||1||
59592027|NCT03019796|75700100|FG001|NOT COMPLETED|Second Intervention Training (4 Months)||1||
59592028|NCT03019796|75700099|FG000|STARTED|Third Intervention Drug Test||19||
59592029|NCT03019796|75700100|FG001|STARTED|Third Intervention Drug Test||19||
59592030|NCT03019796|75700099|FG000|COMPLETED|Third Intervention Drug Test||19||
59592031|NCT03019796|75700100|FG001|COMPLETED|Third Intervention Drug Test||19||
59592032|NCT03019796|75700099|FG000|NOT COMPLETED|Third Intervention Drug Test||0||
59592033|NCT03019796|75700100|FG001|NOT COMPLETED|Third Intervention Drug Test||0||
59592034|NCT03020719|75700109|FG000|STARTED|Overall Study||30|Treated defined as having taken at least one dose of study drug.|
59592035|NCT03020719|75700110|FG001|STARTED|Overall Study||30|Treated defined as having taken at least one dose of study drug.|
59592036|NCT03020719|75700109|FG000|COMPLETED|Overall Study||30|Completed last study visit (Week 24).|
59592037|NCT03020719|75700110|FG001|COMPLETED|Overall Study||28|Completed last study visit (Week 24).|
59592038|NCT03020719|75700109|FG000|NOT COMPLETED|Overall Study||0||
59592039|NCT03020719|75700110|FG001|NOT COMPLETED|Overall Study||2||
59592040|NCT02935088|75700116|FG000|STARTED|Overall Study||2217|Subjects consented|
59592041|NCT02935088|75700116|FG000|COMPLETED|Overall Study||2115||
59592042|NCT02935088|75700116|FG000|NOT COMPLETED|Overall Study||102||
59592043|NCT03021343|75700129|FG000|STARTED|Overall Study||179||
59592044|NCT03021343|75700130|FG001|STARTED|Overall Study||181||
59592045|NCT03021343|75700129|FG000|COMPLETED|Overall Study||174||
59592046|NCT03021343|75700130|FG001|COMPLETED|Overall Study||174||
59592047|NCT03021343|75700129|FG000|NOT COMPLETED|Overall Study||5||
59592048|NCT03021343|75700130|FG001|NOT COMPLETED|Overall Study||7||
59592049|NCT03022435|75700141|FG000|STARTED|Overall Study||5||
59592050|NCT03022435|75700142|FG001|STARTED|Overall Study||5||
59592051|NCT03022435|75700143|FG002|STARTED|Overall Study||6||
59592052|NCT03022435|75700144|FG003|STARTED|Overall Study||3||
59592053|NCT03022435|75700145|FG004|STARTED|Overall Study||3||
59592054|NCT03022435|75700141|FG000|COMPLETED|Overall Study||5||
59592055|NCT03022435|75700142|FG001|COMPLETED|Overall Study||5||
59592056|NCT03022435|75700143|FG002|COMPLETED|Overall Study||6||
59592057|NCT03022435|75700144|FG003|COMPLETED|Overall Study||3||
59592058|NCT03022435|75700145|FG004|COMPLETED|Overall Study||3||
59592059|NCT03022435|75700141|FG000|NOT COMPLETED|Overall Study||0||
59592060|NCT03022435|75700142|FG001|NOT COMPLETED|Overall Study||0||
59592061|NCT03022435|75700143|FG002|NOT COMPLETED|Overall Study||0||
59592062|NCT03022435|75700144|FG003|NOT COMPLETED|Overall Study||0||
59592063|NCT03022435|75700145|FG004|NOT COMPLETED|Overall Study||0||
59592064|NCT02936648|75700160|FG000|STARTED|Overall Study||2209||
59592065|NCT02936648|75700160|FG000|COMPLETED|Overall Study||2209||
59592066|NCT02936648|75700160|FG000|NOT COMPLETED|Overall Study||0||
59592067|NCT03023683|75700166|FG000|STARTED|Overall Study||0||
59592068|NCT03023683|75700167|FG001|STARTED|Overall Study||18||
59726238|NCT01016262|75845053|FG002|COMPLETED|Double-blind Phase||30||
59726239|NCT01016262|75845054|FG003|COMPLETED|Double-blind Phase||0||
59726240|NCT01016262|75845055|FG004|COMPLETED|Double-blind Phase||0||
59856454|NCT03267940|75981076|FG000|Received at Least 1 Dose of Study Drug|Expansion (Maximum Exposure: 421 Days)||0||
59856455|NCT03267940|75981077|FG001|Received at Least 1 Dose of Study Drug|Expansion (Maximum Exposure: 421 Days)||0||
59592069|NCT03023683|75700166|FG000|COMPLETED|Overall Study||0||
59592070|NCT03023683|75700167|FG001|COMPLETED|Overall Study||17||
59592071|NCT03023683|75700166|FG000|NOT COMPLETED|Overall Study||0||
59592072|NCT03023683|75700167|FG001|NOT COMPLETED|Overall Study||1||
59592073|NCT03020498|75700176|FG000|STARTED|Overall Study||14||
59592074|NCT03020498|75700177|FG001|STARTED|Overall Study||41||
59592075|NCT03020498|75700178|FG002|STARTED|Overall Study||36||
59592076|NCT03020498|75700176|FG000|COMPLETED|Overall Study||14||
59592077|NCT03020498|75700177|FG001|COMPLETED|Overall Study||38||
59592078|NCT03020498|75700178|FG002|COMPLETED|Overall Study||36||
59592079|NCT03020498|75700176|FG000|NOT COMPLETED|Overall Study||0||
59592080|NCT03020498|75700177|FG001|NOT COMPLETED|Overall Study||3||
59592081|NCT03020498|75700178|FG002|NOT COMPLETED|Overall Study||0||
59592082|NCT03025945|75700188|FG000|STARTED|Overall Study||331||
59592083|NCT03025945|75700189|FG001|STARTED|Overall Study||331||
59592084|NCT03025945|75700188|FG000|COMPLETED|Overall Study||331||
59592085|NCT03025945|75700189|FG001|COMPLETED|Overall Study||331||
59592086|NCT03025945|75700188|FG000|NOT COMPLETED|Overall Study||0||
59592087|NCT03025945|75700189|FG001|NOT COMPLETED|Overall Study||0||
59592088|NCT02937194|75700197|FG000|STARTED|1-year Followup||294||
59592089|NCT02937194|75700198|FG001|STARTED|1-year Followup||286||
59592090|NCT02937194|75700197|FG000|COMPLETED|1-year Followup||223||
59592091|NCT02937194|75700198|FG001|COMPLETED|1-year Followup||218||
59592092|NCT02937194|75700197|FG000|NOT COMPLETED|1-year Followup||71||
59592093|NCT02937194|75700198|FG001|NOT COMPLETED|1-year Followup||68||
59592094|NCT02937194|75700197|FG000|STARTED|2-years Followup|The researchers contacted all the participants recruited/enrolled at baseline at each follow-up regardless if they had participated in the previous follow-up or not. So the number started equals 294 for each follow-up.|294||
59592095|NCT02937194|75700198|FG001|STARTED|2-years Followup|The researchers contacted all the participants recruited/enrolled at baseline at each follow-up regardless if they had participated in the previous follow-up or not. So the number started equals 286 for each follow-up.|286||
59592096|NCT02937194|75700197|FG000|COMPLETED|2-years Followup||216||
59592097|NCT02937194|75700198|FG001|COMPLETED|2-years Followup||208||
59592098|NCT02937194|75700197|FG000|NOT COMPLETED|2-years Followup||78||
59592099|NCT02937194|75700198|FG001|NOT COMPLETED|2-years Followup||78||
59592100|NCT02937194|75700197|FG000|STARTED|3-years Followup|The researchers contacted all the participants recruited/enrolled at baseline at each follow-up regardless if they had participated in the previous follow-up or not. So the number started equals 294 for each follow-up.|294||
59592101|NCT02937194|75700198|FG001|STARTED|3-years Followup|The researchers contacted all the participants recruited/enrolled at baseline at each follow-up regardless if they had participated in the previous follow-up or not. So the number started equals 286 for each follow-up.|286||
59592102|NCT02937194|75700197|FG000|COMPLETED|3-years Followup||228||
59592103|NCT02937194|75700198|FG001|COMPLETED|3-years Followup||208||
59726241|NCT01016262|75845056|FG005|COMPLETED|Double-blind Phase||0||
59726242|NCT01016262|75845051|FG000|NOT COMPLETED|Double-blind Phase||1||
59726243|NCT01016262|75845052|FG001|NOT COMPLETED|Double-blind Phase||1||
59726244|NCT01016262|75845053|FG002|NOT COMPLETED|Double-blind Phase||9||
59726245|NCT01016262|75845054|FG003|NOT COMPLETED|Double-blind Phase||0||
59726246|NCT01016262|75845055|FG004|NOT COMPLETED|Double-blind Phase||0||
59726247|NCT01016262|75845056|FG005|NOT COMPLETED|Double-blind Phase||0||
59726248|NCT01016262|75845051|FG000|STARTED|Open-Label Phase||0||
59856456|NCT03267940|75981078|FG002|Received at Least 1 Dose of Study Drug|Expansion (Maximum Exposure: 421 Days)||24||
59856457|NCT03267940|75981079|FG003|Received at Least 1 Dose of Study Drug|Expansion (Maximum Exposure: 421 Days)||22||
60121809|NCT03028948|76242804|FG000|COMPLETED|48 Week Follow-up||180||
60121810|NCT03028948|76242805|FG001|COMPLETED|48 Week Follow-up||202||
60121811|NCT03028948|76242804|FG000|NOT COMPLETED|48 Week Follow-up||44||
60121812|NCT03028948|76242805|FG001|NOT COMPLETED|48 Week Follow-up||15||
59592104|NCT02937194|75700197|FG000|NOT COMPLETED|3-years Followup||66||
59592105|NCT02937194|75700198|FG001|NOT COMPLETED|3-years Followup||78||
59592106|NCT02937506|75700206|FG000|STARTED|Overall Study||300||
59726249|NCT01016262|75845052|FG001|STARTED|Open-Label Phase||0||
59726250|NCT01016262|75845053|FG002|STARTED|Open-Label Phase||0||
59726251|NCT01016262|75845054|FG003|STARTED|Open-Label Phase||44||
59726252|NCT01016262|75845055|FG004|STARTED|Open-Label Phase||52||
59726253|NCT01016262|75845056|FG005|STARTED|Open-Label Phase||20||
59726254|NCT01016262|75845051|FG000|COMPLETED|Open-Label Phase||0||
59726255|NCT01016262|75845052|FG001|COMPLETED|Open-Label Phase||0||
59726256|NCT01016262|75845053|FG002|COMPLETED|Open-Label Phase||0||
59726257|NCT01016262|75845054|FG003|COMPLETED|Open-Label Phase||42||
59726258|NCT01016262|75845055|FG004|COMPLETED|Open-Label Phase||50||
59726259|NCT01016262|75845056|FG005|COMPLETED|Open-Label Phase||20||
59726260|NCT01016262|75845051|FG000|NOT COMPLETED|Open-Label Phase||0||
59726261|NCT01016262|75845052|FG001|NOT COMPLETED|Open-Label Phase||0||
59726262|NCT01016262|75845053|FG002|NOT COMPLETED|Open-Label Phase||0||
59726263|NCT01016262|75845054|FG003|NOT COMPLETED|Open-Label Phase||2||
59726264|NCT01016262|75845055|FG004|NOT COMPLETED|Open-Label Phase||2||
59726265|NCT01016262|75845056|FG005|NOT COMPLETED|Open-Label Phase||0||
59726266|NCT01001910|75845067|FG000|STARTED|Overall Study|We screened and started 28 patients in the study. However only 22 patients were evaluable for outcome, because 6 patients did not receive adequate number of cycles of treatment for analysis. While we could not evaluate these 6 patients for their outcome, their treatment-cycles were included in the safe analysis.|28||
59726267|NCT01001910|75845067|FG000|COMPLETED|Overall Study|6 patients did not receive 3 cycles required for evaluation of response as per protocol s7.1.1|22||
59726268|NCT01001910|75845067|FG000|NOT COMPLETED|Overall Study||6||
60121813|NCT02683746|76242822|FG000|STARTED|Overall Study||154||
60121814|NCT02683746|76242823|FG001|STARTED|Overall Study||154||
60121815|NCT02683746|76242822|FG000|COMPLETED|Overall Study||138||
60121816|NCT02683746|76242823|FG001|COMPLETED|Overall Study||140||
60121817|NCT02683746|76242822|FG000|NOT COMPLETED|Overall Study||16||
60121818|NCT02683746|76242823|FG001|NOT COMPLETED|Overall Study||14||
60121819|NCT02691468|76242831|FG000|STARTED|Overall Study||54||
60121820|NCT02691468|76242832|FG001|STARTED|Overall Study||54||
60121821|NCT02691468|76242831|FG000|COMPLETED|Overall Study||48||
60121822|NCT02691468|76242832|FG001|COMPLETED|Overall Study||52||
60121823|NCT02691468|76242831|FG000|NOT COMPLETED|Overall Study||6||
60121824|NCT02691468|76242832|FG001|NOT COMPLETED|Overall Study||2||
59856458|NCT03267940|75981080|FG004|Received at Least 1 Dose of Study Drug|Expansion (Maximum Exposure: 421 Days)||11||
59856459|NCT03267940|75981081|FG005|Received at Least 1 Dose of Study Drug|Expansion (Maximum Exposure: 421 Days)||10||
59856460|NCT03267940|75981076|FG000|COMPLETED|Expansion (Maximum Exposure: 421 Days)||0||
59856461|NCT03267940|75981077|FG001|COMPLETED|Expansion (Maximum Exposure: 421 Days)||0||
59856462|NCT03267940|75981078|FG002|COMPLETED|Expansion (Maximum Exposure: 421 Days)||3||
59856463|NCT03267940|75981079|FG003|COMPLETED|Expansion (Maximum Exposure: 421 Days)||0||
59856464|NCT03267940|75981080|FG004|COMPLETED|Expansion (Maximum Exposure: 421 Days)||1||
59856465|NCT03267940|75981081|FG005|COMPLETED|Expansion (Maximum Exposure: 421 Days)||0||
59856466|NCT03267940|75981076|FG000|NOT COMPLETED|Expansion (Maximum Exposure: 421 Days)||0||
59856467|NCT03267940|75981077|FG001|NOT COMPLETED|Expansion (Maximum Exposure: 421 Days)||0||
59856468|NCT03267940|75981078|FG002|NOT COMPLETED|Expansion (Maximum Exposure: 421 Days)||21||
59856469|NCT03267940|75981079|FG003|NOT COMPLETED|Expansion (Maximum Exposure: 421 Days)||22||
59856470|NCT03267940|75981080|FG004|NOT COMPLETED|Expansion (Maximum Exposure: 421 Days)||10||
59856471|NCT03267940|75981081|FG005|NOT COMPLETED|Expansion (Maximum Exposure: 421 Days)||10||
59856472|NCT03296566|75981101|FG000|STARTED|Overall Study||145||
59856473|NCT03296566|75981102|FG001|STARTED|Overall Study||152||
59856474|NCT03296566|75981101|FG000|COMPLETED|Overall Study||126||
59856475|NCT03296566|75981102|FG001|COMPLETED|Overall Study||103||
59856476|NCT03296566|75981101|FG000|NOT COMPLETED|Overall Study||19||
59856477|NCT03296566|75981102|FG001|NOT COMPLETED|Overall Study||49||
59856478|NCT03755882|75981108|FG000|STARTED|Period 1||23||
59856479|NCT03755882|75981109|FG001|STARTED|Period 1||22||
59856480|NCT03755882|75981108|FG000|COMPLETED|Period 1||19||
59856481|NCT03755882|75981109|FG001|COMPLETED|Period 1||22||
59856482|NCT03755882|75981108|FG000|NOT COMPLETED|Period 1||4||
59856483|NCT03755882|75981109|FG001|NOT COMPLETED|Period 1||0||
59856484|NCT03755882|75981108|FG000|STARTED|Period 2||19||
59856485|NCT03755882|75981109|FG001|STARTED|Period 2||22||
59856486|NCT03755882|75981108|FG000|COMPLETED|Period 2||19||
59856487|NCT03755882|75981109|FG001|COMPLETED|Period 2||22||
59856488|NCT03755882|75981108|FG000|NOT COMPLETED|Period 2||0||
59856489|NCT03755882|75981109|FG001|NOT COMPLETED|Period 2||0||
59856490|NCT00312377|75981117|FG000|STARTED|Overall Study|randomised patients|694||
59856491|NCT00312377|75981118|FG001|STARTED|Overall Study|randomised patients|697||
59856492|NCT00312377|75981117|FG000|COMPLETED|Overall Study|ongoing study treatment at data cut-off|50||
59856493|NCT00312377|75981118|FG001|COMPLETED|Overall Study|ongoing study treatment at data cut-off|29||
59856494|NCT00312377|75981117|FG000|NOT COMPLETED|Overall Study||644||
59856495|NCT00312377|75981118|FG001|NOT COMPLETED|Overall Study||668||
59856496|NCT03295318|75981127|FG000|STARTED|Overall Study||150||
59856497|NCT03295318|75981128|FG001|STARTED|Overall Study||150||
59856498|NCT03295318|75981129|FG002|STARTED|Overall Study||76||
59592107|NCT02937506|75700207|FG001|STARTED|Overall Study||300||
59592108|NCT02937506|75700206|FG000|COMPLETED|Overall Study||300||
59592109|NCT02937506|75700207|FG001|COMPLETED|Overall Study||300||
59856499|NCT03295318|75981127|FG000|Received First Vaccination|Overall Study|1 subject withdrew consent after randomization, but prior to vaccination.|149||
59856500|NCT03295318|75981128|FG001|Received First Vaccination|Overall Study||150||
59856501|NCT03295318|75981129|FG002|Received First Vaccination|Overall Study||76||
59856502|NCT03295318|75981127|FG000|Received Second Vaccination|Overall Study||144||
59856503|NCT03295318|75981128|FG001|Received Second Vaccination|Overall Study||145||
59856504|NCT03295318|75981129|FG002|Received Second Vaccination|Overall Study||73||
59856505|NCT03295318|75981127|FG000|COMPLETED|Overall Study||144||
60121825|NCT02678676|76242840|FG000|STARTED|Overall Study||1820||
60121826|NCT02678676|76242841|FG001|STARTED|Overall Study||1779||
59592110|NCT02937506|75700206|FG000|NOT COMPLETED|Overall Study||0||
59592111|NCT02937506|75700207|FG001|NOT COMPLETED|Overall Study||0||
59592112|NCT03026803|75700213|FG000|STARTED|Overall Study||4||
60121827|NCT02678676|76242840|FG000|COMPLETED|Overall Study||932||
60121828|NCT02678676|76242841|FG001|COMPLETED|Overall Study||907||
59592113|NCT03026803|75700213|FG000|COMPLETED|Overall Study||4||
59592114|NCT03026803|75700213|FG000|NOT COMPLETED|Overall Study||0||
59592115|NCT02938052|75700217|FG000|STARTED|Overall Study||10||
59592116|NCT02938052|75700217|FG000|COMPLETED|Overall Study||10||
59592117|NCT02938052|75700217|FG000|NOT COMPLETED|Overall Study||0||
59592118|NCT03027661|75700224|FG000|STARTED|Overall Study||20||
59592119|NCT03027661|75700225|FG001|STARTED|Overall Study||21||
59592120|NCT03027661|75700224|FG000|COMPLETED|Overall Study||20||
59592121|NCT03027661|75700225|FG001|COMPLETED|Overall Study||21||
59592122|NCT03027661|75700224|FG000|NOT COMPLETED|Overall Study||0||
59856506|NCT03295318|75981128|FG001|COMPLETED|Overall Study||145||
59856507|NCT03295318|75981129|FG002|COMPLETED|Overall Study||71||
59856508|NCT03295318|75981127|FG000|NOT COMPLETED|Overall Study||6||
59856509|NCT03295318|75981128|FG001|NOT COMPLETED|Overall Study||5||
59856510|NCT03295318|75981129|FG002|NOT COMPLETED|Overall Study||5||
60121829|NCT02678676|76242840|FG000|NOT COMPLETED|Overall Study||888||
59592123|NCT03027661|75700225|FG001|NOT COMPLETED|Overall Study||0||
59592124|NCT02794207|75700233|FG000|STARTED|Overall Study||32||
59592125|NCT02794207|75700234|FG001|STARTED|Overall Study||54||
59592126|NCT02794207|75700233|FG000|COMPLETED|Overall Study||32||
59592127|NCT02794207|75700234|FG001|COMPLETED|Overall Study||54||
59856511|NCT03311230|75981159|FG000|STARTED|Overall Study||151||
59856512|NCT03311230|75981160|FG001|STARTED|Overall Study||151||
59856513|NCT03311230|75981161|FG002|STARTED|Overall Study||150||
59856514|NCT03311230|75981162|FG003|STARTED|Overall Study||150||
59856515|NCT03311230|75981159|FG000|COMPLETED|Overall Study||150||
59856516|NCT03311230|75981160|FG001|COMPLETED|Overall Study||146||
59856517|NCT03311230|75981161|FG002|COMPLETED|Overall Study||148||
59856518|NCT03311230|75981162|FG003|COMPLETED|Overall Study||143||
59856519|NCT03311230|75981159|FG000|NOT COMPLETED|Overall Study||1||
59856520|NCT03311230|75981160|FG001|NOT COMPLETED|Overall Study||5||
59856521|NCT03311230|75981161|FG002|NOT COMPLETED|Overall Study||2||
59856522|NCT03311230|75981162|FG003|NOT COMPLETED|Overall Study||7||
59856523|NCT00312221|75981175|FG000|STARTED|Open-label Run-in Period||652||
59856524|NCT00312221|75981176|FG001|STARTED|Open-label Run-in Period||0||
59856525|NCT00312221|75981177|FG002|STARTED|Open-label Run-in Period||0||
59856526|NCT00312221|75981178|FG003|STARTED|Open-label Run-in Period||0||
59856527|NCT00312221|75981175|FG000|COMPLETED|Open-label Run-in Period||418||
59856528|NCT00312221|75981176|FG001|COMPLETED|Open-label Run-in Period||0||
59856529|NCT00312221|75981177|FG002|COMPLETED|Open-label Run-in Period||0||
59856530|NCT00312221|75981178|FG003|COMPLETED|Open-label Run-in Period||0||
59856531|NCT00312221|75981175|FG000|NOT COMPLETED|Open-label Run-in Period||234||
59856532|NCT00312221|75981176|FG001|NOT COMPLETED|Open-label Run-in Period||0||
59856533|NCT00312221|75981177|FG002|NOT COMPLETED|Open-label Run-in Period||0||
59856534|NCT00312221|75981178|FG003|NOT COMPLETED|Open-label Run-in Period||0||
59856535|NCT00312221|75981175|FG000|STARTED|Double-blind Phase||0||
59856536|NCT00312221|75981176|FG001|STARTED|Double-blind Phase||136||
59856537|NCT00312221|75981177|FG002|STARTED|Double-blind Phase||149||
59856538|NCT00312221|75981178|FG003|STARTED|Double-blind Phase||133||
59856539|NCT00312221|75981175|FG000|COMPLETED|Double-blind Phase||0||
59856540|NCT00312221|75981176|FG001|COMPLETED|Double-blind Phase||77||
59856541|NCT00312221|75981177|FG002|COMPLETED|Double-blind Phase||77||
59856542|NCT00312221|75981178|FG003|COMPLETED|Double-blind Phase||63||
59856543|NCT00312221|75981175|FG000|NOT COMPLETED|Double-blind Phase||0||
59856544|NCT00312221|75981176|FG001|NOT COMPLETED|Double-blind Phase||59||
59856545|NCT00312221|75981177|FG002|NOT COMPLETED|Double-blind Phase||72||
59856546|NCT00312221|75981178|FG003|NOT COMPLETED|Double-blind Phase||70||
59856547|NCT03349268|75981190|FG000|STARTED|Overall Study||9117||
59856548|NCT03349268|75981191|FG001|STARTED|Overall Study||10296||
59856549|NCT03349268|75981192|FG002|STARTED|Overall Study||6319||
59856550|NCT03349268|75981190|FG000|COMPLETED|Overall Study||9117||
59856551|NCT03349268|75981191|FG001|COMPLETED|Overall Study||10296||
59856552|NCT03349268|75981192|FG002|COMPLETED|Overall Study||6319||
59856553|NCT03349268|75981190|FG000|NOT COMPLETED|Overall Study||0||
59856554|NCT03349268|75981191|FG001|NOT COMPLETED|Overall Study||0||
59856555|NCT03349268|75981192|FG002|NOT COMPLETED|Overall Study||0||
59856556|NCT03294538|75981202|FG000|STARTED|Overall Study||268||
59856557|NCT03294538|75981203|FG001|STARTED|Overall Study||262||
59856558|NCT03294538|75981204|FG002|STARTED|Overall Study||133||
59856559|NCT03294538|75981202|FG000|Safety Population|Overall Study||267|All participants who were randomized and administered at least 1 dose of study drug|
59856560|NCT03294538|75981203|FG001|Safety Population|Overall Study||262|All participants who were randomized and administered at least 1 dose of study drug|
59856561|NCT03294538|75981204|FG002|Safety Population|Overall Study||132|All participants who were randomized and administered at least 1 dose of study drug|
59856562|NCT03294538|75981202|FG000|mITT Population|Overall Study||267|mITT population, administered at least 1 dose of study drug, and had a post-randomization evaluation|
59856563|NCT03294538|75981203|FG001|mITT Population|Overall Study||262|mITT population, administered at least 1 dose of study drug, and had a post-randomization evaluation|
59856564|NCT03294538|75981204|FG002|mITT Population|Overall Study||132|mITT population, administered at least 1 dose of study drug, and had a post-randomization evaluation|
59856565|NCT03294538|75981202|FG000|PP Population|Overall Study||244|Met I/E criteria, didn't develop concurrent vaginal infection, completed Day 8 visit, took 6-8 doses|
59856566|NCT03294538|75981203|FG001|PP Population|Overall Study||227|Met I/E criteria, didn't develop concurrent vaginal infection, completed Day 8 visit, took 6-8 doses|
59856567|NCT03294538|75981204|FG002|PP Population|Overall Study||126|Met I/E criteria, didn't develop concurrent vaginal infection, completed Day 8 visit, took 6-8 doses|
59856568|NCT03294538|75981202|FG000|COMPLETED|Overall Study||263||
59856569|NCT03294538|75981203|FG001|COMPLETED|Overall Study||257||
59856570|NCT03294538|75981204|FG002|COMPLETED|Overall Study||131||
59856571|NCT03294538|75981202|FG000|NOT COMPLETED|Overall Study||5||
59856572|NCT03294538|75981203|FG001|NOT COMPLETED|Overall Study||5||
59856573|NCT03294538|75981204|FG002|NOT COMPLETED|Overall Study||2||
59856574|NCT03265600|75981214|FG000|STARTED|Overall Study||92||
59856575|NCT03265600|75981215|FG001|STARTED|Overall Study||44||
59856576|NCT03265600|75981214|FG000|COMPLETED|Overall Study|Completed 8 or 9 week Action Plan Initiation Survey|68||
59856577|NCT03265600|75981215|FG001|COMPLETED|Overall Study|Completed 8 or 9 week Action Plan Initiation Survey|32||
59856578|NCT03265600|75981214|FG000|NOT COMPLETED|Overall Study||24||
59856579|NCT03265600|75981215|FG001|NOT COMPLETED|Overall Study||12||
59856580|NCT00335153|75981221|FG000|STARTED|Nasojejunal (NJ) Test Period||354||
59856581|NCT00335153|75981221|FG000|COMPLETED|Nasojejunal (NJ) Test Period||324||
59856582|NCT00335153|75981221|FG000|NOT COMPLETED|Nasojejunal (NJ) Test Period||30||
59856583|NCT00335153|75981221|FG000|STARTED|Post-PEG-J Long-Term Treatment Period||324||
59856584|NCT00335153|75981221|FG000|COMPLETED|Post-PEG-J Long-Term Treatment Period||272||
59856585|NCT00335153|75981221|FG000|NOT COMPLETED|Post-PEG-J Long-Term Treatment Period||52||
59856586|NCT03265132|75981227|FG000|STARTED|Overall Study||6||
59856587|NCT03265132|75981228|FG001|STARTED|Overall Study|One patient failed disease specific inclusion criteria and was excluded from efficacy analysis|6||
59856588|NCT03265132|75981227|FG000|COMPLETED|Overall Study||6||
59856589|NCT03265132|75981228|FG001|COMPLETED|Overall Study||0||
59856590|NCT03265132|75981227|FG000|NOT COMPLETED|Overall Study||0||
59856591|NCT03265132|75981228|FG001|NOT COMPLETED|Overall Study||6||
59856592|NCT02939950|75981238|FG000|STARTED|Overall Study||406||812
59856593|NCT02939950|75981239|FG001|STARTED|Overall Study||410||820
59856594|NCT02939950|75981238|FG000|Dispensed the Assigned Lenses|Overall Study||405||810
59856595|NCT02939950|75981239|FG001|Dispensed the Assigned Lenses|Overall Study||410||820
59856596|NCT02939950|75981238|FG000|Eligible at Baseline|Overall Study||403||806
59856597|NCT02939950|75981239|FG001|Eligible at Baseline|Overall Study||402||804
59856598|NCT02939950|75981238|FG000|COMPLETED|Overall Study||340||680
59856599|NCT02939950|75981239|FG001|COMPLETED|Overall Study||329||658
59856600|NCT02939950|75981238|FG000|NOT COMPLETED|Overall Study||66||132
59856601|NCT02939950|75981239|FG001|NOT COMPLETED|Overall Study||81||162
59856602|NCT03753542|75981247|FG000|STARTED|Overall Study|Actual Calculated Sample size was 30 Sample, 100 was taken to restore lost to follow up|50||
59856603|NCT03753542|75981248|FG001|STARTED|Overall Study|Actual Calculated Sample size was 30 Sample, 100 was taken to restore lost to follow up|50||
59856604|NCT03753542|75981247|FG000|COMPLETED|Overall Study|In spite of having lost to follow up the power of study was not lost|41||
59856605|NCT03753542|75981248|FG001|COMPLETED|Overall Study|In spite of having lost to follow up the power of study was not lost|36||
59856606|NCT03753542|75981247|FG000|NOT COMPLETED|Overall Study||9||
59856607|NCT03753542|75981248|FG001|NOT COMPLETED|Overall Study||14||
59856608|NCT03292588|75981256|FG000|STARTED|Overall Study||146||
59856609|NCT03292588|75981257|FG001|STARTED|Overall Study||144||
59856610|NCT03292588|75981256|FG000|COMPLETED|Overall Study||126||
59856611|NCT03292588|75981257|FG001|COMPLETED|Overall Study||122||
59856612|NCT03292588|75981256|FG000|NOT COMPLETED|Overall Study||20||
59856613|NCT03292588|75981257|FG001|NOT COMPLETED|Overall Study||22||
59856614|NCT03752528|75981265|FG000|STARTED|Part A||53||
59856615|NCT03752528|75981265|FG000|COMPLETED|Part A||51||
59856616|NCT03752528|75981265|FG000|NOT COMPLETED|Part A||2||
59856617|NCT03752528|75981265|FG000|STARTED|Part B||24|Requirement: positive for buprenorphine and/or norbuprenorphine and negative for naloxone in Part A|
59856618|NCT03752528|75981265|FG000|COMPLETED|Part B||20||
59856619|NCT03752528|75981265|FG000|NOT COMPLETED|Part B||4||
59856620|NCT00334295|75981272|FG000|STARTED|Overall Study||35||
59856621|NCT00334295|75981272|FG000|COMPLETED|Overall Study||30||
59856622|NCT00334295|75981272|FG000|NOT COMPLETED|Overall Study||5||
59856623|NCT03292432|75981278|FG000|STARTED|Overall Study||46|Number enrolled|
59856624|NCT03292432|75981279|FG001|STARTED|Overall Study||43|Number enrolled|
59856625|NCT03292432|75981278|FG000|Started Study Intervention|Overall Study||45|Number starting intervention|
59856626|NCT03292432|75981279|FG001|Started Study Intervention|Overall Study||43|Number starting intervention|
59856627|NCT03292432|75981278|FG000|COMPLETED|Overall Study||31||
59856628|NCT03292432|75981279|FG001|COMPLETED|Overall Study||32||
59856629|NCT03292432|75981278|FG000|NOT COMPLETED|Overall Study||15||
59856630|NCT03292432|75981279|FG001|NOT COMPLETED|Overall Study||11||
59856631|NCT03291808|75981285|FG000|STARTED|Overall Study||43||
59856632|NCT03291808|75981285|FG000|COMPLETED|Overall Study||33||
59856633|NCT03291808|75981285|FG000|NOT COMPLETED|Overall Study||10||
59856634|NCT03263806|75981291|FG000|STARTED|Overall Study||6||
59856635|NCT03263806|75981292|FG001|STARTED|Overall Study||7||
59856636|NCT03263806|75981291|FG000|COMPLETED|Overall Study|Study Terminated due to lack of enrollment|0||
59856637|NCT03263806|75981292|FG001|COMPLETED|Overall Study|Study Terminated due to lack of enrollment|0||
59856638|NCT03263806|75981291|FG000|NOT COMPLETED|Overall Study||6||
59856639|NCT03263806|75981292|FG001|NOT COMPLETED|Overall Study||7||
59856640|NCT03751280|75981300|FG000|STARTED|Overall Study||56|All enrolled participants were in Randomized Set|
59856641|NCT03751280|75981301|FG001|STARTED|Overall Study||56|All enrolled participants were in Randomized Set|
59856642|NCT03751280|75981300|FG000|Full Analysis Set (FAS)|Overall Study||54||
59856643|NCT03751280|75981301|FG001|Full Analysis Set (FAS)|Overall Study||55||
59856644|NCT03751280|75981300|FG000|Safety Set (SAF)|Overall Study||55||
59856645|NCT03751280|75981301|FG001|Safety Set (SAF)|Overall Study||55||
59856646|NCT03751280|75981300|FG000|COMPLETED|Overall Study||48||
59856647|NCT03751280|75981301|FG001|COMPLETED|Overall Study||44||
59856648|NCT03751280|75981300|FG000|NOT COMPLETED|Overall Study||8||
59856649|NCT03751280|75981301|FG001|NOT COMPLETED|Overall Study||12||
59856650|NCT00311363|75981311|FG000|STARTED|24-Week Single-Blind Treatment Period||327||
59856651|NCT00311363|75981312|FG001|STARTED|24-Week Single-Blind Treatment Period||0||
59856652|NCT00311363|75981313|FG002|STARTED|24-Week Single-Blind Treatment Period||0||
59856653|NCT00311363|75981311|FG000|COMPLETED|24-Week Single-Blind Treatment Period||221||
59856654|NCT00311363|75981312|FG001|COMPLETED|24-Week Single-Blind Treatment Period||0||
59856655|NCT00311363|75981313|FG002|COMPLETED|24-Week Single-Blind Treatment Period||0||
59856656|NCT00311363|75981311|FG000|NOT COMPLETED|24-Week Single-Blind Treatment Period||106||
59856657|NCT00311363|75981312|FG001|NOT COMPLETED|24-Week Single-Blind Treatment Period||0||
59856658|NCT00311363|75981313|FG002|NOT COMPLETED|24-Week Single-Blind Treatment Period||0||
59856659|NCT00311363|75981311|FG000|STARTED|12-Week Double-Blind Treatment Period||0||
59856660|NCT00311363|75981312|FG001|STARTED|12-Week Double-Blind Treatment Period||98||
59856661|NCT00311363|75981313|FG002|STARTED|12-Week Double-Blind Treatment Period||96||
59856662|NCT00311363|75981311|FG000|COMPLETED|12-Week Double-Blind Treatment Period||0||
59856663|NCT00311363|75981312|FG001|COMPLETED|12-Week Double-Blind Treatment Period||84||
59856664|NCT00311363|75981313|FG002|COMPLETED|12-Week Double-Blind Treatment Period||84||
59856665|NCT00311363|75981311|FG000|NOT COMPLETED|12-Week Double-Blind Treatment Period||0||
59856666|NCT00311363|75981312|FG001|NOT COMPLETED|12-Week Double-Blind Treatment Period||14||
59856667|NCT00311363|75981313|FG002|NOT COMPLETED|12-Week Double-Blind Treatment Period||12||
59856668|NCT00333983|75981326|FG000|STARTED|Overall Study||20||
59856669|NCT00333983|75981327|FG001|STARTED|Overall Study||21||
59856670|NCT00333983|75981328|FG002|STARTED|Overall Study||21||
59856671|NCT00333983|75981326|FG000|COMPLETED|Overall Study||17||
59856672|NCT00333983|75981327|FG001|COMPLETED|Overall Study||16||
59856673|NCT00333983|75981328|FG002|COMPLETED|Overall Study||19||
59856674|NCT00333983|75981326|FG000|NOT COMPLETED|Overall Study||3||
59856675|NCT00333983|75981327|FG001|NOT COMPLETED|Overall Study||5||
59856676|NCT00333983|75981328|FG002|NOT COMPLETED|Overall Study||2||
59856677|NCT03262012|75981340|FG000|STARTED|Overall Study||139||
59856678|NCT03262012|75981341|FG001|STARTED|Overall Study||138||
59856679|NCT03262012|75981342|FG002|STARTED|Overall Study||70||
59856680|NCT03262012|75981343|FG003|STARTED|Overall Study||69||
59856681|NCT03262012|75981340|FG000|COMPLETED|Overall Study||112||
59856682|NCT03262012|75981341|FG001|COMPLETED|Overall Study||102||
59856683|NCT03262012|75981342|FG002|COMPLETED|Overall Study||56||
59856684|NCT03262012|75981343|FG003|COMPLETED|Overall Study||54||
59856685|NCT03262012|75981340|FG000|NOT COMPLETED|Overall Study||27||
59856686|NCT03262012|75981341|FG001|NOT COMPLETED|Overall Study||36||
59856687|NCT03262012|75981342|FG002|NOT COMPLETED|Overall Study||14||
59856688|NCT03262012|75981343|FG003|NOT COMPLETED|Overall Study||15||
59856689|NCT03288142|75981355|FG000|STARTED|Overall Study||166||
59856690|NCT03288142|75981356|FG001|STARTED|Overall Study||167||
59856691|NCT03288142|75981355|FG000|COMPLETED|Overall Study||144||
59856692|NCT03288142|75981356|FG001|COMPLETED|Overall Study||152||
59856693|NCT03288142|75981355|FG000|NOT COMPLETED|Overall Study||22||
59856694|NCT03288142|75981356|FG001|NOT COMPLETED|Overall Study||15||
59856695|NCT00310817|75981368|FG000|STARTED|Overall Study||207||
59856696|NCT00310817|75981369|FG001|STARTED|Overall Study||206||
59856697|NCT00310817|75981370|FG002|STARTED|Overall Study||128||
59856698|NCT00310817|75981371|FG003|STARTED|Overall Study||82||
59856699|NCT00310817|75981368|FG000|COMPLETED|Overall Study||196||
59856700|NCT00310817|75981369|FG001|COMPLETED|Overall Study||198||
59856701|NCT00310817|75981370|FG002|COMPLETED|Overall Study||120||
59856702|NCT00310817|75981371|FG003|COMPLETED|Overall Study||74||
59856703|NCT00310817|75981368|FG000|NOT COMPLETED|Overall Study||11||
59856704|NCT00310817|75981369|FG001|NOT COMPLETED|Overall Study||8||
59856705|NCT00310817|75981370|FG002|NOT COMPLETED|Overall Study||8||
59592128|NCT02794207|75700233|FG000|NOT COMPLETED|Overall Study||0||
59592129|NCT02794207|75700234|FG001|NOT COMPLETED|Overall Study||0||
59592130|NCT03022526|75700241|FG000|STARTED|Overall Study||31||
59592131|NCT03022526|75700242|FG001|STARTED|Overall Study||30||
59592132|NCT03022526|75700241|FG000|COMPLETED|Overall Study||21||
59592133|NCT03022526|75700242|FG001|COMPLETED|Overall Study||25||
59592134|NCT03022526|75700241|FG000|NOT COMPLETED|Overall Study||10||
59726269|NCT01009554|75845073|FG000|STARTED|Overall Study||48||
59726270|NCT01009554|75845074|FG001|STARTED|Overall Study||48||
59726271|NCT01009554|75845073|FG000|COMPLETED|Overall Study||46||
59726272|NCT01009554|75845074|FG001|COMPLETED|Overall Study||41||
59726273|NCT01009554|75845073|FG000|NOT COMPLETED|Overall Study||2||
59726274|NCT01009554|75845074|FG001|NOT COMPLETED|Overall Study||7||
59726275|NCT01006590|75845082|FG000|STARTED|Overall Study|Randomised and treated|147||
59726276|NCT01006590|75845083|FG001|STARTED|Overall Study|Randomised and treated|139||
59726277|NCT01006590|75845082|FG000|COMPLETED|Overall Study|Completed 24 weeks of treatment|119||
59726278|NCT01006590|75845083|FG001|COMPLETED|Overall Study|Completed 24 weeks of treatment|107||
59726279|NCT01006590|75845082|FG000|NOT COMPLETED|Overall Study||28||
59726280|NCT01006590|75845083|FG001|NOT COMPLETED|Overall Study||32||
59726281|NCT01001832|75845091|FG000|STARTED|Short-term Period||59||
59726282|NCT01001832|75845092|FG001|STARTED|Short-term Period||59||
59726283|NCT01001832|75845091|FG000|COMPLETED|Short-term Period||57||
59726284|NCT01001832|75845092|FG001|COMPLETED|Short-term Period||56||
59726285|NCT01001832|75845091|FG000|NOT COMPLETED|Short-term Period||2||
59726286|NCT01001832|75845092|FG001|NOT COMPLETED|Short-term Period||3||
59726287|NCT01001832|75845091|FG000|STARTED|Long-term Period|1 participant completed the short term period but discontinued before start of the Long-term Period.|56||
59726288|NCT01001832|75845092|FG001|STARTED|Long-term Period||56||
59856706|NCT00310817|75981371|FG003|NOT COMPLETED|Overall Study||8||
59592135|NCT03022526|75700242|FG001|NOT COMPLETED|Overall Study||5||
59592136|NCT02794441|75700250|FG000|STARTED|Overall Study||7||
59726289|NCT01001832|75845091|FG000|COMPLETED|Long-term Period||52||
59856707|NCT02940886|75981416|FG000|STARTED|Overall Study|Intention-to-treat analysis set included 1009 subjects, safety analysis set included 989 subjects.|1009||
59856708|NCT02940886|75981417|FG001|STARTED|Overall Study|Intention-to-treat analysis set included 503 subjects, safety analysis set included 494 subjects.|503||
59856709|NCT02940886|75981416|FG000|Safety Analysis Set|Overall Study||989||
59856710|NCT02940886|75981417|FG001|Safety Analysis Set|Overall Study||494||
59856711|NCT02940886|75981416|FG000|COMPLETED|Overall Study||907||
59856712|NCT02940886|75981417|FG001|COMPLETED|Overall Study||449||
59856713|NCT02940886|75981416|FG000|NOT COMPLETED|Overall Study||102||
59856714|NCT02940886|75981417|FG001|NOT COMPLETED|Overall Study||54||
59856715|NCT03285958|75981427|FG000|STARTED|Overall Study||33||
59856716|NCT03285958|75981428|FG001|STARTED|Overall Study||24||
59856717|NCT03285958|75981427|FG000|COMPLETED|Overall Study||28||
59856718|NCT03285958|75981428|FG001|COMPLETED|Overall Study||23||
59856719|NCT03285958|75981427|FG000|NOT COMPLETED|Overall Study||5||
59856720|NCT03285958|75981428|FG001|NOT COMPLETED|Overall Study||1||
59856721|NCT03285646|75981437|FG000|STARTED|Overall Study||32||
59856722|NCT03285646|75981438|FG001|STARTED|Overall Study||31||
59856723|NCT03285646|75981437|FG000|COMPLETED|Overall Study||19||
59856724|NCT03285646|75981438|FG001|COMPLETED|Overall Study||27||
59856725|NCT03285646|75981437|FG000|NOT COMPLETED|Overall Study||13||
59856726|NCT03285646|75981438|FG001|NOT COMPLETED|Overall Study||4||
59856727|NCT03309202|75981449|FG000|STARTED|Overall Study||6||
59856728|NCT03309202|75981450|FG001|STARTED|Overall Study||6||
59856729|NCT03309202|75981451|FG002|STARTED|Overall Study||6||
59856730|NCT03309202|75981452|FG003|STARTED|Overall Study||6||
59856731|NCT03309202|75981449|FG000|COMPLETED|Overall Study||5||
59856732|NCT03309202|75981450|FG001|COMPLETED|Overall Study||6||
59856733|NCT03309202|75981451|FG002|COMPLETED|Overall Study||6||
59856734|NCT03309202|75981452|FG003|COMPLETED|Overall Study||6||
59856735|NCT03309202|75981449|FG000|NOT COMPLETED|Overall Study||1||
59856736|NCT03309202|75981450|FG001|NOT COMPLETED|Overall Study||0||
59856737|NCT03309202|75981451|FG002|NOT COMPLETED|Overall Study||0||
59856738|NCT03309202|75981452|FG003|NOT COMPLETED|Overall Study||0||
59856739|NCT00074490|75981467|FG000|STARTED|Overall Study||1||
59856740|NCT00074490|75981468|FG001|STARTED|Overall Study||34||
59856741|NCT00074490|75981469|FG002|STARTED|Overall Study||40||
59856742|NCT00074490|75981470|FG003|STARTED|Overall Study||44||
59856743|NCT00074490|75981471|FG004|STARTED|Overall Study||45||
59856744|NCT00074490|75981472|FG005|STARTED|Overall Study||221||
59856745|NCT00074490|75981467|FG000|COMPLETED|Overall Study||1||
59856746|NCT00074490|75981468|FG001|COMPLETED|Overall Study||27||
59856747|NCT00074490|75981469|FG002|COMPLETED|Overall Study||40||
59856748|NCT00074490|75981470|FG003|COMPLETED|Overall Study||44||
59856749|NCT00074490|75981471|FG004|COMPLETED|Overall Study||42||
59856750|NCT00074490|75981472|FG005|COMPLETED|Overall Study||221||
59856751|NCT00074490|75981467|FG000|NOT COMPLETED|Overall Study||0||
59856752|NCT00074490|75981468|FG001|NOT COMPLETED|Overall Study||7||
59856753|NCT00074490|75981469|FG002|NOT COMPLETED|Overall Study||0||
59856754|NCT00074490|75981470|FG003|NOT COMPLETED|Overall Study||0||
59856755|NCT00074490|75981471|FG004|NOT COMPLETED|Overall Study||3||
59726290|NCT01001832|75845092|FG001|COMPLETED|Long-term Period||51||
59726291|NCT01001832|75845091|FG000|NOT COMPLETED|Long-term Period||4||
59726292|NCT01001832|75845092|FG001|NOT COMPLETED|Long-term Period||5||
59726293|NCT01001832|75845091|FG000|STARTED|Follow-up Period||52||
59726294|NCT01001832|75845092|FG001|STARTED|Follow-up Period||51||
59726295|NCT01001832|75845091|FG000|COMPLETED|Follow-up Period||34||
59726296|NCT01001832|75845092|FG001|COMPLETED|Follow-up Period||30||
59726297|NCT01001832|75845091|FG000|NOT COMPLETED|Follow-up Period||18||
59726298|NCT01001832|75845092|FG001|NOT COMPLETED|Follow-up Period||21||
59726299|NCT01001598|75845101|FG000|STARTED|Overall Study||5|Monitoring visits at 2, 5, 8, 12, 18, 24 wks - visits at 14 and/or 20 weeks if dose escalation|
59726300|NCT01001598|75845101|FG000|COMPLETED|Overall Study|3 completed study (2 FA and 1 DC) in 2011|3||
59856756|NCT00074490|75981472|FG005|NOT COMPLETED|Overall Study||0||
59856757|NCT03285490|75981487|FG000|STARTED|Treatment and Response Assessment Period||173||
59856758|NCT03285490|75981488|FG001|STARTED|Treatment and Response Assessment Period||178||
59856759|NCT03285490|75981487|FG000|COMPLETED|Treatment and Response Assessment Period||173||
59856760|NCT03285490|75981488|FG001|COMPLETED|Treatment and Response Assessment Period||178||
59856761|NCT03285490|75981487|FG000|NOT COMPLETED|Treatment and Response Assessment Period||0||
59856762|NCT03285490|75981488|FG001|NOT COMPLETED|Treatment and Response Assessment Period||0||
59856763|NCT03285490|75981487|FG000|STARTED|Recurrence Follow-up Period||22|Number of participants who achieved 100% AK clearance at Day 57 visit had entered the recurrence follow-up period.|
59856764|NCT03285490|75981488|FG001|STARTED|Recurrence Follow-up Period||97|Number of participants who achieved 100% AK clearance at Day 57 visit had entered the recurrence follow-up period.|
59856765|NCT03285490|75981487|FG000|COMPLETED|Recurrence Follow-up Period||4||
59856766|NCT03285490|75981488|FG001|COMPLETED|Recurrence Follow-up Period||36||
59856767|NCT03285490|75981487|FG000|NOT COMPLETED|Recurrence Follow-up Period||18||
59856768|NCT03285490|75981488|FG001|NOT COMPLETED|Recurrence Follow-up Period||61||
59856769|NCT02939716|75981495|FG000|STARTED|Overall Study||3||
59856770|NCT02939716|75981496|FG001|STARTED|Overall Study||3||
59726301|NCT01001598|75845101|FG000|NOT COMPLETED|Overall Study||2||
59726302|NCT01006356|75845105|FG000|STARTED|Overall Study||141||
59856771|NCT02939716|75981497|FG002|STARTED|Overall Study||3||
59856772|NCT02939716|75981498|FG003|STARTED|Overall Study||3||
59856773|NCT02939716|75981499|FG004|STARTED|Overall Study||3||
59856774|NCT02939716|75981500|FG005|STARTED|Overall Study||3||
59856775|NCT02939716|75981495|FG000|COMPLETED|Overall Study||3||
59856776|NCT02939716|75981496|FG001|COMPLETED|Overall Study||3||
59856777|NCT02939716|75981497|FG002|COMPLETED|Overall Study||3||
59856778|NCT02939716|75981498|FG003|COMPLETED|Overall Study||2||
59856779|NCT02939716|75981499|FG004|COMPLETED|Overall Study||2||
59856780|NCT02939716|75981500|FG005|COMPLETED|Overall Study||2||
59856781|NCT02939716|75981495|FG000|NOT COMPLETED|Overall Study||0||
59856782|NCT02939716|75981496|FG001|NOT COMPLETED|Overall Study||0||
59856783|NCT02939716|75981497|FG002|NOT COMPLETED|Overall Study||0||
59856784|NCT02939716|75981498|FG003|NOT COMPLETED|Overall Study||1||
59856785|NCT02939716|75981499|FG004|NOT COMPLETED|Overall Study||1||
59856786|NCT02939716|75981500|FG005|NOT COMPLETED|Overall Study||1||
59856787|NCT03088826|75981519|FG000|STARTED|Overall Study||40||
59856788|NCT03088826|75981520|FG001|STARTED|Overall Study||40||
59856789|NCT03088826|75981519|FG000|COMPLETED|Overall Study||40||
59856790|NCT03088826|75981520|FG001|COMPLETED|Overall Study||40||
59856791|NCT03088826|75981519|FG000|NOT COMPLETED|Overall Study||0||
59856792|NCT03088826|75981520|FG001|NOT COMPLETED|Overall Study||0||
59856793|NCT00367133|75981529|FG000|STARTED|2 Years|Number of Eyes|330||
59856794|NCT00367133|75981530|FG001|STARTED|2 Years|Number of Eyes|256||
59856795|NCT00367133|75981531|FG002|STARTED|2 Years|Number of Eyes|254||
59856796|NCT00367133|75981529|FG000|COMPLETED|2 Years||272||
59856797|NCT00367133|75981530|FG001|COMPLETED|2 Years||220||
59856798|NCT00367133|75981531|FG002|COMPLETED|2 Years||205||
59856799|NCT00367133|75981529|FG000|NOT COMPLETED|2 Years||58||
59856800|NCT00367133|75981530|FG001|NOT COMPLETED|2 Years||36||
59856801|NCT00367133|75981531|FG002|NOT COMPLETED|2 Years||49||
59856802|NCT00367133|75981529|FG000|STARTED|3 Years|Since trial ended early, includes only those with potential for 3 year follow-up -excludes deaths|143||
59856803|NCT00367133|75981530|FG001|STARTED|3 Years|Since trial ended early, includes only those with potential for 3 year follow-up -excludes deaths|116||
59856804|NCT00367133|75981531|FG002|STARTED|3 Years|Since trial ended early, includes only those with potential for 3 year follow-up -excludes deaths|116||
59856805|NCT00367133|75981529|FG000|COMPLETED|3 Years||115||
59856806|NCT00367133|75981530|FG001|COMPLETED|3 Years||93||
59856807|NCT00367133|75981531|FG002|COMPLETED|3 Years||98||
59856808|NCT00367133|75981529|FG000|NOT COMPLETED|3 Years||28||
59856809|NCT00367133|75981530|FG001|NOT COMPLETED|3 Years||23||
59856810|NCT00367133|75981531|FG002|NOT COMPLETED|3 Years||18||
59856811|NCT00367055|75981541|FG000|STARTED|Overall Study||43||
59856812|NCT00367055|75981542|FG001|STARTED|Overall Study||41||
59856813|NCT00367055|75981541|FG000|COMPLETED|Overall Study||32||
59856814|NCT00367055|75981542|FG001|COMPLETED|Overall Study||30||
59856815|NCT00367055|75981541|FG000|NOT COMPLETED|Overall Study||11||
59856816|NCT00367055|75981542|FG001|NOT COMPLETED|Overall Study||11||
59856817|NCT00057330|75981550|FG000|STARTED|Overall Study||4577||
59856818|NCT00057330|75981551|FG001|STARTED|Overall Study||3746||
59856819|NCT00057330|75981550|FG000|COMPLETED|Overall Study||3445||
59856820|NCT00057330|75981551|FG001|COMPLETED|Overall Study||2826||
59856821|NCT00057330|75981550|FG000|NOT COMPLETED|Overall Study||1132||
59856822|NCT00057330|75981551|FG001|NOT COMPLETED|Overall Study||920||
59856823|NCT03283696|75981559|FG000|STARTED|Overall Study||16||
59856824|NCT03283696|75981560|FG001|STARTED|Overall Study||8||
59856825|NCT03283696|75981559|FG000|Received at Least 1 Dose of Study Drug|Overall Study||16||
59856826|NCT03283696|75981560|FG001|Received at Least 1 Dose of Study Drug|Overall Study||8||
59856827|NCT03283696|75981559|FG000|COMPLETED|Overall Study||9||
59726303|NCT01006356|75845105|FG000|COMPLETED|Overall Study||99||
59856828|NCT03283696|75981560|FG001|COMPLETED|Overall Study||2||
59856829|NCT03283696|75981559|FG000|NOT COMPLETED|Overall Study||7||
59856830|NCT03283696|75981560|FG001|NOT COMPLETED|Overall Study||6||
59856831|NCT02939560|75981566|FG000|STARTED|Overall Study||13||
59856832|NCT02939560|75981566|FG000|COMPLETED|Overall Study||10||
59856833|NCT02939560|75981566|FG000|NOT COMPLETED|Overall Study||3||
59856834|NCT03748706|75981570|FG000|STARTED|Overall Study||13||
59856835|NCT03748706|75981570|FG000|COMPLETED|Overall Study||12||
59856836|NCT03748706|75981570|FG000|NOT COMPLETED|Overall Study||1||
59856837|NCT03747302|75981576|FG000|STARTED|Overall Study||834||
60121830|NCT02678676|76242841|FG001|NOT COMPLETED|Overall Study||872||
59726304|NCT01006356|75845105|FG000|NOT COMPLETED|Overall Study||42||
59726305|NCT01089725|75845114|FG000|STARTED|Overall Study||72||
59726306|NCT01089725|75845115|FG001|STARTED|Overall Study||75||
59726307|NCT01089725|75845116|FG002|STARTED|Overall Study||65||
59726308|NCT01089725|75845117|FG003|STARTED|Overall Study||87||
59726309|NCT01089725|75845118|FG004|STARTED|Overall Study||86||
59726310|NCT01089725|75845114|FG000|Treated|Overall Study||72||
59726311|NCT01089725|75845115|FG001|Treated|Overall Study||74||
59726312|NCT01089725|75845116|FG002|Treated|Overall Study||63||
59726313|NCT01089725|75845117|FG003|Treated|Overall Study||86||
59726314|NCT01089725|75845118|FG004|Treated|Overall Study||84||
59726315|NCT01089725|75845114|FG000|COMPLETED|Overall Study||6||
59856838|NCT03747302|75981577|FG001|STARTED|Overall Study||164||
59856839|NCT03747302|75981576|FG000|COMPLETED|Overall Study||833||
59856840|NCT03747302|75981577|FG001|COMPLETED|Overall Study||162||
59856841|NCT03747302|75981576|FG000|NOT COMPLETED|Overall Study||1||
59856842|NCT03747302|75981577|FG001|NOT COMPLETED|Overall Study||2||
59856843|NCT00056862|75981587|FG000|STARTED|Overall Study||31||
60121831|NCT01558739|76242847|FG000|STARTED|Overall Study||48||
60121832|NCT01558739|76242847|FG000|COMPLETED|Overall Study||31||
60121833|NCT01558739|76242847|FG000|NOT COMPLETED|Overall Study||17||
60121834|NCT02683668|76242851|FG000|STARTED|Period 1||44||
60121835|NCT02683668|76242852|FG001|STARTED|Period 1||0||
60121836|NCT02683668|76242853|FG002|STARTED|Period 1||0||
60121837|NCT02683668|76242851|FG000|COMPLETED|Period 1||44||
60121838|NCT02683668|76242852|FG001|COMPLETED|Period 1||0||
60121839|NCT02683668|76242853|FG002|COMPLETED|Period 1||0||
60121840|NCT02683668|76242851|FG000|NOT COMPLETED|Period 1||0||
60121841|NCT02683668|76242852|FG001|NOT COMPLETED|Period 1||0||
60121842|NCT02683668|76242853|FG002|NOT COMPLETED|Period 1||0||
60121843|NCT02683668|76242851|FG000|STARTED|Period 2||0||
60121844|NCT02683668|76242852|FG001|STARTED|Period 2||44||
60121845|NCT02683668|76242853|FG002|STARTED|Period 2||0||
60121846|NCT02683668|76242851|FG000|COMPLETED|Period 2||0||
60121847|NCT02683668|76242852|FG001|COMPLETED|Period 2||43||
60121848|NCT02683668|76242853|FG002|COMPLETED|Period 2||0||
60121849|NCT02683668|76242851|FG000|NOT COMPLETED|Period 2||0||
60121850|NCT02683668|76242852|FG001|NOT COMPLETED|Period 2||1||
60121851|NCT02683668|76242853|FG002|NOT COMPLETED|Period 2||0||
60121852|NCT02683668|76242851|FG000|STARTED|Period 3||0||
60121853|NCT02683668|76242852|FG001|STARTED|Period 3||0||
60121854|NCT02683668|76242853|FG002|STARTED|Period 3||43||
60121855|NCT02683668|76242851|FG000|COMPLETED|Period 3||0||
60121856|NCT02683668|76242852|FG001|COMPLETED|Period 3||0||
60121857|NCT02683668|76242853|FG002|COMPLETED|Period 3||43||
60121858|NCT02683668|76242851|FG000|NOT COMPLETED|Period 3||0||
60121859|NCT02683668|76242852|FG001|NOT COMPLETED|Period 3||0||
60121860|NCT02683668|76242853|FG002|NOT COMPLETED|Period 3||0||
60121861|NCT02678286|76242861|FG000|STARTED|Treatment Phase (48 Hours Post-Dose 1)||110||
59856844|NCT00056862|75981588|FG001|STARTED|Overall Study||27||
59856845|NCT00056862|75981587|FG000|COMPLETED|Overall Study||30||
59856846|NCT00056862|75981588|FG001|COMPLETED|Overall Study||27||
59856847|NCT00056862|75981587|FG000|NOT COMPLETED|Overall Study||1||
59856848|NCT00056862|75981588|FG001|NOT COMPLETED|Overall Study||0||
59856849|NCT00056316|75981596|FG000|STARTED|Overall Study||33||
59856850|NCT00056316|75981597|FG001|STARTED|Overall Study|over-enrolled due to potential higher rates of drop-out.|41||
60121862|NCT02678286|76242862|FG001|STARTED|Treatment Phase (48 Hours Post-Dose 1)||109||
60121863|NCT02678286|76242861|FG000|COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||108||
60121864|NCT02678286|76242862|FG001|COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||107||
60121865|NCT02678286|76242861|FG000|NOT COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||2||
60121866|NCT02678286|76242862|FG001|NOT COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||2||
60121867|NCT02678286|76242861|FG000|STARTED|Study Overall (28 Day Follow-Up)||110||
60121868|NCT02678286|76242862|FG001|STARTED|Study Overall (28 Day Follow-Up)||109||
60121869|NCT02678286|76242861|FG000|COMPLETED|Study Overall (28 Day Follow-Up)||104||
60121870|NCT02678286|76242862|FG001|COMPLETED|Study Overall (28 Day Follow-Up)||105||
60121871|NCT02678286|76242861|FG000|NOT COMPLETED|Study Overall (28 Day Follow-Up)||6||
60121872|NCT02678286|76242862|FG001|NOT COMPLETED|Study Overall (28 Day Follow-Up)||4||
60121873|NCT02682264|76242870|FG000|STARTED|Overall Study||317||
60121874|NCT02682264|76242871|FG001|STARTED|Overall Study||290||
60121875|NCT02682264|76242870|FG000|COMPLETED|Overall Study||179||
60121876|NCT02682264|76242871|FG001|COMPLETED|Overall Study||168||
60121877|NCT02682264|76242870|FG000|NOT COMPLETED|Overall Study||138||
59726316|NCT01089725|75845115|FG001|COMPLETED|Overall Study||7||
60121878|NCT02682264|76242871|FG001|NOT COMPLETED|Overall Study||122||
60121879|NCT01566721|76242879|FG000|STARTED|Treatment Period||1867||
59726317|NCT01089725|75845116|FG002|COMPLETED|Overall Study||4||
59726318|NCT01089725|75845117|FG003|COMPLETED|Overall Study||8||
59726319|NCT01089725|75845118|FG004|COMPLETED|Overall Study||6||
59726320|NCT01089725|75845114|FG000|NOT COMPLETED|Overall Study||66||
59726321|NCT01089725|75845115|FG001|NOT COMPLETED|Overall Study||68||
59726322|NCT01089725|75845116|FG002|NOT COMPLETED|Overall Study||61||
59726323|NCT01089725|75845117|FG003|NOT COMPLETED|Overall Study||79||
59726324|NCT01089725|75845118|FG004|NOT COMPLETED|Overall Study||80||
59726325|NCT01101191|75845134|FG000|STARTED|Period 1||42||
59726326|NCT01101191|75845135|FG001|STARTED|Period 1||42||
59726327|NCT01101191|75845134|FG000|COMPLETED|Period 1||40||
59726328|NCT01101191|75845135|FG001|COMPLETED|Period 1||40||
59726329|NCT01101191|75845134|FG000|NOT COMPLETED|Period 1||2||
59726330|NCT01101191|75845135|FG001|NOT COMPLETED|Period 1||2||
59726331|NCT01101191|75845134|FG000|STARTED|Period 2||40||
59726332|NCT01101191|75845135|FG001|STARTED|Period 2||40||
59726333|NCT01101191|75845134|FG000|COMPLETED|Period 2||40||
59726334|NCT01101191|75845135|FG001|COMPLETED|Period 2||40||
59726335|NCT01101191|75845134|FG000|NOT COMPLETED|Period 2||0||
59856851|NCT00056316|75981596|FG000|COMPLETED|Overall Study||30||
59856852|NCT00056316|75981597|FG001|COMPLETED|Overall Study||38||
59856853|NCT00056316|75981596|FG000|NOT COMPLETED|Overall Study||3||
59856854|NCT00056316|75981597|FG001|NOT COMPLETED|Overall Study||3||
59856855|NCT03308968|75981606|FG000|STARTED|Double-Blind Period (12 Weeks)||279|Intent-to-treat (ITT) analysis set: all randomized participants.|
59856856|NCT03308968|75981607|FG001|STARTED|Double-Blind Period (12 Weeks)||276|Intent-to-treat (ITT) analysis set: all randomized participants.|
59856857|NCT03308968|75981608|FG002|STARTED|Double-Blind Period (12 Weeks)||283|Intent-to-treat (ITT) analysis set: all randomized participants.|
59856858|NCT03308968|75981606|FG000|DB Safety Analysis Set|Double-Blind Period (12 Weeks)|2 participants (1 with CM and 1 with EM) randomized to placebo but received Fremanezumab monthly.|277|Participants who received at least 1 dose of study drug during DB period.|
59856859|NCT03308968|75981607|FG001|DB Safety Analysis Set|Double-Blind Period (12 Weeks)||276|Participants who received at least 1 dose of study drug during DB period.|
59856860|NCT03308968|75981608|FG002|DB Safety Analysis Set|Double-Blind Period (12 Weeks)|2 participants (1 with CM and 1 with EM) randomized to placebo but received Fremanezumab monthly.|285|Participants who received at least 1 dose of study drug during DB period.|
59856861|NCT03308968|75981606|FG000|DB Modified ITT (mITT) Analysis Set|Double-Blind Period (12 Weeks)||278|Received ≥1 dose of study drug;had ≥10 days of postbaseline efficacy assessment on primary endpoint.|
59856862|NCT03308968|75981607|FG001|DB Modified ITT (mITT) Analysis Set|Double-Blind Period (12 Weeks)||276|Received ≥1 dose of study drug;had ≥10 days of postbaseline efficacy assessment on primary endpoint.|
59856863|NCT03308968|75981608|FG002|DB Modified ITT (mITT) Analysis Set|Double-Blind Period (12 Weeks)||283|Received ≥1 dose of study drug;had ≥10 days of postbaseline efficacy assessment on primary endpoint.|
59856864|NCT03308968|75981606|FG000|COMPLETED|Double-Blind Period (12 Weeks)||264||
59856865|NCT03308968|75981607|FG001|COMPLETED|Double-Blind Period (12 Weeks)||271||
59856866|NCT03308968|75981608|FG002|COMPLETED|Double-Blind Period (12 Weeks)||272||
59856867|NCT03308968|75981606|FG000|NOT COMPLETED|Double-Blind Period (12 Weeks)||15||
59856868|NCT03308968|75981607|FG001|NOT COMPLETED|Double-Blind Period (12 Weeks)||5||
59856869|NCT03308968|75981608|FG002|NOT COMPLETED|Double-Blind Period (12 Weeks)||11||
59856870|NCT03308968|75981606|FG000|STARTED|Open-Label Period (12 Weeks)||264|OL Safety analysis set: Participants who received at least 1 dose of study drug during OL period.|
59856871|NCT03308968|75981607|FG001|STARTED|Open-Label Period (12 Weeks)||271|OL Safety analysis set: Participants who received at least 1 dose of study drug during OL period.|
59856872|NCT03308968|75981608|FG002|STARTED|Open-Label Period (12 Weeks)||272|OL Safety analysis set: Participants who received at least 1 dose of study drug during OL period.|
59856873|NCT03308968|75981606|FG000|OL mITT Analysis Set|Open-Label Period (12 Weeks)||263|Received ≥1 dose of study drug in OL period;had ≥10 days of postbaseline diary entries in OL period.|
59856874|NCT03308968|75981607|FG001|OL mITT Analysis Set|Open-Label Period (12 Weeks)||271|Received ≥1 dose of study drug in OL period;had ≥10 days of postbaseline diary entries in OL period.|
59856875|NCT03308968|75981608|FG002|OL mITT Analysis Set|Open-Label Period (12 Weeks)||272|Received ≥1 dose of study drug in OL period;had ≥10 days of postbaseline diary entries in OL period.|
59856876|NCT03308968|75981606|FG000|COMPLETED|Open-Label Period (12 Weeks)||253||
59856877|NCT03308968|75981607|FG001|COMPLETED|Open-Label Period (12 Weeks)||259||
59856878|NCT03308968|75981608|FG002|COMPLETED|Open-Label Period (12 Weeks)||260||
59856879|NCT03308968|75981606|FG000|NOT COMPLETED|Open-Label Period (12 Weeks)||11||
59856880|NCT03308968|75981607|FG001|NOT COMPLETED|Open-Label Period (12 Weeks)||12||
59856881|NCT03308968|75981608|FG002|NOT COMPLETED|Open-Label Period (12 Weeks)||12||
59856882|NCT02940730|75981621|FG000|STARTED|Intervention 1||10||
59856883|NCT02940730|75981622|FG001|STARTED|Intervention 1||0||
59856884|NCT02940730|75981621|FG000|Received Intervention|Intervention 1||10||
59856885|NCT02940730|75981622|FG001|Received Intervention|Intervention 1||0||
59856886|NCT02940730|75981621|FG000|COMPLETED|Intervention 1||10||
59856887|NCT02940730|75981622|FG001|COMPLETED|Intervention 1||0||
59856888|NCT02940730|75981621|FG000|NOT COMPLETED|Intervention 1||0||
59856889|NCT02940730|75981622|FG001|NOT COMPLETED|Intervention 1||0||
59856890|NCT02940730|75981621|FG000|STARTED|Intervention 2||10||
59856891|NCT02940730|75981622|FG001|STARTED|Intervention 2||0||
59726336|NCT01101191|75845135|FG001|NOT COMPLETED|Period 2||0||
59726337|NCT01178762|75845142|FG000|STARTED|Overall Study||42||
59726338|NCT01178762|75845142|FG000|COMPLETED|Overall Study||27||
59726339|NCT01178762|75845142|FG000|NOT COMPLETED|Overall Study||15||
59726340|NCT01178294|75845146|FG000|STARTED|Overall Study|25 subjects enrolled under OBI-1-301 + 4 subjects enrolled under expanded access OBI-1-301a.|29||
59726341|NCT01178294|75845146|FG000|COMPLETED|Overall Study||18||
59726342|NCT01178294|75845146|FG000|NOT COMPLETED|Overall Study||11||
59726343|NCT01178138|75845150|FG000|STARTED|Overall Study||24||
59726344|NCT01178138|75845150|FG000|Completed 6 Sessions|Overall Study||1||
59726345|NCT01178138|75845150|FG000|Completed 5 Sessions|Overall Study||1||
59726346|NCT01178138|75845150|FG000|Completed 3 Sessions|Overall Study||1||
59726347|NCT01178138|75845150|FG000|COMPLETED|Overall Study||1||
59726348|NCT01178138|75845150|FG000|NOT COMPLETED|Overall Study||23||
59726349|NCT01177670|75845159|FG000|STARTED|Overall Study||169||
59726350|NCT01177670|75845159|FG000|COMPLETED|Overall Study||0||
59726351|NCT01177670|75845159|FG000|NOT COMPLETED|Overall Study||169||
59726352|NCT01190228|75845166|FG000|STARTED|Overall Study||349||
59726353|NCT01190228|75845167|FG001|STARTED|Overall Study||46||
59726354|NCT01190228|75845168|FG002|STARTED|Overall Study||59||
59726355|NCT01190228|75845166|FG000|COMPLETED|Overall Study||344||
59726356|NCT01190228|75845167|FG001|COMPLETED|Overall Study||46||
59726357|NCT01190228|75845168|FG002|COMPLETED|Overall Study||59||
59726358|NCT01190228|75845166|FG000|NOT COMPLETED|Overall Study||5||
59726359|NCT01190228|75845167|FG001|NOT COMPLETED|Overall Study||0||
59856892|NCT02940730|75981621|FG000|Received Intervention|Intervention 2||3||
59856893|NCT02940730|75981622|FG001|Received Intervention|Intervention 2||0||
59856894|NCT02940730|75981621|FG000|COMPLETED|Intervention 2||3||
59856895|NCT02940730|75981622|FG001|COMPLETED|Intervention 2||0||
59856896|NCT02940730|75981621|FG000|NOT COMPLETED|Intervention 2||7||
59856897|NCT02940730|75981622|FG001|NOT COMPLETED|Intervention 2||0||
59856898|NCT03741062|75981630|FG000|STARTED|Overall Study||5||
59856899|NCT03741062|75981631|FG001|STARTED|Overall Study||6||
59856900|NCT03741062|75981630|FG000|COMPLETED|Overall Study||4||
59856901|NCT03741062|75981631|FG001|COMPLETED|Overall Study||6||
59856902|NCT03741062|75981630|FG000|NOT COMPLETED|Overall Study||1||
59856903|NCT03741062|75981631|FG001|NOT COMPLETED|Overall Study||0||
59856904|NCT03281668|75981637|FG000|STARTED|Overall Study||29||
59856905|NCT03281668|75981637|FG000|COMPLETED|Overall Study||21||
59856906|NCT03281668|75981637|FG000|NOT COMPLETED|Overall Study||8||
59856907|NCT03307174|75981643|FG000|STARTED|Overall Study||60||
59856908|NCT03307174|75981644|FG001|STARTED|Overall Study||60||
59856909|NCT03307174|75981643|FG000|COMPLETED|Overall Study||46||
59856910|NCT03307174|75981644|FG001|COMPLETED|Overall Study||53||
59856911|NCT03307174|75981643|FG000|NOT COMPLETED|Overall Study||14||
59856912|NCT03307174|75981644|FG001|NOT COMPLETED|Overall Study||7||
59856913|NCT03258814|75981652|FG000|STARTED|Overall Study||4||
59856914|NCT03258814|75981653|FG001|STARTED|Overall Study||3||
59856915|NCT03258814|75981654|FG002|STARTED|Overall Study||10||
59856916|NCT03258814|75981652|FG000|COMPLETED|Overall Study||0||
59856917|NCT03258814|75981653|FG001|COMPLETED|Overall Study||0||
59856918|NCT03258814|75981654|FG002|COMPLETED|Overall Study||0||
59856919|NCT03258814|75981652|FG000|NOT COMPLETED|Overall Study||4||
59856920|NCT03258814|75981653|FG001|NOT COMPLETED|Overall Study||3||
59856921|NCT03258814|75981654|FG002|NOT COMPLETED|Overall Study||10||
59856922|NCT03257410|75981663|FG000|STARTED|Overall Study||86||
59856923|NCT03257410|75981664|FG001|STARTED|Overall Study||86||
59856924|NCT03257410|75981663|FG000|COMPLETED|Overall Study||65||
59856925|NCT03257410|75981664|FG001|COMPLETED|Overall Study||65||
59856926|NCT03257410|75981663|FG000|NOT COMPLETED|Overall Study||21||
59856927|NCT03257410|75981664|FG001|NOT COMPLETED|Overall Study||21||
59856928|NCT00056160|75981672|FG000|STARTED|Up to Unblinding (07 Jun 2005)||177||
59856929|NCT00056160|75981673|FG001|STARTED|Up to Unblinding (07 Jun 2005)||176||
59856930|NCT00056160|75981672|FG000|COMPLETED|Up to Unblinding (07 Jun 2005)||64||
59856931|NCT00056160|75981673|FG001|COMPLETED|Up to Unblinding (07 Jun 2005)||13||
59856932|NCT00056160|75981672|FG000|NOT COMPLETED|Up to Unblinding (07 Jun 2005)||113||
59856933|NCT00056160|75981673|FG001|NOT COMPLETED|Up to Unblinding (07 Jun 2005)||163||
59856934|NCT00056160|75981672|FG000|STARTED|Extended Follow-up Cutoff (23 Jul 2008)||177||
59856935|NCT00056160|75981673|FG001|STARTED|Extended Follow-up Cutoff (23 Jul 2008)||0||
59856936|NCT00056160|75981672|FG000|COMPLETED|Extended Follow-up Cutoff (23 Jul 2008)||6||
59856937|NCT00056160|75981673|FG001|COMPLETED|Extended Follow-up Cutoff (23 Jul 2008)||0||
59856938|NCT00056160|75981672|FG000|NOT COMPLETED|Extended Follow-up Cutoff (23 Jul 2008)||171||
59856939|NCT00056160|75981673|FG001|NOT COMPLETED|Extended Follow-up Cutoff (23 Jul 2008)||0||
59856940|NCT00056160|75981672|FG000|STARTED|Final Follow-up||6||
59856941|NCT00056160|75981673|FG001|STARTED|Final Follow-up||0||
59856942|NCT00056160|75981672|FG000|COMPLETED|Final Follow-up||0||
59856943|NCT00056160|75981673|FG001|COMPLETED|Final Follow-up||0||
59856944|NCT00056160|75981672|FG000|NOT COMPLETED|Final Follow-up||6||
59856945|NCT00056160|75981673|FG001|NOT COMPLETED|Final Follow-up||0||
59856946|NCT00061932|75981681|FG000|STARTED|Overall Study||29||
59856947|NCT00061932|75981682|FG001|STARTED|Overall Study||12||
59856948|NCT00061932|75981681|FG000|COMPLETED|Overall Study||16||
59856949|NCT00061932|75981682|FG001|COMPLETED|Overall Study||8||
59856950|NCT00061932|75981681|FG000|NOT COMPLETED|Overall Study||13||
59856951|NCT00061932|75981682|FG001|NOT COMPLETED|Overall Study||4||
59856952|NCT05342597|75981693|FG000|STARTED|Period 1||4||
59856953|NCT05342597|75981694|FG001|STARTED|Period 1||4||
59856954|NCT05342597|75981695|FG002|STARTED|Period 1||4||
60121880|NCT01566721|76242880|FG001|STARTED|Treatment Period||710||
60121881|NCT01566721|76242879|FG000|COMPLETED|Treatment Period||1670||
59856955|NCT05342597|75981696|FG003|STARTED|Period 1||4||
59856956|NCT05342597|75981693|FG000|COMPLETED|Period 1||4||
59856957|NCT05342597|75981694|FG001|COMPLETED|Period 1||4||
59856958|NCT05342597|75981695|FG002|COMPLETED|Period 1||4||
59856959|NCT05342597|75981696|FG003|COMPLETED|Period 1||4||
59856960|NCT05342597|75981693|FG000|NOT COMPLETED|Period 1||0||
59856961|NCT05342597|75981694|FG001|NOT COMPLETED|Period 1||0||
59856962|NCT05342597|75981695|FG002|NOT COMPLETED|Period 1||0||
59856963|NCT05342597|75981696|FG003|NOT COMPLETED|Period 1||0||
59856964|NCT05342597|75981693|FG000|STARTED|Period 2||4||
59856965|NCT05342597|75981694|FG001|STARTED|Period 2||4||
59856966|NCT05342597|75981695|FG002|STARTED|Period 2||4||
59856967|NCT05342597|75981696|FG003|STARTED|Period 2||4||
59856968|NCT05342597|75981693|FG000|COMPLETED|Period 2||4||
59856969|NCT05342597|75981694|FG001|COMPLETED|Period 2||4||
59856970|NCT05342597|75981695|FG002|COMPLETED|Period 2||4||
59856971|NCT05342597|75981696|FG003|COMPLETED|Period 2||4||
59856972|NCT05342597|75981693|FG000|NOT COMPLETED|Period 2||0||
59856973|NCT05342597|75981694|FG001|NOT COMPLETED|Period 2||0||
59856974|NCT05342597|75981695|FG002|NOT COMPLETED|Period 2||0||
59856975|NCT05342597|75981696|FG003|NOT COMPLETED|Period 2||0||
59856976|NCT05342597|75981693|FG000|STARTED|Period 3||4||
59856977|NCT05342597|75981694|FG001|STARTED|Period 3||4||
59856978|NCT05342597|75981695|FG002|STARTED|Period 3||4||
59856979|NCT05342597|75981696|FG003|STARTED|Period 3||4||
59856980|NCT05342597|75981693|FG000|COMPLETED|Period 3||4||
59856981|NCT05342597|75981694|FG001|COMPLETED|Period 3||4||
59856982|NCT05342597|75981695|FG002|COMPLETED|Period 3||4||
59856983|NCT05342597|75981696|FG003|COMPLETED|Period 3||4||
59856984|NCT05342597|75981693|FG000|NOT COMPLETED|Period 3||0||
59856985|NCT05342597|75981694|FG001|NOT COMPLETED|Period 3||0||
59856986|NCT05342597|75981695|FG002|NOT COMPLETED|Period 3||0||
59856987|NCT05342597|75981696|FG003|NOT COMPLETED|Period 3||0||
59856988|NCT05342597|75981693|FG000|STARTED|Period 4||4||
59856989|NCT05342597|75981694|FG001|STARTED|Period 4||4||
59856990|NCT05342597|75981695|FG002|STARTED|Period 4||4||
59856991|NCT05342597|75981696|FG003|STARTED|Period 4||4||
59856992|NCT05342597|75981693|FG000|COMPLETED|Period 4||4||
59856993|NCT05342597|75981694|FG001|COMPLETED|Period 4||4||
59856994|NCT05342597|75981695|FG002|COMPLETED|Period 4||4||
59856995|NCT05342597|75981696|FG003|COMPLETED|Period 4||4||
59856996|NCT05342597|75981693|FG000|NOT COMPLETED|Period 4||0||
59856997|NCT05342597|75981694|FG001|NOT COMPLETED|Period 4||0||
59856998|NCT05342597|75981695|FG002|NOT COMPLETED|Period 4||0||
59856999|NCT05342597|75981696|FG003|NOT COMPLETED|Period 4||0||
59857000|NCT05342597|75981693|FG000|STARTED|Period 5||4||
59857001|NCT05342597|75981694|FG001|STARTED|Period 5||4||
59857002|NCT05342597|75981695|FG002|STARTED|Period 5||4||
59857003|NCT05342597|75981696|FG003|STARTED|Period 5||4||
59857004|NCT05342597|75981693|FG000|COMPLETED|Period 5||4||
59857005|NCT05342597|75981694|FG001|COMPLETED|Period 5||4||
59857006|NCT05342597|75981695|FG002|COMPLETED|Period 5||4||
59857007|NCT05342597|75981696|FG003|COMPLETED|Period 5||4||
59857008|NCT05342597|75981693|FG000|NOT COMPLETED|Period 5||0||
59857009|NCT05342597|75981694|FG001|NOT COMPLETED|Period 5||0||
59857010|NCT05342597|75981695|FG002|NOT COMPLETED|Period 5||0||
59857011|NCT05342597|75981696|FG003|NOT COMPLETED|Period 5||0||
59857012|NCT05315947|75981708|FG000|STARTED|Overall Study||12||
59857013|NCT05315947|75981709|FG001|STARTED|Overall Study||12||
59857014|NCT05315947|75981708|FG000|COMPLETED|Overall Study||12||
59857015|NCT05315947|75981709|FG001|COMPLETED|Overall Study||12||
59857016|NCT05315947|75981708|FG000|NOT COMPLETED|Overall Study||0||
59857017|NCT05315947|75981709|FG001|NOT COMPLETED|Overall Study||0||
59857018|NCT05090709|75981717|FG000|STARTED|Overall Study||10||
59857019|NCT05090709|75981718|FG001|STARTED|Overall Study||10||
59857020|NCT05090709|75981717|FG000|COMPLETED|Overall Study||10||
59857021|NCT05090709|75981718|FG001|COMPLETED|Overall Study||10||
59857022|NCT05090709|75981717|FG000|NOT COMPLETED|Overall Study||0||
59857023|NCT05090709|75981718|FG001|NOT COMPLETED|Overall Study||0||
59857024|NCT04984889|75981724|FG000|STARTED|PK Part||5||
59857025|NCT04984889|75981724|FG000|COMPLETED|PK Part||5||
59857026|NCT04984889|75981724|FG000|NOT COMPLETED|PK Part||0||
59857027|NCT04984889|75981724|FG000|STARTED|Extension Part|All participants who completed PK part entered Extension part of the study.|5||
59857028|NCT04984889|75981724|FG000|COMPLETED|Extension Part||0||
59857029|NCT04984889|75981724|FG000|NOT COMPLETED|Extension Part||5||
59857030|NCT04851873|75981731|FG000|STARTED|Overall Study||7||
59857031|NCT04851873|75981732|FG001|STARTED|Overall Study||8||
59857032|NCT04851873|75981733|FG002|STARTED|Overall Study||9||
59857033|NCT04851873|75981731|FG000|COMPLETED|Overall Study||7||
59857034|NCT04851873|75981732|FG001|COMPLETED|Overall Study||8||
59857035|NCT04851873|75981733|FG002|COMPLETED|Overall Study||9||
59857036|NCT04851873|75981731|FG000|NOT COMPLETED|Overall Study||0||
59857037|NCT04851873|75981732|FG001|NOT COMPLETED|Overall Study||0||
59857038|NCT04851873|75981733|FG002|NOT COMPLETED|Overall Study||0||
59857039|NCT04769739|75981750|FG000|STARTED|Overall Study||73||
59857040|NCT04769739|75981751|FG001|STARTED|Overall Study||75||
59857041|NCT04769739|75981752|FG002|STARTED|Overall Study||76||
59857042|NCT04769739|75981753|FG003|STARTED|Overall Study||77||
59857043|NCT04769739|75981750|FG000|COMPLETED|Overall Study||70||
59857044|NCT04769739|75981751|FG001|COMPLETED|Overall Study||75||
59857045|NCT04769739|75981752|FG002|COMPLETED|Overall Study||76||
59857046|NCT04769739|75981753|FG003|COMPLETED|Overall Study||75||
59857047|NCT04769739|75981750|FG000|NOT COMPLETED|Overall Study||3||
59857048|NCT04769739|75981751|FG001|NOT COMPLETED|Overall Study||0||
59857049|NCT04769739|75981752|FG002|NOT COMPLETED|Overall Study||0||
59857050|NCT04769739|75981753|FG003|NOT COMPLETED|Overall Study||2||
59857051|NCT04750278|75981766|FG000|STARTED|Overall Study||30||
59857052|NCT04750278|75981767|FG001|STARTED|Overall Study||29||
59857053|NCT04750278|75981768|FG002|STARTED|Overall Study||31||
59857054|NCT04750278|75981766|FG000|Completed D28 Visit|Overall Study||16||
59857055|NCT04750278|75981767|FG001|Completed D28 Visit|Overall Study||16||
59857056|NCT04750278|75981768|FG002|Completed D28 Visit|Overall Study||18||
59857057|NCT04750278|75981766|FG000|COMPLETED|Overall Study||15||
59857058|NCT04750278|75981767|FG001|COMPLETED|Overall Study||13||
59857059|NCT04750278|75981768|FG002|COMPLETED|Overall Study||15||
59857060|NCT04750278|75981766|FG000|NOT COMPLETED|Overall Study||15||
59857061|NCT04750278|75981767|FG001|NOT COMPLETED|Overall Study||16||
59857062|NCT04750278|75981768|FG002|NOT COMPLETED|Overall Study||16||
59857063|NCT04570150|75981778|FG000|STARTED|Overall Study||45||
59857064|NCT04570150|75981779|FG001|STARTED|Overall Study||45||
59857065|NCT04570150|75981778|FG000|COMPLETED|Overall Study||45||
59857066|NCT04570150|75981779|FG001|COMPLETED|Overall Study||45||
59857067|NCT04570150|75981778|FG000|NOT COMPLETED|Overall Study||0||
59857068|NCT04570150|75981779|FG001|NOT COMPLETED|Overall Study||0||
59857069|NCT04506866|75981788|FG000|STARTED|Overall Study||68||
59857070|NCT04506866|75981789|FG001|STARTED|Overall Study||53||
59857071|NCT04506866|75981790|FG002|STARTED|Overall Study||27||
59857072|NCT04506866|75981788|FG000|COMPLETED|Overall Study||67||
59857073|NCT04506866|75981789|FG001|COMPLETED|Overall Study||52||
59857074|NCT04506866|75981790|FG002|COMPLETED|Overall Study||25||
59857075|NCT04506866|75981788|FG000|NOT COMPLETED|Overall Study||1||
59857076|NCT04506866|75981789|FG001|NOT COMPLETED|Overall Study||1||
59857077|NCT04506866|75981790|FG002|NOT COMPLETED|Overall Study||2||
59857078|NCT04448678|75981800|FG000|STARTED|Overall Study||45||
59857079|NCT04448678|75981801|FG001|STARTED|Overall Study||41||
59857080|NCT04448678|75981800|FG000|COMPLETED|Overall Study||25||
59857081|NCT04448678|75981801|FG001|COMPLETED|Overall Study||39||
59857082|NCT04448678|75981800|FG000|NOT COMPLETED|Overall Study||20||
59857083|NCT04448678|75981801|FG001|NOT COMPLETED|Overall Study||2||
59857084|NCT04423718|75981815|FG000|STARTED|Overall Study||337|Randomized|
59857085|NCT04423718|75981816|FG001|STARTED|Overall Study||336|Randomized|
59857086|NCT04423718|75981817|FG002|STARTED|Overall Study||338|Randomized|
59857087|NCT04423718|75981815|FG000|Treated|Overall Study||336||
59857088|NCT04423718|75981816|FG001|Treated|Overall Study||335||
59726360|NCT01190228|75845168|FG002|NOT COMPLETED|Overall Study||0||
59726361|NCT01009086|75845181|FG000|STARTED|Overall Study||206||
59726362|NCT01009086|75845182|FG001|STARTED|Overall Study||205||
59726363|NCT01009086|75845183|FG002|STARTED|Overall Study||204||
59857089|NCT04423718|75981817|FG002|Treated|Overall Study||338||
59857090|NCT04423718|75981815|FG000|Completed Week 48|Overall Study||309||
59857091|NCT04423718|75981816|FG001|Completed Week 48|Overall Study||316||
59857092|NCT04423718|75981817|FG002|Completed Week 48|Overall Study||312||
59857093|NCT04423718|75981815|FG000|COMPLETED|Overall Study||305|Completed study treatment until Week 60|
59857094|NCT04423718|75981816|FG001|COMPLETED|Overall Study||310|Completed study treatment until Week 60|
59857095|NCT04423718|75981817|FG002|COMPLETED|Overall Study||308|Completed study treatment until Week 60|
59857096|NCT04423718|75981815|FG000|NOT COMPLETED|Overall Study||32||
59857097|NCT04423718|75981816|FG001|NOT COMPLETED|Overall Study||26||
59857098|NCT04423718|75981817|FG002|NOT COMPLETED|Overall Study||30||
59857099|NCT04401904|75981831|FG000|STARTED|Overall Study||10||
59857100|NCT04401904|75981832|FG001|STARTED|Overall Study||10||
59857101|NCT04401904|75981831|FG000|COMPLETED|Overall Study||10||
59857102|NCT04401904|75981832|FG001|COMPLETED|Overall Study||10||
59857103|NCT04401904|75981831|FG000|NOT COMPLETED|Overall Study||0||
59857104|NCT04401904|75981832|FG001|NOT COMPLETED|Overall Study||0||
59857105|NCT04343534|75981840|FG000|STARTED|Overall Study||230||
59857106|NCT04343534|75981841|FG001|STARTED|Overall Study||264||
59857107|NCT04343534|75981840|FG000|COMPLETED|Overall Study||230||
59857108|NCT04343534|75981841|FG001|COMPLETED|Overall Study||264||
59857109|NCT04343534|75981840|FG000|NOT COMPLETED|Overall Study||0||
59857110|NCT04343534|75981841|FG001|NOT COMPLETED|Overall Study||0||
59857111|NCT04317274|75981851|FG000|STARTED|Overall Study||97||
59857112|NCT04317274|75981852|FG001|STARTED|Overall Study||94||
59857113|NCT04317274|75981853|FG002|STARTED|Overall Study||103||
59857114|NCT04317274|75981854|FG003|STARTED|Overall Study||107||
59857115|NCT04317274|75981851|FG000|COMPLETED|Overall Study||95||
59857116|NCT04317274|75981852|FG001|COMPLETED|Overall Study||91||
59857117|NCT04317274|75981853|FG002|COMPLETED|Overall Study||99||
60121882|NCT01566721|76242880|FG001|COMPLETED|Treatment Period||652||
60121883|NCT01566721|76242879|FG000|NOT COMPLETED|Treatment Period||197||
60121884|NCT01566721|76242880|FG001|NOT COMPLETED|Treatment Period||58||
59726364|NCT01009086|75845181|FG000|COMPLETED|Overall Study||162||
59726365|NCT01009086|75845182|FG001|COMPLETED|Overall Study||158||
59857118|NCT04317274|75981854|FG003|COMPLETED|Overall Study||103||
59857119|NCT04317274|75981851|FG000|NOT COMPLETED|Overall Study||2||
59857120|NCT04317274|75981852|FG001|NOT COMPLETED|Overall Study||3||
60121885|NCT01566721|76242879|FG000|STARTED|Safety Follow-up|Participants who discontinued treatment were allowed to join the SFU Period.|1865||
60121886|NCT01566721|76242880|FG001|STARTED|Safety Follow-up|Participants who discontinued treatment were allowed to join the SFU Period.|708||
59726366|NCT01009086|75845183|FG002|COMPLETED|Overall Study||170||
59726367|NCT01009086|75845181|FG000|NOT COMPLETED|Overall Study||44||
59726368|NCT01009086|75845182|FG001|NOT COMPLETED|Overall Study||47||
59857121|NCT04317274|75981853|FG002|NOT COMPLETED|Overall Study||4||
59857122|NCT04317274|75981854|FG003|NOT COMPLETED|Overall Study||4||
59857123|NCT03875911|75981867|FG000|STARTED|Overall Study||6||7
59857124|NCT03875911|75981868|FG001|STARTED|Overall Study||7||7
59857125|NCT03875911|75981869|FG002|STARTED|Overall Study||6||6
59857126|NCT03875911|75981867|FG000|COMPLETED|Overall Study||2||3
59857127|NCT03875911|75981868|FG001|COMPLETED|Overall Study||1||1
59857128|NCT03875911|75981869|FG002|COMPLETED|Overall Study||2||2
59857129|NCT03875911|75981867|FG000|NOT COMPLETED|Overall Study||4||4
59857130|NCT03875911|75981868|FG001|NOT COMPLETED|Overall Study||6||6
59857131|NCT03875911|75981869|FG002|NOT COMPLETED|Overall Study||4||4
59857132|NCT03854019|75981879|FG000|STARTED|First Intervention (4 Weeks)||10||
59857133|NCT03854019|75981880|FG001|STARTED|First Intervention (4 Weeks)||10||
59857134|NCT03854019|75981879|FG000|COMPLETED|First Intervention (4 Weeks)||9||
59857135|NCT03854019|75981880|FG001|COMPLETED|First Intervention (4 Weeks)||9||
59857136|NCT03854019|75981879|FG000|NOT COMPLETED|First Intervention (4 Weeks)||1||
59857137|NCT03854019|75981880|FG001|NOT COMPLETED|First Intervention (4 Weeks)||1||
59857138|NCT03854019|75981879|FG000|STARTED|Washout (1 Week)||9||
59857139|NCT03854019|75981880|FG001|STARTED|Washout (1 Week)||9||
59857140|NCT03854019|75981879|FG000|COMPLETED|Washout (1 Week)||9||
59857141|NCT03854019|75981880|FG001|COMPLETED|Washout (1 Week)||9||
59857142|NCT03854019|75981879|FG000|NOT COMPLETED|Washout (1 Week)||0||
59857143|NCT03854019|75981880|FG001|NOT COMPLETED|Washout (1 Week)||0||
59857144|NCT03854019|75981879|FG000|STARTED|Second Intervention (4 Weeks)||9||
59857145|NCT03854019|75981880|FG001|STARTED|Second Intervention (4 Weeks)||9||
59857146|NCT03854019|75981879|FG000|COMPLETED|Second Intervention (4 Weeks)||9||
59857147|NCT03854019|75981880|FG001|COMPLETED|Second Intervention (4 Weeks)||9||
59857148|NCT03854019|75981879|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0||
59857149|NCT03854019|75981880|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||0||
59857150|NCT03836053|75981891|FG000|STARTED|Overall Study||1||
59857151|NCT03836053|75981892|FG001|STARTED|Overall Study||12||
59857152|NCT03836053|75981893|FG002|STARTED|Overall Study||10||
59857153|NCT03836053|75981891|FG000|COMPLETED|Overall Study||0||
59857154|NCT03836053|75981892|FG001|COMPLETED|Overall Study||2||
59857155|NCT03836053|75981893|FG002|COMPLETED|Overall Study||0||
59857156|NCT03836053|75981891|FG000|NOT COMPLETED|Overall Study||1||
60121887|NCT01566721|76242879|FG000|COMPLETED|Safety Follow-up||1318||
60121888|NCT01566721|76242880|FG001|COMPLETED|Safety Follow-up||501||
60121889|NCT01566721|76242879|FG000|NOT COMPLETED|Safety Follow-up||547||
59726369|NCT01009086|75845183|FG002|NOT COMPLETED|Overall Study||34||
59726370|NCT01190150|75845198|FG000|STARTED|First Treatment|Randomized, as well as Safety and PK populations|11||
59857157|NCT03836053|75981892|FG001|NOT COMPLETED|Overall Study||10||
59857158|NCT03836053|75981893|FG002|NOT COMPLETED|Overall Study||10||
59857159|NCT03711058|75981905|FG000|STARTED|Overall Study||6|started = enrolled and received at least one dose of study drug|
59857160|NCT03711058|75981906|FG001|STARTED|Overall Study||21|started = enrolled and received at least one dose of study drug|
59857161|NCT03711058|75981907|FG002|STARTED|Overall Study||12|started = enrolled and received at least one dose of study drug|
59857162|NCT03711058|75981905|FG000|COMPLETED|Overall Study||6||
59857163|NCT03711058|75981906|FG001|COMPLETED|Overall Study||21||
59857164|NCT03711058|75981907|FG002|COMPLETED|Overall Study||12||
59857165|NCT03711058|75981905|FG000|NOT COMPLETED|Overall Study||0||
59857166|NCT03711058|75981906|FG001|NOT COMPLETED|Overall Study||0||
59857167|NCT03711058|75981907|FG002|NOT COMPLETED|Overall Study||0||
59857168|NCT03647137|75981922|FG000|STARTED|Overall Study||13||
59857169|NCT03647137|75981923|FG001|STARTED|Overall Study||7||
59857170|NCT03647137|75981924|FG002|STARTED|Overall Study||10||
59857171|NCT03647137|75981925|FG003|STARTED|Overall Study||7||
59857172|NCT03647137|75981922|FG000|Received DTBZ, PIB, and FEOVB PET Scan|Overall Study||11||
59857173|NCT03647137|75981923|FG001|Received DTBZ, PIB, and FEOVB PET Scan|Overall Study||6||
59857174|NCT03647137|75981924|FG002|Received DTBZ, PIB, and FEOVB PET Scan|Overall Study||9||
59857175|NCT03647137|75981925|FG003|Received DTBZ, PIB, and FEOVB PET Scan|Overall Study||5||
59857176|NCT03647137|75981922|FG000|COMPLETED|Overall Study||11||
59857177|NCT03647137|75981923|FG001|COMPLETED|Overall Study||6||
59857178|NCT03647137|75981924|FG002|COMPLETED|Overall Study||9||
59857179|NCT03647137|75981925|FG003|COMPLETED|Overall Study||5||
59857180|NCT03647137|75981922|FG000|NOT COMPLETED|Overall Study||2||
59857181|NCT03647137|75981923|FG001|NOT COMPLETED|Overall Study||1||
59857182|NCT03647137|75981924|FG002|NOT COMPLETED|Overall Study||1||
59857183|NCT03647137|75981925|FG003|NOT COMPLETED|Overall Study||2||
59857184|NCT03481660|75981938|FG000|STARTED|Overall Study||179|All randomized treated patients were included in the Full Analysis Set (FAS) and Safety Analysis Set (SAF)|
59857185|NCT03481660|75981939|FG001|STARTED|Overall Study||181|All randomized treated patients were included in the Full Analysis Set (FAS) and Safety Analysis Set (SAF)|
59857186|NCT03481660|75981938|FG000|COMPLETED|Overall Study||143||
59857187|NCT03481660|75981939|FG001|COMPLETED|Overall Study||156||
60121890|NCT01566721|76242880|FG001|NOT COMPLETED|Safety Follow-up||207||
60121891|NCT01541215|76242895|FG000|STARTED|Treatment Period (52 Weeks)||66||
60121892|NCT01541215|76242896|FG001|STARTED|Treatment Period (52 Weeks)||69||
60121893|NCT01541215|76242895|FG000|Exposed|Treatment Period (52 Weeks)||66||
59726371|NCT01190150|75845199|FG001|STARTED|First Treatment|Randomized, as well as Safety and PK populations|9||
59726372|NCT01190150|75845198|FG000|COMPLETED|First Treatment||10||
59726373|NCT01190150|75845199|FG001|COMPLETED|First Treatment||9||
59726374|NCT01190150|75845198|FG000|NOT COMPLETED|First Treatment||1||
59726375|NCT01190150|75845199|FG001|NOT COMPLETED|First Treatment||0||
59726376|NCT01190150|75845198|FG000|STARTED|Washout||10||
59726377|NCT01190150|75845199|FG001|STARTED|Washout||9||
59726378|NCT01190150|75845198|FG000|COMPLETED|Washout||10||
59726379|NCT01190150|75845199|FG001|COMPLETED|Washout||7||
59857188|NCT03481660|75981938|FG000|NOT COMPLETED|Overall Study||36||
59857189|NCT03481660|75981939|FG001|NOT COMPLETED|Overall Study||25||
59857190|NCT03454893|75981946|FG000|STARTED|Overall Study||15||
59857191|NCT03454893|75981946|FG000|Safety Population|Overall Study||11||
59857192|NCT03454893|75981946|FG000|Infused Population|Overall Study||9||
59857193|NCT03454893|75981946|FG000|COMPLETED|Overall Study||6||
59857194|NCT03454893|75981946|FG000|NOT COMPLETED|Overall Study||9||
59857195|NCT03379792|75981956|FG000|STARTED|Overall Study||6||
59857196|NCT03379792|75981957|FG001|STARTED|Overall Study||9||
59857197|NCT03379792|75981958|FG002|STARTED|Overall Study||5||
59857198|NCT03379792|75981959|FG003|STARTED|Overall Study||4||
59857199|NCT03379792|75981960|FG004|STARTED|Overall Study||4||
59857200|NCT03379792|75981961|FG005|STARTED|Overall Study||4||
59857201|NCT03379792|75981956|FG000|COMPLETED|Overall Study||6||
59857202|NCT03379792|75981957|FG001|COMPLETED|Overall Study||9||
59857203|NCT03379792|75981958|FG002|COMPLETED|Overall Study||5||
59857204|NCT03379792|75981959|FG003|COMPLETED|Overall Study||3||
59857205|NCT03379792|75981960|FG004|COMPLETED|Overall Study||3||
59857206|NCT03379792|75981961|FG005|COMPLETED|Overall Study||3||
59857207|NCT03379792|75981956|FG000|NOT COMPLETED|Overall Study||0||
59857208|NCT03379792|75981957|FG001|NOT COMPLETED|Overall Study||0||
59857209|NCT03379792|75981958|FG002|NOT COMPLETED|Overall Study||0||
59857210|NCT03379792|75981959|FG003|NOT COMPLETED|Overall Study||1||
59857211|NCT03379792|75981960|FG004|NOT COMPLETED|Overall Study||1||
59857212|NCT03379792|75981961|FG005|NOT COMPLETED|Overall Study||1||
59857213|NCT03370133|75981978|FG000|STARTED|Initial Treatment Period (WK 16)||83||
59857214|NCT03370133|75981979|FG001|STARTED|Initial Treatment Period (WK 16)||321||
59857215|NCT03370133|75981980|FG002|STARTED|Initial Treatment Period (WK 16)||163||
59857216|NCT03370133|75981981|FG003|STARTED|Initial Treatment Period (WK 16)||0||
59857217|NCT03370133|75981982|FG004|STARTED|Initial Treatment Period (WK 16)||0||
59857218|NCT03370133|75981983|FG005|STARTED|Initial Treatment Period (WK 16)||0||
59857219|NCT03370133|75981978|FG000|COMPLETED|Initial Treatment Period (WK 16)||74||
59857220|NCT03370133|75981979|FG001|COMPLETED|Initial Treatment Period (WK 16)||306||
59857221|NCT03370133|75981980|FG002|COMPLETED|Initial Treatment Period (WK 16)||157||
59857222|NCT03370133|75981981|FG003|COMPLETED|Initial Treatment Period (WK 16)||0||
59857223|NCT03370133|75981982|FG004|COMPLETED|Initial Treatment Period (WK 16)||0||
59857224|NCT03370133|75981983|FG005|COMPLETED|Initial Treatment Period (WK 16)||0||
59857225|NCT03370133|75981978|FG000|NOT COMPLETED|Initial Treatment Period (WK 16)||9||
59857226|NCT03370133|75981979|FG001|NOT COMPLETED|Initial Treatment Period (WK 16)||15||
59857227|NCT03370133|75981980|FG002|NOT COMPLETED|Initial Treatment Period (WK 16)||6||
59857228|NCT03370133|75981981|FG003|NOT COMPLETED|Initial Treatment Period (WK 16)||0||
59857229|NCT03370133|75981982|FG004|NOT COMPLETED|Initial Treatment Period (WK 16)||0||
59857230|NCT03370133|75981983|FG005|NOT COMPLETED|Initial Treatment Period (WK 16)||0||
59857231|NCT03370133|75981978|FG000|STARTED|Maintenance Treatment Period (WK 52)||0||
59857232|NCT03370133|75981979|FG001|STARTED|Maintenance Treatment Period (WK 52)||0||
59857233|NCT03370133|75981980|FG002|STARTED|Maintenance Treatment Period (WK 52)||0||
59857234|NCT03370133|75981981|FG003|STARTED|Maintenance Treatment Period (WK 52)||74||
59857235|NCT03370133|75981982|FG004|STARTED|Maintenance Treatment Period (WK 52)||306||
59857236|NCT03370133|75981983|FG005|STARTED|Maintenance Treatment Period (WK 52)||157||
59857237|NCT03370133|75981978|FG000|COMPLETED|Maintenance Treatment Period (WK 52)||0||
59857238|NCT03370133|75981979|FG001|COMPLETED|Maintenance Treatment Period (WK 52)||0||
59857239|NCT03370133|75981980|FG002|COMPLETED|Maintenance Treatment Period (WK 52)||0||
59857240|NCT03370133|75981981|FG003|COMPLETED|Maintenance Treatment Period (WK 52)||69||
59857241|NCT03370133|75981982|FG004|COMPLETED|Maintenance Treatment Period (WK 52)||283||
59857242|NCT03370133|75981983|FG005|COMPLETED|Maintenance Treatment Period (WK 52)||141||
59857243|NCT03370133|75981978|FG000|NOT COMPLETED|Maintenance Treatment Period (WK 52)||0||
59857244|NCT03370133|75981979|FG001|NOT COMPLETED|Maintenance Treatment Period (WK 52)||0||
59857245|NCT03370133|75981980|FG002|NOT COMPLETED|Maintenance Treatment Period (WK 52)||0||
59857246|NCT03370133|75981981|FG003|NOT COMPLETED|Maintenance Treatment Period (WK 52)||5||
59857247|NCT03370133|75981982|FG004|NOT COMPLETED|Maintenance Treatment Period (WK 52)||23||
59857248|NCT03370133|75981983|FG005|NOT COMPLETED|Maintenance Treatment Period (WK 52)||16||
59857249|NCT03227757|75982001|FG000|STARTED|Overall Study||85||
59857250|NCT03227757|75982001|FG000|COMPLETED|Overall Study||69||
59857251|NCT03227757|75982001|FG000|NOT COMPLETED|Overall Study||16||
59857252|NCT03149549|75982018|FG000|STARTED|Study Discontinuation--Treatment Period||1||
59857253|NCT03149549|75982019|FG001|STARTED|Study Discontinuation--Treatment Period||3||
59857254|NCT03149549|75982020|FG002|STARTED|Study Discontinuation--Treatment Period||3||
59857255|NCT03149549|75982021|FG003|STARTED|Study Discontinuation--Treatment Period||3||
59857256|NCT03149549|75982022|FG004|STARTED|Study Discontinuation--Treatment Period||10||
59857257|NCT03149549|75982023|FG005|STARTED|Study Discontinuation--Treatment Period||9||
59857258|NCT03149549|75982024|FG006|STARTED|Study Discontinuation--Treatment Period||9||
59857259|NCT03149549|75982025|FG007|STARTED|Study Discontinuation--Treatment Period||12||
59857260|NCT03149549|75982026|FG008|STARTED|Study Discontinuation--Treatment Period||22||
59857261|NCT03149549|75982027|FG009|STARTED|Study Discontinuation--Treatment Period||9||
59857262|NCT03149549|75982028|FG010|STARTED|Study Discontinuation--Treatment Period||8||
59857263|NCT03149549|75982029|FG011|STARTED|Study Discontinuation--Treatment Period||4||
59857264|NCT03149549|75982030|FG012|STARTED|Study Discontinuation--Treatment Period||6||
59857265|NCT03149549|75982018|FG000|COMPLETED|Study Discontinuation--Treatment Period||1||
59857266|NCT03149549|75982019|FG001|COMPLETED|Study Discontinuation--Treatment Period||3||
59857267|NCT03149549|75982020|FG002|COMPLETED|Study Discontinuation--Treatment Period||3||
59857268|NCT03149549|75982021|FG003|COMPLETED|Study Discontinuation--Treatment Period||1||
59857269|NCT03149549|75982022|FG004|COMPLETED|Study Discontinuation--Treatment Period||6||
59857270|NCT03149549|75982023|FG005|COMPLETED|Study Discontinuation--Treatment Period||7||
59857271|NCT03149549|75982024|FG006|COMPLETED|Study Discontinuation--Treatment Period||6||
59857272|NCT03149549|75982025|FG007|COMPLETED|Study Discontinuation--Treatment Period||8||
59857273|NCT03149549|75982026|FG008|COMPLETED|Study Discontinuation--Treatment Period||16||
59857274|NCT03149549|75982027|FG009|COMPLETED|Study Discontinuation--Treatment Period||7||
59857275|NCT03149549|75982028|FG010|COMPLETED|Study Discontinuation--Treatment Period||8||
59857276|NCT03149549|75982029|FG011|COMPLETED|Study Discontinuation--Treatment Period||4||
59857277|NCT03149549|75982030|FG012|COMPLETED|Study Discontinuation--Treatment Period||4||
59857278|NCT03149549|75982018|FG000|NOT COMPLETED|Study Discontinuation--Treatment Period||0||
59857279|NCT03149549|75982019|FG001|NOT COMPLETED|Study Discontinuation--Treatment Period||0||
59857280|NCT03149549|75982020|FG002|NOT COMPLETED|Study Discontinuation--Treatment Period||0||
59857281|NCT03149549|75982021|FG003|NOT COMPLETED|Study Discontinuation--Treatment Period||2||
59857282|NCT03149549|75982022|FG004|NOT COMPLETED|Study Discontinuation--Treatment Period||4||
59857283|NCT03149549|75982023|FG005|NOT COMPLETED|Study Discontinuation--Treatment Period||2||
59857284|NCT03149549|75982024|FG006|NOT COMPLETED|Study Discontinuation--Treatment Period||3||
59857285|NCT03149549|75982025|FG007|NOT COMPLETED|Study Discontinuation--Treatment Period||4||
59857286|NCT03149549|75982026|FG008|NOT COMPLETED|Study Discontinuation--Treatment Period||6||
59857287|NCT03149549|75982027|FG009|NOT COMPLETED|Study Discontinuation--Treatment Period||2||
59857288|NCT03149549|75982028|FG010|NOT COMPLETED|Study Discontinuation--Treatment Period||0||
59857289|NCT03149549|75982029|FG011|NOT COMPLETED|Study Discontinuation--Treatment Period||0||
59857290|NCT03149549|75982030|FG012|NOT COMPLETED|Study Discontinuation--Treatment Period||2||
59857291|NCT03149549|75982018|FG000|STARTED|Study Discontinuation--Follow-Up Period||1||
59857292|NCT03149549|75982019|FG001|STARTED|Study Discontinuation--Follow-Up Period||3||
59857293|NCT03149549|75982020|FG002|STARTED|Study Discontinuation--Follow-Up Period||3||
59857294|NCT03149549|75982021|FG003|STARTED|Study Discontinuation--Follow-Up Period||1||
59857295|NCT03149549|75982022|FG004|STARTED|Study Discontinuation--Follow-Up Period||6||
59857296|NCT03149549|75982023|FG005|STARTED|Study Discontinuation--Follow-Up Period||7||
59857297|NCT03149549|75982024|FG006|STARTED|Study Discontinuation--Follow-Up Period||6||
59857298|NCT03149549|75982025|FG007|STARTED|Study Discontinuation--Follow-Up Period||8||
59857299|NCT03149549|75982026|FG008|STARTED|Study Discontinuation--Follow-Up Period||16||
59857300|NCT03149549|75982027|FG009|STARTED|Study Discontinuation--Follow-Up Period||7||
59857301|NCT03149549|75982028|FG010|STARTED|Study Discontinuation--Follow-Up Period||8||
59857302|NCT03149549|75982029|FG011|STARTED|Study Discontinuation--Follow-Up Period||4||
59857303|NCT03149549|75982030|FG012|STARTED|Study Discontinuation--Follow-Up Period||4||
59857304|NCT03149549|75982018|FG000|COMPLETED|Study Discontinuation--Follow-Up Period||0||
59857305|NCT03149549|75982019|FG001|COMPLETED|Study Discontinuation--Follow-Up Period||0||
59857306|NCT03149549|75982020|FG002|COMPLETED|Study Discontinuation--Follow-Up Period||0||
59857307|NCT03149549|75982021|FG003|COMPLETED|Study Discontinuation--Follow-Up Period||0||
59857308|NCT03149549|75982022|FG004|COMPLETED|Study Discontinuation--Follow-Up Period||0||
59857309|NCT03149549|75982023|FG005|COMPLETED|Study Discontinuation--Follow-Up Period||0||
59857310|NCT03149549|75982024|FG006|COMPLETED|Study Discontinuation--Follow-Up Period||0||
59857311|NCT03149549|75982025|FG007|COMPLETED|Study Discontinuation--Follow-Up Period||0||
59857312|NCT03149549|75982026|FG008|COMPLETED|Study Discontinuation--Follow-Up Period||0||
59857313|NCT03149549|75982027|FG009|COMPLETED|Study Discontinuation--Follow-Up Period||0||
59857314|NCT03149549|75982028|FG010|COMPLETED|Study Discontinuation--Follow-Up Period||0||
59857315|NCT03149549|75982029|FG011|COMPLETED|Study Discontinuation--Follow-Up Period||0||
59857316|NCT03149549|75982030|FG012|COMPLETED|Study Discontinuation--Follow-Up Period||0||
59857317|NCT03149549|75982018|FG000|NOT COMPLETED|Study Discontinuation--Follow-Up Period||1||
59857318|NCT03149549|75982019|FG001|NOT COMPLETED|Study Discontinuation--Follow-Up Period||3||
59857319|NCT03149549|75982020|FG002|NOT COMPLETED|Study Discontinuation--Follow-Up Period||3||
59857320|NCT03149549|75982021|FG003|NOT COMPLETED|Study Discontinuation--Follow-Up Period||1||
59857321|NCT03149549|75982022|FG004|NOT COMPLETED|Study Discontinuation--Follow-Up Period||6||
59857322|NCT03149549|75982023|FG005|NOT COMPLETED|Study Discontinuation--Follow-Up Period||7||
59857323|NCT03149549|75982024|FG006|NOT COMPLETED|Study Discontinuation--Follow-Up Period||6||
59857324|NCT03149549|75982025|FG007|NOT COMPLETED|Study Discontinuation--Follow-Up Period||8||
59857325|NCT03149549|75982026|FG008|NOT COMPLETED|Study Discontinuation--Follow-Up Period||16||
59857326|NCT03149549|75982027|FG009|NOT COMPLETED|Study Discontinuation--Follow-Up Period||7||
59857327|NCT03149549|75982028|FG010|NOT COMPLETED|Study Discontinuation--Follow-Up Period||8||
59857328|NCT03149549|75982029|FG011|NOT COMPLETED|Study Discontinuation--Follow-Up Period||4||
60121894|NCT01541215|76242896|FG001|Exposed|Treatment Period (52 Weeks)||68||
60121895|NCT01541215|76242895|FG000|COMPLETED|Treatment Period (52 Weeks)||56||
59857329|NCT03149549|75982030|FG012|NOT COMPLETED|Study Discontinuation--Follow-Up Period||4||
60121896|NCT01541215|76242896|FG001|COMPLETED|Treatment Period (52 Weeks)||53||
60121897|NCT01541215|76242895|FG000|NOT COMPLETED|Treatment Period (52 Weeks)||10||
60121898|NCT01541215|76242896|FG001|NOT COMPLETED|Treatment Period (52 Weeks)||16||
60121899|NCT01541215|76242895|FG000|STARTED|Follow up 1 (Weeks 53-104)|Subjects who attended safety follow up visit at week 104 were included.|52||
60121900|NCT01541215|76242896|FG001|STARTED|Follow up 1 (Weeks 53-104)|Follow up was not planned for the subjects who received placebo.|0||
60121901|NCT01541215|76242895|FG000|COMPLETED|Follow up 1 (Weeks 53-104)||50||
60121902|NCT01541215|76242896|FG001|COMPLETED|Follow up 1 (Weeks 53-104)||0||
60121903|NCT01541215|76242895|FG000|NOT COMPLETED|Follow up 1 (Weeks 53-104)||2||
60121904|NCT01541215|76242896|FG001|NOT COMPLETED|Follow up 1 (Weeks 53-104)||0||
60121905|NCT01541215|76242895|FG000|STARTED|Follow up 2 (Weeks 105-156)|Subjects who attended safety follow up visit at week 156 were included.|48||
60121906|NCT01541215|76242896|FG001|STARTED|Follow up 2 (Weeks 105-156)||0||
60121907|NCT01541215|76242895|FG000|COMPLETED|Follow up 2 (Weeks 105-156)||48||
60121908|NCT01541215|76242896|FG001|COMPLETED|Follow up 2 (Weeks 105-156)||0||
60121909|NCT01541215|76242895|FG000|NOT COMPLETED|Follow up 2 (Weeks 105-156)||0||
60121910|NCT01541215|76242896|FG001|NOT COMPLETED|Follow up 2 (Weeks 105-156)||0||
60121911|NCT01540981|76242908|FG000|STARTED|Overall Study||6||
60121912|NCT01540981|76242909|FG001|STARTED|Overall Study||6||
60121913|NCT01540981|76242908|FG000|COMPLETED|Overall Study||5||
60121914|NCT01540981|76242909|FG001|COMPLETED|Overall Study||6||
60121915|NCT01540981|76242908|FG000|NOT COMPLETED|Overall Study||1||
60121916|NCT01540981|76242909|FG001|NOT COMPLETED|Overall Study||0||
60121917|NCT01585987|76242917|FG000|STARTED|Randomized||57||
60121918|NCT01585987|76242918|FG001|STARTED|Randomized||57||
60121919|NCT01585987|76242917|FG000|COMPLETED|Randomized||57||
60121920|NCT01585987|76242918|FG001|COMPLETED|Randomized||51||
60121921|NCT01585987|76242917|FG000|NOT COMPLETED|Randomized||0||
60121922|NCT01585987|76242918|FG001|NOT COMPLETED|Randomized||6||
60121923|NCT01585987|76242917|FG000|STARTED|Treated||57||
60121924|NCT01585987|76242918|FG001|STARTED|Treated||51||
60121925|NCT01585987|76242917|FG000|COMPLETED|Treated||3||
60121926|NCT01585987|76242918|FG001|COMPLETED|Treated||2||
60121927|NCT01585987|76242917|FG000|NOT COMPLETED|Treated||54||
60121928|NCT01585987|76242918|FG001|NOT COMPLETED|Treated||49||
60121929|NCT01585831|76242927|FG000|STARTED|Overall Study||28||
59857330|NCT03058796|75982061|FG000|STARTED|Overall Study||27||
59857331|NCT03058796|75982062|FG001|STARTED|Overall Study||25||
59857332|NCT03058796|75982061|FG000|COMPLETED|Overall Study||18||
60121930|NCT01585831|76242928|FG001|STARTED|Overall Study||20||
60121931|NCT01585831|76242927|FG000|COMPLETED|Overall Study||26||
60121932|NCT01585831|76242928|FG001|COMPLETED|Overall Study||18||
60121933|NCT01585831|76242927|FG000|NOT COMPLETED|Overall Study||2||
60121934|NCT01585831|76242928|FG001|NOT COMPLETED|Overall Study||2||
60121935|NCT01565941|76242936|FG000|STARTED|Overall Study||360||
60121936|NCT01565941|76242937|FG001|STARTED|Overall Study||353||
60121937|NCT01565941|76242936|FG000|COMPLETED|Overall Study||349||
60121938|NCT01565941|76242937|FG001|COMPLETED|Overall Study||349||
60121939|NCT01565941|76242936|FG000|NOT COMPLETED|Overall Study||11||
60121940|NCT01565941|76242937|FG001|NOT COMPLETED|Overall Study||4||
60121941|NCT01558271|76242948|FG000|STARTED|Overall Study||281||
60121942|NCT01558271|76242949|FG001|STARTED|Overall Study||70||
60121943|NCT01558271|76242950|FG002|STARTED|Overall Study||141||
59857333|NCT03058796|75982062|FG001|COMPLETED|Overall Study||21||
59857334|NCT03058796|75982061|FG000|NOT COMPLETED|Overall Study||9||
59857335|NCT03058796|75982062|FG001|NOT COMPLETED|Overall Study||4||
59857336|NCT02879617|75982068|FG000|STARTED|Overall Study||47|Started Treatment|
59857337|NCT02879617|75982068|FG000|COMPLETED|Overall Study||47|Received at least one dose of the treatment and did not withdraw for reasons other than disease progression or toxicity before second treatment cycle|
59857338|NCT02879617|75982068|FG000|NOT COMPLETED|Overall Study||0||
59857339|NCT02562235|75982072|FG000|STARTED|Overall Study||24||
59857340|NCT02562235|75982072|FG000|COMPLETED|Overall Study||21||
60121944|NCT01558271|76242948|FG000|Received at Least 1 Dose of Study Drug|Overall Study||280||
60121945|NCT01558271|76242949|FG001|Received at Least 1 Dose of Study Drug|Overall Study||70||
60121946|NCT01558271|76242950|FG002|Received at Least 1 Dose of Study Drug|Overall Study||137||
60121947|NCT01558271|76242948|FG000|Completed 26 Weeks|Overall Study||271||
60121948|NCT01558271|76242949|FG001|Completed 26 Weeks|Overall Study||63||
60121949|NCT01558271|76242950|FG002|Completed 26 Weeks|Overall Study||128||
60121950|NCT01558271|76242948|FG000|COMPLETED|Overall Study||263||
60121951|NCT01558271|76242949|FG001|COMPLETED|Overall Study||59||
60121952|NCT01558271|76242950|FG002|COMPLETED|Overall Study||124||
60121953|NCT01558271|76242948|FG000|NOT COMPLETED|Overall Study||18||
60121954|NCT01558271|76242949|FG001|NOT COMPLETED|Overall Study||11||
60121955|NCT01558271|76242950|FG002|NOT COMPLETED|Overall Study||17||
60121956|NCT01565707|76242966|FG000|STARTED|Overall Study||75||
60121957|NCT01565707|76242967|FG001|STARTED|Overall Study||73||
60121958|NCT01565707|76242968|FG002|STARTED|Overall Study||19||
60121959|NCT01565707|76242969|FG003|STARTED|Overall Study||22||
60121960|NCT01565707|76242966|FG000|Treated|Overall Study||73||
60121961|NCT01565707|76242967|FG001|Treated|Overall Study||73||
60121962|NCT01565707|76242968|FG002|Treated|Overall Study||19||
60121963|NCT01565707|76242969|FG003|Treated|Overall Study||22||
60121964|NCT01565707|76242966|FG000|COMPLETED|Overall Study||66||
60121965|NCT01565707|76242967|FG001|COMPLETED|Overall Study||65||
60121966|NCT01565707|76242968|FG002|COMPLETED|Overall Study||16||
60121967|NCT01565707|76242969|FG003|COMPLETED|Overall Study||17||
60121968|NCT01565707|76242966|FG000|NOT COMPLETED|Overall Study||9||
60121969|NCT01565707|76242967|FG001|NOT COMPLETED|Overall Study||8||
60121970|NCT01565707|76242968|FG002|NOT COMPLETED|Overall Study||3||
60121971|NCT01565707|76242969|FG003|NOT COMPLETED|Overall Study||5||
60121972|NCT01557569|76242988|FG000|STARTED|Overall Study|Those who received at least one dose of medication|6||
60121973|NCT01557569|76242989|FG001|STARTED|Overall Study|Those who received at least one dose of medication|7||
60121974|NCT01557569|76242988|FG000|Completed 2-wk Residential Stay|Overall Study||3||
60121975|NCT01557569|76242989|FG001|Completed 2-wk Residential Stay|Overall Study||1||
60121976|NCT01557569|76242988|FG000|COMPLETED|Overall Study||1||
60121977|NCT01557569|76242989|FG001|COMPLETED|Overall Study||0||
60121978|NCT01557569|76242988|FG000|NOT COMPLETED|Overall Study||5||
60121979|NCT01557569|76242989|FG001|NOT COMPLETED|Overall Study||7||
60121980|NCT01538719|76242997|FG000|STARTED|Overall Study||7||
60121981|NCT01538719|76242998|FG001|STARTED|Overall Study||12||
60121982|NCT01538719|76242997|FG000|COMPLETED|Overall Study||5||
60121983|NCT01538719|76242998|FG001|COMPLETED|Overall Study||12||
60121984|NCT01538719|76242997|FG000|NOT COMPLETED|Overall Study||2||
60121985|NCT01538719|76242998|FG001|NOT COMPLETED|Overall Study||0||
60121986|NCT01537783|76243006|FG000|STARTED|Overall Study||25||
60121987|NCT01537783|76243007|FG001|STARTED|Overall Study||25||
60121988|NCT01537783|76243006|FG000|COMPLETED|Overall Study||14||
60121989|NCT01537783|76243007|FG001|COMPLETED|Overall Study||23||
60121990|NCT01537783|76243006|FG000|NOT COMPLETED|Overall Study||11||
60121991|NCT01537783|76243007|FG001|NOT COMPLETED|Overall Study||2||
60121992|NCT01556165|76243015|FG000|STARTED|Overall Study||65||
60121993|NCT01556165|76243016|FG001|STARTED|Overall Study||65||
60121994|NCT01556165|76243015|FG000|COMPLETED|Overall Study||53||
60121995|NCT01556165|76243016|FG001|COMPLETED|Overall Study||58||
60121996|NCT01556165|76243015|FG000|NOT COMPLETED|Overall Study||12||
60121997|NCT01556165|76243016|FG001|NOT COMPLETED|Overall Study||7||
60121998|NCT01537549|76243022|FG000|STARTED|Overall Study||11||
60121999|NCT01537549|76243022|FG000|COMPLETED|Overall Study||8||
60122000|NCT01537549|76243022|FG000|NOT COMPLETED|Overall Study||3||
60122001|NCT01555931|76243030|FG000|STARTED|Overall Study||17||
60122002|NCT01555931|76243031|FG001|STARTED|Overall Study||18||
60122003|NCT01555931|76243030|FG000|COMPLETED|Overall Study||15||
60122004|NCT01555931|76243031|FG001|COMPLETED|Overall Study||13||
60122005|NCT01555931|76243030|FG000|NOT COMPLETED|Overall Study||2||
60122006|NCT01555931|76243031|FG001|NOT COMPLETED|Overall Study||5||
60122007|NCT01583179|76243039|FG000|STARTED|Overall Study||14||
60122008|NCT01583179|76243040|FG001|STARTED|Overall Study||12||
60122009|NCT01583179|76243039|FG000|COMPLETED|Overall Study||13||
60122010|NCT01583179|76243040|FG001|COMPLETED|Overall Study||10||
60122011|NCT01583179|76243039|FG000|NOT COMPLETED|Overall Study||1||
60122012|NCT01583179|76243040|FG001|NOT COMPLETED|Overall Study||2||
60122013|NCT01582945|76243046|FG000|STARTED|Overall Study||14||
60122014|NCT01582945|76243046|FG000|COMPLETED|Overall Study||12||
60122015|NCT01582945|76243046|FG000|NOT COMPLETED|Overall Study||2||
60122016|NCT01565083|76243052|FG000|STARTED|Overall Study||106||
60122017|NCT01565083|76243053|FG001|STARTED|Overall Study||107||
60122018|NCT01565083|76243052|FG000|COMPLETED|Overall Study||73||
60122019|NCT01565083|76243053|FG001|COMPLETED|Overall Study||68||
60122020|NCT01565083|76243052|FG000|NOT COMPLETED|Overall Study||33||
60122021|NCT01565083|76243053|FG001|NOT COMPLETED|Overall Study||39||
60122022|NCT01582789|76243059|FG000|STARTED|First Intervention (14 Days)||34||
60122023|NCT01582789|76243060|FG001|STARTED|First Intervention (14 Days)||27||
60122024|NCT01582789|76243059|FG000|COMPLETED|First Intervention (14 Days)||34||
60122025|NCT01582789|76243060|FG001|COMPLETED|First Intervention (14 Days)||27||
60122026|NCT01582789|76243059|FG000|NOT COMPLETED|First Intervention (14 Days)||0||
60122027|NCT01582789|76243060|FG001|NOT COMPLETED|First Intervention (14 Days)||0||
60122028|NCT01582789|76243059|FG000|STARTED|Second Intervention (14 Days)||34||
60122029|NCT01582789|76243060|FG001|STARTED|Second Intervention (14 Days)||27||
59857341|NCT02562235|75982072|FG000|NOT COMPLETED|Overall Study||3||
60122030|NCT01582789|76243059|FG000|COMPLETED|Second Intervention (14 Days)||33||
60122031|NCT01582789|76243060|FG001|COMPLETED|Second Intervention (14 Days)||27||
60122032|NCT01582789|76243059|FG000|NOT COMPLETED|Second Intervention (14 Days)||1||
60122033|NCT01582789|76243060|FG001|NOT COMPLETED|Second Intervention (14 Days)||0||
60122034|NCT01537393|76243070|FG000|STARTED|Overall Study||707|1046 eyes from 1151 participants randomized|707
60122035|NCT01537393|76243071|FG001|STARTED|Overall Study||698|1046 eyes from 1151 participants randomized|699
60122036|NCT01537393|76243070|FG000|COMPLETED|Overall Study||553|Study eyes with 3-year visit completed|553
60122037|NCT01537393|76243071|FG001|COMPLETED|Overall Study||507|Study eyes with 3-year visit completed|508
60122038|NCT01537393|76243070|FG000|NOT COMPLETED|Overall Study||154||154
60122039|NCT01537393|76243071|FG001|NOT COMPLETED|Overall Study||191||191
60122040|NCT01555151|76243081|FG000|STARTED|Overall Study||188||
60122041|NCT01555151|76243082|FG001|STARTED|Overall Study||181||
60122042|NCT01555151|76243083|FG002|STARTED|Overall Study||184||
60122043|NCT01555151|76243084|FG003|STARTED|Overall Study||186||
60122044|NCT01555151|76243081|FG000|Safety Set (SAF)|Overall Study||186||
60122045|NCT01555151|76243082|FG001|Safety Set (SAF)|Overall Study||180||
60122046|NCT01555151|76243083|FG002|Safety Set (SAF)|Overall Study||183||
60122047|NCT01555151|76243084|FG003|Safety Set (SAF)|Overall Study||186||
60122048|NCT01555151|76243081|FG000|COMPLETED|Overall Study||175||
60122049|NCT01555151|76243082|FG001|COMPLETED|Overall Study||173||
60122050|NCT01555151|76243083|FG002|COMPLETED|Overall Study||178||
60122051|NCT01555151|76243084|FG003|COMPLETED|Overall Study||176||
60122052|NCT01555151|76243081|FG000|NOT COMPLETED|Overall Study||13||
60122053|NCT01555151|76243082|FG001|NOT COMPLETED|Overall Study||8||
60122054|NCT01555151|76243083|FG002|NOT COMPLETED|Overall Study||6||
60122055|NCT01555151|76243084|FG003|NOT COMPLETED|Overall Study||10||
60122056|NCT01537081|76243098|FG000|STARTED|Overall Study||1123||
60122057|NCT01537081|76243099|FG001|STARTED|Overall Study||1124||
60122058|NCT01537081|76243100|FG002|STARTED|Overall Study||563||
60122059|NCT01537081|76243098|FG000|Safety Population|Overall Study||1122||
60122060|NCT01537081|76243099|FG001|Safety Population|Overall Study||1122||
60122061|NCT01537081|76243100|FG002|Safety Population|Overall Study||561||
60122062|NCT01537081|76243098|FG000|Modified Intent to Treat Population|Overall Study||1106||
60122063|NCT01537081|76243099|FG001|Modified Intent to Treat Population|Overall Study||1109||
60122064|NCT01537081|76243100|FG002|Modified Intent to Treat Population|Overall Study||556||
60122065|NCT01537081|76243098|FG000|COMPLETED|Overall Study||1084||
60122066|NCT01537081|76243099|FG001|COMPLETED|Overall Study||1086||
60122067|NCT01537081|76243100|FG002|COMPLETED|Overall Study||547||
60122068|NCT01537081|76243098|FG000|NOT COMPLETED|Overall Study||39||
60122069|NCT01537081|76243099|FG001|NOT COMPLETED|Overall Study||38||
60122070|NCT01537081|76243100|FG002|NOT COMPLETED|Overall Study||16||
60122071|NCT01564459|76243112|FG000|STARTED|Run-In||12||
60122072|NCT01564459|76243113|FG001|STARTED|Run-In|1 participant randomized to placebo arm received MK-6096 10 mg|87||
60122073|NCT01564459|76243114|FG002|STARTED|Run-In|1 participant randomized to placebo arm received MK-6096 10 mg|83||
60122074|NCT01564459|76243112|FG000|COMPLETED|Run-In||0||
60122075|NCT01564459|76243113|FG001|COMPLETED|Run-In||87||
60122076|NCT01564459|76243114|FG002|COMPLETED|Run-In||83||
60122077|NCT01564459|76243112|FG000|NOT COMPLETED|Run-In||12||
60122078|NCT01564459|76243113|FG001|NOT COMPLETED|Run-In||0||
60122079|NCT01564459|76243114|FG002|NOT COMPLETED|Run-In||0||
60122080|NCT01564459|76243112|FG000|STARTED|Double-blind Treatment||0||
60122081|NCT01564459|76243113|FG001|STARTED|Double-blind Treatment|1 participant randomized to placebo arm received MK-6096 10 mg|87||
60122082|NCT01564459|76243114|FG002|STARTED|Double-blind Treatment|1 participant randomized to placebo arm received MK-6096 10 mg|83||
60122083|NCT01564459|76243112|FG000|COMPLETED|Double-blind Treatment||0||
60122084|NCT01564459|76243113|FG001|COMPLETED|Double-blind Treatment||87||
60122085|NCT01564459|76243114|FG002|COMPLETED|Double-blind Treatment||82||
60122086|NCT01564459|76243112|FG000|NOT COMPLETED|Double-blind Treatment||0||
60122087|NCT01564459|76243113|FG001|NOT COMPLETED|Double-blind Treatment||0||
60122088|NCT01564459|76243114|FG002|NOT COMPLETED|Double-blind Treatment||1||
60122089|NCT01555073|76243129|FG000|STARTED|Overall Study||7||
60122090|NCT01555073|76243130|FG001|STARTED|Overall Study||3||
60122091|NCT01555073|76243131|FG002|STARTED|Overall Study||7||
60122092|NCT01555073|76243132|FG003|STARTED|Overall Study||6||
60122093|NCT01555073|76243129|FG000|COMPLETED|Overall Study||6||
60122094|NCT01555073|76243130|FG001|COMPLETED|Overall Study||1||
60122095|NCT01555073|76243131|FG002|COMPLETED|Overall Study||7||
60122096|NCT01555073|76243132|FG003|COMPLETED|Overall Study||1||
60122097|NCT01555073|76243129|FG000|NOT COMPLETED|Overall Study||1||
60122098|NCT01555073|76243130|FG001|NOT COMPLETED|Overall Study||2||
60122099|NCT01555073|76243131|FG002|NOT COMPLETED|Overall Study||0||
60122100|NCT01555073|76243132|FG003|NOT COMPLETED|Overall Study||5||
60122101|NCT01582243|76243142|FG000|STARTED|Overall Study||40||
60122102|NCT01582243|76243142|FG000|COMPLETED|Overall Study||37||
60122103|NCT01582243|76243142|FG000|NOT COMPLETED|Overall Study||3||
60122104|NCT01536535|76243148|FG000|STARTED|Overall Study||178||
60122105|NCT01536535|76243149|FG001|STARTED|Overall Study||250||
60122106|NCT01536535|76243148|FG000|COMPLETED|Overall Study|Patients either completed week 52 visit or had early colectomy or had additional therapy.|163||
59726380|NCT01190150|75845198|FG000|NOT COMPLETED|Washout||0||
60122107|NCT01536535|76243149|FG001|COMPLETED|Overall Study|Patients either completed week 52 visit or had early colectomy or had additional therapy.|237||
60122108|NCT01536535|76243148|FG000|NOT COMPLETED|Overall Study||15||
60122109|NCT01536535|76243149|FG001|NOT COMPLETED|Overall Study||13||
60122110|NCT01554527|76243159|FG000|STARTED|Overall Study||34||
60122111|NCT01554527|76243160|FG001|STARTED|Overall Study||38||
60122112|NCT01554527|76243161|FG002|STARTED|Overall Study||33||
60122113|NCT01554527|76243159|FG000|Crossed Over to Control|Overall Study||0||
60122114|NCT01554527|76243160|FG001|Crossed Over to Control|Overall Study||0||
60122115|NCT01554527|76243161|FG002|Crossed Over to Control|Overall Study||2||
60122116|NCT01554527|76243159|FG000|Had CPAP Titration|Overall Study|No control group members received CPAP (definitionally)|0||
59726381|NCT01190150|75845199|FG001|NOT COMPLETED|Washout||2||
60122117|NCT01554527|76243160|FG001|Had CPAP Titration|Overall Study||38||
60122118|NCT01554527|76243161|FG002|Had CPAP Titration|Overall Study||30||
60122119|NCT01554527|76243159|FG000|Initiated CPAP Treatment at Home|Overall Study||0||
60122120|NCT01554527|76243160|FG001|Initiated CPAP Treatment at Home|Overall Study||38||
60122121|NCT01554527|76243161|FG002|Initiated CPAP Treatment at Home|Overall Study||28||
60122122|NCT01554527|76243159|FG000|Completed as a Control|Overall Study||33||
60122123|NCT01554527|76243160|FG001|Completed as a Control|Overall Study||0||
60122124|NCT01554527|76243161|FG002|Completed as a Control|Overall Study||1||
60122125|NCT01554527|76243159|FG000|COMPLETED|Overall Study||33||
60122126|NCT01554527|76243160|FG001|COMPLETED|Overall Study||38||
60122127|NCT01554527|76243161|FG002|COMPLETED|Overall Study||25||
60122128|NCT01554527|76243159|FG000|NOT COMPLETED|Overall Study||1||
60122129|NCT01554527|76243160|FG001|NOT COMPLETED|Overall Study||0||
60122130|NCT01554527|76243161|FG002|NOT COMPLETED|Overall Study||8||
60122131|NCT01563913|76243172|FG000|STARTED|Overall Study||15||
60122132|NCT01563913|76243173|FG001|STARTED|Overall Study||15||
60122133|NCT01563913|76243172|FG000|COMPLETED|Overall Study||13||
60122134|NCT01563913|76243173|FG001|COMPLETED|Overall Study||15||
60122135|NCT01563913|76243172|FG000|NOT COMPLETED|Overall Study||2||
60122136|NCT01563913|76243173|FG001|NOT COMPLETED|Overall Study||0||
60122137|NCT01553747|76243182|FG000|STARTED|Overall Study||381||
60122138|NCT01553747|76243183|FG001|STARTED|Overall Study||383||
60122139|NCT01553747|76243184|FG002|STARTED|Overall Study||382||
60122140|NCT01553747|76243182|FG000|Attended Week 12 Visit|Overall Study||296||
60122141|NCT01553747|76243183|FG001|Attended Week 12 Visit|Overall Study||301||
60122142|NCT01553747|76243184|FG002|Attended Week 12 Visit|Overall Study||312||
60122143|NCT01553747|76243182|FG000|Attended Week 26 Visit|Overall Study||259||
60122144|NCT01553747|76243183|FG001|Attended Week 26 Visit|Overall Study||271||
60122145|NCT01553747|76243184|FG002|Attended Week 26 Visit|Overall Study||278||
60122146|NCT01553747|76243182|FG000|Participated in Blinded-Placebo Period|Overall Study||246||
60122147|NCT01553747|76243183|FG001|Participated in Blinded-Placebo Period|Overall Study||253||
60122148|NCT01553747|76243184|FG002|Participated in Blinded-Placebo Period|Overall Study||272||
60122149|NCT01553747|76243182|FG000|COMPLETED|Overall Study||250||
60122150|NCT01553747|76243183|FG001|COMPLETED|Overall Study||264||
60122151|NCT01553747|76243184|FG002|COMPLETED|Overall Study||273||
60122152|NCT01553747|76243182|FG000|NOT COMPLETED|Overall Study||131||
60122153|NCT01553747|76243183|FG001|NOT COMPLETED|Overall Study||119||
60122154|NCT01553747|76243184|FG002|NOT COMPLETED|Overall Study||109||
60122155|NCT01536379|76243197|FG000|STARTED|Overall Study||13||
60122156|NCT01536379|76243198|FG001|STARTED|Overall Study||12||
60122157|NCT01536379|76243197|FG000|COMPLETED|Overall Study||11||
60122158|NCT01536379|76243198|FG001|COMPLETED|Overall Study||9||
60122159|NCT01536379|76243197|FG000|NOT COMPLETED|Overall Study||2||
60122160|NCT01536379|76243198|FG001|NOT COMPLETED|Overall Study||3||
60122161|NCT01536145|76243204|FG000|STARTED|Overall Study||3||
60122162|NCT01536145|76243205|FG001|STARTED|Overall Study||4||
60122163|NCT01536145|76243206|FG002|STARTED|Overall Study||3||
60122164|NCT01536145|76243207|FG003|STARTED|Overall Study||3||
60122165|NCT01536145|76243208|FG004|STARTED|Overall Study||4||
60122166|NCT01536145|76243209|FG005|STARTED|Overall Study||3||
60122167|NCT01536145|76243210|FG006|STARTED|Overall Study||3||
60122168|NCT01536145|76243211|FG007|STARTED|Overall Study||4||
60122169|NCT01536145|76243212|FG008|STARTED|Overall Study||3||
60122170|NCT01536145|76243213|FG009|STARTED|Overall Study||7||
60122171|NCT01536145|76243214|FG010|STARTED|Overall Study||10||
60122172|NCT01536145|76243204|FG000|COMPLETED|Overall Study||0||
60122173|NCT01536145|76243205|FG001|COMPLETED|Overall Study||0||
60122174|NCT01536145|76243206|FG002|COMPLETED|Overall Study||1||
60122175|NCT01536145|76243207|FG003|COMPLETED|Overall Study||1||
60122176|NCT01536145|76243208|FG004|COMPLETED|Overall Study||2||
60122177|NCT01536145|76243209|FG005|COMPLETED|Overall Study||0||
60122178|NCT01536145|76243210|FG006|COMPLETED|Overall Study||1||
60122179|NCT01536145|76243211|FG007|COMPLETED|Overall Study||0||
60122180|NCT01536145|76243212|FG008|COMPLETED|Overall Study||0||
60122181|NCT01536145|76243213|FG009|COMPLETED|Overall Study||1||
59592137|NCT02794441|75700251|FG001|STARTED|Overall Study||5||
59592138|NCT02794441|75700250|FG000|COMPLETED|Overall Study||6||
59592139|NCT02794441|75700251|FG001|COMPLETED|Overall Study||5||
60122182|NCT01536145|76243214|FG010|COMPLETED|Overall Study||0||
60122183|NCT01536145|76243204|FG000|NOT COMPLETED|Overall Study||3||
60122184|NCT01536145|76243205|FG001|NOT COMPLETED|Overall Study||4||
60122185|NCT01536145|76243206|FG002|NOT COMPLETED|Overall Study||2||
60122186|NCT01536145|76243207|FG003|NOT COMPLETED|Overall Study||2||
60122187|NCT01536145|76243208|FG004|NOT COMPLETED|Overall Study||2||
60122188|NCT01536145|76243209|FG005|NOT COMPLETED|Overall Study||3||
60122189|NCT01536145|76243210|FG006|NOT COMPLETED|Overall Study||2||
60122190|NCT01536145|76243211|FG007|NOT COMPLETED|Overall Study||4||
60122191|NCT01536145|76243212|FG008|NOT COMPLETED|Overall Study||3||
60122192|NCT01536145|76243213|FG009|NOT COMPLETED|Overall Study||6||
60122193|NCT01536145|76243214|FG010|NOT COMPLETED|Overall Study||10||
59592140|NCT02794441|75700250|FG000|NOT COMPLETED|Overall Study||1||
59592141|NCT02794441|75700251|FG001|NOT COMPLETED|Overall Study||0||
60122194|NCT01536067|76243245|FG000|STARTED|Overall Study||3||
60122195|NCT01536067|76243245|FG000|COMPLETED|Overall Study||2||
60122196|NCT01536067|76243245|FG000|NOT COMPLETED|Overall Study||1||
60122197|NCT01582009|76243249|FG000|STARTED|Overall Study||26||
60122198|NCT01582009|76243249|FG000|COMPLETED|Overall Study||24||
60122199|NCT01582009|76243249|FG000|NOT COMPLETED|Overall Study||2||
60122200|NCT01553591|76243256|FG000|STARTED|Overall Study||429||
60122201|NCT01553591|76243257|FG001|STARTED|Overall Study||426||
60122202|NCT01553591|76243258|FG002|STARTED|Overall Study||427||
60122203|NCT01553591|76243256|FG000|Attended Week 12 Visit|Overall Study||341||
60122204|NCT01553591|76243257|FG001|Attended Week 12 Visit|Overall Study||330||
60122205|NCT01553591|76243258|FG002|Attended Week 12 Visit|Overall Study||342||
60122206|NCT01553591|76243256|FG000|Attended Week 26 Visit|Overall Study||289||
60122207|NCT01553591|76243257|FG001|Attended Week 26 Visit|Overall Study||291||
60122208|NCT01553591|76243258|FG002|Attended Week 26 Visit|Overall Study||290||
60122209|NCT01553591|76243256|FG000|COMPLETED|Overall Study||257||
60122210|NCT01553591|76243257|FG001|COMPLETED|Overall Study||257||
60122211|NCT01553591|76243258|FG002|COMPLETED|Overall Study||269||
60122212|NCT01553591|76243256|FG000|NOT COMPLETED|Overall Study||172||
60122213|NCT01553591|76243257|FG001|NOT COMPLETED|Overall Study||169||
60122214|NCT01553591|76243258|FG002|NOT COMPLETED|Overall Study||158||
60122215|NCT01581931|76243266|FG000|STARTED|First Period||16||
60122216|NCT01581931|76243267|FG001|STARTED|First Period||16||
60122217|NCT01581931|76243266|FG000|COMPLETED|First Period||16||
60122218|NCT01581931|76243267|FG001|COMPLETED|First Period||16||
60122219|NCT01581931|76243266|FG000|NOT COMPLETED|First Period||0||
60122220|NCT01581931|76243267|FG001|NOT COMPLETED|First Period||0||
60122221|NCT01581931|76243266|FG000|STARTED|Washout||16||
60122222|NCT01581931|76243267|FG001|STARTED|Washout||16||
60122223|NCT01581931|76243266|FG000|COMPLETED|Washout||16||
60122224|NCT01581931|76243267|FG001|COMPLETED|Washout||15||
60122225|NCT01581931|76243266|FG000|NOT COMPLETED|Washout||0||
60122226|NCT01581931|76243267|FG001|NOT COMPLETED|Washout||1||
60122227|NCT01581931|76243266|FG000|STARTED|Second Period||16||
60122228|NCT01581931|76243267|FG001|STARTED|Second Period||15||
60122229|NCT01581931|76243266|FG000|COMPLETED|Second Period||16||
60122230|NCT01581931|76243267|FG001|COMPLETED|Second Period||15||
60122231|NCT01581931|76243266|FG000|NOT COMPLETED|Second Period||0||
60122232|NCT01581931|76243267|FG001|NOT COMPLETED|Second Period||0||
60122233|NCT01581619|76243273|FG000|STARTED|Overall Study||54||
60122234|NCT01581619|76243273|FG000|COMPLETED|Overall Study||52||
60122235|NCT01581619|76243273|FG000|NOT COMPLETED|Overall Study||2||
60122236|NCT01581307|76243279|FG000|STARTED|Overall Study||9||
60122237|NCT01581307|76243279|FG000|COMPLETED|Overall Study||8||
60122238|NCT01581307|76243279|FG000|NOT COMPLETED|Overall Study||1||
60122239|NCT01580995|76243285|FG000|STARTED|Overall Study||10||
60122240|NCT01580995|76243286|FG001|STARTED|Overall Study||9||
60122241|NCT01580995|76243285|FG000|COMPLETED|Overall Study||8||
60122242|NCT01580995|76243286|FG001|COMPLETED|Overall Study||7||
60122243|NCT01580995|76243285|FG000|NOT COMPLETED|Overall Study||2||
60122244|NCT01580995|76243286|FG001|NOT COMPLETED|Overall Study||2||
60122245|NCT01535599|76243294|FG000|STARTED|Overall Study||347||
60122246|NCT01535599|76243295|FG001|STARTED|Overall Study||346||
60122247|NCT01535599|76243294|FG000|COMPLETED|Overall Study||297||
60122248|NCT01535599|76243295|FG001|COMPLETED|Overall Study||250||
60122249|NCT01535599|76243294|FG000|NOT COMPLETED|Overall Study||50||
60122250|NCT01535599|76243295|FG001|NOT COMPLETED|Overall Study||96||
60122251|NCT01553279|76243303|FG000|STARTED|Part 1 (Infant Vaccinations)||142|Number Randomized|
60122252|NCT01553279|76243304|FG001|STARTED|Part 1 (Infant Vaccinations)||142|Number Randomized|
60122253|NCT01553279|76243303|FG000|COMPLETED|Part 1 (Infant Vaccinations)||140||
60122254|NCT01553279|76243304|FG001|COMPLETED|Part 1 (Infant Vaccinations)||141||
60122255|NCT01553279|76243303|FG000|NOT COMPLETED|Part 1 (Infant Vaccinations)||2||
60122256|NCT01553279|76243304|FG001|NOT COMPLETED|Part 1 (Infant Vaccinations)||1||
60122257|NCT01553279|76243303|FG000|STARTED|Interim Period||140||
60122258|NCT01553279|76243304|FG001|STARTED|Interim Period||141||
60122259|NCT01553279|76243303|FG000|COMPLETED|Interim Period||137||
60122260|NCT01553279|76243304|FG001|COMPLETED|Interim Period||139||
60122261|NCT01553279|76243303|FG000|NOT COMPLETED|Interim Period||3||
60122262|NCT01553279|76243304|FG001|NOT COMPLETED|Interim Period||2||
60122263|NCT01553279|76243303|FG000|STARTED|Period 2: Toddler Vaccinations||137||
60122264|NCT01553279|76243304|FG001|STARTED|Period 2: Toddler Vaccinations||139||
60122265|NCT01553279|76243303|FG000|COMPLETED|Period 2: Toddler Vaccinations||134||
60122266|NCT01553279|76243304|FG001|COMPLETED|Period 2: Toddler Vaccinations||132||
60122267|NCT01553279|76243303|FG000|NOT COMPLETED|Period 2: Toddler Vaccinations||3||
60122268|NCT01553279|76243304|FG001|NOT COMPLETED|Period 2: Toddler Vaccinations||7||
60122269|NCT01562743|76243311|FG000|STARTED|Overall Study||185||
60122270|NCT01562743|76243311|FG000|COMPLETED|Overall Study||133||
60122271|NCT01562743|76243311|FG000|NOT COMPLETED|Overall Study||52||
60122272|NCT01535443|76243315|FG000|STARTED|Overall Study||35||
60122273|NCT01535443|76243315|FG000|COMPLETED|Overall Study||32||
60122274|NCT01535443|76243315|FG000|NOT COMPLETED|Overall Study||3||
60122275|NCT01535287|76243322|FG000|STARTED|Overall Study||70||
60122276|NCT01535287|76243323|FG001|STARTED|Overall Study||70||
60122277|NCT01535287|76243322|FG000|COMPLETED|Overall Study||65||
60122278|NCT01535287|76243323|FG001|COMPLETED|Overall Study||64||
60122279|NCT01535287|76243322|FG000|NOT COMPLETED|Overall Study||5||
60122280|NCT01535287|76243323|FG001|NOT COMPLETED|Overall Study||6||
60122281|NCT01551173|76243331|FG000|STARTED|Overall Study|"Started indicates randomized"|218||
60122282|NCT01551173|76243332|FG001|STARTED|Overall Study||218||
60122283|NCT01551173|76243331|FG000|Full Analysis Set (FAS)|Overall Study|Patients took at least 1 dose of study drug & had at least 1 post-randomization efficacy parameter|210||
60122284|NCT01551173|76243332|FG001|Full Analysis Set (FAS)|Overall Study||214||
60122285|NCT01551173|76243331|FG000|COMPLETED|Overall Study||190||
60122286|NCT01551173|76243332|FG001|COMPLETED|Overall Study||186||
60122287|NCT01551173|76243331|FG000|NOT COMPLETED|Overall Study||28||
60122288|NCT01551173|76243332|FG001|NOT COMPLETED|Overall Study||32||
60122289|NCT01549613|76243341|FG000|STARTED|Overall Study||50||
60122290|NCT01549613|76243342|FG001|STARTED|Overall Study||50||
60122291|NCT01549613|76243341|FG000|COMPLETED|Overall Study||39||
60122292|NCT01549613|76243342|FG001|COMPLETED|Overall Study||39||
60122293|NCT01549613|76243341|FG000|NOT COMPLETED|Overall Study||11||
60122294|NCT01549613|76243342|FG001|NOT COMPLETED|Overall Study||11||
60122295|NCT01548599|76243350|FG000|STARTED|Overall Study||72||
60122296|NCT01548599|76243351|FG001|STARTED|Overall Study||68||
60122297|NCT01548599|76243350|FG000|COMPLETED|Overall Study||66||
60122298|NCT01548599|76243351|FG001|COMPLETED|Overall Study||66||
60122299|NCT01548599|76243350|FG000|NOT COMPLETED|Overall Study||6||
59592142|NCT02941640|75700261|FG000|STARTED|Overall Study||30||
59592143|NCT02941640|75700262|FG001|STARTED|Overall Study||30||
59592144|NCT02941640|75700263|FG002|STARTED|Overall Study||30||
59592145|NCT02941640|75700264|FG003|STARTED|Overall Study||30||
59592146|NCT02941640|75700261|FG000|COMPLETED|Overall Study||30||
59592147|NCT02941640|75700262|FG001|COMPLETED|Overall Study||30||
59592148|NCT02941640|75700263|FG002|COMPLETED|Overall Study||30||
59592149|NCT02941640|75700264|FG003|COMPLETED|Overall Study||30||
59592150|NCT02941640|75700261|FG000|NOT COMPLETED|Overall Study||0||
59592151|NCT02941640|75700262|FG001|NOT COMPLETED|Overall Study||0||
59592152|NCT02941640|75700263|FG002|NOT COMPLETED|Overall Study||0||
59592153|NCT02941640|75700264|FG003|NOT COMPLETED|Overall Study||0||
59592154|NCT02794597|75700276|FG000|STARTED|Overall Study||63||
59592155|NCT02794597|75700277|FG001|STARTED|Overall Study||56||
59592156|NCT02794597|75700276|FG000|COMPLETED|Overall Study||63||
59592157|NCT02794597|75700277|FG001|COMPLETED|Overall Study||56||
59592158|NCT02794597|75700276|FG000|NOT COMPLETED|Overall Study||0||
59592159|NCT02794597|75700277|FG001|NOT COMPLETED|Overall Study||0||
59592160|NCT02822612|75700288|FG000|STARTED|Overall Study||14||
59592161|NCT02822612|75700289|FG001|STARTED|Overall Study||13||
59592162|NCT02822612|75700290|FG002|STARTED|Overall Study||14||
59592163|NCT02822612|75700291|FG003|STARTED|Overall Study||4||
59592164|NCT02822612|75700292|FG004|STARTED|Overall Study||15||
59592165|NCT02822612|75700288|FG000|COMPLETED|Overall Study||14||
59592166|NCT02822612|75700289|FG001|COMPLETED|Overall Study||13||
59592167|NCT02822612|75700290|FG002|COMPLETED|Overall Study||14||
59592168|NCT02822612|75700291|FG003|COMPLETED|Overall Study||4||
59592169|NCT02822612|75700292|FG004|COMPLETED|Overall Study||15||
59857342|NCT02316340|75982083|FG000|STARTED|First Progression||20||
59857343|NCT02316340|75982084|FG001|STARTED|First Progression||22||
59857344|NCT02316340|75982083|FG000|COMPLETED|First Progression||17||
59857345|NCT02316340|75982084|FG001|COMPLETED|First Progression||21||
59857346|NCT02316340|75982083|FG000|NOT COMPLETED|First Progression||3||
60122300|NCT01548599|76243351|FG001|NOT COMPLETED|Overall Study||2||
60122301|NCT01548287|76243364|FG000|STARTED|Screening||19||
60122302|NCT01548287|76243365|FG001|STARTED|Screening||22||
60122303|NCT01548287|76243366|FG002|STARTED|Screening||20||
60122304|NCT01548287|76243367|FG003|STARTED|Screening||20||
60122305|NCT01548287|76243368|FG004|STARTED|Screening||83||
60122306|NCT01548287|76243364|FG000|COMPLETED|Screening||19||
60122307|NCT01548287|76243365|FG001|COMPLETED|Screening||22||
60122308|NCT01548287|76243366|FG002|COMPLETED|Screening||20||
60122309|NCT01548287|76243367|FG003|COMPLETED|Screening||20||
60122310|NCT01548287|76243368|FG004|COMPLETED|Screening||0||
60122311|NCT01548287|76243364|FG000|NOT COMPLETED|Screening||0||
60122312|NCT01548287|76243365|FG001|NOT COMPLETED|Screening||0||
60122313|NCT01548287|76243366|FG002|NOT COMPLETED|Screening||0||
60122314|NCT01548287|76243367|FG003|NOT COMPLETED|Screening||0||
60122315|NCT01548287|76243368|FG004|NOT COMPLETED|Screening||83||
60122316|NCT01548287|76243364|FG000|STARTED|Randomized Period||19||
60122317|NCT01548287|76243365|FG001|STARTED|Randomized Period||22||
60122318|NCT01548287|76243366|FG002|STARTED|Randomized Period||20||
60122319|NCT01548287|76243367|FG003|STARTED|Randomized Period||20||
60122320|NCT01548287|76243368|FG004|STARTED|Randomized Period||0||
60122321|NCT01548287|76243364|FG000|COMPLETED|Randomized Period||19||
59592170|NCT02822612|75700288|FG000|NOT COMPLETED|Overall Study||0||
59592171|NCT02822612|75700289|FG001|NOT COMPLETED|Overall Study||0||
59592172|NCT02822612|75700290|FG002|NOT COMPLETED|Overall Study||0||
59592173|NCT02822612|75700291|FG003|NOT COMPLETED|Overall Study||0||
59592174|NCT02822612|75700292|FG004|NOT COMPLETED|Overall Study||0||
59592175|NCT03028363|75700306|FG000|STARTED|Overall Study||498||
59592176|NCT03028363|75700307|FG001|STARTED|Overall Study||261||
59592177|NCT03028363|75700306|FG000|COMPLETED|Overall Study||420||
59592178|NCT03028363|75700307|FG001|COMPLETED|Overall Study||228||
59592179|NCT03028363|75700306|FG000|NOT COMPLETED|Overall Study||78||
59592180|NCT03028363|75700307|FG001|NOT COMPLETED|Overall Study||33||
59592181|NCT02823080|75700315|FG000|STARTED|Overall Study||24||
59592182|NCT02823080|75700316|FG001|STARTED|Overall Study||24||
59592183|NCT02823080|75700315|FG000|COMPLETED|Overall Study||24||
59592184|NCT02823080|75700316|FG001|COMPLETED|Overall Study||24||
59592185|NCT02823080|75700315|FG000|NOT COMPLETED|Overall Study||0||
59592186|NCT02823080|75700316|FG001|NOT COMPLETED|Overall Study||0||
59592187|NCT03028987|75700325|FG000|STARTED|Overall Study||5||
59592188|NCT03028987|75700326|FG001|STARTED|Overall Study||5||
59592189|NCT03028987|75700325|FG000|COMPLETED|Overall Study||5||
59592190|NCT03028987|75700326|FG001|COMPLETED|Overall Study||5||
59592191|NCT03028987|75700325|FG000|NOT COMPLETED|Overall Study||0||
59592192|NCT03028987|75700326|FG001|NOT COMPLETED|Overall Study||0||
59592193|NCT03022916|75700332|FG000|STARTED|Overall Study||5||5
59592194|NCT03022916|75700333|FG001|STARTED|Overall Study||5||5
59592195|NCT03022916|75700334|FG002|STARTED|Overall Study||5||5
59592196|NCT03022916|75700335|FG003|STARTED|Overall Study||5||5
59592197|NCT03022916|75700332|FG000|Nail Polish|Overall Study||5||5
59592198|NCT03022916|75700333|FG001|Nail Polish|Overall Study||5||5
59592199|NCT03022916|75700334|FG002|Nail Polish|Overall Study||5||5
59592200|NCT03022916|75700335|FG003|Nail Polish|Overall Study||5||5
59592201|NCT03022916|75700332|FG000|Nail Polish, Base Coat|Overall Study||5||5
59592202|NCT03022916|75700333|FG001|Nail Polish, Base Coat|Overall Study||5||5
59592203|NCT03022916|75700334|FG002|Nail Polish, Base Coat|Overall Study||5||5
59592204|NCT03022916|75700335|FG003|Nail Polish, Base Coat|Overall Study||5||5
59592205|NCT03022916|75700332|FG000|Nail Polish, Top Coat|Overall Study||5||5
59592206|NCT03022916|75700333|FG001|Nail Polish, Top Coat|Overall Study||5||5
59592207|NCT03022916|75700334|FG002|Nail Polish, Top Coat|Overall Study||5||5
59592208|NCT03022916|75700335|FG003|Nail Polish, Top Coat|Overall Study||5||5
59592209|NCT03022916|75700332|FG000|COMPLETED|Overall Study||5||5
59592210|NCT03022916|75700333|FG001|COMPLETED|Overall Study||5||5
59592211|NCT03022916|75700334|FG002|COMPLETED|Overall Study||5||5
59592212|NCT03022916|75700335|FG003|COMPLETED|Overall Study||5||5
59592213|NCT03022916|75700332|FG000|NOT COMPLETED|Overall Study||0||0
59592214|NCT03022916|75700333|FG001|NOT COMPLETED|Overall Study||0||0
59592215|NCT03022916|75700334|FG002|NOT COMPLETED|Overall Study||0||0
59592216|NCT03022916|75700335|FG003|NOT COMPLETED|Overall Study||0||0
59592217|NCT03031795|75700344|FG000|STARTED|Overall Study||35||
59592218|NCT03031795|75700345|FG001|STARTED|Overall Study||36||
59592219|NCT03031795|75700344|FG000|COMPLETED|Overall Study||35||
59592220|NCT03031795|75700345|FG001|COMPLETED|Overall Study||35||
59592221|NCT03031795|75700344|FG000|NOT COMPLETED|Overall Study||0||
59592222|NCT03031795|75700345|FG001|NOT COMPLETED|Overall Study||1||
59592223|NCT02942654|75700351|FG000|STARTED|Period 1||16||
59592224|NCT02942654|75700352|FG001|STARTED|Period 1||16||
59592225|NCT02942654|75700351|FG000|Received at Least 1 Dose of Study Drug|Period 1||16||
59592226|NCT02942654|75700352|FG001|Received at Least 1 Dose of Study Drug|Period 1||16||
59592227|NCT02942654|75700351|FG000|COMPLETED|Period 1||16||
59592228|NCT02942654|75700352|FG001|COMPLETED|Period 1||16||
59592229|NCT02942654|75700351|FG000|NOT COMPLETED|Period 1||0||
59592230|NCT02942654|75700352|FG001|NOT COMPLETED|Period 1||0||
60122322|NCT01548287|76243365|FG001|COMPLETED|Randomized Period||20||
60122323|NCT01548287|76243366|FG002|COMPLETED|Randomized Period||13||
60122324|NCT01548287|76243367|FG003|COMPLETED|Randomized Period||20||
60122325|NCT01548287|76243368|FG004|COMPLETED|Randomized Period||0||
60122326|NCT01548287|76243364|FG000|NOT COMPLETED|Randomized Period||0||
60122327|NCT01548287|76243365|FG001|NOT COMPLETED|Randomized Period||2||
60122328|NCT01548287|76243366|FG002|NOT COMPLETED|Randomized Period||7||
60122329|NCT01548287|76243367|FG003|NOT COMPLETED|Randomized Period||0||
60122330|NCT01548287|76243368|FG004|NOT COMPLETED|Randomized Period||0||
60122331|NCT01546883|76243378|FG000|STARTED|Overall Study||14||
60122332|NCT01546883|76243378|FG000|COMPLETED|Overall Study||2||
60122333|NCT01546883|76243378|FG000|NOT COMPLETED|Overall Study||12||
60122334|NCT01546649|76243384|FG000|STARTED|Overall Study||83||
60122335|NCT01546649|76243385|FG001|STARTED|Overall Study||84||
59592231|NCT02942654|75700351|FG000|STARTED|Washout||16||
59592232|NCT02942654|75700352|FG001|STARTED|Washout||16||
59592233|NCT02942654|75700351|FG000|COMPLETED|Washout||16||
59592234|NCT02942654|75700352|FG001|COMPLETED|Washout||16||
59592235|NCT02942654|75700351|FG000|NOT COMPLETED|Washout||0||
59592236|NCT02942654|75700352|FG001|NOT COMPLETED|Washout||0||
59592237|NCT02942654|75700351|FG000|STARTED|Period 2||16||
59592238|NCT02942654|75700352|FG001|STARTED|Period 2||16||
59592239|NCT02942654|75700351|FG000|COMPLETED|Period 2||16||
59592240|NCT02942654|75700352|FG001|COMPLETED|Period 2||16||
59592241|NCT02942654|75700351|FG000|NOT COMPLETED|Period 2||0||
59592242|NCT02942654|75700352|FG001|NOT COMPLETED|Period 2||0||
59592243|NCT02825966|75700358|FG000|STARTED|Overall Study||35|Same 35 subjects wore the AUDICOR Ambulatory Monitoring (AM) and WCD devices sequentially.|
59592244|NCT02825966|75700358|FG000|COMPLETED|Overall Study||35|Same 35 subjects wore the AUDICOR AM and WCD devices sequentially.|
59592245|NCT02825966|75700358|FG000|NOT COMPLETED|Overall Study||0||
59592246|NCT03028220|75700367|FG000|STARTED|Overall Study||20||
59592247|NCT03028220|75700368|FG001|STARTED|Overall Study||20||
59592248|NCT03028220|75700367|FG000|COMPLETED|Overall Study||20||
59592249|NCT03028220|75700368|FG001|COMPLETED|Overall Study||20||
59592250|NCT03028220|75700367|FG000|NOT COMPLETED|Overall Study||0||
59592251|NCT03028220|75700368|FG001|NOT COMPLETED|Overall Study||0||
59592252|NCT02909959|75700376|FG000|STARTED|Overall Study||24||
59592253|NCT02909959|75700377|FG001|STARTED|Overall Study||24||
59592254|NCT02909959|75700376|FG000|COMPLETED|Overall Study||24||
59592255|NCT02909959|75700377|FG001|COMPLETED|Overall Study||24||
59592256|NCT02909959|75700376|FG000|NOT COMPLETED|Overall Study||0||
59592257|NCT02909959|75700377|FG001|NOT COMPLETED|Overall Study||0||
59592258|NCT02945150|75700383|FG000|STARTED|Overall Study||8||
59592259|NCT02945150|75700383|FG000|SVR12|Overall Study||8||
59592260|NCT02945150|75700383|FG000|COMPLETED|Overall Study||8||
59592261|NCT02945150|75700383|FG000|NOT COMPLETED|Overall Study||0||
59592262|NCT02911753|75700390|FG000|STARTED|Overall Study||21||
59592263|NCT02911753|75700391|FG001|STARTED|Overall Study||19||
59592264|NCT02911753|75700392|FG002|STARTED|Overall Study||10||
59592265|NCT02911753|75700390|FG000|COMPLETED|Overall Study||18||
59592266|NCT02911753|75700391|FG001|COMPLETED|Overall Study||16||
59592267|NCT02911753|75700392|FG002|COMPLETED|Overall Study||10||
59592268|NCT02911753|75700390|FG000|NOT COMPLETED|Overall Study||3||
59592269|NCT02911753|75700391|FG001|NOT COMPLETED|Overall Study||3||
59592270|NCT02911753|75700392|FG002|NOT COMPLETED|Overall Study||0||
59592271|NCT02829320|75700418|FG000|STARTED|Overall Study||28||
59592272|NCT02829320|75700418|FG000|COMPLETED|Overall Study||28||
59592273|NCT02829320|75700418|FG000|NOT COMPLETED|Overall Study||0||
59592274|NCT03032263|75700431|FG000|STARTED|Overall Study||6||
59592275|NCT03032263|75700432|FG001|STARTED|Overall Study||6||
59592276|NCT03032263|75700431|FG000|COMPLETED|Overall Study||6||
59592277|NCT03032263|75700432|FG001|COMPLETED|Overall Study||6||
59592278|NCT03032263|75700431|FG000|NOT COMPLETED|Overall Study||0||
59592279|NCT03032263|75700432|FG001|NOT COMPLETED|Overall Study||0||
59592280|NCT03032965|75700440|FG000|STARTED|Overall Study||61||
59592281|NCT03032965|75700441|FG001|STARTED|Overall Study||68||
59592282|NCT03032965|75700440|FG000|COMPLETED|Overall Study||61||
59592283|NCT03032965|75700441|FG001|COMPLETED|Overall Study||68||
59592284|NCT03032965|75700440|FG000|NOT COMPLETED|Overall Study||0||
59592285|NCT03032965|75700441|FG001|NOT COMPLETED|Overall Study||0||
59592286|NCT03030638|75700455|FG000|STARTED|Overall Study||1386||
59592287|NCT03030638|75700456|FG001|STARTED|Overall Study||1841||
59592288|NCT03030638|75700457|FG002|STARTED|Overall Study||1712||
59592289|NCT03030638|75700458|FG003|STARTED|Overall Study||6406||
59592290|NCT03030638|75700459|FG004|STARTED|Overall Study||696||
59592291|NCT03030638|75700460|FG005|STARTED|Overall Study||1592||
59592292|NCT03030638|75700461|FG006|STARTED|Overall Study||364||
59592293|NCT03030638|75700462|FG007|STARTED|Overall Study||127||
59592294|NCT03030638|75700455|FG000|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||372||
59592295|NCT03030638|75700456|FG001|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||636||
59592296|NCT03030638|75700457|FG002|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||0||
59592297|NCT03030638|75700458|FG003|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||0||
59592298|NCT03030638|75700459|FG004|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||0||
59592299|NCT03030638|75700460|FG005|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||0||
59592300|NCT03030638|75700461|FG006|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||0||
59592301|NCT03030638|75700462|FG007|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||0||
59592302|NCT03030638|75700455|FG000|COMPLETED|Overall Study||1386||
59592303|NCT03030638|75700456|FG001|COMPLETED|Overall Study||1841||
59592304|NCT03030638|75700457|FG002|COMPLETED|Overall Study||1712||
59592305|NCT03030638|75700458|FG003|COMPLETED|Overall Study||6406||
59592306|NCT03030638|75700459|FG004|COMPLETED|Overall Study||696||
59592307|NCT03030638|75700460|FG005|COMPLETED|Overall Study||1592||
59592308|NCT03030638|75700461|FG006|COMPLETED|Overall Study||364||
59592309|NCT03030638|75700462|FG007|COMPLETED|Overall Study||127||
59592310|NCT03030638|75700455|FG000|NOT COMPLETED|Overall Study||0||
59592311|NCT03030638|75700456|FG001|NOT COMPLETED|Overall Study||0||
59592312|NCT03030638|75700457|FG002|NOT COMPLETED|Overall Study||0||
59592313|NCT03030638|75700458|FG003|NOT COMPLETED|Overall Study||0||
59592314|NCT03030638|75700459|FG004|NOT COMPLETED|Overall Study||0||
59592315|NCT03030638|75700460|FG005|NOT COMPLETED|Overall Study||0||
59857347|NCT02316340|75982084|FG001|NOT COMPLETED|First Progression||1||
59592316|NCT03030638|75700461|FG006|NOT COMPLETED|Overall Study||0||
59592317|NCT03030638|75700462|FG007|NOT COMPLETED|Overall Study||0||
59592318|NCT02949518|75700484|FG000|STARTED|Overall Study||28||
59592319|NCT02949518|75700485|FG001|STARTED|Overall Study||28||
59592320|NCT02949518|75700484|FG000|COMPLETED|Overall Study||25||
59592321|NCT02949518|75700485|FG001|COMPLETED|Overall Study||26||
59592322|NCT02949518|75700484|FG000|NOT COMPLETED|Overall Study||3||
59592323|NCT02949518|75700485|FG001|NOT COMPLETED|Overall Study||2||
59592324|NCT02949674|75700496|FG000|STARTED|Overall Study||31||
59592325|NCT02949674|75700497|FG001|STARTED|Overall Study||31||
59592326|NCT02949674|75700498|FG002|STARTED|Overall Study||31||
59592327|NCT02949674|75700496|FG000|COMPLETED|Overall Study||31||
59592328|NCT02949674|75700497|FG001|COMPLETED|Overall Study||31||
59592329|NCT02949674|75700498|FG002|COMPLETED|Overall Study||31||
59592330|NCT02949674|75700496|FG000|NOT COMPLETED|Overall Study||0||
59592331|NCT02949674|75700497|FG001|NOT COMPLETED|Overall Study||0||
59592332|NCT02949674|75700498|FG002|NOT COMPLETED|Overall Study||0||
59592333|NCT03033511|75700508|FG000|STARTED|Overall Study||376||
59592334|NCT03033511|75700509|FG001|STARTED|Overall Study||372||
59592335|NCT03033511|75700508|FG000|COMPLETED|Overall Study||376||
59592336|NCT03033511|75700509|FG001|COMPLETED|Overall Study||372||
59592337|NCT03033511|75700508|FG000|NOT COMPLETED|Overall Study||0||
59592338|NCT03033511|75700509|FG001|NOT COMPLETED|Overall Study||0||
59592339|NCT03033134|75700517|FG000|STARTED|Overall Study||42||
59592340|NCT03033134|75700518|FG001|STARTED|Overall Study||12||
59592341|NCT03033134|75700517|FG000|6-month Primary Endpoints|Overall Study||42||
59592342|NCT03033134|75700518|FG001|6-month Primary Endpoints|Overall Study||12||
59592343|NCT03033134|75700517|FG000|COMPLETED|Overall Study||0||
59592344|NCT03033134|75700518|FG001|COMPLETED|Overall Study||0||
59592345|NCT03033134|75700517|FG000|NOT COMPLETED|Overall Study||42||
59592346|NCT03033134|75700518|FG001|NOT COMPLETED|Overall Study||12||
59592347|NCT02951312|75700530|FG000|STARTED|Study Part 1||6||
59592348|NCT02951312|75700531|FG001|STARTED|Study Part 1||6||
59592349|NCT02951312|75700532|FG002|STARTED|Study Part 1||0||
59592350|NCT02951312|75700533|FG003|STARTED|Study Part 1||0||
59592351|NCT02951312|75700530|FG000|COMPLETED|Study Part 1||6||
59592352|NCT02951312|75700531|FG001|COMPLETED|Study Part 1||6||
59592353|NCT02951312|75700532|FG002|COMPLETED|Study Part 1||0||
59592354|NCT02951312|75700533|FG003|COMPLETED|Study Part 1||0||
59592355|NCT02951312|75700530|FG000|NOT COMPLETED|Study Part 1||0||
59592356|NCT02951312|75700531|FG001|NOT COMPLETED|Study Part 1||0||
59592357|NCT02951312|75700532|FG002|NOT COMPLETED|Study Part 1||0||
59592358|NCT02951312|75700533|FG003|NOT COMPLETED|Study Part 1||0||
59592359|NCT02951312|75700530|FG000|STARTED|Study Part 2||0||
59592360|NCT02951312|75700531|FG001|STARTED|Study Part 2||0||
59592361|NCT02951312|75700532|FG002|STARTED|Study Part 2||6||
59592362|NCT02951312|75700533|FG003|STARTED|Study Part 2||6||
59592363|NCT02951312|75700530|FG000|COMPLETED|Study Part 2||0||
59592364|NCT02951312|75700531|FG001|COMPLETED|Study Part 2||0||
59592365|NCT02951312|75700532|FG002|COMPLETED|Study Part 2||6||
59592366|NCT02951312|75700533|FG003|COMPLETED|Study Part 2||6||
59592367|NCT02951312|75700530|FG000|NOT COMPLETED|Study Part 2||0||
59592368|NCT02951312|75700531|FG001|NOT COMPLETED|Study Part 2||0||
59592369|NCT02951312|75700532|FG002|NOT COMPLETED|Study Part 2||0||
59592370|NCT02951312|75700533|FG003|NOT COMPLETED|Study Part 2||0||
59592371|NCT02796625|75700553|FG000|STARTED|Overall Study||80||
59592372|NCT02796625|75700553|FG000|COMPLETED|Overall Study||61||
59592373|NCT02796625|75700553|FG000|NOT COMPLETED|Overall Study||19||
59592374|NCT03035929|75700557|FG000|STARTED|Overall Study||10||
59592375|NCT03035929|75700557|FG000|COMPLETED|Overall Study||10||
59592376|NCT03035929|75700557|FG000|NOT COMPLETED|Overall Study||0||
59592377|NCT02951702|75700564|FG000|STARTED|Overall Study||34||
59592378|NCT02951702|75700565|FG001|STARTED|Overall Study||17||
59592379|NCT02951702|75700564|FG000|COMPLETED|Overall Study||34||
59592380|NCT02951702|75700565|FG001|COMPLETED|Overall Study||17||
59592381|NCT02951702|75700564|FG000|NOT COMPLETED|Overall Study||0||
60122336|NCT01546649|76243384|FG000|COMPLETED|Overall Study||75||
59592382|NCT02951702|75700565|FG001|NOT COMPLETED|Overall Study||0||
59592383|NCT02911909|75700573|FG000|STARTED|Overall Study||4||
59592384|NCT02911909|75700574|FG001|STARTED|Overall Study||3||
59592385|NCT02911909|75700573|FG000|COMPLETED|Overall Study||2||
59592386|NCT02911909|75700574|FG001|COMPLETED|Overall Study|No Data was obtained in the study group.|0||
59592387|NCT02911909|75700573|FG000|NOT COMPLETED|Overall Study||2||
59592388|NCT02911909|75700574|FG001|NOT COMPLETED|Overall Study||3||
59592389|NCT02952872|75700596|FG000|STARTED|Overall Study||22||
59592390|NCT02952872|75700597|FG001|STARTED|Overall Study||22||
59592391|NCT02952872|75700598|FG002|STARTED|Overall Study||22||
59592392|NCT02952872|75700599|FG003|STARTED|Overall Study||22||
59592393|NCT02952872|75700600|FG004|STARTED|Overall Study||22||
59592394|NCT02952872|75700601|FG005|STARTED|Overall Study||21||
59592395|NCT02952872|75700602|FG006|STARTED|Overall Study||22||
59592396|NCT02952872|75700603|FG007|STARTED|Overall Study||21||
59592397|NCT02952872|75700604|FG008|STARTED|Overall Study||22||
59592398|NCT02952872|75700605|FG009|STARTED|Overall Study||22||
59592399|NCT02952872|75700606|FG010|STARTED|Overall Study||23||
59592400|NCT02952872|75700607|FG011|STARTED|Overall Study||22||
59592401|NCT02952872|75700608|FG012|STARTED|Overall Study||22||
59592402|NCT02952872|75700609|FG013|STARTED|Overall Study||22||
59592403|NCT02952872|75700610|FG014|STARTED|Overall Study||22||
59592404|NCT02952872|75700611|FG015|STARTED|Overall Study||23||
59592405|NCT02952872|75700596|FG000|COMPLETED|Overall Study||22||
59592406|NCT02952872|75700597|FG001|COMPLETED|Overall Study||22||
59592407|NCT02952872|75700598|FG002|COMPLETED|Overall Study||22||
59592408|NCT02952872|75700599|FG003|COMPLETED|Overall Study||22||
59592409|NCT02952872|75700600|FG004|COMPLETED|Overall Study||22||
59592410|NCT02952872|75700601|FG005|COMPLETED|Overall Study||21||
59592411|NCT02952872|75700602|FG006|COMPLETED|Overall Study||22||
59592412|NCT02952872|75700603|FG007|COMPLETED|Overall Study||21||
59592413|NCT02952872|75700604|FG008|COMPLETED|Overall Study||22||
59592414|NCT02952872|75700605|FG009|COMPLETED|Overall Study||22||
59592415|NCT02952872|75700606|FG010|COMPLETED|Overall Study||23||
59592416|NCT02952872|75700607|FG011|COMPLETED|Overall Study||22||
59592417|NCT02952872|75700608|FG012|COMPLETED|Overall Study||22||
59592418|NCT02952872|75700609|FG013|COMPLETED|Overall Study||22||
59592419|NCT02952872|75700610|FG014|COMPLETED|Overall Study||22||
59592420|NCT02952872|75700611|FG015|COMPLETED|Overall Study||23||
59592421|NCT02952872|75700596|FG000|NOT COMPLETED|Overall Study||0||
59592422|NCT02952872|75700597|FG001|NOT COMPLETED|Overall Study||0||
59592423|NCT02952872|75700598|FG002|NOT COMPLETED|Overall Study||0||
59592424|NCT02952872|75700599|FG003|NOT COMPLETED|Overall Study||0||
59592425|NCT02952872|75700600|FG004|NOT COMPLETED|Overall Study||0||
59592426|NCT02952872|75700601|FG005|NOT COMPLETED|Overall Study||0||
59592427|NCT02952872|75700602|FG006|NOT COMPLETED|Overall Study||0||
59592428|NCT02952872|75700603|FG007|NOT COMPLETED|Overall Study||0||
59592429|NCT02952872|75700604|FG008|NOT COMPLETED|Overall Study||0||
59592430|NCT02952872|75700605|FG009|NOT COMPLETED|Overall Study||0||
59592431|NCT02952872|75700606|FG010|NOT COMPLETED|Overall Study||0||
59592432|NCT02952872|75700607|FG011|NOT COMPLETED|Overall Study||0||
59592433|NCT02952872|75700608|FG012|NOT COMPLETED|Overall Study||0||
59592434|NCT02952872|75700609|FG013|NOT COMPLETED|Overall Study||0||
59592435|NCT02952872|75700610|FG014|NOT COMPLETED|Overall Study||0||
59592436|NCT02952872|75700611|FG015|NOT COMPLETED|Overall Study||0||
59592437|NCT02799667|75700647|FG000|STARTED|Overall Study||55||
59592438|NCT02799667|75700648|FG001|STARTED|Overall Study||55||
59592439|NCT02799667|75700647|FG000|COMPLETED|Overall Study||54||
59592440|NCT02799667|75700648|FG001|COMPLETED|Overall Study||54||
59592441|NCT02799667|75700647|FG000|NOT COMPLETED|Overall Study||1||
59592442|NCT02799667|75700648|FG001|NOT COMPLETED|Overall Study||1||
59592443|NCT02914795|75700656|FG000|STARTED|Overall Study||77||
59592444|NCT02914795|75700657|FG001|STARTED|Overall Study||22||
59592445|NCT02914795|75700656|FG000|COMPLETED|Overall Study||77||
59592446|NCT02914795|75700657|FG001|COMPLETED|Overall Study||22||
59592447|NCT02914795|75700656|FG000|NOT COMPLETED|Overall Study||0||
59592448|NCT02914795|75700657|FG001|NOT COMPLETED|Overall Study||0||
59592449|NCT02953418|75700665|FG000|STARTED|Overall Study||34||
59592450|NCT02953418|75700665|FG000|COMPLETED|Overall Study||34||
59592451|NCT02953418|75700665|FG000|NOT COMPLETED|Overall Study||0||
59592452|NCT02915029|75700671|FG000|STARTED|Overall Study||63||24
59592453|NCT02915029|75700672|FG001|STARTED|Overall Study||62||0
59592454|NCT02915029|75700671|FG000|COMPLETED|Overall Study||50||24
59592455|NCT02915029|75700672|FG001|COMPLETED|Overall Study||48||0
59592456|NCT02915029|75700671|FG000|NOT COMPLETED|Overall Study||13||0
59592457|NCT02915029|75700672|FG001|NOT COMPLETED|Overall Study||14||0
59592458|NCT02831660|75700678|FG000|STARTED|Overall Study||1||
59592459|NCT02831660|75700678|FG000|COMPLETED|Overall Study||1||
59592460|NCT02831660|75700678|FG000|NOT COMPLETED|Overall Study||0||
59592461|NCT02831816|75700682|FG000|STARTED|Overall Study||640||640
59592462|NCT02831816|75700682|FG000|ZP|Overall Study||589||589
59592463|NCT02831816|75700682|FG000|CP|Overall Study||590||590
59592464|NCT02831816|75700682|FG000|Vehicle|Overall Study||131||131
59592465|NCT02831816|75700682|FG000|COMPLETED|Overall Study||640||640
59592466|NCT02831816|75700682|FG000|NOT COMPLETED|Overall Study||0||0
59592467|NCT02832284|75700693|FG000|STARTED|Overall Study||23||
59592468|NCT02832284|75700693|FG000|COMPLETED|Overall Study||23||
59592469|NCT02832284|75700693|FG000|NOT COMPLETED|Overall Study||0||
59592470|NCT03036163|75700704|FG000|STARTED|Overall Study||6||
59592471|NCT03036163|75700705|FG001|STARTED|Overall Study||6||
59592472|NCT03036163|75700706|FG002|STARTED|Overall Study||6||
59592473|NCT03036163|75700707|FG003|STARTED|Overall Study||6||
59592474|NCT03036163|75700708|FG004|STARTED|Overall Study||6||
59592475|NCT03036163|75700709|FG005|STARTED|Overall Study||5||
59592476|NCT03036163|75700710|FG006|STARTED|Overall Study||5||
59592477|NCT03036163|75700704|FG000|COMPLETED|Overall Study||6||
59592478|NCT03036163|75700705|FG001|COMPLETED|Overall Study||6||
59592479|NCT03036163|75700706|FG002|COMPLETED|Overall Study||6||
59592480|NCT03036163|75700707|FG003|COMPLETED|Overall Study||6||
59592481|NCT03036163|75700708|FG004|COMPLETED|Overall Study||6||
59592482|NCT03036163|75700709|FG005|COMPLETED|Overall Study||5||
59726382|NCT01190150|75845198|FG000|STARTED|Second Treatment||10||
60122337|NCT01546649|76243385|FG001|COMPLETED|Overall Study||75||
59592483|NCT03036163|75700710|FG006|COMPLETED|Overall Study||5||
59592484|NCT03036163|75700704|FG000|NOT COMPLETED|Overall Study||0||
59592485|NCT03036163|75700705|FG001|NOT COMPLETED|Overall Study||0||
59592486|NCT03036163|75700706|FG002|NOT COMPLETED|Overall Study||0||
59592487|NCT03036163|75700707|FG003|NOT COMPLETED|Overall Study||0||
59592488|NCT03036163|75700708|FG004|NOT COMPLETED|Overall Study||0||
59592489|NCT03036163|75700709|FG005|NOT COMPLETED|Overall Study||0||
59592490|NCT03036163|75700710|FG006|NOT COMPLETED|Overall Study||0||
59592491|NCT02832674|75700726|FG000|STARTED|Overall Study||72||
59592492|NCT02832674|75700726|FG000|COMPLETED|Overall Study||67||
59592493|NCT02832674|75700726|FG000|NOT COMPLETED|Overall Study||5||
59592494|NCT03034928|75700730|FG000|STARTED|Period 1, First 2 Hours of Wear||8|Started = Randomized|
59726383|NCT01190150|75845199|FG001|STARTED|Second Treatment||7||
60122338|NCT01546649|76243384|FG000|NOT COMPLETED|Overall Study||8||
59592495|NCT03034928|75700731|FG001|STARTED|Period 1, First 2 Hours of Wear||8|Started = Randomized|
59592496|NCT03034928|75700732|FG002|STARTED|Period 1, First 2 Hours of Wear||9|Started = Randomized|
59592497|NCT03034928|75700733|FG003|STARTED|Period 1, First 2 Hours of Wear||8|Started = Randomized|
59592498|NCT03034928|75700730|FG000|COMPLETED|Period 1, First 2 Hours of Wear||8||
59592499|NCT03034928|75700731|FG001|COMPLETED|Period 1, First 2 Hours of Wear||8||
59592500|NCT03034928|75700732|FG002|COMPLETED|Period 1, First 2 Hours of Wear||9||
59592501|NCT03034928|75700733|FG003|COMPLETED|Period 1, First 2 Hours of Wear||8||
59592502|NCT03034928|75700730|FG000|NOT COMPLETED|Period 1, First 2 Hours of Wear||0||
59592503|NCT03034928|75700731|FG001|NOT COMPLETED|Period 1, First 2 Hours of Wear||0||
59592504|NCT03034928|75700732|FG002|NOT COMPLETED|Period 1, First 2 Hours of Wear||0||
59592505|NCT03034928|75700733|FG003|NOT COMPLETED|Period 1, First 2 Hours of Wear||0||
59592506|NCT03034928|75700730|FG000|STARTED|Washout Period Between Lens Wear||8||
59592507|NCT03034928|75700731|FG001|STARTED|Washout Period Between Lens Wear||8||
59592508|NCT03034928|75700732|FG002|STARTED|Washout Period Between Lens Wear||9||
59592509|NCT03034928|75700733|FG003|STARTED|Washout Period Between Lens Wear||8||
59592510|NCT03034928|75700730|FG000|COMPLETED|Washout Period Between Lens Wear||8||
59592511|NCT03034928|75700731|FG001|COMPLETED|Washout Period Between Lens Wear||8||
59592512|NCT03034928|75700732|FG002|COMPLETED|Washout Period Between Lens Wear||9||
59592513|NCT03034928|75700733|FG003|COMPLETED|Washout Period Between Lens Wear||8||
59592514|NCT03034928|75700730|FG000|NOT COMPLETED|Washout Period Between Lens Wear||0||
59592515|NCT03034928|75700731|FG001|NOT COMPLETED|Washout Period Between Lens Wear||0||
59592516|NCT03034928|75700732|FG002|NOT COMPLETED|Washout Period Between Lens Wear||0||
59592517|NCT03034928|75700733|FG003|NOT COMPLETED|Washout Period Between Lens Wear||0||
59592518|NCT03034928|75700730|FG000|STARTED|Period 2, Second 2 Hours of Wear||8||
59592519|NCT03034928|75700731|FG001|STARTED|Period 2, Second 2 Hours of Wear||8||
59592520|NCT03034928|75700732|FG002|STARTED|Period 2, Second 2 Hours of Wear||9||
59592521|NCT03034928|75700733|FG003|STARTED|Period 2, Second 2 Hours of Wear||8||
59592522|NCT03034928|75700730|FG000|COMPLETED|Period 2, Second 2 Hours of Wear||8||
59592523|NCT03034928|75700731|FG001|COMPLETED|Period 2, Second 2 Hours of Wear||8||
59592524|NCT03034928|75700732|FG002|COMPLETED|Period 2, Second 2 Hours of Wear||9||
59592525|NCT03034928|75700733|FG003|COMPLETED|Period 2, Second 2 Hours of Wear||8||
59592526|NCT03034928|75700730|FG000|NOT COMPLETED|Period 2, Second 2 Hours of Wear||0||
59592527|NCT03034928|75700731|FG001|NOT COMPLETED|Period 2, Second 2 Hours of Wear||0||
59592528|NCT03034928|75700732|FG002|NOT COMPLETED|Period 2, Second 2 Hours of Wear||0||
59592529|NCT03034928|75700733|FG003|NOT COMPLETED|Period 2, Second 2 Hours of Wear||0||
59592530|NCT03038815|75700744|FG000|STARTED|Controll Condition, 1 Hour||10||
59592531|NCT03038815|75700745|FG001|STARTED|Controll Condition, 1 Hour||10||
59592532|NCT03038815|75700744|FG000|COMPLETED|Controll Condition, 1 Hour||10||
59592533|NCT03038815|75700745|FG001|COMPLETED|Controll Condition, 1 Hour||10||
59592534|NCT03038815|75700744|FG000|NOT COMPLETED|Controll Condition, 1 Hour||0||
59592535|NCT03038815|75700745|FG001|NOT COMPLETED|Controll Condition, 1 Hour||0||
59592536|NCT03038815|75700744|FG000|STARTED|Intervention 1, 1 Hour||10||
59592537|NCT03038815|75700745|FG001|STARTED|Intervention 1, 1 Hour||10||
59592538|NCT03038815|75700744|FG000|COMPLETED|Intervention 1, 1 Hour||10||
59592539|NCT03038815|75700745|FG001|COMPLETED|Intervention 1, 1 Hour||10||
59592540|NCT03038815|75700744|FG000|NOT COMPLETED|Intervention 1, 1 Hour||0||
59592541|NCT03038815|75700745|FG001|NOT COMPLETED|Intervention 1, 1 Hour||0||
59592542|NCT03038815|75700744|FG000|STARTED|Intervention 2, 1 Hour||10||
59592543|NCT03038815|75700745|FG001|STARTED|Intervention 2, 1 Hour||10||
59592544|NCT03038815|75700744|FG000|COMPLETED|Intervention 2, 1 Hour||10||
59592545|NCT03038815|75700745|FG001|COMPLETED|Intervention 2, 1 Hour||10||
59592546|NCT03038815|75700744|FG000|NOT COMPLETED|Intervention 2, 1 Hour||0||
59592547|NCT03038815|75700745|FG001|NOT COMPLETED|Intervention 2, 1 Hour||0||
59592548|NCT02800213|75700754|FG000|STARTED|First Intervention||35||
59592549|NCT02800213|75700755|FG001|STARTED|First Intervention||35||
59592550|NCT02800213|75700754|FG000|COMPLETED|First Intervention||35||
59592551|NCT02800213|75700755|FG001|COMPLETED|First Intervention||35||
59592552|NCT02800213|75700754|FG000|NOT COMPLETED|First Intervention||0||
59592553|NCT02800213|75700755|FG001|NOT COMPLETED|First Intervention||0||
59592554|NCT02800213|75700754|FG000|STARTED|Second Intervention||35||
59726384|NCT01190150|75845198|FG000|COMPLETED|Second Treatment||10||
59726385|NCT01190150|75845199|FG001|COMPLETED|Second Treatment||7||
59592555|NCT02800213|75700755|FG001|STARTED|Second Intervention||35||
59592556|NCT02800213|75700754|FG000|COMPLETED|Second Intervention||35||
59592557|NCT02800213|75700755|FG001|COMPLETED|Second Intervention||35||
59592558|NCT02800213|75700754|FG000|NOT COMPLETED|Second Intervention||0||
59592559|NCT02800213|75700755|FG001|NOT COMPLETED|Second Intervention||0||
59592560|NCT02953886|75700761|FG000|STARTED|Overall Study||20||
59592561|NCT02953886|75700761|FG000|COMPLETED|Overall Study||20||
59592562|NCT02953886|75700761|FG000|NOT COMPLETED|Overall Study||0||
59592563|NCT03035318|75700770|FG000|STARTED|Overall Study||24||
59592564|NCT03035318|75700771|FG001|STARTED|Overall Study||25||
59592565|NCT03035318|75700772|FG002|STARTED|Overall Study||25||
59592566|NCT03035318|75700773|FG003|STARTED|Overall Study||25||
59726386|NCT01190150|75845198|FG000|NOT COMPLETED|Second Treatment||0||
59726387|NCT01190150|75845199|FG001|NOT COMPLETED|Second Treatment||0||
59592567|NCT03035318|75700774|FG004|STARTED|Overall Study||27||
59592568|NCT03035318|75700770|FG000|COMPLETED|Overall Study||22||
59592569|NCT03035318|75700771|FG001|COMPLETED|Overall Study||21||
59592570|NCT03035318|75700772|FG002|COMPLETED|Overall Study||21||
59592571|NCT03035318|75700773|FG003|COMPLETED|Overall Study||23||
59592572|NCT03035318|75700774|FG004|COMPLETED|Overall Study||20||
59592573|NCT03035318|75700770|FG000|NOT COMPLETED|Overall Study||2||
59592574|NCT03035318|75700771|FG001|NOT COMPLETED|Overall Study||4||
59592575|NCT03035318|75700772|FG002|NOT COMPLETED|Overall Study||4||
59592576|NCT03035318|75700773|FG003|NOT COMPLETED|Overall Study||2||
59592577|NCT03035318|75700774|FG004|NOT COMPLETED|Overall Study||7||
59592578|NCT03035708|75700788|FG000|STARTED|Overall Study||23||
59592579|NCT03035708|75700789|FG001|STARTED|Overall Study||24||
59592580|NCT03035708|75700788|FG000|COMPLETED|Overall Study||19||
59592581|NCT03035708|75700789|FG001|COMPLETED|Overall Study||13||
59592582|NCT03035708|75700788|FG000|NOT COMPLETED|Overall Study||4||
59592583|NCT03035708|75700789|FG001|NOT COMPLETED|Overall Study||11||
59592584|NCT03040154|75700799|FG000|STARTED|Overall Study||110||
59592585|NCT03040154|75700800|FG001|STARTED|Overall Study||105||
59592586|NCT03040154|75700799|FG000|COMPLETED|Overall Study||110||
59592587|NCT03040154|75700800|FG001|COMPLETED|Overall Study||105||
59592588|NCT03040154|75700799|FG000|NOT COMPLETED|Overall Study||0||
59592589|NCT03040154|75700800|FG001|NOT COMPLETED|Overall Study||0||
59592590|NCT02916745|75700806|FG000|STARTED|Overall Study||5||
59592591|NCT02916745|75700806|FG000|COMPLETED|Overall Study||5||
59592592|NCT02916745|75700806|FG000|NOT COMPLETED|Overall Study||0||
59592593|NCT02954198|75700812|FG000|STARTED|Overall Study||20||
59592594|NCT02954198|75700813|FG001|STARTED|Overall Study||20||
59592595|NCT02954198|75700812|FG000|COMPLETED|Overall Study||20||
59592596|NCT02954198|75700813|FG001|COMPLETED|Overall Study||20||
59592597|NCT02954198|75700812|FG000|NOT COMPLETED|Overall Study||0||
59592598|NCT02954198|75700813|FG001|NOT COMPLETED|Overall Study||0||
59592599|NCT02956070|75700821|FG000|STARTED|Overall Study||35||
59592600|NCT02956070|75700822|FG001|STARTED|Overall Study||35||
59592601|NCT02956070|75700821|FG000|COMPLETED|Overall Study||35||
59592602|NCT02956070|75700822|FG001|COMPLETED|Overall Study||35||
59592603|NCT02956070|75700821|FG000|NOT COMPLETED|Overall Study||0||
59592604|NCT02956070|75700822|FG001|NOT COMPLETED|Overall Study||0||
59592605|NCT02956616|75700830|FG000|STARTED|Overall Study||58||
59592606|NCT02956616|75700831|FG001|STARTED|Overall Study||60||
59592607|NCT02956616|75700830|FG000|COMPLETED|Overall Study||58||
59592608|NCT02956616|75700831|FG001|COMPLETED|Overall Study||60||
59592609|NCT02956616|75700830|FG000|NOT COMPLETED|Overall Study||0||
59592610|NCT02956616|75700831|FG001|NOT COMPLETED|Overall Study||0||
59592611|NCT02809183|75700842|FG000|STARTED|Overall Study||25||
59592612|NCT02809183|75700843|FG001|STARTED|Overall Study||25||
59592613|NCT02809183|75700844|FG002|STARTED|Overall Study||25||
59592614|NCT02809183|75700845|FG003|STARTED|Overall Study||26||
59592615|NCT02809183|75700846|FG004|STARTED|Overall Study||6||
59592616|NCT02809183|75700847|FG005|STARTED|Overall Study||28||
59592617|NCT02809183|75700842|FG000|COMPLETED|Overall Study||25||
59592618|NCT02809183|75700843|FG001|COMPLETED|Overall Study||25||
59592619|NCT02809183|75700844|FG002|COMPLETED|Overall Study||25||
59592620|NCT02809183|75700845|FG003|COMPLETED|Overall Study||26||
59592621|NCT02809183|75700846|FG004|COMPLETED|Overall Study||6||
59592622|NCT02809183|75700847|FG005|COMPLETED|Overall Study||28||
59592623|NCT02809183|75700842|FG000|NOT COMPLETED|Overall Study||0||
59592624|NCT02809183|75700843|FG001|NOT COMPLETED|Overall Study||0||
59592625|NCT02809183|75700844|FG002|NOT COMPLETED|Overall Study||0||
59592626|NCT02809183|75700845|FG003|NOT COMPLETED|Overall Study||0||
59592627|NCT02809183|75700846|FG004|NOT COMPLETED|Overall Study||0||
59592628|NCT02809183|75700847|FG005|NOT COMPLETED|Overall Study||0||
59592629|NCT02958956|75700866|FG000|STARTED|Overall Study||38190||
59592630|NCT02958956|75700867|FG001|STARTED|Overall Study||198317||
59592631|NCT02958956|75700866|FG000|COMPLETED|Overall Study||38190||
59592632|NCT02958956|75700867|FG001|COMPLETED|Overall Study||198317||
59592633|NCT02958956|75700866|FG000|NOT COMPLETED|Overall Study||0||
59592634|NCT02958956|75700867|FG001|NOT COMPLETED|Overall Study||0||
59592635|NCT02833922|75700874|FG000|STARTED|Overall Study||718||
59592636|NCT02833922|75700874|FG000|COMPLETED|Overall Study||336||
59592637|NCT02833922|75700874|FG000|NOT COMPLETED|Overall Study||382||
59592638|NCT02917447|75700880|FG000|STARTED|Overall Study||51||
59592639|NCT02917447|75700881|FG001|STARTED|Overall Study||51||
59592640|NCT02917447|75700880|FG000|COMPLETED|Overall Study||44||
59592641|NCT02917447|75700881|FG001|COMPLETED|Overall Study||48||
59592642|NCT02917447|75700880|FG000|NOT COMPLETED|Overall Study||7||
59592643|NCT02917447|75700881|FG001|NOT COMPLETED|Overall Study||3||
59592644|NCT04914000|75700887|FG000|STARTED|Overall Study||53||
59592645|NCT04914000|75700887|FG000|COMPLETED|Overall Study||44||
59592646|NCT04914000|75700887|FG000|NOT COMPLETED|Overall Study||9||
59592647|NCT04902950|75700893|FG000|STARTED|Overall Study||4||
59592648|NCT04902950|75700894|FG001|STARTED|Overall Study||5||
59592649|NCT04902950|75700893|FG000|COMPLETED|Overall Study||4||
59592650|NCT04902950|75700894|FG001|COMPLETED|Overall Study||5||
59592651|NCT04902950|75700893|FG000|NOT COMPLETED|Overall Study||0||
59592652|NCT04902950|75700894|FG001|NOT COMPLETED|Overall Study||0||
59592653|NCT04530825|75700904|FG000|STARTED|Overall Study||7||
59592654|NCT04530825|75700905|FG001|STARTED|Overall Study||29||
59592655|NCT04530825|75700906|FG002|STARTED|Overall Study||16||
59592656|NCT04530825|75700907|FG003|STARTED|Overall Study||13||
59592657|NCT04530825|75700904|FG000|COMPLETED|Overall Study||4||
59592658|NCT04530825|75700905|FG001|COMPLETED|Overall Study||28||
59592659|NCT04530825|75700906|FG002|COMPLETED|Overall Study||16||
59592660|NCT04530825|75700907|FG003|COMPLETED|Overall Study||12||
59592661|NCT04530825|75700904|FG000|NOT COMPLETED|Overall Study||3||
59592662|NCT04530825|75700905|FG001|NOT COMPLETED|Overall Study||1||
59592663|NCT04530825|75700906|FG002|NOT COMPLETED|Overall Study||0||
59592664|NCT04530825|75700907|FG003|NOT COMPLETED|Overall Study||1||
59592665|NCT04169373|75700921|FG000|STARTED|Week 1 to Week 14||209|Randomized|
59592666|NCT04169373|75700922|FG001|STARTED|Week 1 to Week 14||211|Randomized|
59592667|NCT04169373|75700923|FG002|STARTED|Week 1 to Week 14||158|Randomized|
59592668|NCT04169373|75700924|FG003|STARTED|Week 1 to Week 14||156|Randomized|
59592669|NCT04169373|75700921|FG000|Received Study Drug|Week 1 to Week 14||209|Study drug refers to either upadacitinib or placebo|
59592670|NCT04169373|75700922|FG001|Received Study Drug|Week 1 to Week 14||211|Study drug refers to either upadacitinib or placebo|
59592671|NCT04169373|75700923|FG002|Received Study Drug|Week 1 to Week 14||157|Study drug refers to either upadacitinib or placebo|
59592672|NCT04169373|75700924|FG003|Received Study Drug|Week 1 to Week 14||156|Study drug refers to either upadacitinib or placebo|
59592673|NCT04169373|75700921|FG000|COMPLETED|Week 1 to Week 14||204|Completed Week 14|
59592674|NCT04169373|75700922|FG001|COMPLETED|Week 1 to Week 14||206|Completed Week 14|
59592675|NCT04169373|75700923|FG002|COMPLETED|Week 1 to Week 14||149|Completed Week 14|
59592676|NCT04169373|75700924|FG003|COMPLETED|Week 1 to Week 14||142|Completed Week 14|
59592677|NCT04169373|75700921|FG000|NOT COMPLETED|Week 1 to Week 14||5||
59592678|NCT04169373|75700922|FG001|NOT COMPLETED|Week 1 to Week 14||5||
59592679|NCT04169373|75700923|FG002|NOT COMPLETED|Week 1 to Week 14||9||
59592680|NCT04169373|75700924|FG003|NOT COMPLETED|Week 1 to Week 14||14||
59592681|NCT04169373|75700921|FG000|STARTED|Week 14 to Week 52||204||
59592682|NCT04169373|75700922|FG001|STARTED|Week 14 to Week 52||206||
59592683|NCT04169373|75700923|FG002|STARTED|Week 14 to Week 52||149||
59592684|NCT04169373|75700924|FG003|STARTED|Week 14 to Week 52||142||
59592685|NCT04169373|75700921|FG000|COMPLETED|Week 14 to Week 52||192|Completed Week 52|
59592686|NCT04169373|75700922|FG001|COMPLETED|Week 14 to Week 52|One participant who was ongoing at the Week 52 data cut off date (19 May 2022) completed their Week 52 visit shortly thereafter.|194|Completed Week 52|
59592687|NCT04169373|75700923|FG002|COMPLETED|Week 14 to Week 52||138|Completed Week 52|
59592688|NCT04169373|75700924|FG003|COMPLETED|Week 14 to Week 52||133|Completed Week 52|
59592689|NCT04169373|75700921|FG000|NOT COMPLETED|Week 14 to Week 52||12||
59592690|NCT04169373|75700922|FG001|NOT COMPLETED|Week 14 to Week 52||12||
59592691|NCT04169373|75700923|FG002|NOT COMPLETED|Week 14 to Week 52||11||
59592692|NCT04169373|75700924|FG003|NOT COMPLETED|Week 14 to Week 52||9||
59592693|NCT04154930|75700939|FG000|STARTED|Overall Study||287||
59592694|NCT04154930|75700940|FG001|STARTED|Overall Study||46||
59592695|NCT04154930|75700939|FG000|COMPLETED|Overall Study||250||
59592696|NCT04154930|75700940|FG001|COMPLETED|Overall Study||33||
59592697|NCT04154930|75700939|FG000|NOT COMPLETED|Overall Study||37||
59592698|NCT04154930|75700940|FG001|NOT COMPLETED|Overall Study||13||
59592699|NCT04124471|75700946|FG000|STARTED|Overall Study||42||
59592700|NCT04124471|75700946|FG000|COMPLETED|Overall Study||41||
59592701|NCT04124471|75700946|FG000|NOT COMPLETED|Overall Study||1||
59592702|NCT04093024|75700952|FG000|STARTED|Double-blind Period||13||
59592703|NCT04093024|75700953|FG001|STARTED|Double-blind Period||26||
59592704|NCT04093024|75700952|FG000|COMPLETED|Double-blind Period||11||
59592705|NCT04093024|75700953|FG001|COMPLETED|Double-blind Period||21||
59592706|NCT04093024|75700952|FG000|NOT COMPLETED|Double-blind Period||2||
59592707|NCT04093024|75700953|FG001|NOT COMPLETED|Double-blind Period||5||
59592708|NCT04093024|75700952|FG000|STARTED|Open-label Nintedanib Period (OLNP)||11||
59592709|NCT04093024|75700953|FG001|STARTED|Open-label Nintedanib Period (OLNP)||21||
59592710|NCT04093024|75700952|FG000|COMPLETED|Open-label Nintedanib Period (OLNP)||11||
59592711|NCT04093024|75700953|FG001|COMPLETED|Open-label Nintedanib Period (OLNP)||20||
59592712|NCT04093024|75700952|FG000|NOT COMPLETED|Open-label Nintedanib Period (OLNP)||0||
59592713|NCT04093024|75700953|FG001|NOT COMPLETED|Open-label Nintedanib Period (OLNP)||1||
59592714|NCT03633929|75700987|FG000|STARTED|Overall Study||19||
59592715|NCT03633929|75700987|FG000|COMPLETED|Overall Study||15||
59592716|NCT03633929|75700987|FG000|NOT COMPLETED|Overall Study||4||
59592717|NCT03625687|75700991|FG000|STARTED|Overall Study||16||
59592718|NCT03625687|75700991|FG000|COMPLETED|Overall Study||15||
59592719|NCT03625687|75700991|FG000|NOT COMPLETED|Overall Study||1||
59592720|NCT03469284|75700999|FG000|STARTED|Overall Study||16||
59592721|NCT03469284|75701000|FG001|STARTED|Overall Study||15||
59592722|NCT03469284|75701001|FG002|STARTED|Overall Study||14||
59592723|NCT03469284|75701002|FG003|STARTED|Overall Study||15||
59592724|NCT03469284|75700999|FG000|COMPLETED|Overall Study||16||
59592725|NCT03469284|75701000|FG001|COMPLETED|Overall Study||15||
59592726|NCT03469284|75701001|FG002|COMPLETED|Overall Study||14||
59592727|NCT03469284|75701002|FG003|COMPLETED|Overall Study||15||
59592728|NCT03469284|75700999|FG000|NOT COMPLETED|Overall Study||0||
59592729|NCT03469284|75701000|FG001|NOT COMPLETED|Overall Study||0||
59592730|NCT03469284|75701001|FG002|NOT COMPLETED|Overall Study||0||
59592731|NCT03469284|75701002|FG003|NOT COMPLETED|Overall Study||0||
59592732|NCT02785952|75701014|FG000|STARTED|Overall Study||125||
59592733|NCT02785952|75701015|FG001|STARTED|Overall Study||127||
59592734|NCT02785952|75701014|FG000|COMPLETED|Overall Study||0||
59592735|NCT02785952|75701015|FG001|COMPLETED|Overall Study||0||
59592736|NCT02785952|75701014|FG000|NOT COMPLETED|Overall Study||125||
59592737|NCT02785952|75701015|FG001|NOT COMPLETED|Overall Study||127||
59592738|NCT02674685|75701023|FG000|STARTED|Overall Study|The number is same as participants enrolled.|241||
59592739|NCT02674685|75701023|FG000|COMPLETED|Overall Study||237||
59592740|NCT02674685|75701023|FG000|NOT COMPLETED|Overall Study||4||
59592741|NCT02654236|75701030|FG000|STARTED|Overall Study||9||
59592742|NCT02654236|75701031|FG001|STARTED|Overall Study||6||
59592743|NCT02654236|75701032|FG002|STARTED|Overall Study||15||
59592744|NCT02654236|75701030|FG000|COMPLETED|Overall Study||9||
59592745|NCT02654236|75701031|FG001|COMPLETED|Overall Study||6||
59592746|NCT02654236|75701032|FG002|COMPLETED|Overall Study||13||
59592747|NCT02654236|75701030|FG000|NOT COMPLETED|Overall Study||0||
59592748|NCT02654236|75701031|FG001|NOT COMPLETED|Overall Study||0||
59592749|NCT02654236|75701032|FG002|NOT COMPLETED|Overall Study||2||
59592750|NCT02372136|75701042|FG000|STARTED|Overall Study||62||
59592751|NCT02372136|75701043|FG001|STARTED|Overall Study||58||
59592752|NCT02372136|75701042|FG000|COMPLETED|Overall Study||59||
59592753|NCT02372136|75701043|FG001|COMPLETED|Overall Study||57||
59592754|NCT02372136|75701042|FG000|NOT COMPLETED|Overall Study||3||
59592755|NCT02372136|75701043|FG001|NOT COMPLETED|Overall Study||1||
59592756|NCT02194829|75701053|FG000|STARTED|Overall Study||2||
59592757|NCT02194829|75701054|FG001|STARTED|Overall Study||6||
59592758|NCT02194829|75701053|FG000|Received Protocol Therapy|Overall Study||2||
59592759|NCT02194829|75701054|FG001|Received Protocol Therapy|Overall Study||5||
59592760|NCT02194829|75701053|FG000|COMPLETED|Overall Study||0||
59592761|NCT02194829|75701054|FG001|COMPLETED|Overall Study||0||
59592762|NCT02194829|75701053|FG000|NOT COMPLETED|Overall Study||2||
59592763|NCT02194829|75701054|FG001|NOT COMPLETED|Overall Study||6||
59592764|NCT02087046|75701061|FG000|STARTED|Overall Study||127||
59592765|NCT02087046|75701061|FG000|Primary Endpoint|Overall Study||121||
59592766|NCT02087046|75701061|FG000|COMPLETED|Overall Study||116||
59592767|NCT02087046|75701061|FG000|NOT COMPLETED|Overall Study||11||
59592768|NCT01891994|75701066|FG000|STARTED|Overall Study||40||
59592769|NCT01891994|75701066|FG000|COMPLETED|Overall Study||40||
59592770|NCT01891994|75701066|FG000|NOT COMPLETED|Overall Study||0||
59592771|NCT01390038|75701070|FG000|STARTED|Overall Study||157||
59592772|NCT01390038|75701070|FG000|COMPLETED|Overall Study||149||
59592773|NCT01390038|75701070|FG000|NOT COMPLETED|Overall Study||8||
59592774|NCT01370460|75701076|FG000|STARTED|Overall Study||50||
59592775|NCT01370460|75701077|FG001|STARTED|Overall Study||51||
59592776|NCT01370460|75701076|FG000|COMPLETED|Overall Study||50||
59592777|NCT01370460|75701077|FG001|COMPLETED|Overall Study||51||
59592778|NCT01370460|75701076|FG000|NOT COMPLETED|Overall Study||0||
59592779|NCT01370460|75701077|FG001|NOT COMPLETED|Overall Study||0||
59592780|NCT00621192|75701088|FG000|STARTED|Overall Study||39||
59592781|NCT00621192|75701089|FG001|STARTED|Overall Study||103||
59592782|NCT00621192|75701090|FG002|STARTED|Overall Study||31||
59592783|NCT00621192|75701091|FG003|STARTED|Overall Study||27||
59592784|NCT00621192|75701088|FG000|Safety Population|Overall Study||39||
59592785|NCT00621192|75701089|FG001|Safety Population|Overall Study||103||
59592786|NCT00621192|75701090|FG002|Safety Population|Overall Study||31||
59592787|NCT00621192|75701091|FG003|Safety Population|Overall Study||27||
59592788|NCT00621192|75701088|FG000|Efficacy Population|Overall Study||39||
59592789|NCT00621192|75701089|FG001|Efficacy Population|Overall Study||101||
59592790|NCT00621192|75701090|FG002|Efficacy Population|Overall Study||28||
59592791|NCT00621192|75701091|FG003|Efficacy Population|Overall Study||27||
59592792|NCT00621192|75701088|FG000|COMPLETED|Overall Study||35||
59592793|NCT00621192|75701089|FG001|COMPLETED|Overall Study||94||
59592794|NCT00621192|75701090|FG002|COMPLETED|Overall Study||26||
59592795|NCT00621192|75701091|FG003|COMPLETED|Overall Study||24||
59726388|NCT01001520|75845205|FG000|STARTED|Medication Period 1||22||
59996785|NCT03434041|76112633|FG001|NOT COMPLETED|Follow-up Phase (Up to 8 Weeks)||3||
59592796|NCT00621192|75701088|FG000|NOT COMPLETED|Overall Study||4||
59592797|NCT00621192|75701089|FG001|NOT COMPLETED|Overall Study||9||
59592798|NCT00621192|75701090|FG002|NOT COMPLETED|Overall Study||5||
59592799|NCT00621192|75701091|FG003|NOT COMPLETED|Overall Study||3||
59592800|NCT00278200|75701103|FG000|STARTED|Overall Study||2||
59592801|NCT00278200|75701104|FG001|STARTED|Overall Study||12||
59592802|NCT00278200|75701103|FG000|COMPLETED|Overall Study||1||
59592803|NCT00278200|75701104|FG001|COMPLETED|Overall Study||8||
59592804|NCT00278200|75701103|FG000|NOT COMPLETED|Overall Study||1||
59592805|NCT00278200|75701104|FG001|NOT COMPLETED|Overall Study||4||
59592806|NCT00255346|75701115|FG000|STARTED|Overall Study||10||
59592807|NCT00255346|75701116|FG001|STARTED|Overall Study||6||
59592808|NCT00255346|75701117|FG002|STARTED|Overall Study||8||
59592809|NCT00255346|75701118|FG003|STARTED|Overall Study||11||
59592810|NCT00255346|75701119|FG004|STARTED|Overall Study||33||
59726389|NCT01001520|75845206|FG001|STARTED|Medication Period 1||24||
59592811|NCT00255346|75701115|FG000|COMPLETED|Overall Study||9||
59592812|NCT00255346|75701116|FG001|COMPLETED|Overall Study||6||
59592813|NCT00255346|75701117|FG002|COMPLETED|Overall Study||8||
59592814|NCT00255346|75701118|FG003|COMPLETED|Overall Study||11||
59592815|NCT00255346|75701119|FG004|COMPLETED|Overall Study||33||
59592816|NCT00255346|75701115|FG000|NOT COMPLETED|Overall Study||1||
59592817|NCT00255346|75701116|FG001|NOT COMPLETED|Overall Study||0||
59592818|NCT00255346|75701117|FG002|NOT COMPLETED|Overall Study||0||
59592819|NCT00255346|75701118|FG003|NOT COMPLETED|Overall Study||0||
60122339|NCT01546649|76243385|FG001|NOT COMPLETED|Overall Study||9||
60122340|NCT01544309|76243393|FG000|STARTED|Overall Study||524||
60122341|NCT01544309|76243394|FG001|STARTED|Overall Study||525||
60122342|NCT01544309|76243393|FG000|COMPLETED|Overall Study||504||
60122343|NCT01544309|76243394|FG001|COMPLETED|Overall Study||514||
60122344|NCT01544309|76243393|FG000|NOT COMPLETED|Overall Study||20||
60122345|NCT01544309|76243394|FG001|NOT COMPLETED|Overall Study||11||
60122346|NCT01544153|76243406|FG000|STARTED|Overall Study||1337||
60122347|NCT01544153|76243407|FG001|STARTED|Overall Study||1324||
60122348|NCT01544153|76243408|FG002|STARTED|Overall Study||1314||
60122349|NCT01544153|76243409|FG003|STARTED|Overall Study||1317||
60122350|NCT01544153|76243406|FG000|COMPLETED|Overall Study||1337||
60122351|NCT01544153|76243407|FG001|COMPLETED|Overall Study||1323||
60122352|NCT01544153|76243408|FG002|COMPLETED|Overall Study||1313||
60122353|NCT01544153|76243409|FG003|COMPLETED|Overall Study||1317||
60122354|NCT01544153|76243406|FG000|NOT COMPLETED|Overall Study||0||
60122355|NCT01544153|76243407|FG001|NOT COMPLETED|Overall Study||1||
60122356|NCT01544153|76243408|FG002|NOT COMPLETED|Overall Study||1||
60122357|NCT01544153|76243409|FG003|NOT COMPLETED|Overall Study||0||
60122358|NCT01543685|76243424|FG000|STARTED|Overall Study||93||
60122359|NCT01543685|76243425|FG001|STARTED|Overall Study||91||
60122360|NCT01543685|76243426|FG002|STARTED|Overall Study||91||
60122361|NCT01543685|76243427|FG003|STARTED|Overall Study||93||
60122362|NCT01543685|76243428|FG004|STARTED|Overall Study||94||
60122363|NCT01543685|76243424|FG000|COMPLETED|Overall Study||90||
60122364|NCT01543685|76243425|FG001|COMPLETED|Overall Study||88||
60122365|NCT01543685|76243426|FG002|COMPLETED|Overall Study||89||
60122366|NCT01543685|76243427|FG003|COMPLETED|Overall Study||93||
60122367|NCT01543685|76243428|FG004|COMPLETED|Overall Study||90||
60122368|NCT01543685|76243424|FG000|NOT COMPLETED|Overall Study||3||
60122369|NCT01543685|76243425|FG001|NOT COMPLETED|Overall Study||3||
60122370|NCT01543685|76243426|FG002|NOT COMPLETED|Overall Study||2||
60122371|NCT01543685|76243427|FG003|NOT COMPLETED|Overall Study||0||
60122372|NCT01543685|76243428|FG004|NOT COMPLETED|Overall Study||4||
60122373|NCT01541969|76243442|FG000|STARTED|Double-blind (0-12 Weeks)||50||
60122374|NCT01541969|76243443|FG001|STARTED|Double-blind (0-12 Weeks)||50||
60122375|NCT01541969|76243442|FG000|COMPLETED|Double-blind (0-12 Weeks)||44||
60122376|NCT01541969|76243443|FG001|COMPLETED|Double-blind (0-12 Weeks)||48||
60122377|NCT01541969|76243442|FG000|NOT COMPLETED|Double-blind (0-12 Weeks)||6||
59592820|NCT00255346|75701119|FG004|NOT COMPLETED|Overall Study||0||
59592821|NCT02834624|75701129|FG000|STARTED|Overall Study||15||
59592822|NCT02834624|75701130|FG001|STARTED|Overall Study||15||
59592823|NCT02834624|75701129|FG000|COMPLETED|Overall Study||15||
59592824|NCT02834624|75701130|FG001|COMPLETED|Overall Study||15||
59592825|NCT02834624|75701129|FG000|NOT COMPLETED|Overall Study||0||
59592826|NCT02834624|75701130|FG001|NOT COMPLETED|Overall Study||0||
59592827|NCT02917603|75701139|FG000|STARTED|Overall Study||20||
59592828|NCT02917603|75701140|FG001|STARTED|Overall Study||20||
59592829|NCT02917603|75701139|FG000|COMPLETED|Overall Study||19||
60122378|NCT01541969|76243443|FG001|NOT COMPLETED|Double-blind (0-12 Weeks)||2||
60122379|NCT01541969|76243442|FG000|STARTED|Open Label Extension (12-36 Weeks)||44||
60122380|NCT01541969|76243443|FG001|STARTED|Open Label Extension (12-36 Weeks)||48||
60122381|NCT01541969|76243442|FG000|COMPLETED|Open Label Extension (12-36 Weeks)||33||
60122382|NCT01541969|76243443|FG001|COMPLETED|Open Label Extension (12-36 Weeks)||35||
60122383|NCT01541969|76243442|FG000|NOT COMPLETED|Open Label Extension (12-36 Weeks)||11||
60122384|NCT01541969|76243443|FG001|NOT COMPLETED|Open Label Extension (12-36 Weeks)||13||
60122385|NCT01540565|76243452|FG000|STARTED|Overall Study||52||
60122386|NCT01540565|76243452|FG000|COMPLETED|Overall Study||50||
60122387|NCT01540565|76243452|FG000|NOT COMPLETED|Overall Study||2||
60122388|NCT01540487|76243458|FG000|STARTED|Overall Study||24||
59592830|NCT02917603|75701140|FG001|COMPLETED|Overall Study||16||
60122389|NCT01540487|76243459|FG001|STARTED|Overall Study||24||
60122390|NCT01540487|76243458|FG000|COMPLETED|Overall Study||23||
59592831|NCT02917603|75701139|FG000|NOT COMPLETED|Overall Study||1||
60122391|NCT01540487|76243459|FG001|COMPLETED|Overall Study||24||
60122392|NCT01540487|76243458|FG000|NOT COMPLETED|Overall Study||1||
60122393|NCT01540487|76243459|FG001|NOT COMPLETED|Overall Study||0||
59592832|NCT02917603|75701140|FG001|NOT COMPLETED|Overall Study||4||
59592833|NCT02837744|75701147|FG000|STARTED|Overall Study||70||
59592834|NCT02837744|75701147|FG000|COMPLETED|Overall Study||70||
59592835|NCT02837744|75701147|FG000|NOT COMPLETED|Overall Study||0||
59592836|NCT02918617|75701160|FG000|STARTED|Overall Study||21||
60122394|NCT01539317|76243471|FG000|STARTED|Overall Study||25||
60122395|NCT01539317|76243472|FG001|STARTED|Overall Study||25||
60122396|NCT01539317|76243471|FG000|COMPLETED|Overall Study||24||
60122397|NCT01539317|76243472|FG001|COMPLETED|Overall Study||25||
60122398|NCT01539317|76243471|FG000|NOT COMPLETED|Overall Study||1||
60122399|NCT01539317|76243472|FG001|NOT COMPLETED|Overall Study||0||
60122400|NCT01539239|76243483|FG000|STARTED|Overall Study||369||
60122401|NCT01539239|76243484|FG001|STARTED|Overall Study||187||
60122402|NCT01539239|76243483|FG000|COMPLETED|Overall Study||357||
60122403|NCT01539239|76243484|FG001|COMPLETED|Overall Study||170||
60122404|NCT01539239|76243483|FG000|NOT COMPLETED|Overall Study||12||
60122405|NCT01539239|76243484|FG001|NOT COMPLETED|Overall Study||17||
60122406|NCT01539083|76243490|FG000|STARTED|Before Randomization (VCD Induction)||256||
60122407|NCT01539083|76243491|FG001|STARTED|Before Randomization (VCD Induction)||0||
60122408|NCT01539083|76243492|FG002|STARTED|Before Randomization (VCD Induction)||0||
60122409|NCT01539083|76243490|FG000|Treated|Before Randomization (VCD Induction)||254||
60122410|NCT01539083|76243491|FG001|Treated|Before Randomization (VCD Induction)||0||
60122411|NCT01539083|76243492|FG002|Treated|Before Randomization (VCD Induction)||0||
60122412|NCT01539083|76243490|FG000|COMPLETED|Before Randomization (VCD Induction)||203||
60122413|NCT01539083|76243491|FG001|COMPLETED|Before Randomization (VCD Induction)||0||
60122414|NCT01539083|76243492|FG002|COMPLETED|Before Randomization (VCD Induction)||0||
60122415|NCT01539083|76243490|FG000|NOT COMPLETED|Before Randomization (VCD Induction)||53||
60122416|NCT01539083|76243491|FG001|NOT COMPLETED|Before Randomization (VCD Induction)||0||
60122417|NCT01539083|76243492|FG002|NOT COMPLETED|Before Randomization (VCD Induction)||0||
60122418|NCT01539083|76243490|FG000|STARTED|After Randomization (TP and VTP)||0||
60122419|NCT01539083|76243491|FG001|STARTED|After Randomization (TP and VTP)|Participants who completed induction phase were randomized for the consolidated treatment.|100||
60122420|NCT01539083|76243492|FG002|STARTED|After Randomization (TP and VTP)|Participants who completed induction phase were randomized for the consolidation treatment phase.|103||
60122421|NCT01539083|76243490|FG000|Safety Population|After Randomization (TP and VTP)||0||
60122422|NCT01539083|76243491|FG001|Safety Population|After Randomization (TP and VTP)|One participant was randomized but not treated. Hence, was not included in safety population.|99||
60122423|NCT01539083|76243492|FG002|Safety Population|After Randomization (TP and VTP)||103||
60122424|NCT01539083|76243490|FG000|COMPLETED|After Randomization (TP and VTP)||0||
60122425|NCT01539083|76243491|FG001|COMPLETED|After Randomization (TP and VTP)||79||
60122426|NCT01539083|76243492|FG002|COMPLETED|After Randomization (TP and VTP)||80||
60122427|NCT01539083|76243490|FG000|NOT COMPLETED|After Randomization (TP and VTP)||0||
60122428|NCT01539083|76243491|FG001|NOT COMPLETED|After Randomization (TP and VTP)||21||
60122429|NCT01539083|76243492|FG002|NOT COMPLETED|After Randomization (TP and VTP)||23||
60122430|NCT01537211|76243501|FG000|STARTED|Overall Study||4||
60122431|NCT01537211|76243502|FG001|STARTED|Overall Study||6||
60122432|NCT01537211|76243501|FG000|COMPLETED|Overall Study||4||
60122433|NCT01537211|76243502|FG001|COMPLETED|Overall Study||5||
60122434|NCT01537211|76243501|FG000|NOT COMPLETED|Overall Study||0||
60122435|NCT01537211|76243502|FG001|NOT COMPLETED|Overall Study||1||
60122436|NCT01537133|76243516|FG000|STARTED|Overall Study||28||
60122437|NCT01537133|76243517|FG001|STARTED|Overall Study||14||
60122438|NCT01537133|76243518|FG002|STARTED|Overall Study||21||
60122439|NCT01537133|76243519|FG003|STARTED|Overall Study||21||
60122440|NCT01537133|76243516|FG000|COMPLETED|Overall Study||25||
60122441|NCT01537133|76243517|FG001|COMPLETED|Overall Study||14||
60122442|NCT01537133|76243518|FG002|COMPLETED|Overall Study||21||
60122443|NCT01537133|76243519|FG003|COMPLETED|Overall Study||21||
60122444|NCT01537133|76243516|FG000|NOT COMPLETED|Overall Study||3||
60122445|NCT01537133|76243517|FG001|NOT COMPLETED|Overall Study||0||
60122446|NCT01537133|76243518|FG002|NOT COMPLETED|Overall Study||0||
60122447|NCT01537133|76243519|FG003|NOT COMPLETED|Overall Study||0||
60122448|NCT01536587|76243527|FG000|STARTED|Overall Study||32||
60122449|NCT01536587|76243527|FG000|COMPLETED|Overall Study||30||
60122450|NCT01536587|76243527|FG000|NOT COMPLETED|Overall Study||2||
60122451|NCT01536119|76243533|FG000|STARTED|Overall Study|(107*2= 214) (107 mothers and 107 fathers)|214||
60122452|NCT01536119|76243534|FG001|STARTED|Overall Study|(107*2=214) (107 mothers and 107 fathers)|214||
60122453|NCT01536119|76243533|FG000|COMPLETED|Overall Study|104 Mothers + 93 fathers = 197 participants 3 mothers + 14 fathers = 17 did not complete the study|197||
60122454|NCT01536119|76243534|FG001|COMPLETED|Overall Study|105 mothers + 95 fathers = 200 participants 2 mothers + 12 fathers = 14 did not complete the study|200||
60122455|NCT01536119|76243533|FG000|NOT COMPLETED|Overall Study||17||
60122456|NCT01536119|76243534|FG001|NOT COMPLETED|Overall Study||14||
59592837|NCT02918617|75701161|FG001|STARTED|Overall Study||20||
59726390|NCT01001520|75845205|FG000|COMPLETED|Medication Period 1||18||
60122457|NCT01535729|76243540|FG000|STARTED|Overall Study||465||
59592838|NCT02918617|75701162|FG002|STARTED|Overall Study||22||
59592839|NCT02918617|75701163|FG003|STARTED|Overall Study||22||
59592840|NCT02918617|75701164|FG004|STARTED|Overall Study||24||
60122458|NCT01535729|76243540|FG000|Treated|Overall Study||385||
60122459|NCT01535729|76243540|FG000|COMPLETED|Overall Study||49||
59592841|NCT02918617|75701165|FG005|STARTED|Overall Study||20||
59592842|NCT02918617|75701166|FG006|STARTED|Overall Study||22||
59592843|NCT02918617|75701167|FG007|STARTED|Overall Study||26||
59592844|NCT02918617|75701168|FG008|STARTED|Overall Study||26||
59726391|NCT01001520|75845206|FG001|COMPLETED|Medication Period 1||17||
60122460|NCT01535729|76243540|FG000|NOT COMPLETED|Overall Study||416||
60122461|NCT01535261|76243544|FG000|STARTED|Overall Study||357||
60122462|NCT01535261|76243544|FG000|COMPLETED|Overall Study||307||
60122463|NCT01535261|76243544|FG000|NOT COMPLETED|Overall Study||50||
60122464|NCT01534637|76243548|FG000|STARTED|Overall Study||22||
60122465|NCT01534637|76243548|FG000|COMPLETED|Overall Study||13||
60122466|NCT01534637|76243548|FG000|NOT COMPLETED|Overall Study||9||
60122467|NCT02655016|76243554|FG000|STARTED|Overall Study||246||
60122468|NCT02655016|76243555|FG001|STARTED|Overall Study||487||
60122469|NCT02655016|76243554|FG000|Received Study Treatment|Overall Study|2 participants never received treatment due to screen failure after randomization.|244||
60122470|NCT02655016|76243555|FG001|Received Study Treatment|Overall Study|3 participants never received treatment (2 failed screening & 1 withdrew consent before first dose).|484||
60122471|NCT02655016|76243554|FG000|Ongoing With Treatment in the Study|Overall Study||69||
60122472|NCT02655016|76243555|FG001|Ongoing With Treatment in the Study|Overall Study||177||
60122473|NCT02655016|76243554|FG000|COMPLETED|Overall Study|69 participants are ongoing in the study.|191||
60122474|NCT02655016|76243555|FG001|COMPLETED|Overall Study|177 participants are ongoing in the study.|397||
60122475|NCT02655016|76243554|FG000|NOT COMPLETED|Overall Study||55||
60122476|NCT02655016|76243555|FG001|NOT COMPLETED|Overall Study||90||
60122477|NCT01533935|76243562|FG000|STARTED|Overall Study||58||
60122478|NCT01533935|76243563|FG001|STARTED|Overall Study||58||
60122479|NCT01533935|76243564|FG002|STARTED|Overall Study||58||
60122480|NCT01533935|76243565|FG003|STARTED|Overall Study||59||
60122481|NCT01533935|76243566|FG004|STARTED|Overall Study||58||
60122482|NCT01533935|76243562|FG000|Received Placebo|Overall Study||0||
60122483|NCT01533935|76243563|FG001|Received Placebo|Overall Study||47||
60122484|NCT01533935|76243564|FG002|Received Placebo|Overall Study||52||
60122485|NCT01533935|76243565|FG003|Received Placebo|Overall Study||57||
60122486|NCT01533935|76243566|FG004|Received Placebo|Overall Study||58||
60122487|NCT01533935|76243562|FG000|Received Olo 5|Overall Study||52||
60122488|NCT01533935|76243563|FG001|Received Olo 5|Overall Study||52||
60122489|NCT01533935|76243564|FG002|Received Olo 5|Overall Study||55||
60122490|NCT01533935|76243565|FG003|Received Olo 5|Overall Study||59||
60122491|NCT01533935|76243566|FG004|Received Olo 5|Overall Study||0||
60122492|NCT01533935|76243562|FG000|Received Tio 5|Overall Study||54||
60122493|NCT01533935|76243563|FG001|Received Tio 5|Overall Study||54||
60122494|NCT01533935|76243564|FG002|Received Tio 5|Overall Study||58||
60122495|NCT01533935|76243565|FG003|Received Tio 5|Overall Study||0||
60122496|NCT01533935|76243566|FG004|Received Tio 5|Overall Study||52||
60122497|NCT01533935|76243562|FG000|Received Tio+Olo 2.5/5|Overall Study||58||
60122498|NCT01533935|76243563|FG001|Received Tio+Olo 2.5/5|Overall Study||0||
60122499|NCT01533935|76243564|FG002|Received Tio+Olo 2.5/5|Overall Study||49||
60122500|NCT01533935|76243565|FG003|Received Tio+Olo 2.5/5|Overall Study||56||
60122501|NCT01533935|76243566|FG004|Received Tio+Olo 2.5/5|Overall Study||56||
60122502|NCT01533935|76243562|FG000|Received Tio+Olo 5/5|Overall Study||56||
60122503|NCT01533935|76243563|FG001|Received Tio+Olo 5/5|Overall Study||58||
60122504|NCT01533935|76243564|FG002|Received Tio+Olo 5/5|Overall Study|One patient received Tio+Olo 5/5 instead of Tio+Olo 2.5/5 by mistake.|1||
60122505|NCT01533935|76243565|FG003|Received Tio+Olo 5/5|Overall Study||54||
60122506|NCT01533935|76243566|FG004|Received Tio+Olo 5/5|Overall Study||55||
60122507|NCT01533935|76243562|FG000|COMPLETED|Overall Study|All treatment periods|52||
60122508|NCT01533935|76243563|FG001|COMPLETED|Overall Study|All treatment periods|45||
60122509|NCT01533935|76243564|FG002|COMPLETED|Overall Study|All treatment periods|50||
60122510|NCT01533935|76243565|FG003|COMPLETED|Overall Study|All treatment periods|52||
60122511|NCT01533935|76243566|FG004|COMPLETED|Overall Study|All treatment periods|50||
60122512|NCT01533935|76243562|FG000|NOT COMPLETED|Overall Study||6||
60122513|NCT01533935|76243563|FG001|NOT COMPLETED|Overall Study||13||
60122514|NCT01533935|76243564|FG002|NOT COMPLETED|Overall Study||8||
60122515|NCT01533935|76243565|FG003|NOT COMPLETED|Overall Study||7||
60122516|NCT01533935|76243566|FG004|NOT COMPLETED|Overall Study||8||
60122517|NCT01532999|76243580|FG000|STARTED|Overall Study||96||
60122518|NCT01532999|76243581|FG001|STARTED|Overall Study||95||
60122519|NCT01532999|76243580|FG000|COMPLETED|Overall Study||65||
60122520|NCT01532999|76243581|FG001|COMPLETED|Overall Study||77||
60122521|NCT01532999|76243580|FG000|NOT COMPLETED|Overall Study||31||
60122522|NCT01532999|76243581|FG001|NOT COMPLETED|Overall Study||18||
60122523|NCT01532921|76243587|FG000|STARTED|Overall Study||85|Enrolled and consented subjects|
60122524|NCT01532921|76243587|FG000|Implantation Procedure|Overall Study||76|Subjects with study device implanted|
60122525|NCT01532921|76243587|FG000|Discharge|Overall Study||75||
59592845|NCT02918617|75701160|FG000|COMPLETED|Overall Study||20||
59726392|NCT01001520|75845205|FG000|NOT COMPLETED|Medication Period 1||4||
59726393|NCT01001520|75845206|FG001|NOT COMPLETED|Medication Period 1||7||
59726394|NCT01001520|75845205|FG000|STARTED|Washout Period||18||
59726395|NCT01001520|75845206|FG001|STARTED|Washout Period||17||
59726396|NCT01001520|75845205|FG000|COMPLETED|Washout Period||16||
59726397|NCT01001520|75845206|FG001|COMPLETED|Washout Period||16||
59726398|NCT01001520|75845205|FG000|NOT COMPLETED|Washout Period||2||
59726399|NCT01001520|75845206|FG001|NOT COMPLETED|Washout Period||1||
59726400|NCT01001520|75845205|FG000|STARTED|Medication Period 2||16||
59726401|NCT01001520|75845206|FG001|STARTED|Medication Period 2||16||
59592846|NCT02918617|75701161|FG001|COMPLETED|Overall Study||20||
59592847|NCT02918617|75701162|FG002|COMPLETED|Overall Study||19||
59592848|NCT02918617|75701163|FG003|COMPLETED|Overall Study||22||
59592849|NCT02918617|75701164|FG004|COMPLETED|Overall Study||24||
59592850|NCT02918617|75701165|FG005|COMPLETED|Overall Study||20||
59592851|NCT02918617|75701166|FG006|COMPLETED|Overall Study||22||
59592852|NCT02918617|75701167|FG007|COMPLETED|Overall Study||25||
59592853|NCT02918617|75701168|FG008|COMPLETED|Overall Study||26||
59592854|NCT02918617|75701160|FG000|NOT COMPLETED|Overall Study||1||
59592855|NCT02918617|75701161|FG001|NOT COMPLETED|Overall Study||0||
59592856|NCT02918617|75701162|FG002|NOT COMPLETED|Overall Study||3||
59592857|NCT02918617|75701163|FG003|NOT COMPLETED|Overall Study||0||
59592858|NCT02918617|75701164|FG004|NOT COMPLETED|Overall Study||0||
59592859|NCT02918617|75701165|FG005|NOT COMPLETED|Overall Study||0||
59592860|NCT02918617|75701166|FG006|NOT COMPLETED|Overall Study||0||
59592861|NCT02918617|75701167|FG007|NOT COMPLETED|Overall Study||1||
59592862|NCT02918617|75701168|FG008|NOT COMPLETED|Overall Study||0||
59592863|NCT02839772|75701190|FG000|STARTED|Overall Study|Stratification was used. Clinic A enrolled 94 participants and Clinic B 99 participants|97||
59592864|NCT02839772|75701191|FG001|STARTED|Overall Study||96||
59592865|NCT02839772|75701190|FG000|COMPLETED|Overall Study|1 participant in Clinic B did not return for the 3 months post- intervention data collection.|96||
59592866|NCT02839772|75701191|FG001|COMPLETED|Overall Study||96||
59592867|NCT02839772|75701190|FG000|NOT COMPLETED|Overall Study||1||
59726402|NCT01001520|75845205|FG000|COMPLETED|Medication Period 2||16||
59726403|NCT01001520|75845206|FG001|COMPLETED|Medication Period 2||13||
59726404|NCT01001520|75845205|FG000|NOT COMPLETED|Medication Period 2||0||
59726405|NCT01001520|75845206|FG001|NOT COMPLETED|Medication Period 2||3||
59726406|NCT02344108|75845215|FG000|STARTED|Overall Study||42||
59726407|NCT02344108|75845215|FG000|COMPLETED|Overall Study||42||
59726408|NCT02344108|75845215|FG000|NOT COMPLETED|Overall Study||0||
59726409|NCT04415658|75845225|FG000|STARTED|Initial Study Period (12 Hours)||419||
59726410|NCT04415658|75845226|FG001|STARTED|Initial Study Period (12 Hours)||419||
59726411|NCT04415658|75845225|FG000|Started Assigned Infusion|Initial Study Period (12 Hours)||411||
59726412|NCT04415658|75845226|FG001|Started Assigned Infusion|Initial Study Period (12 Hours)||384||
59726413|NCT04415658|75845225|FG000|Per-Protocol|Initial Study Period (12 Hours)||351|Received assigned intervention for at least six hours|
59726414|NCT04415658|75845226|FG001|Per-Protocol|Initial Study Period (12 Hours)||374|Received assigned intervention for at least six hours|
59726415|NCT04415658|75845225|FG000|Cross-over|Initial Study Period (12 Hours)||0|Crossed-over to other intervention within 12 hours|
59726416|NCT04415658|75845226|FG001|Cross-over|Initial Study Period (12 Hours)||3|Crossed-over to other intervention within 12 hours|
59726417|NCT04415658|75845225|FG000|Stopped Infusion Early|Initial Study Period (12 Hours)||86||
59726418|NCT04415658|75845226|FG001|Stopped Infusion Early|Initial Study Period (12 Hours)||0||
59726419|NCT04415658|75845225|FG000|COMPLETED|Initial Study Period (12 Hours)||333|Refers to completing donor care, with organ allocation outcomes available|
59726420|NCT04415658|75845226|FG001|COMPLETED|Initial Study Period (12 Hours)||416|Refers to completing donor care, with organ allocation outcomes available|
59726421|NCT04415658|75845225|FG000|NOT COMPLETED|Initial Study Period (12 Hours)||86||
59726422|NCT04415658|75845226|FG001|NOT COMPLETED|Initial Study Period (12 Hours)||3||
59726423|NCT04415658|75845225|FG000|STARTED|Open-Label (T4 Beyond 12 Hours)||333|Total number of donors eligible to receive open-label|
59726424|NCT04415658|75845226|FG001|STARTED|Open-Label (T4 Beyond 12 Hours)||416|Total number of donors eligible to receive open-label|
59726425|NCT04415658|75845225|FG000|COMPLETED|Open-Label (T4 Beyond 12 Hours)||209|number who received thyroxine infusion beyond initial 12-hour study period|
59726426|NCT04415658|75845226|FG001|COMPLETED|Open-Label (T4 Beyond 12 Hours)||50|number who received thyroxine infusion beyond initial 12-hour study period|
59726427|NCT04415658|75845225|FG000|NOT COMPLETED|Open-Label (T4 Beyond 12 Hours)||124||
59726428|NCT04415658|75845226|FG001|NOT COMPLETED|Open-Label (T4 Beyond 12 Hours)||366||
59726429|NCT01189604|75845239|FG000|STARTED|Overall Study||21||
59726430|NCT01189604|75845240|FG001|STARTED|Overall Study||21||
59726431|NCT01189604|75845241|FG002|STARTED|Overall Study||20||
59726432|NCT01189604|75845242|FG003|STARTED|Overall Study||20||
59726433|NCT01189604|75845243|FG004|STARTED|Overall Study||20||
59726434|NCT01189604|75845244|FG005|STARTED|Overall Study||11||
59726435|NCT01189604|75845245|FG006|STARTED|Overall Study||10||
59726436|NCT01189604|75845239|FG000|Administered Study Drug|Overall Study||20||
59726437|NCT01189604|75845240|FG001|Administered Study Drug|Overall Study||20||
59726438|NCT01189604|75845241|FG002|Administered Study Drug|Overall Study||20||
59726439|NCT01189604|75845242|FG003|Administered Study Drug|Overall Study||20||
59592868|NCT02839772|75701191|FG001|NOT COMPLETED|Overall Study||0||
59592869|NCT02918773|75701213|FG000|STARTED|Overall Study||11||776
59592870|NCT02918773|75701214|FG001|STARTED|Overall Study||11||614
59592871|NCT02918773|75701213|FG000|COMPLETED|Overall Study||11||776
59592872|NCT02918773|75701214|FG001|COMPLETED|Overall Study||11||614
59592873|NCT02918773|75701213|FG000|NOT COMPLETED|Overall Study||0||0
59592874|NCT02918773|75701214|FG001|NOT COMPLETED|Overall Study||0||0
59592875|NCT03040466|75701223|FG000|STARTED|Overall Study||65||
59592876|NCT03040466|75701224|FG001|STARTED|Overall Study||115||
59592877|NCT03040466|75701223|FG000|COMPLETED|Overall Study||65||
59592878|NCT03040466|75701224|FG001|COMPLETED|Overall Study||115||
59592879|NCT03040466|75701223|FG000|NOT COMPLETED|Overall Study||0||
59592880|NCT03040466|75701224|FG001|NOT COMPLETED|Overall Study||0||
59592881|NCT02918851|75701233|FG000|STARTED|Overall Study||14||
59592882|NCT02918851|75701234|FG001|STARTED|Overall Study||14||
59592883|NCT02918851|75701235|FG002|STARTED|Overall Study||14||
59592884|NCT02918851|75701233|FG000|COMPLETED|Overall Study||10||
59592885|NCT02918851|75701234|FG001|COMPLETED|Overall Study||10||
59592886|NCT02918851|75701235|FG002|COMPLETED|Overall Study||10||
59592887|NCT02918851|75701233|FG000|NOT COMPLETED|Overall Study||4||
59592888|NCT02918851|75701234|FG001|NOT COMPLETED|Overall Study||4||
59592889|NCT02918851|75701235|FG002|NOT COMPLETED|Overall Study||4||
59592890|NCT03041636|75701243|FG000|STARTED|Overall Study||1||
59592891|NCT03041636|75701243|FG000|COMPLETED|Overall Study||1||
59592892|NCT03041636|75701243|FG000|NOT COMPLETED|Overall Study||0||
59592893|NCT03042715|75701247|FG000|STARTED|Overall Study||6||
59592894|NCT03042715|75701247|FG000|COMPLETED|Overall Study||5||
59592895|NCT03042715|75701247|FG000|NOT COMPLETED|Overall Study||1||
59592896|NCT02844998|75701254|FG000|STARTED|Overall Study||42||
59592897|NCT02844998|75701255|FG001|STARTED|Overall Study||39||
59726440|NCT01189604|75845243|FG004|Administered Study Drug|Overall Study||20||
59726441|NCT01189604|75845244|FG005|Administered Study Drug|Overall Study||10||
59726442|NCT01189604|75845245|FG006|Administered Study Drug|Overall Study||10||
59726443|NCT01189604|75845239|FG000|COMPLETED|Overall Study||20||
59726444|NCT01189604|75845240|FG001|COMPLETED|Overall Study||20||
59726445|NCT01189604|75845241|FG002|COMPLETED|Overall Study||20||
59726446|NCT01189604|75845242|FG003|COMPLETED|Overall Study||20||
59726447|NCT01189604|75845243|FG004|COMPLETED|Overall Study||18||
59726448|NCT01189604|75845244|FG005|COMPLETED|Overall Study||10||
59726449|NCT01189604|75845245|FG006|COMPLETED|Overall Study||9||
59726450|NCT01189604|75845239|FG000|NOT COMPLETED|Overall Study||1||
59726451|NCT01189604|75845240|FG001|NOT COMPLETED|Overall Study||1||
59726452|NCT01189604|75845241|FG002|NOT COMPLETED|Overall Study||0||
59726453|NCT01189604|75845242|FG003|NOT COMPLETED|Overall Study||0||
59726454|NCT01189604|75845243|FG004|NOT COMPLETED|Overall Study||2||
59726455|NCT01189604|75845244|FG005|NOT COMPLETED|Overall Study||1||
59726456|NCT01189604|75845245|FG006|NOT COMPLETED|Overall Study||1||
59726457|NCT01008696|75845263|FG000|STARTED|Overall Study||108||
59726458|NCT01008696|75845264|FG001|STARTED|Overall Study||109||
59726459|NCT01008696|75845263|FG000|COMPLETED|Overall Study||91||
59726460|NCT01008696|75845264|FG001|COMPLETED|Overall Study||92||
59726461|NCT01008696|75845263|FG000|NOT COMPLETED|Overall Study||17||
59726462|NCT01008696|75845264|FG001|NOT COMPLETED|Overall Study||17||
59726463|NCT01955980|75845273|FG000|STARTED|Overall Study||10||
59726464|NCT01955980|75845274|FG001|STARTED|Overall Study||9||
59726465|NCT01955980|75845273|FG000|COMPLETED|Overall Study||10||
59726466|NCT01955980|75845274|FG001|COMPLETED|Overall Study||9||
59726467|NCT01955980|75845273|FG000|NOT COMPLETED|Overall Study||0||
59726468|NCT01955980|75845274|FG001|NOT COMPLETED|Overall Study||0||
59726469|NCT01176968|75845283|FG000|STARTED|Overall Study||506||
59726470|NCT01176968|75845284|FG001|STARTED|Overall Study||506||
59726471|NCT01176968|75845283|FG000|Treated|Overall Study||505||
59726472|NCT01176968|75845284|FG001|Treated|Overall Study||505||
59726473|NCT01176968|75845283|FG000|COMPLETED|Overall Study||422||
59726474|NCT01176968|75845284|FG001|COMPLETED|Overall Study||424||
59726475|NCT01176968|75845283|FG000|NOT COMPLETED|Overall Study||84||
59726476|NCT01176968|75845284|FG001|NOT COMPLETED|Overall Study||82||
59726477|NCT03991468|75845290|FG000|STARTED|Overall Study||2000||
59726478|NCT03991468|75845290|FG000|Glass Slide Light Microscopy|Overall Study||2000||
59726479|NCT03991468|75845290|FG000|NanoZoomer Whole Slide Imaging|Overall Study||2000||
59726480|NCT03991468|75845290|FG000|COMPLETED|Overall Study||2000||
59726481|NCT03991468|75845290|FG000|NOT COMPLETED|Overall Study||0||
59726482|NCT01006122|75845295|FG000|STARTED|First Double-blind Intervention Period||47||
59726483|NCT01006122|75845296|FG001|STARTED|First Double-blind Intervention Period||48||
59726484|NCT01006122|75845295|FG000|COMPLETED|First Double-blind Intervention Period||31||
59726485|NCT01006122|75845296|FG001|COMPLETED|First Double-blind Intervention Period||31||
59726486|NCT01006122|75845295|FG000|NOT COMPLETED|First Double-blind Intervention Period||16||
59726487|NCT01006122|75845296|FG001|NOT COMPLETED|First Double-blind Intervention Period||17||
59726488|NCT01006122|75845295|FG000|STARTED|Wash-out Period (at Least 7 Days)||31||
59726489|NCT01006122|75845296|FG001|STARTED|Wash-out Period (at Least 7 Days)||31||
59726490|NCT01006122|75845295|FG000|COMPLETED|Wash-out Period (at Least 7 Days)||31||
59996786|NCT01842035|76112641|FG000|STARTED|Overall Study||90||
59592898|NCT02844998|75701256|FG002|STARTED|Overall Study||39||
59592899|NCT02844998|75701254|FG000|COMPLETED|Overall Study||35||
59592900|NCT02844998|75701255|FG001|COMPLETED|Overall Study||35||
59726491|NCT01006122|75845296|FG001|COMPLETED|Wash-out Period (at Least 7 Days)||31||
59592901|NCT02844998|75701256|FG002|COMPLETED|Overall Study||35||
59592902|NCT02844998|75701254|FG000|NOT COMPLETED|Overall Study||7||
59592903|NCT02844998|75701255|FG001|NOT COMPLETED|Overall Study||4||
59592904|NCT02844998|75701256|FG002|NOT COMPLETED|Overall Study||4||
59592905|NCT03043105|75701264|FG000|STARTED|Overall Study||25||
59726492|NCT01006122|75845295|FG000|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0||
59726493|NCT01006122|75845296|FG001|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0||
59726494|NCT01006122|75845295|FG000|STARTED|Second Double-blind Intervention Period||31||
59726495|NCT01006122|75845296|FG001|STARTED|Second Double-blind Intervention Period||31||
59726496|NCT01006122|75845295|FG000|COMPLETED|Second Double-blind Intervention Period||29||
59726497|NCT01006122|75845296|FG001|COMPLETED|Second Double-blind Intervention Period||24||
59726498|NCT01006122|75845295|FG000|NOT COMPLETED|Second Double-blind Intervention Period||2||
59726499|NCT01006122|75845296|FG001|NOT COMPLETED|Second Double-blind Intervention Period||7||
59726500|NCT01005966|75845302|FG000|STARTED|Treatment Period 1 (14 Days)||13||
59726501|NCT01005966|75845303|FG001|STARTED|Treatment Period 1 (14 Days)||13||
59726502|NCT01005966|75845304|FG002|STARTED|Treatment Period 1 (14 Days)||13||
59726503|NCT01005966|75845305|FG003|STARTED|Treatment Period 1 (14 Days)||13||
59726504|NCT01005966|75845306|FG004|STARTED|Treatment Period 1 (14 Days)||13||
59726505|NCT01005966|75845302|FG000|COMPLETED|Treatment Period 1 (14 Days)||11||
59726506|NCT01005966|75845303|FG001|COMPLETED|Treatment Period 1 (14 Days)||13||
59726507|NCT01005966|75845304|FG002|COMPLETED|Treatment Period 1 (14 Days)||12||
59726508|NCT01005966|75845305|FG003|COMPLETED|Treatment Period 1 (14 Days)||13||
59726509|NCT01005966|75845306|FG004|COMPLETED|Treatment Period 1 (14 Days)||13||
59726510|NCT01005966|75845302|FG000|NOT COMPLETED|Treatment Period 1 (14 Days)||2||
59726511|NCT01005966|75845303|FG001|NOT COMPLETED|Treatment Period 1 (14 Days)||0||
59726512|NCT01005966|75845304|FG002|NOT COMPLETED|Treatment Period 1 (14 Days)||1||
59726513|NCT01005966|75845305|FG003|NOT COMPLETED|Treatment Period 1 (14 Days)||0||
59726514|NCT01005966|75845306|FG004|NOT COMPLETED|Treatment Period 1 (14 Days)||0||
59726515|NCT01005966|75845302|FG000|STARTED|Washout Period 1 (4 Days)||11||
59726516|NCT01005966|75845303|FG001|STARTED|Washout Period 1 (4 Days)||13||
59726517|NCT01005966|75845304|FG002|STARTED|Washout Period 1 (4 Days)||12||
59726518|NCT01005966|75845305|FG003|STARTED|Washout Period 1 (4 Days)||13||
59726519|NCT01005966|75845306|FG004|STARTED|Washout Period 1 (4 Days)||13||
59726520|NCT01005966|75845302|FG000|COMPLETED|Washout Period 1 (4 Days)||11||
59726521|NCT01005966|75845303|FG001|COMPLETED|Washout Period 1 (4 Days)||13||
59726522|NCT01005966|75845304|FG002|COMPLETED|Washout Period 1 (4 Days)||12||
59726523|NCT01005966|75845305|FG003|COMPLETED|Washout Period 1 (4 Days)||12||
59726524|NCT01005966|75845306|FG004|COMPLETED|Washout Period 1 (4 Days)||13||
59726525|NCT01005966|75845302|FG000|NOT COMPLETED|Washout Period 1 (4 Days)||0||
59726526|NCT01005966|75845303|FG001|NOT COMPLETED|Washout Period 1 (4 Days)||0||
59726527|NCT01005966|75845304|FG002|NOT COMPLETED|Washout Period 1 (4 Days)||0||
59726528|NCT01005966|75845305|FG003|NOT COMPLETED|Washout Period 1 (4 Days)||1||
59726529|NCT01005966|75845306|FG004|NOT COMPLETED|Washout Period 1 (4 Days)||0||
59726530|NCT01005966|75845302|FG000|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|13||
59726531|NCT01005966|75845303|FG001|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|13||
59726532|NCT01005966|75845304|FG002|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|12||
59726533|NCT01005966|75845305|FG003|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|12||
59726534|NCT01005966|75845306|FG004|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|11||
59726535|NCT01005966|75845302|FG000|COMPLETED|Treatment Period 2 (14 Days)||13||
59726536|NCT01005966|75845303|FG001|COMPLETED|Treatment Period 2 (14 Days)||12||
59726537|NCT01005966|75845304|FG002|COMPLETED|Treatment Period 2 (14 Days)||10||
59726538|NCT01005966|75845305|FG003|COMPLETED|Treatment Period 2 (14 Days)||11||
59726539|NCT01005966|75845306|FG004|COMPLETED|Treatment Period 2 (14 Days)||11||
59726540|NCT01005966|75845302|FG000|NOT COMPLETED|Treatment Period 2 (14 Days)||0||
59726541|NCT01005966|75845303|FG001|NOT COMPLETED|Treatment Period 2 (14 Days)||1||
59726542|NCT01005966|75845304|FG002|NOT COMPLETED|Treatment Period 2 (14 Days)||2||
59726543|NCT01005966|75845305|FG003|NOT COMPLETED|Treatment Period 2 (14 Days)||1||
59726544|NCT01005966|75845306|FG004|NOT COMPLETED|Treatment Period 2 (14 Days)||0||
59726545|NCT01005966|75845302|FG000|STARTED|Washout Period 2 (4 Days)||13||
59726546|NCT01005966|75845303|FG001|STARTED|Washout Period 2 (4 Days)||12||
59726547|NCT01005966|75845304|FG002|STARTED|Washout Period 2 (4 Days)||10||
59726548|NCT01005966|75845305|FG003|STARTED|Washout Period 2 (4 Days)||11||
59726549|NCT01005966|75845306|FG004|STARTED|Washout Period 2 (4 Days)||11||
59726550|NCT01005966|75845302|FG000|COMPLETED|Washout Period 2 (4 Days)||13||
59726551|NCT01005966|75845303|FG001|COMPLETED|Washout Period 2 (4 Days)||12||
59996787|NCT01842035|76112641|FG000|COMPLETED|Overall Study||90||
59996788|NCT01842035|76112641|FG000|NOT COMPLETED|Overall Study||0||
59592906|NCT03043105|75701264|FG000|COMPLETED|Overall Study||25||
59592907|NCT03043105|75701264|FG000|NOT COMPLETED|Overall Study||0||
59592908|NCT02845700|75701270|FG000|STARTED|Baseline Appointment||6||
59592909|NCT02845700|75701271|FG001|STARTED|Baseline Appointment||7||
59592910|NCT02845700|75701270|FG000|COMPLETED|Baseline Appointment||6||
59592911|NCT02845700|75701271|FG001|COMPLETED|Baseline Appointment||7||
59592912|NCT02845700|75701270|FG000|NOT COMPLETED|Baseline Appointment||0||
59592913|NCT02845700|75701271|FG001|NOT COMPLETED|Baseline Appointment||0||
59592914|NCT02845700|75701270|FG000|STARTED|Intervention Session 1|1 participant withdrew after completing the Baseline Appointment|5||
59592915|NCT02845700|75701271|FG001|STARTED|Intervention Session 1|1 participant withdrew after completing the Baseline Appointment|6||
59592916|NCT02845700|75701270|FG000|COMPLETED|Intervention Session 1||5||
59726552|NCT01005966|75845304|FG002|COMPLETED|Washout Period 2 (4 Days)||10||
59726553|NCT01005966|75845305|FG003|COMPLETED|Washout Period 2 (4 Days)||11||
59726554|NCT01005966|75845306|FG004|COMPLETED|Washout Period 2 (4 Days)||11||
59726555|NCT01005966|75845302|FG000|NOT COMPLETED|Washout Period 2 (4 Days)||0||
59726556|NCT01005966|75845303|FG001|NOT COMPLETED|Washout Period 2 (4 Days)||0||
59726557|NCT01005966|75845304|FG002|NOT COMPLETED|Washout Period 2 (4 Days)||0||
59726558|NCT01005966|75845305|FG003|NOT COMPLETED|Washout Period 2 (4 Days)||0||
59726559|NCT01005966|75845306|FG004|NOT COMPLETED|Washout Period 2 (4 Days)||0||
59726560|NCT01005966|75845302|FG000|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12||
59726561|NCT01005966|75845303|FG001|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|8||
59726562|NCT01005966|75845304|FG002|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12||
59726563|NCT01005966|75845305|FG003|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|13||
59726564|NCT01005966|75845306|FG004|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12||
59726565|NCT01005966|75845302|FG000|COMPLETED|Treatment Period 3 (14 Days)||12||
59726566|NCT01005966|75845303|FG001|COMPLETED|Treatment Period 3 (14 Days)||7||
59726567|NCT01005966|75845304|FG002|COMPLETED|Treatment Period 3 (14 Days)||12||
59726568|NCT01005966|75845305|FG003|COMPLETED|Treatment Period 3 (14 Days)||13||
59726569|NCT01005966|75845306|FG004|COMPLETED|Treatment Period 3 (14 Days)||11||
59726570|NCT01005966|75845302|FG000|NOT COMPLETED|Treatment Period 3 (14 Days)||0||
59726571|NCT01005966|75845303|FG001|NOT COMPLETED|Treatment Period 3 (14 Days)||1||
59726572|NCT01005966|75845304|FG002|NOT COMPLETED|Treatment Period 3 (14 Days)||0||
59726573|NCT01005966|75845305|FG003|NOT COMPLETED|Treatment Period 3 (14 Days)||0||
59726574|NCT01005966|75845306|FG004|NOT COMPLETED|Treatment Period 3 (14 Days)||1||
59726575|NCT01005966|75845302|FG000|STARTED|Washout Period 3 ( 4 Days)||12||
59726576|NCT01005966|75845303|FG001|STARTED|Washout Period 3 ( 4 Days)||7||
59726577|NCT01005966|75845304|FG002|STARTED|Washout Period 3 ( 4 Days)||12||
59726578|NCT01005966|75845305|FG003|STARTED|Washout Period 3 ( 4 Days)||13||
59726579|NCT01005966|75845306|FG004|STARTED|Washout Period 3 ( 4 Days)||11||
59726580|NCT01005966|75845302|FG000|COMPLETED|Washout Period 3 ( 4 Days)||12||
59726581|NCT01005966|75845303|FG001|COMPLETED|Washout Period 3 ( 4 Days)||7||
59726582|NCT01005966|75845304|FG002|COMPLETED|Washout Period 3 ( 4 Days)||12||
59726583|NCT01005966|75845305|FG003|COMPLETED|Washout Period 3 ( 4 Days)||13||
59726584|NCT01005966|75845306|FG004|COMPLETED|Washout Period 3 ( 4 Days)||11||
59726585|NCT01005966|75845302|FG000|NOT COMPLETED|Washout Period 3 ( 4 Days)||0||
59726586|NCT01005966|75845303|FG001|NOT COMPLETED|Washout Period 3 ( 4 Days)||0||
59726587|NCT01005966|75845304|FG002|NOT COMPLETED|Washout Period 3 ( 4 Days)||0||
59726588|NCT01005966|75845305|FG003|NOT COMPLETED|Washout Period 3 ( 4 Days)||0||
59726589|NCT01005966|75845306|FG004|NOT COMPLETED|Washout Period 3 ( 4 Days)||0||
59726590|NCT01005966|75845302|FG000|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|10||
59726591|NCT01005966|75845303|FG001|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|11||
59726592|NCT01005966|75845304|FG002|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|11||
59726593|NCT01005966|75845305|FG003|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|10||
59726594|NCT01005966|75845306|FG004|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|13||
59726595|NCT01005966|75845302|FG000|COMPLETED|Treatment Period 4 (14 Days)||10||
59726596|NCT01005966|75845303|FG001|COMPLETED|Treatment Period 4 (14 Days)||10||
59726597|NCT01005966|75845304|FG002|COMPLETED|Treatment Period 4 (14 Days)||11||
59726598|NCT01005966|75845305|FG003|COMPLETED|Treatment Period 4 (14 Days)||10||
59726599|NCT01005966|75845306|FG004|COMPLETED|Treatment Period 4 (14 Days)||12||
59726600|NCT01005966|75845302|FG000|NOT COMPLETED|Treatment Period 4 (14 Days)||0||
59726601|NCT01005966|75845303|FG001|NOT COMPLETED|Treatment Period 4 (14 Days)||1||
59726602|NCT01005966|75845304|FG002|NOT COMPLETED|Treatment Period 4 (14 Days)||0||
59726603|NCT01005966|75845305|FG003|NOT COMPLETED|Treatment Period 4 (14 Days)||0||
59726604|NCT01005966|75845306|FG004|NOT COMPLETED|Treatment Period 4 (14 Days)||1||
59726605|NCT01005966|75845302|FG000|STARTED|Washout Period 4 (4 Days)||10||
59726606|NCT01005966|75845303|FG001|STARTED|Washout Period 4 (4 Days)||10||
59726607|NCT01005966|75845304|FG002|STARTED|Washout Period 4 (4 Days)||11||
59726608|NCT01005966|75845305|FG003|STARTED|Washout Period 4 (4 Days)||10||
59726609|NCT01005966|75845306|FG004|STARTED|Washout Period 4 (4 Days)||12||
59726610|NCT01005966|75845302|FG000|COMPLETED|Washout Period 4 (4 Days)||10||
59726611|NCT01005966|75845303|FG001|COMPLETED|Washout Period 4 (4 Days)||10||
59726612|NCT01005966|75845304|FG002|COMPLETED|Washout Period 4 (4 Days)||11||
59726613|NCT01005966|75845305|FG003|COMPLETED|Washout Period 4 (4 Days)||10||
59726614|NCT01005966|75845306|FG004|COMPLETED|Washout Period 4 (4 Days)||12||
59726615|NCT01005966|75845302|FG000|NOT COMPLETED|Washout Period 4 (4 Days)||0||
59726616|NCT01005966|75845303|FG001|NOT COMPLETED|Washout Period 4 (4 Days)||0||
59726617|NCT01005966|75845304|FG002|NOT COMPLETED|Washout Period 4 (4 Days)||0||
59726618|NCT01005966|75845305|FG003|NOT COMPLETED|Washout Period 4 (4 Days)||0||
59726619|NCT01005966|75845306|FG004|NOT COMPLETED|Washout Period 4 (4 Days)||0||
59726620|NCT01005966|75845302|FG000|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|9||
59726621|NCT01005966|75845303|FG001|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|12||
59726622|NCT01005966|75845304|FG002|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|11||
59726623|NCT01005966|75845305|FG003|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|11||
59726624|NCT01005966|75845306|FG004|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|10||
59726625|NCT01005966|75845302|FG000|COMPLETED|Treatment Period 5 (14 Days)||9||
59726626|NCT01005966|75845303|FG001|COMPLETED|Treatment Period 5 (14 Days)||12||
59726627|NCT01005966|75845304|FG002|COMPLETED|Treatment Period 5 (14 Days)||11||
59726628|NCT01005966|75845305|FG003|COMPLETED|Treatment Period 5 (14 Days)||11||
59726629|NCT01005966|75845306|FG004|COMPLETED|Treatment Period 5 (14 Days)||10||
59726630|NCT01005966|75845302|FG000|NOT COMPLETED|Treatment Period 5 (14 Days)||0||
59726631|NCT01005966|75845303|FG001|NOT COMPLETED|Treatment Period 5 (14 Days)||0||
59726632|NCT01005966|75845304|FG002|NOT COMPLETED|Treatment Period 5 (14 Days)||0||
59726633|NCT01005966|75845305|FG003|NOT COMPLETED|Treatment Period 5 (14 Days)||0||
59726634|NCT01005966|75845306|FG004|NOT COMPLETED|Treatment Period 5 (14 Days)||0||
59726635|NCT03937960|75845325|FG000|STARTED|Overall Study||15||
59726636|NCT03937960|75845326|FG001|STARTED|Overall Study||15||
59726637|NCT03937960|75845325|FG000|COMPLETED|Overall Study||15||
59726638|NCT03937960|75845326|FG001|COMPLETED|Overall Study||15||
59726639|NCT03937960|75845325|FG000|NOT COMPLETED|Overall Study||0||
59726640|NCT03937960|75845326|FG001|NOT COMPLETED|Overall Study||0||
59726641|NCT01005732|75845332|FG000|STARTED|Overall Study||54||
59726642|NCT01005732|75845332|FG000|COMPLETED|Overall Study||43||
59726643|NCT01005732|75845332|FG000|NOT COMPLETED|Overall Study||11||
59726644|NCT00603382|75845346|FG000|STARTED|Overall Study||94||
59726645|NCT00603382|75845347|FG001|STARTED|Overall Study||97||
59726646|NCT00603382|75845348|FG002|STARTED|Overall Study||100||
59726647|NCT00603382|75845349|FG003|STARTED|Overall Study||110||
59726648|NCT00603382|75845350|FG004|STARTED|Overall Study||95||
59726649|NCT00603382|75845351|FG005|STARTED|Overall Study||102||
59726650|NCT00603382|75845346|FG000|COMPLETED|Overall Study||76||
59726651|NCT00603382|75845347|FG001|COMPLETED|Overall Study||83||
59726652|NCT00603382|75845348|FG002|COMPLETED|Overall Study||91||
59726653|NCT00603382|75845349|FG003|COMPLETED|Overall Study||98||
59726654|NCT00603382|75845350|FG004|COMPLETED|Overall Study||86||
59726655|NCT00603382|75845351|FG005|COMPLETED|Overall Study||84||
59726656|NCT00603382|75845346|FG000|NOT COMPLETED|Overall Study||18||
59726657|NCT00603382|75845347|FG001|NOT COMPLETED|Overall Study||14||
59726658|NCT00603382|75845348|FG002|NOT COMPLETED|Overall Study||9||
59726659|NCT00603382|75845349|FG003|NOT COMPLETED|Overall Study||12||
59726660|NCT00603382|75845350|FG004|NOT COMPLETED|Overall Study||9||
59726661|NCT00603382|75845351|FG005|NOT COMPLETED|Overall Study||18||
59726662|NCT01176266|75845365|FG000|STARTED|Overall Study||69||
59726663|NCT01176266|75845365|FG000|COMPLETED|Overall Study||60||
59726664|NCT01176266|75845365|FG000|NOT COMPLETED|Overall Study||9||
59726665|NCT01182428|75845375|FG000|STARTED|Overall Study||304||
59726666|NCT01182428|75845376|FG001|STARTED|Overall Study||151||
59726667|NCT01182428|75845375|FG000|COMPLETED|Overall Study||293||
59726668|NCT01182428|75845376|FG001|COMPLETED|Overall Study||150||
59726669|NCT01182428|75845375|FG000|NOT COMPLETED|Overall Study||11||
59726670|NCT01182428|75845376|FG001|NOT COMPLETED|Overall Study||1||
59726671|NCT00603304|75845384|FG000|STARTED|Overall Study||183||
59726672|NCT00603304|75845385|FG001|STARTED|Overall Study||186||
59726673|NCT00603304|75845384|FG000|COMPLETED|Overall Study||151||
59726674|NCT00603304|75845385|FG001|COMPLETED|Overall Study||155||
59726675|NCT00603304|75845384|FG000|NOT COMPLETED|Overall Study||32||
59726676|NCT00603304|75845385|FG001|NOT COMPLETED|Overall Study||31||
59726677|NCT01176032|75845395|FG000|STARTED|Overall Study|"Started indicates randomized and safety population"|37||
59726678|NCT01176032|75845396|FG001|STARTED|Overall Study||37||
59726679|NCT01176032|75845395|FG000|Intention-to-treat (ITT) Population|Overall Study||32||
59726680|NCT01176032|75845396|FG001|Intention-to-treat (ITT) Population|Overall Study||37||
59726681|NCT01176032|75845395|FG000|COMPLETED|Overall Study||31||
59726682|NCT01176032|75845396|FG001|COMPLETED|Overall Study||36||
59726683|NCT01176032|75845395|FG000|NOT COMPLETED|Overall Study||6||
59726684|NCT01176032|75845396|FG001|NOT COMPLETED|Overall Study||1||
59726685|NCT01008618|75845407|FG000|STARTED|Period 1 (Titration Period)||218||
59726686|NCT01008618|75845408|FG001|STARTED|Period 1 (Titration Period)||0||
59726687|NCT01008618|75845409|FG002|STARTED|Period 1 (Titration Period)||0||
59726688|NCT01008618|75845407|FG000|COMPLETED|Period 1 (Titration Period)||150||
59726689|NCT01008618|75845408|FG001|COMPLETED|Period 1 (Titration Period)||0||
59726690|NCT01008618|75845409|FG002|COMPLETED|Period 1 (Titration Period)||0||
59726691|NCT01008618|75845407|FG000|NOT COMPLETED|Period 1 (Titration Period)||68||
59726692|NCT01008618|75845408|FG001|NOT COMPLETED|Period 1 (Titration Period)||0||
59726693|NCT01008618|75845409|FG002|NOT COMPLETED|Period 1 (Titration Period)||0||
59726694|NCT01008618|75845407|FG000|STARTED|Period 2 (Double-Blind Period)||0||
59726695|NCT01008618|75845408|FG001|STARTED|Period 2 (Double-Blind Period)||73||
59726696|NCT01008618|75845409|FG002|STARTED|Period 2 (Double-Blind Period)||77||
59726697|NCT01008618|75845407|FG000|COMPLETED|Period 2 (Double-Blind Period)||0||
59726698|NCT01008618|75845408|FG001|COMPLETED|Period 2 (Double-Blind Period)||37||
59726699|NCT01008618|75845409|FG002|COMPLETED|Period 2 (Double-Blind Period)||39||
59726700|NCT01008618|75845407|FG000|NOT COMPLETED|Period 2 (Double-Blind Period)||0||
59726701|NCT01008618|75845408|FG001|NOT COMPLETED|Period 2 (Double-Blind Period)||36||
59726702|NCT01008618|75845409|FG002|NOT COMPLETED|Period 2 (Double-Blind Period)||38||
59726703|NCT01001208|75845420|FG000|STARTED|Overall Study||239||
59726704|NCT01001208|75845421|FG001|STARTED|Overall Study||239||
59726705|NCT01001208|75845420|FG000|COMPLETED|Overall Study||211||
59726706|NCT01001208|75845421|FG001|COMPLETED|Overall Study||206||
59726707|NCT01001208|75845420|FG000|NOT COMPLETED|Overall Study||28||
59726708|NCT01001208|75845421|FG001|NOT COMPLETED|Overall Study||33||
59726709|NCT01000974|75845430|FG000|STARTED|Primary Vaccination Phase||2963||
59726710|NCT01000974|75845431|FG001|STARTED|Primary Vaccination Phase||520||
59726711|NCT01000974|75845432|FG002|STARTED|Primary Vaccination Phase||520||
59726712|NCT01000974|75845430|FG000|COMPLETED|Primary Vaccination Phase||2625||
59726713|NCT01000974|75845431|FG001|COMPLETED|Primary Vaccination Phase||470||
59726714|NCT01000974|75845432|FG002|COMPLETED|Primary Vaccination Phase||457||
59726715|NCT01000974|75845430|FG000|NOT COMPLETED|Primary Vaccination Phase||338||
59726716|NCT01000974|75845431|FG001|NOT COMPLETED|Primary Vaccination Phase||50||
59726717|NCT01000974|75845432|FG002|NOT COMPLETED|Primary Vaccination Phase||63||
59726718|NCT01000974|75845430|FG000|STARTED|Booster Vaccination Phase||2337||
59726719|NCT01000974|75845431|FG001|STARTED|Booster Vaccination Phase||435||
59726720|NCT01000974|75845432|FG002|STARTED|Booster Vaccination Phase||400||
59726721|NCT01000974|75845430|FG000|COMPLETED|Booster Vaccination Phase||2270||
59726722|NCT01000974|75845431|FG001|COMPLETED|Booster Vaccination Phase||423||
59726723|NCT01000974|75845432|FG002|COMPLETED|Booster Vaccination Phase||386||
59726724|NCT01000974|75845430|FG000|NOT COMPLETED|Booster Vaccination Phase||67||
59726725|NCT01000974|75845431|FG001|NOT COMPLETED|Booster Vaccination Phase||12||
59726726|NCT01000974|75845432|FG002|NOT COMPLETED|Booster Vaccination Phase||14||
59726727|NCT01004406|75845445|FG000|STARTED|Overall Study||21||
59726728|NCT01004406|75845446|FG001|STARTED|Overall Study||10||
59726729|NCT01004406|75845445|FG000|COMPLETED|Overall Study||18||
59726730|NCT01004406|75845446|FG001|COMPLETED|Overall Study||10||
59726731|NCT01004406|75845445|FG000|NOT COMPLETED|Overall Study||3||
59726732|NCT01004406|75845446|FG001|NOT COMPLETED|Overall Study||0||
59726733|NCT01093612|75845454|FG000|STARTED|Overall Study||11||
59726734|NCT01093612|75845455|FG001|STARTED|Overall Study||7||
59726735|NCT01093612|75845454|FG000|COMPLETED|Overall Study||11||
59726736|NCT01093612|75845455|FG001|COMPLETED|Overall Study||7||
59726737|NCT01093612|75845454|FG000|NOT COMPLETED|Overall Study||0||
59726738|NCT01093612|75845455|FG001|NOT COMPLETED|Overall Study||0||
59726739|NCT01182350|75845461|FG000|STARTED|Overall Study||30||
59726740|NCT01182350|75845462|FG001|STARTED|Overall Study||14||
59726741|NCT01182350|75845463|FG002|STARTED|Overall Study||3||
59726742|NCT01182350|75845464|FG003|STARTED|Overall Study||3||
59726743|NCT01182350|75845465|FG004|STARTED|Overall Study||3||
59726744|NCT01182350|75845461|FG000|Underwent Stereotactic Biopsy|Overall Study||30||
59726745|NCT01182350|75845462|FG001|Underwent Stereotactic Biopsy|Overall Study||14||
59726746|NCT01182350|75845463|FG002|Underwent Stereotactic Biopsy|Overall Study||3||
59726747|NCT01182350|75845464|FG003|Underwent Stereotactic Biopsy|Overall Study||3||
59726748|NCT01182350|75845465|FG004|Underwent Stereotactic Biopsy|Overall Study||0||
59726749|NCT01182350|75845461|FG000|Started Assigned Chemoradiation|Overall Study||27||
59726750|NCT01182350|75845462|FG001|Started Assigned Chemoradiation|Overall Study||14||
59726751|NCT01182350|75845463|FG002|Started Assigned Chemoradiation|Overall Study||2||
59726752|NCT01182350|75845464|FG003|Started Assigned Chemoradiation|Overall Study||2||
59726753|NCT01182350|75845465|FG004|Started Assigned Chemoradiation|Overall Study||0||
59726754|NCT01182350|75845461|FG000|COMPLETED|Overall Study||3||
59726755|NCT01182350|75845462|FG001|COMPLETED|Overall Study||0||
59726756|NCT01182350|75845463|FG002|COMPLETED|Overall Study||0||
59726757|NCT01182350|75845464|FG003|COMPLETED|Overall Study||0||
59726758|NCT01182350|75845465|FG004|COMPLETED|Overall Study||0||
59726759|NCT01182350|75845461|FG000|NOT COMPLETED|Overall Study||27||
59726760|NCT01182350|75845462|FG001|NOT COMPLETED|Overall Study||14||
59726761|NCT01182350|75845463|FG002|NOT COMPLETED|Overall Study||3||
59726762|NCT01182350|75845464|FG003|NOT COMPLETED|Overall Study||3||
59726763|NCT01182350|75845465|FG004|NOT COMPLETED|Overall Study||3||
59996789|NCT00708461|76112648|FG000|STARTED|Overall Study||752||
59726764|NCT01163474|75845481|FG000|STARTED|Overall Study||40||
59726765|NCT01163474|75845481|FG000|COMPLETED|Overall Study||24||
59726766|NCT01163474|75845481|FG000|NOT COMPLETED|Overall Study||16||
59726767|NCT00603538|75845491|FG000|STARTED|Overall Study||6||
59726768|NCT00603538|75845492|FG001|STARTED|Overall Study|Including one participant who discontinued from the study prior to CP-751,871 administration.|7||
59726769|NCT00603538|75845493|FG002|STARTED|Overall Study||6||
59726770|NCT00603538|75845491|FG000|COMPLETED|Overall Study||3||
59726771|NCT00603538|75845492|FG001|COMPLETED|Overall Study||3||
59726772|NCT00603538|75845493|FG002|COMPLETED|Overall Study||4||
59726773|NCT00603538|75845491|FG000|NOT COMPLETED|Overall Study||3||
59726774|NCT00603538|75845492|FG001|NOT COMPLETED|Overall Study||4||
60122526|NCT01532921|76243587|FG000|6 Months Follow Up|Overall Study||68||
60122527|NCT01532921|76243587|FG000|COMPLETED|Overall Study||69||
60122528|NCT01532921|76243587|FG000|NOT COMPLETED|Overall Study||16||
60122529|NCT01532687|76243597|FG000|STARTED|Overall Study||29||
60122530|NCT01532687|76243598|FG001|STARTED|Overall Study||25||
60122531|NCT01532687|76243597|FG000|Crossover to Open-label Pazopanib|Overall Study||0|Participants who progress, unblinded, and found treated with gemcitibine+placebo arm are eligible to crossover into pazopanib open-label treatment phase|
60122532|NCT01532687|76243598|FG001|Crossover to Open-label Pazopanib|Overall Study||14|Participants who progress, unblinded, and found treated with gemcitibine+placebo arm are eligible to crossover into pazopanib open-label treatment phase|
60122533|NCT01532687|76243597|FG000|COMPLETED|Overall Study|Participants remain on treatment until time of progression and through the AE assessment period|15||
60122534|NCT01532687|76243598|FG001|COMPLETED|Overall Study|Participants remain on treatment until time of progression|23||
60122535|NCT01532687|76243597|FG000|NOT COMPLETED|Overall Study||14||
60122536|NCT01532687|76243598|FG001|NOT COMPLETED|Overall Study||2||
60122537|NCT02677116|76243615|FG000|STARTED|Overall Study||10||
60122538|NCT02677116|76243616|FG001|STARTED|Overall Study||11||
60122539|NCT02677116|76243617|FG002|STARTED|Overall Study||9||
60122540|NCT02677116|76243618|FG003|STARTED|Overall Study||10||
60122541|NCT02677116|76243619|FG004|STARTED|Overall Study||1||
60122542|NCT02677116|76243620|FG005|STARTED|Overall Study||13||
59592917|NCT02845700|75701271|FG001|COMPLETED|Intervention Session 1||6||
59592918|NCT02845700|75701270|FG000|NOT COMPLETED|Intervention Session 1||0||
59592919|NCT02845700|75701271|FG001|NOT COMPLETED|Intervention Session 1||0||
59592920|NCT02845700|75701270|FG000|STARTED|Intervention Session 2||5||
59592921|NCT02845700|75701271|FG001|STARTED|Intervention Session 2||6||
59592922|NCT02845700|75701270|FG000|COMPLETED|Intervention Session 2||5||
59592923|NCT02845700|75701271|FG001|COMPLETED|Intervention Session 2||6||
59592924|NCT02845700|75701270|FG000|NOT COMPLETED|Intervention Session 2||0||
59726775|NCT00603538|75845493|FG002|NOT COMPLETED|Overall Study||2||
59726776|NCT01163318|75845504|FG000|STARTED|Overall Study||552||
59726777|NCT01163318|75845504|FG000|COMPLETED|Overall Study||284||
59726778|NCT01163318|75845504|FG000|NOT COMPLETED|Overall Study||268||
59726779|NCT01162304|75845508|FG000|STARTED|Overall Study||18||
59726780|NCT01162304|75845508|FG000|COMPLETED|Overall Study||7||
59726781|NCT01162304|75845508|FG000|NOT COMPLETED|Overall Study||11||
59726782|NCT04515394|75845514|FG000|STARTED|Overall Study||3||
60122543|NCT02677116|76243621|FG006|STARTED|Overall Study||6||
60122544|NCT02677116|76243622|FG007|STARTED|Overall Study||4||
60122545|NCT02677116|76243623|FG008|STARTED|Overall Study||4||
60122546|NCT02677116|76243615|FG000|Cycle 1 Olaratumab Alone|Overall Study||10||
60122547|NCT02677116|76243616|FG001|Cycle 1 Olaratumab Alone|Overall Study||11||
60122548|NCT02677116|76243617|FG002|Cycle 1 Olaratumab Alone|Overall Study||9||
60122549|NCT02677116|76243618|FG003|Cycle 1 Olaratumab Alone|Overall Study||10||
60122550|NCT02677116|76243619|FG004|Cycle 1 Olaratumab Alone|Overall Study||1||
60122551|NCT02677116|76243620|FG005|Cycle 1 Olaratumab Alone|Overall Study||13||
60122552|NCT02677116|76243621|FG006|Cycle 1 Olaratumab Alone|Overall Study||6||
60122553|NCT02677116|76243622|FG007|Cycle 1 Olaratumab Alone|Overall Study||4||
60122554|NCT02677116|76243623|FG008|Cycle 1 Olaratumab Alone|Overall Study||4||
60122555|NCT02677116|76243615|FG000|Progressive Disease|Overall Study||7||
60122556|NCT02677116|76243616|FG001|Progressive Disease|Overall Study||7||
60122557|NCT02677116|76243617|FG002|Progressive Disease|Overall Study||6||
60122558|NCT02677116|76243618|FG003|Progressive Disease|Overall Study||7||
60122559|NCT02677116|76243619|FG004|Progressive Disease|Overall Study||0||
60122560|NCT02677116|76243620|FG005|Progressive Disease|Overall Study||9||
60122561|NCT02677116|76243621|FG006|Progressive Disease|Overall Study||2||
60122562|NCT02677116|76243622|FG007|Progressive Disease|Overall Study||2||
60122563|NCT02677116|76243623|FG008|Progressive Disease|Overall Study||2||
60122564|NCT02677116|76243615|FG000|COMPLETED|Overall Study||7||
60122565|NCT02677116|76243616|FG001|COMPLETED|Overall Study||7||
60122566|NCT02677116|76243617|FG002|COMPLETED|Overall Study||6||
59726783|NCT04515394|75845514|FG000|Treated|Overall Study||2||
59726784|NCT04515394|75845514|FG000|COMPLETED|Overall Study||2||
59726785|NCT04515394|75845514|FG000|NOT COMPLETED|Overall Study||1||
60122567|NCT02677116|76243618|FG003|COMPLETED|Overall Study||7||
60122568|NCT02677116|76243619|FG004|COMPLETED|Overall Study||0||
60122569|NCT02677116|76243620|FG005|COMPLETED|Overall Study||9||
60122570|NCT02677116|76243621|FG006|COMPLETED|Overall Study||2||
60122571|NCT02677116|76243622|FG007|COMPLETED|Overall Study||2||
60122572|NCT02677116|76243623|FG008|COMPLETED|Overall Study||2||
60122573|NCT02677116|76243615|FG000|NOT COMPLETED|Overall Study||3||
60122574|NCT02677116|76243616|FG001|NOT COMPLETED|Overall Study||4||
60122575|NCT02677116|76243617|FG002|NOT COMPLETED|Overall Study||3||
60122576|NCT02677116|76243618|FG003|NOT COMPLETED|Overall Study||3||
60122577|NCT02677116|76243619|FG004|NOT COMPLETED|Overall Study||1||
60122578|NCT02677116|76243620|FG005|NOT COMPLETED|Overall Study||4||
59592925|NCT02845700|75701271|FG001|NOT COMPLETED|Intervention Session 2||0||
59726786|NCT01175018|75845520|FG000|STARTED|Overall Study||15||
59726787|NCT01175018|75845521|FG001|STARTED|Overall Study||15||
60122579|NCT02677116|76243621|FG006|NOT COMPLETED|Overall Study||4||
60122580|NCT02677116|76243622|FG007|NOT COMPLETED|Overall Study||2||
60122581|NCT02677116|76243623|FG008|NOT COMPLETED|Overall Study||2||
60122582|NCT02689518|76243666|FG000|STARTED|Overall Study||49||
60122583|NCT02689518|76243666|FG000|COMPLETED|Overall Study||46||
60122584|NCT02689518|76243666|FG000|NOT COMPLETED|Overall Study||3||
60122585|NCT02681094|76243673|FG000|STARTED|1 -Modified Enrolled Participants Set||293|7 participants of 1 US site were excluded due to serious Good Clinical Practice (GCP)|
60122586|NCT02681094|76243674|FG001|STARTED|1 -Modified Enrolled Participants Set|A participant was randomized but did not receive treatment|294|7 participants of 1 US site were excluded due to serious Good Clinical Practice (GCP)|
60122587|NCT02681094|76243675|FG002|STARTED|1 -Modified Enrolled Participants Set|A participant was randomized but did not receive treatment|296|7 participants of 1 US site were excluded due to serious Good Clinical Practice (GCP)|
60122588|NCT02681094|76243673|FG000|Participants Completed Treatment Period|1 -Modified Enrolled Participants Set||273||
60122589|NCT02681094|76243674|FG001|Participants Completed Treatment Period|1 -Modified Enrolled Participants Set||276||
60122590|NCT02681094|76243675|FG002|Participants Completed Treatment Period|1 -Modified Enrolled Participants Set||283||
60122591|NCT02681094|76243673|FG000|COMPLETED|1 -Modified Enrolled Participants Set||256|Participants who completed study treatment|
60122592|NCT02681094|76243674|FG001|COMPLETED|1 -Modified Enrolled Participants Set||255|Participants who completed study treatment|
60122593|NCT02681094|76243675|FG002|COMPLETED|1 -Modified Enrolled Participants Set||243|Participants who completed study treatment|
60122594|NCT02681094|76243673|FG000|NOT COMPLETED|1 -Modified Enrolled Participants Set||37||
60122595|NCT02681094|76243674|FG001|NOT COMPLETED|1 -Modified Enrolled Participants Set||39||
60122596|NCT02681094|76243675|FG002|NOT COMPLETED|1 -Modified Enrolled Participants Set||53||
60122597|NCT02681094|76243673|FG000|STARTED|2 - Enrolled Participants Set|Population was used for the sensitivity analysis to assess the robustness of the treatment effect.|301|Includes 7 participants of one US site which was excluded in Modified Enrolled participants set|
60122598|NCT02681094|76243674|FG001|STARTED|2 - Enrolled Participants Set|Population was used for the sensitivity analysis to assess the robustness of the treatment effect.|302|Includes 7 participants of one US site which was excluded in Modified Enrolled participants set|
60122599|NCT02681094|76243675|FG002|STARTED|2 - Enrolled Participants Set|Population was used for the sensitivity analysis to assess the robustness of the treatment effect.|302|Includes 7 participants of one US site which was excluded in Modified Enrolled participants set|
60122600|NCT02681094|76243673|FG000|Participants Completed Treatment Period|2 - Enrolled Participants Set||281||
60122601|NCT02681094|76243674|FG001|Participants Completed Treatment Period|2 - Enrolled Participants Set|A participant was randomized but did not receive treatment due to screen failure.|284||
60122602|NCT02681094|76243675|FG002|Participants Completed Treatment Period|2 - Enrolled Participants Set|A participant was randomized but did not receive treatment due to screen failure.|289||
60122603|NCT02681094|76243673|FG000|COMPLETED|2 - Enrolled Participants Set||261|Participants who completed study treatment|
60122604|NCT02681094|76243674|FG001|COMPLETED|2 - Enrolled Participants Set||261|Participants who completed study treatment|
60122605|NCT02681094|76243675|FG002|COMPLETED|2 - Enrolled Participants Set||248|Participants who completed study treatment|
60122606|NCT02681094|76243673|FG000|NOT COMPLETED|2 - Enrolled Participants Set||40||
60122607|NCT02681094|76243674|FG001|NOT COMPLETED|2 - Enrolled Participants Set||41||
60122608|NCT02681094|76243675|FG002|NOT COMPLETED|2 - Enrolled Participants Set||54||
60122609|NCT02689284|76243686|FG000|STARTED|Overall Study||3||
60122610|NCT02689284|76243687|FG001|STARTED|Overall Study||92||
60122611|NCT02689284|76243686|FG000|COMPLETED|Overall Study||0||
60122612|NCT02689284|76243687|FG001|COMPLETED|Overall Study||5||
60122613|NCT02689284|76243686|FG000|NOT COMPLETED|Overall Study||3||
60122614|NCT02689284|76243687|FG001|NOT COMPLETED|Overall Study||87||
60122615|NCT02676882|76243696|FG000|STARTED|Overall Study||13||
60122616|NCT02676882|76243697|FG001|STARTED|Overall Study||7||
60122617|NCT02676882|76243696|FG000|Evaluable|Overall Study||11|Received study drug; completed minimum 1 follow-up visit; if Group 1, discontinued antidepressants.|
60122618|NCT02676882|76243697|FG001|Evaluable|Overall Study||6|Received study drug; completed minimum 1 follow-up visit; if Group 1, discontinued antidepressants.|
60122619|NCT02676882|76243696|FG000|COMPLETED|Overall Study||10||
60122620|NCT02676882|76243697|FG001|COMPLETED|Overall Study||5||
60122621|NCT02676882|76243696|FG000|NOT COMPLETED|Overall Study||3||
60122622|NCT02676882|76243697|FG001|NOT COMPLETED|Overall Study||2||
60122623|NCT02674386|76243706|FG000|STARTED|Overall Study||20||
60122624|NCT02674386|76243707|FG001|STARTED|Overall Study||117||
60122625|NCT02674386|76243708|FG002|STARTED|Overall Study||17||
60122626|NCT02674386|76243706|FG000|Safety Analysis Set|Overall Study||20||
60122627|NCT02674386|76243707|FG001|Safety Analysis Set|Overall Study||113||
60122628|NCT02674386|76243708|FG002|Safety Analysis Set|Overall Study||17||
60122629|NCT02674386|76243706|FG000|COMPLETED|Overall Study||20||
60122630|NCT02674386|76243707|FG001|COMPLETED|Overall Study||107||
60122631|NCT02674386|76243708|FG002|COMPLETED|Overall Study||16||
60122632|NCT02674386|76243706|FG000|NOT COMPLETED|Overall Study||0||
60122633|NCT02674386|76243707|FG001|NOT COMPLETED|Overall Study||10||
60122634|NCT02674386|76243708|FG002|NOT COMPLETED|Overall Study||1||
60122635|NCT02680002|76243727|FG000|STARTED|Overall Study||71||
60122636|NCT02680002|76243728|FG001|STARTED|Overall Study||70||
59726788|NCT01175018|75845520|FG000|COMPLETED|Overall Study||12||
60122637|NCT02680002|76243729|FG002|STARTED|Overall Study||70||
59726789|NCT01175018|75845521|FG001|COMPLETED|Overall Study||14||
60122638|NCT02680002|76243730|FG003|STARTED|Overall Study||71||
60122639|NCT02680002|76243731|FG004|STARTED|Overall Study||70||
60122640|NCT02680002|76243732|FG005|STARTED|Overall Study||70||
60122641|NCT02680002|76243727|FG000|Day 0 (Dose 1)|Overall Study||70||
60122642|NCT02680002|76243728|FG001|Day 0 (Dose 1)|Overall Study||70||
60122643|NCT02680002|76243729|FG002|Day 0 (Dose 1)|Overall Study||70||
60122644|NCT02680002|76243730|FG003|Day 0 (Dose 1)|Overall Study||71||
60122645|NCT02680002|76243731|FG004|Day 0 (Dose 1)|Overall Study||70||
60122646|NCT02680002|76243732|FG005|Day 0 (Dose 1)|Overall Study||68||
60122647|NCT02680002|76243727|FG000|Day 21 (Dose 2)|Overall Study||63||
60122648|NCT02680002|76243728|FG001|Day 21 (Dose 2)|Overall Study||68||
60122649|NCT02680002|76243729|FG002|Day 21 (Dose 2)|Overall Study||65||
60122650|NCT02680002|76243730|FG003|Day 21 (Dose 2)|Overall Study||69||
60122651|NCT02680002|76243731|FG004|Day 21 (Dose 2)|Overall Study||65||
60122652|NCT02680002|76243732|FG005|Day 21 (Dose 2)|Overall Study||63||
60122653|NCT02680002|76243727|FG000|Day 201|Overall Study||58||
60122654|NCT02680002|76243728|FG001|Day 201|Overall Study||66||
60122655|NCT02680002|76243729|FG002|Day 201|Overall Study||60||
60122656|NCT02680002|76243730|FG003|Day 201|Overall Study||67||
60122657|NCT02680002|76243731|FG004|Day 201|Overall Study||59||
60122658|NCT02680002|76243732|FG005|Day 201|Overall Study||61||
60122659|NCT02680002|76243727|FG000|COMPLETED|Overall Study||58||
60122660|NCT02680002|76243728|FG001|COMPLETED|Overall Study||66||
60122661|NCT02680002|76243729|FG002|COMPLETED|Overall Study||60||
60122662|NCT02680002|76243730|FG003|COMPLETED|Overall Study||67||
60122663|NCT02680002|76243731|FG004|COMPLETED|Overall Study||59||
60122664|NCT02680002|76243732|FG005|COMPLETED|Overall Study||61||
60122665|NCT02680002|76243727|FG000|NOT COMPLETED|Overall Study||13||
60122666|NCT02680002|76243728|FG001|NOT COMPLETED|Overall Study||4||
60122667|NCT02680002|76243729|FG002|NOT COMPLETED|Overall Study||10||
60122668|NCT02680002|76243730|FG003|NOT COMPLETED|Overall Study||4||
60122669|NCT02680002|76243731|FG004|NOT COMPLETED|Overall Study||11||
60122670|NCT02680002|76243732|FG005|NOT COMPLETED|Overall Study||9||
60122671|NCT04557384|76243749|FG000|STARTED|Overall Study||3||
60122672|NCT04557384|76243749|FG000|Received At Least 1 Dose of Study Drug|Overall Study||3||
60122673|NCT04557384|76243749|FG000|COMPLETED|Overall Study||1||
60122674|NCT04557384|76243749|FG000|NOT COMPLETED|Overall Study||2||
60122675|NCT02673684|76243755|FG000|STARTED|Overall Study||9||
60122676|NCT02673684|76243756|FG001|STARTED|Overall Study||8||
60122677|NCT02673684|76243755|FG000|COMPLETED|Overall Study||0||
60122678|NCT02673684|76243756|FG001|COMPLETED|Overall Study||0||
60122679|NCT02673684|76243755|FG000|NOT COMPLETED|Overall Study||9||
60122680|NCT02673684|76243756|FG001|NOT COMPLETED|Overall Study||8||
60122681|NCT02675634|76243764|FG000|STARTED|Test Period 1||10||
60122682|NCT02675634|76243765|FG001|STARTED|Test Period 1||8||
60122683|NCT02675634|76243766|FG002|STARTED|Test Period 1||9||
60122684|NCT02675634|76243767|FG003|STARTED|Test Period 1||9||
60122685|NCT02675634|76243768|FG004|STARTED|Test Period 1||10||
60122686|NCT02675634|76243769|FG005|STARTED|Test Period 1||9||
60122687|NCT02675634|76243764|FG000|COMPLETED|Test Period 1||10||
60122688|NCT02675634|76243765|FG001|COMPLETED|Test Period 1||7||
60122689|NCT02675634|76243766|FG002|COMPLETED|Test Period 1||8||
60122690|NCT02675634|76243767|FG003|COMPLETED|Test Period 1||8||
60122691|NCT02675634|76243768|FG004|COMPLETED|Test Period 1||10||
60122692|NCT02675634|76243769|FG005|COMPLETED|Test Period 1||9||
60122693|NCT02675634|76243764|FG000|NOT COMPLETED|Test Period 1||0||
60122694|NCT02675634|76243765|FG001|NOT COMPLETED|Test Period 1||1||
60122695|NCT02675634|76243766|FG002|NOT COMPLETED|Test Period 1||1||
60122696|NCT02675634|76243767|FG003|NOT COMPLETED|Test Period 1||1||
60122697|NCT02675634|76243768|FG004|NOT COMPLETED|Test Period 1||0||
60122698|NCT02675634|76243769|FG005|NOT COMPLETED|Test Period 1||0||
60122699|NCT02675634|76243764|FG000|STARTED|Test Period 2||10||
60122700|NCT02675634|76243765|FG001|STARTED|Test Period 2||7||
60122701|NCT02675634|76243766|FG002|STARTED|Test Period 2||8||
59996790|NCT00708461|76112649|FG001|STARTED|Overall Study||995||
59996791|NCT00708461|76112648|FG000|COMPLETED|Overall Study||611||
59996792|NCT00708461|76112649|FG001|COMPLETED|Overall Study||795||
59996793|NCT00708461|76112648|FG000|NOT COMPLETED|Overall Study||141||
59996794|NCT00708461|76112649|FG001|NOT COMPLETED|Overall Study||200||
59996795|NCT00700999|76112657|FG000|STARTED|Overall Study||36||
59996796|NCT00700999|76112658|FG001|STARTED|Overall Study||29||
59996797|NCT00700999|76112657|FG000|First MRI Scan|Overall Study||29||
59996798|NCT00700999|76112658|FG001|First MRI Scan|Overall Study||22||
59996799|NCT00700999|76112657|FG000|Second MRI Scan|Overall Study||19||
59996800|NCT00700999|76112658|FG001|Second MRI Scan|Overall Study||18||
59996801|NCT00700999|76112657|FG000|COMPLETED|Overall Study||21||
59996802|NCT00700999|76112658|FG001|COMPLETED|Overall Study||20||
59996803|NCT00700999|76112657|FG000|NOT COMPLETED|Overall Study||15||
59996804|NCT00700999|76112658|FG001|NOT COMPLETED|Overall Study||9||
59996805|NCT02729831|76112668|FG000|STARTED|Baseline (Post Decision Aid, Pre-visit)||320||
59996806|NCT02729831|76112669|FG001|STARTED|Baseline (Post Decision Aid, Pre-visit)||315||
59996807|NCT02729831|76112670|FG002|STARTED|Baseline (Post Decision Aid, Pre-visit)||293||
59996808|NCT02729831|76112671|FG003|STARTED|Baseline (Post Decision Aid, Pre-visit)||292||
60122702|NCT02675634|76243767|FG003|STARTED|Test Period 2||8||
60122703|NCT02675634|76243768|FG004|STARTED|Test Period 2||10||
60122704|NCT02675634|76243769|FG005|STARTED|Test Period 2||9||
60122705|NCT02675634|76243764|FG000|COMPLETED|Test Period 2||9||
60122706|NCT02675634|76243765|FG001|COMPLETED|Test Period 2||7||
60122707|NCT02675634|76243766|FG002|COMPLETED|Test Period 2||8||
60122708|NCT02675634|76243767|FG003|COMPLETED|Test Period 2||8||
60122709|NCT02675634|76243768|FG004|COMPLETED|Test Period 2||10||
60122710|NCT02675634|76243769|FG005|COMPLETED|Test Period 2||8||
60122711|NCT02675634|76243764|FG000|NOT COMPLETED|Test Period 2||1||
60122712|NCT02675634|76243765|FG001|NOT COMPLETED|Test Period 2||0||
60122713|NCT02675634|76243766|FG002|NOT COMPLETED|Test Period 2||0||
60122714|NCT02675634|76243767|FG003|NOT COMPLETED|Test Period 2||0||
60122715|NCT02675634|76243768|FG004|NOT COMPLETED|Test Period 2||0||
60122716|NCT02675634|76243769|FG005|NOT COMPLETED|Test Period 2||1||
60122717|NCT02675634|76243764|FG000|STARTED|Test Period 3||9||
60122718|NCT02675634|76243765|FG001|STARTED|Test Period 3||7||
60122719|NCT02675634|76243766|FG002|STARTED|Test Period 3||8||
60122720|NCT02675634|76243767|FG003|STARTED|Test Period 3||8||
60122721|NCT02675634|76243768|FG004|STARTED|Test Period 3||10||
60122722|NCT02675634|76243769|FG005|STARTED|Test Period 3||8||
60122723|NCT02675634|76243764|FG000|COMPLETED|Test Period 3||9||
60122724|NCT02675634|76243765|FG001|COMPLETED|Test Period 3||7||
60122725|NCT02675634|76243766|FG002|COMPLETED|Test Period 3||8||
60122726|NCT02675634|76243767|FG003|COMPLETED|Test Period 3||8||
60122727|NCT02675634|76243768|FG004|COMPLETED|Test Period 3||10||
60122728|NCT02675634|76243769|FG005|COMPLETED|Test Period 3||8||
60122729|NCT02675634|76243764|FG000|NOT COMPLETED|Test Period 3||0||
60122730|NCT02675634|76243765|FG001|NOT COMPLETED|Test Period 3||0||
60122731|NCT02675634|76243766|FG002|NOT COMPLETED|Test Period 3||0||
60122732|NCT02675634|76243767|FG003|NOT COMPLETED|Test Period 3||0||
60122733|NCT02675634|76243768|FG004|NOT COMPLETED|Test Period 3||0||
60122734|NCT02675634|76243769|FG005|NOT COMPLETED|Test Period 3||0||
60122735|NCT02671500|76243777|FG000|STARTED|Overall Study||375||
60122736|NCT02671500|76243777|FG000|COMPLETED|Overall Study||361||
60122737|NCT02671500|76243777|FG000|NOT COMPLETED|Overall Study||14||
60122738|NCT02671422|76243785|FG000|STARTED|Overall Study||260||
60122739|NCT02671422|76243785|FG000|Not Treated With Vargatef®|Overall Study||3||
60122740|NCT02671422|76243785|FG000|COMPLETED|Overall Study||0||
60122741|NCT02671422|76243785|FG000|NOT COMPLETED|Overall Study||260||
60122742|NCT02671266|76243791|FG000|STARTED|Overall Study||20||
60122743|NCT02671266|76243792|FG001|STARTED|Overall Study||21||
60122744|NCT02671266|76243791|FG000|BDD Participants|Overall Study||9||
60122745|NCT02671266|76243792|FG001|BDD Participants|Overall Study||9||
60122746|NCT02671266|76243791|FG000|OCD Participants|Overall Study||2||
60122747|NCT02671266|76243792|FG001|OCD Participants|Overall Study||3||
60122748|NCT02671266|76243791|FG000|Healthy Participants|Overall Study||8||
60122749|NCT02671266|76243792|FG001|Healthy Participants|Overall Study||8||
60122750|NCT02671266|76243791|FG000|COMPLETED|Overall Study||19||
60122751|NCT02671266|76243792|FG001|COMPLETED|Overall Study||20||
60122752|NCT02671266|76243791|FG000|NOT COMPLETED|Overall Study||1||
60122753|NCT02671266|76243792|FG001|NOT COMPLETED|Overall Study||1||
60122754|NCT03320070|76243800|FG000|STARTED|DBT Phase (Week 1 to Week 24)||27||
60122755|NCT03320070|76243801|FG001|STARTED|DBT Phase (Week 1 to Week 24)||28||
60122756|NCT03320070|76243800|FG000|Modified Intent-to-Treat Population (mITT)|DBT Phase (Week 1 to Week 24)||27|The mITT population included all randomized participants who received at least 1 dose of investigational medicinal product (IMP) and who contributed any efficacy data to the study.|
60122757|NCT03320070|76243801|FG001|Modified Intent-to-Treat Population (mITT)|DBT Phase (Week 1 to Week 24)||28|The mITT population included all randomized participants who received at least 1 dose of investigational medicinal product (IMP) and who contributed any efficacy data to the study.|
60122758|NCT03320070|76243800|FG000|Safety Population|DBT Phase (Week 1 to Week 24)||27|The safety population included all randomized participants who received at least 1 dose of IMP.|
60122759|NCT03320070|76243801|FG001|Safety Population|DBT Phase (Week 1 to Week 24)||28|The safety population included all randomized participants who received at least 1 dose of IMP.|
60122760|NCT03320070|76243800|FG000|COMPLETED|DBT Phase (Week 1 to Week 24)||24||
60122761|NCT03320070|76243801|FG001|COMPLETED|DBT Phase (Week 1 to Week 24)||25||
60122762|NCT03320070|76243800|FG000|NOT COMPLETED|DBT Phase (Week 1 to Week 24)||3||
60122763|NCT03320070|76243801|FG001|NOT COMPLETED|DBT Phase (Week 1 to Week 24)||3||
59726790|NCT01175018|75845520|FG000|NOT COMPLETED|Overall Study||3||
59726791|NCT01175018|75845521|FG001|NOT COMPLETED|Overall Study||1||
60122764|NCT03320070|76243800|FG000|STARTED|OLE Phase (Week 25 to Week 48)|Only participants in this arm group who opted to receive treatment in the OLE phase started this period.|22||
60122765|NCT03320070|76243801|FG001|STARTED|OLE Phase (Week 25 to Week 48)||25||
60122766|NCT03320070|76243800|FG000|Open-label Safety Population|OLE Phase (Week 25 to Week 48)||22|The open-label safety population included participants who continued into the optional OLE phase and received at least one dose of IMP during the OLE phase.|
60122767|NCT03320070|76243801|FG001|Open-label Safety Population|OLE Phase (Week 25 to Week 48)||25|The open-label safety population included participants who continued into the optional OLE phase and received at least one dose of IMP during the OLE phase.|
60122768|NCT03320070|76243800|FG000|COMPLETED|OLE Phase (Week 25 to Week 48)||17||
60122769|NCT03320070|76243801|FG001|COMPLETED|OLE Phase (Week 25 to Week 48)||23||
60122770|NCT03320070|76243800|FG000|NOT COMPLETED|OLE Phase (Week 25 to Week 48)||5||
60122771|NCT03320070|76243801|FG001|NOT COMPLETED|OLE Phase (Week 25 to Week 48)||2||
60122772|NCT02667912|76243812|FG000|STARTED|Overall Study||28||
60122773|NCT02667912|76243813|FG001|STARTED|Overall Study||27||
60122774|NCT02667912|76243812|FG000|Six Months|Overall Study||27||
60122775|NCT02667912|76243813|FG001|Six Months|Overall Study||24||
60122776|NCT02667912|76243812|FG000|COMPLETED|Overall Study||23||
60122777|NCT02667912|76243813|FG001|COMPLETED|Overall Study||24||
60122778|NCT02667912|76243812|FG000|NOT COMPLETED|Overall Study||5||
60122779|NCT02667912|76243813|FG001|NOT COMPLETED|Overall Study||3||
60122780|NCT01373346|76243819|FG000|STARTED|Overall Study||15||
60122781|NCT01373346|76243819|FG000|COMPLETED|Overall Study||14||
60122782|NCT01373346|76243819|FG000|NOT COMPLETED|Overall Study||1||
60122783|NCT03284424|76243830|FG000|STARTED|Overall Study||105||
60122784|NCT03284424|76243831|FG001|STARTED|Overall Study||54||
60122785|NCT03284424|76243830|FG000|COMPLETED|Overall Study||0||
60122786|NCT03284424|76243831|FG001|COMPLETED|Overall Study||0||
60122787|NCT03284424|76243830|FG000|NOT COMPLETED|Overall Study||105||
60122788|NCT03284424|76243831|FG001|NOT COMPLETED|Overall Study||54||
60122789|NCT02674854|76243839|FG000|STARTED|Overall Study||245||
60122790|NCT02674854|76243840|FG001|STARTED|Overall Study||255||
60122791|NCT02674854|76243841|FG002|STARTED|Overall Study||250||
60122792|NCT02674854|76243839|FG000|COMPLETED|Overall Study||221||
60122793|NCT02674854|76243840|FG001|COMPLETED|Overall Study||228||
60122794|NCT02674854|76243841|FG002|COMPLETED|Overall Study||236||
60122795|NCT02674854|76243839|FG000|NOT COMPLETED|Overall Study||24||
60122796|NCT02674854|76243840|FG001|NOT COMPLETED|Overall Study||27||
60122797|NCT02674854|76243841|FG002|NOT COMPLETED|Overall Study||14||
60122798|NCT02667288|76243849|FG000|STARTED|Overall Study||147||
60122799|NCT02667288|76243849|FG000|COMPLETED|Overall Study||134||
60122800|NCT02667288|76243849|FG000|NOT COMPLETED|Overall Study||13||
60122801|NCT02670330|76243855|FG000|STARTED|Overall Study||75||
60122802|NCT02670330|76243856|FG001|STARTED|Overall Study||77||
60122803|NCT02670330|76243855|FG000|Received At Least 1 Dose Of Study Drug|Overall Study||75|Safety Population|
60122804|NCT02670330|76243856|FG001|Received At Least 1 Dose Of Study Drug|Overall Study||77|Safety Population|
60122805|NCT02670330|76243855|FG000|COMPLETED|Overall Study||0||
60122806|NCT02670330|76243856|FG001|COMPLETED|Overall Study||0||
60122807|NCT02670330|76243855|FG000|NOT COMPLETED|Overall Study||75||
60122808|NCT02670330|76243856|FG001|NOT COMPLETED|Overall Study||77||
60122809|NCT02669940|76243864|FG000|STARTED|Overall Study||63||
60122810|NCT02669940|76243865|FG001|STARTED|Overall Study||95||
60122811|NCT02669940|76243864|FG000|COMPLETED|Overall Study||62||
60122812|NCT02669940|76243865|FG001|COMPLETED|Overall Study||92||
60122813|NCT02669940|76243864|FG000|NOT COMPLETED|Overall Study||1||
60122814|NCT02669940|76243865|FG001|NOT COMPLETED|Overall Study||3||
60122815|NCT02669862|76243881|FG000|STARTED|Overall Study||33||
60122816|NCT02669862|76243882|FG001|STARTED|Overall Study||34||
60122817|NCT02669862|76243883|FG002|STARTED|Overall Study||31||
60122818|NCT02669862|76243881|FG000|COMPLETED|Overall Study||31|Patients completing visit 10 according to protocol|
60122819|NCT02669862|76243882|FG001|COMPLETED|Overall Study||29|Patients completing visit 10 according to protocol|
60122820|NCT02669862|76243883|FG002|COMPLETED|Overall Study||26|Patients completing visit 10 according to protocol|
60122821|NCT02669862|76243881|FG000|NOT COMPLETED|Overall Study||2||
60122822|NCT02669862|76243882|FG001|NOT COMPLETED|Overall Study||5||
60122823|NCT02669862|76243883|FG002|NOT COMPLETED|Overall Study||5||
60122824|NCT01531673|76243907|FG000|STARTED|Overall Study||33||
60122825|NCT01531673|76243908|FG001|STARTED|Overall Study||8||
60122826|NCT01531673|76243909|FG002|STARTED|Overall Study||8||
60122827|NCT01531673|76243910|FG003|STARTED|Overall Study||18||
60122828|NCT01531673|76243911|FG004|STARTED|Overall Study||8||
60122829|NCT01531673|76243912|FG005|STARTED|Overall Study||19||
60122830|NCT01531673|76243913|FG006|STARTED|Overall Study||17||
60122831|NCT01531673|76243914|FG007|STARTED|Overall Study||9||
60122832|NCT01531673|76243915|FG008|STARTED|Overall Study||17||
59726792|NCT01174784|75845529|FG000|STARTED|Overall Study||88||
59726793|NCT01174784|75845529|FG000|COMPLETED|Overall Study|While 88 subjects did complete the procedure, 4 were considered screen failures post-procedure.|84||
60122833|NCT01531673|76243916|FG009|STARTED|Overall Study||19||
60122834|NCT01531673|76243917|FG010|STARTED|Overall Study||16||
60122835|NCT01531673|76243918|FG011|STARTED|Overall Study||4||
60122836|NCT01531673|76243919|FG012|STARTED|Overall Study||14||
60122837|NCT01531673|76243907|FG000|COMPLETED|Overall Study||33||
60122838|NCT01531673|76243908|FG001|COMPLETED|Overall Study||7||
60122839|NCT01531673|76243909|FG002|COMPLETED|Overall Study||8||
60122840|NCT01531673|76243910|FG003|COMPLETED|Overall Study||17||
60122841|NCT01531673|76243911|FG004|COMPLETED|Overall Study||7||
60122842|NCT01531673|76243912|FG005|COMPLETED|Overall Study||18||
60122843|NCT01531673|76243913|FG006|COMPLETED|Overall Study||17||
60122844|NCT01531673|76243914|FG007|COMPLETED|Overall Study||9||
60122845|NCT01531673|76243915|FG008|COMPLETED|Overall Study||17||
60122846|NCT01531673|76243916|FG009|COMPLETED|Overall Study||18||
60122847|NCT01531673|76243917|FG010|COMPLETED|Overall Study||16||
60122848|NCT01531673|76243918|FG011|COMPLETED|Overall Study||4||
60122849|NCT01531673|76243919|FG012|COMPLETED|Overall Study||14||
60122850|NCT01531673|76243907|FG000|NOT COMPLETED|Overall Study||0||
60122851|NCT01531673|76243908|FG001|NOT COMPLETED|Overall Study||1||
60122852|NCT01531673|76243909|FG002|NOT COMPLETED|Overall Study||0||
60122853|NCT01531673|76243910|FG003|NOT COMPLETED|Overall Study||1||
60122854|NCT01531673|76243911|FG004|NOT COMPLETED|Overall Study||1||
60122855|NCT01531673|76243912|FG005|NOT COMPLETED|Overall Study||1||
60122856|NCT01531673|76243913|FG006|NOT COMPLETED|Overall Study||0||
60122857|NCT01531673|76243914|FG007|NOT COMPLETED|Overall Study||0||
60122858|NCT01531673|76243915|FG008|NOT COMPLETED|Overall Study||0||
60122859|NCT01531673|76243916|FG009|NOT COMPLETED|Overall Study||1||
60122860|NCT01531673|76243917|FG010|NOT COMPLETED|Overall Study||0||
60122861|NCT01531673|76243918|FG011|NOT COMPLETED|Overall Study||0||
60122862|NCT01531673|76243919|FG012|NOT COMPLETED|Overall Study||0||
60122863|NCT01531205|76243971|FG000|STARTED|Overall Study||2||
60122864|NCT01531205|76243971|FG000|COMPLETED|Overall Study||1||
60122865|NCT01531205|76243971|FG000|NOT COMPLETED|Overall Study||1||
60122866|NCT01529645|76243987|FG000|STARTED|Overall Study||42||
60122867|NCT01529645|76243988|FG001|STARTED|Overall Study||42||
60122868|NCT01529645|76243989|FG002|STARTED|Overall Study||42||
60122869|NCT01529645|76243990|FG003|STARTED|Overall Study||42||
60122870|NCT01529645|76243991|FG004|STARTED|Overall Study||42||
60122871|NCT01529645|76243992|FG005|STARTED|Overall Study||42||
60122872|NCT01529645|76243993|FG006|STARTED|Overall Study||42||
60122873|NCT01529645|76243994|FG007|STARTED|Overall Study||42||
60122874|NCT01529645|76243995|FG008|STARTED|Overall Study||42||
60122875|NCT01529645|76243996|FG009|STARTED|Overall Study||42||
60122876|NCT01529645|76243987|FG000|COMPLETED|Overall Study||40||
60122877|NCT01529645|76243988|FG001|COMPLETED|Overall Study||41||
60122878|NCT01529645|76243989|FG002|COMPLETED|Overall Study||40||
60122879|NCT01529645|76243990|FG003|COMPLETED|Overall Study||40||
60122880|NCT01529645|76243991|FG004|COMPLETED|Overall Study||40||
60122881|NCT01529645|76243992|FG005|COMPLETED|Overall Study||41||
60122882|NCT01529645|76243993|FG006|COMPLETED|Overall Study||40||
60122883|NCT01529645|76243994|FG007|COMPLETED|Overall Study||42||
60122884|NCT01529645|76243995|FG008|COMPLETED|Overall Study||41||
60122885|NCT01529645|76243996|FG009|COMPLETED|Overall Study||42||
60122886|NCT01529645|76243987|FG000|NOT COMPLETED|Overall Study||2||
60122887|NCT01529645|76243988|FG001|NOT COMPLETED|Overall Study||1||
60122888|NCT01529645|76243989|FG002|NOT COMPLETED|Overall Study||2||
60122889|NCT01529645|76243990|FG003|NOT COMPLETED|Overall Study||2||
60122890|NCT01529645|76243991|FG004|NOT COMPLETED|Overall Study||2||
60122891|NCT01529645|76243992|FG005|NOT COMPLETED|Overall Study||1||
60122892|NCT01529645|76243993|FG006|NOT COMPLETED|Overall Study||2||
60122893|NCT01529645|76243994|FG007|NOT COMPLETED|Overall Study||0||
60122894|NCT01529645|76243995|FG008|NOT COMPLETED|Overall Study||1||
60122895|NCT01529645|76243996|FG009|NOT COMPLETED|Overall Study||0||
60122896|NCT01528787|76244030|FG000|STARTED|Overall Study||22||
60122897|NCT01528787|76244031|FG001|STARTED|Overall Study||21||
60122898|NCT01528787|76244032|FG002|STARTED|Overall Study||19||
60122899|NCT01528787|76244033|FG003|STARTED|Overall Study||23||
60122900|NCT01528787|76244030|FG000|COMPLETED|Overall Study||22||
60122901|NCT01528787|76244031|FG001|COMPLETED|Overall Study||21||
60122902|NCT01528787|76244032|FG002|COMPLETED|Overall Study||18||
60122903|NCT01528787|76244033|FG003|COMPLETED|Overall Study||22||
60122904|NCT01528787|76244030|FG000|NOT COMPLETED|Overall Study||0||
60122905|NCT01528787|76244031|FG001|NOT COMPLETED|Overall Study||0||
60122906|NCT01528787|76244032|FG002|NOT COMPLETED|Overall Study||1||
60122907|NCT01528787|76244033|FG003|NOT COMPLETED|Overall Study||1||
60122908|NCT01528709|76244045|FG000|STARTED|Overall Study||86||
60122909|NCT01528709|76244046|FG001|STARTED|Overall Study||87||
60122910|NCT01528709|76244045|FG000|COMPLETED|Overall Study||73||
60122911|NCT01528709|76244046|FG001|COMPLETED|Overall Study||72||
60122912|NCT01528709|76244045|FG000|NOT COMPLETED|Overall Study||13||
60122913|NCT01528709|76244046|FG001|NOT COMPLETED|Overall Study||15||
60122914|NCT01527383|76244054|FG000|STARTED|Overall Study||292||
60122915|NCT01527383|76244055|FG001|STARTED|Overall Study||62||
60122916|NCT01527383|76244054|FG000|Vaccination 1 (Day 1)|Overall Study||291||
60122917|NCT01527383|76244055|FG001|Vaccination 1 (Day 1)|Overall Study||62||
59592926|NCT02845700|75701270|FG000|STARTED|Month 1 Follow-Up|3 participants withdrew after completing the Intervention 2 Appointment|2||
59726794|NCT01174784|75845529|FG000|NOT COMPLETED|Overall Study||4||
59726795|NCT01174550|75845536|FG000|STARTED|Overall Study||5007||
59726796|NCT01174550|75845537|FG001|STARTED|Overall Study||4996||
60122918|NCT01527383|76244054|FG000|Vaccination 2 (~Day 30)|Overall Study||283||
60122919|NCT01527383|76244055|FG001|Vaccination 2 (~Day 30)|Overall Study||61||
59726797|NCT01174550|75845536|FG000|COMPLETED|Overall Study||3737||
60122920|NCT01527383|76244054|FG000|Vaccination 3 (~Day 60)|Overall Study||278||
60122921|NCT01527383|76244055|FG001|Vaccination 3 (~Day 60)|Overall Study||58||
60122922|NCT01527383|76244054|FG000|Vaccination 4 (~Day 90)|Overall Study||277||
60122923|NCT01527383|76244055|FG001|Vaccination 4 (~Day 90)|Overall Study||58||
60122924|NCT01527383|76244054|FG000|COMPLETED|Overall Study||277||
60122925|NCT01527383|76244055|FG001|COMPLETED|Overall Study||58||
60122926|NCT01527383|76244054|FG000|NOT COMPLETED|Overall Study||15||
60122927|NCT01527383|76244055|FG001|NOT COMPLETED|Overall Study||4||
60122928|NCT01526057|76244064|FG000|STARTED|Overall Study||73||
60122929|NCT01526057|76244065|FG001|STARTED|Overall Study||74||
60122930|NCT01526057|76244066|FG002|STARTED|Overall Study||73||
60122931|NCT01526057|76244064|FG000|COMPLETED|Overall Study||64||
60122932|NCT01526057|76244065|FG001|COMPLETED|Overall Study||71||
60122933|NCT01526057|76244066|FG002|COMPLETED|Overall Study||67||
60122934|NCT01526057|76244064|FG000|NOT COMPLETED|Overall Study||9||
60122935|NCT01526057|76244065|FG001|NOT COMPLETED|Overall Study||3||
60122936|NCT01526057|76244066|FG002|NOT COMPLETED|Overall Study||6||
60122937|NCT01525901|76244078|FG000|STARTED|Period 1: 12 Weeks||5||
60122938|NCT01525901|76244079|FG001|STARTED|Period 1: 12 Weeks||4||
60122939|NCT01525901|76244080|FG002|STARTED|Period 1: 12 Weeks||5||
60122940|NCT01525901|76244081|FG003|STARTED|Period 1: 12 Weeks||5||
60122941|NCT01525901|76244078|FG000|COMPLETED|Period 1: 12 Weeks||5||
60122942|NCT01525901|76244079|FG001|COMPLETED|Period 1: 12 Weeks||4||
60122943|NCT01525901|76244080|FG002|COMPLETED|Period 1: 12 Weeks||5||
60122944|NCT01525901|76244081|FG003|COMPLETED|Period 1: 12 Weeks||5||
60122945|NCT01525901|76244078|FG000|NOT COMPLETED|Period 1: 12 Weeks||0||
60122946|NCT01525901|76244079|FG001|NOT COMPLETED|Period 1: 12 Weeks||0||
60122947|NCT01525901|76244080|FG002|NOT COMPLETED|Period 1: 12 Weeks||0||
60122948|NCT01525901|76244081|FG003|NOT COMPLETED|Period 1: 12 Weeks||0||
60122949|NCT01525901|76244078|FG000|STARTED|Washout 4 Weeks||5||
60122950|NCT01525901|76244079|FG001|STARTED|Washout 4 Weeks||4||
60122951|NCT01525901|76244080|FG002|STARTED|Washout 4 Weeks||5||
60122952|NCT01525901|76244081|FG003|STARTED|Washout 4 Weeks||5||
60122953|NCT01525901|76244078|FG000|COMPLETED|Washout 4 Weeks||5||
60122954|NCT01525901|76244079|FG001|COMPLETED|Washout 4 Weeks||4||
60122955|NCT01525901|76244080|FG002|COMPLETED|Washout 4 Weeks||5||
60122956|NCT01525901|76244081|FG003|COMPLETED|Washout 4 Weeks||5||
60122957|NCT01525901|76244078|FG000|NOT COMPLETED|Washout 4 Weeks||0||
60122958|NCT01525901|76244079|FG001|NOT COMPLETED|Washout 4 Weeks||0||
60122959|NCT01525901|76244080|FG002|NOT COMPLETED|Washout 4 Weeks||0||
60122960|NCT01525901|76244081|FG003|NOT COMPLETED|Washout 4 Weeks||0||
60122961|NCT01525901|76244078|FG000|STARTED|Period 2: 12 Weeks||5||
60122962|NCT01525901|76244079|FG001|STARTED|Period 2: 12 Weeks||4||
60122963|NCT01525901|76244080|FG002|STARTED|Period 2: 12 Weeks||5||
60122964|NCT01525901|76244081|FG003|STARTED|Period 2: 12 Weeks||5||
60122965|NCT01525901|76244078|FG000|COMPLETED|Period 2: 12 Weeks||5||
60122966|NCT01525901|76244079|FG001|COMPLETED|Period 2: 12 Weeks||3||
60122967|NCT01525901|76244080|FG002|COMPLETED|Period 2: 12 Weeks||5||
60122968|NCT01525901|76244081|FG003|COMPLETED|Period 2: 12 Weeks||5||
60122969|NCT01525901|76244078|FG000|NOT COMPLETED|Period 2: 12 Weeks||0||
60122970|NCT01525901|76244079|FG001|NOT COMPLETED|Period 2: 12 Weeks||1||
60122971|NCT01525901|76244080|FG002|NOT COMPLETED|Period 2: 12 Weeks||0||
60122972|NCT01525901|76244081|FG003|NOT COMPLETED|Period 2: 12 Weeks||0||
60122973|NCT00123123|76244094|FG000|STARTED|Overall Study||59||
60122974|NCT00123123|76244095|FG001|STARTED|Overall Study||58||
60122975|NCT00123123|76244096|FG002|STARTED|Overall Study||58||
60122976|NCT00123123|76244094|FG000|COMPLETED|Overall Study||59||
60122977|NCT00123123|76244095|FG001|COMPLETED|Overall Study||58||
60122978|NCT00123123|76244096|FG002|COMPLETED|Overall Study||58||
60122979|NCT00123123|76244094|FG000|NOT COMPLETED|Overall Study||0||
60122980|NCT00123123|76244095|FG001|NOT COMPLETED|Overall Study||0||
60122981|NCT00123123|76244096|FG002|NOT COMPLETED|Overall Study||0||
60122982|NCT00262509|76244106|FG000|STARTED|Overall Study||8||
60122983|NCT00262509|76244107|FG001|STARTED|Overall Study||9||
60122984|NCT00262509|76244106|FG000|COMPLETED|Overall Study||8||
60122985|NCT00262509|76244107|FG001|COMPLETED|Overall Study||9||
60122986|NCT00262509|76244106|FG000|NOT COMPLETED|Overall Study||0||
60122987|NCT00262509|76244107|FG001|NOT COMPLETED|Overall Study||0||
60122988|NCT00242385|76244113|FG000|STARTED|Period 1||14||
60122989|NCT00242385|76244114|FG001|STARTED|Period 1||11||
60122990|NCT00242385|76244113|FG000|COMPLETED|Period 1||14||
60122991|NCT00242385|76244114|FG001|COMPLETED|Period 1||11||
60122992|NCT00242385|76244113|FG000|NOT COMPLETED|Period 1||0||
60122993|NCT00242385|76244114|FG001|NOT COMPLETED|Period 1||0||
60122994|NCT00242385|76244113|FG000|STARTED|Period 2||14||
60122995|NCT00242385|76244114|FG001|STARTED|Period 2||11||
60122996|NCT00242385|76244113|FG000|COMPLETED|Period 2||14||
60122997|NCT00242385|76244114|FG001|COMPLETED|Period 2||11||
60122998|NCT00242385|76244113|FG000|NOT COMPLETED|Period 2||0||
60122999|NCT00242385|76244114|FG001|NOT COMPLETED|Period 2||0||
60123000|NCT00242619|76244122|FG000|STARTED|Overall Study||8||
60123001|NCT00242619|76244123|FG001|STARTED|Overall Study||4||
60123002|NCT00242619|76244122|FG000|COMPLETED|Overall Study||8||
60123003|NCT00242619|76244123|FG001|COMPLETED|Overall Study||4||
60123004|NCT00242619|76244122|FG000|NOT COMPLETED|Overall Study||0||
60123005|NCT00242619|76244123|FG001|NOT COMPLETED|Overall Study||0||
60123006|NCT00264381|76244133|FG000|STARTED|Overall Study||35||
60123007|NCT00264381|76244134|FG001|STARTED|Overall Study||37||
60123008|NCT00264381|76244133|FG000|COMPLETED|Overall Study||35||
60123009|NCT00264381|76244134|FG001|COMPLETED|Overall Study||37||
60123010|NCT00264381|76244133|FG000|NOT COMPLETED|Overall Study||0||
60123011|NCT00264381|76244134|FG001|NOT COMPLETED|Overall Study||0||
60123012|NCT00243243|76244142|FG000|STARTED|Overall Study||10||
60123013|NCT00243243|76244143|FG001|STARTED|Overall Study||10||
60123014|NCT00243243|76244142|FG000|COMPLETED|Overall Study||10||
60123015|NCT00243243|76244143|FG001|COMPLETED|Overall Study||10||
60123016|NCT00243243|76244142|FG000|NOT COMPLETED|Overall Study||0||
60123017|NCT00243243|76244143|FG001|NOT COMPLETED|Overall Study||0||
60123018|NCT00265473|76244149|FG000|STARTED|Overall Study||5||
60123019|NCT00265473|76244149|FG000|COMPLETED|Overall Study||5||
60123020|NCT00265473|76244149|FG000|NOT COMPLETED|Overall Study||0||
60123021|NCT00246441|76244156|FG000|STARTED|Overall Study||20||
60123022|NCT00246441|76244157|FG001|STARTED|Overall Study||22||
60123023|NCT00246441|76244156|FG000|COMPLETED|Overall Study||19||
60123024|NCT00246441|76244157|FG001|COMPLETED|Overall Study||22||
60123025|NCT00246441|76244156|FG000|NOT COMPLETED|Overall Study||1||
60123026|NCT00246441|76244157|FG001|NOT COMPLETED|Overall Study||0||
60123027|NCT00246519|76244165|FG000|STARTED|Overall Study||442||
60123028|NCT00246519|76244166|FG001|STARTED|Overall Study||446||
60123029|NCT00246519|76244165|FG000|COMPLETED|Overall Study||386||
60123030|NCT00246519|76244166|FG001|COMPLETED|Overall Study||382||
60123031|NCT00246519|76244165|FG000|NOT COMPLETED|Overall Study||56||
60123032|NCT00246519|76244166|FG001|NOT COMPLETED|Overall Study||64||
60123033|NCT00125619|76244174|FG000|STARTED|Overall Study||8||
60123034|NCT00125619|76244175|FG001|STARTED|Overall Study||8||
60123035|NCT00125619|76244174|FG000|COMPLETED|Overall Study||8||
60123036|NCT00125619|76244175|FG001|COMPLETED|Overall Study||8||
60123037|NCT00125619|76244174|FG000|NOT COMPLETED|Overall Study||0||
60123038|NCT00125619|76244175|FG001|NOT COMPLETED|Overall Study||0||
60123039|NCT00248547|76244184|FG000|STARTED|Overall Study||20||
60123040|NCT00248547|76244185|FG001|STARTED|Overall Study||20||
60123041|NCT00248547|76244184|FG000|COMPLETED|Overall Study||20||
60123042|NCT00248547|76244185|FG001|COMPLETED|Overall Study||20||
60123043|NCT00248547|76244184|FG000|NOT COMPLETED|Overall Study||0||
60123044|NCT00248547|76244185|FG001|NOT COMPLETED|Overall Study||0||
60123045|NCT01525589|76244194|FG000|STARTED|Overall Study||56||
60123046|NCT01525589|76244195|FG001|STARTED|Overall Study||20||
60123047|NCT01525589|76244196|FG002|STARTED|Overall Study||35||
60123048|NCT01525589|76244194|FG000|COMPLETED|Overall Study||0||
60123049|NCT01525589|76244195|FG001|COMPLETED|Overall Study||0||
60123050|NCT01525589|76244196|FG002|COMPLETED|Overall Study||0||
60123051|NCT01525589|76244194|FG000|NOT COMPLETED|Overall Study||56||
60123052|NCT01525589|76244195|FG001|NOT COMPLETED|Overall Study||20||
60123053|NCT01525589|76244196|FG002|NOT COMPLETED|Overall Study||35||
60123054|NCT01524887|76244207|FG000|STARTED|Overall Study||85||
60123055|NCT01524887|76244208|FG001|STARTED|Overall Study||90||
60123056|NCT01524887|76244209|FG002|STARTED|Overall Study||86||
60123057|NCT01524887|76244207|FG000|Received Treatment|Overall Study||83||
60123058|NCT01524887|76244208|FG001|Received Treatment|Overall Study||85||
60123059|NCT01524887|76244209|FG002|Received Treatment|Overall Study||83||
60123060|NCT01524887|76244207|FG000|COMPLETED|Overall Study|No subject completed the study as Baxter Healthcare terminated the study early.|0||
60123061|NCT01524887|76244208|FG001|COMPLETED|Overall Study|No subject completed the study as Baxter Healthcare terminated the study early.|0||
60123062|NCT01524887|76244209|FG002|COMPLETED|Overall Study|No subject completed the study as Baxter Healthcare terminated the study early.|0||
60123063|NCT01524887|76244207|FG000|NOT COMPLETED|Overall Study||85||
60123064|NCT01524887|76244208|FG001|NOT COMPLETED|Overall Study||90||
60123065|NCT01524887|76244209|FG002|NOT COMPLETED|Overall Study||86||
60123066|NCT00266799|76244219|FG000|STARTED|Overall Study||98||
60123067|NCT00266799|76244220|FG001|STARTED|Overall Study||102||
60123068|NCT00266799|76244219|FG000|COMPLETED|Overall Study||62||
60123069|NCT00266799|76244220|FG001|COMPLETED|Overall Study||68||
60123070|NCT00266799|76244219|FG000|NOT COMPLETED|Overall Study||36||
60123071|NCT00266799|76244220|FG001|NOT COMPLETED|Overall Study||34||
60123072|NCT00248781|76244228|FG000|STARTED|Overall Study||52||
60123073|NCT00248781|76244229|FG001|STARTED|Overall Study||51||
60123074|NCT00248781|76244228|FG000|COMPLETED|Overall Study||42||
60123075|NCT00248781|76244229|FG001|COMPLETED|Overall Study||47||
59592927|NCT02845700|75701271|FG001|STARTED|Month 1 Follow-Up|2 participants withdrew after completing the Intervention 2 Appointment|4||
59726798|NCT01174550|75845537|FG001|COMPLETED|Overall Study||4123||
60123076|NCT00248781|76244228|FG000|NOT COMPLETED|Overall Study||10||
60123077|NCT00248781|76244229|FG001|NOT COMPLETED|Overall Study||4||
60123078|NCT01523873|76244235|FG000|STARTED|Overall Study||35921||
60123079|NCT01523873|76244235|FG000|Administered With Dotarem|Overall Study||35474||
59592928|NCT02845700|75701270|FG000|COMPLETED|Month 1 Follow-Up||2||
59726799|NCT01174550|75845536|FG000|NOT COMPLETED|Overall Study||1270||
60123080|NCT01523873|76244235|FG000|COMPLETED|Overall Study||35499||
60123081|NCT01523873|76244235|FG000|NOT COMPLETED|Overall Study||422||
60123082|NCT00249249|76244245|FG000|STARTED|Overall Study||321||
60123083|NCT00249249|76244246|FG001|STARTED|Overall Study||103||
60123084|NCT00249249|76244247|FG002|STARTED|Overall Study||303||
60123085|NCT00249249|76244248|FG003|STARTED|Overall Study||103||
60123086|NCT00249249|76244245|FG000|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|316||
60123087|NCT00249249|76244246|FG001|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|102||
60123088|NCT00249249|76244247|FG002|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|300||
60123089|NCT00249249|76244248|FG003|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|103||
60123090|NCT00249249|76244245|FG000|COMPLETED|Overall Study||301||
60123091|NCT00249249|76244246|FG001|COMPLETED|Overall Study||98||
60123092|NCT00249249|76244247|FG002|COMPLETED|Overall Study||288||
60123093|NCT00249249|76244248|FG003|COMPLETED|Overall Study||100||
60123094|NCT00249249|76244245|FG000|NOT COMPLETED|Overall Study||20||
60123095|NCT00249249|76244246|FG001|NOT COMPLETED|Overall Study||5||
60123096|NCT00249249|76244247|FG002|NOT COMPLETED|Overall Study||15||
60123097|NCT00249249|76244248|FG003|NOT COMPLETED|Overall Study||3||
60123098|NCT01522235|76244260|FG000|STARTED|Overall Study||3||
60123099|NCT01522235|76244261|FG001|STARTED|Overall Study||3||
60123100|NCT01522235|76244260|FG000|Randomized|Overall Study||2||
60123101|NCT01522235|76244261|FG001|Randomized|Overall Study||3||
60123102|NCT01522235|76244260|FG000|COMPLETED|Overall Study||2||
60123103|NCT01522235|76244261|FG001|COMPLETED|Overall Study||2||
60123104|NCT01522235|76244260|FG000|NOT COMPLETED|Overall Study||1||
60123105|NCT01522235|76244261|FG001|NOT COMPLETED|Overall Study||1||
60123106|NCT00250497|76244273|FG000|STARTED|Overall Study||182||
60123107|NCT00250497|76244274|FG001|STARTED|Overall Study||174||
60123108|NCT00250497|76244273|FG000|COMPLETED|Overall Study||177||
60123109|NCT00250497|76244274|FG001|COMPLETED|Overall Study||159||
60123110|NCT00250497|76244273|FG000|NOT COMPLETED|Overall Study||5||
60123111|NCT00250497|76244274|FG001|NOT COMPLETED|Overall Study||15||
60123112|NCT00125931|76244280|FG000|STARTED|Overall Study||10||
60123113|NCT00125931|76244280|FG000|COMPLETED|Overall Study||10||
60123114|NCT00125931|76244280|FG000|NOT COMPLETED|Overall Study||0||
60123115|NCT00267111|76244286|FG000|STARTED|Overall Study||55||
60123116|NCT00267111|76244287|FG001|STARTED|Overall Study||55||
60123117|NCT00267111|76244286|FG000|COMPLETED|Overall Study||55||
60123118|NCT00267111|76244287|FG001|COMPLETED|Overall Study||55||
60123119|NCT00267111|76244286|FG000|NOT COMPLETED|Overall Study||0||
60123120|NCT00267111|76244287|FG001|NOT COMPLETED|Overall Study||0||
60123121|NCT01521923|76244298|FG000|STARTED|Overall Study||66||
60123122|NCT01521923|76244299|FG001|STARTED|Overall Study||81||
60123123|NCT01521923|76244300|FG002|STARTED|Overall Study||127||
60123124|NCT01521923|76244301|FG003|STARTED|Overall Study||83||
60123125|NCT01521923|76244298|FG000|COMPLETED|Overall Study||59||
60123126|NCT01521923|76244299|FG001|COMPLETED|Overall Study||72||
60123127|NCT01521923|76244300|FG002|COMPLETED|Overall Study||112||
60123128|NCT01521923|76244301|FG003|COMPLETED|Overall Study||70||
60123129|NCT01521923|76244298|FG000|NOT COMPLETED|Overall Study||7||
60123130|NCT01521923|76244299|FG001|NOT COMPLETED|Overall Study||9||
60123131|NCT01521923|76244300|FG002|NOT COMPLETED|Overall Study||15||
59592929|NCT02845700|75701271|FG001|COMPLETED|Month 1 Follow-Up||4||
59592930|NCT02845700|75701270|FG000|NOT COMPLETED|Month 1 Follow-Up||0||
59592931|NCT02845700|75701271|FG001|NOT COMPLETED|Month 1 Follow-Up||0||
59592932|NCT03043885|75701281|FG000|STARTED|Overall Study||10||
59592933|NCT03043885|75701282|FG001|STARTED|Overall Study||10||
59592934|NCT03043885|75701283|FG002|STARTED|Overall Study||10||
59592935|NCT03043885|75701284|FG003|STARTED|Overall Study||10||
59592936|NCT03043885|75701281|FG000|COMPLETED|Overall Study||10||
59592937|NCT03043885|75701282|FG001|COMPLETED|Overall Study||10||
59592938|NCT03043885|75701283|FG002|COMPLETED|Overall Study||10||
59592939|NCT03043885|75701284|FG003|COMPLETED|Overall Study||10||
59592940|NCT03043885|75701281|FG000|NOT COMPLETED|Overall Study||0||
59592941|NCT03043885|75701282|FG001|NOT COMPLETED|Overall Study||0||
59592942|NCT03043885|75701283|FG002|NOT COMPLETED|Overall Study||0||
59592943|NCT03043885|75701284|FG003|NOT COMPLETED|Overall Study||0||
59592944|NCT02810509|75701296|FG000|STARTED|Overall Study||584||
59592945|NCT02810509|75701297|FG001|STARTED|Overall Study||1230||
59592946|NCT02810509|75701296|FG000|COMPLETED|Overall Study||584||
59592947|NCT02810509|75701297|FG001|COMPLETED|Overall Study||1230||
59592948|NCT02810509|75701296|FG000|NOT COMPLETED|Overall Study||0||
59592949|NCT02810509|75701297|FG001|NOT COMPLETED|Overall Study||0||
60123132|NCT01521923|76244301|FG003|NOT COMPLETED|Overall Study||13||
59726800|NCT01174550|75845537|FG001|NOT COMPLETED|Overall Study||873||
59726801|NCT01008150|75845547|FG000|STARTED|Overall Study||43||
60123133|NCT00128193|76244326|FG000|STARTED|Overall Study||5||
60123134|NCT00128193|76244327|FG001|STARTED|Overall Study||5||
60123135|NCT00128193|76244328|FG002|STARTED|Overall Study||45||
60123136|NCT00128193|76244329|FG003|STARTED|Overall Study||45||
60123137|NCT00128193|76244330|FG004|STARTED|Overall Study||20||
60123138|NCT00128193|76244331|FG005|STARTED|Overall Study||20||
60123139|NCT00128193|76244332|FG006|STARTED|Overall Study||20||
60123140|NCT00128193|76244333|FG007|STARTED|Overall Study||20||
60123141|NCT00128193|76244334|FG008|STARTED|Overall Study||20||
60123142|NCT00128193|76244335|FG009|STARTED|Overall Study||20||
60123143|NCT00128193|76244336|FG010|STARTED|Overall Study||20||
60123144|NCT00128193|76244337|FG011|STARTED|Overall Study||20||
60123145|NCT00128193|76244326|FG000|COMPLETED|Overall Study||5||
59592950|NCT02961062|75701307|FG000|STARTED|Overall Study||20||
59592951|NCT02961062|75701308|FG001|STARTED|Overall Study||20||
59592952|NCT02961062|75701307|FG000|COMPLETED|Overall Study||20||
59592953|NCT02961062|75701308|FG001|COMPLETED|Overall Study||20||
59592954|NCT02961062|75701307|FG000|NOT COMPLETED|Overall Study||0||
59592955|NCT02961062|75701308|FG001|NOT COMPLETED|Overall Study||0||
60123146|NCT00128193|76244327|FG001|COMPLETED|Overall Study||5||
59592956|NCT02962934|75701316|FG000|STARTED|Overall Study||12||
59592957|NCT02962934|75701317|FG001|STARTED|Overall Study||6||
59592958|NCT02962934|75701316|FG000|COMPLETED|Overall Study||12||
59592959|NCT02962934|75701317|FG001|COMPLETED|Overall Study||6||
59592960|NCT02962934|75701316|FG000|NOT COMPLETED|Overall Study||0||
59592961|NCT02962934|75701317|FG001|NOT COMPLETED|Overall Study||0||
59592962|NCT02919007|75701323|FG000|STARTED|Overall Study||25||
59592963|NCT02919007|75701323|FG000|COMPLETED|Overall Study||25||
59592964|NCT02919007|75701323|FG000|NOT COMPLETED|Overall Study||0||
59592965|NCT02811445|75701329|FG000|STARTED|Overall Study||18||
59592966|NCT02811445|75701330|FG001|STARTED|Overall Study||11||
59592967|NCT02811445|75701329|FG000|COMPLETED|Overall Study||18||
59592968|NCT02811445|75701330|FG001|COMPLETED|Overall Study||11||
59592969|NCT02811445|75701329|FG000|NOT COMPLETED|Overall Study||0||
59592970|NCT02811445|75701330|FG001|NOT COMPLETED|Overall Study||0||
59592971|NCT02964416|75701338|FG000|STARTED|Overall Study||39||
59592972|NCT02964416|75701339|FG001|STARTED|Overall Study||41||
59592973|NCT02964416|75701338|FG000|COMPLETED|Overall Study||38||
59592974|NCT02964416|75701339|FG001|COMPLETED|Overall Study||41||
59592975|NCT02964416|75701338|FG000|NOT COMPLETED|Overall Study||1||
59592976|NCT02964416|75701339|FG001|NOT COMPLETED|Overall Study||0||
59592977|NCT02812771|75701346|FG000|STARTED|Overall Study||62||
59592978|NCT02812771|75701346|FG000|COMPLETED|Overall Study||50||
59592979|NCT02812771|75701346|FG000|NOT COMPLETED|Overall Study||12||
59592980|NCT02967458|75701350|FG000|STARTED|Overall Study||55||
59592981|NCT02967458|75701350|FG000|COMPLETED|Overall Study||55||
59592982|NCT02967458|75701350|FG000|NOT COMPLETED|Overall Study||0||
59592983|NCT03046225|75701357|FG000|STARTED|Overall Study||13||
59592984|NCT03046225|75701358|FG001|STARTED|Overall Study||13||
59592985|NCT03046225|75701357|FG000|COMPLETED|Overall Study||13||
59592986|NCT03046225|75701358|FG001|COMPLETED|Overall Study||13||
59592987|NCT03046225|75701357|FG000|NOT COMPLETED|Overall Study||0||
59592988|NCT03046225|75701358|FG001|NOT COMPLETED|Overall Study||0||
59592989|NCT02813473|75701364|FG000|STARTED|Overall Study||223||
59592990|NCT02813473|75701364|FG000|COMPLETED|Overall Study||223||
59592991|NCT02813473|75701364|FG000|NOT COMPLETED|Overall Study||0||
59592992|NCT02969876|75701368|FG000|STARTED|Overall Study||2||
59592993|NCT02969876|75701368|FG000|COMPLETED|Overall Study||2||
59592994|NCT02969876|75701368|FG000|NOT COMPLETED|Overall Study||0||
59592995|NCT02970032|75701373|FG000|STARTED|Standard Heparin Dose||20||
59592996|NCT02970032|75701373|FG000|COMPLETED|Standard Heparin Dose||20||
59592997|NCT02970032|75701373|FG000|NOT COMPLETED|Standard Heparin Dose||0||
59592998|NCT02970032|75701373|FG000|STARTED|Real Time Heparin Dose Adjustment||20||
59592999|NCT02970032|75701373|FG000|COMPLETED|Real Time Heparin Dose Adjustment||20||
59593000|NCT02970032|75701373|FG000|NOT COMPLETED|Real Time Heparin Dose Adjustment||0||
59593001|NCT02813551|75701380|FG000|STARTED|Overall Study||59||
59593002|NCT02813551|75701381|FG001|STARTED|Overall Study||59||
59593003|NCT02813551|75701380|FG000|COMPLETED|Overall Study||58||
59593004|NCT02813551|75701381|FG001|COMPLETED|Overall Study||57||
59593005|NCT02813551|75701380|FG000|NOT COMPLETED|Overall Study||1||
59593006|NCT02813551|75701381|FG001|NOT COMPLETED|Overall Study||2||
59593007|NCT02970422|75701387|FG000|STARTED|Overall Study||200||
59593008|NCT02970422|75701387|FG000|COMPLETED|Overall Study||200||
59593009|NCT02970422|75701387|FG000|NOT COMPLETED|Overall Study||0||
59593010|NCT02817763|75701412|FG000|STARTED|Overall Study||20||
59593011|NCT02817763|75701413|FG001|STARTED|Overall Study||20||
59593012|NCT02817763|75701412|FG000|COMPLETED|Overall Study||20||
59593013|NCT02817763|75701413|FG001|COMPLETED|Overall Study||20||
59593014|NCT02817763|75701412|FG000|NOT COMPLETED|Overall Study||0||
59593015|NCT02817763|75701413|FG001|NOT COMPLETED|Overall Study||0||
59593016|NCT03049501|75701421|FG000|STARTED|Overall Study||123||
59593017|NCT03049501|75701422|FG001|STARTED|Overall Study||121||
59593018|NCT03049501|75701421|FG000|6 Month Follow up|Overall Study||107||
59593019|NCT03049501|75701422|FG001|6 Month Follow up|Overall Study||91||
59593020|NCT03049501|75701421|FG000|12 Month Follow up|Overall Study||101||
59593021|NCT03049501|75701422|FG001|12 Month Follow up|Overall Study||92||
59593022|NCT03049501|75701421|FG000|COMPLETED|Overall Study||101||
59593023|NCT03049501|75701422|FG001|COMPLETED|Overall Study||92||
59726802|NCT01008150|75845548|FG001|STARTED|Overall Study||43||
59593024|NCT03049501|75701421|FG000|NOT COMPLETED|Overall Study||22||
59593025|NCT03049501|75701422|FG001|NOT COMPLETED|Overall Study||29||
59593026|NCT03050203|75701430|FG000|STARTED|Overall Study||19||
59593027|NCT03050203|75701431|FG001|STARTED|Overall Study||18||
59593028|NCT03050203|75701430|FG000|COMPLETED|Overall Study||19||
59593029|NCT03050203|75701431|FG001|COMPLETED|Overall Study||18||
59593030|NCT03050203|75701430|FG000|NOT COMPLETED|Overall Study||0||
59593031|NCT03050203|75701431|FG001|NOT COMPLETED|Overall Study||0||
59593032|NCT02970812|75701439|FG000|STARTED|Overall Study||30||
59593033|NCT02970812|75701440|FG001|STARTED|Overall Study||30||
59593034|NCT02970812|75701439|FG000|COMPLETED|Overall Study||22||
59593035|NCT02970812|75701440|FG001|COMPLETED|Overall Study||28||
59593036|NCT02970812|75701439|FG000|NOT COMPLETED|Overall Study||8||
59593037|NCT02970812|75701440|FG001|NOT COMPLETED|Overall Study||2||
59593038|NCT02846714|75701446|FG000|STARTED|Overall Study||42||
59593039|NCT02846714|75701446|FG000|COMPLETED|Overall Study||36||
59593040|NCT02846714|75701446|FG000|NOT COMPLETED|Overall Study||6||
59593041|NCT02921737|75701450|FG000|STARTED|Overall Study||7||
59593042|NCT02921737|75701450|FG000|COMPLETED|Overall Study||7||
59593043|NCT02921737|75701450|FG000|NOT COMPLETED|Overall Study||0||
59593044|NCT02819011|75701456|FG000|STARTED|Overall Study||22||
59593045|NCT02819011|75701457|FG001|STARTED|Overall Study||22||
59593046|NCT02819011|75701456|FG000|COMPLETED|Overall Study||15||
59593047|NCT02819011|75701457|FG001|COMPLETED|Overall Study||17||
59593048|NCT02819011|75701456|FG000|NOT COMPLETED|Overall Study||7||
59593049|NCT02819011|75701457|FG001|NOT COMPLETED|Overall Study||5||
59593050|NCT02846792|75701464|FG000|STARTED|Overall Study||5||
59593051|NCT02846792|75701464|FG000|COMPLETED|Overall Study||5||
59857348|NCT02316340|75982083|FG000|STARTED|Optional Cross-over (MD Discretion)|Efficacy analysis was completed after Cycle 1, crossover was optional, and if not done, then the patient is off the study and can go on to receive other treatments. 13 subjects crossed over to the VOR/HCQ arm|5||
59996809|NCT02729831|76112668|FG000|COMPLETED|Baseline (Post Decision Aid, Pre-visit)||282||
59996810|NCT02729831|76112669|FG001|COMPLETED|Baseline (Post Decision Aid, Pre-visit)||292||
59996811|NCT02729831|76112670|FG002|COMPLETED|Baseline (Post Decision Aid, Pre-visit)||275||
59996812|NCT02729831|76112671|FG003|COMPLETED|Baseline (Post Decision Aid, Pre-visit)||275||
60123147|NCT00128193|76244328|FG002|COMPLETED|Overall Study||42||
60123148|NCT00128193|76244329|FG003|COMPLETED|Overall Study||44||
60123149|NCT00128193|76244330|FG004|COMPLETED|Overall Study||18||
60123150|NCT00128193|76244331|FG005|COMPLETED|Overall Study||17||
60123151|NCT00128193|76244332|FG006|COMPLETED|Overall Study||16||
60123152|NCT00128193|76244333|FG007|COMPLETED|Overall Study||20||
60123153|NCT00128193|76244334|FG008|COMPLETED|Overall Study||18||
60123154|NCT00128193|76244335|FG009|COMPLETED|Overall Study||18||
59593052|NCT02846792|75701464|FG000|NOT COMPLETED|Overall Study||0||
59996813|NCT02729831|76112668|FG000|NOT COMPLETED|Baseline (Post Decision Aid, Pre-visit)||38||
59996814|NCT02729831|76112669|FG001|NOT COMPLETED|Baseline (Post Decision Aid, Pre-visit)||23||
59996815|NCT02729831|76112670|FG002|NOT COMPLETED|Baseline (Post Decision Aid, Pre-visit)||18||
59996816|NCT02729831|76112671|FG003|NOT COMPLETED|Baseline (Post Decision Aid, Pre-visit)||17||
59996817|NCT02729831|76112668|FG000|STARTED|1 Week Post-visit||282||
59996818|NCT02729831|76112669|FG001|STARTED|1 Week Post-visit||292||
59996819|NCT02729831|76112670|FG002|STARTED|1 Week Post-visit||275||
59996820|NCT02729831|76112671|FG003|STARTED|1 Week Post-visit||275||
59996821|NCT02729831|76112668|FG000|COMPLETED|1 Week Post-visit||239||
59996822|NCT02729831|76112669|FG001|COMPLETED|1 Week Post-visit||252||
59996823|NCT02729831|76112670|FG002|COMPLETED|1 Week Post-visit||237||
59996824|NCT02729831|76112671|FG003|COMPLETED|1 Week Post-visit||239||
59996825|NCT02729831|76112668|FG000|NOT COMPLETED|1 Week Post-visit||43||
59996826|NCT02729831|76112669|FG001|NOT COMPLETED|1 Week Post-visit||40||
59996827|NCT02729831|76112670|FG002|NOT COMPLETED|1 Week Post-visit||38||
59996828|NCT02729831|76112671|FG003|NOT COMPLETED|1 Week Post-visit||36||
59996829|NCT02729831|76112668|FG000|STARTED|6 Month Follow-up||282|Follow-up survey (Period 3) was sent to all those who completed the Baseline (Period 1) survey.|
59996830|NCT02729831|76112669|FG001|STARTED|6 Month Follow-up||292|Follow-up survey (Period 3) was sent to all those who completed the Baseline (Period 1) survey.|
59996831|NCT02729831|76112670|FG002|STARTED|6 Month Follow-up||275|Follow-up survey (Period 3) was sent to all those who completed the Baseline (Period 1) survey.|
60123155|NCT00128193|76244336|FG010|COMPLETED|Overall Study||17||
60123156|NCT00128193|76244337|FG011|COMPLETED|Overall Study||18||
60123157|NCT00128193|76244326|FG000|NOT COMPLETED|Overall Study||0||
60123158|NCT00128193|76244327|FG001|NOT COMPLETED|Overall Study||0||
60123159|NCT00128193|76244328|FG002|NOT COMPLETED|Overall Study||3||
60123160|NCT00128193|76244329|FG003|NOT COMPLETED|Overall Study||1||
60123161|NCT00128193|76244330|FG004|NOT COMPLETED|Overall Study||2||
60123162|NCT00128193|76244331|FG005|NOT COMPLETED|Overall Study||3||
60123163|NCT00128193|76244332|FG006|NOT COMPLETED|Overall Study||4||
60123164|NCT00128193|76244333|FG007|NOT COMPLETED|Overall Study||0||
60123165|NCT00128193|76244334|FG008|NOT COMPLETED|Overall Study||2||
60123166|NCT00128193|76244335|FG009|NOT COMPLETED|Overall Study||2||
60123167|NCT00128193|76244336|FG010|NOT COMPLETED|Overall Study||3||
60123168|NCT00128193|76244337|FG011|NOT COMPLETED|Overall Study||2||
60123169|NCT01520987|76244425|FG000|STARTED|Overall Study||13||
60123170|NCT01520987|76244426|FG001|STARTED|Overall Study||12||
60123171|NCT01520987|76244427|FG002|STARTED|Overall Study||11||
60123172|NCT01520987|76244428|FG003|STARTED|Overall Study||15||
60123173|NCT01520987|76244429|FG004|STARTED|Overall Study||14||
60123174|NCT01520987|76244430|FG005|STARTED|Overall Study||14||
60123175|NCT01520987|76244431|FG006|STARTED|Overall Study||12||
60123176|NCT01520987|76244432|FG007|STARTED|Overall Study||14||
60123177|NCT01520987|76244425|FG000|Dosed|Overall Study||13||
60123178|NCT01520987|76244426|FG001|Dosed|Overall Study||12||
60123179|NCT01520987|76244427|FG002|Dosed|Overall Study||11||
60123180|NCT01520987|76244428|FG003|Dosed|Overall Study||15||
60123181|NCT01520987|76244429|FG004|Dosed|Overall Study||14||
60123182|NCT01520987|76244430|FG005|Dosed|Overall Study||14||
60123183|NCT01520987|76244431|FG006|Dosed|Overall Study||12||
60123184|NCT01520987|76244432|FG007|Dosed|Overall Study||14||
60123185|NCT01520987|76244425|FG000|COMPLETED|Overall Study||12||
60123186|NCT01520987|76244426|FG001|COMPLETED|Overall Study||12||
60123187|NCT01520987|76244427|FG002|COMPLETED|Overall Study||11||
60123188|NCT01520987|76244428|FG003|COMPLETED|Overall Study||15||
60123189|NCT01520987|76244429|FG004|COMPLETED|Overall Study||14||
60123190|NCT01520987|76244430|FG005|COMPLETED|Overall Study||13||
60123191|NCT01520987|76244431|FG006|COMPLETED|Overall Study||12||
60123192|NCT01520987|76244432|FG007|COMPLETED|Overall Study||14||
60123193|NCT01520987|76244425|FG000|NOT COMPLETED|Overall Study||1||
60123194|NCT01520987|76244426|FG001|NOT COMPLETED|Overall Study||0||
60123195|NCT01520987|76244427|FG002|NOT COMPLETED|Overall Study||0||
60123196|NCT01520987|76244428|FG003|NOT COMPLETED|Overall Study||0||
60123197|NCT01520987|76244429|FG004|NOT COMPLETED|Overall Study||0||
60123198|NCT01520987|76244430|FG005|NOT COMPLETED|Overall Study||1||
60123199|NCT01520987|76244431|FG006|NOT COMPLETED|Overall Study||0||
60123200|NCT01520987|76244432|FG007|NOT COMPLETED|Overall Study||0||
60123201|NCT00130923|76244450|FG000|STARTED|Overall Study||49||
60123202|NCT00130923|76244451|FG001|STARTED|Overall Study||46||
60123203|NCT00130923|76244450|FG000|COMPLETED|Overall Study||36||
60123204|NCT00130923|76244451|FG001|COMPLETED|Overall Study||32||
60123205|NCT00130923|76244450|FG000|NOT COMPLETED|Overall Study||13||
60123206|NCT00130923|76244451|FG001|NOT COMPLETED|Overall Study||14||
60123207|NCT02103153|76244458|FG000|STARTED|Overall Study||44||
60123208|NCT02103153|76244458|FG000|COMPLETED|Overall Study||27||
59857349|NCT02316340|75982084|FG001|STARTED|Optional Cross-over (MD Discretion)|Efficacy analysis was completed after Cycle 1. Cross-over was optional, and if not completed then the patient was off-study and could go on to receive other treatments. 5 subjects crossed over to the RGF arm.|13||
59593053|NCT02850068|75701468|FG000|STARTED|Overall Study||20||
59593054|NCT02850068|75701468|FG000|COMPLETED|Overall Study||0||
59593055|NCT02850068|75701468|FG000|NOT COMPLETED|Overall Study||20||
59593056|NCT02819323|75701475|FG000|STARTED|Overall Study||31|Safety population - all subjects that took preparation.|
60123209|NCT02103153|76244458|FG000|NOT COMPLETED|Overall Study||17||
60123210|NCT02103309|76244465|FG000|STARTED|Overall Study||20||
60123211|NCT02103309|76244466|FG001|STARTED|Overall Study||22||
60123212|NCT02103309|76244465|FG000|COMPLETED|Overall Study||20||
60123213|NCT02103309|76244466|FG001|COMPLETED|Overall Study||22||
60123214|NCT02103309|76244465|FG000|NOT COMPLETED|Overall Study||0||
60123215|NCT02103309|76244466|FG001|NOT COMPLETED|Overall Study||0||
60123216|NCT00272337|76244477|FG000|STARTED|Overall Study||8||
60123217|NCT00272337|76244478|FG001|STARTED|Overall Study||7||
60123218|NCT00272337|76244479|FG002|STARTED|Overall Study||7||
60123219|NCT00272337|76244480|FG003|STARTED|Overall Study||7||
60123220|NCT00272337|76244481|FG004|STARTED|Overall Study||8||
60123221|NCT00272337|76244477|FG000|COMPLETED|Overall Study||8||
60123222|NCT00272337|76244478|FG001|COMPLETED|Overall Study||7||
60123223|NCT00272337|76244479|FG002|COMPLETED|Overall Study||7||
60123224|NCT00272337|76244480|FG003|COMPLETED|Overall Study||7||
60123225|NCT00272337|76244481|FG004|COMPLETED|Overall Study||8||
60123226|NCT00272337|76244477|FG000|NOT COMPLETED|Overall Study||0||
60123227|NCT00272337|76244478|FG001|NOT COMPLETED|Overall Study||0||
60123228|NCT00272337|76244479|FG002|NOT COMPLETED|Overall Study||0||
60123229|NCT00272337|76244480|FG003|NOT COMPLETED|Overall Study||0||
60123230|NCT00272337|76244481|FG004|NOT COMPLETED|Overall Study||0||
60123231|NCT01562275|76244506|FG000|STARTED|Stage 1||3||
60123232|NCT01562275|76244507|FG001|STARTED|Stage 1||7||
60123233|NCT01562275|76244508|FG002|STARTED|Stage 1||3||
60123234|NCT01562275|76244509|FG003|STARTED|Stage 1||4||
60123235|NCT01562275|76244510|FG004|STARTED|Stage 1||4||
60123236|NCT01562275|76244511|FG005|STARTED|Stage 1||4||
60123237|NCT01562275|76244512|FG006|STARTED|Stage 1||3||
60123238|NCT01562275|76244513|FG007|STARTED|Stage 1||7||
60123239|NCT01562275|76244514|FG008|STARTED|Stage 1||3||
60123240|NCT01562275|76244515|FG009|STARTED|Stage 1||7||
60123241|NCT01562275|76244516|FG010|STARTED|Stage 1||3||
60123242|NCT01562275|76244517|FG011|STARTED|Stage 1||0||
60123243|NCT01562275|76244518|FG012|STARTED|Stage 1||0||
60123244|NCT01562275|76244506|FG000|COMPLETED|Stage 1||0||
60123245|NCT01562275|76244507|FG001|COMPLETED|Stage 1||0||
60123246|NCT01562275|76244508|FG002|COMPLETED|Stage 1||0||
60123247|NCT01562275|76244509|FG003|COMPLETED|Stage 1||0||
60123248|NCT01562275|76244510|FG004|COMPLETED|Stage 1||0||
60123249|NCT01562275|76244511|FG005|COMPLETED|Stage 1||0||
60123250|NCT01562275|76244512|FG006|COMPLETED|Stage 1||0||
60123251|NCT01562275|76244513|FG007|COMPLETED|Stage 1||0||
60123252|NCT01562275|76244514|FG008|COMPLETED|Stage 1||0||
60123253|NCT01562275|76244515|FG009|COMPLETED|Stage 1||0||
60123254|NCT01562275|76244516|FG010|COMPLETED|Stage 1||0||
60123255|NCT01562275|76244517|FG011|COMPLETED|Stage 1||0||
60123256|NCT01562275|76244518|FG012|COMPLETED|Stage 1||0||
60123257|NCT01562275|76244506|FG000|NOT COMPLETED|Stage 1||3||
60123258|NCT01562275|76244507|FG001|NOT COMPLETED|Stage 1||7||
60123259|NCT01562275|76244508|FG002|NOT COMPLETED|Stage 1||3||
60123260|NCT01562275|76244509|FG003|NOT COMPLETED|Stage 1||4||
60123261|NCT01562275|76244510|FG004|NOT COMPLETED|Stage 1||4||
60123262|NCT01562275|76244511|FG005|NOT COMPLETED|Stage 1||4||
60123263|NCT01562275|76244512|FG006|NOT COMPLETED|Stage 1||3||
60123264|NCT01562275|76244513|FG007|NOT COMPLETED|Stage 1||7||
60123265|NCT01562275|76244514|FG008|NOT COMPLETED|Stage 1||3||
60123266|NCT01562275|76244515|FG009|NOT COMPLETED|Stage 1||7||
60123267|NCT01562275|76244516|FG010|NOT COMPLETED|Stage 1||3||
60123268|NCT01562275|76244517|FG011|NOT COMPLETED|Stage 1||0||
60123269|NCT01562275|76244518|FG012|NOT COMPLETED|Stage 1||0||
60123270|NCT01562275|76244506|FG000|STARTED|Stage 2||0||
60123271|NCT01562275|76244507|FG001|STARTED|Stage 2||0||
60123272|NCT01562275|76244508|FG002|STARTED|Stage 2||0||
60123273|NCT01562275|76244509|FG003|STARTED|Stage 2||0||
60123274|NCT01562275|76244510|FG004|STARTED|Stage 2||0||
60123275|NCT01562275|76244511|FG005|STARTED|Stage 2||0||
60123276|NCT01562275|76244512|FG006|STARTED|Stage 2||0||
60123277|NCT01562275|76244513|FG007|STARTED|Stage 2||0||
60123278|NCT01562275|76244514|FG008|STARTED|Stage 2||0||
60123279|NCT01562275|76244515|FG009|STARTED|Stage 2||0||
60123280|NCT01562275|76244516|FG010|STARTED|Stage 2||0||
60123281|NCT01562275|76244517|FG011|STARTED|Stage 2||14||
60123282|NCT01562275|76244518|FG012|STARTED|Stage 2||5||
60123283|NCT01562275|76244506|FG000|COMPLETED|Stage 2||0||
60123284|NCT01562275|76244507|FG001|COMPLETED|Stage 2||0||
60123285|NCT01562275|76244508|FG002|COMPLETED|Stage 2||0||
60123286|NCT01562275|76244509|FG003|COMPLETED|Stage 2||0||
60123287|NCT01562275|76244510|FG004|COMPLETED|Stage 2||0||
59593057|NCT02819323|75701476|FG001|STARTED|Overall Study||28|Safety population - all subjects that took preparation.|
60123288|NCT01562275|76244511|FG005|COMPLETED|Stage 2||0||
60123289|NCT01562275|76244512|FG006|COMPLETED|Stage 2||0||
60123290|NCT01562275|76244513|FG007|COMPLETED|Stage 2||0||
60123291|NCT01562275|76244514|FG008|COMPLETED|Stage 2||0||
60123292|NCT01562275|76244515|FG009|COMPLETED|Stage 2||0||
60123293|NCT01562275|76244516|FG010|COMPLETED|Stage 2||0||
60123294|NCT01562275|76244517|FG011|COMPLETED|Stage 2||0||
60123295|NCT01562275|76244518|FG012|COMPLETED|Stage 2||0||
60123296|NCT01562275|76244506|FG000|NOT COMPLETED|Stage 2||0||
60123297|NCT01562275|76244507|FG001|NOT COMPLETED|Stage 2||0||
60123298|NCT01562275|76244508|FG002|NOT COMPLETED|Stage 2||0||
59593058|NCT02819323|75701477|FG002|STARTED|Overall Study||32|Safety population - all subjects that took preparation.|
60123299|NCT01562275|76244509|FG003|NOT COMPLETED|Stage 2||0||
60123300|NCT01562275|76244510|FG004|NOT COMPLETED|Stage 2||0||
60123301|NCT01562275|76244511|FG005|NOT COMPLETED|Stage 2||0||
60123302|NCT01562275|76244512|FG006|NOT COMPLETED|Stage 2||0||
60123303|NCT01562275|76244513|FG007|NOT COMPLETED|Stage 2||0||
60123304|NCT01562275|76244514|FG008|NOT COMPLETED|Stage 2||0||
60123305|NCT01562275|76244515|FG009|NOT COMPLETED|Stage 2||0||
60123306|NCT01562275|76244516|FG010|NOT COMPLETED|Stage 2||0||
60123307|NCT01562275|76244517|FG011|NOT COMPLETED|Stage 2||14||
60123308|NCT01562275|76244518|FG012|NOT COMPLETED|Stage 2||5||
60123309|NCT01535053|76244550|FG000|STARTED|Overall Study||29||
60123310|NCT01535053|76244551|FG001|STARTED|Overall Study||28||
60123311|NCT01535053|76244550|FG000|COMPLETED|Overall Study|treated for 3 cycles after hCG <5mIU/ml or until biologic,disease progression, unacceptable toxicity|28||
60123312|NCT01535053|76244551|FG001|COMPLETED|Overall Study|treated for 3 cycles after hCG <5mIU/ml or until biologic,disease progression, unacceptable toxicity|26||
60123313|NCT01535053|76244550|FG000|NOT COMPLETED|Overall Study||1||
60123314|NCT01535053|76244551|FG001|NOT COMPLETED|Overall Study||2||
60123315|NCT01534663|76244559|FG000|STARTED|Overall Study||14||
60123316|NCT01534663|76244560|FG001|STARTED|Overall Study||17||
60123317|NCT01534663|76244559|FG000|COMPLETED|Overall Study||12||
60123318|NCT01534663|76244560|FG001|COMPLETED|Overall Study||14||
60123319|NCT01534663|76244559|FG000|NOT COMPLETED|Overall Study||2||
60123320|NCT01534663|76244560|FG001|NOT COMPLETED|Overall Study||3||
60123321|NCT01520909|76244568|FG000|STARTED|Part 1 (Randomized Period)||29||
60123322|NCT01520909|76244569|FG001|STARTED|Part 1 (Randomized Period)||63||
60123323|NCT01520909|76244570|FG002|STARTED|Part 1 (Randomized Period)||0||
60123324|NCT01520909|76244568|FG000|COMPLETED|Part 1 (Randomized Period)||28||
60123325|NCT01520909|76244569|FG001|COMPLETED|Part 1 (Randomized Period)||61||
60123326|NCT01520909|76244570|FG002|COMPLETED|Part 1 (Randomized Period)||0||
60123327|NCT01520909|76244568|FG000|NOT COMPLETED|Part 1 (Randomized Period)||1||
60123328|NCT01520909|76244569|FG001|NOT COMPLETED|Part 1 (Randomized Period)||2||
60123329|NCT01520909|76244570|FG002|NOT COMPLETED|Part 1 (Randomized Period)||0||
60123330|NCT01520909|76244568|FG000|STARTED|Part 2 (Open-Label Period)-Eltrombopag||0||
60123331|NCT01520909|76244569|FG001|STARTED|Part 2 (Open-Label Period)-Eltrombopag||0||
60123332|NCT01520909|76244570|FG002|STARTED|Part 2 (Open-Label Period)-Eltrombopag|Two participants that completed Part 1 did not start Part 2 because of lack of efficacy.|87||
60123333|NCT01520909|76244568|FG000|COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||0||
60123334|NCT01520909|76244569|FG001|COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||0||
60123335|NCT01520909|76244570|FG002|COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||80||
60123336|NCT01520909|76244568|FG000|NOT COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||0||
60123337|NCT01520909|76244569|FG001|NOT COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||0||
60123338|NCT01520909|76244570|FG002|NOT COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||7||
60123339|NCT01520363|76244592|FG000|STARTED|Overall Study||26||
60123340|NCT01520363|76244593|FG001|STARTED|Overall Study||26||
60123341|NCT01520363|76244592|FG000|COMPLETED|Overall Study||24||
60123342|NCT01520363|76244593|FG001|COMPLETED|Overall Study||26||
60123343|NCT01520363|76244592|FG000|NOT COMPLETED|Overall Study||2||
60123344|NCT01520363|76244593|FG001|NOT COMPLETED|Overall Study||0||
60123345|NCT01578499|76244625|FG000|STARTED|Overall Study||66||
60123346|NCT01578499|76244626|FG001|STARTED|Overall Study||65||
60123347|NCT01578499|76244625|FG000|Safety Population: Treated|Overall Study||66||
60123348|NCT01578499|76244626|FG001|Safety Population: Treated|Overall Study||62||
60123349|NCT01578499|76244625|FG000|Intent to Treat Population: CD30+|Overall Study||64||
60123350|NCT01578499|76244626|FG001|Intent to Treat Population: CD30+|Overall Study||64||
60123351|NCT01578499|76244625|FG000|COMPLETED|Overall Study||32||
60123352|NCT01578499|76244626|FG001|COMPLETED|Overall Study||22||
60123353|NCT01578499|76244625|FG000|NOT COMPLETED|Overall Study||34||
60123354|NCT01578499|76244626|FG001|NOT COMPLETED|Overall Study||43||
60123355|NCT01578187|76244636|FG000|STARTED|Label Comprehension Phase||63||
60123356|NCT01578187|76244636|FG000|COMPLETED|Label Comprehension Phase||63||
60123357|NCT01578187|76244636|FG000|NOT COMPLETED|Label Comprehension Phase||0||
60123358|NCT01578187|76244636|FG000|STARTED|Usability Phase||48||
60123359|NCT01578187|76244636|FG000|COMPLETED|Usability Phase||47||
60123360|NCT01578187|76244636|FG000|NOT COMPLETED|Usability Phase||1||
60123361|NCT01561963|76244642|FG000|STARTED|Overall Study||21||
60123362|NCT01561963|76244642|FG000|Received Period 1 Treatment|Overall Study||21||
60123363|NCT01561963|76244642|FG000|Received Period 2 Treatment|Overall Study||20||
60123364|NCT01561963|76244642|FG000|Received Period 3 Treatment|Overall Study||20||
60123365|NCT01561963|76244642|FG000|COMPLETED|Overall Study||20||
60123366|NCT01561963|76244642|FG000|NOT COMPLETED|Overall Study||1||
60123367|NCT01576783|76244653|FG000|STARTED|Overall Study||189||
60123368|NCT01576783|76244654|FG001|STARTED|Overall Study||188||
60123369|NCT01576783|76244653|FG000|COMPLETED|Overall Study||169||
60123370|NCT01576783|76244654|FG001|COMPLETED|Overall Study||171||
60123371|NCT01576783|76244653|FG000|NOT COMPLETED|Overall Study||20||
60123372|NCT01576783|76244654|FG001|NOT COMPLETED|Overall Study||17||
60123373|NCT01534351|76244663|FG000|STARTED|Overall Study||1||
60123374|NCT01534351|76244664|FG001|STARTED|Overall Study||0||
60123375|NCT01534351|76244665|FG002|STARTED|Overall Study||0||
60123376|NCT01534351|76244663|FG000|COMPLETED|Overall Study||0||
60123377|NCT01534351|76244664|FG001|COMPLETED|Overall Study||0||
60123378|NCT01534351|76244665|FG002|COMPLETED|Overall Study||0||
60123379|NCT01534351|76244663|FG000|NOT COMPLETED|Overall Study||1||
60123380|NCT01534351|76244664|FG001|NOT COMPLETED|Overall Study||0||
60123381|NCT01534351|76244665|FG002|NOT COMPLETED|Overall Study||0||
60123382|NCT01534273|76244677|FG000|STARTED|Period 1||3||
60123383|NCT01534273|76244678|FG001|STARTED|Period 1||6||
60123384|NCT01534273|76244679|FG002|STARTED|Period 1||2||
60123385|NCT01534273|76244680|FG003|STARTED|Period 1||7||
60123386|NCT01534273|76244681|FG004|STARTED|Period 1||3||
60123387|NCT01534273|76244682|FG005|STARTED|Period 1||3||
60123388|NCT01534273|76244683|FG006|STARTED|Period 1||6||
60123389|NCT01534273|76244677|FG000|Received at Least 1 Dose of Study Drug|Period 1||3||
59593059|NCT02819323|75701475|FG000|COMPLETED|Overall Study||26||
59593060|NCT02819323|75701476|FG001|COMPLETED|Overall Study||26||
60123390|NCT01534273|76244678|FG001|Received at Least 1 Dose of Study Drug|Period 1||6||
60123391|NCT01534273|76244679|FG002|Received at Least 1 Dose of Study Drug|Period 1||2||
60123392|NCT01534273|76244680|FG003|Received at Least 1 Dose of Study Drug|Period 1||7||
60123393|NCT01534273|76244681|FG004|Received at Least 1 Dose of Study Drug|Period 1||3||
60123394|NCT01534273|76244682|FG005|Received at Least 1 Dose of Study Drug|Period 1||3||
60123395|NCT01534273|76244683|FG006|Received at Least 1 Dose of Study Drug|Period 1||6||
60123396|NCT01534273|76244677|FG000|COMPLETED|Period 1||3||
60123397|NCT01534273|76244678|FG001|COMPLETED|Period 1||6||
60123398|NCT01534273|76244679|FG002|COMPLETED|Period 1||2||
60123399|NCT01534273|76244680|FG003|COMPLETED|Period 1||6||
60123400|NCT01534273|76244681|FG004|COMPLETED|Period 1||3||
60123401|NCT01534273|76244682|FG005|COMPLETED|Period 1||3||
60123402|NCT01534273|76244683|FG006|COMPLETED|Period 1||6||
60123403|NCT01534273|76244677|FG000|NOT COMPLETED|Period 1||0||
60123404|NCT01534273|76244678|FG001|NOT COMPLETED|Period 1||0||
60123405|NCT01534273|76244679|FG002|NOT COMPLETED|Period 1||0||
60123406|NCT01534273|76244680|FG003|NOT COMPLETED|Period 1||1||
60123407|NCT01534273|76244681|FG004|NOT COMPLETED|Period 1||0||
60123408|NCT01534273|76244682|FG005|NOT COMPLETED|Period 1||0||
60123409|NCT01534273|76244683|FG006|NOT COMPLETED|Period 1||0||
60123410|NCT01534273|76244677|FG000|STARTED|Period 2|Participants in Cohort A participated in only 1 treatment period.|0||
60123411|NCT01534273|76244678|FG001|STARTED|Period 2|Participants in Cohort A participated in only 1 treatment period.|0||
60123412|NCT01534273|76244679|FG002|STARTED|Period 2||2||
60123413|NCT01534273|76244680|FG003|STARTED|Period 2||6||
60123414|NCT01534273|76244681|FG004|STARTED|Period 2|Participants in Cohort C participated in only 1 treatment period.|0||
60123415|NCT01534273|76244682|FG005|STARTED|Period 2|Participants in Cohort C participated in only 1 treatment period.|0||
60123416|NCT01534273|76244683|FG006|STARTED|Period 2|Participants in Cohort C participated in only 1 treatment period.|0||
60123417|NCT01534273|76244677|FG000|COMPLETED|Period 2||0||
60123418|NCT01534273|76244678|FG001|COMPLETED|Period 2||0||
60123419|NCT01534273|76244679|FG002|COMPLETED|Period 2||2||
60123420|NCT01534273|76244680|FG003|COMPLETED|Period 2||6||
60123421|NCT01534273|76244681|FG004|COMPLETED|Period 2||0||
60123422|NCT01534273|76244682|FG005|COMPLETED|Period 2||0||
60123423|NCT01534273|76244683|FG006|COMPLETED|Period 2||0||
60123424|NCT01534273|76244677|FG000|NOT COMPLETED|Period 2||0||
60123425|NCT01534273|76244678|FG001|NOT COMPLETED|Period 2||0||
60123426|NCT01534273|76244679|FG002|NOT COMPLETED|Period 2||0||
60123427|NCT01534273|76244680|FG003|NOT COMPLETED|Period 2||0||
60123428|NCT01534273|76244681|FG004|NOT COMPLETED|Period 2||0||
60123429|NCT01534273|76244682|FG005|NOT COMPLETED|Period 2||0||
60123430|NCT01534273|76244683|FG006|NOT COMPLETED|Period 2||0||
60123431|NCT01534195|76244706|FG000|STARTED|Overall Study||5||
60123432|NCT01534195|76244707|FG001|STARTED|Overall Study||6||
60123433|NCT01534195|76244706|FG000|COMPLETED|Overall Study||4||
60123434|NCT01534195|76244707|FG001|COMPLETED|Overall Study||5||
60123435|NCT01534195|76244706|FG000|NOT COMPLETED|Overall Study||1||
60123436|NCT01534195|76244707|FG001|NOT COMPLETED|Overall Study||1||
60123437|NCT01560949|76244713|FG000|STARTED|Systemic Phase: mFOLFIRINOX||33||
60123438|NCT01560949|76244713|FG000|COMPLETED|Systemic Phase: mFOLFIRINOX||27||
60123439|NCT01560949|76244713|FG000|NOT COMPLETED|Systemic Phase: mFOLFIRINOX||6||
60123440|NCT01560949|76244713|FG000|STARTED|Chemoradiation Phase: With Gemcitabine||23||
60123441|NCT01560949|76244713|FG000|COMPLETED|Chemoradiation Phase: With Gemcitabine||23||
60123442|NCT01560949|76244713|FG000|NOT COMPLETED|Chemoradiation Phase: With Gemcitabine||0||
60123443|NCT01560949|76244713|FG000|STARTED|Surgery Phase||18||
60123444|NCT01560949|76244713|FG000|COMPLETED|Surgery Phase||15||
60123445|NCT01560949|76244713|FG000|NOT COMPLETED|Surgery Phase||3||
60123446|NCT01372878|76244721|FG000|STARTED|Overall Study||884||
60123447|NCT01372878|76244721|FG000|COMPLETED|Overall Study||700||
60123448|NCT01372878|76244721|FG000|NOT COMPLETED|Overall Study||184||
60123449|NCT01533493|76244727|FG000|STARTED|Overall Study||12||
60123450|NCT01533493|76244728|FG001|STARTED|Overall Study||14||
60123451|NCT01533493|76244727|FG000|COMPLETED|Overall Study||7||
60123452|NCT01533493|76244728|FG001|COMPLETED|Overall Study||11||
59593061|NCT02819323|75701477|FG002|COMPLETED|Overall Study||31||
59593062|NCT02819323|75701475|FG000|NOT COMPLETED|Overall Study||5||
59726803|NCT01008150|75845549|FG002|STARTED|Overall Study||43||
59726804|NCT01008150|75845550|FG003|STARTED|Overall Study||12||
60123453|NCT01533493|76244727|FG000|NOT COMPLETED|Overall Study||5||
60123454|NCT01533493|76244728|FG001|NOT COMPLETED|Overall Study||3||
60123455|NCT00133575|76244741|FG000|STARTED|Overall Study||10||
60123456|NCT00133575|76244742|FG001|STARTED|Overall Study||10||
60123457|NCT00133575|76244743|FG002|STARTED|Overall Study||10||
60123458|NCT00133575|76244744|FG003|STARTED|Overall Study||10||
60123459|NCT00133575|76244745|FG004|STARTED|Overall Study||10||
60123460|NCT00133575|76244746|FG005|STARTED|Overall Study||10||
60123461|NCT00133575|76244747|FG006|STARTED|Overall Study||12||
60123462|NCT00133575|76244741|FG000|COMPLETED|Overall Study||10||
60123463|NCT00133575|76244742|FG001|COMPLETED|Overall Study||10||
60123464|NCT00133575|76244743|FG002|COMPLETED|Overall Study||8||
60123465|NCT00133575|76244744|FG003|COMPLETED|Overall Study||9||
60123466|NCT00133575|76244745|FG004|COMPLETED|Overall Study||6||
60123467|NCT00133575|76244746|FG005|COMPLETED|Overall Study||9||
60123468|NCT00133575|76244747|FG006|COMPLETED|Overall Study||9||
60123469|NCT00133575|76244741|FG000|NOT COMPLETED|Overall Study||0||
60123470|NCT00133575|76244742|FG001|NOT COMPLETED|Overall Study||0||
60123471|NCT00133575|76244743|FG002|NOT COMPLETED|Overall Study||2||
60123472|NCT00133575|76244744|FG003|NOT COMPLETED|Overall Study||1||
60123473|NCT00133575|76244745|FG004|NOT COMPLETED|Overall Study||4||
60123474|NCT00133575|76244746|FG005|NOT COMPLETED|Overall Study||1||
60123475|NCT00133575|76244747|FG006|NOT COMPLETED|Overall Study||3||
60123476|NCT00133809|76244763|FG000|STARTED|Overall Study||8||
60123477|NCT00133809|76244763|FG000|COMPLETED|Overall Study||8||
60123478|NCT00133809|76244763|FG000|NOT COMPLETED|Overall Study||0||
60123479|NCT00134043|76244769|FG000|STARTED|Overall Study||16||
60123480|NCT00134043|76244770|FG001|STARTED|Overall Study||3||
60123481|NCT00134043|76244769|FG000|COMPLETED|Overall Study||16||
60123482|NCT00134043|76244770|FG001|COMPLETED|Overall Study||3||
60123483|NCT00134043|76244769|FG000|NOT COMPLETED|Overall Study||0||
60123484|NCT00134043|76244770|FG001|NOT COMPLETED|Overall Study||0||
60123485|NCT03715998|76244778|FG000|STARTED|Overall Study||98||
60123486|NCT03715998|76244779|FG001|STARTED|Overall Study||99||
60123487|NCT03715998|76244780|FG002|STARTED|Overall Study||98||
60123488|NCT03715998|76244778|FG000|COMPLETED|Overall Study||81||
60123489|NCT03715998|76244779|FG001|COMPLETED|Overall Study||80||
60123490|NCT03715998|76244780|FG002|COMPLETED|Overall Study||88||
60123491|NCT03715998|76244778|FG000|NOT COMPLETED|Overall Study||17||
59593063|NCT02819323|75701476|FG001|NOT COMPLETED|Overall Study||2||
59593064|NCT02819323|75701477|FG002|NOT COMPLETED|Overall Study||1||
59593065|NCT03053401|75701487|FG000|STARTED|Overall Study||26||
59593066|NCT03053401|75701488|FG001|STARTED|Overall Study||26||
59593067|NCT03053401|75701487|FG000|COMPLETED|Overall Study||26||
59593068|NCT03053401|75701488|FG001|COMPLETED|Overall Study||26||
59593069|NCT03053401|75701487|FG000|NOT COMPLETED|Overall Study||0||
59593070|NCT03053401|75701488|FG001|NOT COMPLETED|Overall Study||0||
59593071|NCT02819557|75701495|FG000|STARTED|Overall Study||14||
59593072|NCT02819557|75701495|FG000|Safety Population|Overall Study||14|All participants who received at least 1 dose of ataluren.|
59593073|NCT02819557|75701495|FG000|Pharmacokinetics (PK) Population|Overall Study||14|All participants who received at least 1 dose of ataluren and had at least 1 PK concentration value.|
59593074|NCT02819557|75701495|FG000|Evaluable Population|Overall Study||14|Received ≥1 dose, baseline and a postbaseline TFT, NSAA, or answer to ataluren palatability question|
59593075|NCT02819557|75701495|FG000|COMPLETED|Overall Study||14||
59593076|NCT02819557|75701495|FG000|NOT COMPLETED|Overall Study||0||
59593077|NCT02820181|75701501|FG000|STARTED|Overall Study||30||
59593078|NCT02820181|75701502|FG001|STARTED|Overall Study||30||
59593079|NCT02820181|75701501|FG000|COMPLETED|Overall Study||30||
59593080|NCT02820181|75701502|FG001|COMPLETED|Overall Study||30||
59593081|NCT02820181|75701501|FG000|NOT COMPLETED|Overall Study||0||
59593082|NCT02820181|75701502|FG001|NOT COMPLETED|Overall Study||0||
59593083|NCT02860286|75701510|FG000|STARTED|Overall Study||13||
59593084|NCT02860286|75701511|FG001|STARTED|Overall Study||61||
59593085|NCT02860286|75701510|FG000|COMPLETED|Overall Study||13||
59593086|NCT02860286|75701511|FG001|COMPLETED|Overall Study||61||
59593087|NCT02860286|75701510|FG000|NOT COMPLETED|Overall Study||0||
59593088|NCT02860286|75701511|FG001|NOT COMPLETED|Overall Study||0||
59593089|NCT03054103|75701529|FG000|STARTED|Overall Study||41||
59593090|NCT03054103|75701530|FG001|STARTED|Overall Study||29||
59593091|NCT03054103|75701531|FG002|STARTED|Overall Study||35||
59593092|NCT03054103|75701529|FG000|COMPLETED|Overall Study||41||
59593093|NCT03054103|75701530|FG001|COMPLETED|Overall Study||29||
60123492|NCT03715998|76244779|FG001|NOT COMPLETED|Overall Study||19||
60123493|NCT03715998|76244780|FG002|NOT COMPLETED|Overall Study||10||
60123494|NCT04717323|76244790|FG000|STARTED|Overall Study||0||
60123495|NCT04717323|76244791|FG001|STARTED|Overall Study||10||
60123496|NCT04717323|76244790|FG000|COMPLETED|Overall Study||0||
59593094|NCT03054103|75701531|FG002|COMPLETED|Overall Study||35||
59593095|NCT03054103|75701529|FG000|NOT COMPLETED|Overall Study||0||
59593096|NCT03054103|75701530|FG001|NOT COMPLETED|Overall Study||0||
60123497|NCT04717323|76244791|FG001|COMPLETED|Overall Study||10||
60123498|NCT04717323|76244790|FG000|NOT COMPLETED|Overall Study||0||
60123499|NCT04717323|76244791|FG001|NOT COMPLETED|Overall Study||0||
60123500|NCT00278655|76244797|FG000|STARTED|Overall Study||21||
60123501|NCT00278655|76244797|FG000|COMPLETED|Overall Study||21||
59593097|NCT03054103|75701531|FG002|NOT COMPLETED|Overall Study||0||
59593098|NCT02860988|75701541|FG000|STARTED|Overall Study||201||
59593099|NCT02860988|75701542|FG001|STARTED|Overall Study||200||
59593100|NCT02860988|75701541|FG000|COMPLETED|Overall Study||117||
59593101|NCT02860988|75701542|FG001|COMPLETED|Overall Study||94||
59593102|NCT02860988|75701541|FG000|NOT COMPLETED|Overall Study||84||
59593103|NCT02860988|75701542|FG001|NOT COMPLETED|Overall Study||106||
59593104|NCT02822287|75701548|FG000|STARTED|Overall Study||57||
59593105|NCT02822287|75701548|FG000|COMPLETED|Overall Study||57||
59593106|NCT02822287|75701548|FG000|NOT COMPLETED|Overall Study||0||
59593107|NCT03043274|75701554|FG000|STARTED|Overall Study||13||
59593108|NCT03043274|75701555|FG001|STARTED|Overall Study||10||
59593109|NCT03043274|75701554|FG000|COMPLETED|Overall Study|The study was terminated because of slow recruitment.|13||
59593110|NCT03043274|75701555|FG001|COMPLETED|Overall Study|The study was terminated because of slow recruitment.|9||
59593111|NCT03043274|75701554|FG000|NOT COMPLETED|Overall Study||0||
59593112|NCT03043274|75701555|FG001|NOT COMPLETED|Overall Study||1||
60123502|NCT00278655|76244797|FG000|NOT COMPLETED|Overall Study||0||
60123503|NCT01533181|76244804|FG000|STARTED|Overall Study||15||
60123504|NCT01533181|76244805|FG001|STARTED|Overall Study||29||
59593113|NCT03054649|75701561|FG000|STARTED|Overall Study||27||27
59593114|NCT03054649|75701562|FG001|STARTED|Overall Study||27||26
59593115|NCT03054649|75701561|FG000|COMPLETED|Overall Study||27||27
59593116|NCT03054649|75701562|FG001|COMPLETED|Overall Study||27||26
59593117|NCT03054649|75701561|FG000|NOT COMPLETED|Overall Study||0||0
59593118|NCT03054649|75701562|FG001|NOT COMPLETED|Overall Study||0||0
59593119|NCT02975804|75701593|FG000|STARTED|Overall Study||9||
59593120|NCT02975804|75701594|FG001|STARTED|Overall Study||9||
59593121|NCT02975804|75701593|FG000|COMPLETED|Overall Study||9||
59593122|NCT02975804|75701594|FG001|COMPLETED|Overall Study||9||
59593123|NCT02975804|75701593|FG000|NOT COMPLETED|Overall Study||0||
59593124|NCT02975804|75701594|FG001|NOT COMPLETED|Overall Study||0||
59593125|NCT03054805|75701603|FG000|STARTED|Overall Study||58||
59593126|NCT03054805|75701604|FG001|STARTED|Overall Study||51||
59593127|NCT03054805|75701605|FG002|STARTED|Overall Study||44||
59593128|NCT03054805|75701603|FG000|COMPLETED|Overall Study||42||
59593129|NCT03054805|75701604|FG001|COMPLETED|Overall Study||41||
59593130|NCT03054805|75701605|FG002|COMPLETED|Overall Study||42||
59593131|NCT03054805|75701603|FG000|NOT COMPLETED|Overall Study||16||
59593132|NCT03054805|75701604|FG001|NOT COMPLETED|Overall Study||10||
59593133|NCT03054805|75701605|FG002|NOT COMPLETED|Overall Study||2||
59593134|NCT02979626|75701615|FG000|STARTED|Overall Study||313||
59593135|NCT02979626|75701616|FG001|STARTED|Overall Study||98||
59593136|NCT02979626|75701615|FG000|COMPLETED|Overall Study||313||
59726805|NCT01008150|75845547|FG000|COMPLETED|Overall Study||42||
59726806|NCT01008150|75845548|FG001|COMPLETED|Overall Study||42||
59726807|NCT01008150|75845549|FG002|COMPLETED|Overall Study||42||
59726808|NCT01008150|75845550|FG003|COMPLETED|Overall Study||12||
59726809|NCT01008150|75845547|FG000|NOT COMPLETED|Overall Study||1||
59593137|NCT02979626|75701616|FG001|COMPLETED|Overall Study||98||
59593138|NCT02979626|75701615|FG000|NOT COMPLETED|Overall Study||0||
59593139|NCT02979626|75701616|FG001|NOT COMPLETED|Overall Study||0||
59593140|NCT02822599|75701624|FG000|STARTED|Overall Study|First subject enrolled on 6-1-17.|15||
59593141|NCT02822599|75701625|FG001|STARTED|Overall Study|First subject enrolled on 6-1-17.|15||
59593142|NCT02822599|75701624|FG000|COMPLETED|Overall Study||15||
59593143|NCT02822599|75701625|FG001|COMPLETED|Overall Study||15||
59593144|NCT02822599|75701624|FG000|NOT COMPLETED|Overall Study||0||
59593145|NCT02822599|75701625|FG001|NOT COMPLETED|Overall Study||0||
59593146|NCT03045926|75701631|FG000|STARTED|Overall Study||35||
59593147|NCT03045926|75701631|FG000|COMPLETED|Overall Study||35||
59593148|NCT03045926|75701631|FG000|NOT COMPLETED|Overall Study||0||
59593149|NCT02928055|75701638|FG000|STARTED|Overall Study||8||
59593150|NCT02928055|75701639|FG001|STARTED|Overall Study||8||
59593151|NCT02928055|75701640|FG002|STARTED|Overall Study||7||
59593152|NCT02928055|75701638|FG000|End of Treatment|Overall Study||8||
59593153|NCT02928055|75701639|FG001|End of Treatment|Overall Study||8||
59593154|NCT02928055|75701640|FG002|End of Treatment|Overall Study||6||
59593155|NCT02928055|75701638|FG000|1 Month Follow up|Overall Study||7||
59593156|NCT02928055|75701639|FG001|1 Month Follow up|Overall Study||7||
59593157|NCT02928055|75701640|FG002|1 Month Follow up|Overall Study||6||
59593158|NCT02928055|75701638|FG000|2 Month Follow up|Overall Study||6||
59593159|NCT02928055|75701639|FG001|2 Month Follow up|Overall Study||7||
59593160|NCT02928055|75701640|FG002|2 Month Follow up|Overall Study||5||
59593161|NCT02928055|75701638|FG000|3 Month Follow up|Overall Study||5||
59593162|NCT02928055|75701639|FG001|3 Month Follow up|Overall Study||6||
59593163|NCT02928055|75701640|FG002|3 Month Follow up|Overall Study||5||
59593164|NCT02928055|75701638|FG000|COMPLETED|Overall Study||5|complete study(all milestones)|
59593165|NCT02928055|75701639|FG001|COMPLETED|Overall Study||6|complete study(all milestones)|
59593166|NCT02928055|75701640|FG002|COMPLETED|Overall Study||5|complete study(all milestones)|
59593167|NCT02928055|75701638|FG000|NOT COMPLETED|Overall Study||3||
59593168|NCT02928055|75701639|FG001|NOT COMPLETED|Overall Study||2||
59593169|NCT02928055|75701640|FG002|NOT COMPLETED|Overall Study||2||
59593170|NCT02983058|75701650|FG000|STARTED|Overall Study||7||
59593171|NCT02983058|75701651|FG001|STARTED|Overall Study||5||
59726810|NCT01008150|75845548|FG001|NOT COMPLETED|Overall Study||1||
59726811|NCT01008150|75845549|FG002|NOT COMPLETED|Overall Study||1||
59857350|NCT02316340|75982083|FG000|COMPLETED|Optional Cross-over (MD Discretion)||2||
59593172|NCT02983058|75701650|FG000|COMPLETED|Overall Study||2||
59593173|NCT02983058|75701651|FG001|COMPLETED|Overall Study||2||
59593174|NCT02983058|75701650|FG000|NOT COMPLETED|Overall Study||5||
59593175|NCT02983058|75701651|FG001|NOT COMPLETED|Overall Study||3||
59593176|NCT02983448|75701657|FG000|STARTED|Overall Study||12||
59593177|NCT02983448|75701658|FG001|STARTED|Overall Study||12||
59593178|NCT02983448|75701657|FG000|COMPLETED|Overall Study||12||
59593179|NCT02983448|75701658|FG001|COMPLETED|Overall Study||12||
59593180|NCT02983448|75701657|FG000|NOT COMPLETED|Overall Study||0||
59593181|NCT02983448|75701658|FG001|NOT COMPLETED|Overall Study||0||
59593182|NCT03061513|75701668|FG000|STARTED|Overall Study||6||
59593183|NCT03061513|75701669|FG001|STARTED|Overall Study||5||
59593184|NCT03061513|75701668|FG000|COMPLETED|Overall Study||6||
59593185|NCT03061513|75701669|FG001|COMPLETED|Overall Study||4||
59593186|NCT03061513|75701668|FG000|NOT COMPLETED|Overall Study||0||
59726812|NCT01008150|75845550|FG003|NOT COMPLETED|Overall Study||0||
59593187|NCT03061513|75701669|FG001|NOT COMPLETED|Overall Study||1||
59593188|NCT03046472|75701677|FG000|STARTED|Overall Study||33||
59593189|NCT03046472|75701678|FG001|STARTED|Overall Study||17||
59593190|NCT03046472|75701677|FG000|COMPLETED|Overall Study||33||
59593191|NCT03046472|75701678|FG001|COMPLETED|Overall Study||17||
59593192|NCT03046472|75701677|FG000|NOT COMPLETED|Overall Study||0||
59593193|NCT03046472|75701678|FG001|NOT COMPLETED|Overall Study||0||
59593194|NCT02828137|75701687|FG000|STARTED|Overall Study||41||
59593195|NCT02828137|75701688|FG001|STARTED|Overall Study||41||
59593196|NCT02828137|75701689|FG002|STARTED|Overall Study||41||
59593197|NCT02828137|75701687|FG000|COMPLETED|Overall Study||41||
59593198|NCT02828137|75701688|FG001|COMPLETED|Overall Study||41||
59593199|NCT02828137|75701689|FG002|COMPLETED|Overall Study||41||
59593200|NCT02828137|75701687|FG000|NOT COMPLETED|Overall Study||0||
59593201|NCT02828137|75701688|FG001|NOT COMPLETED|Overall Study||0||
59593202|NCT02828137|75701689|FG002|NOT COMPLETED|Overall Study||0||
59593203|NCT03062605|75701699|FG000|STARTED|Overall Study||25||
59593204|NCT03062605|75701700|FG001|STARTED|Overall Study||23||
59593205|NCT03062605|75701699|FG000|COMPLETED|Overall Study||14||
59593206|NCT03062605|75701700|FG001|COMPLETED|Overall Study||13||
59593207|NCT03062605|75701699|FG000|NOT COMPLETED|Overall Study||11||
59593208|NCT03062605|75701700|FG001|NOT COMPLETED|Overall Study||10||
59593209|NCT03062917|75701711|FG000|STARTED|Overall Study||32||
59593210|NCT03062917|75701712|FG001|STARTED|Overall Study||51||
59593211|NCT03062917|75701713|FG002|STARTED|Overall Study||49||
59593212|NCT03062917|75701714|FG003|STARTED|Overall Study||20||
59593213|NCT03062917|75701715|FG004|STARTED|Overall Study||0||
59593214|NCT03062917|75701711|FG000|COMPLETED|Overall Study||32||
59593215|NCT03062917|75701712|FG001|COMPLETED|Overall Study||51||
59593216|NCT03062917|75701713|FG002|COMPLETED|Overall Study||49||
59593217|NCT03062917|75701714|FG003|COMPLETED|Overall Study||20||
59593218|NCT03062917|75701715|FG004|COMPLETED|Overall Study||0||
59593219|NCT03062917|75701711|FG000|NOT COMPLETED|Overall Study||0||
59593220|NCT03062917|75701712|FG001|NOT COMPLETED|Overall Study||0||
59593221|NCT03062917|75701713|FG002|NOT COMPLETED|Overall Study||0||
59593222|NCT03062917|75701714|FG003|NOT COMPLETED|Overall Study||0||
59593223|NCT03062917|75701715|FG004|NOT COMPLETED|Overall Study||0||
59593224|NCT03047174|75701728|FG000|STARTED|Overall Study||28||
59593225|NCT03047174|75701729|FG001|STARTED|Overall Study||29||
59593226|NCT03047174|75701728|FG000|COMPLETED|Overall Study||9||
59593227|NCT03047174|75701729|FG001|COMPLETED|Overall Study||27||
59593228|NCT03047174|75701728|FG000|NOT COMPLETED|Overall Study||19||
59593229|NCT03047174|75701729|FG001|NOT COMPLETED|Overall Study||2||
59593230|NCT02829307|75701749|FG000|STARTED|Overall Study||8||
59593231|NCT02829307|75701749|FG000|COMPLETED|Overall Study||8||
59593232|NCT02829307|75701749|FG000|NOT COMPLETED|Overall Study||0||
59593233|NCT02985710|75701755|FG000|STARTED|Overall Study||69||
59593234|NCT02985710|75701756|FG001|STARTED|Overall Study||33||
59593235|NCT02985710|75701755|FG000|COMPLETED|Overall Study||65||
59593236|NCT02985710|75701756|FG001|COMPLETED|Overall Study||33||
59593237|NCT02985710|75701755|FG000|NOT COMPLETED|Overall Study||4||
59593238|NCT02985710|75701756|FG001|NOT COMPLETED|Overall Study||0||
59593239|NCT03063385|75701764|FG000|STARTED|Overall Study||330||
59593240|NCT03063385|75701765|FG001|STARTED|Overall Study||330||
59593241|NCT03063385|75701764|FG000|3-month Follow-up|Overall Study||257||
59593242|NCT03063385|75701765|FG001|3-month Follow-up|Overall Study||259||
59593243|NCT03063385|75701764|FG000|6-month Follow-up|Overall Study||265||
59593244|NCT03063385|75701765|FG001|6-month Follow-up|Overall Study||259||
59593245|NCT03063385|75701764|FG000|12-month Follow-up|Overall Study||243||
59726813|NCT01007916|75845561|FG000|STARTED|Period 1, 4 Weeks of Wear||23||
59593246|NCT03063385|75701765|FG001|12-month Follow-up|Overall Study||254||
59593247|NCT03063385|75701764|FG000|COMPLETED|Overall Study||243||
59593248|NCT03063385|75701765|FG001|COMPLETED|Overall Study||254||
59593249|NCT03063385|75701764|FG000|NOT COMPLETED|Overall Study||87||
59593250|NCT03063385|75701765|FG001|NOT COMPLETED|Overall Study||76||
59593251|NCT02986802|75701775|FG000|STARTED|Overall Study||1360||
59593252|NCT02986802|75701776|FG001|STARTED|Overall Study||2839||
59857351|NCT02316340|75982084|FG001|COMPLETED|Optional Cross-over (MD Discretion)||4||
59593253|NCT02986802|75701777|FG002|STARTED|Overall Study||1873||
59593254|NCT02986802|75701778|FG003|STARTED|Overall Study||83060||
59593255|NCT02986802|75701775|FG000|COMPLETED|Overall Study||1360||
59593256|NCT02986802|75701776|FG001|COMPLETED|Overall Study||2839||
59593257|NCT02986802|75701777|FG002|COMPLETED|Overall Study||1873||
59593258|NCT02986802|75701778|FG003|COMPLETED|Overall Study||83060||
59593259|NCT02986802|75701775|FG000|NOT COMPLETED|Overall Study||0||
59593260|NCT02986802|75701776|FG001|NOT COMPLETED|Overall Study||0||
59593261|NCT02986802|75701777|FG002|NOT COMPLETED|Overall Study||0||
59593262|NCT02986802|75701778|FG003|NOT COMPLETED|Overall Study||0||
59593263|NCT02931565|75701788|FG000|STARTED|Overall Study||2||
59593264|NCT02931565|75701789|FG001|STARTED|Overall Study||7||
59593265|NCT02931565|75701788|FG000|COMPLETED|Overall Study||2||
59593266|NCT02931565|75701789|FG001|COMPLETED|Overall Study||7||
59593267|NCT02931565|75701788|FG000|NOT COMPLETED|Overall Study||0||
59593268|NCT02931565|75701789|FG001|NOT COMPLETED|Overall Study||0||
59593269|NCT02986958|75701798|FG000|STARTED|Overall Study||49||
59593270|NCT02986958|75701799|FG001|STARTED|Overall Study||44||
59593271|NCT02986958|75701798|FG000|COMPLETED|Overall Study||49||
59593272|NCT02986958|75701799|FG001|COMPLETED|Overall Study||44||
59593273|NCT02986958|75701798|FG000|NOT COMPLETED|Overall Study||0||
59593274|NCT02986958|75701799|FG001|NOT COMPLETED|Overall Study||0||
59593275|NCT02829463|75701807|FG000|STARTED|Overall Study||59||
59593276|NCT02829463|75701808|FG001|STARTED|Overall Study||62||
59593277|NCT02829463|75701807|FG000|COMPLETED|Overall Study||59||
59593278|NCT02829463|75701808|FG001|COMPLETED|Overall Study||62||
59593279|NCT02829463|75701807|FG000|NOT COMPLETED|Overall Study||0||
59593280|NCT02829463|75701808|FG001|NOT COMPLETED|Overall Study||0||
59593281|NCT03050294|75701818|FG000|STARTED|Overall Study||6||
59593282|NCT03050294|75701819|FG001|STARTED|Overall Study||6||
59593283|NCT03050294|75701820|FG002|STARTED|Overall Study||6||
59593284|NCT03050294|75701821|FG003|STARTED|Overall Study||6||
59593285|NCT03050294|75701818|FG000|COMPLETED|Overall Study||6||
59593286|NCT03050294|75701819|FG001|COMPLETED|Overall Study||6||
59593287|NCT03050294|75701820|FG002|COMPLETED|Overall Study||6||
59593288|NCT03050294|75701821|FG003|COMPLETED|Overall Study||6||
59593289|NCT03050294|75701818|FG000|NOT COMPLETED|Overall Study||0||
59593290|NCT03050294|75701819|FG001|NOT COMPLETED|Overall Study||0||
59593291|NCT03050294|75701820|FG002|NOT COMPLETED|Overall Study||0||
59593292|NCT03050294|75701821|FG003|NOT COMPLETED|Overall Study||0||
59593293|NCT02831569|75701831|FG000|STARTED|Overall Study||80||
59593294|NCT02831569|75701831|FG000|COMPLETED|Overall Study||80||
59593295|NCT02831569|75701831|FG000|NOT COMPLETED|Overall Study||0||
59593296|NCT03050918|75701837|FG000|STARTED|Overall Study||1534||
59593297|NCT03050918|75701838|FG001|STARTED|Overall Study||1520||
59593298|NCT03050918|75701837|FG000|COMPLETED|Overall Study||1534||
59593299|NCT03050918|75701838|FG001|COMPLETED|Overall Study||1520||
59593300|NCT03050918|75701837|FG000|NOT COMPLETED|Overall Study||0||
59593301|NCT03050918|75701838|FG001|NOT COMPLETED|Overall Study||0||
59593302|NCT03065179|75701844|FG000|STARTED|Overall Study||25||
59593303|NCT03065179|75701844|FG000|COMPLETED|Overall Study||25||
59593304|NCT03065179|75701844|FG000|NOT COMPLETED|Overall Study||0||
59593305|NCT02988050|75701850|FG000|STARTED|Overall Study||30||
59593306|NCT02988050|75701851|FG001|STARTED|Overall Study||30||
59593307|NCT02988050|75701850|FG000|COMPLETED|Overall Study||30||
59593308|NCT02988050|75701851|FG001|COMPLETED|Overall Study||30||
59593309|NCT02988050|75701850|FG000|NOT COMPLETED|Overall Study||0||
59593310|NCT02988050|75701851|FG001|NOT COMPLETED|Overall Study||0||
59593311|NCT03065647|75701859|FG000|STARTED|Overall Study||3||
59593312|NCT03065647|75701860|FG001|STARTED|Overall Study||12||
59593313|NCT03065647|75701859|FG000|COMPLETED|Overall Study||3||
59593314|NCT03065647|75701860|FG001|COMPLETED|Overall Study||12||
59593315|NCT03065647|75701859|FG000|NOT COMPLETED|Overall Study||0||
59593316|NCT03065647|75701860|FG001|NOT COMPLETED|Overall Study||0||
59593317|NCT02988986|75701866|FG000|STARTED|Overall Study||28||
59593318|NCT02988986|75701866|FG000|COMPLETED|Overall Study||25||
59593319|NCT02988986|75701866|FG000|NOT COMPLETED|Overall Study||3||
59593320|NCT02832115|75701873|FG000|STARTED|Overall Study||48||
59593321|NCT02832115|75701874|FG001|STARTED|Overall Study||52||
59593322|NCT02832115|75701873|FG000|COMPLETED|Overall Study||48||
59593323|NCT02832115|75701874|FG001|COMPLETED|Overall Study||52||
59593324|NCT02832115|75701873|FG000|NOT COMPLETED|Overall Study||0||
59593325|NCT02832115|75701874|FG001|NOT COMPLETED|Overall Study||0||
59593326|NCT02862080|75701882|FG000|STARTED|7 Days Before Any Intervention||1||
59593327|NCT02862080|75701883|FG001|STARTED|7 Days Before Any Intervention||1||
59593328|NCT02862080|75701884|FG002|STARTED|7 Days Before Any Intervention||1||
59593329|NCT02862080|75701885|FG003|STARTED|7 Days Before Any Intervention||1||
59593330|NCT02862080|75701882|FG000|COMPLETED|7 Days Before Any Intervention||1||
59593331|NCT02862080|75701883|FG001|COMPLETED|7 Days Before Any Intervention||1||
59593332|NCT02862080|75701884|FG002|COMPLETED|7 Days Before Any Intervention||1||
59593333|NCT02862080|75701885|FG003|COMPLETED|7 Days Before Any Intervention||1||
59593334|NCT02862080|75701882|FG000|NOT COMPLETED|7 Days Before Any Intervention||0||
59593335|NCT02862080|75701883|FG001|NOT COMPLETED|7 Days Before Any Intervention||0||
59593336|NCT02862080|75701884|FG002|NOT COMPLETED|7 Days Before Any Intervention||0||
59593337|NCT02862080|75701885|FG003|NOT COMPLETED|7 Days Before Any Intervention||0||
59593338|NCT02862080|75701882|FG000|STARTED|3 Days Before Any Intervention||1||
59593339|NCT02862080|75701883|FG001|STARTED|3 Days Before Any Intervention||1||
59593340|NCT02862080|75701884|FG002|STARTED|3 Days Before Any Intervention||1||
59593341|NCT02862080|75701885|FG003|STARTED|3 Days Before Any Intervention||1||
59593342|NCT02862080|75701882|FG000|COMPLETED|3 Days Before Any Intervention||1||
59593343|NCT02862080|75701883|FG001|COMPLETED|3 Days Before Any Intervention||1||
59593344|NCT02862080|75701884|FG002|COMPLETED|3 Days Before Any Intervention||1||
59593345|NCT02862080|75701885|FG003|COMPLETED|3 Days Before Any Intervention||1||
59593346|NCT02862080|75701882|FG000|NOT COMPLETED|3 Days Before Any Intervention||0||
59593347|NCT02862080|75701883|FG001|NOT COMPLETED|3 Days Before Any Intervention||0||
59593348|NCT02862080|75701884|FG002|NOT COMPLETED|3 Days Before Any Intervention||0||
59593349|NCT02862080|75701885|FG003|NOT COMPLETED|3 Days Before Any Intervention||0||
59593350|NCT02862080|75701882|FG000|STARTED|Intervention 1 (1 Week)||1||
59593351|NCT02862080|75701883|FG001|STARTED|Intervention 1 (1 Week)||1||
59593352|NCT02862080|75701884|FG002|STARTED|Intervention 1 (1 Week)||1||
59593353|NCT02862080|75701885|FG003|STARTED|Intervention 1 (1 Week)||1||
59593354|NCT02862080|75701882|FG000|COMPLETED|Intervention 1 (1 Week)||1||
59593355|NCT02862080|75701883|FG001|COMPLETED|Intervention 1 (1 Week)||1||
59593356|NCT02862080|75701884|FG002|COMPLETED|Intervention 1 (1 Week)||1||
59593357|NCT02862080|75701885|FG003|COMPLETED|Intervention 1 (1 Week)||1||
59593358|NCT02862080|75701882|FG000|NOT COMPLETED|Intervention 1 (1 Week)||0||
59593359|NCT02862080|75701883|FG001|NOT COMPLETED|Intervention 1 (1 Week)||0||
59593360|NCT02862080|75701884|FG002|NOT COMPLETED|Intervention 1 (1 Week)||0||
59593361|NCT02862080|75701885|FG003|NOT COMPLETED|Intervention 1 (1 Week)||0||
59593362|NCT02862080|75701882|FG000|STARTED|Washout (1 Week)||1||
59593363|NCT02862080|75701883|FG001|STARTED|Washout (1 Week)||1||
59593364|NCT02862080|75701884|FG002|STARTED|Washout (1 Week)||1||
59593365|NCT02862080|75701885|FG003|STARTED|Washout (1 Week)||1||
59593366|NCT02862080|75701882|FG000|COMPLETED|Washout (1 Week)||1||
59593367|NCT02862080|75701883|FG001|COMPLETED|Washout (1 Week)||1||
59593368|NCT02862080|75701884|FG002|COMPLETED|Washout (1 Week)||1||
59593369|NCT02862080|75701885|FG003|COMPLETED|Washout (1 Week)||1||
59593370|NCT02862080|75701882|FG000|NOT COMPLETED|Washout (1 Week)||0||
59593371|NCT02862080|75701883|FG001|NOT COMPLETED|Washout (1 Week)||0||
59593372|NCT02862080|75701884|FG002|NOT COMPLETED|Washout (1 Week)||0||
59593373|NCT02862080|75701885|FG003|NOT COMPLETED|Washout (1 Week)||0||
59593374|NCT02862080|75701882|FG000|STARTED|Intervention 2 (1 Week)||1||
59593375|NCT02862080|75701883|FG001|STARTED|Intervention 2 (1 Week)||1||
59593376|NCT02862080|75701884|FG002|STARTED|Intervention 2 (1 Week)||1||
59593377|NCT02862080|75701885|FG003|STARTED|Intervention 2 (1 Week)||1||
59726814|NCT01007916|75845562|FG001|STARTED|Period 1, 4 Weeks of Wear||26||
59726815|NCT01007916|75845561|FG000|COMPLETED|Period 1, 4 Weeks of Wear||22||
59726816|NCT01007916|75845562|FG001|COMPLETED|Period 1, 4 Weeks of Wear||26||
59726817|NCT01007916|75845561|FG000|NOT COMPLETED|Period 1, 4 Weeks of Wear||1||
59726818|NCT01007916|75845562|FG001|NOT COMPLETED|Period 1, 4 Weeks of Wear||0||
59726819|NCT01007916|75845561|FG000|STARTED|Period 2, 4 Weeks of Wear||22||
59726820|NCT01007916|75845562|FG001|STARTED|Period 2, 4 Weeks of Wear|One participant completed Period 1 but did not start Period 2 due to failing inclusion criteria.|25||
59726821|NCT01007916|75845561|FG000|COMPLETED|Period 2, 4 Weeks of Wear||21||
59726822|NCT01007916|75845562|FG001|COMPLETED|Period 2, 4 Weeks of Wear||25||
59726823|NCT01007916|75845561|FG000|NOT COMPLETED|Period 2, 4 Weeks of Wear||1||
59726824|NCT01007916|75845562|FG001|NOT COMPLETED|Period 2, 4 Weeks of Wear||0||
59726825|NCT01007838|75845572|FG000|STARTED|Overall Study||12||
59726826|NCT01007838|75845573|FG001|STARTED|Overall Study||11||
59726827|NCT01007838|75845574|FG002|STARTED|Overall Study||5||
59726828|NCT01007838|75845575|FG003|STARTED|Overall Study||4||
59726829|NCT01007838|75845572|FG000|COMPLETED|Overall Study||9||
59726830|NCT01007838|75845573|FG001|COMPLETED|Overall Study||11||
59726831|NCT01007838|75845574|FG002|COMPLETED|Overall Study||5||
59726832|NCT01007838|75845575|FG003|COMPLETED|Overall Study||4||
59726833|NCT01007838|75845572|FG000|NOT COMPLETED|Overall Study||3||
59726834|NCT01007838|75845573|FG001|NOT COMPLETED|Overall Study||0||
59726835|NCT01007838|75845574|FG002|NOT COMPLETED|Overall Study||0||
59726836|NCT01007838|75845575|FG003|NOT COMPLETED|Overall Study||0||
59726837|NCT01007448|75845587|FG000|STARTED|Overall Study||30||
59726838|NCT01007448|75845588|FG001|STARTED|Overall Study||29||
59726839|NCT01007448|75845587|FG000|Full Analysis Population|Overall Study||30|Received at Least 1 Dose of Study Drug|
59726840|NCT01007448|75845588|FG001|Full Analysis Population|Overall Study||29|Received at Least 1 Dose of Study Drug|
59726841|NCT01007448|75845587|FG000|Safety Population|Overall Study||30|Received at Least 1 Dose of Study Drug and had at least 1 safety assessment after treatment.|
59726842|NCT01007448|75845588|FG001|Safety Population|Overall Study||29|Received at Least 1 Dose of Study Drug and had at least 1 safety assessment after treatment.|
59726843|NCT01007448|75845587|FG000|COMPLETED|Overall Study||20||
59726844|NCT01007448|75845588|FG001|COMPLETED|Overall Study||20||
59726845|NCT01007448|75845587|FG000|NOT COMPLETED|Overall Study||10||
59593378|NCT02862080|75701882|FG000|COMPLETED|Intervention 2 (1 Week)||1||
59593379|NCT02862080|75701883|FG001|COMPLETED|Intervention 2 (1 Week)||1||
59593380|NCT02862080|75701884|FG002|COMPLETED|Intervention 2 (1 Week)||1||
59593381|NCT02862080|75701885|FG003|COMPLETED|Intervention 2 (1 Week)||1||
59726846|NCT01007448|75845588|FG001|NOT COMPLETED|Overall Study||9||
59726847|NCT03538756|75845594|FG000|STARTED|Baseline Cross-over||36||
59726848|NCT03538756|75845595|FG001|STARTED|Baseline Cross-over||33||
59726849|NCT03538756|75845596|FG002|STARTED|Baseline Cross-over||0||
59726850|NCT03538756|75845594|FG000|COMPLETED|Baseline Cross-over||36||
60123505|NCT01533181|76244804|FG000|COMPLETED|Overall Study||14||
59593382|NCT02862080|75701882|FG000|NOT COMPLETED|Intervention 2 (1 Week)||0||
59593383|NCT02862080|75701883|FG001|NOT COMPLETED|Intervention 2 (1 Week)||0||
59593384|NCT02862080|75701884|FG002|NOT COMPLETED|Intervention 2 (1 Week)||0||
59593385|NCT02862080|75701885|FG003|NOT COMPLETED|Intervention 2 (1 Week)||0||
59726851|NCT03538756|75845595|FG001|COMPLETED|Baseline Cross-over||33||
59726852|NCT03538756|75845596|FG002|COMPLETED|Baseline Cross-over||0||
59726853|NCT03538756|75845594|FG000|NOT COMPLETED|Baseline Cross-over||0||
59726854|NCT03538756|75845595|FG001|NOT COMPLETED|Baseline Cross-over||0||
59726855|NCT03538756|75845596|FG002|NOT COMPLETED|Baseline Cross-over||0||
59593386|NCT02862080|75701882|FG000|STARTED|Washout (1 Week)||1||
59593387|NCT02862080|75701883|FG001|STARTED|Washout (1 Week)||1||
59593388|NCT02862080|75701884|FG002|STARTED|Washout (1 Week)||1||
59593389|NCT02862080|75701885|FG003|STARTED|Washout (1 Week)||1||
59593390|NCT02862080|75701882|FG000|COMPLETED|Washout (1 Week)||1||
59593391|NCT02862080|75701883|FG001|COMPLETED|Washout (1 Week)||1||
59593392|NCT02862080|75701884|FG002|COMPLETED|Washout (1 Week)||1||
59593393|NCT02862080|75701885|FG003|COMPLETED|Washout (1 Week)||1||
59593394|NCT02862080|75701882|FG000|NOT COMPLETED|Washout (1 Week)||0||
59593395|NCT02862080|75701883|FG001|NOT COMPLETED|Washout (1 Week)||0||
59593396|NCT02862080|75701884|FG002|NOT COMPLETED|Washout (1 Week)||0||
59593397|NCT02862080|75701885|FG003|NOT COMPLETED|Washout (1 Week)||0||
59593398|NCT02862080|75701882|FG000|STARTED|Intervention 1 Again (1 Week)||1||
59593399|NCT02862080|75701883|FG001|STARTED|Intervention 1 Again (1 Week)||1||
59593400|NCT02862080|75701884|FG002|STARTED|Intervention 1 Again (1 Week)||1||
59593401|NCT02862080|75701885|FG003|STARTED|Intervention 1 Again (1 Week)||1||
59593402|NCT02862080|75701882|FG000|COMPLETED|Intervention 1 Again (1 Week)||1||
59593403|NCT02862080|75701883|FG001|COMPLETED|Intervention 1 Again (1 Week)||1||
59593404|NCT02862080|75701884|FG002|COMPLETED|Intervention 1 Again (1 Week)||1||
59593405|NCT02862080|75701885|FG003|COMPLETED|Intervention 1 Again (1 Week)||1||
59593406|NCT02862080|75701882|FG000|NOT COMPLETED|Intervention 1 Again (1 Week)||0||
59593407|NCT02862080|75701883|FG001|NOT COMPLETED|Intervention 1 Again (1 Week)||0||
59593408|NCT02862080|75701884|FG002|NOT COMPLETED|Intervention 1 Again (1 Week)||0||
59593409|NCT02862080|75701885|FG003|NOT COMPLETED|Intervention 1 Again (1 Week)||0||
59593410|NCT03054506|75701898|FG000|STARTED|Overall Study||20||
59593411|NCT03054506|75701899|FG001|STARTED|Overall Study||11||
59593412|NCT03054506|75701900|FG002|STARTED|Overall Study||9||
59593413|NCT03054506|75701898|FG000|COMPLETED|Overall Study||19||
59593414|NCT03054506|75701899|FG001|COMPLETED|Overall Study||11||
59593415|NCT03054506|75701900|FG002|COMPLETED|Overall Study||9||
59593416|NCT03054506|75701898|FG000|NOT COMPLETED|Overall Study||1||
59593417|NCT03054506|75701899|FG001|NOT COMPLETED|Overall Study||0||
59593418|NCT03054506|75701900|FG002|NOT COMPLETED|Overall Study||0||
59593419|NCT03068611|75701910|FG000|STARTED|Overall Study||61||
59593420|NCT03068611|75701911|FG001|STARTED|Overall Study||58||
59593421|NCT03068611|75701910|FG000|COMPLETED|Overall Study|This is the number of participants followed through 6 months from enrollment.|30||
59593422|NCT03068611|75701911|FG001|COMPLETED|Overall Study|This is the number of participants followed through 6 months from enrollment.|33||
59593423|NCT03068611|75701910|FG000|NOT COMPLETED|Overall Study||31||
59593424|NCT03068611|75701911|FG001|NOT COMPLETED|Overall Study||25||
59593425|NCT02835625|75701919|FG000|STARTED|Overall Study||14734||
59593426|NCT02835625|75701920|FG001|STARTED|Overall Study||14719||
59593427|NCT02835625|75701919|FG000|COMPLETED|Overall Study||14734||
59593428|NCT02835625|75701920|FG001|COMPLETED|Overall Study||14719||
59593429|NCT02835625|75701919|FG000|NOT COMPLETED|Overall Study||0||
59593430|NCT02835625|75701920|FG001|NOT COMPLETED|Overall Study||0||
59593431|NCT03071887|75701927|FG000|STARTED|Overall Study||13||
59593432|NCT03071887|75701927|FG000|COMPLETED|Overall Study||7||
59593433|NCT03071887|75701927|FG000|NOT COMPLETED|Overall Study||6||
59593434|NCT02935699|75701933|FG000|STARTED|Overall Study||127||
59593435|NCT02935699|75701934|FG001|STARTED|Overall Study||135||
59593436|NCT02935699|75701933|FG000|COMPLETED|Overall Study||127||
59593437|NCT02935699|75701934|FG001|COMPLETED|Overall Study||135||
59593438|NCT02935699|75701933|FG000|NOT COMPLETED|Overall Study||0||
59593439|NCT02935699|75701934|FG001|NOT COMPLETED|Overall Study||0||
59593440|NCT03073759|75701942|FG000|STARTED|Overall Study||2||
59593441|NCT03073759|75701943|FG001|STARTED|Overall Study||2||
59593442|NCT03073759|75701942|FG000|COMPLETED|Overall Study||2||
59593443|NCT03073759|75701943|FG001|COMPLETED|Overall Study||2||
59593444|NCT03073759|75701942|FG000|NOT COMPLETED|Overall Study||0||
59593445|NCT03073759|75701943|FG001|NOT COMPLETED|Overall Study||0||
59593446|NCT02936479|75701950|FG000|STARTED|Overall Study||1||
59726856|NCT03538756|75845594|FG000|STARTED|Long-Term Follow-up||0||
59726857|NCT03538756|75845595|FG001|STARTED|Long-Term Follow-up||0||
59726858|NCT03538756|75845596|FG002|STARTED|Long-Term Follow-up||69||
59593447|NCT02936479|75701950|FG000|COMPLETED|Overall Study||1||
59593448|NCT02936479|75701950|FG000|NOT COMPLETED|Overall Study||0||
59593449|NCT02841241|75701954|FG000|STARTED|Overall Study||7||
59593450|NCT02841241|75701954|FG000|COMPLETED|Overall Study||7||
59593451|NCT02841241|75701954|FG000|NOT COMPLETED|Overall Study||0||
59593452|NCT02865434|75701969|FG000|STARTED|Overall Study||3||
59593453|NCT02865434|75701970|FG001|STARTED|Overall Study||3||
59593454|NCT02865434|75701971|FG002|STARTED|Overall Study||3||
59593455|NCT02865434|75701972|FG003|STARTED|Overall Study||3||
59593456|NCT02865434|75701973|FG004|STARTED|Overall Study||3||
59593457|NCT02865434|75701974|FG005|STARTED|Overall Study||3||
59593458|NCT02865434|75701975|FG006|STARTED|Overall Study||3||
59593459|NCT02865434|75701976|FG007|STARTED|Overall Study||3||
59726859|NCT03538756|75845594|FG000|COMPLETED|Long-Term Follow-up||0|Week 52 Follow-up Visit|
59726860|NCT03538756|75845595|FG001|COMPLETED|Long-Term Follow-up||0|Week 52 Follow-up Visit|
59593460|NCT02865434|75701977|FG008|STARTED|Overall Study||3||
59593461|NCT02865434|75701978|FG009|STARTED|Overall Study||6||
59593462|NCT02865434|75701979|FG010|STARTED|Overall Study||6||
59593463|NCT02865434|75701969|FG000|COMPLETED|Overall Study||3||
59593464|NCT02865434|75701970|FG001|COMPLETED|Overall Study||3||
59593465|NCT02865434|75701971|FG002|COMPLETED|Overall Study||3||
59593466|NCT02865434|75701972|FG003|COMPLETED|Overall Study||3||
59593467|NCT02865434|75701973|FG004|COMPLETED|Overall Study||3||
59593468|NCT02865434|75701974|FG005|COMPLETED|Overall Study||3||
59593469|NCT02865434|75701975|FG006|COMPLETED|Overall Study||3||
59593470|NCT02865434|75701976|FG007|COMPLETED|Overall Study||3||
59593471|NCT02865434|75701977|FG008|COMPLETED|Overall Study||3||
59593472|NCT02865434|75701978|FG009|COMPLETED|Overall Study||6||
59593473|NCT02865434|75701979|FG010|COMPLETED|Overall Study||6||
59593474|NCT02865434|75701969|FG000|NOT COMPLETED|Overall Study||0||
59593475|NCT02865434|75701970|FG001|NOT COMPLETED|Overall Study||0||
59593476|NCT02865434|75701971|FG002|NOT COMPLETED|Overall Study||0||
59593477|NCT02865434|75701972|FG003|NOT COMPLETED|Overall Study||0||
59593478|NCT02865434|75701973|FG004|NOT COMPLETED|Overall Study||0||
59593479|NCT02865434|75701974|FG005|NOT COMPLETED|Overall Study||0||
59593480|NCT02865434|75701975|FG006|NOT COMPLETED|Overall Study||0||
59593481|NCT02865434|75701976|FG007|NOT COMPLETED|Overall Study||0||
59593482|NCT02865434|75701977|FG008|NOT COMPLETED|Overall Study||0||
59593483|NCT02865434|75701978|FG009|NOT COMPLETED|Overall Study||0||
59593484|NCT02865434|75701979|FG010|NOT COMPLETED|Overall Study||0||
59593485|NCT02841397|75702009|FG000|STARTED|Overall Study||50||
59593486|NCT02841397|75702009|FG000|COMPLETED|Overall Study||48||
59593487|NCT02841397|75702009|FG000|NOT COMPLETED|Overall Study||2||
59593488|NCT02846233|75702015|FG000|STARTED|Overall Study||12||
59593489|NCT02846233|75702016|FG001|STARTED|Overall Study||10||
59593490|NCT02846233|75702015|FG000|COMPLETED|Overall Study||10||
59593491|NCT02846233|75702016|FG001|COMPLETED|Overall Study||8||
59593492|NCT02846233|75702015|FG000|NOT COMPLETED|Overall Study||2||
59593493|NCT02846233|75702016|FG001|NOT COMPLETED|Overall Study||2||
59593494|NCT02865590|75702024|FG000|STARTED|Overall Study||8||
59593495|NCT02865590|75702025|FG001|STARTED|Overall Study||8||
59593496|NCT02865590|75702024|FG000|COMPLETED|Overall Study||8||
59593497|NCT02865590|75702025|FG001|COMPLETED|Overall Study||8||
59593498|NCT02865590|75702024|FG000|NOT COMPLETED|Overall Study||0||
59593499|NCT02865590|75702025|FG001|NOT COMPLETED|Overall Study||0||
59593500|NCT02867150|75702031|FG000|STARTED|Overall Study||58||
59593501|NCT02867150|75702031|FG000|COMPLETED|Overall Study||58||
59593502|NCT02867150|75702031|FG000|NOT COMPLETED|Overall Study||0||
59593503|NCT03075085|75702037|FG000|STARTED|Overall Study||352||5
59593504|NCT03075085|75702038|FG001|STARTED|Overall Study||344||4
59593505|NCT03075085|75702037|FG000|COMPLETED|Overall Study||247||5
59593506|NCT03075085|75702038|FG001|COMPLETED|Overall Study||232||4
59593507|NCT03075085|75702037|FG000|NOT COMPLETED|Overall Study||105||0
59593508|NCT03075085|75702038|FG001|NOT COMPLETED|Overall Study||112||0
59593509|NCT02867618|75702044|FG000|STARTED|Overall Study||11||
59593510|NCT02867618|75702044|FG000|COMPLETED|Overall Study||11||
59593511|NCT02867618|75702044|FG000|NOT COMPLETED|Overall Study||0||
59593512|NCT02868242|75702048|FG000|STARTED|Overall Study||19||
59593513|NCT02868242|75702048|FG000|COMPLETED|Overall Study||19||
59593514|NCT02868242|75702048|FG000|NOT COMPLETED|Overall Study||0||
59593515|NCT03075553|75702054|FG000|STARTED|Overall Study||12||
59593516|NCT03075553|75702054|FG000|COMPLETED|Overall Study||12||
59593517|NCT03075553|75702054|FG000|NOT COMPLETED|Overall Study||0||
59593518|NCT03076333|75702058|FG000|STARTED|Overall Study||3||
59593519|NCT03076333|75702058|FG000|COMPLETED|Overall Study||3||
59593520|NCT03076333|75702058|FG000|NOT COMPLETED|Overall Study||0||
59593521|NCT02869334|75702064|FG000|STARTED|Overall Study||10||
59593522|NCT02869334|75702065|FG001|STARTED|Overall Study||10||
59593523|NCT02869334|75702064|FG000|COMPLETED|Overall Study||2||
59593524|NCT02869334|75702065|FG001|COMPLETED|Overall Study||3||
59593525|NCT02869334|75702064|FG000|NOT COMPLETED|Overall Study||8||
59593526|NCT02869334|75702065|FG001|NOT COMPLETED|Overall Study||7||
59593527|NCT03077893|75702073|FG000|STARTED|Overall Study||18||
59593528|NCT03077893|75702074|FG001|STARTED|Overall Study||19||
59726861|NCT03538756|75845596|FG002|COMPLETED|Long-Term Follow-up||36|Week 52 Follow-up Visit|
59593529|NCT03077893|75702073|FG000|COMPLETED|Overall Study||14||
59593530|NCT03077893|75702074|FG001|COMPLETED|Overall Study||16||
59593531|NCT03077893|75702073|FG000|NOT COMPLETED|Overall Study||4||
59726862|NCT03538756|75845594|FG000|NOT COMPLETED|Long-Term Follow-up||0||
59593532|NCT03077893|75702074|FG001|NOT COMPLETED|Overall Study||3||
59593533|NCT03054740|75702083|FG000|STARTED|Overall Study||15||
59593534|NCT03054740|75702084|FG001|STARTED|Overall Study||15||
59593535|NCT03054740|75702083|FG000|COMPLETED|Overall Study||15||
59593536|NCT03054740|75702084|FG001|COMPLETED|Overall Study||15||
59593537|NCT03054740|75702083|FG000|NOT COMPLETED|Overall Study||0||
59726863|NCT03538756|75845595|FG001|NOT COMPLETED|Long-Term Follow-up||0||
59593538|NCT03054740|75702084|FG001|NOT COMPLETED|Overall Study||0||
59593539|NCT02997722|75702092|FG000|STARTED|Overall Study||3||
59593540|NCT02997722|75702093|FG001|STARTED|Overall Study||1||
59593541|NCT02997722|75702092|FG000|COMPLETED|Overall Study||3||
59593542|NCT02997722|75702093|FG001|COMPLETED|Overall Study||1||
59593543|NCT02997722|75702092|FG000|NOT COMPLETED|Overall Study||0||
59593544|NCT02997722|75702093|FG001|NOT COMPLETED|Overall Study||0||
59593545|NCT03078127|75702102|FG000|STARTED|First Intervention||4||
59593546|NCT03078127|75702103|FG001|STARTED|First Intervention||3||
59593547|NCT03078127|75702104|FG002|STARTED|First Intervention||3||
59593548|NCT03078127|75702102|FG000|COMPLETED|First Intervention||4||
59593549|NCT03078127|75702103|FG001|COMPLETED|First Intervention||3||
59593550|NCT03078127|75702104|FG002|COMPLETED|First Intervention||3||
59593551|NCT03078127|75702102|FG000|NOT COMPLETED|First Intervention||0||
59593552|NCT03078127|75702103|FG001|NOT COMPLETED|First Intervention||0||
59593553|NCT03078127|75702104|FG002|NOT COMPLETED|First Intervention||0||
59593554|NCT03078127|75702102|FG000|STARTED|Washout (3-21 Days)||4||
59593555|NCT03078127|75702103|FG001|STARTED|Washout (3-21 Days)||3||
59593556|NCT03078127|75702104|FG002|STARTED|Washout (3-21 Days)||3||
59593557|NCT03078127|75702102|FG000|COMPLETED|Washout (3-21 Days)||4||
59593558|NCT03078127|75702103|FG001|COMPLETED|Washout (3-21 Days)||3||
59593559|NCT03078127|75702104|FG002|COMPLETED|Washout (3-21 Days)||3||
59593560|NCT03078127|75702102|FG000|NOT COMPLETED|Washout (3-21 Days)||0||
59593561|NCT03078127|75702103|FG001|NOT COMPLETED|Washout (3-21 Days)||0||
59593562|NCT03078127|75702104|FG002|NOT COMPLETED|Washout (3-21 Days)||0||
59593563|NCT03078127|75702102|FG000|STARTED|Second Intervention||4||
59593564|NCT03078127|75702103|FG001|STARTED|Second Intervention||3||
59593565|NCT03078127|75702104|FG002|STARTED|Second Intervention||3||
59593566|NCT03078127|75702102|FG000|COMPLETED|Second Intervention||4||
59593567|NCT03078127|75702103|FG001|COMPLETED|Second Intervention||3||
59593568|NCT03078127|75702104|FG002|COMPLETED|Second Intervention||3||
59593569|NCT03078127|75702102|FG000|NOT COMPLETED|Second Intervention||0||
59593570|NCT03078127|75702103|FG001|NOT COMPLETED|Second Intervention||0||
59593571|NCT03078127|75702104|FG002|NOT COMPLETED|Second Intervention||0||
59593572|NCT03078127|75702102|FG000|STARTED|Washout (3-21 Days)||4||
59593573|NCT03078127|75702103|FG001|STARTED|Washout (3-21 Days)||3||
59593574|NCT03078127|75702104|FG002|STARTED|Washout (3-21 Days)||3||
59593575|NCT03078127|75702102|FG000|COMPLETED|Washout (3-21 Days)||4||
59593576|NCT03078127|75702103|FG001|COMPLETED|Washout (3-21 Days)||3||
59593577|NCT03078127|75702104|FG002|COMPLETED|Washout (3-21 Days)||3||
59593578|NCT03078127|75702102|FG000|NOT COMPLETED|Washout (3-21 Days)||0||
59593579|NCT03078127|75702103|FG001|NOT COMPLETED|Washout (3-21 Days)||0||
59593580|NCT03078127|75702104|FG002|NOT COMPLETED|Washout (3-21 Days)||0||
59593581|NCT03078127|75702102|FG000|STARTED|Third Intervention||4||
59593582|NCT03078127|75702103|FG001|STARTED|Third Intervention||3||
59593583|NCT03078127|75702104|FG002|STARTED|Third Intervention||3||
59593584|NCT03078127|75702102|FG000|COMPLETED|Third Intervention||4||
59593585|NCT03078127|75702103|FG001|COMPLETED|Third Intervention||3||
59593586|NCT03078127|75702104|FG002|COMPLETED|Third Intervention||3||
59593587|NCT03078127|75702102|FG000|NOT COMPLETED|Third Intervention||0||
59593588|NCT03078127|75702103|FG001|NOT COMPLETED|Third Intervention||0||
59593589|NCT03078127|75702104|FG002|NOT COMPLETED|Third Intervention||0||
59593590|NCT03056144|75702115|FG000|STARTED|Overall Study||1||
59593591|NCT03056144|75702115|FG000|COMPLETED|Overall Study||1||
59593592|NCT03056144|75702115|FG000|NOT COMPLETED|Overall Study||0||
59593593|NCT02943499|75702121|FG000|STARTED|Overall Study||41||
59593594|NCT02943499|75702122|FG001|STARTED|Overall Study||39||
59593595|NCT02943499|75702121|FG000|COMPLETED|Overall Study||34||
59593596|NCT02943499|75702122|FG001|COMPLETED|Overall Study||34||
59593597|NCT02943499|75702121|FG000|NOT COMPLETED|Overall Study||7||
59593598|NCT02943499|75702122|FG001|NOT COMPLETED|Overall Study||5||
59593599|NCT03000608|75702130|FG000|STARTED|Overall Study||46||
59593600|NCT03000608|75702131|FG001|STARTED|Overall Study||23||
59593601|NCT03000608|75702130|FG000|COMPLETED|Overall Study||40||
59593602|NCT03000608|75702131|FG001|COMPLETED|Overall Study||19||
59593603|NCT03000608|75702130|FG000|NOT COMPLETED|Overall Study||6||
59593604|NCT03000608|75702131|FG001|NOT COMPLETED|Overall Study||4||
59726864|NCT03538756|75845596|FG002|NOT COMPLETED|Long-Term Follow-up||33||
59726865|NCT01004250|75845606|FG000|STARTED|Induction Therapy Period||109||
59726866|NCT01004250|75845606|FG000|Received at Least One Dose of Study Drug|Induction Therapy Period||109||
59726867|NCT01004250|75845606|FG000|Death (Any Cause) or Disease Progression|Induction Therapy Period|Participants (pts) with death or disease progression considered to have completed phase.|21||
59726868|NCT01004250|75845606|FG000|COMPLETED|Induction Therapy Period||94||
59726869|NCT01004250|75845606|FG000|NOT COMPLETED|Induction Therapy Period||15||
60123506|NCT01533181|76244805|FG001|COMPLETED|Overall Study||28||
59593605|NCT02847169|75702137|FG000|STARTED|First Intervention (1 Week)||15||
59593606|NCT02847169|75702138|FG001|STARTED|First Intervention (1 Week)||15||
59593607|NCT02847169|75702137|FG000|COMPLETED|First Intervention (1 Week)||15||
59593608|NCT02847169|75702138|FG001|COMPLETED|First Intervention (1 Week)||15||
59593609|NCT02847169|75702137|FG000|NOT COMPLETED|First Intervention (1 Week)||0||
59593610|NCT02847169|75702138|FG001|NOT COMPLETED|First Intervention (1 Week)||0||
59593611|NCT02847169|75702137|FG000|STARTED|Second Intervention (1 Week)||15||
59593612|NCT02847169|75702138|FG001|STARTED|Second Intervention (1 Week)||15||
59593613|NCT02847169|75702137|FG000|COMPLETED|Second Intervention (1 Week)||15||
59593614|NCT02847169|75702138|FG001|COMPLETED|Second Intervention (1 Week)||15||
59593615|NCT02847169|75702137|FG000|NOT COMPLETED|Second Intervention (1 Week)||0||
59593616|NCT02847169|75702138|FG001|NOT COMPLETED|Second Intervention (1 Week)||0||
59593617|NCT03078595|75702161|FG000|STARTED|Overall Study||24||
59593618|NCT03078595|75702162|FG001|STARTED|Overall Study||24||
59593619|NCT03078595|75702161|FG000|COMPLETED|Overall Study||24||
59593620|NCT03078595|75702162|FG001|COMPLETED|Overall Study||24||
59593621|NCT03078595|75702161|FG000|NOT COMPLETED|Overall Study||0||
59593622|NCT03078595|75702162|FG001|NOT COMPLETED|Overall Study||0||
59593623|NCT03108482|75702172|FG000|STARTED|Overall Study||183|Safety Analysis Set (Study Treatments as actually received)|
59593624|NCT03108482|75702173|FG001|STARTED|Overall Study||183|Safety Analysis Set (Study Treatments as actually received)|
59593625|NCT03108482|75702174|FG002|STARTED|Overall Study||182|Safety Analysis Set (Study Treatments as actually received)|
59593626|NCT03108482|75702175|FG003|STARTED|Overall Study||89|Safety Analysis Set (Study Treatments as actually received)|
59593627|NCT03108482|75702172|FG000|COMPLETED|Overall Study||183||
59593628|NCT03108482|75702173|FG001|COMPLETED|Overall Study||179||
59593629|NCT03108482|75702174|FG002|COMPLETED|Overall Study||180||
59593630|NCT03108482|75702175|FG003|COMPLETED|Overall Study||86||
59593631|NCT03108482|75702172|FG000|NOT COMPLETED|Overall Study||0||
59593632|NCT03108482|75702173|FG001|NOT COMPLETED|Overall Study||4||
59593633|NCT03108482|75702174|FG002|NOT COMPLETED|Overall Study||2||
59593634|NCT03108482|75702175|FG003|NOT COMPLETED|Overall Study||3||
59593635|NCT03079375|75702188|FG000|STARTED|Overall Study||503||
59593636|NCT03079375|75702189|FG001|STARTED|Overall Study||499||
59593637|NCT03079375|75702190|FG002|STARTED|Overall Study||497||
59593638|NCT03079375|75702188|FG000|COMPLETED|Overall Study||498||
59593639|NCT03079375|75702189|FG001|COMPLETED|Overall Study||493||
59593640|NCT03079375|75702190|FG002|COMPLETED|Overall Study||476||
59593641|NCT03079375|75702188|FG000|NOT COMPLETED|Overall Study||5||
59593642|NCT03079375|75702189|FG001|NOT COMPLETED|Overall Study||6||
59593643|NCT03079375|75702190|FG002|NOT COMPLETED|Overall Study||21||
59593644|NCT02871128|75702205|FG000|STARTED|Overall Study||20||
59593645|NCT02871128|75702206|FG001|STARTED|Overall Study||20||
59593646|NCT02871128|75702207|FG002|STARTED|Overall Study||16||
59593647|NCT02871128|75702205|FG000|COMPLETED|Overall Study||20||
59593648|NCT02871128|75702206|FG001|COMPLETED|Overall Study||19||
59593649|NCT02871128|75702207|FG002|COMPLETED|Overall Study||15||
59593650|NCT02871128|75702205|FG000|NOT COMPLETED|Overall Study||0||
59593651|NCT02871128|75702206|FG001|NOT COMPLETED|Overall Study||1||
59593652|NCT02871128|75702207|FG002|NOT COMPLETED|Overall Study||1||
59593653|NCT02850601|75702217|FG000|STARTED|Overall Study||12||
59593654|NCT02850601|75702218|FG001|STARTED|Overall Study||12||
59593655|NCT02850601|75702217|FG000|COMPLETED|Overall Study||12||
59593656|NCT02850601|75702218|FG001|COMPLETED|Overall Study||12||
59593657|NCT02850601|75702217|FG000|NOT COMPLETED|Overall Study||0||
59593658|NCT02850601|75702218|FG001|NOT COMPLETED|Overall Study||0||
59593659|NCT02871440|75702227|FG000|STARTED|Overall Study||12||
59593660|NCT02871440|75702228|FG001|STARTED|Overall Study||13||
59593661|NCT02871440|75702229|FG002|STARTED|Overall Study||15||
59593662|NCT02871440|75702227|FG000|COMPLETED|Overall Study||12||
59593663|NCT02871440|75702228|FG001|COMPLETED|Overall Study||13||
59593664|NCT02871440|75702229|FG002|COMPLETED|Overall Study||15||
59593665|NCT02871440|75702227|FG000|NOT COMPLETED|Overall Study||0||
59593666|NCT02871440|75702228|FG001|NOT COMPLETED|Overall Study||0||
59593667|NCT02871440|75702229|FG002|NOT COMPLETED|Overall Study||0||
59593668|NCT03079531|75702240|FG000|STARTED|Overall Study||24||
59593669|NCT03079531|75702240|FG000|Attended ≥1 Post-baseline Visit|Overall Study||23||
59593670|NCT03079531|75702240|FG000|COMPLETED|Overall Study||17||
59593671|NCT03079531|75702240|FG000|NOT COMPLETED|Overall Study||7||
59593672|NCT03056456|75702244|FG000|STARTED|Period 1||6||
59593673|NCT03056456|75702245|FG001|STARTED|Period 1||6||
59593674|NCT03056456|75702246|FG002|STARTED|Period 1||6||
59593675|NCT03056456|75702247|FG003|STARTED|Period 1||6||
59593676|NCT03056456|75702244|FG000|Received One Dose of Study Drug|Period 1||6||
59593677|NCT03056456|75702245|FG001|Received One Dose of Study Drug|Period 1||6||
59593678|NCT03056456|75702246|FG002|Received One Dose of Study Drug|Period 1||6||
59593679|NCT03056456|75702247|FG003|Received One Dose of Study Drug|Period 1||6||
59593680|NCT03056456|75702244|FG000|COMPLETED|Period 1||6||
59593681|NCT03056456|75702245|FG001|COMPLETED|Period 1||6||
59593682|NCT03056456|75702246|FG002|COMPLETED|Period 1||6||
59593683|NCT03056456|75702247|FG003|COMPLETED|Period 1||6||
59593684|NCT03056456|75702244|FG000|NOT COMPLETED|Period 1||0||
59593685|NCT03056456|75702245|FG001|NOT COMPLETED|Period 1||0||
59593686|NCT03056456|75702246|FG002|NOT COMPLETED|Period 1||0||
59593687|NCT03056456|75702247|FG003|NOT COMPLETED|Period 1||0||
59593688|NCT03056456|75702244|FG000|STARTED|Period 2||6||
59593689|NCT03056456|75702245|FG001|STARTED|Period 2||6||
59593690|NCT03056456|75702246|FG002|STARTED|Period 2||6||
59593691|NCT03056456|75702247|FG003|STARTED|Period 2||6||
59593692|NCT03056456|75702244|FG000|COMPLETED|Period 2||6||
59593693|NCT03056456|75702245|FG001|COMPLETED|Period 2||6||
59593694|NCT03056456|75702246|FG002|COMPLETED|Period 2||6||
59593695|NCT03056456|75702247|FG003|COMPLETED|Period 2||6||
59593696|NCT03056456|75702244|FG000|NOT COMPLETED|Period 2||0||
59593697|NCT03056456|75702245|FG001|NOT COMPLETED|Period 2||0||
59593698|NCT03056456|75702246|FG002|NOT COMPLETED|Period 2||0||
59593699|NCT03056456|75702247|FG003|NOT COMPLETED|Period 2||0||
59593700|NCT03056456|75702244|FG000|STARTED|Period 3||6||
59593701|NCT03056456|75702245|FG001|STARTED|Period 3||6||
59593702|NCT03056456|75702246|FG002|STARTED|Period 3||6||
59593703|NCT03056456|75702247|FG003|STARTED|Period 3||6||
59593704|NCT03056456|75702244|FG000|COMPLETED|Period 3||6||
59593705|NCT03056456|75702245|FG001|COMPLETED|Period 3||6||
59593706|NCT03056456|75702246|FG002|COMPLETED|Period 3||6||
59593707|NCT03056456|75702247|FG003|COMPLETED|Period 3||6||
59593708|NCT03056456|75702244|FG000|NOT COMPLETED|Period 3||0||
59593709|NCT03056456|75702245|FG001|NOT COMPLETED|Period 3||0||
59593710|NCT03056456|75702246|FG002|NOT COMPLETED|Period 3||0||
59593711|NCT03056456|75702247|FG003|NOT COMPLETED|Period 3||0||
59593712|NCT03056456|75702244|FG000|STARTED|Period 4||6||
59593713|NCT03056456|75702245|FG001|STARTED|Period 4||6||
59593714|NCT03056456|75702246|FG002|STARTED|Period 4||6||
59593715|NCT03056456|75702247|FG003|STARTED|Period 4|Participant deviated from 1 week maximum between consecutive periods and did not start Period 4.|5||
59593716|NCT03056456|75702244|FG000|COMPLETED|Period 4||6||
59593717|NCT03056456|75702245|FG001|COMPLETED|Period 4||6||
59593718|NCT03056456|75702246|FG002|COMPLETED|Period 4||6||
59593719|NCT03056456|75702247|FG003|COMPLETED|Period 4||5||
59593720|NCT03056456|75702244|FG000|NOT COMPLETED|Period 4||0||
59593721|NCT03056456|75702245|FG001|NOT COMPLETED|Period 4||0||
59593722|NCT03056456|75702246|FG002|NOT COMPLETED|Period 4||0||
59593723|NCT03056456|75702247|FG003|NOT COMPLETED|Period 4||0||
59593724|NCT03057704|75702262|FG000|STARTED|Overall Study||25||
59593725|NCT03057704|75702263|FG001|STARTED|Overall Study||25||
59593726|NCT03057704|75702262|FG000|COMPLETED|Overall Study||25||
59593727|NCT03057704|75702263|FG001|COMPLETED|Overall Study||25||
59593728|NCT03057704|75702262|FG000|NOT COMPLETED|Overall Study||0||
59593729|NCT03057704|75702263|FG001|NOT COMPLETED|Overall Study||0||
59593730|NCT02874092|75702271|FG000|STARTED|Overall Study||7||
59593731|NCT02874092|75702272|FG001|STARTED|Overall Study||2||
59593732|NCT02874092|75702271|FG000|COMPLETED|Overall Study||7||
59593733|NCT02874092|75702272|FG001|COMPLETED|Overall Study||2||
59593734|NCT02874092|75702271|FG000|NOT COMPLETED|Overall Study||0||
59593735|NCT02874092|75702272|FG001|NOT COMPLETED|Overall Study||0||
59593736|NCT03059810|75702277|FG000|STARTED|Overall Study||63||
59593737|NCT03059810|75702277|FG000|COMPLETED|Overall Study||63||
59593738|NCT03059810|75702277|FG000|NOT COMPLETED|Overall Study||0||
59593739|NCT03062228|75702281|FG000|STARTED|Overall Study||162||
59593740|NCT03062228|75702281|FG000|COMPLETED|Overall Study||162||
59593741|NCT03062228|75702281|FG000|NOT COMPLETED|Overall Study||0||
59593742|NCT02876900|75702288|FG000|STARTED|Overall Study||205||
59593743|NCT02876900|75702289|FG001|STARTED|Overall Study||206||
59593744|NCT02876900|75702290|FG002|STARTED|Overall Study||206||
59593745|NCT02876900|75702288|FG000|COMPLETED|Overall Study||166||
59593746|NCT02876900|75702289|FG001|COMPLETED|Overall Study||158||
59593747|NCT02876900|75702290|FG002|COMPLETED|Overall Study||162||
59593748|NCT02876900|75702288|FG000|NOT COMPLETED|Overall Study||39||
59593749|NCT02876900|75702289|FG001|NOT COMPLETED|Overall Study||48||
59593750|NCT02876900|75702290|FG002|NOT COMPLETED|Overall Study||44||
59593751|NCT03063476|75702298|FG000|STARTED|Overall Study||2||
59593752|NCT03063476|75702298|FG000|COMPLETED|Overall Study||2||
59593753|NCT03063476|75702298|FG000|NOT COMPLETED|Overall Study||0||
59593754|NCT02878382|75702302|FG000|STARTED|Overall Study|total 20 patients.split-scalp: 20 split -scalp received CAL-PDT and the other 20 received C-PDT|20||20
59593755|NCT02878382|75702303|FG001|STARTED|Overall Study|otal 20 patients.split-scalp: 20 split -scalp received CAL-PDT and the other 20 received C-PDT|20||20
59593756|NCT02878382|75702302|FG000|COMPLETED|Overall Study||20||20
59593757|NCT02878382|75702303|FG001|COMPLETED|Overall Study||20||20
59593758|NCT02878382|75702302|FG000|NOT COMPLETED|Overall Study||0||0
59593759|NCT02878382|75702303|FG001|NOT COMPLETED|Overall Study||0||0
59593760|NCT02880176|75702313|FG000|STARTED|Overall Study||23||
59593761|NCT02880176|75702314|FG001|STARTED|Overall Study||11||
59593762|NCT02880176|75702313|FG000|Underwent Cystectomy|Overall Study||22||
59593763|NCT02880176|75702314|FG001|Underwent Cystectomy|Overall Study||11||
59593764|NCT02880176|75702313|FG000|Collected Postop Step Data|Overall Study||22||
59593765|NCT02880176|75702314|FG001|Collected Postop Step Data|Overall Study||11||
59593766|NCT02880176|75702313|FG000|Responded to 30 Day Survey|Overall Study||20||
59593767|NCT02880176|75702314|FG001|Responded to 30 Day Survey|Overall Study||9||
59593768|NCT02880176|75702313|FG000|COMPLETED|Overall Study||20||
59593769|NCT02880176|75702314|FG001|COMPLETED|Overall Study||9||
59593770|NCT02880176|75702313|FG000|NOT COMPLETED|Overall Study||3||
59593771|NCT02880176|75702314|FG001|NOT COMPLETED|Overall Study||2||
59726870|NCT01004250|75845606|FG000|STARTED|Maintenance Therapy Period|Did not enter Maint: 21 pts due to death or disease progression; 1 pts had performance status 2.|72||
59726871|NCT01004250|75845606|FG000|Death (Any Cause) or Disease Progression|Maintenance Therapy Period|Pts with death or disease progression considered to have completed phase.|46||
59593772|NCT02880254|75702322|FG000|STARTED|Overall Study||13||
59593773|NCT02880254|75702323|FG001|STARTED|Overall Study||14||
59593774|NCT02880254|75702322|FG000|COMPLETED|Overall Study||4||
59593775|NCT02880254|75702323|FG001|COMPLETED|Overall Study||4||
59593776|NCT02880254|75702322|FG000|NOT COMPLETED|Overall Study||9||
59593777|NCT02880254|75702323|FG001|NOT COMPLETED|Overall Study||10||
59593778|NCT03115580|75702331|FG000|STARTED|Overall Study||35||
59593779|NCT03115580|75702332|FG001|STARTED|Overall Study||36||
59593780|NCT03115580|75702331|FG000|COMPLETED|Overall Study||35||
59593781|NCT03115580|75702332|FG001|COMPLETED|Overall Study||36||
59593782|NCT03115580|75702331|FG000|NOT COMPLETED|Overall Study||0||
59593783|NCT03115580|75702332|FG001|NOT COMPLETED|Overall Study||0||
59593784|NCT03117140|75702342|FG000|STARTED|Overall Study||40||
59593785|NCT03117140|75702343|FG001|STARTED|Overall Study||40||
59593786|NCT03117140|75702344|FG002|STARTED|Overall Study||40||
59593787|NCT03117140|75702345|FG003|STARTED|Overall Study||40||
59593788|NCT03117140|75702342|FG000|COMPLETED|Overall Study||40||
59593789|NCT03117140|75702343|FG001|COMPLETED|Overall Study||40||
59593790|NCT03117140|75702344|FG002|COMPLETED|Overall Study||40||
59593791|NCT03117140|75702345|FG003|COMPLETED|Overall Study||40||
59593792|NCT03117140|75702342|FG000|NOT COMPLETED|Overall Study||0||
59593793|NCT03117140|75702343|FG001|NOT COMPLETED|Overall Study||0||
59593794|NCT03117140|75702344|FG002|NOT COMPLETED|Overall Study||0||
59593795|NCT03117140|75702345|FG003|NOT COMPLETED|Overall Study||0||
59593796|NCT03118466|75702358|FG000|STARTED|Overall Study||40||
59593797|NCT03118466|75702358|FG000|COMPLETED|Overall Study||40||
59593798|NCT03118466|75702358|FG000|NOT COMPLETED|Overall Study||0||
59593799|NCT03068312|75702364|FG000|STARTED|Overall Study||19||
59593800|NCT03068312|75702365|FG001|STARTED|Overall Study||19||
59593801|NCT03068312|75702364|FG000|COMPLETED|Overall Study||19||
59593802|NCT03068312|75702365|FG001|COMPLETED|Overall Study||19||
59593803|NCT03068312|75702364|FG000|NOT COMPLETED|Overall Study||0||
59593804|NCT03068312|75702365|FG001|NOT COMPLETED|Overall Study||0||
59593805|NCT03119168|75702373|FG000|STARTED|Overall Study||129||
59593806|NCT03119168|75702374|FG001|STARTED|Overall Study||139||
59593807|NCT03119168|75702373|FG000|COMPLETED|Overall Study||129||
59593808|NCT03119168|75702374|FG001|COMPLETED|Overall Study||139||
59593809|NCT03119168|75702373|FG000|NOT COMPLETED|Overall Study||0||
59593810|NCT03119168|75702374|FG001|NOT COMPLETED|Overall Study||0||
59593811|NCT02881112|75702382|FG000|STARTED|Overall Study||180||
59593812|NCT02881112|75702382|FG000|COMPLETED|Overall Study||152||
59593813|NCT02881112|75702382|FG000|NOT COMPLETED|Overall Study||28||
59593814|NCT02881658|75702388|FG000|STARTED|Overall Study||100||
59593815|NCT02881658|75702389|FG001|STARTED|Overall Study||101||
59593816|NCT02881658|75702388|FG000|COMPLETED|Overall Study||98||
59593817|NCT02881658|75702389|FG001|COMPLETED|Overall Study||96||
59593818|NCT02881658|75702388|FG000|NOT COMPLETED|Overall Study||2||
59593819|NCT02881658|75702389|FG001|NOT COMPLETED|Overall Study||5||
59593820|NCT03070730|75702400|FG000|STARTED|Overall Study||0||
59593821|NCT03070730|75702401|FG001|STARTED|Overall Study||0||
59593822|NCT03070730|75702402|FG002|STARTED|Overall Study||0||
59593823|NCT03070730|75702400|FG000|COMPLETED|Overall Study||0||
59593824|NCT03070730|75702401|FG001|COMPLETED|Overall Study||0||
59593825|NCT03070730|75702402|FG002|COMPLETED|Overall Study||0||
59593826|NCT03070730|75702400|FG000|NOT COMPLETED|Overall Study||0||
59593827|NCT03070730|75702401|FG001|NOT COMPLETED|Overall Study||0||
59593828|NCT03070730|75702402|FG002|NOT COMPLETED|Overall Study||0||
59593829|NCT03121820|75702412|FG000|STARTED|First Period||9||
59593830|NCT03121820|75702413|FG001|STARTED|First Period||9||
59593831|NCT03121820|75702412|FG000|COMPLETED|First Period||9||
59593832|NCT03121820|75702413|FG001|COMPLETED|First Period||9||
59593833|NCT03121820|75702412|FG000|NOT COMPLETED|First Period||0||
59593834|NCT03121820|75702413|FG001|NOT COMPLETED|First Period||0||
59593835|NCT03121820|75702412|FG000|STARTED|Second Period (After Washout)||9||
59593836|NCT03121820|75702413|FG001|STARTED|Second Period (After Washout)||9||
59593837|NCT03121820|75702412|FG000|COMPLETED|Second Period (After Washout)||9||
59593838|NCT03121820|75702413|FG001|COMPLETED|Second Period (After Washout)||9||
59593839|NCT03121820|75702412|FG000|NOT COMPLETED|Second Period (After Washout)||0||
59593840|NCT03121820|75702413|FG001|NOT COMPLETED|Second Period (After Washout)||0||
59593841|NCT03123614|75702421|FG000|STARTED|Overall Study||57||114
59593842|NCT03123614|75702422|FG001|STARTED|Overall Study||74||147
59593843|NCT03123614|75702421|FG000|COMPLETED|Overall Study||57||114
59593844|NCT03123614|75702422|FG001|COMPLETED|Overall Study||74||147
59593845|NCT03123614|75702421|FG000|NOT COMPLETED|Overall Study||0||0
59593846|NCT03123614|75702422|FG001|NOT COMPLETED|Overall Study||0||0
59593847|NCT03123848|75702428|FG000|STARTED|Overall Study||8||
59593848|NCT03123848|75702428|FG000|COMPLETED|Overall Study||8||
59593849|NCT03123848|75702428|FG000|NOT COMPLETED|Overall Study||0||
59593850|NCT03124550|75702434|FG000|STARTED|Overall Study||18||
59593851|NCT03124550|75702434|FG000|COMPLETED|Overall Study||18||
59593852|NCT03124550|75702434|FG000|NOT COMPLETED|Overall Study||0||
59593853|NCT02946073|75702442|FG000|STARTED|Titration Phase||811|Subjects were not randomized at this time, so all were receiving open-label CAM2038.|
59593854|NCT02946073|75702443|FG001|STARTED|Titration Phase||0|Subjects were not randomized at this time, so all were receiving open-label CAM2038.|
59593855|NCT02946073|75702444|FG002|STARTED|Titration Phase||98|Subjects were not randomized at this time, so all were receiving open-label CAM2038.|
59593856|NCT02946073|75702445|FG003|STARTED|Titration Phase||0|Subjects were not randomized at this time, so all were receiving open-label CAM2038.|
59593857|NCT02946073|75702442|FG000|COMPLETED|Titration Phase||222|Subjects were not randomized at this time, so all were receiving open-label CAM2038.|
59726872|NCT01004250|75845606|FG000|COMPLETED|Maintenance Therapy Period||46||
59593858|NCT02946073|75702443|FG001|COMPLETED|Titration Phase||0|Subjects were not randomized at this time, so all were receiving open-label CAM2038.|
59593859|NCT02946073|75702444|FG002|COMPLETED|Titration Phase||75|Subjects were not randomized at this time, so all were receiving open-label CAM2038.|
59593860|NCT02946073|75702445|FG003|COMPLETED|Titration Phase||0|Subjects were not randomized at this time, so all were receiving open-label CAM2038.|
59593861|NCT02946073|75702442|FG000|NOT COMPLETED|Titration Phase||589||
59593862|NCT02946073|75702443|FG001|NOT COMPLETED|Titration Phase||0||
59593863|NCT02946073|75702444|FG002|NOT COMPLETED|Titration Phase||23||
59593864|NCT02946073|75702445|FG003|NOT COMPLETED|Titration Phase||0||
59593865|NCT02946073|75702442|FG000|STARTED|Double Blind Phase||112||
59593866|NCT02946073|75702443|FG001|STARTED|Double Blind Phase||110||
59593867|NCT02946073|75702444|FG002|STARTED|Double Blind Phase||0||
59593868|NCT02946073|75702445|FG003|STARTED|Double Blind Phase||0||
59593869|NCT02946073|75702442|FG000|COMPLETED|Double Blind Phase||88||
59593870|NCT02946073|75702443|FG001|COMPLETED|Double Blind Phase||70||
59593871|NCT02946073|75702444|FG002|COMPLETED|Double Blind Phase||0||
59593872|NCT02946073|75702445|FG003|COMPLETED|Double Blind Phase||0||
59593873|NCT02946073|75702442|FG000|NOT COMPLETED|Double Blind Phase||24||
59593874|NCT02946073|75702443|FG001|NOT COMPLETED|Double Blind Phase||40||
59593875|NCT02946073|75702444|FG002|NOT COMPLETED|Double Blind Phase||0||
59593876|NCT02946073|75702445|FG003|NOT COMPLETED|Double Blind Phase||0||
59593877|NCT02946073|75702442|FG000|STARTED|Open Label Phase||0||
59593878|NCT02946073|75702443|FG001|STARTED|Open Label Phase||0||
59593879|NCT02946073|75702444|FG002|STARTED|Open Label Phase||75||
59593880|NCT02946073|75702445|FG003|STARTED|Open Label Phase||57||
59593881|NCT02946073|75702442|FG000|COMPLETED|Open Label Phase||0||
59593882|NCT02946073|75702443|FG001|COMPLETED|Open Label Phase||0||
59593883|NCT02946073|75702444|FG002|COMPLETED|Open Label Phase||54||
59593884|NCT02946073|75702445|FG003|COMPLETED|Open Label Phase||44||
59593885|NCT02946073|75702442|FG000|NOT COMPLETED|Open Label Phase||0||
59593886|NCT02946073|75702443|FG001|NOT COMPLETED|Open Label Phase||0||
59593887|NCT02946073|75702444|FG002|NOT COMPLETED|Open Label Phase||21||
59593888|NCT02946073|75702445|FG003|NOT COMPLETED|Open Label Phase||13||
59593889|NCT03071744|75702464|FG000|STARTED|Overall Study||6||
59593890|NCT03071744|75702464|FG000|COMPLETED|Overall Study||4||
59593891|NCT03071744|75702464|FG000|NOT COMPLETED|Overall Study||2||
59593892|NCT03073148|75702470|FG000|STARTED|Overall Study||21||
59593893|NCT03073148|75702471|FG001|STARTED|Overall Study||10||
59593894|NCT03073148|75702472|FG002|STARTED|Overall Study||4||
59593895|NCT03073148|75702470|FG000|COMPLETED|Overall Study||21||
59593896|NCT03073148|75702471|FG001|COMPLETED|Overall Study||10||
59593897|NCT03073148|75702472|FG002|COMPLETED|Overall Study||0||
59593898|NCT03073148|75702470|FG000|NOT COMPLETED|Overall Study||0||
59593899|NCT03073148|75702471|FG001|NOT COMPLETED|Overall Study||0||
59593900|NCT03073148|75702472|FG002|NOT COMPLETED|Overall Study||4||
59593901|NCT02855281|75702480|FG000|STARTED|Overall Study||50||
59593902|NCT02855281|75702480|FG000|COMPLETED|Overall Study||50||
59593903|NCT02855281|75702480|FG000|NOT COMPLETED|Overall Study||0||
59593904|NCT02946229|75702488|FG000|STARTED|Overall Study||142||
59593905|NCT02946229|75702488|FG000|COMPLETED|Overall Study||142||
59593906|NCT02946229|75702488|FG000|NOT COMPLETED|Overall Study||0||
59593907|NCT03074630|75702492|FG000|STARTED|Overall Study||12||
59593908|NCT03074630|75702492|FG000|COMPLETED|Overall Study||11||
59593909|NCT03074630|75702492|FG000|NOT COMPLETED|Overall Study||1||
59593910|NCT03086707|75702499|FG000|STARTED|Overall Study||7||
59593911|NCT03086707|75702500|FG001|STARTED|Overall Study||7||
59593912|NCT03086707|75702499|FG000|COMPLETED|Overall Study||7||
59593913|NCT03086707|75702500|FG001|COMPLETED|Overall Study||7||
59593914|NCT03086707|75702499|FG000|NOT COMPLETED|Overall Study||0||
59593915|NCT03086707|75702500|FG001|NOT COMPLETED|Overall Study||0||
59593916|NCT03125018|75702508|FG000|STARTED|Overall Study||13||
59593917|NCT03125018|75702508|FG000|COMPLETED|Overall Study||13||
59593918|NCT03125018|75702508|FG000|NOT COMPLETED|Overall Study||0||
59726873|NCT01004250|75845606|FG000|NOT COMPLETED|Maintenance Therapy Period||26||
59726874|NCT01004250|75845606|FG000|STARTED|Follow-Up (FU) Period|Did not enter FU:Death-4pts Ind,1pts Maint; Pt Withdrew-1 pts Ind,1pts Maint; Lost to FU-1 pts Maint|101||
59593919|NCT03088267|75702512|FG000|STARTED|Overall Study||9||
59593920|NCT03088267|75702513|FG001|STARTED|Overall Study||9||
59593921|NCT03088267|75702512|FG000|COMPLETED|Overall Study||9||
59593922|NCT03088267|75702513|FG001|COMPLETED|Overall Study||9||
59593923|NCT03088267|75702512|FG000|NOT COMPLETED|Overall Study||0||
59593924|NCT03088267|75702513|FG001|NOT COMPLETED|Overall Study||0||
59593925|NCT03127358|75702523|FG000|STARTED|Overall Study|3/9/18:Date first participant was randomized to this arm.|3||
59593926|NCT03127358|75702524|FG001|STARTED|Overall Study|3/22/18: Date first participant randomized to this arm.|3||
59593927|NCT03127358|75702525|FG002|STARTED|Overall Study|3/14/18: Date first participant randomized to this arm..|5||
59593928|NCT03127358|75702523|FG000|COMPLETED|Overall Study|12/26/18: Date of SVR for last participant randomized to this arm.|3||
59593929|NCT03127358|75702524|FG001|COMPLETED|Overall Study|2/6/19: Date of SVR for last participant randomized to this arm.|3||
59593930|NCT03127358|75702525|FG002|COMPLETED|Overall Study|11/20/18: Date of SVR for last participant randomized to this arm.|5||
59593931|NCT03127358|75702523|FG000|NOT COMPLETED|Overall Study||0||
59593932|NCT03127358|75702524|FG001|NOT COMPLETED|Overall Study||0||
59593933|NCT03127358|75702525|FG002|NOT COMPLETED|Overall Study||0||
59593934|NCT03088345|75702541|FG000|STARTED|Overall Study||10||
59593935|NCT03088345|75702542|FG001|STARTED|Overall Study||10||
59593936|NCT03088345|75702541|FG000|COMPLETED|Overall Study||10||
59593937|NCT03088345|75702542|FG001|COMPLETED|Overall Study||10||
59593938|NCT03088345|75702541|FG000|NOT COMPLETED|Overall Study||0||
59593939|NCT03088345|75702542|FG001|NOT COMPLETED|Overall Study||0||
59593940|NCT02855437|75702548|FG000|STARTED|Phase 1||23||
59593941|NCT02855437|75702549|FG001|STARTED|Phase 1||21||
59593942|NCT02855437|75702548|FG000|COMPLETED|Phase 1||21||
59593943|NCT02855437|75702549|FG001|COMPLETED|Phase 1||19||
59593944|NCT02855437|75702548|FG000|NOT COMPLETED|Phase 1||2||
59593945|NCT02855437|75702549|FG001|NOT COMPLETED|Phase 1||2||
59593946|NCT02855437|75702548|FG000|STARTED|Crossover Period (Same Day)||21||
59593947|NCT02855437|75702549|FG001|STARTED|Crossover Period (Same Day)||19||
59593948|NCT02855437|75702548|FG000|COMPLETED|Crossover Period (Same Day)||21||
59593949|NCT02855437|75702549|FG001|COMPLETED|Crossover Period (Same Day)||19||
59593950|NCT02855437|75702548|FG000|NOT COMPLETED|Crossover Period (Same Day)||0||
59593951|NCT02855437|75702549|FG001|NOT COMPLETED|Crossover Period (Same Day)||0||
59593952|NCT02855437|75702548|FG000|STARTED|Phase 2||21||
59593953|NCT02855437|75702549|FG001|STARTED|Phase 2||19||
59593954|NCT02855437|75702548|FG000|COMPLETED|Phase 2||20||
59593955|NCT02855437|75702549|FG001|COMPLETED|Phase 2||18||
59593956|NCT02855437|75702548|FG000|NOT COMPLETED|Phase 2||1||
59593957|NCT02855437|75702549|FG001|NOT COMPLETED|Phase 2||1||
59593958|NCT02948257|75702556|FG000|STARTED|Overall Study||52||
59593959|NCT02948257|75702556|FG000|COMPLETED|Overall Study||52||
59593960|NCT02948257|75702556|FG000|NOT COMPLETED|Overall Study||0||
59593961|NCT03127514|75702562|FG000|STARTED|Overall Study||48||
59593962|NCT03127514|75702563|FG001|STARTED|Overall Study||89||
59593963|NCT03127514|75702562|FG000|COMPLETED|Overall Study||38||
59593964|NCT03127514|75702563|FG001|COMPLETED|Overall Study||67||
59593965|NCT03127514|75702562|FG000|NOT COMPLETED|Overall Study||10||
59593966|NCT03127514|75702563|FG001|NOT COMPLETED|Overall Study||22||
59593967|NCT02858713|75702571|FG000|STARTED|Overall Study||68||
59593968|NCT02858713|75702572|FG001|STARTED|Overall Study||66||
59593969|NCT02858713|75702571|FG000|COMPLETED|Overall Study||61||
59593970|NCT02858713|75702572|FG001|COMPLETED|Overall Study||61||
59593971|NCT02858713|75702571|FG000|NOT COMPLETED|Overall Study||7||
59593972|NCT02858713|75702572|FG001|NOT COMPLETED|Overall Study||5||
59593973|NCT03128372|75702582|FG000|STARTED|Overall Study||32||
59593974|NCT03128372|75702582|FG000|COMPLETED|Overall Study||32||
59593975|NCT03128372|75702582|FG000|NOT COMPLETED|Overall Study||0||
59593976|NCT02860507|75702588|FG000|STARTED|Overall Study||25||
59593977|NCT02860507|75702589|FG001|STARTED|Overall Study||25||
59593978|NCT02860507|75702588|FG000|COMPLETED|Overall Study||25||
59593979|NCT02860507|75702589|FG001|COMPLETED|Overall Study||25||
59593980|NCT02860507|75702588|FG000|NOT COMPLETED|Overall Study||0||
59593981|NCT02860507|75702589|FG001|NOT COMPLETED|Overall Study||0||
59593982|NCT03082196|75702597|FG000|STARTED|Overall Study||142||
59593983|NCT03082196|75702598|FG001|STARTED|Overall Study||142||
59593984|NCT03082196|75702597|FG000|COMPLETED|Overall Study||133||
59593985|NCT03082196|75702598|FG001|COMPLETED|Overall Study||129||
59593986|NCT03082196|75702597|FG000|NOT COMPLETED|Overall Study||9||
59593987|NCT03082196|75702598|FG001|NOT COMPLETED|Overall Study||13||
59593988|NCT03092089|75702604|FG000|STARTED|Overall Study||15||
59593989|NCT03092089|75702604|FG000|COMPLETED|Overall Study||15||
59593990|NCT03092089|75702604|FG000|NOT COMPLETED|Overall Study||0||
59593991|NCT03134144|75702610|FG000|STARTED|Overall Study||15||
59593992|NCT03134144|75702611|FG001|STARTED|Overall Study||30||
59593993|NCT03134144|75702610|FG000|COMPLETED|Overall Study||15||
59593994|NCT03134144|75702611|FG001|COMPLETED|Overall Study||30||
59593995|NCT03134144|75702610|FG000|NOT COMPLETED|Overall Study||0||
59593996|NCT03134144|75702611|FG001|NOT COMPLETED|Overall Study||0||
59593997|NCT02861131|75702624|FG000|STARTED|Overall Study||100||
59593998|NCT02861131|75702625|FG001|STARTED|Overall Study||100||
59593999|NCT02861131|75702624|FG000|COMPLETED|Overall Study||100||
59594000|NCT02861131|75702625|FG001|COMPLETED|Overall Study||100||
59594001|NCT02861131|75702624|FG000|NOT COMPLETED|Overall Study||0||
59594002|NCT02861131|75702625|FG001|NOT COMPLETED|Overall Study||0||
59594003|NCT03134768|75702631|FG000|STARTED|Overall Study||50||
59594004|NCT03134768|75702631|FG000|COMPLETED|Overall Study||50||
59594005|NCT03134768|75702631|FG000|NOT COMPLETED|Overall Study||0||
59594006|NCT03093025|75702638|FG000|STARTED|Overall Study||16||
59594007|NCT03093025|75702639|FG001|STARTED|Overall Study|One participant did not take any dose of investigational product after randomization.|17||
59594008|NCT03093025|75702640|FG002|STARTED|Overall Study||18||
59594009|NCT03093025|75702638|FG000|COMPLETED|Overall Study||12||
59594010|NCT03093025|75702639|FG001|COMPLETED|Overall Study||15||
59594011|NCT03093025|75702640|FG002|COMPLETED|Overall Study||16||
59594012|NCT03093025|75702638|FG000|NOT COMPLETED|Overall Study||4||
59594013|NCT03093025|75702639|FG001|NOT COMPLETED|Overall Study||2||
59594014|NCT03093025|75702640|FG002|NOT COMPLETED|Overall Study||2||
59594015|NCT02950753|75702650|FG000|STARTED|Overall Study||15||
59594016|NCT02950753|75702651|FG001|STARTED|Overall Study||15||
59594017|NCT02950753|75702650|FG000|COMPLETED|Overall Study||15||
59594018|NCT02950753|75702651|FG001|COMPLETED|Overall Study||15||
59594019|NCT02950753|75702650|FG000|NOT COMPLETED|Overall Study||0||
59594020|NCT02950753|75702651|FG001|NOT COMPLETED|Overall Study||0||
59594021|NCT03082586|75702663|FG000|STARTED|Overall Study|the patients received a total radiation dose of 57.2 Gy in this group|3||
59594022|NCT03082586|75702664|FG001|STARTED|Overall Study|the patients received a total radiation dose of 64.4 Gy in this group|3||
59594023|NCT03082586|75702665|FG002|STARTED|Overall Study|the patients received a total radiation dose of 71.6 Gy in this group|3||
59594024|NCT03082586|75702666|FG003|STARTED|Overall Study|the patients received a total radiation dose of 78.8 Gy in this group|6||
59594025|NCT03082586|75702667|FG004|STARTED|Overall Study|the patients received a total radiation dose of 86 Gy in this group|13||
59594026|NCT03082586|75702668|FG005|STARTED|Overall Study|the patients received a total radiation dose of 93.2 Gy in this group|3||
59594027|NCT03082586|75702663|FG000|COMPLETED|Overall Study|the patients received a total radiation dose of 57.2 Gy in this group|3||
59594028|NCT03082586|75702664|FG001|COMPLETED|Overall Study|the patients received a total radiation dose of 64.4 Gy in this group|3||
59594029|NCT03082586|75702665|FG002|COMPLETED|Overall Study|the patients received a total radiation dose of 71.6 Gy in this group|3||
59594030|NCT03082586|75702666|FG003|COMPLETED|Overall Study|the patients received a total radiation dose of 78.8 Gy in this group|6||
59594031|NCT03082586|75702667|FG004|COMPLETED|Overall Study|the patients received a total radiation dose of 86 Gy in this group|13||
59594032|NCT03082586|75702668|FG005|COMPLETED|Overall Study|the patients received a total radiation dose of 93.2 Gy in this group|3||
59594033|NCT03082586|75702663|FG000|NOT COMPLETED|Overall Study||0||
59594034|NCT03082586|75702664|FG001|NOT COMPLETED|Overall Study||0||
59594035|NCT03082586|75702665|FG002|NOT COMPLETED|Overall Study||0||
59594036|NCT03082586|75702666|FG003|NOT COMPLETED|Overall Study||0||
59594037|NCT03082586|75702667|FG004|NOT COMPLETED|Overall Study||0||
59594038|NCT03082586|75702668|FG005|NOT COMPLETED|Overall Study||0||
59594039|NCT03086408|75702690|FG000|STARTED|Overall Study||10||
59594040|NCT03086408|75702691|FG001|STARTED|Overall Study||10||
59594041|NCT03086408|75702690|FG000|COMPLETED|Overall Study||10||
59594042|NCT03086408|75702691|FG001|COMPLETED|Overall Study||10||
59594043|NCT03086408|75702690|FG000|NOT COMPLETED|Overall Study||0||
59594044|NCT03086408|75702691|FG001|NOT COMPLETED|Overall Study||0||
59594045|NCT02951143|75702703|FG000|STARTED|Overall Study||97||
59594046|NCT02951143|75702704|FG001|STARTED|Overall Study||41||
59594047|NCT02951143|75702705|FG002|STARTED|Overall Study||47||
59594048|NCT02951143|75702706|FG003|STARTED|Overall Study||39||
59594049|NCT02951143|75702707|FG004|STARTED|Overall Study||37||
59594050|NCT02951143|75702708|FG005|STARTED|Overall Study||44||
59594051|NCT02951143|75702703|FG000|COMPLETED|Overall Study||36||
59594052|NCT02951143|75702704|FG001|COMPLETED|Overall Study||32||
59594053|NCT02951143|75702705|FG002|COMPLETED|Overall Study||29||
59594054|NCT02951143|75702706|FG003|COMPLETED|Overall Study||30||
59594055|NCT02951143|75702707|FG004|COMPLETED|Overall Study||31||
59594056|NCT02951143|75702708|FG005|COMPLETED|Overall Study||29||
59594057|NCT02951143|75702703|FG000|NOT COMPLETED|Overall Study||61||
59594058|NCT02951143|75702704|FG001|NOT COMPLETED|Overall Study||9||
59594059|NCT02951143|75702705|FG002|NOT COMPLETED|Overall Study||18||
59594060|NCT02951143|75702706|FG003|NOT COMPLETED|Overall Study||9||
59594061|NCT02951143|75702707|FG004|NOT COMPLETED|Overall Study||6||
59594062|NCT02951143|75702708|FG005|NOT COMPLETED|Overall Study||15||
59594063|NCT02867059|75702724|FG000|STARTED|Overall Study||7||
59594064|NCT02867059|75702725|FG001|STARTED|Overall Study||10||
59594065|NCT02867059|75702724|FG000|COMPLETED|Overall Study||7||
59594066|NCT02867059|75702725|FG001|COMPLETED|Overall Study||8||
59594067|NCT02867059|75702724|FG000|NOT COMPLETED|Overall Study||0||
59594068|NCT02867059|75702725|FG001|NOT COMPLETED|Overall Study||2||
59594069|NCT03088748|75702733|FG000|STARTED|Overall Study||40||
59594070|NCT03088748|75702734|FG001|STARTED|Overall Study||10||
59594071|NCT03088748|75702733|FG000|COMPLETED|Overall Study||40||
59594072|NCT03088748|75702734|FG001|COMPLETED|Overall Study||10||
59594073|NCT03088748|75702733|FG000|NOT COMPLETED|Overall Study||0||
59594074|NCT03088748|75702734|FG001|NOT COMPLETED|Overall Study||0||
59594075|NCT02953561|75702740|FG000|STARTED|Overall Study||19||
59594076|NCT02953561|75702740|FG000|COMPLETED|Overall Study||19||
59594077|NCT02953561|75702740|FG000|NOT COMPLETED|Overall Study||0||
59594078|NCT03090620|75702746|FG000|STARTED|Overall Study||9||
59594079|NCT03090620|75702747|FG001|STARTED|Overall Study||10||
59594080|NCT03090620|75702746|FG000|COMPLETED|Overall Study||9||
59594081|NCT03090620|75702747|FG001|COMPLETED|Overall Study||10||
59594082|NCT03090620|75702746|FG000|NOT COMPLETED|Overall Study||0||
59594083|NCT03090620|75702747|FG001|NOT COMPLETED|Overall Study||0||
59594084|NCT02953873|75702753|FG000|STARTED|Overall Study||25||
59594085|NCT02953873|75702753|FG000|COMPLETED|Overall Study||25||
59594086|NCT02953873|75702753|FG000|NOT COMPLETED|Overall Study||0||
59594087|NCT03141242|75702759|FG000|STARTED|Overall Study||55||
59594088|NCT03141242|75702760|FG001|STARTED|Overall Study||55||
59594089|NCT03141242|75702759|FG000|Received Allocated Intervenion|Overall Study|11 subjects didn't attend their scheduled group session; all were included in ITT analysis|44|Either attended group session or received mailed material, depending on arm|
59594090|NCT03141242|75702760|FG001|Received Allocated Intervenion|Overall Study||55|Either attended group session or received mailed material, depending on arm|
59594091|NCT03141242|75702759|FG000|6 Month Interview|Overall Study||51||
59594092|NCT03141242|75702760|FG001|6 Month Interview|Overall Study||49||
59594093|NCT03141242|75702759|FG000|COMPLETED|Overall Study||55|Received 12 month Chart Review|
59594094|NCT03141242|75702760|FG001|COMPLETED|Overall Study||55|Received 12 month Chart Review|
59594095|NCT03141242|75702759|FG000|NOT COMPLETED|Overall Study||0||
59594096|NCT03141242|75702760|FG001|NOT COMPLETED|Overall Study||0||
59594097|NCT03095053|75702769|FG000|STARTED|Overall Study|All blastocysts scored morphologically PGT-A of the single best blastocyst from the cohort|109||
59594098|NCT03095053|75702770|FG001|STARTED|Overall Study|All blastocysts scored morphologically|111||
59594099|NCT03095053|75702769|FG000|COMPLETED|Overall Study|29 excluded as blastocyst was predicted to be aneuploid|80||
59594100|NCT03095053|75702770|FG001|COMPLETED|Overall Study||111||
59594101|NCT03095053|75702769|FG000|NOT COMPLETED|Overall Study||29||
59594102|NCT03095053|75702770|FG001|NOT COMPLETED|Overall Study||0||
59594103|NCT03098173|75702778|FG000|STARTED|Overall Study||81||
59594104|NCT03098173|75702779|FG001|STARTED|Overall Study||81||
59594105|NCT03098173|75702778|FG000|COMPLETED|Overall Study||80||
59594106|NCT03098173|75702779|FG001|COMPLETED|Overall Study||79||
59594107|NCT03098173|75702778|FG000|NOT COMPLETED|Overall Study||1||
59594108|NCT03098173|75702779|FG001|NOT COMPLETED|Overall Study||2||
59594109|NCT03091478|75702787|FG000|STARTED|Overall Study||13||
59594110|NCT03091478|75702787|FG000|COMPLETED|Overall Study||13||
59594111|NCT03091478|75702787|FG000|NOT COMPLETED|Overall Study||0||
59594112|NCT02867605|75702791|FG000|STARTED|Overall Study||20||
59594113|NCT02867605|75702791|FG000|COMPLETED|Overall Study||20||
59594114|NCT02867605|75702791|FG000|NOT COMPLETED|Overall Study||0||
59594115|NCT03092024|75702810|FG000|STARTED|Overall Study||24||
59594116|NCT03092024|75702811|FG001|STARTED|Overall Study||16||
59594117|NCT03092024|75702810|FG000|COMPLETED|Overall Study||24||
59594118|NCT03092024|75702811|FG001|COMPLETED|Overall Study||16||
59594119|NCT03092024|75702810|FG000|NOT COMPLETED|Overall Study||0||
59594120|NCT03092024|75702811|FG001|NOT COMPLETED|Overall Study||0||
59594121|NCT03092960|75702819|FG000|STARTED|Overall Study||212||
59594122|NCT03092960|75702820|FG001|STARTED|Overall Study||212||
59594123|NCT03092960|75702819|FG000|COMPLETED|Overall Study||180||
59594124|NCT03092960|75702820|FG001|COMPLETED|Overall Study||186||
59594125|NCT03092960|75702819|FG000|NOT COMPLETED|Overall Study||32||
59594126|NCT03092960|75702820|FG001|NOT COMPLETED|Overall Study||26||
59594127|NCT02870101|75702826|FG000|STARTED|Overall Study||2767||
59594128|NCT02870101|75702826|FG000|COMPLETED|Overall Study||2598||
59594129|NCT02870101|75702826|FG000|NOT COMPLETED|Overall Study||169||
59594130|NCT03143894|75702843|FG000|STARTED|First Intervention (5 Days)||3||
59594131|NCT03143894|75702844|FG001|STARTED|First Intervention (5 Days)||4||
59594132|NCT03143894|75702843|FG000|COMPLETED|First Intervention (5 Days)||3||
59594133|NCT03143894|75702844|FG001|COMPLETED|First Intervention (5 Days)||4||
59594134|NCT03143894|75702843|FG000|NOT COMPLETED|First Intervention (5 Days)||0||
59594135|NCT03143894|75702844|FG001|NOT COMPLETED|First Intervention (5 Days)||0||
59594136|NCT03143894|75702843|FG000|STARTED|Washout (4 Weeks)||3||
59594137|NCT03143894|75702844|FG001|STARTED|Washout (4 Weeks)||4||
59594138|NCT03143894|75702843|FG000|COMPLETED|Washout (4 Weeks)||3||
59594139|NCT03143894|75702844|FG001|COMPLETED|Washout (4 Weeks)||4||
59594140|NCT03143894|75702843|FG000|NOT COMPLETED|Washout (4 Weeks)||0||
59594141|NCT03143894|75702844|FG001|NOT COMPLETED|Washout (4 Weeks)||0||
59594142|NCT03143894|75702843|FG000|STARTED|Second Intervention (5 Days)||3||
59594143|NCT03143894|75702844|FG001|STARTED|Second Intervention (5 Days)||4||
59594144|NCT03143894|75702843|FG000|COMPLETED|Second Intervention (5 Days)||3||
59594145|NCT03143894|75702844|FG001|COMPLETED|Second Intervention (5 Days)||3||
59594146|NCT03143894|75702843|FG000|NOT COMPLETED|Second Intervention (5 Days)||0||
59594147|NCT03143894|75702844|FG001|NOT COMPLETED|Second Intervention (5 Days)||1||
59594148|NCT03144518|75702854|FG000|STARTED|Primary Outcome (Mood)||52||
59594149|NCT03144518|75702855|FG001|STARTED|Primary Outcome (Mood)||51||
59726875|NCT01004250|75845606|FG000|COMPLETED|Follow-Up (FU) Period||100||
59594150|NCT03144518|75702854|FG000|COMPLETED|Primary Outcome (Mood)||52||
59594151|NCT03144518|75702855|FG001|COMPLETED|Primary Outcome (Mood)||51||
59594152|NCT03144518|75702854|FG000|NOT COMPLETED|Primary Outcome (Mood)||0||
59594153|NCT03144518|75702855|FG001|NOT COMPLETED|Primary Outcome (Mood)||0||
59594154|NCT03144518|75702854|FG000|STARTED|4 Weeks Post-Vaccination||52||
59594155|NCT03144518|75702855|FG001|STARTED|4 Weeks Post-Vaccination||51||
59594156|NCT03144518|75702854|FG000|COMPLETED|4 Weeks Post-Vaccination||51||
59594157|NCT03144518|75702855|FG001|COMPLETED|4 Weeks Post-Vaccination||51||
59594158|NCT03144518|75702854|FG000|NOT COMPLETED|4 Weeks Post-Vaccination||1||
59594159|NCT03144518|75702855|FG001|NOT COMPLETED|4 Weeks Post-Vaccination||0||
59594160|NCT03144518|75702854|FG000|STARTED|16 Week Post-Vaccination||52||
59594161|NCT03144518|75702855|FG001|STARTED|16 Week Post-Vaccination||51||
59594162|NCT03144518|75702854|FG000|COMPLETED|16 Week Post-Vaccination||49||
59594163|NCT03144518|75702855|FG001|COMPLETED|16 Week Post-Vaccination||49||
59594164|NCT03144518|75702854|FG000|NOT COMPLETED|16 Week Post-Vaccination||3||
59594165|NCT03144518|75702855|FG001|NOT COMPLETED|16 Week Post-Vaccination||2||
59594166|NCT03148262|75702864|FG000|STARTED|Overall Study||31||
59594167|NCT03148262|75702865|FG001|STARTED|Overall Study||32||
59594168|NCT03148262|75702864|FG000|COMPLETED|Overall Study||28||
59594169|NCT03148262|75702865|FG001|COMPLETED|Overall Study||31||
59594170|NCT03148262|75702864|FG000|NOT COMPLETED|Overall Study||3||
59594171|NCT03148262|75702865|FG001|NOT COMPLETED|Overall Study||1||
59594172|NCT03099655|75702871|FG000|STARTED|Overall Study||440||
59594173|NCT03099655|75702871|FG000|COMPLETED|Overall Study|6-Month visit with original 4798 lead implanted|379||
59594174|NCT03099655|75702871|FG000|NOT COMPLETED|Overall Study||61||
59594175|NCT03093272|75702878|FG000|STARTED|Overall Study||9||
59594176|NCT03093272|75702878|FG000|COMPLETED|Overall Study||9||
59594177|NCT03093272|75702878|FG000|NOT COMPLETED|Overall Study||0||
59594178|NCT03093662|75702884|FG000|STARTED|First Intervention (3 Minutes)||18||
59594179|NCT03093662|75702885|FG001|STARTED|First Intervention (3 Minutes)||19||
59594180|NCT03093662|75702884|FG000|COMPLETED|First Intervention (3 Minutes)||18||
59594181|NCT03093662|75702885|FG001|COMPLETED|First Intervention (3 Minutes)||19||
59594182|NCT03093662|75702884|FG000|NOT COMPLETED|First Intervention (3 Minutes)||0||
59594183|NCT03093662|75702885|FG001|NOT COMPLETED|First Intervention (3 Minutes)||0||
59594184|NCT03093662|75702884|FG000|STARTED|Washout Period (5 Minutes)||18||
59594185|NCT03093662|75702885|FG001|STARTED|Washout Period (5 Minutes)||19||
59594186|NCT03093662|75702884|FG000|COMPLETED|Washout Period (5 Minutes)||18||
59594187|NCT03093662|75702885|FG001|COMPLETED|Washout Period (5 Minutes)||19||
59594188|NCT03093662|75702884|FG000|NOT COMPLETED|Washout Period (5 Minutes)||0||
59594189|NCT03093662|75702885|FG001|NOT COMPLETED|Washout Period (5 Minutes)||0||
59594190|NCT03093662|75702884|FG000|STARTED|Second Intervention (3 Minutes)||18||
59594191|NCT03093662|75702885|FG001|STARTED|Second Intervention (3 Minutes)||19||
59594192|NCT03093662|75702884|FG000|COMPLETED|Second Intervention (3 Minutes)||18||
59594193|NCT03093662|75702885|FG001|COMPLETED|Second Intervention (3 Minutes)||19||
59594194|NCT03093662|75702884|FG000|NOT COMPLETED|Second Intervention (3 Minutes)||0||
59594195|NCT03093662|75702885|FG001|NOT COMPLETED|Second Intervention (3 Minutes)||0||
59594196|NCT03100123|75702893|FG000|STARTED|Overall Study||0||
59594197|NCT03100123|75702894|FG001|STARTED|Overall Study||1||
59594198|NCT03100123|75702893|FG000|COMPLETED|Overall Study||0||
59594199|NCT03100123|75702894|FG001|COMPLETED|Overall Study||1||
59594200|NCT03100123|75702893|FG000|NOT COMPLETED|Overall Study||0||
59594201|NCT03100123|75702894|FG001|NOT COMPLETED|Overall Study||0||
59594202|NCT03097484|75702907|FG000|STARTED|Overall Study||19||
59594203|NCT03097484|75702908|FG001|STARTED|Overall Study||19||
59594204|NCT03097484|75702907|FG000|COMPLETED|Overall Study||19||
59594205|NCT03097484|75702908|FG001|COMPLETED|Overall Study||19||
59594206|NCT03097484|75702907|FG000|NOT COMPLETED|Overall Study||0||
59594207|NCT03097484|75702908|FG001|NOT COMPLETED|Overall Study||0||
59594208|NCT02872909|75702916|FG000|STARTED|Overall Study||32||
59594209|NCT02872909|75702917|FG001|STARTED|Overall Study||18||
59594210|NCT02872909|75702916|FG000|COMPLETED|Overall Study||32||
59594211|NCT02872909|75702917|FG001|COMPLETED|Overall Study||18||
59594212|NCT02872909|75702916|FG000|NOT COMPLETED|Overall Study||0||
59594213|NCT02872909|75702917|FG001|NOT COMPLETED|Overall Study||0||
59594214|NCT02957305|75702925|FG000|STARTED|Overall Study||106||
59594215|NCT02957305|75702926|FG001|STARTED|Overall Study||105||
59594216|NCT02957305|75702925|FG000|COMPLETED|Overall Study||106||
59594217|NCT02957305|75702926|FG001|COMPLETED|Overall Study||105||
59594218|NCT02957305|75702925|FG000|NOT COMPLETED|Overall Study||0||
59857352|NCT02316340|75982083|FG000|NOT COMPLETED|Optional Cross-over (MD Discretion)||3||
59857353|NCT02316340|75982084|FG001|NOT COMPLETED|Optional Cross-over (MD Discretion)||9||
59857354|NCT02063724|75982090|FG000|STARTED|Overall Study||15||
59857355|NCT02063724|75982090|FG000|COMPLETED|Overall Study||14||
59857356|NCT02063724|75982090|FG000|NOT COMPLETED|Overall Study||1||
59857357|NCT01722266|75982098|FG000|STARTED|Overall Study||18||
59857358|NCT01722266|75982099|FG001|STARTED|Overall Study||18||
59857359|NCT01722266|75982100|FG002|STARTED|Overall Study||18||
59857360|NCT01722266|75982101|FG003|STARTED|Overall Study|3 withdrew consent; 1 dropped out due to nausea|18||
59594219|NCT02957305|75702926|FG001|NOT COMPLETED|Overall Study||0||
59594220|NCT02873923|75702932|FG000|STARTED|Overall Study||2846||
59594221|NCT02873923|75702932|FG000|COMPLETED|Overall Study||2846||
59594222|NCT02873923|75702932|FG000|NOT COMPLETED|Overall Study||0||
59594223|NCT03104647|75702936|FG000|STARTED|Overall Study||20||
59857361|NCT01722266|75982098|FG000|COMPLETED|Overall Study||17||
59857362|NCT01722266|75982099|FG001|COMPLETED|Overall Study||15||
59594224|NCT03104647|75702936|FG000|COMPLETED|Overall Study||20||
59594225|NCT03104647|75702936|FG000|NOT COMPLETED|Overall Study||0||
59594226|NCT03104725|75702942|FG000|STARTED|Overall Study||2||
59594227|NCT03104725|75702943|FG001|STARTED|Overall Study||4||
59594228|NCT03104725|75702942|FG000|COMPLETED|Overall Study||2||
59594229|NCT03104725|75702943|FG001|COMPLETED|Overall Study||4||
59594230|NCT03104725|75702942|FG000|NOT COMPLETED|Overall Study||0||
59594231|NCT03104725|75702943|FG001|NOT COMPLETED|Overall Study||0||
59594232|NCT03153956|75702951|FG000|STARTED|Overall Study||39||
59594233|NCT03153956|75702952|FG001|STARTED|Overall Study||38||
59594234|NCT03153956|75702951|FG000|COMPLETED|Overall Study||39||
59594235|NCT03153956|75702952|FG001|COMPLETED|Overall Study||38||
59594236|NCT03153956|75702951|FG000|NOT COMPLETED|Overall Study||0||
59594237|NCT03153956|75702952|FG001|NOT COMPLETED|Overall Study||0||
59857363|NCT01722266|75982100|FG002|COMPLETED|Overall Study||13||
59857364|NCT01722266|75982101|FG003|COMPLETED|Overall Study|3 subjects randomized to 1.2 mg group and 1 to 1.8 mg group tolerated only 0.6 mg|18||
59594238|NCT02876575|75702958|FG000|STARTED|Overall Study||48||
59594239|NCT02876575|75702958|FG000|COMPLETED|Overall Study||48||
59594240|NCT02876575|75702958|FG000|NOT COMPLETED|Overall Study||0||
59594241|NCT03154658|75702965|FG000|STARTED|Overall Study||33||
59594242|NCT03154658|75702966|FG001|STARTED|Overall Study||33||
59594243|NCT03154658|75702965|FG000|COMPLETED|Overall Study||32||
59594244|NCT03154658|75702966|FG001|COMPLETED|Overall Study||32||
59594245|NCT03154658|75702965|FG000|NOT COMPLETED|Overall Study||1||
59594246|NCT03154658|75702966|FG001|NOT COMPLETED|Overall Study||1||
59594247|NCT03157232|75702972|FG000|STARTED|Overall Study||18||
59726876|NCT01004250|75845606|FG000|NOT COMPLETED|Follow-Up (FU) Period||1||
59726877|NCT01004172|75845614|FG000|STARTED|Overall Study||38||
59726878|NCT01004172|75845614|FG000|COMPLETED|Overall Study||0||
59726879|NCT01004172|75845614|FG000|NOT COMPLETED|Overall Study||38||
59726880|NCT01161524|75845621|FG000|STARTED|Core Study (23 Weeks)||85||
59726881|NCT01161524|75845622|FG001|STARTED|Core Study (23 Weeks)||48||
59726882|NCT01161524|75845623|FG002|STARTED|Core Study (23 Weeks)||0||
59726883|NCT01161524|75845621|FG000|COMPLETED|Core Study (23 Weeks)||76||
59726884|NCT01161524|75845622|FG001|COMPLETED|Core Study (23 Weeks)||43||
59726885|NCT01161524|75845623|FG002|COMPLETED|Core Study (23 Weeks)||0||
59726886|NCT01161524|75845621|FG000|NOT COMPLETED|Core Study (23 Weeks)||9||
59726887|NCT01161524|75845622|FG001|NOT COMPLETED|Core Study (23 Weeks)||5||
59726888|NCT01161524|75845623|FG002|NOT COMPLETED|Core Study (23 Weeks)||0||
59726889|NCT01161524|75845621|FG000|STARTED|Extension Phase (Approximately 83 Weeks)||0||
59726890|NCT01161524|75845622|FG001|STARTED|Extension Phase (Approximately 83 Weeks)||0||
59726891|NCT01161524|75845623|FG002|STARTED|Extension Phase (Approximately 83 Weeks)||114||
59726892|NCT01161524|75845621|FG000|COMPLETED|Extension Phase (Approximately 83 Weeks)||0||
59726893|NCT01161524|75845622|FG001|COMPLETED|Extension Phase (Approximately 83 Weeks)||0||
59726894|NCT01161524|75845623|FG002|COMPLETED|Extension Phase (Approximately 83 Weeks)||90||
59726895|NCT01161524|75845621|FG000|NOT COMPLETED|Extension Phase (Approximately 83 Weeks)||0||
59726896|NCT01161524|75845622|FG001|NOT COMPLETED|Extension Phase (Approximately 83 Weeks)||0||
59726897|NCT01161524|75845623|FG002|NOT COMPLETED|Extension Phase (Approximately 83 Weeks)||24||
59726898|NCT01000506|75845636|FG000|STARTED|Overall Study||155||
59726899|NCT01000506|75845637|FG001|STARTED|Overall Study||153||
59726900|NCT01000506|75845638|FG002|STARTED|Overall Study||152||
59726901|NCT01000506|75845639|FG003|STARTED|Overall Study||156||
59726902|NCT01000506|75845636|FG000|COMPLETED|Overall Study||127||
59726903|NCT01000506|75845637|FG001|COMPLETED|Overall Study||129||
59726904|NCT01000506|75845638|FG002|COMPLETED|Overall Study||131||
59726905|NCT01000506|75845639|FG003|COMPLETED|Overall Study||133||
59726906|NCT01000506|75845636|FG000|NOT COMPLETED|Overall Study||28||
59726907|NCT01000506|75845637|FG001|NOT COMPLETED|Overall Study||24||
59726908|NCT01000506|75845638|FG002|NOT COMPLETED|Overall Study||21||
59726909|NCT01000506|75845639|FG003|NOT COMPLETED|Overall Study||23||
59726910|NCT01174238|75845649|FG000|STARTED|Overall Study||38||
59726911|NCT01174238|75845649|FG000|Participants That Underwent FLT-PET Scan|Overall Study||6||
59726912|NCT01174238|75845649|FG000|COMPLETED|Overall Study||36||
59726913|NCT01174238|75845649|FG000|NOT COMPLETED|Overall Study||2||
59726914|NCT01174160|75845658|FG000|STARTED|Overall Study||61||
59726915|NCT01174160|75845659|FG001|STARTED|Overall Study||62||
59726916|NCT01174160|75845658|FG000|Discontinued Pre Dose|Overall Study||6||
59726917|NCT01174160|75845659|FG001|Discontinued Pre Dose|Overall Study||6||
59726918|NCT01174160|75845658|FG000|Dosed|Overall Study||55||
59726919|NCT01174160|75845659|FG001|Dosed|Overall Study||56||
59726920|NCT01174160|75845658|FG000|Discontinued Post Dose|Overall Study||2||
59726921|NCT01174160|75845659|FG001|Discontinued Post Dose|Overall Study||0||
59726922|NCT01174160|75845658|FG000|COMPLETED|Overall Study||53||
59726923|NCT01174160|75845659|FG001|COMPLETED|Overall Study||56||
59726924|NCT01174160|75845658|FG000|NOT COMPLETED|Overall Study||8||
59726925|NCT01174160|75845659|FG001|NOT COMPLETED|Overall Study||6||
59726926|NCT01161446|75845667|FG000|STARTED|Overall Study||116||
59726927|NCT01161446|75845668|FG001|STARTED|Overall Study||114||
59726928|NCT01161446|75845667|FG000|COMPLETED|Overall Study||98||
59726929|NCT01161446|75845668|FG001|COMPLETED|Overall Study||99||
59726930|NCT01161446|75845667|FG000|NOT COMPLETED|Overall Study||18||
59726931|NCT01161446|75845668|FG001|NOT COMPLETED|Overall Study||15||
59726932|NCT01174004|75845676|FG000|STARTED|Overall Study||94||
59726933|NCT01174004|75845677|FG001|STARTED|Overall Study||105||
59726934|NCT01174004|75845676|FG000|COMPLETED|Overall Study||87||
59726935|NCT01174004|75845677|FG001|COMPLETED|Overall Study||89||
60123507|NCT01533181|76244804|FG000|NOT COMPLETED|Overall Study||1||
59594248|NCT03157232|75702972|FG000|COMPLETED|Overall Study||18||
59594249|NCT03157232|75702972|FG000|NOT COMPLETED|Overall Study||0||
59594250|NCT02958787|75702976|FG000|STARTED|Overall Study||135||
59594251|NCT02958787|75702976|FG000|COMPLETED|Overall Study||135||
59726936|NCT01174004|75845676|FG000|NOT COMPLETED|Overall Study||7||
59726937|NCT01174004|75845677|FG001|NOT COMPLETED|Overall Study||16||
59726938|NCT01173692|75845685|FG000|STARTED|Overall Study||22||
59726939|NCT01173692|75845686|FG001|STARTED|Overall Study||25||
59726940|NCT01173692|75845685|FG000|COMPLETED|Overall Study||20||
59726941|NCT01173692|75845686|FG001|COMPLETED|Overall Study||20||
60123508|NCT01533181|76244805|FG001|NOT COMPLETED|Overall Study||1||
59726942|NCT01173692|75845685|FG000|NOT COMPLETED|Overall Study||2||
59726943|NCT01173692|75845686|FG001|NOT COMPLETED|Overall Study||5||
59726944|NCT01101035|75845694|FG000|STARTED|Overall Study||3101||
59726945|NCT01101035|75845695|FG001|STARTED|Overall Study||3097||
59726946|NCT01101035|75845694|FG000|COMPLETED|Overall Study||1704||
59726947|NCT01101035|75845695|FG001|COMPLETED|Overall Study||1706||
59726948|NCT01101035|75845694|FG000|NOT COMPLETED|Overall Study||1397||
59726949|NCT01101035|75845695|FG001|NOT COMPLETED|Overall Study||1391||
59726950|NCT01100567|75845703|FG000|STARTED|Overall Study||50||
59726951|NCT01100567|75845704|FG001|STARTED|Overall Study||51||
59726952|NCT01100567|75845703|FG000|COMPLETED|Overall Study||38||
59726953|NCT01100567|75845704|FG001|COMPLETED|Overall Study||35||
59726954|NCT01100567|75845703|FG000|NOT COMPLETED|Overall Study||12||
59726955|NCT01100567|75845704|FG001|NOT COMPLETED|Overall Study||16||
59726956|NCT01160822|75845717|FG000|STARTED|Overall Study||6||
59726957|NCT01160822|75845718|FG001|STARTED|Overall Study||7||
59726958|NCT01160822|75845719|FG002|STARTED|Overall Study||6||
59726959|NCT01160822|75845720|FG003|STARTED|Overall Study||5||
59726960|NCT01160822|75845721|FG004|STARTED|Overall Study||45||
59726961|NCT01160822|75845722|FG005|STARTED|Overall Study||47||
59726962|NCT01160822|75845723|FG006|STARTED|Overall Study||53||
59726963|NCT01160822|75845717|FG000|COMPLETED|Overall Study||6||
59726964|NCT01160822|75845718|FG001|COMPLETED|Overall Study||7||
59726965|NCT01160822|75845719|FG002|COMPLETED|Overall Study||6||
59726966|NCT01160822|75845720|FG003|COMPLETED|Overall Study||5||
59726967|NCT01160822|75845721|FG004|COMPLETED|Overall Study||36||
59726968|NCT01160822|75845722|FG005|COMPLETED|Overall Study||40||
59726969|NCT01160822|75845723|FG006|COMPLETED|Overall Study||44||
59726970|NCT01160822|75845717|FG000|NOT COMPLETED|Overall Study||0||
59726971|NCT01160822|75845718|FG001|NOT COMPLETED|Overall Study||0||
59726972|NCT01160822|75845719|FG002|NOT COMPLETED|Overall Study||0||
59726973|NCT01160822|75845720|FG003|NOT COMPLETED|Overall Study||0||
59726974|NCT01160822|75845721|FG004|NOT COMPLETED|Overall Study||9||
59726975|NCT01160822|75845722|FG005|NOT COMPLETED|Overall Study||7||
59726976|NCT01160822|75845723|FG006|NOT COMPLETED|Overall Study||9||
59726977|NCT01006980|75845742|FG000|STARTED|Vemurafenib and Dacarbazine||337||
59726978|NCT01006980|75845743|FG001|STARTED|Vemurafenib and Dacarbazine||338||
59726979|NCT01006980|75845742|FG000|Treated|Vemurafenib and Dacarbazine||336||
59726980|NCT01006980|75845743|FG001|Treated|Vemurafenib and Dacarbazine||293||
59726981|NCT01006980|75845742|FG000|COMPLETED|Vemurafenib and Dacarbazine||0||
59726982|NCT01006980|75845743|FG001|COMPLETED|Vemurafenib and Dacarbazine||0||
59726983|NCT01006980|75845742|FG000|NOT COMPLETED|Vemurafenib and Dacarbazine||337||
59726984|NCT01006980|75845743|FG001|NOT COMPLETED|Vemurafenib and Dacarbazine||338||
59726985|NCT01006980|75845742|FG000|STARTED|Crossover: Dacarbazine to Vemurafenib||0||
59726986|NCT01006980|75845743|FG001|STARTED|Crossover: Dacarbazine to Vemurafenib|Participants who crossed over from dacarbazine to vemurafenib treatment.|84||
59726987|NCT01006980|75845742|FG000|COMPLETED|Crossover: Dacarbazine to Vemurafenib||0||
59726988|NCT01006980|75845743|FG001|COMPLETED|Crossover: Dacarbazine to Vemurafenib||0||
59726989|NCT01006980|75845742|FG000|NOT COMPLETED|Crossover: Dacarbazine to Vemurafenib||0||
59857365|NCT01722266|75982098|FG000|NOT COMPLETED|Overall Study||1||
59857366|NCT01722266|75982099|FG001|NOT COMPLETED|Overall Study||3||
60123509|NCT02669082|76244811|FG000|STARTED|Overall Study||26||
59857367|NCT01722266|75982100|FG002|NOT COMPLETED|Overall Study||5||
60123510|NCT02669082|76244811|FG000|COMPLETED|Overall Study||25||
60123511|NCT02669082|76244811|FG000|NOT COMPLETED|Overall Study||1||
60123512|NCT00138645|76244817|FG000|STARTED|Overall Study||30||
60123513|NCT00138645|76244818|FG001|STARTED|Overall Study||30||
60123514|NCT00138645|76244817|FG000|COMPLETED|Overall Study||24||
60123515|NCT00138645|76244818|FG001|COMPLETED|Overall Study||23||
60123516|NCT00138645|76244817|FG000|NOT COMPLETED|Overall Study||6||
60123517|NCT00138645|76244818|FG001|NOT COMPLETED|Overall Study||7||
60123518|NCT00140205|76244827|FG000|STARTED|Overall Study||5||
59726990|NCT01006980|75845743|FG001|NOT COMPLETED|Crossover: Dacarbazine to Vemurafenib||84||
59726991|NCT00887926|75845754|FG000|STARTED|Overall Study||3||
59726992|NCT00887926|75845755|FG001|STARTED|Overall Study||14||
59726993|NCT00887926|75845756|FG002|STARTED|Overall Study||3||
59726994|NCT00887926|75845757|FG003|STARTED|Overall Study||5||
59726995|NCT00887926|75845754|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3||
59857368|NCT01722266|75982101|FG003|NOT COMPLETED|Overall Study||0||
59857369|NCT01468896|75982113|FG000|STARTED|Overall Study||6||
59726996|NCT00887926|75845755|FG001|Received at Least 1 Dose of Study Drug|Overall Study||13||
59726997|NCT00887926|75845756|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3||
59726998|NCT00887926|75845757|FG003|Received at Least 1 Dose of Study Drug|Overall Study||5||
60123519|NCT00140205|76244828|FG001|STARTED|Overall Study||5||
60123520|NCT00140205|76244829|FG002|STARTED|Overall Study||5||
59726999|NCT00887926|75845754|FG000|COMPLETED|Overall Study||3||
59727000|NCT00887926|75845755|FG001|COMPLETED|Overall Study||13||
59727001|NCT00887926|75845756|FG002|COMPLETED|Overall Study||3||
59727002|NCT00887926|75845757|FG003|COMPLETED|Overall Study||5||
59727003|NCT00887926|75845754|FG000|NOT COMPLETED|Overall Study||0||
59727004|NCT00887926|75845755|FG001|NOT COMPLETED|Overall Study||1||
59727005|NCT00887926|75845756|FG002|NOT COMPLETED|Overall Study||0||
59727006|NCT00887926|75845757|FG003|NOT COMPLETED|Overall Study||0||
59727007|NCT00998400|75845771|FG000|STARTED|Overall Study||50||
59727008|NCT00998400|75845772|FG001|STARTED|Overall Study||50||
59727009|NCT00998400|75845771|FG000|COMPLETED|Overall Study||48||
59727010|NCT00998400|75845772|FG001|COMPLETED|Overall Study||48||
59727011|NCT00998400|75845771|FG000|NOT COMPLETED|Overall Study||2||
59727012|NCT00998400|75845772|FG001|NOT COMPLETED|Overall Study||2||
59727013|NCT00997386|75845779|FG000|STARTED|Overall Study||16||
59727014|NCT00997386|75845779|FG000|COMPLETED|Overall Study||9||
59727015|NCT00997386|75845779|FG000|NOT COMPLETED|Overall Study||7||
59727016|NCT00996996|75845783|FG000|STARTED|Overall Study||77||
59727017|NCT00996996|75845783|FG000|COMPLETED|Overall Study|These participants completed 12 years of follow-up.|44||
59727018|NCT00996996|75845783|FG000|NOT COMPLETED|Overall Study||33||
59727019|NCT00996918|75845792|FG000|STARTED|Overall Study||39||
59727020|NCT00996918|75845793|FG001|STARTED|Overall Study||66||
59727021|NCT00996918|75845794|FG002|STARTED|Overall Study||37||
59727022|NCT00996918|75845795|FG003|STARTED|Overall Study||56||
59727023|NCT00996918|75845796|FG004|STARTED|Overall Study||4||
59727024|NCT00996918|75845792|FG000|Treated|Overall Study||39||
59727025|NCT00996918|75845793|FG001|Treated|Overall Study||66||
59727026|NCT00996918|75845794|FG002|Treated|Overall Study||37||
59727027|NCT00996918|75845795|FG003|Treated|Overall Study||56||
59727028|NCT00996918|75845796|FG004|Treated|Overall Study||4||
59727029|NCT00996918|75845792|FG000|COMPLETED|Overall Study||0||
59727030|NCT00996918|75845793|FG001|COMPLETED|Overall Study||0||
59727031|NCT00996918|75845794|FG002|COMPLETED|Overall Study||0||
59727032|NCT00996918|75845795|FG003|COMPLETED|Overall Study||0||
59727033|NCT00996918|75845796|FG004|COMPLETED|Overall Study||0||
59727034|NCT00996918|75845792|FG000|NOT COMPLETED|Overall Study||39||
59727035|NCT00996918|75845793|FG001|NOT COMPLETED|Overall Study||66||
59727036|NCT00996918|75845794|FG002|NOT COMPLETED|Overall Study||37||
59727037|NCT00996918|75845795|FG003|NOT COMPLETED|Overall Study||56||
59727038|NCT00996918|75845796|FG004|NOT COMPLETED|Overall Study||4||
59727039|NCT01160744|75845812|FG000|STARTED|Overall Study||71||
59727040|NCT01160744|75845813|FG001|STARTED|Overall Study||69||
59727041|NCT01160744|75845814|FG002|STARTED|Overall Study||69||
59727042|NCT01160744|75845815|FG003|STARTED|Overall Study||71||
59727043|NCT01160744|75845812|FG000|Received Study Drug|Overall Study||69||
59727044|NCT01160744|75845813|FG001|Received Study Drug|Overall Study||67||
59727045|NCT01160744|75845814|FG002|Received Study Drug|Overall Study||63||
59727046|NCT01160744|75845815|FG003|Received Study Drug|Overall Study||71||
59727047|NCT01160744|75845812|FG000|COMPLETED|Overall Study||60||
59727048|NCT01160744|75845813|FG001|COMPLETED|Overall Study||64||
59727049|NCT01160744|75845814|FG002|COMPLETED|Overall Study||62||
59727050|NCT01160744|75845815|FG003|COMPLETED|Overall Study||67||
59727051|NCT01160744|75845812|FG000|NOT COMPLETED|Overall Study||11||
59727052|NCT01160744|75845813|FG001|NOT COMPLETED|Overall Study||5||
59727053|NCT01160744|75845814|FG002|NOT COMPLETED|Overall Study||7||
59727054|NCT01160744|75845815|FG003|NOT COMPLETED|Overall Study||4||
59727055|NCT01160354|75845830|FG000|STARTED|Overall Study||3||
59727056|NCT01160354|75845831|FG001|STARTED|Overall Study||4||
59727057|NCT01160354|75845832|FG002|STARTED|Overall Study||15||
59727058|NCT01160354|75845830|FG000|COMPLETED|Overall Study||3||
59727059|NCT01160354|75845831|FG001|COMPLETED|Overall Study||3||
59727060|NCT01160354|75845832|FG002|COMPLETED|Overall Study||14||
59727061|NCT01160354|75845830|FG000|NOT COMPLETED|Overall Study||0||
59727062|NCT01160354|75845831|FG001|NOT COMPLETED|Overall Study||1||
59727063|NCT01160354|75845832|FG002|NOT COMPLETED|Overall Study||1||
59727064|NCT01160198|75845843|FG000|STARTED|Overall Study||89||
59727065|NCT01160198|75845844|FG001|STARTED|Overall Study||91||
59727066|NCT01160198|75845845|FG002|STARTED|Overall Study||90||
59727067|NCT01160198|75845843|FG000|COMPLETED|Overall Study||87||
59727068|NCT01160198|75845844|FG001|COMPLETED|Overall Study||88||
59727069|NCT01160198|75845845|FG002|COMPLETED|Overall Study||89||
59727070|NCT01160198|75845843|FG000|NOT COMPLETED|Overall Study||2||
59727071|NCT01160198|75845844|FG001|NOT COMPLETED|Overall Study||3||
59727072|NCT01160198|75845845|FG002|NOT COMPLETED|Overall Study||1||
59727073|NCT01159574|75845853|FG000|STARTED|Treatment Phase||121||
59727074|NCT01159574|75845853|FG000|COMPLETED|Treatment Phase||100|Completion defined as those that were removed from treatment due to disease progression.|
59727075|NCT01159574|75845853|FG000|NOT COMPLETED|Treatment Phase||21||
59727076|NCT01159574|75845853|FG000|STARTED|Follow Up Phase||112|Follow-up includes all patients except those that passed away on treatment or were non-evaluable.|
59727077|NCT01159574|75845853|FG000|COMPLETED|Follow Up Phase|Completion defined as those that are no longer in long term follow up due to death.|92||
59727078|NCT01159574|75845853|FG000|NOT COMPLETED|Follow Up Phase||20||
59727079|NCT01158950|75845857|FG000|STARTED|1st Intervention (1 Day)||13||
59727080|NCT01158950|75845858|FG001|STARTED|1st Intervention (1 Day)||13||
59727081|NCT01158950|75845857|FG000|Data Collected|1st Intervention (1 Day)||12||
59727082|NCT01158950|75845858|FG001|Data Collected|1st Intervention (1 Day)||11||
59727083|NCT01158950|75845857|FG000|COMPLETED|1st Intervention (1 Day)||12|Data included in analysis|
59727084|NCT01158950|75845858|FG001|COMPLETED|1st Intervention (1 Day)||11|Data included in analysis|
59727085|NCT01158950|75845857|FG000|NOT COMPLETED|1st Intervention (1 Day)||1||
59727086|NCT01158950|75845858|FG001|NOT COMPLETED|1st Intervention (1 Day)||2||
59727087|NCT01158950|75845857|FG000|STARTED|Washout (1 Week)||12||
59727088|NCT01158950|75845858|FG001|STARTED|Washout (1 Week)||11||
59727089|NCT01158950|75845857|FG000|COMPLETED|Washout (1 Week)||12||
59727090|NCT01158950|75845858|FG001|COMPLETED|Washout (1 Week)||11||
59727091|NCT01158950|75845857|FG000|NOT COMPLETED|Washout (1 Week)||0||
59727092|NCT01158950|75845858|FG001|NOT COMPLETED|Washout (1 Week)||0||
59727093|NCT01158950|75845857|FG000|STARTED|2nd Intervention (1 Day)||12||
59727094|NCT01158950|75845858|FG001|STARTED|2nd Intervention (1 Day)||11||
59727095|NCT01158950|75845857|FG000|COMPLETED|2nd Intervention (1 Day)||12||
59857370|NCT01468896|75982114|FG001|STARTED|Overall Study||17||
59857371|NCT01468896|75982113|FG000|COMPLETED|Overall Study||6||
59857372|NCT01468896|75982114|FG001|COMPLETED|Overall Study||17||
59857373|NCT01468896|75982113|FG000|NOT COMPLETED|Overall Study||0||
59857374|NCT01468896|75982114|FG001|NOT COMPLETED|Overall Study||0||
60123521|NCT00140205|76244827|FG000|COMPLETED|Overall Study||5||
60123522|NCT00140205|76244828|FG001|COMPLETED|Overall Study||5||
60123523|NCT00140205|76244829|FG002|COMPLETED|Overall Study||5||
60123524|NCT00140205|76244827|FG000|NOT COMPLETED|Overall Study||0||
60123525|NCT00140205|76244828|FG001|NOT COMPLETED|Overall Study||0||
60123526|NCT00140205|76244829|FG002|NOT COMPLETED|Overall Study||0||
60123527|NCT00279591|76244860|FG000|STARTED|Overall Study||48||
60123528|NCT00279591|76244861|FG001|STARTED|Overall Study||46||
60123529|NCT00279591|76244860|FG000|COMPLETED|Overall Study||48||
60123530|NCT00279591|76244861|FG001|COMPLETED|Overall Study||46||
60123531|NCT00279591|76244860|FG000|NOT COMPLETED|Overall Study||0||
60123532|NCT00279591|76244861|FG001|NOT COMPLETED|Overall Study||0||
59857387|NCT00953771|75982132|FG000|STARTED|Overall Study||9||
59857388|NCT00953771|75982133|FG001|STARTED|Overall Study||20||
59727096|NCT01158950|75845858|FG001|COMPLETED|2nd Intervention (1 Day)||11||
59727097|NCT01158950|75845857|FG000|NOT COMPLETED|2nd Intervention (1 Day)||0||
59727098|NCT01158950|75845858|FG001|NOT COMPLETED|2nd Intervention (1 Day)||0||
59727099|NCT01172288|75845865|FG000|STARTED|Overall Study||17||
59727100|NCT01172288|75845866|FG001|STARTED|Overall Study||14||
59727101|NCT01172288|75845865|FG000|COMPLETED|Overall Study||16||
59727102|NCT01172288|75845866|FG001|COMPLETED|Overall Study||13||
59727103|NCT01172288|75845865|FG000|NOT COMPLETED|Overall Study||1||
59727104|NCT01172288|75845866|FG001|NOT COMPLETED|Overall Study||1||
59727105|NCT00996840|75845877|FG000|STARTED|Overall Study||20||
59727106|NCT00996840|75845878|FG001|STARTED|Overall Study||9||
59727107|NCT00996840|75845879|FG002|STARTED|Overall Study||12||
59727108|NCT00996840|75845880|FG003|STARTED|Overall Study||18||
59727109|NCT00996840|75845881|FG004|STARTED|Overall Study||18||
59727110|NCT00996840|75845877|FG000|COMPLETED|Overall Study||19||
59727111|NCT00996840|75845878|FG001|COMPLETED|Overall Study||7||
59727112|NCT00996840|75845879|FG002|COMPLETED|Overall Study||11||
59727113|NCT00996840|75845880|FG003|COMPLETED|Overall Study||17||
59727114|NCT00996840|75845881|FG004|COMPLETED|Overall Study||16||
59727115|NCT00996840|75845877|FG000|NOT COMPLETED|Overall Study||1||
59727116|NCT00996840|75845878|FG001|NOT COMPLETED|Overall Study||2||
59727117|NCT00996840|75845879|FG002|NOT COMPLETED|Overall Study||1||
59727118|NCT00996840|75845880|FG003|NOT COMPLETED|Overall Study||1||
59727119|NCT00996840|75845881|FG004|NOT COMPLETED|Overall Study||2||
59727120|NCT00998946|75845897|FG000|STARTED|Overall Study||29||
59727121|NCT00998946|75845897|FG000|Safety Population|Overall Study|Safety population included all participants who received at least 1 dose of the study drug.|27||
59727122|NCT00998946|75845897|FG000|COMPLETED|Overall Study||20||
59727123|NCT00998946|75845897|FG000|NOT COMPLETED|Overall Study||9||
59727124|NCT01158404|75845909|FG000|STARTED|Overall Study||3||
59727125|NCT01158404|75845910|FG001|STARTED|Overall Study||4||
59727126|NCT01158404|75845911|FG002|STARTED|Overall Study||3||
59727127|NCT01158404|75845912|FG003|STARTED|Overall Study||3||
59727128|NCT01158404|75845913|FG004|STARTED|Overall Study||6||
59727129|NCT01158404|75845914|FG005|STARTED|Overall Study||5||
59727130|NCT01158404|75845915|FG006|STARTED|Overall Study||3||
59727131|NCT01158404|75845916|FG007|STARTED|Overall Study||8||
59727132|NCT01158404|75845909|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3||
59727133|NCT01158404|75845910|FG001|Received at Least 1 Dose of Study Drug|Overall Study||4||
59857389|NCT00953771|75982132|FG000|COMPLETED|Overall Study||8||
59857390|NCT00953771|75982133|FG001|COMPLETED|Overall Study||20||
59727134|NCT01158404|75845911|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3||
59727135|NCT01158404|75845912|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3||
59857391|NCT00953771|75982132|FG000|NOT COMPLETED|Overall Study||1||
59857392|NCT00953771|75982133|FG001|NOT COMPLETED|Overall Study||0||
59857393|NCT00711490|75982139|FG000|STARTED|Overall Study||5||
60123533|NCT00141765|76244869|FG000|STARTED|Overall Study||25||
59727136|NCT01158404|75845913|FG004|Received at Least 1 Dose of Study Drug|Overall Study||6||
59857394|NCT00711490|75982139|FG000|COMPLETED|Overall Study||5||
59857395|NCT00711490|75982139|FG000|NOT COMPLETED|Overall Study||0||
59857396|NCT00673816|75982145|FG000|STARTED|Overall Study||2||
59857397|NCT00673816|75982145|FG000|COMPLETED|Overall Study||0||
59857398|NCT00673816|75982145|FG000|NOT COMPLETED|Overall Study||2||
59857399|NCT00533117|75982155|FG000|STARTED|Overall Study||18||
59857400|NCT00533117|75982156|FG001|STARTED|Overall Study||19||
59857401|NCT00533117|75982157|FG002|STARTED|Overall Study||20||
59857402|NCT00533117|75982158|FG003|STARTED|Overall Study||18||
59857403|NCT00533117|75982155|FG000|COMPLETED|Overall Study||14||
59857404|NCT00533117|75982156|FG001|COMPLETED|Overall Study||14||
59857405|NCT00533117|75982157|FG002|COMPLETED|Overall Study||14||
59857406|NCT00533117|75982158|FG003|COMPLETED|Overall Study||13||
59857407|NCT00533117|75982155|FG000|NOT COMPLETED|Overall Study||4||
59857408|NCT00533117|75982156|FG001|NOT COMPLETED|Overall Study||5||
59857409|NCT00533117|75982157|FG002|NOT COMPLETED|Overall Study||6||
59857410|NCT00533117|75982158|FG003|NOT COMPLETED|Overall Study||5||
59857411|NCT00026312|75982170|FG000|STARTED|Overall Study||116||
59857412|NCT00026312|75982171|FG001|STARTED|Overall Study||1333||
59857413|NCT00026312|75982170|FG000|COMPLETED|Overall Study||82||
59857414|NCT00026312|75982171|FG001|COMPLETED|Overall Study||1064||
59857415|NCT00026312|75982170|FG000|NOT COMPLETED|Overall Study||34||
59857416|NCT00026312|75982171|FG001|NOT COMPLETED|Overall Study||269||
59857417|NCT03280264|75982181|FG000|STARTED|Overall Study||18||
59857418|NCT03280264|75982181|FG000|COMPLETED|Overall Study||15||
59857419|NCT03280264|75982181|FG000|NOT COMPLETED|Overall Study||3||
59857420|NCT00060840|75982188|FG000|STARTED|Overall Study||73||
59857421|NCT00060840|75982189|FG001|STARTED|Overall Study||77||
59857422|NCT00060840|75982188|FG000|COMPLETED|Overall Study||69||
59857423|NCT00060840|75982189|FG001|COMPLETED|Overall Study||68||
59857424|NCT00060840|75982188|FG000|NOT COMPLETED|Overall Study||4||
59857425|NCT00060840|75982189|FG001|NOT COMPLETED|Overall Study||9||
59857426|NCT03280108|75982197|FG000|STARTED|Overall Study||129|Successful Implantation|
59857427|NCT03280108|75982198|FG001|STARTED|Overall Study||114|Successful Implantation|
59857428|NCT03280108|75982197|FG000|COMPLETED|Overall Study||127||
59857429|NCT03280108|75982198|FG001|COMPLETED|Overall Study||114||
59857430|NCT03280108|75982197|FG000|NOT COMPLETED|Overall Study||2||
59857431|NCT03280108|75982198|FG001|NOT COMPLETED|Overall Study||0||
59857432|NCT00059202|75982211|FG000|STARTED|Overall Study||76||
59857433|NCT00059202|75982212|FG001|STARTED|Overall Study||74||
59857434|NCT00059202|75982211|FG000|COMPLETED|Overall Study||70||
59857435|NCT00059202|75982212|FG001|COMPLETED|Overall Study||59||
59857436|NCT00059202|75982211|FG000|NOT COMPLETED|Overall Study||6||
59857437|NCT00059202|75982212|FG001|NOT COMPLETED|Overall Study||15||
59857438|NCT03278626|75982221|FG000|STARTED|Overall Study||12||
59857439|NCT03278626|75982221|FG000|COMPLETED|Overall Study||7||
59857440|NCT03278626|75982221|FG000|NOT COMPLETED|Overall Study||5||
59857441|NCT03277846|75982227|FG000|STARTED|Overall Study||50||
59857442|NCT03277846|75982228|FG001|STARTED|Overall Study||51||
59857443|NCT03277846|75982227|FG000|COMPLETED|Overall Study||38||
59857444|NCT03277846|75982228|FG001|COMPLETED|Overall Study||40||
59857445|NCT03277846|75982227|FG000|NOT COMPLETED|Overall Study||12||
59857446|NCT03277846|75982228|FG001|NOT COMPLETED|Overall Study||11||
59857447|NCT00073008|75982236|FG000|STARTED|Overall Study||65||
59857448|NCT00073008|75982237|FG001|STARTED|Overall Study||66||
59857449|NCT00073008|75982236|FG000|COMPLETED|Overall Study||3||
59857450|NCT00073008|75982237|FG001|COMPLETED|Overall Study||3||
59727137|NCT01158404|75845914|FG005|Received at Least 1 Dose of Study Drug|Overall Study||5||
59857451|NCT00073008|75982236|FG000|NOT COMPLETED|Overall Study||62||
59857452|NCT00073008|75982237|FG001|NOT COMPLETED|Overall Study||63||
59857453|NCT00058422|75982243|FG000|STARTED|Overall Study||65||
59857454|NCT00058422|75982243|FG000|COMPLETED|Overall Study||63||
59857455|NCT00058422|75982243|FG000|NOT COMPLETED|Overall Study||2||
60123534|NCT00141765|76244869|FG000|COMPLETED|Overall Study||25||
59594252|NCT02958787|75702976|FG000|NOT COMPLETED|Overall Study||0||
59594253|NCT03098420|75702983|FG000|STARTED|Overall Study||7||
59727138|NCT01158404|75845915|FG006|Received at Least 1 Dose of Study Drug|Overall Study||3||
59727139|NCT01158404|75845916|FG007|Received at Least 1 Dose of Study Drug|Overall Study||8||
59727140|NCT01158404|75845909|FG000|COMPLETED|Overall Study||3||
59727141|NCT01158404|75845910|FG001|COMPLETED|Overall Study||3||
59727142|NCT01158404|75845911|FG002|COMPLETED|Overall Study||3||
59727143|NCT01158404|75845912|FG003|COMPLETED|Overall Study||3||
59727144|NCT01158404|75845913|FG004|COMPLETED|Overall Study||3||
59727145|NCT01158404|75845914|FG005|COMPLETED|Overall Study||4||
59727146|NCT01158404|75845915|FG006|COMPLETED|Overall Study||2||
59727147|NCT01158404|75845916|FG007|COMPLETED|Overall Study||6||
59857456|NCT00072384|75982247|FG000|STARTED|Overall Study||30||
59857457|NCT00072384|75982247|FG000|COMPLETED|Overall Study||21||
59857458|NCT00072384|75982247|FG000|NOT COMPLETED|Overall Study||9||
59857459|NCT00054132|75982253|FG000|STARTED|Overall Study||38||
59857460|NCT00054132|75982253|FG000|COMPLETED|Overall Study||37||
59857461|NCT00054132|75982253|FG000|NOT COMPLETED|Overall Study||1||
59857462|NCT00053898|75982260|FG000|STARTED|Overall Study||1552||
59857463|NCT00053898|75982261|FG001|STARTED|Overall Study||1552||
60123535|NCT00141765|76244869|FG000|NOT COMPLETED|Overall Study||0||
59857464|NCT00053898|75982260|FG000|COMPLETED|Overall Study||1538||
59857465|NCT00053898|75982261|FG001|COMPLETED|Overall Study||1539||
59857466|NCT00053898|75982260|FG000|NOT COMPLETED|Overall Study||14||
59857467|NCT00053898|75982261|FG001|NOT COMPLETED|Overall Study||13||
59857468|NCT03138538|75982273|FG000|STARTED|Overall Study||3||
59857469|NCT03138538|75982274|FG001|STARTED|Overall Study||3||
59857470|NCT03138538|75982275|FG002|STARTED|Overall Study||3||
59857471|NCT03138538|75982276|FG003|STARTED|Overall Study||8||
59857472|NCT03138538|75982277|FG004|STARTED|Overall Study||7||
59857473|NCT03138538|75982278|FG005|STARTED|Overall Study||3||
59857474|NCT03138538|75982273|FG000|COMPLETED|Overall Study||3||
59857475|NCT03138538|75982274|FG001|COMPLETED|Overall Study||3||
59857476|NCT03138538|75982275|FG002|COMPLETED|Overall Study||3||
59857477|NCT03138538|75982276|FG003|COMPLETED|Overall Study||8||
59857478|NCT03138538|75982277|FG004|COMPLETED|Overall Study||7||
59857479|NCT03138538|75982278|FG005|COMPLETED|Overall Study||3||
59857480|NCT03138538|75982273|FG000|NOT COMPLETED|Overall Study||0||
59857481|NCT03138538|75982274|FG001|NOT COMPLETED|Overall Study||0||
59857482|NCT03138538|75982275|FG002|NOT COMPLETED|Overall Study||0||
59857483|NCT03138538|75982276|FG003|NOT COMPLETED|Overall Study||0||
59857484|NCT03138538|75982277|FG004|NOT COMPLETED|Overall Study||0||
59857485|NCT03138538|75982278|FG005|NOT COMPLETED|Overall Study||0||
59857486|NCT03256552|75982297|FG000|STARTED|Overall Study||66||66
59857487|NCT03256552|75982297|FG000|GP MDI 28.8 µg|Overall Study||61|Glycopyrronium Metered Dose Inhaler (MDI) 28.8 µg BID|61
59857488|NCT03256552|75982297|FG000|GP MDI 14.4 µg|Overall Study||63|Glycopyrronium Metered Dose Inhaler (MDI) 14.4 µg BID|63
59857489|NCT03256552|75982297|FG000|GP MDI 7.2 µg|Overall Study||62|Glycopyrronium Metered Dose Inhaler (MDI) 7.2 µg BID|62
59857490|NCT03256552|75982297|FG000|Placebo MDI|Overall Study||65|Placebo Metered Dose Inhaler BID|65
59857491|NCT03256552|75982297|FG000|COMPLETED|Overall Study||61||61
59857492|NCT03256552|75982297|FG000|NOT COMPLETED|Overall Study||5||5
59857493|NCT00071058|75982307|FG000|STARTED|Overall Study||50||
59857494|NCT00071058|75982307|FG000|COMPLETED|Overall Study||49||
59857495|NCT00071058|75982307|FG000|NOT COMPLETED|Overall Study||1||
59857496|NCT00053352|75982314|FG000|STARTED|Overall Study||190||
59857497|NCT00053352|75982315|FG001|STARTED|Overall Study||112||
59857498|NCT00053352|75982314|FG000|COMPLETED|Overall Study||169||
59857499|NCT00053352|75982315|FG001|COMPLETED|Overall Study||102||
59857500|NCT00053352|75982314|FG000|NOT COMPLETED|Overall Study||21||
59857501|NCT00053352|75982315|FG001|NOT COMPLETED|Overall Study||10||
59857502|NCT03245398|75982324|FG000|STARTED|Overall Study||93||
59857503|NCT03245398|75982325|FG001|STARTED|Overall Study||93||
59857504|NCT03245398|75982324|FG000|COMPLETED|Overall Study||92||
59857505|NCT03245398|75982325|FG001|COMPLETED|Overall Study||93||
59857506|NCT03245398|75982324|FG000|NOT COMPLETED|Overall Study||1||
59857507|NCT03245398|75982325|FG001|NOT COMPLETED|Overall Study||0||
59857508|NCT03244618|75982335|FG000|STARTED|Overall Study||132||
59857509|NCT03244618|75982336|FG001|STARTED|Overall Study||131||
59857510|NCT03244618|75982335|FG000|Week 2|Overall Study||128||
59857511|NCT03244618|75982336|FG001|Week 2|Overall Study||125||
59857512|NCT03244618|75982335|FG000|COMPLETED|Overall Study||125||
59857513|NCT03244618|75982336|FG001|COMPLETED|Overall Study||122||
59857514|NCT03244618|75982335|FG000|NOT COMPLETED|Overall Study||7||
59857515|NCT03244618|75982336|FG001|NOT COMPLETED|Overall Study||9||
59857516|NCT00052962|75982344|FG000|STARTED|Overall Study||13||
59857517|NCT00052962|75982345|FG001|STARTED|Overall Study||17||
59857518|NCT00052962|75982344|FG000|COMPLETED|Overall Study||12||
59857519|NCT00052962|75982345|FG001|COMPLETED|Overall Study||15||
59857520|NCT00052962|75982344|FG000|NOT COMPLETED|Overall Study||1||
59857521|NCT00052962|75982345|FG001|NOT COMPLETED|Overall Study||2||
59857522|NCT00051636|75982353|FG000|STARTED|Period 1 - Core||90||
59857523|NCT00051636|75982354|FG001|STARTED|Period 1 - Core||82||
59857524|NCT00051636|75982353|FG000|COMPLETED|Period 1 - Core||86||
59857525|NCT00051636|75982354|FG001|COMPLETED|Period 1 - Core||76||
59857526|NCT00051636|75982353|FG000|NOT COMPLETED|Period 1 - Core||4||
59857527|NCT00051636|75982354|FG001|NOT COMPLETED|Period 1 - Core||6||
59857528|NCT00051636|75982353|FG000|STARTED|Period 2- Extended Observation Period||75||
59857529|NCT00051636|75982354|FG001|STARTED|Period 2- Extended Observation Period||52||
59857530|NCT00051636|75982353|FG000|COMPLETED|Period 2- Extended Observation Period|Includes patients retreated for Paget's disease and patients discontinued when sponsor ended study|5||
59857531|NCT00051636|75982354|FG001|COMPLETED|Period 2- Extended Observation Period|Includes patients retreated for Paget's disease|22||
59857532|NCT00051636|75982353|FG000|NOT COMPLETED|Period 2- Extended Observation Period||70||
59857533|NCT00051636|75982354|FG001|NOT COMPLETED|Period 2- Extended Observation Period||30||
59857534|NCT03255382|75982362|FG000|STARTED|Overall Study||60||
59857535|NCT03255382|75982363|FG001|STARTED|Overall Study||60||
59857536|NCT03255382|75982362|FG000|COMPLETED|Overall Study||47||
59857537|NCT03255382|75982363|FG001|COMPLETED|Overall Study||60||
59857538|NCT03255382|75982362|FG000|NOT COMPLETED|Overall Study||13||
59857539|NCT03255382|75982363|FG001|NOT COMPLETED|Overall Study||0||
59857540|NCT03254602|75982370|FG000|STARTED|Overall Study||33||
59857541|NCT03254602|75982370|FG000|COMPLETED|Overall Study||29||
59857542|NCT03254602|75982370|FG000|NOT COMPLETED|Overall Study||4||
60123536|NCT02668692|76244875|FG000|STARTED|Overall Study||101||
59857543|NCT00038142|75982376|FG000|STARTED|Overall Study||32||
59857544|NCT00038142|75982377|FG001|STARTED|Overall Study||14||
59857545|NCT00038142|75982376|FG000|COMPLETED|Overall Study||10||
59857546|NCT00038142|75982377|FG001|COMPLETED|Overall Study||7||
59857547|NCT00038142|75982376|FG000|NOT COMPLETED|Overall Study||22||
59857548|NCT00038142|75982377|FG001|NOT COMPLETED|Overall Study||7||
59857549|NCT00366899|75982385|FG000|STARTED|Infant Series|1 participant was counted twice, 1 participant randomized to 13vPnC, incorrectly received 7vPnC|303||
59857550|NCT00366899|75982386|FG001|STARTED|Infant Series|1 participant randomized to 7vPnC but never vaccinated|303||
59857551|NCT00366899|75982385|FG000|Vaccinated Dose 1|Infant Series|2 participants randomized to 13vPnC, incorrectly received 7vPnC|302||
59857552|NCT00366899|75982386|FG001|Vaccinated Dose 1|Infant Series||302||
59857553|NCT00366899|75982385|FG000|Vaccinated Dose 2|Infant Series|1 participant randomized to 13vPnC, incorrectly received 7vPnC|296||
59857554|NCT00366899|75982386|FG001|Vaccinated Dose 2|Infant Series||293||
59857555|NCT00366899|75982385|FG000|COMPLETED|Infant Series||294||
59857556|NCT00366899|75982386|FG001|COMPLETED|Infant Series||291||
59857557|NCT00366899|75982385|FG000|NOT COMPLETED|Infant Series||9||
59857558|NCT00366899|75982386|FG001|NOT COMPLETED|Infant Series||12||
59857559|NCT00366899|75982385|FG000|STARTED|After Infant Series||294||
59857560|NCT00366899|75982386|FG001|STARTED|After Infant Series||291||
59857561|NCT00366899|75982385|FG000|COMPLETED|After Infant Series||287||
59857562|NCT00366899|75982386|FG001|COMPLETED|After Infant Series||282||
59857563|NCT00366899|75982385|FG000|NOT COMPLETED|After Infant Series||7||
59857564|NCT00366899|75982386|FG001|NOT COMPLETED|After Infant Series||9||
59857565|NCT00366899|75982385|FG000|STARTED|Toddler Dose||287||
59857566|NCT00366899|75982386|FG001|STARTED|Toddler Dose||282||
59857567|NCT00366899|75982385|FG000|COMPLETED|Toddler Dose||285||
59857568|NCT00366899|75982386|FG001|COMPLETED|Toddler Dose||281||
59857569|NCT00366899|75982385|FG000|NOT COMPLETED|Toddler Dose||2||
59857570|NCT00366899|75982386|FG001|NOT COMPLETED|Toddler Dose||1||
59857571|NCT03254134|75982420|FG000|STARTED|Overall Study||5745||
59857572|NCT03254134|75982421|FG001|STARTED|Overall Study||16745||
59857573|NCT03254134|75982420|FG000|COMPLETED|Overall Study||5146||
59857574|NCT03254134|75982421|FG001|COMPLETED|Overall Study||13115||
59857575|NCT03254134|75982420|FG000|NOT COMPLETED|Overall Study||599||
59857576|NCT03254134|75982421|FG001|NOT COMPLETED|Overall Study||3630||
59857577|NCT00037830|75982430|FG000|STARTED|Overall Study||39||
59857578|NCT00037830|75982431|FG001|STARTED|Overall Study||38||
59857579|NCT00037830|75982432|FG002|STARTED|Overall Study||17||
59857580|NCT00037830|75982430|FG000|COMPLETED|Overall Study||29||
59857581|NCT00037830|75982431|FG001|COMPLETED|Overall Study||31||
59857582|NCT00037830|75982432|FG002|COMPLETED|Overall Study||16||
59857583|NCT00037830|75982430|FG000|NOT COMPLETED|Overall Study||10||
59857584|NCT00037830|75982431|FG001|NOT COMPLETED|Overall Study||7||
59857585|NCT00037830|75982432|FG002|NOT COMPLETED|Overall Study||1||
59857586|NCT03242434|75982442|FG000|STARTED|Overall Study||15||
59857587|NCT03242434|75982443|FG001|STARTED|Overall Study||3||
59857588|NCT03242434|75982442|FG000|COMPLETED|Overall Study||15||
59857589|NCT03242434|75982443|FG001|COMPLETED|Overall Study||1||
59857590|NCT03242434|75982442|FG000|NOT COMPLETED|Overall Study||0||
59857591|NCT03242434|75982443|FG001|NOT COMPLETED|Overall Study||2||
59857592|NCT02939014|75982452|FG000|STARTED|Overall Study||30||
59857593|NCT02939014|75982453|FG001|STARTED|Overall Study||9||
59857594|NCT02939014|75982452|FG000|COMPLETED|Overall Study||25|Completed included participants who completed 16 cycles of treatment with brentuximab vedotin and 18-months post-treatment follow-up.|
59857595|NCT02939014|75982453|FG001|COMPLETED|Overall Study||6|Completed included participants who completed 16 cycles of treatment with brentuximab vedotin and 18-months post-treatment follow-up.|
59857596|NCT02939014|75982452|FG000|NOT COMPLETED|Overall Study||5||
59857597|NCT02939014|75982453|FG001|NOT COMPLETED|Overall Study||3||
59857598|NCT00051558|75982462|FG000|STARTED|Overall Study||214||
59857599|NCT00051558|75982463|FG001|STARTED|Overall Study||214||
59857600|NCT00051558|75982462|FG000|COMPLETED|Overall Study||123||
59857601|NCT00051558|75982463|FG001|COMPLETED|Overall Study||118||
59857602|NCT00051558|75982462|FG000|NOT COMPLETED|Overall Study||91||
59857603|NCT00051558|75982463|FG001|NOT COMPLETED|Overall Study||96||
59727148|NCT01158404|75845909|FG000|NOT COMPLETED|Overall Study||0||
59727149|NCT01158404|75845910|FG001|NOT COMPLETED|Overall Study||1||
59727150|NCT01158404|75845911|FG002|NOT COMPLETED|Overall Study||0||
59727151|NCT01158404|75845912|FG003|NOT COMPLETED|Overall Study||0||
59727152|NCT01158404|75845913|FG004|NOT COMPLETED|Overall Study||3||
59727153|NCT01158404|75845914|FG005|NOT COMPLETED|Overall Study||1||
59727154|NCT01158404|75845915|FG006|NOT COMPLETED|Overall Study||1||
59727155|NCT01158404|75845916|FG007|NOT COMPLETED|Overall Study||2||
59727156|NCT00998790|75845936|FG000|STARTED|Overall Study||114||
59857604|NCT03251482|75982474|FG000|STARTED|Overall Study||39||
59857605|NCT03251482|75982475|FG001|STARTED|Overall Study||41||
59857606|NCT03251482|75982476|FG002|STARTED|Overall Study||43||
59857607|NCT03251482|75982477|FG003|STARTED|Overall Study||122||
59857608|NCT03251482|75982478|FG004|STARTED|Overall Study||63||
59857609|NCT03251482|75982474|FG000|Treated|Overall Study||38||
59857610|NCT03251482|75982475|FG001|Treated|Overall Study||40||
59857611|NCT03251482|75982476|FG002|Treated|Overall Study||42||
59857612|NCT03251482|75982477|FG003|Treated|Overall Study||122||
59857613|NCT03251482|75982478|FG004|Treated|Overall Study||63||
59857614|NCT03251482|75982474|FG000|COMPLETED|Overall Study||39||
59857615|NCT03251482|75982475|FG001|COMPLETED|Overall Study||40||
59857616|NCT03251482|75982476|FG002|COMPLETED|Overall Study||43||
59857617|NCT03251482|75982477|FG003|COMPLETED|Overall Study||122||
59857618|NCT03251482|75982478|FG004|COMPLETED|Overall Study||63||
59857619|NCT03251482|75982474|FG000|NOT COMPLETED|Overall Study||0||
59857620|NCT03251482|75982475|FG001|NOT COMPLETED|Overall Study||1||
59857621|NCT03251482|75982476|FG002|NOT COMPLETED|Overall Study||0||
59857622|NCT03251482|75982477|FG003|NOT COMPLETED|Overall Study||0||
59857623|NCT03251482|75982478|FG004|NOT COMPLETED|Overall Study||0||
59857624|NCT03249454|75982490|FG000|STARTED|Overall Study||1||
59857625|NCT03249454|75982491|FG001|STARTED|Overall Study||1||
59857626|NCT03249454|75982492|FG002|STARTED|Overall Study||2||
59857627|NCT03249454|75982493|FG003|STARTED|Overall Study||1||
59857628|NCT03249454|75982494|FG004|STARTED|Overall Study||1||
59857629|NCT03249454|75982495|FG005|STARTED|Overall Study||2||
59857630|NCT03249454|75982496|FG006|STARTED|Overall Study||1||
59857631|NCT03249454|75982497|FG007|STARTED|Overall Study||1||
59857632|NCT03249454|75982498|FG008|STARTED|Overall Study||1||
59857633|NCT03249454|75982499|FG009|STARTED|Overall Study||1||
59857634|NCT03249454|75982500|FG010|STARTED|Overall Study||1||
59857635|NCT03249454|75982490|FG000|First Intervention (1 Day)|Overall Study||1||
59857636|NCT03249454|75982491|FG001|First Intervention (1 Day)|Overall Study||1||
59857637|NCT03249454|75982492|FG002|First Intervention (1 Day)|Overall Study||2||
59857638|NCT03249454|75982493|FG003|First Intervention (1 Day)|Overall Study||1||
59857639|NCT03249454|75982494|FG004|First Intervention (1 Day)|Overall Study||1||
59857640|NCT03249454|75982495|FG005|First Intervention (1 Day)|Overall Study||2||
59857641|NCT03249454|75982496|FG006|First Intervention (1 Day)|Overall Study||1||
59857642|NCT03249454|75982497|FG007|First Intervention (1 Day)|Overall Study||1||
59857643|NCT03249454|75982498|FG008|First Intervention (1 Day)|Overall Study||1||
59857644|NCT03249454|75982499|FG009|First Intervention (1 Day)|Overall Study||0||
59857645|NCT03249454|75982500|FG010|First Intervention (1 Day)|Overall Study||0||
59857646|NCT03249454|75982490|FG000|Washout (1 Week)|Overall Study||1||
59857647|NCT03249454|75982491|FG001|Washout (1 Week)|Overall Study||1||
59857648|NCT03249454|75982492|FG002|Washout (1 Week)|Overall Study||2||
59857649|NCT03249454|75982493|FG003|Washout (1 Week)|Overall Study||1||
59857650|NCT03249454|75982494|FG004|Washout (1 Week)|Overall Study||1||
59857651|NCT03249454|75982495|FG005|Washout (1 Week)|Overall Study||2||
59857652|NCT03249454|75982496|FG006|Washout (1 Week)|Overall Study||1||
59857653|NCT03249454|75982497|FG007|Washout (1 Week)|Overall Study||1||
59857654|NCT03249454|75982498|FG008|Washout (1 Week)|Overall Study||1||
59857655|NCT03249454|75982499|FG009|Washout (1 Week)|Overall Study||0||
59857656|NCT03249454|75982500|FG010|Washout (1 Week)|Overall Study||0||
59857657|NCT03249454|75982490|FG000|Second Intervention (1 Day)|Overall Study||1||
59857658|NCT03249454|75982491|FG001|Second Intervention (1 Day)|Overall Study||1||
59857659|NCT03249454|75982492|FG002|Second Intervention (1 Day)|Overall Study||2||
59857660|NCT03249454|75982493|FG003|Second Intervention (1 Day)|Overall Study||1||
59857661|NCT03249454|75982494|FG004|Second Intervention (1 Day)|Overall Study||1||
59857662|NCT03249454|75982495|FG005|Second Intervention (1 Day)|Overall Study||2||
59857663|NCT03249454|75982496|FG006|Second Intervention (1 Day)|Overall Study||1||
59857664|NCT03249454|75982497|FG007|Second Intervention (1 Day)|Overall Study||1||
59857665|NCT03249454|75982498|FG008|Second Intervention (1 Day)|Overall Study||1||
59857666|NCT03249454|75982499|FG009|Second Intervention (1 Day)|Overall Study||0||
59857667|NCT03249454|75982500|FG010|Second Intervention (1 Day)|Overall Study||0||
59857668|NCT03249454|75982490|FG000|Washout (1 Week)|Overall Study||1||
59857669|NCT03249454|75982491|FG001|Washout (1 Week)|Overall Study||1||
59857670|NCT03249454|75982492|FG002|Washout (1 Week)|Overall Study||2||
59857671|NCT03249454|75982493|FG003|Washout (1 Week)|Overall Study||1||
59857672|NCT03249454|75982494|FG004|Washout (1 Week)|Overall Study||1||
59857673|NCT03249454|75982495|FG005|Washout (1 Week)|Overall Study||2||
59857674|NCT03249454|75982496|FG006|Washout (1 Week)|Overall Study||1||
59857675|NCT03249454|75982497|FG007|Washout (1 Week)|Overall Study||1||
59857676|NCT03249454|75982498|FG008|Washout (1 Week)|Overall Study||1||
59857677|NCT03249454|75982499|FG009|Washout (1 Week)|Overall Study||0||
59857678|NCT03249454|75982500|FG010|Washout (1 Week)|Overall Study||0||
59857679|NCT03249454|75982490|FG000|Third Intervention (1 Day)|Overall Study||1||
59857680|NCT03249454|75982491|FG001|Third Intervention (1 Day)|Overall Study||1||
59857681|NCT03249454|75982492|FG002|Third Intervention (1 Day)|Overall Study||2||
59857682|NCT03249454|75982493|FG003|Third Intervention (1 Day)|Overall Study||1||
60123537|NCT02668692|76244876|FG001|STARTED|Overall Study||105||
60123538|NCT02668692|76244875|FG000|COMPLETED|Overall Study||100||
60123539|NCT02668692|76244876|FG001|COMPLETED|Overall Study||105||
59857683|NCT03249454|75982494|FG004|Third Intervention (1 Day)|Overall Study||1||
59857684|NCT03249454|75982495|FG005|Third Intervention (1 Day)|Overall Study||2||
59857685|NCT03249454|75982496|FG006|Third Intervention (1 Day)|Overall Study||1||
59857686|NCT03249454|75982497|FG007|Third Intervention (1 Day)|Overall Study||1||
59857687|NCT03249454|75982498|FG008|Third Intervention (1 Day)|Overall Study||1||
59857688|NCT03249454|75982499|FG009|Third Intervention (1 Day)|Overall Study||0||
59857689|NCT03249454|75982500|FG010|Third Intervention (1 Day)|Overall Study||0||
59857690|NCT03249454|75982490|FG000|Washout (1 Week)|Overall Study||1||
59857691|NCT03249454|75982491|FG001|Washout (1 Week)|Overall Study||1||
59857692|NCT03249454|75982492|FG002|Washout (1 Week)|Overall Study||2||
59857693|NCT03249454|75982493|FG003|Washout (1 Week)|Overall Study||1||
59857694|NCT03249454|75982494|FG004|Washout (1 Week)|Overall Study||1||
59857695|NCT03249454|75982495|FG005|Washout (1 Week)|Overall Study||2||
59857696|NCT03249454|75982496|FG006|Washout (1 Week)|Overall Study||1||
59857697|NCT03249454|75982497|FG007|Washout (1 Week)|Overall Study||1||
59857698|NCT03249454|75982498|FG008|Washout (1 Week)|Overall Study||1||
59857699|NCT03249454|75982499|FG009|Washout (1 Week)|Overall Study||0||
59857700|NCT03249454|75982500|FG010|Washout (1 Week)|Overall Study||0||
59857701|NCT03249454|75982490|FG000|Fourth Intervention (1 Day)|Overall Study||1||
59857702|NCT03249454|75982491|FG001|Fourth Intervention (1 Day)|Overall Study||1||
59857703|NCT03249454|75982492|FG002|Fourth Intervention (1 Day)|Overall Study||2||
59857704|NCT03249454|75982493|FG003|Fourth Intervention (1 Day)|Overall Study||1||
59857705|NCT03249454|75982494|FG004|Fourth Intervention (1 Day)|Overall Study||1||
59857706|NCT03249454|75982495|FG005|Fourth Intervention (1 Day)|Overall Study||2||
59857707|NCT03249454|75982496|FG006|Fourth Intervention (1 Day)|Overall Study||1||
59857708|NCT03249454|75982497|FG007|Fourth Intervention (1 Day)|Overall Study||1||
59857709|NCT03249454|75982498|FG008|Fourth Intervention (1 Day)|Overall Study||1||
59857710|NCT03249454|75982499|FG009|Fourth Intervention (1 Day)|Overall Study||0||
59857711|NCT03249454|75982500|FG010|Fourth Intervention (1 Day)|Overall Study||0||
59857712|NCT03249454|75982490|FG000|Washout (1 Week)|Overall Study||1||
59857713|NCT03249454|75982491|FG001|Washout (1 Week)|Overall Study||1||
59857714|NCT03249454|75982492|FG002|Washout (1 Week)|Overall Study||2||
59857715|NCT03249454|75982493|FG003|Washout (1 Week)|Overall Study||1||
59857716|NCT03249454|75982494|FG004|Washout (1 Week)|Overall Study||1||
59857717|NCT03249454|75982495|FG005|Washout (1 Week)|Overall Study||2||
59857718|NCT03249454|75982496|FG006|Washout (1 Week)|Overall Study||1||
59857719|NCT03249454|75982497|FG007|Washout (1 Week)|Overall Study||1||
59857720|NCT03249454|75982498|FG008|Washout (1 Week)|Overall Study||1||
59857721|NCT03249454|75982499|FG009|Washout (1 Week)|Overall Study||0||
59857722|NCT03249454|75982500|FG010|Washout (1 Week)|Overall Study||0||
59857723|NCT03249454|75982490|FG000|Fifth Intervention (1 Day)|Overall Study||1||
59857724|NCT03249454|75982491|FG001|Fifth Intervention (1 Day)|Overall Study||1||
59857725|NCT03249454|75982492|FG002|Fifth Intervention (1 Day)|Overall Study||2||
59857726|NCT03249454|75982493|FG003|Fifth Intervention (1 Day)|Overall Study||1||
59857727|NCT03249454|75982494|FG004|Fifth Intervention (1 Day)|Overall Study||1||
59857728|NCT03249454|75982495|FG005|Fifth Intervention (1 Day)|Overall Study||2||
59857729|NCT03249454|75982496|FG006|Fifth Intervention (1 Day)|Overall Study||1||
59857730|NCT03249454|75982497|FG007|Fifth Intervention (1 Day)|Overall Study||1||
59857731|NCT03249454|75982498|FG008|Fifth Intervention (1 Day)|Overall Study||1||
59857732|NCT03249454|75982499|FG009|Fifth Intervention (1 Day)|Overall Study||0||
59857733|NCT03249454|75982500|FG010|Fifth Intervention (1 Day)|Overall Study||0||
59857734|NCT03249454|75982490|FG000|COMPLETED|Overall Study||1||
59857735|NCT03249454|75982491|FG001|COMPLETED|Overall Study||1||
59857736|NCT03249454|75982492|FG002|COMPLETED|Overall Study||2||
59857737|NCT03249454|75982493|FG003|COMPLETED|Overall Study||1||
59857738|NCT03249454|75982494|FG004|COMPLETED|Overall Study||1||
59857739|NCT03249454|75982495|FG005|COMPLETED|Overall Study||2||
59727157|NCT00998790|75845936|FG000|Participants Who Were Treated|Overall Study||113||
59727158|NCT00998790|75845936|FG000|COMPLETED|Overall Study||93||
59727159|NCT00998790|75845936|FG000|NOT COMPLETED|Overall Study||21||
59727160|NCT01001988|75845940|FG000|STARTED|Overall Study||596||
59727161|NCT01001988|75845940|FG000|COMPLETED|Overall Study||479||
59727162|NCT01001988|75845940|FG000|NOT COMPLETED|Overall Study||117||
59857740|NCT03249454|75982496|FG006|COMPLETED|Overall Study||1||
59857741|NCT03249454|75982497|FG007|COMPLETED|Overall Study||1||
59857742|NCT03249454|75982498|FG008|COMPLETED|Overall Study||1||
59857743|NCT03249454|75982499|FG009|COMPLETED|Overall Study||0||
59857744|NCT03249454|75982500|FG010|COMPLETED|Overall Study||0||
59857745|NCT03249454|75982490|FG000|NOT COMPLETED|Overall Study||0||
59857746|NCT03249454|75982491|FG001|NOT COMPLETED|Overall Study||0||
59857747|NCT03249454|75982492|FG002|NOT COMPLETED|Overall Study||0||
59857748|NCT03249454|75982493|FG003|NOT COMPLETED|Overall Study||0||
59857749|NCT03249454|75982494|FG004|NOT COMPLETED|Overall Study||0||
59857750|NCT03249454|75982495|FG005|NOT COMPLETED|Overall Study||0||
59857751|NCT03249454|75982496|FG006|NOT COMPLETED|Overall Study||0||
59857752|NCT03249454|75982497|FG007|NOT COMPLETED|Overall Study||0||
59857753|NCT03249454|75982498|FG008|NOT COMPLETED|Overall Study||0||
59857754|NCT03249454|75982499|FG009|NOT COMPLETED|Overall Study||1||
59857755|NCT03249454|75982500|FG010|NOT COMPLETED|Overall Study||1||
59857756|NCT03732248|75982513|FG000|STARTED|Overall Study||11||
59857757|NCT03732248|75982514|FG001|STARTED|Overall Study||10||
59857758|NCT03732248|75982513|FG000|COMPLETED|Overall Study||10||
59857759|NCT03732248|75982514|FG001|COMPLETED|Overall Study||10||
59857760|NCT03732248|75982513|FG000|NOT COMPLETED|Overall Study||1||
59727163|NCT00996606|75845944|FG000|STARTED|Overall Study||58||
59727164|NCT00996606|75845944|FG000|COMPLETED|Overall Study||50||
59727165|NCT00996606|75845944|FG000|NOT COMPLETED|Overall Study||8||
59727166|NCT00995436|75845951|FG000|STARTED|Overall Study|25|25||
59857761|NCT03732248|75982514|FG001|NOT COMPLETED|Overall Study||0||
59857762|NCT00310037|75982522|FG000|STARTED|Overall Study||52||
59857763|NCT00310037|75982523|FG001|STARTED|Overall Study||50||
59857764|NCT00310037|75982522|FG000|COMPLETED|Overall Study||34||
59857765|NCT00310037|75982523|FG001|COMPLETED|Overall Study||33||
59857766|NCT00310037|75982522|FG000|NOT COMPLETED|Overall Study||18||
59857767|NCT00310037|75982523|FG001|NOT COMPLETED|Overall Study||17||
59857768|NCT00309959|75982529|FG000|STARTED|Overall Study||37||
59857769|NCT00309959|75982529|FG000|COMPLETED|Overall Study||35|Eligible and treated patients|
59857770|NCT00309959|75982529|FG000|NOT COMPLETED|Overall Study||2||
59857771|NCT03238924|75982540|FG000|STARTED|Overall Study||8||
59857772|NCT03238924|75982541|FG001|STARTED|Overall Study||9||
59857773|NCT03238924|75982540|FG000|COMPLETED|Overall Study||6||
59857774|NCT03238924|75982541|FG001|COMPLETED|Overall Study||7||
59857775|NCT03238924|75982540|FG000|NOT COMPLETED|Overall Study||2||
59857776|NCT03238924|75982541|FG001|NOT COMPLETED|Overall Study||2||
59857777|NCT03247816|75982547|FG000|STARTED|Overall Study||59||
59857778|NCT03247816|75982547|FG000|COMPLETED|Overall Study||30||
59857779|NCT03247816|75982547|FG000|NOT COMPLETED|Overall Study||29||
59857780|NCT02918500|75982555|FG000|STARTED|Overall Study||2||
59857781|NCT02918500|75982556|FG001|STARTED|Overall Study||2||
59857782|NCT02918500|75982555|FG000|COMPLETED|Overall Study||2||
59857783|NCT02918500|75982556|FG001|COMPLETED|Overall Study||2||
59857784|NCT02918500|75982555|FG000|NOT COMPLETED|Overall Study||0||
59857785|NCT02918500|75982556|FG001|NOT COMPLETED|Overall Study||0||
59857786|NCT00333359|75982565|FG000|STARTED|Overall Study||199||
59857787|NCT00333359|75982566|FG001|STARTED|Overall Study||382||
59857788|NCT00333359|75982565|FG000|COMPLETED|Overall Study||126||
59857789|NCT00333359|75982566|FG001|COMPLETED|Overall Study||260||
59857790|NCT00333359|75982565|FG000|NOT COMPLETED|Overall Study||73||
59857791|NCT00333359|75982566|FG001|NOT COMPLETED|Overall Study||122||
59857792|NCT03246724|75982578|FG000|STARTED|Overall Study||99||
59857793|NCT03246724|75982579|FG001|STARTED|Overall Study||91||
59857794|NCT03246724|75982580|FG002|STARTED|Overall Study||85||
59857795|NCT03246724|75982581|FG003|STARTED|Overall Study||52||
59857796|NCT03246724|75982578|FG000|COMPLETED|Overall Study||85||
59857797|NCT03246724|75982579|FG001|COMPLETED|Overall Study||84||
59857798|NCT03246724|75982580|FG002|COMPLETED|Overall Study||70||
59857799|NCT03246724|75982581|FG003|COMPLETED|Overall Study||44||
59857800|NCT03246724|75982578|FG000|NOT COMPLETED|Overall Study||14||
59857801|NCT03246724|75982579|FG001|NOT COMPLETED|Overall Study||7||
59857802|NCT03246724|75982580|FG002|NOT COMPLETED|Overall Study||15||
59857803|NCT03246724|75982581|FG003|NOT COMPLETED|Overall Study||8||
59857804|NCT03246646|75982593|FG000|STARTED|Overall Study||26||
59727167|NCT00995436|75845952|FG001|STARTED|Overall Study||27||
59727168|NCT00995436|75845953|FG002|STARTED|Overall Study||26||
59727169|NCT00995436|75845951|FG000|COMPLETED|Overall Study||23||
59727170|NCT00995436|75845952|FG001|COMPLETED|Overall Study||22||
59727171|NCT00995436|75845953|FG002|COMPLETED|Overall Study||26||
59727172|NCT00995436|75845951|FG000|NOT COMPLETED|Overall Study||2||
59727173|NCT00995436|75845952|FG001|NOT COMPLETED|Overall Study||5||
59727174|NCT00995436|75845953|FG002|NOT COMPLETED|Overall Study||0||
59727175|NCT00994890|75845964|FG000|STARTED|Overall Study||231||
59727176|NCT00994890|75845965|FG001|STARTED|Overall Study||222||
59727177|NCT00994890|75845966|FG002|STARTED|Overall Study||226||
59727178|NCT00994890|75845964|FG000|Treated|Overall Study||230||
59727179|NCT00994890|75845965|FG001|Treated|Overall Study||222||
59727180|NCT00994890|75845966|FG002|Treated|Overall Study||226||
59727181|NCT00994890|75845964|FG000|COMPLETED|Overall Study||0||
59727182|NCT00994890|75845965|FG001|COMPLETED|Overall Study||0||
59857805|NCT03246646|75982594|FG001|STARTED|Overall Study||26||
59857806|NCT03246646|75982593|FG000|COMPLETED|Overall Study|15 participants completed either 6-month or 12-month follow-up or both.|15||
59857807|NCT03246646|75982594|FG001|COMPLETED|Overall Study|Follow-up was limited to chart follow-up in CIC services|26||
59857808|NCT03246646|75982593|FG000|NOT COMPLETED|Overall Study||11||
60123540|NCT02668692|76244875|FG000|NOT COMPLETED|Overall Study||1||
60123541|NCT02668692|76244876|FG001|NOT COMPLETED|Overall Study||0||
59727183|NCT00994890|75845966|FG002|COMPLETED|Overall Study||0||
59727184|NCT00994890|75845964|FG000|NOT COMPLETED|Overall Study||231||
59727185|NCT00994890|75845965|FG001|NOT COMPLETED|Overall Study||222||
59857809|NCT03246646|75982594|FG001|NOT COMPLETED|Overall Study||0||
59857810|NCT01347112|75982602|FG000|STARTED|Overall Study||16||
59857811|NCT01347112|75982603|FG001|STARTED|Overall Study||17||
59857812|NCT01347112|75982602|FG000|COMPLETED|Overall Study||12||
59857813|NCT01347112|75982603|FG001|COMPLETED|Overall Study||5||
60123542|NCT00281463|76244882|FG000|STARTED|Overall Study||45||
59727186|NCT00994890|75845966|FG002|NOT COMPLETED|Overall Study||226||
59727187|NCT00994422|75845976|FG000|STARTED|Overall Study||192||
59727188|NCT00994422|75845977|FG001|STARTED|Overall Study||55||
59857814|NCT01347112|75982602|FG000|NOT COMPLETED|Overall Study||4||
59857815|NCT01347112|75982603|FG001|NOT COMPLETED|Overall Study||12||
59857816|NCT00308711|75982613|FG000|STARTED|Overall Study||428||
59857817|NCT00308711|75982614|FG001|STARTED|Overall Study||444||
59857818|NCT00308711|75982615|FG002|STARTED|Overall Study||436||
59857819|NCT00308711|75982613|FG000|COMPLETED|Overall Study||426||
59857820|NCT00308711|75982614|FG001|COMPLETED|Overall Study||440||
59857821|NCT00308711|75982615|FG002|COMPLETED|Overall Study||431||
59857822|NCT00308711|75982613|FG000|NOT COMPLETED|Overall Study||2||
59857823|NCT00308711|75982614|FG001|NOT COMPLETED|Overall Study||4||
59857824|NCT00308711|75982615|FG002|NOT COMPLETED|Overall Study||5||
59857825|NCT00308555|75982625|FG000|STARTED|Overall Study||13||
59857826|NCT00308555|75982626|FG001|STARTED|Overall Study||11||
59857827|NCT00308555|75982625|FG000|COMPLETED|Overall Study||10||
59857828|NCT00308555|75982626|FG001|COMPLETED|Overall Study||11||
59857829|NCT00308555|75982625|FG000|NOT COMPLETED|Overall Study||3||
59857830|NCT00308555|75982626|FG001|NOT COMPLETED|Overall Study||0||
59857831|NCT00050778|75982635|FG000|STARTED|Overall Study|Randomized.|111||
59857832|NCT00050778|75982636|FG001|STARTED|Overall Study||113||
59857833|NCT00050778|75982637|FG002|STARTED|Overall Study||110||
59857834|NCT00050778|75982635|FG000|Treated|Overall Study||107||
59857835|NCT00050778|75982636|FG001|Treated|Overall Study||108||
59857836|NCT00050778|75982637|FG002|Treated|Overall Study||108||
59857837|NCT00050778|75982635|FG000|COMPLETED|Overall Study||66||
59857838|NCT00050778|75982636|FG001|COMPLETED|Overall Study||92||
59857839|NCT00050778|75982637|FG002|COMPLETED|Overall Study||92||
59857840|NCT00050778|75982635|FG000|NOT COMPLETED|Overall Study||45||
59857841|NCT00050778|75982636|FG001|NOT COMPLETED|Overall Study||21||
59857842|NCT00050778|75982637|FG002|NOT COMPLETED|Overall Study||18||
59857843|NCT00050622|75982647|FG000|STARTED|Overall Study||154||
59857844|NCT00050622|75982647|FG000|COMPLETED|Overall Study||153||
59857845|NCT00050622|75982647|FG000|NOT COMPLETED|Overall Study||1||
59857846|NCT00308087|75982673|FG000|STARTED|Overall Study||37||
59857847|NCT00308087|75982674|FG001|STARTED|Overall Study||38||
59857848|NCT00308087|75982673|FG000|COMPLETED|Overall Study|Completers finished treatment and the 24 month follow-up.|1||
59857849|NCT00308087|75982674|FG001|COMPLETED|Overall Study|Completers finished treatment and the 24 month follow-up.|1||
59857850|NCT00308087|75982673|FG000|NOT COMPLETED|Overall Study||36||
59857851|NCT00308087|75982674|FG001|NOT COMPLETED|Overall Study||37||
59857852|NCT00307931|75982680|FG000|STARTED|Overall Study|Number of subjects who entered the study and have been treated|16||
59857853|NCT00307931|75982680|FG000|COMPLETED|Overall Study|Number of subjects who completed the Week 12 visit|15||
59857854|NCT00307931|75982680|FG000|NOT COMPLETED|Overall Study||1||
59857855|NCT02796170|75982686|FG000|STARTED|Overall Study||8||
59857856|NCT02796170|75982687|FG001|STARTED|Overall Study||3||
59857857|NCT02796170|75982686|FG000|COMPLETED|Overall Study||5||
59857858|NCT02796170|75982687|FG001|COMPLETED|Overall Study||3||
59857859|NCT02796170|75982686|FG000|NOT COMPLETED|Overall Study||3||
59857860|NCT02796170|75982687|FG001|NOT COMPLETED|Overall Study||0||
59857861|NCT00049842|75982695|FG000|STARTED|Treatment Phase||270||
59857862|NCT00049842|75982696|FG001|STARTED|Treatment Phase||270||
59857863|NCT00049842|75982695|FG000|COMPLETED|Treatment Phase||177||
59857864|NCT00049842|75982696|FG001|COMPLETED|Treatment Phase||192||
59857865|NCT00049842|75982695|FG000|NOT COMPLETED|Treatment Phase||93||
59857866|NCT00049842|75982696|FG001|NOT COMPLETED|Treatment Phase||78||
59857867|NCT00049842|75982695|FG000|STARTED|Follow-up Phase|Population is all treatment phase completers plus some who discontinued the treatment phase.|218||
59857868|NCT00049842|75982696|FG001|STARTED|Follow-up Phase|Population is all treatment phase completers plus some who discontinued the treatment phase.|194||
59857869|NCT00049842|75982695|FG000|COMPLETED|Follow-up Phase||211||
59857870|NCT00049842|75982696|FG001|COMPLETED|Follow-up Phase||189||
59857871|NCT00049842|75982695|FG000|NOT COMPLETED|Follow-up Phase||7||
59857872|NCT00049842|75982696|FG001|NOT COMPLETED|Follow-up Phase||5||
59857873|NCT00307151|75982706|FG000|STARTED|Overall Study||82||
59857874|NCT00307151|75982707|FG001|STARTED|Overall Study||82||
59857875|NCT00307151|75982708|FG002|STARTED|Overall Study||147||
59857876|NCT00307151|75982709|FG003|STARTED|Overall Study|One participant never started treatment, were not followed and not included in analysis.|140||
59857877|NCT00307151|75982706|FG000|COMPLETED|Overall Study|Results are through date DSMB closed Cohort I to accrual (April 20, 2009)|71||
59857878|NCT00307151|75982707|FG001|COMPLETED|Overall Study|Results are through date DSMB closed Cohort I to accrual (April 20, 2009)|75||
59857879|NCT00307151|75982708|FG002|COMPLETED|Overall Study|Results are through date DSMB recommended Cohort II results be unblinded (October 27, 2010)|127||
59857880|NCT00307151|75982709|FG003|COMPLETED|Overall Study|Results are through date DSMB recommended Cohort II results be unblinded (October 27, 2010)|129||
59857881|NCT00307151|75982706|FG000|NOT COMPLETED|Overall Study||11||
59857882|NCT00307151|75982707|FG001|NOT COMPLETED|Overall Study||7||
59857883|NCT00307151|75982708|FG002|NOT COMPLETED|Overall Study||20||
59857884|NCT00307151|75982709|FG003|NOT COMPLETED|Overall Study||11||
59857885|NCT02654132|75982721|FG000|STARTED|Pre-Treatment Period||60|Started = Randomized|
59857886|NCT02654132|75982722|FG001|STARTED|Pre-Treatment Period||57|Started = Randomized|
60123543|NCT00281463|76244882|FG000|COMPLETED|Overall Study||45||
59857887|NCT02654132|75982721|FG000|COMPLETED|Pre-Treatment Period||60|Completed = Continued into Treatment Period|
59857888|NCT02654132|75982722|FG001|COMPLETED|Pre-Treatment Period||55|Completed = Continued into Treatment Period|
59857889|NCT02654132|75982721|FG000|NOT COMPLETED|Pre-Treatment Period||0||
59857890|NCT02654132|75982722|FG001|NOT COMPLETED|Pre-Treatment Period||2||
59857891|NCT02654132|75982721|FG000|STARTED|Treatment Period||60||
59857892|NCT02654132|75982722|FG001|STARTED|Treatment Period||55||
60123544|NCT00281463|76244882|FG000|NOT COMPLETED|Overall Study||0||
59857893|NCT02654132|75982721|FG000|COMPLETED|Treatment Period||0||
59857894|NCT02654132|75982722|FG001|COMPLETED|Treatment Period||0||
59857895|NCT02654132|75982721|FG000|NOT COMPLETED|Treatment Period||60||
59857896|NCT02654132|75982722|FG001|NOT COMPLETED|Treatment Period||55||
59857897|NCT03241342|75982731|FG000|STARTED|Overall Study||163||
59857898|NCT03241342|75982732|FG001|STARTED|Overall Study||163||
59857899|NCT03241342|75982733|FG002|STARTED|Overall Study||165||
59857900|NCT03241342|75982731|FG000|COMPLETED|Overall Study||141||
59857901|NCT03241342|75982732|FG001|COMPLETED|Overall Study||132||
59857902|NCT03241342|75982733|FG002|COMPLETED|Overall Study||138||
59857903|NCT03241342|75982731|FG000|NOT COMPLETED|Overall Study||22||
59857904|NCT03241342|75982732|FG001|NOT COMPLETED|Overall Study||31||
59857905|NCT03241342|75982733|FG002|NOT COMPLETED|Overall Study||27||
59857906|NCT00306995|75982748|FG000|STARTED|Study Part I||55||
59857907|NCT00306995|75982749|FG001|STARTED|Study Part I||55||
59857908|NCT00306995|75982750|FG002|STARTED|Study Part I||55||
59857909|NCT00306995|75982751|FG003|STARTED|Study Part I||55||
59857910|NCT00306995|75982752|FG004|STARTED|Study Part I||55||
59857911|NCT00306995|75982753|FG005|STARTED|Study Part I||55||
59857912|NCT00306995|75982754|FG006|STARTED|Study Part I||55||
59857913|NCT00306995|75982748|FG000|COMPLETED|Study Part I||55||
59857914|NCT00306995|75982749|FG001|COMPLETED|Study Part I||55||
59857915|NCT00306995|75982750|FG002|COMPLETED|Study Part I||55||
59857916|NCT00306995|75982751|FG003|COMPLETED|Study Part I||55||
59857917|NCT00306995|75982752|FG004|COMPLETED|Study Part I||55||
59857918|NCT00306995|75982753|FG005|COMPLETED|Study Part I||55||
59857919|NCT00306995|75982754|FG006|COMPLETED|Study Part I||54||
59857920|NCT00306995|75982748|FG000|NOT COMPLETED|Study Part I||0||
59857921|NCT00306995|75982749|FG001|NOT COMPLETED|Study Part I||0||
59857922|NCT00306995|75982750|FG002|NOT COMPLETED|Study Part I||0||
59857923|NCT00306995|75982751|FG003|NOT COMPLETED|Study Part I||0||
59857924|NCT00306995|75982752|FG004|NOT COMPLETED|Study Part I||0||
59857925|NCT00306995|75982753|FG005|NOT COMPLETED|Study Part I||0||
59857926|NCT00306995|75982754|FG006|NOT COMPLETED|Study Part I||1||
59857927|NCT00306995|75982748|FG000|STARTED|Study Part II for Subset 1||27||
59857928|NCT00306995|75982749|FG001|STARTED|Study Part II for Subset 1||26||
59857929|NCT00306995|75982750|FG002|STARTED|Study Part II for Subset 1||27||
59857930|NCT00306995|75982751|FG003|STARTED|Study Part II for Subset 1||27||
59857931|NCT00306995|75982752|FG004|STARTED|Study Part II for Subset 1||27||
59857932|NCT00306995|75982753|FG005|STARTED|Study Part II for Subset 1||26||
59857933|NCT00306995|75982754|FG006|STARTED|Study Part II for Subset 1||23||
59857934|NCT00306995|75982748|FG000|COMPLETED|Study Part II for Subset 1||27||
59857935|NCT00306995|75982749|FG001|COMPLETED|Study Part II for Subset 1||26||
59857936|NCT00306995|75982750|FG002|COMPLETED|Study Part II for Subset 1||27||
59857937|NCT00306995|75982751|FG003|COMPLETED|Study Part II for Subset 1||27||
59857938|NCT00306995|75982752|FG004|COMPLETED|Study Part II for Subset 1||27||
59857939|NCT00306995|75982753|FG005|COMPLETED|Study Part II for Subset 1||26||
59857940|NCT00306995|75982754|FG006|COMPLETED|Study Part II for Subset 1||23||
59857941|NCT00306995|75982748|FG000|NOT COMPLETED|Study Part II for Subset 1||0||
59857942|NCT00306995|75982749|FG001|NOT COMPLETED|Study Part II for Subset 1||0||
59857943|NCT00306995|75982750|FG002|NOT COMPLETED|Study Part II for Subset 1||0||
59857944|NCT00306995|75982751|FG003|NOT COMPLETED|Study Part II for Subset 1||0||
59857945|NCT00306995|75982752|FG004|NOT COMPLETED|Study Part II for Subset 1||0||
59857946|NCT00306995|75982753|FG005|NOT COMPLETED|Study Part II for Subset 1||0||
59857947|NCT00306995|75982754|FG006|NOT COMPLETED|Study Part II for Subset 1||0||
59857948|NCT00306995|75982748|FG000|STARTED|Study Part II for Subset 2||23||
59857949|NCT00306995|75982749|FG001|STARTED|Study Part II for Subset 2||24||
59857950|NCT00306995|75982750|FG002|STARTED|Study Part II for Subset 2||23||
59857951|NCT00306995|75982751|FG003|STARTED|Study Part II for Subset 2||22||
59857952|NCT00306995|75982752|FG004|STARTED|Study Part II for Subset 2||23||
59857953|NCT00306995|75982753|FG005|STARTED|Study Part II for Subset 2||26||
59857954|NCT00306995|75982754|FG006|STARTED|Study Part II for Subset 2||24||
59857955|NCT00306995|75982748|FG000|COMPLETED|Study Part II for Subset 2||23||
59857956|NCT00306995|75982749|FG001|COMPLETED|Study Part II for Subset 2||23||
59857957|NCT00306995|75982750|FG002|COMPLETED|Study Part II for Subset 2||23||
59857958|NCT00306995|75982751|FG003|COMPLETED|Study Part II for Subset 2||22||
59857959|NCT00306995|75982752|FG004|COMPLETED|Study Part II for Subset 2||23||
59857960|NCT00306995|75982753|FG005|COMPLETED|Study Part II for Subset 2||26||
59857961|NCT00306995|75982754|FG006|COMPLETED|Study Part II for Subset 2||24||
59857962|NCT00306995|75982748|FG000|NOT COMPLETED|Study Part II for Subset 2||0||
59857963|NCT00306995|75982749|FG001|NOT COMPLETED|Study Part II for Subset 2||1||
59857964|NCT00306995|75982750|FG002|NOT COMPLETED|Study Part II for Subset 2||0||
59857965|NCT00306995|75982751|FG003|NOT COMPLETED|Study Part II for Subset 2||0||
59857966|NCT00306995|75982752|FG004|NOT COMPLETED|Study Part II for Subset 2||0||
59857967|NCT00306995|75982753|FG005|NOT COMPLETED|Study Part II for Subset 2||0||
59857968|NCT00306995|75982754|FG006|NOT COMPLETED|Study Part II for Subset 2||0||
59857969|NCT00121108|75982801|FG000|STARTED|Overall Study||710||
59857970|NCT00121108|75982802|FG001|STARTED|Overall Study||1417||
59857971|NCT00121108|75982801|FG000|COMPLETED|Overall Study||589||
59857972|NCT00121108|75982802|FG001|COMPLETED|Overall Study||1192||
59857973|NCT00121108|75982801|FG000|NOT COMPLETED|Overall Study||121||
59857974|NCT00121108|75982802|FG001|NOT COMPLETED|Overall Study||225||
59857975|NCT02387996|75982809|FG000|STARTED|Overall Study||270||
59857976|NCT02387996|75982809|FG000|COMPLETED|Overall Study||0|Completed=continuing in the study treatment|
59857977|NCT02387996|75982809|FG000|NOT COMPLETED|Overall Study||270||
59857978|NCT03212326|75982813|FG000|STARTED|Overall Study||24||
59857979|NCT03212326|75982813|FG000|COMPLETED|Overall Study||20||
59857980|NCT03212326|75982813|FG000|NOT COMPLETED|Overall Study||4||
59857981|NCT03834194|75982825|FG000|STARTED|Overall Study|5 participants were not started with the intervention with this condition, because 1 participant was immediately withdrawn (without orientation to the condition) because of a staff member's error in assessing this participant's age eligibility|4||
59857982|NCT03834194|75982826|FG001|STARTED|Overall Study||5||
59857983|NCT03834194|75982827|FG002|STARTED|Overall Study||5||
59857984|NCT03834194|75982828|FG003|STARTED|Overall Study||5||
59857985|NCT03834194|75982829|FG004|STARTED|Overall Study||5||
59857986|NCT03834194|75982830|FG005|STARTED|Overall Study||5||
59857987|NCT03834194|75982831|FG006|STARTED|Overall Study||5||
59857988|NCT03834194|75982832|FG007|STARTED|Overall Study||5||
59857989|NCT03834194|75982825|FG000|COMPLETED|Overall Study||3||
59857990|NCT03834194|75982826|FG001|COMPLETED|Overall Study||4||
59857991|NCT03834194|75982827|FG002|COMPLETED|Overall Study||4||
59857992|NCT03834194|75982828|FG003|COMPLETED|Overall Study||5||
59857993|NCT03834194|75982829|FG004|COMPLETED|Overall Study||5||
59857994|NCT03834194|75982830|FG005|COMPLETED|Overall Study||4||
59857995|NCT03834194|75982831|FG006|COMPLETED|Overall Study||5||
59857996|NCT03834194|75982832|FG007|COMPLETED|Overall Study||5||
59857997|NCT03834194|75982825|FG000|NOT COMPLETED|Overall Study||1||
59857998|NCT03834194|75982826|FG001|NOT COMPLETED|Overall Study||1||
59857999|NCT03834194|75982827|FG002|NOT COMPLETED|Overall Study||1||
59858000|NCT03834194|75982828|FG003|NOT COMPLETED|Overall Study||0||
59858001|NCT03834194|75982829|FG004|NOT COMPLETED|Overall Study||0||
59858002|NCT03834194|75982830|FG005|NOT COMPLETED|Overall Study||1||
59858003|NCT03834194|75982831|FG006|NOT COMPLETED|Overall Study||0||
59858004|NCT03834194|75982832|FG007|NOT COMPLETED|Overall Study||0||
59858005|NCT03229486|75982852|FG000|STARTED|Overall Study||20||
59858006|NCT03229486|75982853|FG001|STARTED|Overall Study||20||
59858007|NCT03229486|75982852|FG000|COMPLETED|Overall Study||20||
59594254|NCT03098420|75702984|FG001|STARTED|Overall Study||9||
59594255|NCT03098420|75702985|FG002|STARTED|Overall Study||13||
59727189|NCT00994422|75845976|FG000|COMPLETED|Overall Study||185||
59727190|NCT00994422|75845977|FG001|COMPLETED|Overall Study||54||
59727191|NCT00994422|75845976|FG000|NOT COMPLETED|Overall Study||7||
59727192|NCT00994422|75845977|FG001|NOT COMPLETED|Overall Study||1||
59727193|NCT01171976|75845988|FG000|STARTED|Overall Study||121||
59727194|NCT01171976|75845989|FG001|STARTED|Overall Study||128||
59727195|NCT01171976|75845990|FG002|STARTED|Overall Study||123||
59727196|NCT01171976|75845988|FG000|Safety Set|Overall Study|Include 4 from PRN and 3 from TE alone who got laser treatment, exclude 2 with no laser treatment.|126||
59727197|NCT01171976|75845989|FG001|Safety Set|Overall Study|Exclude 1 who did not get drug and 3 got laser treatment, include 2 from 1st arm with no laser|126||
59727198|NCT01171976|75845990|FG002|Safety Set|Overall Study|Exclude 1 who did not get drug and 4 got laser treatment|118||
59727199|NCT01171976|75845988|FG000|COMPLETED|Overall Study||107||
59727200|NCT01171976|75845989|FG001|COMPLETED|Overall Study||117||
59727201|NCT01171976|75845990|FG002|COMPLETED|Overall Study||108||
59727202|NCT01171976|75845988|FG000|NOT COMPLETED|Overall Study||14||
59727203|NCT01171976|75845989|FG001|NOT COMPLETED|Overall Study||11||
59727204|NCT01171976|75845990|FG002|NOT COMPLETED|Overall Study||15||
59727205|NCT00996216|75845998|FG000|STARTED|Part 1 (Pre-Antiviral Treatment Phase)||27||
59727206|NCT00996216|75845998|FG000|COMPLETED|Part 1 (Pre-Antiviral Treatment Phase)||26||
59727207|NCT00996216|75845998|FG000|NOT COMPLETED|Part 1 (Pre-Antiviral Treatment Phase)||1||
59727208|NCT00996216|75845998|FG000|STARTED|Part 2 (Antiviral Treatment Phase)|One participant who completed Part 1 didn't qualify to begin antiviral treatment in Part 2.|25||
59727209|NCT00996216|75845998|FG000|COMPLETED|Part 2 (Antiviral Treatment Phase)||21||
59727210|NCT00996216|75845998|FG000|NOT COMPLETED|Part 2 (Antiviral Treatment Phase)||4||
59727211|NCT00830869|75846015|FG000|STARTED|Period 1: Part 1||1||
59727212|NCT00830869|75846016|FG001|STARTED|Period 1: Part 1||1||
59727213|NCT00830869|75846017|FG002|STARTED|Period 1: Part 1||1||
59727214|NCT00830869|75846018|FG003|STARTED|Period 1: Part 1||7||
59727215|NCT00830869|75846019|FG004|STARTED|Period 1: Part 1||4||
59858008|NCT03229486|75982853|FG001|COMPLETED|Overall Study||19||
59858009|NCT03229486|75982852|FG000|NOT COMPLETED|Overall Study||0||
59594256|NCT03098420|75702983|FG000|COMPLETED|Overall Study||7||
59727216|NCT00830869|75846020|FG005|STARTED|Period 1: Part 1||6||
59727217|NCT00830869|75846021|FG006|STARTED|Period 1: Part 1||3||
59727218|NCT00830869|75846022|FG007|STARTED|Period 1: Part 1||0||
59727219|NCT00830869|75846023|FG008|STARTED|Period 1: Part 1||0||
59727220|NCT00830869|75846024|FG009|STARTED|Period 1: Part 1||0||
59727221|NCT00830869|75846025|FG010|STARTED|Period 1: Part 1||0||
59727222|NCT00830869|75846026|FG011|STARTED|Period 1: Part 1||0||
59727223|NCT00830869|75846015|FG000|COMPLETED|Period 1: Part 1||0||
59858010|NCT03229486|75982853|FG001|NOT COMPLETED|Overall Study||1||
59858011|NCT01779050|75982861|FG000|STARTED|Overall Study||4||
59858012|NCT01779050|75982862|FG001|STARTED|Overall Study||3||
59858013|NCT01779050|75982861|FG000|COMPLETED|Overall Study||3||
59858014|NCT01779050|75982862|FG001|COMPLETED|Overall Study||3||
59858015|NCT01779050|75982861|FG000|NOT COMPLETED|Overall Study||1||
59858016|NCT01779050|75982862|FG001|NOT COMPLETED|Overall Study||0||
59858017|NCT00306527|75982872|FG000|STARTED|Overall Study||533||
59858018|NCT00306527|75982873|FG001|STARTED|Overall Study||534||
59858019|NCT00306527|75982874|FG002|STARTED|Overall Study||572||
59858020|NCT00306527|75982875|FG003|STARTED|Overall Study||596||
59858021|NCT00306527|75982872|FG000|COMPLETED|Overall Study||527||
59858022|NCT00306527|75982873|FG001|COMPLETED|Overall Study||527||
59858023|NCT00306527|75982874|FG002|COMPLETED|Overall Study|3 of 4 deaths in the elderly subjects resulted in premature discontinuation. Refer to OM2 .|567||
59858024|NCT00306527|75982875|FG003|COMPLETED|Overall Study||590||
59858025|NCT00306527|75982872|FG000|NOT COMPLETED|Overall Study||6||
59858026|NCT00306527|75982873|FG001|NOT COMPLETED|Overall Study||7||
59858027|NCT00306527|75982874|FG002|NOT COMPLETED|Overall Study||5||
59858028|NCT00306527|75982875|FG003|NOT COMPLETED|Overall Study||6||
59858029|NCT00306293|75982889|FG000|STARTED|Period 1 (Day 1 to Day 60)||35||
59858030|NCT00306293|75982890|FG001|STARTED|Period 1 (Day 1 to Day 60)||35||
59858031|NCT00306293|75982889|FG000|COMPLETED|Period 1 (Day 1 to Day 60)||27||
59858032|NCT00306293|75982890|FG001|COMPLETED|Period 1 (Day 1 to Day 60)||27||
59858033|NCT00306293|75982889|FG000|NOT COMPLETED|Period 1 (Day 1 to Day 60)||8||
59858034|NCT00306293|75982890|FG001|NOT COMPLETED|Period 1 (Day 1 to Day 60)||8||
59858035|NCT00306293|75982889|FG000|STARTED|Washout (Day 61 to Day 66)||27||
59858036|NCT00306293|75982890|FG001|STARTED|Washout (Day 61 to Day 66)||27||
59858037|NCT00306293|75982889|FG000|COMPLETED|Washout (Day 61 to Day 66)||27||
59858038|NCT00306293|75982890|FG001|COMPLETED|Washout (Day 61 to Day 66)||27||
59858039|NCT00306293|75982889|FG000|NOT COMPLETED|Washout (Day 61 to Day 66)||0||
59858040|NCT00306293|75982890|FG001|NOT COMPLETED|Washout (Day 61 to Day 66)||0||
59858041|NCT00306293|75982889|FG000|STARTED|Period 2 (Day 67 to Day 126 )||27||
59858042|NCT00306293|75982890|FG001|STARTED|Period 2 (Day 67 to Day 126 )||27||
59858043|NCT00306293|75982889|FG000|COMPLETED|Period 2 (Day 67 to Day 126 )||24||
59858044|NCT00306293|75982890|FG001|COMPLETED|Period 2 (Day 67 to Day 126 )||26||
59858045|NCT00306293|75982889|FG000|NOT COMPLETED|Period 2 (Day 67 to Day 126 )||3||
59858046|NCT00306293|75982890|FG001|NOT COMPLETED|Period 2 (Day 67 to Day 126 )||1||
59858047|NCT00294671|75982900|FG000|STARTED|Overall Study||64||
59858048|NCT00294671|75982901|FG001|STARTED|Overall Study||66||
59858049|NCT00294671|75982900|FG000|COMPLETED|Overall Study||37||
59858050|NCT00294671|75982901|FG001|COMPLETED|Overall Study||26||
59858051|NCT00294671|75982900|FG000|NOT COMPLETED|Overall Study||27||
59858052|NCT00294671|75982901|FG001|NOT COMPLETED|Overall Study||40||
59858053|NCT01495598|75982907|FG000|STARTED|Overall Study||28||
59858054|NCT01495598|75982907|FG000|COMPLETED|Overall Study||14||
59858055|NCT01495598|75982907|FG000|NOT COMPLETED|Overall Study||14||
59858056|NCT02937454|75982938|FG000|STARTED|Overall Study||567|All Randomised Set|
59858057|NCT02937454|75982939|FG001|STARTED|Overall Study||565|All Randomised Set|
59858058|NCT02937454|75982938|FG000|Started Treatment|Overall Study||559||
59858059|NCT02937454|75982939|FG001|Started Treatment|Overall Study||551||
59858060|NCT02937454|75982938|FG000|COMPLETED|Overall Study||427||
59858061|NCT02937454|75982939|FG001|COMPLETED|Overall Study||437||
60123545|NCT00144963|76244886|FG000|STARTED|Overall Study||36||
60123546|NCT00144963|76244886|FG000|COMPLETED|Overall Study||36||
60123547|NCT00144963|76244886|FG000|NOT COMPLETED|Overall Study||0||
60123548|NCT02662764|76244890|FG000|STARTED|Overall Study||320||
60123549|NCT02662764|76244890|FG000|COMPLETED|Overall Study|First 24-hours of study treatment|290||
59594257|NCT03098420|75702984|FG001|COMPLETED|Overall Study||9||
59858062|NCT02937454|75982938|FG000|NOT COMPLETED|Overall Study||140||
59858063|NCT02937454|75982939|FG001|NOT COMPLETED|Overall Study||128||
60123550|NCT02662764|76244890|FG000|NOT COMPLETED|Overall Study||30||
60123551|NCT01519817|76244899|FG000|STARTED|Overall Study||4||
59858064|NCT03012386|75982948|FG000|STARTED|Overall Study||8||
59858065|NCT03012386|75982949|FG001|STARTED|Overall Study||18||
59858066|NCT03012386|75982948|FG000|COMPLETED|Overall Study||8||
59858067|NCT03012386|75982949|FG001|COMPLETED|Overall Study||13||
59858068|NCT03012386|75982948|FG000|NOT COMPLETED|Overall Study||0||
59858069|NCT03012386|75982949|FG001|NOT COMPLETED|Overall Study||5||
59858070|NCT03211858|75982958|FG000|STARTED|Overall Study||301||
59858071|NCT03211858|75982959|FG001|STARTED|Overall Study||296||
59858072|NCT03211858|75982958|FG000|Treated|Overall Study||301||
59996832|NCT02729831|76112671|FG003|STARTED|6 Month Follow-up||275|Follow-up survey (Period 3) was sent to all those who completed the Baseline (Period 1) survey.|
59996833|NCT02729831|76112668|FG000|COMPLETED|6 Month Follow-up||227||
59996834|NCT02729831|76112669|FG001|COMPLETED|6 Month Follow-up||238||
59996835|NCT02729831|76112670|FG002|COMPLETED|6 Month Follow-up||227||
59996836|NCT02729831|76112671|FG003|COMPLETED|6 Month Follow-up||232||
59996837|NCT02729831|76112668|FG000|NOT COMPLETED|6 Month Follow-up||55||
59996838|NCT02729831|76112669|FG001|NOT COMPLETED|6 Month Follow-up||54||
59996839|NCT02729831|76112670|FG002|NOT COMPLETED|6 Month Follow-up||48||
59996840|NCT02729831|76112671|FG003|NOT COMPLETED|6 Month Follow-up||43||
59996841|NCT02729753|76112683|FG000|STARTED|Overall Study|First patient enrolled April 2016|3||
60123552|NCT01519817|76244900|FG001|STARTED|Overall Study||3||
60123553|NCT01519817|76244901|FG002|STARTED|Overall Study||16||
59858073|NCT03211858|75982959|FG001|Treated|Overall Study||296||
59858074|NCT03211858|75982958|FG000|COMPLETED|Overall Study||264|Completed 12-month on treatment period.|
59858075|NCT03211858|75982959|FG001|COMPLETED|Overall Study||263|Completed 12-month on treatment period.|
59858076|NCT03211858|75982958|FG000|NOT COMPLETED|Overall Study||37||
59858077|NCT03211858|75982959|FG001|NOT COMPLETED|Overall Study||33||
59858078|NCT03211156|75982971|FG000|STARTED|Overall Study||49||
59858079|NCT03211156|75982972|FG001|STARTED|Overall Study||48||
59858080|NCT03211156|75982971|FG000|Received Study Drug|Overall Study||47||
59858081|NCT03211156|75982972|FG001|Received Study Drug|Overall Study||45||
59858082|NCT03211156|75982971|FG000|COMPLETED|Overall Study||47||
59858083|NCT03211156|75982972|FG001|COMPLETED|Overall Study||45||
59858084|NCT03211156|75982971|FG000|NOT COMPLETED|Overall Study||2||
59858085|NCT03211156|75982972|FG001|NOT COMPLETED|Overall Study||3||
59858086|NCT04472494|75982980|FG000|STARTED|Pre-treatment||42|Started = Randomized|
59858087|NCT04472494|75982981|FG001|STARTED|Pre-treatment||19|Started = Randomized|
59858088|NCT04472494|75982980|FG000|COMPLETED|Pre-treatment||40|Completed = Entering treatment period|
59858089|NCT04472494|75982981|FG001|COMPLETED|Pre-treatment||19|Completed = Entering treatment period|
59858090|NCT04472494|75982980|FG000|NOT COMPLETED|Pre-treatment||2||
59858091|NCT04472494|75982981|FG001|NOT COMPLETED|Pre-treatment||0||
59858092|NCT04472494|75982980|FG000|STARTED|Treatment||40|Started = Entering treatment period|
59858093|NCT04472494|75982981|FG001|STARTED|Treatment||19|Started = Entering treatment period|
59858094|NCT04472494|75982980|FG000|COMPLETED|Treatment||34|Completed = Completed treatment period|
59858095|NCT04472494|75982981|FG001|COMPLETED|Treatment||16|Completed = Completed treatment period|
59858096|NCT04472494|75982980|FG000|NOT COMPLETED|Treatment||6||
59858097|NCT04472494|75982981|FG001|NOT COMPLETED|Treatment||3||
59858098|NCT04419506|75982991|FG000|STARTED|Overall Study||25||
59858099|NCT04419506|75982992|FG001|STARTED|Overall Study||49||
59858100|NCT04419506|75982993|FG002|STARTED|Overall Study||25||
59858101|NCT04419506|75982994|FG003|STARTED|Overall Study||48||
59858102|NCT04419506|75982991|FG000|COMPLETED|Overall Study||25|Completion of trial medication|
59858103|NCT04419506|75982992|FG001|COMPLETED|Overall Study||39|Completion of trial medication|
59858104|NCT04419506|75982993|FG002|COMPLETED|Overall Study||25|Completion of trial medication|
59858105|NCT04419506|75982994|FG003|COMPLETED|Overall Study||43|Completion of trial medication|
59858106|NCT04419506|75982991|FG000|NOT COMPLETED|Overall Study||0||
59858107|NCT04419506|75982992|FG001|NOT COMPLETED|Overall Study||10||
59858108|NCT04419506|75982993|FG002|NOT COMPLETED|Overall Study||0||
59858109|NCT04419506|75982994|FG003|NOT COMPLETED|Overall Study||5||
59858110|NCT03236506|75983007|FG000|STARTED|Overall Study||39||
59858111|NCT03236506|75983008|FG001|STARTED|Overall Study||42||
59858112|NCT03236506|75983009|FG002|STARTED|Overall Study||47||
59858113|NCT03236506|75983007|FG000|COMPLETED|Overall Study||33||
59858114|NCT03236506|75983008|FG001|COMPLETED|Overall Study||37||
59858115|NCT03236506|75983009|FG002|COMPLETED|Overall Study||40||
59858116|NCT03236506|75983007|FG000|NOT COMPLETED|Overall Study||6||
59858117|NCT03236506|75983008|FG001|NOT COMPLETED|Overall Study||5||
59858118|NCT03236506|75983009|FG002|NOT COMPLETED|Overall Study||7||
59858119|NCT04421404|75983019|FG000|STARTED|Overall Study||16||
59858120|NCT04421404|75983020|FG001|STARTED|Overall Study||18||
59858121|NCT04421404|75983019|FG000|COMPLETED|Overall Study||16|Completion of study defined as completing 29 day follow up (or died prior to day 29)|
59858122|NCT04421404|75983020|FG001|COMPLETED|Overall Study||18|Completion of study defined as completing 29 day follow up (or died prior to day 29)|
59858123|NCT04421404|75983019|FG000|NOT COMPLETED|Overall Study||0||
59858124|NCT04421404|75983020|FG001|NOT COMPLETED|Overall Study||0||
59858125|NCT03227692|75983028|FG000|STARTED|Overall Study||47||
59858126|NCT03227692|75983029|FG001|STARTED|Overall Study||46||
59858127|NCT03227692|75983028|FG000|COMPLETED|Overall Study||42||
59858128|NCT03227692|75983029|FG001|COMPLETED|Overall Study||41||
59858129|NCT03227692|75983028|FG000|NOT COMPLETED|Overall Study||5||
60123554|NCT01519817|76244902|FG003|STARTED|Overall Study||11||
60123555|NCT01519817|76244899|FG000|COMPLETED|Overall Study||3||
59858130|NCT03227692|75983029|FG001|NOT COMPLETED|Overall Study||5||
59858131|NCT03210220|75983037|FG000|STARTED|Overall Study||20||
59858132|NCT03210220|75983038|FG001|STARTED|Overall Study||20||
59858133|NCT03210220|75983037|FG000|COMPLETED|Overall Study||19||
59858134|NCT03210220|75983038|FG001|COMPLETED|Overall Study||20||
60123556|NCT01519817|76244900|FG001|COMPLETED|Overall Study||3||
59858135|NCT03210220|75983037|FG000|NOT COMPLETED|Overall Study||1||
59858136|NCT03210220|75983038|FG001|NOT COMPLETED|Overall Study||0||
59858137|NCT03209518|75983044|FG000|STARTED|Overall Study||312||
59858138|NCT03209518|75983044|FG000|COMPLETED|Overall Study||310||
59858139|NCT03209518|75983044|FG000|NOT COMPLETED|Overall Study||2||
59858140|NCT03725852|75983050|FG000|STARTED|Overall Study||45||
59858141|NCT03725852|75983051|FG001|STARTED|Overall Study||23||
59858142|NCT03725852|75983050|FG000|COMPLETED|Overall Study||41||
59858143|NCT03725852|75983051|FG001|COMPLETED|Overall Study||23||
59858144|NCT03725852|75983050|FG000|NOT COMPLETED|Overall Study||4||
59858145|NCT03725852|75983051|FG001|NOT COMPLETED|Overall Study||0||
59858146|NCT00304031|75983060|FG000|STARTED|Concomitant RT+TMZ (Pre-randomization)|All participants registered to concomitant treatment; randomized after completing this treatment.|1125||
60123557|NCT01519817|76244901|FG002|COMPLETED|Overall Study||16||
59858147|NCT00304031|75983061|FG001|STARTED|Concomitant RT+TMZ (Pre-randomization)|Participants were not randomized to adjuvant TMZ until after completion of concomitant treatment.|0||
59858148|NCT00304031|75983062|FG002|STARTED|Concomitant RT+TMZ (Pre-randomization)|Participants were not randomized to adjuvant TMZ until after completion of concomitant treatment.|0||
59858149|NCT00304031|75983060|FG000|Eligible Pre-randomization Population|Concomitant RT+TMZ (Pre-randomization)||1125||
59858150|NCT00304031|75983061|FG001|Eligible Pre-randomization Population|Concomitant RT+TMZ (Pre-randomization)||0||
59858151|NCT00304031|75983062|FG002|Eligible Pre-randomization Population|Concomitant RT+TMZ (Pre-randomization)||0||
59858152|NCT00304031|75983060|FG000|Eligible Pre-randomization Follow-up|Concomitant RT+TMZ (Pre-randomization)||1120|Eligible pre-randomization participants with any follow-up data.|
59858153|NCT00304031|75983061|FG001|Eligible Pre-randomization Follow-up|Concomitant RT+TMZ (Pre-randomization)||0|Eligible pre-randomization participants with any follow-up data.|
59858154|NCT00304031|75983062|FG002|Eligible Pre-randomization Follow-up|Concomitant RT+TMZ (Pre-randomization)||0|Eligible pre-randomization participants with any follow-up data.|
59858155|NCT00304031|75983060|FG000|COMPLETED|Concomitant RT+TMZ (Pre-randomization)|These participants completed concomitant treatment and met requirements for randomization.|833||
59858156|NCT00304031|75983061|FG001|COMPLETED|Concomitant RT+TMZ (Pre-randomization)||0||
59858157|NCT00304031|75983062|FG002|COMPLETED|Concomitant RT+TMZ (Pre-randomization)||0||
59858158|NCT00304031|75983060|FG000|NOT COMPLETED|Concomitant RT+TMZ (Pre-randomization)||292||
60123558|NCT01519817|76244902|FG003|COMPLETED|Overall Study||10||
60123559|NCT01519817|76244899|FG000|NOT COMPLETED|Overall Study||1||
60123560|NCT01519817|76244900|FG001|NOT COMPLETED|Overall Study||0||
60123561|NCT01519817|76244901|FG002|NOT COMPLETED|Overall Study||0||
60123562|NCT01519817|76244902|FG003|NOT COMPLETED|Overall Study||1||
60123563|NCT01519661|76244912|FG000|STARTED|Overall Study||157||
60123564|NCT01519661|76244912|FG000|COMPLETED|Overall Study||96||
60123565|NCT01519661|76244912|FG000|NOT COMPLETED|Overall Study||61||
60123566|NCT01519427|76244917|FG000|STARTED|Overall Study||2||
60123567|NCT01519427|76244917|FG000|COMPLETED|Overall Study||0||
60123568|NCT01519427|76244917|FG000|NOT COMPLETED|Overall Study||2||
60123569|NCT01518257|76244923|FG000|STARTED|Overall Study||61||
60123570|NCT01518257|76244924|FG001|STARTED|Overall Study||60||
60123571|NCT01518257|76244923|FG000|COMPLETED|Overall Study||59||
60123572|NCT01518257|76244924|FG001|COMPLETED|Overall Study||60||
60123573|NCT01518257|76244923|FG000|NOT COMPLETED|Overall Study||2||
60123574|NCT01518257|76244924|FG001|NOT COMPLETED|Overall Study||0||
60123575|NCT02668302|76244932|FG000|STARTED|Overall Study||20||
60123576|NCT02668302|76244933|FG001|STARTED|Overall Study||20||
60123577|NCT02668302|76244932|FG000|COMPLETED|Overall Study||19||
60123578|NCT02668302|76244933|FG001|COMPLETED|Overall Study||20||
60123579|NCT02668302|76244932|FG000|NOT COMPLETED|Overall Study||1||
60123580|NCT02668302|76244933|FG001|NOT COMPLETED|Overall Study||0||
60123581|NCT01517867|76244941|FG000|STARTED|Overall Study||81||
60123582|NCT01517867|76244942|FG001|STARTED|Overall Study||80||
60123583|NCT01517867|76244941|FG000|COMPLETED|Overall Study||18||
60123584|NCT01517867|76244942|FG001|COMPLETED|Overall Study||15||
60123585|NCT01517867|76244941|FG000|NOT COMPLETED|Overall Study||63||
60123586|NCT01517867|76244942|FG001|NOT COMPLETED|Overall Study||65||
60123587|NCT01514357|76244950|FG000|STARTED|Overall Study||12||
60123588|NCT01514357|76244951|FG001|STARTED|Overall Study||0||
60123589|NCT01514357|76244950|FG000|COMPLETED|Overall Study||8||
60123590|NCT01514357|76244951|FG001|COMPLETED|Overall Study||0||
60123591|NCT01514357|76244950|FG000|NOT COMPLETED|Overall Study||4||
60123592|NCT01514357|76244951|FG001|NOT COMPLETED|Overall Study||0||
60123593|NCT01532869|76244959|FG000|STARTED|Blinded-Treatment Period (Up to Week 24)||44||
60123594|NCT01532869|76244960|FG001|STARTED|Blinded-Treatment Period (Up to Week 24)||43||
60123595|NCT01532869|76244959|FG000|COMPLETED|Blinded-Treatment Period (Up to Week 24)|Number of participants who completed the first 24 weeks of full 48 weeks blinded-treatment period.|36||
60123596|NCT01532869|76244960|FG001|COMPLETED|Blinded-Treatment Period (Up to Week 24)|Number of participants who completed the first 24 weeks of full 48 weeks blinded-treatment period.|35||
60123597|NCT01532869|76244959|FG000|NOT COMPLETED|Blinded-Treatment Period (Up to Week 24)||8||
60123598|NCT01532869|76244960|FG001|NOT COMPLETED|Blinded-Treatment Period (Up to Week 24)||8||
60123599|NCT01532869|76244959|FG000|STARTED|Blinded-Treatment Period (Up to Week 48)||44||
60123600|NCT01532869|76244960|FG001|STARTED|Blinded-Treatment Period (Up to Week 48)||43||
60123601|NCT01532869|76244959|FG000|COMPLETED|Blinded-Treatment Period (Up to Week 48)|Number of participants who completed 48 weeks of blinded-treatment period.|33||
60123602|NCT01532869|76244960|FG001|COMPLETED|Blinded-Treatment Period (Up to Week 48)|Number of participants who completed 48 weeks of blinded-treatment period.|30||
60123603|NCT01532869|76244959|FG000|NOT COMPLETED|Blinded-Treatment Period (Up to Week 48)||11||
60123604|NCT01532869|76244960|FG001|NOT COMPLETED|Blinded-Treatment Period (Up to Week 48)||13||
60123605|NCT01532869|76244959|FG000|STARTED|Open-label Period (Week 48 to Week 96)|Two participants did not start the open label extension period.|31||
60123606|NCT01532869|76244960|FG001|STARTED|Open-label Period (Week 48 to Week 96)||30||
60123607|NCT01532869|76244959|FG000|COMPLETED|Open-label Period (Week 48 to Week 96)|Number of participants who completed study to Week 96.|24||
60123608|NCT01532869|76244960|FG001|COMPLETED|Open-label Period (Week 48 to Week 96)|Number of participants who completed study to Week 96.|27||
60123609|NCT01532869|76244959|FG000|NOT COMPLETED|Open-label Period (Week 48 to Week 96)||7||
60123610|NCT01532869|76244960|FG001|NOT COMPLETED|Open-label Period (Week 48 to Week 96)||3||
60123611|NCT01531387|76244973|FG000|STARTED|Overall Study||11||
60123612|NCT01531387|76244974|FG001|STARTED|Overall Study||11||
60123613|NCT01531387|76244973|FG000|COMPLETED|Overall Study||0||
60123614|NCT01531387|76244974|FG001|COMPLETED|Overall Study||0||
60123615|NCT01531387|76244973|FG000|NOT COMPLETED|Overall Study||11||
60123616|NCT01531387|76244974|FG001|NOT COMPLETED|Overall Study||11||
60123617|NCT01531153|76244983|FG000|STARTED|Overall Study||32||
60123618|NCT01531153|76244984|FG001|STARTED|Overall Study||31||
60123619|NCT01531153|76244985|FG002|STARTED|Overall Study||30||
60123620|NCT01531153|76244983|FG000|COMPLETED|Overall Study||22||
60123621|NCT01531153|76244984|FG001|COMPLETED|Overall Study||22||
60123622|NCT01531153|76244985|FG002|COMPLETED|Overall Study||15||
60123623|NCT01531153|76244983|FG000|NOT COMPLETED|Overall Study||10||
60123624|NCT01531153|76244984|FG001|NOT COMPLETED|Overall Study||9||
60123625|NCT01531153|76244985|FG002|NOT COMPLETED|Overall Study||15||
60123626|NCT01529749|76245000|FG000|STARTED|Overall Study||12||
60123627|NCT01529749|76245001|FG001|STARTED|Overall Study||12||
60123628|NCT01529749|76245002|FG002|STARTED|Overall Study||12||
60123629|NCT01529749|76245003|FG003|STARTED|Overall Study||12||
60123630|NCT01529749|76245000|FG000|COMPLETED|Overall Study||12||
60123631|NCT01529749|76245001|FG001|COMPLETED|Overall Study||10||
60123632|NCT01529749|76245002|FG002|COMPLETED|Overall Study||10||
60123633|NCT01529749|76245003|FG003|COMPLETED|Overall Study||10||
60123634|NCT01529749|76245000|FG000|NOT COMPLETED|Overall Study||0||
60123635|NCT01529749|76245001|FG001|NOT COMPLETED|Overall Study||2||
60123636|NCT01529749|76245002|FG002|NOT COMPLETED|Overall Study||2||
60123637|NCT01529749|76245003|FG003|NOT COMPLETED|Overall Study||2||
60123638|NCT01529515|76245015|FG000|STARTED|TRANSITION PHASE||506||
60123639|NCT01529515|76245016|FG001|STARTED|TRANSITION PHASE||0||
60123640|NCT01529515|76245017|FG002|STARTED|TRANSITION PHASE||0||
60123641|NCT01529515|76245018|FG003|STARTED|TRANSITION PHASE||0||
60123642|NCT01529515|76245015|FG000|COMPLETED|TRANSITION PHASE||379||
60123643|NCT01529515|76245016|FG001|COMPLETED|TRANSITION PHASE||0||
60123644|NCT01529515|76245017|FG002|COMPLETED|TRANSITION PHASE||0||
60123645|NCT01529515|76245018|FG003|COMPLETED|TRANSITION PHASE||0||
60123646|NCT01529515|76245015|FG000|NOT COMPLETED|TRANSITION PHASE||127||
60123647|NCT01529515|76245016|FG001|NOT COMPLETED|TRANSITION PHASE||0||
60123648|NCT01529515|76245017|FG002|NOT COMPLETED|TRANSITION PHASE||0||
60123649|NCT01529515|76245018|FG003|NOT COMPLETED|TRANSITION PHASE||0||
60123650|NCT01529515|76245015|FG000|STARTED|MAINTENANCE PHASE||0||
60123651|NCT01529515|76245016|FG001|STARTED|MAINTENANCE PHASE||379||
60123652|NCT01529515|76245017|FG002|STARTED|MAINTENANCE PHASE||0||
60123653|NCT01529515|76245018|FG003|STARTED|MAINTENANCE PHASE||0||
60123654|NCT01529515|76245015|FG000|COMPLETED|MAINTENANCE PHASE||0||
60123655|NCT01529515|76245016|FG001|COMPLETED|MAINTENANCE PHASE||305||
60123656|NCT01529515|76245017|FG002|COMPLETED|MAINTENANCE PHASE||0||
60123657|NCT01529515|76245018|FG003|COMPLETED|MAINTENANCE PHASE||0||
60123658|NCT01529515|76245015|FG000|NOT COMPLETED|MAINTENANCE PHASE||0||
60123659|NCT01529515|76245016|FG001|NOT COMPLETED|MAINTENANCE PHASE||74||
60123660|NCT01529515|76245017|FG002|NOT COMPLETED|MAINTENANCE PHASE||0||
60123661|NCT01529515|76245018|FG003|NOT COMPLETED|MAINTENANCE PHASE||0||
59594258|NCT03098420|75702985|FG002|COMPLETED|Overall Study||13||
59594259|NCT03098420|75702983|FG000|NOT COMPLETED|Overall Study||0||
59594260|NCT03098420|75702984|FG001|NOT COMPLETED|Overall Study||0||
59594261|NCT03098420|75702985|FG002|NOT COMPLETED|Overall Study||0||
59727224|NCT00830869|75846016|FG001|COMPLETED|Period 1: Part 1||0||
60123662|NCT01529515|76245015|FG000|STARTED|DOUBLE BLIND PHASE||0||
60123663|NCT01529515|76245016|FG001|STARTED|DOUBLE BLIND PHASE||0||
60123664|NCT01529515|76245017|FG002|STARTED|DOUBLE BLIND PHASE||145||
60123665|NCT01529515|76245018|FG003|STARTED|DOUBLE BLIND PHASE||160||
59594262|NCT02876887|75702995|FG000|STARTED|Overall Study||23||
59594263|NCT02876887|75702996|FG001|STARTED|Overall Study||21||
59594264|NCT02876887|75702995|FG000|COMPLETED|Overall Study||19||
59594265|NCT02876887|75702996|FG001|COMPLETED|Overall Study||21||
59594266|NCT02876887|75702995|FG000|NOT COMPLETED|Overall Study||4||
60123666|NCT01529515|76245015|FG000|COMPLETED|DOUBLE BLIND PHASE||0||
60123667|NCT01529515|76245016|FG001|COMPLETED|DOUBLE BLIND PHASE||0||
60123668|NCT01529515|76245017|FG002|COMPLETED|DOUBLE BLIND PHASE||122||
60123669|NCT01529515|76245018|FG003|COMPLETED|DOUBLE BLIND PHASE||148||
60123670|NCT01529515|76245015|FG000|NOT COMPLETED|DOUBLE BLIND PHASE||0||
60123671|NCT01529515|76245016|FG001|NOT COMPLETED|DOUBLE BLIND PHASE||0||
60123672|NCT01529515|76245017|FG002|NOT COMPLETED|DOUBLE BLIND PHASE||23||
60123673|NCT01529515|76245018|FG003|NOT COMPLETED|DOUBLE BLIND PHASE||12||
60123674|NCT01528969|76245027|FG000|STARTED|Overall Study||37||
60123675|NCT01528969|76245028|FG001|STARTED|Overall Study||38||
60123676|NCT01528969|76245027|FG000|COMPLETED|Overall Study||35||
60123677|NCT01528969|76245028|FG001|COMPLETED|Overall Study||38||
59727225|NCT00830869|75846017|FG002|COMPLETED|Period 1: Part 1||0||
59727226|NCT00830869|75846018|FG003|COMPLETED|Period 1: Part 1||0||
59727227|NCT00830869|75846019|FG004|COMPLETED|Period 1: Part 1||0||
59727228|NCT00830869|75846020|FG005|COMPLETED|Period 1: Part 1||0||
59727229|NCT00830869|75846021|FG006|COMPLETED|Period 1: Part 1||0||
60123678|NCT01528969|76245027|FG000|NOT COMPLETED|Overall Study||2||
60123679|NCT01528969|76245028|FG001|NOT COMPLETED|Overall Study||0||
60123680|NCT01514201|76245038|FG000|STARTED|PHASE I: Veliparib + Radiation Therapy||6||
60123681|NCT01514201|76245039|FG001|STARTED|PHASE I: Veliparib + Radiation Therapy||6||
60123682|NCT01514201|76245040|FG002|STARTED|PHASE I: Veliparib + Radiation Therapy||6||
60123683|NCT01514201|76245041|FG003|STARTED|PHASE I: Veliparib + Radiation Therapy||0||
60123684|NCT01514201|76245038|FG000|COMPLETED|PHASE I: Veliparib + Radiation Therapy||5||
60123685|NCT01514201|76245039|FG001|COMPLETED|PHASE I: Veliparib + Radiation Therapy||6||
60123686|NCT01514201|76245040|FG002|COMPLETED|PHASE I: Veliparib + Radiation Therapy||6||
60123687|NCT01514201|76245041|FG003|COMPLETED|PHASE I: Veliparib + Radiation Therapy||0||
60123688|NCT01514201|76245038|FG000|NOT COMPLETED|PHASE I: Veliparib + Radiation Therapy||1||
60123689|NCT01514201|76245039|FG001|NOT COMPLETED|PHASE I: Veliparib + Radiation Therapy||0||
60123690|NCT01514201|76245040|FG002|NOT COMPLETED|PHASE I: Veliparib + Radiation Therapy||0||
60123691|NCT01514201|76245041|FG003|NOT COMPLETED|PHASE I: Veliparib + Radiation Therapy||0||
60123692|NCT01514201|76245038|FG000|STARTED|PHASE I: Maintenance With Veliparib/TMZ||5||
60123693|NCT01514201|76245039|FG001|STARTED|PHASE I: Maintenance With Veliparib/TMZ||6||
60123694|NCT01514201|76245040|FG002|STARTED|PHASE I: Maintenance With Veliparib/TMZ||6||
60123695|NCT01514201|76245041|FG003|STARTED|PHASE I: Maintenance With Veliparib/TMZ||0||
60123696|NCT01514201|76245038|FG000|COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||0||
60123697|NCT01514201|76245039|FG001|COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||0||
60123698|NCT01514201|76245040|FG002|COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||0||
60123699|NCT01514201|76245041|FG003|COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||0||
60123700|NCT01514201|76245038|FG000|NOT COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||5||
60123701|NCT01514201|76245039|FG001|NOT COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||6||
60123702|NCT01514201|76245040|FG002|NOT COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||6||
60123703|NCT01514201|76245041|FG003|NOT COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||0||
60123704|NCT01514201|76245038|FG000|STARTED|PHASE II: Veliparib + Radiation Therapy||0||
60123705|NCT01514201|76245039|FG001|STARTED|PHASE II: Veliparib + Radiation Therapy||0||
60123706|NCT01514201|76245040|FG002|STARTED|PHASE II: Veliparib + Radiation Therapy||0||
60123707|NCT01514201|76245041|FG003|STARTED|PHASE II: Veliparib + Radiation Therapy||47||
60123708|NCT01514201|76245038|FG000|COMPLETED|PHASE II: Veliparib + Radiation Therapy||0||
60123709|NCT01514201|76245039|FG001|COMPLETED|PHASE II: Veliparib + Radiation Therapy||0||
60123710|NCT01514201|76245040|FG002|COMPLETED|PHASE II: Veliparib + Radiation Therapy||0||
60123711|NCT01514201|76245041|FG003|COMPLETED|PHASE II: Veliparib + Radiation Therapy||35||
60123712|NCT01514201|76245038|FG000|NOT COMPLETED|PHASE II: Veliparib + Radiation Therapy||0||
60123713|NCT01514201|76245039|FG001|NOT COMPLETED|PHASE II: Veliparib + Radiation Therapy||0||
60123714|NCT01514201|76245040|FG002|NOT COMPLETED|PHASE II: Veliparib + Radiation Therapy||0||
60123715|NCT01514201|76245041|FG003|NOT COMPLETED|PHASE II: Veliparib + Radiation Therapy||12||
60123716|NCT01514201|76245038|FG000|STARTED|PHASE II: Maintenance With Veliparib/TMZ||0||
60123717|NCT01514201|76245039|FG001|STARTED|PHASE II: Maintenance With Veliparib/TMZ||0||
60123718|NCT01514201|76245040|FG002|STARTED|PHASE II: Maintenance With Veliparib/TMZ||0||
60123719|NCT01514201|76245041|FG003|STARTED|PHASE II: Maintenance With Veliparib/TMZ||35||
60123720|NCT01514201|76245038|FG000|COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||0||
60123721|NCT01514201|76245039|FG001|COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||0||
60123722|NCT01514201|76245040|FG002|COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||0||
60123723|NCT01514201|76245041|FG003|COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||2||
60123724|NCT01514201|76245038|FG000|NOT COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||0||
60123725|NCT01514201|76245039|FG001|NOT COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||0||
60123726|NCT01514201|76245040|FG002|NOT COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||0||
60123727|NCT01514201|76245041|FG003|NOT COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||33||
60123728|NCT02666664|76245063|FG000|STARTED|Overall Study||742||
60123729|NCT02666664|76245064|FG001|STARTED|Overall Study||1488||
60123730|NCT02666664|76245063|FG000|COMPLETED|Overall Study||706||
60123731|NCT02666664|76245064|FG001|COMPLETED|Overall Study||1404||
60123732|NCT02666664|76245063|FG000|NOT COMPLETED|Overall Study||36||
60123733|NCT02666664|76245064|FG001|NOT COMPLETED|Overall Study||84||
60123734|NCT01528735|76245072|FG000|STARTED|Treatment Period 1: Faldap/Del/RBV||12||
60123735|NCT01528735|76245073|FG001|STARTED|Treatment Period 1: Faldap/Del/RBV||13||
60123736|NCT01528735|76245072|FG000|COMPLETED|Treatment Period 1: Faldap/Del/RBV||11||
60123737|NCT01528735|76245073|FG001|COMPLETED|Treatment Period 1: Faldap/Del/RBV||12||
60123738|NCT01528735|76245072|FG000|NOT COMPLETED|Treatment Period 1: Faldap/Del/RBV||1||
60123739|NCT01528735|76245073|FG001|NOT COMPLETED|Treatment Period 1: Faldap/Del/RBV||1||
60123740|NCT01528735|76245072|FG000|STARTED|Treatment Period 2: Faldap/PegIFN/RBV||11||
60123741|NCT01528735|76245073|FG001|STARTED|Treatment Period 2: Faldap/PegIFN/RBV|One patient was treated with only PegIFN/RBV, as faldaprevir was discontinued due to adverse events|12||
60123742|NCT01528735|76245072|FG000|COMPLETED|Treatment Period 2: Faldap/PegIFN/RBV||10||
60123743|NCT01528735|76245073|FG001|COMPLETED|Treatment Period 2: Faldap/PegIFN/RBV||12||
60123744|NCT01528735|76245072|FG000|NOT COMPLETED|Treatment Period 2: Faldap/PegIFN/RBV||1||
60123745|NCT01528735|76245073|FG001|NOT COMPLETED|Treatment Period 2: Faldap/PegIFN/RBV||0||
60123746|NCT02661594|76245085|FG000|STARTED|Overall Study||10||
60123747|NCT02661594|76245086|FG001|STARTED|Overall Study||11||
60123748|NCT02661594|76245087|FG002|STARTED|Overall Study||10||
60123749|NCT02661594|76245088|FG003|STARTED|Overall Study||9||
60123750|NCT02661594|76245085|FG000|COMPLETED|Overall Study||9||
60123751|NCT02661594|76245086|FG001|COMPLETED|Overall Study||11||
60123752|NCT02661594|76245087|FG002|COMPLETED|Overall Study||9||
60123753|NCT02661594|76245088|FG003|COMPLETED|Overall Study||9||
60123754|NCT02661594|76245085|FG000|NOT COMPLETED|Overall Study||1||
60123755|NCT02661594|76245086|FG001|NOT COMPLETED|Overall Study||0||
60123756|NCT02661594|76245087|FG002|NOT COMPLETED|Overall Study||1||
60123757|NCT02661594|76245088|FG003|NOT COMPLETED|Overall Study||0||
60123758|NCT01528345|76245100|FG000|STARTED|Overall Study||47||
60123759|NCT01528345|76245101|FG001|STARTED|Overall Study||50||
60123760|NCT01528345|76245100|FG000|COMPLETED|Overall Study||0||
60123761|NCT01528345|76245101|FG001|COMPLETED|Overall Study||0||
60123762|NCT01528345|76245100|FG000|NOT COMPLETED|Overall Study||47||
60123763|NCT01528345|76245101|FG001|NOT COMPLETED|Overall Study||50||
60123764|NCT01513967|76245115|FG000|STARTED|Overall Study||4||
60123765|NCT01513967|76245116|FG001|STARTED|Overall Study||4||
60123766|NCT01513967|76245117|FG002|STARTED|Overall Study||4||
60123767|NCT01513967|76245118|FG003|STARTED|Overall Study||6||
60123768|NCT01513967|76245119|FG004|STARTED|Overall Study||4||
60123769|NCT01513967|76245120|FG005|STARTED|Overall Study||4||
60123770|NCT01513967|76245121|FG006|STARTED|Overall Study||5||
60123771|NCT01513967|76245122|FG007|STARTED|Overall Study||8||
60123772|NCT01513967|76245115|FG000|COMPLETED|Overall Study||4||
60123773|NCT01513967|76245116|FG001|COMPLETED|Overall Study||4||
60123774|NCT01513967|76245117|FG002|COMPLETED|Overall Study||4||
60123775|NCT01513967|76245118|FG003|COMPLETED|Overall Study||6||
60123776|NCT01513967|76245119|FG004|COMPLETED|Overall Study||4||
60123777|NCT01513967|76245120|FG005|COMPLETED|Overall Study||3||
60123778|NCT01513967|76245121|FG006|COMPLETED|Overall Study||3||
60123779|NCT01513967|76245122|FG007|COMPLETED|Overall Study||6||
60123780|NCT01513967|76245115|FG000|NOT COMPLETED|Overall Study||0||
60123781|NCT01513967|76245116|FG001|NOT COMPLETED|Overall Study||0||
60123782|NCT01513967|76245117|FG002|NOT COMPLETED|Overall Study||0||
60123783|NCT01513967|76245118|FG003|NOT COMPLETED|Overall Study||0||
60123784|NCT01513967|76245119|FG004|NOT COMPLETED|Overall Study||0||
60123785|NCT01513967|76245120|FG005|NOT COMPLETED|Overall Study||1||
60123786|NCT01513967|76245121|FG006|NOT COMPLETED|Overall Study||2||
60123787|NCT01513967|76245122|FG007|NOT COMPLETED|Overall Study||2||
60123788|NCT02099721|76245146|FG000|STARTED|Overall Study||1066||
60123789|NCT02099721|76245147|FG001|STARTED|Overall Study||127||
60123790|NCT02099721|76245148|FG002|STARTED|Overall Study||1068||
60123791|NCT02099721|76245149|FG003|STARTED|Overall Study||845||
60123792|NCT02099721|76245150|FG004|STARTED|Overall Study||331||
60123793|NCT02099721|76245151|FG005|STARTED|Overall Study||452||
60123794|NCT02099721|76245146|FG000|COMPLETED|Overall Study||990|Non-exited patients. Patients from China were considered completers if they had a 24 month visit.|
60123795|NCT02099721|76245147|FG001|COMPLETED|Overall Study|Not implanted secondary patients were automatically exited.|0|Non-exited patients. Patients from China were considered completers if they had a 24 month visit.|
60123796|NCT02099721|76245148|FG002|COMPLETED|Overall Study||983|Non-exited patients. Patients from China were considered completers if they had a 24 month visit.|
60123797|NCT02099721|76245149|FG003|COMPLETED|Overall Study||774|Non-exited patients. Patients from China were considered completers if they had a 24 month visit.|
60123798|NCT02099721|76245150|FG004|COMPLETED|Overall Study||304|Non-exited patients. Patients from China were considered completers if they had a 24 month visit.|
60123799|NCT02099721|76245151|FG005|COMPLETED|Overall Study||432|Non-exited patients. Patients from China were considered completers if they had a 24 month visit.|
60123800|NCT02099721|76245146|FG000|NOT COMPLETED|Overall Study||76||
60123801|NCT02099721|76245147|FG001|NOT COMPLETED|Overall Study||127||
60123802|NCT02099721|76245148|FG002|NOT COMPLETED|Overall Study||85||
60123803|NCT02099721|76245149|FG003|NOT COMPLETED|Overall Study||71||
59594267|NCT02876887|75702996|FG001|NOT COMPLETED|Overall Study||0||
59594268|NCT03098966|75703002|FG000|STARTED|Overall Study||368||
59594269|NCT03098966|75703002|FG000|COMPLETED|Overall Study||368||
59594270|NCT03098966|75703002|FG000|NOT COMPLETED|Overall Study||0||
59594271|NCT03158714|75703009|FG000|STARTED|Overall Study|Number of participants enrolled and Started represents number of individual participants rather than couples|626||
59594272|NCT03158714|75703010|FG001|STARTED|Overall Study|Number of participants enrolled and Started represents number of individual participants rather than couples|626||
59727230|NCT00830869|75846022|FG007|COMPLETED|Period 1: Part 1||0||
60123804|NCT02099721|76245150|FG004|NOT COMPLETED|Overall Study||27||
60123805|NCT02099721|76245151|FG005|NOT COMPLETED|Overall Study||20||
60123806|NCT01511939|76245166|FG000|STARTED|Overall Study|Includes 1 subject who was also taking aspirin.|9||
60123807|NCT01511939|76245167|FG001|STARTED|Overall Study|Includes one patient who was also taking aspirin.|5||
60123808|NCT01511939|76245168|FG002|STARTED|Overall Study||8||
60123809|NCT01511939|76245166|FG000|COMPLETED|Overall Study||7||
60123810|NCT01511939|76245167|FG001|COMPLETED|Overall Study||4||
60123811|NCT01511939|76245168|FG002|COMPLETED|Overall Study||8||
60123812|NCT01511939|76245166|FG000|NOT COMPLETED|Overall Study||2||
60123813|NCT01511939|76245167|FG001|NOT COMPLETED|Overall Study||1||
60123814|NCT01511939|76245168|FG002|NOT COMPLETED|Overall Study||0||
60123815|NCT01576705|76245180|FG000|STARTED|Overall Study||43||
60123816|NCT01576705|76245181|FG001|STARTED|Overall Study||45||
60123817|NCT01576705|76245182|FG002|STARTED|Overall Study||43||
60123818|NCT01576705|76245183|FG003|STARTED|Overall Study||44||
60123819|NCT01576705|76245180|FG000|COMPLETED|Overall Study||40||
60123820|NCT01576705|76245181|FG001|COMPLETED|Overall Study||37||
60123821|NCT01576705|76245182|FG002|COMPLETED|Overall Study||38||
60123822|NCT01576705|76245183|FG003|COMPLETED|Overall Study||41||
60123823|NCT01576705|76245180|FG000|NOT COMPLETED|Overall Study||3||
60123824|NCT01576705|76245181|FG001|NOT COMPLETED|Overall Study||8||
60123825|NCT01576705|76245182|FG002|NOT COMPLETED|Overall Study||5||
60123826|NCT01576705|76245183|FG003|NOT COMPLETED|Overall Study||3||
60123827|NCT02666430|76245195|FG000|STARTED|Baseline||64||
60123828|NCT02666430|76245196|FG001|STARTED|Baseline||63||
60123829|NCT02666430|76245195|FG000|COMPLETED|Baseline||64||
60123830|NCT02666430|76245196|FG001|COMPLETED|Baseline||63||
60123831|NCT02666430|76245195|FG000|NOT COMPLETED|Baseline||0||
60123832|NCT02666430|76245196|FG001|NOT COMPLETED|Baseline||0||
60123833|NCT02666430|76245195|FG000|STARTED|Period 1||64||
60123834|NCT02666430|76245196|FG001|STARTED|Period 1||63||
60123835|NCT02666430|76245195|FG000|COMPLETED|Period 1||63||
60123836|NCT02666430|76245196|FG001|COMPLETED|Period 1||62||
60123837|NCT02666430|76245195|FG000|NOT COMPLETED|Period 1||1||
60123838|NCT02666430|76245196|FG001|NOT COMPLETED|Period 1||1||
60123839|NCT02666430|76245195|FG000|STARTED|Period 2||63||
60123840|NCT02666430|76245196|FG001|STARTED|Period 2||62||
60123841|NCT02666430|76245195|FG000|COMPLETED|Period 2||62||
60123842|NCT02666430|76245196|FG001|COMPLETED|Period 2||58||
59594273|NCT03158714|75703011|FG002|STARTED|Overall Study|Number of participants enrolled and Started represents number of individual participants rather than couples|606||
59594274|NCT03158714|75703009|FG000|COMPLETED|Overall Study|Participated in half or more of program.|445||
59594275|NCT03158714|75703010|FG001|COMPLETED|Overall Study|Participated in half or more of program.|398||
59594276|NCT03158714|75703011|FG002|COMPLETED|Overall Study|All control group participants completed the control protocol (no program).|606||
59594277|NCT03158714|75703009|FG000|NOT COMPLETED|Overall Study||181||
59594278|NCT03158714|75703010|FG001|NOT COMPLETED|Overall Study||228||
59594279|NCT03158714|75703011|FG002|NOT COMPLETED|Overall Study||0||
59594280|NCT03108469|75703021|FG000|STARTED|Overall Study||15||
59594281|NCT03108469|75703022|FG001|STARTED|Overall Study||15||
59594282|NCT03108469|75703021|FG000|COMPLETED|Overall Study||11||
59594283|NCT03108469|75703022|FG001|COMPLETED|Overall Study||11||
59594284|NCT03108469|75703021|FG000|NOT COMPLETED|Overall Study||4||
59594285|NCT03108469|75703022|FG001|NOT COMPLETED|Overall Study||4||
59594286|NCT03159260|75703030|FG000|STARTED|Overall Study||28||
59727231|NCT00830869|75846023|FG008|COMPLETED|Period 1: Part 1||0||
59727232|NCT00830869|75846024|FG009|COMPLETED|Period 1: Part 1||0||
59727233|NCT00830869|75846025|FG010|COMPLETED|Period 1: Part 1||0||
59727234|NCT00830869|75846026|FG011|COMPLETED|Period 1: Part 1||0||
59727235|NCT00830869|75846015|FG000|NOT COMPLETED|Period 1: Part 1||1||
59858159|NCT00304031|75983061|FG001|NOT COMPLETED|Concomitant RT+TMZ (Pre-randomization)||0||
60123843|NCT02666430|76245195|FG000|NOT COMPLETED|Period 2||1||
60123844|NCT02666430|76245196|FG001|NOT COMPLETED|Period 2||4||
60123845|NCT02666430|76245195|FG000|STARTED|Period 3||62||
60123846|NCT02666430|76245196|FG001|STARTED|Period 3||58||
60123847|NCT02666430|76245195|FG000|COMPLETED|Period 3||61||
60123848|NCT02666430|76245196|FG001|COMPLETED|Period 3||58||
60123849|NCT02666430|76245195|FG000|NOT COMPLETED|Period 3||1||
60123850|NCT02666430|76245196|FG001|NOT COMPLETED|Period 3||0||
60123851|NCT01576549|76245202|FG000|STARTED|Overall Study||2||
59727236|NCT00830869|75846016|FG001|NOT COMPLETED|Period 1: Part 1||1||
59727237|NCT00830869|75846017|FG002|NOT COMPLETED|Period 1: Part 1||1||
59727238|NCT00830869|75846018|FG003|NOT COMPLETED|Period 1: Part 1||7||
59727239|NCT00830869|75846019|FG004|NOT COMPLETED|Period 1: Part 1||4||
59727240|NCT00830869|75846020|FG005|NOT COMPLETED|Period 1: Part 1||6||
59727241|NCT00830869|75846021|FG006|NOT COMPLETED|Period 1: Part 1||3||
59727242|NCT00830869|75846022|FG007|NOT COMPLETED|Period 1: Part 1||0||
59727243|NCT00830869|75846023|FG008|NOT COMPLETED|Period 1: Part 1||0||
59727244|NCT00830869|75846024|FG009|NOT COMPLETED|Period 1: Part 1||0||
59727245|NCT00830869|75846025|FG010|NOT COMPLETED|Period 1: Part 1||0||
59727246|NCT00830869|75846026|FG011|NOT COMPLETED|Period 1: Part 1||0||
59727247|NCT00830869|75846015|FG000|STARTED|Period 2: Part 2||0||
59727248|NCT00830869|75846016|FG001|STARTED|Period 2: Part 2||0||
59727249|NCT00830869|75846017|FG002|STARTED|Period 2: Part 2||0||
59727250|NCT00830869|75846018|FG003|STARTED|Period 2: Part 2||0||
59727251|NCT00830869|75846019|FG004|STARTED|Period 2: Part 2||0||
59727252|NCT00830869|75846020|FG005|STARTED|Period 2: Part 2||0||
59727253|NCT00830869|75846021|FG006|STARTED|Period 2: Part 2||0||
59727254|NCT00830869|75846022|FG007|STARTED|Period 2: Part 2||20||
60123852|NCT01576549|76245202|FG000|Received at Least 1 Dose of Study Drug|Overall Study||2||
60123853|NCT01576549|76245202|FG000|Completed Post-Treatment Follow-Up|Overall Study|Each participant discontinued dosing and completed the Post-Treatment Follow-Up Period.|2||
60123854|NCT01576549|76245202|FG000|COMPLETED|Overall Study||0||
60123855|NCT01576549|76245202|FG000|NOT COMPLETED|Overall Study||2||
60123856|NCT00145041|76245207|FG000|STARTED|Overall Study||7||
59727255|NCT00830869|75846023|FG008|STARTED|Period 2: Part 2||22||
59727256|NCT00830869|75846024|FG009|STARTED|Period 2: Part 2||20||
60123857|NCT00145041|76245207|FG000|COMPLETED|Overall Study||7||
60123858|NCT00145041|76245207|FG000|NOT COMPLETED|Overall Study||0||
59594287|NCT03159260|75703031|FG001|STARTED|Overall Study||29||
59594288|NCT03159260|75703030|FG000|COMPLETED|Overall Study||25||
59594289|NCT03159260|75703031|FG001|COMPLETED|Overall Study||25||
59594290|NCT03159260|75703030|FG000|NOT COMPLETED|Overall Study||3||
59594291|NCT03159260|75703031|FG001|NOT COMPLETED|Overall Study||4||
59594292|NCT02878057|75703037|FG000|STARTED|Overall Study||30||
59594293|NCT02878057|75703037|FG000|COMPLETED|Overall Study||26||
59594294|NCT02878057|75703037|FG000|NOT COMPLETED|Overall Study||4||
59594295|NCT03104738|75703043|FG000|STARTED|Overall Study||20||
59594296|NCT03104738|75703044|FG001|STARTED|Overall Study||20||
59594297|NCT03104738|75703043|FG000|COMPLETED|Overall Study||20||
59594298|NCT03104738|75703044|FG001|COMPLETED|Overall Study||20||
59594299|NCT03104738|75703043|FG000|NOT COMPLETED|Overall Study||0||
59594300|NCT03104738|75703044|FG001|NOT COMPLETED|Overall Study||0||
59594301|NCT03162458|75703052|FG000|STARTED|Overall Study||71||
59594302|NCT03162458|75703053|FG001|STARTED|Overall Study||71||
59594303|NCT03162458|75703052|FG000|COMPLETED|Overall Study||71||
59594304|NCT03162458|75703053|FG001|COMPLETED|Overall Study||71||
59594305|NCT03162458|75703052|FG000|NOT COMPLETED|Overall Study||0||
59594306|NCT03162458|75703053|FG001|NOT COMPLETED|Overall Study||0||
59594307|NCT03163472|75703061|FG000|STARTED|Overall Study||15||
59594308|NCT03163472|75703062|FG001|STARTED|Overall Study||15||
59594309|NCT03163472|75703061|FG000|COMPLETED|Overall Study||15||
59594310|NCT03163472|75703062|FG001|COMPLETED|Overall Study||15||
59594311|NCT03163472|75703061|FG000|NOT COMPLETED|Overall Study||0||
59594312|NCT03163472|75703062|FG001|NOT COMPLETED|Overall Study||0||
59594313|NCT02880475|75703072|FG000|STARTED|Overall Study||13||
59594314|NCT02880475|75703073|FG001|STARTED|Overall Study||17||
59594315|NCT02880475|75703072|FG000|COMPLETED|Overall Study||13||
59594316|NCT02880475|75703073|FG001|COMPLETED|Overall Study||17||
59594317|NCT02880475|75703072|FG000|NOT COMPLETED|Overall Study||0||
59594318|NCT02880475|75703073|FG001|NOT COMPLETED|Overall Study||0||
59594319|NCT03106844|75703081|FG000|STARTED|Overall Study||50||
59594320|NCT03106844|75703081|FG000|COMPLETED|Overall Study||49||
59594321|NCT03106844|75703081|FG000|NOT COMPLETED|Overall Study||1||
59594322|NCT03168308|75703087|FG000|STARTED|Overall Study||48||
59594323|NCT03168308|75703088|FG001|STARTED|Overall Study||44||
59594324|NCT03168308|75703087|FG000|COMPLETED|Overall Study||48||
59594325|NCT03168308|75703088|FG001|COMPLETED|Overall Study||44||
59594326|NCT03168308|75703087|FG000|NOT COMPLETED|Overall Study||0||
59594327|NCT03168308|75703088|FG001|NOT COMPLETED|Overall Study||0||
59594328|NCT03168542|75703094|FG000|STARTED|Overall Study||7||
59594329|NCT03168542|75703095|FG001|STARTED|Overall Study||5||
59594330|NCT03168542|75703096|FG002|STARTED|Overall Study||9||
59594331|NCT03168542|75703094|FG000|COMPLETED|Overall Study||7||
59594332|NCT03168542|75703095|FG001|COMPLETED|Overall Study||5||
59594333|NCT03168542|75703096|FG002|COMPLETED|Overall Study||9||
59594334|NCT03168542|75703094|FG000|NOT COMPLETED|Overall Study||0||
59594335|NCT03168542|75703095|FG001|NOT COMPLETED|Overall Study||0||
59594336|NCT03168542|75703096|FG002|NOT COMPLETED|Overall Study||0||
59594337|NCT03109015|75703103|FG000|STARTED|Overall Study||4||
59594338|NCT03109015|75703104|FG001|STARTED|Overall Study||3||
59594339|NCT03109015|75703103|FG000|COMPLETED|Overall Study||4||
59594340|NCT03109015|75703104|FG001|COMPLETED|Overall Study||3||
59594341|NCT03109015|75703103|FG000|NOT COMPLETED|Overall Study||0||
59594342|NCT03109015|75703104|FG001|NOT COMPLETED|Overall Study||0||
59594343|NCT04253756|75703110|FG000|STARTED|Overall Study||26||
59594344|NCT04253756|75703110|FG000|Procedure 1: 18 Guage|Overall Study||12||
59594345|NCT04253756|75703110|FG000|Procedure 1: 20 Gauge|Overall Study||14||
59594346|NCT04253756|75703110|FG000|Procedure 2: 18 Gauge|Overall Study||9||
59594347|NCT04253756|75703110|FG000|Procedure 2: 20 Gauge|Overall Study||7||
59594348|NCT04253756|75703110|FG000|Procedure 3: 18 Gauge|Overall Study||6||
59594349|NCT04253756|75703110|FG000|Procedure 3: 20 Gauge|Overall Study||5||
59594350|NCT04253756|75703110|FG000|Procedure 4: 18 Gauge|Overall Study||5||
59594351|NCT04253756|75703110|FG000|Procedure 4: 20 Gauge|Overall Study||3||
59594352|NCT04253756|75703110|FG000|Procedure 5: 18 Gauge|Overall Study||2||
59594353|NCT04253756|75703110|FG000|Procedure 5: 20 Gauge|Overall Study||3||
59594354|NCT04253756|75703110|FG000|Procedure 6: 18 Gauge|Overall Study||1||
59594355|NCT04253756|75703110|FG000|Procedure 6: 20 Gauge|Overall Study||2||
59594356|NCT04253756|75703110|FG000|Procedure 7: 18 Gauge|Overall Study||1||
59594357|NCT04253756|75703110|FG000|Procedure 7: 20 Gauge|Overall Study||1||
59594358|NCT04253756|75703110|FG000|Procedure 8: 18 Gauge|Overall Study||0||
59594359|NCT04253756|75703110|FG000|Procedure 8: 20 Gauge|Overall Study||2||
59594360|NCT04253756|75703110|FG000|COMPLETED|Overall Study||21||
59594361|NCT04253756|75703110|FG000|NOT COMPLETED|Overall Study||5||
59594362|NCT03115177|75703118|FG000|STARTED|Overall Study||27||
59594363|NCT03115177|75703119|FG001|STARTED|Overall Study||29||
59594364|NCT03115177|75703118|FG000|COMPLETED|Overall Study||27||
59594365|NCT03115177|75703119|FG001|COMPLETED|Overall Study||29||
59594366|NCT03115177|75703118|FG000|NOT COMPLETED|Overall Study||0||
59594367|NCT03115177|75703119|FG001|NOT COMPLETED|Overall Study||0||
59594368|NCT02962609|75703127|FG000|STARTED|Overall Study||38||
59594369|NCT02962609|75703128|FG001|STARTED|Overall Study||42||
59594370|NCT02962609|75703127|FG000|COMPLETED|Overall Study||38||
59594371|NCT02962609|75703128|FG001|COMPLETED|Overall Study||42||
59594372|NCT02962609|75703127|FG000|NOT COMPLETED|Overall Study||0||
59594373|NCT02962609|75703128|FG001|NOT COMPLETED|Overall Study||0||
59594374|NCT02962687|75703136|FG000|STARTED|Overall Study|This number represents 20 dyads (1 Veteran and 1 caregiver in each dyad)|40||
59594375|NCT02962687|75703137|FG001|STARTED|Overall Study|This number represents 20 dyads (1 Veteran and 1 caregiver in each dyad)|40||
59594376|NCT02962687|75703136|FG000|COMPLETED|Overall Study|This number represents 15 dyads (1 Veteran and 1 caregiver in each dyad)|30||
59594377|NCT02962687|75703137|FG001|COMPLETED|Overall Study|This number represents 16 dyads (1 Veteran and 1 caregiver in each dyad)|32||
59594378|NCT02962687|75703136|FG000|NOT COMPLETED|Overall Study||10||
59594379|NCT02962687|75703137|FG001|NOT COMPLETED|Overall Study||8||
59594380|NCT03174158|75703149|FG000|STARTED|Overall Study||39||
59594381|NCT03174158|75703150|FG001|STARTED|Overall Study||39||
59594382|NCT03174158|75703151|FG002|STARTED|Overall Study||36||
59594383|NCT03174158|75703152|FG003|STARTED|Overall Study||39||
59594384|NCT03174158|75703149|FG000|COMPLETED|Overall Study||35||
59594385|NCT03174158|75703150|FG001|COMPLETED|Overall Study||37||
59594386|NCT03174158|75703151|FG002|COMPLETED|Overall Study||34||
59594387|NCT03174158|75703152|FG003|COMPLETED|Overall Study||38||
59594388|NCT03174158|75703149|FG000|NOT COMPLETED|Overall Study||4||
59594389|NCT03174158|75703150|FG001|NOT COMPLETED|Overall Study||2||
59594390|NCT03174158|75703151|FG002|NOT COMPLETED|Overall Study||2||
59594391|NCT03174158|75703152|FG003|NOT COMPLETED|Overall Study||1||
59594392|NCT03115411|75703170|FG000|STARTED|Overall Study||23||
59594393|NCT03115411|75703170|FG000|COMPLETED|Overall Study||23||
59594394|NCT03115411|75703170|FG000|NOT COMPLETED|Overall Study||0||
59594395|NCT03176654|75703176|FG000|STARTED|Overall Study||13||
59594396|NCT03176654|75703177|FG001|STARTED|Overall Study||15||
59594397|NCT03176654|75703176|FG000|COMPLETED|Overall Study||13||
59594398|NCT03176654|75703177|FG001|COMPLETED|Overall Study||15||
59594399|NCT03176654|75703176|FG000|NOT COMPLETED|Overall Study||0||
59594400|NCT03176654|75703177|FG001|NOT COMPLETED|Overall Study||0||
59594401|NCT03115801|75703185|FG000|STARTED|Overall Study||4||
59594402|NCT03115801|75703186|FG001|STARTED|Overall Study||2||
59594403|NCT03115801|75703185|FG000|COMPLETED|Overall Study||1||
59594404|NCT03115801|75703186|FG001|COMPLETED|Overall Study||0||
59594405|NCT03115801|75703185|FG000|NOT COMPLETED|Overall Study||3||
59594406|NCT03115801|75703186|FG001|NOT COMPLETED|Overall Study||2||
59594407|NCT03177512|75703194|FG000|STARTED|Overall Study||40||
59594408|NCT03177512|75703195|FG001|STARTED|Overall Study||21||
59594409|NCT03177512|75703194|FG000|COMPLETED|Overall Study||31||
59594410|NCT03177512|75703195|FG001|COMPLETED|Overall Study||18||
59594411|NCT03177512|75703194|FG000|NOT COMPLETED|Overall Study||9||
59594412|NCT03177512|75703195|FG001|NOT COMPLETED|Overall Study||3||
59594413|NCT03117517|75703203|FG000|STARTED|Overall Study||53||
59594414|NCT03117517|75703204|FG001|STARTED|Overall Study||53||
59594415|NCT03117517|75703203|FG000|COMPLETED|Overall Study||48||
59594416|NCT03117517|75703204|FG001|COMPLETED|Overall Study||49||
59594417|NCT03117517|75703203|FG000|NOT COMPLETED|Overall Study||5||
59594418|NCT03117517|75703204|FG001|NOT COMPLETED|Overall Study||4||
59594419|NCT02966275|75703214|FG000|STARTED|Overall Study||10||
59594420|NCT02966275|75703214|FG000|COMPLETED|Overall Study||10||
59594421|NCT02966275|75703214|FG000|NOT COMPLETED|Overall Study||0||
59594422|NCT02967367|75703221|FG000|STARTED|Overall Study||36||
59594423|NCT02967367|75703221|FG000|COMPLETED|Overall Study||22||
59594424|NCT02967367|75703221|FG000|NOT COMPLETED|Overall Study||14||
59594425|NCT03118843|75703225|FG000|STARTED|Overall Study||31||
59594426|NCT03118843|75703225|FG000|COMPLETED|Overall Study||31||
59594427|NCT03118843|75703225|FG000|NOT COMPLETED|Overall Study||0||
59594428|NCT03119389|75703231|FG000|STARTED|Overall Study||6791||7
59594429|NCT03119389|75703232|FG001|STARTED|Overall Study||7627||6
59858160|NCT00304031|75983062|FG002|NOT COMPLETED|Concomitant RT+TMZ (Pre-randomization)||0||
60123859|NCT01576159|76245215|FG000|STARTED|Overall Study||12||
59594430|NCT03119389|75703231|FG000|COMPLETED|Overall Study||6791||7
59594431|NCT03119389|75703232|FG001|COMPLETED|Overall Study||7627||6
59594432|NCT03119389|75703231|FG000|NOT COMPLETED|Overall Study||0||0
59594433|NCT03119389|75703232|FG001|NOT COMPLETED|Overall Study||0||0
59594434|NCT02967991|75703240|FG000|STARTED|Overall Study|First Intervention: 10 minutes Washout: 1 minute Second Intervention: 10 minutes|10||
59594435|NCT02967991|75703241|FG001|STARTED|Overall Study|First Intervention: 10 minutes Washout: 1 minute Second Intervention: 10 minutes|10||
59594436|NCT02967991|75703240|FG000|COMPLETED|Overall Study||10||
59594437|NCT02967991|75703241|FG001|COMPLETED|Overall Study||10||
59594438|NCT02967991|75703240|FG000|NOT COMPLETED|Overall Study||0||
59594439|NCT02967991|75703241|FG001|NOT COMPLETED|Overall Study||0||
59594440|NCT02222922|75703260|FG000|STARTED|Overall Study||2||
59594441|NCT02222922|75703261|FG001|STARTED|Overall Study||2||
59594442|NCT02222922|75703262|FG002|STARTED|Overall Study||2||
59594443|NCT02222922|75703263|FG003|STARTED|Overall Study||5||
59594444|NCT02222922|75703264|FG004|STARTED|Overall Study||96||
59594445|NCT02222922|75703265|FG005|STARTED|Overall Study||6||
59594446|NCT02222922|75703266|FG006|STARTED|Overall Study||3||
59594447|NCT02222922|75703267|FG007|STARTED|Overall Study||10||
59594448|NCT02222922|75703268|FG008|STARTED|Overall Study||12||
59594449|NCT02222922|75703260|FG000|Received Treatment|Overall Study||2||
59594450|NCT02222922|75703261|FG001|Received Treatment|Overall Study||2||
59594451|NCT02222922|75703262|FG002|Received Treatment|Overall Study||2||
59594452|NCT02222922|75703263|FG003|Received Treatment|Overall Study||4||
59594453|NCT02222922|75703264|FG004|Received Treatment|Overall Study||96||
59594454|NCT02222922|75703265|FG005|Received Treatment|Overall Study||6||
59594455|NCT02222922|75703266|FG006|Received Treatment|Overall Study||3||
59594456|NCT02222922|75703267|FG007|Received Treatment|Overall Study||10||
59594457|NCT02222922|75703268|FG008|Received Treatment|Overall Study||12||
59594458|NCT02222922|75703260|FG000|COMPLETED|Overall Study||1||
59594459|NCT02222922|75703261|FG001|COMPLETED|Overall Study||2||
59594460|NCT02222922|75703262|FG002|COMPLETED|Overall Study||1||
59594461|NCT02222922|75703263|FG003|COMPLETED|Overall Study||2||
59594462|NCT02222922|75703264|FG004|COMPLETED|Overall Study||58||
59594463|NCT02222922|75703265|FG005|COMPLETED|Overall Study||3||
59594464|NCT02222922|75703266|FG006|COMPLETED|Overall Study||1||
59594465|NCT02222922|75703267|FG007|COMPLETED|Overall Study||6||
59594466|NCT02222922|75703268|FG008|COMPLETED|Overall Study||6||
59594467|NCT02222922|75703260|FG000|NOT COMPLETED|Overall Study||1||
59594468|NCT02222922|75703261|FG001|NOT COMPLETED|Overall Study||0||
59594469|NCT02222922|75703262|FG002|NOT COMPLETED|Overall Study||1||
59594470|NCT02222922|75703263|FG003|NOT COMPLETED|Overall Study||3||
59594471|NCT02222922|75703264|FG004|NOT COMPLETED|Overall Study||38||
59594472|NCT02222922|75703265|FG005|NOT COMPLETED|Overall Study||3||
59594473|NCT02222922|75703266|FG006|NOT COMPLETED|Overall Study||2||
59594474|NCT02222922|75703267|FG007|NOT COMPLETED|Overall Study||4||
59594475|NCT02222922|75703268|FG008|NOT COMPLETED|Overall Study||6||
59594476|NCT03122587|75703305|FG000|STARTED|Overall Study||13||
59594477|NCT03122587|75703306|FG001|STARTED|Overall Study||12||
59594478|NCT03122587|75703307|FG002|STARTED|Overall Study||13||
59594479|NCT03122587|75703305|FG000|COMPLETED|Overall Study||11||
59594480|NCT03122587|75703306|FG001|COMPLETED|Overall Study||10||
59594481|NCT03122587|75703307|FG002|COMPLETED|Overall Study||12||
59594482|NCT03122587|75703305|FG000|NOT COMPLETED|Overall Study||2||
59594483|NCT03122587|75703306|FG001|NOT COMPLETED|Overall Study||2||
59594484|NCT03122587|75703307|FG002|NOT COMPLETED|Overall Study||1||
59594485|NCT02161146|75703320|FG000|STARTED|Overall Study||47||
59594486|NCT02161146|75703321|FG001|STARTED|Overall Study||47||
59594487|NCT02161146|75703322|FG002|STARTED|Overall Study||49||
59594488|NCT02161146|75703323|FG003|STARTED|Overall Study||48||
59594489|NCT02161146|75703324|FG004|STARTED|Overall Study||49||
59594490|NCT02161146|75703320|FG000|COMPLETED|Overall Study||46||
59594491|NCT02161146|75703321|FG001|COMPLETED|Overall Study||43||
59594492|NCT02161146|75703322|FG002|COMPLETED|Overall Study||49||
59594493|NCT02161146|75703323|FG003|COMPLETED|Overall Study||45||
59594494|NCT02161146|75703324|FG004|COMPLETED|Overall Study||48||
59594495|NCT02161146|75703320|FG000|NOT COMPLETED|Overall Study||1||
59594496|NCT02161146|75703321|FG001|NOT COMPLETED|Overall Study||4||
59594497|NCT02161146|75703322|FG002|NOT COMPLETED|Overall Study||0||
59594498|NCT02161146|75703323|FG003|NOT COMPLETED|Overall Study||3||
59594499|NCT02161146|75703324|FG004|NOT COMPLETED|Overall Study||1||
59594500|NCT03447782|75703334|FG000|STARTED|Overall Study||45||
59594501|NCT03447782|75703334|FG000|COMPLETED|Overall Study||25||
59594502|NCT03447782|75703334|FG000|NOT COMPLETED|Overall Study||20||
59594503|NCT03109951|75703338|FG000|STARTED|Overall Study||187||
59594504|NCT03109951|75703338|FG000|COMPLETED|Overall Study||187||
59594505|NCT03109951|75703338|FG000|NOT COMPLETED|Overall Study||0||
59594506|NCT03123055|75703342|FG000|STARTED|Overall Study||28||
59594507|NCT03123055|75703342|FG000|COMPLETED|Overall Study||28||
59594508|NCT03123055|75703342|FG000|NOT COMPLETED|Overall Study||0||
59594509|NCT03124069|75703347|FG000|STARTED|Overall Study||37||
59594510|NCT03124069|75703347|FG000|COMPLETED|Overall Study||37||
59594511|NCT03124069|75703347|FG000|NOT COMPLETED|Overall Study||0||
59594512|NCT02969317|75703353|FG000|STARTED|Overall Study||12||
59594513|NCT02969317|75703353|FG000|COMPLETED|Overall Study||12||
59594514|NCT02969317|75703353|FG000|NOT COMPLETED|Overall Study||0||
59594515|NCT03124693|75703358|FG000|STARTED|Overall Study||90||
59594516|NCT03124693|75703358|FG000|COMPLETED|Overall Study||90||
59594517|NCT03124693|75703358|FG000|NOT COMPLETED|Overall Study||0||
59594518|NCT03124771|75703362|FG000|STARTED|Overall Study||132||
59594519|NCT03124771|75703362|FG000|COMPLETED|Overall Study||132||
59594520|NCT03124771|75703362|FG000|NOT COMPLETED|Overall Study||0||
59594521|NCT03124927|75703366|FG000|STARTED|Overall Study||25||
59594522|NCT03124927|75703366|FG000|COMPLETED|Overall Study||25||
59594523|NCT03124927|75703366|FG000|NOT COMPLETED|Overall Study||0||
59594524|NCT03125005|75703370|FG000|STARTED|Overall Study||51||
59594525|NCT03125005|75703370|FG000|COMPLETED|Overall Study||51||
59594526|NCT03125005|75703370|FG000|NOT COMPLETED|Overall Study||0||
59594527|NCT02971735|75703376|FG000|STARTED|Overall Study||30||
59594528|NCT02971735|75703377|FG001|STARTED|Overall Study||30||
59594529|NCT02971735|75703376|FG000|COMPLETED|Overall Study||30||
59594530|NCT02971735|75703377|FG001|COMPLETED|Overall Study||30||
59594531|NCT02971735|75703376|FG000|NOT COMPLETED|Overall Study||0||
59594532|NCT02971735|75703377|FG001|NOT COMPLETED|Overall Study||0||
59594533|NCT02975557|75703386|FG000|STARTED|Overall Study||4||
59594534|NCT02975557|75703387|FG001|STARTED|Overall Study||5||
59594535|NCT02975557|75703388|FG002|STARTED|Overall Study||6||
59594536|NCT02975557|75703386|FG000|COMPLETED|Overall Study||3||
59594537|NCT02975557|75703387|FG001|COMPLETED|Overall Study||2||
59594538|NCT02975557|75703388|FG002|COMPLETED|Overall Study||5||
59594539|NCT02975557|75703386|FG000|NOT COMPLETED|Overall Study||1||
59594540|NCT02975557|75703387|FG001|NOT COMPLETED|Overall Study||3||
59594541|NCT02975557|75703388|FG002|NOT COMPLETED|Overall Study||1||
59594542|NCT02976181|75703396|FG000|STARTED|Overall Study||113||
59594543|NCT02976181|75703396|FG000|COMPLETED|Overall Study||112||
59594544|NCT02976181|75703396|FG000|NOT COMPLETED|Overall Study||1||
59594545|NCT03132571|75703403|FG000|STARTED|Overall Study||3||
59594546|NCT03132571|75703404|FG001|STARTED|Overall Study||2||
59594547|NCT03132571|75703403|FG000|COMPLETED|Overall Study||3||
59594548|NCT03132571|75703404|FG001|COMPLETED|Overall Study||2||
59594549|NCT03132571|75703403|FG000|NOT COMPLETED|Overall Study||0||
59594550|NCT03132571|75703404|FG001|NOT COMPLETED|Overall Study||0||
59594551|NCT03134209|75703413|FG000|STARTED|Overall Study||53||
59594552|NCT03134209|75703414|FG001|STARTED|Overall Study||54||
59594553|NCT03134209|75703415|FG002|STARTED|Overall Study||53||
59594554|NCT03134209|75703413|FG000|COMPLETED|Overall Study||53||
59594555|NCT03134209|75703414|FG001|COMPLETED|Overall Study||54||
59594556|NCT03134209|75703415|FG002|COMPLETED|Overall Study||53||
59594557|NCT03134209|75703413|FG000|NOT COMPLETED|Overall Study||0||
59594558|NCT03134209|75703414|FG001|NOT COMPLETED|Overall Study||0||
59594559|NCT03134209|75703415|FG002|NOT COMPLETED|Overall Study||0||
59594560|NCT03134989|75703423|FG000|STARTED|Overall Study||80||
59594561|NCT03134989|75703423|FG000|COMPLETED|Overall Study|Clinical investigation termination date: Last Subject, Final Visit 18-Jun-2020|80||
59594562|NCT03134989|75703423|FG000|NOT COMPLETED|Overall Study||0||
59594563|NCT03135379|75703430|FG000|STARTED|Overall Study||62||
59594564|NCT03135379|75703431|FG001|STARTED|Overall Study||62||
59594565|NCT03135379|75703430|FG000|COMPLETED|Overall Study||61||
59594566|NCT03135379|75703431|FG001|COMPLETED|Overall Study||59||
59594567|NCT03135379|75703430|FG000|NOT COMPLETED|Overall Study||1||
59594568|NCT03135379|75703431|FG001|NOT COMPLETED|Overall Study||3||
59594569|NCT03135535|75703437|FG000|STARTED|Overall Study||30||
59594570|NCT03135535|75703437|FG000|COMPLETED|Overall Study||30||
59594571|NCT03135535|75703437|FG000|NOT COMPLETED|Overall Study||0||
59594572|NCT02979301|75703443|FG000|STARTED|Overall Study||11||
59594573|NCT02979301|75703444|FG001|STARTED|Overall Study||11||
59594574|NCT02979301|75703443|FG000|COMPLETED|Overall Study||10||
59594575|NCT02979301|75703444|FG001|COMPLETED|Overall Study||11||
59594576|NCT02979301|75703443|FG000|NOT COMPLETED|Overall Study||1||
59594577|NCT02979301|75703444|FG001|NOT COMPLETED|Overall Study||0||
59594578|NCT02979925|75703452|FG000|STARTED|Overall Study||28||
59594579|NCT02979925|75703453|FG001|STARTED|Overall Study||29||
59594580|NCT02979925|75703452|FG000|COMPLETED|Overall Study||28||
59594581|NCT02979925|75703453|FG001|COMPLETED|Overall Study||23||
59594582|NCT02979925|75703452|FG000|NOT COMPLETED|Overall Study||0||
59594583|NCT02979925|75703453|FG001|NOT COMPLETED|Overall Study||6||
59594584|NCT02983825|75703459|FG000|STARTED|Overall Study|Of 21 enrolled subjects, 9 became ineligible for between consent and intervention|12||
59594585|NCT02983825|75703459|FG000|COMPLETED|Overall Study|Of 12 subjects starting intervention, 3 met specified stopping critieria|9||
59594586|NCT02983825|75703459|FG000|NOT COMPLETED|Overall Study||3||
59594587|NCT01818986|75703463|FG000|STARTED|Overall Study||20||
59594588|NCT01818986|75703463|FG000|COMPLETED|Overall Study||20||
59594589|NCT01818986|75703463|FG000|NOT COMPLETED|Overall Study||0||
59594590|NCT03138577|75703474|FG000|STARTED|Overall Study||3||
59594591|NCT03138577|75703475|FG001|STARTED|Overall Study||3||
60123860|NCT01576159|76245216|FG001|STARTED|Overall Study||12||
60123861|NCT01576159|76245217|FG002|STARTED|Overall Study||12||
60123862|NCT01576159|76245218|FG003|STARTED|Overall Study||12||
60123863|NCT01576159|76245215|FG000|COMPLETED|Overall Study||11||
60123864|NCT01576159|76245216|FG001|COMPLETED|Overall Study||11||
60123865|NCT01576159|76245217|FG002|COMPLETED|Overall Study||11||
60123866|NCT01576159|76245218|FG003|COMPLETED|Overall Study||11||
60123867|NCT01576159|76245215|FG000|NOT COMPLETED|Overall Study||1||
60123868|NCT01576159|76245216|FG001|NOT COMPLETED|Overall Study||1||
60123869|NCT01576159|76245217|FG002|NOT COMPLETED|Overall Study||1||
60123870|NCT01576159|76245218|FG003|NOT COMPLETED|Overall Study||1||
60123871|NCT02099799|76245237|FG000|STARTED|Overall Study||75||
60123872|NCT02099799|76245238|FG001|STARTED|Overall Study||78||
60123873|NCT02099799|76245237|FG000|COMPLETED|Overall Study||60||
60123874|NCT02099799|76245238|FG001|COMPLETED|Overall Study||54||
60123875|NCT02099799|76245237|FG000|NOT COMPLETED|Overall Study||15||
59594592|NCT03138577|75703476|FG002|STARTED|Overall Study||3||
59594593|NCT03138577|75703477|FG003|STARTED|Overall Study||3||
59594594|NCT03138577|75703478|FG004|STARTED|Overall Study||3||
59594595|NCT03138577|75703479|FG005|STARTED|Overall Study||3||
59594596|NCT03138577|75703480|FG006|STARTED|Overall Study||3||
59594597|NCT03138577|75703474|FG000|COMPLETED|Overall Study||3||
59594598|NCT03138577|75703475|FG001|COMPLETED|Overall Study||3||
59594599|NCT03138577|75703476|FG002|COMPLETED|Overall Study||3||
59594600|NCT03138577|75703477|FG003|COMPLETED|Overall Study||3||
59594601|NCT03138577|75703478|FG004|COMPLETED|Overall Study||3||
60123876|NCT02099799|76245238|FG001|NOT COMPLETED|Overall Study||24||
59594602|NCT03138577|75703479|FG005|COMPLETED|Overall Study||3||
59594603|NCT03138577|75703480|FG006|COMPLETED|Overall Study||3||
59594604|NCT03138577|75703474|FG000|NOT COMPLETED|Overall Study||0||
59594605|NCT03138577|75703475|FG001|NOT COMPLETED|Overall Study||0||
59594606|NCT03138577|75703476|FG002|NOT COMPLETED|Overall Study||0||
59594607|NCT03138577|75703477|FG003|NOT COMPLETED|Overall Study||0||
59594608|NCT03138577|75703478|FG004|NOT COMPLETED|Overall Study||0||
59594609|NCT03138577|75703479|FG005|NOT COMPLETED|Overall Study||0||
59594610|NCT03138577|75703480|FG006|NOT COMPLETED|Overall Study||0||
59594611|NCT03181724|75703500|FG000|STARTED|Overall Study||45||
59594612|NCT03181724|75703501|FG001|STARTED|Overall Study||45||
59594613|NCT03181724|75703500|FG000|COMPLETED|Overall Study||45||
59594614|NCT03181724|75703501|FG001|COMPLETED|Overall Study||45||
59594615|NCT03181724|75703500|FG000|NOT COMPLETED|Overall Study||0||
59594616|NCT03181724|75703501|FG001|NOT COMPLETED|Overall Study||0||
59594617|NCT02983981|75703507|FG000|STARTED|Overall Study||20||
59594618|NCT02983981|75703507|FG000|COMPLETED|Overall Study||20||
59594619|NCT02983981|75703507|FG000|NOT COMPLETED|Overall Study||0||
59594620|NCT03182582|75703511|FG000|STARTED|Treatment 1||12||
59594621|NCT03182582|75703512|FG001|STARTED|Treatment 1||10||
59594622|NCT03182582|75703511|FG000|COMPLETED|Treatment 1||12||
59594623|NCT03182582|75703512|FG001|COMPLETED|Treatment 1||10||
59594624|NCT03182582|75703511|FG000|NOT COMPLETED|Treatment 1||0||
59594625|NCT03182582|75703512|FG001|NOT COMPLETED|Treatment 1||0||
59594626|NCT03182582|75703511|FG000|STARTED|Treatment 2||12||
59594627|NCT03182582|75703512|FG001|STARTED|Treatment 2||10||
59594628|NCT03182582|75703511|FG000|COMPLETED|Treatment 2||12||
59594629|NCT03182582|75703512|FG001|COMPLETED|Treatment 2||10||
59594630|NCT03182582|75703511|FG000|NOT COMPLETED|Treatment 2||0||
59594631|NCT03182582|75703512|FG001|NOT COMPLETED|Treatment 2||0||
59594632|NCT02986711|75703525|FG000|STARTED|Overall Study||78||
59594633|NCT02986711|75703526|FG001|STARTED|Overall Study||80||
59594634|NCT02986711|75703525|FG000|COMPLETED|Overall Study||70||
59594635|NCT02986711|75703526|FG001|COMPLETED|Overall Study||70||
59594636|NCT02986711|75703525|FG000|NOT COMPLETED|Overall Study||8||
59594637|NCT02986711|75703526|FG001|NOT COMPLETED|Overall Study||10||
59594638|NCT03141931|75703534|FG000|STARTED|Overall Study||61||
59594639|NCT03141931|75703535|FG001|STARTED|Overall Study||58||
59594640|NCT03141931|75703534|FG000|COMPLETED|Overall Study||49||
59594641|NCT03141931|75703535|FG001|COMPLETED|Overall Study||52||
59594642|NCT03141931|75703534|FG000|NOT COMPLETED|Overall Study||12||
59594643|NCT03141931|75703535|FG001|NOT COMPLETED|Overall Study||6||
59594644|NCT03143569|75703543|FG000|STARTED|Overall Study||10||
59594645|NCT03143569|75703544|FG001|STARTED|Overall Study||10||
59594646|NCT03143569|75703543|FG000|COMPLETED|Overall Study||10||
59594647|NCT03143569|75703544|FG001|COMPLETED|Overall Study||8||
59594648|NCT03143569|75703543|FG000|NOT COMPLETED|Overall Study||0||
59594649|NCT03143569|75703544|FG001|NOT COMPLETED|Overall Study||2||
59594650|NCT02222688|75703559|FG000|STARTED|Overall Study||4||
59594651|NCT02222688|75703560|FG001|STARTED|Overall Study||3||
59594652|NCT02222688|75703561|FG002|STARTED|Overall Study||3||
59594653|NCT02222688|75703562|FG003|STARTED|Overall Study||5||
59594654|NCT02222688|75703563|FG004|STARTED|Overall Study||3||
59594655|NCT02222688|75703564|FG005|STARTED|Overall Study||3||
59594656|NCT02222688|75703565|FG006|STARTED|Overall Study||6||
59594657|NCT02222688|75703559|FG000|COMPLETED|Overall Study||3||
59594658|NCT02222688|75703560|FG001|COMPLETED|Overall Study||3||
59594659|NCT02222688|75703561|FG002|COMPLETED|Overall Study||3||
59594660|NCT02222688|75703562|FG003|COMPLETED|Overall Study||3||
59594661|NCT02222688|75703563|FG004|COMPLETED|Overall Study||2||
59594662|NCT02222688|75703564|FG005|COMPLETED|Overall Study||3||
59594663|NCT02222688|75703565|FG006|COMPLETED|Overall Study||5||
59594664|NCT02222688|75703559|FG000|NOT COMPLETED|Overall Study||1||
59594665|NCT02222688|75703560|FG001|NOT COMPLETED|Overall Study||0||
59594666|NCT02222688|75703561|FG002|NOT COMPLETED|Overall Study||0||
59594667|NCT02222688|75703562|FG003|NOT COMPLETED|Overall Study||2||
59727257|NCT00830869|75846025|FG010|STARTED|Period 2: Part 2||11||
59996842|NCT02729753|76112684|FG001|STARTED|Overall Study|First patient enrolled April 2016|7||
59594668|NCT02222688|75703563|FG004|NOT COMPLETED|Overall Study||1||
59594669|NCT02222688|75703564|FG005|NOT COMPLETED|Overall Study||0||
59594670|NCT02222688|75703565|FG006|NOT COMPLETED|Overall Study||1||
59594671|NCT03149887|75703585|FG000|STARTED|Overall Study||27||
59594672|NCT03149887|75703586|FG001|STARTED|Overall Study||27||
59594673|NCT03149887|75703585|FG000|COMPLETED|Overall Study||27||
59594674|NCT03149887|75703586|FG001|COMPLETED|Overall Study||27||
59594675|NCT03149887|75703585|FG000|NOT COMPLETED|Overall Study||0||
59594676|NCT03149887|75703586|FG001|NOT COMPLETED|Overall Study||0||
59594677|NCT02988193|75703594|FG000|STARTED|Overall Study||12||
59594678|NCT02988193|75703595|FG001|STARTED|Overall Study||16||
59594679|NCT02988193|75703594|FG000|COMPLETED|Overall Study||12||
59594680|NCT02988193|75703595|FG001|COMPLETED|Overall Study||16||
59594681|NCT02988193|75703594|FG000|NOT COMPLETED|Overall Study||0||
59594682|NCT02988193|75703595|FG001|NOT COMPLETED|Overall Study||0||
59594683|NCT02988349|75703603|FG000|STARTED|Overall Study||21||
59594684|NCT02988349|75703604|FG001|STARTED|Overall Study||21||
59594685|NCT02988349|75703603|FG000|COMPLETED|Overall Study||21||
59594686|NCT02988349|75703604|FG001|COMPLETED|Overall Study||21||
59594687|NCT02988349|75703603|FG000|NOT COMPLETED|Overall Study||0||
59594688|NCT02988349|75703604|FG001|NOT COMPLETED|Overall Study||0||
59594689|NCT03150043|75703610|FG000|STARTED|Overall Study||65||
59594690|NCT03150043|75703610|FG000|COMPLETED|Overall Study||65||
59594691|NCT03150043|75703610|FG000|NOT COMPLETED|Overall Study||0||
59594692|NCT02159352|75703617|FG000|STARTED|Overall Study||14||
59594693|NCT02159352|75703618|FG001|STARTED|Overall Study||14||
59594694|NCT02159352|75703617|FG000|Phase 1 (Day 1- 4)|Overall Study||14||
59594695|NCT02159352|75703618|FG001|Phase 1 (Day 1- 4)|Overall Study||14||
59594696|NCT02159352|75703617|FG000|Phase 2 (Day 5-14)|Overall Study||11||
59594697|NCT02159352|75703618|FG001|Phase 2 (Day 5-14)|Overall Study||12||
59594698|NCT02159352|75703617|FG000|COMPLETED|Overall Study||11||
59594699|NCT02159352|75703618|FG001|COMPLETED|Overall Study||12||
59594700|NCT02159352|75703617|FG000|NOT COMPLETED|Overall Study||3||
59594701|NCT02159352|75703618|FG001|NOT COMPLETED|Overall Study||2||
59594702|NCT03150199|75703645|FG000|STARTED|Overall Study||30||
59594703|NCT03150199|75703646|FG001|STARTED|Overall Study||30||
59594704|NCT03150199|75703645|FG000|COMPLETED|Overall Study||30||
59594705|NCT03150199|75703646|FG001|COMPLETED|Overall Study||30||
59594706|NCT03150199|75703645|FG000|NOT COMPLETED|Overall Study||0||
59594707|NCT03150199|75703646|FG001|NOT COMPLETED|Overall Study||0||
59594708|NCT02187744|75703655|FG000|STARTED|Study|Received treatment|113||
59594709|NCT02187744|75703656|FG001|STARTED|Study|Received treatment|112||
59594710|NCT02187744|75703655|FG000|COMPLETED|Study||109||
59594711|NCT02187744|75703656|FG001|COMPLETED|Study||106||
59594712|NCT02187744|75703655|FG000|NOT COMPLETED|Study||4||
59594713|NCT02187744|75703656|FG001|NOT COMPLETED|Study||6||
59594714|NCT02187744|75703655|FG000|STARTED|Treatment||113||
59594715|NCT02187744|75703656|FG001|STARTED|Treatment||112||
59727258|NCT00830869|75846026|FG011|STARTED|Period 2: Part 2||20||
59727259|NCT00830869|75846015|FG000|COMPLETED|Period 2: Part 2||0||
59727260|NCT00830869|75846016|FG001|COMPLETED|Period 2: Part 2||0||
59727261|NCT00830869|75846017|FG002|COMPLETED|Period 2: Part 2||0||
59727262|NCT00830869|75846018|FG003|COMPLETED|Period 2: Part 2||0||
59727263|NCT00830869|75846019|FG004|COMPLETED|Period 2: Part 2||0||
59727264|NCT00830869|75846020|FG005|COMPLETED|Period 2: Part 2||0||
59727265|NCT00830869|75846021|FG006|COMPLETED|Period 2: Part 2||0||
59996843|NCT02729753|76112683|FG000|COMPLETED|Overall Study|Study Complete on 30 Oct 2016|3||
59727266|NCT00830869|75846022|FG007|COMPLETED|Period 2: Part 2||0||
59727267|NCT00830869|75846023|FG008|COMPLETED|Period 2: Part 2||0||
59727268|NCT00830869|75846024|FG009|COMPLETED|Period 2: Part 2||0||
59727269|NCT00830869|75846025|FG010|COMPLETED|Period 2: Part 2||0||
59727270|NCT00830869|75846026|FG011|COMPLETED|Period 2: Part 2||0||
59727271|NCT00830869|75846015|FG000|NOT COMPLETED|Period 2: Part 2||0||
59727272|NCT00830869|75846016|FG001|NOT COMPLETED|Period 2: Part 2||0||
59727273|NCT00830869|75846017|FG002|NOT COMPLETED|Period 2: Part 2||0||
59727274|NCT00830869|75846018|FG003|NOT COMPLETED|Period 2: Part 2||0||
59727275|NCT00830869|75846019|FG004|NOT COMPLETED|Period 2: Part 2||0||
59727276|NCT00830869|75846020|FG005|NOT COMPLETED|Period 2: Part 2||0||
59727277|NCT00830869|75846021|FG006|NOT COMPLETED|Period 2: Part 2||0||
59727278|NCT00830869|75846022|FG007|NOT COMPLETED|Period 2: Part 2||20||
59727279|NCT00830869|75846023|FG008|NOT COMPLETED|Period 2: Part 2||22||
59727280|NCT00830869|75846024|FG009|NOT COMPLETED|Period 2: Part 2||20||
59727281|NCT00830869|75846025|FG010|NOT COMPLETED|Period 2: Part 2||11||
59727282|NCT00830869|75846026|FG011|NOT COMPLETED|Period 2: Part 2||20||
59727283|NCT00844519|75846055|FG000|STARTED|Overall Study||26||
59727284|NCT00844519|75846056|FG001|STARTED|Overall Study||26||
59727285|NCT00844519|75846055|FG000|COMPLETED|Overall Study||24||
59727286|NCT00844519|75846056|FG001|COMPLETED|Overall Study||25||
59727287|NCT00844519|75846055|FG000|NOT COMPLETED|Overall Study||2||
59727288|NCT00844519|75846056|FG001|NOT COMPLETED|Overall Study||1||
59727289|NCT01171820|75846064|FG000|STARTED|Overall Study||106||
59727290|NCT01171820|75846065|FG001|STARTED|Overall Study||218||
59727291|NCT01171820|75846064|FG000|COMPLETED|Overall Study||100||
59727292|NCT01171820|75846065|FG001|COMPLETED|Overall Study||212||
59727293|NCT01171820|75846064|FG000|NOT COMPLETED|Overall Study||6||
59727294|NCT01171820|75846065|FG001|NOT COMPLETED|Overall Study||6||
59727295|NCT00994110|75846073|FG000|STARTED|Overall Study||217||
59727296|NCT00994110|75846074|FG001|STARTED|Overall Study||222||
59727297|NCT00994110|75846073|FG000|COMPLETED|Overall Study||152||
59727298|NCT00994110|75846074|FG001|COMPLETED|Overall Study||148||
59727299|NCT00994110|75846073|FG000|NOT COMPLETED|Overall Study||65||
59594716|NCT02187744|75703655|FG000|COMPLETED|Treatment||109||
59594717|NCT02187744|75703656|FG001|COMPLETED|Treatment||107||
59594718|NCT02187744|75703655|FG000|NOT COMPLETED|Treatment||4||
59594719|NCT02187744|75703656|FG001|NOT COMPLETED|Treatment||5||
59594720|NCT03154333|75703664|FG000|STARTED|Overall Study||28||
59594721|NCT03154333|75703665|FG001|STARTED|Overall Study||26||
59594722|NCT03154333|75703664|FG000|COMPLETED|Overall Study||21||
59594723|NCT03154333|75703665|FG001|COMPLETED|Overall Study||21||
59594724|NCT03154333|75703664|FG000|NOT COMPLETED|Overall Study||7||
59594725|NCT03154333|75703665|FG001|NOT COMPLETED|Overall Study||5||
59727300|NCT00994110|75846074|FG001|NOT COMPLETED|Overall Study||74||
59727301|NCT00993954|75846082|FG000|STARTED|Overall Study||145||
59727302|NCT00993954|75846083|FG001|STARTED|Overall Study||123||
59727303|NCT00993954|75846082|FG000|COMPLETED|Overall Study||124||
59727304|NCT00993954|75846083|FG001|COMPLETED|Overall Study||121||
59727305|NCT00993954|75846082|FG000|NOT COMPLETED|Overall Study||21||
59727306|NCT00993954|75846083|FG001|NOT COMPLETED|Overall Study||2||
59727307|NCT01157234|75846091|FG000|STARTED|Overall Study||15||
59727308|NCT01157234|75846092|FG001|STARTED|Overall Study||15||
59727309|NCT01157234|75846091|FG000|COMPLETED|Overall Study||14||
59727310|NCT01157234|75846092|FG001|COMPLETED|Overall Study||15||
59727311|NCT01157234|75846091|FG000|NOT COMPLETED|Overall Study||1||
59727312|NCT01157234|75846092|FG001|NOT COMPLETED|Overall Study||0||
59727313|NCT00991302|75846107|FG000|STARTED|Overall Study||86||
59727314|NCT00991302|75846108|FG001|STARTED|Overall Study||86||
59727315|NCT00991302|75846107|FG000|COMPLETED|Overall Study||72||
60123877|NCT01510769|76245249|FG000|STARTED|Overall Study||106||
59727316|NCT00991302|75846108|FG001|COMPLETED|Overall Study||73||
59727317|NCT00991302|75846107|FG000|NOT COMPLETED|Overall Study||14||
59727318|NCT00991302|75846108|FG001|NOT COMPLETED|Overall Study||13||
59727319|NCT00995670|75846117|FG000|STARTED|Overall Study||26||
59727320|NCT00995670|75846118|FG001|STARTED|Overall Study||16||
59727321|NCT00995670|75846119|FG002|STARTED|Overall Study||17||
59727322|NCT00995670|75846117|FG000|COMPLETED|Overall Study|These 26 subjects underwent a total of 58 studies to determine the effect of dose of glucose on I/R.|25||
59727323|NCT00995670|75846118|FG001|COMPLETED|Overall Study|These 16 subjects underwent a total of 25 studies on the effect of Vitamin C.|16||
59727324|NCT00995670|75846119|FG002|COMPLETED|Overall Study|These 17 volunteers underwent 33 studies on the effect of statins, glucose, and glucose & statins.|14||
59727325|NCT00995670|75846117|FG000|NOT COMPLETED|Overall Study||1||
59727326|NCT00995670|75846118|FG001|NOT COMPLETED|Overall Study||0||
59727327|NCT00995670|75846119|FG002|NOT COMPLETED|Overall Study||3||
59727328|NCT00601354|75846129|FG000|STARTED|Overall Study||8||
59727329|NCT00601354|75846130|FG001|STARTED|Overall Study||9||
59727330|NCT00601354|75846129|FG000|COMPLETED|Overall Study||4||
59727331|NCT00601354|75846130|FG001|COMPLETED|Overall Study||4||
59727332|NCT00601354|75846129|FG000|NOT COMPLETED|Overall Study||4||
59727333|NCT00601354|75846130|FG001|NOT COMPLETED|Overall Study||5||
59727334|NCT00853099|75846139|FG000|STARTED|Double-blind Period||96||
59727335|NCT00853099|75846140|FG001|STARTED|Double-blind Period||87||
59727336|NCT00853099|75846141|FG002|STARTED|Double-blind Period||91||
59727337|NCT00853099|75846142|FG003|STARTED|Double-blind Period||0||
59727338|NCT00853099|75846139|FG000|Treated|Double-blind Period||96||
59727339|NCT00853099|75846140|FG001|Treated|Double-blind Period||87||
59727340|NCT00853099|75846141|FG002|Treated|Double-blind Period|1 participant, incorrectly treated with open-label (rescue) study drug at Week 0, was excluded.|90||
59727341|NCT00853099|75846142|FG003|Treated|Double-blind Period||0||
59727342|NCT00853099|75846139|FG000|Completed Week 8|Double-blind Period||92||
59727343|NCT00853099|75846140|FG001|Completed Week 8|Double-blind Period||85||
59727344|NCT00853099|75846141|FG002|Completed Week 8|Double-blind Period||86||
59727345|NCT00853099|75846142|FG003|Completed Week 8|Double-blind Period||0||
59727346|NCT00853099|75846139|FG000|COMPLETED|Double-blind Period|Participants who completed Week 52.|73||
59727347|NCT00853099|75846140|FG001|COMPLETED|Double-blind Period|Participants who completed Week 52.|58||
59727348|NCT00853099|75846141|FG002|COMPLETED|Double-blind Period|Participants who completed Week 52.|60||
59727349|NCT00853099|75846142|FG003|COMPLETED|Double-blind Period||0||
59727350|NCT00853099|75846139|FG000|NOT COMPLETED|Double-blind Period||23||
59727351|NCT00853099|75846140|FG001|NOT COMPLETED|Double-blind Period||29||
59727352|NCT00853099|75846141|FG002|NOT COMPLETED|Double-blind Period||31||
59727353|NCT00853099|75846142|FG003|NOT COMPLETED|Double-blind Period||0||
59727354|NCT00853099|75846139|FG000|STARTED|Double-blind + Open-label Periods||0||
59727355|NCT00853099|75846140|FG001|STARTED|Double-blind + Open-label Periods||0||
59727356|NCT00853099|75846141|FG002|STARTED|Double-blind + Open-label Periods||0||
59727357|NCT00853099|75846142|FG003|STARTED|Double-blind + Open-label Periods|7 participants randomized to placebo did not receive any adalimumab; 1 participant was excluded.|266||
59727358|NCT00853099|75846139|FG000|COMPLETED|Double-blind + Open-label Periods||0||
59727359|NCT00853099|75846140|FG001|COMPLETED|Double-blind + Open-label Periods||0||
59727360|NCT00853099|75846141|FG002|COMPLETED|Double-blind + Open-label Periods||0||
59727361|NCT00853099|75846142|FG003|COMPLETED|Double-blind + Open-label Periods||119||
59727362|NCT00853099|75846139|FG000|NOT COMPLETED|Double-blind + Open-label Periods||0||
59727363|NCT00853099|75846140|FG001|NOT COMPLETED|Double-blind + Open-label Periods||0||
59727364|NCT00853099|75846141|FG002|NOT COMPLETED|Double-blind + Open-label Periods||0||
59727365|NCT00853099|75846142|FG003|NOT COMPLETED|Double-blind + Open-label Periods||147||
59727366|NCT00992784|75846155|FG000|STARTED|Overall Study||180||
59727367|NCT00992784|75846156|FG001|STARTED|Overall Study||104||
59727368|NCT00992784|75846157|FG002|STARTED|Overall Study||86||
59727369|NCT00992784|75846155|FG000|COMPLETED|Overall Study||177||
59727370|NCT00992784|75846156|FG001|COMPLETED|Overall Study||102||
59727371|NCT00992784|75846157|FG002|COMPLETED|Overall Study||85||
59727372|NCT00992784|75846155|FG000|NOT COMPLETED|Overall Study||3||
59727373|NCT00992784|75846156|FG001|NOT COMPLETED|Overall Study||2||
59727374|NCT00992784|75846157|FG002|NOT COMPLETED|Overall Study||1||
59727375|NCT00830167|75846167|FG000|STARTED|Overall Study|Treated|248||
59727376|NCT00830167|75846168|FG001|STARTED|Overall Study|Treated|250||
59727377|NCT00830167|75846167|FG000|COMPLETED|Overall Study||208||
59727378|NCT00830167|75846168|FG001|COMPLETED|Overall Study||207||
59727379|NCT00830167|75846167|FG000|NOT COMPLETED|Overall Study||40||
59727380|NCT00830167|75846168|FG001|NOT COMPLETED|Overall Study||43||
59727381|NCT00992394|75846176|FG000|STARTED|Overall Study||88||
59727382|NCT00992394|75846177|FG001|STARTED|Overall Study||86||
59727383|NCT00992394|75846176|FG000|Safety Population|Overall Study||87||
59727384|NCT00992394|75846177|FG001|Safety Population|Overall Study||84||
59727385|NCT00992394|75846176|FG000|mITT Population|Overall Study||86||
59727386|NCT00992394|75846177|FG001|mITT Population|Overall Study||84||
59727387|NCT00992394|75846176|FG000|COMPLETED|Overall Study||64||
59727388|NCT00992394|75846177|FG001|COMPLETED|Overall Study||72||
59727389|NCT00992394|75846176|FG000|NOT COMPLETED|Overall Study||24||
59727390|NCT00992394|75846177|FG001|NOT COMPLETED|Overall Study||14||
59727391|NCT00829933|75846187|FG000|STARTED|Overall Study||135||
59727392|NCT00829933|75846188|FG001|STARTED|Overall Study||135||
59727393|NCT00829933|75846189|FG002|STARTED|Overall Study||132||
59727394|NCT00829933|75846190|FG003|STARTED|Overall Study||134||
59727395|NCT00829933|75846187|FG000|Baseline Analysis Population|Overall Study||131||
59727396|NCT00829933|75846188|FG001|Baseline Analysis Population|Overall Study||134||
59727397|NCT00829933|75846189|FG002|Baseline Analysis Population|Overall Study||131||
59727398|NCT00829933|75846190|FG003|Baseline Analysis Population|Overall Study||129||
59727399|NCT00829933|75846187|FG000|COMPLETED|Overall Study||121||
59727400|NCT00829933|75846188|FG001|COMPLETED|Overall Study||122||
59727401|NCT00829933|75846189|FG002|COMPLETED|Overall Study||119||
59727402|NCT00829933|75846190|FG003|COMPLETED|Overall Study||120||
59727403|NCT00829933|75846187|FG000|NOT COMPLETED|Overall Study||14||
59727404|NCT00829933|75846188|FG001|NOT COMPLETED|Overall Study||13||
59727405|NCT00829933|75846189|FG002|NOT COMPLETED|Overall Study||13||
59727406|NCT00829933|75846190|FG003|NOT COMPLETED|Overall Study||14||
59727407|NCT01170962|75846203|FG000|STARTED|Treatment Period||203||
59727408|NCT01170962|75846204|FG001|STARTED|Treatment Period||199||
59727409|NCT01170962|75846205|FG002|STARTED|Treatment Period||17||
59727410|NCT01170962|75846203|FG000|No PDR|Treatment Period||145||
59727411|NCT01170962|75846204|FG001|No PDR|Treatment Period||127||
59727412|NCT01170962|75846205|FG002|No PDR|Treatment Period||17||
59858161|NCT00304031|75983060|FG000|STARTED|Randomization to Adjuvant TMZ Arm||0|Participants who met requirements after concomitant treatment were randomized to an adjuvant arm.|
59858162|NCT00304031|75983061|FG001|STARTED|Randomization to Adjuvant TMZ Arm||411|Participants who met requirements after concomitant treatment were randomized to an adjuvant arm.|
59996844|NCT02729753|76112684|FG001|COMPLETED|Overall Study|Study Complete on 30 Oct 2016|6||
59996845|NCT02729753|76112683|FG000|NOT COMPLETED|Overall Study||0||
59996846|NCT02729753|76112684|FG001|NOT COMPLETED|Overall Study||1||
59727413|NCT01170962|75846203|FG000|PDR -Randomized to 24 Weeks pegIFNα--2a|Treatment Period||30||
59727414|NCT01170962|75846204|FG001|PDR -Randomized to 24 Weeks pegIFNα--2a|Treatment Period||36||
59727415|NCT01170962|75846205|FG002|PDR -Randomized to 24 Weeks pegIFNα--2a|Treatment Period||0||
59727416|NCT01170962|75846203|FG000|PDR -Randomized to 48 Weeks Follow--up|Treatment Period||28||
59727417|NCT01170962|75846204|FG001|PDR -Randomized to 48 Weeks Follow--up|Treatment Period||36||
59727418|NCT01170962|75846205|FG002|PDR -Randomized to 48 Weeks Follow--up|Treatment Period||0||
59727419|NCT01170962|75846203|FG000|COMPLETED|Treatment Period||76||
59727420|NCT01170962|75846204|FG001|COMPLETED|Treatment Period||88||
59727421|NCT01170962|75846205|FG002|COMPLETED|Treatment Period||5||
59727422|NCT01170962|75846203|FG000|NOT COMPLETED|Treatment Period||127||
59727423|NCT01170962|75846204|FG001|NOT COMPLETED|Treatment Period||111||
59727424|NCT01170962|75846205|FG002|NOT COMPLETED|Treatment Period||12||
59727425|NCT01170962|75846203|FG000|STARTED|Follow up Period|Out of 203 participants who entered the treatment period, 198 continued in the follow-up period.|198||
59727426|NCT01170962|75846204|FG001|STARTED|Follow up Period|Out of 199 participants who entered the treatment period, 192 continued in the follow-up period.|192||
59727427|NCT01170962|75846205|FG002|STARTED|Follow up Period|Out of 17 participants who entered the treatment period, 15 continued in the follow-up period.|15||
59727428|NCT01170962|75846203|FG000|COMPLETED|Follow up Period||159||
59727429|NCT01170962|75846204|FG001|COMPLETED|Follow up Period||165||
59727430|NCT01170962|75846205|FG002|COMPLETED|Follow up Period||9||
59727431|NCT01170962|75846203|FG000|NOT COMPLETED|Follow up Period||39||
59727432|NCT01170962|75846204|FG001|NOT COMPLETED|Follow up Period||27||
59727433|NCT01170962|75846205|FG002|NOT COMPLETED|Follow up Period||6||
59727434|NCT00843193|75846224|FG000|STARTED|Overall Study||99||
59727435|NCT00843193|75846225|FG001|STARTED|Overall Study||99||
59727436|NCT00843193|75846224|FG000|COMPLETED|Overall Study||91||
59727437|NCT00843193|75846225|FG001|COMPLETED|Overall Study||88||
59727438|NCT00843193|75846224|FG000|NOT COMPLETED|Overall Study||8||
59727439|NCT00843193|75846225|FG001|NOT COMPLETED|Overall Study||11||
59727440|NCT00829621|75846234|FG000|STARTED|Overall Study||8||
59727441|NCT00829621|75846235|FG001|STARTED|Overall Study||12||
59727442|NCT00829621|75846234|FG000|COMPLETED|Overall Study||4||
59727443|NCT00829621|75846235|FG001|COMPLETED|Overall Study||8||
59727444|NCT00829621|75846234|FG000|NOT COMPLETED|Overall Study||4||
59996847|NCT00709319|76112693|FG000|STARTED|Overall Study||87||
59727445|NCT00829621|75846235|FG001|NOT COMPLETED|Overall Study||4||
59727446|NCT01157078|75846243|FG000|STARTED|Overall Study||159||
59727447|NCT01157078|75846244|FG001|STARTED|Overall Study||160||
59727448|NCT01157078|75846243|FG000|Received Treatment|Overall Study||157||
59727449|NCT01157078|75846244|FG001|Received Treatment|Overall Study||159||
59727450|NCT01157078|75846243|FG000|COMPLETED|Overall Study||124||
59727451|NCT01157078|75846244|FG001|COMPLETED|Overall Study||124||
59727452|NCT01157078|75846243|FG000|NOT COMPLETED|Overall Study||35||
59727453|NCT01157078|75846244|FG001|NOT COMPLETED|Overall Study||36||
59727454|NCT00591721|75846252|FG000|STARTED|Overall Study||89||
59727455|NCT00591721|75846253|FG001|STARTED|Overall Study||92||
59727456|NCT00591721|75846252|FG000|COMPLETED|Overall Study||68||
59727457|NCT00591721|75846253|FG001|COMPLETED|Overall Study||70||
59858163|NCT00304031|75983062|FG002|STARTED|Randomization to Adjuvant TMZ Arm||422|Participants who met requirements after concomitant treatment were randomized to an adjuvant arm.|
59727458|NCT00591721|75846252|FG000|NOT COMPLETED|Overall Study||21||
59727459|NCT00591721|75846253|FG001|NOT COMPLETED|Overall Study||22||
59727460|NCT01156844|75846263|FG000|STARTED|Overall Study|Randomized participants.|48||
59727461|NCT01156844|75846264|FG001|STARTED|Overall Study||48||
59727462|NCT01156844|75846265|FG002|STARTED|Overall Study||48||
59727463|NCT01156844|75846266|FG003|STARTED|Overall Study||47||
59727464|NCT01156844|75846263|FG000|PD & Safety Sets: Received Study Drug|Overall Study|PD=Pharmacodynamic|48||
59727465|NCT01156844|75846264|FG001|PD & Safety Sets: Received Study Drug|Overall Study||47||
59727466|NCT01156844|75846265|FG002|PD & Safety Sets: Received Study Drug|Overall Study||48||
59727467|NCT01156844|75846266|FG003|PD & Safety Sets: Received Study Drug|Overall Study||46||
59727468|NCT01156844|75846263|FG000|COMPLETED|Overall Study||46||
59727469|NCT01156844|75846264|FG001|COMPLETED|Overall Study||46||
59727470|NCT01156844|75846265|FG002|COMPLETED|Overall Study||42||
59727471|NCT01156844|75846266|FG003|COMPLETED|Overall Study||41||
59727472|NCT01156844|75846263|FG000|NOT COMPLETED|Overall Study||2||
59727473|NCT01156844|75846264|FG001|NOT COMPLETED|Overall Study||2||
59727474|NCT01156844|75846265|FG002|NOT COMPLETED|Overall Study||6||
59727475|NCT01156844|75846266|FG003|NOT COMPLETED|Overall Study||6||
59727476|NCT00853021|75846279|FG000|STARTED|Overall Study||26||
59727477|NCT00853021|75846279|FG000|COMPLETED|Overall Study||21||
59727478|NCT00853021|75846279|FG000|NOT COMPLETED|Overall Study||5||
59727479|NCT01156532|75846283|FG000|STARTED|Overall Study||30||
59727480|NCT01156532|75846283|FG000|COMPLETED|Overall Study||28||
59727481|NCT01156532|75846283|FG000|NOT COMPLETED|Overall Study||2||
59727482|NCT00843115|75846287|FG000|STARTED|Overall Study||370||
59727483|NCT00843115|75846287|FG000|COMPLETED|Overall Study||304||
59727484|NCT00843115|75846287|FG000|NOT COMPLETED|Overall Study||66||
59727485|NCT01156376|75846294|FG000|STARTED|Overall Study||27||
59727486|NCT01156376|75846295|FG001|STARTED|Overall Study||26||
59727487|NCT01156376|75846296|FG002|STARTED|Overall Study||27||
59727488|NCT01156376|75846294|FG000|COMPLETED|Overall Study||26||
59727489|NCT01156376|75846295|FG001|COMPLETED|Overall Study||26||
59727490|NCT01156376|75846296|FG002|COMPLETED|Overall Study||23||
59727491|NCT01156376|75846294|FG000|NOT COMPLETED|Overall Study||1||
59727492|NCT01156376|75846295|FG001|NOT COMPLETED|Overall Study||0||
59727493|NCT01156376|75846296|FG002|NOT COMPLETED|Overall Study||4||
59727494|NCT00829387|75846306|FG000|STARTED|Overall Study||23||
59727495|NCT00829387|75846307|FG001|STARTED|Overall Study||24||
59727496|NCT00829387|75846306|FG000|COMPLETED|Overall Study||20||
59727497|NCT00829387|75846307|FG001|COMPLETED|Overall Study||21||
59727498|NCT00829387|75846306|FG000|NOT COMPLETED|Overall Study||3||
59727499|NCT00829387|75846307|FG001|NOT COMPLETED|Overall Study||3||
59727500|NCT01156142|75846315|FG000|STARTED|Overall Study||77||
59727501|NCT01156142|75846316|FG001|STARTED|Overall Study||78||
59727502|NCT01156142|75846315|FG000|COMPLETED|Overall Study||69||
59727503|NCT01156142|75846316|FG001|COMPLETED|Overall Study||71||
59727504|NCT01156142|75846315|FG000|NOT COMPLETED|Overall Study||8||
59727505|NCT01156142|75846316|FG001|NOT COMPLETED|Overall Study||7||
59727506|NCT00842257|75846322|FG000|STARTED|Overall Study||20||
59727507|NCT00842257|75846322|FG000|COMPLETED|Overall Study||19||
59727508|NCT00842257|75846322|FG000|NOT COMPLETED|Overall Study||1||
59727509|NCT00852475|75846328|FG000|STARTED|Overall Study||26||
59727510|NCT00852475|75846329|FG001|STARTED|Overall Study||20||
59727511|NCT00852475|75846328|FG000|COMPLETED|Overall Study||23||
59727512|NCT00852475|75846329|FG001|COMPLETED|Overall Study||16||
59727513|NCT00852475|75846328|FG000|NOT COMPLETED|Overall Study||3||
59727514|NCT00852475|75846329|FG001|NOT COMPLETED|Overall Study||4||
59727515|NCT01155284|75846339|FG000|STARTED|Overall Study||47||
59727516|NCT01155284|75846340|FG001|STARTED|Overall Study||23||
59727517|NCT01155284|75846339|FG000|COMPLETED|Overall Study||40||
59727518|NCT01155284|75846340|FG001|COMPLETED|Overall Study||18||
59727519|NCT01155284|75846339|FG000|NOT COMPLETED|Overall Study||7||
59727520|NCT01155284|75846340|FG001|NOT COMPLETED|Overall Study||5||
59727521|NCT00852397|75846351|FG000|STARTED|Overall Study||52||
59727522|NCT00852397|75846352|FG001|STARTED|Overall Study||49||
59727523|NCT00852397|75846353|FG002|STARTED|Overall Study||50||
59727524|NCT00852397|75846351|FG000|Treated Participants|Overall Study||51||
59727525|NCT00852397|75846352|FG001|Treated Participants|Overall Study||49||
59727526|NCT00852397|75846353|FG002|Treated Participants|Overall Study||49||
59727527|NCT00852397|75846351|FG000|COMPLETED|Overall Study||41||
59727528|NCT00852397|75846352|FG001|COMPLETED|Overall Study||41||
59727529|NCT00852397|75846353|FG002|COMPLETED|Overall Study||36||
59727530|NCT00852397|75846351|FG000|NOT COMPLETED|Overall Study||11||
59727531|NCT00852397|75846352|FG001|NOT COMPLETED|Overall Study||8||
59727532|NCT00852397|75846353|FG002|NOT COMPLETED|Overall Study||14||
59727533|NCT00841321|75846363|FG000|STARTED|Overall Study||59||
59727534|NCT00841321|75846364|FG001|STARTED|Overall Study||61||
59727535|NCT00841321|75846363|FG000|COMPLETED|Overall Study||58||
59727536|NCT00841321|75846364|FG001|COMPLETED|Overall Study||58||
59727537|NCT00841321|75846363|FG000|NOT COMPLETED|Overall Study||1||
59727538|NCT00841321|75846364|FG001|NOT COMPLETED|Overall Study||3||
59858164|NCT00304031|75983060|FG000|Eligible Population|Randomization to Adjuvant TMZ Arm||0||
59858165|NCT00304031|75983061|FG001|Eligible Population|Randomization to Adjuvant TMZ Arm||411||
59858166|NCT00304031|75983062|FG002|Eligible Population|Randomization to Adjuvant TMZ Arm||420||
59858167|NCT00304031|75983060|FG000|Unmethylated MGMT Population|Randomization to Adjuvant TMZ Arm||0|Eligible participants determined to have unmethylated MGMT.|
59727539|NCT00986232|75846376|FG000|STARTED|Overall Study||387||
59727540|NCT00986232|75846377|FG001|STARTED|Overall Study|Excludes 1 patient who was randomized to receive ProQuad (Middle Dose), but was not vaccinated.|393||
59727541|NCT00986232|75846378|FG002|STARTED|Overall Study||381||
59727542|NCT00986232|75846379|FG003|STARTED|Overall Study|Excludes 1 patient who was randomized to receive M-M-R™ II + PUVV, but was not vaccinated.|390||
59727543|NCT00986232|75846376|FG000|Vaccination Visit 1|Overall Study||387||
59727544|NCT00986232|75846377|FG001|Vaccination Visit 1|Overall Study||393||
59727545|NCT00986232|75846378|FG002|Vaccination Visit 1|Overall Study||381||
59727546|NCT00986232|75846379|FG003|Vaccination Visit 1|Overall Study||390||
59727547|NCT00986232|75846376|FG000|Vaccination Visit 2|Overall Study||360||
59727548|NCT00986232|75846377|FG001|Vaccination Visit 2|Overall Study||365||
59727549|NCT00986232|75846378|FG002|Vaccination Visit 2|Overall Study||360||
59727550|NCT00986232|75846379|FG003|Vaccination Visit 2|Overall Study||0||
59727551|NCT00986232|75846376|FG000|COMPLETED|Overall Study||336||
59727552|NCT00986232|75846377|FG001|COMPLETED|Overall Study||343||
59727553|NCT00986232|75846378|FG002|COMPLETED|Overall Study||346||
59727554|NCT00986232|75846379|FG003|COMPLETED|Overall Study||370||
59727555|NCT00986232|75846376|FG000|NOT COMPLETED|Overall Study||51||
59727556|NCT00986232|75846377|FG001|NOT COMPLETED|Overall Study||50||
59727557|NCT00986232|75846378|FG002|NOT COMPLETED|Overall Study||35||
59727558|NCT00986232|75846379|FG003|NOT COMPLETED|Overall Study||20||
59727559|NCT00852241|75846395|FG000|STARTED|Overall Study||18||
59727560|NCT00852241|75846395|FG000|COMPLETED|Overall Study||0||
59727561|NCT00852241|75846395|FG000|NOT COMPLETED|Overall Study||18||
59727562|NCT01169636|75846404|FG000|STARTED|Overall Study||3||
59727563|NCT01169636|75846405|FG001|STARTED|Overall Study||6||
59727564|NCT01169636|75846406|FG002|STARTED|Overall Study||20||
59727565|NCT01169636|75846407|FG003|STARTED|Overall Study||13||
59727566|NCT01169636|75846408|FG004|STARTED|Overall Study||14||
59727567|NCT01169636|75846404|FG000|COMPLETED|Overall Study||3||
59727568|NCT01169636|75846405|FG001|COMPLETED|Overall Study||6||
59727569|NCT01169636|75846406|FG002|COMPLETED|Overall Study||17||
59727570|NCT01169636|75846407|FG003|COMPLETED|Overall Study||12||
59727571|NCT01169636|75846408|FG004|COMPLETED|Overall Study||11||
59727572|NCT01169636|75846404|FG000|NOT COMPLETED|Overall Study||0||
59727573|NCT01169636|75846405|FG001|NOT COMPLETED|Overall Study||0||
59727574|NCT01169636|75846406|FG002|NOT COMPLETED|Overall Study||3||
59727575|NCT01169636|75846407|FG003|NOT COMPLETED|Overall Study||1||
59727576|NCT01169636|75846408|FG004|NOT COMPLETED|Overall Study||3||
59727577|NCT01169558|75846418|FG000|STARTED|Overall Study||162||
59727578|NCT01169558|75846418|FG000|COMPLETED|Overall Study||6||
59727579|NCT01169558|75846418|FG000|NOT COMPLETED|Overall Study||156||
59727580|NCT00840463|75846424|FG000|STARTED|Overall Study||3||
59727581|NCT00840463|75846425|FG001|STARTED|Overall Study||1||
59727582|NCT00840463|75846424|FG000|COMPLETED|Overall Study||2||
59727583|NCT00840463|75846425|FG001|COMPLETED|Overall Study||1||
59727584|NCT00840463|75846424|FG000|NOT COMPLETED|Overall Study||1||
59727585|NCT00840463|75846425|FG001|NOT COMPLETED|Overall Study||0||
59727586|NCT01168856|75846433|FG000|STARTED|Overall Study||176||
59727587|NCT01168856|75846434|FG001|STARTED|Overall Study||558||
59727588|NCT01168856|75846433|FG000|COMPLETED|Overall Study||158||
59727589|NCT01168856|75846434|FG001|COMPLETED|Overall Study||215||
59727590|NCT01168856|75846433|FG000|NOT COMPLETED|Overall Study||18||
59727591|NCT01168856|75846434|FG001|NOT COMPLETED|Overall Study||343||
59727592|NCT00828451|75846445|FG000|STARTED|Overall Study||29||
59727593|NCT00828451|75846445|FG000|COMPLETED|Overall Study||18||
59727594|NCT00828451|75846445|FG000|NOT COMPLETED|Overall Study||11||
59727595|NCT00839917|75846451|FG000|STARTED|Overall Study||13||
59727596|NCT00839917|75846452|FG001|STARTED|Overall Study||17||
59727597|NCT00839917|75846451|FG000|COMPLETED|Overall Study|Study completers were randomized participants who received study vaccination and had follow-up data|12||
59727598|NCT00839917|75846452|FG001|COMPLETED|Overall Study|Study completers were randomized participants who received study vaccination and had follow-up data|16||
59727599|NCT00839917|75846451|FG000|NOT COMPLETED|Overall Study||1||
59727600|NCT00839917|75846452|FG001|NOT COMPLETED|Overall Study||1||
59727601|NCT00839527|75846461|FG000|STARTED|Treatment Period (TP) (156 Weeks)||115||
59727602|NCT00839527|75846462|FG001|STARTED|Treatment Period (TP) (156 Weeks)||277||
59727603|NCT00839527|75846463|FG002|STARTED|Treatment Period (TP) (156 Weeks)||271||
59727604|NCT00839527|75846461|FG000|COMPLETED|Treatment Period (TP) (156 Weeks)||55||
59727605|NCT00839527|75846462|FG001|COMPLETED|Treatment Period (TP) (156 Weeks)||159||
59727606|NCT00839527|75846463|FG002|COMPLETED|Treatment Period (TP) (156 Weeks)||152||
59727607|NCT00839527|75846461|FG000|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||60||
59727608|NCT00839527|75846462|FG001|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||118||
59727609|NCT00839527|75846463|FG002|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||119||
59727610|NCT00839527|75846461|FG000|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. One par. did not participate in the FUP.|114||
59727611|NCT00839527|75846462|FG001|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. Four par. did not participate in the FUP.|273||
59727612|NCT00839527|75846463|FG002|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. Five par. did not participate in the FUP.|266||
59727613|NCT00839527|75846461|FG000|COMPLETED|Follow-up Period (FUP) (8 Weeks)||86||
59727614|NCT00839527|75846462|FG001|COMPLETED|Follow-up Period (FUP) (8 Weeks)||217||
59727615|NCT00839527|75846463|FG002|COMPLETED|Follow-up Period (FUP) (8 Weeks)||204||
59727616|NCT00839527|75846461|FG000|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||28||
59727617|NCT00839527|75846462|FG001|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||56||
59727618|NCT00839527|75846463|FG002|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||62||
59727619|NCT00600886|75846475|FG000|STARTED|Core Phase - Full Analysis Set (FAS)||176||
59727620|NCT00600886|75846476|FG001|STARTED|Core Phase - Full Analysis Set (FAS)||182||
59727621|NCT00600886|75846475|FG000|Did Not Enter Extension|Core Phase - Full Analysis Set (FAS)||29||
59727622|NCT00600886|75846476|FG001|Did Not Enter Extension|Core Phase - Full Analysis Set (FAS)||29||
59727623|NCT00600886|75846475|FG000|Entered Extension, Crossed Over|Core Phase - Full Analysis Set (FAS)||38||
59727624|NCT00600886|75846476|FG001|Entered Extension, Crossed Over|Core Phase - Full Analysis Set (FAS)||81||
59727625|NCT00600886|75846475|FG000|Entered Ext Continued Same Treatment|Core Phase - Full Analysis Set (FAS)||74||
59727626|NCT00600886|75846476|FG001|Entered Ext Continued Same Treatment|Core Phase - Full Analysis Set (FAS)||46||
59727627|NCT00600886|75846475|FG000|COMPLETED|Core Phase - Full Analysis Set (FAS)|Completed = anyone who did not discontinue prior to month 12.|141||
59727628|NCT00600886|75846476|FG001|COMPLETED|Core Phase - Full Analysis Set (FAS)|Completed = anyone who did not discontinue prior to month 12.|156||
59727629|NCT00600886|75846475|FG000|NOT COMPLETED|Core Phase - Full Analysis Set (FAS)||35||
59727630|NCT00600886|75846476|FG001|NOT COMPLETED|Core Phase - Full Analysis Set (FAS)||26||
59727631|NCT00600886|75846475|FG000|STARTED|Extension - Same Treatment (FAS)|Started = anyone who entered the extension and continued the same treatment of Pasireotide LAR|74||
59727632|NCT00600886|75846476|FG001|STARTED|Extension - Same Treatment (FAS)|Started = anyone who entered the extension and continued the same treatment of Octreotide LAR|46||
59727633|NCT00600886|75846475|FG000|Completed Study at Month 26|Extension - Same Treatment (FAS)|Pas. LAR pts in Ext. were not considered completers at M26 as treatment could continue after M26.|0||
59727634|NCT00600886|75846476|FG001|Completed Study at Month 26|Extension - Same Treatment (FAS)|Per protocol, pts who received Octreotide LAR in ext. phase were not followed in the study after M26|31||
59727635|NCT00600886|75846475|FG000|Completed Study After Month 26|Extension - Same Treatment (FAS)|Completed = Pts who transferred to a roll-over protocol or commercial supply of Pasireotide LAR|28||
59727636|NCT00600886|75846476|FG001|Completed Study After Month 26|Extension - Same Treatment (FAS)|Received treatment and completed after M26: Recorded as protocol deviation|4||
59727637|NCT00600886|75846475|FG000|Discontinued After Month 26|Extension - Same Treatment (FAS)||23||
59727638|NCT00600886|75846476|FG001|Discontinued After Month 26|Extension - Same Treatment (FAS)|Received treatment and discontinued after M26: Recorded as protocol deviation|1||
59727639|NCT00600886|75846475|FG000|Discontinued Between M12 and M26|Extension - Same Treatment (FAS)||23||
59727640|NCT00600886|75846476|FG001|Discontinued Between M12 and M26|Extension - Same Treatment (FAS)||10||
59727641|NCT00600886|75846475|FG000|COMPLETED|Extension - Same Treatment (FAS)|Completed= completed after M26, switched to commercial pasireotide LAR or entered roll-over protocol|28||
59727642|NCT00600886|75846476|FG001|COMPLETED|Extension - Same Treatment (FAS)|Completed = completed the study|35||
59727643|NCT00600886|75846475|FG000|NOT COMPLETED|Extension - Same Treatment (FAS)||46||
59727644|NCT00600886|75846476|FG001|NOT COMPLETED|Extension - Same Treatment (FAS)||11||
59727645|NCT00600886|75846475|FG000|STARTED|Extension - After Crossover (CAS)|Started = anyone who entered the extension and crossed over to Pasireotide LAR|81||
59727646|NCT00600886|75846476|FG001|STARTED|Extension - After Crossover (CAS)|Started = anyone who entered the extension and crossed over to Octreotide LAR|38||
59727647|NCT00600886|75846475|FG000|Completed Study at Month 26|Extension - After Crossover (CAS)|Pas. LAR pts in Ext. were not considered completers at M26 as treatment could continue after M26.|0||
59727648|NCT00600886|75846476|FG001|Completed Study at Month 26|Extension - After Crossover (CAS)|Per protocol, Pts who received Octreotide LAR in Ext. phase were not followed in study after M26|25||
59727649|NCT00600886|75846475|FG000|Completed After Month 26|Extension - After Crossover (CAS)|Completed = Pts who transferred to a roll-over protocol or commercial supply of Pasireotide LAR|19||
59727650|NCT00600886|75846476|FG001|Completed After Month 26|Extension - After Crossover (CAS)|Per protocol, pts who received Octreotide LAR in ext. phase were not followed in study after M26|0||
59727651|NCT00600886|75846475|FG000|Discontinued Between M12 and M26|Extension - After Crossover (CAS)||31||
59727652|NCT00600886|75846476|FG001|Discontinued Between M12 and M26|Extension - After Crossover (CAS)||13||
59996848|NCT00709319|76112693|FG000|COMPLETED|Overall Study||81||
59727653|NCT00600886|75846475|FG000|Discontinued After M26|Extension - After Crossover (CAS)||31||
59727654|NCT00600886|75846476|FG001|Discontinued After M26|Extension - After Crossover (CAS)|Per protocol, Pts who received Octreotide LAR in Ext. phase were not followed in study after M26|0||
59727655|NCT00600886|75846475|FG000|COMPLETED|Extension - After Crossover (CAS)|Completed after month 26: transferred to a roll-over protocol or commercial supply of Pas.LAR|19||
59727656|NCT00600886|75846476|FG001|COMPLETED|Extension - After Crossover (CAS)|Completed the study|25||
59727657|NCT00600886|75846475|FG000|NOT COMPLETED|Extension - After Crossover (CAS)||62||
59727658|NCT00600886|75846476|FG001|NOT COMPLETED|Extension - After Crossover (CAS)||13||
59727659|NCT00838903|75846500|FG000|STARTED|Treatment Period (156 Weeks)||101||
59727660|NCT00838903|75846501|FG001|STARTED|Treatment Period (156 Weeks)||302||
59727661|NCT00838903|75846502|FG002|STARTED|Treatment Period (156 Weeks)||307||
59727662|NCT00838903|75846503|FG003|STARTED|Treatment Period (156 Weeks)||302||
59727663|NCT00838903|75846500|FG000|Missing Active Treatment Status|Treatment Period (156 Weeks)||1||
59727664|NCT00838903|75846501|FG001|Missing Active Treatment Status|Treatment Period (156 Weeks)||0||
59727665|NCT00838903|75846502|FG002|Missing Active Treatment Status|Treatment Period (156 Weeks)||0||
59727666|NCT00838903|75846503|FG003|Missing Active Treatment Status|Treatment Period (156 Weeks)||0||
59727667|NCT00838903|75846500|FG000|COMPLETED|Treatment Period (156 Weeks)||55||
59727668|NCT00838903|75846501|FG001|COMPLETED|Treatment Period (156 Weeks)||190||
59727669|NCT00838903|75846502|FG002|COMPLETED|Treatment Period (156 Weeks)||191||
59727670|NCT00838903|75846503|FG003|COMPLETED|Treatment Period (156 Weeks)||192||
59727671|NCT00838903|75846500|FG000|NOT COMPLETED|Treatment Period (156 Weeks)||46||
59727672|NCT00838903|75846501|FG001|NOT COMPLETED|Treatment Period (156 Weeks)||112||
59727673|NCT00838903|75846502|FG002|NOT COMPLETED|Treatment Period (156 Weeks)||116||
59727674|NCT00838903|75846503|FG003|NOT COMPLETED|Treatment Period (156 Weeks)||110||
59727675|NCT00838903|75846500|FG000|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|101||
59727676|NCT00838903|75846501|FG001|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|302||
59727677|NCT00838903|75846502|FG002|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|307||
59727678|NCT00838903|75846503|FG003|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|302||
59727679|NCT00838903|75846500|FG000|COMPLETED|Follow-up Period (8 Weeks)||75||
59727680|NCT00838903|75846501|FG001|COMPLETED|Follow-up Period (8 Weeks)||237||
59727681|NCT00838903|75846502|FG002|COMPLETED|Follow-up Period (8 Weeks)||243||
59727682|NCT00838903|75846503|FG003|COMPLETED|Follow-up Period (8 Weeks)||244||
59727683|NCT00838903|75846500|FG000|NOT COMPLETED|Follow-up Period (8 Weeks)||26||
59727684|NCT00838903|75846501|FG001|NOT COMPLETED|Follow-up Period (8 Weeks)||65||
59727685|NCT00838903|75846502|FG002|NOT COMPLETED|Follow-up Period (8 Weeks)||64||
59727686|NCT00838903|75846503|FG003|NOT COMPLETED|Follow-up Period (8 Weeks)||58||
59727687|NCT00828139|75846517|FG000|STARTED|Overall Study||42||
59727688|NCT00828139|75846518|FG001|STARTED|Overall Study||41||
59727689|NCT00828139|75846519|FG002|STARTED|Overall Study||55||
59727690|NCT00828139|75846520|FG003|STARTED|Overall Study||51||
59727691|NCT00828139|75846517|FG000|COMPLETED|Overall Study||1||
59727692|NCT00828139|75846518|FG001|COMPLETED|Overall Study||0||
59727693|NCT00828139|75846519|FG002|COMPLETED|Overall Study||0||
59727694|NCT00828139|75846520|FG003|COMPLETED|Overall Study||0||
59727695|NCT00828139|75846517|FG000|NOT COMPLETED|Overall Study||41||
59727696|NCT00828139|75846518|FG001|NOT COMPLETED|Overall Study||41||
59727697|NCT00828139|75846519|FG002|NOT COMPLETED|Overall Study||55||
59727698|NCT00828139|75846520|FG003|NOT COMPLETED|Overall Study||51||
59727699|NCT00838513|75846530|FG000|STARTED|Screening Period||23||
59727700|NCT00838513|75846530|FG000|COMPLETED|Screening Period||20||
59727701|NCT00838513|75846530|FG000|NOT COMPLETED|Screening Period||3||
59727702|NCT00838513|75846530|FG000|STARTED|Observation Period (8 Weeks)||20||
59727703|NCT00838513|75846530|FG000|COMPLETED|Observation Period (8 Weeks)||20||
59727704|NCT00838513|75846530|FG000|NOT COMPLETED|Observation Period (8 Weeks)||0||
59727705|NCT00838513|75846530|FG000|STARTED|Treatment Period (26 Weeks)||20||
59727706|NCT00838513|75846530|FG000|COMPLETED|Treatment Period (26 Weeks)||20||
59727707|NCT00838513|75846530|FG000|NOT COMPLETED|Treatment Period (26 Weeks)||0||
59727708|NCT00838513|75846530|FG000|STARTED|Extension Treatment Period||19||
59727709|NCT00838513|75846530|FG000|COMPLETED|Extension Treatment Period||18||
59727710|NCT00838513|75846530|FG000|NOT COMPLETED|Extension Treatment Period||1||
59727711|NCT00838513|75846530|FG000|STARTED|Post Treatment Period (Patients Who Disc||5||
59727712|NCT00838513|75846530|FG000|COMPLETED|Post Treatment Period (Patients Who Disc||4||
59727713|NCT00838513|75846530|FG000|NOT COMPLETED|Post Treatment Period (Patients Who Disc||1||
59727714|NCT00600106|75846536|FG000|STARTED|Overall Study||18||
59727715|NCT00600106|75846537|FG001|STARTED|Overall Study||19||
59727716|NCT00600106|75846536|FG000|COMPLETED|Overall Study||17||
59727717|NCT00600106|75846537|FG001|COMPLETED|Overall Study||18||
59727718|NCT00600106|75846536|FG000|NOT COMPLETED|Overall Study||1||
59727719|NCT00600106|75846537|FG001|NOT COMPLETED|Overall Study||1||
59727720|NCT00850993|75846547|FG000|STARTED|Overall Study||17||
59727721|NCT00850993|75846548|FG001|STARTED|Overall Study||18||
59727722|NCT00850993|75846549|FG002|STARTED|Overall Study||8||
59727723|NCT00850993|75846550|FG003|STARTED|Overall Study||15||
59727724|NCT00850993|75846547|FG000|Safety|Overall Study||17||
59727725|NCT00850993|75846548|FG001|Safety|Overall Study||18||
59727726|NCT00850993|75846549|FG002|Safety|Overall Study||8||
59727727|NCT00850993|75846550|FG003|Safety|Overall Study||15||
59727728|NCT00850993|75846547|FG000|Intent-to-treat|Overall Study||17||
59727729|NCT00850993|75846548|FG001|Intent-to-treat|Overall Study||18||
59727730|NCT00850993|75846549|FG002|Intent-to-treat|Overall Study||8||
59727731|NCT00850993|75846550|FG003|Intent-to-treat|Overall Study||15||
59727732|NCT00850993|75846547|FG000|Received Phototherapy|Overall Study||3||
59727733|NCT00850993|75846548|FG001|Received Phototherapy|Overall Study||6||
59727734|NCT00850993|75846549|FG002|Received Phototherapy|Overall Study||2||
59727735|NCT00850993|75846550|FG003|Received Phototherapy|Overall Study||8||
59727736|NCT00850993|75846547|FG000|Per Protocol|Overall Study||10||
59727737|NCT00850993|75846548|FG001|Per Protocol|Overall Study||13||
59727738|NCT00850993|75846549|FG002|Per Protocol|Overall Study||5||
59727739|NCT00850993|75846550|FG003|Per Protocol|Overall Study||13||
59727740|NCT00850993|75846547|FG000|COMPLETED|Overall Study||16||
59727741|NCT00850993|75846548|FG001|COMPLETED|Overall Study||18||
59727742|NCT00850993|75846549|FG002|COMPLETED|Overall Study||8||
59727743|NCT00850993|75846550|FG003|COMPLETED|Overall Study||14||
59727744|NCT00850993|75846547|FG000|NOT COMPLETED|Overall Study||1||
59727745|NCT00850993|75846548|FG001|NOT COMPLETED|Overall Study||0||
59727746|NCT00850993|75846549|FG002|NOT COMPLETED|Overall Study||0||
59727747|NCT00850993|75846550|FG003|NOT COMPLETED|Overall Study||1||
59727748|NCT00818779|75846562|FG000|STARTED|Overall Study||22||
59727749|NCT00818779|75846563|FG001|STARTED|Overall Study||16||
59727750|NCT00818779|75846562|FG000|COMPLETED|Overall Study||16||
59727751|NCT00818779|75846563|FG001|COMPLETED|Overall Study||15||
59727752|NCT00818779|75846562|FG000|NOT COMPLETED|Overall Study||6||
59727753|NCT00818779|75846563|FG001|NOT COMPLETED|Overall Study||1||
59727754|NCT00850759|75846573|FG000|STARTED|Overall Study||59||
59727755|NCT00850759|75846574|FG001|STARTED|Overall Study||57||
59727756|NCT00850759|75846575|FG002|STARTED|Overall Study||57||
59727757|NCT00850759|75846576|FG003|STARTED|Overall Study||58||
59727758|NCT00850759|75846573|FG000|COMPLETED|Overall Study||52||
59727759|NCT00850759|75846574|FG001|COMPLETED|Overall Study||52||
59727760|NCT00850759|75846575|FG002|COMPLETED|Overall Study||52||
59727761|NCT00850759|75846576|FG003|COMPLETED|Overall Study||55||
59727762|NCT00850759|75846573|FG000|NOT COMPLETED|Overall Study||7||
59727763|NCT00850759|75846574|FG001|NOT COMPLETED|Overall Study||5||
59727764|NCT00850759|75846575|FG002|NOT COMPLETED|Overall Study||5||
59727765|NCT00850759|75846576|FG003|NOT COMPLETED|Overall Study||3||
59727766|NCT00827827|75846588|FG000|STARTED|Overall Study||22||
59727767|NCT00827827|75846589|FG001|STARTED|Overall Study||16||
59727768|NCT00827827|75846588|FG000|COMPLETED|Overall Study||14||
59727769|NCT00827827|75846589|FG001|COMPLETED|Overall Study||16||
59727770|NCT00827827|75846588|FG000|NOT COMPLETED|Overall Study||8||
59727771|NCT00827827|75846589|FG001|NOT COMPLETED|Overall Study||0||
59727772|NCT00600028|75846598|FG000|STARTED|First Intervention (12 Weeks)|Number of participants starting the first intervention (prior to washout)|13||
59727773|NCT00600028|75846599|FG001|STARTED|First Intervention (12 Weeks)|Number of participants starting the first intervention (prior to washout)|11||
59727774|NCT00600028|75846598|FG000|COMPLETED|First Intervention (12 Weeks)||12||
59727775|NCT00600028|75846599|FG001|COMPLETED|First Intervention (12 Weeks)||10||
59727776|NCT00600028|75846598|FG000|NOT COMPLETED|First Intervention (12 Weeks)||1||
59727777|NCT00600028|75846599|FG001|NOT COMPLETED|First Intervention (12 Weeks)||1||
59727778|NCT00600028|75846598|FG000|STARTED|Second Intervention (12 Weeks)|Number of participants starting the second intervention (after a 2-week washout)|12||
59727779|NCT00600028|75846599|FG001|STARTED|Second Intervention (12 Weeks)|Number of participants starting the second intervention (after a 2-week washout)|10||
59727780|NCT00600028|75846598|FG000|COMPLETED|Second Intervention (12 Weeks)||12||
59727781|NCT00600028|75846599|FG001|COMPLETED|Second Intervention (12 Weeks)||8||
59727782|NCT00600028|75846598|FG000|NOT COMPLETED|Second Intervention (12 Weeks)||0||
59727783|NCT00600028|75846599|FG001|NOT COMPLETED|Second Intervention (12 Weeks)||2||
59727784|NCT03542266|75846608|FG000|STARTED|Treatment Phase||21||
59727785|NCT03542266|75846608|FG000|COMPLETED|Treatment Phase||18||
59727786|NCT03542266|75846608|FG000|NOT COMPLETED|Treatment Phase||3||
59727787|NCT03542266|75846608|FG000|STARTED|Post-treatment Follow-up Phase|Three subjects did not enter follow-up: 1 had PD at EOT, 2 withdrew consent|15||
59727788|NCT03542266|75846608|FG000|COMPLETED|Post-treatment Follow-up Phase||0||
59727789|NCT03542266|75846608|FG000|NOT COMPLETED|Post-treatment Follow-up Phase||15||
59727790|NCT00827359|75846612|FG000|STARTED|Overall Study||25||
59727791|NCT00827359|75846612|FG000|Treated|Overall Study||24||
59727792|NCT00827359|75846612|FG000|COMPLETED|Overall Study||0||
59727793|NCT00827359|75846612|FG000|NOT COMPLETED|Overall Study||25||
59727794|NCT00818389|75846618|FG000|STARTED|Overall Study||40||
59727795|NCT00818389|75846619|FG001|STARTED|Overall Study||44||
59727796|NCT00818389|75846618|FG000|COMPLETED|Overall Study|4 subjects terminated study early before 1st interim analysis. Study terminated early for futility.|36||
59727797|NCT00818389|75846619|FG001|COMPLETED|Overall Study|6 subjects terminated study early before 1st interim analysis. Study terminated early for futility.|38||
59727798|NCT00818389|75846618|FG000|NOT COMPLETED|Overall Study||4||
59727799|NCT00818389|75846619|FG001|NOT COMPLETED|Overall Study||6||
59727800|NCT00850135|75846625|FG000|STARTED|Overall Study||57||
59727801|NCT00850135|75846625|FG000|COMPLETED|Overall Study||56||
59727802|NCT00850135|75846625|FG000|NOT COMPLETED|Overall Study||1||
59727803|NCT01154816|75846643|FG000|STARTED|Overall Study||20||
59727804|NCT01154816|75846644|FG001|STARTED|Overall Study||12||
59727805|NCT01154816|75846645|FG002|STARTED|Overall Study||10||
59727806|NCT01154816|75846646|FG003|STARTED|Overall Study||10||
59727807|NCT01154816|75846647|FG004|STARTED|Overall Study||10||
59727808|NCT01154816|75846648|FG005|STARTED|Overall Study||8||
59727809|NCT01154816|75846649|FG006|STARTED|Overall Study||6||
59727810|NCT01154816|75846650|FG007|STARTED|Overall Study||7||
59727811|NCT01154816|75846651|FG008|STARTED|Overall Study||10||
59727812|NCT01154816|75846652|FG009|STARTED|Overall Study||10||
59727813|NCT01154816|75846653|FG010|STARTED|Overall Study||11||
59727814|NCT01154816|75846654|FG011|STARTED|Overall Study||4||
59727815|NCT01154816|75846643|FG000|COMPLETED|Overall Study||0||
59727816|NCT01154816|75846644|FG001|COMPLETED|Overall Study||2||
59727817|NCT01154816|75846645|FG002|COMPLETED|Overall Study||0||
59727818|NCT01154816|75846646|FG003|COMPLETED|Overall Study||0||
59727819|NCT01154816|75846647|FG004|COMPLETED|Overall Study||0||
59727820|NCT01154816|75846648|FG005|COMPLETED|Overall Study||0||
59727821|NCT01154816|75846649|FG006|COMPLETED|Overall Study||0||
59727822|NCT01154816|75846650|FG007|COMPLETED|Overall Study||0||
59727823|NCT01154816|75846651|FG008|COMPLETED|Overall Study||1||
59727824|NCT01154816|75846652|FG009|COMPLETED|Overall Study||0||
59727825|NCT01154816|75846653|FG010|COMPLETED|Overall Study||0||
59727826|NCT01154816|75846654|FG011|COMPLETED|Overall Study||0||
59727827|NCT01154816|75846643|FG000|NOT COMPLETED|Overall Study||20||
59727828|NCT01154816|75846644|FG001|NOT COMPLETED|Overall Study||10||
59727829|NCT01154816|75846645|FG002|NOT COMPLETED|Overall Study||10||
59727830|NCT01154816|75846646|FG003|NOT COMPLETED|Overall Study||10||
59727831|NCT01154816|75846647|FG004|NOT COMPLETED|Overall Study||10||
59727832|NCT01154816|75846648|FG005|NOT COMPLETED|Overall Study||8||
59727833|NCT01154816|75846649|FG006|NOT COMPLETED|Overall Study||6||
59727834|NCT01154816|75846650|FG007|NOT COMPLETED|Overall Study||7||
59727835|NCT01154816|75846651|FG008|NOT COMPLETED|Overall Study||9||
59727836|NCT01154816|75846652|FG009|NOT COMPLETED|Overall Study||10||
59727837|NCT01154816|75846653|FG010|NOT COMPLETED|Overall Study||11||
59727838|NCT01154816|75846654|FG011|NOT COMPLETED|Overall Study||4||
59727839|NCT03057808|75846685|FG000|STARTED|Overall Study||144||
59727840|NCT03057808|75846686|FG001|STARTED|Overall Study||142||
59727841|NCT03057808|75846687|FG002|STARTED|Overall Study||144||
59727842|NCT03057808|75846685|FG000|32-36 Weeks Gestation|Overall Study||129||
59727843|NCT03057808|75846686|FG001|32-36 Weeks Gestation|Overall Study||129||
59727844|NCT03057808|75846687|FG002|32-36 Weeks Gestation|Overall Study||120||
59727845|NCT03057808|75846685|FG000|COMPLETED|Overall Study||132||
59727846|NCT03057808|75846686|FG001|COMPLETED|Overall Study||121||
59727847|NCT03057808|75846687|FG002|COMPLETED|Overall Study||127||
59727848|NCT03057808|75846685|FG000|NOT COMPLETED|Overall Study||12||
59727849|NCT03057808|75846686|FG001|NOT COMPLETED|Overall Study||21||
59727850|NCT03057808|75846687|FG002|NOT COMPLETED|Overall Study||17||
59727851|NCT00849901|75846700|FG000|STARTED|Acute Treatment Phase||117||
59727852|NCT00849901|75846701|FG001|STARTED|Acute Treatment Phase||117||
59727853|NCT00849901|75846702|FG002|STARTED|Acute Treatment Phase||103||
59727854|NCT00849901|75846700|FG000|COMPLETED|Acute Treatment Phase|4 didn't enter extension phase.|87||
59727855|NCT00849901|75846701|FG001|COMPLETED|Acute Treatment Phase||91||
59727856|NCT00849901|75846702|FG002|COMPLETED|Acute Treatment Phase|1 didn't enter extension phase.|87||
59727857|NCT00849901|75846700|FG000|NOT COMPLETED|Acute Treatment Phase||30||
59727858|NCT00849901|75846701|FG001|NOT COMPLETED|Acute Treatment Phase||26||
59727859|NCT00849901|75846702|FG002|NOT COMPLETED|Acute Treatment Phase||16||
59727860|NCT00849901|75846700|FG000|STARTED|Extension Phase||83||
59727861|NCT00849901|75846701|FG001|STARTED|Extension Phase||91||
59727862|NCT00849901|75846702|FG002|STARTED|Extension Phase||86||
59727863|NCT00849901|75846700|FG000|COMPLETED|Extension Phase||56||
59727864|NCT00849901|75846701|FG001|COMPLETED|Extension Phase||65||
59727865|NCT00849901|75846702|FG002|COMPLETED|Extension Phase||69||
59727866|NCT00849901|75846700|FG000|NOT COMPLETED|Extension Phase||27||
59727867|NCT00849901|75846701|FG001|NOT COMPLETED|Extension Phase||26||
59727868|NCT00849901|75846702|FG002|NOT COMPLETED|Extension Phase||17||
59727869|NCT01168232|75846716|FG000|STARTED|Overall Study||42||
59727870|NCT01168232|75846716|FG000|COMPLETED|Overall Study|Eligible and treated patients|34||
59727871|NCT01168232|75846716|FG000|NOT COMPLETED|Overall Study||8||
59727872|NCT00817531|75846720|FG000|STARTED|Overall Study|22 patients were eligible for this study and started the treatment.|22||
59727873|NCT00817531|75846720|FG000|COMPLETED|Overall Study|20 out of 22 patients finished study treatment. 2 patients stopped the treatment after the 1st week.|20||
59727874|NCT00817531|75846720|FG000|NOT COMPLETED|Overall Study||2||
59727875|NCT00817063|75846726|FG000|STARTED|Overall Study||298||
59727876|NCT00817063|75846727|FG001|STARTED|Overall Study||298||
59727877|NCT00817063|75846726|FG000|COMPLETED|Overall Study||161||
59727878|NCT00817063|75846727|FG001|COMPLETED|Overall Study||128||
59727879|NCT00817063|75846726|FG000|NOT COMPLETED|Overall Study||137||
59727880|NCT00817063|75846727|FG001|NOT COMPLETED|Overall Study||170||
59727881|NCT01166750|75846735|FG000|STARTED|Overall Study||10||
59727882|NCT01166750|75846736|FG001|STARTED|Overall Study||13||
59727883|NCT01166750|75846735|FG000|COMPLETED|Overall Study||9||
59727884|NCT01166750|75846736|FG001|COMPLETED|Overall Study||13||
59727885|NCT01166750|75846735|FG000|NOT COMPLETED|Overall Study||1||
59727886|NCT01166750|75846736|FG001|NOT COMPLETED|Overall Study||0||
59727887|NCT00826267|75846745|FG000|STARTED|Overall Study||10||
59727888|NCT00826267|75846746|FG001|STARTED|Overall Study||8||
59727889|NCT00826267|75846747|FG002|STARTED|Overall Study||11||
59727890|NCT00826267|75846745|FG000|COMPLETED|Overall Study||9||
59727891|NCT00826267|75846746|FG001|COMPLETED|Overall Study||8||
59727892|NCT00826267|75846747|FG002|COMPLETED|Overall Study||11||
59727893|NCT00826267|75846745|FG000|NOT COMPLETED|Overall Study||1||
59727894|NCT00826267|75846746|FG001|NOT COMPLETED|Overall Study||0||
59727895|NCT00826267|75846747|FG002|NOT COMPLETED|Overall Study||0||
59727896|NCT00986154|75846758|FG000|STARTED|Overall Study||4143||
59727897|NCT00986154|75846759|FG001|STARTED|Overall Study||4149||
59727898|NCT00986154|75846758|FG000|Safety Analysis Set (Received Drug)|Overall Study||4118||
59727899|NCT00986154|75846759|FG001|Safety Analysis Set (Received Drug)|Overall Study||4122||
59727900|NCT00986154|75846758|FG000|COMPLETED|Overall Study||3937||
59727901|NCT00986154|75846759|FG001|COMPLETED|Overall Study||3955||
59727902|NCT00986154|75846758|FG000|NOT COMPLETED|Overall Study||206||
59727903|NCT00986154|75846759|FG001|NOT COMPLETED|Overall Study||194||
59727904|NCT00848965|75846765|FG000|STARTED|Overall Study||59||
59727905|NCT00848965|75846765|FG000|COMPLETED|Overall Study||57||
59727906|NCT00848965|75846765|FG000|NOT COMPLETED|Overall Study||2||
59727907|NCT04274556|75846777|FG000|STARTED|Overall Study||86||
59727908|NCT04274556|75846777|FG000|COMPLETED|Overall Study||86||
59727909|NCT04274556|75846777|FG000|NOT COMPLETED|Overall Study||0||
59727910|NCT01154036|75846784|FG000|STARTED|Phase I||120||
59727911|NCT01154036|75846785|FG001|STARTED|Phase I||483||
59727912|NCT01154036|75846786|FG002|STARTED|Phase I||944||
59727913|NCT01154036|75846787|FG003|STARTED|Phase I||0||
59727914|NCT01154036|75846788|FG004|STARTED|Phase I||0||
59727915|NCT01154036|75846789|FG005|STARTED|Phase I||0||
59727916|NCT01154036|75846790|FG006|STARTED|Phase I||0||
59727917|NCT01154036|75846791|FG007|STARTED|Phase I||0||
59727918|NCT01154036|75846784|FG000|COMPLETED|Phase I|Not all completers were eligible for Phase II|117||
59727919|NCT01154036|75846785|FG001|COMPLETED|Phase I|Not all completers were eligible for Phase II|455||
59727920|NCT01154036|75846786|FG002|COMPLETED|Phase I|Not all completers were eligible for Phase II|888||
59727921|NCT01154036|75846787|FG003|COMPLETED|Phase I||0||
59727922|NCT01154036|75846788|FG004|COMPLETED|Phase I||0||
59727923|NCT01154036|75846789|FG005|COMPLETED|Phase I||0||
59727924|NCT01154036|75846790|FG006|COMPLETED|Phase I||0||
60123878|NCT01510769|76245250|FG001|STARTED|Overall Study||109||
59727925|NCT01154036|75846791|FG007|COMPLETED|Phase I||0||
59727926|NCT01154036|75846784|FG000|NOT COMPLETED|Phase I||3||
59727927|NCT01154036|75846785|FG001|NOT COMPLETED|Phase I||28||
59727928|NCT01154036|75846786|FG002|NOT COMPLETED|Phase I||56||
59727929|NCT01154036|75846787|FG003|NOT COMPLETED|Phase I||0||
59727930|NCT01154036|75846788|FG004|NOT COMPLETED|Phase I||0||
59727931|NCT01154036|75846789|FG005|NOT COMPLETED|Phase I||0||
59727932|NCT01154036|75846790|FG006|NOT COMPLETED|Phase I||0||
59727933|NCT01154036|75846791|FG007|NOT COMPLETED|Phase I||0||
59727934|NCT01154036|75846784|FG000|STARTED|Phase II||0||
59727935|NCT01154036|75846785|FG001|STARTED|Phase II||0||
59727936|NCT01154036|75846786|FG002|STARTED|Phase II||0||
59727937|NCT01154036|75846787|FG003|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|28||
59727938|NCT01154036|75846788|FG004|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|124||
59727939|NCT01154036|75846789|FG005|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|126||
59727940|NCT01154036|75846790|FG006|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|234||
59727941|NCT01154036|75846791|FG007|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|206||
59727942|NCT01154036|75846784|FG000|COMPLETED|Phase II||0||
59727943|NCT01154036|75846785|FG001|COMPLETED|Phase II||0||
59727944|NCT01154036|75846786|FG002|COMPLETED|Phase II||0||
59727945|NCT01154036|75846787|FG003|COMPLETED|Phase II||27||
59727946|NCT01154036|75846788|FG004|COMPLETED|Phase II||116||
59727947|NCT01154036|75846789|FG005|COMPLETED|Phase II||121||
59727948|NCT01154036|75846790|FG006|COMPLETED|Phase II||225||
59727949|NCT01154036|75846791|FG007|COMPLETED|Phase II||200||
59727950|NCT01154036|75846784|FG000|NOT COMPLETED|Phase II||0||
59727951|NCT01154036|75846785|FG001|NOT COMPLETED|Phase II||0||
59727952|NCT01154036|75846786|FG002|NOT COMPLETED|Phase II||0||
59727953|NCT01154036|75846787|FG003|NOT COMPLETED|Phase II||1||
59727954|NCT01154036|75846788|FG004|NOT COMPLETED|Phase II||8||
59727955|NCT01154036|75846789|FG005|NOT COMPLETED|Phase II||5||
59727956|NCT01154036|75846790|FG006|NOT COMPLETED|Phase II||9||
59727957|NCT01154036|75846791|FG007|NOT COMPLETED|Phase II||6||
59727958|NCT00816595|75846813|FG000|STARTED|Overall Study||35||
59727959|NCT00816595|75846814|FG001|STARTED|Overall Study||33||
59727960|NCT00816595|75846813|FG000|COMPLETED|Overall Study||33||
59727961|NCT00816595|75846814|FG001|COMPLETED|Overall Study||33||
59727962|NCT00816595|75846813|FG000|NOT COMPLETED|Overall Study||2||
59727963|NCT00816595|75846814|FG001|NOT COMPLETED|Overall Study||0||
59727964|NCT01166438|75846824|FG000|STARTED|Double-blind Phase: 1st 6 Months||122||
59727965|NCT01166438|75846825|FG001|STARTED|Double-blind Phase: 1st 6 Months||127||
59727966|NCT01166438|75846824|FG000|Treated|Double-blind Phase: 1st 6 Months||121||
59727967|NCT01166438|75846825|FG001|Treated|Double-blind Phase: 1st 6 Months||126||
59727968|NCT01166438|75846824|FG000|COMPLETED|Double-blind Phase: 1st 6 Months|Completion of 12 month follow-up visit|113||
59727969|NCT01166438|75846825|FG001|COMPLETED|Double-blind Phase: 1st 6 Months|Completion of 12 month follow-up visit|118||
59727970|NCT01166438|75846824|FG000|NOT COMPLETED|Double-blind Phase: 1st 6 Months||9||
59727971|NCT01166438|75846825|FG001|NOT COMPLETED|Double-blind Phase: 1st 6 Months||9||
59727972|NCT01166438|75846824|FG000|STARTED|Off Treatment Follow-up Phase||85||
59727973|NCT01166438|75846825|FG001|STARTED|Off Treatment Follow-up Phase||89||
59727974|NCT01166438|75846824|FG000|COMPLETED|Off Treatment Follow-up Phase||51||
59727975|NCT01166438|75846825|FG001|COMPLETED|Off Treatment Follow-up Phase||33||
59727976|NCT01166438|75846824|FG000|NOT COMPLETED|Off Treatment Follow-up Phase||34||
59727977|NCT01166438|75846825|FG001|NOT COMPLETED|Off Treatment Follow-up Phase||56||
59727978|NCT01153958|75846834|FG000|STARTED|Overall Study||66||
59727979|NCT01153958|75846835|FG001|STARTED|Overall Study||67||
59727980|NCT01153958|75846834|FG000|COMPLETED|Overall Study||30||
59727981|NCT01153958|75846835|FG001|COMPLETED|Overall Study||35||
59727982|NCT01153958|75846834|FG000|NOT COMPLETED|Overall Study||36||
59727983|NCT01153958|75846835|FG001|NOT COMPLETED|Overall Study||32||
59727984|NCT00599638|75846845|FG000|STARTED|First Intervention Period (2 Weeks)||16||
59727985|NCT00599638|75846846|FG001|STARTED|First Intervention Period (2 Weeks)||14||
59727986|NCT00599638|75846847|FG002|STARTED|First Intervention Period (2 Weeks)||20||
59727987|NCT00599638|75846848|FG003|STARTED|First Intervention Period (2 Weeks)||22||
59727988|NCT00599638|75846845|FG000|Treated|First Intervention Period (2 Weeks)||16||
59727989|NCT00599638|75846846|FG001|Treated|First Intervention Period (2 Weeks)||13||
59727990|NCT00599638|75846847|FG002|Treated|First Intervention Period (2 Weeks)||20||
59727991|NCT00599638|75846848|FG003|Treated|First Intervention Period (2 Weeks)||21||
59727992|NCT00599638|75846845|FG000|COMPLETED|First Intervention Period (2 Weeks)||14||
59727993|NCT00599638|75846846|FG001|COMPLETED|First Intervention Period (2 Weeks)||12||
59727994|NCT00599638|75846847|FG002|COMPLETED|First Intervention Period (2 Weeks)||17||
59727995|NCT00599638|75846848|FG003|COMPLETED|First Intervention Period (2 Weeks)||17||
59727996|NCT00599638|75846845|FG000|NOT COMPLETED|First Intervention Period (2 Weeks)||2||
59727997|NCT00599638|75846846|FG001|NOT COMPLETED|First Intervention Period (2 Weeks)||2||
59727998|NCT00599638|75846847|FG002|NOT COMPLETED|First Intervention Period (2 Weeks)||3||
59727999|NCT00599638|75846848|FG003|NOT COMPLETED|First Intervention Period (2 Weeks)||5||
59728000|NCT00599638|75846845|FG000|STARTED|Washout Period (2 Weeks)||14||
59728001|NCT00599638|75846846|FG001|STARTED|Washout Period (2 Weeks)||12||
59728002|NCT00599638|75846847|FG002|STARTED|Washout Period (2 Weeks)||17||
59728003|NCT00599638|75846848|FG003|STARTED|Washout Period (2 Weeks)||17||
59728004|NCT00599638|75846845|FG000|COMPLETED|Washout Period (2 Weeks)||13||
59728005|NCT00599638|75846846|FG001|COMPLETED|Washout Period (2 Weeks)||11||
59728006|NCT00599638|75846847|FG002|COMPLETED|Washout Period (2 Weeks)||17||
59728007|NCT00599638|75846848|FG003|COMPLETED|Washout Period (2 Weeks)||14||
59728008|NCT00599638|75846845|FG000|NOT COMPLETED|Washout Period (2 Weeks)||1||
59858168|NCT00304031|75983061|FG001|Unmethylated MGMT Population|Randomization to Adjuvant TMZ Arm||254|Eligible participants determined to have unmethylated MGMT.|
59728009|NCT00599638|75846846|FG001|NOT COMPLETED|Washout Period (2 Weeks)||1||
59728010|NCT00599638|75846847|FG002|NOT COMPLETED|Washout Period (2 Weeks)||0||
59728011|NCT00599638|75846848|FG003|NOT COMPLETED|Washout Period (2 Weeks)||3||
59728012|NCT00599638|75846845|FG000|STARTED|Second Intervention Period (2 Weeks)||13||
59728013|NCT00599638|75846846|FG001|STARTED|Second Intervention Period (2 Weeks)||11||
59728014|NCT00599638|75846847|FG002|STARTED|Second Intervention Period (2 Weeks)||17||
59728015|NCT00599638|75846848|FG003|STARTED|Second Intervention Period (2 Weeks)||14||
59728016|NCT00599638|75846845|FG000|COMPLETED|Second Intervention Period (2 Weeks)||12||
59728017|NCT00599638|75846846|FG001|COMPLETED|Second Intervention Period (2 Weeks)||11||
59728018|NCT00599638|75846847|FG002|COMPLETED|Second Intervention Period (2 Weeks)||17||
59728019|NCT00599638|75846848|FG003|COMPLETED|Second Intervention Period (2 Weeks)||14||
59728020|NCT00599638|75846845|FG000|NOT COMPLETED|Second Intervention Period (2 Weeks)||1||
59728021|NCT00599638|75846846|FG001|NOT COMPLETED|Second Intervention Period (2 Weeks)||0||
59728022|NCT00599638|75846847|FG002|NOT COMPLETED|Second Intervention Period (2 Weeks)||0||
59728023|NCT00599638|75846848|FG003|NOT COMPLETED|Second Intervention Period (2 Weeks)||0||
59728024|NCT01166282|75846858|FG000|STARTED|Double-blind Period||15||
59728025|NCT01166282|75846859|FG001|STARTED|Double-blind Period||31||
59728026|NCT01166282|75846860|FG002|STARTED|Double-blind Period||0||
59728027|NCT01166282|75846858|FG000|COMPLETED|Double-blind Period||15||
59728028|NCT01166282|75846859|FG001|COMPLETED|Double-blind Period||31||
59728029|NCT01166282|75846860|FG002|COMPLETED|Double-blind Period||0||
59728030|NCT01166282|75846858|FG000|NOT COMPLETED|Double-blind Period||0||
59728031|NCT01166282|75846859|FG001|NOT COMPLETED|Double-blind Period||0||
59728032|NCT01166282|75846860|FG002|NOT COMPLETED|Double-blind Period||0||
59728033|NCT01166282|75846858|FG000|STARTED|Open-label Period||0||
59728034|NCT01166282|75846859|FG001|STARTED|Open-label Period||0||
59728035|NCT01166282|75846860|FG002|STARTED|Open-label Period||46||
59728036|NCT01166282|75846858|FG000|COMPLETED|Open-label Period||0||
59728037|NCT01166282|75846859|FG001|COMPLETED|Open-label Period||0||
59728038|NCT01166282|75846860|FG002|COMPLETED|Open-label Period||29||
59728039|NCT01166282|75846858|FG000|NOT COMPLETED|Open-label Period||0||
59728040|NCT01166282|75846859|FG001|NOT COMPLETED|Open-label Period||0||
59728041|NCT01166282|75846860|FG002|NOT COMPLETED|Open-label Period||17||
59728042|NCT01153724|75846868|FG000|STARTED|Treatment Period 1||35||
59728043|NCT01153724|75846868|FG000|COMPLETED|Treatment Period 1||34||
59728044|NCT01153724|75846868|FG000|NOT COMPLETED|Treatment Period 1||1||
59728045|NCT01153724|75846868|FG000|STARTED|Treatment Period 2||34||
59728046|NCT01153724|75846868|FG000|COMPLETED|Treatment Period 2||32||
59728047|NCT01153724|75846868|FG000|NOT COMPLETED|Treatment Period 2||2||
59728048|NCT01152788|75846876|FG000|STARTED|Overall Study||32||
59728049|NCT01152788|75846877|FG001|STARTED|Overall Study||32||
59728050|NCT01152788|75846876|FG000|COMPLETED|Overall Study||32||
59728051|NCT01152788|75846877|FG001|COMPLETED|Overall Study||28||
59728052|NCT01152788|75846876|FG000|NOT COMPLETED|Overall Study||0||
59728053|NCT01152788|75846877|FG001|NOT COMPLETED|Overall Study||4||
59728054|NCT01165424|75846883|FG000|STARTED|Overall Study||80||
59728055|NCT01165424|75846883|FG000|COMPLETED|Overall Study||76||
59728056|NCT01165424|75846883|FG000|NOT COMPLETED|Overall Study||4||
59728057|NCT01152554|75846889|FG000|STARTED|Overall Study||610||
59728058|NCT01152554|75846890|FG001|STARTED|Overall Study||203||
59728059|NCT01152554|75846889|FG000|Received Treatment|Overall Study||607||
59728060|NCT01152554|75846890|FG001|Received Treatment|Overall Study||201||
59728061|NCT01152554|75846889|FG000|COMPLETED|Overall Study||276||
59728062|NCT01152554|75846890|FG001|COMPLETED|Overall Study||92||
59728063|NCT01152554|75846889|FG000|NOT COMPLETED|Overall Study||334||
59728064|NCT01152554|75846890|FG001|NOT COMPLETED|Overall Study||111||
59728065|NCT00598702|75846904|FG000|STARTED|Overall Study||1||
59728066|NCT00598702|75846905|FG001|STARTED|Overall Study||3||
59728067|NCT00598702|75846906|FG002|STARTED|Overall Study||7||
59728068|NCT00598702|75846907|FG003|STARTED|Overall Study||33||
59728069|NCT00598702|75846908|FG004|STARTED|Overall Study||9||
59728070|NCT00598702|75846909|FG005|STARTED|Overall Study||42||
59728071|NCT00598702|75846910|FG006|STARTED|Overall Study||1||
59728072|NCT00598702|75846911|FG007|STARTED|Overall Study||4||
59728073|NCT00598702|75846904|FG000|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|1||
59728074|NCT00598702|75846905|FG001|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|1||
59728075|NCT00598702|75846906|FG002|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|5||
59728076|NCT00598702|75846907|FG003|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|25||
59728077|NCT00598702|75846908|FG004|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|6||
59728078|NCT00598702|75846909|FG005|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|30||
59728079|NCT00598702|75846910|FG006|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|0||
59728080|NCT00598702|75846911|FG007|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|4||
59728081|NCT00598702|75846904|FG000|NOT COMPLETED|Overall Study||0||
59728082|NCT00598702|75846905|FG001|NOT COMPLETED|Overall Study||2||
59728083|NCT00598702|75846906|FG002|NOT COMPLETED|Overall Study||2||
59728084|NCT00598702|75846907|FG003|NOT COMPLETED|Overall Study||8||
59728085|NCT00598702|75846908|FG004|NOT COMPLETED|Overall Study||3||
59728086|NCT00598702|75846909|FG005|NOT COMPLETED|Overall Study||12||
59728087|NCT00598702|75846910|FG006|NOT COMPLETED|Overall Study||1||
59728088|NCT00598702|75846911|FG007|NOT COMPLETED|Overall Study||0||
59728089|NCT01148810|75846931|FG000|STARTED|Overall Study||8||
59728090|NCT01148810|75846932|FG001|STARTED|Overall Study||10||
59728091|NCT01148810|75846931|FG000|COMPLETED|Overall Study||7||
59728092|NCT01148810|75846932|FG001|COMPLETED|Overall Study||5||
59728093|NCT01148810|75846931|FG000|NOT COMPLETED|Overall Study||1||
59728094|NCT01148810|75846932|FG001|NOT COMPLETED|Overall Study||5||
59728095|NCT01151618|75846939|FG000|STARTED|Overall Study||22||
59728096|NCT01151618|75846939|FG000|COMPLETED|Overall Study||13||
59728097|NCT01151618|75846939|FG000|NOT COMPLETED|Overall Study||9||
59728098|NCT01164956|75846943|FG000|STARTED|Overall Study||1||
59728099|NCT01164956|75846944|FG001|STARTED|Overall Study||1||
59728100|NCT01164956|75846945|FG002|STARTED|Overall Study||1||
59728101|NCT01164956|75846943|FG000|Evaluable for pedsFACIT-F Score Change|Overall Study||0||
59728102|NCT01164956|75846944|FG001|Evaluable for pedsFACIT-F Score Change|Overall Study||1||
59728103|NCT01164956|75846945|FG002|Evaluable for pedsFACIT-F Score Change|Overall Study||0||
59728104|NCT01164956|75846943|FG000|COMPLETED|Overall Study||0||
59728105|NCT01164956|75846944|FG001|COMPLETED|Overall Study||1||
59728106|NCT01164956|75846945|FG002|COMPLETED|Overall Study||0||
59728107|NCT01164956|75846943|FG000|NOT COMPLETED|Overall Study||1||
59728108|NCT01164956|75846944|FG001|NOT COMPLETED|Overall Study||0||
59728109|NCT01164956|75846945|FG002|NOT COMPLETED|Overall Study||1||
59728110|NCT01164722|75846955|FG000|STARTED|Overall Study||60||
59728111|NCT01164722|75846956|FG001|STARTED|Overall Study||60||
59728112|NCT01164722|75846955|FG000|COMPLETED|Overall Study||42||
59728113|NCT01164722|75846956|FG001|COMPLETED|Overall Study||45||
59728114|NCT01164722|75846955|FG000|NOT COMPLETED|Overall Study||18||
59728115|NCT01164722|75846956|FG001|NOT COMPLETED|Overall Study||15||
59728116|NCT01151540|75846962|FG000|STARTED|Overall Study||54||
59728117|NCT01151540|75846962|FG000|COMPLETED|Overall Study||41||
59728118|NCT01151540|75846962|FG000|NOT COMPLETED|Overall Study||13||
59728119|NCT01163786|75846966|FG000|STARTED|Treatment With Bortezomib||17||
59728120|NCT01163786|75846966|FG000|Completed 1st Cycle|Treatment With Bortezomib||17||
59728121|NCT01163786|75846966|FG000|Completed 2nd Cycle|Treatment With Bortezomib|One patient completed cycle 2 but missed one dose of Bortezomib.|14||
59728122|NCT01163786|75846966|FG000|COMPLETED|Treatment With Bortezomib||14||
59728123|NCT01163786|75846966|FG000|NOT COMPLETED|Treatment With Bortezomib||3||
59728124|NCT01163786|75846966|FG000|STARTED|Completed Follow up (Visit 9 and 10)||14||
59728125|NCT01163786|75846966|FG000|Completed Week 12 Follow up (Visit 9)|Completed Follow up (Visit 9 and 10)||14||
59728126|NCT01163786|75846966|FG000|Completed Week 18 Follow up (Visit 10)|Completed Follow up (Visit 9 and 10)||13||
59728127|NCT01163786|75846966|FG000|COMPLETED|Completed Follow up (Visit 9 and 10)||13||
59728128|NCT01163786|75846966|FG000|NOT COMPLETED|Completed Follow up (Visit 9 and 10)||1||
59728129|NCT00984282|75846972|FG000|STARTED|Double Blind Treatment||207||
59728130|NCT00984282|75846973|FG001|STARTED|Double Blind Treatment||210||
59728131|NCT00984282|75846972|FG000|Received Treatment|Double Blind Treatment|Subjects at Risk/Safety Population - in RG1 (RG= Reporting Group for Safety Data)|207||
59728132|NCT00984282|75846973|FG001|Received Treatment|Double Blind Treatment|Subjects at Risk/Safety Population - in RG2 (RG= Reporting Group for Safety Data)|209||
59728133|NCT00984282|75846972|FG000|COMPLETED|Double Blind Treatment||103||
59728134|NCT00984282|75846973|FG001|COMPLETED|Double Blind Treatment||172||
59728135|NCT00984282|75846972|FG000|NOT COMPLETED|Double Blind Treatment||104||
59728136|NCT00984282|75846973|FG001|NOT COMPLETED|Double Blind Treatment||38||
59728137|NCT00984282|75846972|FG000|STARTED|Open-label Treatment||86||
59728138|NCT00984282|75846973|FG001|STARTED|Open-label Treatment||161||
59728139|NCT00984282|75846972|FG000|Received Treatment|Open-label Treatment|Subjects at Risk/Safety Population - in RG3 (RG= Reporting Group for Safety Data)|86||
59728140|NCT00984282|75846973|FG001|Received Treatment|Open-label Treatment|Subjects at Risk/Safety Population - in RG4 (RG= Reporting Group for Safety Data)|161||
59728141|NCT00984282|75846972|FG000|COMPLETED|Open-label Treatment||0||
59728142|NCT00984282|75846973|FG001|COMPLETED|Open-label Treatment||0||
59728143|NCT00984282|75846972|FG000|NOT COMPLETED|Open-label Treatment||86||
59728144|NCT00984282|75846973|FG001|NOT COMPLETED|Open-label Treatment||161||
59728145|NCT00984282|75846972|FG000|STARTED|Long Term Follow-up|Participants entered long-term follow-up if terminated double-blind or open-label periods|72||
59728146|NCT00984282|75846973|FG001|STARTED|Long Term Follow-up|Participants entered long-term follow-up if terminated double-blind or open-label periods|124||
59728147|NCT00984282|75846972|FG000|COMPLETED|Long Term Follow-up||3||
59728148|NCT00984282|75846973|FG001|COMPLETED|Long Term Follow-up||4||
59728149|NCT00984282|75846972|FG000|NOT COMPLETED|Long Term Follow-up||69||
59728150|NCT00984282|75846973|FG001|NOT COMPLETED|Long Term Follow-up||120||
59728151|NCT01147874|75846981|FG000|STARTED|Overall Study||1013||
59728152|NCT01147874|75846981|FG000|COMPLETED|Overall Study||946||
59728153|NCT01147874|75846981|FG000|NOT COMPLETED|Overall Study||67||
59728154|NCT01147640|75846987|FG000|STARTED|Overall Study||83||
59728155|NCT01147640|75846988|FG001|STARTED|Overall Study||39||
59728156|NCT01147640|75846987|FG000|COMPLETED|Overall Study||78||
59728157|NCT01147640|75846988|FG001|COMPLETED|Overall Study||38||
59728158|NCT01147640|75846987|FG000|NOT COMPLETED|Overall Study||5||
59728159|NCT01147640|75846988|FG001|NOT COMPLETED|Overall Study||1||
59728160|NCT01121900|75846994|FG000|STARTED|First Intervention Period||13||
59728161|NCT01121900|75846995|FG001|STARTED|First Intervention Period||13||
59728162|NCT01121900|75846994|FG000|COMPLETED|First Intervention Period||12||
59728163|NCT01121900|75846995|FG001|COMPLETED|First Intervention Period||12||
59728164|NCT01121900|75846994|FG000|NOT COMPLETED|First Intervention Period||1||
59728165|NCT01121900|75846995|FG001|NOT COMPLETED|First Intervention Period||1||
59728166|NCT01121900|75846994|FG000|STARTED|Washout Period of 7 Days||12||
59728167|NCT01121900|75846995|FG001|STARTED|Washout Period of 7 Days||12||
59594726|NCT03160027|75703676|FG000|STARTED|Overall Study||6||
59594727|NCT03160027|75703677|FG001|STARTED|Overall Study||4||
59594728|NCT03160027|75703678|FG002|STARTED|Overall Study||6||
59594729|NCT03160027|75703679|FG003|STARTED|Overall Study||4||
59594730|NCT03160027|75703676|FG000|COMPLETED|Overall Study||6||
59728168|NCT01121900|75846994|FG000|COMPLETED|Washout Period of 7 Days||12||
59728169|NCT01121900|75846995|FG001|COMPLETED|Washout Period of 7 Days||11||
59728170|NCT01121900|75846994|FG000|NOT COMPLETED|Washout Period of 7 Days||0||
59728171|NCT01121900|75846995|FG001|NOT COMPLETED|Washout Period of 7 Days||1||
59728172|NCT01121900|75846994|FG000|STARTED|Second Intervention Period||12||
59594731|NCT03160027|75703677|FG001|COMPLETED|Overall Study||4||
59594732|NCT03160027|75703678|FG002|COMPLETED|Overall Study||6||
59728173|NCT01121900|75846995|FG001|STARTED|Second Intervention Period||11||
59728174|NCT01121900|75846994|FG000|COMPLETED|Second Intervention Period||12||
59594733|NCT03160027|75703679|FG003|COMPLETED|Overall Study||4||
59594734|NCT03160027|75703676|FG000|NOT COMPLETED|Overall Study||0||
59728175|NCT01121900|75846995|FG001|COMPLETED|Second Intervention Period||11||
59728176|NCT01121900|75846994|FG000|NOT COMPLETED|Second Intervention Period||0||
59728177|NCT01121900|75846995|FG001|NOT COMPLETED|Second Intervention Period||0||
59728178|NCT01121666|75847003|FG000|STARTED|Overall Study||249||
59728179|NCT01121666|75847004|FG001|STARTED|Overall Study||123||
59728180|NCT01121666|75847003|FG000|COMPLETED|Overall Study||220||
59728181|NCT01121666|75847004|FG001|COMPLETED|Overall Study||113||
59728182|NCT01121666|75847003|FG000|NOT COMPLETED|Overall Study||29||
59728183|NCT01121666|75847004|FG001|NOT COMPLETED|Overall Study||10||
59728184|NCT00984126|75847014|FG000|STARTED|Overall Study||27||
59728185|NCT00984126|75847015|FG001|STARTED|Overall Study||28||
59728186|NCT00984126|75847016|FG002|STARTED|Overall Study||23||
59728187|NCT00984126|75847017|FG003|STARTED|Overall Study||135||
59728188|NCT00984126|75847014|FG000|COMPLETED|Overall Study||20||
59728189|NCT00984126|75847015|FG001|COMPLETED|Overall Study||20||
59728190|NCT00984126|75847016|FG002|COMPLETED|Overall Study||16||
59728191|NCT00984126|75847017|FG003|COMPLETED|Overall Study||76||
59728192|NCT00984126|75847014|FG000|NOT COMPLETED|Overall Study||7||
59728193|NCT00984126|75847015|FG001|NOT COMPLETED|Overall Study||8||
59728194|NCT00984126|75847016|FG002|NOT COMPLETED|Overall Study||7||
59728195|NCT00984126|75847017|FG003|NOT COMPLETED|Overall Study||59||
59728196|NCT00979602|75847038|FG000|STARTED|Overall Study||2025||
59728197|NCT00979602|75847039|FG001|STARTED|Overall Study||2023||
59728198|NCT00979602|75847038|FG000|COMPLETED|Overall Study||1880||
59728199|NCT00979602|75847039|FG001|COMPLETED|Overall Study||1890||
59728200|NCT00979602|75847038|FG000|NOT COMPLETED|Overall Study||145||
59728201|NCT00979602|75847039|FG001|NOT COMPLETED|Overall Study||133||
59728202|NCT00816361|75847064|FG000|STARTED|Overall Study||4||
59728203|NCT00816361|75847065|FG001|STARTED|Overall Study||3||
59728204|NCT00816361|75847066|FG002|STARTED|Overall Study||4||
59728205|NCT00816361|75847067|FG003|STARTED|Overall Study||3||
59728206|NCT00816361|75847068|FG004|STARTED|Overall Study||3||
60123879|NCT01510769|76245251|FG002|STARTED|Overall Study||109||
60123880|NCT01510769|76245249|FG000|COMPLETED|Overall Study||79||
60123881|NCT01510769|76245250|FG001|COMPLETED|Overall Study||84||
60123882|NCT01510769|76245251|FG002|COMPLETED|Overall Study||87||
60123883|NCT01510769|76245249|FG000|NOT COMPLETED|Overall Study||27||
60123884|NCT01510769|76245250|FG001|NOT COMPLETED|Overall Study||25||
59728207|NCT00816361|75847069|FG005|STARTED|Overall Study||3||
59728208|NCT00816361|75847070|FG006|STARTED|Overall Study||3||
59728209|NCT00816361|75847071|FG007|STARTED|Overall Study||10||
59728210|NCT00816361|75847072|FG008|STARTED|Overall Study||10||
59728211|NCT00816361|75847064|FG000|COMPLETED|Overall Study||0||
59728212|NCT00816361|75847065|FG001|COMPLETED|Overall Study||0||
59728213|NCT00816361|75847066|FG002|COMPLETED|Overall Study||1||
59728214|NCT00816361|75847067|FG003|COMPLETED|Overall Study||0||
59728215|NCT00816361|75847068|FG004|COMPLETED|Overall Study||1||
59728216|NCT00816361|75847069|FG005|COMPLETED|Overall Study||0||
59728217|NCT00816361|75847070|FG006|COMPLETED|Overall Study||0||
59728218|NCT00816361|75847071|FG007|COMPLETED|Overall Study||1||
59728219|NCT00816361|75847072|FG008|COMPLETED|Overall Study||0||
59728220|NCT00816361|75847064|FG000|NOT COMPLETED|Overall Study||4||
59728221|NCT00816361|75847065|FG001|NOT COMPLETED|Overall Study||3||
59728222|NCT00816361|75847066|FG002|NOT COMPLETED|Overall Study||3||
59728223|NCT00816361|75847067|FG003|NOT COMPLETED|Overall Study||3||
59728224|NCT00816361|75847068|FG004|NOT COMPLETED|Overall Study||2||
59728225|NCT00816361|75847069|FG005|NOT COMPLETED|Overall Study||3||
59728226|NCT00816361|75847070|FG006|NOT COMPLETED|Overall Study||3||
59728227|NCT00816361|75847071|FG007|NOT COMPLETED|Overall Study||9||
60123885|NCT01510769|76245251|FG002|NOT COMPLETED|Overall Study||22||
60123886|NCT01575769|76245259|FG000|STARTED|Overall Study||41||
59728228|NCT00816361|75847072|FG008|NOT COMPLETED|Overall Study||10||
60123887|NCT01575769|76245259|FG000|COMPLETED|Overall Study||0||
60123888|NCT01575769|76245259|FG000|NOT COMPLETED|Overall Study||41||
59594735|NCT03160027|75703677|FG001|NOT COMPLETED|Overall Study||0||
59594736|NCT03160027|75703678|FG002|NOT COMPLETED|Overall Study||0||
59728229|NCT00826111|75847095|FG000|STARTED|Overall Study||14||
59728230|NCT00826111|75847096|FG001|STARTED|Overall Study||5||
59728231|NCT00826111|75847095|FG000|COMPLETED|Overall Study||7||
59728232|NCT00826111|75847096|FG001|COMPLETED|Overall Study||3||
59728233|NCT00826111|75847095|FG000|NOT COMPLETED|Overall Study||7||
59728234|NCT00826111|75847096|FG001|NOT COMPLETED|Overall Study||2||
59728235|NCT00982644|75847107|FG000|STARTED|Main: Week 0 to 52 (NN1250-3579)||773||
59728236|NCT00982644|75847108|FG001|STARTED|Main: Week 0 to 52 (NN1250-3579)||257||
59728237|NCT00982644|75847107|FG000|Full Analysis Set|Main: Week 0 to 52 (NN1250-3579)||773||
59728238|NCT00982644|75847108|FG001|Full Analysis Set|Main: Week 0 to 52 (NN1250-3579)||257||
59728239|NCT00982644|75847107|FG000|Exposed|Main: Week 0 to 52 (NN1250-3579)|7 subjects were withdrawn prior to exposure to trial products|766||
60123889|NCT01510145|76245265|FG000|STARTED|Overall Study||191||
60123890|NCT01510145|76245265|FG000|COMPLETED|Overall Study||173||
59728240|NCT00982644|75847108|FG001|Exposed|Main: Week 0 to 52 (NN1250-3579)||257||
60123891|NCT01510145|76245265|FG000|NOT COMPLETED|Overall Study||18||
60123892|NCT01528033|76245271|FG000|STARTED|Primary Endpoint Assessment ITT||273||
59728241|NCT00982644|75847107|FG000|COMPLETED|Main: Week 0 to 52 (NN1250-3579)||607||
59728242|NCT00982644|75847108|FG001|COMPLETED|Main: Week 0 to 52 (NN1250-3579)||197||
59728243|NCT00982644|75847107|FG000|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3579)||166||
59728244|NCT00982644|75847108|FG001|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3579)||60||
59728245|NCT00982644|75847107|FG000|STARTED|Extension: Week 53 to 104 (NN1250-3643)|Fifty-six subjects did not continue into extension trial|551||
59728246|NCT00982644|75847108|FG001|STARTED|Extension: Week 53 to 104 (NN1250-3643)|Twenty-three subjects did not continue into extension trial|174||
59728247|NCT00982644|75847107|FG000|COMPLETED|Extension: Week 53 to 104 (NN1250-3643)||505||
59728248|NCT00982644|75847108|FG001|COMPLETED|Extension: Week 53 to 104 (NN1250-3643)||154||
59728249|NCT00982644|75847107|FG000|NOT COMPLETED|Extension: Week 53 to 104 (NN1250-3643)||46||
59728250|NCT00982644|75847108|FG001|NOT COMPLETED|Extension: Week 53 to 104 (NN1250-3643)||20||
59728251|NCT00815659|75847114|FG000|STARTED|Overall Study||97||
59728252|NCT00815659|75847114|FG000|COMPLETED|Overall Study||74||
59728253|NCT00815659|75847114|FG000|NOT COMPLETED|Overall Study||23||
59728254|NCT00825175|75847120|FG000|STARTED|Overall Study||10||
59728255|NCT00825175|75847121|FG001|STARTED|Overall Study||12||
59728256|NCT00825175|75847120|FG000|COMPLETED|Overall Study||10||
59728257|NCT00825175|75847121|FG001|COMPLETED|Overall Study||7||
59728258|NCT00825175|75847120|FG000|NOT COMPLETED|Overall Study||0||
59728259|NCT00825175|75847121|FG001|NOT COMPLETED|Overall Study||5||
59728260|NCT00824473|75847129|FG000|STARTED|Overall Study|1 subject was randomized in error|255||
59728261|NCT00824473|75847130|FG001|STARTED|Overall Study||251||
59728262|NCT00824473|75847129|FG000|COMPLETED|Overall Study||240||
59728263|NCT00824473|75847130|FG001|COMPLETED|Overall Study||238||
59728264|NCT00824473|75847129|FG000|NOT COMPLETED|Overall Study||15||
59728265|NCT00824473|75847130|FG001|NOT COMPLETED|Overall Study||13||
59728266|NCT04041037|75847136|FG000|STARTED|Overall Study||2||
59728267|NCT04041037|75847136|FG000|COMPLETED|Overall Study||2||
59728268|NCT04041037|75847136|FG000|NOT COMPLETED|Overall Study||0||
59728269|NCT00815191|75847142|FG000|STARTED|Overall Study||38||
59728270|NCT00815191|75847143|FG001|STARTED|Overall Study||35||
59728271|NCT00815191|75847142|FG000|COMPLETED|Overall Study||37||
59728272|NCT00815191|75847143|FG001|COMPLETED|Overall Study||34||
59728273|NCT00815191|75847142|FG000|NOT COMPLETED|Overall Study||1||
59728274|NCT00815191|75847143|FG001|NOT COMPLETED|Overall Study||1||
59728275|NCT00812929|75847149|FG000|STARTED|Treatment Period 1||5||
59728276|NCT00812929|75847150|FG001|STARTED|Treatment Period 1||4||
59594737|NCT03160027|75703679|FG003|NOT COMPLETED|Overall Study||0||
59594738|NCT02994979|75703692|FG000|STARTED|Overall Study||114||
59594739|NCT02994979|75703693|FG001|STARTED|Overall Study||105||
59594740|NCT02994979|75703692|FG000|COMPLETED|Overall Study||114||
59594741|NCT02994979|75703693|FG001|COMPLETED|Overall Study||105||
59728277|NCT00812929|75847151|FG002|STARTED|Treatment Period 1||5||
59728278|NCT00812929|75847152|FG003|STARTED|Treatment Period 1||4||
59728279|NCT00812929|75847153|FG004|STARTED|Treatment Period 1||5||
59728280|NCT00812929|75847154|FG005|STARTED|Treatment Period 1||5||
59728281|NCT00812929|75847155|FG006|STARTED|Treatment Period 1||5||
59728282|NCT00812929|75847156|FG007|STARTED|Treatment Period 1||5||
59728283|NCT00812929|75847157|FG008|STARTED|Treatment Period 1||4||
59728284|NCT00812929|75847158|FG009|STARTED|Treatment Period 1||5||
59728285|NCT00812929|75847149|FG000|COMPLETED|Treatment Period 1||5||
59728286|NCT00812929|75847150|FG001|COMPLETED|Treatment Period 1||4||
59728287|NCT00812929|75847151|FG002|COMPLETED|Treatment Period 1||5||
59728288|NCT00812929|75847152|FG003|COMPLETED|Treatment Period 1||4||
59728289|NCT00812929|75847153|FG004|COMPLETED|Treatment Period 1||5||
59728290|NCT00812929|75847154|FG005|COMPLETED|Treatment Period 1||5||
59728291|NCT00812929|75847155|FG006|COMPLETED|Treatment Period 1||5||
59728292|NCT00812929|75847156|FG007|COMPLETED|Treatment Period 1||5||
59728293|NCT00812929|75847157|FG008|COMPLETED|Treatment Period 1||4||
59728294|NCT00812929|75847158|FG009|COMPLETED|Treatment Period 1||5||
59728295|NCT00812929|75847149|FG000|NOT COMPLETED|Treatment Period 1||0||
59858169|NCT00304031|75983062|FG002|Unmethylated MGMT Population|Randomization to Adjuvant TMZ Arm||262|Eligible participants determined to have unmethylated MGMT.|
59594742|NCT02994979|75703692|FG000|NOT COMPLETED|Overall Study||0||
59594743|NCT02994979|75703693|FG001|NOT COMPLETED|Overall Study||0||
59594744|NCT02995915|75703701|FG000|STARTED|Overall Study||30||
59594745|NCT02995915|75703702|FG001|STARTED|Overall Study||15||
59594746|NCT02995915|75703701|FG000|COMPLETED|Overall Study||30||
59594747|NCT02995915|75703702|FG001|COMPLETED|Overall Study||15||
59594748|NCT02995915|75703701|FG000|NOT COMPLETED|Overall Study||0||
59594749|NCT02995915|75703702|FG001|NOT COMPLETED|Overall Study||0||
59594750|NCT02997085|75703711|FG000|STARTED|Overall Study||34||
59594751|NCT02997085|75703712|FG001|STARTED|Overall Study||35||
59594752|NCT02997085|75703713|FG002|STARTED|Overall Study||34||
59594753|NCT02997085|75703711|FG000|COMPLETED|Overall Study||34||
59594754|NCT02997085|75703712|FG001|COMPLETED|Overall Study||35||
59594755|NCT02997085|75703713|FG002|COMPLETED|Overall Study||34||
59594756|NCT02997085|75703711|FG000|NOT COMPLETED|Overall Study||0||
59594757|NCT02997085|75703712|FG001|NOT COMPLETED|Overall Study||0||
59728296|NCT00812929|75847150|FG001|NOT COMPLETED|Treatment Period 1||0||
59728297|NCT00812929|75847151|FG002|NOT COMPLETED|Treatment Period 1||0||
59728298|NCT00812929|75847152|FG003|NOT COMPLETED|Treatment Period 1||0||
59728299|NCT00812929|75847153|FG004|NOT COMPLETED|Treatment Period 1||0||
59728300|NCT00812929|75847154|FG005|NOT COMPLETED|Treatment Period 1||0||
59728301|NCT00812929|75847155|FG006|NOT COMPLETED|Treatment Period 1||0||
59728302|NCT00812929|75847156|FG007|NOT COMPLETED|Treatment Period 1||0||
59728303|NCT00812929|75847157|FG008|NOT COMPLETED|Treatment Period 1||0||
59728304|NCT00812929|75847158|FG009|NOT COMPLETED|Treatment Period 1||0||
59728305|NCT00812929|75847149|FG000|STARTED|Washout Period 1 (7 Days)||5||
59728306|NCT00812929|75847150|FG001|STARTED|Washout Period 1 (7 Days)||4||
59728307|NCT00812929|75847151|FG002|STARTED|Washout Period 1 (7 Days)||5||
59728308|NCT00812929|75847152|FG003|STARTED|Washout Period 1 (7 Days)||4||
59728309|NCT00812929|75847153|FG004|STARTED|Washout Period 1 (7 Days)||5||
59728310|NCT00812929|75847154|FG005|STARTED|Washout Period 1 (7 Days)||5||
59728311|NCT00812929|75847155|FG006|STARTED|Washout Period 1 (7 Days)||5||
59728312|NCT00812929|75847156|FG007|STARTED|Washout Period 1 (7 Days)||5||
59728313|NCT00812929|75847157|FG008|STARTED|Washout Period 1 (7 Days)||4||
59728314|NCT00812929|75847158|FG009|STARTED|Washout Period 1 (7 Days)||5||
59728315|NCT00812929|75847149|FG000|COMPLETED|Washout Period 1 (7 Days)||5||
59728316|NCT00812929|75847150|FG001|COMPLETED|Washout Period 1 (7 Days)||4||
59728317|NCT00812929|75847151|FG002|COMPLETED|Washout Period 1 (7 Days)||4||
59728318|NCT00812929|75847152|FG003|COMPLETED|Washout Period 1 (7 Days)||4||
59728319|NCT00812929|75847153|FG004|COMPLETED|Washout Period 1 (7 Days)||5||
59728320|NCT00812929|75847154|FG005|COMPLETED|Washout Period 1 (7 Days)||5||
59728321|NCT00812929|75847155|FG006|COMPLETED|Washout Period 1 (7 Days)||5||
59728322|NCT00812929|75847156|FG007|COMPLETED|Washout Period 1 (7 Days)||5||
59728323|NCT00812929|75847157|FG008|COMPLETED|Washout Period 1 (7 Days)||4||
59728324|NCT00812929|75847158|FG009|COMPLETED|Washout Period 1 (7 Days)||5||
59728325|NCT00812929|75847149|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0||
59728326|NCT00812929|75847150|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0||
59728327|NCT00812929|75847151|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||1||
59728328|NCT00812929|75847152|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0||
59728329|NCT00812929|75847153|FG004|NOT COMPLETED|Washout Period 1 (7 Days)||0||
59728330|NCT00812929|75847154|FG005|NOT COMPLETED|Washout Period 1 (7 Days)||0||
59728331|NCT00812929|75847155|FG006|NOT COMPLETED|Washout Period 1 (7 Days)||0||
59728332|NCT00812929|75847156|FG007|NOT COMPLETED|Washout Period 1 (7 Days)||0||
59728333|NCT00812929|75847157|FG008|NOT COMPLETED|Washout Period 1 (7 Days)||0||
59728334|NCT00812929|75847158|FG009|NOT COMPLETED|Washout Period 1 (7 Days)||0||
59728335|NCT00812929|75847149|FG000|STARTED|Treatment Period 2||5||
59728336|NCT00812929|75847150|FG001|STARTED|Treatment Period 2||4||
59728337|NCT00812929|75847151|FG002|STARTED|Treatment Period 2||4||
59858170|NCT00304031|75983060|FG000|Methylated MGMT Population|Randomization to Adjuvant TMZ Arm||0|Eligible participants determined to have methylated MGMT.|
59858171|NCT00304031|75983061|FG001|Methylated MGMT Population|Randomization to Adjuvant TMZ Arm||122|Eligible participants determined to have methylated MGMT.|
59858172|NCT00304031|75983062|FG002|Methylated MGMT Population|Randomization to Adjuvant TMZ Arm||122|Eligible participants determined to have methylated MGMT.|
59858173|NCT00304031|75983060|FG000|Quality of Life Population|Randomization to Adjuvant TMZ Arm||0|Eligible participants who consented to the quality of life study component, offered after 07-12-2007|
59858174|NCT00304031|75983061|FG001|Quality of Life Population|Randomization to Adjuvant TMZ Arm||96|Eligible participants who consented to the quality of life study component, offered after 07-12-2007|
59858175|NCT00304031|75983062|FG002|Quality of Life Population|Randomization to Adjuvant TMZ Arm||95|Eligible participants who consented to the quality of life study component, offered after 07-12-2007|
59858176|NCT00304031|75983060|FG000|COMPLETED|Randomization to Adjuvant TMZ Arm||0||
59858177|NCT00304031|75983061|FG001|COMPLETED|Randomization to Adjuvant TMZ Arm|Randomized participants contributing data to results are considered to have completed the study.|411||
59858178|NCT00304031|75983062|FG002|COMPLETED|Randomization to Adjuvant TMZ Arm|Randomized participants contributing data to results are considered to have completed the study.|420||
59858179|NCT00304031|75983060|FG000|NOT COMPLETED|Randomization to Adjuvant TMZ Arm||0||
59858180|NCT00304031|75983061|FG001|NOT COMPLETED|Randomization to Adjuvant TMZ Arm||0||
59858181|NCT00304031|75983062|FG002|NOT COMPLETED|Randomization to Adjuvant TMZ Arm||2||
59858182|NCT00332189|75983077|FG000|STARTED|Overall Study||111||
59858183|NCT00332189|75983077|FG000|COMPLETED|Overall Study|Subjects in this extension study continued until there was market approval in their region.|90||
59858184|NCT00332189|75983077|FG000|NOT COMPLETED|Overall Study||21||
59858185|NCT00331799|75983082|FG000|STARTED|Overall Study||18||
59858186|NCT00331799|75983082|FG000|COMPLETED|Overall Study||15||
59858187|NCT00331799|75983082|FG000|NOT COMPLETED|Overall Study||3||
59858188|NCT00303719|75983088|FG000|STARTED|Overall Study||13||
59858189|NCT00303719|75983089|FG001|STARTED|Overall Study||329||
59858190|NCT00303719|75983088|FG000|COMPLETED|Overall Study||13||
59858191|NCT00303719|75983089|FG001|COMPLETED|Overall Study||292||
59858192|NCT00303719|75983088|FG000|NOT COMPLETED|Overall Study||0||
59858193|NCT00303719|75983089|FG001|NOT COMPLETED|Overall Study||37||
59728338|NCT00812929|75847152|FG003|STARTED|Treatment Period 2||4||
59728339|NCT00812929|75847153|FG004|STARTED|Treatment Period 2||5||
59728340|NCT00812929|75847154|FG005|STARTED|Treatment Period 2||5||
59858194|NCT00331409|75983096|FG000|STARTED|Overall Study|19 patients were enrolled in the first stage due to 4 patients who withdrew early.|19||
59858195|NCT00331409|75983096|FG000|COMPLETED|Overall Study|15 patients accrued to the first stage;if>9 were progression-free at 3 months,enrollment continued.|15||
59858196|NCT00331409|75983096|FG000|NOT COMPLETED|Overall Study||4||
59858197|NCT00303485|75983102|FG000|STARTED|Overall Study||49||
59858198|NCT00303485|75983103|FG001|STARTED|Overall Study||17||
59858199|NCT00303485|75983102|FG000|COMPLETED|Overall Study||48||
59858200|NCT00303485|75983103|FG001|COMPLETED|Overall Study||15||
59858201|NCT00303485|75983102|FG000|NOT COMPLETED|Overall Study||1||
59858202|NCT00303485|75983103|FG001|NOT COMPLETED|Overall Study||2||
59858203|NCT03235726|75983117|FG000|STARTED|Part 1 (Cohort A 60 mg - Day 1)||6||
59858204|NCT03235726|75983118|FG001|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0||
59858205|NCT03235726|75983119|FG002|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0||
59858206|NCT03235726|75983120|FG003|STARTED|Part 1 (Cohort A 60 mg - Day 1)||2||
59858207|NCT03235726|75983121|FG004|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0||
59858208|NCT03235726|75983122|FG005|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0||
59858209|NCT03235726|75983123|FG006|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0||
59858210|NCT03235726|75983124|FG007|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0||
59858211|NCT03235726|75983125|FG008|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0||
59858212|NCT03235726|75983126|FG009|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0||
59858213|NCT03235726|75983117|FG000|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||6||
59858214|NCT03235726|75983118|FG001|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0||
59858215|NCT03235726|75983119|FG002|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0||
59858216|NCT03235726|75983120|FG003|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||2||
59858217|NCT03235726|75983121|FG004|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0||
59858218|NCT03235726|75983122|FG005|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0||
59858219|NCT03235726|75983123|FG006|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0||
59858220|NCT03235726|75983124|FG007|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0||
59858221|NCT03235726|75983125|FG008|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0||
59858222|NCT03235726|75983126|FG009|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0||
59858223|NCT03235726|75983117|FG000|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0||
59858224|NCT03235726|75983118|FG001|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0||
59858225|NCT03235726|75983119|FG002|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0||
59858226|NCT03235726|75983120|FG003|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0||
59858227|NCT03235726|75983121|FG004|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0||
59858228|NCT03235726|75983122|FG005|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0||
59858229|NCT03235726|75983123|FG006|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0||
59858230|NCT03235726|75983124|FG007|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0||
59858231|NCT03235726|75983125|FG008|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0||
59858232|NCT03235726|75983126|FG009|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0||
59858233|NCT03235726|75983117|FG000|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0||
59858234|NCT03235726|75983118|FG001|STARTED|Part 1 (Cohort A 120 mg - Day 3)||6||
59858235|NCT03235726|75983119|FG002|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0||
59858236|NCT03235726|75983120|FG003|STARTED|Part 1 (Cohort A 120 mg - Day 3)||2||
59858237|NCT03235726|75983121|FG004|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0||
59858238|NCT03235726|75983122|FG005|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0||
59858239|NCT03235726|75983123|FG006|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0||
59858240|NCT03235726|75983124|FG007|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0||
59858241|NCT03235726|75983125|FG008|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0||
59858242|NCT03235726|75983126|FG009|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0||
59858243|NCT03235726|75983117|FG000|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0||
59858244|NCT03235726|75983118|FG001|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||6||
59858245|NCT03235726|75983119|FG002|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0||
59858246|NCT03235726|75983120|FG003|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||2||
59858247|NCT03235726|75983121|FG004|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0||
59858248|NCT03235726|75983122|FG005|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0||
59858249|NCT03235726|75983123|FG006|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0||
59858250|NCT03235726|75983124|FG007|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0||
59858251|NCT03235726|75983125|FG008|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0||
59858252|NCT03235726|75983126|FG009|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0||
59858253|NCT03235726|75983117|FG000|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0||
59858254|NCT03235726|75983118|FG001|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0||
59858255|NCT03235726|75983119|FG002|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0||
59858256|NCT03235726|75983120|FG003|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0||
59858257|NCT03235726|75983121|FG004|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0||
59858258|NCT03235726|75983122|FG005|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0||
59858259|NCT03235726|75983123|FG006|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0||
59858260|NCT03235726|75983124|FG007|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0||
59858261|NCT03235726|75983125|FG008|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0||
59858262|NCT03235726|75983126|FG009|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0||
59858263|NCT03235726|75983117|FG000|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0||
59858264|NCT03235726|75983118|FG001|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0||
59858265|NCT03235726|75983119|FG002|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||6||
59858266|NCT03235726|75983120|FG003|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||2||
59858267|NCT03235726|75983121|FG004|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0||
59858268|NCT03235726|75983122|FG005|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0||
59858269|NCT03235726|75983123|FG006|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0||
59858270|NCT03235726|75983124|FG007|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0||
59858271|NCT03235726|75983125|FG008|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0||
59858272|NCT03235726|75983126|FG009|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0||
59858273|NCT03235726|75983117|FG000|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0||
59858274|NCT03235726|75983118|FG001|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0||
59858275|NCT03235726|75983119|FG002|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||6||
59858276|NCT03235726|75983120|FG003|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||2||
59858277|NCT03235726|75983121|FG004|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0||
59858278|NCT03235726|75983122|FG005|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0||
59858279|NCT03235726|75983123|FG006|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0||
59858280|NCT03235726|75983124|FG007|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0||
59858281|NCT03235726|75983125|FG008|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0||
59858282|NCT03235726|75983126|FG009|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0||
59858283|NCT03235726|75983117|FG000|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0||
59858284|NCT03235726|75983118|FG001|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0||
59858285|NCT03235726|75983119|FG002|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0||
59858286|NCT03235726|75983120|FG003|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0||
59858287|NCT03235726|75983121|FG004|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0||
59858288|NCT03235726|75983122|FG005|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0||
59858289|NCT03235726|75983123|FG006|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0||
59858290|NCT03235726|75983124|FG007|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0||
59858291|NCT03235726|75983125|FG008|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0||
59858292|NCT03235726|75983126|FG009|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0||
59858293|NCT03235726|75983117|FG000|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0||
59858294|NCT03235726|75983118|FG001|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0||
59858295|NCT03235726|75983119|FG002|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0||
59858296|NCT03235726|75983120|FG003|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0||
59858297|NCT03235726|75983121|FG004|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||12||
59858298|NCT03235726|75983122|FG005|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||2||
59858299|NCT03235726|75983123|FG006|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||14||
59858300|NCT03235726|75983124|FG007|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0||
59858301|NCT03235726|75983125|FG008|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0||
59858302|NCT03235726|75983126|FG009|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0||
59858303|NCT03235726|75983117|FG000|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0||
59858304|NCT03235726|75983118|FG001|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0||
59858305|NCT03235726|75983119|FG002|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0||
59858306|NCT03235726|75983120|FG003|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0||
59858307|NCT03235726|75983121|FG004|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||10||
59858308|NCT03235726|75983122|FG005|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||2||
59858309|NCT03235726|75983123|FG006|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||14||
59858310|NCT03235726|75983124|FG007|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0||
59858311|NCT03235726|75983125|FG008|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0||
59858312|NCT03235726|75983126|FG009|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0||
59858313|NCT03235726|75983117|FG000|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0||
59858314|NCT03235726|75983118|FG001|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0||
59858315|NCT03235726|75983119|FG002|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0||
59858316|NCT03235726|75983120|FG003|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0||
59858317|NCT03235726|75983121|FG004|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||2||
59858318|NCT03235726|75983122|FG005|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0||
59858319|NCT03235726|75983123|FG006|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0||
59858320|NCT03235726|75983124|FG007|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0||
59858321|NCT03235726|75983125|FG008|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0||
59858322|NCT03235726|75983126|FG009|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0||
59858323|NCT03235726|75983117|FG000|STARTED|Part 2 (Cohort A - Day 1)||0||
59858324|NCT03235726|75983118|FG001|STARTED|Part 2 (Cohort A - Day 1)||0||
59858325|NCT03235726|75983119|FG002|STARTED|Part 2 (Cohort A - Day 1)||0||
59858326|NCT03235726|75983120|FG003|STARTED|Part 2 (Cohort A - Day 1)||0||
59858327|NCT03235726|75983121|FG004|STARTED|Part 2 (Cohort A - Day 1)||0||
59858328|NCT03235726|75983122|FG005|STARTED|Part 2 (Cohort A - Day 1)||0||
59858329|NCT03235726|75983123|FG006|STARTED|Part 2 (Cohort A - Day 1)||0||
59858330|NCT03235726|75983124|FG007|STARTED|Part 2 (Cohort A - Day 1)||6||
59858331|NCT03235726|75983125|FG008|STARTED|Part 2 (Cohort A - Day 1)||2||
59858332|NCT03235726|75983126|FG009|STARTED|Part 2 (Cohort A - Day 1)||0||
59858333|NCT03235726|75983117|FG000|COMPLETED|Part 2 (Cohort A - Day 1)||0||
59858334|NCT03235726|75983118|FG001|COMPLETED|Part 2 (Cohort A - Day 1)||0||
59858335|NCT03235726|75983119|FG002|COMPLETED|Part 2 (Cohort A - Day 1)||0||
59858336|NCT03235726|75983120|FG003|COMPLETED|Part 2 (Cohort A - Day 1)||0||
59858337|NCT03235726|75983121|FG004|COMPLETED|Part 2 (Cohort A - Day 1)||0||
59728341|NCT00812929|75847155|FG006|STARTED|Treatment Period 2||5||
59728342|NCT00812929|75847156|FG007|STARTED|Treatment Period 2||5||
59728343|NCT00812929|75847157|FG008|STARTED|Treatment Period 2||4||
59858338|NCT03235726|75983122|FG005|COMPLETED|Part 2 (Cohort A - Day 1)||0||
59858339|NCT03235726|75983123|FG006|COMPLETED|Part 2 (Cohort A - Day 1)||0||
59858340|NCT03235726|75983124|FG007|COMPLETED|Part 2 (Cohort A - Day 1)||6||
59858341|NCT03235726|75983125|FG008|COMPLETED|Part 2 (Cohort A - Day 1)||2||
59858342|NCT03235726|75983126|FG009|COMPLETED|Part 2 (Cohort A - Day 1)||0||
59858343|NCT03235726|75983117|FG000|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0||
59858344|NCT03235726|75983118|FG001|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0||
59858345|NCT03235726|75983119|FG002|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0||
59858346|NCT03235726|75983120|FG003|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0||
59858347|NCT03235726|75983121|FG004|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0||
59858348|NCT03235726|75983122|FG005|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0||
59858349|NCT03235726|75983123|FG006|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0||
59858350|NCT03235726|75983124|FG007|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0||
59858351|NCT03235726|75983125|FG008|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0||
59858352|NCT03235726|75983126|FG009|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0||
59858353|NCT03235726|75983117|FG000|STARTED|Part 2 (Cohort B - Days 1 to 14)||0||
59858354|NCT03235726|75983118|FG001|STARTED|Part 2 (Cohort B - Days 1 to 14)||0||
59858355|NCT03235726|75983119|FG002|STARTED|Part 2 (Cohort B - Days 1 to 14)||0||
59858356|NCT03235726|75983120|FG003|STARTED|Part 2 (Cohort B - Days 1 to 14)||0||
59858357|NCT03235726|75983121|FG004|STARTED|Part 2 (Cohort B - Days 1 to 14)||0||
59858358|NCT03235726|75983122|FG005|STARTED|Part 2 (Cohort B - Days 1 to 14)||0||
59858359|NCT03235726|75983123|FG006|STARTED|Part 2 (Cohort B - Days 1 to 14)||0||
59858360|NCT03235726|75983124|FG007|STARTED|Part 2 (Cohort B - Days 1 to 14)||0||
59858361|NCT03235726|75983125|FG008|STARTED|Part 2 (Cohort B - Days 1 to 14)||0||
59858362|NCT03235726|75983126|FG009|STARTED|Part 2 (Cohort B - Days 1 to 14)||8||
59858363|NCT03235726|75983117|FG000|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0||
59858364|NCT03235726|75983118|FG001|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0||
59858365|NCT03235726|75983119|FG002|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0||
59858366|NCT03235726|75983120|FG003|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0||
59858367|NCT03235726|75983121|FG004|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0||
59858368|NCT03235726|75983122|FG005|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0||
59858369|NCT03235726|75983123|FG006|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0||
59858370|NCT03235726|75983124|FG007|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0||
59858371|NCT03235726|75983125|FG008|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0||
59858372|NCT03235726|75983126|FG009|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||8||
59858373|NCT03235726|75983117|FG000|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0||
59858374|NCT03235726|75983118|FG001|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0||
59858375|NCT03235726|75983119|FG002|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0||
59858376|NCT03235726|75983120|FG003|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0||
59858377|NCT03235726|75983121|FG004|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0||
59858378|NCT03235726|75983122|FG005|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0||
59858379|NCT03235726|75983123|FG006|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0||
59858380|NCT03235726|75983124|FG007|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0||
59858381|NCT03235726|75983125|FG008|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0||
59858382|NCT03235726|75983126|FG009|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0||
59858383|NCT00303953|75983161|FG000|STARTED|Overall Study||22||
59858384|NCT00303953|75983161|FG000|Eligible|Overall Study||21||
59858385|NCT00303953|75983161|FG000|Eligible and Treated|Overall Study||20||
59858386|NCT00303953|75983161|FG000|COMPLETED|Overall Study||3||
59858387|NCT00303953|75983161|FG000|NOT COMPLETED|Overall Study||19||
59858388|NCT02935894|75983165|FG000|STARTED|Overall Study||14||
59858389|NCT02935894|75983165|FG000|COMPLETED|Overall Study||13||
59728344|NCT00812929|75847158|FG009|STARTED|Treatment Period 2||5||
59728345|NCT00812929|75847149|FG000|COMPLETED|Treatment Period 2||5||
59728346|NCT00812929|75847150|FG001|COMPLETED|Treatment Period 2||4||
59728347|NCT00812929|75847151|FG002|COMPLETED|Treatment Period 2||4||
59728348|NCT00812929|75847152|FG003|COMPLETED|Treatment Period 2||4||
59728349|NCT00812929|75847153|FG004|COMPLETED|Treatment Period 2||5||
59728350|NCT00812929|75847154|FG005|COMPLETED|Treatment Period 2||5||
59728351|NCT00812929|75847155|FG006|COMPLETED|Treatment Period 2||5||
59728352|NCT00812929|75847156|FG007|COMPLETED|Treatment Period 2||5||
59728353|NCT00812929|75847157|FG008|COMPLETED|Treatment Period 2||4||
59728354|NCT00812929|75847158|FG009|COMPLETED|Treatment Period 2||5||
59728355|NCT00812929|75847149|FG000|NOT COMPLETED|Treatment Period 2||0||
59728356|NCT00812929|75847150|FG001|NOT COMPLETED|Treatment Period 2||0||
59728357|NCT00812929|75847151|FG002|NOT COMPLETED|Treatment Period 2||0||
59728358|NCT00812929|75847152|FG003|NOT COMPLETED|Treatment Period 2||0||
59858390|NCT02935894|75983165|FG000|NOT COMPLETED|Overall Study||1||
59858391|NCT03224182|75983171|FG000|STARTED|Overall Study||81||
59858392|NCT03224182|75983172|FG001|STARTED|Overall Study||37||
59858393|NCT03224182|75983171|FG000|Safety Population|Overall Study||73||
59858394|NCT03224182|75983172|FG001|Safety Population|Overall Study||36||
59858395|NCT03224182|75983171|FG000|COMPLETED|Overall Study||0||
59858396|NCT03224182|75983172|FG001|COMPLETED|Overall Study||1||
59858397|NCT03224182|75983171|FG000|NOT COMPLETED|Overall Study||81||
59858398|NCT03224182|75983172|FG001|NOT COMPLETED|Overall Study||36||
59858399|NCT02935192|75983180|FG000|STARTED|Overall Study|312 subjects were included in the Full Protocol Analysis because 8 withdrew without getting product.|320||
59858400|NCT02935192|75983181|FG001|STARTED|Overall Study|156 subjects were included in the Full Protocol Analysis because 4 withdrew without getting product.|160||
59858401|NCT02935192|75983180|FG000|Received Vaccine/Placebo|Overall Study||312||
59858402|NCT02935192|75983181|FG001|Received Vaccine/Placebo|Overall Study||156||
59858403|NCT02935192|75983180|FG000|COMPLETED|Overall Study||312||
59858404|NCT02935192|75983181|FG001|COMPLETED|Overall Study||156||
59858405|NCT02935192|75983180|FG000|NOT COMPLETED|Overall Study||8||
59858406|NCT02935192|75983181|FG001|NOT COMPLETED|Overall Study||4||
59858407|NCT03722264|75983187|FG000|STARTED|Overall Study||12||
59858408|NCT03722264|75983187|FG000|COMPLETED|Overall Study||9||
59858409|NCT03722264|75983187|FG000|NOT COMPLETED|Overall Study||3||
59858410|NCT03722030|75983195|FG000|STARTED|Overall Study||20||
59858411|NCT03722030|75983196|FG001|STARTED|Overall Study||20||
59858412|NCT03722030|75983195|FG000|COMPLETED|Overall Study||19||
59858413|NCT03722030|75983196|FG001|COMPLETED|Overall Study||20||
59858414|NCT03722030|75983195|FG000|NOT COMPLETED|Overall Study||1||
59858415|NCT03722030|75983196|FG001|NOT COMPLETED|Overall Study||0||
59858416|NCT03221842|75983203|FG000|STARTED|Period 1 (Open-label)||63||
59858417|NCT03221842|75983204|FG001|STARTED|Period 1 (Open-label)||0||
59858418|NCT03221842|75983203|FG000|COMPLETED|Period 1 (Open-label)||53||
59858419|NCT03221842|75983204|FG001|COMPLETED|Period 1 (Open-label)||0||
59858420|NCT03221842|75983203|FG000|NOT COMPLETED|Period 1 (Open-label)||10||
59858421|NCT03221842|75983204|FG001|NOT COMPLETED|Period 1 (Open-label)||0||
59858422|NCT03221842|75983203|FG000|STARTED|Period 2 (Randomized, Blinded)||7||
59858423|NCT03221842|75983204|FG001|STARTED|Period 2 (Randomized, Blinded)||6||
59858424|NCT03221842|75983203|FG000|COMPLETED|Period 2 (Randomized, Blinded)||6||
59858425|NCT03221842|75983204|FG001|COMPLETED|Period 2 (Randomized, Blinded)||5||
59858426|NCT03221842|75983203|FG000|NOT COMPLETED|Period 2 (Randomized, Blinded)||1||
59858427|NCT03221842|75983204|FG001|NOT COMPLETED|Period 2 (Randomized, Blinded)||1||
59858428|NCT03364738|75983214|FG000|STARTED|Overall Study||22||
59858429|NCT03364738|75983214|FG000|COMPLETED|Overall Study||14||
59858430|NCT03364738|75983214|FG000|NOT COMPLETED|Overall Study||8||
59858431|NCT00303329|75983221|FG000|STARTED|Overall Study||85||
59858432|NCT00303329|75983222|FG001|STARTED|Overall Study||99||
59858433|NCT00303329|75983221|FG000|COMPLETED|Overall Study||50||
59858434|NCT00303329|75983222|FG001|COMPLETED|Overall Study||37||
59858435|NCT00303329|75983221|FG000|NOT COMPLETED|Overall Study||35||
59858436|NCT00303329|75983222|FG001|NOT COMPLETED|Overall Study||62||
59858437|NCT00329849|75983230|FG000|STARTED|Overall Study||950||
59858438|NCT00329849|75983231|FG001|STARTED|Overall Study||550||
59858439|NCT00329849|75983230|FG000|COMPLETED|Overall Study||944||
59858440|NCT00329849|75983231|FG001|COMPLETED|Overall Study||546||
59858441|NCT00329849|75983230|FG000|NOT COMPLETED|Overall Study||6||
59858442|NCT00329849|75983231|FG001|NOT COMPLETED|Overall Study||4||
59858443|NCT02934178|75983243|FG000|STARTED|Received Vaccination 1||12||
59858444|NCT02934178|75983244|FG001|STARTED|Received Vaccination 1||4||
59858445|NCT02934178|75983243|FG000|COMPLETED|Received Vaccination 1||12||
59858446|NCT02934178|75983244|FG001|COMPLETED|Received Vaccination 1||4||
59858447|NCT02934178|75983243|FG000|NOT COMPLETED|Received Vaccination 1||0||
59858448|NCT02934178|75983244|FG001|NOT COMPLETED|Received Vaccination 1||0||
59858449|NCT02934178|75983243|FG000|STARTED|Received Vaccination 2||12||
59858450|NCT02934178|75983244|FG001|STARTED|Received Vaccination 2||4||
59858451|NCT02934178|75983243|FG000|COMPLETED|Received Vaccination 2||12||
60123893|NCT01528033|76245272|FG001|STARTED|Primary Endpoint Assessment ITT||266||
60123894|NCT01528033|76245271|FG000|COMPLETED|Primary Endpoint Assessment ITT||256||
59858452|NCT02934178|75983244|FG001|COMPLETED|Received Vaccination 2||3||
59858453|NCT02934178|75983243|FG000|NOT COMPLETED|Received Vaccination 2||0||
59858454|NCT02934178|75983244|FG001|NOT COMPLETED|Received Vaccination 2||1||
59858455|NCT02934178|75983243|FG000|STARTED|Received Vaccination 3||12||
59858456|NCT02934178|75983244|FG001|STARTED|Received Vaccination 3||3||
59858457|NCT02934178|75983243|FG000|COMPLETED|Received Vaccination 3||11||
59858458|NCT02934178|75983244|FG001|COMPLETED|Received Vaccination 3||3||
59858459|NCT02934178|75983243|FG000|NOT COMPLETED|Received Vaccination 3||1||
59858460|NCT02934178|75983244|FG001|NOT COMPLETED|Received Vaccination 3||0||
59858461|NCT00329303|75983253|FG000|STARTED|Overall Study||34||
59858462|NCT00329303|75983254|FG001|STARTED|Overall Study||37||
59858463|NCT00329303|75983253|FG000|COMPLETED|Overall Study||32||
59858464|NCT00329303|75983254|FG001|COMPLETED|Overall Study||35||
59858465|NCT00329303|75983253|FG000|NOT COMPLETED|Overall Study||2||
59858466|NCT00329303|75983254|FG001|NOT COMPLETED|Overall Study||2||
60123895|NCT01528033|76245272|FG001|COMPLETED|Primary Endpoint Assessment ITT||251||
60123896|NCT01528033|76245271|FG000|NOT COMPLETED|Primary Endpoint Assessment ITT||17||
60123897|NCT01528033|76245272|FG001|NOT COMPLETED|Primary Endpoint Assessment ITT||15||
60123898|NCT01528033|76245271|FG000|STARTED|Follow Up||256||
60123899|NCT01528033|76245272|FG001|STARTED|Follow Up||251||
59858467|NCT03216850|75983261|FG000|STARTED|Overall Study||15||
59858468|NCT03216850|75983261|FG000|COMPLETED|Overall Study|6 patients did not complete the study because of the pre-analytical error.|9||
59858469|NCT03216850|75983261|FG000|NOT COMPLETED|Overall Study||6||
59858470|NCT00302159|75983265|FG000|STARTED|Overall Study||43||
59858471|NCT00302159|75983265|FG000|COMPLETED|Overall Study||41||
59858472|NCT00302159|75983265|FG000|NOT COMPLETED|Overall Study||2||
59858473|NCT00302081|75983273|FG000|STARTED|Overall Study||237||
59858474|NCT00302081|75983274|FG001|STARTED|Overall Study||229||
59858475|NCT00302081|75983275|FG002|STARTED|Overall Study||230||
59858476|NCT00302081|75983273|FG000|COMPLETED|Overall Study||181||
59858477|NCT00302081|75983274|FG001|COMPLETED|Overall Study||186||
59858478|NCT00302081|75983275|FG002|COMPLETED|Overall Study||178||
59858479|NCT00302081|75983273|FG000|NOT COMPLETED|Overall Study||56||
59858480|NCT00302081|75983274|FG001|NOT COMPLETED|Overall Study||43||
59858481|NCT00302081|75983275|FG002|NOT COMPLETED|Overall Study||52||
59858482|NCT00302003|75983283|FG000|STARTED|Overall Study||287||
59858483|NCT00302003|75983283|FG000|COMPLETED|Overall Study||207||
59858484|NCT00302003|75983283|FG000|NOT COMPLETED|Overall Study||80||
59858485|NCT00036270|75983289|FG000|STARTED|Randomized to Study Treatment||4904||
59858486|NCT00036270|75983290|FG001|STARTED|Randomized to Study Treatment||4875||
59858487|NCT00036270|75983289|FG000|COMPLETED|Randomized to Study Treatment||4898||
59858488|NCT00036270|75983290|FG001|COMPLETED|Randomized to Study Treatment||4868||
59858489|NCT00036270|75983289|FG000|NOT COMPLETED|Randomized to Study Treatment||6||
59858490|NCT00036270|75983290|FG001|NOT COMPLETED|Randomized to Study Treatment||7||
59858491|NCT00036270|75983289|FG000|STARTED|Study Treatment to 5 Year Report||4898||
59858492|NCT00036270|75983290|FG001|STARTED|Study Treatment to 5 Year Report||4868||
59858493|NCT00036270|75983289|FG000|Treated|Study Treatment to 5 Year Report||4852||
59858494|NCT00036270|75983290|FG001|Treated|Study Treatment to 5 Year Report||4814||
59858495|NCT00036270|75983289|FG000|COMPLETED|Study Treatment to 5 Year Report||2333||
59858496|NCT00036270|75983290|FG001|COMPLETED|Study Treatment to 5 Year Report||1380||
59858497|NCT00036270|75983289|FG000|NOT COMPLETED|Study Treatment to 5 Year Report||2565||
59858498|NCT00036270|75983290|FG001|NOT COMPLETED|Study Treatment to 5 Year Report||3488||
59858499|NCT00301067|75983296|FG000|STARTED|Completed DLT Period/1st Cycle||4||
59858500|NCT00301067|75983297|FG001|STARTED|Completed DLT Period/1st Cycle||3||
59858501|NCT00301067|75983298|FG002|STARTED|Completed DLT Period/1st Cycle||3||
59858502|NCT00301067|75983299|FG003|STARTED|Completed DLT Period/1st Cycle|Patients did not participate in the DLT portion of the trial, they completed 1st cycle of treatment.|10||
59858503|NCT00301067|75983296|FG000|COMPLETED|Completed DLT Period/1st Cycle||3||
59858504|NCT00301067|75983297|FG001|COMPLETED|Completed DLT Period/1st Cycle||3||
59858505|NCT00301067|75983298|FG002|COMPLETED|Completed DLT Period/1st Cycle||3||
59858506|NCT00301067|75983299|FG003|COMPLETED|Completed DLT Period/1st Cycle||9||
59858507|NCT00301067|75983296|FG000|NOT COMPLETED|Completed DLT Period/1st Cycle||1||
59858508|NCT00301067|75983297|FG001|NOT COMPLETED|Completed DLT Period/1st Cycle||0||
59858509|NCT00301067|75983298|FG002|NOT COMPLETED|Completed DLT Period/1st Cycle||0||
59858510|NCT00301067|75983299|FG003|NOT COMPLETED|Completed DLT Period/1st Cycle||1||
59858511|NCT00301067|75983296|FG000|STARTED|Reached 1st Response/2 Cycles||3||
59858512|NCT00301067|75983297|FG001|STARTED|Reached 1st Response/2 Cycles||3||
59858513|NCT00301067|75983298|FG002|STARTED|Reached 1st Response/2 Cycles||3||
59858514|NCT00301067|75983299|FG003|STARTED|Reached 1st Response/2 Cycles||9||
59858515|NCT00301067|75983296|FG000|COMPLETED|Reached 1st Response/2 Cycles||1||
59858516|NCT00301067|75983297|FG001|COMPLETED|Reached 1st Response/2 Cycles||2||
59858517|NCT00301067|75983298|FG002|COMPLETED|Reached 1st Response/2 Cycles||2||
59858518|NCT00301067|75983299|FG003|COMPLETED|Reached 1st Response/2 Cycles||7||
59858519|NCT00301067|75983296|FG000|NOT COMPLETED|Reached 1st Response/2 Cycles||2||
59858520|NCT00301067|75983297|FG001|NOT COMPLETED|Reached 1st Response/2 Cycles||1||
59858521|NCT00301067|75983298|FG002|NOT COMPLETED|Reached 1st Response/2 Cycles||1||
59858522|NCT00301067|75983299|FG003|NOT COMPLETED|Reached 1st Response/2 Cycles||2||
59858523|NCT00301067|75983296|FG000|STARTED|Completed 4 Cycles of Treatment||1||
59858524|NCT00301067|75983297|FG001|STARTED|Completed 4 Cycles of Treatment||2||
59858525|NCT00301067|75983298|FG002|STARTED|Completed 4 Cycles of Treatment||2||
59858526|NCT00301067|75983299|FG003|STARTED|Completed 4 Cycles of Treatment||7||
59858527|NCT00301067|75983296|FG000|COMPLETED|Completed 4 Cycles of Treatment||0||
59858528|NCT00301067|75983297|FG001|COMPLETED|Completed 4 Cycles of Treatment||1||
59858529|NCT00301067|75983298|FG002|COMPLETED|Completed 4 Cycles of Treatment||0||
59858530|NCT00301067|75983299|FG003|COMPLETED|Completed 4 Cycles of Treatment||2||
59858531|NCT00301067|75983296|FG000|NOT COMPLETED|Completed 4 Cycles of Treatment||1||
59858532|NCT00301067|75983297|FG001|NOT COMPLETED|Completed 4 Cycles of Treatment||1||
60123900|NCT01528033|76245271|FG000|COMPLETED|Follow Up||210||
59858533|NCT00301067|75983298|FG002|NOT COMPLETED|Completed 4 Cycles of Treatment||2||
59858534|NCT00301067|75983299|FG003|NOT COMPLETED|Completed 4 Cycles of Treatment||5||
59858535|NCT00301067|75983296|FG000|STARTED|Completed 12 Cycles of Treatment||0||
59858536|NCT00301067|75983297|FG001|STARTED|Completed 12 Cycles of Treatment||1||
59858537|NCT00301067|75983298|FG002|STARTED|Completed 12 Cycles of Treatment||0||
59858538|NCT00301067|75983299|FG003|STARTED|Completed 12 Cycles of Treatment||2||
59858539|NCT00301067|75983296|FG000|COMPLETED|Completed 12 Cycles of Treatment||0||
60123901|NCT01528033|76245272|FG001|COMPLETED|Follow Up||207||
59858540|NCT00301067|75983297|FG001|COMPLETED|Completed 12 Cycles of Treatment||0||
59858541|NCT00301067|75983298|FG002|COMPLETED|Completed 12 Cycles of Treatment||0||
59858542|NCT00301067|75983299|FG003|COMPLETED|Completed 12 Cycles of Treatment||0||
59858543|NCT00301067|75983296|FG000|NOT COMPLETED|Completed 12 Cycles of Treatment||0||
59858544|NCT00301067|75983297|FG001|NOT COMPLETED|Completed 12 Cycles of Treatment||1||
59858545|NCT00301067|75983298|FG002|NOT COMPLETED|Completed 12 Cycles of Treatment||0||
59858546|NCT00301067|75983299|FG003|NOT COMPLETED|Completed 12 Cycles of Treatment||2||
59858547|NCT00301067|75983296|FG000|STARTED|Follow up Until Death||4|All patients that receive treatment on study go into the follow up period for study.|
59858548|NCT00301067|75983297|FG001|STARTED|Follow up Until Death||3|All patients that receive treatment on study go into the follow up period for study.|
59858549|NCT00301067|75983298|FG002|STARTED|Follow up Until Death||3|All patients that receive treatment on study go into the follow up period for study.|
59858550|NCT00301067|75983299|FG003|STARTED|Follow up Until Death||3|All patients that receive treatment on study go into the follow up period for study.|
59858551|NCT00301067|75983296|FG000|COMPLETED|Follow up Until Death||3||
59858552|NCT00301067|75983297|FG001|COMPLETED|Follow up Until Death||3||
59858553|NCT00301067|75983298|FG002|COMPLETED|Follow up Until Death||3||
59858554|NCT00301067|75983299|FG003|COMPLETED|Follow up Until Death||2||
59858555|NCT00301067|75983296|FG000|NOT COMPLETED|Follow up Until Death||1||
59858556|NCT00301067|75983297|FG001|NOT COMPLETED|Follow up Until Death||0||
59858557|NCT00301067|75983298|FG002|NOT COMPLETED|Follow up Until Death||0||
59858558|NCT00301067|75983299|FG003|NOT COMPLETED|Follow up Until Death||1||
59858559|NCT00007020|75983310|FG000|STARTED|Overall Study||85||
59858560|NCT00007020|75983310|FG000|COMPLETED|Overall Study||41||
59858561|NCT00007020|75983310|FG000|NOT COMPLETED|Overall Study||44||
59858562|NCT00300755|75983319|FG000|STARTED|Overall Study||18||
59858563|NCT00300755|75983320|FG001|STARTED|Overall Study||21||
59858564|NCT00300755|75983321|FG002|STARTED|Overall Study||21||
59858565|NCT00300755|75983319|FG000|COMPLETED|Overall Study||17||
59858566|NCT00300755|75983320|FG001|COMPLETED|Overall Study||17||
59858567|NCT00300755|75983321|FG002|COMPLETED|Overall Study||19||
59858568|NCT00300755|75983319|FG000|NOT COMPLETED|Overall Study||1||
59858569|NCT00300755|75983320|FG001|NOT COMPLETED|Overall Study||4||
59858570|NCT00300755|75983321|FG002|NOT COMPLETED|Overall Study||2||
59858571|NCT00033540|75983329|FG000|STARTED|Overall Study||57||
59858572|NCT00033540|75983329|FG000|Eligible|Overall Study||54||
59858573|NCT00033540|75983329|FG000|Eligible and Began Protocol Therapy|Overall Study|One patient went off study prior to any toxicity assessments and is not evaluable for toxicities.|52||
59858574|NCT00033540|75983329|FG000|COMPLETED|Overall Study||0||
59858575|NCT00033540|75983329|FG000|NOT COMPLETED|Overall Study||57||
59858576|NCT00300365|75983336|FG000|STARTED|Overall Study||38||
59858577|NCT00300365|75983337|FG001|STARTED|Overall Study||40||
59858578|NCT00300365|75983336|FG000|COMPLETED|Overall Study||34||
59858579|NCT00300365|75983337|FG001|COMPLETED|Overall Study||38||
59858580|NCT00300365|75983336|FG000|NOT COMPLETED|Overall Study||4||
59858581|NCT00300365|75983337|FG001|NOT COMPLETED|Overall Study||2||
59858582|NCT00048048|75983352|FG000|STARTED|Core Treatment||6||
59858583|NCT00048048|75983353|FG001|STARTED|Core Treatment||6||
59858584|NCT00048048|75983354|FG002|STARTED|Core Treatment||10||
59858585|NCT00048048|75983355|FG003|STARTED|Core Treatment||6||
59858586|NCT00048048|75983356|FG004|STARTED|Core Treatment||6||
59858587|NCT00048048|75983357|FG005|STARTED|Core Treatment||9||
59858588|NCT00048048|75983358|FG006|STARTED|Core Treatment||6||
59858589|NCT00048048|75983359|FG007|STARTED|Core Treatment||6||
59858590|NCT00048048|75983360|FG008|STARTED|Core Treatment||10||
59858591|NCT00048048|75983361|FG009|STARTED|Core Treatment||0||
59858592|NCT00048048|75983362|FG010|STARTED|Core Treatment||0||
59858593|NCT00048048|75983363|FG011|STARTED|Core Treatment||0||
59858594|NCT00048048|75983352|FG000|COMPLETED|Core Treatment||6||
59858595|NCT00048048|75983353|FG001|COMPLETED|Core Treatment||6||
59858596|NCT00048048|75983354|FG002|COMPLETED|Core Treatment||9||
59858597|NCT00048048|75983355|FG003|COMPLETED|Core Treatment||6||
59858598|NCT00048048|75983356|FG004|COMPLETED|Core Treatment||6||
59858599|NCT00048048|75983357|FG005|COMPLETED|Core Treatment||9||
59858600|NCT00048048|75983358|FG006|COMPLETED|Core Treatment||6||
59858601|NCT00048048|75983359|FG007|COMPLETED|Core Treatment||5||
59858602|NCT00048048|75983360|FG008|COMPLETED|Core Treatment||10||
59858603|NCT00048048|75983361|FG009|COMPLETED|Core Treatment||0||
59858604|NCT00048048|75983362|FG010|COMPLETED|Core Treatment||0||
59858605|NCT00048048|75983363|FG011|COMPLETED|Core Treatment||0||
59858606|NCT00048048|75983352|FG000|NOT COMPLETED|Core Treatment||0||
59858607|NCT00048048|75983353|FG001|NOT COMPLETED|Core Treatment||0||
59858608|NCT00048048|75983354|FG002|NOT COMPLETED|Core Treatment||1||
59858609|NCT00048048|75983355|FG003|NOT COMPLETED|Core Treatment||0||
59858610|NCT00048048|75983356|FG004|NOT COMPLETED|Core Treatment||0||
59858611|NCT00048048|75983357|FG005|NOT COMPLETED|Core Treatment||0||
59858612|NCT00048048|75983358|FG006|NOT COMPLETED|Core Treatment||0||
59858613|NCT00048048|75983359|FG007|NOT COMPLETED|Core Treatment||1||
59858614|NCT00048048|75983360|FG008|NOT COMPLETED|Core Treatment||0||
59858615|NCT00048048|75983361|FG009|NOT COMPLETED|Core Treatment||0||
59858616|NCT00048048|75983362|FG010|NOT COMPLETED|Core Treatment||0||
59858617|NCT00048048|75983363|FG011|NOT COMPLETED|Core Treatment||0||
59858618|NCT00048048|75983352|FG000|STARTED|Extension Year 1||0||
59858619|NCT00048048|75983353|FG001|STARTED|Extension Year 1||0||
59858620|NCT00048048|75983354|FG002|STARTED|Extension Year 1||0||
59858621|NCT00048048|75983355|FG003|STARTED|Extension Year 1||0||
59858622|NCT00048048|75983356|FG004|STARTED|Extension Year 1||0||
59858623|NCT00048048|75983357|FG005|STARTED|Extension Year 1||0||
59858624|NCT00048048|75983358|FG006|STARTED|Extension Year 1||0||
59858625|NCT00048048|75983359|FG007|STARTED|Extension Year 1||0||
59858626|NCT00048048|75983360|FG008|STARTED|Extension Year 1||0||
59858627|NCT00048048|75983361|FG009|STARTED|Extension Year 1|Participants (Cohorts 1, 2, and 3) who completed core, entered extension period (entry optional).|16||
59858628|NCT00048048|75983362|FG010|STARTED|Extension Year 1|Participants (Cohorts 4, 5, and 6) who completed core, entered extension period (entry optional).|16||
59858629|NCT00048048|75983363|FG011|STARTED|Extension Year 1|Participants (Cohorts 7, 8, and 9) who completed core, entered extension period (entry optional).|19||
59858630|NCT00048048|75983352|FG000|COMPLETED|Extension Year 1||0||
59858631|NCT00048048|75983353|FG001|COMPLETED|Extension Year 1||0||
59858632|NCT00048048|75983354|FG002|COMPLETED|Extension Year 1||0||
59858633|NCT00048048|75983355|FG003|COMPLETED|Extension Year 1||0||
59858634|NCT00048048|75983356|FG004|COMPLETED|Extension Year 1||0||
59858635|NCT00048048|75983357|FG005|COMPLETED|Extension Year 1||0||
59858636|NCT00048048|75983358|FG006|COMPLETED|Extension Year 1||0||
59858637|NCT00048048|75983359|FG007|COMPLETED|Extension Year 1||0||
59858638|NCT00048048|75983360|FG008|COMPLETED|Extension Year 1||0||
59858639|NCT00048048|75983361|FG009|COMPLETED|Extension Year 1||14||
59858640|NCT00048048|75983362|FG010|COMPLETED|Extension Year 1||14||
59858641|NCT00048048|75983363|FG011|COMPLETED|Extension Year 1||15||
59858642|NCT00048048|75983352|FG000|NOT COMPLETED|Extension Year 1||0||
59858643|NCT00048048|75983353|FG001|NOT COMPLETED|Extension Year 1||0||
59858644|NCT00048048|75983354|FG002|NOT COMPLETED|Extension Year 1||0||
59858645|NCT00048048|75983355|FG003|NOT COMPLETED|Extension Year 1||0||
59858646|NCT00048048|75983356|FG004|NOT COMPLETED|Extension Year 1||0||
59858647|NCT00048048|75983357|FG005|NOT COMPLETED|Extension Year 1||0||
59858648|NCT00048048|75983358|FG006|NOT COMPLETED|Extension Year 1||0||
59858649|NCT00048048|75983359|FG007|NOT COMPLETED|Extension Year 1||0||
59858650|NCT00048048|75983360|FG008|NOT COMPLETED|Extension Year 1||0||
59858651|NCT00048048|75983361|FG009|NOT COMPLETED|Extension Year 1||2||
59858652|NCT00048048|75983362|FG010|NOT COMPLETED|Extension Year 1||2||
59858653|NCT00048048|75983363|FG011|NOT COMPLETED|Extension Year 1||4||
59858654|NCT00048048|75983352|FG000|STARTED|Extension Year 2||0||
59858655|NCT00048048|75983353|FG001|STARTED|Extension Year 2||0||
59858656|NCT00048048|75983354|FG002|STARTED|Extension Year 2||0||
59858657|NCT00048048|75983355|FG003|STARTED|Extension Year 2||0||
59858658|NCT00048048|75983356|FG004|STARTED|Extension Year 2||0||
59858659|NCT00048048|75983357|FG005|STARTED|Extension Year 2||0||
59858660|NCT00048048|75983358|FG006|STARTED|Extension Year 2||0||
59858661|NCT00048048|75983359|FG007|STARTED|Extension Year 2||0||
59858662|NCT00048048|75983360|FG008|STARTED|Extension Year 2||0||
59858663|NCT00048048|75983361|FG009|STARTED|Extension Year 2|Twelve participants who completed Extension Year 1 were switched to RO0503821 (1x/2Week).|2||
59858664|NCT00048048|75983362|FG010|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1 + 12 participants from RO0503821 (1X/Week).|23||
59858665|NCT00048048|75983363|FG011|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|15||
59858666|NCT00048048|75983352|FG000|COMPLETED|Extension Year 2||0||
59858667|NCT00048048|75983353|FG001|COMPLETED|Extension Year 2||0||
59858668|NCT00048048|75983354|FG002|COMPLETED|Extension Year 2||0||
59858669|NCT00048048|75983355|FG003|COMPLETED|Extension Year 2||0||
59858670|NCT00048048|75983356|FG004|COMPLETED|Extension Year 2||0||
59858671|NCT00048048|75983357|FG005|COMPLETED|Extension Year 2||0||
59858672|NCT00048048|75983358|FG006|COMPLETED|Extension Year 2||0||
59858673|NCT00048048|75983359|FG007|COMPLETED|Extension Year 2||0||
59858674|NCT00048048|75983360|FG008|COMPLETED|Extension Year 2||0||
59858675|NCT00048048|75983361|FG009|COMPLETED|Extension Year 2||2||
59858676|NCT00048048|75983362|FG010|COMPLETED|Extension Year 2||19||
59858677|NCT00048048|75983363|FG011|COMPLETED|Extension Year 2||13||
59858678|NCT00048048|75983352|FG000|NOT COMPLETED|Extension Year 2||0||
59858679|NCT00048048|75983353|FG001|NOT COMPLETED|Extension Year 2||0||
59858680|NCT00048048|75983354|FG002|NOT COMPLETED|Extension Year 2||0||
59858681|NCT00048048|75983355|FG003|NOT COMPLETED|Extension Year 2||0||
59858682|NCT00048048|75983356|FG004|NOT COMPLETED|Extension Year 2||0||
59858683|NCT00048048|75983357|FG005|NOT COMPLETED|Extension Year 2||0||
59858684|NCT00048048|75983358|FG006|NOT COMPLETED|Extension Year 2||0||
60123902|NCT01528033|76245271|FG000|NOT COMPLETED|Follow Up||46||
59858685|NCT00048048|75983359|FG007|NOT COMPLETED|Extension Year 2||0||
59858686|NCT00048048|75983360|FG008|NOT COMPLETED|Extension Year 2||0||
59858687|NCT00048048|75983361|FG009|NOT COMPLETED|Extension Year 2||0||
59858688|NCT00048048|75983362|FG010|NOT COMPLETED|Extension Year 2||4||
60123903|NCT01528033|76245272|FG001|NOT COMPLETED|Follow Up||44||
60123904|NCT00145587|76245280|FG000|STARTED|Overall Study||5||
59858689|NCT00048048|75983363|FG011|NOT COMPLETED|Extension Year 2||2||
59858690|NCT00300053|75983393|FG000|STARTED|Overall Study|started = randomized and treated/injected|55||
60123905|NCT00145587|76245281|FG001|STARTED|Overall Study||1||
59858691|NCT00300053|75983394|FG001|STARTED|Overall Study|started = randomized and treated/injected|56||
59858692|NCT00300053|75983395|FG002|STARTED|Overall Study|started = randomized and treated/injected|56||
59858693|NCT00300053|75983393|FG000|3-Month Evaluation|Overall Study||55||
59858694|NCT00300053|75983394|FG001|3-Month Evaluation|Overall Study||56||
59858695|NCT00300053|75983395|FG002|3-Month Evaluation|Overall Study||54||
59858696|NCT00300053|75983393|FG000|6-Month Evaluation|Overall Study||54||
59858697|NCT00300053|75983394|FG001|6-Month Evaluation|Overall Study||55||
59858698|NCT00300053|75983395|FG002|6-Month Evaluation|Overall Study||53||
59858699|NCT00300053|75983393|FG000|COMPLETED|Overall Study||53||
59858700|NCT00300053|75983394|FG001|COMPLETED|Overall Study||53||
59858701|NCT00300053|75983395|FG002|COMPLETED|Overall Study||50||
59858702|NCT00300053|75983393|FG000|NOT COMPLETED|Overall Study||2||
59858703|NCT00300053|75983394|FG001|NOT COMPLETED|Overall Study||3||
59858704|NCT00300053|75983395|FG002|NOT COMPLETED|Overall Study||6||
59858705|NCT00299975|75983407|FG000|STARTED|Overall Study||32||
59858706|NCT00299975|75983408|FG001|STARTED|Overall Study||32||
59858707|NCT00299975|75983409|FG002|STARTED|Overall Study||33||
59858708|NCT00299975|75983407|FG000|Received Allocated Intervention|Overall Study||32||
59858709|NCT00299975|75983408|FG001|Received Allocated Intervention|Overall Study||32||
59858710|NCT00299975|75983409|FG002|Received Allocated Intervention|Overall Study||32||
59858711|NCT00299975|75983407|FG000|COMPLETED|Overall Study||29||
59858712|NCT00299975|75983408|FG001|COMPLETED|Overall Study||31||
59858713|NCT00299975|75983409|FG002|COMPLETED|Overall Study||25||
59858714|NCT00299975|75983407|FG000|NOT COMPLETED|Overall Study||3||
59858715|NCT00299975|75983408|FG001|NOT COMPLETED|Overall Study||1||
59858716|NCT00299975|75983409|FG002|NOT COMPLETED|Overall Study||8||
59858717|NCT00004980|75983419|FG000|STARTED|Overall Study||27||
59858718|NCT00004980|75983420|FG001|STARTED|Overall Study||23||
59858719|NCT00004980|75983419|FG000|COMPLETED|Overall Study||25||
59858720|NCT00004980|75983420|FG001|COMPLETED|Overall Study||21||
59858721|NCT00004980|75983419|FG000|NOT COMPLETED|Overall Study||2||
59858722|NCT00004980|75983420|FG001|NOT COMPLETED|Overall Study||2||
59858723|NCT00326963|75983426|FG000|STARTED|Overall Study||140||
59858724|NCT00326963|75983426|FG000|COMPLETED|Overall Study||107||
59858725|NCT00326963|75983426|FG000|NOT COMPLETED|Overall Study||33||
59858726|NCT00326885|75983431|FG000|STARTED|Overall Study||32||
59858727|NCT00326885|75983431|FG000|COMPLETED|Overall Study||25||
59858728|NCT00326885|75983431|FG000|NOT COMPLETED|Overall Study||7||
59858729|NCT00326495|75983436|FG000|STARTED|Overall Study||51||
59858730|NCT00326495|75983436|FG000|COMPLETED|Overall Study||46||
59858731|NCT00326495|75983436|FG000|NOT COMPLETED|Overall Study||5||
59858732|NCT00326417|75983442|FG000|STARTED|Overall Study||14||
59858733|NCT00326417|75983443|FG001|STARTED|Overall Study||41||
59858734|NCT00326417|75983444|FG002|STARTED|Overall Study||39||
59858735|NCT00326417|75983445|FG003|STARTED|Overall Study||3||
59858736|NCT00326417|75983442|FG000|Phase I|Overall Study||6||
59858737|NCT00326417|75983443|FG001|Phase I|Overall Study||6||
59858738|NCT00326417|75983444|FG002|Phase I|Overall Study||6||
59858739|NCT00326417|75983445|FG003|Phase I|Overall Study||3||
59858740|NCT00326417|75983442|FG000|Phase II|Overall Study||8||
59858741|NCT00326417|75983443|FG001|Phase II|Overall Study||35||
59858742|NCT00326417|75983444|FG002|Phase II|Overall Study||33||
59858743|NCT00326417|75983445|FG003|Phase II|Overall Study||0||
59858744|NCT00326417|75983442|FG000|COMPLETED|Overall Study|Dose level was closed for excessive toxicity after 8 patients in Phase II accrued.|0||
59858745|NCT00326417|75983443|FG001|COMPLETED|Overall Study||41||
59858746|NCT00326417|75983444|FG002|COMPLETED|Overall Study||38||
59858747|NCT00326417|75983445|FG003|COMPLETED|Overall Study|Arm was closed to accrual after 3 patients experienced graft failure.|0||
59858748|NCT00326417|75983442|FG000|NOT COMPLETED|Overall Study||14||
59858749|NCT00326417|75983443|FG001|NOT COMPLETED|Overall Study||0||
59858750|NCT00326417|75983444|FG002|NOT COMPLETED|Overall Study||1||
59858751|NCT00326417|75983445|FG003|NOT COMPLETED|Overall Study||3||
59858752|NCT03825341|75983455|FG000|STARTED|Overall Study||0||
59858753|NCT03825341|75983456|FG001|STARTED|Overall Study||1||
59858754|NCT03825341|75983455|FG000|COMPLETED|Overall Study||0||
59858755|NCT03825341|75983456|FG001|COMPLETED|Overall Study||0||
59858756|NCT03825341|75983455|FG000|NOT COMPLETED|Overall Study||0||
59858757|NCT03825341|75983456|FG001|NOT COMPLETED|Overall Study||1||
59858758|NCT00297479|75983467|FG000|STARTED|Overall Study||103||
59858759|NCT00297479|75983468|FG001|STARTED|Overall Study||155||
59858760|NCT00297479|75983469|FG002|STARTED|Overall Study||154||
59858761|NCT00297479|75983467|FG000|4-Week Follow Up|Overall Study||78||
59858762|NCT00297479|75983468|FG001|4-Week Follow Up|Overall Study||132||
59858763|NCT00297479|75983469|FG002|4-Week Follow Up|Overall Study||128||
59858764|NCT00297479|75983467|FG000|26- Week Follow Up|Overall Study||66||
59858765|NCT00297479|75983468|FG001|26- Week Follow Up|Overall Study||101||
59858766|NCT00297479|75983469|FG002|26- Week Follow Up|Overall Study||103||
59858767|NCT00297479|75983467|FG000|COMPLETED|Overall Study||66||
59858768|NCT00297479|75983468|FG001|COMPLETED|Overall Study||101||
59858769|NCT00297479|75983469|FG002|COMPLETED|Overall Study||103||
59858770|NCT00297479|75983467|FG000|NOT COMPLETED|Overall Study||37||
59858771|NCT00297479|75983468|FG001|NOT COMPLETED|Overall Study||54||
59858772|NCT00297479|75983469|FG002|NOT COMPLETED|Overall Study||51||
59858773|NCT00688870|75983479|FG000|STARTED|Infant Series||84||
59858774|NCT00688870|75983480|FG001|STARTED|Infant Series||84||
59858775|NCT00688870|75983479|FG000|Vaccinated Dose 1|Infant Series||83||
59858776|NCT00688870|75983480|FG001|Vaccinated Dose 1|Infant Series||84||
59858777|NCT00688870|75983479|FG000|Vaccinated Dose 2|Infant Series||80||
59858778|NCT00688870|75983480|FG001|Vaccinated Dose 2|Infant Series||84||
59858779|NCT00688870|75983479|FG000|Vaccinated Dose 3|Infant Series||80||
59858780|NCT00688870|75983480|FG001|Vaccinated Dose 3|Infant Series||84||
59858781|NCT00688870|75983479|FG000|COMPLETED|Infant Series||80||
59858782|NCT00688870|75983480|FG001|COMPLETED|Infant Series||84||
59858783|NCT00688870|75983479|FG000|NOT COMPLETED|Infant Series||4||
59858784|NCT00688870|75983480|FG001|NOT COMPLETED|Infant Series||0||
59858785|NCT00688870|75983479|FG000|STARTED|After Infant Series||80||
59858786|NCT00688870|75983480|FG001|STARTED|After Infant Series||84||
59858787|NCT00688870|75983479|FG000|COMPLETED|After Infant Series||80||
59858788|NCT00688870|75983480|FG001|COMPLETED|After Infant Series||84||
59858789|NCT00688870|75983479|FG000|NOT COMPLETED|After Infant Series||0||
59858790|NCT00688870|75983480|FG001|NOT COMPLETED|After Infant Series||0||
59858791|NCT00688870|75983479|FG000|STARTED|Toddler Dose||80||
59858792|NCT00688870|75983480|FG001|STARTED|Toddler Dose||84||
59858793|NCT00688870|75983479|FG000|COMPLETED|Toddler Dose||80||
59858794|NCT00688870|75983480|FG001|COMPLETED|Toddler Dose||84||
59858795|NCT00688870|75983479|FG000|NOT COMPLETED|Toddler Dose||0||
59858796|NCT00688870|75983480|FG001|NOT COMPLETED|Toddler Dose||0||
59858797|NCT00297167|75983490|FG000|STARTED|First Double-blind Intervention Period||17||
59858798|NCT00297167|75983491|FG001|STARTED|First Double-blind Intervention Period||16||
59858799|NCT00297167|75983492|FG002|STARTED|First Double-blind Intervention Period||0||
59858800|NCT00297167|75983490|FG000|COMPLETED|First Double-blind Intervention Period||17||
59858801|NCT00297167|75983491|FG001|COMPLETED|First Double-blind Intervention Period||16||
59858802|NCT00297167|75983492|FG002|COMPLETED|First Double-blind Intervention Period||0||
59858803|NCT00297167|75983490|FG000|NOT COMPLETED|First Double-blind Intervention Period||0||
59858804|NCT00297167|75983491|FG001|NOT COMPLETED|First Double-blind Intervention Period||0||
59858805|NCT00297167|75983492|FG002|NOT COMPLETED|First Double-blind Intervention Period||0||
59858806|NCT00297167|75983490|FG000|STARTED|Open-label Dose Normalization Period 1||0||
59858807|NCT00297167|75983491|FG001|STARTED|Open-label Dose Normalization Period 1||0||
59858808|NCT00297167|75983492|FG002|STARTED|Open-label Dose Normalization Period 1||33||
59858809|NCT00297167|75983490|FG000|COMPLETED|Open-label Dose Normalization Period 1||0||
59858810|NCT00297167|75983491|FG001|COMPLETED|Open-label Dose Normalization Period 1||0||
59858811|NCT00297167|75983492|FG002|COMPLETED|Open-label Dose Normalization Period 1||32||
59858812|NCT00297167|75983490|FG000|NOT COMPLETED|Open-label Dose Normalization Period 1||0||
59858813|NCT00297167|75983491|FG001|NOT COMPLETED|Open-label Dose Normalization Period 1||0||
59858814|NCT00297167|75983492|FG002|NOT COMPLETED|Open-label Dose Normalization Period 1||1||
59858815|NCT00297167|75983490|FG000|STARTED|Second Double-blind Intervention Period||17||
59858816|NCT00297167|75983491|FG001|STARTED|Second Double-blind Intervention Period||15||
59858817|NCT00297167|75983492|FG002|STARTED|Second Double-blind Intervention Period||0||
59858818|NCT00297167|75983490|FG000|COMPLETED|Second Double-blind Intervention Period||16||
59858819|NCT00297167|75983491|FG001|COMPLETED|Second Double-blind Intervention Period||15||
59858820|NCT00297167|75983492|FG002|COMPLETED|Second Double-blind Intervention Period||0||
59858821|NCT00297167|75983490|FG000|NOT COMPLETED|Second Double-blind Intervention Period||1||
59858822|NCT00297167|75983491|FG001|NOT COMPLETED|Second Double-blind Intervention Period||0||
59858823|NCT00297167|75983492|FG002|NOT COMPLETED|Second Double-blind Intervention Period||0||
59858824|NCT00297167|75983490|FG000|STARTED|Open-label Dose Normalization Period 2||0||
59858825|NCT00297167|75983491|FG001|STARTED|Open-label Dose Normalization Period 2||0||
59858826|NCT00297167|75983492|FG002|STARTED|Open-label Dose Normalization Period 2||31||
59858827|NCT00297167|75983490|FG000|COMPLETED|Open-label Dose Normalization Period 2||0||
59858828|NCT00297167|75983491|FG001|COMPLETED|Open-label Dose Normalization Period 2||0||
59858829|NCT00297167|75983492|FG002|COMPLETED|Open-label Dose Normalization Period 2||31||
59858830|NCT00297167|75983490|FG000|NOT COMPLETED|Open-label Dose Normalization Period 2||0||
59858831|NCT00297167|75983491|FG001|NOT COMPLETED|Open-label Dose Normalization Period 2||0||
59858832|NCT00297167|75983492|FG002|NOT COMPLETED|Open-label Dose Normalization Period 2||0||
59858833|NCT03216226|75983501|FG000|STARTED|Overall Study||57|Randomized|
59858834|NCT03216226|75983502|FG001|STARTED|Overall Study||55|Randomized|
59858835|NCT03216226|75983501|FG000|Randomized and Treated|Overall Study||57||
59858836|NCT03216226|75983502|FG001|Randomized and Treated|Overall Study||54||
59858837|NCT03216226|75983501|FG000|COMPLETED|Overall Study||52||
59858838|NCT03216226|75983502|FG001|COMPLETED|Overall Study||50||
59858839|NCT03216226|75983501|FG000|NOT COMPLETED|Overall Study||5||
59858840|NCT03216226|75983502|FG001|NOT COMPLETED|Overall Study||5||
59858841|NCT03215758|75983510|FG000|STARTED|Overall Study||339||
59858842|NCT03215758|75983511|FG001|STARTED|Overall Study||336||
59858843|NCT03215758|75983510|FG000|COMPLETED|Overall Study||334||
59858844|NCT03215758|75983511|FG001|COMPLETED|Overall Study||328||
59858845|NCT03215758|75983510|FG000|NOT COMPLETED|Overall Study||5||
59858846|NCT03215758|75983511|FG001|NOT COMPLETED|Overall Study||8||
59996849|NCT00709319|76112693|FG000|NOT COMPLETED|Overall Study||6||
59996850|NCT04164563|76112699|FG000|STARTED|Overall Study||3||
59858847|NCT00290771|75983519|FG000|STARTED|Overall Study||131||
59858848|NCT00290771|75983520|FG001|STARTED|Overall Study||100||
59858849|NCT00290771|75983519|FG000|COMPLETED|Overall Study||4||
59858850|NCT00290771|75983520|FG001|COMPLETED|Overall Study||3||
59858851|NCT00290771|75983519|FG000|NOT COMPLETED|Overall Study||127||
59858852|NCT00290771|75983520|FG001|NOT COMPLETED|Overall Study||97||
59858853|NCT00274625|75983529|FG000|STARTED|Overall Study||199||
59858854|NCT00274625|75983530|FG001|STARTED|Overall Study||203||
59858855|NCT00274625|75983529|FG000|COMPLETED|Overall Study||139||
59858856|NCT00274625|75983530|FG001|COMPLETED|Overall Study||141||
59858857|NCT00274625|75983529|FG000|NOT COMPLETED|Overall Study||60||
59858858|NCT00274625|75983530|FG001|NOT COMPLETED|Overall Study||62||
59858859|NCT00290693|75983536|FG000|STARTED|Overall Study||45||
59858860|NCT00290693|75983536|FG000|COMPLETED|Overall Study||43||
59858861|NCT00290693|75983536|FG000|NOT COMPLETED|Overall Study||2||
59858862|NCT03214666|75983547|FG000|STARTED|Cohort 1: Dose Level 1: 5 ug/kg/Day||2||
59858863|NCT03214666|75983548|FG001|STARTED|Cohort 1: Dose Level 1: 5 ug/kg/Day||0||
59858864|NCT03214666|75983549|FG002|STARTED|Cohort 1: Dose Level 1: 5 ug/kg/Day||0||
59858865|NCT03214666|75983550|FG003|STARTED|Cohort 1: Dose Level 1: 5 ug/kg/Day||0||
59858866|NCT03214666|75983551|FG004|STARTED|Cohort 1: Dose Level 1: 5 ug/kg/Day||0||
59858867|NCT03214666|75983552|FG005|STARTED|Cohort 1: Dose Level 1: 5 ug/kg/Day||0||
59858868|NCT03214666|75983547|FG000|COMPLETED|Cohort 1: Dose Level 1: 5 ug/kg/Day||2||
59858869|NCT03214666|75983548|FG001|COMPLETED|Cohort 1: Dose Level 1: 5 ug/kg/Day||0||
59858870|NCT03214666|75983549|FG002|COMPLETED|Cohort 1: Dose Level 1: 5 ug/kg/Day||0||
59858871|NCT03214666|75983550|FG003|COMPLETED|Cohort 1: Dose Level 1: 5 ug/kg/Day||0||
59858872|NCT03214666|75983551|FG004|COMPLETED|Cohort 1: Dose Level 1: 5 ug/kg/Day||0||
59858873|NCT03214666|75983552|FG005|COMPLETED|Cohort 1: Dose Level 1: 5 ug/kg/Day||0||
59858874|NCT03214666|75983547|FG000|NOT COMPLETED|Cohort 1: Dose Level 1: 5 ug/kg/Day||0||
59858875|NCT03214666|75983548|FG001|NOT COMPLETED|Cohort 1: Dose Level 1: 5 ug/kg/Day||0||
59858876|NCT03214666|75983549|FG002|NOT COMPLETED|Cohort 1: Dose Level 1: 5 ug/kg/Day||0||
59858877|NCT03214666|75983550|FG003|NOT COMPLETED|Cohort 1: Dose Level 1: 5 ug/kg/Day||0||
59858878|NCT03214666|75983551|FG004|NOT COMPLETED|Cohort 1: Dose Level 1: 5 ug/kg/Day||0||
59858879|NCT03214666|75983552|FG005|NOT COMPLETED|Cohort 1: Dose Level 1: 5 ug/kg/Day||0||
59858880|NCT03214666|75983547|FG000|STARTED|Cohort 2: Dose Level 2: 10ug/kg/Day||0||
59858881|NCT03214666|75983548|FG001|STARTED|Cohort 2: Dose Level 2: 10ug/kg/Day||2||
59858882|NCT03214666|75983549|FG002|STARTED|Cohort 2: Dose Level 2: 10ug/kg/Day||0||
60123906|NCT00145587|76245280|FG000|COMPLETED|Overall Study||5||
59858883|NCT03214666|75983550|FG003|STARTED|Cohort 2: Dose Level 2: 10ug/kg/Day||0||
59858884|NCT03214666|75983551|FG004|STARTED|Cohort 2: Dose Level 2: 10ug/kg/Day||0||
59858885|NCT03214666|75983552|FG005|STARTED|Cohort 2: Dose Level 2: 10ug/kg/Day||0||
59858886|NCT03214666|75983547|FG000|COMPLETED|Cohort 2: Dose Level 2: 10ug/kg/Day||0||
59858887|NCT03214666|75983548|FG001|COMPLETED|Cohort 2: Dose Level 2: 10ug/kg/Day||2||
59858888|NCT03214666|75983549|FG002|COMPLETED|Cohort 2: Dose Level 2: 10ug/kg/Day||0||
59858889|NCT03214666|75983550|FG003|COMPLETED|Cohort 2: Dose Level 2: 10ug/kg/Day||0||
59858890|NCT03214666|75983551|FG004|COMPLETED|Cohort 2: Dose Level 2: 10ug/kg/Day||0||
59858891|NCT03214666|75983552|FG005|COMPLETED|Cohort 2: Dose Level 2: 10ug/kg/Day||0||
59858892|NCT03214666|75983547|FG000|NOT COMPLETED|Cohort 2: Dose Level 2: 10ug/kg/Day||0||
59858893|NCT03214666|75983548|FG001|NOT COMPLETED|Cohort 2: Dose Level 2: 10ug/kg/Day||0||
59858894|NCT03214666|75983549|FG002|NOT COMPLETED|Cohort 2: Dose Level 2: 10ug/kg/Day||0||
59858895|NCT03214666|75983550|FG003|NOT COMPLETED|Cohort 2: Dose Level 2: 10ug/kg/Day||0||
59858896|NCT03214666|75983551|FG004|NOT COMPLETED|Cohort 2: Dose Level 2: 10ug/kg/Day||0||
59858897|NCT03214666|75983552|FG005|NOT COMPLETED|Cohort 2: Dose Level 2: 10ug/kg/Day||0||
59996851|NCT04164563|76112700|FG001|STARTED|Overall Study||3||
59996852|NCT04164563|76112699|FG000|COMPLETED|Overall Study||3||
59996853|NCT04164563|76112700|FG001|COMPLETED|Overall Study||3||
59996854|NCT04164563|76112699|FG000|NOT COMPLETED|Overall Study||0||
59996855|NCT04164563|76112700|FG001|NOT COMPLETED|Overall Study||0||
59996856|NCT03397589|76112708|FG000|STARTED|Overall Study||211||
59996857|NCT03397589|76112709|FG001|STARTED|Overall Study||209||
59996858|NCT03397589|76112708|FG000|COMPLETED|Overall Study||175||
59996859|NCT03397589|76112709|FG001|COMPLETED|Overall Study||187||
59996860|NCT03397589|76112708|FG000|NOT COMPLETED|Overall Study||36||
59996861|NCT03397589|76112709|FG001|NOT COMPLETED|Overall Study||22||
59996862|NCT03369197|76112717|FG000|STARTED|Overall Study||53||
59996863|NCT03369197|76112718|FG001|STARTED|Overall Study||58||
59996864|NCT03369197|76112717|FG000|COMPLETED|Overall Study||53||
59996865|NCT03369197|76112718|FG001|COMPLETED|Overall Study||58||
59996866|NCT03369197|76112717|FG000|NOT COMPLETED|Overall Study||0||
59996867|NCT03369197|76112718|FG001|NOT COMPLETED|Overall Study||0||
59996868|NCT03148613|76112726|FG000|STARTED|Overall Study||39||
59996869|NCT03148613|76112727|FG001|STARTED|Overall Study||31||
59996870|NCT03148613|76112726|FG000|COMPLETED|Overall Study||39||
59996871|NCT03148613|76112727|FG001|COMPLETED|Overall Study||31||
59996872|NCT03148613|76112726|FG000|NOT COMPLETED|Overall Study||0||
59996873|NCT03148613|76112727|FG001|NOT COMPLETED|Overall Study||0||
59996874|NCT02729051|76112738|FG000|STARTED|Overall Study||527||
59996875|NCT02729051|76112739|FG001|STARTED|Overall Study||528||
59858898|NCT03214666|75983547|FG000|STARTED|Cohort 3: Dose Level 3: 25 ug/kg/Day||0||
59858899|NCT03214666|75983548|FG001|STARTED|Cohort 3: Dose Level 3: 25 ug/kg/Day||0||
59858900|NCT03214666|75983549|FG002|STARTED|Cohort 3: Dose Level 3: 25 ug/kg/Day||2||
59858901|NCT03214666|75983550|FG003|STARTED|Cohort 3: Dose Level 3: 25 ug/kg/Day||0||
60123907|NCT00145587|76245281|FG001|COMPLETED|Overall Study||1||
60123908|NCT00145587|76245280|FG000|NOT COMPLETED|Overall Study||0||
60123909|NCT00145587|76245281|FG001|NOT COMPLETED|Overall Study||0||
60123910|NCT01560871|76245289|FG000|STARTED|Overall Study||9||
60123911|NCT01560871|76245290|FG001|STARTED|Overall Study||7||
60123912|NCT01560871|76245289|FG000|COMPLETED|Overall Study||3||
60123913|NCT01560871|76245290|FG001|COMPLETED|Overall Study||5||
60123914|NCT01560871|76245289|FG000|NOT COMPLETED|Overall Study||6||
60123915|NCT01560871|76245290|FG001|NOT COMPLETED|Overall Study||2||
60123916|NCT01509053|76245297|FG000|STARTED|Oral Aripirazole (Phase A)||19||
60123917|NCT01509053|76245297|FG000|COMPLETED|Oral Aripirazole (Phase A)||8||
60123918|NCT01509053|76245297|FG000|NOT COMPLETED|Oral Aripirazole (Phase A)||11||
60123919|NCT01509053|76245297|FG000|STARTED|Aripiprazole IM Depot Treatment Phase(B)|Includes 8 patients from Phase A + 11 patients who entered directly into Phase B.|19||
60123920|NCT01509053|76245297|FG000|COMPLETED|Aripiprazole IM Depot Treatment Phase(B)||3||
60123921|NCT01509053|76245297|FG000|NOT COMPLETED|Aripiprazole IM Depot Treatment Phase(B)||16||
60123922|NCT01509053|76245297|FG000|STARTED|Aripiprazole IM Depot Extension Phase(C)||3||
60123923|NCT01509053|76245297|FG000|COMPLETED|Aripiprazole IM Depot Extension Phase(C)||0||
60123924|NCT01509053|76245297|FG000|NOT COMPLETED|Aripiprazole IM Depot Extension Phase(C)||3||
60123925|NCT02100189|76245305|FG000|STARTED|Overall Study||50||
60123926|NCT02100189|76245305|FG000|COMPLETED|Overall Study||50||
60123927|NCT02100189|76245305|FG000|NOT COMPLETED|Overall Study||0||
60123928|NCT01560403|76245311|FG000|STARTED|Overall Study||5||
60123929|NCT01560403|76245312|FG001|STARTED|Overall Study||9||
60123930|NCT01560403|76245311|FG000|COMPLETED|Overall Study||5||
60123931|NCT01560403|76245312|FG001|COMPLETED|Overall Study||8||
60123932|NCT01560403|76245311|FG000|NOT COMPLETED|Overall Study||0||
60123933|NCT01560403|76245312|FG001|NOT COMPLETED|Overall Study||1||
60123934|NCT02100579|76245320|FG000|STARTED|Overall Study||20||
60123935|NCT02100579|76245321|FG001|STARTED|Overall Study||20||
60123936|NCT02100579|76245320|FG000|COMPLETED|Overall Study||20||
60123937|NCT02100579|76245321|FG001|COMPLETED|Overall Study||20||
60123938|NCT02100579|76245320|FG000|NOT COMPLETED|Overall Study||0||
60123939|NCT02100579|76245321|FG001|NOT COMPLETED|Overall Study||0||
60123940|NCT04096001|76245327|FG000|STARTED|Overall Study||101||
60123941|NCT04096001|76245327|FG000|COMPLETED|Overall Study||51||
60123942|NCT04096001|76245327|FG000|NOT COMPLETED|Overall Study||50||
60123943|NCT00147069|76245335|FG000|STARTED|Overall Study||15||
60123944|NCT00147069|76245336|FG001|STARTED|Overall Study||15||
60123945|NCT00147069|76245337|FG002|STARTED|Overall Study||15||
60123946|NCT00147069|76245338|FG003|STARTED|Overall Study||15||
60123947|NCT00147069|76245335|FG000|COMPLETED|Overall Study||15||
60123948|NCT00147069|76245336|FG001|COMPLETED|Overall Study||15||
60123949|NCT00147069|76245337|FG002|COMPLETED|Overall Study||15||
60123950|NCT00147069|76245338|FG003|COMPLETED|Overall Study||15||
60123951|NCT00147069|76245335|FG000|NOT COMPLETED|Overall Study||0||
60123952|NCT00147069|76245336|FG001|NOT COMPLETED|Overall Study||0||
60123953|NCT00147069|76245337|FG002|NOT COMPLETED|Overall Study||0||
60123954|NCT00147069|76245338|FG003|NOT COMPLETED|Overall Study||0||
60123955|NCT00284739|76245350|FG000|STARTED|Overall Study||11||
60123956|NCT00284739|76245351|FG001|STARTED|Overall Study||9||
60123957|NCT00284739|76245350|FG000|COMPLETED|Overall Study||11||
60123958|NCT00284739|76245351|FG001|COMPLETED|Overall Study||9||
60123959|NCT00284739|76245350|FG000|NOT COMPLETED|Overall Study||0||
60123960|NCT00284739|76245351|FG001|NOT COMPLETED|Overall Study||0||
60123961|NCT01527487|76245359|FG000|STARTED|Overall Study|Includes 10 patients from safety lead-in.|54||
60123962|NCT01527487|76245360|FG001|STARTED|Overall Study||22||
60123963|NCT01527487|76245359|FG000|COMPLETED|Overall Study|Patients who completed 6 cycles plus surgery.|46||
60123964|NCT01527487|76245360|FG001|COMPLETED|Overall Study||15||
59858902|NCT03214666|75983551|FG004|STARTED|Cohort 3: Dose Level 3: 25 ug/kg/Day||0||
59858903|NCT03214666|75983552|FG005|STARTED|Cohort 3: Dose Level 3: 25 ug/kg/Day||0||
59858904|NCT03214666|75983547|FG000|COMPLETED|Cohort 3: Dose Level 3: 25 ug/kg/Day||0||
59858905|NCT03214666|75983548|FG001|COMPLETED|Cohort 3: Dose Level 3: 25 ug/kg/Day||0||
60123965|NCT01527487|76245359|FG000|NOT COMPLETED|Overall Study||8||
60123966|NCT01527487|76245360|FG001|NOT COMPLETED|Overall Study||7||
60123967|NCT01506947|76245371|FG000|STARTED|Overall Study||65||
59858906|NCT03214666|75983549|FG002|COMPLETED|Cohort 3: Dose Level 3: 25 ug/kg/Day||2||
59858907|NCT03214666|75983550|FG003|COMPLETED|Cohort 3: Dose Level 3: 25 ug/kg/Day||0||
59858908|NCT03214666|75983551|FG004|COMPLETED|Cohort 3: Dose Level 3: 25 ug/kg/Day||0||
60123968|NCT01506947|76245371|FG000|COMPLETED|Overall Study||49||
60123969|NCT01506947|76245371|FG000|NOT COMPLETED|Overall Study||16||
60123970|NCT00149643|76245379|FG000|STARTED|Overall Study||34||
60123971|NCT00149643|76245380|FG001|STARTED|Overall Study||36||
60123972|NCT00149643|76245379|FG000|COMPLETED|Overall Study||0||
60123973|NCT00149643|76245380|FG001|COMPLETED|Overall Study||0||
60123974|NCT00149643|76245379|FG000|NOT COMPLETED|Overall Study||34||
60123975|NCT00149643|76245380|FG001|NOT COMPLETED|Overall Study||36||
60123976|NCT02665338|76245388|FG000|STARTED|Overall Study||5||
60123977|NCT02665338|76245389|FG001|STARTED|Overall Study||6||
60123978|NCT02665338|76245388|FG000|COMPLETED|Overall Study||5||
60123979|NCT02665338|76245389|FG001|COMPLETED|Overall Study||5||
60123980|NCT02665338|76245388|FG000|NOT COMPLETED|Overall Study||0||
60123981|NCT02665338|76245389|FG001|NOT COMPLETED|Overall Study||1||
60123982|NCT01506479|76245398|FG000|STARTED|Overall Study||40||
60123983|NCT01506479|76245399|FG001|STARTED|Overall Study||43||
60123984|NCT01506479|76245400|FG002|STARTED|Overall Study||45||
60123985|NCT01506479|76245398|FG000|COMPLETED|Overall Study||37|Number of participants with 6 month follow-up.|
60123986|NCT01506479|76245399|FG001|COMPLETED|Overall Study||38|Number of participants with 6 month follow-up.|
60123987|NCT01506479|76245400|FG002|COMPLETED|Overall Study||42|Number of participants with 6 month follow-up.|
60123988|NCT01506479|76245398|FG000|NOT COMPLETED|Overall Study||3||
60123989|NCT01506479|76245399|FG001|NOT COMPLETED|Overall Study||5||
60123990|NCT01506479|76245400|FG002|NOT COMPLETED|Overall Study||3||
60123991|NCT00149799|76245412|FG000|STARTED|Open Label Escitalopram (Phase I)||100||
60123992|NCT00149799|76245413|FG001|STARTED|Open Label Escitalopram (Phase I)||0||
60123993|NCT00149799|76245414|FG002|STARTED|Open Label Escitalopram (Phase I)||0||
60123994|NCT00149799|76245412|FG000|COMPLETED|Open Label Escitalopram (Phase I)|14 completers were non-responders and 2 responders terminated the study after completing Phase I|74||
60123995|NCT00149799|76245413|FG001|COMPLETED|Open Label Escitalopram (Phase I)||0||
60123996|NCT00149799|76245414|FG002|COMPLETED|Open Label Escitalopram (Phase I)||0||
60123997|NCT00149799|76245412|FG000|NOT COMPLETED|Open Label Escitalopram (Phase I)||26||
60123998|NCT00149799|76245413|FG001|NOT COMPLETED|Open Label Escitalopram (Phase I)||0||
60123999|NCT00149799|76245414|FG002|NOT COMPLETED|Open Label Escitalopram (Phase I)||0||
60124000|NCT00149799|76245412|FG000|STARTED|Discontinuation (Phase II)||0||
60124001|NCT00149799|76245413|FG001|STARTED|Discontinuation (Phase II)|Only responders who completed Phase I and were willing to continue were randomized in Phase II|28||
60124002|NCT00149799|76245414|FG002|STARTED|Discontinuation (Phase II)|Only responders who completed Phase I and were willing to continue were randomized in Phase II|30||
60124003|NCT00149799|76245412|FG000|COMPLETED|Discontinuation (Phase II)||0||
60124004|NCT00149799|76245413|FG001|COMPLETED|Discontinuation (Phase II)||25||
60124005|NCT00149799|76245414|FG002|COMPLETED|Discontinuation (Phase II)||21||
60124006|NCT00149799|76245412|FG000|NOT COMPLETED|Discontinuation (Phase II)||0||
60124007|NCT00149799|76245413|FG001|NOT COMPLETED|Discontinuation (Phase II)||3||
60124008|NCT00149799|76245414|FG002|NOT COMPLETED|Discontinuation (Phase II)||9||
60124009|NCT01506323|76245424|FG000|STARTED|Overall Study||89||
60124010|NCT01506323|76245425|FG001|STARTED|Overall Study||84||
60124011|NCT01506323|76245424|FG000|Post-treatment Completers|Overall Study||69||
60124012|NCT01506323|76245425|FG001|Post-treatment Completers|Overall Study||72||
60124013|NCT01506323|76245424|FG000|Post-treatment Completed CAPS|Overall Study||68||
60124014|NCT01506323|76245425|FG001|Post-treatment Completed CAPS|Overall Study||72||
60124015|NCT01506323|76245424|FG000|COMPLETED|Overall Study||65||
60124016|NCT01506323|76245425|FG001|COMPLETED|Overall Study||71||
60124017|NCT01506323|76245424|FG000|NOT COMPLETED|Overall Study||24||
60124018|NCT01506323|76245425|FG001|NOT COMPLETED|Overall Study||13||
60124019|NCT01505387|76245438|FG000|STARTED|Overall Study||25||
60124020|NCT01505387|76245439|FG001|STARTED|Overall Study||25||
60124021|NCT01505387|76245438|FG000|Treated|Overall Study||24||
60124022|NCT01505387|76245439|FG001|Treated|Overall Study||24||
60124023|NCT01505387|76245438|FG000|COMPLETED|Overall Study|1 subject not included in intention to treat population as violated inclusion criteria|23||
60124024|NCT01505387|76245439|FG001|COMPLETED|Overall Study||24||
60124025|NCT01505387|76245438|FG000|NOT COMPLETED|Overall Study||2||
60124026|NCT01505387|76245439|FG001|NOT COMPLETED|Overall Study||1||
60124027|NCT00324753|76245447|FG000|STARTED|Overall Study||190||
60124028|NCT00324753|76245448|FG001|STARTED|Overall Study||264||
60124029|NCT00324753|76245447|FG000|COMPLETED|Overall Study||190||
60124030|NCT00324753|76245448|FG001|COMPLETED|Overall Study||264||
60124031|NCT00324753|76245447|FG000|NOT COMPLETED|Overall Study||0||
60124032|NCT00324753|76245448|FG001|NOT COMPLETED|Overall Study||0||
60124033|NCT00326781|76245458|FG000|STARTED|Overall Study||344||
60124034|NCT00326781|76245459|FG001|STARTED|Overall Study||330||
60124035|NCT00326781|76245458|FG000|COMPLETED|Overall Study||302||
60124036|NCT00326781|76245459|FG001|COMPLETED|Overall Study||298||
60124037|NCT00326781|76245458|FG000|NOT COMPLETED|Overall Study||42||
60124038|NCT00326781|76245459|FG001|NOT COMPLETED|Overall Study||32||
60124039|NCT00328263|76245467|FG000|STARTED|Overall Study||216||
60124040|NCT00328263|76245468|FG001|STARTED|Overall Study||221||
60124041|NCT00328263|76245467|FG000|COMPLETED|Overall Study|3 deaths occured during the study. None of the deaths were causally related to the study product.|213||
60124042|NCT00328263|76245468|FG001|COMPLETED|Overall Study|4 deaths occured during the study. None of the deaths were causally related to the study product.|217||
60124043|NCT00328263|76245467|FG000|NOT COMPLETED|Overall Study||3||
60124044|NCT00328263|76245468|FG001|NOT COMPLETED|Overall Study||4||
60124045|NCT00329433|76245476|FG000|STARTED|Overall Study||61||
60124046|NCT00329433|76245477|FG001|STARTED|Overall Study||59||
60124047|NCT00329433|76245476|FG000|COMPLETED|Overall Study||61||
60124048|NCT00329433|76245477|FG001|COMPLETED|Overall Study||59||
60124049|NCT00329433|76245476|FG000|NOT COMPLETED|Overall Study||0||
60124050|NCT00329433|76245477|FG001|NOT COMPLETED|Overall Study||0||
60124051|NCT00289341|76245485|FG000|STARTED|Overall Study||12||
60124052|NCT00289341|76245486|FG001|STARTED|Overall Study||12||
60124053|NCT00289341|76245485|FG000|COMPLETED|Overall Study||12||
60124054|NCT00289341|76245486|FG001|COMPLETED|Overall Study||12||
60124055|NCT00289341|76245485|FG000|NOT COMPLETED|Overall Study||0||
60124056|NCT00289341|76245486|FG001|NOT COMPLETED|Overall Study||0||
60124057|NCT00289653|76245496|FG000|STARTED|Overall Study||23||
60124058|NCT00289653|76245496|FG000|COMPLETED|Overall Study||12||
60124059|NCT00289653|76245496|FG000|NOT COMPLETED|Overall Study||11||
60124060|NCT00290199|76245503|FG000|STARTED|Overall Study||87||
60124061|NCT00290199|76245504|FG001|STARTED|Overall Study||82||
60124062|NCT00290199|76245503|FG000|COMPLETED|Overall Study||87||
60124063|NCT00290199|76245504|FG001|COMPLETED|Overall Study||82||
60124064|NCT00290199|76245503|FG000|NOT COMPLETED|Overall Study||0||
60124065|NCT00290199|76245504|FG001|NOT COMPLETED|Overall Study||0||
60124066|NCT00291135|76245512|FG000|STARTED|Overall Study||42||
60124067|NCT00291135|76245512|FG000|COMPLETED|Overall Study||42||
60124068|NCT00291135|76245512|FG000|NOT COMPLETED|Overall Study||0||
60124069|NCT02103855|76245516|FG000|STARTED|Overall Study||6||
60124070|NCT02103855|76245516|FG000|COMPLETED|Overall Study||4||
60124071|NCT02103855|76245516|FG000|NOT COMPLETED|Overall Study||2||
60124072|NCT02104167|76245520|FG000|STARTED|Overall Study||110||
60124073|NCT02104167|76245520|FG000|COMPLETED|Overall Study||110||
60124074|NCT02104167|76245520|FG000|NOT COMPLETED|Overall Study||0||
60124075|NCT01504841|76245527|FG000|STARTED|Overall Study||20||
60124076|NCT01504841|76245528|FG001|STARTED|Overall Study||6||
60124077|NCT01504841|76245529|FG002|STARTED|Overall Study|No enrollments occurred into Cohort 3 during the study.|0||
60124078|NCT01504841|76245527|FG000|COMPLETED|Overall Study||19||
60124079|NCT01504841|76245528|FG001|COMPLETED|Overall Study||5||
60124080|NCT01504841|76245529|FG002|COMPLETED|Overall Study||0||
60124081|NCT01504841|76245527|FG000|NOT COMPLETED|Overall Study||1||
60124082|NCT01504841|76245528|FG001|NOT COMPLETED|Overall Study||1||
60124083|NCT01504841|76245529|FG002|NOT COMPLETED|Overall Study||0||
60124084|NCT00330915|76245536|FG000|STARTED|Overall Study||37||
60124085|NCT00330915|76245536|FG000|COMPLETED|Overall Study||37||
60124086|NCT00330915|76245536|FG000|NOT COMPLETED|Overall Study||0||
60124087|NCT01502423|76245542|FG000|STARTED|Overall Study||31||
60124088|NCT01502423|76245543|FG001|STARTED|Overall Study||30||
60124089|NCT01502423|76245542|FG000|COMPLETED|Overall Study||31||
60124090|NCT01502423|76245543|FG001|COMPLETED|Overall Study||29||
60124091|NCT01502423|76245542|FG000|NOT COMPLETED|Overall Study||0||
60124092|NCT01502423|76245543|FG001|NOT COMPLETED|Overall Study||1||
60124093|NCT01502033|76245549|FG000|STARTED|Overall Study|Milestone (10 participants) met.|10||
60124094|NCT01502033|76245549|FG000|COMPLETED|Overall Study|Milestone (10 participants) met|7||
60124095|NCT01502033|76245549|FG000|NOT COMPLETED|Overall Study||3||
60124096|NCT01500629|76245557|FG000|STARTED|Period 1 (Single Dose)||11||
60124097|NCT01500629|76245558|FG001|STARTED|Period 1 (Single Dose)||10||
60124098|NCT01500629|76245557|FG000|COMPLETED|Period 1 (Single Dose)||11||
60124099|NCT01500629|76245558|FG001|COMPLETED|Period 1 (Single Dose)||10||
60124100|NCT01500629|76245557|FG000|NOT COMPLETED|Period 1 (Single Dose)||0||
60124101|NCT01500629|76245558|FG001|NOT COMPLETED|Period 1 (Single Dose)||0||
60124102|NCT01500629|76245557|FG000|STARTED|Washout Period of 14 to 30 Days||11||
60124103|NCT01500629|76245558|FG001|STARTED|Washout Period of 14 to 30 Days||10||
60124104|NCT01500629|76245557|FG000|COMPLETED|Washout Period of 14 to 30 Days||10||
60124105|NCT01500629|76245558|FG001|COMPLETED|Washout Period of 14 to 30 Days||10||
60124106|NCT01500629|76245557|FG000|NOT COMPLETED|Washout Period of 14 to 30 Days||1||
60124107|NCT01500629|76245558|FG001|NOT COMPLETED|Washout Period of 14 to 30 Days||0||
60124108|NCT01500629|76245557|FG000|STARTED|Period 2 (Single Dose)||10||
60124109|NCT01500629|76245558|FG001|STARTED|Period 2 (Single Dose)||10||
60124110|NCT01500629|76245557|FG000|COMPLETED|Period 2 (Single Dose)||10||
60124111|NCT01500629|76245558|FG001|COMPLETED|Period 2 (Single Dose)||10||
60124112|NCT01500629|76245557|FG000|NOT COMPLETED|Period 2 (Single Dose)||0||
60124113|NCT01500629|76245558|FG001|NOT COMPLETED|Period 2 (Single Dose)||0||
60124114|NCT01500317|76245574|FG000|STARTED|Overall Study||13||
60124115|NCT01500317|76245575|FG001|STARTED|Overall Study||12||
60124116|NCT01500317|76245576|FG002|STARTED|Overall Study||13||
60124117|NCT01500317|76245574|FG000|COMPLETED|Overall Study||10||
60124118|NCT01500317|76245575|FG001|COMPLETED|Overall Study||10||
60124119|NCT01500317|76245576|FG002|COMPLETED|Overall Study||13||
60124120|NCT01500317|76245574|FG000|NOT COMPLETED|Overall Study||3||
60124121|NCT01500317|76245575|FG001|NOT COMPLETED|Overall Study||2||
60124122|NCT01500317|76245576|FG002|NOT COMPLETED|Overall Study||0||
60124123|NCT00332163|76245586|FG000|STARTED|Overall Study||48||
60124124|NCT00332163|76245587|FG001|STARTED|Overall Study||47||
60124125|NCT00332163|76245586|FG000|Received Treatment|Overall Study||48||
60124126|NCT00332163|76245587|FG001|Received Treatment|Overall Study||47||
60124127|NCT00332163|76245586|FG000|COMPLETED|Overall Study||48||
60124128|NCT00332163|76245587|FG001|COMPLETED|Overall Study||47||
60124129|NCT00332163|76245586|FG000|NOT COMPLETED|Overall Study||0||
60124130|NCT00332163|76245587|FG001|NOT COMPLETED|Overall Study||0||
60124131|NCT00333177|76245597|FG000|STARTED|Overall Study||12||
60124132|NCT00333177|76245598|FG001|STARTED|Overall Study||17||
60124133|NCT00333177|76245599|FG002|STARTED|Overall Study||17||
60124134|NCT00333177|76245600|FG003|STARTED|Overall Study||14||
60124135|NCT00333177|76245597|FG000|Received Intervention|Overall Study||12||
60124136|NCT00333177|76245598|FG001|Received Intervention|Overall Study||16||
60124137|NCT00333177|76245599|FG002|Received Intervention|Overall Study||16||
60124138|NCT00333177|76245600|FG003|Received Intervention|Overall Study||12||
60124139|NCT00333177|76245597|FG000|COMPLETED|Overall Study||12||
60124140|NCT00333177|76245598|FG001|COMPLETED|Overall Study||16||
60124141|NCT00333177|76245599|FG002|COMPLETED|Overall Study||16||
60124142|NCT00333177|76245600|FG003|COMPLETED|Overall Study||12||
60124143|NCT00333177|76245597|FG000|NOT COMPLETED|Overall Study||0||
60124144|NCT00333177|76245598|FG001|NOT COMPLETED|Overall Study||1||
60124145|NCT00333177|76245599|FG002|NOT COMPLETED|Overall Study||1||
60124146|NCT00333177|76245600|FG003|NOT COMPLETED|Overall Study||2||
60124147|NCT00333879|76245612|FG000|STARTED|Overall Study||4||
60124148|NCT00333879|76245612|FG000|COMPLETED|Overall Study||4||
60124149|NCT00333879|76245612|FG000|NOT COMPLETED|Overall Study||0||
60124150|NCT01899261|76245616|FG000|STARTED|Overall Study||20||
60124151|NCT01899261|76245616|FG000|COMPLETED|Overall Study||20||
60124152|NCT01899261|76245616|FG000|NOT COMPLETED|Overall Study||0||
60124153|NCT00335283|76245622|FG000|STARTED|Overall Study||36||
60124154|NCT00335283|76245623|FG001|STARTED|Overall Study||39||
60124155|NCT00335283|76245622|FG000|COMPLETED|Overall Study||30||
60124156|NCT00335283|76245623|FG001|COMPLETED|Overall Study||34||
60124157|NCT00335283|76245622|FG000|NOT COMPLETED|Overall Study||6||
60124158|NCT00335283|76245623|FG001|NOT COMPLETED|Overall Study||5||
60124159|NCT01500083|76245631|FG000|STARTED|Overall Study||16||
60124160|NCT01500083|76245632|FG001|STARTED|Overall Study||74||
60124161|NCT01500083|76245631|FG000|COMPLETED|Overall Study||4||
60124162|NCT01500083|76245632|FG001|COMPLETED|Overall Study||31||
60124163|NCT01500083|76245631|FG000|NOT COMPLETED|Overall Study||12||
60124164|NCT01500083|76245632|FG001|NOT COMPLETED|Overall Study||43||
60124165|NCT00295503|76245638|FG000|STARTED|Overall Study||53||
60124166|NCT00295503|76245638|FG000|COMPLETED|Overall Study||53||
60124167|NCT00295503|76245638|FG000|NOT COMPLETED|Overall Study||0||
60124168|NCT00335517|76245643|FG000|STARTED|Overall Study||100||
60124169|NCT00335517|76245643|FG000|COMPLETED|Overall Study|Due to pharmacy error two patients were enolled and recieved EREM, but were not included in analysis|98||
60124170|NCT00335517|76245643|FG000|NOT COMPLETED|Overall Study||2||
60124171|NCT00298155|76245650|FG000|STARTED|Overall Study||12||
60124172|NCT00298155|76245651|FG001|STARTED|Overall Study||10||
60124173|NCT00298155|76245652|FG002|STARTED|Overall Study||13||
60124174|NCT00298155|76245650|FG000|COMPLETED|Overall Study||12||
60124175|NCT00298155|76245651|FG001|COMPLETED|Overall Study||10||
60124176|NCT00298155|76245652|FG002|COMPLETED|Overall Study||13||
60124177|NCT00298155|76245650|FG000|NOT COMPLETED|Overall Study||0||
60124178|NCT00298155|76245651|FG001|NOT COMPLETED|Overall Study||0||
60124179|NCT00298155|76245652|FG002|NOT COMPLETED|Overall Study||0||
60124180|NCT01499849|76245662|FG000|STARTED|Overall Study|Number of randomized patients|266||
60124181|NCT01499849|76245663|FG001|STARTED|Overall Study||266||
60124182|NCT01499849|76245662|FG000|COMPLETED|Overall Study|Number of patients who completed 6 cycles|42||
60124183|NCT01499849|76245663|FG001|COMPLETED|Overall Study||40||
60124184|NCT01499849|76245662|FG000|NOT COMPLETED|Overall Study||224||
60124185|NCT01499849|76245663|FG001|NOT COMPLETED|Overall Study||226||
60124186|NCT00298233|76245671|FG000|STARTED|Overall Study||39||
60124187|NCT00298233|76245672|FG001|STARTED|Overall Study||41||
60124188|NCT00298233|76245673|FG002|STARTED|Overall Study||122||
60124189|NCT00298233|76245674|FG003|STARTED|Overall Study||124||
60124190|NCT00298233|76245671|FG000|COMPLETED|Overall Study||39||
60124191|NCT00298233|76245672|FG001|COMPLETED|Overall Study||41||
60124192|NCT00298233|76245673|FG002|COMPLETED|Overall Study||122||
60124193|NCT00298233|76245674|FG003|COMPLETED|Overall Study||124||
60124194|NCT00298233|76245671|FG000|NOT COMPLETED|Overall Study||0||
60124195|NCT00298233|76245672|FG001|NOT COMPLETED|Overall Study||0||
60124196|NCT00298233|76245673|FG002|NOT COMPLETED|Overall Study||0||
60124197|NCT00298233|76245674|FG003|NOT COMPLETED|Overall Study||0||
60124198|NCT01499303|76245682|FG000|STARTED|Overall Study||21||
60124199|NCT01499303|76245683|FG001|STARTED|Overall Study||47||
60124200|NCT01499303|76245682|FG000|COMPLETED|Overall Study||18||
60124201|NCT01499303|76245683|FG001|COMPLETED|Overall Study||40||
60124202|NCT01499303|76245682|FG000|NOT COMPLETED|Overall Study||3||
60124203|NCT01499303|76245683|FG001|NOT COMPLETED|Overall Study||7||
60124204|NCT00298389|76245692|FG000|STARTED|Overall Study||20||
60124205|NCT00298389|76245693|FG001|STARTED|Overall Study||17||
60124206|NCT00298389|76245694|FG002|STARTED|Overall Study||19||
60124207|NCT00298389|76245692|FG000|COMPLETED|Overall Study||20||
60124208|NCT00298389|76245693|FG001|COMPLETED|Overall Study||17||
60124209|NCT00298389|76245694|FG002|COMPLETED|Overall Study||19||
60124210|NCT00298389|76245692|FG000|NOT COMPLETED|Overall Study||0||
60124211|NCT00298389|76245693|FG001|NOT COMPLETED|Overall Study||0||
60124212|NCT00298389|76245694|FG002|NOT COMPLETED|Overall Study||0||
60124213|NCT01498679|76245704|FG000|STARTED|Overall Study||154||
60124214|NCT01498679|76245705|FG001|STARTED|Overall Study||153||
60124215|NCT01498679|76245704|FG000|COMPLETED|Overall Study||65||
60124216|NCT01498679|76245705|FG001|COMPLETED|Overall Study||131||
60124217|NCT01498679|76245704|FG000|NOT COMPLETED|Overall Study||89||
60124218|NCT01498679|76245705|FG001|NOT COMPLETED|Overall Study||22||
60124219|NCT02101437|76245715|FG000|STARTED|Overall Study||20||
60124220|NCT02101437|76245716|FG001|STARTED|Overall Study||54||
60124221|NCT02101437|76245717|FG002|STARTED|Overall Study||52||
60124222|NCT02101437|76245718|FG003|STARTED|Overall Study||49||
60124223|NCT02101437|76245715|FG000|COMPLETED|Overall Study||20||
60124224|NCT02101437|76245716|FG001|COMPLETED|Overall Study||54||
60124225|NCT02101437|76245717|FG002|COMPLETED|Overall Study||52||
60124226|NCT02101437|76245718|FG003|COMPLETED|Overall Study||49||
60124227|NCT02101437|76245715|FG000|NOT COMPLETED|Overall Study||0||
60124228|NCT02101437|76245716|FG001|NOT COMPLETED|Overall Study||0||
60124229|NCT02101437|76245717|FG002|NOT COMPLETED|Overall Study||0||
60124230|NCT02101437|76245718|FG003|NOT COMPLETED|Overall Study||0||
60124231|NCT01526785|76245728|FG000|STARTED|Overall Study||113||
60124232|NCT01526785|76245728|FG000|COMPLETED|Overall Study||100||
60124233|NCT01526785|76245728|FG000|NOT COMPLETED|Overall Study||13||
60124234|NCT01559389|76245734|FG000|STARTED|Overall Study||69||
60124235|NCT01559389|76245735|FG001|STARTED|Overall Study||69||
60124236|NCT01559389|76245734|FG000|COMPLETED|Overall Study||49||
60124237|NCT01559389|76245735|FG001|COMPLETED|Overall Study||49||
60124238|NCT01559389|76245734|FG000|NOT COMPLETED|Overall Study||20||
60124239|NCT01559389|76245735|FG001|NOT COMPLETED|Overall Study||20||
60124240|NCT01526551|76245745|FG000|STARTED|Overall Study||935||
60124241|NCT01526551|76245745|FG000|COMPLETED|Overall Study||511||
60124242|NCT01526551|76245745|FG000|NOT COMPLETED|Overall Study||424||
60124243|NCT00305565|76245752|FG000|STARTED|Overall Study (Safety Population)||111||
60124244|NCT00305565|76245753|FG001|STARTED|Overall Study (Safety Population)||107||
60124245|NCT00305565|76245754|FG002|STARTED|Overall Study (Safety Population)||113||
60124246|NCT00305565|76245752|FG000|COMPLETED|Overall Study (Safety Population)||97||
60124247|NCT00305565|76245753|FG001|COMPLETED|Overall Study (Safety Population)||95||
60124248|NCT00305565|76245754|FG002|COMPLETED|Overall Study (Safety Population)||106||
60124249|NCT00305565|76245752|FG000|NOT COMPLETED|Overall Study (Safety Population)||14||
60124250|NCT00305565|76245753|FG001|NOT COMPLETED|Overall Study (Safety Population)||12||
60124251|NCT00305565|76245754|FG002|NOT COMPLETED|Overall Study (Safety Population)||7||
60124252|NCT00305565|76245752|FG000|STARTED|Overall Study (ITT Population)||102||
60124253|NCT00305565|76245753|FG001|STARTED|Overall Study (ITT Population)||101||
60124254|NCT00305565|76245754|FG002|STARTED|Overall Study (ITT Population)||107||
60124255|NCT00305565|76245752|FG000|COMPLETED|Overall Study (ITT Population)||89||
60124256|NCT00305565|76245753|FG001|COMPLETED|Overall Study (ITT Population)||90||
60124257|NCT00305565|76245754|FG002|COMPLETED|Overall Study (ITT Population)||102||
60124258|NCT00305565|76245752|FG000|NOT COMPLETED|Overall Study (ITT Population)||13||
60124259|NCT00305565|76245753|FG001|NOT COMPLETED|Overall Study (ITT Population)||11||
60124260|NCT00305565|76245754|FG002|NOT COMPLETED|Overall Study (ITT Population)||5||
60124261|NCT00343083|76245763|FG000|STARTED|Overall Study||43||
60124262|NCT00343083|76245763|FG000|COMPLETED|Overall Study||22||
60124263|NCT00343083|76245763|FG000|NOT COMPLETED|Overall Study||21||
60124264|NCT00343785|76245768|FG000|STARTED|Overall Study||21||
60124265|NCT00343785|76245768|FG000|COMPLETED|Overall Study||21||
60124266|NCT00343785|76245768|FG000|NOT COMPLETED|Overall Study||0||
60124267|NCT00343863|76245775|FG000|STARTED|Overall Study||7||
60124268|NCT00343863|76245776|FG001|STARTED|Overall Study||34||
60124269|NCT00343863|76245775|FG000|COMPLETED|Overall Study||7||
60124270|NCT00343863|76245776|FG001|COMPLETED|Overall Study||34||
60124271|NCT00343863|76245775|FG000|NOT COMPLETED|Overall Study||0||
60124272|NCT00343863|76245776|FG001|NOT COMPLETED|Overall Study||0||
60124273|NCT00344175|76245786|FG000|STARTED|Overall Study||121||
60124274|NCT00344175|76245787|FG001|STARTED|Overall Study||57||
60124275|NCT00344175|76245786|FG000|COMPLETED|Overall Study||109||
60124276|NCT00344175|76245787|FG001|COMPLETED|Overall Study||47||
60124277|NCT00344175|76245786|FG000|NOT COMPLETED|Overall Study||12||
60124278|NCT00344175|76245787|FG001|NOT COMPLETED|Overall Study||10||
60124279|NCT02101515|76245795|FG000|STARTED|Overall Study||37||
60124280|NCT02101515|76245796|FG001|STARTED|Overall Study||41||
60124281|NCT02101515|76245795|FG000|COMPLETED|Overall Study||37||
60124282|NCT02101515|76245796|FG001|COMPLETED|Overall Study||41||
60124283|NCT02101515|76245795|FG000|NOT COMPLETED|Overall Study||0||
60124284|NCT02101515|76245796|FG001|NOT COMPLETED|Overall Study||0||
60124285|NCT00345033|76245804|FG000|STARTED|Overall Study||20||
60124286|NCT00345033|76245805|FG001|STARTED|Overall Study||18||
60124287|NCT00345033|76245804|FG000|COMPLETED|Overall Study||16||
60124288|NCT00345033|76245805|FG001|COMPLETED|Overall Study||14||
60124289|NCT00345033|76245804|FG000|NOT COMPLETED|Overall Study||4||
60124290|NCT00345033|76245805|FG001|NOT COMPLETED|Overall Study||4||
60124291|NCT00302055|76245813|FG000|STARTED|Overall Study||23||
60124292|NCT00302055|76245814|FG001|STARTED|Overall Study||49||
60124293|NCT00302055|76245813|FG000|COMPLETED|Overall Study||14||
60124294|NCT00302055|76245814|FG001|COMPLETED|Overall Study||36||
60124295|NCT00302055|76245813|FG000|NOT COMPLETED|Overall Study||9||
60124296|NCT00302055|76245814|FG001|NOT COMPLETED|Overall Study||13||
60124297|NCT01559311|76245823|FG000|STARTED|Overall Study|Enrollment & Baseline|30||
60124298|NCT01559311|76245824|FG001|STARTED|Overall Study|Enrollment & Baseline|34||
60124299|NCT01559311|76245825|FG002|STARTED|Overall Study|Enrollment & Baseline|34||
60124300|NCT01559311|76245823|FG000|Implant|Overall Study||28||
60124301|NCT01559311|76245824|FG001|Implant|Overall Study||34||
60124302|NCT01559311|76245825|FG002|Implant|Overall Study||32||
60124303|NCT01559311|76245823|FG000|1-Month|Overall Study||27||
60124304|NCT01559311|76245824|FG001|1-Month|Overall Study||34||
60124305|NCT01559311|76245825|FG002|1-Month|Overall Study||29||
60124306|NCT01559311|76245823|FG000|3-Month|Overall Study||27||
60124307|NCT01559311|76245824|FG001|3-Month|Overall Study||34||
60124308|NCT01559311|76245825|FG002|3-Month|Overall Study||29||
60124309|NCT01559311|76245823|FG000|6-Month|Overall Study||27||
60124310|NCT01559311|76245824|FG001|6-Month|Overall Study||33||
60124311|NCT01559311|76245825|FG002|6-Month|Overall Study||28||
60124312|NCT01559311|76245823|FG000|COMPLETED|Overall Study|12-Month|27||
60124313|NCT01559311|76245824|FG001|COMPLETED|Overall Study|12-Month|28||
60124314|NCT01559311|76245825|FG002|COMPLETED|Overall Study|12-Month|26||
60124315|NCT01559311|76245823|FG000|NOT COMPLETED|Overall Study||3||
60124316|NCT01559311|76245824|FG001|NOT COMPLETED|Overall Study||6||
60124317|NCT01559311|76245825|FG002|NOT COMPLETED|Overall Study||8||
60124318|NCT00345969|76245835|FG000|STARTED|Overall Study||12||
60124319|NCT00345969|76245836|FG001|STARTED|Overall Study||13||
60124320|NCT00345969|76245835|FG000|COMPLETED|Overall Study||11||
60124321|NCT00345969|76245836|FG001|COMPLETED|Overall Study||11||
60124322|NCT00345969|76245835|FG000|NOT COMPLETED|Overall Study||1||
60124323|NCT00345969|76245836|FG001|NOT COMPLETED|Overall Study||2||
60124324|NCT01498445|76245848|FG000|STARTED|Overall Study||4||
60124325|NCT01498445|76245849|FG001|STARTED|Overall Study||3||
60124326|NCT01498445|76245850|FG002|STARTED|Overall Study||8||
59996876|NCT02729051|76112738|FG000|COMPLETED|Overall Study||497||
59996877|NCT02729051|76112739|FG001|COMPLETED|Overall Study||496||
59996878|NCT02729051|76112738|FG000|NOT COMPLETED|Overall Study||30||
59996879|NCT02729051|76112739|FG001|NOT COMPLETED|Overall Study||32||
59996880|NCT00707993|76112747|FG000|STARTED|Overall Study||222||
59996881|NCT00707993|76112748|FG001|STARTED|Overall Study||219||
59996882|NCT00707993|76112747|FG000|COMPLETED|Overall Study||133||
59996883|NCT00707993|76112748|FG001|COMPLETED|Overall Study||125||
59996884|NCT00707993|76112747|FG000|NOT COMPLETED|Overall Study||89||
59996885|NCT00707993|76112748|FG001|NOT COMPLETED|Overall Study||94||
59996886|NCT00708227|76112758|FG000|STARTED|Overall Study||19||
59996887|NCT00708227|76112759|FG001|STARTED|Overall Study||26||
59996888|NCT00708227|76112760|FG002|STARTED|Overall Study||18||
59996889|NCT00708227|76112761|FG003|STARTED|Overall Study||25||
59996890|NCT00708227|76112758|FG000|COMPLETED|Overall Study||18||
59996891|NCT00708227|76112759|FG001|COMPLETED|Overall Study||21||
59996892|NCT00708227|76112760|FG002|COMPLETED|Overall Study||17||
59996893|NCT00708227|76112761|FG003|COMPLETED|Overall Study||22||
59996894|NCT00708227|76112758|FG000|NOT COMPLETED|Overall Study||1||
59996895|NCT00708227|76112759|FG001|NOT COMPLETED|Overall Study||5||
59996896|NCT00708227|76112760|FG002|NOT COMPLETED|Overall Study||1||
59996897|NCT00708227|76112761|FG003|NOT COMPLETED|Overall Study||3||
59996898|NCT02425891|76112793|FG000|STARTED|Overall Study||451||
59996899|NCT02425891|76112794|FG001|STARTED|Overall Study||451||
59996900|NCT02425891|76112793|FG000|COMPLETED|Overall Study||0||
59996901|NCT02425891|76112794|FG001|COMPLETED|Overall Study||0||
59996902|NCT02425891|76112793|FG000|NOT COMPLETED|Overall Study||451||
59996903|NCT02425891|76112794|FG001|NOT COMPLETED|Overall Study||451||
59996904|NCT03241225|76112804|FG000|STARTED|Overall Study||24||
59996905|NCT03241225|76112805|FG001|STARTED|Overall Study||16||
59996906|NCT03241225|76112804|FG000|COMPLETED|Overall Study||17||
59996907|NCT03241225|76112805|FG001|COMPLETED|Overall Study||14||
59996908|NCT03241225|76112804|FG000|NOT COMPLETED|Overall Study||7||
59996909|NCT03241225|76112805|FG001|NOT COMPLETED|Overall Study||2||
59996910|NCT01597245|76112815|FG000|STARTED|Induction Period (Week 0 - Week 12)||168||
59996911|NCT01597245|76112816|FG001|STARTED|Induction Period (Week 0 - Week 12)||358||
59996912|NCT01597245|76112817|FG002|STARTED|Induction Period (Week 0 - Week 12)||347||
59996913|NCT01597245|76112818|FG003|STARTED|Induction Period (Week 0 - Week 12)||351||
59996914|NCT01597245|76112819|FG004|STARTED|Induction Period (Week 0 - Week 12)||0||
59996915|NCT01597245|76112820|FG005|STARTED|Induction Period (Week 0 - Week 12)||0||
59996916|NCT01597245|76112821|FG006|STARTED|Induction Period (Week 0 - Week 12)||0||
59996917|NCT01597245|76112822|FG007|STARTED|Induction Period (Week 0 - Week 12)||0||
59996918|NCT01597245|76112823|FG008|STARTED|Induction Period (Week 0 - Week 12)||0||
59996919|NCT01597245|76112824|FG009|STARTED|Induction Period (Week 0 - Week 12)||0||
59996920|NCT01597245|76112825|FG010|STARTED|Induction Period (Week 0 - Week 12)||0||
59996921|NCT01597245|76112826|FG011|STARTED|Induction Period (Week 0 - Week 12)||0||
59996922|NCT01597245|76112827|FG012|STARTED|Induction Period (Week 0 - Week 12)||0||
59996923|NCT01597245|76112828|FG013|STARTED|Induction Period (Week 0 - Week 12)||0||
59996924|NCT01597245|76112829|FG014|STARTED|Induction Period (Week 0 - Week 12)||0||
59996925|NCT01597245|76112830|FG015|STARTED|Induction Period (Week 0 - Week 12)||0||
60124327|NCT01498445|76245851|FG003|STARTED|Overall Study||8||
60124328|NCT01498445|76245852|FG004|STARTED|Overall Study||4||
60124329|NCT01498445|76245853|FG005|STARTED|Overall Study||5||
60124330|NCT01498445|76245848|FG000|COMPLETED|Overall Study||4||
60124331|NCT01498445|76245849|FG001|COMPLETED|Overall Study||3||
60124332|NCT01498445|76245850|FG002|COMPLETED|Overall Study||7||
60124333|NCT01498445|76245851|FG003|COMPLETED|Overall Study||6||
60124334|NCT01498445|76245852|FG004|COMPLETED|Overall Study||3||
60124335|NCT01498445|76245853|FG005|COMPLETED|Overall Study||4||
60124336|NCT01498445|76245848|FG000|NOT COMPLETED|Overall Study||0||
60124337|NCT01498445|76245849|FG001|NOT COMPLETED|Overall Study||0||
60124338|NCT01498445|76245850|FG002|NOT COMPLETED|Overall Study||1||
60124339|NCT01498445|76245851|FG003|NOT COMPLETED|Overall Study||2||
60124340|NCT01498445|76245852|FG004|NOT COMPLETED|Overall Study||1||
60124341|NCT01498445|76245853|FG005|NOT COMPLETED|Overall Study||1||
60124342|NCT01558297|76245870|FG000|STARTED|Overall Study||30||
60124343|NCT01558297|76245871|FG001|STARTED|Overall Study||29||
60124344|NCT01558297|76245872|FG002|STARTED|Overall Study||30||
60124345|NCT01558297|76245870|FG000|COMPLETED|Overall Study||28||
60124346|NCT01558297|76245871|FG001|COMPLETED|Overall Study||27||
60124347|NCT01558297|76245872|FG002|COMPLETED|Overall Study||29||
60124348|NCT01558297|76245870|FG000|NOT COMPLETED|Overall Study||2||
60124349|NCT01558297|76245871|FG001|NOT COMPLETED|Overall Study||2||
60124350|NCT01558297|76245872|FG002|NOT COMPLETED|Overall Study||1||
60124351|NCT01525849|76245882|FG000|STARTED|Overall Study||76||
60124352|NCT01525849|76245883|FG001|STARTED|Overall Study||75||
60124353|NCT01525849|76245882|FG000|Treated|Overall Study|2 withdrew before treatment: 1 didn't want balloon dilation, 1 unrelated medical issue.|74||
60124354|NCT01525849|76245883|FG001|Treated|Overall Study|14 withdrew before treatment: 8 didn't want FESS, 1 too busy, 2 medical issues, 3 excl. criteria.|61||
60124355|NCT01525849|76245882|FG000|6-Months|Overall Study||73||
60124356|NCT01525849|76245883|FG001|6-Months|Overall Study||60||
60124357|NCT01525849|76245882|FG000|COMPLETED|Overall Study||71||
60124358|NCT01525849|76245883|FG001|COMPLETED|Overall Study||59||
60124359|NCT01525849|76245882|FG000|NOT COMPLETED|Overall Study||5||
60124360|NCT01525849|76245883|FG001|NOT COMPLETED|Overall Study||16||
60124361|NCT00308061|76245891|FG000|STARTED|Overall Study||20||
60124362|NCT00308061|76245892|FG001|STARTED|Overall Study||20||
60124363|NCT00308061|76245891|FG000|COMPLETED|Overall Study||20||
60124364|NCT00308061|76245892|FG001|COMPLETED|Overall Study||20||
60124365|NCT00308061|76245891|FG000|NOT COMPLETED|Overall Study||0||
60124366|NCT00308061|76245892|FG001|NOT COMPLETED|Overall Study||0||
60124367|NCT01525615|76245902|FG000|STARTED|Overall Study||132||
60124368|NCT01525615|76245903|FG001|STARTED|Overall Study||133||
60124369|NCT01525615|76245904|FG002|STARTED|Overall Study||139||
60124370|NCT01525615|76245902|FG000|COMPLETED|Overall Study||118||
60124371|NCT01525615|76245903|FG001|COMPLETED|Overall Study||126||
60124372|NCT01525615|76245904|FG002|COMPLETED|Overall Study||133||
60124373|NCT01525615|76245902|FG000|NOT COMPLETED|Overall Study||14||
60124374|NCT01525615|76245903|FG001|NOT COMPLETED|Overall Study||7||
60124375|NCT01525615|76245904|FG002|NOT COMPLETED|Overall Study||6||
60124376|NCT00309465|76245918|FG000|STARTED|Overall Study||58||
60124377|NCT00309465|76245919|FG001|STARTED|Overall Study||58||
60124378|NCT00309465|76245920|FG002|STARTED|Overall Study||58||
60124379|NCT00309465|76245921|FG003|STARTED|Overall Study||76||
60124380|NCT00309465|76245922|FG004|STARTED|Overall Study||76||
60124381|NCT00309465|76245923|FG005|STARTED|Overall Study||76||
60124382|NCT00309465|76245918|FG000|COMPLETED|Overall Study||58||
60124383|NCT00309465|76245919|FG001|COMPLETED|Overall Study||58||
60124384|NCT00309465|76245920|FG002|COMPLETED|Overall Study||58||
60124385|NCT00309465|76245921|FG003|COMPLETED|Overall Study|One subject was excluded due to eligibility error.|75||
60124386|NCT00309465|76245922|FG004|COMPLETED|Overall Study||76||
60124387|NCT00309465|76245923|FG005|COMPLETED|Overall Study||76||
60124388|NCT00309465|76245918|FG000|NOT COMPLETED|Overall Study||0||
60124389|NCT00309465|76245919|FG001|NOT COMPLETED|Overall Study||0||
60124390|NCT00309465|76245920|FG002|NOT COMPLETED|Overall Study||0||
60124391|NCT00309465|76245921|FG003|NOT COMPLETED|Overall Study||1||
60124392|NCT00309465|76245922|FG004|NOT COMPLETED|Overall Study||0||
60124393|NCT00309465|76245923|FG005|NOT COMPLETED|Overall Study||0||
60124394|NCT00302133|76245939|FG000|STARTED|Overall Study||9||
60124395|NCT00302133|76245940|FG001|STARTED|Overall Study||9||
60124396|NCT00302133|76245939|FG000|COMPLETED|Overall Study||5||
60124397|NCT00302133|76245940|FG001|COMPLETED|Overall Study||5||
60124398|NCT00302133|76245939|FG000|NOT COMPLETED|Overall Study||4||
60124399|NCT00302133|76245940|FG001|NOT COMPLETED|Overall Study||4||
60124400|NCT01525225|76245946|FG000|STARTED|Enrollment||4||
60124401|NCT01525225|76245946|FG000|COMPLETED|Enrollment||2||
60124402|NCT01525225|76245946|FG000|NOT COMPLETED|Enrollment||2||
60124403|NCT01525225|76245946|FG000|STARTED|Treated||2||
60124404|NCT01525225|76245946|FG000|COMPLETED|Treated||2||
60124405|NCT01525225|76245946|FG000|NOT COMPLETED|Treated||0||
60124406|NCT00346905|76245950|FG000|STARTED|Overall Study||16||
60124407|NCT00346905|76245950|FG000|COMPLETED|Overall Study||12||
60124408|NCT00346905|76245950|FG000|NOT COMPLETED|Overall Study||4||
60124409|NCT00304161|76245956|FG000|STARTED|Overall Study||28||
60124410|NCT00304161|76245957|FG001|STARTED|Overall Study||27||
60124411|NCT00304161|76245956|FG000|COMPLETED|Overall Study||22||
60124412|NCT00304161|76245957|FG001|COMPLETED|Overall Study||21||
60124413|NCT00304161|76245956|FG000|NOT COMPLETED|Overall Study||6||
60124414|NCT00304161|76245957|FG001|NOT COMPLETED|Overall Study||6||
60124415|NCT01524991|76245963|FG000|STARTED|Overall Study||36||
60124416|NCT01524991|76245963|FG000|COMPLETED|Overall Study||2||
60124417|NCT01524991|76245963|FG000|NOT COMPLETED|Overall Study||34||
60124418|NCT01524913|76245970|FG000|STARTED|Overall Study||35||
60124419|NCT01524913|76245971|FG001|STARTED|Overall Study||36||
60124420|NCT01524913|76245972|FG002|STARTED|Overall Study||31||
60124421|NCT01524913|76245970|FG000|COMPLETED|Overall Study||31||
60124422|NCT01524913|76245971|FG001|COMPLETED|Overall Study||36||
60124423|NCT01524913|76245972|FG002|COMPLETED|Overall Study||31||
60124424|NCT01524913|76245970|FG000|NOT COMPLETED|Overall Study||4||
60124425|NCT01524913|76245971|FG001|NOT COMPLETED|Overall Study||0||
60124426|NCT01524913|76245972|FG002|NOT COMPLETED|Overall Study||0||
60124427|NCT01524679|76245982|FG000|STARTED|Overall Study||112||
60124428|NCT01524679|76245983|FG001|STARTED|Overall Study||58||
60124429|NCT01524679|76245982|FG000|COMPLETED|Overall Study||89||
60124430|NCT01524679|76245983|FG001|COMPLETED|Overall Study||49||
60124431|NCT01524679|76245982|FG000|NOT COMPLETED|Overall Study||23||
60124432|NCT01524679|76245983|FG001|NOT COMPLETED|Overall Study||9||
60124433|NCT01880541|76245991|FG000|STARTED|Overall Study||10||
60124434|NCT01880541|76245992|FG001|STARTED|Overall Study||20||
60124435|NCT01880541|76245991|FG000|COMPLETED|Overall Study||10||
60124436|NCT01880541|76245992|FG001|COMPLETED|Overall Study||20||
60124437|NCT01880541|76245991|FG000|NOT COMPLETED|Overall Study||0||
60124438|NCT01880541|76245992|FG001|NOT COMPLETED|Overall Study||0||
60124439|NCT01524289|76246000|FG000|STARTED|Overall Study||204||
60124440|NCT01524289|76246001|FG001|STARTED|Overall Study||102||
60124441|NCT01524289|76246000|FG000|Treated|Overall Study||203||
60124442|NCT01524289|76246001|FG001|Treated|Overall Study||102||
60124443|NCT01524289|76246000|FG000|COMPLETED|Overall Study||174||
60124444|NCT01524289|76246001|FG001|COMPLETED|Overall Study||88||
60124445|NCT01524289|76246000|FG000|NOT COMPLETED|Overall Study||30||
60124446|NCT01524289|76246001|FG001|NOT COMPLETED|Overall Study||14||
60124447|NCT01498289|76246011|FG000|STARTED|Overall Study||98||
60124448|NCT01498289|76246012|FG001|STARTED|Overall Study||104||
60124449|NCT01498289|76246011|FG000|Participants Assessed for AEs|Overall Study||91||
60124450|NCT01498289|76246012|FG001|Participants Assessed for AEs|Overall Study||98||
60124451|NCT01498289|76246011|FG000|COMPLETED|Overall Study||0||
60124452|NCT01498289|76246012|FG001|COMPLETED|Overall Study||0||
60124453|NCT01498289|76246011|FG000|NOT COMPLETED|Overall Study||98||
60124454|NCT01498289|76246012|FG001|NOT COMPLETED|Overall Study||104||
60124455|NCT01524133|76246025|FG000|STARTED|Treatment Phase||71||
60124456|NCT01524133|76246026|FG001|STARTED|Treatment Phase||69||
60124457|NCT01524133|76246027|FG002|STARTED|Treatment Phase||67||
60124458|NCT01524133|76246025|FG000|COMPLETED|Treatment Phase|Completed Both Assigned treatment|52||
60124459|NCT01524133|76246026|FG001|COMPLETED|Treatment Phase|Completed Both Assigned Treatments|37||
60124460|NCT01524133|76246027|FG002|COMPLETED|Treatment Phase|Completed both assigned treatments|31||
60124461|NCT01524133|76246025|FG000|NOT COMPLETED|Treatment Phase||19||
60124462|NCT01524133|76246026|FG001|NOT COMPLETED|Treatment Phase||32||
60124463|NCT01524133|76246027|FG002|NOT COMPLETED|Treatment Phase||36||
60124464|NCT01524133|76246025|FG000|STARTED|Overall Study 52 Weeks||71|Treatment occurred weeks 0-24 and naturalistic follow-up continued through to week 52.|
60124465|NCT01524133|76246026|FG001|STARTED|Overall Study 52 Weeks||69|Treatment occurred weeks 0-24 and naturalistic follow-up continued through to week 52.|
60124466|NCT01524133|76246027|FG002|STARTED|Overall Study 52 Weeks||67|Treatment occurred weeks 0-24 and naturalistic follow-up continued through to week 52.|
60124467|NCT01524133|76246025|FG000|COMPLETED|Overall Study 52 Weeks||50||
60124468|NCT01524133|76246026|FG001|COMPLETED|Overall Study 52 Weeks||49||
60124469|NCT01524133|76246027|FG002|COMPLETED|Overall Study 52 Weeks||40||
60124470|NCT01524133|76246025|FG000|NOT COMPLETED|Overall Study 52 Weeks||21||
60124471|NCT01524133|76246026|FG001|NOT COMPLETED|Overall Study 52 Weeks||20||
60124472|NCT01524133|76246027|FG002|NOT COMPLETED|Overall Study 52 Weeks||27||
60124473|NCT04992494|76246037|FG000|STARTED|Overall Study||8||
60124474|NCT04992494|76246038|FG001|STARTED|Overall Study||8||
60124475|NCT04992494|76246037|FG000|COMPLETED|Overall Study||8||
60124476|NCT04992494|76246038|FG001|COMPLETED|Overall Study||8||
60124477|NCT04992494|76246037|FG000|NOT COMPLETED|Overall Study||0||
60124478|NCT04992494|76246038|FG001|NOT COMPLETED|Overall Study||0||
60124479|NCT04754230|76246046|FG000|STARTED|Overall Study||19||
60124480|NCT04754230|76246047|FG001|STARTED|Overall Study||21||
60124481|NCT04754230|76246046|FG000|COMPLETED|Overall Study||19||
60124482|NCT04754230|76246047|FG001|COMPLETED|Overall Study||21||
60124483|NCT04754230|76246046|FG000|NOT COMPLETED|Overall Study||0||
60124484|NCT04754230|76246047|FG001|NOT COMPLETED|Overall Study||0||
60124485|NCT04442581|76246053|FG000|STARTED|Stage 1||2||
60124486|NCT04442581|76246053|FG000|COMPLETED|Stage 1||2||
60124487|NCT04442581|76246053|FG000|NOT COMPLETED|Stage 1||0||
60124488|NCT04442581|76246053|FG000|STARTED|Stage 2||0||
60124489|NCT04442581|76246053|FG000|COMPLETED|Stage 2||0||
60124490|NCT04442581|76246053|FG000|NOT COMPLETED|Stage 2||0||
60124491|NCT04304534|76246061|FG000|STARTED|Overall Study||397|Full analysis set (FAS)|
60124492|NCT04304534|76246062|FG001|STARTED|Overall Study||401|Full analysis set (FAS)|
60124493|NCT04304534|76246063|FG002|STARTED|Overall Study||402|Full analysis set (FAS)|
60124494|NCT04304534|76246064|FG003|STARTED|Overall Study||401|Full analysis set (FAS)|
60124495|NCT04304534|76246061|FG000|Treated|Overall Study||395|Safety analysis set (SAF)|
60124496|NCT04304534|76246062|FG001|Treated|Overall Study||397|Safety analysis set (SAF)|
60124497|NCT04304534|76246063|FG002|Treated|Overall Study||402|Safety analysis set (SAF)|
60124498|NCT04304534|76246064|FG003|Treated|Overall Study||399|Safety analysis set (SAF)|
60124499|NCT04304534|76246061|FG000|COMPLETED|Overall Study|Treatment completed|303||
60124500|NCT04304534|76246062|FG001|COMPLETED|Overall Study|Treatment completed|317||
60124501|NCT04304534|76246063|FG002|COMPLETED|Overall Study|Treatment completed|309||
60124502|NCT04304534|76246064|FG003|COMPLETED|Overall Study|Treatment completed|309||
60124503|NCT04304534|76246061|FG000|NOT COMPLETED|Overall Study||94||
60124504|NCT04304534|76246062|FG001|NOT COMPLETED|Overall Study||84||
60124505|NCT04304534|76246063|FG002|NOT COMPLETED|Overall Study||93||
60124506|NCT04304534|76246064|FG003|NOT COMPLETED|Overall Study||92||
60124507|NCT04223609|76246077|FG000|STARTED|Overall Study||6||
60124508|NCT04223609|76246078|FG001|STARTED|Overall Study||8||
60124509|NCT04223609|76246077|FG000|COMPLETED|Overall Study||6||
60124510|NCT04223609|76246078|FG001|COMPLETED|Overall Study||6||
60124511|NCT04223609|76246077|FG000|NOT COMPLETED|Overall Study||0||
60124512|NCT04223609|76246078|FG001|NOT COMPLETED|Overall Study||2||
60124513|NCT04176458|76246084|FG000|STARTED|Overall Study|Four subjects had their first MBT test but due to Covid 19 restrictions unable to return to site for second test.|4||
60124514|NCT04176458|76246084|FG000|COMPLETED|Overall Study|We did not complete enrollment of 20 subjects as per protocol due to COVID 19 restrictions at our site. Due to covid 19 non-essential procedures were not permitted, in this case the MBT procedure. This limited enrollment and thus we had to close study as we were unable to enroll in a timely manner.|0||
60124515|NCT04176458|76246084|FG000|NOT COMPLETED|Overall Study||4||
60124516|NCT03941548|76246090|FG000|STARTED|Overall Study||34||
60124517|NCT03941548|76246091|FG001|STARTED|Overall Study||32||
60124518|NCT03941548|76246090|FG000|Safety Population|Overall Study||34|Safety population included all participants who received at least one dose of study drug. Participants were summarized according to study drug regimen received.|
60124519|NCT03941548|76246091|FG001|Safety Population|Overall Study||32|Safety population included all participants who received at least one dose of study drug. Participants were summarized according to study drug regimen received.|
60124520|NCT03941548|76246090|FG000|mITT Population|Overall Study||34|Modified Intent-to-treat (mITT) population included all randomized participants who received at least one dose of study drug and had at least 1 post-treatment SALT assessment. Participants were summarized according to study drug regimen to which they were randomized.|
60124521|NCT03941548|76246091|FG001|mITT Population|Overall Study||32|Modified Intent-to-treat (mITT) population included all randomized participants who received at least one dose of study drug and had at least 1 post-treatment SALT assessment. Participants were summarized according to study drug regimen to which they were randomized.|
60124522|NCT03941548|76246090|FG000|COMPLETED|Overall Study||33||
60124523|NCT03941548|76246091|FG001|COMPLETED|Overall Study||30||
60124524|NCT03941548|76246090|FG000|NOT COMPLETED|Overall Study||1||
60124525|NCT03941548|76246091|FG001|NOT COMPLETED|Overall Study||2||
60124526|NCT03925727|76246100|FG000|STARTED|Overall Study||263||
60124527|NCT03925727|76246101|FG001|STARTED|Overall Study||100||
60124528|NCT03925727|76246102|FG002|STARTED|Overall Study||260||
60124529|NCT03925727|76246100|FG000|COMPLETED|Overall Study||244||
60124530|NCT03925727|76246101|FG001|COMPLETED|Overall Study||94||
60124531|NCT03925727|76246102|FG002|COMPLETED|Overall Study||242||
60124532|NCT03925727|76246100|FG000|NOT COMPLETED|Overall Study||19||
60124533|NCT03925727|76246101|FG001|NOT COMPLETED|Overall Study||6||
60124534|NCT03925727|76246102|FG002|NOT COMPLETED|Overall Study||18||
60124535|NCT03387150|76246119|FG000|STARTED|Overall Study||19||
60124536|NCT03387150|76246120|FG001|STARTED|Overall Study||19||
60124537|NCT03387150|76246121|FG002|STARTED|Overall Study||21||
60124538|NCT03387150|76246122|FG003|STARTED|Overall Study||21||
60124539|NCT03387150|76246123|FG004|STARTED|Overall Study||20||
60124540|NCT03387150|76246124|FG005|STARTED|Overall Study||21||
60124541|NCT03387150|76246125|FG006|STARTED|Overall Study||3||
60124542|NCT03387150|76246119|FG000|Safety Population|Overall Study||19||
60124543|NCT03387150|76246120|FG001|Safety Population|Overall Study||19||
60124544|NCT03387150|76246121|FG002|Safety Population|Overall Study||21||
59996926|NCT01597245|76112831|FG016|STARTED|Induction Period (Week 0 - Week 12)||0||
59996927|NCT01597245|76112832|FG017|STARTED|Induction Period (Week 0 - Week 12)||0||
59996928|NCT01597245|76112833|FG018|STARTED|Induction Period (Week 0 - Week 12)||0||
59996929|NCT01597245|76112834|FG019|STARTED|Induction Period (Week 0 - Week 12)||0||
59996930|NCT01597245|76112835|FG020|STARTED|Induction Period (Week 0 - Week 12)||0||
59996931|NCT01597245|76112815|FG000|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||167||
59996932|NCT01597245|76112816|FG001|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||357||
59996933|NCT01597245|76112817|FG002|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||347||
59996934|NCT01597245|76112818|FG003|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||350||
59996935|NCT01597245|76112819|FG004|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0||
60124545|NCT03387150|76246122|FG003|Safety Population|Overall Study||21||
60124546|NCT03387150|76246123|FG004|Safety Population|Overall Study||20||
60124547|NCT03387150|76246124|FG005|Safety Population|Overall Study||21||
60124548|NCT03387150|76246125|FG006|Safety Population|Overall Study||3||
60124549|NCT03387150|76246119|FG000|COMPLETED|Overall Study||13||
60124550|NCT03387150|76246120|FG001|COMPLETED|Overall Study||16||
60124551|NCT03387150|76246121|FG002|COMPLETED|Overall Study||16||
60124552|NCT03387150|76246122|FG003|COMPLETED|Overall Study||14||
60124553|NCT03387150|76246123|FG004|COMPLETED|Overall Study||14||
60124554|NCT03387150|76246124|FG005|COMPLETED|Overall Study||14||
60124555|NCT03387150|76246125|FG006|COMPLETED|Overall Study||3||
60124556|NCT03387150|76246119|FG000|NOT COMPLETED|Overall Study||6||
60124557|NCT03387150|76246120|FG001|NOT COMPLETED|Overall Study||3||
60124558|NCT03387150|76246121|FG002|NOT COMPLETED|Overall Study||5||
60124559|NCT03387150|76246122|FG003|NOT COMPLETED|Overall Study||7||
60124560|NCT03387150|76246123|FG004|NOT COMPLETED|Overall Study||6||
60124561|NCT03387150|76246124|FG005|NOT COMPLETED|Overall Study||7||
60124562|NCT03387150|76246125|FG006|NOT COMPLETED|Overall Study||0||
60124563|NCT03289234|76246144|FG000|STARTED|Overall Study||8||
60124564|NCT03289234|76246145|FG001|STARTED|Overall Study||6||
60124565|NCT03289234|76246146|FG002|STARTED|Overall Study||8||
60124566|NCT03289234|76246144|FG000|COMPLETED|Overall Study||8||
60124567|NCT03289234|76246145|FG001|COMPLETED|Overall Study||6||
60124568|NCT03289234|76246146|FG002|COMPLETED|Overall Study||8||
60124569|NCT03289234|76246144|FG000|NOT COMPLETED|Overall Study||0||
60124570|NCT03289234|76246145|FG001|NOT COMPLETED|Overall Study||0||
60124571|NCT03289234|76246146|FG002|NOT COMPLETED|Overall Study||0||
60124572|NCT03289208|76246157|FG000|STARTED|Overall Study||11||
60124573|NCT03289208|76246158|FG001|STARTED|Overall Study||8||
60124574|NCT03289208|76246159|FG002|STARTED|Overall Study||11||
60124575|NCT03289208|76246157|FG000|COMPLETED|Overall Study||10||
60124576|NCT03289208|76246158|FG001|COMPLETED|Overall Study||8||
60124577|NCT03289208|76246159|FG002|COMPLETED|Overall Study||11||
60124578|NCT03289208|76246157|FG000|NOT COMPLETED|Overall Study||1||
60124579|NCT03289208|76246158|FG001|NOT COMPLETED|Overall Study||0||
60124580|NCT03289208|76246159|FG002|NOT COMPLETED|Overall Study||0||
60124581|NCT03244059|76246169|FG000|STARTED|Specific Aim 1||11||
60124582|NCT03244059|76246170|FG001|STARTED|Specific Aim 1||6||
60124583|NCT03244059|76246169|FG000|COMPLETED|Specific Aim 1||10||
60124584|NCT03244059|76246170|FG001|COMPLETED|Specific Aim 1||6||
60124585|NCT03244059|76246169|FG000|NOT COMPLETED|Specific Aim 1||1||
60124586|NCT03244059|76246170|FG001|NOT COMPLETED|Specific Aim 1||0||
60124587|NCT03244059|76246169|FG000|STARTED|Specific Aim 2||11||
60124588|NCT03244059|76246170|FG001|STARTED|Specific Aim 2||6||
60124589|NCT03244059|76246169|FG000|COMPLETED|Specific Aim 2||10||
60124590|NCT03244059|76246170|FG001|COMPLETED|Specific Aim 2||6||
60124591|NCT03244059|76246169|FG000|NOT COMPLETED|Specific Aim 2||1||
60124592|NCT03244059|76246170|FG001|NOT COMPLETED|Specific Aim 2||0||
60124593|NCT03036566|76246176|FG000|STARTED|Overall Study||30||
60124594|NCT03036566|76246176|FG000|COMPLETED|Overall Study||27||
60124595|NCT03036566|76246176|FG000|NOT COMPLETED|Overall Study||3||
60124596|NCT02927249|76246182|FG000|STARTED|Overall Study||1511||
60124597|NCT02927249|76246183|FG001|STARTED|Overall Study||1510||
60124598|NCT02927249|76246182|FG000|COMPLETED|Overall Study||1511||
60124599|NCT02927249|76246183|FG001|COMPLETED|Overall Study||1510||
60124600|NCT02927249|76246182|FG000|NOT COMPLETED|Overall Study||0||
60124601|NCT02927249|76246183|FG001|NOT COMPLETED|Overall Study||0||
60124602|NCT02754141|76246207|FG000|STARTED|Overall Study||14||
60124603|NCT02754141|76246208|FG001|STARTED|Overall Study||12||
60124604|NCT02754141|76246209|FG002|STARTED|Overall Study||12||
60124605|NCT02754141|76246210|FG003|STARTED|Overall Study||9||
60124606|NCT02754141|76246211|FG004|STARTED|Overall Study||12||
60124607|NCT02754141|76246212|FG005|STARTED|Overall Study||9||
60124608|NCT02754141|76246213|FG006|STARTED|Overall Study||8||
60124609|NCT02754141|76246214|FG007|STARTED|Overall Study||7||
60124610|NCT02754141|76246215|FG008|STARTED|Overall Study||18||
59858909|NCT03214666|75983552|FG005|COMPLETED|Cohort 3: Dose Level 3: 25 ug/kg/Day||0||
60124611|NCT02754141|76246216|FG009|STARTED|Overall Study||19||
60124612|NCT02754141|76246217|FG010|STARTED|Overall Study||31||
60124613|NCT02754141|76246218|FG011|STARTED|Overall Study||15||
60124614|NCT02754141|76246219|FG012|STARTED|Overall Study||15||
60124615|NCT02754141|76246220|FG013|STARTED|Overall Study||19||
60124616|NCT02754141|76246221|FG014|STARTED|Overall Study||18||
59594758|NCT02997085|75703713|FG002|NOT COMPLETED|Overall Study||0||
59858910|NCT03214666|75983547|FG000|NOT COMPLETED|Cohort 3: Dose Level 3: 25 ug/kg/Day||0||
60124617|NCT02754141|76246222|FG015|STARTED|Overall Study||14||
60124618|NCT02754141|76246223|FG016|STARTED|Overall Study||2||
60124619|NCT02754141|76246224|FG017|STARTED|Overall Study||1||
60124620|NCT02754141|76246207|FG000|Continuing to Combo Therapy|Overall Study||12||
60124621|NCT02754141|76246208|FG001|Continuing to Combo Therapy|Overall Study||11||
60124622|NCT02754141|76246209|FG002|Continuing to Combo Therapy|Overall Study||12||
60124623|NCT02754141|76246210|FG003|Continuing to Combo Therapy|Overall Study||7||
60124624|NCT02754141|76246211|FG004|Continuing to Combo Therapy|Overall Study||10||
60124625|NCT02754141|76246212|FG005|Continuing to Combo Therapy|Overall Study||0||
60124626|NCT02754141|76246213|FG006|Continuing to Combo Therapy|Overall Study||0||
60124627|NCT02754141|76246214|FG007|Continuing to Combo Therapy|Overall Study||0||
60124628|NCT02754141|76246215|FG008|Continuing to Combo Therapy|Overall Study||0||
60124629|NCT02754141|76246216|FG009|Continuing to Combo Therapy|Overall Study||0||
60124630|NCT02754141|76246217|FG010|Continuing to Combo Therapy|Overall Study||0||
60124631|NCT02754141|76246218|FG011|Continuing to Combo Therapy|Overall Study||0||
60124632|NCT02754141|76246219|FG012|Continuing to Combo Therapy|Overall Study||0||
60124633|NCT02754141|76246220|FG013|Continuing to Combo Therapy|Overall Study||0||
60124634|NCT02754141|76246221|FG014|Continuing to Combo Therapy|Overall Study||0||
60124635|NCT02754141|76246222|FG015|Continuing to Combo Therapy|Overall Study||0||
60124636|NCT02754141|76246223|FG016|Continuing to Combo Therapy|Overall Study||0||
60124637|NCT02754141|76246224|FG017|Continuing to Combo Therapy|Overall Study||0||
60124638|NCT02754141|76246207|FG000|Crossing Over to RCC Combo Therapy|Overall Study||0||
60124639|NCT02754141|76246208|FG001|Crossing Over to RCC Combo Therapy|Overall Study||0||
60124640|NCT02754141|76246209|FG002|Crossing Over to RCC Combo Therapy|Overall Study||0||
60124641|NCT02754141|76246210|FG003|Crossing Over to RCC Combo Therapy|Overall Study||0||
60124642|NCT02754141|76246211|FG004|Crossing Over to RCC Combo Therapy|Overall Study||0||
60124643|NCT02754141|76246212|FG005|Crossing Over to RCC Combo Therapy|Overall Study||0||
60124644|NCT02754141|76246213|FG006|Crossing Over to RCC Combo Therapy|Overall Study||0||
60124645|NCT02754141|76246214|FG007|Crossing Over to RCC Combo Therapy|Overall Study||0||
60124646|NCT02754141|76246215|FG008|Crossing Over to RCC Combo Therapy|Overall Study||0||
60124647|NCT02754141|76246216|FG009|Crossing Over to RCC Combo Therapy|Overall Study||0||
60124648|NCT02754141|76246217|FG010|Crossing Over to RCC Combo Therapy|Overall Study||0||
60124649|NCT02754141|76246218|FG011|Crossing Over to RCC Combo Therapy|Overall Study||0||
60124650|NCT02754141|76246219|FG012|Crossing Over to RCC Combo Therapy|Overall Study||0||
60124651|NCT02754141|76246220|FG013|Crossing Over to RCC Combo Therapy|Overall Study||3||
60124652|NCT02754141|76246221|FG014|Crossing Over to RCC Combo Therapy|Overall Study||0||
60124653|NCT02754141|76246222|FG015|Crossing Over to RCC Combo Therapy|Overall Study||0||
60124654|NCT02754141|76246223|FG016|Crossing Over to RCC Combo Therapy|Overall Study||0||
60124655|NCT02754141|76246224|FG017|Crossing Over to RCC Combo Therapy|Overall Study||0||
60124656|NCT02754141|76246207|FG000|COMPLETED|Overall Study||1||
60124657|NCT02754141|76246208|FG001|COMPLETED|Overall Study||2||
60124658|NCT02754141|76246209|FG002|COMPLETED|Overall Study||4||
60124659|NCT02754141|76246210|FG003|COMPLETED|Overall Study||1||
60124660|NCT02754141|76246211|FG004|COMPLETED|Overall Study||2||
60124661|NCT02754141|76246212|FG005|COMPLETED|Overall Study||0||
60124662|NCT02754141|76246213|FG006|COMPLETED|Overall Study||0||
60124663|NCT02754141|76246214|FG007|COMPLETED|Overall Study||0||
60124664|NCT02754141|76246215|FG008|COMPLETED|Overall Study||6||
60124665|NCT02754141|76246216|FG009|COMPLETED|Overall Study||2||
60124666|NCT02754141|76246217|FG010|COMPLETED|Overall Study||11||
60124667|NCT02754141|76246218|FG011|COMPLETED|Overall Study||1||
60124668|NCT02754141|76246219|FG012|COMPLETED|Overall Study||1||
60124669|NCT02754141|76246220|FG013|COMPLETED|Overall Study||5||
60124670|NCT02754141|76246221|FG014|COMPLETED|Overall Study||5||
60124671|NCT02754141|76246222|FG015|COMPLETED|Overall Study||0||
60124672|NCT02754141|76246223|FG016|COMPLETED|Overall Study||2||
60124673|NCT02754141|76246224|FG017|COMPLETED|Overall Study||0||
60124674|NCT02754141|76246207|FG000|NOT COMPLETED|Overall Study||13||
60124675|NCT02754141|76246208|FG001|NOT COMPLETED|Overall Study||10||
60124676|NCT02754141|76246209|FG002|NOT COMPLETED|Overall Study||8||
60124677|NCT02754141|76246210|FG003|NOT COMPLETED|Overall Study||8||
60124678|NCT02754141|76246211|FG004|NOT COMPLETED|Overall Study||10||
60124679|NCT02754141|76246212|FG005|NOT COMPLETED|Overall Study||9||
60124680|NCT02754141|76246213|FG006|NOT COMPLETED|Overall Study||8||
60124681|NCT02754141|76246214|FG007|NOT COMPLETED|Overall Study||7||
60124682|NCT02754141|76246215|FG008|NOT COMPLETED|Overall Study||12||
60124683|NCT02754141|76246216|FG009|NOT COMPLETED|Overall Study||17||
60124684|NCT02754141|76246217|FG010|NOT COMPLETED|Overall Study||20||
59858911|NCT03214666|75983548|FG001|NOT COMPLETED|Cohort 3: Dose Level 3: 25 ug/kg/Day||0||
60124685|NCT02754141|76246218|FG011|NOT COMPLETED|Overall Study||14||
60124686|NCT02754141|76246219|FG012|NOT COMPLETED|Overall Study||14||
60124687|NCT02754141|76246220|FG013|NOT COMPLETED|Overall Study||14||
60124688|NCT02754141|76246221|FG014|NOT COMPLETED|Overall Study||13||
60124689|NCT02754141|76246222|FG015|NOT COMPLETED|Overall Study||14||
60124690|NCT02754141|76246223|FG016|NOT COMPLETED|Overall Study||0||
60124691|NCT02754141|76246224|FG017|NOT COMPLETED|Overall Study||1||
60124692|NCT02659059|76246303|FG000|STARTED|Overall Study||288||
59594759|NCT03163303|75703722|FG000|STARTED|Overall Study||85||
59858912|NCT03214666|75983549|FG002|NOT COMPLETED|Cohort 3: Dose Level 3: 25 ug/kg/Day||0||
60124693|NCT02659059|76246304|FG001|STARTED|Overall Study||36||
60124694|NCT02659059|76246303|FG000|COMPLETED|Overall Study||37||
60124695|NCT02659059|76246304|FG001|COMPLETED|Overall Study||4||
60124696|NCT02659059|76246303|FG000|NOT COMPLETED|Overall Study||251||
60124697|NCT02659059|76246304|FG001|NOT COMPLETED|Overall Study||32||
60124698|NCT02572427|76246312|FG000|STARTED|Overall Study||37||
60124699|NCT02572427|76246313|FG001|STARTED|Overall Study||45||
59858913|NCT03214666|75983550|FG003|NOT COMPLETED|Cohort 3: Dose Level 3: 25 ug/kg/Day||0||
60124700|NCT02572427|76246312|FG000|COMPLETED|Overall Study||31||
60124701|NCT02572427|76246313|FG001|COMPLETED|Overall Study||36||
60124702|NCT02572427|76246312|FG000|NOT COMPLETED|Overall Study||6||
60124703|NCT02572427|76246313|FG001|NOT COMPLETED|Overall Study||9||
60124704|NCT01164891|76246319|FG000|STARTED|Overall Study||7||
59858914|NCT03214666|75983551|FG004|NOT COMPLETED|Cohort 3: Dose Level 3: 25 ug/kg/Day||0||
59858915|NCT03214666|75983552|FG005|NOT COMPLETED|Cohort 3: Dose Level 3: 25 ug/kg/Day||0||
59858916|NCT03214666|75983547|FG000|STARTED|Cohort 4: Dose Level 4: 50 ug/kg/Day||0||
60124705|NCT01164891|76246319|FG000|COMPLETED|Overall Study||1||
60124706|NCT01164891|76246319|FG000|NOT COMPLETED|Overall Study||6||
60124707|NCT01497899|76246328|FG000|STARTED|Double-Blind Phase||113||
60124708|NCT01497899|76246329|FG001|STARTED|Double-Blind Phase||58||
60124709|NCT01497899|76246330|FG002|STARTED|Double-Blind Phase||0||
60124710|NCT01497899|76246331|FG003|STARTED|Double-Blind Phase||0||
60124711|NCT01497899|76246328|FG000|COMPLETED|Double-Blind Phase||107||
60124712|NCT01497899|76246329|FG001|COMPLETED|Double-Blind Phase||53||
60124713|NCT01497899|76246330|FG002|COMPLETED|Double-Blind Phase||0||
60124714|NCT01497899|76246331|FG003|COMPLETED|Double-Blind Phase||0||
60124715|NCT01497899|76246328|FG000|NOT COMPLETED|Double-Blind Phase||6||
60124716|NCT01497899|76246329|FG001|NOT COMPLETED|Double-Blind Phase||5||
60124717|NCT01497899|76246330|FG002|NOT COMPLETED|Double-Blind Phase||0||
60124718|NCT01497899|76246331|FG003|NOT COMPLETED|Double-Blind Phase||0||
60124719|NCT01497899|76246328|FG000|STARTED|Open-Label Extension Phase|2 participants completed the Double-Blind Phase, but did not continue in the Open-Label Extension.|105||
60124720|NCT01497899|76246329|FG001|STARTED|Open-Label Extension Phase||53||
60124721|NCT01497899|76246330|FG002|STARTED|Open-Label Extension Phase|Participants enrolled from other Gilead-sponsored Study GS-US-299-0102.|70||
60124722|NCT01497899|76246331|FG003|STARTED|Open-Label Extension Phase|Participants enrolled from other Gilead-sponsored Study GS-US-299-0102.|38||
60124723|NCT01497899|76246328|FG000|COMPLETED|Open-Label Extension Phase||86||
60124724|NCT01497899|76246329|FG001|COMPLETED|Open-Label Extension Phase||46||
60124725|NCT01497899|76246330|FG002|COMPLETED|Open-Label Extension Phase||61||
60124726|NCT01497899|76246331|FG003|COMPLETED|Open-Label Extension Phase||33||
60124727|NCT01497899|76246328|FG000|NOT COMPLETED|Open-Label Extension Phase||19||
60124728|NCT01497899|76246329|FG001|NOT COMPLETED|Open-Label Extension Phase||7||
60124729|NCT01497899|76246330|FG002|NOT COMPLETED|Open-Label Extension Phase||9||
60124730|NCT01497899|76246331|FG003|NOT COMPLETED|Open-Label Extension Phase||5||
60124731|NCT01497275|76246338|FG000|STARTED|Overall Study||5||
60124732|NCT01497275|76246338|FG000|COMPLETED|Overall Study||3||
60124733|NCT01497275|76246338|FG000|NOT COMPLETED|Overall Study||2||
60124734|NCT01557517|76246344|FG000|STARTED|Overall Study||19||
60124735|NCT01557517|76246345|FG001|STARTED|Overall Study||21||
60124736|NCT01557517|76246344|FG000|COMPLETED|Overall Study||17||
60124737|NCT01557517|76246345|FG001|COMPLETED|Overall Study||17||
60124738|NCT01557517|76246344|FG000|NOT COMPLETED|Overall Study||2||
60124739|NCT01557517|76246345|FG001|NOT COMPLETED|Overall Study||4||
60124740|NCT01497197|76246360|FG000|STARTED|Overall Study||89||
60124741|NCT01497197|76246361|FG001|STARTED|Overall Study||85||
60124742|NCT01497197|76246360|FG000|COMPLETED|Overall Study||72||
60124743|NCT01497197|76246361|FG001|COMPLETED|Overall Study||70||
60124744|NCT01497197|76246360|FG000|NOT COMPLETED|Overall Study||17||
60124745|NCT01497197|76246361|FG001|NOT COMPLETED|Overall Study||15||
60124746|NCT01496885|76246367|FG000|STARTED|Overall Study||120||
60124747|NCT01496885|76246367|FG000|COMPLETED|Overall Study||97||
60124748|NCT01496885|76246367|FG000|NOT COMPLETED|Overall Study||23||
59858917|NCT03214666|75983548|FG001|STARTED|Cohort 4: Dose Level 4: 50 ug/kg/Day||0||
60124749|NCT01557283|76246371|FG000|STARTED|Overall Study||140||
60124750|NCT01557283|76246371|FG000|COMPLETED|Overall Study||96||
60124751|NCT01557283|76246371|FG000|NOT COMPLETED|Overall Study||44||
60124752|NCT00349713|76246378|FG000|STARTED|Overall Study||20||
60124753|NCT00349713|76246379|FG001|STARTED|Overall Study||20||
60124754|NCT00349713|76246380|FG002|STARTED|Overall Study||20||
60124755|NCT00349713|76246378|FG000|COMPLETED|Overall Study||20||
60124756|NCT00349713|76246379|FG001|COMPLETED|Overall Study||20||
60124757|NCT00349713|76246380|FG002|COMPLETED|Overall Study||20||
60124758|NCT00349713|76246378|FG000|NOT COMPLETED|Overall Study||0||
60124759|NCT00349713|76246379|FG001|NOT COMPLETED|Overall Study||0||
60124760|NCT00349713|76246380|FG002|NOT COMPLETED|Overall Study||0||
60124761|NCT01523743|76246388|FG000|STARTED|Period 1||63||
60124762|NCT01523743|76246389|FG001|STARTED|Period 1||62||
60124763|NCT01523743|76246388|FG000|COMPLETED|Period 1||53||
60124764|NCT01523743|76246389|FG001|COMPLETED|Period 1||60||
60124765|NCT01523743|76246388|FG000|NOT COMPLETED|Period 1||10||
60124766|NCT01523743|76246389|FG001|NOT COMPLETED|Period 1||2||
59594760|NCT03163303|75703723|FG001|STARTED|Overall Study||94||
59858918|NCT03214666|75983549|FG002|STARTED|Cohort 4: Dose Level 4: 50 ug/kg/Day||0||
60124767|NCT01523743|76246388|FG000|STARTED|Period 2||53||
60124768|NCT01523743|76246389|FG001|STARTED|Period 2||60||
60124769|NCT01523743|76246388|FG000|COMPLETED|Period 2||52||
60124770|NCT01523743|76246389|FG001|COMPLETED|Period 2||58||
60124771|NCT01523743|76246388|FG000|NOT COMPLETED|Period 2||1||
60124772|NCT01523743|76246389|FG001|NOT COMPLETED|Period 2||2||
60124773|NCT00350025|76246397|FG000|STARTED|Overall Study||11||
60124774|NCT00350025|76246398|FG001|STARTED|Overall Study||30||
60124775|NCT00350025|76246397|FG000|COMPLETED|Overall Study||11||
60124776|NCT00350025|76246398|FG001|COMPLETED|Overall Study||28||
60124777|NCT00350025|76246397|FG000|NOT COMPLETED|Overall Study||0||
60124778|NCT00350025|76246398|FG001|NOT COMPLETED|Overall Study||2||
60124779|NCT01496807|76246404|FG000|STARTED|Overall Study||31||
60124780|NCT01496807|76246404|FG000|COMPLETED|Overall Study||1||
60124781|NCT01496807|76246404|FG000|NOT COMPLETED|Overall Study||30||
60124782|NCT01496183|76246410|FG000|STARTED|Overall Study||9||
60124783|NCT01496183|76246411|FG001|STARTED|Overall Study||15||
60124784|NCT01496183|76246410|FG000|COMPLETED|Overall Study||6||
60124785|NCT01496183|76246411|FG001|COMPLETED|Overall Study||13||
60124786|NCT01496183|76246410|FG000|NOT COMPLETED|Overall Study||3||
60124787|NCT01496183|76246411|FG001|NOT COMPLETED|Overall Study||2||
60124788|NCT01495793|76246418|FG000|STARTED|Overall Study||24||
60124789|NCT01495793|76246418|FG000|COMPLETED|Overall Study||22||
60124790|NCT01495793|76246418|FG000|NOT COMPLETED|Overall Study||2||
60124791|NCT01494467|76246424|FG000|STARTED|Part A Vehicle Control (12 Weeks)||459||
60124792|NCT01494467|76246425|FG001|STARTED|Part A Vehicle Control (12 Weeks)||229||
60124793|NCT01494467|76246424|FG000|COMPLETED|Part A Vehicle Control (12 Weeks)||429||
60124794|NCT01494467|76246425|FG001|COMPLETED|Part A Vehicle Control (12 Weeks)||208||
60124795|NCT01494467|76246424|FG000|NOT COMPLETED|Part A Vehicle Control (12 Weeks)||30||
60124796|NCT01494467|76246425|FG001|NOT COMPLETED|Part A Vehicle Control (12 Weeks)||21||
60124797|NCT01494467|76246424|FG000|STARTED|Part B Long Term Active Control 40 Weeks|429 completed Part A. Subsequently, one subject discontinued so only 428 entered Part B|428||
60124798|NCT01494467|76246425|FG001|STARTED|Part B Long Term Active Control 40 Weeks||208||
60124799|NCT01494467|76246424|FG000|COMPLETED|Part B Long Term Active Control 40 Weeks||353||
60124800|NCT01494467|76246425|FG001|COMPLETED|Part B Long Term Active Control 40 Weeks||159||
60124801|NCT01494467|76246424|FG000|NOT COMPLETED|Part B Long Term Active Control 40 Weeks||75||
60124802|NCT01494467|76246425|FG001|NOT COMPLETED|Part B Long Term Active Control 40 Weeks||49||
60124803|NCT01494467|76246424|FG000|STARTED|Part C Safety Follow up (4 Weeks)||353||
60124804|NCT01494467|76246425|FG001|STARTED|Part C Safety Follow up (4 Weeks)||159||
60124805|NCT01494467|76246424|FG000|COMPLETED|Part C Safety Follow up (4 Weeks)||353||
60124806|NCT01494467|76246425|FG001|COMPLETED|Part C Safety Follow up (4 Weeks)||159||
60124807|NCT01494467|76246424|FG000|NOT COMPLETED|Part C Safety Follow up (4 Weeks)||0||
60124808|NCT01494467|76246425|FG001|NOT COMPLETED|Part C Safety Follow up (4 Weeks)||0||
60124809|NCT01493687|76246439|FG000|STARTED|Part A Vehicle Control (12 Weeks)||451||
60124810|NCT01493687|76246440|FG001|STARTED|Part A Vehicle Control (12 Weeks)||232||
60124811|NCT01493687|76246439|FG000|COMPLETED|Part A Vehicle Control (12 Weeks)||414||
60124812|NCT01493687|76246440|FG001|COMPLETED|Part A Vehicle Control (12 Weeks)||210||
60124813|NCT01493687|76246439|FG000|NOT COMPLETED|Part A Vehicle Control (12 Weeks)||37||
60124814|NCT01493687|76246440|FG001|NOT COMPLETED|Part A Vehicle Control (12 Weeks)||22||
60124815|NCT01493687|76246439|FG000|STARTED|Part B Long Term Active Control 40 Weeks|414 completed Part A. Then 2 discontinued (lack of efficacy, subject request) prior to Part B.|412||
60124816|NCT01493687|76246440|FG001|STARTED|Part B Long Term Active Control 40 Weeks||210||
60124817|NCT01493687|76246439|FG000|COMPLETED|Part B Long Term Active Control 40 Weeks||351||
60124818|NCT01493687|76246440|FG001|COMPLETED|Part B Long Term Active Control 40 Weeks||175||
60124819|NCT01493687|76246439|FG000|NOT COMPLETED|Part B Long Term Active Control 40 Weeks||61||
60124820|NCT01493687|76246440|FG001|NOT COMPLETED|Part B Long Term Active Control 40 Weeks||35||
60124821|NCT01493687|76246439|FG000|STARTED|Part C Safety Follow up (4 Weeks)|351 completed Part B. Then 1 discontinued (subject request) prior to Part C.|350||
60124822|NCT01493687|76246440|FG001|STARTED|Part C Safety Follow up (4 Weeks)||175||
60124823|NCT01493687|76246439|FG000|COMPLETED|Part C Safety Follow up (4 Weeks)||350||
60124824|NCT01493687|76246440|FG001|COMPLETED|Part C Safety Follow up (4 Weeks)||174||
60124825|NCT01493687|76246439|FG000|NOT COMPLETED|Part C Safety Follow up (4 Weeks)||0||
60124826|NCT01493687|76246440|FG001|NOT COMPLETED|Part C Safety Follow up (4 Weeks)||1||
60124827|NCT00350337|76246456|FG000|STARTED|Overall Study||22||
60124828|NCT00350337|76246457|FG001|STARTED|Overall Study||22||
60124829|NCT00350337|76246458|FG002|STARTED|Overall Study||21||
60124830|NCT00350337|76246459|FG003|STARTED|Overall Study||21||
60124831|NCT00350337|76246456|FG000|COMPLETED|Overall Study||17||
60124832|NCT00350337|76246457|FG001|COMPLETED|Overall Study||19||
60124833|NCT00350337|76246458|FG002|COMPLETED|Overall Study||18||
60124834|NCT00350337|76246459|FG003|COMPLETED|Overall Study||21||
60124835|NCT00350337|76246456|FG000|NOT COMPLETED|Overall Study||5||
60124836|NCT00350337|76246457|FG001|NOT COMPLETED|Overall Study||3||
60124837|NCT00350337|76246458|FG002|NOT COMPLETED|Overall Study||3||
60124838|NCT00350337|76246459|FG003|NOT COMPLETED|Overall Study||0||
60124839|NCT01523587|76246472|FG000|STARTED|Overall Study||398||
60124840|NCT01523587|76246473|FG001|STARTED|Overall Study||397||
60124841|NCT01523587|76246472|FG000|Treated|Overall Study||392||
59594761|NCT03163303|75703722|FG000|COMPLETED|Overall Study||85||
60124842|NCT01523587|76246473|FG001|Treated|Overall Study||395||
60124843|NCT01523587|76246472|FG000|COMPLETED|Overall Study||0||
60124844|NCT01523587|76246473|FG001|COMPLETED|Overall Study||0||
60124845|NCT01523587|76246472|FG000|NOT COMPLETED|Overall Study||398||
60124846|NCT01523587|76246473|FG001|NOT COMPLETED|Overall Study||397||
60124847|NCT00310401|76246481|FG000|STARTED|Overall Study||260||
60124848|NCT00310401|76246482|FG001|STARTED|Overall Study||246||
60124849|NCT00310401|76246481|FG000|COMPLETED|Overall Study||260||
60124850|NCT00310401|76246482|FG001|COMPLETED|Overall Study||246||
60124851|NCT00310401|76246481|FG000|NOT COMPLETED|Overall Study||0||
60124852|NCT00310401|76246482|FG001|NOT COMPLETED|Overall Study||0||
60124853|NCT00310791|76246492|FG000|STARTED|Overall Study||40||
60124854|NCT00310791|76246493|FG001|STARTED|Overall Study||40||
60124855|NCT00310791|76246492|FG000|COMPLETED|Overall Study||30||
60124856|NCT00310791|76246493|FG001|COMPLETED|Overall Study||30||
60124857|NCT00310791|76246492|FG000|NOT COMPLETED|Overall Study||10||
60124858|NCT00310791|76246493|FG001|NOT COMPLETED|Overall Study||10||
60124859|NCT01493531|76246502|FG000|STARTED|Overall Study||204||
60124860|NCT01493531|76246503|FG001|STARTED|Overall Study||200||
60124861|NCT01493531|76246504|FG002|STARTED|Overall Study||206||
60124862|NCT01493531|76246502|FG000|COMPLETED|Overall Study||163||
60124863|NCT01493531|76246503|FG001|COMPLETED|Overall Study||150||
60124864|NCT01493531|76246504|FG002|COMPLETED|Overall Study||158||
60124865|NCT01493531|76246502|FG000|NOT COMPLETED|Overall Study||41||
60124866|NCT01493531|76246503|FG001|NOT COMPLETED|Overall Study||50||
59858919|NCT03214666|75983550|FG003|STARTED|Cohort 4: Dose Level 4: 50 ug/kg/Day||2||
59858920|NCT03214666|75983551|FG004|STARTED|Cohort 4: Dose Level 4: 50 ug/kg/Day||0||
59858921|NCT03214666|75983552|FG005|STARTED|Cohort 4: Dose Level 4: 50 ug/kg/Day||0||
59858922|NCT03214666|75983547|FG000|COMPLETED|Cohort 4: Dose Level 4: 50 ug/kg/Day||0||
59858923|NCT03214666|75983548|FG001|COMPLETED|Cohort 4: Dose Level 4: 50 ug/kg/Day||0||
59858924|NCT03214666|75983549|FG002|COMPLETED|Cohort 4: Dose Level 4: 50 ug/kg/Day||0||
59858925|NCT03214666|75983550|FG003|COMPLETED|Cohort 4: Dose Level 4: 50 ug/kg/Day||2||
59858926|NCT03214666|75983551|FG004|COMPLETED|Cohort 4: Dose Level 4: 50 ug/kg/Day||0||
59858927|NCT03214666|75983552|FG005|COMPLETED|Cohort 4: Dose Level 4: 50 ug/kg/Day||0||
59858928|NCT03214666|75983547|FG000|NOT COMPLETED|Cohort 4: Dose Level 4: 50 ug/kg/Day||0||
59858929|NCT03214666|75983548|FG001|NOT COMPLETED|Cohort 4: Dose Level 4: 50 ug/kg/Day||0||
59858930|NCT03214666|75983549|FG002|NOT COMPLETED|Cohort 4: Dose Level 4: 50 ug/kg/Day||0||
59858931|NCT03214666|75983550|FG003|NOT COMPLETED|Cohort 4: Dose Level 4: 50 ug/kg/Day||0||
59858932|NCT03214666|75983551|FG004|NOT COMPLETED|Cohort 4: Dose Level 4: 50 ug/kg/Day||0||
59858933|NCT03214666|75983552|FG005|NOT COMPLETED|Cohort 4: Dose Level 4: 50 ug/kg/Day||0||
59858934|NCT03214666|75983547|FG000|STARTED|Cohort 5: Dose Level 5: 100 ug/kg/Day||0||
59858935|NCT03214666|75983548|FG001|STARTED|Cohort 5: Dose Level 5: 100 ug/kg/Day||0||
59858936|NCT03214666|75983549|FG002|STARTED|Cohort 5: Dose Level 5: 100 ug/kg/Day||0||
59858937|NCT03214666|75983550|FG003|STARTED|Cohort 5: Dose Level 5: 100 ug/kg/Day||0||
59858938|NCT03214666|75983551|FG004|STARTED|Cohort 5: Dose Level 5: 100 ug/kg/Day||2||
59858939|NCT03214666|75983552|FG005|STARTED|Cohort 5: Dose Level 5: 100 ug/kg/Day||0||
59858940|NCT03214666|75983547|FG000|COMPLETED|Cohort 5: Dose Level 5: 100 ug/kg/Day||0||
59858941|NCT03214666|75983548|FG001|COMPLETED|Cohort 5: Dose Level 5: 100 ug/kg/Day||0||
59858942|NCT03214666|75983549|FG002|COMPLETED|Cohort 5: Dose Level 5: 100 ug/kg/Day||0||
59858943|NCT03214666|75983550|FG003|COMPLETED|Cohort 5: Dose Level 5: 100 ug/kg/Day||0||
59858944|NCT03214666|75983551|FG004|COMPLETED|Cohort 5: Dose Level 5: 100 ug/kg/Day||1||
59858945|NCT03214666|75983552|FG005|COMPLETED|Cohort 5: Dose Level 5: 100 ug/kg/Day||0||
59858946|NCT03214666|75983547|FG000|NOT COMPLETED|Cohort 5: Dose Level 5: 100 ug/kg/Day||0||
59858947|NCT03214666|75983548|FG001|NOT COMPLETED|Cohort 5: Dose Level 5: 100 ug/kg/Day||0||
59858948|NCT03214666|75983549|FG002|NOT COMPLETED|Cohort 5: Dose Level 5: 100 ug/kg/Day||0||
59858949|NCT03214666|75983550|FG003|NOT COMPLETED|Cohort 5: Dose Level 5: 100 ug/kg/Day||0||
59858950|NCT03214666|75983551|FG004|NOT COMPLETED|Cohort 5: Dose Level 5: 100 ug/kg/Day||1||
59858951|NCT03214666|75983552|FG005|NOT COMPLETED|Cohort 5: Dose Level 5: 100 ug/kg/Day||0||
59858952|NCT03214666|75983547|FG000|STARTED|Cohort 6: Dose Level 6: 150 ug/kg/Day||0||
59858953|NCT03214666|75983548|FG001|STARTED|Cohort 6: Dose Level 6: 150 ug/kg/Day||0||
59858954|NCT03214666|75983549|FG002|STARTED|Cohort 6: Dose Level 6: 150 ug/kg/Day||0||
59858955|NCT03214666|75983550|FG003|STARTED|Cohort 6: Dose Level 6: 150 ug/kg/Day||0||
59858956|NCT03214666|75983551|FG004|STARTED|Cohort 6: Dose Level 6: 150 ug/kg/Day||0||
59858957|NCT03214666|75983552|FG005|STARTED|Cohort 6: Dose Level 6: 150 ug/kg/Day||2||
59858958|NCT03214666|75983547|FG000|COMPLETED|Cohort 6: Dose Level 6: 150 ug/kg/Day||0||
59858959|NCT03214666|75983548|FG001|COMPLETED|Cohort 6: Dose Level 6: 150 ug/kg/Day||0||
59858960|NCT03214666|75983549|FG002|COMPLETED|Cohort 6: Dose Level 6: 150 ug/kg/Day||0||
59858961|NCT03214666|75983550|FG003|COMPLETED|Cohort 6: Dose Level 6: 150 ug/kg/Day||0||
59858962|NCT03214666|75983551|FG004|COMPLETED|Cohort 6: Dose Level 6: 150 ug/kg/Day||0||
59858963|NCT03214666|75983552|FG005|COMPLETED|Cohort 6: Dose Level 6: 150 ug/kg/Day||2||
59858964|NCT03214666|75983547|FG000|NOT COMPLETED|Cohort 6: Dose Level 6: 150 ug/kg/Day||0||
59858965|NCT03214666|75983548|FG001|NOT COMPLETED|Cohort 6: Dose Level 6: 150 ug/kg/Day||0||
59858966|NCT03214666|75983549|FG002|NOT COMPLETED|Cohort 6: Dose Level 6: 150 ug/kg/Day||0||
60124867|NCT01493531|76246504|FG002|NOT COMPLETED|Overall Study||48||
60124868|NCT02105415|76246514|FG000|STARTED|Overall Study||76||
60124869|NCT02105415|76246515|FG001|STARTED|Overall Study||84||
60124870|NCT02105415|76246514|FG000|COMPLETED|Overall Study||73||
60124871|NCT02105415|76246515|FG001|COMPLETED|Overall Study||79||
60124872|NCT02105415|76246514|FG000|NOT COMPLETED|Overall Study||3||
60124873|NCT02105415|76246515|FG001|NOT COMPLETED|Overall Study||5||
60124874|NCT01523275|76246528|FG000|STARTED|Overall Study||6||
60124875|NCT01523275|76246529|FG001|STARTED|Overall Study||9||
60124876|NCT01523275|76246528|FG000|COMPLETED|Overall Study||4||
60124877|NCT01523275|76246529|FG001|COMPLETED|Overall Study||7||
60124878|NCT01523275|76246528|FG000|NOT COMPLETED|Overall Study||2||
60124879|NCT01523275|76246529|FG001|NOT COMPLETED|Overall Study||2||
60124880|NCT00304707|76246537|FG000|STARTED|Overall Study||73||
60124881|NCT00304707|76246538|FG001|STARTED|Overall Study||70||
60124882|NCT00304707|76246537|FG000|COMPLETED|Overall Study||66||
60124883|NCT00304707|76246538|FG001|COMPLETED|Overall Study||64||
60124884|NCT00304707|76246537|FG000|NOT COMPLETED|Overall Study||7||
60124885|NCT00304707|76246538|FG001|NOT COMPLETED|Overall Study||6||
60124886|NCT01492439|76246546|FG000|STARTED|Overall Study||19||
60124887|NCT01492439|76246547|FG001|STARTED|Overall Study||18||
60124888|NCT01492439|76246546|FG000|Post-intervention|Overall Study||18||
60124889|NCT01492439|76246547|FG001|Post-intervention|Overall Study||13||
60124890|NCT01492439|76246546|FG000|COMPLETED|Overall Study||15||
60124891|NCT01492439|76246547|FG001|COMPLETED|Overall Study||9||
60124892|NCT01492439|76246546|FG000|NOT COMPLETED|Overall Study||4||
60124893|NCT01492439|76246547|FG001|NOT COMPLETED|Overall Study||9||
60124894|NCT00313209|76246555|FG000|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|466||
60124895|NCT00313209|76246556|FG001|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|467||
60124896|NCT00313209|76246555|FG000|COMPLETED|Overall Study||359||
60124897|NCT00313209|76246556|FG001|COMPLETED|Overall Study||385||
60124898|NCT00313209|76246555|FG000|NOT COMPLETED|Overall Study||107||
60124899|NCT00313209|76246556|FG001|NOT COMPLETED|Overall Study||82||
60124900|NCT00313443|76246562|FG000|STARTED|Overall Study||30||
60124901|NCT00313443|76246562|FG000|COMPLETED|Overall Study||30||
60124902|NCT00313443|76246562|FG000|NOT COMPLETED|Overall Study||0||
60124903|NCT00351039|76246566|FG000|STARTED|Overall Study||8||
60124904|NCT00351039|76246566|FG000|COMPLETED|Overall Study|The study was halted before Phase II was initiated.|8||
60124905|NCT00351039|76246566|FG000|NOT COMPLETED|Overall Study||0||
60124906|NCT00351741|76246573|FG000|STARTED|Overall Study||31||
60124907|NCT00351741|76246574|FG001|STARTED|Overall Study||31||
60124908|NCT00351741|76246573|FG000|COMPLETED|Overall Study||31||
60124909|NCT00351741|76246574|FG001|COMPLETED|Overall Study||31||
60124910|NCT00351741|76246573|FG000|NOT COMPLETED|Overall Study||0||
60124911|NCT00351741|76246574|FG001|NOT COMPLETED|Overall Study||0||
60124912|NCT01572727|76246582|FG000|STARTED|Overall Study||207||
60124913|NCT01572727|76246583|FG001|STARTED|Overall Study||209||
60124914|NCT01572727|76246582|FG000|Pts With Treatment + Safety Assessment|Overall Study|patients who received study treatment and had at least one post-baseline safety assessment|202||
60124915|NCT01572727|76246583|FG001|Pts With Treatment + Safety Assessment|Overall Study|patients who received study treatment and had at least one post-baseline safety assessment|201||
60124916|NCT01572727|76246582|FG000|COMPLETED|Overall Study||0||
60124917|NCT01572727|76246583|FG001|COMPLETED|Overall Study||0||
60124918|NCT01572727|76246582|FG000|NOT COMPLETED|Overall Study||207||
60124919|NCT01572727|76246583|FG001|NOT COMPLETED|Overall Study||209||
60124920|NCT00315627|76246589|FG000|STARTED|Overall Study||3||
60124921|NCT00315627|76246589|FG000|COMPLETED|Overall Study||3||
60124922|NCT00315627|76246589|FG000|NOT COMPLETED|Overall Study||0||
60124923|NCT00315939|76246597|FG000|STARTED|Admission 1 (3 Months)||59||
60124924|NCT00315939|76246598|FG001|STARTED|Admission 1 (3 Months)||61||
60124925|NCT00315939|76246597|FG000|COMPLETED|Admission 1 (3 Months)||56||
60124926|NCT00315939|76246598|FG001|COMPLETED|Admission 1 (3 Months)||55||
60124927|NCT00315939|76246597|FG000|NOT COMPLETED|Admission 1 (3 Months)||3||
60124928|NCT00315939|76246598|FG001|NOT COMPLETED|Admission 1 (3 Months)||6||
60124929|NCT00315939|76246597|FG000|STARTED|Admission 2 (3 Months)||56||
60124930|NCT00315939|76246598|FG001|STARTED|Admission 2 (3 Months)||55||
60124931|NCT00315939|76246597|FG000|COMPLETED|Admission 2 (3 Months)||52||
60124932|NCT00315939|76246598|FG001|COMPLETED|Admission 2 (3 Months)||51||
60124933|NCT00315939|76246597|FG000|NOT COMPLETED|Admission 2 (3 Months)||4||
60124934|NCT00315939|76246598|FG001|NOT COMPLETED|Admission 2 (3 Months)||4||
59858967|NCT03214666|75983550|FG003|NOT COMPLETED|Cohort 6: Dose Level 6: 150 ug/kg/Day||0||
60124935|NCT00315939|76246597|FG000|STARTED|Admission 3 (3 Months)||52||
60124936|NCT00315939|76246598|FG001|STARTED|Admission 3 (3 Months)||51||
60124937|NCT00315939|76246597|FG000|COMPLETED|Admission 3 (3 Months)||48||
60124938|NCT00315939|76246598|FG001|COMPLETED|Admission 3 (3 Months)||49||
60124939|NCT00315939|76246597|FG000|NOT COMPLETED|Admission 3 (3 Months)||4||
60124940|NCT00315939|76246598|FG001|NOT COMPLETED|Admission 3 (3 Months)||2||
59594762|NCT03163303|75703723|FG001|COMPLETED|Overall Study||94||
59858968|NCT03214666|75983551|FG004|NOT COMPLETED|Cohort 6: Dose Level 6: 150 ug/kg/Day||0||
60124941|NCT00352911|76246605|FG000|STARTED|150mg Twice Daily (14 Days)||16||
60124942|NCT00352911|76246606|FG001|STARTED|150mg Twice Daily (14 Days)||3||
60124943|NCT00352911|76246605|FG000|COMPLETED|150mg Twice Daily (14 Days)||16||
60124944|NCT00352911|76246606|FG001|COMPLETED|150mg Twice Daily (14 Days)||3||
60124945|NCT00352911|76246605|FG000|NOT COMPLETED|150mg Twice Daily (14 Days)||0||
60124946|NCT00352911|76246606|FG001|NOT COMPLETED|150mg Twice Daily (14 Days)||0||
60124947|NCT00352911|76246605|FG000|STARTED|300mg Twice Daily (14 Days)||16||
60124948|NCT00352911|76246606|FG001|STARTED|300mg Twice Daily (14 Days)||3||
60124949|NCT00352911|76246605|FG000|COMPLETED|300mg Twice Daily (14 Days)||15||
60124950|NCT00352911|76246606|FG001|COMPLETED|300mg Twice Daily (14 Days)||3||
60124951|NCT00352911|76246605|FG000|NOT COMPLETED|300mg Twice Daily (14 Days)||1||
60124952|NCT00352911|76246606|FG001|NOT COMPLETED|300mg Twice Daily (14 Days)||0||
60124953|NCT00353301|76246612|FG000|STARTED|Overall Study||25||
60124954|NCT00353301|76246612|FG000|COMPLETED|Overall Study||25||
60124955|NCT00353301|76246612|FG000|NOT COMPLETED|Overall Study||0||
60124956|NCT00318357|76246618|FG000|STARTED|Overall Study||173||
60124957|NCT00318357|76246619|FG001|STARTED|Overall Study||136||
60124958|NCT00318357|76246618|FG000|COMPLETED|Overall Study||134||
60124959|NCT00318357|76246619|FG001|COMPLETED|Overall Study||104||
60124960|NCT00318357|76246618|FG000|NOT COMPLETED|Overall Study||39||
60124961|NCT00318357|76246619|FG001|NOT COMPLETED|Overall Study||32||
60124962|NCT01522651|76246630|FG000|STARTED|Overall Study||26||
60124963|NCT01522651|76246631|FG001|STARTED|Overall Study||27||
60124964|NCT01522651|76246632|FG002|STARTED|Overall Study||26||
60124965|NCT01522651|76246633|FG003|STARTED|Overall Study||28||
60124966|NCT01522651|76246634|FG004|STARTED|Overall Study||27||
60124967|NCT01522651|76246630|FG000|COMPLETED|Overall Study||17||
60124968|NCT01522651|76246631|FG001|COMPLETED|Overall Study||19||
60124969|NCT01522651|76246632|FG002|COMPLETED|Overall Study||22||
60124970|NCT01522651|76246633|FG003|COMPLETED|Overall Study||20||
60124971|NCT01522651|76246634|FG004|COMPLETED|Overall Study||21||
60124972|NCT01522651|76246630|FG000|NOT COMPLETED|Overall Study||9||
60124973|NCT01522651|76246631|FG001|NOT COMPLETED|Overall Study||8||
60124974|NCT01522651|76246632|FG002|NOT COMPLETED|Overall Study||4||
60124975|NCT01522651|76246633|FG003|NOT COMPLETED|Overall Study||8||
60124976|NCT01522651|76246634|FG004|NOT COMPLETED|Overall Study||6||
60124977|NCT00318591|76246648|FG000|STARTED|Overall Study||105||
60124978|NCT00318591|76246649|FG001|STARTED|Overall Study||114||
60124979|NCT00318591|76246648|FG000|COMPLETED|Overall Study||45||
60124980|NCT00318591|76246649|FG001|COMPLETED|Overall Study||69||
60124981|NCT00318591|76246648|FG000|NOT COMPLETED|Overall Study||60||
60124982|NCT00318591|76246649|FG001|NOT COMPLETED|Overall Study||45||
60124983|NCT01554241|76246661|FG000|STARTED|Overall Study||23||
60124984|NCT01554241|76246662|FG001|STARTED|Overall Study||20||
60124985|NCT01554241|76246663|FG002|STARTED|Overall Study||24||
60124986|NCT01554241|76246664|FG003|STARTED|Overall Study||14||
60124987|NCT01554241|76246661|FG000|COMPLETED|Overall Study||20||
60124988|NCT01554241|76246662|FG001|COMPLETED|Overall Study||19||
60124989|NCT01554241|76246663|FG002|COMPLETED|Overall Study||20||
60124990|NCT01554241|76246664|FG003|COMPLETED|Overall Study||13||
60124991|NCT01554241|76246661|FG000|NOT COMPLETED|Overall Study||3||
60124992|NCT01554241|76246662|FG001|NOT COMPLETED|Overall Study||1||
60124993|NCT01554241|76246663|FG002|NOT COMPLETED|Overall Study||4||
60124994|NCT01554241|76246664|FG003|NOT COMPLETED|Overall Study||1||
60124995|NCT01521559|76246676|FG000|STARTED|Overall Study||92||
60124996|NCT01521559|76246677|FG001|STARTED|Overall Study||91||
60124997|NCT01521559|76246676|FG000|Completed Week 24|Overall Study||83||
60124998|NCT01521559|76246677|FG001|Completed Week 24|Overall Study||85||
60124999|NCT01521559|76246676|FG000|Completed Week 52|Overall Study||77||
60125000|NCT01521559|76246677|FG001|Completed Week 52|Overall Study||73||
60125001|NCT01521559|76246676|FG000|COMPLETED|Overall Study||77||
60125002|NCT01521559|76246677|FG001|COMPLETED|Overall Study||73||
60125003|NCT01521559|76246676|FG000|NOT COMPLETED|Overall Study||15||
60125004|NCT01521559|76246677|FG001|NOT COMPLETED|Overall Study||18||
60125005|NCT01554163|76246686|FG000|STARTED|Overall Study||120||
60125006|NCT01554163|76246687|FG001|STARTED|Overall Study||119||
60125007|NCT01554163|76246686|FG000|Number Treated|Overall Study||119||
60125008|NCT01554163|76246687|FG001|Number Treated|Overall Study||119||
60125009|NCT01554163|76246686|FG000|COMPLETED|Overall Study||112||
60125010|NCT01554163|76246687|FG001|COMPLETED|Overall Study||109||
60125011|NCT01554163|76246686|FG000|NOT COMPLETED|Overall Study||8||
60125012|NCT01554163|76246687|FG001|NOT COMPLETED|Overall Study||10||
60125013|NCT01553851|76246693|FG000|STARTED|Overall Study||20||
60125014|NCT01553851|76246693|FG000|COMPLETED|Overall Study||17||
60125015|NCT01553851|76246693|FG000|NOT COMPLETED|Overall Study||3||
60125016|NCT00355797|76246700|FG000|STARTED|Overall Study||741||
60125017|NCT00355797|76246701|FG001|STARTED|Overall Study||369||
60125018|NCT00355797|76246702|FG002|STARTED|Overall Study||381||
60125019|NCT00355797|76246700|FG000|COMPLETED|Overall Study||501||
60125020|NCT00355797|76246701|FG001|COMPLETED|Overall Study||221||
60125021|NCT00355797|76246702|FG002|COMPLETED|Overall Study||239||
60125022|NCT00355797|76246700|FG000|NOT COMPLETED|Overall Study||240||
60125023|NCT00355797|76246701|FG001|NOT COMPLETED|Overall Study||148||
59594763|NCT03163303|75703722|FG000|NOT COMPLETED|Overall Study||0||
59594764|NCT03163303|75703723|FG001|NOT COMPLETED|Overall Study||0||
60125024|NCT00355797|76246702|FG002|NOT COMPLETED|Overall Study||142||
60125025|NCT01552915|76246713|FG000|STARTED|Overall Study|This population is from the Safety Set. Two randomized subjects were not dosed and were excluded.|91||
60125026|NCT01552915|76246714|FG001|STARTED|Overall Study|This population is from the Safety Set. Two randomized subjects were not dosed and were excluded.|184||
60125027|NCT01552915|76246715|FG002|STARTED|Overall Study|This population is from the Safety Set. One randomized subject was not dosed and was excluded.|184||
60125028|NCT01552915|76246713|FG000|COMPLETED|Overall Study||68||
60125029|NCT01552915|76246714|FG001|COMPLETED|Overall Study||155||
60125030|NCT01552915|76246715|FG002|COMPLETED|Overall Study||157||
60125031|NCT01552915|76246713|FG000|NOT COMPLETED|Overall Study||23||
60125032|NCT01552915|76246714|FG001|NOT COMPLETED|Overall Study||29||
60125033|NCT01552915|76246715|FG002|NOT COMPLETED|Overall Study||27||
60125034|NCT00356031|76246723|FG000|STARTED|Overall Study||20||
60125035|NCT00356031|76246723|FG000|COMPLETED|Overall Study||20||
60125036|NCT00356031|76246723|FG000|NOT COMPLETED|Overall Study||0||
60125037|NCT00321321|76246729|FG000|STARTED|Overall Study||12||
60125038|NCT00321321|76246729|FG000|COMPLETED|Overall Study||12||
60125039|NCT00321321|76246729|FG000|NOT COMPLETED|Overall Study||0||
60125040|NCT00322101|76246735|FG000|STARTED|Overall Study||14||
60125041|NCT00322101|76246736|FG001|STARTED|Overall Study||11||
60125042|NCT00322101|76246735|FG000|COMPLETED|Overall Study||14||
60125043|NCT00322101|76246736|FG001|COMPLETED|Overall Study||11||
60125044|NCT00322101|76246735|FG000|NOT COMPLETED|Overall Study||0||
60125045|NCT00322101|76246736|FG001|NOT COMPLETED|Overall Study||0||
60125046|NCT01552681|76246744|FG000|STARTED|Overall Study||33||
60125047|NCT01552681|76246745|FG001|STARTED|Overall Study||19||
60125048|NCT01552681|76246744|FG000|COMPLETED|Overall Study||28||
60125049|NCT01552681|76246745|FG001|COMPLETED|Overall Study||18||
60125050|NCT01552681|76246744|FG000|NOT COMPLETED|Overall Study||5||
60125051|NCT01552681|76246745|FG001|NOT COMPLETED|Overall Study||1||
60125052|NCT00322335|76246754|FG000|STARTED|Subjects 18 Months After Booster Dose||58||
60125053|NCT00322335|76246755|FG001|STARTED|Subjects 18 Months After Booster Dose||123||
60125054|NCT00322335|76246756|FG002|STARTED|Subjects 18 Months After Booster Dose|Subjects who received Meningitec booster outside scope study NCT00323050 eliminated from this period|3||
60125055|NCT00322335|76246754|FG000|COMPLETED|Subjects 18 Months After Booster Dose||58||
60125056|NCT00322335|76246755|FG001|COMPLETED|Subjects 18 Months After Booster Dose||123||
60125057|NCT00322335|76246756|FG002|COMPLETED|Subjects 18 Months After Booster Dose||3||
60125058|NCT00322335|76246754|FG000|NOT COMPLETED|Subjects 18 Months After Booster Dose||0||
60125059|NCT00322335|76246755|FG001|NOT COMPLETED|Subjects 18 Months After Booster Dose||0||
60125060|NCT00322335|76246756|FG002|NOT COMPLETED|Subjects 18 Months After Booster Dose||0||
60125061|NCT00322335|76246754|FG000|STARTED|Subjects 30 Months After Booster Dose||54||
60125062|NCT00322335|76246755|FG001|STARTED|Subjects 30 Months After Booster Dose||119||
60125063|NCT00322335|76246756|FG002|STARTED|Subjects 30 Months After Booster Dose|Subjects eliminated from previous timepoint were included again from this timepoint onwards|57||
60125064|NCT00322335|76246754|FG000|COMPLETED|Subjects 30 Months After Booster Dose||54||
60125065|NCT00322335|76246755|FG001|COMPLETED|Subjects 30 Months After Booster Dose||119||
60125066|NCT00322335|76246756|FG002|COMPLETED|Subjects 30 Months After Booster Dose||57||
60125067|NCT00322335|76246754|FG000|NOT COMPLETED|Subjects 30 Months After Booster Dose||0||
60125068|NCT00322335|76246755|FG001|NOT COMPLETED|Subjects 30 Months After Booster Dose||0||
60125069|NCT00322335|76246756|FG002|NOT COMPLETED|Subjects 30 Months After Booster Dose||0||
60125070|NCT00322335|76246754|FG000|STARTED|Subjects 42 Months After Booster Dose||51||
60125071|NCT00322335|76246755|FG001|STARTED|Subjects 42 Months After Booster Dose||113||
60125072|NCT00322335|76246756|FG002|STARTED|Subjects 42 Months After Booster Dose||56||
60125073|NCT00322335|76246754|FG000|COMPLETED|Subjects 42 Months After Booster Dose||51||
60125074|NCT00322335|76246755|FG001|COMPLETED|Subjects 42 Months After Booster Dose||113||
60125075|NCT00322335|76246756|FG002|COMPLETED|Subjects 42 Months After Booster Dose||56||
60125076|NCT00322335|76246754|FG000|NOT COMPLETED|Subjects 42 Months After Booster Dose||0||
60125077|NCT00322335|76246755|FG001|NOT COMPLETED|Subjects 42 Months After Booster Dose||0||
60125078|NCT00322335|76246756|FG002|NOT COMPLETED|Subjects 42 Months After Booster Dose||0||
60125079|NCT00322335|76246754|FG000|STARTED|Subjects 54 Months After Booster Dose||50||
60125080|NCT00322335|76246755|FG001|STARTED|Subjects 54 Months After Booster Dose||108||
60125081|NCT00322335|76246756|FG002|STARTED|Subjects 54 Months After Booster Dose||56||
60125082|NCT00322335|76246754|FG000|COMPLETED|Subjects 54 Months After Booster Dose||50||
60125083|NCT00322335|76246755|FG001|COMPLETED|Subjects 54 Months After Booster Dose||108||
60125084|NCT00322335|76246756|FG002|COMPLETED|Subjects 54 Months After Booster Dose||56||
60125085|NCT00322335|76246754|FG000|NOT COMPLETED|Subjects 54 Months After Booster Dose||0||
60125086|NCT00322335|76246755|FG001|NOT COMPLETED|Subjects 54 Months After Booster Dose||0||
60125087|NCT00322335|76246756|FG002|NOT COMPLETED|Subjects 54 Months After Booster Dose||0||
60125088|NCT00322335|76246754|FG000|STARTED|Subjects 66 Months After Booster Dose||48||
60125089|NCT00322335|76246755|FG001|STARTED|Subjects 66 Months After Booster Dose||104||
60125090|NCT00322335|76246756|FG002|STARTED|Subjects 66 Months After Booster Dose||53||
60125091|NCT00322335|76246754|FG000|COMPLETED|Subjects 66 Months After Booster Dose||48||
60125092|NCT00322335|76246755|FG001|COMPLETED|Subjects 66 Months After Booster Dose||104||
60125093|NCT00322335|76246756|FG002|COMPLETED|Subjects 66 Months After Booster Dose||53||
60125094|NCT00322335|76246754|FG000|NOT COMPLETED|Subjects 66 Months After Booster Dose||0||
60125095|NCT00322335|76246755|FG001|NOT COMPLETED|Subjects 66 Months After Booster Dose||0||
60125096|NCT00322335|76246756|FG002|NOT COMPLETED|Subjects 66 Months After Booster Dose||0||
60125097|NCT00323193|76246766|FG000|STARTED|Overall Study||53||
60125098|NCT00323193|76246767|FG001|STARTED|Overall Study||56||
60125099|NCT00323193|76246766|FG000|COMPLETED|Overall Study||30||
60125100|NCT00323193|76246767|FG001|COMPLETED|Overall Study||41||
60125101|NCT00323193|76246766|FG000|NOT COMPLETED|Overall Study||23||
60125102|NCT00323193|76246767|FG001|NOT COMPLETED|Overall Study||15||
60125103|NCT01570387|76246777|FG000|STARTED|Overall Study||6||
60125104|NCT01570387|76246778|FG001|STARTED|Overall Study||3||
60125105|NCT01570387|76246779|FG002|STARTED|Overall Study||6||
60125106|NCT01570387|76246780|FG003|STARTED|Overall Study||12||
60125107|NCT01570387|76246777|FG000|Dose Limiting Toxicity|Overall Study||0||
60125108|NCT01570387|76246778|FG001|Dose Limiting Toxicity|Overall Study||0||
60125109|NCT01570387|76246779|FG002|Dose Limiting Toxicity|Overall Study||6||
60125110|NCT01570387|76246780|FG003|Dose Limiting Toxicity|Overall Study||12||
60125111|NCT01570387|76246777|FG000|Response to Maximal Tolerated Dose|Overall Study||0||
60125112|NCT01570387|76246778|FG001|Response to Maximal Tolerated Dose|Overall Study||0||
60125113|NCT01570387|76246779|FG002|Response to Maximal Tolerated Dose|Overall Study||3||
60125114|NCT01570387|76246780|FG003|Response to Maximal Tolerated Dose|Overall Study||6||
60125115|NCT01570387|76246777|FG000|COMPLETED|Overall Study||5||
60125116|NCT01570387|76246778|FG001|COMPLETED|Overall Study||3||
60125117|NCT01570387|76246779|FG002|COMPLETED|Overall Study||6||
60125118|NCT01570387|76246780|FG003|COMPLETED|Overall Study||10||
60125119|NCT01570387|76246777|FG000|NOT COMPLETED|Overall Study||1||
60125120|NCT01570387|76246778|FG001|NOT COMPLETED|Overall Study||0||
60125121|NCT01570387|76246779|FG002|NOT COMPLETED|Overall Study||0||
60125122|NCT01570387|76246780|FG003|NOT COMPLETED|Overall Study||2||
60125123|NCT01570309|76246789|FG000|STARTED|Overall Study||48||
60125124|NCT01570309|76246790|FG001|STARTED|Overall Study||48||
60125125|NCT01570309|76246789|FG000|COMPLETED|Overall Study||45||
60125126|NCT01570309|76246790|FG001|COMPLETED|Overall Study||45||
60125127|NCT01570309|76246789|FG000|NOT COMPLETED|Overall Study||3||
60125128|NCT01570309|76246790|FG001|NOT COMPLETED|Overall Study||3||
60125129|NCT01519921|76246802|FG000|STARTED|Overall Study||86||
60125130|NCT01519921|76246803|FG001|STARTED|Overall Study||64||
60125131|NCT01519921|76246802|FG000|COMPLETED|Overall Study||65||
60125132|NCT01519921|76246803|FG001|COMPLETED|Overall Study||49||
60125133|NCT01519921|76246802|FG000|NOT COMPLETED|Overall Study||21||
60125134|NCT01519921|76246803|FG001|NOT COMPLETED|Overall Study||15||
60125135|NCT01519765|76246811|FG000|STARTED|Overall Study||37||
60125136|NCT01519765|76246812|FG001|STARTED|Overall Study||36||
60125137|NCT01519765|76246811|FG000|COMPLETED|Overall Study||34||
60125138|NCT01519765|76246812|FG001|COMPLETED|Overall Study||34||
60125139|NCT01519765|76246811|FG000|NOT COMPLETED|Overall Study||3||
60125140|NCT01519765|76246812|FG001|NOT COMPLETED|Overall Study||2||
60125141|NCT01552603|76246819|FG000|STARTED|Overall Study||14||
60125142|NCT01552603|76246819|FG000|COMPLETED|Overall Study||13||
60125143|NCT01552603|76246819|FG000|NOT COMPLETED|Overall Study||1||
60125144|NCT01552369|76246825|FG000|STARTED|Overall Study||100||
60125145|NCT01552369|76246826|FG001|STARTED|Overall Study||105||
60125146|NCT01552369|76246825|FG000|One Year|Overall Study||100|Subjects completed major endpoints; CMV disease and/or all-cause mortality|
60125147|NCT01552369|76246826|FG001|One Year|Overall Study||105|Subjects completed major endpoints; CMV disease and/or all-cause mortality|
60125148|NCT01552369|76246825|FG000|Final Follow up|Overall Study||92||
60125149|NCT01552369|76246826|FG001|Final Follow up|Overall Study||96||
60125150|NCT01552369|76246825|FG000|COMPLETED|Overall Study||92|Subjects that completed major endpoint; CMV disease and/or all-cause mortality|
60125151|NCT01552369|76246826|FG001|COMPLETED|Overall Study||96|Subjects that completed major endpoint; CMV disease and/or all-cause mortality|
60125152|NCT01552369|76246825|FG000|NOT COMPLETED|Overall Study||8||
60125153|NCT01552369|76246826|FG001|NOT COMPLETED|Overall Study||9||
60125154|NCT01552057|76246836|FG000|STARTED|Overall Study||196||
60125155|NCT01552057|76246837|FG001|STARTED|Overall Study||197||
60125156|NCT01552057|76246836|FG000|Received at Least 1 Dose of Study Drug|Overall Study||194||
60125157|NCT01552057|76246837|FG001|Received at Least 1 Dose of Study Drug|Overall Study||196||
60125158|NCT01552057|76246836|FG000|COMPLETED|Overall Study||166||
60125159|NCT01552057|76246837|FG001|COMPLETED|Overall Study||149||
60125160|NCT01552057|76246836|FG000|NOT COMPLETED|Overall Study||30||
60125161|NCT01552057|76246837|FG001|NOT COMPLETED|Overall Study||48||
60125162|NCT01551745|76246843|FG000|STARTED|Overall Study||5||
60125163|NCT01551745|76246843|FG000|COMPLETED|Overall Study|"Completed means subject had been given all manufactured doses"|2||
60125164|NCT01551745|76246843|FG000|NOT COMPLETED|Overall Study||3||
60125165|NCT01551355|76246853|FG000|STARTED|Overall Study||622||
60125166|NCT01551355|76246854|FG001|STARTED|Overall Study||594||
60125167|NCT01551355|76246855|FG002|STARTED|Overall Study||493||
60125168|NCT01551355|76246856|FG003|STARTED|Overall Study||435||
60125169|NCT01551355|76246857|FG004|STARTED|Overall Study||64||
60125170|NCT01551355|76246858|FG005|STARTED|Overall Study||71||
60125171|NCT01551355|76246853|FG000|COMPLETED|Overall Study||571||
60125172|NCT01551355|76246854|FG001|COMPLETED|Overall Study||545||
60125173|NCT01551355|76246855|FG002|COMPLETED|Overall Study||459||
60125174|NCT01551355|76246856|FG003|COMPLETED|Overall Study||411||
60125175|NCT01551355|76246857|FG004|COMPLETED|Overall Study||55||
60125176|NCT01551355|76246858|FG005|COMPLETED|Overall Study||65||
60125177|NCT01551355|76246853|FG000|NOT COMPLETED|Overall Study||51||
60125178|NCT01551355|76246854|FG001|NOT COMPLETED|Overall Study||49||
60125179|NCT01551355|76246855|FG002|NOT COMPLETED|Overall Study||34||
60125180|NCT01551355|76246856|FG003|NOT COMPLETED|Overall Study||24||
60125181|NCT01551355|76246857|FG004|NOT COMPLETED|Overall Study||9||
60125182|NCT01551355|76246858|FG005|NOT COMPLETED|Overall Study||6||
60125183|NCT01569841|76246866|FG000|STARTED|Period A (6 Weeks)||12||
60125184|NCT01569841|76246867|FG001|STARTED|Period A (6 Weeks)||12||
60125185|NCT01569841|76246866|FG000|Exposed|Period A (6 Weeks)||12||
60125186|NCT01569841|76246867|FG001|Exposed|Period A (6 Weeks)||12||
60125187|NCT01569841|76246866|FG000|COMPLETED|Period A (6 Weeks)||12||
60125188|NCT01569841|76246867|FG001|COMPLETED|Period A (6 Weeks)||11||
60125189|NCT01569841|76246866|FG000|NOT COMPLETED|Period A (6 Weeks)||0||
60125190|NCT01569841|76246867|FG001|NOT COMPLETED|Period A (6 Weeks)||1||
60125191|NCT01569841|76246866|FG000|STARTED|Period B (6 Weeks)||12||
60125192|NCT01569841|76246867|FG001|STARTED|Period B (6 Weeks)||11||
60125193|NCT01569841|76246866|FG000|Exposed|Period B (6 Weeks)||12||
60125194|NCT01569841|76246867|FG001|Exposed|Period B (6 Weeks)||11||
60125195|NCT01569841|76246866|FG000|COMPLETED|Period B (6 Weeks)||12||
60125196|NCT01569841|76246867|FG001|COMPLETED|Period B (6 Weeks)||11||
60125197|NCT01569841|76246866|FG000|NOT COMPLETED|Period B (6 Weeks)||0||
60125198|NCT01569841|76246867|FG001|NOT COMPLETED|Period B (6 Weeks)||0||
60125199|NCT01569763|76246877|FG000|STARTED|Overall Study||102||
60125200|NCT01569763|76246878|FG001|STARTED|Overall Study||51||
60125201|NCT01569763|76246877|FG000|Treated|Overall Study||102||
60125202|NCT01569763|76246878|FG001|Treated|Overall Study||51||
60125203|NCT01569763|76246877|FG000|COMPLETED|Overall Study|Completed 12 Months of Follow-up|99||
60125204|NCT01569763|76246878|FG001|COMPLETED|Overall Study|Completed 12 Months of Follow-up|44||
60125205|NCT01569763|76246877|FG000|NOT COMPLETED|Overall Study||3||
60125206|NCT01569763|76246878|FG001|NOT COMPLETED|Overall Study||7||
60125207|NCT01550965|76246884|FG000|STARTED|Overall Study||463||
60125208|NCT01550965|76246884|FG000|COMPLETED|Overall Study||353||
60125209|NCT01550965|76246884|FG000|NOT COMPLETED|Overall Study||110||
60125210|NCT02268474|76246889|FG000|STARTED|Overall Study||22||44
60125211|NCT02268474|76246889|FG000|Treatment With the 532nm KTP Laser|Overall Study||22||22
60125212|NCT02268474|76246889|FG000|Treatment With the 595nm Pulse Dye Laser|Overall Study||22||22
60125213|NCT02268474|76246889|FG000|COMPLETED|Overall Study||19||38
60125214|NCT02268474|76246889|FG000|NOT COMPLETED|Overall Study||3||6
60125215|NCT03658629|76246902|FG000|STARTED|Overall Study||158||
60125216|NCT03658629|76246903|FG001|STARTED|Overall Study||309||
60125217|NCT03658629|76246904|FG002|STARTED|Overall Study||155||
60125218|NCT03658629|76246905|FG003|STARTED|Overall Study||133||
60125219|NCT03658629|76246906|FG004|STARTED|Overall Study||313||
60125220|NCT03658629|76246907|FG005|STARTED|Overall Study||154||
60125221|NCT03658629|76246908|FG006|STARTED|Overall Study||153||
60125222|NCT03658629|76246902|FG000|Participants in Safety Population|Overall Study||157||
60125223|NCT03658629|76246903|FG001|Participants in Safety Population|Overall Study||305||
60125224|NCT03658629|76246904|FG002|Participants in Safety Population|Overall Study||156||
60125225|NCT03658629|76246905|FG003|Participants in Safety Population|Overall Study||132||
60125226|NCT03658629|76246906|FG004|Participants in Safety Population|Overall Study||311||
60125227|NCT03658629|76246907|FG005|Participants in Safety Population|Overall Study||153||
60125228|NCT03658629|76246908|FG006|Participants in Safety Population|Overall Study||151||
60125229|NCT03658629|76246902|FG000|COMPLETED|Overall Study||151||
60125230|NCT03658629|76246903|FG001|COMPLETED|Overall Study||296||
60125231|NCT03658629|76246904|FG002|COMPLETED|Overall Study||149||
60125232|NCT03658629|76246905|FG003|COMPLETED|Overall Study||125||
60125233|NCT03658629|76246906|FG004|COMPLETED|Overall Study||303||
60125234|NCT03658629|76246907|FG005|COMPLETED|Overall Study||151||
60125235|NCT03658629|76246908|FG006|COMPLETED|Overall Study||148||
60125236|NCT03658629|76246902|FG000|NOT COMPLETED|Overall Study||7||
60125237|NCT03658629|76246903|FG001|NOT COMPLETED|Overall Study||13||
60125238|NCT03658629|76246904|FG002|NOT COMPLETED|Overall Study||6||
60125239|NCT03658629|76246905|FG003|NOT COMPLETED|Overall Study||8||
60125240|NCT03658629|76246906|FG004|NOT COMPLETED|Overall Study||10||
60125241|NCT03658629|76246907|FG005|NOT COMPLETED|Overall Study||3||
60125242|NCT03658629|76246908|FG006|NOT COMPLETED|Overall Study||5||
60125243|NCT00323271|76246926|FG000|STARTED|Overall Study||13||
60125244|NCT00323271|76246927|FG001|STARTED|Overall Study||12||
60125245|NCT00323271|76246926|FG000|COMPLETED|Overall Study||11||
60125246|NCT00323271|76246927|FG001|COMPLETED|Overall Study||9||
60125247|NCT00323271|76246926|FG000|NOT COMPLETED|Overall Study||2||
60125248|NCT00323271|76246927|FG001|NOT COMPLETED|Overall Study||3||
60125249|NCT00323427|76246935|FG000|STARTED|Overall Study||69||
60125250|NCT00323427|76246936|FG001|STARTED|Overall Study||66||
60125251|NCT00323427|76246935|FG000|COMPLETED|Overall Study||38||
60125252|NCT00323427|76246936|FG001|COMPLETED|Overall Study||43||
60125253|NCT00323427|76246935|FG000|NOT COMPLETED|Overall Study||31||
60125254|NCT00323427|76246936|FG001|NOT COMPLETED|Overall Study||23||
60125255|NCT00323739|76246942|FG000|STARTED|Overall Study||80||
59594765|NCT03165175|75703731|FG000|STARTED|1-month to 3-month||41||
60125256|NCT00323739|76246942|FG000|COMPLETED|Overall Study||80||
60125257|NCT00323739|76246942|FG000|NOT COMPLETED|Overall Study||0||
60125258|NCT00390429|76246949|FG000|STARTED|Overall Study||5||
60125259|NCT00390429|76246950|FG001|STARTED|Overall Study||12||
60125260|NCT00390429|76246951|FG002|STARTED|Overall Study||25||
60125261|NCT00390429|76246952|FG003|STARTED|Overall Study||39||
60125262|NCT00390429|76246949|FG000|COMPLETED|Overall Study||5||
60125263|NCT00390429|76246950|FG001|COMPLETED|Overall Study||12||
60125264|NCT00390429|76246951|FG002|COMPLETED|Overall Study||25||
60125265|NCT00390429|76246952|FG003|COMPLETED|Overall Study||39||
60125266|NCT00390429|76246949|FG000|NOT COMPLETED|Overall Study||0||
60125267|NCT00390429|76246950|FG001|NOT COMPLETED|Overall Study||0||
60125268|NCT00390429|76246951|FG002|NOT COMPLETED|Overall Study||0||
60125269|NCT00390429|76246952|FG003|NOT COMPLETED|Overall Study||0||
60125270|NCT00391443|76246965|FG000|STARTED|Overall Study|1 patient in the bosentan arm did not receive treatment & was excluded from the Safety Population.|209||
60125271|NCT00391443|76246966|FG001|STARTED|Overall Study||407||
60125272|NCT00391443|76246965|FG000|COMPLETED|Overall Study||209||
60125273|NCT00391443|76246966|FG001|COMPLETED|Overall Study||407||
60125274|NCT00391443|76246965|FG000|NOT COMPLETED|Overall Study||0||
60125275|NCT00391443|76246966|FG001|NOT COMPLETED|Overall Study||0||
60125276|NCT00391599|76246974|FG000|STARTED|Overall Study||65||
60125277|NCT00391599|76246975|FG001|STARTED|Overall Study||65||
60125278|NCT00391599|76246974|FG000|COMPLETED|Overall Study||65||
60125279|NCT00391599|76246975|FG001|COMPLETED|Overall Study||65||
60125280|NCT00391599|76246974|FG000|NOT COMPLETED|Overall Study||0||
60125281|NCT00391599|76246975|FG001|NOT COMPLETED|Overall Study||0||
60125282|NCT00391989|76246983|FG000|STARTED|Overall Study||55||
60125283|NCT00391989|76246983|FG000|COMPLETED|Overall Study||53||
60125284|NCT00391989|76246983|FG000|NOT COMPLETED|Overall Study||2||
60125285|NCT02108223|76246990|FG000|STARTED|Overall Study||52||
60125286|NCT02108223|76246991|FG001|STARTED|Overall Study||50||
60125287|NCT02108223|76246992|FG002|STARTED|Overall Study||35||
60125288|NCT02108223|76246990|FG000|COMPLETED|Overall Study||52||
60125289|NCT02108223|76246991|FG001|COMPLETED|Overall Study||50||
60125290|NCT02108223|76246992|FG002|COMPLETED|Overall Study||35||
60125291|NCT02108223|76246990|FG000|NOT COMPLETED|Overall Study||0||
60125292|NCT02108223|76246991|FG001|NOT COMPLETED|Overall Study||0||
60125293|NCT02108223|76246992|FG002|NOT COMPLETED|Overall Study||0||
60125294|NCT01569295|76247005|FG000|STARTED|Overall Study||207||
60125295|NCT01569295|76247006|FG001|STARTED|Overall Study||209||
60125296|NCT01569295|76247005|FG000|Long-Term Follow-up|Overall Study||109||
60125297|NCT01569295|76247006|FG001|Long-Term Follow-up|Overall Study||161||
60125298|NCT01569295|76247005|FG000|COMPLETED|Overall Study||0||
60125299|NCT01569295|76247006|FG001|COMPLETED|Overall Study||0||
60125300|NCT01569295|76247005|FG000|NOT COMPLETED|Overall Study||207||
60125301|NCT01569295|76247006|FG001|NOT COMPLETED|Overall Study||209||
60125302|NCT02108457|76247015|FG000|STARTED|Overall Study||3||
60125303|NCT02108457|76247016|FG001|STARTED|Overall Study||12||
60125304|NCT02108457|76247015|FG000|COMPLETED|Overall Study||3||
60125305|NCT02108457|76247016|FG001|COMPLETED|Overall Study||10||
60125306|NCT02108457|76247015|FG000|NOT COMPLETED|Overall Study||0||
60125307|NCT02108457|76247016|FG001|NOT COMPLETED|Overall Study||2||
60125308|NCT00394329|76247026|FG000|STARTED|Overall Study||71||
60125309|NCT00394329|76247027|FG001|STARTED|Overall Study||72||
60125310|NCT00394329|76247028|FG002|STARTED|Overall Study||71||
60125311|NCT00394329|76247029|FG003|STARTED|Overall Study||74||
60125312|NCT00394329|76247026|FG000|COMPLETED|Overall Study||63||
60125313|NCT00394329|76247027|FG001|COMPLETED|Overall Study||63||
60125314|NCT00394329|76247028|FG002|COMPLETED|Overall Study||58||
60125315|NCT00394329|76247029|FG003|COMPLETED|Overall Study||50||
60125316|NCT00394329|76247026|FG000|NOT COMPLETED|Overall Study||8||
60125317|NCT00394329|76247027|FG001|NOT COMPLETED|Overall Study||9||
60125318|NCT00394329|76247028|FG002|NOT COMPLETED|Overall Study||13||
60125319|NCT00394329|76247029|FG003|NOT COMPLETED|Overall Study||24||
60125320|NCT02108691|76247047|FG000|STARTED|Overall Study||40||
60125321|NCT02108691|76247048|FG001|STARTED|Overall Study||40||
60125322|NCT02108691|76247047|FG000|COMPLETED|Overall Study||32||
60125323|NCT02108691|76247048|FG001|COMPLETED|Overall Study||31||
60125324|NCT02108691|76247047|FG000|NOT COMPLETED|Overall Study||8||
60125325|NCT02108691|76247048|FG001|NOT COMPLETED|Overall Study||9||
60125326|NCT02109159|76247056|FG000|STARTED|Overall Study||4178||
60125327|NCT02109159|76247057|FG001|STARTED|Overall Study||4175||
60125328|NCT02109159|76247056|FG000|COMPLETED|Overall Study||4178||
60125329|NCT02109159|76247057|FG001|COMPLETED|Overall Study||4175||
60125330|NCT02109159|76247056|FG000|NOT COMPLETED|Overall Study||0||
60125331|NCT02109159|76247057|FG001|NOT COMPLETED|Overall Study||0||
60125332|NCT01549951|76247063|FG000|STARTED|Overall Study||50||
60125333|NCT01549951|76247063|FG000|Primary Reason Off Study Treatment|Overall Study||50||
60125334|NCT01549951|76247063|FG000|COMPLETED|Overall Study||0||
60125335|NCT01549951|76247063|FG000|NOT COMPLETED|Overall Study||50||
60125336|NCT01517893|76247069|FG000|STARTED|Overall Study||8||
59858969|NCT03214666|75983552|FG005|NOT COMPLETED|Cohort 6: Dose Level 6: 150 ug/kg/Day||0||
60125337|NCT01517893|76247070|FG001|STARTED|Overall Study||7||
60125338|NCT01517893|76247069|FG000|COMPLETED|Overall Study||5||
60125339|NCT01517893|76247070|FG001|COMPLETED|Overall Study||7||
60125340|NCT01517893|76247069|FG000|NOT COMPLETED|Overall Study||3||
60125341|NCT01517893|76247070|FG001|NOT COMPLETED|Overall Study||0||
60125342|NCT01489891|76247078|FG000|STARTED|Overall Study||60||
60125343|NCT01489891|76247079|FG001|STARTED|Overall Study||60||
60125344|NCT01489891|76247078|FG000|COMPLETED|Overall Study||59||
60125345|NCT01489891|76247079|FG001|COMPLETED|Overall Study||60||
60125346|NCT01489891|76247078|FG000|NOT COMPLETED|Overall Study||1||
60125347|NCT01489891|76247079|FG001|NOT COMPLETED|Overall Study||0||
60125348|NCT00360009|76247088|FG000|STARTED|Overall Study||10||
60125349|NCT00360009|76247089|FG001|STARTED|Overall Study||26||
60125350|NCT00360009|76247090|FG002|STARTED|Overall Study||26||
60125351|NCT00360009|76247088|FG000|COMPLETED|Overall Study||10||
60125352|NCT00360009|76247089|FG001|COMPLETED|Overall Study||22||
60125353|NCT00360009|76247090|FG002|COMPLETED|Overall Study||23||
60125354|NCT00360009|76247088|FG000|NOT COMPLETED|Overall Study||0||
60125355|NCT00360009|76247089|FG001|NOT COMPLETED|Overall Study||4||
60125356|NCT00360009|76247090|FG002|NOT COMPLETED|Overall Study||3||
60125357|NCT00360243|76247102|FG000|STARTED|Overall Study||337||
60125358|NCT00360243|76247103|FG001|STARTED|Overall Study||363||
60125359|NCT00360243|76247104|FG002|STARTED|Overall Study||336||
60125360|NCT00360243|76247105|FG003|STARTED|Overall Study||349||
60125361|NCT00360243|76247102|FG000|COMPLETED|Overall Study||235||
60125362|NCT00360243|76247103|FG001|COMPLETED|Overall Study||243||
60125363|NCT00360243|76247104|FG002|COMPLETED|Overall Study||180||
60125364|NCT00360243|76247105|FG003|COMPLETED|Overall Study||224||
60125365|NCT00360243|76247102|FG000|NOT COMPLETED|Overall Study||102||
60125366|NCT00360243|76247103|FG001|NOT COMPLETED|Overall Study||120||
60125367|NCT00360243|76247104|FG002|NOT COMPLETED|Overall Study||156||
60125368|NCT00360243|76247105|FG003|NOT COMPLETED|Overall Study||125||
60125369|NCT00396201|76247115|FG000|STARTED|Treatment Period||22||
60125370|NCT00396201|76247115|FG000|COMPLETED|Treatment Period|Completed refers to completed all treatment visits.|22||
60125371|NCT00396201|76247115|FG000|NOT COMPLETED|Treatment Period||0||
60125372|NCT00396201|76247115|FG000|STARTED|Follow-up Period|Participants who had transplants. One had insufficient collection of cells so no transplant.|21||
60125373|NCT00396201|76247115|FG000|COMPLETED|Follow-up Period|Follow-up visit 12 months post-transplant|21||
60125374|NCT00396201|76247115|FG000|NOT COMPLETED|Follow-up Period||0||
60125375|NCT00360399|76247123|FG000|STARTED|Overall Study||114||
60125376|NCT00360399|76247124|FG001|STARTED|Overall Study||115||
60125377|NCT00360399|76247125|FG002|STARTED|Overall Study||115||
60125378|NCT00360399|76247123|FG000|Had Post-randomization Assessment|Overall Study||105||
60125379|NCT00360399|76247124|FG001|Had Post-randomization Assessment|Overall Study||106||
60125380|NCT00360399|76247125|FG002|Had Post-randomization Assessment|Overall Study||105||
60125381|NCT00360399|76247123|FG000|COMPLETED|Overall Study||86||
60125382|NCT00360399|76247124|FG001|COMPLETED|Overall Study||79||
60125383|NCT00360399|76247125|FG002|COMPLETED|Overall Study||69||
60125384|NCT00360399|76247123|FG000|NOT COMPLETED|Overall Study||28||
60125385|NCT00360399|76247124|FG001|NOT COMPLETED|Overall Study||36||
60125386|NCT00360399|76247125|FG002|NOT COMPLETED|Overall Study||46||
60125387|NCT00360555|76247137|FG000|STARTED|Overall Study||396||
60125388|NCT00360555|76247138|FG001|STARTED|Overall Study||393||
60125389|NCT00360555|76247139|FG002|STARTED|Overall Study||396||
60125390|NCT00360555|76247140|FG003|STARTED|Overall Study||399||
60125391|NCT00360555|76247137|FG000|COMPLETED|Overall Study||274||
60125392|NCT00360555|76247138|FG001|COMPLETED|Overall Study||259||
60125393|NCT00360555|76247139|FG002|COMPLETED|Overall Study||251||
60125394|NCT00360555|76247140|FG003|COMPLETED|Overall Study||287||
60125395|NCT00360555|76247137|FG000|NOT COMPLETED|Overall Study||122||
60125396|NCT00360555|76247138|FG001|NOT COMPLETED|Overall Study||134||
60125397|NCT00360555|76247139|FG002|NOT COMPLETED|Overall Study||145||
60125398|NCT00360555|76247140|FG003|NOT COMPLETED|Overall Study||112||
60125399|NCT00361257|76247152|FG000|STARTED|Step 1: Minocycline vs. Placebo||52||
60125400|NCT00361257|76247153|FG001|STARTED|Step 1: Minocycline vs. Placebo||55||
60125401|NCT00361257|76247152|FG000|COMPLETED|Step 1: Minocycline vs. Placebo||40||
60125402|NCT00361257|76247153|FG001|COMPLETED|Step 1: Minocycline vs. Placebo||43||
59858970|NCT00274469|75983569|FG000|STARTED|Overall Study|Number of patients randomized|102||
59858971|NCT00274469|75983570|FG001|STARTED|Overall Study|Number of patients randomized|103||
59858972|NCT00274469|75983569|FG000|COMPLETED|Overall Study|Number of patients ongoing study treatment at data cut-off|23||
60125403|NCT00361257|76247152|FG000|NOT COMPLETED|Step 1: Minocycline vs. Placebo||12||
60125404|NCT00361257|76247153|FG001|NOT COMPLETED|Step 1: Minocycline vs. Placebo||12||
60125405|NCT00361257|76247152|FG000|STARTED|Step 2: Minocycline(Open Label) for All|40 participants completed Step 1; however,12 decided not to enroll Step 2,so 40-12=28 started Step 2|28||
60125406|NCT00361257|76247153|FG001|STARTED|Step 2: Minocycline(Open Label) for All|43 participants completed Step 1; however, 9 decided not to enroll Step 2,so 43-9=34 started Step 2.|34||
60125407|NCT00361257|76247152|FG000|COMPLETED|Step 2: Minocycline(Open Label) for All||13||
60125408|NCT00361257|76247153|FG001|COMPLETED|Step 2: Minocycline(Open Label) for All||19||
60125409|NCT00361257|76247152|FG000|NOT COMPLETED|Step 2: Minocycline(Open Label) for All||15||
60125410|NCT00361257|76247153|FG001|NOT COMPLETED|Step 2: Minocycline(Open Label) for All||15||
60125411|NCT04062240|76247161|FG000|STARTED|Overall Study||15||
60125412|NCT04062240|76247161|FG000|COMPLETED|Overall Study||14||
60125413|NCT04062240|76247161|FG000|NOT COMPLETED|Overall Study||1||
60125414|NCT02790138|76247167|FG000|STARTED|Overall Study||51||
60125415|NCT02790138|76247168|FG001|STARTED|Overall Study||51||
60125416|NCT02790138|76247167|FG000|COMPLETED|Overall Study||30||
60125417|NCT02790138|76247168|FG001|COMPLETED|Overall Study||32||
60125418|NCT02790138|76247167|FG000|NOT COMPLETED|Overall Study||21||
60125419|NCT02790138|76247168|FG001|NOT COMPLETED|Overall Study||19||
60125420|NCT00396981|76247177|FG000|STARTED|Overall Study||311||
60125421|NCT00396981|76247178|FG001|STARTED|Overall Study||315||
60125422|NCT00396981|76247177|FG000|COMPLETED|Overall Study||296||
60125423|NCT00396981|76247178|FG001|COMPLETED|Overall Study||306||
60125424|NCT00396981|76247177|FG000|NOT COMPLETED|Overall Study||15||
60125425|NCT00396981|76247178|FG001|NOT COMPLETED|Overall Study||9||
60125426|NCT00397839|76247186|FG000|STARTED|Overall Study||48||
60125427|NCT00397839|76247187|FG001|STARTED|Overall Study||87||
60125428|NCT00397839|76247186|FG000|COMPLETED|Overall Study||41||
60125429|NCT00397839|76247187|FG001|COMPLETED|Overall Study||69||
60125430|NCT00397839|76247186|FG000|NOT COMPLETED|Overall Study||7||
60125431|NCT00397839|76247187|FG001|NOT COMPLETED|Overall Study||18||
60125432|NCT00400803|76247193|FG000|STARTED|Overall Study||35||
60125433|NCT00400803|76247193|FG000|COMPLETED|Overall Study||35||
60125434|NCT00400803|76247193|FG000|NOT COMPLETED|Overall Study||0||
60125435|NCT04615299|76247203|FG000|STARTED|Overall Study||36||
60125436|NCT04615299|76247204|FG001|STARTED|Overall Study||36||
60125437|NCT04615299|76247203|FG000|COMPLETED|Overall Study||36||
60125438|NCT04615299|76247204|FG001|COMPLETED|Overall Study||36||
60125439|NCT04615299|76247203|FG000|NOT COMPLETED|Overall Study||0||
60125440|NCT04615299|76247204|FG001|NOT COMPLETED|Overall Study||0||
60125441|NCT00362817|76247210|FG000|STARTED|Overall Study||17||
60125442|NCT00362817|76247210|FG000|COMPLETED|Overall Study||17||
60125443|NCT00362817|76247210|FG000|NOT COMPLETED|Overall Study||0||
60125444|NCT00363675|76247215|FG000|STARTED|Overall Study||3||
60125445|NCT00363675|76247215|FG000|Completed Testing|Overall Study||3||
60125446|NCT00363675|76247215|FG000|COMPLETED|Overall Study||3||
60125447|NCT00363675|76247215|FG000|NOT COMPLETED|Overall Study||0||
60125448|NCT00400881|76247222|FG000|STARTED|Overall Study||62||
60125449|NCT00400881|76247223|FG001|STARTED|Overall Study||60||
60125450|NCT00400881|76247222|FG000|COMPLETED|Overall Study||62||
60125451|NCT00400881|76247223|FG001|COMPLETED|Overall Study||60||
60125452|NCT00400881|76247222|FG000|NOT COMPLETED|Overall Study||0||
60125453|NCT00400881|76247223|FG001|NOT COMPLETED|Overall Study||0||
60125454|NCT02040792|76247235|FG000|STARTED|Overall Study||70||
60125455|NCT02040792|76247236|FG001|STARTED|Overall Study||68||
60125456|NCT02040792|76247237|FG002|STARTED|Overall Study||71||
60125457|NCT02040792|76247238|FG003|STARTED|Overall Study||71||
60125458|NCT02040792|76247239|FG004|STARTED|Overall Study||74||
60125459|NCT02040792|76247235|FG000|COMPLETED|Overall Study||64||
60125460|NCT02040792|76247236|FG001|COMPLETED|Overall Study||65||
60125461|NCT02040792|76247237|FG002|COMPLETED|Overall Study||68||
60125462|NCT02040792|76247238|FG003|COMPLETED|Overall Study||64||
60125463|NCT02040792|76247239|FG004|COMPLETED|Overall Study||67||
60125464|NCT02040792|76247235|FG000|NOT COMPLETED|Overall Study||6||
60125465|NCT02040792|76247236|FG001|NOT COMPLETED|Overall Study||3||
60125466|NCT02040792|76247237|FG002|NOT COMPLETED|Overall Study||3||
60125467|NCT02040792|76247238|FG003|NOT COMPLETED|Overall Study||7||
60125468|NCT02040792|76247239|FG004|NOT COMPLETED|Overall Study||7||
60125469|NCT00364377|76247253|FG000|STARTED|Overall Study||11||
60125470|NCT00364377|76247254|FG001|STARTED|Overall Study||11||
60125471|NCT00364377|76247253|FG000|COMPLETED|Overall Study||11||
60125472|NCT00364377|76247254|FG001|COMPLETED|Overall Study||11||
60125473|NCT00364377|76247253|FG000|NOT COMPLETED|Overall Study||0||
60125474|NCT00364377|76247254|FG001|NOT COMPLETED|Overall Study||0||
60125475|NCT00365391|76247260|FG000|STARTED|Overall Study||27||
60125476|NCT00365391|76247260|FG000|COMPLETED|Overall Study||27||
60125477|NCT00365391|76247260|FG000|NOT COMPLETED|Overall Study||0||
60125478|NCT00401817|76247264|FG000|STARTED|Overall Study||11||
60125479|NCT00401817|76247264|FG000|COMPLETED|Overall Study||11||
60125480|NCT00401817|76247264|FG000|NOT COMPLETED|Overall Study||0||
60125481|NCT00365859|76247272|FG000|STARTED|Overall Study||86||
60125482|NCT00365859|76247273|FG001|STARTED|Overall Study||70||
60125483|NCT00365859|76247274|FG002|STARTED|Overall Study||174||
60125484|NCT00365859|76247275|FG003|STARTED|Overall Study||330||
60125485|NCT00365859|76247272|FG000|Safety Population|Overall Study||86||
60125486|NCT00365859|76247273|FG001|Safety Population|Overall Study||70||
60125487|NCT00365859|76247274|FG002|Safety Population|Overall Study||174||
60125488|NCT00365859|76247275|FG003|Safety Population|Overall Study||330||
59594766|NCT03165175|75703732|FG001|STARTED|1-month to 3-month||39||
60125489|NCT00365859|76247272|FG000|Efficacy Population|Overall Study|1 patient was lost to follow-up and 1 not included due to moderate sedation (total=2)|84||
60125490|NCT00365859|76247273|FG001|Efficacy Population|Overall Study|1 not included due to increased alanine aminotransferase (ALT) prior to treatment with aripiprazole|69||
60125491|NCT00365859|76247274|FG002|Efficacy Population|Overall Study|3 lost to follow-up, 1 not included due to mild increased appetite, 1 to family emergency (total=5)|169||
60125492|NCT00365859|76247275|FG003|Efficacy Population|Overall Study||322||
60125493|NCT00365859|76247272|FG000|COMPLETED|Overall Study||55||
60125494|NCT00365859|76247273|FG001|COMPLETED|Overall Study||37||
60125495|NCT00365859|76247274|FG002|COMPLETED|Overall Study||107||
60125496|NCT00365859|76247275|FG003|COMPLETED|Overall Study||199||
60125497|NCT00365859|76247272|FG000|NOT COMPLETED|Overall Study||31||
60125498|NCT00365859|76247273|FG001|NOT COMPLETED|Overall Study||33||
60125499|NCT00365859|76247274|FG002|NOT COMPLETED|Overall Study||67||
60125500|NCT00365859|76247275|FG003|NOT COMPLETED|Overall Study||131||
60125501|NCT00406107|76247286|FG000|STARTED|Overall Study||15||
60125502|NCT00406107|76247287|FG001|STARTED|Overall Study||5||
60125503|NCT00406107|76247286|FG000|COMPLETED|Overall Study||14||
60125504|NCT00406107|76247287|FG001|COMPLETED|Overall Study||4||
60125505|NCT00406107|76247286|FG000|NOT COMPLETED|Overall Study||1||
60125506|NCT00406107|76247287|FG001|NOT COMPLETED|Overall Study||1||
60125507|NCT00407355|76247296|FG000|STARTED|Overall Study||20||
60125508|NCT00407355|76247297|FG001|STARTED|Overall Study||20||
60125509|NCT00407355|76247296|FG000|COMPLETED|Overall Study||10||
60125510|NCT00407355|76247297|FG001|COMPLETED|Overall Study||9||
60125511|NCT00407355|76247296|FG000|NOT COMPLETED|Overall Study||10||
60125512|NCT00407355|76247297|FG001|NOT COMPLETED|Overall Study||11||
60125513|NCT02110485|76247305|FG000|STARTED|Overall Study||98||
60125514|NCT02110485|76247306|FG001|STARTED|Overall Study||102||
60125515|NCT02110485|76247305|FG000|COMPLETED|Overall Study||91||
60125516|NCT02110485|76247306|FG001|COMPLETED|Overall Study||83||
60125517|NCT02110485|76247305|FG000|NOT COMPLETED|Overall Study||7||
60125518|NCT02110485|76247306|FG001|NOT COMPLETED|Overall Study||19||
60125519|NCT02111187|76247314|FG000|STARTED|Overall Study||7||
60125520|NCT02111187|76247315|FG001|STARTED|Overall Study||7||
60125521|NCT02111187|76247314|FG000|COMPLETED|Overall Study||7||
60125522|NCT02111187|76247315|FG001|COMPLETED|Overall Study||7||
60125523|NCT02111187|76247314|FG000|NOT COMPLETED|Overall Study||0||
60125524|NCT02111187|76247315|FG001|NOT COMPLETED|Overall Study||0||
60125525|NCT05385224|76247321|FG000|STARTED|Overall Study||131||
60125526|NCT05385224|76247321|FG000|Modified Intent-to-Treat (Effectiveness Population)|Overall Study||124||
60125527|NCT05385224|76247321|FG000|Safety Population|Overall Study||126||
60125528|NCT05385224|76247321|FG000|COMPLETED|Overall Study||126||
60125529|NCT05385224|76247321|FG000|NOT COMPLETED|Overall Study||5||
60125530|NCT04710979|76247327|FG000|STARTED|Overall Study|Thirty-four participants were randomized to the yoga intervention group. However, one participant involuntarily withdrew from the study after randomization but prior to the start of the intervention due to injuries sustained in an accident unrelated to the study. Thus, only 33 intervention participants actually started the intervention.|34||
60125531|NCT04710979|76247328|FG001|STARTED|Overall Study||34||
60125532|NCT04710979|76247327|FG000|Post-Intervention|Overall Study||31||
60125533|NCT04710979|76247328|FG001|Post-Intervention|Overall Study||26||
60125534|NCT04710979|76247327|FG000|3-Month Follow-Up|Overall Study||23||
60125535|NCT04710979|76247328|FG001|3-Month Follow-Up|Overall Study||28||
60125536|NCT04710979|76247327|FG000|COMPLETED|Overall Study||31||
60125537|NCT04710979|76247328|FG001|COMPLETED|Overall Study||30||
60125538|NCT04710979|76247327|FG000|NOT COMPLETED|Overall Study||3||
60125539|NCT04710979|76247328|FG001|NOT COMPLETED|Overall Study||4||
60125540|NCT04682639|76247338|FG000|STARTED|Double-Blind Treatment Period (24 Weeks)||41||
60125541|NCT04682639|76247339|FG001|STARTED|Double-Blind Treatment Period (24 Weeks)||39||
60125542|NCT04682639|76247340|FG002|STARTED|Double-Blind Treatment Period (24 Weeks)||28||
60125543|NCT04682639|76247341|FG003|STARTED|Double-Blind Treatment Period (24 Weeks)||0||
60125544|NCT04682639|76247342|FG004|STARTED|Double-Blind Treatment Period (24 Weeks)||0||
60125545|NCT04682639|76247338|FG000|COMPLETED|Double-Blind Treatment Period (24 Weeks)||30||
60125546|NCT04682639|76247339|FG001|COMPLETED|Double-Blind Treatment Period (24 Weeks)||31||
60125547|NCT04682639|76247340|FG002|COMPLETED|Double-Blind Treatment Period (24 Weeks)||24||
60125548|NCT04682639|76247341|FG003|COMPLETED|Double-Blind Treatment Period (24 Weeks)||0||
60125549|NCT04682639|76247342|FG004|COMPLETED|Double-Blind Treatment Period (24 Weeks)||0||
60125550|NCT04682639|76247338|FG000|NOT COMPLETED|Double-Blind Treatment Period (24 Weeks)||11||
60125551|NCT04682639|76247339|FG001|NOT COMPLETED|Double-Blind Treatment Period (24 Weeks)||8||
60125552|NCT04682639|76247340|FG002|NOT COMPLETED|Double-Blind Treatment Period (24 Weeks)||4||
60125553|NCT04682639|76247341|FG003|NOT COMPLETED|Double-Blind Treatment Period (24 Weeks)||0||
60125554|NCT04682639|76247342|FG004|NOT COMPLETED|Double-Blind Treatment Period (24 Weeks)||0||
60125555|NCT04682639|76247338|FG000|STARTED|OLE Period (28 Weeks)||30||
60125556|NCT04682639|76247339|FG001|STARTED|OLE Period (28 Weeks)||31||
60125557|NCT04682639|76247340|FG002|STARTED|OLE Period (28 Weeks)|Participants received placebo in Double-Blind treatment period were re-randomized into OLE Etrasimod 1 mg and Etrasimod 2 mg groups.|0||
60125558|NCT04682639|76247341|FG003|STARTED|OLE Period (28 Weeks)|Participants received placebo in Double-Blind treatment period were re-randomized into OLE Etrasimod 1 mg and Etrasimod 2 mg groups.|12||
60125559|NCT04682639|76247342|FG004|STARTED|OLE Period (28 Weeks)|Participants received placebo in Double-Blind treatment period were re-randomized into OLE Etrasimod 1 mg and Etrasimod 2 mg groups.|12||
60125560|NCT04682639|76247338|FG000|COMPLETED|OLE Period (28 Weeks)||21||
60125561|NCT04682639|76247339|FG001|COMPLETED|OLE Period (28 Weeks)||24||
60125562|NCT04682639|76247340|FG002|COMPLETED|OLE Period (28 Weeks)||0||
60125563|NCT04682639|76247341|FG003|COMPLETED|OLE Period (28 Weeks)||11||
60125564|NCT04682639|76247342|FG004|COMPLETED|OLE Period (28 Weeks)||10||
60125565|NCT04682639|76247338|FG000|NOT COMPLETED|OLE Period (28 Weeks)||9||
60125566|NCT04682639|76247339|FG001|NOT COMPLETED|OLE Period (28 Weeks)||7||
60125567|NCT04682639|76247340|FG002|NOT COMPLETED|OLE Period (28 Weeks)||0||
60125568|NCT04682639|76247341|FG003|NOT COMPLETED|OLE Period (28 Weeks)||1||
60125569|NCT04682639|76247342|FG004|NOT COMPLETED|OLE Period (28 Weeks)||2||
60125570|NCT04470050|76247361|FG000|STARTED|Opioid Maintenance Phase||29||
60125571|NCT04470050|76247362|FG001|STARTED|Opioid Maintenance Phase||35||
60125572|NCT04470050|76247363|FG002|STARTED|Opioid Maintenance Phase||31||
60125573|NCT04470050|76247364|FG003|STARTED|Opioid Maintenance Phase||32||
60125574|NCT04470050|76247365|FG004|STARTED|Opioid Maintenance Phase||40||
60125575|NCT04470050|76247366|FG005|STARTED|Opioid Maintenance Phase||33||
60125576|NCT04470050|76247367|FG006|STARTED|Opioid Maintenance Phase||25||
60125577|NCT04470050|76247361|FG000|COMPLETED|Opioid Maintenance Phase||17||
60125578|NCT04470050|76247362|FG001|COMPLETED|Opioid Maintenance Phase||17||
60125579|NCT04470050|76247363|FG002|COMPLETED|Opioid Maintenance Phase||21||
60125580|NCT04470050|76247364|FG003|COMPLETED|Opioid Maintenance Phase||19||
60125581|NCT04470050|76247365|FG004|COMPLETED|Opioid Maintenance Phase||21||
60125582|NCT04470050|76247366|FG005|COMPLETED|Opioid Maintenance Phase||15||
60125583|NCT04470050|76247367|FG006|COMPLETED|Opioid Maintenance Phase||25||
60125584|NCT04470050|76247361|FG000|NOT COMPLETED|Opioid Maintenance Phase||12||
60125585|NCT04470050|76247362|FG001|NOT COMPLETED|Opioid Maintenance Phase||18||
60125586|NCT04470050|76247363|FG002|NOT COMPLETED|Opioid Maintenance Phase||10||
60125587|NCT04470050|76247364|FG003|NOT COMPLETED|Opioid Maintenance Phase||13||
60125588|NCT04470050|76247365|FG004|NOT COMPLETED|Opioid Maintenance Phase||19||
60125589|NCT04470050|76247366|FG005|NOT COMPLETED|Opioid Maintenance Phase||18||
60125590|NCT04470050|76247367|FG006|NOT COMPLETED|Opioid Maintenance Phase||0||
60125591|NCT04470050|76247361|FG000|STARTED|Double-blind Treatment Phase||17||
60125592|NCT04470050|76247362|FG001|STARTED|Double-blind Treatment Phase||17||
60125593|NCT04470050|76247363|FG002|STARTED|Double-blind Treatment Phase||21||
60125594|NCT04470050|76247364|FG003|STARTED|Double-blind Treatment Phase||19||
60125595|NCT04470050|76247365|FG004|STARTED|Double-blind Treatment Phase||21||
60125596|NCT04470050|76247366|FG005|STARTED|Double-blind Treatment Phase||15||
60125597|NCT04470050|76247367|FG006|STARTED|Double-blind Treatment Phase||25||
60125598|NCT04470050|76247361|FG000|COMPLETED|Double-blind Treatment Phase||7||
60125599|NCT04470050|76247362|FG001|COMPLETED|Double-blind Treatment Phase||5||
60125600|NCT04470050|76247363|FG002|COMPLETED|Double-blind Treatment Phase||6||
60125601|NCT04470050|76247364|FG003|COMPLETED|Double-blind Treatment Phase||7||
60125602|NCT04470050|76247365|FG004|COMPLETED|Double-blind Treatment Phase||5||
60125603|NCT04470050|76247366|FG005|COMPLETED|Double-blind Treatment Phase||6||
60125604|NCT04470050|76247367|FG006|COMPLETED|Double-blind Treatment Phase||6||
60125605|NCT04470050|76247361|FG000|NOT COMPLETED|Double-blind Treatment Phase||10||
60125606|NCT04470050|76247362|FG001|NOT COMPLETED|Double-blind Treatment Phase||12||
60125607|NCT04470050|76247363|FG002|NOT COMPLETED|Double-blind Treatment Phase||15||
60125608|NCT04470050|76247364|FG003|NOT COMPLETED|Double-blind Treatment Phase||12||
60125609|NCT04470050|76247365|FG004|NOT COMPLETED|Double-blind Treatment Phase||16||
60125610|NCT04470050|76247366|FG005|NOT COMPLETED|Double-blind Treatment Phase||9||
60125611|NCT04470050|76247367|FG006|NOT COMPLETED|Double-blind Treatment Phase||19||
60125612|NCT04430894|76247384|FG000|STARTED|Overall Study||50||
60125613|NCT04430894|76247384|FG000|COMPLETED|Overall Study||47||
60125614|NCT04430894|76247384|FG000|NOT COMPLETED|Overall Study||3||
60125615|NCT04284553|76247406|FG000|STARTED|Stage 1: October 2020-August 2021||8|"The numbers reflect the number of primary care providers assigned to each arm in Stage 1 of trial (n=201). Primary care providers were identified from electronic health record data and cluster randomized but were not evaluated for effectiveness outcomes. The number of patients cared for by these providers and evaluated for outcomes are shown in the next row (Number of Patients Analyzed)."|
60125616|NCT04284553|76247407|FG001|STARTED|Stage 1: October 2020-August 2021||8|"The numbers reflect the number of primary care providers assigned to each arm in Stage 1 of trial (n=201). Primary care providers were identified from electronic health record data and cluster randomized but were not evaluated for effectiveness outcomes. The number of patients cared for by these providers and evaluated for outcomes are shown in the next row (Number of Patients Analyzed)."|
60125617|NCT04284553|76247408|FG002|STARTED|Stage 1: October 2020-August 2021||8|"The numbers reflect the number of primary care providers assigned to each arm in Stage 1 of trial (n=201). Primary care providers were identified from electronic health record data and cluster randomized but were not evaluated for effectiveness outcomes. The number of patients cared for by these providers and evaluated for outcomes are shown in the next row (Number of Patients Analyzed)."|
60125618|NCT04284553|76247409|FG003|STARTED|Stage 1: October 2020-August 2021||8|"The numbers reflect the number of primary care providers assigned to each arm in Stage 1 of trial (n=201). Primary care providers were identified from electronic health record data and cluster randomized but were not evaluated for effectiveness outcomes. The number of patients cared for by these providers and evaluated for outcomes are shown in the next row (Number of Patients Analyzed)."|
60125619|NCT04284553|76247410|FG004|STARTED|Stage 1: October 2020-August 2021||8|"The numbers reflect the number of primary care providers assigned to each arm in Stage 1 of trial (n=201). Primary care providers were identified from electronic health record data and cluster randomized but were not evaluated for effectiveness outcomes. The number of patients cared for by these providers and evaluated for outcomes are shown in the next row (Number of Patients Analyzed)."|
60125620|NCT04284553|76247411|FG005|STARTED|Stage 1: October 2020-August 2021||8|"The numbers reflect the number of primary care providers assigned to each arm in Stage 1 of trial (n=201). Primary care providers were identified from electronic health record data and cluster randomized but were not evaluated for effectiveness outcomes. The number of patients cared for by these providers and evaluated for outcomes are shown in the next row (Number of Patients Analyzed)."|
60125621|NCT04284553|76247412|FG006|STARTED|Stage 1: October 2020-August 2021||8|"The numbers reflect the number of primary care providers assigned to each arm in Stage 1 of trial (n=201). Primary care providers were identified from electronic health record data and cluster randomized but were not evaluated for effectiveness outcomes. The number of patients cared for by these providers and evaluated for outcomes are shown in the next row (Number of Patients Analyzed)."|
60125622|NCT04284553|76247413|FG007|STARTED|Stage 1: October 2020-August 2021||8|"The numbers reflect the number of primary care providers assigned to each arm in Stage 1 of trial (n=201). Primary care providers were identified from electronic health record data and cluster randomized but were not evaluated for effectiveness outcomes. The number of patients cared for by these providers and evaluated for outcomes are shown in the next row (Number of Patients Analyzed)."|
60125623|NCT04284553|76247414|FG008|STARTED|Stage 1: October 2020-August 2021||8|"The numbers reflect the number of primary care providers assigned to each arm in Stage 1 of trial (n=201). Primary care providers were identified from electronic health record data and cluster randomized but were not evaluated for effectiveness outcomes. The number of patients cared for by these providers and evaluated for outcomes are shown in the next row (Number of Patients Analyzed)."|
60125624|NCT04284553|76247415|FG009|STARTED|Stage 1: October 2020-August 2021||8|"The numbers reflect the number of primary care providers assigned to each arm in Stage 1 of trial (n=201). Primary care providers were identified from electronic health record data and cluster randomized but were not evaluated for effectiveness outcomes. The number of patients cared for by these providers and evaluated for outcomes are shown in the next row (Number of Patients Analyzed)."|
60125625|NCT04284553|76247416|FG010|STARTED|Stage 1: October 2020-August 2021||8|"The numbers reflect the number of primary care providers assigned to each arm in Stage 1 of trial (n=201). Primary care providers were identified from electronic health record data and cluster randomized but were not evaluated for effectiveness outcomes. The number of patients cared for by these providers and evaluated for outcomes are shown in the next row (Number of Patients Analyzed)."|
60125626|NCT04284553|76247417|FG011|STARTED|Stage 1: October 2020-August 2021||8|"The numbers reflect the number of primary care providers assigned to each arm in Stage 1 of trial (n=201). Primary care providers were identified from electronic health record data and cluster randomized but were not evaluated for effectiveness outcomes. The number of patients cared for by these providers and evaluated for outcomes are shown in the next row (Number of Patients Analyzed)."|
60125627|NCT04284553|76247418|FG012|STARTED|Stage 1: October 2020-August 2021||8|"The numbers reflect the number of primary care providers assigned to each arm in Stage 1 of trial (n=201). Primary care providers were identified from electronic health record data and cluster randomized but were not evaluated for effectiveness outcomes. The number of patients cared for by these providers and evaluated for outcomes are shown in the next row (Number of Patients Analyzed)."|
60125628|NCT04284553|76247419|FG013|STARTED|Stage 1: October 2020-August 2021||8|"The numbers reflect the number of primary care providers assigned to each arm in Stage 1 of trial (n=201). Primary care providers were identified from electronic health record data and cluster randomized but were not evaluated for effectiveness outcomes. The number of patients cared for by these providers and evaluated for outcomes are shown in the next row (Number of Patients Analyzed)."|
60125629|NCT04284553|76247420|FG014|STARTED|Stage 1: October 2020-August 2021||8|"The numbers reflect the number of primary care providers assigned to each arm in Stage 1 of trial (n=201). Primary care providers were identified from electronic health record data and cluster randomized but were not evaluated for effectiveness outcomes. The number of patients cared for by these providers and evaluated for outcomes are shown in the next row (Number of Patients Analyzed)."|
60125630|NCT04284553|76247421|FG015|STARTED|Stage 1: October 2020-August 2021||81|"The numbers reflect the number of primary care providers assigned to each arm in Stage 1 of trial (n=201). Primary care providers were identified from electronic health record data and cluster randomized but were not evaluated for effectiveness outcomes. The number of patients cared for by these providers and evaluated for outcomes are shown in the next row (Number of Patients Analyzed)."|
60125631|NCT04284553|76247406|FG000|Number of Patients Analyzed|Stage 1: October 2020-August 2021||91|These are the number of patients analyzed for effectiveness outcomes from each arm of Stage 1. Patients were eligible for inclusion in the effectiveness evaluation if they met eligibility criteria based on electronic health record data, including being cared for by the providers in the row above. Patients were not directly intervened upon nor actively enrolled.|
60125632|NCT04284553|76247407|FG001|Number of Patients Analyzed|Stage 1: October 2020-August 2021||91|These are the number of patients analyzed for effectiveness outcomes from each arm of Stage 1. Patients were eligible for inclusion in the effectiveness evaluation if they met eligibility criteria based on electronic health record data, including being cared for by the providers in the row above. Patients were not directly intervened upon nor actively enrolled.|
60125633|NCT04284553|76247408|FG002|Number of Patients Analyzed|Stage 1: October 2020-August 2021||87|These are the number of patients analyzed for effectiveness outcomes from each arm of Stage 1. Patients were eligible for inclusion in the effectiveness evaluation if they met eligibility criteria based on electronic health record data, including being cared for by the providers in the row above. Patients were not directly intervened upon nor actively enrolled.|
60125634|NCT04284553|76247409|FG003|Number of Patients Analyzed|Stage 1: October 2020-August 2021||140|These are the number of patients analyzed for effectiveness outcomes from each arm of Stage 1. Patients were eligible for inclusion in the effectiveness evaluation if they met eligibility criteria based on electronic health record data, including being cared for by the providers in the row above. Patients were not directly intervened upon nor actively enrolled.|
60125635|NCT04284553|76247410|FG004|Number of Patients Analyzed|Stage 1: October 2020-August 2021||174|These are the number of patients analyzed for effectiveness outcomes from each arm of Stage 1. Patients were eligible for inclusion in the effectiveness evaluation if they met eligibility criteria based on electronic health record data, including being cared for by the providers in the row above. Patients were not directly intervened upon nor actively enrolled.|
60125636|NCT04284553|76247411|FG005|Number of Patients Analyzed|Stage 1: October 2020-August 2021||102|These are the number of patients analyzed for effectiveness outcomes from each arm of Stage 1. Patients were eligible for inclusion in the effectiveness evaluation if they met eligibility criteria based on electronic health record data, including being cared for by the providers in the row above. Patients were not directly intervened upon nor actively enrolled.|
60125637|NCT04284553|76247412|FG006|Number of Patients Analyzed|Stage 1: October 2020-August 2021||130|These are the number of patients analyzed for effectiveness outcomes from each arm of Stage 1. Patients were eligible for inclusion in the effectiveness evaluation if they met eligibility criteria based on electronic health record data, including being cared for by the providers in the row above. Patients were not directly intervened upon nor actively enrolled.|
60125638|NCT04284553|76247413|FG007|Number of Patients Analyzed|Stage 1: October 2020-August 2021||104|These are the number of patients analyzed for effectiveness outcomes from each arm of Stage 1. Patients were eligible for inclusion in the effectiveness evaluation if they met eligibility criteria based on electronic health record data, including being cared for by the providers in the row above. Patients were not directly intervened upon nor actively enrolled.|
60125639|NCT04284553|76247414|FG008|Number of Patients Analyzed|Stage 1: October 2020-August 2021||153|These are the number of patients analyzed for effectiveness outcomes from each arm of Stage 1. Patients were eligible for inclusion in the effectiveness evaluation if they met eligibility criteria based on electronic health record data, including being cared for by the providers in the row above. Patients were not directly intervened upon nor actively enrolled.|
60125640|NCT04284553|76247415|FG009|Number of Patients Analyzed|Stage 1: October 2020-August 2021||113|These are the number of patients analyzed for effectiveness outcomes from each arm of Stage 1. Patients were eligible for inclusion in the effectiveness evaluation if they met eligibility criteria based on electronic health record data, including being cared for by the providers in the row above. Patients were not directly intervened upon nor actively enrolled.|
60125641|NCT04284553|76247416|FG010|Number of Patients Analyzed|Stage 1: October 2020-August 2021||118|These are the number of patients analyzed for effectiveness outcomes from each arm of Stage 1. Patients were eligible for inclusion in the effectiveness evaluation if they met eligibility criteria based on electronic health record data, including being cared for by the providers in the row above. Patients were not directly intervened upon nor actively enrolled.|
60125642|NCT04284553|76247417|FG011|Number of Patients Analyzed|Stage 1: October 2020-August 2021||147|These are the number of patients analyzed for effectiveness outcomes from each arm of Stage 1. Patients were eligible for inclusion in the effectiveness evaluation if they met eligibility criteria based on electronic health record data, including being cared for by the providers in the row above. Patients were not directly intervened upon nor actively enrolled.|
60125643|NCT04284553|76247418|FG012|Number of Patients Analyzed|Stage 1: October 2020-August 2021||87|These are the number of patients analyzed for effectiveness outcomes from each arm of Stage 1. Patients were eligible for inclusion in the effectiveness evaluation if they met eligibility criteria based on electronic health record data, including being cared for by the providers in the row above. Patients were not directly intervened upon nor actively enrolled.|
60125644|NCT04284553|76247419|FG013|Number of Patients Analyzed|Stage 1: October 2020-August 2021||90|These are the number of patients analyzed for effectiveness outcomes from each arm of Stage 1. Patients were eligible for inclusion in the effectiveness evaluation if they met eligibility criteria based on electronic health record data, including being cared for by the providers in the row above. Patients were not directly intervened upon nor actively enrolled.|
60125645|NCT04284553|76247420|FG014|Number of Patients Analyzed|Stage 1: October 2020-August 2021||109|These are the number of patients analyzed for effectiveness outcomes from each arm of Stage 1. Patients were eligible for inclusion in the effectiveness evaluation if they met eligibility criteria based on electronic health record data, including being cared for by the providers in the row above. Patients were not directly intervened upon nor actively enrolled.|
60125646|NCT04284553|76247421|FG015|Number of Patients Analyzed|Stage 1: October 2020-August 2021||1173|These are the number of patients analyzed for effectiveness outcomes from each arm of Stage 1. Patients were eligible for inclusion in the effectiveness evaluation if they met eligibility criteria based on electronic health record data, including being cared for by the providers in the row above. Patients were not directly intervened upon nor actively enrolled.|
60125647|NCT04284553|76247406|FG000|COMPLETED|Stage 1: October 2020-August 2021||8||
60125648|NCT04284553|76247407|FG001|COMPLETED|Stage 1: October 2020-August 2021||8||
60125649|NCT04284553|76247408|FG002|COMPLETED|Stage 1: October 2020-August 2021||8||
60125650|NCT04284553|76247409|FG003|COMPLETED|Stage 1: October 2020-August 2021||8||
60125651|NCT04284553|76247410|FG004|COMPLETED|Stage 1: October 2020-August 2021||8||
60125652|NCT04284553|76247411|FG005|COMPLETED|Stage 1: October 2020-August 2021||8||
60125653|NCT04284553|76247412|FG006|COMPLETED|Stage 1: October 2020-August 2021||8||
60125654|NCT04284553|76247413|FG007|COMPLETED|Stage 1: October 2020-August 2021||8||
60125655|NCT04284553|76247414|FG008|COMPLETED|Stage 1: October 2020-August 2021||8||
60125656|NCT04284553|76247415|FG009|COMPLETED|Stage 1: October 2020-August 2021||8||
60125657|NCT04284553|76247416|FG010|COMPLETED|Stage 1: October 2020-August 2021||8||
60125658|NCT04284553|76247417|FG011|COMPLETED|Stage 1: October 2020-August 2021||8||
60125659|NCT04284553|76247418|FG012|COMPLETED|Stage 1: October 2020-August 2021||8||
60125660|NCT04284553|76247419|FG013|COMPLETED|Stage 1: October 2020-August 2021||8||
60125661|NCT04284553|76247420|FG014|COMPLETED|Stage 1: October 2020-August 2021||8||
60125662|NCT04284553|76247421|FG015|COMPLETED|Stage 1: October 2020-August 2021||81||
60125663|NCT04284553|76247406|FG000|NOT COMPLETED|Stage 1: October 2020-August 2021||0||
60125664|NCT04284553|76247407|FG001|NOT COMPLETED|Stage 1: October 2020-August 2021||0||
60125665|NCT04284553|76247408|FG002|NOT COMPLETED|Stage 1: October 2020-August 2021||0||
60125666|NCT04284553|76247409|FG003|NOT COMPLETED|Stage 1: October 2020-August 2021||0||
60125667|NCT04284553|76247410|FG004|NOT COMPLETED|Stage 1: October 2020-August 2021||0||
60125668|NCT04284553|76247411|FG005|NOT COMPLETED|Stage 1: October 2020-August 2021||0||
60125669|NCT04284553|76247412|FG006|NOT COMPLETED|Stage 1: October 2020-August 2021||0||
60125670|NCT04284553|76247413|FG007|NOT COMPLETED|Stage 1: October 2020-August 2021||0||
60125671|NCT04284553|76247414|FG008|NOT COMPLETED|Stage 1: October 2020-August 2021||0||
60125672|NCT04284553|76247415|FG009|NOT COMPLETED|Stage 1: October 2020-August 2021||0||
60125673|NCT04284553|76247416|FG010|NOT COMPLETED|Stage 1: October 2020-August 2021||0||
60125674|NCT04284553|76247417|FG011|NOT COMPLETED|Stage 1: October 2020-August 2021||0||
60125675|NCT04284553|76247418|FG012|NOT COMPLETED|Stage 1: October 2020-August 2021||0||
60125676|NCT04284553|76247419|FG013|NOT COMPLETED|Stage 1: October 2020-August 2021||0||
60125677|NCT04284553|76247420|FG014|NOT COMPLETED|Stage 1: October 2020-August 2021||0||
60125678|NCT04284553|76247421|FG015|NOT COMPLETED|Stage 1: October 2020-August 2021||0||
60125679|NCT04284553|76247406|FG000|STARTED|Stage 2: September 2021-August 2022||0|The numbers reflect the number of primary care providers assigned to each arm in Stage 2 of trial. As in Stage 1, providers were not evaluated for effectiveness outcomes. The number of patients cared for by them and evaluated for outcomes are shown in the next row. The number of providers in each arm for Stage 2 differs from Stage 1 because not all arms were selected for Stage 2, and not all of the providers from Stage 1 were eligible after interim analysis. 15 new providers were also added.|
60125680|NCT04284553|76247407|FG001|STARTED|Stage 2: September 2021-August 2022||27|The numbers reflect the number of primary care providers assigned to each arm in Stage 2 of trial. As in Stage 1, providers were not evaluated for effectiveness outcomes. The number of patients cared for by them and evaluated for outcomes are shown in the next row. The number of providers in each arm for Stage 2 differs from Stage 1 because not all arms were selected for Stage 2, and not all of the providers from Stage 1 were eligible after interim analysis. 15 new providers were also added.|
60125681|NCT04284553|76247408|FG002|STARTED|Stage 2: September 2021-August 2022||0|The numbers reflect the number of primary care providers assigned to each arm in Stage 2 of trial. As in Stage 1, providers were not evaluated for effectiveness outcomes. The number of patients cared for by them and evaluated for outcomes are shown in the next row. The number of providers in each arm for Stage 2 differs from Stage 1 because not all arms were selected for Stage 2, and not all of the providers from Stage 1 were eligible after interim analysis. 15 new providers were also added.|
60125682|NCT04284553|76247409|FG003|STARTED|Stage 2: September 2021-August 2022||27|The numbers reflect the number of primary care providers assigned to each arm in Stage 2 of trial. As in Stage 1, providers were not evaluated for effectiveness outcomes. The number of patients cared for by them and evaluated for outcomes are shown in the next row. The number of providers in each arm for Stage 2 differs from Stage 1 because not all arms were selected for Stage 2, and not all of the providers from Stage 1 were eligible after interim analysis. 15 new providers were also added.|
60125683|NCT04284553|76247410|FG004|STARTED|Stage 2: September 2021-August 2022||0|The numbers reflect the number of primary care providers assigned to each arm in Stage 2 of trial. As in Stage 1, providers were not evaluated for effectiveness outcomes. The number of patients cared for by them and evaluated for outcomes are shown in the next row. The number of providers in each arm for Stage 2 differs from Stage 1 because not all arms were selected for Stage 2, and not all of the providers from Stage 1 were eligible after interim analysis. 15 new providers were also added.|
60125684|NCT04284553|76247411|FG005|STARTED|Stage 2: September 2021-August 2022||0|The numbers reflect the number of primary care providers assigned to each arm in Stage 2 of trial. As in Stage 1, providers were not evaluated for effectiveness outcomes. The number of patients cared for by them and evaluated for outcomes are shown in the next row. The number of providers in each arm for Stage 2 differs from Stage 1 because not all arms were selected for Stage 2, and not all of the providers from Stage 1 were eligible after interim analysis. 15 new providers were also added.|
60125685|NCT04284553|76247412|FG006|STARTED|Stage 2: September 2021-August 2022||0|The numbers reflect the number of primary care providers assigned to each arm in Stage 2 of trial. As in Stage 1, providers were not evaluated for effectiveness outcomes. The number of patients cared for by them and evaluated for outcomes are shown in the next row. The number of providers in each arm for Stage 2 differs from Stage 1 because not all arms were selected for Stage 2, and not all of the providers from Stage 1 were eligible after interim analysis. 15 new providers were also added.|
60125686|NCT04284553|76247413|FG007|STARTED|Stage 2: September 2021-August 2022||28|The numbers reflect the number of primary care providers assigned to each arm in Stage 2 of trial. As in Stage 1, providers were not evaluated for effectiveness outcomes. The number of patients cared for by them and evaluated for outcomes are shown in the next row. The number of providers in each arm for Stage 2 differs from Stage 1 because not all arms were selected for Stage 2, and not all of the providers from Stage 1 were eligible after interim analysis. 15 new providers were also added.|
60125687|NCT04284553|76247414|FG008|STARTED|Stage 2: September 2021-August 2022||0|The numbers reflect the number of primary care providers assigned to each arm in Stage 2 of trial. As in Stage 1, providers were not evaluated for effectiveness outcomes. The number of patients cared for by them and evaluated for outcomes are shown in the next row. The number of providers in each arm for Stage 2 differs from Stage 1 because not all arms were selected for Stage 2, and not all of the providers from Stage 1 were eligible after interim analysis. 15 new providers were also added.|
60125688|NCT04284553|76247415|FG009|STARTED|Stage 2: September 2021-August 2022||28|The numbers reflect the number of primary care providers assigned to each arm in Stage 2 of trial. As in Stage 1, providers were not evaluated for effectiveness outcomes. The number of patients cared for by them and evaluated for outcomes are shown in the next row. The number of providers in each arm for Stage 2 differs from Stage 1 because not all arms were selected for Stage 2, and not all of the providers from Stage 1 were eligible after interim analysis. 15 new providers were also added.|
60125689|NCT04284553|76247416|FG010|STARTED|Stage 2: September 2021-August 2022||0|The numbers reflect the number of primary care providers assigned to each arm in Stage 2 of trial. As in Stage 1, providers were not evaluated for effectiveness outcomes. The number of patients cared for by them and evaluated for outcomes are shown in the next row. The number of providers in each arm for Stage 2 differs from Stage 1 because not all arms were selected for Stage 2, and not all of the providers from Stage 1 were eligible after interim analysis. 15 new providers were also added.|
60125690|NCT04284553|76247417|FG011|STARTED|Stage 2: September 2021-August 2022||27|The numbers reflect the number of primary care providers assigned to each arm in Stage 2 of trial. As in Stage 1, providers were not evaluated for effectiveness outcomes. The number of patients cared for by them and evaluated for outcomes are shown in the next row. The number of providers in each arm for Stage 2 differs from Stage 1 because not all arms were selected for Stage 2, and not all of the providers from Stage 1 were eligible after interim analysis. 15 new providers were also added.|
60125691|NCT04284553|76247418|FG012|STARTED|Stage 2: September 2021-August 2022||0|The numbers reflect the number of primary care providers assigned to each arm in Stage 2 of trial. As in Stage 1, providers were not evaluated for effectiveness outcomes. The number of patients cared for by them and evaluated for outcomes are shown in the next row. The number of providers in each arm for Stage 2 differs from Stage 1 because not all arms were selected for Stage 2, and not all of the providers from Stage 1 were eligible after interim analysis. 15 new providers were also added.|
60125692|NCT04284553|76247419|FG013|STARTED|Stage 2: September 2021-August 2022||0|The numbers reflect the number of primary care providers assigned to each arm in Stage 2 of trial. As in Stage 1, providers were not evaluated for effectiveness outcomes. The number of patients cared for by them and evaluated for outcomes are shown in the next row. The number of providers in each arm for Stage 2 differs from Stage 1 because not all arms were selected for Stage 2, and not all of the providers from Stage 1 were eligible after interim analysis. 15 new providers were also added.|
60125693|NCT04284553|76247420|FG014|STARTED|Stage 2: September 2021-August 2022||0|The numbers reflect the number of primary care providers assigned to each arm in Stage 2 of trial. As in Stage 1, providers were not evaluated for effectiveness outcomes. The number of patients cared for by them and evaluated for outcomes are shown in the next row. The number of providers in each arm for Stage 2 differs from Stage 1 because not all arms were selected for Stage 2, and not all of the providers from Stage 1 were eligible after interim analysis. 15 new providers were also added.|
60125694|NCT04284553|76247421|FG015|STARTED|Stage 2: September 2021-August 2022||60|The numbers reflect the number of primary care providers assigned to each arm in Stage 2 of trial. As in Stage 1, providers were not evaluated for effectiveness outcomes. The number of patients cared for by them and evaluated for outcomes are shown in the next row. The number of providers in each arm for Stage 2 differs from Stage 1 because not all arms were selected for Stage 2, and not all of the providers from Stage 1 were eligible after interim analysis. 15 new providers were also added.|
60125695|NCT04284553|76247406|FG000|Number of Patients Analyzed|Stage 2: September 2021-August 2022||0|These are the number of patients analyzed for effectiveness outcomes from each arm of Stage 2. Patients were eligible for inclusion in the effectiveness evaluation if they met eligibility criteria based on electronic health record data, including being cared for by the providers in the row above. Patients were not directly intervened upon nor actively enrolled. These numbers represent unique patients not previously identified in Stage 1.|
60125696|NCT04284553|76247407|FG001|Number of Patients Analyzed|Stage 2: September 2021-August 2022||15|These are the number of patients analyzed for effectiveness outcomes from each arm of Stage 2. Patients were eligible for inclusion in the effectiveness evaluation if they met eligibility criteria based on electronic health record data, including being cared for by the providers in the row above. Patients were not directly intervened upon nor actively enrolled. These numbers represent unique patients not previously identified in Stage 1.|
60125697|NCT04284553|76247408|FG002|Number of Patients Analyzed|Stage 2: September 2021-August 2022||0|These are the number of patients analyzed for effectiveness outcomes from each arm of Stage 2. Patients were eligible for inclusion in the effectiveness evaluation if they met eligibility criteria based on electronic health record data, including being cared for by the providers in the row above. Patients were not directly intervened upon nor actively enrolled. These numbers represent unique patients not previously identified in Stage 1.|
60125698|NCT04284553|76247409|FG003|Number of Patients Analyzed|Stage 2: September 2021-August 2022||35|These are the number of patients analyzed for effectiveness outcomes from each arm of Stage 2. Patients were eligible for inclusion in the effectiveness evaluation if they met eligibility criteria based on electronic health record data, including being cared for by the providers in the row above. Patients were not directly intervened upon nor actively enrolled. These numbers represent unique patients not previously identified in Stage 1.|
60125699|NCT04284553|76247410|FG004|Number of Patients Analyzed|Stage 2: September 2021-August 2022||0|These are the number of patients analyzed for effectiveness outcomes from each arm of Stage 2. Patients were eligible for inclusion in the effectiveness evaluation if they met eligibility criteria based on electronic health record data, including being cared for by the providers in the row above. Patients were not directly intervened upon nor actively enrolled. These numbers represent unique patients not previously identified in Stage 1.|
60125700|NCT04284553|76247411|FG005|Number of Patients Analyzed|Stage 2: September 2021-August 2022||0|These are the number of patients analyzed for effectiveness outcomes from each arm of Stage 2. Patients were eligible for inclusion in the effectiveness evaluation if they met eligibility criteria based on electronic health record data, including being cared for by the providers in the row above. Patients were not directly intervened upon nor actively enrolled. These numbers represent unique patients not previously identified in Stage 1.|
60125701|NCT04284553|76247412|FG006|Number of Patients Analyzed|Stage 2: September 2021-August 2022||0|These are the number of patients analyzed for effectiveness outcomes from each arm of Stage 2. Patients were eligible for inclusion in the effectiveness evaluation if they met eligibility criteria based on electronic health record data, including being cared for by the providers in the row above. Patients were not directly intervened upon nor actively enrolled. These numbers represent unique patients not previously identified in Stage 1.|
60125702|NCT04284553|76247413|FG007|Number of Patients Analyzed|Stage 2: September 2021-August 2022||33|These are the number of patients analyzed for effectiveness outcomes from each arm of Stage 2. Patients were eligible for inclusion in the effectiveness evaluation if they met eligibility criteria based on electronic health record data, including being cared for by the providers in the row above. Patients were not directly intervened upon nor actively enrolled. These numbers represent unique patients not previously identified in Stage 1.|
60125703|NCT04284553|76247414|FG008|Number of Patients Analyzed|Stage 2: September 2021-August 2022||0|These are the number of patients analyzed for effectiveness outcomes from each arm of Stage 2. Patients were eligible for inclusion in the effectiveness evaluation if they met eligibility criteria based on electronic health record data, including being cared for by the providers in the row above. Patients were not directly intervened upon nor actively enrolled. These numbers represent unique patients not previously identified in Stage 1.|
60125704|NCT04284553|76247415|FG009|Number of Patients Analyzed|Stage 2: September 2021-August 2022||23|These are the number of patients analyzed for effectiveness outcomes from each arm of Stage 2. Patients were eligible for inclusion in the effectiveness evaluation if they met eligibility criteria based on electronic health record data, including being cared for by the providers in the row above. Patients were not directly intervened upon nor actively enrolled. These numbers represent unique patients not previously identified in Stage 1.|
60125705|NCT04284553|76247416|FG010|Number of Patients Analyzed|Stage 2: September 2021-August 2022||0|These are the number of patients analyzed for effectiveness outcomes from each arm of Stage 2. Patients were eligible for inclusion in the effectiveness evaluation if they met eligibility criteria based on electronic health record data, including being cared for by the providers in the row above. Patients were not directly intervened upon nor actively enrolled. These numbers represent unique patients not previously identified in Stage 1.|
60125706|NCT04284553|76247417|FG011|Number of Patients Analyzed|Stage 2: September 2021-August 2022||17|These are the number of patients analyzed for effectiveness outcomes from each arm of Stage 2. Patients were eligible for inclusion in the effectiveness evaluation if they met eligibility criteria based on electronic health record data, including being cared for by the providers in the row above. Patients were not directly intervened upon nor actively enrolled. These numbers represent unique patients not previously identified in Stage 1.|
60125707|NCT04284553|76247418|FG012|Number of Patients Analyzed|Stage 2: September 2021-August 2022||0|These are the number of patients analyzed for effectiveness outcomes from each arm of Stage 2. Patients were eligible for inclusion in the effectiveness evaluation if they met eligibility criteria based on electronic health record data, including being cared for by the providers in the row above. Patients were not directly intervened upon nor actively enrolled. These numbers represent unique patients not previously identified in Stage 1.|
60125708|NCT04284553|76247419|FG013|Number of Patients Analyzed|Stage 2: September 2021-August 2022||0|These are the number of patients analyzed for effectiveness outcomes from each arm of Stage 2. Patients were eligible for inclusion in the effectiveness evaluation if they met eligibility criteria based on electronic health record data, including being cared for by the providers in the row above. Patients were not directly intervened upon nor actively enrolled. These numbers represent unique patients not previously identified in Stage 1.|
60125709|NCT04284553|76247420|FG014|Number of Patients Analyzed|Stage 2: September 2021-August 2022||0|These are the number of patients analyzed for effectiveness outcomes from each arm of Stage 2. Patients were eligible for inclusion in the effectiveness evaluation if they met eligibility criteria based on electronic health record data, including being cared for by the providers in the row above. Patients were not directly intervened upon nor actively enrolled. These numbers represent unique patients not previously identified in Stage 1.|
60125710|NCT04284553|76247421|FG015|Number of Patients Analyzed|Stage 2: September 2021-August 2022||31|These are the number of patients analyzed for effectiveness outcomes from each arm of Stage 2. Patients were eligible for inclusion in the effectiveness evaluation if they met eligibility criteria based on electronic health record data, including being cared for by the providers in the row above. Patients were not directly intervened upon nor actively enrolled. These numbers represent unique patients not previously identified in Stage 1.|
60125711|NCT04284553|76247406|FG000|COMPLETED|Stage 2: September 2021-August 2022||0||
60125712|NCT04284553|76247407|FG001|COMPLETED|Stage 2: September 2021-August 2022||27||
60125713|NCT04284553|76247408|FG002|COMPLETED|Stage 2: September 2021-August 2022||0||
60125714|NCT04284553|76247409|FG003|COMPLETED|Stage 2: September 2021-August 2022||27||
60125715|NCT04284553|76247410|FG004|COMPLETED|Stage 2: September 2021-August 2022||0||
60125716|NCT04284553|76247411|FG005|COMPLETED|Stage 2: September 2021-August 2022||0||
60125717|NCT04284553|76247412|FG006|COMPLETED|Stage 2: September 2021-August 2022||0||
60125718|NCT04284553|76247413|FG007|COMPLETED|Stage 2: September 2021-August 2022||28||
60125719|NCT04284553|76247414|FG008|COMPLETED|Stage 2: September 2021-August 2022||0||
60125720|NCT04284553|76247415|FG009|COMPLETED|Stage 2: September 2021-August 2022||28||
60125721|NCT04284553|76247416|FG010|COMPLETED|Stage 2: September 2021-August 2022||0||
60125722|NCT04284553|76247417|FG011|COMPLETED|Stage 2: September 2021-August 2022||27||
60125723|NCT04284553|76247418|FG012|COMPLETED|Stage 2: September 2021-August 2022||0||
60125724|NCT04284553|76247419|FG013|COMPLETED|Stage 2: September 2021-August 2022||0||
60125725|NCT04284553|76247420|FG014|COMPLETED|Stage 2: September 2021-August 2022||0||
60125726|NCT04284553|76247421|FG015|COMPLETED|Stage 2: September 2021-August 2022||60||
60125727|NCT04284553|76247406|FG000|NOT COMPLETED|Stage 2: September 2021-August 2022||0||
60125728|NCT04284553|76247407|FG001|NOT COMPLETED|Stage 2: September 2021-August 2022||0||
60125729|NCT04284553|76247408|FG002|NOT COMPLETED|Stage 2: September 2021-August 2022||0||
60125730|NCT04284553|76247409|FG003|NOT COMPLETED|Stage 2: September 2021-August 2022||0||
60125731|NCT04284553|76247410|FG004|NOT COMPLETED|Stage 2: September 2021-August 2022||0||
60125732|NCT04284553|76247411|FG005|NOT COMPLETED|Stage 2: September 2021-August 2022||0||
60125733|NCT04284553|76247412|FG006|NOT COMPLETED|Stage 2: September 2021-August 2022||0||
60125734|NCT04284553|76247413|FG007|NOT COMPLETED|Stage 2: September 2021-August 2022||0||
60125735|NCT04284553|76247414|FG008|NOT COMPLETED|Stage 2: September 2021-August 2022||0||
60125736|NCT04284553|76247415|FG009|NOT COMPLETED|Stage 2: September 2021-August 2022||0||
60125737|NCT04284553|76247416|FG010|NOT COMPLETED|Stage 2: September 2021-August 2022||0||
60125738|NCT04284553|76247417|FG011|NOT COMPLETED|Stage 2: September 2021-August 2022||0||
60125739|NCT04284553|76247418|FG012|NOT COMPLETED|Stage 2: September 2021-August 2022||0||
60125740|NCT04284553|76247419|FG013|NOT COMPLETED|Stage 2: September 2021-August 2022||0||
60125741|NCT04284553|76247420|FG014|NOT COMPLETED|Stage 2: September 2021-August 2022||0||
60125742|NCT04284553|76247421|FG015|NOT COMPLETED|Stage 2: September 2021-August 2022||0||
60125743|NCT04204772|76247469|FG000|STARTED|Overall Study||3||
60125744|NCT04204772|76247470|FG001|STARTED|Overall Study||3||
60125745|NCT04204772|76247471|FG002|STARTED|Overall Study||3||
60125746|NCT04204772|76247472|FG003|STARTED|Overall Study||3||
60125747|NCT04204772|76247469|FG000|COMPLETED|Overall Study||3||
60125748|NCT04204772|76247470|FG001|COMPLETED|Overall Study||3||
60125749|NCT04204772|76247471|FG002|COMPLETED|Overall Study||3||
60125750|NCT04204772|76247472|FG003|COMPLETED|Overall Study||3||
60125751|NCT04204772|76247469|FG000|NOT COMPLETED|Overall Study||0||
60125752|NCT04204772|76247470|FG001|NOT COMPLETED|Overall Study||0||
60125753|NCT04204772|76247471|FG002|NOT COMPLETED|Overall Study||0||
60125754|NCT04204772|76247472|FG003|NOT COMPLETED|Overall Study||0||
60125755|NCT04179409|76247489|FG000|STARTED|Overall Study||2||
60125756|NCT04179409|76247490|FG001|STARTED|Overall Study||0||
60125757|NCT04179409|76247491|FG002|STARTED|Overall Study||1||
60125758|NCT04179409|76247489|FG000|COMPLETED|Overall Study||2||
60125759|NCT04179409|76247490|FG001|COMPLETED|Overall Study||0||
60125760|NCT04179409|76247491|FG002|COMPLETED|Overall Study||1||
60125761|NCT04179409|76247489|FG000|NOT COMPLETED|Overall Study||0||
60125762|NCT04179409|76247490|FG001|NOT COMPLETED|Overall Study||0||
60125763|NCT04179409|76247491|FG002|NOT COMPLETED|Overall Study||0||
60125764|NCT03887052|76247499|FG000|STARTED|Overall Study||130||
60125765|NCT03887052|76247499|FG000|COMPLETED|Overall Study||121||
60125766|NCT03887052|76247499|FG000|NOT COMPLETED|Overall Study||9||
60125767|NCT03758066|76247503|FG000|STARTED|Overall Study|20 CMs and 45 AYA living with HIV were enrolled|65||
60125768|NCT03758066|76247503|FG000|COMPLETED|Overall Study|13 CMs and 38 AYA living with HIV completed all study activities|51||
60125769|NCT03758066|76247503|FG000|NOT COMPLETED|Overall Study||14||
60125770|NCT03750786|76247512|FG000|STARTED|Overall Study||245||
60125771|NCT03750786|76247513|FG001|STARTED|Overall Study||245||
60125772|NCT03750786|76247512|FG000|COMPLETED|Overall Study||0||
60125773|NCT03750786|76247513|FG001|COMPLETED|Overall Study||0||
60125774|NCT03750786|76247512|FG000|NOT COMPLETED|Overall Study||245||
60125775|NCT03750786|76247513|FG001|NOT COMPLETED|Overall Study||245||
60125776|NCT03728933|76247522|FG000|STARTED|Overall Study||8||
60125777|NCT03728933|76247523|FG001|STARTED|Overall Study||8||
60125778|NCT03728933|76247524|FG002|STARTED|Overall Study||7||
60125779|NCT03728933|76247522|FG000|COMPLETED|Overall Study||5||
60125780|NCT03728933|76247523|FG001|COMPLETED|Overall Study||7||
60125781|NCT03728933|76247524|FG002|COMPLETED|Overall Study||6||
60125782|NCT03728933|76247522|FG000|NOT COMPLETED|Overall Study||3||
60125783|NCT03728933|76247523|FG001|NOT COMPLETED|Overall Study||1||
60125784|NCT03728933|76247524|FG002|NOT COMPLETED|Overall Study||1||
60125785|NCT03649841|76247534|FG000|STARTED|Overall Study||6||
60125786|NCT03649841|76247535|FG001|STARTED|Overall Study||4||
60125787|NCT03649841|76247534|FG000|COMPLETED|Overall Study||6||
60125788|NCT03649841|76247535|FG001|COMPLETED|Overall Study||4||
60125789|NCT03649841|76247534|FG000|NOT COMPLETED|Overall Study||0||
60125790|NCT03649841|76247535|FG001|NOT COMPLETED|Overall Study||0||
60125791|NCT03599713|76247543|FG000|STARTED|Overall Study||101||
60125792|NCT03599713|76247544|FG001|STARTED|Overall Study||6||
60125793|NCT03599713|76247543|FG000|Safety Evaluable Population|Overall Study||101||
60125794|NCT03599713|76247544|FG001|Safety Evaluable Population|Overall Study||6||
60125795|NCT03599713|76247543|FG000|Enrolled Population|Overall Study||101||
60125796|NCT03599713|76247544|FG001|Enrolled Population|Overall Study||6||
60125797|NCT03599713|76247543|FG000|Full Analysis Set|Overall Study||65||
60125798|NCT03599713|76247544|FG001|Full Analysis Set|Overall Study||6||
60125799|NCT03599713|76247543|FG000|COMPLETED|Overall Study||0||
60125800|NCT03599713|76247544|FG001|COMPLETED|Overall Study||0||
60125801|NCT03599713|76247543|FG000|NOT COMPLETED|Overall Study||101||
60125802|NCT03599713|76247544|FG001|NOT COMPLETED|Overall Study||6||
60125803|NCT03557372|76247552|FG000|STARTED|Overall Study||14||
60125804|NCT03557372|76247552|FG000|COMPLETED|Overall Study||14||
60125805|NCT03557372|76247552|FG000|NOT COMPLETED|Overall Study||0||
60125806|NCT03557281|76247561|FG000|STARTED|Overall Study||18||
60125807|NCT03557281|76247562|FG001|STARTED|Overall Study||9||
60125808|NCT03557281|76247563|FG002|STARTED|Overall Study||17||
60125809|NCT03557281|76247564|FG003|STARTED|Overall Study||16||
60125810|NCT03557281|76247565|FG004|STARTED|Overall Study||16||
60125811|NCT03557281|76247561|FG000|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Overall Study||18||
60125812|NCT03557281|76247562|FG001|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Overall Study||9||
60125813|NCT03557281|76247563|FG002|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Overall Study||17||
60125814|NCT03557281|76247564|FG003|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Overall Study||16||
60125815|NCT03557281|76247565|FG004|Safety Population Consisted of All Randomized Participants Who Received at Least 1 Dose of Treatment|Overall Study||15||
60125816|NCT03557281|76247561|FG000|COMPLETED|Overall Study||18||
60125817|NCT03557281|76247562|FG001|COMPLETED|Overall Study||8||
60125818|NCT03557281|76247563|FG002|COMPLETED|Overall Study||15||
60125819|NCT03557281|76247564|FG003|COMPLETED|Overall Study||15||
60125820|NCT03557281|76247565|FG004|COMPLETED|Overall Study||13||
60125821|NCT03557281|76247561|FG000|NOT COMPLETED|Overall Study||0||
60125822|NCT03557281|76247562|FG001|NOT COMPLETED|Overall Study||1||
60125823|NCT03557281|76247563|FG002|NOT COMPLETED|Overall Study||2||
60125824|NCT03557281|76247564|FG003|NOT COMPLETED|Overall Study||1||
60125825|NCT03557281|76247565|FG004|NOT COMPLETED|Overall Study||3||
60125826|NCT03538041|76247583|FG000|STARTED|12-Week Treatment Period||10||
60125827|NCT03538041|76247584|FG001|STARTED|12-Week Treatment Period||15||
60125828|NCT03538041|76247583|FG000|COMPLETED|12-Week Treatment Period||9||
60125829|NCT03538041|76247584|FG001|COMPLETED|12-Week Treatment Period||13||
60125830|NCT03538041|76247583|FG000|NOT COMPLETED|12-Week Treatment Period||1||
60125831|NCT03538041|76247584|FG001|NOT COMPLETED|12-Week Treatment Period||2||
60125832|NCT03538041|76247583|FG000|STARTED|Treatment Extension Period|These participants completed the 24-week Treatment Period and were eligible for an extension of treatment based on their clinical response.|7||
60125833|NCT03538041|76247584|FG001|STARTED|Treatment Extension Period|These participants completed the 24-week Treatment Period and were eligible for an extension of treatment based on their clinical response.|10||
60125834|NCT03538041|76247583|FG000|COMPLETED|Treatment Extension Period||0||
60125835|NCT03538041|76247584|FG001|COMPLETED|Treatment Extension Period||0||
60125836|NCT03538041|76247583|FG000|NOT COMPLETED|Treatment Extension Period||7||
60125837|NCT03538041|76247584|FG001|NOT COMPLETED|Treatment Extension Period||10||
60125838|NCT03502746|76247593|FG000|STARTED|Overall Study||34||
60125839|NCT03502746|76247593|FG000|COMPLETED|Overall Study||34||
60125840|NCT03502746|76247593|FG000|NOT COMPLETED|Overall Study||0||
60125841|NCT03260894|76247599|FG000|STARTED|Overall Study||64||
60125842|NCT03260894|76247600|FG001|STARTED|Overall Study||65||
60125843|NCT03260894|76247599|FG000|Intention-to-Treat (ITT)|Overall Study||64||
60125844|NCT03260894|76247600|FG001|Intention-to-Treat (ITT)|Overall Study||65||
60125845|NCT03260894|76247599|FG000|All Subjects as Treated (ASaT)|Overall Study||64||
60125846|NCT03260894|76247600|FG001|All Subjects as Treated (ASaT)|Overall Study||63||
60125847|NCT03260894|76247599|FG000|COMPLETED|Overall Study||18||
60125848|NCT03260894|76247600|FG001|COMPLETED|Overall Study||15||
60125849|NCT03260894|76247599|FG000|NOT COMPLETED|Overall Study||46||
60125850|NCT03260894|76247600|FG001|NOT COMPLETED|Overall Study||50||
60125851|NCT03197935|76247608|FG000|STARTED|Overall Study||168||
60125852|NCT03197935|76247609|FG001|STARTED|Overall Study||165||
60125853|NCT03197935|76247608|FG000|COMPLETED|Overall Study||121||
60125854|NCT03197935|76247609|FG001|COMPLETED|Overall Study||136||
60125855|NCT03197935|76247608|FG000|NOT COMPLETED|Overall Study||47||
60125856|NCT03197935|76247609|FG001|NOT COMPLETED|Overall Study||29||
60125857|NCT03144674|76247621|FG000|STARTED|Overall Study||4||
60125858|NCT03144674|76247622|FG001|STARTED|Overall Study||6||
60125859|NCT03144674|76247623|FG002|STARTED|Overall Study||28||
60125860|NCT03144674|76247624|FG003|STARTED|Overall Study||72||
60125861|NCT03144674|76247621|FG000|COMPLETED|Overall Study||0||
60125862|NCT03144674|76247622|FG001|COMPLETED|Overall Study||0||
60125863|NCT03144674|76247623|FG002|COMPLETED|Overall Study||0||
60125864|NCT03144674|76247624|FG003|COMPLETED|Overall Study||0||
60125865|NCT03144674|76247621|FG000|NOT COMPLETED|Overall Study||4||
60125866|NCT03144674|76247622|FG001|NOT COMPLETED|Overall Study||6||
60125867|NCT03144674|76247623|FG002|NOT COMPLETED|Overall Study||28||
60125868|NCT03144674|76247624|FG003|NOT COMPLETED|Overall Study||72||
60125869|NCT03136965|76247642|FG000|STARTED|Overall Study||10||
60125870|NCT03136965|76247643|FG001|STARTED|Overall Study||10||
60125871|NCT03136965|76247644|FG002|STARTED|Overall Study||9||
60125872|NCT03136965|76247642|FG000|COMPLETED|Overall Study||10||
60125873|NCT03136965|76247643|FG001|COMPLETED|Overall Study||9||
60125874|NCT03136965|76247644|FG002|COMPLETED|Overall Study||9||
60125875|NCT03136965|76247642|FG000|NOT COMPLETED|Overall Study||0||
60125876|NCT03136965|76247643|FG001|NOT COMPLETED|Overall Study||1||
60125877|NCT03136965|76247644|FG002|NOT COMPLETED|Overall Study||0||
60125878|NCT03115151|76247654|FG000|STARTED|Overall Study||23||
60125879|NCT03115151|76247655|FG001|STARTED|Overall Study||23||
60125880|NCT03115151|76247654|FG000|COMPLETED|Overall Study|Study closed because study surgeon left the Institution|17||
60125881|NCT03115151|76247655|FG001|COMPLETED|Overall Study|Study closed because study surgeon left the Institution|18||
60125882|NCT03115151|76247654|FG000|NOT COMPLETED|Overall Study||6||
60125883|NCT03115151|76247655|FG001|NOT COMPLETED|Overall Study||5||
60125884|NCT03068130|76247661|FG000|STARTED|Overall Study||261||
60125885|NCT03068130|76247661|FG000|COMPLETED|Overall Study||0||
60125886|NCT03068130|76247661|FG000|NOT COMPLETED|Overall Study||261||
60125887|NCT03019185|76247668|FG000|STARTED|Overall Study||30||
60125888|NCT03019185|76247669|FG001|STARTED|Overall Study||80||
60125889|NCT03019185|76247670|FG002|STARTED|Overall Study||77||
60125890|NCT03019185|76247668|FG000|COMPLETED|Overall Study||24||
60125891|NCT03019185|76247669|FG001|COMPLETED|Overall Study||79||
60125892|NCT03019185|76247670|FG002|COMPLETED|Overall Study||75||
60125893|NCT03019185|76247668|FG000|NOT COMPLETED|Overall Study||6||
60125894|NCT03019185|76247669|FG001|NOT COMPLETED|Overall Study||1||
60125895|NCT03019185|76247670|FG002|NOT COMPLETED|Overall Study||2||
60125896|NCT02908685|76247690|FG000|STARTED|Part 1 Exploratory||7||
59728359|NCT00812929|75847153|FG004|NOT COMPLETED|Treatment Period 2||0||
59728360|NCT00812929|75847154|FG005|NOT COMPLETED|Treatment Period 2||0||
59728361|NCT00812929|75847155|FG006|NOT COMPLETED|Treatment Period 2||0||
60125897|NCT02908685|76247691|FG001|STARTED|Part 1 Exploratory||7||
60125898|NCT02908685|76247692|FG002|STARTED|Part 1 Exploratory||3||
60125899|NCT02908685|76247693|FG003|STARTED|Part 1 Exploratory||3||
60125900|NCT02908685|76247694|FG004|STARTED|Part 1 Exploratory||7||
60125901|NCT02908685|76247695|FG005|STARTED|Part 1 Exploratory||7||
60125902|NCT02908685|76247696|FG006|STARTED|Part 1 Exploratory||7||
60125903|NCT02908685|76247697|FG007|STARTED|Part 1 Exploratory||3||
60125904|NCT02908685|76247698|FG008|STARTED|Part 1 Exploratory||4||
60125905|NCT02908685|76247699|FG009|STARTED|Part 1 Exploratory||3||
60125906|NCT02908685|76247700|FG010|STARTED|Part 1 Exploratory||0||
60125907|NCT02908685|76247701|FG011|STARTED|Part 1 Exploratory||0||
60125908|NCT02908685|76247690|FG000|COMPLETED|Part 1 Exploratory||7||
60125909|NCT02908685|76247691|FG001|COMPLETED|Part 1 Exploratory||6||
60125910|NCT02908685|76247692|FG002|COMPLETED|Part 1 Exploratory||3||
60125911|NCT02908685|76247693|FG003|COMPLETED|Part 1 Exploratory||3||
60125912|NCT02908685|76247694|FG004|COMPLETED|Part 1 Exploratory||7||
60125913|NCT02908685|76247695|FG005|COMPLETED|Part 1 Exploratory||7||
60125914|NCT02908685|76247696|FG006|COMPLETED|Part 1 Exploratory||7||
60125915|NCT02908685|76247697|FG007|COMPLETED|Part 1 Exploratory||3||
60125916|NCT02908685|76247698|FG008|COMPLETED|Part 1 Exploratory||4||
60125917|NCT02908685|76247699|FG009|COMPLETED|Part 1 Exploratory||3||
60125918|NCT02908685|76247700|FG010|COMPLETED|Part 1 Exploratory||0||
60125919|NCT02908685|76247701|FG011|COMPLETED|Part 1 Exploratory||0||
60125920|NCT02908685|76247690|FG000|NOT COMPLETED|Part 1 Exploratory||0||
60125921|NCT02908685|76247691|FG001|NOT COMPLETED|Part 1 Exploratory||1||
60125922|NCT02908685|76247692|FG002|NOT COMPLETED|Part 1 Exploratory||0||
60125923|NCT02908685|76247693|FG003|NOT COMPLETED|Part 1 Exploratory||0||
60125924|NCT02908685|76247694|FG004|NOT COMPLETED|Part 1 Exploratory||0||
60125925|NCT02908685|76247695|FG005|NOT COMPLETED|Part 1 Exploratory||0||
60125926|NCT02908685|76247696|FG006|NOT COMPLETED|Part 1 Exploratory||0||
60125927|NCT02908685|76247697|FG007|NOT COMPLETED|Part 1 Exploratory||0||
60125928|NCT02908685|76247698|FG008|NOT COMPLETED|Part 1 Exploratory||0||
60125929|NCT02908685|76247699|FG009|NOT COMPLETED|Part 1 Exploratory||0||
60125930|NCT02908685|76247700|FG010|NOT COMPLETED|Part 1 Exploratory||0||
60125931|NCT02908685|76247701|FG011|NOT COMPLETED|Part 1 Exploratory||0||
60125932|NCT02908685|76247690|FG000|STARTED|Part 2 Confirmatory||0||
60125933|NCT02908685|76247691|FG001|STARTED|Part 2 Confirmatory||0||
60125934|NCT02908685|76247692|FG002|STARTED|Part 2 Confirmatory||0||
60125935|NCT02908685|76247693|FG003|STARTED|Part 2 Confirmatory||0||
60125936|NCT02908685|76247694|FG004|STARTED|Part 2 Confirmatory||0||
60125937|NCT02908685|76247695|FG005|STARTED|Part 2 Confirmatory||0||
60125938|NCT02908685|76247696|FG006|STARTED|Part 2 Confirmatory||0||
60125939|NCT02908685|76247697|FG007|STARTED|Part 2 Confirmatory||0||
60125940|NCT02908685|76247698|FG008|STARTED|Part 2 Confirmatory||0||
60125941|NCT02908685|76247699|FG009|STARTED|Part 2 Confirmatory||0||
60125942|NCT02908685|76247700|FG010|STARTED|Part 2 Confirmatory||120||
60125943|NCT02908685|76247701|FG011|STARTED|Part 2 Confirmatory||60||
60125944|NCT02908685|76247690|FG000|COMPLETED|Part 2 Confirmatory||0||
60125945|NCT02908685|76247691|FG001|COMPLETED|Part 2 Confirmatory||0||
60125946|NCT02908685|76247692|FG002|COMPLETED|Part 2 Confirmatory||0||
60125947|NCT02908685|76247693|FG003|COMPLETED|Part 2 Confirmatory||0||
60125948|NCT02908685|76247694|FG004|COMPLETED|Part 2 Confirmatory||0||
60125949|NCT02908685|76247695|FG005|COMPLETED|Part 2 Confirmatory||0||
60125950|NCT02908685|76247696|FG006|COMPLETED|Part 2 Confirmatory||0||
60125951|NCT02908685|76247697|FG007|COMPLETED|Part 2 Confirmatory||0||
60125952|NCT02908685|76247698|FG008|COMPLETED|Part 2 Confirmatory||0||
60125953|NCT02908685|76247699|FG009|COMPLETED|Part 2 Confirmatory||0||
60125954|NCT02908685|76247700|FG010|COMPLETED|Part 2 Confirmatory||117||
60125955|NCT02908685|76247701|FG011|COMPLETED|Part 2 Confirmatory||59||
60125956|NCT02908685|76247690|FG000|NOT COMPLETED|Part 2 Confirmatory||0||
60125957|NCT02908685|76247691|FG001|NOT COMPLETED|Part 2 Confirmatory||0||
60125958|NCT02908685|76247692|FG002|NOT COMPLETED|Part 2 Confirmatory||0||
60125959|NCT02908685|76247693|FG003|NOT COMPLETED|Part 2 Confirmatory||0||
60125960|NCT02908685|76247694|FG004|NOT COMPLETED|Part 2 Confirmatory||0||
60125961|NCT02908685|76247695|FG005|NOT COMPLETED|Part 2 Confirmatory||0||
60125962|NCT02908685|76247696|FG006|NOT COMPLETED|Part 2 Confirmatory||0||
60125963|NCT02908685|76247697|FG007|NOT COMPLETED|Part 2 Confirmatory||0||
60125964|NCT02908685|76247698|FG008|NOT COMPLETED|Part 2 Confirmatory||0||
60125965|NCT02908685|76247699|FG009|NOT COMPLETED|Part 2 Confirmatory||0||
60125966|NCT02908685|76247700|FG010|NOT COMPLETED|Part 2 Confirmatory||3||
60125967|NCT02908685|76247701|FG011|NOT COMPLETED|Part 2 Confirmatory||1||
60125968|NCT02772276|76247731|FG000|STARTED|Overall Study||31||
60125969|NCT02772276|76247732|FG001|STARTED|Overall Study||29||
60125970|NCT02772276|76247733|FG002|STARTED|Overall Study||20||
60125971|NCT02772276|76247734|FG003|STARTED|Overall Study||40||
60125972|NCT02772276|76247735|FG004|STARTED|Overall Study||9||
60125973|NCT02772276|76247736|FG005|STARTED|Overall Study||7||
60125974|NCT02772276|76247737|FG006|STARTED|Overall Study||18||
60125975|NCT02772276|76247738|FG007|STARTED|Overall Study||30||
60125976|NCT02772276|76247739|FG008|STARTED|Overall Study||18||
60125977|NCT02772276|76247740|FG009|STARTED|Overall Study||12||
60125978|NCT02772276|76247741|FG010|STARTED|Overall Study||4||
60125979|NCT02772276|76247742|FG011|STARTED|Overall Study||4||
60125980|NCT02772276|76247743|FG012|STARTED|Overall Study||12||
60125981|NCT02772276|76247731|FG000|COMPLETED|Overall Study||31||
60125982|NCT02772276|76247732|FG001|COMPLETED|Overall Study||29||
60125983|NCT02772276|76247733|FG002|COMPLETED|Overall Study||20||
60125984|NCT02772276|76247734|FG003|COMPLETED|Overall Study||40||
60125985|NCT02772276|76247735|FG004|COMPLETED|Overall Study||9||
60125986|NCT02772276|76247736|FG005|COMPLETED|Overall Study||7||
60125987|NCT02772276|76247737|FG006|COMPLETED|Overall Study||17||
60125988|NCT02772276|76247738|FG007|COMPLETED|Overall Study||29||
60125989|NCT02772276|76247739|FG008|COMPLETED|Overall Study||18||
60125990|NCT02772276|76247740|FG009|COMPLETED|Overall Study||12||
60125991|NCT02772276|76247741|FG010|COMPLETED|Overall Study||4||
60125992|NCT02772276|76247742|FG011|COMPLETED|Overall Study||4||
60125993|NCT02772276|76247743|FG012|COMPLETED|Overall Study||12||
60125994|NCT02772276|76247731|FG000|NOT COMPLETED|Overall Study||0||
60125995|NCT02772276|76247732|FG001|NOT COMPLETED|Overall Study||0||
60125996|NCT02772276|76247733|FG002|NOT COMPLETED|Overall Study||0||
60125997|NCT02772276|76247734|FG003|NOT COMPLETED|Overall Study||0||
60125998|NCT02772276|76247735|FG004|NOT COMPLETED|Overall Study||0||
60125999|NCT02772276|76247736|FG005|NOT COMPLETED|Overall Study||0||
60126000|NCT02772276|76247737|FG006|NOT COMPLETED|Overall Study||1||
60126001|NCT02772276|76247738|FG007|NOT COMPLETED|Overall Study||1||
60126002|NCT02772276|76247739|FG008|NOT COMPLETED|Overall Study||0||
60126003|NCT02772276|76247740|FG009|NOT COMPLETED|Overall Study||0||
60126004|NCT02772276|76247741|FG010|NOT COMPLETED|Overall Study||0||
60126005|NCT02772276|76247742|FG011|NOT COMPLETED|Overall Study||0||
60126006|NCT02772276|76247743|FG012|NOT COMPLETED|Overall Study||0||
60126007|NCT02601313|76247796|FG000|STARTED|Overall Study||14||
60126008|NCT02601313|76247797|FG001|STARTED|Overall Study||74||
60126009|NCT02601313|76247798|FG002|STARTED|Overall Study||17||
60126010|NCT02601313|76247796|FG000|COMPLETED|Overall Study||8||
60126011|NCT02601313|76247797|FG001|COMPLETED|Overall Study||0||
60126012|NCT02601313|76247798|FG002|COMPLETED|Overall Study||0||
60126013|NCT02601313|76247796|FG000|NOT COMPLETED|Overall Study||6||
60126014|NCT02601313|76247797|FG001|NOT COMPLETED|Overall Study||74||
60126015|NCT02601313|76247798|FG002|NOT COMPLETED|Overall Study||17||
60126016|NCT02550652|76247808|FG000|STARTED|Overall Study||63||
60126017|NCT02550652|76247809|FG001|STARTED|Overall Study||62||
60126018|NCT02550652|76247808|FG000|COMPLETED|Overall Study||42|Week 104|
60126019|NCT02550652|76247809|FG001|COMPLETED|Overall Study||41|Week 104|
60126020|NCT02550652|76247808|FG000|NOT COMPLETED|Overall Study||21||
60126021|NCT02550652|76247809|FG001|NOT COMPLETED|Overall Study||21||
60126022|NCT02484443|76247815|FG000|STARTED|Overall Study||41||
60126023|NCT02484443|76247815|FG000|COMPLETED|Overall Study||9|Completion of planned therapy of Five Cycles and Disease Control Success (event-free for at least 12 months).|
60126024|NCT02484443|76247815|FG000|NOT COMPLETED|Overall Study||32||
60126025|NCT02371941|76247821|FG000|STARTED|Overall Study||9||
60126026|NCT02371941|76247822|FG001|STARTED|Overall Study||7||
60126027|NCT02371941|76247821|FG000|COMPLETED|Overall Study||9||
60126028|NCT02371941|76247822|FG001|COMPLETED|Overall Study||6||
60126029|NCT02371941|76247821|FG000|NOT COMPLETED|Overall Study||0||
60126030|NCT02371941|76247822|FG001|NOT COMPLETED|Overall Study||1||
60126031|NCT02140788|76247828|FG000|STARTED|Overall Study||0||
60126032|NCT02140788|76247829|FG001|STARTED|Overall Study||0||
60126033|NCT02140788|76247830|FG002|STARTED|Overall Study||0||
60126034|NCT02140788|76247831|FG003|STARTED|Overall Study||0||
60126035|NCT02140788|76247828|FG000|COMPLETED|Overall Study||0||
60126036|NCT02140788|76247829|FG001|COMPLETED|Overall Study||0||
60126037|NCT02140788|76247830|FG002|COMPLETED|Overall Study||0||
60126038|NCT02140788|76247831|FG003|COMPLETED|Overall Study||0||
60126039|NCT02140788|76247828|FG000|NOT COMPLETED|Overall Study||0||
60126040|NCT02140788|76247829|FG001|NOT COMPLETED|Overall Study||0||
60126041|NCT02140788|76247830|FG002|NOT COMPLETED|Overall Study||0||
60126042|NCT02140788|76247831|FG003|NOT COMPLETED|Overall Study||0||
60126043|NCT01385176|76247843|FG000|STARTED|Randomization Phase|The randomization phase of the study started after implant of the investigational device system.|63||
60126044|NCT01385176|76247844|FG001|STARTED|Randomization Phase|The randomization phase of the study started after implant of the investigational device system.|32||
60126045|NCT01385176|76247843|FG000|COMPLETED|Randomization Phase|The study randomization phase ended after all patients have had their 6 month follow-up visit.|62||
60126046|NCT01385176|76247844|FG001|COMPLETED|Randomization Phase|The study randomization phase ended after all patients have had their 6 month follow-up visit.|30||
60126047|NCT01385176|76247843|FG000|NOT COMPLETED|Randomization Phase||1||
60126048|NCT01385176|76247844|FG001|NOT COMPLETED|Randomization Phase||2||
60126049|NCT01385176|76247843|FG000|STARTED|6-18 Month All VNS Active|Primary Study Phase ended with completion of the 18 months follow-up visit for the last patient|62||
60126050|NCT01385176|76247844|FG001|STARTED|6-18 Month All VNS Active|Primary Study Phase ended with completion of the 18 months follow-up visit for the last patient|30||
60126051|NCT01385176|76247843|FG000|COMPLETED|6-18 Month All VNS Active||58||
60126052|NCT01385176|76247844|FG001|COMPLETED|6-18 Month All VNS Active||27||
60126053|NCT01385176|76247843|FG000|NOT COMPLETED|6-18 Month All VNS Active||4||
60126054|NCT01385176|76247844|FG001|NOT COMPLETED|6-18 Month All VNS Active||3||
60126055|NCT01307956|76247855|FG000|STARTED|Overall Study||11||
60126056|NCT01307956|76247855|FG000|COMPLETED|Overall Study||11||
60126057|NCT01307956|76247855|FG000|NOT COMPLETED|Overall Study||0||
60126058|NCT01041027|76247859|FG000|STARTED|Overall Study||31||
60126059|NCT01041027|76247859|FG000|COMPLETED|Overall Study||23||
60126060|NCT01041027|76247859|FG000|NOT COMPLETED|Overall Study||8||
60126061|NCT00389610|76247865|FG000|STARTED|Overall Study||11||
60126062|NCT00389610|76247866|FG001|STARTED|Overall Study||45||
60126063|NCT00389610|76247865|FG000|COMPLETED|Overall Study||11||
60126064|NCT00389610|76247866|FG001|COMPLETED|Overall Study|milestone period is defined as receiving at least one booster vaccine|23||
60126065|NCT00389610|76247865|FG000|NOT COMPLETED|Overall Study||0||
60126066|NCT00389610|76247866|FG001|NOT COMPLETED|Overall Study||22||
60126067|NCT01489189|76247874|FG000|STARTED|Overall Study|Number of Eyes|191||
60126068|NCT01489189|76247875|FG001|STARTED|Overall Study|Number of Eyes|203||
60126069|NCT01489189|76247874|FG000|COMPLETED|Overall Study|Number of Eyes|160||
60126070|NCT01489189|76247875|FG001|COMPLETED|Overall Study|Number of Eyes|168||
60126071|NCT01489189|76247874|FG000|NOT COMPLETED|Overall Study||31||
60126072|NCT01489189|76247875|FG001|NOT COMPLETED|Overall Study||35||
60126073|NCT01549873|76247884|FG000|STARTED|Overall Study||15||
60126074|NCT01549873|76247885|FG001|STARTED|Overall Study||15||
60126075|NCT01549873|76247884|FG000|COMPLETED|Overall Study||15||
60126076|NCT01549873|76247885|FG001|COMPLETED|Overall Study||14||
60126077|NCT01549873|76247884|FG000|NOT COMPLETED|Overall Study||0||
60126078|NCT01549873|76247885|FG001|NOT COMPLETED|Overall Study||1||
60126079|NCT01489111|76247891|FG000|STARTED|Overall Study||36||53
60126080|NCT01489111|76247891|FG000|COMPLETED|Overall Study||35||49
60126081|NCT01489111|76247891|FG000|NOT COMPLETED|Overall Study||1||4
60126082|NCT01488487|76247895|FG000|STARTED|Overall Study||24||
60126083|NCT01488487|76247895|FG000|Received Treatment|Overall Study||24||
60126084|NCT01488487|76247895|FG000|COMPLETED|Overall Study||15||
60126085|NCT01488487|76247895|FG000|NOT COMPLETED|Overall Study||9||
60126086|NCT01488097|76247899|FG000|STARTED|Overall Study||8||
60126087|NCT01488097|76247899|FG000|Received Study Drug in Extension Study|Overall Study||8||
60126088|NCT01488097|76247899|FG000|COMPLETED|Overall Study||7||
60126089|NCT01488097|76247899|FG000|NOT COMPLETED|Overall Study||1||
60126090|NCT01516879|76247905|FG000|STARTED|Overall Study||303||
60126091|NCT01516879|76247906|FG001|STARTED|Overall Study||602||
60126092|NCT01516879|76247905|FG000|Received Treatment|Overall Study||302||
60126093|NCT01516879|76247906|FG001|Received Treatment|Overall Study||599||
60126094|NCT01516879|76247905|FG000|COMPLETED|Overall Study||287||
60126095|NCT01516879|76247906|FG001|COMPLETED|Overall Study||568||
60126096|NCT01516879|76247905|FG000|NOT COMPLETED|Overall Study||16||
60126097|NCT01516879|76247906|FG001|NOT COMPLETED|Overall Study||34||
60126098|NCT01515865|76247912|FG000|STARTED|Part A (Open-label)||98||
60126099|NCT01515865|76247913|FG001|STARTED|Part A (Open-label)||0||
60126100|NCT01515865|76247914|FG002|STARTED|Part A (Open-label)||0||
60126101|NCT01515865|76247912|FG000|COMPLETED|Part A (Open-label)||95||
60126102|NCT01515865|76247913|FG001|COMPLETED|Part A (Open-label)||0||
60126103|NCT01515865|76247914|FG002|COMPLETED|Part A (Open-label)||0||
60126104|NCT01515865|76247912|FG000|NOT COMPLETED|Part A (Open-label)||3||
60126105|NCT01515865|76247913|FG001|NOT COMPLETED|Part A (Open-label)||0||
60126106|NCT01515865|76247914|FG002|NOT COMPLETED|Part A (Open-label)||0||
60126107|NCT01515865|76247912|FG000|STARTED|Part B (Open-label)|Twenty-four subjects from Part A did not meet the criteria required to be enrolled into Part B.|71||
60126108|NCT01515865|76247913|FG001|STARTED|Part B (Open-label)||0||
60126109|NCT01515865|76247914|FG002|STARTED|Part B (Open-label)||0||
60126110|NCT01515865|76247912|FG000|COMPLETED|Part B (Open-label)||69||
60126111|NCT01515865|76247913|FG001|COMPLETED|Part B (Open-label)||0||
60126112|NCT01515865|76247914|FG002|COMPLETED|Part B (Open-label)||0||
60126113|NCT01515865|76247912|FG000|NOT COMPLETED|Part B (Open-label)||2||
60126114|NCT01515865|76247913|FG001|NOT COMPLETED|Part B (Open-label)||0||
60126115|NCT01515865|76247914|FG002|NOT COMPLETED|Part B (Open-label)||0||
60126116|NCT01515865|76247912|FG000|STARTED|Part C (Randomized)||0||
60126117|NCT01515865|76247913|FG001|STARTED|Part C (Randomized)|A total of two subjects from Part B did not meet the criteria required to be enrolled into Part C.|33||
60126118|NCT01515865|76247914|FG002|STARTED|Part C (Randomized)||34||
60126119|NCT01515865|76247912|FG000|COMPLETED|Part C (Randomized)||0||
60126120|NCT01515865|76247913|FG001|COMPLETED|Part C (Randomized)||33||
60126121|NCT01515865|76247914|FG002|COMPLETED|Part C (Randomized)||34||
60126122|NCT01515865|76247912|FG000|NOT COMPLETED|Part C (Randomized)||0||
60126123|NCT01515865|76247913|FG001|NOT COMPLETED|Part C (Randomized)||0||
60126124|NCT01515865|76247914|FG002|NOT COMPLETED|Part C (Randomized)||0||
60126125|NCT01547299|76247924|FG000|STARTED|Overall Study||25||
60126126|NCT01547299|76247925|FG001|STARTED|Overall Study||27||
60126127|NCT01547299|76247924|FG000|COMPLETED|Overall Study||23||
60126128|NCT01547299|76247925|FG001|COMPLETED|Overall Study||25||
59858973|NCT00274469|75983570|FG001|COMPLETED|Overall Study|Number of patients ongoing study treatment at data cut-off|10||
59858974|NCT00274469|75983569|FG000|NOT COMPLETED|Overall Study||79||
59858975|NCT00274469|75983570|FG001|NOT COMPLETED|Overall Study||93||
60126129|NCT01547299|76247924|FG000|NOT COMPLETED|Overall Study||2||
60126130|NCT01547299|76247925|FG001|NOT COMPLETED|Overall Study||2||
60126131|NCT01515475|76247935|FG000|STARTED|Overall Study||61||
60126132|NCT01515475|76247936|FG001|STARTED|Overall Study||58||
60126133|NCT01515475|76247937|FG002|STARTED|Overall Study||65||
59594767|NCT03165175|75703731|FG000|COMPLETED|1-month to 3-month||35||
59858976|NCT03214588|75983579|FG000|STARTED|Overall Study||27||
60126134|NCT01515475|76247938|FG003|STARTED|Overall Study||65||
60126135|NCT01515475|76247935|FG000|COMPLETED|Overall Study||41||
60126136|NCT01515475|76247936|FG001|COMPLETED|Overall Study||43||
59858977|NCT03214588|75983580|FG001|STARTED|Overall Study||14||
59858978|NCT03214588|75983581|FG002|STARTED|Overall Study||26||
59858979|NCT03214588|75983579|FG000|COMPLETED|Overall Study||26||
60126137|NCT01515475|76247937|FG002|COMPLETED|Overall Study||53||
60126138|NCT01515475|76247938|FG003|COMPLETED|Overall Study||53||
60126139|NCT01515475|76247935|FG000|NOT COMPLETED|Overall Study||20||
60126140|NCT01515475|76247936|FG001|NOT COMPLETED|Overall Study||15||
60126141|NCT01515475|76247937|FG002|NOT COMPLETED|Overall Study||12||
60126142|NCT01515475|76247938|FG003|NOT COMPLETED|Overall Study||12||
60126143|NCT00408603|76247951|FG000|STARTED|Overall Study||69||
60126144|NCT00408603|76247952|FG001|STARTED|Overall Study||39||
60126145|NCT00408603|76247953|FG002|STARTED|Overall Study||75||
60126146|NCT00408603|76247951|FG000|COMPLETED|Overall Study||65||
60126147|NCT00408603|76247952|FG001|COMPLETED|Overall Study||37||
60126148|NCT00408603|76247953|FG002|COMPLETED|Overall Study||35||
60126149|NCT00408603|76247951|FG000|NOT COMPLETED|Overall Study||4||
60126150|NCT00408603|76247952|FG001|NOT COMPLETED|Overall Study||2||
60126151|NCT00408603|76247953|FG002|NOT COMPLETED|Overall Study||40||
60126152|NCT00409539|76247968|FG000|STARTED|Overall Study||111||
60126153|NCT00409539|76247969|FG001|STARTED|Overall Study||111||
60126154|NCT00409539|76247970|FG002|STARTED|Overall Study||109||
60126155|NCT00409539|76247971|FG003|STARTED|Overall Study||109||
60126156|NCT00409539|76247972|FG004|STARTED|Overall Study||110||
60126157|NCT00409539|76247968|FG000|COMPLETED|Overall Study||100||
60126158|NCT00409539|76247969|FG001|COMPLETED|Overall Study||100||
60126159|NCT00409539|76247970|FG002|COMPLETED|Overall Study||95||
60126160|NCT00409539|76247971|FG003|COMPLETED|Overall Study||97||
60126161|NCT00409539|76247972|FG004|COMPLETED|Overall Study||85||
60126162|NCT00409539|76247968|FG000|NOT COMPLETED|Overall Study||11||
60126163|NCT00409539|76247969|FG001|NOT COMPLETED|Overall Study||11||
60126164|NCT00409539|76247970|FG002|NOT COMPLETED|Overall Study||14||
60126165|NCT00409539|76247971|FG003|NOT COMPLETED|Overall Study||12||
60126166|NCT00409539|76247972|FG004|NOT COMPLETED|Overall Study||25||
60126167|NCT00411411|76247986|FG000|STARTED|Overall Study||24||
60126168|NCT00411411|76247987|FG001|STARTED|Overall Study||25||
60126169|NCT00411411|76247986|FG000|COMPLETED|Overall Study||24||
60126170|NCT00411411|76247987|FG001|COMPLETED|Overall Study||25||
60126171|NCT00411411|76247986|FG000|NOT COMPLETED|Overall Study||0||
60126172|NCT00411411|76247987|FG001|NOT COMPLETED|Overall Study||0||
60126173|NCT02107599|76247994|FG000|STARTED|Overall Study||96||
60126174|NCT02107599|76247994|FG000|COMPLETED|Overall Study||96||
60126175|NCT02107599|76247994|FG000|NOT COMPLETED|Overall Study||0||
60126176|NCT02109939|76248003|FG000|STARTED|Overall Study||681||
60126177|NCT02109939|76248004|FG001|STARTED|Overall Study||717||
60126178|NCT02109939|76248003|FG000|COMPLETED|Overall Study||560||
60126179|NCT02109939|76248004|FG001|COMPLETED|Overall Study||607||
60126180|NCT02109939|76248003|FG000|NOT COMPLETED|Overall Study||121||
60126181|NCT02109939|76248004|FG001|NOT COMPLETED|Overall Study||110||
60126182|NCT01515319|76248024|FG000|STARTED|Overall Study||3||
60126183|NCT01515319|76248025|FG001|STARTED|Overall Study||3||
60126184|NCT01515319|76248026|FG002|STARTED|Overall Study||6||
60126185|NCT01515319|76248027|FG003|STARTED|Overall Study||6||
60126186|NCT01515319|76248028|FG004|STARTED|Overall Study||6||
60126187|NCT01515319|76248029|FG005|STARTED|Overall Study||6||
60126188|NCT01515319|76248030|FG006|STARTED|Overall Study||10||
60126189|NCT01515319|76248031|FG007|STARTED|Overall Study||6||
60126190|NCT01515319|76248032|FG008|STARTED|Overall Study||14||
60126191|NCT01515319|76248033|FG009|STARTED|Overall Study||8||
60126192|NCT01515319|76248024|FG000|COMPLETED|Overall Study||3||
60126193|NCT01515319|76248025|FG001|COMPLETED|Overall Study||3||
60126194|NCT01515319|76248026|FG002|COMPLETED|Overall Study||6||
60126195|NCT01515319|76248027|FG003|COMPLETED|Overall Study||6||
60126196|NCT01515319|76248028|FG004|COMPLETED|Overall Study||6||
60126197|NCT01515319|76248029|FG005|COMPLETED|Overall Study||6||
60126198|NCT01515319|76248030|FG006|COMPLETED|Overall Study||9||
60126199|NCT01515319|76248031|FG007|COMPLETED|Overall Study||6||
60126200|NCT01515319|76248032|FG008|COMPLETED|Overall Study||9||
60126201|NCT01515319|76248033|FG009|COMPLETED|Overall Study||8||
60126202|NCT01515319|76248024|FG000|NOT COMPLETED|Overall Study||0||
60126203|NCT01515319|76248025|FG001|NOT COMPLETED|Overall Study||0||
60126204|NCT01515319|76248026|FG002|NOT COMPLETED|Overall Study||0||
59594768|NCT03165175|75703732|FG001|COMPLETED|1-month to 3-month||39||
59858980|NCT03214588|75983580|FG001|COMPLETED|Overall Study||13||
59858981|NCT03214588|75983581|FG002|COMPLETED|Overall Study||24||
60126205|NCT01515319|76248027|FG003|NOT COMPLETED|Overall Study||0||
60126206|NCT01515319|76248028|FG004|NOT COMPLETED|Overall Study||0||
60126207|NCT01515319|76248029|FG005|NOT COMPLETED|Overall Study||0||
60126208|NCT01515319|76248030|FG006|NOT COMPLETED|Overall Study||1||
60126209|NCT01515319|76248031|FG007|NOT COMPLETED|Overall Study||0||
60126210|NCT01515319|76248032|FG008|NOT COMPLETED|Overall Study||5||
60126211|NCT01515319|76248033|FG009|NOT COMPLETED|Overall Study||0||
60126212|NCT02110095|76248055|FG000|STARTED|Overall Study||15||
60126213|NCT02110095|76248055|FG000|COMPLETED|Overall Study||8||
60126214|NCT02110095|76248055|FG000|NOT COMPLETED|Overall Study||7||
60126215|NCT00412425|76248061|FG000|STARTED|Overall Study||15||
60126216|NCT00412425|76248062|FG001|STARTED|Overall Study||15||
60126217|NCT00412425|76248061|FG000|COMPLETED|Overall Study||15||
60126218|NCT00412425|76248062|FG001|COMPLETED|Overall Study||15||
60126219|NCT00412425|76248061|FG000|NOT COMPLETED|Overall Study||0||
60126220|NCT00412425|76248062|FG001|NOT COMPLETED|Overall Study||0||
60126221|NCT01492361|76248070|FG000|STARTED|Overall Study||4089||
60126222|NCT01492361|76248071|FG001|STARTED|Overall Study||4090||
60126223|NCT01492361|76248070|FG000|Completed Final Visit|Overall Study||3419||
60126224|NCT01492361|76248071|FG001|Completed Final Visit|Overall Study||3335||
60126225|NCT01492361|76248070|FG000|Death Before Final Visit|Overall Study||265|Participants who died on trial were considered completed|
60126226|NCT01492361|76248071|FG001|Death Before Final Visit|Overall Study||295|Participants who died on trial were considered completed|
60126227|NCT01492361|76248070|FG000|COMPLETED|Overall Study||3684||
60126228|NCT01492361|76248071|FG001|COMPLETED|Overall Study||3630||
60126229|NCT01492361|76248070|FG000|NOT COMPLETED|Overall Study||405||
60126230|NCT01492361|76248071|FG001|NOT COMPLETED|Overall Study||460||
60126231|NCT00415857|76248079|FG000|STARTED|Overall Study||2||
60126232|NCT00415857|76248080|FG001|STARTED|Overall Study||3||
60126233|NCT00415857|76248079|FG000|COMPLETED|Overall Study||2||
60126234|NCT00415857|76248080|FG001|COMPLETED|Overall Study||3||
60126235|NCT00415857|76248079|FG000|NOT COMPLETED|Overall Study||0||
60126236|NCT00415857|76248080|FG001|NOT COMPLETED|Overall Study||0||
60126237|NCT00416793|76248086|FG000|STARTED|Overall Study||9||
60126238|NCT00416793|76248086|FG000|COMPLETED|Overall Study||9||
60126239|NCT00416793|76248086|FG000|NOT COMPLETED|Overall Study||0||
60126240|NCT00417417|76248092|FG000|STARTED|Overall Study||4||
60126241|NCT00417417|76248093|FG001|STARTED|Overall Study||6||
60126242|NCT00417417|76248092|FG000|COMPLETED|Overall Study||4||
60126243|NCT00417417|76248093|FG001|COMPLETED|Overall Study||6||
60126244|NCT00417417|76248092|FG000|NOT COMPLETED|Overall Study||0||
60126245|NCT00417417|76248093|FG001|NOT COMPLETED|Overall Study||0||
60126246|NCT00418977|76248103|FG000|STARTED|Overall Study||43||
60126247|NCT00418977|76248104|FG001|STARTED|Overall Study||16||
60126248|NCT00418977|76248103|FG000|COMPLETED|Overall Study||40||
60126249|NCT00418977|76248104|FG001|COMPLETED|Overall Study||13||
60126250|NCT00418977|76248103|FG000|NOT COMPLETED|Overall Study||3||
60126251|NCT00418977|76248104|FG001|NOT COMPLETED|Overall Study||3||
60126252|NCT02539563|76248112|FG000|STARTED|Overall Study||45||
60126253|NCT02539563|76248113|FG001|STARTED|Overall Study||56||
60126254|NCT02539563|76248112|FG000|COMPLETED|Overall Study||39||
60126255|NCT02539563|76248113|FG001|COMPLETED|Overall Study||42||
60126256|NCT02539563|76248112|FG000|NOT COMPLETED|Overall Study||6||
60126257|NCT02539563|76248113|FG001|NOT COMPLETED|Overall Study||14||
60126258|NCT00419445|76248122|FG000|STARTED|Overall Study||8||
60126259|NCT00419445|76248123|FG001|STARTED|Overall Study||16||
60126260|NCT00419445|76248124|FG002|STARTED|Overall Study||8||
60126261|NCT00419445|76248122|FG000|COMPLETED|Overall Study||7||
60126262|NCT00419445|76248123|FG001|COMPLETED|Overall Study||14||
60126263|NCT00419445|76248124|FG002|COMPLETED|Overall Study||7||
60126264|NCT00419445|76248122|FG000|NOT COMPLETED|Overall Study||1||
60126265|NCT00419445|76248123|FG001|NOT COMPLETED|Overall Study||2||
60126266|NCT00419445|76248124|FG002|NOT COMPLETED|Overall Study||1||
60126267|NCT00420147|76248134|FG000|STARTED|Overall Study||19||
60126268|NCT00420147|76248135|FG001|STARTED|Overall Study||19||
60126269|NCT00420147|76248134|FG000|COMPLETED|Overall Study||19||
60126270|NCT00420147|76248135|FG001|COMPLETED|Overall Study||19||
60126271|NCT00420147|76248134|FG000|NOT COMPLETED|Overall Study||0||
60126272|NCT00420147|76248135|FG001|NOT COMPLETED|Overall Study||0||
60126273|NCT00420459|76248141|FG000|STARTED|Overall Study||12||
60126274|NCT00420459|76248141|FG000|COMPLETED|Overall Study||12||
60126275|NCT00420459|76248141|FG000|NOT COMPLETED|Overall Study||0||
60126276|NCT01514461|76248150|FG000|STARTED|Overall Study||15||
60126277|NCT01514461|76248151|FG001|STARTED|Overall Study||15||
59594769|NCT03165175|75703731|FG000|NOT COMPLETED|1-month to 3-month||6||
59858982|NCT03214588|75983579|FG000|NOT COMPLETED|Overall Study||1||
59594770|NCT03165175|75703732|FG001|NOT COMPLETED|1-month to 3-month||0||
59594771|NCT03165175|75703731|FG000|STARTED|Baseline to 3-month||35||
59594772|NCT03165175|75703732|FG001|STARTED|Baseline to 3-month||39||
59594773|NCT03165175|75703731|FG000|COMPLETED|Baseline to 3-month||31||
59858983|NCT03214588|75983580|FG001|NOT COMPLETED|Overall Study||1||
60126278|NCT01514461|76248152|FG002|STARTED|Overall Study||15||
60126279|NCT01514461|76248150|FG000|COMPLETED|Overall Study||10||
60126280|NCT01514461|76248151|FG001|COMPLETED|Overall Study||12||
60126281|NCT01514461|76248152|FG002|COMPLETED|Overall Study||11||
60126282|NCT01514461|76248150|FG000|NOT COMPLETED|Overall Study||5||
60126283|NCT01514461|76248151|FG001|NOT COMPLETED|Overall Study||3||
59858984|NCT03214588|75983581|FG002|NOT COMPLETED|Overall Study||2||
60126284|NCT01514461|76248152|FG002|NOT COMPLETED|Overall Study||4||
60126285|NCT00420771|76248165|FG000|STARTED|Overall Study||8||
60126286|NCT00420771|76248166|FG001|STARTED|Overall Study||11||
59594774|NCT03165175|75703732|FG001|COMPLETED|Baseline to 3-month||39||
60126287|NCT00420771|76248165|FG000|COMPLETED|Overall Study||5||
60126288|NCT00420771|76248166|FG001|COMPLETED|Overall Study||7||
60126289|NCT00420771|76248165|FG000|NOT COMPLETED|Overall Study||3||
60126290|NCT00420771|76248166|FG001|NOT COMPLETED|Overall Study||4||
60126291|NCT00426153|76248174|FG000|STARTED|Overall Study|Participants were randomized in a 2:1 ratio, Octreotide LAR depot: Placebo|28||
60126292|NCT00426153|76248175|FG001|STARTED|Overall Study||14||
60126293|NCT00426153|76248174|FG000|COMPLETED|Overall Study||28||
60126294|NCT00426153|76248175|FG001|COMPLETED|Overall Study||14||
60126295|NCT00426153|76248174|FG000|NOT COMPLETED|Overall Study||0||
60126296|NCT00426153|76248175|FG001|NOT COMPLETED|Overall Study||0||
60126297|NCT01996449|76248183|FG000|STARTED|Period 1: First Drug||6||
60126298|NCT01996449|76248184|FG001|STARTED|Period 1: First Drug||8||
60126299|NCT01996449|76248183|FG000|COMPLETED|Period 1: First Drug||6||
60126300|NCT01996449|76248184|FG001|COMPLETED|Period 1: First Drug||8||
60126301|NCT01996449|76248183|FG000|NOT COMPLETED|Period 1: First Drug||0||
60126302|NCT01996449|76248184|FG001|NOT COMPLETED|Period 1: First Drug||0||
60126303|NCT01996449|76248183|FG000|STARTED|Period 2: Second Drug||6||
60126304|NCT01996449|76248184|FG001|STARTED|Period 2: Second Drug||8||
60126305|NCT01996449|76248183|FG000|COMPLETED|Period 2: Second Drug||6||
60126306|NCT01996449|76248184|FG001|COMPLETED|Period 2: Second Drug||8||
60126307|NCT01996449|76248183|FG000|NOT COMPLETED|Period 2: Second Drug||0||
60126308|NCT01996449|76248184|FG001|NOT COMPLETED|Period 2: Second Drug||0||
60126309|NCT00426855|76248192|FG000|STARTED|Overall Study||12||
60126310|NCT00426855|76248192|FG000|COMPLETED|Overall Study||12||
60126311|NCT00426855|76248192|FG000|NOT COMPLETED|Overall Study||0||
60126312|NCT01491737|76248198|FG000|STARTED|Overall Study||129|Intent-to-Treat (ITT) Population|
60126313|NCT01491737|76248199|FG001|STARTED|Overall Study||129|Intent-to-Treat (ITT) Population|
60126314|NCT01491737|76248198|FG000|Received at Least One Dose of Study Drug|Overall Study||127|Safety Population|
60126315|NCT01491737|76248199|FG001|Received at Least One Dose of Study Drug|Overall Study||124|Safety Population|
60126316|NCT01491737|76248198|FG000|Entered Follow-Up (Post-Treatment)|Overall Study||120||
60126317|NCT01491737|76248199|FG001|Entered Follow-Up (Post-Treatment)|Overall Study||116||
60126318|NCT01491737|76248198|FG000|COMPLETED|Overall Study||0||
60126319|NCT01491737|76248199|FG001|COMPLETED|Overall Study||0||
60126320|NCT01491737|76248198|FG000|NOT COMPLETED|Overall Study||129||
60126321|NCT01491737|76248199|FG001|NOT COMPLETED|Overall Study||129||
60126322|NCT00427557|76248205|FG000|STARTED|Overall Study||30||
60126323|NCT00427557|76248205|FG000|COMPLETED|Overall Study||30||
60126324|NCT00427557|76248205|FG000|NOT COMPLETED|Overall Study||0||
60126325|NCT01487863|76248211|FG000|STARTED|Overall Study||35||
60126326|NCT01487863|76248212|FG001|STARTED|Overall Study||34||
60126327|NCT01487863|76248211|FG000|Subjects Randomized (Efficacy Analysis)|Overall Study||35||
60126328|NCT01487863|76248212|FG001|Subjects Randomized (Efficacy Analysis)|Overall Study||34||
60126329|NCT01487863|76248211|FG000|Rcvd ≥1 Leukapheresis (Safety Analysis)|Overall Study||35||
60126330|NCT01487863|76248212|FG001|Rcvd ≥1 Leukapheresis (Safety Analysis)|Overall Study||34||
60126331|NCT01487863|76248211|FG000|COMPLETED|Overall Study||16||
60126332|NCT01487863|76248212|FG001|COMPLETED|Overall Study||15||
60126333|NCT01487863|76248211|FG000|NOT COMPLETED|Overall Study||19||
60126334|NCT01487863|76248212|FG001|NOT COMPLETED|Overall Study||19||
60126335|NCT00427791|76248220|FG000|STARTED|Overall Study||10||
60126336|NCT00427791|76248221|FG001|STARTED|Overall Study||13||
60126337|NCT00427791|76248220|FG000|COMPLETED|Overall Study||10||
60126338|NCT00427791|76248221|FG001|COMPLETED|Overall Study||13||
60126339|NCT00427791|76248220|FG000|NOT COMPLETED|Overall Study||0||
60126340|NCT00427791|76248221|FG001|NOT COMPLETED|Overall Study||0||
60126341|NCT01487161|76248231|FG000|STARTED|Overall Study||58||
60126342|NCT01487161|76248232|FG001|STARTED|Overall Study||59||
60126343|NCT01487161|76248233|FG002|STARTED|Overall Study||60||
60126344|NCT01487161|76248234|FG003|STARTED|Overall Study||52||
60126345|NCT01487161|76248231|FG000|COMPLETED|Overall Study||56||
60126346|NCT01487161|76248232|FG001|COMPLETED|Overall Study||57||
60126347|NCT01487161|76248233|FG002|COMPLETED|Overall Study||59||
60126348|NCT01487161|76248234|FG003|COMPLETED|Overall Study||50||
60126349|NCT01487161|76248231|FG000|NOT COMPLETED|Overall Study||2||
60126350|NCT01487161|76248232|FG001|NOT COMPLETED|Overall Study||2||
60126351|NCT01487161|76248233|FG002|NOT COMPLETED|Overall Study||1||
60126352|NCT01487161|76248234|FG003|NOT COMPLETED|Overall Study||2||
60126353|NCT00429507|76248249|FG000|STARTED|Overall Study||12||
60126354|NCT00429507|76248249|FG000|COMPLETED|Overall Study||12||
60126355|NCT00429507|76248249|FG000|NOT COMPLETED|Overall Study||0||
60126356|NCT00371631|76248253|FG000|STARTED|Overall Study||13||
60126357|NCT00371631|76248253|FG000|COMPLETED|Overall Study||13||
60126358|NCT00371631|76248253|FG000|NOT COMPLETED|Overall Study||0||
60126359|NCT00372957|76248260|FG000|STARTED|Overall Study||10||
60126360|NCT00372957|76248261|FG001|STARTED|Overall Study||10||
60126361|NCT00372957|76248262|FG002|STARTED|Overall Study||10||
60126362|NCT00372957|76248260|FG000|COMPLETED|Overall Study||10||
60126363|NCT00372957|76248261|FG001|COMPLETED|Overall Study||10||
60126364|NCT00372957|76248262|FG002|COMPLETED|Overall Study||10||
60126365|NCT00372957|76248260|FG000|NOT COMPLETED|Overall Study||0||
60126366|NCT00372957|76248261|FG001|NOT COMPLETED|Overall Study||0||
60126367|NCT00372957|76248262|FG002|NOT COMPLETED|Overall Study||0||
60126368|NCT00373269|76248274|FG000|STARTED|Overall Study||11||
60126369|NCT00373269|76248275|FG001|STARTED|Overall Study||10||
60126370|NCT00373269|76248274|FG000|COMPLETED|Overall Study||11||
60126371|NCT00373269|76248275|FG001|COMPLETED|Overall Study||10||
60126372|NCT00373269|76248274|FG000|NOT COMPLETED|Overall Study||0||
60126373|NCT00373269|76248275|FG001|NOT COMPLETED|Overall Study||0||
60126374|NCT01491035|76248289|FG000|STARTED|Overall Study||6||
60126375|NCT01491035|76248290|FG001|STARTED|Overall Study||6||
60126376|NCT01491035|76248291|FG002|STARTED|Overall Study||6||
60126377|NCT01491035|76248292|FG003|STARTED|Overall Study||6||
60126378|NCT01491035|76248293|FG004|STARTED|Overall Study||6||
60126379|NCT01491035|76248294|FG005|STARTED|Overall Study||6||
60126380|NCT01491035|76248295|FG006|STARTED|Overall Study||6||
60126381|NCT01491035|76248296|FG007|STARTED|Overall Study||6||
60126382|NCT01491035|76248289|FG000|COMPLETED|Overall Study||6||
60126383|NCT01491035|76248290|FG001|COMPLETED|Overall Study||6||
60126384|NCT01491035|76248291|FG002|COMPLETED|Overall Study||6||
60126385|NCT01491035|76248292|FG003|COMPLETED|Overall Study||6||
60126386|NCT01491035|76248293|FG004|COMPLETED|Overall Study||5||
60126387|NCT01491035|76248294|FG005|COMPLETED|Overall Study||6||
60126388|NCT01491035|76248295|FG006|COMPLETED|Overall Study||6||
60126389|NCT01491035|76248296|FG007|COMPLETED|Overall Study||6||
60126390|NCT01491035|76248289|FG000|NOT COMPLETED|Overall Study||0||
60126391|NCT01491035|76248290|FG001|NOT COMPLETED|Overall Study||0||
60126392|NCT01491035|76248291|FG002|NOT COMPLETED|Overall Study||0||
60126393|NCT01491035|76248292|FG003|NOT COMPLETED|Overall Study||0||
60126394|NCT01491035|76248293|FG004|NOT COMPLETED|Overall Study||1||
60126395|NCT01491035|76248294|FG005|NOT COMPLETED|Overall Study||0||
60126396|NCT01491035|76248295|FG006|NOT COMPLETED|Overall Study||0||
60126397|NCT01491035|76248296|FG007|NOT COMPLETED|Overall Study||0||
60126398|NCT00375999|76248314|FG000|STARTED|Overall Study||34||
60126399|NCT00375999|76248314|FG000|COMPLETED|Overall Study||32||
60126400|NCT00375999|76248314|FG000|NOT COMPLETED|Overall Study||2||
60126401|NCT01488071|76248320|FG000|STARTED|Overall Study|all-patients-treated set (APTS)|253||
60126402|NCT01488071|76248321|FG001|STARTED|Overall Study|APTS|242||
60126403|NCT01488071|76248320|FG000|COMPLETED|Overall Study||200||
60126404|NCT01488071|76248321|FG001|COMPLETED|Overall Study||179||
60126405|NCT01488071|76248320|FG000|NOT COMPLETED|Overall Study||53||
60126406|NCT01488071|76248321|FG001|NOT COMPLETED|Overall Study||63||
60126407|NCT01487525|76248329|FG000|STARTED|Overall Study||22||
60126408|NCT01487525|76248330|FG001|STARTED|Overall Study||20||
60126409|NCT01487525|76248329|FG000|COMPLETED|Overall Study||22||
60126410|NCT01487525|76248330|FG001|COMPLETED|Overall Study||19||
60126411|NCT01487525|76248329|FG000|NOT COMPLETED|Overall Study||0||
60126412|NCT01487525|76248330|FG001|NOT COMPLETED|Overall Study||1||
60126413|NCT01486199|76248338|FG000|STARTED|Baseline Study Day||10||
60126414|NCT01486199|76248339|FG001|STARTED|Baseline Study Day||10||
60126415|NCT01486199|76248338|FG000|COMPLETED|Baseline Study Day||10||
60126416|NCT01486199|76248339|FG001|COMPLETED|Baseline Study Day||9||
60126417|NCT01486199|76248338|FG000|NOT COMPLETED|Baseline Study Day||0||
60126418|NCT01486199|76248339|FG001|NOT COMPLETED|Baseline Study Day||1||
60126419|NCT01486199|76248338|FG000|STARTED|Two Year Period Between Study Days||10||
60126420|NCT01486199|76248339|FG001|STARTED|Two Year Period Between Study Days||0||
60126421|NCT01486199|76248338|FG000|COMPLETED|Two Year Period Between Study Days||9||
60126422|NCT01486199|76248339|FG001|COMPLETED|Two Year Period Between Study Days||0||
60126423|NCT01486199|76248338|FG000|NOT COMPLETED|Two Year Period Between Study Days||1||
60126424|NCT01486199|76248339|FG001|NOT COMPLETED|Two Year Period Between Study Days||0||
60126425|NCT01486199|76248338|FG000|STARTED|Study Day at t= 2 Years||9||
60126426|NCT01486199|76248339|FG001|STARTED|Study Day at t= 2 Years||0||
60126427|NCT01486199|76248338|FG000|COMPLETED|Study Day at t= 2 Years||9||
60126428|NCT01486199|76248339|FG001|COMPLETED|Study Day at t= 2 Years||0||
60126429|NCT01486199|76248338|FG000|NOT COMPLETED|Study Day at t= 2 Years||0||
60126430|NCT01486199|76248339|FG001|NOT COMPLETED|Study Day at t= 2 Years||0||
60126431|NCT01485887|76248345|FG000|STARTED|Overall Study||50||
60126432|NCT01485887|76248345|FG000|COMPLETED|Overall Study||38||
60126433|NCT01485887|76248345|FG000|NOT COMPLETED|Overall Study||12||
60126434|NCT01546519|76248353|FG000|STARTED|Overall Study||9||
60126435|NCT01546519|76248354|FG001|STARTED|Overall Study||8||
60126436|NCT01546519|76248355|FG002|STARTED|Overall Study||8||
60126437|NCT01546519|76248356|FG003|STARTED|Overall Study||6||
59594775|NCT03165175|75703731|FG000|NOT COMPLETED|Baseline to 3-month||4||
60126438|NCT01546519|76248353|FG000|Safety-Evaluable Participants|Overall Study||9||
60126439|NCT01546519|76248354|FG001|Safety-Evaluable Participants|Overall Study||8||
60126440|NCT01546519|76248355|FG002|Safety-Evaluable Participants|Overall Study||8||
60126441|NCT01546519|76248356|FG003|Safety-Evaluable Participants|Overall Study||6||
60126442|NCT01546519|76248353|FG000|COMPLETED|Overall Study||0||
60126443|NCT01546519|76248354|FG001|COMPLETED|Overall Study||0||
60126444|NCT01546519|76248355|FG002|COMPLETED|Overall Study||0||
60126445|NCT01546519|76248356|FG003|COMPLETED|Overall Study||0||
60126446|NCT01546519|76248353|FG000|NOT COMPLETED|Overall Study||9||
60126447|NCT01546519|76248354|FG001|NOT COMPLETED|Overall Study||8||
60126448|NCT01546519|76248355|FG002|NOT COMPLETED|Overall Study||8||
60126449|NCT01546519|76248356|FG003|NOT COMPLETED|Overall Study||6||
60126450|NCT01484951|76248370|FG000|STARTED|Overall Study||74||
60126451|NCT01484951|76248370|FG000|COMPLETED|Overall Study||69||
60126452|NCT01484951|76248370|FG000|NOT COMPLETED|Overall Study||5||
60126453|NCT01484873|76248374|FG000|STARTED|Overall Study||10||
60126454|NCT01484873|76248374|FG000|COMPLETED|Overall Study||8||
60126455|NCT01484873|76248374|FG000|NOT COMPLETED|Overall Study||2||
60126456|NCT01486927|76248379|FG000|STARTED|Overall Study||174||
60126457|NCT01486927|76248379|FG000|COMPLETED|Overall Study||161||
60126458|NCT01486927|76248379|FG000|NOT COMPLETED|Overall Study||13||
60126459|NCT00376935|76248394|FG000|STARTED|Overall Study||25||
60126460|NCT00376935|76248395|FG001|STARTED|Overall Study||25||
60126461|NCT00376935|76248396|FG002|STARTED|Overall Study||25||
60126462|NCT00376935|76248397|FG003|STARTED|Overall Study||24||
60126463|NCT00376935|76248394|FG000|COMPLETED|Overall Study||25||
60126464|NCT00376935|76248395|FG001|COMPLETED|Overall Study||25||
60126465|NCT00376935|76248396|FG002|COMPLETED|Overall Study||25||
60126466|NCT00376935|76248397|FG003|COMPLETED|Overall Study||24||
60126467|NCT00376935|76248394|FG000|NOT COMPLETED|Overall Study||0||
60126468|NCT00376935|76248395|FG001|NOT COMPLETED|Overall Study||0||
60126469|NCT00376935|76248396|FG002|NOT COMPLETED|Overall Study||0||
60126470|NCT00376935|76248397|FG003|NOT COMPLETED|Overall Study||0||
60126471|NCT00379197|76248407|FG000|STARTED|Overall Study||13||
60126472|NCT00379197|76248407|FG000|COMPLETED|Overall Study||8||
60126473|NCT00379197|76248407|FG000|NOT COMPLETED|Overall Study||5||
60126474|NCT01513759|76248412|FG000|STARTED|Overall Study||150||
60126475|NCT01513759|76248412|FG000|At Least One Device Successfully Placed|Overall Study||149||
60126476|NCT01513759|76248412|FG000|COMPLETED|Overall Study||145||
60126477|NCT01513759|76248412|FG000|NOT COMPLETED|Overall Study||5||
60126478|NCT01484561|76248418|FG000|STARTED|Overall Study||97||
60126479|NCT01484561|76248419|FG001|STARTED|Overall Study||51||
60126480|NCT01484561|76248418|FG000|COMPLETED|Overall Study||88||
60126481|NCT01484561|76248419|FG001|COMPLETED|Overall Study||45||
60126482|NCT01484561|76248418|FG000|NOT COMPLETED|Overall Study||9||
60126483|NCT01484561|76248419|FG001|NOT COMPLETED|Overall Study||6||
60126484|NCT01546207|76248425|FG000|STARTED|Overall Study||4||
60126485|NCT01546207|76248425|FG000|COMPLETED|Overall Study||3||
60126486|NCT01546207|76248425|FG000|NOT COMPLETED|Overall Study||1||
60126487|NCT01513291|76248431|FG000|STARTED|Treatment Period||120||
60126488|NCT01513291|76248432|FG001|STARTED|Treatment Period||117||
60126489|NCT01513291|76248433|FG002|STARTED|Treatment Period||0||
60126490|NCT01513291|76248434|FG003|STARTED|Treatment Period||0||
60126491|NCT01513291|76248435|FG004|STARTED|Treatment Period||0||
60126492|NCT01513291|76248431|FG000|Treated|Treatment Period||120||
60126493|NCT01513291|76248432|FG001|Treated|Treatment Period||115||
60126494|NCT01513291|76248433|FG002|Treated|Treatment Period||0||
60126495|NCT01513291|76248434|FG003|Treated|Treatment Period||0||
60126496|NCT01513291|76248435|FG004|Treated|Treatment Period||0||
60126497|NCT01513291|76248431|FG000|COMPLETED|Treatment Period||97||
60126498|NCT01513291|76248432|FG001|COMPLETED|Treatment Period||101||
60126499|NCT01513291|76248433|FG002|COMPLETED|Treatment Period||0||
60126500|NCT01513291|76248434|FG003|COMPLETED|Treatment Period||0||
60126501|NCT01513291|76248435|FG004|COMPLETED|Treatment Period||0||
60126502|NCT01513291|76248431|FG000|NOT COMPLETED|Treatment Period||23||
60126503|NCT01513291|76248432|FG001|NOT COMPLETED|Treatment Period||16||
60126504|NCT01513291|76248433|FG002|NOT COMPLETED|Treatment Period||0||
60126505|NCT01513291|76248434|FG003|NOT COMPLETED|Treatment Period||0||
60126506|NCT01513291|76248435|FG004|NOT COMPLETED|Treatment Period||0||
60126507|NCT01513291|76248431|FG000|STARTED|Run-out Period||0||
60126508|NCT01513291|76248432|FG001|STARTED|Run-out Period||0||
60126509|NCT01513291|76248433|FG002|STARTED|Run-out Period|These participants were pre-randomized from participants in the Treatment Period: MK-6096 group|50||
60126510|NCT01513291|76248434|FG003|STARTED|Run-out Period|These participants were pre-randomized from participants in the Treatment Period: MK-6096 group|47||
60126511|NCT01513291|76248435|FG004|STARTED|Run-out Period|These participants were completers from the Treatment Period: Placebo group|101||
60126512|NCT01513291|76248431|FG000|COMPLETED|Run-out Period||0||
60126513|NCT01513291|76248432|FG001|COMPLETED|Run-out Period||0||
60126514|NCT01513291|76248433|FG002|COMPLETED|Run-out Period||50||
59858985|NCT03166618|75983591|FG000|STARTED|Overall Study||0||
60126515|NCT01513291|76248434|FG003|COMPLETED|Run-out Period||45||
60126516|NCT01513291|76248435|FG004|COMPLETED|Run-out Period||101||
60126517|NCT01513291|76248431|FG000|NOT COMPLETED|Run-out Period||0||
60126518|NCT01513291|76248432|FG001|NOT COMPLETED|Run-out Period||0||
60126519|NCT01513291|76248433|FG002|NOT COMPLETED|Run-out Period||0||
60126520|NCT01513291|76248434|FG003|NOT COMPLETED|Run-out Period||2||
60126521|NCT01513291|76248435|FG004|NOT COMPLETED|Run-out Period||0||
60126522|NCT01483937|76248449|FG000|STARTED|Overall Study||15||
60126523|NCT01483937|76248450|FG001|STARTED|Overall Study||17||
60126524|NCT01483937|76248449|FG000|COMPLETED|Overall Study||11||
60126525|NCT01483937|76248450|FG001|COMPLETED|Overall Study||14||
60126526|NCT01483937|76248449|FG000|NOT COMPLETED|Overall Study||4||
60126527|NCT01483937|76248450|FG001|NOT COMPLETED|Overall Study||3||
60126528|NCT01483625|76248461|FG000|STARTED|Overall Study||72||
60126529|NCT01483625|76248462|FG001|STARTED|Overall Study||68||
60126530|NCT01483625|76248461|FG000|COMPLETED|Overall Study||68||
60126531|NCT01483625|76248462|FG001|COMPLETED|Overall Study||66||
60126532|NCT01483625|76248461|FG000|NOT COMPLETED|Overall Study||4||
60126533|NCT01483625|76248462|FG001|NOT COMPLETED|Overall Study||2||
60126534|NCT01485991|76248470|FG000|STARTED|Overall Study||385||
60126535|NCT01485991|76248471|FG001|STARTED|Overall Study||386||
60126536|NCT01485991|76248470|FG000|Treated|Overall Study||379||
60126537|NCT01485991|76248471|FG001|Treated|Overall Study||384||
60126538|NCT01485991|76248470|FG000|COMPLETED|Overall Study||353||
60126539|NCT01485991|76248471|FG001|COMPLETED|Overall Study||350||
60126540|NCT01485991|76248470|FG000|NOT COMPLETED|Overall Study||32||
60126541|NCT01485991|76248471|FG001|NOT COMPLETED|Overall Study||36||
60126542|NCT00379821|76248481|FG000|STARTED|Overall Study||160||
60126543|NCT00379821|76248482|FG001|STARTED|Overall Study||160||
60126544|NCT00379821|76248483|FG002|STARTED|Overall Study||160||
60126545|NCT00379821|76248484|FG003|STARTED|Overall Study||160||
60126546|NCT00379821|76248481|FG000|COMPLETED|Overall Study||87||
60126547|NCT00379821|76248482|FG001|COMPLETED|Overall Study||71||
60126548|NCT00379821|76248483|FG002|COMPLETED|Overall Study||93||
60126549|NCT00379821|76248484|FG003|COMPLETED|Overall Study||81||
60126550|NCT00379821|76248481|FG000|NOT COMPLETED|Overall Study||73||
60126551|NCT00379821|76248482|FG001|NOT COMPLETED|Overall Study||89||
60126552|NCT00379821|76248483|FG002|NOT COMPLETED|Overall Study||67||
60126553|NCT00379821|76248484|FG003|NOT COMPLETED|Overall Study||79||
60126554|NCT01482767|76248503|FG000|STARTED|Overall Study||135||
60126555|NCT01482767|76248504|FG001|STARTED|Overall Study||127||
60126556|NCT01482767|76248503|FG000|COMPLETED|Overall Study||81||
60126557|NCT01482767|76248504|FG001|COMPLETED|Overall Study||78||
60126558|NCT01482767|76248503|FG000|NOT COMPLETED|Overall Study||54||
60126559|NCT01482767|76248504|FG001|NOT COMPLETED|Overall Study||49||
60126560|NCT00435591|76248514|FG000|STARTED|Overall Study||30||
60126561|NCT00435591|76248515|FG001|STARTED|Overall Study||31||
60126562|NCT00435591|76248516|FG002|STARTED|Overall Study||30||
60126563|NCT00435591|76248517|FG003|STARTED|Overall Study||30||
60126564|NCT00435591|76248514|FG000|Safety Analysis Set|Overall Study||28||
60126565|NCT00435591|76248515|FG001|Safety Analysis Set|Overall Study||30||
60126566|NCT00435591|76248516|FG002|Safety Analysis Set|Overall Study||30||
60126567|NCT00435591|76248517|FG003|Safety Analysis Set|Overall Study||29||
60126568|NCT00435591|76248514|FG000|Full Analysis Set|Overall Study||28||
60126569|NCT00435591|76248515|FG001|Full Analysis Set|Overall Study||29||
60126570|NCT00435591|76248516|FG002|Full Analysis Set|Overall Study||30||
60126571|NCT00435591|76248517|FG003|Full Analysis Set|Overall Study||29||
60126572|NCT00435591|76248514|FG000|End of Treatment|Overall Study||25||
60126573|NCT00435591|76248515|FG001|End of Treatment|Overall Study||27||
60126574|NCT00435591|76248516|FG002|End of Treatment|Overall Study||27||
60126575|NCT00435591|76248517|FG003|End of Treatment|Overall Study||23||
60126576|NCT00435591|76248514|FG000|COMPLETED|Overall Study||23||
60126577|NCT00435591|76248515|FG001|COMPLETED|Overall Study||27||
60126578|NCT00435591|76248516|FG002|COMPLETED|Overall Study||25||
60126579|NCT00435591|76248517|FG003|COMPLETED|Overall Study||19||
60126580|NCT00435591|76248514|FG000|NOT COMPLETED|Overall Study||7||
60126581|NCT00435591|76248515|FG001|NOT COMPLETED|Overall Study||4||
60126582|NCT00435591|76248516|FG002|NOT COMPLETED|Overall Study||5||
60126583|NCT00435591|76248517|FG003|NOT COMPLETED|Overall Study||11||
60126584|NCT01482221|76248533|FG000|STARTED|Overall Study||101||
60126585|NCT01482221|76248534|FG001|STARTED|Overall Study||101||
60126586|NCT01482221|76248535|FG002|STARTED|Overall Study||100||
60126587|NCT01482221|76248533|FG000|COMPLETED|Overall Study||80||
60126588|NCT01482221|76248534|FG001|COMPLETED|Overall Study||81||
60126589|NCT01482221|76248535|FG002|COMPLETED|Overall Study||77||
60126590|NCT01482221|76248533|FG000|NOT COMPLETED|Overall Study||21||
60126591|NCT01482221|76248534|FG001|NOT COMPLETED|Overall Study||20||
60126592|NCT01482221|76248535|FG002|NOT COMPLETED|Overall Study||23||
60126593|NCT01482065|76248545|FG000|STARTED|Overall Study||4||
60126594|NCT01482065|76248546|FG001|STARTED|Overall Study||5||
60126595|NCT01482065|76248545|FG000|COMPLETED|Overall Study||4||
60126596|NCT01482065|76248546|FG001|COMPLETED|Overall Study||4||
60126597|NCT01482065|76248545|FG000|NOT COMPLETED|Overall Study||0||
60126598|NCT01482065|76248546|FG001|NOT COMPLETED|Overall Study||1||
60126599|NCT00439335|76248554|FG000|STARTED|Overall Study||113||
60126600|NCT00439335|76248555|FG001|STARTED|Overall Study||114||
60126601|NCT00439335|76248554|FG000|COMPLETED|Overall Study||111||
60126602|NCT00439335|76248555|FG001|COMPLETED|Overall Study||114||
60126603|NCT00439335|76248554|FG000|NOT COMPLETED|Overall Study||2||
60126604|NCT00439335|76248555|FG001|NOT COMPLETED|Overall Study||0||
60126605|NCT01545817|76248561|FG000|STARTED|Pazopanib||74||
60126606|NCT01545817|76248562|FG001|STARTED|Pazopanib||0||
60126607|NCT01545817|76248561|FG000|COMPLETED|Pazopanib||0||
60126608|NCT01545817|76248562|FG001|COMPLETED|Pazopanib||0||
60126609|NCT01545817|76248561|FG000|NOT COMPLETED|Pazopanib||74||
60126610|NCT01545817|76248562|FG001|NOT COMPLETED|Pazopanib||0||
60126611|NCT01545817|76248561|FG000|STARTED|Everolimus||0||
60126612|NCT01545817|76248562|FG001|STARTED|Everolimus||38||
60126613|NCT01545817|76248561|FG000|COMPLETED|Everolimus||0||
60126614|NCT01545817|76248562|FG001|COMPLETED|Everolimus||0||
60126615|NCT01545817|76248561|FG000|NOT COMPLETED|Everolimus||0||
60126616|NCT01545817|76248562|FG001|NOT COMPLETED|Everolimus||38||
60126617|NCT00382785|76248572|FG000|STARTED|Overall Study||25||
60126618|NCT00382785|76248573|FG001|STARTED|Overall Study||26||
60126619|NCT00382785|76248572|FG000|COMPLETED|Overall Study||25||
60126620|NCT00382785|76248573|FG001|COMPLETED|Overall Study||26||
60126621|NCT00382785|76248572|FG000|NOT COMPLETED|Overall Study||0||
60126622|NCT00382785|76248573|FG001|NOT COMPLETED|Overall Study||0||
60126623|NCT01512979|76248581|FG000|STARTED|Overall Study|Randomised and treated|159||
60126624|NCT01512979|76248582|FG001|STARTED|Overall Study|Randomised and treated|157||
60126625|NCT01512979|76248581|FG000|COMPLETED|Overall Study||140||
60126626|NCT01512979|76248582|FG001|COMPLETED|Overall Study||135||
60126627|NCT01512979|76248581|FG000|NOT COMPLETED|Overall Study||19||
60126628|NCT01512979|76248582|FG001|NOT COMPLETED|Overall Study||22||
60126629|NCT00383565|76248588|FG000|STARTED|Overall Study||9||
60126630|NCT00383565|76248588|FG000|COMPLETED|Overall Study||9||
60126631|NCT00383565|76248588|FG000|NOT COMPLETED|Overall Study||0||
60126632|NCT01512745|76248594|FG000|STARTED|Overall Study||176||
60126633|NCT01512745|76248595|FG001|STARTED|Overall Study||91||
60126634|NCT01512745|76248594|FG000|COMPLETED|Overall Study||136||
60126635|NCT01512745|76248595|FG001|COMPLETED|Overall Study||71||
60126636|NCT01512745|76248594|FG000|NOT COMPLETED|Overall Study||40||
60126637|NCT01512745|76248595|FG001|NOT COMPLETED|Overall Study||20||
60126638|NCT01478321|76248601|FG000|STARTED|Concurrent Therapy (5 Weeks)||54||
60126639|NCT01478321|76248601|FG000|COMPLETED|Concurrent Therapy (5 Weeks)||38||
60126640|NCT01478321|76248601|FG000|NOT COMPLETED|Concurrent Therapy (5 Weeks)||16||
60126641|NCT01478321|76248601|FG000|STARTED|Started Adjuvant Therapy||38||
60126642|NCT01478321|76248601|FG000|Completed First Cycle|Started Adjuvant Therapy||37||
60126643|NCT01478321|76248601|FG000|COMPLETED|Started Adjuvant Therapy||37||
60126644|NCT01478321|76248601|FG000|NOT COMPLETED|Started Adjuvant Therapy||1||
60126645|NCT01478321|76248601|FG000|STARTED|Adjuvant Therapy Until PD or Toxicity||37||
60126646|NCT01478321|76248601|FG000|Went on to Cycle 2 +|Adjuvant Therapy Until PD or Toxicity||27||
60126647|NCT01478321|76248601|FG000|COMPLETED|Adjuvant Therapy Until PD or Toxicity||27||
60126648|NCT01478321|76248601|FG000|NOT COMPLETED|Adjuvant Therapy Until PD or Toxicity||10||
60126649|NCT01478321|76248601|FG000|STARTED|Follow-up Until Death or 12.31.18 Occurs||54|All patients that receive one dose of study treatment go into the follow up portion of the study.|
60126650|NCT01478321|76248601|FG000|COMPLETED|Follow-up Until Death or 12.31.18 Occurs||54||
60126651|NCT01478321|76248601|FG000|NOT COMPLETED|Follow-up Until Death or 12.31.18 Occurs||0||
60126652|NCT01544491|76248607|FG000|STARTED|Overall Study||52||
60126653|NCT01544491|76248608|FG001|STARTED|Overall Study||54||
60126654|NCT01544491|76248607|FG000|COMPLETED|Overall Study||47||
60126655|NCT01544491|76248608|FG001|COMPLETED|Overall Study||51||
60126656|NCT01544491|76248607|FG000|NOT COMPLETED|Overall Study||5||
60126657|NCT01544491|76248608|FG001|NOT COMPLETED|Overall Study||3||
60126658|NCT00383643|76248617|FG000|STARTED|Overall Study||18||
60126659|NCT00383643|76248618|FG001|STARTED|Overall Study||16||
60126660|NCT00383643|76248619|FG002|STARTED|Overall Study||14||
60126661|NCT00383643|76248617|FG000|COMPLETED|Overall Study||17||
60126662|NCT00383643|76248618|FG001|COMPLETED|Overall Study||15||
60126663|NCT00383643|76248619|FG002|COMPLETED|Overall Study||13||
60126664|NCT00383643|76248617|FG000|NOT COMPLETED|Overall Study||1||
60126665|NCT00383643|76248618|FG001|NOT COMPLETED|Overall Study||1||
60126666|NCT00383643|76248619|FG002|NOT COMPLETED|Overall Study||1||
60126667|NCT01478087|76248627|FG000|STARTED|Overall Study||3||
60126668|NCT01478087|76248627|FG000|COMPLETED|Overall Study||2||
60126669|NCT01478087|76248627|FG000|NOT COMPLETED|Overall Study||1||
60126670|NCT00439413|76248633|FG000|STARTED|Overall Study||121||
60126671|NCT00439413|76248634|FG001|STARTED|Overall Study||125||
60126672|NCT00439413|76248633|FG000|COMPLETED|Overall Study||90||
60126673|NCT00439413|76248634|FG001|COMPLETED|Overall Study||88||
60126674|NCT00439413|76248633|FG000|NOT COMPLETED|Overall Study||31||
60126675|NCT00439413|76248634|FG001|NOT COMPLETED|Overall Study||37||
60126676|NCT01477853|76248645|FG000|STARTED|Phase A||55||
60126677|NCT01477853|76248646|FG001|STARTED|Phase A||56||
60126678|NCT01477853|76248647|FG002|STARTED|Phase A||55||
60126679|NCT01477853|76248645|FG000|COMPLETED|Phase A||12||
60126680|NCT01477853|76248646|FG001|COMPLETED|Phase A||11||
60126681|NCT01477853|76248647|FG002|COMPLETED|Phase A||11||
60126682|NCT01477853|76248645|FG000|NOT COMPLETED|Phase A||43||
60126683|NCT01477853|76248646|FG001|NOT COMPLETED|Phase A||45||
60126684|NCT01477853|76248647|FG002|NOT COMPLETED|Phase A||44||
60126685|NCT01477853|76248645|FG000|STARTED|Phase B||12||
60126686|NCT01477853|76248646|FG001|STARTED|Phase B||11||
60126687|NCT01477853|76248647|FG002|STARTED|Phase B||11||
60126688|NCT01477853|76248645|FG000|COMPLETED|Phase B||0||
60126689|NCT01477853|76248646|FG001|COMPLETED|Phase B||0||
60126690|NCT01477853|76248647|FG002|COMPLETED|Phase B||0||
60126691|NCT01477853|76248645|FG000|NOT COMPLETED|Phase B||12||
60126692|NCT01477853|76248646|FG001|NOT COMPLETED|Phase B||11||
60126693|NCT01477853|76248647|FG002|NOT COMPLETED|Phase B||11||
60126694|NCT00384813|76248657|FG000|STARTED|Overall Study||23||
60126695|NCT00384813|76248658|FG001|STARTED|Overall Study||20||
60126696|NCT00384813|76248657|FG000|COMPLETED|Overall Study||21||
60126697|NCT00384813|76248658|FG001|COMPLETED|Overall Study||20||
60126698|NCT00384813|76248657|FG000|NOT COMPLETED|Overall Study||2||
60126699|NCT00384813|76248658|FG001|NOT COMPLETED|Overall Study||0||
60126700|NCT00440505|76248664|FG000|STARTED|First Intervention||5||
60126701|NCT00440505|76248665|FG001|STARTED|First Intervention||2||
60126702|NCT00440505|76248666|FG002|STARTED|First Intervention||1||
60126703|NCT00440505|76248667|FG003|STARTED|First Intervention||2||
60126704|NCT00440505|76248668|FG004|STARTED|First Intervention||5||
60126705|NCT00440505|76248669|FG005|STARTED|First Intervention||5||
60126706|NCT00440505|76248664|FG000|COMPLETED|First Intervention||5||
60126707|NCT00440505|76248665|FG001|COMPLETED|First Intervention||2||
60126708|NCT00440505|76248666|FG002|COMPLETED|First Intervention||1||
60126709|NCT00440505|76248667|FG003|COMPLETED|First Intervention||2||
60126710|NCT00440505|76248668|FG004|COMPLETED|First Intervention||5||
60126711|NCT00440505|76248669|FG005|COMPLETED|First Intervention||5||
60126712|NCT00440505|76248664|FG000|NOT COMPLETED|First Intervention||0||
60126713|NCT00440505|76248665|FG001|NOT COMPLETED|First Intervention||0||
60126714|NCT00440505|76248666|FG002|NOT COMPLETED|First Intervention||0||
60126715|NCT00440505|76248667|FG003|NOT COMPLETED|First Intervention||0||
60126716|NCT00440505|76248668|FG004|NOT COMPLETED|First Intervention||0||
60126717|NCT00440505|76248669|FG005|NOT COMPLETED|First Intervention||0||
60126718|NCT00440505|76248664|FG000|STARTED|Second Intervention||5||
60126719|NCT00440505|76248665|FG001|STARTED|Second Intervention||2||
60126720|NCT00440505|76248666|FG002|STARTED|Second Intervention||1||
60126721|NCT00440505|76248667|FG003|STARTED|Second Intervention||2||
60126722|NCT00440505|76248668|FG004|STARTED|Second Intervention||5||
60126723|NCT00440505|76248669|FG005|STARTED|Second Intervention||5||
60126724|NCT00440505|76248664|FG000|COMPLETED|Second Intervention||5||
60126725|NCT00440505|76248665|FG001|COMPLETED|Second Intervention||2||
60126726|NCT00440505|76248666|FG002|COMPLETED|Second Intervention||1||
60126727|NCT00440505|76248667|FG003|COMPLETED|Second Intervention||2||
60126728|NCT00440505|76248668|FG004|COMPLETED|Second Intervention||5||
60126729|NCT00440505|76248669|FG005|COMPLETED|Second Intervention||5||
60126730|NCT00440505|76248664|FG000|NOT COMPLETED|Second Intervention||0||
59858986|NCT03166618|75983592|FG001|STARTED|Overall Study||1||
59858987|NCT03166618|75983591|FG000|COMPLETED|Overall Study||0||
59858988|NCT03166618|75983592|FG001|COMPLETED|Overall Study||0||
59858989|NCT03166618|75983591|FG000|NOT COMPLETED|Overall Study||0||
59858990|NCT03166618|75983592|FG001|NOT COMPLETED|Overall Study||1||
59858991|NCT02599558|75983598|FG000|STARTED|Overall Study||22||
59858992|NCT02599558|75983598|FG000|COMPLETED|Overall Study||22||
59858993|NCT02599558|75983598|FG000|NOT COMPLETED|Overall Study||0||
59858994|NCT01882816|75983602|FG000|STARTED|Overall Study||27||
59858995|NCT01882816|75983602|FG000|COMPLETED|Overall Study||27||
59858996|NCT01882816|75983602|FG000|NOT COMPLETED|Overall Study||0||
59858997|NCT03162796|75983609|FG000|STARTED|Placebo Controlled Period: Week 0 - 24||126||
59858998|NCT03162796|75983610|FG001|STARTED|Placebo Controlled Period: Week 0 - 24||127||
59858999|NCT03162796|75983611|FG002|STARTED|Placebo Controlled Period: Week 0 - 24||128||
59859000|NCT03162796|75983609|FG000|COMPLETED|Placebo Controlled Period: Week 0 - 24||114||
59859001|NCT03162796|75983610|FG001|COMPLETED|Placebo Controlled Period: Week 0 - 24||123||
59859002|NCT03162796|75983611|FG002|COMPLETED|Placebo Controlled Period: Week 0 - 24||125||
59859003|NCT03162796|75983609|FG000|NOT COMPLETED|Placebo Controlled Period: Week 0 - 24||12||
59859004|NCT03162796|75983610|FG001|NOT COMPLETED|Placebo Controlled Period: Week 0 - 24||4||
59859005|NCT03162796|75983611|FG002|NOT COMPLETED|Placebo Controlled Period: Week 0 - 24||3||
59859006|NCT03162796|75983609|FG000|STARTED|Active Treatment Period: Week 24 - 52||114||
59859007|NCT03162796|75983610|FG001|STARTED|Active Treatment Period: Week 24 - 52||123||
59859008|NCT03162796|75983611|FG002|STARTED|Active Treatment Period: Week 24 - 52||125||
59859009|NCT03162796|75983609|FG000|COMPLETED|Active Treatment Period: Week 24 - 52||107||
59859010|NCT03162796|75983610|FG001|COMPLETED|Active Treatment Period: Week 24 - 52||116||
59859011|NCT03162796|75983611|FG002|COMPLETED|Active Treatment Period: Week 24 - 52||124||
59859012|NCT03162796|75983609|FG000|NOT COMPLETED|Active Treatment Period: Week 24 - 52||7||
59859013|NCT03162796|75983610|FG001|NOT COMPLETED|Active Treatment Period: Week 24 - 52||7||
60126731|NCT00440505|76248665|FG001|NOT COMPLETED|Second Intervention||0||
60126732|NCT00440505|76248666|FG002|NOT COMPLETED|Second Intervention||0||
60126733|NCT00440505|76248667|FG003|NOT COMPLETED|Second Intervention||0||
59859014|NCT03162796|75983611|FG002|NOT COMPLETED|Active Treatment Period: Week 24 - 52||1||
59859015|NCT03162796|75983609|FG000|STARTED|Safety Follow-up: Week 52 - 60||107||
59859016|NCT03162796|75983610|FG001|STARTED|Safety Follow-up: Week 52 - 60||116||
60126734|NCT00440505|76248668|FG004|NOT COMPLETED|Second Intervention||0||
60126735|NCT00440505|76248669|FG005|NOT COMPLETED|Second Intervention||0||
60126736|NCT00440505|76248664|FG000|STARTED|Third Intervention||5||
60126737|NCT00440505|76248665|FG001|STARTED|Third Intervention||2||
60126738|NCT00440505|76248666|FG002|STARTED|Third Intervention||1||
60126739|NCT00440505|76248667|FG003|STARTED|Third Intervention||2||
60126740|NCT00440505|76248668|FG004|STARTED|Third Intervention||5||
60126741|NCT00440505|76248669|FG005|STARTED|Third Intervention||5||
60126742|NCT00440505|76248664|FG000|COMPLETED|Third Intervention||5||
59594776|NCT03165175|75703732|FG001|NOT COMPLETED|Baseline to 3-month||0||
59594777|NCT03000283|75703738|FG000|STARTED|Overall Study||7||
60126743|NCT00440505|76248665|FG001|COMPLETED|Third Intervention||2||
60126744|NCT00440505|76248666|FG002|COMPLETED|Third Intervention||1||
60126745|NCT00440505|76248667|FG003|COMPLETED|Third Intervention||1||
60126746|NCT00440505|76248668|FG004|COMPLETED|Third Intervention||5||
60126747|NCT00440505|76248669|FG005|COMPLETED|Third Intervention||5||
60126748|NCT00440505|76248664|FG000|NOT COMPLETED|Third Intervention||0||
60126749|NCT00440505|76248665|FG001|NOT COMPLETED|Third Intervention||0||
60126750|NCT00440505|76248666|FG002|NOT COMPLETED|Third Intervention||0||
60126751|NCT00440505|76248667|FG003|NOT COMPLETED|Third Intervention||1||
60126752|NCT00440505|76248668|FG004|NOT COMPLETED|Third Intervention||0||
60126753|NCT00440505|76248669|FG005|NOT COMPLETED|Third Intervention||0||
60126754|NCT01511419|76248679|FG000|STARTED|Dose 1||30||
60126755|NCT01511419|76248680|FG001|STARTED|Dose 1||10||
60126756|NCT01511419|76248679|FG000|COMPLETED|Dose 1||30||
60126757|NCT01511419|76248680|FG001|COMPLETED|Dose 1||10||
60126758|NCT01511419|76248679|FG000|NOT COMPLETED|Dose 1||0||
60126759|NCT01511419|76248680|FG001|NOT COMPLETED|Dose 1||0||
60126760|NCT01511419|76248679|FG000|STARTED|Dose 2||30||
60126761|NCT01511419|76248680|FG001|STARTED|Dose 2||10||
60126762|NCT01511419|76248679|FG000|COMPLETED|Dose 2||29||
60126763|NCT01511419|76248680|FG001|COMPLETED|Dose 2||10||
60126764|NCT01511419|76248679|FG000|NOT COMPLETED|Dose 2||1||
60126765|NCT01511419|76248680|FG001|NOT COMPLETED|Dose 2||0||
60126766|NCT00441285|76248715|FG000|STARTED|Overall Study||16||
60126767|NCT00441285|76248716|FG001|STARTED|Overall Study||16||
60126768|NCT00441285|76248717|FG002|STARTED|Overall Study||41||
60126769|NCT00441285|76248718|FG003|STARTED|Overall Study||40||
60126770|NCT00441285|76248719|FG004|STARTED|Overall Study||43||
60126771|NCT00441285|76248715|FG000|COMPLETED|Overall Study||16||
60126772|NCT00441285|76248716|FG001|COMPLETED|Overall Study||16||
60126773|NCT00441285|76248717|FG002|COMPLETED|Overall Study||41||
60126774|NCT00441285|76248718|FG003|COMPLETED|Overall Study||40||
60126775|NCT00441285|76248719|FG004|COMPLETED|Overall Study||43||
60126776|NCT00441285|76248715|FG000|NOT COMPLETED|Overall Study||0||
60126777|NCT00441285|76248716|FG001|NOT COMPLETED|Overall Study||0||
60126778|NCT00441285|76248717|FG002|NOT COMPLETED|Overall Study||0||
60126779|NCT00441285|76248718|FG003|NOT COMPLETED|Overall Study||0||
60126780|NCT00441285|76248719|FG004|NOT COMPLETED|Overall Study||0||
60126781|NCT00442611|76248733|FG000|STARTED|Overall Study||7||
60126782|NCT00442611|76248734|FG001|STARTED|Overall Study||3||
60126783|NCT00442611|76248733|FG000|COMPLETED|Overall Study||6||
60126784|NCT00442611|76248734|FG001|COMPLETED|Overall Study||3||
60126785|NCT00442611|76248733|FG000|NOT COMPLETED|Overall Study||1||
60126786|NCT00442611|76248734|FG001|NOT COMPLETED|Overall Study||0||
60126787|NCT01511107|76248742|FG000|STARTED|Overall Study|Randomized to the treatment group.|260||
60126788|NCT01511107|76248743|FG001|STARTED|Overall Study|Randomized to the treatment group.|260||
60126789|NCT01511107|76248742|FG000|COMPLETED|Overall Study|Completed - Assessed at a final visit in Sep or at the end of the respiratory season in Apr or May.|238||
60126790|NCT01511107|76248743|FG001|COMPLETED|Overall Study|Completed - Assessed at a final visit in Sep or at the end of the respiratory season in Apr or May.|219||
60126791|NCT01511107|76248742|FG000|NOT COMPLETED|Overall Study||22||
60126792|NCT01511107|76248743|FG001|NOT COMPLETED|Overall Study||41||
60126793|NCT00387621|76248752|FG000|STARTED|First Intervention||29||
60126794|NCT00387621|76248753|FG001|STARTED|First Intervention||29||
60126795|NCT00387621|76248752|FG000|COMPLETED|First Intervention||29||
60126796|NCT00387621|76248753|FG001|COMPLETED|First Intervention||29||
60126797|NCT00387621|76248752|FG000|NOT COMPLETED|First Intervention||0||
60126798|NCT00387621|76248753|FG001|NOT COMPLETED|First Intervention||0||
60126799|NCT00387621|76248752|FG000|STARTED|Washout Period of 2 Weeks||29||
60126800|NCT00387621|76248753|FG001|STARTED|Washout Period of 2 Weeks||29||
60126801|NCT00387621|76248752|FG000|COMPLETED|Washout Period of 2 Weeks||29||
60126802|NCT00387621|76248753|FG001|COMPLETED|Washout Period of 2 Weeks||29||
60126803|NCT00387621|76248752|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0||
60126804|NCT00387621|76248753|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0||
60126805|NCT00387621|76248752|FG000|STARTED|Second Intervention||29||
60126806|NCT00387621|76248753|FG001|STARTED|Second Intervention||29||
60126807|NCT00387621|76248752|FG000|COMPLETED|Second Intervention||29||
60126808|NCT00387621|76248753|FG001|COMPLETED|Second Intervention||29||
60126809|NCT00387621|76248752|FG000|NOT COMPLETED|Second Intervention||0||
60126810|NCT00387621|76248753|FG001|NOT COMPLETED|Second Intervention||0||
60126811|NCT00442689|76248768|FG000|STARTED|Overall Study||21||
60126812|NCT00442689|76248769|FG001|STARTED|Overall Study||24||
60126813|NCT00442689|76248770|FG002|STARTED|Overall Study||22||
60126814|NCT00442689|76248768|FG000|COMPLETED|Overall Study||11||
60126815|NCT00442689|76248769|FG001|COMPLETED|Overall Study||13||
60126816|NCT00442689|76248770|FG002|COMPLETED|Overall Study||13||
60126817|NCT00442689|76248768|FG000|NOT COMPLETED|Overall Study||10||
60126818|NCT00442689|76248769|FG001|NOT COMPLETED|Overall Study||11||
60126819|NCT00442689|76248770|FG002|NOT COMPLETED|Overall Study||9||
60126820|NCT01484977|76248778|FG000|STARTED|Overall Study||120||
60126821|NCT01484977|76248778|FG000|COMPLETED|Overall Study||93||
60126822|NCT01484977|76248778|FG000|NOT COMPLETED|Overall Study||27||
60126823|NCT00442767|76248782|FG000|STARTED|Overall Study||8||
60126824|NCT00442767|76248782|FG000|COMPLETED|Overall Study||8||
60126825|NCT00442767|76248782|FG000|NOT COMPLETED|Overall Study||0||
60126826|NCT00443547|76248792|FG000|STARTED|Overall Study|Enrolled and Treated Per Protocol|89||
60126827|NCT00443547|76248793|FG001|STARTED|Overall Study|Enrolled and Treated Per Protocol|88||
60126828|NCT00443547|76248794|FG002|STARTED|Overall Study|Enrolled and Treated Per Protocol|48||
60126829|NCT00443547|76248795|FG003|STARTED|Overall Study|Enrolled and Treated Per Protocol|6||
60126830|NCT00443547|76248792|FG000|Evaluated at 12 Months|Overall Study||58||
60126831|NCT00443547|76248793|FG001|Evaluated at 12 Months|Overall Study||55||
60126832|NCT00443547|76248794|FG002|Evaluated at 12 Months|Overall Study||37||
60126833|NCT00443547|76248795|FG003|Evaluated at 12 Months|Overall Study||5||
60126834|NCT00443547|76248792|FG000|COMPLETED|Overall Study||44||
60126835|NCT00443547|76248793|FG001|COMPLETED|Overall Study||46||
60126836|NCT00443547|76248794|FG002|COMPLETED|Overall Study||27||
60126837|NCT00443547|76248795|FG003|COMPLETED|Overall Study||4||
60126838|NCT00443547|76248792|FG000|NOT COMPLETED|Overall Study||45||
60126839|NCT00443547|76248793|FG001|NOT COMPLETED|Overall Study||42||
60126840|NCT00443547|76248794|FG002|NOT COMPLETED|Overall Study||21||
60126841|NCT00443547|76248795|FG003|NOT COMPLETED|Overall Study||2||
60126842|NCT00445263|76248807|FG000|STARTED|Overall Study||83||
60126843|NCT00445263|76248808|FG001|STARTED|Overall Study||87||
60126844|NCT00445263|76248807|FG000|COMPLETED|Overall Study||83||
60126845|NCT00445263|76248808|FG001|COMPLETED|Overall Study||86||
60126846|NCT00445263|76248807|FG000|NOT COMPLETED|Overall Study||0||
60126847|NCT00445263|76248808|FG001|NOT COMPLETED|Overall Study||1||
60126848|NCT00389493|76248817|FG000|STARTED|Overall Study||40||
60126849|NCT00389493|76248818|FG001|STARTED|Overall Study||40||
60126850|NCT00389493|76248819|FG002|STARTED|Overall Study||20||
60126851|NCT00389493|76248817|FG000|COMPLETED|Overall Study||37||
60126852|NCT00389493|76248818|FG001|COMPLETED|Overall Study||32||
60126853|NCT00389493|76248819|FG002|COMPLETED|Overall Study||17||
60126854|NCT00389493|76248817|FG000|NOT COMPLETED|Overall Study||3||
60126855|NCT00389493|76248818|FG001|NOT COMPLETED|Overall Study||8||
60126856|NCT00389493|76248819|FG002|NOT COMPLETED|Overall Study||3||
60126857|NCT00389805|76248832|FG000|STARTED|Phase I||15||
60126858|NCT00389805|76248833|FG001|STARTED|Phase I||12||
60126859|NCT00389805|76248832|FG000|COMPLETED|Phase I||15||
60126860|NCT00389805|76248833|FG001|COMPLETED|Phase I||12||
60126861|NCT00389805|76248832|FG000|NOT COMPLETED|Phase I||0||
60126862|NCT00389805|76248833|FG001|NOT COMPLETED|Phase I||0||
60126863|NCT00389805|76248832|FG000|STARTED|Phase II|The Phase II study was not conducted.|0||
60126864|NCT00389805|76248833|FG001|STARTED|Phase II|The Phase II study was not conducted.|0||
60126865|NCT00389805|76248832|FG000|COMPLETED|Phase II||0||
60126866|NCT00389805|76248833|FG001|COMPLETED|Phase II||0||
60126867|NCT00389805|76248832|FG000|NOT COMPLETED|Phase II||0||
60126868|NCT00389805|76248833|FG001|NOT COMPLETED|Phase II||0||
60126869|NCT00456807|76248841|FG000|STARTED|Overall Study||53||
60126870|NCT00456807|76248842|FG001|STARTED|Overall Study||47||
60126871|NCT00456807|76248841|FG000|COMPLETED|Overall Study||52||
60126872|NCT00456807|76248842|FG001|COMPLETED|Overall Study||47||
60126873|NCT00456807|76248841|FG000|NOT COMPLETED|Overall Study||1||
60126874|NCT00456807|76248842|FG001|NOT COMPLETED|Overall Study||0||
60126875|NCT00456885|76248848|FG000|STARTED|First Treatment Period, 16 Weeks||24||
60126876|NCT00456885|76248849|FG001|STARTED|First Treatment Period, 16 Weeks||17||
60126877|NCT00456885|76248848|FG000|COMPLETED|First Treatment Period, 16 Weeks||24||
60126878|NCT00456885|76248849|FG001|COMPLETED|First Treatment Period, 16 Weeks||17||
60126879|NCT00456885|76248848|FG000|NOT COMPLETED|First Treatment Period, 16 Weeks||0||
60126880|NCT00456885|76248849|FG001|NOT COMPLETED|First Treatment Period, 16 Weeks||0||
60126881|NCT00456885|76248848|FG000|STARTED|Washout, 3 Weeks||24||
60126882|NCT00456885|76248849|FG001|STARTED|Washout, 3 Weeks||17||
60126883|NCT00456885|76248848|FG000|COMPLETED|Washout, 3 Weeks||24||
60126884|NCT00456885|76248849|FG001|COMPLETED|Washout, 3 Weeks||17||
60126885|NCT00456885|76248848|FG000|NOT COMPLETED|Washout, 3 Weeks||0||
60126886|NCT00456885|76248849|FG001|NOT COMPLETED|Washout, 3 Weeks||0||
59859017|NCT03162796|75983611|FG002|STARTED|Safety Follow-up: Week 52 - 60||124||
59859018|NCT03162796|75983609|FG000|COMPLETED|Safety Follow-up: Week 52 - 60||106||
59859019|NCT03162796|75983610|FG001|COMPLETED|Safety Follow-up: Week 52 - 60||114||
59859020|NCT03162796|75983611|FG002|COMPLETED|Safety Follow-up: Week 52 - 60||123||
59859021|NCT03162796|75983609|FG000|NOT COMPLETED|Safety Follow-up: Week 52 - 60||1||
59859022|NCT03162796|75983610|FG001|NOT COMPLETED|Safety Follow-up: Week 52 - 60||2||
59859023|NCT03162796|75983611|FG002|NOT COMPLETED|Safety Follow-up: Week 52 - 60||1||
60126887|NCT00456885|76248848|FG000|STARTED|Second Treatment Period, 16 Weeks||24||
60126888|NCT00456885|76248849|FG001|STARTED|Second Treatment Period, 16 Weeks||17||
60126889|NCT00456885|76248848|FG000|COMPLETED|Second Treatment Period, 16 Weeks||23||
60126890|NCT00456885|76248849|FG001|COMPLETED|Second Treatment Period, 16 Weeks||17||
60126891|NCT00456885|76248848|FG000|NOT COMPLETED|Second Treatment Period, 16 Weeks||1||
60126892|NCT00456885|76248849|FG001|NOT COMPLETED|Second Treatment Period, 16 Weeks||0||
60126893|NCT01475825|76248858|FG000|STARTED|Overall Study||104||
60126894|NCT01475825|76248859|FG001|STARTED|Overall Study||51||
60126895|NCT01475825|76248860|FG002|STARTED|Overall Study||102||
60126896|NCT01475825|76248861|FG003|STARTED|Overall Study||52||
60126897|NCT01475825|76248858|FG000|Randomized and Treated|Overall Study||104||
60126898|NCT01475825|76248859|FG001|Randomized and Treated|Overall Study||51||
60126899|NCT01475825|76248860|FG002|Randomized and Treated|Overall Study||102||
60126900|NCT01475825|76248861|FG003|Randomized and Treated|Overall Study||52||
60126901|NCT01475825|76248858|FG000|Completed Blinded Treatment Period|Overall Study||60||
60126902|NCT01475825|76248859|FG001|Completed Blinded Treatment Period|Overall Study||42||
60126903|NCT01475825|76248860|FG002|Completed Blinded Treatment Period|Overall Study||59||
60126904|NCT01475825|76248861|FG003|Completed Blinded Treatment Period|Overall Study||40||
60126905|NCT01475825|76248858|FG000|Entered Open-Label Continuation|Overall Study||45||
60126906|NCT01475825|76248859|FG001|Entered Open-Label Continuation|Overall Study||31||
60126907|NCT01475825|76248860|FG002|Entered Open-Label Continuation|Overall Study||44||
60126908|NCT01475825|76248861|FG003|Entered Open-Label Continuation|Overall Study||29||
60126909|NCT01475825|76248858|FG000|Completed Open-Label Continuation|Overall Study||37||
60126910|NCT01475825|76248859|FG001|Completed Open-Label Continuation|Overall Study||19||
60126911|NCT01475825|76248860|FG002|Completed Open-Label Continuation|Overall Study||38||
60126912|NCT01475825|76248861|FG003|Completed Open-Label Continuation|Overall Study||22||
60126913|NCT01475825|76248858|FG000|COMPLETED|Overall Study||37||
60126914|NCT01475825|76248859|FG001|COMPLETED|Overall Study||19||
60126915|NCT01475825|76248860|FG002|COMPLETED|Overall Study||38||
60126916|NCT01475825|76248861|FG003|COMPLETED|Overall Study||22||
60126917|NCT01475825|76248858|FG000|NOT COMPLETED|Overall Study||67||
60126918|NCT01475825|76248859|FG001|NOT COMPLETED|Overall Study||32||
60126919|NCT01475825|76248860|FG002|NOT COMPLETED|Overall Study||64||
60126920|NCT01475825|76248861|FG003|NOT COMPLETED|Overall Study||30||
60126921|NCT00457197|76248873|FG000|STARTED|Overall Study||45||
60126922|NCT00457197|76248874|FG001|STARTED|Overall Study||45||
60126923|NCT00457197|76248873|FG000|COMPLETED|Overall Study||44||
60126924|NCT00457197|76248874|FG001|COMPLETED|Overall Study||44||
60126925|NCT00457197|76248873|FG000|NOT COMPLETED|Overall Study||1||
60126926|NCT00457197|76248874|FG001|NOT COMPLETED|Overall Study||1||
60126927|NCT01484431|76248883|FG000|STARTED|Period 1: Low Dose||6||
60126928|NCT01484431|76248884|FG001|STARTED|Period 1: Low Dose||7||
60126929|NCT01484431|76248885|FG002|STARTED|Period 1: Low Dose||6||
60126930|NCT01484431|76248883|FG000|Received 2 mg|Period 1: Low Dose||1||
60126931|NCT01484431|76248884|FG001|Received 2 mg|Period 1: Low Dose||0||
60126932|NCT01484431|76248885|FG002|Received 2 mg|Period 1: Low Dose||0||
60126933|NCT01484431|76248883|FG000|Received 4 mg|Period 1: Low Dose||5||
60126934|NCT01484431|76248884|FG001|Received 4 mg|Period 1: Low Dose||0||
60126935|NCT01484431|76248885|FG002|Received 4 mg|Period 1: Low Dose||0||
60126936|NCT01484431|76248883|FG000|Received 5 mg|Period 1: Low Dose||0||
60126937|NCT01484431|76248884|FG001|Received 5 mg|Period 1: Low Dose||7||
60126938|NCT01484431|76248885|FG002|Received 5 mg|Period 1: Low Dose||0||
60126939|NCT01484431|76248883|FG000|Received 10 mg|Period 1: Low Dose||0||
60126940|NCT01484431|76248884|FG001|Received 10 mg|Period 1: Low Dose||0||
60126941|NCT01484431|76248885|FG002|Received 10 mg|Period 1: Low Dose||6||
60126942|NCT01484431|76248883|FG000|COMPLETED|Period 1: Low Dose||6||
60126943|NCT01484431|76248884|FG001|COMPLETED|Period 1: Low Dose||7||
60126944|NCT01484431|76248885|FG002|COMPLETED|Period 1: Low Dose||6||
60126945|NCT01484431|76248883|FG000|NOT COMPLETED|Period 1: Low Dose||0||
60126946|NCT01484431|76248884|FG001|NOT COMPLETED|Period 1: Low Dose||0||
60126947|NCT01484431|76248885|FG002|NOT COMPLETED|Period 1: Low Dose||0||
60126948|NCT01484431|76248883|FG000|STARTED|Period 1: High Dose||6||
60126949|NCT01484431|76248884|FG001|STARTED|Period 1: High Dose||7||
60126950|NCT01484431|76248885|FG002|STARTED|Period 1: High Dose||6||
60126951|NCT01484431|76248883|FG000|Received 8 mg|Period 1: High Dose||1||
60126952|NCT01484431|76248884|FG001|Received 8 mg|Period 1: High Dose||0||
60126953|NCT01484431|76248885|FG002|Received 8 mg|Period 1: High Dose||0||
60126954|NCT01484431|76248883|FG000|Received 10 mg|Period 1: High Dose||1||
60126955|NCT01484431|76248884|FG001|Received 10 mg|Period 1: High Dose||1||
60126956|NCT01484431|76248885|FG002|Received 10 mg|Period 1: High Dose||0||
60126957|NCT01484431|76248883|FG000|Received 15 mg|Period 1: High Dose||1||
59859024|NCT03162328|75983624|FG000|STARTED|Screening Period||84||
59859025|NCT03162328|75983625|FG001|STARTED|Screening Period||0||
59859026|NCT03162328|75983626|FG002|STARTED|Screening Period||0||
60126958|NCT01484431|76248884|FG001|Received 15 mg|Period 1: High Dose||1||
60126959|NCT01484431|76248885|FG002|Received 15 mg|Period 1: High Dose||0||
60126960|NCT01484431|76248883|FG000|Received 20 mg|Period 1: High Dose||3||
60126961|NCT01484431|76248884|FG001|Received 20 mg|Period 1: High Dose||5||
60126962|NCT01484431|76248885|FG002|Received 20 mg|Period 1: High Dose||1||
60126963|NCT01484431|76248883|FG000|Received 40 mg|Period 1: High Dose||0||
60126964|NCT01484431|76248884|FG001|Received 40 mg|Period 1: High Dose||0||
60126965|NCT01484431|76248885|FG002|Received 40 mg|Period 1: High Dose||5||
60126966|NCT01484431|76248883|FG000|COMPLETED|Period 1: High Dose||6||
60126967|NCT01484431|76248884|FG001|COMPLETED|Period 1: High Dose||6||
60126968|NCT01484431|76248885|FG002|COMPLETED|Period 1: High Dose||6||
60126969|NCT01484431|76248883|FG000|NOT COMPLETED|Period 1: High Dose||0||
60126970|NCT01484431|76248884|FG001|NOT COMPLETED|Period 1: High Dose||1||
59859027|NCT03162328|75983624|FG000|COMPLETED|Screening Period||62||
59859028|NCT03162328|75983625|FG001|COMPLETED|Screening Period||0||
60126971|NCT01484431|76248885|FG002|NOT COMPLETED|Period 1: High Dose||0||
60126972|NCT01484431|76248883|FG000|STARTED|Period 2||6||
60126973|NCT01484431|76248884|FG001|STARTED|Period 2||6||
60126974|NCT01484431|76248885|FG002|STARTED|Period 2||6||
60126975|NCT01484431|76248883|FG000|Received 7 mg|Period 2||1||
60126976|NCT01484431|76248884|FG001|Received 7 mg|Period 2||0||
60126977|NCT01484431|76248885|FG002|Received 7 mg|Period 2||0||
60126978|NCT01484431|76248883|FG000|Received 7.5 mg|Period 2||0||
60126979|NCT01484431|76248884|FG001|Received 7.5 mg|Period 2||2||
60126980|NCT01484431|76248885|FG002|Received 7.5 mg|Period 2||0||
60126981|NCT01484431|76248883|FG000|Received 8 mg|Period 2||1||
60126982|NCT01484431|76248884|FG001|Received 8 mg|Period 2||0||
60126983|NCT01484431|76248885|FG002|Received 8 mg|Period 2||0||
60126984|NCT01484431|76248883|FG000|Received 10 mg|Period 2||0||
60126985|NCT01484431|76248884|FG001|Received 10 mg|Period 2||1||
60126986|NCT01484431|76248885|FG002|Received 10 mg|Period 2||0||
60126987|NCT01484431|76248883|FG000|Received 15 mg|Period 2||1||
60126988|NCT01484431|76248884|FG001|Received 15 mg|Period 2||2||
60126989|NCT01484431|76248885|FG002|Received 15 mg|Period 2||1||
60126990|NCT01484431|76248883|FG000|Received 20 mg|Period 2||3||
60126991|NCT01484431|76248884|FG001|Received 20 mg|Period 2||1||
60126992|NCT01484431|76248885|FG002|Received 20 mg|Period 2||4||
60126993|NCT01484431|76248883|FG000|Received 40 mg|Period 2||0||
60126994|NCT01484431|76248884|FG001|Received 40 mg|Period 2||0||
60126995|NCT01484431|76248885|FG002|Received 40 mg|Period 2||1||
60126996|NCT01484431|76248883|FG000|COMPLETED|Period 2||5||
60126997|NCT01484431|76248884|FG001|COMPLETED|Period 2||5||
60126998|NCT01484431|76248885|FG002|COMPLETED|Period 2||4||
60126999|NCT01484431|76248883|FG000|NOT COMPLETED|Period 2||1||
60127000|NCT01484431|76248884|FG001|NOT COMPLETED|Period 2||1||
60127001|NCT01484431|76248885|FG002|NOT COMPLETED|Period 2||2||
60127002|NCT00445887|76248900|FG000|STARTED|Overall Study||33||
60127003|NCT00445887|76248901|FG001|STARTED|Overall Study||31||
60127004|NCT00445887|76248900|FG000|COMPLETED|Overall Study||33||
60127005|NCT00445887|76248901|FG001|COMPLETED|Overall Study||31||
60127006|NCT00445887|76248900|FG000|NOT COMPLETED|Overall Study||0||
60127007|NCT00445887|76248901|FG001|NOT COMPLETED|Overall Study||0||
60127008|NCT02114307|76248919|FG000|STARTED|Overall Study||11||
60127009|NCT02114307|76248920|FG001|STARTED|Overall Study||11||
60127010|NCT02114307|76248919|FG000|COMPLETED|Overall Study||10||
60127011|NCT02114307|76248920|FG001|COMPLETED|Overall Study||11||
60127012|NCT02114307|76248919|FG000|NOT COMPLETED|Overall Study||1||
60127013|NCT02114307|76248920|FG001|NOT COMPLETED|Overall Study||0||
60127014|NCT01473953|76248933|FG000|STARTED|Overall Study||6||
60127015|NCT01473953|76248934|FG001|STARTED|Overall Study||6||
60127016|NCT01473953|76248935|FG002|STARTED|Overall Study||6||
60127017|NCT01473953|76248936|FG003|STARTED|Overall Study||5||
60127018|NCT01473953|76248937|FG004|STARTED|Overall Study||8||
60127019|NCT01473953|76248933|FG000|COMPLETED|Overall Study||5||
60127020|NCT01473953|76248934|FG001|COMPLETED|Overall Study||6||
60127021|NCT01473953|76248935|FG002|COMPLETED|Overall Study||6||
59594778|NCT03000283|75703738|FG000|COMPLETED|Overall Study||7||
59594779|NCT03000283|75703738|FG000|NOT COMPLETED|Overall Study||0||
59594780|NCT03164629|75703744|FG000|STARTED|Overall Study||25||
60127022|NCT01473953|76248936|FG003|COMPLETED|Overall Study||5||
60127023|NCT01473953|76248937|FG004|COMPLETED|Overall Study||8||
60127024|NCT01473953|76248933|FG000|NOT COMPLETED|Overall Study||1||
60127025|NCT01473953|76248934|FG001|NOT COMPLETED|Overall Study||0||
60127026|NCT01473953|76248935|FG002|NOT COMPLETED|Overall Study||0||
60127027|NCT01473953|76248936|FG003|NOT COMPLETED|Overall Study||0||
60127028|NCT01473953|76248937|FG004|NOT COMPLETED|Overall Study||0||
60127029|NCT01510717|76248951|FG000|STARTED|Overall Study||155||
60127030|NCT01510717|76248952|FG001|STARTED|Overall Study||165||
60127031|NCT01510717|76248951|FG000|COMPLETED|Overall Study||153||
60127032|NCT01510717|76248952|FG001|COMPLETED|Overall Study||160||
60127033|NCT01510717|76248951|FG000|NOT COMPLETED|Overall Study||2||
60127034|NCT01510717|76248952|FG001|NOT COMPLETED|Overall Study||5||
60127035|NCT00457977|76248961|FG000|STARTED|Overall Study||90||
60127036|NCT00457977|76248962|FG001|STARTED|Overall Study||91||
60127037|NCT00457977|76248961|FG000|1-Month|Overall Study||88||
60127038|NCT00457977|76248962|FG001|1-Month|Overall Study||87||
60127039|NCT00457977|76248961|FG000|1-Year|Overall Study||69||
60127040|NCT00457977|76248962|FG001|1-Year|Overall Study||76||
60127041|NCT00457977|76248961|FG000|2-Year|Overall Study||62||
60127042|NCT00457977|76248962|FG001|2-Year|Overall Study||66||
60127043|NCT00457977|76248961|FG000|COMPLETED|Overall Study||62||
60127044|NCT00457977|76248962|FG001|COMPLETED|Overall Study||66||
60127045|NCT00457977|76248961|FG000|NOT COMPLETED|Overall Study||28||
60127046|NCT00457977|76248962|FG001|NOT COMPLETED|Overall Study||25||
60127047|NCT01473563|76248968|FG000|STARTED|Overall Study||52||
60127048|NCT01473563|76248968|FG000|Received at Least 1 Dose of Study Drug|Overall Study||52||
60127049|NCT01473563|76248968|FG000|COMPLETED|Overall Study||51||
60127050|NCT01473563|76248968|FG000|NOT COMPLETED|Overall Study||1||
60127051|NCT02115633|76248974|FG000|STARTED|Overall Study||15||
60127052|NCT02115633|76248975|FG001|STARTED|Overall Study||16||
60127053|NCT02115633|76248974|FG000|COMPLETED|Overall Study||15||
60127054|NCT02115633|76248975|FG001|COMPLETED|Overall Study||16||
60127055|NCT02115633|76248974|FG000|NOT COMPLETED|Overall Study||0||
60127056|NCT02115633|76248975|FG001|NOT COMPLETED|Overall Study||0||
60127057|NCT01484275|76248986|FG000|STARTED|Overall Study||43||
60127058|NCT01484275|76248987|FG001|STARTED|Overall Study||42||
60127059|NCT01484275|76248986|FG000|COMPLETED|Overall Study||0||
60127060|NCT01484275|76248987|FG001|COMPLETED|Overall Study||0||
60127061|NCT01484275|76248986|FG000|NOT COMPLETED|Overall Study||43||
60127062|NCT01484275|76248987|FG001|NOT COMPLETED|Overall Study||42||
60127063|NCT01544335|76248993|FG000|STARTED|Overall Study||191||
59594781|NCT03164629|75703745|FG001|STARTED|Overall Study||25||
59594782|NCT03164629|75703744|FG000|COMPLETED|Overall Study||25||
59594783|NCT03164629|75703745|FG001|COMPLETED|Overall Study||25||
59594784|NCT03164629|75703744|FG000|NOT COMPLETED|Overall Study||0||
59594785|NCT03164629|75703745|FG001|NOT COMPLETED|Overall Study||0||
59594786|NCT03168295|75703754|FG000|STARTED|Overall Study||3||
59859029|NCT03162328|75983626|FG002|COMPLETED|Screening Period||0||
59859030|NCT03162328|75983624|FG000|NOT COMPLETED|Screening Period||22||
59859031|NCT03162328|75983625|FG001|NOT COMPLETED|Screening Period||0||
59859032|NCT03162328|75983626|FG002|NOT COMPLETED|Screening Period||0||
59859033|NCT03162328|75983624|FG000|STARTED|Study Period||0||
59594787|NCT03168295|75703755|FG001|STARTED|Overall Study||3||
59594788|NCT03168295|75703756|FG002|STARTED|Overall Study||4||
59594789|NCT03168295|75703757|FG003|STARTED|Overall Study||4||
59859034|NCT03162328|75983625|FG001|STARTED|Study Period||30||
59859035|NCT03162328|75983626|FG002|STARTED|Study Period||32||
59859036|NCT03162328|75983624|FG000|COMPLETED|Study Period||0||
59859037|NCT03162328|75983625|FG001|COMPLETED|Study Period||30||
59859038|NCT03162328|75983626|FG002|COMPLETED|Study Period||31||
59859039|NCT03162328|75983624|FG000|NOT COMPLETED|Study Period||0||
59859040|NCT03162328|75983625|FG001|NOT COMPLETED|Study Period||0||
59859041|NCT03162328|75983626|FG002|NOT COMPLETED|Study Period||1||
59859042|NCT00272987|75983640|FG000|STARTED|Overall Study||29||
59859043|NCT00272987|75983641|FG001|STARTED|Overall Study||14||
59859044|NCT00272987|75983642|FG002|STARTED|Overall Study||20||
59859045|NCT00272987|75983640|FG000|COMPLETED|Overall Study||20||
59859046|NCT00272987|75983641|FG001|COMPLETED|Overall Study||10||
59859047|NCT00272987|75983642|FG002|COMPLETED|Overall Study||9||
59859048|NCT00272987|75983640|FG000|NOT COMPLETED|Overall Study||9||
59859049|NCT00272987|75983641|FG001|NOT COMPLETED|Overall Study||4||
59859050|NCT00272987|75983642|FG002|NOT COMPLETED|Overall Study||11||
59859051|NCT01730950|75983652|FG000|STARTED|Overall Study||90||
59859052|NCT01730950|75983653|FG001|STARTED|Overall Study||92||
59859053|NCT01730950|75983652|FG000|Eligible Population|Overall Study||84||
59859054|NCT01730950|75983653|FG001|Eligible Population|Overall Study||86||
59859055|NCT01730950|75983652|FG000|Adverse Event Population|Overall Study||76|Eligible participants who started protocol treatment|
59859056|NCT01730950|75983653|FG001|Adverse Event Population|Overall Study||83|Eligible participants who started protocol treatment|
59859057|NCT01730950|75983652|FG000|Response Population|Overall Study||78|Eligible participants with response evaluations|
59859058|NCT01730950|75983653|FG001|Response Population|Overall Study||77|Eligible participants with response evaluations|
59859059|NCT01730950|75983652|FG000|6-month Progression-free Analysis|Overall Study||79|Eligible participants with data at 6 months|
59859060|NCT01730950|75983653|FG001|6-month Progression-free Analysis|Overall Study||81|Eligible participants with data at 6 months|
59859061|NCT01730950|75983652|FG000|Delayed Toxicity Population|Overall Study||0|Eligible participants on RT arm who started RT and were alive at least 91 days from the start of RT|
59859062|NCT01730950|75983653|FG001|Delayed Toxicity Population|Overall Study||83|Eligible participants on RT arm who started RT and were alive at least 91 days from the start of RT|
59859063|NCT01730950|75983652|FG000|COMPLETED|Overall Study||84|Subjects contributing data to results are considered to have completed the study.|
59859064|NCT01730950|75983653|FG001|COMPLETED|Overall Study||86|Subjects contributing data to results are considered to have completed the study.|
59859065|NCT01730950|75983652|FG000|NOT COMPLETED|Overall Study||6||
59859066|NCT01730950|75983653|FG001|NOT COMPLETED|Overall Study||6||
59859067|NCT00271505|75983660|FG000|STARTED|Overall Study||43||
59859068|NCT00271505|75983660|FG000|COMPLETED|Overall Study||38||
60127064|NCT01544335|76248993|FG000|COMPLETED|Overall Study||138||
60127065|NCT01544335|76248993|FG000|NOT COMPLETED|Overall Study||53||
60127066|NCT01484197|76248997|FG000|STARTED|Treatment Period 1||9||
60127067|NCT01484197|76248998|FG001|STARTED|Treatment Period 1||9||
59594790|NCT03168295|75703758|FG004|STARTED|Overall Study||20||
59594791|NCT03168295|75703754|FG000|COMPLETED|Overall Study||3||
60127068|NCT01484197|76248999|FG002|STARTED|Treatment Period 1||9||
60127069|NCT01484197|76249000|FG003|STARTED|Treatment Period 1||9||
60127070|NCT01484197|76248997|FG000|COMPLETED|Treatment Period 1||8||
60127071|NCT01484197|76248998|FG001|COMPLETED|Treatment Period 1||9||
60127072|NCT01484197|76248999|FG002|COMPLETED|Treatment Period 1||9||
60127073|NCT01484197|76249000|FG003|COMPLETED|Treatment Period 1||9||
60127074|NCT01484197|76248997|FG000|NOT COMPLETED|Treatment Period 1||1||
60127075|NCT01484197|76248998|FG001|NOT COMPLETED|Treatment Period 1||0||
59594792|NCT03168295|75703755|FG001|COMPLETED|Overall Study||3||
59859069|NCT00271505|75983660|FG000|NOT COMPLETED|Overall Study||5||
59859070|NCT01642186|75983668|FG000|STARTED|Overall Study||9||
59859071|NCT01642186|75983669|FG001|STARTED|Overall Study||9||
59859072|NCT01642186|75983670|FG002|STARTED|Overall Study||10||
59859073|NCT01642186|75983668|FG000|COMPLETED|Overall Study||9||
59594793|NCT03168295|75703756|FG002|COMPLETED|Overall Study||4||
59594794|NCT03168295|75703757|FG003|COMPLETED|Overall Study||4||
59594795|NCT03168295|75703758|FG004|COMPLETED|Overall Study||20||
59859074|NCT01642186|75983669|FG001|COMPLETED|Overall Study||7||
59859075|NCT01642186|75983670|FG002|COMPLETED|Overall Study||7||
59859076|NCT01642186|75983668|FG000|NOT COMPLETED|Overall Study||0||
59859077|NCT01642186|75983669|FG001|NOT COMPLETED|Overall Study||2||
59859078|NCT01642186|75983670|FG002|NOT COMPLETED|Overall Study||3||
59859079|NCT00423514|75983680|FG000|STARTED|Overall Study||31||
59859080|NCT00423514|75983681|FG001|STARTED|Overall Study||7||
59859081|NCT00423514|75983680|FG000|COMPLETED|Overall Study||30||
59859082|NCT00423514|75983681|FG001|COMPLETED|Overall Study||7||
59859083|NCT00423514|75983680|FG000|NOT COMPLETED|Overall Study||1||
59859084|NCT00423514|75983681|FG001|NOT COMPLETED|Overall Study||0||
59859085|NCT00289991|75983689|FG000|STARTED|Overall Study||234||
59859086|NCT00289991|75983690|FG001|STARTED|Overall Study||255||
59859087|NCT00289991|75983689|FG000|COMPLETED|Overall Study||176||
59859088|NCT00289991|75983690|FG001|COMPLETED|Overall Study||175||
59859089|NCT00289991|75983689|FG000|NOT COMPLETED|Overall Study||58||
59859090|NCT00289991|75983690|FG001|NOT COMPLETED|Overall Study||80||
59859091|NCT00289913|75983701|FG000|STARTED|Visit 1 (Stage I and Stage II)||155||
59859092|NCT00289913|75983702|FG001|STARTED|Visit 1 (Stage I and Stage II)||151||
59859093|NCT00289913|75983703|FG002|STARTED|Visit 1 (Stage I and Stage II)||159||
59859094|NCT00289913|75983704|FG003|STARTED|Visit 1 (Stage I and Stage II)||152||
59859095|NCT00289913|75983705|FG004|STARTED|Visit 1 (Stage I and Stage II)|Participants were enrolled during Stage II.|654||
59859096|NCT00289913|75983701|FG000|COMPLETED|Visit 1 (Stage I and Stage II)||146||
59859097|NCT00289913|75983702|FG001|COMPLETED|Visit 1 (Stage I and Stage II)||135||
59859098|NCT00289913|75983703|FG002|COMPLETED|Visit 1 (Stage I and Stage II)||150||
59859099|NCT00289913|75983704|FG003|COMPLETED|Visit 1 (Stage I and Stage II)||141||
59859100|NCT00289913|75983705|FG004|COMPLETED|Visit 1 (Stage I and Stage II)||645||
59859101|NCT00289913|75983701|FG000|NOT COMPLETED|Visit 1 (Stage I and Stage II)||9||
59859102|NCT00289913|75983702|FG001|NOT COMPLETED|Visit 1 (Stage I and Stage II)||16||
59859103|NCT00289913|75983703|FG002|NOT COMPLETED|Visit 1 (Stage I and Stage II)||9||
59859104|NCT00289913|75983704|FG003|NOT COMPLETED|Visit 1 (Stage I and Stage II)||11||
59859105|NCT00289913|75983705|FG004|NOT COMPLETED|Visit 1 (Stage I and Stage II)||9||
59859106|NCT00289913|75983701|FG000|STARTED|Visit 2 (Stage I and Stage II)||146||
59859107|NCT00289913|75983702|FG001|STARTED|Visit 2 (Stage I and Stage II)||135||
59859108|NCT00289913|75983703|FG002|STARTED|Visit 2 (Stage I and Stage II)||150||
59859109|NCT00289913|75983704|FG003|STARTED|Visit 2 (Stage I and Stage II)||141||
59859110|NCT00289913|75983705|FG004|STARTED|Visit 2 (Stage I and Stage II)|No vaccine administered at Visit 2 (Stage II), therefore there was no safety F/U period.|645||
59859111|NCT00289913|75983701|FG000|COMPLETED|Visit 2 (Stage I and Stage II)||131||
59859112|NCT00289913|75983702|FG001|COMPLETED|Visit 2 (Stage I and Stage II)||114||
59859113|NCT00289913|75983703|FG002|COMPLETED|Visit 2 (Stage I and Stage II)||140||
59859114|NCT00289913|75983704|FG003|COMPLETED|Visit 2 (Stage I and Stage II)||135||
59859115|NCT00289913|75983705|FG004|COMPLETED|Visit 2 (Stage I and Stage II)||605||
59859116|NCT00289913|75983701|FG000|NOT COMPLETED|Visit 2 (Stage I and Stage II)||15||
59859117|NCT00289913|75983702|FG001|NOT COMPLETED|Visit 2 (Stage I and Stage II)||21||
59859118|NCT00289913|75983703|FG002|NOT COMPLETED|Visit 2 (Stage I and Stage II)||10||
59859119|NCT00289913|75983704|FG003|NOT COMPLETED|Visit 2 (Stage I and Stage II)||6||
59859120|NCT00289913|75983705|FG004|NOT COMPLETED|Visit 2 (Stage I and Stage II)||40||
59859121|NCT00289913|75983701|FG000|STARTED|Visit 3 (Stage I and Stage II)||131||
59859122|NCT00289913|75983702|FG001|STARTED|Visit 3 (Stage I and Stage II)||114||
59859123|NCT00289913|75983703|FG002|STARTED|Visit 3 (Stage I and Stage II)||140||
59859124|NCT00289913|75983704|FG003|STARTED|Visit 3 (Stage I and Stage II)||135||
59859125|NCT00289913|75983705|FG004|STARTED|Visit 3 (Stage I and Stage II)||605||
59859126|NCT00289913|75983701|FG000|COMPLETED|Visit 3 (Stage I and Stage II)||122||
59859127|NCT00289913|75983702|FG001|COMPLETED|Visit 3 (Stage I and Stage II)||106||
59859128|NCT00289913|75983703|FG002|COMPLETED|Visit 3 (Stage I and Stage II)||138||
59859129|NCT00289913|75983704|FG003|COMPLETED|Visit 3 (Stage I and Stage II)||131||
59859130|NCT00289913|75983705|FG004|COMPLETED|Visit 3 (Stage I and Stage II)||597||
59859131|NCT00289913|75983701|FG000|NOT COMPLETED|Visit 3 (Stage I and Stage II)||9||
59859132|NCT00289913|75983702|FG001|NOT COMPLETED|Visit 3 (Stage I and Stage II)||8||
59859133|NCT00289913|75983703|FG002|NOT COMPLETED|Visit 3 (Stage I and Stage II)||2||
59859134|NCT00289913|75983704|FG003|NOT COMPLETED|Visit 3 (Stage I and Stage II)||4||
59859135|NCT00289913|75983705|FG004|NOT COMPLETED|Visit 3 (Stage I and Stage II)||8||
59859136|NCT00289913|75983701|FG000|STARTED|Visit 4 (Stage I and Stage II)||122||
59859137|NCT00289913|75983702|FG001|STARTED|Visit 4 (Stage I and Stage II)||106||
59859138|NCT00289913|75983703|FG002|STARTED|Visit 4 (Stage I and Stage II)||138||
59859139|NCT00289913|75983704|FG003|STARTED|Visit 4 (Stage I and Stage II)||131||
59859140|NCT00289913|75983705|FG004|STARTED|Visit 4 (Stage I and Stage II)||597||
59859141|NCT00289913|75983701|FG000|COMPLETED|Visit 4 (Stage I and Stage II)||122||
59859142|NCT00289913|75983702|FG001|COMPLETED|Visit 4 (Stage I and Stage II)||106||
59859143|NCT00289913|75983703|FG002|COMPLETED|Visit 4 (Stage I and Stage II)||138||
59859144|NCT00289913|75983704|FG003|COMPLETED|Visit 4 (Stage I and Stage II)||131||
59859145|NCT00289913|75983705|FG004|COMPLETED|Visit 4 (Stage I and Stage II)||597||
59859146|NCT00289913|75983701|FG000|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0||
59859147|NCT00289913|75983702|FG001|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0||
59859148|NCT00289913|75983703|FG002|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0||
59859149|NCT00289913|75983704|FG003|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0||
59859150|NCT00289913|75983705|FG004|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0||
59859151|NCT00289289|75983723|FG000|STARTED|Overall Study||132||
59859152|NCT00289289|75983724|FG001|STARTED|Overall Study||124||
59859153|NCT00289289|75983725|FG002|STARTED|Overall Study||144||
59859154|NCT00289289|75983723|FG000|COMPLETED|Overall Study||113||
59859155|NCT00289289|75983724|FG001|COMPLETED|Overall Study||114||
59859156|NCT00289289|75983725|FG002|COMPLETED|Overall Study||95||
59859157|NCT00289289|75983723|FG000|NOT COMPLETED|Overall Study||19||
59859158|NCT00289289|75983724|FG001|NOT COMPLETED|Overall Study||10||
59859159|NCT00289289|75983725|FG002|NOT COMPLETED|Overall Study||49||
59859160|NCT00270257|75983734|FG000|STARTED|Overall Study||623||
59859161|NCT00270257|75983735|FG001|STARTED|Overall Study|1 excluded from analysis (enrollment date exceeded eligibility window by 13 days)|628||
59859162|NCT00270257|75983734|FG000|Week 8|Overall Study||510||
59859163|NCT00270257|75983735|FG001|Week 8|Overall Study||443||
59859164|NCT00270257|75983734|FG000|Week 26|Overall Study||460||
59859165|NCT00270257|75983735|FG001|Week 26|Overall Study||440||
59859166|NCT00270257|75983734|FG000|Week 52|Overall Study||362||
59859167|NCT00270257|75983735|FG001|Week 52|Overall Study||340||
59859168|NCT00270257|75983734|FG000|Week 78|Overall Study||283||
59859169|NCT00270257|75983735|FG001|Week 78|Overall Study||285||
59859170|NCT00270257|75983734|FG000|Visit 104|Overall Study||211||
59859171|NCT00270257|75983735|FG001|Visit 104|Overall Study||204||
59859172|NCT00270257|75983734|FG000|COMPLETED|Overall Study||211||
59859173|NCT00270257|75983735|FG001|COMPLETED|Overall Study||204||
59859174|NCT00270257|75983734|FG000|NOT COMPLETED|Overall Study||412||
59859175|NCT00270257|75983735|FG001|NOT COMPLETED|Overall Study||424||
59859176|NCT00269633|75983745|FG000|STARTED|Overall Study||4||
59859177|NCT00269633|75983746|FG001|STARTED|Overall Study||5||
59859178|NCT00269633|75983745|FG000|COMPLETED|Overall Study||3||
59859179|NCT00269633|75983746|FG001|COMPLETED|Overall Study||5||
59859180|NCT00269633|75983745|FG000|NOT COMPLETED|Overall Study||1||
59859181|NCT00269633|75983746|FG001|NOT COMPLETED|Overall Study||0||
59859182|NCT00269477|75983756|FG000|STARTED|Overall Study||9||
59859183|NCT00269477|75983757|FG001|STARTED|Overall Study||18||
59859184|NCT00269477|75983758|FG002|STARTED|Overall Study||58||
59859185|NCT00269477|75983759|FG003|STARTED|Overall Study||60||
59859186|NCT00269477|75983756|FG000|COMPLETED|Overall Study||4||
59859187|NCT00269477|75983757|FG001|COMPLETED|Overall Study||12||
59859188|NCT00269477|75983758|FG002|COMPLETED|Overall Study||57||
59859189|NCT00269477|75983759|FG003|COMPLETED|Overall Study||60||
59859190|NCT00269477|75983756|FG000|NOT COMPLETED|Overall Study||5||
59859191|NCT00269477|75983757|FG001|NOT COMPLETED|Overall Study||6||
59859192|NCT00269477|75983758|FG002|NOT COMPLETED|Overall Study||1||
59859193|NCT00269477|75983759|FG003|NOT COMPLETED|Overall Study||0||
59859194|NCT00269399|75983771|FG000|STARTED|Overall Study||119||
59859195|NCT00269399|75983772|FG001|STARTED|Overall Study||118||
59859196|NCT00269399|75983771|FG000|COMPLETED|Overall Study||78||
59859197|NCT00269399|75983772|FG001|COMPLETED|Overall Study||91||
59859198|NCT00269399|75983771|FG000|NOT COMPLETED|Overall Study||41||
59859199|NCT00269399|75983772|FG001|NOT COMPLETED|Overall Study||27||
59859200|NCT00269087|75983778|FG000|STARTED|Overall Study||122||
59859201|NCT00269087|75983778|FG000|COMPLETED|Overall Study||88||
59859202|NCT00269087|75983778|FG000|NOT COMPLETED|Overall Study||34||
59859203|NCT00289133|75983784|FG000|STARTED|Overall Study||461||
59859204|NCT00289133|75983785|FG001|STARTED|Overall Study||477||
59859205|NCT00289133|75983784|FG000|COMPLETED|Overall Study||189||
59859206|NCT00289133|75983785|FG001|COMPLETED|Overall Study||179||
59859207|NCT00289133|75983784|FG000|NOT COMPLETED|Overall Study||272||
59859208|NCT00289133|75983785|FG001|NOT COMPLETED|Overall Study||298||
59859209|NCT00288587|75983797|FG000|STARTED|Overall Study||19||
59859210|NCT00288587|75983798|FG001|STARTED|Overall Study||17||
59859211|NCT00288587|75983797|FG000|COMPLETED|Overall Study||14||
59859212|NCT00288587|75983798|FG001|COMPLETED|Overall Study||7||
59859213|NCT00288587|75983797|FG000|NOT COMPLETED|Overall Study||5||
59859214|NCT00288587|75983798|FG001|NOT COMPLETED|Overall Study||10||
59859215|NCT00268463|75983806|FG000|STARTED|Overall Study||10||
59859216|NCT00268463|75983807|FG001|STARTED|Overall Study||12||
59859217|NCT00268463|75983806|FG000|COMPLETED|Overall Study||0||
59859218|NCT00268463|75983807|FG001|COMPLETED|Overall Study||0||
59859219|NCT00268463|75983806|FG000|NOT COMPLETED|Overall Study||10||
59859220|NCT00268463|75983807|FG001|NOT COMPLETED|Overall Study||12||
59859221|NCT00288509|75983813|FG000|STARTED|Treatment Cycle 1||108||
59859222|NCT00288509|75983813|FG000|COMPLETED|Treatment Cycle 1||102||
59859223|NCT00288509|75983813|FG000|NOT COMPLETED|Treatment Cycle 1||6||
59859224|NCT00288509|75983813|FG000|STARTED|Treatment Cycle 2|2 subjects completed Cycle 1 but withdrew before Cycle 2 due to insufficient clinical response|100||
59859225|NCT00288509|75983813|FG000|COMPLETED|Treatment Cycle 2||97||
59859226|NCT00288509|75983813|FG000|NOT COMPLETED|Treatment Cycle 2||3||
59859227|NCT00288509|75983813|FG000|STARTED|Treatment Cycle 3|One subject completed Cycle 2 but withdrew before Cycle 3 due to insufficient clinical response|96||
59859228|NCT00288509|75983813|FG000|COMPLETED|Treatment Cycle 3||91||
59859229|NCT00288509|75983813|FG000|NOT COMPLETED|Treatment Cycle 3||5||
59996936|NCT01597245|76112820|FG005|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0||
59859230|NCT00288509|75983813|FG000|STARTED|Treatment Cycle 4|3 subjects completed Cycle 3 but withdrew before Cycle 4, treatment stopped according to protocol|88||
59859231|NCT00288509|75983813|FG000|COMPLETED|Treatment Cycle 4||80||
59859232|NCT00288509|75983813|FG000|NOT COMPLETED|Treatment Cycle 4||8||
59859233|NCT00266825|75983819|FG000|STARTED|Enrolled and Allocated Intervention||172||
59859234|NCT00266825|75983820|FG001|STARTED|Enrolled and Allocated Intervention||178||
59859235|NCT00266825|75983819|FG000|COMPLETED|Enrolled and Allocated Intervention||172||
59859236|NCT00266825|75983820|FG001|COMPLETED|Enrolled and Allocated Intervention||178||
59859237|NCT00266825|75983819|FG000|NOT COMPLETED|Enrolled and Allocated Intervention||0||
59859238|NCT00266825|75983820|FG001|NOT COMPLETED|Enrolled and Allocated Intervention||0||
59859239|NCT00266825|75983819|FG000|STARTED|Completed Follow-Up||172||
59859240|NCT00266825|75983820|FG001|STARTED|Completed Follow-Up||178||
59859241|NCT00266825|75983819|FG000|COMPLETED|Completed Follow-Up||147||
59859242|NCT00266825|75983820|FG001|COMPLETED|Completed Follow-Up||154||
59859243|NCT00266825|75983819|FG000|NOT COMPLETED|Completed Follow-Up||25||
59859244|NCT00266825|75983820|FG001|NOT COMPLETED|Completed Follow-Up||24||
59859245|NCT00265889|75983828|FG000|STARTED|Overall Study||42||
59859246|NCT00265889|75983828|FG000|Cycle 1: 1st Regimen/Transplant|Overall Study||37||
59859247|NCT00265889|75983828|FG000|Cycle 2: 2nd Regimen/Transplant|Overall Study||37||
59859248|NCT00265889|75983828|FG000|COMPLETED|Overall Study||37||
59859249|NCT00265889|75983828|FG000|NOT COMPLETED|Overall Study||5||
59859250|NCT03209362|75983834|FG000|STARTED|Overall Study||39||
59859251|NCT03209362|75983835|FG001|STARTED|Overall Study||41||
59859252|NCT03209362|75983834|FG000|COMPLETED|Overall Study||37||
59859253|NCT03209362|75983835|FG001|COMPLETED|Overall Study||38||
59859254|NCT03209362|75983834|FG000|NOT COMPLETED|Overall Study||2||
59859255|NCT03209362|75983835|FG001|NOT COMPLETED|Overall Study||3||
59859256|NCT02932462|75983843|FG000|STARTED|Overall Study||184||
59859257|NCT02932462|75983844|FG001|STARTED|Overall Study||189||
59859258|NCT02932462|75983843|FG000|COMPLETED|Overall Study||177||
59859259|NCT02932462|75983844|FG001|COMPLETED|Overall Study||176||
59859260|NCT02932462|75983843|FG000|NOT COMPLETED|Overall Study||7||
59859261|NCT02932462|75983844|FG001|NOT COMPLETED|Overall Study||13||
59859262|NCT03206788|75983852|FG000|STARTED|Overall Study||2||
59859263|NCT03206788|75983853|FG001|STARTED|Overall Study||5||
59859264|NCT03206788|75983852|FG000|COMPLETED|Overall Study||2||
59859265|NCT03206788|75983853|FG001|COMPLETED|Overall Study||2||
59859266|NCT03206788|75983852|FG000|NOT COMPLETED|Overall Study||0||
59859267|NCT03206788|75983853|FG001|NOT COMPLETED|Overall Study||3||
59859268|NCT03205150|75983862|FG000|STARTED|Overall Study||43|Participants randomized|
59859269|NCT03205150|75983863|FG001|STARTED|Overall Study||43|Participants randomized|
59859270|NCT03205150|75983864|FG002|STARTED|Overall Study||21|Participants randomized|
59859271|NCT03205150|75983862|FG000|Safety Analysis Set|Overall Study||43||
59859272|NCT03205150|75983863|FG001|Safety Analysis Set|Overall Study||43||
59859273|NCT03205150|75983864|FG002|Safety Analysis Set|Overall Study||21||
59859274|NCT03205150|75983862|FG000|Pharmacokinetics (PK) Analysis Set|Overall Study|all patients with valid PK measurements|42||
59859275|NCT03205150|75983863|FG001|Pharmacokinetics (PK) Analysis Set|Overall Study|all patients with valid PK measurements|36||
59859276|NCT03205150|75983864|FG002|Pharmacokinetics (PK) Analysis Set|Overall Study|Placebo patients were excluded from the PK analyses|0||
59859277|NCT03205150|75983862|FG000|Pharmacodynamics (PD) Analysis Set|Overall Study|all patients with available PD data and no protocol deviations|43||
59859278|NCT03205150|75983863|FG001|Pharmacodynamics (PD) Analysis Set|Overall Study|all patients with available PD data and no protocol deviations|41||
59859279|NCT03205150|75983864|FG002|Pharmacodynamics (PD) Analysis Set|Overall Study|all patients with available PD data and no protocol deviations|21||
59859280|NCT03205150|75983862|FG000|COMPLETED|Overall Study||41||
59859281|NCT03205150|75983863|FG001|COMPLETED|Overall Study||36||
59859282|NCT03205150|75983864|FG002|COMPLETED|Overall Study||19||
59859283|NCT03205150|75983862|FG000|NOT COMPLETED|Overall Study||2||
59859284|NCT03205150|75983863|FG001|NOT COMPLETED|Overall Study||7||
59859285|NCT03205150|75983864|FG002|NOT COMPLETED|Overall Study||2||
59859286|NCT02932306|75983875|FG000|STARTED|Overall Study||406||
59859287|NCT02932306|75983876|FG001|STARTED|Overall Study||414||
59859288|NCT02932306|75983875|FG000|Intent-to-treat (ITT) Population|Overall Study||406|All randomized participants who received study drug.|
59859289|NCT02932306|75983876|FG001|Intent-to-treat (ITT) Population|Overall Study||414|All randomized participants who received study drug.|
59859290|NCT02932306|75983875|FG000|Safety Population|Overall Study||378|All randomized participants with ≥1 confirmed dose of study drug and ≥1 post baseline evaluation.|
59859291|NCT02932306|75983876|FG001|Safety Population|Overall Study||385|All randomized participants with ≥1 confirmed dose of study drug and ≥1 post baseline evaluation.|
59859292|NCT02932306|75983875|FG000|COMPLETED|Overall Study||338||
59859293|NCT02932306|75983876|FG001|COMPLETED|Overall Study||337||
59859294|NCT02932306|75983875|FG000|NOT COMPLETED|Overall Study||68||
59859295|NCT02932306|75983876|FG001|NOT COMPLETED|Overall Study||77||
59859296|NCT02932228|75983884|FG000|STARTED|Overall Study||150||
59859297|NCT02932228|75983885|FG001|STARTED|Overall Study||433||
59859298|NCT02932228|75983884|FG000|COMPLETED|Overall Study||140||
59859299|NCT02932228|75983885|FG001|COMPLETED|Overall Study||405||
59859300|NCT02932228|75983884|FG000|NOT COMPLETED|Overall Study||10||
59859301|NCT02932228|75983885|FG001|NOT COMPLETED|Overall Study||28||
59859302|NCT02931838|75983899|FG000|STARTED|Overall Study||45||
59859303|NCT02931838|75983900|FG001|STARTED|Overall Study||44||
59859304|NCT02931838|75983901|FG002|STARTED|Overall Study||44||
59859305|NCT02931838|75983902|FG003|STARTED|Overall Study||45||
59859306|NCT02931838|75983903|FG004|STARTED|Overall Study||45||
59859307|NCT02931838|75983904|FG005|STARTED|Overall Study||44||
59859308|NCT02931838|75983899|FG000|COMPLETED|Overall Study||31||
59859309|NCT02931838|75983900|FG001|COMPLETED|Overall Study||34||
59859310|NCT02931838|75983901|FG002|COMPLETED|Overall Study||36||
59859311|NCT02931838|75983902|FG003|COMPLETED|Overall Study||42||
59859312|NCT02931838|75983903|FG004|COMPLETED|Overall Study||39||
59859313|NCT02931838|75983904|FG005|COMPLETED|Overall Study||42||
59859314|NCT02931838|75983899|FG000|NOT COMPLETED|Overall Study||14||
59859315|NCT02931838|75983900|FG001|NOT COMPLETED|Overall Study||10||
59859316|NCT02931838|75983901|FG002|NOT COMPLETED|Overall Study||8||
59859317|NCT02931838|75983902|FG003|NOT COMPLETED|Overall Study||3||
59859318|NCT02931838|75983903|FG004|NOT COMPLETED|Overall Study||6||
59859319|NCT02931838|75983904|FG005|NOT COMPLETED|Overall Study||2||
59859320|NCT03201562|75983926|FG000|STARTED|Overall Study||18||
59859321|NCT03201562|75983927|FG001|STARTED|Overall Study||20||
59859322|NCT03201562|75983928|FG002|STARTED|Overall Study||20||
59859323|NCT03201562|75983926|FG000|COMPLETED|Overall Study||18||
59859324|NCT03201562|75983927|FG001|COMPLETED|Overall Study||19||
59859325|NCT03201562|75983928|FG002|COMPLETED|Overall Study||16||
59859326|NCT03201562|75983926|FG000|NOT COMPLETED|Overall Study||0||
59859327|NCT03201562|75983927|FG001|NOT COMPLETED|Overall Study||1||
59859328|NCT03201562|75983928|FG002|NOT COMPLETED|Overall Study||4||
59859329|NCT03200860|75983938|FG000|STARTED|Overall Study||41||
59859330|NCT03200860|75983939|FG001|STARTED|Overall Study||39||
59859331|NCT03200860|75983938|FG000|COMPLETED|Overall Study||40||
59859332|NCT03200860|75983939|FG001|COMPLETED|Overall Study||39||
59859333|NCT03200860|75983938|FG000|NOT COMPLETED|Overall Study||1||
59859334|NCT03200860|75983939|FG001|NOT COMPLETED|Overall Study||0||
59859335|NCT03198754|75983947|FG000|STARTED|Overall Study||38||
59859336|NCT03198754|75983948|FG001|STARTED|Overall Study||35||
59859337|NCT03198754|75983947|FG000|COMPLETED|Overall Study||27||
59859338|NCT03198754|75983948|FG001|COMPLETED|Overall Study||27||
59859339|NCT03198754|75983947|FG000|NOT COMPLETED|Overall Study||11||
59859340|NCT03198754|75983948|FG001|NOT COMPLETED|Overall Study||8||
59859341|NCT03198520|75983954|FG000|STARTED|Overall Study||46||
59859342|NCT03198520|75983954|FG000|COMPLETED|Overall Study||40||
59859343|NCT03198520|75983954|FG000|NOT COMPLETED|Overall Study||6||
59859344|NCT03194464|75983966|FG000|STARTED|Overall Study||15||
59859345|NCT03194464|75983966|FG000|COMPLETED|Overall Study||13||
59859346|NCT03194464|75983966|FG000|NOT COMPLETED|Overall Study||2||
59859347|NCT03192904|75983974|FG000|STARTED|Overall Study||35||
59859348|NCT03192904|75983975|FG001|STARTED|Overall Study||35||
59859349|NCT03192904|75983974|FG000|COMPLETED|Overall Study||32||
59859350|NCT03192904|75983975|FG001|COMPLETED|Overall Study||33||
59859351|NCT03192904|75983974|FG000|NOT COMPLETED|Overall Study||3||
59859352|NCT03192904|75983975|FG001|NOT COMPLETED|Overall Study||2||
59859353|NCT03188536|75983981|FG000|STARTED|Overall Study||282||
59859354|NCT03188536|75983981|FG000|COMPLETED|Overall Study||276||
59859355|NCT03188536|75983981|FG000|NOT COMPLETED|Overall Study||6||
59859356|NCT03187756|75983985|FG000|STARTED|Overall Study||6||
59859357|NCT03187756|75983985|FG000|COMPLETED|Overall Study||2||
59859358|NCT03187756|75983985|FG000|NOT COMPLETED|Overall Study||4||
59859359|NCT03187132|75983991|FG000|STARTED|Inpatient Trauma Only||12||
59859360|NCT03187132|75983992|FG001|STARTED|Inpatient Trauma Only||12||
59859361|NCT03187132|75983991|FG000|COMPLETED|Inpatient Trauma Only||8||
59859362|NCT03187132|75983992|FG001|COMPLETED|Inpatient Trauma Only||0||
59859363|NCT03187132|75983991|FG000|NOT COMPLETED|Inpatient Trauma Only||4||
59859364|NCT03187132|75983992|FG001|NOT COMPLETED|Inpatient Trauma Only||12||
59859365|NCT03187132|75983991|FG000|STARTED|Inpatient Trauma+Pain Clinic, no Opioid||4||
59859366|NCT03187132|75983992|FG001|STARTED|Inpatient Trauma+Pain Clinic, no Opioid||5||
59859367|NCT03187132|75983991|FG000|COMPLETED|Inpatient Trauma+Pain Clinic, no Opioid||3||
59859368|NCT03187132|75983992|FG001|COMPLETED|Inpatient Trauma+Pain Clinic, no Opioid||0||
59859369|NCT03187132|75983991|FG000|NOT COMPLETED|Inpatient Trauma+Pain Clinic, no Opioid||1||
59859370|NCT03187132|75983992|FG001|NOT COMPLETED|Inpatient Trauma+Pain Clinic, no Opioid||5||
59859371|NCT03187132|75983991|FG000|STARTED|Inpatient Trauma+Pain Clinic||11||
59859372|NCT03187132|75983992|FG001|STARTED|Inpatient Trauma+Pain Clinic||7||
59859373|NCT03187132|75983991|FG000|COMPLETED|Inpatient Trauma+Pain Clinic||8||
59859374|NCT03187132|75983992|FG001|COMPLETED|Inpatient Trauma+Pain Clinic||0||
59859375|NCT03187132|75983991|FG000|NOT COMPLETED|Inpatient Trauma+Pain Clinic||3||
59859376|NCT03187132|75983992|FG001|NOT COMPLETED|Inpatient Trauma+Pain Clinic||7||
59859377|NCT03187132|75983991|FG000|STARTED|Pain Clinic Only, Fully Remote||76||
59859378|NCT03187132|75983992|FG001|STARTED|Pain Clinic Only, Fully Remote||118||
59859379|NCT03187132|75983991|FG000|COMPLETED|Pain Clinic Only, Fully Remote||43||
59859380|NCT03187132|75983992|FG001|COMPLETED|Pain Clinic Only, Fully Remote||64||
59859381|NCT03187132|75983991|FG000|NOT COMPLETED|Pain Clinic Only, Fully Remote||33||
59859382|NCT03187132|75983992|FG001|NOT COMPLETED|Pain Clinic Only, Fully Remote||54||
59859383|NCT03184558|75983998|FG000|STARTED|Overall Study||29||
59859384|NCT03184558|75983998|FG000|COMPLETED|Overall Study||0||
59859385|NCT03184558|75983998|FG000|NOT COMPLETED|Overall Study||29||
59859386|NCT03183778|75984002|FG000|STARTED|Overall Study||3||
59859387|NCT03183778|75984002|FG000|COMPLETED|Overall Study||2||
59859388|NCT03183778|75984002|FG000|NOT COMPLETED|Overall Study||1||
59859389|NCT03182686|75984008|FG000|STARTED|Overall Study||144||
59859390|NCT03182686|75984009|FG001|STARTED|Overall Study||24||
59859391|NCT03182686|75984008|FG000|COMPLETED|Overall Study||137||
59859392|NCT03182686|75984009|FG001|COMPLETED|Overall Study||24||
59859393|NCT03182686|75984008|FG000|NOT COMPLETED|Overall Study||7||
59859394|NCT03182686|75984009|FG001|NOT COMPLETED|Overall Study||0||
59859395|NCT03181594|75984015|FG000|STARTED|Initial Study Protocol (12-month FU)||100||
59859396|NCT03181594|75984015|FG000|30-day Follow-up|Initial Study Protocol (12-month FU)||99|1 participant missed the 30-day visit but continued in later follow-up visits.|
59859397|NCT03181594|75984015|FG000|90-day Follow-up|Initial Study Protocol (12-month FU)||98||
59859398|NCT03181594|75984015|FG000|6-month Follow-up|Initial Study Protocol (12-month FU)||98||
59859399|NCT03181594|75984015|FG000|9-month Follow-up|Initial Study Protocol (12-month FU)||95||
59859400|NCT03181594|75984015|FG000|12-month Follow-up|Initial Study Protocol (12-month FU)||91||
59859401|NCT03181594|75984015|FG000|COMPLETED|Initial Study Protocol (12-month FU)||91||
59859402|NCT03181594|75984015|FG000|NOT COMPLETED|Initial Study Protocol (12-month FU)||9||
59859403|NCT03181594|75984015|FG000|STARTED|Long-term Extension (15-24 Month FU)||62||
59859404|NCT03181594|75984015|FG000|15-month Follow-up|Long-term Extension (15-24 Month FU)||56|Of the 91 participants who completed the 12-month visit, 28 did not consent to the long-term follow-up and 1 participant died before the long-term follow-up started resulting in 62 participants being eligible for long-term follow-up . 6/62 participants missed the 15-month missed visit.|
59859405|NCT03181594|75984015|FG000|18-month Follow-up|Long-term Extension (15-24 Month FU)||57|5/62 participants missed the 18-month visit.|
59859406|NCT03181594|75984015|FG000|21-month Follow-up|Long-term Extension (15-24 Month FU)||55|6 participants missed the 21-month visit.|
59859407|NCT03181594|75984015|FG000|24-month Follow-up|Long-term Extension (15-24 Month FU)||57||
59859408|NCT03181594|75984015|FG000|COMPLETED|Long-term Extension (15-24 Month FU)||57||
59859409|NCT03181594|75984015|FG000|NOT COMPLETED|Long-term Extension (15-24 Month FU)||5||
59859410|NCT03180736|75984021|FG000|STARTED|Overall Study||151||
59859411|NCT03180736|75984022|FG001|STARTED|Overall Study||153||
59859412|NCT03180736|75984021|FG000|Treated|Overall Study||149||
59859413|NCT03180736|75984022|FG001|Treated|Overall Study||150||
59859414|NCT03180736|75984021|FG000|COMPLETED|Overall Study||60||
59859415|NCT03180736|75984022|FG001|COMPLETED|Overall Study||33||
59859416|NCT03180736|75984021|FG000|NOT COMPLETED|Overall Study||91||
59859417|NCT03180736|75984022|FG001|NOT COMPLETED|Overall Study||120||
59859418|NCT03178942|75984035|FG000|STARTED|Overall Study||129||
59859419|NCT03178942|75984036|FG001|STARTED|Overall Study||125||
59859420|NCT03178942|75984035|FG000|COMPLETED|Overall Study||126||
59859421|NCT03178942|75984036|FG001|COMPLETED|Overall Study||123||
59859422|NCT03178942|75984035|FG000|NOT COMPLETED|Overall Study||3||
59859423|NCT03178942|75984036|FG001|NOT COMPLETED|Overall Study||2||
59859424|NCT03175198|75984042|FG000|STARTED|Overall Study||5565|CRF collected|
59859425|NCT03175198|75984042|FG000|Safety Set 1|Overall Study||5436||
59859426|NCT03175198|75984042|FG000|COMPLETED|Overall Study||3238||
59859427|NCT03175198|75984042|FG000|NOT COMPLETED|Overall Study||2327||
59859428|NCT03175120|75984048|FG000|STARTED|Overall Study||302||
59859429|NCT03175120|75984049|FG001|STARTED|Overall Study||151||
59859430|NCT03175120|75984048|FG000|Treated|Overall Study||301||
59859431|NCT03175120|75984049|FG001|Treated|Overall Study||151||
59859432|NCT03175120|75984048|FG000|Full Analysis Set (FAS)|Overall Study||302|FAS included all randomised participants.|
59859433|NCT03175120|75984049|FG001|Full Analysis Set (FAS)|Overall Study||151|FAS included all randomised participants.|
59859434|NCT03175120|75984048|FG000|Safety Analysis Set (SAS)|Overall Study||301|SAS included all participants who received at least one dose of IDegLira or IDeg.|
59859435|NCT03175120|75984049|FG001|Safety Analysis Set (SAS)|Overall Study||151|SAS included all participants who received at least one dose of IDegLira or IDeg.|
59859436|NCT03175120|75984048|FG000|COMPLETED|Overall Study||290||
59859437|NCT03175120|75984049|FG001|COMPLETED|Overall Study||139||
59859438|NCT03175120|75984048|FG000|NOT COMPLETED|Overall Study||12||
59859439|NCT03175120|75984049|FG001|NOT COMPLETED|Overall Study||12||
59859440|NCT03172702|75984055|FG000|STARTED|Overall Study||150|Started the CP|
59859441|NCT03172702|75984055|FG000|Received Treatment in CP|Overall Study||150||
59859442|NCT03172702|75984055|FG000|Received Treatment in MP|Overall Study||150||
59859443|NCT03172702|75984055|FG000|COMPLETED|Overall Study||122|Completed treatment in the MP|
59859444|NCT03172702|75984055|FG000|NOT COMPLETED|Overall Study||28||
59859445|NCT02795182|75984064|FG000|STARTED|Overall Study||15||
59859446|NCT02795182|75984065|FG001|STARTED|Overall Study||10||
59859447|NCT02795182|75984066|FG002|STARTED|Overall Study||7||
59859448|NCT02795182|75984067|FG003|STARTED|Overall Study||43||
59859449|NCT02795182|75984064|FG000|COMPLETED|Overall Study||0||
59859450|NCT02795182|75984065|FG001|COMPLETED|Overall Study||0||
59859451|NCT02795182|75984066|FG002|COMPLETED|Overall Study||0||
59859452|NCT02795182|75984067|FG003|COMPLETED|Overall Study||0||
59859453|NCT02795182|75984064|FG000|NOT COMPLETED|Overall Study||15||
60127076|NCT01484197|76248999|FG002|NOT COMPLETED|Treatment Period 1||0||
60127077|NCT01484197|76249000|FG003|NOT COMPLETED|Treatment Period 1||0||
59859454|NCT02795182|75984065|FG001|NOT COMPLETED|Overall Study||10||
59859455|NCT02795182|75984066|FG002|NOT COMPLETED|Overall Study||7||
59859456|NCT02795182|75984067|FG003|NOT COMPLETED|Overall Study||43||
59859457|NCT03167242|75984096|FG000|STARTED|Overall Study||12|All participants who were enrolled in the PK Run-in part or randomized in Parts A or B.|
59859458|NCT03167242|75984097|FG001|STARTED|Overall Study||51|All participants who were enrolled in the PK Run-in part or randomized in Parts A or B.|
59859459|NCT03167242|75984098|FG002|STARTED|Overall Study||51|All participants who were enrolled in the PK Run-in part or randomized in Parts A or B.|
59859460|NCT03167242|75984099|FG003|STARTED|Overall Study||51|All participants who were enrolled in the PK Run-in part or randomized in Parts A or B.|
59859461|NCT03167242|75984100|FG004|STARTED|Overall Study||54|All participants who were enrolled in the PK Run-in part or randomized in Parts A or B.|
59859462|NCT03167242|75984101|FG005|STARTED|Overall Study||51|All participants who were enrolled in the PK Run-in part or randomized in Parts A or B.|
59859463|NCT03167242|75984102|FG006|STARTED|Overall Study||52|All participants who were enrolled in the PK Run-in part or randomized in Parts A or B.|
59859464|NCT03167242|75984103|FG007|STARTED|Overall Study||27|All participants who were enrolled in the PK Run-in part or randomized in Parts A or B.|
59859465|NCT03167242|75984104|FG008|STARTED|Overall Study||53|All participants who were enrolled in the PK Run-in part or randomized in Parts A or B.|
59859466|NCT03167242|75984105|FG009|STARTED|Overall Study||53|All participants who were enrolled in the PK Run-in part or randomized in Parts A or B.|
59859467|NCT03167242|75984106|FG010|STARTED|Overall Study||45|All participants who were enrolled in the PK Run-in part or randomized in Parts A or B.|
59859468|NCT03167242|75984107|FG011|STARTED|Overall Study||24|All participants who were enrolled in the PK Run-in part or randomized in Parts A or B.|
59859469|NCT03167242|75984096|FG000|Full Analysis Set (FAS)|Overall Study||12|All enrolled participants, who received at least one dose of the study treatment|
59859470|NCT03167242|75984097|FG001|Full Analysis Set (FAS)|Overall Study||51|All enrolled participants, who received at least one dose of the study treatment|
59859471|NCT03167242|75984098|FG002|Full Analysis Set (FAS)|Overall Study||51|All enrolled participants, who received at least one dose of the study treatment|
59859472|NCT03167242|75984099|FG003|Full Analysis Set (FAS)|Overall Study||51|All enrolled participants, who received at least one dose of the study treatment|
59859473|NCT03167242|75984100|FG004|Full Analysis Set (FAS)|Overall Study||54|All enrolled participants, who received at least one dose of the study treatment|
59859474|NCT03167242|75984101|FG005|Full Analysis Set (FAS)|Overall Study||51|All enrolled participants, who received at least one dose of the study treatment|
59859475|NCT03167242|75984102|FG006|Full Analysis Set (FAS)|Overall Study||52|All enrolled participants, who received at least one dose of the study treatment|
59859476|NCT03167242|75984103|FG007|Full Analysis Set (FAS)|Overall Study||27|All enrolled participants, who received at least one dose of the study treatment|
59859477|NCT03167242|75984104|FG008|Full Analysis Set (FAS)|Overall Study||52|All enrolled participants, who received at least one dose of the study treatment|
59859478|NCT03167242|75984105|FG009|Full Analysis Set (FAS)|Overall Study||53|All enrolled participants, who received at least one dose of the study treatment|
59859479|NCT03167242|75984106|FG010|Full Analysis Set (FAS)|Overall Study||45|All enrolled participants, who received at least one dose of the study treatment|
59859480|NCT03167242|75984107|FG011|Full Analysis Set (FAS)|Overall Study||24|All enrolled participants, who received at least one dose of the study treatment|
59859481|NCT03167242|75984096|FG000|Pharmacokinetics (PK) Analysis Set|Overall Study||12|All enrolled participants with at least 80% compliance to study treatment who had evaluable PK parameter data and did not receive the prohibited medications which could impact PK parameters.|
59859482|NCT03167242|75984097|FG001|Pharmacokinetics (PK) Analysis Set|Overall Study||47|All enrolled participants with at least 80% compliance to study treatment who had evaluable PK parameter data and did not receive the prohibited medications which could impact PK parameters.|
59859483|NCT03167242|75984098|FG002|Pharmacokinetics (PK) Analysis Set|Overall Study||51|All enrolled participants with at least 80% compliance to study treatment who had evaluable PK parameter data and did not receive the prohibited medications which could impact PK parameters.|
59859484|NCT03167242|75984099|FG003|Pharmacokinetics (PK) Analysis Set|Overall Study||46|All enrolled participants with at least 80% compliance to study treatment who had evaluable PK parameter data and did not receive the prohibited medications which could impact PK parameters.|
59859485|NCT03167242|75984100|FG004|Pharmacokinetics (PK) Analysis Set|Overall Study||48|All enrolled participants with at least 80% compliance to study treatment who had evaluable PK parameter data and did not receive the prohibited medications which could impact PK parameters.|
59859486|NCT03167242|75984101|FG005|Pharmacokinetics (PK) Analysis Set|Overall Study||46|All enrolled participants with at least 80% compliance to study treatment who had evaluable PK parameter data and did not receive the prohibited medications which could impact PK parameters.|
59859487|NCT03167242|75984102|FG006|Pharmacokinetics (PK) Analysis Set|Overall Study||45|All enrolled participants with at least 80% compliance to study treatment who had evaluable PK parameter data and did not receive the prohibited medications which could impact PK parameters.|
59859488|NCT03167242|75984103|FG007|Pharmacokinetics (PK) Analysis Set|Overall Study||24|All enrolled participants with at least 80% compliance to study treatment who had evaluable PK parameter data and did not receive the prohibited medications which could impact PK parameters.|
59859489|NCT03167242|75984104|FG008|Pharmacokinetics (PK) Analysis Set|Overall Study||48|All enrolled participants with at least 80% compliance to study treatment who had evaluable PK parameter data and did not receive the prohibited medications which could impact PK parameters.|
59859490|NCT03167242|75984105|FG009|Pharmacokinetics (PK) Analysis Set|Overall Study||46|All enrolled participants with at least 80% compliance to study treatment who had evaluable PK parameter data and did not receive the prohibited medications which could impact PK parameters.|
59594796|NCT03168295|75703754|FG000|NOT COMPLETED|Overall Study||0||
59859491|NCT03167242|75984106|FG010|Pharmacokinetics (PK) Analysis Set|Overall Study||41|All enrolled participants with at least 80% compliance to study treatment who had evaluable PK parameter data and did not receive the prohibited medications which could impact PK parameters.|
59859492|NCT03167242|75984107|FG011|Pharmacokinetics (PK) Analysis Set|Overall Study||24|All enrolled participants with at least 80% compliance to study treatment who had evaluable PK parameter data and did not receive the prohibited medications which could impact PK parameters.|
59859493|NCT03167242|75984096|FG000|Per-Protocol Set (PPS)|Overall Study||12|All participants comprised in FAS who met predefined criteria related to protocol and treatment compliance.|
59859494|NCT03167242|75984097|FG001|Per-Protocol Set (PPS)|Overall Study||50|All participants comprised in FAS who met predefined criteria related to protocol and treatment compliance.|
59859495|NCT03167242|75984098|FG002|Per-Protocol Set (PPS)|Overall Study||48|All participants comprised in FAS who met predefined criteria related to protocol and treatment compliance.|
59859496|NCT03167242|75984099|FG003|Per-Protocol Set (PPS)|Overall Study||48|All participants comprised in FAS who met predefined criteria related to protocol and treatment compliance.|
59859497|NCT03167242|75984100|FG004|Per-Protocol Set (PPS)|Overall Study||47|All participants comprised in FAS who met predefined criteria related to protocol and treatment compliance.|
59859498|NCT03167242|75984101|FG005|Per-Protocol Set (PPS)|Overall Study||44|All participants comprised in FAS who met predefined criteria related to protocol and treatment compliance.|
59859499|NCT03167242|75984102|FG006|Per-Protocol Set (PPS)|Overall Study||43|All participants comprised in FAS who met predefined criteria related to protocol and treatment compliance.|
59859500|NCT03167242|75984103|FG007|Per-Protocol Set (PPS)|Overall Study||25|All participants comprised in FAS who met predefined criteria related to protocol and treatment compliance.|
59859501|NCT03167242|75984104|FG008|Per-Protocol Set (PPS)|Overall Study||48|All participants comprised in FAS who met predefined criteria related to protocol and treatment compliance.|
59859502|NCT03167242|75984105|FG009|Per-Protocol Set (PPS)|Overall Study||46|All participants comprised in FAS who met predefined criteria related to protocol and treatment compliance.|
59859503|NCT03167242|75984106|FG010|Per-Protocol Set (PPS)|Overall Study||40|All participants comprised in FAS who met predefined criteria related to protocol and treatment compliance.|
59859504|NCT03167242|75984107|FG011|Per-Protocol Set (PPS)|Overall Study||22|All participants comprised in FAS who met predefined criteria related to protocol and treatment compliance.|
59859505|NCT03167242|75984096|FG000|Rich Pharmacokinetics (PK) Analysis Subset|Overall Study||12|Subset of participants within PK Run-in and Part A and comprised in PK Analysis set from whom rich PK data was collected.|
59859506|NCT03167242|75984097|FG001|Rich Pharmacokinetics (PK) Analysis Subset|Overall Study||5|Subset of participants within PK Run-in and Part A and comprised in PK Analysis set from whom rich PK data was collected.|
59859507|NCT03167242|75984098|FG002|Rich Pharmacokinetics (PK) Analysis Subset|Overall Study||6|Subset of participants within PK Run-in and Part A and comprised in PK Analysis set from whom rich PK data was collected.|
59859508|NCT03167242|75984099|FG003|Rich Pharmacokinetics (PK) Analysis Subset|Overall Study||6|Subset of participants within PK Run-in and Part A and comprised in PK Analysis set from whom rich PK data was collected.|
59859509|NCT03167242|75984100|FG004|Rich Pharmacokinetics (PK) Analysis Subset|Overall Study||6|Subset of participants within PK Run-in and Part A and comprised in PK Analysis set from whom rich PK data was collected.|
59859510|NCT03167242|75984101|FG005|Rich Pharmacokinetics (PK) Analysis Subset|Overall Study||12|Subset of participants within PK Run-in and Part A and comprised in PK Analysis set from whom rich PK data was collected.|
59859511|NCT03167242|75984102|FG006|Rich Pharmacokinetics (PK) Analysis Subset|Overall Study||5|Subset of participants within PK Run-in and Part A and comprised in PK Analysis set from whom rich PK data was collected.|
59859512|NCT03167242|75984103|FG007|Rich Pharmacokinetics (PK) Analysis Subset|Overall Study||0|Subset of participants within PK Run-in and Part A and comprised in PK Analysis set from whom rich PK data was collected.|
59859513|NCT03167242|75984104|FG008|Rich Pharmacokinetics (PK) Analysis Subset|Overall Study||0|Subset of participants within PK Run-in and Part A and comprised in PK Analysis set from whom rich PK data was collected.|
59859514|NCT03167242|75984105|FG009|Rich Pharmacokinetics (PK) Analysis Subset|Overall Study||0|Subset of participants within PK Run-in and Part A and comprised in PK Analysis set from whom rich PK data was collected.|
59859515|NCT03167242|75984106|FG010|Rich Pharmacokinetics (PK) Analysis Subset|Overall Study||0|Subset of participants within PK Run-in and Part A and comprised in PK Analysis set from whom rich PK data was collected.|
59859516|NCT03167242|75984107|FG011|Rich Pharmacokinetics (PK) Analysis Subset|Overall Study||0|Subset of participants within PK Run-in and Part A and comprised in PK Analysis set from whom rich PK data was collected.|
59859517|NCT03167242|75984096|FG000|COMPLETED|Overall Study||12||
59859518|NCT03167242|75984097|FG001|COMPLETED|Overall Study||50||
59859519|NCT03167242|75984098|FG002|COMPLETED|Overall Study||48||
59859520|NCT03167242|75984099|FG003|COMPLETED|Overall Study||50||
59859521|NCT03167242|75984100|FG004|COMPLETED|Overall Study||53||
59859522|NCT03167242|75984101|FG005|COMPLETED|Overall Study||49||
59859523|NCT03167242|75984102|FG006|COMPLETED|Overall Study||50||
59859524|NCT03167242|75984103|FG007|COMPLETED|Overall Study||26||
59859525|NCT03167242|75984104|FG008|COMPLETED|Overall Study||52||
59859526|NCT03167242|75984105|FG009|COMPLETED|Overall Study||53||
59859527|NCT03167242|75984106|FG010|COMPLETED|Overall Study||43||
59859528|NCT03167242|75984107|FG011|COMPLETED|Overall Study||23||
59859529|NCT03167242|75984096|FG000|NOT COMPLETED|Overall Study||0||
59859530|NCT03167242|75984097|FG001|NOT COMPLETED|Overall Study||1||
59859531|NCT03167242|75984098|FG002|NOT COMPLETED|Overall Study||3||
59859532|NCT03167242|75984099|FG003|NOT COMPLETED|Overall Study||1||
59859533|NCT03167242|75984100|FG004|NOT COMPLETED|Overall Study||1||
59859534|NCT03167242|75984101|FG005|NOT COMPLETED|Overall Study||2||
60127078|NCT01484197|76248997|FG000|STARTED|Treatment Period 2|1 patient completed Period 1 but did not enter Period 2 due to a Protocol deviation.|7||
59859535|NCT03167242|75984102|FG006|NOT COMPLETED|Overall Study||2||
59859536|NCT03167242|75984103|FG007|NOT COMPLETED|Overall Study||1||
59594797|NCT03168295|75703755|FG001|NOT COMPLETED|Overall Study||0||
59594798|NCT03168295|75703756|FG002|NOT COMPLETED|Overall Study||0||
59594799|NCT03168295|75703757|FG003|NOT COMPLETED|Overall Study||0||
59594800|NCT03168295|75703758|FG004|NOT COMPLETED|Overall Study||0||
59594801|NCT03168841|75703769|FG000|STARTED|Overall Study||40||
59594802|NCT03168841|75703769|FG000|COMPLETED|Overall Study||36||
59594803|NCT03168841|75703769|FG000|NOT COMPLETED|Overall Study||4||
59594804|NCT03180385|75703775|FG000|STARTED|Overall Study||0||
59594805|NCT03180385|75703776|FG001|STARTED|Overall Study||2||
59594806|NCT03180385|75703775|FG000|COMPLETED|Overall Study||0||
59594807|NCT03180385|75703776|FG001|COMPLETED|Overall Study||2||
59594808|NCT03180385|75703775|FG000|NOT COMPLETED|Overall Study||0||
59594809|NCT03180385|75703776|FG001|NOT COMPLETED|Overall Study||0||
59594810|NCT03185546|75703790|FG000|STARTED|Baseline Through Week 12||6||
59594811|NCT03185546|75703791|FG001|STARTED|Baseline Through Week 12||10||
59594812|NCT03185546|75703792|FG002|STARTED|Baseline Through Week 12||5||
59594813|NCT03185546|75703793|FG003|STARTED|Baseline Through Week 12||5||
59594814|NCT03185546|75703794|FG004|STARTED|Baseline Through Week 12||6||
59594815|NCT03185546|75703795|FG005|STARTED|Baseline Through Week 12||6||
59594816|NCT03185546|75703796|FG006|STARTED|Baseline Through Week 12||7||
59594817|NCT03185546|75703797|FG007|STARTED|Baseline Through Week 12||5||
59594818|NCT03185546|75703790|FG000|COMPLETED|Baseline Through Week 12||2||
59594819|NCT03185546|75703791|FG001|COMPLETED|Baseline Through Week 12||7||
59594820|NCT03185546|75703792|FG002|COMPLETED|Baseline Through Week 12||4||
59594821|NCT03185546|75703793|FG003|COMPLETED|Baseline Through Week 12||4||
59594822|NCT03185546|75703794|FG004|COMPLETED|Baseline Through Week 12||5||
59594823|NCT03185546|75703795|FG005|COMPLETED|Baseline Through Week 12||4||
59594824|NCT03185546|75703796|FG006|COMPLETED|Baseline Through Week 12||4||
59594825|NCT03185546|75703797|FG007|COMPLETED|Baseline Through Week 12||2||
59594826|NCT03185546|75703790|FG000|NOT COMPLETED|Baseline Through Week 12||4||
59594827|NCT03185546|75703791|FG001|NOT COMPLETED|Baseline Through Week 12||3||
59594828|NCT03185546|75703792|FG002|NOT COMPLETED|Baseline Through Week 12||1||
59594829|NCT03185546|75703793|FG003|NOT COMPLETED|Baseline Through Week 12||1||
59594830|NCT03185546|75703794|FG004|NOT COMPLETED|Baseline Through Week 12||1||
59594831|NCT03185546|75703795|FG005|NOT COMPLETED|Baseline Through Week 12||2||
59594832|NCT03185546|75703796|FG006|NOT COMPLETED|Baseline Through Week 12||3||
59594833|NCT03185546|75703797|FG007|NOT COMPLETED|Baseline Through Week 12||3||
59594834|NCT03185546|75703790|FG000|STARTED|Week 12 Through Day 30 Follow up||2||
59594835|NCT03185546|75703791|FG001|STARTED|Week 12 Through Day 30 Follow up||7||
59594836|NCT03185546|75703792|FG002|STARTED|Week 12 Through Day 30 Follow up||4||
59594837|NCT03185546|75703793|FG003|STARTED|Week 12 Through Day 30 Follow up||4||
59594838|NCT03185546|75703794|FG004|STARTED|Week 12 Through Day 30 Follow up||5||
59594839|NCT03185546|75703795|FG005|STARTED|Week 12 Through Day 30 Follow up||4||
59594840|NCT03185546|75703796|FG006|STARTED|Week 12 Through Day 30 Follow up||4||
59594841|NCT03185546|75703797|FG007|STARTED|Week 12 Through Day 30 Follow up||2||
59594842|NCT03185546|75703790|FG000|COMPLETED|Week 12 Through Day 30 Follow up||2||
59594843|NCT03185546|75703791|FG001|COMPLETED|Week 12 Through Day 30 Follow up||7||
59594844|NCT03185546|75703792|FG002|COMPLETED|Week 12 Through Day 30 Follow up||4||
59594845|NCT03185546|75703793|FG003|COMPLETED|Week 12 Through Day 30 Follow up||3||
59594846|NCT03185546|75703794|FG004|COMPLETED|Week 12 Through Day 30 Follow up||5||
59594847|NCT03185546|75703795|FG005|COMPLETED|Week 12 Through Day 30 Follow up||4||
59594848|NCT03185546|75703796|FG006|COMPLETED|Week 12 Through Day 30 Follow up||3||
59594849|NCT03185546|75703797|FG007|COMPLETED|Week 12 Through Day 30 Follow up||2||
59594850|NCT03185546|75703790|FG000|NOT COMPLETED|Week 12 Through Day 30 Follow up||0||
59594851|NCT03185546|75703791|FG001|NOT COMPLETED|Week 12 Through Day 30 Follow up||0||
59594852|NCT03185546|75703792|FG002|NOT COMPLETED|Week 12 Through Day 30 Follow up||0||
59594853|NCT03185546|75703793|FG003|NOT COMPLETED|Week 12 Through Day 30 Follow up||1||
59594854|NCT03185546|75703794|FG004|NOT COMPLETED|Week 12 Through Day 30 Follow up||0||
59594855|NCT03185546|75703795|FG005|NOT COMPLETED|Week 12 Through Day 30 Follow up||0||
59594856|NCT03185546|75703796|FG006|NOT COMPLETED|Week 12 Through Day 30 Follow up||1||
59594857|NCT03185546|75703797|FG007|NOT COMPLETED|Week 12 Through Day 30 Follow up||0||
59594858|NCT04613882|75703822|FG000|STARTED|First Intervention||14||23
59594859|NCT04613882|75703823|FG001|STARTED|First Intervention||6||9
59594860|NCT04613882|75703824|FG002|STARTED|First Intervention||9||15
59594861|NCT04613882|75703825|FG003|STARTED|First Intervention||5||6
59728362|NCT00812929|75847156|FG007|NOT COMPLETED|Treatment Period 2||0||
59728363|NCT00812929|75847157|FG008|NOT COMPLETED|Treatment Period 2||0||
59728364|NCT00812929|75847158|FG009|NOT COMPLETED|Treatment Period 2||0||
59728365|NCT00812929|75847149|FG000|STARTED|Washout Period 2 (7 Days)||5||
59728366|NCT00812929|75847150|FG001|STARTED|Washout Period 2 (7 Days)||4||
59728367|NCT00812929|75847151|FG002|STARTED|Washout Period 2 (7 Days)||4||
59728368|NCT00812929|75847152|FG003|STARTED|Washout Period 2 (7 Days)||4||
59728369|NCT00812929|75847153|FG004|STARTED|Washout Period 2 (7 Days)||5||
59728370|NCT00812929|75847154|FG005|STARTED|Washout Period 2 (7 Days)||5||
59594862|NCT04613882|75703826|FG004|STARTED|First Intervention||6||9
59594863|NCT04613882|75703827|FG005|STARTED|First Intervention||13||22
59594864|NCT04613882|75703822|FG000|COMPLETED|First Intervention||14||23
59594865|NCT04613882|75703823|FG001|COMPLETED|First Intervention||6||9
59594866|NCT04613882|75703824|FG002|COMPLETED|First Intervention||9||15
59594867|NCT04613882|75703825|FG003|COMPLETED|First Intervention||5||6
59594868|NCT04613882|75703826|FG004|COMPLETED|First Intervention||6||9
59594869|NCT04613882|75703827|FG005|COMPLETED|First Intervention||13||22
59594870|NCT04613882|75703822|FG000|NOT COMPLETED|First Intervention||0||0
59594871|NCT04613882|75703823|FG001|NOT COMPLETED|First Intervention||0||0
59594872|NCT04613882|75703824|FG002|NOT COMPLETED|First Intervention||0||0
59594873|NCT04613882|75703825|FG003|NOT COMPLETED|First Intervention||0||0
59594874|NCT04613882|75703826|FG004|NOT COMPLETED|First Intervention||0||0
59594875|NCT04613882|75703827|FG005|NOT COMPLETED|First Intervention||0||0
59594876|NCT04613882|75703822|FG000|STARTED|Second Intervention||14||23
59594877|NCT04613882|75703823|FG001|STARTED|Second Intervention||6||9
59594878|NCT04613882|75703824|FG002|STARTED|Second Intervention||9||15
59594879|NCT04613882|75703825|FG003|STARTED|Second Intervention||5||6
59594880|NCT04613882|75703826|FG004|STARTED|Second Intervention||6||9
59594881|NCT04613882|75703827|FG005|STARTED|Second Intervention||13||22
59594882|NCT04613882|75703822|FG000|COMPLETED|Second Intervention||14||23
59594883|NCT04613882|75703823|FG001|COMPLETED|Second Intervention||6||9
59594884|NCT04613882|75703824|FG002|COMPLETED|Second Intervention||9||15
59594885|NCT04613882|75703825|FG003|COMPLETED|Second Intervention||5||6
59594886|NCT04613882|75703826|FG004|COMPLETED|Second Intervention||6||9
59594887|NCT04613882|75703827|FG005|COMPLETED|Second Intervention||13||22
59594888|NCT04613882|75703822|FG000|NOT COMPLETED|Second Intervention||0||0
59594889|NCT04613882|75703823|FG001|NOT COMPLETED|Second Intervention||0||0
59594890|NCT04613882|75703824|FG002|NOT COMPLETED|Second Intervention||0||0
59594891|NCT04613882|75703825|FG003|NOT COMPLETED|Second Intervention||0||0
59594892|NCT04613882|75703826|FG004|NOT COMPLETED|Second Intervention||0||0
59594893|NCT04613882|75703827|FG005|NOT COMPLETED|Second Intervention||0||0
59594894|NCT04613882|75703822|FG000|STARTED|Third Intervention||14||23
59594895|NCT04613882|75703823|FG001|STARTED|Third Intervention||6||9
59594896|NCT04613882|75703824|FG002|STARTED|Third Intervention||9||15
59594897|NCT04613882|75703825|FG003|STARTED|Third Intervention||5||6
59594898|NCT04613882|75703826|FG004|STARTED|Third Intervention||6||9
59594899|NCT04613882|75703827|FG005|STARTED|Third Intervention||13||22
59594900|NCT04613882|75703822|FG000|COMPLETED|Third Intervention||14||23
59594901|NCT04613882|75703823|FG001|COMPLETED|Third Intervention||6||9
59594902|NCT04613882|75703824|FG002|COMPLETED|Third Intervention||9||15
59594903|NCT04613882|75703825|FG003|COMPLETED|Third Intervention||5||6
59594904|NCT04613882|75703826|FG004|COMPLETED|Third Intervention||6||9
59594905|NCT04613882|75703827|FG005|COMPLETED|Third Intervention||13||22
59594906|NCT04613882|75703822|FG000|NOT COMPLETED|Third Intervention||0||0
59594907|NCT04613882|75703823|FG001|NOT COMPLETED|Third Intervention||0||0
59594908|NCT04613882|75703824|FG002|NOT COMPLETED|Third Intervention||0||0
59594909|NCT04613882|75703825|FG003|NOT COMPLETED|Third Intervention||0||0
59594910|NCT04613882|75703826|FG004|NOT COMPLETED|Third Intervention||0||0
59594911|NCT04613882|75703827|FG005|NOT COMPLETED|Third Intervention||0||0
59594912|NCT02186652|75703837|FG000|STARTED|Overall Study||19||
59594913|NCT02186652|75703838|FG001|STARTED|Overall Study||22||
59594914|NCT02186652|75703837|FG000|COMPLETED|Overall Study||17||
59594915|NCT02186652|75703838|FG001|COMPLETED|Overall Study||22||
59594916|NCT02186652|75703837|FG000|NOT COMPLETED|Overall Study||2||
59594917|NCT02186652|75703838|FG001|NOT COMPLETED|Overall Study||0||
59594918|NCT03187418|75703851|FG000|STARTED|Overall Study||52||
59594919|NCT03187418|75703851|FG000|COMPLETED|Overall Study||52||
59594920|NCT03187418|75703851|FG000|NOT COMPLETED|Overall Study||0||
59594921|NCT03187730|75703857|FG000|STARTED|Overall Study||208||
59594922|NCT03187730|75703858|FG001|STARTED|Overall Study||202||
59594923|NCT03187730|75703857|FG000|COMPLETED|Overall Study||129||
59594924|NCT03187730|75703858|FG001|COMPLETED|Overall Study||154||
59594925|NCT03187730|75703857|FG000|NOT COMPLETED|Overall Study||79||
59594926|NCT03187730|75703858|FG001|NOT COMPLETED|Overall Study||48||
59594927|NCT03189134|75703864|FG000|STARTED|Overall Study||6||
59594928|NCT03189134|75703864|FG000|COMPLETED|Overall Study||6||
59594929|NCT03189134|75703864|FG000|NOT COMPLETED|Overall Study||0||
59594930|NCT02185794|75703874|FG000|STARTED|Overall Study||9||
59594931|NCT02185794|75703875|FG001|STARTED|Overall Study||20||
59594932|NCT02185794|75703876|FG002|STARTED|Overall Study||33||
59594933|NCT02185794|75703877|FG003|STARTED|Overall Study||16||
59594934|NCT02185794|75703878|FG004|STARTED|Overall Study||7||
59594935|NCT02185794|75703879|FG005|STARTED|Overall Study||16||
59594936|NCT02185794|75703874|FG000|COMPLETED|Overall Study||4||
60127079|NCT01484197|76248998|FG001|STARTED|Treatment Period 2|1 patient completed Period 1 but did not enter Period 2 due to an Adverse event (AE).|8||
60127080|NCT01484197|76248999|FG002|STARTED|Treatment Period 2||9||
59594937|NCT02185794|75703875|FG001|COMPLETED|Overall Study||7||
59594938|NCT02185794|75703876|FG002|COMPLETED|Overall Study||17||
59594939|NCT02185794|75703877|FG003|COMPLETED|Overall Study||8||
59594940|NCT02185794|75703878|FG004|COMPLETED|Overall Study||4||
59594941|NCT02185794|75703879|FG005|COMPLETED|Overall Study||0||
59594942|NCT02185794|75703874|FG000|NOT COMPLETED|Overall Study||5||
59594943|NCT02185794|75703875|FG001|NOT COMPLETED|Overall Study||13||
59594944|NCT02185794|75703876|FG002|NOT COMPLETED|Overall Study||16||
59594945|NCT02185794|75703877|FG003|NOT COMPLETED|Overall Study||8||
59594946|NCT02185794|75703878|FG004|NOT COMPLETED|Overall Study||3||
59594947|NCT02185794|75703879|FG005|NOT COMPLETED|Overall Study||16||
59594948|NCT02221674|75703910|FG000|STARTED|Overall Study||8||
59594949|NCT02221674|75703911|FG001|STARTED|Overall Study||6||
59594950|NCT02221674|75703912|FG002|STARTED|Overall Study||5||
59594951|NCT02221674|75703910|FG000|COMPLETED|Overall Study||7||
59594952|NCT02221674|75703911|FG001|COMPLETED|Overall Study||6||
59594953|NCT02221674|75703912|FG002|COMPLETED|Overall Study||5||
59594954|NCT02221674|75703910|FG000|NOT COMPLETED|Overall Study||1||
59594955|NCT02221674|75703911|FG001|NOT COMPLETED|Overall Study||0||
59594956|NCT02221674|75703912|FG002|NOT COMPLETED|Overall Study||0||
59594957|NCT02221284|75703927|FG000|STARTED|Overall Study||964||
59594958|NCT02221284|75703927|FG000|COMPLETED|Overall Study||903||
59594959|NCT02221284|75703927|FG000|NOT COMPLETED|Overall Study||61||
59594960|NCT03196076|75703940|FG000|STARTED|Overall Study||5||
59594961|NCT03196076|75703941|FG001|STARTED|Overall Study||20||
59594962|NCT03196076|75703942|FG002|STARTED|Overall Study||0||
59594963|NCT03196076|75703940|FG000|COMPLETED|Overall Study||5||
59594964|NCT03196076|75703941|FG001|COMPLETED|Overall Study||20||
59594965|NCT03196076|75703942|FG002|COMPLETED|Overall Study||0||
59594966|NCT03196076|75703940|FG000|NOT COMPLETED|Overall Study||0||
59594967|NCT03196076|75703941|FG001|NOT COMPLETED|Overall Study||0||
59594968|NCT03196076|75703942|FG002|NOT COMPLETED|Overall Study||0||
59594969|NCT02971033|75703953|FG000|STARTED|Overall Study||1||
59594970|NCT02971033|75703954|FG001|STARTED|Overall Study||1||
59594971|NCT02971033|75703955|FG002|STARTED|Overall Study||0||
59594972|NCT02971033|75703953|FG000|COMPLETED|Overall Study||1||
59594973|NCT02971033|75703954|FG001|COMPLETED|Overall Study||1||
59594974|NCT02971033|75703955|FG002|COMPLETED|Overall Study||0||
59594975|NCT02971033|75703953|FG000|NOT COMPLETED|Overall Study||0||
59594976|NCT02971033|75703954|FG001|NOT COMPLETED|Overall Study||0||
59594977|NCT02971033|75703955|FG002|NOT COMPLETED|Overall Study||0||
59594978|NCT02796001|75703966|FG000|STARTED|Overall Study||20||
59594979|NCT02796001|75703967|FG001|STARTED|Overall Study||22||
59594980|NCT02796001|75703968|FG002|STARTED|Overall Study||4||
59594981|NCT02796001|75703966|FG000|COMPLETED|Overall Study||20||
59594982|NCT02796001|75703967|FG001|COMPLETED|Overall Study||22||
59594983|NCT02796001|75703968|FG002|COMPLETED|Overall Study||4||
59594984|NCT02796001|75703966|FG000|NOT COMPLETED|Overall Study||0||
59594985|NCT02796001|75703967|FG001|NOT COMPLETED|Overall Study||0||
59594986|NCT02796001|75703968|FG002|NOT COMPLETED|Overall Study||0||
59594987|NCT03198884|75703975|FG000|STARTED|Overall Study||20||
59594988|NCT03198884|75703975|FG000|COMPLETED|Overall Study||20||
59594989|NCT03198884|75703975|FG000|NOT COMPLETED|Overall Study||0||
59594990|NCT01801189|75703991|FG000|STARTED|Overall Study||28||
59594991|NCT01801189|75703992|FG001|STARTED|Overall Study||33||
59594992|NCT01801189|75703991|FG000|COMPLETED|Overall Study||28||
59594993|NCT01801189|75703992|FG001|COMPLETED|Overall Study||33||
59594994|NCT01801189|75703991|FG000|NOT COMPLETED|Overall Study||0||
59594995|NCT01801189|75703992|FG001|NOT COMPLETED|Overall Study||0||
59594996|NCT03199118|75704000|FG000|STARTED|Overall Study||14||
59594997|NCT03199118|75704001|FG001|STARTED|Overall Study||14||
59594998|NCT03199118|75704000|FG000|COMPLETED|Overall Study|6 months follow-up|14||
59594999|NCT03199118|75704001|FG001|COMPLETED|Overall Study|6 months follow-up|14||
59595000|NCT03199118|75704000|FG000|NOT COMPLETED|Overall Study||0||
59595001|NCT03199118|75704001|FG001|NOT COMPLETED|Overall Study||0||
59595002|NCT03202472|75704012|FG000|STARTED|Overall Study||50||
59595003|NCT03202472|75704012|FG000|COMPLETED|Overall Study||50||
59595004|NCT03202472|75704012|FG000|NOT COMPLETED|Overall Study||0||
59595005|NCT03202550|75704018|FG000|STARTED|Overall Study||13||
59595006|NCT03202550|75704019|FG001|STARTED|Overall Study||11||
59595007|NCT03202550|75704018|FG000|COMPLETED|Overall Study||13||
59595008|NCT03202550|75704019|FG001|COMPLETED|Overall Study||11||
59595009|NCT03202550|75704018|FG000|NOT COMPLETED|Overall Study||0||
59595010|NCT03202550|75704019|FG001|NOT COMPLETED|Overall Study||0||
59595011|NCT03203564|75704029|FG000|STARTED|Overall Study||8||
59595012|NCT03203564|75704030|FG001|STARTED|Overall Study||8||
59595013|NCT03203564|75704031|FG002|STARTED|Overall Study||8||
59595014|NCT03203564|75704032|FG003|STARTED|Overall Study||9||
59595015|NCT03203564|75704029|FG000|COMPLETED|Overall Study||8||
59595016|NCT03203564|75704030|FG001|COMPLETED|Overall Study||8||
59595017|NCT03203564|75704031|FG002|COMPLETED|Overall Study||8||
59595018|NCT03203564|75704032|FG003|COMPLETED|Overall Study||9||
59595019|NCT03203564|75704029|FG000|NOT COMPLETED|Overall Study||0||
59595020|NCT03203564|75704030|FG001|NOT COMPLETED|Overall Study||0||
59595021|NCT03203564|75704031|FG002|NOT COMPLETED|Overall Study||0||
59595022|NCT03203564|75704032|FG003|NOT COMPLETED|Overall Study||0||
59595023|NCT03285542|75704044|FG000|STARTED|Overall Study||30||
59595024|NCT03285542|75704045|FG001|STARTED|Overall Study||30||
59595025|NCT03285542|75704044|FG000|COMPLETED|Overall Study||30||
59595026|NCT03285542|75704045|FG001|COMPLETED|Overall Study||30||
59595027|NCT03285542|75704044|FG000|NOT COMPLETED|Overall Study||0||
59595028|NCT03285542|75704045|FG001|NOT COMPLETED|Overall Study||0||
59595029|NCT03207074|75704051|FG000|STARTED|Overall Study||150||
59595030|NCT03207074|75704051|FG000|COMPLETED|Overall Study||150||
59595031|NCT03207074|75704051|FG000|NOT COMPLETED|Overall Study||0||
59595032|NCT03207386|75704055|FG000|STARTED|Overall Study||2647||
59595033|NCT03207386|75704055|FG000|COMPLETED|Overall Study||1487||
59595034|NCT03207386|75704055|FG000|NOT COMPLETED|Overall Study||1160||
59595035|NCT00392821|75704065|FG000|STARTED|Overall Study||3||
59595036|NCT00392821|75704066|FG001|STARTED|Overall Study||6||
59595037|NCT00392821|75704067|FG002|STARTED|Overall Study||69||
59595038|NCT00392821|75704065|FG000|COMPLETED|Overall Study||0||
59595039|NCT00392821|75704066|FG001|COMPLETED|Overall Study||0||
59595040|NCT00392821|75704067|FG002|COMPLETED|Overall Study||0||
59595041|NCT00392821|75704065|FG000|NOT COMPLETED|Overall Study||3||
59595042|NCT00392821|75704066|FG001|NOT COMPLETED|Overall Study||6||
59595043|NCT00392821|75704067|FG002|NOT COMPLETED|Overall Study||69||
59595044|NCT03208166|75704075|FG000|STARTED|Overall Study||1||
59595045|NCT03208166|75704076|FG001|STARTED|Overall Study||1||
59595046|NCT03208166|75704075|FG000|COMPLETED|Overall Study||1||
59595047|NCT03208166|75704076|FG001|COMPLETED|Overall Study||1||
59595048|NCT03208166|75704075|FG000|NOT COMPLETED|Overall Study||0||
59595049|NCT03208166|75704076|FG001|NOT COMPLETED|Overall Study||0||
59595050|NCT02187042|75704084|FG000|STARTED|Overall Study||42||
59595051|NCT02187042|75704085|FG001|STARTED|Overall Study||27||
59595052|NCT02187042|75704084|FG000|COMPLETED|Overall Study||29||
59595053|NCT02187042|75704085|FG001|COMPLETED|Overall Study||13||
59595054|NCT02187042|75704084|FG000|NOT COMPLETED|Overall Study||13||
59595055|NCT02187042|75704085|FG001|NOT COMPLETED|Overall Study||14||
59595056|NCT03209882|75704094|FG000|STARTED|Overall Study||6||
59595057|NCT03209882|75704095|FG001|STARTED|Overall Study||3||
59595058|NCT03209882|75704094|FG000|COMPLETED|Overall Study||6||
59595059|NCT03209882|75704095|FG001|COMPLETED|Overall Study||3||
59595060|NCT03209882|75704094|FG000|NOT COMPLETED|Overall Study||0||
59595061|NCT03209882|75704095|FG001|NOT COMPLETED|Overall Study||0||
59595062|NCT03290378|75704106|FG000|STARTED|Overall Study||140||
59595063|NCT03290378|75704107|FG001|STARTED|Overall Study||133||
59595064|NCT03290378|75704108|FG002|STARTED|Overall Study||136||
59595065|NCT03290378|75704106|FG000|COMPLETED|Overall Study||137||
59595066|NCT03290378|75704107|FG001|COMPLETED|Overall Study||123||
59595067|NCT03290378|75704108|FG002|COMPLETED|Overall Study||120||
59595068|NCT03290378|75704106|FG000|NOT COMPLETED|Overall Study||3||
59595069|NCT03290378|75704107|FG001|NOT COMPLETED|Overall Study||10||
59595070|NCT03290378|75704108|FG002|NOT COMPLETED|Overall Study||16||
59595071|NCT03290768|75704116|FG000|STARTED|Overall Study||358||
59595072|NCT03290768|75704116|FG000|COMPLETED|Overall Study||193||
59595073|NCT03290768|75704116|FG000|NOT COMPLETED|Overall Study||165||
59595074|NCT03291080|75704122|FG000|STARTED|First Cycle (2 Weeks)||11||
59595075|NCT03291080|75704123|FG001|STARTED|First Cycle (2 Weeks)||9||
59595076|NCT03291080|75704122|FG000|COMPLETED|First Cycle (2 Weeks)||11||
59595077|NCT03291080|75704123|FG001|COMPLETED|First Cycle (2 Weeks)||9||
59595078|NCT03291080|75704122|FG000|NOT COMPLETED|First Cycle (2 Weeks)||0||
59595079|NCT03291080|75704123|FG001|NOT COMPLETED|First Cycle (2 Weeks)||0||
59595080|NCT03291080|75704122|FG000|STARTED|Washout (2 Weeks)||11||
59595081|NCT03291080|75704123|FG001|STARTED|Washout (2 Weeks)||9||
59595082|NCT03291080|75704122|FG000|COMPLETED|Washout (2 Weeks)||11||
59595083|NCT03291080|75704123|FG001|COMPLETED|Washout (2 Weeks)||9||
59595084|NCT03291080|75704122|FG000|NOT COMPLETED|Washout (2 Weeks)||0||
59595085|NCT03291080|75704123|FG001|NOT COMPLETED|Washout (2 Weeks)||0||
59595086|NCT03291080|75704122|FG000|STARTED|Second Cylcle (2 Weeks)||9||
59595087|NCT03291080|75704123|FG001|STARTED|Second Cylcle (2 Weeks)||11||
59595088|NCT03291080|75704122|FG000|COMPLETED|Second Cylcle (2 Weeks)||8||
59595089|NCT03291080|75704123|FG001|COMPLETED|Second Cylcle (2 Weeks)||11||
59595090|NCT03291080|75704122|FG000|NOT COMPLETED|Second Cylcle (2 Weeks)||1||
59595091|NCT03291080|75704123|FG001|NOT COMPLETED|Second Cylcle (2 Weeks)||0||
59595092|NCT03292562|75704132|FG000|STARTED|Overall Study||35||
59595093|NCT03292562|75704133|FG001|STARTED|Overall Study||31||
59595094|NCT03292562|75704132|FG000|COMPLETED|Overall Study||29||
59595095|NCT03292562|75704133|FG001|COMPLETED|Overall Study||30||
59595096|NCT03292562|75704132|FG000|NOT COMPLETED|Overall Study||6||
59595097|NCT03292562|75704133|FG001|NOT COMPLETED|Overall Study||1||
59595098|NCT03216200|75704139|FG000|STARTED|Overall Study||5||
59595099|NCT03216200|75704139|FG000|COMPLETED|Overall Study||5||
59595100|NCT03216200|75704139|FG000|NOT COMPLETED|Overall Study||0||
59595101|NCT03418064|75704143|FG000|STARTED|First Intervention (1 Month)||21||
59595102|NCT03418064|75704144|FG001|STARTED|First Intervention (1 Month)||21||
59595103|NCT03418064|75704143|FG000|COMPLETED|First Intervention (1 Month)||21||
59595104|NCT03418064|75704144|FG001|COMPLETED|First Intervention (1 Month)||21||
59595105|NCT03418064|75704143|FG000|NOT COMPLETED|First Intervention (1 Month)||0||
59595106|NCT03418064|75704144|FG001|NOT COMPLETED|First Intervention (1 Month)||0||
59595107|NCT03418064|75704143|FG000|STARTED|Second Intervention (1 Month)||21||
59595108|NCT03418064|75704144|FG001|STARTED|Second Intervention (1 Month)||21||
59595109|NCT03418064|75704143|FG000|COMPLETED|Second Intervention (1 Month)||21||
59595110|NCT03418064|75704144|FG001|COMPLETED|Second Intervention (1 Month)||21||
59595111|NCT03418064|75704143|FG000|NOT COMPLETED|Second Intervention (1 Month)||0||
59595112|NCT03418064|75704144|FG001|NOT COMPLETED|Second Intervention (1 Month)||0||
59595113|NCT03181009|75704160|FG000|STARTED|Overall Study||30||
59595114|NCT03181009|75704161|FG001|STARTED|Overall Study||30||
59595115|NCT03181009|75704160|FG000|COMPLETED|Overall Study||30||
59595116|NCT03181009|75704161|FG001|COMPLETED|Overall Study||28||
59595117|NCT03181009|75704160|FG000|NOT COMPLETED|Overall Study||0||
59595118|NCT03181009|75704161|FG001|NOT COMPLETED|Overall Study||2||
59595119|NCT03292952|75704169|FG000|STARTED|Open-Label Dose Optimization||155||
59595120|NCT03292952|75704170|FG001|STARTED|Open-Label Dose Optimization|All subjects were treated with open-label KP415 during the Open-Label Phase|0||
59595121|NCT03292952|75704171|FG002|STARTED|Open-Label Dose Optimization|All subjects were treated with open-label KP415 during the Open-Label Phase|0||
59595122|NCT03292952|75704169|FG000|COMPLETED|Open-Label Dose Optimization||150||
59595123|NCT03292952|75704170|FG001|COMPLETED|Open-Label Dose Optimization||0||
59595124|NCT03292952|75704171|FG002|COMPLETED|Open-Label Dose Optimization||0||
59595125|NCT03292952|75704169|FG000|NOT COMPLETED|Open-Label Dose Optimization||5||
59595126|NCT03292952|75704170|FG001|NOT COMPLETED|Open-Label Dose Optimization||0||
59595127|NCT03292952|75704171|FG002|NOT COMPLETED|Open-Label Dose Optimization||0||
59595128|NCT03292952|75704169|FG000|STARTED|Double-Blind Treatment Phase|Subjects were randomized to the double-blind Treatment Phase after Open-Label Dose Optimization|0||
59595129|NCT03292952|75704170|FG001|STARTED|Double-Blind Treatment Phase||74||
59595130|NCT03292952|75704171|FG002|STARTED|Double-Blind Treatment Phase||76||
59595131|NCT03292952|75704169|FG000|COMPLETED|Double-Blind Treatment Phase||0||
60127081|NCT01484197|76249000|FG003|STARTED|Treatment Period 2||9||
60127082|NCT01484197|76248997|FG000|COMPLETED|Treatment Period 2||7||
60127083|NCT01484197|76248998|FG001|COMPLETED|Treatment Period 2||8||
60127084|NCT01484197|76248999|FG002|COMPLETED|Treatment Period 2||9||
60127085|NCT01484197|76249000|FG003|COMPLETED|Treatment Period 2||8||
60127086|NCT01484197|76248997|FG000|NOT COMPLETED|Treatment Period 2||0||
60127087|NCT01484197|76248998|FG001|NOT COMPLETED|Treatment Period 2||0||
60127088|NCT01484197|76248999|FG002|NOT COMPLETED|Treatment Period 2||0||
60127089|NCT01484197|76249000|FG003|NOT COMPLETED|Treatment Period 2||1||
60127090|NCT01484197|76248997|FG000|STARTED|Treatment Period 3||7||
60127091|NCT01484197|76248998|FG001|STARTED|Treatment Period 3||8||
60127092|NCT01484197|76248999|FG002|STARTED|Treatment Period 3||9||
60127093|NCT01484197|76249000|FG003|STARTED|Treatment Period 3||8||
60127094|NCT01484197|76248997|FG000|COMPLETED|Treatment Period 3||7||
60127095|NCT01484197|76248998|FG001|COMPLETED|Treatment Period 3||8||
60127096|NCT01484197|76248999|FG002|COMPLETED|Treatment Period 3||9||
60127097|NCT01484197|76249000|FG003|COMPLETED|Treatment Period 3||8||
60127098|NCT01484197|76248997|FG000|NOT COMPLETED|Treatment Period 3||0||
60127099|NCT01484197|76248998|FG001|NOT COMPLETED|Treatment Period 3||0||
60127100|NCT01484197|76248999|FG002|NOT COMPLETED|Treatment Period 3||0||
59595132|NCT03292952|75704170|FG001|COMPLETED|Double-Blind Treatment Phase||74||
59595133|NCT03292952|75704171|FG002|COMPLETED|Double-Blind Treatment Phase||75||
59728371|NCT00812929|75847155|FG006|STARTED|Washout Period 2 (7 Days)||5||
60127101|NCT01484197|76249000|FG003|NOT COMPLETED|Treatment Period 3||0||
60127102|NCT01484197|76248997|FG000|STARTED|Treatment Period 4||7||
60127103|NCT01484197|76248998|FG001|STARTED|Treatment Period 4||8||
60127104|NCT01484197|76248999|FG002|STARTED|Treatment Period 4||9||
60127105|NCT01484197|76249000|FG003|STARTED|Treatment Period 4|2 patients completed Period 3 but did not enter Period 4 due to a Protocol deviation and an AE.|6||
60127106|NCT01484197|76248997|FG000|COMPLETED|Treatment Period 4||7||
60127107|NCT01484197|76248998|FG001|COMPLETED|Treatment Period 4||8||
60127108|NCT01484197|76248999|FG002|COMPLETED|Treatment Period 4||9||
60127109|NCT01484197|76249000|FG003|COMPLETED|Treatment Period 4||6||
60127110|NCT01484197|76248997|FG000|NOT COMPLETED|Treatment Period 4||0||
60127111|NCT01484197|76248998|FG001|NOT COMPLETED|Treatment Period 4||0||
60127112|NCT01484197|76248999|FG002|NOT COMPLETED|Treatment Period 4||0||
60127113|NCT01484197|76249000|FG003|NOT COMPLETED|Treatment Period 4||0||
60127114|NCT01473407|76249012|FG000|STARTED|Overall Study||306||
60127115|NCT01473407|76249013|FG001|STARTED|Overall Study||306||
60127116|NCT01473407|76249012|FG000|COMPLETED|Overall Study||252||
60127117|NCT01473407|76249013|FG001|COMPLETED|Overall Study||259||
60127118|NCT01473407|76249012|FG000|NOT COMPLETED|Overall Study||54||
60127119|NCT01473407|76249013|FG001|NOT COMPLETED|Overall Study||47||
60127120|NCT01472939|76249023|FG000|STARTED|Overall Study||123||
60127121|NCT01472939|76249024|FG001|STARTED|Overall Study||119||
60127122|NCT01472939|76249025|FG002|STARTED|Overall Study||119||
60127123|NCT01472939|76249026|FG003|STARTED|Overall Study||119||
60127124|NCT01472939|76249023|FG000|COMPLETED|Overall Study||103||
60127125|NCT01472939|76249024|FG001|COMPLETED|Overall Study||105||
60127126|NCT01472939|76249025|FG002|COMPLETED|Overall Study||108||
60127127|NCT01472939|76249026|FG003|COMPLETED|Overall Study||99||
60127128|NCT01472939|76249023|FG000|NOT COMPLETED|Overall Study||20||
60127129|NCT01472939|76249024|FG001|NOT COMPLETED|Overall Study||14||
60127130|NCT01472939|76249025|FG002|NOT COMPLETED|Overall Study||11||
60127131|NCT01472939|76249026|FG003|NOT COMPLETED|Overall Study||20||
60127132|NCT01544179|76249041|FG000|STARTED|Overall Study||133||
60127133|NCT01544179|76249042|FG001|STARTED|Overall Study||132||
60127134|NCT01544179|76249041|FG000|Received Treatment|Overall Study||132||
60127135|NCT01544179|76249042|FG001|Received Treatment|Overall Study||132||
60127136|NCT01544179|76249041|FG000|Did Not Receive Treatment|Overall Study||1||
60127137|NCT01544179|76249042|FG001|Did Not Receive Treatment|Overall Study||0||
60127138|NCT01544179|76249041|FG000|COMPLETED|Overall Study|Patients are ongoing in the study|70||
60127139|NCT01544179|76249042|FG001|COMPLETED|Overall Study|Patients are ongoing in the study|86||
60127140|NCT01544179|76249041|FG000|NOT COMPLETED|Overall Study||63||
60127141|NCT01544179|76249042|FG001|NOT COMPLETED|Overall Study||46||
60127142|NCT01483651|76249048|FG000|STARTED|Overall Study||1||
60127143|NCT01483651|76249049|FG001|STARTED|Overall Study||3||
60127144|NCT01483651|76249050|FG002|STARTED|Overall Study||2||
60127145|NCT01483651|76249051|FG003|STARTED|Overall Study||1||
60127146|NCT01483651|76249052|FG004|STARTED|Overall Study||2||
60127147|NCT01483651|76249053|FG005|STARTED|Overall Study||2||
60127148|NCT01483651|76249048|FG000|COMPLETED|Overall Study||1||
60127149|NCT01483651|76249049|FG001|COMPLETED|Overall Study||2||
60127150|NCT01483651|76249050|FG002|COMPLETED|Overall Study||1||
60127151|NCT01483651|76249051|FG003|COMPLETED|Overall Study||1||
60127152|NCT01483651|76249052|FG004|COMPLETED|Overall Study||2||
60127153|NCT01483651|76249053|FG005|COMPLETED|Overall Study||1||
60127154|NCT01483651|76249048|FG000|NOT COMPLETED|Overall Study||0||
60127155|NCT01483651|76249049|FG001|NOT COMPLETED|Overall Study||1||
60127156|NCT01483651|76249050|FG002|NOT COMPLETED|Overall Study||1||
60127157|NCT01483651|76249051|FG003|NOT COMPLETED|Overall Study||0||
60127158|NCT01483651|76249052|FG004|NOT COMPLETED|Overall Study||0||
60127159|NCT01483651|76249053|FG005|NOT COMPLETED|Overall Study||1||
60127160|NCT01464307|76249063|FG000|STARTED|Main Period||144||
60127161|NCT01464307|76249064|FG001|STARTED|Main Period||145||
60127162|NCT01464307|76249063|FG000|Treated|Main Period||144||
59595134|NCT03292952|75704169|FG000|NOT COMPLETED|Double-Blind Treatment Phase||0||
59595135|NCT03292952|75704170|FG001|NOT COMPLETED|Double-Blind Treatment Phase||0||
59728372|NCT00812929|75847156|FG007|STARTED|Washout Period 2 (7 Days)||5||
59728373|NCT00812929|75847157|FG008|STARTED|Washout Period 2 (7 Days)||4||
60127163|NCT01464307|76249064|FG001|Treated|Main Period||145||
60127164|NCT01464307|76249063|FG000|COMPLETED|Main Period||129||
60127165|NCT01464307|76249064|FG001|COMPLETED|Main Period||140||
60127166|NCT01464307|76249063|FG000|NOT COMPLETED|Main Period||15||
60127167|NCT01464307|76249064|FG001|NOT COMPLETED|Main Period||5||
60127168|NCT01464307|76249063|FG000|STARTED|Open-Label Extension Period||269||
60127169|NCT01464307|76249064|FG001|STARTED|Open-Label Extension Period||0||
60127170|NCT01464307|76249063|FG000|Treated|Open-Label Extension Period||269||
60127171|NCT01464307|76249064|FG001|Treated|Open-Label Extension Period||0||
60127172|NCT01464307|76249063|FG000|COMPLETED|Open-Label Extension Period||218||
60127173|NCT01464307|76249064|FG001|COMPLETED|Open-Label Extension Period||0||
60127174|NCT01464307|76249063|FG000|NOT COMPLETED|Open-Label Extension Period||51||
60127175|NCT01464307|76249064|FG001|NOT COMPLETED|Open-Label Extension Period||0||
60127176|NCT01483183|76249081|FG000|STARTED|Overall Study||4||
60127177|NCT01483183|76249082|FG001|STARTED|Overall Study||1||
60127178|NCT01483183|76249083|FG002|STARTED|Overall Study||5||
60127179|NCT01483183|76249084|FG003|STARTED|Overall Study||3||
60127180|NCT01483183|76249085|FG004|STARTED|Overall Study||4||
60127181|NCT01483183|76249086|FG005|STARTED|Overall Study||4||
60127182|NCT01483183|76249087|FG006|STARTED|Overall Study||6||
60127183|NCT01483183|76249088|FG007|STARTED|Overall Study||4||
60127184|NCT01483183|76249089|FG008|STARTED|Overall Study||4||
60127185|NCT01483183|76249090|FG009|STARTED|Overall Study||5||
60127186|NCT01483183|76249081|FG000|COMPLETED|Overall Study||4||
60127187|NCT01483183|76249082|FG001|COMPLETED|Overall Study||1||
60127188|NCT01483183|76249083|FG002|COMPLETED|Overall Study||5||
60127189|NCT01483183|76249084|FG003|COMPLETED|Overall Study||3||
60127190|NCT01483183|76249085|FG004|COMPLETED|Overall Study||4||
60127191|NCT01483183|76249086|FG005|COMPLETED|Overall Study||4||
60127192|NCT01483183|76249087|FG006|COMPLETED|Overall Study||4||
60127193|NCT01483183|76249088|FG007|COMPLETED|Overall Study||4||
60127194|NCT01483183|76249089|FG008|COMPLETED|Overall Study||4||
60127195|NCT01483183|76249090|FG009|COMPLETED|Overall Study||4||
60127196|NCT01483183|76249081|FG000|NOT COMPLETED|Overall Study||0||
60127197|NCT01483183|76249082|FG001|NOT COMPLETED|Overall Study||0||
60127198|NCT01483183|76249083|FG002|NOT COMPLETED|Overall Study||0||
60127199|NCT01483183|76249084|FG003|NOT COMPLETED|Overall Study||0||
60127200|NCT01483183|76249085|FG004|NOT COMPLETED|Overall Study||0||
60127201|NCT01483183|76249086|FG005|NOT COMPLETED|Overall Study||0||
60127202|NCT01483183|76249087|FG006|NOT COMPLETED|Overall Study||2||
60127203|NCT01483183|76249088|FG007|NOT COMPLETED|Overall Study||0||
60127204|NCT01483183|76249089|FG008|NOT COMPLETED|Overall Study||0||
60127205|NCT01483183|76249090|FG009|NOT COMPLETED|Overall Study||1||
60127206|NCT01483027|76249120|FG000|STARTED|Overall Study||215||
60127207|NCT01483027|76249121|FG001|STARTED|Overall Study||213||
60127208|NCT01483027|76249120|FG000|COMPLETED|Overall Study||169||
60127209|NCT01483027|76249121|FG001|COMPLETED|Overall Study||153||
60127210|NCT01483027|76249120|FG000|NOT COMPLETED|Overall Study||46||
60127211|NCT01483027|76249121|FG001|NOT COMPLETED|Overall Study||60||
60127212|NCT01463683|76249130|FG000|STARTED|Overall Study||309||
60127213|NCT01463683|76249131|FG001|STARTED|Overall Study||309||
60127214|NCT01463683|76249132|FG002|STARTED|Overall Study||104||
60127215|NCT01463683|76249130|FG000|Received Vaccination 1 (Day 1)|Overall Study||309||
60127216|NCT01463683|76249131|FG001|Received Vaccination 1 (Day 1)|Overall Study||308||
60127217|NCT01463683|76249132|FG002|Received Vaccination 1 (Day 1)|Overall Study||104||
60127218|NCT01463683|76249130|FG000|Received Vaccination 2 (Month 1)|Overall Study||302||
60127219|NCT01463683|76249131|FG001|Received Vaccination 2 (Month 1)|Overall Study||300||
60127220|NCT01463683|76249132|FG002|Received Vaccination 2 (Month 1)|Overall Study||103||
60127221|NCT01463683|76249130|FG000|Received Vaccination 3 (Month 6)|Overall Study||290||
60127222|NCT01463683|76249131|FG001|Received Vaccination 3 (Month 6)|Overall Study||281||
60127223|NCT01463683|76249132|FG002|Received Vaccination 3 (Month 6)|Overall Study||93||
60127224|NCT01463683|76249130|FG000|COMPLETED|Overall Study||290||
60127225|NCT01463683|76249131|FG001|COMPLETED|Overall Study||278||
60127226|NCT01463683|76249132|FG002|COMPLETED|Overall Study||93||
60127227|NCT01463683|76249130|FG000|NOT COMPLETED|Overall Study||19||
60127228|NCT01463683|76249131|FG001|NOT COMPLETED|Overall Study||31||
60127229|NCT01463683|76249132|FG002|NOT COMPLETED|Overall Study||11||
60127230|NCT01482169|76249140|FG000|STARTED|Overall Study||48||
60127231|NCT01482169|76249140|FG000|COMPLETED|Overall Study||46||
60127232|NCT01482169|76249140|FG000|NOT COMPLETED|Overall Study||2||
60127233|NCT01481779|76249149|FG000|STARTED|Overall Study||295||
60127234|NCT01481779|76249150|FG001|STARTED|Overall Study||160||
60127235|NCT01481779|76249149|FG000|Received at Least 1 Dose of Study Drug|Overall Study||294||
60127236|NCT01481779|76249150|FG001|Received at Least 1 Dose of Study Drug|Overall Study||159||
60127237|NCT01481779|76249149|FG000|COMPLETED|Overall Study||225||
60127238|NCT01481779|76249150|FG001|COMPLETED|Overall Study||132||
60127239|NCT01481779|76249149|FG000|NOT COMPLETED|Overall Study||70||
60127240|NCT01481779|76249150|FG001|NOT COMPLETED|Overall Study||28||
60127241|NCT01463527|76249158|FG000|STARTED|Overall Study||83||
60127242|NCT01463527|76249159|FG001|STARTED|Overall Study||84||
60127243|NCT01463527|76249158|FG000|COMPLETED|Overall Study||77||
60127244|NCT01463527|76249159|FG001|COMPLETED|Overall Study||77||
60127245|NCT01463527|76249158|FG000|NOT COMPLETED|Overall Study||6||
60127246|NCT01463527|76249159|FG001|NOT COMPLETED|Overall Study||7||
60127247|NCT01509547|76249167|FG000|STARTED|Overall Study||77||
60127248|NCT01509547|76249168|FG001|STARTED|Overall Study||80||
60127249|NCT01509547|76249167|FG000|COMPLETED|Overall Study||42||
60127250|NCT01509547|76249168|FG001|COMPLETED|Overall Study||41||
60127251|NCT01509547|76249167|FG000|NOT COMPLETED|Overall Study||35||
60127252|NCT01509547|76249168|FG001|NOT COMPLETED|Overall Study||39||
60127253|NCT01509079|76249176|FG000|STARTED|Overall Study||57||
60127254|NCT01509079|76249177|FG001|STARTED|Overall Study||59||
60127255|NCT01509079|76249176|FG000|COMPLETED|Overall Study||57||
60127256|NCT01509079|76249177|FG001|COMPLETED|Overall Study||56||
60127257|NCT01509079|76249176|FG000|NOT COMPLETED|Overall Study||0||
60127258|NCT01509079|76249177|FG001|NOT COMPLETED|Overall Study||3||
60127259|NCT01463293|76249186|FG000|STARTED|Overall Study||74||
60127260|NCT01463293|76249187|FG001|STARTED|Overall Study||79||
60127261|NCT01463293|76249188|FG002|STARTED|Overall Study||71||
60127262|NCT01463293|76249186|FG000|COMPLETED|Overall Study||68||
60127263|NCT01463293|76249187|FG001|COMPLETED|Overall Study||63||
60127264|NCT01463293|76249188|FG002|COMPLETED|Overall Study||59||
60127265|NCT01463293|76249186|FG000|NOT COMPLETED|Overall Study||6||
60127266|NCT01463293|76249187|FG001|NOT COMPLETED|Overall Study||16||
60127267|NCT01463293|76249188|FG002|NOT COMPLETED|Overall Study||12||
60127268|NCT04650217|76249201|FG000|STARTED|Overall Study||0||
60127269|NCT04650217|76249202|FG001|STARTED|Overall Study||0||
60127270|NCT04650217|76249203|FG002|STARTED|Overall Study||0||
60127271|NCT04650217|76249204|FG003|STARTED|Overall Study||0||
60127272|NCT04650217|76249205|FG004|STARTED|Overall Study||1||
60127273|NCT04650217|76249201|FG000|COMPLETED|Overall Study||0||
60127274|NCT04650217|76249202|FG001|COMPLETED|Overall Study||0||
60127275|NCT04650217|76249203|FG002|COMPLETED|Overall Study||0||
60127276|NCT04650217|76249204|FG003|COMPLETED|Overall Study||0||
60127277|NCT04650217|76249205|FG004|COMPLETED|Overall Study||0||
60127278|NCT04650217|76249201|FG000|NOT COMPLETED|Overall Study||0||
60127279|NCT04650217|76249202|FG001|NOT COMPLETED|Overall Study||0||
60127280|NCT04650217|76249203|FG002|NOT COMPLETED|Overall Study||0||
60127281|NCT04650217|76249204|FG003|NOT COMPLETED|Overall Study||0||
60127282|NCT04650217|76249205|FG004|NOT COMPLETED|Overall Study||1||
60127283|NCT01479985|76249219|FG000|STARTED|Overall Study||167||
60127284|NCT01479985|76249220|FG001|STARTED|Overall Study||86||
60127285|NCT01479985|76249219|FG000|Baseline Survey|Overall Study||166||
60127286|NCT01479985|76249220|FG001|Baseline Survey|Overall Study||85||
60127287|NCT01479985|76249219|FG000|COMPLETED|Overall Study||161||
60127288|NCT01479985|76249220|FG001|COMPLETED|Overall Study||80||
60127289|NCT01479985|76249219|FG000|NOT COMPLETED|Overall Study||6||
60127290|NCT01479985|76249220|FG001|NOT COMPLETED|Overall Study||6||
60127291|NCT02074345|76249226|FG000|STARTED|Overall Study||31||
60127292|NCT02074345|76249226|FG000|COMPLETED|Overall Study||31||
60127293|NCT02074345|76249226|FG000|NOT COMPLETED|Overall Study||0||
60127294|NCT01462435|76249234|FG000|STARTED|Overall Study||106||
60127295|NCT01462435|76249235|FG001|STARTED|Overall Study||109||
60127296|NCT01462435|76249236|FG002|STARTED|Overall Study||107||
60127297|NCT01462435|76249237|FG003|STARTED|Overall Study||106||
60127298|NCT01462435|76249234|FG000|COMPLETED|Overall Study||105||
60127299|NCT01462435|76249235|FG001|COMPLETED|Overall Study||109||
60127300|NCT01462435|76249236|FG002|COMPLETED|Overall Study||106||
60127301|NCT01462435|76249237|FG003|COMPLETED|Overall Study||101||
60127302|NCT01462435|76249234|FG000|NOT COMPLETED|Overall Study||1||
60127303|NCT01462435|76249235|FG001|NOT COMPLETED|Overall Study||0||
60127304|NCT01462435|76249236|FG002|NOT COMPLETED|Overall Study||1||
60127305|NCT01462435|76249237|FG003|NOT COMPLETED|Overall Study||5||
60127306|NCT01472081|76249253|FG000|STARTED|Overall Study||7||
60127307|NCT01472081|76249254|FG001|STARTED|Overall Study||26||
60127308|NCT01472081|76249255|FG002|STARTED|Overall Study||20||
60127309|NCT01472081|76249256|FG003|STARTED|Overall Study||47||
60127310|NCT01472081|76249257|FG004|STARTED|Overall Study||47||
60127311|NCT01472081|76249258|FG005|STARTED|Overall Study||6||
60127312|NCT01472081|76249253|FG000|COMPLETED|Overall Study||0||
60127313|NCT01472081|76249254|FG001|COMPLETED|Overall Study||0||
60127314|NCT01472081|76249255|FG002|COMPLETED|Overall Study||0||
60127315|NCT01472081|76249256|FG003|COMPLETED|Overall Study||1||
60127316|NCT01472081|76249257|FG004|COMPLETED|Overall Study||0||
60127317|NCT01472081|76249258|FG005|COMPLETED|Overall Study||0||
60127318|NCT01472081|76249253|FG000|NOT COMPLETED|Overall Study||7||
60127319|NCT01472081|76249254|FG001|NOT COMPLETED|Overall Study||26||
60127320|NCT01472081|76249255|FG002|NOT COMPLETED|Overall Study||20||
60127321|NCT01472081|76249256|FG003|NOT COMPLETED|Overall Study||46||
60127322|NCT01472081|76249257|FG004|NOT COMPLETED|Overall Study||47||
60127323|NCT01472081|76249258|FG005|NOT COMPLETED|Overall Study||6||
60127324|NCT01471691|76249273|FG000|STARTED|Overall Study||8||
60127325|NCT01471691|76249274|FG001|STARTED|Overall Study||6||
60127326|NCT01471691|76249273|FG000|COMPLETED|Overall Study||8||
60127327|NCT01471691|76249274|FG001|COMPLETED|Overall Study||5||
60127328|NCT01471691|76249273|FG000|NOT COMPLETED|Overall Study||0||
60127329|NCT01471691|76249274|FG001|NOT COMPLETED|Overall Study||1||
60127330|NCT01471379|76249283|FG000|STARTED|Overall Study||1||
60127331|NCT01471379|76249284|FG001|STARTED|Overall Study||1||
60127332|NCT01471379|76249285|FG002|STARTED|Overall Study||0||
60127333|NCT01471379|76249283|FG000|COMPLETED|Overall Study||0||
60127334|NCT01471379|76249284|FG001|COMPLETED|Overall Study||0||
60127335|NCT01471379|76249285|FG002|COMPLETED|Overall Study||0||
60127336|NCT01471379|76249283|FG000|NOT COMPLETED|Overall Study||1||
60127337|NCT01471379|76249284|FG001|NOT COMPLETED|Overall Study||1||
60127338|NCT01471379|76249285|FG002|NOT COMPLETED|Overall Study||0||
60127339|NCT01470989|76249296|FG000|STARTED|Overall Study||227||
60127340|NCT01470989|76249297|FG001|STARTED|Overall Study||229||
60127341|NCT01470989|76249296|FG000|Completed Core Study|Overall Study||208||
60127342|NCT01470989|76249297|FG001|Completed Core Study|Overall Study||208||
60127343|NCT01470989|76249296|FG000|Entered Extension 1 Study|Overall Study||174||
60127344|NCT01470989|76249297|FG001|Entered Extension 1 Study|Overall Study||161||
60127345|NCT01470989|76249296|FG000|Completed Extension 1 Study|Overall Study||165||
60127346|NCT01470989|76249297|FG001|Completed Extension 1 Study|Overall Study||152||
60127347|NCT01470989|76249296|FG000|Entered Extension 2 Study|Overall Study||141||
60127348|NCT01470989|76249297|FG001|Entered Extension 2 Study|Overall Study||131||
60127349|NCT01470989|76249296|FG000|Completed Extension 2 Study|Overall Study||132||
60127350|NCT01470989|76249297|FG001|Completed Extension 2 Study|Overall Study||117||
59595136|NCT03292952|75704171|FG002|NOT COMPLETED|Double-Blind Treatment Phase||1||
59595137|NCT03296072|75704180|FG000|STARTED|Treatment Period 1||10||
59595138|NCT03296072|75704181|FG001|STARTED|Treatment Period 1||11||
59595139|NCT03296072|75704182|FG002|STARTED|Treatment Period 1||10||
60127351|NCT01470989|76249296|FG000|Entered Extension 3|Overall Study||87||
60127352|NCT01470989|76249297|FG001|Entered Extension 3|Overall Study||49||
60127353|NCT01470989|76249296|FG000|COMPLETED|Overall Study||79||
60127354|NCT01470989|76249297|FG001|COMPLETED|Overall Study||43||
60127355|NCT01470989|76249296|FG000|NOT COMPLETED|Overall Study||148||
60127356|NCT01470989|76249297|FG001|NOT COMPLETED|Overall Study||186||
60127357|NCT01470599|76249307|FG000|STARTED|Overall Study||62||
60127358|NCT01470599|76249308|FG001|STARTED|Overall Study||88||
60127359|NCT01470599|76249307|FG000|COMPLETED|Overall Study||43||
60127360|NCT01470599|76249308|FG001|COMPLETED|Overall Study||45||
60127361|NCT01470599|76249307|FG000|NOT COMPLETED|Overall Study||19||
60127362|NCT01470599|76249308|FG001|NOT COMPLETED|Overall Study||43||
60127363|NCT01469819|76249314|FG000|STARTED|Overall Study||37||
60127364|NCT01469819|76249314|FG000|COMPLETED|Overall Study||29||
60127365|NCT01469819|76249314|FG000|NOT COMPLETED|Overall Study||8||
60127366|NCT01507831|76249326|FG000|STARTED|Overall Study|Randomized|788||
60127367|NCT01507831|76249327|FG001|STARTED|Overall Study|Randomized|1553||
60127368|NCT01507831|76249326|FG000|Treated|Overall Study||788||
60127369|NCT01507831|76249327|FG001|Treated|Overall Study||1550||
60127370|NCT01507831|76249326|FG000|COMPLETED|Overall Study||595||
60127371|NCT01507831|76249327|FG001|COMPLETED|Overall Study||1113||
60127372|NCT01507831|76249326|FG000|NOT COMPLETED|Overall Study||193||
60127373|NCT01507831|76249327|FG001|NOT COMPLETED|Overall Study||440||
60127374|NCT01479595|76249335|FG000|STARTED|Overall Study||44||
60127375|NCT01479595|76249336|FG001|STARTED|Overall Study||21||
60127376|NCT01479595|76249335|FG000|PK Analysis Set|Overall Study||42||
60127377|NCT01479595|76249336|FG001|PK Analysis Set|Overall Study||0||
60127378|NCT01479595|76249335|FG000|Per Protocol Analysis Set|Overall Study||41||
60127379|NCT01479595|76249336|FG001|Per Protocol Analysis Set|Overall Study||20||
60127380|NCT01479595|76249335|FG000|COMPLETED|Overall Study||42||
60127381|NCT01479595|76249336|FG001|COMPLETED|Overall Study||19||
60127382|NCT01479595|76249335|FG000|NOT COMPLETED|Overall Study||2||
60127383|NCT01479595|76249336|FG001|NOT COMPLETED|Overall Study||2||
60127384|NCT01462357|76249345|FG000|STARTED|Overall Study||359||
60127385|NCT01462357|76249346|FG001|STARTED|Overall Study||358||
60127386|NCT01462357|76249347|FG002|STARTED|Overall Study||358||
60127387|NCT01462357|76249345|FG000|COMPLETED|Overall Study||351||
60127388|NCT01462357|76249346|FG001|COMPLETED|Overall Study||339||
60127389|NCT01462357|76249347|FG002|COMPLETED|Overall Study||346||
60127390|NCT01462357|76249345|FG000|NOT COMPLETED|Overall Study||8||
60127391|NCT01462357|76249346|FG001|NOT COMPLETED|Overall Study||19||
60127392|NCT01462357|76249347|FG002|NOT COMPLETED|Overall Study||12||
60127393|NCT01479439|76249358|FG000|STARTED|Overall Study||15||
60127394|NCT01479439|76249359|FG001|STARTED|Overall Study||13||
60127395|NCT01479439|76249360|FG002|STARTED|Overall Study||8||
60127396|NCT01479439|76249358|FG000|COMPLETED|Overall Study||14||
60127397|NCT01479439|76249359|FG001|COMPLETED|Overall Study||12||
60127398|NCT01479439|76249360|FG002|COMPLETED|Overall Study||6||
60127399|NCT01479439|76249358|FG000|NOT COMPLETED|Overall Study||1||
60127400|NCT01479439|76249359|FG001|NOT COMPLETED|Overall Study||1||
60127401|NCT01479439|76249360|FG002|NOT COMPLETED|Overall Study||2||
60127402|NCT01478971|76249371|FG000|STARTED|Standard of Care Period||184||
60127403|NCT01478971|76249371|FG000|Received Treatment|Standard of Care Period||178||
60127404|NCT01478971|76249371|FG000|COMPLETED|Standard of Care Period||159||
60127405|NCT01478971|76249371|FG000|NOT COMPLETED|Standard of Care Period||25||
60127406|NCT01478971|76249371|FG000|STARTED|Peginesatide Treatment Period|2 participants terminated the study before transitioning to peginesatide for unknown reasons|157||
60127407|NCT01478971|76249371|FG000|COMPLETED|Peginesatide Treatment Period||143||
60127408|NCT01478971|76249371|FG000|NOT COMPLETED|Peginesatide Treatment Period||14||
60127409|NCT01507051|76249383|FG000|STARTED|Overall Study||29||
60127410|NCT01507051|76249384|FG001|STARTED|Overall Study||31||
60127411|NCT01507051|76249385|FG002|STARTED|Overall Study||29||
60127412|NCT01507051|76249386|FG003|STARTED|Overall Study||7||
60127413|NCT01507051|76249383|FG000|Warfarin run-in Phase|Overall Study||28||
60127414|NCT01507051|76249384|FG001|Warfarin run-in Phase|Overall Study||28||
60127415|NCT01507051|76249385|FG002|Warfarin run-in Phase|Overall Study||0||
60127416|NCT01507051|76249386|FG003|Warfarin run-in Phase|Overall Study|Safety Population: in RG4|7||
60127417|NCT01507051|76249383|FG000|Received Placebo or Rivaroxaban|Overall Study|Safety Population: in RG1 and in RG4 (RG = Reporting Group for Safety Data)|28||
60127418|NCT01507051|76249384|FG001|Received Placebo or Rivaroxaban|Overall Study|Safety Population: in RG2 and in RG4|28||
60127419|NCT01507051|76249385|FG002|Received Placebo or Rivaroxaban|Overall Study|Safety Population: in RG3|28||
60127420|NCT01507051|76249386|FG003|Received Placebo or Rivaroxaban|Overall Study||0||
60127421|NCT01507051|76249383|FG000|COMPLETED|Overall Study||27||
60127422|NCT01507051|76249384|FG001|COMPLETED|Overall Study||28||
60127423|NCT01507051|76249385|FG002|COMPLETED|Overall Study||28||
60127424|NCT01507051|76249386|FG003|COMPLETED|Overall Study||0||
60127425|NCT01507051|76249383|FG000|NOT COMPLETED|Overall Study||2||
60127426|NCT01507051|76249384|FG001|NOT COMPLETED|Overall Study||3||
60127427|NCT01507051|76249385|FG002|NOT COMPLETED|Overall Study||1||
60127428|NCT01507051|76249386|FG003|NOT COMPLETED|Overall Study||7||
60127429|NCT01478347|76249396|FG000|STARTED|Visit 1-Visit 3 (Day 0-91) - Part I||18||
60127430|NCT01478347|76249396|FG000|COMPLETED|Visit 1-Visit 3 (Day 0-91) - Part I||17||
60127431|NCT01478347|76249396|FG000|NOT COMPLETED|Visit 1-Visit 3 (Day 0-91) - Part I||1||
60127432|NCT01478347|76249396|FG000|STARTED|Visit 4-Visit 7 (Day 151-331) - Part II||12||
59595140|NCT03296072|75704183|FG003|STARTED|Treatment Period 1||10||
59595141|NCT03296072|75704184|FG004|STARTED|Treatment Period 1||10||
59595142|NCT03296072|75704185|FG005|STARTED|Treatment Period 1||11||
59728374|NCT00812929|75847158|FG009|STARTED|Washout Period 2 (7 Days)||5||
60127433|NCT01478347|76249396|FG000|COMPLETED|Visit 4-Visit 7 (Day 151-331) - Part II||4||
60127434|NCT01478347|76249396|FG000|NOT COMPLETED|Visit 4-Visit 7 (Day 151-331) - Part II||8||
60127435|NCT01478113|76249402|FG000|STARTED|Overall Study||2||
60127436|NCT01478113|76249403|FG001|STARTED|Overall Study||2||
60127437|NCT01478113|76249402|FG000|COMPLETED|Overall Study||1||
59595143|NCT03296072|75704180|FG000|COMPLETED|Treatment Period 1||10||
60127438|NCT01478113|76249403|FG001|COMPLETED|Overall Study||1||
60127439|NCT01478113|76249402|FG000|NOT COMPLETED|Overall Study||1||
60127440|NCT01478113|76249403|FG001|NOT COMPLETED|Overall Study||1||
60127441|NCT01506271|76249414|FG000|STARTED|Overall Study||118||
60127442|NCT01506271|76249415|FG001|STARTED|Overall Study||116||
60127443|NCT01506271|76249416|FG002|STARTED|Overall Study||117||
60127444|NCT01506271|76249414|FG000|Treated|Overall Study||117||
60127445|NCT01506271|76249415|FG001|Treated|Overall Study||116||
60127446|NCT01506271|76249416|FG002|Treated|Overall Study||114||
60127447|NCT01506271|76249414|FG000|COMPLETED|Overall Study||114||
60127448|NCT01506271|76249415|FG001|COMPLETED|Overall Study||109||
60127449|NCT01506271|76249416|FG002|COMPLETED|Overall Study||114||
60127450|NCT01506271|76249414|FG000|NOT COMPLETED|Overall Study||4||
60127451|NCT01506271|76249415|FG001|NOT COMPLETED|Overall Study||7||
60127452|NCT01506271|76249416|FG002|NOT COMPLETED|Overall Study||3||
60127453|NCT01506193|76249427|FG000|STARTED|Overall Study||351||
60127454|NCT01506193|76249428|FG001|STARTED|Overall Study||183||
60127455|NCT01506193|76249429|FG002|STARTED|Overall Study||182||
60127456|NCT01506193|76249427|FG000|COMPLETED|Overall Study||337||
60127457|NCT01506193|76249428|FG001|COMPLETED|Overall Study||179||
60127458|NCT01506193|76249429|FG002|COMPLETED|Overall Study||168||
60127459|NCT01506193|76249427|FG000|NOT COMPLETED|Overall Study||14||
60127460|NCT01506193|76249428|FG001|NOT COMPLETED|Overall Study||4||
60127461|NCT01506193|76249429|FG002|NOT COMPLETED|Overall Study||14||
60127462|NCT01505881|76249440|FG000|STARTED|Overall Study||99||
60127463|NCT01505881|76249441|FG001|STARTED|Overall Study||59||
60127464|NCT01505881|76249440|FG000|COMPLETED|Overall Study||95||
60127465|NCT01505881|76249441|FG001|COMPLETED|Overall Study||58||
60127466|NCT01505881|76249440|FG000|NOT COMPLETED|Overall Study||4||
60127467|NCT01505881|76249441|FG001|NOT COMPLETED|Overall Study||1||
60127468|NCT01462045|76249451|FG000|STARTED|Overall Study||11||
60127469|NCT01462045|76249452|FG001|STARTED|Overall Study||11||
60127470|NCT01462045|76249453|FG002|STARTED|Overall Study||7||
60127471|NCT01462045|76249451|FG000|COMPLETED|Overall Study||11||
60127472|NCT01462045|76249452|FG001|COMPLETED|Overall Study||10||
60127473|NCT01462045|76249453|FG002|COMPLETED|Overall Study||7||
60127474|NCT01462045|76249451|FG000|NOT COMPLETED|Overall Study||0||
60127475|NCT01462045|76249452|FG001|NOT COMPLETED|Overall Study||1||
60127476|NCT01462045|76249453|FG002|NOT COMPLETED|Overall Study||0||
60127477|NCT01505647|76249463|FG000|STARTED|Day 1 Through Day 42 Follow-up||332||
60127478|NCT01505647|76249464|FG001|STARTED|Day 1 Through Day 42 Follow-up||166||
60127479|NCT01505647|76249463|FG000|Vaccinated|Day 1 Through Day 42 Follow-up||331||
60127480|NCT01505647|76249464|FG001|Vaccinated|Day 1 Through Day 42 Follow-up||166||
60127481|NCT01505647|76249463|FG000|COMPLETED|Day 1 Through Day 42 Follow-up||329||
60127482|NCT01505647|76249464|FG001|COMPLETED|Day 1 Through Day 42 Follow-up||166||
60127483|NCT01505647|76249463|FG000|NOT COMPLETED|Day 1 Through Day 42 Follow-up||3||
60127484|NCT01505647|76249464|FG001|NOT COMPLETED|Day 1 Through Day 42 Follow-up||0||
60127485|NCT01505647|76249463|FG000|STARTED|Day 43 Through Day 182 Follow-up||329||
60127486|NCT01505647|76249464|FG001|STARTED|Day 43 Through Day 182 Follow-up||166||
60127487|NCT01505647|76249463|FG000|COMPLETED|Day 43 Through Day 182 Follow-up||328||
60127488|NCT01505647|76249464|FG001|COMPLETED|Day 43 Through Day 182 Follow-up||163||
60127489|NCT01505647|76249463|FG000|NOT COMPLETED|Day 43 Through Day 182 Follow-up||1||
60127490|NCT01505647|76249464|FG001|NOT COMPLETED|Day 43 Through Day 182 Follow-up||3||
60127491|NCT01461811|76249472|FG000|STARTED|Overall Study||95||
60127492|NCT01461811|76249473|FG001|STARTED|Overall Study||49||
60127493|NCT01461811|76249472|FG000|COMPLETED|Overall Study||91||
60127494|NCT01461811|76249473|FG001|COMPLETED|Overall Study||46||
60127495|NCT01461811|76249472|FG000|NOT COMPLETED|Overall Study||4||
60127496|NCT01461811|76249473|FG001|NOT COMPLETED|Overall Study||3||
60127497|NCT01505491|76249482|FG000|STARTED|Overall Study||67||
60127498|NCT01505491|76249483|FG001|STARTED|Overall Study||62||
60127499|NCT01505491|76249484|FG002|STARTED|Overall Study||64||
60127500|NCT01505491|76249482|FG000|COMPLETED|Overall Study||65||
60127501|NCT01505491|76249483|FG001|COMPLETED|Overall Study||61||
60127502|NCT01505491|76249484|FG002|COMPLETED|Overall Study||59||
60127503|NCT01505491|76249482|FG000|NOT COMPLETED|Overall Study||2||
60127504|NCT01505491|76249483|FG001|NOT COMPLETED|Overall Study||1||
60127505|NCT01505491|76249484|FG002|NOT COMPLETED|Overall Study||5||
60127506|NCT01504867|76249494|FG000|STARTED|Overall Study||202||
59595144|NCT03296072|75704181|FG001|COMPLETED|Treatment Period 1||11||
60127507|NCT01504867|76249495|FG001|STARTED|Overall Study||198||
60127508|NCT01504867|76249494|FG000|COMPLETED|Overall Study||195||
60127509|NCT01504867|76249495|FG001|COMPLETED|Overall Study||195||
60127510|NCT01504867|76249494|FG000|NOT COMPLETED|Overall Study||7||
60127511|NCT01504867|76249495|FG001|NOT COMPLETED|Overall Study||3||
60127512|NCT01476475|76249503|FG000|STARTED|Overall Study||161||
60127513|NCT01476475|76249504|FG001|STARTED|Overall Study||162||
60127514|NCT01476475|76249503|FG000|COMPLETED|Overall Study||150||
60127515|NCT01476475|76249504|FG001|COMPLETED|Overall Study||159||
60127516|NCT01476475|76249503|FG000|NOT COMPLETED|Overall Study||11||
60127517|NCT01476475|76249504|FG001|NOT COMPLETED|Overall Study||3||
60127518|NCT01475851|76249513|FG000|STARTED|Overall Study||13||
60127519|NCT01475851|76249514|FG001|STARTED|Overall Study||21||
60127520|NCT01475851|76249513|FG000|COMPLETED|Overall Study||12||
60127521|NCT01475851|76249514|FG001|COMPLETED|Overall Study||21||
60127522|NCT01475851|76249513|FG000|NOT COMPLETED|Overall Study||1||
60127523|NCT01475851|76249514|FG001|NOT COMPLETED|Overall Study||0||
60127524|NCT01460719|76249520|FG000|STARTED|Overall Study||80||
60127525|NCT01460719|76249520|FG000|Vaccination 1 (Day 1)|Overall Study||80||
60127526|NCT01460719|76249520|FG000|Vaccination 2 (~Day 30)|Overall Study||78||
60127527|NCT01460719|76249520|FG000|Vaccination 3 (~Day 60)|Overall Study||78||
59728375|NCT00812929|75847149|FG000|COMPLETED|Washout Period 2 (7 Days)||5||
59728376|NCT00812929|75847150|FG001|COMPLETED|Washout Period 2 (7 Days)||4||
59728377|NCT00812929|75847151|FG002|COMPLETED|Washout Period 2 (7 Days)||4||
59728378|NCT00812929|75847152|FG003|COMPLETED|Washout Period 2 (7 Days)||4||
59728379|NCT00812929|75847153|FG004|COMPLETED|Washout Period 2 (7 Days)||5||
59728380|NCT00812929|75847154|FG005|COMPLETED|Washout Period 2 (7 Days)||5||
59728381|NCT00812929|75847155|FG006|COMPLETED|Washout Period 2 (7 Days)||5||
59728382|NCT00812929|75847156|FG007|COMPLETED|Washout Period 2 (7 Days)||5||
59728383|NCT00812929|75847157|FG008|COMPLETED|Washout Period 2 (7 Days)||4||
59728384|NCT00812929|75847158|FG009|COMPLETED|Washout Period 2 (7 Days)||4||
59728385|NCT00812929|75847149|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0||
59728386|NCT00812929|75847150|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0||
59728387|NCT00812929|75847151|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0||
59728388|NCT00812929|75847152|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0||
59728389|NCT00812929|75847153|FG004|NOT COMPLETED|Washout Period 2 (7 Days)||0||
59728390|NCT00812929|75847154|FG005|NOT COMPLETED|Washout Period 2 (7 Days)||0||
59728391|NCT00812929|75847155|FG006|NOT COMPLETED|Washout Period 2 (7 Days)||0||
59728392|NCT00812929|75847156|FG007|NOT COMPLETED|Washout Period 2 (7 Days)||0||
59728393|NCT00812929|75847157|FG008|NOT COMPLETED|Washout Period 2 (7 Days)||0||
59728394|NCT00812929|75847158|FG009|NOT COMPLETED|Washout Period 2 (7 Days)||1||
59728395|NCT00812929|75847149|FG000|STARTED|Treatment Period 3||5||
59728396|NCT00812929|75847150|FG001|STARTED|Treatment Period 3||4||
59728397|NCT00812929|75847151|FG002|STARTED|Treatment Period 3||4||
59728398|NCT00812929|75847152|FG003|STARTED|Treatment Period 3||4||
59728399|NCT00812929|75847153|FG004|STARTED|Treatment Period 3||5||
59728400|NCT00812929|75847154|FG005|STARTED|Treatment Period 3||5||
59728401|NCT00812929|75847155|FG006|STARTED|Treatment Period 3||5||
59728402|NCT00812929|75847156|FG007|STARTED|Treatment Period 3||5||
59728403|NCT00812929|75847157|FG008|STARTED|Treatment Period 3||4||
59728404|NCT00812929|75847158|FG009|STARTED|Treatment Period 3||4||
59728405|NCT00812929|75847149|FG000|COMPLETED|Treatment Period 3||5||
59728406|NCT00812929|75847150|FG001|COMPLETED|Treatment Period 3||4||
59728407|NCT00812929|75847151|FG002|COMPLETED|Treatment Period 3||4||
59728408|NCT00812929|75847152|FG003|COMPLETED|Treatment Period 3||4||
59728409|NCT00812929|75847153|FG004|COMPLETED|Treatment Period 3||5||
60127528|NCT01460719|76249520|FG000|Vaccination 4 (~Day 90)|Overall Study||78||
60127529|NCT01460719|76249520|FG000|COMPLETED|Overall Study||78||
60127530|NCT01460719|76249520|FG000|NOT COMPLETED|Overall Study||2||
60127531|NCT00527943|76249526|FG000|STARTED|Overall Study||6471||
60127532|NCT00527943|76249527|FG001|STARTED|Overall Study||6473||
60127533|NCT00527943|76249526|FG000|Received Treatment|Overall Study||6441||
60127534|NCT00527943|76249527|FG001|Received Treatment|Overall Study||6446||
60127535|NCT00527943|76249526|FG000|COMPLETED|Overall Study||6311||
60127536|NCT00527943|76249527|FG001|COMPLETED|Overall Study||6327||
60127537|NCT00527943|76249526|FG000|NOT COMPLETED|Overall Study||160||
60127538|NCT00527943|76249527|FG001|NOT COMPLETED|Overall Study||146||
60127539|NCT00448227|76249533|FG000|STARTED|Overall Study||18||
60127540|NCT00448227|76249533|FG000|COMPLETED|Overall Study||18||
60127541|NCT00448227|76249533|FG000|NOT COMPLETED|Overall Study||0||
60127542|NCT00529191|76249542|FG000|STARTED|Overall Study||27||
60127543|NCT00529191|76249543|FG001|STARTED|Overall Study||13||
60127544|NCT00529191|76249542|FG000|COMPLETED|Overall Study||24||
60127545|NCT00529191|76249543|FG001|COMPLETED|Overall Study||13||
60127546|NCT00529191|76249542|FG000|NOT COMPLETED|Overall Study||3||
60127547|NCT00529191|76249543|FG001|NOT COMPLETED|Overall Study||0||
60127548|NCT00459303|76249558|FG000|STARTED|Overall Study||20||
60127549|NCT00459303|76249558|FG000|COMPLETED|Overall Study||20||
60127550|NCT00459303|76249558|FG000|NOT COMPLETED|Overall Study||0||
60127551|NCT00459381|76249566|FG000|STARTED|Overall Study||35||
60127552|NCT00459381|76249566|FG000|COMPLETED|Overall Study||35||
60127553|NCT00459381|76249566|FG000|NOT COMPLETED|Overall Study||0||
60127554|NCT00449007|76249572|FG000|STARTED|Overall Study||2||
60127555|NCT00449007|76249573|FG001|STARTED|Overall Study||3||
60127556|NCT00449007|76249572|FG000|COMPLETED|Overall Study||2||
60127557|NCT00449007|76249573|FG001|COMPLETED|Overall Study||3||
60127558|NCT00449007|76249572|FG000|NOT COMPLETED|Overall Study||0||
60127559|NCT00449007|76249573|FG001|NOT COMPLETED|Overall Study||0||
60127560|NCT00460551|76249581|FG000|STARTED|Overall Study||13||
60127561|NCT00460551|76249581|FG000|COMPLETED|Overall Study|The trial was terminated after Period 1A. Only safety was measured.|13||
59728410|NCT00812929|75847154|FG005|COMPLETED|Treatment Period 3||5||
59728411|NCT00812929|75847155|FG006|COMPLETED|Treatment Period 3||5||
59728412|NCT00812929|75847156|FG007|COMPLETED|Treatment Period 3||5||
59728413|NCT00812929|75847157|FG008|COMPLETED|Treatment Period 3||4||
59728414|NCT00812929|75847158|FG009|COMPLETED|Treatment Period 3||4||
60127562|NCT00460551|76249581|FG000|NOT COMPLETED|Overall Study||0||
60127563|NCT01468181|76249590|FG000|STARTED|Overall Study||131||
60127564|NCT01468181|76249591|FG001|STARTED|Overall Study||61||
60127565|NCT01468181|76249592|FG002|STARTED|Overall Study||65||
60127566|NCT01468181|76249593|FG003|STARTED|Overall Study||66||
60127567|NCT01468181|76249594|FG004|STARTED|Overall Study||71||
60127568|NCT01468181|76249590|FG000|Received at Least 1 Dose of Study Drug|Overall Study||131||
60127569|NCT01468181|76249591|FG001|Received at Least 1 Dose of Study Drug|Overall Study||61||
60127570|NCT01468181|76249592|FG002|Received at Least 1 Dose of Study Drug|Overall Study||65||
60127571|NCT01468181|76249593|FG003|Received at Least 1 Dose of Study Drug|Overall Study||66||
60127572|NCT01468181|76249594|FG004|Received at Least 1 Dose of Study Drug|Overall Study||71||
60127573|NCT01468181|76249590|FG000|COMPLETED|Overall Study||121||
60127574|NCT01468181|76249591|FG001|COMPLETED|Overall Study||59||
60127575|NCT01468181|76249592|FG002|COMPLETED|Overall Study||57||
60127576|NCT01468181|76249593|FG003|COMPLETED|Overall Study||63||
60127577|NCT01468181|76249594|FG004|COMPLETED|Overall Study||66||
60127578|NCT01468181|76249590|FG000|NOT COMPLETED|Overall Study||10||
60127579|NCT01468181|76249591|FG001|NOT COMPLETED|Overall Study||2||
60127580|NCT01468181|76249592|FG002|NOT COMPLETED|Overall Study||8||
60127581|NCT01468181|76249593|FG003|NOT COMPLETED|Overall Study||3||
60127582|NCT01468181|76249594|FG004|NOT COMPLETED|Overall Study||5||
60127583|NCT01693562|76249629|FG000|STARTED|Escalation Phase||4||
60127584|NCT01693562|76249630|FG001|STARTED|Escalation Phase||4||
60127585|NCT01693562|76249631|FG002|STARTED|Escalation Phase||3||
60127586|NCT01693562|76249632|FG003|STARTED|Escalation Phase||3||
60127587|NCT01693562|76249633|FG004|STARTED|Escalation Phase||6||
60127588|NCT01693562|76249634|FG005|STARTED|Escalation Phase||7||
60127589|NCT01693562|76249635|FG006|STARTED|Escalation Phase||0||
60127590|NCT01693562|76249636|FG007|STARTED|Escalation Phase||0||
60127591|NCT01693562|76249637|FG008|STARTED|Escalation Phase||0||
60127592|NCT01693562|76249638|FG009|STARTED|Escalation Phase||0||
60127593|NCT01693562|76249639|FG010|STARTED|Escalation Phase||0||
60127594|NCT01693562|76249640|FG011|STARTED|Escalation Phase||0||
60127595|NCT01693562|76249641|FG012|STARTED|Escalation Phase||0||
60127596|NCT01693562|76249642|FG013|STARTED|Escalation Phase||0||
60127597|NCT01693562|76249643|FG014|STARTED|Escalation Phase||0||
60127598|NCT01693562|76249644|FG015|STARTED|Escalation Phase||0||
59595145|NCT03296072|75704182|FG002|COMPLETED|Treatment Period 1||10||
59595146|NCT03296072|75704183|FG003|COMPLETED|Treatment Period 1||10||
59595147|NCT03296072|75704184|FG004|COMPLETED|Treatment Period 1||10||
59595148|NCT03296072|75704185|FG005|COMPLETED|Treatment Period 1||11||
60127599|NCT01693562|76249645|FG016|STARTED|Escalation Phase||0||
60127600|NCT01693562|76249646|FG017|STARTED|Escalation Phase||0||
60127601|NCT01693562|76249647|FG018|STARTED|Escalation Phase||0||
60127602|NCT01693562|76249648|FG019|STARTED|Escalation Phase||0||
60127603|NCT01693562|76249649|FG020|STARTED|Escalation Phase||0||
60127604|NCT01693562|76249650|FG021|STARTED|Escalation Phase||0||
60127605|NCT01693562|76249651|FG022|STARTED|Escalation Phase||0||
60127606|NCT01693562|76249629|FG000|COMPLETED|Escalation Phase||0||
60127607|NCT01693562|76249630|FG001|COMPLETED|Escalation Phase||0||
60127608|NCT01693562|76249631|FG002|COMPLETED|Escalation Phase||0||
60127609|NCT01693562|76249632|FG003|COMPLETED|Escalation Phase||0||
60127610|NCT01693562|76249633|FG004|COMPLETED|Escalation Phase||0||
60127611|NCT01693562|76249634|FG005|COMPLETED|Escalation Phase||0||
60127612|NCT01693562|76249635|FG006|COMPLETED|Escalation Phase||0||
60127613|NCT01693562|76249636|FG007|COMPLETED|Escalation Phase||0||
60127614|NCT01693562|76249637|FG008|COMPLETED|Escalation Phase||0||
60127615|NCT01693562|76249638|FG009|COMPLETED|Escalation Phase||0||
60127616|NCT01693562|76249639|FG010|COMPLETED|Escalation Phase||0||
60127617|NCT01693562|76249640|FG011|COMPLETED|Escalation Phase||0||
60127618|NCT01693562|76249641|FG012|COMPLETED|Escalation Phase||0||
60127619|NCT01693562|76249642|FG013|COMPLETED|Escalation Phase||0||
60127620|NCT01693562|76249643|FG014|COMPLETED|Escalation Phase||0||
60127621|NCT01693562|76249644|FG015|COMPLETED|Escalation Phase||0||
60127622|NCT01693562|76249645|FG016|COMPLETED|Escalation Phase||0||
60127623|NCT01693562|76249646|FG017|COMPLETED|Escalation Phase||0||
60127624|NCT01693562|76249647|FG018|COMPLETED|Escalation Phase||0||
60127625|NCT01693562|76249648|FG019|COMPLETED|Escalation Phase||0||
60127626|NCT01693562|76249649|FG020|COMPLETED|Escalation Phase||0||
60127627|NCT01693562|76249650|FG021|COMPLETED|Escalation Phase||0||
60127628|NCT01693562|76249651|FG022|COMPLETED|Escalation Phase||0||
60127629|NCT01693562|76249629|FG000|NOT COMPLETED|Escalation Phase||4||
60127630|NCT01693562|76249630|FG001|NOT COMPLETED|Escalation Phase||4||
60127631|NCT01693562|76249631|FG002|NOT COMPLETED|Escalation Phase||3||
60127632|NCT01693562|76249632|FG003|NOT COMPLETED|Escalation Phase||3||
60127633|NCT01693562|76249633|FG004|NOT COMPLETED|Escalation Phase||6||
60127634|NCT01693562|76249634|FG005|NOT COMPLETED|Escalation Phase||7||
60127635|NCT01693562|76249635|FG006|NOT COMPLETED|Escalation Phase||0||
60127636|NCT01693562|76249636|FG007|NOT COMPLETED|Escalation Phase||0||
60127637|NCT01693562|76249637|FG008|NOT COMPLETED|Escalation Phase||0||
60127638|NCT01693562|76249638|FG009|NOT COMPLETED|Escalation Phase||0||
60127639|NCT01693562|76249639|FG010|NOT COMPLETED|Escalation Phase||0||
60127640|NCT01693562|76249640|FG011|NOT COMPLETED|Escalation Phase||0||
60127641|NCT01693562|76249641|FG012|NOT COMPLETED|Escalation Phase||0||
60127642|NCT01693562|76249642|FG013|NOT COMPLETED|Escalation Phase||0||
60127643|NCT01693562|76249643|FG014|NOT COMPLETED|Escalation Phase||0||
60127644|NCT01693562|76249644|FG015|NOT COMPLETED|Escalation Phase||0||
60127645|NCT01693562|76249645|FG016|NOT COMPLETED|Escalation Phase||0||
60127646|NCT01693562|76249646|FG017|NOT COMPLETED|Escalation Phase||0||
60127647|NCT01693562|76249647|FG018|NOT COMPLETED|Escalation Phase||0||
60127648|NCT01693562|76249648|FG019|NOT COMPLETED|Escalation Phase||0||
60127649|NCT01693562|76249649|FG020|NOT COMPLETED|Escalation Phase||0||
60127650|NCT01693562|76249650|FG021|NOT COMPLETED|Escalation Phase||0||
60127651|NCT01693562|76249651|FG022|NOT COMPLETED|Escalation Phase||0||
60127652|NCT01693562|76249629|FG000|STARTED|Exploration Phase||0||
60127653|NCT01693562|76249630|FG001|STARTED|Exploration Phase||0||
60127654|NCT01693562|76249631|FG002|STARTED|Exploration Phase||0||
60127655|NCT01693562|76249632|FG003|STARTED|Exploration Phase||0||
60127656|NCT01693562|76249633|FG004|STARTED|Exploration Phase||0||
60127657|NCT01693562|76249634|FG005|STARTED|Exploration Phase||0||
60127658|NCT01693562|76249635|FG006|STARTED|Exploration Phase||21||
60127659|NCT01693562|76249636|FG007|STARTED|Exploration Phase||0||
60127660|NCT01693562|76249637|FG008|STARTED|Exploration Phase||0||
60127661|NCT01693562|76249638|FG009|STARTED|Exploration Phase||0||
60127662|NCT01693562|76249639|FG010|STARTED|Exploration Phase||0||
60127663|NCT01693562|76249640|FG011|STARTED|Exploration Phase||0||
60127664|NCT01693562|76249641|FG012|STARTED|Exploration Phase||0||
60127665|NCT01693562|76249642|FG013|STARTED|Exploration Phase||0||
60127666|NCT01693562|76249643|FG014|STARTED|Exploration Phase||0||
60127667|NCT01693562|76249644|FG015|STARTED|Exploration Phase||0||
60127668|NCT01693562|76249645|FG016|STARTED|Exploration Phase||0||
60127669|NCT01693562|76249646|FG017|STARTED|Exploration Phase||0||
60127670|NCT01693562|76249647|FG018|STARTED|Exploration Phase||0||
60127671|NCT01693562|76249648|FG019|STARTED|Exploration Phase||0||
60127672|NCT01693562|76249649|FG020|STARTED|Exploration Phase||0||
60127673|NCT01693562|76249650|FG021|STARTED|Exploration Phase||0||
60127674|NCT01693562|76249651|FG022|STARTED|Exploration Phase||0||
60127675|NCT01693562|76249629|FG000|COMPLETED|Exploration Phase||0||
60127676|NCT01693562|76249630|FG001|COMPLETED|Exploration Phase||0||
60127677|NCT01693562|76249631|FG002|COMPLETED|Exploration Phase||0||
60127678|NCT01693562|76249632|FG003|COMPLETED|Exploration Phase||0||
60127679|NCT01693562|76249633|FG004|COMPLETED|Exploration Phase||0||
60127680|NCT01693562|76249634|FG005|COMPLETED|Exploration Phase||0||
60127681|NCT01693562|76249635|FG006|COMPLETED|Exploration Phase||0||
60127682|NCT01693562|76249636|FG007|COMPLETED|Exploration Phase||0||
60127683|NCT01693562|76249637|FG008|COMPLETED|Exploration Phase||0||
60127684|NCT01693562|76249638|FG009|COMPLETED|Exploration Phase||0||
60127685|NCT01693562|76249639|FG010|COMPLETED|Exploration Phase||0||
60127686|NCT01693562|76249640|FG011|COMPLETED|Exploration Phase||0||
60127687|NCT01693562|76249641|FG012|COMPLETED|Exploration Phase||0||
60127688|NCT01693562|76249642|FG013|COMPLETED|Exploration Phase||0||
60127689|NCT01693562|76249643|FG014|COMPLETED|Exploration Phase||0||
60127690|NCT01693562|76249644|FG015|COMPLETED|Exploration Phase||0||
60127691|NCT01693562|76249645|FG016|COMPLETED|Exploration Phase||0||
60127692|NCT01693562|76249646|FG017|COMPLETED|Exploration Phase||0||
60127693|NCT01693562|76249647|FG018|COMPLETED|Exploration Phase||0||
60127694|NCT01693562|76249648|FG019|COMPLETED|Exploration Phase||0||
60127695|NCT01693562|76249649|FG020|COMPLETED|Exploration Phase||0||
60127696|NCT01693562|76249650|FG021|COMPLETED|Exploration Phase||0||
60127697|NCT01693562|76249651|FG022|COMPLETED|Exploration Phase||0||
60127698|NCT01693562|76249629|FG000|NOT COMPLETED|Exploration Phase||0||
60127699|NCT01693562|76249630|FG001|NOT COMPLETED|Exploration Phase||0||
60127700|NCT01693562|76249631|FG002|NOT COMPLETED|Exploration Phase||0||
60127701|NCT01693562|76249632|FG003|NOT COMPLETED|Exploration Phase||0||
60127702|NCT01693562|76249633|FG004|NOT COMPLETED|Exploration Phase||0||
60127703|NCT01693562|76249634|FG005|NOT COMPLETED|Exploration Phase||0||
60127704|NCT01693562|76249635|FG006|NOT COMPLETED|Exploration Phase||21||
60127705|NCT01693562|76249636|FG007|NOT COMPLETED|Exploration Phase||0||
60127706|NCT01693562|76249637|FG008|NOT COMPLETED|Exploration Phase||0||
60127707|NCT01693562|76249638|FG009|NOT COMPLETED|Exploration Phase||0||
60127708|NCT01693562|76249639|FG010|NOT COMPLETED|Exploration Phase||0||
60127709|NCT01693562|76249640|FG011|NOT COMPLETED|Exploration Phase||0||
60127710|NCT01693562|76249641|FG012|NOT COMPLETED|Exploration Phase||0||
60127711|NCT01693562|76249642|FG013|NOT COMPLETED|Exploration Phase||0||
60127712|NCT01693562|76249643|FG014|NOT COMPLETED|Exploration Phase||0||
60127713|NCT01693562|76249644|FG015|NOT COMPLETED|Exploration Phase||0||
60127714|NCT01693562|76249645|FG016|NOT COMPLETED|Exploration Phase||0||
60127715|NCT01693562|76249646|FG017|NOT COMPLETED|Exploration Phase||0||
60127716|NCT01693562|76249647|FG018|NOT COMPLETED|Exploration Phase||0||
60127717|NCT01693562|76249648|FG019|NOT COMPLETED|Exploration Phase||0||
60127718|NCT01693562|76249649|FG020|NOT COMPLETED|Exploration Phase||0||
60127719|NCT01693562|76249650|FG021|NOT COMPLETED|Exploration Phase||0||
60127720|NCT01693562|76249651|FG022|NOT COMPLETED|Exploration Phase||0||
60127721|NCT01693562|76249629|FG000|STARTED|Expansion Phase||0||
60127722|NCT01693562|76249630|FG001|STARTED|Expansion Phase||0||
60127723|NCT01693562|76249631|FG002|STARTED|Expansion Phase||0||
60127724|NCT01693562|76249632|FG003|STARTED|Expansion Phase||0||
60127725|NCT01693562|76249633|FG004|STARTED|Expansion Phase||0||
60127726|NCT01693562|76249634|FG005|STARTED|Expansion Phase||0||
60127727|NCT01693562|76249635|FG006|STARTED|Expansion Phase||0||
60127728|NCT01693562|76249636|FG007|STARTED|Expansion Phase||62||
60127729|NCT01693562|76249637|FG008|STARTED|Expansion Phase||22||
60127730|NCT01693562|76249638|FG009|STARTED|Expansion Phase|2 eligible NSCLC participants from dose-escalation were added to the dose expansion summaries.|304||
60127731|NCT01693562|76249639|FG010|STARTED|Expansion Phase||40||
60127732|NCT01693562|76249640|FG011|STARTED|Expansion Phase||21||
60127733|NCT01693562|76249641|FG012|STARTED|Expansion Phase||24||
60127734|NCT01693562|76249642|FG013|STARTED|Expansion Phase||51||
60127735|NCT01693562|76249643|FG014|STARTED|Expansion Phase||40||
60127736|NCT01693562|76249644|FG015|STARTED|Expansion Phase||31||
60127737|NCT01693562|76249645|FG016|STARTED|Expansion Phase||201||
60127738|NCT01693562|76249646|FG017|STARTED|Expansion Phase||20||
60127739|NCT01693562|76249647|FG018|STARTED|Expansion Phase||47||
60127740|NCT01693562|76249648|FG019|STARTED|Expansion Phase||20||
60127741|NCT01693562|76249649|FG020|STARTED|Expansion Phase||21||
60127742|NCT01693562|76249650|FG021|STARTED|Expansion Phase||62||
60127743|NCT01693562|76249651|FG022|STARTED|Expansion Phase||10||
60127744|NCT01693562|76249629|FG000|COMPLETED|Expansion Phase||0||
60127745|NCT01693562|76249630|FG001|COMPLETED|Expansion Phase||0||
60127746|NCT01693562|76249631|FG002|COMPLETED|Expansion Phase||0||
60127747|NCT01693562|76249632|FG003|COMPLETED|Expansion Phase||0||
60127748|NCT01693562|76249633|FG004|COMPLETED|Expansion Phase||0||
60127749|NCT01693562|76249634|FG005|COMPLETED|Expansion Phase||0||
60127750|NCT01693562|76249635|FG006|COMPLETED|Expansion Phase||0||
60127751|NCT01693562|76249636|FG007|COMPLETED|Expansion Phase||0||
60127752|NCT01693562|76249637|FG008|COMPLETED|Expansion Phase||0||
60127753|NCT01693562|76249638|FG009|COMPLETED|Expansion Phase||4||
60127754|NCT01693562|76249639|FG010|COMPLETED|Expansion Phase||0||
60127755|NCT01693562|76249640|FG011|COMPLETED|Expansion Phase||0||
60127756|NCT01693562|76249641|FG012|COMPLETED|Expansion Phase||1||
60127757|NCT01693562|76249642|FG013|COMPLETED|Expansion Phase||0||
60127758|NCT01693562|76249643|FG014|COMPLETED|Expansion Phase||0||
60127759|NCT01693562|76249644|FG015|COMPLETED|Expansion Phase||0||
60127760|NCT01693562|76249645|FG016|COMPLETED|Expansion Phase||4||
60127761|NCT01693562|76249646|FG017|COMPLETED|Expansion Phase||0||
60127762|NCT01693562|76249647|FG018|COMPLETED|Expansion Phase||0||
60127763|NCT01693562|76249648|FG019|COMPLETED|Expansion Phase||0||
60127764|NCT01693562|76249649|FG020|COMPLETED|Expansion Phase||0||
60127765|NCT01693562|76249650|FG021|COMPLETED|Expansion Phase||0||
60127766|NCT01693562|76249651|FG022|COMPLETED|Expansion Phase||0||
60127767|NCT01693562|76249629|FG000|NOT COMPLETED|Expansion Phase||0||
60127768|NCT01693562|76249630|FG001|NOT COMPLETED|Expansion Phase||0||
60127769|NCT01693562|76249631|FG002|NOT COMPLETED|Expansion Phase||0||
60127770|NCT01693562|76249632|FG003|NOT COMPLETED|Expansion Phase||0||
60127771|NCT01693562|76249633|FG004|NOT COMPLETED|Expansion Phase||0||
60127772|NCT01693562|76249634|FG005|NOT COMPLETED|Expansion Phase||0||
60127773|NCT01693562|76249635|FG006|NOT COMPLETED|Expansion Phase||0||
60127774|NCT01693562|76249636|FG007|NOT COMPLETED|Expansion Phase||62||
60127775|NCT01693562|76249637|FG008|NOT COMPLETED|Expansion Phase||22||
60127776|NCT01693562|76249638|FG009|NOT COMPLETED|Expansion Phase||300||
60127777|NCT01693562|76249639|FG010|NOT COMPLETED|Expansion Phase||40||
60127778|NCT01693562|76249640|FG011|NOT COMPLETED|Expansion Phase||21||
60127779|NCT01693562|76249641|FG012|NOT COMPLETED|Expansion Phase||23||
60127780|NCT01693562|76249642|FG013|NOT COMPLETED|Expansion Phase||51||
60127781|NCT01693562|76249643|FG014|NOT COMPLETED|Expansion Phase||40||
60127782|NCT01693562|76249644|FG015|NOT COMPLETED|Expansion Phase||31||
60127783|NCT01693562|76249645|FG016|NOT COMPLETED|Expansion Phase||197||
60127784|NCT01693562|76249646|FG017|NOT COMPLETED|Expansion Phase||20||
60127785|NCT01693562|76249647|FG018|NOT COMPLETED|Expansion Phase||47||
60127786|NCT01693562|76249648|FG019|NOT COMPLETED|Expansion Phase||20||
60127787|NCT01693562|76249649|FG020|NOT COMPLETED|Expansion Phase||21||
60127788|NCT01693562|76249650|FG021|NOT COMPLETED|Expansion Phase||62||
60127789|NCT01693562|76249651|FG022|NOT COMPLETED|Expansion Phase||10||
60127790|NCT00461097|76249736|FG000|STARTED|Overall Study||40||
60127791|NCT00461097|76249737|FG001|STARTED|Overall Study||15||
60127792|NCT00461097|76249736|FG000|Had Month 10 (Wk 44) Oral Food Challenge|Overall Study||35||
60127793|NCT00461097|76249737|FG001|Had Month 10 (Wk 44) Oral Food Challenge|Overall Study||13||
60127794|NCT00461097|76249736|FG000|Had Month 22 (Wk 96) Oral Food Challenge|Overall Study||34||
60127795|NCT00461097|76249737|FG001|Had Month 22 (Wk 96) Oral Food Challenge|Overall Study||1||
60127796|NCT00461097|76249736|FG000|Had Year 3 (Mnth 36) Oral Food Challenge|Overall Study||16||
60127797|NCT00461097|76249737|FG001|Had Year 3 (Mnth 36) Oral Food Challenge|Overall Study||0||
60127798|NCT00461097|76249736|FG000|Had Year 4 (Mnth 48) Oral Food Challenge|Overall Study||7||
60127799|NCT00461097|76249737|FG001|Had Year 4 (Mnth 48) Oral Food Challenge|Overall Study||0||
60127800|NCT00461097|76249736|FG000|COMPLETED|Overall Study|Completed: Participants who were assessed for the primary outcome measure and outcome measure #6.|40||
60127801|NCT00461097|76249737|FG001|COMPLETED|Overall Study|Completed: Participants who were assessed for the primary outcome measure.|15||
60127802|NCT00461097|76249736|FG000|NOT COMPLETED|Overall Study||0||
60127803|NCT00461097|76249737|FG001|NOT COMPLETED|Overall Study||0||
60127804|NCT01467713|76249748|FG000|STARTED|Overall Study||164||
60127805|NCT01467713|76249749|FG001|STARTED|Overall Study||164||
60127806|NCT01467713|76249750|FG002|STARTED|Overall Study||160||
60127807|NCT01467713|76249751|FG003|STARTED|Overall Study||154||
60127808|NCT01467713|76249748|FG000|Safety Analysis Set: Received Treatment|Overall Study||163||
60127809|NCT01467713|76249749|FG001|Safety Analysis Set: Received Treatment|Overall Study||164||
60127810|NCT01467713|76249750|FG002|Safety Analysis Set: Received Treatment|Overall Study||159||
60127811|NCT01467713|76249751|FG003|Safety Analysis Set: Received Treatment|Overall Study||154||
60127812|NCT01467713|76249748|FG000|COMPLETED|Overall Study||62||
60127813|NCT01467713|76249749|FG001|COMPLETED|Overall Study||60||
60127814|NCT01467713|76249750|FG002|COMPLETED|Overall Study||58||
60127815|NCT01467713|76249751|FG003|COMPLETED|Overall Study||45||
60127816|NCT01467713|76249748|FG000|NOT COMPLETED|Overall Study||102||
60127817|NCT01467713|76249749|FG001|NOT COMPLETED|Overall Study||104||
60127818|NCT01467713|76249750|FG002|NOT COMPLETED|Overall Study||102||
60127819|NCT01467713|76249751|FG003|NOT COMPLETED|Overall Study||109||
60127820|NCT00531453|76249763|FG000|STARTED|Overall Study|02 October 2007|49||
60127821|NCT00531453|76249764|FG001|STARTED|Overall Study|02 October 2007|49||
60127822|NCT00531453|76249763|FG000|COMPLETED|Overall Study|10 April 2009|49||
60127823|NCT00531453|76249764|FG001|COMPLETED|Overall Study|10 April 2009|49||
60127824|NCT00531453|76249763|FG000|NOT COMPLETED|Overall Study||0||
60127825|NCT00531453|76249764|FG001|NOT COMPLETED|Overall Study||0||
60127826|NCT00531843|76249772|FG000|STARTED|Overall Study||81||
60127827|NCT00531843|76249773|FG001|STARTED|Overall Study||6||
60127828|NCT00531843|76249772|FG000|COMPLETED|Overall Study||81||
60127829|NCT00531843|76249773|FG001|COMPLETED|Overall Study||6||
60127830|NCT00531843|76249772|FG000|NOT COMPLETED|Overall Study||0||
60127831|NCT00531843|76249773|FG001|NOT COMPLETED|Overall Study||0||
60127832|NCT01693250|76249781|FG000|STARTED|Overall Study|3 months post baseline assessment|23||
60127833|NCT01693250|76249782|FG001|STARTED|Overall Study|three month post baseline assessment|17||
60127834|NCT01693250|76249781|FG000|COMPLETED|Overall Study|21 teens completed 6 months post baseline assessment|21||
60127835|NCT01693250|76249782|FG001|COMPLETED|Overall Study|15 teens completed 6 months post baseline assessment|15||
60127836|NCT01693250|76249781|FG000|NOT COMPLETED|Overall Study||2||
60127837|NCT01693250|76249782|FG001|NOT COMPLETED|Overall Study||2||
60127838|NCT02073461|76249793|FG000|STARTED|Overall Study||79||
60127839|NCT02073461|76249794|FG001|STARTED|Overall Study||78||
60127840|NCT02073461|76249795|FG002|STARTED|Overall Study||79||
60127841|NCT02073461|76249793|FG000|COMPLETED|Overall Study||75||
60127842|NCT02073461|76249794|FG001|COMPLETED|Overall Study||77||
60127843|NCT02073461|76249795|FG002|COMPLETED|Overall Study||78||
60127844|NCT02073461|76249793|FG000|NOT COMPLETED|Overall Study||4||
60127845|NCT02073461|76249794|FG001|NOT COMPLETED|Overall Study||1||
60127846|NCT02073461|76249795|FG002|NOT COMPLETED|Overall Study||1||
60127847|NCT01590758|76249805|FG000|STARTED|Overall Study||85||
60127848|NCT01590758|76249806|FG001|STARTED|Overall Study||104||
60127849|NCT01590758|76249805|FG000|COMPLETED|Overall Study||80||
60127850|NCT01590758|76249806|FG001|COMPLETED|Overall Study||97||
60127851|NCT01590758|76249805|FG000|NOT COMPLETED|Overall Study||5||
60127852|NCT01590758|76249806|FG001|NOT COMPLETED|Overall Study||7||
60127853|NCT01590212|76249815|FG000|STARTED|Overall Study||12||
60127854|NCT01590212|76249816|FG001|STARTED|Overall Study||9||
60127855|NCT01590212|76249817|FG002|STARTED|Overall Study||14||
60127856|NCT01590212|76249815|FG000|Baseline (Pre-intervention)|Overall Study|withdrew=2|10||
60127857|NCT01590212|76249816|FG001|Baseline (Pre-intervention)|Overall Study||9||
60127858|NCT01590212|76249817|FG002|Baseline (Pre-intervention)|Overall Study|failed contact=2|12||
60127859|NCT01590212|76249815|FG000|Post-intervention|Overall Study|failed contact=3|7||
60127860|NCT01590212|76249816|FG001|Post-intervention|Overall Study|failed contact=2; withdrew=1|6||
60127861|NCT01590212|76249817|FG002|Post-intervention|Overall Study|failed contact=1|10||
60127862|NCT01590212|76249815|FG000|COMPLETED|Overall Study|Includes 2 contacted who failed contact at post-intervention data collection point|9||
60127863|NCT01590212|76249816|FG001|COMPLETED|Overall Study||5||
60127864|NCT01590212|76249817|FG002|COMPLETED|Overall Study||9||
59595149|NCT03296072|75704180|FG000|NOT COMPLETED|Treatment Period 1||0||
59728415|NCT00812929|75847149|FG000|NOT COMPLETED|Treatment Period 3||0||
60127865|NCT01590212|76249815|FG000|NOT COMPLETED|Overall Study||3||
60127866|NCT01590212|76249816|FG001|NOT COMPLETED|Overall Study||4||
60127867|NCT01590212|76249817|FG002|NOT COMPLETED|Overall Study||5||
60127868|NCT01692938|76249828|FG000|STARTED|Overall Study||16||
60127869|NCT01692938|76249829|FG001|STARTED|Overall Study||16||
60127870|NCT01692938|76249828|FG000|COMPLETED|Overall Study||12||
60127871|NCT01692938|76249829|FG001|COMPLETED|Overall Study||12||
60127872|NCT01692938|76249828|FG000|NOT COMPLETED|Overall Study||4||
60127873|NCT01692938|76249829|FG001|NOT COMPLETED|Overall Study||4||
60127874|NCT00534417|76249835|FG000|STARTED|Overall Study||41||
60127875|NCT00534417|76249835|FG000|COMPLETED|Overall Study||41||
60127876|NCT00534417|76249835|FG000|NOT COMPLETED|Overall Study||0||
60127877|NCT01692782|76249842|FG000|STARTED|Overall Study||116||
60127878|NCT01692782|76249843|FG001|STARTED|Overall Study||115||
60127879|NCT01692782|76249844|FG002|STARTED|Overall Study||110||
60127880|NCT01692782|76249842|FG000|COMPLETED|Overall Study||96||
60127881|NCT01692782|76249843|FG001|COMPLETED|Overall Study||59||
60127882|NCT01692782|76249844|FG002|COMPLETED|Overall Study||100||
60127883|NCT01692782|76249842|FG000|NOT COMPLETED|Overall Study||20||
60127884|NCT01692782|76249843|FG001|NOT COMPLETED|Overall Study||56||
60127885|NCT01692782|76249844|FG002|NOT COMPLETED|Overall Study||10||
60127886|NCT01692626|76249852|FG000|STARTED|Overall Study||6||
60127887|NCT01692626|76249853|FG001|STARTED|Overall Study||7||
60127888|NCT01692626|76249852|FG000|COMPLETED|Overall Study||2||
60127889|NCT01692626|76249853|FG001|COMPLETED|Overall Study||1||
60127890|NCT01692626|76249852|FG000|NOT COMPLETED|Overall Study||4||
60127891|NCT01692626|76249853|FG001|NOT COMPLETED|Overall Study||6||
60127892|NCT00535587|76249862|FG000|STARTED|Overall Study||53||
60127893|NCT00535587|76249863|FG001|STARTED|Overall Study||53||
60127894|NCT00535587|76249864|FG002|STARTED|Overall Study||47||
60127895|NCT00535587|76249865|FG003|STARTED|Overall Study||54||
60127896|NCT00535587|76249862|FG000|COMPLETED|Overall Study||43||
60127897|NCT00535587|76249863|FG001|COMPLETED|Overall Study||42||
60127898|NCT00535587|76249864|FG002|COMPLETED|Overall Study||39||
60127899|NCT00535587|76249865|FG003|COMPLETED|Overall Study||41||
60127900|NCT00535587|76249862|FG000|NOT COMPLETED|Overall Study||10||
60127901|NCT00535587|76249863|FG001|NOT COMPLETED|Overall Study||11||
60127902|NCT00535587|76249864|FG002|NOT COMPLETED|Overall Study||8||
60127903|NCT00535587|76249865|FG003|NOT COMPLETED|Overall Study||13||
60127904|NCT01475461|76249879|FG000|STARTED|Run-in Period||376||
60127905|NCT01475461|76249880|FG001|STARTED|Run-in Period||0||
60127906|NCT01475461|76249881|FG002|STARTED|Run-in Period||0||
60127907|NCT01475461|76249882|FG003|STARTED|Run-in Period||0||
60127908|NCT01475461|76249883|FG004|STARTED|Run-in Period||0||
60127909|NCT01475461|76249884|FG005|STARTED|Run-in Period||0||
60127910|NCT01475461|76249885|FG006|STARTED|Run-in Period||0||
60127911|NCT01475461|76249879|FG000|COMPLETED|Run-in Period||335||
60127912|NCT01475461|76249880|FG001|COMPLETED|Run-in Period||0||
60127913|NCT01475461|76249881|FG002|COMPLETED|Run-in Period||0||
60127914|NCT01475461|76249882|FG003|COMPLETED|Run-in Period||0||
60127915|NCT01475461|76249883|FG004|COMPLETED|Run-in Period||0||
60127916|NCT01475461|76249884|FG005|COMPLETED|Run-in Period||0||
60127917|NCT01475461|76249885|FG006|COMPLETED|Run-in Period||0||
60127918|NCT01475461|76249879|FG000|NOT COMPLETED|Run-in Period||41||
60127919|NCT01475461|76249880|FG001|NOT COMPLETED|Run-in Period||0||
60127920|NCT01475461|76249881|FG002|NOT COMPLETED|Run-in Period||0||
60127921|NCT01475461|76249882|FG003|NOT COMPLETED|Run-in Period||0||
60127922|NCT01475461|76249883|FG004|NOT COMPLETED|Run-in Period||0||
60127923|NCT01475461|76249884|FG005|NOT COMPLETED|Run-in Period||0||
60127924|NCT01475461|76249885|FG006|NOT COMPLETED|Run-in Period||0||
60127925|NCT01475461|76249879|FG000|STARTED|Treatment Period||0||
60127926|NCT01475461|76249880|FG001|STARTED|Treatment Period||57||
60127927|NCT01475461|76249881|FG002|STARTED|Treatment Period||57||
60127928|NCT01475461|76249882|FG003|STARTED|Treatment Period||54||
60127929|NCT01475461|76249883|FG004|STARTED|Treatment Period||56||
60127930|NCT01475461|76249884|FG005|STARTED|Treatment Period||56||
60127931|NCT01475461|76249885|FG006|STARTED|Treatment Period||55||
60127932|NCT01475461|76249879|FG000|COMPLETED|Treatment Period||0||
60127933|NCT01475461|76249880|FG001|COMPLETED|Treatment Period||48||
60127934|NCT01475461|76249881|FG002|COMPLETED|Treatment Period||53||
60127935|NCT01475461|76249882|FG003|COMPLETED|Treatment Period||46||
60127936|NCT01475461|76249883|FG004|COMPLETED|Treatment Period||52||
60127937|NCT01475461|76249884|FG005|COMPLETED|Treatment Period||51||
60127938|NCT01475461|76249885|FG006|COMPLETED|Treatment Period||53||
60127939|NCT01475461|76249879|FG000|NOT COMPLETED|Treatment Period||0||
60127940|NCT01475461|76249880|FG001|NOT COMPLETED|Treatment Period||9||
60127941|NCT01475461|76249881|FG002|NOT COMPLETED|Treatment Period||4||
60127942|NCT01475461|76249882|FG003|NOT COMPLETED|Treatment Period||8||
60127943|NCT01475461|76249883|FG004|NOT COMPLETED|Treatment Period||4||
60127944|NCT01475461|76249884|FG005|NOT COMPLETED|Treatment Period||5||
60127945|NCT01475461|76249885|FG006|NOT COMPLETED|Treatment Period||2||
60127946|NCT01589822|76249921|FG000|STARTED|Overall Study||84||
60127947|NCT01589822|76249922|FG001|STARTED|Overall Study||89||
60127948|NCT01589822|76249923|FG002|STARTED|Overall Study||41||
60127949|NCT01589822|76249921|FG000|COMPLETED|Overall Study||80||
60127950|NCT01589822|76249922|FG001|COMPLETED|Overall Study||86||
60127951|NCT01589822|76249923|FG002|COMPLETED|Overall Study||40||
60127952|NCT01589822|76249921|FG000|NOT COMPLETED|Overall Study||4||
60127953|NCT01589822|76249922|FG001|NOT COMPLETED|Overall Study||3||
60127954|NCT01589822|76249923|FG002|NOT COMPLETED|Overall Study||1||
60127955|NCT01565642|76249935|FG000|STARTED|Overall Study||151||11
60127956|NCT01565642|76249936|FG001|STARTED|Overall Study||151||11
60127957|NCT01565642|76249935|FG000|COMPLETED|Overall Study||149||11
60127958|NCT01565642|76249936|FG001|COMPLETED|Overall Study||150||11
60127959|NCT01565642|76249935|FG000|NOT COMPLETED|Overall Study||2||0
60127960|NCT01565642|76249936|FG001|NOT COMPLETED|Overall Study||1||0
60127961|NCT01475071|76249942|FG000|STARTED|Overall Study||100||
60127962|NCT01475071|76249942|FG000|COMPLETED|Overall Study||92||
60127963|NCT01475071|76249942|FG000|NOT COMPLETED|Overall Study||8||
60127964|NCT01474993|76249950|FG000|STARTED|Overall Study||15||
60127965|NCT01474993|76249951|FG001|STARTED|Overall Study||29||
60127966|NCT01474993|76249950|FG000|COMPLETED|Overall Study||14||
60127967|NCT01474993|76249951|FG001|COMPLETED|Overall Study||26||
60127968|NCT01474993|76249950|FG000|NOT COMPLETED|Overall Study||1||
60127969|NCT01474993|76249951|FG001|NOT COMPLETED|Overall Study||3||
60127970|NCT01691768|76249961|FG000|STARTED|Overall Study||189||
60127971|NCT01691768|76249962|FG001|STARTED|Overall Study||183||
60127972|NCT01691768|76249961|FG000|COMPLETED|Overall Study||174||
60127973|NCT01691768|76249962|FG001|COMPLETED|Overall Study||167||
60127974|NCT01691768|76249961|FG000|NOT COMPLETED|Overall Study||15||
60127975|NCT01691768|76249962|FG001|NOT COMPLETED|Overall Study||16||
60127976|NCT01503229|76249969|FG000|STARTED|Overall Study||30||
60127977|NCT01503229|76249969|FG000|COMPLETED|Overall Study||29||
60127978|NCT01503229|76249969|FG000|NOT COMPLETED|Overall Study||1||
60127979|NCT01691612|76249973|FG000|STARTED|Overall Study||14||
60127980|NCT01691612|76249973|FG000|First Visit (Allergen Challenge)|Overall Study||8||
60127981|NCT01691612|76249973|FG000|Second Visit (Bronchoscopy)|Overall Study||7||
60127982|NCT01691612|76249973|FG000|COMPLETED|Overall Study||7||
60127983|NCT01691612|76249973|FG000|NOT COMPLETED|Overall Study||7||
60127984|NCT01565564|76249979|FG000|STARTED|Overall Study||344||
60127985|NCT01565564|76249980|FG001|STARTED|Overall Study||362||
60127986|NCT01565564|76249979|FG000|COMPLETED|Overall Study||339||
60127987|NCT01565564|76249980|FG001|COMPLETED|Overall Study||361||
60127988|NCT01565564|76249979|FG000|NOT COMPLETED|Overall Study||5||
60127989|NCT01565564|76249980|FG001|NOT COMPLETED|Overall Study||1||
60127990|NCT01460407|76249986|FG000|STARTED|Period 1: Day 1 to Day 5||14||
60127991|NCT01460407|76249987|FG001|STARTED|Period 1: Day 1 to Day 5||0||
60127992|NCT01460407|76249986|FG000|COMPLETED|Period 1: Day 1 to Day 5||14||
60127993|NCT01460407|76249987|FG001|COMPLETED|Period 1: Day 1 to Day 5||0||
60127994|NCT01460407|76249986|FG000|NOT COMPLETED|Period 1: Day 1 to Day 5||0||
60127995|NCT01460407|76249987|FG001|NOT COMPLETED|Period 1: Day 1 to Day 5||0||
60127996|NCT01460407|76249986|FG000|STARTED|Period 2: Day 6 to Day 14||0||
60127997|NCT01460407|76249987|FG001|STARTED|Period 2: Day 6 to Day 14||14||
60127998|NCT01460407|76249986|FG000|COMPLETED|Period 2: Day 6 to Day 14||0||
60127999|NCT01460407|76249987|FG001|COMPLETED|Period 2: Day 6 to Day 14||13||
60128000|NCT01460407|76249986|FG000|NOT COMPLETED|Period 2: Day 6 to Day 14||0||
60128001|NCT01460407|76249987|FG001|NOT COMPLETED|Period 2: Day 6 to Day 14||1||
60128002|NCT01502371|76249999|FG000|STARTED|Overall Study||120||
60128003|NCT01502371|76250000|FG001|STARTED|Overall Study||113||
60128004|NCT01502371|76250001|FG002|STARTED|Overall Study||108||
60128005|NCT01502371|76250002|FG003|STARTED|Overall Study||125||
60128006|NCT01502371|76250003|FG004|STARTED|Overall Study||112||
60128007|NCT01502371|76249999|FG000|COMPLETED|Overall Study||79||
60128008|NCT01502371|76250000|FG001|COMPLETED|Overall Study||81||
60128009|NCT01502371|76250001|FG002|COMPLETED|Overall Study||83||
59595150|NCT03296072|75704181|FG001|NOT COMPLETED|Treatment Period 1||0||
59595151|NCT03296072|75704182|FG002|NOT COMPLETED|Treatment Period 1||0||
60128010|NCT01502371|76250002|FG003|COMPLETED|Overall Study||88||
60128011|NCT01502371|76250003|FG004|COMPLETED|Overall Study||60||
60128012|NCT01502371|76249999|FG000|NOT COMPLETED|Overall Study||41||
60128013|NCT01502371|76250000|FG001|NOT COMPLETED|Overall Study||32||
60128014|NCT01502371|76250001|FG002|NOT COMPLETED|Overall Study||25||
60128015|NCT01502371|76250002|FG003|NOT COMPLETED|Overall Study||37||
60128016|NCT01502371|76250003|FG004|NOT COMPLETED|Overall Study||52||
60128017|NCT01588496|76250019|FG000|STARTED|Overall Study||8||
60128018|NCT01588496|76250020|FG001|STARTED|Overall Study||17||
60128019|NCT01588496|76250021|FG002|STARTED|Overall Study||33||
60128020|NCT01588496|76250019|FG000|Received Treatment|Overall Study||8||
60128021|NCT01588496|76250020|FG001|Received Treatment|Overall Study||16||
60128022|NCT01588496|76250021|FG002|Received Treatment|Overall Study||33||
60128023|NCT01588496|76250019|FG000|COMPLETED|Overall Study||8||
60128024|NCT01588496|76250020|FG001|COMPLETED|Overall Study||16||
60128025|NCT01588496|76250021|FG002|COMPLETED|Overall Study||33||
60128026|NCT01588496|76250019|FG000|NOT COMPLETED|Overall Study||0||
60128027|NCT01588496|76250020|FG001|NOT COMPLETED|Overall Study||1||
60128028|NCT01588496|76250021|FG002|NOT COMPLETED|Overall Study||0||
60128029|NCT01502293|76250032|FG000|STARTED|Overall Study||30||
60128030|NCT01502293|76250033|FG001|STARTED|Overall Study||17||
60128031|NCT01502293|76250034|FG002|STARTED|Overall Study||4||
60128032|NCT01502293|76250032|FG000|COMPLETED|Overall Study||5||
60128033|NCT01502293|76250033|FG001|COMPLETED|Overall Study||0||
60128034|NCT01502293|76250034|FG002|COMPLETED|Overall Study||0||
60128035|NCT01502293|76250032|FG000|NOT COMPLETED|Overall Study||25||
60128036|NCT01502293|76250033|FG001|NOT COMPLETED|Overall Study||17||
60128037|NCT01502293|76250034|FG002|NOT COMPLETED|Overall Study||4||
60128038|NCT01474681|76250047|FG000|STARTED|Overall Study||1||
59595152|NCT03296072|75704183|FG003|NOT COMPLETED|Treatment Period 1||0||
60128039|NCT01474681|76250048|FG001|STARTED|Overall Study||8||
60128040|NCT01474681|76250049|FG002|STARTED|Overall Study||3||
60128041|NCT01474681|76250050|FG003|STARTED|Overall Study||15||
60128042|NCT01474681|76250047|FG000|COMPLETED|Overall Study||1||
60128043|NCT01474681|76250048|FG001|COMPLETED|Overall Study||5||
60128044|NCT01474681|76250049|FG002|COMPLETED|Overall Study||1||
60128045|NCT01474681|76250050|FG003|COMPLETED|Overall Study||9||
60128046|NCT01474681|76250047|FG000|NOT COMPLETED|Overall Study||0||
60128047|NCT01474681|76250048|FG001|NOT COMPLETED|Overall Study||3||
60128048|NCT01474681|76250049|FG002|NOT COMPLETED|Overall Study||2||
60128049|NCT01474681|76250050|FG003|NOT COMPLETED|Overall Study||6||
60128050|NCT01459783|76250066|FG000|STARTED|Baseline to 6 Months||71||
60128051|NCT01459783|76250067|FG001|STARTED|Baseline to 6 Months||73||
60128052|NCT01459783|76250066|FG000|COMPLETED|Baseline to 6 Months||39||
60128053|NCT01459783|76250067|FG001|COMPLETED|Baseline to 6 Months||53||
60128054|NCT01459783|76250066|FG000|NOT COMPLETED|Baseline to 6 Months||32||
60128055|NCT01459783|76250067|FG001|NOT COMPLETED|Baseline to 6 Months||20||
60128056|NCT01459783|76250066|FG000|STARTED|6 Months to 12 Months||39||
60128057|NCT01459783|76250067|FG001|STARTED|6 Months to 12 Months||53||
60128058|NCT01459783|76250066|FG000|COMPLETED|6 Months to 12 Months||20||
60128059|NCT01459783|76250067|FG001|COMPLETED|6 Months to 12 Months||23||
60128060|NCT01459783|76250066|FG000|NOT COMPLETED|6 Months to 12 Months||19||
60128061|NCT01459783|76250067|FG001|NOT COMPLETED|6 Months to 12 Months||30||
60128062|NCT01588184|76250079|FG000|STARTED|Overall Study||11||
60128063|NCT01588184|76250080|FG001|STARTED|Overall Study||41||
60128064|NCT01588184|76250081|FG002|STARTED|Overall Study||7||
60128065|NCT01588184|76250082|FG003|STARTED|Overall Study||6||
60128066|NCT01588184|76250083|FG004|STARTED|Overall Study||16||
60128067|NCT01588184|76250084|FG005|STARTED|Overall Study||14||
60128068|NCT01588184|76250079|FG000|COMPLETED|Overall Study||8||
60128069|NCT01588184|76250080|FG001|COMPLETED|Overall Study||28||
60128070|NCT01588184|76250081|FG002|COMPLETED|Overall Study||5||
60128071|NCT01588184|76250082|FG003|COMPLETED|Overall Study||3||
60128072|NCT01588184|76250083|FG004|COMPLETED|Overall Study||14||
60128073|NCT01588184|76250084|FG005|COMPLETED|Overall Study||10||
60128074|NCT01588184|76250079|FG000|NOT COMPLETED|Overall Study||3||
60128075|NCT01588184|76250080|FG001|NOT COMPLETED|Overall Study||13||
60128076|NCT01588184|76250081|FG002|NOT COMPLETED|Overall Study||2||
60128077|NCT01588184|76250082|FG003|NOT COMPLETED|Overall Study||3||
60128078|NCT01588184|76250083|FG004|NOT COMPLETED|Overall Study||2||
60128079|NCT01588184|76250084|FG005|NOT COMPLETED|Overall Study||4||
60128080|NCT01588106|76250100|FG000|STARTED|Overall Study||78||
60128081|NCT01588106|76250101|FG001|STARTED|Overall Study||76||
60128082|NCT01588106|76250100|FG000|COMPLETED|Overall Study||73||
60128083|NCT01588106|76250101|FG001|COMPLETED|Overall Study||72||
60128084|NCT01588106|76250100|FG000|NOT COMPLETED|Overall Study||5||
60128085|NCT01588106|76250101|FG001|NOT COMPLETED|Overall Study||4||
60128086|NCT01564862|76250110|FG000|STARTED|Overall Study||198||
60128087|NCT01564862|76250111|FG001|STARTED|Overall Study||210||
60128088|NCT01564862|76250112|FG002|STARTED|Overall Study||194||
60128089|NCT01564862|76250110|FG000|Received Treatment|Overall Study||196||
60128090|NCT01564862|76250111|FG001|Received Treatment|Overall Study||207||
60128091|NCT01564862|76250112|FG002|Received Treatment|Overall Study||191||
60128092|NCT01564862|76250110|FG000|COMPLETED|Overall Study||168||
60128093|NCT01564862|76250111|FG001|COMPLETED|Overall Study||176||
60128094|NCT01564862|76250112|FG002|COMPLETED|Overall Study||164||
60128095|NCT01564862|76250110|FG000|NOT COMPLETED|Overall Study||30||
60128096|NCT01564862|76250111|FG001|NOT COMPLETED|Overall Study||34||
59595153|NCT03296072|75704184|FG004|NOT COMPLETED|Treatment Period 1||0||
59595154|NCT03296072|75704185|FG005|NOT COMPLETED|Treatment Period 1||0||
59595155|NCT03296072|75704180|FG000|STARTED|Treament Period 1: Wash Out Period||10||
59595156|NCT03296072|75704181|FG001|STARTED|Treament Period 1: Wash Out Period||11||
59595157|NCT03296072|75704182|FG002|STARTED|Treament Period 1: Wash Out Period||10||
60128097|NCT01564862|76250112|FG002|NOT COMPLETED|Overall Study||30||
60128098|NCT01691378|76250122|FG000|STARTED|Overall Study||22||
60128099|NCT01691378|76250123|FG001|STARTED|Overall Study||22||
60128100|NCT01691378|76250122|FG000|COMPLETED|Overall Study||15||
60128101|NCT01691378|76250123|FG001|COMPLETED|Overall Study||20||
60128102|NCT01691378|76250122|FG000|NOT COMPLETED|Overall Study||7||
60128103|NCT01691378|76250123|FG001|NOT COMPLETED|Overall Study||2||
60128104|NCT01467479|76250132|FG000|STARTED|Overall Study||55||
60128105|NCT01467479|76250133|FG001|STARTED|Overall Study||69||
59595158|NCT03296072|75704183|FG003|STARTED|Treament Period 1: Wash Out Period||10||
60128106|NCT01467479|76250134|FG002|STARTED|Overall Study||61||
60128107|NCT01467479|76250132|FG000|Treated|Overall Study||54||
60128108|NCT01467479|76250133|FG001|Treated|Overall Study||69||
60128109|NCT01467479|76250134|FG002|Treated|Overall Study||59||
60128110|NCT01467479|76250132|FG000|COMPLETED|Overall Study||46||
60128111|NCT01467479|76250133|FG001|COMPLETED|Overall Study||52||
60128112|NCT01467479|76250134|FG002|COMPLETED|Overall Study||45||
60128113|NCT01467479|76250132|FG000|NOT COMPLETED|Overall Study||9||
60128114|NCT01467479|76250133|FG001|NOT COMPLETED|Overall Study||17||
60128115|NCT01467479|76250134|FG002|NOT COMPLETED|Overall Study||16||
60128116|NCT01466387|76250149|FG000|STARTED|Overall Study||101||
59595159|NCT03296072|75704184|FG004|STARTED|Treament Period 1: Wash Out Period||10||
59595160|NCT03296072|75704185|FG005|STARTED|Treament Period 1: Wash Out Period||11||
59595161|NCT03296072|75704180|FG000|COMPLETED|Treament Period 1: Wash Out Period||10||
59595162|NCT03296072|75704181|FG001|COMPLETED|Treament Period 1: Wash Out Period||11||
59595163|NCT03296072|75704182|FG002|COMPLETED|Treament Period 1: Wash Out Period||10||
59595164|NCT03296072|75704183|FG003|COMPLETED|Treament Period 1: Wash Out Period||10||
59595165|NCT03296072|75704184|FG004|COMPLETED|Treament Period 1: Wash Out Period||10||
59595166|NCT03296072|75704185|FG005|COMPLETED|Treament Period 1: Wash Out Period||11||
59595167|NCT03296072|75704180|FG000|NOT COMPLETED|Treament Period 1: Wash Out Period||0||
59595168|NCT03296072|75704181|FG001|NOT COMPLETED|Treament Period 1: Wash Out Period||0||
59595169|NCT03296072|75704182|FG002|NOT COMPLETED|Treament Period 1: Wash Out Period||0||
59595170|NCT03296072|75704183|FG003|NOT COMPLETED|Treament Period 1: Wash Out Period||0||
59595171|NCT03296072|75704184|FG004|NOT COMPLETED|Treament Period 1: Wash Out Period||0||
59595172|NCT03296072|75704185|FG005|NOT COMPLETED|Treament Period 1: Wash Out Period||0||
59595173|NCT03296072|75704180|FG000|STARTED|Treament Period 2||10||
59595174|NCT03296072|75704181|FG001|STARTED|Treament Period 2||11||
59595175|NCT03296072|75704182|FG002|STARTED|Treament Period 2||10||
59595176|NCT03296072|75704183|FG003|STARTED|Treament Period 2||10||
59595177|NCT03296072|75704184|FG004|STARTED|Treament Period 2||10||
59595178|NCT03296072|75704185|FG005|STARTED|Treament Period 2||11||
59595179|NCT03296072|75704180|FG000|COMPLETED|Treament Period 2||10||
59595180|NCT03296072|75704181|FG001|COMPLETED|Treament Period 2||11||
59595181|NCT03296072|75704182|FG002|COMPLETED|Treament Period 2||10||
59595182|NCT03296072|75704183|FG003|COMPLETED|Treament Period 2||10||
59595183|NCT03296072|75704184|FG004|COMPLETED|Treament Period 2||10||
59595184|NCT03296072|75704185|FG005|COMPLETED|Treament Period 2||11||
59595185|NCT03296072|75704180|FG000|NOT COMPLETED|Treament Period 2||0||
59595186|NCT03296072|75704181|FG001|NOT COMPLETED|Treament Period 2||0||
59595187|NCT03296072|75704182|FG002|NOT COMPLETED|Treament Period 2||0||
59595188|NCT03296072|75704183|FG003|NOT COMPLETED|Treament Period 2||0||
59595189|NCT03296072|75704184|FG004|NOT COMPLETED|Treament Period 2||0||
59595190|NCT03296072|75704185|FG005|NOT COMPLETED|Treament Period 2||0||
59595191|NCT03296072|75704180|FG000|STARTED|Treament Period 2: Wash Out Period||10||
59595192|NCT03296072|75704181|FG001|STARTED|Treament Period 2: Wash Out Period||11||
59595193|NCT03296072|75704182|FG002|STARTED|Treament Period 2: Wash Out Period||10||
59595194|NCT03296072|75704183|FG003|STARTED|Treament Period 2: Wash Out Period||10||
59595195|NCT03296072|75704184|FG004|STARTED|Treament Period 2: Wash Out Period||10||
59595196|NCT03296072|75704185|FG005|STARTED|Treament Period 2: Wash Out Period||11||
59595197|NCT03296072|75704180|FG000|COMPLETED|Treament Period 2: Wash Out Period||10||
59595198|NCT03296072|75704181|FG001|COMPLETED|Treament Period 2: Wash Out Period||11||
59595199|NCT03296072|75704182|FG002|COMPLETED|Treament Period 2: Wash Out Period||10||
59595200|NCT03296072|75704183|FG003|COMPLETED|Treament Period 2: Wash Out Period||10||
59595201|NCT03296072|75704184|FG004|COMPLETED|Treament Period 2: Wash Out Period||10||
59595202|NCT03296072|75704185|FG005|COMPLETED|Treament Period 2: Wash Out Period||11||
59595203|NCT03296072|75704180|FG000|NOT COMPLETED|Treament Period 2: Wash Out Period||0||
59595204|NCT03296072|75704181|FG001|NOT COMPLETED|Treament Period 2: Wash Out Period||0||
59595205|NCT03296072|75704182|FG002|NOT COMPLETED|Treament Period 2: Wash Out Period||0||
59595206|NCT03296072|75704183|FG003|NOT COMPLETED|Treament Period 2: Wash Out Period||0||
59595207|NCT03296072|75704184|FG004|NOT COMPLETED|Treament Period 2: Wash Out Period||0||
59595208|NCT03296072|75704185|FG005|NOT COMPLETED|Treament Period 2: Wash Out Period||0||
59595209|NCT03296072|75704180|FG000|STARTED|Treament Period 3||10||
59595210|NCT03296072|75704181|FG001|STARTED|Treament Period 3||11||
59595211|NCT03296072|75704182|FG002|STARTED|Treament Period 3||10||
59595212|NCT03296072|75704183|FG003|STARTED|Treament Period 3||10||
59595213|NCT03296072|75704184|FG004|STARTED|Treament Period 3||10||
59595214|NCT03296072|75704185|FG005|STARTED|Treament Period 3||11||
59595215|NCT03296072|75704180|FG000|COMPLETED|Treament Period 3||10||
59595216|NCT03296072|75704181|FG001|COMPLETED|Treament Period 3||11||
59595217|NCT03296072|75704182|FG002|COMPLETED|Treament Period 3||10||
59595218|NCT03296072|75704183|FG003|COMPLETED|Treament Period 3||10||
59595219|NCT03296072|75704184|FG004|COMPLETED|Treament Period 3||10||
59595220|NCT03296072|75704185|FG005|COMPLETED|Treament Period 3||11||
59595221|NCT03296072|75704180|FG000|NOT COMPLETED|Treament Period 3||0||
59595222|NCT03296072|75704181|FG001|NOT COMPLETED|Treament Period 3||0||
59595223|NCT03296072|75704182|FG002|NOT COMPLETED|Treament Period 3||0||
59595224|NCT03296072|75704183|FG003|NOT COMPLETED|Treament Period 3||0||
59595225|NCT03296072|75704184|FG004|NOT COMPLETED|Treament Period 3||0||
59595226|NCT03296072|75704185|FG005|NOT COMPLETED|Treament Period 3||0||
59595227|NCT03182725|75704195|FG000|STARTED|Treatment Arm 1 (First Half of Study)||16||
59595228|NCT03182725|75704196|FG001|STARTED|Treatment Arm 1 (First Half of Study)||10||
59595229|NCT03182725|75704195|FG000|COMPLETED|Treatment Arm 1 (First Half of Study)||16||
59595230|NCT03182725|75704196|FG001|COMPLETED|Treatment Arm 1 (First Half of Study)||7||
59595231|NCT03182725|75704195|FG000|NOT COMPLETED|Treatment Arm 1 (First Half of Study)||0||
59595232|NCT03182725|75704196|FG001|NOT COMPLETED|Treatment Arm 1 (First Half of Study)||3||
59595233|NCT03182725|75704195|FG000|STARTED|Treatment Arm 2 (Second Half of Study)||16||
59728416|NCT00812929|75847150|FG001|NOT COMPLETED|Treatment Period 3||0||
59595234|NCT03182725|75704196|FG001|STARTED|Treatment Arm 2 (Second Half of Study)|One participant withdrew during crossover and therefore did not start Treatment Arm 2.|6||
59595235|NCT03182725|75704195|FG000|COMPLETED|Treatment Arm 2 (Second Half of Study)||16||
59595236|NCT03182725|75704196|FG001|COMPLETED|Treatment Arm 2 (Second Half of Study)||6||
59595237|NCT03182725|75704195|FG000|NOT COMPLETED|Treatment Arm 2 (Second Half of Study)||0||
59595238|NCT03182725|75704196|FG001|NOT COMPLETED|Treatment Arm 2 (Second Half of Study)||0||
59595239|NCT03419078|75704205|FG000|STARTED|Overall Study||245||
59595240|NCT03419078|75704206|FG001|STARTED|Overall Study||148||
59595241|NCT03419078|75704207|FG002|STARTED|Overall Study||91||
59595242|NCT03419078|75704205|FG000|COMPLETED|Overall Study||245||
59595243|NCT03419078|75704206|FG001|COMPLETED|Overall Study||148||
59595244|NCT03419078|75704207|FG002|COMPLETED|Overall Study||91||
59595245|NCT03419078|75704205|FG000|NOT COMPLETED|Overall Study||0||
59595246|NCT03419078|75704206|FG001|NOT COMPLETED|Overall Study||0||
59595247|NCT03419078|75704207|FG002|NOT COMPLETED|Overall Study||0||
59595248|NCT03216512|75704217|FG000|STARTED|Overall Study||17||
59595249|NCT03216512|75704218|FG001|STARTED|Overall Study||14||
59595250|NCT03216512|75704217|FG000|COMPLETED|Overall Study||17||
59595251|NCT03216512|75704218|FG001|COMPLETED|Overall Study||13||
59595252|NCT03216512|75704217|FG000|NOT COMPLETED|Overall Study||0||
59595253|NCT03216512|75704218|FG001|NOT COMPLETED|Overall Study||1||
59595254|NCT03185065|75704230|FG000|STARTED|Period 1 (6 Weeks)||35||
59595255|NCT03185065|75704231|FG001|STARTED|Period 1 (6 Weeks)||34||
59595256|NCT03185065|75704232|FG002|STARTED|Period 1 (6 Weeks)||35||
59595257|NCT03185065|75704233|FG003|STARTED|Period 1 (6 Weeks)||37||
59595258|NCT03185065|75704230|FG000|COMPLETED|Period 1 (6 Weeks)||32||
59595259|NCT03185065|75704231|FG001|COMPLETED|Period 1 (6 Weeks)||33||
59595260|NCT03185065|75704232|FG002|COMPLETED|Period 1 (6 Weeks)||32||
59595261|NCT03185065|75704233|FG003|COMPLETED|Period 1 (6 Weeks)||36||
59595262|NCT03185065|75704230|FG000|NOT COMPLETED|Period 1 (6 Weeks)||3||
59595263|NCT03185065|75704231|FG001|NOT COMPLETED|Period 1 (6 Weeks)||1||
59595264|NCT03185065|75704232|FG002|NOT COMPLETED|Period 1 (6 Weeks)||3||
59595265|NCT03185065|75704233|FG003|NOT COMPLETED|Period 1 (6 Weeks)||1||
59595266|NCT03185065|75704230|FG000|STARTED|Washout (2 Weeks)||32||
59595267|NCT03185065|75704231|FG001|STARTED|Washout (2 Weeks)||33||
59595268|NCT03185065|75704232|FG002|STARTED|Washout (2 Weeks)||32||
59595269|NCT03185065|75704233|FG003|STARTED|Washout (2 Weeks)||36||
59595270|NCT03185065|75704230|FG000|COMPLETED|Washout (2 Weeks)||32||
59595271|NCT03185065|75704231|FG001|COMPLETED|Washout (2 Weeks)||31||
59595272|NCT03185065|75704232|FG002|COMPLETED|Washout (2 Weeks)||32||
59595273|NCT03185065|75704233|FG003|COMPLETED|Washout (2 Weeks)||35||
59595274|NCT03185065|75704230|FG000|NOT COMPLETED|Washout (2 Weeks)||0||
59595275|NCT03185065|75704231|FG001|NOT COMPLETED|Washout (2 Weeks)||2||
59595276|NCT03185065|75704232|FG002|NOT COMPLETED|Washout (2 Weeks)||0||
59595277|NCT03185065|75704233|FG003|NOT COMPLETED|Washout (2 Weeks)||1||
59595278|NCT03185065|75704230|FG000|STARTED|Period 2 (6 Weeks)||32||
59595279|NCT03185065|75704231|FG001|STARTED|Period 2 (6 Weeks)||31||
59595280|NCT03185065|75704232|FG002|STARTED|Period 2 (6 Weeks)||32||
59595281|NCT03185065|75704233|FG003|STARTED|Period 2 (6 Weeks)||35||
59595282|NCT03185065|75704230|FG000|COMPLETED|Period 2 (6 Weeks)||32||
59595283|NCT03185065|75704231|FG001|COMPLETED|Period 2 (6 Weeks)||31||
59595284|NCT03185065|75704232|FG002|COMPLETED|Period 2 (6 Weeks)||32||
59595285|NCT03185065|75704233|FG003|COMPLETED|Period 2 (6 Weeks)||34||
59595286|NCT03185065|75704230|FG000|NOT COMPLETED|Period 2 (6 Weeks)||0||
59595287|NCT03185065|75704231|FG001|NOT COMPLETED|Period 2 (6 Weeks)||0||
59595288|NCT03185065|75704232|FG002|NOT COMPLETED|Period 2 (6 Weeks)||0||
59595289|NCT03185065|75704233|FG003|NOT COMPLETED|Period 2 (6 Weeks)||1||
59595290|NCT03185065|75704230|FG000|STARTED|Washout (2 Weeks)||32||
59595291|NCT03185065|75704231|FG001|STARTED|Washout (2 Weeks)||31||
59595292|NCT03185065|75704232|FG002|STARTED|Washout (2 Weeks)||32||
59595293|NCT03185065|75704233|FG003|STARTED|Washout (2 Weeks)||34||
59595294|NCT03185065|75704230|FG000|COMPLETED|Washout (2 Weeks)||31||
59595295|NCT03185065|75704231|FG001|COMPLETED|Washout (2 Weeks)||29||
59595296|NCT03185065|75704232|FG002|COMPLETED|Washout (2 Weeks)||31||
59595297|NCT03185065|75704233|FG003|COMPLETED|Washout (2 Weeks)||32||
59595298|NCT03185065|75704230|FG000|NOT COMPLETED|Washout (2 Weeks)||1||
59595299|NCT03185065|75704231|FG001|NOT COMPLETED|Washout (2 Weeks)||2||
59595300|NCT03185065|75704232|FG002|NOT COMPLETED|Washout (2 Weeks)||1||
59595301|NCT03185065|75704233|FG003|NOT COMPLETED|Washout (2 Weeks)||2||
59595302|NCT03185065|75704230|FG000|STARTED|Period 3 (6 Weeks)||31||
59595303|NCT03185065|75704231|FG001|STARTED|Period 3 (6 Weeks)||29||
59595304|NCT03185065|75704232|FG002|STARTED|Period 3 (6 Weeks)||31||
59595305|NCT03185065|75704233|FG003|STARTED|Period 3 (6 Weeks)||32||
59595306|NCT03185065|75704230|FG000|COMPLETED|Period 3 (6 Weeks)||31||
59595307|NCT03185065|75704231|FG001|COMPLETED|Period 3 (6 Weeks)||29||
59595308|NCT03185065|75704232|FG002|COMPLETED|Period 3 (6 Weeks)||29||
59595309|NCT03185065|75704233|FG003|COMPLETED|Period 3 (6 Weeks)||32||
59595310|NCT03185065|75704230|FG000|NOT COMPLETED|Period 3 (6 Weeks)||0||
59595311|NCT03185065|75704231|FG001|NOT COMPLETED|Period 3 (6 Weeks)||0||
59595312|NCT03185065|75704232|FG002|NOT COMPLETED|Period 3 (6 Weeks)||2||
59595313|NCT03185065|75704233|FG003|NOT COMPLETED|Period 3 (6 Weeks)||0||
59595314|NCT03185065|75704230|FG000|STARTED|Washout (2 Weeks)||31||
59595315|NCT03185065|75704231|FG001|STARTED|Washout (2 Weeks)||29||
59595316|NCT03185065|75704232|FG002|STARTED|Washout (2 Weeks)||29||
59595317|NCT03185065|75704233|FG003|STARTED|Washout (2 Weeks)||32||
59595318|NCT03185065|75704230|FG000|COMPLETED|Washout (2 Weeks)||31||
59595319|NCT03185065|75704231|FG001|COMPLETED|Washout (2 Weeks)||28||
59595320|NCT03185065|75704232|FG002|COMPLETED|Washout (2 Weeks)||27||
59595321|NCT03185065|75704233|FG003|COMPLETED|Washout (2 Weeks)||32||
59595322|NCT03185065|75704230|FG000|NOT COMPLETED|Washout (2 Weeks)||0||
59595323|NCT03185065|75704231|FG001|NOT COMPLETED|Washout (2 Weeks)||1||
59595324|NCT03185065|75704232|FG002|NOT COMPLETED|Washout (2 Weeks)||2||
59595325|NCT03185065|75704233|FG003|NOT COMPLETED|Washout (2 Weeks)||0||
59595326|NCT03185065|75704230|FG000|STARTED|Period 4 (6 Weeks)||31||
59595327|NCT03185065|75704231|FG001|STARTED|Period 4 (6 Weeks)||28||
59595328|NCT03185065|75704232|FG002|STARTED|Period 4 (6 Weeks)||27||
59595329|NCT03185065|75704233|FG003|STARTED|Period 4 (6 Weeks)||32||
59595330|NCT03185065|75704230|FG000|COMPLETED|Period 4 (6 Weeks)||31||
59595331|NCT03185065|75704231|FG001|COMPLETED|Period 4 (6 Weeks)||27||
59595332|NCT03185065|75704232|FG002|COMPLETED|Period 4 (6 Weeks)||26||
59595333|NCT03185065|75704233|FG003|COMPLETED|Period 4 (6 Weeks)||31||
59595334|NCT03185065|75704230|FG000|NOT COMPLETED|Period 4 (6 Weeks)||0||
59595335|NCT03185065|75704231|FG001|NOT COMPLETED|Period 4 (6 Weeks)||1||
59595336|NCT03185065|75704232|FG002|NOT COMPLETED|Period 4 (6 Weeks)||1||
59595337|NCT03185065|75704233|FG003|NOT COMPLETED|Period 4 (6 Weeks)||1||
59595338|NCT03419780|75704246|FG000|STARTED|Overall Study||33||
59595339|NCT03419780|75704247|FG001|STARTED|Overall Study||33||
59595340|NCT03419780|75704246|FG000|COMPLETED|Overall Study||33||
59595341|NCT03419780|75704247|FG001|COMPLETED|Overall Study||33||
59595342|NCT03419780|75704246|FG000|NOT COMPLETED|Overall Study||0||
59595343|NCT03419780|75704247|FG001|NOT COMPLETED|Overall Study||0||
59595344|NCT04398199|75704253|FG000|STARTED|Overall Study||1||
59595345|NCT04398199|75704253|FG000|COMPLETED|Overall Study||1||
59595346|NCT04398199|75704253|FG000|NOT COMPLETED|Overall Study||0||
59595347|NCT03285061|75704259|FG000|STARTED|Overall Study||37||
59595348|NCT03285061|75704260|FG001|STARTED|Overall Study||38||
59595349|NCT03285061|75704259|FG000|COMPLETED|Overall Study||36||
59595350|NCT03285061|75704260|FG001|COMPLETED|Overall Study||36||
59595351|NCT03285061|75704259|FG000|NOT COMPLETED|Overall Study||1||
59595352|NCT03285061|75704260|FG001|NOT COMPLETED|Overall Study||2||
59595353|NCT02219334|75704268|FG000|STARTED|Overall Study||32||
59595354|NCT02219334|75704269|FG001|STARTED|Overall Study||23||
59595355|NCT02219334|75704268|FG000|COMPLETED|Overall Study||24||
59595356|NCT02219334|75704269|FG001|COMPLETED|Overall Study||20||
59595357|NCT02219334|75704268|FG000|NOT COMPLETED|Overall Study||8||
59595358|NCT02219334|75704269|FG001|NOT COMPLETED|Overall Study||3||
59595359|NCT03285373|75704275|FG000|STARTED|Overall Study||314||
59595360|NCT03285373|75704276|FG001|STARTED|Overall Study||253||
59595361|NCT03285373|75704277|FG002|STARTED|Overall Study||266||
59595362|NCT03285373|75704278|FG003|STARTED|Overall Study||130||
59595363|NCT03285373|75704275|FG000|COMPLETED|Overall Study||314||
59595364|NCT03285373|75704276|FG001|COMPLETED|Overall Study||253||
59595365|NCT03285373|75704277|FG002|COMPLETED|Overall Study||266||
59595366|NCT03285373|75704278|FG003|COMPLETED|Overall Study||130||
59595367|NCT03285373|75704275|FG000|NOT COMPLETED|Overall Study||0||
59595368|NCT03285373|75704276|FG001|NOT COMPLETED|Overall Study||0||
59595369|NCT03285373|75704277|FG002|NOT COMPLETED|Overall Study||0||
59595370|NCT03285373|75704278|FG003|NOT COMPLETED|Overall Study||0||
59595371|NCT02159040|75704287|FG000|STARTED|Overall Study||1||
59595372|NCT02159040|75704287|FG000|COMPLETED|Overall Study||0||
59595373|NCT02159040|75704287|FG000|NOT COMPLETED|Overall Study||1||
59595374|NCT03285529|75704293|FG000|STARTED|Overall Study||30||
59595375|NCT03285529|75704294|FG001|STARTED|Overall Study||30||
59595376|NCT03285529|75704293|FG000|COMPLETED|Overall Study||30||
59595377|NCT03285529|75704294|FG001|COMPLETED|Overall Study||30||
59595378|NCT03285529|75704293|FG000|NOT COMPLETED|Overall Study||0||
59595379|NCT03285529|75704294|FG001|NOT COMPLETED|Overall Study||0||
59595380|NCT03189589|75704302|FG000|STARTED|Overall Study||6||
59595381|NCT03189589|75704303|FG001|STARTED|Overall Study||6||
59595382|NCT03189589|75704302|FG000|COMPLETED|Overall Study||6||
59595383|NCT03189589|75704303|FG001|COMPLETED|Overall Study||6||
59595384|NCT03189589|75704302|FG000|NOT COMPLETED|Overall Study||0||
59595385|NCT03189589|75704303|FG001|NOT COMPLETED|Overall Study||0||
59595386|NCT02218008|75704312|FG000|STARTED|Stage 1 (S1)||280||
59595387|NCT02218008|75704313|FG001|STARTED|Stage 1 (S1)||63||
59728417|NCT00812929|75847151|FG002|NOT COMPLETED|Treatment Period 3||0||
59595388|NCT02218008|75704314|FG002|STARTED|Stage 1 (S1)||63||
59595389|NCT02218008|75704315|FG003|STARTED|Stage 1 (S1)||0||
59595390|NCT02218008|75704316|FG004|STARTED|Stage 1 (S1)||0||
59595391|NCT02218008|75704317|FG005|STARTED|Stage 1 (S1)||0||
59595392|NCT02218008|75704312|FG000|COMPLETED|Stage 1 (S1)||258||
59595393|NCT02218008|75704313|FG001|COMPLETED|Stage 1 (S1)||56||
59595394|NCT02218008|75704314|FG002|COMPLETED|Stage 1 (S1)||48||
59595395|NCT02218008|75704315|FG003|COMPLETED|Stage 1 (S1)||0||
59595396|NCT02218008|75704316|FG004|COMPLETED|Stage 1 (S1)||0||
59595397|NCT02218008|75704317|FG005|COMPLETED|Stage 1 (S1)||0||
59595398|NCT02218008|75704312|FG000|NOT COMPLETED|Stage 1 (S1)||22||
59595399|NCT02218008|75704313|FG001|NOT COMPLETED|Stage 1 (S1)||7||
59595400|NCT02218008|75704314|FG002|NOT COMPLETED|Stage 1 (S1)||15||
59595401|NCT02218008|75704315|FG003|NOT COMPLETED|Stage 1 (S1)||0||
59595402|NCT02218008|75704316|FG004|NOT COMPLETED|Stage 1 (S1)||0||
59595403|NCT02218008|75704317|FG005|NOT COMPLETED|Stage 1 (S1)||0||
59595404|NCT02218008|75704312|FG000|STARTED|Stage 2 (S2)||0|Subjects randomized in Stage 2 are a subset of those randomized to placebo in Stage 1.|
59595405|NCT02218008|75704313|FG001|STARTED|Stage 2 (S2)||0|Subjects randomized in Stage 2 are a subset of those randomized to placebo in Stage 1.|
59595406|NCT02218008|75704314|FG002|STARTED|Stage 2 (S2)||0|Subjects randomized in Stage 2 are a subset of those randomized to placebo in Stage 1.|
59595407|NCT02218008|75704315|FG003|STARTED|Stage 2 (S2)||62|Subjects randomized in Stage 2 are a subset of those randomized to placebo in Stage 1.|
59595408|NCT02218008|75704316|FG004|STARTED|Stage 2 (S2)||62|Subjects randomized in Stage 2 are a subset of those randomized to placebo in Stage 1.|
59595409|NCT02218008|75704317|FG005|STARTED|Stage 2 (S2)||63|Subjects randomized in Stage 2 are a subset of those randomized to placebo in Stage 1.|
59595410|NCT02218008|75704312|FG000|COMPLETED|Stage 2 (S2)||0||
59595411|NCT02218008|75704313|FG001|COMPLETED|Stage 2 (S2)||0||
59595412|NCT02218008|75704314|FG002|COMPLETED|Stage 2 (S2)||0||
59595413|NCT02218008|75704315|FG003|COMPLETED|Stage 2 (S2)||58||
59595414|NCT02218008|75704316|FG004|COMPLETED|Stage 2 (S2)||58||
59595415|NCT02218008|75704317|FG005|COMPLETED|Stage 2 (S2)||57||
59595416|NCT02218008|75704312|FG000|NOT COMPLETED|Stage 2 (S2)||0||
59595417|NCT02218008|75704313|FG001|NOT COMPLETED|Stage 2 (S2)||0||
59595418|NCT02218008|75704314|FG002|NOT COMPLETED|Stage 2 (S2)||0||
59595419|NCT02218008|75704315|FG003|NOT COMPLETED|Stage 2 (S2)||4||
59595420|NCT02218008|75704316|FG004|NOT COMPLETED|Stage 2 (S2)||4||
59595421|NCT02218008|75704317|FG005|NOT COMPLETED|Stage 2 (S2)||6||
59595422|NCT03216902|75704337|FG000|STARTED|Overall Study||22||
59595423|NCT03216902|75704338|FG001|STARTED|Overall Study||44||
59595424|NCT03216902|75704339|FG002|STARTED|Overall Study||43||
59595425|NCT03216902|75704340|FG003|STARTED|Overall Study||43||
59595426|NCT03216902|75704341|FG004|STARTED|Overall Study||44||
59595427|NCT03216902|75704342|FG005|STARTED|Overall Study||45||
59595428|NCT03216902|75704337|FG000|COMPLETED|Overall Study||20||
59595429|NCT03216902|75704338|FG001|COMPLETED|Overall Study||43||
59595430|NCT03216902|75704339|FG002|COMPLETED|Overall Study||42||
59595431|NCT03216902|75704340|FG003|COMPLETED|Overall Study||43||
59595432|NCT03216902|75704341|FG004|COMPLETED|Overall Study||43||
59595433|NCT03216902|75704342|FG005|COMPLETED|Overall Study||42||
59595434|NCT03216902|75704337|FG000|NOT COMPLETED|Overall Study||2||
59595435|NCT03216902|75704338|FG001|NOT COMPLETED|Overall Study||1||
59595436|NCT03216902|75704339|FG002|NOT COMPLETED|Overall Study||1||
59595437|NCT03216902|75704340|FG003|NOT COMPLETED|Overall Study||0||
59595438|NCT03216902|75704341|FG004|NOT COMPLETED|Overall Study||1||
59595439|NCT03216902|75704342|FG005|NOT COMPLETED|Overall Study||3||
59595440|NCT03190213|75704364|FG000|STARTED|Overall Study||6||
59595441|NCT03190213|75704364|FG000|COMPLETED|Overall Study||6||
59595442|NCT03190213|75704364|FG000|NOT COMPLETED|Overall Study||0||
59595443|NCT03190993|75704370|FG000|STARTED|Overall Study||10||
59595444|NCT03190993|75704371|FG001|STARTED|Overall Study||10||
59595445|NCT03190993|75704370|FG000|COMPLETED|Overall Study||10||
59595446|NCT03190993|75704371|FG001|COMPLETED|Overall Study||10||
59595447|NCT03190993|75704370|FG000|NOT COMPLETED|Overall Study||0||
59595448|NCT03190993|75704371|FG001|NOT COMPLETED|Overall Study||0||
59595449|NCT03194503|75704379|FG000|STARTED|Overall Study||458||
59595450|NCT03194503|75704380|FG001|STARTED|Overall Study||1054||
59595451|NCT03194503|75704379|FG000|COMPLETED|Overall Study||458||
59595452|NCT03194503|75704380|FG001|COMPLETED|Overall Study||1054||
59595453|NCT03194503|75704379|FG000|NOT COMPLETED|Overall Study||0||
59595454|NCT03194503|75704380|FG001|NOT COMPLETED|Overall Study||0||
59595455|NCT03219320|75704392|FG000|STARTED|Overall Study||75||
59595456|NCT03219320|75704393|FG001|STARTED|Overall Study||77||
59595457|NCT03219320|75704394|FG002|STARTED|Overall Study||77||
59595458|NCT03219320|75704395|FG003|STARTED|Overall Study||72||
59595459|NCT03219320|75704392|FG000|COMPLETED|Overall Study||73||
59595460|NCT03219320|75704393|FG001|COMPLETED|Overall Study||74||
59595461|NCT03219320|75704394|FG002|COMPLETED|Overall Study||72||
59595462|NCT03219320|75704395|FG003|COMPLETED|Overall Study||69||
59595463|NCT03219320|75704392|FG000|NOT COMPLETED|Overall Study||2||
59595464|NCT03219320|75704393|FG001|NOT COMPLETED|Overall Study||3||
59595465|NCT03219320|75704394|FG002|NOT COMPLETED|Overall Study||5||
59595466|NCT03219320|75704395|FG003|NOT COMPLETED|Overall Study||3||
59595467|NCT03194737|75704407|FG000|STARTED|Overall Study||52||
59595468|NCT03194737|75704408|FG001|STARTED|Overall Study||49||
59728418|NCT00812929|75847152|FG003|NOT COMPLETED|Treatment Period 3||0||
59595469|NCT03194737|75704407|FG000|COMPLETED|Overall Study||47||
59595470|NCT03194737|75704408|FG001|COMPLETED|Overall Study||49||
59595471|NCT03194737|75704407|FG000|NOT COMPLETED|Overall Study||5||
59595472|NCT03194737|75704408|FG001|NOT COMPLETED|Overall Study||0||
59595473|NCT01632150|75704414|FG000|STARTED|Overall Study||40||
59595474|NCT01632150|75704414|FG000|Received Cyclophosphamide|Overall Study||11||
59595475|NCT01632150|75704414|FG000|COMPLETED|Overall Study|Completed=still receiving treatment|0||
59595476|NCT01632150|75704414|FG000|NOT COMPLETED|Overall Study||40||
59595477|NCT03421886|75704423|FG000|STARTED|Overall Study||30||
59595478|NCT03421886|75704424|FG001|STARTED|Overall Study||15||
59595479|NCT03421886|75704423|FG000|COMPLETED|Overall Study||23||
59595480|NCT03421886|75704424|FG001|COMPLETED|Overall Study||13||
59595481|NCT03421886|75704423|FG000|NOT COMPLETED|Overall Study||7||
59595482|NCT03421886|75704424|FG001|NOT COMPLETED|Overall Study||2||
59595483|NCT03286465|75704432|FG000|STARTED|Overall Study||100||
59595484|NCT03286465|75704433|FG001|STARTED|Overall Study||100||
59595485|NCT03286465|75704432|FG000|COMPLETED|Overall Study||100||
59595486|NCT03286465|75704433|FG001|COMPLETED|Overall Study||100||
59595487|NCT03286465|75704432|FG000|NOT COMPLETED|Overall Study||0||
59595488|NCT03286465|75704433|FG001|NOT COMPLETED|Overall Study||0||
59595489|NCT02185014|75704439|FG000|STARTED|Overall Study||252||
60128117|NCT01466387|76250150|FG001|STARTED|Overall Study||100||
60128118|NCT01466387|76250151|FG002|STARTED|Overall Study||99||
60128119|NCT01466387|76250152|FG003|STARTED|Overall Study||101||
60128120|NCT01466387|76250153|FG004|STARTED|Overall Study||51||
60128121|NCT01466387|76250154|FG005|STARTED|Overall Study||100||
60128122|NCT01466387|76250149|FG000|COMPLETED|Overall Study||100||
60128123|NCT01466387|76250150|FG001|COMPLETED|Overall Study||100||
60128124|NCT01466387|76250151|FG002|COMPLETED|Overall Study||98||
60128125|NCT01466387|76250152|FG003|COMPLETED|Overall Study||99||
60128126|NCT01466387|76250153|FG004|COMPLETED|Overall Study||51||
60128127|NCT01466387|76250154|FG005|COMPLETED|Overall Study||99||
60128128|NCT01466387|76250149|FG000|NOT COMPLETED|Overall Study||1||
60128129|NCT01466387|76250150|FG001|NOT COMPLETED|Overall Study||0||
60128130|NCT01466387|76250151|FG002|NOT COMPLETED|Overall Study||1||
60128131|NCT01466387|76250152|FG003|NOT COMPLETED|Overall Study||2||
60128132|NCT01466387|76250153|FG004|NOT COMPLETED|Overall Study||0||
60128133|NCT01466387|76250154|FG005|NOT COMPLETED|Overall Study||1||
60128134|NCT00535743|76250201|FG000|STARTED|Overall Study||5||
60128135|NCT00535743|76250202|FG001|STARTED|Overall Study||11||
60128136|NCT00535743|76250203|FG002|STARTED|Overall Study||11||
60128137|NCT00535743|76250204|FG003|STARTED|Overall Study||11||
60128138|NCT00535743|76250205|FG004|STARTED|Overall Study||11||
60128139|NCT00535743|76250206|FG005|STARTED|Overall Study||10||
60128140|NCT00535743|76250207|FG006|STARTED|Overall Study||3||
60128141|NCT00535743|76250208|FG007|STARTED|Overall Study||5||
60128142|NCT00535743|76250209|FG008|STARTED|Overall Study||5||
60128143|NCT00535743|76250210|FG009|STARTED|Overall Study||5||
60128144|NCT00535743|76250211|FG010|STARTED|Overall Study||5||
60128145|NCT00535743|76250212|FG011|STARTED|Overall Study||5||
60128146|NCT00535743|76250213|FG012|STARTED|Overall Study||5||
60128147|NCT00535743|76250214|FG013|STARTED|Overall Study||10||
60128148|NCT00535743|76250215|FG014|STARTED|Overall Study||9||
60128149|NCT00535743|76250216|FG015|STARTED|Overall Study|N=11 randomized to Arm P. An additional N=2 (randomized to Arm O) are counted as Started in Arm P|13||
60128150|NCT00535743|76250217|FG016|STARTED|Overall Study||10||
60128151|NCT00535743|76250218|FG017|STARTED|Overall Study||11||
60128152|NCT00535743|76250219|FG018|STARTED|Overall Study||3||
60128153|NCT00535743|76250220|FG019|STARTED|Overall Study||5||
60128154|NCT00535743|76250221|FG020|STARTED|Overall Study||5||
60128155|NCT00535743|76250222|FG021|STARTED|Overall Study||5||
60128156|NCT00535743|76250223|FG022|STARTED|Overall Study|N=5 randomized to Arm W. An additional N=1 (randomized to Arm Q) is counted as Started in Arm W|6||
60128157|NCT00535743|76250224|FG023|STARTED|Overall Study||5||
60128158|NCT00535743|76250201|FG000|Treated|Overall Study||5|All participants as treated|
60128159|NCT00535743|76250202|FG001|Treated|Overall Study||11|All participants as treated|
60128160|NCT00535743|76250203|FG002|Treated|Overall Study||11|All participants as treated|
59595490|NCT02185014|75704439|FG000|COMPLETED|Overall Study||198||
59595491|NCT02185014|75704439|FG000|NOT COMPLETED|Overall Study||54||
59595492|NCT03297944|75704443|FG000|STARTED|Overall Study||15||
59595493|NCT03297944|75704443|FG000|2ALP/PLC|Overall Study||15||
59595494|NCT03297944|75704443|FG000|1ALP/PLC|Overall Study||15||
59595495|NCT03297944|75704443|FG000|0.5ALP/PLC|Overall Study||15||
59595496|NCT03297944|75704443|FG000|ZOL/PLC|Overall Study||15||
59595497|NCT03297944|75704443|FG000|PLC/PLC|Overall Study||15||
59595498|NCT03297944|75704443|FG000|PLC/ALP|Overall Study||15||
59595499|NCT03297944|75704443|FG000|COMPLETED|Overall Study||15||
59595500|NCT03297944|75704443|FG000|NOT COMPLETED|Overall Study||0||
59595501|NCT03298880|75704452|FG000|STARTED|Overall Study||75||
59595502|NCT03298880|75704452|FG000|COMPLETED|Overall Study||75||
59595503|NCT03298880|75704452|FG000|NOT COMPLETED|Overall Study||0||
59595504|NCT03219866|75704465|FG000|STARTED|Overall Study||21||
59595505|NCT03219866|75704466|FG001|STARTED|Overall Study||19||
59595506|NCT03219866|75704465|FG000|COMPLETED|Overall Study||21||
59595507|NCT03219866|75704466|FG001|COMPLETED|Overall Study||19||
59595508|NCT03219866|75704465|FG000|NOT COMPLETED|Overall Study||0||
59595509|NCT03219866|75704466|FG001|NOT COMPLETED|Overall Study||0||
60128161|NCT00535743|76250204|FG003|Treated|Overall Study||11|All participants as treated|
60128162|NCT00535743|76250205|FG004|Treated|Overall Study||11|All participants as treated|
59595510|NCT03291379|75704472|FG000|STARTED|Overall Study||8||
59595511|NCT03291379|75704472|FG000|COMPLETED|Overall Study||8||
59595512|NCT03291379|75704472|FG000|NOT COMPLETED|Overall Study||0||
60128163|NCT00535743|76250206|FG005|Treated|Overall Study||10|All participants as treated|
59595513|NCT03300674|75704479|FG000|STARTED|Overall Study||77||
59595514|NCT03300674|75704480|FG001|STARTED|Overall Study||77||
59595515|NCT03300674|75704479|FG000|COMPLETED|Overall Study||77||
59595516|NCT03300674|75704480|FG001|COMPLETED|Overall Study||77||
59595517|NCT03300674|75704479|FG000|NOT COMPLETED|Overall Study||0||
59595518|NCT03300674|75704480|FG001|NOT COMPLETED|Overall Study||0||
59595519|NCT02184156|75704489|FG000|STARTED|Phase 1 Safety||7||
59595520|NCT02184156|75704490|FG001|STARTED|Phase 1 Safety||0||
59595521|NCT02184156|75704489|FG000|COMPLETED|Phase 1 Safety||7||
59595522|NCT02184156|75704490|FG001|COMPLETED|Phase 1 Safety||0||
59595523|NCT02184156|75704489|FG000|NOT COMPLETED|Phase 1 Safety||0||
59595524|NCT02184156|75704490|FG001|NOT COMPLETED|Phase 1 Safety||0||
59595525|NCT02184156|75704489|FG000|STARTED|Phase 2 20 Week Efficacy||20||
59595526|NCT02184156|75704490|FG001|STARTED|Phase 2 20 Week Efficacy||20||
59595527|NCT02184156|75704489|FG000|COMPLETED|Phase 2 20 Week Efficacy||19||
59595528|NCT02184156|75704490|FG001|COMPLETED|Phase 2 20 Week Efficacy||19||
59595529|NCT02184156|75704489|FG000|NOT COMPLETED|Phase 2 20 Week Efficacy||1||
59595530|NCT02184156|75704490|FG001|NOT COMPLETED|Phase 2 20 Week Efficacy||1||
59595531|NCT03291613|75704500|FG000|STARTED|Overall Study||13||
59595532|NCT03291613|75704500|FG000|COMPLETED|Overall Study||12||
59595533|NCT03291613|75704500|FG000|NOT COMPLETED|Overall Study||1||
59595534|NCT03300752|75704506|FG000|STARTED|Overall Study||40||
59595535|NCT03300752|75704507|FG001|STARTED|Overall Study||40||
59595536|NCT03300752|75704506|FG000|COMPLETED|Overall Study||38||
59595537|NCT03300752|75704507|FG001|COMPLETED|Overall Study||38||
59595538|NCT03300752|75704506|FG000|NOT COMPLETED|Overall Study||2||
59595539|NCT03300752|75704507|FG001|NOT COMPLETED|Overall Study||2||
59595540|NCT02158884|75704513|FG000|STARTED|Baseline Assessment||91||
59595541|NCT02158884|75704513|FG000|COMPLETED|Baseline Assessment||87||
59595542|NCT02158884|75704513|FG000|NOT COMPLETED|Baseline Assessment||4||
59595543|NCT02158884|75704513|FG000|STARTED|Intervention: IDEO and PT Program||87||
59595544|NCT02158884|75704513|FG000|COMPLETED|Intervention: IDEO and PT Program||81||
59595545|NCT02158884|75704513|FG000|NOT COMPLETED|Intervention: IDEO and PT Program||6||
59595546|NCT02158884|75704513|FG000|STARTED|Post Intervention (~4 Weeks)||81||
59595547|NCT02158884|75704513|FG000|COMPLETED|Post Intervention (~4 Weeks)||71||
59595548|NCT02158884|75704513|FG000|NOT COMPLETED|Post Intervention (~4 Weeks)||10||
59595549|NCT02158884|75704513|FG000|STARTED|6 Month Assessment||81|All those that completed the intervention (n = 81) were eligible to start.|
59595550|NCT02158884|75704513|FG000|COMPLETED|6 Month Assessment||61||
59595551|NCT02158884|75704513|FG000|NOT COMPLETED|6 Month Assessment||20||
59595552|NCT02158884|75704513|FG000|STARTED|12 Month Assessment||81|All those that completed the intervention (n = 81) were eligible to start.|
59595553|NCT02158884|75704513|FG000|COMPLETED|12 Month Assessment||64||
59595554|NCT02158884|75704513|FG000|NOT COMPLETED|12 Month Assessment||17||
59595555|NCT03220412|75704520|FG000|STARTED|Overall Study||54||
59595556|NCT03220412|75704521|FG001|STARTED|Overall Study||50||
59595557|NCT03220412|75704520|FG000|COMPLETED|Overall Study||54||
59595558|NCT03220412|75704521|FG001|COMPLETED|Overall Study||50||
59595559|NCT03220412|75704520|FG000|NOT COMPLETED|Overall Study||0||
59595560|NCT03220412|75704521|FG001|NOT COMPLETED|Overall Study||0||
59595561|NCT03195517|75704529|FG000|STARTED|Overall Study||33||
59595562|NCT03195517|75704529|FG000|COMPLETED|Overall Study||33||
59595563|NCT03195517|75704529|FG000|NOT COMPLETED|Overall Study||0||
59595564|NCT03419533|75704539|FG000|STARTED|Overall Study||4107||
59595565|NCT03419533|75704540|FG001|STARTED|Overall Study||2695||
59595566|NCT03419533|75704539|FG000|COMPLETED|Overall Study||4107||
59595567|NCT03419533|75704540|FG001|COMPLETED|Overall Study||2695||
59595568|NCT03419533|75704539|FG000|NOT COMPLETED|Overall Study||0||
59595569|NCT03419533|75704540|FG001|NOT COMPLETED|Overall Study||0||
59595570|NCT02158806|75704556|FG000|STARTED|Overall Study||125||
59595571|NCT02158806|75704557|FG001|STARTED|Overall Study||126||
59595572|NCT02158806|75704556|FG000|COMPLETED|Overall Study|We had information on all participants for the primary outcome (time to complete healing).|121||
59595573|NCT02158806|75704557|FG001|COMPLETED|Overall Study|We had information on all participants for the primary outcome (time to complete healing).|121||
59595574|NCT02158806|75704556|FG000|NOT COMPLETED|Overall Study||4||
59595575|NCT02158806|75704557|FG001|NOT COMPLETED|Overall Study||5||
59595576|NCT03197389|75704569|FG000|STARTED|Overall Study||16||
59595577|NCT03197389|75704570|FG001|STARTED|Overall Study||5||
59595578|NCT03197389|75704571|FG002|STARTED|Overall Study||18||
59595579|NCT03197389|75704572|FG003|STARTED|Overall Study||9||
59595580|NCT03197389|75704573|FG004|STARTED|Overall Study||1||
59595581|NCT03197389|75704574|FG005|STARTED|Overall Study||5||
59595582|NCT03197389|75704569|FG000|COMPLETED|Overall Study||16||
59595583|NCT03197389|75704570|FG001|COMPLETED|Overall Study||5||
59595584|NCT03197389|75704571|FG002|COMPLETED|Overall Study||18||
59595585|NCT03197389|75704572|FG003|COMPLETED|Overall Study||9||
59595586|NCT03197389|75704573|FG004|COMPLETED|Overall Study||1||
59595587|NCT03197389|75704574|FG005|COMPLETED|Overall Study||5||
59595588|NCT03197389|75704569|FG000|NOT COMPLETED|Overall Study||0||
59595589|NCT03197389|75704570|FG001|NOT COMPLETED|Overall Study||0||
59595590|NCT03197389|75704571|FG002|NOT COMPLETED|Overall Study||0||
59595591|NCT03197389|75704572|FG003|NOT COMPLETED|Overall Study||0||
59595592|NCT03197389|75704573|FG004|NOT COMPLETED|Overall Study||0||
59595593|NCT03197389|75704574|FG005|NOT COMPLETED|Overall Study||0||
59595594|NCT02158728|75704588|FG000|STARTED|Overall Study||80||
59595595|NCT02158728|75704588|FG000|COMPLETED|Overall Study||53||
59595596|NCT02158728|75704588|FG000|NOT COMPLETED|Overall Study||27||
59595597|NCT03198871|75704594|FG000|STARTED|Overall Study||90||
59595598|NCT03198871|75704595|FG001|STARTED|Overall Study||90||
59595599|NCT03198871|75704594|FG000|COMPLETED|Overall Study||76||
59595600|NCT03198871|75704595|FG001|COMPLETED|Overall Study||78||
59595601|NCT03198871|75704594|FG000|NOT COMPLETED|Overall Study||14||
59595602|NCT03198871|75704595|FG001|NOT COMPLETED|Overall Study||12||
59595603|NCT03301298|75704608|FG000|STARTED|Unfed Conditions||6||
59595604|NCT03301298|75704609|FG001|STARTED|Unfed Conditions||6||
59595605|NCT03301298|75704610|FG002|STARTED|Unfed Conditions||6||
59595606|NCT03301298|75704611|FG003|STARTED|Unfed Conditions||6||
59595607|NCT03301298|75704612|FG004|STARTED|Unfed Conditions||6||
59595608|NCT03301298|75704613|FG005|STARTED|Unfed Conditions||6||
59595609|NCT03301298|75704614|FG006|STARTED|Unfed Conditions||12||
59595610|NCT03301298|75704608|FG000|COMPLETED|Unfed Conditions||6||
59595611|NCT03301298|75704609|FG001|COMPLETED|Unfed Conditions||6||
59595612|NCT03301298|75704610|FG002|COMPLETED|Unfed Conditions||6||
59595613|NCT03301298|75704611|FG003|COMPLETED|Unfed Conditions||6||
59595614|NCT03301298|75704612|FG004|COMPLETED|Unfed Conditions||6||
59595615|NCT03301298|75704613|FG005|COMPLETED|Unfed Conditions||6||
59595616|NCT03301298|75704614|FG006|COMPLETED|Unfed Conditions||12||
59595617|NCT03301298|75704608|FG000|NOT COMPLETED|Unfed Conditions||0||
59595618|NCT03301298|75704609|FG001|NOT COMPLETED|Unfed Conditions||0||
59595619|NCT03301298|75704610|FG002|NOT COMPLETED|Unfed Conditions||0||
59595620|NCT03301298|75704611|FG003|NOT COMPLETED|Unfed Conditions||0||
59595621|NCT03301298|75704612|FG004|NOT COMPLETED|Unfed Conditions||0||
59595622|NCT03301298|75704613|FG005|NOT COMPLETED|Unfed Conditions||0||
59595623|NCT03301298|75704614|FG006|NOT COMPLETED|Unfed Conditions||0||
59595624|NCT03301298|75704608|FG000|STARTED|Fed Conditions||0|Only cohort 5 participated in the fed portion of the study, subject 5004 elected to discontinue.|
59595625|NCT03301298|75704609|FG001|STARTED|Fed Conditions||0|Only cohort 5 participated in the fed portion of the study, subject 5004 elected to discontinue.|
59595626|NCT03301298|75704610|FG002|STARTED|Fed Conditions||0|Only cohort 5 participated in the fed portion of the study, subject 5004 elected to discontinue.|
59595627|NCT03301298|75704611|FG003|STARTED|Fed Conditions||0|Only cohort 5 participated in the fed portion of the study, subject 5004 elected to discontinue.|
59595628|NCT03301298|75704612|FG004|STARTED|Fed Conditions||5|Only cohort 5 participated in the fed portion of the study, subject 5004 elected to discontinue.|
59595629|NCT03301298|75704613|FG005|STARTED|Fed Conditions||0|Only cohort 5 participated in the fed portion of the study, subject 5004 elected to discontinue.|
59595630|NCT03301298|75704614|FG006|STARTED|Fed Conditions||2|Only cohort 5 participated in the fed portion of the study, subject 5004 elected to discontinue.|
59595631|NCT03301298|75704608|FG000|COMPLETED|Fed Conditions||0||
59595632|NCT03301298|75704609|FG001|COMPLETED|Fed Conditions||0||
59595633|NCT03301298|75704610|FG002|COMPLETED|Fed Conditions||0||
59595634|NCT03301298|75704611|FG003|COMPLETED|Fed Conditions||0||
59595635|NCT03301298|75704612|FG004|COMPLETED|Fed Conditions||5||
59595636|NCT03301298|75704613|FG005|COMPLETED|Fed Conditions||0||
59595637|NCT03301298|75704614|FG006|COMPLETED|Fed Conditions||2||
59595638|NCT03301298|75704608|FG000|NOT COMPLETED|Fed Conditions||0||
59595639|NCT03301298|75704609|FG001|NOT COMPLETED|Fed Conditions||0||
59595640|NCT03301298|75704610|FG002|NOT COMPLETED|Fed Conditions||0||
59595641|NCT03301298|75704611|FG003|NOT COMPLETED|Fed Conditions||0||
59595642|NCT03301298|75704612|FG004|NOT COMPLETED|Fed Conditions||0||
59595643|NCT03301298|75704613|FG005|NOT COMPLETED|Fed Conditions||0||
59595644|NCT03301298|75704614|FG006|NOT COMPLETED|Fed Conditions||0||
59595645|NCT02157948|75704633|FG000|STARTED|Overall Study||197||
59595646|NCT02157948|75704634|FG001|STARTED|Overall Study||197||
59595647|NCT02157948|75704633|FG000|Received Treatment|Overall Study||196||
59595648|NCT02157948|75704634|FG001|Received Treatment|Overall Study||196||
59595649|NCT02157948|75704633|FG000|COMPLETED|Overall Study||188||
59595650|NCT02157948|75704634|FG001|COMPLETED|Overall Study||188||
59595651|NCT02157948|75704633|FG000|NOT COMPLETED|Overall Study||9||
59595652|NCT02157948|75704634|FG001|NOT COMPLETED|Overall Study||9||
59595653|NCT03302767|75704640|FG000|STARTED|Overall Study||29||
59595654|NCT03302767|75704640|FG000|COMPLETED|Overall Study||29||
59595655|NCT03302767|75704640|FG000|NOT COMPLETED|Overall Study||0||
59595656|NCT03220958|75704646|FG000|STARTED|Overall Study||81||
59595657|NCT03220958|75704647|FG001|STARTED|Overall Study||79||
59595658|NCT03220958|75704646|FG000|COMPLETED|Overall Study||81||
59595659|NCT03220958|75704647|FG001|COMPLETED|Overall Study||79||
59595660|NCT03220958|75704646|FG000|NOT COMPLETED|Overall Study||0||
59595661|NCT03220958|75704647|FG001|NOT COMPLETED|Overall Study||0||
59595662|NCT03420625|75704653|FG000|STARTED|Overall Study||10||
59595663|NCT03420625|75704653|FG000|Baseline|Overall Study||10|Venous flow in the popliteal vein during supine position|
59595664|NCT03420625|75704653|FG000|Foot IPC|Overall Study||10|Intermittent pneumatic compression of the foot using A-V Impulse™, Covidien®, New Haven, CT, USA|
59595665|NCT03420625|75704653|FG000|Rapid Calf IPC|Overall Study||10|Intermittent pneumatic compression of the calf using the VenaFlow® Elite, DJO Global, USA|
59595666|NCT03420625|75704653|FG000|Slow Calf IPC|Overall Study||10|Intermittent pneumatic compression of the calf using the Kendall SCD™ 700, Covidien, Medtronic, USA|
59595667|NCT03420625|75704653|FG000|Calf NMES|Overall Study||10|Neuromuscular electrical stimulation of the calf using the CefarCompex Mi-Theta 500 stimulator|
59595668|NCT03420625|75704653|FG000|COMPLETED|Overall Study||10||
59595669|NCT03420625|75704653|FG000|NOT COMPLETED|Overall Study||0||
59595670|NCT03221192|75704669|FG000|STARTED|Overall Study||27||
59595671|NCT03221192|75704669|FG000|COMPLETED|Overall Study||27||
59595672|NCT03221192|75704669|FG000|NOT COMPLETED|Overall Study||0||
59595673|NCT02182830|75704675|FG000|STARTED|Overall Study||83||
59595674|NCT02182830|75704676|FG001|STARTED|Overall Study||83||
59595675|NCT02182830|75704675|FG000|Randomised Set (RS)|Overall Study|From started, 2 duplicate patients and 2 patients from one site were removed|79|Randomised Patients screened for trial, regardless of whether any trial drug was taken.|
59595676|NCT02182830|75704676|FG001|Randomised Set (RS)|Overall Study|From started, 1 patient from one site was removed|82|Randomised Patients screened for trial, regardless of whether any trial drug was taken.|
59595677|NCT02182830|75704675|FG000|Treated Set (TS)|Overall Study|From RS, 1 duplicate patient and 1 non treated patient was removed|77|All patients in the RS who received at least one dose of trial medication.|
59595678|NCT02182830|75704676|FG001|Treated Set (TS)|Overall Study|From RS, 1 duplicate patient and 1 non treated patient was removed|80|All patients in the RS who received at least one dose of trial medication.|
59595679|NCT02182830|75704675|FG000|COMPLETED|Overall Study||68||
59595680|NCT02182830|75704676|FG001|COMPLETED|Overall Study||68||
59595681|NCT02182830|75704675|FG000|NOT COMPLETED|Overall Study||15||
59595682|NCT02182830|75704676|FG001|NOT COMPLETED|Overall Study||15||
59595683|NCT03424681|75704684|FG000|STARTED|Overall Study||6||
59595684|NCT03424681|75704685|FG001|STARTED|Overall Study||6||
59595685|NCT03424681|75704684|FG000|COMPLETED|Overall Study||6||
59595686|NCT03424681|75704685|FG001|COMPLETED|Overall Study||5||
59595687|NCT03424681|75704684|FG000|NOT COMPLETED|Overall Study||0||
59595688|NCT03424681|75704685|FG001|NOT COMPLETED|Overall Study||1||
59595689|NCT03305653|75704691|FG000|STARTED|Overall Study||21||
59595690|NCT03305653|75704691|FG000|COMPLETED|Overall Study||21||
59595691|NCT03305653|75704691|FG000|NOT COMPLETED|Overall Study||0||
59595692|NCT03431012|75704699|FG000|STARTED|Overall Study||47||
59595693|NCT03431012|75704700|FG001|STARTED|Overall Study||60||
59595694|NCT03431012|75704701|FG002|STARTED|Overall Study||56||
59595695|NCT03431012|75704702|FG003|STARTED|Overall Study||53||
59595696|NCT03431012|75704699|FG000|COMPLETED|Overall Study||47||
59595697|NCT03431012|75704700|FG001|COMPLETED|Overall Study||60||
59595698|NCT03431012|75704701|FG002|COMPLETED|Overall Study||56||
59595699|NCT03431012|75704702|FG003|COMPLETED|Overall Study||53||
59595700|NCT03431012|75704699|FG000|NOT COMPLETED|Overall Study||0||
59595701|NCT03431012|75704700|FG001|NOT COMPLETED|Overall Study||0||
59595702|NCT03431012|75704701|FG002|NOT COMPLETED|Overall Study||0||
59595703|NCT03431012|75704702|FG003|NOT COMPLETED|Overall Study||0||
59595704|NCT03427177|75704718|FG000|STARTED|Overall Study||125||
59595705|NCT03427177|75704719|FG001|STARTED|Overall Study||132||
59595706|NCT03427177|75704718|FG000|COMPLETED|Overall Study||92||
59595707|NCT03427177|75704719|FG001|COMPLETED|Overall Study||105||
59595708|NCT03427177|75704718|FG000|NOT COMPLETED|Overall Study||33||
59595709|NCT03427177|75704719|FG001|NOT COMPLETED|Overall Study||27||
59595710|NCT03302780|75704725|FG000|STARTED|Overall Study||3||
59595711|NCT03302780|75704726|FG001|STARTED|Overall Study||3||
59595712|NCT03302780|75704725|FG000|COMPLETED|Overall Study||3||
59595713|NCT03302780|75704726|FG001|COMPLETED|Overall Study||3||
59595714|NCT03302780|75704725|FG000|NOT COMPLETED|Overall Study||0||
59595715|NCT03302780|75704726|FG001|NOT COMPLETED|Overall Study||0||
59595716|NCT03305887|75704734|FG000|STARTED|Overall Study||91|First Patient In 2017.06.12|
59595717|NCT03305887|75704735|FG001|STARTED|Overall Study||93|First Patient In 2017.06.12|
59595718|NCT03305887|75704734|FG000|COMPLETED|Overall Study||80|Last Patient Out 2018.05.21|
59595719|NCT03305887|75704735|FG001|COMPLETED|Overall Study||83|Last Patient Out 2018.05.21|
59595720|NCT03305887|75704734|FG000|NOT COMPLETED|Overall Study||11||
59595721|NCT03305887|75704735|FG001|NOT COMPLETED|Overall Study||10||
59595722|NCT03221738|75704741|FG000|STARTED|Overall Study||10||
59595723|NCT03221738|75704741|FG000|COMPLETED|Overall Study||10||
59595724|NCT03221738|75704741|FG000|NOT COMPLETED|Overall Study||0||
59595725|NCT03306199|75704745|FG000|STARTED|Overall Study||82||
59595726|NCT03306199|75704745|FG000|COMPLETED|Overall Study||67||
59595727|NCT03306199|75704745|FG000|NOT COMPLETED|Overall Study||15||
59595728|NCT03303404|75704749|FG000|STARTED|Overall Study||22||
59595729|NCT03303404|75704749|FG000|COMPLETED|Overall Study||22||
59595730|NCT03303404|75704749|FG000|NOT COMPLETED|Overall Study||0||
59595731|NCT03224390|75704755|FG000|STARTED|Overall Study||56||
59595732|NCT03224390|75704756|FG001|STARTED|Overall Study||56||
59595733|NCT03224390|75704755|FG000|COMPLETED|Overall Study||29||
59595734|NCT03224390|75704756|FG001|COMPLETED|Overall Study||21||
59595735|NCT03224390|75704755|FG000|NOT COMPLETED|Overall Study||27||
59595736|NCT03224390|75704756|FG001|NOT COMPLETED|Overall Study||35||
59595737|NCT03303794|75704766|FG000|STARTED|Overall Study||13||
59595738|NCT03303794|75704767|FG001|STARTED|Overall Study||12||
59595739|NCT03303794|75704766|FG000|COMPLETED|Overall Study||13||
59595740|NCT03303794|75704767|FG001|COMPLETED|Overall Study||12||
59595741|NCT03303794|75704766|FG000|NOT COMPLETED|Overall Study||0||
59595742|NCT03303794|75704767|FG001|NOT COMPLETED|Overall Study||0||
59595743|NCT03304106|75704775|FG000|STARTED|Overall Study||44||
59595744|NCT03304106|75704776|FG001|STARTED|Overall Study||58||
59595745|NCT03304106|75704775|FG000|COMPLETED|Overall Study||31||
59595746|NCT03304106|75704776|FG001|COMPLETED|Overall Study||56||
59595747|NCT03304106|75704775|FG000|NOT COMPLETED|Overall Study||13||
59595748|NCT03304106|75704776|FG001|NOT COMPLETED|Overall Study||2||
59595749|NCT03305822|75704782|FG000|STARTED|Period 1||20||
59595750|NCT03305822|75704783|FG001|STARTED|Period 1||18||
59595751|NCT03305822|75704782|FG000|Received at Least 1 Dose of Study Drug|Period 1||20||
59595752|NCT03305822|75704783|FG001|Received at Least 1 Dose of Study Drug|Period 1||18||
59595753|NCT03305822|75704782|FG000|COMPLETED|Period 1||20||
59595754|NCT03305822|75704783|FG001|COMPLETED|Period 1||18||
59595755|NCT03305822|75704782|FG000|NOT COMPLETED|Period 1||0||
59595756|NCT03305822|75704783|FG001|NOT COMPLETED|Period 1||0||
59595757|NCT03305822|75704782|FG000|STARTED|Washout|Cross-over study. All participants from Period 1 went on to Washout and Period 2.|20||
59595758|NCT03305822|75704783|FG001|STARTED|Washout|Cross-over study. All participants from Period 1 went on to Washout and Period 2.|18||
59595759|NCT03305822|75704782|FG000|COMPLETED|Washout||20||
59595760|NCT03305822|75704783|FG001|COMPLETED|Washout||18||
59595761|NCT03305822|75704782|FG000|NOT COMPLETED|Washout||0||
59595762|NCT03305822|75704783|FG001|NOT COMPLETED|Washout||0||
59595763|NCT03305822|75704782|FG000|STARTED|Period 2||20||
59595764|NCT03305822|75704783|FG001|STARTED|Period 2||18||
59595765|NCT03305822|75704782|FG000|Received at Least 1 Dose of Study Drug|Period 2||20||
59595766|NCT03305822|75704783|FG001|Received at Least 1 Dose of Study Drug|Period 2||18||
59595767|NCT03305822|75704782|FG000|COMPLETED|Period 2||20||
59595768|NCT03305822|75704783|FG001|COMPLETED|Period 2||18||
59595769|NCT03305822|75704782|FG000|NOT COMPLETED|Period 2||0||
59595770|NCT03305822|75704783|FG001|NOT COMPLETED|Period 2||0||
59595771|NCT03226652|75704789|FG000|STARTED|Overall Study||101||
59595772|NCT03226652|75704789|FG000|COMPLETED|Overall Study||101||
59595773|NCT03226652|75704789|FG000|NOT COMPLETED|Overall Study||0||
59595774|NCT03435614|75704795|FG000|STARTED|Overall Study||6||
59595775|NCT03435614|75704796|FG001|STARTED|Overall Study||23||
59595776|NCT03435614|75704795|FG000|COMPLETED|Overall Study||6||
59595777|NCT03435614|75704796|FG001|COMPLETED|Overall Study||23||
59595778|NCT03435614|75704795|FG000|NOT COMPLETED|Overall Study||0||
59595779|NCT03435614|75704796|FG001|NOT COMPLETED|Overall Study||0||
59595780|NCT03437564|75704803|FG000|STARTED|Overall Study||14||
59595781|NCT03437564|75704804|FG001|STARTED|Overall Study||14||
59595782|NCT03437564|75704803|FG000|COMPLETED|Overall Study||14||
59595783|NCT03437564|75704804|FG001|COMPLETED|Overall Study||14||
59595784|NCT03437564|75704803|FG000|NOT COMPLETED|Overall Study||0||
59595785|NCT03437564|75704804|FG001|NOT COMPLETED|Overall Study||0||
59595786|NCT03438266|75704810|FG000|STARTED|Overall Study||60||
59595787|NCT03438266|75704810|FG000|COMPLETED|Overall Study||60||
59595788|NCT03438266|75704810|FG000|NOT COMPLETED|Overall Study||0||
59595789|NCT03438578|75704818|FG000|STARTED|Overall Study||100||
59595790|NCT03438578|75704819|FG001|STARTED|Overall Study||100||
59595791|NCT03438578|75704818|FG000|COMPLETED|Overall Study||99||
59595792|NCT03438578|75704819|FG001|COMPLETED|Overall Study||96||
59595793|NCT03438578|75704818|FG000|NOT COMPLETED|Overall Study||1||
59595794|NCT03438578|75704819|FG001|NOT COMPLETED|Overall Study||4||
59595795|NCT03315104|75704828|FG000|STARTED|Overall Study||21||
59595796|NCT03315104|75704829|FG001|STARTED|Overall Study||20||
59595797|NCT03315104|75704830|FG002|STARTED|Overall Study||24||
59595798|NCT03315104|75704828|FG000|Dosed (Safety Population)|Overall Study||19||
59595799|NCT03315104|75704829|FG001|Dosed (Safety Population)|Overall Study||19||
59595800|NCT03315104|75704830|FG002|Dosed (Safety Population)|Overall Study||22||
59595801|NCT03315104|75704828|FG000|COMPLETED|Overall Study||18||
59595802|NCT03315104|75704829|FG001|COMPLETED|Overall Study||16||
59595803|NCT03315104|75704830|FG002|COMPLETED|Overall Study||19||
59595804|NCT03315104|75704828|FG000|NOT COMPLETED|Overall Study||3||
59595805|NCT03315104|75704829|FG001|NOT COMPLETED|Overall Study||4||
59595806|NCT03315104|75704830|FG002|NOT COMPLETED|Overall Study||5||
59595807|NCT03228914|75704838|FG000|STARTED|Overall Study||20||20
59595808|NCT03228914|75704839|FG001|STARTED|Overall Study||20||20
59595809|NCT03228914|75704838|FG000|COMPLETED|Overall Study||20||20
59595810|NCT03228914|75704839|FG001|COMPLETED|Overall Study||20||20
59595811|NCT03228914|75704838|FG000|NOT COMPLETED|Overall Study||0||0
59595812|NCT03228914|75704839|FG001|NOT COMPLETED|Overall Study||0||0
59595813|NCT03315572|75704847|FG000|STARTED|Overall Study||14||
59595814|NCT03315572|75704848|FG001|STARTED|Overall Study||14||
59595815|NCT03315572|75704847|FG000|COMPLETED|Overall Study||14||
59595816|NCT03315572|75704848|FG001|COMPLETED|Overall Study||14||
59595817|NCT03315572|75704847|FG000|NOT COMPLETED|Overall Study||0||
59595818|NCT03315572|75704848|FG001|NOT COMPLETED|Overall Study||0||
59595819|NCT03232580|75704855|FG000|STARTED|Overall Study||5||
59595820|NCT03232580|75704855|FG000|COMPLETED|Overall Study||5||
59595821|NCT03232580|75704855|FG000|NOT COMPLETED|Overall Study||0||
59595822|NCT03316976|75704861|FG000|STARTED|Overall Study||20||
59595823|NCT03316976|75704862|FG001|STARTED|Overall Study||20||
59595824|NCT03316976|75704861|FG000|COMPLETED|Overall Study||20||
59595825|NCT03316976|75704862|FG001|COMPLETED|Overall Study||20||
59595826|NCT03316976|75704861|FG000|NOT COMPLETED|Overall Study||0||
59595827|NCT03316976|75704862|FG001|NOT COMPLETED|Overall Study||0||
59595828|NCT03317288|75704868|FG000|STARTED|Overall Study||15||
59595829|NCT03317288|75704868|FG000|COMPLETED|Overall Study||15||
59595830|NCT03317288|75704868|FG000|NOT COMPLETED|Overall Study||0||
59595831|NCT03317444|75704888|FG000|STARTED|Overall Study||124||
59595832|NCT03317444|75704889|FG001|STARTED|Overall Study||93||
59595833|NCT03317444|75704888|FG000|COMPLETED|Overall Study||119||
59595834|NCT03317444|75704889|FG001|COMPLETED|Overall Study||89||
59595835|NCT03317444|75704888|FG000|NOT COMPLETED|Overall Study||5||
59595836|NCT03317444|75704889|FG001|NOT COMPLETED|Overall Study||4||
59595837|NCT03442868|75704895|FG000|STARTED|Overall Study||15||
59595838|NCT03442868|75704895|FG000|COMPLETED|Overall Study||15||
59595839|NCT03442868|75704895|FG000|NOT COMPLETED|Overall Study||0||
59595840|NCT03234374|75704901|FG000|STARTED|Overall Study||35||
59595841|NCT03234374|75704902|FG001|STARTED|Overall Study||17||
59595842|NCT03234374|75704901|FG000|COMPLETED|Overall Study||34||
59595843|NCT03234374|75704902|FG001|COMPLETED|Overall Study||16||
59595844|NCT03234374|75704901|FG000|NOT COMPLETED|Overall Study||1||
59595845|NCT03234374|75704902|FG001|NOT COMPLETED|Overall Study||1||
59595846|NCT03236168|75704908|FG000|STARTED|Overall Study||118||
59595847|NCT03236168|75704908|FG000|COMPLETED|Overall Study||107||
59595848|NCT03236168|75704908|FG000|NOT COMPLETED|Overall Study||11||
59595849|NCT03306589|75704918|FG000|STARTED|Part 1 (69 Days)||2||
59595850|NCT03306589|75704919|FG001|STARTED|Part 1 (69 Days)||4||
59595851|NCT03306589|75704920|FG002|STARTED|Part 1 (69 Days)||2||
59595852|NCT03306589|75704921|FG003|STARTED|Part 1 (69 Days)||4||
59595853|NCT03306589|75704922|FG004|STARTED|Part 1 (69 Days)||0||
59595854|NCT03306589|75704923|FG005|STARTED|Part 1 (69 Days)||0||
59595855|NCT03306589|75704918|FG000|COMPLETED|Part 1 (69 Days)||2||
59595856|NCT03306589|75704919|FG001|COMPLETED|Part 1 (69 Days)||4||
59595857|NCT03306589|75704920|FG002|COMPLETED|Part 1 (69 Days)||2||
59595858|NCT03306589|75704921|FG003|COMPLETED|Part 1 (69 Days)||4||
59595859|NCT03306589|75704922|FG004|COMPLETED|Part 1 (69 Days)||0||
59595860|NCT03306589|75704923|FG005|COMPLETED|Part 1 (69 Days)||0||
59595861|NCT03306589|75704918|FG000|NOT COMPLETED|Part 1 (69 Days)||0||
59595862|NCT03306589|75704919|FG001|NOT COMPLETED|Part 1 (69 Days)||0||
59595863|NCT03306589|75704920|FG002|NOT COMPLETED|Part 1 (69 Days)||0||
59595864|NCT03306589|75704921|FG003|NOT COMPLETED|Part 1 (69 Days)||0||
59595865|NCT03306589|75704922|FG004|NOT COMPLETED|Part 1 (69 Days)||0||
59595866|NCT03306589|75704923|FG005|NOT COMPLETED|Part 1 (69 Days)||0||
59595867|NCT03306589|75704918|FG000|STARTED|Part 2 (69 Days)||0||
59595868|NCT03306589|75704919|FG001|STARTED|Part 2 (69 Days)||0||
59595869|NCT03306589|75704920|FG002|STARTED|Part 2 (69 Days)||0||
59595870|NCT03306589|75704921|FG003|STARTED|Part 2 (69 Days)||0||
59595871|NCT03306589|75704922|FG004|STARTED|Part 2 (69 Days)||0||
59595872|NCT03306589|75704923|FG005|STARTED|Part 2 (69 Days)||0||
59595873|NCT03306589|75704918|FG000|COMPLETED|Part 2 (69 Days)||0||
59595874|NCT03306589|75704919|FG001|COMPLETED|Part 2 (69 Days)||0||
59595875|NCT03306589|75704920|FG002|COMPLETED|Part 2 (69 Days)||0||
59595876|NCT03306589|75704921|FG003|COMPLETED|Part 2 (69 Days)||0||
59595877|NCT03306589|75704922|FG004|COMPLETED|Part 2 (69 Days)||0||
59595878|NCT03306589|75704923|FG005|COMPLETED|Part 2 (69 Days)||0||
59595879|NCT03306589|75704918|FG000|NOT COMPLETED|Part 2 (69 Days)||0||
59595880|NCT03306589|75704919|FG001|NOT COMPLETED|Part 2 (69 Days)||0||
59595881|NCT03306589|75704920|FG002|NOT COMPLETED|Part 2 (69 Days)||0||
59595882|NCT03306589|75704921|FG003|NOT COMPLETED|Part 2 (69 Days)||0||
59595883|NCT03306589|75704922|FG004|NOT COMPLETED|Part 2 (69 Days)||0||
59595884|NCT03306589|75704923|FG005|NOT COMPLETED|Part 2 (69 Days)||0||
59595885|NCT03320096|75704939|FG000|STARTED|Overall Study||20||
59595886|NCT03320096|75704939|FG000|COMPLETED|Overall Study||20||
59595887|NCT03320096|75704939|FG000|NOT COMPLETED|Overall Study||0||
59595888|NCT03309787|75704946|FG000|STARTED|Overall Study||8||
59595889|NCT03309787|75704947|FG001|STARTED|Overall Study||20||
59595890|NCT03309787|75704948|FG002|STARTED|Overall Study||9||
59595891|NCT03309787|75704946|FG000|COMPLETED|Overall Study||6||
59595892|NCT03309787|75704947|FG001|COMPLETED|Overall Study||14||
59595893|NCT03309787|75704948|FG002|COMPLETED|Overall Study||7||
59595894|NCT03309787|75704946|FG000|NOT COMPLETED|Overall Study||2||
59595895|NCT03309787|75704947|FG001|NOT COMPLETED|Overall Study||6||
59595896|NCT03309787|75704948|FG002|NOT COMPLETED|Overall Study||2||
59595897|NCT03446846|75704965|FG000|STARTED|Overall Study||90||
59595898|NCT03446846|75704966|FG001|STARTED|Overall Study||92||
59595899|NCT03446846|75704967|FG002|STARTED|Overall Study||178||
59595900|NCT03446846|75704965|FG000|COMPLETED|Overall Study||83||
59595901|NCT03446846|75704966|FG001|COMPLETED|Overall Study||87||
59595902|NCT03446846|75704967|FG002|COMPLETED|Overall Study||162||
59595903|NCT03446846|75704965|FG000|NOT COMPLETED|Overall Study||7||
59595904|NCT03446846|75704966|FG001|NOT COMPLETED|Overall Study||5||
59595905|NCT03446846|75704967|FG002|NOT COMPLETED|Overall Study||16||
59595906|NCT03312517|75704975|FG000|STARTED|Overall Study||2||
59595907|NCT03312517|75704976|FG001|STARTED|Overall Study||2||
59595908|NCT03312517|75704977|FG002|STARTED|Overall Study||2||
59595909|NCT03312517|75704978|FG003|STARTED|Overall Study||2||
59595910|NCT03312517|75704979|FG004|STARTED|Overall Study||2||
59595911|NCT03312517|75704980|FG005|STARTED|Overall Study||2||
59595912|NCT03312517|75704975|FG000|COMPLETED|Overall Study||2||
59595913|NCT03312517|75704976|FG001|COMPLETED|Overall Study||2||
59595914|NCT03312517|75704977|FG002|COMPLETED|Overall Study||2||
59595915|NCT03312517|75704978|FG003|COMPLETED|Overall Study||2||
59595916|NCT03312517|75704979|FG004|COMPLETED|Overall Study||2||
60128164|NCT00535743|76250207|FG006|Treated|Overall Study||3|All participants as treated|
60128165|NCT00535743|76250208|FG007|Treated|Overall Study||5|All participants as treated|
60128166|NCT00535743|76250209|FG008|Treated|Overall Study||4|All participants as treated|
60128167|NCT00535743|76250210|FG009|Treated|Overall Study||5|All participants as treated|
60128168|NCT00535743|76250211|FG010|Treated|Overall Study||5|All participants as treated|
60128169|NCT00535743|76250212|FG011|Treated|Overall Study||5|All participants as treated|
59595917|NCT03312517|75704980|FG005|COMPLETED|Overall Study||2||
59595918|NCT03312517|75704975|FG000|NOT COMPLETED|Overall Study||0||
59595919|NCT03312517|75704976|FG001|NOT COMPLETED|Overall Study||0||
59595920|NCT03312517|75704977|FG002|NOT COMPLETED|Overall Study||0||
59595921|NCT03312517|75704978|FG003|NOT COMPLETED|Overall Study||0||
59595922|NCT03312517|75704979|FG004|NOT COMPLETED|Overall Study||0||
60128170|NCT00535743|76250213|FG012|Treated|Overall Study||5|All participants as treated|
60128171|NCT00535743|76250214|FG013|Treated|Overall Study||10|All participants as treated|
60128172|NCT00535743|76250215|FG014|Treated|Overall Study||9|All participants as treated|
60128173|NCT00535743|76250216|FG015|Treated|Overall Study|N=2 (randomized to Arm O) rec'd 8 mg/kg Sugammadex, 3 min after 1.2 mg/kg Esmeron®|13|All participants as treated|
60128174|NCT00535743|76250217|FG016|Treated|Overall Study||10|All participants as treated|
60128175|NCT00535743|76250218|FG017|Treated|Overall Study||11|All participants as treated|
60128176|NCT00535743|76250219|FG018|Treated|Overall Study||3|All participants as treated|
60128177|NCT00535743|76250220|FG019|Treated|Overall Study||5|All participants as treated|
60128178|NCT00535743|76250221|FG020|Treated|Overall Study||5|All participants as treated|
60128179|NCT00535743|76250222|FG021|Treated|Overall Study||5|All participants as treated|
60128180|NCT00535743|76250223|FG022|Treated|Overall Study|N=1 (randomized to Arm Q) rec'd 12 mg/kg Sugammadex, 29 min after 1.2 mg/kg Esmeron®|6|All participants as treated|
60128181|NCT00535743|76250224|FG023|Treated|Overall Study||5|All participants as treated|
60128182|NCT00535743|76250201|FG000|COMPLETED|Overall Study||5||
60128183|NCT00535743|76250202|FG001|COMPLETED|Overall Study||11||
60128184|NCT00535743|76250203|FG002|COMPLETED|Overall Study||11||
60128185|NCT00535743|76250204|FG003|COMPLETED|Overall Study||11||
60128186|NCT00535743|76250205|FG004|COMPLETED|Overall Study||11||
60128187|NCT00535743|76250206|FG005|COMPLETED|Overall Study||10||
60128188|NCT00535743|76250207|FG006|COMPLETED|Overall Study||3||
60128189|NCT00535743|76250208|FG007|COMPLETED|Overall Study||5||
60128190|NCT00535743|76250209|FG008|COMPLETED|Overall Study||4||
60128191|NCT00535743|76250210|FG009|COMPLETED|Overall Study||4||
60128192|NCT00535743|76250211|FG010|COMPLETED|Overall Study||5||
60128193|NCT00535743|76250212|FG011|COMPLETED|Overall Study||5||
59595923|NCT03312517|75704980|FG005|NOT COMPLETED|Overall Study||0||
59595924|NCT03449342|75704990|FG000|STARTED|Overall Study||10||
59595925|NCT03449342|75704991|FG001|STARTED|Overall Study||50||
59595926|NCT03449342|75704990|FG000|COMPLETED|Overall Study||10||
59595927|NCT03449342|75704991|FG001|COMPLETED|Overall Study||50||
60128194|NCT00535743|76250213|FG012|COMPLETED|Overall Study||5||
60128195|NCT00535743|76250214|FG013|COMPLETED|Overall Study||10||
60128196|NCT00535743|76250215|FG014|COMPLETED|Overall Study||9||
60128197|NCT00535743|76250216|FG015|COMPLETED|Overall Study||13||
60128198|NCT00535743|76250217|FG016|COMPLETED|Overall Study||10||
60128199|NCT00535743|76250218|FG017|COMPLETED|Overall Study||11||
60128200|NCT00535743|76250219|FG018|COMPLETED|Overall Study||3||
60128201|NCT00535743|76250220|FG019|COMPLETED|Overall Study||5||
60128202|NCT00535743|76250221|FG020|COMPLETED|Overall Study||5||
60128203|NCT00535743|76250222|FG021|COMPLETED|Overall Study||4||
60128204|NCT00535743|76250223|FG022|COMPLETED|Overall Study||6||
60128205|NCT00535743|76250224|FG023|COMPLETED|Overall Study||5||
60128206|NCT00535743|76250201|FG000|NOT COMPLETED|Overall Study||0||
60128207|NCT00535743|76250202|FG001|NOT COMPLETED|Overall Study||0||
60128208|NCT00535743|76250203|FG002|NOT COMPLETED|Overall Study||0||
60128209|NCT00535743|76250204|FG003|NOT COMPLETED|Overall Study||0||
60128210|NCT00535743|76250205|FG004|NOT COMPLETED|Overall Study||0||
60128211|NCT00535743|76250206|FG005|NOT COMPLETED|Overall Study||0||
60128212|NCT00535743|76250207|FG006|NOT COMPLETED|Overall Study||0||
60128213|NCT00535743|76250208|FG007|NOT COMPLETED|Overall Study||0||
60128214|NCT00535743|76250209|FG008|NOT COMPLETED|Overall Study||1||
59595928|NCT03449342|75704990|FG000|NOT COMPLETED|Overall Study||0||
60128215|NCT00535743|76250210|FG009|NOT COMPLETED|Overall Study||1||
60128216|NCT00535743|76250211|FG010|NOT COMPLETED|Overall Study||0||
59595929|NCT03449342|75704991|FG001|NOT COMPLETED|Overall Study||0||
59595930|NCT03312595|75704997|FG000|STARTED|Overall Study||30||
59595931|NCT03312595|75704997|FG000|COMPLETED|Overall Study||24||
59595932|NCT03312595|75704997|FG000|NOT COMPLETED|Overall Study||6||
59595933|NCT03315559|75705001|FG000|STARTED|Treatment Period 1 (8 Days)||6||
59595934|NCT03315559|75705001|FG000|COMPLETED|Treatment Period 1 (8 Days)||6||
59595935|NCT03315559|75705001|FG000|NOT COMPLETED|Treatment Period 1 (8 Days)||0||
59595936|NCT03315559|75705001|FG000|STARTED|Washout Period (14 Days)||6||
59595937|NCT03315559|75705001|FG000|COMPLETED|Washout Period (14 Days)||6||
59595938|NCT03315559|75705001|FG000|NOT COMPLETED|Washout Period (14 Days)||0||
59595939|NCT03315559|75705001|FG000|STARTED|Treatment Period 2 (15 Days)||6||
59595940|NCT03315559|75705001|FG000|COMPLETED|Treatment Period 2 (15 Days)||6||
59595941|NCT03315559|75705001|FG000|NOT COMPLETED|Treatment Period 2 (15 Days)||0||
59595942|NCT03239522|75705008|FG000|STARTED|Treatment Period 1 (Up to 7 Days)||6||
59595943|NCT03239522|75705008|FG000|COMPLETED|Treatment Period 1 (Up to 7 Days)||6||
59595944|NCT03239522|75705008|FG000|NOT COMPLETED|Treatment Period 1 (Up to 7 Days)||0||
59595945|NCT03239522|75705008|FG000|STARTED|Washout Period (Up to 7 Days)||6||
59595946|NCT03239522|75705008|FG000|COMPLETED|Washout Period (Up to 7 Days)||6||
59595947|NCT03239522|75705008|FG000|NOT COMPLETED|Washout Period (Up to 7 Days)||0||
59595948|NCT03239522|75705008|FG000|STARTED|Treatment Period 2 (Up to 15 Days)||6||
59595949|NCT03239522|75705008|FG000|COMPLETED|Treatment Period 2 (Up to 15 Days)||6||
59595950|NCT03239522|75705008|FG000|NOT COMPLETED|Treatment Period 2 (Up to 15 Days)||0||
59595951|NCT03315949|75705021|FG000|STARTED|Overall Study||176||
59595952|NCT03315949|75705022|FG001|STARTED|Overall Study||176||
59595953|NCT03315949|75705021|FG000|COMPLETED|Overall Study||171||
59595954|NCT03315949|75705022|FG001|COMPLETED|Overall Study||166||
59595955|NCT03315949|75705021|FG000|NOT COMPLETED|Overall Study||5||
59595956|NCT03315949|75705022|FG001|NOT COMPLETED|Overall Study||10||
59595957|NCT03241862|75705028|FG000|STARTED|Overall Study||20||
59595958|NCT03241862|75705028|FG000|COMPLETED|Overall Study||20||
59595959|NCT03241862|75705028|FG000|NOT COMPLETED|Overall Study||0||
59595960|NCT03328208|75705034|FG000|STARTED|Overall Study||37||
59595961|NCT03328208|75705035|FG001|STARTED|Overall Study||35||
59595962|NCT03328208|75705034|FG000|COMPLETED|Overall Study||37||
59595963|NCT03328208|75705035|FG001|COMPLETED|Overall Study||35||
59595964|NCT03328208|75705034|FG000|NOT COMPLETED|Overall Study||0||
59595965|NCT03328208|75705035|FG001|NOT COMPLETED|Overall Study||0||
59595966|NCT03210337|75705043|FG000|STARTED|Overall Study||78||
59595967|NCT03210337|75705044|FG001|STARTED|Overall Study||79||
59595968|NCT03210337|75705043|FG000|COMPLETED|Overall Study||70||
59595969|NCT03210337|75705044|FG001|COMPLETED|Overall Study||74||
59595970|NCT03210337|75705043|FG000|NOT COMPLETED|Overall Study||8||
60128217|NCT00535743|76250212|FG011|NOT COMPLETED|Overall Study||0||
60128218|NCT00535743|76250213|FG012|NOT COMPLETED|Overall Study||0||
60128219|NCT00535743|76250214|FG013|NOT COMPLETED|Overall Study||0||
60128220|NCT00535743|76250215|FG014|NOT COMPLETED|Overall Study||0||
60128221|NCT00535743|76250216|FG015|NOT COMPLETED|Overall Study||0||
60128222|NCT00535743|76250217|FG016|NOT COMPLETED|Overall Study||0||
60128223|NCT00535743|76250218|FG017|NOT COMPLETED|Overall Study||0||
60128224|NCT00535743|76250219|FG018|NOT COMPLETED|Overall Study||0||
60128225|NCT00535743|76250220|FG019|NOT COMPLETED|Overall Study||0||
60128226|NCT00535743|76250221|FG020|NOT COMPLETED|Overall Study||0||
60128227|NCT00535743|76250222|FG021|NOT COMPLETED|Overall Study||1||
60128228|NCT00535743|76250223|FG022|NOT COMPLETED|Overall Study||0||
60128229|NCT00535743|76250224|FG023|NOT COMPLETED|Overall Study||0||
60128230|NCT00535821|76250276|FG000|STARTED|Overall Study||2||
60128231|NCT00535821|76250277|FG001|STARTED|Overall Study||3||
60128232|NCT00535821|76250276|FG000|COMPLETED|Overall Study||2||
60128233|NCT00535821|76250277|FG001|COMPLETED|Overall Study||3||
60128234|NCT00535821|76250276|FG000|NOT COMPLETED|Overall Study||0||
60128235|NCT00535821|76250277|FG001|NOT COMPLETED|Overall Study||0||
60128236|NCT01564784|76250285|FG000|STARTED|Overall Study|Treated (164 randomized)|164||
60128237|NCT01564784|76250286|FG001|STARTED|Overall Study|Treated (162 randomized)|143||
60128238|NCT01564784|76250285|FG000|COMPLETED|Overall Study||30||
60128239|NCT01564784|76250286|FG001|COMPLETED|Overall Study||10||
60128240|NCT01564784|76250285|FG000|NOT COMPLETED|Overall Study||134||
60128241|NCT01564784|76250286|FG001|NOT COMPLETED|Overall Study||133||
60128242|NCT00536601|76250297|FG000|STARTED|Overall Study||6||
60128243|NCT00536601|76250298|FG001|STARTED|Overall Study||21||
60128244|NCT00536601|76250299|FG002|STARTED|Overall Study||71||
60128245|NCT00536601|76250300|FG003|STARTED|Overall Study||65||
60128246|NCT00536601|76250301|FG004|STARTED|Overall Study||11||
60128247|NCT00536601|76250297|FG000|COMPLETED|Overall Study||6||
60128248|NCT00536601|76250298|FG001|COMPLETED|Overall Study||21||
60128249|NCT00536601|76250299|FG002|COMPLETED|Overall Study||71||
60128250|NCT00536601|76250300|FG003|COMPLETED|Overall Study||65||
60128251|NCT00536601|76250301|FG004|COMPLETED|Overall Study||11||
60128252|NCT00536601|76250297|FG000|NOT COMPLETED|Overall Study||0||
60128253|NCT00536601|76250298|FG001|NOT COMPLETED|Overall Study||0||
60128254|NCT00536601|76250299|FG002|NOT COMPLETED|Overall Study||0||
60128255|NCT00536601|76250300|FG003|NOT COMPLETED|Overall Study||0||
60128256|NCT00536601|76250301|FG004|NOT COMPLETED|Overall Study||0||
60128257|NCT00536913|76250315|FG000|STARTED|Overall Study||55||
60128258|NCT00536913|76250316|FG001|STARTED|Overall Study||52||
60128259|NCT00536913|76250315|FG000|COMPLETED|Overall Study||55||
60128260|NCT00536913|76250316|FG001|COMPLETED|Overall Study||52||
60128261|NCT00536913|76250315|FG000|NOT COMPLETED|Overall Study||0||
60128262|NCT00536913|76250316|FG001|NOT COMPLETED|Overall Study||0||
60128263|NCT00462423|76250322|FG000|STARTED|Overall Study||50||
60128264|NCT00462423|76250322|FG000|COMPLETED|Overall Study||50||
59595971|NCT03210337|75705044|FG001|NOT COMPLETED|Overall Study||5||
59595972|NCT03242408|75705050|FG000|STARTED|Overall Study||100||
59595973|NCT03242408|75705050|FG000|COMPLETED|Overall Study||98||
59595974|NCT03242408|75705050|FG000|NOT COMPLETED|Overall Study||2||
59595975|NCT03242954|75705058|FG000|STARTED|Overall Study||43||
59595976|NCT03242954|75705059|FG001|STARTED|Overall Study||45||
59595977|NCT03242954|75705060|FG002|STARTED|Overall Study||41||
59595978|NCT03242954|75705061|FG003|STARTED|Overall Study||125||
59595979|NCT03242954|75705058|FG000|COMPLETED|Overall Study||43||
59595980|NCT03242954|75705059|FG001|COMPLETED|Overall Study||45||
59595981|NCT03242954|75705060|FG002|COMPLETED|Overall Study||41||
59595982|NCT03242954|75705061|FG003|COMPLETED|Overall Study||125||
59595983|NCT03242954|75705058|FG000|NOT COMPLETED|Overall Study||0||
59595984|NCT03242954|75705059|FG001|NOT COMPLETED|Overall Study||0||
59595985|NCT03242954|75705060|FG002|NOT COMPLETED|Overall Study||0||
60128265|NCT00462423|76250322|FG000|NOT COMPLETED|Overall Study||0||
60128266|NCT00461331|76250327|FG000|STARTED|Intervention 1||10||
60128267|NCT00461331|76250328|FG001|STARTED|Intervention 1||10||
60128268|NCT00461331|76250327|FG000|COMPLETED|Intervention 1||10||
60128269|NCT00461331|76250328|FG001|COMPLETED|Intervention 1||10||
60128270|NCT00461331|76250327|FG000|NOT COMPLETED|Intervention 1||0||
60128271|NCT00461331|76250328|FG001|NOT COMPLETED|Intervention 1||0||
60128272|NCT00461331|76250327|FG000|STARTED|Washout||10||
60128273|NCT00461331|76250328|FG001|STARTED|Washout||10||
59595986|NCT03242954|75705061|FG003|NOT COMPLETED|Overall Study||0||
59595987|NCT03459794|75705073|FG000|STARTED|Overall Study||8||
59595988|NCT03459794|75705074|FG001|STARTED|Overall Study||4||
59595989|NCT03459794|75705073|FG000|COMPLETED|Overall Study||8||
59595990|NCT03459794|75705074|FG001|COMPLETED|Overall Study||4||
59595991|NCT03459794|75705073|FG000|NOT COMPLETED|Overall Study||0||
59595992|NCT03459794|75705074|FG001|NOT COMPLETED|Overall Study||0||
59595993|NCT03211117|75705086|FG000|STARTED|Overall Study||0||
59595994|NCT03211117|75705087|FG001|STARTED|Overall Study||3||
59595995|NCT03211117|75705086|FG000|COMPLETED|Overall Study||0||
59595996|NCT03211117|75705087|FG001|COMPLETED|Overall Study||3||
59595997|NCT03211117|75705086|FG000|NOT COMPLETED|Overall Study||0||
59595998|NCT03211117|75705087|FG001|NOT COMPLETED|Overall Study||0||
59595999|NCT03436147|75705095|FG000|STARTED|Overall Study||19||
59596000|NCT03436147|75705096|FG001|STARTED|Overall Study||30||
60128274|NCT00461331|76250327|FG000|COMPLETED|Washout||10||
60128275|NCT00461331|76250328|FG001|COMPLETED|Washout||10||
59596001|NCT03436147|75705095|FG000|COMPLETED|Overall Study||15||
59596002|NCT03436147|75705096|FG001|COMPLETED|Overall Study||19||
59596003|NCT03436147|75705095|FG000|NOT COMPLETED|Overall Study||4||
59596004|NCT03436147|75705096|FG001|NOT COMPLETED|Overall Study||11||
59596005|NCT03245372|75705106|FG000|STARTED|Overall Study||15||
59596006|NCT03245372|75705107|FG001|STARTED|Overall Study||15||
59596007|NCT03245372|75705106|FG000|COMPLETED|Overall Study||15||
59596008|NCT03245372|75705107|FG001|COMPLETED|Overall Study||15||
59596009|NCT03245372|75705106|FG000|NOT COMPLETED|Overall Study||0||
59596010|NCT03245372|75705107|FG001|NOT COMPLETED|Overall Study||0||
59596011|NCT03317431|75705113|FG000|STARTED|Overall Study||46||
59596012|NCT03317431|75705113|FG000|COMPLETED|Overall Study||46||
59596013|NCT03317431|75705113|FG000|NOT COMPLETED|Overall Study||0||
59596014|NCT03460652|75705117|FG000|STARTED|Overall Study||282||
59596015|NCT03460652|75705117|FG000|Entered Treatment Phase|Overall Study||238|Treatment Phase Safety Population, which includes all enrolled subjects who received at least 1 dose of study medication and had at least 1 post-dose safety assessment in the Treatment Phase|
59596016|NCT03460652|75705117|FG000|COMPLETED|Overall Study||155||
59596017|NCT03460652|75705117|FG000|NOT COMPLETED|Overall Study||127||
59596018|NCT03321097|75705124|FG000|STARTED|Overall Study||18||
59596019|NCT03321097|75705125|FG001|STARTED|Overall Study||18||
59596020|NCT03321097|75705124|FG000|COMPLETED|Overall Study||18||
59596021|NCT03321097|75705125|FG001|COMPLETED|Overall Study||18||
59596022|NCT03321097|75705124|FG000|NOT COMPLETED|Overall Study||0||
59596023|NCT03321097|75705125|FG001|NOT COMPLETED|Overall Study||0||
60128276|NCT00461331|76250327|FG000|NOT COMPLETED|Washout||0||
60128277|NCT00461331|76250328|FG001|NOT COMPLETED|Washout||0||
60128278|NCT00461331|76250327|FG000|STARTED|Intervention 2||10||
60128279|NCT00461331|76250328|FG001|STARTED|Intervention 2||10||
60128280|NCT00461331|76250327|FG000|COMPLETED|Intervention 2||10||
60128281|NCT00461331|76250328|FG001|COMPLETED|Intervention 2||10||
60128282|NCT00461331|76250327|FG000|NOT COMPLETED|Intervention 2||0||
60128283|NCT00461331|76250328|FG001|NOT COMPLETED|Intervention 2||0||
59596024|NCT03245762|75705133|FG000|STARTED|Overall Study||10||
59596025|NCT03245762|75705134|FG001|STARTED|Overall Study||5||
60128284|NCT01564394|76250337|FG000|STARTED|Overall Study|Prostate cancer survivors n=20, family n=10. Only survivors were randomized.|30||
60128285|NCT01564394|76250338|FG001|STARTED|Overall Study|Prostate cancer survivors n=20, family n=10. Only survivors were randomized.|30||
60128286|NCT01564394|76250337|FG000|COMPLETED|Overall Study|Prostate cancer survivors n=16, family n=8.|24||
60128287|NCT01564394|76250338|FG001|COMPLETED|Overall Study|Prostate cancer survivors n=13, family n=7.|20||
60128288|NCT01564394|76250337|FG000|NOT COMPLETED|Overall Study||6||
60128289|NCT01564394|76250338|FG001|NOT COMPLETED|Overall Study||10||
60128290|NCT00462735|76250344|FG000|STARTED|Overall Study||33||
60128291|NCT00462735|76250344|FG000|COMPLETED|Overall Study||33||
60128292|NCT00462735|76250344|FG000|NOT COMPLETED|Overall Study||0||
60128293|NCT01690988|76250352|FG000|STARTED|Overall Study||227||
60128294|NCT01690988|76250353|FG001|STARTED|Overall Study||222||
60128295|NCT01690988|76250354|FG002|STARTED|Overall Study||223||
60128296|NCT01690988|76250352|FG000|COMPLETED|Overall Study||221||
60128297|NCT01690988|76250353|FG001|COMPLETED|Overall Study||217||
60128298|NCT01690988|76250354|FG002|COMPLETED|Overall Study||216||
60128299|NCT01690988|76250352|FG000|NOT COMPLETED|Overall Study||6||
60128300|NCT01690988|76250353|FG001|NOT COMPLETED|Overall Study||5||
60128301|NCT01690988|76250354|FG002|NOT COMPLETED|Overall Study||7||
60128302|NCT00463437|76250369|FG000|STARTED|Overall Study||359||
60128303|NCT00463437|76250370|FG001|STARTED|Overall Study||363||
60128304|NCT00463437|76250371|FG002|STARTED|Overall Study||358||
60128305|NCT00463437|76250372|FG003|STARTED|Overall Study||357||
60128306|NCT00463437|76250369|FG000|COMPLETED|Overall Study||355||
60128307|NCT00463437|76250370|FG001|COMPLETED|Overall Study||352||
60128308|NCT00463437|76250371|FG002|COMPLETED|Overall Study||352||
60128309|NCT00463437|76250372|FG003|COMPLETED|Overall Study||350||
60128310|NCT00463437|76250369|FG000|NOT COMPLETED|Overall Study||4||
60128311|NCT00463437|76250370|FG001|NOT COMPLETED|Overall Study||11||
60128312|NCT00463437|76250371|FG002|NOT COMPLETED|Overall Study||6||
60128313|NCT00463437|76250372|FG003|NOT COMPLETED|Overall Study||7||
60128314|NCT01466153|76250385|FG000|STARTED|Overall Study||62||
60128315|NCT01466153|76250386|FG001|STARTED|Overall Study||36||
60128316|NCT01466153|76250387|FG002|STARTED|Overall Study||61||
60128317|NCT01466153|76250385|FG000|COMPLETED|Overall Study||33||
60128318|NCT01466153|76250386|FG001|COMPLETED|Overall Study||12||
60128319|NCT01466153|76250387|FG002|COMPLETED|Overall Study||36||
60128320|NCT01466153|76250385|FG000|NOT COMPLETED|Overall Study||29||
60128321|NCT01466153|76250386|FG001|NOT COMPLETED|Overall Study||24||
60128322|NCT01466153|76250387|FG002|NOT COMPLETED|Overall Study||25||
59596026|NCT03245762|75705133|FG000|COMPLETED|Overall Study||10||
59596027|NCT03245762|75705134|FG001|COMPLETED|Overall Study||5||
59596028|NCT03245762|75705133|FG000|NOT COMPLETED|Overall Study||0||
59596029|NCT03245762|75705134|FG001|NOT COMPLETED|Overall Study||0||
59596030|NCT03321253|75705140|FG000|STARTED|Overall Study||38||
59596031|NCT03321253|75705140|FG000|COMPLETED|Overall Study||38||
59596032|NCT03321253|75705140|FG000|NOT COMPLETED|Overall Study||0||
59596033|NCT03322657|75705146|FG000|STARTED|Overall Study||34||
59596034|NCT03322657|75705147|FG001|STARTED|Overall Study||35||
59596035|NCT03322657|75705146|FG000|COMPLETED|Overall Study||33||
59596036|NCT03322657|75705147|FG001|COMPLETED|Overall Study||35||
59596037|NCT03322657|75705146|FG000|NOT COMPLETED|Overall Study||1||
59596038|NCT03322657|75705147|FG001|NOT COMPLETED|Overall Study||0||
59596039|NCT03247322|75705155|FG000|STARTED|Overall Study||68||
59596040|NCT03247322|75705156|FG001|STARTED|Overall Study||68||
59596041|NCT03247322|75705155|FG000|COMPLETED|Overall Study||66||
59596042|NCT03247322|75705156|FG001|COMPLETED|Overall Study||68||
59596043|NCT03247322|75705155|FG000|NOT COMPLETED|Overall Study||2||
59596044|NCT03247322|75705156|FG001|NOT COMPLETED|Overall Study||0||
59596045|NCT03324451|75705166|FG000|STARTED|Overall Study||97||
59596046|NCT03324451|75705167|FG001|STARTED|Overall Study||54||
59596047|NCT03324451|75705166|FG000|COMPLETED|Overall Study||65||
59596048|NCT03324451|75705167|FG001|COMPLETED|Overall Study||41||
59596049|NCT03324451|75705166|FG000|NOT COMPLETED|Overall Study||32||
59596050|NCT03324451|75705167|FG001|NOT COMPLETED|Overall Study||13||
59596051|NCT03324607|75705173|FG000|STARTED|Overall Study||20||
59596052|NCT03324607|75705173|FG000|COMPLETED|Overall Study||20||
59596053|NCT03324607|75705173|FG000|NOT COMPLETED|Overall Study||0||
59596054|NCT03247790|75705180|FG000|STARTED|Period 1: Migraine Attack||16||
59596055|NCT03247790|75705180|FG000|Received at Least One Dose of Study Drug|Period 1: Migraine Attack||16||
59596056|NCT03247790|75705180|FG000|COMPLETED|Period 1: Migraine Attack||16||
59596057|NCT03247790|75705180|FG000|NOT COMPLETED|Period 1: Migraine Attack||0||
59596058|NCT03247790|75705180|FG000|STARTED|Period 2: Inter-ictal Period||16||
59596059|NCT03247790|75705180|FG000|COMPLETED|Period 2: Inter-ictal Period||16||
59596060|NCT03247790|75705180|FG000|NOT COMPLETED|Period 2: Inter-ictal Period||0||
59596061|NCT03249116|75705189|FG000|STARTED|Overall Study||25||
59596062|NCT03249116|75705190|FG001|STARTED|Overall Study||25||
60128323|NCT00464685|76250399|FG000|STARTED|Overall Study||126||
60128324|NCT00464685|76250400|FG001|STARTED|Overall Study||127||
60128325|NCT00464685|76250399|FG000|COMPLETED|Overall Study||103||
60128326|NCT00464685|76250400|FG001|COMPLETED|Overall Study||94||
60128327|NCT00464685|76250399|FG000|NOT COMPLETED|Overall Study||23||
60128328|NCT00464685|76250400|FG001|NOT COMPLETED|Overall Study||33||
60128329|NCT01474291|76250408|FG000|STARTED|Overall Study||603||
60128330|NCT01474291|76250408|FG000|Evaluable for Efficacy|Overall Study|Received tocilizumab infusion and met all inclusion/exclusion criteria|577||
60128331|NCT01474291|76250408|FG000|COMPLETED|Overall Study||383||
60128332|NCT01474291|76250408|FG000|NOT COMPLETED|Overall Study||220||
60128333|NCT01465997|76250417|FG000|STARTED|Overall Study||279||
60128334|NCT01465997|76250418|FG001|STARTED|Overall Study||269||
60128335|NCT01465997|76250417|FG000|COMPLETED|Overall Study||211||
60128336|NCT01465997|76250418|FG001|COMPLETED|Overall Study||180||
60128337|NCT01465997|76250417|FG000|NOT COMPLETED|Overall Study||68||
60128338|NCT01465997|76250418|FG001|NOT COMPLETED|Overall Study||89||
60128339|NCT00538863|76250426|FG000|STARTED|Open-label Titration||229||
60128340|NCT00538863|76250426|FG000|COMPLETED|Open-label Titration||184||
60128341|NCT00538863|76250426|FG000|NOT COMPLETED|Open-label Titration||45||
60128342|NCT00538863|76250426|FG000|STARTED|Open-label Maintenance|Five participants who completed the titration period did not start the maintenance period.|269||
60128343|NCT00538863|76250426|FG000|COMPLETED|Open-label Maintenance||163||
60128344|NCT00538863|76250426|FG000|NOT COMPLETED|Open-label Maintenance||106||
60128345|NCT00539253|76250432|FG000|STARTED|Overall Study||45||
60128346|NCT00539253|76250432|FG000|COMPLETED|Overall Study||19||
60128347|NCT00539253|76250432|FG000|NOT COMPLETED|Overall Study||26||
60128348|NCT01465763|76250439|FG000|STARTED|Overall Study||476||
60128349|NCT01465763|76250440|FG001|STARTED|Overall Study||16||
60128350|NCT01465763|76250441|FG002|STARTED|Overall Study||122||
60128351|NCT01465763|76250439|FG000|COMPLETED|Overall Study||445||
60128352|NCT01465763|76250440|FG001|COMPLETED|Overall Study||15||
60128353|NCT01465763|76250441|FG002|COMPLETED|Overall Study||118||
60128354|NCT01465763|76250439|FG000|NOT COMPLETED|Overall Study||31||
60128355|NCT01465763|76250440|FG001|NOT COMPLETED|Overall Study||1||
60128356|NCT01465763|76250441|FG002|NOT COMPLETED|Overall Study||4||
60128357|NCT00540579|76250448|FG000|STARTED|Overall Study||23||
60128358|NCT00540579|76250448|FG000|COMPLETED|Overall Study||23||
60128359|NCT00540579|76250448|FG000|NOT COMPLETED|Overall Study||0||
60128360|NCT00466323|76250454|FG000|STARTED|Overall Study||117||
60128361|NCT00466323|76250455|FG001|STARTED|Overall Study||115||
60128362|NCT00466323|76250454|FG000|COMPLETED|Overall Study||89||
60128363|NCT00466323|76250455|FG001|COMPLETED|Overall Study||92||
60128364|NCT00466323|76250454|FG000|NOT COMPLETED|Overall Study||28||
60128365|NCT00466323|76250455|FG001|NOT COMPLETED|Overall Study||23||
60128366|NCT04081727|76250463|FG000|STARTED|Overall Study||2||
60128367|NCT04081727|76250464|FG001|STARTED|Overall Study||0||
60128368|NCT04081727|76250463|FG000|As-treated Analysis|Overall Study||1||
60128369|NCT04081727|76250464|FG001|As-treated Analysis|Overall Study||1||
60128370|NCT04081727|76250463|FG000|COMPLETED|Overall Study||2||
60128371|NCT04081727|76250464|FG001|COMPLETED|Overall Study||0||
59596063|NCT03249116|75705191|FG002|STARTED|Overall Study||25||
59596064|NCT03249116|75705189|FG000|COMPLETED|Overall Study||25||
59596065|NCT03249116|75705190|FG001|COMPLETED|Overall Study||25||
59596066|NCT03249116|75705191|FG002|COMPLETED|Overall Study||25||
59596067|NCT03249116|75705189|FG000|NOT COMPLETED|Overall Study||0||
59596068|NCT03249116|75705190|FG001|NOT COMPLETED|Overall Study||0||
59596069|NCT03249116|75705191|FG002|NOT COMPLETED|Overall Study||0||
59596070|NCT03437863|75705200|FG000|STARTED|Overall Study||12||
59596071|NCT03437863|75705200|FG000|COMPLETED|Overall Study||12||
60128372|NCT04081727|76250463|FG000|NOT COMPLETED|Overall Study||0||
60128373|NCT04081727|76250464|FG001|NOT COMPLETED|Overall Study||0||
60128374|NCT01690520|76250474|FG000|STARTED|Overall Study||78||
60128375|NCT01690520|76250475|FG001|STARTED|Overall Study||82||
60128376|NCT01690520|76250474|FG000|Modified Intent to Treat (mITT)|Overall Study||78||
60128377|NCT01690520|76250475|FG001|Modified Intent to Treat (mITT)|Overall Study||80||
60128378|NCT01690520|76250474|FG000|COMPLETED|Overall Study||27||
60128379|NCT01690520|76250475|FG001|COMPLETED|Overall Study||35||
60128380|NCT01690520|76250474|FG000|NOT COMPLETED|Overall Study||51||
60128381|NCT01690520|76250475|FG001|NOT COMPLETED|Overall Study||47||
60128382|NCT00541593|76250481|FG000|STARTED|Overall Study||5||
60128383|NCT00541593|76250481|FG000|COMPLETED|Overall Study||5||
60128384|NCT00541593|76250481|FG000|NOT COMPLETED|Overall Study||0||
60128385|NCT00541671|76250487|FG000|STARTED|Overall Study||13||
60128386|NCT00541671|76250488|FG001|STARTED|Overall Study||12||
60128387|NCT00541671|76250487|FG000|COMPLETED|Overall Study||13||
60128388|NCT00541671|76250488|FG001|COMPLETED|Overall Study||12||
60128389|NCT00541671|76250487|FG000|NOT COMPLETED|Overall Study||0||
60128390|NCT00541671|76250488|FG001|NOT COMPLETED|Overall Study||0||
60128391|NCT01563536|76250496|FG000|STARTED|Overall Study||6||
60128392|NCT01563536|76250497|FG001|STARTED|Overall Study||6||
59596072|NCT03437863|75705200|FG000|NOT COMPLETED|Overall Study||0||
60128393|NCT01563536|76250496|FG000|COMPLETED|Overall Study||5||
60128394|NCT01563536|76250497|FG001|COMPLETED|Overall Study||4||
60128395|NCT01563536|76250496|FG000|NOT COMPLETED|Overall Study||1||
60128396|NCT01563536|76250497|FG001|NOT COMPLETED|Overall Study||2||
60128397|NCT01690130|76250505|FG000|STARTED|Overall Study||10||
60128398|NCT01690130|76250506|FG001|STARTED|Overall Study||9||
60128399|NCT01690130|76250505|FG000|COMPLETED|Overall Study||9||
60128400|NCT01690130|76250506|FG001|COMPLETED|Overall Study||9||
59596073|NCT03467048|75705206|FG000|STARTED|Overall Study||66||
60128401|NCT01690130|76250505|FG000|NOT COMPLETED|Overall Study||1||
60128402|NCT01690130|76250506|FG001|NOT COMPLETED|Overall Study||0||
60128403|NCT01690052|76250512|FG000|STARTED|FIRST INTERVENTION: 4 WEEKS||7||
60128404|NCT01690052|76250513|FG001|STARTED|FIRST INTERVENTION: 4 WEEKS||8||
60128405|NCT01690052|76250512|FG000|COMPLETED|FIRST INTERVENTION: 4 WEEKS||6||
60128406|NCT01690052|76250513|FG001|COMPLETED|FIRST INTERVENTION: 4 WEEKS||6||
60128407|NCT01690052|76250512|FG000|NOT COMPLETED|FIRST INTERVENTION: 4 WEEKS||1||
60128408|NCT01690052|76250513|FG001|NOT COMPLETED|FIRST INTERVENTION: 4 WEEKS||2||
60128409|NCT01690052|76250512|FG000|STARTED|Washout Period of 1 Week||6||
60128410|NCT01690052|76250513|FG001|STARTED|Washout Period of 1 Week||6||
59596074|NCT03467048|75705207|FG001|STARTED|Overall Study||64||
59596075|NCT03467048|75705206|FG000|COMPLETED|Overall Study||66||
59596076|NCT03467048|75705207|FG001|COMPLETED|Overall Study||63||
59596077|NCT03467048|75705206|FG000|NOT COMPLETED|Overall Study||0||
59596078|NCT03467048|75705207|FG001|NOT COMPLETED|Overall Study||1||
59596079|NCT03249272|75705216|FG000|STARTED|Overall Study||19||
59596080|NCT03249272|75705217|FG001|STARTED|Overall Study||6||
59596081|NCT03249272|75705218|FG002|STARTED|Overall Study||6||
59596082|NCT03249272|75705216|FG000|COMPLETED|Overall Study||19||
59596083|NCT03249272|75705217|FG001|COMPLETED|Overall Study||6||
59596084|NCT03249272|75705218|FG002|COMPLETED|Overall Study||6||
59596085|NCT03249272|75705216|FG000|NOT COMPLETED|Overall Study||0||
59596086|NCT03249272|75705217|FG001|NOT COMPLETED|Overall Study||0||
59596087|NCT03249272|75705218|FG002|NOT COMPLETED|Overall Study||0||
59596088|NCT03249584|75705240|FG000|STARTED|Overall Study||184|Subjects who received RF Ablation|
59596089|NCT03249584|75705241|FG001|STARTED|Overall Study||22|Subjects who received RF Ablation|
60128411|NCT01690052|76250512|FG000|COMPLETED|Washout Period of 1 Week||6||
60128412|NCT01690052|76250513|FG001|COMPLETED|Washout Period of 1 Week||6||
60128413|NCT01690052|76250512|FG000|NOT COMPLETED|Washout Period of 1 Week||0||
60128414|NCT01690052|76250513|FG001|NOT COMPLETED|Washout Period of 1 Week||0||
60128415|NCT01690052|76250512|FG000|STARTED|SECOND INTERVENTION: 4 WEEKS||6||
60128416|NCT01690052|76250513|FG001|STARTED|SECOND INTERVENTION: 4 WEEKS||6||
60128417|NCT01690052|76250512|FG000|COMPLETED|SECOND INTERVENTION: 4 WEEKS||6||
60128418|NCT01690052|76250513|FG001|COMPLETED|SECOND INTERVENTION: 4 WEEKS||6||
60128419|NCT01690052|76250512|FG000|NOT COMPLETED|SECOND INTERVENTION: 4 WEEKS||0||
59596090|NCT03249584|75705240|FG000|Month 3|Overall Study||132||
59596091|NCT03249584|75705241|FG001|Month 3|Overall Study||15||
59596092|NCT03249584|75705240|FG000|Month 3 Primary/Secondary Objectives|Overall Study|As prespecified, the primary objective included the first 42 Thoracic/Lumbar RF Ablation subjects to complete Month 3.|42||
59596093|NCT03249584|75705241|FG001|Month 3 Primary/Secondary Objectives|Overall Study|As prespecified, the secondary objective included all Periacetabulum/Iliac Crest/Sacrum RF Ablation subjects.|15||
59596094|NCT03249584|75705240|FG000|Month 6|Overall Study||101||
59596095|NCT03249584|75705241|FG001|Month 6|Overall Study||13||
60128420|NCT01690052|76250513|FG001|NOT COMPLETED|SECOND INTERVENTION: 4 WEEKS||0||
60128421|NCT02117193|76250519|FG000|STARTED|Overall Study||10||
60128422|NCT02117193|76250519|FG000|Alcohol Intake + Normal Sleep|Overall Study||10||
60128423|NCT02117193|76250519|FG000|Placebo Intake + Normal Sleep|Overall Study||10||
60128424|NCT02117193|76250519|FG000|Alcohol Intake + Sleep Deprivation|Overall Study||10||
60128425|NCT02117193|76250519|FG000|Placebo Intake + Sleep Deprivation|Overall Study||10||
59596096|NCT03249584|75705240|FG000|COMPLETED|Overall Study||51|The objectives are based on Month 3 outcomes (study 'Completed' is Month 12). The study ended when all subjects completed the 6 month visit.|
59596097|NCT03249584|75705241|FG001|COMPLETED|Overall Study||8|The objectives are based on Month 3 outcomes (study 'Completed' is Month 12). The study ended when all subjects completed the 6 month visit.|
60128426|NCT02117193|76250519|FG000|COMPLETED|Overall Study||10||
60128427|NCT02117193|76250519|FG000|NOT COMPLETED|Overall Study||0||
60128428|NCT01689974|76250540|FG000|STARTED|Overall Study||5||
60128429|NCT01689974|76250541|FG001|STARTED|Overall Study||5||
60128430|NCT01689974|76250540|FG000|COMPLETED|Overall Study||0||
60128431|NCT01689974|76250541|FG001|COMPLETED|Overall Study||0||
60128432|NCT01689974|76250540|FG000|NOT COMPLETED|Overall Study||5||
60128433|NCT01689974|76250541|FG001|NOT COMPLETED|Overall Study||5||
60128434|NCT01587014|76250547|FG000|STARTED|Overall Study||26||
60128435|NCT01587014|76250547|FG000|COMPLETED|Overall Study||24||
60128436|NCT01587014|76250547|FG000|NOT COMPLETED|Overall Study||2||
60128437|NCT02124603|76250551|FG000|STARTED|Overall Study||120||
60128438|NCT02124603|76250551|FG000|COMPLETED|Overall Study||120||
60128439|NCT02124603|76250551|FG000|NOT COMPLETED|Overall Study||0||
60128440|NCT02945787|76250558|FG000|STARTED|Overall Study||714||
60128441|NCT02945787|76250559|FG001|STARTED|Overall Study||703||
60128442|NCT02945787|76250558|FG000|COMPLETED|Overall Study||714||
60128443|NCT02945787|76250559|FG001|COMPLETED|Overall Study||703||
60128444|NCT02945787|76250558|FG000|NOT COMPLETED|Overall Study||0||
60128445|NCT02945787|76250559|FG001|NOT COMPLETED|Overall Study||0||
60128446|NCT00469911|76250567|FG000|STARTED|Overall Study||8||
60128447|NCT00469911|76250568|FG001|STARTED|Overall Study||10||
60128448|NCT00469911|76250567|FG000|COMPLETED|Overall Study||8||
60128449|NCT00469911|76250568|FG001|COMPLETED|Overall Study||10||
60128450|NCT00469911|76250567|FG000|NOT COMPLETED|Overall Study||0||
60128451|NCT00469911|76250568|FG001|NOT COMPLETED|Overall Study||0||
60128452|NCT00470301|76250573|FG000|STARTED|Overall Study||60||
60128453|NCT00470301|76250573|FG000|COMPLETED|Overall Study||55||
60128454|NCT00470301|76250573|FG000|NOT COMPLETED|Overall Study||5||
60128455|NCT00543777|76250578|FG000|STARTED|Overall Study||44||
60128456|NCT00543777|76250578|FG000|COMPLETED|Overall Study||44||
60128457|NCT00543777|76250578|FG000|NOT COMPLETED|Overall Study||0||
60128458|NCT00544713|76250584|FG000|STARTED|Overall Study||114||
59596098|NCT03249584|75705240|FG000|NOT COMPLETED|Overall Study||133||
59596099|NCT03249584|75705241|FG001|NOT COMPLETED|Overall Study||14||
59596100|NCT02182440|75705250|FG000|STARTED|Overall Study||116||
59596101|NCT02182440|75705251|FG001|STARTED|Overall Study||39||
59596102|NCT02182440|75705252|FG002|STARTED|Overall Study||35||
59596103|NCT02182440|75705253|FG003|STARTED|Overall Study||111||
59596104|NCT02182440|75705250|FG000|ITTcombined|Overall Study||116|Enrolled patients randomized to study drug, excl patients randomized during IA to 2 dropped doses|
59596105|NCT02182440|75705251|FG001|ITTcombined|Overall Study||31|Enrolled patients randomized to study drug, excl patients randomized during IA to 2 dropped doses|
59596106|NCT02182440|75705252|FG002|ITTcombined|Overall Study||32|Enrolled patients randomized to study drug, excl patients randomized during IA to 2 dropped doses|
59596107|NCT02182440|75705253|FG003|ITTcombined|Overall Study||111|Enrolled patients randomized to study drug, excl patients randomized during IA to 2 dropped doses|
59596108|NCT02182440|75705250|FG000|ITTinterim|Overall Study||30|All randomized patients and included in the interim analysis (IA)|
59596109|NCT02182440|75705251|FG001|ITTinterim|Overall Study||31|All randomized patients and included in the interim analysis (IA)|
59596110|NCT02182440|75705252|FG002|ITTinterim|Overall Study||32|All randomized patients and included in the interim analysis (IA)|
59596111|NCT02182440|75705253|FG003|ITTinterim|Overall Study||29|All randomized patients and included in the interim analysis (IA)|
59596112|NCT02182440|75705250|FG000|Safety Population|Overall Study||112|All randomized patients who received at least one dose of study drug|
59596113|NCT02182440|75705251|FG001|Safety Population|Overall Study||38|All randomized patients who received at least one dose of study drug|
59596114|NCT02182440|75705252|FG002|Safety Population|Overall Study||35|All randomized patients who received at least one dose of study drug|
59596115|NCT02182440|75705253|FG003|Safety Population|Overall Study||109|All randomized patients who received at least one dose of study drug|
59596116|NCT02182440|75705250|FG000|COMPLETED|Overall Study||71||
59596117|NCT02182440|75705251|FG001|COMPLETED|Overall Study||25||
59596118|NCT02182440|75705252|FG002|COMPLETED|Overall Study||24||
59596119|NCT02182440|75705253|FG003|COMPLETED|Overall Study||81||
59596120|NCT02182440|75705250|FG000|NOT COMPLETED|Overall Study||45||
59596121|NCT02182440|75705251|FG001|NOT COMPLETED|Overall Study||14||
59596122|NCT02182440|75705252|FG002|NOT COMPLETED|Overall Study||11||
59596123|NCT02182440|75705253|FG003|NOT COMPLETED|Overall Study||30||
59596124|NCT03255902|75705265|FG000|STARTED|Overall Study||7||
59596125|NCT03255902|75705265|FG000|COMPLETED|Overall Study||5||
59596126|NCT03255902|75705265|FG000|NOT COMPLETED|Overall Study||2||
59596127|NCT03468920|75705271|FG000|STARTED|Overall Study||60||
59596128|NCT03468920|75705272|FG001|STARTED|Overall Study||60||
59596129|NCT03468920|75705271|FG000|COMPLETED|Overall Study||60||
59596130|NCT03468920|75705272|FG001|COMPLETED|Overall Study||60||
59596131|NCT03468920|75705271|FG000|NOT COMPLETED|Overall Study||0||
59596132|NCT03468920|75705272|FG001|NOT COMPLETED|Overall Study||0||
59596133|NCT03470012|75705278|FG000|STARTED|Overall Study||24||
59596134|NCT03470012|75705278|FG000|COMPLETED|Overall Study||24||
59596135|NCT03470012|75705278|FG000|NOT COMPLETED|Overall Study||0||
59596136|NCT03339206|75705285|FG000|STARTED|Overall Study||262||
59596137|NCT03339206|75705286|FG001|STARTED|Overall Study||263||
59596138|NCT03339206|75705287|FG002|STARTED|Overall Study||264||
59596139|NCT03339206|75705285|FG000|COMPLETED|Overall Study||262||
59596140|NCT03339206|75705286|FG001|COMPLETED|Overall Study||263||
59596141|NCT03339206|75705287|FG002|COMPLETED|Overall Study||264||
59596142|NCT03339206|75705285|FG000|NOT COMPLETED|Overall Study||0||
59596143|NCT03339206|75705286|FG001|NOT COMPLETED|Overall Study||0||
59596144|NCT03339206|75705287|FG002|NOT COMPLETED|Overall Study||0||
59596145|NCT02181816|75705295|FG000|STARTED|Overall Study||1090||
59596146|NCT02181816|75705295|FG000|COMPLETED|Overall Study||1031||
59596147|NCT02181816|75705295|FG000|NOT COMPLETED|Overall Study||59||
59596148|NCT03256136|75705303|FG000|STARTED|Overall Study||3||
59859537|NCT03167242|75984104|FG008|NOT COMPLETED|Overall Study||1||
59728419|NCT00812929|75847153|FG004|NOT COMPLETED|Treatment Period 3||0||
59859538|NCT03167242|75984105|FG009|NOT COMPLETED|Overall Study||0||
60128459|NCT00544713|76250585|FG001|STARTED|Overall Study||114||
60128460|NCT00544713|76250584|FG000|COMPLETED|Overall Study||111||
60128461|NCT00544713|76250585|FG001|COMPLETED|Overall Study||109||
60128462|NCT00544713|76250584|FG000|NOT COMPLETED|Overall Study||3||
60128463|NCT00544713|76250585|FG001|NOT COMPLETED|Overall Study||5||
60128464|NCT02126319|76250593|FG000|STARTED|Overall Study||61||
60128465|NCT02126319|76250594|FG001|STARTED|Overall Study||67||
60128466|NCT02126319|76250593|FG000|COMPLETED|Overall Study||40||
60128467|NCT02126319|76250594|FG001|COMPLETED|Overall Study||43||
60128468|NCT02126319|76250593|FG000|NOT COMPLETED|Overall Study||21||
60128469|NCT02126319|76250594|FG001|NOT COMPLETED|Overall Study||24||
60128470|NCT00545025|76250604|FG000|STARTED|Overall Study||160||
60128471|NCT00545025|76250605|FG001|STARTED|Overall Study||83||
60128472|NCT00545025|76250604|FG000|COMPLETED|Overall Study||160||
60128473|NCT00545025|76250605|FG001|COMPLETED|Overall Study||83||
60128474|NCT00545025|76250604|FG000|NOT COMPLETED|Overall Study||0||
60128475|NCT00545025|76250605|FG001|NOT COMPLETED|Overall Study||0||
60128476|NCT00545181|76250613|FG000|STARTED|Overall Study||29||
59596149|NCT03256136|75705304|FG001|STARTED|Overall Study||1||
59596150|NCT03256136|75705305|FG002|STARTED|Overall Study||4||
59596151|NCT03256136|75705306|FG003|STARTED|Overall Study||1||
60128477|NCT00545181|76250614|FG001|STARTED|Overall Study||25||
60128478|NCT00545181|76250613|FG000|COMPLETED|Overall Study||29||
60128479|NCT00545181|76250614|FG001|COMPLETED|Overall Study||25||
60128480|NCT00545181|76250613|FG000|NOT COMPLETED|Overall Study||0||
60128481|NCT00545181|76250614|FG001|NOT COMPLETED|Overall Study||0||
60128482|NCT00471705|76250623|FG000|STARTED|Overall Study||145||
60128483|NCT00471705|76250624|FG001|STARTED|Overall Study||143||
60128484|NCT00471705|76250625|FG002|STARTED|Overall Study||149||
59596152|NCT03256136|75705303|FG000|COMPLETED|Overall Study||3||
59596153|NCT03256136|75705304|FG001|COMPLETED|Overall Study||1||
59596154|NCT03256136|75705305|FG002|COMPLETED|Overall Study||4||
59596155|NCT03256136|75705306|FG003|COMPLETED|Overall Study||1||
59596156|NCT03256136|75705303|FG000|NOT COMPLETED|Overall Study||0||
59596157|NCT03256136|75705304|FG001|NOT COMPLETED|Overall Study||0||
59596158|NCT03256136|75705305|FG002|NOT COMPLETED|Overall Study||0||
59596159|NCT03256136|75705306|FG003|NOT COMPLETED|Overall Study||0||
59596160|NCT03260426|75705318|FG000|STARTED|Overall Study||50||
59596161|NCT03260426|75705319|FG001|STARTED|Overall Study||50||
59596162|NCT03260426|75705318|FG000|COMPLETED|Overall Study||50||
59596163|NCT03260426|75705319|FG001|COMPLETED|Overall Study||50||
59596164|NCT03260426|75705318|FG000|NOT COMPLETED|Overall Study||0||
59596165|NCT03260426|75705319|FG001|NOT COMPLETED|Overall Study||0||
59596166|NCT03340610|75705325|FG000|STARTED|Overall Study||30||
59596167|NCT03340610|75705325|FG000|COMPLETED|Overall Study||27||
59596168|NCT03340610|75705325|FG000|NOT COMPLETED|Overall Study||3||
59596169|NCT03341546|75705329|FG000|STARTED|Overall Study||20||
59596170|NCT03341546|75705329|FG000|COMPLETED|Overall Study||20||
59596171|NCT03341546|75705329|FG000|NOT COMPLETED|Overall Study||0||
59596172|NCT03344510|75705333|FG000|STARTED|First Injection (5 Minutes)||21||
59596173|NCT03344510|75705334|FG001|STARTED|First Injection (5 Minutes)||26||
59596174|NCT03344510|75705333|FG000|Received Injection|First Injection (5 Minutes)||21||
59596175|NCT03344510|75705334|FG001|Received Injection|First Injection (5 Minutes)||26||
59596176|NCT03344510|75705333|FG000|COMPLETED|First Injection (5 Minutes)||21||
59596177|NCT03344510|75705334|FG001|COMPLETED|First Injection (5 Minutes)||26||
59596178|NCT03344510|75705333|FG000|NOT COMPLETED|First Injection (5 Minutes)||0||
59596179|NCT03344510|75705334|FG001|NOT COMPLETED|First Injection (5 Minutes)||0||
59596180|NCT03344510|75705333|FG000|STARTED|Wash Out (10 Minutes||21||
59596181|NCT03344510|75705334|FG001|STARTED|Wash Out (10 Minutes||26||
59596182|NCT03344510|75705333|FG000|COMPLETED|Wash Out (10 Minutes||21||
59596183|NCT03344510|75705334|FG001|COMPLETED|Wash Out (10 Minutes||26||
59596184|NCT03344510|75705333|FG000|NOT COMPLETED|Wash Out (10 Minutes||0||
59596185|NCT03344510|75705334|FG001|NOT COMPLETED|Wash Out (10 Minutes||0||
59596186|NCT03344510|75705333|FG000|STARTED|Second Injection (5 Minutes)||21||
59596187|NCT03344510|75705334|FG001|STARTED|Second Injection (5 Minutes)||26||
59596188|NCT03344510|75705333|FG000|Received Injection|Second Injection (5 Minutes)||21||
59596189|NCT03344510|75705334|FG001|Received Injection|Second Injection (5 Minutes)||26||
59596190|NCT03344510|75705333|FG000|COMPLETED|Second Injection (5 Minutes)||21||
59596191|NCT03344510|75705334|FG001|COMPLETED|Second Injection (5 Minutes)||26||
59596192|NCT03344510|75705333|FG000|NOT COMPLETED|Second Injection (5 Minutes)||0||
59596193|NCT03344510|75705334|FG001|NOT COMPLETED|Second Injection (5 Minutes)||0||
59596194|NCT03264092|75705344|FG000|STARTED|Overall Study||17||
59596195|NCT03264092|75705345|FG001|STARTED|Overall Study||20||
59596196|NCT03264092|75705346|FG002|STARTED|Overall Study||18||
59596197|NCT03264092|75705344|FG000|COMPLETED|Overall Study||17||
59596198|NCT03264092|75705345|FG001|COMPLETED|Overall Study||20||
59596199|NCT03264092|75705346|FG002|COMPLETED|Overall Study||18||
59596200|NCT03264092|75705344|FG000|NOT COMPLETED|Overall Study||0||
59596201|NCT03264092|75705345|FG001|NOT COMPLETED|Overall Study||0||
59596202|NCT03264092|75705346|FG002|NOT COMPLETED|Overall Study||0||
59596203|NCT03346850|75705362|FG000|STARTED|Overall Study||20||
59596204|NCT03346850|75705363|FG001|STARTED|Overall Study||20||
59596205|NCT03346850|75705362|FG000|COMPLETED|Overall Study||18||
59596206|NCT03346850|75705363|FG001|COMPLETED|Overall Study||17||
59596207|NCT03346850|75705362|FG000|NOT COMPLETED|Overall Study||2||
59728420|NCT00812929|75847154|FG005|NOT COMPLETED|Treatment Period 3||0||
59596208|NCT03346850|75705363|FG001|NOT COMPLETED|Overall Study||3||
59596209|NCT03478904|75705369|FG000|STARTED|Overall Study||1||
59596210|NCT03478904|75705369|FG000|COMPLETED|Overall Study||1||
59596211|NCT03478904|75705369|FG000|NOT COMPLETED|Overall Study||0||
59596212|NCT03478982|75705384|FG000|STARTED|Overall Study||11||
59596213|NCT03478982|75705385|FG001|STARTED|Overall Study||50||
59596214|NCT03478982|75705386|FG002|STARTED|Overall Study||47||
59596215|NCT03478982|75705387|FG003|STARTED|Overall Study||48||
60128485|NCT00471705|76250623|FG000|COMPLETED|Overall Study||121||
60128486|NCT00471705|76250624|FG001|COMPLETED|Overall Study||121||
60128487|NCT00471705|76250625|FG002|COMPLETED|Overall Study||134||
60128488|NCT00471705|76250623|FG000|NOT COMPLETED|Overall Study||24||
59596216|NCT03478982|75705384|FG000|Enrolled Participants But Not Treated|Overall Study||3||
59596217|NCT03478982|75705385|FG001|Enrolled Participants But Not Treated|Overall Study||10||
59596218|NCT03478982|75705386|FG002|Enrolled Participants But Not Treated|Overall Study||9||
59596219|NCT03478982|75705387|FG003|Enrolled Participants But Not Treated|Overall Study||10||
59596220|NCT03478982|75705384|FG000|Intent-to-treat (ITT) Population|Overall Study||8||
59596221|NCT03478982|75705385|FG001|Intent-to-treat (ITT) Population|Overall Study||40||
59596222|NCT03478982|75705386|FG002|Intent-to-treat (ITT) Population|Overall Study||38||
59596223|NCT03478982|75705387|FG003|Intent-to-treat (ITT) Population|Overall Study||38||
59596224|NCT03478982|75705384|FG000|COMPLETED|Overall Study||11||
59596225|NCT03478982|75705385|FG001|COMPLETED|Overall Study||50||
59596226|NCT03478982|75705386|FG002|COMPLETED|Overall Study||47||
59596227|NCT03478982|75705387|FG003|COMPLETED|Overall Study||48||
59596228|NCT03478982|75705384|FG000|NOT COMPLETED|Overall Study||0||
59596229|NCT03478982|75705385|FG001|NOT COMPLETED|Overall Study||0||
59596230|NCT03478982|75705386|FG002|NOT COMPLETED|Overall Study||0||
59596231|NCT03478982|75705387|FG003|NOT COMPLETED|Overall Study||0||
59596232|NCT03264248|75705397|FG000|STARTED|Overall Study||9||
59596233|NCT03264248|75705397|FG000|COMPLETED|Overall Study||9||
59596234|NCT03264248|75705397|FG000|NOT COMPLETED|Overall Study||0||
59596235|NCT03270332|75705403|FG000|STARTED|Overall Study||5||
59596236|NCT03270332|75705404|FG001|STARTED|Overall Study||5||
59596237|NCT03270332|75705403|FG000|COMPLETED|Overall Study||5||
59596238|NCT03270332|75705404|FG001|COMPLETED|Overall Study||4||
59596239|NCT03270332|75705403|FG000|NOT COMPLETED|Overall Study||0||
59596240|NCT03270332|75705404|FG001|NOT COMPLETED|Overall Study||1||
60128489|NCT00471705|76250624|FG001|NOT COMPLETED|Overall Study||22||
60128490|NCT00471705|76250625|FG002|NOT COMPLETED|Overall Study||15||
60128491|NCT00472797|76250635|FG000|STARTED|Overall Study||119||
60128492|NCT00472797|76250636|FG001|STARTED|Overall Study||113||
59596241|NCT03349892|75705412|FG000|STARTED|Overall Study||1||
59596242|NCT03349892|75705412|FG000|COMPLETED|Overall Study||1||
59596243|NCT03349892|75705412|FG000|NOT COMPLETED|Overall Study||0||
59596244|NCT03483506|75705416|FG000|STARTED|Overall Study||12|Started are treated|
59596245|NCT03483506|75705416|FG000|COMPLETED|Overall Study||12||
59596246|NCT03483506|75705416|FG000|NOT COMPLETED|Overall Study||0||
59596247|NCT03271424|75705425|FG000|STARTED|November 2015||20||
59859539|NCT03167242|75984106|FG010|NOT COMPLETED|Overall Study||2||
59859540|NCT03167242|75984107|FG011|NOT COMPLETED|Overall Study||1||
59859541|NCT03286426|75984143|FG000|STARTED|Overall Study||3||
59859542|NCT03286426|75984143|FG000|COMPLETED|Overall Study||0||
59859543|NCT03286426|75984143|FG000|NOT COMPLETED|Overall Study||3||
59859544|NCT02818582|75984149|FG000|STARTED|Overall Study||20||
59859545|NCT02818582|75984150|FG001|STARTED|Overall Study||18||
59859546|NCT02818582|75984149|FG000|COMPLETED|Overall Study||20||
59859547|NCT02818582|75984150|FG001|COMPLETED|Overall Study||18||
59859548|NCT02818582|75984149|FG000|NOT COMPLETED|Overall Study||0||
59859549|NCT02818582|75984150|FG001|NOT COMPLETED|Overall Study||0||
59859550|NCT02728258|75984156|FG000|STARTED|Overall Study||11||
59859551|NCT02728258|75984156|FG000|COMPLETED|Overall Study||11||
60128493|NCT00472797|76250635|FG000|COMPLETED|Overall Study||115||
60128494|NCT00472797|76250636|FG001|COMPLETED|Overall Study||112||
59596248|NCT03271424|75705426|FG001|STARTED|November 2015||0||
59596249|NCT03271424|75705427|FG002|STARTED|November 2015||0||
59596250|NCT03271424|75705425|FG000|COMPLETED|November 2015||20||
59596251|NCT03271424|75705426|FG001|COMPLETED|November 2015||0||
59596252|NCT03271424|75705427|FG002|COMPLETED|November 2015||0||
59596253|NCT03271424|75705425|FG000|NOT COMPLETED|November 2015||0||
59596254|NCT03271424|75705426|FG001|NOT COMPLETED|November 2015||0||
59596255|NCT03271424|75705427|FG002|NOT COMPLETED|November 2015||0||
59596256|NCT03271424|75705425|FG000|STARTED|December 2015||0||
59596257|NCT03271424|75705426|FG001|STARTED|December 2015||35||
59596258|NCT03271424|75705427|FG002|STARTED|December 2015||0||
59596259|NCT03271424|75705425|FG000|COMPLETED|December 2015||0||
59596260|NCT03271424|75705426|FG001|COMPLETED|December 2015||35||
59596261|NCT03271424|75705427|FG002|COMPLETED|December 2015||0||
59596262|NCT03271424|75705425|FG000|NOT COMPLETED|December 2015||0||
59596263|NCT03271424|75705426|FG001|NOT COMPLETED|December 2015||0||
59596264|NCT03271424|75705427|FG002|NOT COMPLETED|December 2015||0||
60128495|NCT00472797|76250635|FG000|NOT COMPLETED|Overall Study||4||
60128496|NCT00472797|76250636|FG001|NOT COMPLETED|Overall Study||1||
60128497|NCT01458535|76250651|FG000|STARTED|Overall Study||10||
60128498|NCT01458535|76250652|FG001|STARTED|Overall Study||10||
60128499|NCT01458535|76250653|FG002|STARTED|Overall Study||10||
60128500|NCT01458535|76250654|FG003|STARTED|Overall Study||10||
60128501|NCT01458535|76250655|FG004|STARTED|Overall Study||10||
59859552|NCT02728258|75984156|FG000|NOT COMPLETED|Overall Study||0||
59859553|NCT02882152|75984162|FG000|STARTED|Overall Study||20||
59859554|NCT02882152|75984163|FG001|STARTED|Overall Study||20||
59859555|NCT02882152|75984162|FG000|COMPLETED|Overall Study||19||
59859556|NCT02882152|75984163|FG001|COMPLETED|Overall Study||20||
59859557|NCT02882152|75984162|FG000|NOT COMPLETED|Overall Study||1||
59859558|NCT02882152|75984163|FG001|NOT COMPLETED|Overall Study||0||
60128502|NCT01458535|76250656|FG005|STARTED|Overall Study||11||
59859559|NCT00286091|75984171|FG000|STARTED|Double-blind Treatment Phase||716||
59859560|NCT00286091|75984172|FG001|STARTED|Double-blind Treatment Phase||716||
59859561|NCT00286091|75984171|FG000|Received Treatment|Double-blind Treatment Phase|4 participants received ≥ 1 dose of denosumab in error|709||
59859562|NCT00286091|75984172|FG001|Received Treatment|Double-blind Treatment Phase||716||
59859563|NCT00286091|75984171|FG000|On Study at Primary Data Analysis Cutoff|Double-blind Treatment Phase|Primary analysis cut-off date was 30 July 2010|164||
59859564|NCT00286091|75984172|FG001|On Study at Primary Data Analysis Cutoff|Double-blind Treatment Phase|Primary analysis cut-off date was 30 July 2010|174||
59859565|NCT00286091|75984171|FG000|COMPLETED|Double-blind Treatment Phase|On study through blinded treatment cutoff date of 09 January 2011|132||
59859566|NCT00286091|75984172|FG001|COMPLETED|Double-blind Treatment Phase|On study through blinded treatment cutoff date of 09 January 2011|123||
59859567|NCT00286091|75984171|FG000|NOT COMPLETED|Double-blind Treatment Phase||584||
59859568|NCT00286091|75984172|FG001|NOT COMPLETED|Double-blind Treatment Phase||593||
59859569|NCT00286091|75984171|FG000|STARTED|Open-label Treatment Phase|Participants in the Czech Republic and UK are reported separately (Study 20080585; NCT01824342)|110||
59859570|NCT00286091|75984172|FG001|STARTED|Open-label Treatment Phase|Participants in the Czech Republic and UK are reported separately (Study 20080585; NCT01824342)|104||
59859571|NCT00286091|75984171|FG000|Received Treatment|Open-label Treatment Phase||109||
59859572|NCT00286091|75984172|FG001|Received Treatment|Open-label Treatment Phase||101||
59859573|NCT00286091|75984171|FG000|COMPLETED|Open-label Treatment Phase|Completed 3 years of open-label treatment|33||
59859574|NCT00286091|75984172|FG001|COMPLETED|Open-label Treatment Phase|Completed 3 years of open-label treatment|33||
59859575|NCT00286091|75984171|FG000|NOT COMPLETED|Open-label Treatment Phase||77||
59859576|NCT00286091|75984172|FG001|NOT COMPLETED|Open-label Treatment Phase||71||
59859577|NCT00285857|75984180|FG000|STARTED|Overall Study||30||
59859578|NCT00285857|75984180|FG000|COMPLETED|Overall Study||26||
59859579|NCT00285857|75984180|FG000|NOT COMPLETED|Overall Study||4||
59859580|NCT00284141|75984189|FG000|STARTED|Overall Study||98||
59859581|NCT00284141|75984189|FG000|TREATED|Overall Study|Participants received at least part of one dose of Aflibercept.|96||
59859582|NCT00284141|75984189|FG000|ONGOING TREATMENT|Overall Study|Participants were still on study treatment at the clinical database cut-off date.|2||
59859583|NCT00284141|75984189|FG000|COMPLETED|Overall Study|Participants met treatment discontinuation criteria or were still ongoing treatment.|0||
59859584|NCT00284141|75984189|FG000|NOT COMPLETED|Overall Study||98||
59859585|NCT00265343|75984197|FG000|STARTED|Overall Study||134||
59859586|NCT00265343|75984198|FG001|STARTED|Overall Study||172||
59859587|NCT00265343|75984197|FG000|COMPLETED|Overall Study||113||
59859588|NCT00265343|75984198|FG001|COMPLETED|Overall Study||153||
59859589|NCT00265343|75984197|FG000|NOT COMPLETED|Overall Study||21||
59859590|NCT00265343|75984198|FG001|NOT COMPLETED|Overall Study||19||
59859591|NCT00283595|75984206|FG000|STARTED|Overall Study||10||
59859592|NCT00283595|75984207|FG001|STARTED|Overall Study||11||
59859593|NCT00283595|75984206|FG000|COMPLETED|Overall Study||9||
59859594|NCT00283595|75984207|FG001|COMPLETED|Overall Study||9||
59859595|NCT00283595|75984206|FG000|NOT COMPLETED|Overall Study||1||
59859596|NCT00283595|75984207|FG001|NOT COMPLETED|Overall Study||2||
59859597|NCT00265109|75984213|FG000|STARTED|Overall Study||17||
59859598|NCT00265109|75984213|FG000|COMPLETED|Overall Study||11||
59859599|NCT00265109|75984213|FG000|NOT COMPLETED|Overall Study||6||
59859600|NCT03235024|75984220|FG000|STARTED|Overall Study||61||
59859601|NCT03235024|75984221|FG001|STARTED|Overall Study||61||
59859602|NCT03235024|75984220|FG000|COMPLETED|Overall Study||55||
59859603|NCT03235024|75984221|FG001|COMPLETED|Overall Study||51||
59859604|NCT03235024|75984220|FG000|NOT COMPLETED|Overall Study||6||
59859605|NCT03235024|75984221|FG001|NOT COMPLETED|Overall Study||10||
59859606|NCT03233308|75984227|FG000|STARTED|Overall Study||20||
59859607|NCT03233308|75984227|FG000|COMPLETED|Overall Study||18||
59859608|NCT03233308|75984227|FG000|NOT COMPLETED|Overall Study||2||
59859609|NCT00283439|75984242|FG000|STARTED|Overall Study||8||
59859610|NCT00283439|75984243|FG001|STARTED|Overall Study||11||
59859611|NCT00283439|75984244|FG002|STARTED|Overall Study||11||
59859612|NCT00283439|75984245|FG003|STARTED|Overall Study||9||
59859613|NCT00283439|75984242|FG000|COMPLETED|Overall Study||0||
59859614|NCT00283439|75984243|FG001|COMPLETED|Overall Study||0||
59859615|NCT00283439|75984244|FG002|COMPLETED|Overall Study||0||
59859616|NCT00283439|75984245|FG003|COMPLETED|Overall Study||0||
59859617|NCT00283439|75984242|FG000|NOT COMPLETED|Overall Study||8||
59859618|NCT00283439|75984243|FG001|NOT COMPLETED|Overall Study||11||
59859619|NCT00283439|75984244|FG002|NOT COMPLETED|Overall Study||11||
60128503|NCT01458535|76250651|FG000|COMPLETED|Overall Study||10||
60128504|NCT01458535|76250652|FG001|COMPLETED|Overall Study||8||
60128505|NCT01458535|76250653|FG002|COMPLETED|Overall Study||8||
59596265|NCT03271424|75705425|FG000|STARTED|April-May 2016||0||
60128506|NCT01458535|76250654|FG003|COMPLETED|Overall Study||6||
60128507|NCT01458535|76250655|FG004|COMPLETED|Overall Study||6||
59859620|NCT00283439|75984245|FG003|NOT COMPLETED|Overall Study||9||
59859621|NCT03233230|75984259|FG000|STARTED|Overall Study||97||
59859622|NCT03233230|75984260|FG001|STARTED|Overall Study||98||
59859623|NCT03233230|75984261|FG002|STARTED|Overall Study||96||
59859624|NCT03233230|75984262|FG003|STARTED|Overall Study||99||
59859625|NCT03233230|75984259|FG000|COMPLETED|Overall Study||82||
59859626|NCT03233230|75984260|FG001|COMPLETED|Overall Study||83||
59859627|NCT03233230|75984261|FG002|COMPLETED|Overall Study||84||
59859628|NCT03233230|75984262|FG003|COMPLETED|Overall Study||91||
59859629|NCT03233230|75984259|FG000|NOT COMPLETED|Overall Study||15||
59859630|NCT03233230|75984260|FG001|NOT COMPLETED|Overall Study||15||
59859631|NCT03233230|75984261|FG002|NOT COMPLETED|Overall Study||12||
59859632|NCT03233230|75984262|FG003|NOT COMPLETED|Overall Study||8||
59859633|NCT00283049|75984275|FG000|STARTED|Overall Study|2 randomized patients did not receive study drug and were not included in the safety population|128||
59859634|NCT00283049|75984276|FG001|STARTED|Overall Study|1 randomized patient did not receive study drug and was not included in the safety population|128||
59859635|NCT00283049|75984277|FG002|STARTED|Overall Study|1 randomized patient did not receive study drug and was not included in the safety population|130||
59859636|NCT00283049|75984275|FG000|COMPLETED|Overall Study||70||
59859637|NCT00283049|75984276|FG001|COMPLETED|Overall Study||83||
59859638|NCT00283049|75984277|FG002|COMPLETED|Overall Study||76||
59859639|NCT00283049|75984275|FG000|NOT COMPLETED|Overall Study||58||
59859640|NCT00283049|75984276|FG001|NOT COMPLETED|Overall Study||45||
59859641|NCT00283049|75984277|FG002|NOT COMPLETED|Overall Study||54||
59859642|NCT00264875|75984285|FG000|STARTED|Overall Study||220||
59859643|NCT00264875|75984285|FG000|COMPLETED|Overall Study||190||
59859644|NCT00264875|75984285|FG000|NOT COMPLETED|Overall Study||30||
59859645|NCT03152110|75984289|FG000|STARTED|Overall Study||10||
59859646|NCT03152110|75984289|FG000|COMPLETED|Overall Study||7||
59859647|NCT03152110|75984289|FG000|NOT COMPLETED|Overall Study||3||
59859648|NCT03151408|75984296|FG000|STARTED|Overall Study|Screened patients|203||
59859649|NCT03151408|75984297|FG001|STARTED|Overall Study|Screened patients|203||
59859650|NCT03151408|75984296|FG000|Treated|Overall Study||201||
59859651|NCT03151408|75984297|FG001|Treated|Overall Study||201||
59859652|NCT03151408|75984296|FG000|COMPLETED|Overall Study||0||
59859653|NCT03151408|75984297|FG001|COMPLETED|Overall Study||0||
59859654|NCT03151408|75984296|FG000|NOT COMPLETED|Overall Study||203||
59859655|NCT03151408|75984297|FG001|NOT COMPLETED|Overall Study||203||
59859656|NCT00546754|75984305|FG000|STARTED|Overall Study|Number of patients enrolled and randomized|425||
59859657|NCT00546754|75984306|FG001|STARTED|Overall Study|Number of patients enrolled and randomized|383||
59859658|NCT00546754|75984305|FG000|Treated|Overall Study|Patients that received at least one dose of study medication and had 1 follow-up visit|416||
59859659|NCT00546754|75984306|FG001|Treated|Overall Study|Patients that received at least one dose of study medication and had 1 follow-up visit|373||
59859660|NCT00546754|75984305|FG000|Week 6|Overall Study||396||
59859661|NCT00546754|75984306|FG001|Week 6|Overall Study||347||
59859662|NCT00546754|75984305|FG000|Week 12|Overall Study||375||
59859663|NCT00546754|75984306|FG001|Week 12|Overall Study||334||
59859664|NCT00546754|75984305|FG000|COMPLETED|Overall Study||375||
59859665|NCT00546754|75984306|FG001|COMPLETED|Overall Study||334||
59859666|NCT00546754|75984305|FG000|NOT COMPLETED|Overall Study||50||
59859667|NCT00546754|75984306|FG001|NOT COMPLETED|Overall Study||49||
59859668|NCT00282347|75984314|FG000|STARTED|Treatment Period||72||
59859669|NCT00282347|75984315|FG001|STARTED|Treatment Period||72||
59859670|NCT00282347|75984314|FG000|COMPLETED|Treatment Period||67||
59859671|NCT00282347|75984315|FG001|COMPLETED|Treatment Period||63||
59859672|NCT00282347|75984314|FG000|NOT COMPLETED|Treatment Period||5||
59859673|NCT00282347|75984315|FG001|NOT COMPLETED|Treatment Period||9||
59859674|NCT00282347|75984314|FG000|STARTED|Safety Follow-up Period||67||
59859675|NCT00282347|75984315|FG001|STARTED|Safety Follow-up Period||63||
59859676|NCT00282347|75984314|FG000|COMPLETED|Safety Follow-up Period||64||
59859677|NCT00282347|75984315|FG001|COMPLETED|Safety Follow-up Period||57||
59859678|NCT00282347|75984314|FG000|NOT COMPLETED|Safety Follow-up Period||3||
59859679|NCT00282347|75984315|FG001|NOT COMPLETED|Safety Follow-up Period||6||
59859680|NCT00282347|75984314|FG000|STARTED|B Cell Follow-up Period||20||
59859681|NCT00282347|75984315|FG001|STARTED|B Cell Follow-up Period||4||
59859682|NCT00282347|75984314|FG000|COMPLETED|B Cell Follow-up Period||15||
59859683|NCT00282347|75984315|FG001|COMPLETED|B Cell Follow-up Period||4||
59859684|NCT00282347|75984314|FG000|NOT COMPLETED|B Cell Follow-up Period||5||
59859685|NCT00282347|75984315|FG001|NOT COMPLETED|B Cell Follow-up Period||0||
59859686|NCT00405964|75984325|FG000|STARTED|Overall Study||360||
59859687|NCT00405964|75984326|FG001|STARTED|Overall Study||356||
59859688|NCT00405964|75984325|FG000|COMPLETED|Overall Study||301||
59859689|NCT00405964|75984326|FG001|COMPLETED|Overall Study||261||
59859690|NCT00405964|75984325|FG000|NOT COMPLETED|Overall Study||59||
59859691|NCT00405964|75984326|FG001|NOT COMPLETED|Overall Study||95||
59859692|NCT00264797|75984334|FG000|STARTED|Overall Study||151||
59859693|NCT00264797|75984335|FG001|STARTED|Overall Study||152||
59859694|NCT00264797|75984334|FG000|COMPLETED|Overall Study||118||
59859695|NCT00264797|75984335|FG001|COMPLETED|Overall Study||109||
59859696|NCT00264797|75984334|FG000|NOT COMPLETED|Overall Study||33||
59859697|NCT00264797|75984335|FG001|NOT COMPLETED|Overall Study||43||
59859698|NCT03148756|75984343|FG000|STARTED|Overall Study||0||
59859699|NCT03148756|75984344|FG001|STARTED|Overall Study||2||
59859700|NCT03148756|75984343|FG000|COMPLETED|Overall Study||0||
59859701|NCT03148756|75984344|FG001|COMPLETED|Overall Study||1||
59859702|NCT03148756|75984343|FG000|NOT COMPLETED|Overall Study||0||
59859703|NCT03148756|75984344|FG001|NOT COMPLETED|Overall Study||1||
59859704|NCT00282113|75984353|FG000|STARTED|Overall Study||31||
59859705|NCT00282113|75984354|FG001|STARTED|Overall Study||30||
59859706|NCT00282113|75984355|FG002|STARTED|Overall Study||29||
59859707|NCT00282113|75984353|FG000|COMPLETED|Overall Study||30||
59859708|NCT00282113|75984354|FG001|COMPLETED|Overall Study||30||
59859709|NCT00282113|75984355|FG002|COMPLETED|Overall Study||29||
59859710|NCT00282113|75984353|FG000|NOT COMPLETED|Overall Study||1||
59859711|NCT00282113|75984354|FG001|NOT COMPLETED|Overall Study||0||
59859712|NCT00282113|75984355|FG002|NOT COMPLETED|Overall Study||0||
59859713|NCT00281957|75984365|FG000|STARTED|Overall Study||67||
59859714|NCT00281957|75984366|FG001|STARTED|Overall Study||42||
59859715|NCT00281957|75984365|FG000|Eligible|Overall Study||66||
59859716|NCT00281957|75984366|FG001|Eligible|Overall Study||40||
59859717|NCT00281957|75984365|FG000|Eligible and Received Treatment|Overall Study||63||
59859718|NCT00281957|75984366|FG001|Eligible and Received Treatment|Overall Study||39||
59859719|NCT00281957|75984365|FG000|COMPLETED|Overall Study||0||
59859720|NCT00281957|75984366|FG001|COMPLETED|Overall Study||0||
59859721|NCT00281957|75984365|FG000|NOT COMPLETED|Overall Study||67||
59859722|NCT00281957|75984366|FG001|NOT COMPLETED|Overall Study||42||
59859723|NCT00281099|75984376|FG000|STARTED|Overall Study||513||
59859724|NCT00281099|75984377|FG001|STARTED|Overall Study||518||
59859725|NCT00281099|75984376|FG000|COMPLETED|Overall Study||308||
59859726|NCT00281099|75984377|FG001|COMPLETED|Overall Study||296||
59859727|NCT00281099|75984376|FG000|NOT COMPLETED|Overall Study||205||
59859728|NCT00281099|75984377|FG001|NOT COMPLETED|Overall Study||222||
59859729|NCT00262925|75984384|FG000|STARTED|Overall Study|7 patients were enrolled to step 1, and 5 patients were enrolled to step 2|12||
59859730|NCT00262925|75984384|FG000|COMPLETED|Overall Study||1||
59859731|NCT00262925|75984384|FG000|NOT COMPLETED|Overall Study||11||
59859732|NCT03720470|75984394|FG000|STARTED|Treatment Period: First Part 16 Weeks||131||
59859733|NCT03720470|75984395|FG001|STARTED|Treatment Period: First Part 16 Weeks||0||
59859734|NCT03720470|75984396|FG002|STARTED|Treatment Period: First Part 16 Weeks||0||
59859735|NCT03720470|75984397|FG003|STARTED|Treatment Period: First Part 16 Weeks||238||
59859736|NCT03720470|75984398|FG004|STARTED|Treatment Period: First Part 16 Weeks||226||
59859737|NCT03720470|75984399|FG005|STARTED|Treatment Period: First Part 16 Weeks||243||
59859738|NCT03720470|75984394|FG000|Treated/ Safety Analysis Set|Treatment Period: First Part 16 Weeks||131||
59859739|NCT03720470|75984395|FG001|Treated/ Safety Analysis Set|Treatment Period: First Part 16 Weeks||0||
59859740|NCT03720470|75984396|FG002|Treated/ Safety Analysis Set|Treatment Period: First Part 16 Weeks||0||
59859741|NCT03720470|75984397|FG003|Treated/ Safety Analysis Set|Treatment Period: First Part 16 Weeks||238||
59859742|NCT03720470|75984398|FG004|Treated/ Safety Analysis Set|Treatment Period: First Part 16 Weeks||226||
59859743|NCT03720470|75984399|FG005|Treated/ Safety Analysis Set|Treatment Period: First Part 16 Weeks||242||
59859744|NCT03720470|75984394|FG000|Full Analysis Set|Treatment Period: First Part 16 Weeks||131||
59859745|NCT03720470|75984395|FG001|Full Analysis Set|Treatment Period: First Part 16 Weeks||0||
59859746|NCT03720470|75984396|FG002|Full Analysis Set|Treatment Period: First Part 16 Weeks||0||
59859747|NCT03720470|75984397|FG003|Full Analysis Set|Treatment Period: First Part 16 Weeks||238||
59859748|NCT03720470|75984398|FG004|Full Analysis Set|Treatment Period: First Part 16 Weeks||226||
59859749|NCT03720470|75984399|FG005|Full Analysis Set|Treatment Period: First Part 16 Weeks||242||
59859750|NCT03720470|75984394|FG000|COMPLETED|Treatment Period: First Part 16 Weeks||117||
59859751|NCT03720470|75984395|FG001|COMPLETED|Treatment Period: First Part 16 Weeks||0||
59859752|NCT03720470|75984396|FG002|COMPLETED|Treatment Period: First Part 16 Weeks||0||
59859753|NCT03720470|75984397|FG003|COMPLETED|Treatment Period: First Part 16 Weeks||217||
59859754|NCT03720470|75984398|FG004|COMPLETED|Treatment Period: First Part 16 Weeks||208||
59859755|NCT03720470|75984399|FG005|COMPLETED|Treatment Period: First Part 16 Weeks||223||
59859756|NCT03720470|75984394|FG000|NOT COMPLETED|Treatment Period: First Part 16 Weeks||14||
59859757|NCT03720470|75984395|FG001|NOT COMPLETED|Treatment Period: First Part 16 Weeks||0||
59859758|NCT03720470|75984396|FG002|NOT COMPLETED|Treatment Period: First Part 16 Weeks||0||
59859759|NCT03720470|75984397|FG003|NOT COMPLETED|Treatment Period: First Part 16 Weeks||21||
59859760|NCT03720470|75984398|FG004|NOT COMPLETED|Treatment Period: First Part 16 Weeks||18||
59859761|NCT03720470|75984399|FG005|NOT COMPLETED|Treatment Period: First Part 16 Weeks||20||
59859762|NCT03720470|75984394|FG000|STARTED|Treatment Period: Final 4 Weeks|Participants received placebo till Week 16 then allocated to receive PF-04965842 post Week 16.|0||
59859763|NCT03720470|75984395|FG001|STARTED|Treatment Period: Final 4 Weeks|Participants received placebo till Week 16 then allocated to receive PF-04965842 post Week 16.|60||
59859764|NCT03720470|75984396|FG002|STARTED|Treatment Period: Final 4 Weeks|Participants received placebo till Week 16 then allocated to receive PF-04965842 post Week 16.|57||
59859765|NCT03720470|75984397|FG003|STARTED|Treatment Period: Final 4 Weeks||217||
59859766|NCT03720470|75984398|FG004|STARTED|Treatment Period: Final 4 Weeks||208||
59859767|NCT03720470|75984399|FG005|STARTED|Treatment Period: Final 4 Weeks||223||
59859768|NCT03720470|75984394|FG000|Treated/ Safety Analysis Set|Treatment Period: Final 4 Weeks||0||
59859769|NCT03720470|75984395|FG001|Treated/ Safety Analysis Set|Treatment Period: Final 4 Weeks||60||
59859770|NCT03720470|75984396|FG002|Treated/ Safety Analysis Set|Treatment Period: Final 4 Weeks||57||
60128508|NCT01458535|76250656|FG005|COMPLETED|Overall Study||7||
59859771|NCT03720470|75984397|FG003|Treated/ Safety Analysis Set|Treatment Period: Final 4 Weeks||217||
59859772|NCT03720470|75984398|FG004|Treated/ Safety Analysis Set|Treatment Period: Final 4 Weeks||208||
59859773|NCT03720470|75984399|FG005|Treated/ Safety Analysis Set|Treatment Period: Final 4 Weeks||223||
59859774|NCT03720470|75984394|FG000|Full Analysis Set|Treatment Period: Final 4 Weeks||0||
59859775|NCT03720470|75984395|FG001|Full Analysis Set|Treatment Period: Final 4 Weeks||60||
59859776|NCT03720470|75984396|FG002|Full Analysis Set|Treatment Period: Final 4 Weeks||57||
59859777|NCT03720470|75984397|FG003|Full Analysis Set|Treatment Period: Final 4 Weeks||217||
59859778|NCT03720470|75984398|FG004|Full Analysis Set|Treatment Period: Final 4 Weeks||208||
59859779|NCT03720470|75984399|FG005|Full Analysis Set|Treatment Period: Final 4 Weeks||223||
59859780|NCT03720470|75984394|FG000|COMPLETED|Treatment Period: Final 4 Weeks||0||
59859781|NCT03720470|75984395|FG001|COMPLETED|Treatment Period: Final 4 Weeks||58||
59859782|NCT03720470|75984396|FG002|COMPLETED|Treatment Period: Final 4 Weeks||55||
59859783|NCT03720470|75984397|FG003|COMPLETED|Treatment Period: Final 4 Weeks||210||
59859784|NCT03720470|75984398|FG004|COMPLETED|Treatment Period: Final 4 Weeks||204||
59859785|NCT03720470|75984399|FG005|COMPLETED|Treatment Period: Final 4 Weeks||218||
59859786|NCT03720470|75984394|FG000|NOT COMPLETED|Treatment Period: Final 4 Weeks||0||
59859787|NCT03720470|75984395|FG001|NOT COMPLETED|Treatment Period: Final 4 Weeks||2||
59859788|NCT03720470|75984396|FG002|NOT COMPLETED|Treatment Period: Final 4 Weeks||2||
59859789|NCT03720470|75984397|FG003|NOT COMPLETED|Treatment Period: Final 4 Weeks||7||
59859790|NCT03720470|75984398|FG004|NOT COMPLETED|Treatment Period: Final 4 Weeks||4||
59859791|NCT03720470|75984399|FG005|NOT COMPLETED|Treatment Period: Final 4 Weeks||5||
59859792|NCT00262847|75984422|FG000|STARTED|Overall Study|Total enrolled and included in efficacy analysis|625||
59859793|NCT00262847|75984423|FG001|STARTED|Overall Study|Total enrolled and included in efficacy analysis|625||
59859794|NCT00262847|75984424|FG002|STARTED|Overall Study|Total enrolled and included in efficacy analysis|623||
59859795|NCT00262847|75984422|FG000|COMPLETED|Overall Study||107||
59859796|NCT00262847|75984423|FG001|COMPLETED|Overall Study||112||
59859797|NCT00262847|75984424|FG002|COMPLETED|Overall Study||227||
59859798|NCT00262847|75984422|FG000|NOT COMPLETED|Overall Study||518||
59859799|NCT00262847|75984423|FG001|NOT COMPLETED|Overall Study||513||
59859800|NCT00262847|75984424|FG002|NOT COMPLETED|Overall Study||396||
59859801|NCT00280397|75984435|FG000|STARTED|Overall Study||27||
59859802|NCT00280397|75984435|FG000|COMPLETED|Overall Study||26||
59859803|NCT00280397|75984435|FG000|NOT COMPLETED|Overall Study||1||
59859804|NCT00262301|75984444|FG000|STARTED|Double-blind Phase||16||
59859805|NCT00262301|75984445|FG001|STARTED|Double-blind Phase||16||
59859806|NCT00262301|75984446|FG002|STARTED|Double-blind Phase||0||
59859807|NCT00262301|75984444|FG000|COMPLETED|Double-blind Phase||15||
59859808|NCT00262301|75984445|FG001|COMPLETED|Double-blind Phase||15||
59859809|NCT00262301|75984446|FG002|COMPLETED|Double-blind Phase||0||
59859810|NCT00262301|75984444|FG000|NOT COMPLETED|Double-blind Phase||1||
59859811|NCT00262301|75984445|FG001|NOT COMPLETED|Double-blind Phase||1||
59859812|NCT00262301|75984446|FG002|NOT COMPLETED|Double-blind Phase||0||
59859813|NCT00262301|75984444|FG000|STARTED|Open-label Phase||0||
59859814|NCT00262301|75984445|FG001|STARTED|Open-label Phase||0||
59859815|NCT00262301|75984446|FG002|STARTED|Open-label Phase|"14/57 patients crossed over from the double-blind phase (7/14 were treated with 100 U/kg rhC1INH)"|57||
59859816|NCT00262301|75984444|FG000|COMPLETED|Open-label Phase||0||
59859817|NCT00262301|75984445|FG001|COMPLETED|Open-label Phase||0||
59859818|NCT00262301|75984446|FG002|COMPLETED|Open-label Phase||57||
59859819|NCT00262301|75984444|FG000|NOT COMPLETED|Open-label Phase||0||
59859820|NCT00262301|75984445|FG001|NOT COMPLETED|Open-label Phase||0||
59859821|NCT00262301|75984446|FG002|NOT COMPLETED|Open-label Phase||0||
59859822|NCT00279305|75984456|FG000|STARTED|Overall Study||57||
59859823|NCT00279305|75984457|FG001|STARTED|Overall Study||30||
59859824|NCT00279305|75984456|FG000|COMPLETED|Overall Study||49||
59859825|NCT00279305|75984457|FG001|COMPLETED|Overall Study||29||
59859826|NCT00279305|75984456|FG000|NOT COMPLETED|Overall Study||8||
59859827|NCT00279305|75984457|FG001|NOT COMPLETED|Overall Study||1||
59859828|NCT00278993|75984463|FG000|STARTED|Overall Study||108||
59859829|NCT00278993|75984463|FG000|COMPLETED|Overall Study||1||
59859830|NCT00278993|75984463|FG000|NOT COMPLETED|Overall Study||107||
59859831|NCT00277355|75984469|FG000|STARTED|Overall Study||87||
59859832|NCT00277355|75984470|FG001|STARTED|Overall Study||27||
59859833|NCT00277355|75984469|FG000|COMPLETED|Overall Study||73||
59859834|NCT00277355|75984470|FG001|COMPLETED|Overall Study||22||
59859835|NCT00277355|75984469|FG000|NOT COMPLETED|Overall Study||14||
59859836|NCT00277355|75984470|FG001|NOT COMPLETED|Overall Study||5||
59859837|NCT00262223|75984479|FG000|STARTED|Treatment Phase||32||
59859838|NCT00262223|75984480|FG001|STARTED|Treatment Phase||37||
59859839|NCT00262223|75984479|FG000|COMPLETED|Treatment Phase||28||
59859840|NCT00262223|75984480|FG001|COMPLETED|Treatment Phase||29||
59859841|NCT00262223|75984479|FG000|NOT COMPLETED|Treatment Phase||4||
59859842|NCT00262223|75984480|FG001|NOT COMPLETED|Treatment Phase||8||
59859843|NCT00262223|75984479|FG000|STARTED|1-week Post-treatment Follow-up||28||
59859844|NCT00262223|75984480|FG001|STARTED|1-week Post-treatment Follow-up||29||
59859845|NCT00262223|75984479|FG000|COMPLETED|1-week Post-treatment Follow-up||24||
59859846|NCT00262223|75984480|FG001|COMPLETED|1-week Post-treatment Follow-up||25||
59859847|NCT00262223|75984479|FG000|NOT COMPLETED|1-week Post-treatment Follow-up||4||
59859848|NCT00262223|75984480|FG001|NOT COMPLETED|1-week Post-treatment Follow-up||4||
59859849|NCT00262223|75984479|FG000|STARTED|6-month Post-treatment Follow-up|Subjects were included in subsequent follow-ups even if lost to contact during previous follow-up.|28||
59859850|NCT00262223|75984480|FG001|STARTED|6-month Post-treatment Follow-up|Subjects were included in subsequent follow-ups even if lost to contact during previous follow-up.|29||
59859851|NCT00262223|75984479|FG000|COMPLETED|6-month Post-treatment Follow-up||22||
59859852|NCT00262223|75984480|FG001|COMPLETED|6-month Post-treatment Follow-up||28||
59859853|NCT00262223|75984479|FG000|NOT COMPLETED|6-month Post-treatment Follow-up||6||
59859854|NCT00262223|75984480|FG001|NOT COMPLETED|6-month Post-treatment Follow-up||1||
59859855|NCT00262223|75984479|FG000|STARTED|12-month Post-treatment Follow-up|Subjects were included in subsequent follow-ups even if lost to contact during previous follow-up.|28||
59859856|NCT00262223|75984480|FG001|STARTED|12-month Post-treatment Follow-up|Subjects were included in subsequent follow-ups even if lost to contact during previous follow-up.|29||
59859857|NCT00262223|75984479|FG000|COMPLETED|12-month Post-treatment Follow-up||21||
59859858|NCT00262223|75984480|FG001|COMPLETED|12-month Post-treatment Follow-up||22||
59859859|NCT00262223|75984479|FG000|NOT COMPLETED|12-month Post-treatment Follow-up||7||
59859860|NCT00262223|75984480|FG001|NOT COMPLETED|12-month Post-treatment Follow-up||7||
59859861|NCT00276419|75984489|FG000|STARTED|First Intervention||8||
59859862|NCT00276419|75984490|FG001|STARTED|First Intervention||10||
59859863|NCT00276419|75984489|FG000|COMPLETED|First Intervention||7||
59859864|NCT00276419|75984490|FG001|COMPLETED|First Intervention||8||
59859865|NCT00276419|75984489|FG000|NOT COMPLETED|First Intervention||1||
59859866|NCT00276419|75984490|FG001|NOT COMPLETED|First Intervention||2||
59859867|NCT00276419|75984489|FG000|STARTED|Wash-out Phase||7||
59859868|NCT00276419|75984490|FG001|STARTED|Wash-out Phase||8||
59859869|NCT00276419|75984489|FG000|COMPLETED|Wash-out Phase||7||
59859870|NCT00276419|75984490|FG001|COMPLETED|Wash-out Phase||8||
59859871|NCT00276419|75984489|FG000|NOT COMPLETED|Wash-out Phase||0||
59859872|NCT00276419|75984490|FG001|NOT COMPLETED|Wash-out Phase||0||
59859873|NCT00276419|75984489|FG000|STARTED|Second Intervention||7||
59859874|NCT00276419|75984490|FG001|STARTED|Second Intervention||8||
59859875|NCT00276419|75984489|FG000|COMPLETED|Second Intervention||7||
59859876|NCT00276419|75984490|FG001|COMPLETED|Second Intervention||8||
59859877|NCT00276419|75984489|FG000|NOT COMPLETED|Second Intervention||0||
59859878|NCT00276419|75984490|FG001|NOT COMPLETED|Second Intervention||0||
59859879|NCT00956930|75984498|FG000|STARTED|Overall Study||24||
59859880|NCT00956930|75984499|FG001|STARTED|Overall Study||21||
59859881|NCT00956930|75984498|FG000|COMPLETED|Overall Study||24||
59859882|NCT00956930|75984499|FG001|COMPLETED|Overall Study||21||
59859883|NCT00956930|75984498|FG000|NOT COMPLETED|Overall Study||0||
59859884|NCT00956930|75984499|FG001|NOT COMPLETED|Overall Study||0||
59859885|NCT00262067|75984511|FG000|STARTED|Overall Study||415||
59859886|NCT00262067|75984512|FG001|STARTED|Overall Study||207||
59859887|NCT00262067|75984513|FG002|STARTED|Overall Study||409||
59859888|NCT00262067|75984514|FG003|STARTED|Overall Study||206||
59859889|NCT00262067|75984511|FG000|COMPLETED|Overall Study||196||
59859890|NCT00262067|75984512|FG001|COMPLETED|Overall Study||107||
59859891|NCT00262067|75984513|FG002|COMPLETED|Overall Study||193||
59859892|NCT00262067|75984514|FG003|COMPLETED|Overall Study||93||
59859893|NCT00262067|75984511|FG000|NOT COMPLETED|Overall Study||219||
59859894|NCT00262067|75984512|FG001|NOT COMPLETED|Overall Study||100||
59859895|NCT00262067|75984513|FG002|NOT COMPLETED|Overall Study||216||
59859896|NCT00262067|75984514|FG003|NOT COMPLETED|Overall Study||113||
59859897|NCT00275561|75984526|FG000|STARTED|Overall Study||21||
59859898|NCT00275561|75984527|FG001|STARTED|Overall Study||21||
59859899|NCT00275561|75984526|FG000|COMPLETED|Overall Study||19||
59859900|NCT00275561|75984527|FG001|COMPLETED|Overall Study||15||
59859901|NCT00275561|75984526|FG000|NOT COMPLETED|Overall Study||2||
59859902|NCT00275561|75984527|FG001|NOT COMPLETED|Overall Study||6||
59859903|NCT02802020|75984533|FG000|STARTED|Overall Study||67||
59859904|NCT02802020|75984533|FG000|COMPLETED|Overall Study||63||
59859905|NCT02802020|75984533|FG000|NOT COMPLETED|Overall Study||4||
59859906|NCT00274937|75984537|FG000|STARTED|Overall Study||111||
59859907|NCT00274937|75984537|FG000|COMPLETED|Overall Study||91||
59859908|NCT00274937|75984537|FG000|NOT COMPLETED|Overall Study||20||
59859909|NCT00251693|75984544|FG000|STARTED|Overall Study||680||
59859910|NCT00251693|75984545|FG001|STARTED|Overall Study||668||
59859911|NCT00251693|75984546|FG002|STARTED|Overall Study||690||
59859912|NCT00251693|75984544|FG000|COMPLETED|Overall Study||629||
59859913|NCT00251693|75984545|FG001|COMPLETED|Overall Study||624||
59859914|NCT00251693|75984546|FG002|COMPLETED|Overall Study||644||
59859915|NCT00251693|75984544|FG000|NOT COMPLETED|Overall Study||51||
59859916|NCT00251693|75984545|FG001|NOT COMPLETED|Overall Study||44||
59859917|NCT00251693|75984546|FG002|NOT COMPLETED|Overall Study||46||
59859918|NCT00250835|75984554|FG000|STARTED|Overall Study||38||
59859919|NCT00250835|75984554|FG000|COMPLETED|Overall Study||37||
59859920|NCT00250835|75984554|FG000|NOT COMPLETED|Overall Study||1||
59859921|NCT04869644|75984558|FG000|STARTED|Assessed for Eligibility||114||
59859922|NCT04869644|75984558|FG000|Did Not Meet or Complete Inclusion Criteria|Assessed for Eligibility||35||
59859923|NCT04869644|75984558|FG000|Did Not Consent to Study|Assessed for Eligibility||30||
59859924|NCT04869644|75984558|FG000|COMPLETED|Assessed for Eligibility||49||
59859925|NCT04869644|75984558|FG000|NOT COMPLETED|Assessed for Eligibility||65||
59859926|NCT04869644|75984558|FG000|STARTED|Enrolled in Study||49||
59859927|NCT04869644|75984558|FG000|Withdrew From Study|Enrolled in Study||5||
59859928|NCT04869644|75984558|FG000|COMPLETED|Enrolled in Study||44||
59859929|NCT04869644|75984558|FG000|NOT COMPLETED|Enrolled in Study||5||
59859930|NCT04869644|75984558|FG000|STARTED|Baseline||44||
59859931|NCT04869644|75984558|FG000|Ineligible After Baseline|Baseline||8||
59859932|NCT04869644|75984558|FG000|Withdrew From Study|Baseline||2||
59859933|NCT04869644|75984558|FG000|COMPLETED|Baseline||34||
59859934|NCT04869644|75984558|FG000|NOT COMPLETED|Baseline||10||
59859935|NCT04869644|75984558|FG000|STARTED|Intervention||34||
59859936|NCT04869644|75984558|FG000|Discontinued Intervention|Intervention||2||
59859937|NCT04869644|75984558|FG000|COMPLETED|Intervention||32||
59859938|NCT04869644|75984558|FG000|NOT COMPLETED|Intervention||2||
59859939|NCT03716024|75984564|FG000|STARTED|Overall Study||118||
59859940|NCT03716024|75984565|FG001|STARTED|Overall Study||116||
59859941|NCT03716024|75984564|FG000|COMPLETED|Overall Study||107||
59859942|NCT03716024|75984565|FG001|COMPLETED|Overall Study||98||
59859943|NCT03716024|75984564|FG000|NOT COMPLETED|Overall Study||11||
59859944|NCT03716024|75984565|FG001|NOT COMPLETED|Overall Study||18||
59859945|NCT00250679|75984574|FG000|STARTED|Overall Study||147||
59859946|NCT00250679|75984575|FG001|STARTED|Overall Study||149||
59859947|NCT00250679|75984576|FG002|STARTED|Overall Study||147||
59859948|NCT00250679|75984574|FG000|COMPLETED|Overall Study||108||
59859949|NCT00250679|75984575|FG001|COMPLETED|Overall Study||100||
59859950|NCT00250679|75984576|FG002|COMPLETED|Overall Study||103||
59859951|NCT00250679|75984574|FG000|NOT COMPLETED|Overall Study||39||
59859952|NCT00250679|75984575|FG001|NOT COMPLETED|Overall Study||49||
59859953|NCT00250679|75984576|FG002|NOT COMPLETED|Overall Study||44||
59859954|NCT00261833|75984586|FG000|STARTED|Overall Study||93||
59859955|NCT00261833|75984587|FG001|STARTED|Overall Study||87||
59859956|NCT00261833|75984586|FG000|COMPLETED|Overall Study||84||
59859957|NCT00261833|75984587|FG001|COMPLETED|Overall Study||69||
59859958|NCT00261833|75984586|FG000|NOT COMPLETED|Overall Study||9||
59859959|NCT00261833|75984587|FG001|NOT COMPLETED|Overall Study||18||
59859960|NCT03713684|75984598|FG000|STARTED|Overall Study||92||
59859961|NCT03713684|75984599|FG001|STARTED|Overall Study||92||
59859962|NCT03713684|75984600|FG002|STARTED|Overall Study||93||
59859963|NCT03713684|75984601|FG003|STARTED|Overall Study||93||
59859964|NCT03713684|75984598|FG000|Safety Population|Overall Study||92|Participants who received at least 1 dose or part of a dose of the Investigational Medicinal Product (IMP), analyzed according to the treatment actually received.|
59859965|NCT03713684|75984599|FG001|Safety Population|Overall Study||92|Participants who received at least 1 dose or part of a dose of the Investigational Medicinal Product (IMP), analyzed according to the treatment actually received.|
59859966|NCT03713684|75984600|FG002|Safety Population|Overall Study|For safety analysis participants were included in the treatment arm that they were exposed for longer duration. 3 participants randomized to Efpeglenatide 6 mg arm received 4 mg dose for longer duration; and considered in Efpeglenatide 4 mg arm for safety analysis.|96|Participants who received at least 1 dose or part of a dose of the Investigational Medicinal Product (IMP), analyzed according to the treatment actually received.|
59859967|NCT03713684|75984601|FG003|Safety Population|Overall Study||90|Participants who received at least 1 dose or part of a dose of the Investigational Medicinal Product (IMP), analyzed according to the treatment actually received.|
59859968|NCT03713684|75984598|FG000|Completed 30-Week Core Treatment Period|Overall Study||50||
59859969|NCT03713684|75984599|FG001|Completed 30-Week Core Treatment Period|Overall Study||52||
59859970|NCT03713684|75984600|FG002|Completed 30-Week Core Treatment Period|Overall Study||51||
59859971|NCT03713684|75984601|FG003|Completed 30-Week Core Treatment Period|Overall Study||49||
59859972|NCT03713684|75984598|FG000|COMPLETED|Overall Study||6|Completed 56-Week treatment period.|
59859973|NCT03713684|75984599|FG001|COMPLETED|Overall Study||5|Completed 56-Week treatment period.|
59859974|NCT03713684|75984600|FG002|COMPLETED|Overall Study||5|Completed 56-Week treatment period.|
59859975|NCT03713684|75984601|FG003|COMPLETED|Overall Study||6|Completed 56-Week treatment period.|
59859976|NCT03713684|75984598|FG000|NOT COMPLETED|Overall Study||86||
59859977|NCT03713684|75984599|FG001|NOT COMPLETED|Overall Study||87||
60128509|NCT01458535|76250651|FG000|NOT COMPLETED|Overall Study||0||
60128510|NCT01458535|76250652|FG001|NOT COMPLETED|Overall Study||2||
60128511|NCT01458535|76250653|FG002|NOT COMPLETED|Overall Study||2||
60128512|NCT01458535|76250654|FG003|NOT COMPLETED|Overall Study||4||
60128513|NCT01458535|76250655|FG004|NOT COMPLETED|Overall Study||4||
60128514|NCT01458535|76250656|FG005|NOT COMPLETED|Overall Study||4||
60128515|NCT01464827|76250684|FG000|STARTED|Overall Study||80||
60128516|NCT01464827|76250685|FG001|STARTED|Overall Study||43||
60128517|NCT01464827|76250686|FG002|STARTED|Overall Study||39||
60128518|NCT01464827|76250687|FG003|STARTED|Overall Study||40||
60128519|NCT01464827|76250688|FG004|STARTED|Overall Study||80||
60128520|NCT01464827|76250689|FG005|STARTED|Overall Study||39||
59859978|NCT03713684|75984600|FG002|NOT COMPLETED|Overall Study||88||
59859979|NCT03713684|75984601|FG003|NOT COMPLETED|Overall Study||87||
59859980|NCT03711266|75984611|FG000|STARTED|Overall Study||30||
59859981|NCT03711266|75984611|FG000|COMPLETED|Overall Study||20||
59859982|NCT03711266|75984611|FG000|NOT COMPLETED|Overall Study||10||
59859983|NCT03150862|75984623|FG000|STARTED|Overall Study||3||
59859984|NCT03150862|75984624|FG001|STARTED|Overall Study||8||
59859985|NCT03150862|75984625|FG002|STARTED|Overall Study||9||
60128521|NCT01464827|76250690|FG006|STARTED|Overall Study||41||
60128522|NCT01464827|76250691|FG007|STARTED|Overall Study||40||
59859986|NCT03150862|75984626|FG003|STARTED|Overall Study||40||
59859987|NCT03150862|75984627|FG004|STARTED|Overall Study||9||
59859988|NCT03150862|75984628|FG005|STARTED|Overall Study||9||
59859989|NCT03150862|75984629|FG006|STARTED|Overall Study||8||
59859990|NCT03150862|75984630|FG007|STARTED|Overall Study||30||
59859991|NCT03150862|75984623|FG000|COMPLETED|Overall Study||0||
59859992|NCT03150862|75984624|FG001|COMPLETED|Overall Study||0||
59859993|NCT03150862|75984625|FG002|COMPLETED|Overall Study||0||
59859994|NCT03150862|75984626|FG003|COMPLETED|Overall Study||0||
59859995|NCT03150862|75984627|FG004|COMPLETED|Overall Study||0||
59859996|NCT03150862|75984628|FG005|COMPLETED|Overall Study||0||
59859997|NCT03150862|75984629|FG006|COMPLETED|Overall Study||0||
59859998|NCT03150862|75984630|FG007|COMPLETED|Overall Study||0||
59859999|NCT03150862|75984623|FG000|NOT COMPLETED|Overall Study||3||
59860000|NCT03150862|75984624|FG001|NOT COMPLETED|Overall Study||8||
59860001|NCT03150862|75984625|FG002|NOT COMPLETED|Overall Study||9||
59860002|NCT03150862|75984626|FG003|NOT COMPLETED|Overall Study||40||
59860003|NCT03150862|75984627|FG004|NOT COMPLETED|Overall Study||9||
59860004|NCT03150862|75984628|FG005|NOT COMPLETED|Overall Study||9||
59860005|NCT03150862|75984629|FG006|NOT COMPLETED|Overall Study||8||
59860006|NCT03150862|75984630|FG007|NOT COMPLETED|Overall Study||30||
59860007|NCT00260429|75984659|FG000|STARTED|Overall Study||23||
59860008|NCT00260429|75984660|FG001|STARTED|Overall Study||12||
59860009|NCT00260429|75984659|FG000|COMPLETED|Overall Study||21||
59860010|NCT00260429|75984660|FG001|COMPLETED|Overall Study||12||
59860011|NCT00260429|75984659|FG000|NOT COMPLETED|Overall Study||2||
59860012|NCT00260429|75984660|FG001|NOT COMPLETED|Overall Study||0||
59860013|NCT00379288|75984670|FG000|STARTED|Overall Study||141||
59860014|NCT00379288|75984671|FG001|STARTED|Overall Study||130||
59860015|NCT00379288|75984672|FG002|STARTED|Overall Study||68||
59860016|NCT00379288|75984673|FG003|STARTED|Overall Study||65||
59860017|NCT00379288|75984670|FG000|COMPLETED|Overall Study||122||
59860018|NCT00379288|75984671|FG001|COMPLETED|Overall Study||108||
59860019|NCT00379288|75984672|FG002|COMPLETED|Overall Study||58||
59860020|NCT00379288|75984673|FG003|COMPLETED|Overall Study||57||
59860021|NCT00379288|75984670|FG000|NOT COMPLETED|Overall Study||19||
59860022|NCT00379288|75984671|FG001|NOT COMPLETED|Overall Study||22||
59860023|NCT00379288|75984672|FG002|NOT COMPLETED|Overall Study||10||
59860024|NCT00379288|75984673|FG003|NOT COMPLETED|Overall Study||8||
59860025|NCT00243503|75984683|FG000|STARTED|Overall Study|3 participants discontinued and only took Trastuzumab.|60||
59860026|NCT00243503|75984683|FG000|COMPLETED|Overall Study||2||
59860027|NCT00243503|75984683|FG000|NOT COMPLETED|Overall Study||58||
59860028|NCT00239837|75984690|FG000|STARTED|Overall Study||48||
59860029|NCT00239837|75984691|FG001|STARTED|Overall Study||52||
59860030|NCT00239837|75984690|FG000|6 Months|Overall Study||48||
59860031|NCT00239837|75984691|FG001|6 Months|Overall Study||50||
59860032|NCT00239837|75984690|FG000|COMPLETED|Overall Study|3-year follow-up|45||
59860033|NCT00239837|75984691|FG001|COMPLETED|Overall Study|3-year follow-up|45||
59860034|NCT00239837|75984690|FG000|NOT COMPLETED|Overall Study||3||
59860035|NCT00239837|75984691|FG001|NOT COMPLETED|Overall Study||7||
59860036|NCT00259649|75984699|FG000|STARTED|Overall Study||71||
59860037|NCT00259649|75984699|FG000|COMPLETED|Overall Study||61||
59860038|NCT00259649|75984699|FG000|NOT COMPLETED|Overall Study||10||
59860039|NCT03712280|75984707|FG000|STARTED|Overall Study||12|Participants randomized|
59860040|NCT03712280|75984708|FG001|STARTED|Overall Study||12|Participants randomized|
59860041|NCT03712280|75984709|FG002|STARTED|Overall Study||13|Participants randomized|
59860042|NCT03712280|75984710|FG003|STARTED|Overall Study||13|Participants randomized|
59860043|NCT03712280|75984707|FG000|Safety Population|Overall Study||12|All participants randomized and treated|
59860044|NCT03712280|75984708|FG001|Safety Population|Overall Study||11|All participants randomized and treated|
59860045|NCT03712280|75984709|FG002|Safety Population|Overall Study||13|All participants randomized and treated|
59860046|NCT03712280|75984710|FG003|Safety Population|Overall Study||12|All participants randomized and treated|
59860047|NCT03712280|75984707|FG000|Modified Intent to Treat Population|Overall Study||12||
59860048|NCT03712280|75984708|FG001|Modified Intent to Treat Population|Overall Study||11||
59860049|NCT03712280|75984709|FG002|Modified Intent to Treat Population|Overall Study||13||
59860050|NCT03712280|75984710|FG003|Modified Intent to Treat Population|Overall Study||12||
59860051|NCT03712280|75984707|FG000|Completed 5 Day Treatment|Overall Study||11||
59860052|NCT03712280|75984708|FG001|Completed 5 Day Treatment|Overall Study||11||
59860053|NCT03712280|75984709|FG002|Completed 5 Day Treatment|Overall Study||12||
60128523|NCT01464827|76250692|FG008|STARTED|Overall Study||40||
59860054|NCT03712280|75984710|FG003|Completed 5 Day Treatment|Overall Study||12||
59860055|NCT03712280|75984707|FG000|COMPLETED|Overall Study||11||
59860056|NCT03712280|75984708|FG001|COMPLETED|Overall Study||11||
59860057|NCT03712280|75984709|FG002|COMPLETED|Overall Study||12||
59860058|NCT03712280|75984710|FG003|COMPLETED|Overall Study||12||
59860059|NCT03712280|75984707|FG000|NOT COMPLETED|Overall Study||1||
60128524|NCT01464827|76250693|FG009|STARTED|Overall Study||47||
59860060|NCT03712280|75984708|FG001|NOT COMPLETED|Overall Study||1||
59860061|NCT03712280|75984709|FG002|NOT COMPLETED|Overall Study||1||
59860062|NCT03712280|75984710|FG003|NOT COMPLETED|Overall Study||1||
59860063|NCT01345240|75984725|FG000|STARTED|Overall Study||142||
60128525|NCT01464827|76250694|FG010|STARTED|Overall Study||23||
59860064|NCT01345240|75984726|FG001|STARTED|Overall Study||142||
59860065|NCT01345240|75984727|FG002|STARTED|Overall Study||141||
59860066|NCT01345240|75984728|FG003|STARTED|Overall Study||141||
59860067|NCT01345240|75984729|FG004|STARTED|Overall Study||139||
59860068|NCT01345240|75984725|FG000|COMPLETED|Overall Study||131||
59860069|NCT01345240|75984726|FG001|COMPLETED|Overall Study||128||
59860070|NCT01345240|75984727|FG002|COMPLETED|Overall Study||123||
59860071|NCT01345240|75984728|FG003|COMPLETED|Overall Study||132||
59860072|NCT01345240|75984729|FG004|COMPLETED|Overall Study||129||
59860073|NCT01345240|75984725|FG000|NOT COMPLETED|Overall Study||11||
59860074|NCT01345240|75984726|FG001|NOT COMPLETED|Overall Study||14||
59860075|NCT01345240|75984727|FG002|NOT COMPLETED|Overall Study||18||
59860076|NCT01345240|75984728|FG003|NOT COMPLETED|Overall Study||9||
59860077|NCT01345240|75984729|FG004|NOT COMPLETED|Overall Study||10||
59860078|NCT03778112|75984752|FG000|STARTED|Overall Study||4||
59860079|NCT03778112|75984753|FG001|STARTED|Overall Study||50||
59860080|NCT03778112|75984752|FG000|COMPLETED|Overall Study||4||
59860081|NCT03778112|75984753|FG001|COMPLETED|Overall Study||50||
59860082|NCT03778112|75984752|FG000|NOT COMPLETED|Overall Study||0||
59860083|NCT03778112|75984753|FG001|NOT COMPLETED|Overall Study||0||
59860084|NCT03707912|75984761|FG000|STARTED|Overall Study||104||
59860085|NCT03707912|75984762|FG001|STARTED|Overall Study||100||
59860086|NCT03707912|75984761|FG000|COMPLETED|Overall Study||103||
59860087|NCT03707912|75984762|FG001|COMPLETED|Overall Study||100||
59860088|NCT03707912|75984761|FG000|NOT COMPLETED|Overall Study||1||
59860089|NCT03707912|75984762|FG001|NOT COMPLETED|Overall Study||0||
59860090|NCT02883244|75984770|FG000|STARTED|Overall Study||24||
59860091|NCT02883244|75984771|FG001|STARTED|Overall Study||26||
59860092|NCT02883244|75984770|FG000|COMPLETED|Overall Study||24||
59860093|NCT02883244|75984771|FG001|COMPLETED|Overall Study||25||
59860094|NCT02883244|75984770|FG000|NOT COMPLETED|Overall Study||0||
59860095|NCT02883244|75984771|FG001|NOT COMPLETED|Overall Study||1||
59860096|NCT02882854|75984779|FG000|STARTED|Overall Study||40||
59860097|NCT02882854|75984780|FG001|STARTED|Overall Study||44||
59860098|NCT02882854|75984779|FG000|COMPLETED|Overall Study||39||
59860099|NCT02882854|75984780|FG001|COMPLETED|Overall Study||41||
59860100|NCT02882854|75984779|FG000|NOT COMPLETED|Overall Study||1||
59860101|NCT02882854|75984780|FG001|NOT COMPLETED|Overall Study||3||
59860102|NCT03707522|75984790|FG000|STARTED|Overall Study||31||
59860103|NCT03707522|75984791|FG001|STARTED|Overall Study||36||
59860104|NCT03707522|75984792|FG002|STARTED|Overall Study||52||
59860105|NCT03707522|75984793|FG003|STARTED|Overall Study||43||
59860106|NCT03707522|75984790|FG000|COMPLETED|Overall Study||7||
59860107|NCT03707522|75984791|FG001|COMPLETED|Overall Study||9||
59860108|NCT03707522|75984792|FG002|COMPLETED|Overall Study||11||
59860109|NCT03707522|75984793|FG003|COMPLETED|Overall Study||7||
59860110|NCT03707522|75984790|FG000|NOT COMPLETED|Overall Study||24||
59860111|NCT03707522|75984791|FG001|NOT COMPLETED|Overall Study||27||
59860112|NCT03707522|75984792|FG002|NOT COMPLETED|Overall Study||41||
59860113|NCT03707522|75984793|FG003|NOT COMPLETED|Overall Study||36||
60128526|NCT01464827|76250695|FG011|STARTED|Overall Study||23||
60128527|NCT01464827|76250696|FG012|STARTED|Overall Study||23||
60128528|NCT01464827|76250697|FG013|STARTED|Overall Study||22||
60128529|NCT01464827|76250684|FG000|Treated|Overall Study||80||
59860114|NCT03150082|75984803|FG000|STARTED|Treatment Period 1 (Up to 4 Weeks)||13||
59860115|NCT03150082|75984804|FG001|STARTED|Treatment Period 1 (Up to 4 Weeks)||13||
59860116|NCT03150082|75984803|FG000|COMPLETED|Treatment Period 1 (Up to 4 Weeks)||12||
59860117|NCT03150082|75984804|FG001|COMPLETED|Treatment Period 1 (Up to 4 Weeks)||13||
59860118|NCT03150082|75984803|FG000|NOT COMPLETED|Treatment Period 1 (Up to 4 Weeks)||1||
59860119|NCT03150082|75984804|FG001|NOT COMPLETED|Treatment Period 1 (Up to 4 Weeks)||0||
59860120|NCT03150082|75984803|FG000|STARTED|Washout Period (Up to 4 Weeks)||12||
59860121|NCT03150082|75984804|FG001|STARTED|Washout Period (Up to 4 Weeks)||13||
59860122|NCT03150082|75984803|FG000|COMPLETED|Washout Period (Up to 4 Weeks)||12||
59860123|NCT03150082|75984804|FG001|COMPLETED|Washout Period (Up to 4 Weeks)||13||
59860124|NCT03150082|75984803|FG000|NOT COMPLETED|Washout Period (Up to 4 Weeks)||0||
59860125|NCT03150082|75984804|FG001|NOT COMPLETED|Washout Period (Up to 4 Weeks)||0||
59860126|NCT03150082|75984803|FG000|STARTED|Treatment Period 2 (Up to 4 Weeks)||12||
59860127|NCT03150082|75984804|FG001|STARTED|Treatment Period 2 (Up to 4 Weeks)||13||
59860128|NCT03150082|75984803|FG000|COMPLETED|Treatment Period 2 (Up to 4 Weeks)||12||
59860129|NCT03150082|75984804|FG001|COMPLETED|Treatment Period 2 (Up to 4 Weeks)||13||
59860130|NCT03150082|75984803|FG000|NOT COMPLETED|Treatment Period 2 (Up to 4 Weeks)||0||
59860131|NCT03150082|75984804|FG001|NOT COMPLETED|Treatment Period 2 (Up to 4 Weeks)||0||
59860132|NCT02118610|75984814|FG000|STARTED|Overall Study||30||
59860133|NCT02118610|75984815|FG001|STARTED|Overall Study||33||
59860134|NCT02118610|75984814|FG000|COMPLETED|Overall Study||29||
59860135|NCT02118610|75984815|FG001|COMPLETED|Overall Study||32||
59860136|NCT02118610|75984814|FG000|NOT COMPLETED|Overall Study||1||
59860137|NCT02118610|75984815|FG001|NOT COMPLETED|Overall Study||1||
59860138|NCT01909570|75984823|FG000|STARTED|Overall Study||84||
59860139|NCT01909570|75984824|FG001|STARTED|Overall Study||91||
59860140|NCT01909570|75984823|FG000|COMPLETED|Overall Study||57||
59860141|NCT01909570|75984824|FG001|COMPLETED|Overall Study||64||
59860142|NCT01909570|75984823|FG000|NOT COMPLETED|Overall Study||27||
59860143|NCT01909570|75984824|FG001|NOT COMPLETED|Overall Study||27||
59860144|NCT03142750|75984832|FG000|STARTED|Overall Study||14||
59860145|NCT03142750|75984833|FG001|STARTED|Overall Study||10||
59860146|NCT03142750|75984832|FG000|COMPLETED|Overall Study||10||
59860147|NCT03142750|75984833|FG001|COMPLETED|Overall Study||9||
59860148|NCT03142750|75984832|FG000|NOT COMPLETED|Overall Study||4||
59860149|NCT03142750|75984833|FG001|NOT COMPLETED|Overall Study||1||
59860150|NCT03149848|75984843|FG000|STARTED|Period 1 (Day 1 to Day 14)||15||
59860151|NCT03149848|75984843|FG000|COMPLETED|Period 1 (Day 1 to Day 14)||14||
59860152|NCT03149848|75984843|FG000|NOT COMPLETED|Period 1 (Day 1 to Day 14)||1||
59860153|NCT03149848|75984843|FG000|STARTED|Period 2 (Day 15 to Day 28)||14||
59860154|NCT03149848|75984843|FG000|COMPLETED|Period 2 (Day 15 to Day 28)||12||
59860155|NCT03149848|75984843|FG000|NOT COMPLETED|Period 2 (Day 15 to Day 28)||2||
59860156|NCT03706040|75984853|FG000|STARTED|Period A (Week 0 to Week 16)||34|Randomized|
59860157|NCT03706040|75984854|FG001|STARTED|Period A (Week 0 to Week 16)||69|Randomized|
59860158|NCT03706040|75984855|FG002|STARTED|Period A (Week 0 to Week 16)||69|Randomized|
59860159|NCT03706040|75984856|FG003|STARTED|Period A (Week 0 to Week 16)||0|Randomized|
59860160|NCT03706040|75984857|FG004|STARTED|Period A (Week 0 to Week 16)||0|Randomized|
59860161|NCT03706040|75984858|FG005|STARTED|Period A (Week 0 to Week 16)||0|Randomized|
59860162|NCT03706040|75984859|FG006|STARTED|Period A (Week 0 to Week 16)||0|Randomized|
59860163|NCT03706040|75984853|FG000|Received Study Drug|Period A (Week 0 to Week 16)||34||
59860164|NCT03706040|75984854|FG001|Received Study Drug|Period A (Week 0 to Week 16)||69||
59860165|NCT03706040|75984855|FG002|Received Study Drug|Period A (Week 0 to Week 16)||69||
59860166|NCT03706040|75984856|FG003|Received Study Drug|Period A (Week 0 to Week 16)||0||
59860167|NCT03706040|75984857|FG004|Received Study Drug|Period A (Week 0 to Week 16)||0||
59860168|NCT03706040|75984858|FG005|Received Study Drug|Period A (Week 0 to Week 16)||0||
59860169|NCT03706040|75984859|FG006|Received Study Drug|Period A (Week 0 to Week 16)||0||
59860170|NCT03706040|75984853|FG000|COMPLETED|Period A (Week 0 to Week 16)||25|Competed Period A|
59860171|NCT03706040|75984854|FG001|COMPLETED|Period A (Week 0 to Week 16)||61|Competed Period A|
59860172|NCT03706040|75984855|FG002|COMPLETED|Period A (Week 0 to Week 16)||58|Competed Period A|
59860173|NCT03706040|75984856|FG003|COMPLETED|Period A (Week 0 to Week 16)||0|Competed Period A|
59860174|NCT03706040|75984857|FG004|COMPLETED|Period A (Week 0 to Week 16)||0|Competed Period A|
59860175|NCT03706040|75984858|FG005|COMPLETED|Period A (Week 0 to Week 16)||0|Competed Period A|
59860176|NCT03706040|75984859|FG006|COMPLETED|Period A (Week 0 to Week 16)||0|Competed Period A|
59860177|NCT03706040|75984853|FG000|NOT COMPLETED|Period A (Week 0 to Week 16)||9||
59860178|NCT03706040|75984854|FG001|NOT COMPLETED|Period A (Week 0 to Week 16)||8||
59860179|NCT03706040|75984855|FG002|NOT COMPLETED|Period A (Week 0 to Week 16)||11||
59860180|NCT03706040|75984856|FG003|NOT COMPLETED|Period A (Week 0 to Week 16)||0||
59860181|NCT03706040|75984857|FG004|NOT COMPLETED|Period A (Week 0 to Week 16)||0||
59860182|NCT03706040|75984858|FG005|NOT COMPLETED|Period A (Week 0 to Week 16)||0||
59860183|NCT03706040|75984859|FG006|NOT COMPLETED|Period A (Week 0 to Week 16)||0||
59860184|NCT03706040|75984853|FG000|STARTED|Period B (Week 16 to Week 52)||0||
59860185|NCT03706040|75984854|FG001|STARTED|Period B (Week 16 to Week 52)||0||
59860186|NCT03706040|75984855|FG002|STARTED|Period B (Week 16 to Week 52)||0||
59860187|NCT03706040|75984856|FG003|STARTED|Period B (Week 16 to Week 52)||13||
59860188|NCT03706040|75984857|FG004|STARTED|Period B (Week 16 to Week 52)||12||
60128530|NCT01464827|76250685|FG001|Treated|Overall Study||41||
60128531|NCT01464827|76250686|FG002|Treated|Overall Study||39||
59860189|NCT03706040|75984858|FG005|STARTED|Period B (Week 16 to Week 52)||61||
59860190|NCT03706040|75984859|FG006|STARTED|Period B (Week 16 to Week 52)||58||
59860191|NCT03706040|75984853|FG000|Received Study Drug|Period B (Week 16 to Week 52)||0||
59860192|NCT03706040|75984854|FG001|Received Study Drug|Period B (Week 16 to Week 52)||0||
59860193|NCT03706040|75984855|FG002|Received Study Drug|Period B (Week 16 to Week 52)||0||
59860194|NCT03706040|75984856|FG003|Received Study Drug|Period B (Week 16 to Week 52)||13||
59860195|NCT03706040|75984857|FG004|Received Study Drug|Period B (Week 16 to Week 52)||11||
59860196|NCT03706040|75984858|FG005|Received Study Drug|Period B (Week 16 to Week 52)||61||
59860197|NCT03706040|75984859|FG006|Received Study Drug|Period B (Week 16 to Week 52)||57||
59860198|NCT03706040|75984853|FG000|COMPLETED|Period B (Week 16 to Week 52)||0|Completed study|
59860199|NCT03706040|75984854|FG001|COMPLETED|Period B (Week 16 to Week 52)||0|Completed study|
59860200|NCT03706040|75984855|FG002|COMPLETED|Period B (Week 16 to Week 52)||0|Completed study|
59860201|NCT03706040|75984856|FG003|COMPLETED|Period B (Week 16 to Week 52)||5|Completed study|
59860202|NCT03706040|75984857|FG004|COMPLETED|Period B (Week 16 to Week 52)||3|Completed study|
59860203|NCT03706040|75984858|FG005|COMPLETED|Period B (Week 16 to Week 52)||33|Completed study|
59860204|NCT03706040|75984859|FG006|COMPLETED|Period B (Week 16 to Week 52)||30|Completed study|
59860205|NCT03706040|75984853|FG000|NOT COMPLETED|Period B (Week 16 to Week 52)||0||
59860206|NCT03706040|75984854|FG001|NOT COMPLETED|Period B (Week 16 to Week 52)||0||
59860207|NCT03706040|75984855|FG002|NOT COMPLETED|Period B (Week 16 to Week 52)||0||
59860208|NCT03706040|75984856|FG003|NOT COMPLETED|Period B (Week 16 to Week 52)||8||
59860209|NCT03706040|75984857|FG004|NOT COMPLETED|Period B (Week 16 to Week 52)||9||
60128532|NCT01464827|76250687|FG003|Treated|Overall Study||40||
60128533|NCT01464827|76250688|FG004|Treated|Overall Study||79||
59860210|NCT03706040|75984858|FG005|NOT COMPLETED|Period B (Week 16 to Week 52)||28||
59860211|NCT03706040|75984859|FG006|NOT COMPLETED|Period B (Week 16 to Week 52)||28||
59860212|NCT03770000|75984880|FG000|STARTED|Overall Study||3||
59860213|NCT03770000|75984881|FG001|STARTED|Overall Study||3||
59860214|NCT03770000|75984882|FG002|STARTED|Overall Study||3||
59860215|NCT03770000|75984883|FG003|STARTED|Overall Study||12||
59860216|NCT03770000|75984884|FG004|STARTED|Overall Study||12||
59860217|NCT03770000|75984880|FG000|COMPLETED|Overall Study||3||
59860218|NCT03770000|75984881|FG001|COMPLETED|Overall Study||3||
59860219|NCT03770000|75984882|FG002|COMPLETED|Overall Study||2||
59860220|NCT03770000|75984883|FG003|COMPLETED|Overall Study||9||
59860221|NCT03770000|75984884|FG004|COMPLETED|Overall Study||10||
59860222|NCT03770000|75984880|FG000|NOT COMPLETED|Overall Study||0||
59860223|NCT03770000|75984881|FG001|NOT COMPLETED|Overall Study||0||
59860224|NCT03770000|75984882|FG002|NOT COMPLETED|Overall Study||1||
59860225|NCT03770000|75984883|FG003|NOT COMPLETED|Overall Study||3||
59860226|NCT03770000|75984884|FG004|NOT COMPLETED|Overall Study||2||
59860227|NCT03158272|75984903|FG000|STARTED|Overall Study||3|Started = Entered treatment period|
59860228|NCT03158272|75984904|FG001|STARTED|Overall Study||4|Started = Entered treatment period|
59860229|NCT03158272|75984905|FG002|STARTED|Overall Study||6|Started = Entered treatment period|
59860230|NCT03158272|75984906|FG003|STARTED|Overall Study||6|Started = Entered treatment period|
59860231|NCT03158272|75984903|FG000|COMPLETED|Overall Study||0||
59860232|NCT03158272|75984904|FG001|COMPLETED|Overall Study||0||
59860233|NCT03158272|75984905|FG002|COMPLETED|Overall Study||0||
59860234|NCT03158272|75984906|FG003|COMPLETED|Overall Study||0||
59860235|NCT03158272|75984903|FG000|NOT COMPLETED|Overall Study||3||
59860236|NCT03158272|75984904|FG001|NOT COMPLETED|Overall Study||4||
59860237|NCT03158272|75984905|FG002|NOT COMPLETED|Overall Study||6||
59860238|NCT03158272|75984906|FG003|NOT COMPLETED|Overall Study||6||
59860239|NCT03705494|75984920|FG000|STARTED|Overall Study||10||
59860240|NCT03705494|75984921|FG001|STARTED|Overall Study||10||
59860241|NCT03705494|75984920|FG000|COMPLETED|Overall Study||3||
59860242|NCT03705494|75984921|FG001|COMPLETED|Overall Study||7||
59860243|NCT03705494|75984920|FG000|NOT COMPLETED|Overall Study||7||
59860244|NCT03705494|75984921|FG001|NOT COMPLETED|Overall Study||3||
59860245|NCT01431508|75984927|FG000|STARTED|Overall Study||15||
59860246|NCT01431508|75984927|FG000|COMPLETED|Overall Study||13||
59860247|NCT01431508|75984927|FG000|NOT COMPLETED|Overall Study||2||
59860248|NCT00654628|75984931|FG000|STARTED|6-week Active Treatment Period||173||
59860249|NCT00654628|75984931|FG000|COMPLETED|6-week Active Treatment Period||152||
59860250|NCT00654628|75984931|FG000|NOT COMPLETED|6-week Active Treatment Period||21||
60128534|NCT01464827|76250689|FG005|Treated|Overall Study||39||
59728421|NCT00812929|75847155|FG006|NOT COMPLETED|Treatment Period 3||0||
59728422|NCT00812929|75847156|FG007|NOT COMPLETED|Treatment Period 3||0||
59728423|NCT00812929|75847157|FG008|NOT COMPLETED|Treatment Period 3||0||
59728424|NCT00812929|75847158|FG009|NOT COMPLETED|Treatment Period 3||0||
59728425|NCT00812929|75847149|FG000|STARTED|Washout Period 3 (7 Days)||5||
59728426|NCT00812929|75847150|FG001|STARTED|Washout Period 3 (7 Days)||4||
59728427|NCT00812929|75847151|FG002|STARTED|Washout Period 3 (7 Days)||4||
59728428|NCT00812929|75847152|FG003|STARTED|Washout Period 3 (7 Days)||4||
59728429|NCT00812929|75847153|FG004|STARTED|Washout Period 3 (7 Days)||5||
59728430|NCT00812929|75847154|FG005|STARTED|Washout Period 3 (7 Days)||5||
59860251|NCT00654628|75984931|FG000|STARTED|6 -Week Extension Period (Single Site)|Subjects who completed the first 6-week period and participated in the second 6-week study period.|60||
59860252|NCT00654628|75984931|FG000|COMPLETED|6 -Week Extension Period (Single Site)||55||
59860253|NCT00654628|75984931|FG000|NOT COMPLETED|6 -Week Extension Period (Single Site)||5||
59860254|NCT00536380|75984938|FG000|STARTED|Overall Study||106||
59860255|NCT00536380|75984939|FG001|STARTED|Overall Study||104||
59860256|NCT00536380|75984940|FG002|STARTED|Overall Study||104||
59860257|NCT00536380|75984938|FG000|COMPLETED|Overall Study||94||
59860258|NCT00536380|75984939|FG001|COMPLETED|Overall Study||95||
59860259|NCT00536380|75984940|FG002|COMPLETED|Overall Study||94||
59860260|NCT00536380|75984938|FG000|NOT COMPLETED|Overall Study||12||
59860261|NCT00536380|75984939|FG001|NOT COMPLETED|Overall Study||9||
59860262|NCT00536380|75984940|FG002|NOT COMPLETED|Overall Study||10||
59860263|NCT00496834|75984950|FG000|STARTED|Overall Study||101||
59860264|NCT00496834|75984951|FG001|STARTED|Overall Study||100||
59860265|NCT00496834|75984950|FG000|COMPLETED|Overall Study||83||
59860266|NCT00496834|75984951|FG001|COMPLETED|Overall Study||87||
59860267|NCT00496834|75984950|FG000|NOT COMPLETED|Overall Study||18||
59860268|NCT00496834|75984951|FG001|NOT COMPLETED|Overall Study||13||
59860269|NCT05244122|75984959|FG000|STARTED|Overall Study||1121|This is the number of individuals who started the online study|
59860270|NCT05244122|75984959|FG000|Completed a Full Block of Trials|Overall Study|Those 630 participants completed 2988 blocks in aggregate|630||
59860271|NCT05244122|75984959|FG000|COMPLETED|Overall Study||803|This is the number of participants who produced usable data. In an online study, participants often start a study but then decide they are not interested or don't have time. In any event, they do not complete the study.|
59860272|NCT05244122|75984959|FG000|NOT COMPLETED|Overall Study||318||
59860273|NCT00166504|75984980|FG000|STARTED|Overall Study||108||
59860274|NCT00166504|75984981|FG001|STARTED|Overall Study||95||
59860275|NCT00166504|75984980|FG000|COMPLETED|Overall Study||103||
59860276|NCT00166504|75984981|FG001|COMPLETED|Overall Study||91||
59860277|NCT00166504|75984980|FG000|NOT COMPLETED|Overall Study||5||
59860278|NCT00166504|75984981|FG001|NOT COMPLETED|Overall Study||4||
59860279|NCT03137992|75984987|FG000|STARTED|Period 1 (Visit 2)||62|Three of the 377 participants enrolled and randomized did not receive any treatment.|
59860280|NCT03137992|75984988|FG001|STARTED|Period 1 (Visit 2)||63|Three of the 377 participants enrolled and randomized did not receive any treatment.|
59860281|NCT03137992|75984989|FG002|STARTED|Period 1 (Visit 2)||63|Three of the 377 participants enrolled and randomized did not receive any treatment.|
59860282|NCT03137992|75984990|FG003|STARTED|Period 1 (Visit 2)||63|Three of the 377 participants enrolled and randomized did not receive any treatment.|
59860283|NCT03137992|75984991|FG004|STARTED|Period 1 (Visit 2)||62|Three of the 377 participants enrolled and randomized did not receive any treatment.|
59860284|NCT03137992|75984992|FG005|STARTED|Period 1 (Visit 2)||61|Three of the 377 participants enrolled and randomized did not receive any treatment.|
59860285|NCT03137992|75984987|FG000|COMPLETED|Period 1 (Visit 2)||62|One subject randomized to Sequence A received treatment P in period 1 (visit 2)|
59860286|NCT03137992|75984988|FG001|COMPLETED|Period 1 (Visit 2)||63|One subject randomized to Sequence A received treatment P in period 1 (visit 2)|
59860287|NCT03137992|75984989|FG002|COMPLETED|Period 1 (Visit 2)||63|One subject randomized to Sequence A received treatment P in period 1 (visit 2)|
59860288|NCT03137992|75984990|FG003|COMPLETED|Period 1 (Visit 2)||63|One subject randomized to Sequence A received treatment P in period 1 (visit 2)|
59860289|NCT03137992|75984991|FG004|COMPLETED|Period 1 (Visit 2)||62|One subject randomized to Sequence A received treatment P in period 1 (visit 2)|
59860290|NCT03137992|75984992|FG005|COMPLETED|Period 1 (Visit 2)||61|One subject randomized to Sequence A received treatment P in period 1 (visit 2)|
59860291|NCT03137992|75984987|FG000|NOT COMPLETED|Period 1 (Visit 2)||0||
59860292|NCT03137992|75984988|FG001|NOT COMPLETED|Period 1 (Visit 2)||0||
59860293|NCT03137992|75984989|FG002|NOT COMPLETED|Period 1 (Visit 2)||0||
59860294|NCT03137992|75984990|FG003|NOT COMPLETED|Period 1 (Visit 2)||0||
59860295|NCT03137992|75984991|FG004|NOT COMPLETED|Period 1 (Visit 2)||0||
59860296|NCT03137992|75984992|FG005|NOT COMPLETED|Period 1 (Visit 2)||0||
59860297|NCT03137992|75984987|FG000|STARTED|Washout Period 1||62||
59860298|NCT03137992|75984988|FG001|STARTED|Washout Period 1||63||
59860299|NCT03137992|75984989|FG002|STARTED|Washout Period 1||63||
59860300|NCT03137992|75984990|FG003|STARTED|Washout Period 1||63||
59860301|NCT03137992|75984991|FG004|STARTED|Washout Period 1||62||
59860302|NCT03137992|75984992|FG005|STARTED|Washout Period 1||61||
59860303|NCT03137992|75984987|FG000|COMPLETED|Washout Period 1||59||
59860304|NCT03137992|75984988|FG001|COMPLETED|Washout Period 1||59||
59860305|NCT03137992|75984989|FG002|COMPLETED|Washout Period 1||61||
59860306|NCT03137992|75984990|FG003|COMPLETED|Washout Period 1||63||
59860307|NCT03137992|75984991|FG004|COMPLETED|Washout Period 1||60||
59860308|NCT03137992|75984992|FG005|COMPLETED|Washout Period 1||59||
59860309|NCT03137992|75984987|FG000|NOT COMPLETED|Washout Period 1||3||
59860310|NCT03137992|75984988|FG001|NOT COMPLETED|Washout Period 1||4||
59860311|NCT03137992|75984989|FG002|NOT COMPLETED|Washout Period 1||2||
59860312|NCT03137992|75984990|FG003|NOT COMPLETED|Washout Period 1||0||
59860313|NCT03137992|75984991|FG004|NOT COMPLETED|Washout Period 1||2||
59860314|NCT03137992|75984992|FG005|NOT COMPLETED|Washout Period 1||2||
59860315|NCT03137992|75984987|FG000|STARTED|Period 2 (Visit 3)||59||
59860316|NCT03137992|75984988|FG001|STARTED|Period 2 (Visit 3)||59||
59860317|NCT03137992|75984989|FG002|STARTED|Period 2 (Visit 3)||61||
59860318|NCT03137992|75984990|FG003|STARTED|Period 2 (Visit 3)||63||
59860319|NCT03137992|75984991|FG004|STARTED|Period 2 (Visit 3)||60||
59860320|NCT03137992|75984992|FG005|STARTED|Period 2 (Visit 3)||59||
59860321|NCT03137992|75984987|FG000|COMPLETED|Period 2 (Visit 3)||56||
59860322|NCT03137992|75984988|FG001|COMPLETED|Period 2 (Visit 3)||52||
59860323|NCT03137992|75984989|FG002|COMPLETED|Period 2 (Visit 3)||58||
59860324|NCT03137992|75984990|FG003|COMPLETED|Period 2 (Visit 3)||58||
59860325|NCT03137992|75984991|FG004|COMPLETED|Period 2 (Visit 3)||56||
59860326|NCT03137992|75984992|FG005|COMPLETED|Period 2 (Visit 3)||51||
59860327|NCT03137992|75984987|FG000|NOT COMPLETED|Period 2 (Visit 3)||3||
59860328|NCT03137992|75984988|FG001|NOT COMPLETED|Period 2 (Visit 3)||7||
59860329|NCT03137992|75984989|FG002|NOT COMPLETED|Period 2 (Visit 3)||3||
59860330|NCT03137992|75984990|FG003|NOT COMPLETED|Period 2 (Visit 3)||5||
59860331|NCT03137992|75984991|FG004|NOT COMPLETED|Period 2 (Visit 3)||4||
59860332|NCT03137992|75984992|FG005|NOT COMPLETED|Period 2 (Visit 3)||8||
59860333|NCT03137992|75984987|FG000|STARTED|Washout Period 2||56||
59860334|NCT03137992|75984988|FG001|STARTED|Washout Period 2||52||
59860335|NCT03137992|75984989|FG002|STARTED|Washout Period 2||58||
59860336|NCT03137992|75984990|FG003|STARTED|Washout Period 2||58||
59860337|NCT03137992|75984991|FG004|STARTED|Washout Period 2||56||
59860338|NCT03137992|75984992|FG005|STARTED|Washout Period 2||51||
59860339|NCT03137992|75984987|FG000|COMPLETED|Washout Period 2||54||
59860340|NCT03137992|75984988|FG001|COMPLETED|Washout Period 2||50||
59860341|NCT03137992|75984989|FG002|COMPLETED|Washout Period 2||58||
59860342|NCT03137992|75984990|FG003|COMPLETED|Washout Period 2||57||
59860343|NCT03137992|75984991|FG004|COMPLETED|Washout Period 2||53||
59860344|NCT03137992|75984992|FG005|COMPLETED|Washout Period 2||50||
59860345|NCT03137992|75984987|FG000|NOT COMPLETED|Washout Period 2||2||
59860346|NCT03137992|75984988|FG001|NOT COMPLETED|Washout Period 2||2||
59860347|NCT03137992|75984989|FG002|NOT COMPLETED|Washout Period 2||0||
59860348|NCT03137992|75984990|FG003|NOT COMPLETED|Washout Period 2||1||
59860349|NCT03137992|75984991|FG004|NOT COMPLETED|Washout Period 2||3||
59860350|NCT03137992|75984992|FG005|NOT COMPLETED|Washout Period 2||1||
59860351|NCT03137992|75984987|FG000|STARTED|Period 3 (Visit 04)||54||
59860352|NCT03137992|75984988|FG001|STARTED|Period 3 (Visit 04)||50||
59860353|NCT03137992|75984989|FG002|STARTED|Period 3 (Visit 04)||58||
59860354|NCT03137992|75984990|FG003|STARTED|Period 3 (Visit 04)||57||
59860355|NCT03137992|75984991|FG004|STARTED|Period 3 (Visit 04)||53||
59860356|NCT03137992|75984992|FG005|STARTED|Period 3 (Visit 04)||50||
59860357|NCT03137992|75984987|FG000|COMPLETED|Period 3 (Visit 04)||48||
59860358|NCT03137992|75984988|FG001|COMPLETED|Period 3 (Visit 04)||48||
59860359|NCT03137992|75984989|FG002|COMPLETED|Period 3 (Visit 04)||55||
59860360|NCT03137992|75984990|FG003|COMPLETED|Period 3 (Visit 04)||57||
59860361|NCT03137992|75984991|FG004|COMPLETED|Period 3 (Visit 04)||50||
59860362|NCT03137992|75984992|FG005|COMPLETED|Period 3 (Visit 04)||47||
59860363|NCT03137992|75984987|FG000|NOT COMPLETED|Period 3 (Visit 04)||6||
59860364|NCT03137992|75984988|FG001|NOT COMPLETED|Period 3 (Visit 04)||2||
59860365|NCT03137992|75984989|FG002|NOT COMPLETED|Period 3 (Visit 04)||3||
59860366|NCT03137992|75984990|FG003|NOT COMPLETED|Period 3 (Visit 04)||0||
59860367|NCT03137992|75984991|FG004|NOT COMPLETED|Period 3 (Visit 04)||3||
59860368|NCT03137992|75984992|FG005|NOT COMPLETED|Period 3 (Visit 04)||3||
59860369|NCT03137992|75984987|FG000|STARTED|Part 2 (Open-label Extension)||22|Part 2 of the study enrolled a subset of 125 (from select investigational centers) participants who had successfully completed Part 1 of the study and who met the continuation criteria.|
59860370|NCT03137992|75984988|FG001|STARTED|Part 2 (Open-label Extension)||17|Part 2 of the study enrolled a subset of 125 (from select investigational centers) participants who had successfully completed Part 1 of the study and who met the continuation criteria.|
60128535|NCT01464827|76250690|FG006|Treated|Overall Study||40||
60128536|NCT01464827|76250691|FG007|Treated|Overall Study||40||
60128537|NCT01464827|76250692|FG008|Treated|Overall Study||40||
60128538|NCT01464827|76250693|FG009|Treated|Overall Study||45||
60128539|NCT01464827|76250694|FG010|Treated|Overall Study||23||
60128540|NCT01464827|76250695|FG011|Treated|Overall Study||22||
60128541|NCT01464827|76250696|FG012|Treated|Overall Study||23||
60128542|NCT01464827|76250697|FG013|Treated|Overall Study||20||
60128543|NCT01464827|76250684|FG000|COMPLETED|Overall Study||77||
60128544|NCT01464827|76250685|FG001|COMPLETED|Overall Study||36||
60128545|NCT01464827|76250686|FG002|COMPLETED|Overall Study||39||
60128546|NCT01464827|76250687|FG003|COMPLETED|Overall Study||36||
60128547|NCT01464827|76250688|FG004|COMPLETED|Overall Study||72||
60128548|NCT01464827|76250689|FG005|COMPLETED|Overall Study||38||
60128549|NCT01464827|76250690|FG006|COMPLETED|Overall Study||37||
60128550|NCT01464827|76250691|FG007|COMPLETED|Overall Study||37||
60128551|NCT01464827|76250692|FG008|COMPLETED|Overall Study||37||
60128552|NCT01464827|76250693|FG009|COMPLETED|Overall Study||44||
60128553|NCT01464827|76250694|FG010|COMPLETED|Overall Study||21||
60128554|NCT01464827|76250695|FG011|COMPLETED|Overall Study||21||
60128555|NCT01464827|76250696|FG012|COMPLETED|Overall Study||21||
60128556|NCT01464827|76250697|FG013|COMPLETED|Overall Study||19||
60128557|NCT01464827|76250684|FG000|NOT COMPLETED|Overall Study||3||
60128558|NCT01464827|76250685|FG001|NOT COMPLETED|Overall Study||7||
60128559|NCT01464827|76250686|FG002|NOT COMPLETED|Overall Study||0||
60128560|NCT01464827|76250687|FG003|NOT COMPLETED|Overall Study||4||
60128561|NCT01464827|76250688|FG004|NOT COMPLETED|Overall Study||8||
60128562|NCT01464827|76250689|FG005|NOT COMPLETED|Overall Study||1||
60128563|NCT01464827|76250690|FG006|NOT COMPLETED|Overall Study||4||
60128564|NCT01464827|76250691|FG007|NOT COMPLETED|Overall Study||3||
60128565|NCT01464827|76250692|FG008|NOT COMPLETED|Overall Study||3||
60128566|NCT01464827|76250693|FG009|NOT COMPLETED|Overall Study||3||
60128567|NCT01464827|76250694|FG010|NOT COMPLETED|Overall Study||2||
60128568|NCT01464827|76250695|FG011|NOT COMPLETED|Overall Study||2||
59728431|NCT00812929|75847155|FG006|STARTED|Washout Period 3 (7 Days)||5||
59728432|NCT00812929|75847156|FG007|STARTED|Washout Period 3 (7 Days)||5||
59728433|NCT00812929|75847157|FG008|STARTED|Washout Period 3 (7 Days)||4||
59728434|NCT00812929|75847158|FG009|STARTED|Washout Period 3 (7 Days)||4||
59728435|NCT00812929|75847149|FG000|COMPLETED|Washout Period 3 (7 Days)||5||
59728436|NCT00812929|75847150|FG001|COMPLETED|Washout Period 3 (7 Days)||4||
59728437|NCT00812929|75847151|FG002|COMPLETED|Washout Period 3 (7 Days)||4||
59728438|NCT00812929|75847152|FG003|COMPLETED|Washout Period 3 (7 Days)||4||
59728439|NCT00812929|75847153|FG004|COMPLETED|Washout Period 3 (7 Days)||5||
59728440|NCT00812929|75847154|FG005|COMPLETED|Washout Period 3 (7 Days)||4||
59728441|NCT00812929|75847155|FG006|COMPLETED|Washout Period 3 (7 Days)||5||
59728442|NCT00812929|75847156|FG007|COMPLETED|Washout Period 3 (7 Days)||5||
59728443|NCT00812929|75847157|FG008|COMPLETED|Washout Period 3 (7 Days)||4||
59728444|NCT00812929|75847158|FG009|COMPLETED|Washout Period 3 (7 Days)||4||
59728445|NCT00812929|75847149|FG000|NOT COMPLETED|Washout Period 3 (7 Days)||0||
59728446|NCT00812929|75847150|FG001|NOT COMPLETED|Washout Period 3 (7 Days)||0||
60128569|NCT01464827|76250696|FG012|NOT COMPLETED|Overall Study||2||
60128570|NCT01464827|76250697|FG013|NOT COMPLETED|Overall Study||3||
60128571|NCT01463111|76250738|FG000|STARTED|Overall Study||26||
60128572|NCT01463111|76250738|FG000|COMPLETED|Overall Study||17||
60128573|NCT01463111|76250738|FG000|NOT COMPLETED|Overall Study||9||
60128574|NCT01463033|76250744|FG000|STARTED|Overall Study||66||
60128575|NCT01463033|76250745|FG001|STARTED|Overall Study||60||
60128576|NCT01463033|76250744|FG000|COMPLETED|Overall Study|3 deaths, 4 lost to follow up|59||
60128577|NCT01463033|76250745|FG001|COMPLETED|Overall Study|2 deaths, 4 lost to follow up|54||
60128578|NCT01463033|76250744|FG000|NOT COMPLETED|Overall Study||7||
60128579|NCT01463033|76250745|FG001|NOT COMPLETED|Overall Study||6||
60128580|NCT01461707|76250754|FG000|STARTED|Overall Study||15||
60128581|NCT01461707|76250755|FG001|STARTED|Overall Study||15||
60128582|NCT01461707|76250754|FG000|COMPLETED|Overall Study||14||
60128583|NCT01461707|76250755|FG001|COMPLETED|Overall Study||15||
60128584|NCT01461707|76250754|FG000|NOT COMPLETED|Overall Study||1||
60128585|NCT01461707|76250755|FG001|NOT COMPLETED|Overall Study||0||
60128586|NCT01461551|76250764|FG000|STARTED|Overall Study||35||
60128587|NCT01461551|76250765|FG001|STARTED|Overall Study||35||
60128588|NCT01461551|76250766|FG002|STARTED|Overall Study||35||
60128589|NCT01461551|76250764|FG000|COMPLETED|Overall Study||33||
60128590|NCT01461551|76250765|FG001|COMPLETED|Overall Study||34||
60128591|NCT01461551|76250766|FG002|COMPLETED|Overall Study||33||
60128592|NCT01461551|76250764|FG000|NOT COMPLETED|Overall Study||2||
60128593|NCT01461551|76250765|FG001|NOT COMPLETED|Overall Study||1||
60128594|NCT01461551|76250766|FG002|NOT COMPLETED|Overall Study||2||
60128595|NCT01461005|76250774|FG000|STARTED|Overall Study||1||
60128596|NCT01461005|76250774|FG000|COMPLETED|Overall Study||0||
60128597|NCT01461005|76250774|FG000|NOT COMPLETED|Overall Study||1||
60128598|NCT01460381|76250781|FG000|STARTED|Period 1 (Days 1-7)||7||
59728447|NCT00812929|75847151|FG002|NOT COMPLETED|Washout Period 3 (7 Days)||0||
59728448|NCT00812929|75847152|FG003|NOT COMPLETED|Washout Period 3 (7 Days)||0||
60128599|NCT01460381|76250782|FG001|STARTED|Period 1 (Days 1-7)||11||
60128600|NCT01460381|76250781|FG000|Received at Least 1 Dose of Study Drug|Period 1 (Days 1-7)||7||
60128601|NCT01460381|76250782|FG001|Received at Least 1 Dose of Study Drug|Period 1 (Days 1-7)||11||
60128602|NCT01460381|76250781|FG000|COMPLETED|Period 1 (Days 1-7)||7||
60128603|NCT01460381|76250782|FG001|COMPLETED|Period 1 (Days 1-7)||11||
60128604|NCT01460381|76250781|FG000|NOT COMPLETED|Period 1 (Days 1-7)||0||
60128605|NCT01460381|76250782|FG001|NOT COMPLETED|Period 1 (Days 1-7)||0||
60128606|NCT01460381|76250781|FG000|STARTED|Period 2 (Days 8-15)||7||
60128607|NCT01460381|76250782|FG001|STARTED|Period 2 (Days 8-15)|CYP2C19 extensive metabolizers did not participate in Period 2.|0||
60128608|NCT01460381|76250781|FG000|COMPLETED|Period 2 (Days 8-15)|One participant was lost to follow-up after completing Period 2 and did not complete the study.|6||
60128609|NCT01460381|76250782|FG001|COMPLETED|Period 2 (Days 8-15)|CYP2C19 extensive metabolizers did not participate in Period 2|0||
60128610|NCT01460381|76250781|FG000|NOT COMPLETED|Period 2 (Days 8-15)||1||
60128611|NCT01460381|76250782|FG001|NOT COMPLETED|Period 2 (Days 8-15)||0||
60128612|NCT00546897|76250792|FG000|STARTED|Overall Study||15||
60128613|NCT00546897|76250793|FG001|STARTED|Overall Study||33||
60128614|NCT00546897|76250792|FG000|COMPLETED|Overall Study||15||
60128615|NCT00546897|76250793|FG001|COMPLETED|Overall Study||33||
60128616|NCT00546897|76250792|FG000|NOT COMPLETED|Overall Study||0||
60128617|NCT00546897|76250793|FG001|NOT COMPLETED|Overall Study||0||
60128618|NCT00474123|76250801|FG000|STARTED|Overall Study||38||
60128619|NCT00474123|76250802|FG001|STARTED|Overall Study||40||
60128620|NCT00474123|76250801|FG000|COMPLETED|Overall Study||38||
60128621|NCT00474123|76250802|FG001|COMPLETED|Overall Study||40||
60128622|NCT00474123|76250801|FG000|NOT COMPLETED|Overall Study||0||
60128623|NCT00474123|76250802|FG001|NOT COMPLETED|Overall Study||0||
60128624|NCT00474201|76250808|FG000|STARTED|Overall Study||15||
60128625|NCT00474201|76250808|FG000|COMPLETED|Overall Study||15||
60128626|NCT00474201|76250808|FG000|NOT COMPLETED|Overall Study||0||
60128627|NCT00548691|76250815|FG000|STARTED|Overall Study||258||
60128628|NCT00548691|76250816|FG001|STARTED|Overall Study||259||
60128629|NCT00548691|76250815|FG000|COMPLETED|Overall Study||251||
60128630|NCT00548691|76250816|FG001|COMPLETED|Overall Study||250||
60128631|NCT00548691|76250815|FG000|NOT COMPLETED|Overall Study||7||
60128632|NCT00548691|76250816|FG001|NOT COMPLETED|Overall Study||9||
60128633|NCT03431259|76250824|FG000|STARTED|Overall Study||115||
60128634|NCT03431259|76250825|FG001|STARTED|Overall Study||117||
60128635|NCT03431259|76250824|FG000|COMPLETED|Overall Study||113||
60128636|NCT03431259|76250825|FG001|COMPLETED|Overall Study||116||
60128637|NCT03431259|76250824|FG000|NOT COMPLETED|Overall Study||2||
60128638|NCT03431259|76250825|FG001|NOT COMPLETED|Overall Study||1||
60128639|NCT00549393|76250833|FG000|STARTED|Period 1 (6 Months)|intention to treat (ITT)|1319||
60128640|NCT00549393|76250834|FG001|STARTED|Period 1 (6 Months)|ITT|1199||
60128641|NCT00549393|76250833|FG000|Per Protocol|Period 1 (6 Months)||880||
60128642|NCT00549393|76250834|FG001|Per Protocol|Period 1 (6 Months)||1199||
60128643|NCT00549393|76250833|FG000|COMPLETED|Period 1 (6 Months)||1319||
60128644|NCT00549393|76250834|FG001|COMPLETED|Period 1 (6 Months)||1199||
60128645|NCT00549393|76250833|FG000|NOT COMPLETED|Period 1 (6 Months)||0||
60128646|NCT00549393|76250834|FG001|NOT COMPLETED|Period 1 (6 Months)||0||
60128647|NCT00549393|76250833|FG000|STARTED|Period 2 Washout (2 Weeks)||0||
60128648|NCT00549393|76250834|FG001|STARTED|Period 2 Washout (2 Weeks)||0||
60128649|NCT00549393|76250833|FG000|COMPLETED|Period 2 Washout (2 Weeks)||0||
60128650|NCT00549393|76250834|FG001|COMPLETED|Period 2 Washout (2 Weeks)||0||
60128651|NCT00549393|76250833|FG000|NOT COMPLETED|Period 2 Washout (2 Weeks)||0||
60128652|NCT00549393|76250834|FG001|NOT COMPLETED|Period 2 Washout (2 Weeks)||0||
60128653|NCT00549393|76250833|FG000|STARTED|Period 3 (6 Months)|number not equal to period 1 due to unit cross over design|1103||
60128654|NCT00549393|76250834|FG001|STARTED|Period 3 (6 Months)|number not equal to period 1 due to unit cross over design|1326||
60128655|NCT00549393|76250833|FG000|Per Protocol|Period 3 (6 Months)||667||
60128656|NCT00549393|76250834|FG001|Per Protocol|Period 3 (6 Months)||1326||
60128657|NCT00549393|76250833|FG000|COMPLETED|Period 3 (6 Months)||1103||
60128658|NCT00549393|76250834|FG001|COMPLETED|Period 3 (6 Months)||1326||
60128659|NCT00549393|76250833|FG000|NOT COMPLETED|Period 3 (6 Months)||0||
60128660|NCT00549393|76250834|FG001|NOT COMPLETED|Period 3 (6 Months)||0||
60128661|NCT00549783|76250844|FG000|STARTED|Overall Study||139||
60128662|NCT00549783|76250845|FG001|STARTED|Overall Study||135||
60128663|NCT00549783|76250844|FG000|COMPLETED|Overall Study||131||
60128664|NCT00549783|76250845|FG001|COMPLETED|Overall Study||122||
60128665|NCT00549783|76250844|FG000|NOT COMPLETED|Overall Study||8||
60128666|NCT00549783|76250845|FG001|NOT COMPLETED|Overall Study||13||
60128667|NCT00475215|76250853|FG000|STARTED|Overall Study||44|Randomized|
60128668|NCT00475215|76250854|FG001|STARTED|Overall Study||42|Randomized|
60128669|NCT00475215|76250853|FG000|Treated|Overall Study||39||
60128670|NCT00475215|76250854|FG001|Treated|Overall Study||38||
60128671|NCT00475215|76250853|FG000|COMPLETED|Overall Study||39||
60128672|NCT00475215|76250854|FG001|COMPLETED|Overall Study||38||
60128673|NCT00475215|76250853|FG000|NOT COMPLETED|Overall Study||5||
60128674|NCT00475215|76250854|FG001|NOT COMPLETED|Overall Study||4||
60128675|NCT00477087|76250860|FG000|STARTED|Overall Study||10||
60128676|NCT00477087|76250860|FG000|COMPLETED|Overall Study||10||
60128677|NCT00477087|76250860|FG000|NOT COMPLETED|Overall Study||0||
60128678|NCT01473589|76250866|FG000|STARTED|Overall Study||60||
60128679|NCT01473589|76250867|FG001|STARTED|Overall Study||62||
60128680|NCT01473589|76250866|FG000|Received at Least 1 Dose of Study Drug|Overall Study|Randomized participants who received at least 1 dose of study drug.|60||
60128681|NCT01473589|76250867|FG001|Received at Least 1 Dose of Study Drug|Overall Study|Randomized participants who received at least 1 dose of study drug.|61||
60128682|NCT01473589|76250866|FG000|Completed 6 Months|Overall Study||51||
60128683|NCT01473589|76250867|FG001|Completed 6 Months|Overall Study||54||
60128684|NCT01473589|76250866|FG000|Completed 12 Months|Overall Study||49||
60128685|NCT01473589|76250867|FG001|Completed 12 Months|Overall Study||48||
60128686|NCT01473589|76250866|FG000|COMPLETED|Overall Study||49||
60128687|NCT01473589|76250867|FG001|COMPLETED|Overall Study||46||
60128688|NCT01473589|76250866|FG000|NOT COMPLETED|Overall Study||11||
60128689|NCT01473589|76250867|FG001|NOT COMPLETED|Overall Study||16||
60128690|NCT00478335|76250877|FG000|STARTED|Period 1 (4 Days)||2||
60128691|NCT00478335|76250878|FG001|STARTED|Period 1 (4 Days)||2||
60128692|NCT00478335|76250877|FG000|COMPLETED|Period 1 (4 Days)||2||
60128693|NCT00478335|76250878|FG001|COMPLETED|Period 1 (4 Days)||2||
60128694|NCT00478335|76250877|FG000|NOT COMPLETED|Period 1 (4 Days)||0||
60128695|NCT00478335|76250878|FG001|NOT COMPLETED|Period 1 (4 Days)||0||
60128696|NCT00478335|76250877|FG000|STARTED|Period 2 (4 Days)||2||
60128697|NCT00478335|76250878|FG001|STARTED|Period 2 (4 Days)||2||
60128698|NCT00478335|76250877|FG000|COMPLETED|Period 2 (4 Days)||2||
60128699|NCT00478335|76250878|FG001|COMPLETED|Period 2 (4 Days)||2||
60128700|NCT00478335|76250877|FG000|NOT COMPLETED|Period 2 (4 Days)||0||
60128701|NCT00478335|76250878|FG001|NOT COMPLETED|Period 2 (4 Days)||0||
60128702|NCT01500187|76250886|FG000|STARTED|Overall Study||23||106
60128703|NCT01500187|76250887|FG001|STARTED|Overall Study||15||74
60128704|NCT01500187|76250886|FG000|COMPLETED|Overall Study||17||76
60128705|NCT01500187|76250887|FG001|COMPLETED|Overall Study||15||72
60128706|NCT01500187|76250886|FG000|NOT COMPLETED|Overall Study||6||30
60128707|NCT01500187|76250887|FG001|NOT COMPLETED|Overall Study||0||2
60128708|NCT00478569|76250893|FG000|STARTED|Overall Study||1170||
60128709|NCT00478569|76250893|FG000|COMPLETED|Overall Study||761||
60128710|NCT00478569|76250893|FG000|NOT COMPLETED|Overall Study||409||
60128711|NCT01500031|76250905|FG000|STARTED|Overall Study||92||
60128712|NCT01500031|76250905|FG000|COMPLETED|Overall Study||87||
60128713|NCT01500031|76250905|FG000|NOT COMPLETED|Overall Study||5||
60128714|NCT00479037|76250911|FG000|STARTED|Overall Study||41||
60128715|NCT00479037|76250912|FG001|STARTED|Overall Study||40||
60128716|NCT00479037|76250911|FG000|COMPLETED|Overall Study||38||
60128717|NCT00479037|76250912|FG001|COMPLETED|Overall Study||34||
60128718|NCT00479037|76250911|FG000|NOT COMPLETED|Overall Study||3||
60128719|NCT00479037|76250912|FG001|NOT COMPLETED|Overall Study||6||
60128720|NCT01473355|76250918|FG000|STARTED|Overall Study||45||75
60128721|NCT01473355|76250918|FG000|COMPLETED|Overall Study||39||65
60128722|NCT01473355|76250918|FG000|NOT COMPLETED|Overall Study||6||10
60128723|NCT00479115|76250922|FG000|STARTED|Overall Study||1||
60128724|NCT00479115|76250922|FG000|COMPLETED|Overall Study||1||
60128725|NCT00479115|76250922|FG000|NOT COMPLETED|Overall Study||0||
60128726|NCT01472965|76250928|FG000|STARTED|Overall Study||49||
60128727|NCT01472965|76250929|FG001|STARTED|Overall Study||46||
60128728|NCT01472965|76250928|FG000|COMPLETED|Overall Study||48||
60128729|NCT01472965|76250929|FG001|COMPLETED|Overall Study||46||
60128730|NCT01472965|76250928|FG000|NOT COMPLETED|Overall Study||1||
60128731|NCT01472965|76250929|FG001|NOT COMPLETED|Overall Study||0||
60128732|NCT00480987|76250935|FG000|STARTED|Overall Study||27||
60128733|NCT00480987|76250935|FG000|COMPLETED|Overall Study||27||
60128734|NCT00480987|76250935|FG000|NOT COMPLETED|Overall Study||0||
60128735|NCT01457053|76250939|FG000|STARTED|Overall Study||2||
60128736|NCT01457053|76250940|FG001|STARTED|Overall Study||2||
60128737|NCT01457053|76250939|FG000|COMPLETED|Overall Study||1||
60128738|NCT01457053|76250940|FG001|COMPLETED|Overall Study||1||
59596266|NCT03271424|75705426|FG001|STARTED|April-May 2016||0||
59596267|NCT03271424|75705427|FG002|STARTED|April-May 2016||40||
59596268|NCT03271424|75705425|FG000|COMPLETED|April-May 2016||0||
60128739|NCT01457053|76250939|FG000|NOT COMPLETED|Overall Study||1||
60128740|NCT01457053|76250940|FG001|NOT COMPLETED|Overall Study||1||
60128741|NCT00481845|76250948|FG000|STARTED|Overall Study||1||
60128742|NCT00481845|76250949|FG001|STARTED|Overall Study||0||
60128743|NCT00481845|76250948|FG000|COMPLETED|Overall Study||1||
60128744|NCT00481845|76250949|FG001|COMPLETED|Overall Study||0||
60128745|NCT00481845|76250948|FG000|NOT COMPLETED|Overall Study||0||
60128746|NCT00481845|76250949|FG001|NOT COMPLETED|Overall Study||0||
60128747|NCT01472341|76250955|FG000|STARTED|Overall Study||507||
60128748|NCT01472341|76250955|FG000|COMPLETED|Overall Study||235||
60128749|NCT01472341|76250955|FG000|NOT COMPLETED|Overall Study||272||
60128750|NCT01472185|76250961|FG000|STARTED|Overall Study||232||
60128751|NCT01472185|76250962|FG001|STARTED|Overall Study||233||
60128752|NCT01472185|76250961|FG000|COMPLETED|Overall Study||198||
60128753|NCT01472185|76250962|FG001|COMPLETED|Overall Study||199||
60128754|NCT01472185|76250961|FG000|NOT COMPLETED|Overall Study||34||
60128755|NCT01472185|76250962|FG001|NOT COMPLETED|Overall Study||34||
60128756|NCT00482547|76250970|FG000|STARTED|Overall Study|599 subjects were enrolled in the silver-coated catheter group.|599||
60128757|NCT00482547|76250971|FG001|STARTED|Overall Study|589 subjects were enrolled in the silicone-coated catheter group.|589||
60128758|NCT00482547|76250970|FG000|Successful Catheterization|Overall Study|Out of the 599 AgCS subjects 565 (94.3%) had a successful catheterization.|565||
60128759|NCT00482547|76250971|FG001|Successful Catheterization|Overall Study|Out of the 589 SiCS catheter subjects 568 (96.4%) had a successful catheterization.|568||
60128760|NCT00482547|76250970|FG000|48 Hour Evaluation|Overall Study|426 went on to be included in the Silver-coated 48 hour efficacy evaluable population.|426||
60128761|NCT00482547|76250971|FG001|48 Hour Evaluation|Overall Study|428 went on to be included in the Silicone-coated 48 hour efficacy evaluable population.|428||
60128762|NCT00482547|76250970|FG000|COMPLETED|Overall Study||426||
60128763|NCT00482547|76250971|FG001|COMPLETED|Overall Study||428||
60128764|NCT00482547|76250970|FG000|NOT COMPLETED|Overall Study||173||
60128765|NCT00482547|76250971|FG001|NOT COMPLETED|Overall Study||161||
60128766|NCT00482625|76250977|FG000|STARTED|Overall Study||6||
60128767|NCT00482625|76250977|FG000|COMPLETED|Overall Study||6||
60128768|NCT00482625|76250977|FG000|NOT COMPLETED|Overall Study||0||
60128769|NCT01456897|76250983|FG000|STARTED|Overall Study||184||
60128770|NCT01456897|76250984|FG001|STARTED|Overall Study||98||
60128771|NCT01456897|76250983|FG000|COMPLETED|Overall Study||109||
60128772|NCT01456897|76250984|FG001|COMPLETED|Overall Study||41||
60128773|NCT01456897|76250983|FG000|NOT COMPLETED|Overall Study||75||
60128774|NCT01456897|76250984|FG001|NOT COMPLETED|Overall Study||57||
60128775|NCT00553839|76250990|FG000|STARTED|Overall Study||21||
60128776|NCT00553839|76250990|FG000|COMPLETED|Overall Study||21||
60128777|NCT00553839|76250990|FG000|NOT COMPLETED|Overall Study||0||
60128778|NCT01456195|76250997|FG000|STARTED|Overall Study||143||
60128779|NCT01456195|76250998|FG001|STARTED|Overall Study||137||
60128780|NCT01456195|76250999|FG002|STARTED|Overall Study||141||
60128781|NCT01456195|76250997|FG000|COMPLETED|Overall Study||132||
60128782|NCT01456195|76250998|FG001|COMPLETED|Overall Study||127||
60128783|NCT01456195|76250999|FG002|COMPLETED|Overall Study||127||
60128784|NCT01456195|76250997|FG000|NOT COMPLETED|Overall Study||11||
60128785|NCT01456195|76250998|FG001|NOT COMPLETED|Overall Study||10||
60128786|NCT01456195|76250999|FG002|NOT COMPLETED|Overall Study||14||
60128787|NCT00554463|76251007|FG000|STARTED|Overall Study||5||
60128788|NCT00554463|76251007|FG000|COMPLETED|Overall Study||5|Subjects contributing any data to results are considered to have completed the study|
60128789|NCT00554463|76251007|FG000|NOT COMPLETED|Overall Study||0||
60128790|NCT00554853|76251013|FG000|STARTED|First Arm of Study||72||
60128791|NCT00554853|76251014|FG001|STARTED|First Arm of Study||71||
60128792|NCT00554853|76251013|FG000|COMPLETED|First Arm of Study||56||
60128793|NCT00554853|76251014|FG001|COMPLETED|First Arm of Study||64||
59596269|NCT03271424|75705426|FG001|COMPLETED|April-May 2016||0||
59596270|NCT03271424|75705427|FG002|COMPLETED|April-May 2016||40||
59596271|NCT03271424|75705425|FG000|NOT COMPLETED|April-May 2016||0||
59596272|NCT03271424|75705426|FG001|NOT COMPLETED|April-May 2016||0||
59596273|NCT03271424|75705427|FG002|NOT COMPLETED|April-May 2016||0||
59596274|NCT03483896|75705439|FG000|STARTED|Overall Study||33||
59596275|NCT03483896|75705440|FG001|STARTED|Overall Study||50||
59596276|NCT03483896|75705439|FG000|COMPLETED|Overall Study||31||
59596277|NCT03483896|75705440|FG001|COMPLETED|Overall Study||46||
59596278|NCT03483896|75705439|FG000|NOT COMPLETED|Overall Study||2||
59596279|NCT03483896|75705440|FG001|NOT COMPLETED|Overall Study||4||
59596280|NCT02156466|75705451|FG000|STARTED|Overall Study||8||
59596281|NCT02156466|75705452|FG001|STARTED|Overall Study||8||
59596282|NCT02156466|75705453|FG002|STARTED|Overall Study||8||
59596283|NCT02156466|75705454|FG003|STARTED|Overall Study||9||
59596284|NCT02156466|75705455|FG004|STARTED|Overall Study||8||
60128794|NCT00554853|76251013|FG000|NOT COMPLETED|First Arm of Study||16||
60128795|NCT00554853|76251014|FG001|NOT COMPLETED|First Arm of Study||7||
60128796|NCT00554853|76251013|FG000|STARTED|Washout Period (2 Weeks)||56||
60128797|NCT00554853|76251014|FG001|STARTED|Washout Period (2 Weeks)||64||
60128798|NCT00554853|76251013|FG000|COMPLETED|Washout Period (2 Weeks)||56||
60128799|NCT00554853|76251014|FG001|COMPLETED|Washout Period (2 Weeks)||57||
60128800|NCT00554853|76251013|FG000|NOT COMPLETED|Washout Period (2 Weeks)||0||
60128801|NCT00554853|76251014|FG001|NOT COMPLETED|Washout Period (2 Weeks)||7||
60128802|NCT00554853|76251013|FG000|STARTED|Crossover Arm (3 Months)||56||
60128803|NCT00554853|76251014|FG001|STARTED|Crossover Arm (3 Months)||57||
60128804|NCT00554853|76251013|FG000|COMPLETED|Crossover Arm (3 Months)||53||
60128805|NCT00554853|76251014|FG001|COMPLETED|Crossover Arm (3 Months)||55||
60128806|NCT00554853|76251013|FG000|NOT COMPLETED|Crossover Arm (3 Months)||3||
59596285|NCT02156466|75705451|FG000|COMPLETED|Overall Study||8||
59596286|NCT02156466|75705452|FG001|COMPLETED|Overall Study||8||
59596287|NCT02156466|75705453|FG002|COMPLETED|Overall Study||7||
59596288|NCT02156466|75705454|FG003|COMPLETED|Overall Study||7||
59596289|NCT02156466|75705455|FG004|COMPLETED|Overall Study||8||
59596290|NCT02156466|75705451|FG000|NOT COMPLETED|Overall Study||0||
60128807|NCT00554853|76251014|FG001|NOT COMPLETED|Crossover Arm (3 Months)||2||
60128808|NCT00556491|76251028|FG000|STARTED|Overall Study|January 2008|20||
60128809|NCT00556491|76251029|FG001|STARTED|Overall Study||20||
60128810|NCT00556491|76251028|FG000|COMPLETED|Overall Study||19||
60128811|NCT00556491|76251029|FG001|COMPLETED|Overall Study||19||
60128812|NCT00556491|76251028|FG000|NOT COMPLETED|Overall Study||1||
60128813|NCT00556491|76251029|FG001|NOT COMPLETED|Overall Study||1||
60128814|NCT00485433|76251049|FG000|STARTED|Overall Study||24||
60128815|NCT00485433|76251050|FG001|STARTED|Overall Study||25||
60128816|NCT00485433|76251051|FG002|STARTED|Overall Study||24||
60128817|NCT00485433|76251052|FG003|STARTED|Overall Study||25||
60128818|NCT00485433|76251049|FG000|COMPLETED|Overall Study||24||
60128819|NCT00485433|76251050|FG001|COMPLETED|Overall Study||25||
60128820|NCT00485433|76251051|FG002|COMPLETED|Overall Study||24||
60128821|NCT00485433|76251052|FG003|COMPLETED|Overall Study||25||
60128822|NCT00485433|76251049|FG000|NOT COMPLETED|Overall Study||0||
60128823|NCT00485433|76251050|FG001|NOT COMPLETED|Overall Study||0||
60128824|NCT00485433|76251051|FG002|NOT COMPLETED|Overall Study||0||
60128825|NCT00485433|76251052|FG003|NOT COMPLETED|Overall Study||0||
60128826|NCT01456039|76251063|FG000|STARTED|Phase 1 (First Step)||3||
59596291|NCT02156466|75705452|FG001|NOT COMPLETED|Overall Study||0||
59596292|NCT02156466|75705453|FG002|NOT COMPLETED|Overall Study||1||
59596293|NCT02156466|75705454|FG003|NOT COMPLETED|Overall Study||2||
60128827|NCT01456039|76251064|FG001|STARTED|Phase 1 (First Step)||8||
60128828|NCT01456039|76251065|FG002|STARTED|Phase 1 (First Step)||0||
60128829|NCT01456039|76251063|FG000|COMPLETED|Phase 1 (First Step)|Completed = on treatment|1||
60128830|NCT01456039|76251064|FG001|COMPLETED|Phase 1 (First Step)|Completed = on treatment|1||
60128831|NCT01456039|76251065|FG002|COMPLETED|Phase 1 (First Step)||0||
60128832|NCT01456039|76251063|FG000|NOT COMPLETED|Phase 1 (First Step)||2||
60128833|NCT01456039|76251064|FG001|NOT COMPLETED|Phase 1 (First Step)||7||
60128834|NCT01456039|76251065|FG002|NOT COMPLETED|Phase 1 (First Step)||0||
60128835|NCT01456039|76251063|FG000|STARTED|Phase 2 (Second Step)||0||
60128836|NCT01456039|76251064|FG001|STARTED|Phase 2 (Second Step)||0||
60128837|NCT01456039|76251065|FG002|STARTED|Phase 2 (Second Step)||40||
60128838|NCT01456039|76251063|FG000|COMPLETED|Phase 2 (Second Step)||0||
60128839|NCT01456039|76251064|FG001|COMPLETED|Phase 2 (Second Step)||0||
60128840|NCT01456039|76251065|FG002|COMPLETED|Phase 2 (Second Step)||7||
60128841|NCT01456039|76251063|FG000|NOT COMPLETED|Phase 2 (Second Step)||0||
60128842|NCT01456039|76251064|FG001|NOT COMPLETED|Phase 2 (Second Step)||0||
60128843|NCT01456039|76251065|FG002|NOT COMPLETED|Phase 2 (Second Step)||33||
60128844|NCT01455415|76251083|FG000|STARTED|Period 1|Started=Treated|154||
60128845|NCT01455415|76251084|FG001|STARTED|Period 1|Started=Treated|147||
60128846|NCT01455415|76251083|FG000|COMPLETED|Period 1||135||
60128847|NCT01455415|76251084|FG001|COMPLETED|Period 1||123||
60128848|NCT01455415|76251083|FG000|NOT COMPLETED|Period 1||19||
60128849|NCT01455415|76251084|FG001|NOT COMPLETED|Period 1||24||
59596294|NCT02156466|75705455|FG004|NOT COMPLETED|Overall Study||0||
59596295|NCT03353246|75705476|FG000|STARTED|Overall Study||500||
59596296|NCT03353246|75705476|FG000|COMPLETED|Overall Study||500||
59596297|NCT03353246|75705476|FG000|NOT COMPLETED|Overall Study||0||
59596298|NCT03274856|75705482|FG000|STARTED|Overall Study||10||
59596299|NCT03274856|75705483|FG001|STARTED|Overall Study||9||
59596300|NCT03274856|75705482|FG000|COMPLETED|Overall Study||10||
59596301|NCT03274856|75705483|FG001|COMPLETED|Overall Study||9||
60128850|NCT01455415|76251083|FG000|STARTED|Washout||135||
60128851|NCT01455415|76251084|FG001|STARTED|Washout||123||
60128852|NCT01455415|76251083|FG000|COMPLETED|Washout||127||
60128853|NCT01455415|76251084|FG001|COMPLETED|Washout||116||
60128854|NCT01455415|76251083|FG000|NOT COMPLETED|Washout||8||
60128855|NCT01455415|76251084|FG001|NOT COMPLETED|Washout||7||
60128856|NCT01455415|76251083|FG000|STARTED|Period 2||127||
60128857|NCT01455415|76251084|FG001|STARTED|Period 2||116||
60128858|NCT01455415|76251083|FG000|COMPLETED|Period 2||114||
60128859|NCT01455415|76251084|FG001|COMPLETED|Period 2||106||
60128860|NCT01455415|76251083|FG000|NOT COMPLETED|Period 2||13||
60128861|NCT01455415|76251084|FG001|NOT COMPLETED|Period 2||10||
60128862|NCT01455415|76251083|FG000|STARTED|Follow-up||114||
60128863|NCT01455415|76251084|FG001|STARTED|Follow-up||106||
60128864|NCT01455415|76251083|FG000|COMPLETED|Follow-up||111||
60128865|NCT01455415|76251084|FG001|COMPLETED|Follow-up||104||
59596302|NCT03274856|75705482|FG000|NOT COMPLETED|Overall Study||0||
59596303|NCT03274856|75705483|FG001|NOT COMPLETED|Overall Study||0||
59596304|NCT02216526|75705494|FG000|STARTED|Overall Study||45||
59596305|NCT02216526|75705495|FG001|STARTED|Overall Study||44||
59596306|NCT02216526|75705496|FG002|STARTED|Overall Study||44||
59596307|NCT02216526|75705494|FG000|COMPLETED|Overall Study||40||
59596308|NCT02216526|75705495|FG001|COMPLETED|Overall Study||41||
59596309|NCT02216526|75705496|FG002|COMPLETED|Overall Study||36||
59596310|NCT02216526|75705494|FG000|NOT COMPLETED|Overall Study||5||
59596311|NCT02216526|75705495|FG001|NOT COMPLETED|Overall Study||3||
59596312|NCT02216526|75705496|FG002|NOT COMPLETED|Overall Study||8||
59596313|NCT03355820|75705504|FG000|STARTED|Overall Study||227||
59596314|NCT03355820|75705504|FG000|COMPLETED|Overall Study||227||
59596315|NCT03355820|75705504|FG000|NOT COMPLETED|Overall Study||0||
59596316|NCT03357614|75705510|FG000|STARTED|Overall Study||697||
59596317|NCT03357614|75705511|FG001|STARTED|Overall Study||698||
59596318|NCT03357614|75705510|FG000|COMPLETED|Overall Study||672||
59596319|NCT03357614|75705511|FG001|COMPLETED|Overall Study||670||
59596320|NCT03357614|75705510|FG000|NOT COMPLETED|Overall Study||25||
59596321|NCT03357614|75705511|FG001|NOT COMPLETED|Overall Study||28||
59596322|NCT03487718|75705519|FG000|STARTED|Overall Study||12||
60128866|NCT01455415|76251083|FG000|NOT COMPLETED|Follow-up||3||
60128867|NCT01455415|76251084|FG001|NOT COMPLETED|Follow-up||2||
60128868|NCT01471171|76251090|FG000|STARTED|Treatment Period 1||57||
60128869|NCT01471171|76251091|FG001|STARTED|Treatment Period 1||55||
60128870|NCT01471171|76251090|FG000|COMPLETED|Treatment Period 1||53||
60128871|NCT01471171|76251091|FG001|COMPLETED|Treatment Period 1||54||
60128872|NCT01471171|76251090|FG000|NOT COMPLETED|Treatment Period 1||4||
60128873|NCT01471171|76251091|FG001|NOT COMPLETED|Treatment Period 1||1||
60128874|NCT01471171|76251090|FG000|STARTED|Treatment Period 2||53||
60128875|NCT01471171|76251091|FG001|STARTED|Treatment Period 2||54||
60128876|NCT01471171|76251090|FG000|COMPLETED|Treatment Period 2||52||
60128877|NCT01471171|76251091|FG001|COMPLETED|Treatment Period 2||54||
60128878|NCT01471171|76251090|FG000|NOT COMPLETED|Treatment Period 2||1||
60128879|NCT01471171|76251091|FG001|NOT COMPLETED|Treatment Period 2||0||
60128880|NCT01471093|76251099|FG000|STARTED|Overall Study||25||
60128881|NCT01471093|76251100|FG001|STARTED|Overall Study||25||
60128882|NCT01471093|76251101|FG002|STARTED|Overall Study||25||
60128883|NCT01471093|76251102|FG003|STARTED|Overall Study||25||
60128884|NCT01471093|76251099|FG000|COMPLETED|Overall Study||24||
60128885|NCT01471093|76251100|FG001|COMPLETED|Overall Study||25||
60128886|NCT01471093|76251101|FG002|COMPLETED|Overall Study||25||
60128887|NCT01471093|76251102|FG003|COMPLETED|Overall Study||25||
60128888|NCT01471093|76251099|FG000|NOT COMPLETED|Overall Study||1||
60128889|NCT01471093|76251100|FG001|NOT COMPLETED|Overall Study||0||
60128890|NCT01471093|76251101|FG002|NOT COMPLETED|Overall Study||0||
60128891|NCT01471093|76251102|FG003|NOT COMPLETED|Overall Study||0||
60128892|NCT01471015|76251111|FG000|STARTED|Overall Study||10||
60128893|NCT01471015|76251112|FG001|STARTED|Overall Study||10||
60128894|NCT01471015|76251113|FG002|STARTED|Overall Study||10||
60128895|NCT01471015|76251111|FG000|COMPLETED|Overall Study||10||
60128896|NCT01471015|76251112|FG001|COMPLETED|Overall Study||9||
60128897|NCT01471015|76251113|FG002|COMPLETED|Overall Study||9||
60128898|NCT01471015|76251111|FG000|NOT COMPLETED|Overall Study||0||
60128899|NCT01471015|76251112|FG001|NOT COMPLETED|Overall Study||1||
60128900|NCT01471015|76251113|FG002|NOT COMPLETED|Overall Study||1||
60128901|NCT01497067|76251121|FG000|STARTED|Overall Study||657||
60128902|NCT01497067|76251121|FG000|COMPLETED|Overall Study||575||
60128903|NCT01497067|76251121|FG000|NOT COMPLETED|Overall Study||82||
60128904|NCT02334787|76251130|FG000|STARTED|Overall Study||8||
60128905|NCT02334787|76251131|FG001|STARTED|Overall Study||8||
60128906|NCT02334787|76251132|FG002|STARTED|Overall Study||8||
60128907|NCT02334787|76251133|FG003|STARTED|Overall Study||8||
60128908|NCT02334787|76251130|FG000|COMPLETED|Overall Study||8||
60128909|NCT02334787|76251131|FG001|COMPLETED|Overall Study||8||
60128910|NCT02334787|76251132|FG002|COMPLETED|Overall Study||8||
60128911|NCT02334787|76251133|FG003|COMPLETED|Overall Study||8||
60128912|NCT02334787|76251130|FG000|NOT COMPLETED|Overall Study||0||
59596323|NCT03487718|75705520|FG001|STARTED|Overall Study||15||
59596324|NCT03487718|75705519|FG000|COMPLETED|Overall Study||11||
59596325|NCT03487718|75705520|FG001|COMPLETED|Overall Study||11||
59596326|NCT03487718|75705519|FG000|NOT COMPLETED|Overall Study||1||
59596327|NCT03487718|75705520|FG001|NOT COMPLETED|Overall Study||4||
59596328|NCT03275870|75705526|FG000|STARTED|Overall Study||17||
59596329|NCT03275870|75705526|FG000|COMPLETED|Overall Study||3||
60128913|NCT02334787|76251131|FG001|NOT COMPLETED|Overall Study||0||
60128914|NCT02334787|76251132|FG002|NOT COMPLETED|Overall Study||0||
60128915|NCT02334787|76251133|FG003|NOT COMPLETED|Overall Study||0||
60128916|NCT01470469|76251151|FG000|STARTED|Overall Study||21||
60128917|NCT01470469|76251152|FG001|STARTED|Overall Study||62||
60128918|NCT01470469|76251151|FG000|COMPLETED|Overall Study||11||
60128919|NCT01470469|76251152|FG001|COMPLETED|Overall Study||38||
60128920|NCT01470469|76251151|FG000|NOT COMPLETED|Overall Study||10||
60128921|NCT01470469|76251152|FG001|NOT COMPLETED|Overall Study||24||
60128922|NCT01470001|76251160|FG000|STARTED|Overall Study||58||
60128923|NCT01470001|76251161|FG001|STARTED|Overall Study||60||
60128924|NCT01470001|76251160|FG000|COMPLETED|Overall Study||53||
59596330|NCT03275870|75705526|FG000|NOT COMPLETED|Overall Study||14||
59596331|NCT03276494|75705530|FG000|STARTED|Overall Study||6||
59596332|NCT03276494|75705530|FG000|COMPLETED|Overall Study||5||
59596333|NCT03276494|75705530|FG000|NOT COMPLETED|Overall Study||1||
59596334|NCT02216214|75705536|FG000|STARTED|Overall Study||443||
59596335|NCT02216214|75705537|FG001|STARTED|Overall Study||445||
59596336|NCT02216214|75705536|FG000|Treated|Overall Study||442||
59596337|NCT02216214|75705537|FG001|Treated|Overall Study||445||
59596338|NCT02216214|75705536|FG000|COMPLETED|Overall Study||400||
59596339|NCT02216214|75705537|FG001|COMPLETED|Overall Study||409||
59596340|NCT02216214|75705536|FG000|NOT COMPLETED|Overall Study||43||
59596341|NCT02216214|75705537|FG001|NOT COMPLETED|Overall Study||36||
59596342|NCT03277274|75705546|FG000|STARTED|Overall Study||8||
59596343|NCT03277274|75705547|FG001|STARTED|Overall Study||10||
59596344|NCT03277274|75705548|FG002|STARTED|Overall Study||7||
59596345|NCT03277274|75705546|FG000|COMPLETED|Overall Study||8||
59596346|NCT03277274|75705547|FG001|COMPLETED|Overall Study||10||
59596347|NCT03277274|75705548|FG002|COMPLETED|Overall Study||7||
59596348|NCT03277274|75705546|FG000|NOT COMPLETED|Overall Study||0||
59596349|NCT03277274|75705547|FG001|NOT COMPLETED|Overall Study||0||
59596350|NCT03277274|75705548|FG002|NOT COMPLETED|Overall Study||0||
59596351|NCT03279458|75705556|FG000|STARTED|Overall Study||40||
59596352|NCT03279458|75705556|FG000|COMPLETED|Overall Study||40|The milestone was met if the participant was able to complete the breathing exercise.|
59596353|NCT03279458|75705556|FG000|NOT COMPLETED|Overall Study||0||
59596354|NCT03491228|75705562|FG000|STARTED|Overall Study||107||
59596355|NCT03491228|75705562|FG000|COMPLETED|Overall Study||107||
59596356|NCT03491228|75705562|FG000|NOT COMPLETED|Overall Study||0||
59596357|NCT02214186|75705568|FG000|STARTED|Overall Study||23||
59596358|NCT02214186|75705569|FG001|STARTED|Overall Study||23||
59596359|NCT02214186|75705568|FG000|COMPLETED|Overall Study||21||
60128925|NCT01470001|76251161|FG001|COMPLETED|Overall Study||58||
60128926|NCT01470001|76251160|FG000|NOT COMPLETED|Overall Study||5||
60128927|NCT01470001|76251161|FG001|NOT COMPLETED|Overall Study||2||
60128928|NCT01469377|76251170|FG000|STARTED|Overall Study||269||
60128929|NCT01469377|76251171|FG001|STARTED|Overall Study||274||
60128930|NCT01469377|76251172|FG002|STARTED|Overall Study||276||
60128931|NCT01469377|76251170|FG000|COMPLETED|Overall Study||234||
60128932|NCT01469377|76251171|FG001|COMPLETED|Overall Study||226||
59596360|NCT02214186|75705569|FG001|COMPLETED|Overall Study||21||
60128933|NCT01469377|76251172|FG002|COMPLETED|Overall Study||210||
59596361|NCT02214186|75705568|FG000|NOT COMPLETED|Overall Study||2||
60128934|NCT01469377|76251170|FG000|NOT COMPLETED|Overall Study||35||
60128935|NCT01469377|76251171|FG001|NOT COMPLETED|Overall Study||48||
60128936|NCT01469377|76251172|FG002|NOT COMPLETED|Overall Study||66||
60128937|NCT01469221|76251182|FG000|STARTED|Open Label Phase||0||
59596362|NCT02214186|75705569|FG001|NOT COMPLETED|Overall Study||2||
59596363|NCT03492398|75705584|FG000|STARTED|Overall Study||8||
59596364|NCT03492398|75705585|FG001|STARTED|Overall Study||6||
59596365|NCT03492398|75705586|FG002|STARTED|Overall Study||6||
59596366|NCT03492398|75705587|FG003|STARTED|Overall Study||6||
59596367|NCT03492398|75705588|FG004|STARTED|Overall Study||6||
59596368|NCT03492398|75705589|FG005|STARTED|Overall Study||6||
59596369|NCT03492398|75705590|FG006|STARTED|Overall Study||6||
59596370|NCT03492398|75705591|FG007|STARTED|Overall Study||6||
59596371|NCT03492398|75705592|FG008|STARTED|Overall Study||6||
59596372|NCT03492398|75705584|FG000|COMPLETED|Overall Study||8||
59596373|NCT03492398|75705585|FG001|COMPLETED|Overall Study||6||
59596374|NCT03492398|75705586|FG002|COMPLETED|Overall Study||6||
60128938|NCT01469221|76251183|FG001|STARTED|Open Label Phase||0||
60128939|NCT01469221|76251184|FG002|STARTED|Open Label Phase||47||
60128940|NCT01469221|76251182|FG000|COMPLETED|Open Label Phase||0||
60128941|NCT01469221|76251183|FG001|COMPLETED|Open Label Phase||0||
60128942|NCT01469221|76251184|FG002|COMPLETED|Open Label Phase||44||
60128943|NCT01469221|76251182|FG000|NOT COMPLETED|Open Label Phase||0||
60128944|NCT01469221|76251183|FG001|NOT COMPLETED|Open Label Phase||0||
60128945|NCT01469221|76251184|FG002|NOT COMPLETED|Open Label Phase||3||
60128946|NCT01469221|76251182|FG000|STARTED|Double Blind Phase||14||
60128947|NCT01469221|76251183|FG001|STARTED|Double Blind Phase||17||
60128948|NCT01469221|76251184|FG002|STARTED|Double Blind Phase||0||
60128949|NCT01469221|76251182|FG000|COMPLETED|Double Blind Phase||0||
60128950|NCT01469221|76251183|FG001|COMPLETED|Double Blind Phase||0||
60128951|NCT01469221|76251184|FG002|COMPLETED|Double Blind Phase||0||
60128952|NCT01469221|76251182|FG000|NOT COMPLETED|Double Blind Phase||14||
60128953|NCT01469221|76251183|FG001|NOT COMPLETED|Double Blind Phase||17||
60128954|NCT01469221|76251184|FG002|NOT COMPLETED|Double Blind Phase||0||
60128955|NCT01453855|76251193|FG000|STARTED|Overall Study||442||
60128956|NCT01453855|76251194|FG001|STARTED|Overall Study||422||
60128957|NCT01453855|76251193|FG000|COMPLETED|Overall Study||432||
60128958|NCT01453855|76251194|FG001|COMPLETED|Overall Study||408||
60128959|NCT01453855|76251193|FG000|NOT COMPLETED|Overall Study||10||
60128960|NCT01453855|76251194|FG001|NOT COMPLETED|Overall Study||14||
59596375|NCT03492398|75705587|FG003|COMPLETED|Overall Study||6||
59596376|NCT03492398|75705588|FG004|COMPLETED|Overall Study||6||
59596377|NCT03492398|75705589|FG005|COMPLETED|Overall Study||6||
59596378|NCT03492398|75705590|FG006|COMPLETED|Overall Study||5||
59596379|NCT03492398|75705591|FG007|COMPLETED|Overall Study||5||
59596380|NCT03492398|75705592|FG008|COMPLETED|Overall Study||6||
59596381|NCT03492398|75705584|FG000|NOT COMPLETED|Overall Study||0||
59596382|NCT03492398|75705585|FG001|NOT COMPLETED|Overall Study||0||
59596383|NCT03492398|75705586|FG002|NOT COMPLETED|Overall Study||0||
59596384|NCT03492398|75705587|FG003|NOT COMPLETED|Overall Study||0||
59596385|NCT03492398|75705588|FG004|NOT COMPLETED|Overall Study||0||
59596386|NCT03492398|75705589|FG005|NOT COMPLETED|Overall Study||0||
60128961|NCT01469065|76251205|FG000|STARTED|Overall Study||16||
59596387|NCT03492398|75705590|FG006|NOT COMPLETED|Overall Study||1||
60128962|NCT01469065|76251206|FG001|STARTED|Overall Study||17||
60128963|NCT01469065|76251207|FG002|STARTED|Overall Study||16||
60128964|NCT01469065|76251208|FG003|STARTED|Overall Study||16||
60128965|NCT01469065|76251209|FG004|STARTED|Overall Study||17||
60128966|NCT01469065|76251205|FG000|COMPLETED|Overall Study||16||
60128967|NCT01469065|76251206|FG001|COMPLETED|Overall Study||16||
60128968|NCT01469065|76251207|FG002|COMPLETED|Overall Study||16||
60128969|NCT01469065|76251208|FG003|COMPLETED|Overall Study||16||
60128970|NCT01469065|76251209|FG004|COMPLETED|Overall Study||16||
60128971|NCT01469065|76251205|FG000|NOT COMPLETED|Overall Study||0||
60128972|NCT01469065|76251206|FG001|NOT COMPLETED|Overall Study||1||
60128973|NCT01469065|76251207|FG002|NOT COMPLETED|Overall Study||0||
60128974|NCT01469065|76251208|FG003|NOT COMPLETED|Overall Study||0||
60128975|NCT01469065|76251209|FG004|NOT COMPLETED|Overall Study||1||
60128976|NCT01586624|76251233|FG000|STARTED|Overall Study||6||
60128977|NCT01586624|76251234|FG001|STARTED|Overall Study||6||
60128978|NCT01586624|76251235|FG002|STARTED|Overall Study||6||
59596388|NCT03492398|75705591|FG007|NOT COMPLETED|Overall Study||1||
59596389|NCT03492398|75705592|FG008|NOT COMPLETED|Overall Study||0||
59596390|NCT03496220|75705614|FG000|STARTED|First Intervention||15||
59596391|NCT03496220|75705615|FG001|STARTED|First Intervention||4||
59596392|NCT03496220|75705616|FG002|STARTED|First Intervention||10||
59596393|NCT03496220|75705614|FG000|COMPLETED|First Intervention||15||
59596394|NCT03496220|75705615|FG001|COMPLETED|First Intervention||4||
59596395|NCT03496220|75705616|FG002|COMPLETED|First Intervention||10||
59596396|NCT03496220|75705614|FG000|NOT COMPLETED|First Intervention||0||
59596397|NCT03496220|75705615|FG001|NOT COMPLETED|First Intervention||0||
59728449|NCT00812929|75847153|FG004|NOT COMPLETED|Washout Period 3 (7 Days)||0||
59728450|NCT00812929|75847154|FG005|NOT COMPLETED|Washout Period 3 (7 Days)||1||
59728451|NCT00812929|75847155|FG006|NOT COMPLETED|Washout Period 3 (7 Days)||0||
59728452|NCT00812929|75847156|FG007|NOT COMPLETED|Washout Period 3 (7 Days)||0||
59728453|NCT00812929|75847157|FG008|NOT COMPLETED|Washout Period 3 (7 Days)||0||
59728454|NCT00812929|75847158|FG009|NOT COMPLETED|Washout Period 3 (7 Days)||0||
59728455|NCT00812929|75847149|FG000|STARTED|Treatment Period 4||5||
59728456|NCT00812929|75847150|FG001|STARTED|Treatment Period 4||4||
59728457|NCT00812929|75847151|FG002|STARTED|Treatment Period 4||4||
59728458|NCT00812929|75847152|FG003|STARTED|Treatment Period 4||4||
59728459|NCT00812929|75847153|FG004|STARTED|Treatment Period 4||5||
59728460|NCT00812929|75847154|FG005|STARTED|Treatment Period 4||4||
59728461|NCT00812929|75847155|FG006|STARTED|Treatment Period 4||5||
59728462|NCT00812929|75847156|FG007|STARTED|Treatment Period 4||5||
59728463|NCT00812929|75847157|FG008|STARTED|Treatment Period 4||4||
59728464|NCT00812929|75847158|FG009|STARTED|Treatment Period 4||4||
59728465|NCT00812929|75847149|FG000|COMPLETED|Treatment Period 4||5||
59728466|NCT00812929|75847150|FG001|COMPLETED|Treatment Period 4||4||
59728467|NCT00812929|75847151|FG002|COMPLETED|Treatment Period 4||4||
59728468|NCT00812929|75847152|FG003|COMPLETED|Treatment Period 4||4||
59728469|NCT00812929|75847153|FG004|COMPLETED|Treatment Period 4||5||
59728470|NCT00812929|75847154|FG005|COMPLETED|Treatment Period 4||4||
59728471|NCT00812929|75847155|FG006|COMPLETED|Treatment Period 4||5||
59728472|NCT00812929|75847156|FG007|COMPLETED|Treatment Period 4||5||
59728473|NCT00812929|75847157|FG008|COMPLETED|Treatment Period 4||4||
59728474|NCT00812929|75847158|FG009|COMPLETED|Treatment Period 4||4||
59728475|NCT00812929|75847149|FG000|NOT COMPLETED|Treatment Period 4||0||
59728476|NCT00812929|75847150|FG001|NOT COMPLETED|Treatment Period 4||0||
59728477|NCT00812929|75847151|FG002|NOT COMPLETED|Treatment Period 4||0||
59728478|NCT00812929|75847152|FG003|NOT COMPLETED|Treatment Period 4||0||
59728479|NCT00812929|75847153|FG004|NOT COMPLETED|Treatment Period 4||0||
59728480|NCT00812929|75847154|FG005|NOT COMPLETED|Treatment Period 4||0||
59728481|NCT00812929|75847155|FG006|NOT COMPLETED|Treatment Period 4||0||
59728482|NCT00812929|75847156|FG007|NOT COMPLETED|Treatment Period 4||0||
59728483|NCT00812929|75847157|FG008|NOT COMPLETED|Treatment Period 4||0||
59728484|NCT00812929|75847158|FG009|NOT COMPLETED|Treatment Period 4||0||
59728485|NCT00812929|75847149|FG000|STARTED|Washout Period 4 (7 Days)||5||
59728486|NCT00812929|75847150|FG001|STARTED|Washout Period 4 (7 Days)||4||
59728487|NCT00812929|75847151|FG002|STARTED|Washout Period 4 (7 Days)||4||
59728488|NCT00812929|75847152|FG003|STARTED|Washout Period 4 (7 Days)||4||
59728489|NCT00812929|75847153|FG004|STARTED|Washout Period 4 (7 Days)||5||
59728490|NCT00812929|75847154|FG005|STARTED|Washout Period 4 (7 Days)||4||
59728491|NCT00812929|75847155|FG006|STARTED|Washout Period 4 (7 Days)||5||
59728492|NCT00812929|75847156|FG007|STARTED|Washout Period 4 (7 Days)||5||
59728493|NCT00812929|75847157|FG008|STARTED|Washout Period 4 (7 Days)||4||
59728494|NCT00812929|75847158|FG009|STARTED|Washout Period 4 (7 Days)||4||
59728495|NCT00812929|75847149|FG000|COMPLETED|Washout Period 4 (7 Days)||5||
59728496|NCT00812929|75847150|FG001|COMPLETED|Washout Period 4 (7 Days)||4||
59728497|NCT00812929|75847151|FG002|COMPLETED|Washout Period 4 (7 Days)||4||
59728498|NCT00812929|75847152|FG003|COMPLETED|Washout Period 4 (7 Days)||4||
59728499|NCT00812929|75847153|FG004|COMPLETED|Washout Period 4 (7 Days)||5||
59728500|NCT00812929|75847154|FG005|COMPLETED|Washout Period 4 (7 Days)||4||
59728501|NCT00812929|75847155|FG006|COMPLETED|Washout Period 4 (7 Days)||5||
59728502|NCT00812929|75847156|FG007|COMPLETED|Washout Period 4 (7 Days)||5||
59728503|NCT00812929|75847157|FG008|COMPLETED|Washout Period 4 (7 Days)||4||
59728504|NCT00812929|75847158|FG009|COMPLETED|Washout Period 4 (7 Days)||4||
59728505|NCT00812929|75847149|FG000|NOT COMPLETED|Washout Period 4 (7 Days)||0||
59728506|NCT00812929|75847150|FG001|NOT COMPLETED|Washout Period 4 (7 Days)||0||
59728507|NCT00812929|75847151|FG002|NOT COMPLETED|Washout Period 4 (7 Days)||0||
59728508|NCT00812929|75847152|FG003|NOT COMPLETED|Washout Period 4 (7 Days)||0||
59728509|NCT00812929|75847153|FG004|NOT COMPLETED|Washout Period 4 (7 Days)||0||
59728510|NCT00812929|75847154|FG005|NOT COMPLETED|Washout Period 4 (7 Days)||0||
59728511|NCT00812929|75847155|FG006|NOT COMPLETED|Washout Period 4 (7 Days)||0||
59728512|NCT00812929|75847156|FG007|NOT COMPLETED|Washout Period 4 (7 Days)||0||
59728513|NCT00812929|75847157|FG008|NOT COMPLETED|Washout Period 4 (7 Days)||0||
59728514|NCT00812929|75847158|FG009|NOT COMPLETED|Washout Period 4 (7 Days)||0||
59728515|NCT00812929|75847149|FG000|STARTED|Treatment Period 5||5||
59728516|NCT00812929|75847150|FG001|STARTED|Treatment Period 5||4||
59728517|NCT00812929|75847151|FG002|STARTED|Treatment Period 5||4||
59728518|NCT00812929|75847152|FG003|STARTED|Treatment Period 5||4||
59728519|NCT00812929|75847153|FG004|STARTED|Treatment Period 5||5||
59596398|NCT03496220|75705616|FG002|NOT COMPLETED|First Intervention||0||
59596399|NCT03496220|75705614|FG000|STARTED|Second Intervention||17||
59596400|NCT03496220|75705615|FG001|STARTED|Second Intervention||9||
59596401|NCT03496220|75705616|FG002|STARTED|Second Intervention||11||
59596402|NCT03496220|75705614|FG000|COMPLETED|Second Intervention||17||
59596403|NCT03496220|75705615|FG001|COMPLETED|Second Intervention||9||
59596404|NCT03496220|75705616|FG002|COMPLETED|Second Intervention||11||
59596405|NCT03496220|75705614|FG000|NOT COMPLETED|Second Intervention||0||
59596406|NCT03496220|75705615|FG001|NOT COMPLETED|Second Intervention||0||
59596407|NCT03496220|75705616|FG002|NOT COMPLETED|Second Intervention||0||
59596408|NCT03496220|75705614|FG000|STARTED|Third Intervention||11||
59596409|NCT03496220|75705615|FG001|STARTED|Third Intervention||8||
59596410|NCT03496220|75705616|FG002|STARTED|Third Intervention||5||
59596411|NCT03496220|75705614|FG000|COMPLETED|Third Intervention||11||
59596412|NCT03496220|75705615|FG001|COMPLETED|Third Intervention||8||
59596413|NCT03496220|75705616|FG002|COMPLETED|Third Intervention||5||
59596414|NCT03496220|75705614|FG000|NOT COMPLETED|Third Intervention||0||
59596415|NCT03496220|75705615|FG001|NOT COMPLETED|Third Intervention||0||
59596416|NCT03496220|75705616|FG002|NOT COMPLETED|Third Intervention||0||
59596417|NCT02181504|75705625|FG000|STARTED|Overall Study||10||
59596418|NCT02181504|75705626|FG001|STARTED|Overall Study||10||
59596419|NCT02181504|75705627|FG002|STARTED|Overall Study||5||
59596420|NCT02181504|75705625|FG000|COMPLETED|Overall Study||9||
59596421|NCT02181504|75705626|FG001|COMPLETED|Overall Study||9||
59596422|NCT02181504|75705627|FG002|COMPLETED|Overall Study||4||
59596423|NCT02181504|75705625|FG000|NOT COMPLETED|Overall Study||1||
59596424|NCT02181504|75705626|FG001|NOT COMPLETED|Overall Study||1||
59596425|NCT02181504|75705627|FG002|NOT COMPLETED|Overall Study||1||
59596426|NCT03360110|75705636|FG000|STARTED|First Intervention||27||
59596427|NCT03360110|75705637|FG001|STARTED|First Intervention||26||
59596428|NCT03360110|75705636|FG000|COMPLETED|First Intervention||27||
59596429|NCT03360110|75705637|FG001|COMPLETED|First Intervention||26||
59596430|NCT03360110|75705636|FG000|NOT COMPLETED|First Intervention||0||
59596431|NCT03360110|75705637|FG001|NOT COMPLETED|First Intervention||0||
59596432|NCT03360110|75705636|FG000|STARTED|Second Intervention||27||
59596433|NCT03360110|75705637|FG001|STARTED|Second Intervention||26||
59596434|NCT03360110|75705636|FG000|COMPLETED|Second Intervention||27||
59596435|NCT03360110|75705637|FG001|COMPLETED|Second Intervention||26||
59596436|NCT03360110|75705636|FG000|NOT COMPLETED|Second Intervention||0||
59596437|NCT03360110|75705637|FG001|NOT COMPLETED|Second Intervention||0||
59596438|NCT02179398|75705657|FG000|STARTED|Overall Study||134||
59596439|NCT02179398|75705658|FG001|STARTED|Overall Study||144||
59596440|NCT02179398|75705657|FG000|COMPLETED|Overall Study||131||
59596441|NCT02179398|75705658|FG001|COMPLETED|Overall Study||140||
59596442|NCT02179398|75705657|FG000|NOT COMPLETED|Overall Study||3||
59596443|NCT02179398|75705658|FG001|NOT COMPLETED|Overall Study||4||
59596444|NCT02156076|75705672|FG000|STARTED|Treatment Period||7||
59596445|NCT02156076|75705673|FG001|STARTED|Treatment Period||7||
59596446|NCT02156076|75705674|FG002|STARTED|Treatment Period||6||
59596447|NCT02156076|75705675|FG003|STARTED|Treatment Period||6||
59596448|NCT02156076|75705672|FG000|COMPLETED|Treatment Period||7||
59596449|NCT02156076|75705673|FG001|COMPLETED|Treatment Period||5||
59596450|NCT02156076|75705674|FG002|COMPLETED|Treatment Period||4||
59596451|NCT02156076|75705675|FG003|COMPLETED|Treatment Period||4||
59596452|NCT02156076|75705672|FG000|NOT COMPLETED|Treatment Period||0||
59596453|NCT02156076|75705673|FG001|NOT COMPLETED|Treatment Period||2||
59596454|NCT02156076|75705674|FG002|NOT COMPLETED|Treatment Period||2||
59596455|NCT02156076|75705675|FG003|NOT COMPLETED|Treatment Period||2||
59596456|NCT02156076|75705672|FG000|STARTED|Follow-up Period||7||
59596457|NCT02156076|75705673|FG001|STARTED|Follow-up Period||5||
59596458|NCT02156076|75705674|FG002|STARTED|Follow-up Period||4||
59596459|NCT02156076|75705675|FG003|STARTED|Follow-up Period||4||
59596460|NCT02156076|75705672|FG000|COMPLETED|Follow-up Period||6||
59596461|NCT02156076|75705673|FG001|COMPLETED|Follow-up Period||5||
59596462|NCT02156076|75705674|FG002|COMPLETED|Follow-up Period||4||
59596463|NCT02156076|75705675|FG003|COMPLETED|Follow-up Period||4||
59596464|NCT02156076|75705672|FG000|NOT COMPLETED|Follow-up Period||1||
59596465|NCT02156076|75705673|FG001|NOT COMPLETED|Follow-up Period||0||
59596466|NCT02156076|75705674|FG002|NOT COMPLETED|Follow-up Period||0||
59596467|NCT02156076|75705675|FG003|NOT COMPLETED|Follow-up Period||0||
59596468|NCT02213094|75705687|FG000|STARTED|Overall Study||5||
59596469|NCT02213094|75705688|FG001|STARTED|Overall Study||5||
59596470|NCT02213094|75705687|FG000|COMPLETED|Overall Study|One subject stopped study agent early because of elevation in LFTs > 3x ULN|4||
59596471|NCT02213094|75705688|FG001|COMPLETED|Overall Study||5||
59596472|NCT02213094|75705687|FG000|NOT COMPLETED|Overall Study||1||
59596473|NCT02213094|75705688|FG001|NOT COMPLETED|Overall Study||0||
59596474|NCT02155608|75705696|FG000|STARTED|1a: 4 Week Double Blind Sham Controlled||32||
59596475|NCT02155608|75705697|FG001|STARTED|1a: 4 Week Double Blind Sham Controlled||30||
59596476|NCT02155608|75705696|FG000|COMPLETED|1a: 4 Week Double Blind Sham Controlled||32||
59596477|NCT02155608|75705697|FG001|COMPLETED|1a: 4 Week Double Blind Sham Controlled||29||
59596478|NCT02155608|75705696|FG000|NOT COMPLETED|1a: 4 Week Double Blind Sham Controlled||0||
59596479|NCT02155608|75705697|FG001|NOT COMPLETED|1a: 4 Week Double Blind Sham Controlled||1||
59596480|NCT02155608|75705696|FG000|STARTED|1b: 1 Week Blinded Post Treatment||32||
59596481|NCT02155608|75705697|FG001|STARTED|1b: 1 Week Blinded Post Treatment||29||
59596482|NCT02155608|75705696|FG000|COMPLETED|1b: 1 Week Blinded Post Treatment||31||
59596483|NCT02155608|75705697|FG001|COMPLETED|1b: 1 Week Blinded Post Treatment||28||
59596484|NCT02155608|75705696|FG000|NOT COMPLETED|1b: 1 Week Blinded Post Treatment||1||
59596485|NCT02155608|75705697|FG001|NOT COMPLETED|1b: 1 Week Blinded Post Treatment||1||
59596486|NCT01629966|75705712|FG000|STARTED|Overall Study||221||
59596487|NCT01629966|75705713|FG001|STARTED|Overall Study||227||
59596488|NCT01629966|75705714|FG002|STARTED|Overall Study||225||
59596489|NCT01629966|75705712|FG000|COMPLETED|Overall Study||180||
59596490|NCT01629966|75705713|FG001|COMPLETED|Overall Study||175||
59596491|NCT01629966|75705714|FG002|COMPLETED|Overall Study||159||
59596492|NCT01629966|75705712|FG000|NOT COMPLETED|Overall Study||41||
59596493|NCT01629966|75705713|FG001|NOT COMPLETED|Overall Study||52||
59596494|NCT01629966|75705714|FG002|NOT COMPLETED|Overall Study||66||
59596495|NCT03363854|75705724|FG000|STARTED|Initial Treatment Period||253||
59596496|NCT03363854|75705725|FG001|STARTED|Initial Treatment Period||127||
59596497|NCT03363854|75705726|FG002|STARTED|Initial Treatment Period|This treatment group applies to the continuation treatment period (see below).|0||
59596498|NCT03363854|75705727|FG003|STARTED|Initial Treatment Period|This treatment group applies to the continuation treatment period (see below).|0||
59596499|NCT03363854|75705728|FG004|STARTED|Initial Treatment Period|This treatment group applies to the continuation treatment period (see below).|0||
59596500|NCT03363854|75705729|FG005|STARTED|Initial Treatment Period|This treatment group applies to the continuation treatment period (see below).|0||
59596501|NCT03363854|75705730|FG006|STARTED|Initial Treatment Period|This treatment group applies to the continuation treatment period (see below).|0||
59596502|NCT03363854|75705731|FG007|STARTED|Initial Treatment Period|This treatment group applies to the safety follow-up period (see below).|0||
59596503|NCT03363854|75705724|FG000|COMPLETED|Initial Treatment Period||235||
59596504|NCT03363854|75705725|FG001|COMPLETED|Initial Treatment Period||120||
59596505|NCT03363854|75705726|FG002|COMPLETED|Initial Treatment Period||0||
59596506|NCT03363854|75705727|FG003|COMPLETED|Initial Treatment Period||0||
59596507|NCT03363854|75705728|FG004|COMPLETED|Initial Treatment Period||0||
59596508|NCT03363854|75705729|FG005|COMPLETED|Initial Treatment Period||0||
59596509|NCT03363854|75705730|FG006|COMPLETED|Initial Treatment Period||0||
59596510|NCT03363854|75705731|FG007|COMPLETED|Initial Treatment Period||0||
59596511|NCT03363854|75705724|FG000|NOT COMPLETED|Initial Treatment Period||18||
59596512|NCT03363854|75705725|FG001|NOT COMPLETED|Initial Treatment Period||7||
59596513|NCT03363854|75705726|FG002|NOT COMPLETED|Initial Treatment Period||0||
59596514|NCT03363854|75705727|FG003|NOT COMPLETED|Initial Treatment Period||0||
59596515|NCT03363854|75705728|FG004|NOT COMPLETED|Initial Treatment Period||0||
59596516|NCT03363854|75705729|FG005|NOT COMPLETED|Initial Treatment Period||0||
59596517|NCT03363854|75705730|FG006|NOT COMPLETED|Initial Treatment Period||0||
59596518|NCT03363854|75705731|FG007|NOT COMPLETED|Initial Treatment Period||0||
59596519|NCT03363854|75705724|FG000|STARTED|Continuation Treatment Period|This treatment group applies to the initial treatment period (see above).|0|Between the inital and continuation treatment periods, 2 participants discontinued treatment.|
59596520|NCT03363854|75705725|FG001|STARTED|Continuation Treatment Period|This treatment group applies to the initial treatment period (see above).|0|Between the inital and continuation treatment periods, 2 participants discontinued treatment.|
59596521|NCT03363854|75705726|FG002|STARTED|Continuation Treatment Period||69|Between the inital and continuation treatment periods, 2 participants discontinued treatment.|
59596522|NCT03363854|75705727|FG003|STARTED|Continuation Treatment Period||69|Between the inital and continuation treatment periods, 2 participants discontinued treatment.|
59596523|NCT03363854|75705728|FG004|STARTED|Continuation Treatment Period||95|Between the inital and continuation treatment periods, 2 participants discontinued treatment.|
59596524|NCT03363854|75705729|FG005|STARTED|Continuation Treatment Period||79|Between the inital and continuation treatment periods, 2 participants discontinued treatment.|
59596525|NCT03363854|75705730|FG006|STARTED|Continuation Treatment Period||41|Between the inital and continuation treatment periods, 2 participants discontinued treatment.|
59596526|NCT03363854|75705731|FG007|STARTED|Continuation Treatment Period|This treatment group applies to the safety follow-up period (see below).|0|Between the inital and continuation treatment periods, 2 participants discontinued treatment.|
59596527|NCT03363854|75705724|FG000|COMPLETED|Continuation Treatment Period||0||
59596528|NCT03363854|75705725|FG001|COMPLETED|Continuation Treatment Period||0||
59596529|NCT03363854|75705726|FG002|COMPLETED|Continuation Treatment Period||68||
59596530|NCT03363854|75705727|FG003|COMPLETED|Continuation Treatment Period||65||
59596531|NCT03363854|75705728|FG004|COMPLETED|Continuation Treatment Period||87||
59596532|NCT03363854|75705729|FG005|COMPLETED|Continuation Treatment Period||72||
59596533|NCT03363854|75705730|FG006|COMPLETED|Continuation Treatment Period||38||
59596534|NCT03363854|75705731|FG007|COMPLETED|Continuation Treatment Period||0||
59596535|NCT03363854|75705724|FG000|NOT COMPLETED|Continuation Treatment Period||0||
59596536|NCT03363854|75705725|FG001|NOT COMPLETED|Continuation Treatment Period||0||
59596537|NCT03363854|75705726|FG002|NOT COMPLETED|Continuation Treatment Period||1||
59596538|NCT03363854|75705727|FG003|NOT COMPLETED|Continuation Treatment Period||4||
59596539|NCT03363854|75705728|FG004|NOT COMPLETED|Continuation Treatment Period||8||
59596540|NCT03363854|75705729|FG005|NOT COMPLETED|Continuation Treatment Period||7||
59596541|NCT03363854|75705730|FG006|NOT COMPLETED|Continuation Treatment Period||3||
59728520|NCT00812929|75847154|FG005|STARTED|Treatment Period 5||4||
59596542|NCT03363854|75705731|FG007|NOT COMPLETED|Continuation Treatment Period||0||
59596543|NCT03363854|75705724|FG000|STARTED|Safety Follow-up Period|This treatment group applies to the initial treatment period (see above).|0||
59596544|NCT03363854|75705725|FG001|STARTED|Safety Follow-up Period|This treatment group applies to the initial treatment period (see above).|0||
59596545|NCT03363854|75705726|FG002|STARTED|Safety Follow-up Period|This treatment group applies to the continuation treatment period (see above).|0||
59596546|NCT03363854|75705727|FG003|STARTED|Safety Follow-up Period|This treatment group applies to the continuation treatment period (see above).|0||
59596547|NCT03363854|75705728|FG004|STARTED|Safety Follow-up Period|This treatment group applies to the continuation treatment period (see above).|0||
59596548|NCT03363854|75705729|FG005|STARTED|Safety Follow-up Period|This treatment group applies to the continuation treatment period (see above).|0||
59596549|NCT03363854|75705730|FG006|STARTED|Safety Follow-up Period|This treatment group applies to the continuation treatment period (see above).|0||
59596550|NCT03363854|75705731|FG007|STARTED|Safety Follow-up Period||278||
59596551|NCT03363854|75705724|FG000|COMPLETED|Safety Follow-up Period||0|Of the 278 participants who started safety follow-up, 180 transferred to the extension trial.|
59596552|NCT03363854|75705725|FG001|COMPLETED|Safety Follow-up Period||0|Of the 278 participants who started safety follow-up, 180 transferred to the extension trial.|
59596553|NCT03363854|75705726|FG002|COMPLETED|Safety Follow-up Period||0|Of the 278 participants who started safety follow-up, 180 transferred to the extension trial.|
59596554|NCT03363854|75705727|FG003|COMPLETED|Safety Follow-up Period||0|Of the 278 participants who started safety follow-up, 180 transferred to the extension trial.|
59596555|NCT03363854|75705728|FG004|COMPLETED|Safety Follow-up Period||0|Of the 278 participants who started safety follow-up, 180 transferred to the extension trial.|
59596556|NCT03363854|75705729|FG005|COMPLETED|Safety Follow-up Period||0|Of the 278 participants who started safety follow-up, 180 transferred to the extension trial.|
59596557|NCT03363854|75705730|FG006|COMPLETED|Safety Follow-up Period||0|Of the 278 participants who started safety follow-up, 180 transferred to the extension trial.|
59596558|NCT03363854|75705731|FG007|COMPLETED|Safety Follow-up Period||62|Of the 278 participants who started safety follow-up, 180 transferred to the extension trial.|
59596559|NCT03363854|75705724|FG000|NOT COMPLETED|Safety Follow-up Period||0||
59596560|NCT03363854|75705725|FG001|NOT COMPLETED|Safety Follow-up Period||0||
59596561|NCT03363854|75705726|FG002|NOT COMPLETED|Safety Follow-up Period||0||
59596562|NCT03363854|75705727|FG003|NOT COMPLETED|Safety Follow-up Period||0||
59596563|NCT03363854|75705728|FG004|NOT COMPLETED|Safety Follow-up Period||0||
59596564|NCT03363854|75705729|FG005|NOT COMPLETED|Safety Follow-up Period||0||
59596565|NCT03363854|75705730|FG006|NOT COMPLETED|Safety Follow-up Period||0||
59596566|NCT03363854|75705731|FG007|NOT COMPLETED|Safety Follow-up Period||216||
59596567|NCT02177838|75705754|FG000|STARTED|Overall Study||8||
59596568|NCT02177838|75705754|FG000|COMPLETED|Overall Study||5||
59596569|NCT02177838|75705754|FG000|NOT COMPLETED|Overall Study||3||
59596570|NCT03369158|75705760|FG000|STARTED|Overall Study||14||
59596571|NCT03369158|75705761|FG001|STARTED|Overall Study||15||
59596572|NCT03369158|75705760|FG000|COMPLETED|Overall Study||14||
59596573|NCT03369158|75705761|FG001|COMPLETED|Overall Study||15||
59596574|NCT03369158|75705760|FG000|NOT COMPLETED|Overall Study||0||
59596575|NCT03369158|75705761|FG001|NOT COMPLETED|Overall Study||0||
59596576|NCT03372434|75705770|FG000|STARTED|Overall Study||78|Implanted with a study lens in at least one eye|78
59596577|NCT03372434|75705771|FG001|STARTED|Overall Study||73|Implanted with a study lens in at least one eye|73
59596578|NCT03372434|75705772|FG002|STARTED|Overall Study||74|Implanted with a study lens in at least one eye|74
59596579|NCT03372434|75705770|FG000|1 Month Follow-up|Overall Study||76||76
59596580|NCT03372434|75705771|FG001|1 Month Follow-up|Overall Study||72||72
59596581|NCT03372434|75705772|FG002|1 Month Follow-up|Overall Study||73||73
59596582|NCT03372434|75705770|FG000|COMPLETED|Overall Study||76|6 months follow up|76
59596583|NCT03372434|75705771|FG001|COMPLETED|Overall Study||70|6 months follow up|70
59596584|NCT03372434|75705772|FG002|COMPLETED|Overall Study||72|6 months follow up|72
59596585|NCT03372434|75705770|FG000|NOT COMPLETED|Overall Study||2||2
59596586|NCT03372434|75705771|FG001|NOT COMPLETED|Overall Study||3||3
59596587|NCT03372434|75705772|FG002|NOT COMPLETED|Overall Study||2||2
59596588|NCT03376256|75705782|FG000|STARTED|Overall Study||2||
59596589|NCT03376256|75705783|FG001|STARTED|Overall Study||0||
59596590|NCT03376256|75705782|FG000|COMPLETED|Overall Study||2||
59596591|NCT03376256|75705783|FG001|COMPLETED|Overall Study||0||
59596592|NCT03376256|75705782|FG000|NOT COMPLETED|Overall Study||0||
59596593|NCT03376256|75705783|FG001|NOT COMPLETED|Overall Study||0||
59596594|NCT03283436|75705791|FG000|STARTED|Overall Study||50||
59596595|NCT03283436|75705792|FG001|STARTED|Overall Study||50||
59596596|NCT03283436|75705791|FG000|COMPLETED|Overall Study||44||
59596597|NCT03283436|75705792|FG001|COMPLETED|Overall Study||50||
59596598|NCT03283436|75705791|FG000|NOT COMPLETED|Overall Study||6||
59596599|NCT03283436|75705792|FG001|NOT COMPLETED|Overall Study||0||
59596600|NCT03380624|75705798|FG000|STARTED|Overall Study||10||
59596601|NCT03380624|75705799|FG001|STARTED|Overall Study||9||
59596602|NCT03380624|75705798|FG000|COMPLETED|Overall Study||10||
59596603|NCT03380624|75705799|FG001|COMPLETED|Overall Study||9||
59596604|NCT03380624|75705798|FG000|NOT COMPLETED|Overall Study||0||
59596605|NCT03380624|75705799|FG001|NOT COMPLETED|Overall Study||0||
59596606|NCT03380780|75705805|FG000|STARTED|Overall Study||16||
59596607|NCT03380780|75705805|FG000|COMPLETED|Overall Study||16||
60128979|NCT01586624|76251236|FG003|STARTED|Overall Study||7||
59596608|NCT03380780|75705805|FG000|NOT COMPLETED|Overall Study||0||
59596609|NCT03581084|75705809|FG000|STARTED|Overall Study||1||
59596610|NCT03581084|75705809|FG000|COMPLETED|Overall Study||1||
59596611|NCT03581084|75705809|FG000|NOT COMPLETED|Overall Study||0||
59596612|NCT03383588|75705816|FG000|STARTED|Overall Study||8||
59596613|NCT03383588|75705817|FG001|STARTED|Overall Study||9||
59596614|NCT03383588|75705818|FG002|STARTED|Overall Study||9||
59596615|NCT03383588|75705816|FG000|COMPLETED|Overall Study||8||
59596616|NCT03383588|75705817|FG001|COMPLETED|Overall Study||9||
59596617|NCT03383588|75705818|FG002|COMPLETED|Overall Study||9||
59596618|NCT03383588|75705816|FG000|NOT COMPLETED|Overall Study||0||
59596619|NCT03383588|75705817|FG001|NOT COMPLETED|Overall Study||0||
59596620|NCT03383588|75705818|FG002|NOT COMPLETED|Overall Study||0||
59596621|NCT03388268|75705828|FG000|STARTED|Overall Study||8||
59596622|NCT03388268|75705829|FG001|STARTED|Overall Study||7||
59596623|NCT03388268|75705828|FG000|COMPLETED|Overall Study||7||
59596624|NCT03388268|75705829|FG001|COMPLETED|Overall Study||4||
59596625|NCT03388268|75705828|FG000|NOT COMPLETED|Overall Study||1||
59596626|NCT03388268|75705829|FG001|NOT COMPLETED|Overall Study||3||
59596627|NCT03581474|75705835|FG000|STARTED|Overall Study||12||
59596628|NCT03581474|75705835|FG000|COMPLETED|Overall Study||12|Early completion due to recruitment issues. Originally the study aimed to include 90 subjects.|
59596629|NCT03581474|75705835|FG000|NOT COMPLETED|Overall Study||0||
59596630|NCT03390842|75705841|FG000|STARTED|Overall Study||114||
59596631|NCT03390842|75705842|FG001|STARTED|Overall Study||82||
59596632|NCT03390842|75705841|FG000|COMPLETED|Overall Study||111||
59596633|NCT03390842|75705842|FG001|COMPLETED|Overall Study||74||
59596634|NCT03390842|75705841|FG000|NOT COMPLETED|Overall Study||3||
59596635|NCT03390842|75705842|FG001|NOT COMPLETED|Overall Study||8||
59596636|NCT02177136|75705851|FG000|STARTED|DB Phase||26||
59596637|NCT02177136|75705852|FG001|STARTED|DB Phase||26||
59596638|NCT02177136|75705853|FG002|STARTED|DB Phase||25||
59596639|NCT02177136|75705854|FG003|STARTED|DB Phase||0||
59596640|NCT02177136|75705851|FG000|Received At Least 1 Dose Of Study Drug|DB Phase|One participant randomized to receive 1.5 mg OCA titrating to 3 mg OCA withdrew prior to dosing.|25||
59596641|NCT02177136|75705852|FG001|Received At Least 1 Dose Of Study Drug|DB Phase||26||
59596642|NCT02177136|75705853|FG002|Received At Least 1 Dose Of Study Drug|DB Phase||25||
59596643|NCT02177136|75705854|FG003|Received At Least 1 Dose Of Study Drug|DB Phase||0||
59596644|NCT02177136|75705851|FG000|COMPLETED|DB Phase||19||
59596645|NCT02177136|75705852|FG001|COMPLETED|DB Phase||21||
59596646|NCT02177136|75705853|FG002|COMPLETED|DB Phase||21||
59596647|NCT02177136|75705854|FG003|COMPLETED|DB Phase||0||
59596648|NCT02177136|75705851|FG000|NOT COMPLETED|DB Phase||7||
59596649|NCT02177136|75705852|FG001|NOT COMPLETED|DB Phase||5||
59596650|NCT02177136|75705853|FG002|NOT COMPLETED|DB Phase||4||
59596651|NCT02177136|75705854|FG003|NOT COMPLETED|DB Phase||0||
59596652|NCT02177136|75705851|FG000|STARTED|LTSE Phase|Eligible participants who completed the DB phase could enroll in the LTSE phase.|0||
59596653|NCT02177136|75705852|FG001|STARTED|LTSE Phase|Eligible participants who completed the DB phase could enroll in the LTSE phase.|0||
59596654|NCT02177136|75705853|FG002|STARTED|LTSE Phase|Eligible participants who completed the DB phase could enroll in the LTSE phase.|0||
59596655|NCT02177136|75705854|FG003|STARTED|LTSE Phase|Eligible participants who completed the DB phase could enroll in the LTSE phase.|59||
59596656|NCT02177136|75705851|FG000|Received At Least 1 Dose Of Study Drug|LTSE Phase||0|All participants received open-label OCA during the LTSE phase of the study.|
59596657|NCT02177136|75705852|FG001|Received At Least 1 Dose Of Study Drug|LTSE Phase||0|All participants received open-label OCA during the LTSE phase of the study.|
59596658|NCT02177136|75705853|FG002|Received At Least 1 Dose Of Study Drug|LTSE Phase||0|All participants received open-label OCA during the LTSE phase of the study.|
59596659|NCT02177136|75705854|FG003|Received At Least 1 Dose Of Study Drug|LTSE Phase||59|All participants received open-label OCA during the LTSE phase of the study.|
59596660|NCT02177136|75705851|FG000|COMPLETED|LTSE Phase||0||
59596661|NCT02177136|75705852|FG001|COMPLETED|LTSE Phase||0||
59596662|NCT02177136|75705853|FG002|COMPLETED|LTSE Phase||0||
59596663|NCT02177136|75705854|FG003|COMPLETED|LTSE Phase||35||
59596664|NCT02177136|75705851|FG000|NOT COMPLETED|LTSE Phase||0||
59596665|NCT02177136|75705852|FG001|NOT COMPLETED|LTSE Phase||0||
59596666|NCT02177136|75705853|FG002|NOT COMPLETED|LTSE Phase||0||
59596667|NCT02177136|75705854|FG003|NOT COMPLETED|LTSE Phase||24||
59596668|NCT03393494|75705868|FG000|STARTED|Overall Study||329||
59596669|NCT03393494|75705869|FG001|STARTED|Overall Study||331||
59596670|NCT03393494|75705870|FG002|STARTED|Overall Study||165||
60128980|NCT01586624|76251237|FG004|STARTED|Overall Study||9||
60128981|NCT01586624|76251238|FG005|STARTED|Overall Study||8||
59596671|NCT03393494|75705868|FG000|COMPLETED|Overall Study||261||
59596672|NCT03393494|75705869|FG001|COMPLETED|Overall Study||256||
59596673|NCT03393494|75705870|FG002|COMPLETED|Overall Study||140||
59596674|NCT03393494|75705868|FG000|NOT COMPLETED|Overall Study||68||
59596675|NCT03393494|75705869|FG001|NOT COMPLETED|Overall Study||75||
59596676|NCT03393494|75705870|FG002|NOT COMPLETED|Overall Study||25||
59596677|NCT03588806|75705878|FG000|STARTED|Overall Study||11||
59596678|NCT03588806|75705878|FG000|COMPLETED|Overall Study||11||
59596679|NCT03588806|75705878|FG000|NOT COMPLETED|Overall Study||0||
59596680|NCT02176356|75705882|FG000|STARTED|Overall Study||116||
59596681|NCT02176356|75705882|FG000|Eligible and Received Treatment|Overall Study||100||
59596682|NCT02176356|75705882|FG000|COMPLETED|Overall Study||93||
59596683|NCT02176356|75705882|FG000|NOT COMPLETED|Overall Study||23||
59596684|NCT03591068|75705886|FG000|STARTED|Overall Study||11||
59596685|NCT03591068|75705886|FG000|COMPLETED|Overall Study||9||
59596686|NCT03591068|75705886|FG000|NOT COMPLETED|Overall Study||2||
59596687|NCT02210208|75705892|FG000|STARTED|Period A (Graft Site)||25||
59596688|NCT02210208|75705892|FG000|COMPLETED|Period A (Graft Site)||23||
59596689|NCT02210208|75705892|FG000|NOT COMPLETED|Period A (Graft Site)||2||
59596690|NCT02210208|75705892|FG000|STARTED|Period B (Donor Site)|6 subjects was decided by the Physician not to be included in the Part B.|19||
59596691|NCT02210208|75705892|FG000|COMPLETED|Period B (Donor Site)||12||
59596692|NCT02210208|75705892|FG000|NOT COMPLETED|Period B (Donor Site)||7||
59596693|NCT03395990|75705900|FG000|STARTED|Overall Study||8||
59596694|NCT03395990|75705901|FG001|STARTED|Overall Study||8||
59596695|NCT03395990|75705900|FG000|COMPLETED|Overall Study||8||
59596696|NCT03395990|75705901|FG001|COMPLETED|Overall Study||8||
59596697|NCT03395990|75705900|FG000|NOT COMPLETED|Overall Study||0||
59596698|NCT03395990|75705901|FG001|NOT COMPLETED|Overall Study||0||
59596699|NCT02209506|75705912|FG000|STARTED|Overall Study||3||
59596700|NCT02209506|75705913|FG001|STARTED|Overall Study||6||
59596701|NCT02209506|75705914|FG002|STARTED|Overall Study||6||
59596702|NCT02209506|75705915|FG003|STARTED|Overall Study||2||
59596703|NCT02209506|75705916|FG004|STARTED|Overall Study||6||
59860371|NCT03137992|75984989|FG002|STARTED|Part 2 (Open-label Extension)||21|Part 2 of the study enrolled a subset of 125 (from select investigational centers) participants who had successfully completed Part 1 of the study and who met the continuation criteria.|
59860372|NCT03137992|75984990|FG003|STARTED|Part 2 (Open-label Extension)||25|Part 2 of the study enrolled a subset of 125 (from select investigational centers) participants who had successfully completed Part 1 of the study and who met the continuation criteria.|
59860373|NCT03137992|75984991|FG004|STARTED|Part 2 (Open-label Extension)||18|Part 2 of the study enrolled a subset of 125 (from select investigational centers) participants who had successfully completed Part 1 of the study and who met the continuation criteria.|
59860374|NCT03137992|75984992|FG005|STARTED|Part 2 (Open-label Extension)||22|Part 2 of the study enrolled a subset of 125 (from select investigational centers) participants who had successfully completed Part 1 of the study and who met the continuation criteria.|
59860375|NCT03137992|75984987|FG000|COMPLETED|Part 2 (Open-label Extension)||20||
59860376|NCT03137992|75984988|FG001|COMPLETED|Part 2 (Open-label Extension)||17||
59860377|NCT03137992|75984989|FG002|COMPLETED|Part 2 (Open-label Extension)||20||
59860378|NCT03137992|75984990|FG003|COMPLETED|Part 2 (Open-label Extension)||24||
59860379|NCT03137992|75984991|FG004|COMPLETED|Part 2 (Open-label Extension)||18||
59860380|NCT03137992|75984992|FG005|COMPLETED|Part 2 (Open-label Extension)||21||
59860381|NCT03137992|75984987|FG000|NOT COMPLETED|Part 2 (Open-label Extension)||2||
59860382|NCT03137992|75984988|FG001|NOT COMPLETED|Part 2 (Open-label Extension)||0||
59860383|NCT03137992|75984989|FG002|NOT COMPLETED|Part 2 (Open-label Extension)||1||
59860384|NCT03137992|75984990|FG003|NOT COMPLETED|Part 2 (Open-label Extension)||1||
59860385|NCT03137992|75984991|FG004|NOT COMPLETED|Part 2 (Open-label Extension)||0||
59860386|NCT03137992|75984992|FG005|NOT COMPLETED|Part 2 (Open-label Extension)||1||
59596704|NCT02209506|75705912|FG000|COMPLETED|Overall Study||3||
59596705|NCT02209506|75705913|FG001|COMPLETED|Overall Study||6||
59596706|NCT02209506|75705914|FG002|COMPLETED|Overall Study||6||
59596707|NCT02209506|75705915|FG003|COMPLETED|Overall Study||2||
59596708|NCT02209506|75705916|FG004|COMPLETED|Overall Study||5||
59596709|NCT02209506|75705912|FG000|NOT COMPLETED|Overall Study||0||
59596710|NCT02209506|75705913|FG001|NOT COMPLETED|Overall Study||0||
59596711|NCT02209506|75705914|FG002|NOT COMPLETED|Overall Study||0||
59596712|NCT02209506|75705915|FG003|NOT COMPLETED|Overall Study||0||
59596713|NCT02209506|75705916|FG004|NOT COMPLETED|Overall Study||1||
59596714|NCT02153736|75705933|FG000|STARTED|Overall Study||7||
59596715|NCT02153736|75705934|FG001|STARTED|Overall Study||7||
59596716|NCT02153736|75705933|FG000|COMPLETED|Overall Study||5||
59596717|NCT02153736|75705934|FG001|COMPLETED|Overall Study||5||
59596718|NCT02153736|75705933|FG000|NOT COMPLETED|Overall Study||2||
59596719|NCT02153736|75705934|FG001|NOT COMPLETED|Overall Study||2||
59596720|NCT02175966|75705942|FG000|STARTED|Treatment Period||14||
59860387|NCT03704636|75985000|FG000|STARTED|Overall Study||23||
59860388|NCT03704636|75985000|FG000|COMPLETED|Overall Study||20||
59860389|NCT03704636|75985000|FG000|NOT COMPLETED|Overall Study||3||
59860390|NCT03689920|75985006|FG000|STARTED|Overall Study||47||
59860391|NCT03689920|75985007|FG001|STARTED|Overall Study||52||
59860392|NCT03689920|75985006|FG000|COMPLETED|Overall Study||41||
59860393|NCT03689920|75985007|FG001|COMPLETED|Overall Study||48||
59860394|NCT03689920|75985006|FG000|NOT COMPLETED|Overall Study||6||
59860395|NCT03689920|75985007|FG001|NOT COMPLETED|Overall Study||4||
59860396|NCT05096312|75985015|FG000|STARTED|Overall Study||11||
59860397|NCT05096312|75985016|FG001|STARTED|Overall Study||12||
59596721|NCT02175966|75705943|FG001|STARTED|Treatment Period||14||
59596722|NCT02175966|75705942|FG000|COMPLETED|Treatment Period||14||
59596723|NCT02175966|75705943|FG001|COMPLETED|Treatment Period||14||
59596724|NCT02175966|75705942|FG000|NOT COMPLETED|Treatment Period||0||
59596725|NCT02175966|75705943|FG001|NOT COMPLETED|Treatment Period||0||
59596726|NCT02175966|75705942|FG000|STARTED|Follow-up Period||14||
59596727|NCT02175966|75705943|FG001|STARTED|Follow-up Period||14||
59596728|NCT02175966|75705942|FG000|COMPLETED|Follow-up Period||4||
59596729|NCT02175966|75705943|FG001|COMPLETED|Follow-up Period||8||
59596730|NCT02175966|75705942|FG000|NOT COMPLETED|Follow-up Period||10||
59596731|NCT02175966|75705943|FG001|NOT COMPLETED|Follow-up Period||6||
59596732|NCT02153346|75705949|FG000|STARTED|Overall Study||101||
59596733|NCT02153346|75705949|FG000|COMPLETED|Overall Study||90||
59596734|NCT02153346|75705949|FG000|NOT COMPLETED|Overall Study||11||
59596735|NCT02174562|75705956|FG000|STARTED|Overall Study||50||
59596736|NCT02174562|75705957|FG001|STARTED|Overall Study||51||
59596737|NCT02174562|75705956|FG000|COMPLETED|Overall Study||41||
59596738|NCT02174562|75705957|FG001|COMPLETED|Overall Study||46||
59596739|NCT02174562|75705956|FG000|NOT COMPLETED|Overall Study||9||
59596740|NCT02174562|75705957|FG001|NOT COMPLETED|Overall Study||5||
59596741|NCT02136576|75705966|FG000|STARTED|Overall Study||13||13
59596742|NCT02136576|75705967|FG001|STARTED|Overall Study||13||13
59596743|NCT02136576|75705968|FG002|STARTED|Overall Study||13||13
59596744|NCT02136576|75705966|FG000|COMPLETED|Overall Study||11||11
59596745|NCT02136576|75705967|FG001|COMPLETED|Overall Study||13||13
59596746|NCT02136576|75705968|FG002|COMPLETED|Overall Study||13||13
59596747|NCT02136576|75705966|FG000|NOT COMPLETED|Overall Study||2||2
59596748|NCT02136576|75705967|FG001|NOT COMPLETED|Overall Study||0||0
59596749|NCT02136576|75705968|FG002|NOT COMPLETED|Overall Study||0||0
59596750|NCT03600194|75705976|FG000|STARTED|Screening||38||
59596751|NCT03600194|75705977|FG001|STARTED|Screening||0||
59596752|NCT03600194|75705978|FG002|STARTED|Screening||0||
59596753|NCT03600194|75705976|FG000|COMPLETED|Screening||11||
59596754|NCT03600194|75705977|FG001|COMPLETED|Screening||0||
59596755|NCT03600194|75705978|FG002|COMPLETED|Screening||0||
59596756|NCT03600194|75705976|FG000|NOT COMPLETED|Screening||27||
59596757|NCT03600194|75705977|FG001|NOT COMPLETED|Screening||0||
59596758|NCT03600194|75705978|FG002|NOT COMPLETED|Screening||0||
59596759|NCT03600194|75705976|FG000|STARTED|In Lab Phase||0||
59596760|NCT03600194|75705977|FG001|STARTED|In Lab Phase||5||
59596761|NCT03600194|75705978|FG002|STARTED|In Lab Phase||6||
59596762|NCT03600194|75705976|FG000|COMPLETED|In Lab Phase||0||
59596763|NCT03600194|75705977|FG001|COMPLETED|In Lab Phase||5||
59596764|NCT03600194|75705978|FG002|COMPLETED|In Lab Phase||6||
59596765|NCT03600194|75705976|FG000|NOT COMPLETED|In Lab Phase||0||
59596766|NCT03600194|75705977|FG001|NOT COMPLETED|In Lab Phase||0||
59596767|NCT03600194|75705978|FG002|NOT COMPLETED|In Lab Phase||0||
59596768|NCT03398330|75705991|FG000|STARTED|Period 1||21||
59596769|NCT03398330|75705992|FG001|STARTED|Period 1||21||
59596770|NCT03398330|75705991|FG000|COMPLETED|Period 1||20||
59596771|NCT03398330|75705992|FG001|COMPLETED|Period 1||17||
59596772|NCT03398330|75705991|FG000|NOT COMPLETED|Period 1||1||
59596773|NCT03398330|75705992|FG001|NOT COMPLETED|Period 1||4||
59596774|NCT03398330|75705991|FG000|STARTED|Period 2||20||
59596775|NCT03398330|75705992|FG001|STARTED|Period 2||17||
59596776|NCT03398330|75705991|FG000|COMPLETED|Period 2||19||
59596777|NCT03398330|75705992|FG001|COMPLETED|Period 2||17||
59596778|NCT03398330|75705991|FG000|NOT COMPLETED|Period 2||1||
59596779|NCT03398330|75705992|FG001|NOT COMPLETED|Period 2||0||
59596780|NCT03398798|75706016|FG000|STARTED|Overall Study||9||
59596781|NCT03398798|75706017|FG001|STARTED|Overall Study||9||
59596782|NCT03398798|75706018|FG002|STARTED|Overall Study||9||
59596783|NCT03398798|75706019|FG003|STARTED|Overall Study||9||
59596784|NCT03398798|75706016|FG000|COMPLETED|Overall Study||9||
59596785|NCT03398798|75706017|FG001|COMPLETED|Overall Study||9||
59596786|NCT03398798|75706018|FG002|COMPLETED|Overall Study||9||
59596787|NCT03398798|75706019|FG003|COMPLETED|Overall Study||9||
59596788|NCT03398798|75706016|FG000|NOT COMPLETED|Overall Study||0||
59596789|NCT03398798|75706017|FG001|NOT COMPLETED|Overall Study||0||
59596790|NCT03398798|75706018|FG002|NOT COMPLETED|Overall Study||0||
59596791|NCT03398798|75706019|FG003|NOT COMPLETED|Overall Study||0||
59596792|NCT03400748|75706029|FG000|STARTED|Overall Study||6||
59596793|NCT03400748|75706029|FG000|COMPLETED|Overall Study||6||
59596794|NCT03400748|75706029|FG000|NOT COMPLETED|Overall Study||0||
59596795|NCT03505190|75706038|FG000|STARTED|Overall Study||9||
59596796|NCT03505190|75706039|FG001|STARTED|Overall Study||8||
59596797|NCT03505190|75706040|FG002|STARTED|Overall Study||8||
59596798|NCT03505190|75706041|FG003|STARTED|Overall Study||8||
59596799|NCT03505190|75706042|FG004|STARTED|Overall Study||8||
59596800|NCT03505190|75706038|FG000|COMPLETED|Overall Study||9||
59596801|NCT03505190|75706039|FG001|COMPLETED|Overall Study||8||
59596802|NCT03505190|75706040|FG002|COMPLETED|Overall Study||8||
59596803|NCT03505190|75706041|FG003|COMPLETED|Overall Study||8||
59596804|NCT03505190|75706042|FG004|COMPLETED|Overall Study||8||
59596805|NCT03505190|75706038|FG000|NOT COMPLETED|Overall Study||0||
59596806|NCT03505190|75706039|FG001|NOT COMPLETED|Overall Study||0||
59596807|NCT03505190|75706040|FG002|NOT COMPLETED|Overall Study||0||
59596808|NCT03505190|75706041|FG003|NOT COMPLETED|Overall Study||0||
59596809|NCT03505190|75706042|FG004|NOT COMPLETED|Overall Study||0||
59596810|NCT03513848|75706056|FG000|STARTED|Overall Study||9||
59596811|NCT03513848|75706057|FG001|STARTED|Overall Study||6||
59596812|NCT03513848|75706056|FG000|COMPLETED|Overall Study||9||
59596813|NCT03513848|75706057|FG001|COMPLETED|Overall Study||6||
59596814|NCT03513848|75706056|FG000|NOT COMPLETED|Overall Study||0||
59596815|NCT03513848|75706057|FG001|NOT COMPLETED|Overall Study||0||
59596816|NCT03402932|75706067|FG000|STARTED|Overall Study||13||
59596817|NCT03402932|75706068|FG001|STARTED|Overall Study||8||
59596818|NCT03402932|75706069|FG002|STARTED|Overall Study||8||
59596819|NCT03402932|75706070|FG003|STARTED|Overall Study||8||
59596820|NCT03402932|75706067|FG000|COMPLETED|Overall Study||13||
59596821|NCT03402932|75706068|FG001|COMPLETED|Overall Study||8||
59596822|NCT03402932|75706069|FG002|COMPLETED|Overall Study||8||
59596823|NCT03402932|75706070|FG003|COMPLETED|Overall Study||8||
59596824|NCT03402932|75706067|FG000|NOT COMPLETED|Overall Study||0||
59596825|NCT03402932|75706068|FG001|NOT COMPLETED|Overall Study||0||
59596826|NCT03402932|75706069|FG002|NOT COMPLETED|Overall Study||0||
59596827|NCT03402932|75706070|FG003|NOT COMPLETED|Overall Study||0||
59596828|NCT03621878|75706087|FG000|STARTED|Overall Study||17|the data from subject whom completed the trials only was used in the statistical analysis and result|
59596829|NCT03621878|75706088|FG001|STARTED|Overall Study||17|the data from subject whom completed the trials only was used in the statistical analysis and result|
59596830|NCT03621878|75706089|FG002|STARTED|Overall Study||17|the data from subject whom completed the trials only was used in the statistical analysis and result|
59596831|NCT03621878|75706087|FG000|COMPLETED|Overall Study||17||
59596832|NCT03621878|75706088|FG001|COMPLETED|Overall Study||17||
59596833|NCT03621878|75706089|FG002|COMPLETED|Overall Study||17||
59596834|NCT03621878|75706087|FG000|NOT COMPLETED|Overall Study||0||
59596835|NCT03621878|75706088|FG001|NOT COMPLETED|Overall Study||0||
59596836|NCT03621878|75706089|FG002|NOT COMPLETED|Overall Study||0||
59596837|NCT03403712|75706099|FG000|STARTED|Overall Study||200||
59596838|NCT03403712|75706100|FG001|STARTED|Overall Study||202||
59596839|NCT03403712|75706099|FG000|COMPLETED|Overall Study||95||
59596840|NCT03403712|75706100|FG001|COMPLETED|Overall Study||102||
59596841|NCT03403712|75706099|FG000|NOT COMPLETED|Overall Study||105||
59596842|NCT03403712|75706100|FG001|NOT COMPLETED|Overall Study||100||
59596843|NCT03404648|75706106|FG000|STARTED|Overall Study||19||
59596844|NCT03404648|75706106|FG000|COMPLETED|Overall Study||19||
59596845|NCT03404648|75706106|FG000|NOT COMPLETED|Overall Study||0||
59596846|NCT03383198|75706112|FG000|STARTED|Overall Study||4||
59596847|NCT03383198|75706113|FG001|STARTED|Overall Study||1||
59596848|NCT03383198|75706112|FG000|COMPLETED|Overall Study||4||
59596849|NCT03383198|75706113|FG001|COMPLETED|Overall Study||1||
59596850|NCT03383198|75706112|FG000|NOT COMPLETED|Overall Study||0||
59596851|NCT03383198|75706113|FG001|NOT COMPLETED|Overall Study||0||
59596852|NCT03407612|75706121|FG000|STARTED|Overall Study||19||
59596853|NCT03407612|75706122|FG001|STARTED|Overall Study||23||
59596854|NCT03407612|75706121|FG000|COMPLETED|Overall Study||19||
59596855|NCT03407612|75706122|FG001|COMPLETED|Overall Study||23||
59596856|NCT03407612|75706121|FG000|NOT COMPLETED|Overall Study||0||
59596857|NCT03407612|75706122|FG001|NOT COMPLETED|Overall Study||0||
59596858|NCT03408392|75706128|FG000|STARTED|Treatment Period 1 (16 Days)||14||
59596859|NCT03408392|75706129|FG001|STARTED|Treatment Period 1 (16 Days)||14||
59596860|NCT03408392|75706128|FG000|COMPLETED|Treatment Period 1 (16 Days)||14||
59596861|NCT03408392|75706129|FG001|COMPLETED|Treatment Period 1 (16 Days)||14||
59596862|NCT03408392|75706128|FG000|NOT COMPLETED|Treatment Period 1 (16 Days)||0||
59596863|NCT03408392|75706129|FG001|NOT COMPLETED|Treatment Period 1 (16 Days)||0||
59596864|NCT03408392|75706128|FG000|STARTED|Wash-out Period (14 Days)||14||
59596865|NCT03408392|75706129|FG001|STARTED|Wash-out Period (14 Days)||14||
59596866|NCT03408392|75706128|FG000|COMPLETED|Wash-out Period (14 Days)||14||
59596867|NCT03408392|75706129|FG001|COMPLETED|Wash-out Period (14 Days)||14||
59596868|NCT03408392|75706128|FG000|NOT COMPLETED|Wash-out Period (14 Days)||0||
59596869|NCT03408392|75706129|FG001|NOT COMPLETED|Wash-out Period (14 Days)||0||
59596870|NCT03408392|75706128|FG000|STARTED|Treatment Period 2 (16 Days)||14||
59596871|NCT03408392|75706129|FG001|STARTED|Treatment Period 2 (16 Days)||14||
59596872|NCT03408392|75706128|FG000|COMPLETED|Treatment Period 2 (16 Days)||14||
59596873|NCT03408392|75706129|FG001|COMPLETED|Treatment Period 2 (16 Days)||14||
59596874|NCT03408392|75706128|FG000|NOT COMPLETED|Treatment Period 2 (16 Days)||0||
59596875|NCT03408392|75706129|FG001|NOT COMPLETED|Treatment Period 2 (16 Days)||0||
59596876|NCT03413618|75706137|FG000|STARTED|Overall Study||45||
59596877|NCT03413618|75706138|FG001|STARTED|Overall Study||45||
59596878|NCT03413618|75706137|FG000|COMPLETED|Overall Study||45||
59596879|NCT03413618|75706138|FG001|COMPLETED|Overall Study||45||
59596880|NCT03413618|75706137|FG000|NOT COMPLETED|Overall Study||0||
59596881|NCT03413618|75706138|FG001|NOT COMPLETED|Overall Study||0||
59596882|NCT03522350|75706144|FG000|STARTED|Overall Study||18||115
59596883|NCT03522350|75706145|FG001|STARTED|Overall Study||18||116
59596884|NCT03522350|75706144|FG000|COMPLETED|Overall Study||18||115
59596885|NCT03522350|75706145|FG001|COMPLETED|Overall Study||18||116
59596886|NCT03522350|75706144|FG000|NOT COMPLETED|Overall Study||0||0
59596887|NCT03522350|75706145|FG001|NOT COMPLETED|Overall Study||0||0
59596888|NCT03523988|75706153|FG000|STARTED|Overall Study||24||
59596889|NCT03523988|75706154|FG001|STARTED|Overall Study||24||
59596890|NCT03523988|75706155|FG002|STARTED|Overall Study||25||
59596891|NCT03523988|75706153|FG000|COMPLETED|Overall Study||7||
59596892|NCT03523988|75706154|FG001|COMPLETED|Overall Study||8||
59596893|NCT03523988|75706155|FG002|COMPLETED|Overall Study||7||
59596894|NCT03523988|75706153|FG000|NOT COMPLETED|Overall Study||17||
59596895|NCT03523988|75706154|FG001|NOT COMPLETED|Overall Study||16||
59596896|NCT03523988|75706155|FG002|NOT COMPLETED|Overall Study||18||
59596897|NCT03525548|75706165|FG000|STARTED|Overall Study||52||
59596898|NCT03525548|75706166|FG001|STARTED|Overall Study||55||
59596899|NCT03525548|75706165|FG000|COMPLETED|Overall Study||52||
59596900|NCT03525548|75706166|FG001|COMPLETED|Overall Study||55||
59596901|NCT03525548|75706165|FG000|NOT COMPLETED|Overall Study||0||
59596902|NCT03525548|75706166|FG001|NOT COMPLETED|Overall Study||0||
59596903|NCT03528512|75706174|FG000|STARTED|Overall Study||3||
59596904|NCT03528512|75706175|FG001|STARTED|Overall Study||2||
59596905|NCT03528512|75706174|FG000|COMPLETED|Overall Study||3||
59596906|NCT03528512|75706175|FG001|COMPLETED|Overall Study||2||
59596907|NCT03528512|75706174|FG000|NOT COMPLETED|Overall Study||0||
59596908|NCT03528512|75706175|FG001|NOT COMPLETED|Overall Study||0||
59596909|NCT03531710|75706187|FG000|STARTED|Overall Study||10||
59596910|NCT03531710|75706188|FG001|STARTED|Overall Study||2||
59596911|NCT03531710|75706189|FG002|STARTED|Overall Study||7||
59596912|NCT03531710|75706190|FG003|STARTED|Overall Study||5||
59596913|NCT03531710|75706191|FG004|STARTED|Overall Study||8||
59596914|NCT03531710|75706192|FG005|STARTED|Overall Study||2||
59596915|NCT03531710|75706187|FG000|COMPLETED|Overall Study||8||
59596916|NCT03531710|75706188|FG001|COMPLETED|Overall Study||2||
59596917|NCT03531710|75706189|FG002|COMPLETED|Overall Study||7||
59596918|NCT03531710|75706190|FG003|COMPLETED|Overall Study||5||
59596919|NCT03531710|75706191|FG004|COMPLETED|Overall Study||8||
59596920|NCT03531710|75706192|FG005|COMPLETED|Overall Study||2||
59596921|NCT03531710|75706187|FG000|NOT COMPLETED|Overall Study||2||
59596922|NCT03531710|75706188|FG001|NOT COMPLETED|Overall Study||0||
59596923|NCT03531710|75706189|FG002|NOT COMPLETED|Overall Study||0||
59596924|NCT03531710|75706190|FG003|NOT COMPLETED|Overall Study||0||
59596925|NCT03531710|75706191|FG004|NOT COMPLETED|Overall Study||0||
59596926|NCT03531710|75706192|FG005|NOT COMPLETED|Overall Study||0||
59596927|NCT03533036|75706208|FG000|STARTED|Overall Study||15||
59596928|NCT03533036|75706209|FG001|STARTED|Overall Study||15||
59596929|NCT03533036|75706208|FG000|COMPLETED|Overall Study||15||
59596930|NCT03533036|75706209|FG001|COMPLETED|Overall Study||15||
59596931|NCT03533036|75706208|FG000|NOT COMPLETED|Overall Study||0||
59596932|NCT03533036|75706209|FG001|NOT COMPLETED|Overall Study||0||
59596933|NCT02153112|75706225|FG000|STARTED|Overall Study||61||
59596934|NCT02153112|75706226|FG001|STARTED|Overall Study||59||
59596935|NCT02153112|75706227|FG002|STARTED|Overall Study||61||
59596936|NCT02153112|75706228|FG003|STARTED|Overall Study||59||
59596937|NCT02153112|75706229|FG004|STARTED|Overall Study||60||
59596938|NCT02153112|75706230|FG005|STARTED|Overall Study||60||
59596939|NCT02153112|75706231|FG006|STARTED|Overall Study||60||
59596940|NCT02153112|75706232|FG007|STARTED|Overall Study||60||
59596941|NCT02153112|75706233|FG008|STARTED|Overall Study||180||
59596942|NCT02153112|75706234|FG009|STARTED|Overall Study||180||
59596943|NCT02153112|75706225|FG000|COMPLETED|Overall Study||57||
59596944|NCT02153112|75706226|FG001|COMPLETED|Overall Study||57||
59596945|NCT02153112|75706227|FG002|COMPLETED|Overall Study||58||
59596946|NCT02153112|75706228|FG003|COMPLETED|Overall Study||57||
59596947|NCT02153112|75706229|FG004|COMPLETED|Overall Study||57||
59596948|NCT02153112|75706230|FG005|COMPLETED|Overall Study||58||
59596949|NCT02153112|75706231|FG006|COMPLETED|Overall Study||52||
59596950|NCT02153112|75706232|FG007|COMPLETED|Overall Study||58||
59596951|NCT02153112|75706233|FG008|COMPLETED|Overall Study||165||
59596952|NCT02153112|75706234|FG009|COMPLETED|Overall Study||166||
59596953|NCT02153112|75706225|FG000|NOT COMPLETED|Overall Study||4||
59596954|NCT02153112|75706226|FG001|NOT COMPLETED|Overall Study||2||
59596955|NCT02153112|75706227|FG002|NOT COMPLETED|Overall Study||3||
59596956|NCT02153112|75706228|FG003|NOT COMPLETED|Overall Study||2||
59596957|NCT02153112|75706229|FG004|NOT COMPLETED|Overall Study||3||
59596958|NCT02153112|75706230|FG005|NOT COMPLETED|Overall Study||2||
59596959|NCT02153112|75706231|FG006|NOT COMPLETED|Overall Study||8||
59596960|NCT02153112|75706232|FG007|NOT COMPLETED|Overall Study||2||
59596961|NCT02153112|75706233|FG008|NOT COMPLETED|Overall Study||15||
59596962|NCT02153112|75706234|FG009|NOT COMPLETED|Overall Study||14||
59596963|NCT03534986|75706261|FG000|STARTED|Overall Study||10||
59596964|NCT03534986|75706262|FG001|STARTED|Overall Study||10||
59596965|NCT03534986|75706263|FG002|STARTED|Overall Study||12||
59596966|NCT03534986|75706261|FG000|COMPLETED|Overall Study||10||
59596967|NCT03534986|75706262|FG001|COMPLETED|Overall Study||10||
59596968|NCT03534986|75706263|FG002|COMPLETED|Overall Study||10||
59596969|NCT03534986|75706261|FG000|NOT COMPLETED|Overall Study||0||
59596970|NCT03534986|75706262|FG001|NOT COMPLETED|Overall Study||0||
59596971|NCT03534986|75706263|FG002|NOT COMPLETED|Overall Study||2||
59596972|NCT03536702|75706273|FG000|STARTED|Overall Study||40||
59596973|NCT03536702|75706274|FG001|STARTED|Overall Study||20||
59596974|NCT03536702|75706273|FG000|COMPLETED|Overall Study||26|Competers are those who signed consent took baseline measures and at least one class|
59596975|NCT03536702|75706274|FG001|COMPLETED|Overall Study||8|Competers are those who signed consent took baseline measures and at least one class|
59596976|NCT03536702|75706273|FG000|NOT COMPLETED|Overall Study||14||
59728521|NCT00812929|75847155|FG006|STARTED|Treatment Period 5||5||
59596977|NCT03536702|75706274|FG001|NOT COMPLETED|Overall Study||12||
59596978|NCT03537092|75706280|FG000|STARTED|Overall Study||64||
59596979|NCT03537092|75706280|FG000|COMPLETED|Overall Study||64||
59596980|NCT03537092|75706280|FG000|NOT COMPLETED|Overall Study||0||
59596981|NCT02133924|75706284|FG000|STARTED|Overall Study||76||
59596982|NCT02133924|75706284|FG000|COMPLETED|Overall Study||34||
59596983|NCT02133924|75706284|FG000|NOT COMPLETED|Overall Study||42||
59596984|NCT03624920|75706294|FG000|STARTED|Overall Study||14||
59596985|NCT03624920|75706295|FG001|STARTED|Overall Study||14||
59596986|NCT03624920|75706296|FG002|STARTED|Overall Study||13||
59596987|NCT03624920|75706297|FG003|STARTED|Overall Study||13||
59596988|NCT03624920|75706298|FG004|STARTED|Overall Study||11||
59596989|NCT03624920|75706299|FG005|STARTED|Overall Study||12||
59596990|NCT03624920|75706294|FG000|COMPLETED|Overall Study||13||
59596991|NCT03624920|75706295|FG001|COMPLETED|Overall Study||12||
59596992|NCT03624920|75706296|FG002|COMPLETED|Overall Study||12||
59596993|NCT03624920|75706297|FG003|COMPLETED|Overall Study||12||
59596994|NCT03624920|75706298|FG004|COMPLETED|Overall Study||7||
59596995|NCT03624920|75706299|FG005|COMPLETED|Overall Study||11||
59596996|NCT03624920|75706294|FG000|NOT COMPLETED|Overall Study||1||
59596997|NCT03624920|75706295|FG001|NOT COMPLETED|Overall Study||2||
59596998|NCT03624920|75706296|FG002|NOT COMPLETED|Overall Study||1||
59596999|NCT03624920|75706297|FG003|NOT COMPLETED|Overall Study||1||
59597000|NCT03624920|75706298|FG004|NOT COMPLETED|Overall Study||4||
59597001|NCT03624920|75706299|FG005|NOT COMPLETED|Overall Study||1||
59597002|NCT03537404|75706310|FG000|STARTED|First Intervention (A or B or C)||18||
59597003|NCT03537404|75706311|FG001|STARTED|First Intervention (A or B or C)||18||
59597004|NCT03537404|75706310|FG000|COMPLETED|First Intervention (A or B or C)||18||
59597005|NCT03537404|75706311|FG001|COMPLETED|First Intervention (A or B or C)||18||
59597006|NCT03537404|75706310|FG000|NOT COMPLETED|First Intervention (A or B or C)||0||
59597007|NCT03537404|75706311|FG001|NOT COMPLETED|First Intervention (A or B or C)||0||
59597008|NCT03537404|75706310|FG000|STARTED|First Washout Period (8 Days)||18||
59597009|NCT03537404|75706311|FG001|STARTED|First Washout Period (8 Days)||18||
59597010|NCT03537404|75706310|FG000|COMPLETED|First Washout Period (8 Days)||18||
59597011|NCT03537404|75706311|FG001|COMPLETED|First Washout Period (8 Days)||18||
59597012|NCT03537404|75706310|FG000|NOT COMPLETED|First Washout Period (8 Days)||0||
59597013|NCT03537404|75706311|FG001|NOT COMPLETED|First Washout Period (8 Days)||0||
59597014|NCT03537404|75706310|FG000|STARTED|Second Intervention (A or B or C)||18||
59597015|NCT03537404|75706311|FG001|STARTED|Second Intervention (A or B or C)||18||
59597016|NCT03537404|75706310|FG000|COMPLETED|Second Intervention (A or B or C)||18||
59597017|NCT03537404|75706311|FG001|COMPLETED|Second Intervention (A or B or C)||18||
59597018|NCT03537404|75706310|FG000|NOT COMPLETED|Second Intervention (A or B or C)||0||
59597019|NCT03537404|75706311|FG001|NOT COMPLETED|Second Intervention (A or B or C)||0||
59597020|NCT03537404|75706310|FG000|STARTED|Second Washout Period (8 Days)||18||
59597021|NCT03537404|75706311|FG001|STARTED|Second Washout Period (8 Days)||18||
59597022|NCT03537404|75706310|FG000|COMPLETED|Second Washout Period (8 Days)||18||
59597023|NCT03537404|75706311|FG001|COMPLETED|Second Washout Period (8 Days)||18||
59597024|NCT03537404|75706310|FG000|NOT COMPLETED|Second Washout Period (8 Days)||0||
59597025|NCT03537404|75706311|FG001|NOT COMPLETED|Second Washout Period (8 Days)||0||
59597026|NCT03537404|75706310|FG000|STARTED|Third Intervention (A or B or C)||18||
59597027|NCT03537404|75706311|FG001|STARTED|Third Intervention (A or B or C)||18||
59597028|NCT03537404|75706310|FG000|COMPLETED|Third Intervention (A or B or C)||18||
59597029|NCT03537404|75706311|FG001|COMPLETED|Third Intervention (A or B or C)||18||
59597030|NCT03537404|75706310|FG000|NOT COMPLETED|Third Intervention (A or B or C)||0||
59597031|NCT03537404|75706311|FG001|NOT COMPLETED|Third Intervention (A or B or C)||0||
59597032|NCT03417752|75706338|FG000|STARTED|Overall Study||149||
59597033|NCT03417752|75706339|FG001|STARTED|Overall Study||175||
59597034|NCT03417752|75706340|FG002|STARTED|Overall Study||150||
59597035|NCT03417752|75706338|FG000|COMPLETED|Overall Study||115||
59597036|NCT03417752|75706339|FG001|COMPLETED|Overall Study||133||
59597037|NCT03417752|75706340|FG002|COMPLETED|Overall Study||110||
59597038|NCT03417752|75706338|FG000|NOT COMPLETED|Overall Study||34||
59597039|NCT03417752|75706339|FG001|NOT COMPLETED|Overall Study||42||
59597040|NCT03417752|75706340|FG002|NOT COMPLETED|Overall Study||40||
59597041|NCT03626714|75706348|FG000|STARTED|Overall Study||8||
59597042|NCT03626714|75706348|FG000|COMPLETED|Overall Study||8||
59597043|NCT03626714|75706348|FG000|NOT COMPLETED|Overall Study||0||
59597044|NCT03538808|75706356|FG000|STARTED|Overall Study||20||
59597045|NCT03538808|75706357|FG001|STARTED|Overall Study||20||
59597046|NCT03538808|75706358|FG002|STARTED|Overall Study||20||
59728522|NCT00812929|75847156|FG007|STARTED|Treatment Period 5||5||
59728523|NCT00812929|75847157|FG008|STARTED|Treatment Period 5||4||
59597047|NCT03538808|75706359|FG003|STARTED|Overall Study||20||
59597048|NCT03538808|75706356|FG000|COMPLETED|Overall Study||18||
59597049|NCT03538808|75706357|FG001|COMPLETED|Overall Study||20||
59597050|NCT03538808|75706358|FG002|COMPLETED|Overall Study||16||
59597051|NCT03538808|75706359|FG003|COMPLETED|Overall Study||18||
59597052|NCT03538808|75706356|FG000|NOT COMPLETED|Overall Study||2||
59597053|NCT03538808|75706357|FG001|NOT COMPLETED|Overall Study||0||
59597054|NCT03538808|75706358|FG002|NOT COMPLETED|Overall Study||4||
59597055|NCT03538808|75706359|FG003|NOT COMPLETED|Overall Study||2||
59597056|NCT03540134|75706369|FG000|STARTED|Overall Study||4||
59597057|NCT03540134|75706369|FG000|COMPLETED|Overall Study||4||
59597058|NCT03540134|75706369|FG000|NOT COMPLETED|Overall Study||0||
59597059|NCT02173704|75706375|FG000|STARTED|Overall Study||150||
59597060|NCT02173704|75706376|FG001|STARTED|Overall Study||75||
59597061|NCT02173704|75706375|FG000|COMPLETED|Overall Study||137||
59597062|NCT02173704|75706376|FG001|COMPLETED|Overall Study||71||
59597063|NCT02173704|75706375|FG000|NOT COMPLETED|Overall Study||13||
59597064|NCT02173704|75706376|FG001|NOT COMPLETED|Overall Study||4||
59597065|NCT03542474|75706382|FG000|STARTED|Overall Study||8||
59597066|NCT03542474|75706382|FG000|COMPLETED|Overall Study||8||
59597067|NCT03542474|75706382|FG000|NOT COMPLETED|Overall Study||0||
59597068|NCT03543176|75706388|FG000|STARTED|Overall Study||392||
59597069|NCT03543176|75706389|FG001|STARTED|Overall Study||397||
59597070|NCT03543176|75706388|FG000|COMPLETED|Overall Study||392||
59597071|NCT03543176|75706389|FG001|COMPLETED|Overall Study||397||
59597072|NCT03543176|75706388|FG000|NOT COMPLETED|Overall Study||0||
59597073|NCT03543176|75706389|FG001|NOT COMPLETED|Overall Study||0||
59597074|NCT02173548|75706397|FG000|STARTED|Overall Study||21||
59597075|NCT02173548|75706398|FG001|STARTED|Overall Study||10||
59597076|NCT02173548|75706397|FG000|COMPLETED|Overall Study||20||
59597077|NCT02173548|75706398|FG001|COMPLETED|Overall Study||8||
59597078|NCT02173548|75706397|FG000|NOT COMPLETED|Overall Study||1||
59597079|NCT02173548|75706398|FG001|NOT COMPLETED|Overall Study||2||
59597080|NCT03543878|75706406|FG000|STARTED|Overall Study||5||
59597081|NCT03543878|75706407|FG001|STARTED|Overall Study||5||
59597082|NCT03543878|75706406|FG000|COMPLETED|Overall Study||5||
59597083|NCT03543878|75706407|FG001|COMPLETED|Overall Study||5||
59597084|NCT03543878|75706406|FG000|NOT COMPLETED|Overall Study||0||
59597085|NCT03543878|75706407|FG001|NOT COMPLETED|Overall Study||0||
59597086|NCT02173158|75706414|FG000|STARTED|Efficacy Phase||9||
59597087|NCT02173158|75706414|FG000|COMPLETED|Efficacy Phase||8||
59597088|NCT02173158|75706414|FG000|NOT COMPLETED|Efficacy Phase||1||
59597089|NCT02173158|75706414|FG000|STARTED|Safety Phase||8||
59597090|NCT02173158|75706414|FG000|COMPLETED|Safety Phase||8||
59597091|NCT02173158|75706414|FG000|NOT COMPLETED|Safety Phase||0||
59597092|NCT04501640|75706423|FG000|STARTED|Period 1 (5 Days)||6||
59597093|NCT04501640|75706424|FG001|STARTED|Period 1 (5 Days)||6||
59597094|NCT04501640|75706425|FG002|STARTED|Period 1 (5 Days)||6||
59597095|NCT04501640|75706426|FG003|STARTED|Period 1 (5 Days)||6||
59597096|NCT04501640|75706423|FG000|COMPLETED|Period 1 (5 Days)||6||
59597097|NCT04501640|75706424|FG001|COMPLETED|Period 1 (5 Days)||6||
59597098|NCT04501640|75706425|FG002|COMPLETED|Period 1 (5 Days)||6||
59597099|NCT04501640|75706426|FG003|COMPLETED|Period 1 (5 Days)||6||
59597100|NCT04501640|75706423|FG000|NOT COMPLETED|Period 1 (5 Days)||0||
59597101|NCT04501640|75706424|FG001|NOT COMPLETED|Period 1 (5 Days)||0||
59597102|NCT04501640|75706425|FG002|NOT COMPLETED|Period 1 (5 Days)||0||
59597103|NCT04501640|75706426|FG003|NOT COMPLETED|Period 1 (5 Days)||0||
59597104|NCT04501640|75706423|FG000|STARTED|Washout Period (10 Days)||6||
59597105|NCT04501640|75706424|FG001|STARTED|Washout Period (10 Days)||6||
59597106|NCT04501640|75706425|FG002|STARTED|Washout Period (10 Days)||6||
59597107|NCT04501640|75706426|FG003|STARTED|Washout Period (10 Days)||6||
59597108|NCT04501640|75706423|FG000|COMPLETED|Washout Period (10 Days)||6||
59597109|NCT04501640|75706424|FG001|COMPLETED|Washout Period (10 Days)||6||
59597110|NCT04501640|75706425|FG002|COMPLETED|Washout Period (10 Days)||6||
59597111|NCT04501640|75706426|FG003|COMPLETED|Washout Period (10 Days)||6||
59597112|NCT04501640|75706423|FG000|NOT COMPLETED|Washout Period (10 Days)||0||
59597113|NCT04501640|75706424|FG001|NOT COMPLETED|Washout Period (10 Days)||0||
59597114|NCT04501640|75706425|FG002|NOT COMPLETED|Washout Period (10 Days)||0||
59597115|NCT04501640|75706426|FG003|NOT COMPLETED|Washout Period (10 Days)||0||
59597116|NCT04501640|75706423|FG000|STARTED|Period 2 (5 Days)||6||
59597117|NCT04501640|75706424|FG001|STARTED|Period 2 (5 Days)||6||
59597118|NCT04501640|75706425|FG002|STARTED|Period 2 (5 Days)||6||
59597119|NCT04501640|75706426|FG003|STARTED|Period 2 (5 Days)||6||
59597120|NCT04501640|75706423|FG000|COMPLETED|Period 2 (5 Days)||6||
59597121|NCT04501640|75706424|FG001|COMPLETED|Period 2 (5 Days)||6||
59597122|NCT04501640|75706425|FG002|COMPLETED|Period 2 (5 Days)||6||
59597123|NCT04501640|75706426|FG003|COMPLETED|Period 2 (5 Days)||6||
59597124|NCT04501640|75706423|FG000|NOT COMPLETED|Period 2 (5 Days)||0||
59597125|NCT04501640|75706424|FG001|NOT COMPLETED|Period 2 (5 Days)||0||
59597126|NCT04501640|75706425|FG002|NOT COMPLETED|Period 2 (5 Days)||0||
59597127|NCT04501640|75706426|FG003|NOT COMPLETED|Period 2 (5 Days)||0||
59597128|NCT02152566|75706436|FG000|STARTED|Overall Study||6||
59597129|NCT02152566|75706436|FG000|COMPLETED|Overall Study||3||
59597130|NCT02152566|75706436|FG000|NOT COMPLETED|Overall Study||3||
59597131|NCT03632954|75706440|FG000|STARTED|Overall Study||37||
59597132|NCT03632954|75706440|FG000|COMPLETED|Overall Study||3||
59597133|NCT03632954|75706440|FG000|NOT COMPLETED|Overall Study||34||
59597134|NCT04559282|75706444|FG000|STARTED|Intervention 1 (Day 0)||8||
59597135|NCT04559282|75706445|FG001|STARTED|Intervention 1 (Day 0)||8||
59597136|NCT04559282|75706444|FG000|COMPLETED|Intervention 1 (Day 0)||8||
59597137|NCT04559282|75706445|FG001|COMPLETED|Intervention 1 (Day 0)||8||
59597138|NCT04559282|75706444|FG000|NOT COMPLETED|Intervention 1 (Day 0)||0||
59597139|NCT04559282|75706445|FG001|NOT COMPLETED|Intervention 1 (Day 0)||0||
59597140|NCT04559282|75706444|FG000|STARTED|Intervention 2 (Day 7)||8||
59597141|NCT04559282|75706445|FG001|STARTED|Intervention 2 (Day 7)||8||
59597142|NCT04559282|75706444|FG000|COMPLETED|Intervention 2 (Day 7)||8||
59597143|NCT04559282|75706445|FG001|COMPLETED|Intervention 2 (Day 7)||8||
59597144|NCT04559282|75706444|FG000|NOT COMPLETED|Intervention 2 (Day 7)||0||
59597145|NCT04559282|75706445|FG001|NOT COMPLETED|Intervention 2 (Day 7)||0||
59597146|NCT04559282|75706444|FG000|STARTED|Intervention 3 (Day 14)||8||
59597147|NCT04559282|75706445|FG001|STARTED|Intervention 3 (Day 14)||8||
59597148|NCT04559282|75706444|FG000|COMPLETED|Intervention 3 (Day 14)||8||
59597149|NCT04559282|75706445|FG001|COMPLETED|Intervention 3 (Day 14)||8||
59597150|NCT04559282|75706444|FG000|NOT COMPLETED|Intervention 3 (Day 14)||0||
59597151|NCT04559282|75706445|FG001|NOT COMPLETED|Intervention 3 (Day 14)||0||
59597152|NCT03633344|75706456|FG000|STARTED|Overall Study||120||
59597153|NCT03633344|75706457|FG001|STARTED|Overall Study||24||
59597154|NCT03633344|75706456|FG000|COMPLETED|Overall Study||120||
59597155|NCT03633344|75706457|FG001|COMPLETED|Overall Study||24||
59597156|NCT03633344|75706456|FG000|NOT COMPLETED|Overall Study||0||
59597157|NCT03633344|75706457|FG001|NOT COMPLETED|Overall Study||0||
59597158|NCT02171130|75706465|FG000|STARTED|Overall Study||129||
59597159|NCT02171130|75706465|FG000|Received at Least One Dose of Study Drug|Overall Study||87||
59597160|NCT02171130|75706465|FG000|Experienced Hypoglycemic Event|Overall Study|Experienced at least one hypoglycemic event and received at least one dose of study drug.|87||
59597161|NCT02171130|75706465|FG000|COMPLETED|Overall Study|Including participants who completed the 6-month study but did not experience any hypoglycemia event|101||
59597162|NCT02171130|75706465|FG000|NOT COMPLETED|Overall Study||28||
59597163|NCT04777214|75706471|FG000|STARTED|Initial Randomization||5||
59597164|NCT04777214|75706472|FG001|STARTED|Initial Randomization||5||
59597165|NCT04777214|75706471|FG000|COMPLETED|Initial Randomization||5||
59597166|NCT04777214|75706472|FG001|COMPLETED|Initial Randomization||5||
59597167|NCT04777214|75706471|FG000|NOT COMPLETED|Initial Randomization||0||
59597168|NCT04777214|75706472|FG001|NOT COMPLETED|Initial Randomization||0||
59597169|NCT04777214|75706471|FG000|STARTED|Sham Crossover to Active TMS Arm||0|Only patients initially randomized to Sham arm continue on the crossover arm. Patients initially randomized to Active arm do not crossover to Sham arm|
59597170|NCT04777214|75706472|FG001|STARTED|Sham Crossover to Active TMS Arm||5|Only patients initially randomized to Sham arm continue on the crossover arm. Patients initially randomized to Active arm do not crossover to Sham arm|
59597171|NCT04777214|75706471|FG000|COMPLETED|Sham Crossover to Active TMS Arm||0||
59597172|NCT04777214|75706472|FG001|COMPLETED|Sham Crossover to Active TMS Arm||5||
59597173|NCT04777214|75706471|FG000|NOT COMPLETED|Sham Crossover to Active TMS Arm||0||
59597174|NCT04777214|75706472|FG001|NOT COMPLETED|Sham Crossover to Active TMS Arm||0||
59597175|NCT04495712|75706482|FG000|STARTED|Overall Study||44||
59597176|NCT04495712|75706483|FG001|STARTED|Overall Study||46||
59597177|NCT04495712|75706482|FG000|COMPLETED|Overall Study||44||
59597178|NCT04495712|75706483|FG001|COMPLETED|Overall Study||46||
59597179|NCT04495712|75706482|FG000|NOT COMPLETED|Overall Study||0||
59597180|NCT04495712|75706483|FG001|NOT COMPLETED|Overall Study||0||
59597181|NCT04474496|75706489|FG000|STARTED|Overall Study||120||
59597182|NCT04474496|75706489|FG000|COMPLETED|Overall Study|120 individuals were deemed eligible based on inclusion criteria, completed at least 10 survey items, and were included in the final analytical sample|120||
59597183|NCT04474496|75706489|FG000|NOT COMPLETED|Overall Study||0||
59597184|NCT03552536|75706496|FG000|STARTED|Overall Study||5||
59597185|NCT03552536|75706497|FG001|STARTED|Overall Study||0||
59597186|NCT03552536|75706498|FG002|STARTED|Overall Study||0||
59597187|NCT03552536|75706496|FG000|COMPLETED|Overall Study||5||
59597188|NCT03552536|75706497|FG001|COMPLETED|Overall Study||0||
59597189|NCT03552536|75706498|FG002|COMPLETED|Overall Study||0||
59597190|NCT03552536|75706496|FG000|NOT COMPLETED|Overall Study||0||
59597191|NCT03552536|75706497|FG001|NOT COMPLETED|Overall Study||0||
59597192|NCT03552536|75706498|FG002|NOT COMPLETED|Overall Study||0||
59597193|NCT03553940|75706506|FG000|STARTED|Overall Study||22||
59597194|NCT03553940|75706507|FG001|STARTED|Overall Study||21||
59597195|NCT03553940|75706506|FG000|COMPLETED|Overall Study||22||
59597196|NCT03553940|75706507|FG001|COMPLETED|Overall Study||21||
59597197|NCT03553940|75706506|FG000|NOT COMPLETED|Overall Study||0||
59597198|NCT03553940|75706507|FG001|NOT COMPLETED|Overall Study||0||
59597199|NCT03554954|75706513|FG000|STARTED|Overall Study||108||
59597200|NCT03554954|75706513|FG000|COMPLETED|Overall Study||108||
59597201|NCT03554954|75706513|FG000|NOT COMPLETED|Overall Study||0||
59597202|NCT04448210|75706523|FG000|STARTED|Overall Study||22||
59597203|NCT04448210|75706524|FG001|STARTED|Overall Study||20||
59597204|NCT04448210|75706523|FG000|COMPLETED|Overall Study||22||
59597205|NCT04448210|75706524|FG001|COMPLETED|Overall Study||20||
59597206|NCT04448210|75706523|FG000|NOT COMPLETED|Overall Study||0||
59597207|NCT04448210|75706524|FG001|NOT COMPLETED|Overall Study||0||
59597208|NCT03640832|75706532|FG000|STARTED|Overall Study||44||
59597209|NCT03640832|75706533|FG001|STARTED|Overall Study||46||
59597210|NCT03640832|75706532|FG000|COMPLETED|Overall Study||44||
59597211|NCT03640832|75706533|FG001|COMPLETED|Overall Study||46||
59597212|NCT03640832|75706532|FG000|NOT COMPLETED|Overall Study||0||
59597213|NCT03640832|75706533|FG001|NOT COMPLETED|Overall Study||0||
59597214|NCT04458818|75706539|FG000|STARTED|Overall Study|May 01 2020|39||
59597215|NCT04458818|75706539|FG000|COMPLETED|Overall Study|Jan 30 2021|39||
59597216|NCT04458818|75706539|FG000|NOT COMPLETED|Overall Study||0||
59597217|NCT04456634|75706545|FG000|STARTED|Overall Study||6||
59597218|NCT04456634|75706546|FG001|STARTED|Overall Study||2||
59597219|NCT04456634|75706545|FG000|COMPLETED|Overall Study||5||
59597220|NCT04456634|75706546|FG001|COMPLETED|Overall Study||2||
59597221|NCT04456634|75706545|FG000|NOT COMPLETED|Overall Study||1||
59597222|NCT04456634|75706546|FG001|NOT COMPLETED|Overall Study||0||
59597223|NCT04454138|75706554|FG000|STARTED|Overall Study||65||
59597224|NCT04454138|75706555|FG001|STARTED|Overall Study||77||
59597225|NCT04454138|75706554|FG000|COMPLETED|Overall Study||65||
59597226|NCT04454138|75706555|FG001|COMPLETED|Overall Study||77||
59597227|NCT04454138|75706554|FG000|NOT COMPLETED|Overall Study||0||
59597228|NCT04454138|75706555|FG001|NOT COMPLETED|Overall Study||0||
59597229|NCT04431908|75706563|FG000|STARTED|Overall Study||1042||
59597230|NCT04431908|75706564|FG001|STARTED|Overall Study||278||
59597231|NCT04431908|75706563|FG000|COMPLETED|Overall Study||1042||
59597232|NCT04431908|75706564|FG001|COMPLETED|Overall Study||278||
59597233|NCT04431908|75706563|FG000|NOT COMPLETED|Overall Study||0||
59597234|NCT04431908|75706564|FG001|NOT COMPLETED|Overall Study||0||
59597235|NCT03558074|75706571|FG000|STARTED|Overall Study||26||
59597236|NCT03558074|75706571|FG000|COMPLETED|Overall Study||24||
59597237|NCT03558074|75706571|FG000|NOT COMPLETED|Overall Study||2||
59597238|NCT03558230|75706578|FG000|STARTED|Overall Study||7||
59597239|NCT03558230|75706579|FG001|STARTED|Overall Study||6||
59597240|NCT03558230|75706578|FG000|COMPLETED|Overall Study||7||
59597241|NCT03558230|75706579|FG001|COMPLETED|Overall Study||6||
59597242|NCT03558230|75706578|FG000|NOT COMPLETED|Overall Study||0||
59597243|NCT03558230|75706579|FG001|NOT COMPLETED|Overall Study||0||
59597244|NCT03560102|75706585|FG000|STARTED|Overall Study||1||
59597245|NCT03560102|75706585|FG000|COMPLETED|Overall Study||1||
59597246|NCT03560102|75706585|FG000|NOT COMPLETED|Overall Study||0||
59597247|NCT03562988|75706589|FG000|STARTED|Overall Study||17||
59597248|NCT03562988|75706590|FG001|STARTED|Overall Study||18||
59597249|NCT03562988|75706589|FG000|COMPLETED|Overall Study||15||
59597250|NCT03562988|75706590|FG001|COMPLETED|Overall Study||15||
59597251|NCT03562988|75706589|FG000|NOT COMPLETED|Overall Study||2||
59597252|NCT03562988|75706590|FG001|NOT COMPLETED|Overall Study||3||
59597253|NCT03644108|75706600|FG000|STARTED|Overall Study||30||
59597254|NCT03644108|75706600|FG000|COMPLETED|Overall Study||30||
59597255|NCT03644108|75706600|FG000|NOT COMPLETED|Overall Study||0||
59597256|NCT03565874|75706604|FG000|STARTED|Overall Study||6||
59597257|NCT03565874|75706604|FG000|COMPLETED|Overall Study||4||
59597258|NCT03565874|75706604|FG000|NOT COMPLETED|Overall Study||2||
59597259|NCT03569618|75706610|FG000|STARTED|Overall Study||23||
59597260|NCT03569618|75706611|FG001|STARTED|Overall Study||21||
59597261|NCT03569618|75706610|FG000|COMPLETED|Overall Study||20||
59597262|NCT03569618|75706611|FG001|COMPLETED|Overall Study||20||
59597263|NCT03569618|75706610|FG000|NOT COMPLETED|Overall Study||3||
59597264|NCT03569618|75706611|FG001|NOT COMPLETED|Overall Study||1||
59597265|NCT04425746|75706620|FG000|STARTED|Overall Study||9||
59597266|NCT04425746|75706621|FG001|STARTED|Overall Study||7||
59597267|NCT04425746|75706620|FG000|COMPLETED|Overall Study||9||
59597268|NCT04425746|75706621|FG001|COMPLETED|Overall Study||6||
59597269|NCT04425746|75706620|FG000|NOT COMPLETED|Overall Study||0||
59597270|NCT04425746|75706621|FG001|NOT COMPLETED|Overall Study||1||
59597271|NCT04402970|75706631|FG000|STARTED|Overall Study||10||
59597272|NCT04402970|75706632|FG001|STARTED|Overall Study||20||
59597273|NCT04402970|75706631|FG000|COMPLETED|Overall Study||10||
59597274|NCT04402970|75706632|FG001|COMPLETED|Overall Study||20||
59597275|NCT04402970|75706631|FG000|NOT COMPLETED|Overall Study||0||
59597276|NCT04402970|75706632|FG001|NOT COMPLETED|Overall Study||0||
59597277|NCT04392362|75706640|FG000|STARTED|Overall Study||23||
59597278|NCT04392362|75706641|FG001|STARTED|Overall Study||7||
59597279|NCT04392362|75706640|FG000|COMPLETED|Overall Study||23||
59597280|NCT04392362|75706641|FG001|COMPLETED|Overall Study||7||
59597281|NCT04392362|75706640|FG000|NOT COMPLETED|Overall Study||0||
59597282|NCT04392362|75706641|FG001|NOT COMPLETED|Overall Study||0||
59597283|NCT04390022|75706649|FG000|STARTED|Overall Study||12||
59597284|NCT04390022|75706650|FG001|STARTED|Overall Study||12||
59597285|NCT04390022|75706649|FG000|COMPLETED|Overall Study||12||
59597286|NCT04390022|75706650|FG001|COMPLETED|Overall Study||12||
59597287|NCT04390022|75706649|FG000|NOT COMPLETED|Overall Study||0||
59597288|NCT04390022|75706650|FG001|NOT COMPLETED|Overall Study||0||
59597289|NCT03649646|75706656|FG000|STARTED|Overall Study||4542||
59597290|NCT03649646|75706656|FG000|COMPLETED|Overall Study||4075||
59597291|NCT03649646|75706656|FG000|NOT COMPLETED|Overall Study||467||
59597292|NCT04370834|75706660|FG000|STARTED|Overall Study||1||
59597293|NCT04370834|75706660|FG000|COMPLETED|Overall Study||1||
59597294|NCT04370834|75706660|FG000|NOT COMPLETED|Overall Study||0||
59597295|NCT03570476|75706670|FG000|STARTED|Overall Study||2||
59597296|NCT03570476|75706670|FG000|COMPLETED|Overall Study||2||
59597297|NCT03570476|75706670|FG000|NOT COMPLETED|Overall Study||0||
59597298|NCT03571724|75706679|FG000|STARTED|Week -1 (Prior to Switching)||0||
59597299|NCT03571724|75706680|FG001|STARTED|Week -1 (Prior to Switching)||0||
59597300|NCT03571724|75706681|FG002|STARTED|Week -1 (Prior to Switching)||72||
59597301|NCT03571724|75706682|FG003|STARTED|Week -1 (Prior to Switching)||70||
59597302|NCT03571724|75706679|FG000|Topography|Week -1 (Prior to Switching)||0||
59597303|NCT03571724|75706680|FG001|Topography|Week -1 (Prior to Switching)||0||
59597304|NCT03571724|75706681|FG002|Topography|Week -1 (Prior to Switching)|These subjects switched into VLN arms.|18||
59597305|NCT03571724|75706682|FG003|Topography|Week -1 (Prior to Switching)|These subjects switched into VLN arms.|18||
59597306|NCT03571724|75706679|FG000|PK Nicotine|Week -1 (Prior to Switching)||0||
59597307|NCT03571724|75706680|FG001|PK Nicotine|Week -1 (Prior to Switching)||0||
59597308|NCT03571724|75706681|FG002|PK Nicotine|Week -1 (Prior to Switching)|These subjects switched into VLN arms.|12||
59597309|NCT03571724|75706682|FG003|PK Nicotine|Week -1 (Prior to Switching)|These subjects switched into VLN arms.|12||
59597310|NCT03571724|75706679|FG000|COMPLETED|Week -1 (Prior to Switching)||0||
59597311|NCT03571724|75706680|FG001|COMPLETED|Week -1 (Prior to Switching)||0||
59597312|NCT03571724|75706681|FG002|COMPLETED|Week -1 (Prior to Switching)||72||
59597313|NCT03571724|75706682|FG003|COMPLETED|Week -1 (Prior to Switching)||70||
59597314|NCT03571724|75706679|FG000|NOT COMPLETED|Week -1 (Prior to Switching)||0||
59597315|NCT03571724|75706680|FG001|NOT COMPLETED|Week -1 (Prior to Switching)||0||
59597316|NCT03571724|75706681|FG002|NOT COMPLETED|Week -1 (Prior to Switching)||0||
59597317|NCT03571724|75706682|FG003|NOT COMPLETED|Week -1 (Prior to Switching)||0||
59597318|NCT03571724|75706679|FG000|STARTED|Week 1-6|Non-menthol VLN subjects were assigned to this arm after randomization at week 1|50||
59597319|NCT03571724|75706680|FG001|STARTED|Week 1-6|Menthol VLN subjects were assigned to this arm after randomization at week 1|50||
59597320|NCT03571724|75706681|FG002|STARTED|Week 1-6||22||
59597321|NCT03571724|75706682|FG003|STARTED|Week 1-6||20||
59597322|NCT03571724|75706679|FG000|COMPLETED|Week 1-6||43||
59860398|NCT05096312|75985015|FG000|COMPLETED|Overall Study||8||
59860399|NCT05096312|75985016|FG001|COMPLETED|Overall Study||8||
59860400|NCT05096312|75985015|FG000|NOT COMPLETED|Overall Study||3||
59860401|NCT05096312|75985016|FG001|NOT COMPLETED|Overall Study||4||
59597323|NCT03571724|75706680|FG001|COMPLETED|Week 1-6||42||
59597324|NCT03571724|75706681|FG002|COMPLETED|Week 1-6||19||
59597325|NCT03571724|75706682|FG003|COMPLETED|Week 1-6||20||
59597326|NCT03571724|75706679|FG000|NOT COMPLETED|Week 1-6||7||
59597327|NCT03571724|75706680|FG001|NOT COMPLETED|Week 1-6||8||
59597328|NCT03571724|75706681|FG002|NOT COMPLETED|Week 1-6||3||
59597329|NCT03571724|75706682|FG003|NOT COMPLETED|Week 1-6||0||
59597330|NCT03572972|75706708|FG000|STARTED|Overall Study||10548||
59597331|NCT03572972|75706709|FG001|STARTED|Overall Study||11414||
59597332|NCT03572972|75706710|FG002|STARTED|Overall Study||17779||
59597333|NCT03572972|75706711|FG003|STARTED|Overall Study||8648||
59597334|NCT03572972|75706712|FG004|STARTED|Overall Study||16295||
59597335|NCT03572972|75706708|FG000|COMPLETED|Overall Study||10548||
59597336|NCT03572972|75706709|FG001|COMPLETED|Overall Study||11414||
59597337|NCT03572972|75706710|FG002|COMPLETED|Overall Study||17779||
59597338|NCT03572972|75706711|FG003|COMPLETED|Overall Study||8648||
59597339|NCT03572972|75706712|FG004|COMPLETED|Overall Study||16295||
59597340|NCT03572972|75706708|FG000|NOT COMPLETED|Overall Study||0||
59597341|NCT03572972|75706709|FG001|NOT COMPLETED|Overall Study||0||
59597342|NCT03572972|75706710|FG002|NOT COMPLETED|Overall Study||0||
59597343|NCT03572972|75706711|FG003|NOT COMPLETED|Overall Study||0||
59597344|NCT03572972|75706712|FG004|NOT COMPLETED|Overall Study||0||
59597345|NCT04352660|75706734|FG000|STARTED|Overall Study||50||
59597346|NCT04352660|75706735|FG001|STARTED|Overall Study||50||
59597347|NCT04352660|75706734|FG000|COMPLETED|Overall Study||36||
59597348|NCT04352660|75706735|FG001|COMPLETED|Overall Study||40||
59597349|NCT04352660|75706734|FG000|NOT COMPLETED|Overall Study||14||
59597350|NCT04352660|75706735|FG001|NOT COMPLETED|Overall Study||10||
59597351|NCT03650192|75706741|FG000|STARTED|Overall Study||40||
59597352|NCT03650192|75706741|FG000|COMPLETED|Overall Study||40||
59860402|NCT04908488|75985024|FG000|STARTED|First Wear Period (8 -0/+3 Days)||56||112
59860403|NCT04908488|75985025|FG001|STARTED|First Wear Period (8 -0/+3 Days)||58||116
59597353|NCT03650192|75706741|FG000|NOT COMPLETED|Overall Study||0||
59597354|NCT04342130|75706745|FG000|STARTED|Overall Study||10||
59597355|NCT04342130|75706745|FG000|COMPLETED|Overall Study||10||
59597356|NCT04342130|75706745|FG000|NOT COMPLETED|Overall Study||0||
59597357|NCT04338074|75706751|FG000|STARTED|Overall Study||3||
59597358|NCT04338074|75706752|FG001|STARTED|Overall Study||2||
59597359|NCT04338074|75706751|FG000|COMPLETED|Overall Study||3||
59597360|NCT04338074|75706752|FG001|COMPLETED|Overall Study||2||
59597361|NCT04338074|75706751|FG000|NOT COMPLETED|Overall Study||0||
59597362|NCT04338074|75706752|FG001|NOT COMPLETED|Overall Study||0||
59597363|NCT03964220|75706760|FG000|STARTED|Overall Study||2619||
59597364|NCT03964220|75706761|FG001|STARTED|Overall Study||5238||
59597365|NCT03964220|75706760|FG000|COMPLETED|Overall Study||2619||
59597366|NCT03964220|75706761|FG001|COMPLETED|Overall Study||5238||
59597367|NCT03964220|75706760|FG000|NOT COMPLETED|Overall Study||0||
59597368|NCT03964220|75706761|FG001|NOT COMPLETED|Overall Study||0||
59597369|NCT04337138|75706767|FG000|STARTED|Overall Study||32||
59597370|NCT04337138|75706767|FG000|COMPLETED|Overall Study||32||
59597371|NCT04337138|75706767|FG000|NOT COMPLETED|Overall Study||0||
59597372|NCT03657134|75706771|FG000|STARTED|Overall Study||20||
59597373|NCT03657134|75706771|FG000|COMPLETED|Overall Study||20||
59597374|NCT03657134|75706771|FG000|NOT COMPLETED|Overall Study||0||
59597375|NCT03327571|75706778|FG000|STARTED|Group 1: cHL||1598||
59597376|NCT03327571|75706779|FG001|STARTED|Group 1: cHL||0||
59597377|NCT03327571|75706778|FG000|COMPLETED|Group 1: cHL||1598||
59597378|NCT03327571|75706779|FG001|COMPLETED|Group 1: cHL||0||
59597379|NCT03327571|75706778|FG000|NOT COMPLETED|Group 1: cHL||0||
59597380|NCT03327571|75706779|FG001|NOT COMPLETED|Group 1: cHL||0||
59597381|NCT03327571|75706778|FG000|STARTED|Group 2: RRHL||0||
59597382|NCT03327571|75706779|FG001|STARTED|Group 2: RRHL|105 RRHL only participants and 321 common participants who had CHL, and subsequently RRHL between 2010-2013.|426||
59597383|NCT03327571|75706778|FG000|Participants Were Counted in Both Groups|Group 2: RRHL||0||
59597384|NCT03327571|75706779|FG001|Participants Were Counted in Both Groups|Group 2: RRHL|Participants who were diagnosed with CHL, and subsequently RRHL between 2010 and 2013.|321||
59597385|NCT03327571|75706778|FG000|COMPLETED|Group 2: RRHL||0||
59597386|NCT03327571|75706779|FG001|COMPLETED|Group 2: RRHL||426||
59597387|NCT03327571|75706778|FG000|NOT COMPLETED|Group 2: RRHL||0||
59597388|NCT03327571|75706779|FG001|NOT COMPLETED|Group 2: RRHL||0||
59597389|NCT04332614|75706792|FG000|STARTED|~1 Week After Study Launch||2350|Randomized and attempted to email|
59597390|NCT04332614|75706793|FG001|STARTED|~1 Week After Study Launch||2350|Randomized and attempted to email|
59597391|NCT04332614|75706794|FG002|STARTED|~1 Week After Study Launch||2350|Randomized and attempted to email|
59597392|NCT04332614|75706795|FG003|STARTED|~1 Week After Study Launch||2350|Randomized and attempted to email|
59597393|NCT04332614|75706796|FG004|STARTED|~1 Week After Study Launch||2350|Randomized and attempted to email|
59597394|NCT04332614|75706797|FG005|STARTED|~1 Week After Study Launch||2349|Randomized and attempted to email|
59597395|NCT04332614|75706792|FG000|Data in EHR|~1 Week After Study Launch||2245|Patient was found in Electronic Health Record ~1 week after intervention|
59597396|NCT04332614|75706793|FG001|Data in EHR|~1 Week After Study Launch||2273|Patient was found in Electronic Health Record ~1 week after intervention|
59597397|NCT04332614|75706794|FG002|Data in EHR|~1 Week After Study Launch||2251|Patient was found in Electronic Health Record ~1 week after intervention|
59597398|NCT04332614|75706795|FG003|Data in EHR|~1 Week After Study Launch||2254|Patient was found in Electronic Health Record ~1 week after intervention|
59597399|NCT04332614|75706796|FG004|Data in EHR|~1 Week After Study Launch||2251|Patient was found in Electronic Health Record ~1 week after intervention|
59597400|NCT04332614|75706797|FG005|Data in EHR|~1 Week After Study Launch||2249|Patient was found in Electronic Health Record ~1 week after intervention|
59597401|NCT04332614|75706792|FG000|COMPLETED|~1 Week After Study Launch||2117|Email delivered (did not bounce back)|
59597402|NCT04332614|75706793|FG001|COMPLETED|~1 Week After Study Launch||2129|Email delivered (did not bounce back)|
59597403|NCT04332614|75706794|FG002|COMPLETED|~1 Week After Study Launch||2124|Email delivered (did not bounce back)|
59597404|NCT04332614|75706795|FG003|COMPLETED|~1 Week After Study Launch||2131|Email delivered (did not bounce back)|
59597405|NCT04332614|75706796|FG004|COMPLETED|~1 Week After Study Launch||2127|Email delivered (did not bounce back)|
59597406|NCT04332614|75706797|FG005|COMPLETED|~1 Week After Study Launch||2115|Email delivered (did not bounce back)|
59597407|NCT04332614|75706792|FG000|NOT COMPLETED|~1 Week After Study Launch||233||
59597408|NCT04332614|75706793|FG001|NOT COMPLETED|~1 Week After Study Launch||221||
59597409|NCT04332614|75706794|FG002|NOT COMPLETED|~1 Week After Study Launch||226||
59597410|NCT04332614|75706795|FG003|NOT COMPLETED|~1 Week After Study Launch||219||
59597411|NCT04332614|75706796|FG004|NOT COMPLETED|~1 Week After Study Launch||223||
59597412|NCT04332614|75706797|FG005|NOT COMPLETED|~1 Week After Study Launch||234||
59597413|NCT04332614|75706792|FG000|STARTED|~1 Month After Study Launch||2117||
59597414|NCT04332614|75706793|FG001|STARTED|~1 Month After Study Launch||2129||
59597415|NCT04332614|75706794|FG002|STARTED|~1 Month After Study Launch||2124||
59597416|NCT04332614|75706795|FG003|STARTED|~1 Month After Study Launch||2131||
59597417|NCT04332614|75706796|FG004|STARTED|~1 Month After Study Launch||2127||
59597418|NCT04332614|75706797|FG005|STARTED|~1 Month After Study Launch||2115||
59597419|NCT04332614|75706792|FG000|COMPLETED|~1 Month After Study Launch||2095|Record was found in EHR ~1 month after intervention AND email was delivered (did not bounce back)|
59728524|NCT00812929|75847158|FG009|STARTED|Treatment Period 5||4||
59597420|NCT04332614|75706793|FG001|COMPLETED|~1 Month After Study Launch||2107|Record was found in EHR ~1 month after intervention AND email was delivered (did not bounce back)|
59597421|NCT04332614|75706794|FG002|COMPLETED|~1 Month After Study Launch||2094|Record was found in EHR ~1 month after intervention AND email was delivered (did not bounce back)|
59597422|NCT04332614|75706795|FG003|COMPLETED|~1 Month After Study Launch||2107|Record was found in EHR ~1 month after intervention AND email was delivered (did not bounce back)|
59597423|NCT04332614|75706796|FG004|COMPLETED|~1 Month After Study Launch||2107|Record was found in EHR ~1 month after intervention AND email was delivered (did not bounce back)|
59597424|NCT04332614|75706797|FG005|COMPLETED|~1 Month After Study Launch||2096|Record was found in EHR ~1 month after intervention AND email was delivered (did not bounce back)|
59597425|NCT04332614|75706792|FG000|NOT COMPLETED|~1 Month After Study Launch||22||
59597426|NCT04332614|75706793|FG001|NOT COMPLETED|~1 Month After Study Launch||22||
59597427|NCT04332614|75706794|FG002|NOT COMPLETED|~1 Month After Study Launch||30||
59597428|NCT04332614|75706795|FG003|NOT COMPLETED|~1 Month After Study Launch||24||
59597429|NCT04332614|75706796|FG004|NOT COMPLETED|~1 Month After Study Launch||20||
59597430|NCT04332614|75706797|FG005|NOT COMPLETED|~1 Month After Study Launch||19||
59597431|NCT04326842|75706814|FG000|STARTED|Overall Study||40||
59597432|NCT04326842|75706815|FG001|STARTED|Overall Study||89||
59597433|NCT04326842|75706814|FG000|COMPLETED|Overall Study||31||
59597434|NCT04326842|75706815|FG001|COMPLETED|Overall Study||31||
59597435|NCT04326842|75706814|FG000|NOT COMPLETED|Overall Study||9||
59597436|NCT04326842|75706815|FG001|NOT COMPLETED|Overall Study||58||
59597437|NCT03329209|75706821|FG000|STARTED|Overall Study||16||
59597438|NCT03329209|75706821|FG000|COMPLETED|Overall Study||16||
59597439|NCT03329209|75706821|FG000|NOT COMPLETED|Overall Study||0||
59597440|NCT03661346|75706827|FG000|STARTED|Overall Study|Esmolol administration|13||
59597441|NCT03661346|75706828|FG001|STARTED|Overall Study||15||
59597442|NCT03661346|75706827|FG000|COMPLETED|Overall Study||13||
59597443|NCT03661346|75706828|FG001|COMPLETED|Overall Study||15||
59597444|NCT03661346|75706827|FG000|NOT COMPLETED|Overall Study||0||
59597445|NCT03661346|75706828|FG001|NOT COMPLETED|Overall Study||0||
59597446|NCT03329911|75706836|FG000|STARTED|Overall Study||326||
59597447|NCT03329911|75706837|FG001|STARTED|Overall Study||325||
59597448|NCT03329911|75706836|FG000|COMPLETED|Overall Study||209||
59597449|NCT03329911|75706837|FG001|COMPLETED|Overall Study||222||
59597450|NCT03329911|75706836|FG000|NOT COMPLETED|Overall Study||117||
59597451|NCT03329911|75706837|FG001|NOT COMPLETED|Overall Study||103||
59597452|NCT04322396|75706845|FG000|STARTED|Overall Study||56||
59597453|NCT04322396|75706846|FG001|STARTED|Overall Study||61||
59597454|NCT04322396|75706845|FG000|COMPLETED|Overall Study||56||
59597455|NCT04322396|75706846|FG001|COMPLETED|Overall Study||61||
59597456|NCT04322396|75706845|FG000|NOT COMPLETED|Overall Study||0||
59597457|NCT04322396|75706846|FG001|NOT COMPLETED|Overall Study||0||
59597458|NCT03222037|75706852|FG000|STARTED|Period 1||21||
59597459|NCT03222037|75706853|FG001|STARTED|Period 1||22||
59597460|NCT03222037|75706852|FG000|COMPLETED|Period 1||21||
59597461|NCT03222037|75706853|FG001|COMPLETED|Period 1||22||
59597462|NCT03222037|75706852|FG000|NOT COMPLETED|Period 1||0||
59597463|NCT03222037|75706853|FG001|NOT COMPLETED|Period 1||0||
59597464|NCT03222037|75706852|FG000|STARTED|Period 2||21||
59597465|NCT03222037|75706853|FG001|STARTED|Period 2||22||
59597466|NCT03222037|75706852|FG000|COMPLETED|Period 2||21||
59597467|NCT03222037|75706853|FG001|COMPLETED|Period 2||22||
59597468|NCT03222037|75706852|FG000|NOT COMPLETED|Period 2||0||
59597469|NCT03222037|75706853|FG001|NOT COMPLETED|Period 2||0||
59597470|NCT03961100|75706864|FG000|STARTED|Part 1||5||
59597471|NCT03961100|75706865|FG001|STARTED|Part 1||5||
59597472|NCT03961100|75706866|FG002|STARTED|Part 1||5||
59597473|NCT03961100|75706867|FG003|STARTED|Part 1||0||
59597474|NCT03961100|75706868|FG004|STARTED|Part 1||0||
59597475|NCT03961100|75706864|FG000|COMPLETED|Part 1||5||
59597476|NCT03961100|75706865|FG001|COMPLETED|Part 1||5||
59597477|NCT03961100|75706866|FG002|COMPLETED|Part 1||5||
59597478|NCT03961100|75706867|FG003|COMPLETED|Part 1||0||
59597479|NCT03961100|75706868|FG004|COMPLETED|Part 1||0||
59597480|NCT03961100|75706864|FG000|NOT COMPLETED|Part 1||0||
59597481|NCT03961100|75706865|FG001|NOT COMPLETED|Part 1||0||
59597482|NCT03961100|75706866|FG002|NOT COMPLETED|Part 1||0||
59597483|NCT03961100|75706867|FG003|NOT COMPLETED|Part 1||0||
59597484|NCT03961100|75706868|FG004|NOT COMPLETED|Part 1||0||
59597485|NCT03961100|75706864|FG000|STARTED|Part 2||0||
59597486|NCT03961100|75706865|FG001|STARTED|Part 2||0||
59597487|NCT03961100|75706866|FG002|STARTED|Part 2||0||
59597488|NCT03961100|75706867|FG003|STARTED|Part 2||8||
59597489|NCT03961100|75706868|FG004|STARTED|Part 2||8||
59597490|NCT03961100|75706864|FG000|COMPLETED|Part 2||0||
59597491|NCT03961100|75706865|FG001|COMPLETED|Part 2||0||
59597492|NCT03961100|75706866|FG002|COMPLETED|Part 2||0||
59597493|NCT03961100|75706867|FG003|COMPLETED|Part 2||8||
59597494|NCT03961100|75706868|FG004|COMPLETED|Part 2||8||
59597495|NCT03961100|75706864|FG000|NOT COMPLETED|Part 2||0||
59597496|NCT03961100|75706865|FG001|NOT COMPLETED|Part 2||0||
59597497|NCT03961100|75706866|FG002|NOT COMPLETED|Part 2||0||
59597498|NCT03961100|75706867|FG003|NOT COMPLETED|Part 2||0||
59597499|NCT03961100|75706868|FG004|NOT COMPLETED|Part 2||0||
59597500|NCT03222427|75706880|FG000|STARTED|Overall Study||8||
59597501|NCT03222427|75706880|FG000|Received One Dose of Study Drug|Overall Study||8||
59597502|NCT03222427|75706880|FG000|COMPLETED|Overall Study||8||
59597503|NCT03222427|75706880|FG000|NOT COMPLETED|Overall Study||0||
59597504|NCT03442699|75706885|FG000|STARTED|Overall Study||6||
59597505|NCT03442699|75706885|FG000|COMPLETED|Overall Study||6||
59597506|NCT03442699|75706885|FG000|NOT COMPLETED|Overall Study||0||
59597507|NCT03954158|75706895|FG000|STARTED|Overall Study||20||
59597508|NCT03954158|75706896|FG001|STARTED|Overall Study||21||
59597509|NCT03954158|75706897|FG002|STARTED|Overall Study||20||
59597510|NCT03954158|75706898|FG003|STARTED|Overall Study||20||
59597511|NCT03954158|75706895|FG000|COMPLETED|Overall Study||20||
59597512|NCT03954158|75706896|FG001|COMPLETED|Overall Study||21||
59597513|NCT03954158|75706897|FG002|COMPLETED|Overall Study||20||
59597514|NCT03954158|75706898|FG003|COMPLETED|Overall Study||20||
59597515|NCT03954158|75706895|FG000|NOT COMPLETED|Overall Study||0||
59597516|NCT03954158|75706896|FG001|NOT COMPLETED|Overall Study||0||
59597517|NCT03954158|75706897|FG002|NOT COMPLETED|Overall Study||0||
59597518|NCT03954158|75706898|FG003|NOT COMPLETED|Overall Study||0||
59597519|NCT03222505|75706933|FG000|STARTED|Overall Study||5||
59597520|NCT03222505|75706934|FG001|STARTED|Overall Study||7||
59597521|NCT03222505|75706933|FG000|COMPLETED|Overall Study||5||
59597522|NCT03222505|75706934|FG001|COMPLETED|Overall Study||7||
59597523|NCT03222505|75706933|FG000|NOT COMPLETED|Overall Study||0||
59597524|NCT03222505|75706934|FG001|NOT COMPLETED|Overall Study||0||
59597525|NCT03224299|75706941|FG000|STARTED|Overall Study||131|Enrolled|
59597526|NCT03224299|75706942|FG001|STARTED|Overall Study||424|Enrolled|
59597527|NCT03224299|75706941|FG000|Treated With IP#1|Overall Study||65||
59597528|NCT03224299|75706942|FG001|Treated With IP#1|Overall Study||101||
59597529|NCT03224299|75706941|FG000|Treated With IP#2|Overall Study||66||
59597530|NCT03224299|75706942|FG001|Treated With IP#2|Overall Study||107||
59597531|NCT03224299|75706941|FG000|Treated With AC|Overall Study||66||
59597532|NCT03224299|75706942|FG001|Treated With AC|Overall Study||110||
59597533|NCT03224299|75706941|FG000|Treated With NC|Overall Study||65||
59597534|NCT03224299|75706942|FG001|Treated With NC|Overall Study||106||
59597535|NCT03224299|75706941|FG000|COMPLETED|Overall Study||131||
59597536|NCT03224299|75706942|FG001|COMPLETED|Overall Study||424||
59597537|NCT03224299|75706941|FG000|NOT COMPLETED|Overall Study||0||
59597538|NCT03224299|75706942|FG001|NOT COMPLETED|Overall Study||0||
59597539|NCT03333577|75706956|FG000|STARTED|Overall Study||32||
59597540|NCT03333577|75706956|FG000|COMPLETED|Overall Study||25||
59597541|NCT03333577|75706956|FG000|NOT COMPLETED|Overall Study||7||
59597542|NCT03334825|75706962|FG000|STARTED|Overall Study||119||
59597543|NCT03334825|75706963|FG001|STARTED|Overall Study||117||
59597544|NCT03334825|75706962|FG000|COMPLETED|Overall Study||112||
59597545|NCT03334825|75706963|FG001|COMPLETED|Overall Study||113||
59597546|NCT03334825|75706962|FG000|NOT COMPLETED|Overall Study||7||
59597547|NCT03334825|75706963|FG001|NOT COMPLETED|Overall Study||4||
59597548|NCT03442933|75706969|FG000|STARTED|Overall Study||20||
59597549|NCT03442933|75706970|FG001|STARTED|Overall Study||20||
59597550|NCT03442933|75706969|FG000|COMPLETED|Overall Study||20||
59597551|NCT03442933|75706970|FG001|COMPLETED|Overall Study||20||
59597552|NCT03442933|75706969|FG000|NOT COMPLETED|Overall Study||0||
59597553|NCT03442933|75706970|FG001|NOT COMPLETED|Overall Study||0||
59597554|NCT03444961|75706979|FG000|STARTED|Overall Study||4||
59597555|NCT03444961|75706979|FG000|COMPLETED|Overall Study||4||
59597556|NCT03444961|75706979|FG000|NOT COMPLETED|Overall Study||0||
59597557|NCT03661814|75706989|FG000|STARTED|Overall Study||2||
59597558|NCT03661814|75706990|FG001|STARTED|Overall Study||5||
59597559|NCT03661814|75706989|FG000|COMPLETED|Overall Study||2||
59597560|NCT03661814|75706990|FG001|COMPLETED|Overall Study||5||
59597561|NCT03661814|75706989|FG000|NOT COMPLETED|Overall Study||0||
59597562|NCT03661814|75706990|FG001|NOT COMPLETED|Overall Study||0||
59597563|NCT03335761|75706999|FG000|STARTED|Overall Study||19||
59597564|NCT03335761|75707000|FG001|STARTED|Overall Study||14||
59597565|NCT03335761|75707001|FG002|STARTED|Overall Study||15||
59597566|NCT03335761|75706999|FG000|Implanted With a Neurostimulator Device|Overall Study||18||
59597567|NCT03335761|75707000|FG001|Implanted With a Neurostimulator Device|Overall Study||14||
59597568|NCT03335761|75707001|FG002|Implanted With a Neurostimulator Device|Overall Study||14||
59597569|NCT03335761|75706999|FG000|COMPLETED|Overall Study||17||
59597570|NCT03335761|75707000|FG001|COMPLETED|Overall Study||13||
59597571|NCT03335761|75707001|FG002|COMPLETED|Overall Study||13||
59597572|NCT03335761|75706999|FG000|NOT COMPLETED|Overall Study||2||
59597573|NCT03335761|75707000|FG001|NOT COMPLETED|Overall Study||1||
59597574|NCT03335761|75707001|FG002|NOT COMPLETED|Overall Study||2||
59597575|NCT03662282|75707009|FG000|STARTED|Overall Study||2||
59597576|NCT03662282|75707009|FG000|COMPLETED|Overall Study||2||
59597577|NCT03662282|75707009|FG000|NOT COMPLETED|Overall Study||0||
59597578|NCT03336853|75707015|FG000|STARTED|Overall Study||30||
59597579|NCT03336853|75707016|FG001|STARTED|Overall Study||30||
59597580|NCT03336853|75707015|FG000|COMPLETED|Overall Study||30||
59597581|NCT03336853|75707016|FG001|COMPLETED|Overall Study||30||
59597582|NCT03336853|75707015|FG000|NOT COMPLETED|Overall Study||0||
59597583|NCT03336853|75707016|FG001|NOT COMPLETED|Overall Study||0||
59597584|NCT03954626|75707022|FG000|STARTED|Overall Study||14||
59597585|NCT03954626|75707022|FG000|COMPLETED|Overall Study||14||
59597586|NCT03954626|75707022|FG000|NOT COMPLETED|Overall Study||0||
59597587|NCT03662360|75707028|FG000|STARTED|Overall Study||16||
59597588|NCT03662360|75707029|FG001|STARTED|Overall Study||16||
59597589|NCT03662360|75707028|FG000|COMPLETED|Overall Study||16||
59597590|NCT03662360|75707029|FG001|COMPLETED|Overall Study||14||
59597591|NCT03662360|75707028|FG000|NOT COMPLETED|Overall Study||0||
59597592|NCT03662360|75707029|FG001|NOT COMPLETED|Overall Study||2||
59597593|NCT03225001|75707036|FG000|STARTED|Overall Study||197||
59597594|NCT03225001|75707036|FG000|Valve-Implanted|Overall Study||195||
59597595|NCT03225001|75707036|FG000|COMPLETED|Overall Study||188||
59597596|NCT03225001|75707036|FG000|NOT COMPLETED|Overall Study||9||
59597597|NCT03225313|75707043|FG000|STARTED|Overall Study|25 Patients|25||
59597598|NCT03225313|75707044|FG001|STARTED|Overall Study|25 Patients|25||
59597599|NCT03225313|75707045|FG002|STARTED|Overall Study|25 Patients|25||
59597600|NCT03225313|75707043|FG000|COMPLETED|Overall Study|25 Patients|25||
59597601|NCT03225313|75707044|FG001|COMPLETED|Overall Study|25 Patients|25||
59597602|NCT03225313|75707045|FG002|COMPLETED|Overall Study|25 Patients|25||
59597603|NCT03225313|75707043|FG000|NOT COMPLETED|Overall Study||0||
59597604|NCT03225313|75707044|FG001|NOT COMPLETED|Overall Study||0||
59597605|NCT03225313|75707045|FG002|NOT COMPLETED|Overall Study||0||
59597606|NCT03949244|75707058|FG000|STARTED|Overall Study||12||
59597607|NCT03949244|75707059|FG001|STARTED|Overall Study||21||
59597608|NCT03949244|75707060|FG002|STARTED|Overall Study||14||
59597609|NCT03949244|75707058|FG000|COMPLETED|Overall Study||12||
59597610|NCT03949244|75707059|FG001|COMPLETED|Overall Study||21||
59597611|NCT03949244|75707060|FG002|COMPLETED|Overall Study||14||
59597612|NCT03949244|75707058|FG000|NOT COMPLETED|Overall Study||0||
59597613|NCT03949244|75707059|FG001|NOT COMPLETED|Overall Study||0||
59597614|NCT03949244|75707060|FG002|NOT COMPLETED|Overall Study||0||
59597615|NCT03225859|75707068|FG000|STARTED|Overall Study||12||
59597616|NCT03225859|75707068|FG000|COMPLETED|Overall Study||11||
59597617|NCT03225859|75707068|FG000|NOT COMPLETED|Overall Study||1||
59597618|NCT03948386|75707075|FG000|STARTED|Overall Study||52||
59597619|NCT03948386|75707076|FG001|STARTED|Overall Study||54||
59597620|NCT03948386|75707077|FG002|STARTED|Overall Study||53||
59597621|NCT03948386|75707075|FG000|COMPLETED|Overall Study||51||
59597622|NCT03948386|75707076|FG001|COMPLETED|Overall Study||53||
59597623|NCT03948386|75707077|FG002|COMPLETED|Overall Study||50||
59597624|NCT03948386|75707075|FG000|NOT COMPLETED|Overall Study||1||
59597625|NCT03948386|75707076|FG001|NOT COMPLETED|Overall Study||1||
59597626|NCT03948386|75707077|FG002|NOT COMPLETED|Overall Study||3||
59597627|NCT03445195|75707087|FG000|STARTED|Overall Study||53||
59597628|NCT03445195|75707088|FG001|STARTED|Overall Study||27||
59597629|NCT03445195|75707087|FG000|COMPLETED|Overall Study||51||
59597630|NCT03445195|75707088|FG001|COMPLETED|Overall Study||27||
59597631|NCT03445195|75707087|FG000|NOT COMPLETED|Overall Study||2||
59597632|NCT03445195|75707088|FG001|NOT COMPLETED|Overall Study||0||
59597633|NCT04289714|75707097|FG000|STARTED|Overall Study||14||
59597634|NCT04289714|75707098|FG001|STARTED|Overall Study||11||
59597635|NCT04289714|75707099|FG002|STARTED|Overall Study||10||
59597636|NCT04289714|75707097|FG000|COMPLETED|Overall Study||8||
59597637|NCT04289714|75707098|FG001|COMPLETED|Overall Study||6||
59597638|NCT04289714|75707099|FG002|COMPLETED|Overall Study||4||
59597639|NCT04289714|75707097|FG000|NOT COMPLETED|Overall Study||6||
59597640|NCT04289714|75707098|FG001|NOT COMPLETED|Overall Study||5||
59597641|NCT04289714|75707099|FG002|NOT COMPLETED|Overall Study||6||
59597642|NCT04277936|75707107|FG000|STARTED|Overall Study||1||
59597643|NCT04277936|75707107|FG000|COMPLETED|Overall Study||1||
59597644|NCT04277936|75707107|FG000|NOT COMPLETED|Overall Study||0||
59597645|NCT03666026|75707115|FG000|STARTED|Overall Study||41070||
59597646|NCT03666026|75707116|FG001|STARTED|Overall Study||41055||
59597647|NCT03666026|75707117|FG002|STARTED|Overall Study||41046||
59597648|NCT03666026|75707118|FG003|STARTED|Overall Study||41034||
59597649|NCT03666026|75707115|FG000|COMPLETED|Overall Study||41070||
59597650|NCT03666026|75707116|FG001|COMPLETED|Overall Study||41055||
59597651|NCT03666026|75707117|FG002|COMPLETED|Overall Study||41046||
59597652|NCT03666026|75707118|FG003|COMPLETED|Overall Study||41034||
59597653|NCT03666026|75707115|FG000|NOT COMPLETED|Overall Study||0||
59597654|NCT03666026|75707116|FG001|NOT COMPLETED|Overall Study||0||
59597655|NCT03666026|75707117|FG002|NOT COMPLETED|Overall Study||0||
59597656|NCT03666026|75707118|FG003|NOT COMPLETED|Overall Study||0||
59597657|NCT03936608|75707130|FG000|STARTED|Overall Study||2||
59597658|NCT03936608|75707131|FG001|STARTED|Overall Study||2||
59597659|NCT03936608|75707130|FG000|COMPLETED|Overall Study||0||
59597660|NCT03936608|75707131|FG001|COMPLETED|Overall Study||0||
59597661|NCT03936608|75707130|FG000|NOT COMPLETED|Overall Study||2||
59597662|NCT03936608|75707131|FG001|NOT COMPLETED|Overall Study||2||
59597663|NCT03670160|75707139|FG000|STARTED|Overall Study||11||
59597664|NCT03670160|75707140|FG001|STARTED|Overall Study||14||
59597665|NCT03670160|75707139|FG000|COMPLETED|Overall Study||11||
59597666|NCT03670160|75707140|FG001|COMPLETED|Overall Study||14||
59597667|NCT03670160|75707139|FG000|NOT COMPLETED|Overall Study||0||
59597668|NCT03670160|75707140|FG001|NOT COMPLETED|Overall Study||0||
59597669|NCT03672032|75707148|FG000|STARTED|Overall Study||67||75
59597670|NCT03672032|75707149|FG001|STARTED|Overall Study||67||75
59597671|NCT03672032|75707148|FG000|COMPLETED|Overall Study||67||75
59597672|NCT03672032|75707149|FG001|COMPLETED|Overall Study||67||75
59597673|NCT03672032|75707148|FG000|NOT COMPLETED|Overall Study||0||0
59597674|NCT03672032|75707149|FG001|NOT COMPLETED|Overall Study||0||0
59597675|NCT03446053|75707160|FG000|STARTED|Overall Study||2||
59597676|NCT03446053|75707161|FG001|STARTED|Overall Study||6||
59597677|NCT03446053|75707162|FG002|STARTED|Overall Study||6||
59597678|NCT03446053|75707163|FG003|STARTED|Overall Study||7||
59597679|NCT03446053|75707164|FG004|STARTED|Overall Study||6||
59597680|NCT03446053|75707165|FG005|STARTED|Overall Study||6||
59597681|NCT03446053|75707160|FG000|Randomized Set|Overall Study||2||
59597682|NCT03446053|75707161|FG001|Randomized Set|Overall Study||6||
59597683|NCT03446053|75707162|FG002|Randomized Set|Overall Study||6||
59597684|NCT03446053|75707163|FG003|Randomized Set|Overall Study||7||
59597685|NCT03446053|75707164|FG004|Randomized Set|Overall Study||6||
59597686|NCT03446053|75707165|FG005|Randomized Set|Overall Study||6||
59597687|NCT03446053|75707160|FG000|Safety Analysis Set|Overall Study||2||
59597688|NCT03446053|75707161|FG001|Safety Analysis Set|Overall Study||6||
59597689|NCT03446053|75707162|FG002|Safety Analysis Set|Overall Study||6||
59597690|NCT03446053|75707163|FG003|Safety Analysis Set|Overall Study||6||
59597691|NCT03446053|75707164|FG004|Safety Analysis Set|Overall Study||6||
59597692|NCT03446053|75707165|FG005|Safety Analysis Set|Overall Study||6||
59597693|NCT03446053|75707160|FG000|PK/PD Analysis Set|Overall Study||2||
59597694|NCT03446053|75707161|FG001|PK/PD Analysis Set|Overall Study||6||
59597695|NCT03446053|75707162|FG002|PK/PD Analysis Set|Overall Study||6||
59597696|NCT03446053|75707163|FG003|PK/PD Analysis Set|Overall Study||6||
59597697|NCT03446053|75707164|FG004|PK/PD Analysis Set|Overall Study||6||
59597698|NCT03446053|75707165|FG005|PK/PD Analysis Set|Overall Study||5||
59597699|NCT03446053|75707160|FG000|COMPLETED|Overall Study||2||
59597700|NCT03446053|75707161|FG001|COMPLETED|Overall Study||5||
59597701|NCT03446053|75707162|FG002|COMPLETED|Overall Study||6||
59597702|NCT03446053|75707163|FG003|COMPLETED|Overall Study||6||
59597703|NCT03446053|75707164|FG004|COMPLETED|Overall Study||6||
59597704|NCT03446053|75707165|FG005|COMPLETED|Overall Study||5||
59597705|NCT03446053|75707160|FG000|NOT COMPLETED|Overall Study||0||
59597706|NCT03446053|75707161|FG001|NOT COMPLETED|Overall Study||1||
59597707|NCT03446053|75707162|FG002|NOT COMPLETED|Overall Study||0||
59597708|NCT03446053|75707163|FG003|NOT COMPLETED|Overall Study||1||
59597709|NCT03446053|75707164|FG004|NOT COMPLETED|Overall Study||0||
59597710|NCT03446053|75707165|FG005|NOT COMPLETED|Overall Study||1||
59597711|NCT03338803|75707192|FG000|STARTED|Overall Study||11001||
59597712|NCT03338803|75707192|FG000|COMPLETED|Overall Study||11001||
59597713|NCT03338803|75707192|FG000|NOT COMPLETED|Overall Study||0||
59597714|NCT03452371|75707198|FG000|STARTED|Overall Study||21||
59597715|NCT03452371|75707199|FG001|STARTED|Overall Study||23||
59597716|NCT03452371|75707198|FG000|COMPLETED|Overall Study||21||
59597717|NCT03452371|75707199|FG001|COMPLETED|Overall Study||23||
59597718|NCT03452371|75707198|FG000|NOT COMPLETED|Overall Study||0||
59597719|NCT03452371|75707199|FG001|NOT COMPLETED|Overall Study||0||
59597720|NCT03906968|75707205|FG000|STARTED|Overall Study||40||
59597721|NCT03906968|75707205|FG000|COMPLETED|Overall Study||40||
59597722|NCT03906968|75707205|FG000|NOT COMPLETED|Overall Study||0||
59597723|NCT04206800|75707211|FG000|STARTED|Overall Study||4||
59597724|NCT04206800|75707212|FG001|STARTED|Overall Study||1||
59597725|NCT04206800|75707211|FG000|COMPLETED|Overall Study||4||
59597726|NCT04206800|75707212|FG001|COMPLETED|Overall Study||1||
59597727|NCT04206800|75707211|FG000|NOT COMPLETED|Overall Study||0||
59597728|NCT04206800|75707212|FG001|NOT COMPLETED|Overall Study||0||
59597729|NCT03689504|75707220|FG000|STARTED|Overall Study||70||
59597730|NCT03689504|75707221|FG001|STARTED|Overall Study||70||
59597731|NCT03689504|75707220|FG000|COMPLETED|Overall Study||65||
59597732|NCT03689504|75707221|FG001|COMPLETED|Overall Study||70||
59597733|NCT03689504|75707220|FG000|NOT COMPLETED|Overall Study||5||
59597734|NCT03689504|75707221|FG001|NOT COMPLETED|Overall Study||0||
59597735|NCT03455491|75707230|FG000|STARTED|Overall Study||40||
59597736|NCT03455491|75707231|FG001|STARTED|Overall Study||40||
59597737|NCT03455491|75707232|FG002|STARTED|Overall Study||40||
59597738|NCT03455491|75707230|FG000|COMPLETED|Overall Study||40||
59597739|NCT03455491|75707231|FG001|COMPLETED|Overall Study||40||
59597740|NCT03455491|75707232|FG002|COMPLETED|Overall Study||40||
59597741|NCT03455491|75707230|FG000|NOT COMPLETED|Overall Study||0||
59597742|NCT03455491|75707231|FG001|NOT COMPLETED|Overall Study||0||
59597743|NCT03455491|75707232|FG002|NOT COMPLETED|Overall Study||0||
59597744|NCT03349567|75707244|FG000|STARTED|Overall Study||2||
59597745|NCT03349567|75707245|FG001|STARTED|Overall Study||2||
59597746|NCT03349567|75707244|FG000|COMPLETED|Overall Study||2||
59597747|NCT03349567|75707245|FG001|COMPLETED|Overall Study||2||
59597748|NCT03349567|75707244|FG000|NOT COMPLETED|Overall Study||0||
59597749|NCT03349567|75707245|FG001|NOT COMPLETED|Overall Study||0||
59597750|NCT03691844|75707257|FG000|STARTED|Overall Study||121||
59597751|NCT03691844|75707258|FG001|STARTED|Overall Study||121||
59597752|NCT03691844|75707259|FG002|STARTED|Overall Study||121||
59597753|NCT03691844|75707260|FG003|STARTED|Overall Study||81||
59597754|NCT03691844|75707257|FG000|COMPLETED|Overall Study||114||
59597755|NCT03691844|75707258|FG001|COMPLETED|Overall Study||109||
59597756|NCT03691844|75707259|FG002|COMPLETED|Overall Study||108||
59597757|NCT03691844|75707260|FG003|COMPLETED|Overall Study||70||
59597758|NCT03691844|75707257|FG000|NOT COMPLETED|Overall Study||7||
59597759|NCT03691844|75707258|FG001|NOT COMPLETED|Overall Study||12||
59597760|NCT03691844|75707259|FG002|NOT COMPLETED|Overall Study||13||
59597761|NCT03691844|75707260|FG003|NOT COMPLETED|Overall Study||11||
59597762|NCT03456427|75707272|FG000|STARTED|Overall Study||36||
59597763|NCT03456427|75707272|FG000|COMPLETED|Overall Study||33||
59597764|NCT03456427|75707272|FG000|NOT COMPLETED|Overall Study||3||
59597765|NCT04195880|75707279|FG000|STARTED|Overall Study||3205||
59597766|NCT04195880|75707280|FG001|STARTED|Overall Study||3338||
59597767|NCT04195880|75707279|FG000|COMPLETED|Overall Study||3205||
59597768|NCT04195880|75707280|FG001|COMPLETED|Overall Study||3338||
59597769|NCT04195880|75707279|FG000|NOT COMPLETED|Overall Study||0||
59597770|NCT04195880|75707280|FG001|NOT COMPLETED|Overall Study||0||
59728525|NCT00812929|75847149|FG000|COMPLETED|Treatment Period 5||5||
59728526|NCT00812929|75847150|FG001|COMPLETED|Treatment Period 5||4||
59728527|NCT00812929|75847151|FG002|COMPLETED|Treatment Period 5||4||
59860404|NCT04908488|75985024|FG000|COMPLETED|First Wear Period (8 -0/+3 Days)||55||110
59860405|NCT04908488|75985025|FG001|COMPLETED|First Wear Period (8 -0/+3 Days)||58||116
59860406|NCT04908488|75985024|FG000|NOT COMPLETED|First Wear Period (8 -0/+3 Days)||1||2
59597771|NCT03352609|75707288|FG000|STARTED|Overall Study||2||
59597772|NCT03352609|75707289|FG001|STARTED|Overall Study||3||
59597773|NCT03352609|75707288|FG000|COMPLETED|Overall Study||2||
59597774|NCT03352609|75707289|FG001|COMPLETED|Overall Study||3||
59597775|NCT03352609|75707288|FG000|NOT COMPLETED|Overall Study||0||
59597776|NCT03352609|75707289|FG001|NOT COMPLETED|Overall Study||0||
59597777|NCT04191668|75707295|FG000|STARTED|Overall Study||106||
59597778|NCT04191668|75707295|FG000|COMPLETED|Overall Study||106||
59597779|NCT04191668|75707295|FG000|NOT COMPLETED|Overall Study||0||
59597780|NCT03354325|75707301|FG000|STARTED|Overall Study||151||
59597781|NCT03354325|75707302|FG001|STARTED|Overall Study||153||
59597782|NCT03354325|75707301|FG000|COMPLETED|Overall Study||131||
59597783|NCT03354325|75707302|FG001|COMPLETED|Overall Study||138||
59597784|NCT03354325|75707301|FG000|NOT COMPLETED|Overall Study||20||
59597785|NCT03354325|75707302|FG001|NOT COMPLETED|Overall Study||15||
59597786|NCT03892460|75707310|FG000|STARTED|Overall Study||30||
59597787|NCT03892460|75707311|FG001|STARTED|Overall Study||24||
59597788|NCT03892460|75707310|FG000|Randomization|Overall Study||25||
59597789|NCT03892460|75707311|FG001|Randomization|Overall Study||20||
59597790|NCT03892460|75707310|FG000|COMPLETED|Overall Study||18||
59597791|NCT03892460|75707311|FG001|COMPLETED|Overall Study||19||
59597792|NCT03892460|75707310|FG000|NOT COMPLETED|Overall Study||12||
59597793|NCT03892460|75707311|FG001|NOT COMPLETED|Overall Study||5||
59597794|NCT03232645|75707318|FG000|STARTED|Overall Study||62||
59597795|NCT03232645|75707318|FG000|COMPLETED|Overall Study||58||
59597796|NCT03232645|75707318|FG000|NOT COMPLETED|Overall Study||4||
59597797|NCT03457909|75707323|FG000|STARTED|Overall Study||25||
59597798|NCT03457909|75707323|FG000|COMPLETED|Overall Study||25||
59597799|NCT03457909|75707323|FG000|NOT COMPLETED|Overall Study||0||
59597800|NCT03696758|75707327|FG000|STARTED|First Intervention||3||
59597801|NCT03696758|75707328|FG001|STARTED|First Intervention||6||
59597802|NCT03696758|75707327|FG000|COMPLETED|First Intervention||3||
59597803|NCT03696758|75707328|FG001|COMPLETED|First Intervention||6||
59597804|NCT03696758|75707327|FG000|NOT COMPLETED|First Intervention||0||
59597805|NCT03696758|75707328|FG001|NOT COMPLETED|First Intervention||0||
59597806|NCT03696758|75707327|FG000|STARTED|Wash Out>12 Hours||3||
59597807|NCT03696758|75707328|FG001|STARTED|Wash Out>12 Hours||6||
59597808|NCT03696758|75707327|FG000|COMPLETED|Wash Out>12 Hours||3||
59597809|NCT03696758|75707328|FG001|COMPLETED|Wash Out>12 Hours||6||
59597810|NCT03696758|75707327|FG000|NOT COMPLETED|Wash Out>12 Hours||0||
59597811|NCT03696758|75707328|FG001|NOT COMPLETED|Wash Out>12 Hours||0||
59597812|NCT03696758|75707327|FG000|STARTED|Second Intervention||3||
59597813|NCT03696758|75707328|FG001|STARTED|Second Intervention||6||
59597814|NCT03696758|75707327|FG000|COMPLETED|Second Intervention||3||
59597815|NCT03696758|75707328|FG001|COMPLETED|Second Intervention||6||
59597816|NCT03696758|75707327|FG000|NOT COMPLETED|Second Intervention||0||
59597817|NCT03696758|75707328|FG001|NOT COMPLETED|Second Intervention||0||
59597818|NCT03461965|75707336|FG000|STARTED|Overall Study||42||
59597819|NCT03461965|75707337|FG001|STARTED|Overall Study||40||
59597820|NCT03461965|75707336|FG000|COMPLETED|Overall Study||42||
59597821|NCT03461965|75707337|FG001|COMPLETED|Overall Study||40||
59597822|NCT03461965|75707336|FG000|NOT COMPLETED|Overall Study||0||
59597823|NCT03461965|75707337|FG001|NOT COMPLETED|Overall Study||0||
59597824|NCT03702608|75707343|FG000|STARTED|Overall Study||50||
59597825|NCT03702608|75707343|FG000|COMPLETED|Overall Study||50||
59597826|NCT03702608|75707343|FG000|NOT COMPLETED|Overall Study||0||
59597827|NCT03233737|75707352|FG000|STARTED|Overall Study||10||
59597828|NCT03233737|75707353|FG001|STARTED|Overall Study||10||
59597829|NCT03233737|75707354|FG002|STARTED|Overall Study||5||
59597830|NCT03233737|75707355|FG003|STARTED|Overall Study||24||
59597831|NCT03233737|75707356|FG004|STARTED|Overall Study||26||
59597832|NCT03233737|75707352|FG000|COMPLETED|Overall Study||10||
59597833|NCT03233737|75707353|FG001|COMPLETED|Overall Study||10||
59597834|NCT03233737|75707354|FG002|COMPLETED|Overall Study||5||
59597835|NCT03233737|75707355|FG003|COMPLETED|Overall Study||24||
59597836|NCT03233737|75707356|FG004|COMPLETED|Overall Study||26||
59597837|NCT03233737|75707352|FG000|NOT COMPLETED|Overall Study||0||
59597838|NCT03233737|75707353|FG001|NOT COMPLETED|Overall Study||0||
59860407|NCT04908488|75985025|FG001|NOT COMPLETED|First Wear Period (8 -0/+3 Days)||0||0
59860408|NCT04908488|75985024|FG000|STARTED|Second Wear Period (8 -0/+3 Days)||55||110
59860409|NCT04908488|75985025|FG001|STARTED|Second Wear Period (8 -0/+3 Days)||58||116
59860410|NCT04908488|75985024|FG000|COMPLETED|Second Wear Period (8 -0/+3 Days)||54||108
59860411|NCT04908488|75985025|FG001|COMPLETED|Second Wear Period (8 -0/+3 Days)||58||116
59860412|NCT04908488|75985024|FG000|NOT COMPLETED|Second Wear Period (8 -0/+3 Days)||1||2
59860413|NCT04908488|75985025|FG001|NOT COMPLETED|Second Wear Period (8 -0/+3 Days)||0||0
59860414|NCT04876274|75985036|FG000|STARTED|Overall Study||91||
59860415|NCT04876274|75985037|FG001|STARTED|Overall Study||90||
59860416|NCT04876274|75985036|FG000|COMPLETED|Overall Study||82||
59860417|NCT04876274|75985037|FG001|COMPLETED|Overall Study||78||
59860418|NCT04876274|75985036|FG000|NOT COMPLETED|Overall Study||9||
59860419|NCT04876274|75985037|FG001|NOT COMPLETED|Overall Study||12||
59860420|NCT04865354|75985045|FG000|STARTED|First Wear Period (8 Days)||83||
59860421|NCT04865354|75985046|FG001|STARTED|First Wear Period (8 Days)||84||
59860422|NCT04865354|75985045|FG000|COMPLETED|First Wear Period (8 Days)||82||
59860423|NCT04865354|75985046|FG001|COMPLETED|First Wear Period (8 Days)||83||
59860424|NCT04865354|75985045|FG000|NOT COMPLETED|First Wear Period (8 Days)||1||
59860425|NCT04865354|75985046|FG001|NOT COMPLETED|First Wear Period (8 Days)||1||
59860426|NCT04865354|75985045|FG000|STARTED|Second Wear Period (8 Days)||82||
59860427|NCT04865354|75985046|FG001|STARTED|Second Wear Period (8 Days)||83||
59860428|NCT04865354|75985045|FG000|COMPLETED|Second Wear Period (8 Days)||81||
59860429|NCT04865354|75985046|FG001|COMPLETED|Second Wear Period (8 Days)||83||
59860430|NCT04865354|75985045|FG000|NOT COMPLETED|Second Wear Period (8 Days)||1||
59860431|NCT04865354|75985046|FG001|NOT COMPLETED|Second Wear Period (8 Days)||0||
59860432|NCT04860518|75985057|FG000|STARTED|Overall Study||3||
59860433|NCT04860518|75985058|FG001|STARTED|Overall Study||4||
59860434|NCT04860518|75985057|FG000|COMPLETED|Overall Study||2||
59860435|NCT04860518|75985058|FG001|COMPLETED|Overall Study||3||
59860436|NCT04860518|75985057|FG000|NOT COMPLETED|Overall Study||1||
59860437|NCT04860518|75985058|FG001|NOT COMPLETED|Overall Study||1||
59860438|NCT03110380|75985066|FG000|STARTED|Double-Blind Treatment Phase||284||
59860439|NCT03110380|75985067|FG001|STARTED|Double-Blind Treatment Phase||283||
59860440|NCT03110380|75985068|FG002|STARTED|Double-Blind Treatment Phase||0||
59860441|NCT03110380|75985069|FG003|STARTED|Double-Blind Treatment Phase||0||
59860442|NCT03110380|75985066|FG000|Safety Analysis Set|Double-Blind Treatment Phase||284||
59860443|NCT03110380|75985067|FG001|Safety Analysis Set|Double-Blind Treatment Phase||281||
59860444|NCT03110380|75985068|FG002|Safety Analysis Set|Double-Blind Treatment Phase||0||
59860445|NCT03110380|75985069|FG003|Safety Analysis Set|Double-Blind Treatment Phase||0||
59860446|NCT03110380|75985066|FG000|COMPLETED|Double-Blind Treatment Phase||263||
59860447|NCT03110380|75985067|FG001|COMPLETED|Double-Blind Treatment Phase||253||
59860448|NCT03110380|75985068|FG002|COMPLETED|Double-Blind Treatment Phase||0||
59860449|NCT03110380|75985069|FG003|COMPLETED|Double-Blind Treatment Phase||0||
59860450|NCT03110380|75985066|FG000|NOT COMPLETED|Double-Blind Treatment Phase||21||
59860451|NCT03110380|75985067|FG001|NOT COMPLETED|Double-Blind Treatment Phase||30||
59597839|NCT03233737|75707354|FG002|NOT COMPLETED|Overall Study||0||
59597840|NCT03233737|75707355|FG003|NOT COMPLETED|Overall Study||0||
59597841|NCT03233737|75707356|FG004|NOT COMPLETED|Overall Study||0||
59597842|NCT04144088|75707372|FG000|STARTED|Overall Study||20||
59860452|NCT03110380|75985068|FG002|NOT COMPLETED|Double-Blind Treatment Phase||0||
59860453|NCT03110380|75985069|FG003|NOT COMPLETED|Double-Blind Treatment Phase||0||
59597843|NCT04144088|75707373|FG001|STARTED|Overall Study||20||
59597844|NCT04144088|75707374|FG002|STARTED|Overall Study||20||
59597845|NCT04144088|75707372|FG000|COMPLETED|Overall Study||14||
59597846|NCT04144088|75707373|FG001|COMPLETED|Overall Study||15||
59597847|NCT04144088|75707374|FG002|COMPLETED|Overall Study||13||
59597848|NCT04144088|75707372|FG000|NOT COMPLETED|Overall Study||6||
59597849|NCT04144088|75707373|FG001|NOT COMPLETED|Overall Study||5||
59597850|NCT04144088|75707374|FG002|NOT COMPLETED|Overall Study||7||
59597851|NCT03359629|75707384|FG000|STARTED|Overall Study||200||
59597852|NCT03359629|75707385|FG001|STARTED|Overall Study||10||
59597853|NCT03359629|75707384|FG000|COMPLETED|Overall Study||200||
59597854|NCT03359629|75707385|FG001|COMPLETED|Overall Study||10||
59597855|NCT03359629|75707384|FG000|NOT COMPLETED|Overall Study||0||
59597856|NCT03359629|75707385|FG001|NOT COMPLETED|Overall Study||0||
59597857|NCT03462745|75707393|FG000|STARTED|Overall Study||92||
59597858|NCT03462745|75707394|FG001|STARTED|Overall Study||92||
59597859|NCT03462745|75707393|FG000|COMPLETED|Overall Study||92||
59597860|NCT03462745|75707394|FG001|COMPLETED|Overall Study||92||
59597861|NCT03462745|75707393|FG000|NOT COMPLETED|Overall Study||0||
59597862|NCT03462745|75707394|FG001|NOT COMPLETED|Overall Study||0||
59597863|NCT03711578|75707400|FG000|STARTED|Overall Study||20||
59597864|NCT03711578|75707400|FG000|COMPLETED|Overall Study||20||
59597865|NCT03711578|75707400|FG000|NOT COMPLETED|Overall Study||0||
59860454|NCT03110380|75985066|FG000|STARTED|Open-label B/F/TAF Extension Phase|Following the end of Double-Blind treatment phase, participants in a country where B/F/TAF FDC was not available were given the option to receive open-label B/F/TAF.|0||
59860455|NCT03110380|75985067|FG001|STARTED|Open-label B/F/TAF Extension Phase|Following the end of Double-Blind treatment phase, participants in a country where B/F/TAF FDC was not available were given the option to receive open-label B/F/TAF.|0||
59860456|NCT03110380|75985068|FG002|STARTED|Open-label B/F/TAF Extension Phase|138 participants completed the Double-Blind treatment phase, but did not continue in the Open-label B/F/TAF extension phase.|125||
59860457|NCT03110380|75985069|FG003|STARTED|Open-label B/F/TAF Extension Phase|137 participants completed the Double-Blind treatment phase, but did not continue in the Open-label B/F/TAF extension phase.|116||
59860458|NCT03110380|75985066|FG000|COMPLETED|Open-label B/F/TAF Extension Phase||0||
59860459|NCT03110380|75985067|FG001|COMPLETED|Open-label B/F/TAF Extension Phase||0||
59860460|NCT03110380|75985068|FG002|COMPLETED|Open-label B/F/TAF Extension Phase||121||
59860461|NCT03110380|75985069|FG003|COMPLETED|Open-label B/F/TAF Extension Phase||113||
59860462|NCT03110380|75985066|FG000|NOT COMPLETED|Open-label B/F/TAF Extension Phase||0||
59860463|NCT03110380|75985067|FG001|NOT COMPLETED|Open-label B/F/TAF Extension Phase||0||
59860464|NCT03110380|75985068|FG002|NOT COMPLETED|Open-label B/F/TAF Extension Phase||4||
59860465|NCT03110380|75985069|FG003|NOT COMPLETED|Open-label B/F/TAF Extension Phase||3||
59860466|NCT04851314|75985079|FG000|STARTED|Overall Study||55||
59860467|NCT04851314|75985080|FG001|STARTED|Overall Study||55||
59860468|NCT04851314|75985079|FG000|COMPLETED|Overall Study||52||
59860469|NCT04851314|75985080|FG001|COMPLETED|Overall Study||51||
59860470|NCT04851314|75985079|FG000|NOT COMPLETED|Overall Study||3||
59860471|NCT04851314|75985080|FG001|NOT COMPLETED|Overall Study||4||
59860472|NCT04848662|75985088|FG000|STARTED|Period 1 (First Treatment Intervention)||6||
59860473|NCT04848662|75985089|FG001|STARTED|Period 1 (First Treatment Intervention)||6||
59860474|NCT04848662|75985088|FG000|COMPLETED|Period 1 (First Treatment Intervention)||6||
59860475|NCT04848662|75985089|FG001|COMPLETED|Period 1 (First Treatment Intervention)||6||
59860476|NCT04848662|75985088|FG000|NOT COMPLETED|Period 1 (First Treatment Intervention)||0||
59860477|NCT04848662|75985089|FG001|NOT COMPLETED|Period 1 (First Treatment Intervention)||0||
59860478|NCT04848662|75985088|FG000|STARTED|Period 2 (Second Treatment Intervention)||6||
59860479|NCT04848662|75985089|FG001|STARTED|Period 2 (Second Treatment Intervention)||6||
59860480|NCT04848662|75985088|FG000|COMPLETED|Period 2 (Second Treatment Intervention)||5||
59860481|NCT04848662|75985089|FG001|COMPLETED|Period 2 (Second Treatment Intervention)||6||
59860482|NCT04848662|75985088|FG000|NOT COMPLETED|Period 2 (Second Treatment Intervention)||1||
59860483|NCT04848662|75985089|FG001|NOT COMPLETED|Period 2 (Second Treatment Intervention)||0||
59860484|NCT03701516|75985095|FG000|STARTED|Period 1||131||
59860485|NCT03701516|75985096|FG001|STARTED|Period 1||132||
59860486|NCT03701516|75985095|FG000|COMPLETED|Period 1||127||
59860487|NCT03701516|75985096|FG001|COMPLETED|Period 1||127||
59860488|NCT03701516|75985095|FG000|NOT COMPLETED|Period 1||4||
59860489|NCT03701516|75985096|FG001|NOT COMPLETED|Period 1||5||
59860490|NCT03701516|75985095|FG000|STARTED|Period 2||127||
59860491|NCT03701516|75985096|FG001|STARTED|Period 2||127||
59860492|NCT03701516|75985095|FG000|COMPLETED|Period 2||126||
59860493|NCT03701516|75985096|FG001|COMPLETED|Period 2||126||
59860494|NCT03701516|75985095|FG000|NOT COMPLETED|Period 2||1||
59860495|NCT03701516|75985096|FG001|NOT COMPLETED|Period 2||1||
59860496|NCT03700892|75985104|FG000|STARTED|Baseline||15||
59860497|NCT03700892|75985105|FG001|STARTED|Baseline||0||
59860498|NCT03700892|75985106|FG002|STARTED|Baseline||4||
59860499|NCT03700892|75985104|FG000|COMPLETED|Baseline||15||
59860500|NCT03700892|75985105|FG001|COMPLETED|Baseline||0||
59860501|NCT03700892|75985106|FG002|COMPLETED|Baseline||4||
59860502|NCT03700892|75985104|FG000|NOT COMPLETED|Baseline||0||
59860503|NCT03700892|75985105|FG001|NOT COMPLETED|Baseline||0||
59860504|NCT03700892|75985106|FG002|NOT COMPLETED|Baseline||0||
59860505|NCT03700892|75985104|FG000|STARTED|First Intervention (Single 1-Day Visit)||1||
59860506|NCT03700892|75985105|FG001|STARTED|First Intervention (Single 1-Day Visit)||4||
59860507|NCT03700892|75985106|FG002|STARTED|First Intervention (Single 1-Day Visit)||0||
59860508|NCT03700892|75985104|FG000|COMPLETED|First Intervention (Single 1-Day Visit)||1||
59860509|NCT03700892|75985105|FG001|COMPLETED|First Intervention (Single 1-Day Visit)||4||
59860510|NCT03700892|75985106|FG002|COMPLETED|First Intervention (Single 1-Day Visit)||0||
59860511|NCT03700892|75985104|FG000|NOT COMPLETED|First Intervention (Single 1-Day Visit)||0||
59860512|NCT03700892|75985105|FG001|NOT COMPLETED|First Intervention (Single 1-Day Visit)||0||
59860513|NCT03700892|75985106|FG002|NOT COMPLETED|First Intervention (Single 1-Day Visit)||0||
59860514|NCT03700892|75985104|FG000|STARTED|Washout (2-3 Weeks)||1||
59860515|NCT03700892|75985105|FG001|STARTED|Washout (2-3 Weeks)||4||
59860516|NCT03700892|75985106|FG002|STARTED|Washout (2-3 Weeks)||0||
59860517|NCT03700892|75985104|FG000|COMPLETED|Washout (2-3 Weeks)||1||
59860518|NCT03700892|75985105|FG001|COMPLETED|Washout (2-3 Weeks)||4||
59860519|NCT03700892|75985106|FG002|COMPLETED|Washout (2-3 Weeks)||0||
59860520|NCT03700892|75985104|FG000|NOT COMPLETED|Washout (2-3 Weeks)||0||
59860521|NCT03700892|75985105|FG001|NOT COMPLETED|Washout (2-3 Weeks)||0||
59860522|NCT03700892|75985106|FG002|NOT COMPLETED|Washout (2-3 Weeks)||0||
59860523|NCT03700892|75985104|FG000|STARTED|Second Intervention (Single 1-Day Visit)||1||
59860524|NCT03700892|75985105|FG001|STARTED|Second Intervention (Single 1-Day Visit)||4||
59860525|NCT03700892|75985106|FG002|STARTED|Second Intervention (Single 1-Day Visit)||0||
59860526|NCT03700892|75985104|FG000|Received Intervention|Second Intervention (Single 1-Day Visit)||1||
59860527|NCT03700892|75985105|FG001|Received Intervention|Second Intervention (Single 1-Day Visit)||3||
59860528|NCT03700892|75985106|FG002|Received Intervention|Second Intervention (Single 1-Day Visit)||0||
59860529|NCT03700892|75985104|FG000|COMPLETED|Second Intervention (Single 1-Day Visit)||1||
59860530|NCT03700892|75985105|FG001|COMPLETED|Second Intervention (Single 1-Day Visit)||3||
59860531|NCT03700892|75985106|FG002|COMPLETED|Second Intervention (Single 1-Day Visit)||0||
59860532|NCT03700892|75985104|FG000|NOT COMPLETED|Second Intervention (Single 1-Day Visit)||0||
59860533|NCT03700892|75985105|FG001|NOT COMPLETED|Second Intervention (Single 1-Day Visit)||1||
59860534|NCT03700892|75985106|FG002|NOT COMPLETED|Second Intervention (Single 1-Day Visit)||0||
59860535|NCT03700736|75985117|FG000|STARTED|Overall Study||30|Intervention|
59860536|NCT03700736|75985118|FG001|STARTED|Overall Study||32|Intervention|
59860537|NCT03700736|75985117|FG000|COMPLETED|Overall Study||27||
59860538|NCT03700736|75985118|FG001|COMPLETED|Overall Study||25||
59860539|NCT03700736|75985117|FG000|NOT COMPLETED|Overall Study||3||
59860540|NCT03700736|75985118|FG001|NOT COMPLETED|Overall Study||7||
59860541|NCT04737278|75985129|FG000|STARTED|Overall Study||28||
59860542|NCT04737278|75985130|FG001|STARTED|Overall Study||28||
59860543|NCT04737278|75985129|FG000|COMPLETED|Overall Study||24||
59860544|NCT04737278|75985130|FG001|COMPLETED|Overall Study||25||
59860545|NCT04737278|75985129|FG000|NOT COMPLETED|Overall Study||4||
59860546|NCT04737278|75985130|FG001|NOT COMPLETED|Overall Study||3||
59860547|NCT04725500|75985136|FG000|STARTED|Screening||42||
59860548|NCT04725500|75985136|FG000|COMPLETED|Screening||15||
59860549|NCT04725500|75985136|FG000|NOT COMPLETED|Screening||27||
59860550|NCT04725500|75985136|FG000|STARTED|Overnight Polysomnography (PSG)||15||
59860551|NCT04725500|75985136|FG000|COMPLETED|Overnight Polysomnography (PSG)||15||
59860552|NCT04725500|75985136|FG000|NOT COMPLETED|Overnight Polysomnography (PSG)||0||
59860553|NCT04725500|75985136|FG000|STARTED|2 Week Take Home||15||
59860554|NCT04725500|75985136|FG000|COMPLETED|2 Week Take Home||10||
59860555|NCT04725500|75985136|FG000|NOT COMPLETED|2 Week Take Home||5||
59860556|NCT04684394|75985142|FG000|STARTED|Overall Study||34||68
59860557|NCT04684394|75985143|FG001|STARTED|Overall Study||16||32
59860558|NCT04684394|75985142|FG000|Study Eye|Overall Study||34||34
59860559|NCT04684394|75985143|FG001|Study Eye|Overall Study||16||16
59860560|NCT04684394|75985142|FG000|Fellow Eye|Overall Study||34||34
59860561|NCT04684394|75985143|FG001|Fellow Eye|Overall Study||16||16
59860562|NCT04684394|75985142|FG000|COMPLETED|Overall Study||5||10
59860563|NCT04684394|75985143|FG001|COMPLETED|Overall Study||1||2
59860564|NCT04684394|75985142|FG000|NOT COMPLETED|Overall Study||29||58
59860565|NCT04684394|75985143|FG001|NOT COMPLETED|Overall Study||15||30
59860566|NCT04674644|75985149|FG000|STARTED|Overall Study||850|number of participants|
59860567|NCT04674644|75985149|FG000|COMPLETED|Overall Study||813|number of participants|
59860568|NCT04674644|75985149|FG000|NOT COMPLETED|Overall Study||37||
59860569|NCT04668950|75985156|FG000|STARTED|Overall Study||334||
59860570|NCT04668950|75985157|FG001|STARTED|Overall Study||336||
59860571|NCT04668950|75985156|FG000|COMPLETED|Overall Study||272||
59860572|NCT04668950|75985157|FG001|COMPLETED|Overall Study||275||
59860573|NCT04668950|75985156|FG000|NOT COMPLETED|Overall Study||62||
59860574|NCT04668950|75985157|FG001|NOT COMPLETED|Overall Study||61||
59860575|NCT03078478|75985165|FG000|STARTED|Titration Period (16 Weeks)||805||
59860576|NCT03078478|75985166|FG001|STARTED|Titration Period (16 Weeks)||804||
59860577|NCT03078478|75985165|FG000|Full Analysis Set|Titration Period (16 Weeks)||805||
59860578|NCT03078478|75985166|FG001|Full Analysis Set|Titration Period (16 Weeks)||804||
60128982|NCT01586624|76251239|FG006|STARTED|Overall Study||8||
59860579|NCT03078478|75985165|FG000|Safety Analysis Set|Titration Period (16 Weeks)||802||
59860580|NCT03078478|75985166|FG001|Safety Analysis Set|Titration Period (16 Weeks)||798||
59860581|NCT03078478|75985165|FG000|COMPLETED|Titration Period (16 Weeks)||805||
59860582|NCT03078478|75985166|FG001|COMPLETED|Titration Period (16 Weeks)||804||
59860583|NCT03078478|75985165|FG000|NOT COMPLETED|Titration Period (16 Weeks)||0||
59860584|NCT03078478|75985166|FG001|NOT COMPLETED|Titration Period (16 Weeks)||0||
59860585|NCT03078478|75985165|FG000|STARTED|Maintenance Period 1 (36 Weeks)||805||
59860586|NCT03078478|75985166|FG001|STARTED|Maintenance Period 1 (36 Weeks)||804||
59860587|NCT03078478|75985165|FG000|COMPLETED|Maintenance Period 1 (36 Weeks)||758||
59860588|NCT03078478|75985166|FG001|COMPLETED|Maintenance Period 1 (36 Weeks)||761||
59860589|NCT03078478|75985165|FG000|NOT COMPLETED|Maintenance Period 1 (36 Weeks)||47||
59860590|NCT03078478|75985166|FG001|NOT COMPLETED|Maintenance Period 1 (36 Weeks)||43||
59860591|NCT03078478|75985165|FG000|STARTED|Maintencance Period 2 (36 Weeks)||758||
59860592|NCT03078478|75985166|FG001|STARTED|Maintencance Period 2 (36 Weeks)||761||
59860593|NCT03078478|75985165|FG000|COMPLETED|Maintencance Period 2 (36 Weeks)||733||
59860594|NCT03078478|75985166|FG001|COMPLETED|Maintencance Period 2 (36 Weeks)||734||
59860595|NCT03078478|75985165|FG000|NOT COMPLETED|Maintencance Period 2 (36 Weeks)||25||
59860596|NCT03078478|75985166|FG001|NOT COMPLETED|Maintencance Period 2 (36 Weeks)||27||
59860597|NCT02879578|75985175|FG000|STARTED|Overall Study||33||
59860598|NCT02879578|75985176|FG001|STARTED|Overall Study||41||
59860599|NCT02879578|75985177|FG002|STARTED|Overall Study||81||
59860600|NCT02879578|75985175|FG000|Safety Analysis Set|Overall Study||33|Safety analysis set includes all participants who received at least one dose of study drug and have any postbaseline data.|
59860601|NCT02879578|75985176|FG001|Safety Analysis Set|Overall Study||40|Safety analysis set includes all participants who received at least one dose of study drug and have any postbaseline data.|
59860602|NCT02879578|75985177|FG002|Safety Analysis Set|Overall Study||79|Safety analysis set includes all participants who received at least one dose of study drug and have any postbaseline data.|
59860603|NCT02879578|75985175|FG000|COMPLETED|Overall Study||23||
59860604|NCT02879578|75985176|FG001|COMPLETED|Overall Study||32||
59860605|NCT02879578|75985177|FG002|COMPLETED|Overall Study||49||
59860606|NCT02879578|75985175|FG000|NOT COMPLETED|Overall Study||10||
59860607|NCT02879578|75985176|FG001|NOT COMPLETED|Overall Study||9||
59860608|NCT02879578|75985177|FG002|NOT COMPLETED|Overall Study||32||
59860609|NCT00045942|75985194|FG000|STARTED|PKC412A2104 (Core)||20||
59860610|NCT00045942|75985195|FG001|STARTED|PKC412A2104 (Core)||0||
59860611|NCT00045942|75985196|FG002|STARTED|PKC412A2104 (Core)||0||
59860612|NCT00045942|75985197|FG003|STARTED|PKC412A2104 (Core)||0||
59860613|NCT00045942|75985198|FG004|STARTED|PKC412A2104 (Core)||0||
59860614|NCT00045942|75985199|FG005|STARTED|PKC412A2104 (Core)||0||
59860615|NCT00045942|75985200|FG006|STARTED|PKC412A2104 (Core)||0||
59860616|NCT00045942|75985201|FG007|STARTED|PKC412A2104 (Core)||0||
59860617|NCT00045942|75985202|FG008|STARTED|PKC412A2104 (Core)||0||
59860618|NCT00045942|75985194|FG000|Core Primary Efficacy|PKC412A2104 (Core)||20||
59860619|NCT00045942|75985195|FG001|Core Primary Efficacy|PKC412A2104 (Core)||0||
59860620|NCT00045942|75985196|FG002|Core Primary Efficacy|PKC412A2104 (Core)||0||
59860621|NCT00045942|75985197|FG003|Core Primary Efficacy|PKC412A2104 (Core)||0||
59860622|NCT00045942|75985198|FG004|Core Primary Efficacy|PKC412A2104 (Core)||0||
59860623|NCT00045942|75985199|FG005|Core Primary Efficacy|PKC412A2104 (Core)||0||
59860624|NCT00045942|75985200|FG006|Core Primary Efficacy|PKC412A2104 (Core)||0||
59860625|NCT00045942|75985201|FG007|Core Primary Efficacy|PKC412A2104 (Core)||0||
59860626|NCT00045942|75985202|FG008|Core Primary Efficacy|PKC412A2104 (Core)||0||
59860627|NCT00045942|75985194|FG000|COMPLETED|PKC412A2104 (Core)||0||
59860628|NCT00045942|75985195|FG001|COMPLETED|PKC412A2104 (Core)||0||
59860629|NCT00045942|75985196|FG002|COMPLETED|PKC412A2104 (Core)||0||
59860630|NCT00045942|75985197|FG003|COMPLETED|PKC412A2104 (Core)||0||
59860631|NCT00045942|75985198|FG004|COMPLETED|PKC412A2104 (Core)||0||
59860632|NCT00045942|75985199|FG005|COMPLETED|PKC412A2104 (Core)||0||
59860633|NCT00045942|75985200|FG006|COMPLETED|PKC412A2104 (Core)||0||
59860634|NCT00045942|75985201|FG007|COMPLETED|PKC412A2104 (Core)||0||
59860635|NCT00045942|75985202|FG008|COMPLETED|PKC412A2104 (Core)||0||
59860636|NCT00045942|75985194|FG000|NOT COMPLETED|PKC412A2104 (Core)||20||
59860637|NCT00045942|75985195|FG001|NOT COMPLETED|PKC412A2104 (Core)||0||
59860638|NCT00045942|75985196|FG002|NOT COMPLETED|PKC412A2104 (Core)||0||
59860639|NCT00045942|75985197|FG003|NOT COMPLETED|PKC412A2104 (Core)||0||
59860640|NCT00045942|75985198|FG004|NOT COMPLETED|PKC412A2104 (Core)||0||
59860641|NCT00045942|75985199|FG005|NOT COMPLETED|PKC412A2104 (Core)||0||
59860642|NCT00045942|75985200|FG006|NOT COMPLETED|PKC412A2104 (Core)||0||
59860643|NCT00045942|75985201|FG007|NOT COMPLETED|PKC412A2104 (Core)||0||
59860644|NCT00045942|75985202|FG008|NOT COMPLETED|PKC412A2104 (Core)||0||
59860645|NCT00045942|75985194|FG000|STARTED|PKC412A2104E1||0||
59860646|NCT00045942|75985195|FG001|STARTED|PKC412A2104E1||18||
59860647|NCT00045942|75985196|FG002|STARTED|PKC412A2104E1||17||
59860648|NCT00045942|75985197|FG003|STARTED|PKC412A2104E1||33||
59860649|NCT00045942|75985198|FG004|STARTED|PKC412A2104E1||27||
59860650|NCT00045942|75985199|FG005|STARTED|PKC412A2104E1||0||
59860651|NCT00045942|75985200|FG006|STARTED|PKC412A2104E1||0||
59860652|NCT00045942|75985201|FG007|STARTED|PKC412A2104E1||0||
59860653|NCT00045942|75985202|FG008|STARTED|PKC412A2104E1||0||
59860654|NCT00045942|75985194|FG000|Primary Efficacy|PKC412A2104E1||0||
59860655|NCT00045942|75985195|FG001|Primary Efficacy|PKC412A2104E1||18||
59860656|NCT00045942|75985196|FG002|Primary Efficacy|PKC412A2104E1||17||
59860657|NCT00045942|75985197|FG003|Primary Efficacy|PKC412A2104E1||32||
59860658|NCT00045942|75985198|FG004|Primary Efficacy|PKC412A2104E1||25||
59860659|NCT00045942|75985199|FG005|Primary Efficacy|PKC412A2104E1||0||
59860660|NCT00045942|75985200|FG006|Primary Efficacy|PKC412A2104E1||0||
59860661|NCT00045942|75985201|FG007|Primary Efficacy|PKC412A2104E1||0||
59860662|NCT00045942|75985202|FG008|Primary Efficacy|PKC412A2104E1||0||
59860663|NCT00045942|75985194|FG000|COMPLETED|PKC412A2104E1||0||
59860664|NCT00045942|75985195|FG001|COMPLETED|PKC412A2104E1||0||
59860665|NCT00045942|75985196|FG002|COMPLETED|PKC412A2104E1||0||
59860666|NCT00045942|75985197|FG003|COMPLETED|PKC412A2104E1||0||
59860667|NCT00045942|75985198|FG004|COMPLETED|PKC412A2104E1||0||
59860668|NCT00045942|75985199|FG005|COMPLETED|PKC412A2104E1||0||
59860669|NCT00045942|75985200|FG006|COMPLETED|PKC412A2104E1||0||
59860670|NCT00045942|75985201|FG007|COMPLETED|PKC412A2104E1||0||
59860671|NCT00045942|75985202|FG008|COMPLETED|PKC412A2104E1||0||
59860672|NCT00045942|75985194|FG000|NOT COMPLETED|PKC412A2104E1||0||
59860673|NCT00045942|75985195|FG001|NOT COMPLETED|PKC412A2104E1||18||
59860674|NCT00045942|75985196|FG002|NOT COMPLETED|PKC412A2104E1||17||
59860675|NCT00045942|75985197|FG003|NOT COMPLETED|PKC412A2104E1||33||
59860676|NCT00045942|75985198|FG004|NOT COMPLETED|PKC412A2104E1||27||
59860677|NCT00045942|75985199|FG005|NOT COMPLETED|PKC412A2104E1||0||
59860678|NCT00045942|75985200|FG006|NOT COMPLETED|PKC412A2104E1||0||
59860679|NCT00045942|75985201|FG007|NOT COMPLETED|PKC412A2104E1||0||
59860680|NCT00045942|75985202|FG008|NOT COMPLETED|PKC412A2104E1||0||
59860681|NCT00045942|75985194|FG000|STARTED|PKC412A2104E2||0||
59860682|NCT00045942|75985195|FG001|STARTED|PKC412A2104E2||0||
59860683|NCT00045942|75985196|FG002|STARTED|PKC412A2104E2||0||
59860684|NCT00045942|75985197|FG003|STARTED|PKC412A2104E2||0||
59860685|NCT00045942|75985198|FG004|STARTED|PKC412A2104E2||0||
59860686|NCT00045942|75985199|FG005|STARTED|PKC412A2104E2||9||
59860687|NCT00045942|75985200|FG006|STARTED|PKC412A2104E2||7||
59860688|NCT00045942|75985201|FG007|STARTED|PKC412A2104E2||7||
59860689|NCT00045942|75985202|FG008|STARTED|PKC412A2104E2||6||
59860690|NCT00045942|75985194|FG000|Primary Efficacy|PKC412A2104E2||0||
59860691|NCT00045942|75985195|FG001|Primary Efficacy|PKC412A2104E2||0||
59860692|NCT00045942|75985196|FG002|Primary Efficacy|PKC412A2104E2||0||
59860693|NCT00045942|75985197|FG003|Primary Efficacy|PKC412A2104E2||0||
59860694|NCT00045942|75985198|FG004|Primary Efficacy|PKC412A2104E2||0||
59860695|NCT00045942|75985199|FG005|Primary Efficacy|PKC412A2104E2||9||
59860696|NCT00045942|75985200|FG006|Primary Efficacy|PKC412A2104E2||7||
59860697|NCT00045942|75985201|FG007|Primary Efficacy|PKC412A2104E2||7||
59860698|NCT00045942|75985202|FG008|Primary Efficacy|PKC412A2104E2||6||
59860699|NCT00045942|75985194|FG000|COMPLETED|PKC412A2104E2||0||
59860700|NCT00045942|75985195|FG001|COMPLETED|PKC412A2104E2||0||
59860701|NCT00045942|75985196|FG002|COMPLETED|PKC412A2104E2||0||
59860702|NCT00045942|75985197|FG003|COMPLETED|PKC412A2104E2||0||
59860703|NCT00045942|75985198|FG004|COMPLETED|PKC412A2104E2||0||
59860704|NCT00045942|75985199|FG005|COMPLETED|PKC412A2104E2||0||
59860705|NCT00045942|75985200|FG006|COMPLETED|PKC412A2104E2||0||
59860706|NCT00045942|75985201|FG007|COMPLETED|PKC412A2104E2||0||
59860707|NCT00045942|75985202|FG008|COMPLETED|PKC412A2104E2||0||
59860708|NCT00045942|75985194|FG000|NOT COMPLETED|PKC412A2104E2||0||
59860709|NCT00045942|75985195|FG001|NOT COMPLETED|PKC412A2104E2||0||
59860710|NCT00045942|75985196|FG002|NOT COMPLETED|PKC412A2104E2||0||
59860711|NCT00045942|75985197|FG003|NOT COMPLETED|PKC412A2104E2||0||
59860712|NCT00045942|75985198|FG004|NOT COMPLETED|PKC412A2104E2||0||
59860713|NCT00045942|75985199|FG005|NOT COMPLETED|PKC412A2104E2||9||
59860714|NCT00045942|75985200|FG006|NOT COMPLETED|PKC412A2104E2||7||
59860715|NCT00045942|75985201|FG007|NOT COMPLETED|PKC412A2104E2||7||
59860716|NCT00045942|75985202|FG008|NOT COMPLETED|PKC412A2104E2||6||
59860717|NCT04386616|75985229|FG000|STARTED|Overall Study||134||
59860718|NCT04386616|75985230|FG001|STARTED|Overall Study||130||
59860719|NCT04386616|75985231|FG002|STARTED|Overall Study||132||
59860720|NCT04386616|75985229|FG000|Received at Least One Dose of Study Drug|Overall Study|In this arm, 68 and 66 participants received MSTT1041A-matched placebo and UTTR1147A-matched placebo, respectively.|134|Safety Population|
59860721|NCT04386616|75985230|FG001|Received at Least One Dose of Study Drug|Overall Study||130|Safety Population|
59860722|NCT04386616|75985231|FG002|Received at Least One Dose of Study Drug|Overall Study||132|Safety Population|
59860723|NCT04386616|75985229|FG000|Completed Both Doses of Study Drug at Day 15|Overall Study||31||
59860724|NCT04386616|75985230|FG001|Completed Both Doses of Study Drug at Day 15|Overall Study||27||
59860725|NCT04386616|75985231|FG002|Completed Both Doses of Study Drug at Day 15|Overall Study||25||
59860726|NCT04386616|75985229|FG000|COMPLETED|Overall Study||104||
59860727|NCT04386616|75985230|FG001|COMPLETED|Overall Study||95||
59860728|NCT04386616|75985231|FG002|COMPLETED|Overall Study||104||
59860729|NCT04386616|75985229|FG000|NOT COMPLETED|Overall Study||30||
59860730|NCT04386616|75985230|FG001|NOT COMPLETED|Overall Study||35||
59860731|NCT04386616|75985231|FG002|NOT COMPLETED|Overall Study||28||
59860732|NCT00045708|75985251|FG000|STARTED|Phase 1||21||
59860733|NCT00045708|75985252|FG001|STARTED|Phase 1||17||
59860734|NCT00045708|75985253|FG002|STARTED|Phase 1||0||
59860735|NCT00045708|75985251|FG000|COMPLETED|Phase 1||21||
59860736|NCT00045708|75985252|FG001|COMPLETED|Phase 1||16||
59860737|NCT00045708|75985253|FG002|COMPLETED|Phase 1||0||
59860738|NCT00045708|75985251|FG000|NOT COMPLETED|Phase 1||0||
59860739|NCT00045708|75985252|FG001|NOT COMPLETED|Phase 1||1||
59860740|NCT00045708|75985253|FG002|NOT COMPLETED|Phase 1||0||
59860741|NCT00045708|75985251|FG000|STARTED|Phase 2||0||
59860742|NCT00045708|75985252|FG001|STARTED|Phase 2||0||
59860743|NCT00045708|75985253|FG002|STARTED|Phase 2||19||
59860744|NCT00045708|75985251|FG000|COMPLETED|Phase 2||0||
59860745|NCT00045708|75985252|FG001|COMPLETED|Phase 2||0||
59860746|NCT00045708|75985253|FG002|COMPLETED|Phase 2||19||
59860747|NCT00045708|75985251|FG000|NOT COMPLETED|Phase 2||0||
59860748|NCT00045708|75985252|FG001|NOT COMPLETED|Phase 2||0||
59860749|NCT00045708|75985253|FG002|NOT COMPLETED|Phase 2||0||
59860750|NCT00045630|75985270|FG000|STARTED|Overall Study||77||
59860751|NCT00045630|75985270|FG000|Eligible|Overall Study||75||
59860752|NCT00045630|75985270|FG000|Eligible and Began Protocol Therapy|Overall Study||74||
59860753|NCT00045630|75985270|FG000|COMPLETED|Overall Study||71||
59860754|NCT00045630|75985270|FG000|NOT COMPLETED|Overall Study||6||
59860755|NCT00003702|75985276|FG000|STARTED|Overall Study||120||
59860756|NCT00003702|75985277|FG001|STARTED|Overall Study||120||
59860757|NCT00003702|75985276|FG000|COMPLETED|Overall Study||107||
59860758|NCT00003702|75985277|FG001|COMPLETED|Overall Study||109||
59860759|NCT00003702|75985276|FG000|NOT COMPLETED|Overall Study||13||
59860760|NCT00003702|75985277|FG001|NOT COMPLETED|Overall Study||11||
59860761|NCT00031590|75985284|FG000|STARTED|Overall Study||28||
59860762|NCT00031590|75985284|FG000|COMPLETED|Overall Study||25||
59860763|NCT00031590|75985284|FG000|NOT COMPLETED|Overall Study||3||
59860764|NCT00239681|75985291|FG000|STARTED|Overall Study||8901||
59860765|NCT00239681|75985292|FG001|STARTED|Overall Study||8901||
59860766|NCT00239681|75985291|FG000|Randomized and Treated (Safety Pop)|Overall Study||8869||
59860767|NCT00239681|75985292|FG001|Randomized and Treated (Safety Pop)|Overall Study||8864||
59860768|NCT00239681|75985291|FG000|COMPLETED|Overall Study||8208||
59860769|NCT00239681|75985292|FG001|COMPLETED|Overall Study||8186||
59860770|NCT00239681|75985291|FG000|NOT COMPLETED|Overall Study||693||
59860771|NCT00239681|75985292|FG001|NOT COMPLETED|Overall Study||715||
59860772|NCT02878330|75985300|FG000|STARTED|Overall Study||484||
59860773|NCT02878330|75985301|FG001|STARTED|Overall Study||969||
59860774|NCT02878330|75985300|FG000|COMPLETED|Overall Study||455||
59860775|NCT02878330|75985301|FG001|COMPLETED|Overall Study||913||
59860776|NCT02878330|75985300|FG000|NOT COMPLETED|Overall Study||29||
59860777|NCT02878330|75985301|FG001|NOT COMPLETED|Overall Study||56||
59860778|NCT00238433|75985308|FG000|STARTED|Overall Study||37||
59860779|NCT00238433|75985308|FG000|COMPLETED|Overall Study||34||
59860780|NCT00238433|75985308|FG000|NOT COMPLETED|Overall Study||3||
59860781|NCT00045162|75985315|FG000|STARTED|Overall Study||336||
59860782|NCT00045162|75985316|FG001|STARTED|Overall Study||335||
59860783|NCT00045162|75985315|FG000|COMPLETED|Overall Study||194||
59860784|NCT00045162|75985316|FG001|COMPLETED|Overall Study||217||
59860785|NCT00045162|75985315|FG000|NOT COMPLETED|Overall Study||142||
59860786|NCT00045162|75985316|FG001|NOT COMPLETED|Overall Study||118||
59860787|NCT02748616|75985322|FG000|STARTED|Overall Study||9||
59860788|NCT02748616|75985322|FG000|COMPLETED|Overall Study||2||
59860789|NCT02748616|75985322|FG000|NOT COMPLETED|Overall Study||7||
59860790|NCT00238121|75985328|FG000|STARTED|Overall Study||40||
59860791|NCT00238121|75985329|FG001|STARTED|Overall Study||16||
59860792|NCT00238121|75985328|FG000|COMPLETED|Overall Study||37||
59860793|NCT00238121|75985329|FG001|COMPLETED|Overall Study||14||
59860794|NCT00238121|75985328|FG000|NOT COMPLETED|Overall Study||3||
59860795|NCT00238121|75985329|FG001|NOT COMPLETED|Overall Study||2||
59860796|NCT03139552|75985334|FG000|STARTED|Overall Study||150||
59860797|NCT03139552|75985334|FG000|COMPLETED|Overall Study||147|3 subjects did not complete tastings of all three items.|
59860798|NCT03139552|75985334|FG000|NOT COMPLETED|Overall Study||3||
59860799|NCT03804918|75985345|FG000|STARTED|Overall Study||17||
59860800|NCT03804918|75985345|FG000|COMPLETED|Overall Study||16||
59860801|NCT03804918|75985345|FG000|NOT COMPLETED|Overall Study||1||
59860802|NCT03139240|75985353|FG000|STARTED|Overall Study||48||
59860803|NCT03139240|75985354|FG001|STARTED|Overall Study||48||
59860804|NCT03139240|75985355|FG002|STARTED|Overall Study||38||
59860805|NCT03139240|75985356|FG003|STARTED|Overall Study||38||
59860806|NCT03139240|75985353|FG000|COMPLETED|Overall Study||48||
59860807|NCT03139240|75985354|FG001|COMPLETED|Overall Study||47||
59860808|NCT03139240|75985355|FG002|COMPLETED|Overall Study||37||
59860809|NCT03139240|75985356|FG003|COMPLETED|Overall Study||38||
59860810|NCT03139240|75985353|FG000|NOT COMPLETED|Overall Study||0||
59860811|NCT03139240|75985354|FG001|NOT COMPLETED|Overall Study||1||
59860812|NCT03139240|75985355|FG002|NOT COMPLETED|Overall Study||1||
59860813|NCT03139240|75985356|FG003|NOT COMPLETED|Overall Study||0||
59860814|NCT00237809|75985368|FG000|STARTED|Overall Study||27||
59860815|NCT00237809|75985369|FG001|STARTED|Overall Study||27||
59860816|NCT00237809|75985370|FG002|STARTED|Overall Study||24||
59860817|NCT00237809|75985371|FG003|STARTED|Overall Study||26||
59860818|NCT00237809|75985368|FG000|COMPLETED|Overall Study||16||
60128983|NCT01586624|76251240|FG007|STARTED|Overall Study||11||
59860819|NCT00237809|75985369|FG001|COMPLETED|Overall Study||17||
59860820|NCT00237809|75985370|FG002|COMPLETED|Overall Study||15||
59860821|NCT00237809|75985371|FG003|COMPLETED|Overall Study||17||
59860822|NCT00237809|75985368|FG000|NOT COMPLETED|Overall Study||11||
59860823|NCT00237809|75985369|FG001|NOT COMPLETED|Overall Study||10||
59860824|NCT00237809|75985370|FG002|NOT COMPLETED|Overall Study||9||
59860825|NCT00237809|75985371|FG003|NOT COMPLETED|Overall Study||9||
59860826|NCT00003498|75985381|FG000|STARTED|Overall Study||5||
59860827|NCT00003498|75985381|FG000|COMPLETED|Overall Study||1||
59860828|NCT00003498|75985381|FG000|NOT COMPLETED|Overall Study||4||
59860829|NCT00003492|75985385|FG000|STARTED|Overall Study||9||
59860830|NCT00003492|75985385|FG000|COMPLETED|Overall Study||3||
59860831|NCT00003492|75985385|FG000|NOT COMPLETED|Overall Study||6||
59860832|NCT03136198|75985391|FG000|STARTED|Overall Study||66||
59860833|NCT03136198|75985392|FG001|STARTED|Overall Study||64||
59860834|NCT03136198|75985391|FG000|COMPLETED|Overall Study||66||
59860835|NCT03136198|75985392|FG001|COMPLETED|Overall Study||63||
59860836|NCT03136198|75985391|FG000|NOT COMPLETED|Overall Study||0||
60128984|NCT01586624|76251233|FG000|COMPLETED|Overall Study||2||
60128985|NCT01586624|76251234|FG001|COMPLETED|Overall Study||2||
59860837|NCT03136198|75985392|FG001|NOT COMPLETED|Overall Study||1||
59860838|NCT00042666|75985398|FG000|STARTED|Overall Study||55||
60128986|NCT01586624|76251235|FG002|COMPLETED|Overall Study||1||
60128987|NCT01586624|76251236|FG003|COMPLETED|Overall Study||0||
59860839|NCT00042666|75985398|FG000|Received at Least 1 Dose of Study Drug|Overall Study||55||
59860840|NCT00042666|75985398|FG000|Completed at Least 1 Cycle of Study Drug|Overall Study||42||
59860841|NCT00042666|75985398|FG000|COMPLETED|Overall Study||1||
59860842|NCT00042666|75985398|FG000|NOT COMPLETED|Overall Study||54||
59860843|NCT00042432|75985405|FG000|STARTED|Overall Study||27||
59860844|NCT00042432|75985406|FG001|STARTED|Overall Study||27||
59860845|NCT00042432|75985405|FG000|COMPLETED|Overall Study||18||
59860846|NCT00042432|75985406|FG001|COMPLETED|Overall Study||20||
59860847|NCT00042432|75985405|FG000|NOT COMPLETED|Overall Study||9||
59860848|NCT00042432|75985406|FG001|NOT COMPLETED|Overall Study||7||
59860849|NCT00003474|75985412|FG000|STARTED|Overall Study||40||
59860850|NCT00003474|75985412|FG000|COMPLETED|Overall Study||26||
59860851|NCT00003474|75985412|FG000|NOT COMPLETED|Overall Study||14||
59860852|NCT01542736|75985416|FG000|STARTED|Overall Study||8||
59728528|NCT00812929|75847152|FG003|COMPLETED|Treatment Period 5||4||
59728529|NCT00812929|75847153|FG004|COMPLETED|Treatment Period 5||5||
59728530|NCT00812929|75847154|FG005|COMPLETED|Treatment Period 5||4||
59860853|NCT01542736|75985416|FG000|COMPLETED|Overall Study||7||
59860854|NCT01542736|75985416|FG000|NOT COMPLETED|Overall Study||1||
59860855|NCT01346410|75985420|FG000|STARTED|Overall Study||1||
59860856|NCT01346410|75985420|FG000|COMPLETED|Overall Study||0||
59860857|NCT01346410|75985420|FG000|NOT COMPLETED|Overall Study||1||
59860858|NCT00003456|75985424|FG000|STARTED|Overall Study||40||
59860859|NCT00003456|75985424|FG000|COMPLETED|Overall Study||32||
59860860|NCT00003456|75985424|FG000|NOT COMPLETED|Overall Study||8||
59860861|NCT02719522|75985428|FG000|STARTED|Overall Study|In 1 consented subject, device deployment was not attempted due to significant arterial stenosis.|204||
59860862|NCT02719522|75985428|FG000|COMPLETED|Overall Study||193||
59860863|NCT02719522|75985428|FG000|NOT COMPLETED|Overall Study||11||
59860864|NCT00237185|75985434|FG000|STARTED|Core||74||
59860865|NCT00237185|75985435|FG001|STARTED|Core||74||
59860866|NCT00237185|75985434|FG000|Treated Participants|Core||73||
59860867|NCT00237185|75985435|FG001|Treated Participants|Core||74||
59860868|NCT00237185|75985434|FG000|COMPLETED|Core||30||
59860869|NCT00237185|75985435|FG001|COMPLETED|Core||37||
59860870|NCT00237185|75985434|FG000|NOT COMPLETED|Core||44||
59860871|NCT00237185|75985435|FG001|NOT COMPLETED|Core||37||
59860872|NCT00237185|75985434|FG000|STARTED|Extension|A portion of the participants, who completed the core, entered the extension.|24||
59860873|NCT00237185|75985435|FG001|STARTED|Extension|A portion of the participants, who completed the core, entered the extension.|32||
59860874|NCT00237185|75985434|FG000|COMPLETED|Extension||8||
59860875|NCT00237185|75985435|FG001|COMPLETED|Extension||13||
59860876|NCT00237185|75985434|FG000|NOT COMPLETED|Extension||16||
59860877|NCT00237185|75985435|FG001|NOT COMPLETED|Extension||19||
59860878|NCT00003222|75985443|FG000|STARTED|Overall Study||13||
59860879|NCT00003222|75985444|FG001|STARTED|Overall Study||28||
59860880|NCT00003222|75985443|FG000|COMPLETED|Overall Study||13||
59860881|NCT00003222|75985444|FG001|COMPLETED|Overall Study|Decline in performance status between enrollment and initiation of therapy.|27||
59860882|NCT00003222|75985443|FG000|NOT COMPLETED|Overall Study||0||
59860883|NCT00003222|75985444|FG001|NOT COMPLETED|Overall Study||1||
59860884|NCT02877082|75985450|FG000|STARTED|Overall Study||5||
59860885|NCT02877082|75985450|FG000|COMPLETED|Overall Study||0||
59860886|NCT02877082|75985450|FG000|NOT COMPLETED|Overall Study||5||
59860887|NCT02875834|75985458|FG000|STARTED|Open-label Phase||267||
59860888|NCT02875834|75985459|FG001|STARTED|Open-label Phase||0||
59860889|NCT02875834|75985460|FG002|STARTED|Open-label Phase||0||
59860890|NCT02875834|75985461|FG003|STARTED|Open-label Phase||0||
59860891|NCT02875834|75985458|FG000|COMPLETED|Open-label Phase||260||
59860892|NCT02875834|75985459|FG001|COMPLETED|Open-label Phase||0||
59860893|NCT02875834|75985460|FG002|COMPLETED|Open-label Phase||0||
59860894|NCT02875834|75985461|FG003|COMPLETED|Open-label Phase||0||
59860895|NCT02875834|75985458|FG000|NOT COMPLETED|Open-label Phase||7||
59860896|NCT02875834|75985459|FG001|NOT COMPLETED|Open-label Phase||0||
59860897|NCT02875834|75985460|FG002|NOT COMPLETED|Open-label Phase||0||
59860898|NCT02875834|75985461|FG003|NOT COMPLETED|Open-label Phase||0||
59860899|NCT02875834|75985458|FG000|STARTED|Randomized Treatment Phase|No subjects were randomized in 10g TID group in RTP.|0||
59860900|NCT02875834|75985459|FG001|STARTED|Randomized Treatment Phase|99 subjects were randomized in 5g QD group in RTP.|99||
59860901|NCT02875834|75985460|FG002|STARTED|Randomized Treatment Phase|99 subjects were randomized in 10g QD group in RTP.|99||
59860902|NCT02875834|75985461|FG003|STARTED|Randomized Treatment Phase|50 subjects were randomized in placebo group in RTP.|50||
59860903|NCT02875834|75985458|FG000|COMPLETED|Randomized Treatment Phase||0||
59860904|NCT02875834|75985459|FG001|COMPLETED|Randomized Treatment Phase||85||
59728531|NCT00812929|75847155|FG006|COMPLETED|Treatment Period 5||5||
59728532|NCT00812929|75847156|FG007|COMPLETED|Treatment Period 5||5||
59728533|NCT00812929|75847157|FG008|COMPLETED|Treatment Period 5||4||
59728534|NCT00812929|75847158|FG009|COMPLETED|Treatment Period 5||4||
59728535|NCT00812929|75847149|FG000|NOT COMPLETED|Treatment Period 5||0||
59728536|NCT00812929|75847150|FG001|NOT COMPLETED|Treatment Period 5||0||
59728537|NCT00812929|75847151|FG002|NOT COMPLETED|Treatment Period 5||0||
59728538|NCT00812929|75847152|FG003|NOT COMPLETED|Treatment Period 5||0||
59728539|NCT00812929|75847153|FG004|NOT COMPLETED|Treatment Period 5||0||
59860905|NCT02875834|75985460|FG002|COMPLETED|Randomized Treatment Phase||88||
59860906|NCT02875834|75985461|FG003|COMPLETED|Randomized Treatment Phase||41||
59860907|NCT02875834|75985458|FG000|NOT COMPLETED|Randomized Treatment Phase||0||
59860908|NCT02875834|75985459|FG001|NOT COMPLETED|Randomized Treatment Phase||14||
59860909|NCT02875834|75985460|FG002|NOT COMPLETED|Randomized Treatment Phase||11||
59860910|NCT02875834|75985461|FG003|NOT COMPLETED|Randomized Treatment Phase||9||
59860911|NCT02875366|75985473|FG000|STARTED|Overall Study||36||
59860912|NCT02875366|75985474|FG001|STARTED|Overall Study||34||
59860913|NCT02875366|75985473|FG000|COMPLETED|Overall Study||36||
59860914|NCT02875366|75985474|FG001|COMPLETED|Overall Study||31||
59860915|NCT02875366|75985473|FG000|NOT COMPLETED|Overall Study||0||
59860916|NCT02875366|75985474|FG001|NOT COMPLETED|Overall Study||3||
59860917|NCT00002850|75985483|FG000|STARTED|Overall Study||69||
59860918|NCT00002850|75985484|FG001|STARTED|Overall Study||76||
59860919|NCT00002850|75985485|FG002|STARTED|Overall Study||67||
59860920|NCT00002850|75985483|FG000|COMPLETED|Overall Study||64||
59860921|NCT00002850|75985484|FG001|COMPLETED|Overall Study||74||
59860922|NCT00002850|75985485|FG002|COMPLETED|Overall Study||63||
59860923|NCT00002850|75985483|FG000|NOT COMPLETED|Overall Study||5||
59860924|NCT00002850|75985484|FG001|NOT COMPLETED|Overall Study||2||
59860925|NCT00002850|75985485|FG002|NOT COMPLETED|Overall Study||4||
59860926|NCT00002766|75985495|FG000|STARTED|Overall Study||81||
59860927|NCT00002766|75985496|FG001|STARTED|Overall Study||89||
59860928|NCT00002766|75985495|FG000|COMPLETED|Overall Study||78||
59860929|NCT00002766|75985496|FG001|COMPLETED|Overall Study||85||
59860930|NCT00002766|75985495|FG000|NOT COMPLETED|Overall Study||3||
59860931|NCT00002766|75985496|FG001|NOT COMPLETED|Overall Study||4||
59860932|NCT02306122|75985509|FG000|STARTED|Initial Physician Randomization||0|Patent participants are not included in this period.|
59860933|NCT02306122|75985510|FG001|STARTED|Initial Physician Randomization||0|Patent participants are not included in this period.|
59860934|NCT02306122|75985511|FG002|STARTED|Initial Physician Randomization||0|Patent participants are not included in this period.|
59860935|NCT02306122|75985512|FG003|STARTED|Initial Physician Randomization||0|Patent participants are not included in this period.|
59860936|NCT02306122|75985513|FG004|STARTED|Initial Physician Randomization||0|Patent participants are not included in this period.|
59860937|NCT02306122|75985514|FG005|STARTED|Initial Physician Randomization||0|Patent participants are not included in this period.|
59860938|NCT02306122|75985515|FG006|STARTED|Initial Physician Randomization||0|Patent participants are not included in this period.|
59860939|NCT02306122|75985516|FG007|STARTED|Initial Physician Randomization||0|Patent participants are not included in this period.|
59860940|NCT02306122|75985517|FG008|STARTED|Initial Physician Randomization||29|Patent participants are not included in this period.|
59860941|NCT02306122|75985518|FG009|STARTED|Initial Physician Randomization||31|Patent participants are not included in this period.|
59860942|NCT02306122|75985519|FG010|STARTED|Initial Physician Randomization||31|Patent participants are not included in this period.|
59860943|NCT02306122|75985509|FG000|COMPLETED|Initial Physician Randomization||0|Patient participants are not included in this period.|
59860944|NCT02306122|75985510|FG001|COMPLETED|Initial Physician Randomization||0|Patient participants are not included in this period.|
59860945|NCT02306122|75985511|FG002|COMPLETED|Initial Physician Randomization||0|Patient participants are not included in this period.|
59860946|NCT02306122|75985512|FG003|COMPLETED|Initial Physician Randomization||0|Patient participants are not included in this period.|
59860947|NCT02306122|75985513|FG004|COMPLETED|Initial Physician Randomization||0|Patient participants are not included in this period.|
59860948|NCT02306122|75985514|FG005|COMPLETED|Initial Physician Randomization||0|Patient participants are not included in this period.|
59860949|NCT02306122|75985515|FG006|COMPLETED|Initial Physician Randomization||0|Patient participants are not included in this period.|
59860950|NCT02306122|75985516|FG007|COMPLETED|Initial Physician Randomization||0|Patient participants are not included in this period.|
59860951|NCT02306122|75985517|FG008|COMPLETED|Initial Physician Randomization||28|Patient participants are not included in this period.|
59860952|NCT02306122|75985518|FG009|COMPLETED|Initial Physician Randomization||31|Patient participants are not included in this period.|
59860953|NCT02306122|75985519|FG010|COMPLETED|Initial Physician Randomization||31|Patient participants are not included in this period.|
59860954|NCT02306122|75985509|FG000|NOT COMPLETED|Initial Physician Randomization||0||
59860955|NCT02306122|75985510|FG001|NOT COMPLETED|Initial Physician Randomization||0||
59860956|NCT02306122|75985511|FG002|NOT COMPLETED|Initial Physician Randomization||0||
59860957|NCT02306122|75985512|FG003|NOT COMPLETED|Initial Physician Randomization||0||
59860958|NCT02306122|75985513|FG004|NOT COMPLETED|Initial Physician Randomization||0||
59860959|NCT02306122|75985514|FG005|NOT COMPLETED|Initial Physician Randomization||0||
59860960|NCT02306122|75985515|FG006|NOT COMPLETED|Initial Physician Randomization||0||
59860961|NCT02306122|75985516|FG007|NOT COMPLETED|Initial Physician Randomization||0||
59860962|NCT02306122|75985517|FG008|NOT COMPLETED|Initial Physician Randomization||1||
59860963|NCT02306122|75985518|FG009|NOT COMPLETED|Initial Physician Randomization||0||
59860964|NCT02306122|75985519|FG010|NOT COMPLETED|Initial Physician Randomization||0||
59860965|NCT02306122|75985509|FG000|STARTED|Post Nonadherence Subgroup Randomization||244|Only those patients with a nonadherence event are included in this period.|
59860966|NCT02306122|75985510|FG001|STARTED|Post Nonadherence Subgroup Randomization||123|Only those patients with a nonadherence event are included in this period.|
59860967|NCT02306122|75985511|FG002|STARTED|Post Nonadherence Subgroup Randomization||121|Only those patients with a nonadherence event are included in this period.|
59860968|NCT02306122|75985512|FG003|STARTED|Post Nonadherence Subgroup Randomization||274|Only those patients with a nonadherence event are included in this period.|
59860969|NCT02306122|75985513|FG004|STARTED|Post Nonadherence Subgroup Randomization||134|Only those patients with a nonadherence event are included in this period.|
59860970|NCT02306122|75985514|FG005|STARTED|Post Nonadherence Subgroup Randomization||137|Only those patients with a nonadherence event are included in this period.|
59860971|NCT02306122|75985515|FG006|STARTED|Post Nonadherence Subgroup Randomization||220|Only those patients with a nonadherence event are included in this period.|
59860972|NCT02306122|75985516|FG007|STARTED|Post Nonadherence Subgroup Randomization||221|Only those patients with a nonadherence event are included in this period.|
59860973|NCT02306122|75985517|FG008|STARTED|Post Nonadherence Subgroup Randomization||28|Only those patients with a nonadherence event are included in this period.|
59860974|NCT02306122|75985518|FG009|STARTED|Post Nonadherence Subgroup Randomization||31|Only those patients with a nonadherence event are included in this period.|
59860975|NCT02306122|75985519|FG010|STARTED|Post Nonadherence Subgroup Randomization||31|Only those patients with a nonadherence event are included in this period.|
59860976|NCT02306122|75985509|FG000|COMPLETED|Post Nonadherence Subgroup Randomization||244||
59860977|NCT02306122|75985510|FG001|COMPLETED|Post Nonadherence Subgroup Randomization||123||
59860978|NCT02306122|75985511|FG002|COMPLETED|Post Nonadherence Subgroup Randomization||121||
59860979|NCT02306122|75985512|FG003|COMPLETED|Post Nonadherence Subgroup Randomization||274||
59860980|NCT02306122|75985513|FG004|COMPLETED|Post Nonadherence Subgroup Randomization||134||
59860981|NCT02306122|75985514|FG005|COMPLETED|Post Nonadherence Subgroup Randomization||137||
59860982|NCT02306122|75985515|FG006|COMPLETED|Post Nonadherence Subgroup Randomization||220||
59860983|NCT02306122|75985516|FG007|COMPLETED|Post Nonadherence Subgroup Randomization||221||
59860984|NCT02306122|75985517|FG008|COMPLETED|Post Nonadherence Subgroup Randomization||28||
59860985|NCT02306122|75985518|FG009|COMPLETED|Post Nonadherence Subgroup Randomization||31||
59860986|NCT02306122|75985519|FG010|COMPLETED|Post Nonadherence Subgroup Randomization||31||
59860987|NCT02306122|75985509|FG000|NOT COMPLETED|Post Nonadherence Subgroup Randomization||0||
59860988|NCT02306122|75985510|FG001|NOT COMPLETED|Post Nonadherence Subgroup Randomization||0||
59860989|NCT02306122|75985511|FG002|NOT COMPLETED|Post Nonadherence Subgroup Randomization||0||
59860990|NCT02306122|75985512|FG003|NOT COMPLETED|Post Nonadherence Subgroup Randomization||0||
59860991|NCT02306122|75985513|FG004|NOT COMPLETED|Post Nonadherence Subgroup Randomization||0||
59860992|NCT02306122|75985514|FG005|NOT COMPLETED|Post Nonadherence Subgroup Randomization||0||
59860993|NCT02306122|75985515|FG006|NOT COMPLETED|Post Nonadherence Subgroup Randomization||0||
59860994|NCT02306122|75985516|FG007|NOT COMPLETED|Post Nonadherence Subgroup Randomization||0||
60128988|NCT01586624|76251237|FG004|COMPLETED|Overall Study||1||
59860995|NCT02306122|75985517|FG008|NOT COMPLETED|Post Nonadherence Subgroup Randomization||0||
59860996|NCT02306122|75985518|FG009|NOT COMPLETED|Post Nonadherence Subgroup Randomization||0||
59860997|NCT02306122|75985519|FG010|NOT COMPLETED|Post Nonadherence Subgroup Randomization||0||
59860998|NCT00001962|75985537|FG000|STARTED|Overall Study||100||
59860999|NCT00001962|75985537|FG000|COMPLETED|Overall Study||72||
59861000|NCT00001962|75985537|FG000|NOT COMPLETED|Overall Study||28||
59861001|NCT00028002|75985541|FG000|STARTED|Overall Study||63||
59861002|NCT00028002|75985541|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|52||
59861003|NCT00028002|75985541|FG000|NOT COMPLETED|Overall Study||11||
59861004|NCT00256997|75985548|FG000|STARTED|Overall Study||81||
59861005|NCT00256997|75985549|FG001|STARTED|Overall Study||86||
59861006|NCT00256997|75985548|FG000|Treated|Overall Study||79||
59861007|NCT00256997|75985549|FG001|Treated|Overall Study||86||
59861008|NCT00256997|75985548|FG000|COMPLETED|Overall Study||33||
59861009|NCT00256997|75985549|FG001|COMPLETED|Overall Study||31||
59861010|NCT00256997|75985548|FG000|NOT COMPLETED|Overall Study||48||
59861011|NCT00256997|75985549|FG001|NOT COMPLETED|Overall Study||55||
59861012|NCT00027846|75985559|FG000|STARTED|Overall Study||13||
59861013|NCT00027846|75985560|FG001|STARTED|Overall Study||287||
59861014|NCT00027846|75985561|FG002|STARTED|Overall Study||78||
59861015|NCT00027846|75985559|FG000|COMPLETED|Overall Study||11||
59861016|NCT00027846|75985560|FG001|COMPLETED|Overall Study||219||
59861017|NCT00027846|75985561|FG002|COMPLETED|Overall Study||41||
59861018|NCT00027846|75985559|FG000|NOT COMPLETED|Overall Study||2||
59861019|NCT00027846|75985560|FG001|NOT COMPLETED|Overall Study||68||
59861020|NCT00027846|75985561|FG002|NOT COMPLETED|Overall Study||37||
59861021|NCT00027378|75985573|FG000|STARTED|Overall Study||24||
59861022|NCT00027378|75985574|FG001|STARTED|Overall Study||26||
59861023|NCT00027378|75985573|FG000|COMPLETED|Overall Study||24||
59861024|NCT00027378|75985574|FG001|COMPLETED|Overall Study||23||
59861025|NCT00027378|75985573|FG000|NOT COMPLETED|Overall Study||0||
59861026|NCT00027378|75985574|FG001|NOT COMPLETED|Overall Study||3||
59861027|NCT00235391|75985586|FG000|STARTED|Overall Study||97||
59861028|NCT00235391|75985587|FG001|STARTED|Overall Study||200||
59861029|NCT00235391|75985588|FG002|STARTED|Overall Study||172||
59861030|NCT00235391|75985589|FG003|STARTED|Overall Study||1164||
59861031|NCT00235391|75985590|FG004|STARTED|Overall Study||43||
59861032|NCT00235391|75985591|FG005|STARTED|Overall Study||7||
60128989|NCT01586624|76251238|FG005|COMPLETED|Overall Study||0||
60128990|NCT01586624|76251239|FG006|COMPLETED|Overall Study||0||
60128991|NCT01586624|76251240|FG007|COMPLETED|Overall Study||1||
59861033|NCT00235391|75985586|FG000|Deferasirox Treatment|Overall Study||97||
59861034|NCT00235391|75985587|FG001|Deferasirox Treatment|Overall Study||200||
59861035|NCT00235391|75985588|FG002|Deferasirox Treatment|Overall Study||172||
59861036|NCT00235391|75985589|FG003|Deferasirox Treatment|Overall Study||1164||
59861037|NCT00235391|75985590|FG004|Deferasirox Treatment|Overall Study||43||
59861038|NCT00235391|75985591|FG005|Deferasirox Treatment|Overall Study||7||
59861039|NCT00235391|75985586|FG000|COMPLETED|Overall Study||85||
59861040|NCT00235391|75985587|FG001|COMPLETED|Overall Study||182||
59861041|NCT00235391|75985588|FG002|COMPLETED|Overall Study||148||
59861042|NCT00235391|75985589|FG003|COMPLETED|Overall Study||944||
59861043|NCT00235391|75985590|FG004|COMPLETED|Overall Study||31||
59861044|NCT00235391|75985591|FG005|COMPLETED|Overall Study||3||
59861045|NCT00235391|75985586|FG000|NOT COMPLETED|Overall Study||12||
60128992|NCT01586624|76251233|FG000|NOT COMPLETED|Overall Study||4||
59861046|NCT00235391|75985587|FG001|NOT COMPLETED|Overall Study||18||
59861047|NCT00235391|75985588|FG002|NOT COMPLETED|Overall Study||24||
59861048|NCT00235391|75985589|FG003|NOT COMPLETED|Overall Study||220||
59861049|NCT00235391|75985590|FG004|NOT COMPLETED|Overall Study||12||
59861050|NCT00235391|75985591|FG005|NOT COMPLETED|Overall Study||4||
59861051|NCT02981108|75985608|FG000|STARTED|Overall Study||6||
59861052|NCT02981108|75985609|FG001|STARTED|Overall Study||6||
59861053|NCT02981108|75985610|FG002|STARTED|Overall Study||8||
59861054|NCT02981108|75985611|FG003|STARTED|Overall Study||6||
59861055|NCT02981108|75985612|FG004|STARTED|Overall Study||30||
59861056|NCT02981108|75985613|FG005|STARTED|Overall Study||33||
59861057|NCT02981108|75985614|FG006|STARTED|Overall Study||31||
59861058|NCT02981108|75985615|FG007|STARTED|Overall Study||244||
59861059|NCT02981108|75985608|FG000|COMPLETED|Overall Study||5|Discontinuation of treatment|
59861060|NCT02981108|75985609|FG001|COMPLETED|Overall Study||6|Discontinuation of treatment|
59861061|NCT02981108|75985610|FG002|COMPLETED|Overall Study||7|Discontinuation of treatment|
59861062|NCT02981108|75985611|FG003|COMPLETED|Overall Study||6|Discontinuation of treatment|
59861063|NCT02981108|75985612|FG004|COMPLETED|Overall Study||21|Discontinuation of treatment|
59861064|NCT02981108|75985613|FG005|COMPLETED|Overall Study||15|Discontinuation of treatment|
59861065|NCT02981108|75985614|FG006|COMPLETED|Overall Study||13|Discontinuation of treatment|
59861066|NCT02981108|75985615|FG007|COMPLETED|Overall Study||62|Discontinuation of treatment|
59861067|NCT02981108|75985608|FG000|NOT COMPLETED|Overall Study||1||
59861068|NCT02981108|75985609|FG001|NOT COMPLETED|Overall Study||0||
59861069|NCT02981108|75985610|FG002|NOT COMPLETED|Overall Study||1||
59861070|NCT02981108|75985611|FG003|NOT COMPLETED|Overall Study||0||
59861071|NCT02981108|75985612|FG004|NOT COMPLETED|Overall Study||9||
59861072|NCT02981108|75985613|FG005|NOT COMPLETED|Overall Study||18||
59861073|NCT02981108|75985614|FG006|NOT COMPLETED|Overall Study||18||
59861074|NCT02981108|75985615|FG007|NOT COMPLETED|Overall Study||182||
59861075|NCT00234533|75985635|FG000|STARTED|Overall Study||251||
59861076|NCT00234533|75985635|FG000|COMPLETED|Overall Study||240||
59861077|NCT00234533|75985635|FG000|NOT COMPLETED|Overall Study||11||
59861078|NCT00026208|75985642|FG000|STARTED|Overall Study||72||
59861079|NCT00026208|75985643|FG001|STARTED|Overall Study||4||
59861080|NCT00026208|75985642|FG000|COMPLETED|Overall Study||71||
59861081|NCT00026208|75985643|FG001|COMPLETED|Overall Study||4||
59861082|NCT00026208|75985642|FG000|NOT COMPLETED|Overall Study||1||
59861083|NCT00026208|75985643|FG001|NOT COMPLETED|Overall Study||0||
59861084|NCT00025662|75985649|FG000|STARTED|Overall Study||25||
59861085|NCT00025662|75985649|FG000|COMPLETED|Overall Study|One patient who received a transplant did not meet eligibility and was a special exemption.|22||
59861086|NCT00025662|75985649|FG000|NOT COMPLETED|Overall Study||3||
59861087|NCT00025506|75985653|FG000|STARTED|Overall Study||55||
59861088|NCT00025506|75985653|FG000|COMPLETED|Overall Study|Eligible and treated patients.|45||
59861089|NCT00025506|75985653|FG000|NOT COMPLETED|Overall Study||10||
59861090|NCT00024258|75985662|FG000|STARTED|Overall Study||22||
59861091|NCT00024258|75985662|FG000|COMPLETED|Overall Study||13||
59861092|NCT00024258|75985662|FG000|NOT COMPLETED|Overall Study||9||
59861093|NCT00023712|75985668|FG000|STARTED|Overall Study|total number of participants enrolled on study|28||
59861094|NCT00023712|75985669|FG001|STARTED|Overall Study|total number of participants enrolled on study|30||
59861095|NCT00023712|75985668|FG000|COMPLETED|Overall Study|total number of participants eligible and evaluable|26||
59861096|NCT00023712|75985669|FG001|COMPLETED|Overall Study|total number of participants eligible and evaluable|29||
59861097|NCT00023712|75985668|FG000|NOT COMPLETED|Overall Study||2||
59861098|NCT00023712|75985669|FG001|NOT COMPLETED|Overall Study||1||
59861099|NCT00023322|75985685|FG000|STARTED|Overall Study||13||
59861100|NCT00023322|75985685|FG000|COMPLETED|Overall Study||12||
59861101|NCT00023322|75985685|FG000|NOT COMPLETED|Overall Study||1||
59861102|NCT04640168|75985691|FG000|STARTED|Overall Study||516||
60128993|NCT01586624|76251234|FG001|NOT COMPLETED|Overall Study||4||
60128994|NCT01586624|76251235|FG002|NOT COMPLETED|Overall Study||5||
59861103|NCT04640168|75985692|FG001|STARTED|Overall Study||494||
59861104|NCT04640168|75985691|FG000|Treated|Overall Study||503||
59861105|NCT04640168|75985692|FG001|Treated|Overall Study||482||
59861106|NCT04640168|75985691|FG000|ITT and Modified ITT Population|Overall Study||516||
59861107|NCT04640168|75985692|FG001|ITT and Modified ITT Population|Overall Study||494||
59861108|NCT04640168|75985691|FG000|As Treated Population|Overall Study||503||
59861109|NCT04640168|75985692|FG001|As Treated Population|Overall Study||482||
59861110|NCT04640168|75985691|FG000|COMPLETED|Overall Study||495||
59861111|NCT04640168|75985692|FG001|COMPLETED|Overall Study||475||
59861112|NCT04640168|75985691|FG000|NOT COMPLETED|Overall Study||21||
59861113|NCT04640168|75985692|FG001|NOT COMPLETED|Overall Study||19||
59861114|NCT00022698|75985700|FG000|STARTED|Overall Study||15||
59861115|NCT00022698|75985701|FG001|STARTED|Overall Study||52||
59861116|NCT00022698|75985700|FG000|COMPLETED|Overall Study||7||
59861117|NCT00022698|75985701|FG001|COMPLETED|Overall Study||17||
59861118|NCT00022698|75985700|FG000|NOT COMPLETED|Overall Study||8||
59861119|NCT00022698|75985701|FG001|NOT COMPLETED|Overall Study||35||
59861120|NCT05332145|75985709|FG000|STARTED|Overall Study||35||
59861121|NCT05332145|75985709|FG000|COMPLETED|Overall Study||33||
59861122|NCT05332145|75985709|FG000|NOT COMPLETED|Overall Study||2||
59861123|NCT05261126|75985718|FG000|STARTED|Overall Study||77||
59861124|NCT05261126|75985719|FG001|STARTED|Overall Study||76||
59861125|NCT05261126|75985720|FG002|STARTED|Overall Study||76||
59861126|NCT05261126|75985721|FG003|STARTED|Overall Study||76||
59861127|NCT05261126|75985722|FG004|STARTED|Overall Study||76||
59861128|NCT05261126|75985718|FG000|Treated|Overall Study||77||
59861129|NCT05261126|75985719|FG001|Treated|Overall Study||76||
59861130|NCT05261126|75985720|FG002|Treated|Overall Study||76||
59861131|NCT05261126|75985721|FG003|Treated|Overall Study||76||
59861132|NCT05261126|75985722|FG004|Treated|Overall Study||75||
59861133|NCT05261126|75985718|FG000|COMPLETED|Overall Study||75||
59861134|NCT05261126|75985719|FG001|COMPLETED|Overall Study||76||
59861135|NCT05261126|75985720|FG002|COMPLETED|Overall Study||74||
59861136|NCT05261126|75985721|FG003|COMPLETED|Overall Study||74||
59861137|NCT05261126|75985722|FG004|COMPLETED|Overall Study||74||
59861138|NCT05261126|75985718|FG000|NOT COMPLETED|Overall Study||2||
59861139|NCT05261126|75985719|FG001|NOT COMPLETED|Overall Study||0||
59861140|NCT05261126|75985720|FG002|NOT COMPLETED|Overall Study||2||
59861141|NCT05261126|75985721|FG003|NOT COMPLETED|Overall Study||2||
59861142|NCT05261126|75985722|FG004|NOT COMPLETED|Overall Study||2||
59861143|NCT05116683|75985734|FG000|STARTED|Overall Study||4||
59861144|NCT05116683|75985734|FG000|COMPLETED|Overall Study||0||
59861145|NCT05116683|75985734|FG000|NOT COMPLETED|Overall Study||4||
59861146|NCT05102383|75985738|FG000|STARTED|Overall Study||30||
59861147|NCT05102383|75985738|FG000|COMPLETED|Overall Study||30||
59861148|NCT05102383|75985738|FG000|NOT COMPLETED|Overall Study||0||
59861149|NCT05012865|75985742|FG000|STARTED|Overall Study||48||
59861150|NCT05012865|75985742|FG000|COMPLETED|Overall Study||48||
59861151|NCT05012865|75985742|FG000|NOT COMPLETED|Overall Study||0||
59861152|NCT04585815|75985748|FG000|STARTED|Sub-study A- Treatment Phase||4||
59861153|NCT04585815|75985749|FG001|STARTED|Sub-study A- Treatment Phase||9||
59861154|NCT04585815|75985748|FG000|COMPLETED|Sub-study A- Treatment Phase||0||
59861155|NCT04585815|75985749|FG001|COMPLETED|Sub-study A- Treatment Phase||0||
59861156|NCT04585815|75985748|FG000|NOT COMPLETED|Sub-study A- Treatment Phase||4||
59861157|NCT04585815|75985749|FG001|NOT COMPLETED|Sub-study A- Treatment Phase||9||
59861158|NCT04585815|75985748|FG000|STARTED|Sub-study A- Follow-up Phase||0||
59861159|NCT04585815|75985749|FG001|STARTED|Sub-study A- Follow-up Phase|Eligible participants entered follow-up period following discontinuation of study treatment.|1||
59861160|NCT04585815|75985748|FG000|COMPLETED|Sub-study A- Follow-up Phase||0||
59861161|NCT04585815|75985749|FG001|COMPLETED|Sub-study A- Follow-up Phase||0||
59861162|NCT04585815|75985748|FG000|NOT COMPLETED|Sub-study A- Follow-up Phase||0||
59861163|NCT04585815|75985749|FG001|NOT COMPLETED|Sub-study A- Follow-up Phase||1||
59861164|NCT04570436|75985757|FG000|STARTED|Overall Study||5||
59861165|NCT04570436|75985758|FG001|STARTED|Overall Study||5||
59861166|NCT04570436|75985759|FG002|STARTED|Overall Study||6||
59861167|NCT04570436|75985760|FG003|STARTED|Overall Study||5||
59861168|NCT04570436|75985761|FG004|STARTED|Overall Study||5||
59861169|NCT04570436|75985762|FG005|STARTED|Overall Study||5||
59861170|NCT04570436|75985763|FG006|STARTED|Overall Study||6||
59861171|NCT04570436|75985764|FG007|STARTED|Overall Study||5||
59861172|NCT04570436|75985765|FG008|STARTED|Overall Study||5||
59861173|NCT04570436|75985766|FG009|STARTED|Overall Study||5||
59861174|NCT04570436|75985757|FG000|COMPLETED|Overall Study||4||
59861175|NCT04570436|75985758|FG001|COMPLETED|Overall Study||5||
59861176|NCT04570436|75985759|FG002|COMPLETED|Overall Study||5||
59861177|NCT04570436|75985760|FG003|COMPLETED|Overall Study||5||
59861178|NCT04570436|75985761|FG004|COMPLETED|Overall Study||5||
59861179|NCT04570436|75985762|FG005|COMPLETED|Overall Study||5||
59861180|NCT04570436|75985763|FG006|COMPLETED|Overall Study||6||
59861181|NCT04570436|75985764|FG007|COMPLETED|Overall Study||5||
59861182|NCT04570436|75985765|FG008|COMPLETED|Overall Study||5||
59861183|NCT04570436|75985766|FG009|COMPLETED|Overall Study||5||
59861184|NCT04570436|75985757|FG000|NOT COMPLETED|Overall Study||1||
59861185|NCT04570436|75985758|FG001|NOT COMPLETED|Overall Study||0||
59861186|NCT04570436|75985759|FG002|NOT COMPLETED|Overall Study||1||
59861187|NCT04570436|75985760|FG003|NOT COMPLETED|Overall Study||0||
60128995|NCT01586624|76251236|FG003|NOT COMPLETED|Overall Study||7||
59861188|NCT04570436|75985761|FG004|NOT COMPLETED|Overall Study||0||
59861189|NCT04570436|75985762|FG005|NOT COMPLETED|Overall Study||0||
59861190|NCT04570436|75985763|FG006|NOT COMPLETED|Overall Study||0||
59861191|NCT04570436|75985764|FG007|NOT COMPLETED|Overall Study||0||
59861192|NCT04570436|75985765|FG008|NOT COMPLETED|Overall Study||0||
59861193|NCT04570436|75985766|FG009|NOT COMPLETED|Overall Study||0||
59861194|NCT04563845|75985800|FG000|STARTED|Part 1: (Up to Day 9)||2||
59861195|NCT04563845|75985801|FG001|STARTED|Part 1: (Up to Day 9)||6||
59861196|NCT04563845|75985802|FG002|STARTED|Part 1: (Up to Day 9)||0||
59861197|NCT04563845|75985803|FG003|STARTED|Part 1: (Up to Day 9)||0||
59861198|NCT04563845|75985804|FG004|STARTED|Part 1: (Up to Day 9)||0||
59861199|NCT04563845|75985805|FG005|STARTED|Part 1: (Up to Day 9)||0||
59861200|NCT04563845|75985806|FG006|STARTED|Part 1: (Up to Day 9)||0||
59861201|NCT04563845|75985807|FG007|STARTED|Part 1: (Up to Day 9)||0||
59861202|NCT04563845|75985808|FG008|STARTED|Part 1: (Up to Day 9)||0||
59861203|NCT04563845|75985809|FG009|STARTED|Part 1: (Up to Day 9)||0||
59861204|NCT04563845|75985810|FG010|STARTED|Part 1: (Up to Day 9)||0||
59861205|NCT04563845|75985811|FG011|STARTED|Part 1: (Up to Day 9)||0||
59861206|NCT04563845|75985812|FG012|STARTED|Part 1: (Up to Day 9)||0||
59861207|NCT04563845|75985813|FG013|STARTED|Part 1: (Up to Day 9)||0||
59861208|NCT04563845|75985800|FG000|COMPLETED|Part 1: (Up to Day 9)||2||
59861209|NCT04563845|75985801|FG001|COMPLETED|Part 1: (Up to Day 9)||6||
59861210|NCT04563845|75985802|FG002|COMPLETED|Part 1: (Up to Day 9)||0||
59861211|NCT04563845|75985803|FG003|COMPLETED|Part 1: (Up to Day 9)||0||
59861212|NCT04563845|75985804|FG004|COMPLETED|Part 1: (Up to Day 9)||0||
59861213|NCT04563845|75985805|FG005|COMPLETED|Part 1: (Up to Day 9)||0||
59861214|NCT04563845|75985806|FG006|COMPLETED|Part 1: (Up to Day 9)||0||
59861215|NCT04563845|75985807|FG007|COMPLETED|Part 1: (Up to Day 9)||0||
59861216|NCT04563845|75985808|FG008|COMPLETED|Part 1: (Up to Day 9)||0||
59861217|NCT04563845|75985809|FG009|COMPLETED|Part 1: (Up to Day 9)||0||
59861218|NCT04563845|75985810|FG010|COMPLETED|Part 1: (Up to Day 9)||0||
59861219|NCT04563845|75985811|FG011|COMPLETED|Part 1: (Up to Day 9)||0||
59861220|NCT04563845|75985812|FG012|COMPLETED|Part 1: (Up to Day 9)||0||
59861221|NCT04563845|75985813|FG013|COMPLETED|Part 1: (Up to Day 9)||0||
59861222|NCT04563845|75985800|FG000|NOT COMPLETED|Part 1: (Up to Day 9)||0||
59861223|NCT04563845|75985801|FG001|NOT COMPLETED|Part 1: (Up to Day 9)||0||
59861224|NCT04563845|75985802|FG002|NOT COMPLETED|Part 1: (Up to Day 9)||0||
59861225|NCT04563845|75985803|FG003|NOT COMPLETED|Part 1: (Up to Day 9)||0||
59861226|NCT04563845|75985804|FG004|NOT COMPLETED|Part 1: (Up to Day 9)||0||
59861227|NCT04563845|75985805|FG005|NOT COMPLETED|Part 1: (Up to Day 9)||0||
59861228|NCT04563845|75985806|FG006|NOT COMPLETED|Part 1: (Up to Day 9)||0||
59861229|NCT04563845|75985807|FG007|NOT COMPLETED|Part 1: (Up to Day 9)||0||
59861230|NCT04563845|75985808|FG008|NOT COMPLETED|Part 1: (Up to Day 9)||0||
59861231|NCT04563845|75985809|FG009|NOT COMPLETED|Part 1: (Up to Day 9)||0||
59861232|NCT04563845|75985810|FG010|NOT COMPLETED|Part 1: (Up to Day 9)||0||
59861233|NCT04563845|75985811|FG011|NOT COMPLETED|Part 1: (Up to Day 9)||0||
59861234|NCT04563845|75985812|FG012|NOT COMPLETED|Part 1: (Up to Day 9)||0||
59861235|NCT04563845|75985813|FG013|NOT COMPLETED|Part 1: (Up to Day 9)||0||
59861236|NCT04563845|75985800|FG000|STARTED|Part 2:Treatment Period 1(Up to 7 Days)||0||
59861237|NCT04563845|75985801|FG001|STARTED|Part 2:Treatment Period 1(Up to 7 Days)||0||
59861238|NCT04563845|75985802|FG002|STARTED|Part 2:Treatment Period 1(Up to 7 Days)||3||
59861239|NCT04563845|75985803|FG003|STARTED|Part 2:Treatment Period 1(Up to 7 Days)||4||
59861240|NCT04563845|75985804|FG004|STARTED|Part 2:Treatment Period 1(Up to 7 Days)||4||
59861241|NCT04563845|75985805|FG005|STARTED|Part 2:Treatment Period 1(Up to 7 Days)||4||
59861242|NCT04563845|75985806|FG006|STARTED|Part 2:Treatment Period 1(Up to 7 Days)||4||
59861243|NCT04563845|75985807|FG007|STARTED|Part 2:Treatment Period 1(Up to 7 Days)||3||
59861244|NCT04563845|75985808|FG008|STARTED|Part 2:Treatment Period 1(Up to 7 Days)||3||
59861245|NCT04563845|75985809|FG009|STARTED|Part 2:Treatment Period 1(Up to 7 Days)||3||
59861246|NCT04563845|75985810|FG010|STARTED|Part 2:Treatment Period 1(Up to 7 Days)||4||
59861247|NCT04563845|75985811|FG011|STARTED|Part 2:Treatment Period 1(Up to 7 Days)||4||
59861248|NCT04563845|75985812|FG012|STARTED|Part 2:Treatment Period 1(Up to 7 Days)||3||
59861249|NCT04563845|75985813|FG013|STARTED|Part 2:Treatment Period 1(Up to 7 Days)||3||
59861250|NCT04563845|75985800|FG000|COMPLETED|Part 2:Treatment Period 1(Up to 7 Days)||0||
59861251|NCT04563845|75985801|FG001|COMPLETED|Part 2:Treatment Period 1(Up to 7 Days)||0||
59861252|NCT04563845|75985802|FG002|COMPLETED|Part 2:Treatment Period 1(Up to 7 Days)||3||
59861253|NCT04563845|75985803|FG003|COMPLETED|Part 2:Treatment Period 1(Up to 7 Days)||4||
59861254|NCT04563845|75985804|FG004|COMPLETED|Part 2:Treatment Period 1(Up to 7 Days)||4||
59861255|NCT04563845|75985805|FG005|COMPLETED|Part 2:Treatment Period 1(Up to 7 Days)||4||
59861256|NCT04563845|75985806|FG006|COMPLETED|Part 2:Treatment Period 1(Up to 7 Days)||4||
59861257|NCT04563845|75985807|FG007|COMPLETED|Part 2:Treatment Period 1(Up to 7 Days)||2||
59861258|NCT04563845|75985808|FG008|COMPLETED|Part 2:Treatment Period 1(Up to 7 Days)||3||
59861259|NCT04563845|75985809|FG009|COMPLETED|Part 2:Treatment Period 1(Up to 7 Days)||3||
59861260|NCT04563845|75985810|FG010|COMPLETED|Part 2:Treatment Period 1(Up to 7 Days)||4||
59861261|NCT04563845|75985811|FG011|COMPLETED|Part 2:Treatment Period 1(Up to 7 Days)||4||
59861262|NCT04563845|75985812|FG012|COMPLETED|Part 2:Treatment Period 1(Up to 7 Days)||3||
59861263|NCT04563845|75985813|FG013|COMPLETED|Part 2:Treatment Period 1(Up to 7 Days)||3||
60128996|NCT01586624|76251237|FG004|NOT COMPLETED|Overall Study||8||
59861264|NCT04563845|75985800|FG000|NOT COMPLETED|Part 2:Treatment Period 1(Up to 7 Days)||0||
59861265|NCT04563845|75985801|FG001|NOT COMPLETED|Part 2:Treatment Period 1(Up to 7 Days)||0||
59861266|NCT04563845|75985802|FG002|NOT COMPLETED|Part 2:Treatment Period 1(Up to 7 Days)||0||
59861267|NCT04563845|75985803|FG003|NOT COMPLETED|Part 2:Treatment Period 1(Up to 7 Days)||0||
59861268|NCT04563845|75985804|FG004|NOT COMPLETED|Part 2:Treatment Period 1(Up to 7 Days)||0||
59861269|NCT04563845|75985805|FG005|NOT COMPLETED|Part 2:Treatment Period 1(Up to 7 Days)||0||
59861270|NCT04563845|75985806|FG006|NOT COMPLETED|Part 2:Treatment Period 1(Up to 7 Days)||0||
59861271|NCT04563845|75985807|FG007|NOT COMPLETED|Part 2:Treatment Period 1(Up to 7 Days)||1||
59861272|NCT04563845|75985808|FG008|NOT COMPLETED|Part 2:Treatment Period 1(Up to 7 Days)||0||
59861273|NCT04563845|75985809|FG009|NOT COMPLETED|Part 2:Treatment Period 1(Up to 7 Days)||0||
59861274|NCT04563845|75985810|FG010|NOT COMPLETED|Part 2:Treatment Period 1(Up to 7 Days)||0||
59861275|NCT04563845|75985811|FG011|NOT COMPLETED|Part 2:Treatment Period 1(Up to 7 Days)||0||
59861276|NCT04563845|75985812|FG012|NOT COMPLETED|Part 2:Treatment Period 1(Up to 7 Days)||0||
59861277|NCT04563845|75985813|FG013|NOT COMPLETED|Part 2:Treatment Period 1(Up to 7 Days)||0||
59861278|NCT04563845|75985800|FG000|STARTED|Part 2:Washout Period 1(Up to 7 Days)||0||
59861279|NCT04563845|75985801|FG001|STARTED|Part 2:Washout Period 1(Up to 7 Days)||0||
59861280|NCT04563845|75985802|FG002|STARTED|Part 2:Washout Period 1(Up to 7 Days)||3||
59861281|NCT04563845|75985803|FG003|STARTED|Part 2:Washout Period 1(Up to 7 Days)||4||
59861282|NCT04563845|75985804|FG004|STARTED|Part 2:Washout Period 1(Up to 7 Days)||4||
59861283|NCT04563845|75985805|FG005|STARTED|Part 2:Washout Period 1(Up to 7 Days)||4||
59861284|NCT04563845|75985806|FG006|STARTED|Part 2:Washout Period 1(Up to 7 Days)||4||
59861285|NCT04563845|75985807|FG007|STARTED|Part 2:Washout Period 1(Up to 7 Days)||2||
59861286|NCT04563845|75985808|FG008|STARTED|Part 2:Washout Period 1(Up to 7 Days)||3||
59861287|NCT04563845|75985809|FG009|STARTED|Part 2:Washout Period 1(Up to 7 Days)||3||
59861288|NCT04563845|75985810|FG010|STARTED|Part 2:Washout Period 1(Up to 7 Days)||4||
59861289|NCT04563845|75985811|FG011|STARTED|Part 2:Washout Period 1(Up to 7 Days)||4||
59861290|NCT04563845|75985812|FG012|STARTED|Part 2:Washout Period 1(Up to 7 Days)||3||
59861291|NCT04563845|75985813|FG013|STARTED|Part 2:Washout Period 1(Up to 7 Days)||3||
59861292|NCT04563845|75985800|FG000|COMPLETED|Part 2:Washout Period 1(Up to 7 Days)||0||
59861293|NCT04563845|75985801|FG001|COMPLETED|Part 2:Washout Period 1(Up to 7 Days)||0||
59861294|NCT04563845|75985802|FG002|COMPLETED|Part 2:Washout Period 1(Up to 7 Days)||3||
59861295|NCT04563845|75985803|FG003|COMPLETED|Part 2:Washout Period 1(Up to 7 Days)||4||
59861296|NCT04563845|75985804|FG004|COMPLETED|Part 2:Washout Period 1(Up to 7 Days)||3||
59861297|NCT04563845|75985805|FG005|COMPLETED|Part 2:Washout Period 1(Up to 7 Days)||4||
59861298|NCT04563845|75985806|FG006|COMPLETED|Part 2:Washout Period 1(Up to 7 Days)||4||
59861299|NCT04563845|75985807|FG007|COMPLETED|Part 2:Washout Period 1(Up to 7 Days)||2||
59861300|NCT04563845|75985808|FG008|COMPLETED|Part 2:Washout Period 1(Up to 7 Days)||3||
59861301|NCT04563845|75985809|FG009|COMPLETED|Part 2:Washout Period 1(Up to 7 Days)||3||
59861302|NCT04563845|75985810|FG010|COMPLETED|Part 2:Washout Period 1(Up to 7 Days)||4||
59861303|NCT04563845|75985811|FG011|COMPLETED|Part 2:Washout Period 1(Up to 7 Days)||4||
59861304|NCT04563845|75985812|FG012|COMPLETED|Part 2:Washout Period 1(Up to 7 Days)||3||
59861305|NCT04563845|75985813|FG013|COMPLETED|Part 2:Washout Period 1(Up to 7 Days)||3||
59861306|NCT04563845|75985800|FG000|NOT COMPLETED|Part 2:Washout Period 1(Up to 7 Days)||0||
59861307|NCT04563845|75985801|FG001|NOT COMPLETED|Part 2:Washout Period 1(Up to 7 Days)||0||
59861308|NCT04563845|75985802|FG002|NOT COMPLETED|Part 2:Washout Period 1(Up to 7 Days)||0||
59861309|NCT04563845|75985803|FG003|NOT COMPLETED|Part 2:Washout Period 1(Up to 7 Days)||0||
59861310|NCT04563845|75985804|FG004|NOT COMPLETED|Part 2:Washout Period 1(Up to 7 Days)||1||
59861311|NCT04563845|75985805|FG005|NOT COMPLETED|Part 2:Washout Period 1(Up to 7 Days)||0||
59861312|NCT04563845|75985806|FG006|NOT COMPLETED|Part 2:Washout Period 1(Up to 7 Days)||0||
59861313|NCT04563845|75985807|FG007|NOT COMPLETED|Part 2:Washout Period 1(Up to 7 Days)||0||
59861314|NCT04563845|75985808|FG008|NOT COMPLETED|Part 2:Washout Period 1(Up to 7 Days)||0||
59861315|NCT04563845|75985809|FG009|NOT COMPLETED|Part 2:Washout Period 1(Up to 7 Days)||0||
59861316|NCT04563845|75985810|FG010|NOT COMPLETED|Part 2:Washout Period 1(Up to 7 Days)||0||
59861317|NCT04563845|75985811|FG011|NOT COMPLETED|Part 2:Washout Period 1(Up to 7 Days)||0||
59861318|NCT04563845|75985812|FG012|NOT COMPLETED|Part 2:Washout Period 1(Up to 7 Days)||0||
59861319|NCT04563845|75985813|FG013|NOT COMPLETED|Part 2:Washout Period 1(Up to 7 Days)||0||
59861320|NCT04563845|75985800|FG000|STARTED|Part 2:Treatment Period 2(Up to 7 Days)||0||
59861321|NCT04563845|75985801|FG001|STARTED|Part 2:Treatment Period 2(Up to 7 Days)||0||
59861322|NCT04563845|75985802|FG002|STARTED|Part 2:Treatment Period 2(Up to 7 Days)||3||
59861323|NCT04563845|75985803|FG003|STARTED|Part 2:Treatment Period 2(Up to 7 Days)||4||
59861324|NCT04563845|75985804|FG004|STARTED|Part 2:Treatment Period 2(Up to 7 Days)||3||
59861325|NCT04563845|75985805|FG005|STARTED|Part 2:Treatment Period 2(Up to 7 Days)||4||
59861326|NCT04563845|75985806|FG006|STARTED|Part 2:Treatment Period 2(Up to 7 Days)||4||
59861327|NCT04563845|75985807|FG007|STARTED|Part 2:Treatment Period 2(Up to 7 Days)||2||
59861328|NCT04563845|75985808|FG008|STARTED|Part 2:Treatment Period 2(Up to 7 Days)||3||
59861329|NCT04563845|75985809|FG009|STARTED|Part 2:Treatment Period 2(Up to 7 Days)||3||
59861330|NCT04563845|75985810|FG010|STARTED|Part 2:Treatment Period 2(Up to 7 Days)||4||
59861331|NCT04563845|75985811|FG011|STARTED|Part 2:Treatment Period 2(Up to 7 Days)||4||
59861332|NCT04563845|75985812|FG012|STARTED|Part 2:Treatment Period 2(Up to 7 Days)||3||
59861333|NCT04563845|75985813|FG013|STARTED|Part 2:Treatment Period 2(Up to 7 Days)||3||
59861334|NCT04563845|75985800|FG000|COMPLETED|Part 2:Treatment Period 2(Up to 7 Days)||0||
59861335|NCT04563845|75985801|FG001|COMPLETED|Part 2:Treatment Period 2(Up to 7 Days)||0||
59861336|NCT04563845|75985802|FG002|COMPLETED|Part 2:Treatment Period 2(Up to 7 Days)||3||
59861337|NCT04563845|75985803|FG003|COMPLETED|Part 2:Treatment Period 2(Up to 7 Days)||4||
59861338|NCT04563845|75985804|FG004|COMPLETED|Part 2:Treatment Period 2(Up to 7 Days)||3||
59861339|NCT04563845|75985805|FG005|COMPLETED|Part 2:Treatment Period 2(Up to 7 Days)||4||
59861340|NCT04563845|75985806|FG006|COMPLETED|Part 2:Treatment Period 2(Up to 7 Days)||4||
59861341|NCT04563845|75985807|FG007|COMPLETED|Part 2:Treatment Period 2(Up to 7 Days)||2||
59861342|NCT04563845|75985808|FG008|COMPLETED|Part 2:Treatment Period 2(Up to 7 Days)||3||
59861343|NCT04563845|75985809|FG009|COMPLETED|Part 2:Treatment Period 2(Up to 7 Days)||3||
59861344|NCT04563845|75985810|FG010|COMPLETED|Part 2:Treatment Period 2(Up to 7 Days)||4||
59861345|NCT04563845|75985811|FG011|COMPLETED|Part 2:Treatment Period 2(Up to 7 Days)||4||
59861346|NCT04563845|75985812|FG012|COMPLETED|Part 2:Treatment Period 2(Up to 7 Days)||3||
59861347|NCT04563845|75985813|FG013|COMPLETED|Part 2:Treatment Period 2(Up to 7 Days)||3||
59861348|NCT04563845|75985800|FG000|NOT COMPLETED|Part 2:Treatment Period 2(Up to 7 Days)||0||
59861349|NCT04563845|75985801|FG001|NOT COMPLETED|Part 2:Treatment Period 2(Up to 7 Days)||0||
59861350|NCT04563845|75985802|FG002|NOT COMPLETED|Part 2:Treatment Period 2(Up to 7 Days)||0||
59861351|NCT04563845|75985803|FG003|NOT COMPLETED|Part 2:Treatment Period 2(Up to 7 Days)||0||
59861352|NCT04563845|75985804|FG004|NOT COMPLETED|Part 2:Treatment Period 2(Up to 7 Days)||0||
59861353|NCT04563845|75985805|FG005|NOT COMPLETED|Part 2:Treatment Period 2(Up to 7 Days)||0||
59861354|NCT04563845|75985806|FG006|NOT COMPLETED|Part 2:Treatment Period 2(Up to 7 Days)||0||
59861355|NCT04563845|75985807|FG007|NOT COMPLETED|Part 2:Treatment Period 2(Up to 7 Days)||0||
59861356|NCT04563845|75985808|FG008|NOT COMPLETED|Part 2:Treatment Period 2(Up to 7 Days)||0||
59861357|NCT04563845|75985809|FG009|NOT COMPLETED|Part 2:Treatment Period 2(Up to 7 Days)||0||
59861358|NCT04563845|75985810|FG010|NOT COMPLETED|Part 2:Treatment Period 2(Up to 7 Days)||0||
59861359|NCT04563845|75985811|FG011|NOT COMPLETED|Part 2:Treatment Period 2(Up to 7 Days)||0||
59861360|NCT04563845|75985812|FG012|NOT COMPLETED|Part 2:Treatment Period 2(Up to 7 Days)||0||
59861361|NCT04563845|75985813|FG013|NOT COMPLETED|Part 2:Treatment Period 2(Up to 7 Days)||0||
59861362|NCT04563845|75985800|FG000|STARTED|Part 2:Washout Period 2(Up to 7 Days)||0||
59861363|NCT04563845|75985801|FG001|STARTED|Part 2:Washout Period 2(Up to 7 Days)||0||
59861364|NCT04563845|75985802|FG002|STARTED|Part 2:Washout Period 2(Up to 7 Days)||3||
59861365|NCT04563845|75985803|FG003|STARTED|Part 2:Washout Period 2(Up to 7 Days)||4||
59861366|NCT04563845|75985804|FG004|STARTED|Part 2:Washout Period 2(Up to 7 Days)||3||
59861367|NCT04563845|75985805|FG005|STARTED|Part 2:Washout Period 2(Up to 7 Days)||4||
59861368|NCT04563845|75985806|FG006|STARTED|Part 2:Washout Period 2(Up to 7 Days)||4||
59861369|NCT04563845|75985807|FG007|STARTED|Part 2:Washout Period 2(Up to 7 Days)||2||
59861370|NCT04563845|75985808|FG008|STARTED|Part 2:Washout Period 2(Up to 7 Days)||3||
59861371|NCT04563845|75985809|FG009|STARTED|Part 2:Washout Period 2(Up to 7 Days)||3||
59861372|NCT04563845|75985810|FG010|STARTED|Part 2:Washout Period 2(Up to 7 Days)||4||
59861373|NCT04563845|75985811|FG011|STARTED|Part 2:Washout Period 2(Up to 7 Days)||4||
59861374|NCT04563845|75985812|FG012|STARTED|Part 2:Washout Period 2(Up to 7 Days)||3||
59861375|NCT04563845|75985813|FG013|STARTED|Part 2:Washout Period 2(Up to 7 Days)||3||
59861376|NCT04563845|75985800|FG000|COMPLETED|Part 2:Washout Period 2(Up to 7 Days)||0||
59861377|NCT04563845|75985801|FG001|COMPLETED|Part 2:Washout Period 2(Up to 7 Days)||0||
59861378|NCT04563845|75985802|FG002|COMPLETED|Part 2:Washout Period 2(Up to 7 Days)||3||
59861379|NCT04563845|75985803|FG003|COMPLETED|Part 2:Washout Period 2(Up to 7 Days)||4||
59861380|NCT04563845|75985804|FG004|COMPLETED|Part 2:Washout Period 2(Up to 7 Days)||3||
59861381|NCT04563845|75985805|FG005|COMPLETED|Part 2:Washout Period 2(Up to 7 Days)||4||
59861382|NCT04563845|75985806|FG006|COMPLETED|Part 2:Washout Period 2(Up to 7 Days)||4||
59861383|NCT04563845|75985807|FG007|COMPLETED|Part 2:Washout Period 2(Up to 7 Days)||2||
59861384|NCT04563845|75985808|FG008|COMPLETED|Part 2:Washout Period 2(Up to 7 Days)||3||
59861385|NCT04563845|75985809|FG009|COMPLETED|Part 2:Washout Period 2(Up to 7 Days)||3||
59861386|NCT04563845|75985810|FG010|COMPLETED|Part 2:Washout Period 2(Up to 7 Days)||4||
59861387|NCT04563845|75985811|FG011|COMPLETED|Part 2:Washout Period 2(Up to 7 Days)||4||
59861388|NCT04563845|75985812|FG012|COMPLETED|Part 2:Washout Period 2(Up to 7 Days)||3||
59861389|NCT04563845|75985813|FG013|COMPLETED|Part 2:Washout Period 2(Up to 7 Days)||3||
59861390|NCT04563845|75985800|FG000|NOT COMPLETED|Part 2:Washout Period 2(Up to 7 Days)||0||
59861391|NCT04563845|75985801|FG001|NOT COMPLETED|Part 2:Washout Period 2(Up to 7 Days)||0||
59861392|NCT04563845|75985802|FG002|NOT COMPLETED|Part 2:Washout Period 2(Up to 7 Days)||0||
59861393|NCT04563845|75985803|FG003|NOT COMPLETED|Part 2:Washout Period 2(Up to 7 Days)||0||
59861394|NCT04563845|75985804|FG004|NOT COMPLETED|Part 2:Washout Period 2(Up to 7 Days)||0||
59861395|NCT04563845|75985805|FG005|NOT COMPLETED|Part 2:Washout Period 2(Up to 7 Days)||0||
59861396|NCT04563845|75985806|FG006|NOT COMPLETED|Part 2:Washout Period 2(Up to 7 Days)||0||
59861397|NCT04563845|75985807|FG007|NOT COMPLETED|Part 2:Washout Period 2(Up to 7 Days)||0||
59861398|NCT04563845|75985808|FG008|NOT COMPLETED|Part 2:Washout Period 2(Up to 7 Days)||0||
59861399|NCT04563845|75985809|FG009|NOT COMPLETED|Part 2:Washout Period 2(Up to 7 Days)||0||
59861400|NCT04563845|75985810|FG010|NOT COMPLETED|Part 2:Washout Period 2(Up to 7 Days)||0||
59861401|NCT04563845|75985811|FG011|NOT COMPLETED|Part 2:Washout Period 2(Up to 7 Days)||0||
59861402|NCT04563845|75985812|FG012|NOT COMPLETED|Part 2:Washout Period 2(Up to 7 Days)||0||
59861403|NCT04563845|75985813|FG013|NOT COMPLETED|Part 2:Washout Period 2(Up to 7 Days)||0||
59861404|NCT04563845|75985800|FG000|STARTED|Part 2:Treatment Period 3(Up to 7 Days)||0||
59861405|NCT04563845|75985801|FG001|STARTED|Part 2:Treatment Period 3(Up to 7 Days)||0||
59861406|NCT04563845|75985802|FG002|STARTED|Part 2:Treatment Period 3(Up to 7 Days)||3||
59861407|NCT04563845|75985803|FG003|STARTED|Part 2:Treatment Period 3(Up to 7 Days)||4||
59861408|NCT04563845|75985804|FG004|STARTED|Part 2:Treatment Period 3(Up to 7 Days)||3||
59861409|NCT04563845|75985805|FG005|STARTED|Part 2:Treatment Period 3(Up to 7 Days)||4||
59861410|NCT04563845|75985806|FG006|STARTED|Part 2:Treatment Period 3(Up to 7 Days)||4||
59861411|NCT04563845|75985807|FG007|STARTED|Part 2:Treatment Period 3(Up to 7 Days)||2||
59861412|NCT04563845|75985808|FG008|STARTED|Part 2:Treatment Period 3(Up to 7 Days)||3||
59861413|NCT04563845|75985809|FG009|STARTED|Part 2:Treatment Period 3(Up to 7 Days)||3||
59861414|NCT04563845|75985810|FG010|STARTED|Part 2:Treatment Period 3(Up to 7 Days)||4||
59861415|NCT04563845|75985811|FG011|STARTED|Part 2:Treatment Period 3(Up to 7 Days)||4||
59861416|NCT04563845|75985812|FG012|STARTED|Part 2:Treatment Period 3(Up to 7 Days)||3||
59861417|NCT04563845|75985813|FG013|STARTED|Part 2:Treatment Period 3(Up to 7 Days)||3||
59861418|NCT04563845|75985800|FG000|COMPLETED|Part 2:Treatment Period 3(Up to 7 Days)||0||
59861419|NCT04563845|75985801|FG001|COMPLETED|Part 2:Treatment Period 3(Up to 7 Days)||0||
59861420|NCT04563845|75985802|FG002|COMPLETED|Part 2:Treatment Period 3(Up to 7 Days)||3||
59861421|NCT04563845|75985803|FG003|COMPLETED|Part 2:Treatment Period 3(Up to 7 Days)||4||
59861422|NCT04563845|75985804|FG004|COMPLETED|Part 2:Treatment Period 3(Up to 7 Days)||3||
59861423|NCT04563845|75985805|FG005|COMPLETED|Part 2:Treatment Period 3(Up to 7 Days)||4||
59861424|NCT04563845|75985806|FG006|COMPLETED|Part 2:Treatment Period 3(Up to 7 Days)||4||
59861425|NCT04563845|75985807|FG007|COMPLETED|Part 2:Treatment Period 3(Up to 7 Days)||2||
59861426|NCT04563845|75985808|FG008|COMPLETED|Part 2:Treatment Period 3(Up to 7 Days)||3||
59861427|NCT04563845|75985809|FG009|COMPLETED|Part 2:Treatment Period 3(Up to 7 Days)||3||
59861428|NCT04563845|75985810|FG010|COMPLETED|Part 2:Treatment Period 3(Up to 7 Days)||4||
59861429|NCT04563845|75985811|FG011|COMPLETED|Part 2:Treatment Period 3(Up to 7 Days)||4||
59861430|NCT04563845|75985812|FG012|COMPLETED|Part 2:Treatment Period 3(Up to 7 Days)||3||
59861431|NCT04563845|75985813|FG013|COMPLETED|Part 2:Treatment Period 3(Up to 7 Days)||3||
59861432|NCT04563845|75985800|FG000|NOT COMPLETED|Part 2:Treatment Period 3(Up to 7 Days)||0||
59861433|NCT04563845|75985801|FG001|NOT COMPLETED|Part 2:Treatment Period 3(Up to 7 Days)||0||
59861434|NCT04563845|75985802|FG002|NOT COMPLETED|Part 2:Treatment Period 3(Up to 7 Days)||0||
59861435|NCT04563845|75985803|FG003|NOT COMPLETED|Part 2:Treatment Period 3(Up to 7 Days)||0||
59861436|NCT04563845|75985804|FG004|NOT COMPLETED|Part 2:Treatment Period 3(Up to 7 Days)||0||
59861437|NCT04563845|75985805|FG005|NOT COMPLETED|Part 2:Treatment Period 3(Up to 7 Days)||0||
59861438|NCT04563845|75985806|FG006|NOT COMPLETED|Part 2:Treatment Period 3(Up to 7 Days)||0||
59861439|NCT04563845|75985807|FG007|NOT COMPLETED|Part 2:Treatment Period 3(Up to 7 Days)||0||
59861440|NCT04563845|75985808|FG008|NOT COMPLETED|Part 2:Treatment Period 3(Up to 7 Days)||0||
59861441|NCT04563845|75985809|FG009|NOT COMPLETED|Part 2:Treatment Period 3(Up to 7 Days)||0||
59861442|NCT04563845|75985810|FG010|NOT COMPLETED|Part 2:Treatment Period 3(Up to 7 Days)||0||
59861443|NCT04563845|75985811|FG011|NOT COMPLETED|Part 2:Treatment Period 3(Up to 7 Days)||0||
59861444|NCT04563845|75985812|FG012|NOT COMPLETED|Part 2:Treatment Period 3(Up to 7 Days)||0||
59861445|NCT04563845|75985813|FG013|NOT COMPLETED|Part 2:Treatment Period 3(Up to 7 Days)||0||
59861446|NCT04563845|75985800|FG000|STARTED|Part 2:Washout Period 3(Up to 7 Days)||0||
59861447|NCT04563845|75985801|FG001|STARTED|Part 2:Washout Period 3(Up to 7 Days)||0||
59861448|NCT04563845|75985802|FG002|STARTED|Part 2:Washout Period 3(Up to 7 Days)||3||
59861449|NCT04563845|75985803|FG003|STARTED|Part 2:Washout Period 3(Up to 7 Days)||4||
59861450|NCT04563845|75985804|FG004|STARTED|Part 2:Washout Period 3(Up to 7 Days)||3||
59861451|NCT04563845|75985805|FG005|STARTED|Part 2:Washout Period 3(Up to 7 Days)||4||
59861452|NCT04563845|75985806|FG006|STARTED|Part 2:Washout Period 3(Up to 7 Days)||4||
59861453|NCT04563845|75985807|FG007|STARTED|Part 2:Washout Period 3(Up to 7 Days)||2||
59861454|NCT04563845|75985808|FG008|STARTED|Part 2:Washout Period 3(Up to 7 Days)||3||
59861455|NCT04563845|75985809|FG009|STARTED|Part 2:Washout Period 3(Up to 7 Days)||3||
59861456|NCT04563845|75985810|FG010|STARTED|Part 2:Washout Period 3(Up to 7 Days)||4||
59861457|NCT04563845|75985811|FG011|STARTED|Part 2:Washout Period 3(Up to 7 Days)||4||
59861458|NCT04563845|75985812|FG012|STARTED|Part 2:Washout Period 3(Up to 7 Days)||3||
59861459|NCT04563845|75985813|FG013|STARTED|Part 2:Washout Period 3(Up to 7 Days)||3||
59861460|NCT04563845|75985800|FG000|COMPLETED|Part 2:Washout Period 3(Up to 7 Days)||0||
59861461|NCT04563845|75985801|FG001|COMPLETED|Part 2:Washout Period 3(Up to 7 Days)||0||
59861462|NCT04563845|75985802|FG002|COMPLETED|Part 2:Washout Period 3(Up to 7 Days)||3||
59861463|NCT04563845|75985803|FG003|COMPLETED|Part 2:Washout Period 3(Up to 7 Days)||4||
59861464|NCT04563845|75985804|FG004|COMPLETED|Part 2:Washout Period 3(Up to 7 Days)||3||
59861465|NCT04563845|75985805|FG005|COMPLETED|Part 2:Washout Period 3(Up to 7 Days)||4||
59861466|NCT04563845|75985806|FG006|COMPLETED|Part 2:Washout Period 3(Up to 7 Days)||4||
59861467|NCT04563845|75985807|FG007|COMPLETED|Part 2:Washout Period 3(Up to 7 Days)||2||
59861468|NCT04563845|75985808|FG008|COMPLETED|Part 2:Washout Period 3(Up to 7 Days)||3||
59861469|NCT04563845|75985809|FG009|COMPLETED|Part 2:Washout Period 3(Up to 7 Days)||3||
59861470|NCT04563845|75985810|FG010|COMPLETED|Part 2:Washout Period 3(Up to 7 Days)||4||
59861471|NCT04563845|75985811|FG011|COMPLETED|Part 2:Washout Period 3(Up to 7 Days)||4||
59861472|NCT04563845|75985812|FG012|COMPLETED|Part 2:Washout Period 3(Up to 7 Days)||3||
59861473|NCT04563845|75985813|FG013|COMPLETED|Part 2:Washout Period 3(Up to 7 Days)||3||
59861474|NCT04563845|75985800|FG000|NOT COMPLETED|Part 2:Washout Period 3(Up to 7 Days)||0||
59861475|NCT04563845|75985801|FG001|NOT COMPLETED|Part 2:Washout Period 3(Up to 7 Days)||0||
59861476|NCT04563845|75985802|FG002|NOT COMPLETED|Part 2:Washout Period 3(Up to 7 Days)||0||
59861477|NCT04563845|75985803|FG003|NOT COMPLETED|Part 2:Washout Period 3(Up to 7 Days)||0||
59861478|NCT04563845|75985804|FG004|NOT COMPLETED|Part 2:Washout Period 3(Up to 7 Days)||0||
59861479|NCT04563845|75985805|FG005|NOT COMPLETED|Part 2:Washout Period 3(Up to 7 Days)||0||
59861480|NCT04563845|75985806|FG006|NOT COMPLETED|Part 2:Washout Period 3(Up to 7 Days)||0||
59861481|NCT04563845|75985807|FG007|NOT COMPLETED|Part 2:Washout Period 3(Up to 7 Days)||0||
59861482|NCT04563845|75985808|FG008|NOT COMPLETED|Part 2:Washout Period 3(Up to 7 Days)||0||
59861483|NCT04563845|75985809|FG009|NOT COMPLETED|Part 2:Washout Period 3(Up to 7 Days)||0||
59861484|NCT04563845|75985810|FG010|NOT COMPLETED|Part 2:Washout Period 3(Up to 7 Days)||0||
59861485|NCT04563845|75985811|FG011|NOT COMPLETED|Part 2:Washout Period 3(Up to 7 Days)||0||
59861486|NCT04563845|75985812|FG012|NOT COMPLETED|Part 2:Washout Period 3(Up to 7 Days)||0||
59861487|NCT04563845|75985813|FG013|NOT COMPLETED|Part 2:Washout Period 3(Up to 7 Days)||0||
59861488|NCT04563845|75985800|FG000|STARTED|Part 2:Treatment Period 4(Up to 7 Days)||0||
59861489|NCT04563845|75985801|FG001|STARTED|Part 2:Treatment Period 4(Up to 7 Days)||0||
59861490|NCT04563845|75985802|FG002|STARTED|Part 2:Treatment Period 4(Up to 7 Days)||3||
59861491|NCT04563845|75985803|FG003|STARTED|Part 2:Treatment Period 4(Up to 7 Days)||4||
59861492|NCT04563845|75985804|FG004|STARTED|Part 2:Treatment Period 4(Up to 7 Days)||3||
59861493|NCT04563845|75985805|FG005|STARTED|Part 2:Treatment Period 4(Up to 7 Days)||4||
59861494|NCT04563845|75985806|FG006|STARTED|Part 2:Treatment Period 4(Up to 7 Days)||4||
59861495|NCT04563845|75985807|FG007|STARTED|Part 2:Treatment Period 4(Up to 7 Days)||2||
59861496|NCT04563845|75985808|FG008|STARTED|Part 2:Treatment Period 4(Up to 7 Days)||3||
59861497|NCT04563845|75985809|FG009|STARTED|Part 2:Treatment Period 4(Up to 7 Days)||3||
59861498|NCT04563845|75985810|FG010|STARTED|Part 2:Treatment Period 4(Up to 7 Days)||4||
59861499|NCT04563845|75985811|FG011|STARTED|Part 2:Treatment Period 4(Up to 7 Days)||4||
59861500|NCT04563845|75985812|FG012|STARTED|Part 2:Treatment Period 4(Up to 7 Days)||3||
59861501|NCT04563845|75985813|FG013|STARTED|Part 2:Treatment Period 4(Up to 7 Days)||3||
59861502|NCT04563845|75985800|FG000|COMPLETED|Part 2:Treatment Period 4(Up to 7 Days)||0||
59861503|NCT04563845|75985801|FG001|COMPLETED|Part 2:Treatment Period 4(Up to 7 Days)||0||
59861504|NCT04563845|75985802|FG002|COMPLETED|Part 2:Treatment Period 4(Up to 7 Days)||3||
59861505|NCT04563845|75985803|FG003|COMPLETED|Part 2:Treatment Period 4(Up to 7 Days)||4||
59861506|NCT04563845|75985804|FG004|COMPLETED|Part 2:Treatment Period 4(Up to 7 Days)||3||
59861507|NCT04563845|75985805|FG005|COMPLETED|Part 2:Treatment Period 4(Up to 7 Days)||4||
59861508|NCT04563845|75985806|FG006|COMPLETED|Part 2:Treatment Period 4(Up to 7 Days)||4||
59861509|NCT04563845|75985807|FG007|COMPLETED|Part 2:Treatment Period 4(Up to 7 Days)||2||
59861510|NCT04563845|75985808|FG008|COMPLETED|Part 2:Treatment Period 4(Up to 7 Days)||3||
59861511|NCT04563845|75985809|FG009|COMPLETED|Part 2:Treatment Period 4(Up to 7 Days)||3||
59861512|NCT04563845|75985810|FG010|COMPLETED|Part 2:Treatment Period 4(Up to 7 Days)||4||
59861513|NCT04563845|75985811|FG011|COMPLETED|Part 2:Treatment Period 4(Up to 7 Days)||4||
59861514|NCT04563845|75985812|FG012|COMPLETED|Part 2:Treatment Period 4(Up to 7 Days)||3||
59861515|NCT04563845|75985813|FG013|COMPLETED|Part 2:Treatment Period 4(Up to 7 Days)||3||
59861516|NCT04563845|75985800|FG000|NOT COMPLETED|Part 2:Treatment Period 4(Up to 7 Days)||0||
59861517|NCT04563845|75985801|FG001|NOT COMPLETED|Part 2:Treatment Period 4(Up to 7 Days)||0||
59861518|NCT04563845|75985802|FG002|NOT COMPLETED|Part 2:Treatment Period 4(Up to 7 Days)||0||
59861519|NCT04563845|75985803|FG003|NOT COMPLETED|Part 2:Treatment Period 4(Up to 7 Days)||0||
59861520|NCT04563845|75985804|FG004|NOT COMPLETED|Part 2:Treatment Period 4(Up to 7 Days)||0||
59861521|NCT04563845|75985805|FG005|NOT COMPLETED|Part 2:Treatment Period 4(Up to 7 Days)||0||
59861522|NCT04563845|75985806|FG006|NOT COMPLETED|Part 2:Treatment Period 4(Up to 7 Days)||0||
59861523|NCT04563845|75985807|FG007|NOT COMPLETED|Part 2:Treatment Period 4(Up to 7 Days)||0||
59861524|NCT04563845|75985808|FG008|NOT COMPLETED|Part 2:Treatment Period 4(Up to 7 Days)||0||
59861525|NCT04563845|75985809|FG009|NOT COMPLETED|Part 2:Treatment Period 4(Up to 7 Days)||0||
59861526|NCT04563845|75985810|FG010|NOT COMPLETED|Part 2:Treatment Period 4(Up to 7 Days)||0||
59861527|NCT04563845|75985811|FG011|NOT COMPLETED|Part 2:Treatment Period 4(Up to 7 Days)||0||
59861528|NCT04563845|75985812|FG012|NOT COMPLETED|Part 2:Treatment Period 4(Up to 7 Days)||0||
59861529|NCT04563845|75985813|FG013|NOT COMPLETED|Part 2:Treatment Period 4(Up to 7 Days)||0||
59861530|NCT04537650|75985834|FG000|STARTED|Overall Study||8||
59861531|NCT04537650|75985835|FG001|STARTED|Overall Study||36||
59861532|NCT04537650|75985834|FG000|COMPLETED|Overall Study||8||
59861533|NCT04537650|75985835|FG001|COMPLETED|Overall Study||36||
59861534|NCT04537650|75985834|FG000|NOT COMPLETED|Overall Study||0||
59861535|NCT04537650|75985835|FG001|NOT COMPLETED|Overall Study||0||
59861536|NCT04517253|75985844|FG000|STARTED|Overall Study||5||
59861537|NCT04517253|75985845|FG001|STARTED|Overall Study||2||
59861538|NCT04517253|75985846|FG002|STARTED|Overall Study||1||
59861539|NCT04517253|75985844|FG000|Received at Least One Dose of Study Drug|Overall Study||5||
59861540|NCT04517253|75985845|FG001|Received at Least One Dose of Study Drug|Overall Study||2||
59861541|NCT04517253|75985846|FG002|Received at Least One Dose of Study Drug|Overall Study||1||
59861542|NCT04517253|75985844|FG000|COMPLETED|Overall Study||4||
59861543|NCT04517253|75985845|FG001|COMPLETED|Overall Study||1||
59861544|NCT04517253|75985846|FG002|COMPLETED|Overall Study||1||
59861545|NCT04517253|75985844|FG000|NOT COMPLETED|Overall Study||1||
59861546|NCT04517253|75985845|FG001|NOT COMPLETED|Overall Study||1||
59861547|NCT04517253|75985846|FG002|NOT COMPLETED|Overall Study||0||
59861548|NCT04433767|75985856|FG000|STARTED|Overall Study||29||
59861549|NCT04433767|75985856|FG000|COMPLETED|Overall Study||28||
59861550|NCT04433767|75985856|FG000|NOT COMPLETED|Overall Study||1||
59861551|NCT04419467|75985863|FG000|STARTED|Overall Study||29||
59861552|NCT04419467|75985864|FG001|STARTED|Overall Study||29||
59861553|NCT04419467|75985865|FG002|STARTED|Overall Study||56||
59861554|NCT04419467|75985863|FG000|COMPLETED|Overall Study||27||
59861555|NCT04419467|75985864|FG001|COMPLETED|Overall Study||26||
59861556|NCT04419467|75985865|FG002|COMPLETED|Overall Study||47||
59861557|NCT04419467|75985863|FG000|NOT COMPLETED|Overall Study||2||
59861558|NCT04419467|75985864|FG001|NOT COMPLETED|Overall Study||3||
59861559|NCT04419467|75985865|FG002|NOT COMPLETED|Overall Study||9||
59861560|NCT04382326|75985884|FG000|STARTED|Overall Study||1001||
59861561|NCT04382326|75985885|FG001|STARTED|Overall Study||987||
59861562|NCT04382326|75985884|FG000|COMPLETED|Overall Study||821||
59861563|NCT04382326|75985885|FG001|COMPLETED|Overall Study||799||
59861564|NCT04382326|75985884|FG000|NOT COMPLETED|Overall Study||180||
59861565|NCT04382326|75985885|FG001|NOT COMPLETED|Overall Study||188||
59861566|NCT04359901|75985893|FG000|STARTED|Overall Study||20||
59861567|NCT04359901|75985894|FG001|STARTED|Overall Study||30||
59861568|NCT04359901|75985893|FG000|Follow up to 14 Days|Overall Study|Died within 14 days (n=5)|15||
59861569|NCT04359901|75985894|FG001|Follow up to 14 Days|Overall Study|Withdrawn (n=1) Died within 14 days (n=1)|28||
59861570|NCT04359901|75985893|FG000|Follow up to 30 Days|Overall Study|Died between 15-30 days (n=1)|14||
59861571|NCT04359901|75985894|FG001|Follow up to 30 Days|Overall Study|Died between 15-30 days (n=1)|27||
59861572|NCT04359901|75985893|FG000|COMPLETED|Overall Study||14||
59861573|NCT04359901|75985894|FG001|COMPLETED|Overall Study||27||
59861574|NCT04359901|75985893|FG000|NOT COMPLETED|Overall Study||6||
59861575|NCT04359901|75985894|FG001|NOT COMPLETED|Overall Study||3||
59861576|NCT04080739|75985902|FG000|STARTED|Overall Study||50||
59861577|NCT04080739|75985903|FG001|STARTED|Overall Study||50||
59861578|NCT04080739|75985902|FG000|COMPLETED|Overall Study||48||
59861579|NCT04080739|75985903|FG001|COMPLETED|Overall Study||50||
59861580|NCT04080739|75985902|FG000|NOT COMPLETED|Overall Study||2||
59861581|NCT04080739|75985903|FG001|NOT COMPLETED|Overall Study||0||
59861582|NCT03945591|75985909|FG000|STARTED|Overall Study||21||
59861583|NCT03945591|75985909|FG000|COMPLETED|Overall Study||16||
59861584|NCT03945591|75985909|FG000|NOT COMPLETED|Overall Study||5||
59861585|NCT03744676|75985913|FG000|STARTED|Pre-Treatment Phase||104|Participants who underwent leukapheresis|
59861586|NCT03744676|75985913|FG000|COMPLETED|Pre-Treatment Phase||83|Participants who completed leukapheresis and continued to lymphodepleting chemotherapy (LDC) treatment period and JCAR017|
59861587|NCT03744676|75985913|FG000|NOT COMPLETED|Pre-Treatment Phase||21||
59861588|NCT03744676|75985913|FG000|STARTED|Treatment Phase||82|Participants who underwent lymphodepleting chemotherapy (LDC) treatment with conforming JCAR017|
59861589|NCT03744676|75985913|FG000|Participants Who Received LDC and Non Conforming Product|Treatment Phase||1||
59861590|NCT03744676|75985913|FG000|COMPLETED|Treatment Phase||19|Completed study|
59861591|NCT03744676|75985913|FG000|NOT COMPLETED|Treatment Phase||63||
59861592|NCT03732820|75985919|FG000|STARTED|Overall Study||399||
59861593|NCT03732820|75985920|FG001|STARTED|Overall Study||397||
59861594|NCT03732820|75985919|FG000|COMPLETED|Overall Study||0||
59861595|NCT03732820|75985920|FG001|COMPLETED|Overall Study||0||
59861596|NCT03732820|75985919|FG000|NOT COMPLETED|Overall Study||399||
59861597|NCT03732820|75985920|FG001|NOT COMPLETED|Overall Study||397||
59861598|NCT03605667|75985928|FG000|STARTED|Randomization Phase (Weeks 1 Through 48)||178||
59861599|NCT03605667|75985929|FG001|STARTED|Randomization Phase (Weeks 1 Through 48)||172||
59861600|NCT03605667|75985928|FG000|COMPLETED|Randomization Phase (Weeks 1 Through 48)||130||
59861601|NCT03605667|75985929|FG001|COMPLETED|Randomization Phase (Weeks 1 Through 48)||133||
59861602|NCT03605667|75985928|FG000|NOT COMPLETED|Randomization Phase (Weeks 1 Through 48)||48||
59861603|NCT03605667|75985929|FG001|NOT COMPLETED|Randomization Phase (Weeks 1 Through 48)||39||
59861604|NCT03605667|75985928|FG000|STARTED|OLE Phase (48 Weeks)|Troriluzole - Randomization Phase/ Troriluzole - OLE Phase: Participants who continued into the extension phase.|90||
59861605|NCT03605667|75985929|FG001|STARTED|OLE Phase (48 Weeks)|Placebo - Randomization Phase/ Troriluzole - OLE Phase: Participants who continued into the extension phase.|104||
59861606|NCT03605667|75985928|FG000|COMPLETED|OLE Phase (48 Weeks)||35||
59861607|NCT03605667|75985929|FG001|COMPLETED|OLE Phase (48 Weeks)||24||
59861608|NCT03605667|75985928|FG000|NOT COMPLETED|OLE Phase (48 Weeks)||55||
59861609|NCT03605667|75985929|FG001|NOT COMPLETED|OLE Phase (48 Weeks)||80||
59861610|NCT03600350|75985941|FG000|STARTED|Overall Study||19||
59861611|NCT03600350|75985941|FG000|On Treatment|Overall Study||19||
59861612|NCT03600350|75985941|FG000|Off Treatment|Overall Study||19||
59861613|NCT03600350|75985941|FG000|COMPLETED|Overall Study||0||
59861614|NCT03600350|75985941|FG000|NOT COMPLETED|Overall Study||19||
59861615|NCT03382561|75985947|FG000|STARTED|Overall Study||80||
59861616|NCT03382561|75985948|FG001|STARTED|Overall Study||80||
59861617|NCT03382561|75985947|FG000|Received Treatment|Overall Study||77||
59861618|NCT03382561|75985948|FG001|Received Treatment|Overall Study||74||
59861619|NCT03382561|75985947|FG000|Eligible and Treated Patients|Overall Study||75||
59861620|NCT03382561|75985948|FG001|Eligible and Treated Patients|Overall Study||69||
59861621|NCT03382561|75985947|FG000|COMPLETED|Overall Study||4||
59861622|NCT03382561|75985948|FG001|COMPLETED|Overall Study||47||
59861623|NCT03382561|75985947|FG000|NOT COMPLETED|Overall Study||76||
59861624|NCT03382561|75985948|FG001|NOT COMPLETED|Overall Study||33||
59861625|NCT03229278|75985958|FG000|STARTED|Overall Study||3||
59861626|NCT03229278|75985959|FG001|STARTED|Overall Study||6||
59861627|NCT03229278|75985960|FG002|STARTED|Overall Study||3||
59861628|NCT03229278|75985961|FG003|STARTED|Overall Study||2||
59861629|NCT03229278|75985958|FG000|COMPLETED|Overall Study||3||
59861630|NCT03229278|75985959|FG001|COMPLETED|Overall Study||6||
59861631|NCT03229278|75985960|FG002|COMPLETED|Overall Study||3||
59861632|NCT03229278|75985961|FG003|COMPLETED|Overall Study||2||
59861633|NCT03229278|75985958|FG000|NOT COMPLETED|Overall Study||0||
59861634|NCT03229278|75985959|FG001|NOT COMPLETED|Overall Study||0||
59861635|NCT03229278|75985960|FG002|NOT COMPLETED|Overall Study||0||
59861636|NCT03229278|75985961|FG003|NOT COMPLETED|Overall Study||0||
59861637|NCT03201445|75985975|FG000|STARTED|Part A DB Phase (Through Week 13)||69||
59861638|NCT03201445|75985976|FG001|STARTED|Part A DB Phase (Through Week 13)||70||
59861639|NCT03201445|75985975|FG000|COMPLETED|Part A DB Phase (Through Week 13)||68||
59861640|NCT03201445|75985976|FG001|COMPLETED|Part A DB Phase (Through Week 13)||67||
59861641|NCT03201445|75985975|FG000|NOT COMPLETED|Part A DB Phase (Through Week 13)||1||
59861642|NCT03201445|75985976|FG001|NOT COMPLETED|Part A DB Phase (Through Week 13)||3||
59861643|NCT03201445|75985975|FG000|STARTED|Part B DB Phase (Week 13 to 26)|45 participants continued DB after Week 13, 1 participant switched to MP, 22 participants switched to OL|45||
59861644|NCT03201445|75985976|FG001|STARTED|Part B DB Phase (Week 13 to 26)|38 participants continued DB after Week 13, 6 participants switched to MP, 23 participants switched to OL|38||
59861645|NCT03201445|75985975|FG000|COMPLETED|Part B DB Phase (Week 13 to 26)|38 participants continued DB after Week 26, 2 participants stopped DB study drug at Week 26, 2 participants switched to MP|42||
59861646|NCT03201445|75985976|FG001|COMPLETED|Part B DB Phase (Week 13 to 26)|34 participants continued DB after Week 26, 1 participant stopped DB study drug at Week 26, 3 participants switched to MP|38||
59861647|NCT03201445|75985975|FG000|NOT COMPLETED|Part B DB Phase (Week 13 to 26)||3||
59861648|NCT03201445|75985976|FG001|NOT COMPLETED|Part B DB Phase (Week 13 to 26)||0||
59861649|NCT03201445|75985975|FG000|STARTED|OL Phase (13 Weeks)|2 additional participants in the Filgotinib group who were responders discontinued study drug between Weeks 13 and 26 due to disease worsening and switched to OL filgotinib, per protocol.|24||
59861650|NCT03201445|75985976|FG001|STARTED|OL Phase (13 Weeks)||23||
59861651|NCT03201445|75985975|FG000|COMPLETED|OL Phase (13 Weeks)|18 participants continued OL filgotinib in LTE, 3 participants stopped OL filgotinib in LTE, 1 participant switched to MP|22||
59861652|NCT03201445|75985976|FG001|COMPLETED|OL Phase (13 Weeks)|16 participants continued OL filgotinib in LTE, 2 participants stopped OL filgotinib in LTE, 2 participant switched to MP|20||
59861653|NCT03201445|75985975|FG000|NOT COMPLETED|OL Phase (13 Weeks)||2||
59861654|NCT03201445|75985976|FG001|NOT COMPLETED|OL Phase (13 Weeks)||3||
59861655|NCT03189914|75985988|FG000|STARTED|Overall Study||8||
59861656|NCT03189914|75985989|FG001|STARTED|Overall Study||38||
59861657|NCT03189914|75985988|FG000|Completed Cycle 1|Overall Study||6||
59861658|NCT03189914|75985989|FG001|Completed Cycle 1|Overall Study||31||
59861659|NCT03189914|75985988|FG000|COMPLETED|Overall Study||1||
59861660|NCT03189914|75985989|FG001|COMPLETED|Overall Study||4||
59861661|NCT03189914|75985988|FG000|NOT COMPLETED|Overall Study||7||
59861662|NCT03189914|75985989|FG001|NOT COMPLETED|Overall Study||34||
59861663|NCT02839720|75986001|FG000|STARTED|Overall Study||11||
59861664|NCT02839720|75986001|FG000|COMPLETED|Overall Study||4||
59861665|NCT02839720|75986001|FG000|NOT COMPLETED|Overall Study||7||
59861666|NCT02643095|75986007|FG000|STARTED|Overall Study||22||
59861667|NCT02643095|75986007|FG000|COMPLETED|Overall Study||21||
59861668|NCT02643095|75986007|FG000|NOT COMPLETED|Overall Study||1||
59861669|NCT02642042|75986011|FG000|STARTED|Overall Study||54||
59861670|NCT02642042|75986011|FG000|COMPLETED|Overall Study||0||
59861671|NCT02642042|75986011|FG000|NOT COMPLETED|Overall Study||54||
59861672|NCT02608268|75986045|FG000|STARTED|Overall Study||14||
59861673|NCT02608268|75986046|FG001|STARTED|Overall Study||9||
59861674|NCT02608268|75986047|FG002|STARTED|Overall Study||16||
59861675|NCT02608268|75986048|FG003|STARTED|Overall Study||5||
59861676|NCT02608268|75986049|FG004|STARTED|Overall Study||2||
59861677|NCT02608268|75986050|FG005|STARTED|Overall Study||4||
59861678|NCT02608268|75986051|FG006|STARTED|Overall Study||6||
59861679|NCT02608268|75986052|FG007|STARTED|Overall Study||2||
59861680|NCT02608268|75986053|FG008|STARTED|Overall Study||8||
59861681|NCT02608268|75986054|FG009|STARTED|Overall Study||9||
59861682|NCT02608268|75986055|FG010|STARTED|Overall Study||6||
59861683|NCT02608268|75986056|FG011|STARTED|Overall Study||6||
59861684|NCT02608268|75986057|FG012|STARTED|Overall Study||6||
59861685|NCT02608268|75986058|FG013|STARTED|Overall Study||13||
59861686|NCT02608268|75986059|FG014|STARTED|Overall Study||6||
59861687|NCT02608268|75986060|FG015|STARTED|Overall Study||5||
59861688|NCT02608268|75986061|FG016|STARTED|Overall Study||5||
59861689|NCT02608268|75986062|FG017|STARTED|Overall Study||6||
59861690|NCT02608268|75986063|FG018|STARTED|Overall Study||6||
59861691|NCT02608268|75986064|FG019|STARTED|Overall Study||3||
59861692|NCT02608268|75986065|FG020|STARTED|Overall Study||12||
59861693|NCT02608268|75986066|FG021|STARTED|Overall Study||5||
59861694|NCT02608268|75986067|FG022|STARTED|Overall Study||7||
59861695|NCT02608268|75986068|FG023|STARTED|Overall Study||6||
59861696|NCT02608268|75986069|FG024|STARTED|Overall Study||6||
59861697|NCT02608268|75986070|FG025|STARTED|Overall Study||14||
59861698|NCT02608268|75986071|FG026|STARTED|Overall Study||17||
59861699|NCT02608268|75986072|FG027|STARTED|Overall Study||15||
59861700|NCT02608268|75986073|FG028|STARTED|Overall Study||17||
59861701|NCT02608268|75986074|FG029|STARTED|Overall Study||16||
59861702|NCT02608268|75986045|FG000|COMPLETED|Overall Study||0||
59861703|NCT02608268|75986046|FG001|COMPLETED|Overall Study||0||
59861704|NCT02608268|75986047|FG002|COMPLETED|Overall Study||0||
59861705|NCT02608268|75986048|FG003|COMPLETED|Overall Study||0||
59861706|NCT02608268|75986049|FG004|COMPLETED|Overall Study||0||
59861707|NCT02608268|75986050|FG005|COMPLETED|Overall Study||0||
59861708|NCT02608268|75986051|FG006|COMPLETED|Overall Study||0||
59861709|NCT02608268|75986052|FG007|COMPLETED|Overall Study||0||
59861710|NCT02608268|75986053|FG008|COMPLETED|Overall Study||0||
59861711|NCT02608268|75986054|FG009|COMPLETED|Overall Study||0||
59861712|NCT02608268|75986055|FG010|COMPLETED|Overall Study||0||
59861713|NCT02608268|75986056|FG011|COMPLETED|Overall Study||0||
59861714|NCT02608268|75986057|FG012|COMPLETED|Overall Study||0||
59861715|NCT02608268|75986058|FG013|COMPLETED|Overall Study||0||
59861716|NCT02608268|75986059|FG014|COMPLETED|Overall Study||0||
59861717|NCT02608268|75986060|FG015|COMPLETED|Overall Study||0||
59861718|NCT02608268|75986061|FG016|COMPLETED|Overall Study||0||
59861719|NCT02608268|75986062|FG017|COMPLETED|Overall Study||0||
59861720|NCT02608268|75986063|FG018|COMPLETED|Overall Study||0||
59861721|NCT02608268|75986064|FG019|COMPLETED|Overall Study||0||
59861722|NCT02608268|75986065|FG020|COMPLETED|Overall Study||0||
59861723|NCT02608268|75986066|FG021|COMPLETED|Overall Study||0||
59861724|NCT02608268|75986067|FG022|COMPLETED|Overall Study||0||
59861725|NCT02608268|75986068|FG023|COMPLETED|Overall Study||0||
59861726|NCT02608268|75986069|FG024|COMPLETED|Overall Study||0||
59861727|NCT02608268|75986070|FG025|COMPLETED|Overall Study||0||
59861728|NCT02608268|75986071|FG026|COMPLETED|Overall Study||0||
59861729|NCT02608268|75986072|FG027|COMPLETED|Overall Study||0||
59861730|NCT02608268|75986073|FG028|COMPLETED|Overall Study||0||
59861731|NCT02608268|75986074|FG029|COMPLETED|Overall Study||0||
59861732|NCT02608268|75986045|FG000|NOT COMPLETED|Overall Study||14||
59861733|NCT02608268|75986046|FG001|NOT COMPLETED|Overall Study||9||
59861734|NCT02608268|75986047|FG002|NOT COMPLETED|Overall Study||16||
59861735|NCT02608268|75986048|FG003|NOT COMPLETED|Overall Study||5||
59861736|NCT02608268|75986049|FG004|NOT COMPLETED|Overall Study||2||
59861737|NCT02608268|75986050|FG005|NOT COMPLETED|Overall Study||4||
59861738|NCT02608268|75986051|FG006|NOT COMPLETED|Overall Study||6||
59861739|NCT02608268|75986052|FG007|NOT COMPLETED|Overall Study||2||
59861740|NCT02608268|75986053|FG008|NOT COMPLETED|Overall Study||8||
59861741|NCT02608268|75986054|FG009|NOT COMPLETED|Overall Study||9||
59861742|NCT02608268|75986055|FG010|NOT COMPLETED|Overall Study||6||
59861743|NCT02608268|75986056|FG011|NOT COMPLETED|Overall Study||6||
59861744|NCT02608268|75986057|FG012|NOT COMPLETED|Overall Study||6||
59861745|NCT02608268|75986058|FG013|NOT COMPLETED|Overall Study||13||
59861746|NCT02608268|75986059|FG014|NOT COMPLETED|Overall Study||6||
59861747|NCT02608268|75986060|FG015|NOT COMPLETED|Overall Study||5||
59861748|NCT02608268|75986061|FG016|NOT COMPLETED|Overall Study||5||
59861749|NCT02608268|75986062|FG017|NOT COMPLETED|Overall Study||6||
59861750|NCT02608268|75986063|FG018|NOT COMPLETED|Overall Study||6||
59861751|NCT02608268|75986064|FG019|NOT COMPLETED|Overall Study||3||
59861752|NCT02608268|75986065|FG020|NOT COMPLETED|Overall Study||12||
59861753|NCT02608268|75986066|FG021|NOT COMPLETED|Overall Study||5||
59861754|NCT02608268|75986067|FG022|NOT COMPLETED|Overall Study||7||
59861755|NCT02608268|75986068|FG023|NOT COMPLETED|Overall Study||6||
59861756|NCT02608268|75986069|FG024|NOT COMPLETED|Overall Study||6||
59861757|NCT02608268|75986070|FG025|NOT COMPLETED|Overall Study||14||
59861758|NCT02608268|75986071|FG026|NOT COMPLETED|Overall Study||17||
59861759|NCT02608268|75986072|FG027|NOT COMPLETED|Overall Study||15||
59861760|NCT02608268|75986073|FG028|NOT COMPLETED|Overall Study||17||
59861761|NCT02608268|75986074|FG029|NOT COMPLETED|Overall Study||16||
59861762|NCT02510261|75986187|FG000|STARTED|Overall Study||49||
59861763|NCT02510261|75986188|FG001|STARTED|Overall Study||137||
59861764|NCT02510261|75986189|FG002|STARTED|Overall Study||25||
59861765|NCT02510261|75986187|FG000|Full Analysis Set|Overall Study||49|Full analysis set included all participants who were enrolled in this study.|
59861766|NCT02510261|75986188|FG001|Full Analysis Set|Overall Study||137|Full analysis set included all participants who were enrolled in this study.|
59861767|NCT02510261|75986189|FG002|Full Analysis Set|Overall Study||25|Full analysis set included all participants who were enrolled in this study.|
59861768|NCT02510261|75986187|FG000|Safety Analysis Set|Overall Study||49|Safety analysis set included all the enrolled participants who received at least 1 dose of patisiran in this study.|
59861769|NCT02510261|75986188|FG001|Safety Analysis Set|Overall Study||137|Safety analysis set included all the enrolled participants who received at least 1 dose of patisiran in this study.|
59861770|NCT02510261|75986189|FG002|Safety Analysis Set|Overall Study||25|Safety analysis set included all the enrolled participants who received at least 1 dose of patisiran in this study.|
59861771|NCT02510261|75986187|FG000|Pharmacodynamic (PD) Analysis Set|Overall Study||40|PD analysis set included all participants who received at least 1 dose of patisiran in this study and have had both baseline and at least 1 post-baseline PD assessment (either transthyretin [TTR] or vitamin A).|
59861772|NCT02510261|75986188|FG001|Pharmacodynamic (PD) Analysis Set|Overall Study||128|PD analysis set included all participants who received at least 1 dose of patisiran in this study and have had both baseline and at least 1 post-baseline PD assessment (either transthyretin [TTR] or vitamin A).|
59861773|NCT02510261|75986189|FG002|Pharmacodynamic (PD) Analysis Set|Overall Study||24|PD analysis set included all participants who received at least 1 dose of patisiran in this study and have had both baseline and at least 1 post-baseline PD assessment (either transthyretin [TTR] or vitamin A).|
59861774|NCT02510261|75986187|FG000|COMPLETED|Overall Study||21||
59861775|NCT02510261|75986188|FG001|COMPLETED|Overall Study||95||
59861776|NCT02510261|75986189|FG002|COMPLETED|Overall Study||22||
59861777|NCT02510261|75986187|FG000|NOT COMPLETED|Overall Study||28||
59861778|NCT02510261|75986188|FG001|NOT COMPLETED|Overall Study||42||
59861779|NCT02510261|75986189|FG002|NOT COMPLETED|Overall Study||3||
59861780|NCT02506192|75986200|FG000|STARTED|Overall Study||42||
59861781|NCT02506192|75986201|FG001|STARTED|Overall Study||41||
59861782|NCT02506192|75986200|FG000|COMPLETED|Overall Study||41||
59861783|NCT02506192|75986201|FG001|COMPLETED|Overall Study||40||
59861784|NCT02506192|75986200|FG000|NOT COMPLETED|Overall Study||1||
59861785|NCT02506192|75986201|FG001|NOT COMPLETED|Overall Study||1||
59861786|NCT02395666|75986209|FG000|STARTED|Overall Study||101||
59861787|NCT02395666|75986210|FG001|STARTED|Overall Study||39||
59861788|NCT02395666|75986209|FG000|COMPLETED|Overall Study||95||
59861789|NCT02395666|75986210|FG001|COMPLETED|Overall Study||38||
59861790|NCT02395666|75986209|FG000|NOT COMPLETED|Overall Study||6||
59861791|NCT02395666|75986210|FG001|NOT COMPLETED|Overall Study||1||
59861792|NCT02257528|75986220|FG000|STARTED|Overall Study||26||
59861793|NCT02257528|75986220|FG000|COMPLETED|Overall Study||25||
59861794|NCT02257528|75986220|FG000|NOT COMPLETED|Overall Study||1||
59861795|NCT02223819|75986224|FG000|STARTED|Overall Study||34||
59861796|NCT02223819|75986224|FG000|COMPLETED|Overall Study||32||
59861797|NCT02223819|75986224|FG000|NOT COMPLETED|Overall Study||2||
59861798|NCT02078648|75986230|FG000|STARTED|Overall Study||46||
59861799|NCT02078648|75986231|FG001|STARTED|Overall Study||28||
59861800|NCT02078648|75986230|FG000|COMPLETED|Overall Study||0||
59861801|NCT02078648|75986231|FG001|COMPLETED|Overall Study||0||
59861802|NCT02078648|75986230|FG000|NOT COMPLETED|Overall Study||46||
59861803|NCT02078648|75986231|FG001|NOT COMPLETED|Overall Study||28||
59861804|NCT02048813|75986239|FG000|STARTED|Overall Study||354||
59861805|NCT02048813|75986240|FG001|STARTED|Overall Study||175||
59861806|NCT02048813|75986239|FG000|COMPLETED|Overall Study||0||
59861807|NCT02048813|75986240|FG001|COMPLETED|Overall Study||105||
59861808|NCT02048813|75986239|FG000|NOT COMPLETED|Overall Study||354||
59861809|NCT02048813|75986240|FG001|NOT COMPLETED|Overall Study||70||
59861810|NCT02030067|75986259|FG000|STARTED|Overall Study||1||
59861811|NCT02030067|75986260|FG001|STARTED|Overall Study||1||
59861812|NCT02030067|75986261|FG002|STARTED|Overall Study||3||
59861813|NCT02030067|75986262|FG003|STARTED|Overall Study||3||
59861814|NCT02030067|75986263|FG004|STARTED|Overall Study||3||
59861815|NCT02030067|75986264|FG005|STARTED|Overall Study||3||
59861816|NCT02030067|75986265|FG006|STARTED|Overall Study||3||
59861817|NCT02030067|75986266|FG007|STARTED|Overall Study||4||
59861818|NCT02030067|75986267|FG008|STARTED|Overall Study||6||
59861819|NCT02030067|75986268|FG009|STARTED|Overall Study||3||
59861820|NCT02030067|75986269|FG010|STARTED|Overall Study||11||
59861821|NCT02030067|75986270|FG011|STARTED|Overall Study||3||
59861822|NCT02030067|75986271|FG012|STARTED|Overall Study||80||
59861823|NCT02030067|75986259|FG000|COMPLETED|Overall Study|only 1 patient in phase 1 completed; 0 patients in phase 2 completed|0||
59861824|NCT02030067|75986260|FG001|COMPLETED|Overall Study||0||
59861825|NCT02030067|75986261|FG002|COMPLETED|Overall Study||1||
59861826|NCT02030067|75986262|FG003|COMPLETED|Overall Study||0||
59861827|NCT02030067|75986263|FG004|COMPLETED|Overall Study||0||
59861828|NCT02030067|75986264|FG005|COMPLETED|Overall Study||0||
59861829|NCT02030067|75986265|FG006|COMPLETED|Overall Study||0||
59861830|NCT02030067|75986266|FG007|COMPLETED|Overall Study||0||
59861831|NCT02030067|75986267|FG008|COMPLETED|Overall Study||0||
59861832|NCT02030067|75986268|FG009|COMPLETED|Overall Study||0||
59861833|NCT02030067|75986269|FG010|COMPLETED|Overall Study||0||
59861834|NCT02030067|75986270|FG011|COMPLETED|Overall Study||0||
59861835|NCT02030067|75986271|FG012|COMPLETED|Overall Study||0||
59861836|NCT02030067|75986259|FG000|NOT COMPLETED|Overall Study||1||
59861837|NCT02030067|75986260|FG001|NOT COMPLETED|Overall Study||1||
59861838|NCT02030067|75986261|FG002|NOT COMPLETED|Overall Study||2||
59861839|NCT02030067|75986262|FG003|NOT COMPLETED|Overall Study||3||
59861840|NCT02030067|75986263|FG004|NOT COMPLETED|Overall Study||3||
59861841|NCT02030067|75986264|FG005|NOT COMPLETED|Overall Study||3||
59861842|NCT02030067|75986265|FG006|NOT COMPLETED|Overall Study||3||
59861843|NCT02030067|75986266|FG007|NOT COMPLETED|Overall Study||4||
59861844|NCT02030067|75986267|FG008|NOT COMPLETED|Overall Study||6||
59861845|NCT02030067|75986268|FG009|NOT COMPLETED|Overall Study||3||
59861846|NCT02030067|75986269|FG010|NOT COMPLETED|Overall Study||11||
59861847|NCT02030067|75986270|FG011|NOT COMPLETED|Overall Study||3||
59861848|NCT02030067|75986271|FG012|NOT COMPLETED|Overall Study||80||
59861849|NCT02003209|75986303|FG000|STARTED|Overall Study||158||
59861850|NCT02003209|75986304|FG001|STARTED|Overall Study||157||
59861851|NCT02003209|75986303|FG000|COMPLETED|Overall Study||153||
59861852|NCT02003209|75986304|FG001|COMPLETED|Overall Study||155||
59861853|NCT02003209|75986303|FG000|NOT COMPLETED|Overall Study||5||
59861854|NCT02003209|75986304|FG001|NOT COMPLETED|Overall Study||2||
59861855|NCT01708941|75986314|FG000|STARTED|Overall Study||21||
59861856|NCT01708941|75986315|FG001|STARTED|Overall Study||23||
59861857|NCT01708941|75986316|FG002|STARTED|Overall Study||22||
59861858|NCT01708941|75986317|FG003|STARTED|Overall Study||22||
59861859|NCT01708941|75986314|FG000|Eligible and Started Treatment|Overall Study||18||
59861860|NCT01708941|75986315|FG001|Eligible and Started Treatment|Overall Study||22||
59861861|NCT01708941|75986316|FG002|Eligible and Started Treatment|Overall Study||19||
59861862|NCT01708941|75986317|FG003|Eligible and Started Treatment|Overall Study||22||
59861863|NCT01708941|75986314|FG000|COMPLETED|Overall Study||3||
59861864|NCT01708941|75986315|FG001|COMPLETED|Overall Study||5||
59861865|NCT01708941|75986316|FG002|COMPLETED|Overall Study||3||
59861866|NCT01708941|75986317|FG003|COMPLETED|Overall Study||4||
59861867|NCT01708941|75986314|FG000|NOT COMPLETED|Overall Study||18||
59861868|NCT01708941|75986315|FG001|NOT COMPLETED|Overall Study||18||
59861869|NCT01708941|75986316|FG002|NOT COMPLETED|Overall Study||19||
59861870|NCT01708941|75986317|FG003|NOT COMPLETED|Overall Study||18||
59861871|NCT00762645|75986329|FG000|STARTED|Overall Study||16||
59861872|NCT00762645|75986330|FG001|STARTED|Overall Study||14||
59861873|NCT00762645|75986329|FG000|COMPLETED|Overall Study||12||
59861874|NCT00762645|75986330|FG001|COMPLETED|Overall Study||12||
59861875|NCT00762645|75986329|FG000|NOT COMPLETED|Overall Study||4||
59861876|NCT00762645|75986330|FG001|NOT COMPLETED|Overall Study||2||
59861877|NCT00234065|75986338|FG000|STARTED|Overall Study||1356||
59861878|NCT00234065|75986339|FG001|STARTED|Overall Study||1360||
59861879|NCT00234065|75986338|FG000|COMPLETED|Overall Study||881||
59861880|NCT00234065|75986339|FG001|COMPLETED|Overall Study||1004||
59861881|NCT00234065|75986338|FG000|NOT COMPLETED|Overall Study||475||
59861882|NCT00234065|75986339|FG001|NOT COMPLETED|Overall Study||356||
59861883|NCT00233987|75986345|FG000|STARTED|Overall Study||98||
59861884|NCT00233987|75986345|FG000|Eligible|Overall Study||94||
59861885|NCT00233987|75986345|FG000|Eligible and Treated|Overall Study||92||
59861886|NCT00233987|75986345|FG000|COMPLETED|Overall Study||83||
59861887|NCT00233987|75986345|FG000|NOT COMPLETED|Overall Study||15||
59861888|NCT04623242|75986354|FG000|STARTED|Overall Study||52||
59861889|NCT04623242|75986355|FG001|STARTED|Overall Study||52||
59861890|NCT04623242|75986356|FG002|STARTED|Overall Study||40||
59861891|NCT04623242|75986357|FG003|STARTED|Overall Study||49||
59861892|NCT04623242|75986358|FG004|STARTED|Overall Study||69||
59861893|NCT04623242|75986354|FG000|COMPLETED|Overall Study||39||
59861894|NCT04623242|75986355|FG001|COMPLETED|Overall Study||36||
59861895|NCT04623242|75986356|FG002|COMPLETED|Overall Study||30||
59861896|NCT04623242|75986357|FG003|COMPLETED|Overall Study||26||
59861897|NCT04623242|75986358|FG004|COMPLETED|Overall Study||69||
59861898|NCT04623242|75986354|FG000|NOT COMPLETED|Overall Study||13||
59861899|NCT04623242|75986355|FG001|NOT COMPLETED|Overall Study||16||
59861900|NCT04623242|75986356|FG002|NOT COMPLETED|Overall Study||10||
59861901|NCT04623242|75986357|FG003|NOT COMPLETED|Overall Study||23||
59861902|NCT04623242|75986358|FG004|NOT COMPLETED|Overall Study||0||
59861903|NCT00233363|75986375|FG000|STARTED|Overall Study||53||
59861904|NCT00233363|75986376|FG001|STARTED|Overall Study||51||
59861905|NCT00233363|75986375|FG000|COMPLETED|Overall Study||50||
59861906|NCT00233363|75986376|FG001|COMPLETED|Overall Study||46||
59861907|NCT00233363|75986375|FG000|NOT COMPLETED|Overall Study||3||
59861908|NCT00233363|75986376|FG001|NOT COMPLETED|Overall Study||5||
59861909|NCT01147666|75986397|FG000|STARTED|Dosing Period 1: 6-Week Treatment||12||
59861910|NCT01147666|75986398|FG001|STARTED|Dosing Period 1: 6-Week Treatment||12||
59861911|NCT01147666|75986399|FG002|STARTED|Dosing Period 1: 6-Week Treatment||12||
59861912|NCT01147666|75986400|FG003|STARTED|Dosing Period 1: 6-Week Treatment||12||
59861913|NCT01147666|75986401|FG004|STARTED|Dosing Period 1: 6-Week Treatment||12||
59861914|NCT01147666|75986402|FG005|STARTED|Dosing Period 1: 6-Week Treatment||12||
59861915|NCT01147666|75986403|FG006|STARTED|Dosing Period 1: 6-Week Treatment||12||
59861916|NCT01147666|75986404|FG007|STARTED|Dosing Period 1: 6-Week Treatment||12||
59861917|NCT01147666|75986405|FG008|STARTED|Dosing Period 1: 6-Week Treatment||2||
59861918|NCT01147666|75986406|FG009|STARTED|Dosing Period 1: 6-Week Treatment||10||
59861919|NCT01147666|75986407|FG010|STARTED|Dosing Period 1: 6-Week Treatment||36||
59861920|NCT01147666|75986408|FG011|STARTED|Dosing Period 1: 6-Week Treatment||4||
59861921|NCT01147666|75986409|FG012|STARTED|Dosing Period 1: 6-Week Treatment||5||
59861922|NCT01147666|75986410|FG013|STARTED|Dosing Period 1: 6-Week Treatment||4||
59861923|NCT01147666|75986411|FG014|STARTED|Dosing Period 1: 6-Week Treatment||4||
59861924|NCT01147666|75986397|FG000|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||12||
60128997|NCT01586624|76251238|FG005|NOT COMPLETED|Overall Study||8||
59861925|NCT01147666|75986398|FG001|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||12||
59861926|NCT01147666|75986399|FG002|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||12||
59861927|NCT01147666|75986400|FG003|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||12||
59861928|NCT01147666|75986401|FG004|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||12||
59861929|NCT01147666|75986402|FG005|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||12||
59861930|NCT01147666|75986403|FG006|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||12||
59861931|NCT01147666|75986404|FG007|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||12||
59861932|NCT01147666|75986405|FG008|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||2||
59861933|NCT01147666|75986406|FG009|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||10||
59861934|NCT01147666|75986407|FG010|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||36||
59861935|NCT01147666|75986408|FG011|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||4||
59861936|NCT01147666|75986409|FG012|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||5||
59861937|NCT01147666|75986410|FG013|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||4||
59861938|NCT01147666|75986411|FG014|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||4||
59996937|NCT01597245|76112821|FG006|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0||
59996938|NCT01597245|76112822|FG007|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0||
59996939|NCT01597245|76112823|FG008|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0||
59996940|NCT01597245|76112824|FG009|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0||
59996941|NCT01597245|76112825|FG010|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0||
59996942|NCT01597245|76112826|FG011|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0||
59996943|NCT01597245|76112827|FG012|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0||
59996944|NCT01597245|76112828|FG013|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0||
59996945|NCT01597245|76112829|FG014|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0||
59996946|NCT01597245|76112830|FG015|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0||
59996947|NCT01597245|76112831|FG016|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0||
59996948|NCT01597245|76112832|FG017|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0||
59996949|NCT01597245|76112833|FG018|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0||
59996950|NCT01597245|76112834|FG019|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0||
59996951|NCT01597245|76112835|FG020|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0||
59996952|NCT01597245|76112815|FG000|COMPLETED|Induction Period (Week 0 - Week 12)||158||
59996953|NCT01597245|76112816|FG001|COMPLETED|Induction Period (Week 0 - Week 12)|1 participant randomized to maintenance period but did not receive a dose in the maintenance period.|333||
59996954|NCT01597245|76112817|FG002|COMPLETED|Induction Period (Week 0 - Week 12)||328||
59996955|NCT01597245|76112818|FG003|COMPLETED|Induction Period (Week 0 - Week 12)|2 participants discontinued after IND completion and prior to randomizing into maintenance period.|342||
59996956|NCT01597245|76112819|FG004|COMPLETED|Induction Period (Week 0 - Week 12)||0||
59996957|NCT01597245|76112820|FG005|COMPLETED|Induction Period (Week 0 - Week 12)||0||
59996958|NCT01597245|76112821|FG006|COMPLETED|Induction Period (Week 0 - Week 12)||0||
59996959|NCT01597245|76112822|FG007|COMPLETED|Induction Period (Week 0 - Week 12)||0||
59996960|NCT01597245|76112823|FG008|COMPLETED|Induction Period (Week 0 - Week 12)||0||
59996961|NCT01597245|76112824|FG009|COMPLETED|Induction Period (Week 0 - Week 12)||0||
59996962|NCT01597245|76112825|FG010|COMPLETED|Induction Period (Week 0 - Week 12)||0||
59996963|NCT01597245|76112826|FG011|COMPLETED|Induction Period (Week 0 - Week 12)||0||
59996964|NCT01597245|76112827|FG012|COMPLETED|Induction Period (Week 0 - Week 12)||0||
59996965|NCT01597245|76112828|FG013|COMPLETED|Induction Period (Week 0 - Week 12)||0||
59996966|NCT01597245|76112829|FG014|COMPLETED|Induction Period (Week 0 - Week 12)||0||
59996967|NCT01597245|76112830|FG015|COMPLETED|Induction Period (Week 0 - Week 12)||0||
59996968|NCT01597245|76112831|FG016|COMPLETED|Induction Period (Week 0 - Week 12)||0||
59996969|NCT01597245|76112832|FG017|COMPLETED|Induction Period (Week 0 - Week 12)||0||
59996970|NCT01597245|76112833|FG018|COMPLETED|Induction Period (Week 0 - Week 12)||0||
59996971|NCT01597245|76112834|FG019|COMPLETED|Induction Period (Week 0 - Week 12)||0||
59996972|NCT01597245|76112835|FG020|COMPLETED|Induction Period (Week 0 - Week 12)||0||
59996973|NCT01597245|76112815|FG000|NOT COMPLETED|Induction Period (Week 0 - Week 12)||10||
59597866|NCT03463915|75707406|FG000|STARTED|Overall Study||45||
59597867|NCT03463915|75707407|FG001|STARTED|Overall Study||45||
59597868|NCT03463915|75707406|FG000|COMPLETED|Overall Study||35||
59996974|NCT01597245|76112816|FG001|NOT COMPLETED|Induction Period (Week 0 - Week 12)||25||
59996975|NCT01597245|76112817|FG002|NOT COMPLETED|Induction Period (Week 0 - Week 12)||19||
59996976|NCT01597245|76112818|FG003|NOT COMPLETED|Induction Period (Week 0 - Week 12)||9||
59996977|NCT01597245|76112819|FG004|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0||
59996978|NCT01597245|76112820|FG005|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0||
59996979|NCT01597245|76112821|FG006|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0||
59996980|NCT01597245|76112822|FG007|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0||
59996981|NCT01597245|76112823|FG008|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0||
59996982|NCT01597245|76112824|FG009|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0||
59996983|NCT01597245|76112825|FG010|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0||
59996984|NCT01597245|76112826|FG011|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0||
59996985|NCT01597245|76112827|FG012|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0||
59996986|NCT01597245|76112828|FG013|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0||
59996987|NCT01597245|76112829|FG014|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0||
59996988|NCT01597245|76112830|FG015|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0||
59996989|NCT01597245|76112831|FG016|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0||
59996990|NCT01597245|76112832|FG017|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0||
59996991|NCT01597245|76112833|FG018|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0||
59996992|NCT01597245|76112834|FG019|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0||
59996993|NCT01597245|76112835|FG020|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0||
59996994|NCT01597245|76112815|FG000|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|0||
59996995|NCT01597245|76112816|FG001|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|0||
59996996|NCT01597245|76112817|FG002|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|0||
59996997|NCT01597245|76112818|FG003|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|0||
59996998|NCT01597245|76112819|FG004|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|176||
59996999|NCT01597245|76112820|FG005|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|187||
59997000|NCT01597245|76112821|FG006|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|181||
59997001|NCT01597245|76112822|FG007|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|3||
59997002|NCT01597245|76112823|FG008|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|155||
59997003|NCT01597245|76112824|FG009|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|132||
59997004|NCT01597245|76112825|FG010|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|200||
59997005|NCT01597245|76112826|FG011|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|75||
59997006|NCT01597245|76112827|FG012|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|49||
59997007|NCT01597245|76112828|FG013|STARTED|Maintenance Period (Week 12 to Week 60)||0||
59997008|NCT01597245|76112829|FG014|STARTED|Maintenance Period (Week 12 to Week 60)||0||
59997009|NCT01597245|76112830|FG015|STARTED|Maintenance Period (Week 12 to Week 60)||0||
59997010|NCT01597245|76112831|FG016|STARTED|Maintenance Period (Week 12 to Week 60)||0||
59997011|NCT01597245|76112832|FG017|STARTED|Maintenance Period (Week 12 to Week 60)||0||
59997012|NCT01597245|76112833|FG018|STARTED|Maintenance Period (Week 12 to Week 60)||0||
59997013|NCT01597245|76112834|FG019|STARTED|Maintenance Period (Week 12 to Week 60)||0||
59997014|NCT01597245|76112835|FG020|STARTED|Maintenance Period (Week 12 to Week 60)||0||
59997015|NCT01597245|76112815|FG000|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0||
59997016|NCT01597245|76112816|FG001|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0||
59997017|NCT01597245|76112817|FG002|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0||
59997018|NCT01597245|76112818|FG003|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0||
59997019|NCT01597245|76112819|FG004|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||176||
59997020|NCT01597245|76112820|FG005|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||187||
59997021|NCT01597245|76112821|FG006|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||181||
59997022|NCT01597245|76112822|FG007|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||3||
59997023|NCT01597245|76112823|FG008|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||155||
59997024|NCT01597245|76112824|FG009|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||132||
59997025|NCT01597245|76112825|FG010|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||200||
59997026|NCT01597245|76112826|FG011|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||75||
59997027|NCT01597245|76112827|FG012|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||49||
59997028|NCT01597245|76112828|FG013|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0||
59997029|NCT01597245|76112829|FG014|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0||
59997030|NCT01597245|76112830|FG015|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0||
59997031|NCT01597245|76112831|FG016|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0||
59997032|NCT01597245|76112832|FG017|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0||
59997033|NCT01597245|76112833|FG018|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0||
59997034|NCT01597245|76112834|FG019|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0||
59997035|NCT01597245|76112835|FG020|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0||
59997036|NCT01597245|76112815|FG000|COMPLETED|Maintenance Period (Week 12 to Week 60)||0||
59997037|NCT01597245|76112816|FG001|COMPLETED|Maintenance Period (Week 12 to Week 60)||0||
59997038|NCT01597245|76112817|FG002|COMPLETED|Maintenance Period (Week 12 to Week 60)||0||
59997039|NCT01597245|76112818|FG003|COMPLETED|Maintenance Period (Week 12 to Week 60)||0||
59997040|NCT01597245|76112819|FG004|COMPLETED|Maintenance Period (Week 12 to Week 60)||15||
59997041|NCT01597245|76112820|FG005|COMPLETED|Maintenance Period (Week 12 to Week 60)||149||
59997042|NCT01597245|76112821|FG006|COMPLETED|Maintenance Period (Week 12 to Week 60)||92||
59997043|NCT01597245|76112822|FG007|COMPLETED|Maintenance Period (Week 12 to Week 60)||0||
59997044|NCT01597245|76112823|FG008|COMPLETED|Maintenance Period (Week 12 to Week 60)||135||
59997045|NCT01597245|76112824|FG009|COMPLETED|Maintenance Period (Week 12 to Week 60)||11||
59997046|NCT01597245|76112825|FG010|COMPLETED|Maintenance Period (Week 12 to Week 60)||178||
59997047|NCT01597245|76112826|FG011|COMPLETED|Maintenance Period (Week 12 to Week 60)||56||
59997048|NCT01597245|76112827|FG012|COMPLETED|Maintenance Period (Week 12 to Week 60)||37||
59997049|NCT01597245|76112828|FG013|COMPLETED|Maintenance Period (Week 12 to Week 60)||0||
59997050|NCT01597245|76112829|FG014|COMPLETED|Maintenance Period (Week 12 to Week 60)||0||
59997051|NCT01597245|76112830|FG015|COMPLETED|Maintenance Period (Week 12 to Week 60)||0||
59997052|NCT01597245|76112831|FG016|COMPLETED|Maintenance Period (Week 12 to Week 60)||0||
59997053|NCT01597245|76112832|FG017|COMPLETED|Maintenance Period (Week 12 to Week 60)||0||
59997054|NCT01597245|76112833|FG018|COMPLETED|Maintenance Period (Week 12 to Week 60)||0||
59997055|NCT01597245|76112834|FG019|COMPLETED|Maintenance Period (Week 12 to Week 60)||0||
59997056|NCT01597245|76112835|FG020|COMPLETED|Maintenance Period (Week 12 to Week 60)||0||
59997057|NCT01597245|76112815|FG000|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0||
59997058|NCT01597245|76112816|FG001|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0||
59997059|NCT01597245|76112817|FG002|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0||
59997060|NCT01597245|76112818|FG003|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0||
59997061|NCT01597245|76112819|FG004|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||161||
59997062|NCT01597245|76112820|FG005|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||38||
59997063|NCT01597245|76112821|FG006|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||89||
59997064|NCT01597245|76112822|FG007|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||3||
59997065|NCT01597245|76112823|FG008|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||20||
59997066|NCT01597245|76112824|FG009|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||121||
59997067|NCT01597245|76112825|FG010|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||22||
59997068|NCT01597245|76112826|FG011|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||19||
59997069|NCT01597245|76112827|FG012|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||12||
59997070|NCT01597245|76112828|FG013|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0||
59997071|NCT01597245|76112829|FG014|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0||
59997072|NCT01597245|76112830|FG015|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0||
59997073|NCT01597245|76112831|FG016|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0||
59997074|NCT01597245|76112832|FG017|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0||
59997075|NCT01597245|76112833|FG018|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0||
59997076|NCT01597245|76112834|FG019|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0||
59997077|NCT01597245|76112835|FG020|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0||
59997078|NCT01597245|76112815|FG000|STARTED|Long Term Extension (Week 60 - Week 264)||0||
59997079|NCT01597245|76112816|FG001|STARTED|Long Term Extension (Week 60 - Week 264)||0||
59997080|NCT01597245|76112817|FG002|STARTED|Long Term Extension (Week 60 - Week 264)||0||
59997081|NCT01597245|76112818|FG003|STARTED|Long Term Extension (Week 60 - Week 264)||0||
59997082|NCT01597245|76112819|FG004|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0||
59997083|NCT01597245|76112820|FG005|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0||
59997084|NCT01597245|76112821|FG006|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0||
59997085|NCT01597245|76112822|FG007|STARTED|Long Term Extension (Week 60 - Week 264)||0||
59997086|NCT01597245|76112823|FG008|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0||
59997087|NCT01597245|76112824|FG009|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0||
59997088|NCT01597245|76112825|FG010|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0||
59997089|NCT01597245|76112826|FG011|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0||
59997090|NCT01597245|76112827|FG012|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0||
59997091|NCT01597245|76112828|FG013|STARTED|Long Term Extension (Week 60 - Week 264)|Participants who received placebo at the start of the long-term extension period.|26||
59997092|NCT01597245|76112829|FG014|STARTED|Long Term Extension (Week 60 - Week 264)|Participants received ixe at the start of the long-term extension.|979||
59997093|NCT01597245|76112830|FG015|STARTED|Long Term Extension (Week 60 - Week 264)|Participants received ixe in all dosing regimens, including participants who switched PBO to ixe.|1002||
59997094|NCT01597245|76112831|FG016|STARTED|Long Term Extension (Week 60 - Week 264)||0||
59997095|NCT01597245|76112832|FG017|STARTED|Long Term Extension (Week 60 - Week 264)||0||
59997096|NCT01597245|76112833|FG018|STARTED|Long Term Extension (Week 60 - Week 264)||0||
59997097|NCT01597245|76112834|FG019|STARTED|Long Term Extension (Week 60 - Week 264)||0||
59997098|NCT01597245|76112835|FG020|STARTED|Long Term Extension (Week 60 - Week 264)||0||
59997099|NCT01597245|76112815|FG000|COMPLETED|Long Term Extension (Week 60 - Week 264)||0||
59997100|NCT01597245|76112816|FG001|COMPLETED|Long Term Extension (Week 60 - Week 264)||0||
59997101|NCT01597245|76112817|FG002|COMPLETED|Long Term Extension (Week 60 - Week 264)||0||
59997102|NCT01597245|76112818|FG003|COMPLETED|Long Term Extension (Week 60 - Week 264)||0||
59997103|NCT01597245|76112819|FG004|COMPLETED|Long Term Extension (Week 60 - Week 264)||0||
59997104|NCT01597245|76112820|FG005|COMPLETED|Long Term Extension (Week 60 - Week 264)||0||
59997105|NCT01597245|76112821|FG006|COMPLETED|Long Term Extension (Week 60 - Week 264)||0||
59997106|NCT01597245|76112822|FG007|COMPLETED|Long Term Extension (Week 60 - Week 264)||0||
59997107|NCT01597245|76112823|FG008|COMPLETED|Long Term Extension (Week 60 - Week 264)||0||
59997108|NCT01597245|76112824|FG009|COMPLETED|Long Term Extension (Week 60 - Week 264)||0||
59997109|NCT01597245|76112825|FG010|COMPLETED|Long Term Extension (Week 60 - Week 264)||0||
59997110|NCT01597245|76112826|FG011|COMPLETED|Long Term Extension (Week 60 - Week 264)||0||
59997111|NCT01597245|76112827|FG012|COMPLETED|Long Term Extension (Week 60 - Week 264)||0||
59997112|NCT01597245|76112828|FG013|COMPLETED|Long Term Extension (Week 60 - Week 264)||0||
59997113|NCT01597245|76112829|FG014|COMPLETED|Long Term Extension (Week 60 - Week 264)||754||
59997114|NCT01597245|76112830|FG015|COMPLETED|Long Term Extension (Week 60 - Week 264)||774||
59997115|NCT01597245|76112831|FG016|COMPLETED|Long Term Extension (Week 60 - Week 264)||0||
59997116|NCT01597245|76112832|FG017|COMPLETED|Long Term Extension (Week 60 - Week 264)||0||
59997117|NCT01597245|76112833|FG018|COMPLETED|Long Term Extension (Week 60 - Week 264)||0||
59997118|NCT01597245|76112834|FG019|COMPLETED|Long Term Extension (Week 60 - Week 264)||0||
59997119|NCT01597245|76112835|FG020|COMPLETED|Long Term Extension (Week 60 - Week 264)||0||
59997120|NCT01597245|76112815|FG000|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0||
59997121|NCT01597245|76112816|FG001|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0||
59997122|NCT01597245|76112817|FG002|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0||
59997123|NCT01597245|76112818|FG003|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0||
59997124|NCT01597245|76112819|FG004|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0||
59997125|NCT01597245|76112820|FG005|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0||
59997126|NCT01597245|76112821|FG006|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0||
59997127|NCT01597245|76112822|FG007|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0||
59997128|NCT01597245|76112823|FG008|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0||
59997129|NCT01597245|76112824|FG009|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0||
59997130|NCT01597245|76112825|FG010|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0||
59997131|NCT01597245|76112826|FG011|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0||
59997132|NCT01597245|76112827|FG012|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0||
59997133|NCT01597245|76112828|FG013|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||26||
59997134|NCT01597245|76112829|FG014|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||225||
59997135|NCT01597245|76112830|FG015|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||228||
59997136|NCT01597245|76112831|FG016|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0||
59997137|NCT01597245|76112832|FG017|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0||
59997138|NCT01597245|76112833|FG018|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0||
59997139|NCT01597245|76112834|FG019|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0||
59997140|NCT01597245|76112835|FG020|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0||
59997141|NCT01597245|76112815|FG000|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
59997142|NCT01597245|76112816|FG001|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
59997143|NCT01597245|76112817|FG002|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
59997144|NCT01597245|76112818|FG003|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
59997145|NCT01597245|76112819|FG004|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
59997146|NCT01597245|76112820|FG005|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
59997147|NCT01597245|76112821|FG006|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
59997148|NCT01597245|76112822|FG007|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
59997149|NCT01597245|76112823|FG008|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
59997150|NCT01597245|76112824|FG009|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
59997151|NCT01597245|76112825|FG010|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
59997152|NCT01597245|76112826|FG011|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
59997153|NCT01597245|76112827|FG012|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
59997154|NCT01597245|76112828|FG013|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
59997155|NCT01597245|76112829|FG014|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|0||
59997156|NCT01597245|76112830|FG015|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|0||
60128998|NCT01586624|76251239|FG006|NOT COMPLETED|Overall Study||8||
60128999|NCT01586624|76251240|FG007|NOT COMPLETED|Overall Study||10||
60129000|NCT01586156|76251262|FG000|STARTED|Overall Study||10||
59997157|NCT01597245|76112831|FG016|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|16||
59997158|NCT01597245|76112832|FG017|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|6||
59997159|NCT01597245|76112833|FG018|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|24||
59997160|NCT01597245|76112834|FG019|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|656||
59997161|NCT01597245|76112835|FG020|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|248||
59997162|NCT01597245|76112815|FG000|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
59997163|NCT01597245|76112816|FG001|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
59997164|NCT01597245|76112817|FG002|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
59997165|NCT01597245|76112818|FG003|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
59997166|NCT01597245|76112819|FG004|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
59997167|NCT01597245|76112820|FG005|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
59997168|NCT01597245|76112821|FG006|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
59997169|NCT01597245|76112822|FG007|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
59997170|NCT01597245|76112823|FG008|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
59997171|NCT01597245|76112824|FG009|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
59997172|NCT01597245|76112825|FG010|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
59997173|NCT01597245|76112826|FG011|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
59997174|NCT01597245|76112827|FG012|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
59997175|NCT01597245|76112828|FG013|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
59997176|NCT01597245|76112829|FG014|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
59997177|NCT01597245|76112830|FG015|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
59997178|NCT01597245|76112831|FG016|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
59997179|NCT01597245|76112832|FG017|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
59997180|NCT01597245|76112833|FG018|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||14||
59997181|NCT01597245|76112834|FG019|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||489||
59997182|NCT01597245|76112835|FG020|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||212||
59997183|NCT01597245|76112815|FG000|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
59997184|NCT01597245|76112816|FG001|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
59997185|NCT01597245|76112817|FG002|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
59997186|NCT01597245|76112818|FG003|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
59997187|NCT01597245|76112819|FG004|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
59997188|NCT01597245|76112820|FG005|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
59997189|NCT01597245|76112821|FG006|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
59997190|NCT01597245|76112822|FG007|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
59997191|NCT01597245|76112823|FG008|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
59997192|NCT01597245|76112824|FG009|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
59997193|NCT01597245|76112825|FG010|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
59997194|NCT01597245|76112826|FG011|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
59997195|NCT01597245|76112827|FG012|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
59997196|NCT01597245|76112828|FG013|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
59997197|NCT01597245|76112829|FG014|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
59997198|NCT01597245|76112830|FG015|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0||
59997199|NCT01597245|76112831|FG016|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||16||
59997200|NCT01597245|76112832|FG017|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||6||
59997201|NCT01597245|76112833|FG018|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||10||
59997202|NCT01597245|76112834|FG019|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||167||
59997203|NCT01597245|76112835|FG020|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||36||
59997204|NCT00707057|76112870|FG000|STARTED|Overall Study||169||
59997205|NCT00707057|76112871|FG001|STARTED|Overall Study||87||
59997206|NCT00707057|76112870|FG000|COMPLETED|Overall Study||161||
59997207|NCT00707057|76112871|FG001|COMPLETED|Overall Study||83||
59997208|NCT00707057|76112870|FG000|NOT COMPLETED|Overall Study||8||
59997209|NCT00707057|76112871|FG001|NOT COMPLETED|Overall Study||4||
59997210|NCT02639247|76112879|FG000|STARTED|Overall Study||182||
59997211|NCT02639247|76112880|FG001|STARTED|Overall Study||151||
59997212|NCT02639247|76112879|FG000|COMPLETED|Overall Study||177||
59997213|NCT02639247|76112880|FG001|COMPLETED|Overall Study||149||
59997214|NCT02639247|76112879|FG000|NOT COMPLETED|Overall Study||5||
59997215|NCT02639247|76112880|FG001|NOT COMPLETED|Overall Study||2||
59997216|NCT00706901|76112889|FG000|STARTED|Overall Study||59||
59997217|NCT00706901|76112890|FG001|STARTED|Overall Study||62||
59997218|NCT00706901|76112891|FG002|STARTED|Overall Study||59||
59997219|NCT00706901|76112889|FG000|COMPLETED|Overall Study||51||
59997220|NCT00706901|76112890|FG001|COMPLETED|Overall Study||57||
59997221|NCT00706901|76112891|FG002|COMPLETED|Overall Study||51||
59997222|NCT00706901|76112889|FG000|NOT COMPLETED|Overall Study||8||
59997223|NCT00706901|76112890|FG001|NOT COMPLETED|Overall Study||5||
59997224|NCT00706901|76112891|FG002|NOT COMPLETED|Overall Study||8||
59997225|NCT05274217|76112902|FG000|STARTED|Overall Study||33||
59997226|NCT05274217|76112903|FG001|STARTED|Overall Study||0||
59997227|NCT05274217|76112902|FG000|COMPLETED|Overall Study||22||
59997228|NCT05274217|76112903|FG001|COMPLETED|Overall Study||0||
59997229|NCT05274217|76112902|FG000|NOT COMPLETED|Overall Study||11||
59997230|NCT05274217|76112903|FG001|NOT COMPLETED|Overall Study||0||
59997231|NCT05070546|76112915|FG000|STARTED|Overall Study||320||
59997232|NCT05070546|76112916|FG001|STARTED|Overall Study||68||
59997233|NCT05070546|76112917|FG002|STARTED|Overall Study||320||
59997234|NCT05070546|76112918|FG003|STARTED|Overall Study||70||
59997235|NCT05070546|76112919|FG004|STARTED|Overall Study||316||
59997236|NCT05070546|76112920|FG005|STARTED|Overall Study||30||
59997237|NCT05070546|76112915|FG000|Vaccinated|Overall Study||319||
59997238|NCT05070546|76112916|FG001|Vaccinated|Overall Study||68||
59997239|NCT05070546|76112917|FG002|Vaccinated|Overall Study||319||
59997240|NCT05070546|76112918|FG003|Vaccinated|Overall Study||69||
59997241|NCT05070546|76112919|FG004|Vaccinated|Overall Study||313||
59997242|NCT05070546|76112920|FG005|Vaccinated|Overall Study||30||
59997243|NCT05070546|76112915|FG000|COMPLETED|Overall Study||310||
59997244|NCT05070546|76112916|FG001|COMPLETED|Overall Study||65||
59997245|NCT05070546|76112917|FG002|COMPLETED|Overall Study||309||
59997246|NCT05070546|76112918|FG003|COMPLETED|Overall Study||68||
59997247|NCT05070546|76112919|FG004|COMPLETED|Overall Study||308||
59997248|NCT05070546|76112920|FG005|COMPLETED|Overall Study||29||
59997249|NCT05070546|76112915|FG000|NOT COMPLETED|Overall Study||10||
59997250|NCT05070546|76112916|FG001|NOT COMPLETED|Overall Study||3||
59997251|NCT05070546|76112917|FG002|NOT COMPLETED|Overall Study||11||
59997252|NCT05070546|76112918|FG003|NOT COMPLETED|Overall Study||2||
59997253|NCT05070546|76112919|FG004|NOT COMPLETED|Overall Study||8||
59997254|NCT05070546|76112920|FG005|NOT COMPLETED|Overall Study||1||
59997255|NCT05032950|76112939|FG000|STARTED|Overall Study||2|Assigned to Treatment|
59997256|NCT05032950|76112940|FG001|STARTED|Overall Study||2|Assigned to Treatment|
59997257|NCT05032950|76112941|FG002|STARTED|Overall Study||2|Assigned to Treatment|
59997258|NCT05032950|76112942|FG003|STARTED|Overall Study||2|Assigned to Treatment|
59997259|NCT05032950|76112943|FG004|STARTED|Overall Study||2|Assigned to Treatment|
59997260|NCT05032950|76112944|FG005|STARTED|Overall Study||2|Assigned to Treatment|
59997261|NCT05032950|76112939|FG000|COMPLETED|Overall Study||2|Completed|
59997262|NCT05032950|76112940|FG001|COMPLETED|Overall Study||2|Completed|
59997263|NCT05032950|76112941|FG002|COMPLETED|Overall Study||1|Completed|
59997264|NCT05032950|76112942|FG003|COMPLETED|Overall Study||1|Completed|
59997265|NCT05032950|76112943|FG004|COMPLETED|Overall Study||2|Completed|
59997266|NCT05032950|76112944|FG005|COMPLETED|Overall Study||2|Completed|
59997267|NCT05032950|76112939|FG000|NOT COMPLETED|Overall Study||0||
59997268|NCT05032950|76112940|FG001|NOT COMPLETED|Overall Study||0||
59997269|NCT05032950|76112941|FG002|NOT COMPLETED|Overall Study||1||
59997270|NCT05032950|76112942|FG003|NOT COMPLETED|Overall Study||1||
59997271|NCT05032950|76112943|FG004|NOT COMPLETED|Overall Study||0||
59997272|NCT05032950|76112944|FG005|NOT COMPLETED|Overall Study||0||
59997273|NCT04827680|76112957|FG000|STARTED|Overall Study||20||
59997274|NCT04827680|76112957|FG000|COMPLETED|Overall Study||14||
59997275|NCT04827680|76112957|FG000|NOT COMPLETED|Overall Study||6||
59997276|NCT04776161|76112964|FG000|STARTED|Overall Study||19||
59997277|NCT04776161|76112965|FG001|STARTED|Overall Study||21||
59997278|NCT04776161|76112966|FG002|STARTED|Overall Study||22||
59997279|NCT04776161|76112964|FG000|COMPLETED|Overall Study||17||
59997280|NCT04776161|76112965|FG001|COMPLETED|Overall Study||17||
59997281|NCT04776161|76112966|FG002|COMPLETED|Overall Study||18||
59997282|NCT04776161|76112964|FG000|NOT COMPLETED|Overall Study||2||
59997283|NCT04776161|76112965|FG001|NOT COMPLETED|Overall Study||4||
59997284|NCT04776161|76112966|FG002|NOT COMPLETED|Overall Study||4||
59997285|NCT04631029|76112974|FG000|STARTED|Overall Study||3||
59997286|NCT04631029|76112974|FG000|COMPLETED|Overall Study||3||
59997287|NCT04631029|76112974|FG000|NOT COMPLETED|Overall Study||0||
59997288|NCT04268823|76112980|FG000|STARTED|Overall Study||26||
59997289|NCT04268823|76112981|FG001|STARTED|Overall Study||28||
59997290|NCT04268823|76112980|FG000|COMPLETED|Overall Study||24||
59997291|NCT04268823|76112981|FG001|COMPLETED|Overall Study||28||
59997292|NCT04268823|76112980|FG000|NOT COMPLETED|Overall Study||2||
59997293|NCT04268823|76112981|FG001|NOT COMPLETED|Overall Study||0||
59997294|NCT04226495|76112990|FG000|STARTED|Overall Study||31||
59997295|NCT04226495|76112991|FG001|STARTED|Overall Study||33||
59997296|NCT04226495|76112990|FG000|COMPLETED|Overall Study||26||
59997297|NCT04226495|76112991|FG001|COMPLETED|Overall Study||26||
59997298|NCT04226495|76112990|FG000|NOT COMPLETED|Overall Study||5||
59997299|NCT04226495|76112991|FG001|NOT COMPLETED|Overall Study||7||
59997300|NCT04060212|76112997|FG000|STARTED|Overall Study||36||
59997301|NCT04060212|76112997|FG000|COMPLETED|Overall Study||29||
59997302|NCT04060212|76112997|FG000|NOT COMPLETED|Overall Study||7||
59997303|NCT04007991|76113003|FG000|STARTED|Overall Study||76||
59997304|NCT04007991|76113004|FG001|STARTED|Overall Study||77||
59997305|NCT04007991|76113003|FG000|Safety Set|Overall Study||76|The Safety Set (SS) included all participants who received at least one dose of study drug.|
59997306|NCT04007991|76113004|FG001|Safety Set|Overall Study||77|The Safety Set (SS) included all participants who received at least one dose of study drug.|
59997307|NCT04007991|76113003|FG000|The Modified Intention-to-Treat Set|Overall Study||74|The Modified Intention-to-Treat (mITT) set included all randomized participants who received at least one dose of study drug and had at least 1 post-baseline scoring of the YGTSS (Yale Global Tic Severity Scale).|
59997308|NCT04007991|76113004|FG001|The Modified Intention-to-Treat Set|Overall Study||75|The Modified Intention-to-Treat (mITT) set included all randomized participants who received at least one dose of study drug and had at least 1 post-baseline scoring of the YGTSS (Yale Global Tic Severity Scale).|
59997309|NCT04007991|76113003|FG000|COMPLETED|Overall Study||66||
59997310|NCT04007991|76113004|FG001|COMPLETED|Overall Study||71||
59997311|NCT04007991|76113003|FG000|NOT COMPLETED|Overall Study||10||
59997312|NCT04007991|76113004|FG001|NOT COMPLETED|Overall Study||6||
59997313|NCT03998670|76113012|FG000|STARTED|Overall Study||28||
59997314|NCT03998670|76113013|FG001|STARTED|Overall Study||29||
59997315|NCT03998670|76113012|FG000|COMPLETED|Overall Study||25||
59997316|NCT03998670|76113013|FG001|COMPLETED|Overall Study||25||
59997317|NCT03998670|76113012|FG000|NOT COMPLETED|Overall Study||3||
59997318|NCT03998670|76113013|FG001|NOT COMPLETED|Overall Study||4||
59997319|NCT03998176|76113019|FG000|STARTED|Overall Study||43||
59997320|NCT03998176|76113019|FG000|COMPLETED|Overall Study||31||
59997321|NCT03998176|76113019|FG000|NOT COMPLETED|Overall Study||12||
59997322|NCT03935217|76113025|FG000|STARTED|Overall Study||74||
59997323|NCT03935217|76113026|FG001|STARTED|Overall Study||73||
59997324|NCT03935217|76113025|FG000|COMPLETED|Overall Study||73||
59997325|NCT03935217|76113026|FG001|COMPLETED|Overall Study||70||
59997326|NCT03935217|76113025|FG000|NOT COMPLETED|Overall Study||1||
59997327|NCT03935217|76113026|FG001|NOT COMPLETED|Overall Study||3||
59997328|NCT03861871|76113032|FG000|STARTED|Overall Study||7||
59997329|NCT03861871|76113032|FG000|COMPLETED|Overall Study||7||
59997330|NCT03861871|76113032|FG000|NOT COMPLETED|Overall Study||0||
59997331|NCT03806933|76113040|FG000|STARTED|Main Period||61||
59997332|NCT03806933|76113041|FG001|STARTED|Main Period||60||
59997333|NCT03806933|76113042|FG002|STARTED|Main Period||61||
59997334|NCT03806933|76113043|FG003|STARTED|Main Period||59||
59997335|NCT03806933|76113040|FG000|Safety Evaluation Set (SES)|Main Period||62|One participant randomized to NT 201 100 U dose group was actually treated with NT 201 20 U. The participant was re-assigned to the Pooled: NT 201 20 U dose group for safety analyses.|
59997336|NCT03806933|76113041|FG001|Safety Evaluation Set (SES)|Main Period||60|One participant randomized to NT 201 100 U dose group was actually treated with NT 201 20 U. The participant was re-assigned to the Pooled: NT 201 20 U dose group for safety analyses.|
59997337|NCT03806933|76113042|FG002|Safety Evaluation Set (SES)|Main Period||61|One participant randomized to NT 201 100 U dose group was actually treated with NT 201 20 U. The participant was re-assigned to the Pooled: NT 201 20 U dose group for safety analyses.|
59997338|NCT03806933|76113043|FG003|Safety Evaluation Set (SES)|Main Period||58|One participant randomized to NT 201 100 U dose group was actually treated with NT 201 20 U. The participant was re-assigned to the Pooled: NT 201 20 U dose group for safety analyses.|
59997339|NCT03806933|76113040|FG000|COMPLETED|Main Period||57||
59997340|NCT03806933|76113041|FG001|COMPLETED|Main Period||57||
59997341|NCT03806933|76113042|FG002|COMPLETED|Main Period||59||
59997342|NCT03806933|76113043|FG003|COMPLETED|Main Period||56||
59997343|NCT03806933|76113040|FG000|NOT COMPLETED|Main Period||4||
59997344|NCT03806933|76113041|FG001|NOT COMPLETED|Main Period||3||
59997345|NCT03806933|76113042|FG002|NOT COMPLETED|Main Period||2||
59997346|NCT03806933|76113043|FG003|NOT COMPLETED|Main Period||3||
59997347|NCT03806933|76113040|FG000|STARTED|OLEX Period|Only participants who relapsed to baseline status of their glabellar frown lines (GFL) in the MP and completed the MP had the opportunity to receive optional follow-up treatment; those receiving optional treatment were entered in the OLEX period.|52||
59997348|NCT03806933|76113041|FG001|STARTED|OLEX Period|Only participants who relapsed to baseline status of their glabellar frown lines (GFL) in the MP and completed the MP had the opportunity to receive optional follow-up treatment; those receiving optional treatment were entered in the OLEX period.|53||
59997349|NCT03806933|76113042|FG002|STARTED|OLEX Period|Only participants who relapsed to baseline status of their glabellar frown lines (GFL) in the MP and completed the MP had the opportunity to receive optional follow-up treatment; those receiving optional treatment were entered in the OLEX period.|56||
59997350|NCT03806933|76113043|FG003|STARTED|OLEX Period|Only participants who relapsed to baseline status of their glabellar frown lines (GFL) in the MP and completed the MP had the opportunity to receive optional follow-up treatment; those receiving optional treatment were entered in the OLEX period.|50||
59997351|NCT03806933|76113040|FG000|COMPLETED|OLEX Period||52||
59997352|NCT03806933|76113041|FG001|COMPLETED|OLEX Period||53||
59997353|NCT03806933|76113042|FG002|COMPLETED|OLEX Period||56||
59997354|NCT03806933|76113043|FG003|COMPLETED|OLEX Period||49||
59997355|NCT03806933|76113040|FG000|NOT COMPLETED|OLEX Period||0||
59997356|NCT03806933|76113041|FG001|NOT COMPLETED|OLEX Period||0||
59997357|NCT03806933|76113042|FG002|NOT COMPLETED|OLEX Period||0||
59997358|NCT03806933|76113043|FG003|NOT COMPLETED|OLEX Period||1||
59997359|NCT03758274|76113055|FG000|STARTED|Overall Study||197||
59997360|NCT03758274|76113056|FG001|STARTED|Overall Study||203||
59997361|NCT03758274|76113055|FG000|COMPLETED|Overall Study|3-month follow-up|186||
59997362|NCT03758274|76113056|FG001|COMPLETED|Overall Study|3-month follow-up|190||
59997363|NCT03758274|76113055|FG000|NOT COMPLETED|Overall Study||11||
59997364|NCT03758274|76113056|FG001|NOT COMPLETED|Overall Study||13||
59997365|NCT03680521|76113064|FG000|STARTED|Overall Study||7||
59997366|NCT03680521|76113065|FG001|STARTED|Overall Study||13||
59997367|NCT03680521|76113064|FG000|COMPLETED|Overall Study||7||
59997368|NCT03680521|76113065|FG001|COMPLETED|Overall Study||13||
59997369|NCT03680521|76113064|FG000|NOT COMPLETED|Overall Study||0||
59997370|NCT03680521|76113065|FG001|NOT COMPLETED|Overall Study||0||
59997371|NCT03590613|76113074|FG000|STARTED|Period 1, 4 Days||3||
59997372|NCT03590613|76113075|FG001|STARTED|Period 1, 4 Days||3||
59997373|NCT03590613|76113076|FG002|STARTED|Period 1, 4 Days||3||
59997374|NCT03590613|76113077|FG003|STARTED|Period 1, 4 Days||3||
59997375|NCT03590613|76113074|FG000|COMPLETED|Period 1, 4 Days||3||
59997376|NCT03590613|76113075|FG001|COMPLETED|Period 1, 4 Days||3||
59997377|NCT03590613|76113076|FG002|COMPLETED|Period 1, 4 Days||3||
59997378|NCT03590613|76113077|FG003|COMPLETED|Period 1, 4 Days||3||
59997379|NCT03590613|76113074|FG000|NOT COMPLETED|Period 1, 4 Days||0||
59997380|NCT03590613|76113075|FG001|NOT COMPLETED|Period 1, 4 Days||0||
59997381|NCT03590613|76113076|FG002|NOT COMPLETED|Period 1, 4 Days||0||
59997382|NCT03590613|76113077|FG003|NOT COMPLETED|Period 1, 4 Days||0||
59997383|NCT03590613|76113074|FG000|STARTED|Period 1, Wash-out, at Least 3 Days||3||
59997384|NCT03590613|76113075|FG001|STARTED|Period 1, Wash-out, at Least 3 Days||3||
59997385|NCT03590613|76113076|FG002|STARTED|Period 1, Wash-out, at Least 3 Days||3||
59997386|NCT03590613|76113077|FG003|STARTED|Period 1, Wash-out, at Least 3 Days||3||
59997387|NCT03590613|76113074|FG000|COMPLETED|Period 1, Wash-out, at Least 3 Days||3||
59997388|NCT03590613|76113075|FG001|COMPLETED|Period 1, Wash-out, at Least 3 Days||3||
59997389|NCT03590613|76113076|FG002|COMPLETED|Period 1, Wash-out, at Least 3 Days||3||
59997390|NCT03590613|76113077|FG003|COMPLETED|Period 1, Wash-out, at Least 3 Days||3||
59997391|NCT03590613|76113074|FG000|NOT COMPLETED|Period 1, Wash-out, at Least 3 Days||0||
59997392|NCT03590613|76113075|FG001|NOT COMPLETED|Period 1, Wash-out, at Least 3 Days||0||
59997393|NCT03590613|76113076|FG002|NOT COMPLETED|Period 1, Wash-out, at Least 3 Days||0||
59997394|NCT03590613|76113077|FG003|NOT COMPLETED|Period 1, Wash-out, at Least 3 Days||0||
59997395|NCT03590613|76113074|FG000|STARTED|Period 2, 4 Days||3||
59997396|NCT03590613|76113075|FG001|STARTED|Period 2, 4 Days||3||
59997397|NCT03590613|76113076|FG002|STARTED|Period 2, 4 Days||3||
59997398|NCT03590613|76113077|FG003|STARTED|Period 2, 4 Days|One additional participant was enrolled in Period 2.|4||
59997399|NCT03590613|76113074|FG000|COMPLETED|Period 2, 4 Days||3||
59997400|NCT03590613|76113075|FG001|COMPLETED|Period 2, 4 Days||3||
59997401|NCT03590613|76113076|FG002|COMPLETED|Period 2, 4 Days||3||
59997402|NCT03590613|76113077|FG003|COMPLETED|Period 2, 4 Days||3||
59997403|NCT03590613|76113074|FG000|NOT COMPLETED|Period 2, 4 Days||0||
59997404|NCT03590613|76113075|FG001|NOT COMPLETED|Period 2, 4 Days||0||
59997405|NCT03590613|76113076|FG002|NOT COMPLETED|Period 2, 4 Days||0||
59997406|NCT03590613|76113077|FG003|NOT COMPLETED|Period 2, 4 Days||1||
59997407|NCT03590613|76113074|FG000|STARTED|Period 2, Wash-out, at Least 3 Days||3||
59997408|NCT03590613|76113075|FG001|STARTED|Period 2, Wash-out, at Least 3 Days||3||
59997409|NCT03590613|76113076|FG002|STARTED|Period 2, Wash-out, at Least 3 Days||3||
59997410|NCT03590613|76113077|FG003|STARTED|Period 2, Wash-out, at Least 3 Days||3||
59997411|NCT03590613|76113074|FG000|COMPLETED|Period 2, Wash-out, at Least 3 Days||3||
59997412|NCT03590613|76113075|FG001|COMPLETED|Period 2, Wash-out, at Least 3 Days||3||
59997413|NCT03590613|76113076|FG002|COMPLETED|Period 2, Wash-out, at Least 3 Days||3||
59997414|NCT03590613|76113077|FG003|COMPLETED|Period 2, Wash-out, at Least 3 Days||3||
59997415|NCT03590613|76113074|FG000|NOT COMPLETED|Period 2, Wash-out, at Least 3 Days||0||
59997416|NCT03590613|76113075|FG001|NOT COMPLETED|Period 2, Wash-out, at Least 3 Days||0||
59997417|NCT03590613|76113076|FG002|NOT COMPLETED|Period 2, Wash-out, at Least 3 Days||0||
59997418|NCT03590613|76113077|FG003|NOT COMPLETED|Period 2, Wash-out, at Least 3 Days||0||
59997419|NCT03590613|76113074|FG000|STARTED|Period 3, 4 Days||3||
59997420|NCT03590613|76113075|FG001|STARTED|Period 3, 4 Days||3||
59997421|NCT03590613|76113076|FG002|STARTED|Period 3, 4 Days||3||
59997422|NCT03590613|76113077|FG003|STARTED|Period 3, 4 Days||3||
59997423|NCT03590613|76113074|FG000|COMPLETED|Period 3, 4 Days||3||
59997424|NCT03590613|76113075|FG001|COMPLETED|Period 3, 4 Days||3||
59997425|NCT03590613|76113076|FG002|COMPLETED|Period 3, 4 Days||3||
59997426|NCT03590613|76113077|FG003|COMPLETED|Period 3, 4 Days||3||
59997427|NCT03590613|76113074|FG000|NOT COMPLETED|Period 3, 4 Days||0||
59997428|NCT03590613|76113075|FG001|NOT COMPLETED|Period 3, 4 Days||0||
59997429|NCT03590613|76113076|FG002|NOT COMPLETED|Period 3, 4 Days||0||
59997430|NCT03590613|76113077|FG003|NOT COMPLETED|Period 3, 4 Days||0||
59997431|NCT03590613|76113074|FG000|STARTED|Period 3,Wash-out, at Least 3 Days||3||
59997432|NCT03590613|76113075|FG001|STARTED|Period 3,Wash-out, at Least 3 Days||3||
59997433|NCT03590613|76113076|FG002|STARTED|Period 3,Wash-out, at Least 3 Days||3||
59997434|NCT03590613|76113077|FG003|STARTED|Period 3,Wash-out, at Least 3 Days||3||
59997435|NCT03590613|76113074|FG000|COMPLETED|Period 3,Wash-out, at Least 3 Days||3||
59997436|NCT03590613|76113075|FG001|COMPLETED|Period 3,Wash-out, at Least 3 Days||3||
59997437|NCT03590613|76113076|FG002|COMPLETED|Period 3,Wash-out, at Least 3 Days||3||
59997438|NCT03590613|76113077|FG003|COMPLETED|Period 3,Wash-out, at Least 3 Days||3||
59997439|NCT03590613|76113074|FG000|NOT COMPLETED|Period 3,Wash-out, at Least 3 Days||0||
59997440|NCT03590613|76113075|FG001|NOT COMPLETED|Period 3,Wash-out, at Least 3 Days||0||
59997441|NCT03590613|76113076|FG002|NOT COMPLETED|Period 3,Wash-out, at Least 3 Days||0||
59997442|NCT03590613|76113077|FG003|NOT COMPLETED|Period 3,Wash-out, at Least 3 Days||0||
59997443|NCT03590613|76113074|FG000|STARTED|Period 4, 4 Days||3||
59997444|NCT03590613|76113075|FG001|STARTED|Period 4, 4 Days||3||
59997445|NCT03590613|76113076|FG002|STARTED|Period 4, 4 Days||3||
59997446|NCT03590613|76113077|FG003|STARTED|Period 4, 4 Days||3||
59997447|NCT03590613|76113074|FG000|COMPLETED|Period 4, 4 Days||3||
59997448|NCT03590613|76113075|FG001|COMPLETED|Period 4, 4 Days||3||
59997449|NCT03590613|76113076|FG002|COMPLETED|Period 4, 4 Days||3||
59997450|NCT03590613|76113077|FG003|COMPLETED|Period 4, 4 Days||3||
59997451|NCT03590613|76113074|FG000|NOT COMPLETED|Period 4, 4 Days||0||
59997452|NCT03590613|76113075|FG001|NOT COMPLETED|Period 4, 4 Days||0||
59997453|NCT03590613|76113076|FG002|NOT COMPLETED|Period 4, 4 Days||0||
59997454|NCT03590613|76113077|FG003|NOT COMPLETED|Period 4, 4 Days||0||
59997455|NCT02912507|76113092|FG000|STARTED|Overall Study||5||5
59997456|NCT02912507|76113093|FG001|STARTED|Overall Study||5||5
59997457|NCT02912507|76113094|FG002|STARTED|Overall Study||5||5
59997458|NCT02912507|76113092|FG000|COMPLETED|Overall Study||1||1
59997459|NCT02912507|76113093|FG001|COMPLETED|Overall Study||1||1
59997460|NCT02912507|76113094|FG002|COMPLETED|Overall Study||1||1
59997461|NCT02912507|76113092|FG000|NOT COMPLETED|Overall Study||4||4
59997462|NCT02912507|76113093|FG001|NOT COMPLETED|Overall Study||4||4
59997463|NCT02912507|76113094|FG002|NOT COMPLETED|Overall Study||4||4
59997464|NCT02851173|76113104|FG000|STARTED|Overall Study||44||
59997465|NCT02851173|76113105|FG001|STARTED|Overall Study||47||
59997466|NCT02851173|76113104|FG000|COMPLETED|Overall Study||42||
59997467|NCT02851173|76113105|FG001|COMPLETED|Overall Study||43||
59997468|NCT02851173|76113104|FG000|NOT COMPLETED|Overall Study||2||
59997469|NCT02851173|76113105|FG001|NOT COMPLETED|Overall Study||4||
59997470|NCT02689258|76113118|FG000|STARTED|Overall Study||20||
59997471|NCT02689258|76113119|FG001|STARTED|Overall Study||63||
59997472|NCT02689258|76113120|FG002|STARTED|Overall Study||10||
59997473|NCT02689258|76113121|FG003|STARTED|Overall Study||11||
59997474|NCT02689258|76113122|FG004|STARTED|Overall Study||17||
59997475|NCT02689258|76113123|FG005|STARTED|Overall Study||10||
59997476|NCT02689258|76113124|FG006|STARTED|Overall Study||17||
59997477|NCT02689258|76113125|FG007|STARTED|Overall Study||17||
59997478|NCT02689258|76113126|FG008|STARTED|Overall Study||27||
59997479|NCT02689258|76113127|FG009|STARTED|Overall Study||35||
59997480|NCT02689258|76113128|FG010|STARTED|Overall Study||17||
59997481|NCT02689258|76113129|FG011|STARTED|Overall Study||32||
59997482|NCT02689258|76113118|FG000|COMPLETED|Overall Study||20||
59997483|NCT02689258|76113119|FG001|COMPLETED|Overall Study||59||
59997484|NCT02689258|76113120|FG002|COMPLETED|Overall Study||10||
59997485|NCT02689258|76113121|FG003|COMPLETED|Overall Study||11||
59997486|NCT02689258|76113122|FG004|COMPLETED|Overall Study||16||
59997487|NCT02689258|76113123|FG005|COMPLETED|Overall Study||10||
59997488|NCT02689258|76113124|FG006|COMPLETED|Overall Study||17||
59997489|NCT02689258|76113125|FG007|COMPLETED|Overall Study||17||
59997490|NCT02689258|76113126|FG008|COMPLETED|Overall Study||25||
59997491|NCT02689258|76113127|FG009|COMPLETED|Overall Study||35||
59997492|NCT02689258|76113128|FG010|COMPLETED|Overall Study||17||
59997493|NCT02689258|76113129|FG011|COMPLETED|Overall Study||31||
59997494|NCT02689258|76113118|FG000|NOT COMPLETED|Overall Study||0||
59997495|NCT02689258|76113119|FG001|NOT COMPLETED|Overall Study||4||
59997496|NCT02689258|76113120|FG002|NOT COMPLETED|Overall Study||0||
59997497|NCT02689258|76113121|FG003|NOT COMPLETED|Overall Study||0||
59997498|NCT02689258|76113122|FG004|NOT COMPLETED|Overall Study||1||
59997499|NCT02689258|76113123|FG005|NOT COMPLETED|Overall Study||0||
59997500|NCT02689258|76113124|FG006|NOT COMPLETED|Overall Study||0||
59997501|NCT02689258|76113125|FG007|NOT COMPLETED|Overall Study||0||
59997502|NCT02689258|76113126|FG008|NOT COMPLETED|Overall Study||2||
59997503|NCT02689258|76113127|FG009|NOT COMPLETED|Overall Study||0||
59997504|NCT02689258|76113128|FG010|NOT COMPLETED|Overall Study||0||
59997505|NCT02689258|76113129|FG011|NOT COMPLETED|Overall Study||1||
59997506|NCT02685735|76113152|FG000|STARTED|Overall Study||124||
59997507|NCT02685735|76113153|FG001|STARTED|Overall Study||129||
59997508|NCT02685735|76113152|FG000|COMPLETED|Overall Study||101|These subjects completed and provide data for the primary analysis. The total completed for secondary analyses is 89 in the gabapentin group and 93 in the placebo group. The reason for not completing was failure to complete questionnaires on at least one of the three occasions that these were performed.|
59997509|NCT02685735|76113153|FG001|COMPLETED|Overall Study||107|These subjects completed and provide data for the primary analysis. The total completed for secondary analyses is 89 in the gabapentin group and 93 in the placebo group. The reason for not completing was failure to complete questionnaires on at least one of the three occasions that these were performed.|
59997510|NCT02685735|76113152|FG000|NOT COMPLETED|Overall Study||23||
59997511|NCT02685735|76113153|FG001|NOT COMPLETED|Overall Study||22||
59997512|NCT02628145|76113165|FG000|STARTED|Overall Study||13||
59997513|NCT02628145|76113166|FG001|STARTED|Overall Study||12||
59997514|NCT02628145|76113165|FG000|COMPLETED|Overall Study||12||
59997515|NCT02628145|76113166|FG001|COMPLETED|Overall Study||10||
59997516|NCT02628145|76113165|FG000|NOT COMPLETED|Overall Study||1||
59997517|NCT02628145|76113166|FG001|NOT COMPLETED|Overall Study||2||
59997518|NCT02606136|76113178|FG000|STARTED|Overall Study||21||
59997519|NCT02606136|76113178|FG000|Received at Least 1 Dose of Study Drug|Overall Study||21||
59997520|NCT02606136|76113178|FG000|COMPLETED|Overall Study||15||
59997521|NCT02606136|76113178|FG000|NOT COMPLETED|Overall Study||6||
59997522|NCT02477358|76113184|FG000|STARTED|Overall Study||18||36
59997523|NCT02477358|76113185|FG001|STARTED|Overall Study||18||36
59997524|NCT02477358|76113184|FG000|COMPLETED|Overall Study||18|2 teeth (1 Treatment and 1 control) were withdrawn from the study due to early removal and excluded from statistical data.|35
59997525|NCT02477358|76113185|FG001|COMPLETED|Overall Study||18|2 teeth (1 Treatment and 1 control) were withdrawn from the study due to early removal and excluded from statistical data.|35
59997526|NCT02477358|76113184|FG000|NOT COMPLETED|Overall Study||0||1
59997527|NCT02477358|76113185|FG001|NOT COMPLETED|Overall Study||0||1
59997528|NCT02455804|76113193|FG000|STARTED|Overall Study||65||
59997529|NCT02455804|76113193|FG000|COMPLETED|Overall Study||46||
59997530|NCT02455804|76113193|FG000|NOT COMPLETED|Overall Study||19||
59997531|NCT02292706|76113204|FG000|STARTED|Overall Study||95||
59997532|NCT02292706|76113205|FG001|STARTED|Overall Study||277||
59997533|NCT02292706|76113206|FG002|STARTED|Overall Study||265||
59997534|NCT02292706|76113207|FG003|STARTED|Overall Study||374||
59997535|NCT02292706|76113208|FG004|STARTED|Overall Study||100||
59997536|NCT02292706|76113209|FG005|STARTED|Overall Study||338||
59997537|NCT02292706|76113210|FG006|STARTED|Overall Study||141||
59997538|NCT02292706|76113211|FG007|STARTED|Overall Study||19||
59997539|NCT02292706|76113204|FG000|COMPLETED|Overall Study||49||
59997540|NCT02292706|76113205|FG001|COMPLETED|Overall Study||145||
59997541|NCT02292706|76113206|FG002|COMPLETED|Overall Study||157||
59997542|NCT02292706|76113207|FG003|COMPLETED|Overall Study||201||
59997543|NCT02292706|76113208|FG004|COMPLETED|Overall Study||35||
59997544|NCT02292706|76113209|FG005|COMPLETED|Overall Study||181||
59997545|NCT02292706|76113210|FG006|COMPLETED|Overall Study||82||
59997546|NCT02292706|76113211|FG007|COMPLETED|Overall Study||0||
59997547|NCT02292706|76113204|FG000|NOT COMPLETED|Overall Study||46||
59997548|NCT02292706|76113205|FG001|NOT COMPLETED|Overall Study||132||
59997549|NCT02292706|76113206|FG002|NOT COMPLETED|Overall Study||108||
59997550|NCT02292706|76113207|FG003|NOT COMPLETED|Overall Study||173||
59997551|NCT02292706|76113208|FG004|NOT COMPLETED|Overall Study||65||
59997552|NCT02292706|76113209|FG005|NOT COMPLETED|Overall Study||157||
59997553|NCT02292706|76113210|FG006|NOT COMPLETED|Overall Study||59||
59997554|NCT02292706|76113211|FG007|NOT COMPLETED|Overall Study||19||
59997555|NCT01931033|76113229|FG000|STARTED|Overall Study||8||
59997556|NCT01931033|76113229|FG000|COMPLETED|Overall Study||5||
59997557|NCT01931033|76113229|FG000|NOT COMPLETED|Overall Study||3||
59997558|NCT01930539|76113235|FG000|STARTED|Overall Study|participants|5||
59997559|NCT01930539|76113236|FG001|STARTED|Overall Study|participants|6||
59997560|NCT01930539|76113235|FG000|COMPLETED|Overall Study|participants|3||
59997561|NCT01930539|76113236|FG001|COMPLETED|Overall Study|participants|4||
59997562|NCT01930539|76113235|FG000|NOT COMPLETED|Overall Study||2||
59997563|NCT01930539|76113236|FG001|NOT COMPLETED|Overall Study||2||
59997564|NCT01459068|76113244|FG000|STARTED|Overall Study||165||
59997565|NCT01459068|76113245|FG001|STARTED|Overall Study||182||
59997566|NCT01459068|76113244|FG000|COMPLETED|Overall Study||126||
59997567|NCT01459068|76113245|FG001|COMPLETED|Overall Study||148||
59997568|NCT01459068|76113244|FG000|NOT COMPLETED|Overall Study||39||
59997569|NCT01459068|76113245|FG001|NOT COMPLETED|Overall Study||34||
59997570|NCT01216202|76113253|FG000|STARTED|Overall Study||101|Included in the study|
59997571|NCT01216202|76113254|FG001|STARTED|Overall Study||77|Included in the study|
59997572|NCT01216202|76113253|FG000|Analysed at Baseline|Overall Study||93||
59997573|NCT01216202|76113254|FG001|Analysed at Baseline|Overall Study||75||
59997574|NCT01216202|76113253|FG000|Analysed After RT|Overall Study||79||
59997575|NCT01216202|76113254|FG001|Analysed After RT|Overall Study||0||
59997576|NCT01216202|76113253|FG000|COMPLETED|Overall Study||79|Analysed at baseline|
59997577|NCT01216202|76113254|FG001|COMPLETED|Overall Study||75|Analysed at baseline|
59997578|NCT01216202|76113253|FG000|NOT COMPLETED|Overall Study||22||
59997579|NCT01216202|76113254|FG001|NOT COMPLETED|Overall Study||2||
59597869|NCT03463915|75707407|FG001|COMPLETED|Overall Study||36||
59997580|NCT01186016|76113264|FG000|STARTED|Overall Study||57||
59997581|NCT01186016|76113265|FG001|STARTED|Overall Study||46||
59997582|NCT01186016|76113264|FG000|Started Original Protocol|Overall Study||50|This milestone indicates the number of participants included in the original protocol.|
59997583|NCT01186016|76113265|FG001|Started Original Protocol|Overall Study||39|This milestone indicates the number of participants included in the original protocol.|
59997584|NCT01186016|76113264|FG000|Completed Original Protocol|Overall Study||10|This milestone indicates the number of participants who completed the original protocol.|
59997585|NCT01186016|76113265|FG001|Completed Original Protocol|Overall Study||12|This milestone indicates the number of participants who completed the original protocol.|
59997586|NCT01186016|76113264|FG000|COMPLETED|Overall Study|11 participants in the experimental (GES) arm completed the study, of which 10 completed the original protocol.|11|This row indicates the number of participants who completed the study (i.e., both the original protocol and the revised protocol that occurred at the end of the funding period) as stated in the Pre-Assignment Details.|
60000307|NCT02712983|76116057|FG004|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|2|All patients who discontinued treatment and entered Post-Treatment Efficacy Follow-Up Phase|
60129001|NCT01586156|76251263|FG001|STARTED|Overall Study||10||
59997587|NCT01186016|76113265|FG001|COMPLETED|Overall Study|17 participants in the control group (NES) completed the study, of which 12 completed the original protocol.|17|This row indicates the number of participants who completed the study (i.e., both the original protocol and the revised protocol that occurred at the end of the funding period) as stated in the Pre-Assignment Details.|
59997588|NCT01186016|76113264|FG000|NOT COMPLETED|Overall Study||46||
59997589|NCT01186016|76113265|FG001|NOT COMPLETED|Overall Study||29||
59997590|NCT01113749|76113273|FG000|STARTED|Overall Study||127||
59997591|NCT01113749|76113274|FG001|STARTED|Overall Study||129||
59997592|NCT01113749|76113273|FG000|COMPLETED|Overall Study||126||
59997593|NCT01113749|76113274|FG001|COMPLETED|Overall Study||127||
59997594|NCT01113749|76113273|FG000|NOT COMPLETED|Overall Study||1||
59997595|NCT01113749|76113274|FG001|NOT COMPLETED|Overall Study||2||
59997596|NCT01060384|76113280|FG000|STARTED|Overall Study||6||
59997597|NCT01060384|76113281|FG001|STARTED|Overall Study||4||
59997598|NCT01060384|76113282|FG002|STARTED|Overall Study||0||
59997599|NCT01060384|76113283|FG003|STARTED|Overall Study||0||
59997600|NCT01060384|76113284|FG004|STARTED|Overall Study||36||
59997601|NCT01060384|76113280|FG000|COMPLETED|Overall Study||6||
59997602|NCT01060384|76113281|FG001|COMPLETED|Overall Study||3||
59997603|NCT01060384|76113282|FG002|COMPLETED|Overall Study||0||
59997604|NCT01060384|76113283|FG003|COMPLETED|Overall Study||0||
59997605|NCT01060384|76113284|FG004|COMPLETED|Overall Study||34||
59997606|NCT01060384|76113280|FG000|NOT COMPLETED|Overall Study||0||
59997607|NCT01060384|76113281|FG001|NOT COMPLETED|Overall Study||1||
59997608|NCT01060384|76113282|FG002|NOT COMPLETED|Overall Study||0||
59997609|NCT01060384|76113283|FG003|NOT COMPLETED|Overall Study||0||
59997610|NCT01060384|76113284|FG004|NOT COMPLETED|Overall Study||2||
59997611|NCT00618657|76113295|FG000|STARTED|Overall Study||42||
59997612|NCT00618657|76113296|FG001|STARTED|Overall Study||85||
59997613|NCT00618657|76113295|FG000|COMPLETED|Overall Study||42||
59997614|NCT00618657|76113296|FG001|COMPLETED|Overall Study||85||
59997615|NCT00618657|76113295|FG000|NOT COMPLETED|Overall Study||0||
59997616|NCT00618657|76113296|FG001|NOT COMPLETED|Overall Study||0||
59997617|NCT00580047|76113307|FG000|STARTED|Overall Study||24||
59997618|NCT00580047|76113308|FG001|STARTED|Overall Study||23||
59997619|NCT00580047|76113309|FG002|STARTED|Overall Study||12||
59997620|NCT00580047|76113307|FG000|COMPLETED|Overall Study||21||
59997621|NCT00580047|76113308|FG001|COMPLETED|Overall Study||21||
59997622|NCT00580047|76113309|FG002|COMPLETED|Overall Study||10||
59997623|NCT00580047|76113307|FG000|NOT COMPLETED|Overall Study||3||
59997624|NCT00580047|76113308|FG001|NOT COMPLETED|Overall Study||2||
59997625|NCT00580047|76113309|FG002|NOT COMPLETED|Overall Study||2||
59997626|NCT00561340|76113322|FG000|STARTED|Overall Study||13||
59997627|NCT00561340|76113323|FG001|STARTED|Overall Study||16||
59997628|NCT00561340|76113322|FG000|COMPLETED|Overall Study||7||
59997629|NCT00561340|76113323|FG001|COMPLETED|Overall Study||16||
59997630|NCT00561340|76113322|FG000|NOT COMPLETED|Overall Study||6||
59997631|NCT00561340|76113323|FG001|NOT COMPLETED|Overall Study||0||
59997632|NCT00292045|76113329|FG000|STARTED|Core Study (Through Week 13)||15||
59997633|NCT00292045|76113329|FG000|COMPLETED|Core Study (Through Week 13)||13|Completion of Cycle 1 (4 vaccinations given once every 3 weeks, for a total cycle length of 12 weeks) plus 3 weeks of follow-up|
59997634|NCT00292045|76113329|FG000|NOT COMPLETED|Core Study (Through Week 13)||2||
59997635|NCT00292045|76113329|FG000|STARTED|Extended Treatment Beyond Week 13||10||
59997636|NCT00292045|76113329|FG000|COMPLETED|Extended Treatment Beyond Week 13||10|Completion of extended treatment was not defined; patients received between 1 and 4 vaccinations during extended treatment (in addition to the 4 vaccinations in the Core Study)|
59997637|NCT00292045|76113329|FG000|NOT COMPLETED|Extended Treatment Beyond Week 13||0||
59997638|NCT00084799|76113335|FG000|STARTED|Overall Study||5||
59997639|NCT00084799|76113336|FG001|STARTED|Overall Study||5||
59997640|NCT00084799|76113335|FG000|COMPLETED|Overall Study||4||
59997641|NCT00084799|76113336|FG001|COMPLETED|Overall Study||5||
59997642|NCT00084799|76113335|FG000|NOT COMPLETED|Overall Study||1||
59997643|NCT00084799|76113336|FG001|NOT COMPLETED|Overall Study||0||
59997644|NCT00072410|76113344|FG000|STARTED|Overall Study||3||
59997645|NCT00072410|76113345|FG001|STARTED|Overall Study||4||
59997646|NCT00072410|76113344|FG000|COMPLETED|Overall Study||3||
59997647|NCT00072410|76113345|FG001|COMPLETED|Overall Study||1||
59997648|NCT00072410|76113344|FG000|NOT COMPLETED|Overall Study||0||
59997649|NCT00072410|76113345|FG001|NOT COMPLETED|Overall Study||3||
59997650|NCT00066729|76113351|FG000|STARTED|Overall Study||9||
59997651|NCT00066729|76113351|FG000|COMPLETED|Overall Study||7||
59997652|NCT00066729|76113351|FG000|NOT COMPLETED|Overall Study||2||
59997653|NCT00006099|76113357|FG000|STARTED|Overall Study||1||
59997654|NCT00006099|76113358|FG001|STARTED|Overall Study||0||
59997655|NCT00006099|76113357|FG000|COMPLETED|Overall Study||1||
59997656|NCT00006099|76113358|FG001|COMPLETED|Overall Study||0||
59997657|NCT00006099|76113357|FG000|NOT COMPLETED|Overall Study||0||
59997658|NCT00006099|76113358|FG001|NOT COMPLETED|Overall Study||0||
59997659|NCT00006046|76113369|FG000|STARTED|Overall Study||7||
59997660|NCT00006046|76113370|FG001|STARTED|Overall Study||0||
59997661|NCT00006046|76113371|FG002|STARTED|Overall Study||0||
59997662|NCT00006046|76113372|FG003|STARTED|Overall Study||0||
59997663|NCT00006046|76113373|FG004|STARTED|Overall Study||0||
59997664|NCT00006046|76113369|FG000|COMPLETED|Overall Study||2||
59997665|NCT00006046|76113370|FG001|COMPLETED|Overall Study||0||
59997666|NCT00006046|76113371|FG002|COMPLETED|Overall Study||0||
59997667|NCT00006046|76113372|FG003|COMPLETED|Overall Study||0||
59997668|NCT00006046|76113373|FG004|COMPLETED|Overall Study||0||
59997669|NCT00006046|76113369|FG000|NOT COMPLETED|Overall Study||5||
59997670|NCT00006046|76113370|FG001|NOT COMPLETED|Overall Study||0||
59997671|NCT00006046|76113371|FG002|NOT COMPLETED|Overall Study||0||
59997672|NCT00006046|76113372|FG003|NOT COMPLETED|Overall Study||0||
59997673|NCT00006046|76113373|FG004|NOT COMPLETED|Overall Study||0||
59997674|NCT00003102|76113388|FG000|STARTED|Overall Study||3||
59997675|NCT00003102|76113389|FG001|STARTED|Overall Study||9||
59997676|NCT00003102|76113390|FG002|STARTED|Overall Study||3||
59997677|NCT00003102|76113388|FG000|COMPLETED|Overall Study||2||
59997678|NCT00003102|76113389|FG001|COMPLETED|Overall Study||6||
59997679|NCT00003102|76113390|FG002|COMPLETED|Overall Study||1||
59997680|NCT00003102|76113388|FG000|NOT COMPLETED|Overall Study||1||
59997681|NCT00003102|76113389|FG001|NOT COMPLETED|Overall Study||3||
59997682|NCT00003102|76113390|FG002|NOT COMPLETED|Overall Study||2||
59997683|NCT01673373|76113398|FG000|STARTED|Overall Study||68||
59997684|NCT01673373|76113398|FG000|COMPLETED|Overall Study|Completed primary endpoint follow up.|66||
59997685|NCT01673373|76113398|FG000|NOT COMPLETED|Overall Study||2||
59997686|NCT01236547|76113407|FG000|STARTED|Overall Study||11||
59997687|NCT01236547|76113408|FG001|STARTED|Overall Study||11||
59997688|NCT01236547|76113409|FG002|STARTED|Overall Study||12||
59997689|NCT01236547|76113410|FG003|STARTED|Overall Study||42||
59997690|NCT01236547|76113411|FG004|STARTED|Overall Study||47||
59997691|NCT01236547|76113407|FG000|Eligible|Overall Study||11||
59997692|NCT01236547|76113408|FG001|Eligible|Overall Study||10||
59997693|NCT01236547|76113409|FG002|Eligible|Overall Study||11||
59997694|NCT01236547|76113410|FG003|Eligible|Overall Study||36||
59997695|NCT01236547|76113411|FG004|Eligible|Overall Study||35||
59997696|NCT01236547|76113407|FG000|Eligible and Started Study Treatment|Overall Study||11||
59997697|NCT01236547|76113408|FG001|Eligible and Started Study Treatment|Overall Study||10||
59997698|NCT01236547|76113409|FG002|Eligible and Started Study Treatment|Overall Study||11||
59997699|NCT01236547|76113410|FG003|Eligible and Started Study Treatment|Overall Study||36||
59997700|NCT01236547|76113411|FG004|Eligible and Started Study Treatment|Overall Study||34||
59997701|NCT01236547|76113407|FG000|Eligible and Response Assessed|Overall Study||0||
59997702|NCT01236547|76113408|FG001|Eligible and Response Assessed|Overall Study||0||
59997703|NCT01236547|76113409|FG002|Eligible and Response Assessed|Overall Study||0||
59997704|NCT01236547|76113410|FG003|Eligible and Response Assessed|Overall Study||23||
59997705|NCT01236547|76113411|FG004|Eligible and Response Assessed|Overall Study||27||
59997706|NCT01236547|76113407|FG000|COMPLETED|Overall Study||11|Participants contributing data to results are considered to have completed the study|
59997707|NCT01236547|76113408|FG001|COMPLETED|Overall Study||10|Participants contributing data to results are considered to have completed the study|
59997708|NCT01236547|76113409|FG002|COMPLETED|Overall Study||11|Participants contributing data to results are considered to have completed the study|
59997709|NCT01236547|76113410|FG003|COMPLETED|Overall Study||36|Participants contributing data to results are considered to have completed the study|
59997710|NCT01236547|76113411|FG004|COMPLETED|Overall Study||35|Participants contributing data to results are considered to have completed the study|
59997711|NCT01236547|76113407|FG000|NOT COMPLETED|Overall Study||0||
59997712|NCT01236547|76113408|FG001|NOT COMPLETED|Overall Study||1||
59997713|NCT01236547|76113409|FG002|NOT COMPLETED|Overall Study||1||
59997714|NCT01236547|76113410|FG003|NOT COMPLETED|Overall Study||6||
59997715|NCT01236547|76113411|FG004|NOT COMPLETED|Overall Study||12||
59997716|NCT02167945|76113424|FG000|STARTED|Overall Study||615||
59997717|NCT02167945|76113424|FG000|COMPLETED|Overall Study||366||
59997718|NCT02167945|76113424|FG000|NOT COMPLETED|Overall Study||249||
59997719|NCT01375075|76113442|FG000|STARTED|Overall Study||27||
59997720|NCT01375075|76113443|FG001|STARTED|Overall Study||28||
59997721|NCT01375075|76113444|FG002|STARTED|Overall Study||27||
59997722|NCT01375075|76113445|FG003|STARTED|Overall Study||28||
59997723|NCT01375075|76113446|FG004|STARTED|Overall Study||27||
60129002|NCT01586156|76251264|FG002|STARTED|Overall Study||10||
59728540|NCT00812929|75847154|FG005|NOT COMPLETED|Treatment Period 5||0||
59997724|NCT01375075|76113447|FG005|STARTED|Overall Study||28||
59997725|NCT01375075|76113442|FG000|Received at Least One Dose of Study Drug|Overall Study||27||
59997726|NCT01375075|76113443|FG001|Received at Least One Dose of Study Drug|Overall Study||28||
59997727|NCT01375075|76113444|FG002|Received at Least One Dose of Study Drug|Overall Study||27||
59997728|NCT01375075|76113445|FG003|Received at Least One Dose of Study Drug|Overall Study||28||
59997729|NCT01375075|76113446|FG004|Received at Least One Dose of Study Drug|Overall Study||27||
59997730|NCT01375075|76113447|FG005|Received at Least One Dose of Study Drug|Overall Study||28||
59997731|NCT01375075|76113442|FG000|COMPLETED|Overall Study||26||
59997732|NCT01375075|76113443|FG001|COMPLETED|Overall Study||27||
59997733|NCT01375075|76113444|FG002|COMPLETED|Overall Study||24||
59997734|NCT01375075|76113445|FG003|COMPLETED|Overall Study||27||
59997735|NCT01375075|76113446|FG004|COMPLETED|Overall Study||27||
59997736|NCT01375075|76113447|FG005|COMPLETED|Overall Study||25||
59997737|NCT01375075|76113442|FG000|NOT COMPLETED|Overall Study||1||
59997738|NCT01375075|76113443|FG001|NOT COMPLETED|Overall Study||1||
59597870|NCT03463915|75707406|FG000|NOT COMPLETED|Overall Study||10||
59597871|NCT03463915|75707407|FG001|NOT COMPLETED|Overall Study||9||
59597872|NCT04147442|75707415|FG000|STARTED|Overall Study||20||
59597873|NCT04147442|75707415|FG000|COMPLETED|Overall Study||20||
59997739|NCT01375075|76113444|FG002|NOT COMPLETED|Overall Study||3||
59997740|NCT01375075|76113445|FG003|NOT COMPLETED|Overall Study||1||
59997741|NCT01375075|76113446|FG004|NOT COMPLETED|Overall Study||0||
59997742|NCT01375075|76113447|FG005|NOT COMPLETED|Overall Study||3||
59997743|NCT00706433|76113469|FG000|STARTED|Overall Study||68||
59997744|NCT00706433|76113470|FG001|STARTED|Overall Study||65||
59997745|NCT00706433|76113471|FG002|STARTED|Overall Study||67||
59997746|NCT00706433|76113472|FG003|STARTED|Overall Study||66||
59997747|NCT00706433|76113469|FG000|COMPLETED|Overall Study||63||
59997748|NCT00706433|76113470|FG001|COMPLETED|Overall Study||62||
59997749|NCT00706433|76113471|FG002|COMPLETED|Overall Study||57||
59997750|NCT00706433|76113472|FG003|COMPLETED|Overall Study||64||
59997751|NCT00706433|76113469|FG000|NOT COMPLETED|Overall Study||5||
59997752|NCT00706433|76113470|FG001|NOT COMPLETED|Overall Study||3||
59997753|NCT00706433|76113471|FG002|NOT COMPLETED|Overall Study||10||
59997754|NCT00706433|76113472|FG003|NOT COMPLETED|Overall Study||2||
59997755|NCT02638623|76113484|FG000|STARTED|Overall Study||27||
59997756|NCT02638623|76113485|FG001|STARTED|Overall Study||25||
59997757|NCT02638623|76113484|FG000|COMPLETED|Overall Study||20||
59997758|NCT02638623|76113485|FG001|COMPLETED|Overall Study||19||
59997759|NCT02638623|76113484|FG000|NOT COMPLETED|Overall Study||7||
59997760|NCT02638623|76113485|FG001|NOT COMPLETED|Overall Study||6||
59997761|NCT02637141|76113494|FG000|STARTED|Overall Study||22||
59997762|NCT02637141|76113495|FG001|STARTED|Overall Study||22||
59997763|NCT02637141|76113496|FG002|STARTED|Overall Study||20||
59997764|NCT02637141|76113494|FG000|Received Study Drug|Overall Study||22||
59997765|NCT02637141|76113495|FG001|Received Study Drug|Overall Study||21||
59997766|NCT02637141|76113496|FG002|Received Study Drug|Overall Study||19||
59997767|NCT02637141|76113494|FG000|COMPLETED|Overall Study||20||
59997768|NCT02637141|76113495|FG001|COMPLETED|Overall Study||20||
59997769|NCT02637141|76113496|FG002|COMPLETED|Overall Study||19||
59997770|NCT02637141|76113494|FG000|NOT COMPLETED|Overall Study||2||
59997771|NCT02637141|76113495|FG001|NOT COMPLETED|Overall Study||2||
59997772|NCT02637141|76113496|FG002|NOT COMPLETED|Overall Study||1||
59997773|NCT02637063|76113507|FG000|STARTED|Overall Study||67||
59997774|NCT02637063|76113508|FG001|STARTED|Overall Study||68||
59997775|NCT02637063|76113509|FG002|STARTED|Overall Study||68||
59997776|NCT02637063|76113507|FG000|COMPLETED|Overall Study||62||
59997777|NCT02637063|76113508|FG001|COMPLETED|Overall Study||64||
59997778|NCT02637063|76113509|FG002|COMPLETED|Overall Study||62||
59997779|NCT02637063|76113507|FG000|NOT COMPLETED|Overall Study||5||
59997780|NCT02637063|76113508|FG001|NOT COMPLETED|Overall Study||4||
59997781|NCT02637063|76113509|FG002|NOT COMPLETED|Overall Study||6||
59997782|NCT02635737|76113517|FG000|STARTED|Overall Study||29||
59997783|NCT02635737|76113517|FG000|COMPLETED|Overall Study||28||
59997784|NCT02635737|76113517|FG000|NOT COMPLETED|Overall Study||1||
59997785|NCT02636907|76113521|FG000|STARTED|Autoinjector Assessment Period|Assigned to treatment.|77||
59997786|NCT02636907|76113521|FG000|COMPLETED|Autoinjector Assessment Period|Completed autoinjector assessment period (Day 50).|73||
59997787|NCT02636907|76113521|FG000|NOT COMPLETED|Autoinjector Assessment Period||4||
59997788|NCT02636907|76113521|FG000|STARTED|Extension Phase||72||
59997789|NCT02636907|76113521|FG000|COMPLETED|Extension Phase||62||
59997790|NCT02636907|76113521|FG000|NOT COMPLETED|Extension Phase||10||
59997791|NCT01374919|76113525|FG000|STARTED|Overall Study||60||
59997792|NCT01374919|76113525|FG000|COMPLETED|Overall Study||58||
59997793|NCT01374919|76113525|FG000|NOT COMPLETED|Overall Study||2||
59997794|NCT04456959|76113529|FG000|STARTED|Overall Study||28||
59997795|NCT04456959|76113529|FG000|COMPLETED|Overall Study||28||
59997796|NCT04456959|76113529|FG000|NOT COMPLETED|Overall Study||0||
59997797|NCT02726945|76113536|FG000|STARTED|Overall Study||13||
59997798|NCT02726945|76113537|FG001|STARTED|Overall Study||13||
59997799|NCT02726945|76113538|FG002|STARTED|Overall Study||13||
59997800|NCT02726945|76113536|FG000|COMPLETED|Overall Study||13||
59597874|NCT04147442|75707415|FG000|NOT COMPLETED|Overall Study||0||
59997801|NCT02726945|76113537|FG001|COMPLETED|Overall Study||12||
59997802|NCT02726945|76113538|FG002|COMPLETED|Overall Study||12||
59997803|NCT02726945|76113536|FG000|NOT COMPLETED|Overall Study||0||
59997804|NCT02726945|76113537|FG001|NOT COMPLETED|Overall Study||1||
59997805|NCT02726945|76113538|FG002|NOT COMPLETED|Overall Study||1||
59997806|NCT02635347|76113548|FG000|STARTED|Overall Study||51||
59997807|NCT02635347|76113549|FG001|STARTED|Overall Study||70||
59997808|NCT02635347|76113548|FG000|Screening|Overall Study||51||
59997809|NCT02635347|76113549|FG001|Screening|Overall Study||70||
59997810|NCT02635347|76113548|FG000|Enrollment|Overall Study||31||
59997811|NCT02635347|76113549|FG001|Enrollment|Overall Study||63||
59997812|NCT02635347|76113548|FG000|Protocol Completion|Overall Study||22||
59997813|NCT02635347|76113549|FG001|Protocol Completion|Overall Study||63||
59997814|NCT02635347|76113548|FG000|Follow up|Overall Study||31||
59997815|NCT02635347|76113549|FG001|Follow up|Overall Study||63||
59997816|NCT02635347|76113548|FG000|Analyses|Overall Study||30|One in RIC cohort excluded in analyses of graft related outcomes since no transplant was performed|
59997817|NCT02635347|76113549|FG001|Analyses|Overall Study||63|One in RIC cohort excluded in analyses of graft related outcomes since no transplant was performed|
59997818|NCT02635347|76113548|FG000|COMPLETED|Overall Study||31||
59997819|NCT02635347|76113549|FG001|COMPLETED|Overall Study||63||
59997820|NCT02635347|76113548|FG000|NOT COMPLETED|Overall Study||20||
59997821|NCT02635347|76113549|FG001|NOT COMPLETED|Overall Study||7||
59997822|NCT03211039|76113559|FG000|STARTED|Overall Study||94||
59997823|NCT03211039|76113560|FG001|STARTED|Overall Study||95||
59997824|NCT03211039|76113561|FG002|STARTED|Overall Study||24||
59997825|NCT03211039|76113559|FG000|COMPLETED|Overall Study||94|Diagnostic report issued|
59997826|NCT03211039|76113560|FG001|COMPLETED|Overall Study||95|Diagnostic report issued|
59997827|NCT03211039|76113561|FG002|COMPLETED|Overall Study||24|Diagnostic report issued|
59997828|NCT03211039|76113559|FG000|NOT COMPLETED|Overall Study||0||
59997829|NCT03211039|76113560|FG001|NOT COMPLETED|Overall Study||0||
59997830|NCT03211039|76113561|FG002|NOT COMPLETED|Overall Study||0||
59997831|NCT02726399|76113569|FG000|STARTED|Overall Study||7||
59997832|NCT02726399|76113569|FG000|COMPLETED|Overall Study||0||
59997833|NCT02726399|76113569|FG000|NOT COMPLETED|Overall Study||7||
59997834|NCT02634801|76113576|FG000|STARTED|Treatment Period (Weeks 0 to 24)||54||
59997835|NCT02634801|76113577|FG001|STARTED|Treatment Period (Weeks 0 to 24)||54||
59997836|NCT02634801|76113578|FG002|STARTED|Treatment Period (Weeks 0 to 24)||54||
59997837|NCT02634801|76113576|FG000|Received at Least 1 Dose of Study Drug|Treatment Period (Weeks 0 to 24)||54||
59997838|NCT02634801|76113577|FG001|Received at Least 1 Dose of Study Drug|Treatment Period (Weeks 0 to 24)||52||
59997839|NCT02634801|76113578|FG002|Received at Least 1 Dose of Study Drug|Treatment Period (Weeks 0 to 24)||52||
59997840|NCT02634801|76113576|FG000|COMPLETED|Treatment Period (Weeks 0 to 24)||50||
59997841|NCT02634801|76113577|FG001|COMPLETED|Treatment Period (Weeks 0 to 24)||23||
59997842|NCT02634801|76113578|FG002|COMPLETED|Treatment Period (Weeks 0 to 24)||49||
59997843|NCT02634801|76113576|FG000|NOT COMPLETED|Treatment Period (Weeks 0 to 24)||4||
59997844|NCT02634801|76113577|FG001|NOT COMPLETED|Treatment Period (Weeks 0 to 24)||31||
59997845|NCT02634801|76113578|FG002|NOT COMPLETED|Treatment Period (Weeks 0 to 24)||5||
59997846|NCT02634801|76113576|FG000|STARTED|Extension Period (Weeks 24 to 36)|Participants had the option to enter the Extension Period or proceed directly to the Followup Period|48||
59997847|NCT02634801|76113577|FG001|STARTED|Extension Period (Weeks 24 to 36)|Participants had the option to enter the Extension Period or proceed directly to the Followup Period|19||
59997848|NCT02634801|76113578|FG002|STARTED|Extension Period (Weeks 24 to 36)|Participants had the option to enter the Extension Period or proceed directly to the Followup Period|31||
59997849|NCT02634801|76113576|FG000|COMPLETED|Extension Period (Weeks 24 to 36)||45||
59997850|NCT02634801|76113577|FG001|COMPLETED|Extension Period (Weeks 24 to 36)||18||
59997851|NCT02634801|76113578|FG002|COMPLETED|Extension Period (Weeks 24 to 36)||29||
59997852|NCT02634801|76113576|FG000|NOT COMPLETED|Extension Period (Weeks 24 to 36)||3||
59997853|NCT02634801|76113577|FG001|NOT COMPLETED|Extension Period (Weeks 24 to 36)||1||
59997854|NCT02634801|76113578|FG002|NOT COMPLETED|Extension Period (Weeks 24 to 36)||2||
59997855|NCT02634801|76113576|FG000|STARTED|Follow-up Period|Participants who discontinued previous periods had option to enter post treatment follow-up period.|41||
59997856|NCT02634801|76113577|FG001|STARTED|Follow-up Period|Participants who discontinued previous periods had option to enter post treatment follow-up period.|26||
59997857|NCT02634801|76113578|FG002|STARTED|Follow-up Period|Participants who discontinued previous periods had option to enter post treatment follow-up period.|46||
59997858|NCT02634801|76113576|FG000|COMPLETED|Follow-up Period||36||
59997859|NCT02634801|76113577|FG001|COMPLETED|Follow-up Period||18||
59997860|NCT02634801|76113578|FG002|COMPLETED|Follow-up Period||38||
59997861|NCT02634801|76113576|FG000|NOT COMPLETED|Follow-up Period||5||
59997862|NCT02634801|76113577|FG001|NOT COMPLETED|Follow-up Period||8||
59997863|NCT02634801|76113578|FG002|NOT COMPLETED|Follow-up Period||8||
59997864|NCT02724839|76113593|FG000|STARTED|Overall Study||13||
59997865|NCT02724839|76113594|FG001|STARTED|Overall Study||12||
59997866|NCT02724839|76113595|FG002|STARTED|Overall Study||11||
59997867|NCT02724839|76113593|FG000|COMPLETED|Overall Study||12||
59997868|NCT02724839|76113594|FG001|COMPLETED|Overall Study||8||
59997869|NCT02724839|76113595|FG002|COMPLETED|Overall Study||6||
59997870|NCT02724839|76113593|FG000|NOT COMPLETED|Overall Study||1||
59997871|NCT02724839|76113594|FG001|NOT COMPLETED|Overall Study||4||
59997872|NCT02724839|76113595|FG002|NOT COMPLETED|Overall Study||5||
59997873|NCT01375751|76113613|FG000|STARTED|Overall Study||56||
59997874|NCT01375751|76113614|FG001|STARTED|Overall Study||56||
59997875|NCT01375751|76113615|FG002|STARTED|Overall Study||56||
59997876|NCT01375751|76113613|FG000|Received Treatment|Overall Study||56||
59997877|NCT01375751|76113614|FG001|Received Treatment|Overall Study||55||
59997878|NCT01375751|76113615|FG002|Received Treatment|Overall Study||56||
59997879|NCT01375751|76113613|FG000|COMPLETED|Overall Study||56||
59997880|NCT01375751|76113614|FG001|COMPLETED|Overall Study||55||
59997881|NCT01375751|76113615|FG002|COMPLETED|Overall Study||56||
59997882|NCT01375751|76113613|FG000|NOT COMPLETED|Overall Study||0||
59997883|NCT01375751|76113614|FG001|NOT COMPLETED|Overall Study||1||
59997884|NCT01375751|76113615|FG002|NOT COMPLETED|Overall Study||0||
59997885|NCT00705575|76113625|FG000|STARTED|Overall Study||349||
59997886|NCT00705575|76113626|FG001|STARTED|Overall Study||339||
59997887|NCT00705575|76113625|FG000|COMPLETED|Overall Study||326||
59997888|NCT00705575|76113626|FG001|COMPLETED|Overall Study||293||
59997889|NCT00705575|76113625|FG000|NOT COMPLETED|Overall Study||23||
59997890|NCT00705575|76113626|FG001|NOT COMPLETED|Overall Study||46||
59997891|NCT02636595|76113632|FG000|STARTED|Overall Study||121||
59997892|NCT02636595|76113632|FG000|COMPLETED|Overall Study||119||
59997893|NCT02636595|76113632|FG000|NOT COMPLETED|Overall Study||2||
59997894|NCT02636361|76113636|FG000|STARTED|Period 1||5||
59997895|NCT02636361|76113637|FG001|STARTED|Period 1||6||
59997896|NCT02636361|76113638|FG002|STARTED|Period 1||5||
59997897|NCT02636361|76113639|FG003|STARTED|Period 1||5||
59997898|NCT02636361|76113640|FG004|STARTED|Period 1||5||
59997899|NCT02636361|76113636|FG000|Received at Least One Dose of Study Drug|Period 1||5||
59997900|NCT02636361|76113637|FG001|Received at Least One Dose of Study Drug|Period 1||5||
59997901|NCT02636361|76113638|FG002|Received at Least One Dose of Study Drug|Period 1||5||
59997902|NCT02636361|76113639|FG003|Received at Least One Dose of Study Drug|Period 1||5||
59997903|NCT02636361|76113640|FG004|Received at Least One Dose of Study Drug|Period 1||4||
59997904|NCT02636361|76113636|FG000|COMPLETED|Period 1||5||
59997905|NCT02636361|76113637|FG001|COMPLETED|Period 1||5||
59997906|NCT02636361|76113638|FG002|COMPLETED|Period 1||5||
59997907|NCT02636361|76113639|FG003|COMPLETED|Period 1||5||
59997908|NCT02636361|76113640|FG004|COMPLETED|Period 1||4||
59997909|NCT02636361|76113636|FG000|NOT COMPLETED|Period 1||0||
59997910|NCT02636361|76113637|FG001|NOT COMPLETED|Period 1||1||
59997911|NCT02636361|76113638|FG002|NOT COMPLETED|Period 1||0||
59997912|NCT02636361|76113639|FG003|NOT COMPLETED|Period 1||0||
59997913|NCT02636361|76113640|FG004|NOT COMPLETED|Period 1||1||
59997914|NCT02636361|76113636|FG000|STARTED|Period 2||5||
59997915|NCT02636361|76113637|FG001|STARTED|Period 2||5||
59997916|NCT02636361|76113638|FG002|STARTED|Period 2||5||
59997917|NCT02636361|76113639|FG003|STARTED|Period 2||5||
59997918|NCT02636361|76113640|FG004|STARTED|Period 2||4||
59997919|NCT02636361|76113636|FG000|COMPLETED|Period 2||5||
59997920|NCT02636361|76113637|FG001|COMPLETED|Period 2||5||
59997921|NCT02636361|76113638|FG002|COMPLETED|Period 2||5||
59997922|NCT02636361|76113639|FG003|COMPLETED|Period 2||5||
59997923|NCT02636361|76113640|FG004|COMPLETED|Period 2||4||
59997924|NCT02636361|76113636|FG000|NOT COMPLETED|Period 2||0||
59997925|NCT02636361|76113637|FG001|NOT COMPLETED|Period 2||0||
59997926|NCT02636361|76113638|FG002|NOT COMPLETED|Period 2||0||
59997927|NCT02636361|76113639|FG003|NOT COMPLETED|Period 2||0||
59997928|NCT02636361|76113640|FG004|NOT COMPLETED|Period 2||0||
59997929|NCT02636361|76113636|FG000|STARTED|Period 3||5||
59997930|NCT02636361|76113637|FG001|STARTED|Period 3||5||
59997931|NCT02636361|76113638|FG002|STARTED|Period 3||5||
59997932|NCT02636361|76113639|FG003|STARTED|Period 3||5||
59997933|NCT02636361|76113640|FG004|STARTED|Period 3||4||
59997934|NCT02636361|76113636|FG000|COMPLETED|Period 3||5||
59997935|NCT02636361|76113637|FG001|COMPLETED|Period 3||5||
59997936|NCT02636361|76113638|FG002|COMPLETED|Period 3||5||
59997937|NCT02636361|76113639|FG003|COMPLETED|Period 3||5||
59997938|NCT02636361|76113640|FG004|COMPLETED|Period 3||4||
59997939|NCT02636361|76113636|FG000|NOT COMPLETED|Period 3||0||
59997940|NCT02636361|76113637|FG001|NOT COMPLETED|Period 3||0||
59997941|NCT02636361|76113638|FG002|NOT COMPLETED|Period 3||0||
59997942|NCT02636361|76113639|FG003|NOT COMPLETED|Period 3||0||
59997943|NCT02636361|76113640|FG004|NOT COMPLETED|Period 3||0||
59997944|NCT02636361|76113636|FG000|STARTED|Period 4||5||
59997945|NCT02636361|76113637|FG001|STARTED|Period 4||5||
59997946|NCT02636361|76113638|FG002|STARTED|Period 4||5||
59997947|NCT02636361|76113639|FG003|STARTED|Period 4||5||
59997948|NCT02636361|76113640|FG004|STARTED|Period 4||4||
59997949|NCT02636361|76113636|FG000|COMPLETED|Period 4||5||
59997950|NCT02636361|76113637|FG001|COMPLETED|Period 4||5||
59997951|NCT02636361|76113638|FG002|COMPLETED|Period 4||5||
59997952|NCT02636361|76113639|FG003|COMPLETED|Period 4||4||
59997953|NCT02636361|76113640|FG004|COMPLETED|Period 4||4||
59997954|NCT02636361|76113636|FG000|NOT COMPLETED|Period 4||0||
59997955|NCT02636361|76113637|FG001|NOT COMPLETED|Period 4||0||
59997956|NCT02636361|76113638|FG002|NOT COMPLETED|Period 4||0||
59997957|NCT02636361|76113639|FG003|NOT COMPLETED|Period 4||1||
59997958|NCT02636361|76113640|FG004|NOT COMPLETED|Period 4||0||
59997959|NCT02636361|76113636|FG000|STARTED|Period 5||5||
59997960|NCT02636361|76113637|FG001|STARTED|Period 5||5||
59997961|NCT02636361|76113638|FG002|STARTED|Period 5||5||
59997962|NCT02636361|76113639|FG003|STARTED|Period 5||4||
59997963|NCT02636361|76113640|FG004|STARTED|Period 5||4||
59997964|NCT02636361|76113636|FG000|COMPLETED|Period 5||5||
59997965|NCT02636361|76113637|FG001|COMPLETED|Period 5||5||
59997966|NCT02636361|76113638|FG002|COMPLETED|Period 5||5||
59997967|NCT02636361|76113639|FG003|COMPLETED|Period 5||4||
59997968|NCT02636361|76113640|FG004|COMPLETED|Period 5||4||
59997969|NCT02636361|76113636|FG000|NOT COMPLETED|Period 5||0||
59997970|NCT02636361|76113637|FG001|NOT COMPLETED|Period 5||0||
59997971|NCT02636361|76113638|FG002|NOT COMPLETED|Period 5||0||
59997972|NCT02636361|76113639|FG003|NOT COMPLETED|Period 5||0||
59997973|NCT02636361|76113640|FG004|NOT COMPLETED|Period 5||0||
59997974|NCT02636283|76113656|FG000|STARTED|Overall Study||3||
59997975|NCT02636283|76113657|FG001|STARTED|Overall Study||3||
59997976|NCT02636283|76113656|FG000|COMPLETED|Overall Study||1||
59997977|NCT02636283|76113657|FG001|COMPLETED|Overall Study||0||
59997978|NCT02636283|76113656|FG000|NOT COMPLETED|Overall Study||2||
59997979|NCT02636283|76113657|FG001|NOT COMPLETED|Overall Study||3||
59997980|NCT04430855|76113665|FG000|STARTED|Period 1 (Weeks 1-12)||21||
59997981|NCT04430855|76113666|FG001|STARTED|Period 1 (Weeks 1-12)||47||
59997982|NCT04430855|76113665|FG000|Received Study Drug|Period 1 (Weeks 1-12)||21||
59997983|NCT04430855|76113666|FG001|Received Study Drug|Period 1 (Weeks 1-12)||47||
59997984|NCT04430855|76113665|FG000|COMPLETED|Period 1 (Weeks 1-12)||19||
59997985|NCT04430855|76113666|FG001|COMPLETED|Period 1 (Weeks 1-12)||41||
59997986|NCT04430855|76113665|FG000|NOT COMPLETED|Period 1 (Weeks 1-12)||2||
59997987|NCT04430855|76113666|FG001|NOT COMPLETED|Period 1 (Weeks 1-12)||6||
59997988|NCT04430855|76113665|FG000|STARTED|Period 2 (Weeks 12-48)||19||
59997989|NCT04430855|76113666|FG001|STARTED|Period 2 (Weeks 12-48)||41||
59997990|NCT04430855|76113665|FG000|COMPLETED|Period 2 (Weeks 12-48)||14||
59997991|NCT04430855|76113666|FG001|COMPLETED|Period 2 (Weeks 12-48)||31||
59997992|NCT04430855|76113665|FG000|NOT COMPLETED|Period 2 (Weeks 12-48)||5||
59997993|NCT04430855|76113666|FG001|NOT COMPLETED|Period 2 (Weeks 12-48)||10||
59997994|NCT01375673|76113676|FG000|STARTED|Overall Study||7||
59597875|NCT03237871|75707427|FG000|STARTED|Overall Study||17||
59597876|NCT03237871|75707427|FG000|COMPLETED|Overall Study||11||
59597877|NCT03237871|75707427|FG000|NOT COMPLETED|Overall Study||6||
59597878|NCT04146272|75707435|FG000|STARTED|First Intervention||11||
59861939|NCT01147666|75986397|FG000|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||9|Received study drug for at least 4 weeks with corresponding Hb measurements or permanently discontinued study medication during the dosing period due to lack of efficacy.|
59861940|NCT01147666|75986398|FG001|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||10|Received study drug for at least 4 weeks with corresponding Hb measurements or permanently discontinued study medication during the dosing period due to lack of efficacy.|
59997995|NCT01375673|76113677|FG001|STARTED|Overall Study||7||
59997996|NCT01375673|76113676|FG000|COMPLETED|Overall Study||7||
59997997|NCT01375673|76113677|FG001|COMPLETED|Overall Study||6||
59997998|NCT01375673|76113676|FG000|NOT COMPLETED|Overall Study||0||
59997999|NCT01375673|76113677|FG001|NOT COMPLETED|Overall Study||1||
59998000|NCT02723591|76113685|FG000|STARTED|Overall Study||300||
59998001|NCT02723591|76113686|FG001|STARTED|Overall Study||299||
59998002|NCT02723591|76113685|FG000|COMPLETED|Overall Study||204||
59998003|NCT02723591|76113686|FG001|COMPLETED|Overall Study||198||
59998004|NCT02723591|76113685|FG000|NOT COMPLETED|Overall Study||96||
59998005|NCT02723591|76113686|FG001|NOT COMPLETED|Overall Study||101||
59998006|NCT00705341|76113694|FG000|STARTED|Phase 1:Control Challenge||126||
59998007|NCT00705341|76113695|FG001|STARTED|Phase 1:Control Challenge||93||
59998008|NCT00705341|76113696|FG002|STARTED|Phase 1:Control Challenge||0||
59998009|NCT00705341|76113697|FG003|STARTED|Phase 1:Control Challenge||0||
59998010|NCT00705341|76113694|FG000|COMPLETED|Phase 1:Control Challenge|If participants in this group met criteria, they were randomized into phase 2|126||
59998011|NCT00705341|76113695|FG001|COMPLETED|Phase 1:Control Challenge|Nonasthmatic controls did not advance to phase 2 due to design of study|93||
59998012|NCT00705341|76113696|FG002|COMPLETED|Phase 1:Control Challenge||0||
59998013|NCT00705341|76113697|FG003|COMPLETED|Phase 1:Control Challenge||0||
59998014|NCT00705341|76113694|FG000|NOT COMPLETED|Phase 1:Control Challenge||0||
59998015|NCT00705341|76113695|FG001|NOT COMPLETED|Phase 1:Control Challenge||0||
59998016|NCT00705341|76113696|FG002|NOT COMPLETED|Phase 1:Control Challenge||0||
59998017|NCT00705341|76113697|FG003|NOT COMPLETED|Phase 1:Control Challenge||0||
59998018|NCT00705341|76113694|FG000|STARTED|Phase 2: Trial||0||
59998019|NCT00705341|76113695|FG001|STARTED|Phase 2: Trial||0||
59998020|NCT00705341|76113696|FG002|STARTED|Phase 2: Trial|This group was randomized from asthmatic controls in phase 1 if they met criteria to be in phase 2|30||
59998021|NCT00705341|76113697|FG003|STARTED|Phase 2: Trial|This group was randomized from asthmatic controls in phase 1 if they met criteria to be in phase 2|32||
59998022|NCT00705341|76113694|FG000|COMPLETED|Phase 2: Trial||0||
59998023|NCT00705341|76113695|FG001|COMPLETED|Phase 2: Trial||0||
59998024|NCT00705341|76113696|FG002|COMPLETED|Phase 2: Trial||23||
59998025|NCT00705341|76113697|FG003|COMPLETED|Phase 2: Trial||28||
59998026|NCT00705341|76113694|FG000|NOT COMPLETED|Phase 2: Trial||0||
59998027|NCT00705341|76113695|FG001|NOT COMPLETED|Phase 2: Trial||0||
59998028|NCT00705341|76113696|FG002|NOT COMPLETED|Phase 2: Trial||7||
59998029|NCT00705341|76113697|FG003|NOT COMPLETED|Phase 2: Trial||4||
59998030|NCT02723201|76113708|FG000|STARTED|First Intervention Period||11||
59998031|NCT02723201|76113709|FG001|STARTED|First Intervention Period||7||
59998032|NCT02723201|76113710|FG002|STARTED|First Intervention Period||7||
59998033|NCT02723201|76113708|FG000|COMPLETED|First Intervention Period||11||
59998034|NCT02723201|76113709|FG001|COMPLETED|First Intervention Period||7||
59998035|NCT02723201|76113710|FG002|COMPLETED|First Intervention Period||7||
59998036|NCT02723201|76113708|FG000|NOT COMPLETED|First Intervention Period||0||
59998037|NCT02723201|76113709|FG001|NOT COMPLETED|First Intervention Period||0||
59998038|NCT02723201|76113710|FG002|NOT COMPLETED|First Intervention Period||0||
59998039|NCT02723201|76113708|FG000|STARTED|Washout Period 1||11||
59998040|NCT02723201|76113709|FG001|STARTED|Washout Period 1||7||
59998041|NCT02723201|76113710|FG002|STARTED|Washout Period 1||7||
59998042|NCT02723201|76113708|FG000|COMPLETED|Washout Period 1||11||
59998043|NCT02723201|76113709|FG001|COMPLETED|Washout Period 1||7||
59597879|NCT04146272|75707436|FG001|STARTED|First Intervention||11||
59998044|NCT02723201|76113710|FG002|COMPLETED|Washout Period 1||7||
59998045|NCT02723201|76113708|FG000|NOT COMPLETED|Washout Period 1||0||
59998046|NCT02723201|76113709|FG001|NOT COMPLETED|Washout Period 1||0||
59998047|NCT02723201|76113710|FG002|NOT COMPLETED|Washout Period 1||0||
59998048|NCT02723201|76113708|FG000|STARTED|Second Intervention Period||11||
59998049|NCT02723201|76113709|FG001|STARTED|Second Intervention Period||7||
59998050|NCT02723201|76113710|FG002|STARTED|Second Intervention Period||7||
59998051|NCT02723201|76113708|FG000|COMPLETED|Second Intervention Period||9||
59998052|NCT02723201|76113709|FG001|COMPLETED|Second Intervention Period||7||
59998053|NCT02723201|76113710|FG002|COMPLETED|Second Intervention Period||7||
59998054|NCT02723201|76113708|FG000|NOT COMPLETED|Second Intervention Period||2||
59998055|NCT02723201|76113709|FG001|NOT COMPLETED|Second Intervention Period||0||
59998056|NCT02723201|76113710|FG002|NOT COMPLETED|Second Intervention Period||0||
59998057|NCT02723201|76113708|FG000|STARTED|Washout Period 2||9||
59998058|NCT02723201|76113709|FG001|STARTED|Washout Period 2||0||
59998059|NCT02723201|76113710|FG002|STARTED|Washout Period 2||0||
59998060|NCT02723201|76113708|FG000|COMPLETED|Washout Period 2||9||
59998061|NCT02723201|76113709|FG001|COMPLETED|Washout Period 2||0||
59998062|NCT02723201|76113710|FG002|COMPLETED|Washout Period 2||0||
59998063|NCT02723201|76113708|FG000|NOT COMPLETED|Washout Period 2||0||
59998064|NCT02723201|76113709|FG001|NOT COMPLETED|Washout Period 2||0||
59998065|NCT02723201|76113710|FG002|NOT COMPLETED|Washout Period 2||0||
59998066|NCT02723201|76113708|FG000|STARTED|Third Intervention Period||9||
59998067|NCT02723201|76113709|FG001|STARTED|Third Intervention Period||0||
59998068|NCT02723201|76113710|FG002|STARTED|Third Intervention Period||0||
59998069|NCT02723201|76113708|FG000|COMPLETED|Third Intervention Period||9||
59998070|NCT02723201|76113709|FG001|COMPLETED|Third Intervention Period||0||
59998071|NCT02723201|76113710|FG002|COMPLETED|Third Intervention Period||0||
59998072|NCT02723201|76113708|FG000|NOT COMPLETED|Third Intervention Period||0||
59998073|NCT02723201|76113709|FG001|NOT COMPLETED|Third Intervention Period||0||
59998074|NCT02723201|76113710|FG002|NOT COMPLETED|Third Intervention Period||0||
59998075|NCT02723201|76113708|FG000|STARTED|Washout Period 3||9||
59728541|NCT00812929|75847155|FG006|NOT COMPLETED|Treatment Period 5||0||
59998076|NCT02723201|76113709|FG001|STARTED|Washout Period 3||0||
59998077|NCT02723201|76113710|FG002|STARTED|Washout Period 3||0||
59998078|NCT02723201|76113708|FG000|COMPLETED|Washout Period 3||9||
59998079|NCT02723201|76113709|FG001|COMPLETED|Washout Period 3||0||
59998080|NCT02723201|76113710|FG002|COMPLETED|Washout Period 3||0||
59998081|NCT02723201|76113708|FG000|NOT COMPLETED|Washout Period 3||0||
59998082|NCT02723201|76113709|FG001|NOT COMPLETED|Washout Period 3||0||
59998083|NCT02723201|76113710|FG002|NOT COMPLETED|Washout Period 3||0||
59998084|NCT02723201|76113708|FG000|STARTED|Fourth Intervention Period||9||
59998085|NCT02723201|76113709|FG001|STARTED|Fourth Intervention Period||0||
59998086|NCT02723201|76113710|FG002|STARTED|Fourth Intervention Period||0||
59998087|NCT02723201|76113708|FG000|COMPLETED|Fourth Intervention Period||9||
59998088|NCT02723201|76113709|FG001|COMPLETED|Fourth Intervention Period||0||
59998089|NCT02723201|76113710|FG002|COMPLETED|Fourth Intervention Period||0||
59998090|NCT02723201|76113708|FG000|NOT COMPLETED|Fourth Intervention Period||0||
59998091|NCT02723201|76113709|FG001|NOT COMPLETED|Fourth Intervention Period||0||
59998092|NCT02723201|76113710|FG002|NOT COMPLETED|Fourth Intervention Period||0||
59998093|NCT03846479|76113724|FG000|STARTED|Overall Study||70||
59998094|NCT03846479|76113724|FG000|COMPLETED|Overall Study||61||
59998095|NCT03846479|76113724|FG000|NOT COMPLETED|Overall Study||9||
59998096|NCT00705263|76113728|FG000|STARTED|Overall Study|113 patients started the treatment; however, data were available for only 110 patients.|110||
59998097|NCT00705263|76113728|FG000|COMPLETED|Overall Study||108||
59998098|NCT00705263|76113728|FG000|NOT COMPLETED|Overall Study||2||
59998099|NCT02767427|76113734|FG000|STARTED|Overall Study||21||
59998100|NCT02767427|76113735|FG001|STARTED|Overall Study||19||
59998101|NCT02767427|76113734|FG000|COMPLETED|Overall Study||21||
59998102|NCT02767427|76113735|FG001|COMPLETED|Overall Study||19||
59998103|NCT02767427|76113734|FG000|NOT COMPLETED|Overall Study||0||
59998104|NCT02767427|76113735|FG001|NOT COMPLETED|Overall Study||0||
59998105|NCT00704405|76113746|FG000|STARTED|Overall Study (NC Population)||42||
59998106|NCT00704405|76113747|FG001|STARTED|Overall Study (NC Population)||44||
59998107|NCT00704405|76113748|FG002|STARTED|Overall Study (NC Population)||41||
59998108|NCT00704405|76113749|FG003|STARTED|Overall Study (NC Population)||42||
59998109|NCT00704405|76113750|FG004|STARTED|Overall Study (NC Population)||42||
59998110|NCT00704405|76113746|FG000|COMPLETED|Overall Study (NC Population)||37||
59998111|NCT00704405|76113747|FG001|COMPLETED|Overall Study (NC Population)||40||
59998112|NCT00704405|76113748|FG002|COMPLETED|Overall Study (NC Population)||38||
59998113|NCT00704405|76113749|FG003|COMPLETED|Overall Study (NC Population)||38||
59998114|NCT00704405|76113750|FG004|COMPLETED|Overall Study (NC Population)||37||
59998115|NCT00704405|76113746|FG000|NOT COMPLETED|Overall Study (NC Population)||5||
59998116|NCT00704405|76113747|FG001|NOT COMPLETED|Overall Study (NC Population)||4||
59998117|NCT00704405|76113748|FG002|NOT COMPLETED|Overall Study (NC Population)||3||
59998118|NCT00704405|76113749|FG003|NOT COMPLETED|Overall Study (NC Population)||4||
59998119|NCT00704405|76113750|FG004|NOT COMPLETED|Overall Study (NC Population)||5||
59998120|NCT00704405|76113746|FG000|STARTED|Overall Study (C Population)||16||
59998121|NCT00704405|76113747|FG001|STARTED|Overall Study (C Population)||14||
59998122|NCT00704405|76113748|FG002|STARTED|Overall Study (C Population)||15||
59998123|NCT00704405|76113749|FG003|STARTED|Overall Study (C Population)||15||
59998124|NCT00704405|76113750|FG004|STARTED|Overall Study (C Population)||14||
59998125|NCT00704405|76113746|FG000|COMPLETED|Overall Study (C Population)||15||
59998126|NCT00704405|76113747|FG001|COMPLETED|Overall Study (C Population)||11||
59998127|NCT00704405|76113748|FG002|COMPLETED|Overall Study (C Population)||14||
59998128|NCT00704405|76113749|FG003|COMPLETED|Overall Study (C Population)||14||
59998129|NCT00704405|76113750|FG004|COMPLETED|Overall Study (C Population)||14||
59998130|NCT00704405|76113746|FG000|NOT COMPLETED|Overall Study (C Population)||1||
59998131|NCT00704405|76113747|FG001|NOT COMPLETED|Overall Study (C Population)||3||
59998132|NCT00704405|76113748|FG002|NOT COMPLETED|Overall Study (C Population)||1||
59998133|NCT00704405|76113749|FG003|NOT COMPLETED|Overall Study (C Population)||1||
59998134|NCT00704405|76113750|FG004|NOT COMPLETED|Overall Study (C Population)||0||
59998135|NCT01534481|76113770|FG000|STARTED|Overall Study||239||
59998136|NCT01534481|76113771|FG001|STARTED|Overall Study||244||
59998137|NCT01534481|76113770|FG000|Complete Data for BSID III Cognitive Score at 22-26 Months|Overall Study||175||
59998138|NCT01534481|76113771|FG001|Complete Data for BSID III Cognitive Score at 22-26 Months|Overall Study||192||
59998139|NCT01534481|76113770|FG000|Died After Discharge|Overall Study||5||
59998140|NCT01534481|76113771|FG001|Died After Discharge|Overall Study||7||
59998141|NCT01534481|76113770|FG000|Died Before Discharge|Overall Study||24||
59998142|NCT01534481|76113771|FG001|Died Before Discharge|Overall Study||18||
59998143|NCT01534481|76113770|FG000|Survived to Discharge|Overall Study||215||
59998144|NCT01534481|76113771|FG001|Survived to Discharge|Overall Study||226||
59998145|NCT01534481|76113770|FG000|COMPLETED|Overall Study||204|Death or BSID III cognitive score at 22-26 months|
59998146|NCT01534481|76113771|FG001|COMPLETED|Overall Study||217|Death or BSID III cognitive score at 22-26 months|
59998147|NCT01534481|76113770|FG000|NOT COMPLETED|Overall Study||35||
59998148|NCT01534481|76113771|FG001|NOT COMPLETED|Overall Study||27||
59998149|NCT00704171|76113779|FG000|STARTED|Overall Study||62||
59998150|NCT00704171|76113780|FG001|STARTED|Overall Study||59||
59998151|NCT00704171|76113779|FG000|COMPLETED|Overall Study|One subject withdrew consent prior to study completion. No reason given.|61||
59998152|NCT00704171|76113780|FG001|COMPLETED|Overall Study|All control subjects completed the study.|59||
59998153|NCT00704171|76113779|FG000|NOT COMPLETED|Overall Study||1||
59998154|NCT00704171|76113780|FG001|NOT COMPLETED|Overall Study||0||
59998155|NCT00703781|76113788|FG000|STARTED|Overall Study||63||
59998156|NCT00703781|76113789|FG001|STARTED|Overall Study||63||
59998157|NCT00703781|76113788|FG000|COMPLETED|Overall Study||61||
59998158|NCT00703781|76113789|FG001|COMPLETED|Overall Study||61||
59998159|NCT00703781|76113788|FG000|NOT COMPLETED|Overall Study||2||
59998160|NCT00703781|76113789|FG001|NOT COMPLETED|Overall Study||2||
59597880|NCT04146272|75707437|FG002|STARTED|First Intervention||6||
59597881|NCT04146272|75707438|FG003|STARTED|First Intervention||5||
59597882|NCT04146272|75707435|FG000|COMPLETED|First Intervention||11||
59597883|NCT04146272|75707436|FG001|COMPLETED|First Intervention||11||
59597884|NCT04146272|75707437|FG002|COMPLETED|First Intervention||6||
59597885|NCT04146272|75707438|FG003|COMPLETED|First Intervention||5||
59597886|NCT04146272|75707435|FG000|NOT COMPLETED|First Intervention||0||
59597887|NCT04146272|75707436|FG001|NOT COMPLETED|First Intervention||0||
59597888|NCT04146272|75707437|FG002|NOT COMPLETED|First Intervention||0||
59998161|NCT00703157|76113797|FG000|STARTED|Overall Study||26||
59998162|NCT00703157|76113798|FG001|STARTED|Overall Study||26||
59998163|NCT00703157|76113797|FG000|6 Months FU|Overall Study||25||
59998164|NCT00703157|76113798|FG001|6 Months FU|Overall Study||25||
59998165|NCT00703157|76113797|FG000|24 Months FU|Overall Study||22||
59998166|NCT00703157|76113798|FG001|24 Months FU|Overall Study||24||
59998167|NCT00703157|76113797|FG000|COMPLETED|Overall Study||22||
59998168|NCT00703157|76113798|FG001|COMPLETED|Overall Study||24||
59998169|NCT00703157|76113797|FG000|NOT COMPLETED|Overall Study||4||
59998170|NCT00703157|76113798|FG001|NOT COMPLETED|Overall Study||2||
59597889|NCT04146272|75707438|FG003|NOT COMPLETED|First Intervention||0||
59597890|NCT04146272|75707435|FG000|STARTED|Second Intervention||11||
59597891|NCT04146272|75707436|FG001|STARTED|Second Intervention||11||
59597892|NCT04146272|75707437|FG002|STARTED|Second Intervention||6||
59597893|NCT04146272|75707438|FG003|STARTED|Second Intervention||5||
59597894|NCT04146272|75707435|FG000|COMPLETED|Second Intervention||11||
59597895|NCT04146272|75707436|FG001|COMPLETED|Second Intervention||11||
59597896|NCT04146272|75707437|FG002|COMPLETED|Second Intervention||6||
59597897|NCT04146272|75707438|FG003|COMPLETED|Second Intervention||5||
59597898|NCT04146272|75707435|FG000|NOT COMPLETED|Second Intervention||0||
59998171|NCT03307967|76113806|FG000|STARTED|Overall Study||40||
59998172|NCT03307967|76113806|FG000|COMPLETED|Overall Study||36||
59998173|NCT03307967|76113806|FG000|NOT COMPLETED|Overall Study||4||
59998174|NCT02722967|76113813|FG000|STARTED|Overall Study||22||
59998175|NCT02722967|76113814|FG001|STARTED|Overall Study||12||
59998176|NCT02722967|76113815|FG002|STARTED|Overall Study||15||
59998177|NCT02722967|76113813|FG000|COMPLETED|Overall Study||17||
59998178|NCT02722967|76113814|FG001|COMPLETED|Overall Study||10||
59597899|NCT04146272|75707436|FG001|NOT COMPLETED|Second Intervention||0||
59597900|NCT04146272|75707437|FG002|NOT COMPLETED|Second Intervention||0||
59597901|NCT04146272|75707438|FG003|NOT COMPLETED|Second Intervention||0||
59597902|NCT03473665|75707457|FG000|STARTED|Overall Study||9||
59597903|NCT03473665|75707457|FG000|COMPLETED|Overall Study||9||
59597904|NCT03473665|75707457|FG000|NOT COMPLETED|Overall Study||0||
59597905|NCT03863210|75707466|FG000|STARTED|Overall Study|March 1st, 2014.|104||
59597906|NCT03863210|75707466|FG000|COMPLETED|Overall Study|September 1st, 2014.|102||
59597907|NCT03863210|75707466|FG000|NOT COMPLETED|Overall Study||2||
59597908|NCT03239665|75707472|FG000|STARTED|Overall Study||175||
59597909|NCT03239665|75707473|FG001|STARTED|Overall Study||160||
59597910|NCT03239665|75707472|FG000|Met Inclusion Criteria|Overall Study||150||
59728542|NCT00812929|75847156|FG007|NOT COMPLETED|Treatment Period 5||0||
59998179|NCT02722967|76113815|FG002|COMPLETED|Overall Study||11||
59998180|NCT02722967|76113813|FG000|NOT COMPLETED|Overall Study||5||
59998181|NCT02722967|76113814|FG001|NOT COMPLETED|Overall Study||2||
59998182|NCT02722967|76113815|FG002|NOT COMPLETED|Overall Study||4||
59998183|NCT02722499|76113826|FG000|STARTED|Overall Study||20||
59597911|NCT03239665|75707473|FG001|Met Inclusion Criteria|Overall Study||144||
59597912|NCT03239665|75707472|FG000|Submitted Survey Data|Overall Study||147||
59597913|NCT03239665|75707473|FG001|Submitted Survey Data|Overall Study||140||
59597914|NCT03239665|75707472|FG000|COMPLETED|Overall Study||147||
59597915|NCT03239665|75707473|FG001|COMPLETED|Overall Study||140||
59597916|NCT03239665|75707472|FG000|NOT COMPLETED|Overall Study||28||
59597917|NCT03239665|75707473|FG001|NOT COMPLETED|Overall Study||20||
59597918|NCT03717506|75707482|FG000|STARTED|Overall Study||496||
59597919|NCT03717506|75707483|FG001|STARTED|Overall Study||491||
59597920|NCT03717506|75707484|FG002|STARTED|Overall Study||249||
59597921|NCT03717506|75707482|FG000|COMPLETED|Overall Study||447||
59597922|NCT03717506|75707483|FG001|COMPLETED|Overall Study||441||
59597923|NCT03717506|75707484|FG002|COMPLETED|Overall Study||222||
59597924|NCT03717506|75707482|FG000|NOT COMPLETED|Overall Study||49||
59597925|NCT03717506|75707483|FG001|NOT COMPLETED|Overall Study||50||
59597926|NCT03717506|75707484|FG002|NOT COMPLETED|Overall Study||27||
59597927|NCT03861338|75707492|FG000|STARTED|Overall Study||10||
59597928|NCT03861338|75707492|FG000|COMPLETED|Overall Study||8||
59597929|NCT03861338|75707492|FG000|NOT COMPLETED|Overall Study||2||
59597930|NCT03851744|75707498|FG000|STARTED|Overall Study||4||
59597931|NCT03851744|75707499|FG001|STARTED|Overall Study||6||
59597932|NCT03851744|75707498|FG000|COMPLETED|Overall Study||4||
59597933|NCT03851744|75707499|FG001|COMPLETED|Overall Study||4||
59597934|NCT03851744|75707498|FG000|NOT COMPLETED|Overall Study||0||
59597935|NCT03851744|75707499|FG001|NOT COMPLETED|Overall Study||2||
59597936|NCT03242941|75707505|FG000|STARTED|Overall Study||16||
59597937|NCT03242941|75707505|FG000|COMPLETED|Overall Study||14||
59597938|NCT03242941|75707505|FG000|NOT COMPLETED|Overall Study||2||
59597939|NCT03719300|75707510|FG000|STARTED|Overall Study||32||
59597940|NCT03719300|75707510|FG000|COMPLETED|Overall Study||32||
59597941|NCT03719300|75707510|FG000|NOT COMPLETED|Overall Study||0||
59597942|NCT03719378|75707516|FG000|STARTED|Overall Study||75||
59597943|NCT03719378|75707517|FG001|STARTED|Overall Study||75||
59597944|NCT03719378|75707516|FG000|COMPLETED|Overall Study||65||
59597945|NCT03719378|75707517|FG001|COMPLETED|Overall Study||65||
59597946|NCT03719378|75707516|FG000|NOT COMPLETED|Overall Study||10||
59597947|NCT03719378|75707517|FG001|NOT COMPLETED|Overall Study||10||
59597948|NCT03368053|75707523|FG000|STARTED|Overall Study||36||
59597949|NCT03368053|75707523|FG000|COMPLETED|Overall Study||36||
59597950|NCT03368053|75707523|FG000|NOT COMPLETED|Overall Study||0||
59597951|NCT03719612|75707527|FG000|STARTED|Overall Study||160||
59597952|NCT03719612|75707527|FG000|COMPLETED|Overall Study||148||
59597953|NCT03719612|75707527|FG000|NOT COMPLETED|Overall Study||12||
59597954|NCT03373591|75707536|FG000|STARTED|Overall Study||75||
59597955|NCT03373591|75707537|FG001|STARTED|Overall Study||71||
59597956|NCT03373591|75707538|FG002|STARTED|Overall Study||73||
59597957|NCT03373591|75707536|FG000|COMPLETED|Overall Study||75||
59597958|NCT03373591|75707537|FG001|COMPLETED|Overall Study||71||
59597959|NCT03373591|75707538|FG002|COMPLETED|Overall Study||73||
59597960|NCT03373591|75707536|FG000|NOT COMPLETED|Overall Study||0||
59597961|NCT03373591|75707537|FG001|NOT COMPLETED|Overall Study||0||
59597962|NCT03373591|75707538|FG002|NOT COMPLETED|Overall Study||0||
59597963|NCT03720938|75707548|FG000|STARTED|Overall Study||242||
59597964|NCT03720938|75707549|FG001|STARTED|Overall Study||676||
59597965|NCT03720938|75707548|FG000|COMPLETED|Overall Study||53||
59597966|NCT03720938|75707549|FG001|COMPLETED|Overall Study||53||
59597967|NCT03720938|75707548|FG000|NOT COMPLETED|Overall Study||189||
59597968|NCT03720938|75707549|FG001|NOT COMPLETED|Overall Study||623||
59597969|NCT03374683|75707569|FG000|STARTED|Overall Study||148||
59597970|NCT03374683|75707570|FG001|STARTED|Overall Study||150||
59597971|NCT03374683|75707571|FG002|STARTED|Overall Study||153||
59597972|NCT03374683|75707569|FG000|1-week Post-intervention|Overall Study||135||
59597973|NCT03374683|75707570|FG001|1-week Post-intervention|Overall Study||113||
59597974|NCT03374683|75707571|FG002|1-week Post-intervention|Overall Study||85||
59728543|NCT00812929|75847157|FG008|NOT COMPLETED|Treatment Period 5||0||
59998184|NCT02722499|76113827|FG001|STARTED|Overall Study||20||
59597975|NCT03374683|75707569|FG000|COMPLETED|Overall Study||123||
59597976|NCT03374683|75707570|FG001|COMPLETED|Overall Study||105||
59597977|NCT03374683|75707571|FG002|COMPLETED|Overall Study||84||
59597978|NCT03374683|75707569|FG000|NOT COMPLETED|Overall Study||25||
59597979|NCT03374683|75707570|FG001|NOT COMPLETED|Overall Study||45||
59597980|NCT03374683|75707571|FG002|NOT COMPLETED|Overall Study||69||
59597981|NCT03480685|75707579|FG000|STARTED|Overall Study||12||
59597982|NCT03480685|75707579|FG000|COMPLETED|Overall Study||12||
59597983|NCT03480685|75707579|FG000|NOT COMPLETED|Overall Study||0||
59597984|NCT03378973|75707587|FG000|STARTED|Overall Study||4||
59597985|NCT03378973|75707588|FG001|STARTED|Overall Study||3||
59597986|NCT03378973|75707587|FG000|COMPLETED|Overall Study||4||
59597987|NCT03378973|75707588|FG001|COMPLETED|Overall Study||3||
59728544|NCT00812929|75847158|FG009|NOT COMPLETED|Treatment Period 5||0||
59728545|NCT00824161|75847175|FG000|STARTED|Overall Study||28||
59998185|NCT02722499|76113828|FG002|STARTED|Overall Study||20||
59597988|NCT03378973|75707587|FG000|NOT COMPLETED|Overall Study||0||
59597989|NCT03378973|75707588|FG001|NOT COMPLETED|Overall Study||0||
59597990|NCT03380845|75707594|FG000|STARTED|Overall Study|Participants got bilateral face treatments with Fraxel on one side of face; Fractora on the other.|4||8
59597991|NCT03380845|75707594|FG000|COMPLETED|Overall Study||4||8
59597992|NCT03380845|75707594|FG000|NOT COMPLETED|Overall Study||0||0
59597993|NCT04121078|75707602|FG000|STARTED|Study Period 1 (1 Day)||6||
59597994|NCT04121078|75707603|FG001|STARTED|Study Period 1 (1 Day)||6||
59597995|NCT04121078|75707602|FG000|COMPLETED|Study Period 1 (1 Day)||6||
59597996|NCT04121078|75707603|FG001|COMPLETED|Study Period 1 (1 Day)||6||
59597997|NCT04121078|75707602|FG000|NOT COMPLETED|Study Period 1 (1 Day)||0||
59597998|NCT04121078|75707603|FG001|NOT COMPLETED|Study Period 1 (1 Day)||0||
59597999|NCT04121078|75707602|FG000|STARTED|Washout Period (at Least 7 Days)||6||
59598000|NCT04121078|75707603|FG001|STARTED|Washout Period (at Least 7 Days)||6||
59598001|NCT04121078|75707602|FG000|COMPLETED|Washout Period (at Least 7 Days)||6||
59598002|NCT04121078|75707603|FG001|COMPLETED|Washout Period (at Least 7 Days)||6||
59598003|NCT04121078|75707602|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||0||
59598004|NCT04121078|75707603|FG001|NOT COMPLETED|Washout Period (at Least 7 Days)||0||
59598005|NCT04121078|75707602|FG000|STARTED|Study Period 2 (1 Day)||6||
59598006|NCT04121078|75707603|FG001|STARTED|Study Period 2 (1 Day)||6||
59598007|NCT04121078|75707602|FG000|COMPLETED|Study Period 2 (1 Day)||6||
59598008|NCT04121078|75707603|FG001|COMPLETED|Study Period 2 (1 Day)||6||
59598009|NCT04121078|75707602|FG000|NOT COMPLETED|Study Period 2 (1 Day)||0||
59598010|NCT04121078|75707603|FG001|NOT COMPLETED|Study Period 2 (1 Day)||0||
59598011|NCT03248947|75707609|FG000|STARTED|Overall Study||71||
59598012|NCT03248947|75707609|FG000|COMPLETED|Overall Study||63||
59598013|NCT03248947|75707609|FG000|NOT COMPLETED|Overall Study||8||
59598014|NCT04114058|75707619|FG000|STARTED|Overall Study||20||
59598015|NCT04114058|75707620|FG001|STARTED|Overall Study||17||
59598016|NCT04114058|75707619|FG000|COMPLETED|Overall Study||20||
59598017|NCT04114058|75707620|FG001|COMPLETED|Overall Study||17||
59598018|NCT04114058|75707619|FG000|NOT COMPLETED|Overall Study||0||
59598019|NCT04114058|75707620|FG001|NOT COMPLETED|Overall Study||0||
59598020|NCT03480919|75707629|FG000|STARTED|Overall Study||1||
59598021|NCT03480919|75707630|FG001|STARTED|Overall Study||2||
59598022|NCT03480919|75707631|FG002|STARTED|Overall Study||1||
59598023|NCT03480919|75707629|FG000|COMPLETED|Overall Study||1||
59598024|NCT03480919|75707630|FG001|COMPLETED|Overall Study||2||
59598025|NCT03480919|75707631|FG002|COMPLETED|Overall Study||1||
59598026|NCT03480919|75707629|FG000|NOT COMPLETED|Overall Study||0||
59598027|NCT03480919|75707630|FG001|NOT COMPLETED|Overall Study||0||
59598028|NCT03480919|75707631|FG002|NOT COMPLETED|Overall Study||0||
59598029|NCT03817580|75707642|FG000|STARTED|Overall Study||57||
59598030|NCT03817580|75707643|FG001|STARTED|Overall Study||56||
59598031|NCT03817580|75707644|FG002|STARTED|Overall Study||57||
59598032|NCT03817580|75707642|FG000|COMPLETED|Overall Study||57||
59598033|NCT03817580|75707643|FG001|COMPLETED|Overall Study||56||
59598034|NCT03817580|75707644|FG002|COMPLETED|Overall Study||57||
59598035|NCT03817580|75707642|FG000|NOT COMPLETED|Overall Study||0||
59598036|NCT03817580|75707643|FG001|NOT COMPLETED|Overall Study||0||
59598037|NCT03817580|75707644|FG002|NOT COMPLETED|Overall Study||0||
59598038|NCT03862040|75707652|FG000|STARTED|Overall Study||7||
59598039|NCT03862040|75707652|FG000|COMPLETED|Overall Study||7||
59598040|NCT03862040|75707652|FG000|NOT COMPLETED|Overall Study||0||
59598041|NCT03482713|75707658|FG000|STARTED|Overall Study||11||
59598042|NCT03482713|75707659|FG001|STARTED|Overall Study||12||
59598043|NCT03482713|75707658|FG000|COMPLETED|Overall Study||11||
59598044|NCT03482713|75707659|FG001|COMPLETED|Overall Study||12||
59598045|NCT03482713|75707658|FG000|NOT COMPLETED|Overall Study||0||
59598046|NCT03482713|75707659|FG001|NOT COMPLETED|Overall Study||0||
59598047|NCT03857750|75707667|FG000|STARTED|Overall Study||16||
59598048|NCT03857750|75707668|FG001|STARTED|Overall Study||16||
59598049|NCT03857750|75707667|FG000|COMPLETED|Overall Study||16||
59598050|NCT03857750|75707668|FG001|COMPLETED|Overall Study||16||
59598051|NCT03857750|75707667|FG000|NOT COMPLETED|Overall Study||0||
59598052|NCT03857750|75707668|FG001|NOT COMPLETED|Overall Study||0||
59728546|NCT00824161|75847175|FG000|COMPLETED|Overall Study||26||
59598053|NCT03491917|75707674|FG000|STARTED|First Reading Session||50||
59598054|NCT03491917|75707675|FG001|STARTED|First Reading Session||50||
59598055|NCT03491917|75707674|FG000|COMPLETED|First Reading Session||50||
59598056|NCT03491917|75707675|FG001|COMPLETED|First Reading Session||50||
59598057|NCT03491917|75707674|FG000|NOT COMPLETED|First Reading Session||0||
59598058|NCT03491917|75707675|FG001|NOT COMPLETED|First Reading Session||0||
59598059|NCT03491917|75707674|FG000|STARTED|4 Week Memory Washout Period||50||
59598060|NCT03491917|75707675|FG001|STARTED|4 Week Memory Washout Period||50||
59598061|NCT03491917|75707674|FG000|COMPLETED|4 Week Memory Washout Period||50||
59598062|NCT03491917|75707675|FG001|COMPLETED|4 Week Memory Washout Period||50||
59598063|NCT03491917|75707674|FG000|NOT COMPLETED|4 Week Memory Washout Period||0||
59598064|NCT03491917|75707675|FG001|NOT COMPLETED|4 Week Memory Washout Period||0||
59598065|NCT03491917|75707674|FG000|STARTED|Second Reading Session||50||
59598066|NCT03491917|75707675|FG001|STARTED|Second Reading Session||50||
59598067|NCT03491917|75707674|FG000|COMPLETED|Second Reading Session||50||
59598068|NCT03491917|75707675|FG001|COMPLETED|Second Reading Session||50||
59598069|NCT03491917|75707674|FG000|NOT COMPLETED|Second Reading Session||0||
59598070|NCT03491917|75707675|FG001|NOT COMPLETED|Second Reading Session||0||
59598071|NCT03828422|75707683|FG000|STARTED|Overall Study||40||
59598072|NCT03828422|75707684|FG001|STARTED|Overall Study||42||
59598073|NCT03828422|75707683|FG000|COMPLETED|Overall Study||36||
59598074|NCT03828422|75707684|FG001|COMPLETED|Overall Study||38||
59598075|NCT03828422|75707683|FG000|NOT COMPLETED|Overall Study||4||
59598076|NCT03828422|75707684|FG001|NOT COMPLETED|Overall Study||4||
59598077|NCT03254719|75707691|FG000|STARTED|Overall Study||40||
59598078|NCT03254719|75707691|FG000|COMPLETED|Overall Study||40||
59598079|NCT03254719|75707691|FG000|NOT COMPLETED|Overall Study||0||
59598080|NCT04084028|75707699|FG000|STARTED|Overall Study||18||
59598081|NCT04084028|75707700|FG001|STARTED|Overall Study||16||
59598082|NCT04084028|75707701|FG002|STARTED|Overall Study||9||
59598083|NCT04084028|75707702|FG003|STARTED|Overall Study||10||
59598084|NCT04084028|75707699|FG000|COMPLETED|Overall Study||18||
59598085|NCT04084028|75707700|FG001|COMPLETED|Overall Study||16||
59598086|NCT04084028|75707701|FG002|COMPLETED|Overall Study||9||
59598087|NCT04084028|75707702|FG003|COMPLETED|Overall Study||10||
59598088|NCT04084028|75707699|FG000|NOT COMPLETED|Overall Study||0||
59598089|NCT04084028|75707700|FG001|NOT COMPLETED|Overall Study||0||
59598090|NCT04084028|75707701|FG002|NOT COMPLETED|Overall Study||0||
59598091|NCT04084028|75707702|FG003|NOT COMPLETED|Overall Study||0||
59598092|NCT03387319|75707716|FG000|STARTED|Overall Study||25||
59598093|NCT03387319|75707717|FG001|STARTED|Overall Study||25||
59598094|NCT03387319|75707716|FG000|COMPLETED|Overall Study||25||
59598095|NCT03387319|75707717|FG001|COMPLETED|Overall Study||25||
59598096|NCT03387319|75707716|FG000|NOT COMPLETED|Overall Study||0||
59598097|NCT03387319|75707717|FG001|NOT COMPLETED|Overall Study||0||
59598098|NCT03852524|75707725|FG000|STARTED|Overall Study||41||
59598099|NCT03852524|75707726|FG001|STARTED|Overall Study||41||
59598100|NCT03852524|75707725|FG000|COMPLETED|Overall Study||41||
59598101|NCT03852524|75707726|FG001|COMPLETED|Overall Study||41||
59598102|NCT03852524|75707725|FG000|NOT COMPLETED|Overall Study||0||
59598103|NCT03852524|75707726|FG001|NOT COMPLETED|Overall Study||0||
59598104|NCT03388645|75707734|FG000|STARTED|Low Dose RSV A2||4||
59598105|NCT03388645|75707735|FG001|STARTED|Low Dose RSV A2||0||
59598106|NCT03388645|75707734|FG000|COMPLETED|Low Dose RSV A2||4||
59598107|NCT03388645|75707735|FG001|COMPLETED|Low Dose RSV A2||0||
59598108|NCT03388645|75707734|FG000|NOT COMPLETED|Low Dose RSV A2||0||
59598109|NCT03388645|75707735|FG001|NOT COMPLETED|Low Dose RSV A2||0||
59598110|NCT03388645|75707734|FG000|STARTED|High Dose RSV A2||0||
59598111|NCT03388645|75707735|FG001|STARTED|High Dose RSV A2||8||
59598112|NCT03388645|75707734|FG000|COMPLETED|High Dose RSV A2||0||
59598113|NCT03388645|75707735|FG001|COMPLETED|High Dose RSV A2||7||
59598114|NCT03388645|75707734|FG000|NOT COMPLETED|High Dose RSV A2||0||
59598115|NCT03388645|75707735|FG001|NOT COMPLETED|High Dose RSV A2||1||
59598116|NCT04081610|75707743|FG000|STARTED|Overall Study||16||32
59598117|NCT04081610|75707744|FG001|STARTED|Overall Study||18||36
59598118|NCT04081610|75707743|FG000|COMPLETED|Overall Study||16||32
59598119|NCT04081610|75707744|FG001|COMPLETED|Overall Study||18||36
59598120|NCT04081610|75707743|FG000|NOT COMPLETED|Overall Study||0||0
59598121|NCT04081610|75707744|FG001|NOT COMPLETED|Overall Study||0||0
59598122|NCT03390907|75707750|FG000|STARTED|Overall Study||40||
59598123|NCT03390907|75707750|FG000|COMPLETED|Overall Study||40||
59598124|NCT03390907|75707750|FG000|NOT COMPLETED|Overall Study||0||
59598125|NCT03840278|75707755|FG000|STARTED|Overall Study||5||
59598126|NCT03840278|75707756|FG001|STARTED|Overall Study||5||
59598127|NCT03840278|75707755|FG000|COMPLETED|Overall Study||5|This is a crossover study. All subjects will participate in both arms.|
59598128|NCT03840278|75707756|FG001|COMPLETED|Overall Study||5|This is a crossover study. All subjects will participate in both arms.|
59598129|NCT03840278|75707755|FG000|NOT COMPLETED|Overall Study||0||
59598130|NCT03840278|75707756|FG001|NOT COMPLETED|Overall Study||0||
59598131|NCT03838874|75707764|FG000|STARTED|Overall Study||80||
59598132|NCT03838874|75707765|FG001|STARTED|Overall Study||74||
59598133|NCT03838874|75707764|FG000|COMPLETED|Overall Study||80||
59598134|NCT03838874|75707765|FG001|COMPLETED|Overall Study||74||
59598135|NCT03838874|75707764|FG000|NOT COMPLETED|Overall Study||0||
59598136|NCT03838874|75707765|FG001|NOT COMPLETED|Overall Study||0||
59598137|NCT03815240|75707771|FG000|STARTED|Intervention no Dressing||2|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
59598138|NCT03815240|75707772|FG001|STARTED|Intervention no Dressing||1|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
59598139|NCT03815240|75707773|FG002|STARTED|Intervention no Dressing||1|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
59598140|NCT03815240|75707774|FG003|STARTED|Intervention no Dressing||2|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
59598141|NCT03815240|75707775|FG004|STARTED|Intervention no Dressing||1|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
59598142|NCT03815240|75707776|FG005|STARTED|Intervention no Dressing||2|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
59598143|NCT03815240|75707777|FG006|STARTED|Intervention no Dressing||1|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
59598144|NCT03815240|75707778|FG007|STARTED|Intervention no Dressing||1|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
59598145|NCT03815240|75707779|FG008|STARTED|Intervention no Dressing||1|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
59598146|NCT03815240|75707771|FG000|COMPLETED|Intervention no Dressing||2|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
59598147|NCT03815240|75707772|FG001|COMPLETED|Intervention no Dressing||1|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
59598148|NCT03815240|75707773|FG002|COMPLETED|Intervention no Dressing||1|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
59598149|NCT03815240|75707774|FG003|COMPLETED|Intervention no Dressing||2|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
59598150|NCT03815240|75707775|FG004|COMPLETED|Intervention no Dressing||1|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
59598151|NCT03815240|75707776|FG005|COMPLETED|Intervention no Dressing||2|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
59598152|NCT03815240|75707777|FG006|COMPLETED|Intervention no Dressing||1|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
59598153|NCT03815240|75707778|FG007|COMPLETED|Intervention no Dressing||1|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
59598154|NCT03815240|75707779|FG008|COMPLETED|Intervention no Dressing||1|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
59598155|NCT03815240|75707771|FG000|NOT COMPLETED|Intervention no Dressing||0||
59598156|NCT03815240|75707772|FG001|NOT COMPLETED|Intervention no Dressing||0||
59598157|NCT03815240|75707773|FG002|NOT COMPLETED|Intervention no Dressing||0||
59598158|NCT03815240|75707774|FG003|NOT COMPLETED|Intervention no Dressing||0||
59598159|NCT03815240|75707775|FG004|NOT COMPLETED|Intervention no Dressing||0||
59598160|NCT03815240|75707776|FG005|NOT COMPLETED|Intervention no Dressing||0||
59598161|NCT03815240|75707777|FG006|NOT COMPLETED|Intervention no Dressing||0||
59598162|NCT03815240|75707778|FG007|NOT COMPLETED|Intervention no Dressing||0||
59598163|NCT03815240|75707779|FG008|NOT COMPLETED|Intervention no Dressing||0||
59598164|NCT03815240|75707771|FG000|STARTED|Intervention Mepilex Dressing||2|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
59598165|NCT03815240|75707772|FG001|STARTED|Intervention Mepilex Dressing||1|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
59598166|NCT03815240|75707773|FG002|STARTED|Intervention Mepilex Dressing||1|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
59598167|NCT03815240|75707774|FG003|STARTED|Intervention Mepilex Dressing||2|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
59598168|NCT03815240|75707775|FG004|STARTED|Intervention Mepilex Dressing||1|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
59598169|NCT03815240|75707776|FG005|STARTED|Intervention Mepilex Dressing||2|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
59598170|NCT03815240|75707777|FG006|STARTED|Intervention Mepilex Dressing||1|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
59598171|NCT03815240|75707778|FG007|STARTED|Intervention Mepilex Dressing||1|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
59598172|NCT03815240|75707779|FG008|STARTED|Intervention Mepilex Dressing||1|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
59598173|NCT03815240|75707771|FG000|COMPLETED|Intervention Mepilex Dressing||2|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
59598174|NCT03815240|75707772|FG001|COMPLETED|Intervention Mepilex Dressing||1|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
59598175|NCT03815240|75707773|FG002|COMPLETED|Intervention Mepilex Dressing||1|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
59598176|NCT03815240|75707774|FG003|COMPLETED|Intervention Mepilex Dressing||2|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
59598177|NCT03815240|75707775|FG004|COMPLETED|Intervention Mepilex Dressing||1|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
59598178|NCT03815240|75707776|FG005|COMPLETED|Intervention Mepilex Dressing||2|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
59998186|NCT02722499|76113826|FG000|COMPLETED|Overall Study||18||
59998187|NCT02722499|76113827|FG001|COMPLETED|Overall Study||20||
59598179|NCT03815240|75707777|FG006|COMPLETED|Intervention Mepilex Dressing||1|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
59598180|NCT03815240|75707778|FG007|COMPLETED|Intervention Mepilex Dressing||1|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
59598181|NCT03815240|75707779|FG008|COMPLETED|Intervention Mepilex Dressing||1|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
59598182|NCT03815240|75707771|FG000|NOT COMPLETED|Intervention Mepilex Dressing||0||
59598183|NCT03815240|75707772|FG001|NOT COMPLETED|Intervention Mepilex Dressing||0||
59598184|NCT03815240|75707773|FG002|NOT COMPLETED|Intervention Mepilex Dressing||0||
59598185|NCT03815240|75707774|FG003|NOT COMPLETED|Intervention Mepilex Dressing||0||
59598186|NCT03815240|75707775|FG004|NOT COMPLETED|Intervention Mepilex Dressing||0||
59598187|NCT03815240|75707776|FG005|NOT COMPLETED|Intervention Mepilex Dressing||0||
59598188|NCT03815240|75707777|FG006|NOT COMPLETED|Intervention Mepilex Dressing||0||
59598189|NCT03815240|75707778|FG007|NOT COMPLETED|Intervention Mepilex Dressing||0||
59598190|NCT03815240|75707779|FG008|NOT COMPLETED|Intervention Mepilex Dressing||0||
59598191|NCT03815240|75707771|FG000|STARTED|Intervention Allevyn Dressing||2|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
59598192|NCT03815240|75707772|FG001|STARTED|Intervention Allevyn Dressing||1|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
59598193|NCT03815240|75707773|FG002|STARTED|Intervention Allevyn Dressing||1|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
59598194|NCT03815240|75707774|FG003|STARTED|Intervention Allevyn Dressing||2|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
59598195|NCT03815240|75707775|FG004|STARTED|Intervention Allevyn Dressing||1|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
59598196|NCT03815240|75707776|FG005|STARTED|Intervention Allevyn Dressing||2|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
59598197|NCT03815240|75707777|FG006|STARTED|Intervention Allevyn Dressing||1|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
59598198|NCT03815240|75707778|FG007|STARTED|Intervention Allevyn Dressing||1|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
59598199|NCT03815240|75707779|FG008|STARTED|Intervention Allevyn Dressing||1|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
59598200|NCT03815240|75707771|FG000|COMPLETED|Intervention Allevyn Dressing||2|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
59598201|NCT03815240|75707772|FG001|COMPLETED|Intervention Allevyn Dressing||1|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
59598202|NCT03815240|75707773|FG002|COMPLETED|Intervention Allevyn Dressing||1|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
59598203|NCT03815240|75707774|FG003|COMPLETED|Intervention Allevyn Dressing||2|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
59598204|NCT03815240|75707775|FG004|COMPLETED|Intervention Allevyn Dressing||1|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
59598205|NCT03815240|75707776|FG005|COMPLETED|Intervention Allevyn Dressing||2|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
59598206|NCT03815240|75707777|FG006|COMPLETED|Intervention Allevyn Dressing||1|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
59598207|NCT03815240|75707778|FG007|COMPLETED|Intervention Allevyn Dressing||1|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
59598208|NCT03815240|75707779|FG008|COMPLETED|Intervention Allevyn Dressing||1|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
59598209|NCT03815240|75707771|FG000|NOT COMPLETED|Intervention Allevyn Dressing||0||
59598210|NCT03815240|75707772|FG001|NOT COMPLETED|Intervention Allevyn Dressing||0||
59598211|NCT03815240|75707773|FG002|NOT COMPLETED|Intervention Allevyn Dressing||0||
59598212|NCT03815240|75707774|FG003|NOT COMPLETED|Intervention Allevyn Dressing||0||
59598213|NCT03815240|75707775|FG004|NOT COMPLETED|Intervention Allevyn Dressing||0||
59598214|NCT03815240|75707776|FG005|NOT COMPLETED|Intervention Allevyn Dressing||0||
59598215|NCT03815240|75707777|FG006|NOT COMPLETED|Intervention Allevyn Dressing||0||
59598216|NCT03815240|75707778|FG007|NOT COMPLETED|Intervention Allevyn Dressing||0||
59598217|NCT03815240|75707779|FG008|NOT COMPLETED|Intervention Allevyn Dressing||0||
59598218|NCT03815240|75707771|FG000|STARTED|Intervention Optifoam Dressing||2|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
59598219|NCT03815240|75707772|FG001|STARTED|Intervention Optifoam Dressing||1|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
59598220|NCT03815240|75707773|FG002|STARTED|Intervention Optifoam Dressing||1|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
59598221|NCT03815240|75707774|FG003|STARTED|Intervention Optifoam Dressing||2|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
59598222|NCT03815240|75707775|FG004|STARTED|Intervention Optifoam Dressing||1|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
59598223|NCT03815240|75707776|FG005|STARTED|Intervention Optifoam Dressing||2|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
59598224|NCT03815240|75707777|FG006|STARTED|Intervention Optifoam Dressing||1|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
59598225|NCT03815240|75707778|FG007|STARTED|Intervention Optifoam Dressing||1|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
59598226|NCT03815240|75707779|FG008|STARTED|Intervention Optifoam Dressing||1|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
59598227|NCT03815240|75707771|FG000|COMPLETED|Intervention Optifoam Dressing||2|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
59598228|NCT03815240|75707772|FG001|COMPLETED|Intervention Optifoam Dressing||1|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
59598229|NCT03815240|75707773|FG002|COMPLETED|Intervention Optifoam Dressing||1|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
59598230|NCT03815240|75707774|FG003|COMPLETED|Intervention Optifoam Dressing||2|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
59598231|NCT03815240|75707775|FG004|COMPLETED|Intervention Optifoam Dressing||1|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
59598232|NCT03815240|75707776|FG005|COMPLETED|Intervention Optifoam Dressing||2|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
59598233|NCT03815240|75707777|FG006|COMPLETED|Intervention Optifoam Dressing||1|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
59598234|NCT03815240|75707778|FG007|COMPLETED|Intervention Optifoam Dressing||1|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
59598235|NCT03815240|75707779|FG008|COMPLETED|Intervention Optifoam Dressing||1|Cross-over study. Each of the 12 participants received each intervention once (total number is 12).|
59598236|NCT03815240|75707771|FG000|NOT COMPLETED|Intervention Optifoam Dressing||0||
59598237|NCT03815240|75707772|FG001|NOT COMPLETED|Intervention Optifoam Dressing||0||
59598238|NCT03815240|75707773|FG002|NOT COMPLETED|Intervention Optifoam Dressing||0||
59598239|NCT03815240|75707774|FG003|NOT COMPLETED|Intervention Optifoam Dressing||0||
59598240|NCT03815240|75707775|FG004|NOT COMPLETED|Intervention Optifoam Dressing||0||
59598241|NCT03815240|75707776|FG005|NOT COMPLETED|Intervention Optifoam Dressing||0||
59598242|NCT03815240|75707777|FG006|NOT COMPLETED|Intervention Optifoam Dressing||0||
59598243|NCT03815240|75707778|FG007|NOT COMPLETED|Intervention Optifoam Dressing||0||
59598244|NCT03815240|75707779|FG008|NOT COMPLETED|Intervention Optifoam Dressing||0||
59598245|NCT04071392|75707797|FG000|STARTED|Overall Study||12||
59598246|NCT04071392|75707798|FG001|STARTED|Overall Study||12||
59598247|NCT04071392|75707797|FG000|COMPLETED|Overall Study||10||
59598248|NCT04071392|75707798|FG001|COMPLETED|Overall Study||10||
59598249|NCT04071392|75707797|FG000|NOT COMPLETED|Overall Study||2||
59598250|NCT04071392|75707798|FG001|NOT COMPLETED|Overall Study||2||
59598251|NCT04045964|75707806|FG000|STARTED|Overall Study||16||
59598252|NCT04045964|75707807|FG001|STARTED|Overall Study||16||
59598253|NCT04045964|75707806|FG000|Intervention Visit(s)|Overall Study||15||
59598254|NCT04045964|75707807|FG001|Intervention Visit(s)|Overall Study||16||
59598255|NCT04045964|75707806|FG000|Follow up Visit 1|Overall Study||15||
59598256|NCT04045964|75707807|FG001|Follow up Visit 1|Overall Study||15||
59598257|NCT04045964|75707806|FG000|Follow up Visit 2|Overall Study||15||
59598258|NCT04045964|75707807|FG001|Follow up Visit 2|Overall Study||15||
59598259|NCT04045964|75707806|FG000|COMPLETED|Overall Study||15||
59598260|NCT04045964|75707807|FG001|COMPLETED|Overall Study||15||
59598261|NCT04045964|75707806|FG000|NOT COMPLETED|Overall Study||1||
59598262|NCT04045964|75707807|FG001|NOT COMPLETED|Overall Study||1||
59598263|NCT03941912|75707813|FG000|STARTED|Overall Study||44||
59598264|NCT03941912|75707813|FG000|COMPLETED|Overall Study||44||
59598265|NCT03941912|75707813|FG000|NOT COMPLETED|Overall Study||0||
59598266|NCT04048460|75707817|FG000|STARTED|Overall Study||10||
59598267|NCT04048460|75707817|FG000|COMPLETED|Overall Study||10||
59598268|NCT04048460|75707817|FG000|NOT COMPLETED|Overall Study||0||
59598269|NCT04016324|75707821|FG000|STARTED|Overall Study||110||
59598270|NCT04016324|75707821|FG000|COMPLETED|Overall Study||107||
59598271|NCT04016324|75707821|FG000|NOT COMPLETED|Overall Study||3||
59598272|NCT04039412|75707829|FG000|STARTED|Overall Study||110||
59598273|NCT04039412|75707830|FG001|STARTED|Overall Study||110||
59598274|NCT04039412|75707831|FG002|STARTED|Overall Study||110||
59598275|NCT04039412|75707829|FG000|COMPLETED|Overall Study||109||
59598276|NCT04039412|75707830|FG001|COMPLETED|Overall Study||107||
59598277|NCT04039412|75707831|FG002|COMPLETED|Overall Study||108||
59598278|NCT04039412|75707829|FG000|NOT COMPLETED|Overall Study||1||
59598279|NCT04039412|75707830|FG001|NOT COMPLETED|Overall Study||3||
59598280|NCT04039412|75707831|FG002|NOT COMPLETED|Overall Study||2||
59598281|NCT04036838|75707842|FG000|STARTED|Overall Study||415||
59598282|NCT04036838|75707842|FG000|COMPLETED|Overall Study||324||
59598283|NCT04036838|75707842|FG000|NOT COMPLETED|Overall Study||91||
59598284|NCT03831854|75707848|FG000|STARTED|Overall Study||23||
59598285|NCT03831854|75707849|FG001|STARTED|Overall Study||23||
59598286|NCT03831854|75707848|FG000|COMPLETED|Overall Study||23||
59598287|NCT03831854|75707849|FG001|COMPLETED|Overall Study||23||
59598288|NCT03831854|75707848|FG000|NOT COMPLETED|Overall Study||0||
59598289|NCT03831854|75707849|FG001|NOT COMPLETED|Overall Study||0||
59598290|NCT03806270|75707858|FG000|STARTED|Overall Study||15||
59598291|NCT03806270|75707859|FG001|STARTED|Overall Study||15||
59598292|NCT03806270|75707860|FG002|STARTED|Overall Study||15||
59598293|NCT03806270|75707858|FG000|COMPLETED|Overall Study||15||
59598294|NCT03806270|75707859|FG001|COMPLETED|Overall Study||15||
59598295|NCT03806270|75707860|FG002|COMPLETED|Overall Study||15||
59598296|NCT03806270|75707858|FG000|NOT COMPLETED|Overall Study||0||
59598297|NCT03806270|75707859|FG001|NOT COMPLETED|Overall Study||0||
59598298|NCT03806270|75707860|FG002|NOT COMPLETED|Overall Study||0||
59598299|NCT03828734|75707868|FG000|STARTED|Baseline||32||
59598300|NCT03828734|75707869|FG001|STARTED|Baseline||26||
59598301|NCT03828734|75707868|FG000|COMPLETED|Baseline||32||
59598302|NCT03828734|75707869|FG001|COMPLETED|Baseline||26||
59598303|NCT03828734|75707868|FG000|NOT COMPLETED|Baseline||0||
59598304|NCT03828734|75707869|FG001|NOT COMPLETED|Baseline||0||
59598305|NCT03828734|75707868|FG000|STARTED|Pre-Randomization (1 Week)||32||
59598306|NCT03828734|75707869|FG001|STARTED|Pre-Randomization (1 Week)||26||
59598307|NCT03828734|75707868|FG000|COMPLETED|Pre-Randomization (1 Week)||29||
59598308|NCT03828734|75707869|FG001|COMPLETED|Pre-Randomization (1 Week)||25||
59598309|NCT03828734|75707868|FG000|NOT COMPLETED|Pre-Randomization (1 Week)||3||
59598310|NCT03828734|75707869|FG001|NOT COMPLETED|Pre-Randomization (1 Week)||1||
59598311|NCT03828734|75707868|FG000|STARTED|First Intervention||29||
59598312|NCT03828734|75707869|FG001|STARTED|First Intervention||25||
59598313|NCT03828734|75707868|FG000|COMPLETED|First Intervention||25||
59598314|NCT03828734|75707869|FG001|COMPLETED|First Intervention||25||
59598315|NCT03828734|75707868|FG000|NOT COMPLETED|First Intervention||4||
59598316|NCT03828734|75707869|FG001|NOT COMPLETED|First Intervention||0||
59598317|NCT03828734|75707868|FG000|STARTED|First Washout (1 Week)||25||
59598318|NCT03828734|75707869|FG001|STARTED|First Washout (1 Week)||25||
59598319|NCT03828734|75707868|FG000|COMPLETED|First Washout (1 Week)||25||
59598320|NCT03828734|75707869|FG001|COMPLETED|First Washout (1 Week)||24||
59598321|NCT03828734|75707868|FG000|NOT COMPLETED|First Washout (1 Week)||0||
59598322|NCT03828734|75707869|FG001|NOT COMPLETED|First Washout (1 Week)||1||
59598323|NCT03828734|75707868|FG000|STARTED|Second Intervention||25||
59598324|NCT03828734|75707869|FG001|STARTED|Second Intervention||24||
59598325|NCT03828734|75707868|FG000|COMPLETED|Second Intervention||25||
59598326|NCT03828734|75707869|FG001|COMPLETED|Second Intervention||24||
59598327|NCT03828734|75707868|FG000|NOT COMPLETED|Second Intervention||0||
59598328|NCT03828734|75707869|FG001|NOT COMPLETED|Second Intervention||0||
59598329|NCT04033640|75707877|FG000|STARTED|Overall Study||1736||
59598330|NCT04033640|75707878|FG001|STARTED|Overall Study||18||
59598331|NCT04033640|75707877|FG000|COMPLETED|Overall Study||1736||
59598332|NCT04033640|75707878|FG001|COMPLETED|Overall Study||18||
59598333|NCT04033640|75707877|FG000|NOT COMPLETED|Overall Study||0||
59598334|NCT04033640|75707878|FG001|NOT COMPLETED|Overall Study||0||
59598335|NCT03497845|75707896|FG000|STARTED|Overall Study||60||
59598336|NCT03497845|75707897|FG001|STARTED|Overall Study||58||
59598337|NCT03497845|75707898|FG002|STARTED|Overall Study||61||
59598338|NCT03497845|75707899|FG003|STARTED|Overall Study||60||
59598339|NCT03497845|75707900|FG004|STARTED|Overall Study||59||
59598340|NCT03497845|75707901|FG005|STARTED|Overall Study||62||
59598341|NCT03497845|75707902|FG006|STARTED|Overall Study||59||
59598342|NCT03497845|75707903|FG007|STARTED|Overall Study||60||
59598343|NCT03497845|75707904|FG008|STARTED|Overall Study||61||
59598344|NCT03497845|75707905|FG009|STARTED|Overall Study||59||
59598345|NCT03497845|75707906|FG010|STARTED|Overall Study||61||
59598346|NCT03497845|75707907|FG011|STARTED|Overall Study||60||
59598347|NCT03497845|75707896|FG000|COMPLETED|Overall Study|Day 142|55|Groups A-D and G-J completed Day 142, Groups E, F, K, L completed Day 262.|
59598348|NCT03497845|75707897|FG001|COMPLETED|Overall Study|Day 142|45|Groups A-D and G-J completed Day 142, Groups E, F, K, L completed Day 262.|
59598349|NCT03497845|75707898|FG002|COMPLETED|Overall Study|Day 142|50|Groups A-D and G-J completed Day 142, Groups E, F, K, L completed Day 262.|
59598350|NCT03497845|75707899|FG003|COMPLETED|Overall Study|Day 142|50|Groups A-D and G-J completed Day 142, Groups E, F, K, L completed Day 262.|
59598351|NCT03497845|75707900|FG004|COMPLETED|Overall Study|Day 262|38|Groups A-D and G-J completed Day 142, Groups E, F, K, L completed Day 262.|
59598352|NCT03497845|75707901|FG005|COMPLETED|Overall Study|Day 262|44|Groups A-D and G-J completed Day 142, Groups E, F, K, L completed Day 262.|
59598353|NCT03497845|75707902|FG006|COMPLETED|Overall Study|Day 142|51|Groups A-D and G-J completed Day 142, Groups E, F, K, L completed Day 262.|
59598354|NCT03497845|75707903|FG007|COMPLETED|Overall Study|Day 142|50|Groups A-D and G-J completed Day 142, Groups E, F, K, L completed Day 262.|
59598355|NCT03497845|75707904|FG008|COMPLETED|Overall Study|Day 142|47|Groups A-D and G-J completed Day 142, Groups E, F, K, L completed Day 262.|
59598356|NCT03497845|75707905|FG009|COMPLETED|Overall Study|Day 142|53|Groups A-D and G-J completed Day 142, Groups E, F, K, L completed Day 262.|
59598357|NCT03497845|75707906|FG010|COMPLETED|Overall Study|Day 262|46|Groups A-D and G-J completed Day 142, Groups E, F, K, L completed Day 262.|
59598358|NCT03497845|75707907|FG011|COMPLETED|Overall Study|Day 262|38|Groups A-D and G-J completed Day 142, Groups E, F, K, L completed Day 262.|
59598359|NCT03497845|75707896|FG000|NOT COMPLETED|Overall Study||5||
59598360|NCT03497845|75707897|FG001|NOT COMPLETED|Overall Study||13||
59598361|NCT03497845|75707898|FG002|NOT COMPLETED|Overall Study||11||
59598362|NCT03497845|75707899|FG003|NOT COMPLETED|Overall Study||10||
59598363|NCT03497845|75707900|FG004|NOT COMPLETED|Overall Study||21||
59598364|NCT03497845|75707901|FG005|NOT COMPLETED|Overall Study||18||
59598365|NCT03497845|75707902|FG006|NOT COMPLETED|Overall Study||8||
59598366|NCT03497845|75707903|FG007|NOT COMPLETED|Overall Study||10||
59598367|NCT03497845|75707904|FG008|NOT COMPLETED|Overall Study||14||
59598368|NCT03497845|75707905|FG009|NOT COMPLETED|Overall Study||6||
59598369|NCT03497845|75707906|FG010|NOT COMPLETED|Overall Study||15||
59598370|NCT03497845|75707907|FG011|NOT COMPLETED|Overall Study||22||
59598371|NCT04036292|75707942|FG000|STARTED|Overall Study||260||
59598372|NCT04036292|75707943|FG001|STARTED|Overall Study||246||
59598373|NCT04036292|75707944|FG002|STARTED|Overall Study||252||
59598374|NCT04036292|75707942|FG000|COMPLETED|Overall Study||239||
59598375|NCT04036292|75707943|FG001|COMPLETED|Overall Study||212||
59598376|NCT04036292|75707944|FG002|COMPLETED|Overall Study||228||
59598377|NCT04036292|75707942|FG000|NOT COMPLETED|Overall Study||21||
59598378|NCT04036292|75707943|FG001|NOT COMPLETED|Overall Study||34||
59598379|NCT04036292|75707944|FG002|NOT COMPLETED|Overall Study||24||
59598380|NCT03501043|75707955|FG000|STARTED|Overall Study||11||
59598381|NCT03501043|75707955|FG000|COMPLETED|Overall Study||10||
59598382|NCT03501043|75707955|FG000|NOT COMPLETED|Overall Study||1||
59598383|NCT03261973|75707970|FG000|STARTED|Overall Study||47||
59598384|NCT03261973|75707970|FG000|COMPLETED|Overall Study||43||
59598385|NCT03261973|75707970|FG000|NOT COMPLETED|Overall Study||4||
59598386|NCT03820388|75707977|FG000|STARTED|Overall Study||25||
59598387|NCT03820388|75707978|FG001|STARTED|Overall Study||25||
59598388|NCT03820388|75707979|FG002|STARTED|Overall Study||25||
59998188|NCT02722499|76113828|FG002|COMPLETED|Overall Study||19||
59998189|NCT02722499|76113826|FG000|NOT COMPLETED|Overall Study||2||
59998190|NCT02722499|76113827|FG001|NOT COMPLETED|Overall Study||0||
59998191|NCT02722499|76113828|FG002|NOT COMPLETED|Overall Study||1||
59998192|NCT02721875|76113838|FG000|STARTED|Overall Study||1||
59598389|NCT03820388|75707977|FG000|COMPLETED|Overall Study||25||
59598390|NCT03820388|75707978|FG001|COMPLETED|Overall Study||25||
59598391|NCT03820388|75707979|FG002|COMPLETED|Overall Study||25||
59598392|NCT03820388|75707977|FG000|NOT COMPLETED|Overall Study||0||
59598393|NCT03820388|75707978|FG001|NOT COMPLETED|Overall Study||0||
59598394|NCT03820388|75707979|FG002|NOT COMPLETED|Overall Study||0||
59598395|NCT03264157|75707989|FG000|STARTED|Overall Study||81||
59598396|NCT03264157|75707990|FG001|STARTED|Overall Study||81||
59598397|NCT03264157|75707989|FG000|COMPLETED|Overall Study||68||
59598398|NCT03264157|75707990|FG001|COMPLETED|Overall Study||74||
59598399|NCT03264157|75707989|FG000|NOT COMPLETED|Overall Study||13||
59598400|NCT03264157|75707990|FG001|NOT COMPLETED|Overall Study||7||
59598401|NCT03820544|75708000|FG000|STARTED|Overall Study||2||
59598402|NCT03820544|75708001|FG001|STARTED|Overall Study||2||
59598403|NCT03820544|75708000|FG000|COMPLETED|Overall Study||2||
59598404|NCT03820544|75708001|FG001|COMPLETED|Overall Study||2||
59598405|NCT03820544|75708000|FG000|NOT COMPLETED|Overall Study||0||
59598406|NCT03820544|75708001|FG001|NOT COMPLETED|Overall Study||0||
59598407|NCT03400579|75708007|FG000|STARTED|Overall Study||10||
59598408|NCT03400579|75708007|FG000|COMPLETED|Overall Study||10||
59598409|NCT03400579|75708007|FG000|NOT COMPLETED|Overall Study||0||
59598410|NCT03801044|75708011|FG000|STARTED|Overall Study||21||
59598411|NCT03801044|75708011|FG000|COMPLETED|Overall Study||21||
59598412|NCT03801044|75708011|FG000|NOT COMPLETED|Overall Study||0||
59598413|NCT04029584|75708019|FG000|STARTED|Uninduced Study 1st Intervention (1 Day)||4||
59598414|NCT04029584|75708020|FG001|STARTED|Uninduced Study 1st Intervention (1 Day)||6||
59598415|NCT04029584|75708019|FG000|COMPLETED|Uninduced Study 1st Intervention (1 Day)||4||
59598416|NCT04029584|75708020|FG001|COMPLETED|Uninduced Study 1st Intervention (1 Day)||6||
59598417|NCT04029584|75708019|FG000|NOT COMPLETED|Uninduced Study 1st Intervention (1 Day)||0||
59598418|NCT04029584|75708020|FG001|NOT COMPLETED|Uninduced Study 1st Intervention (1 Day)||0||
59598419|NCT04029584|75708019|FG000|STARTED|Uninduced Washout (1 Day)||4||
59998193|NCT02721875|76113839|FG001|STARTED|Overall Study||0||
59998194|NCT02721875|76113838|FG000|COMPLETED|Overall Study||0||
59998195|NCT02721875|76113839|FG001|COMPLETED|Overall Study||0||
59998196|NCT02721875|76113838|FG000|NOT COMPLETED|Overall Study||1||
59998197|NCT02721875|76113839|FG001|NOT COMPLETED|Overall Study||0||
59998198|NCT02721251|76113848|FG000|STARTED|Overall Study||14||
59998199|NCT02721251|76113849|FG001|STARTED|Overall Study||16||
59998200|NCT02721251|76113850|FG002|STARTED|Overall Study||17||
59998201|NCT02721251|76113848|FG000|COMPLETED|Overall Study||4||
59998202|NCT02721251|76113849|FG001|COMPLETED|Overall Study||7||
59998203|NCT02721251|76113850|FG002|COMPLETED|Overall Study||6||
59998204|NCT02721251|76113848|FG000|NOT COMPLETED|Overall Study||10||
59598420|NCT04029584|75708020|FG001|STARTED|Uninduced Washout (1 Day)||6||
59598421|NCT04029584|75708019|FG000|COMPLETED|Uninduced Washout (1 Day)||4||
59598422|NCT04029584|75708020|FG001|COMPLETED|Uninduced Washout (1 Day)||6||
59598423|NCT04029584|75708019|FG000|NOT COMPLETED|Uninduced Washout (1 Day)||0||
59598424|NCT04029584|75708020|FG001|NOT COMPLETED|Uninduced Washout (1 Day)||0||
59598425|NCT04029584|75708019|FG000|STARTED|Uninduced Study 2nd Intervention (1 Day)||4||
59598426|NCT04029584|75708020|FG001|STARTED|Uninduced Study 2nd Intervention (1 Day)||6||
59598427|NCT04029584|75708019|FG000|COMPLETED|Uninduced Study 2nd Intervention (1 Day)||4||
59598428|NCT04029584|75708020|FG001|COMPLETED|Uninduced Study 2nd Intervention (1 Day)||6||
59598429|NCT04029584|75708019|FG000|NOT COMPLETED|Uninduced Study 2nd Intervention (1 Day)||0||
59598430|NCT04029584|75708020|FG001|NOT COMPLETED|Uninduced Study 2nd Intervention (1 Day)||0||
59998205|NCT02721251|76113849|FG001|NOT COMPLETED|Overall Study||9||
59998206|NCT02721251|76113850|FG002|NOT COMPLETED|Overall Study||11||
59998207|NCT00702221|76113861|FG000|STARTED|Overall Study||10||
59998208|NCT00702221|76113862|FG001|STARTED|Overall Study||10||
59998209|NCT00702221|76113861|FG000|COMPLETED|Overall Study||6||
59998210|NCT00702221|76113862|FG001|COMPLETED|Overall Study||7||
59998211|NCT00702221|76113861|FG000|NOT COMPLETED|Overall Study||4||
59998212|NCT00702221|76113862|FG001|NOT COMPLETED|Overall Study||3||
59998213|NCT00702143|76113871|FG000|STARTED|Overall Study||45||
59998214|NCT00702143|76113872|FG001|STARTED|Overall Study||60||
59998215|NCT00702143|76113873|FG002|STARTED|Overall Study||79||
59998216|NCT00702143|76113871|FG000|COMPLETED|Overall Study||45||
59998217|NCT00702143|76113872|FG001|COMPLETED|Overall Study||60||
59998218|NCT00702143|76113873|FG002|COMPLETED|Overall Study||78||
59998219|NCT00702143|76113871|FG000|NOT COMPLETED|Overall Study||0||
59998220|NCT00702143|76113872|FG001|NOT COMPLETED|Overall Study||0||
59998221|NCT00702143|76113873|FG002|NOT COMPLETED|Overall Study||1||
59998222|NCT00702923|76113879|FG000|STARTED|Overall Study||12||
59998223|NCT00702923|76113879|FG000|COMPLETED|Overall Study||11||
59998224|NCT00702923|76113879|FG000|NOT COMPLETED|Overall Study||1||
59998225|NCT02633787|76113884|FG000|STARTED|Overall Study||110||
59998226|NCT02633787|76113884|FG000|COMPLETED|Overall Study||109||
59998227|NCT02633787|76113884|FG000|NOT COMPLETED|Overall Study||1||
59998228|NCT02719691|76113895|FG000|STARTED|Overall Study||3||
59998229|NCT02719691|76113896|FG001|STARTED|Overall Study||4||
59998230|NCT02719691|76113897|FG002|STARTED|Overall Study||7||
59998231|NCT02719691|76113898|FG003|STARTED|Overall Study||2||
59998232|NCT02719691|76113899|FG004|STARTED|Overall Study||10||
59998233|NCT02719691|76113900|FG005|STARTED|Overall Study||10||
59998234|NCT02719691|76113901|FG006|STARTED|Overall Study||11||
59998235|NCT02719691|76113895|FG000|COMPLETED|Overall Study||3||
59998236|NCT02719691|76113896|FG001|COMPLETED|Overall Study||4||
59998237|NCT02719691|76113897|FG002|COMPLETED|Overall Study||6||
59998238|NCT02719691|76113898|FG003|COMPLETED|Overall Study||2||
59998239|NCT02719691|76113899|FG004|COMPLETED|Overall Study||10||
59998240|NCT02719691|76113900|FG005|COMPLETED|Overall Study||9||
59998241|NCT02719691|76113901|FG006|COMPLETED|Overall Study||11||
59998242|NCT02719691|76113895|FG000|NOT COMPLETED|Overall Study||0||
59998243|NCT02719691|76113896|FG001|NOT COMPLETED|Overall Study||0||
59998244|NCT02719691|76113897|FG002|NOT COMPLETED|Overall Study||1||
59998245|NCT02719691|76113898|FG003|NOT COMPLETED|Overall Study||0||
59998246|NCT02719691|76113899|FG004|NOT COMPLETED|Overall Study||0||
59998247|NCT02719691|76113900|FG005|NOT COMPLETED|Overall Study||1||
59998248|NCT02719691|76113901|FG006|NOT COMPLETED|Overall Study||0||
59998249|NCT02720081|76113920|FG000|STARTED|Overall Study||72||
59998250|NCT02720081|76113921|FG001|STARTED|Overall Study||70||
59998251|NCT02720081|76113920|FG000|Treated|Overall Study||70||
59998252|NCT02720081|76113921|FG001|Treated|Overall Study||69||
59998253|NCT02720081|76113920|FG000|COMPLETED|Overall Study||68||
59998254|NCT02720081|76113921|FG001|COMPLETED|Overall Study||66||
59998255|NCT02720081|76113920|FG000|NOT COMPLETED|Overall Study||4||
59998256|NCT02720081|76113921|FG001|NOT COMPLETED|Overall Study||4||
59998257|NCT04248933|76113927|FG000|STARTED|Overall Study|N = 37 participants were consented and determined to be eligible upon the completion of the baseline assessment.|37||
59998258|NCT04248933|76113927|FG000|Initiated Peer Activate|Overall Study|"Thirty-seven individuals were enrolled in the open-label trial (intent-to-treat sample), with the goal of reaching a minimum of n = 30 Peer Activate initiators (i.e., defined as completing ≥ 1 Peer Activate session). Of the N = 37 intent-to-treat sample, 32 participants completed at least one Peer Activate session and were defined as the treatment initiator group."|32||
59998259|NCT04248933|76113927|FG000|Completed Peer Activate Completers (>= 4 Sessions)|Overall Study|"Thirty-two individuals initiated the Peer Activate intervention, with the goal of reaching a minimum of n = 24 completers (i.e., defined as completing ≥ four Peer Activate sessions). Of the N = 32 treatment initiators group, 26 participants completed at least four Peer Activate sessions and were defined as the treatment completer group."|26||
59998260|NCT04248933|76113927|FG000|COMPLETED|Overall Study|Twenty-six participants completed the post-treatment assessment. This includes n=3 who completed the post-treatment assessment prior to the 4th session and excludes n=3 who completed 4 Peer Activate sessions but did not complete a post-treatment assessment.|26||
59998261|NCT04248933|76113927|FG000|NOT COMPLETED|Overall Study||11||
59998262|NCT02718131|76113933|FG000|STARTED|Overall Study||5||
59998263|NCT02718131|76113934|FG001|STARTED|Overall Study||0||
59998264|NCT02718131|76113933|FG000|Completed 12 Months|Overall Study||2||
59998265|NCT02718131|76113934|FG001|Completed 12 Months|Overall Study||0||
59998266|NCT02718131|76113933|FG000|COMPLETED|Overall Study||2||
59998267|NCT02718131|76113934|FG001|COMPLETED|Overall Study||0||
59998268|NCT02718131|76113933|FG000|NOT COMPLETED|Overall Study||3||
59998269|NCT02718131|76113934|FG001|NOT COMPLETED|Overall Study||0||
59998270|NCT04562597|76113946|FG000|STARTED|Overall Study||5||
59998271|NCT04562597|76113947|FG001|STARTED|Overall Study||5||
59998272|NCT04562597|76113948|FG002|STARTED|Overall Study||5||
59998273|NCT04562597|76113949|FG003|STARTED|Overall Study||5||
59998274|NCT04562597|76113950|FG004|STARTED|Overall Study||15||
59998275|NCT04562597|76113951|FG005|STARTED|Overall Study||15||
59998276|NCT04562597|76113946|FG000|COMPLETED|Overall Study||5||
59998277|NCT04562597|76113947|FG001|COMPLETED|Overall Study||5||
59998278|NCT04562597|76113948|FG002|COMPLETED|Overall Study||5||
59998279|NCT04562597|76113949|FG003|COMPLETED|Overall Study||5||
59998280|NCT04562597|76113950|FG004|COMPLETED|Overall Study||15||
59998281|NCT04562597|76113951|FG005|COMPLETED|Overall Study||15||
59998282|NCT04562597|76113946|FG000|NOT COMPLETED|Overall Study||0||
59998283|NCT04562597|76113947|FG001|NOT COMPLETED|Overall Study||0||
59998284|NCT04562597|76113948|FG002|NOT COMPLETED|Overall Study||0||
59998285|NCT04562597|76113949|FG003|NOT COMPLETED|Overall Study||0||
59998286|NCT04562597|76113950|FG004|NOT COMPLETED|Overall Study||0||
59998287|NCT04562597|76113951|FG005|NOT COMPLETED|Overall Study||0||
60129003|NCT01586156|76251262|FG000|COMPLETED|Overall Study||10||
60129004|NCT01586156|76251263|FG001|COMPLETED|Overall Study||9||
60129005|NCT01586156|76251264|FG002|COMPLETED|Overall Study||10||
60129006|NCT01586156|76251262|FG000|NOT COMPLETED|Overall Study||0||
60129007|NCT01586156|76251263|FG001|NOT COMPLETED|Overall Study||1||
60129008|NCT01586156|76251264|FG002|NOT COMPLETED|Overall Study||0||
60129009|NCT01459913|76251276|FG000|STARTED|Overall Study||106||
60129010|NCT01459913|76251277|FG001|STARTED|Overall Study||52||
60129011|NCT01459913|76251278|FG002|STARTED|Overall Study||19||
60129012|NCT01459913|76251279|FG003|STARTED|Overall Study||62||
60129013|NCT01459913|76251276|FG000|COMPLETED|Overall Study||65||
60129014|NCT01459913|76251277|FG001|COMPLETED|Overall Study||32||
60129015|NCT01459913|76251278|FG002|COMPLETED|Overall Study||6||
60129016|NCT01459913|76251279|FG003|COMPLETED|Overall Study||29||
60129017|NCT01459913|76251276|FG000|NOT COMPLETED|Overall Study||41||
60129018|NCT01459913|76251277|FG001|NOT COMPLETED|Overall Study||20||
60129019|NCT01459913|76251278|FG002|NOT COMPLETED|Overall Study||13||
60129020|NCT01459913|76251279|FG003|NOT COMPLETED|Overall Study||33||
60129021|NCT01458587|76251293|FG000|STARTED|Overall Study||35||
60129022|NCT01458587|76251294|FG001|STARTED|Overall Study||35||
60129023|NCT01458587|76251293|FG000|COMPLETED|Overall Study||34||
60129024|NCT01458587|76251294|FG001|COMPLETED|Overall Study||35||
60129025|NCT01458587|76251293|FG000|NOT COMPLETED|Overall Study||1||
60129026|NCT01458587|76251294|FG001|NOT COMPLETED|Overall Study||0||
60129027|NCT01458275|76251305|FG000|STARTED|Overall Study||283||
60129028|NCT01458275|76251306|FG001|STARTED|Overall Study||282||
60129029|NCT01458275|76251307|FG002|STARTED|Overall Study||282||
60129030|NCT01458275|76251305|FG000|COMPLETED|Overall Study||269||
60129031|NCT01458275|76251306|FG001|COMPLETED|Overall Study||269||
60129032|NCT01458275|76251307|FG002|COMPLETED|Overall Study||273||
60129033|NCT01458275|76251305|FG000|NOT COMPLETED|Overall Study||14||
60129034|NCT01458275|76251306|FG001|NOT COMPLETED|Overall Study||13||
60129035|NCT01458275|76251307|FG002|NOT COMPLETED|Overall Study||9||
60129036|NCT01458119|76251317|FG000|STARTED|Overall Study||85||
60129037|NCT01458119|76251317|FG000|Received at Least 1 Dose of Study Drug|Overall Study||85||
60129038|NCT01458119|76251317|FG000|Safety Population|Overall Study||85||
60129039|NCT01458119|76251317|FG000|Intent to Treat (ITT) Population|Overall Study||85|Received at least 1 dose of study drug.|
60129040|NCT01458119|76251317|FG000|ITT-Amenable Population|Overall Study||68|Amenable mutations based on Good Laboratory Practice (GLP) Human Embryonic Kidney (HEK) assay.|
60129041|NCT01458119|76251317|FG000|COMPLETED|Overall Study||65||
60129042|NCT01458119|76251317|FG000|NOT COMPLETED|Overall Study||20||
60129043|NCT02334527|76251322|FG000|STARTED|Overall Study||12||
60129044|NCT02334527|76251322|FG000|COMPLETED|Overall Study||12||
60129045|NCT02334527|76251322|FG000|NOT COMPLETED|Overall Study||0||
60129046|NCT01688726|76251332|FG000|STARTED|Overall Study||46||
60129047|NCT01688726|76251333|FG001|STARTED|Overall Study||45||
60129048|NCT01688726|76251332|FG000|COMPLETED|Overall Study||45||
60129049|NCT01688726|76251333|FG001|COMPLETED|Overall Study||44||
60129050|NCT01688726|76251332|FG000|NOT COMPLETED|Overall Study||1||
60129051|NCT01688726|76251333|FG001|NOT COMPLETED|Overall Study||1||
60129052|NCT01585766|76251349|FG000|STARTED|Overall Study||7||
60129053|NCT01585766|76251350|FG001|STARTED|Overall Study||5||
60129054|NCT01585766|76251351|FG002|STARTED|Overall Study||3||
60129055|NCT01585766|76251352|FG003|STARTED|Overall Study||4||
60129056|NCT01585766|76251353|FG004|STARTED|Overall Study||3||
60129057|NCT01585766|76251354|FG005|STARTED|Overall Study||6||
60129058|NCT01585766|76251349|FG000|COMPLETED|Overall Study||7||
60129059|NCT01585766|76251350|FG001|COMPLETED|Overall Study||3||
60129060|NCT01585766|76251351|FG002|COMPLETED|Overall Study||1||
59598431|NCT04029584|75708019|FG000|STARTED|Washout Between (>1 Week)||4||
59998288|NCT04504175|76113960|FG000|STARTED|Acute Phase||25||
59998289|NCT04504175|76113960|FG000|COMPLETED|Acute Phase||23||
59998290|NCT04504175|76113960|FG000|NOT COMPLETED|Acute Phase||2||
59998291|NCT04504175|76113960|FG000|STARTED|Continuation Phase||15||
59998292|NCT04504175|76113960|FG000|COMPLETED|Continuation Phase||15||
59998293|NCT04504175|76113960|FG000|NOT COMPLETED|Continuation Phase||0||
59998294|NCT02717195|76113969|FG000|STARTED|Prospective Confirmation (PC) Period||711||
60129061|NCT01585766|76251352|FG003|COMPLETED|Overall Study||4||
60129062|NCT01585766|76251353|FG004|COMPLETED|Overall Study||3||
60129063|NCT01585766|76251354|FG005|COMPLETED|Overall Study||6||
60129064|NCT01585766|76251349|FG000|NOT COMPLETED|Overall Study||0||
60129065|NCT01585766|76251350|FG001|NOT COMPLETED|Overall Study||2||
60129066|NCT01585766|76251351|FG002|NOT COMPLETED|Overall Study||2||
60129067|NCT01585766|76251352|FG003|NOT COMPLETED|Overall Study||0||
60129068|NCT01585766|76251353|FG004|NOT COMPLETED|Overall Study||0||
60129069|NCT01585766|76251354|FG005|NOT COMPLETED|Overall Study||0||
59998295|NCT02717195|76113970|FG001|STARTED|Prospective Confirmation (PC) Period||387||
59998296|NCT02717195|76113971|FG002|STARTED|Prospective Confirmation (PC) Period||0||
60129070|NCT01562444|76251378|FG000|STARTED|Overall Study||48||
60129071|NCT01562444|76251379|FG001|STARTED|Overall Study||51||
60129072|NCT01562444|76251380|FG002|STARTED|Overall Study||106||
60129073|NCT01562444|76251378|FG000|COMPLETED|Overall Study||43||
60129074|NCT01562444|76251379|FG001|COMPLETED|Overall Study||49||
60129075|NCT01562444|76251380|FG002|COMPLETED|Overall Study||99||
60129076|NCT01562444|76251378|FG000|NOT COMPLETED|Overall Study||5||
60129077|NCT01562444|76251379|FG001|NOT COMPLETED|Overall Study||2||
60129078|NCT01562444|76251380|FG002|NOT COMPLETED|Overall Study||7||
60129079|NCT01457339|76251390|FG000|STARTED|Period 1 (50 mg)||7||
60129080|NCT01457339|76251391|FG001|STARTED|Period 1 (50 mg)||24||
60129081|NCT01457339|76251390|FG000|COMPLETED|Period 1 (50 mg)||7||
60129082|NCT01457339|76251391|FG001|COMPLETED|Period 1 (50 mg)||24||
60129083|NCT01457339|76251390|FG000|NOT COMPLETED|Period 1 (50 mg)||0||
60129084|NCT01457339|76251391|FG001|NOT COMPLETED|Period 1 (50 mg)||0||
60129085|NCT01457339|76251390|FG000|STARTED|Period 2 (70 mg)||7||
60129086|NCT01457339|76251391|FG001|STARTED|Period 2 (70 mg)||24||
60129087|NCT01457339|76251390|FG000|COMPLETED|Period 2 (70 mg)||7||
60129088|NCT01457339|76251391|FG001|COMPLETED|Period 2 (70 mg)||24||
60129089|NCT01457339|76251390|FG000|NOT COMPLETED|Period 2 (70 mg)||0||
60129090|NCT01457339|76251391|FG001|NOT COMPLETED|Period 2 (70 mg)||0||
60129091|NCT01457339|76251390|FG000|STARTED|Period 3 (100 mg)||7||
60129092|NCT01457339|76251391|FG001|STARTED|Period 3 (100 mg)||24||
60129093|NCT01457339|76251390|FG000|COMPLETED|Period 3 (100 mg)||7||
60129094|NCT01457339|76251391|FG001|COMPLETED|Period 3 (100 mg)||23||
60129095|NCT01457339|76251390|FG000|NOT COMPLETED|Period 3 (100 mg)||0||
60129096|NCT01457339|76251391|FG001|NOT COMPLETED|Period 3 (100 mg)||1||
60129097|NCT01457339|76251390|FG000|STARTED|Period 4 (150 mg)||7||
60129098|NCT01457339|76251391|FG001|STARTED|Period 4 (150 mg)||23||
60129099|NCT01457339|76251390|FG000|COMPLETED|Period 4 (150 mg)||7||
60129100|NCT01457339|76251391|FG001|COMPLETED|Period 4 (150 mg)||23||
60129101|NCT01457339|76251390|FG000|NOT COMPLETED|Period 4 (150 mg)||0||
60129102|NCT01457339|76251391|FG001|NOT COMPLETED|Period 4 (150 mg)||0||
60129103|NCT01457339|76251390|FG000|STARTED|Period 5 (200 mg)||7||
60129104|NCT01457339|76251391|FG001|STARTED|Period 5 (200 mg)||23||
60129105|NCT01457339|76251390|FG000|COMPLETED|Period 5 (200 mg)||7||
60129106|NCT01457339|76251391|FG001|COMPLETED|Period 5 (200 mg)||22||
60129107|NCT01457339|76251390|FG000|NOT COMPLETED|Period 5 (200 mg)||0||
60129108|NCT01457339|76251391|FG001|NOT COMPLETED|Period 5 (200 mg)||1||
60129109|NCT01457339|76251390|FG000|STARTED|Period 6 (250 mg)||7||
60129110|NCT01457339|76251391|FG001|STARTED|Period 6 (250 mg)||22||
60129111|NCT01457339|76251390|FG000|COMPLETED|Period 6 (250 mg)||6||
60129112|NCT01457339|76251391|FG001|COMPLETED|Period 6 (250 mg)||21||
60129113|NCT01457339|76251390|FG000|NOT COMPLETED|Period 6 (250 mg)||1||
60129114|NCT01457339|76251391|FG001|NOT COMPLETED|Period 6 (250 mg)||1||
60129115|NCT01456949|76251414|FG000|STARTED|Enrollment||402||
60129116|NCT01456949|76251414|FG000|Treated|Enrollment||359|Enrolled subjects who underwent a study cryoablation procedure whether or not they met I/E criteria.|
60129117|NCT01456949|76251414|FG000|Modified Intent to Treat Group (mITT)|Enrollment||354|Enrolled subjects who met all I/E criteria and underwent a study cryoablation procedure.|
60129118|NCT01456949|76251414|FG000|COMPLETED|Enrollment|6 rollover subjects not included in final analysis. 359 treated; 354 treated & met all I/E criteria.|365||
60129119|NCT01456949|76251414|FG000|NOT COMPLETED|Enrollment||37||
60129120|NCT01456949|76251414|FG000|STARTED|Study Cryoablation Procedure & Follow-up||365||
60129121|NCT01456949|76251414|FG000|3-month Follow-up Visit Completed|Study Cryoablation Procedure & Follow-up|Of 354 subjects who were treated and met all I/E criteria (mITT group).|344||
60129122|NCT01456949|76251414|FG000|6-month Follow-up Visit Completed|Study Cryoablation Procedure & Follow-up|Of mITT group.|342||
60129123|NCT01456949|76251414|FG000|12-month Follow-up Visit Completed|Study Cryoablation Procedure & Follow-up|Of mITT group.|325||
60129124|NCT01456949|76251414|FG000|24-month Follow-up Visit Completed|Study Cryoablation Procedure & Follow-up|Of mITT group.|309||
60129125|NCT01456949|76251414|FG000|36-month Follow-up Visit Completed|Study Cryoablation Procedure & Follow-up|Of mITT group.|298||
60129126|NCT01456949|76251414|FG000|COMPLETED|Study Cryoablation Procedure & Follow-up|5 subjects completed at least 36 months of follow-up but did not complete a 36 month follow-up visit|303|Of mITT group.|
60129127|NCT01456949|76251414|FG000|NOT COMPLETED|Study Cryoablation Procedure & Follow-up||62||
60129128|NCT01456169|76251421|FG000|STARTED|Overall Study|Indicates participants who were randomized into the double-blind treatment period|133||
59598432|NCT04029584|75708020|FG001|STARTED|Washout Between (>1 Week)||6||
59598433|NCT04029584|75708019|FG000|COMPLETED|Washout Between (>1 Week)||4||
59598434|NCT04029584|75708020|FG001|COMPLETED|Washout Between (>1 Week)||6||
60129129|NCT01456169|76251422|FG001|STARTED|Overall Study|Indicates participants who were randomized into the double-blind treatment period|127||
60129130|NCT01456169|76251423|FG002|STARTED|Overall Study|Indicates participants who were randomized into the double-blind treatment period|135||
60129131|NCT01456169|76251421|FG000|COMPLETED|Overall Study||123||
60129132|NCT01456169|76251422|FG001|COMPLETED|Overall Study||122||
60129133|NCT01456169|76251423|FG002|COMPLETED|Overall Study||123||
60129134|NCT01456169|76251421|FG000|NOT COMPLETED|Overall Study||10||
60129135|NCT01456169|76251422|FG001|NOT COMPLETED|Overall Study||5||
60129136|NCT01456169|76251423|FG002|NOT COMPLETED|Overall Study||12||
60129137|NCT01454531|76251432|FG000|STARTED|Overall Study||196||
60129138|NCT01454531|76251432|FG000|Subjects Treated|Overall Study||192||
60129139|NCT01454531|76251432|FG000|COMPLETED|Overall Study||173||
60129140|NCT01454531|76251432|FG000|NOT COMPLETED|Overall Study||23||
60129141|NCT01454063|76251438|FG000|STARTED|Randomized||202||
60129142|NCT01454063|76251439|FG001|STARTED|Randomized||203||
60129143|NCT01454063|76251438|FG000|COMPLETED|Randomized||201||
60129144|NCT01454063|76251439|FG001|COMPLETED|Randomized||201||
60129145|NCT01454063|76251438|FG000|NOT COMPLETED|Randomized||1||
60129146|NCT01454063|76251439|FG001|NOT COMPLETED|Randomized||2||
60129147|NCT01454063|76251438|FG000|STARTED|Treated||201||
60129148|NCT01454063|76251439|FG001|STARTED|Treated||201||
60129149|NCT01454063|76251438|FG000|COMPLETED|Treated||199||
60129150|NCT01454063|76251439|FG001|COMPLETED|Treated||201||
60129151|NCT01454063|76251438|FG000|NOT COMPLETED|Treated||2||
60129152|NCT01454063|76251439|FG001|NOT COMPLETED|Treated||0||
60129153|NCT01453595|76251448|FG000|STARTED|Overall Study||2||
60129154|NCT01453595|76251449|FG001|STARTED|Overall Study||6||
60129155|NCT01453595|76251450|FG002|STARTED|Overall Study||2||
60129156|NCT01453595|76251448|FG000|COMPLETED|Overall Study||0||
60129157|NCT01453595|76251449|FG001|COMPLETED|Overall Study||5||
60129158|NCT01453595|76251450|FG002|COMPLETED|Overall Study||0||
60129159|NCT01453595|76251448|FG000|NOT COMPLETED|Overall Study||2||
60129160|NCT01453595|76251449|FG001|NOT COMPLETED|Overall Study||1||
60129161|NCT01453595|76251450|FG002|NOT COMPLETED|Overall Study||2||
60129162|NCT01453439|76251458|FG000|STARTED|Treatment Phase||61||
60129163|NCT01453439|76251459|FG001|STARTED|Treatment Phase||59||
60129164|NCT01453439|76251458|FG000|COMPLETED|Treatment Phase||44||
60129165|NCT01453439|76251459|FG001|COMPLETED|Treatment Phase||48||
60129166|NCT01453439|76251458|FG000|NOT COMPLETED|Treatment Phase||17||
60129167|NCT01453439|76251459|FG001|NOT COMPLETED|Treatment Phase||11||
60129168|NCT01453439|76251458|FG000|STARTED|Follow-up||44||
60129169|NCT01453439|76251459|FG001|STARTED|Follow-up||48||
60129170|NCT01453439|76251458|FG000|COMPLETED|Follow-up||39||
60129171|NCT01453439|76251459|FG001|COMPLETED|Follow-up||37||
60129172|NCT01453439|76251458|FG000|NOT COMPLETED|Follow-up||5||
60129173|NCT01453439|76251459|FG001|NOT COMPLETED|Follow-up||11||
60129174|NCT01453361|76251465|FG000|STARTED|Overall Study||18||
60129175|NCT01453361|76251465|FG000|COMPLETED|Overall Study||2|"Completed means subject had successful Vigil manufacturing and had been given all the doses."|
60129176|NCT01453361|76251465|FG000|NOT COMPLETED|Overall Study||16||
60129177|NCT01585298|76251469|FG000|STARTED|Overall Study||6998||
60129178|NCT01585298|76251469|FG000|COMPLETED|Overall Study||6961||
60129179|NCT01585298|76251469|FG000|NOT COMPLETED|Overall Study||37||
60129180|NCT01453205|76251476|FG000|STARTED|Overall Study||80||
60129181|NCT01453205|76251477|FG001|STARTED|Overall Study||52||
60129182|NCT01453205|76251478|FG002|STARTED|Overall Study||55||
60129183|NCT01453205|76251476|FG000|COMPLETED|Overall Study||0||
60129184|NCT01453205|76251477|FG001|COMPLETED|Overall Study||0||
60129185|NCT01453205|76251478|FG002|COMPLETED|Overall Study||1||
60129186|NCT01453205|76251476|FG000|NOT COMPLETED|Overall Study||80||
60129187|NCT01453205|76251477|FG001|NOT COMPLETED|Overall Study||52||
60129188|NCT01453205|76251478|FG002|NOT COMPLETED|Overall Study||54||
60129189|NCT01453049|76251491|FG000|STARTED|Overall Study||42||
60129190|NCT01453049|76251492|FG001|STARTED|Overall Study||44||
60129191|NCT01453049|76251491|FG000|COMPLETED|Overall Study||1||
60129192|NCT01453049|76251492|FG001|COMPLETED|Overall Study||2||
60129193|NCT01453049|76251491|FG000|NOT COMPLETED|Overall Study||41||
60129194|NCT01453049|76251492|FG001|NOT COMPLETED|Overall Study||42||
60129195|NCT01452347|76251500|FG000|STARTED|Overall Study||168||
60129196|NCT01452347|76251501|FG001|STARTED|Overall Study||84||
60129197|NCT01452347|76251500|FG000|COMPLETED|Overall Study||151||
60129198|NCT01452347|76251501|FG001|COMPLETED|Overall Study||77||
60129199|NCT01452347|76251500|FG000|NOT COMPLETED|Overall Study||17||
60129200|NCT01452347|76251501|FG001|NOT COMPLETED|Overall Study||7||
60129201|NCT01451723|76251511|FG000|STARTED|Overall Study||6||
60129202|NCT01451723|76251512|FG001|STARTED|Overall Study||5||
60129203|NCT01451723|76251511|FG000|COMPLETED|Overall Study||0||
60129204|NCT01451723|76251512|FG001|COMPLETED|Overall Study||0||
60129205|NCT01451723|76251511|FG000|NOT COMPLETED|Overall Study||6||
60129206|NCT01451723|76251512|FG001|NOT COMPLETED|Overall Study||5||
60129207|NCT01451645|76251520|FG000|STARTED|Overall Study||41||
60129208|NCT01451645|76251521|FG001|STARTED|Overall Study||41||
60129209|NCT01451645|76251520|FG000|COMPLETED|Overall Study||32||
60129210|NCT01451645|76251521|FG001|COMPLETED|Overall Study||33||
60129211|NCT01451645|76251520|FG000|NOT COMPLETED|Overall Study||9||
60129212|NCT01451645|76251521|FG001|NOT COMPLETED|Overall Study||8||
60129213|NCT01450943|76251530|FG000|STARTED|Overall Study||28||
60129214|NCT01450943|76251531|FG001|STARTED|Overall Study||42||
60129215|NCT01450943|76251532|FG002|STARTED|Overall Study||48||
60129216|NCT01450943|76251530|FG000|COMPLETED|Overall Study||26||
60129217|NCT01450943|76251531|FG001|COMPLETED|Overall Study||35||
60129218|NCT01450943|76251532|FG002|COMPLETED|Overall Study||42||
60129219|NCT01450943|76251530|FG000|NOT COMPLETED|Overall Study||2||
60129220|NCT01450943|76251531|FG001|NOT COMPLETED|Overall Study||7||
60129221|NCT01450943|76251532|FG002|NOT COMPLETED|Overall Study||6||
60129222|NCT01450631|76251546|FG000|STARTED|Overall Study||46||
60129223|NCT01450631|76251547|FG001|STARTED|Overall Study||46||
60129224|NCT01450631|76251546|FG000|COMPLETED|Overall Study||43||
60129225|NCT01450631|76251547|FG001|COMPLETED|Overall Study||42||
60129226|NCT01450631|76251546|FG000|NOT COMPLETED|Overall Study||3||
60129227|NCT01450631|76251547|FG001|NOT COMPLETED|Overall Study||4||
59598435|NCT04029584|75708019|FG000|NOT COMPLETED|Washout Between (>1 Week)||0||
59598436|NCT04029584|75708020|FG001|NOT COMPLETED|Washout Between (>1 Week)||0||
59598437|NCT04029584|75708019|FG000|STARTED|Induced Study 1st Intervention (1 Day)||2||
59598438|NCT04029584|75708020|FG001|STARTED|Induced Study 1st Intervention (1 Day)||8||
59598439|NCT04029584|75708019|FG000|COMPLETED|Induced Study 1st Intervention (1 Day)||2||
59598440|NCT04029584|75708020|FG001|COMPLETED|Induced Study 1st Intervention (1 Day)||8||
59598441|NCT04029584|75708019|FG000|NOT COMPLETED|Induced Study 1st Intervention (1 Day)||0||
59598442|NCT04029584|75708020|FG001|NOT COMPLETED|Induced Study 1st Intervention (1 Day)||0||
59598443|NCT04029584|75708019|FG000|STARTED|Induced Washout (1 Day)||2||
59598444|NCT04029584|75708020|FG001|STARTED|Induced Washout (1 Day)||8||
59598445|NCT04029584|75708019|FG000|COMPLETED|Induced Washout (1 Day)||2||
59598446|NCT04029584|75708020|FG001|COMPLETED|Induced Washout (1 Day)||8||
59598447|NCT04029584|75708019|FG000|NOT COMPLETED|Induced Washout (1 Day)||0||
59598448|NCT04029584|75708020|FG001|NOT COMPLETED|Induced Washout (1 Day)||0||
59598449|NCT04029584|75708019|FG000|STARTED|Induced Study 2nd Intervention (1 Day)||2||
59598450|NCT04029584|75708020|FG001|STARTED|Induced Study 2nd Intervention (1 Day)||8||
59598451|NCT04029584|75708019|FG000|COMPLETED|Induced Study 2nd Intervention (1 Day)||2||
59598452|NCT04029584|75708020|FG001|COMPLETED|Induced Study 2nd Intervention (1 Day)||8||
59598453|NCT04029584|75708019|FG000|NOT COMPLETED|Induced Study 2nd Intervention (1 Day)||0||
59598454|NCT04029584|75708020|FG001|NOT COMPLETED|Induced Study 2nd Intervention (1 Day)||0||
59598455|NCT04028960|75708032|FG000|STARTED|Overall Study||2||
59598456|NCT04028960|75708033|FG001|STARTED|Overall Study||2||
59598457|NCT04028960|75708032|FG000|COMPLETED|Overall Study||2||
59598458|NCT04028960|75708033|FG001|COMPLETED|Overall Study||2||
59598459|NCT04028960|75708032|FG000|NOT COMPLETED|Overall Study||0||
59598460|NCT04028960|75708033|FG001|NOT COMPLETED|Overall Study||0||
59598461|NCT03401671|75708041|FG000|STARTED|Overall Study||16||
59598462|NCT03401671|75708042|FG001|STARTED|Overall Study||16||
59598463|NCT03401671|75708041|FG000|COMPLETED|Overall Study||16||
59598464|NCT03401671|75708042|FG001|COMPLETED|Overall Study||16||
59598465|NCT03401671|75708041|FG000|NOT COMPLETED|Overall Study||0||
59598466|NCT03401671|75708042|FG001|NOT COMPLETED|Overall Study||0||
59598467|NCT04023578|75708048|FG000|STARTED|Overall Study||15||
59598468|NCT04023578|75708048|FG000|COMPLETED|Overall Study||13||
59598469|NCT04023578|75708048|FG000|NOT COMPLETED|Overall Study||2||
59598470|NCT03502915|75708055|FG000|STARTED|Overall Study||24||
59598471|NCT03502915|75708056|FG001|STARTED|Overall Study||24||
59598472|NCT03502915|75708055|FG000|COMPLETED|Overall Study||24||
59598473|NCT03502915|75708056|FG001|COMPLETED|Overall Study||24||
59728547|NCT00824161|75847175|FG000|NOT COMPLETED|Overall Study||2||
60129228|NCT01450007|76251556|FG000|STARTED|Overall Study||44||
60129229|NCT01450007|76251557|FG001|STARTED|Overall Study||42||
60129230|NCT01450007|76251558|FG002|STARTED|Overall Study||44||
60129231|NCT01450007|76251556|FG000|COMPLETED|Overall Study||42||
59598474|NCT03502915|75708055|FG000|NOT COMPLETED|Overall Study||0||
59598475|NCT03502915|75708056|FG001|NOT COMPLETED|Overall Study||0||
59598476|NCT03506347|75708064|FG000|STARTED|Overall Study||12||
59598477|NCT03506347|75708065|FG001|STARTED|Overall Study||12||
59598478|NCT03506347|75708064|FG000|COMPLETED|Overall Study||12||
59598479|NCT03506347|75708065|FG001|COMPLETED|Overall Study||12||
59598480|NCT03506347|75708064|FG000|NOT COMPLETED|Overall Study||0||
59598481|NCT03506347|75708065|FG001|NOT COMPLETED|Overall Study||0||
59598482|NCT04210232|75708071|FG000|STARTED|Overall Study||54||
59598483|NCT04210232|75708071|FG000|COMPLETED|Overall Study||54||
59598484|NCT04210232|75708071|FG000|NOT COMPLETED|Overall Study||0||
59598485|NCT04019990|75708075|FG000|STARTED|Overall Study||13||
59598486|NCT04019990|75708076|FG001|STARTED|Overall Study||15||
59598487|NCT04019990|75708075|FG000|COMPLETED|Overall Study||12||
59598488|NCT04019990|75708076|FG001|COMPLETED|Overall Study||12||
59598489|NCT04019990|75708075|FG000|NOT COMPLETED|Overall Study||1||
59598490|NCT04019990|75708076|FG001|NOT COMPLETED|Overall Study||3||
59598491|NCT03266419|75708084|FG000|STARTED|Overall Study||51||
59598492|NCT03266419|75708085|FG001|STARTED|Overall Study||49||
59598493|NCT03266419|75708084|FG000|COMPLETED|Overall Study||51||
59598494|NCT03266419|75708085|FG001|COMPLETED|Overall Study||49||
59598495|NCT03266419|75708084|FG000|NOT COMPLETED|Overall Study||0||
59598496|NCT03266419|75708085|FG001|NOT COMPLETED|Overall Study||0||
59598497|NCT03270943|75708093|FG000|STARTED|Intervention Refinement||6||
59598498|NCT03270943|75708094|FG001|STARTED|Intervention Refinement||9||
59598499|NCT03270943|75708093|FG000|COMPLETED|Intervention Refinement||6||
59598500|NCT03270943|75708094|FG001|COMPLETED|Intervention Refinement||6||
59598501|NCT03270943|75708093|FG000|NOT COMPLETED|Intervention Refinement||0||
59598502|NCT03270943|75708094|FG001|NOT COMPLETED|Intervention Refinement||3||
59598503|NCT03270943|75708093|FG000|STARTED|Randomized (Willingness to be)||30||
59598504|NCT03270943|75708094|FG001|STARTED|Randomized (Willingness to be)||32||
59598505|NCT03270943|75708093|FG000|COMPLETED|Randomized (Willingness to be)||30||
59728548|NCT00979134|75847184|FG000|STARTED|Overall Study||43||
60129232|NCT01450007|76251557|FG001|COMPLETED|Overall Study||37||
59598506|NCT03270943|75708094|FG001|COMPLETED|Randomized (Willingness to be)||31||
59598507|NCT03270943|75708093|FG000|NOT COMPLETED|Randomized (Willingness to be)||0||
59598508|NCT03270943|75708094|FG001|NOT COMPLETED|Randomized (Willingness to be)||1||
59598509|NCT03800030|75708100|FG000|STARTED|Baseline||4||
59598510|NCT03800030|75708101|FG001|STARTED|Baseline||4||
59598511|NCT03800030|75708102|FG002|STARTED|Baseline||4||
59598512|NCT03800030|75708103|FG003|STARTED|Baseline||6||
59598513|NCT03800030|75708104|FG004|STARTED|Baseline||4||
59598514|NCT03800030|75708105|FG005|STARTED|Baseline||4||
59598515|NCT03800030|75708100|FG000|COMPLETED|Baseline||4||
59598516|NCT03800030|75708101|FG001|COMPLETED|Baseline||4||
59598517|NCT03800030|75708102|FG002|COMPLETED|Baseline||4||
59598518|NCT03800030|75708103|FG003|COMPLETED|Baseline||6||
59598519|NCT03800030|75708104|FG004|COMPLETED|Baseline||4||
59598520|NCT03800030|75708105|FG005|COMPLETED|Baseline||4||
59598521|NCT03800030|75708100|FG000|NOT COMPLETED|Baseline||0||
59598522|NCT03800030|75708101|FG001|NOT COMPLETED|Baseline||0||
59598523|NCT03800030|75708102|FG002|NOT COMPLETED|Baseline||0||
59598524|NCT03800030|75708103|FG003|NOT COMPLETED|Baseline||0||
59598525|NCT03800030|75708104|FG004|NOT COMPLETED|Baseline||0||
59598526|NCT03800030|75708105|FG005|NOT COMPLETED|Baseline||0||
59598527|NCT03800030|75708100|FG000|STARTED|Pre-Randomization Period (1 Week)||4||
59598528|NCT03800030|75708101|FG001|STARTED|Pre-Randomization Period (1 Week)||4||
59598529|NCT03800030|75708102|FG002|STARTED|Pre-Randomization Period (1 Week)||4||
59598530|NCT03800030|75708103|FG003|STARTED|Pre-Randomization Period (1 Week)||6||
59598531|NCT03800030|75708104|FG004|STARTED|Pre-Randomization Period (1 Week)||4||
59598532|NCT03800030|75708105|FG005|STARTED|Pre-Randomization Period (1 Week)||4||
59598533|NCT03800030|75708100|FG000|COMPLETED|Pre-Randomization Period (1 Week)||4||
59598534|NCT03800030|75708101|FG001|COMPLETED|Pre-Randomization Period (1 Week)||4||
59598535|NCT03800030|75708102|FG002|COMPLETED|Pre-Randomization Period (1 Week)||4||
59598536|NCT03800030|75708103|FG003|COMPLETED|Pre-Randomization Period (1 Week)||6||
59598537|NCT03800030|75708104|FG004|COMPLETED|Pre-Randomization Period (1 Week)||4||
59598538|NCT03800030|75708105|FG005|COMPLETED|Pre-Randomization Period (1 Week)||4||
59598539|NCT03800030|75708100|FG000|NOT COMPLETED|Pre-Randomization Period (1 Week)||0||
59598540|NCT03800030|75708101|FG001|NOT COMPLETED|Pre-Randomization Period (1 Week)||0||
59598541|NCT03800030|75708102|FG002|NOT COMPLETED|Pre-Randomization Period (1 Week)||0||
59598542|NCT03800030|75708103|FG003|NOT COMPLETED|Pre-Randomization Period (1 Week)||0||
59598543|NCT03800030|75708104|FG004|NOT COMPLETED|Pre-Randomization Period (1 Week)||0||
59598544|NCT03800030|75708105|FG005|NOT COMPLETED|Pre-Randomization Period (1 Week)||0||
59598545|NCT03800030|75708100|FG000|STARTED|First Intervention||4||
59598546|NCT03800030|75708101|FG001|STARTED|First Intervention||4||
59598547|NCT03800030|75708102|FG002|STARTED|First Intervention||4||
59598548|NCT03800030|75708103|FG003|STARTED|First Intervention||6||
59598549|NCT03800030|75708104|FG004|STARTED|First Intervention||4||
59598550|NCT03800030|75708105|FG005|STARTED|First Intervention||4||
59598551|NCT03800030|75708100|FG000|COMPLETED|First Intervention||4||
59598552|NCT03800030|75708101|FG001|COMPLETED|First Intervention||4||
59598553|NCT03800030|75708102|FG002|COMPLETED|First Intervention||4||
59598554|NCT03800030|75708103|FG003|COMPLETED|First Intervention||6||
59598555|NCT03800030|75708104|FG004|COMPLETED|First Intervention||4||
59598556|NCT03800030|75708105|FG005|COMPLETED|First Intervention||4||
59598557|NCT03800030|75708100|FG000|NOT COMPLETED|First Intervention||0||
59598558|NCT03800030|75708101|FG001|NOT COMPLETED|First Intervention||0||
59598559|NCT03800030|75708102|FG002|NOT COMPLETED|First Intervention||0||
59598560|NCT03800030|75708103|FG003|NOT COMPLETED|First Intervention||0||
59598561|NCT03800030|75708104|FG004|NOT COMPLETED|First Intervention||0||
59598562|NCT03800030|75708105|FG005|NOT COMPLETED|First Intervention||0||
59598563|NCT03800030|75708100|FG000|STARTED|First Washout (1 Week)||4||
59598564|NCT03800030|75708101|FG001|STARTED|First Washout (1 Week)||4||
59598565|NCT03800030|75708102|FG002|STARTED|First Washout (1 Week)||4||
59598566|NCT03800030|75708103|FG003|STARTED|First Washout (1 Week)||6||
59598567|NCT03800030|75708104|FG004|STARTED|First Washout (1 Week)||4||
59598568|NCT03800030|75708105|FG005|STARTED|First Washout (1 Week)||4||
59598569|NCT03800030|75708100|FG000|COMPLETED|First Washout (1 Week)||4||
59598570|NCT03800030|75708101|FG001|COMPLETED|First Washout (1 Week)||4||
59598571|NCT03800030|75708102|FG002|COMPLETED|First Washout (1 Week)||4||
59598572|NCT03800030|75708103|FG003|COMPLETED|First Washout (1 Week)||6||
59598573|NCT03800030|75708104|FG004|COMPLETED|First Washout (1 Week)||4||
59598574|NCT03800030|75708105|FG005|COMPLETED|First Washout (1 Week)||4||
59598575|NCT03800030|75708100|FG000|NOT COMPLETED|First Washout (1 Week)||0||
59598576|NCT03800030|75708101|FG001|NOT COMPLETED|First Washout (1 Week)||0||
59598577|NCT03800030|75708102|FG002|NOT COMPLETED|First Washout (1 Week)||0||
59598578|NCT03800030|75708103|FG003|NOT COMPLETED|First Washout (1 Week)||0||
59598579|NCT03800030|75708104|FG004|NOT COMPLETED|First Washout (1 Week)||0||
59598580|NCT03800030|75708105|FG005|NOT COMPLETED|First Washout (1 Week)||0||
59598581|NCT03800030|75708100|FG000|STARTED|Second Intervention||4||
59598582|NCT03800030|75708101|FG001|STARTED|Second Intervention||4||
59598583|NCT03800030|75708102|FG002|STARTED|Second Intervention||4||
59598584|NCT03800030|75708103|FG003|STARTED|Second Intervention||6||
59598585|NCT03800030|75708104|FG004|STARTED|Second Intervention||4||
59598586|NCT03800030|75708105|FG005|STARTED|Second Intervention||4||
59598587|NCT03800030|75708100|FG000|COMPLETED|Second Intervention||4||
59598588|NCT03800030|75708101|FG001|COMPLETED|Second Intervention||4||
59598589|NCT03800030|75708102|FG002|COMPLETED|Second Intervention||4||
59598590|NCT03800030|75708103|FG003|COMPLETED|Second Intervention||5||
59598591|NCT03800030|75708104|FG004|COMPLETED|Second Intervention||4||
59598592|NCT03800030|75708105|FG005|COMPLETED|Second Intervention||4||
59598593|NCT03800030|75708100|FG000|NOT COMPLETED|Second Intervention||0||
59598594|NCT03800030|75708101|FG001|NOT COMPLETED|Second Intervention||0||
59598595|NCT03800030|75708102|FG002|NOT COMPLETED|Second Intervention||0||
59598596|NCT03800030|75708103|FG003|NOT COMPLETED|Second Intervention||1||
59598597|NCT03800030|75708104|FG004|NOT COMPLETED|Second Intervention||0||
59598598|NCT03800030|75708105|FG005|NOT COMPLETED|Second Intervention||0||
59598599|NCT03800030|75708100|FG000|STARTED|Second Washout (1 Week)||4||
59598600|NCT03800030|75708101|FG001|STARTED|Second Washout (1 Week)||4||
59598601|NCT03800030|75708102|FG002|STARTED|Second Washout (1 Week)||4||
59598602|NCT03800030|75708103|FG003|STARTED|Second Washout (1 Week)||5||
59598603|NCT03800030|75708104|FG004|STARTED|Second Washout (1 Week)||4||
59598604|NCT03800030|75708105|FG005|STARTED|Second Washout (1 Week)||4||
59598605|NCT03800030|75708100|FG000|COMPLETED|Second Washout (1 Week)||4||
59598606|NCT03800030|75708101|FG001|COMPLETED|Second Washout (1 Week)||4||
59598607|NCT03800030|75708102|FG002|COMPLETED|Second Washout (1 Week)||4||
59598608|NCT03800030|75708103|FG003|COMPLETED|Second Washout (1 Week)||4||
59598609|NCT03800030|75708104|FG004|COMPLETED|Second Washout (1 Week)||4||
59598610|NCT03800030|75708105|FG005|COMPLETED|Second Washout (1 Week)||4||
59598611|NCT03800030|75708100|FG000|NOT COMPLETED|Second Washout (1 Week)||0||
59598612|NCT03800030|75708101|FG001|NOT COMPLETED|Second Washout (1 Week)||0||
59598613|NCT03800030|75708102|FG002|NOT COMPLETED|Second Washout (1 Week)||0||
59598614|NCT03800030|75708103|FG003|NOT COMPLETED|Second Washout (1 Week)||1||
59598615|NCT03800030|75708104|FG004|NOT COMPLETED|Second Washout (1 Week)||0||
59598616|NCT03800030|75708105|FG005|NOT COMPLETED|Second Washout (1 Week)||0||
59598617|NCT03800030|75708100|FG000|STARTED|Third Intervention||4||
59598618|NCT03800030|75708101|FG001|STARTED|Third Intervention||4||
59598619|NCT03800030|75708102|FG002|STARTED|Third Intervention||4||
59598620|NCT03800030|75708103|FG003|STARTED|Third Intervention||4||
59598621|NCT03800030|75708104|FG004|STARTED|Third Intervention||4||
59598622|NCT03800030|75708105|FG005|STARTED|Third Intervention||4||
59598623|NCT03800030|75708100|FG000|COMPLETED|Third Intervention||4||
59598624|NCT03800030|75708101|FG001|COMPLETED|Third Intervention||4||
59598625|NCT03800030|75708102|FG002|COMPLETED|Third Intervention||4||
59598626|NCT03800030|75708103|FG003|COMPLETED|Third Intervention||4||
59598627|NCT03800030|75708104|FG004|COMPLETED|Third Intervention||4||
59598628|NCT03800030|75708105|FG005|COMPLETED|Third Intervention||4||
59598629|NCT03800030|75708100|FG000|NOT COMPLETED|Third Intervention||0||
59598630|NCT03800030|75708101|FG001|NOT COMPLETED|Third Intervention||0||
59598631|NCT03800030|75708102|FG002|NOT COMPLETED|Third Intervention||0||
59598632|NCT03800030|75708103|FG003|NOT COMPLETED|Third Intervention||0||
59598633|NCT03800030|75708104|FG004|NOT COMPLETED|Third Intervention||0||
59598634|NCT03800030|75708105|FG005|NOT COMPLETED|Third Intervention||0||
59598635|NCT03799484|75708113|FG000|STARTED|Overall Study||14||
59598636|NCT03799484|75708113|FG000|COMPLETED|Overall Study||14||
59598637|NCT03799484|75708113|FG000|NOT COMPLETED|Overall Study||0||
59598638|NCT04012970|75708122|FG000|STARTED|Intervention Session, 30 Minutes||26||
60129233|NCT01450007|76251558|FG002|COMPLETED|Overall Study||41||
60129234|NCT01450007|76251556|FG000|NOT COMPLETED|Overall Study||2||
59598639|NCT04012970|75708123|FG001|STARTED|Intervention Session, 30 Minutes||14||
59598640|NCT04012970|75708122|FG000|COMPLETED|Intervention Session, 30 Minutes||26||
59598641|NCT04012970|75708123|FG001|COMPLETED|Intervention Session, 30 Minutes||14||
59598642|NCT04012970|75708122|FG000|NOT COMPLETED|Intervention Session, 30 Minutes||0||
59598643|NCT04012970|75708123|FG001|NOT COMPLETED|Intervention Session, 30 Minutes||0||
59598644|NCT04012970|75708122|FG000|STARTED|Control Session, 30 Minutes||26||
59598645|NCT04012970|75708123|FG001|STARTED|Control Session, 30 Minutes||14||
59598646|NCT04012970|75708122|FG000|COMPLETED|Control Session, 30 Minutes||26||
59598647|NCT04012970|75708123|FG001|COMPLETED|Control Session, 30 Minutes||14||
59598648|NCT04012970|75708122|FG000|NOT COMPLETED|Control Session, 30 Minutes||0||
59598649|NCT04012970|75708123|FG001|NOT COMPLETED|Control Session, 30 Minutes||0||
59598650|NCT03508687|75708137|FG000|STARTED|Overall Study||2||
59598651|NCT03508687|75708138|FG001|STARTED|Overall Study||3||
59598652|NCT03508687|75708137|FG000|COMPLETED|Overall Study||2||
59598653|NCT03508687|75708138|FG001|COMPLETED|Overall Study||3||
59598654|NCT03508687|75708137|FG000|NOT COMPLETED|Overall Study||0||
59598655|NCT03508687|75708138|FG001|NOT COMPLETED|Overall Study||0||
59598656|NCT03999944|75708146|FG000|STARTED|First Sleep Night||26||
59598657|NCT03999944|75708147|FG001|STARTED|First Sleep Night||26||
59598658|NCT03999944|75708146|FG000|COMPLETED|First Sleep Night||22||
59598659|NCT03999944|75708147|FG001|COMPLETED|First Sleep Night||24||
59598660|NCT03999944|75708146|FG000|NOT COMPLETED|First Sleep Night||4||
59598661|NCT03999944|75708147|FG001|NOT COMPLETED|First Sleep Night||2||
59598662|NCT03999944|75708146|FG000|STARTED|Second Sleep Night||22||
60129235|NCT01450007|76251557|FG001|NOT COMPLETED|Overall Study||5||
59598663|NCT03999944|75708147|FG001|STARTED|Second Sleep Night||24||
59598664|NCT03999944|75708146|FG000|COMPLETED|Second Sleep Night||22||
59598665|NCT03999944|75708147|FG001|COMPLETED|Second Sleep Night||20||
59598666|NCT03999944|75708146|FG000|NOT COMPLETED|Second Sleep Night||0||
59598667|NCT03999944|75708147|FG001|NOT COMPLETED|Second Sleep Night||4||
59598668|NCT03273283|75708156|FG000|STARTED|Overall Study||99||
59598669|NCT03273283|75708157|FG001|STARTED|Overall Study||101||
59598670|NCT03273283|75708156|FG000|COMPLETED|Overall Study||72||
59598671|NCT03273283|75708157|FG001|COMPLETED|Overall Study||81||
59598672|NCT03273283|75708156|FG000|NOT COMPLETED|Overall Study||27||
59598673|NCT03273283|75708157|FG001|NOT COMPLETED|Overall Study||20||
59598674|NCT04290494|75708166|FG000|STARTED|Overall Study||10968||
59598675|NCT04290494|75708167|FG001|STARTED|Overall Study||17823||
60129236|NCT01450007|76251558|FG002|NOT COMPLETED|Overall Study||3||
60129237|NCT01496365|76251573|FG000|STARTED|Overall Study||112||
60129238|NCT01496365|76251574|FG001|STARTED|Overall Study||56||
60129239|NCT01496365|76251575|FG002|STARTED|Overall Study||57||
60129240|NCT01496365|76251576|FG003|STARTED|Overall Study||57||
60129241|NCT01496365|76251577|FG004|STARTED|Overall Study||57||
60129242|NCT01496365|76251578|FG005|STARTED|Overall Study||56||
60129243|NCT01496365|76251579|FG006|STARTED|Overall Study||57||
60129244|NCT01496365|76251573|FG000|COMPLETED|Overall Study||97||
60129245|NCT01496365|76251574|FG001|COMPLETED|Overall Study||41||
60129246|NCT01496365|76251575|FG002|COMPLETED|Overall Study||51||
60129247|NCT01496365|76251576|FG003|COMPLETED|Overall Study||53||
60129248|NCT01496365|76251577|FG004|COMPLETED|Overall Study||44||
60129249|NCT01496365|76251578|FG005|COMPLETED|Overall Study||46||
60129250|NCT01496365|76251579|FG006|COMPLETED|Overall Study||51||
60129251|NCT01496365|76251573|FG000|NOT COMPLETED|Overall Study||15||
60129252|NCT01496365|76251574|FG001|NOT COMPLETED|Overall Study||15||
59598676|NCT04290494|75708168|FG002|STARTED|Overall Study||13397||
59598677|NCT04290494|75708166|FG000|COMPLETED|Overall Study||10968||
59598678|NCT04290494|75708167|FG001|COMPLETED|Overall Study||17823||
59598679|NCT04290494|75708168|FG002|COMPLETED|Overall Study||13397||
59598680|NCT04290494|75708166|FG000|NOT COMPLETED|Overall Study||0||
59598681|NCT04290494|75708167|FG001|NOT COMPLETED|Overall Study||0||
59598682|NCT04290494|75708168|FG002|NOT COMPLETED|Overall Study||0||
59598683|NCT04005404|75708179|FG000|STARTED|Overall Study||43||
59598684|NCT04005404|75708180|FG001|STARTED|Overall Study||34||
59598685|NCT04005404|75708181|FG002|STARTED|Overall Study||3||
59598686|NCT04005404|75708179|FG000|COMPLETED|Overall Study||42||
59598687|NCT04005404|75708180|FG001|COMPLETED|Overall Study||33||
59598688|NCT04005404|75708181|FG002|COMPLETED|Overall Study||3||
59598689|NCT04005404|75708179|FG000|NOT COMPLETED|Overall Study||1||
59598690|NCT04005404|75708180|FG001|NOT COMPLETED|Overall Study||1||
59598691|NCT04005404|75708181|FG002|NOT COMPLETED|Overall Study||0||
59598692|NCT03232892|75708189|FG000|STARTED|Overall Study||1||
59598693|NCT03232892|75708189|FG000|COMPLETED|Overall Study||1||
59598694|NCT03232892|75708189|FG000|NOT COMPLETED|Overall Study||0||
59598695|NCT03787472|75708193|FG000|STARTED|Period 1||23||
59598696|NCT03787472|75708194|FG001|STARTED|Period 1||22||
59598697|NCT03787472|75708193|FG000|COMPLETED|Period 1||23||
59598698|NCT03787472|75708194|FG001|COMPLETED|Period 1||22||
59598699|NCT03787472|75708193|FG000|NOT COMPLETED|Period 1||0||
59598700|NCT03787472|75708194|FG001|NOT COMPLETED|Period 1||0||
59598701|NCT03787472|75708193|FG000|STARTED|Period 2||23||
59598702|NCT03787472|75708194|FG001|STARTED|Period 2||22||
59598703|NCT03787472|75708193|FG000|COMPLETED|Period 2||23||
59598704|NCT03787472|75708194|FG001|COMPLETED|Period 2||22||
59598705|NCT03787472|75708193|FG000|NOT COMPLETED|Period 2||0||
59598706|NCT03787472|75708194|FG001|NOT COMPLETED|Period 2||0||
59598707|NCT03778190|75708200|FG000|STARTED|Overall Study||10||
59598708|NCT03778190|75708200|FG000|COMPLETED|Overall Study||10||
59598709|NCT03778190|75708200|FG000|NOT COMPLETED|Overall Study||0||
59598710|NCT03510481|75708208|FG000|STARTED|Year 1||69||
59598711|NCT03510481|75708209|FG001|STARTED|Year 1||70||
59598712|NCT03510481|75708210|FG002|STARTED|Year 1||36||
59598713|NCT03510481|75708211|FG003|STARTED|Year 1||35||
59598714|NCT03510481|75708208|FG000|COMPLETED|Year 1||56||
59598715|NCT03510481|75708209|FG001|COMPLETED|Year 1||61||
59598716|NCT03510481|75708210|FG002|COMPLETED|Year 1||34||
59598717|NCT03510481|75708211|FG003|COMPLETED|Year 1||31||
60129253|NCT01496365|76251575|FG002|NOT COMPLETED|Overall Study||6||
60129254|NCT01496365|76251576|FG003|NOT COMPLETED|Overall Study||4||
60129255|NCT01496365|76251577|FG004|NOT COMPLETED|Overall Study||13||
60129256|NCT01496365|76251578|FG005|NOT COMPLETED|Overall Study||10||
60129257|NCT01496365|76251579|FG006|NOT COMPLETED|Overall Study||6||
60129258|NCT01496287|76251595|FG000|STARTED|Overall Study||70||
60129259|NCT01496287|76251595|FG000|COMPLETED|Overall Study||64||
60129260|NCT01496287|76251595|FG000|NOT COMPLETED|Overall Study||6||
60129261|NCT01495975|76251602|FG000|STARTED|Overall Study||15||
60129262|NCT01495975|76251603|FG001|STARTED|Overall Study||14||
60129263|NCT01495975|76251602|FG000|COMPLETED|Overall Study||14||
60129264|NCT01495975|76251603|FG001|COMPLETED|Overall Study||14||
60129265|NCT01495975|76251602|FG000|NOT COMPLETED|Overall Study||1||
60129266|NCT01495975|76251603|FG001|NOT COMPLETED|Overall Study||0||
60129267|NCT01468987|76251611|FG000|STARTED|Overall Study||691||
60129268|NCT01468987|76251612|FG001|STARTED|Overall Study||678||
60129269|NCT01468987|76251611|FG000|Received at Least 1 Dose of Study Drug|Overall Study||691||
60129270|NCT01468987|76251612|FG001|Received at Least 1 Dose of Study Drug|Overall Study||677||
60129271|NCT01468987|76251611|FG000|COMPLETED|Overall Study||620||
60129272|NCT01468987|76251612|FG001|COMPLETED|Overall Study||618||
60129273|NCT01468987|76251611|FG000|NOT COMPLETED|Overall Study||71||
60129274|NCT01468987|76251612|FG001|NOT COMPLETED|Overall Study||60||
60129275|NCT01687712|76251622|FG000|STARTED|Cycle 1||549||
60129276|NCT01687712|76251623|FG001|STARTED|Cycle 1||551||
60129277|NCT01687712|76251622|FG000|Received hCG|Cycle 1||516||
60129278|NCT01687712|76251623|FG001|Received hCG|Cycle 1||520||
60129279|NCT01687712|76251622|FG000|Oocyte/Ovum Pick Up|Cycle 1||513||
60129280|NCT01687712|76251623|FG001|Oocyte/Ovum Pick Up|Cycle 1||517||
60129281|NCT01687712|76251622|FG000|Fertilization Performed|Cycle 1||508||
60129282|NCT01687712|76251623|FG001|Fertilization Performed|Cycle 1||512||
60129283|NCT01687712|76251622|FG000|Embryo Transfer|Cycle 1||466||
60129284|NCT01687712|76251623|FG001|Embryo Transfer|Cycle 1||483||
60129285|NCT01687712|76251622|FG000|Biochemical Pregnancy|Cycle 1||163||
60129286|NCT01687712|76251623|FG001|Biochemical Pregnancy|Cycle 1||203||
60129287|NCT01687712|76251622|FG000|Clinical Pregnancy|Cycle 1||114|Ascertained via an ultrasound scan.|
60129288|NCT01687712|76251623|FG001|Clinical Pregnancy|Cycle 1||138|Ascertained via an ultrasound scan.|
60129289|NCT01687712|76251622|FG000|COMPLETED|Cycle 1||101|A subject is listed as Completed if they delivered at least one live neonate.|
60129290|NCT01687712|76251623|FG001|COMPLETED|Cycle 1||122|A subject is listed as Completed if they delivered at least one live neonate.|
60129291|NCT01687712|76251622|FG000|NOT COMPLETED|Cycle 1||448||
60129292|NCT01687712|76251623|FG001|NOT COMPLETED|Cycle 1||429||
60129293|NCT01687712|76251622|FG000|STARTED|Cycle 2||109||
60129294|NCT01687712|76251623|FG001|STARTED|Cycle 2||120||
60129295|NCT01687712|76251622|FG000|Received hCG|Cycle 2||107||
60129296|NCT01687712|76251623|FG001|Received hCG|Cycle 2||119||
60129297|NCT01687712|76251622|FG000|Oocyte/Ovum Pick Up|Cycle 2||107||
60129298|NCT01687712|76251623|FG001|Oocyte/Ovum Pick Up|Cycle 2||119||
60129299|NCT01687712|76251622|FG000|Fertilization Performed|Cycle 2||106||
60129300|NCT01687712|76251623|FG001|Fertilization Performed|Cycle 2||119||
60129301|NCT01687712|76251622|FG000|Embryo Transfer|Cycle 2||101||
60129302|NCT01687712|76251623|FG001|Embryo Transfer|Cycle 2||117||
60129303|NCT01687712|76251622|FG000|Biochemical Pregnancy|Cycle 2||35||
60129304|NCT01687712|76251623|FG001|Biochemical Pregnancy|Cycle 2||43||
60129305|NCT01687712|76251622|FG000|Clinical Pregnancy|Cycle 2||17|Ascertained via an ultrasound scan.|
60129306|NCT01687712|76251623|FG001|Clinical Pregnancy|Cycle 2||26|Ascertained via an ultrasound scan.|
60129307|NCT01687712|76251622|FG000|COMPLETED|Cycle 2||16|A subject is listed as Completed if they delivered at least one live neonate.|
60129308|NCT01687712|76251623|FG001|COMPLETED|Cycle 2||25|A subject is listed as Completed if they delivered at least one live neonate.|
60129309|NCT01687712|76251622|FG000|NOT COMPLETED|Cycle 2||93||
60129310|NCT01687712|76251623|FG001|NOT COMPLETED|Cycle 2||95||
60129311|NCT01687712|76251622|FG000|STARTED|Cycle 3||28||
60129312|NCT01687712|76251623|FG001|STARTED|Cycle 3||24||
60129313|NCT01687712|76251622|FG000|Received hCG|Cycle 3||27||
60129314|NCT01687712|76251623|FG001|Received hCG|Cycle 3||24||
60129315|NCT01687712|76251622|FG000|Ooctye/Ovum Pick-Up|Cycle 3||27||
60129316|NCT01687712|76251623|FG001|Ooctye/Ovum Pick-Up|Cycle 3||24||
60129317|NCT01687712|76251622|FG000|Fertilization Performed|Cycle 3||27||
60129318|NCT01687712|76251623|FG001|Fertilization Performed|Cycle 3||24||
60129319|NCT01687712|76251622|FG000|Embryo Transfer|Cycle 3||26||
60129320|NCT01687712|76251623|FG001|Embryo Transfer|Cycle 3||24||
60129321|NCT01687712|76251622|FG000|Biochemically Pregnant|Cycle 3||7||
60129322|NCT01687712|76251623|FG001|Biochemically Pregnant|Cycle 3||2||
60129323|NCT01687712|76251622|FG000|Clinical Pregnancy|Cycle 3||5|Ascertained via an ultrasound scan.|
60129324|NCT01687712|76251623|FG001|Clinical Pregnancy|Cycle 3||0|Ascertained via an ultrasound scan.|
60129325|NCT01687712|76251622|FG000|COMPLETED|Cycle 3||4|A subject is listed as Completed if they delivered at least one live neonate.|
60129326|NCT01687712|76251623|FG001|COMPLETED|Cycle 3||0|A subject is listed as Completed if they delivered at least one live neonate.|
60129327|NCT01687712|76251622|FG000|NOT COMPLETED|Cycle 3||24||
60129328|NCT01687712|76251623|FG001|NOT COMPLETED|Cycle 3||24||
60129329|NCT01603628|76251636|FG000|STARTED|Overall Study||128||
60129330|NCT01603628|76251637|FG001|STARTED|Overall Study||126||
60129331|NCT01603628|76251638|FG002|STARTED|Overall Study||130||
60129332|NCT01603628|76251636|FG000|Safety Population: Received Treatment|Overall Study||128||
60129333|NCT01603628|76251637|FG001|Safety Population: Received Treatment|Overall Study||126||
60129334|NCT01603628|76251638|FG002|Safety Population: Received Treatment|Overall Study||128||
60129335|NCT01603628|76251636|FG000|COMPLETED|Overall Study||125||
60129336|NCT01603628|76251637|FG001|COMPLETED|Overall Study||123||
60129337|NCT01603628|76251638|FG002|COMPLETED|Overall Study||128||
60129338|NCT01603628|76251636|FG000|NOT COMPLETED|Overall Study||3||
60129339|NCT01603628|76251637|FG001|NOT COMPLETED|Overall Study||3||
60129340|NCT01603628|76251638|FG002|NOT COMPLETED|Overall Study||2||
60129341|NCT01453153|76251649|FG000|STARTED|Overall Study||4||
60129342|NCT01453153|76251650|FG001|STARTED|Overall Study||4||
60129343|NCT01453153|76251651|FG002|STARTED|Overall Study||20||
60129344|NCT01453153|76251649|FG000|COMPLETED|Overall Study||0||
60129345|NCT01453153|76251650|FG001|COMPLETED|Overall Study||0||
60129346|NCT01453153|76251651|FG002|COMPLETED|Overall Study||0||
60129347|NCT01453153|76251649|FG000|NOT COMPLETED|Overall Study||4||
60129348|NCT01453153|76251650|FG001|NOT COMPLETED|Overall Study||4||
60129349|NCT01453153|76251651|FG002|NOT COMPLETED|Overall Study||20||
60129350|NCT01584440|76251665|FG000|STARTED|Stage 1 (5 Weeks)||93||
60129351|NCT01584440|76251666|FG001|STARTED|Stage 1 (5 Weeks)||127||
60129352|NCT01584440|76251667|FG002|STARTED|Stage 1 (5 Weeks)||0||
60129353|NCT01584440|76251668|FG003|STARTED|Stage 1 (5 Weeks)||0||
60129354|NCT01584440|76251669|FG004|STARTED|Stage 1 (5 Weeks)||0||
60129355|NCT01584440|76251665|FG000|COMPLETED|Stage 1 (5 Weeks)||83||
60129356|NCT01584440|76251666|FG001|COMPLETED|Stage 1 (5 Weeks)||119||
60129357|NCT01584440|76251667|FG002|COMPLETED|Stage 1 (5 Weeks)||0||
60129358|NCT01584440|76251668|FG003|COMPLETED|Stage 1 (5 Weeks)||0||
60129359|NCT01584440|76251669|FG004|COMPLETED|Stage 1 (5 Weeks)||0||
60129360|NCT01584440|76251665|FG000|NOT COMPLETED|Stage 1 (5 Weeks)||10||
60129361|NCT01584440|76251666|FG001|NOT COMPLETED|Stage 1 (5 Weeks)||8||
60129362|NCT01584440|76251667|FG002|NOT COMPLETED|Stage 1 (5 Weeks)||0||
60129363|NCT01584440|76251668|FG003|NOT COMPLETED|Stage 1 (5 Weeks)||0||
60129364|NCT01584440|76251669|FG004|NOT COMPLETED|Stage 1 (5 Weeks)||0||
60129365|NCT01584440|76251665|FG000|STARTED|Stage 2 (5 Weeks)||0||
60129366|NCT01584440|76251666|FG001|STARTED|Stage 2 (5 Weeks)||0||
60129367|NCT01584440|76251667|FG002|STARTED|Stage 2 (5 Weeks)||83||
60129368|NCT01584440|76251668|FG003|STARTED|Stage 2 (5 Weeks)||59||
60129369|NCT01584440|76251669|FG004|STARTED|Stage 2 (5 Weeks)||60||
60129370|NCT01584440|76251665|FG000|COMPLETED|Stage 2 (5 Weeks)||0||
60129371|NCT01584440|76251666|FG001|COMPLETED|Stage 2 (5 Weeks)||0||
60129372|NCT01584440|76251667|FG002|COMPLETED|Stage 2 (5 Weeks)||80||
60129373|NCT01584440|76251668|FG003|COMPLETED|Stage 2 (5 Weeks)||55||
60129374|NCT01584440|76251669|FG004|COMPLETED|Stage 2 (5 Weeks)||59||
60129375|NCT01584440|76251665|FG000|NOT COMPLETED|Stage 2 (5 Weeks)||0||
60129376|NCT01584440|76251666|FG001|NOT COMPLETED|Stage 2 (5 Weeks)||0||
60129377|NCT01584440|76251667|FG002|NOT COMPLETED|Stage 2 (5 Weeks)||3||
60129378|NCT01584440|76251668|FG003|NOT COMPLETED|Stage 2 (5 Weeks)||4||
60129379|NCT01584440|76251669|FG004|NOT COMPLETED|Stage 2 (5 Weeks)||1||
60129380|NCT01687478|76251684|FG000|STARTED|Overall Study||88||
60129381|NCT01687478|76251685|FG001|STARTED|Overall Study||88||
60129382|NCT01687478|76251684|FG000|Safety Analysis Set|Overall Study||88||
60129383|NCT01687478|76251685|FG001|Safety Analysis Set|Overall Study||87||
60129384|NCT01687478|76251684|FG000|COMPLETED|Overall Study||56||
60129385|NCT01687478|76251685|FG001|COMPLETED|Overall Study||49||
60129386|NCT01687478|76251684|FG000|NOT COMPLETED|Overall Study||32||
60129387|NCT01687478|76251685|FG001|NOT COMPLETED|Overall Study||39||
60129388|NCT01468909|76251693|FG000|STARTED|Overall Study||52||
60129389|NCT01468909|76251694|FG001|STARTED|Overall Study||54||
60129390|NCT01468909|76251693|FG000|COMPLETED|Overall Study||50||
60129391|NCT01468909|76251694|FG001|COMPLETED|Overall Study||52||
60129392|NCT01468909|76251693|FG000|NOT COMPLETED|Overall Study||2||
60129393|NCT01468909|76251694|FG001|NOT COMPLETED|Overall Study||2||
60129394|NCT01468597|76251700|FG000|STARTED|Overall Study||184||
60129395|NCT01468597|76251700|FG000|COMPLETED|Overall Study||149||
60129396|NCT01468597|76251700|FG000|NOT COMPLETED|Overall Study||35||
60129397|NCT01687166|76251708|FG000|STARTED|Overall Study||167||
60129398|NCT01687166|76251709|FG001|STARTED|Overall Study||172||
60129399|NCT01687166|76251710|FG002|STARTED|Overall Study||56||
60129400|NCT01687166|76251711|FG003|STARTED|Overall Study||3||
60129401|NCT01687166|76251708|FG000|COMPLETED|Overall Study||139||
60129402|NCT01687166|76251709|FG001|COMPLETED|Overall Study||145||
60129403|NCT01687166|76251710|FG002|COMPLETED|Overall Study||42||
60129404|NCT01687166|76251711|FG003|COMPLETED|Overall Study||1||
60129405|NCT01687166|76251708|FG000|NOT COMPLETED|Overall Study||28||
60129406|NCT01687166|76251709|FG001|NOT COMPLETED|Overall Study||27||
60129407|NCT01687166|76251710|FG002|NOT COMPLETED|Overall Study||14||
60129408|NCT01687166|76251711|FG003|NOT COMPLETED|Overall Study||2||
60129409|NCT01561976|76251725|FG000|STARTED|Period 1||5||
60129410|NCT01561976|76251726|FG001|STARTED|Period 1||5||
60129411|NCT01561976|76251727|FG002|STARTED|Period 1||5||
60129412|NCT01561976|76251728|FG003|STARTED|Period 1||5||
60129413|NCT01561976|76251729|FG004|STARTED|Period 1||5||
60129414|NCT01561976|76251730|FG005|STARTED|Period 1||5||
60129415|NCT01561976|76251725|FG000|COMPLETED|Period 1||5||
60129416|NCT01561976|76251726|FG001|COMPLETED|Period 1||5||
60129417|NCT01561976|76251727|FG002|COMPLETED|Period 1||4||
60129418|NCT01561976|76251728|FG003|COMPLETED|Period 1||5||
60129419|NCT01561976|76251729|FG004|COMPLETED|Period 1||5||
60129420|NCT01561976|76251730|FG005|COMPLETED|Period 1||5||
60129421|NCT01561976|76251725|FG000|NOT COMPLETED|Period 1||0||
60129422|NCT01561976|76251726|FG001|NOT COMPLETED|Period 1||0||
60129423|NCT01561976|76251727|FG002|NOT COMPLETED|Period 1||1||
60129424|NCT01561976|76251728|FG003|NOT COMPLETED|Period 1||0||
60129425|NCT01561976|76251729|FG004|NOT COMPLETED|Period 1||0||
60129426|NCT01561976|76251730|FG005|NOT COMPLETED|Period 1||0||
60129427|NCT01561976|76251725|FG000|STARTED|Washout Period 1 (7 Days)||5||
60129428|NCT01561976|76251726|FG001|STARTED|Washout Period 1 (7 Days)||5||
60129429|NCT01561976|76251727|FG002|STARTED|Washout Period 1 (7 Days)||4||
60129430|NCT01561976|76251728|FG003|STARTED|Washout Period 1 (7 Days)||5||
60129431|NCT01561976|76251729|FG004|STARTED|Washout Period 1 (7 Days)||5||
60129432|NCT01561976|76251730|FG005|STARTED|Washout Period 1 (7 Days)||5||
60129433|NCT01561976|76251725|FG000|COMPLETED|Washout Period 1 (7 Days)||5||
60129434|NCT01561976|76251726|FG001|COMPLETED|Washout Period 1 (7 Days)||5||
60129435|NCT01561976|76251727|FG002|COMPLETED|Washout Period 1 (7 Days)||4||
60129436|NCT01561976|76251728|FG003|COMPLETED|Washout Period 1 (7 Days)||4||
60129437|NCT01561976|76251729|FG004|COMPLETED|Washout Period 1 (7 Days)||5||
60129438|NCT01561976|76251730|FG005|COMPLETED|Washout Period 1 (7 Days)||4||
60129439|NCT01561976|76251725|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0||
60129440|NCT01561976|76251726|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0||
60129441|NCT01561976|76251727|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0||
60129442|NCT01561976|76251728|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||1||
60129443|NCT01561976|76251729|FG004|NOT COMPLETED|Washout Period 1 (7 Days)||0||
60129444|NCT01561976|76251730|FG005|NOT COMPLETED|Washout Period 1 (7 Days)||1||
60129445|NCT01561976|76251725|FG000|STARTED|Period 2||5||
60129446|NCT01561976|76251726|FG001|STARTED|Period 2||5||
60129447|NCT01561976|76251727|FG002|STARTED|Period 2||4||
60129448|NCT01561976|76251728|FG003|STARTED|Period 2||4||
60129449|NCT01561976|76251729|FG004|STARTED|Period 2||5||
60129450|NCT01561976|76251730|FG005|STARTED|Period 2||4||
60129451|NCT01561976|76251725|FG000|COMPLETED|Period 2||5||
60129452|NCT01561976|76251726|FG001|COMPLETED|Period 2||5||
60129453|NCT01561976|76251727|FG002|COMPLETED|Period 2||4||
60129454|NCT01561976|76251728|FG003|COMPLETED|Period 2||4||
60129455|NCT01561976|76251729|FG004|COMPLETED|Period 2||5||
60129456|NCT01561976|76251730|FG005|COMPLETED|Period 2||4||
60129457|NCT01561976|76251725|FG000|NOT COMPLETED|Period 2||0||
60129458|NCT01561976|76251726|FG001|NOT COMPLETED|Period 2||0||
60129459|NCT01561976|76251727|FG002|NOT COMPLETED|Period 2||0||
60129460|NCT01561976|76251728|FG003|NOT COMPLETED|Period 2||0||
60129461|NCT01561976|76251729|FG004|NOT COMPLETED|Period 2||0||
60129462|NCT01561976|76251730|FG005|NOT COMPLETED|Period 2||0||
60129463|NCT01561976|76251725|FG000|STARTED|Washout Period 2 (7 Days)||5||
60129464|NCT01561976|76251726|FG001|STARTED|Washout Period 2 (7 Days)||5||
60129465|NCT01561976|76251727|FG002|STARTED|Washout Period 2 (7 Days)||4||
60129466|NCT01561976|76251728|FG003|STARTED|Washout Period 2 (7 Days)||4||
60129467|NCT01561976|76251729|FG004|STARTED|Washout Period 2 (7 Days)||5||
60129468|NCT01561976|76251730|FG005|STARTED|Washout Period 2 (7 Days)||4||
60129469|NCT01561976|76251725|FG000|COMPLETED|Washout Period 2 (7 Days)||4||
60129470|NCT01561976|76251726|FG001|COMPLETED|Washout Period 2 (7 Days)||5||
60129471|NCT01561976|76251727|FG002|COMPLETED|Washout Period 2 (7 Days)||3||
60129472|NCT01561976|76251728|FG003|COMPLETED|Washout Period 2 (7 Days)||4||
60129473|NCT01561976|76251729|FG004|COMPLETED|Washout Period 2 (7 Days)||5||
60129474|NCT01561976|76251730|FG005|COMPLETED|Washout Period 2 (7 Days)||4||
60129475|NCT01561976|76251725|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||1||
60129476|NCT01561976|76251726|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0||
60129477|NCT01561976|76251727|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||1||
60129478|NCT01561976|76251728|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0||
60129479|NCT01561976|76251729|FG004|NOT COMPLETED|Washout Period 2 (7 Days)||0||
60129480|NCT01561976|76251730|FG005|NOT COMPLETED|Washout Period 2 (7 Days)||0||
60129481|NCT01561976|76251725|FG000|STARTED|Period 3||4||
60129482|NCT01561976|76251726|FG001|STARTED|Period 3||5||
60129483|NCT01561976|76251727|FG002|STARTED|Period 3||3||
60129484|NCT01561976|76251728|FG003|STARTED|Period 3||4||
60129485|NCT01561976|76251729|FG004|STARTED|Period 3||5||
60129486|NCT01561976|76251730|FG005|STARTED|Period 3||4||
60129487|NCT01561976|76251725|FG000|COMPLETED|Period 3||4||
60129488|NCT01561976|76251726|FG001|COMPLETED|Period 3||5||
60129489|NCT01561976|76251727|FG002|COMPLETED|Period 3||3||
60129490|NCT01561976|76251728|FG003|COMPLETED|Period 3||4||
60129491|NCT01561976|76251729|FG004|COMPLETED|Period 3||5||
60129492|NCT01561976|76251730|FG005|COMPLETED|Period 3||4||
60129493|NCT01561976|76251725|FG000|NOT COMPLETED|Period 3||0||
60129494|NCT01561976|76251726|FG001|NOT COMPLETED|Period 3||0||
60129495|NCT01561976|76251727|FG002|NOT COMPLETED|Period 3||0||
60129496|NCT01561976|76251728|FG003|NOT COMPLETED|Period 3||0||
60129497|NCT01561976|76251729|FG004|NOT COMPLETED|Period 3||0||
60129498|NCT01561976|76251730|FG005|NOT COMPLETED|Period 3||0||
60129499|NCT01686932|76251740|FG000|STARTED|Period 1||25||
60129500|NCT01686932|76251741|FG001|STARTED|Period 1||26||
60129501|NCT01686932|76251740|FG000|COMPLETED|Period 1||24||
60129502|NCT01686932|76251741|FG001|COMPLETED|Period 1||25||
60129503|NCT01686932|76251740|FG000|NOT COMPLETED|Period 1||1||
60129504|NCT01686932|76251741|FG001|NOT COMPLETED|Period 1||1||
60129505|NCT01686932|76251740|FG000|STARTED|Period 2||24||
60129506|NCT01686932|76251741|FG001|STARTED|Period 2||25||
60129507|NCT01686932|76251740|FG000|COMPLETED|Period 2||24||
60129508|NCT01686932|76251741|FG001|COMPLETED|Period 2||25||
60129509|NCT01686932|76251740|FG000|NOT COMPLETED|Period 2||0||
60129510|NCT01686932|76251741|FG001|NOT COMPLETED|Period 2||0||
60129511|NCT01468207|76251749|FG000|STARTED|Treatment Period 1||154||
60129512|NCT01468207|76251750|FG001|STARTED|Treatment Period 1||153||
60129513|NCT01468207|76251751|FG002|STARTED|Treatment Period 1||0||
60129514|NCT01468207|76251752|FG003|STARTED|Treatment Period 1||0||
60129515|NCT01468207|76251753|FG004|STARTED|Treatment Period 1||0||
60129516|NCT01468207|76251754|FG005|STARTED|Treatment Period 1||0||
60129517|NCT01468207|76251749|FG000|Received Study Drug|Treatment Period 1||152||
60129518|NCT01468207|76251750|FG001|Received Study Drug|Treatment Period 1||153||
60129519|NCT01468207|76251751|FG002|Received Study Drug|Treatment Period 1||0||
60129520|NCT01468207|76251752|FG003|Received Study Drug|Treatment Period 1||0||
60129521|NCT01468207|76251753|FG004|Received Study Drug|Treatment Period 1||0||
60129522|NCT01468207|76251754|FG005|Received Study Drug|Treatment Period 1||0||
60129523|NCT01468207|76251749|FG000|COMPLETED|Treatment Period 1||145||
60129524|NCT01468207|76251750|FG001|COMPLETED|Treatment Period 1||145||
60129525|NCT01468207|76251751|FG002|COMPLETED|Treatment Period 1||0||
60129526|NCT01468207|76251752|FG003|COMPLETED|Treatment Period 1||0||
60129527|NCT01468207|76251753|FG004|COMPLETED|Treatment Period 1||0||
60129528|NCT01468207|76251754|FG005|COMPLETED|Treatment Period 1||0||
60129529|NCT01468207|76251749|FG000|NOT COMPLETED|Treatment Period 1||9||
60129530|NCT01468207|76251750|FG001|NOT COMPLETED|Treatment Period 1||8||
60129531|NCT01468207|76251751|FG002|NOT COMPLETED|Treatment Period 1||0||
60129532|NCT01468207|76251752|FG003|NOT COMPLETED|Treatment Period 1||0||
60129533|NCT01468207|76251753|FG004|NOT COMPLETED|Treatment Period 1||0||
60129534|NCT01468207|76251754|FG005|NOT COMPLETED|Treatment Period 1||0||
60129535|NCT01468207|76251749|FG000|STARTED|Treatment Period 2||0||
60129536|NCT01468207|76251750|FG001|STARTED|Treatment Period 2||0||
60129537|NCT01468207|76251751|FG002|STARTED|Treatment Period 2||145||
60129538|NCT01468207|76251752|FG003|STARTED|Treatment Period 2||49||
60129539|NCT01468207|76251753|FG004|STARTED|Treatment Period 2||48||
60129540|NCT01468207|76251754|FG005|STARTED|Treatment Period 2||48||
60129541|NCT01468207|76251749|FG000|COMPLETED|Treatment Period 2||0||
60129542|NCT01468207|76251750|FG001|COMPLETED|Treatment Period 2||0||
60129543|NCT01468207|76251751|FG002|COMPLETED|Treatment Period 2||93||
60129544|NCT01468207|76251752|FG003|COMPLETED|Treatment Period 2||22||
60129545|NCT01468207|76251753|FG004|COMPLETED|Treatment Period 2||27||
60129546|NCT01468207|76251754|FG005|COMPLETED|Treatment Period 2||28||
60129547|NCT01468207|76251749|FG000|NOT COMPLETED|Treatment Period 2||0||
60129548|NCT01468207|76251750|FG001|NOT COMPLETED|Treatment Period 2||0||
60129549|NCT01468207|76251751|FG002|NOT COMPLETED|Treatment Period 2||52||
60129550|NCT01468207|76251752|FG003|NOT COMPLETED|Treatment Period 2||27||
60129551|NCT01468207|76251753|FG004|NOT COMPLETED|Treatment Period 2||21||
60129552|NCT01468207|76251754|FG005|NOT COMPLETED|Treatment Period 2||20||
60129553|NCT01494649|76251774|FG000|STARTED|Overall Study||59||
60129554|NCT01494649|76251775|FG001|STARTED|Overall Study||59||
60129555|NCT01494649|76251774|FG000|COMPLETED|Overall Study||59||
60129556|NCT01494649|76251775|FG001|COMPLETED|Overall Study||58||
60129557|NCT01494649|76251774|FG000|NOT COMPLETED|Overall Study||0||
60129558|NCT01494649|76251775|FG001|NOT COMPLETED|Overall Study||1||
60129559|NCT01686152|76251786|FG000|STARTED|Overall Study||252||
60129560|NCT01686152|76251787|FG001|STARTED|Overall Study||253||
60129561|NCT01686152|76251788|FG002|STARTED|Overall Study||84||
60129562|NCT01686152|76251786|FG000|COMPLETED|Overall Study||211||
60129563|NCT01686152|76251787|FG001|COMPLETED|Overall Study||218||
60129564|NCT01686152|76251788|FG002|COMPLETED|Overall Study||75||
60129565|NCT01686152|76251786|FG000|NOT COMPLETED|Overall Study||41||
60129566|NCT01686152|76251787|FG001|NOT COMPLETED|Overall Study||35||
60129567|NCT01686152|76251788|FG002|NOT COMPLETED|Overall Study||9||
60129568|NCT01452919|76251796|FG000|STARTED|Open-Label Treatment|During the open label treatment, all patients received LY2140023 monotherapy (first column); no patients were randomized yet (thus, 0 patients listed in column 2 and 3)|123||
60129569|NCT01452919|76251797|FG001|STARTED|Open-Label Treatment||0||
60129570|NCT01452919|76251798|FG002|STARTED|Open-Label Treatment||0||
60129571|NCT01452919|76251796|FG000|Received at Least 1 Dose of Study Drug|Open-Label Treatment||123||
60129572|NCT01452919|76251797|FG001|Received at Least 1 Dose of Study Drug|Open-Label Treatment||0||
60129573|NCT01452919|76251798|FG002|Received at Least 1 Dose of Study Drug|Open-Label Treatment||0||
60129574|NCT01452919|76251796|FG000|COMPLETED|Open-Label Treatment||103||
60129575|NCT01452919|76251797|FG001|COMPLETED|Open-Label Treatment||0||
60129576|NCT01452919|76251798|FG002|COMPLETED|Open-Label Treatment||0||
60129577|NCT01452919|76251796|FG000|NOT COMPLETED|Open-Label Treatment||20||
60129578|NCT01452919|76251797|FG001|NOT COMPLETED|Open-Label Treatment||0||
60129579|NCT01452919|76251798|FG002|NOT COMPLETED|Open-Label Treatment||0||
60129580|NCT01452919|76251796|FG000|STARTED|Randomization Treatment||0||
60129581|NCT01452919|76251797|FG001|STARTED|Randomization Treatment|For randomization treatment, the 103 completers of the open label period above were assigned to placebo (50 patients; column 2) and LY2140023 (randomization) (53 patients) (column 3)|50||
60129582|NCT01452919|76251798|FG002|STARTED|Randomization Treatment|For randomization treatment, the 103 completers of the open label period above were assigned to placebo (50 patients; column 2) and LY2140023 (randomization) (53 patients) (column 3)|53||
60129583|NCT01452919|76251796|FG000|Received at Least 1 Dose of Study Drug|Randomization Treatment||0||
60129584|NCT01452919|76251797|FG001|Received at Least 1 Dose of Study Drug|Randomization Treatment||50||
60129585|NCT01452919|76251798|FG002|Received at Least 1 Dose of Study Drug|Randomization Treatment||53||
60129586|NCT01452919|76251796|FG000|COMPLETED|Randomization Treatment||0||
60129587|NCT01452919|76251797|FG001|COMPLETED|Randomization Treatment||47||
60129588|NCT01452919|76251798|FG002|COMPLETED|Randomization Treatment||51||
60129589|NCT01452919|76251796|FG000|NOT COMPLETED|Randomization Treatment||0||
60129590|NCT01452919|76251797|FG001|NOT COMPLETED|Randomization Treatment||3||
60129591|NCT01452919|76251798|FG002|NOT COMPLETED|Randomization Treatment||2||
60129592|NCT01582178|76251810|FG000|STARTED|Overall Study||106||
60129593|NCT01582178|76251811|FG001|STARTED|Overall Study||106||
60129594|NCT01582178|76251810|FG000|COMPLETED|Overall Study||100||
60129595|NCT01582178|76251811|FG001|COMPLETED|Overall Study||101||
60129596|NCT01582178|76251810|FG000|NOT COMPLETED|Overall Study||6||
60129597|NCT01582178|76251811|FG001|NOT COMPLETED|Overall Study||5||
60129598|NCT01561898|76251821|FG000|STARTED|Overall Study||7||
60129599|NCT01561898|76251822|FG001|STARTED|Overall Study||92||
60129600|NCT01561898|76251823|FG002|STARTED|Overall Study||97||
60129601|NCT01561898|76251824|FG003|STARTED|Overall Study||32||
60129602|NCT01561898|76251821|FG000|COMPLETED|Overall Study||5||
60129603|NCT01561898|76251822|FG001|COMPLETED|Overall Study||51||
60129604|NCT01561898|76251823|FG002|COMPLETED|Overall Study||53||
60129605|NCT01561898|76251824|FG003|COMPLETED|Overall Study||12||
60129606|NCT01561898|76251821|FG000|NOT COMPLETED|Overall Study||2||
60129607|NCT01561898|76251822|FG001|NOT COMPLETED|Overall Study||41||
60129608|NCT01561898|76251823|FG002|NOT COMPLETED|Overall Study||44||
60129609|NCT01561898|76251824|FG003|NOT COMPLETED|Overall Study||20||
60129610|NCT01685840|76251834|FG000|STARTED|Overall Study||448||
60129611|NCT01685840|76251835|FG001|STARTED|Overall Study||446||
60129612|NCT01685840|76251834|FG000|COMPLETED|Overall Study||119||
60129613|NCT01685840|76251835|FG001|COMPLETED|Overall Study||114||
60129614|NCT01685840|76251834|FG000|NOT COMPLETED|Overall Study||329||
60129615|NCT01685840|76251835|FG001|NOT COMPLETED|Overall Study||332||
60129616|NCT01452529|76251845|FG000|STARTED|Run-in Period||905||
60129617|NCT01452529|76251846|FG001|STARTED|Run-in Period||0||
60129618|NCT01452529|76251847|FG002|STARTED|Run-in Period||0||
60129619|NCT01452529|76251845|FG000|COMPLETED|Run-in Period||592||
60129620|NCT01452529|76251846|FG001|COMPLETED|Run-in Period||0||
60129621|NCT01452529|76251847|FG002|COMPLETED|Run-in Period||0||
60129622|NCT01452529|76251845|FG000|NOT COMPLETED|Run-in Period||313||
60129623|NCT01452529|76251846|FG001|NOT COMPLETED|Run-in Period||0||
60129624|NCT01452529|76251847|FG002|NOT COMPLETED|Run-in Period||0||
60129625|NCT01452529|76251845|FG000|STARTED|Double-blind (DB) Period||0||
60129626|NCT01452529|76251846|FG001|STARTED|Double-blind (DB) Period|Four subjects were randomized but did not receive DB medication|296||
60129627|NCT01452529|76251847|FG002|STARTED|Double-blind (DB) Period||292||
60129628|NCT01452529|76251845|FG000|COMPLETED|Double-blind (DB) Period||0||
60129629|NCT01452529|76251846|FG001|COMPLETED|Double-blind (DB) Period|4 subjects who did not receive DB medication were still counted as discontinued in the DB period|229||
60129630|NCT01452529|76251847|FG002|COMPLETED|Double-blind (DB) Period||210||
60129631|NCT01452529|76251845|FG000|NOT COMPLETED|Double-blind (DB) Period||0||
60129632|NCT01452529|76251846|FG001|NOT COMPLETED|Double-blind (DB) Period||67||
60129633|NCT01452529|76251847|FG002|NOT COMPLETED|Double-blind (DB) Period||82||
60129634|NCT01685606|76251854|FG000|STARTED|Overall Study||6||
60129635|NCT01685606|76251854|FG000|COMPLETED|Overall Study||5||
60129636|NCT01685606|76251854|FG000|NOT COMPLETED|Overall Study||1||
60129637|NCT01685372|76251860|FG000|STARTED|Timepoint 1 (T1): Vaccine,1st Blood Draw||7||
60129638|NCT01685372|76251861|FG001|STARTED|Timepoint 1 (T1): Vaccine,1st Blood Draw||9||
60129639|NCT01685372|76251860|FG000|COMPLETED|Timepoint 1 (T1): Vaccine,1st Blood Draw||7||
60129640|NCT01685372|76251861|FG001|COMPLETED|Timepoint 1 (T1): Vaccine,1st Blood Draw||9||
60129641|NCT01685372|76251860|FG000|NOT COMPLETED|Timepoint 1 (T1): Vaccine,1st Blood Draw||0||
60129642|NCT01685372|76251861|FG001|NOT COMPLETED|Timepoint 1 (T1): Vaccine,1st Blood Draw||0||
60129643|NCT01685372|76251860|FG000|STARTED|Timepoint 2 (T2): 2nd Blood Draw||7||
60129644|NCT01685372|76251861|FG001|STARTED|Timepoint 2 (T2): 2nd Blood Draw||9||
60129645|NCT01685372|76251860|FG000|COMPLETED|Timepoint 2 (T2): 2nd Blood Draw||7||
60129646|NCT01685372|76251861|FG001|COMPLETED|Timepoint 2 (T2): 2nd Blood Draw||9||
60129647|NCT01685372|76251860|FG000|NOT COMPLETED|Timepoint 2 (T2): 2nd Blood Draw||0||
60129648|NCT01685372|76251861|FG001|NOT COMPLETED|Timepoint 2 (T2): 2nd Blood Draw||0||
60129649|NCT01685372|76251860|FG000|STARTED|Timepoint 3 (T3): 3rd Blood Draw||7||
60129650|NCT01685372|76251861|FG001|STARTED|Timepoint 3 (T3): 3rd Blood Draw||9||
60129651|NCT01685372|76251860|FG000|COMPLETED|Timepoint 3 (T3): 3rd Blood Draw||4||
60129652|NCT01685372|76251861|FG001|COMPLETED|Timepoint 3 (T3): 3rd Blood Draw||5||
60129653|NCT01685372|76251860|FG000|NOT COMPLETED|Timepoint 3 (T3): 3rd Blood Draw||3||
60129654|NCT01685372|76251861|FG001|NOT COMPLETED|Timepoint 3 (T3): 3rd Blood Draw||4||
60129655|NCT01685216|76251867|FG000|STARTED|Overall Study||7||
60129656|NCT01685216|76251867|FG000|COMPLETED|Overall Study||6||
60129657|NCT01685216|76251867|FG000|NOT COMPLETED|Overall Study||1||
60129658|NCT01685138|76251871|FG000|STARTED|Overall Study||124||
60129659|NCT01685138|76251871|FG000|Discontinued From Treatment Phase|Overall Study||124||
60129660|NCT01685138|76251871|FG000|Entered Post-treatment Efficacy f/up|Overall Study||10||
60129661|NCT01685138|76251871|FG000|Entered Survival Follow-up|Overall Study||63||
60129662|NCT01685138|76251871|FG000|Discontinued From Study|Overall Study||51||
60129663|NCT01685138|76251871|FG000|COMPLETED|Overall Study||32|Completed = discontinued from treatment phase|
60129664|NCT01685138|76251871|FG000|NOT COMPLETED|Overall Study||92||
60129665|NCT01685060|76251875|FG000|STARTED|Overall Study||140||
60129666|NCT01685060|76251875|FG000|Entered Post-treatment Efficacy f/u|Overall Study||7||
60129667|NCT01685060|76251875|FG000|Entered Survival Follow up|Overall Study||98||
60129668|NCT01685060|76251875|FG000|Discontinued From Study|Overall Study||35||
60129669|NCT01685060|76251875|FG000|COMPLETED|Overall Study||0||
60129670|NCT01685060|76251875|FG000|NOT COMPLETED|Overall Study||140||
60129671|NCT01582100|76251879|FG000|STARTED|Overall Study||2||
60129672|NCT01582100|76251879|FG000|COMPLETED|Overall Study||0||
60129673|NCT01582100|76251879|FG000|NOT COMPLETED|Overall Study||2||
60129674|NCT01579916|76251885|FG000|STARTED|Overall Study||242||
60129675|NCT01579916|76251886|FG001|STARTED|Overall Study||61||
60129676|NCT01579916|76251885|FG000|COMPLETED|Overall Study||234||
60129677|NCT01579916|76251886|FG001|COMPLETED|Overall Study||59||
60129678|NCT01579916|76251885|FG000|NOT COMPLETED|Overall Study||8||
60129679|NCT01579916|76251886|FG001|NOT COMPLETED|Overall Study||2||
60129680|NCT01684202|76251896|FG000|STARTED|Dose-escalation Period||15||
60129681|NCT01684202|76251897|FG001|STARTED|Dose-escalation Period||8||
60129682|NCT01684202|76251898|FG002|STARTED|Dose-escalation Period||9||
60129683|NCT01684202|76251899|FG003|STARTED|Dose-escalation Period||11||
60129684|NCT01684202|76251896|FG000|COMPLETED|Dose-escalation Period||14||
60129685|NCT01684202|76251897|FG001|COMPLETED|Dose-escalation Period||7||
60129686|NCT01684202|76251898|FG002|COMPLETED|Dose-escalation Period||9||
60129687|NCT01684202|76251899|FG003|COMPLETED|Dose-escalation Period||11||
60129688|NCT01684202|76251896|FG000|NOT COMPLETED|Dose-escalation Period||1||
60129689|NCT01684202|76251897|FG001|NOT COMPLETED|Dose-escalation Period||1||
60129690|NCT01684202|76251898|FG002|NOT COMPLETED|Dose-escalation Period||0||
60129691|NCT01684202|76251899|FG003|NOT COMPLETED|Dose-escalation Period||0||
60129692|NCT01684202|76251896|FG000|STARTED|Maintenance Period||14||
60129693|NCT01684202|76251897|FG001|STARTED|Maintenance Period||7||
60129694|NCT01684202|76251898|FG002|STARTED|Maintenance Period||9||
60129695|NCT01684202|76251899|FG003|STARTED|Maintenance Period||11||
60129696|NCT01684202|76251896|FG000|COMPLETED|Maintenance Period||13||
60129697|NCT01684202|76251897|FG001|COMPLETED|Maintenance Period||4||
60129698|NCT01684202|76251898|FG002|COMPLETED|Maintenance Period||8||
60129699|NCT01684202|76251899|FG003|COMPLETED|Maintenance Period||10||
60129700|NCT01684202|76251896|FG000|NOT COMPLETED|Maintenance Period||1||
60129701|NCT01684202|76251897|FG001|NOT COMPLETED|Maintenance Period||3||
60129702|NCT01684202|76251898|FG002|NOT COMPLETED|Maintenance Period||1||
60129703|NCT01684202|76251899|FG003|NOT COMPLETED|Maintenance Period||1||
60129704|NCT01684046|76251909|FG000|STARTED|Period 1, First 30 Days||97||
60129705|NCT01684046|76251910|FG001|STARTED|Period 1, First 30 Days||95||
60129706|NCT01684046|76251909|FG000|COMPLETED|Period 1, First 30 Days||97||
60129707|NCT01684046|76251910|FG001|COMPLETED|Period 1, First 30 Days||93||
60129708|NCT01684046|76251909|FG000|NOT COMPLETED|Period 1, First 30 Days||0||
60129709|NCT01684046|76251910|FG001|NOT COMPLETED|Period 1, First 30 Days||2||
60129710|NCT01684046|76251909|FG000|STARTED|Period 2, Second 30 Days||97||
60129711|NCT01684046|76251910|FG001|STARTED|Period 2, Second 30 Days||93||
60129712|NCT01684046|76251909|FG000|COMPLETED|Period 2, Second 30 Days||97||
60129713|NCT01684046|76251910|FG001|COMPLETED|Period 2, Second 30 Days||93||
60129714|NCT01684046|76251909|FG000|NOT COMPLETED|Period 2, Second 30 Days||0||
60129715|NCT01684046|76251910|FG001|NOT COMPLETED|Period 2, Second 30 Days||0||
60129716|NCT01559090|76251919|FG000|STARTED|Stage I||6||
60129717|NCT01559090|76251920|FG001|STARTED|Stage I||5||
60129718|NCT01559090|76251921|FG002|STARTED|Stage I||6||
60129719|NCT01559090|76251919|FG000|COMPLETED|Stage I||4||
60129720|NCT01559090|76251920|FG001|COMPLETED|Stage I||3||
60129721|NCT01559090|76251921|FG002|COMPLETED|Stage I||3||
60129722|NCT01559090|76251919|FG000|NOT COMPLETED|Stage I||2||
60129723|NCT01559090|76251920|FG001|NOT COMPLETED|Stage I||2||
60129724|NCT01559090|76251921|FG002|NOT COMPLETED|Stage I||3||
60129725|NCT01559090|76251919|FG000|STARTED|Stage II||4||
60129726|NCT01559090|76251920|FG001|STARTED|Stage II||3||
60129727|NCT01559090|76251921|FG002|STARTED|Stage II|One subject who completed Stage I did not agree to participate in Stage II|2||
60129728|NCT01559090|76251919|FG000|COMPLETED|Stage II||3||
60129729|NCT01559090|76251920|FG001|COMPLETED|Stage II||3||
60129730|NCT01559090|76251921|FG002|COMPLETED|Stage II||2||
60129731|NCT01559090|76251919|FG000|NOT COMPLETED|Stage II||1||
60129732|NCT01559090|76251920|FG001|NOT COMPLETED|Stage II||0||
60129733|NCT01559090|76251921|FG002|NOT COMPLETED|Stage II||0||
60129734|NCT01683266|76251931|FG000|STARTED|Overall Study||274||
60129735|NCT01683266|76251932|FG001|STARTED|Overall Study||275||
60129736|NCT01683266|76251931|FG000|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|273||
60129737|NCT01683266|76251932|FG001|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|273||
60129738|NCT01683266|76251931|FG000|COMPLETED|Overall Study||219||
60129739|NCT01683266|76251932|FG001|COMPLETED|Overall Study||225||
60129740|NCT01683266|76251931|FG000|NOT COMPLETED|Overall Study||55||
60129741|NCT01683266|76251932|FG001|NOT COMPLETED|Overall Study||50||
60129742|NCT01467661|76251938|FG000|STARTED|Overall Study||53||
60129743|NCT01467661|76251938|FG000|Completed SPD422-308 (NCT01214915)|Overall Study||42||
60129744|NCT01467661|76251938|FG000|Started SPD422-309 (NCT01467661)|Overall Study||41||
60129745|NCT01467661|76251938|FG000|Started Post Marketing Trial|Overall Study||33||
60129746|NCT01467661|76251938|FG000|COMPLETED|Overall Study||32||
60129747|NCT01467661|76251938|FG000|NOT COMPLETED|Overall Study||21||
60129748|NCT01577186|76251944|FG000|STARTED|Overall Study||480||
60129749|NCT01577186|76251944|FG000|COMPLETED|Overall Study||350||
60129750|NCT01577186|76251944|FG000|NOT COMPLETED|Overall Study||130||
60129751|NCT01559012|76251950|FG000|STARTED|Overall Study||6||
60129752|NCT01559012|76251951|FG001|STARTED|Overall Study|1 more patient added to randomization list to reach the pre-assignment number of treated patients|7||
60129753|NCT01559012|76251950|FG000|COMPLETED|Overall Study||6||
60129754|NCT01559012|76251951|FG001|COMPLETED|Overall Study|Patient N. 2 withdrew from study for alleged side effects at day 1 of placebo cycle.|6||
60129755|NCT01559012|76251950|FG000|NOT COMPLETED|Overall Study||0||
60129756|NCT01559012|76251951|FG001|NOT COMPLETED|Overall Study||1||
60129757|NCT01451827|76251976|FG000|STARTED|Overall Study||45||
60129758|NCT01451827|76251977|FG001|STARTED|Overall Study||45||
60129759|NCT01451827|76251978|FG002|STARTED|Overall Study||44||
60129760|NCT01451827|76251979|FG003|STARTED|Overall Study||43||
60129761|NCT01451827|76251976|FG000|COMPLETED|Overall Study||42||
60129762|NCT01451827|76251977|FG001|COMPLETED|Overall Study||40||
60129763|NCT01451827|76251978|FG002|COMPLETED|Overall Study||42||
60129764|NCT01451827|76251979|FG003|COMPLETED|Overall Study||39||
60129765|NCT01451827|76251976|FG000|NOT COMPLETED|Overall Study||3||
60129766|NCT01451827|76251977|FG001|NOT COMPLETED|Overall Study||5||
60129767|NCT01451827|76251978|FG002|NOT COMPLETED|Overall Study||2||
60129768|NCT01451827|76251979|FG003|NOT COMPLETED|Overall Study||4||
60129769|NCT01557920|76251989|FG000|STARTED|Overall Study||9||
60129770|NCT01557920|76251990|FG001|STARTED|Overall Study||9||
60129771|NCT01557920|76251989|FG000|COMPLETED|Overall Study||6||
60129772|NCT01557920|76251990|FG001|COMPLETED|Overall Study||6||
60129773|NCT01557920|76251989|FG000|NOT COMPLETED|Overall Study||3||
60129774|NCT01557920|76251990|FG001|NOT COMPLETED|Overall Study||3||
60129775|NCT01688882|76252025|FG000|STARTED|Overall Study||13||
60129776|NCT01688882|76252026|FG001|STARTED|Overall Study|4 patients who completed 12 weeks of placebo changed to open-label QGE031 treatment.|7||
60129777|NCT01688882|76252025|FG000|Safety Follow-up|Overall Study||11||
60129778|NCT01688882|76252026|FG001|Safety Follow-up|Overall Study||5||
60129779|NCT01688882|76252025|FG000|COMPLETED|Overall Study||10||
60129780|NCT01688882|76252026|FG001|COMPLETED|Overall Study|The one patient that discontinued was already switched to open-label QGE031 treatment.|6||
60129781|NCT01688882|76252025|FG000|NOT COMPLETED|Overall Study||3||
60129782|NCT01688882|76252026|FG001|NOT COMPLETED|Overall Study||1||
60129783|NCT01467583|76252039|FG000|STARTED|Overall Study||16||
60129784|NCT01467583|76252040|FG001|STARTED|Overall Study||4||
60129785|NCT01467583|76252041|FG002|STARTED|Overall Study||12||
60129786|NCT01467583|76252039|FG000|COMPLETED|Overall Study|Both patients completed > 1 dose and so their data was included in the results.|14||
60129787|NCT01467583|76252040|FG001|COMPLETED|Overall Study|Death unrelated to study drug on day #3. Data to that point is included in the results|3||
60129788|NCT01467583|76252041|FG002|COMPLETED|Overall Study||10||
60129789|NCT01467583|76252039|FG000|NOT COMPLETED|Overall Study||2||
60129790|NCT01467583|76252040|FG001|NOT COMPLETED|Overall Study||1||
60129791|NCT01467583|76252041|FG002|NOT COMPLETED|Overall Study||2||
60129792|NCT01576718|76252058|FG000|STARTED|Pre-Assignment Period (Run-In Placebo)||889||
60129793|NCT01576718|76252059|FG001|STARTED|Pre-Assignment Period (Run-In Placebo)||0||
60129794|NCT01576718|76252060|FG002|STARTED|Pre-Assignment Period (Run-In Placebo)||0||
60129795|NCT01576718|76252061|FG003|STARTED|Pre-Assignment Period (Run-In Placebo)||0||
60129796|NCT01576718|76252062|FG004|STARTED|Pre-Assignment Period (Run-In Placebo)||0||
60129797|NCT01576718|76252063|FG005|STARTED|Pre-Assignment Period (Run-In Placebo)||0||
60129798|NCT01576718|76252064|FG006|STARTED|Pre-Assignment Period (Run-In Placebo)||0||
60129799|NCT01576718|76252058|FG000|COMPLETED|Pre-Assignment Period (Run-In Placebo)|Participants randomized into the Treatment Period|640||
60129800|NCT01576718|76252059|FG001|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0||
60129801|NCT01576718|76252060|FG002|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0||
60129802|NCT01576718|76252061|FG003|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0||
60129803|NCT01576718|76252062|FG004|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0||
60129804|NCT01576718|76252063|FG005|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0||
60129805|NCT01576718|76252064|FG006|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0||
60129806|NCT01576718|76252058|FG000|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||249||
60129807|NCT01576718|76252059|FG001|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0||
60129808|NCT01576718|76252060|FG002|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0||
60129809|NCT01576718|76252061|FG003|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0||
60129810|NCT01576718|76252062|FG004|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0||
60129811|NCT01576718|76252063|FG005|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0||
60129812|NCT01576718|76252064|FG006|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0||
60129813|NCT01576718|76252058|FG000|STARTED|Treatment Period||0||
60129814|NCT01576718|76252059|FG001|STARTED|Treatment Period||107||
60129815|NCT01576718|76252060|FG002|STARTED|Treatment Period||107||
60129816|NCT01576718|76252061|FG003|STARTED|Treatment Period||106||
60129817|NCT01576718|76252062|FG004|STARTED|Treatment Period||107||
60129818|NCT01576718|76252063|FG005|STARTED|Treatment Period||106||
60129819|NCT01576718|76252064|FG006|STARTED|Treatment Period||107||
60129820|NCT01576718|76252058|FG000|Safety Population|Treatment Period||0||
60129821|NCT01576718|76252059|FG001|Safety Population|Treatment Period||107||
60129822|NCT01576718|76252060|FG002|Safety Population|Treatment Period||107||
60129823|NCT01576718|76252061|FG003|Safety Population|Treatment Period||106||
60129824|NCT01576718|76252062|FG004|Safety Population|Treatment Period||107||
60129825|NCT01576718|76252063|FG005|Safety Population|Treatment Period||106||
60129826|NCT01576718|76252064|FG006|Safety Population|Treatment Period||106||
60129827|NCT01576718|76252058|FG000|Efficacy Population (Full Analysis Set)|Treatment Period||0||
60129828|NCT01576718|76252059|FG001|Efficacy Population (Full Analysis Set)|Treatment Period||107||
60129829|NCT01576718|76252060|FG002|Efficacy Population (Full Analysis Set)|Treatment Period||106||
60129830|NCT01576718|76252061|FG003|Efficacy Population (Full Analysis Set)|Treatment Period||102||
60129831|NCT01576718|76252062|FG004|Efficacy Population (Full Analysis Set)|Treatment Period||107||
60129832|NCT01576718|76252063|FG005|Efficacy Population (Full Analysis Set)|Treatment Period||105||
60129833|NCT01576718|76252064|FG006|Efficacy Population (Full Analysis Set)|Treatment Period||103||
60129834|NCT01576718|76252058|FG000|COMPLETED|Treatment Period||0||
60129835|NCT01576718|76252059|FG001|COMPLETED|Treatment Period||82||
60129836|NCT01576718|76252060|FG002|COMPLETED|Treatment Period||87||
60129837|NCT01576718|76252061|FG003|COMPLETED|Treatment Period||75||
60129838|NCT01576718|76252062|FG004|COMPLETED|Treatment Period||80||
60129839|NCT01576718|76252063|FG005|COMPLETED|Treatment Period||58||
60129840|NCT01576718|76252064|FG006|COMPLETED|Treatment Period||77||
60129841|NCT01576718|76252058|FG000|NOT COMPLETED|Treatment Period||0||
60129842|NCT01576718|76252059|FG001|NOT COMPLETED|Treatment Period||25||
60129843|NCT01576718|76252060|FG002|NOT COMPLETED|Treatment Period||20||
60129844|NCT01576718|76252061|FG003|NOT COMPLETED|Treatment Period||31||
60129845|NCT01576718|76252062|FG004|NOT COMPLETED|Treatment Period||27||
60129846|NCT01576718|76252063|FG005|NOT COMPLETED|Treatment Period||48||
60129847|NCT01576718|76252064|FG006|NOT COMPLETED|Treatment Period||30||
60129848|NCT01493557|76252081|FG000|STARTED|Not Randomized to Management Strategies||0||
60129849|NCT01493557|76252082|FG001|STARTED|Not Randomized to Management Strategies||0||
60129850|NCT01493557|76252083|FG002|STARTED|Not Randomized to Management Strategies||950||
60129851|NCT01493557|76252081|FG000|Without Experiencing GIS|Not Randomized to Management Strategies||0||
60129852|NCT01493557|76252082|FG001|Without Experiencing GIS|Not Randomized to Management Strategies||0||
60129853|NCT01493557|76252083|FG002|Without Experiencing GIS|Not Randomized to Management Strategies|754 patients completed the trial.|854||
60129854|NCT01493557|76252081|FG000|Reported GIS Prior to EOT Visit|Not Randomized to Management Strategies||0||
60129855|NCT01493557|76252082|FG001|Reported GIS Prior to EOT Visit|Not Randomized to Management Strategies||0||
60129856|NCT01493557|76252083|FG002|Reported GIS Prior to EOT Visit|Not Randomized to Management Strategies|32 patients completed the trial.|48||
60129857|NCT01493557|76252081|FG000|Reported GIS Only at EOT Visit|Not Randomized to Management Strategies||0||
60129858|NCT01493557|76252082|FG001|Reported GIS Only at EOT Visit|Not Randomized to Management Strategies||0||
60129859|NCT01493557|76252083|FG002|Reported GIS Only at EOT Visit|Not Randomized to Management Strategies|26 patients completed (GIS resolved ) and 4 patients completed (GIS not resolved ) the trial.|48||
60129860|NCT01493557|76252081|FG000|COMPLETED|Not Randomized to Management Strategies||0||
60129861|NCT01493557|76252082|FG001|COMPLETED|Not Randomized to Management Strategies||0||
60129862|NCT01493557|76252083|FG002|COMPLETED|Not Randomized to Management Strategies||816||
60129863|NCT01493557|76252081|FG000|NOT COMPLETED|Not Randomized to Management Strategies||0||
60129864|NCT01493557|76252082|FG001|NOT COMPLETED|Not Randomized to Management Strategies||0||
60129865|NCT01493557|76252083|FG002|NOT COMPLETED|Not Randomized to Management Strategies||134||
60129866|NCT01493557|76252081|FG000|STARTED|Randomized to Management Strategies||59||
60129867|NCT01493557|76252082|FG001|STARTED|Randomized to Management Strategies||58||
60129868|NCT01493557|76252083|FG002|STARTED|Randomized to Management Strategies||0||
60129869|NCT01493557|76252081|FG000|COMPLETED|Randomized to Management Strategies||44||
60129870|NCT01493557|76252082|FG001|COMPLETED|Randomized to Management Strategies||47||
60129871|NCT01493557|76252083|FG002|COMPLETED|Randomized to Management Strategies||0||
60129872|NCT01493557|76252081|FG000|NOT COMPLETED|Randomized to Management Strategies||15||
60129873|NCT01493557|76252082|FG001|NOT COMPLETED|Randomized to Management Strategies||11||
60129874|NCT01493557|76252083|FG002|NOT COMPLETED|Randomized to Management Strategies||0||
60129875|NCT01493557|76252081|FG000|STARTED|Adding the Second Strategy||14||
60129876|NCT01493557|76252082|FG001|STARTED|Adding the Second Strategy||15||
60129877|NCT01493557|76252083|FG002|STARTED|Adding the Second Strategy||0||
60129878|NCT01493557|76252081|FG000|COMPLETED|Adding the Second Strategy||12||
60129879|NCT01493557|76252082|FG001|COMPLETED|Adding the Second Strategy||11||
60129880|NCT01493557|76252083|FG002|COMPLETED|Adding the Second Strategy||0||
60129881|NCT01493557|76252081|FG000|NOT COMPLETED|Adding the Second Strategy||2||
60129882|NCT01493557|76252082|FG001|NOT COMPLETED|Adding the Second Strategy||4||
60129883|NCT01493557|76252083|FG002|NOT COMPLETED|Adding the Second Strategy||0||
60129884|NCT01451749|76252092|FG000|STARTED|Overall Study||216||
60129885|NCT01451749|76252093|FG001|STARTED|Overall Study||108||
60129886|NCT01451749|76252092|FG000|COMPLETED|Overall Study||184||
60129887|NCT01451749|76252093|FG001|COMPLETED|Overall Study||94||
60129888|NCT01451749|76252092|FG000|NOT COMPLETED|Overall Study||32||
60129889|NCT01451749|76252093|FG001|NOT COMPLETED|Overall Study||14||
60129890|NCT01576484|76252103|FG000|STARTED|Overall Study||12||
60129891|NCT01576484|76252104|FG001|STARTED|Overall Study||46||
60129892|NCT01576484|76252103|FG000|COMPLETED|Overall Study||7||
60129893|NCT01576484|76252104|FG001|COMPLETED|Overall Study||27||
60129894|NCT01576484|76252103|FG000|NOT COMPLETED|Overall Study||5||
60129895|NCT01576484|76252104|FG001|NOT COMPLETED|Overall Study||19||
60129896|NCT01467505|76252114|FG000|STARTED|Overall Study||51||
60129897|NCT01467505|76252115|FG001|STARTED|Overall Study||10||
60129898|NCT01467505|76252114|FG000|COMPLETED|Overall Study||18||
60129899|NCT01467505|76252115|FG001|COMPLETED|Overall Study||7||
60129900|NCT01467505|76252114|FG000|NOT COMPLETED|Overall Study||33||
60129901|NCT01467505|76252115|FG001|NOT COMPLETED|Overall Study||3||
60129902|NCT01467271|76252121|FG000|STARTED|Overall Study||540||
60129903|NCT01467271|76252121|FG000|COMPLETED|Overall Study||338||
60129904|NCT01467271|76252121|FG000|NOT COMPLETED|Overall Study||202||
60129905|NCT01449929|76252127|FG000|STARTED|Randomization Phase 96 Week||242||
60129906|NCT01449929|76252128|FG001|STARTED|Randomization Phase 96 Week||242||
60129907|NCT01449929|76252129|FG002|STARTED|Randomization Phase 96 Week||0||
60129908|NCT01449929|76252127|FG000|COMPLETED|Randomization Phase 96 Week||209||
60129909|NCT01449929|76252128|FG001|COMPLETED|Randomization Phase 96 Week||189||
60129910|NCT01449929|76252129|FG002|COMPLETED|Randomization Phase 96 Week||0||
60129911|NCT01449929|76252127|FG000|NOT COMPLETED|Randomization Phase 96 Week||33||
60129912|NCT01449929|76252128|FG001|NOT COMPLETED|Randomization Phase 96 Week||53||
60129913|NCT01449929|76252129|FG002|NOT COMPLETED|Randomization Phase 96 Week||0||
60129914|NCT01449929|76252127|FG000|STARTED|Extension Phase Approximately 3 Years||0||
60129915|NCT01449929|76252128|FG001|STARTED|Extension Phase Approximately 3 Years||0||
60129916|NCT01449929|76252129|FG002|STARTED|Extension Phase Approximately 3 Years||123||
60129917|NCT01449929|76252127|FG000|COMPLETED|Extension Phase Approximately 3 Years||0||
60129918|NCT01449929|76252128|FG001|COMPLETED|Extension Phase Approximately 3 Years||0||
60129919|NCT01449929|76252129|FG002|COMPLETED|Extension Phase Approximately 3 Years||115||
60129920|NCT01449929|76252127|FG000|NOT COMPLETED|Extension Phase Approximately 3 Years||0||
60129921|NCT01449929|76252128|FG001|NOT COMPLETED|Extension Phase Approximately 3 Years||0||
60129922|NCT01449929|76252129|FG002|NOT COMPLETED|Extension Phase Approximately 3 Years||8||
60129923|NCT01449539|76252139|FG000|STARTED|Overall Study||8||
60129924|NCT01449539|76252139|FG000|COMPLETED|Overall Study||4||
60129925|NCT01449539|76252139|FG000|NOT COMPLETED|Overall Study||4||
60129926|NCT01451515|76252146|FG000|STARTED|Overall Study||12||
60129927|NCT01451515|76252147|FG001|STARTED|Overall Study||7||
60129928|NCT01451515|76252148|FG002|STARTED|Overall Study||4||
60129929|NCT01451515|76252146|FG000|COMPLETED|Overall Study||11||
60129930|NCT01451515|76252147|FG001|COMPLETED|Overall Study||4||
60129931|NCT01451515|76252148|FG002|COMPLETED|Overall Study||3||
60129932|NCT01451515|76252146|FG000|NOT COMPLETED|Overall Study||1||
60129933|NCT01451515|76252147|FG001|NOT COMPLETED|Overall Study||3||
60129934|NCT01451515|76252148|FG002|NOT COMPLETED|Overall Study||1||
60129935|NCT01466881|76252159|FG000|STARTED|Overall Study||42||
60129936|NCT01466881|76252159|FG000|Eligible and Treated|Overall Study||37||
60129937|NCT01466881|76252159|FG000|COMPLETED|Overall Study||2||
60129938|NCT01466881|76252159|FG000|NOT COMPLETED|Overall Study||40||
60129939|NCT01576406|76252171|FG000|STARTED|Overall Study||11||
60129940|NCT01576406|76252172|FG001|STARTED|Overall Study||15||
60129941|NCT01576406|76252173|FG002|STARTED|Overall Study||20||
60129942|NCT01576406|76252174|FG003|STARTED|Overall Study||10||
60129943|NCT01576406|76252175|FG004|STARTED|Overall Study||16||
60129944|NCT01576406|76252176|FG005|STARTED|Overall Study||16||
60129945|NCT01576406|76252171|FG000|COMPLETED|Overall Study||5||
60129946|NCT01576406|76252172|FG001|COMPLETED|Overall Study||7||
60129947|NCT01576406|76252173|FG002|COMPLETED|Overall Study||4||
60129948|NCT01576406|76252174|FG003|COMPLETED|Overall Study||1||
60129949|NCT01576406|76252175|FG004|COMPLETED|Overall Study||8||
60129950|NCT01576406|76252176|FG005|COMPLETED|Overall Study||4||
60129951|NCT01576406|76252171|FG000|NOT COMPLETED|Overall Study||6||
60129952|NCT01576406|76252172|FG001|NOT COMPLETED|Overall Study||8||
60129953|NCT01576406|76252173|FG002|NOT COMPLETED|Overall Study||16||
60129954|NCT01576406|76252174|FG003|NOT COMPLETED|Overall Study||9||
60129955|NCT01576406|76252175|FG004|NOT COMPLETED|Overall Study||8||
60129956|NCT01576406|76252176|FG005|NOT COMPLETED|Overall Study||12||
60129957|NCT01576172|76252192|FG000|STARTED|Overall Study||79||
60129958|NCT01576172|76252193|FG001|STARTED|Overall Study||80||
60129959|NCT01576172|76252192|FG000|COMPLETED|Overall Study||74||
60129960|NCT01576172|76252193|FG001|COMPLETED|Overall Study||79||
60129961|NCT01576172|76252192|FG000|NOT COMPLETED|Overall Study||5||
60129962|NCT01576172|76252193|FG001|NOT COMPLETED|Overall Study||1||
60129963|NCT01542788|76252203|FG000|STARTED|Overall Study||209||
60129964|NCT01542788|76252204|FG001|STARTED|Overall Study||71||
60129965|NCT01542788|76252203|FG000|Randomized and Treated|Overall Study||207||
60129966|NCT01542788|76252204|FG001|Randomized and Treated|Overall Study||71||
60129967|NCT01542788|76252203|FG000|COMPLETED|Overall Study||154||
60129968|NCT01542788|76252204|FG001|COMPLETED|Overall Study||0||
60129969|NCT01542788|76252203|FG000|NOT COMPLETED|Overall Study||55||
60129970|NCT01542788|76252204|FG001|NOT COMPLETED|Overall Study||71||
60129971|NCT01542632|76252216|FG000|STARTED|Overall Study||25||
60129972|NCT01542632|76252217|FG001|STARTED|Overall Study||25||
60129973|NCT01542632|76252218|FG002|STARTED|Overall Study||24||
60129974|NCT01542632|76252219|FG003|STARTED|Overall Study||21||
60129975|NCT01542632|76252220|FG004|STARTED|Overall Study||21||
60129976|NCT01542632|76252221|FG005|STARTED|Overall Study||24||
60129977|NCT01542632|76252216|FG000|COMPLETED|Overall Study||25||
60129978|NCT01542632|76252217|FG001|COMPLETED|Overall Study||24||
60129979|NCT01542632|76252218|FG002|COMPLETED|Overall Study||23||
60129980|NCT01542632|76252219|FG003|COMPLETED|Overall Study||19||
60129981|NCT01542632|76252220|FG004|COMPLETED|Overall Study||17||
60129982|NCT01542632|76252221|FG005|COMPLETED|Overall Study||24||
60129983|NCT01542632|76252216|FG000|NOT COMPLETED|Overall Study||0||
60129984|NCT01542632|76252217|FG001|NOT COMPLETED|Overall Study||1||
60129985|NCT01542632|76252218|FG002|NOT COMPLETED|Overall Study||1||
60129986|NCT01542632|76252219|FG003|NOT COMPLETED|Overall Study||2||
60129987|NCT01542632|76252220|FG004|NOT COMPLETED|Overall Study||4||
60129988|NCT01542632|76252221|FG005|NOT COMPLETED|Overall Study||0||
60129989|NCT01557842|76252242|FG000|STARTED|Overall Study||9||
60129990|NCT01557842|76252243|FG001|STARTED|Overall Study||6||
60129991|NCT01557842|76252242|FG000|COMPLETED|Overall Study||0||
60129992|NCT01557842|76252243|FG001|COMPLETED|Overall Study||0||
60129993|NCT01557842|76252242|FG000|NOT COMPLETED|Overall Study||9||
60129994|NCT01557842|76252243|FG001|NOT COMPLETED|Overall Study||6||
60129995|NCT01541930|76252249|FG000|STARTED|Overall Study||21||
60129996|NCT01541930|76252249|FG000|COMPLETED|Overall Study||20||
60129997|NCT01541930|76252249|FG000|NOT COMPLETED|Overall Study||1||
60129998|NCT01576016|76252266|FG000|STARTED|Lead Safety||920||
60129999|NCT01576016|76252267|FG001|STARTED|Lead Safety||0||
60130000|NCT01576016|76252266|FG000|COMPLETED|Lead Safety||647||
60130001|NCT01576016|76252267|FG001|COMPLETED|Lead Safety||0||
60130002|NCT01576016|76252266|FG000|NOT COMPLETED|Lead Safety||273||
60130003|NCT01576016|76252267|FG001|NOT COMPLETED|Lead Safety||0||
60130004|NCT01576016|76252266|FG000|STARTED|MRI Safety||0||
60130005|NCT01576016|76252267|FG001|STARTED|MRI Safety|255 enrollments includes 30 supplemental scans performed in Australia using the same scan protocol.|255||
60130006|NCT01576016|76252266|FG000|COMPLETED|MRI Safety||0||
60130007|NCT01576016|76252267|FG001|COMPLETED|MRI Safety||181||
60130008|NCT01576016|76252266|FG000|NOT COMPLETED|MRI Safety||0||
60130009|NCT01576016|76252267|FG001|NOT COMPLETED|MRI Safety||74||
60130010|NCT01540838|76252277|FG000|STARTED|Overall Study||188||
60130011|NCT01540838|76252278|FG001|STARTED|Overall Study||187||
60130012|NCT01540838|76252277|FG000|COMPLETED|Overall Study||166||
60130013|NCT01540838|76252278|FG001|COMPLETED|Overall Study||164||
60130014|NCT01540838|76252277|FG000|NOT COMPLETED|Overall Study||22||
60130015|NCT01540838|76252278|FG001|NOT COMPLETED|Overall Study||23||
60130016|NCT01451437|76252293|FG000|STARTED|Overall Study||1||
60130017|NCT01451437|76252294|FG001|STARTED|Overall Study||1||
60130018|NCT01451437|76252295|FG002|STARTED|Overall Study||3||
60130019|NCT01451437|76252296|FG003|STARTED|Overall Study||1||
60130020|NCT01451437|76252297|FG004|STARTED|Overall Study||4||
60130021|NCT01451437|76252298|FG005|STARTED|Overall Study||3||
60130022|NCT01451437|76252299|FG006|STARTED|Overall Study||6||
60130023|NCT01451437|76252300|FG007|STARTED|Overall Study||3||
60130024|NCT01451437|76252301|FG008|STARTED|Overall Study||4||
60130025|NCT01451437|76252293|FG000|COMPLETED|Overall Study||0||
60130026|NCT01451437|76252294|FG001|COMPLETED|Overall Study||0||
60130027|NCT01451437|76252295|FG002|COMPLETED|Overall Study||0||
60130028|NCT01451437|76252296|FG003|COMPLETED|Overall Study||0||
60130029|NCT01451437|76252297|FG004|COMPLETED|Overall Study||0||
60130030|NCT01451437|76252298|FG005|COMPLETED|Overall Study||0||
60130031|NCT01451437|76252299|FG006|COMPLETED|Overall Study||0||
60130032|NCT01451437|76252300|FG007|COMPLETED|Overall Study||0||
60130033|NCT01451437|76252301|FG008|COMPLETED|Overall Study||0||
60130034|NCT01451437|76252293|FG000|NOT COMPLETED|Overall Study||1||
60130035|NCT01451437|76252294|FG001|NOT COMPLETED|Overall Study||1||
60130036|NCT01451437|76252295|FG002|NOT COMPLETED|Overall Study||3||
60130037|NCT01451437|76252296|FG003|NOT COMPLETED|Overall Study||1||
60130038|NCT01451437|76252297|FG004|NOT COMPLETED|Overall Study||4||
60130039|NCT01451437|76252298|FG005|NOT COMPLETED|Overall Study||3||
60130040|NCT01451437|76252299|FG006|NOT COMPLETED|Overall Study||6||
60130041|NCT01451437|76252300|FG007|NOT COMPLETED|Overall Study||3||
60130042|NCT01451437|76252301|FG008|NOT COMPLETED|Overall Study||4||
60130043|NCT01451203|76252332|FG000|STARTED|Double-blind Treatment Period||158||
60130044|NCT01451203|76252333|FG001|STARTED|Double-blind Treatment Period||161||
60130045|NCT01451203|76252332|FG000|Received Treatment|Double-blind Treatment Period||157||
60130046|NCT01451203|76252333|FG001|Received Treatment|Double-blind Treatment Period||159||
60130047|NCT01451203|76252332|FG000|Received Rescue Treatment|Double-blind Treatment Period|Participants who did not achieve improvement at & after Week 24 were dropped out of study schedule.|70||
60130048|NCT01451203|76252333|FG001|Received Rescue Treatment|Double-blind Treatment Period|Participants who did not achieve improvement at & after Week 24 were dropped out of study schedule.|36||
60130049|NCT01451203|76252332|FG000|COMPLETED|Double-blind Treatment Period||73||
60130050|NCT01451203|76252333|FG001|COMPLETED|Double-blind Treatment Period||111||
60130051|NCT01451203|76252332|FG000|NOT COMPLETED|Double-blind Treatment Period||85||
60130052|NCT01451203|76252333|FG001|NOT COMPLETED|Double-blind Treatment Period||50||
60130053|NCT01451203|76252332|FG000|STARTED|Post-treatment Period|Two participants received rescue treatment and did not enter this period.|71||
60130054|NCT01451203|76252333|FG001|STARTED|Post-treatment Period|Three participants received rescue treatment and did not enter this period.|108||
60130055|NCT01451203|76252332|FG000|Received Rescue Treatment|Post-treatment Period|Participants who presented with flares at any time were dropped out of study schedule.|12||
60130056|NCT01451203|76252333|FG001|Received Rescue Treatment|Post-treatment Period|Participants who presented with flares at any time were dropped out of study schedule.|28||
60130057|NCT01451203|76252332|FG000|COMPLETED|Post-treatment Period||57||
60130058|NCT01451203|76252333|FG001|COMPLETED|Post-treatment Period||74||
60130059|NCT01451203|76252332|FG000|NOT COMPLETED|Post-treatment Period||14||
60130060|NCT01451203|76252333|FG001|NOT COMPLETED|Post-treatment Period||34||
60130061|NCT01556438|76252341|FG000|STARTED|Overall Study||4||
60130062|NCT01556438|76252342|FG001|STARTED|Overall Study||12||
60130063|NCT01556438|76252341|FG000|Received at Least 1 Dose of Study Drug|Overall Study|100 mg tabalumab IV|4||
60130064|NCT01556438|76252342|FG001|Received at Least 1 Dose of Study Drug|Overall Study|300 mg tabalumab IV|12||
60130065|NCT01556438|76252341|FG000|Received BTZ IV|Overall Study||4||
60130066|NCT01556438|76252342|FG001|Received BTZ IV|Overall Study||4||
60130067|NCT01556438|76252341|FG000|Received BTZ SC|Overall Study||0||
60130068|NCT01556438|76252342|FG001|Received BTZ SC|Overall Study||8||
60130069|NCT01556438|76252341|FG000|COMPLETED|Overall Study||0||
60130070|NCT01556438|76252342|FG001|COMPLETED|Overall Study||1||
60130071|NCT01556438|76252341|FG000|NOT COMPLETED|Overall Study||4||
60130072|NCT01556438|76252342|FG001|NOT COMPLETED|Overall Study||11||
60130073|NCT02073487|76252358|FG000|STARTED|Overall Study||16||
60130074|NCT02073487|76252359|FG001|STARTED|Overall Study||16||
60130075|NCT02073487|76252358|FG000|COMPLETED|Overall Study||14||
60130076|NCT02073487|76252359|FG001|COMPLETED|Overall Study||16||
60130077|NCT02073487|76252358|FG000|NOT COMPLETED|Overall Study||2||
60130078|NCT02073487|76252359|FG001|NOT COMPLETED|Overall Study||0||
60130079|NCT01554176|76252368|FG000|STARTED|Treatment Phase||65||
60130080|NCT01554176|76252369|FG001|STARTED|Treatment Phase||64||
60130081|NCT01554176|76252370|FG002|STARTED|Treatment Phase||0||
60130082|NCT01554176|76252371|FG003|STARTED|Treatment Phase||0||
60130083|NCT01554176|76252372|FG004|STARTED|Treatment Phase||0||
60130084|NCT01554176|76252368|FG000|Treated|Treatment Phase||64||
60130085|NCT01554176|76252369|FG001|Treated|Treatment Phase||64||
60130086|NCT01554176|76252370|FG002|Treated|Treatment Phase||0||
60130087|NCT01554176|76252371|FG003|Treated|Treatment Phase||0||
60130088|NCT01554176|76252372|FG004|Treated|Treatment Phase||0||
60130089|NCT01554176|76252368|FG000|COMPLETED|Treatment Phase||57||
60130090|NCT01554176|76252369|FG001|COMPLETED|Treatment Phase||59||
60130091|NCT01554176|76252370|FG002|COMPLETED|Treatment Phase||0||
60130092|NCT01554176|76252371|FG003|COMPLETED|Treatment Phase||0||
60130093|NCT01554176|76252372|FG004|COMPLETED|Treatment Phase||0||
60130094|NCT01554176|76252368|FG000|NOT COMPLETED|Treatment Phase||8||
60130095|NCT01554176|76252369|FG001|NOT COMPLETED|Treatment Phase||5||
60130096|NCT01554176|76252370|FG002|NOT COMPLETED|Treatment Phase||0||
60130097|NCT01554176|76252371|FG003|NOT COMPLETED|Treatment Phase||0||
60130098|NCT01554176|76252372|FG004|NOT COMPLETED|Treatment Phase||0||
60130099|NCT01554176|76252368|FG000|STARTED|Run-out Phase||0||
60130100|NCT01554176|76252369|FG001|STARTED|Run-out Phase||0||
60130101|NCT01554176|76252370|FG002|STARTED|Run-out Phase||29||
60130102|NCT01554176|76252371|FG003|STARTED|Run-out Phase||28||
60130103|NCT01554176|76252372|FG004|STARTED|Run-out Phase||59||
60130104|NCT01554176|76252368|FG000|Treated|Run-out Phase||0||
60130105|NCT01554176|76252369|FG001|Treated|Run-out Phase||0||
60130106|NCT01554176|76252370|FG002|Treated|Run-out Phase||29||
60130107|NCT01554176|76252371|FG003|Treated|Run-out Phase||28||
60130108|NCT01554176|76252372|FG004|Treated|Run-out Phase||59||
60130109|NCT01554176|76252368|FG000|COMPLETED|Run-out Phase||0||
60130110|NCT01554176|76252369|FG001|COMPLETED|Run-out Phase||0||
60130111|NCT01554176|76252370|FG002|COMPLETED|Run-out Phase||29||
60130112|NCT01554176|76252371|FG003|COMPLETED|Run-out Phase||27||
60130113|NCT01554176|76252372|FG004|COMPLETED|Run-out Phase||59||
60130114|NCT01554176|76252368|FG000|NOT COMPLETED|Run-out Phase||0||
60130115|NCT01554176|76252369|FG001|NOT COMPLETED|Run-out Phase||0||
60130116|NCT01554176|76252370|FG002|NOT COMPLETED|Run-out Phase||0||
60130117|NCT01554176|76252371|FG003|NOT COMPLETED|Run-out Phase||1||
60130118|NCT01554176|76252372|FG004|NOT COMPLETED|Run-out Phase||0||
60130119|NCT01466491|76252388|FG000|STARTED|Overall Study||83||
60130120|NCT01466491|76252389|FG001|STARTED|Overall Study||83||
60130121|NCT01466491|76252390|FG002|STARTED|Overall Study||83||
60130122|NCT01466491|76252391|FG003|STARTED|Overall Study||83||
60130123|NCT01466491|76252388|FG000|COMPLETED|Overall Study||83||
60130124|NCT01466491|76252389|FG001|COMPLETED|Overall Study||80||
60130125|NCT01466491|76252390|FG002|COMPLETED|Overall Study||80||
60130126|NCT01466491|76252391|FG003|COMPLETED|Overall Study||83||
60130127|NCT01466491|76252388|FG000|NOT COMPLETED|Overall Study||0||
60130128|NCT01466491|76252389|FG001|NOT COMPLETED|Overall Study||3||
60130129|NCT01466491|76252390|FG002|NOT COMPLETED|Overall Study||3||
60130130|NCT01466491|76252391|FG003|NOT COMPLETED|Overall Study||0||
60130131|NCT01466179|76252401|FG000|STARTED|Overall Study|Participants enrolled during the first 3 stages of the study|189||
60130132|NCT01466179|76252401|FG000|COMPLETED|Overall Study|Completed 5 cycles of treatment; Data as of the time of the data cut-off date (10 October 2013).|10||
60130133|NCT01466179|76252401|FG000|NOT COMPLETED|Overall Study||179||
60130134|NCT01493089|76252410|FG000|STARTED|Overall Study||122||
60130135|NCT01493089|76252411|FG001|STARTED|Overall Study||117||
60130136|NCT01493089|76252410|FG000|COMPLETED|Overall Study||119||
60130137|NCT01493089|76252411|FG001|COMPLETED|Overall Study||114||
60130138|NCT01493089|76252410|FG000|NOT COMPLETED|Overall Study||3||
60130139|NCT01493089|76252411|FG001|NOT COMPLETED|Overall Study||3||
60130140|NCT01450813|76252423|FG000|STARTED|Overall Study||20||
60130141|NCT01450813|76252424|FG001|STARTED|Overall Study||20||
60130142|NCT01450813|76252425|FG002|STARTED|Overall Study||20||
60130143|NCT01450813|76252426|FG003|STARTED|Overall Study||20||
60130144|NCT01450813|76252423|FG000|COMPLETED|Overall Study||19||
60130145|NCT01450813|76252424|FG001|COMPLETED|Overall Study||19||
60130146|NCT01450813|76252425|FG002|COMPLETED|Overall Study||20||
60130147|NCT01450813|76252426|FG003|COMPLETED|Overall Study||17||
60130148|NCT01450813|76252423|FG000|NOT COMPLETED|Overall Study||1||
60130149|NCT01450813|76252424|FG001|NOT COMPLETED|Overall Study||1||
60130150|NCT01450813|76252425|FG002|NOT COMPLETED|Overall Study||0||
60130151|NCT01450813|76252426|FG003|NOT COMPLETED|Overall Study||3||
60130152|NCT01539512|76252440|FG000|STARTED|Overall Study||110||
60130153|NCT01539512|76252441|FG001|STARTED|Overall Study||110||
60130154|NCT01539512|76252440|FG000|COMPLETED|Overall Study|Completed=reached primary efficacy endpoint (progressive disease or death) or finished study period.|87||
60130155|NCT01539512|76252441|FG001|COMPLETED|Overall Study|Completed=reached primary efficacy endpoint (progressive disease or death) or finished study period.|97||
60130156|NCT01539512|76252440|FG000|NOT COMPLETED|Overall Study||23||
60130157|NCT01539512|76252441|FG001|NOT COMPLETED|Overall Study||13||
60130158|NCT01449955|76252449|FG000|STARTED|Overall Study||28||
60130159|NCT01449955|76252450|FG001|STARTED|Overall Study||26||
60130160|NCT01449955|76252449|FG000|COMPLETED|Overall Study||27||
60130161|NCT01449955|76252450|FG001|COMPLETED|Overall Study||24||
60130162|NCT01449955|76252449|FG000|NOT COMPLETED|Overall Study||1||
60130163|NCT01449955|76252450|FG001|NOT COMPLETED|Overall Study||2||
60130164|NCT01574612|76252463|FG000|STARTED|Overall Study|patients who were identified as having the appropriate medical history of herpes labialis|54||
60130165|NCT01574612|76252463|FG000|COMPLETED|Overall Study||46||
60130166|NCT01574612|76252463|FG000|NOT COMPLETED|Overall Study||8||
60130167|NCT01573910|76252469|FG000|STARTED|Overall Study||489||
60130168|NCT01573910|76252470|FG001|STARTED|Overall Study||493||
60130169|NCT01573910|76252469|FG000|COMPLETED|Overall Study||469||
60130170|NCT01573910|76252470|FG001|COMPLETED|Overall Study||476||
60130171|NCT01573910|76252469|FG000|NOT COMPLETED|Overall Study||20||
60130172|NCT01573910|76252470|FG001|NOT COMPLETED|Overall Study||17||
60130173|NCT01491919|76252479|FG000|STARTED|Overall Study||13||
60130174|NCT01491919|76252480|FG001|STARTED|Overall Study||10||
60130175|NCT01491919|76252481|FG002|STARTED|Overall Study||3||
60130176|NCT01491919|76252479|FG000|COMPLETED|Overall Study||12||
60130177|NCT01491919|76252480|FG001|COMPLETED|Overall Study||8||
60130178|NCT01491919|76252481|FG002|COMPLETED|Overall Study||2||
60130179|NCT01491919|76252479|FG000|NOT COMPLETED|Overall Study||1||
60130180|NCT01491919|76252480|FG001|NOT COMPLETED|Overall Study||2||
60130181|NCT01491919|76252481|FG002|NOT COMPLETED|Overall Study||1||
60130182|NCT01573442|76252493|FG000|STARTED|Overall Study||113||
60130183|NCT01573442|76252494|FG001|STARTED|Overall Study||114||
60130184|NCT01573442|76252493|FG000|COMPLETED|Overall Study||104||
60130185|NCT01573442|76252494|FG001|COMPLETED|Overall Study||104||
60130186|NCT01573442|76252493|FG000|NOT COMPLETED|Overall Study||9||
60130187|NCT01573442|76252494|FG001|NOT COMPLETED|Overall Study||10||
60130188|NCT02319369|76252513|FG000|STARTED|Overall Study||7||
60130189|NCT02319369|76252514|FG001|STARTED|Overall Study||6||
60130190|NCT02319369|76252515|FG002|STARTED|Overall Study||11||
60130191|NCT02319369|76252516|FG003|STARTED|Overall Study||8||
60130192|NCT02319369|76252517|FG004|STARTED|Overall Study||5||
60130193|NCT02319369|76252518|FG005|STARTED|Overall Study||7||
60130194|NCT02319369|76252519|FG006|STARTED|Overall Study||3||
60130195|NCT02319369|76252520|FG007|STARTED|Overall Study||6||
60130196|NCT02319369|76252521|FG008|STARTED|Overall Study||4||
60130197|NCT02319369|76252522|FG009|STARTED|Overall Study||9||
59598718|NCT03510481|75708208|FG000|NOT COMPLETED|Year 1||13||
59598719|NCT03510481|75708209|FG001|NOT COMPLETED|Year 1||9||
59598720|NCT03510481|75708210|FG002|NOT COMPLETED|Year 1||2||
60130198|NCT02319369|76252523|FG010|STARTED|Overall Study||3||
60130199|NCT02319369|76252524|FG011|STARTED|Overall Study||4||
60130200|NCT02319369|76252525|FG012|STARTED|Overall Study||1||
60130201|NCT02319369|76252513|FG000|COMPLETED|Overall Study||7||
60130202|NCT02319369|76252514|FG001|COMPLETED|Overall Study||6||
60130203|NCT02319369|76252515|FG002|COMPLETED|Overall Study||11||
60130204|NCT02319369|76252516|FG003|COMPLETED|Overall Study||8||
60130205|NCT02319369|76252517|FG004|COMPLETED|Overall Study||5||
60130206|NCT02319369|76252518|FG005|COMPLETED|Overall Study||7||
60130207|NCT02319369|76252519|FG006|COMPLETED|Overall Study||3||
60130208|NCT02319369|76252520|FG007|COMPLETED|Overall Study||6||
60130209|NCT02319369|76252521|FG008|COMPLETED|Overall Study||4||
59598721|NCT03510481|75708211|FG003|NOT COMPLETED|Year 1||4||
60130210|NCT02319369|76252522|FG009|COMPLETED|Overall Study||9||
60130211|NCT02319369|76252523|FG010|COMPLETED|Overall Study||3||
60130212|NCT02319369|76252524|FG011|COMPLETED|Overall Study||4||
60130213|NCT02319369|76252525|FG012|COMPLETED|Overall Study||1||
60130214|NCT02319369|76252513|FG000|NOT COMPLETED|Overall Study||0||
60130215|NCT02319369|76252514|FG001|NOT COMPLETED|Overall Study||0||
60130216|NCT02319369|76252515|FG002|NOT COMPLETED|Overall Study||0||
60130217|NCT02319369|76252516|FG003|NOT COMPLETED|Overall Study||0||
60130218|NCT02319369|76252517|FG004|NOT COMPLETED|Overall Study||0||
60130219|NCT02319369|76252518|FG005|NOT COMPLETED|Overall Study||0||
60130220|NCT02319369|76252519|FG006|NOT COMPLETED|Overall Study||0||
60130221|NCT02319369|76252520|FG007|NOT COMPLETED|Overall Study||0||
60130222|NCT02319369|76252521|FG008|NOT COMPLETED|Overall Study||0||
60130223|NCT02319369|76252522|FG009|NOT COMPLETED|Overall Study||0||
60130224|NCT02319369|76252523|FG010|NOT COMPLETED|Overall Study||0||
60130225|NCT02319369|76252524|FG011|NOT COMPLETED|Overall Study||0||
60130226|NCT02319369|76252525|FG012|NOT COMPLETED|Overall Study||0||
60130227|NCT01491841|76252563|FG000|STARTED|Overall Study||33||
60130228|NCT01491841|76252563|FG000|COMPLETED|Overall Study||22||
60130229|NCT01491841|76252563|FG000|NOT COMPLETED|Overall Study||11||
60130230|NCT00486447|76252575|FG000|STARTED|Overall Study||249||
60130231|NCT00486447|76252575|FG000|COMPLETED|Overall Study||249||
60130232|NCT00486447|76252575|FG000|NOT COMPLETED|Overall Study||0||
60130233|NCT01553318|76252582|FG000|STARTED|Overall Study||24||
60130234|NCT01553318|76252583|FG001|STARTED|Overall Study||27||
60130235|NCT01553318|76252582|FG000|COMPLETED|Overall Study||21||
60130236|NCT01553318|76252583|FG001|COMPLETED|Overall Study||25||
60130237|NCT01553318|76252582|FG000|NOT COMPLETED|Overall Study||3||
60130238|NCT01553318|76252583|FG001|NOT COMPLETED|Overall Study||2||
60130239|NCT00486525|76252593|FG000|STARTED|Overall Study||100||
60130240|NCT00486525|76252594|FG001|STARTED|Overall Study||100||
60130241|NCT00486525|76252593|FG000|COMPLETED|Overall Study||94||
60130242|NCT00486525|76252594|FG001|COMPLETED|Overall Study||87||
60130243|NCT00486525|76252593|FG000|NOT COMPLETED|Overall Study||6||
60130244|NCT00486525|76252594|FG001|NOT COMPLETED|Overall Study||13||
60130245|NCT01572740|76252602|FG000|STARTED|Overall Study||127||
60130246|NCT01572740|76252603|FG001|STARTED|Overall Study||130||
60130247|NCT01572740|76252602|FG000|COMPLETED|Overall Study||121||
60130248|NCT01572740|76252603|FG001|COMPLETED|Overall Study||125||
60130249|NCT01572740|76252602|FG000|NOT COMPLETED|Overall Study||6||
60130250|NCT01572740|76252603|FG001|NOT COMPLETED|Overall Study||5||
60130251|NCT01491607|76252613|FG000|STARTED|Overall Study||200||
60130252|NCT01491607|76252613|FG000|COMPLETED|Overall Study||190||
60130253|NCT01491607|76252613|FG000|NOT COMPLETED|Overall Study||10||
60130254|NCT02338713|76252679|FG000|STARTED|Overall Study||27||
60130255|NCT02338713|76252679|FG000|COMPLETED|Overall Study||27||
60130256|NCT02338713|76252679|FG000|NOT COMPLETED|Overall Study||0||
60130257|NCT00557349|76252687|FG000|STARTED|Overall Study|omeprazole/bicarb|22||
60130258|NCT00557349|76252688|FG001|STARTED|Overall Study||18||
60130259|NCT00557349|76252687|FG000|COMPLETED|Overall Study||17||
60130260|NCT00557349|76252688|FG001|COMPLETED|Overall Study||13||
60130261|NCT00557349|76252687|FG000|NOT COMPLETED|Overall Study||5||
60130262|NCT00557349|76252688|FG001|NOT COMPLETED|Overall Study||5||
60130263|NCT01449721|76252696|FG000|STARTED|Overall Study||112||
60130264|NCT01449721|76252697|FG001|STARTED|Overall Study||30||
60130265|NCT01449721|76252696|FG000|COMPLETED|Overall Study||112||
60130266|NCT01449721|76252697|FG001|COMPLETED|Overall Study||28||
60130267|NCT01449721|76252696|FG000|NOT COMPLETED|Overall Study||0||
60130268|NCT01449721|76252697|FG001|NOT COMPLETED|Overall Study||2||
60130269|NCT01553084|76252706|FG000|STARTED|Overall Study||241||
60130270|NCT01553084|76252707|FG001|STARTED|Overall Study||421||
60130271|NCT01553084|76252708|FG002|STARTED|Overall Study||424||
60130272|NCT01553084|76252706|FG000|COMPLETED|Overall Study||226||
60130273|NCT01553084|76252707|FG001|COMPLETED|Overall Study||408||
60130274|NCT01553084|76252708|FG002|COMPLETED|Overall Study||389||
60130275|NCT01553084|76252706|FG000|NOT COMPLETED|Overall Study||15||
60130276|NCT01553084|76252707|FG001|NOT COMPLETED|Overall Study||13||
60130277|NCT01553084|76252708|FG002|NOT COMPLETED|Overall Study||35||
60130278|NCT01536860|76252718|FG000|STARTED|First Intervention (1 Day)||4||
59728549|NCT00979134|75847185|FG001|STARTED|Overall Study||6||
60130279|NCT01536860|76252719|FG001|STARTED|First Intervention (1 Day)||4||
60130280|NCT01536860|76252720|FG002|STARTED|First Intervention (1 Day)||4||
60130281|NCT01536860|76252718|FG000|COMPLETED|First Intervention (1 Day)||4||
60130282|NCT01536860|76252719|FG001|COMPLETED|First Intervention (1 Day)||4||
60130283|NCT01536860|76252720|FG002|COMPLETED|First Intervention (1 Day)||4||
60130284|NCT01536860|76252718|FG000|NOT COMPLETED|First Intervention (1 Day)||0||
60130285|NCT01536860|76252719|FG001|NOT COMPLETED|First Intervention (1 Day)||0||
60130286|NCT01536860|76252720|FG002|NOT COMPLETED|First Intervention (1 Day)||0||
60130287|NCT01536860|76252718|FG000|STARTED|Washout Period (3 Days)||4||
60130288|NCT01536860|76252719|FG001|STARTED|Washout Period (3 Days)||4||
60130289|NCT01536860|76252720|FG002|STARTED|Washout Period (3 Days)||4||
60130290|NCT01536860|76252718|FG000|COMPLETED|Washout Period (3 Days)||4||
60130291|NCT01536860|76252719|FG001|COMPLETED|Washout Period (3 Days)||4||
60130292|NCT01536860|76252720|FG002|COMPLETED|Washout Period (3 Days)||4||
60130293|NCT01536860|76252718|FG000|NOT COMPLETED|Washout Period (3 Days)||0||
60130294|NCT01536860|76252719|FG001|NOT COMPLETED|Washout Period (3 Days)||0||
60130295|NCT01536860|76252720|FG002|NOT COMPLETED|Washout Period (3 Days)||0||
60130296|NCT01536860|76252718|FG000|STARTED|Second Intervention (1 Day)||4||
60130297|NCT01536860|76252719|FG001|STARTED|Second Intervention (1 Day)||4||
60130298|NCT01536860|76252720|FG002|STARTED|Second Intervention (1 Day)||4||
60130299|NCT01536860|76252718|FG000|COMPLETED|Second Intervention (1 Day)||4||
60130300|NCT01536860|76252719|FG001|COMPLETED|Second Intervention (1 Day)||4||
60130301|NCT01536860|76252720|FG002|COMPLETED|Second Intervention (1 Day)||4||
60130302|NCT01536860|76252718|FG000|NOT COMPLETED|Second Intervention (1 Day)||0||
60130303|NCT01536860|76252719|FG001|NOT COMPLETED|Second Intervention (1 Day)||0||
60130304|NCT01536860|76252720|FG002|NOT COMPLETED|Second Intervention (1 Day)||0||
60130305|NCT01536860|76252718|FG000|STARTED|Washout Period (3 Days)||4||
60130306|NCT01536860|76252719|FG001|STARTED|Washout Period (3 Days)||4||
60130307|NCT01536860|76252720|FG002|STARTED|Washout Period (3 Days)||4||
60130308|NCT01536860|76252718|FG000|COMPLETED|Washout Period (3 Days)||3||
60130309|NCT01536860|76252719|FG001|COMPLETED|Washout Period (3 Days)||4||
60130310|NCT01536860|76252720|FG002|COMPLETED|Washout Period (3 Days)||4||
60130311|NCT01536860|76252718|FG000|NOT COMPLETED|Washout Period (3 Days)||1||
60130312|NCT01536860|76252719|FG001|NOT COMPLETED|Washout Period (3 Days)||0||
60130313|NCT01536860|76252720|FG002|NOT COMPLETED|Washout Period (3 Days)||0||
60130314|NCT01536860|76252718|FG000|STARTED|Third Intervention (1 Day)||3||
60130315|NCT01536860|76252719|FG001|STARTED|Third Intervention (1 Day)||4||
60130316|NCT01536860|76252720|FG002|STARTED|Third Intervention (1 Day)||4||
60130317|NCT01536860|76252718|FG000|COMPLETED|Third Intervention (1 Day)||3||
60130318|NCT01536860|76252719|FG001|COMPLETED|Third Intervention (1 Day)||4||
60130319|NCT01536860|76252720|FG002|COMPLETED|Third Intervention (1 Day)||4||
60130320|NCT01536860|76252718|FG000|NOT COMPLETED|Third Intervention (1 Day)||0||
60130321|NCT01536860|76252719|FG001|NOT COMPLETED|Third Intervention (1 Day)||0||
60130322|NCT01536860|76252720|FG002|NOT COMPLETED|Third Intervention (1 Day)||0||
60130323|NCT01552928|76252732|FG000|STARTED|Period 1||14||
60130324|NCT01552928|76252733|FG001|STARTED|Period 1||15||
60130325|NCT01552928|76252734|FG002|STARTED|Period 1||15||
60130326|NCT01552928|76252735|FG003|STARTED|Period 1||16||
60130327|NCT01552928|76252732|FG000|COMPLETED|Period 1||14||
60130328|NCT01552928|76252733|FG001|COMPLETED|Period 1||15||
60130329|NCT01552928|76252734|FG002|COMPLETED|Period 1||15||
60130330|NCT01552928|76252735|FG003|COMPLETED|Period 1||16||
60130331|NCT01552928|76252732|FG000|NOT COMPLETED|Period 1||0||
60130332|NCT01552928|76252733|FG001|NOT COMPLETED|Period 1||0||
60130333|NCT01552928|76252734|FG002|NOT COMPLETED|Period 1||0||
60130334|NCT01552928|76252735|FG003|NOT COMPLETED|Period 1||0||
60130335|NCT01552928|76252732|FG000|STARTED|Period 2||14||
60130336|NCT01552928|76252733|FG001|STARTED|Period 2||15||
60130337|NCT01552928|76252734|FG002|STARTED|Period 2||15||
60130338|NCT01552928|76252735|FG003|STARTED|Period 2||16||
60130339|NCT01552928|76252732|FG000|COMPLETED|Period 2||14||
60130340|NCT01552928|76252733|FG001|COMPLETED|Period 2||15||
60130341|NCT01552928|76252734|FG002|COMPLETED|Period 2||15||
60130342|NCT01552928|76252735|FG003|COMPLETED|Period 2||16||
60130343|NCT01552928|76252732|FG000|NOT COMPLETED|Period 2||0||
60130344|NCT01552928|76252733|FG001|NOT COMPLETED|Period 2||0||
60130345|NCT01552928|76252734|FG002|NOT COMPLETED|Period 2||0||
60130346|NCT01552928|76252735|FG003|NOT COMPLETED|Period 2||0||
60130347|NCT01552928|76252732|FG000|STARTED|Period 3||14||
60130348|NCT01552928|76252733|FG001|STARTED|Period 3||15||
60130349|NCT01552928|76252734|FG002|STARTED|Period 3||15||
60130350|NCT01552928|76252735|FG003|STARTED|Period 3||16||
60130351|NCT01552928|76252732|FG000|COMPLETED|Period 3||14||
60130352|NCT01552928|76252733|FG001|COMPLETED|Period 3||15||
60130353|NCT01552928|76252734|FG002|COMPLETED|Period 3||14||
60130354|NCT01552928|76252735|FG003|COMPLETED|Period 3||16||
60130355|NCT01552928|76252732|FG000|NOT COMPLETED|Period 3||0||
60130356|NCT01552928|76252733|FG001|NOT COMPLETED|Period 3||0||
60130357|NCT01552928|76252734|FG002|NOT COMPLETED|Period 3||1||
60130358|NCT01552928|76252735|FG003|NOT COMPLETED|Period 3||0||
60130359|NCT01552928|76252732|FG000|STARTED|Period 4||14||
60130360|NCT01552928|76252733|FG001|STARTED|Period 4||15||
60130361|NCT01552928|76252734|FG002|STARTED|Period 4||14||
60130362|NCT01552928|76252735|FG003|STARTED|Period 4||16||
60130363|NCT01552928|76252732|FG000|COMPLETED|Period 4||14||
60130364|NCT01552928|76252733|FG001|COMPLETED|Period 4||15||
60130365|NCT01552928|76252734|FG002|COMPLETED|Period 4||14||
60130366|NCT01552928|76252735|FG003|COMPLETED|Period 4||16||
60130367|NCT01552928|76252732|FG000|NOT COMPLETED|Period 4||0||
60130368|NCT01552928|76252733|FG001|NOT COMPLETED|Period 4||0||
60130369|NCT01552928|76252734|FG002|NOT COMPLETED|Period 4||0||
60130370|NCT01552928|76252735|FG003|NOT COMPLETED|Period 4||0||
60130371|NCT01448707|76252754|FG000|STARTED|Overall Study||137||
60130372|NCT01448707|76252755|FG001|STARTED|Overall Study||136||
60130373|NCT01448707|76252754|FG000|COMPLETED|Overall Study||119||
60130374|NCT01448707|76252755|FG001|COMPLETED|Overall Study||118||
60130375|NCT01448707|76252754|FG000|NOT COMPLETED|Overall Study||18||
60130376|NCT01448707|76252755|FG001|NOT COMPLETED|Overall Study||18||
60130377|NCT01536704|76252761|FG000|STARTED|Period 1||12||
60130378|NCT01536704|76252762|FG001|STARTED|Period 1||12||
60130379|NCT01536704|76252763|FG002|STARTED|Period 1||13||
60130380|NCT01536704|76252764|FG003|STARTED|Period 1||13||
60130381|NCT01536704|76252761|FG000|COMPLETED|Period 1||12||
60130382|NCT01536704|76252762|FG001|COMPLETED|Period 1||12||
60130383|NCT01536704|76252763|FG002|COMPLETED|Period 1||13||
60130384|NCT01536704|76252764|FG003|COMPLETED|Period 1||13||
60130385|NCT01536704|76252761|FG000|NOT COMPLETED|Period 1||0||
60130386|NCT01536704|76252762|FG001|NOT COMPLETED|Period 1||0||
60130387|NCT01536704|76252763|FG002|NOT COMPLETED|Period 1||0||
60130388|NCT01536704|76252764|FG003|NOT COMPLETED|Period 1||0||
60130389|NCT01536704|76252761|FG000|STARTED|Washout Period 1||12||
60130390|NCT01536704|76252762|FG001|STARTED|Washout Period 1||12||
60130391|NCT01536704|76252763|FG002|STARTED|Washout Period 1||13||
60130392|NCT01536704|76252764|FG003|STARTED|Washout Period 1||13||
60130393|NCT01536704|76252761|FG000|COMPLETED|Washout Period 1||11||
60130394|NCT01536704|76252762|FG001|COMPLETED|Washout Period 1||10||
60130395|NCT01536704|76252763|FG002|COMPLETED|Washout Period 1||13||
60130396|NCT01536704|76252764|FG003|COMPLETED|Washout Period 1||13||
60130397|NCT01536704|76252761|FG000|NOT COMPLETED|Washout Period 1||1||
60130398|NCT01536704|76252762|FG001|NOT COMPLETED|Washout Period 1||2||
60130399|NCT01536704|76252763|FG002|NOT COMPLETED|Washout Period 1||0||
60130400|NCT01536704|76252764|FG003|NOT COMPLETED|Washout Period 1||0||
60130401|NCT01536704|76252761|FG000|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1|13||
60130402|NCT01536704|76252762|FG001|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1|11||
60130403|NCT01536704|76252763|FG002|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1|10||
60130404|NCT01536704|76252764|FG003|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1|13||
60130405|NCT01536704|76252761|FG000|COMPLETED|Period 2||13||
60130406|NCT01536704|76252762|FG001|COMPLETED|Period 2||11||
60130407|NCT01536704|76252763|FG002|COMPLETED|Period 2||10||
60130408|NCT01536704|76252764|FG003|COMPLETED|Period 2||13||
60130409|NCT01536704|76252761|FG000|NOT COMPLETED|Period 2||0||
60130410|NCT01536704|76252762|FG001|NOT COMPLETED|Period 2||0||
60130411|NCT01536704|76252763|FG002|NOT COMPLETED|Period 2||0||
60130412|NCT01536704|76252764|FG003|NOT COMPLETED|Period 2||0||
60130413|NCT01536704|76252761|FG000|STARTED|Washout Period 2||13||
60130414|NCT01536704|76252762|FG001|STARTED|Washout Period 2||11||
60130415|NCT01536704|76252763|FG002|STARTED|Washout Period 2||10||
60130416|NCT01536704|76252764|FG003|STARTED|Washout Period 2||13||
60130417|NCT01536704|76252761|FG000|COMPLETED|Washout Period 2||12||
60130418|NCT01536704|76252762|FG001|COMPLETED|Washout Period 2||11||
60130419|NCT01536704|76252763|FG002|COMPLETED|Washout Period 2||10||
60130420|NCT01536704|76252764|FG003|COMPLETED|Washout Period 2||12||
60130421|NCT01536704|76252761|FG000|NOT COMPLETED|Washout Period 2||1||
60130422|NCT01536704|76252762|FG001|NOT COMPLETED|Washout Period 2||0||
60130423|NCT01536704|76252763|FG002|NOT COMPLETED|Washout Period 2||0||
60130424|NCT01536704|76252764|FG003|NOT COMPLETED|Washout Period 2||1||
60130425|NCT01536704|76252761|FG000|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2|10||
60130426|NCT01536704|76252762|FG001|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12||
60130427|NCT01536704|76252763|FG002|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12||
60130428|NCT01536704|76252764|FG003|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2|11||
60130429|NCT01536704|76252761|FG000|COMPLETED|Period 3||10||
60130430|NCT01536704|76252762|FG001|COMPLETED|Period 3||12||
60130431|NCT01536704|76252763|FG002|COMPLETED|Period 3||12||
60130432|NCT01536704|76252764|FG003|COMPLETED|Period 3||10||
60130433|NCT01536704|76252761|FG000|NOT COMPLETED|Period 3||0||
60130434|NCT01536704|76252762|FG001|NOT COMPLETED|Period 3||0||
60130435|NCT01536704|76252763|FG002|NOT COMPLETED|Period 3||0||
60130436|NCT01536704|76252764|FG003|NOT COMPLETED|Period 3||1||
60130437|NCT01536704|76252761|FG000|STARTED|Washout Period 3||10||
60130438|NCT01536704|76252762|FG001|STARTED|Washout Period 3||12||
60130439|NCT01536704|76252763|FG002|STARTED|Washout Period 3||12||
60130440|NCT01536704|76252764|FG003|STARTED|Washout Period 3||10||
60130441|NCT01536704|76252761|FG000|COMPLETED|Washout Period 3||10||
60130442|NCT01536704|76252762|FG001|COMPLETED|Washout Period 3||12||
60130443|NCT01536704|76252763|FG002|COMPLETED|Washout Period 3||11||
60130444|NCT01536704|76252764|FG003|COMPLETED|Washout Period 3||10||
60130445|NCT01536704|76252761|FG000|NOT COMPLETED|Washout Period 3||0||
60130446|NCT01536704|76252762|FG001|NOT COMPLETED|Washout Period 3||0||
60130447|NCT01536704|76252763|FG002|NOT COMPLETED|Washout Period 3||1||
60130448|NCT01536704|76252764|FG003|NOT COMPLETED|Washout Period 3||0||
60130449|NCT01536704|76252761|FG000|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3|12||
60130450|NCT01536704|76252762|FG001|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3|11||
60130451|NCT01536704|76252763|FG002|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3|10||
60130452|NCT01536704|76252764|FG003|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3|10||
60130453|NCT01536704|76252761|FG000|COMPLETED|Period 4||12||
60130454|NCT01536704|76252762|FG001|COMPLETED|Period 4||11||
60130455|NCT01536704|76252763|FG002|COMPLETED|Period 4||10||
60130456|NCT01536704|76252764|FG003|COMPLETED|Period 4||10||
60130457|NCT01536704|76252761|FG000|NOT COMPLETED|Period 4||0||
60130458|NCT01536704|76252762|FG001|NOT COMPLETED|Period 4||0||
60130459|NCT01536704|76252763|FG002|NOT COMPLETED|Period 4||0||
60130460|NCT01536704|76252764|FG003|NOT COMPLETED|Period 4||0||
60130461|NCT01552772|76252778|FG000|STARTED|Overall Study||60||
60130462|NCT01552772|76252778|FG000|COMPLETED|Overall Study|Participants who completed the Day 28 visit were defined as completers for the trial.|56||
60130463|NCT01552772|76252778|FG000|NOT COMPLETED|Overall Study||4||
60130464|NCT01552694|76252785|FG000|STARTED|Overall Study||18||
60130465|NCT01552694|76252786|FG001|STARTED|Overall Study||20||
60130466|NCT01552694|76252785|FG000|COMPLETED|Overall Study||18||
60130467|NCT01552694|76252786|FG001|COMPLETED|Overall Study||18||
60130468|NCT01552694|76252785|FG000|NOT COMPLETED|Overall Study||0||
60130469|NCT01552694|76252786|FG001|NOT COMPLETED|Overall Study||2||
60130470|NCT01464931|76252794|FG000|STARTED|Overall Study||16||
60130471|NCT01464931|76252795|FG001|STARTED|Overall Study||16||
60130472|NCT01464931|76252794|FG000|COMPLETED|Overall Study||15||
60130473|NCT01464931|76252795|FG001|COMPLETED|Overall Study||16||
60130474|NCT01464931|76252794|FG000|NOT COMPLETED|Overall Study||1||
60130475|NCT01464931|76252795|FG001|NOT COMPLETED|Overall Study||0||
60130476|NCT00560859|76252810|FG000|STARTED|Overall Study||226||
60130477|NCT00560859|76252811|FG001|STARTED|Overall Study||227||
60130478|NCT00560859|76252810|FG000|COMPLETED|Overall Study||194||
60130479|NCT00560859|76252811|FG001|COMPLETED|Overall Study||203||
60130480|NCT00560859|76252810|FG000|NOT COMPLETED|Overall Study||32||
60130481|NCT00560859|76252811|FG001|NOT COMPLETED|Overall Study||24||
60130482|NCT01536392|76252820|FG000|STARTED|Overall Study||41||
60130483|NCT01536392|76252821|FG001|STARTED|Overall Study||34||
60130484|NCT01536392|76252820|FG000|COMPLETED|Overall Study||28||
60130485|NCT01536392|76252821|FG001|COMPLETED|Overall Study||19||
59598722|NCT03510481|75708208|FG000|STARTED|Year 2 - Booster Dose|10 participants who completed Period 1 did not re-consent for Period 2.|46||
59598723|NCT03510481|75708209|FG001|STARTED|Year 2 - Booster Dose|9 participants who completed Period 1 did not re-consent for Period 2.|52||
60130486|NCT01536392|76252820|FG000|NOT COMPLETED|Overall Study||13||
59598724|NCT03510481|75708210|FG002|STARTED|Year 2 - Booster Dose|9 participants who completed Period 1 did not re-consent for Period 2.|25||
60130487|NCT01536392|76252821|FG001|NOT COMPLETED|Overall Study||15||
60130488|NCT01464619|76252829|FG000|STARTED|Overall Study||32||
60130489|NCT01464619|76252830|FG001|STARTED|Overall Study||29||
60130490|NCT01464619|76252829|FG000|COMPLETED|Overall Study||29||
60130491|NCT01464619|76252830|FG001|COMPLETED|Overall Study||25||
60130492|NCT01464619|76252829|FG000|NOT COMPLETED|Overall Study||3||
60130493|NCT01464619|76252830|FG001|NOT COMPLETED|Overall Study||4||
60130494|NCT02123745|76252838|FG000|STARTED|Overall Study||71||
60130495|NCT02123745|76252838|FG000|COMPLETED|Overall Study||71||
60130496|NCT02123745|76252838|FG000|NOT COMPLETED|Overall Study||0||
60130497|NCT00488865|76252842|FG000|STARTED|Overall Study||100||
60130498|NCT00488865|76252842|FG000|COMPLETED|Overall Study||100||
60130499|NCT00488865|76252842|FG000|NOT COMPLETED|Overall Study||0||
60130500|NCT02118441|76252848|FG000|STARTED|Overall Study||65||
60130501|NCT02118441|76252849|FG001|STARTED|Overall Study||64||
60130502|NCT02118441|76252848|FG000|COMPLETED|Overall Study||62||
60130503|NCT02118441|76252849|FG001|COMPLETED|Overall Study||63||
60130504|NCT02118441|76252848|FG000|NOT COMPLETED|Overall Study||3||
60130505|NCT02118441|76252849|FG001|NOT COMPLETED|Overall Study||1||
60130506|NCT02118831|76252859|FG000|STARTED|Overall Study||21||
60130507|NCT02118831|76252860|FG001|STARTED|Overall Study||15||
60130508|NCT02118831|76252861|FG002|STARTED|Overall Study||20||
60130509|NCT02118831|76252859|FG000|COMPLETED|Overall Study||21||
60130510|NCT02118831|76252860|FG001|COMPLETED|Overall Study||15||
60130511|NCT02118831|76252861|FG002|COMPLETED|Overall Study||20||
60130512|NCT02118831|76252859|FG000|NOT COMPLETED|Overall Study||0||
60130513|NCT02118831|76252860|FG001|NOT COMPLETED|Overall Study||0||
60130514|NCT02118831|76252861|FG002|NOT COMPLETED|Overall Study||0||
60130515|NCT02119455|76252871|FG000|STARTED|Overall Study||20||
60130516|NCT02119455|76252872|FG001|STARTED|Overall Study||20||
60130517|NCT02119455|76252871|FG000|COMPLETED|Overall Study||20||
60130518|NCT02119455|76252872|FG001|COMPLETED|Overall Study||17||
60130519|NCT02119455|76252871|FG000|NOT COMPLETED|Overall Study||0||
60130520|NCT02119455|76252872|FG001|NOT COMPLETED|Overall Study||3||
60130521|NCT02120001|76252880|FG000|STARTED|Overall Study||17||
60130522|NCT02120001|76252881|FG001|STARTED|Overall Study||19||
60130523|NCT02120001|76252880|FG000|COMPLETED|Overall Study||17||
60130524|NCT02120001|76252881|FG001|COMPLETED|Overall Study||19||
60130525|NCT02120001|76252880|FG000|NOT COMPLETED|Overall Study||0||
60130526|NCT02120001|76252881|FG001|NOT COMPLETED|Overall Study||0||
60130527|NCT00490269|76252889|FG000|STARTED|Dronabinol Then Placebo||6||
60130528|NCT00490269|76252890|FG001|STARTED|Dronabinol Then Placebo||6||
60130529|NCT00490269|76252889|FG000|COMPLETED|Dronabinol Then Placebo||6||
60130530|NCT00490269|76252890|FG001|COMPLETED|Dronabinol Then Placebo||6||
60130531|NCT00490269|76252889|FG000|NOT COMPLETED|Dronabinol Then Placebo||0||
60130532|NCT00490269|76252890|FG001|NOT COMPLETED|Dronabinol Then Placebo||0||
60130533|NCT00490269|76252889|FG000|STARTED|Placebo Then Dronabinol||6||
60130534|NCT00490269|76252890|FG001|STARTED|Placebo Then Dronabinol||6||
60130535|NCT00490269|76252889|FG000|COMPLETED|Placebo Then Dronabinol||6||
60130536|NCT00490269|76252890|FG001|COMPLETED|Placebo Then Dronabinol||6||
60130537|NCT00490269|76252889|FG000|NOT COMPLETED|Placebo Then Dronabinol||0||
60130538|NCT00490269|76252890|FG001|NOT COMPLETED|Placebo Then Dronabinol||0||
60130539|NCT01490125|76252896|FG000|STARTED|Period I||43||
60130540|NCT01490125|76252897|FG001|STARTED|Period I||42||
60130541|NCT01490125|76252898|FG002|STARTED|Period I||41||
60130542|NCT01490125|76252899|FG003|STARTED|Period I||38||
60130543|NCT01490125|76252900|FG004|STARTED|Period I||40||
60130544|NCT01490125|76252901|FG005|STARTED|Period I||42||
60130545|NCT01490125|76252896|FG000|COMPLETED|Period I||37||
60130546|NCT01490125|76252897|FG001|COMPLETED|Period I||37||
60130547|NCT01490125|76252898|FG002|COMPLETED|Period I||37||
60130548|NCT01490125|76252899|FG003|COMPLETED|Period I||33||
60130549|NCT01490125|76252900|FG004|COMPLETED|Period I||36||
60130550|NCT01490125|76252901|FG005|COMPLETED|Period I||37||
60130551|NCT01490125|76252896|FG000|NOT COMPLETED|Period I||6||
60130552|NCT01490125|76252897|FG001|NOT COMPLETED|Period I||5||
60130553|NCT01490125|76252898|FG002|NOT COMPLETED|Period I||4||
60130554|NCT01490125|76252899|FG003|NOT COMPLETED|Period I||5||
60130555|NCT01490125|76252900|FG004|NOT COMPLETED|Period I||4||
60130556|NCT01490125|76252901|FG005|NOT COMPLETED|Period I||5||
60130557|NCT01490125|76252896|FG000|STARTED|Period II||37||
60130558|NCT01490125|76252897|FG001|STARTED|Period II||37||
60130559|NCT01490125|76252898|FG002|STARTED|Period II||37||
60130560|NCT01490125|76252899|FG003|STARTED|Period II||33||
60130561|NCT01490125|76252900|FG004|STARTED|Period II||36||
60130562|NCT01490125|76252901|FG005|STARTED|Period II||37||
60130563|NCT01490125|76252896|FG000|COMPLETED|Period II||34||
60130564|NCT01490125|76252897|FG001|COMPLETED|Period II||33||
60130565|NCT01490125|76252898|FG002|COMPLETED|Period II||34||
60130566|NCT01490125|76252899|FG003|COMPLETED|Period II||30||
60130567|NCT01490125|76252900|FG004|COMPLETED|Period II||32||
60130568|NCT01490125|76252901|FG005|COMPLETED|Period II||35||
60130569|NCT01490125|76252896|FG000|NOT COMPLETED|Period II||3||
60130570|NCT01490125|76252897|FG001|NOT COMPLETED|Period II||4||
60130571|NCT01490125|76252898|FG002|NOT COMPLETED|Period II||3||
60130572|NCT01490125|76252899|FG003|NOT COMPLETED|Period II||3||
60130573|NCT01490125|76252900|FG004|NOT COMPLETED|Period II||4||
60130574|NCT01490125|76252901|FG005|NOT COMPLETED|Period II||2||
60130575|NCT01490125|76252896|FG000|STARTED|Period III||34||
60130576|NCT01490125|76252897|FG001|STARTED|Period III||33||
60130577|NCT01490125|76252898|FG002|STARTED|Period III||34||
60130578|NCT01490125|76252899|FG003|STARTED|Period III||30||
60130579|NCT01490125|76252900|FG004|STARTED|Period III||32||
60130580|NCT01490125|76252901|FG005|STARTED|Period III||35||
60130581|NCT01490125|76252896|FG000|COMPLETED|Period III||31||
60130582|NCT01490125|76252897|FG001|COMPLETED|Period III||32||
60130583|NCT01490125|76252898|FG002|COMPLETED|Period III||34||
60130584|NCT01490125|76252899|FG003|COMPLETED|Period III||28||
60130585|NCT01490125|76252900|FG004|COMPLETED|Period III||31||
60130586|NCT01490125|76252901|FG005|COMPLETED|Period III||35||
60130587|NCT01490125|76252896|FG000|NOT COMPLETED|Period III||3||
60130588|NCT01490125|76252897|FG001|NOT COMPLETED|Period III||1||
60130589|NCT01490125|76252898|FG002|NOT COMPLETED|Period III||0||
60130590|NCT01490125|76252899|FG003|NOT COMPLETED|Period III||2||
60130591|NCT01490125|76252900|FG004|NOT COMPLETED|Period III||1||
60130592|NCT01490125|76252901|FG005|NOT COMPLETED|Period III||0||
60130593|NCT01446913|76252912|FG000|STARTED|Overall Study||86||
60130594|NCT01446913|76252913|FG001|STARTED|Overall Study||82||
60130595|NCT01446913|76252914|FG002|STARTED|Overall Study||84||
60130596|NCT01446913|76252912|FG000|Patients With Sleep Study|Overall Study||53|A sub sample of patients had a valid sleep study conducted.|
60130597|NCT01446913|76252913|FG001|Patients With Sleep Study|Overall Study||56|A sub sample of patients had a valid sleep study conducted.|
60130598|NCT01446913|76252914|FG002|Patients With Sleep Study|Overall Study||29|A sub sample of patients had a valid sleep study conducted.|
60130599|NCT01446913|76252912|FG000|Patients With Sleep Apnea|Overall Study||39|A sub sample of patients with sleep apnea were studied.|
60130600|NCT01446913|76252913|FG001|Patients With Sleep Apnea|Overall Study||45|A sub sample of patients with sleep apnea were studied.|
60130601|NCT01446913|76252914|FG002|Patients With Sleep Apnea|Overall Study||21|A sub sample of patients with sleep apnea were studied.|
60130602|NCT01446913|76252912|FG000|COMPLETED|Overall Study||77||
60130603|NCT01446913|76252913|FG001|COMPLETED|Overall Study||73||
60130604|NCT01446913|76252914|FG002|COMPLETED|Overall Study||73||
60130605|NCT01446913|76252912|FG000|NOT COMPLETED|Overall Study||9||
60130606|NCT01446913|76252913|FG001|NOT COMPLETED|Overall Study||9||
60130607|NCT01446913|76252914|FG002|NOT COMPLETED|Overall Study||11||
60130608|NCT00491751|76252931|FG000|STARTED|Overall Study||22||
60130609|NCT00491751|76252932|FG001|STARTED|Overall Study||44||
60130610|NCT00491751|76252933|FG002|STARTED|Overall Study||42||
60130611|NCT00491751|76252931|FG000|COMPLETED|Overall Study||22||
60130612|NCT00491751|76252932|FG001|COMPLETED|Overall Study||44||
60130613|NCT00491751|76252933|FG002|COMPLETED|Overall Study||42||
60130614|NCT00491751|76252931|FG000|NOT COMPLETED|Overall Study||0||
60130615|NCT00491751|76252932|FG001|NOT COMPLETED|Overall Study||0||
60130616|NCT00491751|76252933|FG002|NOT COMPLETED|Overall Study||0||
60130617|NCT01420549|76252945|FG000|STARTED|Overall Study||66|Treatment (Open- label / 9 weeks)|
60130618|NCT01420549|76252946|FG001|STARTED|Overall Study||63|Treatment (Open- label / 9 weeks)|
60130619|NCT01420549|76252945|FG000|COMPLETED|Overall Study||59||
60130620|NCT01420549|76252946|FG001|COMPLETED|Overall Study||58||
60130621|NCT01420549|76252945|FG000|NOT COMPLETED|Overall Study||7||
60130622|NCT01420549|76252946|FG001|NOT COMPLETED|Overall Study||5||
60130623|NCT00491829|76252955|FG000|STARTED|Overall Study||311||
60130624|NCT00491829|76252956|FG001|STARTED|Overall Study||316||
60130625|NCT00491829|76252957|FG002|STARTED|Overall Study||318||
60130626|NCT00491829|76252955|FG000|COMPLETED|Overall Study||216||
60130627|NCT00491829|76252956|FG001|COMPLETED|Overall Study||202||
60130628|NCT00491829|76252957|FG002|COMPLETED|Overall Study||243||
60130629|NCT00491829|76252955|FG000|NOT COMPLETED|Overall Study||95||
60130630|NCT00491829|76252956|FG001|NOT COMPLETED|Overall Study||114||
60130631|NCT00491829|76252957|FG002|NOT COMPLETED|Overall Study||75||
60130632|NCT01440595|76252967|FG000|STARTED|Overall Study||1||
60130633|NCT01440595|76252968|FG001|STARTED|Overall Study||3||
60130634|NCT01440595|76252969|FG002|STARTED|Overall Study||1||
60130635|NCT01440595|76252967|FG000|COMPLETED|Overall Study||0||
60130636|NCT01440595|76252968|FG001|COMPLETED|Overall Study||0||
60130637|NCT01440595|76252969|FG002|COMPLETED|Overall Study||0||
60130638|NCT01440595|76252967|FG000|NOT COMPLETED|Overall Study||1||
60130639|NCT01440595|76252968|FG001|NOT COMPLETED|Overall Study||3||
60130640|NCT01440595|76252969|FG002|NOT COMPLETED|Overall Study||1||
60130641|NCT01440517|76252975|FG000|STARTED|Overall Study||5||
60130642|NCT01440517|76252975|FG000|COMPLETED|Overall Study||4||
60130643|NCT01440517|76252975|FG000|NOT COMPLETED|Overall Study||1||
60130644|NCT01440283|76252979|FG000|STARTED|Overall Study||14||
60130645|NCT01440283|76252979|FG000|COMPLETED|Overall Study||4||
60130646|NCT01440283|76252979|FG000|NOT COMPLETED|Overall Study||10||
60130647|NCT01440049|76252989|FG000|STARTED|Overall Study||160||
60130648|NCT01440049|76252989|FG000|COMPLETED|Overall Study||155||
60130649|NCT01440049|76252989|FG000|NOT COMPLETED|Overall Study||5||
60130650|NCT00497055|76252995|FG000|STARTED|Overall Study||45||
60130651|NCT00497055|76252996|FG001|STARTED|Overall Study||45||
60130652|NCT00497055|76252995|FG000|COMPLETED|Overall Study||35||
60130653|NCT00497055|76252996|FG001|COMPLETED|Overall Study||40||
60130654|NCT00497055|76252995|FG000|NOT COMPLETED|Overall Study||10||
60130655|NCT00497055|76252996|FG001|NOT COMPLETED|Overall Study||5||
60130656|NCT00497289|76253004|FG000|STARTED|Overall Study||24||
60130657|NCT00497289|76253005|FG001|STARTED|Overall Study||24||
60130658|NCT00497289|76253004|FG000|COMPLETED|Overall Study||19||
60130659|NCT00497289|76253005|FG001|COMPLETED|Overall Study||18||
60130660|NCT00497289|76253004|FG000|NOT COMPLETED|Overall Study||5||
60130661|NCT00497289|76253005|FG001|NOT COMPLETED|Overall Study||6||
60130662|NCT00498615|76253013|FG000|STARTED|Fasudil 80mg||2||
60130663|NCT00498615|76253014|FG001|STARTED|Fasudil 80mg||4||
60130664|NCT00498615|76253015|FG002|STARTED|Fasudil 80mg||3||
60130665|NCT00498615|76253016|FG003|STARTED|Fasudil 80mg||2||
60130666|NCT00498615|76253017|FG004|STARTED|Fasudil 80mg||3||
60130667|NCT00498615|76253018|FG005|STARTED|Fasudil 80mg||3||
60130668|NCT00498615|76253013|FG000|COMPLETED|Fasudil 80mg||2||
60130669|NCT00498615|76253014|FG001|COMPLETED|Fasudil 80mg||4||
60130670|NCT00498615|76253015|FG002|COMPLETED|Fasudil 80mg||3||
60130671|NCT00498615|76253016|FG003|COMPLETED|Fasudil 80mg||2||
60130672|NCT00498615|76253017|FG004|COMPLETED|Fasudil 80mg||3||
60130673|NCT00498615|76253018|FG005|COMPLETED|Fasudil 80mg||3||
60130674|NCT00498615|76253013|FG000|NOT COMPLETED|Fasudil 80mg||0||
60130675|NCT00498615|76253014|FG001|NOT COMPLETED|Fasudil 80mg||0||
60130676|NCT00498615|76253015|FG002|NOT COMPLETED|Fasudil 80mg||0||
60130677|NCT00498615|76253016|FG003|NOT COMPLETED|Fasudil 80mg||0||
60130678|NCT00498615|76253017|FG004|NOT COMPLETED|Fasudil 80mg||0||
60130679|NCT00498615|76253018|FG005|NOT COMPLETED|Fasudil 80mg||0||
60130680|NCT00498615|76253013|FG000|STARTED|Fasudil 40mg||2||
60130681|NCT00498615|76253014|FG001|STARTED|Fasudil 40mg||4||
60130682|NCT00498615|76253015|FG002|STARTED|Fasudil 40mg||3||
60130683|NCT00498615|76253016|FG003|STARTED|Fasudil 40mg||2||
60130684|NCT00498615|76253017|FG004|STARTED|Fasudil 40mg||3||
60130685|NCT00498615|76253018|FG005|STARTED|Fasudil 40mg||3||
60130686|NCT00498615|76253013|FG000|COMPLETED|Fasudil 40mg||2||
60130687|NCT00498615|76253014|FG001|COMPLETED|Fasudil 40mg||4||
60130688|NCT00498615|76253015|FG002|COMPLETED|Fasudil 40mg||3||
60130689|NCT00498615|76253016|FG003|COMPLETED|Fasudil 40mg||2||
60130690|NCT00498615|76253017|FG004|COMPLETED|Fasudil 40mg||3||
60130691|NCT00498615|76253018|FG005|COMPLETED|Fasudil 40mg||3||
60130692|NCT00498615|76253013|FG000|NOT COMPLETED|Fasudil 40mg||0||
60130693|NCT00498615|76253014|FG001|NOT COMPLETED|Fasudil 40mg||0||
60130694|NCT00498615|76253015|FG002|NOT COMPLETED|Fasudil 40mg||0||
60130695|NCT00498615|76253016|FG003|NOT COMPLETED|Fasudil 40mg||0||
60130696|NCT00498615|76253017|FG004|NOT COMPLETED|Fasudil 40mg||0||
60130697|NCT00498615|76253018|FG005|NOT COMPLETED|Fasudil 40mg||0||
60130698|NCT00498615|76253013|FG000|STARTED|Placebo||2||
60130699|NCT00498615|76253014|FG001|STARTED|Placebo||4||
60130700|NCT00498615|76253015|FG002|STARTED|Placebo||3||
60130701|NCT00498615|76253016|FG003|STARTED|Placebo||2||
60130702|NCT00498615|76253017|FG004|STARTED|Placebo||3||
60130703|NCT00498615|76253018|FG005|STARTED|Placebo||3||
60130704|NCT00498615|76253013|FG000|COMPLETED|Placebo||2||
60130705|NCT00498615|76253014|FG001|COMPLETED|Placebo||4||
60130706|NCT00498615|76253015|FG002|COMPLETED|Placebo||3||
60130707|NCT00498615|76253016|FG003|COMPLETED|Placebo||2||
60130708|NCT00498615|76253017|FG004|COMPLETED|Placebo||3||
60130709|NCT00498615|76253018|FG005|COMPLETED|Placebo||3||
60130710|NCT00498615|76253013|FG000|NOT COMPLETED|Placebo||0||
60130711|NCT00498615|76253014|FG001|NOT COMPLETED|Placebo||0||
60130712|NCT00498615|76253015|FG002|NOT COMPLETED|Placebo||0||
60130713|NCT00498615|76253016|FG003|NOT COMPLETED|Placebo||0||
60130714|NCT00498615|76253017|FG004|NOT COMPLETED|Placebo||0||
60130715|NCT00498615|76253018|FG005|NOT COMPLETED|Placebo||0||
60130716|NCT00498927|76253032|FG000|STARTED|Overall Study||47||
60130717|NCT00498927|76253032|FG000|COMPLETED|Overall Study||47||
60130718|NCT00498927|76253032|FG000|NOT COMPLETED|Overall Study||0||
60130719|NCT00499473|76253038|FG000|STARTED|Overall Study||27||
60130720|NCT00499473|76253039|FG001|STARTED|Overall Study||4||
60130721|NCT00499473|76253038|FG000|COMPLETED|Overall Study|Patients evaluable|21||
60130722|NCT00499473|76253039|FG001|COMPLETED|Overall Study||4||
60130723|NCT00499473|76253038|FG000|NOT COMPLETED|Overall Study||6||
60130724|NCT00499473|76253039|FG001|NOT COMPLETED|Overall Study||0||
60130725|NCT01439971|76253050|FG000|STARTED|Overall Study||1||
60130726|NCT01439971|76253051|FG001|STARTED|Overall Study||7||
60130727|NCT01439971|76253052|FG002|STARTED|Overall Study||8||
60130728|NCT01439971|76253053|FG003|STARTED|Overall Study||6||
60130729|NCT01439971|76253054|FG004|STARTED|Overall Study||7||
60130730|NCT01439971|76253050|FG000|Received Treatment|Overall Study||1||
60130731|NCT01439971|76253051|FG001|Received Treatment|Overall Study||6||
60130732|NCT01439971|76253052|FG002|Received Treatment|Overall Study||6||
60130733|NCT01439971|76253053|FG003|Received Treatment|Overall Study||6||
60130734|NCT01439971|76253054|FG004|Received Treatment|Overall Study||6||
60130735|NCT01439971|76253050|FG000|COMPLETED|Overall Study||1||
60130736|NCT01439971|76253051|FG001|COMPLETED|Overall Study||6||
60130737|NCT01439971|76253052|FG002|COMPLETED|Overall Study||6||
60130738|NCT01439971|76253053|FG003|COMPLETED|Overall Study||6||
60130739|NCT01439971|76253054|FG004|COMPLETED|Overall Study||6||
60130740|NCT01439971|76253050|FG000|NOT COMPLETED|Overall Study||0||
60130741|NCT01439971|76253051|FG001|NOT COMPLETED|Overall Study||1||
60130742|NCT01439971|76253052|FG002|NOT COMPLETED|Overall Study||2||
60130743|NCT01439971|76253053|FG003|NOT COMPLETED|Overall Study||0||
60130744|NCT01439971|76253054|FG004|NOT COMPLETED|Overall Study||1||
60130745|NCT00501891|76253066|FG000|STARTED|Overall Study||32||
60130746|NCT00501891|76253066|FG000|COMPLETED|Overall Study||32||
60130747|NCT00501891|76253066|FG000|NOT COMPLETED|Overall Study||0||
60130748|NCT02811003|76253071|FG000|STARTED|Overall Study||20||
60130749|NCT02811003|76253071|FG000|COMPLETED|Overall Study||15||
60130750|NCT02811003|76253071|FG000|NOT COMPLETED|Overall Study||5||
60130751|NCT00502905|76253075|FG000|STARTED|Overall Study||196||
60130752|NCT00502905|76253075|FG000|COMPLETED|Overall Study||196||
60130753|NCT00502905|76253075|FG000|NOT COMPLETED|Overall Study||0||
60130754|NCT00505635|76253079|FG000|STARTED|Overall Study||5||
60130755|NCT00505635|76253079|FG000|COMPLETED|Overall Study||5||
60130756|NCT00505635|76253079|FG000|NOT COMPLETED|Overall Study||0||
60130757|NCT00506025|76253086|FG000|STARTED|Overall Study||10||
60130758|NCT00506025|76253087|FG001|STARTED|Overall Study||9||
60130759|NCT00506025|76253088|FG002|STARTED|Overall Study||8||
60130760|NCT00506025|76253086|FG000|COMPLETED|Overall Study||10||
60130761|NCT00506025|76253087|FG001|COMPLETED|Overall Study||9||
60130762|NCT00506025|76253088|FG002|COMPLETED|Overall Study||8||
60130763|NCT00506025|76253086|FG000|NOT COMPLETED|Overall Study||0||
60130764|NCT00506025|76253087|FG001|NOT COMPLETED|Overall Study||0||
60130765|NCT00506025|76253088|FG002|NOT COMPLETED|Overall Study||0||
60130766|NCT00508521|76253096|FG000|STARTED|Overall Study||4||
60130767|NCT00508521|76253096|FG000|COMPLETED|Overall Study||4||
60130768|NCT00508521|76253096|FG000|NOT COMPLETED|Overall Study||0||
60130769|NCT00511095|76253100|FG000|STARTED|Overall Study||207||
60130770|NCT00511095|76253100|FG000|COMPLETED|Overall Study||196||
60130771|NCT00511095|76253100|FG000|NOT COMPLETED|Overall Study||11||
60130772|NCT00511173|76253110|FG000|STARTED|Overall Study||102||
60130773|NCT00511173|76253110|FG000|COMPLETED|Overall Study||102||
60130774|NCT00511173|76253110|FG000|NOT COMPLETED|Overall Study||0||
60130775|NCT01447927|76253117|FG000|STARTED|Overall Study||38||
60130776|NCT01447927|76253118|FG001|STARTED|Overall Study||36||
60130777|NCT01447927|76253117|FG000|COMPLETED|Overall Study||33||
60130778|NCT01447927|76253118|FG001|COMPLETED|Overall Study||33||
60130779|NCT01447927|76253117|FG000|NOT COMPLETED|Overall Study||5||
60130780|NCT01447927|76253118|FG001|NOT COMPLETED|Overall Study||3||
60130781|NCT04111185|76253126|FG000|STARTED|Overall Study||17||
60130782|NCT04111185|76253127|FG001|STARTED|Overall Study||14||
60130783|NCT04111185|76253126|FG000|COMPLETED|Overall Study||17||
60130784|NCT04111185|76253127|FG001|COMPLETED|Overall Study||14||
60130785|NCT04111185|76253126|FG000|NOT COMPLETED|Overall Study||0||
60130786|NCT04111185|76253127|FG001|NOT COMPLETED|Overall Study||0||
60130787|NCT04053387|76253133|FG000|STARTED|Overall Study||763||
60130788|NCT04053387|76253133|FG000|COMPLETED|Overall Study||531||
60130789|NCT04053387|76253133|FG000|NOT COMPLETED|Overall Study||232||
60130790|NCT01551758|76253140|FG000|STARTED|Overall Study||1403||
60130791|NCT01551758|76253141|FG001|STARTED|Overall Study||1396||
60130792|NCT01551758|76253140|FG000|COMPLETED|Overall Study||1309||
60130793|NCT01551758|76253141|FG001|COMPLETED|Overall Study||1291||
60130794|NCT01551758|76253140|FG000|NOT COMPLETED|Overall Study||94||
60130795|NCT01551758|76253141|FG001|NOT COMPLETED|Overall Study||105||
60130796|NCT00513747|76253154|FG000|STARTED|Overall Study||17||
60130797|NCT00513747|76253155|FG001|STARTED|Overall Study||11||
60130798|NCT00513747|76253156|FG002|STARTED|Overall Study||55||
60130799|NCT00513747|76253154|FG000|Received at Least One Dose of Treatment|Overall Study||9|Participants received at least one dose of treatment and were evaluated for adverse events.|
60130800|NCT00513747|76253155|FG001|Received at Least One Dose of Treatment|Overall Study||11|Participants received at least one dose of treatment and were evaluated for adverse events.|
60130801|NCT00513747|76253156|FG002|Received at Least One Dose of Treatment|Overall Study||40|Participants received at least one dose of treatment and were evaluated for adverse events.|
60130802|NCT00513747|76253154|FG000|COMPLETED|Overall Study||17||
60130803|NCT00513747|76253155|FG001|COMPLETED|Overall Study||11||
60130804|NCT00513747|76253156|FG002|COMPLETED|Overall Study||55||
60130805|NCT00513747|76253154|FG000|NOT COMPLETED|Overall Study||0||
60130806|NCT00513747|76253155|FG001|NOT COMPLETED|Overall Study||0||
60130807|NCT00513747|76253156|FG002|NOT COMPLETED|Overall Study||0||
60130808|NCT00514137|76253166|FG000|STARTED|Overall Study||13||
60130809|NCT00514137|76253166|FG000|COMPLETED|Overall Study||13||
60130810|NCT00514137|76253166|FG000|NOT COMPLETED|Overall Study||0||
60130811|NCT00514215|76253170|FG000|STARTED|Overall Study||8||
60130812|NCT00514215|76253170|FG000|COMPLETED|Overall Study||8||
60130813|NCT00514215|76253170|FG000|NOT COMPLETED|Overall Study||0||
60130814|NCT02130063|76253176|FG000|STARTED|Overall Study||342||
60130815|NCT02130063|76253177|FG001|STARTED|Overall Study||169||
60130816|NCT02130063|76253176|FG000|COMPLETED|Overall Study||317||
60130817|NCT02130063|76253177|FG001|COMPLETED|Overall Study||152||
60130818|NCT02130063|76253176|FG000|NOT COMPLETED|Overall Study||25||
60130819|NCT02130063|76253177|FG001|NOT COMPLETED|Overall Study||17||
60130820|NCT00515697|76253183|FG000|STARTED|Overall Study||39||
60130821|NCT00515697|76253183|FG000|Received at Least 1 Dose of Study Drug|Overall Study||39||
60130822|NCT00515697|76253183|FG000|COMPLETED|Overall Study||39||
60130823|NCT00515697|76253183|FG000|NOT COMPLETED|Overall Study||0||
60130824|NCT00516165|76253187|FG000|STARTED|Overall Study||28||
60130825|NCT00516165|76253187|FG000|COMPLETED|Overall Study||28||
60130826|NCT00516165|76253187|FG000|NOT COMPLETED|Overall Study||0||
60130827|NCT02130999|76253191|FG000|STARTED|Overall Study||6||
60130828|NCT02130999|76253192|FG001|STARTED|Overall Study||8||
60130829|NCT02130999|76253191|FG000|COMPLETED|Overall Study||6||
60130830|NCT02130999|76253192|FG001|COMPLETED|Overall Study||8||
60130831|NCT02130999|76253191|FG000|NOT COMPLETED|Overall Study||0||
60130832|NCT02130999|76253192|FG001|NOT COMPLETED|Overall Study||0||
60130833|NCT00518349|76253205|FG000|STARTED|Overall Study||60||
60130834|NCT00518349|76253206|FG001|STARTED|Overall Study||60||
60130835|NCT00518349|76253205|FG000|COMPLETED|Overall Study||60||
60130836|NCT00518349|76253206|FG001|COMPLETED|Overall Study||60||
60130837|NCT00518349|76253205|FG000|NOT COMPLETED|Overall Study||0||
60130838|NCT00518349|76253206|FG001|NOT COMPLETED|Overall Study||0||
60130839|NCT02132169|76253214|FG000|STARTED|Overall Study||341||
60130840|NCT02132169|76253215|FG001|STARTED|Overall Study||171||
60130841|NCT02132169|76253214|FG000|COMPLETED|Overall Study||326||
60130842|NCT02132169|76253215|FG001|COMPLETED|Overall Study||162||
60130843|NCT02132169|76253214|FG000|NOT COMPLETED|Overall Study||15||
60130844|NCT02132169|76253215|FG001|NOT COMPLETED|Overall Study||9||
60130845|NCT00522171|76253223|FG000|STARTED|Overall Study||15||
60130846|NCT00522171|76253224|FG001|STARTED|Overall Study||15||
60130847|NCT00522171|76253223|FG000|COMPLETED|Overall Study||15||
60130848|NCT00522171|76253224|FG001|COMPLETED|Overall Study||15||
60130849|NCT00522171|76253223|FG000|NOT COMPLETED|Overall Study||0||
60130850|NCT00522171|76253224|FG001|NOT COMPLETED|Overall Study||0||
60130851|NCT00522795|76253230|FG000|STARTED|Overall Study||40||
60130852|NCT00522795|76253230|FG000|COMPLETED|Overall Study||40||
60130853|NCT00522795|76253230|FG000|NOT COMPLETED|Overall Study||0||
60130854|NCT00525057|76253236|FG000|STARTED|Overall Study||25||
60130855|NCT00525057|76253237|FG001|STARTED|Overall Study||25||
60130856|NCT00525057|76253236|FG000|COMPLETED|Overall Study||25||
60130857|NCT00525057|76253237|FG001|COMPLETED|Overall Study||25||
60130858|NCT00525057|76253236|FG000|NOT COMPLETED|Overall Study||0||
60130859|NCT00525057|76253237|FG001|NOT COMPLETED|Overall Study||0||
60130860|NCT00525135|76253243|FG000|STARTED|Overall Study||5||
60130861|NCT00525135|76253243|FG000|COMPLETED|Overall Study||5||
60130862|NCT00525135|76253243|FG000|NOT COMPLETED|Overall Study||0||
60130863|NCT00525525|76253249|FG000|STARTED|Overall Study||59||
60130864|NCT00525525|76253250|FG001|STARTED|Overall Study||15||
60130865|NCT00525525|76253249|FG000|COMPLETED|Overall Study||59||
60130866|NCT00525525|76253250|FG001|COMPLETED|Overall Study||15||
60130867|NCT00525525|76253249|FG000|NOT COMPLETED|Overall Study||0||
60130868|NCT00525525|76253250|FG001|NOT COMPLETED|Overall Study||0||
60130869|NCT00525603|76253256|FG000|STARTED|Overall Study||60||
60130870|NCT00525603|76253256|FG000|COMPLETED|Overall Study||60||
60130871|NCT00525603|76253256|FG000|NOT COMPLETED|Overall Study||0||
60130872|NCT00564447|76253268|FG000|STARTED|Overall Study||6||
60130873|NCT00564447|76253269|FG001|STARTED|Overall Study||6||
60130874|NCT00564447|76253270|FG002|STARTED|Overall Study||6||
60130875|NCT00564447|76253271|FG003|STARTED|Overall Study||6||
60130876|NCT00564447|76253272|FG004|STARTED|Overall Study||6||
60130877|NCT00564447|76253273|FG005|STARTED|Overall Study||6||
60130878|NCT00564447|76253274|FG006|STARTED|Overall Study||6||
60130879|NCT00564447|76253275|FG007|STARTED|Overall Study||6||
60130880|NCT00564447|76253268|FG000|COMPLETED|Overall Study||6||
60130881|NCT00564447|76253269|FG001|COMPLETED|Overall Study||6||
60130882|NCT00564447|76253270|FG002|COMPLETED|Overall Study||6||
60130883|NCT00564447|76253271|FG003|COMPLETED|Overall Study||6||
60130884|NCT00564447|76253272|FG004|COMPLETED|Overall Study||6||
59598725|NCT03510481|75708211|FG003|STARTED|Year 2 - Booster Dose|12 participants who completed Period 1 did not re-consent for Period 2.|19||
59598726|NCT03510481|75708208|FG000|COMPLETED|Year 2 - Booster Dose||42||
59598727|NCT03510481|75708209|FG001|COMPLETED|Year 2 - Booster Dose||49||
59598728|NCT03510481|75708210|FG002|COMPLETED|Year 2 - Booster Dose||23||
59598729|NCT03510481|75708211|FG003|COMPLETED|Year 2 - Booster Dose||18||
59598730|NCT03510481|75708208|FG000|NOT COMPLETED|Year 2 - Booster Dose||4||
59598731|NCT03510481|75708209|FG001|NOT COMPLETED|Year 2 - Booster Dose||3||
59598732|NCT03510481|75708210|FG002|NOT COMPLETED|Year 2 - Booster Dose||2||
59598733|NCT03510481|75708211|FG003|NOT COMPLETED|Year 2 - Booster Dose||1||
59598734|NCT03172520|75708223|FG000|STARTED|Overall Study||10||
59598735|NCT03172520|75708223|FG000|COMPLETED|Overall Study||0||
59598736|NCT03172520|75708223|FG000|NOT COMPLETED|Overall Study||10||
59598737|NCT03109418|75708229|FG000|STARTED|Overall Study||2||
59598738|NCT03109418|75708230|FG001|STARTED|Overall Study||4||
59598739|NCT03109418|75708229|FG000|COMPLETED|Overall Study||2||
59598740|NCT03109418|75708230|FG001|COMPLETED|Overall Study||3||
59598741|NCT03109418|75708229|FG000|NOT COMPLETED|Overall Study||0||
59598742|NCT03109418|75708230|FG001|NOT COMPLETED|Overall Study||1||
59598743|NCT03404167|75708236|FG000|STARTED|Overall Study||8||
59598744|NCT03404167|75708236|FG000|COMPLETED|Overall Study||8||
59598745|NCT03404167|75708236|FG000|NOT COMPLETED|Overall Study||0||
59598746|NCT03771560|75708242|FG000|STARTED|Overall Study||18||
59598747|NCT03771560|75708242|FG000|COMPLETED|Overall Study||12||
59598748|NCT03771560|75708242|FG000|NOT COMPLETED|Overall Study||6||
59598749|NCT03404401|75708248|FG000|STARTED|Overall Study||281|Safety population - all patients that took preparation.|
59598750|NCT03404401|75708249|FG001|STARTED|Overall Study||271|Safety population - all patients that took preparation.|
59598751|NCT03404401|75708248|FG000|COMPLETED|Overall Study||263||
59598752|NCT03404401|75708249|FG001|COMPLETED|Overall Study||252||
59598753|NCT03404401|75708248|FG000|NOT COMPLETED|Overall Study||18||
59598754|NCT03404401|75708249|FG001|NOT COMPLETED|Overall Study||19||
59598755|NCT03767738|75708257|FG000|STARTED|Overall Study||35||35
59598756|NCT03767738|75708258|FG001|STARTED|Overall Study||30||30
59598757|NCT03767738|75708257|FG000|COMPLETED|Overall Study||35||35
59598758|NCT03767738|75708258|FG001|COMPLETED|Overall Study||30||30
59598759|NCT03767738|75708257|FG000|NOT COMPLETED|Overall Study||0||0
59598760|NCT03767738|75708258|FG001|NOT COMPLETED|Overall Study||0||0
59598761|NCT03989570|75708267|FG000|STARTED|Overall Study||31||
59598762|NCT03989570|75708268|FG001|STARTED|Overall Study||31||
59598763|NCT03989570|75708269|FG002|STARTED|Overall Study||31||
59598764|NCT03989570|75708267|FG000|COMPLETED|Overall Study||31||
59598765|NCT03989570|75708268|FG001|COMPLETED|Overall Study||31||
59598766|NCT03989570|75708269|FG002|COMPLETED|Overall Study||31||
59598767|NCT03989570|75708267|FG000|NOT COMPLETED|Overall Study||0||
59598768|NCT03989570|75708268|FG001|NOT COMPLETED|Overall Study||0||
59598769|NCT03989570|75708269|FG002|NOT COMPLETED|Overall Study||0||
59598770|NCT03273673|75708279|FG000|STARTED|Overall Study||18||
59598771|NCT03273673|75708280|FG001|STARTED|Overall Study||22||
59598772|NCT03273673|75708279|FG000|COMPLETED|Overall Study||14||
59598773|NCT03273673|75708280|FG001|COMPLETED|Overall Study||22||
59598774|NCT03273673|75708279|FG000|NOT COMPLETED|Overall Study||4||
59598775|NCT03273673|75708280|FG001|NOT COMPLETED|Overall Study||0||
59598776|NCT03512041|75708290|FG000|STARTED|Overall Study||10||
59598777|NCT03512041|75708291|FG001|STARTED|Overall Study||10||
59598778|NCT03512041|75708292|FG002|STARTED|Overall Study||11||
59598779|NCT03512041|75708293|FG003|STARTED|Overall Study||9||
60130885|NCT00564447|76253273|FG005|COMPLETED|Overall Study||6||
60130886|NCT00564447|76253274|FG006|COMPLETED|Overall Study||6||
60130887|NCT00564447|76253275|FG007|COMPLETED|Overall Study||6||
60130888|NCT00564447|76253268|FG000|NOT COMPLETED|Overall Study||0||
60130889|NCT00564447|76253269|FG001|NOT COMPLETED|Overall Study||0||
60130890|NCT00564447|76253270|FG002|NOT COMPLETED|Overall Study||0||
60130891|NCT00564447|76253271|FG003|NOT COMPLETED|Overall Study||0||
60130892|NCT00564447|76253272|FG004|NOT COMPLETED|Overall Study||0||
59598780|NCT03512041|75708290|FG000|COMPLETED|Overall Study||10||
59598781|NCT03512041|75708291|FG001|COMPLETED|Overall Study||10||
59598782|NCT03512041|75708292|FG002|COMPLETED|Overall Study||11||
59598783|NCT03512041|75708293|FG003|COMPLETED|Overall Study||9||
59598784|NCT03512041|75708290|FG000|NOT COMPLETED|Overall Study||0||
59598785|NCT03512041|75708291|FG001|NOT COMPLETED|Overall Study||0||
59598786|NCT03512041|75708292|FG002|NOT COMPLETED|Overall Study||0||
59598787|NCT03512041|75708293|FG003|NOT COMPLETED|Overall Study||0||
59598788|NCT03053960|75708303|FG000|STARTED|Overall Study||8||
59598789|NCT03053960|75708303|FG000|COMPLETED|Overall Study||8||
59598790|NCT03053960|75708303|FG000|NOT COMPLETED|Overall Study||0||
59598791|NCT03274999|75708307|FG000|STARTED|First Intervention (Day 0)||5||
59598792|NCT03274999|75708308|FG001|STARTED|First Intervention (Day 0)||5||
59598793|NCT03274999|75708307|FG000|COMPLETED|First Intervention (Day 0)||5||
59598794|NCT03274999|75708308|FG001|COMPLETED|First Intervention (Day 0)||5||
59598795|NCT03274999|75708307|FG000|NOT COMPLETED|First Intervention (Day 0)||0||
59598796|NCT03274999|75708308|FG001|NOT COMPLETED|First Intervention (Day 0)||0||
59598797|NCT03274999|75708307|FG000|STARTED|Second Intervention (Day 14)||5||
59598798|NCT03274999|75708308|FG001|STARTED|Second Intervention (Day 14)||5||
59598799|NCT03274999|75708307|FG000|COMPLETED|Second Intervention (Day 14)||5||
59598800|NCT03274999|75708308|FG001|COMPLETED|Second Intervention (Day 14)||5||
59598801|NCT03274999|75708307|FG000|NOT COMPLETED|Second Intervention (Day 14)||0||
59598802|NCT03274999|75708308|FG001|NOT COMPLETED|Second Intervention (Day 14)||0||
59598803|NCT04018664|75708322|FG000|STARTED|Overall Study||14||
59598804|NCT04018664|75708323|FG001|STARTED|Overall Study||6||
59598805|NCT04018664|75708324|FG002|STARTED|Overall Study||6||
59598806|NCT04018664|75708325|FG003|STARTED|Overall Study||6||
59598807|NCT04018664|75708326|FG004|STARTED|Overall Study||6||
59598808|NCT04018664|75708327|FG005|STARTED|Overall Study||6||
59598809|NCT04018664|75708328|FG006|STARTED|Overall Study||6||
59598810|NCT04018664|75708329|FG007|STARTED|Overall Study||6||
59598811|NCT04018664|75708322|FG000|COMPLETED|Overall Study||14||
59598812|NCT04018664|75708323|FG001|COMPLETED|Overall Study||6||
59598813|NCT04018664|75708324|FG002|COMPLETED|Overall Study||6||
59598814|NCT04018664|75708325|FG003|COMPLETED|Overall Study||6||
59598815|NCT04018664|75708326|FG004|COMPLETED|Overall Study||6||
59598816|NCT04018664|75708327|FG005|COMPLETED|Overall Study||6||
59598817|NCT04018664|75708328|FG006|COMPLETED|Overall Study||6||
59598818|NCT04018664|75708329|FG007|COMPLETED|Overall Study||6||
59598819|NCT04018664|75708322|FG000|NOT COMPLETED|Overall Study||0||
59598820|NCT04018664|75708323|FG001|NOT COMPLETED|Overall Study||0||
59598821|NCT04018664|75708324|FG002|NOT COMPLETED|Overall Study||0||
59598822|NCT04018664|75708325|FG003|NOT COMPLETED|Overall Study||0||
59598823|NCT04018664|75708326|FG004|NOT COMPLETED|Overall Study||0||
59598824|NCT04018664|75708327|FG005|NOT COMPLETED|Overall Study||0||
59598825|NCT04018664|75708328|FG006|NOT COMPLETED|Overall Study||0||
59598826|NCT04018664|75708329|FG007|NOT COMPLETED|Overall Study||0||
59598827|NCT03763058|75708347|FG000|STARTED|Overall Study||20||
59598828|NCT03763058|75708347|FG000|COMPLETED|Overall Study||18||
59598829|NCT03763058|75708347|FG000|NOT COMPLETED|Overall Study||2||
59598830|NCT03031340|75708353|FG000|STARTED|Overall Study||2||
59598831|NCT03031340|75708354|FG001|STARTED|Overall Study||1||
59598832|NCT03031340|75708353|FG000|COMPLETED|Overall Study||0||
59598833|NCT03031340|75708354|FG001|COMPLETED|Overall Study||0||
59598834|NCT03031340|75708353|FG000|NOT COMPLETED|Overall Study||2||
59598835|NCT03031340|75708354|FG001|NOT COMPLETED|Overall Study||1||
59598836|NCT03760796|75708362|FG000|STARTED|Overall Study||200||
59598837|NCT03760796|75708363|FG001|STARTED|Overall Study||864||
59598838|NCT03760796|75708362|FG000|COMPLETED|Overall Study||200||
59598839|NCT03760796|75708363|FG001|COMPLETED|Overall Study||864||
59598840|NCT03760796|75708362|FG000|NOT COMPLETED|Overall Study||0||
59598841|NCT03760796|75708363|FG001|NOT COMPLETED|Overall Study||0||
59598842|NCT03405259|75708371|FG000|STARTED|Overall Study||11||
59598843|NCT03405259|75708372|FG001|STARTED|Overall Study||11||
59598844|NCT03405259|75708371|FG000|COMPLETED|Overall Study||11||
59598845|NCT03405259|75708372|FG001|COMPLETED|Overall Study||11||
59598846|NCT03405259|75708371|FG000|NOT COMPLETED|Overall Study||0||
59598847|NCT03405259|75708372|FG001|NOT COMPLETED|Overall Study||0||
59598848|NCT03513757|75708380|FG000|STARTED|Overall Study||22||
59598849|NCT03513757|75708381|FG001|STARTED|Overall Study||18||
59598850|NCT03513757|75708380|FG000|COMPLETED|Overall Study||22||
59598851|NCT03513757|75708381|FG001|COMPLETED|Overall Study||18||
59598852|NCT03513757|75708380|FG000|NOT COMPLETED|Overall Study||0||
59598853|NCT03513757|75708381|FG001|NOT COMPLETED|Overall Study||0||
59598854|NCT03760640|75708392|FG000|STARTED|Period 1||20||
59598855|NCT03760640|75708393|FG001|STARTED|Period 1||22||
59598856|NCT03760640|75708392|FG000|Received at Least 1 Dose of Study Drug|Period 1||20||
59598857|NCT03760640|75708393|FG001|Received at Least 1 Dose of Study Drug|Period 1||22||
59598858|NCT03760640|75708392|FG000|COMPLETED|Period 1||20||
59598859|NCT03760640|75708393|FG001|COMPLETED|Period 1||22||
59598860|NCT03760640|75708392|FG000|NOT COMPLETED|Period 1||0||
59598861|NCT03760640|75708393|FG001|NOT COMPLETED|Period 1||0||
59598862|NCT03760640|75708392|FG000|STARTED|Period 2||20||
59598863|NCT03760640|75708393|FG001|STARTED|Period 2||22||
59598864|NCT03760640|75708392|FG000|COMPLETED|Period 2||20||
59598865|NCT03760640|75708393|FG001|COMPLETED|Period 2||22||
59598866|NCT03760640|75708392|FG000|NOT COMPLETED|Period 2||0||
59598867|NCT03760640|75708393|FG001|NOT COMPLETED|Period 2||0||
59598868|NCT03407053|75708401|FG000|STARTED|Overall Study||10||
59598869|NCT03407053|75708402|FG001|STARTED|Overall Study||10||
59598870|NCT03407053|75708401|FG000|COMPLETED|Overall Study||10||
59598871|NCT03407053|75708402|FG001|COMPLETED|Overall Study||10||
59598872|NCT03407053|75708401|FG000|NOT COMPLETED|Overall Study||0||
59598873|NCT03407053|75708402|FG001|NOT COMPLETED|Overall Study||0||
59598874|NCT03756506|75708410|FG000|STARTED|Overall Study||7||
59598875|NCT03756506|75708411|FG001|STARTED|Overall Study||6||
59598876|NCT03756506|75708410|FG000|COMPLETED|Overall Study||6||
59598877|NCT03756506|75708411|FG001|COMPLETED|Overall Study||6||
59598878|NCT03756506|75708410|FG000|NOT COMPLETED|Overall Study||1||
59598879|NCT03756506|75708411|FG001|NOT COMPLETED|Overall Study||0||
59598880|NCT03275623|75708419|FG000|STARTED|Overall Study||30||
59598881|NCT03275623|75708420|FG001|STARTED|Overall Study||30||
59598882|NCT03275623|75708419|FG000|COMPLETED|Overall Study||25||
59598883|NCT03275623|75708420|FG001|COMPLETED|Overall Study||28||
59598884|NCT03275623|75708419|FG000|NOT COMPLETED|Overall Study||5||
59598885|NCT03275623|75708420|FG001|NOT COMPLETED|Overall Study||2||
59598886|NCT03756038|75708428|FG000|STARTED|Overall Study||1||
59598887|NCT03756038|75708429|FG001|STARTED|Overall Study||0||
59598888|NCT03756038|75708428|FG000|COMPLETED|Overall Study||1||
59598889|NCT03756038|75708429|FG001|COMPLETED|Overall Study||0||
59598890|NCT03756038|75708428|FG000|NOT COMPLETED|Overall Study||0||
59598891|NCT03756038|75708429|FG001|NOT COMPLETED|Overall Study||0||
59598892|NCT03276637|75708435|FG000|STARTED|Overall Study||93|Completed baseline survey|
59598893|NCT03276637|75708435|FG000|Completed Pre Survey|Overall Study||93||
59598894|NCT03276637|75708435|FG000|Underwent Sequencing|Overall Study||75||
59598895|NCT03276637|75708435|FG000|Completed Post Survey|Overall Study||69||
59598896|NCT03276637|75708435|FG000|COMPLETED|Overall Study||69|Completed follow-up survey|
59598897|NCT03276637|75708435|FG000|NOT COMPLETED|Overall Study||24||
59598898|NCT03754556|75708440|FG000|STARTED|Overall Study||326658||
59598899|NCT03754556|75708440|FG000|COMPLETED|Overall Study||326658||
59598900|NCT03754556|75708440|FG000|NOT COMPLETED|Overall Study||0||
59598901|NCT03276871|75708446|FG000|STARTED|Overall Study||21||
59598902|NCT03276871|75708447|FG001|STARTED|Overall Study||19||
59598903|NCT03276871|75708446|FG000|COMPLETED|Overall Study||21||
59598904|NCT03276871|75708447|FG001|COMPLETED|Overall Study||19||
59598905|NCT03276871|75708446|FG000|NOT COMPLETED|Overall Study||0||
59598906|NCT03276871|75708447|FG001|NOT COMPLETED|Overall Study||0||
59598907|NCT03521089|75708455|FG000|STARTED|Overall Study||8||
59598908|NCT03521089|75708456|FG001|STARTED|Overall Study||8||
59598909|NCT03521089|75708455|FG000|COMPLETED|Overall Study||8||
59598910|NCT03521089|75708456|FG001|COMPLETED|Overall Study||8||
59598911|NCT03521089|75708455|FG000|NOT COMPLETED|Overall Study||0||
59598912|NCT03521089|75708456|FG001|NOT COMPLETED|Overall Study||0||
59598913|NCT03410797|75708462|FG000|STARTED|Overall Study||11||
59598914|NCT03410797|75708462|FG000|COMPLETED|Overall Study||11||
59598915|NCT03410797|75708462|FG000|NOT COMPLETED|Overall Study||0||
59598916|NCT03410953|75708467|FG000|STARTED|Overall Study|First patient recruited|67||
59598917|NCT03410953|75708467|FG000|COMPLETED|Overall Study|67 participants were enrolled in the Clinical Trial and included the analyses|67||
59598918|NCT03410953|75708467|FG000|NOT COMPLETED|Overall Study||0||
59598919|NCT03521479|75708475|FG000|STARTED|Overall Study||10||
59598920|NCT03521479|75708476|FG001|STARTED|Overall Study||10||
59598921|NCT03521479|75708477|FG002|STARTED|Overall Study||10||
59598922|NCT03521479|75708478|FG003|STARTED|Overall Study||10||
59598923|NCT03521479|75708475|FG000|COMPLETED|Overall Study||10||
59598924|NCT03521479|75708476|FG001|COMPLETED|Overall Study||10||
59598925|NCT03521479|75708477|FG002|COMPLETED|Overall Study||10||
59598926|NCT03521479|75708478|FG003|COMPLETED|Overall Study||10||
59598927|NCT03521479|75708475|FG000|NOT COMPLETED|Overall Study||0||
59598928|NCT03521479|75708476|FG001|NOT COMPLETED|Overall Study||0||
59598929|NCT03521479|75708477|FG002|NOT COMPLETED|Overall Study||0||
59598930|NCT03521479|75708478|FG003|NOT COMPLETED|Overall Study||0||
59598931|NCT01495988|75708492|FG000|STARTED|Vem +/- Bev (Protocol v2.0)||0||
60130893|NCT00564447|76253273|FG005|NOT COMPLETED|Overall Study||0||
60130894|NCT00564447|76253274|FG006|NOT COMPLETED|Overall Study||0||
60130895|NCT00564447|76253275|FG007|NOT COMPLETED|Overall Study||0||
60130896|NCT00564681|76253297|FG000|STARTED|Overall Study||117||
59598932|NCT01495988|75708493|FG001|STARTED|Vem +/- Bev (Protocol v2.0)||0||
59598933|NCT01495988|75708494|FG002|STARTED|Vem +/- Bev (Protocol v2.0)||5||
59598934|NCT01495988|75708495|FG003|STARTED|Vem +/- Bev (Protocol v2.0)||3||
59598935|NCT01495988|75708492|FG000|COMPLETED|Vem +/- Bev (Protocol v2.0)||0||
59598936|NCT01495988|75708493|FG001|COMPLETED|Vem +/- Bev (Protocol v2.0)||0||
59598937|NCT01495988|75708494|FG002|COMPLETED|Vem +/- Bev (Protocol v2.0)||5||
59598938|NCT01495988|75708495|FG003|COMPLETED|Vem +/- Bev (Protocol v2.0)||3||
59598939|NCT01495988|75708492|FG000|NOT COMPLETED|Vem +/- Bev (Protocol v2.0)||0||
59598940|NCT01495988|75708493|FG001|NOT COMPLETED|Vem +/- Bev (Protocol v2.0)||0||
59598941|NCT01495988|75708494|FG002|NOT COMPLETED|Vem +/- Bev (Protocol v2.0)||0||
59598942|NCT01495988|75708495|FG003|NOT COMPLETED|Vem +/- Bev (Protocol v2.0)||0||
59598943|NCT01495988|75708492|FG000|STARTED|Vem/Cobi +/- Bev (Protocol v4.0)||0||
59598944|NCT01495988|75708493|FG001|STARTED|Vem/Cobi +/- Bev (Protocol v4.0)||2||
59598945|NCT01495988|75708494|FG002|STARTED|Vem/Cobi +/- Bev (Protocol v4.0)||0||
59598946|NCT01495988|75708495|FG003|STARTED|Vem/Cobi +/- Bev (Protocol v4.0)||0||
59598947|NCT01495988|75708492|FG000|COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0||
59598948|NCT01495988|75708493|FG001|COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||2||
59598949|NCT01495988|75708494|FG002|COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0||
59598950|NCT01495988|75708495|FG003|COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0||
59598951|NCT01495988|75708492|FG000|NOT COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0||
59598952|NCT01495988|75708493|FG001|NOT COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0||
59598953|NCT01495988|75708494|FG002|NOT COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0||
59598954|NCT01495988|75708495|FG003|NOT COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0||
59598955|NCT02934932|75708505|FG000|STARTED|Overall Study||9||
59598956|NCT02934932|75708505|FG000|COMPLETED|Overall Study||6||
59598957|NCT02934932|75708505|FG000|NOT COMPLETED|Overall Study||3||
59598958|NCT03415243|75708513|FG000|STARTED|Overall Study||14||
59598959|NCT03415243|75708514|FG001|STARTED|Overall Study||14||
59598960|NCT03415243|75708513|FG000|COMPLETED|Overall Study||14||
59598961|NCT03415243|75708514|FG001|COMPLETED|Overall Study||14||
59598962|NCT03415243|75708513|FG000|NOT COMPLETED|Overall Study||0||
59598963|NCT03415243|75708514|FG001|NOT COMPLETED|Overall Study||0||
59598964|NCT02892500|75708522|FG000|STARTED|Overall Study||0||
59598965|NCT02892500|75708523|FG001|STARTED|Overall Study||0||
59598966|NCT02892500|75708522|FG000|COMPLETED|Overall Study||0||
59598967|NCT02892500|75708523|FG001|COMPLETED|Overall Study||0||
59598968|NCT02892500|75708522|FG000|NOT COMPLETED|Overall Study||0||
59598969|NCT02892500|75708523|FG001|NOT COMPLETED|Overall Study||0||
59598970|NCT02904356|75708529|FG000|STARTED|Overall Study||2||
59598971|NCT02904356|75708529|FG000|COMPLETED|Overall Study||2||
59598972|NCT02904356|75708529|FG000|NOT COMPLETED|Overall Study||0||
59598973|NCT03418051|75708536|FG000|STARTED|Overall Study||20||
59598974|NCT03418051|75708537|FG001|STARTED|Overall Study||20||
59598975|NCT03418051|75708538|FG002|STARTED|Overall Study||20||
59598976|NCT03418051|75708536|FG000|COMPLETED|Overall Study||14||
59598977|NCT03418051|75708537|FG001|COMPLETED|Overall Study||18||
59598978|NCT03418051|75708538|FG002|COMPLETED|Overall Study||17||
59598979|NCT03418051|75708536|FG000|NOT COMPLETED|Overall Study||6||
59598980|NCT03418051|75708537|FG001|NOT COMPLETED|Overall Study||2||
59598981|NCT03418051|75708538|FG002|NOT COMPLETED|Overall Study||3||
59598982|NCT02818946|75708546|FG000|STARTED|Overall Study||30||
59598983|NCT02818946|75708546|FG000|COMPLETED|Overall Study||30||
59598984|NCT02818946|75708546|FG000|NOT COMPLETED|Overall Study||0||
60130897|NCT00564681|76253298|FG001|STARTED|Overall Study||61||
60130898|NCT00564681|76253299|FG002|STARTED|Overall Study||43||
60130899|NCT00564681|76253300|FG003|STARTED|Overall Study||21||
59598985|NCT01440452|75708554|FG000|STARTED|Overall Study||6||
59598986|NCT01440452|75708555|FG001|STARTED|Overall Study||7||
59598987|NCT01440452|75708556|FG002|STARTED|Overall Study||8||
59598988|NCT01440452|75708557|FG003|STARTED|Overall Study||4||
59598989|NCT01440452|75708554|FG000|COMPLETED|Overall Study||6||
59598990|NCT01440452|75708555|FG001|COMPLETED|Overall Study||7||
59598991|NCT01440452|75708556|FG002|COMPLETED|Overall Study||8||
59598992|NCT01440452|75708557|FG003|COMPLETED|Overall Study||4||
59598993|NCT01440452|75708554|FG000|NOT COMPLETED|Overall Study||0||
59598994|NCT01440452|75708555|FG001|NOT COMPLETED|Overall Study||0||
59598995|NCT01440452|75708556|FG002|NOT COMPLETED|Overall Study||0||
59598996|NCT01440452|75708557|FG003|NOT COMPLETED|Overall Study||0||
59598997|NCT03742154|75708569|FG000|STARTED|Overall Study||50||
59598998|NCT03742154|75708570|FG001|STARTED|Overall Study||49||
59598999|NCT03742154|75708569|FG000|COMPLETED|Overall Study||50||
59599000|NCT03742154|75708570|FG001|COMPLETED|Overall Study||49||
60130900|NCT00564681|76253297|FG000|COMPLETED|Overall Study||106||
60130901|NCT00564681|76253298|FG001|COMPLETED|Overall Study||58||
59599001|NCT03742154|75708569|FG000|NOT COMPLETED|Overall Study||0||
59599002|NCT03742154|75708570|FG001|NOT COMPLETED|Overall Study||0||
59599003|NCT03284359|75708578|FG000|STARTED|Overall Study||93||
59599004|NCT03284359|75708579|FG001|STARTED|Overall Study||89||
59599005|NCT03284359|75708578|FG000|COMPLETED|Overall Study||93||
59599006|NCT03284359|75708579|FG001|COMPLETED|Overall Study||89||
59599007|NCT03284359|75708578|FG000|NOT COMPLETED|Overall Study||0||
59599008|NCT03284359|75708579|FG001|NOT COMPLETED|Overall Study||0||
59599009|NCT03738020|75708585|FG000|STARTED|Overall Study||58||
59599010|NCT03738020|75708585|FG000|COMPLETED|Overall Study||57||
59599011|NCT03738020|75708585|FG000|NOT COMPLETED|Overall Study||1||
59599012|NCT02734940|75708594|FG000|STARTED|Overall Study||0||
59599013|NCT02734940|75708595|FG001|STARTED|Overall Study||0||
59599014|NCT02734940|75708594|FG000|COMPLETED|Overall Study||0||
59599015|NCT02734940|75708595|FG001|COMPLETED|Overall Study||0||
59599016|NCT02734940|75708594|FG000|NOT COMPLETED|Overall Study||0||
59599017|NCT02734940|75708595|FG001|NOT COMPLETED|Overall Study||0||
59599018|NCT01347632|75708601|FG000|STARTED|Overall Study||35||
59599019|NCT01347632|75708601|FG000|COMPLETED|Overall Study||33||
59599020|NCT01347632|75708601|FG000|NOT COMPLETED|Overall Study||2||
59599021|NCT02679560|75708607|FG000|STARTED|Overall Study||1||
59599022|NCT02679560|75708608|FG001|STARTED|Overall Study||2||
59599023|NCT02679560|75708607|FG000|COMPLETED|Overall Study||1||
59599024|NCT02679560|75708608|FG001|COMPLETED|Overall Study||2||
59599025|NCT02679560|75708607|FG000|NOT COMPLETED|Overall Study||0||
59599026|NCT02679560|75708608|FG001|NOT COMPLETED|Overall Study||0||
59599027|NCT03734822|75708614|FG000|STARTED|Overall Study||47||
59599028|NCT03734822|75708614|FG000|COMPLETED|Overall Study||47||
59599029|NCT03734822|75708614|FG000|NOT COMPLETED|Overall Study||0||
59599030|NCT02671136|75708620|FG000|STARTED|Overall Study||3||
59599031|NCT02671136|75708621|FG001|STARTED|Overall Study||0||
59599032|NCT02671136|75708620|FG000|COMPLETED|Overall Study||3||
59599033|NCT02671136|75708621|FG001|COMPLETED|Overall Study||0||
59599034|NCT02671136|75708620|FG000|NOT COMPLETED|Overall Study||0||
59599035|NCT02671136|75708621|FG001|NOT COMPLETED|Overall Study||0||
59599036|NCT03728348|75708627|FG000|STARTED|Overall Study||983||
59599037|NCT03728348|75708627|FG000|Did Not Complete Study Procedures|Overall Study||107||
59599038|NCT03728348|75708627|FG000|Multi-target DNA Test Excluded|Overall Study||15||
59599039|NCT03728348|75708627|FG000|Colonoscopy Excluded|Overall Study||19||
59599040|NCT03728348|75708627|FG000|COMPLETED|Overall Study||842||
59599041|NCT03728348|75708627|FG000|NOT COMPLETED|Overall Study||141||
59599042|NCT02665988|75708633|FG000|STARTED|Overall Study||2||
59599043|NCT02665988|75708634|FG001|STARTED|Overall Study||2||
59599044|NCT02665988|75708633|FG000|COMPLETED|Overall Study||2||
59599045|NCT02665988|75708634|FG001|COMPLETED|Overall Study||2||
59599046|NCT02665988|75708633|FG000|NOT COMPLETED|Overall Study||0||
59599047|NCT02665988|75708634|FG001|NOT COMPLETED|Overall Study||0||
59599048|NCT03726164|75708642|FG000|STARTED|Overall Study||310||
59599049|NCT03726164|75708643|FG001|STARTED|Overall Study||316||
59599050|NCT03726164|75708642|FG000|COMPLETED|Overall Study||99||
59599051|NCT03726164|75708643|FG001|COMPLETED|Overall Study||119||
59599052|NCT03726164|75708642|FG000|NOT COMPLETED|Overall Study||211||
59599053|NCT03726164|75708643|FG001|NOT COMPLETED|Overall Study||197||
60130902|NCT00564681|76253299|FG002|COMPLETED|Overall Study||40||
60130903|NCT00564681|76253300|FG003|COMPLETED|Overall Study||19||
60130904|NCT00564681|76253297|FG000|NOT COMPLETED|Overall Study||11||
59599054|NCT03723980|75708651|FG000|STARTED|Overall Study||40||
59599055|NCT03723980|75708652|FG001|STARTED|Overall Study||40||
59599056|NCT03723980|75708651|FG000|COMPLETED|Overall Study||33||
59599057|NCT03723980|75708652|FG001|COMPLETED|Overall Study||35||
59599058|NCT03723980|75708651|FG000|NOT COMPLETED|Overall Study||7||
59599059|NCT03723980|75708652|FG001|NOT COMPLETED|Overall Study||5||
59599060|NCT02660528|75708664|FG000|STARTED|Overall Study||0||
59599061|NCT02660528|75708664|FG000|COMPLETED|Overall Study||0||
59599062|NCT02660528|75708664|FG000|NOT COMPLETED|Overall Study||0||
59599063|NCT02633540|75708668|FG000|STARTED|Overall Study||2||
59599064|NCT02633540|75708668|FG000|COMPLETED|Overall Study||2||
59599065|NCT02633540|75708668|FG000|NOT COMPLETED|Overall Study||0||
59599066|NCT01240304|75708672|FG000|STARTED|Overall Study||10||
59599067|NCT01240304|75708672|FG000|COMPLETED|Overall Study||0||
59599068|NCT01240304|75708672|FG000|NOT COMPLETED|Overall Study||10||
59599069|NCT02614586|75708676|FG000|STARTED|Overall Study||11||
59599070|NCT02614586|75708676|FG000|COMPLETED|Overall Study||11||
59599071|NCT02614586|75708676|FG000|NOT COMPLETED|Overall Study||0||
59599072|NCT01211756|75708680|FG000|STARTED|Overall Study||1||
59599073|NCT01211756|75708680|FG000|COMPLETED|Overall Study||1||
60130905|NCT00564681|76253298|FG001|NOT COMPLETED|Overall Study||3||
60130906|NCT00564681|76253299|FG002|NOT COMPLETED|Overall Study||3||
59599074|NCT01211756|75708680|FG000|NOT COMPLETED|Overall Study||0||
59599075|NCT03591458|75708686|FG000|STARTED|Overall Study||1||
59599076|NCT03591458|75708687|FG001|STARTED|Overall Study||1||
59599077|NCT03591458|75708686|FG000|COMPLETED|Overall Study||1||
59599078|NCT03591458|75708687|FG001|COMPLETED|Overall Study||1||
60130907|NCT00564681|76253300|FG003|NOT COMPLETED|Overall Study||2||
59599079|NCT03591458|75708686|FG000|NOT COMPLETED|Overall Study||0||
59599080|NCT03591458|75708687|FG001|NOT COMPLETED|Overall Study||0||
59599081|NCT03565328|75708693|FG000|STARTED|Overall Study||1||
59599082|NCT03565328|75708693|FG000|COMPLETED|Overall Study||1||
59599083|NCT03565328|75708693|FG000|NOT COMPLETED|Overall Study||0||
59599084|NCT03534362|75708699|FG000|STARTED|Overall Study||0||
59599085|NCT03534362|75708700|FG001|STARTED|Overall Study||1||
59599086|NCT03534362|75708699|FG000|COMPLETED|Overall Study||0||
59599087|NCT03534362|75708700|FG001|COMPLETED|Overall Study||1||
59599088|NCT03534362|75708699|FG000|NOT COMPLETED|Overall Study||0||
59599089|NCT03534362|75708700|FG001|NOT COMPLETED|Overall Study||0||
59599090|NCT01206296|75708708|FG000|STARTED|Overall Study||0|"The study was terminated and the PI has left the institution. Efforts were made to contact the PI/study team members, but were unsuccessful.~Additional efforts were made to obtain study data via publications, IRB and RedCap systems.~No study data are available."|
59599091|NCT01206296|75708708|FG000|COMPLETED|Overall Study||0|"The study was terminated and the PI has left the institution. Efforts were made to contact the PI/study team members, but were unsuccessful.~Additional efforts were made to obtain study data via publications, IRB and RedCap systems.~No study data are available."|
59599092|NCT01206296|75708708|FG000|NOT COMPLETED|Overall Study||0||
59599093|NCT02593682|75708714|FG000|STARTED|Overall Study||0||
59599094|NCT02593682|75708715|FG001|STARTED|Overall Study||0||
59599095|NCT02593682|75708714|FG000|COMPLETED|Overall Study||0||
59599096|NCT02593682|75708715|FG001|COMPLETED|Overall Study||0||
59599097|NCT02593682|75708714|FG000|NOT COMPLETED|Overall Study||0||
59599098|NCT02593682|75708715|FG001|NOT COMPLETED|Overall Study||0||
59599099|NCT02461550|75708721|FG000|STARTED|Overall Study||2||
59599100|NCT02461550|75708721|FG000|COMPLETED|Overall Study||2||
59599101|NCT02461550|75708721|FG000|NOT COMPLETED|Overall Study||0||
59599102|NCT01200602|75708727|FG000|STARTED|Overall Study||0||
59599103|NCT01200602|75708728|FG001|STARTED|Overall Study||0||
59599104|NCT01200602|75708727|FG000|COMPLETED|Overall Study||0||
59599105|NCT01200602|75708728|FG001|COMPLETED|Overall Study||0||
59599106|NCT01200602|75708727|FG000|NOT COMPLETED|Overall Study||0||
59599107|NCT01200602|75708728|FG001|NOT COMPLETED|Overall Study||0||
59599108|NCT01194908|75708734|FG000|STARTED|Overall Study||5||
59599109|NCT01194908|75708734|FG000|COMPLETED|Overall Study||5||
59599110|NCT01194908|75708734|FG000|NOT COMPLETED|Overall Study||0||
59599111|NCT01184456|75708740|FG000|STARTED|Overall Study||0||
59599112|NCT01184456|75708741|FG001|STARTED|Overall Study||0||
59599113|NCT01184456|75708740|FG000|COMPLETED|Overall Study||0||
59599114|NCT01184456|75708741|FG001|COMPLETED|Overall Study||0||
59599115|NCT01184456|75708740|FG000|NOT COMPLETED|Overall Study||0||
59599116|NCT01184456|75708741|FG001|NOT COMPLETED|Overall Study||0||
59599117|NCT01163084|75708749|FG000|STARTED|Overall Study||4||
59599118|NCT01163084|75708750|FG001|STARTED|Overall Study||5||
59599119|NCT01163084|75708749|FG000|COMPLETED|Overall Study||4||
59599120|NCT01163084|75708750|FG001|COMPLETED|Overall Study||5||
59599121|NCT01163084|75708749|FG000|NOT COMPLETED|Overall Study||0||
59599122|NCT01163084|75708750|FG001|NOT COMPLETED|Overall Study||0||
59599123|NCT01162382|75708756|FG000|STARTED|Overall Study||0|No data are available fo this study as the study was terminated and PI has left the institution.|
59599124|NCT01162382|75708756|FG000|COMPLETED|Overall Study||0|No data are available fo this study as the study was terminated and PI has left the institution.|
59599125|NCT01162382|75708756|FG000|NOT COMPLETED|Overall Study||0||
59599126|NCT01155518|75708766|FG000|STARTED|Overall Study||1||
59599127|NCT01155518|75708767|FG001|STARTED|Overall Study||1||
59599128|NCT01155518|75708768|FG002|STARTED|Overall Study||0||
59599129|NCT01155518|75708769|FG003|STARTED|Overall Study||0||
59599130|NCT01155518|75708770|FG004|STARTED|Overall Study||1||
59599131|NCT01155518|75708771|FG005|STARTED|Overall Study||2||
59599132|NCT01155518|75708766|FG000|COMPLETED|Overall Study||1||
59599133|NCT01155518|75708767|FG001|COMPLETED|Overall Study|never started the study|0||
59599134|NCT01155518|75708768|FG002|COMPLETED|Overall Study||0||
59599135|NCT01155518|75708769|FG003|COMPLETED|Overall Study||0||
59599136|NCT01155518|75708770|FG004|COMPLETED|Overall Study||1||
59599137|NCT01155518|75708771|FG005|COMPLETED|Overall Study||2||
59599138|NCT01155518|75708766|FG000|NOT COMPLETED|Overall Study||0||
59599139|NCT01155518|75708767|FG001|NOT COMPLETED|Overall Study||1||
59599140|NCT01155518|75708768|FG002|NOT COMPLETED|Overall Study||0||
59599141|NCT01155518|75708769|FG003|NOT COMPLETED|Overall Study||0||
59599142|NCT01155518|75708770|FG004|NOT COMPLETED|Overall Study||0||
59998297|NCT02717195|76113972|FG003|STARTED|Prospective Confirmation (PC) Period||0||
59599143|NCT01155518|75708771|FG005|NOT COMPLETED|Overall Study||0||
59599144|NCT03490916|75708787|FG000|STARTED|Overall Study||0||
59599145|NCT03490916|75708788|FG001|STARTED|Overall Study||0||
59599146|NCT03490916|75708787|FG000|COMPLETED|Overall Study||0||
59599147|NCT03490916|75708788|FG001|COMPLETED|Overall Study||0||
59599148|NCT03490916|75708787|FG000|NOT COMPLETED|Overall Study||0||
59599149|NCT03490916|75708788|FG001|NOT COMPLETED|Overall Study||0||
59599150|NCT03333746|75708794|FG000|STARTED|Overall Study||1||
59599151|NCT03333746|75708794|FG000|COMPLETED|Overall Study||0||
59599152|NCT03333746|75708794|FG000|NOT COMPLETED|Overall Study||1||
59599153|NCT01139996|75708800|FG000|STARTED|Overall Study||11||
59599154|NCT01139996|75708801|FG001|STARTED|Overall Study||11||
59728550|NCT00979134|75847186|FG002|STARTED|Overall Study||45||
60130908|NCT00525837|76253309|FG000|STARTED|Overall Study||18||
59599155|NCT01139996|75708800|FG000|COMPLETED|Overall Study||11||
59599156|NCT01139996|75708801|FG001|COMPLETED|Overall Study||11||
59599157|NCT01139996|75708800|FG000|NOT COMPLETED|Overall Study||0||
59599158|NCT01139996|75708801|FG001|NOT COMPLETED|Overall Study||0||
59599159|NCT02417870|75708807|FG000|STARTED|Overall Study||2||
59599160|NCT02417870|75708807|FG000|COMPLETED|Overall Study||0||
59599161|NCT02417870|75708807|FG000|NOT COMPLETED|Overall Study||2||
59599162|NCT01131884|75708813|FG000|STARTED|Overall Study||1||
59599163|NCT01131884|75708814|FG001|STARTED|Overall Study||0||
59599164|NCT01131884|75708813|FG000|COMPLETED|Overall Study||1||
59599165|NCT01131884|75708814|FG001|COMPLETED|Overall Study||0||
59599166|NCT01131884|75708813|FG000|NOT COMPLETED|Overall Study||0||
59599167|NCT01131884|75708814|FG001|NOT COMPLETED|Overall Study||0||
59599168|NCT01139294|75708822|FG000|STARTED|Overall Study||0||
59599169|NCT01139294|75708823|FG001|STARTED|Overall Study||0||
59599170|NCT01139294|75708822|FG000|COMPLETED|Overall Study||0||
59599171|NCT01139294|75708823|FG001|COMPLETED|Overall Study||0||
59599172|NCT01139294|75708822|FG000|NOT COMPLETED|Overall Study||0||
59599173|NCT01139294|75708823|FG001|NOT COMPLETED|Overall Study||0||
59599174|NCT02402036|75708829|FG000|STARTED|Overall Study||10||
59599175|NCT02402036|75708829|FG000|COMPLETED|Overall Study||10||
59599176|NCT02402036|75708829|FG000|NOT COMPLETED|Overall Study||0||
59599177|NCT02389712|75708835|FG000|STARTED|Overall Study||1||
59599178|NCT02389712|75708836|FG001|STARTED|Overall Study||1||
59599179|NCT02389712|75708835|FG000|COMPLETED|Overall Study||1||
59599180|NCT02389712|75708836|FG001|COMPLETED|Overall Study||1||
59599181|NCT02389712|75708835|FG000|NOT COMPLETED|Overall Study||0||
59599182|NCT02389712|75708836|FG001|NOT COMPLETED|Overall Study||0||
59599183|NCT03530917|75708850|FG000|STARTED|Overall Study||8||
59599184|NCT03530917|75708851|FG001|STARTED|Overall Study||8||
59599185|NCT03530917|75708852|FG002|STARTED|Overall Study||8||
59599186|NCT03530917|75708853|FG003|STARTED|Overall Study||8||
59599187|NCT03530917|75708854|FG004|STARTED|Overall Study||8||
59599188|NCT03530917|75708855|FG005|STARTED|Overall Study||6||
59599189|NCT03530917|75708856|FG006|STARTED|Overall Study||8||
59599190|NCT03530917|75708857|FG007|STARTED|Overall Study||16||
59599191|NCT03530917|75708850|FG000|COMPLETED|Overall Study||8||
59599192|NCT03530917|75708851|FG001|COMPLETED|Overall Study||8||
59599193|NCT03530917|75708852|FG002|COMPLETED|Overall Study||8||
59599194|NCT03530917|75708853|FG003|COMPLETED|Overall Study||8||
59599195|NCT03530917|75708854|FG004|COMPLETED|Overall Study||8||
59599196|NCT03530917|75708855|FG005|COMPLETED|Overall Study||6||
59599197|NCT03530917|75708856|FG006|COMPLETED|Overall Study||8||
59599198|NCT03530917|75708857|FG007|COMPLETED|Overall Study||16||
59599199|NCT03530917|75708850|FG000|NOT COMPLETED|Overall Study||0||
59599200|NCT03530917|75708851|FG001|NOT COMPLETED|Overall Study||0||
59599201|NCT03530917|75708852|FG002|NOT COMPLETED|Overall Study||0||
59599202|NCT03530917|75708853|FG003|NOT COMPLETED|Overall Study||0||
59599203|NCT03530917|75708854|FG004|NOT COMPLETED|Overall Study||0||
59599204|NCT03530917|75708855|FG005|NOT COMPLETED|Overall Study||0||
59599205|NCT03530917|75708856|FG006|NOT COMPLETED|Overall Study||0||
59599206|NCT03530917|75708857|FG007|NOT COMPLETED|Overall Study||0||
59599207|NCT02365688|75708881|FG000|STARTED|Overall Study|All subjects received a bolus of 500cc before first incision|18||
59599208|NCT02365688|75708881|FG000|COMPLETED|Overall Study|All subjects consented to an change in standard infusion volume pre-incision|18||
59599209|NCT02365688|75708881|FG000|NOT COMPLETED|Overall Study||0||
59599210|NCT02369744|75708887|FG000|STARTED|Overall Study||0||
59599211|NCT02369744|75708888|FG001|STARTED|Overall Study||0||
59599212|NCT02369744|75708887|FG000|COMPLETED|Overall Study||0||
59599213|NCT02369744|75708888|FG001|COMPLETED|Overall Study||0||
59599214|NCT02369744|75708887|FG000|NOT COMPLETED|Overall Study||0||
59599215|NCT02369744|75708888|FG001|NOT COMPLETED|Overall Study||0||
59599216|NCT03577171|75708896|FG000|STARTED|Overall Study||13||
59599217|NCT03577171|75708897|FG001|STARTED|Overall Study||12||
59599218|NCT03577171|75708896|FG000|COMPLETED|Overall Study||13||
59599219|NCT03577171|75708897|FG001|COMPLETED|Overall Study||12||
59599220|NCT03577171|75708896|FG000|NOT COMPLETED|Overall Study||0||
59599221|NCT03577171|75708897|FG001|NOT COMPLETED|Overall Study||0||
59599222|NCT02367170|75708905|FG000|STARTED|Overall Study||1||
59599223|NCT02367170|75708906|FG001|STARTED|Overall Study||0||
59599224|NCT02367170|75708905|FG000|COMPLETED|Overall Study||1||
59599225|NCT02367170|75708906|FG001|COMPLETED|Overall Study||0||
59599226|NCT02367170|75708905|FG000|NOT COMPLETED|Overall Study||0||
59599227|NCT02367170|75708906|FG001|NOT COMPLETED|Overall Study||0||
59599228|NCT01104116|75708912|FG000|STARTED|Overall Study||1||
59599229|NCT01104116|75708912|FG000|COMPLETED|Overall Study||1||
59599230|NCT01104116|75708912|FG000|NOT COMPLETED|Overall Study||0||
59599231|NCT03579433|75708916|FG000|STARTED|Overall Study||104||
59599232|NCT03579433|75708916|FG000|ORA With VerifEye+|Overall Study||96|Successful implantation|
59599233|NCT03579433|75708916|FG000|Barrett Calculator|Overall Study||102|Successful implantation|
59599234|NCT03579433|75708916|FG000|COMPLETED|Overall Study||98||
59599235|NCT03579433|75708916|FG000|NOT COMPLETED|Overall Study||6||
59599236|NCT03534427|75708926|FG000|STARTED|Overall Study||20||
59599237|NCT03534427|75708927|FG001|STARTED|Overall Study||20||
59599238|NCT03534427|75708926|FG000|COMPLETED|Overall Study||20||
59599239|NCT03534427|75708927|FG001|COMPLETED|Overall Study||20||
59599240|NCT03534427|75708926|FG000|NOT COMPLETED|Overall Study||0||
59599241|NCT03534427|75708927|FG001|NOT COMPLETED|Overall Study||0||
59599242|NCT02340728|75708935|FG000|STARTED|Overall Study||13||
59599243|NCT02340728|75708936|FG001|STARTED|Overall Study||11||
59599244|NCT02340728|75708935|FG000|COMPLETED|Overall Study||13||
59599245|NCT02340728|75708936|FG001|COMPLETED|Overall Study||11||
59599246|NCT02340728|75708935|FG000|NOT COMPLETED|Overall Study||0||
59599247|NCT02340728|75708936|FG001|NOT COMPLETED|Overall Study||0||
59599248|NCT01078844|75708942|FG000|STARTED|Overall Study||4||
59599249|NCT01078844|75708942|FG000|COMPLETED|Overall Study||0||
59599250|NCT01078844|75708942|FG000|NOT COMPLETED|Overall Study||4||
59599251|NCT01072526|75708947|FG000|STARTED|Overall Study|Study started in December 2007 (recruited 6 patients total of 20 anticipated)|6||
59599252|NCT01072526|75708948|FG001|STARTED|Overall Study||0||
59599253|NCT01072526|75708947|FG000|COMPLETED|Overall Study|Study completed in September 2008(recruited 6 patients total of 20 anticipated)|6||
59599254|NCT01072526|75708948|FG001|COMPLETED|Overall Study||0||
59599255|NCT01072526|75708947|FG000|NOT COMPLETED|Overall Study||0||
59599256|NCT01072526|75708948|FG001|NOT COMPLETED|Overall Study||0||
59599257|NCT03536923|75708956|FG000|STARTED|Overall Study||23||
59599258|NCT03536923|75708956|FG000|COMPLETED|Overall Study||23||
59599259|NCT03536923|75708956|FG000|NOT COMPLETED|Overall Study||0||
59599260|NCT02307188|75708960|FG000|STARTED|Overall Study||5||
59599261|NCT02307188|75708960|FG000|COMPLETED|Overall Study|Four of 5 patients did not meet required criteria to complete the study after they were enrolled.|1||
59599262|NCT02307188|75708960|FG000|NOT COMPLETED|Overall Study||4||
59599263|NCT01035944|75708968|FG000|STARTED|Overall Study||14||
59599264|NCT01035944|75708969|FG001|STARTED|Overall Study||14||
59599265|NCT01035944|75708970|FG002|STARTED|Overall Study||5||
59599266|NCT01035944|75708971|FG003|STARTED|Overall Study||4||
59599267|NCT01035944|75708968|FG000|COMPLETED|Overall Study||11||
59599268|NCT01035944|75708969|FG001|COMPLETED|Overall Study||13||
59599269|NCT01035944|75708970|FG002|COMPLETED|Overall Study||4||
59599270|NCT01035944|75708971|FG003|COMPLETED|Overall Study||4||
59599271|NCT01035944|75708968|FG000|NOT COMPLETED|Overall Study||3||
59599272|NCT01035944|75708969|FG001|NOT COMPLETED|Overall Study||1||
59599273|NCT01035944|75708970|FG002|NOT COMPLETED|Overall Study||1||
59599274|NCT01035944|75708971|FG003|NOT COMPLETED|Overall Study||0||
59599275|NCT03582553|75708987|FG000|STARTED|Intervention 1/Visit 1||3||
59599276|NCT03582553|75708988|FG001|STARTED|Intervention 1/Visit 1||3||
59599277|NCT03582553|75708989|FG002|STARTED|Intervention 1/Visit 1||3||
59599278|NCT03582553|75708990|FG003|STARTED|Intervention 1/Visit 1||3||
59599279|NCT03582553|75708991|FG004|STARTED|Intervention 1/Visit 1||3||
59599280|NCT03582553|75708992|FG005|STARTED|Intervention 1/Visit 1||3||
59599281|NCT03582553|75708987|FG000|COMPLETED|Intervention 1/Visit 1||3||
59599282|NCT03582553|75708988|FG001|COMPLETED|Intervention 1/Visit 1||3||
59599283|NCT03582553|75708989|FG002|COMPLETED|Intervention 1/Visit 1||3||
59599284|NCT03582553|75708990|FG003|COMPLETED|Intervention 1/Visit 1||3||
59599285|NCT03582553|75708991|FG004|COMPLETED|Intervention 1/Visit 1||3||
59599286|NCT03582553|75708992|FG005|COMPLETED|Intervention 1/Visit 1||3||
59599287|NCT03582553|75708987|FG000|NOT COMPLETED|Intervention 1/Visit 1||0||
59599288|NCT03582553|75708988|FG001|NOT COMPLETED|Intervention 1/Visit 1||0||
59599289|NCT03582553|75708989|FG002|NOT COMPLETED|Intervention 1/Visit 1||0||
59599290|NCT03582553|75708990|FG003|NOT COMPLETED|Intervention 1/Visit 1||0||
59599291|NCT03582553|75708991|FG004|NOT COMPLETED|Intervention 1/Visit 1||0||
59599292|NCT03582553|75708992|FG005|NOT COMPLETED|Intervention 1/Visit 1||0||
59599293|NCT03582553|75708987|FG000|STARTED|Washout Period ( At Least 1 Week)||3||
59599294|NCT03582553|75708988|FG001|STARTED|Washout Period ( At Least 1 Week)||3||
59599295|NCT03582553|75708989|FG002|STARTED|Washout Period ( At Least 1 Week)||3||
59599296|NCT03582553|75708990|FG003|STARTED|Washout Period ( At Least 1 Week)||3||
59599297|NCT03582553|75708991|FG004|STARTED|Washout Period ( At Least 1 Week)||3||
59599298|NCT03582553|75708992|FG005|STARTED|Washout Period ( At Least 1 Week)||3||
59599299|NCT03582553|75708987|FG000|COMPLETED|Washout Period ( At Least 1 Week)||3||
59599300|NCT03582553|75708988|FG001|COMPLETED|Washout Period ( At Least 1 Week)||3||
59599301|NCT03582553|75708989|FG002|COMPLETED|Washout Period ( At Least 1 Week)||3||
59599302|NCT03582553|75708990|FG003|COMPLETED|Washout Period ( At Least 1 Week)||3||
59599303|NCT03582553|75708991|FG004|COMPLETED|Washout Period ( At Least 1 Week)||3||
59599304|NCT03582553|75708992|FG005|COMPLETED|Washout Period ( At Least 1 Week)||3||
59599305|NCT03582553|75708987|FG000|NOT COMPLETED|Washout Period ( At Least 1 Week)||0||
59599306|NCT03582553|75708988|FG001|NOT COMPLETED|Washout Period ( At Least 1 Week)||0||
59599307|NCT03582553|75708989|FG002|NOT COMPLETED|Washout Period ( At Least 1 Week)||0||
59599308|NCT03582553|75708990|FG003|NOT COMPLETED|Washout Period ( At Least 1 Week)||0||
59599309|NCT03582553|75708991|FG004|NOT COMPLETED|Washout Period ( At Least 1 Week)||0||
59599310|NCT03582553|75708992|FG005|NOT COMPLETED|Washout Period ( At Least 1 Week)||0||
59599311|NCT03582553|75708987|FG000|STARTED|Intervention 2/Visit 2||3||
59599312|NCT03582553|75708988|FG001|STARTED|Intervention 2/Visit 2||3||
59599313|NCT03582553|75708989|FG002|STARTED|Intervention 2/Visit 2||3||
59599314|NCT03582553|75708990|FG003|STARTED|Intervention 2/Visit 2||3||
59599315|NCT03582553|75708991|FG004|STARTED|Intervention 2/Visit 2||3||
59599316|NCT03582553|75708992|FG005|STARTED|Intervention 2/Visit 2||3||
59599317|NCT03582553|75708987|FG000|COMPLETED|Intervention 2/Visit 2||3||
59599318|NCT03582553|75708988|FG001|COMPLETED|Intervention 2/Visit 2||3||
59599319|NCT03582553|75708989|FG002|COMPLETED|Intervention 2/Visit 2||3||
59599320|NCT03582553|75708990|FG003|COMPLETED|Intervention 2/Visit 2||3||
59599321|NCT03582553|75708991|FG004|COMPLETED|Intervention 2/Visit 2||3||
59599322|NCT03582553|75708992|FG005|COMPLETED|Intervention 2/Visit 2||3||
59599323|NCT03582553|75708987|FG000|NOT COMPLETED|Intervention 2/Visit 2||0||
59599324|NCT03582553|75708988|FG001|NOT COMPLETED|Intervention 2/Visit 2||0||
59599325|NCT03582553|75708989|FG002|NOT COMPLETED|Intervention 2/Visit 2||0||
59599326|NCT03582553|75708990|FG003|NOT COMPLETED|Intervention 2/Visit 2||0||
59599327|NCT03582553|75708991|FG004|NOT COMPLETED|Intervention 2/Visit 2||0||
59599328|NCT03582553|75708992|FG005|NOT COMPLETED|Intervention 2/Visit 2||0||
59599329|NCT03582553|75708987|FG000|STARTED|Washout Period (At Least 1 Week)||3||
59599330|NCT03582553|75708988|FG001|STARTED|Washout Period (At Least 1 Week)||3||
59599331|NCT03582553|75708989|FG002|STARTED|Washout Period (At Least 1 Week)||3||
59599332|NCT03582553|75708990|FG003|STARTED|Washout Period (At Least 1 Week)||3||
59599333|NCT03582553|75708991|FG004|STARTED|Washout Period (At Least 1 Week)||3||
59599334|NCT03582553|75708992|FG005|STARTED|Washout Period (At Least 1 Week)||3||
59599335|NCT03582553|75708987|FG000|COMPLETED|Washout Period (At Least 1 Week)||3||
59599336|NCT03582553|75708988|FG001|COMPLETED|Washout Period (At Least 1 Week)||3||
59599337|NCT03582553|75708989|FG002|COMPLETED|Washout Period (At Least 1 Week)||3||
59599338|NCT03582553|75708990|FG003|COMPLETED|Washout Period (At Least 1 Week)||3||
59599339|NCT03582553|75708991|FG004|COMPLETED|Washout Period (At Least 1 Week)||3||
59599340|NCT03582553|75708992|FG005|COMPLETED|Washout Period (At Least 1 Week)||3||
59599341|NCT03582553|75708987|FG000|NOT COMPLETED|Washout Period (At Least 1 Week)||0||
59599342|NCT03582553|75708988|FG001|NOT COMPLETED|Washout Period (At Least 1 Week)||0||
59599343|NCT03582553|75708989|FG002|NOT COMPLETED|Washout Period (At Least 1 Week)||0||
59599344|NCT03582553|75708990|FG003|NOT COMPLETED|Washout Period (At Least 1 Week)||0||
59599345|NCT03582553|75708991|FG004|NOT COMPLETED|Washout Period (At Least 1 Week)||0||
59599346|NCT03582553|75708992|FG005|NOT COMPLETED|Washout Period (At Least 1 Week)||0||
59599347|NCT03582553|75708987|FG000|STARTED|Intervention 3/Visit 3||3||
59599348|NCT03582553|75708988|FG001|STARTED|Intervention 3/Visit 3||3||
59599349|NCT03582553|75708989|FG002|STARTED|Intervention 3/Visit 3||3||
59599350|NCT03582553|75708990|FG003|STARTED|Intervention 3/Visit 3||3||
59599351|NCT03582553|75708991|FG004|STARTED|Intervention 3/Visit 3||3||
59599352|NCT03582553|75708992|FG005|STARTED|Intervention 3/Visit 3||3||
59599353|NCT03582553|75708987|FG000|COMPLETED|Intervention 3/Visit 3||3||
59599354|NCT03582553|75708988|FG001|COMPLETED|Intervention 3/Visit 3||3||
59599355|NCT03582553|75708989|FG002|COMPLETED|Intervention 3/Visit 3||3||
59599356|NCT03582553|75708990|FG003|COMPLETED|Intervention 3/Visit 3||3||
59599357|NCT03582553|75708991|FG004|COMPLETED|Intervention 3/Visit 3||3||
59599358|NCT03582553|75708992|FG005|COMPLETED|Intervention 3/Visit 3||3||
59599359|NCT03582553|75708987|FG000|NOT COMPLETED|Intervention 3/Visit 3||0||
59599360|NCT03582553|75708988|FG001|NOT COMPLETED|Intervention 3/Visit 3||0||
59599361|NCT03582553|75708989|FG002|NOT COMPLETED|Intervention 3/Visit 3||0||
59599362|NCT03582553|75708990|FG003|NOT COMPLETED|Intervention 3/Visit 3||0||
59599363|NCT03582553|75708991|FG004|NOT COMPLETED|Intervention 3/Visit 3||0||
59599364|NCT03582553|75708992|FG005|NOT COMPLETED|Intervention 3/Visit 3||0||
59599365|NCT01025492|75709010|FG000|STARTED|Overall Study||24||
59599366|NCT01025492|75709010|FG000|COMPLETED|Overall Study||24||
59599367|NCT01025492|75709010|FG000|NOT COMPLETED|Overall Study||0||
59599368|NCT02202044|75709014|FG000|STARTED|Overall Study||0||
59599369|NCT02202044|75709014|FG000|COMPLETED|Overall Study||0||
59599370|NCT02202044|75709014|FG000|NOT COMPLETED|Overall Study||0||
59599371|NCT03538795|75709018|FG000|STARTED|Overall Study||3||
59728551|NCT00979134|75847184|FG000|COMPLETED|Overall Study|At DCO|10||
59599372|NCT03538795|75709018|FG000|COMPLETED|Overall Study||3||
59599373|NCT03538795|75709018|FG000|NOT COMPLETED|Overall Study||0||
59599374|NCT01023620|75709024|FG000|STARTED|Overall Study||0||
59599375|NCT01023620|75709025|FG001|STARTED|Overall Study||0||
59599376|NCT01023620|75709024|FG000|COMPLETED|Overall Study||0||
59599377|NCT01023620|75709025|FG001|COMPLETED|Overall Study||0||
59599378|NCT01023620|75709024|FG000|NOT COMPLETED|Overall Study||0||
59599379|NCT01023620|75709025|FG001|NOT COMPLETED|Overall Study||0||
59599380|NCT03595579|75709033|FG000|STARTED|Overall Study||48||
59599381|NCT03595579|75709034|FG001|STARTED|Overall Study||49||
59599382|NCT03595579|75709033|FG000|mITT Population|Overall Study||43||
59599383|NCT03595579|75709034|FG001|mITT Population|Overall Study||37||
59599384|NCT03595579|75709033|FG000|Safety Population|Overall Study||48||
59599385|NCT03595579|75709034|FG001|Safety Population|Overall Study||48||
59599386|NCT03595579|75709033|FG000|COMPLETED|Overall Study||38||
59599387|NCT03595579|75709034|FG001|COMPLETED|Overall Study||35||
59599388|NCT03595579|75709033|FG000|NOT COMPLETED|Overall Study||10||
59599389|NCT03595579|75709034|FG001|NOT COMPLETED|Overall Study||14||
59599390|NCT02200328|75709042|FG000|STARTED|Overall Study||43||
59599391|NCT02200328|75709043|FG001|STARTED|Overall Study||33||
59599392|NCT02200328|75709042|FG000|COMPLETED|Overall Study||0||
59599393|NCT02200328|75709043|FG001|COMPLETED|Overall Study||0||
59599394|NCT02200328|75709042|FG000|NOT COMPLETED|Overall Study||43||
59599395|NCT02200328|75709043|FG001|NOT COMPLETED|Overall Study||33||
59599396|NCT04327843|75709049|FG000|STARTED|Baseline Assessment||19||
59599397|NCT04327843|75709049|FG000|COMPLETED|Baseline Assessment||19||
59599398|NCT04327843|75709049|FG000|NOT COMPLETED|Baseline Assessment||0||
59599399|NCT04327843|75709049|FG000|STARTED|Week 13 Assessment||19||
59599400|NCT04327843|75709049|FG000|COMPLETED|Week 13 Assessment||19||
59599401|NCT04327843|75709049|FG000|NOT COMPLETED|Week 13 Assessment||0||
59599402|NCT04327843|75709049|FG000|STARTED|Week 25 Assessment||19||
59599403|NCT04327843|75709049|FG000|COMPLETED|Week 25 Assessment||18||
59599404|NCT04327843|75709049|FG000|NOT COMPLETED|Week 25 Assessment||1||
59599405|NCT02147834|75709055|FG000|STARTED|Overall Study||3||
59599406|NCT02147834|75709056|FG001|STARTED|Overall Study||2||
59599407|NCT02147834|75709055|FG000|COMPLETED|Overall Study||3||
59599408|NCT02147834|75709056|FG001|COMPLETED|Overall Study||2||
59599409|NCT02147834|75709055|FG000|NOT COMPLETED|Overall Study||0||
60130909|NCT00525837|76253309|FG000|COMPLETED|Overall Study||14||
60130910|NCT00525837|76253309|FG000|NOT COMPLETED|Overall Study||4||
60130911|NCT00527475|76253316|FG000|STARTED|Overall Study||30||
60130912|NCT00527475|76253317|FG001|STARTED|Overall Study||30||
60130913|NCT00527475|76253316|FG000|COMPLETED|Overall Study||27||
60130914|NCT00527475|76253317|FG001|COMPLETED|Overall Study||29||
60130915|NCT00527475|76253316|FG000|NOT COMPLETED|Overall Study||3||
60130916|NCT00527475|76253317|FG001|NOT COMPLETED|Overall Study||1||
60130917|NCT00566943|76253325|FG000|STARTED|Overall Study||52||
60130918|NCT00566943|76253326|FG001|STARTED|Overall Study||49||
60130919|NCT00566943|76253325|FG000|COMPLETED|Overall Study||52||
60130920|NCT00566943|76253326|FG001|COMPLETED|Overall Study||49||
60130921|NCT00566943|76253325|FG000|NOT COMPLETED|Overall Study||0||
60130922|NCT00566943|76253326|FG001|NOT COMPLETED|Overall Study||0||
60130923|NCT01449461|76253344|FG000|STARTED|Overall Study||6||
60130924|NCT01449461|76253345|FG001|STARTED|Overall Study||18||
60130925|NCT01449461|76253346|FG002|STARTED|Overall Study||18||
59599410|NCT02147834|75709056|FG001|NOT COMPLETED|Overall Study||0||
59599411|NCT04343287|75709064|FG000|STARTED|Overall Study||108||
59599412|NCT04343287|75709065|FG001|STARTED|Overall Study||112||
59599413|NCT04343287|75709064|FG000|COMPLETED|Overall Study||108||
59599414|NCT04343287|75709065|FG001|COMPLETED|Overall Study||111||
59599415|NCT04343287|75709064|FG000|NOT COMPLETED|Overall Study||0||
59599416|NCT04343287|75709065|FG001|NOT COMPLETED|Overall Study||1||
59599417|NCT04369885|75709073|FG000|STARTED|Overall Study||12||
59599418|NCT04369885|75709073|FG000|COMPLETED|Overall Study||10||
59599419|NCT04369885|75709073|FG000|NOT COMPLETED|Overall Study||2||
59599420|NCT00979550|75709079|FG000|STARTED|Overall Study||4||
59599421|NCT00979550|75709080|FG001|STARTED|Overall Study||3||
59599422|NCT00979550|75709079|FG000|COMPLETED|Overall Study||4||
59599423|NCT00979550|75709080|FG001|COMPLETED|Overall Study||3||
60130926|NCT01449461|76253347|FG003|STARTED|Overall Study||32||
60130927|NCT01449461|76253348|FG004|STARTED|Overall Study||48||
60130928|NCT01449461|76253349|FG005|STARTED|Overall Study||15||
60130929|NCT01449461|76253344|FG000|COMPLETED|Overall Study||0||
60130930|NCT01449461|76253345|FG001|COMPLETED|Overall Study||0||
60130931|NCT01449461|76253346|FG002|COMPLETED|Overall Study||0||
60130932|NCT01449461|76253347|FG003|COMPLETED|Overall Study||0||
60130933|NCT01449461|76253348|FG004|COMPLETED|Overall Study||0||
60130934|NCT01449461|76253349|FG005|COMPLETED|Overall Study||0||
60130935|NCT01449461|76253344|FG000|NOT COMPLETED|Overall Study||6||
60130936|NCT01449461|76253345|FG001|NOT COMPLETED|Overall Study||18||
60130937|NCT01449461|76253346|FG002|NOT COMPLETED|Overall Study||18||
59599424|NCT00979550|75709079|FG000|NOT COMPLETED|Overall Study||0||
59599425|NCT00979550|75709080|FG001|NOT COMPLETED|Overall Study||0||
59599426|NCT04394845|75709086|FG000|STARTED|Overall Study||6||
60130938|NCT01449461|76253347|FG003|NOT COMPLETED|Overall Study||32||
60130939|NCT01449461|76253348|FG004|NOT COMPLETED|Overall Study||48||
60130940|NCT01449461|76253349|FG005|NOT COMPLETED|Overall Study||15||
60130941|NCT02121483|76253375|FG000|STARTED|Overall Study||9||
60130942|NCT02121483|76253376|FG001|STARTED|Overall Study||8||
60130943|NCT02121483|76253377|FG002|STARTED|Overall Study||10||
60130944|NCT02121483|76253375|FG000|COMPLETED|Overall Study||9||
60130945|NCT02121483|76253376|FG001|COMPLETED|Overall Study||8||
60130946|NCT02121483|76253377|FG002|COMPLETED|Overall Study||10||
60130947|NCT02121483|76253375|FG000|NOT COMPLETED|Overall Study||0||
60130948|NCT02121483|76253376|FG001|NOT COMPLETED|Overall Study||0||
60130949|NCT02121483|76253377|FG002|NOT COMPLETED|Overall Study||0||
60130950|NCT01572038|76253385|FG000|STARTED|Overall Study|All participants who were enrolled in the study.|1436|Intent-to-Treat (ITT) Population|
60130951|NCT01572038|76253385|FG000|Received at Least One Dose of Study Drug|Overall Study||1436|Safety Population|
60130952|NCT01572038|76253385|FG000|COMPLETED|Overall Study||445||
60130953|NCT01572038|76253385|FG000|NOT COMPLETED|Overall Study||991||
60130954|NCT01448213|76253413|FG000|STARTED|Overall Study||130||
60130955|NCT01448213|76253414|FG001|STARTED|Overall Study||134||
60130956|NCT01448213|76253413|FG000|COMPLETED|Overall Study||113||
60130957|NCT01448213|76253414|FG001|COMPLETED|Overall Study||112||
60130958|NCT01448213|76253413|FG000|NOT COMPLETED|Overall Study||17||
60130959|NCT01448213|76253414|FG001|NOT COMPLETED|Overall Study||22||
60130960|NCT02122341|76253422|FG000|STARTED|Overall Study||17||
60130961|NCT02122341|76253423|FG001|STARTED|Overall Study||18||
60130962|NCT02122341|76253422|FG000|COMPLETED|Overall Study||17||
60130963|NCT02122341|76253423|FG001|COMPLETED|Overall Study||18||
60130964|NCT02122341|76253422|FG000|NOT COMPLETED|Overall Study||0||
60130965|NCT02122341|76253423|FG001|NOT COMPLETED|Overall Study||0||
60130966|NCT01448057|76253431|FG000|STARTED|Overall Study||170||
60130967|NCT01448057|76253432|FG001|STARTED|Overall Study||171||
60130968|NCT01448057|76253431|FG000|COMPLETED|Overall Study||162||
60130969|NCT01448057|76253432|FG001|COMPLETED|Overall Study||167||
60130970|NCT01448057|76253431|FG000|NOT COMPLETED|Overall Study||8||
60130971|NCT01448057|76253432|FG001|NOT COMPLETED|Overall Study||4||
60130972|NCT01447433|76253440|FG000|STARTED|Overall Study||26||
60130973|NCT01447433|76253441|FG001|STARTED|Overall Study||27||
60130974|NCT01447433|76253440|FG000|COMPLETED|Overall Study||22||
60130975|NCT01447433|76253441|FG001|COMPLETED|Overall Study||21||
60130976|NCT01447433|76253440|FG000|NOT COMPLETED|Overall Study||4||
60130977|NCT01447433|76253441|FG001|NOT COMPLETED|Overall Study||6||
60130978|NCT01446965|76253449|FG000|STARTED|Randominization||1554||
60130979|NCT01446965|76253450|FG001|STARTED|Randominization||794||
60130980|NCT01446965|76253449|FG000|COMPLETED|Randominization||1524||
60130981|NCT01446965|76253450|FG001|COMPLETED|Randominization||778||
60130982|NCT01446965|76253449|FG000|NOT COMPLETED|Randominization||30||
60130983|NCT01446965|76253450|FG001|NOT COMPLETED|Randominization||16||
60130984|NCT01446965|76253449|FG000|STARTED|Participants Followed and Analyzed||1524||
60130985|NCT01446965|76253450|FG001|STARTED|Participants Followed and Analyzed||778||
60130986|NCT01446965|76253449|FG000|Received WCD|Participants Followed and Analyzed||1481||
60130987|NCT01446965|76253450|FG001|Received WCD|Participants Followed and Analyzed||0||
60130988|NCT01446965|76253449|FG000|Never Wore WCD|Participants Followed and Analyzed||43|n=43 participants in the treatment group withdrew consent prior to receiving WCD or refused WCD fitting|
60130989|NCT01446965|76253450|FG001|Never Wore WCD|Participants Followed and Analyzed||0|n=43 participants in the treatment group withdrew consent prior to receiving WCD or refused WCD fitting|
60130990|NCT01446965|76253449|FG000|Never Given WCD|Participants Followed and Analyzed||0||
60130991|NCT01446965|76253450|FG001|Never Given WCD|Participants Followed and Analyzed||758||
60130992|NCT01446965|76253449|FG000|Given WCD Out of Protocol|Participants Followed and Analyzed||0|n=20 participants in the control group received WCD by prescription outside of protocol by treating physician|
60130993|NCT01446965|76253450|FG001|Given WCD Out of Protocol|Participants Followed and Analyzed||20|n=20 participants in the control group received WCD by prescription outside of protocol by treating physician|
60130994|NCT01446965|76253449|FG000|COMPLETED|Participants Followed and Analyzed||1514||
60130995|NCT01446965|76253450|FG001|COMPLETED|Participants Followed and Analyzed||766||
60130996|NCT01446965|76253449|FG000|NOT COMPLETED|Participants Followed and Analyzed||10||
60130997|NCT01446965|76253450|FG001|NOT COMPLETED|Participants Followed and Analyzed||12||
60130998|NCT01446809|76253458|FG000|STARTED|Overall Study||14||
60130999|NCT01446809|76253459|FG001|STARTED|Overall Study||7||
60131000|NCT01446809|76253460|FG002|STARTED|Overall Study||2||
60131001|NCT01446809|76253458|FG000|COMPLETED|Overall Study||14||
60131002|NCT01446809|76253459|FG001|COMPLETED|Overall Study||7||
60131003|NCT01446809|76253460|FG002|COMPLETED|Overall Study||0||
60131004|NCT01446809|76253458|FG000|NOT COMPLETED|Overall Study||0||
60131005|NCT01446809|76253459|FG001|NOT COMPLETED|Overall Study||0||
60131006|NCT01446809|76253460|FG002|NOT COMPLETED|Overall Study||2||
60131007|NCT01446419|76253471|FG000|STARTED|Overall Study||147||
60131008|NCT01446419|76253472|FG001|STARTED|Overall Study||78||
60131009|NCT01446419|76253471|FG000|3 Month Follow-up|Overall Study||146||
60131010|NCT01446419|76253472|FG001|3 Month Follow-up|Overall Study||77||
60131011|NCT01446419|76253471|FG000|6 Month Follow-up|Overall Study||144||
60131012|NCT01446419|76253472|FG001|6 Month Follow-up|Overall Study||77||
60131013|NCT01446419|76253471|FG000|12 Month Follow-up|Overall Study||142||
60131014|NCT01446419|76253472|FG001|12 Month Follow-up|Overall Study||77||
60131015|NCT01446419|76253471|FG000|COMPLETED|Overall Study||142||
60131016|NCT01446419|76253472|FG001|COMPLETED|Overall Study||77||
60131017|NCT01446419|76253471|FG000|NOT COMPLETED|Overall Study||5||
60131018|NCT01446419|76253472|FG001|NOT COMPLETED|Overall Study||1||
60131019|NCT01445951|76253481|FG000|STARTED|Overall Study||174||
60131020|NCT01445951|76253482|FG001|STARTED|Overall Study||174||
60131021|NCT01445951|76253483|FG002|STARTED|Overall Study||170||
60131022|NCT01445951|76253481|FG000|COMPLETED|Overall Study||130||
60131023|NCT01445951|76253482|FG001|COMPLETED|Overall Study||138||
60131024|NCT01445951|76253483|FG002|COMPLETED|Overall Study||151||
60131025|NCT01445951|76253481|FG000|NOT COMPLETED|Overall Study||44||
60131026|NCT01445951|76253482|FG001|NOT COMPLETED|Overall Study||36||
60131027|NCT01445951|76253483|FG002|NOT COMPLETED|Overall Study||19||
60131028|NCT00513435|76253491|FG000|STARTED|Overall Study||9||
60131029|NCT00513435|76253491|FG000|COMPLETED|Overall Study||9||
60131030|NCT00513435|76253491|FG000|NOT COMPLETED|Overall Study||0||
60131031|NCT01444781|76253498|FG000|STARTED|Overall Study||416||
60131032|NCT01444781|76253499|FG001|STARTED|Overall Study||415||
60131033|NCT01444781|76253500|FG002|STARTED|Overall Study||275||
60131034|NCT01444781|76253498|FG000|COMPLETED|Overall Study||413||
60131035|NCT01444781|76253499|FG001|COMPLETED|Overall Study||411||
60131036|NCT01444781|76253500|FG002|COMPLETED|Overall Study||272||
60131037|NCT01444781|76253498|FG000|NOT COMPLETED|Overall Study||3||
60131038|NCT01444781|76253499|FG001|NOT COMPLETED|Overall Study||4||
60131039|NCT01444781|76253500|FG002|NOT COMPLETED|Overall Study||3||
60131040|NCT01444391|76253515|FG000|STARTED|Overall Study||42||
60131041|NCT01444391|76253515|FG000|COMPLETED|Overall Study||41||
60131042|NCT01444391|76253515|FG000|NOT COMPLETED|Overall Study||1||
60131043|NCT01443923|76253521|FG000|STARTED|Overall Study||3||
60131044|NCT01443923|76253522|FG001|STARTED|Overall Study||1||
60131045|NCT01443923|76253521|FG000|COMPLETED|Overall Study||2||
60131046|NCT01443923|76253522|FG001|COMPLETED|Overall Study||1||
60131047|NCT01443923|76253521|FG000|NOT COMPLETED|Overall Study||1||
60131048|NCT01443923|76253522|FG001|NOT COMPLETED|Overall Study||0||
60131049|NCT00569673|76253528|FG000|STARTED|Overall Study|Total number participants enrolled on study|71||
60131050|NCT00569673|76253528|FG000|COMPLETED|Overall Study|Total number participants that are eligible and evaluable.|71||
60131051|NCT00569673|76253528|FG000|NOT COMPLETED|Overall Study||0||
60131052|NCT01551212|76253534|FG000|STARTED|Overall Study||171|Randomized|
60131053|NCT01551212|76253535|FG001|STARTED|Overall Study||168|Randomized|
60131054|NCT01551212|76253534|FG000|Full Anylsis Set (FAS)|Overall Study||169|Randomized and received at least 1 dose of study drug|
60131055|NCT01551212|76253535|FG001|Full Anylsis Set (FAS)|Overall Study||164|Randomized and received at least 1 dose of study drug|
60131056|NCT01551212|76253534|FG000|Safety Set|Overall Study||169|Received at least 1 dose of study drug and had a post-baseline safety assessment|
60131057|NCT01551212|76253535|FG001|Safety Set|Overall Study||164|Received at least 1 dose of study drug and had a post-baseline safety assessment|
60131058|NCT01551212|76253534|FG000|Per Protocol Set (PP)|Overall Study||110|In FAS without a major protocol deviation|
60131059|NCT01551212|76253535|FG001|Per Protocol Set (PP)|Overall Study||101|In FAS without a major protocol deviation|
60131060|NCT01551212|76253534|FG000|COMPLETED|Overall Study||166||
60131061|NCT01551212|76253535|FG001|COMPLETED|Overall Study||148||
60131062|NCT01551212|76253534|FG000|NOT COMPLETED|Overall Study||5||
60131063|NCT01551212|76253535|FG001|NOT COMPLETED|Overall Study||20||
60131064|NCT00573261|76253543|FG000|STARTED|Overall Study||20||
60131065|NCT00573261|76253544|FG001|STARTED|Overall Study||20||
60131066|NCT00573261|76253543|FG000|COMPLETED|Overall Study||14||
60131067|NCT00573261|76253544|FG001|COMPLETED|Overall Study||15||
60131068|NCT00573261|76253543|FG000|NOT COMPLETED|Overall Study||6||
60131069|NCT00573261|76253544|FG001|NOT COMPLETED|Overall Study||5||
60131070|NCT00574197|76253552|FG000|STARTED|Overall Study||11||
60131071|NCT00574197|76253552|FG000|COMPLETED|Overall Study||6||
60131072|NCT00574197|76253552|FG000|NOT COMPLETED|Overall Study||5||
60131073|NCT00574587|76253560|FG000|STARTED|Overall Study||3||
60131074|NCT00574587|76253561|FG001|STARTED|Overall Study||23||
60131075|NCT00574587|76253562|FG002|STARTED|Overall Study||16||
60131076|NCT00574587|76253563|FG003|STARTED|Overall Study||13||
60131077|NCT00574587|76253560|FG000|COMPLETED|Overall Study||3||
60131078|NCT00574587|76253561|FG001|COMPLETED|Overall Study||23||
60131079|NCT00574587|76253562|FG002|COMPLETED|Overall Study||16||
60131080|NCT00574587|76253563|FG003|COMPLETED|Overall Study||13||
60131081|NCT00574587|76253560|FG000|NOT COMPLETED|Overall Study||0||
60131082|NCT00574587|76253561|FG001|NOT COMPLETED|Overall Study||0||
60131083|NCT00574587|76253562|FG002|NOT COMPLETED|Overall Study||0||
60131084|NCT00574587|76253563|FG003|NOT COMPLETED|Overall Study||0||
60131085|NCT00603993|76253574|FG000|STARTED|Overall Study||88||
60131086|NCT00603993|76253574|FG000|COMPLETED|Overall Study||68||
60131087|NCT00603993|76253574|FG000|NOT COMPLETED|Overall Study||20||
60131088|NCT00575367|76253580|FG000|STARTED|Overall Study||19||
60131089|NCT00575367|76253581|FG001|STARTED|Overall Study||18||
60131090|NCT00575367|76253580|FG000|COMPLETED|Overall Study||19||
60131091|NCT00575367|76253581|FG001|COMPLETED|Overall Study||18||
60131092|NCT00575367|76253580|FG000|NOT COMPLETED|Overall Study||0||
60131093|NCT00575367|76253581|FG001|NOT COMPLETED|Overall Study||0||
60131094|NCT00604461|76253587|FG000|STARTED|Overall Study||13||
60131095|NCT00604461|76253587|FG000|COMPLETED|Overall Study|Death within 30 days of treatment occurred in 1 patient.|12||
60131096|NCT00604461|76253587|FG000|NOT COMPLETED|Overall Study||1||
60131097|NCT00576147|76253591|FG000|STARTED|Overall Study||431||
60131098|NCT00576147|76253591|FG000|COMPLETED|Overall Study||431||
60131099|NCT00576147|76253591|FG000|NOT COMPLETED|Overall Study||0||
59599427|NCT04394845|75709086|FG000|COMPLETED|Overall Study||6||
59599428|NCT04394845|75709086|FG000|NOT COMPLETED|Overall Study||0||
59599429|NCT00966992|75709094|FG000|STARTED|Overall Study||3||
59998298|NCT02717195|76113973|FG004|STARTED|Prospective Confirmation (PC) Period||0||
59998299|NCT02717195|76113969|FG000|COMPLETED|Prospective Confirmation (PC) Period||421||
59998300|NCT02717195|76113970|FG001|COMPLETED|Prospective Confirmation (PC) Period||276||
59998301|NCT02717195|76113971|FG002|COMPLETED|Prospective Confirmation (PC) Period||0||
59998302|NCT02717195|76113972|FG003|COMPLETED|Prospective Confirmation (PC) Period||0||
59998303|NCT02717195|76113973|FG004|COMPLETED|Prospective Confirmation (PC) Period||0||
59998304|NCT02717195|76113969|FG000|NOT COMPLETED|Prospective Confirmation (PC) Period||290||
59998305|NCT02717195|76113970|FG001|NOT COMPLETED|Prospective Confirmation (PC) Period||111||
59998306|NCT02717195|76113971|FG002|NOT COMPLETED|Prospective Confirmation (PC) Period||0||
59998307|NCT02717195|76113972|FG003|NOT COMPLETED|Prospective Confirmation (PC) Period||0||
59998308|NCT02717195|76113973|FG004|NOT COMPLETED|Prospective Confirmation (PC) Period||0||
59998309|NCT02717195|76113969|FG000|STARTED|Double-blind Treatment (DBT) Period||0||
59998310|NCT02717195|76113970|FG001|STARTED|Double-blind Treatment (DBT) Period||0||
59998311|NCT02717195|76113971|FG002|STARTED|Double-blind Treatment (DBT) Period||235||
59998312|NCT02717195|76113972|FG003|STARTED|Double-blind Treatment (DBT) Period||232||
59998313|NCT02717195|76113973|FG004|STARTED|Double-blind Treatment (DBT) Period||230||
59998314|NCT02717195|76113969|FG000|COMPLETED|Double-blind Treatment (DBT) Period||0||
59998315|NCT02717195|76113970|FG001|COMPLETED|Double-blind Treatment (DBT) Period||0||
59998316|NCT02717195|76113971|FG002|COMPLETED|Double-blind Treatment (DBT) Period||198||
59998317|NCT02717195|76113972|FG003|COMPLETED|Double-blind Treatment (DBT) Period||188||
59998318|NCT02717195|76113973|FG004|COMPLETED|Double-blind Treatment (DBT) Period||200||
59998319|NCT02717195|76113969|FG000|NOT COMPLETED|Double-blind Treatment (DBT) Period||0||
59998320|NCT02717195|76113970|FG001|NOT COMPLETED|Double-blind Treatment (DBT) Period||0||
59998321|NCT02717195|76113971|FG002|NOT COMPLETED|Double-blind Treatment (DBT) Period||37||
59998322|NCT02717195|76113972|FG003|NOT COMPLETED|Double-blind Treatment (DBT) Period||44||
59998323|NCT02717195|76113973|FG004|NOT COMPLETED|Double-blind Treatment (DBT) Period||30||
59998324|NCT00701441|76113988|FG000|STARTED|Overall Study||9||
59998325|NCT00701441|76113989|FG001|STARTED|Overall Study||16||
59998326|NCT00701441|76113988|FG000|COMPLETED|Overall Study||9||
59998327|NCT00701441|76113989|FG001|COMPLETED|Overall Study||12||
59998328|NCT00701441|76113988|FG000|NOT COMPLETED|Overall Study||0||
59998329|NCT00701441|76113989|FG001|NOT COMPLETED|Overall Study||4||
59998330|NCT02628873|76114001|FG000|STARTED|First Test (1 Hour)||14||
59998331|NCT02628873|76114002|FG001|STARTED|First Test (1 Hour)||7||
59998332|NCT02628873|76114001|FG000|COMPLETED|First Test (1 Hour)||14||
59998333|NCT02628873|76114002|FG001|COMPLETED|First Test (1 Hour)||7||
59998334|NCT02628873|76114001|FG000|NOT COMPLETED|First Test (1 Hour)||0||
59998335|NCT02628873|76114002|FG001|NOT COMPLETED|First Test (1 Hour)||0||
59998336|NCT02628873|76114001|FG000|STARTED|Break (1 Hour)||14||
59998337|NCT02628873|76114002|FG001|STARTED|Break (1 Hour)||7||
59998338|NCT02628873|76114001|FG000|COMPLETED|Break (1 Hour)||14||
59998339|NCT02628873|76114002|FG001|COMPLETED|Break (1 Hour)||6||
59998340|NCT02628873|76114001|FG000|NOT COMPLETED|Break (1 Hour)||0||
59998341|NCT02628873|76114002|FG001|NOT COMPLETED|Break (1 Hour)||1||
59998342|NCT02628873|76114001|FG000|STARTED|Second Test (1 Hour)||14||
59998343|NCT02628873|76114002|FG001|STARTED|Second Test (1 Hour)||6||
59998344|NCT02628873|76114001|FG000|COMPLETED|Second Test (1 Hour)||13||
59998345|NCT02628873|76114002|FG001|COMPLETED|Second Test (1 Hour)||6||
59998346|NCT02628873|76114001|FG000|NOT COMPLETED|Second Test (1 Hour)||1||
59998347|NCT02628873|76114002|FG001|NOT COMPLETED|Second Test (1 Hour)||0||
59998348|NCT03922139|76114008|FG000|STARTED|Overall Study||7||
59998349|NCT03922139|76114008|FG000|Completed 2 Month Surveys|Overall Study||7||
59998350|NCT03922139|76114008|FG000|Completed 4 Month Surveys|Overall Study||6||
59998351|NCT03922139|76114008|FG000|Completed 6 Month Surveys|Overall Study||7||
59998352|NCT03922139|76114008|FG000|COMPLETED|Overall Study||7||
59998353|NCT03922139|76114008|FG000|NOT COMPLETED|Overall Study||0||
59998354|NCT02629965|76114012|FG000|STARTED|Period 1||92||
59998355|NCT02629965|76114013|FG001|STARTED|Period 1||92||
59599430|NCT00966992|75709095|FG001|STARTED|Overall Study||0||
59998356|NCT02629965|76114012|FG000|COMPLETED|Period 1||88||
59998357|NCT02629965|76114013|FG001|COMPLETED|Period 1||90||
59998358|NCT02629965|76114012|FG000|NOT COMPLETED|Period 1||4||
59998359|NCT02629965|76114013|FG001|NOT COMPLETED|Period 1||2||
59998360|NCT02629965|76114012|FG000|STARTED|Period 2||88||
59998361|NCT02629965|76114013|FG001|STARTED|Period 2||90||
59998362|NCT02629965|76114012|FG000|COMPLETED|Period 2||87||
59998363|NCT02629965|76114013|FG001|COMPLETED|Period 2||90||
59998364|NCT02629965|76114012|FG000|NOT COMPLETED|Period 2||1||
59998365|NCT02629965|76114013|FG001|NOT COMPLETED|Period 2||0||
59998366|NCT01671111|76114019|FG000|STARTED|Overall Study||30||
59998367|NCT01671111|76114019|FG000|COMPLETED|Overall Study||0||
59998368|NCT01671111|76114019|FG000|NOT COMPLETED|Overall Study||30||
59998369|NCT01671345|76114025|FG000|STARTED|Overall Study||77||
59998370|NCT01671345|76114026|FG001|STARTED|Overall Study||92||
59998371|NCT01671345|76114025|FG000|COMPLETED|Overall Study||64||
60131100|NCT01550744|76253595|FG000|STARTED|Open-Label||478||
60131101|NCT01550744|76253596|FG001|STARTED|Open-Label||0||
60131102|NCT01550744|76253597|FG002|STARTED|Open-Label||0||
60131103|NCT01550744|76253595|FG000|COMPLETED|Open-Label||378||
60131104|NCT01550744|76253596|FG001|COMPLETED|Open-Label||0||
60131105|NCT01550744|76253597|FG002|COMPLETED|Open-Label||0||
60131106|NCT01550744|76253595|FG000|NOT COMPLETED|Open-Label||100||
60131107|NCT01550744|76253596|FG001|NOT COMPLETED|Open-Label||0||
60131108|NCT01550744|76253597|FG002|NOT COMPLETED|Open-Label||0||
60131109|NCT01550744|76253595|FG000|STARTED|Double-Blind||0||
60131110|NCT01550744|76253596|FG001|STARTED|Double-Blind||76||
60131111|NCT01550744|76253597|FG002|STARTED|Double-Blind||302||
60131112|NCT01550744|76253595|FG000|COMPLETED|Double-Blind||0||
60131113|NCT01550744|76253596|FG001|COMPLETED|Double-Blind||59||
60131114|NCT01550744|76253597|FG002|COMPLETED|Double-Blind||235||
60131115|NCT01550744|76253595|FG000|NOT COMPLETED|Double-Blind||0||
60131116|NCT01550744|76253596|FG001|NOT COMPLETED|Double-Blind||17||
60131117|NCT01550744|76253597|FG002|NOT COMPLETED|Double-Blind||67||
60131118|NCT00577083|76253606|FG000|STARTED|First Intervention (14 Days)||48||
60131119|NCT00577083|76253607|FG001|STARTED|First Intervention (14 Days)||52||
60131120|NCT00577083|76253606|FG000|COMPLETED|First Intervention (14 Days)||48||
60131121|NCT00577083|76253607|FG001|COMPLETED|First Intervention (14 Days)||52||
60131122|NCT00577083|76253606|FG000|NOT COMPLETED|First Intervention (14 Days)||0||
60131123|NCT00577083|76253607|FG001|NOT COMPLETED|First Intervention (14 Days)||0||
60131124|NCT00577083|76253606|FG000|STARTED|Washout (14 Days)||48||
60131125|NCT00577083|76253607|FG001|STARTED|Washout (14 Days)||52||
60131126|NCT00577083|76253606|FG000|COMPLETED|Washout (14 Days)||48||
60131127|NCT00577083|76253607|FG001|COMPLETED|Washout (14 Days)||52||
60131128|NCT00577083|76253606|FG000|NOT COMPLETED|Washout (14 Days)||0||
60131129|NCT00577083|76253607|FG001|NOT COMPLETED|Washout (14 Days)||0||
60131130|NCT00577083|76253606|FG000|STARTED|Second Intervention (14days)||48||
60131131|NCT00577083|76253607|FG001|STARTED|Second Intervention (14days)||52||
60131132|NCT00577083|76253606|FG000|COMPLETED|Second Intervention (14days)||48||
60131133|NCT00577083|76253607|FG001|COMPLETED|Second Intervention (14days)||52||
60131134|NCT00577083|76253606|FG000|NOT COMPLETED|Second Intervention (14days)||0||
60131135|NCT00577083|76253607|FG001|NOT COMPLETED|Second Intervention (14days)||0||
60131136|NCT00606489|76253621|FG000|STARTED|Overall Study||21||
60131137|NCT00606489|76253622|FG001|STARTED|Overall Study||40||
60131138|NCT00606489|76253621|FG000|COMPLETED|Overall Study||21||
60131139|NCT00606489|76253622|FG001|COMPLETED|Overall Study||40||
60131140|NCT00606489|76253621|FG000|NOT COMPLETED|Overall Study||0||
60131141|NCT00606489|76253622|FG001|NOT COMPLETED|Overall Study||0||
60131142|NCT00578331|76253630|FG000|STARTED|Overall Study||445||
60131143|NCT00578331|76253631|FG001|STARTED|Overall Study||445||
60131144|NCT00578331|76253630|FG000|COMPLETED|Overall Study||329||
60131145|NCT00578331|76253631|FG001|COMPLETED|Overall Study||320||
60131146|NCT00578331|76253630|FG000|NOT COMPLETED|Overall Study||116||
60131147|NCT00578331|76253631|FG001|NOT COMPLETED|Overall Study||125||
60131148|NCT00607113|76253639|FG000|STARTED|Overall Study||19||
60131149|NCT00607113|76253640|FG001|STARTED|Overall Study||20||
60131150|NCT00607113|76253639|FG000|COMPLETED|Overall Study||19||
60131151|NCT00607113|76253640|FG001|COMPLETED|Overall Study||20||
60131152|NCT00607113|76253639|FG000|NOT COMPLETED|Overall Study||0||
60131153|NCT00607113|76253640|FG001|NOT COMPLETED|Overall Study||0||
60131154|NCT00607269|76253647|FG000|STARTED|Overall Study||67||
60131155|NCT00607269|76253648|FG001|STARTED|Overall Study||64||
60131156|NCT00607269|76253647|FG000|COMPLETED|Overall Study||67||
60131157|NCT00607269|76253648|FG001|COMPLETED|Overall Study||64||
60131158|NCT00607269|76253647|FG000|NOT COMPLETED|Overall Study||0||
60131159|NCT00607269|76253648|FG001|NOT COMPLETED|Overall Study||0||
60131160|NCT01549964|76253658|FG000|STARTED|24-Week Treatment Period||132||
60131161|NCT01549964|76253659|FG001|STARTED|24-Week Treatment Period||260||
60131162|NCT01549964|76253660|FG002|STARTED|24-Week Treatment Period||263||
60131163|NCT01549964|76253661|FG003|STARTED|24-Week Treatment Period||261||
60131164|NCT01549964|76253658|FG000|Safety Analysis Set=Received Treatment|24-Week Treatment Period||132||
60131165|NCT01549964|76253659|FG001|Safety Analysis Set=Received Treatment|24-Week Treatment Period||260||
60131166|NCT01549964|76253660|FG002|Safety Analysis Set=Received Treatment|24-Week Treatment Period||263||
60131167|NCT01549964|76253661|FG003|Safety Analysis Set=Received Treatment|24-Week Treatment Period||260||
60131168|NCT01549964|76253658|FG000|COMPLETED|24-Week Treatment Period||71||
60131169|NCT01549964|76253659|FG001|COMPLETED|24-Week Treatment Period||149||
60131170|NCT01549964|76253660|FG002|COMPLETED|24-Week Treatment Period||147||
60131171|NCT01549964|76253661|FG003|COMPLETED|24-Week Treatment Period||140||
60131172|NCT01549964|76253658|FG000|NOT COMPLETED|24-Week Treatment Period||61||
60131173|NCT01549964|76253659|FG001|NOT COMPLETED|24-Week Treatment Period||111||
60131174|NCT01549964|76253660|FG002|NOT COMPLETED|24-Week Treatment Period||116||
60131175|NCT01549964|76253661|FG003|NOT COMPLETED|24-Week Treatment Period||121||
60131176|NCT01549964|76253658|FG000|STARTED|80-Week Extension Period||66||
60131177|NCT01549964|76253659|FG001|STARTED|80-Week Extension Period||138||
60131178|NCT01549964|76253660|FG002|STARTED|80-Week Extension Period||140||
60131179|NCT01549964|76253661|FG003|STARTED|80-Week Extension Period||137||
60131180|NCT01549964|76253658|FG000|COMPLETED|80-Week Extension Period||0||
60131181|NCT01549964|76253659|FG001|COMPLETED|80-Week Extension Period||0||
60131182|NCT01549964|76253660|FG002|COMPLETED|80-Week Extension Period||0||
60131183|NCT01549964|76253661|FG003|COMPLETED|80-Week Extension Period||0||
60131184|NCT01549964|76253658|FG000|NOT COMPLETED|80-Week Extension Period||66||
60131185|NCT01549964|76253659|FG001|NOT COMPLETED|80-Week Extension Period||138||
60131186|NCT01549964|76253660|FG002|NOT COMPLETED|80-Week Extension Period||140||
60131187|NCT01549964|76253661|FG003|NOT COMPLETED|80-Week Extension Period||137||
60131188|NCT00607815|76253673|FG000|STARTED|Overall Study||43||
60131189|NCT00607815|76253674|FG001|STARTED|Overall Study||36||
60131190|NCT00607815|76253673|FG000|COMPLETED|Overall Study||20||
60131191|NCT00607815|76253674|FG001|COMPLETED|Overall Study||25||
60131192|NCT00607815|76253673|FG000|NOT COMPLETED|Overall Study||23||
60131193|NCT00607815|76253674|FG001|NOT COMPLETED|Overall Study||11||
60131194|NCT00579111|76253684|FG000|STARTED|Overall Study||3||
60131195|NCT00579111|76253685|FG001|STARTED|Overall Study||1||
60131196|NCT00579111|76253684|FG000|COMPLETED|Overall Study||1||
60131197|NCT00579111|76253685|FG001|COMPLETED|Overall Study||0||
60131198|NCT00579111|76253684|FG000|NOT COMPLETED|Overall Study||2||
60131199|NCT00579111|76253685|FG001|NOT COMPLETED|Overall Study||1||
60131200|NCT04363437|76253693|FG000|STARTED|Overall Study||10||
60131201|NCT04363437|76253694|FG001|STARTED|Overall Study||11||
60131202|NCT04363437|76253693|FG000|COMPLETED|Overall Study||10||
60131203|NCT04363437|76253694|FG001|COMPLETED|Overall Study||11||
60131204|NCT04363437|76253693|FG000|NOT COMPLETED|Overall Study||0||
60131205|NCT04363437|76253694|FG001|NOT COMPLETED|Overall Study||0||
59998372|NCT01671345|76114026|FG001|COMPLETED|Overall Study||83||
59998373|NCT01671345|76114025|FG000|NOT COMPLETED|Overall Study||13||
59998374|NCT01671345|76114026|FG001|NOT COMPLETED|Overall Study||9||
59998375|NCT00695253|76114035|FG000|STARTED|Overall Study|75 patients were screened and a total of 49 were enrolled in the study.|49||
59998376|NCT00695253|76114035|FG000|COMPLETED|Overall Study|Eighteen (18) completed the study up to the 5 year followup.|18||
59998377|NCT00695253|76114035|FG000|NOT COMPLETED|Overall Study||31||
59998378|NCT02487095|76114045|FG000|STARTED|Phase I Dose Escalation||6||
59998379|NCT02487095|76114046|FG001|STARTED|Phase I Dose Escalation||6||
59998380|NCT02487095|76114047|FG002|STARTED|Phase I Dose Escalation||3||
59998381|NCT02487095|76114048|FG003|STARTED|Phase I Dose Escalation||6||
59998382|NCT02487095|76114049|FG004|STARTED|Phase I Dose Escalation||0||
59998383|NCT02487095|76114045|FG000|COMPLETED|Phase I Dose Escalation||6||
59998384|NCT02487095|76114046|FG001|COMPLETED|Phase I Dose Escalation||6||
59998385|NCT02487095|76114047|FG002|COMPLETED|Phase I Dose Escalation||3||
59998386|NCT02487095|76114048|FG003|COMPLETED|Phase I Dose Escalation||6||
60131206|NCT02138097|76253718|FG000|STARTED|Overall Study||155345||
60131207|NCT02138097|76253719|FG001|STARTED|Overall Study||459722||
60131208|NCT02138097|76253718|FG000|COMPLETED|Overall Study||155345||
60131209|NCT02138097|76253719|FG001|COMPLETED|Overall Study||459722||
59599431|NCT00966992|75709094|FG000|COMPLETED|Overall Study||3||
59599432|NCT00966992|75709095|FG001|COMPLETED|Overall Study||0||
59599433|NCT00966992|75709094|FG000|NOT COMPLETED|Overall Study||0||
59599434|NCT00966992|75709095|FG001|NOT COMPLETED|Overall Study||0||
59599435|NCT02099318|75709103|FG000|STARTED|Overall Study||20||
59599436|NCT02099318|75709104|FG001|STARTED|Overall Study||20||
59599437|NCT02099318|75709103|FG000|COMPLETED|Overall Study||20||
59599438|NCT02099318|75709104|FG001|COMPLETED|Overall Study||20||
59599439|NCT02099318|75709103|FG000|NOT COMPLETED|Overall Study||0||
59599440|NCT02099318|75709104|FG001|NOT COMPLETED|Overall Study||0||
59998387|NCT02487095|76114049|FG004|COMPLETED|Phase I Dose Escalation||0||
59998388|NCT02487095|76114045|FG000|NOT COMPLETED|Phase I Dose Escalation||0||
59998389|NCT02487095|76114046|FG001|NOT COMPLETED|Phase I Dose Escalation||0||
59998390|NCT02487095|76114047|FG002|NOT COMPLETED|Phase I Dose Escalation||0||
59998391|NCT02487095|76114048|FG003|NOT COMPLETED|Phase I Dose Escalation||0||
59998392|NCT02487095|76114049|FG004|NOT COMPLETED|Phase I Dose Escalation||0||
59998393|NCT02487095|76114045|FG000|STARTED|Dose Expansion||0||
59998394|NCT02487095|76114046|FG001|STARTED|Dose Expansion||0||
59998395|NCT02487095|76114047|FG002|STARTED|Dose Expansion||0||
59599441|NCT04418947|75709117|FG000|STARTED|Overall Study||1108||
59599442|NCT04418947|75709118|FG001|STARTED|Overall Study||1351||
59599443|NCT04418947|75709119|FG002|STARTED|Overall Study||1351||
59599444|NCT04418947|75709120|FG003|STARTED|Overall Study||3655||
59599445|NCT04418947|75709121|FG004|STARTED|Overall Study||3655||
59599446|NCT04418947|75709117|FG000|COMPLETED|Overall Study||1108||
59599447|NCT04418947|75709118|FG001|COMPLETED|Overall Study||1351||
59599448|NCT04418947|75709119|FG002|COMPLETED|Overall Study||1351||
59599449|NCT04418947|75709120|FG003|COMPLETED|Overall Study||3655||
59599450|NCT04418947|75709121|FG004|COMPLETED|Overall Study||3655||
59599451|NCT04418947|75709117|FG000|NOT COMPLETED|Overall Study||0||
59599452|NCT04418947|75709118|FG001|NOT COMPLETED|Overall Study||0||
59599453|NCT04418947|75709119|FG002|NOT COMPLETED|Overall Study||0||
59599454|NCT04418947|75709120|FG003|NOT COMPLETED|Overall Study||0||
59599455|NCT04418947|75709121|FG004|NOT COMPLETED|Overall Study||0||
59599456|NCT00970736|75709133|FG000|STARTED|Overall Study||20||
59599457|NCT00970736|75709133|FG000|COMPLETED|Overall Study||18||
59599458|NCT00970736|75709133|FG000|NOT COMPLETED|Overall Study||2||
59599459|NCT02074904|75709139|FG000|STARTED|Overall Study||1||
59599460|NCT02074904|75709140|FG001|STARTED|Overall Study||0||
59599461|NCT02074904|75709139|FG000|COMPLETED|Overall Study||1||
59599462|NCT02074904|75709140|FG001|COMPLETED|Overall Study||0||
59599463|NCT02074904|75709139|FG000|NOT COMPLETED|Overall Study||0||
59599464|NCT02074904|75709140|FG001|NOT COMPLETED|Overall Study||0||
59599465|NCT03542305|75709150|FG000|STARTED|Overall Study||8||
59599466|NCT03542305|75709151|FG001|STARTED|Overall Study||8||
59599467|NCT03542305|75709152|FG002|STARTED|Overall Study||8||
59599468|NCT03542305|75709153|FG003|STARTED|Overall Study||5||
59599469|NCT03542305|75709150|FG000|COMPLETED|Overall Study||8||
59599470|NCT03542305|75709151|FG001|COMPLETED|Overall Study||8||
59599471|NCT03542305|75709152|FG002|COMPLETED|Overall Study||8||
59599472|NCT03542305|75709153|FG003|COMPLETED|Overall Study||5||
59599473|NCT03542305|75709150|FG000|NOT COMPLETED|Overall Study||0||
59599474|NCT03542305|75709151|FG001|NOT COMPLETED|Overall Study||0||
59599475|NCT03542305|75709152|FG002|NOT COMPLETED|Overall Study||0||
59599476|NCT03542305|75709153|FG003|NOT COMPLETED|Overall Study||0||
59599477|NCT02057276|75709165|FG000|STARTED|Overall Study||0||
59599478|NCT02057276|75709166|FG001|STARTED|Overall Study||0||
59599479|NCT02057276|75709165|FG000|COMPLETED|Overall Study||0||
59599480|NCT02057276|75709166|FG001|COMPLETED|Overall Study||0||
59599481|NCT02057276|75709165|FG000|NOT COMPLETED|Overall Study||0||
59599482|NCT02057276|75709166|FG001|NOT COMPLETED|Overall Study||0||
59599483|NCT04420273|75709174|FG000|STARTED|Overall Study||501||
59599484|NCT04420273|75709175|FG001|STARTED|Overall Study||499||
59599485|NCT04420273|75709174|FG000|COMPLETED|Overall Study||390||
59599486|NCT04420273|75709175|FG001|COMPLETED|Overall Study||414||
59599487|NCT04420273|75709174|FG000|NOT COMPLETED|Overall Study||111||
59599488|NCT04420273|75709175|FG001|NOT COMPLETED|Overall Study||85||
59599489|NCT00929474|75709183|FG000|STARTED|Overall Study||8||
59599490|NCT00929474|75709184|FG001|STARTED|Overall Study||9||
59599491|NCT00929474|75709183|FG000|COMPLETED|Overall Study||0||
59599492|NCT00929474|75709184|FG001|COMPLETED|Overall Study||0||
59599493|NCT00929474|75709183|FG000|NOT COMPLETED|Overall Study||8||
59599494|NCT00929474|75709184|FG001|NOT COMPLETED|Overall Study||9||
59599495|NCT02043860|75709190|FG000|STARTED|Overall Study||2||
59599496|NCT02043860|75709190|FG000|COMPLETED|Overall Study||2||
59599497|NCT02043860|75709190|FG000|NOT COMPLETED|Overall Study||0||
59599498|NCT03606187|75709196|FG000|STARTED|Overall Study||67||
59599499|NCT03606187|75709197|FG001|STARTED|Overall Study||61||
59599500|NCT03606187|75709196|FG000|COMPLETED|Overall Study||67||
59599501|NCT03606187|75709197|FG001|COMPLETED|Overall Study||61||
59599502|NCT03606187|75709196|FG000|NOT COMPLETED|Overall Study||0||
59599503|NCT03606187|75709197|FG001|NOT COMPLETED|Overall Study||0||
59599504|NCT01974284|75709203|FG000|STARTED|Overall Study||7||
59599505|NCT01974284|75709203|FG000|COMPLETED|Overall Study||0||
59599506|NCT01974284|75709203|FG000|NOT COMPLETED|Overall Study||7||
59599507|NCT03543085|75709207|FG000|STARTED|Overall Study||10||
59599508|NCT03543085|75709207|FG000|COMPLETED|Overall Study||10||
59599509|NCT03543085|75709207|FG000|NOT COMPLETED|Overall Study||0||
59599510|NCT03606343|75709211|FG000|STARTED|Overall Study||21||
59599511|NCT03606343|75709211|FG000|COMPLETED|Overall Study||21||
59599512|NCT03606343|75709211|FG000|NOT COMPLETED|Overall Study||0||
59599513|NCT00869414|75709215|FG000|STARTED|Overall Study||0||
59599514|NCT00869414|75709216|FG001|STARTED|Overall Study||0||
59599515|NCT00869414|75709217|FG002|STARTED|Overall Study||0||
59599516|NCT00869414|75709215|FG000|COMPLETED|Overall Study||0||
59599517|NCT00869414|75709216|FG001|COMPLETED|Overall Study||0||
59599518|NCT00869414|75709217|FG002|COMPLETED|Overall Study||0||
59599519|NCT00869414|75709215|FG000|NOT COMPLETED|Overall Study||0||
59599520|NCT00869414|75709216|FG001|NOT COMPLETED|Overall Study||0||
59599521|NCT00869414|75709217|FG002|NOT COMPLETED|Overall Study||0||
59599522|NCT04536571|75709225|FG000|STARTED|First Intervention||11||
59599523|NCT04536571|75709226|FG001|STARTED|First Intervention||16||
59599524|NCT04536571|75709225|FG000|COMPLETED|First Intervention||11||
59599525|NCT04536571|75709226|FG001|COMPLETED|First Intervention||16||
59599526|NCT04536571|75709225|FG000|NOT COMPLETED|First Intervention||0||
59599527|NCT04536571|75709226|FG001|NOT COMPLETED|First Intervention||0||
59599528|NCT04536571|75709225|FG000|STARTED|Second Intervention||11||
59599529|NCT04536571|75709226|FG001|STARTED|Second Intervention||16||
59599530|NCT04536571|75709225|FG000|COMPLETED|Second Intervention||11||
59599531|NCT04536571|75709226|FG001|COMPLETED|Second Intervention||16||
59599532|NCT04536571|75709225|FG000|NOT COMPLETED|Second Intervention||0||
59599533|NCT04536571|75709226|FG001|NOT COMPLETED|Second Intervention||0||
59599534|NCT00843986|75709238|FG000|STARTED|Overall Study||3||
59599535|NCT00843986|75709239|FG001|STARTED|Overall Study||6||
59599536|NCT00843986|75709238|FG000|Completed Treatment (Infusion)|Overall Study||2||
59599537|NCT00843986|75709239|FG001|Completed Treatment (Infusion)|Overall Study||6||
59599538|NCT00843986|75709238|FG000|COMPLETED|Overall Study||2||
59599539|NCT00843986|75709239|FG001|COMPLETED|Overall Study||5||
59599540|NCT00843986|75709238|FG000|NOT COMPLETED|Overall Study||1||
59599541|NCT00843986|75709239|FG001|NOT COMPLETED|Overall Study||1||
59599542|NCT01965782|75709245|FG000|STARTED|Overall Study||0||
59599543|NCT01965782|75709245|FG000|COMPLETED|Overall Study||0||
59599544|NCT01965782|75709245|FG000|NOT COMPLETED|Overall Study||0||
59599545|NCT03608839|75709252|FG000|STARTED|Overall Study||9||
59599546|NCT03608839|75709253|FG001|STARTED|Overall Study||9||
59599547|NCT03608839|75709254|FG002|STARTED|Overall Study||9||
59599548|NCT03608839|75709252|FG000|COMPLETED|Overall Study||9||
59599549|NCT03608839|75709253|FG001|COMPLETED|Overall Study||9||
59599550|NCT03608839|75709254|FG002|COMPLETED|Overall Study||9||
59599551|NCT03608839|75709252|FG000|NOT COMPLETED|Overall Study||0||
59599552|NCT03608839|75709253|FG001|NOT COMPLETED|Overall Study||0||
59599553|NCT03608839|75709254|FG002|NOT COMPLETED|Overall Study||0||
59599554|NCT03544879|75709264|FG000|STARTED|Overall Study||22||
59599555|NCT03544879|75709265|FG001|STARTED|Overall Study||24||
59599556|NCT03544879|75709264|FG000|Completed Follow-up Physical Assessment|Overall Study||20||
59599557|NCT03544879|75709265|FG001|Completed Follow-up Physical Assessment|Overall Study||21||
59599558|NCT03544879|75709264|FG000|COMPLETED|Overall Study||22|refers to completing follow-up self-report questionnaires|
59599559|NCT03544879|75709265|FG001|COMPLETED|Overall Study||23|refers to completing follow-up self-report questionnaires|
59599560|NCT03544879|75709264|FG000|NOT COMPLETED|Overall Study||0||
59599561|NCT03544879|75709265|FG001|NOT COMPLETED|Overall Study||1||
59599562|NCT00845702|75709273|FG000|STARTED|TOF MRA||33||
59599563|NCT00845702|75709273|FG000|COMPLETED|TOF MRA|One patient did not perform study MRA procedures.|32||
59599564|NCT00845702|75709273|FG000|NOT COMPLETED|TOF MRA||1||
59599565|NCT00845702|75709273|FG000|STARTED|Dotarem MRA||32||
59599566|NCT00845702|75709273|FG000|COMPLETED|Dotarem MRA||32||
59599567|NCT00845702|75709273|FG000|NOT COMPLETED|Dotarem MRA||0||
59599568|NCT03610399|75709282|FG000|STARTED|Overall Study||63|The number of total patients included in the study (254) is different from the study because, upon review of patient records, some patients had to be excluded because they had not met the inclusion criteria.|
59599569|NCT03610399|75709283|FG001|STARTED|Overall Study||96|The number of total patients included in the study (254) is different from the study because, upon review of patient records, some patients had to be excluded because they had not met the inclusion criteria.|
59599570|NCT03610399|75709284|FG002|STARTED|Overall Study||95|The number of total patients included in the study (254) is different from the study because, upon review of patient records, some patients had to be excluded because they had not met the inclusion criteria.|
59599571|NCT03610399|75709282|FG000|COMPLETED|Overall Study||53|Patient enrollment ended in October 2018, follow up ended in March 2019.|
59599572|NCT03610399|75709283|FG001|COMPLETED|Overall Study||78|Patient enrollment ended in October 2018, follow up ended in March 2019.|
59599573|NCT03610399|75709284|FG002|COMPLETED|Overall Study||79|Patient enrollment ended in October 2018, follow up ended in March 2019.|
59599574|NCT03610399|75709282|FG000|NOT COMPLETED|Overall Study||10||
59599575|NCT03610399|75709283|FG001|NOT COMPLETED|Overall Study||18||
59599576|NCT03610399|75709284|FG002|NOT COMPLETED|Overall Study||16||
59599577|NCT00843830|75709292|FG000|STARTED|Overall Study||4||
59599578|NCT00843830|75709292|FG000|COMPLETED|Overall Study||4||
59599579|NCT00843830|75709292|FG000|NOT COMPLETED|Overall Study||0||
59599580|NCT03610633|75709298|FG000|STARTED|Overall Study||5||
59599581|NCT03610633|75709299|FG001|STARTED|Overall Study||6||
59599582|NCT03610633|75709298|FG000|COMPLETED|Overall Study||5||
59599583|NCT03610633|75709299|FG001|COMPLETED|Overall Study||5||
59599584|NCT03610633|75709298|FG000|NOT COMPLETED|Overall Study||0||
59599585|NCT03610633|75709299|FG001|NOT COMPLETED|Overall Study||1||
59599586|NCT00832520|75709305|FG000|STARTED|Overall Study||13||
59599587|NCT00832520|75709305|FG000|COMPLETED|Overall Study||13||
59599588|NCT00832520|75709305|FG000|NOT COMPLETED|Overall Study||0||
59599589|NCT03545893|75709311|FG000|STARTED|Overall Study||35||
59599590|NCT03545893|75709312|FG001|STARTED|Overall Study||35||
59599591|NCT03545893|75709311|FG000|COMPLETED|Overall Study||35||
59599592|NCT03545893|75709312|FG001|COMPLETED|Overall Study||35||
59599593|NCT03545893|75709311|FG000|NOT COMPLETED|Overall Study||0||
59599594|NCT03545893|75709312|FG001|NOT COMPLETED|Overall Study||0||
59599595|NCT03551821|75709318|FG000|STARTED|Overall Study||1||
59599596|NCT03551821|75709318|FG000|COMPLETED|Overall Study||1||
59599597|NCT03551821|75709318|FG000|NOT COMPLETED|Overall Study||0||
59599598|NCT00843050|75709322|FG000|STARTED|Overall Study||13||
59599599|NCT00843050|75709322|FG000|COMPLETED|Overall Study||0||
59599600|NCT00843050|75709322|FG000|NOT COMPLETED|Overall Study||13||
59599601|NCT04658797|75709329|FG000|STARTED|Overall Study||15||
59599602|NCT04658797|75709330|FG001|STARTED|Overall Study||15||
59599603|NCT04658797|75709329|FG000|COMPLETED|Overall Study||15||
59599604|NCT04658797|75709330|FG001|COMPLETED|Overall Study||15||
59599605|NCT04658797|75709329|FG000|NOT COMPLETED|Overall Study||0||
59599606|NCT04658797|75709330|FG001|NOT COMPLETED|Overall Study||0||
59599607|NCT01954160|75709338|FG000|STARTED|Overall Study||5||
59599608|NCT01954160|75709339|FG001|STARTED|Overall Study|Not started|0||
59599609|NCT01954160|75709338|FG000|COMPLETED|Overall Study|Only 4 subjects completed the first early denervation. No subjects completed the late denervation.|0||
59599610|NCT01954160|75709339|FG001|COMPLETED|Overall Study||0||
59599611|NCT01954160|75709338|FG000|NOT COMPLETED|Overall Study||5||
59599612|NCT01954160|75709339|FG001|NOT COMPLETED|Overall Study||0||
59599613|NCT03552289|75709349|FG000|STARTED|Overall Study||102||120
59599614|NCT03552289|75709350|FG001|STARTED|Overall Study||109||130
59599615|NCT03552289|75709349|FG000|COMPLETED|Overall Study||101||119
59599616|NCT03552289|75709350|FG001|COMPLETED|Overall Study||106||125
59599617|NCT03552289|75709349|FG000|NOT COMPLETED|Overall Study||1||1
59599618|NCT03552289|75709350|FG001|NOT COMPLETED|Overall Study||3||5
59599619|NCT03615001|75709356|FG000|STARTED|Overall Study||20||
59599620|NCT03615001|75709356|FG000|COMPLETED|Overall Study||20||
59599621|NCT03615001|75709356|FG000|NOT COMPLETED|Overall Study||0||
59599622|NCT01877564|75709362|FG000|STARTED|Overall Study||6||
59599623|NCT01877564|75709363|FG001|STARTED|Overall Study||4||
59599624|NCT01877564|75709362|FG000|COMPLETED|Overall Study||6||
59599625|NCT01877564|75709363|FG001|COMPLETED|Overall Study||4||
59599626|NCT01877564|75709362|FG000|NOT COMPLETED|Overall Study||0||
59599627|NCT01877564|75709363|FG001|NOT COMPLETED|Overall Study||0||
59599628|NCT03615079|75709369|FG000|STARTED|Overall Study||28||
59599629|NCT03615079|75709369|FG000|COMPLETED|Overall Study||11||
59599630|NCT03615079|75709369|FG000|NOT COMPLETED|Overall Study||17||
59599631|NCT03556579|75709373|FG000|STARTED|Visit 1||16||
59599632|NCT03556579|75709374|FG001|STARTED|Visit 1||14||
59599633|NCT03556579|75709375|FG002|STARTED|Visit 1||14||
59599634|NCT03556579|75709376|FG003|STARTED|Visit 1||16||
59599635|NCT03556579|75709373|FG000|COMPLETED|Visit 1||16||
59599636|NCT03556579|75709374|FG001|COMPLETED|Visit 1||14||
59599637|NCT03556579|75709375|FG002|COMPLETED|Visit 1||14||
59599638|NCT03556579|75709376|FG003|COMPLETED|Visit 1||16||
59599639|NCT03556579|75709373|FG000|NOT COMPLETED|Visit 1||0||
59599640|NCT03556579|75709374|FG001|NOT COMPLETED|Visit 1||0||
59599641|NCT03556579|75709375|FG002|NOT COMPLETED|Visit 1||0||
59599642|NCT03556579|75709376|FG003|NOT COMPLETED|Visit 1||0||
59599643|NCT03556579|75709373|FG000|STARTED|Visit 2||16||
59599644|NCT03556579|75709374|FG001|STARTED|Visit 2||14||
59599645|NCT03556579|75709375|FG002|STARTED|Visit 2||14||
59599646|NCT03556579|75709376|FG003|STARTED|Visit 2||16||
59599647|NCT03556579|75709373|FG000|COMPLETED|Visit 2||16||
59599648|NCT03556579|75709374|FG001|COMPLETED|Visit 2||14||
59599649|NCT03556579|75709375|FG002|COMPLETED|Visit 2||14||
59599650|NCT03556579|75709376|FG003|COMPLETED|Visit 2||16||
59599651|NCT03556579|75709373|FG000|NOT COMPLETED|Visit 2||0||
59599652|NCT03556579|75709374|FG001|NOT COMPLETED|Visit 2||0||
59599653|NCT03556579|75709375|FG002|NOT COMPLETED|Visit 2||0||
59599654|NCT03556579|75709376|FG003|NOT COMPLETED|Visit 2||0||
59599655|NCT00835328|75709390|FG000|STARTED|Cohort 1: Dose Level 1||5||
59599656|NCT00835328|75709391|FG001|STARTED|Cohort 1: Dose Level 1||0||
59599657|NCT00835328|75709392|FG002|STARTED|Cohort 1: Dose Level 1||0||
59599658|NCT00835328|75709393|FG003|STARTED|Cohort 1: Dose Level 1||0||
59599659|NCT00835328|75709390|FG000|COMPLETED|Cohort 1: Dose Level 1||5||
59599660|NCT00835328|75709391|FG001|COMPLETED|Cohort 1: Dose Level 1||0||
59599661|NCT00835328|75709392|FG002|COMPLETED|Cohort 1: Dose Level 1||0||
59599662|NCT00835328|75709393|FG003|COMPLETED|Cohort 1: Dose Level 1||0||
59599663|NCT00835328|75709390|FG000|NOT COMPLETED|Cohort 1: Dose Level 1||0||
59599664|NCT00835328|75709391|FG001|NOT COMPLETED|Cohort 1: Dose Level 1||0||
59599665|NCT00835328|75709392|FG002|NOT COMPLETED|Cohort 1: Dose Level 1||0||
59599666|NCT00835328|75709393|FG003|NOT COMPLETED|Cohort 1: Dose Level 1||0||
59599667|NCT00835328|75709390|FG000|STARTED|Cohort 2: Dose Level 2||0||
59599668|NCT00835328|75709391|FG001|STARTED|Cohort 2: Dose Level 2||2||
59599669|NCT00835328|75709392|FG002|STARTED|Cohort 2: Dose Level 2||0||
59599670|NCT00835328|75709393|FG003|STARTED|Cohort 2: Dose Level 2||0||
59599671|NCT00835328|75709390|FG000|COMPLETED|Cohort 2: Dose Level 2||0||
59599672|NCT00835328|75709391|FG001|COMPLETED|Cohort 2: Dose Level 2||2||
59599673|NCT00835328|75709392|FG002|COMPLETED|Cohort 2: Dose Level 2||0||
59599674|NCT00835328|75709393|FG003|COMPLETED|Cohort 2: Dose Level 2||0||
59599675|NCT00835328|75709390|FG000|NOT COMPLETED|Cohort 2: Dose Level 2||0||
59599676|NCT00835328|75709391|FG001|NOT COMPLETED|Cohort 2: Dose Level 2||0||
59599677|NCT00835328|75709392|FG002|NOT COMPLETED|Cohort 2: Dose Level 2||0||
59599678|NCT00835328|75709393|FG003|NOT COMPLETED|Cohort 2: Dose Level 2||0||
59599679|NCT00835328|75709390|FG000|STARTED|Cohort 3: Dose Level 3||0||
59599680|NCT00835328|75709391|FG001|STARTED|Cohort 3: Dose Level 3||0||
59599681|NCT00835328|75709392|FG002|STARTED|Cohort 3: Dose Level 3||2||
59599682|NCT00835328|75709393|FG003|STARTED|Cohort 3: Dose Level 3||0||
59599683|NCT00835328|75709390|FG000|COMPLETED|Cohort 3: Dose Level 3||0||
59599684|NCT00835328|75709391|FG001|COMPLETED|Cohort 3: Dose Level 3||0||
59599685|NCT00835328|75709392|FG002|COMPLETED|Cohort 3: Dose Level 3||2||
59599686|NCT00835328|75709393|FG003|COMPLETED|Cohort 3: Dose Level 3||0||
59599687|NCT00835328|75709390|FG000|NOT COMPLETED|Cohort 3: Dose Level 3||0||
59599688|NCT00835328|75709391|FG001|NOT COMPLETED|Cohort 3: Dose Level 3||0||
59599689|NCT00835328|75709392|FG002|NOT COMPLETED|Cohort 3: Dose Level 3||0||
59599690|NCT00835328|75709393|FG003|NOT COMPLETED|Cohort 3: Dose Level 3||0||
59599691|NCT00835328|75709390|FG000|STARTED|Cohort 4: Dose Level 4|Cohort#4 enrolled 4 subsequent subjects|0||
59599692|NCT00835328|75709391|FG001|STARTED|Cohort 4: Dose Level 4||0||
59599693|NCT00835328|75709392|FG002|STARTED|Cohort 4: Dose Level 4||0||
59599694|NCT00835328|75709393|FG003|STARTED|Cohort 4: Dose Level 4||4||
59599695|NCT00835328|75709390|FG000|COMPLETED|Cohort 4: Dose Level 4||0||
59599696|NCT00835328|75709391|FG001|COMPLETED|Cohort 4: Dose Level 4||0||
59599697|NCT00835328|75709392|FG002|COMPLETED|Cohort 4: Dose Level 4||0||
59599698|NCT00835328|75709393|FG003|COMPLETED|Cohort 4: Dose Level 4||4||
59599699|NCT00835328|75709390|FG000|NOT COMPLETED|Cohort 4: Dose Level 4||0||
59599700|NCT00835328|75709391|FG001|NOT COMPLETED|Cohort 4: Dose Level 4||0||
59599701|NCT00835328|75709392|FG002|NOT COMPLETED|Cohort 4: Dose Level 4||0||
59599702|NCT00835328|75709393|FG003|NOT COMPLETED|Cohort 4: Dose Level 4||0||
59599703|NCT00832598|75709405|FG000|STARTED|Overall Study||13||
59599704|NCT00832598|75709405|FG000|COMPLETED|Overall Study||13||
59599705|NCT00832598|75709405|FG000|NOT COMPLETED|Overall Study||0||
59599706|NCT04499599|75709412|FG000|STARTED|Overall Study||35||
59599707|NCT04499599|75709413|FG001|STARTED|Overall Study||35||
59599708|NCT04499599|75709414|FG002|STARTED|Overall Study||35||
59599709|NCT04499599|75709412|FG000|COMPLETED|Overall Study||35||
59728552|NCT00979134|75847185|FG001|COMPLETED|Overall Study|At DCO|0||
59599710|NCT04499599|75709413|FG001|COMPLETED|Overall Study||35||
59599711|NCT04499599|75709414|FG002|COMPLETED|Overall Study||35||
59599712|NCT04499599|75709412|FG000|NOT COMPLETED|Overall Study||0||
59599713|NCT04499599|75709413|FG001|NOT COMPLETED|Overall Study||0||
59599714|NCT04499599|75709414|FG002|NOT COMPLETED|Overall Study||0||
59599715|NCT04512703|75709424|FG000|STARTED|Within 7 Days From Start of Device Wear||6||
59599716|NCT04512703|75709425|FG001|STARTED|Within 7 Days From Start of Device Wear||45||
59599717|NCT04512703|75709424|FG000|Wore Front Position|Within 7 Days From Start of Device Wear||6||
59599718|NCT04512703|75709425|FG001|Wore Front Position|Within 7 Days From Start of Device Wear||45||
59599719|NCT04512703|75709424|FG000|Wore Side Position|Within 7 Days From Start of Device Wear||6||
59599720|NCT04512703|75709425|FG001|Wore Side Position|Within 7 Days From Start of Device Wear||45||
59599721|NCT04512703|75709424|FG000|COMPLETED|Within 7 Days From Start of Device Wear||6||
59599722|NCT04512703|75709425|FG001|COMPLETED|Within 7 Days From Start of Device Wear||45||
59599723|NCT04512703|75709424|FG000|NOT COMPLETED|Within 7 Days From Start of Device Wear||0||
59599724|NCT04512703|75709425|FG001|NOT COMPLETED|Within 7 Days From Start of Device Wear||0||
59599725|NCT04512703|75709424|FG000|STARTED|Between 7th and 90th Day of Device Wear||6||
59599726|NCT04512703|75709425|FG001|STARTED|Between 7th and 90th Day of Device Wear||45||
59599727|NCT04512703|75709424|FG000|Wore Side Position Device|Between 7th and 90th Day of Device Wear||3||
59599728|NCT04512703|75709425|FG001|Wore Side Position Device|Between 7th and 90th Day of Device Wear||23||
59599729|NCT04512703|75709424|FG000|Wore Front Position Device|Between 7th and 90th Day of Device Wear||3||
59599730|NCT04512703|75709425|FG001|Wore Front Position Device|Between 7th and 90th Day of Device Wear||22||
59599731|NCT04512703|75709424|FG000|COMPLETED|Between 7th and 90th Day of Device Wear||6||
59599732|NCT04512703|75709425|FG001|COMPLETED|Between 7th and 90th Day of Device Wear||45||
59599733|NCT04512703|75709424|FG000|NOT COMPLETED|Between 7th and 90th Day of Device Wear||0||
59599734|NCT04512703|75709425|FG001|NOT COMPLETED|Between 7th and 90th Day of Device Wear||0||
59599735|NCT01889420|75709434|FG000|STARTED|Overall Study||1||
59599736|NCT01889420|75709434|FG000|COMPLETED|Overall Study||1||
59599737|NCT01889420|75709434|FG000|NOT COMPLETED|Overall Study||0||
59599738|NCT03557125|75709440|FG000|STARTED|Overall Study||22||
59599739|NCT03557125|75709441|FG001|STARTED|Overall Study||24||
59599740|NCT03557125|75709440|FG000|COMPLETED|Overall Study||22||
59599741|NCT03557125|75709441|FG001|COMPLETED|Overall Study||24||
59599742|NCT03557125|75709440|FG000|NOT COMPLETED|Overall Study||0||
59599743|NCT03557125|75709441|FG001|NOT COMPLETED|Overall Study||0||
59599744|NCT03616171|75709449|FG000|STARTED|Overall Study||4||
59599745|NCT03616171|75709450|FG001|STARTED|Overall Study||2||
59599746|NCT03616171|75709449|FG000|COMPLETED|Overall Study||4||
59599747|NCT03616171|75709450|FG001|COMPLETED|Overall Study||2||
59599748|NCT03616171|75709449|FG000|NOT COMPLETED|Overall Study||0||
59599749|NCT03616171|75709450|FG001|NOT COMPLETED|Overall Study||0||
59599750|NCT03558061|75709457|FG000|STARTED|Overall Study||30||
59599751|NCT03558061|75709457|FG000|COMPLETED|Overall Study||29||
59599752|NCT03558061|75709457|FG000|NOT COMPLETED|Overall Study||1||
59599753|NCT01881932|75709464|FG000|STARTED|Overall Study||2||
59599754|NCT01881932|75709465|FG001|STARTED|Overall Study||4||
59599755|NCT01881932|75709466|FG002|STARTED|Overall Study||13||
59599756|NCT01881932|75709464|FG000|COMPLETED|Overall Study||2||
59599757|NCT01881932|75709465|FG001|COMPLETED|Overall Study||4||
59599758|NCT01881932|75709466|FG002|COMPLETED|Overall Study||13||
59599759|NCT01881932|75709464|FG000|NOT COMPLETED|Overall Study||0||
59599760|NCT01881932|75709465|FG001|NOT COMPLETED|Overall Study||0||
59599761|NCT01881932|75709466|FG002|NOT COMPLETED|Overall Study||0||
59599762|NCT03617419|75709474|FG000|STARTED|Part 1||2||
59599763|NCT03617419|75709474|FG000|COMPLETED|Part 1||2||
59599764|NCT03617419|75709474|FG000|NOT COMPLETED|Part 1||0||
59599765|NCT03617419|75709474|FG000|STARTED|Part 2||14||
59599766|NCT03617419|75709474|FG000|COMPLETED|Part 2||14||
59599767|NCT03617419|75709474|FG000|NOT COMPLETED|Part 2||0||
59599768|NCT03619135|75709480|FG000|STARTED|Overall Study||50||
59599769|NCT03619135|75709481|FG001|STARTED|Overall Study||50||
59599770|NCT03619135|75709480|FG000|COMPLETED|Overall Study||50||
59599771|NCT03619135|75709481|FG001|COMPLETED|Overall Study||50||
59599772|NCT03619135|75709480|FG000|NOT COMPLETED|Overall Study||0||
59599773|NCT03619135|75709481|FG001|NOT COMPLETED|Overall Study||0||
59599774|NCT03559933|75709487|FG000|STARTED|Overall Study||12|Date of first treatment for first treated patient (P01).|
59599775|NCT03559933|75709487|FG000|COMPLETED|Overall Study||12|Date of follow-up visit for last treated patient (P12).|
59599776|NCT03559933|75709487|FG000|NOT COMPLETED|Overall Study||0||
59599777|NCT03620383|75709494|FG000|STARTED|Overall Study||30||
59599778|NCT03620383|75709495|FG001|STARTED|Overall Study||15||
59599779|NCT03620383|75709494|FG000|COMPLETED|Overall Study||30||
59599780|NCT03620383|75709495|FG001|COMPLETED|Overall Study||15||
59599781|NCT03620383|75709494|FG000|NOT COMPLETED|Overall Study||0||
59599782|NCT03620383|75709495|FG001|NOT COMPLETED|Overall Study||0||
59599783|NCT00793520|75709503|FG000|STARTED|Milnacipran Crossover to Placebo||1||
59599784|NCT00793520|75709504|FG001|STARTED|Milnacipran Crossover to Placebo||0||
59599785|NCT00793520|75709503|FG000|COMPLETED|Milnacipran Crossover to Placebo||0||
59599786|NCT00793520|75709504|FG001|COMPLETED|Milnacipran Crossover to Placebo||0||
59599787|NCT00793520|75709503|FG000|NOT COMPLETED|Milnacipran Crossover to Placebo||1||
59599788|NCT00793520|75709504|FG001|NOT COMPLETED|Milnacipran Crossover to Placebo||0||
59599789|NCT00793520|75709503|FG000|STARTED|Placebo Crossover to Milnacipran||0||
59599790|NCT00793520|75709504|FG001|STARTED|Placebo Crossover to Milnacipran||1||
59599791|NCT00793520|75709503|FG000|COMPLETED|Placebo Crossover to Milnacipran||0||
59599792|NCT00793520|75709504|FG001|COMPLETED|Placebo Crossover to Milnacipran||0||
59599793|NCT00793520|75709503|FG000|NOT COMPLETED|Placebo Crossover to Milnacipran||0||
59599794|NCT00793520|75709504|FG001|NOT COMPLETED|Placebo Crossover to Milnacipran||1||
59599795|NCT03621085|75709510|FG000|STARTED|Enrollment||22||
59599796|NCT03621085|75709511|FG001|STARTED|Enrollment||21||
59599797|NCT03621085|75709510|FG000|COMPLETED|Enrollment||16||
59599798|NCT03621085|75709511|FG001|COMPLETED|Enrollment||14||
59599799|NCT03621085|75709510|FG000|NOT COMPLETED|Enrollment||6||
59599800|NCT03621085|75709511|FG001|NOT COMPLETED|Enrollment||7||
59599801|NCT03621085|75709510|FG000|STARTED|First Visit||16||
59599802|NCT03621085|75709511|FG001|STARTED|First Visit||14||
59599803|NCT03621085|75709510|FG000|COMPLETED|First Visit||16||
59599804|NCT03621085|75709511|FG001|COMPLETED|First Visit||14||
59599805|NCT03621085|75709510|FG000|NOT COMPLETED|First Visit||0||
59599806|NCT03621085|75709511|FG001|NOT COMPLETED|First Visit||0||
59599807|NCT03621085|75709510|FG000|STARTED|Washout (at Least 48 Hours)||16||
59599808|NCT03621085|75709511|FG001|STARTED|Washout (at Least 48 Hours)||14||
59599809|NCT03621085|75709510|FG000|COMPLETED|Washout (at Least 48 Hours)||16||
59599810|NCT03621085|75709511|FG001|COMPLETED|Washout (at Least 48 Hours)||14||
59599811|NCT03621085|75709510|FG000|NOT COMPLETED|Washout (at Least 48 Hours)||0||
59599812|NCT03621085|75709511|FG001|NOT COMPLETED|Washout (at Least 48 Hours)||0||
59599813|NCT03621085|75709510|FG000|STARTED|Second Visit||16||
59599814|NCT03621085|75709511|FG001|STARTED|Second Visit||14||
59599815|NCT03621085|75709510|FG000|COMPLETED|Second Visit||16||
59599816|NCT03621085|75709511|FG001|COMPLETED|Second Visit||14||
59599817|NCT03621085|75709510|FG000|NOT COMPLETED|Second Visit||0||
59599818|NCT03621085|75709511|FG001|NOT COMPLETED|Second Visit||0||
59599819|NCT00795236|75709519|FG000|STARTED|Overall Study||0||
59599820|NCT00795236|75709520|FG001|STARTED|Overall Study||0||
59599821|NCT00795236|75709519|FG000|COMPLETED|Overall Study|Unable to consistently obtain saliva DLMO in subjects and thus couldn't measure circadian period|0||
59599822|NCT00795236|75709520|FG001|COMPLETED|Overall Study||0||
59599823|NCT00795236|75709519|FG000|NOT COMPLETED|Overall Study||0||
59599824|NCT00795236|75709520|FG001|NOT COMPLETED|Overall Study||0||
59599825|NCT04490863|75709528|FG000|STARTED|Overall Study||26||
59599826|NCT04490863|75709528|FG000|COMPLETED|Overall Study||26||
59599827|NCT04490863|75709528|FG000|NOT COMPLETED|Overall Study||0||
59599828|NCT00790478|75709534|FG000|STARTED|Overall Study||0||
59599829|NCT00790478|75709535|FG001|STARTED|Overall Study||0||
59599830|NCT00790478|75709534|FG000|COMPLETED|Overall Study||0||
59599831|NCT00790478|75709535|FG001|COMPLETED|Overall Study||0||
59599832|NCT00790478|75709534|FG000|NOT COMPLETED|Overall Study||0||
59599833|NCT00790478|75709535|FG001|NOT COMPLETED|Overall Study||0||
59599834|NCT04490239|75709541|FG000|STARTED|1000 U Acute (One Dose, Day 1)||6||
59599835|NCT04490239|75709541|FG000|COMPLETED|1000 U Acute (One Dose, Day 1)||6||
59599836|NCT04490239|75709541|FG000|NOT COMPLETED|1000 U Acute (One Dose, Day 1)||0||
59599837|NCT04490239|75709541|FG000|STARTED|2000 U Acute (One Dose, Day 3)||6||
59599838|NCT04490239|75709541|FG000|COMPLETED|2000 U Acute (One Dose, Day 3)||6||
59599839|NCT04490239|75709541|FG000|NOT COMPLETED|2000 U Acute (One Dose, Day 3)||0||
59599840|NCT04490239|75709541|FG000|STARTED|2000 U Chronic (Daily, 14 Days)||6||
59599841|NCT04490239|75709541|FG000|COMPLETED|2000 U Chronic (Daily, 14 Days)||6||
59599842|NCT04490239|75709541|FG000|NOT COMPLETED|2000 U Chronic (Daily, 14 Days)||0||
59599843|NCT00791336|75709545|FG000|STARTED|Overall Study||1||
59599844|NCT00791336|75709545|FG000|COMPLETED|Overall Study||1||
59599845|NCT00791336|75709545|FG000|NOT COMPLETED|Overall Study||0||
59599846|NCT03621787|75709549|FG000|STARTED|Overall Study||9||
59599847|NCT03621787|75709549|FG000|COMPLETED|Overall Study||9||
59599848|NCT03621787|75709549|FG000|NOT COMPLETED|Overall Study||0||
59599849|NCT00787124|75709555|FG000|STARTED|Overall Study||4||
59599850|NCT00787124|75709556|FG001|STARTED|Overall Study||4||
59599851|NCT00787124|75709555|FG000|COMPLETED|Overall Study||4||
59599852|NCT00787124|75709556|FG001|COMPLETED|Overall Study||4||
59599853|NCT00787124|75709555|FG000|NOT COMPLETED|Overall Study||0||
59599854|NCT00787124|75709556|FG001|NOT COMPLETED|Overall Study||0||
59599855|NCT03562663|75709564|FG000|STARTED|Overall Study||41||
59599856|NCT03562663|75709565|FG001|STARTED|Overall Study||41||
59599857|NCT03562663|75709564|FG000|COMPLETED|Overall Study||34||
59599858|NCT03562663|75709565|FG001|COMPLETED|Overall Study||35||
59599859|NCT03562663|75709564|FG000|NOT COMPLETED|Overall Study||7||
59599860|NCT03562663|75709565|FG001|NOT COMPLETED|Overall Study||6||
59599861|NCT00771602|75709574|FG000|STARTED|Overall Study||1||
59599862|NCT00771602|75709575|FG001|STARTED|Overall Study||0||
59599863|NCT00771602|75709576|FG002|STARTED|Overall Study||0||
59599864|NCT00771602|75709574|FG000|COMPLETED|Overall Study||1||
59599865|NCT00771602|75709575|FG001|COMPLETED|Overall Study||0||
59599866|NCT00771602|75709576|FG002|COMPLETED|Overall Study||0||
59599867|NCT00771602|75709574|FG000|NOT COMPLETED|Overall Study||0||
59599868|NCT00771602|75709575|FG001|NOT COMPLETED|Overall Study||0||
59599869|NCT00771602|75709576|FG002|NOT COMPLETED|Overall Study||0||
59599870|NCT03623035|75709584|FG000|STARTED|Overall Study||10||
59599871|NCT03623035|75709584|FG000|COMPLETED|Overall Study||10||
59599872|NCT03623035|75709584|FG000|NOT COMPLETED|Overall Study||0||
59599873|NCT03563209|75709588|FG000|STARTED|Overall Study||60||
59599874|NCT03563209|75709588|FG000|COMPLETED|Overall Study||60||
59599875|NCT03563209|75709588|FG000|NOT COMPLETED|Overall Study||0||
59599876|NCT03626623|75709596|FG000|STARTED|Overall Study||5||
59599877|NCT03626623|75709597|FG001|STARTED|Overall Study||10||
59599878|NCT03626623|75709596|FG000|COMPLETED|Overall Study||0||
59599879|NCT03626623|75709597|FG001|COMPLETED|Overall Study||0||
59599880|NCT03626623|75709596|FG000|NOT COMPLETED|Overall Study||5||
59599881|NCT03626623|75709597|FG001|NOT COMPLETED|Overall Study||10||
59599882|NCT01804166|75709603|FG000|STARTED|Overall Study||1||
59599883|NCT01804166|75709603|FG000|COMPLETED|Overall Study||1||
59599884|NCT01804166|75709603|FG000|NOT COMPLETED|Overall Study||0||
59599885|NCT04459585|75709607|FG000|STARTED|Period 1 (Day 1 to Day 5)||20||
59599886|NCT04459585|75709607|FG000|COMPLETED|Period 1 (Day 1 to Day 5)||20||
59599887|NCT04459585|75709607|FG000|NOT COMPLETED|Period 1 (Day 1 to Day 5)||0||
59599888|NCT04459585|75709607|FG000|STARTED|Period 2 (Day 5 to Day 12)||20||
59599889|NCT04459585|75709607|FG000|COMPLETED|Period 2 (Day 5 to Day 12)||20||
59599890|NCT04459585|75709607|FG000|NOT COMPLETED|Period 2 (Day 5 to Day 12)||0||
59599891|NCT00746018|75709614|FG000|STARTED|Overall Study||39||
59599892|NCT00746018|75709614|FG000|COMPLETED|Overall Study||39||
59599893|NCT00746018|75709614|FG000|NOT COMPLETED|Overall Study||0||
59599894|NCT01797380|75709620|FG000|STARTED|Overall Study|Terminated due to lack of enrollment|3||
59599895|NCT01797380|75709621|FG001|STARTED|Overall Study||2||
59599896|NCT01797380|75709620|FG000|COMPLETED|Overall Study|Terminated due to lack of enrollment|0||
59599897|NCT01797380|75709621|FG001|COMPLETED|Overall Study||0||
59599898|NCT01797380|75709620|FG000|NOT COMPLETED|Overall Study||3||
59599899|NCT01797380|75709621|FG001|NOT COMPLETED|Overall Study||2||
59599900|NCT03571555|75709629|FG000|STARTED|Overall Study||252||
59599901|NCT03571555|75709630|FG001|STARTED|Overall Study||263||
59599902|NCT03571555|75709629|FG000|COMPLETED|Overall Study||177||
59599903|NCT03571555|75709630|FG001|COMPLETED|Overall Study||195||
59599904|NCT03571555|75709629|FG000|NOT COMPLETED|Overall Study||75||
59599905|NCT03571555|75709630|FG001|NOT COMPLETED|Overall Study||68||
59599906|NCT00737594|75709639|FG000|STARTED|Overall Study||0||
59599907|NCT00737594|75709640|FG001|STARTED|Overall Study||0||
59599908|NCT00737594|75709641|FG002|STARTED|Overall Study||0||
59599909|NCT00737594|75709639|FG000|COMPLETED|Overall Study||0||
59599910|NCT00737594|75709640|FG001|COMPLETED|Overall Study||0||
59599911|NCT00737594|75709641|FG002|COMPLETED|Overall Study||0||
59599912|NCT00737594|75709639|FG000|NOT COMPLETED|Overall Study||0||
59599913|NCT00737594|75709640|FG001|NOT COMPLETED|Overall Study||0||
59599914|NCT00737594|75709641|FG002|NOT COMPLETED|Overall Study||0||
59599915|NCT00732680|75709649|FG000|STARTED|Overall Study||9||
59599916|NCT00732680|75709649|FG000|COMPLETED|Overall Study||9||
59599917|NCT00732680|75709649|FG000|NOT COMPLETED|Overall Study||0||
59599918|NCT04441255|75709655|FG000|STARTED|Period 1 (1 Day)||7||
59599919|NCT04441255|75709656|FG001|STARTED|Period 1 (1 Day)||7||
59599920|NCT04441255|75709655|FG000|COMPLETED|Period 1 (1 Day)||7||
59599921|NCT04441255|75709656|FG001|COMPLETED|Period 1 (1 Day)||7||
59599922|NCT04441255|75709655|FG000|NOT COMPLETED|Period 1 (1 Day)||0||
59599923|NCT04441255|75709656|FG001|NOT COMPLETED|Period 1 (1 Day)||0||
59599924|NCT04441255|75709655|FG000|STARTED|Washout Period (10 Days)||7||
59599925|NCT04441255|75709656|FG001|STARTED|Washout Period (10 Days)||7||
59599926|NCT04441255|75709655|FG000|COMPLETED|Washout Period (10 Days)||7||
59599927|NCT04441255|75709656|FG001|COMPLETED|Washout Period (10 Days)||7||
59599928|NCT04441255|75709655|FG000|NOT COMPLETED|Washout Period (10 Days)||0||
59599929|NCT04441255|75709656|FG001|NOT COMPLETED|Washout Period (10 Days)||0||
59599930|NCT04441255|75709655|FG000|STARTED|Period 2 (1 Day)||7||
59599931|NCT04441255|75709656|FG001|STARTED|Period 2 (1 Day)||7||
59599932|NCT04441255|75709655|FG000|COMPLETED|Period 2 (1 Day)||7||
59599933|NCT04441255|75709656|FG001|COMPLETED|Period 2 (1 Day)||7||
59599934|NCT04441255|75709655|FG000|NOT COMPLETED|Period 2 (1 Day)||0||
59599935|NCT04441255|75709656|FG001|NOT COMPLETED|Period 2 (1 Day)||0||
59599936|NCT00726830|75709664|FG000|STARTED|Overall Study||1||
59599937|NCT00726830|75709665|FG001|STARTED|Overall Study||0||
59599938|NCT00726830|75709664|FG000|COMPLETED|Overall Study||1||
59599939|NCT00726830|75709665|FG001|COMPLETED|Overall Study||0||
59599940|NCT00726830|75709664|FG000|NOT COMPLETED|Overall Study||0||
59599941|NCT00726830|75709665|FG001|NOT COMPLETED|Overall Study||0||
59599942|NCT03628885|75709674|FG000|STARTED|Overall Study||306||
59599943|NCT03628885|75709675|FG001|STARTED|Overall Study||299||
59599944|NCT03628885|75709676|FG002|STARTED|Overall Study||303||
59599945|NCT03628885|75709674|FG000|COMPLETED|Overall Study||267||
59599946|NCT03628885|75709675|FG001|COMPLETED|Overall Study||252||
59599947|NCT03628885|75709676|FG002|COMPLETED|Overall Study||243||
59599948|NCT03628885|75709674|FG000|NOT COMPLETED|Overall Study||39||
59599949|NCT03628885|75709675|FG001|NOT COMPLETED|Overall Study||47||
59998396|NCT02487095|76114048|FG003|STARTED|Dose Expansion||0||
59599950|NCT03628885|75709676|FG002|NOT COMPLETED|Overall Study||60||
59728553|NCT00979134|75847186|FG002|COMPLETED|Overall Study|At DCO|5||
59599951|NCT00691652|75709684|FG000|STARTED|Overall Study||2||
59599952|NCT00691652|75709684|FG000|COMPLETED|Overall Study||1||
59599953|NCT00691652|75709684|FG000|NOT COMPLETED|Overall Study||1||
59599954|NCT00691574|75709690|FG000|STARTED|Overall Study||0||
59599955|NCT00691574|75709691|FG001|STARTED|Overall Study||0||
59599956|NCT00691574|75709690|FG000|COMPLETED|Overall Study||0||
59599957|NCT00691574|75709691|FG001|COMPLETED|Overall Study||0||
59599958|NCT00691574|75709690|FG000|NOT COMPLETED|Overall Study||0||
59599959|NCT00691574|75709691|FG001|NOT COMPLETED|Overall Study||0||
59599960|NCT03630679|75709699|FG000|STARTED|Overall Study||20||
59599961|NCT03630679|75709700|FG001|STARTED|Overall Study||25||
59599962|NCT03630679|75709699|FG000|COMPLETED|Overall Study||13||
59599963|NCT03630679|75709700|FG001|COMPLETED|Overall Study||13||
59599964|NCT03630679|75709699|FG000|NOT COMPLETED|Overall Study||7||
59599965|NCT03630679|75709700|FG001|NOT COMPLETED|Overall Study||12||
59599966|NCT03631927|75709706|FG000|STARTED|Overall Study||5094||
59599967|NCT03631927|75709706|FG000|COMPLETED|Overall Study||4669||
59599968|NCT03631927|75709706|FG000|NOT COMPLETED|Overall Study||425||
59599969|NCT00685880|75709712|FG000|STARTED|Overall Study||0||
59599970|NCT00685880|75709713|FG001|STARTED|Overall Study||2||
59599971|NCT00685880|75709712|FG000|COMPLETED|Overall Study||0||
59599972|NCT00685880|75709713|FG001|COMPLETED|Overall Study||2||
59599973|NCT00685880|75709712|FG000|NOT COMPLETED|Overall Study||0||
59599974|NCT00685880|75709713|FG001|NOT COMPLETED|Overall Study||0||
59599975|NCT00681044|75709719|FG000|STARTED|Overall Study||4||
59599976|NCT00681044|75709719|FG000|COMPLETED|Overall Study||4||
59599977|NCT00681044|75709719|FG000|NOT COMPLETED|Overall Study||0||
59599978|NCT03632083|75709723|FG000|STARTED|First Intervention||5||5
59599979|NCT03632083|75709724|FG001|STARTED|First Intervention||5||5
59599980|NCT03632083|75709725|FG002|STARTED|First Intervention||7||7
59599981|NCT03632083|75709726|FG003|STARTED|First Intervention||7||7
59599982|NCT03632083|75709727|FG004|STARTED|First Intervention||9||9
59599983|NCT03632083|75709728|FG005|STARTED|First Intervention||9||9
59599984|NCT03632083|75709729|FG006|STARTED|First Intervention||7||7
59599985|NCT03632083|75709730|FG007|STARTED|First Intervention||7||7
59599986|NCT03632083|75709723|FG000|COMPLETED|First Intervention||5||5
59599987|NCT03632083|75709724|FG001|COMPLETED|First Intervention||5||5
59599988|NCT03632083|75709725|FG002|COMPLETED|First Intervention||7||7
59599989|NCT03632083|75709726|FG003|COMPLETED|First Intervention||7||7
59599990|NCT03632083|75709727|FG004|COMPLETED|First Intervention||9||9
59599991|NCT03632083|75709728|FG005|COMPLETED|First Intervention||9||9
59599992|NCT03632083|75709729|FG006|COMPLETED|First Intervention||7||7
59599993|NCT03632083|75709730|FG007|COMPLETED|First Intervention||7||7
59599994|NCT03632083|75709723|FG000|NOT COMPLETED|First Intervention||0||0
59599995|NCT03632083|75709724|FG001|NOT COMPLETED|First Intervention||0||0
59599996|NCT03632083|75709725|FG002|NOT COMPLETED|First Intervention||0||0
59599997|NCT03632083|75709726|FG003|NOT COMPLETED|First Intervention||0||0
59599998|NCT03632083|75709727|FG004|NOT COMPLETED|First Intervention||0||0
59599999|NCT03632083|75709728|FG005|NOT COMPLETED|First Intervention||0||0
59600000|NCT03632083|75709729|FG006|NOT COMPLETED|First Intervention||0||0
59600001|NCT03632083|75709730|FG007|NOT COMPLETED|First Intervention||0||0
59600002|NCT03632083|75709723|FG000|STARTED|Second Intervention||5||5
59600003|NCT03632083|75709724|FG001|STARTED|Second Intervention||5||5
59600004|NCT03632083|75709725|FG002|STARTED|Second Intervention||7||7
59600005|NCT03632083|75709726|FG003|STARTED|Second Intervention||7||7
59600006|NCT03632083|75709727|FG004|STARTED|Second Intervention||9||9
59600007|NCT03632083|75709728|FG005|STARTED|Second Intervention||9||9
59600008|NCT03632083|75709729|FG006|STARTED|Second Intervention||7||7
59600009|NCT03632083|75709730|FG007|STARTED|Second Intervention||7||7
59600010|NCT03632083|75709723|FG000|COMPLETED|Second Intervention||5||5
59600011|NCT03632083|75709724|FG001|COMPLETED|Second Intervention||5||5
59600012|NCT03632083|75709725|FG002|COMPLETED|Second Intervention||7||7
59600013|NCT03632083|75709726|FG003|COMPLETED|Second Intervention||7||7
59600014|NCT03632083|75709727|FG004|COMPLETED|Second Intervention||9||9
59600015|NCT03632083|75709728|FG005|COMPLETED|Second Intervention||9||9
59600016|NCT03632083|75709729|FG006|COMPLETED|Second Intervention||7||7
59600017|NCT03632083|75709730|FG007|COMPLETED|Second Intervention||5||5
59600018|NCT03632083|75709723|FG000|NOT COMPLETED|Second Intervention||0||0
59600019|NCT03632083|75709724|FG001|NOT COMPLETED|Second Intervention||0||0
59600020|NCT03632083|75709725|FG002|NOT COMPLETED|Second Intervention||0||0
59600021|NCT03632083|75709726|FG003|NOT COMPLETED|Second Intervention||0||0
59600022|NCT03632083|75709727|FG004|NOT COMPLETED|Second Intervention||0||0
59600023|NCT03632083|75709728|FG005|NOT COMPLETED|Second Intervention||0||0
59600024|NCT03632083|75709729|FG006|NOT COMPLETED|Second Intervention||0||0
59600025|NCT03632083|75709730|FG007|NOT COMPLETED|Second Intervention||2||2
59600026|NCT03633487|75709742|FG000|STARTED|Overall Study||24||
59600027|NCT03633487|75709742|FG000|COMPLETED|Overall Study||24||
59600028|NCT03633487|75709742|FG000|NOT COMPLETED|Overall Study||0||
59600029|NCT03574441|75709749|FG000|STARTED|Overall Study||31||
59600030|NCT03574441|75709750|FG001|STARTED|Overall Study||30||
59600031|NCT03574441|75709751|FG002|STARTED|Overall Study||30||
59600032|NCT03574441|75709749|FG000|COMPLETED|Overall Study||31||
59600033|NCT03574441|75709750|FG001|COMPLETED|Overall Study||30||
59600034|NCT03574441|75709751|FG002|COMPLETED|Overall Study||30||
59600035|NCT03574441|75709749|FG000|NOT COMPLETED|Overall Study||0||
59600036|NCT03574441|75709750|FG001|NOT COMPLETED|Overall Study||0||
59600037|NCT03574441|75709751|FG002|NOT COMPLETED|Overall Study||0||
59600038|NCT00671606|75709759|FG000|STARTED|Overall Study||5||
59600039|NCT00671606|75709759|FG000|COMPLETED|Overall Study||5||
59600040|NCT00671606|75709759|FG000|NOT COMPLETED|Overall Study||0||
59600041|NCT01756586|75709765|FG000|STARTED|Overall Study||2||
59600042|NCT01756586|75709766|FG001|STARTED|Overall Study||2||
59600043|NCT01756586|75709765|FG000|COMPLETED|Overall Study||0||
59600044|NCT01756586|75709766|FG001|COMPLETED|Overall Study||0||
59600045|NCT01756586|75709765|FG000|NOT COMPLETED|Overall Study||2||
59600046|NCT01756586|75709766|FG001|NOT COMPLETED|Overall Study||2||
59600047|NCT03636061|75709776|FG000|STARTED|Overall Study||47||
59600048|NCT03636061|75709777|FG001|STARTED|Overall Study||48||
59600049|NCT03636061|75709778|FG002|STARTED|Overall Study||44||
59600050|NCT03636061|75709779|FG003|STARTED|Overall Study||43||
59600051|NCT03636061|75709776|FG000|COMPLETED|Overall Study||47||
59600052|NCT03636061|75709777|FG001|COMPLETED|Overall Study||46||
59600053|NCT03636061|75709778|FG002|COMPLETED|Overall Study||40||
59600054|NCT03636061|75709779|FG003|COMPLETED|Overall Study||43||
59600055|NCT03636061|75709776|FG000|NOT COMPLETED|Overall Study||0||
59600056|NCT03636061|75709777|FG001|NOT COMPLETED|Overall Study||2||
59600057|NCT03636061|75709778|FG002|NOT COMPLETED|Overall Study||4||
59600058|NCT03636061|75709779|FG003|NOT COMPLETED|Overall Study||0||
59600059|NCT04404907|75709794|FG000|STARTED|Overall Study||442||
59600060|NCT04404907|75709795|FG001|STARTED|Overall Study||95||
59600061|NCT04404907|75709794|FG000|Occasional Tan|Overall Study||0|2-10 times in 3 months|
59600062|NCT04404907|75709795|FG001|Occasional Tan|Overall Study||88|2-10 times in 3 months|
59600063|NCT04404907|75709794|FG000|Frequent Tan|Overall Study||0|>10 times in 3 months|
59600064|NCT04404907|75709795|FG001|Frequent Tan|Overall Study||7|>10 times in 3 months|
59600065|NCT04404907|75709794|FG000|COMPLETED|Overall Study||442||
59600066|NCT04404907|75709795|FG001|COMPLETED|Overall Study||95||
59600067|NCT04404907|75709794|FG000|NOT COMPLETED|Overall Study||0||
59600068|NCT04404907|75709795|FG001|NOT COMPLETED|Overall Study||0||
59600069|NCT00661466|75709803|FG000|STARTED|Overall Study|Participants|4||
59600070|NCT00661466|75709804|FG001|STARTED|Overall Study|Participants|3||
59600071|NCT00661466|75709803|FG000|COMPLETED|Overall Study|Participants|4||
59600072|NCT00661466|75709804|FG001|COMPLETED|Overall Study|Participants|3||
59600073|NCT00661466|75709803|FG000|NOT COMPLETED|Overall Study||0||
59600074|NCT00661466|75709804|FG001|NOT COMPLETED|Overall Study||0||
59600075|NCT04403113|75709812|FG000|STARTED|Overall Study||20||
59600076|NCT04403113|75709813|FG001|STARTED|Overall Study||20||
59600077|NCT04403113|75709812|FG000|COMPLETED|Overall Study||20||
59600078|NCT04403113|75709813|FG001|COMPLETED|Overall Study||20||
59600079|NCT04403113|75709812|FG000|NOT COMPLETED|Overall Study||0||
59600080|NCT04403113|75709813|FG001|NOT COMPLETED|Overall Study||0||
59600081|NCT00639626|75709823|FG000|STARTED|Overall Study||0||
59600082|NCT00639626|75709823|FG000|COMPLETED|Overall Study||0||
59600083|NCT00639626|75709823|FG000|NOT COMPLETED|Overall Study||0||
59600084|NCT01718444|75709829|FG000|STARTED|Overall Study||0||
59600085|NCT01718444|75709830|FG001|STARTED|Overall Study||0||
59600086|NCT01718444|75709829|FG000|COMPLETED|Overall Study||0||
59600087|NCT01718444|75709830|FG001|COMPLETED|Overall Study||0||
59600088|NCT01718444|75709829|FG000|NOT COMPLETED|Overall Study||0||
59600089|NCT01718444|75709830|FG001|NOT COMPLETED|Overall Study||0||
59600090|NCT00641108|75709838|FG000|STARTED|Overall Study||0||
59600091|NCT00641108|75709839|FG001|STARTED|Overall Study||0||
59600092|NCT00641108|75709838|FG000|COMPLETED|Overall Study||0||
59600093|NCT00641108|75709839|FG001|COMPLETED|Overall Study||0||
59600094|NCT00641108|75709838|FG000|NOT COMPLETED|Overall Study||0||
59600095|NCT00641108|75709839|FG001|NOT COMPLETED|Overall Study||0||
59600096|NCT00638222|75709848|FG000|STARTED|Overall Study||0||
59600097|NCT00638222|75709849|FG001|STARTED|Overall Study||0||
59600098|NCT00638222|75709850|FG002|STARTED|Overall Study||6||
59600099|NCT00638222|75709848|FG000|COMPLETED|Overall Study||0||
59728554|NCT00979134|75847184|FG000|NOT COMPLETED|Overall Study||33||
59728555|NCT00979134|75847185|FG001|NOT COMPLETED|Overall Study||6||
59728556|NCT00979134|75847186|FG002|NOT COMPLETED|Overall Study||40||
59728557|NCT00824005|75847201|FG000|STARTED|Overall Study||31||
59600100|NCT00638222|75709849|FG001|COMPLETED|Overall Study||0||
59600101|NCT00638222|75709850|FG002|COMPLETED|Overall Study||6||
59600102|NCT00638222|75709848|FG000|NOT COMPLETED|Overall Study||0||
59600103|NCT00638222|75709849|FG001|NOT COMPLETED|Overall Study||0||
59600104|NCT00638222|75709850|FG002|NOT COMPLETED|Overall Study||0||
59600105|NCT00634322|75709860|FG000|STARTED|Overall Study||1||
59600106|NCT00634322|75709861|FG001|STARTED|Overall Study||1||
59600107|NCT00634322|75709862|FG002|STARTED|Overall Study||5||
59600108|NCT00634322|75709860|FG000|COMPLETED|Overall Study||1||
59600109|NCT00634322|75709861|FG001|COMPLETED|Overall Study||1||
59600110|NCT00634322|75709862|FG002|COMPLETED|Overall Study||5||
59600111|NCT00634322|75709860|FG000|NOT COMPLETED|Overall Study||0||
59600112|NCT00634322|75709861|FG001|NOT COMPLETED|Overall Study||0||
59600113|NCT00634322|75709862|FG002|NOT COMPLETED|Overall Study||0||
59600114|NCT01705106|75709870|FG000|STARTED|Overall Study||21||
59600115|NCT01705106|75709870|FG000|COMPLETED|Overall Study||21||
59600116|NCT01705106|75709870|FG000|NOT COMPLETED|Overall Study||0||
59728558|NCT00824005|75847202|FG001|STARTED|Overall Study||61||
59600117|NCT00626444|75709874|FG000|STARTED|Overall Study||2||
59600118|NCT00626444|75709874|FG000|COMPLETED|Overall Study||2||
59600119|NCT00626444|75709874|FG000|NOT COMPLETED|Overall Study||0||
59600120|NCT00624650|75709880|FG000|STARTED|Overall Study||17||
59600121|NCT00624650|75709881|FG001|STARTED|Overall Study||16||
59600122|NCT00624650|75709880|FG000|COMPLETED|Overall Study||16||
59600123|NCT00624650|75709881|FG001|COMPLETED|Overall Study||15||
59600124|NCT00624650|75709880|FG000|NOT COMPLETED|Overall Study||1||
59600125|NCT00624650|75709881|FG001|NOT COMPLETED|Overall Study||1||
59600126|NCT03965533|75709894|FG000|STARTED|Part A (112 Days)||2||
59600127|NCT03965533|75709895|FG001|STARTED|Part A (112 Days)||6||
59600128|NCT03965533|75709896|FG002|STARTED|Part A (112 Days)||2||
59600129|NCT03965533|75709897|FG003|STARTED|Part A (112 Days)||6||
59600130|NCT03965533|75709898|FG004|STARTED|Part A (112 Days)||0||
59600131|NCT03965533|75709899|FG005|STARTED|Part A (112 Days)||0||
59600132|NCT03965533|75709900|FG006|STARTED|Part A (112 Days)||0||
59600133|NCT03965533|75709894|FG000|COMPLETED|Part A (112 Days)||2||
59600134|NCT03965533|75709895|FG001|COMPLETED|Part A (112 Days)||6||
59600135|NCT03965533|75709896|FG002|COMPLETED|Part A (112 Days)||2||
59600136|NCT03965533|75709897|FG003|COMPLETED|Part A (112 Days)||6||
59600137|NCT03965533|75709898|FG004|COMPLETED|Part A (112 Days)||0||
59600138|NCT03965533|75709899|FG005|COMPLETED|Part A (112 Days)||0||
59600139|NCT03965533|75709900|FG006|COMPLETED|Part A (112 Days)||0||
59600140|NCT03965533|75709894|FG000|NOT COMPLETED|Part A (112 Days)||0||
59600141|NCT03965533|75709895|FG001|NOT COMPLETED|Part A (112 Days)||0||
59600142|NCT03965533|75709896|FG002|NOT COMPLETED|Part A (112 Days)||0||
59600143|NCT03965533|75709897|FG003|NOT COMPLETED|Part A (112 Days)||0||
59600144|NCT03965533|75709898|FG004|NOT COMPLETED|Part A (112 Days)||0||
59600145|NCT03965533|75709899|FG005|NOT COMPLETED|Part A (112 Days)||0||
59600146|NCT03965533|75709900|FG006|NOT COMPLETED|Part A (112 Days)||0||
59600147|NCT03965533|75709894|FG000|STARTED|Part B (112 Days)||0||
59600148|NCT03965533|75709895|FG001|STARTED|Part B (112 Days)||0||
59600149|NCT03965533|75709896|FG002|STARTED|Part B (112 Days)||0||
59600150|NCT03965533|75709897|FG003|STARTED|Part B (112 Days)||0||
59600151|NCT03965533|75709898|FG004|STARTED|Part B (112 Days)||4||
59600152|NCT03965533|75709899|FG005|STARTED|Part B (112 Days)||8||
59600153|NCT03965533|75709900|FG006|STARTED|Part B (112 Days)||8||
59600154|NCT03965533|75709894|FG000|COMPLETED|Part B (112 Days)||0||
59600155|NCT03965533|75709895|FG001|COMPLETED|Part B (112 Days)||0||
59600156|NCT03965533|75709896|FG002|COMPLETED|Part B (112 Days)||0||
59600157|NCT03965533|75709897|FG003|COMPLETED|Part B (112 Days)||0||
59600158|NCT03965533|75709898|FG004|COMPLETED|Part B (112 Days)||4||
59600159|NCT03965533|75709899|FG005|COMPLETED|Part B (112 Days)||8||
59600160|NCT03965533|75709900|FG006|COMPLETED|Part B (112 Days)||8||
59600161|NCT03965533|75709894|FG000|NOT COMPLETED|Part B (112 Days)||0||
59600162|NCT03965533|75709895|FG001|NOT COMPLETED|Part B (112 Days)||0||
59600163|NCT03965533|75709896|FG002|NOT COMPLETED|Part B (112 Days)||0||
59600164|NCT03965533|75709897|FG003|NOT COMPLETED|Part B (112 Days)||0||
59600165|NCT03965533|75709898|FG004|NOT COMPLETED|Part B (112 Days)||0||
59600166|NCT03965533|75709899|FG005|NOT COMPLETED|Part B (112 Days)||0||
59600167|NCT03965533|75709900|FG006|NOT COMPLETED|Part B (112 Days)||0||
59600168|NCT01693484|75709921|FG000|STARTED|Overall Study||13||
59600169|NCT01693484|75709921|FG000|COMPLETED|Overall Study|Study closed by PI|0||
59600170|NCT01693484|75709921|FG000|NOT COMPLETED|Overall Study||13||
59600171|NCT03637699|75709927|FG000|STARTED|Overall Study||15||
59600172|NCT03637699|75709928|FG001|STARTED|Overall Study||15||
59600173|NCT03637699|75709927|FG000|COMPLETED|Overall Study||14||
59600174|NCT03637699|75709928|FG001|COMPLETED|Overall Study||14||
59600175|NCT03637699|75709927|FG000|NOT COMPLETED|Overall Study||1||
59600176|NCT03637699|75709928|FG001|NOT COMPLETED|Overall Study||1||
59600177|NCT01690910|75709937|FG000|STARTED|Overall Study|The study was never completed due to feasibility issues.|0||
59600178|NCT01690910|75709938|FG001|STARTED|Overall Study||0||
59600179|NCT01690910|75709937|FG000|COMPLETED|Overall Study||0||
59600180|NCT01690910|75709938|FG001|COMPLETED|Overall Study||0||
59600181|NCT01690910|75709937|FG000|NOT COMPLETED|Overall Study||0||
59600182|NCT01690910|75709938|FG001|NOT COMPLETED|Overall Study||0||
59600183|NCT00613886|75709944|FG000|STARTED|Overall Study||24||
59600184|NCT00613886|75709944|FG000|COMPLETED|Overall Study||0||
59600185|NCT00613886|75709944|FG000|NOT COMPLETED|Overall Study||24||
59600186|NCT03947983|75709951|FG000|STARTED|Overall Study||19||
59600187|NCT03947983|75709952|FG001|STARTED|Overall Study||19||
59600188|NCT03947983|75709951|FG000|12 Weeks|Overall Study||15||
59600189|NCT03947983|75709952|FG001|12 Weeks|Overall Study||17||
59600190|NCT03947983|75709951|FG000|COMPLETED|Overall Study||14|24 weeks|
59600191|NCT03947983|75709952|FG001|COMPLETED|Overall Study||13|24 weeks|
59600192|NCT03947983|75709951|FG000|NOT COMPLETED|Overall Study||5||
59600193|NCT03947983|75709952|FG001|NOT COMPLETED|Overall Study||6||
59600194|NCT00610532|75709958|FG000|STARTED|Intravenous Phenytoin Alone||8||
59600195|NCT00610532|75709958|FG000|COMPLETED|Intravenous Phenytoin Alone||8||
59600196|NCT00610532|75709958|FG000|NOT COMPLETED|Intravenous Phenytoin Alone||0||
59600197|NCT00610532|75709958|FG000|STARTED|Intravenous Phenytoin Plus Probenecid|one participant dropped out between periods|7||
59600198|NCT00610532|75709958|FG000|COMPLETED|Intravenous Phenytoin Plus Probenecid||7||
59600199|NCT00610532|75709958|FG000|NOT COMPLETED|Intravenous Phenytoin Plus Probenecid||0||
59600200|NCT01669148|75709964|FG000|STARTED|Overall Study||496||
59600201|NCT01669148|75709964|FG000|COMPLETED|Overall Study||426||
59600202|NCT01669148|75709964|FG000|NOT COMPLETED|Overall Study||70||
59600203|NCT03638323|75709971|FG000|STARTED|Overall Study||38||
59600204|NCT03638323|75709971|FG000|COMPLETED|Overall Study||37||
59600205|NCT03638323|75709971|FG000|NOT COMPLETED|Overall Study||1||
59600206|NCT03642457|75709980|FG000|STARTED|Overall Study||35||
59600207|NCT03642457|75709981|FG001|STARTED|Overall Study||30||
59600208|NCT03642457|75709980|FG000|COMPLETED|Overall Study||35||
59600209|NCT03642457|75709981|FG001|COMPLETED|Overall Study||30||
59600210|NCT03642457|75709980|FG000|NOT COMPLETED|Overall Study||0||
59600211|NCT03642457|75709981|FG001|NOT COMPLETED|Overall Study||0||
59600212|NCT03644095|75709987|FG000|STARTED|Period 1||15||
59600213|NCT03644095|75709988|FG001|STARTED|Period 1||15||
59600214|NCT03644095|75709987|FG000|COMPLETED|Period 1||15||
59600215|NCT03644095|75709988|FG001|COMPLETED|Period 1||15||
59600216|NCT03644095|75709987|FG000|NOT COMPLETED|Period 1||0||
59600217|NCT03644095|75709988|FG001|NOT COMPLETED|Period 1||0||
59600218|NCT03644095|75709987|FG000|STARTED|Washout (7 Days)||15||
59600219|NCT03644095|75709988|FG001|STARTED|Washout (7 Days)||15||
59600220|NCT03644095|75709987|FG000|COMPLETED|Washout (7 Days)||15||
59600221|NCT03644095|75709988|FG001|COMPLETED|Washout (7 Days)||15||
59600222|NCT03644095|75709987|FG000|NOT COMPLETED|Washout (7 Days)||0||
59600223|NCT03644095|75709988|FG001|NOT COMPLETED|Washout (7 Days)||0||
59600224|NCT03644095|75709987|FG000|STARTED|Period 2||15||
59600225|NCT03644095|75709988|FG001|STARTED|Period 2||15||
59600226|NCT03644095|75709987|FG000|COMPLETED|Period 2||15||
59600227|NCT03644095|75709988|FG001|COMPLETED|Period 2||15||
59600228|NCT03644095|75709987|FG000|NOT COMPLETED|Period 2||0||
59600229|NCT03644095|75709988|FG001|NOT COMPLETED|Period 2||0||
59600230|NCT01633814|75709994|FG000|STARTED|Overall Study||4||
59600231|NCT01633814|75709994|FG000|COMPLETED|Overall Study||4||
59600232|NCT01633814|75709994|FG000|NOT COMPLETED|Overall Study||0||
59600233|NCT04350307|75710000|FG000|STARTED|Overall Study||84||
59600234|NCT04350307|75710001|FG001|STARTED|Overall Study||78||
59600235|NCT04350307|75710000|FG000|COMPLETED|Overall Study||84||
59600236|NCT04350307|75710001|FG001|COMPLETED|Overall Study||78||
59600237|NCT04350307|75710000|FG000|NOT COMPLETED|Overall Study||0||
59600238|NCT04350307|75710001|FG001|NOT COMPLETED|Overall Study||0||
59600239|NCT04348357|75710009|FG000|STARTED|Overall Study||25||
59600240|NCT04348357|75710010|FG001|STARTED|Overall Study||28||
59600241|NCT04348357|75710009|FG000|COMPLETED|Overall Study||25||
59600242|NCT04348357|75710010|FG001|COMPLETED|Overall Study||16||
59600243|NCT04348357|75710009|FG000|NOT COMPLETED|Overall Study||0||
59600244|NCT04348357|75710010|FG001|NOT COMPLETED|Overall Study||12||
59600245|NCT04342663|75710018|FG000|STARTED|Overall Study||80||
59600246|NCT04342663|75710019|FG001|STARTED|Overall Study||72||
59600247|NCT04342663|75710018|FG000|COMPLETED|Overall Study||62||
59600248|NCT04342663|75710019|FG001|COMPLETED|Overall Study||53||
59600249|NCT04342663|75710018|FG000|NOT COMPLETED|Overall Study||18||
59600250|NCT04342663|75710019|FG001|NOT COMPLETED|Overall Study||19||
59600251|NCT00589550|75710025|FG000|STARTED|Overall Study||1||
59600252|NCT00589550|75710025|FG000|Withdrew From Study|Overall Study||1||
59600253|NCT00589550|75710025|FG000|COMPLETED|Overall Study||0||
59600254|NCT00589550|75710025|FG000|NOT COMPLETED|Overall Study||1||
59600255|NCT01636466|75710031|FG000|STARTED|Overall Study||1||
59600256|NCT01636466|75710032|FG001|STARTED|Overall Study||0||
59600257|NCT01636466|75710031|FG000|COMPLETED|Overall Study||0||
59600258|NCT01636466|75710032|FG001|COMPLETED|Overall Study||0||
59600259|NCT01636466|75710031|FG000|NOT COMPLETED|Overall Study||1||
59600260|NCT01636466|75710032|FG001|NOT COMPLETED|Overall Study||0||
59600261|NCT00583466|75710038|FG000|STARTED|Overall Study||18||
59600262|NCT00583466|75710038|FG000|COMPLETED|Overall Study||18||
59600263|NCT00583466|75710038|FG000|NOT COMPLETED|Overall Study||0||
59600264|NCT00568802|75710044|FG000|STARTED|Overall Study||27||
59600265|NCT00568802|75710044|FG000|COMPLETED|Overall Study||24||
59600266|NCT00568802|75710044|FG000|NOT COMPLETED|Overall Study||3||
59600267|NCT00576524|75710052|FG000|STARTED|Overall Study||2||
59600268|NCT00576524|75710053|FG001|STARTED|Overall Study||0||
59600269|NCT00576524|75710052|FG000|COMPLETED|Overall Study||2||
59600270|NCT00576524|75710053|FG001|COMPLETED|Overall Study||0||
59600271|NCT00576524|75710052|FG000|NOT COMPLETED|Overall Study||0||
59600272|NCT00576524|75710053|FG001|NOT COMPLETED|Overall Study||0||
59600273|NCT03949621|75710065|FG000|STARTED|Overall Study||12||
59600274|NCT03949621|75710066|FG001|STARTED|Overall Study||12||
59600275|NCT03949621|75710065|FG000|COMPLETED|Overall Study||12||
59600276|NCT03949621|75710066|FG001|COMPLETED|Overall Study||12||
59600277|NCT03949621|75710065|FG000|NOT COMPLETED|Overall Study||0||
59600278|NCT03949621|75710066|FG001|NOT COMPLETED|Overall Study||0||
59600279|NCT03645811|75710075|FG000|STARTED|Overall Study||32||
59600280|NCT03645811|75710076|FG001|STARTED|Overall Study||32||
59600281|NCT03645811|75710077|FG002|STARTED|Overall Study||32||
59600282|NCT03645811|75710075|FG000|COMPLETED|Overall Study||30||
59600283|NCT03645811|75710076|FG001|COMPLETED|Overall Study||30||
59600284|NCT03645811|75710077|FG002|COMPLETED|Overall Study||30||
59600285|NCT03645811|75710075|FG000|NOT COMPLETED|Overall Study||2||
59600286|NCT03645811|75710076|FG001|NOT COMPLETED|Overall Study||2||
59600287|NCT03645811|75710077|FG002|NOT COMPLETED|Overall Study||2||
59600288|NCT01570634|75710085|FG000|STARTED|Overall Study||2||
59600289|NCT01570634|75710085|FG000|COMPLETED|Overall Study||2||
59600290|NCT01570634|75710085|FG000|NOT COMPLETED|Overall Study||0||
59600291|NCT03928327|75710091|FG000|STARTED|Period 1||12||
59600292|NCT03928327|75710092|FG001|STARTED|Period 1||12||
59600293|NCT03928327|75710091|FG000|COMPLETED|Period 1||12||
59600294|NCT03928327|75710092|FG001|COMPLETED|Period 1||12||
59600295|NCT03928327|75710091|FG000|NOT COMPLETED|Period 1||0||
59600296|NCT03928327|75710092|FG001|NOT COMPLETED|Period 1||0||
59600297|NCT03928327|75710091|FG000|STARTED|Washout Period||12||
59600298|NCT03928327|75710092|FG001|STARTED|Washout Period||12||
59600299|NCT03928327|75710091|FG000|COMPLETED|Washout Period||12||
59600300|NCT03928327|75710092|FG001|COMPLETED|Washout Period||12||
59600301|NCT03928327|75710091|FG000|NOT COMPLETED|Washout Period||0||
59600302|NCT03928327|75710092|FG001|NOT COMPLETED|Washout Period||0||
59600303|NCT03928327|75710091|FG000|STARTED|Period 2||12||
59600304|NCT03928327|75710092|FG001|STARTED|Period 2||12||
59600305|NCT03928327|75710091|FG000|COMPLETED|Period 2||12||
59600306|NCT03928327|75710092|FG001|COMPLETED|Period 2||12||
59600307|NCT03928327|75710091|FG000|NOT COMPLETED|Period 2||0||
59600308|NCT03928327|75710092|FG001|NOT COMPLETED|Period 2||0||
59600309|NCT03648853|75710104|FG000|STARTED|Overall Study||12||
59600310|NCT03648853|75710104|FG000|COMPLETED|Overall Study||12||
59600311|NCT03648853|75710104|FG000|NOT COMPLETED|Overall Study||0||
59600312|NCT03649867|75710108|FG000|STARTED|Overall Study||13||
59600313|NCT03649867|75710108|FG000|COMPLETED|Overall Study||13||
59600314|NCT03649867|75710108|FG000|NOT COMPLETED|Overall Study||0||
59600315|NCT01550510|75710114|FG000|STARTED|Overall Study||4||
59600316|NCT01550510|75710115|FG001|STARTED|Overall Study||0||
59600317|NCT01550510|75710114|FG000|COMPLETED|Overall Study||4||
59600318|NCT01550510|75710115|FG001|COMPLETED|Overall Study||0||
59600319|NCT01550510|75710114|FG000|NOT COMPLETED|Overall Study||0||
59600320|NCT01550510|75710115|FG001|NOT COMPLETED|Overall Study||0||
59600321|NCT04333225|75710124|FG000|STARTED|Overall Study||101||
59600322|NCT04333225|75710125|FG001|STARTED|Overall Study||120||
59600323|NCT04333225|75710124|FG000|COMPLETED|Overall Study||98||
59600324|NCT04333225|75710125|FG001|COMPLETED|Overall Study||115||
59600325|NCT04333225|75710124|FG000|NOT COMPLETED|Overall Study||3||
59600326|NCT04333225|75710125|FG001|NOT COMPLETED|Overall Study||5||
59600327|NCT00566462|75710133|FG000|STARTED|Overall Study||1||
59600328|NCT00566462|75710134|FG001|STARTED|Overall Study||0||
59600329|NCT00566462|75710133|FG000|COMPLETED|Overall Study||1||
59600330|NCT00566462|75710134|FG001|COMPLETED|Overall Study||0||
59600331|NCT00566462|75710133|FG000|NOT COMPLETED|Overall Study||0||
59600332|NCT00566462|75710134|FG001|NOT COMPLETED|Overall Study||0||
59600333|NCT00556400|75710142|FG000|STARTED|Overall Study||1||
59600334|NCT00556400|75710143|FG001|STARTED|Overall Study||0||
59600335|NCT00556400|75710142|FG000|COMPLETED|Overall Study||1||
59600336|NCT00556400|75710143|FG001|COMPLETED|Overall Study||0||
59600337|NCT00556400|75710142|FG000|NOT COMPLETED|Overall Study||0||
59600338|NCT00556400|75710143|FG001|NOT COMPLETED|Overall Study||0||
59600339|NCT03918811|75710150|FG000|STARTED|Overall Study||367||
59600340|NCT03918811|75710151|FG001|STARTED|Overall Study||358||
59600341|NCT03918811|75710150|FG000|COMPLETED|Overall Study||363||
59600342|NCT03918811|75710151|FG001|COMPLETED|Overall Study||345||
59600343|NCT03918811|75710150|FG000|NOT COMPLETED|Overall Study||4||
59600344|NCT03918811|75710151|FG001|NOT COMPLETED|Overall Study||13||
59600345|NCT00521924|75710159|FG000|STARTED|Overall Study|Subjects randomized|4||
59600346|NCT00521924|75710160|FG001|STARTED|Overall Study|Subjects randomized|4||
59600347|NCT00521924|75710159|FG000|COMPLETED|Overall Study|At Early Termination, 1 patient completed Week 2 and 2 patients completed Week 6.|0||
59600348|NCT00521924|75710160|FG001|COMPLETED|Overall Study|At Early Termination, 3 patients completed Week 6 and 1 completed Week 22.|0||
59600349|NCT00521924|75710159|FG000|NOT COMPLETED|Overall Study||4||
59600350|NCT00521924|75710160|FG001|NOT COMPLETED|Overall Study||4||
59600351|NCT03927781|75710166|FG000|STARTED|Overall Study||10||
59600352|NCT03927781|75710166|FG000|COMPLETED|Overall Study||10||
59600353|NCT03927781|75710166|FG000|NOT COMPLETED|Overall Study||0||
59600354|NCT01553240|75710170|FG000|STARTED|Overall Study||0||
59600355|NCT01553240|75710170|FG000|COMPLETED|Overall Study||0||
59600356|NCT01553240|75710170|FG000|NOT COMPLETED|Overall Study||0||
59600357|NCT03907579|75710174|FG000|STARTED|Overall Study||100||
59600358|NCT03907579|75710174|FG000|COMPLETED|Overall Study||100||
59600359|NCT03907579|75710174|FG000|NOT COMPLETED|Overall Study||0||
59600360|NCT01545518|75710178|FG000|STARTED|Overall Study||20||
59600361|NCT01545518|75710178|FG000|COMPLETED|Overall Study||20||
59600362|NCT01545518|75710178|FG000|NOT COMPLETED|Overall Study||0||
59600363|NCT04320823|75710184|FG000|STARTED|Overall Study||1717||
59600364|NCT04320823|75710185|FG001|STARTED|Overall Study||1726||
59600365|NCT04320823|75710184|FG000|COMPLETED|Overall Study|Includes 47 donors who withdrew from the study after one or more donations.|1717||
59600366|NCT04320823|75710185|FG001|COMPLETED|Overall Study|Includes 38 donors who withdrew from the study after one or more donations.|1726||
59600367|NCT04320823|75710184|FG000|NOT COMPLETED|Overall Study||0||
59600368|NCT04320823|75710185|FG001|NOT COMPLETED|Overall Study||0||
59600369|NCT01539590|75710209|FG000|STARTED|Overall Study||3||
59600370|NCT01539590|75710210|FG001|STARTED|Overall Study||2||
59600371|NCT01539590|75710209|FG000|Complete Study Treatment|Overall Study||1||
59600372|NCT01539590|75710210|FG001|Complete Study Treatment|Overall Study||2||
59600373|NCT01539590|75710209|FG000|COMPLETED|Overall Study||0||
59600374|NCT01539590|75710210|FG001|COMPLETED|Overall Study||2||
59600375|NCT01539590|75710209|FG000|NOT COMPLETED|Overall Study||3||
59600376|NCT01539590|75710210|FG001|NOT COMPLETED|Overall Study||0||
59600377|NCT04313647|75710221|FG000|STARTED|Overall Study||3||
59600378|NCT04313647|75710222|FG001|STARTED|Overall Study||3||
59600379|NCT04313647|75710223|FG002|STARTED|Overall Study||6||
59600380|NCT04313647|75710224|FG003|STARTED|Overall Study||6||
59600381|NCT04313647|75710225|FG004|STARTED|Overall Study||6||
59600382|NCT04313647|75710221|FG000|COMPLETED|Overall Study||3||
59600383|NCT04313647|75710222|FG001|COMPLETED|Overall Study||3||
59600384|NCT04313647|75710223|FG002|COMPLETED|Overall Study||6||
59600385|NCT04313647|75710224|FG003|COMPLETED|Overall Study||6||
59600386|NCT04313647|75710225|FG004|COMPLETED|Overall Study||6||
59600387|NCT04313647|75710221|FG000|NOT COMPLETED|Overall Study||0||
59600388|NCT04313647|75710222|FG001|NOT COMPLETED|Overall Study||0||
59600389|NCT04313647|75710223|FG002|NOT COMPLETED|Overall Study||0||
59600390|NCT04313647|75710224|FG003|NOT COMPLETED|Overall Study||0||
59600391|NCT04313647|75710225|FG004|NOT COMPLETED|Overall Study||0||
59600392|NCT00537446|75710242|FG000|STARTED|Overall Study||8||
59600393|NCT00537446|75710242|FG000|COMPLETED|Overall Study||8||
59600394|NCT00537446|75710242|FG000|NOT COMPLETED|Overall Study||0||
59600395|NCT01526408|75710250|FG000|STARTED|Overall Study|early termination of study and sponsor organization closed|0||
59600396|NCT01526408|75710251|FG001|STARTED|Overall Study|early termination of study and sponsor organization closed|0||
59600397|NCT01526408|75710250|FG000|COMPLETED|Overall Study|early termination of study and sponsor organization closed|0||
59600398|NCT01526408|75710251|FG001|COMPLETED|Overall Study|early termination of study and sponsor organization closed|0||
59600399|NCT01526408|75710250|FG000|NOT COMPLETED|Overall Study||0||
59600400|NCT01526408|75710251|FG001|NOT COMPLETED|Overall Study||0||
59600401|NCT03660787|75710261|FG000|STARTED|Overall Study||26||
59600402|NCT03660787|75710262|FG001|STARTED|Overall Study||26||
59600403|NCT03660787|75710263|FG002|STARTED|Overall Study||26||
59600404|NCT03660787|75710264|FG003|STARTED|Overall Study||26||
59600405|NCT03660787|75710261|FG000|COMPLETED|Overall Study||25||
59600406|NCT03660787|75710262|FG001|COMPLETED|Overall Study||25||
59600407|NCT03660787|75710263|FG002|COMPLETED|Overall Study||25||
59600408|NCT03660787|75710264|FG003|COMPLETED|Overall Study||26||
59600409|NCT03660787|75710261|FG000|NOT COMPLETED|Overall Study||1||
59600410|NCT03660787|75710262|FG001|NOT COMPLETED|Overall Study||1||
59600411|NCT03660787|75710263|FG002|NOT COMPLETED|Overall Study||1||
59600412|NCT03660787|75710264|FG003|NOT COMPLETED|Overall Study||0||
59600413|NCT03926065|75710274|FG000|STARTED|Study Week 1||11||
59600414|NCT03926065|75710275|FG001|STARTED|Study Week 1||9||
59600415|NCT03926065|75710276|FG002|STARTED|Study Week 1||14||
59600416|NCT03926065|75710277|FG003|STARTED|Study Week 1||18||
59600417|NCT03926065|75710278|FG004|STARTED|Study Week 1||15||
59600418|NCT03926065|75710274|FG000|COMPLETED|Study Week 1||11||
59600419|NCT03926065|75710275|FG001|COMPLETED|Study Week 1||9||
59600420|NCT03926065|75710276|FG002|COMPLETED|Study Week 1||14||
59600421|NCT03926065|75710277|FG003|COMPLETED|Study Week 1||18||
59600422|NCT03926065|75710278|FG004|COMPLETED|Study Week 1||15||
59600423|NCT03926065|75710274|FG000|NOT COMPLETED|Study Week 1||0||
59600424|NCT03926065|75710275|FG001|NOT COMPLETED|Study Week 1||0||
59600425|NCT03926065|75710276|FG002|NOT COMPLETED|Study Week 1||0||
59600426|NCT03926065|75710277|FG003|NOT COMPLETED|Study Week 1||0||
59600427|NCT03926065|75710278|FG004|NOT COMPLETED|Study Week 1||0||
59600428|NCT03926065|75710274|FG000|STARTED|Study Week 2||11||
59600429|NCT03926065|75710275|FG001|STARTED|Study Week 2||9||
59600430|NCT03926065|75710276|FG002|STARTED|Study Week 2||14||
59600431|NCT03926065|75710277|FG003|STARTED|Study Week 2||18||
59600432|NCT03926065|75710278|FG004|STARTED|Study Week 2||15||
59600433|NCT03926065|75710274|FG000|COMPLETED|Study Week 2||11||
59600434|NCT03926065|75710275|FG001|COMPLETED|Study Week 2||9||
59600435|NCT03926065|75710276|FG002|COMPLETED|Study Week 2||14||
59600436|NCT03926065|75710277|FG003|COMPLETED|Study Week 2||18||
59600437|NCT03926065|75710278|FG004|COMPLETED|Study Week 2||15||
59600438|NCT03926065|75710274|FG000|NOT COMPLETED|Study Week 2||0||
59600439|NCT03926065|75710275|FG001|NOT COMPLETED|Study Week 2||0||
59600440|NCT03926065|75710276|FG002|NOT COMPLETED|Study Week 2||0||
59600441|NCT03926065|75710277|FG003|NOT COMPLETED|Study Week 2||0||
59600442|NCT03926065|75710278|FG004|NOT COMPLETED|Study Week 2||0||
59600443|NCT03926065|75710274|FG000|STARTED|Study Week 3||11||
59600444|NCT03926065|75710275|FG001|STARTED|Study Week 3||9||
59600445|NCT03926065|75710276|FG002|STARTED|Study Week 3||14||
59600446|NCT03926065|75710277|FG003|STARTED|Study Week 3||18||
59600447|NCT03926065|75710278|FG004|STARTED|Study Week 3||15||
59600448|NCT03926065|75710274|FG000|COMPLETED|Study Week 3||11||
59600449|NCT03926065|75710275|FG001|COMPLETED|Study Week 3||9||
59600450|NCT03926065|75710276|FG002|COMPLETED|Study Week 3||14||
59600451|NCT03926065|75710277|FG003|COMPLETED|Study Week 3||18||
59600452|NCT03926065|75710278|FG004|COMPLETED|Study Week 3||15||
59600453|NCT03926065|75710274|FG000|NOT COMPLETED|Study Week 3||0||
59600454|NCT03926065|75710275|FG001|NOT COMPLETED|Study Week 3||0||
59600455|NCT03926065|75710276|FG002|NOT COMPLETED|Study Week 3||0||
59600456|NCT03926065|75710277|FG003|NOT COMPLETED|Study Week 3||0||
59600457|NCT03926065|75710278|FG004|NOT COMPLETED|Study Week 3||0||
59600458|NCT03926065|75710274|FG000|STARTED|Study Week 4||11||
59600459|NCT03926065|75710275|FG001|STARTED|Study Week 4||9||
59600460|NCT03926065|75710276|FG002|STARTED|Study Week 4||14||
59600461|NCT03926065|75710277|FG003|STARTED|Study Week 4||18||
59600462|NCT03926065|75710278|FG004|STARTED|Study Week 4||15||
59600463|NCT03926065|75710274|FG000|COMPLETED|Study Week 4||11||
59600464|NCT03926065|75710275|FG001|COMPLETED|Study Week 4||9||
59600465|NCT03926065|75710276|FG002|COMPLETED|Study Week 4||14||
59600466|NCT03926065|75710277|FG003|COMPLETED|Study Week 4||18||
59600467|NCT03926065|75710278|FG004|COMPLETED|Study Week 4||15||
59600468|NCT03926065|75710274|FG000|NOT COMPLETED|Study Week 4||0||
59600469|NCT03926065|75710275|FG001|NOT COMPLETED|Study Week 4||0||
59600470|NCT03926065|75710276|FG002|NOT COMPLETED|Study Week 4||0||
59600471|NCT03926065|75710277|FG003|NOT COMPLETED|Study Week 4||0||
59600472|NCT03926065|75710278|FG004|NOT COMPLETED|Study Week 4||0||
59600473|NCT03663283|75710290|FG000|STARTED|Overall Study||52||
59600474|NCT03663283|75710291|FG001|STARTED|Overall Study||52||
59600475|NCT03663283|75710290|FG000|COMPLETED|Overall Study||52||
59600476|NCT03663283|75710291|FG001|COMPLETED|Overall Study||52||
59600477|NCT03663283|75710290|FG000|NOT COMPLETED|Overall Study||0||
59600478|NCT03663283|75710291|FG001|NOT COMPLETED|Overall Study||0||
59600479|NCT03909763|75710297|FG000|STARTED|Overall Study||55||
59600480|NCT03909763|75710297|FG000|COMPLETED|Overall Study||45||
59600481|NCT03909763|75710297|FG000|NOT COMPLETED|Overall Study||10||
59600482|NCT00484718|75710301|FG000|STARTED|Treatment Period 1 (2 Weeks)||1||
59600483|NCT00484718|75710302|FG001|STARTED|Treatment Period 1 (2 Weeks)||1||
59600484|NCT00484718|75710303|FG002|STARTED|Treatment Period 1 (2 Weeks)||1||
59600485|NCT00484718|75710304|FG003|STARTED|Treatment Period 1 (2 Weeks)||1||
59600486|NCT00484718|75710305|FG004|STARTED|Treatment Period 1 (2 Weeks)||1||
59600487|NCT00484718|75710306|FG005|STARTED|Treatment Period 1 (2 Weeks)||1||
59600488|NCT00484718|75710301|FG000|COMPLETED|Treatment Period 1 (2 Weeks)||1||
59600489|NCT00484718|75710302|FG001|COMPLETED|Treatment Period 1 (2 Weeks)||1||
59600490|NCT00484718|75710303|FG002|COMPLETED|Treatment Period 1 (2 Weeks)||1||
59600491|NCT00484718|75710304|FG003|COMPLETED|Treatment Period 1 (2 Weeks)||1||
59600492|NCT00484718|75710305|FG004|COMPLETED|Treatment Period 1 (2 Weeks)||1||
59600493|NCT00484718|75710306|FG005|COMPLETED|Treatment Period 1 (2 Weeks)||1||
59600494|NCT00484718|75710301|FG000|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0||
59600495|NCT00484718|75710302|FG001|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0||
59600496|NCT00484718|75710303|FG002|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0||
59600497|NCT00484718|75710304|FG003|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0||
59600498|NCT00484718|75710305|FG004|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0||
59600499|NCT00484718|75710306|FG005|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0||
59600500|NCT00484718|75710301|FG000|STARTED|Washout Period (2 Weeks)||1||
59600501|NCT00484718|75710302|FG001|STARTED|Washout Period (2 Weeks)||1||
59600502|NCT00484718|75710303|FG002|STARTED|Washout Period (2 Weeks)||1||
59600503|NCT00484718|75710304|FG003|STARTED|Washout Period (2 Weeks)||1||
59600504|NCT00484718|75710305|FG004|STARTED|Washout Period (2 Weeks)||1||
59600505|NCT00484718|75710306|FG005|STARTED|Washout Period (2 Weeks)||1||
59600506|NCT00484718|75710301|FG000|COMPLETED|Washout Period (2 Weeks)||1||
59600507|NCT00484718|75710302|FG001|COMPLETED|Washout Period (2 Weeks)||1||
59600508|NCT00484718|75710303|FG002|COMPLETED|Washout Period (2 Weeks)||1||
59600509|NCT00484718|75710304|FG003|COMPLETED|Washout Period (2 Weeks)||1||
59600510|NCT00484718|75710305|FG004|COMPLETED|Washout Period (2 Weeks)||1||
59600511|NCT00484718|75710306|FG005|COMPLETED|Washout Period (2 Weeks)||1||
59728559|NCT00824005|75847201|FG000|COMPLETED|Overall Study||31||
59728560|NCT00824005|75847202|FG001|COMPLETED|Overall Study||59||
59728561|NCT00824005|75847201|FG000|NOT COMPLETED|Overall Study||0||
59728562|NCT00824005|75847202|FG001|NOT COMPLETED|Overall Study||2||
59728563|NCT00814879|75847210|FG000|STARTED|By Week 24||28||
59728564|NCT00814879|75847211|FG001|STARTED|By Week 24||30||
59728565|NCT00814879|75847210|FG000|COMPLETED|By Week 24||27||
59728566|NCT00814879|75847211|FG001|COMPLETED|By Week 24||29||
59728567|NCT00814879|75847210|FG000|NOT COMPLETED|By Week 24||1||
59600512|NCT00484718|75710301|FG000|NOT COMPLETED|Washout Period (2 Weeks)||0||
59600513|NCT00484718|75710302|FG001|NOT COMPLETED|Washout Period (2 Weeks)||0||
59600514|NCT00484718|75710303|FG002|NOT COMPLETED|Washout Period (2 Weeks)||0||
59600515|NCT00484718|75710304|FG003|NOT COMPLETED|Washout Period (2 Weeks)||0||
59600516|NCT00484718|75710305|FG004|NOT COMPLETED|Washout Period (2 Weeks)||0||
59600517|NCT00484718|75710306|FG005|NOT COMPLETED|Washout Period (2 Weeks)||0||
59600518|NCT00484718|75710301|FG000|STARTED|Treatment Period 2 (2 Weeks)||1||
59728568|NCT00814879|75847211|FG001|NOT COMPLETED|By Week 24||1||
59600519|NCT00484718|75710302|FG001|STARTED|Treatment Period 2 (2 Weeks)||1||
59600520|NCT00484718|75710303|FG002|STARTED|Treatment Period 2 (2 Weeks)||1||
59728569|NCT00814879|75847210|FG000|STARTED|By Week 48||27||
59728570|NCT00814879|75847211|FG001|STARTED|By Week 48||29||
59728571|NCT00814879|75847210|FG000|COMPLETED|By Week 48||25||
59728572|NCT00814879|75847211|FG001|COMPLETED|By Week 48||26||
59728573|NCT00814879|75847210|FG000|NOT COMPLETED|By Week 48||2||
59728574|NCT00814879|75847211|FG001|NOT COMPLETED|By Week 48||3||
59728575|NCT03347422|75847220|FG000|STARTED|Part A (26 Weeks)||22||
59728576|NCT03347422|75847221|FG001|STARTED|Part A (26 Weeks)||20||
59728577|NCT03347422|75847220|FG000|COMPLETED|Part A (26 Weeks)||19||
59728578|NCT03347422|75847221|FG001|COMPLETED|Part A (26 Weeks)||20||
59728579|NCT03347422|75847220|FG000|NOT COMPLETED|Part A (26 Weeks)||3||
59728580|NCT03347422|75847221|FG001|NOT COMPLETED|Part A (26 Weeks)||0||
59728581|NCT03347422|75847220|FG000|STARTED|Part B (149 Weeks)||19||
59728582|NCT03347422|75847221|FG001|STARTED|Part B (149 Weeks)||20||
59728583|NCT03347422|75847220|FG000|COMPLETED|Part B (149 Weeks)||16||
59728584|NCT03347422|75847221|FG001|COMPLETED|Part B (149 Weeks)||16||
59728585|NCT03347422|75847220|FG000|NOT COMPLETED|Part B (149 Weeks)||3||
59728586|NCT03347422|75847221|FG001|NOT COMPLETED|Part B (149 Weeks)||4||
59728587|NCT00814801|75847237|FG000|STARTED|Overall Study||194||
59728588|NCT00814801|75847238|FG001|STARTED|Overall Study||192||
59728589|NCT00814801|75847239|FG002|STARTED|Overall Study||194||
59728590|NCT00814801|75847237|FG000|COMPLETED|Overall Study||160||
59728591|NCT00814801|75847238|FG001|COMPLETED|Overall Study||154||
59728592|NCT00814801|75847239|FG002|COMPLETED|Overall Study||151||
59728593|NCT00814801|75847237|FG000|NOT COMPLETED|Overall Study||34||
59728594|NCT00814801|75847238|FG001|NOT COMPLETED|Overall Study||38||
59728595|NCT00814801|75847239|FG002|NOT COMPLETED|Overall Study||43||
59728596|NCT00823615|75847247|FG000|STARTED|Period 1||19||
59728597|NCT00823615|75847248|FG001|STARTED|Period 1||19||
59728598|NCT00823615|75847247|FG000|COMPLETED|Period 1||19||
59728599|NCT00823615|75847248|FG001|COMPLETED|Period 1||19||
59728600|NCT00823615|75847247|FG000|NOT COMPLETED|Period 1||0||
59728601|NCT00823615|75847248|FG001|NOT COMPLETED|Period 1||0||
59728602|NCT00823615|75847247|FG000|STARTED|Period 2||19||
59728603|NCT00823615|75847248|FG001|STARTED|Period 2||19||
59728604|NCT00823615|75847247|FG000|COMPLETED|Period 2||16||
59728605|NCT00823615|75847248|FG001|COMPLETED|Period 2||17||
59728606|NCT00823615|75847247|FG000|NOT COMPLETED|Period 2||3||
59728607|NCT00823615|75847248|FG001|NOT COMPLETED|Period 2||2||
59728608|NCT00812461|75847256|FG000|STARTED|All Randomised Patients||360||
59728609|NCT00812461|75847257|FG001|STARTED|All Randomised Patients||358||
59728610|NCT00812461|75847256|FG000|COMPLETED|All Randomised Patients||337||
59728611|NCT00812461|75847257|FG001|COMPLETED|All Randomised Patients||341||
59728612|NCT00812461|75847256|FG000|NOT COMPLETED|All Randomised Patients||23||
59728613|NCT00812461|75847257|FG001|NOT COMPLETED|All Randomised Patients||17||
59728614|NCT00812461|75847256|FG000|STARTED|All Treated Patients||337||
59728615|NCT00812461|75847257|FG001|STARTED|All Treated Patients||341||
59728616|NCT00812461|75847256|FG000|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|205||
59728617|NCT00812461|75847257|FG001|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|194||
59728618|NCT00812461|75847256|FG000|NOT COMPLETED|All Treated Patients||132||
59728619|NCT00812461|75847257|FG001|NOT COMPLETED|All Treated Patients||147||
59728620|NCT00599326|75847263|FG000|STARTED|Overall Study||10||
59728621|NCT00599326|75847263|FG000|COMPLETED|Overall Study||8||
59728622|NCT00599326|75847263|FG000|NOT COMPLETED|Overall Study||2||
59728623|NCT00978432|75847270|FG000|STARTED|Overall Study||10||
59728624|NCT00978432|75847271|FG001|STARTED|Overall Study||5||
59728625|NCT00978432|75847272|FG002|STARTED|Overall Study||18||
59728626|NCT00978432|75847270|FG000|COMPLETED|Overall Study||7||
59728627|NCT00978432|75847271|FG001|COMPLETED|Overall Study||4||
59728628|NCT00978432|75847272|FG002|COMPLETED|Overall Study||13||
59728629|NCT00978432|75847270|FG000|NOT COMPLETED|Overall Study||3||
59728630|NCT00978432|75847271|FG001|NOT COMPLETED|Overall Study||1||
59728631|NCT00978432|75847272|FG002|NOT COMPLETED|Overall Study||5||
59728632|NCT00975780|75847282|FG000|STARTED|Allocation||400||
59728633|NCT00975780|75847283|FG001|STARTED|Allocation||434||
59728634|NCT00975780|75847282|FG000|COMPLETED|Allocation||400||
59728635|NCT00975780|75847283|FG001|COMPLETED|Allocation||434||
59728636|NCT00975780|75847282|FG000|NOT COMPLETED|Allocation||0||
59728637|NCT00975780|75847283|FG001|NOT COMPLETED|Allocation||0||
59728638|NCT00975780|75847282|FG000|STARTED|Follow Up||400||
59728639|NCT00975780|75847283|FG001|STARTED|Follow Up||434||
59728640|NCT00975780|75847282|FG000|COMPLETED|Follow Up||298||
59728641|NCT00975780|75847283|FG001|COMPLETED|Follow Up||277||
59728642|NCT00975780|75847282|FG000|NOT COMPLETED|Follow Up||102||
59728643|NCT00975780|75847283|FG001|NOT COMPLETED|Follow Up||157||
59728644|NCT00814489|75847292|FG000|STARTED|Overall Study||15||
59728645|NCT00814489|75847293|FG001|STARTED|Overall Study||17||
59728646|NCT00814489|75847294|FG002|STARTED|Overall Study||8||
59728647|NCT00814489|75847292|FG000|COMPLETED|Overall Study||13||
59728648|NCT00814489|75847293|FG001|COMPLETED|Overall Study||17||
59728649|NCT00814489|75847294|FG002|COMPLETED|Overall Study||7||
59728650|NCT00814489|75847292|FG000|NOT COMPLETED|Overall Study||2||
59728651|NCT00814489|75847293|FG001|NOT COMPLETED|Overall Study||0||
59728652|NCT00814489|75847294|FG002|NOT COMPLETED|Overall Study||1||
59728653|NCT00814333|75847306|FG000|STARTED|Enrollment||1||
59728654|NCT00814333|75847307|FG001|STARTED|Enrollment||0||
59728655|NCT00814333|75847306|FG000|COMPLETED|Enrollment||0||
59728656|NCT00814333|75847307|FG001|COMPLETED|Enrollment||0||
59728657|NCT00814333|75847306|FG000|NOT COMPLETED|Enrollment||1||
59728658|NCT00814333|75847307|FG001|NOT COMPLETED|Enrollment||0||
59728659|NCT00814333|75847306|FG000|STARTED|Treatment Period||0||
59728660|NCT00814333|75847307|FG001|STARTED|Treatment Period||0||
59728661|NCT00814333|75847306|FG000|COMPLETED|Treatment Period||0||
59728662|NCT00814333|75847307|FG001|COMPLETED|Treatment Period||0||
59728663|NCT00814333|75847306|FG000|NOT COMPLETED|Treatment Period||0||
59728664|NCT00814333|75847307|FG001|NOT COMPLETED|Treatment Period||0||
59728665|NCT01147250|75847315|FG000|STARTED|Overall Study||3034||
59728666|NCT01147250|75847316|FG001|STARTED|Overall Study||3034||
59728667|NCT01147250|75847315|FG000|Treated|Overall Study||3032||
59728668|NCT01147250|75847316|FG001|Treated|Overall Study||3031||
59728669|NCT01147250|75847315|FG000|COMPLETED|Overall Study||2924||
59728670|NCT01147250|75847316|FG001|COMPLETED|Overall Study||2929||
59728671|NCT01147250|75847315|FG000|NOT COMPLETED|Overall Study||110||
59728672|NCT01147250|75847316|FG001|NOT COMPLETED|Overall Study||105||
59728673|NCT00813943|75847325|FG000|STARTED|Overall Study||88||
59728674|NCT00813943|75847326|FG001|STARTED|Overall Study||88||
59728675|NCT00813943|75847327|FG002|STARTED|Overall Study||89||
59728676|NCT00813943|75847325|FG000|COMPLETED|Overall Study||83||
59728677|NCT00813943|75847326|FG001|COMPLETED|Overall Study||83||
59728678|NCT00813943|75847327|FG002|COMPLETED|Overall Study||86||
59728679|NCT00813943|75847325|FG000|NOT COMPLETED|Overall Study||5||
59728680|NCT00813943|75847326|FG001|NOT COMPLETED|Overall Study||5||
59728681|NCT00813943|75847327|FG002|NOT COMPLETED|Overall Study||3||
59728682|NCT00821509|75847339|FG000|STARTED|Overall Study||257||
59728683|NCT00821509|75847340|FG001|STARTED|Overall Study||202||
59728684|NCT00821509|75847341|FG002|STARTED|Overall Study||224||
59728685|NCT00821509|75847339|FG000|COMPLETED|Overall Study|This is a result of 56 lost-to-follow-up and 44 new recruits|245||
59728686|NCT00821509|75847340|FG001|COMPLETED|Overall Study|This is a result of 57 lost-to-follow-up and 46 new recruits|191||
59728687|NCT00821509|75847341|FG002|COMPLETED|Overall Study|This is a result of 50 lost-to-follow-up and 16 new recruits|190||
59728688|NCT00821509|75847339|FG000|NOT COMPLETED|Overall Study||12||
59728689|NCT00821509|75847340|FG001|NOT COMPLETED|Overall Study||11||
59728690|NCT00821509|75847341|FG002|NOT COMPLETED|Overall Study||34||
59728691|NCT00821431|75847351|FG000|STARTED|Overall Study||38||
59728692|NCT00821431|75847352|FG001|STARTED|Overall Study||52||
59728693|NCT00821431|75847351|FG000|COMPLETED|Overall Study||23||
59728694|NCT00821431|75847352|FG001|COMPLETED|Overall Study||47||
59728695|NCT00821431|75847351|FG000|NOT COMPLETED|Overall Study||15||
59728696|NCT00821431|75847352|FG001|NOT COMPLETED|Overall Study||5||
59728697|NCT00813865|75847358|FG000|STARTED|Overall Study||8||
59728698|NCT00813865|75847358|FG000|Safety Population|Overall Study||8|All participants who received at least 1 dose of study drug|
59728699|NCT00813865|75847358|FG000|Pharmacodynamic (PD) Population|Overall Study||8|Participants in the Safety Population with a baseline and at least 1 post-baseline PD measurement.|
59728700|NCT00813865|75847358|FG000|COMPLETED|Overall Study||1||
59728701|NCT00813865|75847358|FG000|NOT COMPLETED|Overall Study||7||
59728702|NCT01147172|75847362|FG000|STARTED|Overall Study||100||
59728703|NCT01147172|75847362|FG000|COMPLETED|Overall Study||96||
59728704|NCT01147172|75847362|FG000|NOT COMPLETED|Overall Study||4||
59728705|NCT01120964|75847370|FG000|STARTED|Overall Study||11||
59728706|NCT01120964|75847371|FG001|STARTED|Overall Study||11||
59728707|NCT01120964|75847370|FG000|COMPLETED|Overall Study||10||
59728708|NCT01120964|75847371|FG001|COMPLETED|Overall Study||11||
59728709|NCT01120964|75847370|FG000|NOT COMPLETED|Overall Study||1||
59728710|NCT01120964|75847371|FG001|NOT COMPLETED|Overall Study||0||
59728711|NCT01146860|75847379|FG000|STARTED|Overall Study||194||
59728712|NCT01146860|75847380|FG001|STARTED|Overall Study||192||
59728713|NCT01146860|75847379|FG000|COMPLETED|Overall Study||194||
59728714|NCT01146860|75847380|FG001|COMPLETED|Overall Study||191||
59728715|NCT01146860|75847379|FG000|NOT COMPLETED|Overall Study||0||
59728716|NCT01146860|75847380|FG001|NOT COMPLETED|Overall Study||1||
59728717|NCT00591565|75847386|FG000|STARTED|Overall Study||13||
59728718|NCT00591565|75847386|FG000|COMPLETED|Overall Study||8||
59728719|NCT00591565|75847386|FG000|NOT COMPLETED|Overall Study||5||
59728720|NCT01146782|75847390|FG000|STARTED|Screening Cohort||367||
59728721|NCT01146782|75847390|FG000|COMPLETED|Screening Cohort||146||
59728722|NCT01146782|75847390|FG000|NOT COMPLETED|Screening Cohort||221||
59728723|NCT01146782|75847390|FG000|STARTED|Safety Cohort||146||
59728724|NCT01146782|75847390|FG000|COMPLETED|Safety Cohort||63||
59728725|NCT01146782|75847390|FG000|NOT COMPLETED|Safety Cohort||83||
59728726|NCT01146782|75847390|FG000|STARTED|Primary Endpoint Cohort|63 Subjects in the Primary Endpoint Cohort|63||
59728727|NCT01146782|75847390|FG000|COMPLETED|Primary Endpoint Cohort|57 Subjects in the Primary Endpoint Cohort completed the 28 day study|57||
59728728|NCT01146782|75847390|FG000|NOT COMPLETED|Primary Endpoint Cohort||6||
59728729|NCT00978120|75847399|FG000|STARTED|Overall Study||110||
59728730|NCT00978120|75847400|FG001|STARTED|Overall Study||107||
59728731|NCT00978120|75847401|FG002|STARTED|Overall Study||87||
59728732|NCT00978120|75847402|FG003|STARTED|Overall Study||86||
59728733|NCT00978120|75847399|FG000|COMPLETED|Overall Study||108||
59728734|NCT00978120|75847400|FG001|COMPLETED|Overall Study||107||
59728735|NCT00978120|75847401|FG002|COMPLETED|Overall Study||84||
59728736|NCT00978120|75847402|FG003|COMPLETED|Overall Study||84||
59728737|NCT00978120|75847399|FG000|NOT COMPLETED|Overall Study||2||
59728738|NCT00978120|75847400|FG001|NOT COMPLETED|Overall Study||0||
59728739|NCT00978120|75847401|FG002|NOT COMPLETED|Overall Study||3||
59728740|NCT00978120|75847402|FG003|NOT COMPLETED|Overall Study||2||
59728741|NCT00978042|75847418|FG000|STARTED|Initial Treatment Period||235||
59728742|NCT00978042|75847419|FG001|STARTED|Initial Treatment Period||47||
59728743|NCT00978042|75847418|FG000|MITT_treated With VOLUMA XC|Initial Treatment Period||235||
59728744|NCT00978042|75847419|FG001|MITT_treated With VOLUMA XC|Initial Treatment Period||35||
59728745|NCT00978042|75847418|FG000|COMPLETED|Initial Treatment Period|Completed 24-month Follow-Up|174||
59728746|NCT00978042|75847419|FG001|COMPLETED|Initial Treatment Period||32||
59728747|NCT00978042|75847418|FG000|NOT COMPLETED|Initial Treatment Period||61||
59728748|NCT00978042|75847419|FG001|NOT COMPLETED|Initial Treatment Period||15||
59728749|NCT00978042|75847418|FG000|STARTED|Received Repeat Treatment|Participants who were deemed eligible for re-treatment.|141||
59728750|NCT00978042|75847419|FG001|STARTED|Received Repeat Treatment|Participants who were deemed eligible for re-treatment.|26||
59728751|NCT00978042|75847418|FG000|COMPLETED|Received Repeat Treatment|Completed=Completed Repeat Treatment Follow-up|98||
59728752|NCT00978042|75847419|FG001|COMPLETED|Received Repeat Treatment||23||
59728753|NCT00978042|75847418|FG000|NOT COMPLETED|Received Repeat Treatment||43||
59728754|NCT00978042|75847419|FG001|NOT COMPLETED|Received Repeat Treatment||3||
59728755|NCT01133678|75847427|FG000|STARTED|Overall Study||25||
59728756|NCT01133678|75847428|FG001|STARTED|Overall Study||25||
59728757|NCT01133678|75847427|FG000|COMPLETED|Overall Study||24||
59728758|NCT01133678|75847428|FG001|COMPLETED|Overall Study||24||
59728759|NCT01133678|75847427|FG000|NOT COMPLETED|Overall Study||1||
59728760|NCT01133678|75847428|FG001|NOT COMPLETED|Overall Study||1||
59728761|NCT01133522|75847444|FG000|STARTED|Overall Study||10||
59728762|NCT01133522|75847445|FG001|STARTED|Overall Study||7||
59728763|NCT01133522|75847446|FG002|STARTED|Overall Study||6||
59728764|NCT01133522|75847447|FG003|STARTED|Overall Study||7||
59728765|NCT01133522|75847448|FG004|STARTED|Overall Study||7||
59728766|NCT01133522|75847449|FG005|STARTED|Overall Study||6||
59728767|NCT01133522|75847450|FG006|STARTED|Overall Study||2||
59728768|NCT01133522|75847451|FG007|STARTED|Overall Study||9||
59728769|NCT01133522|75847452|FG008|STARTED|Overall Study||2||
59728770|NCT01133522|75847453|FG009|STARTED|Overall Study||4||
59728771|NCT01133522|75847444|FG000|Received Treatment|Overall Study||10||
59728772|NCT01133522|75847445|FG001|Received Treatment|Overall Study||6||
59728773|NCT01133522|75847446|FG002|Received Treatment|Overall Study||6||
59728774|NCT01133522|75847447|FG003|Received Treatment|Overall Study||6||
59728775|NCT01133522|75847448|FG004|Received Treatment|Overall Study||6||
59728776|NCT01133522|75847449|FG005|Received Treatment|Overall Study||6||
59728777|NCT01133522|75847450|FG006|Received Treatment|Overall Study||2||
59728778|NCT01133522|75847451|FG007|Received Treatment|Overall Study||9||
59728779|NCT01133522|75847452|FG008|Received Treatment|Overall Study||2||
59728780|NCT01133522|75847453|FG009|Received Treatment|Overall Study||4||
59728781|NCT01133522|75847444|FG000|COMPLETED|Overall Study||10||
59728782|NCT01133522|75847445|FG001|COMPLETED|Overall Study||6||
59728783|NCT01133522|75847446|FG002|COMPLETED|Overall Study||6||
59728784|NCT01133522|75847447|FG003|COMPLETED|Overall Study||6||
59728785|NCT01133522|75847448|FG004|COMPLETED|Overall Study||6||
59728786|NCT01133522|75847449|FG005|COMPLETED|Overall Study||6||
59728787|NCT01133522|75847450|FG006|COMPLETED|Overall Study||2||
59728788|NCT01133522|75847451|FG007|COMPLETED|Overall Study||9||
59728789|NCT01133522|75847452|FG008|COMPLETED|Overall Study||2||
59728790|NCT01133522|75847453|FG009|COMPLETED|Overall Study||4||
59728791|NCT01133522|75847444|FG000|NOT COMPLETED|Overall Study||0||
59600521|NCT00484718|75710304|FG003|STARTED|Treatment Period 2 (2 Weeks)||1||
59600522|NCT00484718|75710305|FG004|STARTED|Treatment Period 2 (2 Weeks)||1||
59600523|NCT00484718|75710306|FG005|STARTED|Treatment Period 2 (2 Weeks)||1||
59600524|NCT00484718|75710301|FG000|COMPLETED|Treatment Period 2 (2 Weeks)||1||
59600525|NCT00484718|75710302|FG001|COMPLETED|Treatment Period 2 (2 Weeks)||1||
59600526|NCT00484718|75710303|FG002|COMPLETED|Treatment Period 2 (2 Weeks)||1||
59600527|NCT00484718|75710304|FG003|COMPLETED|Treatment Period 2 (2 Weeks)||1||
59600528|NCT00484718|75710305|FG004|COMPLETED|Treatment Period 2 (2 Weeks)||1||
59728792|NCT01133522|75847445|FG001|NOT COMPLETED|Overall Study||1||
59728793|NCT01133522|75847446|FG002|NOT COMPLETED|Overall Study||0||
59728794|NCT01133522|75847447|FG003|NOT COMPLETED|Overall Study||1||
59728795|NCT01133522|75847448|FG004|NOT COMPLETED|Overall Study||1||
59728796|NCT01133522|75847449|FG005|NOT COMPLETED|Overall Study||0||
59728797|NCT01133522|75847450|FG006|NOT COMPLETED|Overall Study||0||
59998397|NCT02487095|76114049|FG004|STARTED|Dose Expansion||41||
59728798|NCT01133522|75847451|FG007|NOT COMPLETED|Overall Study||0||
59728799|NCT01133522|75847452|FG008|NOT COMPLETED|Overall Study||0||
59728800|NCT01133522|75847453|FG009|NOT COMPLETED|Overall Study||0||
59728801|NCT01133288|75847482|FG000|STARTED|Eligibility Assessment||7||
59728802|NCT01133288|75847482|FG000|COMPLETED|Eligibility Assessment||2||
59728803|NCT01133288|75847482|FG000|NOT COMPLETED|Eligibility Assessment||5||
59728804|NCT01133288|75847482|FG000|STARTED|Intervention Allocation||2||
59728805|NCT01133288|75847482|FG000|COMPLETED|Intervention Allocation||0||
59728806|NCT01133288|75847482|FG000|NOT COMPLETED|Intervention Allocation||2||
59728807|NCT04058626|75847486|FG000|STARTED|Overall Study||305||
59728808|NCT04058626|75847486|FG000|COMPLETED|Overall Study||305||
59728809|NCT04058626|75847486|FG000|NOT COMPLETED|Overall Study||0||
59728810|NCT00883090|75847490|FG000|STARTED|Overall Study|Of the 15 participants started, 14 were administered FXIII|15||
59728811|NCT00883090|75847490|FG000|COMPLETED|Overall Study||13||
59728812|NCT00883090|75847490|FG000|NOT COMPLETED|Overall Study||2||
59728813|NCT01132820|75847494|FG000|STARTED|Overall Study||53||
59728814|NCT01132820|75847494|FG000|COMPLETED|Overall Study||48||
59728815|NCT01132820|75847494|FG000|NOT COMPLETED|Overall Study||5||
59728816|NCT00353470|75847501|FG000|STARTED|Overall Study||81||
59728817|NCT00353470|75847502|FG001|STARTED|Overall Study||81||
59728818|NCT00353470|75847503|FG002|STARTED|Overall Study||39||
59728819|NCT00353470|75847501|FG000|COMPLETED|Overall Study||61||
59728820|NCT00353470|75847502|FG001|COMPLETED|Overall Study||61||
59728821|NCT00353470|75847503|FG002|COMPLETED|Overall Study||23||
59728822|NCT00353470|75847501|FG000|NOT COMPLETED|Overall Study||20||
59728823|NCT00353470|75847502|FG001|NOT COMPLETED|Overall Study||20||
59728824|NCT00353470|75847503|FG002|NOT COMPLETED|Overall Study||16||
59728825|NCT00885352|75847513|FG000|STARTED|Overall Study||157||
59728826|NCT00885352|75847514|FG001|STARTED|Overall Study||156||
59728827|NCT00885352|75847513|FG000|COMPLETED|Overall Study||149||
59728828|NCT00885352|75847514|FG001|COMPLETED|Overall Study||136||
59728829|NCT00885352|75847513|FG000|NOT COMPLETED|Overall Study||8||
59728830|NCT00885352|75847514|FG001|NOT COMPLETED|Overall Study||20||
59728831|NCT00885118|75847525|FG000|STARTED|Overall Study||21||
59728832|NCT00885118|75847526|FG001|STARTED|Overall Study||19||
59728833|NCT00885118|75847527|FG002|STARTED|Overall Study||21||
59728834|NCT00885118|75847528|FG003|STARTED|Overall Study||20||
59728835|NCT00885118|75847529|FG004|STARTED|Overall Study||19||
59728836|NCT00885118|75847525|FG000|COMPLETED|Overall Study||20||
59728837|NCT00885118|75847526|FG001|COMPLETED|Overall Study||19||
59728838|NCT00885118|75847527|FG002|COMPLETED|Overall Study||20||
59728839|NCT00885118|75847528|FG003|COMPLETED|Overall Study||20||
59728840|NCT00885118|75847529|FG004|COMPLETED|Overall Study||18||
59728841|NCT00885118|75847525|FG000|NOT COMPLETED|Overall Study||1||
59728842|NCT00885118|75847526|FG001|NOT COMPLETED|Overall Study||0||
59728843|NCT00885118|75847527|FG002|NOT COMPLETED|Overall Study||1||
59728844|NCT00885118|75847528|FG003|NOT COMPLETED|Overall Study||0||
59728845|NCT00885118|75847529|FG004|NOT COMPLETED|Overall Study||1||
59728846|NCT00880906|75847547|FG000|STARTED|Overall Study||29||
59728847|NCT00880906|75847548|FG001|STARTED|Overall Study||21||
59728848|NCT00880906|75847547|FG000|COMPLETED|Overall Study||17||
59728849|NCT00880906|75847548|FG001|COMPLETED|Overall Study||14||
59728850|NCT00880906|75847547|FG000|NOT COMPLETED|Overall Study||12||
59728851|NCT00880906|75847548|FG001|NOT COMPLETED|Overall Study||7||
59728852|NCT00882310|75847554|FG000|STARTED|Overall Study||37||
59728853|NCT00882310|75847554|FG000|COMPLETED|Overall Study||15||
59728854|NCT00882310|75847554|FG000|NOT COMPLETED|Overall Study||22||
59728855|NCT00884650|75847560|FG000|STARTED|Overall Study||25||
59728856|NCT00884650|75847561|FG001|STARTED|Overall Study||29||
59728857|NCT00884650|75847560|FG000|COMPLETED|Overall Study||16||
59728858|NCT00884650|75847561|FG001|COMPLETED|Overall Study||21||
59728859|NCT00884650|75847560|FG000|NOT COMPLETED|Overall Study||9||
59728860|NCT00884650|75847561|FG001|NOT COMPLETED|Overall Study||8||
59728861|NCT00881608|75847573|FG000|STARTED|Overall Study||11||
59728862|NCT00881608|75847573|FG000|COMPLETED|Overall Study||0||
59728863|NCT00881608|75847573|FG000|NOT COMPLETED|Overall Study||11||
59728864|NCT01088399|75847588|FG000|STARTED|Overall Study||8716||
59728865|NCT01088399|75847589|FG001|STARTED|Overall Study||1655||
59728866|NCT01088399|75847590|FG002|STARTED|Overall Study||302||
59728867|NCT01088399|75847588|FG000|COMPLETED|Overall Study||1595||
59728868|NCT01088399|75847589|FG001|COMPLETED|Overall Study||308||
59728869|NCT01088399|75847590|FG002|COMPLETED|Overall Study||21||
59728870|NCT01088399|75847588|FG000|NOT COMPLETED|Overall Study||7121||
59728871|NCT01088399|75847589|FG001|NOT COMPLETED|Overall Study||1347||
59728872|NCT01088399|75847590|FG002|NOT COMPLETED|Overall Study||281||
59728873|NCT00598078|75847598|FG000|STARTED|Period 1 (Day 1)||10||
59728874|NCT00598078|75847599|FG001|STARTED|Period 1 (Day 1)||10||
59728875|NCT00598078|75847598|FG000|COMPLETED|Period 1 (Day 1)||10||
59728876|NCT00598078|75847599|FG001|COMPLETED|Period 1 (Day 1)||10||
59728877|NCT00598078|75847598|FG000|NOT COMPLETED|Period 1 (Day 1)||0||
59728878|NCT00598078|75847599|FG001|NOT COMPLETED|Period 1 (Day 1)||0||
59728879|NCT00598078|75847598|FG000|STARTED|Period 2 (Day 2)||10||
59728880|NCT00598078|75847599|FG001|STARTED|Period 2 (Day 2)||10||
59728881|NCT00598078|75847598|FG000|COMPLETED|Period 2 (Day 2)||9||
59728882|NCT00598078|75847599|FG001|COMPLETED|Period 2 (Day 2)||10||
59728883|NCT00598078|75847598|FG000|NOT COMPLETED|Period 2 (Day 2)||1||
59728884|NCT00598078|75847599|FG001|NOT COMPLETED|Period 2 (Day 2)||0||
59728885|NCT00598078|75847598|FG000|STARTED|Period 3 (Day 3)||9||
59728886|NCT00598078|75847599|FG001|STARTED|Period 3 (Day 3)||10||
59728887|NCT00598078|75847598|FG000|COMPLETED|Period 3 (Day 3)||9||
59728888|NCT00598078|75847599|FG001|COMPLETED|Period 3 (Day 3)||10||
59728889|NCT00598078|75847598|FG000|NOT COMPLETED|Period 3 (Day 3)||0||
59728890|NCT00598078|75847599|FG001|NOT COMPLETED|Period 3 (Day 3)||0||
59728891|NCT01079195|75847607|FG000|STARTED|Overall Study||15873||
59728892|NCT01079195|75847607|FG000|COMPLETED|Overall Study||14442||
59728893|NCT01079195|75847607|FG000|NOT COMPLETED|Overall Study||1431||
59728894|NCT00883558|75847611|FG000|STARTED|Titration Period (Weeks 0 to 4)||48||
59728895|NCT00883558|75847612|FG001|STARTED|Titration Period (Weeks 0 to 4)||0||
59728896|NCT00883558|75847613|FG002|STARTED|Titration Period (Weeks 0 to 4)||0||
59728897|NCT00883558|75847611|FG000|COMPLETED|Titration Period (Weeks 0 to 4)||46||
59728898|NCT00883558|75847612|FG001|COMPLETED|Titration Period (Weeks 0 to 4)||0||
59728899|NCT00883558|75847613|FG002|COMPLETED|Titration Period (Weeks 0 to 4)||0||
59728900|NCT00883558|75847611|FG000|NOT COMPLETED|Titration Period (Weeks 0 to 4)||2||
59728901|NCT00883558|75847612|FG001|NOT COMPLETED|Titration Period (Weeks 0 to 4)||0||
59728902|NCT00883558|75847613|FG002|NOT COMPLETED|Titration Period (Weeks 0 to 4)||0||
59728903|NCT00883558|75847611|FG000|STARTED|First Treatment Cycle (Weeks 4 to 16)||0||
59728904|NCT00883558|75847612|FG001|STARTED|First Treatment Cycle (Weeks 4 to 16)||22||
59728905|NCT00883558|75847613|FG002|STARTED|First Treatment Cycle (Weeks 4 to 16)||24||
59728906|NCT00883558|75847611|FG000|Received at Least 1 Dose of Study Drug|First Treatment Cycle (Weeks 4 to 16)||0||
59728907|NCT00883558|75847612|FG001|Received at Least 1 Dose of Study Drug|First Treatment Cycle (Weeks 4 to 16)||22||
59728908|NCT00883558|75847613|FG002|Received at Least 1 Dose of Study Drug|First Treatment Cycle (Weeks 4 to 16)||24||
59728909|NCT00883558|75847611|FG000|COMPLETED|First Treatment Cycle (Weeks 4 to 16)||0||
59728910|NCT00883558|75847612|FG001|COMPLETED|First Treatment Cycle (Weeks 4 to 16)||19||
59728911|NCT00883558|75847613|FG002|COMPLETED|First Treatment Cycle (Weeks 4 to 16)||23||
59728912|NCT00883558|75847611|FG000|NOT COMPLETED|First Treatment Cycle (Weeks 4 to 16)||0||
59728913|NCT00883558|75847612|FG001|NOT COMPLETED|First Treatment Cycle (Weeks 4 to 16)||3||
59728914|NCT00883558|75847613|FG002|NOT COMPLETED|First Treatment Cycle (Weeks 4 to 16)||1||
59728915|NCT00883558|75847611|FG000|STARTED|Second Treatment Cycle (Weeks 16 to 28)||0||
59728916|NCT00883558|75847612|FG001|STARTED|Second Treatment Cycle (Weeks 16 to 28)||19||
59728917|NCT00883558|75847613|FG002|STARTED|Second Treatment Cycle (Weeks 16 to 28)||23||
59728918|NCT00883558|75847611|FG000|Received at Least 1 Dose of Study Drug|Second Treatment Cycle (Weeks 16 to 28)||0||
59728919|NCT00883558|75847612|FG001|Received at Least 1 Dose of Study Drug|Second Treatment Cycle (Weeks 16 to 28)||19||
59728920|NCT00883558|75847613|FG002|Received at Least 1 Dose of Study Drug|Second Treatment Cycle (Weeks 16 to 28)||23||
59728921|NCT00883558|75847611|FG000|COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||0||
59728922|NCT00883558|75847612|FG001|COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||19||
59728923|NCT00883558|75847613|FG002|COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||22||
59728924|NCT00883558|75847611|FG000|NOT COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||0||
59728925|NCT00883558|75847612|FG001|NOT COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||0||
59728926|NCT00883558|75847613|FG002|NOT COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||1||
59728927|NCT00880750|75847621|FG000|STARTED|First Intervention||39||
59728928|NCT00880750|75847622|FG001|STARTED|First Intervention||33||
59728929|NCT00880750|75847621|FG000|COMPLETED|First Intervention||30||
59728930|NCT00880750|75847622|FG001|COMPLETED|First Intervention||32||
59728931|NCT00880750|75847621|FG000|NOT COMPLETED|First Intervention||9||
59728932|NCT00880750|75847622|FG001|NOT COMPLETED|First Intervention||1||
59728933|NCT00880750|75847621|FG000|STARTED|Washout Period||30||
59728934|NCT00880750|75847622|FG001|STARTED|Washout Period||32||
59728935|NCT00880750|75847621|FG000|COMPLETED|Washout Period||30||
59728936|NCT00880750|75847622|FG001|COMPLETED|Washout Period||32||
59728937|NCT00880750|75847621|FG000|NOT COMPLETED|Washout Period||0||
59728938|NCT00880750|75847622|FG001|NOT COMPLETED|Washout Period||0||
59728939|NCT00880750|75847621|FG000|STARTED|Second Intervention||30||
59728940|NCT00880750|75847622|FG001|STARTED|Second Intervention||32||
59728941|NCT00880750|75847621|FG000|COMPLETED|Second Intervention||26||
59728942|NCT00880750|75847622|FG001|COMPLETED|Second Intervention||30||
59728943|NCT00880750|75847621|FG000|NOT COMPLETED|Second Intervention||4||
59728944|NCT00880750|75847622|FG001|NOT COMPLETED|Second Intervention||2||
59728945|NCT00597766|75847631|FG000|STARTED|Enrolled||9||
59728946|NCT00597766|75847632|FG001|STARTED|Enrolled||9||
59728947|NCT00597766|75847633|FG002|STARTED|Enrolled||10||
59728948|NCT00597766|75847631|FG000|COMPLETED|Enrolled||9||
59728949|NCT00597766|75847632|FG001|COMPLETED|Enrolled||9||
59728950|NCT00597766|75847633|FG002|COMPLETED|Enrolled||10||
59728951|NCT00597766|75847631|FG000|NOT COMPLETED|Enrolled||0||
59728952|NCT00597766|75847632|FG001|NOT COMPLETED|Enrolled||0||
59728953|NCT00597766|75847633|FG002|NOT COMPLETED|Enrolled||0||
59728954|NCT00597766|75847631|FG000|STARTED|Follow-up 1, Week 4||9||
59728955|NCT00597766|75847632|FG001|STARTED|Follow-up 1, Week 4||9||
59728956|NCT00597766|75847633|FG002|STARTED|Follow-up 1, Week 4||10||
59728957|NCT00597766|75847631|FG000|COMPLETED|Follow-up 1, Week 4||8||
59728958|NCT00597766|75847632|FG001|COMPLETED|Follow-up 1, Week 4||9||
59728959|NCT00597766|75847633|FG002|COMPLETED|Follow-up 1, Week 4||10||
59728960|NCT00597766|75847631|FG000|NOT COMPLETED|Follow-up 1, Week 4||1||
59728961|NCT00597766|75847632|FG001|NOT COMPLETED|Follow-up 1, Week 4||0||
59728962|NCT00597766|75847633|FG002|NOT COMPLETED|Follow-up 1, Week 4||0||
59728963|NCT00597766|75847631|FG000|STARTED|Follow-up 2, Week 8||8||
59728964|NCT00597766|75847632|FG001|STARTED|Follow-up 2, Week 8||9||
59728965|NCT00597766|75847633|FG002|STARTED|Follow-up 2, Week 8||10||
59728966|NCT00597766|75847631|FG000|COMPLETED|Follow-up 2, Week 8||8||
59728967|NCT00597766|75847632|FG001|COMPLETED|Follow-up 2, Week 8||9||
59728968|NCT00597766|75847633|FG002|COMPLETED|Follow-up 2, Week 8||9||
59728969|NCT00597766|75847631|FG000|NOT COMPLETED|Follow-up 2, Week 8||0||
59728970|NCT00597766|75847632|FG001|NOT COMPLETED|Follow-up 2, Week 8||0||
59728971|NCT00597766|75847633|FG002|NOT COMPLETED|Follow-up 2, Week 8||1||
59728972|NCT00597766|75847631|FG000|STARTED|Follow-up 3, Week 12||8||
59728973|NCT00597766|75847632|FG001|STARTED|Follow-up 3, Week 12||9||
59728974|NCT00597766|75847633|FG002|STARTED|Follow-up 3, Week 12||9||
59728975|NCT00597766|75847631|FG000|COMPLETED|Follow-up 3, Week 12||8||
59728976|NCT00597766|75847632|FG001|COMPLETED|Follow-up 3, Week 12||9||
59728977|NCT00597766|75847633|FG002|COMPLETED|Follow-up 3, Week 12||9||
59728978|NCT00597766|75847631|FG000|NOT COMPLETED|Follow-up 3, Week 12||0||
59728979|NCT00597766|75847632|FG001|NOT COMPLETED|Follow-up 3, Week 12||0||
59728980|NCT00597766|75847633|FG002|NOT COMPLETED|Follow-up 3, Week 12||0||
59728981|NCT00979992|75847641|FG000|STARTED|Overall Study||35||
59728982|NCT00979992|75847641|FG000|COMPLETED|Overall Study||30||
59728983|NCT00979992|75847641|FG000|NOT COMPLETED|Overall Study||5||
59728984|NCT01079741|75847650|FG000|STARTED|Cohort 1: Dose Level 1 (Weeks 1-12)||3||
59728985|NCT01079741|75847651|FG001|STARTED|Cohort 1: Dose Level 1 (Weeks 1-12)||0||
59728986|NCT01079741|75847652|FG002|STARTED|Cohort 1: Dose Level 1 (Weeks 1-12)||0||
59728987|NCT01079741|75847653|FG003|STARTED|Cohort 1: Dose Level 1 (Weeks 1-12)||0||
59728988|NCT01079741|75847654|FG004|STARTED|Cohort 1: Dose Level 1 (Weeks 1-12)||0||
59728989|NCT01079741|75847650|FG000|COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||3||
59728990|NCT01079741|75847651|FG001|COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0||
59728991|NCT01079741|75847652|FG002|COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0||
59728992|NCT01079741|75847653|FG003|COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0||
59728993|NCT01079741|75847654|FG004|COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0||
59728994|NCT01079741|75847650|FG000|NOT COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0||
59728995|NCT01079741|75847651|FG001|NOT COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0||
59728996|NCT01079741|75847652|FG002|NOT COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0||
59728997|NCT01079741|75847653|FG003|NOT COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0||
59728998|NCT01079741|75847654|FG004|NOT COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0||
59728999|NCT01079741|75847650|FG000|STARTED|Cohort 2: Dose Level 2 (Weeks 13-24)||0||
59729000|NCT01079741|75847651|FG001|STARTED|Cohort 2: Dose Level 2 (Weeks 13-24)||4||
59729001|NCT01079741|75847652|FG002|STARTED|Cohort 2: Dose Level 2 (Weeks 13-24)||0||
59729002|NCT01079741|75847653|FG003|STARTED|Cohort 2: Dose Level 2 (Weeks 13-24)||0||
59729003|NCT01079741|75847654|FG004|STARTED|Cohort 2: Dose Level 2 (Weeks 13-24)||0||
59729004|NCT01079741|75847650|FG000|COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0||
59729005|NCT01079741|75847651|FG001|COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||3||
59729006|NCT01079741|75847652|FG002|COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0||
59729007|NCT01079741|75847653|FG003|COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0||
59729008|NCT01079741|75847654|FG004|COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0||
59729009|NCT01079741|75847650|FG000|NOT COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0||
59729010|NCT01079741|75847651|FG001|NOT COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||1||
59729011|NCT01079741|75847652|FG002|NOT COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0||
59729012|NCT01079741|75847653|FG003|NOT COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0||
59729013|NCT01079741|75847654|FG004|NOT COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0||
59729014|NCT01079741|75847650|FG000|STARTED|Cohort 3: Dose Level 3 (Weeks 25-36)||0||
59729015|NCT01079741|75847651|FG001|STARTED|Cohort 3: Dose Level 3 (Weeks 25-36)||0||
59729016|NCT01079741|75847652|FG002|STARTED|Cohort 3: Dose Level 3 (Weeks 25-36)||3||
59729017|NCT01079741|75847653|FG003|STARTED|Cohort 3: Dose Level 3 (Weeks 25-36)||0||
59729018|NCT01079741|75847654|FG004|STARTED|Cohort 3: Dose Level 3 (Weeks 25-36)||0||
59729019|NCT01079741|75847650|FG000|COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0||
59729020|NCT01079741|75847651|FG001|COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0||
59729021|NCT01079741|75847652|FG002|COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0||
59729022|NCT01079741|75847653|FG003|COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0||
59729023|NCT01079741|75847654|FG004|COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0||
59729024|NCT01079741|75847650|FG000|NOT COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0||
59729025|NCT01079741|75847651|FG001|NOT COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0||
59729026|NCT01079741|75847652|FG002|NOT COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||3||
59729027|NCT01079741|75847653|FG003|NOT COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0||
59729028|NCT01079741|75847654|FG004|NOT COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0||
59729029|NCT01079741|75847650|FG000|STARTED|Phase 2 (Weeks 37-48)||0||
59729030|NCT01079741|75847651|FG001|STARTED|Phase 2 (Weeks 37-48)||0||
59729031|NCT01079741|75847652|FG002|STARTED|Phase 2 (Weeks 37-48)||0||
59729032|NCT01079741|75847653|FG003|STARTED|Phase 2 (Weeks 37-48)||12||
59729033|NCT01079741|75847654|FG004|STARTED|Phase 2 (Weeks 37-48)||12||
59729034|NCT01079741|75847650|FG000|COMPLETED|Phase 2 (Weeks 37-48)||0||
59729035|NCT01079741|75847651|FG001|COMPLETED|Phase 2 (Weeks 37-48)||0||
59729036|NCT01079741|75847652|FG002|COMPLETED|Phase 2 (Weeks 37-48)||0||
59729037|NCT01079741|75847653|FG003|COMPLETED|Phase 2 (Weeks 37-48)||12||
59729038|NCT01079741|75847654|FG004|COMPLETED|Phase 2 (Weeks 37-48)||9||
59729039|NCT01079741|75847650|FG000|NOT COMPLETED|Phase 2 (Weeks 37-48)||0||
59729040|NCT01079741|75847651|FG001|NOT COMPLETED|Phase 2 (Weeks 37-48)||0||
59729041|NCT01079741|75847652|FG002|NOT COMPLETED|Phase 2 (Weeks 37-48)||0||
59729042|NCT01079741|75847653|FG003|NOT COMPLETED|Phase 2 (Weeks 37-48)||0||
59729043|NCT01079741|75847654|FG004|NOT COMPLETED|Phase 2 (Weeks 37-48)||3||
59729044|NCT01079663|75847668|FG000|STARTED|Overall Study||30||
59729045|NCT01079663|75847669|FG001|STARTED|Overall Study||30||
59729046|NCT01079663|75847668|FG000|COMPLETED|Overall Study||30||
59729047|NCT01079663|75847669|FG001|COMPLETED|Overall Study||26||
59729048|NCT01079663|75847668|FG000|NOT COMPLETED|Overall Study||0||
59729049|NCT01079663|75847669|FG001|NOT COMPLETED|Overall Study||4||
59729050|NCT00879814|75847679|FG000|STARTED|Overall Study||12||
59729051|NCT00879814|75847680|FG001|STARTED|Overall Study||12||
59729052|NCT00879814|75847681|FG002|STARTED|Overall Study||12||
59729053|NCT00879814|75847682|FG003|STARTED|Overall Study||12||
59729054|NCT00879814|75847679|FG000|COMPLETED|Overall Study||8||
59729055|NCT00879814|75847680|FG001|COMPLETED|Overall Study||10||
59729056|NCT00879814|75847681|FG002|COMPLETED|Overall Study||9||
59729057|NCT00879814|75847682|FG003|COMPLETED|Overall Study||7||
59729058|NCT00879814|75847679|FG000|NOT COMPLETED|Overall Study||4||
59729059|NCT00879814|75847680|FG001|NOT COMPLETED|Overall Study||2||
59729060|NCT00879814|75847681|FG002|NOT COMPLETED|Overall Study||3||
59729061|NCT00879814|75847682|FG003|NOT COMPLETED|Overall Study||5||
59729062|NCT01132664|75847697|FG000|STARTED|Phase lb||5||
59729063|NCT01132664|75847698|FG001|STARTED|Phase lb||12||
59729064|NCT01132664|75847699|FG002|STARTED|Phase lb||0||
59729065|NCT01132664|75847700|FG003|STARTED|Phase lb||0||
59729066|NCT01132664|75847701|FG004|STARTED|Phase lb||0||
59729067|NCT01132664|75847697|FG000|COMPLETED|Phase lb||0||
59729068|NCT01132664|75847698|FG001|COMPLETED|Phase lb||0||
59729069|NCT01132664|75847699|FG002|COMPLETED|Phase lb||0||
59729070|NCT01132664|75847700|FG003|COMPLETED|Phase lb||0||
59729071|NCT01132664|75847701|FG004|COMPLETED|Phase lb||0||
59729072|NCT01132664|75847697|FG000|NOT COMPLETED|Phase lb||5||
59729073|NCT01132664|75847698|FG001|NOT COMPLETED|Phase lb||12||
59729074|NCT01132664|75847699|FG002|NOT COMPLETED|Phase lb||0||
59729075|NCT01132664|75847700|FG003|NOT COMPLETED|Phase lb||0||
59729076|NCT01132664|75847701|FG004|NOT COMPLETED|Phase lb||0||
59729077|NCT01132664|75847697|FG000|STARTED|Phase ll||0||
59729078|NCT01132664|75847698|FG001|STARTED|Phase ll||0||
59729079|NCT01132664|75847699|FG002|STARTED|Phase ll|Of the 50 patients, 8 were from phase lb & were eligible for inclusion in Phase II|50||
59729080|NCT01132664|75847700|FG003|STARTED|Phase ll||0||
59729081|NCT01132664|75847701|FG004|STARTED|Phase ll||0||
59729082|NCT01132664|75847697|FG000|COMPLETED|Phase ll||0||
59729083|NCT01132664|75847698|FG001|COMPLETED|Phase ll||0||
59729084|NCT01132664|75847699|FG002|COMPLETED|Phase ll||0||
59729085|NCT01132664|75847700|FG003|COMPLETED|Phase ll||0||
59729086|NCT01132664|75847701|FG004|COMPLETED|Phase ll||0||
59729087|NCT01132664|75847697|FG000|NOT COMPLETED|Phase ll||0||
59729088|NCT01132664|75847698|FG001|NOT COMPLETED|Phase ll||0||
59729089|NCT01132664|75847699|FG002|NOT COMPLETED|Phase ll||50||
59729090|NCT01132664|75847700|FG003|NOT COMPLETED|Phase ll||0||
59729091|NCT01132664|75847701|FG004|NOT COMPLETED|Phase ll||0||
59729092|NCT01132664|75847697|FG000|STARTED|BM Cohort||0||
59729093|NCT01132664|75847698|FG001|STARTED|BM Cohort||0||
59729094|NCT01132664|75847699|FG002|STARTED|BM Cohort||0||
59729095|NCT01132664|75847700|FG003|STARTED|BM Cohort||3||
59729096|NCT01132664|75847701|FG004|STARTED|BM Cohort||6||
59729097|NCT01132664|75847697|FG000|COMPLETED|BM Cohort||0||
59729098|NCT01132664|75847698|FG001|COMPLETED|BM Cohort||0||
59729099|NCT01132664|75847699|FG002|COMPLETED|BM Cohort||0||
59729100|NCT01132664|75847700|FG003|COMPLETED|BM Cohort||0||
59729101|NCT01132664|75847701|FG004|COMPLETED|BM Cohort||0||
59729102|NCT01132664|75847697|FG000|NOT COMPLETED|BM Cohort||0||
59729103|NCT01132664|75847698|FG001|NOT COMPLETED|BM Cohort||0||
59729104|NCT01132664|75847699|FG002|NOT COMPLETED|BM Cohort||0||
59729105|NCT01132664|75847700|FG003|NOT COMPLETED|BM Cohort||3||
59729106|NCT01132664|75847701|FG004|NOT COMPLETED|BM Cohort||6||
59998398|NCT02487095|76114045|FG000|COMPLETED|Dose Expansion||0||
59729107|NCT00591409|75847723|FG000|STARTED|Overall Study||10||
59729108|NCT00591409|75847724|FG001|STARTED|Overall Study||10||
59729109|NCT00591409|75847725|FG002|STARTED|Overall Study||10||
59998399|NCT02487095|76114046|FG001|COMPLETED|Dose Expansion||0||
59729110|NCT00591409|75847726|FG003|STARTED|Overall Study||10||
59729111|NCT00591409|75847727|FG004|STARTED|Overall Study||10||
59729112|NCT00591409|75847728|FG005|STARTED|Overall Study||10||
59998400|NCT02487095|76114047|FG002|COMPLETED|Dose Expansion||0||
59729113|NCT00591409|75847729|FG006|STARTED|Overall Study||10||
59729114|NCT00591409|75847730|FG007|STARTED|Overall Study||10||
59729115|NCT00591409|75847731|FG008|STARTED|Overall Study||9||
59729116|NCT00591409|75847732|FG009|STARTED|Overall Study||11||
59729117|NCT00591409|75847723|FG000|Treated|Overall Study||10||
59729118|NCT00591409|75847724|FG001|Treated|Overall Study||10||
59729119|NCT00591409|75847725|FG002|Treated|Overall Study||10||
59729120|NCT00591409|75847726|FG003|Treated|Overall Study||10||
59729121|NCT00591409|75847727|FG004|Treated|Overall Study||9||
59729122|NCT00591409|75847728|FG005|Treated|Overall Study||10||
59729123|NCT00591409|75847729|FG006|Treated|Overall Study||10||
59729124|NCT00591409|75847730|FG007|Treated|Overall Study||10||
59729125|NCT00591409|75847731|FG008|Treated|Overall Study||9||
59729126|NCT00591409|75847732|FG009|Treated|Overall Study||10||
59729127|NCT00591409|75847723|FG000|COMPLETED|Overall Study||10||
59729128|NCT00591409|75847724|FG001|COMPLETED|Overall Study||10||
59729129|NCT00591409|75847725|FG002|COMPLETED|Overall Study||10||
59729130|NCT00591409|75847726|FG003|COMPLETED|Overall Study||10||
59729131|NCT00591409|75847727|FG004|COMPLETED|Overall Study||9||
59729132|NCT00591409|75847728|FG005|COMPLETED|Overall Study||10||
59729133|NCT00591409|75847729|FG006|COMPLETED|Overall Study||10||
59729134|NCT00591409|75847730|FG007|COMPLETED|Overall Study||10||
59729135|NCT00591409|75847731|FG008|COMPLETED|Overall Study||9||
59729136|NCT00591409|75847732|FG009|COMPLETED|Overall Study||10||
59729137|NCT00591409|75847723|FG000|NOT COMPLETED|Overall Study||0||
59729138|NCT00591409|75847724|FG001|NOT COMPLETED|Overall Study||0||
59729139|NCT00591409|75847725|FG002|NOT COMPLETED|Overall Study||0||
59729140|NCT00591409|75847726|FG003|NOT COMPLETED|Overall Study||0||
59729141|NCT00591409|75847727|FG004|NOT COMPLETED|Overall Study||1||
59729142|NCT00591409|75847728|FG005|NOT COMPLETED|Overall Study||0||
59729143|NCT00591409|75847729|FG006|NOT COMPLETED|Overall Study||0||
59729144|NCT00591409|75847730|FG007|NOT COMPLETED|Overall Study||0||
59729145|NCT00591409|75847731|FG008|NOT COMPLETED|Overall Study||0||
59729146|NCT00591409|75847732|FG009|NOT COMPLETED|Overall Study||1||
59729147|NCT01078805|75847754|FG000|STARTED|Overall Study||4167||
59729148|NCT01078805|75847754|FG000|Took at Least 1 Dose of Study Drug|Overall Study||4085||
59729149|NCT01078805|75847754|FG000|Modified Intent-To-Treat|Overall Study|≥1 dose of study drug (SD) and didn't discontinue SD more than 3 consecutive months during treatment|3720||
59729150|NCT01078805|75847754|FG000|COMPLETED|Overall Study||2117||
59729151|NCT01078805|75847754|FG000|NOT COMPLETED|Overall Study||2050||
59729152|NCT00820027|75847762|FG000|STARTED|Overall Study||224||
59600529|NCT00484718|75710306|FG005|COMPLETED|Treatment Period 2 (2 Weeks)||1||
59600530|NCT00484718|75710301|FG000|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0||
59600531|NCT00484718|75710302|FG001|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0||
59600532|NCT00484718|75710303|FG002|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0||
59600533|NCT00484718|75710304|FG003|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0||
59600534|NCT00484718|75710305|FG004|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0||
59600535|NCT00484718|75710306|FG005|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0||
59600536|NCT00484718|75710301|FG000|STARTED|Washout Period (2 Weeks)||1||
59600537|NCT00484718|75710302|FG001|STARTED|Washout Period (2 Weeks)||1||
59600538|NCT00484718|75710303|FG002|STARTED|Washout Period (2 Weeks)||1||
59600539|NCT00484718|75710304|FG003|STARTED|Washout Period (2 Weeks)||1||
59600540|NCT00484718|75710305|FG004|STARTED|Washout Period (2 Weeks)||1||
59600541|NCT00484718|75710306|FG005|STARTED|Washout Period (2 Weeks)||1||
59600542|NCT00484718|75710301|FG000|COMPLETED|Washout Period (2 Weeks)||1||
59600543|NCT00484718|75710302|FG001|COMPLETED|Washout Period (2 Weeks)||1||
59600544|NCT00484718|75710303|FG002|COMPLETED|Washout Period (2 Weeks)||1||
59600545|NCT00484718|75710304|FG003|COMPLETED|Washout Period (2 Weeks)||1||
59600546|NCT00484718|75710305|FG004|COMPLETED|Washout Period (2 Weeks)||1||
59600547|NCT00484718|75710306|FG005|COMPLETED|Washout Period (2 Weeks)||1||
59600548|NCT00484718|75710301|FG000|NOT COMPLETED|Washout Period (2 Weeks)||0||
59600549|NCT00484718|75710302|FG001|NOT COMPLETED|Washout Period (2 Weeks)||0||
59600550|NCT00484718|75710303|FG002|NOT COMPLETED|Washout Period (2 Weeks)||0||
59600551|NCT00484718|75710304|FG003|NOT COMPLETED|Washout Period (2 Weeks)||0||
59600552|NCT00484718|75710305|FG004|NOT COMPLETED|Washout Period (2 Weeks)||0||
59600553|NCT00484718|75710306|FG005|NOT COMPLETED|Washout Period (2 Weeks)||0||
59729153|NCT00820027|75847763|FG001|STARTED|Overall Study||230||
59729154|NCT00820027|75847764|FG002|STARTED|Overall Study||224||
59729155|NCT00820027|75847765|FG003|STARTED|Overall Study||98||
59729156|NCT00820027|75847762|FG000|COMPLETED|Overall Study||198||
59600554|NCT00484718|75710301|FG000|STARTED|Treatment Period 3 (2 Weeks)||1||
59600555|NCT00484718|75710302|FG001|STARTED|Treatment Period 3 (2 Weeks)||1||
59600556|NCT00484718|75710303|FG002|STARTED|Treatment Period 3 (2 Weeks)||1||
59600557|NCT00484718|75710304|FG003|STARTED|Treatment Period 3 (2 Weeks)||1||
59600558|NCT00484718|75710305|FG004|STARTED|Treatment Period 3 (2 Weeks)||1||
59600559|NCT00484718|75710306|FG005|STARTED|Treatment Period 3 (2 Weeks)||1||
59600560|NCT00484718|75710301|FG000|COMPLETED|Treatment Period 3 (2 Weeks)||1||
59600561|NCT00484718|75710302|FG001|COMPLETED|Treatment Period 3 (2 Weeks)||1||
59600562|NCT00484718|75710303|FG002|COMPLETED|Treatment Period 3 (2 Weeks)||1||
59600563|NCT00484718|75710304|FG003|COMPLETED|Treatment Period 3 (2 Weeks)||1||
59600564|NCT00484718|75710305|FG004|COMPLETED|Treatment Period 3 (2 Weeks)||1||
59600565|NCT00484718|75710306|FG005|COMPLETED|Treatment Period 3 (2 Weeks)||1||
59600566|NCT00484718|75710301|FG000|NOT COMPLETED|Treatment Period 3 (2 Weeks)||0||
59600567|NCT00484718|75710302|FG001|NOT COMPLETED|Treatment Period 3 (2 Weeks)||0||
59729157|NCT00820027|75847763|FG001|COMPLETED|Overall Study||216||
59729158|NCT00820027|75847764|FG002|COMPLETED|Overall Study||203||
59729159|NCT00820027|75847765|FG003|COMPLETED|Overall Study||85||
59729160|NCT00820027|75847762|FG000|NOT COMPLETED|Overall Study||26||
59729161|NCT00820027|75847763|FG001|NOT COMPLETED|Overall Study||14||
59729162|NCT00820027|75847764|FG002|NOT COMPLETED|Overall Study||21||
59729163|NCT00820027|75847765|FG003|NOT COMPLETED|Overall Study||13||
59729164|NCT01076153|75847776|FG000|STARTED|Overall Study||760||
59729165|NCT01076153|75847776|FG000|COMPLETED|Overall Study||749||
59729166|NCT01076153|75847776|FG000|NOT COMPLETED|Overall Study||11||
59729167|NCT01076075|75847786|FG000|STARTED|Overall Study|3 participants were excluded from safety and efficacy analyses due to one site's non-compliance|213||
59729168|NCT01076075|75847787|FG001|STARTED|Overall Study|2 participants were excluded from safety and efficacy analyses due to one site's non-compliance|214||
59729169|NCT01076075|75847786|FG000|Completed Phase A|Overall Study||199||
59729170|NCT01076075|75847787|FG001|Completed Phase A|Overall Study||189||
59729171|NCT01076075|75847786|FG000|COMPLETED|Overall Study||172||
59729172|NCT01076075|75847787|FG001|COMPLETED|Overall Study||167||
59729173|NCT01076075|75847786|FG000|NOT COMPLETED|Overall Study||41||
59729174|NCT01076075|75847787|FG001|NOT COMPLETED|Overall Study||47||
59729175|NCT01075763|75847798|FG000|STARTED|Overall Study||23||
59729176|NCT01075763|75847799|FG001|STARTED|Overall Study||19||
59729177|NCT01075763|75847798|FG000|COMPLETED|Overall Study||19||
59729178|NCT01075763|75847799|FG001|COMPLETED|Overall Study||15||
59729179|NCT01075763|75847798|FG000|NOT COMPLETED|Overall Study||4||
59729180|NCT01075763|75847799|FG001|NOT COMPLETED|Overall Study||4||
59729181|NCT00881530|75847811|FG000|STARTED|Overall Study||106||
59729182|NCT00881530|75847812|FG001|STARTED|Overall Study||109||
59729183|NCT00881530|75847813|FG002|STARTED|Overall Study||56||
59729184|NCT00881530|75847814|FG003|STARTED|Overall Study||166||
59729185|NCT00881530|75847815|FG004|STARTED|Overall Study||166||
59729186|NCT00881530|75847816|FG005|STARTED|Overall Study||56||
59729187|NCT00881530|75847811|FG000|COMPLETED|Overall Study||92||
59729188|NCT00881530|75847812|FG001|COMPLETED|Overall Study||104||
59729189|NCT00881530|75847813|FG002|COMPLETED|Overall Study||51||
59729190|NCT00881530|75847814|FG003|COMPLETED|Overall Study||157||
59729191|NCT00881530|75847815|FG004|COMPLETED|Overall Study||152||
59729192|NCT00881530|75847816|FG005|COMPLETED|Overall Study||51||
59729193|NCT00881530|75847811|FG000|NOT COMPLETED|Overall Study||14||
59998401|NCT02487095|76114048|FG003|COMPLETED|Dose Expansion||0||
59729194|NCT00881530|75847812|FG001|NOT COMPLETED|Overall Study||5||
59729195|NCT00881530|75847813|FG002|NOT COMPLETED|Overall Study||5||
59729196|NCT00881530|75847814|FG003|NOT COMPLETED|Overall Study||9||
59729197|NCT00881530|75847815|FG004|NOT COMPLETED|Overall Study||14||
59729198|NCT00881530|75847816|FG005|NOT COMPLETED|Overall Study||5||
59729199|NCT01075685|75847832|FG000|STARTED|Overall Study||743||
59729200|NCT01075685|75847833|FG001|STARTED|Overall Study||414||
59729201|NCT01075685|75847832|FG000|Met Inclusion Criteria|Overall Study||734||
59729202|NCT01075685|75847833|FG001|Met Inclusion Criteria|Overall Study||413||
59729203|NCT01075685|75847832|FG000|Completed Baseline Measures|Overall Study||225||
59729204|NCT01075685|75847833|FG001|Completed Baseline Measures|Overall Study||263||
59729205|NCT01075685|75847832|FG000|COMPLETED|Overall Study||151||
59729206|NCT01075685|75847833|FG001|COMPLETED|Overall Study||188||
59729207|NCT01075685|75847832|FG000|NOT COMPLETED|Overall Study||592||
59729208|NCT01075685|75847833|FG001|NOT COMPLETED|Overall Study||226||
59729209|NCT01075217|75847841|FG000|STARTED|Overall Study|88 patients randomized to receive Isovue; 4 of the patients did not meet entry requirements|84||
59729210|NCT01075217|75847842|FG001|STARTED|Overall Study|86 patients randomized to receive Visipaque; 1 of the patients did not meet entry requirements|85||
59729211|NCT01075217|75847841|FG000|COMPLETED|Overall Study||82||
59729212|NCT01075217|75847842|FG001|COMPLETED|Overall Study||84||
59729213|NCT01075217|75847841|FG000|NOT COMPLETED|Overall Study||2||
59729214|NCT01075217|75847842|FG001|NOT COMPLETED|Overall Study||1||
59729215|NCT01078571|75847856|FG000|STARTED|Overall Study||705||
59729216|NCT01078571|75847856|FG000|Safety Population|Overall Study||675||
59729217|NCT01078571|75847856|FG000|Intent-to-treat (ITT) Population|Overall Study||591||
59729218|NCT01078571|75847856|FG000|COMPLETED|Overall Study||590||
59729219|NCT01078571|75847856|FG000|NOT COMPLETED|Overall Study||115||
59729220|NCT00977106|75847867|FG000|STARTED|Overall Study||47||
59729221|NCT00977106|75847868|FG001|STARTED|Overall Study|Includes 3 participants who were randomized to placebo, but received tocilizumab.|56||
59729222|NCT00977106|75847867|FG000|COMPLETED|Overall Study||37||
59729223|NCT00977106|75847868|FG001|COMPLETED|Overall Study||45||
59729224|NCT00977106|75847867|FG000|NOT COMPLETED|Overall Study||10||
59729225|NCT00977106|75847868|FG001|NOT COMPLETED|Overall Study||11||
59729226|NCT01077713|75847878|FG000|STARTED|Overall Study||44||
59729227|NCT01077713|75847879|FG001|STARTED|Overall Study||42||
59729228|NCT01077713|75847878|FG000|COMPLETED|Overall Study||8||
59729229|NCT01077713|75847879|FG001|COMPLETED|Overall Study||6||
59729230|NCT01077713|75847878|FG000|NOT COMPLETED|Overall Study||36||
59729231|NCT01077713|75847879|FG001|NOT COMPLETED|Overall Study||36||
59729232|NCT00813709|75847888|FG000|STARTED|Double Blind Period||84||
59729233|NCT00813709|75847889|FG001|STARTED|Double Blind Period||117||
59729234|NCT00813709|75847890|FG002|STARTED|Double Blind Period||99||
59729235|NCT00813709|75847891|FG003|STARTED|Double Blind Period||0||
59729236|NCT00813709|75847892|FG004|STARTED|Double Blind Period||0||
59729237|NCT00813709|75847893|FG005|STARTED|Double Blind Period||0||
59998402|NCT02487095|76114049|FG004|COMPLETED|Dose Expansion||40||
59998403|NCT02487095|76114045|FG000|NOT COMPLETED|Dose Expansion||0||
59729238|NCT00813709|75847888|FG000|Treated|Double Blind Period||83||
59729239|NCT00813709|75847889|FG001|Treated|Double Blind Period||114||
59729240|NCT00813709|75847890|FG002|Treated|Double Blind Period||98||
59729241|NCT00813709|75847891|FG003|Treated|Double Blind Period||0||
59729242|NCT00813709|75847892|FG004|Treated|Double Blind Period||0||
59729243|NCT00813709|75847893|FG005|Treated|Double Blind Period||0||
59729244|NCT00813709|75847888|FG000|COMPLETED|Double Blind Period||53||
59729245|NCT00813709|75847889|FG001|COMPLETED|Double Blind Period||76||
59729246|NCT00813709|75847890|FG002|COMPLETED|Double Blind Period||68||
59729247|NCT00813709|75847891|FG003|COMPLETED|Double Blind Period||0||
59729248|NCT00813709|75847892|FG004|COMPLETED|Double Blind Period||0||
59729249|NCT00813709|75847893|FG005|COMPLETED|Double Blind Period||0||
59729250|NCT00813709|75847888|FG000|NOT COMPLETED|Double Blind Period||31||
59729251|NCT00813709|75847889|FG001|NOT COMPLETED|Double Blind Period||41||
59729252|NCT00813709|75847890|FG002|NOT COMPLETED|Double Blind Period||31||
59729253|NCT00813709|75847891|FG003|NOT COMPLETED|Double Blind Period||0||
59729254|NCT00813709|75847892|FG004|NOT COMPLETED|Double Blind Period||0||
59729255|NCT00813709|75847893|FG005|NOT COMPLETED|Double Blind Period||0||
59729256|NCT00813709|75847888|FG000|STARTED|Open Label Period||0||
59729257|NCT00813709|75847889|FG001|STARTED|Open Label Period||0||
59729258|NCT00813709|75847890|FG002|STARTED|Open Label Period||0||
59729259|NCT00813709|75847891|FG003|STARTED|Open Label Period|49 participants in OL period initially + 9 participants from DB converted to CDMS during the study|58||
59729260|NCT00813709|75847892|FG004|STARTED|Open Label Period|25 participants in OL period initially + 26 participants from DB converted to CDMS during the study|51||
59729261|NCT00813709|75847893|FG005|STARTED|Open Label Period|28 participants in OL period initially + 18 participants from DB converted to CDMS during the study|46||
59729262|NCT00813709|75847888|FG000|Treated|Open Label Period||0||
59729263|NCT00813709|75847889|FG001|Treated|Open Label Period||0||
59729264|NCT00813709|75847890|FG002|Treated|Open Label Period||0||
59729265|NCT00813709|75847891|FG003|Treated|Open Label Period||57||
59729266|NCT00813709|75847892|FG004|Treated|Open Label Period||51||
59729267|NCT00813709|75847893|FG005|Treated|Open Label Period||45||
59729268|NCT00813709|75847888|FG000|COMPLETED|Open Label Period||0||
59729269|NCT00813709|75847889|FG001|COMPLETED|Open Label Period||0||
59729270|NCT00813709|75847890|FG002|COMPLETED|Open Label Period||0||
59729271|NCT00813709|75847891|FG003|COMPLETED|Open Label Period||38||
59729272|NCT00813709|75847892|FG004|COMPLETED|Open Label Period||41||
59729273|NCT00813709|75847893|FG005|COMPLETED|Open Label Period||35||
59729274|NCT00813709|75847888|FG000|NOT COMPLETED|Open Label Period||0||
59729275|NCT00813709|75847889|FG001|NOT COMPLETED|Open Label Period||0||
59729276|NCT00813709|75847890|FG002|NOT COMPLETED|Open Label Period||0||
59729277|NCT00813709|75847891|FG003|NOT COMPLETED|Open Label Period||20||
59729278|NCT00813709|75847892|FG004|NOT COMPLETED|Open Label Period||10||
59729279|NCT00813709|75847893|FG005|NOT COMPLETED|Open Label Period||11||
59729280|NCT01077323|75847925|FG000|STARTED|Overall Study|STARTED = Number of subjects considered for inclusion in this cohort.|37097||
59729281|NCT01077323|75847926|FG001|STARTED|Overall Study|STARTED = Number of subjects considered for inclusion in this cohort.|620799||
59729282|NCT01077323|75847927|FG002|STARTED|Overall Study|STARTED = Number of subjects considered for inclusion in this cohort.|12015600||
59729283|NCT01077323|75847925|FG000|COMPLETED|Overall Study|COMPLETED = Group of subjects for whom data in outcome measures is presented.|25719||
59729284|NCT01077323|75847926|FG001|COMPLETED|Overall Study|COMPLETED = Group of subjects for whom data in outcome measures is presented.|234536||
59729285|NCT01077323|75847927|FG002|COMPLETED|Overall Study|COMPLETED = Group of subjects for whom data in outcome measures is presented.|103511||
59729286|NCT01077323|75847925|FG000|NOT COMPLETED|Overall Study||11378||
59729287|NCT01077323|75847926|FG001|NOT COMPLETED|Overall Study||386263||
59729288|NCT01077323|75847927|FG002|NOT COMPLETED|Overall Study||11912089||
59729289|NCT00976950|75847935|FG000|STARTED|Overall Study||42||
59729290|NCT00976950|75847935|FG000|COMPLETED|Overall Study||36||
59729291|NCT00976950|75847935|FG000|NOT COMPLETED|Overall Study||6||
59729292|NCT05741450|75847939|FG000|STARTED|Period 1: Lens 1, 15 Minutes||45||
59729293|NCT05741450|75847940|FG001|STARTED|Period 1: Lens 1, 15 Minutes|All participants received Lens 1 in Period 1.|0||
59729294|NCT05741450|75847939|FG000|COMPLETED|Period 1: Lens 1, 15 Minutes||45||
59729295|NCT05741450|75847940|FG001|COMPLETED|Period 1: Lens 1, 15 Minutes||0||
59729296|NCT05741450|75847939|FG000|NOT COMPLETED|Period 1: Lens 1, 15 Minutes||0||
59729297|NCT05741450|75847940|FG001|NOT COMPLETED|Period 1: Lens 1, 15 Minutes||0||
59729298|NCT05741450|75847939|FG000|STARTED|Period 2: Lens 2, 15 Minutes|All participants received Lens 2 in Period 2.|0||
59729299|NCT05741450|75847940|FG001|STARTED|Period 2: Lens 2, 15 Minutes||45||
59729300|NCT05741450|75847939|FG000|COMPLETED|Period 2: Lens 2, 15 Minutes||0||
59729301|NCT05741450|75847940|FG001|COMPLETED|Period 2: Lens 2, 15 Minutes||45||
59729302|NCT05741450|75847939|FG000|NOT COMPLETED|Period 2: Lens 2, 15 Minutes||0||
59729303|NCT05741450|75847940|FG001|NOT COMPLETED|Period 2: Lens 2, 15 Minutes||0||
59729304|NCT05734846|75847946|FG000|STARTED|Period 1 (One Week)||13||
59729305|NCT05734846|75847947|FG001|STARTED|Period 1 (One Week)||12||
59729306|NCT05734846|75847946|FG000|COMPLETED|Period 1 (One Week)||13||
59729307|NCT05734846|75847947|FG001|COMPLETED|Period 1 (One Week)||12||
59729308|NCT05734846|75847946|FG000|NOT COMPLETED|Period 1 (One Week)||0||
59729309|NCT05734846|75847947|FG001|NOT COMPLETED|Period 1 (One Week)||0||
59729310|NCT05734846|75847946|FG000|STARTED|Period 2 (One Week)||13||
59729311|NCT05734846|75847947|FG001|STARTED|Period 2 (One Week)||12||
59729312|NCT05734846|75847946|FG000|COMPLETED|Period 2 (One Week)||13||
59729313|NCT05734846|75847947|FG001|COMPLETED|Period 2 (One Week)||12||
59729314|NCT05734846|75847946|FG000|NOT COMPLETED|Period 2 (One Week)||0||
59729315|NCT05734846|75847947|FG001|NOT COMPLETED|Period 2 (One Week)||0||
59729316|NCT05570500|75847956|FG000|STARTED|Overall Study|This is the total number of participants (children) in the online oral health education group, divided into 150 males and 169 females in this study group.|319||8
59729317|NCT05570500|75847957|FG001|STARTED|Overall Study|This is the total number of participants (children) in the conventional oral health education group, divided into 155 males and 162 females in this study group.|317||8
59729318|NCT05570500|75847956|FG000|Classroom 1 in Each Study Group|Overall Study||42||1
59729319|NCT05570500|75847957|FG001|Classroom 1 in Each Study Group|Overall Study||40||1
59729320|NCT05570500|75847956|FG000|Classroom 2 in Each Study Group|Overall Study||38||1
59729321|NCT05570500|75847957|FG001|Classroom 2 in Each Study Group|Overall Study||39||1
59729322|NCT05570500|75847956|FG000|Classroom 3 in Each Study Group|Overall Study||39||1
59729323|NCT05570500|75847957|FG001|Classroom 3 in Each Study Group|Overall Study||41||1
59729324|NCT05570500|75847956|FG000|Classroom 4 in Each Study Group|Overall Study||36||1
59729325|NCT05570500|75847957|FG001|Classroom 4 in Each Study Group|Overall Study||42||1
59729326|NCT05570500|75847956|FG000|Classroom 5 in Each Study Group|Overall Study||41||1
59729327|NCT05570500|75847957|FG001|Classroom 5 in Each Study Group|Overall Study||37||1
59729328|NCT05570500|75847956|FG000|Classroom 6 in Each Study Group|Overall Study||40||1
59729329|NCT05570500|75847957|FG001|Classroom 6 in Each Study Group|Overall Study||39||1
59729330|NCT05570500|75847956|FG000|Classroom 7 in Each Study Group|Overall Study||43||1
59729331|NCT05570500|75847957|FG001|Classroom 7 in Each Study Group|Overall Study||41||1
59729332|NCT05570500|75847956|FG000|Classroom 8 in Each Study Group|Overall Study||40||1
59729333|NCT05570500|75847957|FG001|Classroom 8 in Each Study Group|Overall Study||38||1
59729334|NCT05570500|75847956|FG000|COMPLETED|Overall Study||312||8
59729335|NCT05570500|75847957|FG001|COMPLETED|Overall Study||312||8
59729336|NCT05570500|75847956|FG000|NOT COMPLETED|Overall Study||7||0
59729337|NCT05570500|75847957|FG001|NOT COMPLETED|Overall Study||5||0
59729338|NCT05466682|75847965|FG000|STARTED|Overall Study||24||
59729339|NCT05466682|75847966|FG001|STARTED|Overall Study||24||
59729340|NCT05466682|75847965|FG000|COMPLETED|Overall Study||22||
59729341|NCT05466682|75847966|FG001|COMPLETED|Overall Study||21||
59729342|NCT05466682|75847965|FG000|NOT COMPLETED|Overall Study||2||
59729343|NCT05466682|75847966|FG001|NOT COMPLETED|Overall Study||3||
59729344|NCT05188248|75847972|FG000|STARTED|Overall Study||21||
59729345|NCT05188248|75847972|FG000|COMPLETED|Overall Study||21||
59729346|NCT05188248|75847972|FG000|NOT COMPLETED|Overall Study||0||
59729347|NCT05099640|75847979|FG000|STARTED|Part 1: Open-label (14 Days)||157||
59729348|NCT05099640|75847980|FG001|STARTED|Part 1: Open-label (14 Days)||0||
59729349|NCT05099640|75847981|FG002|STARTED|Part 1: Open-label (14 Days)||0||
59729350|NCT05099640|75847979|FG000|Received at Least 1 Dose of Study Drug|Part 1: Open-label (14 Days)||157||
59729351|NCT05099640|75847980|FG001|Received at Least 1 Dose of Study Drug|Part 1: Open-label (14 Days)||0||
59729352|NCT05099640|75847981|FG002|Received at Least 1 Dose of Study Drug|Part 1: Open-label (14 Days)||0||
59729353|NCT05099640|75847979|FG000|COMPLETED|Part 1: Open-label (14 Days)|110 participants were eligible to progress to Part 2.|111||
59729354|NCT05099640|75847980|FG001|COMPLETED|Part 1: Open-label (14 Days)||0||
59729355|NCT05099640|75847981|FG002|COMPLETED|Part 1: Open-label (14 Days)||0||
59729356|NCT05099640|75847979|FG000|NOT COMPLETED|Part 1: Open-label (14 Days)||46||
59729357|NCT05099640|75847980|FG001|NOT COMPLETED|Part 1: Open-label (14 Days)||0||
59729358|NCT05099640|75847981|FG002|NOT COMPLETED|Part 1: Open-label (14 Days)||0||
59729359|NCT05099640|75847979|FG000|STARTED|Part 2: Randomized Treatment (6 Weeks)||0||
59729360|NCT05099640|75847980|FG001|STARTED|Part 2: Randomized Treatment (6 Weeks)||56||
59729361|NCT05099640|75847981|FG002|STARTED|Part 2: Randomized Treatment (6 Weeks)||54||
59729362|NCT05099640|75847979|FG000|Received at Least 1 Dose of Study Drug|Part 2: Randomized Treatment (6 Weeks)||0||
59729363|NCT05099640|75847980|FG001|Received at Least 1 Dose of Study Drug|Part 2: Randomized Treatment (6 Weeks)||56||
59729364|NCT05099640|75847981|FG002|Received at Least 1 Dose of Study Drug|Part 2: Randomized Treatment (6 Weeks)||54||
59729365|NCT05099640|75847979|FG000|COMPLETED|Part 2: Randomized Treatment (6 Weeks)||0||
59729366|NCT05099640|75847980|FG001|COMPLETED|Part 2: Randomized Treatment (6 Weeks)||55||
59729367|NCT05099640|75847981|FG002|COMPLETED|Part 2: Randomized Treatment (6 Weeks)||54||
59729368|NCT05099640|75847979|FG000|NOT COMPLETED|Part 2: Randomized Treatment (6 Weeks)||0||
59729369|NCT05099640|75847980|FG001|NOT COMPLETED|Part 2: Randomized Treatment (6 Weeks)||1||
59729370|NCT05099640|75847981|FG002|NOT COMPLETED|Part 2: Randomized Treatment (6 Weeks)||0||
59729371|NCT05020665|75847993|FG000|STARTED|Overall Study||8||
59729372|NCT05020665|75847994|FG001|STARTED|Overall Study||7||
59729373|NCT05020665|75847993|FG000|COMPLETED|Overall Study||0||
59729374|NCT05020665|75847994|FG001|COMPLETED|Overall Study||0||
59729375|NCT05020665|75847993|FG000|NOT COMPLETED|Overall Study||8||
59729376|NCT05020665|75847994|FG001|NOT COMPLETED|Overall Study||7||
59729377|NCT04869787|75848003|FG000|STARTED|Screening||7||
59729378|NCT04869787|75848003|FG000|COMPLETED|Screening||6||
59729379|NCT04869787|75848003|FG000|NOT COMPLETED|Screening||1||
59729380|NCT04869787|75848003|FG000|STARTED|SCD Treatment Period (up to 10 Days)||6||
59998404|NCT02487095|76114046|FG001|NOT COMPLETED|Dose Expansion||0||
59729381|NCT04869787|75848003|FG000|COMPLETED|SCD Treatment Period (up to 10 Days)||5||
59729382|NCT04869787|75848003|FG000|NOT COMPLETED|SCD Treatment Period (up to 10 Days)||1||
59729383|NCT04869787|75848003|FG000|STARTED|Observational Follow Up Period (90 Days)||5||
59729384|NCT04869787|75848003|FG000|COMPLETED|Observational Follow Up Period (90 Days)||5||
59729385|NCT04869787|75848003|FG000|NOT COMPLETED|Observational Follow Up Period (90 Days)||0||
59729386|NCT04854057|75848009|FG000|STARTED|Overall Study||1||
59729387|NCT04854057|75848010|FG001|STARTED|Overall Study||2||
59729388|NCT04854057|75848009|FG000|COMPLETED|Overall Study||1||
59729389|NCT04854057|75848010|FG001|COMPLETED|Overall Study||1||
59729390|NCT04854057|75848009|FG000|NOT COMPLETED|Overall Study||0||
59729391|NCT04854057|75848010|FG001|NOT COMPLETED|Overall Study||1||
59729392|NCT04783077|75848023|FG000|STARTED|Overall Study||34||
59729393|NCT04783077|75848024|FG001|STARTED|Overall Study||33||
59729394|NCT04783077|75848025|FG002|STARTED|Overall Study||30||
59729395|NCT04783077|75848026|FG003|STARTED|Overall Study||33||
59729396|NCT04783077|75848027|FG004|STARTED|Overall Study||14||
59729397|NCT04783077|75848023|FG000|COMPLETED|Overall Study||27||
59729398|NCT04783077|75848024|FG001|COMPLETED|Overall Study||30||
59729399|NCT04783077|75848025|FG002|COMPLETED|Overall Study||28||
59729400|NCT04783077|75848026|FG003|COMPLETED|Overall Study||31||
59729401|NCT04783077|75848027|FG004|COMPLETED|Overall Study||14||
59729402|NCT04783077|75848023|FG000|NOT COMPLETED|Overall Study||7||
59729403|NCT04783077|75848024|FG001|NOT COMPLETED|Overall Study||3||
59729404|NCT04783077|75848025|FG002|NOT COMPLETED|Overall Study||2||
59729405|NCT04783077|75848026|FG003|NOT COMPLETED|Overall Study||2||
59729406|NCT04783077|75848027|FG004|NOT COMPLETED|Overall Study||0||
59729407|NCT04639258|75848039|FG000|STARTED|Overall Study||11||
59729408|NCT04639258|75848039|FG000|COMPLETED|Overall Study||0||
59729409|NCT04639258|75848039|FG000|NOT COMPLETED|Overall Study||11||
59729410|NCT04587934|75848045|FG000|STARTED|Overall Study||19||
59729411|NCT04587934|75848046|FG001|STARTED|Overall Study||23||
59729412|NCT04587934|75848045|FG000|COMPLETED|Overall Study||19||
59729413|NCT04587934|75848046|FG001|COMPLETED|Overall Study||23||
59729414|NCT04587934|75848045|FG000|NOT COMPLETED|Overall Study||0||
59729415|NCT04587934|75848046|FG001|NOT COMPLETED|Overall Study||0||
59729416|NCT04575896|75848052|FG000|STARTED|Overall Study||10||
59729417|NCT04575896|75848052|FG000|COMPLETED|Overall Study||10||
59729418|NCT04575896|75848052|FG000|NOT COMPLETED|Overall Study||0||
59729419|NCT04568122|75848061|FG000|STARTED|Overall Study||94||
59729420|NCT04568122|75848062|FG001|STARTED|Overall Study||112||
59729421|NCT04568122|75848063|FG002|STARTED|Overall Study||135||
59729422|NCT04568122|75848064|FG003|STARTED|Overall Study||9||
59729423|NCT04568122|75848065|FG004|STARTED|Overall Study||3||
59729424|NCT04568122|75848061|FG000|Completed One Test|Overall Study||46||
59729425|NCT04568122|75848062|FG001|Completed One Test|Overall Study||68||
59729426|NCT04568122|75848063|FG002|Completed One Test|Overall Study||131||
59729427|NCT04568122|75848064|FG003|Completed One Test|Overall Study||9||
59729428|NCT04568122|75848065|FG004|Completed One Test|Overall Study||3||
59729429|NCT04568122|75848061|FG000|Completed 2 Tests|Overall Study||32||
59729430|NCT04568122|75848062|FG001|Completed 2 Tests|Overall Study||53||
59729431|NCT04568122|75848063|FG002|Completed 2 Tests|Overall Study||0||
59729432|NCT04568122|75848064|FG003|Completed 2 Tests|Overall Study||0||
59729433|NCT04568122|75848065|FG004|Completed 2 Tests|Overall Study||0||
59729434|NCT04568122|75848061|FG000|COMPLETED|Overall Study||46||
59729435|NCT04568122|75848062|FG001|COMPLETED|Overall Study||68||
59729436|NCT04568122|75848063|FG002|COMPLETED|Overall Study||131||
59729437|NCT04568122|75848064|FG003|COMPLETED|Overall Study||9||
59729438|NCT04568122|75848065|FG004|COMPLETED|Overall Study||3||
59729439|NCT04568122|75848061|FG000|NOT COMPLETED|Overall Study||48||
59729440|NCT04568122|75848062|FG001|NOT COMPLETED|Overall Study||44||
59729441|NCT04568122|75848063|FG002|NOT COMPLETED|Overall Study||4||
59729442|NCT04568122|75848064|FG003|NOT COMPLETED|Overall Study||0||
59729443|NCT04568122|75848065|FG004|NOT COMPLETED|Overall Study||0||
59729444|NCT04533815|75848081|FG000|STARTED|Overall Study||23||
59729445|NCT04533815|75848081|FG000|COMPLETED|Overall Study||16||
59729446|NCT04533815|75848081|FG000|NOT COMPLETED|Overall Study||7||
59729447|NCT04447755|75848092|FG000|STARTED|Overall Study||9||
59729448|NCT04447755|75848093|FG001|STARTED|Overall Study||17||
59729449|NCT04447755|75848094|FG002|STARTED|Overall Study||8||
60131210|NCT02138097|76253718|FG000|NOT COMPLETED|Overall Study||0||
59729450|NCT04447755|75848095|FG003|STARTED|Overall Study||9||
59729451|NCT04447755|75848096|FG004|STARTED|Overall Study||9||
59729452|NCT04447755|75848097|FG005|STARTED|Overall Study||9||
59729453|NCT04447755|75848098|FG006|STARTED|Overall Study||66||
59729454|NCT04447755|75848092|FG000|COMPLETED|Overall Study||0||
59729455|NCT04447755|75848093|FG001|COMPLETED|Overall Study||0||
59729456|NCT04447755|75848094|FG002|COMPLETED|Overall Study||0||
59729457|NCT04447755|75848095|FG003|COMPLETED|Overall Study||0||
59729458|NCT04447755|75848096|FG004|COMPLETED|Overall Study||0||
59729459|NCT04447755|75848097|FG005|COMPLETED|Overall Study||0||
59729460|NCT04447755|75848098|FG006|COMPLETED|Overall Study||0||
59729461|NCT04447755|75848092|FG000|NOT COMPLETED|Overall Study||9||
59729462|NCT04447755|75848093|FG001|NOT COMPLETED|Overall Study||17||
59729463|NCT04447755|75848094|FG002|NOT COMPLETED|Overall Study||8||
59729464|NCT04447755|75848095|FG003|NOT COMPLETED|Overall Study||9||
59729465|NCT04447755|75848096|FG004|NOT COMPLETED|Overall Study||9||
59729466|NCT04447755|75848097|FG005|NOT COMPLETED|Overall Study||9||
59729467|NCT04447755|75848098|FG006|NOT COMPLETED|Overall Study||66||
59729468|NCT04119063|75848116|FG000|STARTED|Overall Study||6||
59729469|NCT04119063|75848116|FG000|COMPLETED|Overall Study||6||
59729470|NCT04119063|75848116|FG000|NOT COMPLETED|Overall Study||0||
59729471|NCT04112160|75848126|FG000|STARTED|Overall Study||63||
59729472|NCT04112160|75848127|FG001|STARTED|Overall Study||62||
59729473|NCT04112160|75848126|FG000|COMPLETED|Overall Study||62||
59729474|NCT04112160|75848127|FG001|COMPLETED|Overall Study||62||
59729475|NCT04112160|75848126|FG000|NOT COMPLETED|Overall Study||1||
59729476|NCT04112160|75848127|FG001|NOT COMPLETED|Overall Study||0||
59729477|NCT04060680|75848133|FG000|STARTED|Overall Study|Subjects who underwent an implant attempt of the Extravascular ICD System|316||
59729478|NCT04060680|75848133|FG000|COMPLETED|Overall Study|Subjects followed up at least to the 6-month visit after the Extravascular ICD System having been fully implanted|292||
59729479|NCT04060680|75848133|FG000|NOT COMPLETED|Overall Study||24||
59729480|NCT03981614|75848141|FG000|STARTED|Overall Study||47||
59729481|NCT03981614|75848142|FG001|STARTED|Overall Study||46||
59729482|NCT03981614|75848143|FG002|STARTED|Overall Study||9||
59729483|NCT03981614|75848141|FG000|Crossed Over to Arm A|Overall Study||0||
59729484|NCT03981614|75848142|FG001|Crossed Over to Arm A|Overall Study||21||
59729485|NCT03981614|75848143|FG002|Crossed Over to Arm A|Overall Study||0||
59729486|NCT03981614|75848141|FG000|COMPLETED|Overall Study||42||
59729487|NCT03981614|75848142|FG001|COMPLETED|Overall Study||41||
59729488|NCT03981614|75848143|FG002|COMPLETED|Overall Study||8||
59729489|NCT03981614|75848141|FG000|NOT COMPLETED|Overall Study||5||
59729490|NCT03981614|75848142|FG001|NOT COMPLETED|Overall Study||5||
59729491|NCT03981614|75848143|FG002|NOT COMPLETED|Overall Study||1||
59729492|NCT03965689|75848154|FG000|STARTED|Overall Study||27||
59729493|NCT03965689|75848154|FG000|COMPLETED|Overall Study||25||
59729494|NCT03965689|75848154|FG000|NOT COMPLETED|Overall Study||2||
59729495|NCT03952377|75848161|FG000|STARTED|Overall Study||18||
59998405|NCT02487095|76114047|FG002|NOT COMPLETED|Dose Expansion||0||
59998406|NCT02487095|76114048|FG003|NOT COMPLETED|Dose Expansion||0||
59998407|NCT02487095|76114049|FG004|NOT COMPLETED|Dose Expansion||1||
59998408|NCT03855137|76114072|FG000|STARTED|DB Treatment Period (Day 1 to Week 12)||259||
59998409|NCT03855137|76114073|FG001|STARTED|DB Treatment Period (Day 1 to Week 12)||257||
59998410|NCT03855137|76114074|FG002|STARTED|DB Treatment Period (Day 1 to Week 12)||262||
59998411|NCT03855137|76114072|FG000|Safety Population|DB Treatment Period (Day 1 to Week 12)||255|Safety population included all participants who received at least 1 dose of study intervention.|
59729496|NCT03952377|75848162|FG001|STARTED|Overall Study||21||
59729497|NCT03952377|75848163|FG002|STARTED|Overall Study||17||
59729498|NCT03952377|75848161|FG000|COMPLETED|Overall Study||16||
59729499|NCT03952377|75848162|FG001|COMPLETED|Overall Study||19||
59729500|NCT03952377|75848163|FG002|COMPLETED|Overall Study||16||
59729501|NCT03952377|75848161|FG000|NOT COMPLETED|Overall Study||2||
59729502|NCT03952377|75848162|FG001|NOT COMPLETED|Overall Study||2||
59729503|NCT03952377|75848163|FG002|NOT COMPLETED|Overall Study||1||
59729504|NCT03918629|75848173|FG000|STARTED|Overall Study||996||
59729505|NCT03918629|75848174|FG001|STARTED|Overall Study||998||
59729506|NCT03918629|75848173|FG000|Vaccinated With Dose 1|Overall Study||994||
59729507|NCT03918629|75848174|FG001|Vaccinated With Dose 1|Overall Study||997||
59729508|NCT03918629|75848173|FG000|Vaccinated With Dose 2|Overall Study||961||
59729509|NCT03918629|75848174|FG001|Vaccinated With Dose 2|Overall Study||964||
59729510|NCT03918629|75848173|FG000|Vaccinated With Dose 3|Overall Study||897||
59729511|NCT03918629|75848174|FG001|Vaccinated With Dose 3|Overall Study||917||
59729512|NCT03918629|75848173|FG000|COMPLETED|Overall Study||863||
59729513|NCT03918629|75848174|FG001|COMPLETED|Overall Study||880||
59729514|NCT03918629|75848173|FG000|NOT COMPLETED|Overall Study||133||
59729515|NCT03918629|75848174|FG001|NOT COMPLETED|Overall Study||118||
59729516|NCT03765229|75848180|FG000|STARTED|Overall Study||11||
59729517|NCT03765229|75848180|FG000|COMPLETED|Overall Study||11||
59729518|NCT03765229|75848180|FG000|NOT COMPLETED|Overall Study||0||
59729519|NCT03713593|75848186|FG000|STARTED|Overall Study||395||
59729520|NCT03713593|75848187|FG001|STARTED|Overall Study||399||
59729521|NCT03713593|75848186|FG000|COMPLETED|Overall Study||0||
59729522|NCT03713593|75848187|FG001|COMPLETED|Overall Study||0||
59729523|NCT03713593|75848186|FG000|NOT COMPLETED|Overall Study||395||
59729524|NCT03713593|75848187|FG001|NOT COMPLETED|Overall Study||399||
59729525|NCT03585270|75848195|FG000|STARTED|Overall Study||203|Randomized Analysis Set|
59729526|NCT03585270|75848196|FG001|STARTED|Overall Study||206|Randomized Analysis Set|
59729527|NCT03585270|75848195|FG000|Not Treated|Overall Study||1|Participants were randomized but not treated|
59729528|NCT03585270|75848196|FG001|Not Treated|Overall Study||2|Participants were randomized but not treated|
59729529|NCT03585270|75848195|FG000|Started Treatment (Assigned Treatment Groups)|Overall Study||202|Full Analysis Set: all randomized participants who started study treatment, evaluated according to assigned treatment.|
59729530|NCT03585270|75848196|FG001|Started Treatment (Assigned Treatment Groups)|Overall Study||204|Full Analysis Set: all randomized participants who started study treatment, evaluated according to assigned treatment.|
60131211|NCT02138097|76253719|FG001|NOT COMPLETED|Overall Study||0||
59729531|NCT03585270|75848195|FG000|Started Treatment (Actual Treatment Received)|Overall Study||207|Safety Analysis Set: all randomized participants who started study treatment, evaluated according to the actual treatment received. Note that 5 participants randomized to placebo received at least 1 infusion of clazosentan and were analyzed as part of the clazosentan arm for this analysis set.|
59729532|NCT03585270|75848196|FG001|Started Treatment (Actual Treatment Received)|Overall Study||199|Safety Analysis Set: all randomized participants who started study treatment, evaluated according to the actual treatment received. Note that 5 participants randomized to placebo received at least 1 infusion of clazosentan and were analyzed as part of the clazosentan arm for this analysis set.|
59729533|NCT03585270|75848195|FG000|COMPLETED|Overall Study||187||
59729534|NCT03585270|75848196|FG001|COMPLETED|Overall Study||189||
59729535|NCT03585270|75848195|FG000|NOT COMPLETED|Overall Study||16||
59729536|NCT03585270|75848196|FG001|NOT COMPLETED|Overall Study||17||
59729537|NCT03499249|75848204|FG000|STARTED|Overall Study||13||
59729538|NCT03499249|75848204|FG000|COMPLETED|Overall Study||12||
59729539|NCT03499249|75848204|FG000|NOT COMPLETED|Overall Study||1||
59729540|NCT03138499|75848210|FG000|STARTED|Overall Study||12||
59729541|NCT03138499|75848211|FG001|STARTED|Overall Study||11||
59729542|NCT03138499|75848210|FG000|COMPLETED|Overall Study||3||
59729543|NCT03138499|75848211|FG001|COMPLETED|Overall Study||1||
59729544|NCT03138499|75848210|FG000|NOT COMPLETED|Overall Study||9||
59729545|NCT03138499|75848211|FG001|NOT COMPLETED|Overall Study||10||
59729546|NCT03136185|75848227|FG000|STARTED|Overall Study||9||
59729547|NCT03136185|75848228|FG001|STARTED|Overall Study||3||
59729548|NCT03136185|75848229|FG002|STARTED|Overall Study||6||
59729549|NCT03136185|75848230|FG003|STARTED|Overall Study||8||
59729550|NCT03136185|75848231|FG004|STARTED|Overall Study||5||
59729551|NCT03136185|75848232|FG005|STARTED|Overall Study||11||
59729552|NCT03136185|75848233|FG006|STARTED|Overall Study||24||
59729553|NCT03136185|75848234|FG007|STARTED|Overall Study||11||
59729554|NCT03136185|75848235|FG008|STARTED|Overall Study||13||
59729555|NCT03136185|75848227|FG000|Treated|Overall Study||9||
59729556|NCT03136185|75848228|FG001|Treated|Overall Study||3||
59729557|NCT03136185|75848229|FG002|Treated|Overall Study||6||
59729558|NCT03136185|75848230|FG003|Treated|Overall Study||8||
59729559|NCT03136185|75848231|FG004|Treated|Overall Study||5||
59729560|NCT03136185|75848232|FG005|Treated|Overall Study||11||
59729561|NCT03136185|75848233|FG006|Treated|Overall Study||24||
59729562|NCT03136185|75848234|FG007|Treated|Overall Study||11||
59729563|NCT03136185|75848235|FG008|Treated|Overall Study||13||
59729564|NCT03136185|75848227|FG000|Entered Additional Treatment Period (ATP)|Overall Study||6||
59729565|NCT03136185|75848228|FG001|Entered Additional Treatment Period (ATP)|Overall Study||2||
59729566|NCT03136185|75848229|FG002|Entered Additional Treatment Period (ATP)|Overall Study||3||
59729567|NCT03136185|75848230|FG003|Entered Additional Treatment Period (ATP)|Overall Study||3||
59729568|NCT03136185|75848231|FG004|Entered Additional Treatment Period (ATP)|Overall Study||1||
59729569|NCT03136185|75848232|FG005|Entered Additional Treatment Period (ATP)|Overall Study||4||
59729570|NCT03136185|75848233|FG006|Entered Additional Treatment Period (ATP)|Overall Study||17||
59729571|NCT03136185|75848234|FG007|Entered Additional Treatment Period (ATP)|Overall Study||5||
59729572|NCT03136185|75848235|FG008|Entered Additional Treatment Period (ATP)|Overall Study||9||
59729573|NCT03136185|75848227|FG000|Completed Initial Treatment Period (ITP)|Overall Study||7||
59729574|NCT03136185|75848228|FG001|Completed Initial Treatment Period (ITP)|Overall Study||3||
59729575|NCT03136185|75848229|FG002|Completed Initial Treatment Period (ITP)|Overall Study||4||
59729576|NCT03136185|75848230|FG003|Completed Initial Treatment Period (ITP)|Overall Study||4||
59729577|NCT03136185|75848231|FG004|Completed Initial Treatment Period (ITP)|Overall Study||1||
59729578|NCT03136185|75848232|FG005|Completed Initial Treatment Period (ITP)|Overall Study||4||
59729579|NCT03136185|75848233|FG006|Completed Initial Treatment Period (ITP)|Overall Study||18||
59729580|NCT03136185|75848234|FG007|Completed Initial Treatment Period (ITP)|Overall Study||8||
59729581|NCT03136185|75848235|FG008|Completed Initial Treatment Period (ITP)|Overall Study||10||
59729582|NCT03136185|75848227|FG000|COMPLETED|Overall Study||1||
59729583|NCT03136185|75848228|FG001|COMPLETED|Overall Study||0||
59729584|NCT03136185|75848229|FG002|COMPLETED|Overall Study||0||
59729585|NCT03136185|75848230|FG003|COMPLETED|Overall Study||2||
59729586|NCT03136185|75848231|FG004|COMPLETED|Overall Study||0||
59729587|NCT03136185|75848232|FG005|COMPLETED|Overall Study||3||
59729588|NCT03136185|75848233|FG006|COMPLETED|Overall Study||14||
59729589|NCT03136185|75848234|FG007|COMPLETED|Overall Study||5||
59729590|NCT03136185|75848235|FG008|COMPLETED|Overall Study||7||
59729591|NCT03136185|75848227|FG000|NOT COMPLETED|Overall Study||8||
59729592|NCT03136185|75848228|FG001|NOT COMPLETED|Overall Study||3||
59729593|NCT03136185|75848229|FG002|NOT COMPLETED|Overall Study||6||
59729594|NCT03136185|75848230|FG003|NOT COMPLETED|Overall Study||6||
59729595|NCT03136185|75848231|FG004|NOT COMPLETED|Overall Study||5||
59729596|NCT03136185|75848232|FG005|NOT COMPLETED|Overall Study||8||
59729597|NCT03136185|75848233|FG006|NOT COMPLETED|Overall Study||10||
59729598|NCT03136185|75848234|FG007|NOT COMPLETED|Overall Study||6||
59729599|NCT03136185|75848235|FG008|NOT COMPLETED|Overall Study||6||
59729600|NCT03125902|75848264|FG000|STARTED|Overall Study||220||
59729601|NCT03125902|75848265|FG001|STARTED|Overall Study||431||
59729602|NCT03125902|75848264|FG000|COMPLETED|Overall Study||0||
59729603|NCT03125902|75848265|FG001|COMPLETED|Overall Study||0||
59729604|NCT03125902|75848264|FG000|NOT COMPLETED|Overall Study||220||
59729605|NCT03125902|75848265|FG001|NOT COMPLETED|Overall Study||431||
59729606|NCT03085719|75848274|FG000|STARTED|Overall Study||6||
59729607|NCT03085719|75848275|FG001|STARTED|Overall Study||12||
59729608|NCT03085719|75848274|FG000|COMPLETED|Overall Study||6||
59729609|NCT03085719|75848275|FG001|COMPLETED|Overall Study||11||
59729610|NCT03085719|75848274|FG000|NOT COMPLETED|Overall Study||0||
59729611|NCT03085719|75848275|FG001|NOT COMPLETED|Overall Study||1||
59729612|NCT02985957|75848288|FG000|STARTED|Pre-Treatment Period||2||
59729613|NCT02985957|75848289|FG001|STARTED|Pre-Treatment Period||45||
59729614|NCT02985957|75848290|FG002|STARTED|Pre-Treatment Period||45||
59729615|NCT02985957|75848291|FG003|STARTED|Pre-Treatment Period||73||
59729616|NCT02985957|75848292|FG004|STARTED|Pre-Treatment Period||74||
59729617|NCT02985957|75848293|FG005|STARTED|Pre-Treatment Period||38||
59729618|NCT02985957|75848294|FG006|STARTED|Pre-Treatment Period||74||
59729619|NCT02985957|75848288|FG000|COMPLETED|Pre-Treatment Period||2||
59729620|NCT02985957|75848289|FG001|COMPLETED|Pre-Treatment Period||45||
59729621|NCT02985957|75848290|FG002|COMPLETED|Pre-Treatment Period||45||
59729622|NCT02985957|75848291|FG003|COMPLETED|Pre-Treatment Period||73||
59729623|NCT02985957|75848292|FG004|COMPLETED|Pre-Treatment Period||73||
59729624|NCT02985957|75848293|FG005|COMPLETED|Pre-Treatment Period||38||
59729625|NCT02985957|75848294|FG006|COMPLETED|Pre-Treatment Period||72||
59729626|NCT02985957|75848288|FG000|NOT COMPLETED|Pre-Treatment Period||0||
59729627|NCT02985957|75848289|FG001|NOT COMPLETED|Pre-Treatment Period||0||
59729628|NCT02985957|75848290|FG002|NOT COMPLETED|Pre-Treatment Period||0||
59729629|NCT02985957|75848291|FG003|NOT COMPLETED|Pre-Treatment Period||0||
59729630|NCT02985957|75848292|FG004|NOT COMPLETED|Pre-Treatment Period||1||
59729631|NCT02985957|75848293|FG005|NOT COMPLETED|Pre-Treatment Period||0||
59729632|NCT02985957|75848294|FG006|NOT COMPLETED|Pre-Treatment Period||2||
59729633|NCT02985957|75848288|FG000|STARTED|Treatment Period||2|Started Treatment|
59729634|NCT02985957|75848289|FG001|STARTED|Treatment Period||45|Started Treatment|
59729635|NCT02985957|75848290|FG002|STARTED|Treatment Period||45|Started Treatment|
59729636|NCT02985957|75848291|FG003|STARTED|Treatment Period||73|Started Treatment|
59729637|NCT02985957|75848292|FG004|STARTED|Treatment Period||73|Started Treatment|
59729638|NCT02985957|75848293|FG005|STARTED|Treatment Period||38|Started Treatment|
59729639|NCT02985957|75848294|FG006|STARTED|Treatment Period||72|Started Treatment|
59729640|NCT02985957|75848288|FG000|Eligible Participants Who Progressed and Received Nivolumab 3 mg/kg + Ipilimumab 1 mg/kg|Treatment Period||0||
59729641|NCT02985957|75848289|FG001|Eligible Participants Who Progressed and Received Nivolumab 3 mg/kg + Ipilimumab 1 mg/kg|Treatment Period||0||
59729642|NCT02985957|75848290|FG002|Eligible Participants Who Progressed and Received Nivolumab 3 mg/kg + Ipilimumab 1 mg/kg|Treatment Period||0||
59729643|NCT02985957|75848291|FG003|Eligible Participants Who Progressed and Received Nivolumab 3 mg/kg + Ipilimumab 1 mg/kg|Treatment Period||0||
59729644|NCT02985957|75848292|FG004|Eligible Participants Who Progressed and Received Nivolumab 3 mg/kg + Ipilimumab 1 mg/kg|Treatment Period||0||
59729645|NCT02985957|75848293|FG005|Eligible Participants Who Progressed and Received Nivolumab 3 mg/kg + Ipilimumab 1 mg/kg|Treatment Period||12||
59729646|NCT02985957|75848294|FG006|Eligible Participants Who Progressed and Received Nivolumab 3 mg/kg + Ipilimumab 1 mg/kg|Treatment Period||25||
59729647|NCT02985957|75848288|FG000|COMPLETED|Treatment Period||0||
59729648|NCT02985957|75848289|FG001|COMPLETED|Treatment Period||0||
59729649|NCT02985957|75848290|FG002|COMPLETED|Treatment Period||0||
59729650|NCT02985957|75848291|FG003|COMPLETED|Treatment Period||2||
59729651|NCT02985957|75848292|FG004|COMPLETED|Treatment Period||0||
59729652|NCT02985957|75848293|FG005|COMPLETED|Treatment Period||19||
59729653|NCT02985957|75848294|FG006|COMPLETED|Treatment Period||25||
59729654|NCT02985957|75848288|FG000|NOT COMPLETED|Treatment Period||2||
59729655|NCT02985957|75848289|FG001|NOT COMPLETED|Treatment Period||45||
59729656|NCT02985957|75848290|FG002|NOT COMPLETED|Treatment Period||45||
59729657|NCT02985957|75848291|FG003|NOT COMPLETED|Treatment Period||71||
59729658|NCT02985957|75848292|FG004|NOT COMPLETED|Treatment Period||73||
59729659|NCT02985957|75848293|FG005|NOT COMPLETED|Treatment Period||19||
59729660|NCT02985957|75848294|FG006|NOT COMPLETED|Treatment Period||47||
59729661|NCT02915523|75848320|FG000|STARTED|Dose Determination Phase (Phase 1B)||6||
59729662|NCT02915523|75848321|FG001|STARTED|Dose Determination Phase (Phase 1B)||8||
59729663|NCT02915523|75848322|FG002|STARTED|Dose Determination Phase (Phase 1B)||0||
59729664|NCT02915523|75848323|FG003|STARTED|Dose Determination Phase (Phase 1B)||0||
59729665|NCT02915523|75848320|FG000|Received At Least 1 Dose Of Study Drug|Dose Determination Phase (Phase 1B)||6||
59729666|NCT02915523|75848321|FG001|Received At Least 1 Dose Of Study Drug|Dose Determination Phase (Phase 1B)||8||
59729667|NCT02915523|75848322|FG002|Received At Least 1 Dose Of Study Drug|Dose Determination Phase (Phase 1B)||0||
59729668|NCT02915523|75848323|FG003|Received At Least 1 Dose Of Study Drug|Dose Determination Phase (Phase 1B)||0||
59729669|NCT02915523|75848320|FG000|Dose-limiting Toxicity (DLT) Evaluable|Dose Determination Phase (Phase 1B)||6|Participants who received at least one dose of entinostat or avelumab were evaluated for DLTs over 2 cycles (Cycle 1 and Cycle 2).|
59729670|NCT02915523|75848321|FG001|Dose-limiting Toxicity (DLT) Evaluable|Dose Determination Phase (Phase 1B)||8|Participants who received at least one dose of entinostat or avelumab were evaluated for DLTs over 2 cycles (Cycle 1 and Cycle 2).|
60131212|NCT01570244|76253743|FG000|STARTED|Microgynon||16||
60131213|NCT01570244|76253743|FG000|COMPLETED|Microgynon||16||
59729671|NCT02915523|75848322|FG002|Dose-limiting Toxicity (DLT) Evaluable|Dose Determination Phase (Phase 1B)|DLTs were not evaluated in Phase 2.|0|Participants who received at least one dose of entinostat or avelumab were evaluated for DLTs over 2 cycles (Cycle 1 and Cycle 2).|
59729672|NCT02915523|75848323|FG003|Dose-limiting Toxicity (DLT) Evaluable|Dose Determination Phase (Phase 1B)|DLTs were not evaluated in Phase 2.|0|Participants who received at least one dose of entinostat or avelumab were evaluated for DLTs over 2 cycles (Cycle 1 and Cycle 2).|
59729673|NCT02915523|75848320|FG000|COMPLETED|Dose Determination Phase (Phase 1B)||0||
59729674|NCT02915523|75848321|FG001|COMPLETED|Dose Determination Phase (Phase 1B)||0||
59729675|NCT02915523|75848322|FG002|COMPLETED|Dose Determination Phase (Phase 1B)||0||
59729676|NCT02915523|75848323|FG003|COMPLETED|Dose Determination Phase (Phase 1B)||0||
59729677|NCT02915523|75848320|FG000|NOT COMPLETED|Dose Determination Phase (Phase 1B)||6||
59729678|NCT02915523|75848321|FG001|NOT COMPLETED|Dose Determination Phase (Phase 1B)||8||
59729679|NCT02915523|75848322|FG002|NOT COMPLETED|Dose Determination Phase (Phase 1B)||0||
59729680|NCT02915523|75848323|FG003|NOT COMPLETED|Dose Determination Phase (Phase 1B)||0||
59729681|NCT02915523|75848320|FG000|STARTED|Expansion Phase (Phase 2)||0||
59729682|NCT02915523|75848321|FG001|STARTED|Expansion Phase (Phase 2)||0||
59729683|NCT02915523|75848322|FG002|STARTED|Expansion Phase (Phase 2)||41||
59729684|NCT02915523|75848323|FG003|STARTED|Expansion Phase (Phase 2)||85||
59729685|NCT02915523|75848320|FG000|Received At Least 1 Dose Of Study Drug|Expansion Phase (Phase 2)||0||
59729686|NCT02915523|75848321|FG001|Received At Least 1 Dose Of Study Drug|Expansion Phase (Phase 2)||0||
59729687|NCT02915523|75848322|FG002|Received At Least 1 Dose Of Study Drug|Expansion Phase (Phase 2)||40||
59729688|NCT02915523|75848323|FG003|Received At Least 1 Dose Of Study Drug|Expansion Phase (Phase 2)||85||
59729689|NCT02915523|75848320|FG000|COMPLETED|Expansion Phase (Phase 2)||0||
59729690|NCT02915523|75848321|FG001|COMPLETED|Expansion Phase (Phase 2)||0||
59729691|NCT02915523|75848322|FG002|COMPLETED|Expansion Phase (Phase 2)||5||
59729692|NCT02915523|75848323|FG003|COMPLETED|Expansion Phase (Phase 2)||0||
59729693|NCT02915523|75848320|FG000|NOT COMPLETED|Expansion Phase (Phase 2)||0||
59729694|NCT02915523|75848321|FG001|NOT COMPLETED|Expansion Phase (Phase 2)||0||
59729695|NCT02915523|75848322|FG002|NOT COMPLETED|Expansion Phase (Phase 2)||36||
59729696|NCT02915523|75848323|FG003|NOT COMPLETED|Expansion Phase (Phase 2)||85||
59729697|NCT02890355|75848337|FG000|STARTED|Overall Study||59||
59729698|NCT02890355|75848338|FG001|STARTED|Overall Study||58||
59729699|NCT02890355|75848337|FG000|Treated & Assessed for AEs|Overall Study||56||
59729700|NCT02890355|75848338|FG001|Treated & Assessed for AEs|Overall Study||50||
59729701|NCT02890355|75848337|FG000|COMPLETED|Overall Study||0||
59729702|NCT02890355|75848338|FG001|COMPLETED|Overall Study||0||
59729703|NCT02890355|75848337|FG000|NOT COMPLETED|Overall Study||59||
59729704|NCT02890355|75848338|FG001|NOT COMPLETED|Overall Study||58||
59729705|NCT02844816|75848348|FG000|STARTED|Overall Study||101||
59729706|NCT02844816|75848349|FG001|STARTED|Overall Study||71||
59729707|NCT02844816|75848348|FG000|Safety Analysis Population|Overall Study||96||
59729708|NCT02844816|75848349|FG001|Safety Analysis Population|Overall Study||70||
59729709|NCT02844816|75848348|FG000|Eligible and Evaluable|Overall Study||74||
59729710|NCT02844816|75848349|FG001|Eligible and Evaluable|Overall Study||55||
59729711|NCT02844816|75848348|FG000|COMPLETED|Overall Study||13||
59729712|NCT02844816|75848349|FG001|COMPLETED|Overall Study||20||
59729713|NCT02844816|75848348|FG000|NOT COMPLETED|Overall Study||88||
59729714|NCT02844816|75848349|FG001|NOT COMPLETED|Overall Study||51||
59729715|NCT02664545|75848358|FG000|STARTED|Overall Study||65||
59729716|NCT02664545|75848359|FG001|STARTED|Overall Study||35||
59729717|NCT02664545|75848358|FG000|Surgery|Overall Study||65||
59729718|NCT02664545|75848359|FG001|Surgery|Overall Study||35||
59729719|NCT02664545|75848358|FG000|COMPLETED|Overall Study||58|Completed 2-year Primary Endpoint.|
59729720|NCT02664545|75848359|FG001|COMPLETED|Overall Study||32|Completed 2-year Primary Endpoint.|
59729721|NCT02664545|75848358|FG000|NOT COMPLETED|Overall Study||7||
59729722|NCT02664545|75848359|FG001|NOT COMPLETED|Overall Study||3||
59729723|NCT02581930|75848365|FG000|STARTED|Overall Study||18||
59729724|NCT02581930|75848365|FG000|COMPLETED|Overall Study||16||
59729725|NCT02581930|75848365|FG000|NOT COMPLETED|Overall Study||2||
59729726|NCT02567409|75848371|FG000|STARTED|Overall Study||46||
59729727|NCT02567409|75848372|FG001|STARTED|Overall Study||41||
59729728|NCT02567409|75848371|FG000|COMPLETED|Overall Study||46||
59729729|NCT02567409|75848372|FG001|COMPLETED|Overall Study||41||
59729730|NCT02567409|75848371|FG000|NOT COMPLETED|Overall Study||0||
59729731|NCT02567409|75848372|FG001|NOT COMPLETED|Overall Study||0||
59729732|NCT02513563|75848378|FG000|STARTED|Overall Study||42||
59729733|NCT02513563|75848378|FG000|COMPLETED|Overall Study||33||
59729734|NCT02513563|75848378|FG000|NOT COMPLETED|Overall Study||9||
59729735|NCT02498600|75848384|FG000|STARTED|Overall Study||49||
59729736|NCT02498600|75848385|FG001|STARTED|Overall Study||51||
59729737|NCT02498600|75848384|FG000|COMPLETED|Overall Study||49||
59729738|NCT02498600|75848385|FG001|COMPLETED|Overall Study||51||
59729739|NCT02498600|75848384|FG000|NOT COMPLETED|Overall Study||0||
59729740|NCT02498600|75848385|FG001|NOT COMPLETED|Overall Study||0||
59729741|NCT02466971|75848393|FG000|STARTED|Overall Study||225||
59729742|NCT02466971|75848394|FG001|STARTED|Overall Study||225||
59729743|NCT02466971|75848393|FG000|COMPLETED|Overall Study||207||
59729744|NCT02466971|75848394|FG001|COMPLETED|Overall Study||202||
59729745|NCT02466971|75848393|FG000|NOT COMPLETED|Overall Study||18||
59729746|NCT02466971|75848394|FG001|NOT COMPLETED|Overall Study||23||
59729747|NCT02443545|75848400|FG000|STARTED|Overall Study||89||
59729748|NCT02443545|75848401|FG001|STARTED|Overall Study||45||
59729749|NCT02443545|75848400|FG000|COMPLETED|Overall Study||50||
59729750|NCT02443545|75848401|FG001|COMPLETED|Overall Study||26||
59729751|NCT02443545|75848400|FG000|NOT COMPLETED|Overall Study||39||
59729752|NCT02443545|75848401|FG001|NOT COMPLETED|Overall Study||19||
59729753|NCT02432183|75848409|FG000|STARTED|Overall Study||44||
59729754|NCT02432183|75848410|FG001|STARTED|Overall Study||47||
59729755|NCT02432183|75848411|FG002|STARTED|Overall Study||26||
59729756|NCT02432183|75848412|FG003|STARTED|Overall Study||17||
59729757|NCT02432183|75848409|FG000|COMPLETED|Overall Study||44||
59729758|NCT02432183|75848410|FG001|COMPLETED|Overall Study||47||
59729759|NCT02432183|75848411|FG002|COMPLETED|Overall Study||26||
59729760|NCT02432183|75848412|FG003|COMPLETED|Overall Study||17||
59729761|NCT02432183|75848409|FG000|NOT COMPLETED|Overall Study||0||
59729762|NCT02432183|75848410|FG001|NOT COMPLETED|Overall Study||0||
59729763|NCT02432183|75848411|FG002|NOT COMPLETED|Overall Study||0||
59729764|NCT02432183|75848412|FG003|NOT COMPLETED|Overall Study||0||
59729765|NCT02388906|75848424|FG000|STARTED|Pre-Treatment Period||453|Started=Randomized|
59729766|NCT02388906|75848425|FG001|STARTED|Pre-Treatment Period||453|Started=Randomized|
59729767|NCT02388906|75848424|FG000|COMPLETED|Pre-Treatment Period||452|completed=treated|
59729768|NCT02388906|75848425|FG001|COMPLETED|Pre-Treatment Period||453|completed=treated|
59729769|NCT02388906|75848424|FG000|NOT COMPLETED|Pre-Treatment Period||1||
59729770|NCT02388906|75848425|FG001|NOT COMPLETED|Pre-Treatment Period||0||
59729771|NCT02388906|75848424|FG000|STARTED|Treatment Period||452|Started=Treated|
59729772|NCT02388906|75848425|FG001|STARTED|Treatment Period||453|Started=Treated|
59729773|NCT02388906|75848424|FG000|COMPLETED|Treatment Period||275|Completed=Finished the treatment period|
59729774|NCT02388906|75848425|FG001|COMPLETED|Treatment Period||122|Completed=Finished the treatment period|
59729775|NCT02388906|75848424|FG000|NOT COMPLETED|Treatment Period||177||
59729776|NCT02388906|75848425|FG001|NOT COMPLETED|Treatment Period||331||
59729777|NCT02375555|75848431|FG000|STARTED|Induction Period||40||
59729778|NCT02375555|75848431|FG000|Induction Therapy Cycles 1-4|Induction Period|Of the 40 patients comprising the safety population, 34 patients completed 4 cycles (cycles 1-4) of induction therapy.|34||
59729779|NCT02375555|75848431|FG000|Induction Therapy Cycles 5-8|Induction Period|Of the 40 patients comprising the safety population, 12 patients completed 4 additional cycles (cycles 5-8) of induction therapy.|12||
59729780|NCT02375555|75848431|FG000|Autologous Stem Cell Transplant|Induction Period|Of the 40 patients comprising the safety population, 19 patients received autologous stem cell transplant (ASCT) at the end of Induction cycle 4.|19||
59729781|NCT02375555|75848431|FG000|COMPLETED|Induction Period||29||
59729782|NCT02375555|75848431|FG000|NOT COMPLETED|Induction Period||11||
59729783|NCT02375555|75848431|FG000|STARTED|Maintenance Period||29||
59729784|NCT02375555|75848431|FG000|COMPLETED|Maintenance Period||0||
59729785|NCT02375555|75848431|FG000|NOT COMPLETED|Maintenance Period||29||
59729786|NCT02367040|75848439|FG000|STARTED|Overall Study||307||
59729787|NCT02367040|75848440|FG001|STARTED|Overall Study||151||
59729788|NCT02367040|75848439|FG000|Received Treatment|Overall Study||304||
59729789|NCT02367040|75848440|FG001|Received Treatment|Overall Study||149||
59729790|NCT02367040|75848439|FG000|COMPLETED|Overall Study||32|Ongoing with treatment at 2-year follow-up cut-off date|
59729791|NCT02367040|75848440|FG001|COMPLETED|Overall Study||10|Ongoing with treatment at 2-year follow-up cut-off date|
59729792|NCT02367040|75848439|FG000|NOT COMPLETED|Overall Study||275||
59729793|NCT02367040|75848440|FG001|NOT COMPLETED|Overall Study||141||
59729794|NCT02311933|75848448|FG000|STARTED|Overall Study||41||
59729795|NCT02311933|75848449|FG001|STARTED|Overall Study||40||
59729796|NCT02311933|75848448|FG000|COMPLETED|Overall Study||41||
59729797|NCT02311933|75848449|FG001|COMPLETED|Overall Study||40||
59729798|NCT02311933|75848448|FG000|NOT COMPLETED|Overall Study||0||
59729799|NCT02311933|75848449|FG001|NOT COMPLETED|Overall Study||0||
59729800|NCT02306161|75848457|FG000|STARTED|Overall Study||157||
59729801|NCT02306161|75848458|FG001|STARTED|Overall Study||155||
59729802|NCT02306161|75848457|FG000|COMPLETED|Overall Study||93||
59729803|NCT02306161|75848458|FG001|COMPLETED|Overall Study||86||
59729804|NCT02306161|75848457|FG000|NOT COMPLETED|Overall Study||64||
59729805|NCT02306161|75848458|FG001|NOT COMPLETED|Overall Study||69||
59729806|NCT02251548|75848464|FG000|STARTED|Overall Study||85||
59729807|NCT02251548|75848464|FG000|COMPLETED|Overall Study||0||
59729808|NCT02251548|75848464|FG000|NOT COMPLETED|Overall Study||85||
59729809|NCT02152982|75848473|FG000|STARTED|Overall Study||224||
59729810|NCT02152982|75848474|FG001|STARTED|Overall Study||223||
59729811|NCT02152982|75848473|FG000|Started Treatment|Overall Study||212||
59729812|NCT02152982|75848474|FG001|Started Treatment|Overall Study||217||
59729813|NCT02152982|75848473|FG000|COMPLETED|Overall Study||208||
59729814|NCT02152982|75848474|FG001|COMPLETED|Overall Study||213||
59729815|NCT02152982|75848473|FG000|NOT COMPLETED|Overall Study||16||
59729816|NCT02152982|75848474|FG001|NOT COMPLETED|Overall Study||10||
59729817|NCT02129348|75848488|FG000|STARTED|Overall Study||38||
59729818|NCT02129348|75848489|FG001|STARTED|Overall Study||39||
60131214|NCT01570244|76253743|FG000|NOT COMPLETED|Microgynon||0||
59729819|NCT02129348|75848488|FG000|COMPLETED|Overall Study||29||
59729820|NCT02129348|75848489|FG001|COMPLETED|Overall Study||29||
59729821|NCT02129348|75848488|FG000|NOT COMPLETED|Overall Study||9||
59729822|NCT02129348|75848489|FG001|NOT COMPLETED|Overall Study||10||
59729823|NCT02112526|75848497|FG000|STARTED|Overall Study||11||
59729824|NCT02112526|75848498|FG001|STARTED|Overall Study||10||
59729825|NCT02112526|75848497|FG000|Enrolled|Overall Study||11||
59729826|NCT02112526|75848498|FG001|Enrolled|Overall Study||10||
59729827|NCT02112526|75848497|FG000|Received Study Medication|Overall Study||11||
59729828|NCT02112526|75848498|FG001|Received Study Medication|Overall Study||10||
59729829|NCT02112526|75848497|FG000|Discontinued Study|Overall Study||11||
59729830|NCT02112526|75848498|FG001|Discontinued Study|Overall Study||9||
59729831|NCT02112526|75848497|FG000|Subjects Continuing Study Medication|Overall Study||0||
59729832|NCT02112526|75848498|FG001|Subjects Continuing Study Medication|Overall Study||1||
59729833|NCT02112526|75848497|FG000|COMPLETED|Overall Study||0||
59729834|NCT02112526|75848498|FG001|COMPLETED|Overall Study||1||
59729835|NCT02112526|75848497|FG000|NOT COMPLETED|Overall Study||11||
59729836|NCT02112526|75848498|FG001|NOT COMPLETED|Overall Study||9||
59729837|NCT02101788|75848506|FG000|STARTED|Overall Study||130||
59729838|NCT02101788|75848507|FG001|STARTED|Overall Study||130||
59729839|NCT02101788|75848506|FG000|Crossover From Arm A to Arm B|Overall Study||88||
59729840|NCT02101788|75848507|FG001|Crossover From Arm A to Arm B|Overall Study||0||
59729841|NCT02101788|75848506|FG000|COMPLETED|Overall Study||120||
59729842|NCT02101788|75848507|FG001|COMPLETED|Overall Study||116||
59729843|NCT02101788|75848506|FG000|NOT COMPLETED|Overall Study||10||
59729844|NCT02101788|75848507|FG001|NOT COMPLETED|Overall Study||14||
59729845|NCT02100280|75848522|FG000|STARTED|Overall Study||48||
59729846|NCT02100280|75848523|FG001|STARTED|Overall Study||48||
59729847|NCT02100280|75848522|FG000|COMPLETED|Overall Study||44||
59729848|NCT02100280|75848523|FG001|COMPLETED|Overall Study||44||
59729849|NCT02100280|75848522|FG000|NOT COMPLETED|Overall Study||4||
59729850|NCT02100280|75848523|FG001|NOT COMPLETED|Overall Study||4||
59729851|NCT01935934|75848533|FG000|STARTED|Overall Study||70||
59729852|NCT01935934|75848534|FG001|STARTED|Overall Study||32||
59729853|NCT01935934|75848533|FG000|COMPLETED|Overall Study||70||
59729854|NCT01935934|75848534|FG001|COMPLETED|Overall Study||32||
59729855|NCT01935934|75848533|FG000|NOT COMPLETED|Overall Study||0||
59729856|NCT01935934|75848534|FG001|NOT COMPLETED|Overall Study||0||
59729857|NCT01928394|75848566|FG000|STARTED|Treatment Period||18|Started = Entering initial treatment or combination treatment after completion of monotherapy(MT)|
59729858|NCT01928394|75848567|FG001|STARTED|Treatment Period||3|Started = Entering initial treatment or combination treatment after completion of monotherapy(MT)|
59729859|NCT01928394|75848568|FG002|STARTED|Treatment Period||18|Started = Entering initial treatment or combination treatment after completion of monotherapy(MT)|
59729860|NCT01928394|75848569|FG003|STARTED|Treatment Period||59|Started = Entering initial treatment or combination treatment after completion of monotherapy(MT)|
59729861|NCT01928394|75848570|FG004|STARTED|Treatment Period||3|Started = Entering initial treatment or combination treatment after completion of monotherapy(MT)|
59729862|NCT01928394|75848571|FG005|STARTED|Treatment Period||49|Started = Entering initial treatment or combination treatment after completion of monotherapy(MT)|
59729863|NCT01928394|75848572|FG006|STARTED|Treatment Period||52|Started = Entering initial treatment or combination treatment after completion of monotherapy(MT)|
59729864|NCT01928394|75848573|FG007|STARTED|Treatment Period||18|Started = Entering initial treatment or combination treatment after completion of monotherapy(MT)|
59729865|NCT01928394|75848574|FG008|STARTED|Treatment Period||3|Started = Entering initial treatment or combination treatment after completion of monotherapy(MT)|
59729866|NCT01928394|75848575|FG009|STARTED|Treatment Period||18|Started = Entering initial treatment or combination treatment after completion of monotherapy(MT)|
59729867|NCT01928394|75848576|FG010|STARTED|Treatment Period||30|Started = Entering initial treatment or combination treatment after completion of monotherapy(MT)|
59729868|NCT01928394|75848577|FG011|STARTED|Treatment Period||98|Started = Entering initial treatment or combination treatment after completion of monotherapy(MT)|
59729869|NCT01928394|75848578|FG012|STARTED|Treatment Period||61|Started = Entering initial treatment or combination treatment after completion of monotherapy(MT)|
59729870|NCT01928394|75848579|FG013|STARTED|Treatment Period||147|Started = Entering initial treatment or combination treatment after completion of monotherapy(MT)|
59729871|NCT01928394|75848580|FG014|STARTED|Treatment Period||96|Started = Entering initial treatment or combination treatment after completion of monotherapy(MT)|
59729872|NCT01928394|75848581|FG015|STARTED|Treatment Period||3|Started = Entering initial treatment or combination treatment after completion of monotherapy(MT)|
59729873|NCT01928394|75848582|FG016|STARTED|Treatment Period||55|Started = Entering initial treatment or combination treatment after completion of monotherapy(MT)|
59729874|NCT01928394|75848583|FG017|STARTED|Treatment Period||78|Started = Entering initial treatment or combination treatment after completion of monotherapy(MT)|
59729875|NCT01928394|75848584|FG018|STARTED|Treatment Period||92|Started = Entering initial treatment or combination treatment after completion of monotherapy(MT)|
59729876|NCT01928394|75848585|FG019|STARTED|Treatment Period||104|Started = Entering initial treatment or combination treatment after completion of monotherapy(MT)|
59729877|NCT01928394|75848586|FG020|STARTED|Treatment Period||41|Started = Entering initial treatment or combination treatment after completion of monotherapy(MT)|
59729878|NCT01928394|75848587|FG021|STARTED|Treatment Period||43|Started = Entering initial treatment or combination treatment after completion of monotherapy(MT)|
59729879|NCT01928394|75848588|FG022|STARTED|Treatment Period||42|Started = Entering initial treatment or combination treatment after completion of monotherapy(MT)|
60131215|NCT01570244|76253743|FG000|STARTED|Microgynon+Faldaprevir||16||
59729880|NCT01928394|75848566|FG000|Transition|Treatment Period||3|Participants who will transition after completing MT due to disease progression (DP)|
59729881|NCT01928394|75848567|FG001|Transition|Treatment Period||0|Participants who will transition after completing MT due to disease progression (DP)|
59729882|NCT01928394|75848568|FG002|Transition|Treatment Period||0|Participants who will transition after completing MT due to disease progression (DP)|
59729883|NCT01928394|75848569|FG003|Transition|Treatment Period||9|Participants who will transition after completing MT due to disease progression (DP)|
59729884|NCT01928394|75848570|FG004|Transition|Treatment Period||0|Participants who will transition after completing MT due to disease progression (DP)|
59729885|NCT01928394|75848571|FG005|Transition|Treatment Period||0|Participants who will transition after completing MT due to disease progression (DP)|
59729886|NCT01928394|75848572|FG006|Transition|Treatment Period||0|Participants who will transition after completing MT due to disease progression (DP)|
59729887|NCT01928394|75848573|FG007|Transition|Treatment Period||2|Participants who will transition after completing MT due to disease progression (DP)|
59729888|NCT01928394|75848574|FG008|Transition|Treatment Period||0|Participants who will transition after completing MT due to disease progression (DP)|
59729889|NCT01928394|75848575|FG009|Transition|Treatment Period||0|Participants who will transition after completing MT due to disease progression (DP)|
59729890|NCT01928394|75848576|FG010|Transition|Treatment Period||0|Participants who will transition after completing MT due to disease progression (DP)|
59729891|NCT01928394|75848577|FG011|Transition|Treatment Period||17|Participants who will transition after completing MT due to disease progression (DP)|
59729892|NCT01928394|75848578|FG012|Transition|Treatment Period||0|Participants who will transition after completing MT due to disease progression (DP)|
59729893|NCT01928394|75848579|FG013|Transition|Treatment Period||2|Participants who will transition after completing MT due to disease progression (DP)|
59729894|NCT01928394|75848580|FG014|Transition|Treatment Period||0|Participants who will transition after completing MT due to disease progression (DP)|
59729895|NCT01928394|75848581|FG015|Transition|Treatment Period||0|Participants who will transition after completing MT due to disease progression (DP)|
59729896|NCT01928394|75848582|FG016|Transition|Treatment Period||0|Participants who will transition after completing MT due to disease progression (DP)|
59729897|NCT01928394|75848583|FG017|Transition|Treatment Period||20|Participants who will transition after completing MT due to disease progression (DP)|
59729898|NCT01928394|75848584|FG018|Transition|Treatment Period||0|Participants who will transition after completing MT due to disease progression (DP)|
59729899|NCT01928394|75848585|FG019|Transition|Treatment Period||0|Participants who will transition after completing MT due to disease progression (DP)|
59729900|NCT01928394|75848586|FG020|Transition|Treatment Period||0|Participants who will transition after completing MT due to disease progression (DP)|
59729901|NCT01928394|75848587|FG021|Transition|Treatment Period||0|Participants who will transition after completing MT due to disease progression (DP)|
59729902|NCT01928394|75848588|FG022|Transition|Treatment Period||0|Participants who will transition after completing MT due to disease progression (DP)|
59729903|NCT01928394|75848566|FG000|Transition- Continued|Treatment Period||0|Participants who were transitioned to another treatment after disease progression (DP).|
59729904|NCT01928394|75848567|FG001|Transition- Continued|Treatment Period||0|Participants who were transitioned to another treatment after disease progression (DP).|
59729905|NCT01928394|75848568|FG002|Transition- Continued|Treatment Period||3|Participants who were transitioned to another treatment after disease progression (DP).|
59729906|NCT01928394|75848569|FG003|Transition- Continued|Treatment Period||0|Participants who were transitioned to another treatment after disease progression (DP).|
59729907|NCT01928394|75848570|FG004|Transition- Continued|Treatment Period||0|Participants who were transitioned to another treatment after disease progression (DP).|
59729908|NCT01928394|75848571|FG005|Transition- Continued|Treatment Period||3|Participants who were transitioned to another treatment after disease progression (DP).|
59729909|NCT01928394|75848572|FG006|Transition- Continued|Treatment Period||6|Participants who were transitioned to another treatment after disease progression (DP).|
59729910|NCT01928394|75848573|FG007|Transition- Continued|Treatment Period||0|Participants who were transitioned to another treatment after disease progression (DP).|
59729911|NCT01928394|75848574|FG008|Transition- Continued|Treatment Period||1|Participants who were transitioned to another treatment after disease progression (DP).|
59729912|NCT01928394|75848575|FG009|Transition- Continued|Treatment Period||1|Participants who were transitioned to another treatment after disease progression (DP).|
59729913|NCT01928394|75848576|FG010|Transition- Continued|Treatment Period||0|Participants who were transitioned to another treatment after disease progression (DP).|
59729914|NCT01928394|75848577|FG011|Transition- Continued|Treatment Period||0|Participants who were transitioned to another treatment after disease progression (DP).|
59729915|NCT01928394|75848578|FG012|Transition- Continued|Treatment Period||17|Participants who were transitioned to another treatment after disease progression (DP).|
59729916|NCT01928394|75848579|FG013|Transition- Continued|Treatment Period||0|Participants who were transitioned to another treatment after disease progression (DP).|
59729917|NCT01928394|75848580|FG014|Transition- Continued|Treatment Period||2|Participants who were transitioned to another treatment after disease progression (DP).|
59729918|NCT01928394|75848581|FG015|Transition- Continued|Treatment Period||0|Participants who were transitioned to another treatment after disease progression (DP).|
59729919|NCT01928394|75848582|FG016|Transition- Continued|Treatment Period||0|Participants who were transitioned to another treatment after disease progression (DP).|
59729920|NCT01928394|75848583|FG017|Transition- Continued|Treatment Period||0|Participants who were transitioned to another treatment after disease progression (DP).|
59729921|NCT01928394|75848584|FG018|Transition- Continued|Treatment Period||1|Participants who were transitioned to another treatment after disease progression (DP).|
60131216|NCT01570244|76253743|FG000|COMPLETED|Microgynon+Faldaprevir||15||
59729922|NCT01928394|75848585|FG019|Transition- Continued|Treatment Period||19|Participants who were transitioned to another treatment after disease progression (DP).|
59729923|NCT01928394|75848586|FG020|Transition- Continued|Treatment Period||0|Participants who were transitioned to another treatment after disease progression (DP).|
59729924|NCT01928394|75848587|FG021|Transition- Continued|Treatment Period||0|Participants who were transitioned to another treatment after disease progression (DP).|
59729925|NCT01928394|75848588|FG022|Transition- Continued|Treatment Period||0|Participants who were transitioned to another treatment after disease progression (DP).|
59729926|NCT01928394|75848566|FG000|COMPLETED|Treatment Period||0|Completed = continuing treatment period|
59729927|NCT01928394|75848567|FG001|COMPLETED|Treatment Period||0|Completed = continuing treatment period|
59729928|NCT01928394|75848568|FG002|COMPLETED|Treatment Period||0|Completed = continuing treatment period|
59729929|NCT01928394|75848569|FG003|COMPLETED|Treatment Period||3|Completed = continuing treatment period|
59729930|NCT01928394|75848570|FG004|COMPLETED|Treatment Period||0|Completed = continuing treatment period|
59729931|NCT01928394|75848571|FG005|COMPLETED|Treatment Period||6|Completed = continuing treatment period|
59729932|NCT01928394|75848572|FG006|COMPLETED|Treatment Period||3|Completed = continuing treatment period|
59729933|NCT01928394|75848573|FG007|COMPLETED|Treatment Period||0|Completed = continuing treatment period|
59729934|NCT01928394|75848574|FG008|COMPLETED|Treatment Period||0|Completed = continuing treatment period|
59729935|NCT01928394|75848575|FG009|COMPLETED|Treatment Period||0|Completed = continuing treatment period|
59729936|NCT01928394|75848576|FG010|COMPLETED|Treatment Period||0|Completed = continuing treatment period|
59729937|NCT01928394|75848577|FG011|COMPLETED|Treatment Period||5|Completed = continuing treatment period|
59729938|NCT01928394|75848578|FG012|COMPLETED|Treatment Period||6|Completed = continuing treatment period|
59729939|NCT01928394|75848579|FG013|COMPLETED|Treatment Period||8|Completed = continuing treatment period|
59729940|NCT01928394|75848580|FG014|COMPLETED|Treatment Period||8|Completed = continuing treatment period|
59729941|NCT01928394|75848581|FG015|COMPLETED|Treatment Period||1|Completed = continuing treatment period|
59729942|NCT01928394|75848582|FG016|COMPLETED|Treatment Period||5|Completed = continuing treatment period|
59729943|NCT01928394|75848583|FG017|COMPLETED|Treatment Period||7|Completed = continuing treatment period|
59729944|NCT01928394|75848584|FG018|COMPLETED|Treatment Period||22|Completed = continuing treatment period|
59729945|NCT01928394|75848585|FG019|COMPLETED|Treatment Period||8|Completed = continuing treatment period|
59729946|NCT01928394|75848586|FG020|COMPLETED|Treatment Period||1|Completed = continuing treatment period|
59729947|NCT01928394|75848587|FG021|COMPLETED|Treatment Period||1|Completed = continuing treatment period|
59729948|NCT01928394|75848588|FG022|COMPLETED|Treatment Period||3|Completed = continuing treatment period|
59729949|NCT01928394|75848566|FG000|NOT COMPLETED|Treatment Period||18||
59729950|NCT01928394|75848567|FG001|NOT COMPLETED|Treatment Period||3||
59729951|NCT01928394|75848568|FG002|NOT COMPLETED|Treatment Period||18||
59729952|NCT01928394|75848569|FG003|NOT COMPLETED|Treatment Period||56||
59729953|NCT01928394|75848570|FG004|NOT COMPLETED|Treatment Period||3||
59729954|NCT01928394|75848571|FG005|NOT COMPLETED|Treatment Period||43||
59729955|NCT01928394|75848572|FG006|NOT COMPLETED|Treatment Period||49||
59729956|NCT01928394|75848573|FG007|NOT COMPLETED|Treatment Period||18||
59729957|NCT01928394|75848574|FG008|NOT COMPLETED|Treatment Period||3||
59729958|NCT01928394|75848575|FG009|NOT COMPLETED|Treatment Period||18||
59729959|NCT01928394|75848576|FG010|NOT COMPLETED|Treatment Period||30||
59729960|NCT01928394|75848577|FG011|NOT COMPLETED|Treatment Period||93||
59729961|NCT01928394|75848578|FG012|NOT COMPLETED|Treatment Period||55||
59729962|NCT01928394|75848579|FG013|NOT COMPLETED|Treatment Period||139||
59729963|NCT01928394|75848580|FG014|NOT COMPLETED|Treatment Period||88||
59729964|NCT01928394|75848581|FG015|NOT COMPLETED|Treatment Period||2||
59729965|NCT01928394|75848582|FG016|NOT COMPLETED|Treatment Period||50||
59729966|NCT01928394|75848583|FG017|NOT COMPLETED|Treatment Period||71||
59729967|NCT01928394|75848584|FG018|NOT COMPLETED|Treatment Period||70||
59729968|NCT01928394|75848585|FG019|NOT COMPLETED|Treatment Period||96||
59729969|NCT01928394|75848586|FG020|NOT COMPLETED|Treatment Period||40||
59729970|NCT01928394|75848587|FG021|NOT COMPLETED|Treatment Period||42||
59729971|NCT01928394|75848588|FG022|NOT COMPLETED|Treatment Period||39||
59729972|NCT01928394|75848566|FG000|STARTED|Follow-up Period||15|started = number of Participants regardless of continuing treatment or not.|
59729973|NCT01928394|75848567|FG001|STARTED|Follow-up Period||3|started = number of Participants regardless of continuing treatment or not.|
59729974|NCT01928394|75848568|FG002|STARTED|Follow-up Period||18|started = number of Participants regardless of continuing treatment or not.|
59729975|NCT01928394|75848569|FG003|STARTED|Follow-up Period||50|started = number of Participants regardless of continuing treatment or not.|
59729976|NCT01928394|75848570|FG004|STARTED|Follow-up Period||3|started = number of Participants regardless of continuing treatment or not.|
59729977|NCT01928394|75848571|FG005|STARTED|Follow-up Period||49|started = number of Participants regardless of continuing treatment or not.|
59729978|NCT01928394|75848572|FG006|STARTED|Follow-up Period||52|started = number of Participants regardless of continuing treatment or not.|
59729979|NCT01928394|75848573|FG007|STARTED|Follow-up Period||16|started = number of Participants regardless of continuing treatment or not.|
59729980|NCT01928394|75848574|FG008|STARTED|Follow-up Period||3|started = number of Participants regardless of continuing treatment or not.|
59729981|NCT01928394|75848575|FG009|STARTED|Follow-up Period||18|started = number of Participants regardless of continuing treatment or not.|
60131217|NCT01570244|76253743|FG000|NOT COMPLETED|Microgynon+Faldaprevir||1||
59729982|NCT01928394|75848576|FG010|STARTED|Follow-up Period||30|started = number of Participants regardless of continuing treatment or not.|
59729983|NCT01928394|75848577|FG011|STARTED|Follow-up Period||81|started = number of Participants regardless of continuing treatment or not.|
59729984|NCT01928394|75848578|FG012|STARTED|Follow-up Period||61|started = number of Participants regardless of continuing treatment or not.|
59729985|NCT01928394|75848579|FG013|STARTED|Follow-up Period||145|started = number of Participants regardless of continuing treatment or not.|
59729986|NCT01928394|75848580|FG014|STARTED|Follow-up Period||96|started = number of Participants regardless of continuing treatment or not.|
59729987|NCT01928394|75848581|FG015|STARTED|Follow-up Period||3|started = number of Participants regardless of continuing treatment or not.|
59729988|NCT01928394|75848582|FG016|STARTED|Follow-up Period||55|started = number of Participants regardless of continuing treatment or not.|
59729989|NCT01928394|75848583|FG017|STARTED|Follow-up Period||58|started = number of Participants regardless of continuing treatment or not.|
59729990|NCT01928394|75848584|FG018|STARTED|Follow-up Period||92|started = number of Participants regardless of continuing treatment or not.|
59729991|NCT01928394|75848585|FG019|STARTED|Follow-up Period||104|started = number of Participants regardless of continuing treatment or not.|
59729992|NCT01928394|75848586|FG020|STARTED|Follow-up Period||41|started = number of Participants regardless of continuing treatment or not.|
59729993|NCT01928394|75848587|FG021|STARTED|Follow-up Period||43|started = number of Participants regardless of continuing treatment or not.|
59729994|NCT01928394|75848588|FG022|STARTED|Follow-up Period||42|started = number of Participants regardless of continuing treatment or not.|
59729995|NCT01928394|75848566|FG000|COMPLETED|Follow-up Period||12|completed = continuing to be followed|
59729996|NCT01928394|75848567|FG001|COMPLETED|Follow-up Period||3|completed = continuing to be followed|
59729997|NCT01928394|75848568|FG002|COMPLETED|Follow-up Period||15|completed = continuing to be followed|
59729998|NCT01928394|75848569|FG003|COMPLETED|Follow-up Period||40|completed = continuing to be followed|
59729999|NCT01928394|75848570|FG004|COMPLETED|Follow-up Period||3|completed = continuing to be followed|
59730000|NCT01928394|75848571|FG005|COMPLETED|Follow-up Period||41|completed = continuing to be followed|
59730001|NCT01928394|75848572|FG006|COMPLETED|Follow-up Period||40|completed = continuing to be followed|
59730002|NCT01928394|75848573|FG007|COMPLETED|Follow-up Period||10|completed = continuing to be followed|
59730003|NCT01928394|75848574|FG008|COMPLETED|Follow-up Period||2|completed = continuing to be followed|
59730004|NCT01928394|75848575|FG009|COMPLETED|Follow-up Period||16|completed = continuing to be followed|
59730005|NCT01928394|75848576|FG010|COMPLETED|Follow-up Period||19|completed = continuing to be followed|
59730006|NCT01928394|75848577|FG011|COMPLETED|Follow-up Period||59|completed = continuing to be followed|
59730007|NCT01928394|75848578|FG012|COMPLETED|Follow-up Period||47|completed = continuing to be followed|
59730008|NCT01928394|75848579|FG013|COMPLETED|Follow-up Period||107|completed = continuing to be followed|
59861941|NCT01147666|75986399|FG002|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||9|Received study drug for at least 4 weeks with corresponding Hb measurements or permanently discontinued study medication during the dosing period due to lack of efficacy.|
59861942|NCT01147666|75986400|FG003|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||11|Received study drug for at least 4 weeks with corresponding Hb measurements or permanently discontinued study medication during the dosing period due to lack of efficacy.|
59861943|NCT01147666|75986401|FG004|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||11|Received study drug for at least 4 weeks with corresponding Hb measurements or permanently discontinued study medication during the dosing period due to lack of efficacy.|
59861944|NCT01147666|75986402|FG005|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||11|Received study drug for at least 4 weeks with corresponding Hb measurements or permanently discontinued study medication during the dosing period due to lack of efficacy.|
59861945|NCT01147666|75986403|FG006|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||11|Received study drug for at least 4 weeks with corresponding Hb measurements or permanently discontinued study medication during the dosing period due to lack of efficacy.|
59861946|NCT01147666|75986404|FG007|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||10|Received study drug for at least 4 weeks with corresponding Hb measurements or permanently discontinued study medication during the dosing period due to lack of efficacy.|
59861947|NCT01147666|75986405|FG008|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||2|Received study drug for at least 4 weeks with corresponding Hb measurements or permanently discontinued study medication during the dosing period due to lack of efficacy.|
59861948|NCT01147666|75986406|FG009|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||10|Received study drug for at least 4 weeks with corresponding Hb measurements or permanently discontinued study medication during the dosing period due to lack of efficacy.|
59861949|NCT01147666|75986407|FG010|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||31|Received study drug for at least 4 weeks with corresponding Hb measurements or permanently discontinued study medication during the dosing period due to lack of efficacy.|
59861950|NCT01147666|75986408|FG011|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||1|Received study drug for at least 4 weeks with corresponding Hb measurements or permanently discontinued study medication during the dosing period due to lack of efficacy.|
59861951|NCT01147666|75986409|FG012|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||3|Received study drug for at least 4 weeks with corresponding Hb measurements or permanently discontinued study medication during the dosing period due to lack of efficacy.|
59861952|NCT01147666|75986410|FG013|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||4|Received study drug for at least 4 weeks with corresponding Hb measurements or permanently discontinued study medication during the dosing period due to lack of efficacy.|
60131218|NCT00579813|76253751|FG000|STARTED|Overall Study||60||
59861953|NCT01147666|75986411|FG014|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||3|Received study drug for at least 4 weeks with corresponding Hb measurements or permanently discontinued study medication during the dosing period due to lack of efficacy.|
59861954|NCT01147666|75986397|FG000|COMPLETED|Dosing Period 1: 6-Week Treatment||10||
59861955|NCT01147666|75986398|FG001|COMPLETED|Dosing Period 1: 6-Week Treatment||10||
59861956|NCT01147666|75986399|FG002|COMPLETED|Dosing Period 1: 6-Week Treatment||11||
59861957|NCT01147666|75986400|FG003|COMPLETED|Dosing Period 1: 6-Week Treatment||10||
59861958|NCT01147666|75986401|FG004|COMPLETED|Dosing Period 1: 6-Week Treatment||7||
59861959|NCT01147666|75986402|FG005|COMPLETED|Dosing Period 1: 6-Week Treatment||9||
59861960|NCT01147666|75986403|FG006|COMPLETED|Dosing Period 1: 6-Week Treatment||9||
59861961|NCT01147666|75986404|FG007|COMPLETED|Dosing Period 1: 6-Week Treatment||9||
59861962|NCT01147666|75986405|FG008|COMPLETED|Dosing Period 1: 6-Week Treatment||2||
59861963|NCT01147666|75986406|FG009|COMPLETED|Dosing Period 1: 6-Week Treatment||8||
59861964|NCT01147666|75986407|FG010|COMPLETED|Dosing Period 1: 6-Week Treatment||33||
59861965|NCT01147666|75986408|FG011|COMPLETED|Dosing Period 1: 6-Week Treatment||2||
59861966|NCT01147666|75986409|FG012|COMPLETED|Dosing Period 1: 6-Week Treatment||1||
59861967|NCT01147666|75986410|FG013|COMPLETED|Dosing Period 1: 6-Week Treatment||3||
59861968|NCT01147666|75986411|FG014|COMPLETED|Dosing Period 1: 6-Week Treatment||0||
59861969|NCT01147666|75986397|FG000|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||2||
59861970|NCT01147666|75986398|FG001|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||2||
59861971|NCT01147666|75986399|FG002|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||1||
59861972|NCT01147666|75986400|FG003|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||2||
59861973|NCT01147666|75986401|FG004|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||5||
59861974|NCT01147666|75986402|FG005|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||3||
59861975|NCT01147666|75986403|FG006|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||3||
59861976|NCT01147666|75986404|FG007|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||3||
59861977|NCT01147666|75986405|FG008|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||0||
59861978|NCT01147666|75986406|FG009|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||2||
59861979|NCT01147666|75986407|FG010|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||3||
59861980|NCT01147666|75986408|FG011|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||2||
59861981|NCT01147666|75986409|FG012|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||4||
59861982|NCT01147666|75986410|FG013|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||1||
59861983|NCT01147666|75986411|FG014|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||4||
59861984|NCT01147666|75986397|FG000|STARTED|Dosing Period 2: 19-Week Treatment||0||
59861985|NCT01147666|75986398|FG001|STARTED|Dosing Period 2: 19-Week Treatment||0||
59861986|NCT01147666|75986399|FG002|STARTED|Dosing Period 2: 19-Week Treatment||0||
59861987|NCT01147666|75986400|FG003|STARTED|Dosing Period 2: 19-Week Treatment||7||
59861988|NCT01147666|75986401|FG004|STARTED|Dosing Period 2: 19-Week Treatment||12||
59861989|NCT01147666|75986402|FG005|STARTED|Dosing Period 2: 19-Week Treatment||12||
59861990|NCT01147666|75986403|FG006|STARTED|Dosing Period 2: 19-Week Treatment||12||
59861991|NCT01147666|75986404|FG007|STARTED|Dosing Period 2: 19-Week Treatment||12||
59861992|NCT01147666|75986405|FG008|STARTED|Dosing Period 2: 19-Week Treatment||2||
59861993|NCT01147666|75986406|FG009|STARTED|Dosing Period 2: 19-Week Treatment||10||
59861994|NCT01147666|75986407|FG010|STARTED|Dosing Period 2: 19-Week Treatment||23||
59861995|NCT01147666|75986408|FG011|STARTED|Dosing Period 2: 19-Week Treatment||0||
59861996|NCT01147666|75986409|FG012|STARTED|Dosing Period 2: 19-Week Treatment||5||
59861997|NCT01147666|75986410|FG013|STARTED|Dosing Period 2: 19-Week Treatment||3||
59861998|NCT01147666|75986411|FG014|STARTED|Dosing Period 2: 19-Week Treatment||3||
59861999|NCT01147666|75986397|FG000|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||0||
59862000|NCT01147666|75986398|FG001|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||0||
59862001|NCT01147666|75986399|FG002|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||0||
59862002|NCT01147666|75986400|FG003|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||7||
59862003|NCT01147666|75986401|FG004|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||12||
59862004|NCT01147666|75986402|FG005|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||12||
59862005|NCT01147666|75986403|FG006|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||12||
59862006|NCT01147666|75986404|FG007|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||12||
59862007|NCT01147666|75986405|FG008|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||2||
59862008|NCT01147666|75986406|FG009|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||10||
59862009|NCT01147666|75986407|FG010|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||23||
59862010|NCT01147666|75986408|FG011|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||0||
59862011|NCT01147666|75986409|FG012|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||5||
59862012|NCT01147666|75986410|FG013|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||3||
59862013|NCT01147666|75986411|FG014|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||3||
59862014|NCT01147666|75986397|FG000|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||0|Participants randomized designated to receive 19 weeks of study medication and had received study drug for at least 4 weeks with corresponding Hb measurements or permanently discontinued study medication during the dosing period due to lack of efficacy.|
60131219|NCT00579813|76253752|FG001|STARTED|Overall Study||10||
59862015|NCT01147666|75986398|FG001|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||0|Participants randomized designated to receive 19 weeks of study medication and had received study drug for at least 4 weeks with corresponding Hb measurements or permanently discontinued study medication during the dosing period due to lack of efficacy.|
59862016|NCT01147666|75986399|FG002|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||0|Participants randomized designated to receive 19 weeks of study medication and had received study drug for at least 4 weeks with corresponding Hb measurements or permanently discontinued study medication during the dosing period due to lack of efficacy.|
59862017|NCT01147666|75986400|FG003|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||6|Participants randomized designated to receive 19 weeks of study medication and had received study drug for at least 4 weeks with corresponding Hb measurements or permanently discontinued study medication during the dosing period due to lack of efficacy.|
59862018|NCT01147666|75986401|FG004|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||11|Participants randomized designated to receive 19 weeks of study medication and had received study drug for at least 4 weeks with corresponding Hb measurements or permanently discontinued study medication during the dosing period due to lack of efficacy.|
59862019|NCT01147666|75986402|FG005|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||11|Participants randomized designated to receive 19 weeks of study medication and had received study drug for at least 4 weeks with corresponding Hb measurements or permanently discontinued study medication during the dosing period due to lack of efficacy.|
59862020|NCT01147666|75986403|FG006|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||11|Participants randomized designated to receive 19 weeks of study medication and had received study drug for at least 4 weeks with corresponding Hb measurements or permanently discontinued study medication during the dosing period due to lack of efficacy.|
59862021|NCT01147666|75986404|FG007|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||10|Participants randomized designated to receive 19 weeks of study medication and had received study drug for at least 4 weeks with corresponding Hb measurements or permanently discontinued study medication during the dosing period due to lack of efficacy.|
59862022|NCT01147666|75986405|FG008|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||2|Participants randomized designated to receive 19 weeks of study medication and had received study drug for at least 4 weeks with corresponding Hb measurements or permanently discontinued study medication during the dosing period due to lack of efficacy.|
59862023|NCT01147666|75986406|FG009|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||10|Participants randomized designated to receive 19 weeks of study medication and had received study drug for at least 4 weeks with corresponding Hb measurements or permanently discontinued study medication during the dosing period due to lack of efficacy.|
59862024|NCT01147666|75986407|FG010|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||22|Participants randomized designated to receive 19 weeks of study medication and had received study drug for at least 4 weeks with corresponding Hb measurements or permanently discontinued study medication during the dosing period due to lack of efficacy.|
59862025|NCT01147666|75986408|FG011|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||0|Participants randomized designated to receive 19 weeks of study medication and had received study drug for at least 4 weeks with corresponding Hb measurements or permanently discontinued study medication during the dosing period due to lack of efficacy.|
59862026|NCT01147666|75986409|FG012|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||3|Participants randomized designated to receive 19 weeks of study medication and had received study drug for at least 4 weeks with corresponding Hb measurements or permanently discontinued study medication during the dosing period due to lack of efficacy.|
59862027|NCT01147666|75986410|FG013|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||3|Participants randomized designated to receive 19 weeks of study medication and had received study drug for at least 4 weeks with corresponding Hb measurements or permanently discontinued study medication during the dosing period due to lack of efficacy.|
59862028|NCT01147666|75986411|FG014|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||2|Participants randomized designated to receive 19 weeks of study medication and had received study drug for at least 4 weeks with corresponding Hb measurements or permanently discontinued study medication during the dosing period due to lack of efficacy.|
59862029|NCT01147666|75986397|FG000|COMPLETED|Dosing Period 2: 19-Week Treatment||0||
59862030|NCT01147666|75986398|FG001|COMPLETED|Dosing Period 2: 19-Week Treatment||0||
59862031|NCT01147666|75986399|FG002|COMPLETED|Dosing Period 2: 19-Week Treatment||0||
59862032|NCT01147666|75986400|FG003|COMPLETED|Dosing Period 2: 19-Week Treatment||5||
59862033|NCT01147666|75986401|FG004|COMPLETED|Dosing Period 2: 19-Week Treatment||7||
59862034|NCT01147666|75986402|FG005|COMPLETED|Dosing Period 2: 19-Week Treatment||9||
59862035|NCT01147666|75986403|FG006|COMPLETED|Dosing Period 2: 19-Week Treatment||9||
59862036|NCT01147666|75986404|FG007|COMPLETED|Dosing Period 2: 19-Week Treatment||9||
59862037|NCT01147666|75986405|FG008|COMPLETED|Dosing Period 2: 19-Week Treatment||2||
59862038|NCT01147666|75986406|FG009|COMPLETED|Dosing Period 2: 19-Week Treatment||8||
59862039|NCT01147666|75986407|FG010|COMPLETED|Dosing Period 2: 19-Week Treatment||21||
59862040|NCT01147666|75986408|FG011|COMPLETED|Dosing Period 2: 19-Week Treatment||0||
59862041|NCT01147666|75986409|FG012|COMPLETED|Dosing Period 2: 19-Week Treatment||1||
59862042|NCT01147666|75986410|FG013|COMPLETED|Dosing Period 2: 19-Week Treatment||2||
59862043|NCT01147666|75986411|FG014|COMPLETED|Dosing Period 2: 19-Week Treatment||0||
59862044|NCT01147666|75986397|FG000|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||0||
59862045|NCT01147666|75986398|FG001|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||0||
59862046|NCT01147666|75986399|FG002|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||0||
59862047|NCT01147666|75986400|FG003|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||2||
59862048|NCT01147666|75986401|FG004|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||5||
59862049|NCT01147666|75986402|FG005|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||3||
59862050|NCT01147666|75986403|FG006|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||3||
59862051|NCT01147666|75986404|FG007|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||3||
59862052|NCT01147666|75986405|FG008|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||0||
59862053|NCT01147666|75986406|FG009|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||2||
59862054|NCT01147666|75986407|FG010|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||2||
59862055|NCT01147666|75986408|FG011|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||0||
59862056|NCT01147666|75986409|FG012|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||4||
59862057|NCT01147666|75986410|FG013|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||1||
59862058|NCT01147666|75986411|FG014|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||3||
59862059|NCT00256295|75986473|FG000|STARTED|Overall Study|Of the 8 subjects consented, 1 withdrew prior to treatment.|7||
59862060|NCT00256295|75986473|FG000|COMPLETED|Overall Study||3||
59862061|NCT00256295|75986473|FG000|NOT COMPLETED|Overall Study||4||
59862062|NCT02877004|75986480|FG000|STARTED|Overall Study||20||
59862063|NCT02877004|75986481|FG001|STARTED|Overall Study||20||
59862064|NCT02877004|75986482|FG002|STARTED|Overall Study||20||
59862065|NCT02877004|75986480|FG000|COMPLETED|Overall Study||20||
59862066|NCT02877004|75986481|FG001|COMPLETED|Overall Study||20||
59862067|NCT02877004|75986482|FG002|COMPLETED|Overall Study||19||
59862068|NCT02877004|75986480|FG000|NOT COMPLETED|Overall Study||0||
59862069|NCT02877004|75986481|FG001|NOT COMPLETED|Overall Study||0||
59862070|NCT02877004|75986482|FG002|NOT COMPLETED|Overall Study||1||
59862071|NCT02223520|75986492|FG000|STARTED|Overall Study||147||
59862072|NCT02223520|75986493|FG001|STARTED|Overall Study||160||
59862073|NCT02223520|75986492|FG000|COMPLETED|Overall Study|101 neonates of these parents were enrolled. 12 were lost to follow-up.|147||
59862074|NCT02223520|75986493|FG001|COMPLETED|Overall Study|107 neonates of these parents were enrolled. 6 were lost to follow-up.|160||
59862075|NCT02223520|75986492|FG000|NOT COMPLETED|Overall Study||0||
59862076|NCT02223520|75986493|FG001|NOT COMPLETED|Overall Study||0||
59862077|NCT02122198|75986501|FG000|STARTED|Overall Study||5||
59862078|NCT02122198|75986502|FG001|STARTED|Overall Study||12||
59862079|NCT02122198|75986501|FG000|COMPLETED|Overall Study||3||
59862080|NCT02122198|75986502|FG001|COMPLETED|Overall Study||10||
59862081|NCT02122198|75986501|FG000|NOT COMPLETED|Overall Study||2||
59862082|NCT02122198|75986502|FG001|NOT COMPLETED|Overall Study||2||
59862083|NCT04617860|75986512|FG000|STARTED|Overall Study||8||
59862084|NCT04617860|75986513|FG001|STARTED|Overall Study||10||
59862085|NCT04617860|75986514|FG002|STARTED|Overall Study||18||
59862086|NCT04617860|75986512|FG000|Dose Modified to 8 mg|Overall Study||8||
59862087|NCT04617860|75986513|FG001|Dose Modified to 8 mg|Overall Study||1||
59862088|NCT04617860|75986514|FG002|Dose Modified to 8 mg|Overall Study||0||
59862089|NCT04617860|75986512|FG000|Dose Modified to 16 mg|Overall Study||8||
59862090|NCT04617860|75986513|FG001|Dose Modified to 16 mg|Overall Study||9||
59862091|NCT04617860|75986514|FG002|Dose Modified to 16 mg|Overall Study||8||
59862092|NCT04617860|75986512|FG000|Dose Modified to 32 mg|Overall Study||2||
59862093|NCT04617860|75986513|FG001|Dose Modified to 32 mg|Overall Study||4||
59862094|NCT04617860|75986514|FG002|Dose Modified to 32 mg|Overall Study||11||
59862095|NCT04617860|75986512|FG000|COMPLETED|Overall Study||0||
59862096|NCT04617860|75986513|FG001|COMPLETED|Overall Study||0||
59862097|NCT04617860|75986514|FG002|COMPLETED|Overall Study||0||
59862098|NCT04617860|75986512|FG000|NOT COMPLETED|Overall Study||8||
59862099|NCT04617860|75986513|FG001|NOT COMPLETED|Overall Study||10||
59862100|NCT04617860|75986514|FG002|NOT COMPLETED|Overall Study||18||
59862101|NCT04608500|75986526|FG000|STARTED|Overall Study||514||
59862102|NCT04608500|75986527|FG001|STARTED|Overall Study||257||
59862103|NCT04608500|75986526|FG000|COMPLETED|Overall Study||479||
59862104|NCT04608500|75986527|FG001|COMPLETED|Overall Study||239||
59862105|NCT04608500|75986526|FG000|NOT COMPLETED|Overall Study||35||
59862106|NCT04608500|75986527|FG001|NOT COMPLETED|Overall Study||18||
59862107|NCT04585646|75986533|FG000|STARTED|First Intervention||32||
59862108|NCT04585646|75986534|FG001|STARTED|First Intervention||32||
59862109|NCT04585646|75986533|FG000|COMPLETED|First Intervention||31||
59862110|NCT04585646|75986534|FG001|COMPLETED|First Intervention||28||
59862111|NCT04585646|75986533|FG000|NOT COMPLETED|First Intervention||1||
59862112|NCT04585646|75986534|FG001|NOT COMPLETED|First Intervention||4||
59862113|NCT04585646|75986533|FG000|STARTED|Second Intervention||31||
59862114|NCT04585646|75986534|FG001|STARTED|Second Intervention||28||
59862115|NCT04585646|75986533|FG000|COMPLETED|Second Intervention||31||
59862116|NCT04585646|75986534|FG001|COMPLETED|Second Intervention||28||
59862117|NCT04585646|75986533|FG000|NOT COMPLETED|Second Intervention||0||
59862118|NCT04585646|75986534|FG001|NOT COMPLETED|Second Intervention||0||
59862119|NCT04074928|75986543|FG000|STARTED|Overall Study||1605||
59862120|NCT04074928|75986544|FG001|STARTED|Overall Study||809||
59862121|NCT04074928|75986543|FG000|Received Study Vaccine|Overall Study||1597||
59862122|NCT04074928|75986544|FG001|Received Study Vaccine|Overall Study||805||
59862123|NCT04074928|75986543|FG000|COMPLETED|Overall Study||1370||
59862124|NCT04074928|75986544|FG001|COMPLETED|Overall Study||710||
59862125|NCT04074928|75986543|FG000|NOT COMPLETED|Overall Study||235||
59862126|NCT04074928|75986544|FG001|NOT COMPLETED|Overall Study||99||
59862127|NCT04584788|75986550|FG000|STARTED|Overall Study||37||
59862128|NCT04584788|75986550|FG000|COMPLETED|Overall Study||25||
59862129|NCT04584788|75986550|FG000|NOT COMPLETED|Overall Study||12||
59862130|NCT04575038|75986556|FG000|STARTED|Overall Study||56||
59862131|NCT04575038|75986557|FG001|STARTED|Overall Study||59||
59862132|NCT04575038|75986556|FG000|COMPLETED|Overall Study||55||
59862133|NCT04575038|75986557|FG001|COMPLETED|Overall Study||58||
59862134|NCT04575038|75986556|FG000|NOT COMPLETED|Overall Study||1||
59862135|NCT04575038|75986557|FG001|NOT COMPLETED|Overall Study||1||
59862136|NCT03066622|75986565|FG000|STARTED|Overall Study||61||
59862137|NCT03066622|75986566|FG001|STARTED|Overall Study||61||
59862138|NCT03066622|75986565|FG000|COMPLETED|Overall Study||35||
59862139|NCT03066622|75986566|FG001|COMPLETED|Overall Study||35||
59862140|NCT03066622|75986565|FG000|NOT COMPLETED|Overall Study||26||
59862141|NCT03066622|75986566|FG001|NOT COMPLETED|Overall Study||26||
59862142|NCT03029104|75986575|FG000|STARTED|Overall Study||745||
59862143|NCT03029104|75986576|FG001|STARTED|Overall Study||735||
59862144|NCT03029104|75986577|FG002|STARTED|Overall Study||748||
59862145|NCT03029104|75986575|FG000|COMPLETED|Overall Study||612||
59862146|NCT03029104|75986576|FG001|COMPLETED|Overall Study||597||
59862147|NCT03029104|75986577|FG002|COMPLETED|Overall Study||623||
59862148|NCT03029104|75986575|FG000|NOT COMPLETED|Overall Study||133||
59862149|NCT03029104|75986576|FG001|NOT COMPLETED|Overall Study||138||
59998412|NCT03855137|76114073|FG001|Safety Population|DB Treatment Period (Day 1 to Week 12)||257|Safety population included all participants who received at least 1 dose of study intervention.|
59862150|NCT03029104|75986577|FG002|NOT COMPLETED|Overall Study||125||
59862151|NCT02369536|75986587|FG000|STARTED|Overall Study||62||
59862152|NCT02369536|75986588|FG001|STARTED|Overall Study||64||
59862153|NCT02369536|75986587|FG000|COMPLETED|Overall Study||55||
59862154|NCT02369536|75986588|FG001|COMPLETED|Overall Study||58||
59862155|NCT02369536|75986587|FG000|NOT COMPLETED|Overall Study||7||
59862156|NCT02369536|75986588|FG001|NOT COMPLETED|Overall Study||6||
59862157|NCT04501952|75986598|FG000|STARTED|Overall Study||292||
59862158|NCT04501952|75986599|FG001|STARTED|Overall Study||292||
59862159|NCT04501952|75986598|FG000|COMPLETED|Overall Study||266||
59862160|NCT04501952|75986599|FG001|COMPLETED|Overall Study||272||
59862161|NCT04501952|75986598|FG000|NOT COMPLETED|Overall Study||26||
59862162|NCT04501952|75986599|FG001|NOT COMPLETED|Overall Study||20||
59862163|NCT00321100|75986608|FG000|STARTED|Overall Study||12||
59862164|NCT00321100|75986609|FG001|STARTED|Overall Study||11||
59862165|NCT00321100|75986608|FG000|COMPLETED|Overall Study||12||
59862166|NCT00321100|75986609|FG001|COMPLETED|Overall Study||11||
59862167|NCT00321100|75986608|FG000|NOT COMPLETED|Overall Study||0||
59862168|NCT00321100|75986609|FG001|NOT COMPLETED|Overall Study||0||
59862169|NCT02930122|75986617|FG000|STARTED|Overall Study||3||
59862170|NCT02930122|75986618|FG001|STARTED|Overall Study||3||
59862171|NCT02930122|75986617|FG000|COMPLETED|Overall Study||0||
59862172|NCT02930122|75986618|FG001|COMPLETED|Overall Study||0||
59862173|NCT02930122|75986617|FG000|NOT COMPLETED|Overall Study||3||
59862174|NCT02930122|75986618|FG001|NOT COMPLETED|Overall Study||3||
59862175|NCT03697460|75986625|FG000|STARTED|Overall Study||12||
59862176|NCT03697460|75986625|FG000|COMPLETED|Overall Study||9||
59862177|NCT03697460|75986625|FG000|NOT COMPLETED|Overall Study||3||
59862178|NCT00070018|75986629|FG000|STARTED|Overall Study||46||
59862179|NCT00070018|75986629|FG000|Eligible|Overall Study||46||
59862180|NCT00070018|75986629|FG000|Eligible and Began Protocol Therapy|Overall Study||46||
59862181|NCT00070018|75986629|FG000|COMPLETED|Overall Study||42||
59862182|NCT00070018|75986629|FG000|NOT COMPLETED|Overall Study||4||
59862183|NCT00231413|75986640|FG000|STARTED|Overall Study||88||
59862184|NCT00231413|75986641|FG001|STARTED|Overall Study||50||
59862185|NCT00231413|75986642|FG002|STARTED|Overall Study||49||
59862186|NCT00231413|75986643|FG003|STARTED|Overall Study||48||
59862187|NCT00231413|75986644|FG004|STARTED|Overall Study||48||
59862188|NCT00231413|75986645|FG005|STARTED|Overall Study||50||
59862189|NCT00231413|75986646|FG006|STARTED|Overall Study||50||
59862190|NCT00231413|75986640|FG000|COMPLETED|Overall Study||80||
59862191|NCT00231413|75986641|FG001|COMPLETED|Overall Study||45||
59862192|NCT00231413|75986642|FG002|COMPLETED|Overall Study||42||
59862193|NCT00231413|75986643|FG003|COMPLETED|Overall Study||45||
59862194|NCT00231413|75986644|FG004|COMPLETED|Overall Study||45||
59862195|NCT00231413|75986645|FG005|COMPLETED|Overall Study||45||
59862196|NCT00231413|75986646|FG006|COMPLETED|Overall Study||46||
59862197|NCT00231413|75986640|FG000|NOT COMPLETED|Overall Study||8||
59862198|NCT00231413|75986641|FG001|NOT COMPLETED|Overall Study||5||
59862199|NCT00231413|75986642|FG002|NOT COMPLETED|Overall Study||7||
59862200|NCT00231413|75986643|FG003|NOT COMPLETED|Overall Study||3||
59862201|NCT00231413|75986644|FG004|NOT COMPLETED|Overall Study||3||
59862202|NCT00231413|75986645|FG005|NOT COMPLETED|Overall Study||5||
59862203|NCT00231413|75986646|FG006|NOT COMPLETED|Overall Study||4||
59862204|NCT04494646|75986664|FG000|STARTED|Overall Study||21||
59862205|NCT04494646|75986665|FG001|STARTED|Overall Study||19||
59862206|NCT04494646|75986664|FG000|COMPLETED|Overall Study||21||
59862207|NCT04494646|75986665|FG001|COMPLETED|Overall Study||17||
59862208|NCT04494646|75986664|FG000|NOT COMPLETED|Overall Study||0||
59862209|NCT04494646|75986665|FG001|NOT COMPLETED|Overall Study||2||
59862210|NCT00231179|75986673|FG000|STARTED|Overall Study||152||
59862211|NCT00231179|75986674|FG001|STARTED|Overall Study||150||
59862212|NCT00231179|75986673|FG000|COMPLETED|Overall Study|128 (95%) in intervention group completed the five year follow-up visit.|128||
59862213|NCT00231179|75986674|FG001|COMPLETED|Overall Study|126 (93%) in the control group completed the five year follow-up visit.|126||
59862214|NCT00231179|75986673|FG000|NOT COMPLETED|Overall Study||24||
59862215|NCT00231179|75986674|FG001|NOT COMPLETED|Overall Study||24||
59862216|NCT03135028|75986680|FG000|STARTED|Overall Study||9||
59862217|NCT03135028|75986680|FG000|COMPLETED|Overall Study||0||
59862218|NCT03135028|75986680|FG000|NOT COMPLETED|Overall Study||9||
59862219|NCT00228917|75986692|FG000|STARTED|Overall Study||193||
59862220|NCT00228917|75986693|FG001|STARTED|Overall Study||96||
59862221|NCT00228917|75986694|FG002|STARTED|Overall Study||65||
59862222|NCT00228917|75986695|FG003|STARTED|Overall Study||33||
59862223|NCT00228917|75986696|FG004|STARTED|Overall Study||205||
59862224|NCT00228917|75986697|FG005|STARTED|Overall Study||104||
59862225|NCT00228917|75986698|FG006|STARTED|Overall Study||69||
59862226|NCT00228917|75986699|FG007|STARTED|Overall Study||33||
59862227|NCT00228917|75986692|FG000|COMPLETED|Overall Study||193||
59862228|NCT00228917|75986693|FG001|COMPLETED|Overall Study||96||
59862229|NCT00228917|75986694|FG002|COMPLETED|Overall Study||65||
59862230|NCT00228917|75986695|FG003|COMPLETED|Overall Study||33||
59862231|NCT00228917|75986696|FG004|COMPLETED|Overall Study||205||
59862232|NCT00228917|75986697|FG005|COMPLETED|Overall Study||102||
59862233|NCT00228917|75986698|FG006|COMPLETED|Overall Study||69||
59862234|NCT00228917|75986699|FG007|COMPLETED|Overall Study||33||
59862235|NCT00228917|75986692|FG000|NOT COMPLETED|Overall Study||0||
59862236|NCT00228917|75986693|FG001|NOT COMPLETED|Overall Study||0||
59862237|NCT00228917|75986694|FG002|NOT COMPLETED|Overall Study||0||
59862238|NCT00228917|75986695|FG003|NOT COMPLETED|Overall Study||0||
59862239|NCT00228917|75986696|FG004|NOT COMPLETED|Overall Study||0||
59862240|NCT00228917|75986697|FG005|NOT COMPLETED|Overall Study||2||
59862241|NCT00228917|75986698|FG006|NOT COMPLETED|Overall Study||0||
59862242|NCT00228917|75986699|FG007|NOT COMPLETED|Overall Study||0||
59862243|NCT00227903|75986715|FG000|STARTED|Overall Study||91||
59862244|NCT00227903|75986716|FG001|STARTED|Overall Study||92||
59862245|NCT00227903|75986715|FG000|Received ≥ 1 Follow-up Assessment|Overall Study|1 participant did not receive any treatment sessions.|86||
59862246|NCT00227903|75986716|FG001|Received ≥ 1 Follow-up Assessment|Overall Study|4 participants did not receive any treatment sessions.|82||
59862247|NCT00227903|75986715|FG000|COMPLETED|Overall Study|Participants with at least 1 follow-up assessment were analyzed|86||
59862248|NCT00227903|75986716|FG001|COMPLETED|Overall Study|Participants with at least 1 follow-up assessment were analyzed|82||
59862249|NCT00227903|75986715|FG000|NOT COMPLETED|Overall Study||5||
59862250|NCT00227903|75986716|FG001|NOT COMPLETED|Overall Study||10||
59862251|NCT04411628|75986726|FG000|STARTED|Overall Study||7||
59862252|NCT04411628|75986727|FG001|STARTED|Overall Study||6||
59862253|NCT04411628|75986728|FG002|STARTED|Overall Study||7||
59862254|NCT04411628|75986729|FG003|STARTED|Overall Study||6||
59862255|NCT04411628|75986726|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6||
59862256|NCT04411628|75986727|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6||
59862257|NCT04411628|75986728|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6||
59862258|NCT04411628|75986729|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6||
59862259|NCT04411628|75986726|FG000|COMPLETED|Overall Study||6||
59862260|NCT04411628|75986727|FG001|COMPLETED|Overall Study||4||
59862261|NCT04411628|75986728|FG002|COMPLETED|Overall Study||5||
59862262|NCT04411628|75986729|FG003|COMPLETED|Overall Study||6||
59862263|NCT04411628|75986726|FG000|NOT COMPLETED|Overall Study||1||
59862264|NCT04411628|75986727|FG001|NOT COMPLETED|Overall Study||2||
59862265|NCT04411628|75986728|FG002|NOT COMPLETED|Overall Study||2||
59862266|NCT04411628|75986729|FG003|NOT COMPLETED|Overall Study||0||
59862267|NCT00227591|75986742|FG000|STARTED|Overall Study|48 pts registered to the study|48||
59862268|NCT00227591|75986742|FG000|Began Treatment|Overall Study||47||
59862269|NCT00227591|75986742|FG000|COMPLETED|Overall Study||47||
59862270|NCT00227591|75986742|FG000|NOT COMPLETED|Overall Study||1||
59862271|NCT04512482|75986748|FG000|STARTED|First Intervention (1 Day)||24||
59862272|NCT04512482|75986749|FG001|STARTED|First Intervention (1 Day)||21||
59862273|NCT04512482|75986748|FG000|Baseline Plaque Assessment|First Intervention (1 Day)||24||
59862274|NCT04512482|75986749|FG001|Baseline Plaque Assessment|First Intervention (1 Day)||21||
60131220|NCT00579813|76253751|FG000|COMPLETED|Overall Study||60||
60131221|NCT00579813|76253752|FG001|COMPLETED|Overall Study||10||
59862275|NCT04512482|75986748|FG000|Baseline Photographs|First Intervention (1 Day)||24||
59862276|NCT04512482|75986749|FG001|Baseline Photographs|First Intervention (1 Day)||21||
59862277|NCT04512482|75986748|FG000|Received Rinse Intervention|First Intervention (1 Day)||24||
59862278|NCT04512482|75986749|FG001|Received Rinse Intervention|First Intervention (1 Day)||21||
59862279|NCT04512482|75986748|FG000|Post-rinse Photographs|First Intervention (1 Day)||24||
59862280|NCT04512482|75986749|FG001|Post-rinse Photographs|First Intervention (1 Day)||21||
59862281|NCT04512482|75986748|FG000|Toothbrush Utilization|First Intervention (1 Day)||24||
59862282|NCT04512482|75986749|FG001|Toothbrush Utilization|First Intervention (1 Day)||21||
59862283|NCT04512482|75986748|FG000|Post-toothbrush Photographs|First Intervention (1 Day)||24||
59862284|NCT04512482|75986749|FG001|Post-toothbrush Photographs|First Intervention (1 Day)||21||
59862285|NCT04512482|75986748|FG000|Waterpik Utilization|First Intervention (1 Day)||24||
59862286|NCT04512482|75986749|FG001|Waterpik Utilization|First Intervention (1 Day)||21||
59862287|NCT04512482|75986748|FG000|Post-Waterpik Photographs|First Intervention (1 Day)||24||
59862288|NCT04512482|75986749|FG001|Post-Waterpik Photographs|First Intervention (1 Day)||21||
59862289|NCT04512482|75986748|FG000|COMPLETED|First Intervention (1 Day)||24||
59862290|NCT04512482|75986749|FG001|COMPLETED|First Intervention (1 Day)||21||
59862291|NCT04512482|75986748|FG000|NOT COMPLETED|First Intervention (1 Day)||0||
59862292|NCT04512482|75986749|FG001|NOT COMPLETED|First Intervention (1 Day)||0||
59862293|NCT04512482|75986748|FG000|STARTED|Washout (1 Week)||24||
59862294|NCT04512482|75986749|FG001|STARTED|Washout (1 Week)||21||
59862295|NCT04512482|75986748|FG000|COMPLETED|Washout (1 Week)||24||
59862296|NCT04512482|75986749|FG001|COMPLETED|Washout (1 Week)||21||
59862297|NCT04512482|75986748|FG000|NOT COMPLETED|Washout (1 Week)||0||
59862298|NCT04512482|75986749|FG001|NOT COMPLETED|Washout (1 Week)||0||
59862299|NCT04512482|75986748|FG000|STARTED|Second Intervention (1 Day)||24||
59862300|NCT04512482|75986749|FG001|STARTED|Second Intervention (1 Day)||21||
59862301|NCT04512482|75986748|FG000|Baseline Plaque Assessment|Second Intervention (1 Day)||22||
59862302|NCT04512482|75986749|FG001|Baseline Plaque Assessment|Second Intervention (1 Day)||20||
59862303|NCT04512482|75986748|FG000|Baseline Photographs|Second Intervention (1 Day)||22||
59862304|NCT04512482|75986749|FG001|Baseline Photographs|Second Intervention (1 Day)||20||
59862305|NCT04512482|75986748|FG000|Received Intervention|Second Intervention (1 Day)||22||
59862306|NCT04512482|75986749|FG001|Received Intervention|Second Intervention (1 Day)||20||
59862307|NCT04512482|75986748|FG000|Post-rinse Photographs|Second Intervention (1 Day)||22||
59862308|NCT04512482|75986749|FG001|Post-rinse Photographs|Second Intervention (1 Day)||20||
59862309|NCT04512482|75986748|FG000|Toothbrush Utilization|Second Intervention (1 Day)||22||
59862310|NCT04512482|75986749|FG001|Toothbrush Utilization|Second Intervention (1 Day)||20||
59862311|NCT04512482|75986748|FG000|Post-toothbrush Photographs|Second Intervention (1 Day)||22||
59862312|NCT04512482|75986749|FG001|Post-toothbrush Photographs|Second Intervention (1 Day)||20||
59862313|NCT04512482|75986748|FG000|Waterpik Utilization|Second Intervention (1 Day)||22||
59862314|NCT04512482|75986749|FG001|Waterpik Utilization|Second Intervention (1 Day)||20||
59862315|NCT04512482|75986748|FG000|Post-Waterpik Photographs|Second Intervention (1 Day)||22||
59862316|NCT04512482|75986749|FG001|Post-Waterpik Photographs|Second Intervention (1 Day)||20||
59862317|NCT04512482|75986748|FG000|COMPLETED|Second Intervention (1 Day)||22||
59862318|NCT04512482|75986749|FG001|COMPLETED|Second Intervention (1 Day)||20||
59862319|NCT04512482|75986748|FG000|NOT COMPLETED|Second Intervention (1 Day)||2||
59862320|NCT04512482|75986749|FG001|NOT COMPLETED|Second Intervention (1 Day)||1||
59862321|NCT00226811|75986755|FG000|STARTED|Overall Study||78||
59862322|NCT00226811|75986755|FG000|COMPLETED|Overall Study||2||
59862323|NCT00226811|75986755|FG000|NOT COMPLETED|Overall Study||76||
59862324|NCT00226655|75986759|FG000|STARTED|Overall Study||112||
59862325|NCT00226655|75986759|FG000|COMPLETED|Overall Study||33||
59862326|NCT00226655|75986759|FG000|NOT COMPLETED|Overall Study||79||
59862327|NCT03672344|75986765|FG000|STARTED|Overall Study||25||
59862328|NCT03672344|75986766|FG001|STARTED|Overall Study||29||
59862329|NCT03672344|75986765|FG000|COMPLETED|Overall Study||25||
59862330|NCT03672344|75986766|FG001|COMPLETED|Overall Study||29||
59862331|NCT03672344|75986765|FG000|NOT COMPLETED|Overall Study||0||
59862332|NCT03672344|75986766|FG001|NOT COMPLETED|Overall Study||0||
59862333|NCT03124108|75986775|FG000|STARTED|Overall Study||15||
59862334|NCT03124108|75986776|FG001|STARTED|Overall Study||15||
59862335|NCT03124108|75986777|FG002|STARTED|Overall Study||15||
59862336|NCT03124108|75986775|FG000|COMPLETED|Overall Study||15||
59862337|NCT03124108|75986776|FG001|COMPLETED|Overall Study||14||
59862338|NCT03124108|75986777|FG002|COMPLETED|Overall Study||15||
59862339|NCT03124108|75986775|FG000|NOT COMPLETED|Overall Study||0||
59862340|NCT03124108|75986776|FG001|NOT COMPLETED|Overall Study||1||
59862341|NCT03124108|75986777|FG002|NOT COMPLETED|Overall Study||0||
59862342|NCT04475588|75986789|FG000|STARTED|Overall Study|Stated in protocol apriori, patient not completing 1st infusion were not evaluable & were replaced.|22||
59862343|NCT04475588|75986790|FG001|STARTED|Overall Study||10||
59862344|NCT04475588|75986789|FG000|COMPLETED|Overall Study||20||
59862345|NCT04475588|75986790|FG001|COMPLETED|Overall Study||10||
59862346|NCT04475588|75986789|FG000|NOT COMPLETED|Overall Study||2||
59862347|NCT04475588|75986790|FG001|NOT COMPLETED|Overall Study||0||
59862348|NCT04353596|75986799|FG000|STARTED|Overall Study||109||
59862349|NCT04353596|75986800|FG001|STARTED|Overall Study||107||
59862350|NCT04353596|75986799|FG000|Per Protocol|Overall Study||104||
59862351|NCT04353596|75986800|FG001|Per Protocol|Overall Study||100||
59862352|NCT04353596|75986799|FG000|COMPLETED|Overall Study||104||
59862353|NCT04353596|75986800|FG001|COMPLETED|Overall Study||100||
59862354|NCT04353596|75986799|FG000|NOT COMPLETED|Overall Study||5||
59862355|NCT04353596|75986800|FG001|NOT COMPLETED|Overall Study||7||
59862356|NCT04350788|75986808|FG000|STARTED|Overall Study||62||31
59862357|NCT04350788|75986809|FG001|STARTED|Overall Study||62||31
59862358|NCT04350788|75986808|FG000|COMPLETED|Overall Study||50||25
59862359|NCT04350788|75986809|FG001|COMPLETED|Overall Study||56||28
59862360|NCT04350788|75986808|FG000|NOT COMPLETED|Overall Study||12||6
59862361|NCT04350788|75986809|FG001|NOT COMPLETED|Overall Study||6||3
59862362|NCT03852316|75986820|FG000|STARTED|Overall Study||1585||
59862363|NCT03852316|75986820|FG000|COMPLETED|Overall Study||1581||
59862364|NCT03852316|75986820|FG000|NOT COMPLETED|Overall Study||4||
59862365|NCT04335812|75986826|FG000|STARTED|Overall Study||63||
59862366|NCT04335812|75986827|FG001|STARTED|Overall Study||63||
59862367|NCT04335812|75986826|FG000|COMPLETED|Overall Study||28||
59862368|NCT04335812|75986827|FG001|COMPLETED|Overall Study||30||
59862369|NCT04335812|75986826|FG000|NOT COMPLETED|Overall Study||35||
59862370|NCT04335812|75986827|FG001|NOT COMPLETED|Overall Study||33||
59862371|NCT03127384|75986833|FG000|STARTED|Overall Study||49||
59862372|NCT03127384|75986833|FG000|Completed 3 Month Visit|Overall Study||47||
59862373|NCT03127384|75986833|FG000|COMPLETED|Overall Study||43||
59862374|NCT03127384|75986833|FG000|NOT COMPLETED|Overall Study||6||
59862375|NCT02523274|75986842|FG000|STARTED|Overall Study||20||
59862376|NCT02523274|75986843|FG001|STARTED|Overall Study||20||
59862377|NCT02523274|75986844|FG002|STARTED|Overall Study||20||
59862378|NCT02523274|75986842|FG000|COMPLETED|Overall Study||19||
59862379|NCT02523274|75986843|FG001|COMPLETED|Overall Study||18||
59862380|NCT02523274|75986844|FG002|COMPLETED|Overall Study||18||
59862381|NCT02523274|75986842|FG000|NOT COMPLETED|Overall Study||1||
59862382|NCT02523274|75986843|FG001|NOT COMPLETED|Overall Study||2||
59862383|NCT02523274|75986844|FG002|NOT COMPLETED|Overall Study||2||
59862384|NCT04398134|75986860|FG000|STARTED|Overall Study||32||
59862385|NCT04398134|75986861|FG001|STARTED|Overall Study||11||
59862386|NCT04398134|75986862|FG002|STARTED|Overall Study||33||
59862387|NCT04398134|75986863|FG003|STARTED|Overall Study||12||
59862388|NCT04398134|75986860|FG000|COMPLETED|Overall Study||0||
59862389|NCT04398134|75986861|FG001|COMPLETED|Overall Study||0||
59862390|NCT04398134|75986862|FG002|COMPLETED|Overall Study||0||
59862391|NCT04398134|75986863|FG003|COMPLETED|Overall Study||0||
59862392|NCT04398134|75986860|FG000|NOT COMPLETED|Overall Study||32||
59862393|NCT04398134|75986861|FG001|NOT COMPLETED|Overall Study||11||
59862394|NCT04398134|75986862|FG002|NOT COMPLETED|Overall Study||33||
59862395|NCT04398134|75986863|FG003|NOT COMPLETED|Overall Study||12||
59862396|NCT03122860|75986879|FG000|STARTED|Overall Study||117||
59862397|NCT03122860|75986880|FG001|STARTED|Overall Study||116||
59862398|NCT03122860|75986881|FG002|STARTED|Overall Study||117||
59862399|NCT03122860|75986882|FG003|STARTED|Overall Study||116||
59862400|NCT03122860|75986883|FG004|STARTED|Overall Study||117||
59862401|NCT03122860|75986884|FG005|STARTED|Overall Study||117||
59862402|NCT03122860|75986879|FG000|Full Analysis Set|Overall Study||116||
59862403|NCT03122860|75986880|FG001|Full Analysis Set|Overall Study||115||
59862404|NCT03122860|75986881|FG002|Full Analysis Set|Overall Study||115||
59862405|NCT03122860|75986882|FG003|Full Analysis Set|Overall Study||116||
59862406|NCT03122860|75986883|FG004|Full Analysis Set|Overall Study||116||
59862407|NCT03122860|75986884|FG005|Full Analysis Set|Overall Study||117||
59862408|NCT03122860|75986879|FG000|COMPLETED|Overall Study||107||
59862409|NCT03122860|75986880|FG001|COMPLETED|Overall Study||111||
59862410|NCT03122860|75986881|FG002|COMPLETED|Overall Study||105||
59862411|NCT03122860|75986882|FG003|COMPLETED|Overall Study||105||
59862412|NCT03122860|75986883|FG004|COMPLETED|Overall Study||102||
59862413|NCT03122860|75986884|FG005|COMPLETED|Overall Study||105||
59862414|NCT03122860|75986879|FG000|NOT COMPLETED|Overall Study||10||
59862415|NCT03122860|75986880|FG001|NOT COMPLETED|Overall Study||5||
59862416|NCT03122860|75986881|FG002|NOT COMPLETED|Overall Study||12||
59862417|NCT03122860|75986882|FG003|NOT COMPLETED|Overall Study||11||
59862418|NCT03122860|75986883|FG004|NOT COMPLETED|Overall Study||15||
59862419|NCT03122860|75986884|FG005|NOT COMPLETED|Overall Study||12||
59862420|NCT03798366|75986901|FG000|STARTED|Overall Study||21||
59862421|NCT03798366|75986902|FG001|STARTED|Overall Study||12||
59862422|NCT03798366|75986901|FG000|COMPLETED|Overall Study||21||
59862423|NCT03798366|75986902|FG001|COMPLETED|Overall Study||11||
59862424|NCT03798366|75986901|FG000|NOT COMPLETED|Overall Study||0||
59862425|NCT03798366|75986902|FG001|NOT COMPLETED|Overall Study||1||
59862426|NCT04327388|75986911|FG000|STARTED|Overall Study||161||
59862427|NCT04327388|75986912|FG001|STARTED|Overall Study||173||
59862428|NCT04327388|75986913|FG002|STARTED|Overall Study||86||
59862429|NCT04327388|75986911|FG000|Treated|Overall Study||159||
59862430|NCT04327388|75986912|FG001|Treated|Overall Study||173||
59862431|NCT04327388|75986913|FG002|Treated|Overall Study||84||
59862432|NCT04327388|75986911|FG000|Participants Who Received Second Dose|Overall Study||13|Participants who met prespecified criteria as per protocol amendment 2, received a second dose of the study drug (based on the original treatment group assigned) 24 to 48 hours after the first dose.|
60131222|NCT00579813|76253751|FG000|NOT COMPLETED|Overall Study||0||
59862433|NCT04327388|75986912|FG001|Participants Who Received Second Dose|Overall Study||11|Participants who met prespecified criteria as per protocol amendment 2, received a second dose of the study drug (based on the original treatment group assigned) 24 to 48 hours after the first dose.|
59862434|NCT04327388|75986913|FG002|Participants Who Received Second Dose|Overall Study||5|Participants who met prespecified criteria as per protocol amendment 2, received a second dose of the study drug (based on the original treatment group assigned) 24 to 48 hours after the first dose.|
59862435|NCT04327388|75986911|FG000|COMPLETED|Overall Study||141||
59862436|NCT04327388|75986912|FG001|COMPLETED|Overall Study||153||
59862437|NCT04327388|75986913|FG002|COMPLETED|Overall Study||75||
59862438|NCT04327388|75986911|FG000|NOT COMPLETED|Overall Study||20||
59862439|NCT04327388|75986912|FG001|NOT COMPLETED|Overall Study||20||
59862440|NCT04327388|75986913|FG002|NOT COMPLETED|Overall Study||11||
59862441|NCT03796728|75986921|FG000|STARTED|Overall Study||60||
59862442|NCT03796728|75986921|FG000|COMPLETED|Overall Study||36||
59862443|NCT03796728|75986921|FG000|NOT COMPLETED|Overall Study||24||
59862444|NCT04323800|75986927|FG000|STARTED|Overall Study||87||
59862445|NCT04323800|75986928|FG001|STARTED|Overall Study||93||
59862446|NCT04323800|75986927|FG000|COMPLETED|Overall Study||81||
59862447|NCT04323800|75986928|FG001|COMPLETED|Overall Study||87||
59862448|NCT04323800|75986927|FG000|NOT COMPLETED|Overall Study||6||
59862449|NCT04323800|75986928|FG001|NOT COMPLETED|Overall Study||6||
59862450|NCT04321460|75986936|FG000|STARTED|Overall Study||260||
59862451|NCT04321460|75986937|FG001|STARTED|Overall Study||260||
59862452|NCT04321460|75986936|FG000|Intention to Treat (ITT) Population|Overall Study||260||
59862453|NCT04321460|75986937|FG001|Intention to Treat (ITT) Population|Overall Study||260||
59862454|NCT04321460|75986936|FG000|Per-protocol (PP) Population|Overall Study||252||
59862455|NCT04321460|75986937|FG001|Per-protocol (PP) Population|Overall Study||248||
59862456|NCT04321460|75986936|FG000|COMPLETED|Overall Study||259||
59862457|NCT04321460|75986937|FG001|COMPLETED|Overall Study||259||
59862458|NCT04321460|75986936|FG000|NOT COMPLETED|Overall Study||1||
59862459|NCT04321460|75986937|FG001|NOT COMPLETED|Overall Study||1||
59862460|NCT03122548|75986943|FG000|STARTED|Overall Study||5||
59862461|NCT03122548|75986943|FG000|COMPLETED|Overall Study||0||
59862462|NCT03122548|75986943|FG000|NOT COMPLETED|Overall Study||5||
59862463|NCT04459598|75986949|FG000|STARTED|Overall Study||16||
59862464|NCT04459598|75986950|FG001|STARTED|Overall Study||16||
59862465|NCT04459598|75986949|FG000|COMPLETED|Overall Study||15||
59862466|NCT04459598|75986950|FG001|COMPLETED|Overall Study||15||
59862467|NCT04459598|75986949|FG000|NOT COMPLETED|Overall Study||1||
59862468|NCT04459598|75986950|FG001|NOT COMPLETED|Overall Study||1||
59862469|NCT02929498|75986959|FG000|STARTED|Part 1: Dose Confirmation (Upto 2 Years)||5||
59862470|NCT02929498|75986960|FG001|STARTED|Part 1: Dose Confirmation (Upto 2 Years)||0||
59862471|NCT02929498|75986961|FG002|STARTED|Part 1: Dose Confirmation (Upto 2 Years)||0||
59862472|NCT02929498|75986959|FG000|COMPLETED|Part 1: Dose Confirmation (Upto 2 Years)||0||
59862473|NCT02929498|75986960|FG001|COMPLETED|Part 1: Dose Confirmation (Upto 2 Years)||0||
59862474|NCT02929498|75986961|FG002|COMPLETED|Part 1: Dose Confirmation (Upto 2 Years)||0||
59862475|NCT02929498|75986959|FG000|NOT COMPLETED|Part 1: Dose Confirmation (Upto 2 Years)||5||
59862476|NCT02929498|75986960|FG001|NOT COMPLETED|Part 1: Dose Confirmation (Upto 2 Years)||0||
59862477|NCT02929498|75986961|FG002|NOT COMPLETED|Part 1: Dose Confirmation (Upto 2 Years)||0||
59862478|NCT02929498|75986959|FG000|STARTED|Part 2 : Dose Expansion (Upto 2.5 Years)||0||
59862479|NCT02929498|75986960|FG001|STARTED|Part 2 : Dose Expansion (Upto 2.5 Years)||0||
59862480|NCT02929498|75986961|FG002|STARTED|Part 2 : Dose Expansion (Upto 2.5 Years)||0||
59862481|NCT02929498|75986959|FG000|COMPLETED|Part 2 : Dose Expansion (Upto 2.5 Years)||0||
59862482|NCT02929498|75986960|FG001|COMPLETED|Part 2 : Dose Expansion (Upto 2.5 Years)||0||
59862483|NCT02929498|75986961|FG002|COMPLETED|Part 2 : Dose Expansion (Upto 2.5 Years)||0||
59862484|NCT02929498|75986959|FG000|NOT COMPLETED|Part 2 : Dose Expansion (Upto 2.5 Years)||0||
59862485|NCT02929498|75986960|FG001|NOT COMPLETED|Part 2 : Dose Expansion (Upto 2.5 Years)||0||
59862486|NCT02929498|75986961|FG002|NOT COMPLETED|Part 2 : Dose Expansion (Upto 2.5 Years)||0||
59862487|NCT03792672|75986967|FG000|STARTED|Treatment Period 1 (1 Day)||4||
59862488|NCT03792672|75986968|FG001|STARTED|Treatment Period 1 (1 Day)||4||
59862489|NCT03792672|75986969|FG002|STARTED|Treatment Period 1 (1 Day)||4||
59862490|NCT03792672|75986970|FG003|STARTED|Treatment Period 1 (1 Day)||4||
59862491|NCT03792672|75986971|FG004|STARTED|Treatment Period 1 (1 Day)||4||
59862492|NCT03792672|75986972|FG005|STARTED|Treatment Period 1 (1 Day)||4||
59862493|NCT03792672|75986967|FG000|COMPLETED|Treatment Period 1 (1 Day)||4||
59862494|NCT03792672|75986968|FG001|COMPLETED|Treatment Period 1 (1 Day)||4||
59862495|NCT03792672|75986969|FG002|COMPLETED|Treatment Period 1 (1 Day)||4||
59862496|NCT03792672|75986970|FG003|COMPLETED|Treatment Period 1 (1 Day)||4||
59862497|NCT03792672|75986971|FG004|COMPLETED|Treatment Period 1 (1 Day)||4||
59862498|NCT03792672|75986972|FG005|COMPLETED|Treatment Period 1 (1 Day)||4||
59862499|NCT03792672|75986967|FG000|NOT COMPLETED|Treatment Period 1 (1 Day)||0||
59862500|NCT03792672|75986968|FG001|NOT COMPLETED|Treatment Period 1 (1 Day)||0||
59862501|NCT03792672|75986969|FG002|NOT COMPLETED|Treatment Period 1 (1 Day)||0||
59862502|NCT03792672|75986970|FG003|NOT COMPLETED|Treatment Period 1 (1 Day)||0||
59862503|NCT03792672|75986971|FG004|NOT COMPLETED|Treatment Period 1 (1 Day)||0||
59862504|NCT03792672|75986972|FG005|NOT COMPLETED|Treatment Period 1 (1 Day)||0||
59862505|NCT03792672|75986967|FG000|STARTED|Washout Period 1 (10 Days)||4||
59862506|NCT03792672|75986968|FG001|STARTED|Washout Period 1 (10 Days)||4||
59862507|NCT03792672|75986969|FG002|STARTED|Washout Period 1 (10 Days)||4||
59862508|NCT03792672|75986970|FG003|STARTED|Washout Period 1 (10 Days)||4||
59862509|NCT03792672|75986971|FG004|STARTED|Washout Period 1 (10 Days)||4||
59862510|NCT03792672|75986972|FG005|STARTED|Washout Period 1 (10 Days)||4||
59862511|NCT03792672|75986967|FG000|COMPLETED|Washout Period 1 (10 Days)||4||
59862512|NCT03792672|75986968|FG001|COMPLETED|Washout Period 1 (10 Days)||4||
59862513|NCT03792672|75986969|FG002|COMPLETED|Washout Period 1 (10 Days)||4||
59862514|NCT03792672|75986970|FG003|COMPLETED|Washout Period 1 (10 Days)||4||
59862515|NCT03792672|75986971|FG004|COMPLETED|Washout Period 1 (10 Days)||4||
59862516|NCT03792672|75986972|FG005|COMPLETED|Washout Period 1 (10 Days)||4||
59862517|NCT03792672|75986967|FG000|NOT COMPLETED|Washout Period 1 (10 Days)||0||
59862518|NCT03792672|75986968|FG001|NOT COMPLETED|Washout Period 1 (10 Days)||0||
59862519|NCT03792672|75986969|FG002|NOT COMPLETED|Washout Period 1 (10 Days)||0||
59862520|NCT03792672|75986970|FG003|NOT COMPLETED|Washout Period 1 (10 Days)||0||
59862521|NCT03792672|75986971|FG004|NOT COMPLETED|Washout Period 1 (10 Days)||0||
59862522|NCT03792672|75986972|FG005|NOT COMPLETED|Washout Period 1 (10 Days)||0||
59862523|NCT03792672|75986967|FG000|STARTED|Treatment Period 2 (1 Day)||4||
59862524|NCT03792672|75986968|FG001|STARTED|Treatment Period 2 (1 Day)||4||
59862525|NCT03792672|75986969|FG002|STARTED|Treatment Period 2 (1 Day)||4||
59862526|NCT03792672|75986970|FG003|STARTED|Treatment Period 2 (1 Day)||4||
59862527|NCT03792672|75986971|FG004|STARTED|Treatment Period 2 (1 Day)||4||
59862528|NCT03792672|75986972|FG005|STARTED|Treatment Period 2 (1 Day)||4||
59862529|NCT03792672|75986967|FG000|COMPLETED|Treatment Period 2 (1 Day)||4||
59862530|NCT03792672|75986968|FG001|COMPLETED|Treatment Period 2 (1 Day)||4||
59862531|NCT03792672|75986969|FG002|COMPLETED|Treatment Period 2 (1 Day)||4||
59862532|NCT03792672|75986970|FG003|COMPLETED|Treatment Period 2 (1 Day)||4||
59862533|NCT03792672|75986971|FG004|COMPLETED|Treatment Period 2 (1 Day)||4||
59862534|NCT03792672|75986972|FG005|COMPLETED|Treatment Period 2 (1 Day)||4||
59862535|NCT03792672|75986967|FG000|NOT COMPLETED|Treatment Period 2 (1 Day)||0||
59862536|NCT03792672|75986968|FG001|NOT COMPLETED|Treatment Period 2 (1 Day)||0||
59862537|NCT03792672|75986969|FG002|NOT COMPLETED|Treatment Period 2 (1 Day)||0||
59862538|NCT03792672|75986970|FG003|NOT COMPLETED|Treatment Period 2 (1 Day)||0||
59862539|NCT03792672|75986971|FG004|NOT COMPLETED|Treatment Period 2 (1 Day)||0||
59862540|NCT03792672|75986972|FG005|NOT COMPLETED|Treatment Period 2 (1 Day)||0||
59862541|NCT03792672|75986967|FG000|STARTED|Washout Period 2 (10 Days)||4||
59862542|NCT03792672|75986968|FG001|STARTED|Washout Period 2 (10 Days)||4||
59862543|NCT03792672|75986969|FG002|STARTED|Washout Period 2 (10 Days)||4||
59862544|NCT03792672|75986970|FG003|STARTED|Washout Period 2 (10 Days)||4||
59862545|NCT03792672|75986971|FG004|STARTED|Washout Period 2 (10 Days)||4||
59862546|NCT03792672|75986972|FG005|STARTED|Washout Period 2 (10 Days)||4||
59862547|NCT03792672|75986967|FG000|COMPLETED|Washout Period 2 (10 Days)||4||
59862548|NCT03792672|75986968|FG001|COMPLETED|Washout Period 2 (10 Days)||4||
59862549|NCT03792672|75986969|FG002|COMPLETED|Washout Period 2 (10 Days)||4||
59862550|NCT03792672|75986970|FG003|COMPLETED|Washout Period 2 (10 Days)||4||
59862551|NCT03792672|75986971|FG004|COMPLETED|Washout Period 2 (10 Days)||4||
59862552|NCT03792672|75986972|FG005|COMPLETED|Washout Period 2 (10 Days)||4||
59862553|NCT03792672|75986967|FG000|NOT COMPLETED|Washout Period 2 (10 Days)||0||
59862554|NCT03792672|75986968|FG001|NOT COMPLETED|Washout Period 2 (10 Days)||0||
59862555|NCT03792672|75986969|FG002|NOT COMPLETED|Washout Period 2 (10 Days)||0||
59862556|NCT03792672|75986970|FG003|NOT COMPLETED|Washout Period 2 (10 Days)||0||
59862557|NCT03792672|75986971|FG004|NOT COMPLETED|Washout Period 2 (10 Days)||0||
59862558|NCT03792672|75986972|FG005|NOT COMPLETED|Washout Period 2 (10 Days)||0||
59862559|NCT03792672|75986967|FG000|STARTED|Treatment Period 3 (1 Day)||4||
59862560|NCT03792672|75986968|FG001|STARTED|Treatment Period 3 (1 Day)||4||
59862561|NCT03792672|75986969|FG002|STARTED|Treatment Period 3 (1 Day)||4||
59862562|NCT03792672|75986970|FG003|STARTED|Treatment Period 3 (1 Day)||4||
59862563|NCT03792672|75986971|FG004|STARTED|Treatment Period 3 (1 Day)||4||
59862564|NCT03792672|75986972|FG005|STARTED|Treatment Period 3 (1 Day)||4||
59862565|NCT03792672|75986967|FG000|COMPLETED|Treatment Period 3 (1 Day)||4||
59862566|NCT03792672|75986968|FG001|COMPLETED|Treatment Period 3 (1 Day)||4||
59862567|NCT03792672|75986969|FG002|COMPLETED|Treatment Period 3 (1 Day)||4||
59862568|NCT03792672|75986970|FG003|COMPLETED|Treatment Period 3 (1 Day)||4||
59862569|NCT03792672|75986971|FG004|COMPLETED|Treatment Period 3 (1 Day)||4||
59862570|NCT03792672|75986972|FG005|COMPLETED|Treatment Period 3 (1 Day)||4||
59862571|NCT03792672|75986967|FG000|NOT COMPLETED|Treatment Period 3 (1 Day)||0||
59862572|NCT03792672|75986968|FG001|NOT COMPLETED|Treatment Period 3 (1 Day)||0||
59862573|NCT03792672|75986969|FG002|NOT COMPLETED|Treatment Period 3 (1 Day)||0||
59862574|NCT03792672|75986970|FG003|NOT COMPLETED|Treatment Period 3 (1 Day)||0||
59862575|NCT03792672|75986971|FG004|NOT COMPLETED|Treatment Period 3 (1 Day)||0||
59862576|NCT03792672|75986972|FG005|NOT COMPLETED|Treatment Period 3 (1 Day)||0||
59862577|NCT03792672|75986967|FG000|STARTED|Washout Period 3 (10 Days)||4||
59862578|NCT03792672|75986968|FG001|STARTED|Washout Period 3 (10 Days)||4||
59862579|NCT03792672|75986969|FG002|STARTED|Washout Period 3 (10 Days)||4||
59862580|NCT03792672|75986970|FG003|STARTED|Washout Period 3 (10 Days)||4||
59862581|NCT03792672|75986971|FG004|STARTED|Washout Period 3 (10 Days)||4||
59862582|NCT03792672|75986972|FG005|STARTED|Washout Period 3 (10 Days)||4||
59862583|NCT03792672|75986967|FG000|COMPLETED|Washout Period 3 (10 Days)||3||
59862584|NCT03792672|75986968|FG001|COMPLETED|Washout Period 3 (10 Days)||4||
59862585|NCT03792672|75986969|FG002|COMPLETED|Washout Period 3 (10 Days)||3||
59862586|NCT03792672|75986970|FG003|COMPLETED|Washout Period 3 (10 Days)||2||
59998413|NCT03855137|76114074|FG002|Safety Population|DB Treatment Period (Day 1 to Week 12)||261|Safety population included all participants who received at least 1 dose of study intervention.|
60000308|NCT02712983|76116058|FG005|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|1|All patients who discontinued treatment and entered Post-Treatment Efficacy Follow-Up Phase|
60131223|NCT00579813|76253752|FG001|NOT COMPLETED|Overall Study||0||
59862587|NCT03792672|75986971|FG004|COMPLETED|Washout Period 3 (10 Days)||4||
59862588|NCT03792672|75986972|FG005|COMPLETED|Washout Period 3 (10 Days)||4||
59862589|NCT03792672|75986967|FG000|NOT COMPLETED|Washout Period 3 (10 Days)||1||
59862590|NCT03792672|75986968|FG001|NOT COMPLETED|Washout Period 3 (10 Days)||0||
59862591|NCT03792672|75986969|FG002|NOT COMPLETED|Washout Period 3 (10 Days)||1||
59862592|NCT03792672|75986970|FG003|NOT COMPLETED|Washout Period 3 (10 Days)||2||
59862593|NCT03792672|75986971|FG004|NOT COMPLETED|Washout Period 3 (10 Days)||0||
59862594|NCT03792672|75986972|FG005|NOT COMPLETED|Washout Period 3 (10 Days)||0||
59862595|NCT03792672|75986967|FG000|STARTED|Treatment Period 4 (2 Days)||3||
59862596|NCT03792672|75986968|FG001|STARTED|Treatment Period 4 (2 Days)||4||
59862597|NCT03792672|75986969|FG002|STARTED|Treatment Period 4 (2 Days)||3||
59862598|NCT03792672|75986970|FG003|STARTED|Treatment Period 4 (2 Days)||2||
59862599|NCT03792672|75986971|FG004|STARTED|Treatment Period 4 (2 Days)||4||
59862600|NCT03792672|75986972|FG005|STARTED|Treatment Period 4 (2 Days)||4||
59862601|NCT03792672|75986967|FG000|COMPLETED|Treatment Period 4 (2 Days)||2||
59862602|NCT03792672|75986968|FG001|COMPLETED|Treatment Period 4 (2 Days)||4||
59862603|NCT03792672|75986969|FG002|COMPLETED|Treatment Period 4 (2 Days)||3||
59862604|NCT03792672|75986970|FG003|COMPLETED|Treatment Period 4 (2 Days)||2||
59862605|NCT03792672|75986971|FG004|COMPLETED|Treatment Period 4 (2 Days)||4||
59862606|NCT03792672|75986972|FG005|COMPLETED|Treatment Period 4 (2 Days)||4||
59862607|NCT03792672|75986967|FG000|NOT COMPLETED|Treatment Period 4 (2 Days)||1||
59862608|NCT03792672|75986968|FG001|NOT COMPLETED|Treatment Period 4 (2 Days)||0||
59862609|NCT03792672|75986969|FG002|NOT COMPLETED|Treatment Period 4 (2 Days)||0||
59862610|NCT03792672|75986970|FG003|NOT COMPLETED|Treatment Period 4 (2 Days)||0||
59862611|NCT03792672|75986971|FG004|NOT COMPLETED|Treatment Period 4 (2 Days)||0||
59862612|NCT03792672|75986972|FG005|NOT COMPLETED|Treatment Period 4 (2 Days)||0||
59862613|NCT04231396|75986982|FG000|STARTED|Overall Study||27||
59862614|NCT04231396|75986982|FG000|COMPLETED|Overall Study||27||
59862615|NCT04231396|75986982|FG000|NOT COMPLETED|Overall Study||0||
59862616|NCT03120676|75986987|FG000|STARTED|Overall Study||3||
59862617|NCT03120676|75986987|FG000|COMPLETED|Overall Study||2||
59862618|NCT03120676|75986987|FG000|NOT COMPLETED|Overall Study||1||
59862619|NCT03120520|75986995|FG000|STARTED|Overall Study||31||
59862620|NCT03120520|75986996|FG001|STARTED|Overall Study||31||
59862621|NCT03120520|75986997|FG002|STARTED|Overall Study||30||
59862622|NCT03120520|75986998|FG003|STARTED|Overall Study||32||
59862623|NCT03120520|75986995|FG000|COMPLETED|Overall Study||27||
59862624|NCT03120520|75986996|FG001|COMPLETED|Overall Study||27||
59862625|NCT03120520|75986997|FG002|COMPLETED|Overall Study||26||
59862626|NCT03120520|75986998|FG003|COMPLETED|Overall Study||29||
59862627|NCT03120520|75986995|FG000|NOT COMPLETED|Overall Study||4||
59862628|NCT03120520|75986996|FG001|NOT COMPLETED|Overall Study||4||
59862629|NCT03120520|75986997|FG002|NOT COMPLETED|Overall Study||4||
59862630|NCT03120520|75986998|FG003|NOT COMPLETED|Overall Study||3||
59862631|NCT03787212|75987008|FG000|STARTED|Period 1||2||
59862632|NCT03787212|75987009|FG001|STARTED|Period 1||2||
59862633|NCT03787212|75987008|FG000|COMPLETED|Period 1||2||
59862634|NCT03787212|75987009|FG001|COMPLETED|Period 1||2||
59862635|NCT03787212|75987008|FG000|NOT COMPLETED|Period 1||0||
59862636|NCT03787212|75987009|FG001|NOT COMPLETED|Period 1||0||
59862637|NCT03787212|75987008|FG000|STARTED|Period 1||2||
59862638|NCT03787212|75987009|FG001|STARTED|Period 1||2||
59862639|NCT03787212|75987008|FG000|COMPLETED|Period 1||0||
59862640|NCT03787212|75987009|FG001|COMPLETED|Period 1||0||
59862641|NCT03787212|75987008|FG000|NOT COMPLETED|Period 1||2||
59862642|NCT03787212|75987009|FG001|NOT COMPLETED|Period 1||2||
59862643|NCT03125200|75987022|FG000|STARTED|Overall Study||2||
59862644|NCT03125200|75987023|FG001|STARTED|Overall Study||2||
59862645|NCT03125200|75987024|FG002|STARTED|Overall Study||2||
59862646|NCT03125200|75987025|FG003|STARTED|Overall Study||5||
59862647|NCT03125200|75987026|FG004|STARTED|Overall Study||4||
59862648|NCT03125200|75987027|FG005|STARTED|Overall Study||3||
59862649|NCT03125200|75987028|FG006|STARTED|Overall Study||3||
59862650|NCT03125200|75987022|FG000|COMPLETED|Overall Study||0||
59862651|NCT03125200|75987023|FG001|COMPLETED|Overall Study||0||
59862652|NCT03125200|75987024|FG002|COMPLETED|Overall Study||0||
59862653|NCT03125200|75987025|FG003|COMPLETED|Overall Study||0||
59862654|NCT03125200|75987026|FG004|COMPLETED|Overall Study||0||
59862655|NCT03125200|75987027|FG005|COMPLETED|Overall Study||0||
59862656|NCT03125200|75987028|FG006|COMPLETED|Overall Study||0||
59862657|NCT03125200|75987022|FG000|NOT COMPLETED|Overall Study||2||
59862658|NCT03125200|75987023|FG001|NOT COMPLETED|Overall Study||2||
59862659|NCT03125200|75987024|FG002|NOT COMPLETED|Overall Study||2||
59862660|NCT03125200|75987025|FG003|NOT COMPLETED|Overall Study||5||
59862661|NCT03125200|75987026|FG004|NOT COMPLETED|Overall Study||4||
59862662|NCT03125200|75987027|FG005|NOT COMPLETED|Overall Study||3||
59862663|NCT03125200|75987028|FG006|NOT COMPLETED|Overall Study||3||
59862664|NCT03132220|75987049|FG000|STARTED|Overall Study||65||
59862665|NCT03132220|75987050|FG001|STARTED|Overall Study||66||
59862666|NCT03132220|75987049|FG000|Began Study Sessions|Overall Study|65 participants randomized to intervention arm;17 lost to f/u prior to study start;48 began sessions|48||
59862667|NCT03132220|75987050|FG001|Began Study Sessions|Overall Study|66 participants randomized to control arm;8 were lost to f/u prior to study start; 58 began sessions|58||
59862668|NCT03132220|75987049|FG000|COMPLETED|Overall Study||47||
59862669|NCT03132220|75987050|FG001|COMPLETED|Overall Study||54||
59862670|NCT03132220|75987049|FG000|NOT COMPLETED|Overall Study||18||
59862671|NCT03132220|75987050|FG001|NOT COMPLETED|Overall Study||12||
59862672|NCT03119662|75987058|FG000|STARTED|Overall Study||2||
59862673|NCT03119662|75987059|FG001|STARTED|Overall Study||2||
59862674|NCT03119662|75987058|FG000|COMPLETED|Overall Study||2||
59862675|NCT03119662|75987059|FG001|COMPLETED|Overall Study||1||
59862676|NCT03119662|75987058|FG000|NOT COMPLETED|Overall Study||0||
59862677|NCT03119662|75987059|FG001|NOT COMPLETED|Overall Study||1||
59862678|NCT02728804|75987065|FG000|STARTED|Overall Study||380||
59862679|NCT02728804|75987065|FG000|Eligible and Completed Baseline Questionnaire|Overall Study||368||
59862680|NCT02728804|75987065|FG000|COMPLETED|Overall Study||269||
59862681|NCT02728804|75987065|FG000|NOT COMPLETED|Overall Study||111||
59862682|NCT02699554|75987081|FG000|STARTED|Overall Study||55||
59862683|NCT02699554|75987081|FG000|COMPLETED|Overall Study||46||
59862684|NCT02699554|75987081|FG000|NOT COMPLETED|Overall Study||9||
59862685|NCT04073446|75987085|FG000|STARTED|Overall Study||2||
59862686|NCT04073446|75987085|FG000|DC Perception|Overall Study||2||
59862687|NCT04073446|75987085|FG000|DR Perception|Overall Study||2||
59862688|NCT04073446|75987085|FG000|DR Subperception|Overall Study||2||
59862689|NCT04073446|75987085|FG000|DC Subperception|Overall Study||1||
59862690|NCT04073446|75987085|FG000|COMPLETED|Overall Study||1||
59862691|NCT04073446|75987085|FG000|NOT COMPLETED|Overall Study||1||
59862692|NCT03783780|75987095|FG000|STARTED|Overall Study||21||
59862693|NCT03783780|75987095|FG000|COMPLETED|Overall Study||20||
59862694|NCT03783780|75987095|FG000|NOT COMPLETED|Overall Study||1||
59862695|NCT03783702|75987102|FG000|STARTED|Overall Study||56||
59862696|NCT03783702|75987103|FG001|STARTED|Overall Study||62||
59862697|NCT03783702|75987102|FG000|COMPLETED|Overall Study||49||
59862698|NCT03783702|75987103|FG001|COMPLETED|Overall Study||51||
59862699|NCT03783702|75987102|FG000|NOT COMPLETED|Overall Study||7||
59862700|NCT03783702|75987103|FG001|NOT COMPLETED|Overall Study||11||
59862701|NCT03575572|75987111|FG000|STARTED|Overall Study||9|Started is defined here to mean first sample collected.|
59862702|NCT03575572|75987111|FG000|COMPLETED|Overall Study||5||
59862703|NCT03575572|75987111|FG000|NOT COMPLETED|Overall Study||4||
59862704|NCT02625766|75987126|FG000|STARTED|Overall Study||47||
59862705|NCT02625766|75987127|FG001|STARTED|Overall Study||48||
59862706|NCT02625766|75987126|FG000|COMPLETED|Overall Study||47||
59862707|NCT02625766|75987127|FG001|COMPLETED|Overall Study||48||
59862708|NCT02625766|75987126|FG000|NOT COMPLETED|Overall Study||0||
59862709|NCT02625766|75987127|FG001|NOT COMPLETED|Overall Study||0||
59862710|NCT03116698|75987137|FG000|STARTED|Overall Study||62||
59862711|NCT03116698|75987138|FG001|STARTED|Overall Study||57||
59862712|NCT03116698|75987139|FG002|STARTED|Overall Study||62||
59862713|NCT03116698|75987140|FG003|STARTED|Overall Study||57||
59862714|NCT03116698|75987137|FG000|COMPLETED|Overall Study||56||
59862715|NCT03116698|75987138|FG001|COMPLETED|Overall Study||51||
59862716|NCT03116698|75987139|FG002|COMPLETED|Overall Study||54||
59862717|NCT03116698|75987140|FG003|COMPLETED|Overall Study||55||
59862718|NCT03116698|75987137|FG000|NOT COMPLETED|Overall Study||6||
59862719|NCT03116698|75987138|FG001|NOT COMPLETED|Overall Study||6||
59862720|NCT03116698|75987139|FG002|NOT COMPLETED|Overall Study||8||
59862721|NCT03116698|75987140|FG003|NOT COMPLETED|Overall Study||2||
59862722|NCT03116152|75987152|FG000|STARTED|Overall Study||95||
59862723|NCT03116152|75987153|FG001|STARTED|Overall Study||95||
59862724|NCT03116152|75987152|FG000|Treated|Overall Study||94|The number of participants who were treated after randomization|
59862725|NCT03116152|75987153|FG001|Treated|Overall Study||87|The number of participants who were treated after randomization|
59862726|NCT03116152|75987152|FG000|COMPLETED|Overall Study||4||
59862727|NCT03116152|75987153|FG001|COMPLETED|Overall Study||0||
59862728|NCT03116152|75987152|FG000|NOT COMPLETED|Overall Study||91||
59862729|NCT03116152|75987153|FG001|NOT COMPLETED|Overall Study||95||
59862730|NCT00226499|75987164|FG000|STARTED|Overall Study||2489||
59862731|NCT00226499|75987165|FG001|STARTED|Overall Study||2487||
59862732|NCT00226499|75987166|FG002|STARTED|Overall Study||827||
59862733|NCT00226499|75987164|FG000|COMPLETED|Overall Study||1415||
59862734|NCT00226499|75987165|FG001|COMPLETED|Overall Study||1415||
59862735|NCT00226499|75987166|FG002|COMPLETED|Overall Study||468||
59862736|NCT00226499|75987164|FG000|NOT COMPLETED|Overall Study||1074||
59862737|NCT00226499|75987165|FG001|NOT COMPLETED|Overall Study||1072||
59862738|NCT00226499|75987166|FG002|NOT COMPLETED|Overall Study||359||
59862739|NCT01400776|75987180|FG000|STARTED|Overall Study||238||
59862740|NCT01400776|75987181|FG001|STARTED|Overall Study||124||
59862741|NCT01400776|75987182|FG002|STARTED|Overall Study||237||
59862742|NCT01400776|75987183|FG003|STARTED|Overall Study||123||
59862743|NCT01400776|75987180|FG000|COMPLETED|Overall Study||217||
59862744|NCT01400776|75987181|FG001|COMPLETED|Overall Study||119||
59862745|NCT01400776|75987182|FG002|COMPLETED|Overall Study||209||
59862746|NCT01400776|75987183|FG003|COMPLETED|Overall Study||114||
59862747|NCT01400776|75987180|FG000|NOT COMPLETED|Overall Study||21||
59862748|NCT01400776|75987181|FG001|NOT COMPLETED|Overall Study||5||
59862749|NCT01400776|75987182|FG002|NOT COMPLETED|Overall Study||28||
59862750|NCT01400776|75987183|FG003|NOT COMPLETED|Overall Study||9||
59862751|NCT03131596|75987195|FG000|STARTED|Overall Study||100||
59862752|NCT03131596|75987196|FG001|STARTED|Overall Study||100||
59862753|NCT03131596|75987195|FG000|COMPLETED|Overall Study||94||
59862754|NCT03131596|75987196|FG001|COMPLETED|Overall Study||97||
59862755|NCT03131596|75987195|FG000|NOT COMPLETED|Overall Study||6||
59862756|NCT03131596|75987196|FG001|NOT COMPLETED|Overall Study||3||
59862757|NCT03816202|75987202|FG000|STARTED|Overall Study||100||
59862758|NCT03816202|75987202|FG000|COMPLETED|Overall Study||100||
59862759|NCT03816202|75987202|FG000|NOT COMPLETED|Overall Study||0||
59862760|NCT00255047|75987210|FG000|STARTED|Overall Study||538||
59862761|NCT00255047|75987211|FG001|STARTED|Overall Study||535||
59862762|NCT00255047|75987212|FG002|STARTED|Overall Study||546||
59862763|NCT00255047|75987213|FG003|STARTED|Overall Study||548||
59862764|NCT00255047|75987210|FG000|COMPLETED|Overall Study||490||
59862765|NCT00255047|75987211|FG001|COMPLETED|Overall Study||487||
59862766|NCT00255047|75987212|FG002|COMPLETED|Overall Study||496||
59862767|NCT00255047|75987213|FG003|COMPLETED|Overall Study||502||
59862768|NCT00255047|75987210|FG000|NOT COMPLETED|Overall Study||48||
59862769|NCT00255047|75987211|FG001|NOT COMPLETED|Overall Study||48||
59862770|NCT00255047|75987212|FG002|NOT COMPLETED|Overall Study||50||
59862771|NCT00255047|75987213|FG003|NOT COMPLETED|Overall Study||46||
59862772|NCT00225251|75987225|FG000|STARTED|Overall Study||11||
60000309|NCT02712983|76116059|FG006|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|2|All patients who discontinued treatment and entered Post-Treatment Efficacy Follow-Up Phase|
59862773|NCT00225251|75987226|FG001|STARTED|Overall Study||7||
59862774|NCT00225251|75987225|FG000|COMPLETED|Overall Study||10||
59862775|NCT00225251|75987226|FG001|COMPLETED|Overall Study||6||
59862776|NCT00225251|75987225|FG000|NOT COMPLETED|Overall Study||1||
59862777|NCT00225251|75987226|FG001|NOT COMPLETED|Overall Study||1||
59862778|NCT00254501|75987234|FG000|STARTED|Overall Study||32||
59862779|NCT00254501|75987235|FG001|STARTED|Overall Study||37||
59862780|NCT00254501|75987234|FG000|COMPLETED|Overall Study||31||
59862781|NCT00254501|75987235|FG001|COMPLETED|Overall Study||36||
59862782|NCT00254501|75987234|FG000|NOT COMPLETED|Overall Study||1||
59862783|NCT00254501|75987235|FG001|NOT COMPLETED|Overall Study||1||
59862784|NCT00253643|75987247|FG000|STARTED|Overall Study||14||
59862785|NCT00253643|75987248|FG001|STARTED|Overall Study||15||
59862786|NCT00253643|75987249|FG002|STARTED|Overall Study||29||
59862787|NCT00253643|75987250|FG003|STARTED|Overall Study||31||
59862788|NCT00253643|75987247|FG000|COMPLETED|Overall Study||14||
59862789|NCT00253643|75987248|FG001|COMPLETED|Overall Study||15||
59862790|NCT00253643|75987249|FG002|COMPLETED|Overall Study||28||
59862791|NCT00253643|75987250|FG003|COMPLETED|Overall Study||28||
59862792|NCT00253643|75987247|FG000|NOT COMPLETED|Overall Study||0||
59862793|NCT00253643|75987248|FG001|NOT COMPLETED|Overall Study||0||
59862794|NCT00253643|75987249|FG002|NOT COMPLETED|Overall Study||1||
59862795|NCT00253643|75987250|FG003|NOT COMPLETED|Overall Study||3||
59862796|NCT00221195|75987262|FG000|STARTED|Therapy 1 (Months 1-6)||17||
59862797|NCT00221195|75987263|FG001|STARTED|Therapy 1 (Months 1-6)||17||
59862798|NCT00221195|75987262|FG000|COMPLETED|Therapy 1 (Months 1-6)||14||
59862799|NCT00221195|75987263|FG001|COMPLETED|Therapy 1 (Months 1-6)||15||
59862800|NCT00221195|75987262|FG000|NOT COMPLETED|Therapy 1 (Months 1-6)||3||
59862801|NCT00221195|75987263|FG001|NOT COMPLETED|Therapy 1 (Months 1-6)||2||
59862802|NCT00221195|75987262|FG000|STARTED|Washout Period (Months 7-9)||14||
59862803|NCT00221195|75987263|FG001|STARTED|Washout Period (Months 7-9)||15||
59862804|NCT00221195|75987262|FG000|COMPLETED|Washout Period (Months 7-9)||14||
59862805|NCT00221195|75987263|FG001|COMPLETED|Washout Period (Months 7-9)||14||
59862806|NCT00221195|75987262|FG000|NOT COMPLETED|Washout Period (Months 7-9)||0||
59862807|NCT00221195|75987263|FG001|NOT COMPLETED|Washout Period (Months 7-9)||1||
59862808|NCT00221195|75987262|FG000|STARTED|Therapy 2 (Months 10-15)||14||
59862809|NCT00221195|75987263|FG001|STARTED|Therapy 2 (Months 10-15)||14||
59862810|NCT00221195|75987262|FG000|COMPLETED|Therapy 2 (Months 10-15)||12||
59862811|NCT00221195|75987263|FG001|COMPLETED|Therapy 2 (Months 10-15)||14||
59862812|NCT00221195|75987262|FG000|NOT COMPLETED|Therapy 2 (Months 10-15)||2||
59862813|NCT00221195|75987263|FG001|NOT COMPLETED|Therapy 2 (Months 10-15)||0||
59862814|NCT00220805|75987272|FG000|STARTED|Overall Study||30||
59862815|NCT00220805|75987273|FG001|STARTED|Overall Study||27||
59862816|NCT00220805|75987272|FG000|COMPLETED|Overall Study||22||
59862817|NCT00220805|75987273|FG001|COMPLETED|Overall Study||16||
59862818|NCT00220805|75987272|FG000|NOT COMPLETED|Overall Study||8||
59862819|NCT00220805|75987273|FG001|NOT COMPLETED|Overall Study||11||
59862820|NCT00220727|75987281|FG000|STARTED|First Infusion (Week 0)||4||
59862821|NCT00220727|75987282|FG001|STARTED|First Infusion (Week 0)||4||
59862822|NCT00220727|75987281|FG000|COMPLETED|First Infusion (Week 0)||4||
59862823|NCT00220727|75987282|FG001|COMPLETED|First Infusion (Week 0)||4||
59862824|NCT00220727|75987281|FG000|NOT COMPLETED|First Infusion (Week 0)||0||
59862825|NCT00220727|75987282|FG001|NOT COMPLETED|First Infusion (Week 0)||0||
59862826|NCT00220727|75987281|FG000|STARTED|Second Infusion (Week <6)||4||
59862827|NCT00220727|75987282|FG001|STARTED|Second Infusion (Week <6)||4||
59862828|NCT00220727|75987281|FG000|COMPLETED|Second Infusion (Week <6)||3||
59862829|NCT00220727|75987282|FG001|COMPLETED|Second Infusion (Week <6)||4||
59862830|NCT00220727|75987281|FG000|NOT COMPLETED|Second Infusion (Week <6)||1||
59862831|NCT00220727|75987282|FG001|NOT COMPLETED|Second Infusion (Week <6)||0||
59862832|NCT03971357|75987292|FG000|STARTED|Overall Study||10||
59862833|NCT03971357|75987293|FG001|STARTED|Overall Study||9||
59862834|NCT03971357|75987292|FG000|COMPLETED|Overall Study||10||
59862835|NCT03971357|75987293|FG001|COMPLETED|Overall Study||8||
59862836|NCT03971357|75987292|FG000|NOT COMPLETED|Overall Study||0||
59862837|NCT03971357|75987293|FG001|NOT COMPLETED|Overall Study||1||
59862838|NCT04310566|75987299|FG000|STARTED|Period 1||31||
59862839|NCT04310566|75987300|FG001|STARTED|Period 1||34||
59862840|NCT04310566|75987299|FG000|COMPLETED|Period 1||15||
59862841|NCT04310566|75987300|FG001|COMPLETED|Period 1||14||
59862842|NCT04310566|75987299|FG000|NOT COMPLETED|Period 1||16||
59862843|NCT04310566|75987300|FG001|NOT COMPLETED|Period 1||20||
59862844|NCT04310566|75987299|FG000|STARTED|Period 2||15||
59862845|NCT04310566|75987300|FG001|STARTED|Period 2||14||
59862846|NCT04310566|75987299|FG000|COMPLETED|Period 2||8||
59862847|NCT04310566|75987300|FG001|COMPLETED|Period 2||9||
59862848|NCT04310566|75987299|FG000|NOT COMPLETED|Period 2||7||
59862849|NCT04310566|75987300|FG001|NOT COMPLETED|Period 2||5||
59862850|NCT00252239|75987310|FG000|STARTED|Overall Study||31||
59862851|NCT00252239|75987311|FG001|STARTED|Overall Study||31||
59862852|NCT00252239|75987312|FG002|STARTED|Overall Study||19||
59862853|NCT00252239|75987313|FG003|STARTED|Overall Study||31||
59862854|NCT00252239|75987310|FG000|COMPLETED|Overall Study||30||
59862855|NCT00252239|75987311|FG001|COMPLETED|Overall Study||31||
59862856|NCT00252239|75987312|FG002|COMPLETED|Overall Study||17||
59862857|NCT00252239|75987313|FG003|COMPLETED|Overall Study||30||
59862858|NCT00252239|75987310|FG000|NOT COMPLETED|Overall Study||1||
59862859|NCT00252239|75987311|FG001|NOT COMPLETED|Overall Study||0||
59862860|NCT00252239|75987312|FG002|NOT COMPLETED|Overall Study||2||
59862861|NCT00252239|75987313|FG003|NOT COMPLETED|Overall Study||1||
59862862|NCT03103906|75987325|FG000|STARTED|Overall Study||40||
59862863|NCT03103906|75987326|FG001|STARTED|Overall Study||42||
59862864|NCT03103906|75987325|FG000|COMPLETED|Overall Study||36||
59862865|NCT03103906|75987326|FG001|COMPLETED|Overall Study||39||
59862866|NCT03103906|75987325|FG000|NOT COMPLETED|Overall Study||4||
59862867|NCT03103906|75987326|FG001|NOT COMPLETED|Overall Study||3||
59862868|NCT04799158|75987336|FG000|STARTED|Run-In Period||458||
59862869|NCT04799158|75987337|FG001|STARTED|Run-In Period||0||
59862870|NCT04799158|75987338|FG002|STARTED|Run-In Period||0||
59862871|NCT04799158|75987339|FG003|STARTED|Run-In Period||0||
59862872|NCT04799158|75987340|FG004|STARTED|Run-In Period||0||
59862873|NCT04799158|75987336|FG000|COMPLETED|Run-In Period||207||
59862874|NCT04799158|75987337|FG001|COMPLETED|Run-In Period||0||
59862875|NCT04799158|75987338|FG002|COMPLETED|Run-In Period||0||
59862876|NCT04799158|75987339|FG003|COMPLETED|Run-In Period||0||
59862877|NCT04799158|75987340|FG004|COMPLETED|Run-In Period||0||
59862878|NCT04799158|75987336|FG000|NOT COMPLETED|Run-In Period||251||
59862879|NCT04799158|75987337|FG001|NOT COMPLETED|Run-In Period||0||
59862880|NCT04799158|75987338|FG002|NOT COMPLETED|Run-In Period||0||
59862881|NCT04799158|75987339|FG003|NOT COMPLETED|Run-In Period||0||
59862882|NCT04799158|75987340|FG004|NOT COMPLETED|Run-In Period||0||
59862883|NCT04799158|75987336|FG000|STARTED|On-Demand Treatment Period||0||
59862884|NCT04799158|75987337|FG001|STARTED|On-Demand Treatment Period||52||
59862885|NCT04799158|75987338|FG002|STARTED|On-Demand Treatment Period||52||
59862886|NCT04799158|75987339|FG003|STARTED|On-Demand Treatment Period||51||
59862887|NCT04799158|75987340|FG004|STARTED|On-Demand Treatment Period||52||
59862888|NCT04799158|75987336|FG000|COMPLETED|On-Demand Treatment Period||0||
59862889|NCT04799158|75987337|FG001|COMPLETED|On-Demand Treatment Period||51||
59862890|NCT04799158|75987338|FG002|COMPLETED|On-Demand Treatment Period||52||
59862891|NCT04799158|75987339|FG003|COMPLETED|On-Demand Treatment Period||49||
59862892|NCT04799158|75987340|FG004|COMPLETED|On-Demand Treatment Period||48||
59862893|NCT04799158|75987336|FG000|NOT COMPLETED|On-Demand Treatment Period||0||
59862894|NCT04799158|75987337|FG001|NOT COMPLETED|On-Demand Treatment Period||1||
59862895|NCT04799158|75987338|FG002|NOT COMPLETED|On-Demand Treatment Period||0||
59862896|NCT04799158|75987339|FG003|NOT COMPLETED|On-Demand Treatment Period||2||
59862897|NCT04799158|75987340|FG004|NOT COMPLETED|On-Demand Treatment Period||4||
59862898|NCT01319422|75987353|FG000|STARTED|Overall Study||20||
59862899|NCT01319422|75987354|FG001|STARTED|Overall Study||20||
59862900|NCT01319422|75987353|FG000|COMPLETED|Overall Study||19||
59862901|NCT01319422|75987354|FG001|COMPLETED|Overall Study||20||
59862902|NCT01319422|75987353|FG000|NOT COMPLETED|Overall Study||1||
59862903|NCT01319422|75987354|FG001|NOT COMPLETED|Overall Study||0||
59862904|NCT03102034|75987362|FG000|STARTED|Overall Study||21||
59862905|NCT03102034|75987363|FG001|STARTED|Overall Study||11||
59862906|NCT03102034|75987362|FG000|COMPLETED|Overall Study||20||
59862907|NCT03102034|75987363|FG001|COMPLETED|Overall Study||11||
59862908|NCT03102034|75987362|FG000|NOT COMPLETED|Overall Study||1||
59862909|NCT03102034|75987363|FG001|NOT COMPLETED|Overall Study||0||
59862910|NCT03774576|75987369|FG000|STARTED|Period 1||14||
59862911|NCT03774576|75987369|FG000|COMPLETED|Period 1||14||
59862912|NCT03774576|75987369|FG000|NOT COMPLETED|Period 1||0||
59862913|NCT03774576|75987369|FG000|STARTED|Period 2||14||
59862914|NCT03774576|75987369|FG000|COMPLETED|Period 2||13||
59862915|NCT03774576|75987369|FG000|NOT COMPLETED|Period 2||1||
59862916|NCT02928952|75987380|FG000|STARTED|Overall Study||65||
59862917|NCT02928952|75987381|FG001|STARTED|Overall Study||67||
59862918|NCT02928952|75987380|FG000|COMPLETED|Overall Study||55||
59862919|NCT02928952|75987381|FG001|COMPLETED|Overall Study||60||
59862920|NCT02928952|75987380|FG000|NOT COMPLETED|Overall Study||10||
59862921|NCT02928952|75987381|FG001|NOT COMPLETED|Overall Study||7||
59862922|NCT03773796|75987387|FG000|STARTED|Overall Study||22||
59862923|NCT03773796|75987387|FG000|COMPLETED|Overall Study||19||
59862924|NCT03773796|75987387|FG000|NOT COMPLETED|Overall Study||3||
59862925|NCT02927938|75987395|FG000|STARTED|Overall Study||1|Started/enrollment date is the date that the post-induction bone marrow aspirate was obtained.|
59862926|NCT02927938|75987396|FG001|STARTED|Overall Study||6|Started/enrollment date is the date that the post-induction bone marrow aspirate was obtained.|
59600568|NCT00484718|75710303|FG002|NOT COMPLETED|Treatment Period 3 (2 Weeks)||0||
59600569|NCT00484718|75710304|FG003|NOT COMPLETED|Treatment Period 3 (2 Weeks)||0||
59600570|NCT00484718|75710305|FG004|NOT COMPLETED|Treatment Period 3 (2 Weeks)||0||
59600571|NCT00484718|75710306|FG005|NOT COMPLETED|Treatment Period 3 (2 Weeks)||0||
59600572|NCT03665155|75710317|FG000|STARTED|Overall Study||3||
59600573|NCT03665155|75710318|FG001|STARTED|Overall Study||7||
59600574|NCT03665155|75710319|FG002|STARTED|Overall Study||1||
59600575|NCT03665155|75710317|FG000|COMPLETED|Overall Study||3||
59600576|NCT03665155|75710318|FG001|COMPLETED|Overall Study||7||
59600577|NCT03665155|75710319|FG002|COMPLETED|Overall Study||1||
59600578|NCT03665155|75710317|FG000|NOT COMPLETED|Overall Study||0||
59600579|NCT03665155|75710318|FG001|NOT COMPLETED|Overall Study||0||
59600580|NCT03665155|75710319|FG002|NOT COMPLETED|Overall Study||0||
59600581|NCT00477230|75710327|FG000|STARTED|Overall Study||32||
59600582|NCT00477230|75710328|FG001|STARTED|Overall Study||32||
59600583|NCT00477230|75710327|FG000|COMPLETED|Overall Study||12||
59600584|NCT00477230|75710328|FG001|COMPLETED|Overall Study||1||
59600585|NCT00477230|75710327|FG000|NOT COMPLETED|Overall Study||20||
59600586|NCT00477230|75710328|FG001|NOT COMPLETED|Overall Study||31||
59600587|NCT03901105|75710334|FG000|STARTED|Overall Study||205||
59600588|NCT03901105|75710334|FG000|COMPLETED|Overall Study||205||
59600589|NCT03901105|75710334|FG000|NOT COMPLETED|Overall Study||0||
59600590|NCT00448682|75710344|FG000|STARTED|Overall Study||25||
59600591|NCT00448682|75710344|FG000|COMPLETED|Overall Study||25||
59600592|NCT00448682|75710344|FG000|NOT COMPLETED|Overall Study||0||
59600593|NCT03675451|75710348|FG000|STARTED|Overall Study||20||
59600594|NCT03675451|75710348|FG000|COMPLETED|Overall Study||20||
59600595|NCT03675451|75710348|FG000|NOT COMPLETED|Overall Study||0||
59600596|NCT03675685|75710359|FG000|STARTED|Overall Study||12||
59600597|NCT03675685|75710359|FG000|COMPLETED|Overall Study||12||
59600598|NCT03675685|75710359|FG000|NOT COMPLETED|Overall Study||0||
59600599|NCT03677089|75710367|FG000|STARTED|Overall Study||148||
59600600|NCT03677089|75710367|FG000|Baseline/Pre-Intervention|Overall Study||137|5 participants attended but did not complete forms.|
59600601|NCT03677089|75710367|FG000|Mid-Intervention|Overall Study||120||
59600602|NCT03677089|75710367|FG000|Post-Intervention|Overall Study||117||
59600603|NCT03677089|75710367|FG000|Follow-Up|Overall Study||114||
59600604|NCT03677089|75710367|FG000|COMPLETED|Overall Study||114||
59600605|NCT03677089|75710367|FG000|NOT COMPLETED|Overall Study||34||
59862927|NCT02927938|75987397|FG002|STARTED|Overall Study||4|Started/enrollment date is the date that the post-induction bone marrow aspirate was obtained.|
59862928|NCT02927938|75987398|FG003|STARTED|Overall Study||7|Started/enrollment date is the date that the post-induction bone marrow aspirate was obtained.|
59862929|NCT02927938|75987395|FG000|COMPLETED|Overall Study||0||
59862930|NCT02927938|75987396|FG001|COMPLETED|Overall Study||0||
59862931|NCT02927938|75987397|FG002|COMPLETED|Overall Study||0||
59862932|NCT02927938|75987398|FG003|COMPLETED|Overall Study||0||
59862933|NCT02927938|75987395|FG000|NOT COMPLETED|Overall Study||1||
59862934|NCT02927938|75987396|FG001|NOT COMPLETED|Overall Study||6||
59862935|NCT02927938|75987397|FG002|NOT COMPLETED|Overall Study||4||
59862936|NCT02927938|75987398|FG003|NOT COMPLETED|Overall Study||7||
59862937|NCT03765138|75987406|FG000|STARTED|Overall Study||1||
59862938|NCT03765138|75987406|FG000|COMPLETED|Overall Study||0||
59862939|NCT03765138|75987406|FG000|NOT COMPLETED|Overall Study||1||
59862940|NCT03768726|75987413|FG000|STARTED|Treatment Phase||10||
59862941|NCT03768726|75987414|FG001|STARTED|Treatment Phase||13||
59862942|NCT03768726|75987413|FG000|COMPLETED|Treatment Phase||2||
59862943|NCT03768726|75987414|FG001|COMPLETED|Treatment Phase||10||
59862944|NCT03768726|75987413|FG000|NOT COMPLETED|Treatment Phase||8||
59862945|NCT03768726|75987414|FG001|NOT COMPLETED|Treatment Phase||3||
59862946|NCT03768726|75987413|FG000|STARTED|Follow-Up|Participants were followed up after completion or discontinuation of treatment.|8||
59862947|NCT03768726|75987414|FG001|STARTED|Follow-Up|Participants were followed up after completion or discontinuation of treatment.|12||
59862948|NCT03768726|75987413|FG000|Received Treatment|Follow-Up||8||
59862949|NCT03768726|75987414|FG001|Received Treatment|Follow-Up||12||
59862950|NCT03768726|75987413|FG000|COMPLETED|Follow-Up||2||
59862951|NCT03768726|75987414|FG001|COMPLETED|Follow-Up||9||
59862952|NCT03768726|75987413|FG000|NOT COMPLETED|Follow-Up||6||
59862953|NCT03768726|75987414|FG001|NOT COMPLETED|Follow-Up||3||
59862954|NCT03769896|75987422|FG000|STARTED|Open-label Phase||47||
59862955|NCT03769896|75987423|FG001|STARTED|Open-label Phase||0||
59862956|NCT03769896|75987422|FG000|COMPLETED|Open-label Phase||38||
59862957|NCT03769896|75987423|FG001|COMPLETED|Open-label Phase||0||
59862958|NCT03769896|75987422|FG000|NOT COMPLETED|Open-label Phase||9||
59862959|NCT03769896|75987423|FG001|NOT COMPLETED|Open-label Phase||0||
59862960|NCT03769896|75987422|FG000|STARTED|Double-blind Treatment Phase||19|refers to the double-blind treatment phase|
59862961|NCT03769896|75987423|FG001|STARTED|Double-blind Treatment Phase||19|refers to the double-blind treatment phase|
59862962|NCT03769896|75987422|FG000|COMPLETED|Double-blind Treatment Phase||19|refers to the double-blind treatment phase|
59862963|NCT03769896|75987423|FG001|COMPLETED|Double-blind Treatment Phase||19|refers to the double-blind treatment phase|
59862964|NCT03769896|75987422|FG000|NOT COMPLETED|Double-blind Treatment Phase||0||
59862965|NCT03769896|75987423|FG001|NOT COMPLETED|Double-blind Treatment Phase||0||
59862966|NCT05047601|75987433|FG000|STARTED|Overall Study||921||
59862967|NCT05047601|75987434|FG001|STARTED|Overall Study||917||
59862968|NCT05047601|75987435|FG002|STARTED|Overall Study||898||
59862969|NCT05047601|75987433|FG000|Treated|Overall Study||913||
59862970|NCT05047601|75987434|FG001|Treated|Overall Study||911||
59862971|NCT05047601|75987435|FG002|Treated|Overall Study||897||
59862972|NCT05047601|75987433|FG000|COMPLETED|Overall Study||877||
59862973|NCT05047601|75987434|FG001|COMPLETED|Overall Study||864||
59862974|NCT05047601|75987435|FG002|COMPLETED|Overall Study||863||
59862975|NCT05047601|75987433|FG000|NOT COMPLETED|Overall Study||44||
59862976|NCT05047601|75987434|FG001|NOT COMPLETED|Overall Study||53||
59862977|NCT05047601|75987435|FG002|NOT COMPLETED|Overall Study||35||
59862978|NCT04658784|75987445|FG000|STARTED|Enrollment to 6-week Follow-up||36||
59862979|NCT04658784|75987446|FG001|STARTED|Enrollment to 6-week Follow-up||36||
59862980|NCT04658784|75987445|FG000|COMPLETED|Enrollment to 6-week Follow-up||36||
59862981|NCT04658784|75987446|FG001|COMPLETED|Enrollment to 6-week Follow-up||36||
59862982|NCT04658784|75987445|FG000|NOT COMPLETED|Enrollment to 6-week Follow-up||0||
59862983|NCT04658784|75987446|FG001|NOT COMPLETED|Enrollment to 6-week Follow-up||0||
59862984|NCT04658784|75987445|FG000|STARTED|6-month Follow-up||36||
59862985|NCT04658784|75987446|FG001|STARTED|6-month Follow-up||36||
59862986|NCT04658784|75987445|FG000|COMPLETED|6-month Follow-up||34||
59862987|NCT04658784|75987446|FG001|COMPLETED|6-month Follow-up||31||
59862988|NCT04658784|75987445|FG000|NOT COMPLETED|6-month Follow-up||2||
59862989|NCT04658784|75987446|FG001|NOT COMPLETED|6-month Follow-up||5||
59862990|NCT04606394|75987452|FG000|STARTED|Overall Study|45 subjects recruited/consented. 12 failed entry criteria during screening and 3 withdrew consent during screening for non-medical reasons. 30 subjects met entry criteria per protocol and started/completed the study.|45||
59862991|NCT04606394|75987452|FG000|COMPLETED|Overall Study||30||
59862992|NCT04606394|75987452|FG000|NOT COMPLETED|Overall Study||15||
59862993|NCT04585451|75987466|FG000|STARTED|Overall Study||280||
59862994|NCT04585451|75987467|FG001|STARTED|Overall Study||54||
59862995|NCT04585451|75987466|FG000|COMPLETED|Overall Study||254||
59862996|NCT04585451|75987467|FG001|COMPLETED|Overall Study||54||
59862997|NCT04585451|75987466|FG000|NOT COMPLETED|Overall Study||26||
59862998|NCT04585451|75987467|FG001|NOT COMPLETED|Overall Study||0||
59862999|NCT04378933|75987474|FG000|STARTED|Overall Study||17||
59863000|NCT04378933|75987475|FG001|STARTED|Overall Study||17||
59863001|NCT04378933|75987474|FG000|COMPLETED|Overall Study||17||
59863002|NCT04378933|75987475|FG001|COMPLETED|Overall Study||17||
59863003|NCT04378933|75987474|FG000|NOT COMPLETED|Overall Study||0||
59863004|NCT04378933|75987475|FG001|NOT COMPLETED|Overall Study||0||
59863005|NCT04371536|75987483|FG000|STARTED|Overall Study||1||
59863006|NCT04371536|75987484|FG001|STARTED|Overall Study||0||
59863007|NCT04371536|75987483|FG000|COMPLETED|Overall Study||1||
59863008|NCT04371536|75987484|FG001|COMPLETED|Overall Study||0||
59863009|NCT04371536|75987483|FG000|NOT COMPLETED|Overall Study||0||
59863010|NCT04371536|75987484|FG001|NOT COMPLETED|Overall Study||0||
59863011|NCT04362189|75987492|FG000|STARTED|Overall Study||33||
59863012|NCT04362189|75987493|FG001|STARTED|Overall Study||15||
59863013|NCT04362189|75987492|FG000|COMPLETED|Overall Study||18||
59863014|NCT04362189|75987493|FG001|COMPLETED|Overall Study||9||
59863015|NCT04362189|75987492|FG000|NOT COMPLETED|Overall Study||15||
59863016|NCT04362189|75987493|FG001|NOT COMPLETED|Overall Study||6||
59863017|NCT04341116|75987505|FG000|STARTED|Overall Study||8||
59863018|NCT04341116|75987506|FG001|STARTED|Overall Study||8||
59863019|NCT04341116|75987507|FG002|STARTED|Overall Study||8||
59863020|NCT04341116|75987508|FG003|STARTED|Overall Study|ITT population|77||
59863021|NCT04341116|75987509|FG004|STARTED|Overall Study||6||
59863022|NCT04341116|75987510|FG005|STARTED|Overall Study|ITT population|42||
59863023|NCT04341116|75987505|FG000|COMPLETED|Overall Study||7||
59863024|NCT04341116|75987506|FG001|COMPLETED|Overall Study||6||
59863025|NCT04341116|75987507|FG002|COMPLETED|Overall Study||6||
59863026|NCT04341116|75987508|FG003|COMPLETED|Overall Study||66||
59863027|NCT04341116|75987509|FG004|COMPLETED|Overall Study||5||
59863028|NCT04341116|75987510|FG005|COMPLETED|Overall Study||34||
59863029|NCT04341116|75987505|FG000|NOT COMPLETED|Overall Study||1||
59863030|NCT04341116|75987506|FG001|NOT COMPLETED|Overall Study||2||
59863031|NCT04341116|75987507|FG002|NOT COMPLETED|Overall Study||2||
59863032|NCT04341116|75987508|FG003|NOT COMPLETED|Overall Study||11||
59863033|NCT04341116|75987509|FG004|NOT COMPLETED|Overall Study||1||
59863034|NCT04341116|75987510|FG005|NOT COMPLETED|Overall Study||8||
59863035|NCT04301986|75987547|FG000|STARTED|Overall Study||0||
59863036|NCT04301986|75987548|FG001|STARTED|Overall Study||24||
59863037|NCT04301986|75987547|FG000|COMPLETED|Overall Study||0||
59863038|NCT04301986|75987548|FG001|COMPLETED|Overall Study||24||
59863039|NCT04301986|75987547|FG000|NOT COMPLETED|Overall Study||0||
59863040|NCT04301986|75987548|FG001|NOT COMPLETED|Overall Study||0||
59863041|NCT04259424|75987557|FG000|STARTED|Overall Study||10||
59863042|NCT04259424|75987557|FG000|COMPLETED|Overall Study||10||
59863043|NCT04259424|75987557|FG000|NOT COMPLETED|Overall Study||0||
59863044|NCT04181788|75987567|FG000|STARTED|TREATMENT||4||
59863045|NCT04181788|75987568|FG001|STARTED|TREATMENT||12||
59863046|NCT04181788|75987569|FG002|STARTED|TREATMENT||6||
59863047|NCT04181788|75987570|FG003|STARTED|TREATMENT||12||
59863048|NCT04181788|75987571|FG004|STARTED|TREATMENT||41||
59863049|NCT04181788|75987572|FG005|STARTED|TREATMENT||80||
59863050|NCT04181788|75987567|FG000|COMPLETED|TREATMENT||0||
59863051|NCT04181788|75987568|FG001|COMPLETED|TREATMENT||0||
59863052|NCT04181788|75987569|FG002|COMPLETED|TREATMENT||0||
59863053|NCT04181788|75987570|FG003|COMPLETED|TREATMENT||0||
59863054|NCT04181788|75987571|FG004|COMPLETED|TREATMENT||0||
59863055|NCT04181788|75987572|FG005|COMPLETED|TREATMENT||0||
59863056|NCT04181788|75987567|FG000|NOT COMPLETED|TREATMENT||4||
59863057|NCT04181788|75987568|FG001|NOT COMPLETED|TREATMENT||12||
59863058|NCT04181788|75987569|FG002|NOT COMPLETED|TREATMENT||6||
59863059|NCT04181788|75987570|FG003|NOT COMPLETED|TREATMENT||12||
59863060|NCT04181788|75987571|FG004|NOT COMPLETED|TREATMENT||41||
59863061|NCT04181788|75987572|FG005|NOT COMPLETED|TREATMENT||80||
59863062|NCT04181788|75987567|FG000|STARTED|FOLLOW-UP||3|All participants who entered treatment phase were either on-going on treatment or discontinued treatment. Those who discontinued treatment either entered the follow-up period or discontinued the study at the end of treatment.|
59863063|NCT04181788|75987568|FG001|STARTED|FOLLOW-UP||9|All participants who entered treatment phase were either on-going on treatment or discontinued treatment. Those who discontinued treatment either entered the follow-up period or discontinued the study at the end of treatment.|
59863064|NCT04181788|75987569|FG002|STARTED|FOLLOW-UP||6|All participants who entered treatment phase were either on-going on treatment or discontinued treatment. Those who discontinued treatment either entered the follow-up period or discontinued the study at the end of treatment.|
59863065|NCT04181788|75987570|FG003|STARTED|FOLLOW-UP||7|All participants who entered treatment phase were either on-going on treatment or discontinued treatment. Those who discontinued treatment either entered the follow-up period or discontinued the study at the end of treatment.|
59863066|NCT04181788|75987571|FG004|STARTED|FOLLOW-UP||20|All participants who entered treatment phase were either on-going on treatment or discontinued treatment. Those who discontinued treatment either entered the follow-up period or discontinued the study at the end of treatment.|
59863067|NCT04181788|75987572|FG005|STARTED|FOLLOW-UP||49|All participants who entered treatment phase were either on-going on treatment or discontinued treatment. Those who discontinued treatment either entered the follow-up period or discontinued the study at the end of treatment.|
59600606|NCT03677245|75710375|FG000|STARTED|Overall Study||8||
59600607|NCT03677245|75710375|FG000|COMPLETED|Overall Study||8||
59600608|NCT03677245|75710375|FG000|NOT COMPLETED|Overall Study||0||
59600609|NCT00383630|75710380|FG000|STARTED|Overall Study||1||
59600610|NCT00383630|75710380|FG000|COMPLETED|Overall Study||1||
59600611|NCT00383630|75710380|FG000|NOT COMPLETED|Overall Study||0||
59600612|NCT04285411|75710384|FG000|STARTED|Overall Study||10||
59600613|NCT04285411|75710384|FG000|COMPLETED|Overall Study||10||
59600614|NCT04285411|75710384|FG000|NOT COMPLETED|Overall Study||0||
59600615|NCT00368654|75710393|FG000|STARTED|Overall Study||3||
59600616|NCT00368654|75710394|FG001|STARTED|Overall Study||3||
59600617|NCT00368654|75710395|FG002|STARTED|Overall Study||3||
59600618|NCT00368654|75710396|FG003|STARTED|Overall Study||3||
59600619|NCT00368654|75710393|FG000|COMPLETED|Overall Study||0||
59600620|NCT00368654|75710394|FG001|COMPLETED|Overall Study||0||
59600621|NCT00368654|75710395|FG002|COMPLETED|Overall Study||0||
59600622|NCT00368654|75710396|FG003|COMPLETED|Overall Study||0||
59600623|NCT00368654|75710393|FG000|NOT COMPLETED|Overall Study||3||
59600624|NCT00368654|75710394|FG001|NOT COMPLETED|Overall Study||3||
59863068|NCT04181788|75987567|FG000|COMPLETED|FOLLOW-UP||3||
59863069|NCT04181788|75987568|FG001|COMPLETED|FOLLOW-UP||8||
59863070|NCT04181788|75987569|FG002|COMPLETED|FOLLOW-UP||4||
59863071|NCT04181788|75987570|FG003|COMPLETED|FOLLOW-UP||2||
59863072|NCT04181788|75987571|FG004|COMPLETED|FOLLOW-UP||9||
59863073|NCT04181788|75987572|FG005|COMPLETED|FOLLOW-UP||22||
59863074|NCT04181788|75987567|FG000|NOT COMPLETED|FOLLOW-UP||0||
59863075|NCT04181788|75987568|FG001|NOT COMPLETED|FOLLOW-UP||1||
59863076|NCT04181788|75987569|FG002|NOT COMPLETED|FOLLOW-UP||2||
59863077|NCT04181788|75987570|FG003|NOT COMPLETED|FOLLOW-UP||5||
59863078|NCT04181788|75987571|FG004|NOT COMPLETED|FOLLOW-UP||11||
59863079|NCT04181788|75987572|FG005|NOT COMPLETED|FOLLOW-UP||27||
59863080|NCT04121897|75987588|FG000|STARTED|Overall Study||68||
59863081|NCT04121897|75987588|FG000|Parents|Overall Study||32||
59863082|NCT04121897|75987588|FG000|Infants|Overall Study||36||
59863083|NCT04121897|75987588|FG000|COMPLETED|Overall Study||37||
59863084|NCT04121897|75987588|FG000|NOT COMPLETED|Overall Study||31||
59863085|NCT04120194|75987595|FG000|STARTED|Overall Study||1332||
59863086|NCT04120194|75987596|FG001|STARTED|Overall Study||1322||
59863087|NCT04120194|75987595|FG000|Safety Population|Overall Study||1333|The Safety Population was analyzed as actually treated (ie, based on the actual dose received).|
59863088|NCT04120194|75987596|FG001|Safety Population|Overall Study||1319|The Safety Population was analyzed as actually treated (ie, based on the actual dose received).|
59863089|NCT04120194|75987595|FG000|COMPLETED|Overall Study||1312||
59863090|NCT04120194|75987596|FG001|COMPLETED|Overall Study||1302||
59863091|NCT04120194|75987595|FG000|NOT COMPLETED|Overall Study||20||
59863092|NCT04120194|75987596|FG001|NOT COMPLETED|Overall Study||20||
59863093|NCT04050670|75987602|FG000|STARTED|Period 1||18||
59863094|NCT04050670|75987603|FG001|STARTED|Period 1||18||
59863095|NCT04050670|75987604|FG002|STARTED|Period 1||18||
59863096|NCT04050670|75987602|FG000|Received at Least One Dose of Study Drug|Period 1||18||
59863097|NCT04050670|75987603|FG001|Received at Least One Dose of Study Drug|Period 1||18||
59863098|NCT04050670|75987604|FG002|Received at Least One Dose of Study Drug|Period 1||18||
59863099|NCT04050670|75987602|FG000|COMPLETED|Period 1||18||
59863100|NCT04050670|75987603|FG001|COMPLETED|Period 1||18||
59863101|NCT04050670|75987604|FG002|COMPLETED|Period 1||18||
59863102|NCT04050670|75987602|FG000|NOT COMPLETED|Period 1||0||
59863103|NCT04050670|75987603|FG001|NOT COMPLETED|Period 1||0||
59863104|NCT04050670|75987604|FG002|NOT COMPLETED|Period 1||0||
59863105|NCT04050670|75987602|FG000|STARTED|Period 2||18||
59863106|NCT04050670|75987603|FG001|STARTED|Period 2||18||
59863107|NCT04050670|75987604|FG002|STARTED|Period 2||18||
59863108|NCT04050670|75987602|FG000|Received at Least One Dose|Period 2||18||
59863109|NCT04050670|75987603|FG001|Received at Least One Dose|Period 2||18||
59863110|NCT04050670|75987604|FG002|Received at Least One Dose|Period 2||18||
59863111|NCT04050670|75987602|FG000|COMPLETED|Period 2||18||
59863112|NCT04050670|75987603|FG001|COMPLETED|Period 2||18||
59863113|NCT04050670|75987604|FG002|COMPLETED|Period 2||18||
59863114|NCT04050670|75987602|FG000|NOT COMPLETED|Period 2||0||
59863115|NCT04050670|75987603|FG001|NOT COMPLETED|Period 2||0||
59863116|NCT04050670|75987604|FG002|NOT COMPLETED|Period 2||0||
59863117|NCT04050670|75987602|FG000|STARTED|Period 3||18||
59863118|NCT04050670|75987603|FG001|STARTED|Period 3||18||
59863119|NCT04050670|75987604|FG002|STARTED|Period 3||18||
60000385|NCT02593305|76116130|FG001|NOT COMPLETED|Post 1||0||
59863120|NCT04050670|75987602|FG000|Received at Least One Dose|Period 3||18||
59863121|NCT04050670|75987603|FG001|Received at Least One Dose|Period 3||17||
59863122|NCT04050670|75987604|FG002|Received at Least One Dose|Period 3||18||
59863123|NCT04050670|75987602|FG000|COMPLETED|Period 3||18||
59863124|NCT04050670|75987603|FG001|COMPLETED|Period 3||17||
59863125|NCT04050670|75987604|FG002|COMPLETED|Period 3||18||
59863126|NCT04050670|75987602|FG000|NOT COMPLETED|Period 3||0||
59863127|NCT04050670|75987603|FG001|NOT COMPLETED|Period 3||1||
59863128|NCT04050670|75987604|FG002|NOT COMPLETED|Period 3||0||
59863129|NCT04032106|75987615|FG000|STARTED|Overall Study||412||
59863130|NCT04032106|75987616|FG001|STARTED|Overall Study||407||
59863131|NCT04032106|75987617|FG002|STARTED|Overall Study||408||
59863132|NCT04032106|75987615|FG000|COMPLETED|Overall Study||295||
59863133|NCT04032106|75987616|FG001|COMPLETED|Overall Study||271||
59863134|NCT04032106|75987617|FG002|COMPLETED|Overall Study||276||
59863135|NCT04032106|75987615|FG000|NOT COMPLETED|Overall Study||117||
59863136|NCT04032106|75987616|FG001|NOT COMPLETED|Overall Study||136||
59863137|NCT04032106|75987617|FG002|NOT COMPLETED|Overall Study||132||
59863138|NCT04016714|75987627|FG000|STARTED|Overall Study||595||
59863139|NCT04016714|75987628|FG001|STARTED|Overall Study||596||
59863140|NCT04016714|75987627|FG000|Vaccination 1 (V114 or Prevenar 13™)|Overall Study||595||
59863141|NCT04016714|75987628|FG001|Vaccination 1 (V114 or Prevenar 13™)|Overall Study||596||
60000386|NCT02593305|76116131|FG002|NOT COMPLETED|Post 1||10||
59863142|NCT04016714|75987627|FG000|Vaccination 2 (V114 or Prevenar 13™)|Overall Study||585||
59863143|NCT04016714|75987628|FG001|Vaccination 2 (V114 or Prevenar 13™)|Overall Study||588||
59863144|NCT04016714|75987627|FG000|Vaccination 3 (V114 or Prevenar 13™)|Overall Study||573||
59863145|NCT04016714|75987628|FG001|Vaccination 3 (V114 or Prevenar 13™)|Overall Study||581||
59863146|NCT04016714|75987627|FG000|COMPLETED|Overall Study||572||
59863147|NCT04016714|75987628|FG001|COMPLETED|Overall Study||580||
59863148|NCT04016714|75987627|FG000|NOT COMPLETED|Overall Study||23||
59863149|NCT04016714|75987628|FG001|NOT COMPLETED|Overall Study||16||
59863150|NCT03997409|75987637|FG000|STARTED|Overall Study||14||
59863151|NCT03997409|75987638|FG001|STARTED|Overall Study||13||
59863152|NCT03997409|75987639|FG002|STARTED|Overall Study||12||
59863153|NCT03997409|75987637|FG000|COMPLETED|Overall Study||10||
59863154|NCT03997409|75987638|FG001|COMPLETED|Overall Study||12||
59863155|NCT03997409|75987639|FG002|COMPLETED|Overall Study||11||
59863156|NCT03997409|75987637|FG000|NOT COMPLETED|Overall Study||4||
59863157|NCT03997409|75987638|FG001|NOT COMPLETED|Overall Study||1||
59863158|NCT03997409|75987639|FG002|NOT COMPLETED|Overall Study||1||
59863159|NCT03946124|75987647|FG000|STARTED|Overall Study||74||
59863160|NCT03946124|75987647|FG000|COMPLETED|Overall Study||55||
59863161|NCT03946124|75987647|FG000|NOT COMPLETED|Overall Study||19||
59863162|NCT03812029|75987656|FG000|STARTED|Overall Study||7||
59863163|NCT03812029|75987657|FG001|STARTED|Overall Study||17||
59863164|NCT03812029|75987658|FG002|STARTED|Overall Study||32||
59863165|NCT03812029|75987659|FG003|STARTED|Overall Study||31||
59863166|NCT03812029|75987660|FG004|STARTED|Overall Study||33||
59863167|NCT03812029|75987656|FG000|COMPLETED|Overall Study||5||
59863168|NCT03812029|75987657|FG001|COMPLETED|Overall Study||7||
59863169|NCT03812029|75987658|FG002|COMPLETED|Overall Study||32||
59863170|NCT03812029|75987659|FG003|COMPLETED|Overall Study||25||
59863171|NCT03812029|75987660|FG004|COMPLETED|Overall Study||23||
59863172|NCT03812029|75987656|FG000|NOT COMPLETED|Overall Study||2||
59863173|NCT03812029|75987657|FG001|NOT COMPLETED|Overall Study||10||
59863174|NCT03812029|75987658|FG002|NOT COMPLETED|Overall Study||0||
59863175|NCT03812029|75987659|FG003|NOT COMPLETED|Overall Study||6||
59863176|NCT03812029|75987660|FG004|NOT COMPLETED|Overall Study||10||
59863177|NCT03747575|75987678|FG000|STARTED|Overall Study||32||
59863178|NCT03747575|75987679|FG001|STARTED|Overall Study||33||
59863179|NCT03747575|75987678|FG000|COMPLETED|Overall Study||23||
59863180|NCT03747575|75987679|FG001|COMPLETED|Overall Study||26||
59863181|NCT03747575|75987678|FG000|NOT COMPLETED|Overall Study||9||
59863182|NCT03747575|75987679|FG001|NOT COMPLETED|Overall Study||7||
59863183|NCT03657043|75987688|FG000|STARTED|Overall Study||8||
59863184|NCT03657043|75987689|FG001|STARTED|Overall Study||8||
59863185|NCT03657043|75987690|FG002|STARTED|Overall Study||0||
59863186|NCT03657043|75987691|FG003|STARTED|Overall Study||0||
59863187|NCT03657043|75987692|FG004|STARTED|Overall Study||82||
59863188|NCT03657043|75987688|FG000|COMPLETED|Overall Study||0||
59863189|NCT03657043|75987689|FG001|COMPLETED|Overall Study||0||
59863190|NCT03657043|75987690|FG002|COMPLETED|Overall Study||0||
59863191|NCT03657043|75987691|FG003|COMPLETED|Overall Study||0||
59863192|NCT03657043|75987692|FG004|COMPLETED|Overall Study||0||
59863193|NCT03657043|75987688|FG000|NOT COMPLETED|Overall Study||8||
59863194|NCT03657043|75987689|FG001|NOT COMPLETED|Overall Study||8||
59863195|NCT03657043|75987690|FG002|NOT COMPLETED|Overall Study||0||
59863196|NCT03657043|75987691|FG003|NOT COMPLETED|Overall Study||0||
59863197|NCT03657043|75987692|FG004|NOT COMPLETED|Overall Study||82||
59863198|NCT03646669|75987702|FG000|STARTED|Overall Study||33||
59863199|NCT03646669|75987703|FG001|STARTED|Overall Study||25||
59863200|NCT03646669|75987702|FG000|COMPLETED|Overall Study||28||
59863201|NCT03646669|75987703|FG001|COMPLETED|Overall Study||25||
59863202|NCT03646669|75987702|FG000|NOT COMPLETED|Overall Study||5||
59863203|NCT03646669|75987703|FG001|NOT COMPLETED|Overall Study||0||
59863204|NCT03619876|75987711|FG000|STARTED|Overall Study||4||
59863205|NCT03619876|75987712|FG001|STARTED|Overall Study||6||
59863206|NCT03619876|75987711|FG000|COMPLETED|Overall Study||3||
59863207|NCT03619876|75987712|FG001|COMPLETED|Overall Study||2||
59863208|NCT03619876|75987711|FG000|NOT COMPLETED|Overall Study||1||
59863209|NCT03619876|75987712|FG001|NOT COMPLETED|Overall Study||4||
59863210|NCT03578081|75987720|FG000|STARTED|Overall Study||346||
59863211|NCT03578081|75987721|FG001|STARTED|Overall Study||344||
59863212|NCT03578081|75987720|FG000|COMPLETED|Overall Study||326||
59863213|NCT03578081|75987721|FG001|COMPLETED|Overall Study||320||
59863214|NCT03578081|75987720|FG000|NOT COMPLETED|Overall Study||20||
59863215|NCT03578081|75987721|FG001|NOT COMPLETED|Overall Study||24||
60000387|NCT02593305|76116129|FG000|STARTED|Baseline 2||7||
59863216|NCT03526861|75987734|FG000|STARTED|Initial Treatment Period||101||
59863217|NCT03526861|75987735|FG001|STARTED|Initial Treatment Period||100||
59863218|NCT03526861|75987736|FG002|STARTED|Initial Treatment Period||100||
59863219|NCT03526861|75987737|FG003|STARTED|Initial Treatment Period||0||
59863220|NCT03526861|75987738|FG004|STARTED|Initial Treatment Period||0||
59863221|NCT03526861|75987739|FG005|STARTED|Initial Treatment Period||0||
59863222|NCT03526861|75987740|FG006|STARTED|Initial Treatment Period||0||
59863223|NCT03526861|75987741|FG007|STARTED|Initial Treatment Period||0||
59863224|NCT03526861|75987742|FG008|STARTED|Initial Treatment Period||0||
59863225|NCT03526861|75987734|FG000|COMPLETED|Initial Treatment Period||94||
60000388|NCT02593305|76116130|FG001|STARTED|Baseline 2||6||
59863226|NCT03526861|75987735|FG001|COMPLETED|Initial Treatment Period||93||
59863227|NCT03526861|75987736|FG002|COMPLETED|Initial Treatment Period||86||
59863228|NCT03526861|75987737|FG003|COMPLETED|Initial Treatment Period||0||
59863229|NCT03526861|75987738|FG004|COMPLETED|Initial Treatment Period||0||
60000389|NCT02593305|76116131|FG002|STARTED|Baseline 2||0||
59863230|NCT03526861|75987739|FG005|COMPLETED|Initial Treatment Period||0||
59863231|NCT03526861|75987740|FG006|COMPLETED|Initial Treatment Period||0||
59863232|NCT03526861|75987741|FG007|COMPLETED|Initial Treatment Period||0||
59863233|NCT03526861|75987742|FG008|COMPLETED|Initial Treatment Period||0||
59863234|NCT03526861|75987734|FG000|NOT COMPLETED|Initial Treatment Period||7||
59863235|NCT03526861|75987735|FG001|NOT COMPLETED|Initial Treatment Period||7||
59863236|NCT03526861|75987736|FG002|NOT COMPLETED|Initial Treatment Period||14||
59863237|NCT03526861|75987737|FG003|NOT COMPLETED|Initial Treatment Period||0||
59863238|NCT03526861|75987738|FG004|NOT COMPLETED|Initial Treatment Period||0||
59863239|NCT03526861|75987739|FG005|NOT COMPLETED|Initial Treatment Period||0||
59863240|NCT03526861|75987740|FG006|NOT COMPLETED|Initial Treatment Period||0||
59863241|NCT03526861|75987741|FG007|NOT COMPLETED|Initial Treatment Period||0||
59863242|NCT03526861|75987742|FG008|NOT COMPLETED|Initial Treatment Period||0||
59863243|NCT03526861|75987734|FG000|STARTED|Maintenance Treatment Period||0|Maintenance treatment period was in parallel to the open-label treatment period.|
59863244|NCT03526861|75987735|FG001|STARTED|Maintenance Treatment Period||0|Maintenance treatment period was in parallel to the open-label treatment period.|
59863245|NCT03526861|75987736|FG002|STARTED|Maintenance Treatment Period||0|Maintenance treatment period was in parallel to the open-label treatment period.|
59863246|NCT03526861|75987737|FG003|STARTED|Maintenance Treatment Period||13|Maintenance treatment period was in parallel to the open-label treatment period.|
59863247|NCT03526861|75987738|FG004|STARTED|Maintenance Treatment Period||14|Maintenance treatment period was in parallel to the open-label treatment period.|
59863248|NCT03526861|75987739|FG005|STARTED|Maintenance Treatment Period||12|Maintenance treatment period was in parallel to the open-label treatment period.|
59863249|NCT03526861|75987740|FG006|STARTED|Maintenance Treatment Period||14|Maintenance treatment period was in parallel to the open-label treatment period.|
59863250|NCT03526861|75987741|FG007|STARTED|Maintenance Treatment Period||6|Maintenance treatment period was in parallel to the open-label treatment period.|
59863251|NCT03526861|75987742|FG008|STARTED|Maintenance Treatment Period||0|Maintenance treatment period was in parallel to the open-label treatment period.|
59863252|NCT03526861|75987734|FG000|COMPLETED|Maintenance Treatment Period||0||
59863253|NCT03526861|75987735|FG001|COMPLETED|Maintenance Treatment Period||0||
59863254|NCT03526861|75987736|FG002|COMPLETED|Maintenance Treatment Period||0||
59863255|NCT03526861|75987737|FG003|COMPLETED|Maintenance Treatment Period||5||
59863256|NCT03526861|75987738|FG004|COMPLETED|Maintenance Treatment Period||8||
59863257|NCT03526861|75987739|FG005|COMPLETED|Maintenance Treatment Period||8||
59863258|NCT03526861|75987740|FG006|COMPLETED|Maintenance Treatment Period||8||
59863259|NCT03526861|75987741|FG007|COMPLETED|Maintenance Treatment Period||4||
59863260|NCT03526861|75987742|FG008|COMPLETED|Maintenance Treatment Period||0||
59863261|NCT03526861|75987734|FG000|NOT COMPLETED|Maintenance Treatment Period||0||
59863262|NCT03526861|75987735|FG001|NOT COMPLETED|Maintenance Treatment Period||0||
59863263|NCT03526861|75987736|FG002|NOT COMPLETED|Maintenance Treatment Period||0||
59863264|NCT03526861|75987737|FG003|NOT COMPLETED|Maintenance Treatment Period||8||
59863265|NCT03526861|75987738|FG004|NOT COMPLETED|Maintenance Treatment Period||6||
59863266|NCT03526861|75987739|FG005|NOT COMPLETED|Maintenance Treatment Period||4||
59863267|NCT03526861|75987740|FG006|NOT COMPLETED|Maintenance Treatment Period||6||
59863268|NCT03526861|75987741|FG007|NOT COMPLETED|Maintenance Treatment Period||2||
59863269|NCT03526861|75987742|FG008|NOT COMPLETED|Maintenance Treatment Period||0||
59863270|NCT03526861|75987734|FG000|STARTED|Open-label Treatment Period||0|Open-label treatment period was in parallel to the maintenance treatment period.|
59863271|NCT03526861|75987735|FG001|STARTED|Open-label Treatment Period||0|Open-label treatment period was in parallel to the maintenance treatment period.|
59863272|NCT03526861|75987736|FG002|STARTED|Open-label Treatment Period||0|Open-label treatment period was in parallel to the maintenance treatment period.|
59863273|NCT03526861|75987737|FG003|STARTED|Open-label Treatment Period||0|Open-label treatment period was in parallel to the maintenance treatment period.|
59863274|NCT03526861|75987738|FG004|STARTED|Open-label Treatment Period||0|Open-label treatment period was in parallel to the maintenance treatment period.|
59863275|NCT03526861|75987739|FG005|STARTED|Open-label Treatment Period||0|Open-label treatment period was in parallel to the maintenance treatment period.|
59863276|NCT03526861|75987740|FG006|STARTED|Open-label Treatment Period||0|Open-label treatment period was in parallel to the maintenance treatment period.|
59863277|NCT03526861|75987741|FG007|STARTED|Open-label Treatment Period||0|Open-label treatment period was in parallel to the maintenance treatment period.|
60000390|NCT02593305|76116129|FG000|COMPLETED|Baseline 2||7||
60000391|NCT02593305|76116130|FG001|COMPLETED|Baseline 2||6||
59600625|NCT00368654|75710395|FG002|NOT COMPLETED|Overall Study||3||
59600626|NCT00368654|75710396|FG003|NOT COMPLETED|Overall Study||3||
59600627|NCT03888469|75710408|FG000|STARTED|First Wear Period (8 -1/+2 Days)||46||
59600628|NCT03888469|75710409|FG001|STARTED|First Wear Period (8 -1/+2 Days)||46||
59600629|NCT03888469|75710408|FG000|COMPLETED|First Wear Period (8 -1/+2 Days)||46||
59600630|NCT03888469|75710409|FG001|COMPLETED|First Wear Period (8 -1/+2 Days)||46||
59600631|NCT03888469|75710408|FG000|NOT COMPLETED|First Wear Period (8 -1/+2 Days)||0||
59600632|NCT03888469|75710409|FG001|NOT COMPLETED|First Wear Period (8 -1/+2 Days)||0||
59600633|NCT03888469|75710408|FG000|STARTED|Second Wear Period (8 -1/+2 Days)||46||
59600634|NCT03888469|75710409|FG001|STARTED|Second Wear Period (8 -1/+2 Days)||46||
59600635|NCT03888469|75710408|FG000|COMPLETED|Second Wear Period (8 -1/+2 Days)||46||
59600636|NCT03888469|75710409|FG001|COMPLETED|Second Wear Period (8 -1/+2 Days)||46||
59863278|NCT03526861|75987742|FG008|STARTED|Open-label Treatment Period|226 subjects transferred to open-label treatment at Week 16. 24 subjects transferred to open-label treatment between Week 16 and Week 52.|242|Open-label treatment period was in parallel to the maintenance treatment period.|
59863279|NCT03526861|75987734|FG000|COMPLETED|Open-label Treatment Period||0||
59863280|NCT03526861|75987735|FG001|COMPLETED|Open-label Treatment Period||0||
59863281|NCT03526861|75987736|FG002|COMPLETED|Open-label Treatment Period||0||
59863282|NCT03526861|75987737|FG003|COMPLETED|Open-label Treatment Period||0||
59863283|NCT03526861|75987738|FG004|COMPLETED|Open-label Treatment Period||0||
59863284|NCT03526861|75987739|FG005|COMPLETED|Open-label Treatment Period||0||
59863285|NCT03526861|75987740|FG006|COMPLETED|Open-label Treatment Period||0||
59863286|NCT03526861|75987741|FG007|COMPLETED|Open-label Treatment Period||0||
59863287|NCT03526861|75987742|FG008|COMPLETED|Open-label Treatment Period||214||
59863288|NCT03526861|75987734|FG000|NOT COMPLETED|Open-label Treatment Period||0||
59863289|NCT03526861|75987735|FG001|NOT COMPLETED|Open-label Treatment Period||0||
59863290|NCT03526861|75987736|FG002|NOT COMPLETED|Open-label Treatment Period||0||
59863291|NCT03526861|75987737|FG003|NOT COMPLETED|Open-label Treatment Period||0||
59863292|NCT03526861|75987738|FG004|NOT COMPLETED|Open-label Treatment Period||0||
59863293|NCT03526861|75987739|FG005|NOT COMPLETED|Open-label Treatment Period||0||
59863294|NCT03526861|75987740|FG006|NOT COMPLETED|Open-label Treatment Period||0||
59863295|NCT03526861|75987741|FG007|NOT COMPLETED|Open-label Treatment Period||0||
59863296|NCT03526861|75987742|FG008|NOT COMPLETED|Open-label Treatment Period||28||
59863297|NCT03510884|75987766|FG000|STARTED|Double-blind Period (up to Week 24)||25|Randomized and treated participants.|
59863298|NCT03510884|75987767|FG001|STARTED|Double-blind Period (up to Week 24)||49|Randomized and treated participants.|
59863299|NCT03510884|75987768|FG002|STARTED|Double-blind Period (up to Week 24)||27|Randomized and treated participants.|
59863300|NCT03510884|75987769|FG003|STARTED|Double-blind Period (up to Week 24)||52|Randomized and treated participants.|
59863301|NCT03510884|75987766|FG000|COMPLETED|Double-blind Period (up to Week 24)||25||
59863302|NCT03510884|75987767|FG001|COMPLETED|Double-blind Period (up to Week 24)||45||
59863303|NCT03510884|75987768|FG002|COMPLETED|Double-blind Period (up to Week 24)||26||
59863304|NCT03510884|75987769|FG003|COMPLETED|Double-blind Period (up to Week 24)||49||
59863305|NCT03510884|75987766|FG000|NOT COMPLETED|Double-blind Period (up to Week 24)||0||
59863306|NCT03510884|75987767|FG001|NOT COMPLETED|Double-blind Period (up to Week 24)||4||
59863307|NCT03510884|75987768|FG002|NOT COMPLETED|Double-blind Period (up to Week 24)||1||
59863308|NCT03510884|75987769|FG003|NOT COMPLETED|Double-blind Period (up to Week 24)||3||
59863309|NCT03510884|75987766|FG000|STARTED|Open Label Period (up to Week 104)||25|Post completion of DB treatment period, only eligible participants entered OL treatment period.|
59863310|NCT03510884|75987767|FG001|STARTED|Open Label Period (up to Week 104)|Of the completed 45 participants of DB Alirocumab Q2W arm, 1 participant did not enter in OL period, and 2 participants discontinued DB period but entered in OL period|46|Post completion of DB treatment period, only eligible participants entered OL treatment period.|
59863311|NCT03510884|75987768|FG002|STARTED|Open Label Period (up to Week 104)|Of the completed 26 participants of DB period Placebo arm, 1 participant did not enter in OL period.|25|Post completion of DB treatment period, only eligible participants entered OL treatment period.|
59863312|NCT03510884|75987769|FG003|STARTED|Open Label Period (up to Week 104)||49|Post completion of DB treatment period, only eligible participants entered OL treatment period.|
59863313|NCT03510884|75987766|FG000|COMPLETED|Open Label Period (up to Week 104)||22||
59863314|NCT03510884|75987767|FG001|COMPLETED|Open Label Period (up to Week 104)||43||
59863315|NCT03510884|75987768|FG002|COMPLETED|Open Label Period (up to Week 104)||24||
59863316|NCT03510884|75987769|FG003|COMPLETED|Open Label Period (up to Week 104)||49||
59863317|NCT03510884|75987766|FG000|NOT COMPLETED|Open Label Period (up to Week 104)||3||
59863318|NCT03510884|75987767|FG001|NOT COMPLETED|Open Label Period (up to Week 104)||3||
59863319|NCT03510884|75987768|FG002|NOT COMPLETED|Open Label Period (up to Week 104)||1||
59863320|NCT03510884|75987769|FG003|NOT COMPLETED|Open Label Period (up to Week 104)||0||
59863321|NCT03491007|75987796|FG000|STARTED|Overall Study||3||
59863322|NCT03491007|75987797|FG001|STARTED|Overall Study||2||
59863323|NCT03491007|75987796|FG000|COMPLETED|Overall Study||0||
59863324|NCT03491007|75987797|FG001|COMPLETED|Overall Study||1||
59863325|NCT03491007|75987796|FG000|NOT COMPLETED|Overall Study||3||
59863326|NCT03491007|75987797|FG001|NOT COMPLETED|Overall Study||1||
59863327|NCT03488472|75987803|FG000|STARTED|Overall Study||1||
59863328|NCT03488472|75987803|FG000|COMPLETED|Overall Study||0||
59863329|NCT03488472|75987803|FG000|NOT COMPLETED|Overall Study||1||
59863330|NCT03456453|75987809|FG000|STARTED|Overall Study||30||
59863331|NCT03456453|75987810|FG001|STARTED|Overall Study||30||
59863332|NCT03456453|75987809|FG000|COMPLETED|Overall Study||27||
59863333|NCT03456453|75987810|FG001|COMPLETED|Overall Study||23||
59863334|NCT03456453|75987809|FG000|NOT COMPLETED|Overall Study||3||
59863335|NCT03456453|75987810|FG001|NOT COMPLETED|Overall Study||7||
59863336|NCT03455829|75987821|FG000|STARTED|Overall Study||7||
59863337|NCT03455829|75987822|FG001|STARTED|Overall Study||6||
59863338|NCT03455829|75987823|FG002|STARTED|Overall Study||4||
59863339|NCT03455829|75987824|FG003|STARTED|Overall Study||7||
59863340|NCT03455829|75987825|FG004|STARTED|Overall Study||6||
59863341|NCT03455829|75987821|FG000|COMPLETED|Overall Study||0||
59863342|NCT03455829|75987822|FG001|COMPLETED|Overall Study||0||
59863343|NCT03455829|75987823|FG002|COMPLETED|Overall Study||0||
60000392|NCT02593305|76116131|FG002|COMPLETED|Baseline 2||0||
59863344|NCT03455829|75987824|FG003|COMPLETED|Overall Study||0||
59863345|NCT03455829|75987825|FG004|COMPLETED|Overall Study||0||
59863346|NCT03455829|75987821|FG000|NOT COMPLETED|Overall Study||7||
59863347|NCT03455829|75987822|FG001|NOT COMPLETED|Overall Study||6||
59863348|NCT03455829|75987823|FG002|NOT COMPLETED|Overall Study||4||
59863349|NCT03455829|75987824|FG003|NOT COMPLETED|Overall Study||7||
59863350|NCT03455829|75987825|FG004|NOT COMPLETED|Overall Study||6||
59863351|NCT03441334|75987839|FG000|STARTED|Overall Study|Participant was enrolled in November 2018. Intervention started November 13 2018.|1||
59863352|NCT03441334|75987840|FG001|STARTED|Overall Study|no participant enrolled for the sham group|0||
59863353|NCT03441334|75987839|FG000|COMPLETED|Overall Study|Participant did not complete the protocol. The last treatment session was 11/26/2018|0||
59863354|NCT03441334|75987840|FG001|COMPLETED|Overall Study||0||
59998414|NCT03855137|76114072|FG000|Modified Intent-to-Treat (mITT) Population|DB Treatment Period (Day 1 to Week 12)||246|mITT population included all randomized participants who received at least 1 dose of study intervention, had an evaluable baseline period of eDiary data, and had at least 1 evaluable post-baseline 4-week period (Weeks 1 to 4, 5 to 8, and 9 to 12) of eDiary data during the double-blind treatment period.|
59998415|NCT03855137|76114073|FG001|Modified Intent-to-Treat (mITT) Population|DB Treatment Period (Day 1 to Week 12)||253|mITT population included all randomized participants who received at least 1 dose of study intervention, had an evaluable baseline period of eDiary data, and had at least 1 evaluable post-baseline 4-week period (Weeks 1 to 4, 5 to 8, and 9 to 12) of eDiary data during the double-blind treatment period.|
59998416|NCT03855137|76114074|FG002|Modified Intent-to-Treat (mITT) Population|DB Treatment Period (Day 1 to Week 12)||256|mITT population included all randomized participants who received at least 1 dose of study intervention, had an evaluable baseline period of eDiary data, and had at least 1 evaluable post-baseline 4-week period (Weeks 1 to 4, 5 to 8, and 9 to 12) of eDiary data during the double-blind treatment period.|
59998417|NCT03855137|76114072|FG000|Off-treatment Hypothetical Estimand Population|DB Treatment Period (Day 1 to Week 12)||249|Off-treatment hypothetical estimand population included all randomized participants who received ≥ 1 dose of study intervention, had an evaluable baseline period of eDiary data and had ≥ 1 evaluable postbaseline 4-week period (Weeks 1 to 4, 5 to 8, 9 to 12) of eDiary data during the study, regardless of whether on study treatment or off study treatment.|
59998418|NCT03855137|76114073|FG001|Off-treatment Hypothetical Estimand Population|DB Treatment Period (Day 1 to Week 12)||254|Off-treatment hypothetical estimand population included all randomized participants who received ≥ 1 dose of study intervention, had an evaluable baseline period of eDiary data and had ≥ 1 evaluable postbaseline 4-week period (Weeks 1 to 4, 5 to 8, 9 to 12) of eDiary data during the study, regardless of whether on study treatment or off study treatment.|
60000393|NCT02593305|76116129|FG000|NOT COMPLETED|Baseline 2||0||
59863355|NCT03441334|75987839|FG000|NOT COMPLETED|Overall Study||1||
59863356|NCT03441334|75987840|FG001|NOT COMPLETED|Overall Study||0||
59863357|NCT03436615|75987851|FG000|STARTED|Overall Study||47||
59863358|NCT03436615|75987852|FG001|STARTED|Overall Study||48||
59863359|NCT03436615|75987853|FG002|STARTED|Overall Study||47||
59863360|NCT03436615|75987854|FG003|STARTED|Overall Study||48||
59863361|NCT03436615|75987855|FG004|STARTED|Overall Study||66||
59863362|NCT03436615|75987851|FG000|COMPLETED|Overall Study||38||
59863363|NCT03436615|75987852|FG001|COMPLETED|Overall Study||40||
59863364|NCT03436615|75987853|FG002|COMPLETED|Overall Study||39||
59863365|NCT03436615|75987854|FG003|COMPLETED|Overall Study||43||
59863366|NCT03436615|75987855|FG004|COMPLETED|Overall Study||61||
59863367|NCT03436615|75987851|FG000|NOT COMPLETED|Overall Study||9||
59863368|NCT03436615|75987852|FG001|NOT COMPLETED|Overall Study||8||
59863369|NCT03436615|75987853|FG002|NOT COMPLETED|Overall Study||8||
59863370|NCT03436615|75987854|FG003|NOT COMPLETED|Overall Study||5||
59863371|NCT03436615|75987855|FG004|NOT COMPLETED|Overall Study||5||
59863372|NCT03429244|75987871|FG000|STARTED|Overall Study||16||
59863373|NCT03429244|75987872|FG001|STARTED|Overall Study||11||
59863374|NCT03429244|75987873|FG002|STARTED|Overall Study||9||
59863375|NCT03429244|75987871|FG000|COMPLETED|Overall Study||14||
59863376|NCT03429244|75987872|FG001|COMPLETED|Overall Study||10||
59863377|NCT03429244|75987873|FG002|COMPLETED|Overall Study||8||
59863378|NCT03429244|75987871|FG000|NOT COMPLETED|Overall Study||2||
59863379|NCT03429244|75987872|FG001|NOT COMPLETED|Overall Study||1||
59863380|NCT03429244|75987873|FG002|NOT COMPLETED|Overall Study||1||
59863381|NCT03392935|75987882|FG000|STARTED|Overall Study||37||46
59863382|NCT03392935|75987882|FG000|COMPLETED|Overall Study||35||44
59863383|NCT03392935|75987882|FG000|NOT COMPLETED|Overall Study||2||2
59863384|NCT03250117|75987886|FG000|STARTED|Requip IR [7-10 Days]||3||
59863385|NCT03250117|75987887|FG001|STARTED|Requip IR [7-10 Days]|Study terminated before cohort opened to enrollment|0||
59863386|NCT03250117|75987888|FG002|STARTED|Requip IR [7-10 Days]|Study terminated before cohort opened to enrollment|0||
59863387|NCT03250117|75987889|FG003|STARTED|Requip IR [7-10 Days]|Study terminated before cohort opened to enrollment|0||
59863388|NCT03250117|75987886|FG000|COMPLETED|Requip IR [7-10 Days]||3||
59863389|NCT03250117|75987887|FG001|COMPLETED|Requip IR [7-10 Days]||0||
59863390|NCT03250117|75987888|FG002|COMPLETED|Requip IR [7-10 Days]||0||
59863391|NCT03250117|75987889|FG003|COMPLETED|Requip IR [7-10 Days]||0||
59863392|NCT03250117|75987886|FG000|NOT COMPLETED|Requip IR [7-10 Days]||0||
59863393|NCT03250117|75987887|FG001|NOT COMPLETED|Requip IR [7-10 Days]||0||
59863394|NCT03250117|75987888|FG002|NOT COMPLETED|Requip IR [7-10 Days]||0||
59863395|NCT03250117|75987889|FG003|NOT COMPLETED|Requip IR [7-10 Days]||0||
59863396|NCT03250117|75987886|FG000|STARTED|Ropinirole Implant 12 Weeks||3||
59998419|NCT03855137|76114074|FG002|Off-treatment Hypothetical Estimand Population|DB Treatment Period (Day 1 to Week 12)||257|Off-treatment hypothetical estimand population included all randomized participants who received ≥ 1 dose of study intervention, had an evaluable baseline period of eDiary data and had ≥ 1 evaluable postbaseline 4-week period (Weeks 1 to 4, 5 to 8, 9 to 12) of eDiary data during the study, regardless of whether on study treatment or off study treatment.|
59998420|NCT03855137|76114072|FG000|COMPLETED|DB Treatment Period (Day 1 to Week 12)||230||
59998421|NCT03855137|76114073|FG001|COMPLETED|DB Treatment Period (Day 1 to Week 12)||231||
59998422|NCT03855137|76114074|FG002|COMPLETED|DB Treatment Period (Day 1 to Week 12)||233||
59998423|NCT03855137|76114072|FG000|NOT COMPLETED|DB Treatment Period (Day 1 to Week 12)||29||
59998424|NCT03855137|76114073|FG001|NOT COMPLETED|DB Treatment Period (Day 1 to Week 12)||26||
59998425|NCT03855137|76114074|FG002|NOT COMPLETED|DB Treatment Period (Day 1 to Week 12)||29||
59998426|NCT03855137|76114072|FG000|STARTED|FU Period (Week 12 to Week 16)||169|Out of 694 participants who completed the DB treatment period, only 517 participants continued the follow-up period.|
59998427|NCT03855137|76114073|FG001|STARTED|FU Period (Week 12 to Week 16)||179|Out of 694 participants who completed the DB treatment period, only 517 participants continued the follow-up period.|
59998428|NCT03855137|76114074|FG002|STARTED|FU Period (Week 12 to Week 16)||169|Out of 694 participants who completed the DB treatment period, only 517 participants continued the follow-up period.|
59998429|NCT03855137|76114072|FG000|COMPLETED|FU Period (Week 12 to Week 16)||161|Participants who completed the DB treatment period and rolled-over to other extension studies 3101-312-002 (NCT04686136), 3101-306-002 (NCT04437433),and 3101-311-002 (NCT04829747) were not required to enter the follow-up period.|
59998430|NCT03855137|76114073|FG001|COMPLETED|FU Period (Week 12 to Week 16)||170|Participants who completed the DB treatment period and rolled-over to other extension studies 3101-312-002 (NCT04686136), 3101-306-002 (NCT04437433),and 3101-311-002 (NCT04829747) were not required to enter the follow-up period.|
59998431|NCT03855137|76114074|FG002|COMPLETED|FU Period (Week 12 to Week 16)||165|Participants who completed the DB treatment period and rolled-over to other extension studies 3101-312-002 (NCT04686136), 3101-306-002 (NCT04437433),and 3101-311-002 (NCT04829747) were not required to enter the follow-up period.|
59998432|NCT03855137|76114072|FG000|NOT COMPLETED|FU Period (Week 12 to Week 16)||8||
59998433|NCT03855137|76114073|FG001|NOT COMPLETED|FU Period (Week 12 to Week 16)||9||
59998434|NCT03855137|76114074|FG002|NOT COMPLETED|FU Period (Week 12 to Week 16)||4||
59998435|NCT01530659|76114084|FG000|STARTED|Overall Study||22|22 total participants and 44 eyes|22
59998436|NCT01530659|76114085|FG001|STARTED|Overall Study||22|22 total participants and 44 eyes|22
59998437|NCT01530659|76114084|FG000|COMPLETED|Overall Study||22||22
59998438|NCT01530659|76114085|FG001|COMPLETED|Overall Study||22||22
59998439|NCT01530659|76114084|FG000|NOT COMPLETED|Overall Study||0||0
59998440|NCT01530659|76114085|FG001|NOT COMPLETED|Overall Study||0||0
59998441|NCT00701363|76114096|FG000|STARTED|Screening (Pre-assignment) Phase||128||
59998442|NCT00701363|76114097|FG001|STARTED|Screening (Pre-assignment) Phase||0||
59998443|NCT00701363|76114098|FG002|STARTED|Screening (Pre-assignment) Phase||0||
59998444|NCT00701363|76114099|FG003|STARTED|Screening (Pre-assignment) Phase||0||
59998445|NCT00701363|76114096|FG000|COMPLETED|Screening (Pre-assignment) Phase||124||
59998446|NCT00701363|76114097|FG001|COMPLETED|Screening (Pre-assignment) Phase||0||
59998447|NCT00701363|76114098|FG002|COMPLETED|Screening (Pre-assignment) Phase||0||
59998448|NCT00701363|76114099|FG003|COMPLETED|Screening (Pre-assignment) Phase||0||
59998449|NCT00701363|76114096|FG000|NOT COMPLETED|Screening (Pre-assignment) Phase||4||
59998450|NCT00701363|76114097|FG001|NOT COMPLETED|Screening (Pre-assignment) Phase||0||
59998451|NCT00701363|76114098|FG002|NOT COMPLETED|Screening (Pre-assignment) Phase||0||
59998452|NCT00701363|76114099|FG003|NOT COMPLETED|Screening (Pre-assignment) Phase||0||
59998453|NCT00701363|76114096|FG000|STARTED|Treatment Phase 1||124||
59998454|NCT00701363|76114097|FG001|STARTED|Treatment Phase 1||0||
59998455|NCT00701363|76114098|FG002|STARTED|Treatment Phase 1||0||
59998456|NCT00701363|76114099|FG003|STARTED|Treatment Phase 1||0||
59998457|NCT00701363|76114096|FG000|COMPLETED|Treatment Phase 1||109||
59998458|NCT00701363|76114097|FG001|COMPLETED|Treatment Phase 1||0||
59998459|NCT00701363|76114098|FG002|COMPLETED|Treatment Phase 1||0||
59998460|NCT00701363|76114099|FG003|COMPLETED|Treatment Phase 1||0||
59998461|NCT00701363|76114096|FG000|NOT COMPLETED|Treatment Phase 1||15||
59998462|NCT00701363|76114097|FG001|NOT COMPLETED|Treatment Phase 1||0||
59998463|NCT00701363|76114098|FG002|NOT COMPLETED|Treatment Phase 1||0||
59998464|NCT00701363|76114099|FG003|NOT COMPLETED|Treatment Phase 1||0||
59998465|NCT00701363|76114096|FG000|STARTED|Treatment Phase 2||0||
59998466|NCT00701363|76114097|FG001|STARTED|Treatment Phase 2||13||
59998467|NCT00701363|76114098|FG002|STARTED|Treatment Phase 2||70||
59998468|NCT00701363|76114099|FG003|STARTED|Treatment Phase 2||26||
59998469|NCT00701363|76114096|FG000|COMPLETED|Treatment Phase 2||0||
59998470|NCT00701363|76114097|FG001|COMPLETED|Treatment Phase 2||13||
59998471|NCT00701363|76114098|FG002|COMPLETED|Treatment Phase 2||68||
59998472|NCT00701363|76114099|FG003|COMPLETED|Treatment Phase 2||26||
59998473|NCT00701363|76114096|FG000|NOT COMPLETED|Treatment Phase 2||0||
59998474|NCT00701363|76114097|FG001|NOT COMPLETED|Treatment Phase 2||0||
59998475|NCT00701363|76114098|FG002|NOT COMPLETED|Treatment Phase 2||2||
59998476|NCT00701363|76114099|FG003|NOT COMPLETED|Treatment Phase 2||0||
59998477|NCT01670877|76114123|FG000|STARTED|Part I and Part 2||16||
59998478|NCT01670877|76114124|FG001|STARTED|Part I and Part 2||5||
59998479|NCT01670877|76114125|FG002|STARTED|Part I and Part 2||11||
59998480|NCT01670877|76114126|FG003|STARTED|Part I and Part 2||24||
59998481|NCT01670877|76114127|FG004|STARTED|Part I and Part 2||0||
59998482|NCT01670877|76114128|FG005|STARTED|Part I and Part 2||0||
59998483|NCT01670877|76114123|FG000|COMPLETED|Part I and Part 2||16||
59998484|NCT01670877|76114124|FG001|COMPLETED|Part I and Part 2||4||
59998485|NCT01670877|76114125|FG002|COMPLETED|Part I and Part 2||10||
59998486|NCT01670877|76114126|FG003|COMPLETED|Part I and Part 2||21||
59998487|NCT01670877|76114127|FG004|COMPLETED|Part I and Part 2||0||
59998488|NCT01670877|76114128|FG005|COMPLETED|Part I and Part 2||0||
59998489|NCT01670877|76114123|FG000|NOT COMPLETED|Part I and Part 2||0||
59998490|NCT01670877|76114124|FG001|NOT COMPLETED|Part I and Part 2||1||
59998491|NCT01670877|76114125|FG002|NOT COMPLETED|Part I and Part 2||1||
59998492|NCT01670877|76114126|FG003|NOT COMPLETED|Part I and Part 2||3||
59998493|NCT01670877|76114127|FG004|NOT COMPLETED|Part I and Part 2||0||
59998494|NCT01670877|76114128|FG005|NOT COMPLETED|Part I and Part 2||0||
59998495|NCT01670877|76114123|FG000|STARTED|Crossover||0||
59998496|NCT01670877|76114124|FG001|STARTED|Crossover||0||
59998497|NCT01670877|76114125|FG002|STARTED|Crossover||0||
59998498|NCT01670877|76114126|FG003|STARTED|Crossover||0||
59998499|NCT01670877|76114127|FG004|STARTED|Crossover||3||
59998500|NCT01670877|76114128|FG005|STARTED|Crossover||5||
59998501|NCT01670877|76114123|FG000|COMPLETED|Crossover||0||
59998502|NCT01670877|76114124|FG001|COMPLETED|Crossover||0||
59998503|NCT01670877|76114125|FG002|COMPLETED|Crossover||0||
59998504|NCT01670877|76114126|FG003|COMPLETED|Crossover||0||
59998505|NCT01670877|76114127|FG004|COMPLETED|Crossover||3||
59998506|NCT01670877|76114128|FG005|COMPLETED|Crossover||5||
59998507|NCT01670877|76114123|FG000|NOT COMPLETED|Crossover||0||
59998508|NCT01670877|76114124|FG001|NOT COMPLETED|Crossover||0||
59998509|NCT01670877|76114125|FG002|NOT COMPLETED|Crossover||0||
59998510|NCT01670877|76114126|FG003|NOT COMPLETED|Crossover||0||
59998511|NCT01670877|76114127|FG004|NOT COMPLETED|Crossover||0||
59998512|NCT01670877|76114128|FG005|NOT COMPLETED|Crossover||0||
59998513|NCT00701129|76114142|FG000|STARTED|Overall Study||4||
59998514|NCT00701129|76114142|FG000|Full Analysis Set (FAS)|Overall Study|All enrolled patients who signed informed consent, received at least 1 dose of alglucosidase alfa.|4||
59998515|NCT00701129|76114142|FG000|COMPLETED|Overall Study||2||
59998516|NCT00701129|76114142|FG000|NOT COMPLETED|Overall Study||2||
59998517|NCT01670721|76114146|FG000|STARTED|Overall Study||175||
59998518|NCT01670721|76114146|FG000|COMPLETED|Overall Study|81 participants with DP and 41 with adverse events were considered as completed.|122||
59998519|NCT01670721|76114146|FG000|NOT COMPLETED|Overall Study||53||
60131224|NCT00580671|76253762|FG000|STARTED|Overall Study||51||
60131225|NCT00580671|76253763|FG001|STARTED|Overall Study||51||
59863397|NCT03250117|75987887|FG001|STARTED|Ropinirole Implant 12 Weeks||0||
59863398|NCT03250117|75987888|FG002|STARTED|Ropinirole Implant 12 Weeks||0||
59863399|NCT03250117|75987889|FG003|STARTED|Ropinirole Implant 12 Weeks||0||
59863400|NCT03250117|75987886|FG000|COMPLETED|Ropinirole Implant 12 Weeks||2||
59863401|NCT03250117|75987887|FG001|COMPLETED|Ropinirole Implant 12 Weeks||0||
59863402|NCT03250117|75987888|FG002|COMPLETED|Ropinirole Implant 12 Weeks||0||
59863403|NCT03250117|75987889|FG003|COMPLETED|Ropinirole Implant 12 Weeks||0||
59863404|NCT03250117|75987886|FG000|NOT COMPLETED|Ropinirole Implant 12 Weeks||1||
59863405|NCT03250117|75987887|FG001|NOT COMPLETED|Ropinirole Implant 12 Weeks||0||
59863406|NCT03250117|75987888|FG002|NOT COMPLETED|Ropinirole Implant 12 Weeks||0||
59863407|NCT03250117|75987889|FG003|NOT COMPLETED|Ropinirole Implant 12 Weeks||0||
59863408|NCT03230838|75987895|FG000|STARTED|Overall Study||101||
59863409|NCT03230838|75987896|FG001|STARTED|Overall Study||33||
59863410|NCT03230838|75987895|FG000|Treated|Overall Study||100||
59998520|NCT02711137|76114165|FG000|STARTED|Overall Study||4||
59998521|NCT02711137|76114166|FG001|STARTED|Overall Study||5||
59998522|NCT02711137|76114167|FG002|STARTED|Overall Study||8||
59998523|NCT02711137|76114168|FG003|STARTED|Overall Study||7||
59998524|NCT02711137|76114169|FG004|STARTED|Overall Study||5||
59998525|NCT02711137|76114170|FG005|STARTED|Overall Study||1||
59998526|NCT02711137|76114171|FG006|STARTED|Overall Study||86||
59998527|NCT02711137|76114172|FG007|STARTED|Overall Study||5||
59998528|NCT02711137|76114173|FG008|STARTED|Overall Study||1||
59998529|NCT02711137|76114174|FG009|STARTED|Overall Study||2||
59998530|NCT02711137|76114175|FG010|STARTED|Overall Study||4||
59998531|NCT02711137|76114176|FG011|STARTED|Overall Study||3||
59998532|NCT02711137|76114177|FG012|STARTED|Overall Study||1||
59998533|NCT02711137|76114178|FG013|STARTED|Overall Study||2||
59998534|NCT02711137|76114179|FG014|STARTED|Overall Study||3||
59998535|NCT02711137|76114165|FG000|COMPLETED|Overall Study||0||
59998536|NCT02711137|76114166|FG001|COMPLETED|Overall Study||0||
59998537|NCT02711137|76114167|FG002|COMPLETED|Overall Study||0||
59998538|NCT02711137|76114168|FG003|COMPLETED|Overall Study||0||
59998539|NCT02711137|76114169|FG004|COMPLETED|Overall Study||0||
59998540|NCT02711137|76114170|FG005|COMPLETED|Overall Study||0||
59998541|NCT02711137|76114171|FG006|COMPLETED|Overall Study||0||
59998542|NCT02711137|76114172|FG007|COMPLETED|Overall Study||0||
59998543|NCT02711137|76114173|FG008|COMPLETED|Overall Study||0||
59998544|NCT02711137|76114174|FG009|COMPLETED|Overall Study||0||
59998545|NCT02711137|76114175|FG010|COMPLETED|Overall Study||0||
59998546|NCT02711137|76114176|FG011|COMPLETED|Overall Study||0||
59998547|NCT02711137|76114177|FG012|COMPLETED|Overall Study||0||
59998548|NCT02711137|76114178|FG013|COMPLETED|Overall Study||0||
59998549|NCT02711137|76114179|FG014|COMPLETED|Overall Study||0||
59998550|NCT02711137|76114165|FG000|NOT COMPLETED|Overall Study||4||
59998551|NCT02711137|76114166|FG001|NOT COMPLETED|Overall Study||5||
59998552|NCT02711137|76114167|FG002|NOT COMPLETED|Overall Study||8||
59998553|NCT02711137|76114168|FG003|NOT COMPLETED|Overall Study||7||
59998554|NCT02711137|76114169|FG004|NOT COMPLETED|Overall Study||5||
59998555|NCT02711137|76114170|FG005|NOT COMPLETED|Overall Study||1||
59998556|NCT02711137|76114171|FG006|NOT COMPLETED|Overall Study||86||
59998557|NCT02711137|76114172|FG007|NOT COMPLETED|Overall Study||5||
59998558|NCT02711137|76114173|FG008|NOT COMPLETED|Overall Study||1||
59998559|NCT02711137|76114174|FG009|NOT COMPLETED|Overall Study||2||
59998560|NCT02711137|76114175|FG010|NOT COMPLETED|Overall Study||4||
59998561|NCT02711137|76114176|FG011|NOT COMPLETED|Overall Study||3||
59998562|NCT02711137|76114177|FG012|NOT COMPLETED|Overall Study||1||
59998563|NCT02711137|76114178|FG013|NOT COMPLETED|Overall Study||2||
59998564|NCT02711137|76114179|FG014|NOT COMPLETED|Overall Study||3||
59998565|NCT02710045|76114219|FG000|STARTED|Overall Study||106||
59998566|NCT02710045|76114220|FG001|STARTED|Overall Study||115||
59998567|NCT02710045|76114221|FG002|STARTED|Overall Study||81||
59998568|NCT02710045|76114219|FG000|COMPLETED|Overall Study||95||
59998569|NCT02710045|76114220|FG001|COMPLETED|Overall Study||98||
59998570|NCT02710045|76114221|FG002|COMPLETED|Overall Study||68||
59998571|NCT02710045|76114219|FG000|NOT COMPLETED|Overall Study||11||
59998572|NCT02710045|76114220|FG001|NOT COMPLETED|Overall Study||17||
59998573|NCT02710045|76114221|FG002|NOT COMPLETED|Overall Study||13||
59998574|NCT02714153|76114229|FG000|STARTED|Overall Study||23||
59998575|NCT02714153|76114229|FG000|COMPLETED|Overall Study||22||
59998576|NCT02714153|76114229|FG000|NOT COMPLETED|Overall Study||1||
59998577|NCT04369469|76114235|FG000|STARTED|Overall Study||135||
59998578|NCT04369469|76114236|FG001|STARTED|Overall Study||67||
59998579|NCT04369469|76114235|FG000|Intent to Treat (ITT) Population|Overall Study||135|The ITT Population consisted of all randomized participants. Participants were analyzed as randomized.|
59998580|NCT04369469|76114236|FG001|Intent to Treat (ITT) Population|Overall Study||66|The ITT Population consisted of all randomized participants. Participants were analyzed as randomized.|
59998581|NCT04369469|76114235|FG000|Pharmacokinetic (PK)|Overall Study||127|The PK Set included participants in the ITT population with at least one postdose PK result.|
59998582|NCT04369469|76114236|FG001|Pharmacokinetic (PK)|Overall Study||52|The PK Set included participants in the ITT population with at least one postdose PK result.|
59998583|NCT04369469|76114235|FG000|Safety Population|Overall Study||127|All randomized participants who received at least 1 dose of study drug. Participants were analyzed as treated.|
59998584|NCT04369469|76114236|FG001|Safety Population|Overall Study||67|All randomized participants who received at least 1 dose of study drug. Participants were analyzed as treated.|
59998585|NCT04369469|76114235|FG000|COMPLETED|Overall Study||125||
59998586|NCT04369469|76114236|FG001|COMPLETED|Overall Study||58||
59998587|NCT04369469|76114235|FG000|NOT COMPLETED|Overall Study||10||
59998588|NCT04369469|76114236|FG001|NOT COMPLETED|Overall Study||9||
59998589|NCT03988205|76114242|FG000|STARTED|Overall Study||3||
59998590|NCT03988205|76114242|FG000|COMPLETED|Overall Study||3||
59998591|NCT03988205|76114242|FG000|NOT COMPLETED|Overall Study||0||
59998592|NCT03272711|76114248|FG000|STARTED|Overall Study||51||
59998593|NCT03272711|76114249|FG001|STARTED|Overall Study||49||
59998594|NCT03272711|76114248|FG000|COMPLETED|Overall Study||44||
59998595|NCT03272711|76114249|FG001|COMPLETED|Overall Study||41||
59998596|NCT03272711|76114248|FG000|NOT COMPLETED|Overall Study||7||
59998597|NCT03272711|76114249|FG001|NOT COMPLETED|Overall Study||8||
59998598|NCT04647383|76114259|FG000|STARTED|Treatment Period 1 (8 Days)||16||
59998599|NCT04647383|76114260|FG001|STARTED|Treatment Period 1 (8 Days)||17||
59998600|NCT04647383|76114261|FG002|STARTED|Treatment Period 1 (8 Days)||14||
59998601|NCT04647383|76114262|FG003|STARTED|Treatment Period 1 (8 Days)||16||
59998602|NCT04647383|76114259|FG000|COMPLETED|Treatment Period 1 (8 Days)||16||
59998603|NCT04647383|76114260|FG001|COMPLETED|Treatment Period 1 (8 Days)||17||
59998604|NCT04647383|76114261|FG002|COMPLETED|Treatment Period 1 (8 Days)||14||
59998605|NCT04647383|76114262|FG003|COMPLETED|Treatment Period 1 (8 Days)||16||
59998606|NCT04647383|76114259|FG000|NOT COMPLETED|Treatment Period 1 (8 Days)||0||
59998607|NCT04647383|76114260|FG001|NOT COMPLETED|Treatment Period 1 (8 Days)||0||
59998608|NCT04647383|76114261|FG002|NOT COMPLETED|Treatment Period 1 (8 Days)||0||
59998609|NCT04647383|76114262|FG003|NOT COMPLETED|Treatment Period 1 (8 Days)||0||
59998610|NCT04647383|76114259|FG000|STARTED|Washout Period (14 Days)||16||
59998611|NCT04647383|76114260|FG001|STARTED|Washout Period (14 Days)||17||
59998612|NCT04647383|76114261|FG002|STARTED|Washout Period (14 Days)||14||
59998613|NCT04647383|76114262|FG003|STARTED|Washout Period (14 Days)||16||
59998614|NCT04647383|76114259|FG000|COMPLETED|Washout Period (14 Days)||16||
59998615|NCT04647383|76114260|FG001|COMPLETED|Washout Period (14 Days)||17||
59998616|NCT04647383|76114261|FG002|COMPLETED|Washout Period (14 Days)||14||
59998617|NCT04647383|76114262|FG003|COMPLETED|Washout Period (14 Days)||16||
59998618|NCT04647383|76114259|FG000|NOT COMPLETED|Washout Period (14 Days)||0||
59998619|NCT04647383|76114260|FG001|NOT COMPLETED|Washout Period (14 Days)||0||
59998620|NCT04647383|76114261|FG002|NOT COMPLETED|Washout Period (14 Days)||0||
59998621|NCT04647383|76114262|FG003|NOT COMPLETED|Washout Period (14 Days)||0||
59998622|NCT04647383|76114259|FG000|STARTED|Treatment Period 2 (8 Days)||16||
59998623|NCT04647383|76114260|FG001|STARTED|Treatment Period 2 (8 Days)||17||
59998624|NCT04647383|76114261|FG002|STARTED|Treatment Period 2 (8 Days)||14||
59998625|NCT04647383|76114262|FG003|STARTED|Treatment Period 2 (8 Days)||16||
59998626|NCT04647383|76114259|FG000|COMPLETED|Treatment Period 2 (8 Days)||16||
59998627|NCT04647383|76114260|FG001|COMPLETED|Treatment Period 2 (8 Days)||16||
59998628|NCT04647383|76114261|FG002|COMPLETED|Treatment Period 2 (8 Days)||14||
59998629|NCT04647383|76114262|FG003|COMPLETED|Treatment Period 2 (8 Days)||16||
59998630|NCT04647383|76114259|FG000|NOT COMPLETED|Treatment Period 2 (8 Days)||0||
59998631|NCT04647383|76114260|FG001|NOT COMPLETED|Treatment Period 2 (8 Days)||1||
59998632|NCT04647383|76114261|FG002|NOT COMPLETED|Treatment Period 2 (8 Days)||0||
59998633|NCT04647383|76114262|FG003|NOT COMPLETED|Treatment Period 2 (8 Days)||0||
59998634|NCT01670097|76114274|FG000|STARTED|Overall Study||20||
59998635|NCT01670097|76114275|FG001|STARTED|Overall Study||21||
59998636|NCT01670097|76114274|FG000|Completed Week 1 Intervention|Overall Study||18||
59998637|NCT01670097|76114275|FG001|Completed Week 1 Intervention|Overall Study||17||
59998638|NCT01670097|76114274|FG000|Completed Week 2 Intervention|Overall Study||13||
59998639|NCT01670097|76114275|FG001|Completed Week 2 Intervention|Overall Study||15||
59730009|NCT01928394|75848580|FG014|COMPLETED|Follow-up Period||66|completed = continuing to be followed|
59730010|NCT01928394|75848581|FG015|COMPLETED|Follow-up Period||3|completed = continuing to be followed|
59730011|NCT01928394|75848582|FG016|COMPLETED|Follow-up Period||41|completed = continuing to be followed|
59730012|NCT01928394|75848583|FG017|COMPLETED|Follow-up Period||50|completed = continuing to be followed|
59998640|NCT01670097|76114274|FG000|COMPLETED|Overall Study||18||
59998641|NCT01670097|76114275|FG001|COMPLETED|Overall Study||17||
59998642|NCT01670097|76114274|FG000|NOT COMPLETED|Overall Study||2||
59998643|NCT01670097|76114275|FG001|NOT COMPLETED|Overall Study||4||
59998644|NCT01670019|76114283|FG000|STARTED|Overall Study||23||
59998645|NCT01670019|76114284|FG001|STARTED|Overall Study||23||
59998646|NCT01670019|76114283|FG000|COMPLETED|Overall Study||14||
59998647|NCT01670019|76114284|FG001|COMPLETED|Overall Study||23||
59998648|NCT01670019|76114283|FG000|NOT COMPLETED|Overall Study||9||
59998649|NCT01670019|76114284|FG001|NOT COMPLETED|Overall Study||0||
59998650|NCT01669629|76114290|FG000|STARTED|Period 1||92||
59998651|NCT01669629|76114291|FG001|STARTED|Period 1||91||
59998652|NCT01669629|76114290|FG000|COMPLETED|Period 1||91||
59998653|NCT01669629|76114291|FG001|COMPLETED|Period 1||89||
59998654|NCT01669629|76114290|FG000|NOT COMPLETED|Period 1||1||
59998655|NCT01669629|76114291|FG001|NOT COMPLETED|Period 1||2||
59998656|NCT01669629|76114290|FG000|STARTED|Period 2||91||
59998657|NCT01669629|76114291|FG001|STARTED|Period 2||89||
59998658|NCT01669629|76114290|FG000|COMPLETED|Period 2||91||
59998659|NCT01669629|76114291|FG001|COMPLETED|Period 2||89||
59998660|NCT01669629|76114290|FG000|NOT COMPLETED|Period 2||0||
59998661|NCT01669629|76114291|FG001|NOT COMPLETED|Period 2||0||
59998662|NCT00701051|76114299|FG000|STARTED|Screening|Arm assignment not known until baseline testing; both arms included in this number|90||
59998663|NCT00701051|76114300|FG001|STARTED|Screening||0||
59998664|NCT00701051|76114301|FG002|STARTED|Screening||0||
59998665|NCT00701051|76114299|FG000|COMPLETED|Screening|Arm assignment not known until baseline testing; both arms included in this number|31||
59998666|NCT00701051|76114300|FG001|COMPLETED|Screening||0||
59998667|NCT00701051|76114301|FG002|COMPLETED|Screening||0||
59998668|NCT00701051|76114299|FG000|NOT COMPLETED|Screening||59||
59998669|NCT00701051|76114300|FG001|NOT COMPLETED|Screening||0||
59998670|NCT00701051|76114301|FG002|NOT COMPLETED|Screening||0||
59998671|NCT00701051|76114299|FG000|STARTED|Exercise Intervention|Participants assigned to Normal or Impaired glucose tolerance arm after screening.|0||
59998672|NCT00701051|76114300|FG001|STARTED|Exercise Intervention|Participants assigned to group after Period 1: Screening|19||
59998673|NCT00701051|76114301|FG002|STARTED|Exercise Intervention|Participants assigned to group after Period 1: Screening|12||
59998674|NCT00701051|76114299|FG000|COMPLETED|Exercise Intervention||0||
59998675|NCT00701051|76114300|FG001|COMPLETED|Exercise Intervention||14||
59998676|NCT00701051|76114301|FG002|COMPLETED|Exercise Intervention||9||
59998677|NCT00701051|76114299|FG000|NOT COMPLETED|Exercise Intervention||0||
59998678|NCT00701051|76114300|FG001|NOT COMPLETED|Exercise Intervention||5||
59998679|NCT00701051|76114301|FG002|NOT COMPLETED|Exercise Intervention||3||
59998680|NCT00701051|76114299|FG000|STARTED|Detraining Intervention (Optional)||0||
59998681|NCT00701051|76114300|FG001|STARTED|Detraining Intervention (Optional)|Participation in this period was optional.|6||
59998682|NCT00701051|76114301|FG002|STARTED|Detraining Intervention (Optional)|Participation in this period was optional.|6||
59998683|NCT00701051|76114299|FG000|COMPLETED|Detraining Intervention (Optional)||0||
59998684|NCT00701051|76114300|FG001|COMPLETED|Detraining Intervention (Optional)||6||
59998685|NCT00701051|76114301|FG002|COMPLETED|Detraining Intervention (Optional)||6||
59998686|NCT00701051|76114299|FG000|NOT COMPLETED|Detraining Intervention (Optional)||0||
59998687|NCT00701051|76114300|FG001|NOT COMPLETED|Detraining Intervention (Optional)||0||
59998688|NCT00701051|76114301|FG002|NOT COMPLETED|Detraining Intervention (Optional)||0||
59998689|NCT00700817|76114312|FG000|STARTED|Week 0-26 (Main Period)|Randomised|225||
59998690|NCT00700817|76114313|FG001|STARTED|Week 0-26 (Main Period)|Randomised|221||
59998691|NCT00700817|76114314|FG002|STARTED|Week 0-26 (Main Period)|Randomised|219||
59998692|NCT00700817|76114315|FG003|STARTED|Week 0-26 (Main Period)||0||
59998693|NCT00700817|76114316|FG004|STARTED|Week 0-26 (Main Period)||0||
59998694|NCT00700817|76114312|FG000|Exposed|Week 0-26 (Main Period)|4 subjects withdrew before exposure to trial drug and were not included in Full Analysis Set (FAS)|221||
59998695|NCT00700817|76114313|FG001|Exposed|Week 0-26 (Main Period)|3 subjects withdrew before exposure to trial drug and were not included in Full Analysis Set (FAS)|218||
59998696|NCT00700817|76114314|FG002|Exposed|Week 0-26 (Main Period)||219||
59998697|NCT00700817|76114315|FG003|Exposed|Week 0-26 (Main Period)||0||
59998698|NCT00700817|76114316|FG004|Exposed|Week 0-26 (Main Period)||0||
59998699|NCT00700817|76114312|FG000|COMPLETED|Week 0-26 (Main Period)||169||
59998700|NCT00700817|76114313|FG001|COMPLETED|Week 0-26 (Main Period)||191||
59998701|NCT00700817|76114314|FG002|COMPLETED|Week 0-26 (Main Period)||194||
59998702|NCT00700817|76114315|FG003|COMPLETED|Week 0-26 (Main Period)||0||
59998703|NCT00700817|76114316|FG004|COMPLETED|Week 0-26 (Main Period)||0||
59998704|NCT00700817|76114312|FG000|NOT COMPLETED|Week 0-26 (Main Period)||56||
59998705|NCT00700817|76114313|FG001|NOT COMPLETED|Week 0-26 (Main Period)||30||
59998706|NCT00700817|76114314|FG002|NOT COMPLETED|Week 0-26 (Main Period)||25||
59998707|NCT00700817|76114315|FG003|NOT COMPLETED|Week 0-26 (Main Period)||0||
59998708|NCT00700817|76114316|FG004|NOT COMPLETED|Week 0-26 (Main Period)||0||
59998709|NCT00700817|76114312|FG000|STARTED|Week 26-52 (Extension Period 1)|Subjects withdrew before entry to extension period 1|155||
59998710|NCT00700817|76114313|FG001|STARTED|Week 26-52 (Extension Period 1)|Subjects withdrew before entry to extension period 1|176||
59998711|NCT00700817|76114314|FG002|STARTED|Week 26-52 (Extension Period 1)|Subjects withdrew before entry to extension period 1|166||
59998712|NCT00700817|76114315|FG003|STARTED|Week 26-52 (Extension Period 1)||0||
59998713|NCT00700817|76114316|FG004|STARTED|Week 26-52 (Extension Period 1)||0||
59998714|NCT00700817|76114312|FG000|COMPLETED|Week 26-52 (Extension Period 1)||135||
59998715|NCT00700817|76114313|FG001|COMPLETED|Week 26-52 (Extension Period 1)||150||
59998716|NCT00700817|76114314|FG002|COMPLETED|Week 26-52 (Extension Period 1)||151||
59998717|NCT00700817|76114315|FG003|COMPLETED|Week 26-52 (Extension Period 1)||0||
59998718|NCT00700817|76114316|FG004|COMPLETED|Week 26-52 (Extension Period 1)||0||
59998719|NCT00700817|76114312|FG000|NOT COMPLETED|Week 26-52 (Extension Period 1)||20||
59998720|NCT00700817|76114313|FG001|NOT COMPLETED|Week 26-52 (Extension Period 1)||26||
59998721|NCT00700817|76114314|FG002|NOT COMPLETED|Week 26-52 (Extension Period 1)||15||
59998722|NCT00700817|76114315|FG003|NOT COMPLETED|Week 26-52 (Extension Period 1)||0||
59998723|NCT00700817|76114316|FG004|NOT COMPLETED|Week 26-52 (Extension Period 1)||0||
59998724|NCT00700817|76114312|FG000|STARTED|Week 52-78 (Extension Period 2)|Subject withdrew before entry to extension period 2|134||
59998725|NCT00700817|76114313|FG001|STARTED|Week 52-78 (Extension Period 2)||150||
59998726|NCT00700817|76114314|FG002|STARTED|Week 52-78 (Extension Period 2)|Re-randomised to lira 1.2 or 1.8 mg|0||
59998727|NCT00700817|76114315|FG003|STARTED|Week 52-78 (Extension Period 2)|Re-randomised from sita treatment group. Some subjects withdrew before entry to extension period 2.|67||
59998728|NCT00700817|76114316|FG004|STARTED|Week 52-78 (Extension Period 2)|Re-randomised from sita treatment group. Some subjects withdrew before entry to extension period 2.|68||
59998729|NCT00700817|76114312|FG000|COMPLETED|Week 52-78 (Extension Period 2)||124||
59998730|NCT00700817|76114313|FG001|COMPLETED|Week 52-78 (Extension Period 2)||135||
59998731|NCT00700817|76114314|FG002|COMPLETED|Week 52-78 (Extension Period 2)||0||
59998732|NCT00700817|76114315|FG003|COMPLETED|Week 52-78 (Extension Period 2)||59||
59863411|NCT03230838|75987896|FG001|Treated|Overall Study||33||
59863412|NCT03230838|75987895|FG000|COMPLETED|Overall Study||97||
59863413|NCT03230838|75987896|FG001|COMPLETED|Overall Study||33||
59863414|NCT03230838|75987895|FG000|NOT COMPLETED|Overall Study||4||
59863415|NCT03230838|75987896|FG001|NOT COMPLETED|Overall Study||0||
59863416|NCT03217136|75987904|FG000|STARTED|Overall Study||71||
59863417|NCT03217136|75987905|FG001|STARTED|Overall Study||23||
59863418|NCT03217136|75987904|FG000|Treated|Overall Study||70||
59863419|NCT03217136|75987905|FG001|Treated|Overall Study||21||
59863420|NCT03217136|75987904|FG000|COMPLETED|Overall Study||67||
59863421|NCT03217136|75987905|FG001|COMPLETED|Overall Study||20||
59863422|NCT03217136|75987904|FG000|NOT COMPLETED|Overall Study||4||
59863423|NCT03217136|75987905|FG001|NOT COMPLETED|Overall Study||3||
59863424|NCT03179761|75987913|FG000|STARTED|Overall Study||60||
59863425|NCT03179761|75987914|FG001|STARTED|Overall Study||64||
59863426|NCT03179761|75987913|FG000|Visit 1|Overall Study||60|Study vaccine was administered.|
59863427|NCT03179761|75987914|FG001|Visit 1|Overall Study||64|Study vaccine was administered.|
59863428|NCT03179761|75987913|FG000|Visit 2|Overall Study||59|Study vaccine was administered.|
59863429|NCT03179761|75987914|FG001|Visit 2|Overall Study||59|Study vaccine was administered.|
59863430|NCT03179761|75987913|FG000|Visit 3|Overall Study||59||
59998733|NCT00700817|76114316|FG004|COMPLETED|Week 52-78 (Extension Period 2)||63||
59998734|NCT00700817|76114312|FG000|NOT COMPLETED|Week 52-78 (Extension Period 2)||10||
59998735|NCT00700817|76114313|FG001|NOT COMPLETED|Week 52-78 (Extension Period 2)||15||
59998736|NCT00700817|76114314|FG002|NOT COMPLETED|Week 52-78 (Extension Period 2)||0||
59998737|NCT00700817|76114315|FG003|NOT COMPLETED|Week 52-78 (Extension Period 2)||8||
59998738|NCT00700817|76114316|FG004|NOT COMPLETED|Week 52-78 (Extension Period 2)||5||
59863431|NCT03179761|75987914|FG001|Visit 3|Overall Study||59||
59863432|NCT03179761|75987913|FG000|Visit 4|Overall Study||54||
59863433|NCT03179761|75987914|FG001|Visit 4|Overall Study||51||
59863434|NCT03179761|75987913|FG000|Visit 1 Repeat|Overall Study||23|This visit was attended by subjects who enrolled for a second year following their first year of enrollment, and the study vaccine was administered. See protocol for criteria.|
59863435|NCT03179761|75987914|FG001|Visit 1 Repeat|Overall Study||20|This visit was attended by subjects who enrolled for a second year following their first year of enrollment, and the study vaccine was administered. See protocol for criteria.|
59863436|NCT03179761|75987913|FG000|Visit 2 Repeat|Overall Study||21|This visit was attended by subjects who enrolled for a second year following their first year of enrollment, and the study vaccine was administered. See protocol for criteria.|
59863437|NCT03179761|75987914|FG001|Visit 2 Repeat|Overall Study||20|This visit was attended by subjects who enrolled for a second year following their first year of enrollment, and the study vaccine was administered. See protocol for criteria.|
59863438|NCT03179761|75987913|FG000|Visit 3 Repeat|Overall Study||19|This visit was attended by subjects who enrolled for a second year following their first year of enrollment. See protocol for criteria.|
59863439|NCT03179761|75987914|FG001|Visit 3 Repeat|Overall Study||20|This visit was attended by subjects who enrolled for a second year following their first year of enrollment. See protocol for criteria.|
59863440|NCT03179761|75987913|FG000|Visit 4 Repeat|Overall Study||12|This visit was attended by subjects who enrolled for a second year following their first year of enrollment. See protocol for criteria.|
59863441|NCT03179761|75987914|FG001|Visit 4 Repeat|Overall Study||12|This visit was attended by subjects who enrolled for a second year following their first year of enrollment. See protocol for criteria.|
59863442|NCT03179761|75987913|FG000|COMPLETED|Overall Study||54|"This includes subjects who completed all four visits for their first year of enrollment. This does not account for those who participated in a repeater year."|
59863443|NCT03179761|75987914|FG001|COMPLETED|Overall Study||51|"This includes subjects who completed all four visits for their first year of enrollment. This does not account for those who participated in a repeater year."|
59863444|NCT03179761|75987913|FG000|NOT COMPLETED|Overall Study||6||
59863445|NCT03179761|75987914|FG001|NOT COMPLETED|Overall Study||13||
59863446|NCT03155841|75987922|FG000|STARTED|Overall Study||300||
59863447|NCT03155841|75987923|FG001|STARTED|Overall Study||300||
59863448|NCT03155841|75987922|FG000|COMPLETED|Overall Study||297||
59863449|NCT03155841|75987923|FG001|COMPLETED|Overall Study||296||
59863450|NCT03155841|75987922|FG000|NOT COMPLETED|Overall Study||3||
59863451|NCT03155841|75987923|FG001|NOT COMPLETED|Overall Study||4||
59863452|NCT03114891|75987933|FG000|STARTED|First Treatment Round||12||
59863453|NCT03114891|75987934|FG001|STARTED|First Treatment Round||14||
59863454|NCT03114891|75987935|FG002|STARTED|First Treatment Round||11||
59863455|NCT03114891|75987936|FG003|STARTED|First Treatment Round||13||
59863456|NCT03114891|75987933|FG000|COMPLETED|First Treatment Round||12||
59863457|NCT03114891|75987934|FG001|COMPLETED|First Treatment Round||11||
59863458|NCT03114891|75987935|FG002|COMPLETED|First Treatment Round||10||
59863459|NCT03114891|75987936|FG003|COMPLETED|First Treatment Round||12||
59863460|NCT03114891|75987933|FG000|NOT COMPLETED|First Treatment Round||0||
59863461|NCT03114891|75987934|FG001|NOT COMPLETED|First Treatment Round||3||
59863462|NCT03114891|75987935|FG002|NOT COMPLETED|First Treatment Round||1||
59863463|NCT03114891|75987936|FG003|NOT COMPLETED|First Treatment Round||1||
59863464|NCT03114891|75987933|FG000|STARTED|3 Week Break||12||
59863465|NCT03114891|75987934|FG001|STARTED|3 Week Break||11||
59863466|NCT03114891|75987935|FG002|STARTED|3 Week Break||10||
59998739|NCT02625909|76114328|FG000|STARTED|Overall Study||93||
59998740|NCT02625909|76114329|FG001|STARTED|Overall Study||95||
59998741|NCT02625909|76114328|FG000|COMPLETED|Overall Study||76||
59863467|NCT03114891|75987936|FG003|STARTED|3 Week Break||12||
59863468|NCT03114891|75987933|FG000|COMPLETED|3 Week Break||11||
59863469|NCT03114891|75987934|FG001|COMPLETED|3 Week Break||10||
59863470|NCT03114891|75987935|FG002|COMPLETED|3 Week Break||10||
59863471|NCT03114891|75987936|FG003|COMPLETED|3 Week Break||11||
59863472|NCT03114891|75987933|FG000|NOT COMPLETED|3 Week Break||1||
59863473|NCT03114891|75987934|FG001|NOT COMPLETED|3 Week Break||1||
59863474|NCT03114891|75987935|FG002|NOT COMPLETED|3 Week Break||0||
59863475|NCT03114891|75987936|FG003|NOT COMPLETED|3 Week Break||1||
59863476|NCT03114891|75987933|FG000|STARTED|Second Treatment Round||11||
59863477|NCT03114891|75987934|FG001|STARTED|Second Treatment Round||10||
59863478|NCT03114891|75987935|FG002|STARTED|Second Treatment Round||10||
59863479|NCT03114891|75987936|FG003|STARTED|Second Treatment Round||11||
59863480|NCT03114891|75987933|FG000|COMPLETED|Second Treatment Round||9||
59863481|NCT03114891|75987934|FG001|COMPLETED|Second Treatment Round||10||
59863482|NCT03114891|75987935|FG002|COMPLETED|Second Treatment Round||10||
59863483|NCT03114891|75987936|FG003|COMPLETED|Second Treatment Round||11||
59863484|NCT03114891|75987933|FG000|NOT COMPLETED|Second Treatment Round||2||
59863485|NCT03114891|75987934|FG001|NOT COMPLETED|Second Treatment Round||0||
59863486|NCT03114891|75987935|FG002|NOT COMPLETED|Second Treatment Round||0||
59863487|NCT03114891|75987936|FG003|NOT COMPLETED|Second Treatment Round||0||
59863488|NCT03087708|75987949|FG000|STARTED|Overall Study||17||
59863489|NCT03087708|75987950|FG001|STARTED|Overall Study||16||
59863490|NCT03087708|75987951|FG002|STARTED|Overall Study||17||
59863491|NCT03087708|75987949|FG000|COMPLETED|Overall Study||15||
59863492|NCT03087708|75987950|FG001|COMPLETED|Overall Study||15||
59863493|NCT03087708|75987951|FG002|COMPLETED|Overall Study||13||
59863494|NCT03087708|75987949|FG000|NOT COMPLETED|Overall Study||2||
59863495|NCT03087708|75987950|FG001|NOT COMPLETED|Overall Study||1||
59863496|NCT03087708|75987951|FG002|NOT COMPLETED|Overall Study||4||
59863497|NCT03058783|75987971|FG000|STARTED|Overall Study||216||
59998742|NCT02625909|76114329|FG001|COMPLETED|Overall Study||86||
59998743|NCT02625909|76114328|FG000|NOT COMPLETED|Overall Study||17||
59863498|NCT03058783|75987972|FG001|STARTED|Overall Study||110||
59863499|NCT03058783|75987971|FG000|COMPLETED|Overall Study||180||
59863500|NCT03058783|75987972|FG001|COMPLETED|Overall Study||80||
59863501|NCT03058783|75987971|FG000|NOT COMPLETED|Overall Study||36||
59863502|NCT03058783|75987972|FG001|NOT COMPLETED|Overall Study||30||
59863503|NCT03057847|75987978|FG000|STARTED|Overall Study||32||
59863504|NCT03057847|75987978|FG000|Treatment Initiation|Overall Study||21||
59863505|NCT03057847|75987978|FG000|COMPLETED|Overall Study||16||
59863506|NCT03057847|75987978|FG000|NOT COMPLETED|Overall Study||16||
59863507|NCT03002571|75987984|FG000|STARTED|Overall Study||224||
59863508|NCT03002571|75987985|FG001|STARTED|Overall Study||113||
59863509|NCT03002571|75987984|FG000|COMPLETED|Overall Study||202||
59863510|NCT03002571|75987985|FG001|COMPLETED|Overall Study||99||
59998744|NCT02625909|76114329|FG001|NOT COMPLETED|Overall Study||9||
59998745|NCT02623959|76114337|FG000|STARTED|Overall Study||0||
59998746|NCT02623959|76114338|FG001|STARTED|Overall Study||1||
59863511|NCT03002571|75987984|FG000|NOT COMPLETED|Overall Study||22||
59863512|NCT03002571|75987985|FG001|NOT COMPLETED|Overall Study||14||
59863513|NCT02946463|75987993|FG000|STARTED|Primary Evaluation Period||125||
59863514|NCT02946463|75987994|FG001|STARTED|Primary Evaluation Period||121||
59863515|NCT02946463|75987993|FG000|Received at Least 1 Dose of Study Drug|Primary Evaluation Period||125||
59863516|NCT02946463|75987994|FG001|Received at Least 1 Dose of Study Drug|Primary Evaluation Period||121||
59863517|NCT02946463|75987993|FG000|COMPLETED|Primary Evaluation Period||125||
59863518|NCT02946463|75987994|FG001|COMPLETED|Primary Evaluation Period||119||
59863519|NCT02946463|75987993|FG000|NOT COMPLETED|Primary Evaluation Period||0||
59863520|NCT02946463|75987994|FG001|NOT COMPLETED|Primary Evaluation Period||2||
59863521|NCT02946463|75987993|FG000|STARTED|Extension Period||124|1 participant did not enter the Extension Period.|
59863522|NCT02946463|75987994|FG001|STARTED|Extension Period||119|1 participant did not enter the Extension Period.|
59863523|NCT02946463|75987993|FG000|Received at Least 1 Dose of Ravulizumab|Extension Period||124||
59863524|NCT02946463|75987994|FG001|Received at Least 1 Dose of Ravulizumab|Extension Period||119||
59863525|NCT02946463|75987993|FG000|COMPLETED|Extension Period||0|The Extension Period is ongoing.|
59863526|NCT02946463|75987994|FG001|COMPLETED|Extension Period||0|The Extension Period is ongoing.|
59863527|NCT02946463|75987993|FG000|NOT COMPLETED|Extension Period||124||
59863528|NCT02946463|75987994|FG001|NOT COMPLETED|Extension Period||119||
59863529|NCT02907944|75988002|FG000|STARTED|Overall Study|These are patients assessed through electronic health records and the number can fluctuate at each stage. These patient 'started' total numbers come from the control period prior to stage 1.|3517|Control Stage|4
59863530|NCT02907944|75988003|FG001|STARTED|Overall Study|These are clinicians and staff assessed through surveys and the number can fluctuate at each period. These individuals 'started' totals comes from when they were assessed at the beginning of the first period in the study.|70|Control Stage|4
59863531|NCT02907944|75988002|FG000|Control Period|Overall Study|These are patients assessed through electronic health records and the number can fluctuate at each period.|4259||4
59863532|NCT02907944|75988003|FG001|Control Period|Overall Study|These are clinicians and staff assessed through surveys and the number can fluctuate at each stage.|69||4
59863533|NCT02907944|75988002|FG000|Intervention Period|Overall Study|These are patients assessed through electronic health records and the number can fluctuate at each period.|3780||4
59863534|NCT02907944|75988003|FG001|Intervention Period|Overall Study|These are clinicians and staff assessed through surveys and the number can fluctuate at each period.|59||4
59863535|NCT02907944|75988002|FG000|Evaluation Period|Overall Study|These are patients assessed through electronic health records and the number can fluctuate at each period.|3786||4
59863536|NCT02907944|75988003|FG001|Evaluation Period|Overall Study|These are clinicians and staff assessed through surveys and the number can fluctuate at each period. 1 site had an issue with provider follow up at this during this period.|58||3
59863537|NCT02907944|75988002|FG000|Maintenance Period|Overall Study|These are patients assessed through electronic health records and the number can fluctuate at each stage.|4036||4
59863538|NCT02907944|75988003|FG001|Maintenance Period|Overall Study|These are clinicians and staff assessed through surveys and the number can fluctuate at each period.|88||4
59863539|NCT02907944|75988002|FG000|COMPLETED|Overall Study|These are patients assessed through electronic health records and the number can fluctuate at each period.|3514||4
59863540|NCT02907944|75988003|FG001|COMPLETED|Overall Study|These are the clinicians and staff that were assessed through surveys during the final stage.|62||4
59863541|NCT02907944|75988002|FG000|NOT COMPLETED|Overall Study||3||0
59863542|NCT02907944|75988003|FG001|NOT COMPLETED|Overall Study||8||0
59863543|NCT02860039|75988025|FG000|STARTED|Overall Study||85||
59863544|NCT02860039|75988026|FG001|STARTED|Overall Study||85||
59863545|NCT02860039|75988025|FG000|Visit 1|Overall Study||85|Study vaccine administered.|
59863546|NCT02860039|75988026|FG001|Visit 1|Overall Study||85|Study vaccine administered.|
59863547|NCT02860039|75988025|FG000|Visit 2|Overall Study||84|Study vaccine administered.|
59863548|NCT02860039|75988026|FG001|Visit 2|Overall Study||83|Study vaccine administered.|
59863549|NCT02860039|75988025|FG000|Visit 3|Overall Study||78||
59863550|NCT02860039|75988026|FG001|Visit 3|Overall Study||83||
59863551|NCT02860039|75988025|FG000|Visit 4|Overall Study||74||
59863552|NCT02860039|75988026|FG001|Visit 4|Overall Study||81||
59863553|NCT02860039|75988025|FG000|Visit 1 Repeat|Overall Study||32|This visit was attended by subjects who enrolled for a second year following their first year of enrollment, and the study vaccine was administered. See protocol for criteria.|
59998747|NCT02623959|76114337|FG000|COMPLETED|Overall Study||0||
59998748|NCT02623959|76114338|FG001|COMPLETED|Overall Study|due to progression|0||
59863554|NCT02860039|75988026|FG001|Visit 1 Repeat|Overall Study||34|This visit was attended by subjects who enrolled for a second year following their first year of enrollment, and the study vaccine was administered. See protocol for criteria.|
59863555|NCT02860039|75988025|FG000|Visit 2 Repeat|Overall Study||31|This visit was attended by subjects who enrolled for a second year following their first year of enrollment, and the study vaccine was administered. See protocol for criteria.|
59863556|NCT02860039|75988026|FG001|Visit 2 Repeat|Overall Study||34|This visit was attended by subjects who enrolled for a second year following their first year of enrollment, and the study vaccine was administered. See protocol for criteria.|
59863557|NCT02860039|75988025|FG000|Visit 3 Repeat|Overall Study||30|This visit was attended by subjects who enrolled for a second year following their first year of enrollment. See protocol for criteria.|
59863558|NCT02860039|75988026|FG001|Visit 3 Repeat|Overall Study||34|This visit was attended by subjects who enrolled for a second year following their first year of enrollment. See protocol for criteria.|
59863559|NCT02860039|75988025|FG000|Visit 4 Repeat|Overall Study||26|This visit was attended by subjects who enrolled for a second year following their first year of enrollment. See protocol for criteria.|
59863560|NCT02860039|75988026|FG001|Visit 4 Repeat|Overall Study||22|This visit was attended by subjects who enrolled for a second year following their first year of enrollment. See protocol for criteria.|
59863561|NCT02860039|75988025|FG000|COMPLETED|Overall Study||74|"This includes subjects who completed all four visits for their first year of enrollment. This does not account for those who participated in a repeater year."|
59863562|NCT02860039|75988026|FG001|COMPLETED|Overall Study||81|"This includes subjects who completed all four visits for their first year of enrollment. This does not account for those who participated in a repeater year."|
59863563|NCT02860039|75988025|FG000|NOT COMPLETED|Overall Study||11||
59863564|NCT02860039|75988026|FG001|NOT COMPLETED|Overall Study||4||
59863565|NCT02800785|75988034|FG000|STARTED|Overall Study||776||
59863566|NCT02800785|75988035|FG001|STARTED|Overall Study||776||
59863567|NCT02800785|75988034|FG000|30 Day Follow up|Overall Study||702||
59863568|NCT02800785|75988035|FG001|30 Day Follow up|Overall Study||695||
59863569|NCT02800785|75988034|FG000|COMPLETED|Overall Study||676||
59863570|NCT02800785|75988035|FG001|COMPLETED|Overall Study||656||
59863571|NCT02800785|75988034|FG000|NOT COMPLETED|Overall Study||100||
59863572|NCT02800785|75988035|FG001|NOT COMPLETED|Overall Study||120||
59863573|NCT02761694|75988056|FG000|STARTED|Overall Study||4||
59863574|NCT02761694|75988057|FG001|STARTED|Overall Study||4||
59863575|NCT02761694|75988058|FG002|STARTED|Overall Study||1||
59863576|NCT02761694|75988059|FG003|STARTED|Overall Study||3||
59863577|NCT02761694|75988060|FG004|STARTED|Overall Study||3||
59863578|NCT02761694|75988061|FG005|STARTED|Overall Study||3||
59863579|NCT02761694|75988062|FG006|STARTED|Overall Study||33||
59863580|NCT02761694|75988063|FG007|STARTED|Overall Study||8||
59863581|NCT02761694|75988064|FG008|STARTED|Overall Study||5||
59863582|NCT02761694|75988065|FG009|STARTED|Overall Study||5||
59863583|NCT02761694|75988066|FG010|STARTED|Overall Study||3||
59863584|NCT02761694|75988067|FG011|STARTED|Overall Study||6||
59863585|NCT02761694|75988056|FG000|Treated|Overall Study||4||
59863586|NCT02761694|75988057|FG001|Treated|Overall Study||4||
59863587|NCT02761694|75988058|FG002|Treated|Overall Study||1||
59863588|NCT02761694|75988059|FG003|Treated|Overall Study||3||
59863589|NCT02761694|75988060|FG004|Treated|Overall Study||3||
59863590|NCT02761694|75988061|FG005|Treated|Overall Study||3||
59863591|NCT02761694|75988062|FG006|Treated|Overall Study||32||
59863592|NCT02761694|75988063|FG007|Treated|Overall Study||8||
59863593|NCT02761694|75988064|FG008|Treated|Overall Study||5||
59863594|NCT02761694|75988065|FG009|Treated|Overall Study||5||
59863595|NCT02761694|75988066|FG010|Treated|Overall Study||3||
59863596|NCT02761694|75988067|FG011|Treated|Overall Study||6||
59863597|NCT02761694|75988056|FG000|COMPLETED|Overall Study||0||
59863598|NCT02761694|75988057|FG001|COMPLETED|Overall Study||0||
59863599|NCT02761694|75988058|FG002|COMPLETED|Overall Study||0||
59863600|NCT02761694|75988059|FG003|COMPLETED|Overall Study||0||
59863601|NCT02761694|75988060|FG004|COMPLETED|Overall Study||0||
59863602|NCT02761694|75988061|FG005|COMPLETED|Overall Study||0||
59863603|NCT02761694|75988062|FG006|COMPLETED|Overall Study||0||
59863604|NCT02761694|75988063|FG007|COMPLETED|Overall Study||0||
59863605|NCT02761694|75988064|FG008|COMPLETED|Overall Study||0||
59863606|NCT02761694|75988065|FG009|COMPLETED|Overall Study||0||
59863607|NCT02761694|75988066|FG010|COMPLETED|Overall Study||0||
59863608|NCT02761694|75988067|FG011|COMPLETED|Overall Study||0||
59863609|NCT02761694|75988056|FG000|NOT COMPLETED|Overall Study||4||
59863610|NCT02761694|75988057|FG001|NOT COMPLETED|Overall Study||4||
59863611|NCT02761694|75988058|FG002|NOT COMPLETED|Overall Study||1||
59863612|NCT02761694|75988059|FG003|NOT COMPLETED|Overall Study||3||
59863613|NCT02761694|75988060|FG004|NOT COMPLETED|Overall Study||3||
59863614|NCT02761694|75988061|FG005|NOT COMPLETED|Overall Study||3||
59863615|NCT02761694|75988062|FG006|NOT COMPLETED|Overall Study||33||
59863616|NCT02761694|75988063|FG007|NOT COMPLETED|Overall Study||8||
59863617|NCT02761694|75988064|FG008|NOT COMPLETED|Overall Study||5||
59863618|NCT02761694|75988065|FG009|NOT COMPLETED|Overall Study||5||
59863619|NCT02761694|75988066|FG010|NOT COMPLETED|Overall Study||3||
59863620|NCT02761694|75988067|FG011|NOT COMPLETED|Overall Study||6||
59863621|NCT02641093|75988094|FG000|STARTED|Overall Study||96||
59863622|NCT02641093|75988094|FG000|COMPLETED|Overall Study||67||
59998749|NCT02623959|76114337|FG000|NOT COMPLETED|Overall Study||0||
59998750|NCT02623959|76114338|FG001|NOT COMPLETED|Overall Study||1||
59863623|NCT02641093|75988094|FG000|NOT COMPLETED|Overall Study||29||
59863624|NCT02614768|75988098|FG000|STARTED|Overall Study||12||
59863625|NCT02614768|75988098|FG000|COMPLETED|Overall Study||12||
59863626|NCT02614768|75988098|FG000|NOT COMPLETED|Overall Study||0||
59863627|NCT02578732|75988102|FG000|STARTED|Overall Study||28||
59863628|NCT02578732|75988102|FG000|COMPLETED|Overall Study||28||
59863629|NCT02578732|75988102|FG000|NOT COMPLETED|Overall Study||0||
59863630|NCT02574481|75988110|FG000|STARTED|Overall Study||309||
59863631|NCT02574481|75988111|FG001|STARTED|Overall Study||156||
59863632|NCT02574481|75988112|FG002|STARTED|Overall Study||50||
59863633|NCT02574481|75988113|FG003|STARTED|Overall Study||13||
59863634|NCT02574481|75988110|FG000|COMPLETED|Overall Study||195||
59863635|NCT02574481|75988111|FG001|COMPLETED|Overall Study||102||
59863636|NCT02574481|75988112|FG002|COMPLETED|Overall Study||25||
59863637|NCT02574481|75988113|FG003|COMPLETED|Overall Study||8||
59863638|NCT02574481|75988110|FG000|NOT COMPLETED|Overall Study||114||
59863639|NCT02574481|75988111|FG001|NOT COMPLETED|Overall Study||54||
59863640|NCT02574481|75988112|FG002|NOT COMPLETED|Overall Study||25||
59863641|NCT02574481|75988113|FG003|NOT COMPLETED|Overall Study||5||
59863642|NCT02438722|75988128|FG000|STARTED|Overall Study||83||
59863643|NCT02438722|75988129|FG001|STARTED|Overall Study||85||
59863644|NCT02438722|75988128|FG000|Participants Evaluable for Adverse Events|Overall Study||78||
59863645|NCT02438722|75988129|FG001|Participants Evaluable for Adverse Events|Overall Study||85||
59863646|NCT02438722|75988128|FG000|COMPLETED|Overall Study||0||
59863647|NCT02438722|75988129|FG001|COMPLETED|Overall Study||0||
59863648|NCT02438722|75988128|FG000|NOT COMPLETED|Overall Study||83||
59863649|NCT02438722|75988129|FG001|NOT COMPLETED|Overall Study||85||
59863650|NCT02385279|75988137|FG000|STARTED|Overall Study||703||
59863651|NCT02385279|75988138|FG001|STARTED|Overall Study||695||
59863652|NCT02385279|75988137|FG000|COMPLETED|Overall Study||676||
59863653|NCT02385279|75988138|FG001|COMPLETED|Overall Study||677||
59863654|NCT02385279|75988137|FG000|NOT COMPLETED|Overall Study||27||
59863655|NCT02385279|75988138|FG001|NOT COMPLETED|Overall Study||18||
59863656|NCT02376829|75988146|FG000|STARTED|Overall Study||81||
59863657|NCT02376829|75988147|FG001|STARTED|Overall Study||83||
59863658|NCT02376829|75988146|FG000|COMPLETED|Overall Study||54||
59863659|NCT02376829|75988147|FG001|COMPLETED|Overall Study||39||
59863660|NCT02376829|75988146|FG000|NOT COMPLETED|Overall Study||27||
59863661|NCT02376829|75988147|FG001|NOT COMPLETED|Overall Study||44||
59863662|NCT02297438|75988156|FG000|STARTED|Overall Study||169||
59863663|NCT02297438|75988157|FG001|STARTED|Overall Study||171||
59863664|NCT02297438|75988156|FG000|Received Treatment|Overall Study||168||
59863665|NCT02297438|75988157|FG001|Received Treatment|Overall Study||171||
59863666|NCT02297438|75988156|FG000|COMPLETED|Overall Study||0||
59863667|NCT02297438|75988157|FG001|COMPLETED|Overall Study||0||
59863668|NCT02297438|75988156|FG000|NOT COMPLETED|Overall Study||169||
59863669|NCT02297438|75988157|FG001|NOT COMPLETED|Overall Study||171||
59863670|NCT02297139|75988165|FG000|STARTED|Overall Study||1||
59863671|NCT02297139|75988166|FG001|STARTED|Overall Study||16||
59863672|NCT02297139|75988165|FG000|COMPLETED|Overall Study||0||
59863673|NCT02297139|75988166|FG001|COMPLETED|Overall Study||0||
59863674|NCT02297139|75988165|FG000|NOT COMPLETED|Overall Study||1||
59863675|NCT02297139|75988166|FG001|NOT COMPLETED|Overall Study||16||
59863676|NCT02137122|75988174|FG000|STARTED|Overall Study||15||
59863677|NCT02137122|75988175|FG001|STARTED|Overall Study||16||
59863678|NCT02137122|75988174|FG000|COMPLETED|Overall Study||15||
59863679|NCT02137122|75988175|FG001|COMPLETED|Overall Study||14||
59863680|NCT02137122|75988174|FG000|NOT COMPLETED|Overall Study||0||
59863681|NCT02137122|75988175|FG001|NOT COMPLETED|Overall Study||2||
59863682|NCT02100722|75988183|FG000|STARTED|Overall Study||757||
59863683|NCT02100722|75988184|FG001|STARTED|Overall Study||743||
59863684|NCT02100722|75988183|FG000|Underwent Alternate Procedure|Overall Study||11|Due to patient/physician refusal to undergo/perform procedure or an acute event leading to an alternative treatment|
59863685|NCT02100722|75988184|FG001|Underwent Alternate Procedure|Overall Study||37|Due to patient/physician refusal to undergo/perform procedure or an acute event leading to an alternative treatment|
59863686|NCT02100722|75988183|FG000|COMPLETED|Overall Study||0||
59863687|NCT02100722|75988184|FG001|COMPLETED|Overall Study||0||
59863688|NCT02100722|75988183|FG000|NOT COMPLETED|Overall Study||757||
59863689|NCT02100722|75988184|FG001|NOT COMPLETED|Overall Study||743||
59863690|NCT02090998|75988193|FG000|STARTED|Overall Study||2||
59863691|NCT02090998|75988194|FG001|STARTED|Overall Study||8||
59863692|NCT02090998|75988193|FG000|COMPLETED|Overall Study||2||
59863693|NCT02090998|75988194|FG001|COMPLETED|Overall Study||8||
59863694|NCT02090998|75988193|FG000|NOT COMPLETED|Overall Study||0||
59863695|NCT02090998|75988194|FG001|NOT COMPLETED|Overall Study||0||
59863696|NCT02028988|75988200|FG000|STARTED|Overall Study||64||
59863697|NCT02028988|75988200|FG000|Evaluable if Treatment Completed|Overall Study||62||
59863698|NCT02028988|75988200|FG000|COMPLETED|Overall Study||62||
59863699|NCT02028988|75988200|FG000|NOT COMPLETED|Overall Study||2||
59863700|NCT02004236|75988207|FG000|STARTED|Overall Study||75||
59863701|NCT02004236|75988208|FG001|STARTED|Overall Study||75||
59863702|NCT02004236|75988209|FG002|STARTED|Overall Study||75||
59863703|NCT02004236|75988207|FG000|COMPLETED|Overall Study||75||
59863704|NCT02004236|75988208|FG001|COMPLETED|Overall Study||75||
59863705|NCT02004236|75988209|FG002|COMPLETED|Overall Study|Leave the group because the parents does't find any clinical improvement.|59||
59863706|NCT02004236|75988207|FG000|NOT COMPLETED|Overall Study||0||
59863707|NCT02004236|75988208|FG001|NOT COMPLETED|Overall Study||0||
59863708|NCT02004236|75988209|FG002|NOT COMPLETED|Overall Study||16||
59863709|NCT01894672|75988218|FG000|STARTED|Overall Study||7||
59863710|NCT01894672|75988218|FG000|COMPLETED|Overall Study||7||
59863711|NCT01894672|75988218|FG000|NOT COMPLETED|Overall Study||0||
59863712|NCT01814813|75988226|FG000|STARTED|Overall Study||29||
59863713|NCT01814813|75988227|FG001|STARTED|Overall Study||30||
59863714|NCT01814813|75988228|FG002|STARTED|Overall Study||31||
59863715|NCT01814813|75988226|FG000|COMPLETED|Overall Study||29||
59863716|NCT01814813|75988227|FG001|COMPLETED|Overall Study||30||
59863717|NCT01814813|75988228|FG002|COMPLETED|Overall Study||31||
59863718|NCT01814813|75988226|FG000|NOT COMPLETED|Overall Study||0||
59863719|NCT01814813|75988227|FG001|NOT COMPLETED|Overall Study||0||
59863720|NCT01814813|75988228|FG002|NOT COMPLETED|Overall Study||0||
59863721|NCT01642251|75988239|FG000|STARTED|Overall Study||3||
59863722|NCT01642251|75988240|FG001|STARTED|Overall Study||6||
59863723|NCT01642251|75988241|FG002|STARTED|Overall Study||75||
59863724|NCT01642251|75988242|FG003|STARTED|Overall Study||72||
59863725|NCT01642251|75988239|FG000|Started Protocol Therapy|Overall Study||3||
59863726|NCT01642251|75988240|FG001|Started Protocol Therapy|Overall Study||6||
59863727|NCT01642251|75988241|FG002|Started Protocol Therapy|Overall Study||66||
59863728|NCT01642251|75988242|FG003|Started Protocol Therapy|Overall Study||66||
59863729|NCT01642251|75988239|FG000|Eligible|Overall Study||3||
59863730|NCT01642251|75988240|FG001|Eligible|Overall Study||6||
59863731|NCT01642251|75988241|FG002|Eligible|Overall Study||72||
59863732|NCT01642251|75988242|FG003|Eligible|Overall Study||69||
59863733|NCT01642251|75988239|FG000|Eligible and Treated|Overall Study||3||
59863734|NCT01642251|75988240|FG001|Eligible and Treated|Overall Study||6||
59863735|NCT01642251|75988241|FG002|Eligible and Treated|Overall Study||64||
59863736|NCT01642251|75988242|FG003|Eligible and Treated|Overall Study||64||
59863737|NCT01642251|75988239|FG000|COMPLETED|Overall Study||3||
59863738|NCT01642251|75988240|FG001|COMPLETED|Overall Study||6||
59863739|NCT01642251|75988241|FG002|COMPLETED|Overall Study||53||
59863740|NCT01642251|75988242|FG003|COMPLETED|Overall Study||49||
59863741|NCT01642251|75988239|FG000|NOT COMPLETED|Overall Study||0||
59863742|NCT01642251|75988240|FG001|NOT COMPLETED|Overall Study||0||
59863743|NCT01642251|75988241|FG002|NOT COMPLETED|Overall Study||22||
59863744|NCT01642251|75988242|FG003|NOT COMPLETED|Overall Study||23||
59863745|NCT01606137|75988251|FG000|STARTED|Overall Study||507||
59863746|NCT01606137|75988251|FG000|COMPLETED|Overall Study||245||
59863747|NCT01606137|75988251|FG000|NOT COMPLETED|Overall Study||262||
59863748|NCT01532518|75988258|FG000|STARTED|Overall Study||6||
59863749|NCT01532518|75988259|FG001|STARTED|Overall Study||15||
59863750|NCT01532518|75988260|FG002|STARTED|Overall Study||6||
59863751|NCT01532518|75988258|FG000|COMPLETED|Overall Study||6||
59863752|NCT01532518|75988259|FG001|COMPLETED|Overall Study||15||
59863753|NCT01532518|75988260|FG002|COMPLETED|Overall Study||5||
59863754|NCT01532518|75988258|FG000|NOT COMPLETED|Overall Study||0||
59863755|NCT01532518|75988259|FG001|NOT COMPLETED|Overall Study||0||
59863756|NCT01532518|75988260|FG002|NOT COMPLETED|Overall Study||1||
59863757|NCT01027000|75988281|FG000|STARTED|Overall Study||68||
59863758|NCT01027000|75988281|FG000|COMPLETED|Overall Study||68||
59863759|NCT01027000|75988281|FG000|NOT COMPLETED|Overall Study||0||
59863760|NCT00844285|75988288|FG000|STARTED|Overall Study||1131||
59863761|NCT00844285|75988289|FG001|STARTED|Overall Study||1666||
59863762|NCT00844285|75988290|FG002|STARTED|Overall Study||275||
59863763|NCT00844285|75988288|FG000|COMPLETED|Overall Study||42||
59863764|NCT00844285|75988289|FG001|COMPLETED|Overall Study||62||
59863765|NCT00844285|75988290|FG002|COMPLETED|Overall Study||3||
59863766|NCT00844285|75988288|FG000|NOT COMPLETED|Overall Study||1089||
59998751|NCT00700739|76114348|FG000|STARTED|Overall Study||22||
59998752|NCT00700739|76114349|FG001|STARTED|Overall Study||16||
59863767|NCT00844285|75988289|FG001|NOT COMPLETED|Overall Study||1604||
59863768|NCT00844285|75988290|FG002|NOT COMPLETED|Overall Study||272||
59863769|NCT00841789|75988309|FG000|STARTED|Overall Study||103||
59863770|NCT00841789|75988310|FG001|STARTED|Overall Study||102||
59863771|NCT00841789|75988309|FG000|COMPLETED|Overall Study||98||
59863772|NCT00841789|75988310|FG001|COMPLETED|Overall Study||99||
59863773|NCT00841789|75988309|FG000|NOT COMPLETED|Overall Study||5||
59863774|NCT00841789|75988310|FG001|NOT COMPLETED|Overall Study||3||
59863775|NCT00711646|75988318|FG000|STARTED|Overall Study||124||
59863776|NCT00711646|75988319|FG001|STARTED|Overall Study||65||
59863777|NCT00711646|75988318|FG000|COMPLETED|Overall Study||112||
59863778|NCT00711646|75988319|FG001|COMPLETED|Overall Study||62||
59863779|NCT00711646|75988318|FG000|NOT COMPLETED|Overall Study||12||
59863780|NCT00711646|75988319|FG001|NOT COMPLETED|Overall Study||3||
59863781|NCT00702468|75988327|FG000|STARTED|Overall Study||18||
59863782|NCT00702468|75988328|FG001|STARTED|Overall Study||18||
59863783|NCT00702468|75988327|FG000|COMPLETED|Overall Study||15||
59863784|NCT00702468|75988328|FG001|COMPLETED|Overall Study||2||
59863785|NCT00702468|75988327|FG000|NOT COMPLETED|Overall Study||3||
59863786|NCT00702468|75988328|FG001|NOT COMPLETED|Overall Study||16||
59863787|NCT00681538|75988336|FG000|STARTED|Phase A- 4 Weeks Single Blind||572||
59863788|NCT00681538|75988337|FG001|STARTED|Phase A- 4 Weeks Single Blind||0||
59863789|NCT00681538|75988336|FG000|COMPLETED|Phase A- 4 Weeks Single Blind||538||
59863790|NCT00681538|75988337|FG001|COMPLETED|Phase A- 4 Weeks Single Blind||0||
59863791|NCT00681538|75988336|FG000|NOT COMPLETED|Phase A- 4 Weeks Single Blind||34||
59863792|NCT00681538|75988337|FG001|NOT COMPLETED|Phase A- 4 Weeks Single Blind||0||
59863793|NCT00681538|75988336|FG000|STARTED|Phase B- Responders;12 Week Double-blind||124||
59863794|NCT00681538|75988337|FG001|STARTED|Phase B- Responders;12 Week Double-blind||117||
59863795|NCT00681538|75988336|FG000|COMPLETED|Phase B- Responders;12 Week Double-blind||109||
59863796|NCT00681538|75988337|FG001|COMPLETED|Phase B- Responders;12 Week Double-blind||115||
59863797|NCT00681538|75988336|FG000|NOT COMPLETED|Phase B- Responders;12 Week Double-blind||15||
59863798|NCT00681538|75988337|FG001|NOT COMPLETED|Phase B- Responders;12 Week Double-blind||2||
59863799|NCT00640133|75988345|FG000|STARTED|Randomization Phase (Baseline-Month 3)||15||
59863800|NCT00640133|75988346|FG001|STARTED|Randomization Phase (Baseline-Month 3)||12||
59863801|NCT00640133|75988345|FG000|COMPLETED|Randomization Phase (Baseline-Month 3)||15||
59863802|NCT00640133|75988346|FG001|COMPLETED|Randomization Phase (Baseline-Month 3)||12||
59863803|NCT00640133|75988345|FG000|NOT COMPLETED|Randomization Phase (Baseline-Month 3)||0||
59863804|NCT00640133|75988346|FG001|NOT COMPLETED|Randomization Phase (Baseline-Month 3)||0||
59863805|NCT00640133|75988345|FG000|STARTED|Open Label Phase (Month 4-12)||27||
59863806|NCT00640133|75988346|FG001|STARTED|Open Label Phase (Month 4-12)||0||
59863807|NCT00640133|75988345|FG000|COMPLETED|Open Label Phase (Month 4-12)||24||
59863808|NCT00640133|75988346|FG001|COMPLETED|Open Label Phase (Month 4-12)||0||
59863809|NCT00640133|75988345|FG000|NOT COMPLETED|Open Label Phase (Month 4-12)||3||
59863810|NCT00640133|75988346|FG001|NOT COMPLETED|Open Label Phase (Month 4-12)||0||
59863811|NCT00379340|75988359|FG000|STARTED|Overall Study||120||
59863812|NCT00379340|75988360|FG001|STARTED|Overall Study||135||
59863813|NCT00379340|75988361|FG002|STARTED|Overall Study||52||
59863814|NCT00379340|75988362|FG003|STARTED|Overall Study||50||
59863815|NCT00379340|75988363|FG004|STARTED|Overall Study||23||
59863816|NCT00379340|75988359|FG000|COMPLETED|Overall Study||107||
59863817|NCT00379340|75988360|FG001|COMPLETED|Overall Study||132||
59863818|NCT00379340|75988361|FG002|COMPLETED|Overall Study||50||
59863819|NCT00379340|75988362|FG003|COMPLETED|Overall Study||37||
59863820|NCT00379340|75988363|FG004|COMPLETED|Overall Study||9||
59863821|NCT00379340|75988359|FG000|NOT COMPLETED|Overall Study||13||
59863822|NCT00379340|75988360|FG001|NOT COMPLETED|Overall Study||3||
59863823|NCT00379340|75988361|FG002|NOT COMPLETED|Overall Study||2||
59863824|NCT00379340|75988362|FG003|NOT COMPLETED|Overall Study||13||
59863825|NCT00379340|75988363|FG004|NOT COMPLETED|Overall Study||14||
59863826|NCT00301808|75988376|FG000|STARTED|Overall Study||29||
59863827|NCT00301808|75988376|FG000|COMPLETED|Overall Study||17||
59863828|NCT00301808|75988376|FG000|NOT COMPLETED|Overall Study||12||
59863829|NCT05571267|75988383|FG000|STARTED|Overall Study||1||
59863830|NCT05571267|75988384|FG001|STARTED|Overall Study||0||
59863831|NCT05571267|75988385|FG002|STARTED|Overall Study||0||
59863832|NCT05571267|75988383|FG000|COMPLETED|Overall Study||1||
59863833|NCT05571267|75988384|FG001|COMPLETED|Overall Study||0||
59863834|NCT05571267|75988385|FG002|COMPLETED|Overall Study||0||
59863835|NCT05571267|75988383|FG000|NOT COMPLETED|Overall Study||0||
59863836|NCT05571267|75988384|FG001|NOT COMPLETED|Overall Study||0||
59863837|NCT05571267|75988385|FG002|NOT COMPLETED|Overall Study||0||
59863838|NCT05399290|75988395|FG000|STARTED|Overall Study||11||
59863839|NCT05399290|75988396|FG001|STARTED|Overall Study||11||
59863840|NCT05399290|75988395|FG000|COMPLETED|Overall Study||10||
59863841|NCT05399290|75988396|FG001|COMPLETED|Overall Study||10||
59863842|NCT05399290|75988395|FG000|NOT COMPLETED|Overall Study||1||
59863843|NCT05399290|75988396|FG001|NOT COMPLETED|Overall Study||1||
59863844|NCT04979858|75988404|FG000|STARTED|Pre-Treatment||201|"At the beginning of the study, 201 participants were enrolled. One of the participants was in quarantine at that time. Additionally, during Pre-Treatment, all participants were considered to be in the Control Group. After Pre-Treatment, the participants were randomly assigned to either remain in the Control Group or be assigned to the Treatment Group."|
59863845|NCT04979858|75988405|FG001|STARTED|Pre-Treatment||0|"At the beginning of the study, 201 participants were enrolled. One of the participants was in quarantine at that time. Additionally, during Pre-Treatment, all participants were considered to be in the Control Group. After Pre-Treatment, the participants were randomly assigned to either remain in the Control Group or be assigned to the Treatment Group."|
59863846|NCT04979858|75988404|FG000|COMPLETED|Pre-Treatment||200|The participant who had been quarantining developed contracted COVID-19 and withdrew from the Study in accordance with the Study Protocol. Hence the number at the end of the Pre-Treatment phase was 200.|
59863847|NCT04979858|75988405|FG001|COMPLETED|Pre-Treatment||0|The participant who had been quarantining developed contracted COVID-19 and withdrew from the Study in accordance with the Study Protocol. Hence the number at the end of the Pre-Treatment phase was 200.|
59863848|NCT04979858|75988404|FG000|NOT COMPLETED|Pre-Treatment||1||
59863849|NCT04979858|75988405|FG001|NOT COMPLETED|Pre-Treatment||0||
59863850|NCT04979858|75988404|FG000|STARTED|Treatment||100|The participant who contracted COVID-19 in the Pre-Treatment phase withdrew from the study in accordance with the Study Protocol.|
59863851|NCT04979858|75988405|FG001|STARTED|Treatment||100|The participant who contracted COVID-19 in the Pre-Treatment phase withdrew from the study in accordance with the Study Protocol.|
59863852|NCT04979858|75988404|FG000|COMPLETED|Treatment||100||
59863853|NCT04979858|75988405|FG001|COMPLETED|Treatment||100||
59863854|NCT04979858|75988404|FG000|NOT COMPLETED|Treatment||0||
59863855|NCT04979858|75988405|FG001|NOT COMPLETED|Treatment||0||
59863856|NCT04979858|75988404|FG000|STARTED|Post-Treatment||100||
59863857|NCT04979858|75988405|FG001|STARTED|Post-Treatment||100||
59863858|NCT04979858|75988404|FG000|COMPLETED|Post-Treatment||100||
59863859|NCT04979858|75988405|FG001|COMPLETED|Post-Treatment||100||
59863860|NCT04979858|75988404|FG000|NOT COMPLETED|Post-Treatment||0||
59863861|NCT04979858|75988405|FG001|NOT COMPLETED|Post-Treatment||0||
59863862|NCT04866290|75988411|FG000|STARTED|Enrolled and Completion of TACE Cycle 1||105||
59863863|NCT04866290|75988411|FG000|COMPLETED|Enrolled and Completion of TACE Cycle 1||105||
59863864|NCT04866290|75988411|FG000|NOT COMPLETED|Enrolled and Completion of TACE Cycle 1||0||
59863865|NCT04866290|75988411|FG000|STARTED|Completion of TACE Cycle 2||105||
59863866|NCT04866290|75988411|FG000|COMPLETED|Completion of TACE Cycle 2||58||
59863867|NCT04866290|75988411|FG000|NOT COMPLETED|Completion of TACE Cycle 2||47||
59863868|NCT04630769|75988421|FG000|STARTED|Overall Study||1||
59863869|NCT04630769|75988422|FG001|STARTED|Overall Study||1||
59863870|NCT04630769|75988423|FG002|STARTED|Overall Study||1||
59863871|NCT04630769|75988424|FG003|STARTED|Overall Study||0||
59863872|NCT04630769|75988425|FG004|STARTED|Overall Study||0||
59863873|NCT04630769|75988421|FG000|COMPLETED|Overall Study||1||
59863874|NCT04630769|75988422|FG001|COMPLETED|Overall Study||1||
59863875|NCT04630769|75988423|FG002|COMPLETED|Overall Study||1||
59863876|NCT04630769|75988424|FG003|COMPLETED|Overall Study||0||
59863877|NCT04630769|75988425|FG004|COMPLETED|Overall Study||0||
59863878|NCT04630769|75988421|FG000|NOT COMPLETED|Overall Study||0||
59863879|NCT04630769|75988422|FG001|NOT COMPLETED|Overall Study||0||
59863880|NCT04630769|75988423|FG002|NOT COMPLETED|Overall Study||0||
59863881|NCT04630769|75988424|FG003|NOT COMPLETED|Overall Study||0||
59863882|NCT04630769|75988425|FG004|NOT COMPLETED|Overall Study||0||
59863883|NCT04349124|75988439|FG000|STARTED|Overall Study||6||
59863884|NCT04349124|75988440|FG001|STARTED|Overall Study||6||
59863885|NCT04349124|75988439|FG000|COMPLETED|Overall Study||5||
59863886|NCT04349124|75988440|FG001|COMPLETED|Overall Study||5||
59863887|NCT04349124|75988439|FG000|NOT COMPLETED|Overall Study||1||
59863888|NCT04349124|75988440|FG001|NOT COMPLETED|Overall Study||1||
59863889|NCT04208243|75988446|FG000|STARTED|Overall Study||83||
59863890|NCT04208243|75988446|FG000|COMPLETED|Overall Study||83||
59998753|NCT00700739|76114348|FG000|COMPLETED|Overall Study||18||
59998754|NCT00700739|76114349|FG001|COMPLETED|Overall Study||12||
59998755|NCT00700739|76114348|FG000|NOT COMPLETED|Overall Study||4||
59998756|NCT00700739|76114349|FG001|NOT COMPLETED|Overall Study||4||
59998757|NCT02623335|76114358|FG000|STARTED|Overall Study||223||
59998758|NCT02623335|76114359|FG001|STARTED|Overall Study||223||
59998759|NCT02623335|76114358|FG000|T0 Audio Recording (Day of Consultation)|Overall Study||223||
59998760|NCT02623335|76114359|FG001|T0 Audio Recording (Day of Consultation)|Overall Study||222||
59998761|NCT02623335|76114358|FG000|T1 Survey (24-48 Hours)|Overall Study||216||
59998762|NCT02623335|76114359|FG001|T1 Survey (24-48 Hours)|Overall Study||214||
59998763|NCT02623335|76114358|FG000|T2 Survey (6-8 Weeks)|Overall Study||199||
59998764|NCT02623335|76114359|FG001|T2 Survey (6-8 Weeks)|Overall Study||192||
59998765|NCT02623335|76114358|FG000|T3 Survey (12-14 Weeks)|Overall Study||196||
59998766|NCT02623335|76114359|FG001|T3 Survey (12-14 Weeks)|Overall Study||187||
59998767|NCT02623335|76114358|FG000|COMPLETED|Overall Study||196||
59998768|NCT02623335|76114359|FG001|COMPLETED|Overall Study||187||
59998769|NCT02623335|76114358|FG000|NOT COMPLETED|Overall Study||27||
59998770|NCT02623335|76114359|FG001|NOT COMPLETED|Overall Study||36||
59998771|NCT02349893|76114365|FG000|STARTED|Overall Study||56||
59998772|NCT02349893|76114365|FG000|COMPLETED|Overall Study||43||
59998773|NCT02349893|76114365|FG000|NOT COMPLETED|Overall Study||13||
59998774|NCT00700427|76114369|FG000|STARTED|Study Period 2 (Open-Label Acute Trx)||2017||
59863891|NCT04208243|75988446|FG000|NOT COMPLETED|Overall Study||0||
59863892|NCT04030598|75988453|FG000|STARTED|Overall Study||6||
59863893|NCT04030598|75988454|FG001|STARTED|Overall Study||14||
59863894|NCT04030598|75988455|FG002|STARTED|Overall Study||3||
59863895|NCT04030598|75988453|FG000|COMPLETED|Overall Study||6|Completed=Participants who completed study treatment|
59863896|NCT04030598|75988454|FG001|COMPLETED|Overall Study||13|Completed=Participants who completed study treatment|
59863897|NCT04030598|75988455|FG002|COMPLETED|Overall Study||3|Completed=Participants who completed study treatment|
59863898|NCT04030598|75988453|FG000|NOT COMPLETED|Overall Study||0||
59863899|NCT04030598|75988454|FG001|NOT COMPLETED|Overall Study||1||
59863900|NCT04030598|75988455|FG002|NOT COMPLETED|Overall Study||0||
59863901|NCT03897439|75988465|FG000|STARTED|Randomization (Week 0)||196||
59863902|NCT03897439|75988466|FG001|STARTED|Randomization (Week 0)||196||
59863903|NCT03897439|75988465|FG000|Started on Nicotine Patch|Randomization (Week 0)||196||
59863904|NCT03897439|75988466|FG001|Started on Nicotine Patch|Randomization (Week 0)||196||
59863905|NCT03897439|75988465|FG000|COMPLETED|Randomization (Week 0)||196||
59863906|NCT03897439|75988466|FG001|COMPLETED|Randomization (Week 0)||196||
59863907|NCT03897439|75988465|FG000|NOT COMPLETED|Randomization (Week 0)||0||
59998775|NCT00700427|76114370|FG001|STARTED|Study Period 2 (Open-Label Acute Trx)||0||
59998776|NCT00700427|76114371|FG002|STARTED|Study Period 2 (Open-Label Acute Trx)||0||
59998777|NCT00700427|76114372|FG003|STARTED|Study Period 2 (Open-Label Acute Trx)||0||
59998778|NCT00700427|76114373|FG004|STARTED|Study Period 2 (Open-Label Acute Trx)||0||
59998779|NCT00700427|76114369|FG000|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||2011||
59998780|NCT00700427|76114370|FG001|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||0||
59998781|NCT00700427|76114371|FG002|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||0||
59998782|NCT00700427|76114372|FG003|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||0||
59998783|NCT00700427|76114373|FG004|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||0||
59998784|NCT00700427|76114369|FG000|COMPLETED|Study Period 2 (Open-Label Acute Trx)|One participant was mistakenly recorded as completed. The reason for discontinuation is unknown.|1006||
59998785|NCT00700427|76114370|FG001|COMPLETED|Study Period 2 (Open-Label Acute Trx)||0||
59998786|NCT00700427|76114371|FG002|COMPLETED|Study Period 2 (Open-Label Acute Trx)||0||
59998787|NCT00700427|76114372|FG003|COMPLETED|Study Period 2 (Open-Label Acute Trx)||0||
59998788|NCT00700427|76114373|FG004|COMPLETED|Study Period 2 (Open-Label Acute Trx)||0||
59998789|NCT00700427|76114369|FG000|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||1011||
59998790|NCT00700427|76114370|FG001|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||0||
59998791|NCT00700427|76114371|FG002|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||0||
59998792|NCT00700427|76114372|FG003|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||0||
59998793|NCT00700427|76114373|FG004|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||0||
59998794|NCT00700427|76114369|FG000|STARTED|Study Period 3A (Blinded Maintenance)||0||
59998795|NCT00700427|76114370|FG001|STARTED|Study Period 3A (Blinded Maintenance)||1005||
59998796|NCT00700427|76114371|FG002|STARTED|Study Period 3A (Blinded Maintenance)||0||
59998797|NCT00700427|76114372|FG003|STARTED|Study Period 3A (Blinded Maintenance)||0||
59998798|NCT00700427|76114373|FG004|STARTED|Study Period 3A (Blinded Maintenance)||0||
59998799|NCT00700427|76114369|FG000|COMPLETED|Study Period 3A (Blinded Maintenance)||0||
59998800|NCT00700427|76114370|FG001|COMPLETED|Study Period 3A (Blinded Maintenance)||524||
59998801|NCT00700427|76114371|FG002|COMPLETED|Study Period 3A (Blinded Maintenance)||0||
59998802|NCT00700427|76114372|FG003|COMPLETED|Study Period 3A (Blinded Maintenance)||0||
59998803|NCT00700427|76114373|FG004|COMPLETED|Study Period 3A (Blinded Maintenance)||0||
59998804|NCT00700427|76114369|FG000|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||0||
59998805|NCT00700427|76114370|FG001|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||481||
59998806|NCT00700427|76114371|FG002|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||0||
59998807|NCT00700427|76114372|FG003|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||0||
59998808|NCT00700427|76114373|FG004|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||0||
59998809|NCT00700427|76114369|FG000|STARTED|Study Period 3B (Randomized Withdrawal)||0||
59998810|NCT00700427|76114370|FG001|STARTED|Study Period 3B (Randomized Withdrawal)||0||
59998811|NCT00700427|76114371|FG002|STARTED|Study Period 3B (Randomized Withdrawal)||266||
59998812|NCT00700427|76114372|FG003|STARTED|Study Period 3B (Randomized Withdrawal)||258||
59998813|NCT00700427|76114373|FG004|STARTED|Study Period 3B (Randomized Withdrawal)||0||
59998814|NCT00700427|76114369|FG000|COMPLETED|Study Period 3B (Randomized Withdrawal)||0||
59998815|NCT00700427|76114370|FG001|COMPLETED|Study Period 3B (Randomized Withdrawal)||0||
59998816|NCT00700427|76114371|FG002|COMPLETED|Study Period 3B (Randomized Withdrawal)||184||
59998817|NCT00700427|76114372|FG003|COMPLETED|Study Period 3B (Randomized Withdrawal)||165||
59998818|NCT00700427|76114373|FG004|COMPLETED|Study Period 3B (Randomized Withdrawal)||0||
59998819|NCT00700427|76114369|FG000|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||0||
59998820|NCT00700427|76114370|FG001|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||0||
59998821|NCT00700427|76114371|FG002|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||82||
59998822|NCT00700427|76114372|FG003|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||93||
59998823|NCT00700427|76114373|FG004|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||0||
59998824|NCT00700427|76114369|FG000|STARTED|Study Period 4 (Open-Label Extension)||0||
59998825|NCT00700427|76114370|FG001|STARTED|Study Period 4 (Open-Label Extension)||0||
59998826|NCT00700427|76114371|FG002|STARTED|Study Period 4 (Open-Label Extension)||0||
59998827|NCT00700427|76114372|FG003|STARTED|Study Period 4 (Open-Label Extension)||0||
59998828|NCT00700427|76114373|FG004|STARTED|Study Period 4 (Open-Label Extension)||180||
59998829|NCT00700427|76114369|FG000|COMPLETED|Study Period 4 (Open-Label Extension)||0||
59998830|NCT00700427|76114370|FG001|COMPLETED|Study Period 4 (Open-Label Extension)||0||
59998831|NCT00700427|76114371|FG002|COMPLETED|Study Period 4 (Open-Label Extension)||0||
59998832|NCT00700427|76114372|FG003|COMPLETED|Study Period 4 (Open-Label Extension)||0||
59998833|NCT00700427|76114373|FG004|COMPLETED|Study Period 4 (Open-Label Extension)||96||
59998834|NCT00700427|76114369|FG000|NOT COMPLETED|Study Period 4 (Open-Label Extension)||0||
59998835|NCT00700427|76114370|FG001|NOT COMPLETED|Study Period 4 (Open-Label Extension)||0||
59998836|NCT00700427|76114371|FG002|NOT COMPLETED|Study Period 4 (Open-Label Extension)||0||
59998837|NCT00700427|76114372|FG003|NOT COMPLETED|Study Period 4 (Open-Label Extension)||0||
59998838|NCT00700427|76114373|FG004|NOT COMPLETED|Study Period 4 (Open-Label Extension)||84||
59998839|NCT02128763|76114383|FG000|STARTED|Overall Study||349||
59998840|NCT02128763|76114384|FG001|STARTED|Overall Study||186||
59998841|NCT02128763|76114383|FG000|COMPLETED|Overall Study||329||
59998842|NCT02128763|76114384|FG001|COMPLETED|Overall Study||170||
59998843|NCT02128763|76114383|FG000|NOT COMPLETED|Overall Study||20||
59998844|NCT02128763|76114384|FG001|NOT COMPLETED|Overall Study||16||
59998845|NCT02124772|76114406|FG000|STARTED|Overall Study||3||
59998846|NCT02124772|76114407|FG001|STARTED|Overall Study||19||
59998847|NCT02124772|76114408|FG002|STARTED|Overall Study||12||
59998848|NCT02124772|76114409|FG003|STARTED|Overall Study||16||
59998849|NCT02124772|76114410|FG004|STARTED|Overall Study||11||
59998850|NCT02124772|76114411|FG005|STARTED|Overall Study||10||
59998851|NCT02124772|76114412|FG006|STARTED|Overall Study||10||
59998852|NCT02124772|76114413|FG007|STARTED|Overall Study||10||
59998853|NCT02124772|76114414|FG008|STARTED|Overall Study||3||
59998854|NCT02124772|76114415|FG009|STARTED|Overall Study||9||
59998855|NCT02124772|76114416|FG010|STARTED|Overall Study||6||
59998856|NCT02124772|76114417|FG011|STARTED|Overall Study||20||
59998857|NCT02124772|76114418|FG012|STARTED|Overall Study||10||
59998858|NCT02124772|76114406|FG000|COMPLETED|Overall Study||0||
59998859|NCT02124772|76114407|FG001|COMPLETED|Overall Study||5||
59998860|NCT02124772|76114408|FG002|COMPLETED|Overall Study||6||
59998861|NCT02124772|76114409|FG003|COMPLETED|Overall Study||3||
59998862|NCT02124772|76114410|FG004|COMPLETED|Overall Study||2||
59998863|NCT02124772|76114411|FG005|COMPLETED|Overall Study||2||
59998864|NCT02124772|76114412|FG006|COMPLETED|Overall Study||2||
59998865|NCT02124772|76114413|FG007|COMPLETED|Overall Study||1||
59998866|NCT02124772|76114414|FG008|COMPLETED|Overall Study||2||
59998867|NCT02124772|76114415|FG009|COMPLETED|Overall Study||2||
59998868|NCT02124772|76114416|FG010|COMPLETED|Overall Study||4||
59998869|NCT02124772|76114417|FG011|COMPLETED|Overall Study||14||
59998870|NCT02124772|76114418|FG012|COMPLETED|Overall Study||8||
59998871|NCT02124772|76114406|FG000|NOT COMPLETED|Overall Study||3||
59998872|NCT02124772|76114407|FG001|NOT COMPLETED|Overall Study||14||
59998873|NCT02124772|76114408|FG002|NOT COMPLETED|Overall Study||6||
59998874|NCT02124772|76114409|FG003|NOT COMPLETED|Overall Study||13||
59998875|NCT02124772|76114410|FG004|NOT COMPLETED|Overall Study||9||
59998876|NCT02124772|76114411|FG005|NOT COMPLETED|Overall Study||8||
59998877|NCT02124772|76114412|FG006|NOT COMPLETED|Overall Study||8||
59998878|NCT02124772|76114413|FG007|NOT COMPLETED|Overall Study||9||
59998879|NCT02124772|76114414|FG008|NOT COMPLETED|Overall Study||1||
59998880|NCT02124772|76114415|FG009|NOT COMPLETED|Overall Study||7||
59998881|NCT02124772|76114416|FG010|NOT COMPLETED|Overall Study||2||
59998882|NCT02124772|76114417|FG011|NOT COMPLETED|Overall Study||6||
59998883|NCT02124772|76114418|FG012|NOT COMPLETED|Overall Study||2||
59998884|NCT02159482|76114470|FG000|STARTED|Overall Study||11||
59998885|NCT02159482|76114470|FG000|COMPLETED|Overall Study||6||
59998886|NCT02159482|76114470|FG000|NOT COMPLETED|Overall Study||5||
59998887|NCT02622321|76114478|FG000|STARTED|Overall Study||35||
59998888|NCT02622321|76114479|FG001|STARTED|Overall Study||18||
59998889|NCT02622321|76114480|FG002|STARTED|Overall Study||49||
59998890|NCT02622321|76114481|FG003|STARTED|Overall Study||11||
59998891|NCT02622321|76114478|FG000|Received at Least One Dose of Treatment|Overall Study|1 participant withdrew prior to study Day 1.|34|Safety Population|
59998892|NCT02622321|76114479|FG001|Received at Least One Dose of Treatment|Overall Study||18|Safety Population|
59998893|NCT02622321|76114480|FG002|Received at Least One Dose of Treatment|Overall Study||49|Safety Population|
59998894|NCT02622321|76114481|FG003|Received at Least One Dose of Treatment|Overall Study||11|Safety Population|
59998895|NCT02622321|76114478|FG000|Completed 24 Weeks in the Study|Overall Study||31||
59998896|NCT02622321|76114479|FG001|Completed 24 Weeks in the Study|Overall Study|After 24 weeks, all 18 participants in Arm B switched to receive emicizumab prophylaxis.|18||
59998897|NCT02622321|76114480|FG002|Completed 24 Weeks in the Study|Overall Study||49||
59998898|NCT02622321|76114481|FG003|Completed 24 Weeks in the Study|Overall Study||11||
59998899|NCT02622321|76114478|FG000|Dose Up-Titrated to 3 mg/kg QW|Overall Study||2||
59998900|NCT02622321|76114479|FG001|Dose Up-Titrated to 3 mg/kg QW|Overall Study||0||
59998901|NCT02622321|76114480|FG002|Dose Up-Titrated to 3 mg/kg QW|Overall Study||3||
59998902|NCT02622321|76114481|FG003|Dose Up-Titrated to 3 mg/kg QW|Overall Study||2||
59998903|NCT02622321|76114478|FG000|COMPLETED|Overall Study||32||
59998904|NCT02622321|76114479|FG001|COMPLETED|Overall Study||18||
59998905|NCT02622321|76114480|FG002|COMPLETED|Overall Study||48||
59998906|NCT02622321|76114481|FG003|COMPLETED|Overall Study||11||
59998907|NCT02622321|76114478|FG000|NOT COMPLETED|Overall Study||3||
59998908|NCT02622321|76114479|FG001|NOT COMPLETED|Overall Study||0||
59998909|NCT02622321|76114480|FG002|NOT COMPLETED|Overall Study||1||
59998910|NCT02622321|76114481|FG003|NOT COMPLETED|Overall Study||0||
59998911|NCT02187172|76114507|FG000|STARTED|Overall Study||22||
59998912|NCT02187172|76114508|FG001|STARTED|Overall Study||21||
59998913|NCT02187172|76114507|FG000|RCT Phase Completed|Overall Study||22|Week 12 for both arms|
59998914|NCT02187172|76114508|FG001|RCT Phase Completed|Overall Study||19|Week 12 for both arms|
59998915|NCT02187172|76114507|FG000|COMPLETED|Overall Study||19|Received total of 52 weeks of ustekinumab. Week 52 for Ustekinumab arm, Week 64 for Placebo arm.|
59998916|NCT02187172|76114508|FG001|COMPLETED|Overall Study||15|Received total of 52 weeks of ustekinumab. Week 52 for Ustekinumab arm, Week 64 for Placebo arm.|
59998917|NCT02187172|76114507|FG000|NOT COMPLETED|Overall Study||3||
59998918|NCT02187172|76114508|FG001|NOT COMPLETED|Overall Study||6||
59998919|NCT02621931|76114519|FG000|STARTED|Overall Study||375||
59998920|NCT02621931|76114520|FG001|STARTED|Overall Study||376||
59998921|NCT02621931|76114521|FG002|STARTED|Overall Study||379||
59998922|NCT02621931|76114519|FG000|Safety and ITT Populations|Overall Study||375||
59998923|NCT02621931|76114520|FG001|Safety and ITT Populations|Overall Study||376||
59998924|NCT02621931|76114521|FG002|Safety and ITT Populations|Overall Study||379||
59998925|NCT02621931|76114519|FG000|Full Analysis Set|Overall Study||371||
59998926|NCT02621931|76114520|FG001|Full Analysis Set|Overall Study||375||
59998927|NCT02621931|76114521|FG002|Full Analysis Set|Overall Study||375||
59998928|NCT02621931|76114519|FG000|COMPLETED|Overall Study||342||
59998929|NCT02621931|76114520|FG001|COMPLETED|Overall Study||349||
59998930|NCT02621931|76114521|FG002|COMPLETED|Overall Study||343||
59998931|NCT02621931|76114519|FG000|NOT COMPLETED|Overall Study||33||
59998932|NCT02621931|76114520|FG001|NOT COMPLETED|Overall Study||27||
59998933|NCT02621931|76114521|FG002|NOT COMPLETED|Overall Study||36||
59998934|NCT02621073|76114533|FG000|STARTED|Overall Study||4||
59998935|NCT02621073|76114534|FG001|STARTED|Overall Study||3||
59998936|NCT02621073|76114533|FG000|COMPLETED|Overall Study||1||
59998937|NCT02621073|76114534|FG001|COMPLETED|Overall Study||0||
59998938|NCT02621073|76114533|FG000|NOT COMPLETED|Overall Study||3||
59998939|NCT02621073|76114534|FG001|NOT COMPLETED|Overall Study||3||
59998940|NCT02158936|76114542|FG000|STARTED|Overall Study||179||
59998941|NCT02158936|76114543|FG001|STARTED|Overall Study||177||
59998942|NCT02158936|76114542|FG000|Treated|Overall Study||177||
59998943|NCT02158936|76114543|FG001|Treated|Overall Study||177||
59998944|NCT02158936|76114542|FG000|Untreated|Overall Study||2||
59998945|NCT02158936|76114543|FG001|Untreated|Overall Study||0||
59998946|NCT02158936|76114542|FG000|COMPLETED|Overall Study||0||
59998947|NCT02158936|76114543|FG001|COMPLETED|Overall Study||0||
59998948|NCT02158936|76114542|FG000|NOT COMPLETED|Overall Study||179||
59998949|NCT02158936|76114543|FG001|NOT COMPLETED|Overall Study||177||
59998950|NCT02158546|76114553|FG000|STARTED|Overall Study||152|3 subjects were randomized but did not receive study drug.|
59998951|NCT02158546|76114554|FG001|STARTED|Overall Study||153|3 subjects were randomized but did not receive study drug.|
59998952|NCT02158546|76114555|FG002|STARTED|Overall Study||18|3 subjects were randomized but did not receive study drug.|
59998953|NCT02158546|76114556|FG003|STARTED|Overall Study||19|3 subjects were randomized but did not receive study drug.|
59998954|NCT02158546|76114553|FG000|COMPLETED|Overall Study||133||
59998955|NCT02158546|76114554|FG001|COMPLETED|Overall Study||136||
59998956|NCT02158546|76114555|FG002|COMPLETED|Overall Study||14||
59998957|NCT02158546|76114556|FG003|COMPLETED|Overall Study||13||
59998958|NCT02158546|76114553|FG000|NOT COMPLETED|Overall Study||19||
59998959|NCT02158546|76114554|FG001|NOT COMPLETED|Overall Study||17||
59998960|NCT02158546|76114555|FG002|NOT COMPLETED|Overall Study||4||
59998961|NCT02158546|76114556|FG003|NOT COMPLETED|Overall Study||6||
59998962|NCT02123446|76114566|FG000|STARTED|Period 1 (7 Days)||14||
59998963|NCT02123446|76114567|FG001|STARTED|Period 1 (7 Days)||14||
59998964|NCT02123446|76114566|FG000|COMPLETED|Period 1 (7 Days)||14||
59998965|NCT02123446|76114567|FG001|COMPLETED|Period 1 (7 Days)||14||
59998966|NCT02123446|76114566|FG000|NOT COMPLETED|Period 1 (7 Days)||0||
59998967|NCT02123446|76114567|FG001|NOT COMPLETED|Period 1 (7 Days)||0||
59998968|NCT02123446|76114566|FG000|STARTED|Washout Period (1 Day)||14||
59998969|NCT02123446|76114567|FG001|STARTED|Washout Period (1 Day)||14||
59998970|NCT02123446|76114566|FG000|COMPLETED|Washout Period (1 Day)||13||
59998971|NCT02123446|76114567|FG001|COMPLETED|Washout Period (1 Day)||14||
59998972|NCT02123446|76114566|FG000|NOT COMPLETED|Washout Period (1 Day)||1||
59998973|NCT02123446|76114567|FG001|NOT COMPLETED|Washout Period (1 Day)||0||
59998974|NCT02123446|76114566|FG000|STARTED|Period 2 (7 Days)||13||
59998975|NCT02123446|76114567|FG001|STARTED|Period 2 (7 Days)||14||
59998976|NCT02123446|76114566|FG000|COMPLETED|Period 2 (7 Days)||13||
59998977|NCT02123446|76114567|FG001|COMPLETED|Period 2 (7 Days)||14||
59998978|NCT02123446|76114566|FG000|NOT COMPLETED|Period 2 (7 Days)||0||
59998979|NCT02123446|76114567|FG001|NOT COMPLETED|Period 2 (7 Days)||0||
59998980|NCT02123134|76114575|FG000|STARTED|Overall Study||28||
59998981|NCT02123134|76114576|FG001|STARTED|Overall Study||27||
59998982|NCT02123134|76114575|FG000|COMPLETED|Overall Study||25||
59998983|NCT02123134|76114576|FG001|COMPLETED|Overall Study||24||
59998984|NCT02123134|76114575|FG000|NOT COMPLETED|Overall Study||3||
59998985|NCT02123134|76114576|FG001|NOT COMPLETED|Overall Study||3||
59998986|NCT02185534|76114588|FG000|STARTED|First Period||14||
59998987|NCT02185534|76114589|FG001|STARTED|First Period||14||
59998988|NCT02185534|76114590|FG002|STARTED|First Period||14||
59998989|NCT02185534|76114591|FG003|STARTED|First Period||14||
59998990|NCT02185534|76114592|FG004|STARTED|First Period||14||
59998991|NCT02185534|76114593|FG005|STARTED|First Period||14||
59998992|NCT02185534|76114588|FG000|COMPLETED|First Period||14||
59998993|NCT02185534|76114589|FG001|COMPLETED|First Period||14||
59998994|NCT02185534|76114590|FG002|COMPLETED|First Period||14||
59998995|NCT02185534|76114591|FG003|COMPLETED|First Period||13||
59998996|NCT02185534|76114592|FG004|COMPLETED|First Period||14||
59998997|NCT02185534|76114593|FG005|COMPLETED|First Period||14||
59998998|NCT02185534|76114588|FG000|NOT COMPLETED|First Period||0||
59998999|NCT02185534|76114589|FG001|NOT COMPLETED|First Period||0||
59999000|NCT02185534|76114590|FG002|NOT COMPLETED|First Period||0||
59999001|NCT02185534|76114591|FG003|NOT COMPLETED|First Period||1||
59999002|NCT02185534|76114592|FG004|NOT COMPLETED|First Period||0||
59999003|NCT02185534|76114593|FG005|NOT COMPLETED|First Period||0||
59999004|NCT02185534|76114588|FG000|STARTED|First Washout Period||14||
59999005|NCT02185534|76114589|FG001|STARTED|First Washout Period||14||
59999006|NCT02185534|76114590|FG002|STARTED|First Washout Period||14||
59999007|NCT02185534|76114591|FG003|STARTED|First Washout Period||13||
59999008|NCT02185534|76114592|FG004|STARTED|First Washout Period||14||
59999009|NCT02185534|76114593|FG005|STARTED|First Washout Period||14||
59999010|NCT02185534|76114588|FG000|COMPLETED|First Washout Period||13||
59999011|NCT02185534|76114589|FG001|COMPLETED|First Washout Period||14||
59999012|NCT02185534|76114590|FG002|COMPLETED|First Washout Period||14||
59999013|NCT02185534|76114591|FG003|COMPLETED|First Washout Period||13||
59999014|NCT02185534|76114592|FG004|COMPLETED|First Washout Period||13||
59999015|NCT02185534|76114593|FG005|COMPLETED|First Washout Period||13||
59999016|NCT02185534|76114588|FG000|NOT COMPLETED|First Washout Period||1||
59999017|NCT02185534|76114589|FG001|NOT COMPLETED|First Washout Period||0||
59999018|NCT02185534|76114590|FG002|NOT COMPLETED|First Washout Period||0||
59999019|NCT02185534|76114591|FG003|NOT COMPLETED|First Washout Period||0||
59999020|NCT02185534|76114592|FG004|NOT COMPLETED|First Washout Period||1||
59999021|NCT02185534|76114593|FG005|NOT COMPLETED|First Washout Period||1||
59999022|NCT02185534|76114588|FG000|STARTED|Second Period||13||
59999023|NCT02185534|76114589|FG001|STARTED|Second Period||14||
59999024|NCT02185534|76114590|FG002|STARTED|Second Period||14||
59999025|NCT02185534|76114591|FG003|STARTED|Second Period||13||
59999026|NCT02185534|76114592|FG004|STARTED|Second Period||13||
59999027|NCT02185534|76114593|FG005|STARTED|Second Period||13||
59999028|NCT02185534|76114588|FG000|COMPLETED|Second Period||13||
59999029|NCT02185534|76114589|FG001|COMPLETED|Second Period||14||
59999030|NCT02185534|76114590|FG002|COMPLETED|Second Period||14||
59999031|NCT02185534|76114591|FG003|COMPLETED|Second Period||13||
59999032|NCT02185534|76114592|FG004|COMPLETED|Second Period||13||
59999033|NCT02185534|76114593|FG005|COMPLETED|Second Period||13||
59999034|NCT02185534|76114588|FG000|NOT COMPLETED|Second Period||0||
59999035|NCT02185534|76114589|FG001|NOT COMPLETED|Second Period||0||
59999036|NCT02185534|76114590|FG002|NOT COMPLETED|Second Period||0||
59999037|NCT02185534|76114591|FG003|NOT COMPLETED|Second Period||0||
59999038|NCT02185534|76114592|FG004|NOT COMPLETED|Second Period||0||
59999039|NCT02185534|76114593|FG005|NOT COMPLETED|Second Period||0||
59999040|NCT02185534|76114588|FG000|STARTED|Second Washout Period||13||
59999041|NCT02185534|76114589|FG001|STARTED|Second Washout Period||14||
59999042|NCT02185534|76114590|FG002|STARTED|Second Washout Period||14||
59999043|NCT02185534|76114591|FG003|STARTED|Second Washout Period||13||
59999044|NCT02185534|76114592|FG004|STARTED|Second Washout Period||13||
59999045|NCT02185534|76114593|FG005|STARTED|Second Washout Period||13||
59999046|NCT02185534|76114588|FG000|COMPLETED|Second Washout Period||13||
59999047|NCT02185534|76114589|FG001|COMPLETED|Second Washout Period||14||
59999048|NCT02185534|76114590|FG002|COMPLETED|Second Washout Period||14||
59999049|NCT02185534|76114591|FG003|COMPLETED|Second Washout Period||13||
59999050|NCT02185534|76114592|FG004|COMPLETED|Second Washout Period||13||
59999051|NCT02185534|76114593|FG005|COMPLETED|Second Washout Period||13||
59999052|NCT02185534|76114588|FG000|NOT COMPLETED|Second Washout Period||0||
59999053|NCT02185534|76114589|FG001|NOT COMPLETED|Second Washout Period||0||
59999054|NCT02185534|76114590|FG002|NOT COMPLETED|Second Washout Period||0||
59999055|NCT02185534|76114591|FG003|NOT COMPLETED|Second Washout Period||0||
59999056|NCT02185534|76114592|FG004|NOT COMPLETED|Second Washout Period||0||
59999057|NCT02185534|76114593|FG005|NOT COMPLETED|Second Washout Period||0||
59999058|NCT02185534|76114588|FG000|STARTED|Third Period||13||
59999059|NCT02185534|76114589|FG001|STARTED|Third Period||14||
59999060|NCT02185534|76114590|FG002|STARTED|Third Period||14||
59999061|NCT02185534|76114591|FG003|STARTED|Third Period||13||
59999062|NCT02185534|76114592|FG004|STARTED|Third Period||13||
59999063|NCT02185534|76114593|FG005|STARTED|Third Period||13||
59999064|NCT02185534|76114588|FG000|COMPLETED|Third Period||13||
59999065|NCT02185534|76114589|FG001|COMPLETED|Third Period||14||
59999066|NCT02185534|76114590|FG002|COMPLETED|Third Period||14||
59999067|NCT02185534|76114591|FG003|COMPLETED|Third Period||13||
59999068|NCT02185534|76114592|FG004|COMPLETED|Third Period||13||
59999069|NCT02185534|76114593|FG005|COMPLETED|Third Period||13||
59999070|NCT02185534|76114588|FG000|NOT COMPLETED|Third Period||0||
59999071|NCT02185534|76114589|FG001|NOT COMPLETED|Third Period||0||
59999072|NCT02185534|76114590|FG002|NOT COMPLETED|Third Period||0||
59999073|NCT02185534|76114591|FG003|NOT COMPLETED|Third Period||0||
59999074|NCT02185534|76114592|FG004|NOT COMPLETED|Third Period||0||
59999075|NCT02185534|76114593|FG005|NOT COMPLETED|Third Period||0||
59999076|NCT02121808|76114602|FG000|STARTED|Overall Study||20||
59999077|NCT02121808|76114602|FG000|COMPLETED|Overall Study||17||
59999078|NCT02121808|76114602|FG000|NOT COMPLETED|Overall Study||3||
59999079|NCT02157376|76114613|FG000|STARTED|Overall Study||155||
59999080|NCT02157376|76114614|FG001|STARTED|Overall Study||156||
59999081|NCT02157376|76114613|FG000|COMPLETED|Overall Study||133||
59999082|NCT02157376|76114614|FG001|COMPLETED|Overall Study||138||
59999083|NCT02157376|76114613|FG000|NOT COMPLETED|Overall Study||22||
59999084|NCT02157376|76114614|FG001|NOT COMPLETED|Overall Study||18||
59999085|NCT02157298|76114622|FG000|STARTED|Overall Study||123||
59999086|NCT02157298|76114623|FG001|STARTED|Overall Study||60||
59999087|NCT02157298|76114622|FG000|COMPLETED|Overall Study||119||
59999088|NCT02157298|76114623|FG001|COMPLETED|Overall Study||58||
59999089|NCT02157298|76114622|FG000|NOT COMPLETED|Overall Study||4||
59999090|NCT02157298|76114623|FG001|NOT COMPLETED|Overall Study||2||
59999091|NCT02184988|76114629|FG000|STARTED|Overall Study||352||
59999092|NCT02184988|76114629|FG000|COMPLETED|Overall Study||297||
59999093|NCT02184988|76114629|FG000|NOT COMPLETED|Overall Study||55||
59999094|NCT02121262|76114635|FG000|STARTED|Overall Study||139||
59999095|NCT02121262|76114636|FG001|STARTED|Overall Study||145||
59999096|NCT02121262|76114635|FG000|Treated|Overall Study||129||
59999097|NCT02121262|76114636|FG001|Treated|Overall Study||145||
59999098|NCT02121262|76114635|FG000|Modified Intent-to-treat Population|Overall Study||127||
59999099|NCT02121262|76114636|FG001|Modified Intent-to-treat Population|Overall Study||145||
59999100|NCT02121262|76114635|FG000|COMPLETED|Overall Study||108||
59999101|NCT02121262|76114636|FG001|COMPLETED|Overall Study||135||
59999102|NCT02121262|76114635|FG000|NOT COMPLETED|Overall Study||31||
59999103|NCT02121262|76114636|FG001|NOT COMPLETED|Overall Study||10||
59999104|NCT02120950|76114644|FG000|STARTED|Overall Study||157||
59999105|NCT02120950|76114645|FG001|STARTED|Overall Study||161||
59999106|NCT02120950|76114646|FG002|STARTED|Overall Study||15||
59999107|NCT02120950|76114644|FG000|COMPLETED|Overall Study|Completed Treatment (Week 96)|137||
59999108|NCT02120950|76114645|FG001|COMPLETED|Overall Study|Completed Treatment (Week 96)|147||
59999109|NCT02120950|76114646|FG002|COMPLETED|Overall Study||0||
59999110|NCT02120950|76114644|FG000|NOT COMPLETED|Overall Study||20||
59999111|NCT02120950|76114645|FG001|NOT COMPLETED|Overall Study||14||
59999112|NCT02120950|76114646|FG002|NOT COMPLETED|Overall Study||15||
59999113|NCT02120794|76114653|FG000|STARTED|Overall Study||194||
59999114|NCT02120794|76114653|FG000|COMPLETED|Overall Study||136||
59999115|NCT02120794|76114653|FG000|NOT COMPLETED|Overall Study||58||
59999116|NCT02184442|76114659|FG000|STARTED|Overall Study||284||
59999117|NCT02184442|76114660|FG001|STARTED|Overall Study||276||
59999118|NCT02184442|76114659|FG000|As-Treated|Overall Study||282||
59999119|NCT02184442|76114660|FG001|As-Treated|Overall Study||271||
59999120|NCT02184442|76114659|FG000|Valve-Implant|Overall Study||280||
59999121|NCT02184442|76114660|FG001|Valve-Implant|Overall Study||263||
59999122|NCT02184442|76114659|FG000|COMPLETED|Overall Study||220|One-year Follow-up|
59999123|NCT02184442|76114660|FG001|COMPLETED|Overall Study||200|One-year Follow-up|
59999124|NCT02184442|76114659|FG000|NOT COMPLETED|Overall Study||64||
59999125|NCT02184442|76114660|FG001|NOT COMPLETED|Overall Study||76||
59999126|NCT02155738|76114670|FG000|STARTED|Overall Study||50||
59999127|NCT02155738|76114671|FG001|STARTED|Overall Study||52||
59999128|NCT02155738|76114672|FG002|STARTED|Overall Study||51||
59999129|NCT02155738|76114673|FG003|STARTED|Overall Study||51||
59999130|NCT02155738|76114670|FG000|COMPLETED|Overall Study||49||
59999131|NCT02155738|76114671|FG001|COMPLETED|Overall Study||52||
59999132|NCT02155738|76114672|FG002|COMPLETED|Overall Study||51||
59999133|NCT02155738|76114673|FG003|COMPLETED|Overall Study||50||
59999134|NCT02155738|76114670|FG000|NOT COMPLETED|Overall Study||1||
59999135|NCT02155738|76114671|FG001|NOT COMPLETED|Overall Study||0||
59999136|NCT02155738|76114672|FG002|NOT COMPLETED|Overall Study||0||
59999137|NCT02155738|76114673|FG003|NOT COMPLETED|Overall Study||1||
59999138|NCT02181790|76114685|FG000|STARTED|Overall Study||2||
59999139|NCT02181790|76114686|FG001|STARTED|Overall Study||0||
59999140|NCT02181790|76114685|FG000|COMPLETED|Overall Study||0||
59999141|NCT02181790|76114686|FG001|COMPLETED|Overall Study||0||
59999142|NCT02181790|76114685|FG000|NOT COMPLETED|Overall Study||2||
59999143|NCT02181790|76114686|FG001|NOT COMPLETED|Overall Study||0||
59999144|NCT02618967|76114702|FG000|STARTED|Overall Study||6||
59999145|NCT02618967|76114703|FG001|STARTED|Overall Study||6||
59999146|NCT02618967|76114704|FG002|STARTED|Overall Study||6||
59999147|NCT02618967|76114705|FG003|STARTED|Overall Study||6||
59999148|NCT02618967|76114706|FG004|STARTED|Overall Study||6||
59999149|NCT02618967|76114707|FG005|STARTED|Overall Study||6||
59999150|NCT02618967|76114708|FG006|STARTED|Overall Study||6||
59999151|NCT02618967|76114709|FG007|STARTED|Overall Study||14||
59999152|NCT02618967|76114702|FG000|Received Treatment|Overall Study||6||
59999153|NCT02618967|76114703|FG001|Received Treatment|Overall Study||6||
59999154|NCT02618967|76114704|FG002|Received Treatment|Overall Study||6||
59999155|NCT02618967|76114705|FG003|Received Treatment|Overall Study||6||
59999156|NCT02618967|76114706|FG004|Received Treatment|Overall Study||6||
59999157|NCT02618967|76114707|FG005|Received Treatment|Overall Study||6||
59999158|NCT02618967|76114708|FG006|Received Treatment|Overall Study||6||
59999159|NCT02618967|76114709|FG007|Received Treatment|Overall Study||14||
59999160|NCT02618967|76114702|FG000|COMPLETED|Overall Study||5||
59999161|NCT02618967|76114703|FG001|COMPLETED|Overall Study||6||
59999162|NCT02618967|76114704|FG002|COMPLETED|Overall Study||5||
59999163|NCT02618967|76114705|FG003|COMPLETED|Overall Study||6||
59999164|NCT02618967|76114706|FG004|COMPLETED|Overall Study||4||
59999165|NCT02618967|76114707|FG005|COMPLETED|Overall Study||6||
59999166|NCT02618967|76114708|FG006|COMPLETED|Overall Study||6||
59999167|NCT02618967|76114709|FG007|COMPLETED|Overall Study||14||
59999168|NCT02618967|76114702|FG000|NOT COMPLETED|Overall Study||1||
59999169|NCT02618967|76114703|FG001|NOT COMPLETED|Overall Study||0||
59999170|NCT02618967|76114704|FG002|NOT COMPLETED|Overall Study||1||
59999171|NCT02618967|76114705|FG003|NOT COMPLETED|Overall Study||0||
59999172|NCT02618967|76114706|FG004|NOT COMPLETED|Overall Study||2||
59999173|NCT02618967|76114707|FG005|NOT COMPLETED|Overall Study||0||
59999174|NCT02618967|76114708|FG006|NOT COMPLETED|Overall Study||0||
59999175|NCT02618967|76114709|FG007|NOT COMPLETED|Overall Study||0||
59999176|NCT04897737|76114729|FG000|STARTED|Overall Study||53||
59999177|NCT04897737|76114730|FG001|STARTED|Overall Study||53||
59999178|NCT04897737|76114729|FG000|COMPLETED|Overall Study||53||
59999179|NCT04897737|76114730|FG001|COMPLETED|Overall Study||53||
59999180|NCT04897737|76114729|FG000|NOT COMPLETED|Overall Study||0||
59999181|NCT04897737|76114730|FG001|NOT COMPLETED|Overall Study||0||
59999182|NCT02616783|76114738|FG000|STARTED|Overall Study||111||
59999183|NCT02616783|76114739|FG001|STARTED|Overall Study||56||
59999184|NCT02616783|76114738|FG000|COMPLETED|Overall Study||105||
59999185|NCT02616783|76114739|FG001|COMPLETED|Overall Study||54||
59999186|NCT02616783|76114738|FG000|NOT COMPLETED|Overall Study||6||
59999187|NCT02616783|76114739|FG001|NOT COMPLETED|Overall Study||2||
59999188|NCT02616393|76114748|FG000|STARTED|Overall Study||13||
59999189|NCT02616393|76114749|FG001|STARTED|Overall Study||20||
59999190|NCT02616393|76114750|FG002|STARTED|Overall Study||3||
59999191|NCT02616393|76114748|FG000|COMPLETED|Overall Study||0||
59999192|NCT02616393|76114749|FG001|COMPLETED|Overall Study||0||
59999193|NCT02616393|76114750|FG002|COMPLETED|Overall Study||0||
59999194|NCT02616393|76114748|FG000|NOT COMPLETED|Overall Study||13||
59999195|NCT02616393|76114749|FG001|NOT COMPLETED|Overall Study||20||
59999196|NCT02616393|76114750|FG002|NOT COMPLETED|Overall Study||3||
59999197|NCT02155660|76114778|FG000|STARTED|Overall Study||562||
59999198|NCT02155660|76114779|FG001|STARTED|Overall Study||562||
59999199|NCT02155660|76114780|FG002|STARTED|Overall Study||562||
59999200|NCT02155660|76114781|FG003|STARTED|Overall Study||568||
59999201|NCT02155660|76114778|FG000|COMPLETED|Overall Study||504||
59999202|NCT02155660|76114779|FG001|COMPLETED|Overall Study||489||
59999203|NCT02155660|76114780|FG002|COMPLETED|Overall Study||502||
59999204|NCT02155660|76114781|FG003|COMPLETED|Overall Study||507||
59999205|NCT02155660|76114778|FG000|NOT COMPLETED|Overall Study||58||
59999206|NCT02155660|76114779|FG001|NOT COMPLETED|Overall Study||73||
59999207|NCT02155660|76114780|FG002|NOT COMPLETED|Overall Study||60||
59999208|NCT02155660|76114781|FG003|NOT COMPLETED|Overall Study||61||
59999209|NCT02119936|76114791|FG000|STARTED|Overall Study||10||
59999210|NCT02119936|76114791|FG000|COMPLETED|Overall Study||0||
59999211|NCT02119936|76114791|FG000|NOT COMPLETED|Overall Study||10||
59999212|NCT02181634|76114795|FG000|STARTED|Overall Study||74||
59999213|NCT02181634|76114795|FG000|Eligible and Treated|Overall Study||73||
59999214|NCT02181634|76114795|FG000|COMPLETED|Overall Study||2||
59999215|NCT02181634|76114795|FG000|NOT COMPLETED|Overall Study||72||
59999216|NCT01595529|76114801|FG000|STARTED|Overall Study||348|Randomized.|
59999217|NCT01595529|76114802|FG001|STARTED|Overall Study||345|Randomized.|
59999218|NCT01595529|76114801|FG000|Treated|Overall Study||337||
59999219|NCT01595529|76114802|FG001|Treated|Overall Study||340||
59999220|NCT01595529|76114801|FG000|Evaluated for Primary Endpoint, ITT|Overall Study||328|Participants taking at least one dose of treatment from Day 6-10, evaluated at or failed before TOC.|
59999221|NCT01595529|76114802|FG001|Evaluated for Primary Endpoint, ITT|Overall Study||336|Participants taking at least one dose of treatment from Day 6-10, evaluated at or failed before TOC.|
59999222|NCT01595529|76114801|FG000|ITT Without Treatment Failure|Overall Study||326|This group was used to evaluate recurrent infection.|
59999223|NCT01595529|76114802|FG001|ITT Without Treatment Failure|Overall Study||322|This group was used to evaluate recurrent infection.|
59999224|NCT01595529|76114801|FG000|ITT With Stool Sample at TOC|Overall Study||298|This group was used to evaluate colonization with antibiotic-resistant E. coli and K. pneumoniae.|
59999225|NCT01595529|76114802|FG001|ITT With Stool Sample at TOC|Overall Study||310|This group was used to evaluate colonization with antibiotic-resistant E. coli and K. pneumoniae.|
59999226|NCT01595529|76114801|FG000|Per-protocol, Completed 80% of Dose|Overall Study||308|Participants who completed more than 80% of the prescribed dose between Day 6 and Day 10.|
59999227|NCT01595529|76114802|FG001|Per-protocol, Completed 80% of Dose|Overall Study||314|Participants who completed more than 80% of the prescribed dose between Day 6 and Day 10.|
59999228|NCT01595529|76114801|FG000|Per-protocol Without Treatment Failure|Overall Study||306|This group was used to evaluate recurrent infection.|
59999229|NCT01595529|76114802|FG001|Per-protocol Without Treatment Failure|Overall Study||305|This group was used to evaluate recurrent infection.|
59999230|NCT01595529|76114801|FG000|Per-protocol With Stool Sample at TOC|Overall Study||280|This group was used to evaluate colonization with antibiotic-resistant E. coli and K. pneumoniae.|
59999231|NCT01595529|76114802|FG001|Per-protocol With Stool Sample at TOC|Overall Study||289|This group was used to evaluate colonization with antibiotic-resistant E. coli and K. pneumoniae.|
59999232|NCT01595529|76114801|FG000|Completed All Milestones|Overall Study||318||
59999233|NCT01595529|76114802|FG001|Completed All Milestones|Overall Study||318||
59999234|NCT01595529|76114801|FG000|COMPLETED|Overall Study||324|A subject could have completed the study without completing all appointments.|
59999235|NCT01595529|76114802|FG001|COMPLETED|Overall Study||325|A subject could have completed the study without completing all appointments.|
59999236|NCT01595529|76114801|FG000|NOT COMPLETED|Overall Study||24||
59999237|NCT01595529|76114802|FG001|NOT COMPLETED|Overall Study||20||
59999238|NCT02615145|76114811|FG000|STARTED|Overall Study||145||
59999239|NCT02615145|76114812|FG001|STARTED|Overall Study||278||
59999240|NCT02615145|76114813|FG002|STARTED|Overall Study||48||
59999241|NCT02615145|76114814|FG003|STARTED|Overall Study||1||
60000394|NCT02593305|76116130|FG001|NOT COMPLETED|Baseline 2||0||
59999242|NCT02615145|76114811|FG000|2 DAA + Ribavirin (RBV)|Overall Study||0|2 direct-acting antivirals (2DAA): paritaprevir/ritonavir - ombitasvir (ABBVIE REGIMEN) plus RBV|
59999243|NCT02615145|76114812|FG001|2 DAA + Ribavirin (RBV)|Overall Study||0|2 direct-acting antivirals (2DAA): paritaprevir/ritonavir - ombitasvir (ABBVIE REGIMEN) plus RBV|
59999244|NCT02615145|76114813|FG002|2 DAA + Ribavirin (RBV)|Overall Study||45|2 direct-acting antivirals (2DAA): paritaprevir/ritonavir - ombitasvir (ABBVIE REGIMEN) plus RBV|
59999245|NCT02615145|76114814|FG003|2 DAA + Ribavirin (RBV)|Overall Study||0|2 direct-acting antivirals (2DAA): paritaprevir/ritonavir - ombitasvir (ABBVIE REGIMEN) plus RBV|
59999246|NCT02615145|76114811|FG000|3DAA|Overall Study||5|3 direct-acting antivirals (3DAA): paritaprevir/ritonavir - ombitasvir + dasabuvir (ABBVIE REGIMEN)|
59999247|NCT02615145|76114812|FG001|3DAA|Overall Study||261|3 direct-acting antivirals (3DAA): paritaprevir/ritonavir - ombitasvir + dasabuvir (ABBVIE REGIMEN)|
59999248|NCT02615145|76114813|FG002|3DAA|Overall Study||0|3 direct-acting antivirals (3DAA): paritaprevir/ritonavir - ombitasvir + dasabuvir (ABBVIE REGIMEN)|
59999249|NCT02615145|76114814|FG003|3DAA|Overall Study||0|3 direct-acting antivirals (3DAA): paritaprevir/ritonavir - ombitasvir + dasabuvir (ABBVIE REGIMEN)|
59999250|NCT02615145|76114811|FG000|3DAA + RBV|Overall Study||140|3DAA: paritaprevir/ritonavir - ombitasvir + dasabuvir (ABBVIE REGIMEN) plus RBV|
59999251|NCT02615145|76114812|FG001|3DAA + RBV|Overall Study||17|3DAA: paritaprevir/ritonavir - ombitasvir + dasabuvir (ABBVIE REGIMEN) plus RBV|
59999252|NCT02615145|76114813|FG002|3DAA + RBV|Overall Study||2|3DAA: paritaprevir/ritonavir - ombitasvir + dasabuvir (ABBVIE REGIMEN) plus RBV|
59999253|NCT02615145|76114814|FG003|3DAA + RBV|Overall Study||0|3DAA: paritaprevir/ritonavir - ombitasvir + dasabuvir (ABBVIE REGIMEN) plus RBV|
59999254|NCT02615145|76114811|FG000|COMPLETED|Overall Study||118||
59999255|NCT02615145|76114812|FG001|COMPLETED|Overall Study||263||
59999256|NCT02615145|76114813|FG002|COMPLETED|Overall Study||40||
59999257|NCT02615145|76114814|FG003|COMPLETED|Overall Study||0||
59999258|NCT02615145|76114811|FG000|NOT COMPLETED|Overall Study||27||
59999259|NCT02615145|76114812|FG001|NOT COMPLETED|Overall Study||15||
59999260|NCT02615145|76114813|FG002|NOT COMPLETED|Overall Study||8||
59999261|NCT02615145|76114814|FG003|NOT COMPLETED|Overall Study||1||
59999262|NCT02119156|76114843|FG000|STARTED|Treatment Phase (Up to 52 Weeks)||39||
59999263|NCT02119156|76114844|FG001|STARTED|Treatment Phase (Up to 52 Weeks)||29||
59999264|NCT02119156|76114845|FG002|STARTED|Treatment Phase (Up to 52 Weeks)||12||
59999265|NCT02119156|76114843|FG000|COMPLETED|Treatment Phase (Up to 52 Weeks)||33||
59999266|NCT02119156|76114844|FG001|COMPLETED|Treatment Phase (Up to 52 Weeks)||27||
59999267|NCT02119156|76114845|FG002|COMPLETED|Treatment Phase (Up to 52 Weeks)||11||
59999268|NCT02119156|76114843|FG000|NOT COMPLETED|Treatment Phase (Up to 52 Weeks)||6||
59999269|NCT02119156|76114844|FG001|NOT COMPLETED|Treatment Phase (Up to 52 Weeks)||2||
59999270|NCT02119156|76114845|FG002|NOT COMPLETED|Treatment Phase (Up to 52 Weeks)||1||
59999271|NCT02119156|76114843|FG000|STARTED|Maintenance (Up to 48 Weeks of Year 2-4)|Long-term discontinuation participants were not allowed in Maintenance period|0||
59999272|NCT02119156|76114844|FG001|STARTED|Maintenance (Up to 48 Weeks of Year 2-4)|Eligible participants of Treatment control and holiday group on completion of 52-weeks were included|16||
59999273|NCT02119156|76114845|FG002|STARTED|Maintenance (Up to 48 Weeks of Year 2-4)|Eligible participants of Treatment control and holiday group on completion of 52-weeks were included|10||
59999274|NCT02119156|76114843|FG000|COMPLETED|Maintenance (Up to 48 Weeks of Year 2-4)||0||
59999275|NCT02119156|76114844|FG001|COMPLETED|Maintenance (Up to 48 Weeks of Year 2-4)||6||
59999276|NCT02119156|76114845|FG002|COMPLETED|Maintenance (Up to 48 Weeks of Year 2-4)||3||
59999277|NCT02119156|76114843|FG000|NOT COMPLETED|Maintenance (Up to 48 Weeks of Year 2-4)||0||
59999278|NCT02119156|76114844|FG001|NOT COMPLETED|Maintenance (Up to 48 Weeks of Year 2-4)||10||
59999279|NCT02119156|76114845|FG002|NOT COMPLETED|Maintenance (Up to 48 Weeks of Year 2-4)||7||
59999280|NCT02181556|76114860|FG000|STARTED|Overall Study||41||
59999281|NCT02181556|76114860|FG000|COMPLETED|Overall Study||40||
59999282|NCT02181556|76114860|FG000|NOT COMPLETED|Overall Study||1||
59999283|NCT02614131|76114871|FG000|STARTED|Overall Study||11||
59999284|NCT02614131|76114872|FG001|STARTED|Overall Study||8||
59999285|NCT02614131|76114873|FG002|STARTED|Overall Study||8||
59999286|NCT02614131|76114874|FG003|STARTED|Overall Study||8||
59999287|NCT02614131|76114875|FG004|STARTED|Overall Study||8||
59999288|NCT02614131|76114876|FG005|STARTED|Overall Study||2||
59999289|NCT02614131|76114877|FG006|STARTED|Overall Study||5||
59999290|NCT02614131|76114871|FG000|Received at Least One Dose of Drug|Overall Study||11||
59999291|NCT02614131|76114872|FG001|Received at Least One Dose of Drug|Overall Study||8||
59999292|NCT02614131|76114873|FG002|Received at Least One Dose of Drug|Overall Study||8||
59999293|NCT02614131|76114874|FG003|Received at Least One Dose of Drug|Overall Study||8||
59999294|NCT02614131|76114875|FG004|Received at Least One Dose of Drug|Overall Study||8||
59999295|NCT02614131|76114876|FG005|Received at Least One Dose of Drug|Overall Study||2||
59999296|NCT02614131|76114877|FG006|Received at Least One Dose of Drug|Overall Study||5||
59999297|NCT02614131|76114871|FG000|COMPLETED|Overall Study||10||
59999298|NCT02614131|76114872|FG001|COMPLETED|Overall Study||8||
59999299|NCT02614131|76114873|FG002|COMPLETED|Overall Study||8||
59999300|NCT02614131|76114874|FG003|COMPLETED|Overall Study||8||
59999301|NCT02614131|76114875|FG004|COMPLETED|Overall Study||8||
59999302|NCT02614131|76114876|FG005|COMPLETED|Overall Study||2||
59999303|NCT02614131|76114877|FG006|COMPLETED|Overall Study||4||
59999304|NCT02614131|76114871|FG000|NOT COMPLETED|Overall Study||1||
59999305|NCT02614131|76114872|FG001|NOT COMPLETED|Overall Study||0||
59999306|NCT02614131|76114873|FG002|NOT COMPLETED|Overall Study||0||
59999307|NCT02614131|76114874|FG003|NOT COMPLETED|Overall Study||0||
59999308|NCT02614131|76114875|FG004|NOT COMPLETED|Overall Study||0||
59999309|NCT02614131|76114876|FG005|NOT COMPLETED|Overall Study||0||
59999310|NCT02614131|76114877|FG006|NOT COMPLETED|Overall Study||1||
59999311|NCT05091307|76114903|FG000|STARTED|Overall Study||382|Randomized participants|
59999312|NCT05091307|76114904|FG001|STARTED|Overall Study||386|Randomized participants|
59999313|NCT05091307|76114905|FG002|STARTED|Overall Study||47|Randomized participants|
59999314|NCT05091307|76114906|FG003|STARTED|Overall Study||46|Randomized participants|
59999315|NCT05091307|76114903|FG000|Treated|Overall Study||382|Vaccinated participants|
59999316|NCT05091307|76114904|FG001|Treated|Overall Study||384|Vaccinated participants|
59999317|NCT05091307|76114905|FG002|Treated|Overall Study||47|Vaccinated participants|
59999318|NCT05091307|76114906|FG003|Treated|Overall Study||46|Vaccinated participants|
59999319|NCT05091307|76114903|FG000|COMPLETED|Overall Study||312||
59999320|NCT05091307|76114904|FG001|COMPLETED|Overall Study||316||
59999321|NCT05091307|76114905|FG002|COMPLETED|Overall Study||43||
59999322|NCT05091307|76114906|FG003|COMPLETED|Overall Study||44||
59999323|NCT05091307|76114903|FG000|NOT COMPLETED|Overall Study||70||
59999324|NCT05091307|76114904|FG001|NOT COMPLETED|Overall Study||70||
59999325|NCT05091307|76114905|FG002|NOT COMPLETED|Overall Study||4||
59999326|NCT05091307|76114906|FG003|NOT COMPLETED|Overall Study||2||
59999327|NCT05082116|76114920|FG000|STARTED|Overall Study||13||
59999328|NCT05082116|76114921|FG001|STARTED|Overall Study||23||
59999329|NCT05082116|76114920|FG000|Full Analysis Set|Overall Study||13||
59999330|NCT05082116|76114921|FG001|Full Analysis Set|Overall Study||23||
59999331|NCT05082116|76114920|FG000|Safety Analysis Set|Overall Study||13||
59999332|NCT05082116|76114921|FG001|Safety Analysis Set|Overall Study||23||
59999333|NCT05082116|76114920|FG000|Pharmacokinetic (PK) Analysis Set|Overall Study||4||
59999334|NCT05082116|76114921|FG001|Pharmacokinetic (PK) Analysis Set|Overall Study||11||
59999335|NCT05082116|76114920|FG000|COMPLETED|Overall Study||13||
59999336|NCT05082116|76114921|FG001|COMPLETED|Overall Study||23||
59999337|NCT05082116|76114920|FG000|NOT COMPLETED|Overall Study||0||
59999338|NCT05082116|76114921|FG001|NOT COMPLETED|Overall Study||0||
59999339|NCT05022004|76114929|FG000|STARTED|Overall Study||297||
59999340|NCT05022004|76114930|FG001|STARTED|Overall Study||300||
59999341|NCT05022004|76114929|FG000|COMPLETED|Overall Study||287||
59999342|NCT05022004|76114930|FG001|COMPLETED|Overall Study||289||
59999343|NCT05022004|76114929|FG000|NOT COMPLETED|Overall Study||10||
59999344|NCT05022004|76114930|FG001|NOT COMPLETED|Overall Study||11||
59999345|NCT04930965|76114938|FG000|STARTED|Overall Study||27||
59999346|NCT04930965|76114939|FG001|STARTED|Overall Study||29||
59999347|NCT04930965|76114938|FG000|COMPLETED|Overall Study||20||
59999348|NCT04930965|76114939|FG001|COMPLETED|Overall Study||24||
59999349|NCT04930965|76114938|FG000|NOT COMPLETED|Overall Study||7||
59999350|NCT04930965|76114939|FG001|NOT COMPLETED|Overall Study||5||
59999351|NCT04806334|76114945|FG000|STARTED|Overall Study||11||
59999352|NCT04806334|76114945|FG000|COMPLETED|Overall Study||10||
60131226|NCT00580671|76253764|FG002|STARTED|Overall Study||51||
59999353|NCT04806334|76114945|FG000|NOT COMPLETED|Overall Study||1||
59999354|NCT04785326|76114951|FG000|STARTED|Period 1 (Week 1 to 28)||299||
59999355|NCT04785326|76114952|FG001|STARTED|Period 1 (Week 1 to 28)||299||
59999356|NCT04785326|76114953|FG002|STARTED|Period 1 (Week 1 to 28)||0||
59999357|NCT04785326|76114951|FG000|COMPLETED|Period 1 (Week 1 to 28)||268||
59999358|NCT04785326|76114952|FG001|COMPLETED|Period 1 (Week 1 to 28)||263||
59999359|NCT04785326|76114953|FG002|COMPLETED|Period 1 (Week 1 to 28)||0||
59999360|NCT04785326|76114951|FG000|NOT COMPLETED|Period 1 (Week 1 to 28)||31||
59999361|NCT04785326|76114952|FG001|NOT COMPLETED|Period 1 (Week 1 to 28)||36||
59999362|NCT04785326|76114953|FG002|NOT COMPLETED|Period 1 (Week 1 to 28)||0||
59999363|NCT04785326|76114951|FG000|STARTED|Period 2 (Week 28 to 52)||268||
59999364|NCT04785326|76114952|FG001|STARTED|Period 2 (Week 28 to 52)|Period 1 Stelara Group has been re-randomized by 1:1, to Stelara group and Switch to DMB-3115 group.|132||
59999365|NCT04785326|76114953|FG002|STARTED|Period 2 (Week 28 to 52)|Period 1 Stelara Group has been re-randomized by 1:1, to Stelara group and Switch to DMB-3115 group.|131||
59999366|NCT04785326|76114951|FG000|COMPLETED|Period 2 (Week 28 to 52)||258||
59999367|NCT04785326|76114952|FG001|COMPLETED|Period 2 (Week 28 to 52)||130||
59999368|NCT04785326|76114953|FG002|COMPLETED|Period 2 (Week 28 to 52)||124||
59999369|NCT04785326|76114951|FG000|NOT COMPLETED|Period 2 (Week 28 to 52)||10||
59999370|NCT04785326|76114952|FG001|NOT COMPLETED|Period 2 (Week 28 to 52)||2||
59999371|NCT04785326|76114953|FG002|NOT COMPLETED|Period 2 (Week 28 to 52)||7||
59999372|NCT04740931|76114964|FG000|STARTED|Overall Study||366|Intent-to-Treat (ITT) Population|
59999373|NCT04740931|76114965|FG001|STARTED|Overall Study||363|Intent-to-Treat (ITT) Population|
59999374|NCT04740931|76114964|FG000|Received at Least One Dose of Study Drug|Overall Study||365|Safety-Evaluable Population|
59999375|NCT04740931|76114965|FG001|Received at Least One Dose of Study Drug|Overall Study||361|Safety-Evaluable Population|
59999376|NCT04740931|76114964|FG000|Completed up to Week 24 (Part 1)|Overall Study||360|Clinical Cutoff for Primary Completion Date|
59999377|NCT04740931|76114965|FG001|Completed up to Week 24 (Part 1)|Overall Study||353|Clinical Cutoff for Primary Completion Date|
59999378|NCT04740931|76114964|FG000|COMPLETED|Overall Study||0||
59999379|NCT04740931|76114965|FG001|COMPLETED|Overall Study||0||
59999380|NCT04740931|76114964|FG000|NOT COMPLETED|Overall Study||366||
60131227|NCT00580671|76253762|FG000|COMPLETED|Overall Study||35||
59999381|NCT04740931|76114965|FG001|NOT COMPLETED|Overall Study||363||
59999382|NCT04681352|76114971|FG000|STARTED|Overall Study||99||
59999383|NCT04681352|76114971|FG000|COMPLETED|Overall Study||75||
59999384|NCT04681352|76114971|FG000|NOT COMPLETED|Overall Study||24||
59999385|NCT04471428|76114977|FG000|STARTED|Overall Study||180||
59999386|NCT04471428|76114978|FG001|STARTED|Overall Study||186||
59999387|NCT04471428|76114977|FG000|COMPLETED|Overall Study||0||
59999388|NCT04471428|76114978|FG001|COMPLETED|Overall Study||0||
59999389|NCT04471428|76114977|FG000|NOT COMPLETED|Overall Study||180||
59999390|NCT04471428|76114978|FG001|NOT COMPLETED|Overall Study||186||
59999391|NCT04400058|76114987|FG000|STARTED|Overall Study||105||
59999392|NCT04400058|76114988|FG001|STARTED|Overall Study||102||
59999393|NCT04400058|76114987|FG000|COMPLETED|Overall Study||84||
59999394|NCT04400058|76114988|FG001|COMPLETED|Overall Study||86||
59999395|NCT04400058|76114987|FG000|NOT COMPLETED|Overall Study||21||
59999396|NCT04400058|76114988|FG001|NOT COMPLETED|Overall Study||16||
59999397|NCT04339413|76114996|FG000|STARTED|Overall Study||59||
59999398|NCT04339413|76114997|FG001|STARTED|Overall Study||57||
59999399|NCT04339413|76114996|FG000|Safety Evaluable Population|Overall Study||59|Safety evaluable population included all the participants who received at least one dose of gantenerumab|
59999400|NCT04339413|76114997|FG001|Safety Evaluable Population|Overall Study||56|Safety evaluable population included all the participants who received at least one dose of gantenerumab|
59999401|NCT04339413|76114996|FG000|COMPLETED|Overall Study||1||
59999402|NCT04339413|76114997|FG001|COMPLETED|Overall Study||0||
59999403|NCT04339413|76114996|FG000|NOT COMPLETED|Overall Study||58||
59999404|NCT04339413|76114997|FG001|NOT COMPLETED|Overall Study||57||
59999405|NCT04327999|76115003|FG000|STARTED|Overall Study||9||
59999406|NCT04327999|76115003|FG000|COMPLETED|Overall Study||8|1 patient was excluded for deviation from protocol|
59999407|NCT04327999|76115003|FG000|NOT COMPLETED|Overall Study||1||
59999408|NCT04163952|76115007|FG000|STARTED|Overall Study||5||
59999409|NCT04163952|76115007|FG000|COMPLETED|Overall Study||5||
59999410|NCT04163952|76115007|FG000|NOT COMPLETED|Overall Study||0||
59999411|NCT04145037|76115013|FG000|STARTED|Overall Study||8||
59999412|NCT04145037|76115014|FG001|STARTED|Overall Study||0||
59999413|NCT04145037|76115013|FG000|Mobilized and Apheresed|Overall Study||6||
59999414|NCT04145037|76115014|FG001|Mobilized and Apheresed|Overall Study||0||
59999415|NCT04145037|76115013|FG000|Received AVR-RD-02|Overall Study||5||
59999416|NCT04145037|76115014|FG001|Received AVR-RD-02|Overall Study||0||
59999417|NCT04145037|76115013|FG000|COMPLETED|Overall Study||4||
59999418|NCT04145037|76115014|FG001|COMPLETED|Overall Study||0||
59999419|NCT04145037|76115013|FG000|NOT COMPLETED|Overall Study||4||
59999420|NCT04145037|76115014|FG001|NOT COMPLETED|Overall Study||0||
59999421|NCT04097028|76115022|FG000|STARTED|Overall Study||22||
59999422|NCT04097028|76115022|FG000|COMPLETED|Overall Study||15||
59999423|NCT04097028|76115022|FG000|NOT COMPLETED|Overall Study||7||
59999424|NCT03980561|76115028|FG000|STARTED|Overall Study||90||
59999425|NCT03980561|76115029|FG001|STARTED|Overall Study||84||
59999426|NCT03980561|76115028|FG000|COMPLETED|Overall Study||61||
59999427|NCT03980561|76115029|FG001|COMPLETED|Overall Study||59||
59999428|NCT03980561|76115028|FG000|NOT COMPLETED|Overall Study||29||
59999429|NCT03980561|76115029|FG001|NOT COMPLETED|Overall Study||25||
59999430|NCT03749330|76115041|FG000|STARTED|Overall Study||60||
59999431|NCT03749330|76115042|FG001|STARTED|Overall Study||24||
59999432|NCT03749330|76115043|FG002|STARTED|Overall Study||202||
59999433|NCT03749330|76115044|FG003|STARTED|Overall Study||45||
59999434|NCT03749330|76115045|FG004|STARTED|Overall Study||21||
59999435|NCT03749330|76115046|FG005|STARTED|Overall Study||99||
59999436|NCT03749330|76115041|FG000|COMPLETED|Overall Study||60||
59999437|NCT03749330|76115042|FG001|COMPLETED|Overall Study||22||
59999438|NCT03749330|76115043|FG002|COMPLETED|Overall Study||202||
59999439|NCT03749330|76115044|FG003|COMPLETED|Overall Study||45||
59999440|NCT03749330|76115045|FG004|COMPLETED|Overall Study||21||
59999441|NCT03749330|76115046|FG005|COMPLETED|Overall Study||99||
59999442|NCT03749330|76115041|FG000|NOT COMPLETED|Overall Study||0||
59999443|NCT03749330|76115042|FG001|NOT COMPLETED|Overall Study||2||
59999444|NCT03749330|76115043|FG002|NOT COMPLETED|Overall Study||0||
59999445|NCT03749330|76115044|FG003|NOT COMPLETED|Overall Study||0||
59999446|NCT03749330|76115045|FG004|NOT COMPLETED|Overall Study||0||
59999447|NCT03749330|76115046|FG005|NOT COMPLETED|Overall Study||0||
59999448|NCT03740737|76115068|FG000|STARTED|Overall Study||526|This trial assessed the efficacy and safety of FE 999049 in participants undergoing controlled ovarian stimulation (COS) for in-vitro fertilization (IVF) / intracytoplasmic sperm injection (ICSI) following a GnRH antagonist protocol. The trial was designed to capture the clinical efficacy of a single COS cycle in a more complete manner by following outcomes from both the fresh and subsequent cryopreserved cycles.|
59999449|NCT03740737|76115069|FG001|STARTED|Overall Study||53|This trial assessed the efficacy and safety of FE 999049 in participants undergoing controlled ovarian stimulation (COS) for in-vitro fertilization (IVF) / intracytoplasmic sperm injection (ICSI) following a GnRH antagonist protocol. The trial was designed to capture the clinical efficacy of a single COS cycle in a more complete manner by following outcomes from both the fresh and subsequent cryopreserved cycles.|
59999450|NCT03740737|76115068|FG000|mITT|Overall Study||525||
59999451|NCT03740737|76115069|FG001|mITT|Overall Study||53||
59999452|NCT03740737|76115068|FG000|COMPLETED|Overall Study||506||
59999453|NCT03740737|76115069|FG001|COMPLETED|Overall Study||52||
59999454|NCT03740737|76115068|FG000|NOT COMPLETED|Overall Study||20||
59999455|NCT03740737|76115069|FG001|NOT COMPLETED|Overall Study||1||
59999456|NCT03738618|76115078|FG000|STARTED|Overall Study||534|Data reported for the fresh cycle.|
59999457|NCT03738618|76115079|FG001|STARTED|Overall Study||54|Data reported for the fresh cycle.|
59999458|NCT03738618|76115078|FG000|Modified Intention-to-treat (mITT)|Overall Study||533||
59999459|NCT03738618|76115079|FG001|Modified Intention-to-treat (mITT)|Overall Study||54||
59999460|NCT03738618|76115078|FG000|COMPLETED|Overall Study||502||
59999461|NCT03738618|76115079|FG001|COMPLETED|Overall Study||54||
59999462|NCT03738618|76115078|FG000|NOT COMPLETED|Overall Study||32||
59999463|NCT03738618|76115079|FG001|NOT COMPLETED|Overall Study||0||
59999464|NCT03556891|76115087|FG000|STARTED|Overall Study||133||
59999465|NCT03556891|76115087|FG000|COMPLETED|Overall Study||120||
59999466|NCT03556891|76115087|FG000|NOT COMPLETED|Overall Study||13||
59999467|NCT03484923|76115096|FG000|STARTED|Overall Study||45||
59999468|NCT03484923|76115097|FG001|STARTED|Overall Study||43||
59999469|NCT03484923|76115098|FG002|STARTED|Overall Study||43||
59999470|NCT03484923|76115099|FG003|STARTED|Overall Study||44||
59999471|NCT03484923|76115100|FG004|STARTED|Overall Study||21||
59999472|NCT03484923|76115096|FG000|Treated|Overall Study||45||
59999473|NCT03484923|76115097|FG001|Treated|Overall Study||43||
59999474|NCT03484923|76115098|FG002|Treated|Overall Study||42||
59999475|NCT03484923|76115099|FG003|Treated|Overall Study||44||
59999476|NCT03484923|76115100|FG004|Treated|Overall Study||21||
59999477|NCT03484923|76115096|FG000|COMPLETED|Overall Study||0||
59999478|NCT03484923|76115097|FG001|COMPLETED|Overall Study||0||
59999479|NCT03484923|76115098|FG002|COMPLETED|Overall Study||0||
59999480|NCT03484923|76115099|FG003|COMPLETED|Overall Study||0||
59999481|NCT03484923|76115100|FG004|COMPLETED|Overall Study||0||
59999482|NCT03484923|76115096|FG000|NOT COMPLETED|Overall Study||45||
59999483|NCT03484923|76115097|FG001|NOT COMPLETED|Overall Study||43||
59999484|NCT03484923|76115098|FG002|NOT COMPLETED|Overall Study||43||
59999485|NCT03484923|76115099|FG003|NOT COMPLETED|Overall Study||44||
59999486|NCT03484923|76115100|FG004|NOT COMPLETED|Overall Study||21||
59999487|NCT03479502|76115126|FG000|STARTED|Overall Study||1||
59999488|NCT03479502|76115127|FG001|STARTED|Overall Study||0||
59999489|NCT03479502|76115126|FG000|COMPLETED|Overall Study||1||
60131228|NCT00580671|76253763|FG001|COMPLETED|Overall Study||35||
60131229|NCT00580671|76253764|FG002|COMPLETED|Overall Study||34||
59999490|NCT03479502|76115127|FG001|COMPLETED|Overall Study||0||
59999491|NCT03479502|76115126|FG000|NOT COMPLETED|Overall Study||0||
59999492|NCT03479502|76115127|FG001|NOT COMPLETED|Overall Study||0||
59999493|NCT03433469|76115133|FG000|STARTED|Overall Study||27||
59999494|NCT03433469|76115133|FG000|COMPLETED|Overall Study||27||
59999495|NCT03433469|76115133|FG000|NOT COMPLETED|Overall Study||0||
59999496|NCT03397342|76115139|FG000|STARTED|Overall Study||5||
59999497|NCT03397342|76115140|FG001|STARTED|Overall Study||0||
59999498|NCT03397342|76115139|FG000|COMPLETED|Overall Study||5||
59999499|NCT03397342|76115140|FG001|COMPLETED|Overall Study||0||
59999500|NCT03397342|76115139|FG000|NOT COMPLETED|Overall Study||0||
59999501|NCT03397342|76115140|FG001|NOT COMPLETED|Overall Study||0||
59999502|NCT03323151|76115150|FG000|STARTED|Overall Study||3||
59999503|NCT03323151|76115151|FG001|STARTED|Overall Study||9||
59999504|NCT03323151|76115152|FG002|STARTED|Overall Study||4||
59999505|NCT03323151|76115153|FG003|STARTED|Overall Study||27||
59999506|NCT03323151|76115150|FG000|COMPLETED|Overall Study||3||
59999507|NCT03323151|76115151|FG001|COMPLETED|Overall Study||9||
59999508|NCT03323151|76115152|FG002|COMPLETED|Overall Study||4||
59999509|NCT03323151|76115153|FG003|COMPLETED|Overall Study||27||
59999510|NCT03323151|76115150|FG000|NOT COMPLETED|Overall Study||0||
59999511|NCT03323151|76115151|FG001|NOT COMPLETED|Overall Study||0||
59999512|NCT03323151|76115152|FG002|NOT COMPLETED|Overall Study||0||
59999513|NCT03323151|76115153|FG003|NOT COMPLETED|Overall Study||0||
59999514|NCT03244475|76115169|FG000|STARTED|Overall Study||30||
59999515|NCT03244475|76115170|FG001|STARTED|Overall Study||17||
59999516|NCT03244475|76115171|FG002|STARTED|Overall Study||19||
59999517|NCT03244475|76115169|FG000|COMPLETED|Overall Study||18||
59999518|NCT03244475|76115170|FG001|COMPLETED|Overall Study||4||
59999519|NCT03244475|76115171|FG002|COMPLETED|Overall Study||19||
59999520|NCT03244475|76115169|FG000|NOT COMPLETED|Overall Study||12||
59999521|NCT03244475|76115170|FG001|NOT COMPLETED|Overall Study||13||
59999522|NCT03244475|76115171|FG002|NOT COMPLETED|Overall Study||0||
59999523|NCT03146650|76115179|FG000|STARTED|Registered for Study||25||
59999524|NCT03146650|76115179|FG000|Received First Dose of Study Drug|Registered for Study||24||
59999525|NCT03146650|76115179|FG000|COMPLETED|Registered for Study||24||
59999526|NCT03146650|76115179|FG000|NOT COMPLETED|Registered for Study||1||
59999527|NCT03146650|76115179|FG000|STARTED|Completed Cycle 1 of Treatment(Nivo+Ipi)||24||
59999528|NCT03146650|76115179|FG000|COMPLETED|Completed Cycle 1 of Treatment(Nivo+Ipi)||23||
59999529|NCT03146650|76115179|FG000|NOT COMPLETED|Completed Cycle 1 of Treatment(Nivo+Ipi)||1||
60000395|NCT02593305|76116131|FG002|NOT COMPLETED|Baseline 2||0||
60131230|NCT00580671|76253762|FG000|NOT COMPLETED|Overall Study||16||
60131231|NCT00580671|76253763|FG001|NOT COMPLETED|Overall Study||16||
59999530|NCT03146650|76115179|FG000|STARTED|Continued to Cycle 2 and Beyond||23|Nivolumab and ipilimumab administered intravenously until disease progression/intolerable toxicity.|
59999531|NCT03146650|76115179|FG000|Reached First Response Assessment|Continued to Cycle 2 and Beyond||23||
59999532|NCT03146650|76115179|FG000|Received Cycle 2 Dose of Study Drugs|Continued to Cycle 2 and Beyond||21||
59999533|NCT03146650|76115179|FG000|COMPLETED|Continued to Cycle 2 and Beyond||19|2 patients discontinued after completing Cycle 1 due to disease progression.|
59999534|NCT03146650|76115179|FG000|NOT COMPLETED|Continued to Cycle 2 and Beyond||4||
59999535|NCT03146650|76115179|FG000|STARTED|2 Year Follow-up||22|Patients who received one dose of study drug and have discontinued treatment go into follow-up.|
59999536|NCT03146650|76115179|FG000|COMPLETED|2 Year Follow-up||3||
59999537|NCT03146650|76115179|FG000|NOT COMPLETED|2 Year Follow-up||19||
59999538|NCT03091192|76115185|FG000|STARTED|Overall Study||33||
59999539|NCT03091192|76115186|FG001|STARTED|Overall Study||27||
59999540|NCT03091192|76115185|FG000|COMPLETED|Overall Study||0||
59999541|NCT03091192|76115186|FG001|COMPLETED|Overall Study||0||
59999542|NCT03091192|76115185|FG000|NOT COMPLETED|Overall Study||33||
59999543|NCT03091192|76115186|FG001|NOT COMPLETED|Overall Study||27||
59999544|NCT03087760|76115192|FG000|STARTED|Overall Study||22||
59999545|NCT03087760|76115192|FG000|COMPLETED|Overall Study||3||
59999546|NCT03087760|76115192|FG000|NOT COMPLETED|Overall Study||19||
59999547|NCT02829723|76115222|FG000|STARTED|Overall Study||5|The Full Analysis Set (FAS) comprises all patients who received at least one dose of study treatment. Patients were analyzed according to the planned treatment.|
59999548|NCT02829723|76115223|FG001|STARTED|Overall Study||7|The Full Analysis Set (FAS) comprises all patients who received at least one dose of study treatment. Patients were analyzed according to the planned treatment.|
59999549|NCT02829723|76115224|FG002|STARTED|Overall Study||5|The Full Analysis Set (FAS) comprises all patients who received at least one dose of study treatment. Patients were analyzed according to the planned treatment.|
59999550|NCT02829723|76115225|FG003|STARTED|Overall Study||6|The Full Analysis Set (FAS) comprises all patients who received at least one dose of study treatment. Patients were analyzed according to the planned treatment.|
59999551|NCT02829723|76115226|FG004|STARTED|Overall Study||3|The Full Analysis Set (FAS) comprises all patients who received at least one dose of study treatment. Patients were analyzed according to the planned treatment.|
59999552|NCT02829723|76115227|FG005|STARTED|Overall Study||5|The Full Analysis Set (FAS) comprises all patients who received at least one dose of study treatment. Patients were analyzed according to the planned treatment.|
59999553|NCT02829723|76115228|FG006|STARTED|Overall Study||6|The Full Analysis Set (FAS) comprises all patients who received at least one dose of study treatment. Patients were analyzed according to the planned treatment.|
59999554|NCT02829723|76115229|FG007|STARTED|Overall Study||8|The Full Analysis Set (FAS) comprises all patients who received at least one dose of study treatment. Patients were analyzed according to the planned treatment.|
59999555|NCT02829723|76115230|FG008|STARTED|Overall Study||9|The Full Analysis Set (FAS) comprises all patients who received at least one dose of study treatment. Patients were analyzed according to the planned treatment.|
59999556|NCT02829723|76115231|FG009|STARTED|Overall Study||5|The Full Analysis Set (FAS) comprises all patients who received at least one dose of study treatment. Patients were analyzed according to the planned treatment.|
59999557|NCT02829723|76115232|FG010|STARTED|Overall Study||10|The Full Analysis Set (FAS) comprises all patients who received at least one dose of study treatment. Patients were analyzed according to the planned treatment.|
59999558|NCT02829723|76115233|FG011|STARTED|Overall Study||0|The Full Analysis Set (FAS) comprises all patients who received at least one dose of study treatment. Patients were analyzed according to the planned treatment.|
59999559|NCT02829723|76115234|FG012|STARTED|Overall Study||5|The Full Analysis Set (FAS) comprises all patients who received at least one dose of study treatment. Patients were analyzed according to the planned treatment.|
59999560|NCT02829723|76115235|FG013|STARTED|Overall Study||6|The Full Analysis Set (FAS) comprises all patients who received at least one dose of study treatment. Patients were analyzed according to the planned treatment.|
59999561|NCT02829723|76115236|FG014|STARTED|Overall Study||4|The Full Analysis Set (FAS) comprises all patients who received at least one dose of study treatment. Patients were analyzed according to the planned treatment.|
59999562|NCT02829723|76115237|FG015|STARTED|Overall Study||5|The Full Analysis Set (FAS) comprises all patients who received at least one dose of study treatment. Patients were analyzed according to the planned treatment.|
59999563|NCT02829723|76115238|FG016|STARTED|Overall Study||9|The Full Analysis Set (FAS) comprises all patients who received at least one dose of study treatment. Patients were analyzed according to the planned treatment.|
59999564|NCT02829723|76115239|FG017|STARTED|Overall Study||5|The Full Analysis Set (FAS) comprises all patients who received at least one dose of study treatment. Patients were analyzed according to the planned treatment.|
59999565|NCT02829723|76115240|FG018|STARTED|Overall Study||6|The Full Analysis Set (FAS) comprises all patients who received at least one dose of study treatment. Patients were analyzed according to the planned treatment.|
59999566|NCT02829723|76115241|FG019|STARTED|Overall Study||5|The Full Analysis Set (FAS) comprises all patients who received at least one dose of study treatment. Patients were analyzed according to the planned treatment.|
59999567|NCT02829723|76115242|FG020|STARTED|Overall Study||11|The Full Analysis Set (FAS) comprises all patients who received at least one dose of study treatment. Patients were analyzed according to the planned treatment.|
59999568|NCT02829723|76115243|FG021|STARTED|Overall Study||9|The Full Analysis Set (FAS) comprises all patients who received at least one dose of study treatment. Patients were analyzed according to the planned treatment.|
59999569|NCT02829723|76115244|FG022|STARTED|Overall Study||4|The Full Analysis Set (FAS) comprises all patients who received at least one dose of study treatment. Patients were analyzed according to the planned treatment.|
60131232|NCT00580671|76253764|FG002|NOT COMPLETED|Overall Study||17||
60131233|NCT01535222|76253778|FG000|STARTED|Overall Study||3||
60131234|NCT01535222|76253779|FG001|STARTED|Overall Study||3||
59999570|NCT02829723|76115245|FG023|STARTED|Overall Study||6|The Full Analysis Set (FAS) comprises all patients who received at least one dose of study treatment. Patients were analyzed according to the planned treatment.|
59999571|NCT02829723|76115246|FG024|STARTED|Overall Study||5|The Full Analysis Set (FAS) comprises all patients who received at least one dose of study treatment. Patients were analyzed according to the planned treatment.|
59999572|NCT02829723|76115247|FG025|STARTED|Overall Study||22|The Full Analysis Set (FAS) comprises all patients who received at least one dose of study treatment. Patients were analyzed according to the planned treatment.|
59999573|NCT02829723|76115248|FG026|STARTED|Overall Study||21|The Full Analysis Set (FAS) comprises all patients who received at least one dose of study treatment. Patients were analyzed according to the planned treatment.|
59999574|NCT02829723|76115222|FG000|Safety Set|Overall Study||5|The Safety Set includes all patients who received at least one dose of BLZ945 or PDR001. Patients were analyzed according to the study treatment (regimen) they actually received.|
59999575|NCT02829723|76115223|FG001|Safety Set|Overall Study||7|The Safety Set includes all patients who received at least one dose of BLZ945 or PDR001. Patients were analyzed according to the study treatment (regimen) they actually received.|
59999576|NCT02829723|76115224|FG002|Safety Set|Overall Study||5|The Safety Set includes all patients who received at least one dose of BLZ945 or PDR001. Patients were analyzed according to the study treatment (regimen) they actually received.|
59999577|NCT02829723|76115225|FG003|Safety Set|Overall Study||6|The Safety Set includes all patients who received at least one dose of BLZ945 or PDR001. Patients were analyzed according to the study treatment (regimen) they actually received.|
59999578|NCT02829723|76115226|FG004|Safety Set|Overall Study||3|The Safety Set includes all patients who received at least one dose of BLZ945 or PDR001. Patients were analyzed according to the study treatment (regimen) they actually received.|
59999579|NCT02829723|76115227|FG005|Safety Set|Overall Study||5|The Safety Set includes all patients who received at least one dose of BLZ945 or PDR001. Patients were analyzed according to the study treatment (regimen) they actually received.|
59999580|NCT02829723|76115228|FG006|Safety Set|Overall Study||6|The Safety Set includes all patients who received at least one dose of BLZ945 or PDR001. Patients were analyzed according to the study treatment (regimen) they actually received.|
59999581|NCT02829723|76115229|FG007|Safety Set|Overall Study||8|The Safety Set includes all patients who received at least one dose of BLZ945 or PDR001. Patients were analyzed according to the study treatment (regimen) they actually received.|
59999582|NCT02829723|76115230|FG008|Safety Set|Overall Study||9|The Safety Set includes all patients who received at least one dose of BLZ945 or PDR001. Patients were analyzed according to the study treatment (regimen) they actually received.|
59999583|NCT02829723|76115231|FG009|Safety Set|Overall Study||5|The Safety Set includes all patients who received at least one dose of BLZ945 or PDR001. Patients were analyzed according to the study treatment (regimen) they actually received.|
59999584|NCT02829723|76115232|FG010|Safety Set|Overall Study||10|The Safety Set includes all patients who received at least one dose of BLZ945 or PDR001. Patients were analyzed according to the study treatment (regimen) they actually received.|
59999585|NCT02829723|76115233|FG011|Safety Set|Overall Study||1|The Safety Set includes all patients who received at least one dose of BLZ945 or PDR001. Patients were analyzed according to the study treatment (regimen) they actually received.|
59999586|NCT02829723|76115234|FG012|Safety Set|Overall Study||4|The Safety Set includes all patients who received at least one dose of BLZ945 or PDR001. Patients were analyzed according to the study treatment (regimen) they actually received.|
59999587|NCT02829723|76115235|FG013|Safety Set|Overall Study||6|The Safety Set includes all patients who received at least one dose of BLZ945 or PDR001. Patients were analyzed according to the study treatment (regimen) they actually received.|
59999588|NCT02829723|76115236|FG014|Safety Set|Overall Study||4|The Safety Set includes all patients who received at least one dose of BLZ945 or PDR001. Patients were analyzed according to the study treatment (regimen) they actually received.|
59999589|NCT02829723|76115237|FG015|Safety Set|Overall Study||5|The Safety Set includes all patients who received at least one dose of BLZ945 or PDR001. Patients were analyzed according to the study treatment (regimen) they actually received.|
59999590|NCT02829723|76115238|FG016|Safety Set|Overall Study||9|The Safety Set includes all patients who received at least one dose of BLZ945 or PDR001. Patients were analyzed according to the study treatment (regimen) they actually received.|
59999591|NCT02829723|76115239|FG017|Safety Set|Overall Study||5|The Safety Set includes all patients who received at least one dose of BLZ945 or PDR001. Patients were analyzed according to the study treatment (regimen) they actually received.|
59999592|NCT02829723|76115240|FG018|Safety Set|Overall Study||6|The Safety Set includes all patients who received at least one dose of BLZ945 or PDR001. Patients were analyzed according to the study treatment (regimen) they actually received.|
59999593|NCT02829723|76115241|FG019|Safety Set|Overall Study||5|The Safety Set includes all patients who received at least one dose of BLZ945 or PDR001. Patients were analyzed according to the study treatment (regimen) they actually received.|
59999594|NCT02829723|76115242|FG020|Safety Set|Overall Study||11|The Safety Set includes all patients who received at least one dose of BLZ945 or PDR001. Patients were analyzed according to the study treatment (regimen) they actually received.|
59999595|NCT02829723|76115243|FG021|Safety Set|Overall Study||9|The Safety Set includes all patients who received at least one dose of BLZ945 or PDR001. Patients were analyzed according to the study treatment (regimen) they actually received.|
59999596|NCT02829723|76115244|FG022|Safety Set|Overall Study||4|The Safety Set includes all patients who received at least one dose of BLZ945 or PDR001. Patients were analyzed according to the study treatment (regimen) they actually received.|
59999597|NCT02829723|76115245|FG023|Safety Set|Overall Study||6|The Safety Set includes all patients who received at least one dose of BLZ945 or PDR001. Patients were analyzed according to the study treatment (regimen) they actually received.|
60000396|NCT02593305|76116129|FG000|STARTED|Post 2||7||
60131235|NCT01535222|76253780|FG002|STARTED|Overall Study|Patient randomized but did not meet inclusion/exclusion criteria and did not receive study drug|7||
60131236|NCT01535222|76253781|FG003|STARTED|Overall Study||6||
60131237|NCT01535222|76253782|FG004|STARTED|Overall Study||6||
59999598|NCT02829723|76115246|FG024|Safety Set|Overall Study||5|The Safety Set includes all patients who received at least one dose of BLZ945 or PDR001. Patients were analyzed according to the study treatment (regimen) they actually received.|
59999599|NCT02829723|76115247|FG025|Safety Set|Overall Study||22|The Safety Set includes all patients who received at least one dose of BLZ945 or PDR001. Patients were analyzed according to the study treatment (regimen) they actually received.|
59999600|NCT02829723|76115248|FG026|Safety Set|Overall Study||21|The Safety Set includes all patients who received at least one dose of BLZ945 or PDR001. Patients were analyzed according to the study treatment (regimen) they actually received.|
59999601|NCT02829723|76115222|FG000|Japanese Cohort|Overall Study||0||
59999602|NCT02829723|76115223|FG001|Japanese Cohort|Overall Study||0||
59999603|NCT02829723|76115224|FG002|Japanese Cohort|Overall Study||0||
59999604|NCT02829723|76115225|FG003|Japanese Cohort|Overall Study||0||
59999605|NCT02829723|76115226|FG004|Japanese Cohort|Overall Study||0||
59999606|NCT02829723|76115227|FG005|Japanese Cohort|Overall Study||0||
59999607|NCT02829723|76115228|FG006|Japanese Cohort|Overall Study||0||
59999608|NCT02829723|76115229|FG007|Japanese Cohort|Overall Study||3||
59999609|NCT02829723|76115230|FG008|Japanese Cohort|Overall Study||5||
59999610|NCT02829723|76115231|FG009|Japanese Cohort|Overall Study||0||
59999611|NCT02829723|76115232|FG010|Japanese Cohort|Overall Study||0||
59999612|NCT02829723|76115233|FG011|Japanese Cohort|Overall Study||0||
59999613|NCT02829723|76115234|FG012|Japanese Cohort|Overall Study||0||
59999614|NCT02829723|76115235|FG013|Japanese Cohort|Overall Study||0||
59999615|NCT02829723|76115236|FG014|Japanese Cohort|Overall Study||0||
59999616|NCT02829723|76115237|FG015|Japanese Cohort|Overall Study||0||
59999617|NCT02829723|76115238|FG016|Japanese Cohort|Overall Study||0||
59999618|NCT02829723|76115239|FG017|Japanese Cohort|Overall Study||0||
59999619|NCT02829723|76115240|FG018|Japanese Cohort|Overall Study||0||
59999620|NCT02829723|76115241|FG019|Japanese Cohort|Overall Study||0||
59999621|NCT02829723|76115242|FG020|Japanese Cohort|Overall Study||0||
59999622|NCT02829723|76115243|FG021|Japanese Cohort|Overall Study||0||
59999623|NCT02829723|76115244|FG022|Japanese Cohort|Overall Study||0||
59999624|NCT02829723|76115245|FG023|Japanese Cohort|Overall Study||0||
59999625|NCT02829723|76115246|FG024|Japanese Cohort|Overall Study||0||
59999626|NCT02829723|76115247|FG025|Japanese Cohort|Overall Study||0||
59999627|NCT02829723|76115248|FG026|Japanese Cohort|Overall Study||0||
59999628|NCT02829723|76115222|FG000|COMPLETED|Overall Study||0||
59999629|NCT02829723|76115223|FG001|COMPLETED|Overall Study||0||
59999630|NCT02829723|76115224|FG002|COMPLETED|Overall Study||0||
59999631|NCT02829723|76115225|FG003|COMPLETED|Overall Study||0||
59999632|NCT02829723|76115226|FG004|COMPLETED|Overall Study||0||
59999633|NCT02829723|76115227|FG005|COMPLETED|Overall Study||0||
59999634|NCT02829723|76115228|FG006|COMPLETED|Overall Study||0||
59999635|NCT02829723|76115229|FG007|COMPLETED|Overall Study||0||
59999636|NCT02829723|76115230|FG008|COMPLETED|Overall Study||0||
59999637|NCT02829723|76115231|FG009|COMPLETED|Overall Study||0||
59999638|NCT02829723|76115232|FG010|COMPLETED|Overall Study||0||
59999639|NCT02829723|76115233|FG011|COMPLETED|Overall Study||0||
59999640|NCT02829723|76115234|FG012|COMPLETED|Overall Study||0||
59999641|NCT02829723|76115235|FG013|COMPLETED|Overall Study||0||
59999642|NCT02829723|76115236|FG014|COMPLETED|Overall Study||0||
59999643|NCT02829723|76115237|FG015|COMPLETED|Overall Study||0||
59999644|NCT02829723|76115238|FG016|COMPLETED|Overall Study||0||
59999645|NCT02829723|76115239|FG017|COMPLETED|Overall Study||0||
59999646|NCT02829723|76115240|FG018|COMPLETED|Overall Study||0||
59999647|NCT02829723|76115241|FG019|COMPLETED|Overall Study||0||
59999648|NCT02829723|76115242|FG020|COMPLETED|Overall Study||0||
59999649|NCT02829723|76115243|FG021|COMPLETED|Overall Study||0||
59999650|NCT02829723|76115244|FG022|COMPLETED|Overall Study||0||
59999651|NCT02829723|76115245|FG023|COMPLETED|Overall Study||0||
59999652|NCT02829723|76115246|FG024|COMPLETED|Overall Study||0||
59999653|NCT02829723|76115247|FG025|COMPLETED|Overall Study||0||
59999654|NCT02829723|76115248|FG026|COMPLETED|Overall Study||0||
59999655|NCT02829723|76115222|FG000|NOT COMPLETED|Overall Study||5||
59999656|NCT02829723|76115223|FG001|NOT COMPLETED|Overall Study||7||
59999657|NCT02829723|76115224|FG002|NOT COMPLETED|Overall Study||5||
59999658|NCT02829723|76115225|FG003|NOT COMPLETED|Overall Study||6||
59999659|NCT02829723|76115226|FG004|NOT COMPLETED|Overall Study||3||
59999660|NCT02829723|76115227|FG005|NOT COMPLETED|Overall Study||5||
59999661|NCT02829723|76115228|FG006|NOT COMPLETED|Overall Study||6||
59999662|NCT02829723|76115229|FG007|NOT COMPLETED|Overall Study||8||
59999663|NCT02829723|76115230|FG008|NOT COMPLETED|Overall Study||9||
59999664|NCT02829723|76115231|FG009|NOT COMPLETED|Overall Study||5||
59999665|NCT02829723|76115232|FG010|NOT COMPLETED|Overall Study||10||
59999666|NCT02829723|76115233|FG011|NOT COMPLETED|Overall Study||0||
59999667|NCT02829723|76115234|FG012|NOT COMPLETED|Overall Study||5||
59999668|NCT02829723|76115235|FG013|NOT COMPLETED|Overall Study||6||
59999669|NCT02829723|76115236|FG014|NOT COMPLETED|Overall Study||4||
59999670|NCT02829723|76115237|FG015|NOT COMPLETED|Overall Study||5||
59999671|NCT02829723|76115238|FG016|NOT COMPLETED|Overall Study||9||
59999672|NCT02829723|76115239|FG017|NOT COMPLETED|Overall Study||5||
59999673|NCT02829723|76115240|FG018|NOT COMPLETED|Overall Study||6||
59999674|NCT02829723|76115241|FG019|NOT COMPLETED|Overall Study||5||
59999675|NCT02829723|76115242|FG020|NOT COMPLETED|Overall Study||11||
59999676|NCT02829723|76115243|FG021|NOT COMPLETED|Overall Study||9||
59999677|NCT02829723|76115244|FG022|NOT COMPLETED|Overall Study||4||
59999678|NCT02829723|76115245|FG023|NOT COMPLETED|Overall Study||6||
59999679|NCT02829723|76115246|FG024|NOT COMPLETED|Overall Study||5||
59999680|NCT02829723|76115247|FG025|NOT COMPLETED|Overall Study||22||
59999681|NCT02829723|76115248|FG026|NOT COMPLETED|Overall Study||21||
59999682|NCT02815579|76115367|FG000|STARTED|Overall Study||390||8
59999683|NCT02815579|76115368|FG001|STARTED|Overall Study||356||8
59999684|NCT02815579|76115367|FG000|Started Study Activities|Overall Study||366||8
59999685|NCT02815579|76115368|FG001|Started Study Activities|Overall Study||354||8
59999686|NCT02815579|76115367|FG000|COMPLETED|Overall Study||344||8
59999687|NCT02815579|76115368|FG001|COMPLETED|Overall Study||333||8
59999688|NCT02815579|76115367|FG000|NOT COMPLETED|Overall Study||46||0
59999689|NCT02815579|76115368|FG001|NOT COMPLETED|Overall Study||23||0
59999690|NCT02722616|76115377|FG000|STARTED|Overall Study||2||
59999691|NCT02722616|76115378|FG001|STARTED|Overall Study||0||
59999692|NCT02722616|76115379|FG002|STARTED|Overall Study||0||
59999693|NCT02722616|76115377|FG000|COMPLETED|Overall Study||0||
59999694|NCT02722616|76115378|FG001|COMPLETED|Overall Study||0||
59999695|NCT02722616|76115379|FG002|COMPLETED|Overall Study||0||
59999696|NCT02722616|76115377|FG000|NOT COMPLETED|Overall Study||2||
59999697|NCT02722616|76115378|FG001|NOT COMPLETED|Overall Study||0||
59999698|NCT02722616|76115379|FG002|NOT COMPLETED|Overall Study||0||
59999699|NCT02658487|76115387|FG000|STARTED|Overall Study||42||
59999700|NCT02658487|76115387|FG000|COMPLETED|Overall Study||26||
59999701|NCT02658487|76115387|FG000|NOT COMPLETED|Overall Study||16||
59999702|NCT02607046|76115394|FG000|STARTED|Overall Study||22||
59999703|NCT02607046|76115395|FG001|STARTED|Overall Study||13||
59999704|NCT02607046|76115394|FG000|COMPLETED|Overall Study||14||
59999705|NCT02607046|76115395|FG001|COMPLETED|Overall Study||10||
59999706|NCT02607046|76115394|FG000|NOT COMPLETED|Overall Study||8||
59999707|NCT02607046|76115395|FG001|NOT COMPLETED|Overall Study||3||
59999708|NCT02553460|76115401|FG000|STARTED|Overall Study||50||
59999709|NCT02553460|76115401|FG000|COMPLETED|Overall Study||21||
59999710|NCT02553460|76115401|FG000|NOT COMPLETED|Overall Study||29||
59999711|NCT02453282|76115408|FG000|STARTED|Overall Study||374||
59999712|NCT02453282|76115409|FG001|STARTED|Overall Study||372||
59999713|NCT02453282|76115410|FG002|STARTED|Overall Study||372||
59999714|NCT02453282|76115408|FG000|Received Treatment|Overall Study||369||
59999715|NCT02453282|76115409|FG001|Received Treatment|Overall Study||371||
59999716|NCT02453282|76115410|FG002|Received Treatment|Overall Study||352||
59999717|NCT02453282|76115408|FG000|COMPLETED|Overall Study||0||
59999718|NCT02453282|76115409|FG001|COMPLETED|Overall Study||0||
59999719|NCT02453282|76115410|FG002|COMPLETED|Overall Study||0||
59999720|NCT02453282|76115408|FG000|NOT COMPLETED|Overall Study||374||
59999721|NCT02453282|76115409|FG001|NOT COMPLETED|Overall Study||372||
59999722|NCT02453282|76115410|FG002|NOT COMPLETED|Overall Study||372||
59999723|NCT02296125|76115422|FG000|STARTED|Overall Study||279|There were 19 participants double counted which shows the total participants of 692.|
59999724|NCT02296125|76115423|FG001|STARTED|Overall Study|183 participant received gefitinib and 93 participants received erlotinib.|277|There were 19 participants double counted which shows the total participants of 692.|
59999725|NCT02296125|76115424|FG002|STARTED|Overall Study|There were 12 participants who were in both the Global and China Extension Osimertinib Arm.|71|There were 19 participants double counted which shows the total participants of 692.|
59999726|NCT02296125|76115425|FG003|STARTED|Overall Study|There were 7 participants who were in both the Global and China Extension SoC EGFR-TKI Arm.|65|There were 19 participants double counted which shows the total participants of 692.|
59999727|NCT02296125|76115422|FG000|COMPLETED|Overall Study||61|Participants ongoing study treatment at data cut-off|
59999728|NCT02296125|76115423|FG001|COMPLETED|Overall Study||13|Participants ongoing study treatment at data cut-off|
59999729|NCT02296125|76115424|FG002|COMPLETED|Overall Study||15|Participants ongoing study treatment at data cut-off|
59999730|NCT02296125|76115425|FG003|COMPLETED|Overall Study||3|Participants ongoing study treatment at data cut-off|
59999731|NCT02296125|76115422|FG000|NOT COMPLETED|Overall Study||218||
59999732|NCT02296125|76115423|FG001|NOT COMPLETED|Overall Study||264||
59999733|NCT02296125|76115424|FG002|NOT COMPLETED|Overall Study||56||
59999734|NCT02296125|76115425|FG003|NOT COMPLETED|Overall Study||62||
59999735|NCT02286089|76115440|FG000|STARTED|Overall Study||3||
59999736|NCT02286089|76115441|FG001|STARTED|Overall Study||3||
59999737|NCT02286089|76115442|FG002|STARTED|Overall Study||6||
59999738|NCT02286089|76115443|FG003|STARTED|Overall Study||12||
59999739|NCT02286089|76115440|FG000|COMPLETED|Overall Study||2||
59999740|NCT02286089|76115441|FG001|COMPLETED|Overall Study||2||
59999741|NCT02286089|76115442|FG002|COMPLETED|Overall Study||0||
60131238|NCT01535222|76253783|FG005|STARTED|Overall Study||8||
60131239|NCT01535222|76253778|FG000|COMPLETED|Overall Study||3||
60131240|NCT01535222|76253779|FG001|COMPLETED|Overall Study||3||
60131241|NCT01535222|76253780|FG002|COMPLETED|Overall Study||6||
60131242|NCT01535222|76253781|FG003|COMPLETED|Overall Study||6||
60131243|NCT01535222|76253782|FG004|COMPLETED|Overall Study||6||
60131244|NCT01535222|76253783|FG005|COMPLETED|Overall Study||8||
60131245|NCT01535222|76253778|FG000|NOT COMPLETED|Overall Study||0||
60131246|NCT01535222|76253779|FG001|NOT COMPLETED|Overall Study||0||
60131247|NCT01535222|76253780|FG002|NOT COMPLETED|Overall Study||1||
60131248|NCT01535222|76253781|FG003|NOT COMPLETED|Overall Study||0||
60131249|NCT01535222|76253782|FG004|NOT COMPLETED|Overall Study||0||
60131250|NCT01535222|76253783|FG005|NOT COMPLETED|Overall Study||0||
60131251|NCT01549886|76253799|FG000|STARTED|Overall Study||2||
60131252|NCT01549886|76253800|FG001|STARTED|Overall Study||3||
60131253|NCT01549886|76253799|FG000|COMPLETED|Overall Study||0||
60131254|NCT01549886|76253800|FG001|COMPLETED|Overall Study||0||
60131255|NCT01549886|76253799|FG000|NOT COMPLETED|Overall Study||2||
60131256|NCT01549886|76253800|FG001|NOT COMPLETED|Overall Study||3||
60131257|NCT00610311|76253808|FG000|STARTED|Overall Study||3||
60131258|NCT00610311|76253808|FG000|COMPLETED|Overall Study||3||
60131259|NCT00610311|76253808|FG000|NOT COMPLETED|Overall Study||0||
60131260|NCT00610701|76253814|FG000|STARTED|Overall Study||15||
60131261|NCT00610701|76253815|FG001|STARTED|Overall Study||20||
60131262|NCT00610701|76253814|FG000|COMPLETED|Overall Study||5||
60131263|NCT00610701|76253815|FG001|COMPLETED|Overall Study||9||
60131264|NCT00610701|76253814|FG000|NOT COMPLETED|Overall Study||10||
60131265|NCT00610701|76253815|FG001|NOT COMPLETED|Overall Study||11||
60131266|NCT00581061|76253821|FG000|STARTED|Overall Study||13||
60131267|NCT00581061|76253821|FG000|COMPLETED|Overall Study||13||
60131268|NCT00581061|76253821|FG000|NOT COMPLETED|Overall Study||0||
60131269|NCT01443845|76253829|FG000|STARTED|Overall Study||1176||
60131270|NCT01443845|76253830|FG001|STARTED|Overall Study||1178||
60131271|NCT01443845|76253829|FG000|COMPLETED|Overall Study||922||
60131272|NCT01443845|76253830|FG001|COMPLETED|Overall Study||841||
60131273|NCT01443845|76253829|FG000|NOT COMPLETED|Overall Study||254||
60131274|NCT01443845|76253830|FG001|NOT COMPLETED|Overall Study||337||
60131275|NCT01549652|76253839|FG000|STARTED|Overall Study||27||
60131276|NCT01549652|76253840|FG001|STARTED|Overall Study||30||
60131277|NCT01549652|76253841|FG002|STARTED|Overall Study||40||
60131278|NCT01549652|76253842|FG003|STARTED|Overall Study||36||
60131279|NCT01549652|76253839|FG000|COMPLETED|Overall Study||15||
60131280|NCT01549652|76253840|FG001|COMPLETED|Overall Study||18||
60131281|NCT01549652|76253841|FG002|COMPLETED|Overall Study||23||
60131282|NCT01549652|76253842|FG003|COMPLETED|Overall Study||25||
60131283|NCT01549652|76253839|FG000|NOT COMPLETED|Overall Study||12||
60131284|NCT01549652|76253840|FG001|NOT COMPLETED|Overall Study||12||
60131285|NCT01549652|76253841|FG002|NOT COMPLETED|Overall Study||17||
60131286|NCT01549652|76253842|FG003|NOT COMPLETED|Overall Study||11||
60131287|NCT01569464|76253850|FG000|STARTED|Overall Study||101||
60131288|NCT01569464|76253851|FG001|STARTED|Overall Study||49||
60131289|NCT01569464|76253850|FG000|COMPLETED|Overall Study||91||
60131290|NCT01569464|76253851|FG001|COMPLETED|Overall Study||44||
60131291|NCT01569464|76253850|FG000|NOT COMPLETED|Overall Study||10||
60131292|NCT01569464|76253851|FG001|NOT COMPLETED|Overall Study||5||
60131293|NCT01534676|76253861|FG000|STARTED|Overall Study||2||
60131294|NCT01534676|76253862|FG001|STARTED|Overall Study||1||
60131295|NCT01534676|76253861|FG000|COMPLETED|Overall Study||0||
60131296|NCT01534676|76253862|FG001|COMPLETED|Overall Study||0||
60131297|NCT01534676|76253861|FG000|NOT COMPLETED|Overall Study||2||
60131298|NCT01534676|76253862|FG001|NOT COMPLETED|Overall Study||1||
60131299|NCT01442675|76253868|FG000|STARTED|Overall Study||834||
60131300|NCT01442675|76253868|FG000|Safety Analysis Set|Overall Study|Safety Analysis Set are subjects who received study vaccine and for whom safety data were available.|831||
60131301|NCT01442675|76253868|FG000|Per-Protocol Analysis Set|Overall Study|The Per-Protocol Analysis Set are subjects with no pre-defined protocol deviations.|781||
60131302|NCT01442675|76253868|FG000|COMPLETED|Overall Study||822||
60131303|NCT01442675|76253868|FG000|NOT COMPLETED|Overall Study||12||
60131304|NCT01534520|76253875|FG000|STARTED|Overall Study||30||
60131305|NCT01534520|76253876|FG001|STARTED|Overall Study||29||
60131306|NCT01534520|76253875|FG000|COMPLETED|Overall Study||30||
60131307|NCT01534520|76253876|FG001|COMPLETED|Overall Study|1 subject withdrew consent at time of uterine sound attempt due to intolerable pain|28||
60131308|NCT01534520|76253875|FG000|NOT COMPLETED|Overall Study||0||
60131309|NCT01534520|76253876|FG001|NOT COMPLETED|Overall Study||1||
60131310|NCT00611325|76253888|FG000|STARTED|Overall Study||28||
60131311|NCT00611325|76253889|FG001|STARTED|Overall Study||28||
60131312|NCT00611325|76253888|FG000|COMPLETED|Overall Study||28||
60131313|NCT00611325|76253889|FG001|COMPLETED|Overall Study||28||
60131314|NCT00611325|76253888|FG000|NOT COMPLETED|Overall Study||0||
60131315|NCT00611325|76253889|FG001|NOT COMPLETED|Overall Study||0||
60131316|NCT00611403|76253897|FG000|STARTED|Treatment Phase||68||
60131317|NCT00611403|76253898|FG001|STARTED|Treatment Phase||69||
60131318|NCT00611403|76253897|FG000|COMPLETED|Treatment Phase||62||
60131319|NCT00611403|76253898|FG001|COMPLETED|Treatment Phase||58||
60131320|NCT00611403|76253897|FG000|NOT COMPLETED|Treatment Phase||6||
60131321|NCT00611403|76253898|FG001|NOT COMPLETED|Treatment Phase||11||
60131322|NCT00611403|76253897|FG000|STARTED|Post Treatment Extension Phase|26 of 68 pts who received RESTASIS® in the Treatment Phase entered the Post Treatment Ext. Phase|26||
60131323|NCT00611403|76253898|FG001|STARTED|Post Treatment Extension Phase|25 of 69 pts who received ENDURA® in the Treatment Phase entered the Post Treatment Extension Phase|25||
60131324|NCT00611403|76253897|FG000|COMPLETED|Post Treatment Extension Phase||22||
60131325|NCT00611403|76253898|FG001|COMPLETED|Post Treatment Extension Phase||24||
60131326|NCT00611403|76253897|FG000|NOT COMPLETED|Post Treatment Extension Phase||4||
60131327|NCT00611403|76253898|FG001|NOT COMPLETED|Post Treatment Extension Phase||1||
60131328|NCT01534208|76253906|FG000|STARTED|Overall Study||216||
60131329|NCT01534208|76253907|FG001|STARTED|Overall Study||283||
60131330|NCT01534208|76253906|FG000|COMPLETED|Overall Study||159||
60131331|NCT01534208|76253907|FG001|COMPLETED|Overall Study||234||
60131332|NCT01534208|76253906|FG000|NOT COMPLETED|Overall Study||57||
60131333|NCT01534208|76253907|FG001|NOT COMPLETED|Overall Study||49||
60131334|NCT01548638|76253913|FG000|STARTED|Overall Study||13||
60131335|NCT01548638|76253913|FG000|COMPLETED|Overall Study||9||
60131336|NCT01548638|76253913|FG000|NOT COMPLETED|Overall Study||4||
60131337|NCT00581529|76253918|FG000|STARTED|Overall Study||34||
60131338|NCT00581529|76253918|FG000|COMPLETED|Overall Study||34||
60131339|NCT00581529|76253918|FG000|NOT COMPLETED|Overall Study||0||
60131340|NCT00612339|76253922|FG000|STARTED|Overall Study||41||
60131341|NCT00612339|76253922|FG000|COMPLETED|Overall Study||41||
60131342|NCT00612339|76253922|FG000|NOT COMPLETED|Overall Study||0||
60131343|NCT02134119|76253928|FG000|STARTED|Overall Study||30||
60131344|NCT02134119|76253929|FG001|STARTED|Overall Study||15||
60131345|NCT02134119|76253928|FG000|COMPLETED|Overall Study||30||
60131346|NCT02134119|76253929|FG001|COMPLETED|Overall Study||15||
60131347|NCT02134119|76253928|FG000|NOT COMPLETED|Overall Study||0||
60131348|NCT02134119|76253929|FG001|NOT COMPLETED|Overall Study||0||
60131349|NCT01533428|76253937|FG000|STARTED|Overall Study||186||
60131350|NCT01533428|76253938|FG001|STARTED|Overall Study||183||
60131351|NCT01533428|76253937|FG000|COMPLETED|Overall Study||177||
60131352|NCT01533428|76253938|FG001|COMPLETED|Overall Study||175||
60131353|NCT01533428|76253937|FG000|NOT COMPLETED|Overall Study||9||
60131354|NCT01533428|76253938|FG001|NOT COMPLETED|Overall Study||8||
60131355|NCT01517984|76253947|FG000|STARTED|Overall Study||5||
60131356|NCT01517984|76253948|FG001|STARTED|Overall Study||26||
60131357|NCT01517984|76253949|FG002|STARTED|Overall Study||14||
60131358|NCT01517984|76253950|FG003|STARTED|Overall Study||7||
60131359|NCT01517984|76253947|FG000|COMPLETED|Overall Study||0||
60131360|NCT01517984|76253948|FG001|COMPLETED|Overall Study||3||
60131361|NCT01517984|76253949|FG002|COMPLETED|Overall Study||10||
60131362|NCT01517984|76253950|FG003|COMPLETED|Overall Study||6||
60131363|NCT01517984|76253947|FG000|NOT COMPLETED|Overall Study||5||
60131364|NCT01517984|76253948|FG001|NOT COMPLETED|Overall Study||23||
59600637|NCT03888469|75710408|FG000|NOT COMPLETED|Second Wear Period (8 -1/+2 Days)||0||
59600638|NCT03888469|75710409|FG001|NOT COMPLETED|Second Wear Period (8 -1/+2 Days)||0||
59600639|NCT04283773|75710420|FG000|STARTED|Overall Study||22||
59600640|NCT04283773|75710421|FG001|STARTED|Overall Study||20||
59600641|NCT04283773|75710422|FG002|STARTED|Overall Study||20||
59863908|NCT03897439|75988466|FG001|NOT COMPLETED|Randomization (Week 0)||0||
60131365|NCT01517984|76253949|FG002|NOT COMPLETED|Overall Study||4||
60131366|NCT01517984|76253950|FG003|NOT COMPLETED|Overall Study||1||
59600642|NCT04283773|75710420|FG000|COMPLETED|Overall Study||22||
59600643|NCT04283773|75710421|FG001|COMPLETED|Overall Study||20||
59863909|NCT03897439|75988465|FG000|STARTED|Optimization Point 1 (Week 2)|9 participants were lost to follow-up between period 1 and 2|187||
59863910|NCT03897439|75988466|FG001|STARTED|Optimization Point 1 (Week 2)|9 participants were lost to follow-up between period 1 and period 2|187||
59863911|NCT03897439|75988465|FG000|Stayed on Nicotine Patch|Optimization Point 1 (Week 2)||187||
59863912|NCT03897439|75988466|FG001|Stayed on Nicotine Patch|Optimization Point 1 (Week 2)||61||
60131367|NCT00612573|76253961|FG000|STARTED|Overall Study||64||
60131368|NCT00612573|76253962|FG001|STARTED|Overall Study||65||
60131369|NCT00612573|76253963|FG002|STARTED|Overall Study||61||
60131370|NCT00612573|76253964|FG003|STARTED|Overall Study||67||
60131371|NCT00612573|76253961|FG000|COMPLETED|Overall Study||52||
60131372|NCT00612573|76253962|FG001|COMPLETED|Overall Study||51||
60131373|NCT00612573|76253963|FG002|COMPLETED|Overall Study||52||
60131374|NCT00612573|76253964|FG003|COMPLETED|Overall Study||54||
60131375|NCT00612573|76253961|FG000|NOT COMPLETED|Overall Study||12||
60131376|NCT00612573|76253962|FG001|NOT COMPLETED|Overall Study||14||
60131377|NCT00612573|76253963|FG002|NOT COMPLETED|Overall Study||9||
60131378|NCT00612573|76253964|FG003|NOT COMPLETED|Overall Study||13||
60131379|NCT01517750|76253978|FG000|STARTED|Overall Study||21||
60131380|NCT01517750|76253979|FG001|STARTED|Overall Study||19||
60131381|NCT01517750|76253980|FG002|STARTED|Overall Study||21||
59600644|NCT04283773|75710422|FG002|COMPLETED|Overall Study||20||
59600645|NCT04283773|75710420|FG000|NOT COMPLETED|Overall Study||0||
59600646|NCT04283773|75710421|FG001|NOT COMPLETED|Overall Study||0||
59600647|NCT04283773|75710422|FG002|NOT COMPLETED|Overall Study||0||
59863913|NCT03897439|75988465|FG000|Adapted to VAR|Optimization Point 1 (Week 2)||0||
59863914|NCT03897439|75988466|FG001|Adapted to VAR|Optimization Point 1 (Week 2)||126||
59863915|NCT03897439|75988465|FG000|COMPLETED|Optimization Point 1 (Week 2)||187||
59863916|NCT03897439|75988466|FG001|COMPLETED|Optimization Point 1 (Week 2)||187||
59600648|NCT00329732|75710434|FG000|STARTED|Overall Study||2||
60131382|NCT01517750|76253981|FG003|STARTED|Overall Study||19||
60131383|NCT01517750|76253978|FG000|COMPLETED|Overall Study||20||
60131384|NCT01517750|76253979|FG001|COMPLETED|Overall Study||17||
60131385|NCT01517750|76253980|FG002|COMPLETED|Overall Study||17||
60131386|NCT01517750|76253981|FG003|COMPLETED|Overall Study||18||
60131387|NCT01517750|76253978|FG000|NOT COMPLETED|Overall Study||1||
60131388|NCT01517750|76253979|FG001|NOT COMPLETED|Overall Study||2||
60131389|NCT01517750|76253980|FG002|NOT COMPLETED|Overall Study||4||
60131390|NCT01517750|76253981|FG003|NOT COMPLETED|Overall Study||1||
60131391|NCT00614445|76253997|FG000|STARTED|Overall Study||140||
60131392|NCT00614445|76253998|FG001|STARTED|Overall Study||140||
60131393|NCT00614445|76253997|FG000|COMPLETED|Overall Study||112||
60131394|NCT00614445|76253998|FG001|COMPLETED|Overall Study||91||
59600649|NCT00329732|75710435|FG001|STARTED|Overall Study||0||
59600650|NCT00329732|75710434|FG000|COMPLETED|Overall Study||2||
59600651|NCT00329732|75710435|FG001|COMPLETED|Overall Study||0||
59863917|NCT03897439|75988465|FG000|NOT COMPLETED|Optimization Point 1 (Week 2)||0||
59863918|NCT03897439|75988466|FG001|NOT COMPLETED|Optimization Point 1 (Week 2)||0||
59863919|NCT03897439|75988465|FG000|STARTED|Optimization Point 2 (Week 6)|9 participants were lost to follow-up between period 2 and period 3.|178||
59863920|NCT03897439|75988466|FG001|STARTED|Optimization Point 2 (Week 6)|14 participants were lost to follow-up between period 2 and period 3.|173||
59863921|NCT03897439|75988465|FG000|Stayed on Nicotine Patch|Optimization Point 2 (Week 6)||178||
59863922|NCT03897439|75988466|FG001|Stayed on Nicotine Patch|Optimization Point 2 (Week 6)||52||
59863923|NCT03897439|75988465|FG000|Stayed on VAR|Optimization Point 2 (Week 6)||0||
59863924|NCT03897439|75988466|FG001|Stayed on VAR|Optimization Point 2 (Week 6)||25||
59863925|NCT03897439|75988465|FG000|Adapted to Varenicline|Optimization Point 2 (Week 6)||0||
59863926|NCT03897439|75988466|FG001|Adapted to Varenicline|Optimization Point 2 (Week 6)||9||
59863927|NCT03897439|75988465|FG000|Adapted to BUP + Nicotine Patch|Optimization Point 2 (Week 6)||0||
59863928|NCT03897439|75988466|FG001|Adapted to BUP + Nicotine Patch|Optimization Point 2 (Week 6)||87||
59863929|NCT03897439|75988465|FG000|COMPLETED|Optimization Point 2 (Week 6)||178||
59863930|NCT03897439|75988466|FG001|COMPLETED|Optimization Point 2 (Week 6)||173||
59863931|NCT03897439|75988465|FG000|NOT COMPLETED|Optimization Point 2 (Week 6)||0||
59863932|NCT03897439|75988466|FG001|NOT COMPLETED|Optimization Point 2 (Week 6)||0||
59863933|NCT03897439|75988465|FG000|STARTED|Primary Endpoint (Week 12)|4 participants were lost to follow-up between period 3 and period 4.|174||
59863934|NCT03897439|75988466|FG001|STARTED|Primary Endpoint (Week 12)|8 participants were lost to follow-up between period 3 and period 4.|165||
59863935|NCT03897439|75988465|FG000|COMPLETED|Primary Endpoint (Week 12)||174||
59863936|NCT03897439|75988466|FG001|COMPLETED|Primary Endpoint (Week 12)||165||
59863937|NCT03897439|75988465|FG000|NOT COMPLETED|Primary Endpoint (Week 12)||0||
59863938|NCT03897439|75988466|FG001|NOT COMPLETED|Primary Endpoint (Week 12)||0||
59863939|NCT03897439|75988465|FG000|STARTED|End of Treatment (Week 18)|4 participants were lost to follow-up between period 4 and period 5.|170||
59863940|NCT03897439|75988466|FG001|STARTED|End of Treatment (Week 18)|2 participants were lost to follow-up between period 4 and period 5.|163||
59863941|NCT03897439|75988465|FG000|COMPLETED|End of Treatment (Week 18)||170||
59863942|NCT03897439|75988466|FG001|COMPLETED|End of Treatment (Week 18)||163||
59863943|NCT03897439|75988465|FG000|NOT COMPLETED|End of Treatment (Week 18)||0||
59863944|NCT03897439|75988466|FG001|NOT COMPLETED|End of Treatment (Week 18)||0||
59863945|NCT03897439|75988465|FG000|STARTED|End of Study (Week 26)|8 participants were lost to follow-up between period 5 and period 6.|162||
59863946|NCT03897439|75988466|FG001|STARTED|End of Study (Week 26)|1 participant was lost to follow-up between period 5 and period 6.|162||
59863947|NCT03897439|75988465|FG000|COMPLETED|End of Study (Week 26)||162||
59863948|NCT03897439|75988466|FG001|COMPLETED|End of Study (Week 26)||162||
59863949|NCT03897439|75988465|FG000|NOT COMPLETED|End of Study (Week 26)||0||
59863950|NCT03897439|75988466|FG001|NOT COMPLETED|End of Study (Week 26)||0||
59863951|NCT03777436|75988474|FG000|STARTED|Placebo-controlled Phase||146||
59863952|NCT03777436|75988475|FG001|STARTED|Placebo-controlled Phase||143||
59863953|NCT03777436|75988476|FG002|STARTED|Placebo-controlled Phase|This arm was not included in the Placebo-controlled Phase.|0||
59863954|NCT03777436|75988474|FG000|Took at Least 1 Dose of Investigational Product (IP)|Placebo-controlled Phase||145||
59863955|NCT03777436|75988475|FG001|Took at Least 1 Dose of Investigational Product (IP)|Placebo-controlled Phase||143||
59863956|NCT03777436|75988476|FG002|Took at Least 1 Dose of Investigational Product (IP)|Placebo-controlled Phase|This arm was not included in the Placebo-controlled Phase.|0||
59863957|NCT03777436|75988474|FG000|COMPLETED|Placebo-controlled Phase||111||
59863958|NCT03777436|75988475|FG001|COMPLETED|Placebo-controlled Phase||119||
59863959|NCT03777436|75988476|FG002|COMPLETED|Placebo-controlled Phase|This arm was not included in the Placebo-controlled Phase.|0||
59863960|NCT03777436|75988474|FG000|NOT COMPLETED|Placebo-controlled Phase||35||
59863961|NCT03777436|75988475|FG001|NOT COMPLETED|Placebo-controlled Phase||24||
59863962|NCT03777436|75988476|FG002|NOT COMPLETED|Placebo-controlled Phase||0||
59863963|NCT03777436|75988474|FG000|STARTED|Apremilast Extension Phase|This arm was not included in the Apremilast Extension Phase.|0||
59863964|NCT03777436|75988475|FG001|STARTED|Apremilast Extension Phase|This arm was not included in the Apremilast Extension Phase.|0||
59863965|NCT03777436|75988476|FG002|STARTED|Apremilast Extension Phase|1 participant did not enter the Apremilast Extension Phase as they were lost to follow-up.|229||
59863966|NCT03777436|75988474|FG000|Took at Least 1 Dose of IP|Apremilast Extension Phase|This arm was not included in the Apremilast Extension Phase.|0||
59999742|NCT02286089|76115443|FG003|COMPLETED|Overall Study||0||
59999743|NCT02286089|76115440|FG000|NOT COMPLETED|Overall Study||1||
60131395|NCT00614445|76253997|FG000|NOT COMPLETED|Overall Study||28||
60131396|NCT00614445|76253998|FG001|NOT COMPLETED|Overall Study||49||
60131397|NCT01548404|76254006|FG000|STARTED|Overall Study||54||
60131398|NCT01548404|76254007|FG001|STARTED|Overall Study||55||
60131399|NCT01548404|76254006|FG000|COMPLETED|Overall Study||24||
60131400|NCT01548404|76254007|FG001|COMPLETED|Overall Study||41||
60131401|NCT01548404|76254006|FG000|NOT COMPLETED|Overall Study||30||
60131402|NCT01548404|76254007|FG001|NOT COMPLETED|Overall Study||14||
60131403|NCT00614913|76254014|FG000|STARTED|Overall Study||76||
59999744|NCT02286089|76115441|FG001|NOT COMPLETED|Overall Study||1||
59999745|NCT02286089|76115442|FG002|NOT COMPLETED|Overall Study||6||
59999746|NCT02286089|76115443|FG003|NOT COMPLETED|Overall Study||12||
59999747|NCT02087423|76115456|FG000|STARTED|Overall Study|Treated|111||
59999748|NCT02087423|76115457|FG001|STARTED|Overall Study|Treated|265||
59999749|NCT02087423|76115458|FG002|STARTED|Overall Study|Treated|68||
59999750|NCT02087423|76115456|FG000|Completed 12 Months of Treatment|Overall Study||18||
59999751|NCT02087423|76115457|FG001|Completed 12 Months of Treatment|Overall Study||60||
59863967|NCT03777436|75988475|FG001|Took at Least 1 Dose of IP|Apremilast Extension Phase|This arm was not included in the Apremilast Extension Phase.|0||
59863968|NCT03777436|75988476|FG002|Took at Least 1 Dose of IP|Apremilast Extension Phase||228||
59600652|NCT00329732|75710434|FG000|NOT COMPLETED|Overall Study||0||
59600653|NCT00329732|75710435|FG001|NOT COMPLETED|Overall Study||0||
59999752|NCT02087423|76115458|FG002|Completed 12 Months of Treatment|Overall Study||26||
59863969|NCT03777436|75988474|FG000|COMPLETED|Apremilast Extension Phase|This arm was not included in the Apremilast Extension Phase.|0||
59863970|NCT03777436|75988475|FG001|COMPLETED|Apremilast Extension Phase|This arm was not included in the Apremilast Extension Phase.|0||
59863971|NCT03777436|75988476|FG002|COMPLETED|Apremilast Extension Phase||201||
59863972|NCT03777436|75988474|FG000|NOT COMPLETED|Apremilast Extension Phase||0||
59863973|NCT03777436|75988475|FG001|NOT COMPLETED|Apremilast Extension Phase||0||
59863974|NCT03777436|75988476|FG002|NOT COMPLETED|Apremilast Extension Phase||28||
59863975|NCT03254927|75988483|FG000|STARTED|Overall Study||30||
59863976|NCT03254927|75988483|FG000|COMPLETED|Overall Study||30||
59863977|NCT03254927|75988483|FG000|NOT COMPLETED|Overall Study||0||
59863978|NCT03156023|75988492|FG000|STARTED|Overall Study||8||
59863979|NCT03156023|75988493|FG001|STARTED|Overall Study||7||
59863980|NCT03156023|75988494|FG002|STARTED|Overall Study||6||
59863981|NCT03156023|75988495|FG003|STARTED|Overall Study||6||
59863982|NCT03156023|75988496|FG004|STARTED|Overall Study||7||
59863983|NCT03156023|75988492|FG000|COMPLETED|Overall Study||7||
59863984|NCT03156023|75988493|FG001|COMPLETED|Overall Study||7||
59863985|NCT03156023|75988494|FG002|COMPLETED|Overall Study||4||
59863986|NCT03156023|75988495|FG003|COMPLETED|Overall Study||5||
59863987|NCT03156023|75988496|FG004|COMPLETED|Overall Study||5||
59863988|NCT03156023|75988492|FG000|NOT COMPLETED|Overall Study||1||
59863989|NCT03156023|75988493|FG001|NOT COMPLETED|Overall Study||0||
59863990|NCT03156023|75988494|FG002|NOT COMPLETED|Overall Study||2||
59863991|NCT03156023|75988495|FG003|NOT COMPLETED|Overall Study||1||
59863992|NCT03156023|75988496|FG004|NOT COMPLETED|Overall Study||2||
59863993|NCT03025880|75988514|FG000|STARTED|Overall Study||14||
59863994|NCT03025880|75988515|FG001|STARTED|Overall Study||22||
59863995|NCT03025880|75988514|FG000|COMPLETED|Overall Study||0||
59863996|NCT03025880|75988515|FG001|COMPLETED|Overall Study||0||
59863997|NCT03025880|75988514|FG000|NOT COMPLETED|Overall Study||14||
59863998|NCT03025880|75988515|FG001|NOT COMPLETED|Overall Study||22||
59863999|NCT02390414|75988525|FG000|STARTED|Overall Study||113||
59864000|NCT02390414|75988526|FG001|STARTED|Overall Study||177||
59864001|NCT02390414|75988525|FG000|COMPLETED|Overall Study||113||
59864002|NCT02390414|75988526|FG001|COMPLETED|Overall Study||177||
60131404|NCT00614913|76254014|FG000|COMPLETED|Overall Study||76||
59864003|NCT02390414|75988525|FG000|NOT COMPLETED|Overall Study||0||
59864004|NCT02390414|75988526|FG001|NOT COMPLETED|Overall Study||0||
59864005|NCT02027376|75988532|FG000|STARTED|Overall Study||5||
59864006|NCT02027376|75988533|FG001|STARTED|Overall Study||4||
59864007|NCT02027376|75988534|FG002|STARTED|Overall Study||3||
59864008|NCT02027376|75988532|FG000|COMPLETED|Overall Study||4||
59864009|NCT02027376|75988533|FG001|COMPLETED|Overall Study||4||
59864010|NCT02027376|75988534|FG002|COMPLETED|Overall Study||3||
59864011|NCT02027376|75988532|FG000|NOT COMPLETED|Overall Study||1||
59864012|NCT02027376|75988533|FG001|NOT COMPLETED|Overall Study||0||
59864013|NCT02027376|75988534|FG002|NOT COMPLETED|Overall Study||0||
59864014|NCT01924533|75988546|FG000|STARTED|Overall Study||263||
59864015|NCT01924533|75988547|FG001|STARTED|Overall Study||262||
59864016|NCT01924533|75988546|FG000|COMPLETED|Overall Study||74||
59864017|NCT01924533|75988547|FG001|COMPLETED|Overall Study||57||
59864018|NCT01924533|75988546|FG000|NOT COMPLETED|Overall Study||189||
59864019|NCT01924533|75988547|FG001|NOT COMPLETED|Overall Study||205||
59864020|NCT01606436|75988553|FG000|STARTED|Overall Study||14||
59864021|NCT01606436|75988554|FG001|STARTED|Overall Study||14||
59864022|NCT01606436|75988555|FG002|STARTED|Overall Study||14||
59864023|NCT01606436|75988556|FG003|STARTED|Overall Study||14||
59864024|NCT01606436|75988557|FG004|STARTED|Overall Study||13||
59864025|NCT01606436|75988558|FG005|STARTED|Overall Study||14||
59864026|NCT01606436|75988553|FG000|Received First Intervention|Overall Study||14||
59864027|NCT01606436|75988554|FG001|Received First Intervention|Overall Study||14||
59864028|NCT01606436|75988555|FG002|Received First Intervention|Overall Study||14||
59864029|NCT01606436|75988556|FG003|Received First Intervention|Overall Study||14||
59864030|NCT01606436|75988557|FG004|Received First Intervention|Overall Study||13||
59864031|NCT01606436|75988558|FG005|Received First Intervention|Overall Study||14||
59864032|NCT01606436|75988553|FG000|Received Second Intervention|Overall Study||14||
59864033|NCT01606436|75988554|FG001|Received Second Intervention|Overall Study||14||
59864034|NCT01606436|75988555|FG002|Received Second Intervention|Overall Study||14||
59600654|NCT04281901|75710442|FG000|STARTED|Overall Study||12|Baseline evaluation (i.e., first check-up)|12
59600655|NCT04281901|75710443|FG001|STARTED|Overall Study||12|Baseline evaluation (i.e., first check-up)|14
59600656|NCT04281901|75710442|FG000|2. Check-up|Overall Study||11|1 month after the baseline evaluation|11
59600657|NCT04281901|75710443|FG001|2. Check-up|Overall Study||11|1 month after the baseline evaluation|13
59600658|NCT04281901|75710442|FG000|3. Check-up|Overall Study||11|2 months after baseline evaluation|11
59600659|NCT04281901|75710443|FG001|3. Check-up|Overall Study||11|2 months after baseline evaluation|13
59600660|NCT04281901|75710442|FG000|COMPLETED|Overall Study||11|4. check-up (i.e., 3. months after the baseline evaluation)|11
59600661|NCT04281901|75710443|FG001|COMPLETED|Overall Study||11|4. check-up (i.e., 3. months after the baseline evaluation)|13
59600662|NCT04281901|75710442|FG000|NOT COMPLETED|Overall Study||1||1
59600663|NCT04281901|75710443|FG001|NOT COMPLETED|Overall Study||1||1
59600664|NCT04280653|75710449|FG000|STARTED|Overall Study||15||
59600665|NCT04280653|75710449|FG000|COMPLETED|Overall Study||15||
59600666|NCT04280653|75710449|FG000|NOT COMPLETED|Overall Study||0||
59600667|NCT03679975|75710453|FG000|STARTED|Overall Study||9||
59600668|NCT03679975|75710453|FG000|COMPLETED|Overall Study||9||
59600669|NCT03679975|75710453|FG000|NOT COMPLETED|Overall Study||0||
59600670|NCT03887299|75710459|FG000|STARTED|Overall Study||77||
59600671|NCT03887299|75710460|FG001|STARTED|Overall Study||77||
59600672|NCT03887299|75710459|FG000|COMPLETED|Overall Study||77||
59600673|NCT03887299|75710460|FG001|COMPLETED|Overall Study||77||
59600674|NCT03887299|75710459|FG000|NOT COMPLETED|Overall Study||0||
59600675|NCT03887299|75710460|FG001|NOT COMPLETED|Overall Study||0||
59600676|NCT00244010|75710468|FG000|STARTED|Overall Study||2||
59600677|NCT00244010|75710469|FG001|STARTED|Overall Study||2||
59600678|NCT00244010|75710468|FG000|COMPLETED|Overall Study||2||
59600679|NCT00244010|75710469|FG001|COMPLETED|Overall Study||2||
59600680|NCT00244010|75710468|FG000|NOT COMPLETED|Overall Study||0||
59600681|NCT00244010|75710469|FG001|NOT COMPLETED|Overall Study||0||
59600682|NCT03684265|75710477|FG000|STARTED|Treatment Period 1||13||
59600683|NCT03684265|75710478|FG001|STARTED|Treatment Period 1||13||
59600684|NCT03684265|75710477|FG000|COMPLETED|Treatment Period 1||13||
59600685|NCT03684265|75710478|FG001|COMPLETED|Treatment Period 1||13||
59600686|NCT03684265|75710477|FG000|NOT COMPLETED|Treatment Period 1||0||
59600687|NCT03684265|75710478|FG001|NOT COMPLETED|Treatment Period 1||0||
59600688|NCT03684265|75710477|FG000|STARTED|Washout Period of 1 Week||13||
59600689|NCT03684265|75710478|FG001|STARTED|Washout Period of 1 Week||13||
59600690|NCT03684265|75710477|FG000|COMPLETED|Washout Period of 1 Week||13||
59600691|NCT03684265|75710478|FG001|COMPLETED|Washout Period of 1 Week||13||
59600692|NCT03684265|75710477|FG000|NOT COMPLETED|Washout Period of 1 Week||0||
59600693|NCT03684265|75710478|FG001|NOT COMPLETED|Washout Period of 1 Week||0||
59600694|NCT03684265|75710477|FG000|STARTED|Treatment Period 2||13||
59600695|NCT03684265|75710478|FG001|STARTED|Treatment Period 2||13||
59600696|NCT03684265|75710477|FG000|COMPLETED|Treatment Period 2||13||
59600697|NCT03684265|75710478|FG001|COMPLETED|Treatment Period 2||13||
59600698|NCT03684265|75710477|FG000|NOT COMPLETED|Treatment Period 2||0||
59600699|NCT03684265|75710478|FG001|NOT COMPLETED|Treatment Period 2||0||
59600700|NCT00218036|75710489|FG000|STARTED|Overall Study||11||
59600701|NCT00218036|75710490|FG001|STARTED|Overall Study||6||
59600702|NCT00218036|75710491|FG002|STARTED|Overall Study||13||
59600703|NCT00218036|75710492|FG003|STARTED|Overall Study||12||
59600704|NCT00218036|75710493|FG004|STARTED|Overall Study||9||
59600705|NCT00218036|75710489|FG000|COMPLETED|Overall Study||6||
59600706|NCT00218036|75710490|FG001|COMPLETED|Overall Study||3||
59600707|NCT00218036|75710491|FG002|COMPLETED|Overall Study||5||
59600708|NCT00218036|75710492|FG003|COMPLETED|Overall Study||6||
59600709|NCT00218036|75710493|FG004|COMPLETED|Overall Study||3||
59600710|NCT00218036|75710489|FG000|NOT COMPLETED|Overall Study||5||
59600711|NCT00218036|75710490|FG001|NOT COMPLETED|Overall Study||3||
59600712|NCT00218036|75710491|FG002|NOT COMPLETED|Overall Study||8||
59600713|NCT00218036|75710492|FG003|NOT COMPLETED|Overall Study||6||
59600714|NCT00218036|75710493|FG004|NOT COMPLETED|Overall Study||6||
59600715|NCT03848221|75710508|FG000|STARTED|Overall Study||25||
59600716|NCT03848221|75710509|FG001|STARTED|Overall Study||24||
59600717|NCT03848221|75710510|FG002|STARTED|Overall Study||24||
59600718|NCT03848221|75710508|FG000|COMPLETED|Overall Study||25||
59600719|NCT03848221|75710509|FG001|COMPLETED|Overall Study||24||
59600720|NCT03848221|75710510|FG002|COMPLETED|Overall Study||24||
59600721|NCT03848221|75710508|FG000|NOT COMPLETED|Overall Study||0||
59600722|NCT03848221|75710509|FG001|NOT COMPLETED|Overall Study||0||
59600723|NCT03848221|75710510|FG002|NOT COMPLETED|Overall Study||0||
59600724|NCT00205868|75710518|FG000|STARTED|Overall Study||304||
59600725|NCT00205868|75710518|FG000|COMPLETED|Overall Study||304||
59600726|NCT00205868|75710518|FG000|NOT COMPLETED|Overall Study||0||
59600727|NCT04271761|75710522|FG000|STARTED|Overall Study||14||
59600728|NCT04271761|75710522|FG000|COMPLETED|Overall Study||14||
59600729|NCT04271761|75710522|FG000|NOT COMPLETED|Overall Study||0||
59600730|NCT00233090|75710528|FG000|STARTED|Overall Study||12||
59600731|NCT00233090|75710529|FG001|STARTED|Overall Study||9||
59600732|NCT00233090|75710528|FG000|COMPLETED|Overall Study||12||
59600733|NCT00233090|75710529|FG001|COMPLETED|Overall Study||9||
59600734|NCT00233090|75710528|FG000|NOT COMPLETED|Overall Study||0||
59600735|NCT00233090|75710529|FG001|NOT COMPLETED|Overall Study||0||
59600736|NCT04266925|75710537|FG000|STARTED|1 Referee Game (~1 Hour)||23||
59600737|NCT04266925|75710538|FG001|STARTED|1 Referee Game (~1 Hour)||26||
59600738|NCT04266925|75710537|FG000|COMPLETED|1 Referee Game (~1 Hour)||23||
59600739|NCT04266925|75710538|FG001|COMPLETED|1 Referee Game (~1 Hour)||26||
59600740|NCT04266925|75710537|FG000|NOT COMPLETED|1 Referee Game (~1 Hour)||0||
59600741|NCT04266925|75710538|FG001|NOT COMPLETED|1 Referee Game (~1 Hour)||0||
59600742|NCT04266925|75710537|FG000|STARTED|3 Referee Game (~1 Hour)||23||
59600743|NCT04266925|75710538|FG001|STARTED|3 Referee Game (~1 Hour)||26||
59600744|NCT04266925|75710537|FG000|COMPLETED|3 Referee Game (~1 Hour)||23||
59600745|NCT04266925|75710538|FG001|COMPLETED|3 Referee Game (~1 Hour)||26||
59600746|NCT04266925|75710537|FG000|NOT COMPLETED|3 Referee Game (~1 Hour)||0||
59600747|NCT04266925|75710538|FG001|NOT COMPLETED|3 Referee Game (~1 Hour)||0||
59600748|NCT04247581|75710546|FG000|STARTED|Overall Study||241||
59600749|NCT04247581|75710547|FG001|STARTED|Overall Study||305||
59600750|NCT04247581|75710546|FG000|COMPLETED|Overall Study||241||
59600751|NCT04247581|75710547|FG001|COMPLETED|Overall Study||293||
59600752|NCT04247581|75710546|FG000|NOT COMPLETED|Overall Study||0||
59600753|NCT04247581|75710547|FG001|NOT COMPLETED|Overall Study||12||
59600754|NCT04243369|75710553|FG000|STARTED|Overall Study||30||
59600755|NCT04243369|75710553|FG000|COMPLETED|Overall Study||30||
59600756|NCT04243369|75710553|FG000|NOT COMPLETED|Overall Study||0||
59600757|NCT03849937|75710557|FG000|STARTED|Overall Study||147||
59600758|NCT03849937|75710558|FG001|STARTED|Overall Study||72||
59600759|NCT03849937|75710557|FG000|COMPLETED|Overall Study||94||
59600760|NCT03849937|75710558|FG001|COMPLETED|Overall Study||35||
59600761|NCT03849937|75710557|FG000|NOT COMPLETED|Overall Study||53||
59600762|NCT03849937|75710558|FG001|NOT COMPLETED|Overall Study||37||
59600763|NCT00177866|75710571|FG000|STARTED|Overall Study|No results or publication, data destroyed due to age of study.|0||
59600764|NCT00177866|75710572|FG001|STARTED|Overall Study|No results or publication, data destroyed due to age of study.|0||
59600765|NCT00177866|75710571|FG000|COMPLETED|Overall Study|No results or publication, data destroyed due to age of study.|0||
59600766|NCT00177866|75710572|FG001|COMPLETED|Overall Study|No results or publication, data destroyed due to age of study.|0||
59600767|NCT00177866|75710571|FG000|NOT COMPLETED|Overall Study||0||
59600768|NCT00177866|75710572|FG001|NOT COMPLETED|Overall Study||0||
59600769|NCT03693937|75710578|FG000|STARTED|Overall Study||776||
59600770|NCT03693937|75710578|FG000|COMPLETED|Overall Study||776||
59600771|NCT03693937|75710578|FG000|NOT COMPLETED|Overall Study||0||
59600772|NCT03696589|75710582|FG000|STARTED|Overall Study||13||
59600773|NCT03696589|75710582|FG000|COMPLETED|Overall Study||12||
59600774|NCT03696589|75710582|FG000|NOT COMPLETED|Overall Study||1||
59600775|NCT00089414|75710598|FG000|STARTED|Overall Study||2||
59600776|NCT00089414|75710599|FG001|STARTED|Overall Study||1||
59600777|NCT00089414|75710600|FG002|STARTED|Overall Study||2||
59600778|NCT00089414|75710598|FG000|COMPLETED|Overall Study||2||
59600779|NCT00089414|75710599|FG001|COMPLETED|Overall Study||1||
59600780|NCT00089414|75710600|FG002|COMPLETED|Overall Study||2||
59600781|NCT00089414|75710598|FG000|NOT COMPLETED|Overall Study||0||
59600782|NCT00089414|75710599|FG001|NOT COMPLETED|Overall Study||0||
59600783|NCT00089414|75710600|FG002|NOT COMPLETED|Overall Study||0||
59600784|NCT00075608|75710608|FG000|STARTED|Overall Study||12||
59600785|NCT00075608|75710608|FG000|COMPLETED|Overall Study||12||
59600786|NCT00075608|75710608|FG000|NOT COMPLETED|Overall Study||0||
59864035|NCT01606436|75988556|FG003|Received Second Intervention|Overall Study||14||
59600787|NCT03704467|75710614|FG000|STARTED|Overall Study||3||
59600788|NCT03704467|75710614|FG000|COMPLETED|Overall Study||3||
59600789|NCT03704467|75710614|FG000|NOT COMPLETED|Overall Study||0||
59600790|NCT03705481|75710618|FG000|STARTED|Overall Study||5||
59600791|NCT03705481|75710618|FG000|COMPLETED|Overall Study||5||
59600792|NCT03705481|75710618|FG000|NOT COMPLETED|Overall Study||0||
59600793|NCT02145260|75710627|FG000|STARTED|Overall Study||69|Started|
59600794|NCT02145260|75710628|FG001|STARTED|Overall Study||70|Started|
59600795|NCT02145260|75710627|FG000|COMPLETED|Overall Study||69|Completed follow up|
59600796|NCT02145260|75710628|FG001|COMPLETED|Overall Study||70|Completed follow up|
59600797|NCT02145260|75710627|FG000|NOT COMPLETED|Overall Study||0||
59600798|NCT02145260|75710628|FG001|NOT COMPLETED|Overall Study||0||
59600799|NCT03707041|75710639|FG000|STARTED|Overall Study||6||
59600800|NCT03707041|75710640|FG001|STARTED|Overall Study||2||
59600801|NCT03707041|75710641|FG002|STARTED|Overall Study||9||
59600802|NCT03707041|75710642|FG003|STARTED|Overall Study||3||
59600803|NCT03707041|75710643|FG004|STARTED|Overall Study||9||
59600804|NCT03707041|75710644|FG005|STARTED|Overall Study||3||
59600805|NCT03707041|75710639|FG000|COMPLETED|Overall Study||6||
59600806|NCT03707041|75710640|FG001|COMPLETED|Overall Study||2||
59600807|NCT03707041|75710641|FG002|COMPLETED|Overall Study||9||
59600808|NCT03707041|75710642|FG003|COMPLETED|Overall Study||3||
59600809|NCT03707041|75710643|FG004|COMPLETED|Overall Study||9||
59600810|NCT03707041|75710644|FG005|COMPLETED|Overall Study||3||
59600811|NCT03707041|75710639|FG000|NOT COMPLETED|Overall Study||0||
59600812|NCT03707041|75710640|FG001|NOT COMPLETED|Overall Study||0||
59600813|NCT03707041|75710641|FG002|NOT COMPLETED|Overall Study||0||
59600814|NCT03707041|75710642|FG003|NOT COMPLETED|Overall Study||0||
59864036|NCT01606436|75988557|FG004|Received Second Intervention|Overall Study||12||
59600815|NCT03707041|75710643|FG004|NOT COMPLETED|Overall Study||0||
59600816|NCT03707041|75710644|FG005|NOT COMPLETED|Overall Study||0||
59600817|NCT03879044|75710659|FG000|STARTED|Overall Study||30||
59600818|NCT03879044|75710659|FG000|COMPLETED|Overall Study||26||
59600819|NCT03879044|75710659|FG000|NOT COMPLETED|Overall Study||4||
59600820|NCT02212574|75710663|FG000|STARTED|Overall Study||6||
59600821|NCT02212574|75710663|FG000|COMPLETED|Overall Study||6||
59600822|NCT02212574|75710663|FG000|NOT COMPLETED|Overall Study||0||
59600823|NCT03708367|75710670|FG000|STARTED|Overall Study||59||117
59600824|NCT03708367|75710671|FG001|STARTED|Overall Study||58||115
59600825|NCT03708367|75710670|FG000|COMPLETED|Overall Study||58||116
59600826|NCT03708367|75710671|FG001|COMPLETED|Overall Study||57||114
59600827|NCT03708367|75710670|FG000|NOT COMPLETED|Overall Study||1||1
59600828|NCT03708367|75710671|FG001|NOT COMPLETED|Overall Study||1||1
59600829|NCT03862027|75710678|FG000|STARTED|Overall Study||1||
59600830|NCT03862027|75710678|FG000|COMPLETED|Overall Study||1||
59600831|NCT03862027|75710678|FG000|NOT COMPLETED|Overall Study||0||
59600832|NCT03856255|75710682|FG000|STARTED|Overall Study||23||
59600833|NCT03856255|75710682|FG000|COMPLETED|Overall Study||23||
59600834|NCT03856255|75710682|FG000|NOT COMPLETED|Overall Study||0||
59600835|NCT04298918|75710690|FG000|STARTED|Overall Study||0||
59600836|NCT04298918|75710691|FG001|STARTED|Overall Study||0||
59600837|NCT04298918|75710692|FG002|STARTED|Overall Study||0||
59600838|NCT04298918|75710693|FG003|STARTED|Overall Study||0||
59600839|NCT04298918|75710690|FG000|COMPLETED|Overall Study||0||
59600840|NCT04298918|75710691|FG001|COMPLETED|Overall Study||0||
59600841|NCT04298918|75710692|FG002|COMPLETED|Overall Study||0||
59600842|NCT04298918|75710693|FG003|COMPLETED|Overall Study||0||
59600843|NCT04298918|75710690|FG000|NOT COMPLETED|Overall Study||0||
59600844|NCT04298918|75710691|FG001|NOT COMPLETED|Overall Study||0||
59600845|NCT04298918|75710692|FG002|NOT COMPLETED|Overall Study||0||
59600846|NCT04298918|75710693|FG003|NOT COMPLETED|Overall Study||0||
59600847|NCT03714919|75710708|FG000|STARTED|Overall Study||10||
59600848|NCT03714919|75710708|FG000|COMPLETED|Overall Study||10||
59600849|NCT03714919|75710708|FG000|NOT COMPLETED|Overall Study||0||
59600850|NCT03863522|75710712|FG000|STARTED|Overall Study||116||
59600851|NCT03863522|75710712|FG000|COMPLETED|Overall Study||116||
59600852|NCT03863522|75710712|FG000|NOT COMPLETED|Overall Study||0||
59600853|NCT04223635|75710718|FG000|STARTED|Overall Study||8||
59600854|NCT04223635|75710719|FG001|STARTED|Overall Study||8||
59600855|NCT04223635|75710718|FG000|COMPLETED|Overall Study||8||
59600856|NCT04223635|75710719|FG001|COMPLETED|Overall Study||8||
59600857|NCT04223635|75710718|FG000|NOT COMPLETED|Overall Study||0||
59600858|NCT04223635|75710719|FG001|NOT COMPLETED|Overall Study||0||
59600859|NCT04232137|75710727|FG000|STARTED|Overall Study||254||
59600860|NCT04232137|75710728|FG001|STARTED|Overall Study||185||
59600861|NCT04232137|75710727|FG000|COMPLETED|Overall Study||254||
59600862|NCT04232137|75710728|FG001|COMPLETED|Overall Study||185||
59600863|NCT04232137|75710727|FG000|NOT COMPLETED|Overall Study||0||
59600864|NCT04232137|75710728|FG001|NOT COMPLETED|Overall Study||0||
59600865|NCT03859622|75710734|FG000|STARTED|Overall Study||289||
59600866|NCT03859622|75710734|FG000|COMPLETED|Overall Study||289||
59600867|NCT03859622|75710734|FG000|NOT COMPLETED|Overall Study||0||
59600868|NCT04204057|75710741|FG000|STARTED|Overall Study||21||
59600869|NCT04204057|75710741|FG000|COMPLETED|Overall Study||21||
59600870|NCT04204057|75710741|FG000|NOT COMPLETED|Overall Study||0||
59730013|NCT01928394|75848584|FG018|COMPLETED|Follow-up Period||76|completed = continuing to be followed|
59730014|NCT01928394|75848585|FG019|COMPLETED|Follow-up Period||83|completed = continuing to be followed|
59730015|NCT01928394|75848586|FG020|COMPLETED|Follow-up Period||32|completed = continuing to be followed|
59730016|NCT01928394|75848587|FG021|COMPLETED|Follow-up Period||34|completed = continuing to be followed|
59730017|NCT01928394|75848588|FG022|COMPLETED|Follow-up Period||36|completed = continuing to be followed|
59730018|NCT01928394|75848566|FG000|NOT COMPLETED|Follow-up Period||3||
59730019|NCT01928394|75848567|FG001|NOT COMPLETED|Follow-up Period||0||
59730020|NCT01928394|75848568|FG002|NOT COMPLETED|Follow-up Period||3||
59730021|NCT01928394|75848569|FG003|NOT COMPLETED|Follow-up Period||10||
59730022|NCT01928394|75848570|FG004|NOT COMPLETED|Follow-up Period||0||
59730023|NCT01928394|75848571|FG005|NOT COMPLETED|Follow-up Period||8||
59730024|NCT01928394|75848572|FG006|NOT COMPLETED|Follow-up Period||12||
59730025|NCT01928394|75848573|FG007|NOT COMPLETED|Follow-up Period||6||
59730026|NCT01928394|75848574|FG008|NOT COMPLETED|Follow-up Period||1||
59730027|NCT01928394|75848575|FG009|NOT COMPLETED|Follow-up Period||2||
59730028|NCT01928394|75848576|FG010|NOT COMPLETED|Follow-up Period||11||
59730029|NCT01928394|75848577|FG011|NOT COMPLETED|Follow-up Period||22||
59730030|NCT01928394|75848578|FG012|NOT COMPLETED|Follow-up Period||14||
59730031|NCT01928394|75848579|FG013|NOT COMPLETED|Follow-up Period||38||
59730032|NCT01928394|75848580|FG014|NOT COMPLETED|Follow-up Period||30||
59730033|NCT01928394|75848581|FG015|NOT COMPLETED|Follow-up Period||0||
59730034|NCT01928394|75848582|FG016|NOT COMPLETED|Follow-up Period||14||
59730035|NCT01928394|75848583|FG017|NOT COMPLETED|Follow-up Period||8||
59730036|NCT01928394|75848584|FG018|NOT COMPLETED|Follow-up Period||16||
59730037|NCT01928394|75848585|FG019|NOT COMPLETED|Follow-up Period||21||
59730038|NCT01928394|75848586|FG020|NOT COMPLETED|Follow-up Period||9||
59730039|NCT01928394|75848587|FG021|NOT COMPLETED|Follow-up Period||9||
59730040|NCT01928394|75848588|FG022|NOT COMPLETED|Follow-up Period||6||
59730041|NCT01886872|75848639|FG000|STARTED|Overall Study||183|Registered/Randomized|
59730042|NCT01886872|75848640|FG001|STARTED|Overall Study||182|Registered/Randomized|
59730043|NCT01886872|75848641|FG002|STARTED|Overall Study||182|Registered/Randomized|
59730044|NCT01886872|75848639|FG000|Evaluable for Secondary Endpoints|Overall Study||183||
59730045|NCT01886872|75848640|FG001|Evaluable for Secondary Endpoints|Overall Study||182||
59730046|NCT01886872|75848641|FG002|Evaluable for Secondary Endpoints|Overall Study||182||
59730047|NCT01886872|75848639|FG000|Evaluable for Adverse Events|Overall Study||176|All Patients who Started Therapy|
59730048|NCT01886872|75848640|FG001|Evaluable for Adverse Events|Overall Study||180|All Patients who Started Therapy|
59730049|NCT01886872|75848641|FG002|Evaluable for Adverse Events|Overall Study||181|All Patients who Started Therapy|
59730050|NCT01886872|75848639|FG000|Crossover Cohort|Overall Study||30|Arm A to Arm B|
59730051|NCT01886872|75848640|FG001|Crossover Cohort|Overall Study||0|Arm A to Arm B|
59730052|NCT01886872|75848641|FG002|Crossover Cohort|Overall Study||0|Arm A to Arm B|
59730053|NCT01886872|75848639|FG000|COMPLETED|Overall Study||176|All Eligible Patients Evaluable for the Primary Endpoint|
59730054|NCT01886872|75848640|FG001|COMPLETED|Overall Study||178|All Eligible Patients Evaluable for the Primary Endpoint|
59730055|NCT01886872|75848641|FG002|COMPLETED|Overall Study||170|All Eligible Patients Evaluable for the Primary Endpoint|
59730056|NCT01886872|75848639|FG000|NOT COMPLETED|Overall Study||7||
59730057|NCT01886872|75848640|FG001|NOT COMPLETED|Overall Study||4||
59730058|NCT01886872|75848641|FG002|NOT COMPLETED|Overall Study||12||
59730059|NCT01864018|75848652|FG000|STARTED|Overall Study||51||
59730060|NCT01864018|75848653|FG001|STARTED|Overall Study||36||
59730061|NCT01864018|75848652|FG000|Accrued During Phase I|Overall Study||10||
59730062|NCT01864018|75848653|FG001|Accrued During Phase I|Overall Study||0||
59730063|NCT01864018|75848652|FG000|Accrued During Phase II|Overall Study||41||
59730064|NCT01864018|75848653|FG001|Accrued During Phase II|Overall Study||36||
59730065|NCT01864018|75848652|FG000|COMPLETED|Overall Study||48||
59730066|NCT01864018|75848653|FG001|COMPLETED|Overall Study||35||
59730067|NCT01864018|75848652|FG000|NOT COMPLETED|Overall Study||3||
59730068|NCT01864018|75848653|FG001|NOT COMPLETED|Overall Study||1||
59730069|NCT01856192|75848666|FG000|STARTED|Overall Study||173||
59730070|NCT01856192|75848667|FG001|STARTED|Overall Study||176||
59730071|NCT01856192|75848666|FG000|Treated Patients|Overall Study||166||
59730072|NCT01856192|75848667|FG001|Treated Patients|Overall Study||171||
59730073|NCT01856192|75848666|FG000|Evaluable Patients (Eligible and Treated)|Overall Study||145||
59730074|NCT01856192|75848667|FG001|Evaluable Patients (Eligible and Treated)|Overall Study||135||
59730075|NCT01856192|75848666|FG000|COMPLETED|Overall Study||124||
59730076|NCT01856192|75848667|FG001|COMPLETED|Overall Study||116||
59730077|NCT01856192|75848666|FG000|NOT COMPLETED|Overall Study||49||
59730078|NCT01856192|75848667|FG001|NOT COMPLETED|Overall Study||60||
59730079|NCT01850108|75848673|FG000|STARTED|Overall Study||26||
59730080|NCT01850108|75848673|FG000|COMPLETED|Overall Study||18||
59730081|NCT01850108|75848673|FG000|NOT COMPLETED|Overall Study||8||
59730082|NCT01844505|75848682|FG000|STARTED|Overall Study||313||
59730083|NCT01844505|75848683|FG001|STARTED|Overall Study||313||
59730084|NCT01844505|75848684|FG002|STARTED|Overall Study||311||
59730085|NCT01844505|75848682|FG000|COMPLETED|Overall Study|Completed = Number of subjects continuing in the treatment period|64||
59730086|NCT01844505|75848683|FG001|COMPLETED|Overall Study|Completed = Number of subjects continuing in the treatment period|44||
59730087|NCT01844505|75848684|FG002|COMPLETED|Overall Study|Completed = Number of subjects continuing in the treatment period|16||
59730088|NCT01844505|75848682|FG000|NOT COMPLETED|Overall Study||249||
59730089|NCT01844505|75848683|FG001|NOT COMPLETED|Overall Study||269||
59730090|NCT01844505|75848684|FG002|NOT COMPLETED|Overall Study||295||
59730091|NCT01796171|75848706|FG000|STARTED|Enrolled||4||
59730092|NCT01796171|75848707|FG001|STARTED|Enrolled||36||
59730093|NCT01796171|75848708|FG002|STARTED|Enrolled||3||
59730094|NCT01796171|75848709|FG003|STARTED|Enrolled||1||
59730095|NCT01796171|75848710|FG004|STARTED|Enrolled||2||
59730096|NCT01796171|75848711|FG005|STARTED|Enrolled||3||
59730097|NCT01796171|75848712|FG006|STARTED|Enrolled||3||
59730098|NCT01796171|75848713|FG007|STARTED|Enrolled||18||
59730099|NCT01796171|75848714|FG008|STARTED|Enrolled||4||
59730100|NCT01796171|75848715|FG009|STARTED|Enrolled||2||
59730101|NCT01796171|75848716|FG010|STARTED|Enrolled||76||
59730102|NCT01796171|75848717|FG011|STARTED|Enrolled||28||
59730103|NCT01796171|75848718|FG012|STARTED|Enrolled||9||
59730104|NCT01796171|75848719|FG013|STARTED|Enrolled||1||
59864037|NCT01606436|75988558|FG005|Received Second Intervention|Overall Study||14||
59864038|NCT01606436|75988553|FG000|Received Third Intervention|Overall Study||14||
59864039|NCT01606436|75988554|FG001|Received Third Intervention|Overall Study||14||
59864040|NCT01606436|75988555|FG002|Received Third Intervention|Overall Study||12||
59864041|NCT01606436|75988556|FG003|Received Third Intervention|Overall Study||12||
59864042|NCT01606436|75988557|FG004|Received Third Intervention|Overall Study||12||
59864043|NCT01606436|75988558|FG005|Received Third Intervention|Overall Study||14||
59864044|NCT01606436|75988553|FG000|COMPLETED|Overall Study||14||
59864045|NCT01606436|75988554|FG001|COMPLETED|Overall Study||14||
59730105|NCT01796171|75848720|FG014|STARTED|Enrolled||1||
59730106|NCT01796171|75848706|FG000|COMPLETED|Enrolled||4||
59730107|NCT01796171|75848707|FG001|COMPLETED|Enrolled||36||
59730108|NCT01796171|75848708|FG002|COMPLETED|Enrolled||3||
59730109|NCT01796171|75848709|FG003|COMPLETED|Enrolled||1||
59730110|NCT01796171|75848710|FG004|COMPLETED|Enrolled||2||
59864046|NCT01606436|75988555|FG002|COMPLETED|Overall Study||12||
59864047|NCT01606436|75988556|FG003|COMPLETED|Overall Study||12||
59864048|NCT01606436|75988557|FG004|COMPLETED|Overall Study||12||
59864049|NCT01606436|75988558|FG005|COMPLETED|Overall Study||14||
59864050|NCT01606436|75988553|FG000|NOT COMPLETED|Overall Study||0||
59864051|NCT01606436|75988554|FG001|NOT COMPLETED|Overall Study||0||
59864052|NCT01606436|75988555|FG002|NOT COMPLETED|Overall Study||2||
59864053|NCT01606436|75988556|FG003|NOT COMPLETED|Overall Study||2||
59864054|NCT01606436|75988557|FG004|NOT COMPLETED|Overall Study||1||
59864055|NCT01606436|75988558|FG005|NOT COMPLETED|Overall Study||0||
59864056|NCT01453088|75988568|FG000|STARTED|Overall Study||32||
59864057|NCT01453088|75988569|FG001|STARTED|Overall Study||31||
59864058|NCT01453088|75988568|FG000|COMPLETED|Overall Study||28||
59864059|NCT01453088|75988569|FG001|COMPLETED|Overall Study||31||
59864060|NCT01453088|75988568|FG000|NOT COMPLETED|Overall Study||4||
59864061|NCT01453088|75988569|FG001|NOT COMPLETED|Overall Study||0||
59864062|NCT00219557|75988578|FG000|STARTED|Phase 1||8||
59864063|NCT00219557|75988579|FG001|STARTED|Phase 1||0||
59864064|NCT00219557|75988580|FG002|STARTED|Phase 1||0||
59864065|NCT00219557|75988578|FG000|COMPLETED|Phase 1||1||
59864066|NCT00219557|75988579|FG001|COMPLETED|Phase 1||0||
59864067|NCT00219557|75988580|FG002|COMPLETED|Phase 1||0||
59864068|NCT00219557|75988578|FG000|NOT COMPLETED|Phase 1||7||
59864069|NCT00219557|75988579|FG001|NOT COMPLETED|Phase 1||0||
59864070|NCT00219557|75988580|FG002|NOT COMPLETED|Phase 1||0||
59864071|NCT00219557|75988578|FG000|STARTED|Phase 2||0||
59864072|NCT00219557|75988579|FG001|STARTED|Phase 2||69||
59864073|NCT00219557|75988580|FG002|STARTED|Phase 2||34||
59864074|NCT00219557|75988578|FG000|Treated|Phase 2||0||
59864075|NCT00219557|75988579|FG001|Treated|Phase 2||68||
59864076|NCT00219557|75988580|FG002|Treated|Phase 2||31||
59864077|NCT00219557|75988578|FG000|COMPLETED|Phase 2||0||
59864078|NCT00219557|75988579|FG001|COMPLETED|Phase 2||0||
59864079|NCT00219557|75988580|FG002|COMPLETED|Phase 2||1||
59864080|NCT00219557|75988578|FG000|NOT COMPLETED|Phase 2||0||
59864081|NCT00219557|75988579|FG001|NOT COMPLETED|Phase 2||69||
59864082|NCT00219557|75988580|FG002|NOT COMPLETED|Phase 2||33||
59864083|NCT03835260|75988589|FG000|STARTED|Overall Study||15||
59864084|NCT03835260|75988589|FG000|COMPLETED|Overall Study||15||
59864085|NCT03835260|75988589|FG000|NOT COMPLETED|Overall Study||0||
59864086|NCT00251927|75988595|FG000|STARTED|Overall Study|Randomised|288||
59864087|NCT00251927|75988596|FG001|STARTED|Overall Study|Randomised|266||
59864088|NCT00251927|75988595|FG000|COMPLETED|Overall Study|Completed 5 year visit|180||
59864089|NCT00251927|75988596|FG001|COMPLETED|Overall Study|Completed 5 year visit|192||
59864090|NCT00251927|75988595|FG000|NOT COMPLETED|Overall Study||108||
59864091|NCT00251927|75988596|FG001|NOT COMPLETED|Overall Study||74||
59864092|NCT00165503|75988603|FG000|STARTED|Overall Study||16||
59864093|NCT00165503|75988603|FG000|COMPLETED|Overall Study||0||
59864094|NCT00165503|75988603|FG000|NOT COMPLETED|Overall Study||16||
59864095|NCT00162773|75988607|FG000|STARTED|Overall Study||29||
59864096|NCT00162773|75988607|FG000|COMPLETED|Overall Study||7||
59864097|NCT00162773|75988607|FG000|NOT COMPLETED|Overall Study||22||
59864098|NCT00209339|75988611|FG000|STARTED|At 12 Months Follow-up||55||
59864099|NCT00209339|75988611|FG000|COMPLETED|At 12 Months Follow-up||40||
59864100|NCT00209339|75988611|FG000|NOT COMPLETED|At 12 Months Follow-up||15||
59864101|NCT00209339|75988611|FG000|STARTED|At 24 Months Follow-up||40||
59864102|NCT00209339|75988611|FG000|COMPLETED|At 24 Months Follow-up||29||
59864103|NCT00209339|75988611|FG000|NOT COMPLETED|At 24 Months Follow-up||11||
59864104|NCT00209339|75988611|FG000|STARTED|At 3 Years Follow-up||29||
59864105|NCT00209339|75988611|FG000|COMPLETED|At 3 Years Follow-up||28||
59864106|NCT00209339|75988611|FG000|NOT COMPLETED|At 3 Years Follow-up||1||
59864107|NCT00209339|75988611|FG000|STARTED|At 4 Years Follow-up||28||
59864108|NCT00209339|75988611|FG000|COMPLETED|At 4 Years Follow-up||23||
59864109|NCT00209339|75988611|FG000|NOT COMPLETED|At 4 Years Follow-up||5||
59864110|NCT00209339|75988611|FG000|STARTED|At 5 Years Follow-up||23||
59864111|NCT00209339|75988611|FG000|COMPLETED|At 5 Years Follow-up||15||
59864112|NCT00209339|75988611|FG000|NOT COMPLETED|At 5 Years Follow-up||8||
59864113|NCT03823391|75988617|FG000|STARTED|Period 1: Week 1 to Week 12||17||
59864114|NCT03823391|75988618|FG001|STARTED|Period 1: Week 1 to Week 12||31||
59864115|NCT03823391|75988617|FG000|COMPLETED|Period 1: Week 1 to Week 12||17||
59864116|NCT03823391|75988618|FG001|COMPLETED|Period 1: Week 1 to Week 12||31||
59864117|NCT03823391|75988617|FG000|NOT COMPLETED|Period 1: Week 1 to Week 12||0||
59864118|NCT03823391|75988618|FG001|NOT COMPLETED|Period 1: Week 1 to Week 12||0||
59864119|NCT03823391|75988617|FG000|STARTED|Period 2: Weeks 12 to Week 24||17||
59864120|NCT03823391|75988618|FG001|STARTED|Period 2: Weeks 12 to Week 24||31||
59864121|NCT03823391|75988617|FG000|COMPLETED|Period 2: Weeks 12 to Week 24||15||
59864122|NCT03823391|75988618|FG001|COMPLETED|Period 2: Weeks 12 to Week 24||30||
59864123|NCT03823391|75988617|FG000|NOT COMPLETED|Period 2: Weeks 12 to Week 24||2||
59864124|NCT03823391|75988618|FG001|NOT COMPLETED|Period 2: Weeks 12 to Week 24||1||
59864125|NCT00209027|75988628|FG000|STARTED|Overall Study||10||
59864126|NCT00209027|75988629|FG001|STARTED|Overall Study||10||
59864127|NCT00209027|75988628|FG000|COMPLETED|Overall Study||0||
59864128|NCT00209027|75988629|FG001|COMPLETED|Overall Study||10||
59864129|NCT00209027|75988628|FG000|NOT COMPLETED|Overall Study||10||
59864130|NCT00209027|75988629|FG001|NOT COMPLETED|Overall Study||0||
59864131|NCT00208325|75988639|FG000|STARTED|Overall Study||193||
59864132|NCT00208325|75988640|FG001|STARTED|Overall Study||196||
59864133|NCT00208325|75988641|FG002|STARTED|Overall Study||170||
59864134|NCT00208325|75988642|FG003|STARTED|Overall Study||161||
59864135|NCT00208325|75988639|FG000|COMPLETED|Overall Study||142||
59864136|NCT00208325|75988640|FG001|COMPLETED|Overall Study||142||
59864137|NCT00208325|75988641|FG002|COMPLETED|Overall Study||156||
59864138|NCT00208325|75988642|FG003|COMPLETED|Overall Study||147||
59864139|NCT00208325|75988639|FG000|NOT COMPLETED|Overall Study||51||
59864140|NCT00208325|75988640|FG001|NOT COMPLETED|Overall Study||54||
59864141|NCT00208325|75988641|FG002|NOT COMPLETED|Overall Study||14||
59864142|NCT00208325|75988642|FG003|NOT COMPLETED|Overall Study||14||
59864143|NCT00160667|75988655|FG000|STARTED|Overall Study||50||
59864144|NCT00160667|75988656|FG001|STARTED|Overall Study||51||
59864145|NCT00160667|75988657|FG002|STARTED|Overall Study||51||
59864146|NCT00160667|75988655|FG000|COMPLETED|Overall Study||45||
59864147|NCT00160667|75988656|FG001|COMPLETED|Overall Study||48||
59864148|NCT00160667|75988657|FG002|COMPLETED|Overall Study||45||
59864149|NCT00160667|75988655|FG000|NOT COMPLETED|Overall Study||5||
59864150|NCT00160667|75988656|FG001|NOT COMPLETED|Overall Study||3||
59864151|NCT00160667|75988657|FG002|NOT COMPLETED|Overall Study||6||
59864152|NCT00206375|75988669|FG000|STARTED|Overall Study||6||
59864153|NCT00206375|75988670|FG001|STARTED|Overall Study||3||
59864154|NCT00206375|75988671|FG002|STARTED|Overall Study||7||
59864155|NCT00206375|75988669|FG000|COMPLETED|Overall Study||3||
59864156|NCT00206375|75988670|FG001|COMPLETED|Overall Study||1||
59864157|NCT00206375|75988671|FG002|COMPLETED|Overall Study||3||
59864158|NCT00206375|75988669|FG000|NOT COMPLETED|Overall Study||3||
59864159|NCT00206375|75988670|FG001|NOT COMPLETED|Overall Study||2||
59864160|NCT00206375|75988671|FG002|NOT COMPLETED|Overall Study||4||
59864161|NCT00160199|75988681|FG000|STARTED|Overall Study||122||
59864162|NCT00160199|75988682|FG001|STARTED|Overall Study||118||
59864163|NCT00160199|75988681|FG000|COMPLETED|Overall Study||98||
59864164|NCT00160199|75988682|FG001|COMPLETED|Overall Study||81||
59864165|NCT00160199|75988681|FG000|NOT COMPLETED|Overall Study||24||
59864166|NCT00160199|75988682|FG001|NOT COMPLETED|Overall Study||37||
59864167|NCT00157157|75988688|FG000|STARTED|Overall Study||55||
59864168|NCT00157157|75988688|FG000|COMPLETED|Overall Study||44||
59864169|NCT00157157|75988688|FG000|NOT COMPLETED|Overall Study||11||
59864170|NCT00203411|75988699|FG000|STARTED|Treatment Period||45||
59864171|NCT00203411|75988699|FG000|COMPLETED|Treatment Period||45||
59864172|NCT00203411|75988699|FG000|NOT COMPLETED|Treatment Period||0||
59864173|NCT00203411|75988699|FG000|STARTED|Follow-up||45||
59864174|NCT00203411|75988699|FG000|COMPLETED|Follow-up||41||
59864175|NCT00203411|75988699|FG000|NOT COMPLETED|Follow-up||4||
59864176|NCT00203021|75988706|FG000|STARTED|Overall Study||107||
59864177|NCT00203021|75988707|FG001|STARTED|Overall Study||101||
59864178|NCT00203021|75988706|FG000|Received at Least 1 Dose of Study Drug|Overall Study||107||
59864179|NCT00203021|75988707|FG001|Received at Least 1 Dose of Study Drug|Overall Study||101||
59864180|NCT00203021|75988706|FG000|COMPLETED|Overall Study||28||
59864181|NCT00203021|75988707|FG001|COMPLETED|Overall Study||24||
59864182|NCT00203021|75988706|FG000|NOT COMPLETED|Overall Study||79||
59864183|NCT00203021|75988707|FG001|NOT COMPLETED|Overall Study||77||
59864184|NCT00201851|75988716|FG000|STARTED|Overall Study||252||
59864185|NCT00201851|75988717|FG001|STARTED|Overall Study||257||
59864186|NCT00201851|75988718|FG002|STARTED|Overall Study||231||
59864187|NCT00201851|75988716|FG000|COMPLETED|Overall Study||244||
59864188|NCT00201851|75988717|FG001|COMPLETED|Overall Study||255||
59864189|NCT00201851|75988718|FG002|COMPLETED|Overall Study||230||
59864190|NCT00201851|75988716|FG000|NOT COMPLETED|Overall Study||8||
59864191|NCT00201851|75988717|FG001|NOT COMPLETED|Overall Study||2||
59864192|NCT00201851|75988718|FG002|NOT COMPLETED|Overall Study||1||
59864193|NCT00200057|75988726|FG000|STARTED|Overall Study||120||
59864194|NCT00200057|75988726|FG000|1 Month Follow-up|Overall Study||117||
59864195|NCT00200057|75988726|FG000|3 Month Follow-up|Overall Study||116||
59864196|NCT00200057|75988726|FG000|6 Month Follow-up|Overall Study||114||
59864197|NCT00200057|75988726|FG000|12 Month Follow-up|Overall Study||111||
59864198|NCT00200057|75988726|FG000|COMPLETED|Overall Study||111||
59864199|NCT00200057|75988726|FG000|NOT COMPLETED|Overall Study||9||
59864200|NCT03129100|75988735|FG000|STARTED|Lead-In Period (Period 1)||350||
59864201|NCT03129100|75988736|FG001|STARTED|Lead-In Period (Period 1)||423||
59864202|NCT03129100|75988737|FG002|STARTED|Lead-In Period (Period 1)||0||
59864203|NCT03129100|75988738|FG003|STARTED|Lead-In Period (Period 1)||0||
59864204|NCT03129100|75988739|FG004|STARTED|Lead-In Period (Period 1)||0||
59864205|NCT03129100|75988740|FG005|STARTED|Lead-In Period (Period 1)||0||
59864206|NCT03129100|75988741|FG006|STARTED|Lead-In Period (Period 1)||0||
59864207|NCT03129100|75988742|FG007|STARTED|Lead-In Period (Period 1)||0||
59864208|NCT03129100|75988743|FG008|STARTED|Lead-In Period (Period 1)||0||
59864209|NCT03129100|75988744|FG009|STARTED|Lead-In Period (Period 1)||0||
59864210|NCT03129100|75988745|FG010|STARTED|Lead-In Period (Period 1)||0||
59864211|NCT03129100|75988746|FG011|STARTED|Lead-In Period (Period 1)||0||
59864212|NCT03129100|75988747|FG012|STARTED|Lead-In Period (Period 1)||0||
59864213|NCT03129100|75988748|FG013|STARTED|Lead-In Period (Period 1)||0||
59864214|NCT03129100|75988749|FG014|STARTED|Lead-In Period (Period 1)||0||
59864215|NCT03129100|75988750|FG015|STARTED|Lead-In Period (Period 1)||0||
59864216|NCT03129100|75988751|FG016|STARTED|Lead-In Period (Period 1)||0||
59864217|NCT03129100|75988752|FG017|STARTED|Lead-In Period (Period 1)||0||
59864218|NCT03129100|75988753|FG018|STARTED|Lead-In Period (Period 1)||0||
59864219|NCT03129100|75988754|FG019|STARTED|Lead-In Period (Period 1)||0||
59864220|NCT03129100|75988755|FG020|STARTED|Lead-In Period (Period 1)||0||
59864221|NCT03129100|75988756|FG021|STARTED|Lead-In Period (Period 1)||0||
59864222|NCT03129100|75988757|FG022|STARTED|Lead-In Period (Period 1)||0||
59864223|NCT03129100|75988758|FG023|STARTED|Lead-In Period (Period 1)||0||
59864224|NCT03129100|75988759|FG024|STARTED|Lead-In Period (Period 1)||0||
59864225|NCT03129100|75988760|FG025|STARTED|Lead-In Period (Period 1)||0||
59864226|NCT03129100|75988735|FG000|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||348||
59864227|NCT03129100|75988736|FG001|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||423||
59864228|NCT03129100|75988737|FG002|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0||
59864229|NCT03129100|75988738|FG003|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0||
59864230|NCT03129100|75988739|FG004|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0||
59864231|NCT03129100|75988740|FG005|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0||
59864232|NCT03129100|75988741|FG006|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0||
59864233|NCT03129100|75988742|FG007|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0||
59864234|NCT03129100|75988743|FG008|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0||
59864235|NCT03129100|75988744|FG009|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0||
59864236|NCT03129100|75988745|FG010|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0||
59864237|NCT03129100|75988746|FG011|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0||
59864238|NCT03129100|75988747|FG012|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0||
59864239|NCT03129100|75988748|FG013|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0||
59864240|NCT03129100|75988749|FG014|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0||
59864241|NCT03129100|75988750|FG015|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0||
59864242|NCT03129100|75988751|FG016|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0||
59864243|NCT03129100|75988752|FG017|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0||
59864244|NCT03129100|75988753|FG018|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0||
59864245|NCT03129100|75988754|FG019|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0||
59864246|NCT03129100|75988755|FG020|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0||
59864247|NCT03129100|75988756|FG021|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0||
59864248|NCT03129100|75988757|FG022|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0||
59864249|NCT03129100|75988758|FG023|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0||
59864250|NCT03129100|75988759|FG024|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0||
59864251|NCT03129100|75988760|FG025|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0||
59864252|NCT03129100|75988735|FG000|COMPLETED|Lead-In Period (Period 1)||335||
59864253|NCT03129100|75988736|FG001|COMPLETED|Lead-In Period (Period 1)||406||
59864254|NCT03129100|75988737|FG002|COMPLETED|Lead-In Period (Period 1)||0||
59864255|NCT03129100|75988738|FG003|COMPLETED|Lead-In Period (Period 1)||0||
59864256|NCT03129100|75988739|FG004|COMPLETED|Lead-In Period (Period 1)||0||
59864257|NCT03129100|75988740|FG005|COMPLETED|Lead-In Period (Period 1)||0||
59864258|NCT03129100|75988741|FG006|COMPLETED|Lead-In Period (Period 1)||0||
59864259|NCT03129100|75988742|FG007|COMPLETED|Lead-In Period (Period 1)||0||
59864260|NCT03129100|75988743|FG008|COMPLETED|Lead-In Period (Period 1)||0||
59864261|NCT03129100|75988744|FG009|COMPLETED|Lead-In Period (Period 1)||0||
59864262|NCT03129100|75988745|FG010|COMPLETED|Lead-In Period (Period 1)||0||
59864263|NCT03129100|75988746|FG011|COMPLETED|Lead-In Period (Period 1)||0||
59864264|NCT03129100|75988747|FG012|COMPLETED|Lead-In Period (Period 1)||0||
59864265|NCT03129100|75988748|FG013|COMPLETED|Lead-In Period (Period 1)||0||
59864266|NCT03129100|75988749|FG014|COMPLETED|Lead-In Period (Period 1)||0||
59864267|NCT03129100|75988750|FG015|COMPLETED|Lead-In Period (Period 1)||0||
59864268|NCT03129100|75988751|FG016|COMPLETED|Lead-In Period (Period 1)||0||
59864269|NCT03129100|75988752|FG017|COMPLETED|Lead-In Period (Period 1)||0||
59864270|NCT03129100|75988753|FG018|COMPLETED|Lead-In Period (Period 1)||0||
59864271|NCT03129100|75988754|FG019|COMPLETED|Lead-In Period (Period 1)||0||
59864272|NCT03129100|75988755|FG020|COMPLETED|Lead-In Period (Period 1)||0||
59864273|NCT03129100|75988756|FG021|COMPLETED|Lead-In Period (Period 1)||0||
60131405|NCT00614913|76254014|FG000|NOT COMPLETED|Overall Study||0||
60131406|NCT01547780|76254021|FG000|STARTED|Baseline PET Scan||12||
59864274|NCT03129100|75988757|FG022|COMPLETED|Lead-In Period (Period 1)||0||
59864275|NCT03129100|75988758|FG023|COMPLETED|Lead-In Period (Period 1)||0||
59864276|NCT03129100|75988759|FG024|COMPLETED|Lead-In Period (Period 1)||0||
59864277|NCT03129100|75988760|FG025|COMPLETED|Lead-In Period (Period 1)||0||
59864278|NCT03129100|75988735|FG000|NOT COMPLETED|Lead-In Period (Period 1)||15||
60131407|NCT01547780|76254022|FG001|STARTED|Baseline PET Scan||0||
60131408|NCT01547780|76254023|FG002|STARTED|Baseline PET Scan||19||
59864279|NCT03129100|75988736|FG001|NOT COMPLETED|Lead-In Period (Period 1)||17||
59864280|NCT03129100|75988737|FG002|NOT COMPLETED|Lead-In Period (Period 1)||0||
59864281|NCT03129100|75988738|FG003|NOT COMPLETED|Lead-In Period (Period 1)||0||
59864282|NCT03129100|75988739|FG004|NOT COMPLETED|Lead-In Period (Period 1)||0||
59864283|NCT03129100|75988740|FG005|NOT COMPLETED|Lead-In Period (Period 1)||0||
59864284|NCT03129100|75988741|FG006|NOT COMPLETED|Lead-In Period (Period 1)||0||
59864285|NCT03129100|75988742|FG007|NOT COMPLETED|Lead-In Period (Period 1)||0||
59864286|NCT03129100|75988743|FG008|NOT COMPLETED|Lead-In Period (Period 1)||0||
59864287|NCT03129100|75988744|FG009|NOT COMPLETED|Lead-In Period (Period 1)||0||
59864288|NCT03129100|75988745|FG010|NOT COMPLETED|Lead-In Period (Period 1)||0||
59864289|NCT03129100|75988746|FG011|NOT COMPLETED|Lead-In Period (Period 1)||0||
59864290|NCT03129100|75988747|FG012|NOT COMPLETED|Lead-In Period (Period 1)||0||
59864291|NCT03129100|75988748|FG013|NOT COMPLETED|Lead-In Period (Period 1)||0||
59864292|NCT03129100|75988749|FG014|NOT COMPLETED|Lead-In Period (Period 1)||0||
59864293|NCT03129100|75988750|FG015|NOT COMPLETED|Lead-In Period (Period 1)||0||
59864294|NCT03129100|75988751|FG016|NOT COMPLETED|Lead-In Period (Period 1)||0||
59730111|NCT01796171|75848711|FG005|COMPLETED|Enrolled||3||
59730112|NCT01796171|75848712|FG006|COMPLETED|Enrolled||3||
59730113|NCT01796171|75848713|FG007|COMPLETED|Enrolled||18||
59730114|NCT01796171|75848714|FG008|COMPLETED|Enrolled||4||
59730115|NCT01796171|75848715|FG009|COMPLETED|Enrolled||2||
59730116|NCT01796171|75848716|FG010|COMPLETED|Enrolled||76||
59730117|NCT01796171|75848717|FG011|COMPLETED|Enrolled||28||
59730118|NCT01796171|75848718|FG012|COMPLETED|Enrolled||9||
59730119|NCT01796171|75848719|FG013|COMPLETED|Enrolled||1||
59864295|NCT03129100|75988752|FG017|NOT COMPLETED|Lead-In Period (Period 1)||0||
59864296|NCT03129100|75988753|FG018|NOT COMPLETED|Lead-In Period (Period 1)||0||
59864297|NCT03129100|75988754|FG019|NOT COMPLETED|Lead-In Period (Period 1)||0||
59864298|NCT03129100|75988755|FG020|NOT COMPLETED|Lead-In Period (Period 1)||0||
59864299|NCT03129100|75988756|FG021|NOT COMPLETED|Lead-In Period (Period 1)||0||
59864300|NCT03129100|75988757|FG022|NOT COMPLETED|Lead-In Period (Period 1)||0||
59864301|NCT03129100|75988758|FG023|NOT COMPLETED|Lead-In Period (Period 1)||0||
59864302|NCT03129100|75988759|FG024|NOT COMPLETED|Lead-In Period (Period 1)||0||
59864303|NCT03129100|75988760|FG025|NOT COMPLETED|Lead-In Period (Period 1)||0||
59864304|NCT03129100|75988735|FG000|STARTED|Period2 Extension Period (Group A and B)|Only Extension Period participants were included.|0||
59864305|NCT03129100|75988736|FG001|STARTED|Period2 Extension Period (Group A and B)|Only Extension Period participants were included.|0||
59864306|NCT03129100|75988737|FG002|STARTED|Period2 Extension Period (Group A and B)|Participants who entered extension period (Group A).|255||
59864307|NCT03129100|75988738|FG003|STARTED|Period2 Extension Period (Group A and B)|Participants who entered extension period (Group A).|318||
59864308|NCT03129100|75988739|FG004|STARTED|Period2 Extension Period (Group A and B)|Participants who entered extension period (Group B).|48||
59864309|NCT03129100|75988740|FG005|STARTED|Period2 Extension Period (Group A and B)|Participants who entered extension period (Group B).|54||
59864310|NCT03129100|75988741|FG006|STARTED|Period2 Extension Period (Group A and B)|Participants who entered extension period (Group B).|53||
59864311|NCT03129100|75988742|FG007|STARTED|Period2 Extension Period (Group A and B)||0||
59864312|NCT03129100|75988743|FG008|STARTED|Period2 Extension Period (Group A and B)||0||
59864313|NCT03129100|75988744|FG009|STARTED|Period2 Extension Period (Group A and B)||0||
59864314|NCT03129100|75988745|FG010|STARTED|Period2 Extension Period (Group A and B)||0||
59864315|NCT03129100|75988746|FG011|STARTED|Period2 Extension Period (Group A and B)||0||
59864316|NCT03129100|75988747|FG012|STARTED|Period2 Extension Period (Group A and B)||0||
59864317|NCT03129100|75988748|FG013|STARTED|Period2 Extension Period (Group A and B)||0||
59864318|NCT03129100|75988749|FG014|STARTED|Period2 Extension Period (Group A and B)||0||
59864319|NCT03129100|75988750|FG015|STARTED|Period2 Extension Period (Group A and B)||0||
59864320|NCT03129100|75988751|FG016|STARTED|Period2 Extension Period (Group A and B)||0||
59864321|NCT03129100|75988752|FG017|STARTED|Period2 Extension Period (Group A and B)||0||
59864322|NCT03129100|75988753|FG018|STARTED|Period2 Extension Period (Group A and B)||0||
59864323|NCT03129100|75988754|FG019|STARTED|Period2 Extension Period (Group A and B)||0||
59864324|NCT03129100|75988755|FG020|STARTED|Period2 Extension Period (Group A and B)||0||
59864325|NCT03129100|75988756|FG021|STARTED|Period2 Extension Period (Group A and B)||0||
59864326|NCT03129100|75988757|FG022|STARTED|Period2 Extension Period (Group A and B)||0||
59864327|NCT03129100|75988758|FG023|STARTED|Period2 Extension Period (Group A and B)||0||
59730120|NCT01796171|75848720|FG014|COMPLETED|Enrolled||0||
59730121|NCT01796171|75848706|FG000|NOT COMPLETED|Enrolled||0||
59864328|NCT03129100|75988759|FG024|STARTED|Period2 Extension Period (Group A and B)||0||
59864329|NCT03129100|75988760|FG025|STARTED|Period2 Extension Period (Group A and B)||0||
59999753|NCT02087423|76115456|FG000|COMPLETED|Overall Study||0||
59864330|NCT03129100|75988735|FG000|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0||
59864331|NCT03129100|75988736|FG001|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0||
59864332|NCT03129100|75988737|FG002|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||255||
59864333|NCT03129100|75988738|FG003|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||318||
59864334|NCT03129100|75988739|FG004|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||47||
59864335|NCT03129100|75988740|FG005|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||54||
59864336|NCT03129100|75988741|FG006|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||53||
59864337|NCT03129100|75988742|FG007|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0||
59864338|NCT03129100|75988743|FG008|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0||
59864339|NCT03129100|75988744|FG009|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0||
59864340|NCT03129100|75988745|FG010|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0||
59864341|NCT03129100|75988746|FG011|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0||
59864342|NCT03129100|75988747|FG012|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0||
59864343|NCT03129100|75988748|FG013|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0||
59864344|NCT03129100|75988749|FG014|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0||
59864345|NCT03129100|75988750|FG015|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0||
59864346|NCT03129100|75988751|FG016|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0||
59864347|NCT03129100|75988752|FG017|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0||
59864348|NCT03129100|75988753|FG018|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0||
59864349|NCT03129100|75988754|FG019|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0||
59864350|NCT03129100|75988755|FG020|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0||
59864351|NCT03129100|75988756|FG021|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0||
59864352|NCT03129100|75988757|FG022|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0||
59864353|NCT03129100|75988758|FG023|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0||
59864354|NCT03129100|75988759|FG024|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0||
59864355|NCT03129100|75988760|FG025|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0||
59864356|NCT03129100|75988735|FG000|COMPLETED|Period2 Extension Period (Group A and B)||0||
59864357|NCT03129100|75988736|FG001|COMPLETED|Period2 Extension Period (Group A and B)||0||
59864358|NCT03129100|75988737|FG002|COMPLETED|Period2 Extension Period (Group A and B)||234||
59864359|NCT03129100|75988738|FG003|COMPLETED|Period2 Extension Period (Group A and B)||312||
59864360|NCT03129100|75988739|FG004|COMPLETED|Period2 Extension Period (Group A and B)||42||
59864361|NCT03129100|75988740|FG005|COMPLETED|Period2 Extension Period (Group A and B)||45||
59864362|NCT03129100|75988741|FG006|COMPLETED|Period2 Extension Period (Group A and B)||32||
59864363|NCT03129100|75988742|FG007|COMPLETED|Period2 Extension Period (Group A and B)||0||
59864364|NCT03129100|75988743|FG008|COMPLETED|Period2 Extension Period (Group A and B)||0||
59864365|NCT03129100|75988744|FG009|COMPLETED|Period2 Extension Period (Group A and B)||0||
59864366|NCT03129100|75988745|FG010|COMPLETED|Period2 Extension Period (Group A and B)||0||
59864367|NCT03129100|75988746|FG011|COMPLETED|Period2 Extension Period (Group A and B)||0||
59864368|NCT03129100|75988747|FG012|COMPLETED|Period2 Extension Period (Group A and B)||0||
59864369|NCT03129100|75988748|FG013|COMPLETED|Period2 Extension Period (Group A and B)||0||
59864370|NCT03129100|75988749|FG014|COMPLETED|Period2 Extension Period (Group A and B)||0||
59864371|NCT03129100|75988750|FG015|COMPLETED|Period2 Extension Period (Group A and B)||0||
59864372|NCT03129100|75988751|FG016|COMPLETED|Period2 Extension Period (Group A and B)||0||
59864373|NCT03129100|75988752|FG017|COMPLETED|Period2 Extension Period (Group A and B)||0||
59864374|NCT03129100|75988753|FG018|COMPLETED|Period2 Extension Period (Group A and B)||0||
59864375|NCT03129100|75988754|FG019|COMPLETED|Period2 Extension Period (Group A and B)||0||
59864376|NCT03129100|75988755|FG020|COMPLETED|Period2 Extension Period (Group A and B)||0||
59864377|NCT03129100|75988756|FG021|COMPLETED|Period2 Extension Period (Group A and B)||0||
59864378|NCT03129100|75988757|FG022|COMPLETED|Period2 Extension Period (Group A and B)||0||
59864379|NCT03129100|75988758|FG023|COMPLETED|Period2 Extension Period (Group A and B)||0||
59864380|NCT03129100|75988759|FG024|COMPLETED|Period2 Extension Period (Group A and B)||0||
59864381|NCT03129100|75988760|FG025|COMPLETED|Period2 Extension Period (Group A and B)||0||
59864382|NCT03129100|75988735|FG000|NOT COMPLETED|Period2 Extension Period (Group A and B)||0||
59864383|NCT03129100|75988736|FG001|NOT COMPLETED|Period2 Extension Period (Group A and B)||0||
59864384|NCT03129100|75988737|FG002|NOT COMPLETED|Period2 Extension Period (Group A and B)||21||
59864385|NCT03129100|75988738|FG003|NOT COMPLETED|Period2 Extension Period (Group A and B)||6||
59864386|NCT03129100|75988739|FG004|NOT COMPLETED|Period2 Extension Period (Group A and B)||6||
59864387|NCT03129100|75988740|FG005|NOT COMPLETED|Period2 Extension Period (Group A and B)||9||
59864388|NCT03129100|75988741|FG006|NOT COMPLETED|Period2 Extension Period (Group A and B)||21||
59864389|NCT03129100|75988742|FG007|NOT COMPLETED|Period2 Extension Period (Group A and B)||0||
59999754|NCT02087423|76115457|FG001|COMPLETED|Overall Study||0||
59864390|NCT03129100|75988743|FG008|NOT COMPLETED|Period2 Extension Period (Group A and B)||0||
59864391|NCT03129100|75988744|FG009|NOT COMPLETED|Period2 Extension Period (Group A and B)||0||
59864392|NCT03129100|75988745|FG010|NOT COMPLETED|Period2 Extension Period (Group A and B)||0||
59864393|NCT03129100|75988746|FG011|NOT COMPLETED|Period2 Extension Period (Group A and B)||0||
59864394|NCT03129100|75988747|FG012|NOT COMPLETED|Period2 Extension Period (Group A and B)||0||
59864395|NCT03129100|75988748|FG013|NOT COMPLETED|Period2 Extension Period (Group A and B)||0||
59864396|NCT03129100|75988749|FG014|NOT COMPLETED|Period2 Extension Period (Group A and B)||0||
59864397|NCT03129100|75988750|FG015|NOT COMPLETED|Period2 Extension Period (Group A and B)||0||
59864398|NCT03129100|75988751|FG016|NOT COMPLETED|Period2 Extension Period (Group A and B)||0||
59864399|NCT03129100|75988752|FG017|NOT COMPLETED|Period2 Extension Period (Group A and B)||0||
59864400|NCT03129100|75988753|FG018|NOT COMPLETED|Period2 Extension Period (Group A and B)||0||
59864401|NCT03129100|75988754|FG019|NOT COMPLETED|Period2 Extension Period (Group A and B)||0||
59864402|NCT03129100|75988755|FG020|NOT COMPLETED|Period2 Extension Period (Group A and B)||0||
59864403|NCT03129100|75988756|FG021|NOT COMPLETED|Period2 Extension Period (Group A and B)||0||
59864404|NCT03129100|75988757|FG022|NOT COMPLETED|Period2 Extension Period (Group A and B)||0||
59864405|NCT03129100|75988758|FG023|NOT COMPLETED|Period2 Extension Period (Group A and B)||0||
59864406|NCT03129100|75988759|FG024|NOT COMPLETED|Period2 Extension Period (Group A and B)||0||
59864407|NCT03129100|75988760|FG025|NOT COMPLETED|Period2 Extension Period (Group A and B)||0||
59864408|NCT03129100|75988735|FG000|STARTED|Period 2 (Retreatment Extension Period)||0||
59864409|NCT03129100|75988736|FG001|STARTED|Period 2 (Retreatment Extension Period)||0||
59864410|NCT03129100|75988737|FG002|STARTED|Period 2 (Retreatment Extension Period)||0||
59864411|NCT03129100|75988738|FG003|STARTED|Period 2 (Retreatment Extension Period)||0||
59864412|NCT03129100|75988739|FG004|STARTED|Period 2 (Retreatment Extension Period)||0||
59864413|NCT03129100|75988740|FG005|STARTED|Period 2 (Retreatment Extension Period)||0||
59864414|NCT03129100|75988741|FG006|STARTED|Period 2 (Retreatment Extension Period)||0||
59864415|NCT03129100|75988742|FG007|STARTED|Period 2 (Retreatment Extension Period)|Participants who experienced flare in Group B Extension period.|6||
59864416|NCT03129100|75988743|FG008|STARTED|Period 2 (Retreatment Extension Period)|Participants who experienced flare in Group B Extension period.|5||
59864417|NCT03129100|75988744|FG009|STARTED|Period 2 (Retreatment Extension Period)|Participants who experienced flare in Group B Extension period.|9||
59864418|NCT03129100|75988745|FG010|STARTED|Period 2 (Retreatment Extension Period)|Participants who experienced flare in Group B Extension period.|10||
59864419|NCT03129100|75988746|FG011|STARTED|Period 2 (Retreatment Extension Period)||0||
59864420|NCT03129100|75988747|FG012|STARTED|Period 2 (Retreatment Extension Period)||0||
59864421|NCT03129100|75988748|FG013|STARTED|Period 2 (Retreatment Extension Period)||0||
59864422|NCT03129100|75988749|FG014|STARTED|Period 2 (Retreatment Extension Period)||0||
59864423|NCT03129100|75988750|FG015|STARTED|Period 2 (Retreatment Extension Period)||0||
59864424|NCT03129100|75988751|FG016|STARTED|Period 2 (Retreatment Extension Period)||0||
59864425|NCT03129100|75988752|FG017|STARTED|Period 2 (Retreatment Extension Period)||0||
59864426|NCT03129100|75988753|FG018|STARTED|Period 2 (Retreatment Extension Period)||0||
59864427|NCT03129100|75988754|FG019|STARTED|Period 2 (Retreatment Extension Period)||0||
59864428|NCT03129100|75988755|FG020|STARTED|Period 2 (Retreatment Extension Period)||0||
59864429|NCT03129100|75988756|FG021|STARTED|Period 2 (Retreatment Extension Period)||0||
59864430|NCT03129100|75988757|FG022|STARTED|Period 2 (Retreatment Extension Period)||0||
59864431|NCT03129100|75988758|FG023|STARTED|Period 2 (Retreatment Extension Period)||0||
59864432|NCT03129100|75988759|FG024|STARTED|Period 2 (Retreatment Extension Period)||0||
59864433|NCT03129100|75988760|FG025|STARTED|Period 2 (Retreatment Extension Period)||0||
59864434|NCT03129100|75988735|FG000|COMPLETED|Period 2 (Retreatment Extension Period)||0||
59864435|NCT03129100|75988736|FG001|COMPLETED|Period 2 (Retreatment Extension Period)||0||
59864436|NCT03129100|75988737|FG002|COMPLETED|Period 2 (Retreatment Extension Period)||0||
59864437|NCT03129100|75988738|FG003|COMPLETED|Period 2 (Retreatment Extension Period)||0||
59864438|NCT03129100|75988739|FG004|COMPLETED|Period 2 (Retreatment Extension Period)||0||
59864439|NCT03129100|75988740|FG005|COMPLETED|Period 2 (Retreatment Extension Period)||0||
59864440|NCT03129100|75988741|FG006|COMPLETED|Period 2 (Retreatment Extension Period)||0||
59864441|NCT03129100|75988742|FG007|COMPLETED|Period 2 (Retreatment Extension Period)||6||
59864442|NCT03129100|75988743|FG008|COMPLETED|Period 2 (Retreatment Extension Period)||5||
59864443|NCT03129100|75988744|FG009|COMPLETED|Period 2 (Retreatment Extension Period)||8||
59864444|NCT03129100|75988745|FG010|COMPLETED|Period 2 (Retreatment Extension Period)||10||
59864445|NCT03129100|75988746|FG011|COMPLETED|Period 2 (Retreatment Extension Period)||0||
59864446|NCT03129100|75988747|FG012|COMPLETED|Period 2 (Retreatment Extension Period)||0||
59864447|NCT03129100|75988748|FG013|COMPLETED|Period 2 (Retreatment Extension Period)||0||
59864448|NCT03129100|75988749|FG014|COMPLETED|Period 2 (Retreatment Extension Period)||0||
59864449|NCT03129100|75988750|FG015|COMPLETED|Period 2 (Retreatment Extension Period)||0||
59864450|NCT03129100|75988751|FG016|COMPLETED|Period 2 (Retreatment Extension Period)||0||
59864451|NCT03129100|75988752|FG017|COMPLETED|Period 2 (Retreatment Extension Period)||0||
59864452|NCT03129100|75988753|FG018|COMPLETED|Period 2 (Retreatment Extension Period)||0||
59864453|NCT03129100|75988754|FG019|COMPLETED|Period 2 (Retreatment Extension Period)||0||
59864454|NCT03129100|75988755|FG020|COMPLETED|Period 2 (Retreatment Extension Period)||0||
59864455|NCT03129100|75988756|FG021|COMPLETED|Period 2 (Retreatment Extension Period)||0||
59999755|NCT02087423|76115458|FG002|COMPLETED|Overall Study||0||
59864456|NCT03129100|75988757|FG022|COMPLETED|Period 2 (Retreatment Extension Period)||0||
59864457|NCT03129100|75988758|FG023|COMPLETED|Period 2 (Retreatment Extension Period)||0||
59864458|NCT03129100|75988759|FG024|COMPLETED|Period 2 (Retreatment Extension Period)||0||
59864459|NCT03129100|75988760|FG025|COMPLETED|Period 2 (Retreatment Extension Period)||0||
59864460|NCT03129100|75988735|FG000|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0||
59864461|NCT03129100|75988736|FG001|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0||
59864462|NCT03129100|75988737|FG002|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0||
59864463|NCT03129100|75988738|FG003|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0||
59864464|NCT03129100|75988739|FG004|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0||
59864465|NCT03129100|75988740|FG005|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0||
59864466|NCT03129100|75988741|FG006|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0||
59864467|NCT03129100|75988742|FG007|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0||
59864468|NCT03129100|75988743|FG008|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0||
59864469|NCT03129100|75988744|FG009|NOT COMPLETED|Period 2 (Retreatment Extension Period)||1||
59864470|NCT03129100|75988745|FG010|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0||
59864471|NCT03129100|75988746|FG011|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0||
59864472|NCT03129100|75988747|FG012|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0||
59864473|NCT03129100|75988748|FG013|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0||
59864474|NCT03129100|75988749|FG014|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0||
59864475|NCT03129100|75988750|FG015|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0||
59864476|NCT03129100|75988751|FG016|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0||
59864477|NCT03129100|75988752|FG017|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0||
59864478|NCT03129100|75988753|FG018|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0||
59864479|NCT03129100|75988754|FG019|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0||
59864480|NCT03129100|75988755|FG020|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0||
59864481|NCT03129100|75988756|FG021|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0||
59864482|NCT03129100|75988757|FG022|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0||
59864483|NCT03129100|75988758|FG023|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0||
59864484|NCT03129100|75988759|FG024|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0||
59864485|NCT03129100|75988760|FG025|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0||
59864486|NCT03129100|75988735|FG000|STARTED|Period3-Long-Term Extension Period A & B||0||
59864487|NCT03129100|75988736|FG001|STARTED|Period3-Long-Term Extension Period A & B||0||
59864488|NCT03129100|75988737|FG002|STARTED|Period3-Long-Term Extension Period A & B||0||
59864489|NCT03129100|75988738|FG003|STARTED|Period3-Long-Term Extension Period A & B||0||
59864490|NCT03129100|75988739|FG004|STARTED|Period3-Long-Term Extension Period A & B||0||
59864491|NCT03129100|75988740|FG005|STARTED|Period3-Long-Term Extension Period A & B||0||
59864492|NCT03129100|75988741|FG006|STARTED|Period3-Long-Term Extension Period A & B||0||
59864493|NCT03129100|75988742|FG007|STARTED|Period3-Long-Term Extension Period A & B|This period is to report Long-Term Extension Period participants|0||
59864494|NCT03129100|75988743|FG008|STARTED|Period3-Long-Term Extension Period A & B|This period is to report Long-Term Extension Period participants|0||
59864495|NCT03129100|75988744|FG009|STARTED|Period3-Long-Term Extension Period A & B|This period is to report Long-Term Extension Period participants|0||
59864496|NCT03129100|75988745|FG010|STARTED|Period3-Long-Term Extension Period A & B|This period is to report Long-Term Extension Period participants|0||
59864497|NCT03129100|75988746|FG011|STARTED|Period3-Long-Term Extension Period A & B|This period is to report Long-Term Extension Period participants|306||
59864498|NCT03129100|75988747|FG012|STARTED|Period3-Long-Term Extension Period A & B|This period is to report Long-Term Extension Period participants|177||
59864499|NCT03129100|75988748|FG013|STARTED|Period3-Long-Term Extension Period A & B|This period is to report Long-Term Extension Period participants|45||
59864500|NCT03129100|75988749|FG014|STARTED|Period3-Long-Term Extension Period A & B|This period is to report Long-Term Extension Period participants|42||
59864501|NCT03129100|75988750|FG015|STARTED|Period3-Long-Term Extension Period A & B|This period is to report Long-Term Extension Period participants|30||
59864502|NCT03129100|75988751|FG016|STARTED|Period3-Long-Term Extension Period A & B||0||
59864503|NCT03129100|75988752|FG017|STARTED|Period3-Long-Term Extension Period A & B||0||
59864504|NCT03129100|75988753|FG018|STARTED|Period3-Long-Term Extension Period A & B||0||
59864505|NCT03129100|75988754|FG019|STARTED|Period3-Long-Term Extension Period A & B||0||
59864506|NCT03129100|75988755|FG020|STARTED|Period3-Long-Term Extension Period A & B||0||
59864507|NCT03129100|75988756|FG021|STARTED|Period3-Long-Term Extension Period A & B||0||
59864508|NCT03129100|75988757|FG022|STARTED|Period3-Long-Term Extension Period A & B||0||
59864509|NCT03129100|75988758|FG023|STARTED|Period3-Long-Term Extension Period A & B||0||
59864510|NCT03129100|75988759|FG024|STARTED|Period3-Long-Term Extension Period A & B||0||
59864511|NCT03129100|75988760|FG025|STARTED|Period3-Long-Term Extension Period A & B||0||
59864512|NCT03129100|75988735|FG000|COMPLETED|Period3-Long-Term Extension Period A & B||0||
59864513|NCT03129100|75988736|FG001|COMPLETED|Period3-Long-Term Extension Period A & B||0||
59864514|NCT03129100|75988737|FG002|COMPLETED|Period3-Long-Term Extension Period A & B||0||
59864515|NCT03129100|75988738|FG003|COMPLETED|Period3-Long-Term Extension Period A & B||0||
59864516|NCT03129100|75988739|FG004|COMPLETED|Period3-Long-Term Extension Period A & B||0||
59999756|NCT02087423|76115456|FG000|NOT COMPLETED|Overall Study||111||
59999757|NCT02087423|76115457|FG001|NOT COMPLETED|Overall Study||265||
59864517|NCT03129100|75988740|FG005|COMPLETED|Period3-Long-Term Extension Period A & B||0||
59864518|NCT03129100|75988741|FG006|COMPLETED|Period3-Long-Term Extension Period A & B||0||
59864519|NCT03129100|75988742|FG007|COMPLETED|Period3-Long-Term Extension Period A & B||0||
59864520|NCT03129100|75988743|FG008|COMPLETED|Period3-Long-Term Extension Period A & B||0||
59864521|NCT03129100|75988744|FG009|COMPLETED|Period3-Long-Term Extension Period A & B||0||
59864522|NCT03129100|75988745|FG010|COMPLETED|Period3-Long-Term Extension Period A & B||0||
59864523|NCT03129100|75988746|FG011|COMPLETED|Period3-Long-Term Extension Period A & B||287||
59864524|NCT03129100|75988747|FG012|COMPLETED|Period3-Long-Term Extension Period A & B||146||
59864525|NCT03129100|75988748|FG013|COMPLETED|Period3-Long-Term Extension Period A & B||40||
59864526|NCT03129100|75988749|FG014|COMPLETED|Period3-Long-Term Extension Period A & B||37||
59864527|NCT03129100|75988750|FG015|COMPLETED|Period3-Long-Term Extension Period A & B||21||
59864528|NCT03129100|75988751|FG016|COMPLETED|Period3-Long-Term Extension Period A & B||0||
59864529|NCT03129100|75988752|FG017|COMPLETED|Period3-Long-Term Extension Period A & B||0||
59864530|NCT03129100|75988753|FG018|COMPLETED|Period3-Long-Term Extension Period A & B||0||
59864531|NCT03129100|75988754|FG019|COMPLETED|Period3-Long-Term Extension Period A & B||0||
59864532|NCT03129100|75988755|FG020|COMPLETED|Period3-Long-Term Extension Period A & B||0||
59864533|NCT03129100|75988756|FG021|COMPLETED|Period3-Long-Term Extension Period A & B||0||
59864534|NCT03129100|75988757|FG022|COMPLETED|Period3-Long-Term Extension Period A & B||0||
59864535|NCT03129100|75988758|FG023|COMPLETED|Period3-Long-Term Extension Period A & B||0||
59864536|NCT03129100|75988759|FG024|COMPLETED|Period3-Long-Term Extension Period A & B||0||
59864537|NCT03129100|75988760|FG025|COMPLETED|Period3-Long-Term Extension Period A & B||0||
59864538|NCT03129100|75988735|FG000|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0||
59864539|NCT03129100|75988736|FG001|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0||
59864540|NCT03129100|75988737|FG002|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0||
59864541|NCT03129100|75988738|FG003|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0||
59864542|NCT03129100|75988739|FG004|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0||
59864543|NCT03129100|75988740|FG005|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0||
59864544|NCT03129100|75988741|FG006|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0||
59864545|NCT03129100|75988742|FG007|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0||
59864546|NCT03129100|75988743|FG008|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0||
59864547|NCT03129100|75988744|FG009|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0||
59864548|NCT03129100|75988745|FG010|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0||
59864549|NCT03129100|75988746|FG011|NOT COMPLETED|Period3-Long-Term Extension Period A & B||19||
59864550|NCT03129100|75988747|FG012|NOT COMPLETED|Period3-Long-Term Extension Period A & B||31||
59864551|NCT03129100|75988748|FG013|NOT COMPLETED|Period3-Long-Term Extension Period A & B||5||
59864552|NCT03129100|75988749|FG014|NOT COMPLETED|Period3-Long-Term Extension Period A & B||5||
59864553|NCT03129100|75988750|FG015|NOT COMPLETED|Period3-Long-Term Extension Period A & B||9||
59864554|NCT03129100|75988751|FG016|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0||
59864555|NCT03129100|75988752|FG017|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0||
59864556|NCT03129100|75988753|FG018|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0||
59864557|NCT03129100|75988754|FG019|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0||
59864558|NCT03129100|75988755|FG020|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0||
59864559|NCT03129100|75988756|FG021|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0||
59864560|NCT03129100|75988757|FG022|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0||
59864561|NCT03129100|75988758|FG023|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0||
59864562|NCT03129100|75988759|FG024|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0||
59864563|NCT03129100|75988760|FG025|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0||
59864564|NCT03129100|75988735|FG000|STARTED|Period 3 (Flare)||0||
59864565|NCT03129100|75988736|FG001|STARTED|Period 3 (Flare)||0||
59864566|NCT03129100|75988737|FG002|STARTED|Period 3 (Flare)||0||
59864567|NCT03129100|75988738|FG003|STARTED|Period 3 (Flare)||0||
59864568|NCT03129100|75988739|FG004|STARTED|Period 3 (Flare)||0||
59864569|NCT03129100|75988740|FG005|STARTED|Period 3 (Flare)||0||
59864570|NCT03129100|75988741|FG006|STARTED|Period 3 (Flare)||0||
59864571|NCT03129100|75988742|FG007|STARTED|Period 3 (Flare)||0||
59864572|NCT03129100|75988743|FG008|STARTED|Period 3 (Flare)||0||
59864573|NCT03129100|75988744|FG009|STARTED|Period 3 (Flare)||0||
59864574|NCT03129100|75988745|FG010|STARTED|Period 3 (Flare)||0||
59864575|NCT03129100|75988746|FG011|STARTED|Period 3 (Flare)|This period is to report participants who experienced a flare in Period 3.|0||
59864576|NCT03129100|75988747|FG012|STARTED|Period 3 (Flare)|This period is to report participants who experienced a flare in Period 3.|0||
59864577|NCT03129100|75988748|FG013|STARTED|Period 3 (Flare)|This period is to report participants who experienced a flare in Period 3.|0||
59864578|NCT03129100|75988749|FG014|STARTED|Period 3 (Flare)|This period is to report participants who experienced a flare in Period 3.|0||
59864579|NCT03129100|75988750|FG015|STARTED|Period 3 (Flare)|This period is to report participants who experienced a flare in Period 3.|0||
59864580|NCT03129100|75988751|FG016|STARTED|Period 3 (Flare)|This period is to report participants who experienced a flare in Period 3.|6||
59864581|NCT03129100|75988752|FG017|STARTED|Period 3 (Flare)|This period is to report participants who experienced a flare in Period 3.|4||
59999758|NCT02087423|76115458|FG002|NOT COMPLETED|Overall Study||68||
59864582|NCT03129100|75988753|FG018|STARTED|Period 3 (Flare)|This period is to report participants who experienced a flare in Period 3.|11||
59864583|NCT03129100|75988754|FG019|STARTED|Period 3 (Flare)|This period is to report participants who experienced a flare in Period 3.|15||
59864584|NCT03129100|75988755|FG020|STARTED|Period 3 (Flare)||0||
59864585|NCT03129100|75988756|FG021|STARTED|Period 3 (Flare)||0||
59864586|NCT03129100|75988757|FG022|STARTED|Period 3 (Flare)||0||
59864587|NCT03129100|75988758|FG023|STARTED|Period 3 (Flare)||0||
59864588|NCT03129100|75988759|FG024|STARTED|Period 3 (Flare)||0||
59864589|NCT03129100|75988760|FG025|STARTED|Period 3 (Flare)||0||
59864590|NCT03129100|75988735|FG000|COMPLETED|Period 3 (Flare)||0||
59864591|NCT03129100|75988736|FG001|COMPLETED|Period 3 (Flare)||0||
59864592|NCT03129100|75988737|FG002|COMPLETED|Period 3 (Flare)||0||
59864593|NCT03129100|75988738|FG003|COMPLETED|Period 3 (Flare)||0||
59864594|NCT03129100|75988739|FG004|COMPLETED|Period 3 (Flare)||0||
59864595|NCT03129100|75988740|FG005|COMPLETED|Period 3 (Flare)||0||
59864596|NCT03129100|75988741|FG006|COMPLETED|Period 3 (Flare)||0||
59864597|NCT03129100|75988742|FG007|COMPLETED|Period 3 (Flare)||0||
59864598|NCT03129100|75988743|FG008|COMPLETED|Period 3 (Flare)||0||
59864599|NCT03129100|75988744|FG009|COMPLETED|Period 3 (Flare)||0||
59864600|NCT03129100|75988745|FG010|COMPLETED|Period 3 (Flare)||0||
59864601|NCT03129100|75988746|FG011|COMPLETED|Period 3 (Flare)||0||
59864602|NCT03129100|75988747|FG012|COMPLETED|Period 3 (Flare)||0||
59864603|NCT03129100|75988748|FG013|COMPLETED|Period 3 (Flare)||0||
59864604|NCT03129100|75988749|FG014|COMPLETED|Period 3 (Flare)||0||
59864605|NCT03129100|75988750|FG015|COMPLETED|Period 3 (Flare)||0||
59864606|NCT03129100|75988751|FG016|COMPLETED|Period 3 (Flare)||6||
59864607|NCT03129100|75988752|FG017|COMPLETED|Period 3 (Flare)||2||
59864608|NCT03129100|75988753|FG018|COMPLETED|Period 3 (Flare)||11||
59864609|NCT03129100|75988754|FG019|COMPLETED|Period 3 (Flare)||12||
59864610|NCT03129100|75988755|FG020|COMPLETED|Period 3 (Flare)||0||
59864611|NCT03129100|75988756|FG021|COMPLETED|Period 3 (Flare)||0||
59864612|NCT03129100|75988757|FG022|COMPLETED|Period 3 (Flare)||0||
59864613|NCT03129100|75988758|FG023|COMPLETED|Period 3 (Flare)||0||
59864614|NCT03129100|75988759|FG024|COMPLETED|Period 3 (Flare)||0||
59864615|NCT03129100|75988760|FG025|COMPLETED|Period 3 (Flare)||0||
59864616|NCT03129100|75988735|FG000|NOT COMPLETED|Period 3 (Flare)||0||
59864617|NCT03129100|75988736|FG001|NOT COMPLETED|Period 3 (Flare)||0||
59864618|NCT03129100|75988737|FG002|NOT COMPLETED|Period 3 (Flare)||0||
59864619|NCT03129100|75988738|FG003|NOT COMPLETED|Period 3 (Flare)||0||
59864620|NCT03129100|75988739|FG004|NOT COMPLETED|Period 3 (Flare)||0||
59864621|NCT03129100|75988740|FG005|NOT COMPLETED|Period 3 (Flare)||0||
59864622|NCT03129100|75988741|FG006|NOT COMPLETED|Period 3 (Flare)||0||
59864623|NCT03129100|75988742|FG007|NOT COMPLETED|Period 3 (Flare)||0||
59864624|NCT03129100|75988743|FG008|NOT COMPLETED|Period 3 (Flare)||0||
59864625|NCT03129100|75988744|FG009|NOT COMPLETED|Period 3 (Flare)||0||
59864626|NCT03129100|75988745|FG010|NOT COMPLETED|Period 3 (Flare)||0||
59864627|NCT03129100|75988746|FG011|NOT COMPLETED|Period 3 (Flare)||0||
59864628|NCT03129100|75988747|FG012|NOT COMPLETED|Period 3 (Flare)||0||
59864629|NCT03129100|75988748|FG013|NOT COMPLETED|Period 3 (Flare)||0||
59864630|NCT03129100|75988749|FG014|NOT COMPLETED|Period 3 (Flare)||0||
59864631|NCT03129100|75988750|FG015|NOT COMPLETED|Period 3 (Flare)||0||
59864632|NCT03129100|75988751|FG016|NOT COMPLETED|Period 3 (Flare)||0||
59864633|NCT03129100|75988752|FG017|NOT COMPLETED|Period 3 (Flare)||2||
59864634|NCT03129100|75988753|FG018|NOT COMPLETED|Period 3 (Flare)||0||
59864635|NCT03129100|75988754|FG019|NOT COMPLETED|Period 3 (Flare)||3||
59864636|NCT03129100|75988755|FG020|NOT COMPLETED|Period 3 (Flare)||0||
59864637|NCT03129100|75988756|FG021|NOT COMPLETED|Period 3 (Flare)||0||
59864638|NCT03129100|75988757|FG022|NOT COMPLETED|Period 3 (Flare)||0||
59864639|NCT03129100|75988758|FG023|NOT COMPLETED|Period 3 (Flare)||0||
59864640|NCT03129100|75988759|FG024|NOT COMPLETED|Period 3 (Flare)||0||
59864641|NCT03129100|75988760|FG025|NOT COMPLETED|Period 3 (Flare)||0||
59864642|NCT03129100|75988735|FG000|STARTED|Period 3 (Dose Escalation)||0||
59864643|NCT03129100|75988736|FG001|STARTED|Period 3 (Dose Escalation)||0||
59864644|NCT03129100|75988737|FG002|STARTED|Period 3 (Dose Escalation)||0||
59864645|NCT03129100|75988738|FG003|STARTED|Period 3 (Dose Escalation)||0||
59864646|NCT03129100|75988739|FG004|STARTED|Period 3 (Dose Escalation)||0||
59864647|NCT03129100|75988740|FG005|STARTED|Period 3 (Dose Escalation)||0||
59864648|NCT03129100|75988741|FG006|STARTED|Period 3 (Dose Escalation)||0||
59864649|NCT03129100|75988742|FG007|STARTED|Period 3 (Dose Escalation)||0||
59864650|NCT03129100|75988743|FG008|STARTED|Period 3 (Dose Escalation)||0||
59864651|NCT03129100|75988744|FG009|STARTED|Period 3 (Dose Escalation)||0||
59864652|NCT03129100|75988745|FG010|STARTED|Period 3 (Dose Escalation)||0||
59864653|NCT03129100|75988746|FG011|STARTED|Period 3 (Dose Escalation)||0||
59864654|NCT03129100|75988747|FG012|STARTED|Period 3 (Dose Escalation)||0||
59864655|NCT03129100|75988748|FG013|STARTED|Period 3 (Dose Escalation)||0||
59864656|NCT03129100|75988749|FG014|STARTED|Period 3 (Dose Escalation)||0||
59864657|NCT03129100|75988750|FG015|STARTED|Period 3 (Dose Escalation)||0||
59864658|NCT03129100|75988751|FG016|STARTED|Period 3 (Dose Escalation)|Participants who are eligible for dose escalations.|0||
59864659|NCT03129100|75988752|FG017|STARTED|Period 3 (Dose Escalation)|Participants who are eligible for dose escalations.|0||
59864660|NCT03129100|75988753|FG018|STARTED|Period 3 (Dose Escalation)|Participants who are eligible for dose escalations.|0||
59864661|NCT03129100|75988754|FG019|STARTED|Period 3 (Dose Escalation)|Participants who are eligible for dose escalations.|0||
59864662|NCT03129100|75988755|FG020|STARTED|Period 3 (Dose Escalation)|Participants who are eligible for dose escalations.|77||
59864663|NCT03129100|75988756|FG021|STARTED|Period 3 (Dose Escalation)|Participants who are eligible for dose escalations.|5||
59864664|NCT03129100|75988757|FG022|STARTED|Period 3 (Dose Escalation)|Participants who are eligible for dose escalations.|4||
59864665|NCT03129100|75988758|FG023|STARTED|Period 3 (Dose Escalation)||0||
59864666|NCT03129100|75988759|FG024|STARTED|Period 3 (Dose Escalation)||0||
59864667|NCT03129100|75988760|FG025|STARTED|Period 3 (Dose Escalation)||0||
59864668|NCT03129100|75988735|FG000|COMPLETED|Period 3 (Dose Escalation)||0||
59864669|NCT03129100|75988736|FG001|COMPLETED|Period 3 (Dose Escalation)||0||
59864670|NCT03129100|75988737|FG002|COMPLETED|Period 3 (Dose Escalation)||0||
59864671|NCT03129100|75988738|FG003|COMPLETED|Period 3 (Dose Escalation)||0||
59864672|NCT03129100|75988739|FG004|COMPLETED|Period 3 (Dose Escalation)||0||
59864673|NCT03129100|75988740|FG005|COMPLETED|Period 3 (Dose Escalation)||0||
59864674|NCT03129100|75988741|FG006|COMPLETED|Period 3 (Dose Escalation)||0||
59864675|NCT03129100|75988742|FG007|COMPLETED|Period 3 (Dose Escalation)||0||
59864676|NCT03129100|75988743|FG008|COMPLETED|Period 3 (Dose Escalation)||0||
59864677|NCT03129100|75988744|FG009|COMPLETED|Period 3 (Dose Escalation)||0||
59864678|NCT03129100|75988745|FG010|COMPLETED|Period 3 (Dose Escalation)||0||
59864679|NCT03129100|75988746|FG011|COMPLETED|Period 3 (Dose Escalation)||0||
59864680|NCT03129100|75988747|FG012|COMPLETED|Period 3 (Dose Escalation)||0||
59864681|NCT03129100|75988748|FG013|COMPLETED|Period 3 (Dose Escalation)||0||
59864682|NCT03129100|75988749|FG014|COMPLETED|Period 3 (Dose Escalation)||0||
59864683|NCT03129100|75988750|FG015|COMPLETED|Period 3 (Dose Escalation)||0||
59864684|NCT03129100|75988751|FG016|COMPLETED|Period 3 (Dose Escalation)||0||
59864685|NCT03129100|75988752|FG017|COMPLETED|Period 3 (Dose Escalation)||0||
59864686|NCT03129100|75988753|FG018|COMPLETED|Period 3 (Dose Escalation)||0||
59864687|NCT03129100|75988754|FG019|COMPLETED|Period 3 (Dose Escalation)||0||
59864688|NCT03129100|75988755|FG020|COMPLETED|Period 3 (Dose Escalation)||73||
59864689|NCT03129100|75988756|FG021|COMPLETED|Period 3 (Dose Escalation)||5||
59864690|NCT03129100|75988757|FG022|COMPLETED|Period 3 (Dose Escalation)||4||
59864691|NCT03129100|75988758|FG023|COMPLETED|Period 3 (Dose Escalation)||0||
59864692|NCT03129100|75988759|FG024|COMPLETED|Period 3 (Dose Escalation)||0||
59864693|NCT03129100|75988760|FG025|COMPLETED|Period 3 (Dose Escalation)||0||
59864694|NCT03129100|75988735|FG000|NOT COMPLETED|Period 3 (Dose Escalation)||0||
59864695|NCT03129100|75988736|FG001|NOT COMPLETED|Period 3 (Dose Escalation)||0||
59864696|NCT03129100|75988737|FG002|NOT COMPLETED|Period 3 (Dose Escalation)||0||
59864697|NCT03129100|75988738|FG003|NOT COMPLETED|Period 3 (Dose Escalation)||0||
59864698|NCT03129100|75988739|FG004|NOT COMPLETED|Period 3 (Dose Escalation)||0||
59864699|NCT03129100|75988740|FG005|NOT COMPLETED|Period 3 (Dose Escalation)||0||
59864700|NCT03129100|75988741|FG006|NOT COMPLETED|Period 3 (Dose Escalation)||0||
59864701|NCT03129100|75988742|FG007|NOT COMPLETED|Period 3 (Dose Escalation)||0||
59864702|NCT03129100|75988743|FG008|NOT COMPLETED|Period 3 (Dose Escalation)||0||
59864703|NCT03129100|75988744|FG009|NOT COMPLETED|Period 3 (Dose Escalation)||0||
59864704|NCT03129100|75988745|FG010|NOT COMPLETED|Period 3 (Dose Escalation)||0||
59864705|NCT03129100|75988746|FG011|NOT COMPLETED|Period 3 (Dose Escalation)||0||
59864706|NCT03129100|75988747|FG012|NOT COMPLETED|Period 3 (Dose Escalation)||0||
59864707|NCT03129100|75988748|FG013|NOT COMPLETED|Period 3 (Dose Escalation)||0||
59864708|NCT03129100|75988749|FG014|NOT COMPLETED|Period 3 (Dose Escalation)||0||
59864709|NCT03129100|75988750|FG015|NOT COMPLETED|Period 3 (Dose Escalation)||0||
59864710|NCT03129100|75988751|FG016|NOT COMPLETED|Period 3 (Dose Escalation)||0||
59864711|NCT03129100|75988752|FG017|NOT COMPLETED|Period 3 (Dose Escalation)||0||
59864712|NCT03129100|75988753|FG018|NOT COMPLETED|Period 3 (Dose Escalation)||0||
59864713|NCT03129100|75988754|FG019|NOT COMPLETED|Period 3 (Dose Escalation)||0||
59864714|NCT03129100|75988755|FG020|NOT COMPLETED|Period 3 (Dose Escalation)||4||
59864715|NCT03129100|75988756|FG021|NOT COMPLETED|Period 3 (Dose Escalation)||0||
59864716|NCT03129100|75988757|FG022|NOT COMPLETED|Period 3 (Dose Escalation)||0||
59864717|NCT03129100|75988758|FG023|NOT COMPLETED|Period 3 (Dose Escalation)||0||
59864718|NCT03129100|75988759|FG024|NOT COMPLETED|Period 3 (Dose Escalation)||0||
59864719|NCT03129100|75988760|FG025|NOT COMPLETED|Period 3 (Dose Escalation)||0||
59864720|NCT03129100|75988735|FG000|STARTED|Period 4 (Post Treatment Follow-up)||0||
59864721|NCT03129100|75988736|FG001|STARTED|Period 4 (Post Treatment Follow-up)||0||
59864722|NCT03129100|75988737|FG002|STARTED|Period 4 (Post Treatment Follow-up)||0||
59864723|NCT03129100|75988738|FG003|STARTED|Period 4 (Post Treatment Follow-up)||0||
59864724|NCT03129100|75988739|FG004|STARTED|Period 4 (Post Treatment Follow-up)||0||
59864725|NCT03129100|75988740|FG005|STARTED|Period 4 (Post Treatment Follow-up)||0||
59864726|NCT03129100|75988741|FG006|STARTED|Period 4 (Post Treatment Follow-up)||0||
59864727|NCT03129100|75988742|FG007|STARTED|Period 4 (Post Treatment Follow-up)||0||
59864728|NCT03129100|75988743|FG008|STARTED|Period 4 (Post Treatment Follow-up)||0||
59864729|NCT03129100|75988744|FG009|STARTED|Period 4 (Post Treatment Follow-up)||0||
59864730|NCT03129100|75988745|FG010|STARTED|Period 4 (Post Treatment Follow-up)||0||
59864731|NCT03129100|75988746|FG011|STARTED|Period 4 (Post Treatment Follow-up)||0||
59864732|NCT03129100|75988747|FG012|STARTED|Period 4 (Post Treatment Follow-up)||0||
59864733|NCT03129100|75988748|FG013|STARTED|Period 4 (Post Treatment Follow-up)||0||
59864734|NCT03129100|75988749|FG014|STARTED|Period 4 (Post Treatment Follow-up)||0||
59864735|NCT03129100|75988750|FG015|STARTED|Period 4 (Post Treatment Follow-up)||0||
59864736|NCT03129100|75988751|FG016|STARTED|Period 4 (Post Treatment Follow-up)||0||
59864737|NCT03129100|75988752|FG017|STARTED|Period 4 (Post Treatment Follow-up)||0||
59864738|NCT03129100|75988753|FG018|STARTED|Period 4 (Post Treatment Follow-up)||0||
59864739|NCT03129100|75988754|FG019|STARTED|Period 4 (Post Treatment Follow-up)||0||
59864740|NCT03129100|75988755|FG020|STARTED|Period 4 (Post Treatment Follow-up)|This period is to report Follow-Up period participants.|0||
59864741|NCT03129100|75988756|FG021|STARTED|Period 4 (Post Treatment Follow-up)|This period is to report Follow-Up period participants.|0||
59864742|NCT03129100|75988757|FG022|STARTED|Period 4 (Post Treatment Follow-up)|This period is to report Follow-Up period participants.|0||
59864743|NCT03129100|75988758|FG023|STARTED|Period 4 (Post Treatment Follow-up)|This period is to report Follow-Up period participants.|25||
59864744|NCT03129100|75988759|FG024|STARTED|Period 4 (Post Treatment Follow-up)|This period is to report Follow-Up period participants.|223||
59864745|NCT03129100|75988760|FG025|STARTED|Period 4 (Post Treatment Follow-up)|This period is to report Follow-Up period participants.|453||
59864746|NCT03129100|75988735|FG000|COMPLETED|Period 4 (Post Treatment Follow-up)||0||
59864747|NCT03129100|75988736|FG001|COMPLETED|Period 4 (Post Treatment Follow-up)||0||
59864748|NCT03129100|75988737|FG002|COMPLETED|Period 4 (Post Treatment Follow-up)||0||
59864749|NCT03129100|75988738|FG003|COMPLETED|Period 4 (Post Treatment Follow-up)||0||
59864750|NCT03129100|75988739|FG004|COMPLETED|Period 4 (Post Treatment Follow-up)||0||
59864751|NCT03129100|75988740|FG005|COMPLETED|Period 4 (Post Treatment Follow-up)||0||
59864752|NCT03129100|75988741|FG006|COMPLETED|Period 4 (Post Treatment Follow-up)||0||
59864753|NCT03129100|75988742|FG007|COMPLETED|Period 4 (Post Treatment Follow-up)||0||
59864754|NCT03129100|75988743|FG008|COMPLETED|Period 4 (Post Treatment Follow-up)||0||
59864755|NCT03129100|75988744|FG009|COMPLETED|Period 4 (Post Treatment Follow-up)||0||
59864756|NCT03129100|75988745|FG010|COMPLETED|Period 4 (Post Treatment Follow-up)||0||
59864757|NCT03129100|75988746|FG011|COMPLETED|Period 4 (Post Treatment Follow-up)||0||
59864758|NCT03129100|75988747|FG012|COMPLETED|Period 4 (Post Treatment Follow-up)||0||
59864759|NCT03129100|75988748|FG013|COMPLETED|Period 4 (Post Treatment Follow-up)||0||
59864760|NCT03129100|75988749|FG014|COMPLETED|Period 4 (Post Treatment Follow-up)||0||
59864761|NCT03129100|75988750|FG015|COMPLETED|Period 4 (Post Treatment Follow-up)||0||
59864762|NCT03129100|75988751|FG016|COMPLETED|Period 4 (Post Treatment Follow-up)||0||
59864763|NCT03129100|75988752|FG017|COMPLETED|Period 4 (Post Treatment Follow-up)||0||
59864764|NCT03129100|75988753|FG018|COMPLETED|Period 4 (Post Treatment Follow-up)||0||
59864765|NCT03129100|75988754|FG019|COMPLETED|Period 4 (Post Treatment Follow-up)||0||
59864766|NCT03129100|75988755|FG020|COMPLETED|Period 4 (Post Treatment Follow-up)||0||
59864767|NCT03129100|75988756|FG021|COMPLETED|Period 4 (Post Treatment Follow-up)||0||
59864768|NCT03129100|75988757|FG022|COMPLETED|Period 4 (Post Treatment Follow-up)||0||
59864769|NCT03129100|75988758|FG023|COMPLETED|Period 4 (Post Treatment Follow-up)||22||
59864770|NCT03129100|75988759|FG024|COMPLETED|Period 4 (Post Treatment Follow-up)||198||
59864771|NCT03129100|75988760|FG025|COMPLETED|Period 4 (Post Treatment Follow-up)||411||
59864772|NCT03129100|75988735|FG000|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0||
59864773|NCT03129100|75988736|FG001|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0||
59864774|NCT03129100|75988737|FG002|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0||
59864775|NCT03129100|75988738|FG003|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0||
59864776|NCT03129100|75988739|FG004|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0||
59864777|NCT03129100|75988740|FG005|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0||
59864778|NCT03129100|75988741|FG006|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0||
59864779|NCT03129100|75988742|FG007|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0||
59864780|NCT03129100|75988743|FG008|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0||
59864781|NCT03129100|75988744|FG009|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0||
59864782|NCT03129100|75988745|FG010|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0||
59864783|NCT03129100|75988746|FG011|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0||
59864784|NCT03129100|75988747|FG012|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0||
59864785|NCT03129100|75988748|FG013|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0||
59864786|NCT03129100|75988749|FG014|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0||
59864787|NCT03129100|75988750|FG015|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0||
59864788|NCT03129100|75988751|FG016|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0||
59864789|NCT03129100|75988752|FG017|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0||
59864790|NCT03129100|75988753|FG018|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0||
59864791|NCT03129100|75988754|FG019|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0||
59864792|NCT03129100|75988755|FG020|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0||
59864793|NCT03129100|75988756|FG021|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0||
59864794|NCT03129100|75988757|FG022|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0||
59864795|NCT03129100|75988758|FG023|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||3||
59864796|NCT03129100|75988759|FG024|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||25||
59864797|NCT03129100|75988760|FG025|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||42||
59864798|NCT03101020|75988799|FG000|STARTED|Overall Study||10||
59864799|NCT03101020|75988800|FG001|STARTED|Overall Study||10||
59864800|NCT03101020|75988799|FG000|COMPLETED|Overall Study||9||
59864801|NCT03101020|75988800|FG001|COMPLETED|Overall Study||7||
59864802|NCT03101020|75988799|FG000|NOT COMPLETED|Overall Study||1||
59864803|NCT03101020|75988800|FG001|NOT COMPLETED|Overall Study||3||
59864804|NCT03100942|75988810|FG000|STARTED|Randomized Treatment Period||38||
59864805|NCT03100942|75988811|FG001|STARTED|Randomized Treatment Period||38||
59864806|NCT03100942|75988812|FG002|STARTED|Randomized Treatment Period||39||
59864807|NCT03100942|75988813|FG003|STARTED|Randomized Treatment Period||37||
59864808|NCT03100942|75988814|FG004|STARTED|Randomized Treatment Period||0||
59864809|NCT03100942|75988815|FG005|STARTED|Randomized Treatment Period||0||
59864810|NCT03100942|75988816|FG006|STARTED|Randomized Treatment Period||0||
59864811|NCT03100942|75988810|FG000|COMPLETED|Randomized Treatment Period||26||
59864812|NCT03100942|75988811|FG001|COMPLETED|Randomized Treatment Period||29||
59864813|NCT03100942|75988812|FG002|COMPLETED|Randomized Treatment Period||33||
59864814|NCT03100942|75988813|FG003|COMPLETED|Randomized Treatment Period||32||
59864815|NCT03100942|75988814|FG004|COMPLETED|Randomized Treatment Period||0||
59864816|NCT03100942|75988815|FG005|COMPLETED|Randomized Treatment Period||0||
59864817|NCT03100942|75988816|FG006|COMPLETED|Randomized Treatment Period||0||
59864818|NCT03100942|75988810|FG000|NOT COMPLETED|Randomized Treatment Period||12||
59864819|NCT03100942|75988811|FG001|NOT COMPLETED|Randomized Treatment Period||9||
59864820|NCT03100942|75988812|FG002|NOT COMPLETED|Randomized Treatment Period||6||
59864821|NCT03100942|75988813|FG003|NOT COMPLETED|Randomized Treatment Period||5||
59864822|NCT03100942|75988814|FG004|NOT COMPLETED|Randomized Treatment Period||0||
59864823|NCT03100942|75988815|FG005|NOT COMPLETED|Randomized Treatment Period||0||
59864824|NCT03100942|75988816|FG006|NOT COMPLETED|Randomized Treatment Period||0||
59864825|NCT03100942|75988810|FG000|STARTED|Placebo Arm Re-Randomized||0||
59864826|NCT03100942|75988811|FG001|STARTED|Placebo Arm Re-Randomized||0||
59864827|NCT03100942|75988812|FG002|STARTED|Placebo Arm Re-Randomized||0||
59864828|NCT03100942|75988813|FG003|STARTED|Placebo Arm Re-Randomized||0||
59864829|NCT03100942|75988814|FG004|STARTED|Placebo Arm Re-Randomized||10||
59864830|NCT03100942|75988815|FG005|STARTED|Placebo Arm Re-Randomized||12||
59864831|NCT03100942|75988816|FG006|STARTED|Placebo Arm Re-Randomized||10||
59864832|NCT03100942|75988810|FG000|COMPLETED|Placebo Arm Re-Randomized||0||
59864833|NCT03100942|75988811|FG001|COMPLETED|Placebo Arm Re-Randomized||0||
59864834|NCT03100942|75988812|FG002|COMPLETED|Placebo Arm Re-Randomized||0||
59864835|NCT03100942|75988813|FG003|COMPLETED|Placebo Arm Re-Randomized||0||
59864836|NCT03100942|75988814|FG004|COMPLETED|Placebo Arm Re-Randomized||10||
59864837|NCT03100942|75988815|FG005|COMPLETED|Placebo Arm Re-Randomized||12||
59864838|NCT03100942|75988816|FG006|COMPLETED|Placebo Arm Re-Randomized||9||
59864839|NCT03100942|75988810|FG000|NOT COMPLETED|Placebo Arm Re-Randomized||0||
59864840|NCT03100942|75988811|FG001|NOT COMPLETED|Placebo Arm Re-Randomized||0||
59864841|NCT03100942|75988812|FG002|NOT COMPLETED|Placebo Arm Re-Randomized||0||
59864842|NCT03100942|75988813|FG003|NOT COMPLETED|Placebo Arm Re-Randomized||0||
59864843|NCT03100942|75988814|FG004|NOT COMPLETED|Placebo Arm Re-Randomized||0||
59864844|NCT03100942|75988815|FG005|NOT COMPLETED|Placebo Arm Re-Randomized||0||
59864845|NCT03100942|75988816|FG006|NOT COMPLETED|Placebo Arm Re-Randomized||1||
59864846|NCT03099694|75988831|FG000|STARTED|Overall Study||170||
59864847|NCT03099694|75988832|FG001|STARTED|Overall Study||170||
59864848|NCT03099694|75988831|FG000|COMPLETED|Overall Study||150||
59864849|NCT03099694|75988832|FG001|COMPLETED|Overall Study||152||
59864850|NCT03099694|75988831|FG000|NOT COMPLETED|Overall Study||20||
59864851|NCT03099694|75988832|FG001|NOT COMPLETED|Overall Study||18||
59864852|NCT03099538|75988839|FG000|STARTED|Overall Study||4||
59864853|NCT03099538|75988839|FG000|COMPLETED|Overall Study||1||
59864854|NCT03099538|75988839|FG000|NOT COMPLETED|Overall Study||3||
59864855|NCT03099304|75988848|FG000|STARTED|DB Period: Day 1 to Week 24||32||
59864856|NCT03099304|75988849|FG001|STARTED|DB Period: Day 1 to Week 24||31||
59864857|NCT03099304|75988850|FG002|STARTED|DB Period: Day 1 to Week 24||31||
59864858|NCT03099304|75988851|FG003|STARTED|DB Period: Day 1 to Week 24||30||
59864859|NCT03099304|75988852|FG004|STARTED|DB Period: Day 1 to Week 24||33||
59864860|NCT03099304|75988853|FG005|STARTED|DB Period: Day 1 to Week 24||0||
59864861|NCT03099304|75988848|FG000|COMPLETED|DB Period: Day 1 to Week 24||27||
59864862|NCT03099304|75988849|FG001|COMPLETED|DB Period: Day 1 to Week 24||26||
59864863|NCT03099304|75988850|FG002|COMPLETED|DB Period: Day 1 to Week 24||30||
59864864|NCT03099304|75988851|FG003|COMPLETED|DB Period: Day 1 to Week 24||26||
59864865|NCT03099304|75988852|FG004|COMPLETED|DB Period: Day 1 to Week 24||30||
59864866|NCT03099304|75988853|FG005|COMPLETED|DB Period: Day 1 to Week 24||0||
59864867|NCT03099304|75988848|FG000|NOT COMPLETED|DB Period: Day 1 to Week 24||5||
59864868|NCT03099304|75988849|FG001|NOT COMPLETED|DB Period: Day 1 to Week 24||5||
59864869|NCT03099304|75988850|FG002|NOT COMPLETED|DB Period: Day 1 to Week 24||1||
59864870|NCT03099304|75988851|FG003|NOT COMPLETED|DB Period: Day 1 to Week 24||4||
59864871|NCT03099304|75988852|FG004|NOT COMPLETED|DB Period: Day 1 to Week 24||3||
59864872|NCT03099304|75988853|FG005|NOT COMPLETED|DB Period: Day 1 to Week 24||0||
59864873|NCT03099304|75988848|FG000|STARTED|DB Period: Weeks 24 to 52|Vehicle cream was not used after Week 24. After the 24-week DB period, participants who met criteria were re-randomized to 1 of the 3 higher active blinded treatment groups.|0||
59999759|NCT01874353|76115470|FG000|STARTED|Overall Study||196||
59864874|NCT03099304|75988849|FG001|STARTED|DB Period: Weeks 24 to 52|These participants continued on the initial 0.15% QD treatment.|11||
59864875|NCT03099304|75988850|FG002|STARTED|DB Period: Weeks 24 to 52|Total participants included those initially randomized to 0.5% QD and those re-randomized from vehicle cream and 0.15% QD to 0.5% QD.|45||
59864876|NCT03099304|75988851|FG003|STARTED|DB Period: Weeks 24 to 52|Total participants included those initially randomized to 1.5% QD and those re-randomized from vehicle cream and 0.15% QD to 1.5% QD.|44||
59864877|NCT03099304|75988852|FG004|STARTED|DB Period: Weeks 24 to 52|Total participants included those initially randomized to 1.5% BID and those re-randomized from vehicle cream and 0.15% QD to 1.5% BID|47||
59864878|NCT03099304|75988853|FG005|STARTED|DB Period: Weeks 24 to 52||0||
59864879|NCT03099304|75988848|FG000|COMPLETED|DB Period: Weeks 24 to 52||0||
59864880|NCT03099304|75988849|FG001|COMPLETED|DB Period: Weeks 24 to 52||10||
59864881|NCT03099304|75988850|FG002|COMPLETED|DB Period: Weeks 24 to 52||43||
59864882|NCT03099304|75988851|FG003|COMPLETED|DB Period: Weeks 24 to 52||37||
59864883|NCT03099304|75988852|FG004|COMPLETED|DB Period: Weeks 24 to 52||45||
59864884|NCT03099304|75988853|FG005|COMPLETED|DB Period: Weeks 24 to 52||0||
59864885|NCT03099304|75988848|FG000|NOT COMPLETED|DB Period: Weeks 24 to 52||0||
59864886|NCT03099304|75988849|FG001|NOT COMPLETED|DB Period: Weeks 24 to 52||1||
59864887|NCT03099304|75988850|FG002|NOT COMPLETED|DB Period: Weeks 24 to 52||2||
59864888|NCT03099304|75988851|FG003|NOT COMPLETED|DB Period: Weeks 24 to 52||7||
59864889|NCT03099304|75988852|FG004|NOT COMPLETED|DB Period: Weeks 24 to 52||2||
59864890|NCT03099304|75988853|FG005|NOT COMPLETED|DB Period: Weeks 24 to 52||0||
59864891|NCT03099304|75988848|FG000|STARTED|104-week Open-Label Extension Period||0||
59864892|NCT03099304|75988849|FG001|STARTED|104-week Open-Label Extension Period||0||
59864893|NCT03099304|75988850|FG002|STARTED|104-week Open-Label Extension Period|These participants were initially randomized to receive ruxolitinib cream 0.5% QD on Day 1 and entered the Extension Period.|28||
59864894|NCT03099304|75988851|FG003|STARTED|104-week Open-Label Extension Period|These participants were initially randomized to receive ruxolitinib cream 1.5% QD on Day 1 and entered the Extension Period.|21||
59864895|NCT03099304|75988852|FG004|STARTED|104-week Open-Label Extension Period|These participants were initially randomized to receive ruxolitinib cream 1.5% BID on Day 1 and entered the Extension Period.|28||
59864896|NCT03099304|75988853|FG005|STARTED|104-week Open-Label Extension Period|These participants were initially randomized to receive ruxolitinib cream 0.15% QD or vehicle on Day 1.|46||
59864897|NCT03099304|75988848|FG000|COMPLETED|104-week Open-Label Extension Period||0||
59864898|NCT03099304|75988849|FG001|COMPLETED|104-week Open-Label Extension Period||0||
59864899|NCT03099304|75988850|FG002|COMPLETED|104-week Open-Label Extension Period||11||
59864900|NCT03099304|75988851|FG003|COMPLETED|104-week Open-Label Extension Period||8||
59864901|NCT03099304|75988852|FG004|COMPLETED|104-week Open-Label Extension Period||12||
59864902|NCT03099304|75988853|FG005|COMPLETED|104-week Open-Label Extension Period||23||
59864903|NCT03099304|75988848|FG000|NOT COMPLETED|104-week Open-Label Extension Period||0||
59864904|NCT03099304|75988849|FG001|NOT COMPLETED|104-week Open-Label Extension Period||0||
59864905|NCT03099304|75988850|FG002|NOT COMPLETED|104-week Open-Label Extension Period||17||
59864906|NCT03099304|75988851|FG003|NOT COMPLETED|104-week Open-Label Extension Period||13||
59864907|NCT03099304|75988852|FG004|NOT COMPLETED|104-week Open-Label Extension Period||16||
59864908|NCT03099304|75988853|FG005|NOT COMPLETED|104-week Open-Label Extension Period||23||
59864909|NCT03097588|75988880|FG000|STARTED|Overall Study||43||
59864910|NCT03097588|75988880|FG000|COMPLETED|Overall Study||42||
59864911|NCT03097588|75988880|FG000|NOT COMPLETED|Overall Study||1||
59864912|NCT01631214|75988886|FG000|STARTED|Overall Study||2047||
59864913|NCT01631214|75988887|FG001|STARTED|Overall Study||2046||
60131409|NCT01547780|76254024|FG003|STARTED|Baseline PET Scan||19||
60131410|NCT01547780|76254021|FG000|COMPLETED|Baseline PET Scan||9||
60131411|NCT01547780|76254022|FG001|COMPLETED|Baseline PET Scan||0||
60131412|NCT01547780|76254023|FG002|COMPLETED|Baseline PET Scan||17||
60131413|NCT01547780|76254024|FG003|COMPLETED|Baseline PET Scan||19||
60131414|NCT01547780|76254021|FG000|NOT COMPLETED|Baseline PET Scan||3||
60131415|NCT01547780|76254022|FG001|NOT COMPLETED|Baseline PET Scan||0||
60131416|NCT01547780|76254023|FG002|NOT COMPLETED|Baseline PET Scan||2||
60131417|NCT01547780|76254024|FG003|NOT COMPLETED|Baseline PET Scan||0||
60131418|NCT01547780|76254021|FG000|STARTED|Repeat PET Scan||0|Period 2 only applicable to repeat PET Scan|
60131419|NCT01547780|76254022|FG001|STARTED|Repeat PET Scan||4|Period 2 only applicable to repeat PET Scan|
60131420|NCT01547780|76254023|FG002|STARTED|Repeat PET Scan||0|Period 2 only applicable to repeat PET Scan|
60131421|NCT01547780|76254024|FG003|STARTED|Repeat PET Scan||0|Period 2 only applicable to repeat PET Scan|
60131422|NCT01547780|76254021|FG000|COMPLETED|Repeat PET Scan||0||
60131423|NCT01547780|76254022|FG001|COMPLETED|Repeat PET Scan||4||
60131424|NCT01547780|76254023|FG002|COMPLETED|Repeat PET Scan||0||
60131425|NCT01547780|76254024|FG003|COMPLETED|Repeat PET Scan||0||
60131426|NCT01547780|76254021|FG000|NOT COMPLETED|Repeat PET Scan||0||
60131427|NCT01547780|76254022|FG001|NOT COMPLETED|Repeat PET Scan||0||
60131428|NCT01547780|76254023|FG002|NOT COMPLETED|Repeat PET Scan||0||
60131429|NCT01547780|76254024|FG003|NOT COMPLETED|Repeat PET Scan||0||
60131430|NCT00583011|76254036|FG000|STARTED|Overall Study||36||
60131431|NCT00583011|76254037|FG001|STARTED|Overall Study||40||
60131432|NCT00583011|76254036|FG000|COMPLETED|Overall Study||36||
60131433|NCT00583011|76254037|FG001|COMPLETED|Overall Study||40||
60131434|NCT00583011|76254036|FG000|NOT COMPLETED|Overall Study||0||
60131435|NCT00583011|76254037|FG001|NOT COMPLETED|Overall Study||0||
60131436|NCT01547390|76254046|FG000|STARTED|Overall Study||27||
60131437|NCT01547390|76254047|FG001|STARTED|Overall Study||26||
60131438|NCT01547390|76254046|FG000|COMPLETED|Overall Study||14||
60131439|NCT01547390|76254047|FG001|COMPLETED|Overall Study||16||
60131440|NCT01547390|76254046|FG000|NOT COMPLETED|Overall Study||13||
60131441|NCT01547390|76254047|FG001|NOT COMPLETED|Overall Study||10||
60131442|NCT01546922|76254053|FG000|STARTED|First Period of 10 Weeks||30||
60131443|NCT01546922|76254054|FG001|STARTED|First Period of 10 Weeks||30||
60131444|NCT01546922|76254053|FG000|COMPLETED|First Period of 10 Weeks||25||
60131445|NCT01546922|76254054|FG001|COMPLETED|First Period of 10 Weeks||28||
60131446|NCT01546922|76254053|FG000|NOT COMPLETED|First Period of 10 Weeks||5||
60131447|NCT01546922|76254054|FG001|NOT COMPLETED|First Period of 10 Weeks||2||
60131448|NCT01546922|76254053|FG000|STARTED|Second Period of 10 Weeks||25||
60131449|NCT01546922|76254054|FG001|STARTED|Second Period of 10 Weeks||28||
60131450|NCT01546922|76254053|FG000|COMPLETED|Second Period of 10 Weeks||22||
60131451|NCT01546922|76254054|FG001|COMPLETED|Second Period of 10 Weeks||25||
60131452|NCT01546922|76254053|FG000|NOT COMPLETED|Second Period of 10 Weeks||3||
60131453|NCT01546922|76254054|FG001|NOT COMPLETED|Second Period of 10 Weeks||3||
60131454|NCT00615927|76254062|FG000|STARTED|Overall Study||32||
60131455|NCT00615927|76254063|FG001|STARTED|Overall Study||32||
60131456|NCT00615927|76254062|FG000|COMPLETED|Overall Study||32||
60131457|NCT00615927|76254063|FG001|COMPLETED|Overall Study||32||
60131458|NCT00615927|76254062|FG000|NOT COMPLETED|Overall Study||0||
60131459|NCT00615927|76254063|FG001|NOT COMPLETED|Overall Study||0||
60131460|NCT01532648|76254071|FG000|STARTED|Overall Study||255||
60131461|NCT01532648|76254072|FG001|STARTED|Overall Study||255||
60131462|NCT01532648|76254071|FG000|Safety Population|Overall Study||255|All randomized participants who received at least 1 dose of study drug|
60131463|NCT01532648|76254072|FG001|Safety Population|Overall Study||255|All randomized participants who received at least 1 dose of study drug|
60131464|NCT01532648|76254071|FG000|Intent-To-Treat Population|Overall Study||230|Participants in Safety Population with active ulcerative colitis at study entry as cause of symptoms|
60131465|NCT01532648|76254072|FG001|Intent-To-Treat Population|Overall Study||228|Participants in Safety Population with active ulcerative colitis at study entry as cause of symptoms|
60131466|NCT01532648|76254071|FG000|COMPLETED|Overall Study||219||
60131467|NCT01532648|76254072|FG001|COMPLETED|Overall Study||238||
60131468|NCT01532648|76254071|FG000|NOT COMPLETED|Overall Study||36||
60131469|NCT01532648|76254072|FG001|NOT COMPLETED|Overall Study||17||
60131470|NCT00617097|76254080|FG000|STARTED|Overall Study||25||
60131471|NCT00617097|76254081|FG001|STARTED|Overall Study||25||
60131472|NCT00617097|76254080|FG000|COMPLETED|Overall Study||25||
60131473|NCT00617097|76254081|FG001|COMPLETED|Overall Study||25||
60131474|NCT00617097|76254080|FG000|NOT COMPLETED|Overall Study||0||
60131475|NCT00617097|76254081|FG001|NOT COMPLETED|Overall Study||0||
60131476|NCT00617175|76254091|FG000|STARTED|Overall Study||954||
60131477|NCT00617175|76254092|FG001|STARTED|Overall Study||948||
60131478|NCT00617175|76254091|FG000|COMPLETED|Overall Study||954||
60131479|NCT00617175|76254092|FG001|COMPLETED|Overall Study||948||
60131480|NCT00617175|76254091|FG000|NOT COMPLETED|Overall Study||0||
60131481|NCT00617175|76254092|FG001|NOT COMPLETED|Overall Study||0||
60131482|NCT01532570|76254102|FG000|STARTED|Overall Study||11||
60131483|NCT01532570|76254103|FG001|STARTED|Overall Study||2||
60131484|NCT01532570|76254104|FG002|STARTED|Overall Study||1||
60131485|NCT01532570|76254105|FG003|STARTED|Overall Study||4||
60131486|NCT01532570|76254102|FG000|COMPLETED|Overall Study||10||
60131487|NCT01532570|76254103|FG001|COMPLETED|Overall Study||1||
60131488|NCT01532570|76254104|FG002|COMPLETED|Overall Study||1||
60131489|NCT01532570|76254105|FG003|COMPLETED|Overall Study||4||
60131490|NCT01532570|76254102|FG000|NOT COMPLETED|Overall Study||1||
60131491|NCT01532570|76254103|FG001|NOT COMPLETED|Overall Study||1||
60131492|NCT01532570|76254104|FG002|NOT COMPLETED|Overall Study||0||
60131493|NCT01532570|76254105|FG003|NOT COMPLETED|Overall Study||0||
60131494|NCT00583713|76254125|FG000|STARTED|Overall Study||6||
60131495|NCT00583713|76254126|FG001|STARTED|Overall Study||6||
60131496|NCT00583713|76254127|FG002|STARTED|Overall Study||6||
60131497|NCT00583713|76254125|FG000|COMPLETED|Overall Study||6||
60131498|NCT00583713|76254126|FG001|COMPLETED|Overall Study||6||
60131499|NCT00583713|76254127|FG002|COMPLETED|Overall Study||6||
60131500|NCT00583713|76254125|FG000|NOT COMPLETED|Overall Study||0||
60131501|NCT00583713|76254126|FG001|NOT COMPLETED|Overall Study||0||
60131502|NCT00583713|76254127|FG002|NOT COMPLETED|Overall Study||0||
60131503|NCT01532414|76254138|FG000|STARTED|Overall Study||92||
60131504|NCT01532414|76254139|FG001|STARTED|Overall Study|Up-titrated at 6 weeks from a starting dose of 12.5 mg due to morning testosterone <300 ng/dL|21||
60131505|NCT01532414|76254140|FG002|STARTED|Overall Study||38||
60131506|NCT01532414|76254138|FG000|COMPLETED|Overall Study||85||
60131507|NCT01532414|76254139|FG001|COMPLETED|Overall Study||19||
60131508|NCT01532414|76254140|FG002|COMPLETED|Overall Study||35||
60131509|NCT01532414|76254138|FG000|NOT COMPLETED|Overall Study||7||
60131510|NCT01532414|76254139|FG001|NOT COMPLETED|Overall Study||2||
60131511|NCT01532414|76254140|FG002|NOT COMPLETED|Overall Study||3||
60131512|NCT01441973|76254150|FG000|STARTED|Overall Study||15||
60131513|NCT01441973|76254151|FG001|STARTED|Overall Study||16||
60131514|NCT01441973|76254150|FG000|COMPLETED|Overall Study|Still receiving treatment|0||
60131515|NCT01441973|76254151|FG001|COMPLETED|Overall Study|Still receiving treatment|0||
60131516|NCT01441973|76254150|FG000|NOT COMPLETED|Overall Study||15||
60131517|NCT01441973|76254151|FG001|NOT COMPLETED|Overall Study||16||
60131518|NCT02074709|76254160|FG000|STARTED|Overall Study||30||
60131519|NCT02074709|76254161|FG001|STARTED|Overall Study||30||
60131520|NCT02074709|76254160|FG000|COMPLETED|Overall Study||29||
60131521|NCT02074709|76254161|FG001|COMPLETED|Overall Study||29||
60131522|NCT02074709|76254160|FG000|NOT COMPLETED|Overall Study||1||
60131523|NCT02074709|76254161|FG001|NOT COMPLETED|Overall Study||1||
60131524|NCT01575899|76254170|FG000|STARTED|Overall Study||73||
60131525|NCT01575899|76254171|FG001|STARTED|Overall Study||73||
60131526|NCT01575899|76254172|FG002|STARTED|Overall Study|Included patients still with Hp infection after previous therapy without levofloxacin and Augmentin.|62||
60131527|NCT01575899|76254170|FG000|COMPLETED|Overall Study||68||
60131528|NCT01575899|76254171|FG001|COMPLETED|Overall Study||68||
60131529|NCT01575899|76254172|FG002|COMPLETED|Overall Study||60||
60131530|NCT01575899|76254170|FG000|NOT COMPLETED|Overall Study||5||
60131531|NCT01575899|76254171|FG001|NOT COMPLETED|Overall Study||5||
60131532|NCT01575899|76254172|FG002|NOT COMPLETED|Overall Study||2||
60131533|NCT01440881|76254184|FG000|STARTED|Overall Study||14||
60131534|NCT01440881|76254185|FG001|STARTED|Overall Study||15||
60131535|NCT01440881|76254184|FG000|COMPLETED|Overall Study||14||
60131536|NCT01440881|76254185|FG001|COMPLETED|Overall Study||14||
60131537|NCT01440881|76254184|FG000|NOT COMPLETED|Overall Study||0||
60131538|NCT01440881|76254185|FG001|NOT COMPLETED|Overall Study||1||
60131539|NCT00620061|76254192|FG000|STARTED|Overall Study||439||
60131540|NCT00620061|76254192|FG000|COMPLETED|Overall Study||286||
60131541|NCT00620061|76254192|FG000|NOT COMPLETED|Overall Study||153||
60131542|NCT01575197|76254200|FG000|STARTED|Overall Study||152||
60131543|NCT01575197|76254201|FG001|STARTED|Overall Study||152||
60131544|NCT01575197|76254202|FG002|STARTED|Overall Study||152||
60131545|NCT01575197|76254200|FG000|COMPLETED|Overall Study||149||
60131546|NCT01575197|76254201|FG001|COMPLETED|Overall Study||143||
60131547|NCT01575197|76254202|FG002|COMPLETED|Overall Study||146||
60131548|NCT01575197|76254200|FG000|NOT COMPLETED|Overall Study||3||
60131549|NCT01575197|76254201|FG001|NOT COMPLETED|Overall Study||9||
60131550|NCT01575197|76254202|FG002|NOT COMPLETED|Overall Study||6||
60131551|NCT00587769|76254210|FG000|STARTED|Overall Study||38||
60131552|NCT00587769|76254210|FG000|COMPLETED|Overall Study||38||
60131553|NCT00587769|76254210|FG000|NOT COMPLETED|Overall Study||0||
60131554|NCT00621933|76254214|FG000|STARTED|Overall Study||399||
60131555|NCT00621933|76254214|FG000|COMPLETED|Overall Study||399||
60131556|NCT00621933|76254214|FG000|NOT COMPLETED|Overall Study||0||
60131557|NCT00623181|76254220|FG000|STARTED|Overall Study||56||
60131558|NCT00623181|76254221|FG001|STARTED|Overall Study||54||
60131559|NCT00623181|76254220|FG000|COMPLETED|Overall Study||56||
60131560|NCT00623181|76254221|FG001|COMPLETED|Overall Study||54||
60131561|NCT00623181|76254220|FG000|NOT COMPLETED|Overall Study||0||
60131562|NCT00623181|76254221|FG001|NOT COMPLETED|Overall Study||0||
60131563|NCT01574651|76254233|FG000|STARTED|Overall Study||476||
60131564|NCT01574651|76254234|FG001|STARTED|Overall Study||458||
60131565|NCT01574651|76254233|FG000|Full Analysis Set (FAS)|Overall Study||476||
60131566|NCT01574651|76254234|FG001|Full Analysis Set (FAS)|Overall Study||458||
60131567|NCT01574651|76254233|FG000|Per Protocol Set (PPS)|Overall Study||373||
60131568|NCT01574651|76254234|FG001|Per Protocol Set (PPS)|Overall Study||374||
60131569|NCT01574651|76254233|FG000|COMPLETED|Overall Study||415||
60131570|NCT01574651|76254234|FG001|COMPLETED|Overall Study||406||
60131571|NCT01574651|76254233|FG000|NOT COMPLETED|Overall Study||61||
60131572|NCT01574651|76254234|FG001|NOT COMPLETED|Overall Study||52||
60131573|NCT02139969|76254240|FG000|STARTED|Overall Study||956||
60131574|NCT02139969|76254240|FG000|COMPLETED|Overall Study||956||
60131575|NCT02139969|76254240|FG000|NOT COMPLETED|Overall Study||0||
60131576|NCT01440803|76254246|FG000|STARTED|Overall Study||13||
60131577|NCT01440803|76254247|FG001|STARTED|Overall Study||28||
60131578|NCT01440803|76254246|FG000|Period 1 - Forteo/Placebo|Overall Study||13||
60131579|NCT01440803|76254247|FG001|Period 1 - Forteo/Placebo|Overall Study||28||
60131580|NCT01440803|76254246|FG000|Period 2 - Forteo/Forteo|Overall Study||13||
60131581|NCT01440803|76254247|FG001|Period 2 - Forteo/Forteo|Overall Study||28||
60131582|NCT01440803|76254246|FG000|Period 3 - Forteo Open Label|Overall Study||13||
60131583|NCT01440803|76254247|FG001|Period 3 - Forteo Open Label|Overall Study||27||
60131584|NCT01440803|76254246|FG000|COMPLETED|Overall Study||11||
60131585|NCT01440803|76254247|FG001|COMPLETED|Overall Study||24||
60131586|NCT01440803|76254246|FG000|NOT COMPLETED|Overall Study||2||
60131587|NCT01440803|76254247|FG001|NOT COMPLETED|Overall Study||4||
60131588|NCT01517282|76254258|FG000|STARTED|Overall Study|One patient was randomized but did not receive study medication based on the investigator's decision|9||
60131589|NCT01517282|76254259|FG001|STARTED|Overall Study||8||
60131590|NCT01517282|76254260|FG002|STARTED|Overall Study|1 patient completed the trial, but received only 4 doses of medication and 2 MRIs due to pregnancy|9||
60131591|NCT01517282|76254261|FG003|STARTED|Overall Study||6||
60131592|NCT01517282|76254258|FG000|COMPLETED|Overall Study||8||
60131593|NCT01517282|76254259|FG001|COMPLETED|Overall Study||7||
60131594|NCT01517282|76254260|FG002|COMPLETED|Overall Study||8||
60131595|NCT01517282|76254261|FG003|COMPLETED|Overall Study||5||
60131596|NCT01517282|76254258|FG000|NOT COMPLETED|Overall Study||1||
60131597|NCT01517282|76254259|FG001|NOT COMPLETED|Overall Study||1||
60131598|NCT01517282|76254260|FG002|NOT COMPLETED|Overall Study||1||
60131599|NCT01517282|76254261|FG003|NOT COMPLETED|Overall Study||1||
60131600|NCT00624195|76254273|FG000|STARTED|Overall Study||29||
60131601|NCT00624195|76254274|FG001|STARTED|Overall Study||30||
60131602|NCT00624195|76254273|FG000|COMPLETED|Overall Study||26||
60131603|NCT00624195|76254274|FG001|COMPLETED|Overall Study||23||
60131604|NCT00624195|76254273|FG000|NOT COMPLETED|Overall Study||3||
60131605|NCT00624195|76254274|FG001|NOT COMPLETED|Overall Study||7||
60131606|NCT01440647|76254282|FG000|STARTED|Overall Study||16||
60131607|NCT01440647|76254283|FG001|STARTED|Overall Study||18||
60131608|NCT01440647|76254282|FG000|COMPLETED|Overall Study||14||
60131609|NCT01440647|76254283|FG001|COMPLETED|Overall Study||15||
60131610|NCT01440647|76254282|FG000|NOT COMPLETED|Overall Study||2||
60131611|NCT01440647|76254283|FG001|NOT COMPLETED|Overall Study||3||
60131612|NCT01516970|76254291|FG000|STARTED|Overall Study||159||
60131613|NCT01516970|76254292|FG001|STARTED|Overall Study||153||
60131614|NCT01516970|76254291|FG000|COMPLETED|Overall Study||141||
60131615|NCT01516970|76254292|FG001|COMPLETED|Overall Study||132||
60131616|NCT01516970|76254291|FG000|NOT COMPLETED|Overall Study||18||
60131617|NCT01516970|76254292|FG001|NOT COMPLETED|Overall Study||21||
60131618|NCT00625989|76254298|FG000|STARTED|Overall Study||6||
60131619|NCT00625989|76254299|FG001|STARTED|Overall Study||6||
60131620|NCT00625989|76254298|FG000|COMPLETED|Overall Study||6||
60131621|NCT00625989|76254299|FG001|COMPLETED|Overall Study||6||
60131622|NCT00625989|76254298|FG000|NOT COMPLETED|Overall Study||0||
60131623|NCT00625989|76254299|FG001|NOT COMPLETED|Overall Study||0||
60131624|NCT02140593|76254306|FG000|STARTED|Overall Study||63||
60131625|NCT02140593|76254307|FG001|STARTED|Overall Study||65||
60131626|NCT02140593|76254306|FG000|COMPLETED|Overall Study||63||
60131627|NCT02140593|76254307|FG001|COMPLETED|Overall Study||65||
60131628|NCT02140593|76254306|FG000|NOT COMPLETED|Overall Study||0||
60131629|NCT02140593|76254307|FG001|NOT COMPLETED|Overall Study||0||
60131630|NCT01516892|76254313|FG000|STARTED|Overall Study||716||
60131631|NCT01516892|76254313|FG000|COMPLETED|Overall Study||373||
60131632|NCT01516892|76254313|FG000|NOT COMPLETED|Overall Study||343||
60131633|NCT00668811|76254317|FG000|STARTED|Overall Study||23||
60131634|NCT00668811|76254317|FG000|COMPLETED|Overall Study||23||
60131635|NCT00668811|76254317|FG000|NOT COMPLETED|Overall Study||0||
60131636|NCT00627861|76254321|FG000|STARTED|Overall Study||1||
60131637|NCT00627861|76254321|FG000|COMPLETED|Overall Study||1||
60131638|NCT00627861|76254321|FG000|NOT COMPLETED|Overall Study||0||
60131639|NCT00669279|76254329|FG000|STARTED|Overall Study||22||
60131640|NCT00669279|76254330|FG001|STARTED|Overall Study||19||
60131641|NCT00669279|76254329|FG000|COMPLETED|Overall Study||22||
60131642|NCT00669279|76254330|FG001|COMPLETED|Overall Study||19||
60131643|NCT00669279|76254329|FG000|NOT COMPLETED|Overall Study||0||
60131644|NCT00669279|76254330|FG001|NOT COMPLETED|Overall Study||0||
60131645|NCT01516736|76254338|FG000|STARTED|Overall Study||155|FAS/SAF full analysis set and safety analysis set|
60131646|NCT01516736|76254339|FG001|STARTED|Overall Study||153|FAS/SAF full analysis set and safety analysis set|
60131647|NCT01516736|76254338|FG000|COMPLETED|Overall Study||135|1 more patient, Neulasta arm died but been withdrawn earlier, not included in participant flow-death|
60131648|NCT01516736|76254339|FG001|COMPLETED|Overall Study||140|1 more patient, Neulasta arm died but been withdrawn earlier, not included in participant flow-death|
60131649|NCT01516736|76254338|FG000|NOT COMPLETED|Overall Study||20||
60131650|NCT01516736|76254339|FG001|NOT COMPLETED|Overall Study||13||
60131651|NCT00628407|76254345|FG000|STARTED|Overall Study||13||
60131652|NCT00628407|76254345|FG000|COMPLETED|Overall Study||13||
60131653|NCT00628407|76254345|FG000|NOT COMPLETED|Overall Study||0||
60131654|NCT01546688|76254351|FG000|STARTED|Overall Study||18||
60131655|NCT01546688|76254352|FG001|STARTED|Overall Study||33||
60131656|NCT01546688|76254351|FG000|COMPLETED|Overall Study||15||
60131657|NCT01546688|76254352|FG001|COMPLETED|Overall Study||28||
60131658|NCT01546688|76254351|FG000|NOT COMPLETED|Overall Study||3||
60131659|NCT01546688|76254352|FG001|NOT COMPLETED|Overall Study||5||
60131660|NCT01516034|76254358|FG000|STARTED|Overall Study||8||
60131661|NCT01516034|76254358|FG000|COMPLETED|Overall Study||0||
60131662|NCT01516034|76254358|FG000|NOT COMPLETED|Overall Study||8||
60131663|NCT00672243|76254362|FG000|STARTED|Overall Study||32||
60131664|NCT00672243|76254362|FG000|COMPLETED|Overall Study||32||
60131665|NCT00672243|76254362|FG000|NOT COMPLETED|Overall Study||0||
60131666|NCT01440569|76254369|FG000|STARTED|Main Study||296||
60131667|NCT01440569|76254370|FG001|STARTED|Main Study||18||
60131668|NCT01440569|76254369|FG000|Enrolled and Treated|Main Study||295||
60131669|NCT01440569|76254370|FG001|Enrolled and Treated|Main Study||18||
60131670|NCT01440569|76254369|FG000|COMPLETED|Main Study||260||
60131671|NCT01440569|76254370|FG001|COMPLETED|Main Study||14||
60131672|NCT01440569|76254369|FG000|NOT COMPLETED|Main Study||36||
60131673|NCT01440569|76254370|FG001|NOT COMPLETED|Main Study||4||
60131674|NCT01440569|76254369|FG000|STARTED|Open-Label Rollover Phase|9 participants who completed the Main Study did not enroll into the Rollover Phase.|251||
60131675|NCT01440569|76254370|FG001|STARTED|Open-Label Rollover Phase|1 participant who completed the Main Study did not enroll into the Rollover Phase.|13||
60131676|NCT01440569|76254369|FG000|COMPLETED|Open-Label Rollover Phase||204||
60131677|NCT01440569|76254370|FG001|COMPLETED|Open-Label Rollover Phase||7||
60131678|NCT01440569|76254369|FG000|NOT COMPLETED|Open-Label Rollover Phase||47||
60131679|NCT01440569|76254370|FG001|NOT COMPLETED|Open-Label Rollover Phase||6||
60131680|NCT00629499|76254376|FG000|STARTED|Overall Study||63||
60131681|NCT00629499|76254376|FG000|COMPLETED|Overall Study||63||
60131682|NCT00629499|76254376|FG000|NOT COMPLETED|Overall Study||0||
60131683|NCT00631449|76254382|FG000|STARTED|Overall Study||15||
60131684|NCT00631449|76254383|FG001|STARTED|Overall Study||15||
60131685|NCT00631449|76254382|FG000|COMPLETED|Overall Study||15||
60131686|NCT00631449|76254383|FG001|COMPLETED|Overall Study||15||
60131687|NCT00631449|76254382|FG000|NOT COMPLETED|Overall Study||0||
60131688|NCT00631449|76254383|FG001|NOT COMPLETED|Overall Study||0||
60131689|NCT01546142|76254393|FG000|STARTED|Overall Study||258||
60131690|NCT01546142|76254394|FG001|STARTED|Overall Study||258||
60131691|NCT01546142|76254393|FG000|Received Treatment|Overall Study||257||
60131692|NCT01546142|76254394|FG001|Received Treatment|Overall Study||257||
60131693|NCT01546142|76254393|FG000|COMPLETED|Overall Study|Participants who completed long-term follow-up 24 weeks after the last treatment|214||
60131694|NCT01546142|76254394|FG001|COMPLETED|Overall Study|Participants who completed long-term follow-up 24 weeks after the last treatment|224||
60131695|NCT01546142|76254393|FG000|NOT COMPLETED|Overall Study||44||
60131696|NCT01546142|76254394|FG001|NOT COMPLETED|Overall Study||34||
60131697|NCT00632619|76254402|FG000|STARTED|Overall Study|first cohort started 9/11/09 second cohort started 12/7/11|33||
60131698|NCT00632619|76254403|FG001|STARTED|Overall Study|first cohort started 9/11/09 second cohort started 12/7/11|35||
60131699|NCT00632619|76254402|FG000|COMPLETED|Overall Study|"st cohort completed follow up by 5/24/10~nd cohort completed follow up 7/18/11"|25||
60131700|NCT00632619|76254403|FG001|COMPLETED|Overall Study|"st cohort completed follow up by 5/24/10~nd cohort completed follow up 7/18/11"|31||
60131701|NCT00632619|76254402|FG000|NOT COMPLETED|Overall Study||8||
60131702|NCT00632619|76254403|FG001|NOT COMPLETED|Overall Study||4||
60131703|NCT00633009|76254412|FG000|STARTED|Overall Study||12||
60131704|NCT00633009|76254413|FG001|STARTED|Overall Study||27||
60131705|NCT00633009|76254414|FG002|STARTED|Overall Study||11||
60131706|NCT00633009|76254412|FG000|COMPLETED|Overall Study||8||
60131707|NCT00633009|76254413|FG001|COMPLETED|Overall Study||23||
60131708|NCT00633009|76254414|FG002|COMPLETED|Overall Study||10||
60131709|NCT00633009|76254412|FG000|NOT COMPLETED|Overall Study||4||
60131710|NCT00633009|76254413|FG001|NOT COMPLETED|Overall Study||4||
60131711|NCT00633009|76254414|FG002|NOT COMPLETED|Overall Study||1||
60131712|NCT01440101|76254428|FG000|STARTED|Overall Study||12||
60131713|NCT01440101|76254429|FG001|STARTED|Overall Study||47||
60131714|NCT01440101|76254430|FG002|STARTED|Overall Study||47||
60131715|NCT01440101|76254428|FG000|COMPLETED|Overall Study||10||
60131716|NCT01440101|76254429|FG001|COMPLETED|Overall Study||43||
60131717|NCT01440101|76254430|FG002|COMPLETED|Overall Study||46||
60131718|NCT01440101|76254428|FG000|NOT COMPLETED|Overall Study||2||
60131719|NCT01440101|76254429|FG001|NOT COMPLETED|Overall Study||4||
60131720|NCT01440101|76254430|FG002|NOT COMPLETED|Overall Study||1||
60131721|NCT01530464|76254441|FG000|STARTED|First Intervention (24h)||10||
60131722|NCT01530464|76254442|FG001|STARTED|First Intervention (24h)||8||
60131723|NCT01530464|76254441|FG000|COMPLETED|First Intervention (24h)||10||
60131724|NCT01530464|76254442|FG001|COMPLETED|First Intervention (24h)||8||
60131725|NCT01530464|76254441|FG000|NOT COMPLETED|First Intervention (24h)||0||
60131726|NCT01530464|76254442|FG001|NOT COMPLETED|First Intervention (24h)||0||
60131727|NCT01530464|76254441|FG000|STARTED|Washout (24h)||10||
60131728|NCT01530464|76254442|FG001|STARTED|Washout (24h)||8||
60131729|NCT01530464|76254441|FG000|COMPLETED|Washout (24h)||10||
60131730|NCT01530464|76254442|FG001|COMPLETED|Washout (24h)||8||
60131731|NCT01530464|76254441|FG000|NOT COMPLETED|Washout (24h)||0||
60131732|NCT01530464|76254442|FG001|NOT COMPLETED|Washout (24h)||0||
60131733|NCT01530464|76254441|FG000|STARTED|Second Intervention (24h)||10||
60131734|NCT01530464|76254442|FG001|STARTED|Second Intervention (24h)||8||
60131735|NCT01530464|76254441|FG000|COMPLETED|Second Intervention (24h)||10||
60131736|NCT01530464|76254442|FG001|COMPLETED|Second Intervention (24h)||8||
60131737|NCT01530464|76254441|FG000|NOT COMPLETED|Second Intervention (24h)||0||
60131738|NCT01530464|76254442|FG001|NOT COMPLETED|Second Intervention (24h)||0||
60131739|NCT01530464|76254441|FG000|STARTED|Washout (24h)||10||
60131740|NCT01530464|76254442|FG001|STARTED|Washout (24h)||8||
60131741|NCT01530464|76254441|FG000|COMPLETED|Washout (24h)|1 subject withdrew consent and left due to family emergencies|9||
60131742|NCT01530464|76254442|FG001|COMPLETED|Washout (24h)||8||
60131743|NCT01530464|76254441|FG000|NOT COMPLETED|Washout (24h)||1||
60131744|NCT01530464|76254442|FG001|NOT COMPLETED|Washout (24h)||0||
60131745|NCT01530464|76254441|FG000|STARTED|Third Intervention (24h)||9||
60131746|NCT01530464|76254442|FG001|STARTED|Third Intervention (24h)||8||
60131747|NCT01530464|76254441|FG000|COMPLETED|Third Intervention (24h)||9||
60131748|NCT01530464|76254442|FG001|COMPLETED|Third Intervention (24h)||8||
60131749|NCT01530464|76254441|FG000|NOT COMPLETED|Third Intervention (24h)||0||
60131750|NCT01530464|76254442|FG001|NOT COMPLETED|Third Intervention (24h)||0||
60131751|NCT01530464|76254441|FG000|STARTED|Washout (24h)||9||
60131752|NCT01530464|76254442|FG001|STARTED|Washout (24h)||8||
60131753|NCT01530464|76254441|FG000|COMPLETED|Washout (24h)||9||
60131754|NCT01530464|76254442|FG001|COMPLETED|Washout (24h)|1 subject withdrew consent and left due to family emergencies|7||
60131755|NCT01530464|76254441|FG000|NOT COMPLETED|Washout (24h)||0||
60131756|NCT01530464|76254442|FG001|NOT COMPLETED|Washout (24h)||1||
60131757|NCT00633399|76254455|FG000|STARTED|Overall Study||71||
60131758|NCT00633399|76254456|FG001|STARTED|Overall Study||68||
60131759|NCT00633399|76254455|FG000|COMPLETED|Overall Study||49||
60131760|NCT00633399|76254456|FG001|COMPLETED|Overall Study||53||
60131761|NCT00633399|76254455|FG000|NOT COMPLETED|Overall Study||22||
60131762|NCT00633399|76254456|FG001|NOT COMPLETED|Overall Study||15||
60131763|NCT00633867|76254464|FG000|STARTED|Overall Study||60||
60131764|NCT00633867|76254465|FG001|STARTED|Overall Study||60||
60131765|NCT00633867|76254464|FG000|COMPLETED|Overall Study||60||
60131766|NCT00633867|76254465|FG001|COMPLETED|Overall Study||60||
60131767|NCT00633867|76254464|FG000|NOT COMPLETED|Overall Study||0||
60131768|NCT00633867|76254465|FG001|NOT COMPLETED|Overall Study||0||
60131769|NCT00673959|76254471|FG000|STARTED|Overall Study||10||
60131770|NCT00673959|76254472|FG001|STARTED|Overall Study||10||
60131771|NCT00673959|76254471|FG000|COMPLETED|Overall Study||10||
60131772|NCT00673959|76254472|FG001|COMPLETED|Overall Study||10||
60131773|NCT00673959|76254471|FG000|NOT COMPLETED|Overall Study||0||
60131774|NCT00673959|76254472|FG001|NOT COMPLETED|Overall Study||0||
60131775|NCT00635739|76254480|FG000|STARTED|Overall Study||42||
60131776|NCT00635739|76254481|FG001|STARTED|Overall Study||38||
60131777|NCT00635739|76254480|FG000|COMPLETED|Overall Study||39||
60131778|NCT00635739|76254481|FG001|COMPLETED|Overall Study||36||
60131779|NCT00635739|76254480|FG000|NOT COMPLETED|Overall Study||3||
60131780|NCT00635739|76254481|FG001|NOT COMPLETED|Overall Study||2||
60131781|NCT00635817|76254491|FG000|STARTED|Overall Study||21||
60131782|NCT00635817|76254492|FG001|STARTED|Overall Study||21||
60131783|NCT00635817|76254493|FG002|STARTED|Overall Study||21||
60131784|NCT00635817|76254494|FG003|STARTED|Overall Study||21||
60131785|NCT00635817|76254491|FG000|COMPLETED|Overall Study||15||
60131786|NCT00635817|76254492|FG001|COMPLETED|Overall Study||19||
60131787|NCT00635817|76254493|FG002|COMPLETED|Overall Study||19||
60131788|NCT00635817|76254494|FG003|COMPLETED|Overall Study||21||
60131789|NCT00635817|76254491|FG000|NOT COMPLETED|Overall Study||6||
60131790|NCT00635817|76254492|FG001|NOT COMPLETED|Overall Study||2||
60131791|NCT00635817|76254493|FG002|NOT COMPLETED|Overall Study||2||
60131792|NCT00635817|76254494|FG003|NOT COMPLETED|Overall Study||0||
60131793|NCT01439945|76254509|FG000|STARTED|Double-Blind Treatment Phase||97||
60131794|NCT01439945|76254510|FG001|STARTED|Double-Blind Treatment Phase||96||
60131795|NCT01439945|76254511|FG002|STARTED|Double-Blind Treatment Phase||48||
60131796|NCT01439945|76254512|FG003|STARTED|Double-Blind Treatment Phase||48||
60131797|NCT01439945|76254509|FG000|COMPLETED|Double-Blind Treatment Phase||93||
60131798|NCT01439945|76254510|FG001|COMPLETED|Double-Blind Treatment Phase||91||
60131799|NCT01439945|76254511|FG002|COMPLETED|Double-Blind Treatment Phase||45||
60131800|NCT01439945|76254512|FG003|COMPLETED|Double-Blind Treatment Phase||46||
60131801|NCT01439945|76254509|FG000|NOT COMPLETED|Double-Blind Treatment Phase||4||
60131802|NCT01439945|76254510|FG001|NOT COMPLETED|Double-Blind Treatment Phase||5||
60131803|NCT01439945|76254511|FG002|NOT COMPLETED|Double-Blind Treatment Phase||3||
60131804|NCT01439945|76254512|FG003|NOT COMPLETED|Double-Blind Treatment Phase||2||
60131805|NCT01439945|76254509|FG000|STARTED|Optional Continuation Phase||72||
60131806|NCT01439945|76254510|FG001|STARTED|Optional Continuation Phase||44||
60131807|NCT01439945|76254511|FG002|STARTED|Optional Continuation Phase||0||
60131808|NCT01439945|76254512|FG003|STARTED|Optional Continuation Phase||0||
60131809|NCT01439945|76254509|FG000|COMPLETED|Optional Continuation Phase||72||
60131810|NCT01439945|76254510|FG001|COMPLETED|Optional Continuation Phase||44||
60131811|NCT01439945|76254511|FG002|COMPLETED|Optional Continuation Phase||0||
60131812|NCT01439945|76254512|FG003|COMPLETED|Optional Continuation Phase||0||
60131813|NCT01439945|76254509|FG000|NOT COMPLETED|Optional Continuation Phase||0||
60131814|NCT01439945|76254510|FG001|NOT COMPLETED|Optional Continuation Phase||0||
60131815|NCT01439945|76254511|FG002|NOT COMPLETED|Optional Continuation Phase||0||
60131816|NCT01439945|76254512|FG003|NOT COMPLETED|Optional Continuation Phase||0||
60131817|NCT00674115|76254523|FG000|STARTED|First Intervention||14||
60131818|NCT00674115|76254524|FG001|STARTED|First Intervention||16||
60131819|NCT00674115|76254525|FG002|STARTED|First Intervention||14||
60131820|NCT00674115|76254526|FG003|STARTED|First Intervention||16||
60131821|NCT00674115|76254523|FG000|COMPLETED|First Intervention||14||
60131822|NCT00674115|76254524|FG001|COMPLETED|First Intervention||16||
60131823|NCT00674115|76254525|FG002|COMPLETED|First Intervention||14||
60131824|NCT00674115|76254526|FG003|COMPLETED|First Intervention||16||
60131825|NCT00674115|76254523|FG000|NOT COMPLETED|First Intervention||0||
60131826|NCT00674115|76254524|FG001|NOT COMPLETED|First Intervention||0||
60131827|NCT00674115|76254525|FG002|NOT COMPLETED|First Intervention||0||
60131828|NCT00674115|76254526|FG003|NOT COMPLETED|First Intervention||0||
60131829|NCT00674115|76254523|FG000|STARTED|Washout Period of 2 Weeks||14||
60131830|NCT00674115|76254524|FG001|STARTED|Washout Period of 2 Weeks||16||
60131831|NCT00674115|76254525|FG002|STARTED|Washout Period of 2 Weeks||14||
60131832|NCT00674115|76254526|FG003|STARTED|Washout Period of 2 Weeks||16||
60131833|NCT00674115|76254523|FG000|COMPLETED|Washout Period of 2 Weeks||14||
60131834|NCT00674115|76254524|FG001|COMPLETED|Washout Period of 2 Weeks||16||
60131835|NCT00674115|76254525|FG002|COMPLETED|Washout Period of 2 Weeks||14||
60131836|NCT00674115|76254526|FG003|COMPLETED|Washout Period of 2 Weeks||16||
60131837|NCT00674115|76254523|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0||
60131838|NCT00674115|76254524|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0||
60131839|NCT00674115|76254525|FG002|NOT COMPLETED|Washout Period of 2 Weeks||0||
60131840|NCT00674115|76254526|FG003|NOT COMPLETED|Washout Period of 2 Weeks||0||
60131841|NCT00674115|76254523|FG000|STARTED|Second Intervention||14||
60131842|NCT00674115|76254524|FG001|STARTED|Second Intervention||16||
60131843|NCT00674115|76254525|FG002|STARTED|Second Intervention||14||
60131844|NCT00674115|76254526|FG003|STARTED|Second Intervention||16||
60131845|NCT00674115|76254523|FG000|COMPLETED|Second Intervention||14||
60131846|NCT00674115|76254524|FG001|COMPLETED|Second Intervention||16||
60131847|NCT00674115|76254525|FG002|COMPLETED|Second Intervention||14||
60131848|NCT00674115|76254526|FG003|COMPLETED|Second Intervention||16||
60131849|NCT00674115|76254523|FG000|NOT COMPLETED|Second Intervention||0||
60131850|NCT00674115|76254524|FG001|NOT COMPLETED|Second Intervention||0||
60131851|NCT00674115|76254525|FG002|NOT COMPLETED|Second Intervention||0||
60131852|NCT00674115|76254526|FG003|NOT COMPLETED|Second Intervention||0||
60131853|NCT00674115|76254523|FG000|STARTED|Washout Period of 2 Weeks||14||
60131854|NCT00674115|76254524|FG001|STARTED|Washout Period of 2 Weeks||16||
60131855|NCT00674115|76254525|FG002|STARTED|Washout Period of 2 Weeks||0||
60131856|NCT00674115|76254526|FG003|STARTED|Washout Period of 2 Weeks||0||
60131857|NCT00674115|76254523|FG000|COMPLETED|Washout Period of 2 Weeks||14||
60131858|NCT00674115|76254524|FG001|COMPLETED|Washout Period of 2 Weeks||16||
60131859|NCT00674115|76254525|FG002|COMPLETED|Washout Period of 2 Weeks||0||
60131860|NCT00674115|76254526|FG003|COMPLETED|Washout Period of 2 Weeks||0||
60131861|NCT00674115|76254523|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0||
60131862|NCT00674115|76254524|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0||
60131863|NCT00674115|76254525|FG002|NOT COMPLETED|Washout Period of 2 Weeks||0||
60131864|NCT00674115|76254526|FG003|NOT COMPLETED|Washout Period of 2 Weeks||0||
60131865|NCT00674115|76254523|FG000|STARTED|Third Intervention||14||
60131866|NCT00674115|76254524|FG001|STARTED|Third Intervention||16||
60131867|NCT00674115|76254525|FG002|STARTED|Third Intervention||0||
60131868|NCT00674115|76254526|FG003|STARTED|Third Intervention||0||
60131869|NCT00674115|76254523|FG000|COMPLETED|Third Intervention||14||
60131870|NCT00674115|76254524|FG001|COMPLETED|Third Intervention||16||
60131871|NCT00674115|76254525|FG002|COMPLETED|Third Intervention||0||
60131872|NCT00674115|76254526|FG003|COMPLETED|Third Intervention||0||
60131873|NCT00674115|76254523|FG000|NOT COMPLETED|Third Intervention||0||
60131874|NCT00674115|76254524|FG001|NOT COMPLETED|Third Intervention||0||
60131875|NCT00674115|76254525|FG002|NOT COMPLETED|Third Intervention||0||
60131876|NCT00674115|76254526|FG003|NOT COMPLETED|Third Intervention||0||
60131877|NCT02142153|76254545|FG000|STARTED|Overall Study||6||
60131878|NCT02142153|76254546|FG001|STARTED|Overall Study||2||
60131879|NCT02142153|76254547|FG002|STARTED|Overall Study||6||
60131880|NCT02142153|76254548|FG003|STARTED|Overall Study||2||
60131881|NCT02142153|76254549|FG004|STARTED|Overall Study||6||
60131882|NCT02142153|76254550|FG005|STARTED|Overall Study||2||
60131883|NCT02142153|76254551|FG006|STARTED|Overall Study||6||
60131884|NCT02142153|76254552|FG007|STARTED|Overall Study||2||
60131885|NCT02142153|76254553|FG008|STARTED|Overall Study||6||
60131886|NCT02142153|76254554|FG009|STARTED|Overall Study||2||
60131887|NCT02142153|76254545|FG000|COMPLETED|Overall Study||6||
60131888|NCT02142153|76254546|FG001|COMPLETED|Overall Study||2||
60131889|NCT02142153|76254547|FG002|COMPLETED|Overall Study||6||
60131890|NCT02142153|76254548|FG003|COMPLETED|Overall Study||2||
60131891|NCT02142153|76254549|FG004|COMPLETED|Overall Study||6||
60131892|NCT02142153|76254550|FG005|COMPLETED|Overall Study||2||
60131893|NCT02142153|76254551|FG006|COMPLETED|Overall Study||6||
60131894|NCT02142153|76254552|FG007|COMPLETED|Overall Study||2||
60131895|NCT02142153|76254553|FG008|COMPLETED|Overall Study||6||
60131896|NCT02142153|76254554|FG009|COMPLETED|Overall Study||2||
60131897|NCT02142153|76254545|FG000|NOT COMPLETED|Overall Study||0||
60131898|NCT02142153|76254546|FG001|NOT COMPLETED|Overall Study||0||
60131899|NCT02142153|76254547|FG002|NOT COMPLETED|Overall Study||0||
60131900|NCT02142153|76254548|FG003|NOT COMPLETED|Overall Study||0||
60131901|NCT02142153|76254549|FG004|NOT COMPLETED|Overall Study||0||
60131902|NCT02142153|76254550|FG005|NOT COMPLETED|Overall Study||0||
60131903|NCT02142153|76254551|FG006|NOT COMPLETED|Overall Study||0||
60131904|NCT02142153|76254552|FG007|NOT COMPLETED|Overall Study||0||
60131905|NCT02142153|76254553|FG008|NOT COMPLETED|Overall Study||0||
60131906|NCT02142153|76254554|FG009|NOT COMPLETED|Overall Study||0||
60131907|NCT00674583|76254588|FG000|STARTED|Overall Study||311||
60131908|NCT00674583|76254589|FG001|STARTED|Overall Study||103||
60131909|NCT00674583|76254588|FG000|COMPLETED|Overall Study||311||
60131910|NCT00674583|76254589|FG001|COMPLETED|Overall Study||103||
60131911|NCT00674583|76254588|FG000|NOT COMPLETED|Overall Study||0||
60131912|NCT00674583|76254589|FG001|NOT COMPLETED|Overall Study||0||
60131913|NCT00637299|76254601|FG000|STARTED|Overall Study||10||
60131914|NCT00637299|76254602|FG001|STARTED|Overall Study||10||
60131915|NCT00637299|76254601|FG000|COMPLETED|Overall Study||10||
60131916|NCT00637299|76254602|FG001|COMPLETED|Overall Study||10||
60131917|NCT00637299|76254601|FG000|NOT COMPLETED|Overall Study||0||
60131918|NCT00637299|76254602|FG001|NOT COMPLETED|Overall Study||0||
60131919|NCT01420081|76254617|FG000|STARTED|Overall Study||3||
60131920|NCT01420081|76254618|FG001|STARTED|Overall Study||1||
60131921|NCT01420081|76254619|FG002|STARTED|Overall Study||11||
60131922|NCT01420081|76254620|FG003|STARTED|Overall Study||3||
60131923|NCT01420081|76254621|FG004|STARTED|Overall Study||20||
60131924|NCT01420081|76254622|FG005|STARTED|Overall Study||20||
60131925|NCT01420081|76254623|FG006|STARTED|Overall Study||3||
60131926|NCT01420081|76254624|FG007|STARTED|Overall Study||3||
60131927|NCT01420081|76254625|FG008|STARTED|Overall Study||3||
60131928|NCT01420081|76254617|FG000|COMPLETED|Overall Study||0||
60131929|NCT01420081|76254618|FG001|COMPLETED|Overall Study||0||
60131930|NCT01420081|76254619|FG002|COMPLETED|Overall Study||0||
60131931|NCT01420081|76254620|FG003|COMPLETED|Overall Study||0||
60131932|NCT01420081|76254621|FG004|COMPLETED|Overall Study||0||
60131933|NCT01420081|76254622|FG005|COMPLETED|Overall Study||0||
60131934|NCT01420081|76254623|FG006|COMPLETED|Overall Study||0||
60131935|NCT01420081|76254624|FG007|COMPLETED|Overall Study||0||
60131936|NCT01420081|76254625|FG008|COMPLETED|Overall Study||0||
60131937|NCT01420081|76254617|FG000|NOT COMPLETED|Overall Study||3||
60131938|NCT01420081|76254618|FG001|NOT COMPLETED|Overall Study||1||
60131939|NCT01420081|76254619|FG002|NOT COMPLETED|Overall Study||11||
60131940|NCT01420081|76254620|FG003|NOT COMPLETED|Overall Study||3||
60131941|NCT01420081|76254621|FG004|NOT COMPLETED|Overall Study||20||
60131942|NCT01420081|76254622|FG005|NOT COMPLETED|Overall Study||20||
60131943|NCT01420081|76254623|FG006|NOT COMPLETED|Overall Study||3||
60131944|NCT01420081|76254624|FG007|NOT COMPLETED|Overall Study||3||
60131945|NCT01420081|76254625|FG008|NOT COMPLETED|Overall Study||3||
60131946|NCT01439867|76254643|FG000|STARTED|Overall Study||8||
60131947|NCT01439867|76254644|FG001|STARTED|Overall Study||10||
60131948|NCT01439867|76254643|FG000|Received Treatment|Overall Study||7||
60131949|NCT01439867|76254644|FG001|Received Treatment|Overall Study||10||
60131950|NCT01439867|76254643|FG000|COMPLETED|Overall Study||2||
60131951|NCT01439867|76254644|FG001|COMPLETED|Overall Study||2||
60131952|NCT01439867|76254643|FG000|NOT COMPLETED|Overall Study||6||
60131953|NCT01439867|76254644|FG001|NOT COMPLETED|Overall Study||8||
60131954|NCT00637923|76254654|FG000|STARTED|Overall Study||75||
60131955|NCT00637923|76254655|FG001|STARTED|Overall Study||37||
60131956|NCT00637923|76254654|FG000|COMPLETED|Overall Study||45||
60131957|NCT00637923|76254655|FG001|COMPLETED|Overall Study||18||
60131958|NCT00637923|76254654|FG000|NOT COMPLETED|Overall Study||30||
60131959|NCT00637923|76254655|FG001|NOT COMPLETED|Overall Study||19||
60131960|NCT01439711|76254661|FG000|STARTED|Overall Study||108||
60131961|NCT01439711|76254661|FG000|COMPLETED|Overall Study||68||
60131962|NCT01439711|76254661|FG000|NOT COMPLETED|Overall Study||40||
60131963|NCT01439555|76254665|FG000|STARTED|Overall Study||11||
60131964|NCT01439555|76254665|FG000|COMPLETED|Overall Study||10||
60131965|NCT01439555|76254665|FG000|NOT COMPLETED|Overall Study||1||
60131966|NCT00674739|76254672|FG000|STARTED|Overall Study||178||
60131967|NCT00674739|76254673|FG001|STARTED|Overall Study||195||
60131968|NCT00674739|76254674|FG002|STARTED|Overall Study||97||
60131969|NCT00674739|76254672|FG000|COMPLETED|Overall Study||121||
60131970|NCT00674739|76254673|FG001|COMPLETED|Overall Study||136||
60131971|NCT00674739|76254674|FG002|COMPLETED|Overall Study||65||
60131972|NCT00674739|76254672|FG000|NOT COMPLETED|Overall Study||57||
60131973|NCT00674739|76254673|FG001|NOT COMPLETED|Overall Study||59||
60131974|NCT00674739|76254674|FG002|NOT COMPLETED|Overall Study||32||
60131975|NCT01544582|76254685|FG000|STARTED|Screening/Eligibility||713||
60131976|NCT01544582|76254686|FG001|STARTED|Screening/Eligibility||0||
60131977|NCT01544582|76254687|FG002|STARTED|Screening/Eligibility||0||
60131978|NCT01544582|76254688|FG003|STARTED|Screening/Eligibility||0||
60131979|NCT01544582|76254685|FG000|Analysis Population|Screening/Eligibility||679||
60131980|NCT01544582|76254686|FG001|Analysis Population|Screening/Eligibility||0||
60131981|NCT01544582|76254687|FG002|Analysis Population|Screening/Eligibility||0||
60131982|NCT01544582|76254688|FG003|Analysis Population|Screening/Eligibility||0||
60131983|NCT01544582|76254685|FG000|COMPLETED|Screening/Eligibility|Completed means met criteria for Analysis Population|679||
60131984|NCT01544582|76254686|FG001|COMPLETED|Screening/Eligibility||0||
60131985|NCT01544582|76254687|FG002|COMPLETED|Screening/Eligibility||0||
60131986|NCT01544582|76254688|FG003|COMPLETED|Screening/Eligibility||0||
60131987|NCT01544582|76254685|FG000|NOT COMPLETED|Screening/Eligibility||34||
60131988|NCT01544582|76254686|FG001|NOT COMPLETED|Screening/Eligibility||0||
60131989|NCT01544582|76254687|FG002|NOT COMPLETED|Screening/Eligibility||0||
60131990|NCT01544582|76254688|FG003|NOT COMPLETED|Screening/Eligibility||0||
60131991|NCT01544582|76254685|FG000|STARTED|Analysis Population|Analysis Population was grouped into Boceprevir+PR, Telaprevir+PR, or PR Alone|0||
60131992|NCT01544582|76254686|FG001|STARTED|Analysis Population||298||
60131993|NCT01544582|76254687|FG002|STARTED|Analysis Population||307||
60131994|NCT01544582|76254688|FG003|STARTED|Analysis Population||74||
60131995|NCT01544582|76254685|FG000|COMPLETED|Analysis Population||0||
60131996|NCT01544582|76254686|FG001|COMPLETED|Analysis Population||180||
60131997|NCT01544582|76254687|FG002|COMPLETED|Analysis Population||205||
60131998|NCT01544582|76254688|FG003|COMPLETED|Analysis Population||35||
60131999|NCT01544582|76254685|FG000|NOT COMPLETED|Analysis Population||0||
60132000|NCT01544582|76254686|FG001|NOT COMPLETED|Analysis Population||118||
60132001|NCT01544582|76254687|FG002|NOT COMPLETED|Analysis Population||102||
60132002|NCT01544582|76254688|FG003|NOT COMPLETED|Analysis Population||39||
60132003|NCT00675909|76254704|FG000|STARTED|Overall Study||60||
60132004|NCT00675909|76254705|FG001|STARTED|Overall Study||60||
60132005|NCT00675909|76254706|FG002|STARTED|Overall Study||60||
60132006|NCT00675909|76254704|FG000|COMPLETED|Overall Study||60||
60132007|NCT00675909|76254705|FG001|COMPLETED|Overall Study||60||
60132008|NCT00675909|76254706|FG002|COMPLETED|Overall Study||60||
60132009|NCT00675909|76254704|FG000|NOT COMPLETED|Overall Study||0||
60132010|NCT00675909|76254705|FG001|NOT COMPLETED|Overall Study||0||
60132011|NCT00675909|76254706|FG002|NOT COMPLETED|Overall Study||0||
60132012|NCT01439165|76254716|FG000|STARTED|Overall Study||1002||
60132013|NCT01439165|76254717|FG001|STARTED|Overall Study||328||
60132014|NCT01439165|76254716|FG000|COMPLETED|Overall Study||981||
60132015|NCT01439165|76254717|FG001|COMPLETED|Overall Study||326||
60132016|NCT01439165|76254716|FG000|NOT COMPLETED|Overall Study||21||
60132017|NCT01439165|76254717|FG001|NOT COMPLETED|Overall Study||2||
60132018|NCT00638937|76254723|FG000|STARTED|Overall Study||37||
60132019|NCT00638937|76254723|FG000|COMPLETED|Overall Study||37||
60132020|NCT00638937|76254723|FG000|NOT COMPLETED|Overall Study||0||
60132021|NCT01529606|76254731|FG000|STARTED|Overall Study||55||
60132022|NCT01529606|76254732|FG001|STARTED|Overall Study||47||
60132023|NCT01529606|76254731|FG000|COMPLETED|Overall Study||34||
60132024|NCT01529606|76254732|FG001|COMPLETED|Overall Study||29||
60132025|NCT01529606|76254731|FG000|NOT COMPLETED|Overall Study||21||
60132026|NCT01529606|76254732|FG001|NOT COMPLETED|Overall Study||18||
60132027|NCT00639093|76254740|FG000|STARTED|Overall Study|45|45||
60132028|NCT00639093|76254741|FG001|STARTED|Overall Study|46|46||
60132029|NCT00639093|76254740|FG000|COMPLETED|Overall Study|45|45||
60132030|NCT00639093|76254741|FG001|COMPLETED|Overall Study|46|46||
60132031|NCT00639093|76254740|FG000|NOT COMPLETED|Overall Study||0||
60132032|NCT00639093|76254741|FG001|NOT COMPLETED|Overall Study||0||
60132033|NCT01439009|76254749|FG000|STARTED|Overall Study||50||
60132034|NCT01439009|76254750|FG001|STARTED|Overall Study||50||
60132035|NCT01439009|76254749|FG000|COMPLETED|Overall Study||42||
60132036|NCT01439009|76254750|FG001|COMPLETED|Overall Study||47||
60132037|NCT01439009|76254749|FG000|NOT COMPLETED|Overall Study||8||
60132038|NCT01439009|76254750|FG001|NOT COMPLETED|Overall Study||3||
60132039|NCT00675987|76254758|FG000|STARTED|Overall Study||26||
60132040|NCT00675987|76254759|FG001|STARTED|Overall Study||27||
60132041|NCT00675987|76254758|FG000|COMPLETED|Overall Study||26||
60132042|NCT00675987|76254759|FG001|COMPLETED|Overall Study||27||
60132043|NCT00675987|76254758|FG000|NOT COMPLETED|Overall Study||0||
60132044|NCT00675987|76254759|FG001|NOT COMPLETED|Overall Study||0||
60132045|NCT01572389|76254769|FG000|STARTED|Overall Study||136||
60132046|NCT01572389|76254770|FG001|STARTED|Overall Study||89||
60132047|NCT01572389|76254769|FG000|COMPLETED|Overall Study||90||
60132048|NCT01572389|76254770|FG001|COMPLETED|Overall Study||68||
60132049|NCT01572389|76254769|FG000|NOT COMPLETED|Overall Study||46||
60132050|NCT01572389|76254770|FG001|NOT COMPLETED|Overall Study||21||
60132051|NCT00639717|76254776|FG000|STARTED|Overall Study||48||
60132052|NCT00639717|76254776|FG000|COMPLETED|Overall Study||48||
60132053|NCT00639717|76254776|FG000|NOT COMPLETED|Overall Study||0||
60132054|NCT01571453|76254782|FG000|STARTED|Overall Study||211||
60132055|NCT01571453|76254783|FG001|STARTED|Overall Study||226||
60132056|NCT01571453|76254782|FG000|COMPLETED|Overall Study||173||
60132057|NCT01571453|76254783|FG001|COMPLETED|Overall Study||164||
60132058|NCT01571453|76254782|FG000|NOT COMPLETED|Overall Study||38||
60132059|NCT01571453|76254783|FG001|NOT COMPLETED|Overall Study||62||
60132060|NCT01446289|76254793|FG000|STARTED|Overall Study||51||
60132061|NCT01446289|76254794|FG001|STARTED|Overall Study||35||
60132062|NCT01446289|76254795|FG002|STARTED|Overall Study||51||
60132063|NCT01446289|76254796|FG003|STARTED|Overall Study||35||
60132064|NCT01446289|76254793|FG000|COMPLETED|Overall Study||50||
60132065|NCT01446289|76254794|FG001|COMPLETED|Overall Study||35||
60132066|NCT01446289|76254795|FG002|COMPLETED|Overall Study||50||
60132067|NCT01446289|76254796|FG003|COMPLETED|Overall Study||35||
60132068|NCT01446289|76254793|FG000|NOT COMPLETED|Overall Study||1||
60132069|NCT01446289|76254794|FG001|NOT COMPLETED|Overall Study||0||
60132070|NCT01446289|76254795|FG002|NOT COMPLETED|Overall Study||1||
60132071|NCT01446289|76254796|FG003|NOT COMPLETED|Overall Study||0||
60132072|NCT01438541|76254808|FG000|STARTED|Overall Study||29||
60132073|NCT01438541|76254808|FG000|COMPLETED|Overall Study||22||
60132074|NCT01438541|76254808|FG000|NOT COMPLETED|Overall Study||7||
60132075|NCT01419769|76254812|FG000|STARTED|Overall Study||33||
60132076|NCT01419769|76254812|FG000|COMPLETED|Overall Study||29||
60132077|NCT01419769|76254812|FG000|NOT COMPLETED|Overall Study||4||
60132078|NCT01438307|76254818|FG000|STARTED|Overall Study||14||
60132079|NCT01438307|76254819|FG001|STARTED|Overall Study||14||
60132080|NCT01438307|76254818|FG000|COMPLETED|Overall Study||13||
60132081|NCT01438307|76254819|FG001|COMPLETED|Overall Study||13||
60132082|NCT01438307|76254818|FG000|NOT COMPLETED|Overall Study||1||
60132083|NCT01438307|76254819|FG001|NOT COMPLETED|Overall Study||1||
60132084|NCT01444651|76254827|FG000|STARTED|Overall Study||36||
60132085|NCT01444651|76254828|FG001|STARTED|Overall Study||37||
60132086|NCT01444651|76254827|FG000|COMPLETED|Overall Study||25||
60132087|NCT01444651|76254828|FG001|COMPLETED|Overall Study||28||
60132088|NCT01444651|76254827|FG000|NOT COMPLETED|Overall Study||11||
60132089|NCT01444651|76254828|FG001|NOT COMPLETED|Overall Study||9||
60132090|NCT01570751|76254836|FG000|STARTED|Period A (16 Weeks)||73||
60132091|NCT01570751|76254837|FG001|STARTED|Period A (16 Weeks)||72||
60132092|NCT01570751|76254836|FG000|Exposed|Period A (16 Weeks)||73||
60132093|NCT01570751|76254837|FG001|Exposed|Period A (16 Weeks)||72||
60132094|NCT01570751|76254836|FG000|COMPLETED|Period A (16 Weeks)||70||
60132095|NCT01570751|76254837|FG001|COMPLETED|Period A (16 Weeks)||67||
60132096|NCT01570751|76254836|FG000|NOT COMPLETED|Period A (16 Weeks)||3||
60132097|NCT01570751|76254837|FG001|NOT COMPLETED|Period A (16 Weeks)||5||
60132098|NCT01570751|76254836|FG000|STARTED|Period B (16 Weeks)||70||
60132099|NCT01570751|76254837|FG001|STARTED|Period B (16 Weeks)||67||
60132100|NCT01570751|76254836|FG000|Exposed|Period B (16 Weeks)||70||
60132101|NCT01570751|76254837|FG001|Exposed|Period B (16 Weeks)||67||
60132102|NCT01570751|76254836|FG000|COMPLETED|Period B (16 Weeks)||69||
60132103|NCT01570751|76254837|FG001|COMPLETED|Period B (16 Weeks)||66||
60132104|NCT01570751|76254836|FG000|NOT COMPLETED|Period B (16 Weeks)||1||
60132105|NCT01570751|76254837|FG001|NOT COMPLETED|Period B (16 Weeks)||1||
60132106|NCT01419535|76254847|FG000|STARTED|Overall Study||9||
60132107|NCT01419535|76254848|FG001|STARTED|Overall Study||10||
60132108|NCT01419535|76254847|FG000|COMPLETED|Overall Study||8||
60132109|NCT01419535|76254848|FG001|COMPLETED|Overall Study||8||
60132110|NCT01419535|76254847|FG000|NOT COMPLETED|Overall Study||1||
60132111|NCT01419535|76254848|FG001|NOT COMPLETED|Overall Study||2||
60132112|NCT01438151|76254854|FG000|STARTED|Overall Study||11||
60132113|NCT01438151|76254854|FG000|COMPLETED|Overall Study||3||
60132114|NCT01438151|76254854|FG000|NOT COMPLETED|Overall Study||8||
60132115|NCT02141451|76254862|FG000|STARTED|Overall Study||3||
60132116|NCT02141451|76254863|FG001|STARTED|Overall Study||4||
60132117|NCT02141451|76254864|FG002|STARTED|Overall Study||7||
60132118|NCT02141451|76254865|FG003|STARTED|Overall Study||16||
60132119|NCT02141451|76254862|FG000|COMPLETED|Overall Study||3||
60132120|NCT02141451|76254863|FG001|COMPLETED|Overall Study||2||
60132121|NCT02141451|76254864|FG002|COMPLETED|Overall Study||2||
60132122|NCT02141451|76254865|FG003|COMPLETED|Overall Study||7||
60132123|NCT02141451|76254862|FG000|NOT COMPLETED|Overall Study||0||
60132124|NCT02141451|76254863|FG001|NOT COMPLETED|Overall Study||2||
60132125|NCT02141451|76254864|FG002|NOT COMPLETED|Overall Study||5||
60132126|NCT02141451|76254865|FG003|NOT COMPLETED|Overall Study||9||
60132127|NCT01418365|76254880|FG000|STARTED|First Intervention||15||
60132128|NCT01418365|76254881|FG001|STARTED|First Intervention||15||
60132129|NCT01418365|76254880|FG000|COMPLETED|First Intervention||14||
60132130|NCT01418365|76254881|FG001|COMPLETED|First Intervention||14||
60132131|NCT01418365|76254880|FG000|NOT COMPLETED|First Intervention||1||
60132132|NCT01418365|76254881|FG001|NOT COMPLETED|First Intervention||1||
60132133|NCT01418365|76254880|FG000|STARTED|Second Intervention||14||
60132134|NCT01418365|76254881|FG001|STARTED|Second Intervention||14||
60132135|NCT01418365|76254880|FG000|COMPLETED|Second Intervention||14||
60132136|NCT01418365|76254881|FG001|COMPLETED|Second Intervention||13||
60132137|NCT01418365|76254880|FG000|NOT COMPLETED|Second Intervention||0||
60132138|NCT01418365|76254881|FG001|NOT COMPLETED|Second Intervention||1||
60132139|NCT02075125|76254889|FG000|STARTED|Overall Study||19||
60132140|NCT02075125|76254890|FG001|STARTED|Overall Study||20||
60132141|NCT02075125|76254889|FG000|COMPLETED|Overall Study||19||
60132142|NCT02075125|76254890|FG001|COMPLETED|Overall Study|One patient switched to clopidogrel treatment after 18 days of ticagrelor treatment.|19||
60132143|NCT02075125|76254889|FG000|NOT COMPLETED|Overall Study||0||
60132144|NCT02075125|76254890|FG001|NOT COMPLETED|Overall Study||1||
60132145|NCT00676065|76254899|FG000|STARTED|Overall Study||16534||
60132146|NCT00676065|76254900|FG001|STARTED|Overall Study||15428||
60132147|NCT00676065|76254901|FG002|STARTED|Overall Study||26341||
60132148|NCT00676065|76254899|FG000|COMPLETED|Overall Study||16534||
60132149|NCT00676065|76254900|FG001|COMPLETED|Overall Study||15428||
60132150|NCT00676065|76254901|FG002|COMPLETED|Overall Study||26341||
60132151|NCT00676065|76254899|FG000|NOT COMPLETED|Overall Study||0||
60132152|NCT00676065|76254900|FG001|NOT COMPLETED|Overall Study||0||
60132153|NCT00676065|76254901|FG002|NOT COMPLETED|Overall Study||0||
60132154|NCT00678015|76254909|FG000|STARTED|Overall Study||12||
60132155|NCT00678015|76254909|FG000|COMPLETED|Overall Study||12||
60132156|NCT00678015|76254909|FG000|NOT COMPLETED|Overall Study||0||
60132157|NCT01437995|76254916|FG000|STARTED|Overall Study||151||
60132158|NCT01437995|76254917|FG001|STARTED|Overall Study||149||
60132159|NCT01437995|76254918|FG002|STARTED|Overall Study||155||
60132160|NCT01437995|76254916|FG000|Included in Treatment Failure Analysis|Overall Study||150||
60132161|NCT01437995|76254917|FG001|Included in Treatment Failure Analysis|Overall Study||146||
60132162|NCT01437995|76254918|FG002|Included in Treatment Failure Analysis|Overall Study||151||
60132163|NCT01437995|76254916|FG000|COMPLETED|Overall Study||140||
60132164|NCT01437995|76254917|FG001|COMPLETED|Overall Study||131||
60132165|NCT01437995|76254918|FG002|COMPLETED|Overall Study||135||
60132166|NCT01437995|76254916|FG000|NOT COMPLETED|Overall Study||11||
60132167|NCT01437995|76254917|FG001|NOT COMPLETED|Overall Study||18||
60132168|NCT01437995|76254918|FG002|NOT COMPLETED|Overall Study||20||
60132169|NCT00640653|76254931|FG000|STARTED|Overall Study||131||
60132170|NCT00640653|76254932|FG001|STARTED|Overall Study||134||
60132171|NCT00640653|76254933|FG002|STARTED|Overall Study||129||
60132172|NCT00640653|76254934|FG003|STARTED|Overall Study||134||
60132173|NCT00640653|76254935|FG004|STARTED|Overall Study||134||
60132174|NCT00640653|76254931|FG000|Followed-up at 3 mo|Overall Study||126||
60132175|NCT00640653|76254932|FG001|Followed-up at 3 mo|Overall Study||127||
60132176|NCT00640653|76254933|FG002|Followed-up at 3 mo|Overall Study||125||
60132177|NCT00640653|76254934|FG003|Followed-up at 3 mo|Overall Study||129||
60132178|NCT00640653|76254935|FG004|Followed-up at 3 mo|Overall Study||126||
60132179|NCT00640653|76254931|FG000|Followed-up at 6 mo|Overall Study||127||
60132180|NCT00640653|76254932|FG001|Followed-up at 6 mo|Overall Study||130||
60132181|NCT00640653|76254933|FG002|Followed-up at 6 mo|Overall Study||124||
60132182|NCT00640653|76254934|FG003|Followed-up at 6 mo|Overall Study||130||
60132183|NCT00640653|76254935|FG004|Followed-up at 6 mo|Overall Study||125||
60132184|NCT00640653|76254931|FG000|Followed-up at 12 mo|Overall Study||124||
60132185|NCT00640653|76254932|FG001|Followed-up at 12 mo|Overall Study||121||
60132186|NCT00640653|76254933|FG002|Followed-up at 12 mo|Overall Study||115||
60132187|NCT00640653|76254934|FG003|Followed-up at 12 mo|Overall Study||122||
60132188|NCT00640653|76254935|FG004|Followed-up at 12 mo|Overall Study||116||
60132189|NCT00640653|76254931|FG000|Followed-up at 18 mo|Overall Study||118||
60132190|NCT00640653|76254932|FG001|Followed-up at 18 mo|Overall Study||112||
60132191|NCT00640653|76254933|FG002|Followed-up at 18 mo|Overall Study||113||
60132192|NCT00640653|76254934|FG003|Followed-up at 18 mo|Overall Study||117||
60132193|NCT00640653|76254935|FG004|Followed-up at 18 mo|Overall Study||117||
60132194|NCT00640653|76254931|FG000|Followed-up at 24 mo|Overall Study||114||
60132195|NCT00640653|76254932|FG001|Followed-up at 24 mo|Overall Study||116||
60132196|NCT00640653|76254933|FG002|Followed-up at 24 mo|Overall Study||105||
60132197|NCT00640653|76254934|FG003|Followed-up at 24 mo|Overall Study||112||
60132198|NCT00640653|76254935|FG004|Followed-up at 24 mo|Overall Study||112||
60132199|NCT00640653|76254931|FG000|COMPLETED|Overall Study||128||
60132200|NCT00640653|76254932|FG001|COMPLETED|Overall Study||131||
60132201|NCT00640653|76254933|FG002|COMPLETED|Overall Study||129||
60132202|NCT00640653|76254934|FG003|COMPLETED|Overall Study||132||
60132203|NCT00640653|76254935|FG004|COMPLETED|Overall Study||129||
60132204|NCT00640653|76254931|FG000|NOT COMPLETED|Overall Study||3||
60132205|NCT00640653|76254932|FG001|NOT COMPLETED|Overall Study||3||
60132206|NCT00640653|76254933|FG002|NOT COMPLETED|Overall Study||0||
60132207|NCT00640653|76254934|FG003|NOT COMPLETED|Overall Study||2||
60132208|NCT00640653|76254935|FG004|NOT COMPLETED|Overall Study||5||
60132209|NCT00641745|76254949|FG000|STARTED|Overall Study||427||
60132210|NCT00641745|76254950|FG001|STARTED|Overall Study||202||
60132211|NCT00641745|76254949|FG000|COMPLETED|Overall Study||147||
60132212|NCT00641745|76254950|FG001|COMPLETED|Overall Study||89||
60132213|NCT00641745|76254949|FG000|NOT COMPLETED|Overall Study||280||
60132214|NCT00641745|76254950|FG001|NOT COMPLETED|Overall Study||113||
60132215|NCT00588159|76254958|FG000|STARTED|Overall Study||72||
60132216|NCT00588159|76254959|FG001|STARTED|Overall Study||74||
60132217|NCT00588159|76254958|FG000|COMPLETED|Overall Study||57||
60132218|NCT00588159|76254959|FG001|COMPLETED|Overall Study||63||
60132219|NCT00588159|76254958|FG000|NOT COMPLETED|Overall Study||15||
60132220|NCT00588159|76254959|FG001|NOT COMPLETED|Overall Study||11||
60132221|NCT01439347|76254967|FG000|STARTED|Overall Study||13||
60132222|NCT01439347|76254968|FG001|STARTED|Overall Study||13||
60132223|NCT01439347|76254967|FG000|COMPLETED|Overall Study||0||
60132224|NCT01439347|76254968|FG001|COMPLETED|Overall Study||0||
60132225|NCT01439347|76254967|FG000|NOT COMPLETED|Overall Study||13||
60132226|NCT01439347|76254968|FG001|NOT COMPLETED|Overall Study||13||
60132227|NCT00678249|76254977|FG000|STARTED|Overall Study||97||
60132228|NCT00678249|76254978|FG001|STARTED|Overall Study||93||
60132229|NCT00678249|76254979|FG002|STARTED|Overall Study||37||
60132230|NCT00678249|76254977|FG000|COMPLETED|Overall Study||97||
60132231|NCT00678249|76254978|FG001|COMPLETED|Overall Study||93||
60132232|NCT00678249|76254979|FG002|COMPLETED|Overall Study||37||
60132233|NCT00678249|76254977|FG000|NOT COMPLETED|Overall Study||0||
60132234|NCT00678249|76254978|FG001|NOT COMPLETED|Overall Study||0||
60132235|NCT00678249|76254979|FG002|NOT COMPLETED|Overall Study||0||
60132236|NCT00680823|76254990|FG000|STARTED|Overall Study||50||
60132237|NCT00680823|76254991|FG001|STARTED|Overall Study||50||
60132238|NCT00680823|76254992|FG002|STARTED|Overall Study||50||
60132239|NCT00680823|76254990|FG000|COMPLETED|Overall Study||50||
60132240|NCT00680823|76254991|FG001|COMPLETED|Overall Study||50||
60132241|NCT00680823|76254992|FG002|COMPLETED|Overall Study||50||
60132242|NCT00680823|76254990|FG000|NOT COMPLETED|Overall Study||0||
60132243|NCT00680823|76254991|FG001|NOT COMPLETED|Overall Study||0||
60132244|NCT00680823|76254992|FG002|NOT COMPLETED|Overall Study||0||
60132245|NCT00589329|76255002|FG000|STARTED|Overall Study||10||
60132246|NCT00589329|76255003|FG001|STARTED|Overall Study||10||
60132247|NCT00589329|76255002|FG000|COMPLETED|Overall Study||10||
60132248|NCT00589329|76255003|FG001|COMPLETED|Overall Study||10||
60132249|NCT00589329|76255002|FG000|NOT COMPLETED|Overall Study||0||
60132250|NCT00589329|76255003|FG001|NOT COMPLETED|Overall Study||0||
60132251|NCT01438957|76255015|FG000|STARTED|Overall Study||22||
60132252|NCT01438957|76255016|FG001|STARTED|Overall Study||23||
60132253|NCT01438957|76255017|FG002|STARTED|Overall Study||24||
59730122|NCT01796171|75848707|FG001|NOT COMPLETED|Enrolled||0||
59730123|NCT01796171|75848708|FG002|NOT COMPLETED|Enrolled||0||
59730124|NCT01796171|75848709|FG003|NOT COMPLETED|Enrolled||0||
59730125|NCT01796171|75848710|FG004|NOT COMPLETED|Enrolled||0||
59730126|NCT01796171|75848711|FG005|NOT COMPLETED|Enrolled||0||
59730127|NCT01796171|75848712|FG006|NOT COMPLETED|Enrolled||0||
59730128|NCT01796171|75848713|FG007|NOT COMPLETED|Enrolled||0||
59730129|NCT01796171|75848714|FG008|NOT COMPLETED|Enrolled||0||
59730130|NCT01796171|75848715|FG009|NOT COMPLETED|Enrolled||0||
59730131|NCT01796171|75848716|FG010|NOT COMPLETED|Enrolled||0||
59730132|NCT01796171|75848717|FG011|NOT COMPLETED|Enrolled||0||
59730133|NCT01796171|75848718|FG012|NOT COMPLETED|Enrolled||0||
59730134|NCT01796171|75848719|FG013|NOT COMPLETED|Enrolled||0||
59730135|NCT01796171|75848720|FG014|NOT COMPLETED|Enrolled||1||
59730136|NCT01796171|75848706|FG000|STARTED|Pre-reatment With Rituximab||4|Started pre-treatment with rituximab|
59730137|NCT01796171|75848707|FG001|STARTED|Pre-reatment With Rituximab||36|Started pre-treatment with rituximab|
59730138|NCT01796171|75848708|FG002|STARTED|Pre-reatment With Rituximab||3|Started pre-treatment with rituximab|
59730139|NCT01796171|75848709|FG003|STARTED|Pre-reatment With Rituximab||1|Started pre-treatment with rituximab|
59730140|NCT01796171|75848710|FG004|STARTED|Pre-reatment With Rituximab||2|Started pre-treatment with rituximab|
59730141|NCT01796171|75848711|FG005|STARTED|Pre-reatment With Rituximab||3|Started pre-treatment with rituximab|
59730142|NCT01796171|75848712|FG006|STARTED|Pre-reatment With Rituximab||3|Started pre-treatment with rituximab|
59730143|NCT01796171|75848713|FG007|STARTED|Pre-reatment With Rituximab||18|Started pre-treatment with rituximab|
59730144|NCT01796171|75848714|FG008|STARTED|Pre-reatment With Rituximab||4|Started pre-treatment with rituximab|
59730145|NCT01796171|75848715|FG009|STARTED|Pre-reatment With Rituximab||2|Started pre-treatment with rituximab|
59730146|NCT01796171|75848716|FG010|STARTED|Pre-reatment With Rituximab||76|Started pre-treatment with rituximab|
59730147|NCT01796171|75848717|FG011|STARTED|Pre-reatment With Rituximab||28|Started pre-treatment with rituximab|
59730148|NCT01796171|75848718|FG012|STARTED|Pre-reatment With Rituximab||9|Started pre-treatment with rituximab|
59730149|NCT01796171|75848719|FG013|STARTED|Pre-reatment With Rituximab||1|Started pre-treatment with rituximab|
59730150|NCT01796171|75848720|FG014|STARTED|Pre-reatment With Rituximab||0|Started pre-treatment with rituximab|
59730151|NCT01796171|75848706|FG000|COMPLETED|Pre-reatment With Rituximab||4||
59730152|NCT01796171|75848707|FG001|COMPLETED|Pre-reatment With Rituximab||36||
59730153|NCT01796171|75848708|FG002|COMPLETED|Pre-reatment With Rituximab||3||
59730154|NCT01796171|75848709|FG003|COMPLETED|Pre-reatment With Rituximab||1||
59730155|NCT01796171|75848710|FG004|COMPLETED|Pre-reatment With Rituximab||2||
59730156|NCT01796171|75848711|FG005|COMPLETED|Pre-reatment With Rituximab||3||
59730157|NCT01796171|75848712|FG006|COMPLETED|Pre-reatment With Rituximab||3||
59730158|NCT01796171|75848713|FG007|COMPLETED|Pre-reatment With Rituximab||18||
59730159|NCT01796171|75848714|FG008|COMPLETED|Pre-reatment With Rituximab||4||
59730160|NCT01796171|75848715|FG009|COMPLETED|Pre-reatment With Rituximab||0||
59730161|NCT01796171|75848716|FG010|COMPLETED|Pre-reatment With Rituximab||76||
59730162|NCT01796171|75848717|FG011|COMPLETED|Pre-reatment With Rituximab||28||
59730163|NCT01796171|75848718|FG012|COMPLETED|Pre-reatment With Rituximab||9||
59730164|NCT01796171|75848719|FG013|COMPLETED|Pre-reatment With Rituximab||0||
59730165|NCT01796171|75848720|FG014|COMPLETED|Pre-reatment With Rituximab||0||
59730166|NCT01796171|75848706|FG000|NOT COMPLETED|Pre-reatment With Rituximab||0||
59730167|NCT01796171|75848707|FG001|NOT COMPLETED|Pre-reatment With Rituximab||0||
59730168|NCT01796171|75848708|FG002|NOT COMPLETED|Pre-reatment With Rituximab||0||
59730169|NCT01796171|75848709|FG003|NOT COMPLETED|Pre-reatment With Rituximab||0||
59730170|NCT01796171|75848710|FG004|NOT COMPLETED|Pre-reatment With Rituximab||0||
59730171|NCT01796171|75848711|FG005|NOT COMPLETED|Pre-reatment With Rituximab||0||
59730172|NCT01796171|75848712|FG006|NOT COMPLETED|Pre-reatment With Rituximab||0||
59730173|NCT01796171|75848713|FG007|NOT COMPLETED|Pre-reatment With Rituximab||0||
59730174|NCT01796171|75848714|FG008|NOT COMPLETED|Pre-reatment With Rituximab||0||
59730175|NCT01796171|75848715|FG009|NOT COMPLETED|Pre-reatment With Rituximab||2||
59730176|NCT01796171|75848716|FG010|NOT COMPLETED|Pre-reatment With Rituximab||0||
59730177|NCT01796171|75848717|FG011|NOT COMPLETED|Pre-reatment With Rituximab||0||
59730178|NCT01796171|75848718|FG012|NOT COMPLETED|Pre-reatment With Rituximab||0||
59730179|NCT01796171|75848719|FG013|NOT COMPLETED|Pre-reatment With Rituximab||1||
59730180|NCT01796171|75848720|FG014|NOT COMPLETED|Pre-reatment With Rituximab||0||
59730181|NCT01796171|75848706|FG000|STARTED|Treatment Period With Betalutin||4||
59730182|NCT01796171|75848707|FG001|STARTED|Treatment Period With Betalutin||36||
60132254|NCT01438957|76255018|FG003|STARTED|Overall Study||25||
60132255|NCT01438957|76255019|FG004|STARTED|Overall Study||25||
60132256|NCT01438957|76255015|FG000|COMPLETED|Overall Study||21||
60132257|NCT01438957|76255016|FG001|COMPLETED|Overall Study||22||
60132258|NCT01438957|76255017|FG002|COMPLETED|Overall Study||24||
59730183|NCT01796171|75848708|FG002|STARTED|Treatment Period With Betalutin||3||
59730184|NCT01796171|75848709|FG003|STARTED|Treatment Period With Betalutin||1||
59730185|NCT01796171|75848710|FG004|STARTED|Treatment Period With Betalutin||2||
59730186|NCT01796171|75848711|FG005|STARTED|Treatment Period With Betalutin||3||
59730187|NCT01796171|75848712|FG006|STARTED|Treatment Period With Betalutin||3||
59730188|NCT01796171|75848713|FG007|STARTED|Treatment Period With Betalutin||18||
59730189|NCT01796171|75848714|FG008|STARTED|Treatment Period With Betalutin||4||
59730190|NCT01796171|75848715|FG009|STARTED|Treatment Period With Betalutin||0||
59730191|NCT01796171|75848716|FG010|STARTED|Treatment Period With Betalutin||76||
59730192|NCT01796171|75848717|FG011|STARTED|Treatment Period With Betalutin||28||
59730193|NCT01796171|75848718|FG012|STARTED|Treatment Period With Betalutin||9||
59730194|NCT01796171|75848719|FG013|STARTED|Treatment Period With Betalutin||0||
59730195|NCT01796171|75848720|FG014|STARTED|Treatment Period With Betalutin||0||
59730196|NCT01796171|75848706|FG000|COMPLETED|Treatment Period With Betalutin||4||
59730197|NCT01796171|75848707|FG001|COMPLETED|Treatment Period With Betalutin||35||
59730198|NCT01796171|75848708|FG002|COMPLETED|Treatment Period With Betalutin||3||
59730199|NCT01796171|75848709|FG003|COMPLETED|Treatment Period With Betalutin||1||
59730200|NCT01796171|75848710|FG004|COMPLETED|Treatment Period With Betalutin||2||
59730201|NCT01796171|75848711|FG005|COMPLETED|Treatment Period With Betalutin||3||
59730202|NCT01796171|75848712|FG006|COMPLETED|Treatment Period With Betalutin||3||
59730203|NCT01796171|75848713|FG007|COMPLETED|Treatment Period With Betalutin||18||
59730204|NCT01796171|75848714|FG008|COMPLETED|Treatment Period With Betalutin||3||
59730205|NCT01796171|75848715|FG009|COMPLETED|Treatment Period With Betalutin||0||
59730206|NCT01796171|75848716|FG010|COMPLETED|Treatment Period With Betalutin||65||
59730207|NCT01796171|75848717|FG011|COMPLETED|Treatment Period With Betalutin||25||
59730208|NCT01796171|75848718|FG012|COMPLETED|Treatment Period With Betalutin||8||
59730209|NCT01796171|75848719|FG013|COMPLETED|Treatment Period With Betalutin||0||
59730210|NCT01796171|75848720|FG014|COMPLETED|Treatment Period With Betalutin||0||
59730211|NCT01796171|75848706|FG000|NOT COMPLETED|Treatment Period With Betalutin||0||
59730212|NCT01796171|75848707|FG001|NOT COMPLETED|Treatment Period With Betalutin||1||
59730213|NCT01796171|75848708|FG002|NOT COMPLETED|Treatment Period With Betalutin||0||
59730214|NCT01796171|75848709|FG003|NOT COMPLETED|Treatment Period With Betalutin||0||
59730215|NCT01796171|75848710|FG004|NOT COMPLETED|Treatment Period With Betalutin||0||
59730216|NCT01796171|75848711|FG005|NOT COMPLETED|Treatment Period With Betalutin||0||
59730217|NCT01796171|75848712|FG006|NOT COMPLETED|Treatment Period With Betalutin||0||
59730218|NCT01796171|75848713|FG007|NOT COMPLETED|Treatment Period With Betalutin||0||
59730219|NCT01796171|75848714|FG008|NOT COMPLETED|Treatment Period With Betalutin||1||
59730220|NCT01796171|75848715|FG009|NOT COMPLETED|Treatment Period With Betalutin||0||
59730221|NCT01796171|75848716|FG010|NOT COMPLETED|Treatment Period With Betalutin||11||
59730222|NCT01796171|75848717|FG011|NOT COMPLETED|Treatment Period With Betalutin||3||
59730223|NCT01796171|75848718|FG012|NOT COMPLETED|Treatment Period With Betalutin||1||
59730224|NCT01796171|75848719|FG013|NOT COMPLETED|Treatment Period With Betalutin||0||
59730225|NCT01796171|75848720|FG014|NOT COMPLETED|Treatment Period With Betalutin||0||
59730226|NCT01796171|75848706|FG000|STARTED|Follow-up Period||4||
59730227|NCT01796171|75848707|FG001|STARTED|Follow-up Period||35||
59730228|NCT01796171|75848708|FG002|STARTED|Follow-up Period||3||
59730229|NCT01796171|75848709|FG003|STARTED|Follow-up Period||1||
59730230|NCT01796171|75848710|FG004|STARTED|Follow-up Period||2||
59730231|NCT01796171|75848711|FG005|STARTED|Follow-up Period||3||
59730232|NCT01796171|75848712|FG006|STARTED|Follow-up Period||3||
59730233|NCT01796171|75848713|FG007|STARTED|Follow-up Period||18||
59730234|NCT01796171|75848714|FG008|STARTED|Follow-up Period||3||
59730235|NCT01796171|75848715|FG009|STARTED|Follow-up Period||0||
59730236|NCT01796171|75848716|FG010|STARTED|Follow-up Period||65||
59730237|NCT01796171|75848717|FG011|STARTED|Follow-up Period||25||
59730238|NCT01796171|75848718|FG012|STARTED|Follow-up Period||8||
59730239|NCT01796171|75848719|FG013|STARTED|Follow-up Period||0||
59730240|NCT01796171|75848720|FG014|STARTED|Follow-up Period||0||
59730241|NCT01796171|75848706|FG000|COMPLETED|Follow-up Period||0||
59730242|NCT01796171|75848707|FG001|COMPLETED|Follow-up Period||5||
59730243|NCT01796171|75848708|FG002|COMPLETED|Follow-up Period||1||
59730244|NCT01796171|75848709|FG003|COMPLETED|Follow-up Period||0||
59730245|NCT01796171|75848710|FG004|COMPLETED|Follow-up Period||0||
59730246|NCT01796171|75848711|FG005|COMPLETED|Follow-up Period||0||
59730247|NCT01796171|75848712|FG006|COMPLETED|Follow-up Period||1||
59730248|NCT01796171|75848713|FG007|COMPLETED|Follow-up Period||0||
59730249|NCT01796171|75848714|FG008|COMPLETED|Follow-up Period||1||
59730250|NCT01796171|75848715|FG009|COMPLETED|Follow-up Period||0||
59730251|NCT01796171|75848716|FG010|COMPLETED|Follow-up Period||0||
59730252|NCT01796171|75848717|FG011|COMPLETED|Follow-up Period||0||
59730253|NCT01796171|75848718|FG012|COMPLETED|Follow-up Period||0||
59730254|NCT01796171|75848719|FG013|COMPLETED|Follow-up Period||0||
59730255|NCT01796171|75848720|FG014|COMPLETED|Follow-up Period||0||
59730256|NCT01796171|75848706|FG000|NOT COMPLETED|Follow-up Period||4||
59730257|NCT01796171|75848707|FG001|NOT COMPLETED|Follow-up Period||30||
59730258|NCT01796171|75848708|FG002|NOT COMPLETED|Follow-up Period||2||
59730259|NCT01796171|75848709|FG003|NOT COMPLETED|Follow-up Period||1||
59730260|NCT01796171|75848710|FG004|NOT COMPLETED|Follow-up Period||2||
59730261|NCT01796171|75848711|FG005|NOT COMPLETED|Follow-up Period||3||
59730262|NCT01796171|75848712|FG006|NOT COMPLETED|Follow-up Period||2||
59730263|NCT01796171|75848713|FG007|NOT COMPLETED|Follow-up Period||18||
59730264|NCT01796171|75848714|FG008|NOT COMPLETED|Follow-up Period||2||
59730265|NCT01796171|75848715|FG009|NOT COMPLETED|Follow-up Period||0||
59730266|NCT01796171|75848716|FG010|NOT COMPLETED|Follow-up Period||65||
59730267|NCT01796171|75848717|FG011|NOT COMPLETED|Follow-up Period||25||
59730268|NCT01796171|75848718|FG012|NOT COMPLETED|Follow-up Period||8||
59730269|NCT01796171|75848719|FG013|NOT COMPLETED|Follow-up Period||0||
59730270|NCT01796171|75848720|FG014|NOT COMPLETED|Follow-up Period||0||
59730271|NCT01620944|75848753|FG000|STARTED|Overall Study||2||
59730272|NCT01620944|75848754|FG001|STARTED|Overall Study||1||
59730273|NCT01620944|75848753|FG000|COMPLETED|Overall Study||0||
59730274|NCT01620944|75848754|FG001|COMPLETED|Overall Study||0||
59730275|NCT01620944|75848753|FG000|NOT COMPLETED|Overall Study||2||
59730276|NCT01620944|75848754|FG001|NOT COMPLETED|Overall Study||1||
59730277|NCT01522976|75848763|FG000|STARTED|Overall Study||97||
59730278|NCT01522976|75848764|FG001|STARTED|Overall Study||92||
59730279|NCT01522976|75848765|FG002|STARTED|Overall Study||93||
59730280|NCT01522976|75848763|FG000|COMPLETED|Overall Study||0||
59730281|NCT01522976|75848764|FG001|COMPLETED|Overall Study||0||
59730282|NCT01522976|75848765|FG002|COMPLETED|Overall Study||0||
59730283|NCT01522976|75848763|FG000|NOT COMPLETED|Overall Study||97||
59730284|NCT01522976|75848764|FG001|NOT COMPLETED|Overall Study||92||
59730285|NCT01522976|75848765|FG002|NOT COMPLETED|Overall Study||93||
59730286|NCT01386385|75848781|FG000|STARTED|Phase I 40mg: Concurrent CRT||8||
59730287|NCT01386385|75848782|FG001|STARTED|Phase I 40mg: Concurrent CRT||0||
59730288|NCT01386385|75848783|FG002|STARTED|Phase I 40mg: Concurrent CRT||0||
59730289|NCT01386385|75848784|FG003|STARTED|Phase I 40mg: Concurrent CRT||0||
59730290|NCT01386385|75848785|FG004|STARTED|Phase I 40mg: Concurrent CRT||0||
59730291|NCT01386385|75848786|FG005|STARTED|Phase I 40mg: Concurrent CRT||0||
59730292|NCT01386385|75848787|FG006|STARTED|Phase I 40mg: Concurrent CRT||0||
59730293|NCT01386385|75848788|FG007|STARTED|Phase I 40mg: Concurrent CRT||0||
59730294|NCT01386385|75848781|FG000|COMPLETED|Phase I 40mg: Concurrent CRT||6||
59730295|NCT01386385|75848782|FG001|COMPLETED|Phase I 40mg: Concurrent CRT||0||
59730296|NCT01386385|75848783|FG002|COMPLETED|Phase I 40mg: Concurrent CRT||0||
59730297|NCT01386385|75848784|FG003|COMPLETED|Phase I 40mg: Concurrent CRT||0||
59730298|NCT01386385|75848785|FG004|COMPLETED|Phase I 40mg: Concurrent CRT||0||
59730299|NCT01386385|75848786|FG005|COMPLETED|Phase I 40mg: Concurrent CRT||0||
59730300|NCT01386385|75848787|FG006|COMPLETED|Phase I 40mg: Concurrent CRT||0||
59864914|NCT01631214|75988886|FG000|Received Double-blind Treatment|Overall Study||2040||
59864915|NCT01631214|75988887|FG001|Received Double-blind Treatment|Overall Study||2038||
59999760|NCT01874353|76115471|FG001|STARTED|Overall Study||99||
59730301|NCT01386385|75848788|FG007|COMPLETED|Phase I 40mg: Concurrent CRT||0||
59730302|NCT01386385|75848781|FG000|NOT COMPLETED|Phase I 40mg: Concurrent CRT||2||
59730303|NCT01386385|75848782|FG001|NOT COMPLETED|Phase I 40mg: Concurrent CRT||0||
59730304|NCT01386385|75848783|FG002|NOT COMPLETED|Phase I 40mg: Concurrent CRT||0||
59730305|NCT01386385|75848784|FG003|NOT COMPLETED|Phase I 40mg: Concurrent CRT||0||
59730306|NCT01386385|75848785|FG004|NOT COMPLETED|Phase I 40mg: Concurrent CRT||0||
59730307|NCT01386385|75848786|FG005|NOT COMPLETED|Phase I 40mg: Concurrent CRT||0||
59730308|NCT01386385|75848787|FG006|NOT COMPLETED|Phase I 40mg: Concurrent CRT||0||
59730309|NCT01386385|75848788|FG007|NOT COMPLETED|Phase I 40mg: Concurrent CRT||0||
59730310|NCT01386385|75848781|FG000|STARTED|Phase I 40mg: Consolidation Therapy||0||
59730311|NCT01386385|75848782|FG001|STARTED|Phase I 40mg: Consolidation Therapy||4||
59730312|NCT01386385|75848783|FG002|STARTED|Phase I 40mg: Consolidation Therapy||0||
59730313|NCT01386385|75848784|FG003|STARTED|Phase I 40mg: Consolidation Therapy||0||
59730314|NCT01386385|75848785|FG004|STARTED|Phase I 40mg: Consolidation Therapy||0||
59730315|NCT01386385|75848786|FG005|STARTED|Phase I 40mg: Consolidation Therapy||0||
59730316|NCT01386385|75848787|FG006|STARTED|Phase I 40mg: Consolidation Therapy||0||
59730317|NCT01386385|75848788|FG007|STARTED|Phase I 40mg: Consolidation Therapy||0||
59730318|NCT01386385|75848781|FG000|COMPLETED|Phase I 40mg: Consolidation Therapy||0||
59730319|NCT01386385|75848782|FG001|COMPLETED|Phase I 40mg: Consolidation Therapy||4||
59730320|NCT01386385|75848783|FG002|COMPLETED|Phase I 40mg: Consolidation Therapy||0||
59730321|NCT01386385|75848784|FG003|COMPLETED|Phase I 40mg: Consolidation Therapy||0||
59730322|NCT01386385|75848785|FG004|COMPLETED|Phase I 40mg: Consolidation Therapy||0||
59730323|NCT01386385|75848786|FG005|COMPLETED|Phase I 40mg: Consolidation Therapy||0||
59730324|NCT01386385|75848787|FG006|COMPLETED|Phase I 40mg: Consolidation Therapy||0||
59730325|NCT01386385|75848788|FG007|COMPLETED|Phase I 40mg: Consolidation Therapy||0||
59730326|NCT01386385|75848781|FG000|NOT COMPLETED|Phase I 40mg: Consolidation Therapy||0||
59999761|NCT01874353|76115472|FG002|STARTED|Overall Study||22||
59730327|NCT01386385|75848782|FG001|NOT COMPLETED|Phase I 40mg: Consolidation Therapy||0||
59730328|NCT01386385|75848783|FG002|NOT COMPLETED|Phase I 40mg: Consolidation Therapy||0||
59730329|NCT01386385|75848784|FG003|NOT COMPLETED|Phase I 40mg: Consolidation Therapy||0||
59730330|NCT01386385|75848785|FG004|NOT COMPLETED|Phase I 40mg: Consolidation Therapy||0||
59730331|NCT01386385|75848786|FG005|NOT COMPLETED|Phase I 40mg: Consolidation Therapy||0||
59730332|NCT01386385|75848787|FG006|NOT COMPLETED|Phase I 40mg: Consolidation Therapy||0||
59730333|NCT01386385|75848788|FG007|NOT COMPLETED|Phase I 40mg: Consolidation Therapy||0||
59730334|NCT01386385|75848781|FG000|STARTED|Phase I 80mg: Concurrent CRT||0||
59730335|NCT01386385|75848782|FG001|STARTED|Phase I 80mg: Concurrent CRT||0||
59730336|NCT01386385|75848783|FG002|STARTED|Phase I 80mg: Concurrent CRT||7||
59730337|NCT01386385|75848784|FG003|STARTED|Phase I 80mg: Concurrent CRT||0||
59730338|NCT01386385|75848785|FG004|STARTED|Phase I 80mg: Concurrent CRT||0||
59730339|NCT01386385|75848786|FG005|STARTED|Phase I 80mg: Concurrent CRT||0||
59730340|NCT01386385|75848787|FG006|STARTED|Phase I 80mg: Concurrent CRT||0||
59730341|NCT01386385|75848788|FG007|STARTED|Phase I 80mg: Concurrent CRT||0||
59730342|NCT01386385|75848781|FG000|COMPLETED|Phase I 80mg: Concurrent CRT||0||
59730343|NCT01386385|75848782|FG001|COMPLETED|Phase I 80mg: Concurrent CRT||0||
59730344|NCT01386385|75848783|FG002|COMPLETED|Phase I 80mg: Concurrent CRT||5||
59730345|NCT01386385|75848784|FG003|COMPLETED|Phase I 80mg: Concurrent CRT||0||
59730346|NCT01386385|75848785|FG004|COMPLETED|Phase I 80mg: Concurrent CRT||0||
59730347|NCT01386385|75848786|FG005|COMPLETED|Phase I 80mg: Concurrent CRT||0||
59730348|NCT01386385|75848787|FG006|COMPLETED|Phase I 80mg: Concurrent CRT||0||
59730349|NCT01386385|75848788|FG007|COMPLETED|Phase I 80mg: Concurrent CRT||0||
59730350|NCT01386385|75848781|FG000|NOT COMPLETED|Phase I 80mg: Concurrent CRT||0||
59730351|NCT01386385|75848782|FG001|NOT COMPLETED|Phase I 80mg: Concurrent CRT||0||
59730352|NCT01386385|75848783|FG002|NOT COMPLETED|Phase I 80mg: Concurrent CRT||2||
59730353|NCT01386385|75848784|FG003|NOT COMPLETED|Phase I 80mg: Concurrent CRT||0||
59730354|NCT01386385|75848785|FG004|NOT COMPLETED|Phase I 80mg: Concurrent CRT||0||
59730355|NCT01386385|75848786|FG005|NOT COMPLETED|Phase I 80mg: Concurrent CRT||0||
59730356|NCT01386385|75848787|FG006|NOT COMPLETED|Phase I 80mg: Concurrent CRT||0||
59730357|NCT01386385|75848788|FG007|NOT COMPLETED|Phase I 80mg: Concurrent CRT||0||
59730358|NCT01386385|75848781|FG000|STARTED|Phase I 80mg: Consolidation Therapy||0||
59730359|NCT01386385|75848782|FG001|STARTED|Phase I 80mg: Consolidation Therapy||0||
59730360|NCT01386385|75848783|FG002|STARTED|Phase I 80mg: Consolidation Therapy||0||
59730361|NCT01386385|75848784|FG003|STARTED|Phase I 80mg: Consolidation Therapy||5||
59730362|NCT01386385|75848785|FG004|STARTED|Phase I 80mg: Consolidation Therapy||0||
59730363|NCT01386385|75848786|FG005|STARTED|Phase I 80mg: Consolidation Therapy||0||
59730364|NCT01386385|75848787|FG006|STARTED|Phase I 80mg: Consolidation Therapy||0||
59730365|NCT01386385|75848788|FG007|STARTED|Phase I 80mg: Consolidation Therapy||0||
59730366|NCT01386385|75848781|FG000|COMPLETED|Phase I 80mg: Consolidation Therapy||0||
59730367|NCT01386385|75848782|FG001|COMPLETED|Phase I 80mg: Consolidation Therapy||0||
59730368|NCT01386385|75848783|FG002|COMPLETED|Phase I 80mg: Consolidation Therapy||0||
59730369|NCT01386385|75848784|FG003|COMPLETED|Phase I 80mg: Consolidation Therapy||5||
59730370|NCT01386385|75848785|FG004|COMPLETED|Phase I 80mg: Consolidation Therapy||0||
59730371|NCT01386385|75848786|FG005|COMPLETED|Phase I 80mg: Consolidation Therapy||0||
59730372|NCT01386385|75848787|FG006|COMPLETED|Phase I 80mg: Consolidation Therapy||0||
59730373|NCT01386385|75848788|FG007|COMPLETED|Phase I 80mg: Consolidation Therapy||0||
59730374|NCT01386385|75848781|FG000|NOT COMPLETED|Phase I 80mg: Consolidation Therapy||0||
59730375|NCT01386385|75848782|FG001|NOT COMPLETED|Phase I 80mg: Consolidation Therapy||0||
59730376|NCT01386385|75848783|FG002|NOT COMPLETED|Phase I 80mg: Consolidation Therapy||0||
59730377|NCT01386385|75848784|FG003|NOT COMPLETED|Phase I 80mg: Consolidation Therapy||0||
59730378|NCT01386385|75848785|FG004|NOT COMPLETED|Phase I 80mg: Consolidation Therapy||0||
59730379|NCT01386385|75848786|FG005|NOT COMPLETED|Phase I 80mg: Consolidation Therapy||0||
59730380|NCT01386385|75848787|FG006|NOT COMPLETED|Phase I 80mg: Consolidation Therapy||0||
59730381|NCT01386385|75848788|FG007|NOT COMPLETED|Phase I 80mg: Consolidation Therapy||0||
59730382|NCT01386385|75848781|FG000|STARTED|Phase I 120mg: Concurrent CRT||0||
59730383|NCT01386385|75848782|FG001|STARTED|Phase I 120mg: Concurrent CRT||0||
59730384|NCT01386385|75848783|FG002|STARTED|Phase I 120mg: Concurrent CRT||0||
59730385|NCT01386385|75848784|FG003|STARTED|Phase I 120mg: Concurrent CRT||0||
59730386|NCT01386385|75848785|FG004|STARTED|Phase I 120mg: Concurrent CRT||6||
59730387|NCT01386385|75848786|FG005|STARTED|Phase I 120mg: Concurrent CRT||0||
59730388|NCT01386385|75848787|FG006|STARTED|Phase I 120mg: Concurrent CRT||0||
59730389|NCT01386385|75848788|FG007|STARTED|Phase I 120mg: Concurrent CRT||0||
59730390|NCT01386385|75848781|FG000|COMPLETED|Phase I 120mg: Concurrent CRT||0||
59730391|NCT01386385|75848782|FG001|COMPLETED|Phase I 120mg: Concurrent CRT||0||
59730392|NCT01386385|75848783|FG002|COMPLETED|Phase I 120mg: Concurrent CRT||0||
59730393|NCT01386385|75848784|FG003|COMPLETED|Phase I 120mg: Concurrent CRT||0||
59730394|NCT01386385|75848785|FG004|COMPLETED|Phase I 120mg: Concurrent CRT||5||
59730395|NCT01386385|75848786|FG005|COMPLETED|Phase I 120mg: Concurrent CRT||0||
59730396|NCT01386385|75848787|FG006|COMPLETED|Phase I 120mg: Concurrent CRT||0||
59730397|NCT01386385|75848788|FG007|COMPLETED|Phase I 120mg: Concurrent CRT||0||
59730398|NCT01386385|75848781|FG000|NOT COMPLETED|Phase I 120mg: Concurrent CRT||0||
59730399|NCT01386385|75848782|FG001|NOT COMPLETED|Phase I 120mg: Concurrent CRT||0||
59730400|NCT01386385|75848783|FG002|NOT COMPLETED|Phase I 120mg: Concurrent CRT||0||
59730401|NCT01386385|75848784|FG003|NOT COMPLETED|Phase I 120mg: Concurrent CRT||0||
59730402|NCT01386385|75848785|FG004|NOT COMPLETED|Phase I 120mg: Concurrent CRT||1||
59730403|NCT01386385|75848786|FG005|NOT COMPLETED|Phase I 120mg: Concurrent CRT||0||
59730404|NCT01386385|75848787|FG006|NOT COMPLETED|Phase I 120mg: Concurrent CRT||0||
59730405|NCT01386385|75848788|FG007|NOT COMPLETED|Phase I 120mg: Concurrent CRT||0||
59730406|NCT01386385|75848781|FG000|STARTED|Phase I 120mg: Consolidation Therapy||0||
59730407|NCT01386385|75848782|FG001|STARTED|Phase I 120mg: Consolidation Therapy||0||
59730408|NCT01386385|75848783|FG002|STARTED|Phase I 120mg: Consolidation Therapy||0||
59730409|NCT01386385|75848784|FG003|STARTED|Phase I 120mg: Consolidation Therapy||0||
59730410|NCT01386385|75848785|FG004|STARTED|Phase I 120mg: Consolidation Therapy||0||
59730411|NCT01386385|75848786|FG005|STARTED|Phase I 120mg: Consolidation Therapy||5||
59730412|NCT01386385|75848787|FG006|STARTED|Phase I 120mg: Consolidation Therapy||0||
59730413|NCT01386385|75848788|FG007|STARTED|Phase I 120mg: Consolidation Therapy||0||
59730414|NCT01386385|75848781|FG000|COMPLETED|Phase I 120mg: Consolidation Therapy||0||
59730415|NCT01386385|75848782|FG001|COMPLETED|Phase I 120mg: Consolidation Therapy||0||
59730416|NCT01386385|75848783|FG002|COMPLETED|Phase I 120mg: Consolidation Therapy||0||
59730417|NCT01386385|75848784|FG003|COMPLETED|Phase I 120mg: Consolidation Therapy||0||
59730418|NCT01386385|75848785|FG004|COMPLETED|Phase I 120mg: Consolidation Therapy||0||
59730419|NCT01386385|75848786|FG005|COMPLETED|Phase I 120mg: Consolidation Therapy||5||
59730420|NCT01386385|75848787|FG006|COMPLETED|Phase I 120mg: Consolidation Therapy||0||
59730421|NCT01386385|75848788|FG007|COMPLETED|Phase I 120mg: Consolidation Therapy||0||
59730422|NCT01386385|75848781|FG000|NOT COMPLETED|Phase I 120mg: Consolidation Therapy||0||
59730423|NCT01386385|75848782|FG001|NOT COMPLETED|Phase I 120mg: Consolidation Therapy||0||
59730424|NCT01386385|75848783|FG002|NOT COMPLETED|Phase I 120mg: Consolidation Therapy||0||
59730425|NCT01386385|75848784|FG003|NOT COMPLETED|Phase I 120mg: Consolidation Therapy||0||
59730426|NCT01386385|75848785|FG004|NOT COMPLETED|Phase I 120mg: Consolidation Therapy||0||
59730427|NCT01386385|75848786|FG005|NOT COMPLETED|Phase I 120mg: Consolidation Therapy||0||
59730428|NCT01386385|75848787|FG006|NOT COMPLETED|Phase I 120mg: Consolidation Therapy||0||
59730429|NCT01386385|75848788|FG007|NOT COMPLETED|Phase I 120mg: Consolidation Therapy||0||
59730430|NCT01386385|75848781|FG000|STARTED|Phase II Concurrent CRT||0||
59730431|NCT01386385|75848782|FG001|STARTED|Phase II Concurrent CRT||0||
59730432|NCT01386385|75848783|FG002|STARTED|Phase II Concurrent CRT||0||
59730433|NCT01386385|75848784|FG003|STARTED|Phase II Concurrent CRT||0||
59730434|NCT01386385|75848785|FG004|STARTED|Phase II Concurrent CRT||0||
59730435|NCT01386385|75848786|FG005|STARTED|Phase II Concurrent CRT||0||
59730436|NCT01386385|75848787|FG006|STARTED|Phase II Concurrent CRT||18||
59730437|NCT01386385|75848788|FG007|STARTED|Phase II Concurrent CRT||13||
59730438|NCT01386385|75848781|FG000|COMPLETED|Phase II Concurrent CRT||0||
59730439|NCT01386385|75848782|FG001|COMPLETED|Phase II Concurrent CRT||0||
59730440|NCT01386385|75848783|FG002|COMPLETED|Phase II Concurrent CRT||0||
59730441|NCT01386385|75848784|FG003|COMPLETED|Phase II Concurrent CRT||0||
59730442|NCT01386385|75848785|FG004|COMPLETED|Phase II Concurrent CRT||0||
59730443|NCT01386385|75848786|FG005|COMPLETED|Phase II Concurrent CRT||0||
59730444|NCT01386385|75848787|FG006|COMPLETED|Phase II Concurrent CRT||12||
59730445|NCT01386385|75848788|FG007|COMPLETED|Phase II Concurrent CRT||10||
59730446|NCT01386385|75848781|FG000|NOT COMPLETED|Phase II Concurrent CRT||0||
59730447|NCT01386385|75848782|FG001|NOT COMPLETED|Phase II Concurrent CRT||0||
59730448|NCT01386385|75848783|FG002|NOT COMPLETED|Phase II Concurrent CRT||0||
59730449|NCT01386385|75848784|FG003|NOT COMPLETED|Phase II Concurrent CRT||0||
59730450|NCT01386385|75848785|FG004|NOT COMPLETED|Phase II Concurrent CRT||0||
59730451|NCT01386385|75848786|FG005|NOT COMPLETED|Phase II Concurrent CRT||0||
59730452|NCT01386385|75848787|FG006|NOT COMPLETED|Phase II Concurrent CRT||6||
59730453|NCT01386385|75848788|FG007|NOT COMPLETED|Phase II Concurrent CRT||3||
59730454|NCT01386385|75848781|FG000|STARTED|Phase II: Consolidation Therapy||0||
59730455|NCT01386385|75848782|FG001|STARTED|Phase II: Consolidation Therapy||0||
59730456|NCT01386385|75848783|FG002|STARTED|Phase II: Consolidation Therapy||0||
59730457|NCT01386385|75848784|FG003|STARTED|Phase II: Consolidation Therapy||0||
59730458|NCT01386385|75848785|FG004|STARTED|Phase II: Consolidation Therapy||0||
59730459|NCT01386385|75848786|FG005|STARTED|Phase II: Consolidation Therapy||0||
59730460|NCT01386385|75848787|FG006|STARTED|Phase II: Consolidation Therapy||13||
59730461|NCT01386385|75848788|FG007|STARTED|Phase II: Consolidation Therapy||10||
59730462|NCT01386385|75848781|FG000|COMPLETED|Phase II: Consolidation Therapy||0||
59730463|NCT01386385|75848782|FG001|COMPLETED|Phase II: Consolidation Therapy||0||
59730464|NCT01386385|75848783|FG002|COMPLETED|Phase II: Consolidation Therapy||0||
59730465|NCT01386385|75848784|FG003|COMPLETED|Phase II: Consolidation Therapy||0||
59730466|NCT01386385|75848785|FG004|COMPLETED|Phase II: Consolidation Therapy||0||
59730467|NCT01386385|75848786|FG005|COMPLETED|Phase II: Consolidation Therapy||0||
59730468|NCT01386385|75848787|FG006|COMPLETED|Phase II: Consolidation Therapy||8||
59730469|NCT01386385|75848788|FG007|COMPLETED|Phase II: Consolidation Therapy||8||
59730470|NCT01386385|75848781|FG000|NOT COMPLETED|Phase II: Consolidation Therapy||0||
59730471|NCT01386385|75848782|FG001|NOT COMPLETED|Phase II: Consolidation Therapy||0||
59730472|NCT01386385|75848783|FG002|NOT COMPLETED|Phase II: Consolidation Therapy||0||
59730473|NCT01386385|75848784|FG003|NOT COMPLETED|Phase II: Consolidation Therapy||0||
59730474|NCT01386385|75848785|FG004|NOT COMPLETED|Phase II: Consolidation Therapy||0||
59730475|NCT01386385|75848786|FG005|NOT COMPLETED|Phase II: Consolidation Therapy||0||
59730476|NCT01386385|75848787|FG006|NOT COMPLETED|Phase II: Consolidation Therapy||5||
59730477|NCT01386385|75848788|FG007|NOT COMPLETED|Phase II: Consolidation Therapy||2||
59730478|NCT01371981|75848815|FG000|STARTED|Overall Study||580||
59730479|NCT01371981|75848816|FG001|STARTED|Overall Study||591||
59730480|NCT01371981|75848817|FG002|STARTED|Overall Study||12||
59730481|NCT01371981|75848818|FG003|STARTED|Overall Study||33||
59730482|NCT01371981|75848819|FG004|STARTED|Overall Study||47||
59730483|NCT01371981|75848820|FG005|STARTED|Overall Study||382||
59730484|NCT01371981|75848815|FG000|COMPLETED|Overall Study||396||
59730485|NCT01371981|75848816|FG001|COMPLETED|Overall Study||399||
59730486|NCT01371981|75848817|FG002|COMPLETED|Overall Study||6||
59730487|NCT01371981|75848818|FG003|COMPLETED|Overall Study||12||
59730488|NCT01371981|75848819|FG004|COMPLETED|Overall Study||15||
59730489|NCT01371981|75848820|FG005|COMPLETED|Overall Study||368||
59730490|NCT01371981|75848815|FG000|NOT COMPLETED|Overall Study||184||
59730491|NCT01371981|75848816|FG001|NOT COMPLETED|Overall Study||192||
59730492|NCT01371981|75848817|FG002|NOT COMPLETED|Overall Study||6||
59730493|NCT01371981|75848818|FG003|NOT COMPLETED|Overall Study||21||
59730494|NCT01371981|75848819|FG004|NOT COMPLETED|Overall Study||32||
59730495|NCT01371981|75848820|FG005|NOT COMPLETED|Overall Study||14||
59730496|NCT01274338|75848845|FG000|STARTED|Overall Study||511||
59730497|NCT01274338|75848846|FG001|STARTED|Overall Study||636||
59730498|NCT01274338|75848847|FG002|STARTED|Overall Study||523||
59730499|NCT01274338|75848848|FG003|STARTED|Overall Study||1||
59730500|NCT01274338|75848849|FG004|STARTED|Overall Study||1||
59730501|NCT01274338|75848850|FG005|STARTED|Overall Study||1||
59730502|NCT01274338|75848845|FG000|Received Treatment|Overall Study||503||
59730503|NCT01274338|75848846|FG001|Received Treatment|Overall Study||520||
59730504|NCT01274338|75848847|FG002|Received Treatment|Overall Study||516||
59730505|NCT01274338|75848848|FG003|Received Treatment|Overall Study||1||
59730506|NCT01274338|75848849|FG004|Received Treatment|Overall Study||1||
59730507|NCT01274338|75848850|FG005|Received Treatment|Overall Study||1||
59730508|NCT01274338|75848845|FG000|Data Available for the FACT-G and FACT-BRM Analyses|Overall Study||110||
59730509|NCT01274338|75848846|FG001|Data Available for the FACT-G and FACT-BRM Analyses|Overall Study||114||
59730510|NCT01274338|75848847|FG002|Data Available for the FACT-G and FACT-BRM Analyses|Overall Study||97||
59730511|NCT01274338|75848848|FG003|Data Available for the FACT-G and FACT-BRM Analyses|Overall Study||0||
59730512|NCT01274338|75848849|FG004|Data Available for the FACT-G and FACT-BRM Analyses|Overall Study||0||
59730513|NCT01274338|75848850|FG005|Data Available for the FACT-G and FACT-BRM Analyses|Overall Study||0||
59730514|NCT01274338|75848845|FG000|Data Available for FACIT-D Analysis|Overall Study||109||
59730515|NCT01274338|75848846|FG001|Data Available for FACIT-D Analysis|Overall Study||114||
59730516|NCT01274338|75848847|FG002|Data Available for FACIT-D Analysis|Overall Study||97||
59730517|NCT01274338|75848848|FG003|Data Available for FACIT-D Analysis|Overall Study||0||
59730518|NCT01274338|75848849|FG004|Data Available for FACIT-D Analysis|Overall Study||0||
59730519|NCT01274338|75848850|FG005|Data Available for FACIT-D Analysis|Overall Study||0||
59730520|NCT01274338|75848845|FG000|COMPLETED|Overall Study||108||
59730521|NCT01274338|75848846|FG001|COMPLETED|Overall Study||182||
59730522|NCT01274338|75848847|FG002|COMPLETED|Overall Study||198||
59730523|NCT01274338|75848848|FG003|COMPLETED|Overall Study||0||
59730524|NCT01274338|75848849|FG004|COMPLETED|Overall Study||0||
59730525|NCT01274338|75848850|FG005|COMPLETED|Overall Study||1||
59730526|NCT01274338|75848845|FG000|NOT COMPLETED|Overall Study||403||
59730527|NCT01274338|75848846|FG001|NOT COMPLETED|Overall Study||454||
59730528|NCT01274338|75848847|FG002|NOT COMPLETED|Overall Study||325||
59730529|NCT01274338|75848848|FG003|NOT COMPLETED|Overall Study||1||
59730530|NCT01274338|75848849|FG004|NOT COMPLETED|Overall Study||1||
59730531|NCT01274338|75848850|FG005|NOT COMPLETED|Overall Study||0||
59730532|NCT01272037|75848865|FG000|STARTED|Overall Study||2511||
59730533|NCT01272037|75848866|FG001|STARTED|Overall Study||2507||
59730534|NCT01272037|75848865|FG000|COMPLETED|Overall Study||1504||
59730535|NCT01272037|75848866|FG001|COMPLETED|Overall Study||1547||
59730536|NCT01272037|75848865|FG000|NOT COMPLETED|Overall Study||1007||
59730537|NCT01272037|75848866|FG001|NOT COMPLETED|Overall Study||960||
59730538|NCT01199575|75848872|FG000|STARTED|Overall Study||30||
59730539|NCT01199575|75848872|FG000|COMPLETED|Overall Study||25||
59730540|NCT01199575|75848872|FG000|NOT COMPLETED|Overall Study||5||
59730541|NCT01194570|75848879|FG000|STARTED|Overall Study||244||
59730542|NCT01194570|75848880|FG001|STARTED|Overall Study||488||
59730543|NCT01194570|75848879|FG000|COMPLETED|Overall Study||89||
59730544|NCT01194570|75848880|FG001|COMPLETED|Overall Study||218||
59730545|NCT01194570|75848879|FG000|NOT COMPLETED|Overall Study||155||
59730546|NCT01194570|75848880|FG001|NOT COMPLETED|Overall Study||270||
59730547|NCT01169337|75848893|FG000|STARTED|Overall Study||44||
59730548|NCT01169337|75848894|FG001|STARTED|Overall Study||90||
59730549|NCT01169337|75848895|FG002|STARTED|Overall Study||92||
59730550|NCT01169337|75848893|FG000|Received Treatment/Observation|Overall Study||44||
59730551|NCT01169337|75848894|FG001|Received Treatment/Observation|Overall Study||88||
59730552|NCT01169337|75848895|FG002|Received Treatment/Observation|Overall Study||86||
59730553|NCT01169337|75848893|FG000|COMPLETED|Overall Study||0||
59730554|NCT01169337|75848894|FG001|COMPLETED|Overall Study||0||
59730555|NCT01169337|75848895|FG002|COMPLETED|Overall Study||86||
59730556|NCT01169337|75848893|FG000|NOT COMPLETED|Overall Study||44||
59730557|NCT01169337|75848894|FG001|NOT COMPLETED|Overall Study||90||
59730558|NCT01169337|75848895|FG002|NOT COMPLETED|Overall Study||6||
59730559|NCT01167712|75848905|FG000|STARTED|Overall Study||346||
59730560|NCT01167712|75848906|FG001|STARTED|Overall Study||346||
59730561|NCT01167712|75848905|FG000|COMPLETED|Overall Study||346||
59730562|NCT01167712|75848906|FG001|COMPLETED|Overall Study||346||
59730563|NCT01167712|75848905|FG000|NOT COMPLETED|Overall Study||0||
59730564|NCT01167712|75848906|FG001|NOT COMPLETED|Overall Study||0||
59730565|NCT01081262|75848916|FG000|STARTED|Overall Study||13||
59730566|NCT01081262|75848917|FG001|STARTED|Overall Study||13||
59730567|NCT01081262|75848918|FG002|STARTED|Overall Study||13||
59730568|NCT01081262|75848919|FG003|STARTED|Overall Study||11||
59730569|NCT01081262|75848916|FG000|COMPLETED|Overall Study||13||
59730570|NCT01081262|75848917|FG001|COMPLETED|Overall Study||13||
59730571|NCT01081262|75848918|FG002|COMPLETED|Overall Study||13||
59730572|NCT01081262|75848919|FG003|COMPLETED|Overall Study||11||
59730573|NCT01081262|75848916|FG000|NOT COMPLETED|Overall Study||0||
59730574|NCT01081262|75848917|FG001|NOT COMPLETED|Overall Study||0||
59730575|NCT01081262|75848918|FG002|NOT COMPLETED|Overall Study||0||
59730576|NCT01081262|75848919|FG003|NOT COMPLETED|Overall Study||0||
59730577|NCT01064648|75848932|FG000|STARTED|Phase I Cohort1: Dose Level 1||7||
59730578|NCT01064648|75848933|FG001|STARTED|Phase I Cohort1: Dose Level 1||0||
59730579|NCT01064648|75848934|FG002|STARTED|Phase I Cohort1: Dose Level 1||0||
59730580|NCT01064648|75848935|FG003|STARTED|Phase I Cohort1: Dose Level 1||0||
59730581|NCT01064648|75848932|FG000|COMPLETED|Phase I Cohort1: Dose Level 1||0||
59730582|NCT01064648|75848933|FG001|COMPLETED|Phase I Cohort1: Dose Level 1||0||
59730583|NCT01064648|75848934|FG002|COMPLETED|Phase I Cohort1: Dose Level 1||0||
59730584|NCT01064648|75848935|FG003|COMPLETED|Phase I Cohort1: Dose Level 1||0||
59730585|NCT01064648|75848932|FG000|NOT COMPLETED|Phase I Cohort1: Dose Level 1||7||
59730586|NCT01064648|75848933|FG001|NOT COMPLETED|Phase I Cohort1: Dose Level 1||0||
59730587|NCT01064648|75848934|FG002|NOT COMPLETED|Phase I Cohort1: Dose Level 1||0||
59730588|NCT01064648|75848935|FG003|NOT COMPLETED|Phase I Cohort1: Dose Level 1||0||
59730589|NCT01064648|75848932|FG000|STARTED|Phase I Cohort 2: Dose Level 2||0||
59730590|NCT01064648|75848933|FG001|STARTED|Phase I Cohort 2: Dose Level 2||13||
59730591|NCT01064648|75848934|FG002|STARTED|Phase I Cohort 2: Dose Level 2||0||
59730592|NCT01064648|75848935|FG003|STARTED|Phase I Cohort 2: Dose Level 2||0||
59730593|NCT01064648|75848932|FG000|COMPLETED|Phase I Cohort 2: Dose Level 2||0||
59730594|NCT01064648|75848933|FG001|COMPLETED|Phase I Cohort 2: Dose Level 2||0||
59730595|NCT01064648|75848934|FG002|COMPLETED|Phase I Cohort 2: Dose Level 2||0||
59730596|NCT01064648|75848935|FG003|COMPLETED|Phase I Cohort 2: Dose Level 2||0||
59730597|NCT01064648|75848932|FG000|NOT COMPLETED|Phase I Cohort 2: Dose Level 2||0||
59730598|NCT01064648|75848933|FG001|NOT COMPLETED|Phase I Cohort 2: Dose Level 2||13||
59730599|NCT01064648|75848934|FG002|NOT COMPLETED|Phase I Cohort 2: Dose Level 2||0||
59730600|NCT01064648|75848935|FG003|NOT COMPLETED|Phase I Cohort 2: Dose Level 2||0||
59730601|NCT01064648|75848932|FG000|STARTED|Phase II||0||
59730602|NCT01064648|75848933|FG001|STARTED|Phase II||0||
59730603|NCT01064648|75848934|FG002|STARTED|Phase II||49||
59730604|NCT01064648|75848935|FG003|STARTED|Phase II||48||
59730605|NCT01064648|75848932|FG000|COMPLETED|Phase II||0||
59730606|NCT01064648|75848933|FG001|COMPLETED|Phase II||0||
59730607|NCT01064648|75848934|FG002|COMPLETED|Phase II||0||
59730608|NCT01064648|75848935|FG003|COMPLETED|Phase II||0||
59730609|NCT01064648|75848932|FG000|NOT COMPLETED|Phase II||0||
59730610|NCT01064648|75848933|FG001|NOT COMPLETED|Phase II||0||
59730611|NCT01064648|75848934|FG002|NOT COMPLETED|Phase II||49||
59730612|NCT01064648|75848935|FG003|NOT COMPLETED|Phase II||48||
59730613|NCT00980460|75848953|FG000|STARTED|Overall Study||8||
59730614|NCT00980460|75848954|FG001|STARTED|Overall Study||51||
59730615|NCT00980460|75848955|FG002|STARTED|Overall Study||105||
59730616|NCT00980460|75848956|FG003|STARTED|Overall Study||32||
59730617|NCT00980460|75848957|FG004|STARTED|Overall Study||40||
59730618|NCT00980460|75848953|FG000|COMPLETED|Overall Study||8||
59730619|NCT00980460|75848954|FG001|COMPLETED|Overall Study||47||
59730620|NCT00980460|75848955|FG002|COMPLETED|Overall Study||70||
59730621|NCT00980460|75848956|FG003|COMPLETED|Overall Study||14||
59730622|NCT00980460|75848957|FG004|COMPLETED|Overall Study||24||
59730623|NCT00980460|75848953|FG000|NOT COMPLETED|Overall Study||0||
59730624|NCT00980460|75848954|FG001|NOT COMPLETED|Overall Study||4||
59730625|NCT00980460|75848955|FG002|NOT COMPLETED|Overall Study||35||
59730626|NCT00980460|75848956|FG003|NOT COMPLETED|Overall Study||18||
59730627|NCT00980460|75848957|FG004|NOT COMPLETED|Overall Study||16||
59730628|NCT00977574|75848979|FG000|STARTED|Overall Study||116||
59730629|NCT00977574|75848980|FG001|STARTED|Overall Study||115||
59730630|NCT00977574|75848981|FG002|STARTED|Overall Study||118||
59730631|NCT00977574|75848979|FG000|COMPLETED|Overall Study||112||
59730632|NCT00977574|75848980|FG001|COMPLETED|Overall Study||113||
59730633|NCT00977574|75848981|FG002|COMPLETED|Overall Study||114||
59730634|NCT00977574|75848979|FG000|NOT COMPLETED|Overall Study||4||
59730635|NCT00977574|75848980|FG001|NOT COMPLETED|Overall Study||2||
59730636|NCT00977574|75848981|FG002|NOT COMPLETED|Overall Study||4||
59730637|NCT00972478|75848991|FG000|STARTED|Overall Study||11||
59730638|NCT00972478|75848992|FG001|STARTED|Overall Study||72||
59730639|NCT00972478|75848991|FG000|Eligible and Began Protocol Therapy|Overall Study||9||
59730640|NCT00972478|75848992|FG001|Eligible and Began Protocol Therapy|Overall Study||63||
59730641|NCT00972478|75848991|FG000|COMPLETED|Overall Study||4||
59730642|NCT00972478|75848992|FG001|COMPLETED|Overall Study||34||
59730643|NCT00972478|75848991|FG000|NOT COMPLETED|Overall Study||7||
59730644|NCT00972478|75848992|FG001|NOT COMPLETED|Overall Study||38||
59730645|NCT00861705|75849003|FG000|STARTED|Overall Study||115||
59730646|NCT00861705|75849004|FG001|STARTED|Overall Study||113||
59730647|NCT00861705|75849005|FG002|STARTED|Overall Study||113||
59730648|NCT00861705|75849006|FG003|STARTED|Overall Study||113||
59730649|NCT00861705|75849003|FG000|COMPLETED|Overall Study||108||
59730650|NCT00861705|75849004|FG001|COMPLETED|Overall Study||110||
59730651|NCT00861705|75849005|FG002|COMPLETED|Overall Study||113||
59730652|NCT00861705|75849006|FG003|COMPLETED|Overall Study||112||
59730653|NCT00861705|75849003|FG000|NOT COMPLETED|Overall Study||7||
59730654|NCT00861705|75849004|FG001|NOT COMPLETED|Overall Study||3||
59730655|NCT00861705|75849005|FG002|NOT COMPLETED|Overall Study||0||
59730656|NCT00861705|75849006|FG003|NOT COMPLETED|Overall Study||1||
59730657|NCT00843882|75849027|FG000|STARTED|Step 1||38||
59730658|NCT00843882|75849028|FG001|STARTED|Step 1||103||
59730659|NCT00843882|75849029|FG002|STARTED|Step 1||106||
59730660|NCT00843882|75849027|FG000|Treated Patients|Step 1||36||
59730661|NCT00843882|75849028|FG001|Treated Patients|Step 1||103||
59730662|NCT00843882|75849029|FG002|Treated Patients|Step 1||106||
59730663|NCT00843882|75849027|FG000|Evaluable Patients Included in Primary Analysis|Step 1||0||
59730664|NCT00843882|75849028|FG001|Evaluable Patients Included in Primary Analysis|Step 1||96||
59730665|NCT00843882|75849029|FG002|Evaluable Patients Included in Primary Analysis|Step 1||99||
59730666|NCT00843882|75849027|FG000|Patients With Cytogenetic Response Data Available|Step 1||0||
59730667|NCT00843882|75849028|FG001|Patients With Cytogenetic Response Data Available|Step 1||55||
59730668|NCT00843882|75849029|FG002|Patients With Cytogenetic Response Data Available|Step 1||51||
59730669|NCT00843882|75849027|FG000|COMPLETED|Step 1||6||
59730670|NCT00843882|75849028|FG001|COMPLETED|Step 1||48||
59730671|NCT00843882|75849029|FG002|COMPLETED|Step 1||41||
59730672|NCT00843882|75849027|FG000|NOT COMPLETED|Step 1||32||
59730673|NCT00843882|75849028|FG001|NOT COMPLETED|Step 1||55||
59730674|NCT00843882|75849029|FG002|NOT COMPLETED|Step 1||65||
59730675|NCT00843882|75849027|FG000|STARTED|Step 2 (Cross-over to Arm B)|All patients in Arm A that did not achieve major erythroid response (MER) were offered to receive combined treatment in Step 2.|7||
59730676|NCT00843882|75849028|FG001|STARTED|Step 2 (Cross-over to Arm B)|All patients in Arm A that did not achieve major erythroid response (MER) were offered to receive combined treatment in Step 2.|46||
59730677|NCT00843882|75849029|FG002|STARTED|Step 2 (Cross-over to Arm B)|Only patients in Arm A that did not achieve major erythroid response (MER) were offered to receive combined treatment in Step 2.|0||
59730678|NCT00843882|75849027|FG000|Evaluable Patients Included in Primary Analysis|Step 2 (Cross-over to Arm B)||7||
59730679|NCT00843882|75849028|FG001|Evaluable Patients Included in Primary Analysis|Step 2 (Cross-over to Arm B)||37||
59730680|NCT00843882|75849029|FG002|Evaluable Patients Included in Primary Analysis|Step 2 (Cross-over to Arm B)||0||
59730681|NCT00843882|75849027|FG000|COMPLETED|Step 2 (Cross-over to Arm B)||3||
59730682|NCT00843882|75849028|FG001|COMPLETED|Step 2 (Cross-over to Arm B)||20||
59730683|NCT00843882|75849029|FG002|COMPLETED|Step 2 (Cross-over to Arm B)||0||
59730684|NCT00843882|75849027|FG000|NOT COMPLETED|Step 2 (Cross-over to Arm B)||4||
59730685|NCT00843882|75849028|FG001|NOT COMPLETED|Step 2 (Cross-over to Arm B)||26||
59730686|NCT00843882|75849029|FG002|NOT COMPLETED|Step 2 (Cross-over to Arm B)||0||
59730687|NCT00792948|75849042|FG000|STARTED|Overall Study|Patients registered to induction/consolidation step|97||
59730688|NCT00792948|75849042|FG000|COMPLETED|Overall Study|Patients who completed induction/consolidation step|69||
59730689|NCT00792948|75849042|FG000|NOT COMPLETED|Overall Study||28||
59730690|NCT00769379|75849051|FG000|STARTED|Overall Study||1008||
59730691|NCT00769379|75849052|FG001|STARTED|Overall Study||1006||
59730692|NCT00769379|75849051|FG000|COMPLETED|Overall Study||1005||
59730693|NCT00769379|75849052|FG001|COMPLETED|Overall Study||993||
59730694|NCT00769379|75849051|FG000|NOT COMPLETED|Overall Study||3||
59730695|NCT00769379|75849052|FG001|NOT COMPLETED|Overall Study||13||
59730696|NCT00658814|75849060|FG000|STARTED|Remission Induction Chemotherapy||83||
59730697|NCT00658814|75849061|FG001|STARTED|Remission Induction Chemotherapy||59||
59730698|NCT00658814|75849060|FG000|Eligible|Remission Induction Chemotherapy||82||
59730699|NCT00658814|75849061|FG001|Eligible|Remission Induction Chemotherapy||57||
59730700|NCT00658814|75849060|FG000|Eligible and Began Protocol Therapy|Remission Induction Chemotherapy||79||
59730701|NCT00658814|75849061|FG001|Eligible and Began Protocol Therapy|Remission Induction Chemotherapy||54||
59730702|NCT00658814|75849060|FG000|COMPLETED|Remission Induction Chemotherapy||75||
59730703|NCT00658814|75849061|FG001|COMPLETED|Remission Induction Chemotherapy||41||
59730704|NCT00658814|75849060|FG000|NOT COMPLETED|Remission Induction Chemotherapy||8||
59730705|NCT00658814|75849061|FG001|NOT COMPLETED|Remission Induction Chemotherapy||18||
59730706|NCT00658814|75849060|FG000|STARTED|Consolidation Therapy||24||
59730707|NCT00658814|75849061|FG001|STARTED|Consolidation Therapy||13||
59730708|NCT00658814|75849060|FG000|Eligible|Consolidation Therapy||22||
59730709|NCT00658814|75849061|FG001|Eligible|Consolidation Therapy||11||
59730710|NCT00658814|75849060|FG000|COMPLETED|Consolidation Therapy||22||
59730711|NCT00658814|75849061|FG001|COMPLETED|Consolidation Therapy||10||
59730712|NCT00658814|75849060|FG000|NOT COMPLETED|Consolidation Therapy||2||
59730713|NCT00658814|75849061|FG001|NOT COMPLETED|Consolidation Therapy||3||
59730714|NCT00658814|75849060|FG000|STARTED|Maintenance Therapy||20||
59730715|NCT00658814|75849061|FG001|STARTED|Maintenance Therapy||8||
59730716|NCT00658814|75849060|FG000|Eligible|Maintenance Therapy||19||
59730717|NCT00658814|75849061|FG001|Eligible|Maintenance Therapy||8||
59730718|NCT00658814|75849060|FG000|COMPLETED|Maintenance Therapy||17||
59730719|NCT00658814|75849061|FG001|COMPLETED|Maintenance Therapy||7||
59730720|NCT00658814|75849060|FG000|NOT COMPLETED|Maintenance Therapy||3||
59730721|NCT00658814|75849061|FG001|NOT COMPLETED|Maintenance Therapy||1||
59730722|NCT00644228|75849073|FG000|STARTED|Randomization & Eligibility||261||
59730723|NCT00644228|75849074|FG001|STARTED|Randomization & Eligibility||264||
59730724|NCT00644228|75849073|FG000|Eligible and Analyzable|Randomization & Eligibility||229|"All patients who were consented and did not withdraw consent prior to treatment are Analyzable."|
59730725|NCT00644228|75849074|FG001|Eligible and Analyzable|Randomization & Eligibility||242|"All patients who were consented and did not withdraw consent prior to treatment are Analyzable."|
59730726|NCT00644228|75849073|FG000|COMPLETED|Randomization & Eligibility||229|"Completed does not apply to this study period."|
59730727|NCT00644228|75849074|FG001|COMPLETED|Randomization & Eligibility||242|"Completed does not apply to this study period."|
59730728|NCT00644228|75849073|FG000|NOT COMPLETED|Randomization & Eligibility||32||
59730729|NCT00644228|75849074|FG001|NOT COMPLETED|Randomization & Eligibility||22||
59730730|NCT00644228|75849073|FG000|STARTED|Induction Therapy||229||
59730731|NCT00644228|75849074|FG001|STARTED|Induction Therapy||242||
59730732|NCT00644228|75849073|FG000|COMPLETED|Induction Therapy||146||
59730733|NCT00644228|75849074|FG001|COMPLETED|Induction Therapy||137||
59730734|NCT00644228|75849073|FG000|NOT COMPLETED|Induction Therapy||83||
59730735|NCT00644228|75849074|FG001|NOT COMPLETED|Induction Therapy||105||
59730736|NCT00644228|75849073|FG000|STARTED|Maintenance|3 patients who completed induction did not continue on to maintenance due to refusal (1), other (2).|143||
59730737|NCT00644228|75849074|FG001|STARTED|Maintenance|2 patients who completed induction did not continue on to maintenance due to other (2).|135||
59730738|NCT00644228|75849073|FG000|COMPLETED|Maintenance||0|"Patients were treated until progression or removal/refusal. Completed does not apply."|
59730739|NCT00644228|75849074|FG001|COMPLETED|Maintenance||0|"Patients were treated until progression or removal/refusal. Completed does not apply."|
59730740|NCT00644228|75849073|FG000|NOT COMPLETED|Maintenance||143||
59730741|NCT00644228|75849074|FG001|NOT COMPLETED|Maintenance||135||
59730742|NCT00588770|75849082|FG000|STARTED|Overall Study||200||
59730743|NCT00588770|75849083|FG001|STARTED|Overall Study||203||
59730744|NCT00588770|75849082|FG000|Eligible|Overall Study||188||
59730745|NCT00588770|75849083|FG001|Eligible|Overall Study||183||
59730746|NCT00588770|75849082|FG000|Start Protocol Therapy|Overall Study||200||
59730747|NCT00588770|75849083|FG001|Start Protocol Therapy|Overall Study||194||
59730748|NCT00588770|75849082|FG000|COMPLETED|Overall Study||41||
59730749|NCT00588770|75849083|FG001|COMPLETED|Overall Study||3||
59730750|NCT00588770|75849082|FG000|NOT COMPLETED|Overall Study||159||
59730751|NCT00588770|75849083|FG001|NOT COMPLETED|Overall Study||200||
59730752|NCT00433511|75849092|FG000|STARTED|Step 1||1000||
59730753|NCT00433511|75849093|FG001|STARTED|Step 1||1986||
59730754|NCT00433511|75849094|FG002|STARTED|Step 1||2008||
59730755|NCT00433511|75849092|FG000|Patients Who Received Treatment|Step 1||972||
59730756|NCT00433511|75849093|FG001|Patients Who Received Treatment|Step 1||1922||
59730757|NCT00433511|75849094|FG002|Patients Who Received Treatment|Step 1||1942||
59730758|NCT00433511|75849092|FG000|Patients in Genetic Ancestry Analysis|Step 1||575||
59730759|NCT00433511|75849093|FG001|Patients in Genetic Ancestry Analysis|Step 1||1126||
59730760|NCT00433511|75849094|FG002|Patients in Genetic Ancestry Analysis|Step 1||1158||
59730761|NCT00433511|75849092|FG000|COMPLETED|Step 1||864||
59730762|NCT00433511|75849093|FG001|COMPLETED|Step 1||1601||
59730763|NCT00433511|75849094|FG002|COMPLETED|Step 1||1618||
59730764|NCT00433511|75849092|FG000|NOT COMPLETED|Step 1||136||
59730765|NCT00433511|75849093|FG001|NOT COMPLETED|Step 1||385||
59730766|NCT00433511|75849094|FG002|NOT COMPLETED|Step 1||390||
59730767|NCT00433511|75849092|FG000|STARTED|Step 2 (Arm D)|Only Arm C patients at Step 1 who did not end protocol therapy early were eligible for Step 2, Arm D|0||
59730768|NCT00433511|75849093|FG001|STARTED|Step 2 (Arm D)|Only Arm C patients at Step 1 who did not end protocol therapy early were eligible for Step 2, Arm D|0||
59730769|NCT00433511|75849094|FG002|STARTED|Step 2 (Arm D)|Only Arm C patients at Step 1 who did not end protocol therapy early were eligible for Step 2, Arm D|1316||
59730770|NCT00433511|75849092|FG000|Patients Who Received Treatment|Step 2 (Arm D)||0||
59730771|NCT00433511|75849093|FG001|Patients Who Received Treatment|Step 2 (Arm D)||0||
59730772|NCT00433511|75849094|FG002|Patients Who Received Treatment|Step 2 (Arm D)||1168||
59730773|NCT00433511|75849092|FG000|COMPLETED|Step 2 (Arm D)||0||
59730774|NCT00433511|75849093|FG001|COMPLETED|Step 2 (Arm D)||0||
59730775|NCT00433511|75849094|FG002|COMPLETED|Step 2 (Arm D)||825||
59730776|NCT00433511|75849092|FG000|NOT COMPLETED|Step 2 (Arm D)||0||
59730777|NCT00433511|75849093|FG001|NOT COMPLETED|Step 2 (Arm D)||0||
59730778|NCT00433511|75849094|FG002|NOT COMPLETED|Step 2 (Arm D)||491||
59730779|NCT00408005|75849107|FG000|STARTED|Induction||1596||
59730780|NCT00408005|75849108|FG001|STARTED|Induction||299||
59730781|NCT00408005|75849109|FG002|STARTED|Induction||0||
59730782|NCT00408005|75849110|FG003|STARTED|Induction||0||
59730783|NCT00408005|75849111|FG004|STARTED|Induction||0||
59730784|NCT00408005|75849112|FG005|STARTED|Induction||0||
59730785|NCT00408005|75849113|FG006|STARTED|Induction||0||
59730786|NCT00408005|75849114|FG007|STARTED|Induction||0||
59730787|NCT00408005|75849107|FG000|COMPLETED|Induction||1189||
59730788|NCT00408005|75849108|FG001|COMPLETED|Induction||205||
59730789|NCT00408005|75849109|FG002|COMPLETED|Induction||0||
59730790|NCT00408005|75849110|FG003|COMPLETED|Induction||0||
59730791|NCT00408005|75849111|FG004|COMPLETED|Induction||0||
59730792|NCT00408005|75849112|FG005|COMPLETED|Induction||0||
59730793|NCT00408005|75849113|FG006|COMPLETED|Induction||0||
59730794|NCT00408005|75849114|FG007|COMPLETED|Induction||0||
59730795|NCT00408005|75849107|FG000|NOT COMPLETED|Induction||407||
59730796|NCT00408005|75849108|FG001|NOT COMPLETED|Induction||94||
59730797|NCT00408005|75849109|FG002|NOT COMPLETED|Induction||0||
59730798|NCT00408005|75849110|FG003|NOT COMPLETED|Induction||0||
59730799|NCT00408005|75849111|FG004|NOT COMPLETED|Induction||0||
59730800|NCT00408005|75849112|FG005|NOT COMPLETED|Induction||0||
59730801|NCT00408005|75849113|FG006|NOT COMPLETED|Induction||0||
59730802|NCT00408005|75849114|FG007|NOT COMPLETED|Induction||0||
59730803|NCT00408005|75849107|FG000|STARTED|Post Induction Therapy by Tx Assignment||0||
59730804|NCT00408005|75849108|FG001|STARTED|Post Induction Therapy by Tx Assignment||0||
59730805|NCT00408005|75849109|FG002|STARTED|Post Induction Therapy by Tx Assignment||372||
59730806|NCT00408005|75849110|FG003|STARTED|Post Induction Therapy by Tx Assignment||147||
59730807|NCT00408005|75849111|FG004|STARTED|Post Induction Therapy by Tx Assignment||451||
59730808|NCT00408005|75849112|FG005|STARTED|Post Induction Therapy by Tx Assignment||219||
59730809|NCT00408005|75849113|FG006|STARTED|Post Induction Therapy by Tx Assignment||143||
59730810|NCT00408005|75849114|FG007|STARTED|Post Induction Therapy by Tx Assignment||62||
59730811|NCT00408005|75849107|FG000|Low Risk|Post Induction Therapy by Tx Assignment||0||
59730812|NCT00408005|75849108|FG001|Low Risk|Post Induction Therapy by Tx Assignment||0||
59730813|NCT00408005|75849109|FG002|Low Risk|Post Induction Therapy by Tx Assignment||217||
59730814|NCT00408005|75849110|FG003|Low Risk|Post Induction Therapy by Tx Assignment||0||
59730815|NCT00408005|75849111|FG004|Low Risk|Post Induction Therapy by Tx Assignment||55||
59730816|NCT00408005|75849112|FG005|Low Risk|Post Induction Therapy by Tx Assignment||0||
59730817|NCT00408005|75849113|FG006|Low Risk|Post Induction Therapy by Tx Assignment||0||
59730818|NCT00408005|75849114|FG007|Low Risk|Post Induction Therapy by Tx Assignment||0||
59730819|NCT00408005|75849107|FG000|Intermediate Risk|Post Induction Therapy by Tx Assignment||0||
59730820|NCT00408005|75849108|FG001|Intermediate Risk|Post Induction Therapy by Tx Assignment||0||
59730821|NCT00408005|75849109|FG002|Intermediate Risk|Post Induction Therapy by Tx Assignment||99||
59730822|NCT00408005|75849110|FG003|Intermediate Risk|Post Induction Therapy by Tx Assignment||95||
59730823|NCT00408005|75849111|FG004|Intermediate Risk|Post Induction Therapy by Tx Assignment||257||
59730824|NCT00408005|75849112|FG005|Intermediate Risk|Post Induction Therapy by Tx Assignment||93||
59730825|NCT00408005|75849113|FG006|Intermediate Risk|Post Induction Therapy by Tx Assignment||0||
59730826|NCT00408005|75849114|FG007|Intermediate Risk|Post Induction Therapy by Tx Assignment||0||
59730827|NCT00408005|75849107|FG000|High Risk|Post Induction Therapy by Tx Assignment||0||
59730828|NCT00408005|75849108|FG001|High Risk|Post Induction Therapy by Tx Assignment||0||
59730829|NCT00408005|75849109|FG002|High Risk|Post Induction Therapy by Tx Assignment||56||
59730830|NCT00408005|75849110|FG003|High Risk|Post Induction Therapy by Tx Assignment||52||
59730831|NCT00408005|75849111|FG004|High Risk|Post Induction Therapy by Tx Assignment||55||
59730832|NCT00408005|75849112|FG005|High Risk|Post Induction Therapy by Tx Assignment||52||
59730833|NCT00408005|75849113|FG006|High Risk|Post Induction Therapy by Tx Assignment||0||
59730834|NCT00408005|75849114|FG007|High Risk|Post Induction Therapy by Tx Assignment||0||
59730835|NCT00408005|75849107|FG000|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||0||
59730836|NCT00408005|75849108|FG001|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||0||
59730837|NCT00408005|75849109|FG002|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||0||
59730838|NCT00408005|75849110|FG003|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||0||
59730839|NCT00408005|75849111|FG004|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||84||
59730840|NCT00408005|75849112|FG005|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||31||
59730841|NCT00408005|75849113|FG006|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||0||
59730842|NCT00408005|75849114|FG007|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||0||
59730843|NCT00408005|75849107|FG000|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0||
59730844|NCT00408005|75849108|FG001|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0||
59730845|NCT00408005|75849109|FG002|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0||
59730846|NCT00408005|75849110|FG003|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0||
59730847|NCT00408005|75849111|FG004|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0||
59730848|NCT00408005|75849112|FG005|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||43||
59730849|NCT00408005|75849113|FG006|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0||
59730850|NCT00408005|75849114|FG007|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0||
59730851|NCT00408005|75849107|FG000|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0||
59730852|NCT00408005|75849108|FG001|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0||
59730853|NCT00408005|75849109|FG002|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0||
59730854|NCT00408005|75849110|FG003|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0||
59730855|NCT00408005|75849111|FG004|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0||
59730856|NCT00408005|75849112|FG005|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0||
59730857|NCT00408005|75849113|FG006|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||82||
59730858|NCT00408005|75849114|FG007|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0||
59730859|NCT00408005|75849107|FG000|T-LLy High Risk|Post Induction Therapy by Tx Assignment||0||
59730860|NCT00408005|75849108|FG001|T-LLy High Risk|Post Induction Therapy by Tx Assignment||0||
59730861|NCT00408005|75849109|FG002|T-LLy High Risk|Post Induction Therapy by Tx Assignment||0||
59730862|NCT00408005|75849110|FG003|T-LLy High Risk|Post Induction Therapy by Tx Assignment||0||
59730863|NCT00408005|75849111|FG004|T-LLy High Risk|Post Induction Therapy by Tx Assignment||0||
59730864|NCT00408005|75849112|FG005|T-LLy High Risk|Post Induction Therapy by Tx Assignment||0||
59730865|NCT00408005|75849113|FG006|T-LLy High Risk|Post Induction Therapy by Tx Assignment||61||
59730866|NCT00408005|75849114|FG007|T-LLy High Risk|Post Induction Therapy by Tx Assignment||60||
59730867|NCT00408005|75849107|FG000|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0||
59730868|NCT00408005|75849108|FG001|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0||
59730869|NCT00408005|75849109|FG002|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0||
59730870|NCT00408005|75849110|FG003|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0||
59730871|NCT00408005|75849111|FG004|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0||
59730872|NCT00408005|75849112|FG005|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0||
59730873|NCT00408005|75849113|FG006|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0||
59730874|NCT00408005|75849114|FG007|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||2||
59730875|NCT00408005|75849107|FG000|COMPLETED|Post Induction Therapy by Tx Assignment||0||
59730876|NCT00408005|75849108|FG001|COMPLETED|Post Induction Therapy by Tx Assignment||0||
59730877|NCT00408005|75849109|FG002|COMPLETED|Post Induction Therapy by Tx Assignment||287||
59730878|NCT00408005|75849110|FG003|COMPLETED|Post Induction Therapy by Tx Assignment||103||
59730879|NCT00408005|75849111|FG004|COMPLETED|Post Induction Therapy by Tx Assignment||319||
59730880|NCT00408005|75849112|FG005|COMPLETED|Post Induction Therapy by Tx Assignment||118||
59730881|NCT00408005|75849113|FG006|COMPLETED|Post Induction Therapy by Tx Assignment||115||
59730882|NCT00408005|75849114|FG007|COMPLETED|Post Induction Therapy by Tx Assignment||48||
59730883|NCT00408005|75849107|FG000|NOT COMPLETED|Post Induction Therapy by Tx Assignment||0||
59730884|NCT00408005|75849108|FG001|NOT COMPLETED|Post Induction Therapy by Tx Assignment||0||
59730885|NCT00408005|75849109|FG002|NOT COMPLETED|Post Induction Therapy by Tx Assignment||85||
59730886|NCT00408005|75849110|FG003|NOT COMPLETED|Post Induction Therapy by Tx Assignment||44||
59730887|NCT00408005|75849111|FG004|NOT COMPLETED|Post Induction Therapy by Tx Assignment||132||
59730888|NCT00408005|75849112|FG005|NOT COMPLETED|Post Induction Therapy by Tx Assignment||101||
59730889|NCT00408005|75849113|FG006|NOT COMPLETED|Post Induction Therapy by Tx Assignment||28||
59730890|NCT00408005|75849114|FG007|NOT COMPLETED|Post Induction Therapy by Tx Assignment||14||
59730891|NCT00324805|75849136|FG000|STARTED|Overall Study||749||
59730892|NCT00324805|75849137|FG001|STARTED|Overall Study||752||
59730893|NCT00324805|75849136|FG000|Started Assigned Therapy|Overall Study||737||
59730894|NCT00324805|75849137|FG001|Started Assigned Therapy|Overall Study||735||
59730895|NCT00324805|75849136|FG000|COMPLETED|Overall Study||599||
59730896|NCT00324805|75849137|FG001|COMPLETED|Overall Study||269||
59730897|NCT00324805|75849136|FG000|NOT COMPLETED|Overall Study||150||
59730898|NCT00324805|75849137|FG001|NOT COMPLETED|Overall Study||483||
59730899|NCT00310180|75849147|FG000|STARTED|Overall Study||1629||
59730900|NCT00310180|75849148|FG001|STARTED|Overall Study||3458||
59730901|NCT00310180|75849149|FG002|STARTED|Overall Study||3449||
59730902|NCT00310180|75849150|FG003|STARTED|Overall Study||1737||
59730903|NCT00310180|75849147|FG000|No On-study Data|Overall Study||0||
59730904|NCT00310180|75849148|FG001|No On-study Data|Overall Study||2||
59730905|NCT00310180|75849149|FG002|No On-study Data|Overall Study||10||
59730906|NCT00310180|75849150|FG003|No On-study Data|Overall Study||172||
59730907|NCT00310180|75849147|FG000|Ineligible|Overall Study||3||
59730908|NCT00310180|75849148|FG001|Ineligible|Overall Study||4||
59730909|NCT00310180|75849149|FG002|Ineligible|Overall Study||6||
59730910|NCT00310180|75849150|FG003|Ineligible|Overall Study||7||
59730911|NCT00310180|75849147|FG000|No Follow-up Data|Overall Study||7||
59730912|NCT00310180|75849148|FG001|No Follow-up Data|Overall Study||55||
59730913|NCT00310180|75849149|FG002|No Follow-up Data|Overall Study||131||
59730914|NCT00310180|75849150|FG003|No Follow-up Data|Overall Study||245||
59730915|NCT00310180|75849147|FG000|COMPLETED|Overall Study||1619|Patients analyzed in the main analysis|
59730916|NCT00310180|75849148|FG001|COMPLETED|Overall Study||3399|Patients analyzed in the main analysis|
59730917|NCT00310180|75849149|FG002|COMPLETED|Overall Study||3312|Patients analyzed in the main analysis|
59730918|NCT00310180|75849150|FG003|COMPLETED|Overall Study||1389|Patients analyzed in the main analysis|
59730919|NCT00310180|75849147|FG000|NOT COMPLETED|Overall Study||10||
59730920|NCT00310180|75849148|FG001|NOT COMPLETED|Overall Study||59||
59730921|NCT00310180|75849149|FG002|NOT COMPLETED|Overall Study||137||
59730922|NCT00310180|75849150|FG003|NOT COMPLETED|Overall Study||348||
59730923|NCT00248040|75849163|FG000|STARTED|Overall Study||25||
59730924|NCT00248040|75849164|FG001|STARTED|Overall Study||23||
59730925|NCT00248040|75849165|FG002|STARTED|Overall Study||26||
59730926|NCT00248040|75849163|FG000|COMPLETED|Overall Study||22||
59730927|NCT00248040|75849164|FG001|COMPLETED|Overall Study||22||
59730928|NCT00248040|75849165|FG002|COMPLETED|Overall Study||22||
59730929|NCT00248040|75849163|FG000|NOT COMPLETED|Overall Study||3||
59730930|NCT00248040|75849164|FG001|NOT COMPLETED|Overall Study||1||
59730931|NCT00248040|75849165|FG002|NOT COMPLETED|Overall Study||4||
59730932|NCT00976716|75849174|FG000|STARTED|Overall Study||80||
59730933|NCT00976716|75849174|FG000|COMPLETED|Overall Study||79||
59730934|NCT00976716|75849174|FG000|NOT COMPLETED|Overall Study||1||
59730935|NCT00973674|75849181|FG000|STARTED|Overall Study||24||
59730936|NCT00973674|75849182|FG001|STARTED|Overall Study||26||
59730937|NCT00973674|75849181|FG000|COMPLETED|Overall Study||22||
59730938|NCT00973674|75849182|FG001|COMPLETED|Overall Study||26||
59730939|NCT00973674|75849181|FG000|NOT COMPLETED|Overall Study||2||
59730940|NCT00973674|75849182|FG001|NOT COMPLETED|Overall Study||0||
59730941|NCT00819091|75849191|FG000|STARTED|Overall Study||84||
59730942|NCT00819091|75849192|FG001|STARTED|Overall Study||161||
59730943|NCT00819091|75849191|FG000|COMPLETED|Overall Study||77||
59730944|NCT00819091|75849192|FG001|COMPLETED|Overall Study||151||
59730945|NCT00819091|75849191|FG000|NOT COMPLETED|Overall Study||7||
59730946|NCT00819091|75849192|FG001|NOT COMPLETED|Overall Study||10||
59730947|NCT00973362|75849200|FG000|STARTED|Baseline Evaluation||11644||
59730948|NCT00973362|75849201|FG001|STARTED|Baseline Evaluation||1252||
59730949|NCT00973362|75849200|FG000|Evaluable for Analysis|Baseline Evaluation||10871||
59730950|NCT00973362|75849201|FG001|Evaluable for Analysis|Baseline Evaluation||958||
59730951|NCT00973362|75849200|FG000|Conclusive Disease Status|Baseline Evaluation||819||
59730952|NCT00973362|75849201|FG001|Conclusive Disease Status|Baseline Evaluation||939||
59730953|NCT00973362|75849200|FG000|COMPLETED|Baseline Evaluation||10871||
59730954|NCT00973362|75849201|FG001|COMPLETED|Baseline Evaluation||1029||
59730955|NCT00973362|75849200|FG000|NOT COMPLETED|Baseline Evaluation||773||
59730956|NCT00973362|75849201|FG001|NOT COMPLETED|Baseline Evaluation||223||
59730957|NCT00973362|75849200|FG000|STARTED|3-Year Follow-up||10871||
59730958|NCT00973362|75849201|FG001|STARTED|3-Year Follow-up|ASC-US study arm did not have a follow-up period|0||
59730959|NCT00973362|75849200|FG000|COMPLETED|3-Year Follow-up||10854||
59730960|NCT00973362|75849201|FG001|COMPLETED|3-Year Follow-up||0||
59730961|NCT00973362|75849200|FG000|NOT COMPLETED|3-Year Follow-up||17||
59730962|NCT00973362|75849201|FG001|NOT COMPLETED|3-Year Follow-up||0||
59730963|NCT00819013|75849214|FG000|STARTED|Overall Study||22||
59730964|NCT00819013|75849215|FG001|STARTED|Overall Study||23||
59730965|NCT00819013|75849216|FG002|STARTED|Overall Study||21||
59730966|NCT00819013|75849217|FG003|STARTED|Overall Study||21||
59730967|NCT00819013|75849214|FG000|COMPLETED|Overall Study||19||
59730968|NCT00819013|75849215|FG001|COMPLETED|Overall Study||22||
59730969|NCT00819013|75849216|FG002|COMPLETED|Overall Study||16||
59730970|NCT00819013|75849217|FG003|COMPLETED|Overall Study||17||
59730971|NCT00819013|75849214|FG000|NOT COMPLETED|Overall Study||3||
59730972|NCT00819013|75849215|FG001|NOT COMPLETED|Overall Study||1||
59730973|NCT00819013|75849216|FG002|NOT COMPLETED|Overall Study||5||
59730974|NCT00819013|75849217|FG003|NOT COMPLETED|Overall Study||4||
59730975|NCT00976560|75849229|FG000|STARTED|Overall Study||64||
59730976|NCT00976560|75849230|FG001|STARTED|Overall Study||64||
59730977|NCT00976560|75849229|FG000|COMPLETED|Overall Study||50||
59730978|NCT00976560|75849230|FG001|COMPLETED|Overall Study||51||
59730979|NCT00976560|75849229|FG000|NOT COMPLETED|Overall Study||14||
59730980|NCT00976560|75849230|FG001|NOT COMPLETED|Overall Study||13||
59730981|NCT00976482|75849236|FG000|STARTED|Overall Study||1745||
59730982|NCT00976482|75849236|FG000|Eligible for Last Follow up|Overall Study||1487||
59730983|NCT00976482|75849236|FG000|COMPLETED|Overall Study||1486||
59730984|NCT00976482|75849236|FG000|NOT COMPLETED|Overall Study||259||
59730985|NCT00975156|75849242|FG000|STARTED|Overall Study||11||
59730986|NCT00975156|75849243|FG001|STARTED|Overall Study||10||
59730987|NCT00975156|75849242|FG000|COMPLETED|Overall Study||11||
59730988|NCT00975156|75849243|FG001|COMPLETED|Overall Study||9||
59730989|NCT00975156|75849242|FG000|NOT COMPLETED|Overall Study||0||
59730990|NCT00975156|75849243|FG001|NOT COMPLETED|Overall Study||1||
59730991|NCT00810043|75849255|FG000|STARTED|Overall Study||57||
59730992|NCT00810043|75849256|FG001|STARTED|Overall Study||55||
59730993|NCT00810043|75849257|FG002|STARTED|Overall Study||8||
59730994|NCT00810043|75849255|FG000|COMPLETED|Overall Study||53||
59730995|NCT00810043|75849256|FG001|COMPLETED|Overall Study||54||
59730996|NCT00810043|75849257|FG002|COMPLETED|Overall Study||0||
59730997|NCT00810043|75849255|FG000|NOT COMPLETED|Overall Study||4||
59730998|NCT00810043|75849256|FG001|NOT COMPLETED|Overall Study||1||
59730999|NCT00810043|75849257|FG002|NOT COMPLETED|Overall Study||8||
59731000|NCT01120184|75849269|FG000|STARTED|Overall Study||365||
59731001|NCT01120184|75849270|FG001|STARTED|Overall Study||367||
59731002|NCT01120184|75849271|FG002|STARTED|Overall Study||363||
59731003|NCT01120184|75849269|FG000|Treated|Overall Study||355||
59731004|NCT01120184|75849270|FG001|Treated|Overall Study||365||
59731005|NCT01120184|75849271|FG002|Treated|Overall Study||360||
59731006|NCT01120184|75849269|FG000|COMPLETED|Overall Study||0||
59731007|NCT01120184|75849270|FG001|COMPLETED|Overall Study||0||
59731008|NCT01120184|75849271|FG002|COMPLETED|Overall Study||0||
59731009|NCT01120184|75849269|FG000|NOT COMPLETED|Overall Study||365||
59731010|NCT01120184|75849270|FG001|NOT COMPLETED|Overall Study||367||
59731011|NCT01120184|75849271|FG002|NOT COMPLETED|Overall Study||363||
59731012|NCT01120028|75849283|FG000|STARTED|Period 1: Alemtuzumab or Basiliximab||426||
59731013|NCT01120028|75849284|FG001|STARTED|Period 1: Alemtuzumab or Basiliximab||426||
59731014|NCT01120028|75849285|FG002|STARTED|Period 1: Alemtuzumab or Basiliximab||0||
59731015|NCT01120028|75849286|FG003|STARTED|Period 1: Alemtuzumab or Basiliximab||0||
59731016|NCT01120028|75849283|FG000|COMPLETED|Period 1: Alemtuzumab or Basiliximab||412||
59731017|NCT01120028|75849284|FG001|COMPLETED|Period 1: Alemtuzumab or Basiliximab||403||
59731018|NCT01120028|75849285|FG002|COMPLETED|Period 1: Alemtuzumab or Basiliximab||0||
59731019|NCT01120028|75849286|FG003|COMPLETED|Period 1: Alemtuzumab or Basiliximab||0||
59731020|NCT01120028|75849283|FG000|NOT COMPLETED|Period 1: Alemtuzumab or Basiliximab||14||
59731021|NCT01120028|75849284|FG001|NOT COMPLETED|Period 1: Alemtuzumab or Basiliximab||23||
59731022|NCT01120028|75849285|FG002|NOT COMPLETED|Period 1: Alemtuzumab or Basiliximab||0||
59731023|NCT01120028|75849286|FG003|NOT COMPLETED|Period 1: Alemtuzumab or Basiliximab||0||
59731024|NCT01120028|75849283|FG000|STARTED|Period 2: Tacrolimus or Sirolimus||0||
59731025|NCT01120028|75849284|FG001|STARTED|Period 2: Tacrolimus or Sirolimus||0||
59731026|NCT01120028|75849285|FG002|STARTED|Period 2: Tacrolimus or Sirolimus||197||
59731027|NCT01120028|75849286|FG003|STARTED|Period 2: Tacrolimus or Sirolimus||197||
59731028|NCT01120028|75849283|FG000|COMPLETED|Period 2: Tacrolimus or Sirolimus||0||
59731029|NCT01120028|75849284|FG001|COMPLETED|Period 2: Tacrolimus or Sirolimus||0||
59731030|NCT01120028|75849285|FG002|COMPLETED|Period 2: Tacrolimus or Sirolimus||197||
59731031|NCT01120028|75849286|FG003|COMPLETED|Period 2: Tacrolimus or Sirolimus||197||
59731032|NCT01120028|75849283|FG000|NOT COMPLETED|Period 2: Tacrolimus or Sirolimus||0||
59731033|NCT01120028|75849284|FG001|NOT COMPLETED|Period 2: Tacrolimus or Sirolimus||0||
59731034|NCT01120028|75849285|FG002|NOT COMPLETED|Period 2: Tacrolimus or Sirolimus||0||
59731035|NCT01120028|75849286|FG003|NOT COMPLETED|Period 2: Tacrolimus or Sirolimus||0||
59731036|NCT00878800|75849302|FG000|STARTED|Overall Study||3||
59731037|NCT00878800|75849303|FG001|STARTED|Overall Study||7||
59731038|NCT00878800|75849304|FG002|STARTED|Overall Study||9||
59731039|NCT00878800|75849305|FG003|STARTED|Overall Study||6||
59731040|NCT00878800|75849306|FG004|STARTED|Overall Study||16||
59731041|NCT00878800|75849302|FG000|COMPLETED|Overall Study|Mean number of cycles administered: 4.0|0||
59731042|NCT00878800|75849303|FG001|COMPLETED|Overall Study|Mean number of cycles administered: 4.6|0||
59731043|NCT00878800|75849304|FG002|COMPLETED|Overall Study|Mean number of cycles administered: 3.0|0||
59731044|NCT00878800|75849305|FG003|COMPLETED|Overall Study|Mean number of cycles administered: 5.3|0||
59731045|NCT00878800|75849306|FG004|COMPLETED|Overall Study|Mean number of cycles administered: 6.4|0||
59731046|NCT00878800|75849302|FG000|NOT COMPLETED|Overall Study||3||
59731047|NCT00878800|75849303|FG001|NOT COMPLETED|Overall Study||7||
59731048|NCT00878800|75849304|FG002|NOT COMPLETED|Overall Study||9||
59731049|NCT00878800|75849305|FG003|NOT COMPLETED|Overall Study||6||
59731050|NCT00878800|75849306|FG004|NOT COMPLETED|Overall Study||16||
59731051|NCT01119950|75849317|FG000|STARTED|Overall Study|These participants were randomized to 2 different treatment sequences during period 1 and 2.|388||
59731052|NCT01119950|75849317|FG000|NVA237 12.5 ug q.d.|Overall Study|5 randomized and 2 misrandomized patients did not receive study drug, 80 completed, 9 discontinued.|96||
59731053|NCT01119950|75849317|FG000|NVA237 25 ug q.d.|Overall Study|3 randomized participants did not receive study drug, 91 completed treatment, 5 discontinued.|99||
59731054|NCT01119950|75849317|FG000|NVA237 12.5 ug b.i.d.|Overall Study|4 randomized participants did not receive study drug, 93 completed treatment, 2 discontinued.|99||
59731055|NCT01119950|75849317|FG000|NVA237 50 ug q.d.|Overall Study|4 randomized participants did not receive study drug, 89 completed treatment, 3 discontinued.|96||
59731056|NCT01119950|75849317|FG000|NVA237 25 ug b.i.d.|Overall Study|4 randomized participants did not receive study drug, 89 completed treatment, 7 discontinued.|100||
59731057|NCT01119950|75849317|FG000|NVA237 100 ug q.d.|Overall Study|2 randomized participants did not receive study drug, 92 completed treatment, 4 discontinued.|98||
59731058|NCT01119950|75849317|FG000|NVA237 50 ug b.i.d.|Overall Study|6 randomized and 1 misrandomized patients did not receive study drug, 82 completed, 5 discontinued.|94||
59731059|NCT01119950|75849317|FG000|Placebo|Overall Study|3 randomized participants did not receive study drug, 82 completed treatment, 5 discontinued.|94||
59731060|NCT01119950|75849317|FG000|COMPLETED|Overall Study|These participants completed both periods 1 and 2|341||
59731061|NCT01119950|75849317|FG000|NOT COMPLETED|Overall Study||47||
59731062|NCT01145222|75849347|FG000|STARTED|Overall Study||40||
59731063|NCT01145222|75849348|FG001|STARTED|Overall Study||40||
59731064|NCT01145222|75849349|FG002|STARTED|Overall Study||41||
59731065|NCT01145222|75849350|FG003|STARTED|Overall Study||41||
59731066|NCT01145222|75849347|FG000|Safety Population|Overall Study||40|Safety population included all randomized patients who received any amount of study drug|
59731067|NCT01145222|75849348|FG001|Safety Population|Overall Study||40|Safety population included all randomized patients who received any amount of study drug|
59731068|NCT01145222|75849349|FG002|Safety Population|Overall Study||40|Safety population included all randomized patients who received any amount of study drug|
59731069|NCT01145222|75849350|FG003|Safety Population|Overall Study||41|Safety population included all randomized patients who received any amount of study drug|
59731070|NCT01145222|75849347|FG000|Intention to Treat (ITT) Population|Overall Study||40|Received any amount of study drug, started the procedure, and had at least 1 efficacy assessment|
59731071|NCT01145222|75849348|FG001|Intention to Treat (ITT) Population|Overall Study||40|Received any amount of study drug, started the procedure, and had at least 1 efficacy assessment|
59731072|NCT01145222|75849349|FG002|Intention to Treat (ITT) Population|Overall Study||40|Received any amount of study drug, started the procedure, and had at least 1 efficacy assessment|
59731073|NCT01145222|75849350|FG003|Intention to Treat (ITT) Population|Overall Study||40|Received any amount of study drug, started the procedure, and had at least 1 efficacy assessment|
59731074|NCT01145222|75849347|FG000|COMPLETED|Overall Study||40||
59731075|NCT01145222|75849348|FG001|COMPLETED|Overall Study||40||
59731076|NCT01145222|75849349|FG002|COMPLETED|Overall Study||40||
59731077|NCT01145222|75849350|FG003|COMPLETED|Overall Study||40||
59731078|NCT01145222|75849347|FG000|NOT COMPLETED|Overall Study||0||
59731079|NCT01145222|75849348|FG001|NOT COMPLETED|Overall Study||0||
59731080|NCT01145222|75849349|FG002|NOT COMPLETED|Overall Study||1||
59731081|NCT01145222|75849350|FG003|NOT COMPLETED|Overall Study||1||
59731082|NCT01145066|75849363|FG000|STARTED|Overall Study||26||
59731083|NCT01145066|75849364|FG001|STARTED|Overall Study||20||
59731084|NCT01145066|75849365|FG002|STARTED|Overall Study||25||
59731085|NCT01145066|75849363|FG000|COMPLETED|Overall Study||22||
59731086|NCT01145066|75849364|FG001|COMPLETED|Overall Study||16||
59731087|NCT01145066|75849365|FG002|COMPLETED|Overall Study||21||
59731088|NCT01145066|75849363|FG000|NOT COMPLETED|Overall Study||4||
59731089|NCT01145066|75849364|FG001|NOT COMPLETED|Overall Study||4||
59731090|NCT01145066|75849365|FG002|NOT COMPLETED|Overall Study||4||
59731091|NCT01132118|75849375|FG000|STARTED|First Intervention (8 Weeks)||15||
59731092|NCT01132118|75849376|FG001|STARTED|First Intervention (8 Weeks)||15||
59731093|NCT01132118|75849375|FG000|COMPLETED|First Intervention (8 Weeks)||12||
59731094|NCT01132118|75849376|FG001|COMPLETED|First Intervention (8 Weeks)||12||
59731095|NCT01132118|75849375|FG000|NOT COMPLETED|First Intervention (8 Weeks)||3||
59731096|NCT01132118|75849376|FG001|NOT COMPLETED|First Intervention (8 Weeks)||3||
59731097|NCT01132118|75849375|FG000|STARTED|Second Intervention (8 Weeks)||12||
59731098|NCT01132118|75849376|FG001|STARTED|Second Intervention (8 Weeks)||12||
59731099|NCT01132118|75849375|FG000|COMPLETED|Second Intervention (8 Weeks)||12||
59731100|NCT01132118|75849376|FG001|COMPLETED|Second Intervention (8 Weeks)||11||
59731101|NCT01132118|75849375|FG000|NOT COMPLETED|Second Intervention (8 Weeks)||0||
59731102|NCT01132118|75849376|FG001|NOT COMPLETED|Second Intervention (8 Weeks)||1||
59731103|NCT00972816|75849390|FG000|STARTED|Overall Study||173||
59731104|NCT00972816|75849391|FG001|STARTED|Overall Study||169||
59731105|NCT00972816|75849392|FG002|STARTED|Overall Study||169||
59731106|NCT00972816|75849393|FG003|STARTED|Overall Study||169||
59731107|NCT00972816|75849394|FG004|STARTED|Overall Study||169||
59731108|NCT00972816|75849395|FG005|STARTED|Overall Study||169||
59731109|NCT00972816|75849396|FG006|STARTED|Overall Study||169||
59731110|NCT00972816|75849397|FG007|STARTED|Overall Study||170||
59731111|NCT00972816|75849390|FG000|COMPLETED|Overall Study||156||
59731112|NCT00972816|75849391|FG001|COMPLETED|Overall Study||158||
59731113|NCT00972816|75849392|FG002|COMPLETED|Overall Study||160||
59731114|NCT00972816|75849393|FG003|COMPLETED|Overall Study||161||
59731115|NCT00972816|75849394|FG004|COMPLETED|Overall Study||157||
59731116|NCT00972816|75849395|FG005|COMPLETED|Overall Study||158||
59731117|NCT00972816|75849396|FG006|COMPLETED|Overall Study||159||
59731118|NCT00972816|75849397|FG007|COMPLETED|Overall Study||161||
59731119|NCT00972816|75849390|FG000|NOT COMPLETED|Overall Study||17||
59731120|NCT00972816|75849391|FG001|NOT COMPLETED|Overall Study||11||
59731121|NCT00972816|75849392|FG002|NOT COMPLETED|Overall Study||9||
59731122|NCT00972816|75849393|FG003|NOT COMPLETED|Overall Study||8||
59731123|NCT00972816|75849394|FG004|NOT COMPLETED|Overall Study||12||
59731124|NCT00972816|75849395|FG005|NOT COMPLETED|Overall Study||11||
59999762|NCT01874353|76115473|FG003|STARTED|Overall Study||10||
59731125|NCT00972816|75849396|FG006|NOT COMPLETED|Overall Study||10||
59731126|NCT00972816|75849397|FG007|NOT COMPLETED|Overall Study||9||
59731127|NCT00969618|75849415|FG000|STARTED|Overall Study||211||
59731128|NCT00969618|75849415|FG000|COMPLETED|Overall Study||133||
59731129|NCT00969618|75849415|FG000|NOT COMPLETED|Overall Study||78||
59731130|NCT00969540|75849421|FG000|STARTED|Overall Study||4||
59731131|NCT00969540|75849422|FG001|STARTED|Overall Study||4||
59731132|NCT00969540|75849421|FG000|COMPLETED|Overall Study||3||
59731133|NCT00969540|75849422|FG001|COMPLETED|Overall Study||3||
59731134|NCT00969540|75849421|FG000|NOT COMPLETED|Overall Study||1||
59731135|NCT00969540|75849422|FG001|NOT COMPLETED|Overall Study||1||
59731136|NCT00975000|75849442|FG000|STARTED|Overall Study||57||
59731137|NCT00975000|75849443|FG001|STARTED|Overall Study||57||
59731138|NCT00975000|75849442|FG000|Completed Titration Phase|Overall Study||54||
59731139|NCT00975000|75849443|FG001|Completed Titration Phase|Overall Study||55||
59731140|NCT00975000|75849442|FG000|Completed Efficacy Assessment Phase|Overall Study||54||
59731141|NCT00975000|75849443|FG001|Completed Efficacy Assessment Phase|Overall Study||54||
59731142|NCT00975000|75849442|FG000|Completed Maintenance Phase|Overall Study||52||
59731143|NCT00975000|75849443|FG001|Completed Maintenance Phase|Overall Study||52||
59731144|NCT00975000|75849442|FG000|COMPLETED|Overall Study|Completed post-treatment follow-up phase|52||
59731145|NCT00975000|75849443|FG001|COMPLETED|Overall Study|Completed post-treatment follow-up phase|52||
59731146|NCT00975000|75849442|FG000|NOT COMPLETED|Overall Study||5||
59731147|NCT00975000|75849443|FG001|NOT COMPLETED|Overall Study||5||
59731148|NCT00974922|75849449|FG000|STARTED|Overall Study||40|Group assignment was never unblinded due to discontinuation of study; randomization info unavailable|
59731149|NCT00974922|75849449|FG000|COMPLETED|Overall Study||16||
59731150|NCT00974922|75849449|FG000|NOT COMPLETED|Overall Study||24||
59731151|NCT00972504|75849453|FG000|STARTED|Overall Study||54||
59731152|NCT00972504|75849453|FG000|COMPLETED|Overall Study||51||
59731153|NCT00972504|75849453|FG000|NOT COMPLETED|Overall Study||3||
59731154|NCT00969228|75849465|FG000|STARTED|Overall Study||508||
59731155|NCT00969228|75849466|FG001|STARTED|Overall Study||176||
59731156|NCT00969228|75849465|FG000|COMPLETED|Overall Study||465||
59731157|NCT00969228|75849466|FG001|COMPLETED|Overall Study||162||
59731158|NCT00969228|75849465|FG000|NOT COMPLETED|Overall Study||43||
59731159|NCT00969228|75849466|FG001|NOT COMPLETED|Overall Study||14||
59731160|NCT00969150|75849474|FG000|STARTED|Overall Study||182||
59731161|NCT00969150|75849475|FG001|STARTED|Overall Study||175||
59731162|NCT00969150|75849474|FG000|COMPLETED|Overall Study||149||
59731163|NCT00969150|75849475|FG001|COMPLETED|Overall Study||135||
59731164|NCT00969150|75849474|FG000|NOT COMPLETED|Overall Study||33||
59731165|NCT00969150|75849475|FG001|NOT COMPLETED|Overall Study||40||
59731166|NCT00974220|75849483|FG000|STARTED|Treatment Period 1||9||
59731167|NCT00974220|75849484|FG001|STARTED|Treatment Period 1||7||
59731168|NCT00974220|75849483|FG000|COMPLETED|Treatment Period 1||7||
59731169|NCT00974220|75849484|FG001|COMPLETED|Treatment Period 1||5||
59731170|NCT00974220|75849483|FG000|NOT COMPLETED|Treatment Period 1||2||
59731171|NCT00974220|75849484|FG001|NOT COMPLETED|Treatment Period 1||2||
59731172|NCT00974220|75849483|FG000|STARTED|Treatment Period 2||7||
59731173|NCT00974220|75849484|FG001|STARTED|Treatment Period 2||5||
59731174|NCT00974220|75849483|FG000|COMPLETED|Treatment Period 2||7||
59731175|NCT00974220|75849484|FG001|COMPLETED|Treatment Period 2||5||
59731176|NCT00974220|75849483|FG000|NOT COMPLETED|Treatment Period 2||0||
59731177|NCT00974220|75849484|FG001|NOT COMPLETED|Treatment Period 2||0||
59731178|NCT00971178|75849493|FG000|STARTED|Overall Study||35||
59731179|NCT00971178|75849494|FG001|STARTED|Overall Study||35||
59731180|NCT00971178|75849495|FG002|STARTED|Overall Study||35||
59731181|NCT00971178|75849493|FG000|COMPLETED|Overall Study||33||
59731182|NCT00971178|75849494|FG001|COMPLETED|Overall Study||33||
59731183|NCT00971178|75849495|FG002|COMPLETED|Overall Study||33||
59731184|NCT00971178|75849493|FG000|NOT COMPLETED|Overall Study||2||
59731185|NCT00971178|75849494|FG001|NOT COMPLETED|Overall Study||2||
59731186|NCT00971178|75849495|FG002|NOT COMPLETED|Overall Study||2||
59731187|NCT03670602|75849505|FG000|STARTED|Overall Study||31||
59731188|NCT03670602|75849506|FG001|STARTED|Overall Study||33||
59731189|NCT03670602|75849505|FG000|Received Intervention Treatment|Overall Study||30||
59731190|NCT03670602|75849506|FG001|Received Intervention Treatment|Overall Study||30||
59731191|NCT03670602|75849505|FG000|Completed Session 2 (Week 12)|Overall Study||29|Completed Session 2 refers to participants who completed the follow up assessment measures for week 12|
59731192|NCT03670602|75849506|FG001|Completed Session 2 (Week 12)|Overall Study||30|Completed Session 2 refers to participants who completed the follow up assessment measures for week 12|
59731193|NCT03670602|75849505|FG000|Completed Session 3 (Week 24)|Overall Study||28|Completed Session 3 refers to participants who were able to complete follow-up assessment measures at week 24|
59731194|NCT03670602|75849506|FG001|Completed Session 3 (Week 24)|Overall Study||31|Completed Session 3 refers to participants who were able to complete follow-up assessment measures at week 24|
59731195|NCT03670602|75849505|FG000|COMPLETED|Overall Study||30||
59731196|NCT03670602|75849506|FG001|COMPLETED|Overall Study||30||
59731197|NCT03670602|75849505|FG000|NOT COMPLETED|Overall Study||1||
59731198|NCT03670602|75849506|FG001|NOT COMPLETED|Overall Study||3||
59731199|NCT00968526|75849514|FG000|STARTED|Overall Study||138||
59731200|NCT00968526|75849515|FG001|STARTED|Overall Study||102||
59731201|NCT00968526|75849514|FG000|COMPLETED|Overall Study||135||
59731202|NCT00968526|75849515|FG001|COMPLETED|Overall Study||102||
59731203|NCT00968526|75849514|FG000|NOT COMPLETED|Overall Study||3||
59731204|NCT00968526|75849515|FG001|NOT COMPLETED|Overall Study||0||
59731205|NCT03664674|75849532|FG000|STARTED|Overall Study||73||
59731206|NCT03664674|75849533|FG001|STARTED|Overall Study||75||
59731207|NCT03664674|75849532|FG000|COMPLETED|Overall Study||70||
59731208|NCT03664674|75849533|FG001|COMPLETED|Overall Study||73||
59731209|NCT03664674|75849532|FG000|NOT COMPLETED|Overall Study||3||
59731210|NCT03664674|75849533|FG001|NOT COMPLETED|Overall Study||2||
59731211|NCT00967668|75849544|FG000|STARTED|Overall Study||162||
59731212|NCT00967668|75849545|FG001|STARTED|Overall Study||160||
59731213|NCT00967668|75849546|FG002|STARTED|Overall Study||159||
59731214|NCT00967668|75849544|FG000|3-mo Assessment|Overall Study||131||
59731215|NCT00967668|75849545|FG001|3-mo Assessment|Overall Study||127||
59731216|NCT00967668|75849546|FG002|3-mo Assessment|Overall Study||115||
59731217|NCT00967668|75849544|FG000|Completed Year 1 - 12-mo Assessment|Overall Study||120||
59731218|NCT00967668|75849545|FG001|Completed Year 1 - 12-mo Assessment|Overall Study||122||
59731219|NCT00967668|75849546|FG002|Completed Year 1 - 12-mo Assessment|Overall Study||119||
59731220|NCT00967668|75849544|FG000|18-mo Assessment|Overall Study||95||
59731221|NCT00967668|75849545|FG001|18-mo Assessment|Overall Study||102||
59731222|NCT00967668|75849546|FG002|18-mo Assessment|Overall Study||92||
59731223|NCT00967668|75849544|FG000|COMPLETED|Overall Study||91||
59731224|NCT00967668|75849545|FG001|COMPLETED|Overall Study||104||
59731225|NCT00967668|75849546|FG002|COMPLETED|Overall Study||90||
59731226|NCT00967668|75849544|FG000|NOT COMPLETED|Overall Study||71||
59731227|NCT00967668|75849545|FG001|NOT COMPLETED|Overall Study||56||
59731228|NCT00967668|75849546|FG002|NOT COMPLETED|Overall Study||69||
59731229|NCT00970944|75849559|FG000|STARTED|Overall Study||87||
59731230|NCT00970944|75849560|FG001|STARTED|Overall Study||97||
59731231|NCT00970944|75849559|FG000|COMPLETED|Overall Study||86||
59731232|NCT00970944|75849560|FG001|COMPLETED|Overall Study||95||
59731233|NCT00970944|75849559|FG000|NOT COMPLETED|Overall Study||1||
59731234|NCT00970944|75849560|FG001|NOT COMPLETED|Overall Study||2||
59731235|NCT04892147|75849569|FG000|STARTED|Overall Study||15||
59731236|NCT04892147|75849570|FG001|STARTED|Overall Study||11||
59731237|NCT04892147|75849569|FG000|COMPLETED|Overall Study||13||
59731238|NCT04892147|75849570|FG001|COMPLETED|Overall Study||11||
59731239|NCT04892147|75849569|FG000|NOT COMPLETED|Overall Study||2||
59731240|NCT04892147|75849570|FG001|NOT COMPLETED|Overall Study||0||
59731241|NCT04839289|75849579|FG000|STARTED|Overall Study||18||
59731242|NCT04839289|75849580|FG001|STARTED|Overall Study||9||
59731243|NCT04839289|75849579|FG000|COMPLETED|Overall Study||17||
59731244|NCT04839289|75849580|FG001|COMPLETED|Overall Study||9||
59731245|NCT04839289|75849579|FG000|NOT COMPLETED|Overall Study||1||
59731246|NCT04839289|75849580|FG001|NOT COMPLETED|Overall Study||0||
59731247|NCT04544865|75849588|FG000|STARTED|Overall Study||109||
59731248|NCT04544865|75849589|FG001|STARTED|Overall Study||131||
59731249|NCT04544865|75849588|FG000|COMPLETED|Overall Study||98||
59731250|NCT04544865|75849589|FG001|COMPLETED|Overall Study||120||
59731251|NCT04544865|75849588|FG000|NOT COMPLETED|Overall Study||11||
59731252|NCT04544865|75849589|FG001|NOT COMPLETED|Overall Study||11||
59731253|NCT04440813|75849598|FG000|STARTED|Overall Study||69||
59731254|NCT04440813|75849599|FG001|STARTED|Overall Study||67||
59731255|NCT04440813|75849598|FG000|COMPLETED|Overall Study||64||
59731256|NCT04440813|75849599|FG001|COMPLETED|Overall Study||62||
59731257|NCT04440813|75849598|FG000|NOT COMPLETED|Overall Study||5||
59731258|NCT04440813|75849599|FG001|NOT COMPLETED|Overall Study||5||
59731259|NCT04336995|75849605|FG000|STARTED|Overall Study||14||
59731260|NCT04336995|75849605|FG000|COMPLETED|Overall Study||14||
59731261|NCT04336995|75849605|FG000|NOT COMPLETED|Overall Study||0||
59731262|NCT04262232|75849609|FG000|STARTED|Overall Study||30||
59731263|NCT04262232|75849609|FG000|COMPLETED|Overall Study||30||
59731264|NCT04262232|75849609|FG000|NOT COMPLETED|Overall Study||0||
59731265|NCT04233073|75849613|FG000|STARTED|Overall Study||10||
59731266|NCT04233073|75849613|FG000|Treated With Any Amount of Andexanet|Overall Study||10||
59731267|NCT04233073|75849613|FG000|Efficacy Set|Overall Study||6||
59731268|NCT04233073|75849613|FG000|COMPLETED|Overall Study||5||
59731269|NCT04233073|75849613|FG000|NOT COMPLETED|Overall Study||5||
59731270|NCT04120116|75849621|FG000|STARTED|Overall Study||23||
59731271|NCT04120116|75849622|FG001|STARTED|Overall Study||25||
59731272|NCT04120116|75849623|FG002|STARTED|Overall Study||24||
59731273|NCT04120116|75849624|FG003|STARTED|Overall Study||23||
59731274|NCT04120116|75849621|FG000|COMPLETED|Overall Study||22||
59731275|NCT04120116|75849622|FG001|COMPLETED|Overall Study||24||
59731276|NCT04120116|75849623|FG002|COMPLETED|Overall Study||22||
59731277|NCT04120116|75849624|FG003|COMPLETED|Overall Study||20||
59731278|NCT04120116|75849621|FG000|NOT COMPLETED|Overall Study||1||
59731279|NCT04120116|75849622|FG001|NOT COMPLETED|Overall Study||1||
59731280|NCT04120116|75849623|FG002|NOT COMPLETED|Overall Study||2||
59731281|NCT04120116|75849624|FG003|NOT COMPLETED|Overall Study||3||
59731282|NCT04084171|75849639|FG000|STARTED|Overall Study||12||
59731283|NCT04084171|75849639|FG000|Baseline|Overall Study||12||
59999763|NCT01874353|76115470|FG000|COMPLETED|Overall Study||69||
59731284|NCT04084171|75849639|FG000|COMPLETED|Overall Study||12||
59731285|NCT04084171|75849639|FG000|NOT COMPLETED|Overall Study||0||
59731286|NCT03657810|75849647|FG000|STARTED|Overall Study||87||
59731287|NCT03657810|75849648|FG001|STARTED|Overall Study||90||
59731288|NCT03657810|75849649|FG002|STARTED|Overall Study||44||
59731289|NCT03657810|75849647|FG000|COMPLETED|Overall Study||82||
59731290|NCT03657810|75849648|FG001|COMPLETED|Overall Study||86||
59731291|NCT03657810|75849649|FG002|COMPLETED|Overall Study||41||
59731292|NCT03657810|75849647|FG000|NOT COMPLETED|Overall Study||5||
59731293|NCT03657810|75849648|FG001|NOT COMPLETED|Overall Study||4||
59731294|NCT03657810|75849649|FG002|NOT COMPLETED|Overall Study||3||
59731295|NCT03374631|75849659|FG000|STARTED|First Intervention (20 Minutes)||20||
59731296|NCT03374631|75849660|FG001|STARTED|First Intervention (20 Minutes)||20||
59731297|NCT03374631|75849659|FG000|COMPLETED|First Intervention (20 Minutes)||20||
59731298|NCT03374631|75849660|FG001|COMPLETED|First Intervention (20 Minutes)||20||
59731299|NCT03374631|75849659|FG000|NOT COMPLETED|First Intervention (20 Minutes)||0||
59731300|NCT03374631|75849660|FG001|NOT COMPLETED|First Intervention (20 Minutes)||0||
59731301|NCT03374631|75849659|FG000|STARTED|Washout (1 Week)||20||
59731302|NCT03374631|75849660|FG001|STARTED|Washout (1 Week)||20||
59731303|NCT03374631|75849659|FG000|COMPLETED|Washout (1 Week)||20||
59731304|NCT03374631|75849660|FG001|COMPLETED|Washout (1 Week)||20||
59731305|NCT03374631|75849659|FG000|NOT COMPLETED|Washout (1 Week)||0||
59731306|NCT03374631|75849660|FG001|NOT COMPLETED|Washout (1 Week)||0||
59731307|NCT03374631|75849659|FG000|STARTED|Second Intervention (20 Minutes)||20||
59731308|NCT03374631|75849660|FG001|STARTED|Second Intervention (20 Minutes)||20||
59731309|NCT03374631|75849659|FG000|COMPLETED|Second Intervention (20 Minutes)||20||
59731310|NCT03374631|75849660|FG001|COMPLETED|Second Intervention (20 Minutes)||20||
59731311|NCT03374631|75849659|FG000|NOT COMPLETED|Second Intervention (20 Minutes)||0||
59731312|NCT03374631|75849660|FG001|NOT COMPLETED|Second Intervention (20 Minutes)||0||
59731313|NCT03370341|75849671|FG000|STARTED|Overall Study||21||
59731314|NCT03370341|75849672|FG001|STARTED|Overall Study||20||
59731315|NCT03370341|75849671|FG000|COMPLETED|Overall Study||21||
59731316|NCT03370341|75849672|FG001|COMPLETED|Overall Study||19||
59731317|NCT03370341|75849671|FG000|NOT COMPLETED|Overall Study||0||
59731318|NCT03370341|75849672|FG001|NOT COMPLETED|Overall Study||1||
59731319|NCT03294148|75849681|FG000|STARTED|Overall Study||50||
59731320|NCT03294148|75849682|FG001|STARTED|Overall Study||51||
59731321|NCT03294148|75849683|FG002|STARTED|Overall Study||50||
59731322|NCT03294148|75849681|FG000|COMPLETED|Overall Study||44||
59731323|NCT03294148|75849682|FG001|COMPLETED|Overall Study||44||
59731324|NCT03294148|75849683|FG002|COMPLETED|Overall Study||47||
59731325|NCT03294148|75849681|FG000|NOT COMPLETED|Overall Study||6||
59731326|NCT03294148|75849682|FG001|NOT COMPLETED|Overall Study||7||
59731327|NCT03294148|75849683|FG002|NOT COMPLETED|Overall Study||3||
59731328|NCT03181282|75849694|FG000|STARTED|Overall Study||15||
59731329|NCT03181282|75849695|FG001|STARTED|Overall Study||14||
59731330|NCT03181282|75849694|FG000|COMPLETED|Overall Study||14||
59731331|NCT03181282|75849695|FG001|COMPLETED|Overall Study||14||
59731332|NCT03181282|75849694|FG000|NOT COMPLETED|Overall Study||1||
59731333|NCT03181282|75849695|FG001|NOT COMPLETED|Overall Study||0||
59731334|NCT03094637|75849703|FG000|STARTED|Overall Study||17||
59731335|NCT03094637|75849704|FG001|STARTED|Overall Study||20||
59731336|NCT03094637|75849703|FG000|COMPLETED|Overall Study||17||
59731337|NCT03094637|75849704|FG001|COMPLETED|Overall Study||20||
59731338|NCT03094637|75849703|FG000|NOT COMPLETED|Overall Study||0||
59731339|NCT03094637|75849704|FG001|NOT COMPLETED|Overall Study||0||
59731340|NCT03055507|75849713|FG000|STARTED|Overall Study||16||
59731341|NCT03055507|75849714|FG001|STARTED|Overall Study||26||
59731342|NCT03055507|75849713|FG000|COMPLETED|Overall Study||16||
59731343|NCT03055507|75849714|FG001|COMPLETED|Overall Study||26||
59731344|NCT03055507|75849713|FG000|NOT COMPLETED|Overall Study||0||
59731345|NCT03055507|75849714|FG001|NOT COMPLETED|Overall Study||0||
59731346|NCT02544074|75849741|FG000|STARTED|Overall Study||1||
59731347|NCT02544074|75849742|FG001|STARTED|Overall Study||1||
59731348|NCT02544074|75849743|FG002|STARTED|Overall Study||1||
59731349|NCT02544074|75849744|FG003|STARTED|Overall Study||1||
59731350|NCT02544074|75849745|FG004|STARTED|Overall Study||4||
59731351|NCT02544074|75849746|FG005|STARTED|Overall Study||1||
59731352|NCT02544074|75849747|FG006|STARTED|Overall Study||2||
59731353|NCT02544074|75849748|FG007|STARTED|Overall Study||4||
59731354|NCT02544074|75849749|FG008|STARTED|Overall Study||6||
59731355|NCT02544074|75849750|FG009|STARTED|Overall Study||2||
59731356|NCT02544074|75849751|FG010|STARTED|Overall Study||2||
59731357|NCT02544074|75849752|FG011|STARTED|Overall Study||3||
59731358|NCT02544074|75849753|FG012|STARTED|Overall Study||4||
59731359|NCT02544074|75849754|FG013|STARTED|Overall Study||5||
59731360|NCT02544074|75849755|FG014|STARTED|Overall Study||5||
59731361|NCT02544074|75849756|FG015|STARTED|Overall Study||8||
59731362|NCT02544074|75849757|FG016|STARTED|Overall Study||6||
59731363|NCT02544074|75849758|FG017|STARTED|Overall Study||3||
59731364|NCT02544074|75849759|FG018|STARTED|Overall Study||4||
59731365|NCT02544074|75849760|FG019|STARTED|Overall Study||3||
59731366|NCT02544074|75849761|FG020|STARTED|Overall Study||3||
59731367|NCT02544074|75849741|FG000|COMPLETED|Overall Study||1||
59731368|NCT02544074|75849742|FG001|COMPLETED|Overall Study||0||
59731369|NCT02544074|75849743|FG002|COMPLETED|Overall Study||1||
59731370|NCT02544074|75849744|FG003|COMPLETED|Overall Study||1||
59731371|NCT02544074|75849745|FG004|COMPLETED|Overall Study||4||
59731372|NCT02544074|75849746|FG005|COMPLETED|Overall Study||0||
59731373|NCT02544074|75849747|FG006|COMPLETED|Overall Study||2||
59731374|NCT02544074|75849748|FG007|COMPLETED|Overall Study||4||
59731375|NCT02544074|75849749|FG008|COMPLETED|Overall Study||6||
59731376|NCT02544074|75849750|FG009|COMPLETED|Overall Study||1||
59731377|NCT02544074|75849751|FG010|COMPLETED|Overall Study||2||
59731378|NCT02544074|75849752|FG011|COMPLETED|Overall Study||3||
59731379|NCT02544074|75849753|FG012|COMPLETED|Overall Study||4||
59731380|NCT02544074|75849754|FG013|COMPLETED|Overall Study||5||
59731381|NCT02544074|75849755|FG014|COMPLETED|Overall Study||5||
59731382|NCT02544074|75849756|FG015|COMPLETED|Overall Study||8||
59731383|NCT02544074|75849757|FG016|COMPLETED|Overall Study||6||
59731384|NCT02544074|75849758|FG017|COMPLETED|Overall Study||3||
59731385|NCT02544074|75849759|FG018|COMPLETED|Overall Study||4||
59731386|NCT02544074|75849760|FG019|COMPLETED|Overall Study||3||
59731387|NCT02544074|75849761|FG020|COMPLETED|Overall Study||3||
59731388|NCT02544074|75849741|FG000|NOT COMPLETED|Overall Study||0||
59731389|NCT02544074|75849742|FG001|NOT COMPLETED|Overall Study||1||
59731390|NCT02544074|75849743|FG002|NOT COMPLETED|Overall Study||0||
59731391|NCT02544074|75849744|FG003|NOT COMPLETED|Overall Study||0||
59731392|NCT02544074|75849745|FG004|NOT COMPLETED|Overall Study||0||
59731393|NCT02544074|75849746|FG005|NOT COMPLETED|Overall Study||1||
59731394|NCT02544074|75849747|FG006|NOT COMPLETED|Overall Study||0||
59731395|NCT02544074|75849748|FG007|NOT COMPLETED|Overall Study||0||
59731396|NCT02544074|75849749|FG008|NOT COMPLETED|Overall Study||0||
59731397|NCT02544074|75849750|FG009|NOT COMPLETED|Overall Study||1||
59731398|NCT02544074|75849751|FG010|NOT COMPLETED|Overall Study||0||
59731399|NCT02544074|75849752|FG011|NOT COMPLETED|Overall Study||0||
59731400|NCT02544074|75849753|FG012|NOT COMPLETED|Overall Study||0||
59731401|NCT02544074|75849754|FG013|NOT COMPLETED|Overall Study||0||
59731402|NCT02544074|75849755|FG014|NOT COMPLETED|Overall Study||0||
59731403|NCT02544074|75849756|FG015|NOT COMPLETED|Overall Study||0||
59731404|NCT02544074|75849757|FG016|NOT COMPLETED|Overall Study||0||
59731405|NCT02544074|75849758|FG017|NOT COMPLETED|Overall Study||0||
59731406|NCT02544074|75849759|FG018|NOT COMPLETED|Overall Study||0||
59731407|NCT02544074|75849760|FG019|NOT COMPLETED|Overall Study||0||
59731408|NCT02544074|75849761|FG020|NOT COMPLETED|Overall Study||0||
59731409|NCT02502799|75849799|FG000|STARTED|Phase 1: Brief Intervention Sessions|"This group did not yet exist during Phase 1: Brief Intervention Sessions. Participants were not randomized to a treatment arm until Phase 2: Intervention Phase. Only participants identified as Non-responders during Phase 1, continued to Phase 2."|0||
59731410|NCT02502799|75849800|FG001|STARTED|Phase 1: Brief Intervention Sessions|"This group did not yet exist during Phase 1: Brief Intervention Sessions. Participants were not randomized to a treatment arm until Phase 2: Intervention Phase. Only participants identified as Non-responders during Phase 1, continued to Phase 2."|0||
59731411|NCT02502799|75849801|FG002|STARTED|Phase 1: Brief Intervention Sessions|"This group did not yet exist during Phase 1: Brief Intervention Sessions. Participants were not randomized to a treatment arm until Phase 2: Intervention Phase. Only participants identified as Non-responders during Phase 1, continued to Phase 2."|0||
59731412|NCT02502799|75849802|FG003|STARTED|Phase 1: Brief Intervention Sessions||158||
59731413|NCT02502799|75849799|FG000|COMPLETED|Phase 1: Brief Intervention Sessions||0||
59731414|NCT02502799|75849800|FG001|COMPLETED|Phase 1: Brief Intervention Sessions||0||
59731415|NCT02502799|75849801|FG002|COMPLETED|Phase 1: Brief Intervention Sessions||0||
59731416|NCT02502799|75849802|FG003|COMPLETED|Phase 1: Brief Intervention Sessions||141||
59731417|NCT02502799|75849799|FG000|NOT COMPLETED|Phase 1: Brief Intervention Sessions||0||
59731418|NCT02502799|75849800|FG001|NOT COMPLETED|Phase 1: Brief Intervention Sessions||0||
59731419|NCT02502799|75849801|FG002|NOT COMPLETED|Phase 1: Brief Intervention Sessions||0||
59731420|NCT02502799|75849802|FG003|NOT COMPLETED|Phase 1: Brief Intervention Sessions||17||
59731421|NCT02502799|75849799|FG000|STARTED|Phase 2: Intervention Phase||16||
59731422|NCT02502799|75849800|FG001|STARTED|Phase 2: Intervention Phase||17||
59731423|NCT02502799|75849801|FG002|STARTED|Phase 2: Intervention Phase||16||
59731424|NCT02502799|75849802|FG003|STARTED|Phase 2: Intervention Phase|"Only those participants identified as Non-responders during Phase 1 continued to Phase 2 of this study and were randomized to one of the three arms: 1) Continued Monitoring and Assessment; 2) PT with ACBT; 3) PT with ACBT and Methylphenidate"|0||
59731425|NCT02502799|75849799|FG000|COMPLETED|Phase 2: Intervention Phase||6||
59731426|NCT02502799|75849800|FG001|COMPLETED|Phase 2: Intervention Phase||6||
59731427|NCT02502799|75849801|FG002|COMPLETED|Phase 2: Intervention Phase||7||
59731428|NCT02502799|75849802|FG003|COMPLETED|Phase 2: Intervention Phase||0||
59731429|NCT02502799|75849799|FG000|NOT COMPLETED|Phase 2: Intervention Phase||10||
59731430|NCT02502799|75849800|FG001|NOT COMPLETED|Phase 2: Intervention Phase||11||
59731431|NCT02502799|75849801|FG002|NOT COMPLETED|Phase 2: Intervention Phase||9||
59731432|NCT02502799|75849802|FG003|NOT COMPLETED|Phase 2: Intervention Phase||0||
59731433|NCT02086448|75849815|FG000|STARTED|Overall Study||25||
59731434|NCT02086448|75849816|FG001|STARTED|Overall Study||26||
59731435|NCT02086448|75849817|FG002|STARTED|Overall Study||20||
59731436|NCT02086448|75849818|FG003|STARTED|Overall Study||18||
59731437|NCT02086448|75849815|FG000|COMPLETED|Overall Study||24||
59731438|NCT02086448|75849816|FG001|COMPLETED|Overall Study||26||
59731439|NCT02086448|75849817|FG002|COMPLETED|Overall Study||20||
59731440|NCT02086448|75849818|FG003|COMPLETED|Overall Study||16||
59731441|NCT02086448|75849815|FG000|NOT COMPLETED|Overall Study||1||
59731442|NCT02086448|75849816|FG001|NOT COMPLETED|Overall Study||0||
59731443|NCT02086448|75849817|FG002|NOT COMPLETED|Overall Study||0||
59731444|NCT02086448|75849818|FG003|NOT COMPLETED|Overall Study||2||
59731445|NCT01993836|75849831|FG000|STARTED|Overall Study|This represents the number of enrolled patients who completed baseline cognitive testing|72||
59731446|NCT01993836|75849832|FG001|STARTED|Overall Study||68||
59731447|NCT01993836|75849833|FG002|STARTED|Overall Study||51||
59731448|NCT01993836|75849831|FG000|COMPLETED|Overall Study||55||
59731449|NCT01993836|75849832|FG001|COMPLETED|Overall Study||55||
59731450|NCT01993836|75849833|FG002|COMPLETED|Overall Study||46||
59731451|NCT01993836|75849831|FG000|NOT COMPLETED|Overall Study||17||
59731452|NCT01993836|75849832|FG001|NOT COMPLETED|Overall Study||13||
59731453|NCT01993836|75849833|FG002|NOT COMPLETED|Overall Study||5||
59731454|NCT01818739|75849841|FG000|STARTED|Overall Study||204||
59731455|NCT01818739|75849841|FG000|COMPLETED|Overall Study||204||
59731456|NCT01818739|75849841|FG000|NOT COMPLETED|Overall Study||0||
59731457|NCT00753545|75849848|FG000|STARTED|Overall Study|Patients randomized|136||
59731458|NCT00753545|75849849|FG001|STARTED|Overall Study|Patients randomized|129||
59731459|NCT00753545|75849848|FG000|COMPLETED|Overall Study|Patients completing the Study|28||
59731460|NCT00753545|75849849|FG001|COMPLETED|Overall Study|Patients completing the Study|11||
59731461|NCT00753545|75849848|FG000|NOT COMPLETED|Overall Study||108||
59731462|NCT00753545|75849849|FG001|NOT COMPLETED|Overall Study||118||
59731463|NCT00635362|75849857|FG000|STARTED|Overall Study||22||
59731464|NCT00635362|75849858|FG001|STARTED|Overall Study||20||
59731465|NCT00635362|75849857|FG000|COMPLETED|Overall Study||9||
59731466|NCT00635362|75849858|FG001|COMPLETED|Overall Study||12||
59864916|NCT01631214|75988886|FG000|Completed Double-blind Period|Overall Study||1823|Completion of the double-blind period is defined as having attended the month 12 study visit.|
59864917|NCT01631214|75988887|FG001|Completed Double-blind Period|Overall Study||1831|Completion of the double-blind period is defined as having attended the month 12 study visit.|
59864918|NCT01631214|75988886|FG000|Completed Primary Analysis Period|Overall Study||1576|Completion of the primary analysis period is defined as ongoing at the primary analysis cutoff date.|
59864919|NCT01631214|75988887|FG001|Completed Primary Analysis Period|Overall Study||1574|Completion of the primary analysis period is defined as ongoing at the primary analysis cutoff date.|
59864920|NCT01631214|75988886|FG000|COMPLETED|Overall Study||1503||
59864921|NCT01631214|75988887|FG001|COMPLETED|Overall Study||1523||
59864922|NCT01631214|75988886|FG000|NOT COMPLETED|Overall Study||544||
59864923|NCT01631214|75988887|FG001|NOT COMPLETED|Overall Study||523||
59864924|NCT03093454|75988897|FG000|STARTED|Overall Study||28||
59864925|NCT03093454|75988898|FG001|STARTED|Overall Study||30||
59864926|NCT03093454|75988897|FG000|COMPLETED|Overall Study||22||
59864927|NCT03093454|75988898|FG001|COMPLETED|Overall Study||27||
59864928|NCT03093454|75988897|FG000|NOT COMPLETED|Overall Study||6||
59864929|NCT03093454|75988898|FG001|NOT COMPLETED|Overall Study||3||
59864930|NCT02614690|75988907|FG000|STARTED|Overall Study||20||
59864931|NCT02614690|75988908|FG001|STARTED|Overall Study||20||
59864932|NCT02614690|75988909|FG002|STARTED|Overall Study||20||
59864933|NCT02614690|75988907|FG000|COMPLETED|Overall Study||20||
59864934|NCT02614690|75988908|FG001|COMPLETED|Overall Study||20||
59864935|NCT02614690|75988909|FG002|COMPLETED|Overall Study||20||
59864936|NCT02614690|75988907|FG000|NOT COMPLETED|Overall Study||0||
59864937|NCT02614690|75988908|FG001|NOT COMPLETED|Overall Study||0||
59864938|NCT02614690|75988909|FG002|NOT COMPLETED|Overall Study||0||
59864939|NCT00468130|75988919|FG000|STARTED|Overall Study||7||
59864940|NCT00468130|75988920|FG001|STARTED|Overall Study||6||
59864941|NCT00468130|75988919|FG000|COMPLETED|Overall Study||5||
59864942|NCT00468130|75988920|FG001|COMPLETED|Overall Study||4||
59864943|NCT00468130|75988919|FG000|NOT COMPLETED|Overall Study||2||
59864944|NCT00468130|75988920|FG001|NOT COMPLETED|Overall Study||2||
59864945|NCT00911820|75988930|FG000|STARTED|Overall Study||45||
59864946|NCT00911820|75988931|FG001|STARTED|Overall Study||43||
59864947|NCT00911820|75988930|FG000|Treated|Overall Study|Randomized patients not treated: unable to confirm pathology (n=1)|44||
59864948|NCT00911820|75988931|FG001|Treated|Overall Study|Randomized patients not treated: withdrew consent (n=2)|41||
59864949|NCT00911820|75988930|FG000|COMPLETED|Overall Study||0|Since treatment was not of fixed duration, all patients were considered as 'Not Completed'.|
59864950|NCT00911820|75988931|FG001|COMPLETED|Overall Study||0|Since treatment was not of fixed duration, all patients were considered as 'Not Completed'.|
59864951|NCT00911820|75988930|FG000|NOT COMPLETED|Overall Study||45||
59864952|NCT00911820|75988931|FG001|NOT COMPLETED|Overall Study||43||
59864953|NCT00603642|75988939|FG000|STARTED|Overall Study||12||
59864954|NCT00603642|75988940|FG001|STARTED|Overall Study||22||
59864955|NCT00603642|75988939|FG000|COMPLETED|Overall Study||12||
59864956|NCT00603642|75988940|FG001|COMPLETED|Overall Study||22||
59864957|NCT00603642|75988939|FG000|NOT COMPLETED|Overall Study||0||
59864958|NCT00603642|75988940|FG001|NOT COMPLETED|Overall Study||0||
59864959|NCT00246324|75988946|FG000|STARTED|Overall Study||16||
59864960|NCT00246324|75988946|FG000|COMPLETED|Overall Study||15||
59864961|NCT00246324|75988946|FG000|NOT COMPLETED|Overall Study||1||
59864962|NCT04234984|75988952|FG000|STARTED|Follow-up at 6 Weeks||61||
59864963|NCT04234984|75988952|FG000|COMPLETED|Follow-up at 6 Weeks||59||
59864964|NCT04234984|75988952|FG000|NOT COMPLETED|Follow-up at 6 Weeks||2||
59864965|NCT04234984|75988952|FG000|STARTED|Follow-up at the Second Time Point||19|All patients experiencing a successful treatment at 6 weeks were followed up at the second time point.|
59731467|NCT00635362|75849857|FG000|NOT COMPLETED|Overall Study||13||
59731468|NCT00635362|75849858|FG001|NOT COMPLETED|Overall Study||8||
59731469|NCT00278915|75849864|FG000|STARTED|Overall Study|First 6 patients were dosed at 2mg/kg then increased to 4 mg/kg. Remaining 24 were dosed at 4mg/kg.|30||
59731470|NCT00278915|75849864|FG000|COMPLETED|Overall Study||29||
59731471|NCT00278915|75849864|FG000|NOT COMPLETED|Overall Study||1||
59864966|NCT04234984|75988952|FG000|COMPLETED|Follow-up at the Second Time Point||17||
59864967|NCT04234984|75988952|FG000|NOT COMPLETED|Follow-up at the Second Time Point||2||
59864968|NCT02658136|75988958|FG000|STARTED|Overall Study|Approved to start in year 2016. Goal was to reach 15 participants (1 day study).|15|Approved: 02-03-2016 (1-day study)|
59864969|NCT02658136|75988958|FG000|COMPLETED|Overall Study|Date of end of study: June 2017, N=15|15||
59864970|NCT02658136|75988958|FG000|NOT COMPLETED|Overall Study||0||
59864971|NCT03922750|75988966|FG000|STARTED|Overall Study||50||
59864972|NCT03922750|75988967|FG001|STARTED|Overall Study||54||
59864973|NCT03922750|75988968|FG002|STARTED|Overall Study||50||
59864974|NCT03922750|75988966|FG000|Full Analysis Set (FAS)|Overall Study||50||
59864975|NCT03922750|75988967|FG001|Full Analysis Set (FAS)|Overall Study||54||
59864976|NCT03922750|75988968|FG002|Full Analysis Set (FAS)|Overall Study||50||
59864977|NCT03922750|75988966|FG000|Safety Analysis Set (SAS)|Overall Study||50||
59864978|NCT03922750|75988967|FG001|Safety Analysis Set (SAS)|Overall Study||54||
59864979|NCT03922750|75988968|FG002|Safety Analysis Set (SAS)|Overall Study||50||
59864980|NCT03922750|75988966|FG000|COMPLETED|Overall Study||50||
59864981|NCT03922750|75988967|FG001|COMPLETED|Overall Study||53||
59864982|NCT03922750|75988968|FG002|COMPLETED|Overall Study||49||
59864983|NCT03922750|75988966|FG000|NOT COMPLETED|Overall Study||0||
59864984|NCT03922750|75988967|FG001|NOT COMPLETED|Overall Study||1||
59864985|NCT03922750|75988968|FG002|NOT COMPLETED|Overall Study||1||
59864986|NCT04682730|75988976|FG000|STARTED|Overall Study||47||1
59864987|NCT04682730|75988977|FG001|STARTED|Overall Study||166||3
59864988|NCT04682730|75988978|FG002|STARTED|Overall Study||190||3
59864989|NCT04682730|75988979|FG003|STARTED|Overall Study||164||3
59864990|NCT04682730|75988980|FG004|STARTED|Overall Study||131||3
59864991|NCT04682730|75988981|FG005|STARTED|Overall Study||198||3
59864992|NCT04682730|75988976|FG000|Intro Session|Overall Study||48||1
59864993|NCT04682730|75988977|FG001|Intro Session|Overall Study||80||3
59864994|NCT04682730|75988978|FG002|Intro Session|Overall Study||83||3
59864995|NCT04682730|75988979|FG003|Intro Session|Overall Study||68||3
59864996|NCT04682730|75988980|FG004|Intro Session|Overall Study||60||3
59864997|NCT04682730|75988981|FG005|Intro Session|Overall Study||58||3
59864998|NCT04682730|75988976|FG000|Deliberative Forum|Overall Study||25||1
59864999|NCT04682730|75988977|FG001|Deliberative Forum|Overall Study||89||3
59865000|NCT04682730|75988978|FG002|Deliberative Forum|Overall Study||76||3
59865001|NCT04682730|75988979|FG003|Deliberative Forum|Overall Study||64||3
59865002|NCT04682730|75988980|FG004|Deliberative Forum|Overall Study||54||3
59865003|NCT04682730|75988981|FG005|Deliberative Forum|Overall Study||55||3
59865004|NCT04682730|75988976|FG000|Surveys Received|Overall Study||8||1
59865005|NCT04682730|75988977|FG001|Surveys Received|Overall Study||70||3
59865006|NCT04682730|75988978|FG002|Surveys Received|Overall Study||55||3
59865007|NCT04682730|75988979|FG003|Surveys Received|Overall Study||42||3
59865008|NCT04682730|75988980|FG004|Surveys Received|Overall Study||48||3
59865009|NCT04682730|75988981|FG005|Surveys Received|Overall Study||30||3
59865010|NCT04682730|75988976|FG000|COMPLETED|Overall Study||8||1
59865011|NCT04682730|75988977|FG001|COMPLETED|Overall Study||70||3
59865012|NCT04682730|75988978|FG002|COMPLETED|Overall Study||55||3
59865013|NCT04682730|75988979|FG003|COMPLETED|Overall Study||42||3
59865014|NCT04682730|75988980|FG004|COMPLETED|Overall Study||48||3
59865015|NCT04682730|75988981|FG005|COMPLETED|Overall Study|Out of 896 potential participants (providers and staff employed at 16 intervention clinics at KP) 253 completed all study components.|30||3
59865016|NCT04682730|75988976|FG000|NOT COMPLETED|Overall Study||39||0
59865017|NCT04682730|75988977|FG001|NOT COMPLETED|Overall Study||96||0
59865018|NCT04682730|75988978|FG002|NOT COMPLETED|Overall Study||135||0
59865019|NCT04682730|75988979|FG003|NOT COMPLETED|Overall Study||122||0
59865020|NCT04682730|75988980|FG004|NOT COMPLETED|Overall Study||83||0
59865021|NCT04682730|75988981|FG005|NOT COMPLETED|Overall Study||168||0
59865022|NCT04634253|75988990|FG000|STARTED|Overall Study||24||
59865023|NCT04634253|75988991|FG001|STARTED|Overall Study||25||
59865024|NCT04634253|75988992|FG002|STARTED|Overall Study||49||
59865025|NCT04634253|75988990|FG000|Received at Least One Dose|Overall Study||24||
59865026|NCT04634253|75988991|FG001|Received at Least One Dose|Overall Study||25||
59865027|NCT04634253|75988992|FG002|Received at Least One Dose|Overall Study||49||
59865028|NCT04634253|75988990|FG000|COMPLETED|Overall Study||22||
59865029|NCT04634253|75988991|FG001|COMPLETED|Overall Study||23||
59865030|NCT04634253|75988992|FG002|COMPLETED|Overall Study||46||
59865031|NCT04634253|75988990|FG000|NOT COMPLETED|Overall Study||2||
59865032|NCT04634253|75988991|FG001|NOT COMPLETED|Overall Study||2||
59865033|NCT04634253|75988992|FG002|NOT COMPLETED|Overall Study||3||
59865034|NCT04549259|75989018|FG000|STARTED|Overall Study||4||
59865035|NCT04549259|75989019|FG001|STARTED|Overall Study||4||
59865036|NCT04549259|75989020|FG002|STARTED|Overall Study||3||
59865037|NCT04549259|75989021|FG003|STARTED|Overall Study||3||
59865038|NCT04549259|75989022|FG004|STARTED|Overall Study||4||
59865039|NCT04549259|75989023|FG005|STARTED|Overall Study||4||
59865040|NCT04549259|75989024|FG006|STARTED|Overall Study||4||
59865041|NCT04549259|75989025|FG007|STARTED|Overall Study||4||
59999764|NCT01874353|76115471|FG001|COMPLETED|Overall Study||26||
59999765|NCT01874353|76115472|FG002|COMPLETED|Overall Study||7||
59999766|NCT01874353|76115473|FG003|COMPLETED|Overall Study||3||
59865042|NCT04549259|75989026|FG008|STARTED|Overall Study||4||
59865043|NCT04549259|75989027|FG009|STARTED|Overall Study||3||
59865044|NCT04549259|75989028|FG010|STARTED|Overall Study||4||
59865045|NCT04549259|75989029|FG011|STARTED|Overall Study||4||
59865046|NCT04549259|75989030|FG012|STARTED|Overall Study||4||
59865047|NCT04549259|75989031|FG013|STARTED|Overall Study||4||
59865048|NCT04549259|75989032|FG014|STARTED|Overall Study||4||
59865049|NCT04549259|75989033|FG015|STARTED|Overall Study||4||
59865050|NCT04549259|75989018|FG000|COMPLETED|Overall Study||4||
59865051|NCT04549259|75989019|FG001|COMPLETED|Overall Study||4||
59865052|NCT04549259|75989020|FG002|COMPLETED|Overall Study||3||
59865053|NCT04549259|75989021|FG003|COMPLETED|Overall Study||2||
59865054|NCT04549259|75989022|FG004|COMPLETED|Overall Study||4||
59865055|NCT04549259|75989023|FG005|COMPLETED|Overall Study||2||
59865056|NCT04549259|75989024|FG006|COMPLETED|Overall Study||3||
59865057|NCT04549259|75989025|FG007|COMPLETED|Overall Study||2||
59865058|NCT04549259|75989026|FG008|COMPLETED|Overall Study||3||
59865059|NCT04549259|75989027|FG009|COMPLETED|Overall Study||3||
59865060|NCT04549259|75989028|FG010|COMPLETED|Overall Study||4||
59865061|NCT04549259|75989029|FG011|COMPLETED|Overall Study||3||
59865062|NCT04549259|75989030|FG012|COMPLETED|Overall Study||3||
59865063|NCT04549259|75989031|FG013|COMPLETED|Overall Study||3||
59865064|NCT04549259|75989032|FG014|COMPLETED|Overall Study||4||
59865065|NCT04549259|75989033|FG015|COMPLETED|Overall Study||4||
59865066|NCT04549259|75989018|FG000|NOT COMPLETED|Overall Study||0||
59865067|NCT04549259|75989019|FG001|NOT COMPLETED|Overall Study||0||
59865068|NCT04549259|75989020|FG002|NOT COMPLETED|Overall Study||0||
59865069|NCT04549259|75989021|FG003|NOT COMPLETED|Overall Study||1||
59865070|NCT04549259|75989022|FG004|NOT COMPLETED|Overall Study||0||
59865071|NCT04549259|75989023|FG005|NOT COMPLETED|Overall Study||2||
59865072|NCT04549259|75989024|FG006|NOT COMPLETED|Overall Study||1||
59865073|NCT04549259|75989025|FG007|NOT COMPLETED|Overall Study||2||
59865074|NCT04549259|75989026|FG008|NOT COMPLETED|Overall Study||1||
59865075|NCT04549259|75989027|FG009|NOT COMPLETED|Overall Study||0||
59865076|NCT04549259|75989028|FG010|NOT COMPLETED|Overall Study||0||
59865077|NCT04549259|75989029|FG011|NOT COMPLETED|Overall Study||1||
59865078|NCT04549259|75989030|FG012|NOT COMPLETED|Overall Study||1||
59865079|NCT04549259|75989031|FG013|NOT COMPLETED|Overall Study||1||
59865080|NCT04549259|75989032|FG014|NOT COMPLETED|Overall Study||0||
59865081|NCT04549259|75989033|FG015|NOT COMPLETED|Overall Study||0||
59865082|NCT04209634|75989059|FG000|STARTED|Overall Study||10||
59865083|NCT04209634|75989059|FG000|COMPLETED|Overall Study||0||
59865084|NCT04209634|75989059|FG000|NOT COMPLETED|Overall Study||10||
59865085|NCT03915951|75989065|FG000|STARTED|Overall Study||59||
59865086|NCT03915951|75989066|FG001|STARTED|Overall Study||39||
59865087|NCT03915951|75989065|FG000|COMPLETED|Overall Study||0||
59865088|NCT03915951|75989066|FG001|COMPLETED|Overall Study||0||
59865089|NCT03915951|75989065|FG000|NOT COMPLETED|Overall Study||59||
59865090|NCT03915951|75989066|FG001|NOT COMPLETED|Overall Study||39||
59865091|NCT03793621|75989078|FG000|STARTED|Overall Study||6||
59865092|NCT03793621|75989079|FG001|STARTED|Overall Study||6||
59865093|NCT03793621|75989080|FG002|STARTED|Overall Study||6||
59865094|NCT03793621|75989081|FG003|STARTED|Overall Study||6||
59865095|NCT03793621|75989078|FG000|COMPLETED|Overall Study||6||
59865096|NCT03793621|75989079|FG001|COMPLETED|Overall Study||6||
59865097|NCT03793621|75989080|FG002|COMPLETED|Overall Study||6||
59865098|NCT03793621|75989081|FG003|COMPLETED|Overall Study||6||
59865099|NCT03793621|75989078|FG000|NOT COMPLETED|Overall Study||0||
59865100|NCT03793621|75989079|FG001|NOT COMPLETED|Overall Study||0||
59865101|NCT03793621|75989080|FG002|NOT COMPLETED|Overall Study||0||
59865102|NCT03793621|75989081|FG003|NOT COMPLETED|Overall Study||0||
59865103|NCT03782987|75989095|FG000|STARTED|Period 1||14|Started are treated|
59865104|NCT03782987|75989095|FG000|COMPLETED|Period 1||14||
59865105|NCT03782987|75989095|FG000|NOT COMPLETED|Period 1||0||
59865106|NCT03782987|75989095|FG000|STARTED|Washout Period||14||
59865107|NCT03782987|75989095|FG000|COMPLETED|Washout Period||14||
59865108|NCT03782987|75989095|FG000|NOT COMPLETED|Washout Period||0||
59865109|NCT03782987|75989095|FG000|STARTED|Period 2||14||
59865110|NCT03782987|75989095|FG000|COMPLETED|Period 2||14||
59865111|NCT03782987|75989095|FG000|NOT COMPLETED|Period 2||0||
59865112|NCT03725982|75989104|FG000|STARTED|First Intervention||20||
59865113|NCT03725982|75989105|FG001|STARTED|First Intervention||19||
59865114|NCT03725982|75989104|FG000|COMPLETED|First Intervention||19||
59865115|NCT03725982|75989105|FG001|COMPLETED|First Intervention||17||
59865116|NCT03725982|75989104|FG000|NOT COMPLETED|First Intervention||1||
59865117|NCT03725982|75989105|FG001|NOT COMPLETED|First Intervention||2||
59865118|NCT03725982|75989104|FG000|STARTED|Second Intervention||19||
59865119|NCT03725982|75989105|FG001|STARTED|Second Intervention||17||
59865120|NCT03725982|75989104|FG000|COMPLETED|Second Intervention||19||
59865121|NCT03725982|75989105|FG001|COMPLETED|Second Intervention||17||
59865122|NCT03725982|75989104|FG000|NOT COMPLETED|Second Intervention||0||
59865123|NCT03725982|75989105|FG001|NOT COMPLETED|Second Intervention||0||
59865124|NCT03708770|75989115|FG000|STARTED|Overall Study||32||
59865125|NCT03708770|75989115|FG000|COMPLETED|Overall Study||22||
59865126|NCT03708770|75989115|FG000|NOT COMPLETED|Overall Study||10||
59865127|NCT03664011|75989119|FG000|STARTED|Overall Study||6|Started are treated|
59865128|NCT03664011|75989119|FG000|COMPLETED|Overall Study||6||
59865129|NCT03664011|75989119|FG000|NOT COMPLETED|Overall Study||0||
59865130|NCT03624023|75989124|FG000|STARTED|Overall Study||10||
59865131|NCT03624023|75989124|FG000|COMPLETED|Overall Study||6||
59865132|NCT03624023|75989124|FG000|NOT COMPLETED|Overall Study||4||
59865133|NCT03395080|75989136|FG000|STARTED|Overall Study||29|Number Started is the Safety Analysis Set defined as all subjects who received >= 1 administration of assigned study treatment (DKN-01 or paclitaxel).Subjects with carcinosarcoma were initially enrolled in the EEC group to receive monotherapy or DKN-01+paclitaxel, but as part of a subsequent protocol amendment, carcinosarcoma subjects were enrolled & received 600mg DKN-01 or 600mg DKN-01+paclitaxel. Results are reported by disease type and treatment received.|
59865134|NCT03395080|75989137|FG001|STARTED|Overall Study||24|Number Started is the Safety Analysis Set defined as all subjects who received >= 1 administration of assigned study treatment (DKN-01 or paclitaxel).Subjects with carcinosarcoma were initially enrolled in the EEC group to receive monotherapy or DKN-01+paclitaxel, but as part of a subsequent protocol amendment, carcinosarcoma subjects were enrolled & received 600mg DKN-01 or 600mg DKN-01+paclitaxel. Results are reported by disease type and treatment received.|
59865135|NCT03395080|75989138|FG002|STARTED|Overall Study||14|Number Started is the Safety Analysis Set defined as all subjects who received >= 1 administration of assigned study treatment (DKN-01 or paclitaxel).Subjects with carcinosarcoma were initially enrolled in the EEC group to receive monotherapy or DKN-01+paclitaxel, but as part of a subsequent protocol amendment, carcinosarcoma subjects were enrolled & received 600mg DKN-01 or 600mg DKN-01+paclitaxel. Results are reported by disease type and treatment received.|
59865136|NCT03395080|75989139|FG003|STARTED|Overall Study||19|Number Started is the Safety Analysis Set defined as all subjects who received >= 1 administration of assigned study treatment (DKN-01 or paclitaxel).Subjects with carcinosarcoma were initially enrolled in the EEC group to receive monotherapy or DKN-01+paclitaxel, but as part of a subsequent protocol amendment, carcinosarcoma subjects were enrolled & received 600mg DKN-01 or 600mg DKN-01+paclitaxel. Results are reported by disease type and treatment received.|
59999767|NCT01874353|76115470|FG000|NOT COMPLETED|Overall Study||127||
59999768|NCT01874353|76115471|FG001|NOT COMPLETED|Overall Study||73||
59999769|NCT01874353|76115472|FG002|NOT COMPLETED|Overall Study||15||
59999770|NCT01874353|76115473|FG003|NOT COMPLETED|Overall Study||7||
59999771|NCT01802632|76115491|FG000|STARTED|Overall Study||201||
59999772|NCT01802632|76115492|FG001|STARTED|Overall Study||31||
59999773|NCT01802632|76115493|FG002|STARTED|Overall Study||271||
59999774|NCT01802632|76115494|FG003|STARTED|Overall Study||60||
59999775|NCT01802632|76115495|FG004|STARTED|Overall Study||12||
59999776|NCT01802632|76115496|FG005|STARTED|Overall Study||28||
59999777|NCT01802632|76115491|FG000|COMPLETED|Overall Study||0||
59999778|NCT01802632|76115492|FG001|COMPLETED|Overall Study||0||
59999779|NCT01802632|76115493|FG002|COMPLETED|Overall Study||0||
59999780|NCT01802632|76115494|FG003|COMPLETED|Overall Study||0||
59999781|NCT01802632|76115495|FG004|COMPLETED|Overall Study||0||
59999782|NCT01802632|76115496|FG005|COMPLETED|Overall Study||0||
59999783|NCT01802632|76115491|FG000|NOT COMPLETED|Overall Study||201||
59999784|NCT01802632|76115492|FG001|NOT COMPLETED|Overall Study||31||
59999785|NCT01802632|76115493|FG002|NOT COMPLETED|Overall Study||271||
60132259|NCT01438957|76255018|FG003|COMPLETED|Overall Study||24||
60132260|NCT01438957|76255019|FG004|COMPLETED|Overall Study||25||
60132261|NCT01438957|76255015|FG000|NOT COMPLETED|Overall Study||1||
60132262|NCT01438957|76255016|FG001|NOT COMPLETED|Overall Study||1||
60132263|NCT01438957|76255017|FG002|NOT COMPLETED|Overall Study||0||
60132264|NCT01438957|76255018|FG003|NOT COMPLETED|Overall Study||1||
60132265|NCT01438957|76255019|FG004|NOT COMPLETED|Overall Study||0||
60132266|NCT00589563|76255031|FG000|STARTED|Overall Study||32||
60132267|NCT00589563|76255031|FG000|COMPLETED|Overall Study||32||
60132268|NCT00589563|76255031|FG000|NOT COMPLETED|Overall Study||0||
60132269|NCT00645333|76255035|FG000|STARTED|Overall Study||30||
60132270|NCT00645333|76255035|FG000|COMPLETED|Overall Study||30||
60132271|NCT00645333|76255035|FG000|NOT COMPLETED|Overall Study||0||
60132272|NCT00646581|76255041|FG000|STARTED|Overall Study||15||
60132273|NCT00646581|76255042|FG001|STARTED|Overall Study||15||
60132274|NCT00646581|76255041|FG000|COMPLETED|Overall Study||15||
60132275|NCT00646581|76255042|FG001|COMPLETED|Overall Study||15||
60132276|NCT00646581|76255041|FG000|NOT COMPLETED|Overall Study||0||
60132277|NCT00646581|76255042|FG001|NOT COMPLETED|Overall Study||0||
60132278|NCT00681291|76255050|FG000|STARTED|Overall Study||88||
60132279|NCT00681291|76255051|FG001|STARTED|Overall Study||84||
60132280|NCT00681291|76255050|FG000|COMPLETED|Overall Study||75||
60132281|NCT00681291|76255051|FG001|COMPLETED|Overall Study||57||
60132282|NCT00681291|76255050|FG000|NOT COMPLETED|Overall Study||13||
60132283|NCT00681291|76255051|FG001|NOT COMPLETED|Overall Study||27||
60132284|NCT00648375|76255059|FG000|STARTED|Overall Study||1||
60132285|NCT00648375|76255060|FG001|STARTED|Overall Study||2||
60132286|NCT00648375|76255059|FG000|COMPLETED|Overall Study||1||
60132287|NCT00648375|76255060|FG001|COMPLETED|Overall Study||2||
60132288|NCT00648375|76255059|FG000|NOT COMPLETED|Overall Study||0||
60132289|NCT00648375|76255060|FG001|NOT COMPLETED|Overall Study||0||
60132290|NCT01444417|76255068|FG000|STARTED|Overall Study||20||
59999786|NCT01802632|76115494|FG003|NOT COMPLETED|Overall Study||60||
59999787|NCT01802632|76115495|FG004|NOT COMPLETED|Overall Study||12||
59999788|NCT01802632|76115496|FG005|NOT COMPLETED|Overall Study||28||
59999789|NCT01782131|76115510|FG000|STARTED|Overall Study||293||
60132291|NCT01444417|76255069|FG001|STARTED|Overall Study||42||
60132292|NCT01444417|76255068|FG000|Received Treatment|Overall Study||19||
60132293|NCT01444417|76255069|FG001|Received Treatment|Overall Study||42||
60132294|NCT01444417|76255068|FG000|COMPLETED|Overall Study||18||
60132295|NCT01444417|76255069|FG001|COMPLETED|Overall Study||41||
60132296|NCT01444417|76255068|FG000|NOT COMPLETED|Overall Study||2||
60132297|NCT01444417|76255069|FG001|NOT COMPLETED|Overall Study||1||
60132298|NCT00651573|76255077|FG000|STARTED|Overall Study||365||
60132299|NCT00651573|76255078|FG001|STARTED|Overall Study||357||
60132300|NCT00651573|76255077|FG000|COMPLETED|Overall Study||363||
60132301|NCT00651573|76255078|FG001|COMPLETED|Overall Study||354||
60132302|NCT00651573|76255077|FG000|NOT COMPLETED|Overall Study||2||
60132303|NCT00651573|76255078|FG001|NOT COMPLETED|Overall Study||3||
60132304|NCT00653133|76255086|FG000|STARTED|Overall Study||1324||
60132305|NCT00653133|76255087|FG001|STARTED|Overall Study||497||
60132306|NCT00653133|76255086|FG000|COMPLETED|Overall Study||1324||
60132307|NCT00653133|76255087|FG001|COMPLETED|Overall Study||497||
60132308|NCT00653133|76255086|FG000|NOT COMPLETED|Overall Study||0||
60132309|NCT00653133|76255087|FG001|NOT COMPLETED|Overall Study||0||
60132310|NCT01444027|76255096|FG000|STARTED|Overall Study||172||
60132311|NCT01444027|76255097|FG001|STARTED|Overall Study||171||
60132312|NCT01444027|76255098|FG002|STARTED|Overall Study||171||
60132313|NCT01444027|76255096|FG000|Received Intervention as Assigned|Overall Study||168||
60132314|NCT01444027|76255097|FG001|Received Intervention as Assigned|Overall Study||161||
60132315|NCT01444027|76255098|FG002|Received Intervention as Assigned|Overall Study||147||
60132316|NCT01444027|76255096|FG000|1 Month Follow-up|Overall Study||160||
60132317|NCT01444027|76255097|FG001|1 Month Follow-up|Overall Study||159||
60132318|NCT01444027|76255098|FG002|1 Month Follow-up|Overall Study||141||
60132319|NCT01444027|76255096|FG000|3 Month Follow-up|Overall Study||142||
60132320|NCT01444027|76255097|FG001|3 Month Follow-up|Overall Study||141||
60132321|NCT01444027|76255098|FG002|3 Month Follow-up|Overall Study||133||
60132322|NCT01444027|76255096|FG000|COMPLETED|Overall Study||142||
60132323|NCT01444027|76255097|FG001|COMPLETED|Overall Study||141||
60132324|NCT01444027|76255098|FG002|COMPLETED|Overall Study||133||
60132325|NCT01444027|76255096|FG000|NOT COMPLETED|Overall Study||30||
60132326|NCT01444027|76255097|FG001|NOT COMPLETED|Overall Study||30||
60132327|NCT01444027|76255098|FG002|NOT COMPLETED|Overall Study||38||
60132328|NCT00654069|76255109|FG000|STARTED|Overall Study||136||
60132329|NCT00654069|76255110|FG001|STARTED|Overall Study||135||
60132330|NCT00654069|76255111|FG002|STARTED|Overall Study||134||
60132331|NCT00654069|76255109|FG000|COMPLETED|Overall Study||119||
60132332|NCT00654069|76255110|FG001|COMPLETED|Overall Study||124||
60132333|NCT00654069|76255111|FG002|COMPLETED|Overall Study||116||
60132334|NCT00654069|76255109|FG000|NOT COMPLETED|Overall Study||17||
60132335|NCT00654069|76255110|FG001|NOT COMPLETED|Overall Study||11||
60132336|NCT00654069|76255111|FG002|NOT COMPLETED|Overall Study||18||
60132337|NCT00654147|76255121|FG000|STARTED|Overall Study||21||
60132338|NCT00654147|76255122|FG001|STARTED|Overall Study||23||
60132339|NCT00654147|76255121|FG000|COMPLETED|Overall Study||19||
60132340|NCT00654147|76255122|FG001|COMPLETED|Overall Study||19||
60132341|NCT00654147|76255121|FG000|NOT COMPLETED|Overall Study||2||
60132342|NCT00654147|76255122|FG001|NOT COMPLETED|Overall Study||4||
60132343|NCT00654615|76255130|FG000|STARTED|Overall Study||30||
60132344|NCT00654615|76255131|FG001|STARTED|Overall Study||30||
60132345|NCT00654615|76255130|FG000|COMPLETED|Overall Study||22||
60132346|NCT00654615|76255131|FG001|COMPLETED|Overall Study||23||
60132347|NCT00654615|76255130|FG000|NOT COMPLETED|Overall Study||8||
60132348|NCT00654615|76255131|FG001|NOT COMPLETED|Overall Study||7||
60132349|NCT01438489|76255140|FG000|STARTED|Overall Study||103||
60132350|NCT01438489|76255141|FG001|STARTED|Overall Study||100||
60132351|NCT01438489|76255142|FG002|STARTED|Overall Study||104||
60132352|NCT01438489|76255140|FG000|COMPLETED|Overall Study||77||
60132353|NCT01438489|76255141|FG001|COMPLETED|Overall Study||84||
60132354|NCT01438489|76255142|FG002|COMPLETED|Overall Study||85||
60132355|NCT01438489|76255140|FG000|NOT COMPLETED|Overall Study||26||
60132356|NCT01438489|76255141|FG001|NOT COMPLETED|Overall Study||16||
60132357|NCT01438489|76255142|FG002|NOT COMPLETED|Overall Study||19||
60132358|NCT00654927|76255152|FG000|STARTED|Overall Study||177||
60132359|NCT00654927|76255152|FG000|COMPLETED|Overall Study||70||
60132360|NCT00654927|76255152|FG000|NOT COMPLETED|Overall Study||107||
60132361|NCT00655083|76255158|FG000|STARTED|Overall Study||12||
60132362|NCT00655083|76255159|FG001|STARTED|Overall Study||8||
60132363|NCT00655083|76255158|FG000|COMPLETED|Overall Study||12||
60132364|NCT00655083|76255159|FG001|COMPLETED|Overall Study||8||
60132365|NCT00655083|76255158|FG000|NOT COMPLETED|Overall Study||0||
60132366|NCT00655083|76255159|FG001|NOT COMPLETED|Overall Study||0||
60132367|NCT01418209|76255168|FG000|STARTED|Overall Study||97||
60132368|NCT01418209|76255169|FG001|STARTED|Overall Study||96||
60132369|NCT01418209|76255170|FG002|STARTED|Overall Study||146||
60132370|NCT01418209|76255168|FG000|COMPLETED|Overall Study||95||
60132371|NCT01418209|76255169|FG001|COMPLETED|Overall Study||93||
60132372|NCT01418209|76255170|FG002|COMPLETED|Overall Study||142||
60132373|NCT01418209|76255168|FG000|NOT COMPLETED|Overall Study||2||
60132374|NCT01418209|76255169|FG001|NOT COMPLETED|Overall Study||3||
60132375|NCT01418209|76255170|FG002|NOT COMPLETED|Overall Study||4||
60132376|NCT00655473|76255180|FG000|STARTED|Overall Study||64||
60132377|NCT00655473|76255181|FG001|STARTED|Overall Study||66||
60132378|NCT00655473|76255180|FG000|COMPLETED|Overall Study||53||
60132379|NCT00655473|76255181|FG001|COMPLETED|Overall Study||51||
60132380|NCT00655473|76255180|FG000|NOT COMPLETED|Overall Study||11||
60132381|NCT00655473|76255181|FG001|NOT COMPLETED|Overall Study||15||
60132382|NCT01570361|76255189|FG000|STARTED|Overall Study||128||
60132383|NCT01570361|76255190|FG001|STARTED|Overall Study||127||
60132384|NCT01570361|76255189|FG000|Received Study Treatment|Overall Study||102||
60132385|NCT01570361|76255190|FG001|Received Study Treatment|Overall Study||123||
60132386|NCT01570361|76255189|FG000|Cross-over (AAD Therapy to RF Ablation)|Overall Study||0||
60132387|NCT01570361|76255190|FG001|Cross-over (AAD Therapy to RF Ablation)|Overall Study||15||
60132388|NCT01570361|76255189|FG000|AAD Therapy Only|Overall Study||0||
60132389|NCT01570361|76255190|FG001|AAD Therapy Only|Overall Study||108||
60132390|NCT01570361|76255189|FG000|COMPLETED|Overall Study||46||
60132391|NCT01570361|76255190|FG001|COMPLETED|Overall Study||52||
60132392|NCT01570361|76255189|FG000|NOT COMPLETED|Overall Study||82||
60132393|NCT01570361|76255190|FG001|NOT COMPLETED|Overall Study||75||
60132394|NCT01417195|76255201|FG000|STARTED|Overall Study||60||
60132395|NCT01417195|76255202|FG001|STARTED|Overall Study||62||
60132396|NCT01417195|76255201|FG000|COMPLETED|Overall Study||57||
60132397|NCT01417195|76255202|FG001|COMPLETED|Overall Study||61||
60132398|NCT01417195|76255201|FG000|NOT COMPLETED|Overall Study||3||
60132399|NCT01417195|76255202|FG001|NOT COMPLETED|Overall Study||1||
60132400|NCT00655707|76255209|FG000|STARTED|Overall Study||5||
60132401|NCT00655707|76255209|FG000|COMPLETED|Overall Study||5||
60132402|NCT00655707|76255209|FG000|NOT COMPLETED|Overall Study||0||
60132403|NCT00656487|76255217|FG000|STARTED|Overall Study||23||
60132404|NCT00656487|76255218|FG001|STARTED|Overall Study||23||
60132405|NCT00656487|76255219|FG002|STARTED|Overall Study||20||
60132406|NCT00656487|76255217|FG000|COMPLETED|Overall Study||21||
60132407|NCT00656487|76255218|FG001|COMPLETED|Overall Study||19||
60132408|NCT00656487|76255219|FG002|COMPLETED|Overall Study||20||
60132409|NCT00656487|76255217|FG000|NOT COMPLETED|Overall Study||2||
60132410|NCT00656487|76255218|FG001|NOT COMPLETED|Overall Study||4||
60132411|NCT00656487|76255219|FG002|NOT COMPLETED|Overall Study||0||
60132412|NCT00657657|76255227|FG000|STARTED|Overall Study||29||
60132413|NCT00657657|76255227|FG000|COMPLETED|Overall Study||29||
60132414|NCT00657657|76255227|FG000|NOT COMPLETED|Overall Study||0||
60132415|NCT01443403|76255235|FG000|STARTED|Overall Study||61||
60132416|NCT01443403|76255236|FG001|STARTED|Overall Study||61||
60132417|NCT01443403|76255237|FG002|STARTED|Overall Study||61||
60132418|NCT01443403|76255238|FG003|STARTED|Overall Study||61||
60132419|NCT01443403|76255235|FG000|Received Treatment|Overall Study||61||
60132420|NCT01443403|76255236|FG001|Received Treatment|Overall Study||61||
60132421|NCT01443403|76255237|FG002|Received Treatment|Overall Study||60||
60132422|NCT01443403|76255238|FG003|Received Treatment|Overall Study||61||
60132423|NCT01443403|76255235|FG000|COMPLETED|Overall Study||55||
60132424|NCT01443403|76255236|FG001|COMPLETED|Overall Study||55||
60132425|NCT01443403|76255237|FG002|COMPLETED|Overall Study||54||
60132426|NCT01443403|76255238|FG003|COMPLETED|Overall Study||52||
60132427|NCT01443403|76255235|FG000|NOT COMPLETED|Overall Study||6||
60132428|NCT01443403|76255236|FG001|NOT COMPLETED|Overall Study||6||
60132429|NCT01443403|76255237|FG002|NOT COMPLETED|Overall Study||7||
60132430|NCT01443403|76255238|FG003|NOT COMPLETED|Overall Study||9||
60132431|NCT01438177|76255251|FG000|STARTED|Overall Study||11||
60132432|NCT01438177|76255251|FG000|COMPLETED|Overall Study|Patients who were off due to disease progression|9||
60132433|NCT01438177|76255251|FG000|NOT COMPLETED|Overall Study||2||
60132434|NCT01442779|76255255|FG000|STARTED|Overall Study||18||
60132435|NCT01442779|76255255|FG000|COMPLETED|Overall Study||11||
60132436|NCT01442779|76255255|FG000|NOT COMPLETED|Overall Study||7||
60132437|NCT01416805|76255261|FG000|STARTED|Overall Study||49||
60132438|NCT01416805|76255262|FG001|STARTED|Overall Study||51||
60132439|NCT01416805|76255261|FG000|COMPLETED|Overall Study||45||
60132440|NCT01416805|76255262|FG001|COMPLETED|Overall Study||47||
60132441|NCT01416805|76255261|FG000|NOT COMPLETED|Overall Study||4||
60132442|NCT01416805|76255262|FG001|NOT COMPLETED|Overall Study||4||
60132443|NCT01437943|76255270|FG000|STARTED|Overall Study||7||
60132444|NCT01437943|76255271|FG001|STARTED|Overall Study||3||
60132445|NCT01437943|76255270|FG000|COMPLETED|Overall Study||0||
60132446|NCT01437943|76255271|FG001|COMPLETED|Overall Study||1||
60132447|NCT01437943|76255270|FG000|NOT COMPLETED|Overall Study||7||
60132448|NCT01437943|76255271|FG001|NOT COMPLETED|Overall Study||2||
60132449|NCT01570283|76255280|FG000|STARTED|Cohort 1: Dose Level 1||1||
60132450|NCT01570283|76255281|FG001|STARTED|Cohort 1: Dose Level 1||3||
60132451|NCT01570283|76255282|FG002|STARTED|Cohort 1: Dose Level 1||0||
60132452|NCT01570283|76255283|FG003|STARTED|Cohort 1: Dose Level 1||0||
60132453|NCT01570283|76255284|FG004|STARTED|Cohort 1: Dose Level 1||0||
60132454|NCT01570283|76255285|FG005|STARTED|Cohort 1: Dose Level 1||0||
60132455|NCT01570283|76255280|FG000|COMPLETED|Cohort 1: Dose Level 1||1||
60132456|NCT01570283|76255281|FG001|COMPLETED|Cohort 1: Dose Level 1||1||
60132457|NCT01570283|76255282|FG002|COMPLETED|Cohort 1: Dose Level 1||0||
60132458|NCT01570283|76255283|FG003|COMPLETED|Cohort 1: Dose Level 1||0||
60132459|NCT01570283|76255284|FG004|COMPLETED|Cohort 1: Dose Level 1||0||
60132460|NCT01570283|76255285|FG005|COMPLETED|Cohort 1: Dose Level 1||0||
60132461|NCT01570283|76255280|FG000|NOT COMPLETED|Cohort 1: Dose Level 1||0||
60132462|NCT01570283|76255281|FG001|NOT COMPLETED|Cohort 1: Dose Level 1||2||
60132463|NCT01570283|76255282|FG002|NOT COMPLETED|Cohort 1: Dose Level 1||0||
60132464|NCT01570283|76255283|FG003|NOT COMPLETED|Cohort 1: Dose Level 1||0||
60132465|NCT01570283|76255284|FG004|NOT COMPLETED|Cohort 1: Dose Level 1||0||
60132466|NCT01570283|76255285|FG005|NOT COMPLETED|Cohort 1: Dose Level 1||0||
60132467|NCT01570283|76255280|FG000|STARTED|Cohort 2: Dose Level 2||0||
60132468|NCT01570283|76255281|FG001|STARTED|Cohort 2: Dose Level 2||0||
60132469|NCT01570283|76255282|FG002|STARTED|Cohort 2: Dose Level 2||2||
60132470|NCT01570283|76255283|FG003|STARTED|Cohort 2: Dose Level 2||2||
60132471|NCT01570283|76255284|FG004|STARTED|Cohort 2: Dose Level 2||0||
60132472|NCT01570283|76255285|FG005|STARTED|Cohort 2: Dose Level 2||0||
60132473|NCT01570283|76255280|FG000|COMPLETED|Cohort 2: Dose Level 2||0||
60132474|NCT01570283|76255281|FG001|COMPLETED|Cohort 2: Dose Level 2||0||
60132475|NCT01570283|76255282|FG002|COMPLETED|Cohort 2: Dose Level 2||1||
60132476|NCT01570283|76255283|FG003|COMPLETED|Cohort 2: Dose Level 2||1||
60132477|NCT01570283|76255284|FG004|COMPLETED|Cohort 2: Dose Level 2||0||
60132478|NCT01570283|76255285|FG005|COMPLETED|Cohort 2: Dose Level 2||0||
60132479|NCT01570283|76255280|FG000|NOT COMPLETED|Cohort 2: Dose Level 2||0||
60132480|NCT01570283|76255281|FG001|NOT COMPLETED|Cohort 2: Dose Level 2||0||
60132481|NCT01570283|76255282|FG002|NOT COMPLETED|Cohort 2: Dose Level 2||1||
60132482|NCT01570283|76255283|FG003|NOT COMPLETED|Cohort 2: Dose Level 2||1||
60132483|NCT01570283|76255284|FG004|NOT COMPLETED|Cohort 2: Dose Level 2||0||
60132484|NCT01570283|76255285|FG005|NOT COMPLETED|Cohort 2: Dose Level 2||0||
60132485|NCT01570283|76255280|FG000|STARTED|Cohort 3: Dose Level 3||0||
60132486|NCT01570283|76255281|FG001|STARTED|Cohort 3: Dose Level 3||0||
60132487|NCT01570283|76255282|FG002|STARTED|Cohort 3: Dose Level 3||0||
60132488|NCT01570283|76255283|FG003|STARTED|Cohort 3: Dose Level 3||0||
60132489|NCT01570283|76255284|FG004|STARTED|Cohort 3: Dose Level 3||1||
60132490|NCT01570283|76255285|FG005|STARTED|Cohort 3: Dose Level 3||12||
60132491|NCT01570283|76255280|FG000|COMPLETED|Cohort 3: Dose Level 3||0||
60132492|NCT01570283|76255281|FG001|COMPLETED|Cohort 3: Dose Level 3||0||
60132493|NCT01570283|76255282|FG002|COMPLETED|Cohort 3: Dose Level 3||0||
60132494|NCT01570283|76255283|FG003|COMPLETED|Cohort 3: Dose Level 3||0||
60132495|NCT01570283|76255284|FG004|COMPLETED|Cohort 3: Dose Level 3||1||
60132496|NCT01570283|76255285|FG005|COMPLETED|Cohort 3: Dose Level 3||10||
60132497|NCT01570283|76255280|FG000|NOT COMPLETED|Cohort 3: Dose Level 3||0||
60132498|NCT01570283|76255281|FG001|NOT COMPLETED|Cohort 3: Dose Level 3||0||
60132499|NCT01570283|76255282|FG002|NOT COMPLETED|Cohort 3: Dose Level 3||0||
60132500|NCT01570283|76255283|FG003|NOT COMPLETED|Cohort 3: Dose Level 3||0||
60132501|NCT01570283|76255284|FG004|NOT COMPLETED|Cohort 3: Dose Level 3||0||
60132502|NCT01570283|76255285|FG005|NOT COMPLETED|Cohort 3: Dose Level 3||2||
60132503|NCT01436357|76255301|FG000|STARTED|Overall Study||274||
60132504|NCT01436357|76255302|FG001|STARTED|Overall Study||274||
60132505|NCT01436357|76255301|FG000|Stage 1|Overall Study||49||
60132506|NCT01436357|76255302|FG001|Stage 1|Overall Study||48||
60132507|NCT01436357|76255301|FG000|Stage 2|Overall Study||225||
60132508|NCT01436357|76255302|FG001|Stage 2|Overall Study||226||
60132509|NCT01436357|76255301|FG000|COMPLETED|Overall Study||152||
60132510|NCT01436357|76255302|FG001|COMPLETED|Overall Study||146||
60132511|NCT01436357|76255301|FG000|NOT COMPLETED|Overall Study||122||
60132512|NCT01436357|76255302|FG001|NOT COMPLETED|Overall Study||128||
60132513|NCT01436201|76255308|FG000|STARTED|Overall Study||24||
60132514|NCT01436201|76255308|FG000|Received at Least 1 Dose of Study Drug|Overall Study||24||
60132515|NCT01436201|76255308|FG000|COMPLETED|Overall Study||20||
60132516|NCT01436201|76255308|FG000|NOT COMPLETED|Overall Study||4||
60132517|NCT01437397|76255319|FG000|STARTED|Overall Study||338||
60132518|NCT01437397|76255320|FG001|STARTED|Overall Study||338||
60132519|NCT01437397|76255321|FG002|STARTED|Overall Study||340||
60132520|NCT01437397|76255322|FG003|STARTED|Overall Study||339||
60132521|NCT01437397|76255323|FG004|STARTED|Overall Study||337||
60132522|NCT01437397|76255319|FG000|COMPLETED|Overall Study||272||
60132523|NCT01437397|76255320|FG001|COMPLETED|Overall Study||276||
60132524|NCT01437397|76255321|FG002|COMPLETED|Overall Study||268||
60132525|NCT01437397|76255322|FG003|COMPLETED|Overall Study||270||
60132526|NCT01437397|76255323|FG004|COMPLETED|Overall Study||236||
60132527|NCT01437397|76255319|FG000|NOT COMPLETED|Overall Study||66||
60132528|NCT01437397|76255320|FG001|NOT COMPLETED|Overall Study||62||
60132529|NCT01437397|76255321|FG002|NOT COMPLETED|Overall Study||72||
60132530|NCT01437397|76255322|FG003|NOT COMPLETED|Overall Study||69||
60132531|NCT01437397|76255323|FG004|NOT COMPLETED|Overall Study||101||
60132532|NCT01437319|76255335|FG000|STARTED|Phase I||282||
60132533|NCT01437319|76255336|FG001|STARTED|Phase I||0||
60132534|NCT01437319|76255337|FG002|STARTED|Phase I||0||
60132535|NCT01437319|76255335|FG000|COMPLETED|Phase I||227||
60132536|NCT01437319|76255336|FG001|COMPLETED|Phase I||0||
60132537|NCT01437319|76255337|FG002|COMPLETED|Phase I||0||
60132538|NCT01437319|76255335|FG000|NOT COMPLETED|Phase I||55||
60132539|NCT01437319|76255336|FG001|NOT COMPLETED|Phase I||0||
60132540|NCT01437319|76255337|FG002|NOT COMPLETED|Phase I||0||
60132541|NCT01437319|76255335|FG000|STARTED|Phase II||0||
60132542|NCT01437319|76255336|FG001|STARTED|Phase II||115||
60132543|NCT01437319|76255337|FG002|STARTED|Phase II||112||
60132544|NCT01437319|76255335|FG000|COMPLETED|Phase II||0||
60132545|NCT01437319|76255336|FG001|COMPLETED|Phase II||71||
60132546|NCT01437319|76255337|FG002|COMPLETED|Phase II||75||
60132547|NCT01437319|76255335|FG000|NOT COMPLETED|Phase II||0||
60132548|NCT01437319|76255336|FG001|NOT COMPLETED|Phase II||44||
60132549|NCT01437319|76255337|FG002|NOT COMPLETED|Phase II||37||
60132550|NCT01416571|76255346|FG000|STARTED|Overall Study||78||
60132551|NCT01416571|76255346|FG000|COMPLETED|Overall Study|Number of subjects completed at Day 385.|76||
60132552|NCT01416571|76255346|FG000|NOT COMPLETED|Overall Study||2||
60132553|NCT04070833|76255354|FG000|STARTED|Overall Study||66||
60132554|NCT04070833|76255355|FG001|STARTED|Overall Study||75||
60132555|NCT04070833|76255356|FG002|STARTED|Overall Study||82||
60132556|NCT04070833|76255357|FG003|STARTED|Overall Study||67||
60132557|NCT04070833|76255354|FG000|COMPLETED|Overall Study||58||
60132558|NCT04070833|76255355|FG001|COMPLETED|Overall Study||69||
60132559|NCT04070833|76255356|FG002|COMPLETED|Overall Study||71||
60132560|NCT04070833|76255357|FG003|COMPLETED|Overall Study||60||
60132561|NCT04070833|76255354|FG000|NOT COMPLETED|Overall Study||8||
60132562|NCT04070833|76255355|FG001|NOT COMPLETED|Overall Study||6||
60132563|NCT04070833|76255356|FG002|NOT COMPLETED|Overall Study||11||
60132564|NCT04070833|76255357|FG003|NOT COMPLETED|Overall Study||7||
60132565|NCT01442155|76255367|FG000|STARTED|Overall Study||74||
60132566|NCT01442155|76255367|FG000|COMPLETED|Overall Study||9||
60132567|NCT01442155|76255367|FG000|NOT COMPLETED|Overall Study||65||
60132568|NCT01416181|76255373|FG000|STARTED|Part 1||449||
60132569|NCT01416181|76255374|FG001|STARTED|Part 1||440||
60132570|NCT01416181|76255373|FG000|Withdrew Prior to Dosing|Part 1||0||
60132571|NCT01416181|76255374|FG001|Withdrew Prior to Dosing|Part 1||1||
60132572|NCT01416181|76255373|FG000|COMPLETED|Part 1|Completed Study through Week 108|312||
60132573|NCT01416181|76255374|FG001|COMPLETED|Part 1|Completed Study through Week 108|326||
60132574|NCT01416181|76255373|FG000|NOT COMPLETED|Part 1||137||
60132575|NCT01416181|76255374|FG001|NOT COMPLETED|Part 1||114||
60132576|NCT01416181|76255373|FG000|STARTED|Part 2||274||
60132577|NCT01416181|76255374|FG001|STARTED|Part 2||292||
60132578|NCT01416181|76255373|FG000|Completed Treatment for 48 Weeks|Part 2|completed study treatment for 48 weeks in Part 2|98||
60132579|NCT01416181|76255374|FG001|Completed Treatment for 48 Weeks|Part 2|completed study treatment for 48 weeks in Part 2|111||
60132580|NCT01416181|76255373|FG000|Completed Treatment for 96 Weeks|Part 2|completed study treatment for 96 weeks in Part 2|1||
60132581|NCT01416181|76255374|FG001|Completed Treatment for 96 Weeks|Part 2|completed study treatment for 96 weeks in Part 2|0||
60132582|NCT01416181|76255373|FG000|Completed Treatment for > 96 Weeks|Part 2||1||
60132583|NCT01416181|76255374|FG001|Completed Treatment for > 96 Weeks|Part 2||0||
60132584|NCT01416181|76255373|FG000|COMPLETED|Part 2||3||
60132585|NCT01416181|76255374|FG001|COMPLETED|Part 2||6||
60132586|NCT01416181|76255373|FG000|NOT COMPLETED|Part 2||271||
60132587|NCT01416181|76255374|FG001|NOT COMPLETED|Part 2||286||
60132588|NCT01441765|76255382|FG000|STARTED|Overall Study||11||
60132589|NCT01441765|76255383|FG001|STARTED|Overall Study|not opened|0||
60132590|NCT01441765|76255382|FG000|COMPLETED|Overall Study||10||
60132591|NCT01441765|76255383|FG001|COMPLETED|Overall Study|not opened|0||
60132592|NCT01441765|76255382|FG000|NOT COMPLETED|Overall Study||1||
60132593|NCT01441765|76255383|FG001|NOT COMPLETED|Overall Study||0||
60132594|NCT01419665|76255391|FG000|STARTED|Combination Treatment||312||
60132595|NCT01419665|76255392|FG001|STARTED|Combination Treatment||315||
60132596|NCT01419665|76255391|FG000|COMPLETED|Combination Treatment||274|completed treatment at week 24|
60132597|NCT01419665|76255392|FG001|COMPLETED|Combination Treatment||274|completed treatment at week 24|
60132598|NCT01419665|76255391|FG000|NOT COMPLETED|Combination Treatment||38||
60132599|NCT01419665|76255392|FG001|NOT COMPLETED|Combination Treatment||41||
60132600|NCT01419665|76255391|FG000|STARTED|Maintenance Treatment and/or Follow up||254||
60132601|NCT01419665|76255392|FG001|STARTED|Maintenance Treatment and/or Follow up||252||
60132602|NCT01419665|76255391|FG000|COMPLETED|Maintenance Treatment and/or Follow up||132||
60132603|NCT01419665|76255392|FG001|COMPLETED|Maintenance Treatment and/or Follow up||150||
59865137|NCT03395080|75989140|FG004|STARTED|Overall Study||1|Number Started is the Safety Analysis Set defined as all subjects who received >= 1 administration of assigned study treatment (DKN-01 or paclitaxel).Subjects with carcinosarcoma were initially enrolled in the EEC group to receive monotherapy or DKN-01+paclitaxel, but as part of a subsequent protocol amendment, carcinosarcoma subjects were enrolled & received 600mg DKN-01 or 600mg DKN-01+paclitaxel. Results are reported by disease type and treatment received.|
60132604|NCT01419665|76255391|FG000|NOT COMPLETED|Maintenance Treatment and/or Follow up||122||
60132605|NCT01419665|76255392|FG001|NOT COMPLETED|Maintenance Treatment and/or Follow up||102||
60132606|NCT01419665|76255391|FG000|STARTED|Open Label Phase||44||
60132607|NCT01419665|76255392|FG001|STARTED|Open Label Phase||39||
60132608|NCT01419665|76255391|FG000|COMPLETED|Open Label Phase||43||
60132609|NCT01419665|76255392|FG001|COMPLETED|Open Label Phase||38||
60132610|NCT01419665|76255391|FG000|NOT COMPLETED|Open Label Phase||1||
60132611|NCT01419665|76255392|FG001|NOT COMPLETED|Open Label Phase||1||
60132612|NCT01436305|76255403|FG000|STARTED|Overall Study||6||
60132613|NCT01436305|76255404|FG001|STARTED|Overall Study||6||
60132614|NCT01436305|76255405|FG002|STARTED|Overall Study||7||
60132615|NCT01436305|76255403|FG000|COMPLETED|Overall Study||4||
60132616|NCT01436305|76255404|FG001|COMPLETED|Overall Study||2||
60132617|NCT01436305|76255405|FG002|COMPLETED|Overall Study||7||
60132618|NCT01436305|76255403|FG000|NOT COMPLETED|Overall Study||2||
60132619|NCT01436305|76255404|FG001|NOT COMPLETED|Overall Study||4||
60132620|NCT01436305|76255405|FG002|NOT COMPLETED|Overall Study||0||
60132621|NCT01436149|76255415|FG000|STARTED|Antidepressant Lead-in Phase|Twenty-three subjects were enrolled but not dosed.|1262||
60132622|NCT01436149|76255416|FG001|STARTED|Antidepressant Lead-in Phase||0||
60132623|NCT01436149|76255417|FG002|STARTED|Antidepressant Lead-in Phase||0||
60132624|NCT01436149|76255415|FG000|COMPLETED|Antidepressant Lead-in Phase||896||
60132625|NCT01436149|76255416|FG001|COMPLETED|Antidepressant Lead-in Phase||0||
60132626|NCT01436149|76255417|FG002|COMPLETED|Antidepressant Lead-in Phase||0||
60132627|NCT01436149|76255415|FG000|NOT COMPLETED|Antidepressant Lead-in Phase||366||
60132628|NCT01436149|76255416|FG001|NOT COMPLETED|Antidepressant Lead-in Phase||0||
60132629|NCT01436149|76255417|FG002|NOT COMPLETED|Antidepressant Lead-in Phase||0||
60132630|NCT01436149|76255415|FG000|STARTED|Randomized Phase|These subjects were not included in the Safety Analysis Set or Full Analysis Set.|492||
60132631|NCT01436149|76255416|FG001|STARTED|Randomized Phase|One subject did not receive at least 1 dose of double-blind treatment.|202||
60132632|NCT01436149|76255417|FG002|STARTED|Randomized Phase|One subject did not receive at least 1 dose of double-blind treatment.|202||
60132633|NCT01436149|76255415|FG000|COMPLETED|Randomized Phase||415||
60132634|NCT01436149|76255416|FG001|COMPLETED|Randomized Phase||164||
60132635|NCT01436149|76255417|FG002|COMPLETED|Randomized Phase|1 subject completed the study without a Visit 14 MADRS and was not included in the completers set.|160||
60132636|NCT01436149|76255415|FG000|NOT COMPLETED|Randomized Phase||77||
60132637|NCT01436149|76255416|FG001|NOT COMPLETED|Randomized Phase||38||
60132638|NCT01436149|76255417|FG002|NOT COMPLETED|Randomized Phase||42||
60132639|NCT01415401|76255423|FG000|STARTED|Overall Study||54||
60132640|NCT01415401|76255423|FG000|COMPLETED|Overall Study||47||
60132641|NCT01415401|76255423|FG000|NOT COMPLETED|Overall Study||7||
60132642|NCT01414855|76255427|FG000|STARTED|Overall Study||100||
60132643|NCT01414855|76255427|FG000|COMPLETED|Overall Study||71||
60132644|NCT01414855|76255427|FG000|NOT COMPLETED|Overall Study||29||
60132645|NCT01527500|76255435|FG000|STARTED|Part A||99||
60132646|NCT01527500|76255436|FG001|STARTED|Part A||51||
60132647|NCT01527500|76255435|FG000|COMPLETED|Part A||69||
60132648|NCT01527500|76255436|FG001|COMPLETED|Part A||38||
60132649|NCT01527500|76255435|FG000|NOT COMPLETED|Part A||30||
60132650|NCT01527500|76255436|FG001|NOT COMPLETED|Part A||13||
60132651|NCT01527500|76255435|FG000|STARTED|Part B||7||
60132652|NCT01527500|76255436|FG001|STARTED|Part B||1||
60132653|NCT01527500|76255435|FG000|COMPLETED|Part B||6||
60132654|NCT01527500|76255436|FG001|COMPLETED|Part B||1||
60132655|NCT01527500|76255435|FG000|NOT COMPLETED|Part B||1||
60132656|NCT01527500|76255436|FG001|NOT COMPLETED|Part B||0||
60132657|NCT02074735|76255454|FG000|STARTED|Overall Study||29||
60132658|NCT02074735|76255455|FG001|STARTED|Overall Study||33||
60132659|NCT02074735|76255454|FG000|COMPLETED|Overall Study||26||
60132660|NCT02074735|76255455|FG001|COMPLETED|Overall Study||29||
60132661|NCT02074735|76255454|FG000|NOT COMPLETED|Overall Study||3||
60132662|NCT02074735|76255455|FG001|NOT COMPLETED|Overall Study||4||
60132663|NCT01527110|76255461|FG000|STARTED|Overall Study||21||
60132664|NCT01527110|76255461|FG000|COMPLETED|Overall Study||20||
60132665|NCT01527110|76255461|FG000|NOT COMPLETED|Overall Study||1||
60132666|NCT01441063|76255465|FG000|STARTED|Tocilizumab Alone||8||
60132667|NCT01441063|76255465|FG000|COMPLETED|Tocilizumab Alone||5||
60132668|NCT01441063|76255465|FG000|NOT COMPLETED|Tocilizumab Alone||3||
60132669|NCT01441063|76255465|FG000|STARTED|Tocilizumab + Zidovudine /Valganciclovir||3||
60132670|NCT01441063|76255465|FG000|COMPLETED|Tocilizumab + Zidovudine /Valganciclovir||2||
60132671|NCT01441063|76255465|FG000|NOT COMPLETED|Tocilizumab + Zidovudine /Valganciclovir||1||
60132672|NCT01436071|76255474|FG000|STARTED|Overall Study|These participants were randomized to trial medication.|124||
60132673|NCT01436071|76255475|FG001|STARTED|Overall Study|These participants were randomized to trial medication.|124||
60132674|NCT01436071|76255474|FG000|Safety Population|Overall Study|These randomized participants received at least a single dose of trial medication.|121||
60132675|NCT01436071|76255475|FG001|Safety Population|Overall Study|These randomized participants received at least a single dose of trial medication.|121||
60132676|NCT01436071|76255474|FG000|COMPLETED|Overall Study||98||
60132677|NCT01436071|76255475|FG001|COMPLETED|Overall Study||110||
60132678|NCT01436071|76255474|FG000|NOT COMPLETED|Overall Study||26||
60132679|NCT01436071|76255475|FG001|NOT COMPLETED|Overall Study||14||
60132680|NCT01514240|76255483|FG000|STARTED|Overall Study||56||
60132681|NCT01514240|76255484|FG001|STARTED|Overall Study||56||
60132682|NCT01514240|76255483|FG000|COMPLETED|Overall Study||50||
60132683|NCT01514240|76255484|FG001|COMPLETED|Overall Study||45||
60132684|NCT01514240|76255483|FG000|NOT COMPLETED|Overall Study||6||
60132685|NCT01514240|76255484|FG001|NOT COMPLETED|Overall Study||11||
60132686|NCT01435759|76255495|FG000|STARTED|Antidepressant Lead-in Phase|Of these 1197 subjects, 19 subjects were not dosed.|1197||
60132687|NCT01435759|76255496|FG001|STARTED|Antidepressant Lead-in Phase||0||
60132688|NCT01435759|76255497|FG002|STARTED|Antidepressant Lead-in Phase||0||
60132689|NCT01435759|76255498|FG003|STARTED|Antidepressant Lead-in Phase||0||
60132690|NCT01435759|76255499|FG004|STARTED|Antidepressant Lead-in Phase||0||
60132691|NCT01435759|76255500|FG005|STARTED|Antidepressant Lead-in Phase||0||
60132692|NCT01435759|76255495|FG000|COMPLETED|Antidepressant Lead-in Phase||855||
60132693|NCT01435759|76255496|FG001|COMPLETED|Antidepressant Lead-in Phase||0||
60132694|NCT01435759|76255497|FG002|COMPLETED|Antidepressant Lead-in Phase||0||
60132695|NCT01435759|76255498|FG003|COMPLETED|Antidepressant Lead-in Phase||0||
60132696|NCT01435759|76255499|FG004|COMPLETED|Antidepressant Lead-in Phase||0||
60132697|NCT01435759|76255500|FG005|COMPLETED|Antidepressant Lead-in Phase||0||
60132698|NCT01435759|76255495|FG000|NOT COMPLETED|Antidepressant Lead-in Phase||342||
60132699|NCT01435759|76255496|FG001|NOT COMPLETED|Antidepressant Lead-in Phase||0||
60132700|NCT01435759|76255497|FG002|NOT COMPLETED|Antidepressant Lead-in Phase||0||
60132701|NCT01435759|76255498|FG003|NOT COMPLETED|Antidepressant Lead-in Phase||0||
60132702|NCT01435759|76255499|FG004|NOT COMPLETED|Antidepressant Lead-in Phase||0||
60132703|NCT01435759|76255500|FG005|NOT COMPLETED|Antidepressant Lead-in Phase||0||
60132704|NCT01435759|76255495|FG000|STARTED|Double-blind Phase|These subjects were not included in the Safety Dose Response Evaluable Set or Safety Analysis Set.|463||
60132705|NCT01435759|76255496|FG001|STARTED|Double-blind Phase||78||
60132706|NCT01435759|76255497|FG002|STARTED|Double-blind Phase|One subject was not dosed.|78||
60132707|NCT01435759|76255498|FG003|STARTED|Double-blind Phase|Two subjects were not dosed.|78||
60132708|NCT01435759|76255499|FG004|STARTED|Double-blind Phase||78||
60132709|NCT01435759|76255500|FG005|STARTED|Double-blind Phase||80||
60132710|NCT01435759|76255495|FG000|COMPLETED|Double-blind Phase||397||
60132711|NCT01435759|76255496|FG001|COMPLETED|Double-blind Phase||71||
60132712|NCT01435759|76255497|FG002|COMPLETED|Double-blind Phase||71||
60132713|NCT01435759|76255498|FG003|COMPLETED|Double-blind Phase||69||
60132714|NCT01435759|76255499|FG004|COMPLETED|Double-blind Phase||69||
60132715|NCT01435759|76255500|FG005|COMPLETED|Double-blind Phase||71||
60132716|NCT01435759|76255495|FG000|NOT COMPLETED|Double-blind Phase||66||
60132717|NCT01435759|76255496|FG001|NOT COMPLETED|Double-blind Phase||7||
60132718|NCT01435759|76255497|FG002|NOT COMPLETED|Double-blind Phase||7||
60132719|NCT01435759|76255498|FG003|NOT COMPLETED|Double-blind Phase||9||
60132720|NCT01435759|76255499|FG004|NOT COMPLETED|Double-blind Phase||9||
60132721|NCT01435759|76255500|FG005|NOT COMPLETED|Double-blind Phase||9||
60132722|NCT01393405|76255512|FG000|STARTED|Induction Period (week1-16)||179||
60132723|NCT01393405|76255513|FG001|STARTED|Induction Period (week1-16)||0||
60132724|NCT01393405|76255514|FG002|STARTED|Induction Period (week1-16)||0||
60132725|NCT01393405|76255512|FG000|COMPLETED|Induction Period (week1-16)||84||
60132726|NCT01393405|76255513|FG001|COMPLETED|Induction Period (week1-16)||0||
60132727|NCT01393405|76255514|FG002|COMPLETED|Induction Period (week1-16)||0||
60132728|NCT01393405|76255512|FG000|NOT COMPLETED|Induction Period (week1-16)||95||
60132729|NCT01393405|76255513|FG001|NOT COMPLETED|Induction Period (week1-16)||0||
60132730|NCT01393405|76255514|FG002|NOT COMPLETED|Induction Period (week1-16)||0||
60132731|NCT01393405|76255512|FG000|STARTED|Maintenance Period Week||0|84 patients completed the induction period and were randomized to maintenance period|
60132732|NCT01393405|76255513|FG001|STARTED|Maintenance Period Week||44|84 patients completed the induction period and were randomized to maintenance period|
60132733|NCT01393405|76255514|FG002|STARTED|Maintenance Period Week||40|84 patients completed the induction period and were randomized to maintenance period|
60132734|NCT01393405|76255512|FG000|COMPLETED|Maintenance Period Week||0||
60132735|NCT01393405|76255513|FG001|COMPLETED|Maintenance Period Week||15||
60132736|NCT01393405|76255514|FG002|COMPLETED|Maintenance Period Week||16||
60132737|NCT01393405|76255512|FG000|NOT COMPLETED|Maintenance Period Week||0||
60132738|NCT01393405|76255513|FG001|NOT COMPLETED|Maintenance Period Week||29||
60132739|NCT01393405|76255514|FG002|NOT COMPLETED|Maintenance Period Week||24||
60132740|NCT01419197|76255526|FG000|STARTED|Overall Study||404||
60132741|NCT01419197|76255527|FG001|STARTED|Overall Study||198||
60132742|NCT01419197|76255526|FG000|Switched to Trastuzumab Emtansine|Overall Study||0||
60132743|NCT01419197|76255527|FG001|Switched to Trastuzumab Emtansine|Overall Study||94||
60132744|NCT01419197|76255526|FG000|COMPLETED|Overall Study||0||
60132745|NCT01419197|76255527|FG001|COMPLETED|Overall Study||0||
60132746|NCT01419197|76255526|FG000|NOT COMPLETED|Overall Study||404||
60132747|NCT01419197|76255527|FG001|NOT COMPLETED|Overall Study||198||
60132748|NCT01414075|76255538|FG000|STARTED|Overall Study||24|Safety population: all participants who received any dose of study drug.|
60132749|NCT01414075|76255539|FG001|STARTED|Overall Study||12|Safety population: all participants who received any dose of study drug.|
60132750|NCT01414075|76255540|FG002|STARTED|Overall Study||12|Safety population: all participants who received any dose of study drug.|
60132751|NCT01414075|76255541|FG003|STARTED|Overall Study||12|Safety population: all participants who received any dose of study drug.|
60132752|NCT01414075|76255538|FG000|Efficacy Evaluable (EE) Population|Overall Study||23|All participants who received study treatment for 6 weeks or longer and had valid corresponding Hb measurements.|
60132753|NCT01414075|76255539|FG001|Efficacy Evaluable (EE) Population|Overall Study||12|All participants who received study treatment for 6 weeks or longer and had valid corresponding Hb measurements.|
60132754|NCT01414075|76255540|FG002|Efficacy Evaluable (EE) Population|Overall Study||10|All participants who received study treatment for 6 weeks or longer and had valid corresponding Hb measurements.|
60132755|NCT01414075|76255541|FG003|Efficacy Evaluable (EE) Population|Overall Study||10|All participants who received study treatment for 6 weeks or longer and had valid corresponding Hb measurements.|
60132756|NCT01414075|76255538|FG000|COMPLETED|Overall Study||21||
60132757|NCT01414075|76255539|FG001|COMPLETED|Overall Study||12||
60132758|NCT01414075|76255540|FG002|COMPLETED|Overall Study||10||
60132759|NCT01414075|76255541|FG003|COMPLETED|Overall Study||10||
60132760|NCT01414075|76255538|FG000|NOT COMPLETED|Overall Study||3||
60132761|NCT01414075|76255539|FG001|NOT COMPLETED|Overall Study||0||
60132762|NCT01414075|76255540|FG002|NOT COMPLETED|Overall Study||2||
60132763|NCT01414075|76255541|FG003|NOT COMPLETED|Overall Study||2||
60132764|NCT01434823|76255553|FG000|STARTED|Overall Study||824||
60132765|NCT01434823|76255554|FG001|STARTED|Overall Study||785||
60132766|NCT01434823|76255553|FG000|COMPLETED|Overall Study||820||
60132767|NCT01434823|76255554|FG001|COMPLETED|Overall Study||778||
60132768|NCT01434823|76255553|FG000|NOT COMPLETED|Overall Study||4||
60132769|NCT01434823|76255554|FG001|NOT COMPLETED|Overall Study||7||
60132770|NCT01513460|76255564|FG000|STARTED|Overall Study||258||
60132771|NCT01513460|76255565|FG001|STARTED|Overall Study||258||
60132772|NCT01513460|76255566|FG002|STARTED|Overall Study||257||
60132773|NCT01513460|76255564|FG000|Full Analysis Set|Overall Study||257||
60132774|NCT01513460|76255565|FG001|Full Analysis Set|Overall Study||258||
60132775|NCT01513460|76255566|FG002|Full Analysis Set|Overall Study||257||
60132776|NCT01513460|76255564|FG000|Per-protocol Set|Overall Study||196||
60132777|NCT01513460|76255565|FG001|Per-protocol Set|Overall Study||186||
60132778|NCT01513460|76255566|FG002|Per-protocol Set|Overall Study||166||
60132779|NCT01513460|76255564|FG000|COMPLETED|Overall Study||229||
60132780|NCT01513460|76255565|FG001|COMPLETED|Overall Study||226||
60132781|NCT01513460|76255566|FG002|COMPLETED|Overall Study||201||
60132782|NCT01513460|76255564|FG000|NOT COMPLETED|Overall Study||29||
60132783|NCT01513460|76255565|FG001|NOT COMPLETED|Overall Study||32||
60132784|NCT01513460|76255566|FG002|NOT COMPLETED|Overall Study||56||
60132785|NCT01392547|76255576|FG000|STARTED|Overall Study|567 bleeds by 69 subjects, 340 were treated with vatreptacog alfa and 227 with rFVIIa|72||
60132786|NCT01392547|76255576|FG000|COMPLETED|Overall Study||64||
60132787|NCT01392547|76255576|FG000|NOT COMPLETED|Overall Study||8||
60132788|NCT01435655|76255582|FG000|STARTED|Overall Study||10||
60132789|NCT01435655|76255582|FG000|COMPLETED|Overall Study||7||
60132790|NCT01435655|76255582|FG000|NOT COMPLETED|Overall Study||3||
60132791|NCT01434667|76255588|FG000|STARTED|Overall Study||39||
60132792|NCT01434667|76255589|FG001|STARTED|Overall Study||75||
60132793|NCT01434667|76255588|FG000|COMPLETED|Overall Study||34||
60132794|NCT01434667|76255589|FG001|COMPLETED|Overall Study||65||
60132795|NCT01434667|76255588|FG000|NOT COMPLETED|Overall Study||5||
60132796|NCT01434667|76255589|FG001|NOT COMPLETED|Overall Study||10||
60132797|NCT01513148|76255597|FG000|STARTED|Overall Study||16||
60132798|NCT01513148|76255598|FG001|STARTED|Overall Study||16||
60132799|NCT01513148|76255597|FG000|COMPLETED|Overall Study||14||
60132800|NCT01513148|76255598|FG001|COMPLETED|Overall Study||14||
60132801|NCT01513148|76255597|FG000|NOT COMPLETED|Overall Study||2||
60132802|NCT01513148|76255598|FG001|NOT COMPLETED|Overall Study||2||
60132803|NCT01418339|76255646|FG000|STARTED|Overall Study||90||
60132804|NCT01418339|76255647|FG001|STARTED|Overall Study||45||
60132805|NCT01418339|76255646|FG000|COMPLETED|Overall Study||78||
60132806|NCT01418339|76255647|FG001|COMPLETED|Overall Study||35||
60132807|NCT01418339|76255646|FG000|NOT COMPLETED|Overall Study||12||
60132808|NCT01418339|76255647|FG001|NOT COMPLETED|Overall Study||10||
60132809|NCT01512368|76255653|FG000|STARTED|Overall Study||63||
60132810|NCT01512368|76255653|FG000|COMPLETED|Overall Study||60||
60132811|NCT01512368|76255653|FG000|NOT COMPLETED|Overall Study||3||
60132812|NCT01412983|76255657|FG000|STARTED|1st Period||50||
60132813|NCT01412983|76255658|FG001|STARTED|1st Period||50||
60132814|NCT01412983|76255657|FG000|COMPLETED|1st Period||50||
60132815|NCT01412983|76255658|FG001|COMPLETED|1st Period||46||
60132816|NCT01412983|76255657|FG000|NOT COMPLETED|1st Period||0||
60132817|NCT01412983|76255658|FG001|NOT COMPLETED|1st Period||4||
60132818|NCT01412983|76255657|FG000|STARTED|2nd Period||50||
60132819|NCT01412983|76255658|FG001|STARTED|2nd Period||46||
60132820|NCT01412983|76255657|FG000|COMPLETED|2nd Period||50||
60132821|NCT01412983|76255658|FG001|COMPLETED|2nd Period||46||
60132822|NCT01412983|76255657|FG000|NOT COMPLETED|2nd Period||0||
60132823|NCT01412983|76255658|FG001|NOT COMPLETED|2nd Period||0||
60132824|NCT01417481|76255667|FG000|STARTED|First Intervention (8 Weeks)||8||
60132825|NCT01417481|76255668|FG001|STARTED|First Intervention (8 Weeks)||7||
60132826|NCT01417481|76255667|FG000|COMPLETED|First Intervention (8 Weeks)||8||
60132827|NCT01417481|76255668|FG001|COMPLETED|First Intervention (8 Weeks)||5||
60132828|NCT01417481|76255667|FG000|NOT COMPLETED|First Intervention (8 Weeks)||0||
60132829|NCT01417481|76255668|FG001|NOT COMPLETED|First Intervention (8 Weeks)||2||
60132830|NCT01417481|76255667|FG000|STARTED|Washout (2 Weeks)||8||
60132831|NCT01417481|76255668|FG001|STARTED|Washout (2 Weeks)||5||
60132832|NCT01417481|76255667|FG000|COMPLETED|Washout (2 Weeks)||8||
60132833|NCT01417481|76255668|FG001|COMPLETED|Washout (2 Weeks)||5||
60132834|NCT01417481|76255667|FG000|NOT COMPLETED|Washout (2 Weeks)||0||
60132835|NCT01417481|76255668|FG001|NOT COMPLETED|Washout (2 Weeks)||0||
60132836|NCT01417481|76255667|FG000|STARTED|Second Period (8 Weeks)||8||
60132837|NCT01417481|76255668|FG001|STARTED|Second Period (8 Weeks)||5||
60132838|NCT01417481|76255667|FG000|COMPLETED|Second Period (8 Weeks)||8||
60132839|NCT01417481|76255668|FG001|COMPLETED|Second Period (8 Weeks)||5||
60132840|NCT01417481|76255667|FG000|NOT COMPLETED|Second Period (8 Weeks)||0||
60132841|NCT01417481|76255668|FG001|NOT COMPLETED|Second Period (8 Weeks)||0||
60132842|NCT01392469|76255674|FG000|STARTED|Overall Study||21||
60132843|NCT01392469|76255674|FG000|COMPLETED|Overall Study||17||
60132844|NCT01392469|76255674|FG000|NOT COMPLETED|Overall Study||4||
60132845|NCT01435577|76255691|FG000|STARTED|Overall Study||64||
60132846|NCT01435577|76255692|FG001|STARTED|Overall Study||65||
60132847|NCT01435577|76255691|FG000|COMPLETED|Overall Study||47||
60132848|NCT01435577|76255692|FG001|COMPLETED|Overall Study||13||
60132849|NCT01435577|76255691|FG000|NOT COMPLETED|Overall Study||17||
60132850|NCT01435577|76255692|FG001|NOT COMPLETED|Overall Study||52||
60132851|NCT01411891|76255704|FG000|STARTED|Overall Study||50||
60132852|NCT01411891|76255705|FG001|STARTED|Overall Study||50||
60132853|NCT01411891|76255704|FG000|COMPLETED|Overall Study||47||
60132854|NCT01411891|76255705|FG001|COMPLETED|Overall Study||48||
60132855|NCT01411891|76255704|FG000|NOT COMPLETED|Overall Study||3||
60132856|NCT01411891|76255705|FG001|NOT COMPLETED|Overall Study||2||
60132857|NCT01416389|76255713|FG000|STARTED|Overall Study||26||
60132858|NCT01416389|76255714|FG001|STARTED|Overall Study||13||
60132859|NCT01416389|76255713|FG000|Received at Least 1 Dose of Study Drug|Overall Study||26||
60132860|NCT01416389|76255714|FG001|Received at Least 1 Dose of Study Drug|Overall Study||13||
60132861|NCT01416389|76255713|FG000|COMPLETED|Overall Study||23||
60132862|NCT01416389|76255714|FG001|COMPLETED|Overall Study||13||
60132863|NCT01416389|76255713|FG000|NOT COMPLETED|Overall Study||3||
60132864|NCT01416389|76255714|FG001|NOT COMPLETED|Overall Study||0||
60132865|NCT01544348|76255730|FG000|STARTED|Overall Study||17||
60132866|NCT01544348|76255731|FG001|STARTED|Overall Study||6||
60132867|NCT01544348|76255732|FG002|STARTED|Overall Study||3||
60132868|NCT01544348|76255733|FG003|STARTED|Overall Study||3||
60132869|NCT01544348|76255734|FG004|STARTED|Overall Study||16||
60132870|NCT01544348|76255735|FG005|STARTED|Overall Study||19||
60132871|NCT01544348|76255736|FG006|STARTED|Overall Study||14||
60132872|NCT01544348|76255737|FG007|STARTED|Overall Study||8||
60132873|NCT01544348|76255730|FG000|Treated|Overall Study||17||
60132874|NCT01544348|76255731|FG001|Treated|Overall Study||6||
60132875|NCT01544348|76255732|FG002|Treated|Overall Study||3||
60132876|NCT01544348|76255733|FG003|Treated|Overall Study||3||
60132877|NCT01544348|76255734|FG004|Treated|Overall Study||15||
60132878|NCT01544348|76255735|FG005|Treated|Overall Study||18||
60132879|NCT01544348|76255736|FG006|Treated|Overall Study||14||
60132880|NCT01544348|76255737|FG007|Treated|Overall Study||8||
60132881|NCT01544348|76255730|FG000|COMPLETED|Overall Study||15||
60132882|NCT01544348|76255731|FG001|COMPLETED|Overall Study||6||
60132883|NCT01544348|76255732|FG002|COMPLETED|Overall Study||3||
60132884|NCT01544348|76255733|FG003|COMPLETED|Overall Study||3||
60132885|NCT01544348|76255734|FG004|COMPLETED|Overall Study||15||
60132886|NCT01544348|76255735|FG005|COMPLETED|Overall Study||16||
60132887|NCT01544348|76255736|FG006|COMPLETED|Overall Study||12||
60132888|NCT01544348|76255737|FG007|COMPLETED|Overall Study||8||
60132889|NCT01544348|76255730|FG000|NOT COMPLETED|Overall Study||2||
60132890|NCT01544348|76255731|FG001|NOT COMPLETED|Overall Study||0||
60132891|NCT01544348|76255732|FG002|NOT COMPLETED|Overall Study||0||
60132892|NCT01544348|76255733|FG003|NOT COMPLETED|Overall Study||0||
60132893|NCT01544348|76255734|FG004|NOT COMPLETED|Overall Study||1||
60132894|NCT01544348|76255735|FG005|NOT COMPLETED|Overall Study||3||
60132895|NCT01544348|76255736|FG006|NOT COMPLETED|Overall Study||2||
60132896|NCT01544348|76255737|FG007|NOT COMPLETED|Overall Study||0||
60132897|NCT01416155|76255762|FG000|STARTED|Overall Study||97||
60132898|NCT01416155|76255762|FG000|COMPLETED|Overall Study||39||
60132899|NCT01416155|76255762|FG000|NOT COMPLETED|Overall Study||58||
60132900|NCT01415921|76255768|FG000|STARTED|Overall Study||16||
60132901|NCT01415921|76255769|FG001|STARTED|Overall Study||17||
60132902|NCT01415921|76255768|FG000|COMPLETED|Overall Study||13||
60132903|NCT01415921|76255769|FG001|COMPLETED|Overall Study||14||
60132904|NCT01415921|76255768|FG000|NOT COMPLETED|Overall Study||3||
60132905|NCT01415921|76255769|FG001|NOT COMPLETED|Overall Study||3||
60132906|NCT01415531|76255777|FG000|STARTED|Overall Study||214||
60132907|NCT01415531|76255778|FG001|STARTED|Overall Study||427||
60132908|NCT01415531|76255777|FG000|COMPLETED|Overall Study||189||
60132909|NCT01415531|76255778|FG001|COMPLETED|Overall Study||390||
60132910|NCT01415531|76255777|FG000|NOT COMPLETED|Overall Study||25||
60132911|NCT01415531|76255778|FG001|NOT COMPLETED|Overall Study||37||
60132912|NCT01544114|76255787|FG000|STARTED|Overall Study||4||
60132913|NCT01544114|76255788|FG001|STARTED|Overall Study||20||
60132914|NCT01544114|76255789|FG002|STARTED|Overall Study||22||
60132915|NCT01544114|76255787|FG000|COMPLETED|Overall Study|completed study and received 6 months of study drug|3|completed study and received 6 months of study drug|
60132916|NCT01544114|76255788|FG001|COMPLETED|Overall Study|completed study and received 6 months of study drug|16|completed study and received 6 months of study drug|
60132917|NCT01544114|76255789|FG002|COMPLETED|Overall Study|completed study and received 6 months of study drug|17|completed study and received 6 months of study drug|
60132918|NCT01544114|76255787|FG000|NOT COMPLETED|Overall Study||1||
60132919|NCT01544114|76255788|FG001|NOT COMPLETED|Overall Study||4||
60132920|NCT01544114|76255789|FG002|NOT COMPLETED|Overall Study||5||
60132921|NCT01435265|76255801|FG000|STARTED|Overall Study||3||
60132922|NCT01435265|76255802|FG001|STARTED|Overall Study||4||
60132923|NCT01435265|76255801|FG000|COMPLETED|Overall Study||3||
60132924|NCT01435265|76255802|FG001|COMPLETED|Overall Study||3||
60132925|NCT01435265|76255801|FG000|NOT COMPLETED|Overall Study||0||
60132926|NCT01435265|76255802|FG001|NOT COMPLETED|Overall Study||1||
60132927|NCT01433263|76255810|FG000|STARTED|Overall Study||29||
60132928|NCT01433263|76255811|FG001|STARTED|Overall Study||28||
60132929|NCT01433263|76255810|FG000|COMPLETED|Overall Study||10||
60132930|NCT01433263|76255811|FG001|COMPLETED|Overall Study||16||
60132931|NCT01433263|76255810|FG000|NOT COMPLETED|Overall Study||19||
60132932|NCT01433263|76255811|FG001|NOT COMPLETED|Overall Study||12||
60132933|NCT01432951|76255820|FG000|STARTED|Treatment Phase (Day 1 to 30)||26||
60132934|NCT01432951|76255820|FG000|Received at Least One Dose of Study Drug|Treatment Phase (Day 1 to 30)||25||
60132935|NCT01432951|76255820|FG000|PK Sampling (no Dosing) Days 15-17|Treatment Phase (Day 1 to 30)||23||
60132936|NCT01432951|76255820|FG000|Progressive Disease|Treatment Phase (Day 1 to 30)||10||
60132937|NCT01432951|76255820|FG000|COMPLETED|Treatment Phase (Day 1 to 30)||25||
60132938|NCT01432951|76255820|FG000|NOT COMPLETED|Treatment Phase (Day 1 to 30)||1||
60132939|NCT01432951|76255820|FG000|STARTED|Safety Extension Day 30 to End of Study|Participants had the option to continue on to safety extension period.|15||
60132940|NCT01432951|76255820|FG000|COMPLETED|Safety Extension Day 30 to End of Study||15||
60132941|NCT01432951|76255820|FG000|NOT COMPLETED|Safety Extension Day 30 to End of Study||0||
60132942|NCT01432327|76255829|FG000|STARTED|Baseline||56||
60132943|NCT01432327|76255830|FG001|STARTED|Baseline||57||
60132944|NCT01432327|76255831|FG002|STARTED|Baseline||57||
60132945|NCT01432327|76255832|FG003|STARTED|Baseline||57||
60132946|NCT01432327|76255829|FG000|COMPLETED|Baseline||56||
60132947|NCT01432327|76255830|FG001|COMPLETED|Baseline||57||
60132948|NCT01432327|76255831|FG002|COMPLETED|Baseline||57||
60132949|NCT01432327|76255832|FG003|COMPLETED|Baseline||57||
60132950|NCT01432327|76255829|FG000|NOT COMPLETED|Baseline||0||
60132951|NCT01432327|76255830|FG001|NOT COMPLETED|Baseline||0||
60132952|NCT01432327|76255831|FG002|NOT COMPLETED|Baseline||0||
60132953|NCT01432327|76255832|FG003|NOT COMPLETED|Baseline||0||
60132954|NCT01432327|76255829|FG000|STARTED|Posttest 3 Months||56||
60132955|NCT01432327|76255830|FG001|STARTED|Posttest 3 Months||57||
60132956|NCT01432327|76255831|FG002|STARTED|Posttest 3 Months||57||
60132957|NCT01432327|76255832|FG003|STARTED|Posttest 3 Months||57||
60132958|NCT01432327|76255829|FG000|COMPLETED|Posttest 3 Months||52||
60132959|NCT01432327|76255830|FG001|COMPLETED|Posttest 3 Months||55||
60132960|NCT01432327|76255831|FG002|COMPLETED|Posttest 3 Months||55||
60132961|NCT01432327|76255832|FG003|COMPLETED|Posttest 3 Months||56||
60132962|NCT01432327|76255829|FG000|NOT COMPLETED|Posttest 3 Months||4||
60132963|NCT01432327|76255830|FG001|NOT COMPLETED|Posttest 3 Months||2||
60132964|NCT01432327|76255831|FG002|NOT COMPLETED|Posttest 3 Months||2||
60132965|NCT01432327|76255832|FG003|NOT COMPLETED|Posttest 3 Months||1||
60132966|NCT01432327|76255829|FG000|STARTED|Posttest 6 Months||52||
60132967|NCT01432327|76255830|FG001|STARTED|Posttest 6 Months||55||
60132968|NCT01432327|76255831|FG002|STARTED|Posttest 6 Months||55||
60132969|NCT01432327|76255832|FG003|STARTED|Posttest 6 Months||56||
60132970|NCT01432327|76255829|FG000|COMPLETED|Posttest 6 Months||52||
60132971|NCT01432327|76255830|FG001|COMPLETED|Posttest 6 Months||55||
60132972|NCT01432327|76255831|FG002|COMPLETED|Posttest 6 Months||50||
60132973|NCT01432327|76255832|FG003|COMPLETED|Posttest 6 Months||54||
60132974|NCT01432327|76255829|FG000|NOT COMPLETED|Posttest 6 Months||0||
60132975|NCT01432327|76255830|FG001|NOT COMPLETED|Posttest 6 Months||0||
60132976|NCT01432327|76255831|FG002|NOT COMPLETED|Posttest 6 Months||5||
60132977|NCT01432327|76255832|FG003|NOT COMPLETED|Posttest 6 Months||2||
60132978|NCT01432327|76255829|FG000|STARTED|Posttest 1 Year||52||
60132979|NCT01432327|76255830|FG001|STARTED|Posttest 1 Year||55||
60132980|NCT01432327|76255831|FG002|STARTED|Posttest 1 Year||50||
60132981|NCT01432327|76255832|FG003|STARTED|Posttest 1 Year||54||
60132982|NCT01432327|76255829|FG000|COMPLETED|Posttest 1 Year||28||
60132983|NCT01432327|76255830|FG001|COMPLETED|Posttest 1 Year||27||
60132984|NCT01432327|76255831|FG002|COMPLETED|Posttest 1 Year||30||
60132985|NCT01432327|76255832|FG003|COMPLETED|Posttest 1 Year||31||
60132986|NCT01432327|76255829|FG000|NOT COMPLETED|Posttest 1 Year||24||
60132987|NCT01432327|76255830|FG001|NOT COMPLETED|Posttest 1 Year||28||
60132988|NCT01432327|76255831|FG002|NOT COMPLETED|Posttest 1 Year||20||
60132989|NCT01432327|76255832|FG003|NOT COMPLETED|Posttest 1 Year||23||
60132990|NCT01410799|76255842|FG000|STARTED|Overall Study||13||
60132991|NCT01410799|76255842|FG000|COMPLETED|Overall Study||0||
60132992|NCT01410799|76255842|FG000|NOT COMPLETED|Overall Study||13||
60132993|NCT01432171|76255848|FG000|STARTED|Overall Study||18||
60132994|NCT01432171|76255849|FG001|STARTED|Overall Study||19||
60132995|NCT01432171|76255848|FG000|COMPLETED|Overall Study||4||
60132996|NCT01432171|76255849|FG001|COMPLETED|Overall Study||8||
60132997|NCT01432171|76255848|FG000|NOT COMPLETED|Overall Study||14||
60132998|NCT01432171|76255849|FG001|NOT COMPLETED|Overall Study||11||
60132999|NCT04046263|76255855|FG000|STARTED|Overall Study||17||
60133000|NCT04046263|76255855|FG000|COMPLETED|Overall Study||12||
60133001|NCT04046263|76255855|FG000|NOT COMPLETED|Overall Study||5||
60133002|NCT01435031|76255859|FG000|STARTED|ITT at 1 Month|ITT population|222||
60133003|NCT01435031|76255859|FG000|COMPLETED|ITT at 1 Month||216||
60133004|NCT01435031|76255859|FG000|NOT COMPLETED|ITT at 1 Month||6||
60133005|NCT01435031|76255859|FG000|STARTED|ITT at 6 Months||216||
60133006|NCT01435031|76255859|FG000|COMPLETED|ITT at 6 Months||211||
60133007|NCT01435031|76255859|FG000|NOT COMPLETED|ITT at 6 Months||5||
60133008|NCT01435031|76255859|FG000|STARTED|ITT at 1 Year||211||
60133009|NCT01435031|76255859|FG000|COMPLETED|ITT at 1 Year||202||
60133010|NCT01435031|76255859|FG000|NOT COMPLETED|ITT at 1 Year||9||
60133011|NCT01435031|76255859|FG000|STARTED|ITT at 2 Years||202||
60133012|NCT01435031|76255859|FG000|COMPLETED|ITT at 2 Years||189||
60133013|NCT01435031|76255859|FG000|NOT COMPLETED|ITT at 2 Years||13||
60133014|NCT01435031|76255859|FG000|STARTED|ITT at 3 Years||189||
60133015|NCT01435031|76255859|FG000|COMPLETED|ITT at 3 Years||178||
60133016|NCT01435031|76255859|FG000|NOT COMPLETED|ITT at 3 Years||11||
60133017|NCT01435031|76255859|FG000|STARTED|ITT at 4 Years||178||
60133018|NCT01435031|76255859|FG000|COMPLETED|ITT at 4 Years||171||
60133019|NCT01435031|76255859|FG000|NOT COMPLETED|ITT at 4 Years||7||
60133020|NCT01433549|76255863|FG000|STARTED|Phase 1: First Study Product||12||
60133021|NCT01433549|76255864|FG001|STARTED|Phase 1: First Study Product||13||
60133022|NCT01433549|76255863|FG000|COMPLETED|Phase 1: First Study Product||12||
60133023|NCT01433549|76255864|FG001|COMPLETED|Phase 1: First Study Product||13||
60133024|NCT01433549|76255863|FG000|NOT COMPLETED|Phase 1: First Study Product||0||
60133025|NCT01433549|76255864|FG001|NOT COMPLETED|Phase 1: First Study Product||0||
60133026|NCT01433549|76255863|FG000|STARTED|Phase 2: Second Study Product||12||
60133027|NCT01433549|76255864|FG001|STARTED|Phase 2: Second Study Product||13||
60133028|NCT01433549|76255863|FG000|COMPLETED|Phase 2: Second Study Product||12||
60133029|NCT01433549|76255864|FG001|COMPLETED|Phase 2: Second Study Product||12||
60133030|NCT01433549|76255863|FG000|NOT COMPLETED|Phase 2: Second Study Product||0||
60133031|NCT01433549|76255864|FG001|NOT COMPLETED|Phase 2: Second Study Product||1||
60133032|NCT01414205|76255872|FG000|STARTED|Overall Study||41||
60133033|NCT01414205|76255873|FG001|STARTED|Overall Study||39||
60133034|NCT01414205|76255872|FG000|Received Study Drug|Overall Study||40||
60133035|NCT01414205|76255873|FG001|Received Study Drug|Overall Study||38||
60133036|NCT01414205|76255872|FG000|COMPLETED|Overall Study||34||
60133037|NCT01414205|76255873|FG001|COMPLETED|Overall Study||32||
60133038|NCT01414205|76255872|FG000|NOT COMPLETED|Overall Study||7||
60133039|NCT01414205|76255873|FG001|NOT COMPLETED|Overall Study||7||
60133040|NCT01433471|76255881|FG000|STARTED|Overall Study||2||
60133041|NCT01433471|76255882|FG001|STARTED|Overall Study||2||
60133042|NCT01433471|76255881|FG000|COMPLETED|Overall Study||2||
60133043|NCT01433471|76255882|FG001|COMPLETED|Overall Study||1||
60133044|NCT01433471|76255881|FG000|NOT COMPLETED|Overall Study||0||
60133045|NCT01433471|76255882|FG001|NOT COMPLETED|Overall Study||1||
60133046|NCT01433159|76255892|FG000|STARTED|Overall Study||9||
60133047|NCT01433159|76255893|FG001|STARTED|Overall Study||10||
60133048|NCT01433159|76255892|FG000|COMPLETED|Overall Study||7||
60133049|NCT01433159|76255893|FG001|COMPLETED|Overall Study||9||
60133050|NCT01433159|76255892|FG000|NOT COMPLETED|Overall Study||2||
60133051|NCT01433159|76255893|FG001|NOT COMPLETED|Overall Study||1||
60133052|NCT02076425|76255901|FG000|STARTED|Overall Study||114||
60133053|NCT02076425|76255902|FG001|STARTED|Overall Study||115||
60133054|NCT02076425|76255901|FG000|COMPLETED|Overall Study||100||
60133055|NCT02076425|76255902|FG001|COMPLETED|Overall Study||91||
60133056|NCT02076425|76255901|FG000|NOT COMPLETED|Overall Study||14||
60133057|NCT02076425|76255902|FG001|NOT COMPLETED|Overall Study||24||
60133058|NCT01413503|76255908|FG000|STARTED|Overall Study||50||
60133059|NCT01413503|76255908|FG000|COMPLETED|Overall Study||49||
60133060|NCT01413503|76255908|FG000|NOT COMPLETED|Overall Study||1||
60133061|NCT01413191|76255912|FG000|STARTED|Overall Study||18||
60133062|NCT01413191|76255912|FG000|COMPLETED|Overall Study||7||
60133063|NCT01413191|76255912|FG000|NOT COMPLETED|Overall Study||11||
60133064|NCT01412957|76255918|FG000|STARTED|Overall Study||189||
60133065|NCT01412957|76255919|FG001|STARTED|Overall Study||188||
60133066|NCT01412957|76255918|FG000|COMPLETED|Overall Study|Participants continuing study at the time of data cut-off|40||
60133067|NCT01412957|76255919|FG001|COMPLETED|Overall Study|Participants continuing study at the time of data cut-off|31||
60133068|NCT01412957|76255918|FG000|NOT COMPLETED|Overall Study||149||
60133069|NCT01412957|76255919|FG001|NOT COMPLETED|Overall Study||157||
60133070|NCT04973826|76255925|FG000|STARTED|Overall Study||12||
60133071|NCT04973826|76255925|FG000|COMPLETED|Overall Study||12||
60133072|NCT04973826|76255925|FG000|NOT COMPLETED|Overall Study||0||
60133073|NCT01432457|76255932|FG000|STARTED|Overall Study||306||
60133074|NCT01432457|76255933|FG001|STARTED|Overall Study||306||
60133075|NCT01432457|76255934|FG002|STARTED|Overall Study||312||
60133076|NCT01432457|76255932|FG000|COMPLETED|Overall Study||269||
60133077|NCT01432457|76255933|FG001|COMPLETED|Overall Study||258||
60133078|NCT01432457|76255934|FG002|COMPLETED|Overall Study||253||
60133079|NCT01432457|76255932|FG000|NOT COMPLETED|Overall Study||37||
60133080|NCT01432457|76255933|FG001|NOT COMPLETED|Overall Study||48||
60133081|NCT01432457|76255934|FG002|NOT COMPLETED|Overall Study||59||
60133082|NCT00658515|76255944|FG000|STARTED|Overall Study||7938||
60133083|NCT00658515|76255945|FG001|STARTED|Overall Study||7933||
60133084|NCT00658515|76255944|FG000|COMPLETED|Overall Study||7626||
60133085|NCT00658515|76255945|FG001|COMPLETED|Overall Study||7668||
60133086|NCT00658515|76255944|FG000|NOT COMPLETED|Overall Study||312||
60133087|NCT00658515|76255945|FG001|NOT COMPLETED|Overall Study||265||
60133088|NCT01390441|76255956|FG000|STARTED|Treatment Period||23||
60133089|NCT01390441|76255957|FG001|STARTED|Treatment Period||22||
60133090|NCT01390441|76255958|FG002|STARTED|Treatment Period||18||
60133091|NCT01390441|76255959|FG003|STARTED|Treatment Period||19||
60133092|NCT01390441|76255960|FG004|STARTED|Treatment Period||18||
60133093|NCT01390441|76255956|FG000|COMPLETED|Treatment Period||22||
60133094|NCT01390441|76255957|FG001|COMPLETED|Treatment Period||21||
60133095|NCT01390441|76255958|FG002|COMPLETED|Treatment Period||8||
60133096|NCT01390441|76255959|FG003|COMPLETED|Treatment Period||6||
60133097|NCT01390441|76255960|FG004|COMPLETED|Treatment Period||7||
60133098|NCT01390441|76255956|FG000|NOT COMPLETED|Treatment Period||1||
60133099|NCT01390441|76255957|FG001|NOT COMPLETED|Treatment Period||1||
60133100|NCT01390441|76255958|FG002|NOT COMPLETED|Treatment Period||10||
60133101|NCT01390441|76255959|FG003|NOT COMPLETED|Treatment Period||13||
60133102|NCT01390441|76255960|FG004|NOT COMPLETED|Treatment Period||11||
60133103|NCT01390441|76255956|FG000|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|15||
60133104|NCT01390441|76255957|FG001|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|13||
60133105|NCT01390441|76255958|FG002|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|1||
60133106|NCT01390441|76255959|FG003|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|1||
60133107|NCT01390441|76255960|FG004|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|3||
60133108|NCT01390441|76255956|FG000|COMPLETED|Extension Period||12||
60133109|NCT01390441|76255957|FG001|COMPLETED|Extension Period||12||
60133110|NCT01390441|76255958|FG002|COMPLETED|Extension Period||1||
60133111|NCT01390441|76255959|FG003|COMPLETED|Extension Period||0||
60133112|NCT01390441|76255960|FG004|COMPLETED|Extension Period||3||
60133113|NCT01390441|76255956|FG000|NOT COMPLETED|Extension Period||3||
60133114|NCT01390441|76255957|FG001|NOT COMPLETED|Extension Period||1||
60133115|NCT01390441|76255958|FG002|NOT COMPLETED|Extension Period||0||
60133116|NCT01390441|76255959|FG003|NOT COMPLETED|Extension Period||1||
60133117|NCT01390441|76255960|FG004|NOT COMPLETED|Extension Period||0||
60133118|NCT02175576|76256000|FG000|STARTED|Overall Study|Two (2) participants enrolled both knees into the study.|20||22
60133119|NCT02175576|76256001|FG001|STARTED|Overall Study|Three (3) participants enrolled both knees into the study.|30||33
60133120|NCT02175576|76256000|FG000|12 Month Follow-Up Visit|Overall Study||8|Participants for which the primary endpoint of Modified Knee Society Score (mKSS) at 12 months could be analyzed.|10
60133121|NCT02175576|76256001|FG001|12 Month Follow-Up Visit|Overall Study||18|Participants for which the primary endpoint of Modified Knee Society Score (mKSS) at 12 months could be analyzed.|21
60133122|NCT02175576|76256000|FG000|COMPLETED|Overall Study|Study was terminated prior to reaching the final follow-up visit as described in the protocol.|0||0
60133123|NCT02175576|76256001|FG001|COMPLETED|Overall Study|Study was terminated prior to reaching the final follow-up visit as described in the protocol.|0||0
60133124|NCT02175576|76256000|FG000|NOT COMPLETED|Overall Study||20||22
60133125|NCT02175576|76256001|FG001|NOT COMPLETED|Overall Study||30||33
60133126|NCT01412879|76256009|FG000|STARTED|Initial Registration (Induction Therapy)||18||
60133127|NCT01412879|76256010|FG001|STARTED|Initial Registration (Induction Therapy)||35||
60133128|NCT01412879|76256011|FG002|STARTED|Initial Registration (Induction Therapy)||0||
60133129|NCT01412879|76256009|FG000|Treatment Started|Initial Registration (Induction Therapy)||17||
60133130|NCT01412879|76256010|FG001|Treatment Started|Initial Registration (Induction Therapy)||35||
60133131|NCT01412879|76256011|FG002|Treatment Started|Initial Registration (Induction Therapy)||0||
60133132|NCT01412879|76256009|FG000|COMPLETED|Initial Registration (Induction Therapy)||5||
60133133|NCT01412879|76256010|FG001|COMPLETED|Initial Registration (Induction Therapy)||27||
60133134|NCT01412879|76256011|FG002|COMPLETED|Initial Registration (Induction Therapy)||0||
60133135|NCT01412879|76256009|FG000|NOT COMPLETED|Initial Registration (Induction Therapy)||13||
60133136|NCT01412879|76256010|FG001|NOT COMPLETED|Initial Registration (Induction Therapy)||8||
60133137|NCT01412879|76256011|FG002|NOT COMPLETED|Initial Registration (Induction Therapy)||0||
60133138|NCT01412879|76256009|FG000|STARTED|Consolidation Therapy||0||
60133139|NCT01412879|76256010|FG001|STARTED|Consolidation Therapy||0||
60133140|NCT01412879|76256011|FG002|STARTED|Consolidation Therapy|Only eligible patients who are able to have stem cell harvested receive consolidation therapy.|26||
60133141|NCT01412879|76256009|FG000|COMPLETED|Consolidation Therapy||0||
60133142|NCT01412879|76256010|FG001|COMPLETED|Consolidation Therapy||0||
60133143|NCT01412879|76256011|FG002|COMPLETED|Consolidation Therapy||26||
60133144|NCT01412879|76256009|FG000|NOT COMPLETED|Consolidation Therapy||0||
60133145|NCT01412879|76256010|FG001|NOT COMPLETED|Consolidation Therapy||0||
60133146|NCT01412879|76256011|FG002|NOT COMPLETED|Consolidation Therapy||0||
60133147|NCT01431079|76256023|FG000|STARTED|Overall Study||45||
60133148|NCT01431079|76256024|FG001|STARTED|Overall Study||45||
60133149|NCT01431079|76256023|FG000|Post-test|Overall Study||45||
60133150|NCT01431079|76256024|FG001|Post-test|Overall Study||45||
60133151|NCT01431079|76256023|FG000|COMPLETED|Overall Study||10||
60133152|NCT01431079|76256024|FG001|COMPLETED|Overall Study||6||
59731472|NCT00970632|75849871|FG000|STARTED|Overall Study||172||
60133153|NCT01431079|76256023|FG000|NOT COMPLETED|Overall Study||35||
60133154|NCT01431079|76256024|FG001|NOT COMPLETED|Overall Study||39||
60133155|NCT01430611|76256056|FG000|STARTED|Overall Study||332||
60133156|NCT01430611|76256057|FG001|STARTED|Overall Study||333||
60133157|NCT01430611|76256056|FG000|COMPLETED|Overall Study||315||
60133158|NCT01430611|76256057|FG001|COMPLETED|Overall Study||318||
60133159|NCT01430611|76256056|FG000|NOT COMPLETED|Overall Study||17||
60133160|NCT01430611|76256057|FG001|NOT COMPLETED|Overall Study||15||
60133161|NCT01409707|76256066|FG000|STARTED|Overall Study||41||
60133162|NCT01409707|76256067|FG001|STARTED|Overall Study||45||
60133163|NCT01409707|76256068|FG002|STARTED|Overall Study||40||
60133164|NCT01409707|76256066|FG000|COMPLETED|Overall Study||36||
60133165|NCT01409707|76256067|FG001|COMPLETED|Overall Study||28||
60133166|NCT01409707|76256068|FG002|COMPLETED|Overall Study||24||
60133167|NCT01409707|76256066|FG000|NOT COMPLETED|Overall Study||5||
60133168|NCT01409707|76256067|FG001|NOT COMPLETED|Overall Study||17||
60133169|NCT01409707|76256068|FG002|NOT COMPLETED|Overall Study||16||
60133170|NCT01389973|76256075|FG000|STARTED|Overall Study||20||
60133171|NCT01389973|76256075|FG000|COMPLETED|Overall Study||0||
60133172|NCT01389973|76256075|FG000|NOT COMPLETED|Overall Study||20||
60133173|NCT03506568|76256082|FG000|STARTED|Stage 1||0||
60133174|NCT03506568|76256083|FG001|STARTED|Stage 1||0||
60133175|NCT03506568|76256084|FG002|STARTED|Stage 1||50||
60133176|NCT03506568|76256082|FG000|COMPLETED|Stage 1||0||
60133177|NCT03506568|76256083|FG001|COMPLETED|Stage 1||0||
60133178|NCT03506568|76256084|FG002|COMPLETED|Stage 1||5||
60133179|NCT03506568|76256082|FG000|NOT COMPLETED|Stage 1||0||
60133180|NCT03506568|76256083|FG001|NOT COMPLETED|Stage 1||0||
60133181|NCT03506568|76256084|FG002|NOT COMPLETED|Stage 1||45||
60133182|NCT03506568|76256082|FG000|STARTED|Stage 2||2||
60133183|NCT03506568|76256083|FG001|STARTED|Stage 2||3||
60133184|NCT03506568|76256084|FG002|STARTED|Stage 2||0||
60133185|NCT03506568|76256082|FG000|COMPLETED|Stage 2||1||
60133186|NCT03506568|76256083|FG001|COMPLETED|Stage 2||2||
60133187|NCT03506568|76256084|FG002|COMPLETED|Stage 2||0||
60133188|NCT03506568|76256082|FG000|NOT COMPLETED|Stage 2||1||
60133189|NCT03506568|76256083|FG001|NOT COMPLETED|Stage 2||1||
60133190|NCT03506568|76256084|FG002|NOT COMPLETED|Stage 2||0||
60133191|NCT01389817|76256095|FG000|STARTED|Overall Study||4||
60133192|NCT01389817|76256096|FG001|STARTED|Overall Study||0||
60133193|NCT01389817|76256095|FG000|COMPLETED|Overall Study||0||
60133194|NCT01389817|76256096|FG001|COMPLETED|Overall Study||0||
60133195|NCT01389817|76256095|FG000|NOT COMPLETED|Overall Study||4||
60133196|NCT01389817|76256096|FG001|NOT COMPLETED|Overall Study||0||
60133197|NCT00659295|76256104|FG000|STARTED|Overall Study||13529||
60133198|NCT00659295|76256105|FG001|STARTED|Overall Study||37641||
60133199|NCT00659295|76256104|FG000|COMPLETED|Overall Study||10821||
60133200|NCT00659295|76256105|FG001|COMPLETED|Overall Study||32038||
60133201|NCT00659295|76256104|FG000|NOT COMPLETED|Overall Study||2708||
60133202|NCT00659295|76256105|FG001|NOT COMPLETED|Overall Study||5603||
60133203|NCT01430455|76256111|FG000|STARTED|Overall Study||7||
60133204|NCT01430455|76256111|FG000|COMPLETED|Overall Study||5||
60133205|NCT01430455|76256111|FG000|NOT COMPLETED|Overall Study||2||
60133206|NCT04051957|76256117|FG000|STARTED|Overall Study||7||
60133207|NCT04051957|76256118|FG001|STARTED|Overall Study||2||
60133208|NCT04051957|76256117|FG000|COMPLETED|Overall Study||5||
60133209|NCT04051957|76256118|FG001|COMPLETED|Overall Study||2||
60133210|NCT04051957|76256117|FG000|NOT COMPLETED|Overall Study||2||
60133211|NCT04051957|76256118|FG001|NOT COMPLETED|Overall Study||0||
60133212|NCT00590889|76256126|FG000|STARTED|Overall Study||404||
60133213|NCT00590889|76256127|FG001|STARTED|Overall Study||403||
60133214|NCT00590889|76256126|FG000|COMPLETED|Overall Study||118||
60133215|NCT00590889|76256127|FG001|COMPLETED|Overall Study||104||
60133216|NCT00590889|76256126|FG000|NOT COMPLETED|Overall Study||286||
60133217|NCT00590889|76256127|FG001|NOT COMPLETED|Overall Study||299||
60133218|NCT00591123|76256133|FG000|STARTED|Overall Study||38||
60133219|NCT00591123|76256133|FG000|COMPLETED|Overall Study|38 were analyzed for safety, 33 were included for efficacy.|38||
60133220|NCT00591123|76256133|FG000|NOT COMPLETED|Overall Study||0||
60133221|NCT01429441|76256139|FG000|STARTED|Overall Study||146||
60133222|NCT01429441|76256140|FG001|STARTED|Overall Study||74||
60133223|NCT01429441|76256139|FG000|COMPLETED|Overall Study||108||
60133224|NCT01429441|76256140|FG001|COMPLETED|Overall Study||51||
60133225|NCT01429441|76256139|FG000|NOT COMPLETED|Overall Study||38||
60133226|NCT01429441|76256140|FG001|NOT COMPLETED|Overall Study||23||
60133227|NCT00591825|76256150|FG000|STARTED|Overall Study||14||
60133228|NCT00591825|76256151|FG001|STARTED|Overall Study||13||
60133229|NCT00591825|76256152|FG002|STARTED|Overall Study||13||
60133230|NCT00591825|76256153|FG003|STARTED|Overall Study||14||
60133231|NCT00591825|76256150|FG000|COMPLETED|Overall Study||14||
60133232|NCT00591825|76256151|FG001|COMPLETED|Overall Study||13||
60133233|NCT00591825|76256152|FG002|COMPLETED|Overall Study||13||
60133234|NCT00591825|76256153|FG003|COMPLETED|Overall Study||14||
60133235|NCT00591825|76256150|FG000|NOT COMPLETED|Overall Study||0||
60133236|NCT00591825|76256151|FG001|NOT COMPLETED|Overall Study||0||
60133237|NCT00591825|76256152|FG002|NOT COMPLETED|Overall Study||0||
60133238|NCT00591825|76256153|FG003|NOT COMPLETED|Overall Study||0||
60133239|NCT01429285|76256175|FG000|STARTED|Overall Study||175||
60133240|NCT01429285|76256176|FG001|STARTED|Overall Study||175||
60133241|NCT01429285|76256175|FG000|Given IV Opioids|Overall Study|9 patients never given IV opioids|166||
60133242|NCT01429285|76256176|FG001|Given IV Opioids|Overall Study|4 patients never given IV opioids|171||
60133243|NCT01429285|76256175|FG000|Completed Primary Outcome Data|Overall Study|5 patients had missing data|161||
60133244|NCT01429285|76256176|FG001|Completed Primary Outcome Data|Overall Study|3 patients had missing data|168||
60133245|NCT01429285|76256175|FG000|Confirmation of no Duplicate Enrollment|Overall Study|8 patients were enrolled twice at two separate ED visits, which was only noted at study conclusion.|153||
60133246|NCT01429285|76256176|FG001|Confirmation of no Duplicate Enrollment|Overall Study|2 patients were enrolled twice, at two separate ED visits, which was only noted at study conclusion|166||
60133247|NCT01429285|76256175|FG000|COMPLETED|Overall Study||153||
60133248|NCT01429285|76256176|FG001|COMPLETED|Overall Study||166||
60133249|NCT01429285|76256175|FG000|NOT COMPLETED|Overall Study||22||
60133250|NCT01429285|76256176|FG001|NOT COMPLETED|Overall Study||9||
60133251|NCT00592761|76256182|FG000|STARTED|First Intervention (2 Weeks)||9||
60133252|NCT00592761|76256183|FG001|STARTED|First Intervention (2 Weeks)||9||
60133253|NCT00592761|76256182|FG000|COMPLETED|First Intervention (2 Weeks)||9||
60133254|NCT00592761|76256183|FG001|COMPLETED|First Intervention (2 Weeks)||9||
60133255|NCT00592761|76256182|FG000|NOT COMPLETED|First Intervention (2 Weeks)||0||
60133256|NCT00592761|76256183|FG001|NOT COMPLETED|First Intervention (2 Weeks)||0||
60133257|NCT00592761|76256182|FG000|STARTED|Second Intervention (2 Weeks)||9||
60133258|NCT00592761|76256183|FG001|STARTED|Second Intervention (2 Weeks)||9||
60133259|NCT00592761|76256182|FG000|COMPLETED|Second Intervention (2 Weeks)||9||
60133260|NCT00592761|76256183|FG001|COMPLETED|Second Intervention (2 Weeks)||9||
60133261|NCT00592761|76256182|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||0||
60133262|NCT00592761|76256183|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||0||
60133263|NCT00594009|76256189|FG000|STARTED|Overall Study||1||
60133264|NCT00594009|76256189|FG000|COMPLETED|Overall Study||1||
60133265|NCT00594009|76256189|FG000|NOT COMPLETED|Overall Study||0||
60133266|NCT00594945|76256196|FG000|STARTED|Cohort 1 / Treatment Period 1||4||
60133267|NCT00594945|76256197|FG001|STARTED|Cohort 1 / Treatment Period 1||0||
60133268|NCT00594945|76256198|FG002|STARTED|Cohort 1 / Treatment Period 1||2||
60133269|NCT00594945|76256196|FG000|COMPLETED|Cohort 1 / Treatment Period 1||4||
60133270|NCT00594945|76256197|FG001|COMPLETED|Cohort 1 / Treatment Period 1||0||
60133271|NCT00594945|76256198|FG002|COMPLETED|Cohort 1 / Treatment Period 1||2||
60133272|NCT00594945|76256196|FG000|NOT COMPLETED|Cohort 1 / Treatment Period 1||0||
60133273|NCT00594945|76256197|FG001|NOT COMPLETED|Cohort 1 / Treatment Period 1||0||
60133274|NCT00594945|76256198|FG002|NOT COMPLETED|Cohort 1 / Treatment Period 1||0||
60133275|NCT00594945|76256196|FG000|STARTED|Cohort 2 / Treatment Period 2||0||
60133276|NCT00594945|76256197|FG001|STARTED|Cohort 2 / Treatment Period 2||3||
60133277|NCT00594945|76256198|FG002|STARTED|Cohort 2 / Treatment Period 2||2||
60133278|NCT00594945|76256196|FG000|COMPLETED|Cohort 2 / Treatment Period 2||0||
60133279|NCT00594945|76256197|FG001|COMPLETED|Cohort 2 / Treatment Period 2||3||
60133280|NCT00594945|76256198|FG002|COMPLETED|Cohort 2 / Treatment Period 2||2||
60133281|NCT00594945|76256196|FG000|NOT COMPLETED|Cohort 2 / Treatment Period 2||0||
60133282|NCT00594945|76256197|FG001|NOT COMPLETED|Cohort 2 / Treatment Period 2||0||
60133283|NCT00594945|76256198|FG002|NOT COMPLETED|Cohort 2 / Treatment Period 2||0||
60133284|NCT00595101|76256208|FG000|STARTED|Overall Study||29||
60133285|NCT00595101|76256209|FG001|STARTED|Overall Study||29||
60133286|NCT00595101|76256210|FG002|STARTED|Overall Study||29||
60133287|NCT00595101|76256211|FG003|STARTED|Overall Study||30||
60133288|NCT00595101|76256208|FG000|COMPLETED|Overall Study||29||
60133289|NCT00595101|76256209|FG001|COMPLETED|Overall Study||28||
60133290|NCT00595101|76256210|FG002|COMPLETED|Overall Study||29||
60133291|NCT00595101|76256211|FG003|COMPLETED|Overall Study||30||
60133292|NCT00595101|76256208|FG000|NOT COMPLETED|Overall Study||0||
60133293|NCT00595101|76256209|FG001|NOT COMPLETED|Overall Study||1||
60133294|NCT00595101|76256210|FG002|NOT COMPLETED|Overall Study||0||
60133295|NCT00595101|76256211|FG003|NOT COMPLETED|Overall Study||0||
60133296|NCT00660075|76256223|FG000|STARTED|First Intervention (Week 1 to Week 6)||18||
60133297|NCT00660075|76256224|FG001|STARTED|First Intervention (Week 1 to Week 6)||18||
60133298|NCT00660075|76256223|FG000|COMPLETED|First Intervention (Week 1 to Week 6)||18||
60133299|NCT00660075|76256224|FG001|COMPLETED|First Intervention (Week 1 to Week 6)||18||
60133300|NCT00660075|76256223|FG000|NOT COMPLETED|First Intervention (Week 1 to Week 6)||0||
60133301|NCT00660075|76256224|FG001|NOT COMPLETED|First Intervention (Week 1 to Week 6)||0||
60133302|NCT00660075|76256223|FG000|STARTED|Washout Period (Week 7 to Week 10)||18||
60133303|NCT00660075|76256224|FG001|STARTED|Washout Period (Week 7 to Week 10)||18||
60133304|NCT00660075|76256223|FG000|COMPLETED|Washout Period (Week 7 to Week 10)||18||
60133305|NCT00660075|76256224|FG001|COMPLETED|Washout Period (Week 7 to Week 10)||18||
60133306|NCT00660075|76256223|FG000|NOT COMPLETED|Washout Period (Week 7 to Week 10)||0||
60133307|NCT00660075|76256224|FG001|NOT COMPLETED|Washout Period (Week 7 to Week 10)||0||
60133308|NCT00660075|76256223|FG000|STARTED|Second Intervention (Week 11 to Week 16||18||
60133309|NCT00660075|76256224|FG001|STARTED|Second Intervention (Week 11 to Week 16||18||
60133310|NCT00660075|76256223|FG000|COMPLETED|Second Intervention (Week 11 to Week 16||18||
60133311|NCT00660075|76256224|FG001|COMPLETED|Second Intervention (Week 11 to Week 16||18||
59731473|NCT00970632|75849872|FG001|STARTED|Overall Study||171||
59731474|NCT00970632|75849873|FG002|STARTED|Overall Study||168||
59731475|NCT00970632|75849871|FG000|COMPLETED|Overall Study||148||
59731476|NCT00970632|75849872|FG001|COMPLETED|Overall Study||156||
59731477|NCT00970632|75849873|FG002|COMPLETED|Overall Study||150||
59731478|NCT00970632|75849871|FG000|NOT COMPLETED|Overall Study||24||
59731479|NCT00970632|75849872|FG001|NOT COMPLETED|Overall Study||15||
59731480|NCT00970632|75849873|FG002|NOT COMPLETED|Overall Study||18||
59731481|NCT01144364|75849883|FG000|STARTED|Induction Phase||234||
59731482|NCT01144364|75849884|FG001|STARTED|Induction Phase||0||
59731483|NCT01144364|75849885|FG002|STARTED|Induction Phase||0||
59731484|NCT01144364|75849883|FG000|COMPLETED|Induction Phase||202||
59731485|NCT01144364|75849884|FG001|COMPLETED|Induction Phase||0||
59731486|NCT01144364|75849885|FG002|COMPLETED|Induction Phase||0||
59731487|NCT01144364|75849883|FG000|NOT COMPLETED|Induction Phase||32||
59731488|NCT01144364|75849884|FG001|NOT COMPLETED|Induction Phase||0||
59731489|NCT01144364|75849885|FG002|NOT COMPLETED|Induction Phase||0||
59731490|NCT01144364|75849883|FG000|STARTED|Follow-Up/Maintenance Phase||0||
59731491|NCT01144364|75849884|FG001|STARTED|Follow-Up/Maintenance Phase||101||
59731492|NCT01144364|75849885|FG002|STARTED|Follow-Up/Maintenance Phase||101||
59731493|NCT01144364|75849883|FG000|COMPLETED|Follow-Up/Maintenance Phase||0||
59731494|NCT01144364|75849884|FG001|COMPLETED|Follow-Up/Maintenance Phase||66||
59731495|NCT01144364|75849885|FG002|COMPLETED|Follow-Up/Maintenance Phase||60||
59731496|NCT01144364|75849883|FG000|NOT COMPLETED|Follow-Up/Maintenance Phase||0||
59731497|NCT01144364|75849884|FG001|NOT COMPLETED|Follow-Up/Maintenance Phase||35||
59731498|NCT01144364|75849885|FG002|NOT COMPLETED|Follow-Up/Maintenance Phase||41||
59731499|NCT01119248|75849895|FG000|STARTED|Overall Study||120||
59731500|NCT01119248|75849895|FG000|COMPLETED|Overall Study||115||
59731501|NCT01119248|75849895|FG000|NOT COMPLETED|Overall Study||5||
59731502|NCT01131494|75849900|FG000|STARTED|Overall Study||17||
59731503|NCT01131494|75849900|FG000|COMPLETED|Overall Study||15||
59731504|NCT01131494|75849900|FG000|NOT COMPLETED|Overall Study||2||
59731505|NCT01131260|75849907|FG000|STARTED|Overall Study||5532||
59731506|NCT01131260|75849908|FG001|STARTED|Overall Study||5576||
59731507|NCT01131260|75849907|FG000|COMPLETED|Overall Study||5488||
59731508|NCT01131260|75849908|FG001|COMPLETED|Overall Study||5529||
59731509|NCT01131260|75849907|FG000|NOT COMPLETED|Overall Study||44||
59731510|NCT01131260|75849908|FG001|NOT COMPLETED|Overall Study||47||
59731511|NCT00965094|75849918|FG000|STARTED|Overall Study||19||
59731512|NCT00965094|75849919|FG001|STARTED|Overall Study||17||
59731513|NCT00965094|75849918|FG000|COMPLETED|Overall Study||14||
59731514|NCT00965094|75849919|FG001|COMPLETED|Overall Study||16||
59731515|NCT00965094|75849918|FG000|NOT COMPLETED|Overall Study||5||
59731516|NCT00965094|75849919|FG001|NOT COMPLETED|Overall Study||1||
59731517|NCT01131182|75849928|FG000|STARTED|Overall Study||529||
59731518|NCT01131182|75849929|FG001|STARTED|Overall Study||537||
59731519|NCT01131182|75849928|FG000|COMPLETED|Overall Study||513||
59731520|NCT01131182|75849929|FG001|COMPLETED|Overall Study||521||
59731521|NCT01131182|75849928|FG000|NOT COMPLETED|Overall Study||16||
59731522|NCT01131182|75849929|FG001|NOT COMPLETED|Overall Study||16||
59731523|NCT00964860|75849937|FG000|STARTED|Overall Study||30||
59731524|NCT00964860|75849938|FG001|STARTED|Overall Study||30||
59731525|NCT00964860|75849937|FG000|COMPLETED|Overall Study||30||
59731526|NCT00964860|75849938|FG001|COMPLETED|Overall Study||29||
59731527|NCT00964860|75849937|FG000|NOT COMPLETED|Overall Study||0||
59731528|NCT00964860|75849938|FG001|NOT COMPLETED|Overall Study||1||
59731529|NCT01131104|75849944|FG000|STARTED|Overall Study||345||
59731530|NCT01131104|75849944|FG000|Study Set|Overall Study||344||
59731531|NCT01131104|75849944|FG000|Adjudication-Confirmed NAION Set|Overall Study||279||
59731532|NCT01131104|75849944|FG000|30-Day Analysis Set|Overall Study||24|Participants had adjudication-confirmed NAION and complete PDE5 inhibitor information.|
59731533|NCT01131104|75849944|FG000|42-Day Analysis Set|Overall Study||28|Participants had adjudication-confirmed NAION and complete PDE5 inhibitor information.|
59731534|NCT01131104|75849944|FG000|12-Month Analysis Set|Overall Study||26|Participants had adjudication-confirmed NAION and complete PDE5 inhibitor information.|
59731535|NCT01131104|75849944|FG000|COMPLETED|Overall Study||332||
59731536|NCT01131104|75849944|FG000|NOT COMPLETED|Overall Study||13||
59731537|NCT01118780|75849950|FG000|STARTED|Overall Study||151||
59731538|NCT01118780|75849951|FG001|STARTED|Overall Study||140||
59731539|NCT01118780|75849950|FG000|COMPLETED|Overall Study||115||
59731540|NCT01118780|75849951|FG001|COMPLETED|Overall Study||105||
59731541|NCT01118780|75849950|FG000|NOT COMPLETED|Overall Study||36||
59731542|NCT01118780|75849951|FG001|NOT COMPLETED|Overall Study||35||
59731543|NCT00964782|75849962|FG000|STARTED|Overall Study||8||
59731544|NCT00964782|75849963|FG001|STARTED|Overall Study||8||
59731545|NCT00964782|75849962|FG000|COMPLETED|Overall Study||7||
59731546|NCT00964782|75849963|FG001|COMPLETED|Overall Study||8||
59731547|NCT00964782|75849962|FG000|NOT COMPLETED|Overall Study||1||
59731548|NCT00964782|75849963|FG001|NOT COMPLETED|Overall Study||0||
59731549|NCT00966654|75849971|FG000|STARTED|Overall Study||12||
59731550|NCT00966654|75849971|FG000|COMPLETED|Overall Study||0||
59731551|NCT00966654|75849971|FG000|NOT COMPLETED|Overall Study||12||
59731552|NCT03262116|75849983|FG000|STARTED|Overall Study||2||
59731553|NCT03262116|75849984|FG001|STARTED|Overall Study||3||
59731554|NCT03262116|75849985|FG002|STARTED|Overall Study||2||
59731555|NCT03262116|75849986|FG003|STARTED|Overall Study||2||
59731556|NCT03262116|75849987|FG004|STARTED|Overall Study||2||
59731557|NCT03262116|75849988|FG005|STARTED|Overall Study||2||
59731558|NCT03262116|75849983|FG000|COMPLETED|Overall Study||2||
59731559|NCT03262116|75849984|FG001|COMPLETED|Overall Study||1||
59731560|NCT03262116|75849985|FG002|COMPLETED|Overall Study||1||
59731561|NCT03262116|75849986|FG003|COMPLETED|Overall Study||1||
59731562|NCT03262116|75849987|FG004|COMPLETED|Overall Study||1||
59731563|NCT03262116|75849988|FG005|COMPLETED|Overall Study||0||
59731564|NCT03262116|75849983|FG000|NOT COMPLETED|Overall Study||0||
59731565|NCT03262116|75849984|FG001|NOT COMPLETED|Overall Study||2||
59731566|NCT03262116|75849985|FG002|NOT COMPLETED|Overall Study||1||
59731567|NCT03262116|75849986|FG003|NOT COMPLETED|Overall Study||1||
59731568|NCT03262116|75849987|FG004|NOT COMPLETED|Overall Study||1||
59731569|NCT03262116|75849988|FG005|NOT COMPLETED|Overall Study||2||
59731570|NCT01130168|75849996|FG000|STARTED|Period 1||6||
59731571|NCT01130168|75849997|FG001|STARTED|Period 1||7||
59731572|NCT01130168|75849998|FG002|STARTED|Period 1||6||
59731573|NCT01130168|75849999|FG003|STARTED|Period 1||8||
59731574|NCT01130168|75850000|FG004|STARTED|Period 1||5||
59731575|NCT01130168|75850001|FG005|STARTED|Period 1||6||
59731576|NCT01130168|75849996|FG000|COMPLETED|Period 1||6||
59731577|NCT01130168|75849997|FG001|COMPLETED|Period 1||6||
59731578|NCT01130168|75849998|FG002|COMPLETED|Period 1||5||
59731579|NCT01130168|75849999|FG003|COMPLETED|Period 1||5||
59731580|NCT01130168|75850000|FG004|COMPLETED|Period 1||5||
59731581|NCT01130168|75850001|FG005|COMPLETED|Period 1||6||
59731582|NCT01130168|75849996|FG000|NOT COMPLETED|Period 1||0||
59731583|NCT01130168|75849997|FG001|NOT COMPLETED|Period 1||1||
59731584|NCT01130168|75849998|FG002|NOT COMPLETED|Period 1||1||
59731585|NCT01130168|75849999|FG003|NOT COMPLETED|Period 1||3||
59731586|NCT01130168|75850000|FG004|NOT COMPLETED|Period 1||0||
59731587|NCT01130168|75850001|FG005|NOT COMPLETED|Period 1||0||
59731588|NCT01130168|75849996|FG000|STARTED|Period 2||6||
59731589|NCT01130168|75849997|FG001|STARTED|Period 2||6||
59731590|NCT01130168|75849998|FG002|STARTED|Period 2||5||
59731591|NCT01130168|75849999|FG003|STARTED|Period 2||5||
59731592|NCT01130168|75850000|FG004|STARTED|Period 2||5||
59731593|NCT01130168|75850001|FG005|STARTED|Period 2||6||
59731594|NCT01130168|75849996|FG000|COMPLETED|Period 2||6||
59731595|NCT01130168|75849997|FG001|COMPLETED|Period 2||6||
59731596|NCT01130168|75849998|FG002|COMPLETED|Period 2||5||
59731597|NCT01130168|75849999|FG003|COMPLETED|Period 2||5||
59731598|NCT01130168|75850000|FG004|COMPLETED|Period 2||5||
59731599|NCT01130168|75850001|FG005|COMPLETED|Period 2||6||
59731600|NCT01130168|75849996|FG000|NOT COMPLETED|Period 2||0||
59731601|NCT01130168|75849997|FG001|NOT COMPLETED|Period 2||0||
59731602|NCT01130168|75849998|FG002|NOT COMPLETED|Period 2||0||
59731603|NCT01130168|75849999|FG003|NOT COMPLETED|Period 2||0||
59731604|NCT01130168|75850000|FG004|NOT COMPLETED|Period 2||0||
59731605|NCT01130168|75850001|FG005|NOT COMPLETED|Period 2||0||
59731606|NCT01130168|75849996|FG000|STARTED|Period 3||6||
59731607|NCT01130168|75849997|FG001|STARTED|Period 3||6||
59731608|NCT01130168|75849998|FG002|STARTED|Period 3||5||
59731609|NCT01130168|75849999|FG003|STARTED|Period 3||5||
59731610|NCT01130168|75850000|FG004|STARTED|Period 3||5||
59731611|NCT01130168|75850001|FG005|STARTED|Period 3||6||
59731612|NCT01130168|75849996|FG000|COMPLETED|Period 3||6||
59731613|NCT01130168|75849997|FG001|COMPLETED|Period 3||6||
59731614|NCT01130168|75849998|FG002|COMPLETED|Period 3||5||
59731615|NCT01130168|75849999|FG003|COMPLETED|Period 3||5||
59731616|NCT01130168|75850000|FG004|COMPLETED|Period 3||5||
59731617|NCT01130168|75850001|FG005|COMPLETED|Period 3||6||
59731618|NCT01130168|75849996|FG000|NOT COMPLETED|Period 3||0||
59731619|NCT01130168|75849997|FG001|NOT COMPLETED|Period 3||0||
59731620|NCT01130168|75849998|FG002|NOT COMPLETED|Period 3||0||
59731621|NCT01130168|75849999|FG003|NOT COMPLETED|Period 3||0||
59731622|NCT01130168|75850000|FG004|NOT COMPLETED|Period 3||0||
59731623|NCT01130168|75850001|FG005|NOT COMPLETED|Period 3||0||
59731624|NCT01144052|75850012|FG000|STARTED|Overall Study||10||
59731625|NCT01144052|75850013|FG001|STARTED|Overall Study||9||
59731626|NCT01144052|75850012|FG000|COMPLETED|Overall Study||9||
59731627|NCT01144052|75850013|FG001|COMPLETED|Overall Study||8||
59731628|NCT01144052|75850012|FG000|NOT COMPLETED|Overall Study||1||
59731629|NCT01144052|75850013|FG001|NOT COMPLETED|Overall Study||1||
59731630|NCT01143896|75850023|FG000|STARTED|Overall Study||156||
59731631|NCT01143896|75850024|FG001|STARTED|Overall Study||153||
59731632|NCT01143896|75850023|FG000|COMPLETED|Overall Study||114||
59731633|NCT01143896|75850024|FG001|COMPLETED|Overall Study||128||
59731634|NCT01143896|75850023|FG000|NOT COMPLETED|Overall Study||42||
59731635|NCT01143896|75850024|FG001|NOT COMPLETED|Overall Study||25||
59731636|NCT01118312|75850033|FG000|STARTED|Overall Study||189||
59731637|NCT01118312|75850034|FG001|STARTED|Overall Study||199||
59731638|NCT01118312|75850033|FG000|COMPLETED|Overall Study||155||
59731639|NCT01118312|75850034|FG001|COMPLETED|Overall Study||164||
59731640|NCT01118312|75850033|FG000|NOT COMPLETED|Overall Study||34||
59731641|NCT01118312|75850034|FG001|NOT COMPLETED|Overall Study||35||
59731642|NCT01117766|75850040|FG000|STARTED|First Intervention||14||
59731643|NCT01117766|75850041|FG001|STARTED|First Intervention||17||
59731644|NCT01117766|75850040|FG000|Received Treatment|First Intervention||14||
59731645|NCT01117766|75850041|FG001|Received Treatment|First Intervention||17||
59731646|NCT01117766|75850040|FG000|COMPLETED|First Intervention||13||
59731647|NCT01117766|75850041|FG001|COMPLETED|First Intervention||16||
59731648|NCT01117766|75850040|FG000|NOT COMPLETED|First Intervention||1||
59731649|NCT01117766|75850041|FG001|NOT COMPLETED|First Intervention||1||
59731650|NCT01117766|75850040|FG000|STARTED|Washout Period||13||
59731651|NCT01117766|75850041|FG001|STARTED|Washout Period||16||
59731652|NCT01117766|75850040|FG000|COMPLETED|Washout Period||13||
59731653|NCT01117766|75850041|FG001|COMPLETED|Washout Period||14||
59731654|NCT01117766|75850040|FG000|NOT COMPLETED|Washout Period||0||
59731655|NCT01117766|75850041|FG001|NOT COMPLETED|Washout Period||2||
59731656|NCT01117766|75850040|FG000|STARTED|Second Intervention||13||
59731657|NCT01117766|75850041|FG001|STARTED|Second Intervention||14||
59731658|NCT01117766|75850040|FG000|COMPLETED|Second Intervention||11||
59731659|NCT01117766|75850041|FG001|COMPLETED|Second Intervention||9||
59731660|NCT01117766|75850040|FG000|NOT COMPLETED|Second Intervention||2||
59731661|NCT01117766|75850041|FG001|NOT COMPLETED|Second Intervention||5||
59731662|NCT01117454|75850049|FG000|STARTED|Overall Study||6||
59731663|NCT01117454|75850050|FG001|STARTED|Overall Study||8||
59731664|NCT01117454|75850049|FG000|COMPLETED|Overall Study||6||
59731665|NCT01117454|75850050|FG001|COMPLETED|Overall Study||7||
59731666|NCT01117454|75850049|FG000|NOT COMPLETED|Overall Study||0||
59731667|NCT01117454|75850050|FG001|NOT COMPLETED|Overall Study||1||
59731668|NCT01116440|75850058|FG000|STARTED|Treatment||11||
59731669|NCT01116440|75850059|FG001|STARTED|Treatment||16||
59731670|NCT01116440|75850058|FG000|COMPLETED|Treatment||8||
59731671|NCT01116440|75850059|FG001|COMPLETED|Treatment||9||
59731672|NCT01116440|75850058|FG000|NOT COMPLETED|Treatment||3||
59731673|NCT01116440|75850059|FG001|NOT COMPLETED|Treatment||7||
59731674|NCT01116440|75850058|FG000|STARTED|Withdrawal||8||
59731675|NCT01116440|75850059|FG001|STARTED|Withdrawal||9||
59731676|NCT01116440|75850058|FG000|COMPLETED|Withdrawal||8||
59731677|NCT01116440|75850059|FG001|COMPLETED|Withdrawal||7||
59731678|NCT01116440|75850058|FG000|NOT COMPLETED|Withdrawal||0||
59731679|NCT01116440|75850059|FG001|NOT COMPLETED|Withdrawal||2||
59731680|NCT01116440|75850058|FG000|STARTED|Follow-up||8||
59731681|NCT01116440|75850059|FG001|STARTED|Follow-up||7||
59731682|NCT01116440|75850058|FG000|COMPLETED|Follow-up||8||
59731683|NCT01116440|75850059|FG001|COMPLETED|Follow-up||5||
59731684|NCT01116440|75850058|FG000|NOT COMPLETED|Follow-up||0||
59731685|NCT01116440|75850059|FG001|NOT COMPLETED|Follow-up||2||
59731686|NCT01129622|75850067|FG000|STARTED|Overall Study||16||
59731687|NCT01129622|75850067|FG000|COMPLETED|Overall Study||14||
59731688|NCT01129622|75850067|FG000|NOT COMPLETED|Overall Study||2||
59731689|NCT01128842|75850072|FG000|STARTED|Overall Study||7||
59731690|NCT01128842|75850072|FG000|COMPLETED|Overall Study||0||
59731691|NCT01128842|75850072|FG000|NOT COMPLETED|Overall Study||7||
59731692|NCT01143038|75850077|FG000|STARTED|Overall Study||75||
59731693|NCT01143038|75850077|FG000|COMPLETED|Overall Study|Defined as completion of romiplostim treatment|59||
59731694|NCT01143038|75850077|FG000|NOT COMPLETED|Overall Study||16||
59731695|NCT00966264|75850083|FG000|STARTED|Overall Study||119||
59731696|NCT00966264|75850084|FG001|STARTED|Overall Study||117||
59731697|NCT00966264|75850083|FG000|COMPLETED|Overall Study|5 years results|115||
59731698|NCT00966264|75850084|FG001|COMPLETED|Overall Study|5 years results|114||
59731699|NCT00966264|75850083|FG000|NOT COMPLETED|Overall Study||4||
59731700|NCT00966264|75850084|FG001|NOT COMPLETED|Overall Study||3||
59731701|NCT00915525|75850092|FG000|STARTED|Overall Study||543||
59731702|NCT00915525|75850093|FG001|STARTED|Overall Study||286||
59731703|NCT00915525|75850092|FG000|COMPLETED|Overall Study||278||
59731704|NCT00915525|75850093|FG001|COMPLETED|Overall Study||151||
59731705|NCT00915525|75850092|FG000|NOT COMPLETED|Overall Study||265||
59731706|NCT00915525|75850093|FG001|NOT COMPLETED|Overall Study||135||
59731707|NCT01074047|75850121|FG000|STARTED|Treatment Phase||241||
59731708|NCT01074047|75850122|FG001|STARTED|Treatment Phase||247||
59731709|NCT01074047|75850121|FG000|Treated Population|Treatment Phase|5 patients not treated with any drug regimen|236||
59731710|NCT01074047|75850122|FG001|Treated Population|Treatment Phase|7 patients not treated with any drug regimen|240||
59731711|NCT01074047|75850121|FG000|Safety Population|Treatment Phase|Received at least one dose of study medication and had at least 1 post dose safety assessment|236||
59731712|NCT01074047|75850122|FG001|Safety Population|Treatment Phase|Received at least one dose of study medication and had at least 1 post dose safety assessment|235||
59731713|NCT01074047|75850121|FG000|Evaluable Population|Treatment Phase|Did not meet criteria for exclusion, received ≥1 cycle of treatment and had ≥ 1 efficacy assessment|179||
59731714|NCT01074047|75850122|FG001|Evaluable Population|Treatment Phase|Did not meet criteria for exclusion, received ≥1 cycle of treatment and had ≥ 1 efficacy assessment|191||
59731715|NCT01074047|75850121|FG000|COMPLETED|Treatment Phase|Participants who were continuing study treatment at the time of study closure|24||
59731716|NCT01074047|75850122|FG001|COMPLETED|Treatment Phase|Participants who were continuing study treatment at the time of study closure|13||
59731717|NCT01074047|75850121|FG000|NOT COMPLETED|Treatment Phase||217||
59731718|NCT01074047|75850122|FG001|NOT COMPLETED|Treatment Phase||234||
59731719|NCT01074047|75850121|FG000|STARTED|Survival Follow-Up Phase||140||
59731720|NCT01074047|75850122|FG001|STARTED|Survival Follow-Up Phase||163||
59731721|NCT01074047|75850121|FG000|COMPLETED|Survival Follow-Up Phase||16||
59731722|NCT01074047|75850122|FG001|COMPLETED|Survival Follow-Up Phase||27||
59731723|NCT01074047|75850121|FG000|NOT COMPLETED|Survival Follow-Up Phase||124||
59731724|NCT01074047|75850122|FG001|NOT COMPLETED|Survival Follow-Up Phase||136||
59731725|NCT01074047|75850121|FG000|STARTED|Extension Phase|2 participants did not enroll in the extension period.|22||
59731726|NCT01074047|75850122|FG001|STARTED|Extension Phase||0||
59731727|NCT01074047|75850121|FG000|Safety Population|Extension Phase|Participants who enrolled in the extension phase|22||
59731728|NCT01074047|75850122|FG001|Safety Population|Extension Phase||0||
59731729|NCT01074047|75850121|FG000|COMPLETED|Extension Phase||0||
59731730|NCT01074047|75850122|FG001|COMPLETED|Extension Phase||0||
59731731|NCT01074047|75850121|FG000|NOT COMPLETED|Extension Phase||22||
59731732|NCT01074047|75850122|FG001|NOT COMPLETED|Extension Phase||0||
59731733|NCT01142726|75850138|FG000|STARTED|Treatment Phase: Day 1 Through Month 12||119||
59731734|NCT01142726|75850139|FG001|STARTED|Treatment Phase: Day 1 Through Month 12||116||
59731735|NCT01142726|75850140|FG002|STARTED|Treatment Phase: Day 1 Through Month 12||116||
59731736|NCT01142726|75850138|FG000|COMPLETED|Treatment Phase: Day 1 Through Month 12||103||
59731737|NCT01142726|75850139|FG001|COMPLETED|Treatment Phase: Day 1 Through Month 12||91||
59731738|NCT01142726|75850140|FG002|COMPLETED|Treatment Phase: Day 1 Through Month 12||96||
59731739|NCT01142726|75850138|FG000|NOT COMPLETED|Treatment Phase: Day 1 Through Month 12||16||
59731740|NCT01142726|75850139|FG001|NOT COMPLETED|Treatment Phase: Day 1 Through Month 12||25||
59731741|NCT01142726|75850140|FG002|NOT COMPLETED|Treatment Phase: Day 1 Through Month 12||20||
59731742|NCT01142726|75850138|FG000|STARTED|Withdrawal Phase: Months 12 up to 24||84||
59731743|NCT01142726|75850139|FG001|STARTED|Withdrawal Phase: Months 12 up to 24||66||
59731744|NCT01142726|75850140|FG002|STARTED|Withdrawal Phase: Months 12 up to 24||75||
59731745|NCT01142726|75850138|FG000|COMPLETED|Withdrawal Phase: Months 12 up to 24||14||
59731746|NCT01142726|75850139|FG001|COMPLETED|Withdrawal Phase: Months 12 up to 24||10||
59731747|NCT01142726|75850140|FG002|COMPLETED|Withdrawal Phase: Months 12 up to 24||17||
59731748|NCT01142726|75850138|FG000|NOT COMPLETED|Withdrawal Phase: Months 12 up to 24||70||
59731749|NCT01142726|75850139|FG001|NOT COMPLETED|Withdrawal Phase: Months 12 up to 24||56||
59731750|NCT01142726|75850140|FG002|NOT COMPLETED|Withdrawal Phase: Months 12 up to 24||58||
59731751|NCT01142726|75850138|FG000|STARTED|Re-Exposure Phase: Months 24 up to 30||55||
59731752|NCT01142726|75850139|FG001|STARTED|Re-Exposure Phase: Months 24 up to 30||48||
59731753|NCT01142726|75850140|FG002|STARTED|Re-Exposure Phase: Months 24 up to 30||43||
59731754|NCT01142726|75850138|FG000|COMPLETED|Re-Exposure Phase: Months 24 up to 30||54||
59731755|NCT01142726|75850139|FG001|COMPLETED|Re-Exposure Phase: Months 24 up to 30||46||
59731756|NCT01142726|75850140|FG002|COMPLETED|Re-Exposure Phase: Months 24 up to 30||40||
59731757|NCT01142726|75850138|FG000|NOT COMPLETED|Re-Exposure Phase: Months 24 up to 30||1||
59731758|NCT01142726|75850139|FG001|NOT COMPLETED|Re-Exposure Phase: Months 24 up to 30||2||
59731759|NCT01142726|75850140|FG002|NOT COMPLETED|Re-Exposure Phase: Months 24 up to 30||3||
59731760|NCT01073267|75850156|FG000|STARTED|Overall Study||4||
59731761|NCT01073267|75850156|FG000|COMPLETED|Overall Study||1||
59731762|NCT01073267|75850156|FG000|NOT COMPLETED|Overall Study||3||
59731763|NCT01142336|75850162|FG000|STARTED|Overall Study||26||
59731764|NCT01142336|75850163|FG001|STARTED|Overall Study||23||
59731765|NCT01142336|75850162|FG000|COMPLETED|Overall Study||25||
59731766|NCT01142336|75850163|FG001|COMPLETED|Overall Study||21||
59731767|NCT01142336|75850162|FG000|NOT COMPLETED|Overall Study||1||
59731768|NCT01142336|75850163|FG001|NOT COMPLETED|Overall Study||2||
59731769|NCT00915681|75850172|FG000|STARTED|Overall Study||148||
59731770|NCT00915681|75850172|FG000|COMPLETED|Overall Study||102||
59731771|NCT00915681|75850172|FG000|NOT COMPLETED|Overall Study||46||
59731772|NCT01128296|75850176|FG000|STARTED|Overall Study||1||
59731773|NCT01128296|75850177|FG001|STARTED|Overall Study||1||
59731774|NCT01128296|75850178|FG002|STARTED|Overall Study||1||
59731775|NCT01128296|75850179|FG003|STARTED|Overall Study||1||
59731776|NCT01128296|75850180|FG004|STARTED|Overall Study||1||
59731777|NCT01128296|75850181|FG005|STARTED|Overall Study||26||
59731778|NCT01128296|75850176|FG000|COMPLETED|Overall Study||1||
59731779|NCT01128296|75850177|FG001|COMPLETED|Overall Study||1||
59731780|NCT01128296|75850178|FG002|COMPLETED|Overall Study||1||
59731781|NCT01128296|75850179|FG003|COMPLETED|Overall Study||1||
59731782|NCT01128296|75850180|FG004|COMPLETED|Overall Study||1||
59731783|NCT01128296|75850181|FG005|COMPLETED|Overall Study||21||
59731784|NCT01128296|75850176|FG000|NOT COMPLETED|Overall Study||0||
59731785|NCT01128296|75850177|FG001|NOT COMPLETED|Overall Study||0||
59731786|NCT01128296|75850178|FG002|NOT COMPLETED|Overall Study||0||
59731787|NCT01128296|75850179|FG003|NOT COMPLETED|Overall Study||0||
59731788|NCT01128296|75850180|FG004|NOT COMPLETED|Overall Study||0||
59731789|NCT01128296|75850181|FG005|NOT COMPLETED|Overall Study||5||
59731790|NCT01115738|75850195|FG000|STARTED|Overall Study||110||
59731791|NCT01115738|75850196|FG001|STARTED|Overall Study||83||
59731792|NCT01115738|75850197|FG002|STARTED|Overall Study||89||
59731793|NCT01115738|75850195|FG000|Received Any Treatment|Overall Study||109||
59731794|NCT01115738|75850196|FG001|Received Any Treatment|Overall Study||79||
59999790|NCT01782131|76115511|FG001|STARTED|Overall Study||292||
59999791|NCT01782131|76115510|FG000|Treated|Overall Study||288||
59731795|NCT01115738|75850197|FG002|Received Any Treatment|Overall Study||88||
59731796|NCT01115738|75850195|FG000|Pharmacodynamic (PD) Population|Overall Study|Received prasugrel LD and had at least one evaluable PD measurement after prasugrel LD.|52||
59731797|NCT01115738|75850196|FG001|Pharmacodynamic (PD) Population|Overall Study|Received prasugrel LD and had at least one evaluable PD measurement after prasugrel LD.|47||
59731798|NCT01115738|75850197|FG002|Pharmacodynamic (PD) Population|Overall Study|Received prasugrel LD and had at least one evaluable PD measurement after prasugrel LD.|50||
59731799|NCT01115738|75850195|FG000|COMPLETED|Overall Study||85||
59731800|NCT01115738|75850196|FG001|COMPLETED|Overall Study||62||
59731801|NCT01115738|75850197|FG002|COMPLETED|Overall Study||62||
59731802|NCT01115738|75850195|FG000|NOT COMPLETED|Overall Study||25||
59731803|NCT01115738|75850196|FG001|NOT COMPLETED|Overall Study||21||
59731804|NCT01115738|75850197|FG002|NOT COMPLETED|Overall Study||27||
59731805|NCT01141478|75850215|FG000|STARTED|Overall Study||4||
59731806|NCT01141478|75850216|FG001|STARTED|Overall Study||4||
59731807|NCT01141478|75850215|FG000|COMPLETED|Overall Study||3||
59731808|NCT01141478|75850216|FG001|COMPLETED|Overall Study||3||
59731809|NCT01141478|75850215|FG000|NOT COMPLETED|Overall Study||1||
59731810|NCT01141478|75850216|FG001|NOT COMPLETED|Overall Study||1||
59731811|NCT01114880|75850224|FG000|STARTED|Period 1 (Week 0 to Week 12)||229||
59731812|NCT01114880|75850225|FG001|STARTED|Period 1 (Week 0 to Week 12)||115||
59731813|NCT01114880|75850224|FG000|COMPLETED|Period 1 (Week 0 to Week 12)||224||
59731814|NCT01114880|75850225|FG001|COMPLETED|Period 1 (Week 0 to Week 12)||113||
59731815|NCT01114880|75850224|FG000|NOT COMPLETED|Period 1 (Week 0 to Week 12)||5||
59731816|NCT01114880|75850225|FG001|NOT COMPLETED|Period 1 (Week 0 to Week 12)||2||
59731817|NCT01114880|75850224|FG000|STARTED|Period 2 (Week 12 to Week 24)||224||
59731818|NCT01114880|75850225|FG001|STARTED|Period 2 (Week 12 to Week 24)||113||
59731819|NCT01114880|75850224|FG000|COMPLETED|Period 2 (Week 12 to Week 24)||221||
59731820|NCT01114880|75850225|FG001|COMPLETED|Period 2 (Week 12 to Week 24)||111||
59731821|NCT01114880|75850224|FG000|NOT COMPLETED|Period 2 (Week 12 to Week 24)||3||
59731822|NCT01114880|75850225|FG001|NOT COMPLETED|Period 2 (Week 12 to Week 24)||2||
59731823|NCT01114724|75850233|FG000|STARTED|Overall Study||50||
59731824|NCT01114724|75850233|FG000|COMPLETED|Overall Study||40||
59731825|NCT01114724|75850233|FG000|NOT COMPLETED|Overall Study||10||
59731826|NCT00964392|75850240|FG000|STARTED|Overall Study|Both safety and efficacy cohort: Total 128 (3 MEP Excluded)|125||
59731827|NCT00964392|75850241|FG001|STARTED|Overall Study|Both safety and efficacy cohort: Total 292 (10 LEP Excluded)|282||
59731828|NCT00964392|75850240|FG000|COMPLETED|Overall Study||72||
59731829|NCT00964392|75850241|FG001|COMPLETED|Overall Study||92||
59731830|NCT00964392|75850240|FG000|NOT COMPLETED|Overall Study||53||
59731831|NCT00964392|75850241|FG001|NOT COMPLETED|Overall Study||190||
59731832|NCT00914589|75850250|FG000|STARTED|Overall Study||128||
59731833|NCT00914589|75850251|FG001|STARTED|Overall Study||143||
59731834|NCT00914589|75850252|FG002|STARTED|Overall Study||138||
59731835|NCT00914589|75850250|FG000|COMPLETED|Overall Study||103||
59731836|NCT00914589|75850251|FG001|COMPLETED|Overall Study||127||
59731837|NCT00914589|75850252|FG002|COMPLETED|Overall Study||126||
59731838|NCT00914589|75850250|FG000|NOT COMPLETED|Overall Study||25||
59731839|NCT00914589|75850251|FG001|NOT COMPLETED|Overall Study||16||
59731840|NCT00914589|75850252|FG002|NOT COMPLETED|Overall Study||12||
59731841|NCT00912405|75850260|FG000|STARTED|Overall Study||50||
59731842|NCT00912405|75850260|FG000|COMPLETED|Overall Study||45||
59731843|NCT00912405|75850260|FG000|NOT COMPLETED|Overall Study||5||
59731844|NCT00878722|75850272|FG000|STARTED|Overall Study||3||
59731845|NCT00878722|75850273|FG001|STARTED|Overall Study||3||
59731846|NCT00878722|75850274|FG002|STARTED|Overall Study||3||
59731847|NCT00878722|75850275|FG003|STARTED|Overall Study||9||
59731848|NCT00878722|75850276|FG004|STARTED|Overall Study||7||
59731849|NCT00878722|75850277|FG005|STARTED|Overall Study||3||
59731850|NCT00878722|75850278|FG006|STARTED|Overall Study||6||
59731851|NCT00878722|75850279|FG007|STARTED|Overall Study||7||
59731852|NCT00878722|75850272|FG000|COMPLETED|Overall Study||0||
59731853|NCT00878722|75850273|FG001|COMPLETED|Overall Study||0||
59731854|NCT00878722|75850274|FG002|COMPLETED|Overall Study||0||
59731855|NCT00878722|75850275|FG003|COMPLETED|Overall Study||0||
59731856|NCT00878722|75850276|FG004|COMPLETED|Overall Study||0||
59731857|NCT00878722|75850277|FG005|COMPLETED|Overall Study||1||
59731858|NCT00878722|75850278|FG006|COMPLETED|Overall Study||0||
59731859|NCT00878722|75850279|FG007|COMPLETED|Overall Study||0||
59731860|NCT00878722|75850272|FG000|NOT COMPLETED|Overall Study||3||
59731861|NCT00878722|75850273|FG001|NOT COMPLETED|Overall Study||3||
59731862|NCT00878722|75850274|FG002|NOT COMPLETED|Overall Study||3||
59731863|NCT00878722|75850275|FG003|NOT COMPLETED|Overall Study||9||
59731864|NCT00878722|75850276|FG004|NOT COMPLETED|Overall Study||7||
59731865|NCT00878722|75850277|FG005|NOT COMPLETED|Overall Study||2||
59731866|NCT00878722|75850278|FG006|NOT COMPLETED|Overall Study||6||
59731867|NCT00878722|75850279|FG007|NOT COMPLETED|Overall Study||7||
59731868|NCT03432897|75850300|FG000|STARTED|Overall Study||1||
59731869|NCT03432897|75850300|FG000|COMPLETED|Overall Study||1||
59731870|NCT03432897|75850300|FG000|NOT COMPLETED|Overall Study||0||
59731871|NCT00964158|75850307|FG000|STARTED|Overall Study||53||
59731872|NCT00964158|75850308|FG001|STARTED|Overall Study||57||
59731873|NCT00964158|75850309|FG002|STARTED|Overall Study||100||
59731874|NCT00964158|75850307|FG000|COMPLETED|Overall Study||53||
59731875|NCT00964158|75850308|FG001|COMPLETED|Overall Study||56||
59731876|NCT00964158|75850309|FG002|COMPLETED|Overall Study||92||
59731877|NCT00964158|75850307|FG000|NOT COMPLETED|Overall Study||0||
59731878|NCT00964158|75850308|FG001|NOT COMPLETED|Overall Study||1||
59731879|NCT00964158|75850309|FG002|NOT COMPLETED|Overall Study||8||
59731880|NCT00961350|75850322|FG000|STARTED|Overall Study||265||
59731881|NCT00961350|75850323|FG001|STARTED|Overall Study||265||
59731882|NCT00961350|75850322|FG000|Intent-to-Treat Population (ITT)|Overall Study||265||
59731883|NCT00961350|75850323|FG001|Intent-to-Treat Population (ITT)|Overall Study||265||
59731884|NCT00961350|75850322|FG000|Safety Population|Overall Study|1. One sub rand to PA32540 took EC-Aspirin|264||
59731885|NCT00961350|75850323|FG001|Safety Population|Overall Study||265||
59731886|NCT00961350|75850322|FG000|COMPLETED|Overall Study||218||
59731887|NCT00961350|75850323|FG001|COMPLETED|Overall Study||198||
59731888|NCT00961350|75850322|FG000|NOT COMPLETED|Overall Study||47||
59731889|NCT00961350|75850323|FG001|NOT COMPLETED|Overall Study||67||
59731890|NCT00963924|75850331|FG000|STARTED|Overall Study||18||
59731891|NCT00963924|75850332|FG001|STARTED|Overall Study||18||
59731892|NCT00963924|75850331|FG000|COMPLETED|Overall Study||17||
59731893|NCT00963924|75850332|FG001|COMPLETED|Overall Study||15||
59731894|NCT00963924|75850331|FG000|NOT COMPLETED|Overall Study||1||
59731895|NCT00963924|75850332|FG001|NOT COMPLETED|Overall Study||3||
59731896|NCT03265665|75850342|FG000|STARTED|24-week Data Collection||25||
59731897|NCT03265665|75850343|FG001|STARTED|24-week Data Collection||28||
59731898|NCT03265665|75850342|FG000|COMPLETED|24-week Data Collection||19||
59731899|NCT03265665|75850343|FG001|COMPLETED|24-week Data Collection||21||
59731900|NCT03265665|75850342|FG000|NOT COMPLETED|24-week Data Collection||6||
59731901|NCT03265665|75850343|FG001|NOT COMPLETED|24-week Data Collection||7||
59731902|NCT03265665|75850342|FG000|STARTED|36-week Data Collection|Used the number of participants that did not withdraw from the study. If a participant did not complete the 24 week week data collection, they were still allowed to complete the 36-week data collection. Thus the number we started with for this period was the total number of participants in each group that did not withdraw from the study.|23||
59731903|NCT03265665|75850343|FG001|STARTED|36-week Data Collection|Used the number of participants that did not withdraw from the study. If a participant did not complete the 24 week week data collection, they were still allowed to complete the 36-week data collection. Thus the number we started with for this period was the total number of participants in each group that did not withdraw from the study.|26||
59731904|NCT03265665|75850342|FG000|COMPLETED|36-week Data Collection||17||
59731905|NCT03265665|75850343|FG001|COMPLETED|36-week Data Collection||18||
59731906|NCT03265665|75850342|FG000|NOT COMPLETED|36-week Data Collection||6||
59731907|NCT03265665|75850343|FG001|NOT COMPLETED|36-week Data Collection||8||
59731908|NCT01114646|75850353|FG000|STARTED|Overall Study||66||
59731909|NCT01114646|75850354|FG001|STARTED|Overall Study||64||
59731910|NCT01114646|75850353|FG000|COMPLETED|Overall Study||63||
59731911|NCT01114646|75850354|FG001|COMPLETED|Overall Study||62||
59731912|NCT01114646|75850353|FG000|NOT COMPLETED|Overall Study||3||
59731913|NCT01114646|75850354|FG001|NOT COMPLETED|Overall Study||2||
59731914|NCT00965562|75850363|FG000|STARTED|Overall Study||16||
59731915|NCT00965562|75850364|FG001|STARTED|Overall Study||17||
59731916|NCT00965562|75850365|FG002|STARTED|Overall Study||16||
59731917|NCT00965562|75850363|FG000|Women With at Least 2 Follow up Visits|Overall Study|3 patients with no follow up visits: 1 out of contact, 2 patient requests|13||
59731918|NCT00965562|75850364|FG001|Women With at Least 2 Follow up Visits|Overall Study|4 patients with no follow up visits: 2 out of contact, 2 patient requests|13||
59731919|NCT00965562|75850365|FG002|Women With at Least 2 Follow up Visits|Overall Study|3 patients with no follow up visits: 3 out of contact|13||
59731920|NCT00965562|75850363|FG000|Women Who Participated Full Follow up|Overall Study|7 patients discontinued intervention: 2 out of contact, 4 patient requests, 1 suspended by IRB|6||
59731921|NCT00965562|75850364|FG001|Women Who Participated Full Follow up|Overall Study|3 patients discontinued intervention: 1 out of contact, 2 patient requests|10||
59731922|NCT00965562|75850365|FG002|Women Who Participated Full Follow up|Overall Study|2 patients discontinued intervention: 2 patient requests|11||
59731923|NCT00965562|75850363|FG000|COMPLETED|Overall Study|Participants who completed at least 2 visits were analyzed.|13||
59731924|NCT00965562|75850364|FG001|COMPLETED|Overall Study|Participants who completed at least 2 visits were analyzed.|13||
59731925|NCT00965562|75850365|FG002|COMPLETED|Overall Study|Participants who completed at least 2 visits were analyzed.|13||
59731926|NCT00965562|75850363|FG000|NOT COMPLETED|Overall Study||3||
59731927|NCT00965562|75850364|FG001|NOT COMPLETED|Overall Study||4||
59731928|NCT00965562|75850365|FG002|NOT COMPLETED|Overall Study||3||
59731929|NCT00912093|75850379|FG000|STARTED|The Controlled Phase||43||
59731930|NCT00912093|75850380|FG001|STARTED|The Controlled Phase||45||
59731931|NCT00912093|75850381|FG002|STARTED|The Controlled Phase||3||
59731932|NCT00912093|75850382|FG003|STARTED|The Controlled Phase||2||
59731933|NCT00912093|75850383|FG004|STARTED|The Controlled Phase||5||
59731934|NCT00912093|75850379|FG000|COMPLETED|The Controlled Phase||43||
59731935|NCT00912093|75850380|FG001|COMPLETED|The Controlled Phase||43||
59731936|NCT00912093|75850381|FG002|COMPLETED|The Controlled Phase||3||
59731937|NCT00912093|75850382|FG003|COMPLETED|The Controlled Phase||2||
59731938|NCT00912093|75850383|FG004|COMPLETED|The Controlled Phase||4||
59731939|NCT00912093|75850379|FG000|NOT COMPLETED|The Controlled Phase||0||
59731940|NCT00912093|75850380|FG001|NOT COMPLETED|The Controlled Phase||2||
59731941|NCT00912093|75850381|FG002|NOT COMPLETED|The Controlled Phase||0||
59731942|NCT00912093|75850382|FG003|NOT COMPLETED|The Controlled Phase||0||
59731943|NCT00912093|75850383|FG004|NOT COMPLETED|The Controlled Phase||1||
59731944|NCT00912093|75850379|FG000|STARTED|The Open Label Extension (OLE) Phase||38||
59731945|NCT00912093|75850380|FG001|STARTED|The Open Label Extension (OLE) Phase||35||
59731946|NCT00912093|75850381|FG002|STARTED|The Open Label Extension (OLE) Phase||3||
59731947|NCT00912093|75850382|FG003|STARTED|The Open Label Extension (OLE) Phase||2||
59731948|NCT00912093|75850383|FG004|STARTED|The Open Label Extension (OLE) Phase||4||
59731949|NCT00912093|75850379|FG000|COMPLETED|The Open Label Extension (OLE) Phase||38||
59731950|NCT00912093|75850380|FG001|COMPLETED|The Open Label Extension (OLE) Phase||35||
59731951|NCT00912093|75850381|FG002|COMPLETED|The Open Label Extension (OLE) Phase||3||
59731952|NCT00912093|75850382|FG003|COMPLETED|The Open Label Extension (OLE) Phase||2||
59731953|NCT00912093|75850383|FG004|COMPLETED|The Open Label Extension (OLE) Phase||4||
59731954|NCT00912093|75850379|FG000|NOT COMPLETED|The Open Label Extension (OLE) Phase||0||
59731955|NCT00912093|75850380|FG001|NOT COMPLETED|The Open Label Extension (OLE) Phase||0||
59731956|NCT00912093|75850381|FG002|NOT COMPLETED|The Open Label Extension (OLE) Phase||0||
59731957|NCT00912093|75850382|FG003|NOT COMPLETED|The Open Label Extension (OLE) Phase||0||
59731958|NCT00912093|75850383|FG004|NOT COMPLETED|The Open Label Extension (OLE) Phase||0||
59731959|NCT00965484|75850391|FG000|STARTED|Overall Study||136||
59731960|NCT00965484|75850391|FG000|COMPLETED|Overall Study||134||
59731961|NCT00965484|75850391|FG000|NOT COMPLETED|Overall Study||2||
59731962|NCT00961116|75850395|FG000|STARTED|First Intervention||27||
59731963|NCT00961116|75850396|FG001|STARTED|First Intervention||27||
59731964|NCT00961116|75850395|FG000|COMPLETED|First Intervention||27||
59731965|NCT00961116|75850396|FG001|COMPLETED|First Intervention||27||
59731966|NCT00961116|75850395|FG000|NOT COMPLETED|First Intervention||0||
59731967|NCT00961116|75850396|FG001|NOT COMPLETED|First Intervention||0||
59731968|NCT00961116|75850395|FG000|STARTED|Washout Period of 7 Days||27||
59731969|NCT00961116|75850396|FG001|STARTED|Washout Period of 7 Days||27||
59731970|NCT00961116|75850395|FG000|COMPLETED|Washout Period of 7 Days||25||
59731971|NCT00961116|75850396|FG001|COMPLETED|Washout Period of 7 Days||24||
59731972|NCT00961116|75850395|FG000|NOT COMPLETED|Washout Period of 7 Days||2||
59731973|NCT00961116|75850396|FG001|NOT COMPLETED|Washout Period of 7 Days||3||
59731974|NCT00961116|75850395|FG000|STARTED|Second Intervention||25||
59731975|NCT00961116|75850396|FG001|STARTED|Second Intervention||24||
59731976|NCT00961116|75850395|FG000|COMPLETED|Second Intervention||25||
59731977|NCT00961116|75850396|FG001|COMPLETED|Second Intervention||24||
59731978|NCT00961116|75850395|FG000|NOT COMPLETED|Second Intervention||0||
59731979|NCT00961116|75850396|FG001|NOT COMPLETED|Second Intervention||0||
59731980|NCT00912015|75850407|FG000|STARTED|Overall Study|Dose at which a patient spent the longest time.|141||
59731981|NCT00912015|75850408|FG001|STARTED|Overall Study|Dose at which a patient spent the longest time.|70||
59731982|NCT00912015|75850409|FG002|STARTED|Overall Study|Dose at which a patient spent the longest time.|25||
59731983|NCT00912015|75850410|FG003|STARTED|Overall Study|Two patients took 100 mg against instructions in protocol that the minimum daily dose was 200 mg.|2||
59731984|NCT00912015|75850407|FG000|COMPLETED|Overall Study||125||
59731985|NCT00912015|75850408|FG001|COMPLETED|Overall Study||62||
59731986|NCT00912015|75850409|FG002|COMPLETED|Overall Study||22||
59731987|NCT00912015|75850410|FG003|COMPLETED|Overall Study||0||
59731988|NCT00912015|75850407|FG000|NOT COMPLETED|Overall Study||16||
59731989|NCT00912015|75850408|FG001|NOT COMPLETED|Overall Study||8||
59731990|NCT00912015|75850409|FG002|NOT COMPLETED|Overall Study||3||
59731991|NCT00912015|75850410|FG003|NOT COMPLETED|Overall Study||2||
59731992|NCT00960804|75850423|FG000|STARTED|Overall Study||7||
59731993|NCT00960804|75850424|FG001|STARTED|Overall Study||4||
59731994|NCT00960804|75850425|FG002|STARTED|Overall Study||10||
59731995|NCT00960804|75850423|FG000|COMPLETED|Overall Study||0||
59731996|NCT00960804|75850424|FG001|COMPLETED|Overall Study||0||
59731997|NCT00960804|75850425|FG002|COMPLETED|Overall Study||0||
59731998|NCT00960804|75850423|FG000|NOT COMPLETED|Overall Study||7||
59731999|NCT00960804|75850424|FG001|NOT COMPLETED|Overall Study||4||
59732000|NCT00960804|75850425|FG002|NOT COMPLETED|Overall Study||10||
59732001|NCT01126580|75850436|FG000|STARTED|Overall Study||269||
59732002|NCT01126580|75850437|FG001|STARTED|Overall Study||270||
59732003|NCT01126580|75850438|FG002|STARTED|Overall Study||268||
59732004|NCT01126580|75850436|FG000|Received at Least 1 Dose of Study Drug|Overall Study||269||
59732005|NCT01126580|75850437|FG001|Received at Least 1 Dose of Study Drug|Overall Study||270||
59732006|NCT01126580|75850438|FG002|Received at Least 1 Dose of Study Drug|Overall Study||268||
59732007|NCT01126580|75850436|FG000|Completed 26 Weeks|Overall Study||233||
59732008|NCT01126580|75850437|FG001|Completed 26 Weeks|Overall Study||242||
59732009|NCT01126580|75850438|FG002|Completed 26 Weeks|Overall Study||226||
59732010|NCT01126580|75850436|FG000|COMPLETED|Overall Study||220||
59732011|NCT01126580|75850437|FG001|COMPLETED|Overall Study||218||
59732012|NCT01126580|75850438|FG002|COMPLETED|Overall Study||213||
59732013|NCT01126580|75850436|FG000|NOT COMPLETED|Overall Study||49||
59732014|NCT01126580|75850437|FG001|NOT COMPLETED|Overall Study||52||
59732015|NCT01126580|75850438|FG002|NOT COMPLETED|Overall Study||55||
59732016|NCT00911157|75850449|FG000|STARTED|Overall Study||29||
59732017|NCT00911157|75850450|FG001|STARTED|Overall Study||10||
59732018|NCT00911157|75850449|FG000|COMPLETED|Overall Study||22||
59732019|NCT00911157|75850450|FG001|COMPLETED|Overall Study||8||
59732020|NCT00911157|75850449|FG000|NOT COMPLETED|Overall Study||7||
59732021|NCT00911157|75850450|FG001|NOT COMPLETED|Overall Study||2||
59732022|NCT00960570|75850456|FG000|STARTED|Efavirenz Alone||30||
59732023|NCT00960570|75850456|FG000|COMPLETED|Efavirenz Alone||30||
59732024|NCT00960570|75850456|FG000|NOT COMPLETED|Efavirenz Alone||0||
59732025|NCT00960570|75850456|FG000|STARTED|21 Day Washout Period||30||
59732026|NCT00960570|75850456|FG000|COMPLETED|21 Day Washout Period||28||
59732027|NCT00960570|75850456|FG000|NOT COMPLETED|21 Day Washout Period||2||
59732028|NCT00960570|75850456|FG000|STARTED|Fenofibric Acid Alone||28||
59732029|NCT00960570|75850456|FG000|COMPLETED|Fenofibric Acid Alone||28||
59732030|NCT00960570|75850456|FG000|NOT COMPLETED|Fenofibric Acid Alone||0||
59732031|NCT00960570|75850456|FG000|STARTED|1 Day Period Between Dosing||28||
59732032|NCT00960570|75850456|FG000|COMPLETED|1 Day Period Between Dosing||25||
59732033|NCT00960570|75850456|FG000|NOT COMPLETED|1 Day Period Between Dosing||3||
59732034|NCT00960570|75850456|FG000|STARTED|Efavirenz and Fenofibric Acid||25||
59732035|NCT00960570|75850456|FG000|COMPLETED|Efavirenz and Fenofibric Acid||25||
59732036|NCT00960570|75850456|FG000|NOT COMPLETED|Efavirenz and Fenofibric Acid||0||
59732037|NCT01126424|75850469|FG000|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|3||
59732038|NCT01126424|75850470|FG001|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|4||
59732039|NCT01126424|75850471|FG002|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|5||
59732040|NCT01126424|75850472|FG003|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|6||
59732041|NCT01126424|75850473|FG004|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|4||
59732042|NCT01126424|75850474|FG005|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|4||
59732043|NCT01126424|75850469|FG000|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|3||
59732044|NCT01126424|75850470|FG001|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4||
59732045|NCT01126424|75850471|FG002|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4||
59732046|NCT01126424|75850472|FG003|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4||
59732047|NCT01126424|75850473|FG004|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4||
59732048|NCT01126424|75850474|FG005|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4||
59732049|NCT01126424|75850469|FG000|COMPLETED|Overall Study||3||
59732050|NCT01126424|75850470|FG001|COMPLETED|Overall Study||4||
59732051|NCT01126424|75850471|FG002|COMPLETED|Overall Study||4||
59732052|NCT01126424|75850472|FG003|COMPLETED|Overall Study||3||
59732053|NCT01126424|75850473|FG004|COMPLETED|Overall Study||2||
59732054|NCT01126424|75850474|FG005|COMPLETED|Overall Study||4||
59732055|NCT01126424|75850469|FG000|NOT COMPLETED|Overall Study||0||
59732056|NCT01126424|75850470|FG001|NOT COMPLETED|Overall Study||0||
59732057|NCT01126424|75850471|FG002|NOT COMPLETED|Overall Study||1||
59732058|NCT01126424|75850472|FG003|NOT COMPLETED|Overall Study||3||
59732059|NCT01126424|75850473|FG004|NOT COMPLETED|Overall Study||2||
59732060|NCT01126424|75850474|FG005|NOT COMPLETED|Overall Study||0||
59732061|NCT01126268|75850482|FG000|STARTED|Overall Study||38||
59732062|NCT01126268|75850482|FG000|COMPLETED|Overall Study||37||
59732063|NCT01126268|75850482|FG000|NOT COMPLETED|Overall Study||1||
59732064|NCT00879658|75850493|FG000|STARTED|Overall Study||50||
59732065|NCT00879658|75850494|FG001|STARTED|Overall Study||49||
59732066|NCT00879658|75850495|FG002|STARTED|Overall Study||43||
59732067|NCT00879658|75850496|FG003|STARTED|Overall Study||46||
59732068|NCT00879658|75850497|FG004|STARTED|Overall Study||42||
59732069|NCT00879658|75850498|FG005|STARTED|Overall Study||51||
59732070|NCT00879658|75850499|FG006|STARTED|Overall Study||16||
59732071|NCT00879658|75850493|FG000|COMPLETED|Overall Study||35||
59732072|NCT00879658|75850494|FG001|COMPLETED|Overall Study||44||
59732073|NCT00879658|75850495|FG002|COMPLETED|Overall Study||36||
59732074|NCT00879658|75850496|FG003|COMPLETED|Overall Study||42||
59732075|NCT00879658|75850497|FG004|COMPLETED|Overall Study||40||
59732076|NCT00879658|75850498|FG005|COMPLETED|Overall Study||50||
59732077|NCT00879658|75850499|FG006|COMPLETED|Overall Study||16||
59732078|NCT00879658|75850493|FG000|NOT COMPLETED|Overall Study||15||
59732079|NCT00879658|75850494|FG001|NOT COMPLETED|Overall Study||5||
59732080|NCT00879658|75850495|FG002|NOT COMPLETED|Overall Study||7||
59732081|NCT00879658|75850496|FG003|NOT COMPLETED|Overall Study||4||
59732082|NCT00879658|75850497|FG004|NOT COMPLETED|Overall Study||2||
59732083|NCT00879658|75850498|FG005|NOT COMPLETED|Overall Study||1||
59732084|NCT00879658|75850499|FG006|NOT COMPLETED|Overall Study||0||
59732085|NCT00959946|75850529|FG000|STARTED|Overall Study||2||
59732086|NCT00959946|75850530|FG001|STARTED|Overall Study||4||
59732087|NCT00959946|75850531|FG002|STARTED|Overall Study||4||
59732088|NCT00959946|75850532|FG003|STARTED|Overall Study||5||
59732089|NCT00959946|75850533|FG004|STARTED|Overall Study||4||
59732090|NCT00959946|75850534|FG005|STARTED|Overall Study||9||
59732091|NCT00959946|75850535|FG006|STARTED|Overall Study||2||
59732092|NCT00959946|75850536|FG007|STARTED|Overall Study||2||
59732093|NCT00959946|75850529|FG000|COMPLETED|Overall Study||0||
59732094|NCT00959946|75850530|FG001|COMPLETED|Overall Study||0||
59732095|NCT00959946|75850531|FG002|COMPLETED|Overall Study||0||
59732096|NCT00959946|75850532|FG003|COMPLETED|Overall Study||0||
59732097|NCT00959946|75850533|FG004|COMPLETED|Overall Study||0||
59732098|NCT00959946|75850534|FG005|COMPLETED|Overall Study||0||
59732099|NCT00959946|75850535|FG006|COMPLETED|Overall Study||0||
59732100|NCT00959946|75850536|FG007|COMPLETED|Overall Study||0||
59732101|NCT00959946|75850529|FG000|NOT COMPLETED|Overall Study||2||
59732102|NCT00959946|75850530|FG001|NOT COMPLETED|Overall Study||4||
59732103|NCT00959946|75850531|FG002|NOT COMPLETED|Overall Study||4||
59732104|NCT00959946|75850532|FG003|NOT COMPLETED|Overall Study||5||
59732105|NCT00959946|75850533|FG004|NOT COMPLETED|Overall Study||4||
59732106|NCT00959946|75850534|FG005|NOT COMPLETED|Overall Study||9||
59732107|NCT00959946|75850535|FG006|NOT COMPLETED|Overall Study||2||
59732108|NCT00959946|75850536|FG007|NOT COMPLETED|Overall Study||2||
59732109|NCT00911937|75850561|FG000|STARTED|Overall Study||487||
59732110|NCT00911937|75850562|FG001|STARTED|Overall Study||476||
59732111|NCT00911937|75850561|FG000|Treated|Overall Study||474||
59732112|NCT00911937|75850562|FG001|Treated|Overall Study||463||
59732113|NCT00911937|75850561|FG000|COMPLETED|Overall Study||400||
59732114|NCT00911937|75850562|FG001|COMPLETED|Overall Study||381||
59732115|NCT00911937|75850561|FG000|NOT COMPLETED|Overall Study||87||
59732116|NCT00911937|75850562|FG001|NOT COMPLETED|Overall Study||95||
59732117|NCT00880048|75850571|FG000|STARTED|Overall Study||116||
59732118|NCT00880048|75850572|FG001|STARTED|Overall Study||115||
59732119|NCT00880048|75850573|FG002|STARTED|Overall Study||112||
59732120|NCT00880048|75850571|FG000|COMPLETED|Overall Study||88||
59732121|NCT00880048|75850572|FG001|COMPLETED|Overall Study||82||
59732122|NCT00880048|75850573|FG002|COMPLETED|Overall Study||77||
59732123|NCT00880048|75850571|FG000|NOT COMPLETED|Overall Study||28||
59732124|NCT00880048|75850572|FG001|NOT COMPLETED|Overall Study||33||
59732125|NCT00880048|75850573|FG002|NOT COMPLETED|Overall Study||35||
59732126|NCT00962208|75850583|FG000|STARTED|Overall Study||51||
59732127|NCT00962208|75850584|FG001|STARTED|Overall Study||51||
59732128|NCT00962208|75850583|FG000|COMPLETED|Overall Study||37||
59732129|NCT00962208|75850584|FG001|COMPLETED|Overall Study||41||
59732130|NCT00962208|75850583|FG000|NOT COMPLETED|Overall Study||14||
59732131|NCT00962208|75850584|FG001|NOT COMPLETED|Overall Study||10||
59732132|NCT01076543|75850596|FG000|STARTED|Overall Study||8||
59732133|NCT01076543|75850597|FG001|STARTED|Overall Study||3||
59732134|NCT01076543|75850598|FG002|STARTED|Overall Study||6||
59732135|NCT01076543|75850599|FG003|STARTED|Overall Study||39||
59732136|NCT01076543|75850600|FG004|STARTED|Overall Study||15||
59732137|NCT01076543|75850601|FG005|STARTED|Overall Study||39||
59732138|NCT01076543|75850596|FG000|COMPLETED|Overall Study||6||
59732139|NCT01076543|75850597|FG001|COMPLETED|Overall Study||3||
59732140|NCT01076543|75850598|FG002|COMPLETED|Overall Study||6||
59732141|NCT01076543|75850599|FG003|COMPLETED|Overall Study||39||
59732142|NCT01076543|75850600|FG004|COMPLETED|Overall Study||15||
59732143|NCT01076543|75850601|FG005|COMPLETED|Overall Study||39||
59732144|NCT01076543|75850596|FG000|NOT COMPLETED|Overall Study||2||
59732145|NCT01076543|75850597|FG001|NOT COMPLETED|Overall Study||0||
59732146|NCT01076543|75850598|FG002|NOT COMPLETED|Overall Study||0||
59732147|NCT01076543|75850599|FG003|NOT COMPLETED|Overall Study||0||
59732148|NCT01076543|75850600|FG004|NOT COMPLETED|Overall Study||0||
59732149|NCT01076543|75850601|FG005|NOT COMPLETED|Overall Study||0||
59732150|NCT01072877|75850621|FG000|STARTED|Overall Study||56||
59732151|NCT01072877|75850622|FG001|STARTED|Overall Study||57||
59732152|NCT01072877|75850623|FG002|STARTED|Overall Study||51||
59732153|NCT01072877|75850624|FG003|STARTED|Overall Study||52||
59732154|NCT01072877|75850625|FG004|STARTED|Overall Study||63||
59732155|NCT01072877|75850621|FG000|COMPLETED|Overall Study||55||
59732156|NCT01072877|75850622|FG001|COMPLETED|Overall Study||56||
59732157|NCT01072877|75850623|FG002|COMPLETED|Overall Study||51||
59732158|NCT01072877|75850624|FG003|COMPLETED|Overall Study||50||
59732159|NCT01072877|75850625|FG004|COMPLETED|Overall Study||63||
59732160|NCT01072877|75850621|FG000|NOT COMPLETED|Overall Study||1||
59732161|NCT01072877|75850622|FG001|NOT COMPLETED|Overall Study||1||
59732162|NCT01072877|75850623|FG002|NOT COMPLETED|Overall Study||0||
59732163|NCT01072877|75850624|FG003|NOT COMPLETED|Overall Study||2||
59732164|NCT01072877|75850625|FG004|NOT COMPLETED|Overall Study||0||
59732165|NCT00961896|75850642|FG000|STARTED|Overall Study||8||
59732166|NCT00961896|75850643|FG001|STARTED|Overall Study||3||
59732167|NCT00961896|75850644|FG002|STARTED|Overall Study||7||
59732168|NCT00961896|75850642|FG000|COMPLETED|Overall Study||8||
59732169|NCT00961896|75850643|FG001|COMPLETED|Overall Study||3||
59732170|NCT00961896|75850644|FG002|COMPLETED|Overall Study||6||
59732171|NCT00961896|75850642|FG000|NOT COMPLETED|Overall Study||0||
59732172|NCT00961896|75850643|FG001|NOT COMPLETED|Overall Study||0||
59732173|NCT00961896|75850644|FG002|NOT COMPLETED|Overall Study||1||
59732174|NCT00957528|75850658|FG000|STARTED|Overall Study||8||
59732175|NCT00957528|75850659|FG001|STARTED|Overall Study||9||
59732176|NCT00957528|75850660|FG002|STARTED|Overall Study||9||
59732177|NCT00957528|75850658|FG000|COMPLETED|Overall Study||8||
59732178|NCT00957528|75850659|FG001|COMPLETED|Overall Study||8||
59732179|NCT00957528|75850660|FG002|COMPLETED|Overall Study||8||
59732180|NCT00957528|75850658|FG000|NOT COMPLETED|Overall Study||0||
59732181|NCT00957528|75850659|FG001|NOT COMPLETED|Overall Study||1||
59732182|NCT00957528|75850660|FG002|NOT COMPLETED|Overall Study||1||
59732183|NCT00958776|75850670|FG000|STARTED|Overall Study||137||
59732184|NCT00958776|75850671|FG001|STARTED|Overall Study||268||
59732185|NCT00958776|75850670|FG000|COMPLETED|Overall Study||121||
59732186|NCT00958776|75850671|FG001|COMPLETED|Overall Study||239||
59732187|NCT00958776|75850670|FG000|NOT COMPLETED|Overall Study||16||
59732188|NCT00958776|75850671|FG001|NOT COMPLETED|Overall Study||29||
59732189|NCT00596830|75850680|FG000|STARTED|Overall Study|1 participant in this group only received paclitaxel and carboplatin (chemo).|342||
59732190|NCT00596830|75850681|FG001|STARTED|Overall Study||339||
59732191|NCT00596830|75850680|FG000|Treated|Overall Study|1 participant in this group only received chemo and did not complete due to death.|339||
59732192|NCT00596830|75850681|FG001|Treated|Overall Study||332||
59732193|NCT00596830|75850680|FG000|COMPLETED|Overall Study||0||
59732194|NCT00596830|75850681|FG001|COMPLETED|Overall Study||0||
59732195|NCT00596830|75850680|FG000|NOT COMPLETED|Overall Study||342||
59732196|NCT00596830|75850681|FG001|NOT COMPLETED|Overall Study||339||
59732197|NCT00957372|75850690|FG000|STARTED|PART I||80||
59732198|NCT00957372|75850691|FG001|STARTED|PART I||85||
59732199|NCT00957372|75850692|FG002|STARTED|PART I||88||
59732200|NCT00957372|75850693|FG003|STARTED|PART I||0||
59732201|NCT00957372|75850690|FG000|Safety Population|PART I||80||
59732202|NCT00957372|75850691|FG001|Safety Population|PART I||85||
59732203|NCT00957372|75850692|FG002|Safety Population|PART I||87||
59732204|NCT00957372|75850693|FG003|Safety Population|PART I||0||
59732205|NCT00957372|75850690|FG000|Intention-to-Treat Population|PART I||77||
59732206|NCT00957372|75850691|FG001|Intention-to-Treat Population|PART I||84||
59732207|NCT00957372|75850692|FG002|Intention-to-Treat Population|PART I||84||
59732208|NCT00957372|75850693|FG003|Intention-to-Treat Population|PART I||0||
59732209|NCT00957372|75850690|FG000|Per-Protocol Population|PART I||35||
59732210|NCT00957372|75850691|FG001|Per-Protocol Population|PART I||47||
59732211|NCT00957372|75850692|FG002|Per-Protocol Population|PART I||51||
59732212|NCT00957372|75850693|FG003|Per-Protocol Population|PART I||0||
59732213|NCT00957372|75850690|FG000|Randomized But Not Treated|PART I||0||
59732214|NCT00957372|75850691|FG001|Randomized But Not Treated|PART I||0||
59732215|NCT00957372|75850692|FG002|Randomized But Not Treated|PART I||1||
59732216|NCT00957372|75850693|FG003|Randomized But Not Treated|PART I||0||
59732217|NCT00957372|75850690|FG000|COMPLETED|PART I||80||
59732218|NCT00957372|75850691|FG001|COMPLETED|PART I||85||
59732219|NCT00957372|75850692|FG002|COMPLETED|PART I||87||
59732220|NCT00957372|75850693|FG003|COMPLETED|PART I||0||
59732221|NCT00957372|75850690|FG000|NOT COMPLETED|PART I||0||
59732222|NCT00957372|75850691|FG001|NOT COMPLETED|PART I||0||
59732223|NCT00957372|75850692|FG002|NOT COMPLETED|PART I||1||
59732224|NCT00957372|75850693|FG003|NOT COMPLETED|PART I||0||
59732225|NCT00957372|75850690|FG000|STARTED|PART II||0||
59732226|NCT00957372|75850691|FG001|STARTED|PART II||0||
59732227|NCT00957372|75850692|FG002|STARTED|PART II||0||
59732228|NCT00957372|75850693|FG003|STARTED|PART II||194||
59732229|NCT00957372|75850690|FG000|Safety Population|PART II||0||
59732230|NCT00957372|75850691|FG001|Safety Population|PART II||0||
59732231|NCT00957372|75850692|FG002|Safety Population|PART II||0||
59732232|NCT00957372|75850693|FG003|Safety Population|PART II||194||
59732233|NCT00957372|75850690|FG000|Intention-to-treat (ITT) Population|PART II||0||
59732234|NCT00957372|75850691|FG001|Intention-to-treat (ITT) Population|PART II||0||
59732235|NCT00957372|75850692|FG002|Intention-to-treat (ITT) Population|PART II||0||
59732236|NCT00957372|75850693|FG003|Intention-to-treat (ITT) Population|PART II||191||
59732237|NCT00957372|75850690|FG000|Per-Protocol Population|PART II||0||
59732238|NCT00957372|75850691|FG001|Per-Protocol Population|PART II||0||
59732239|NCT00957372|75850692|FG002|Per-Protocol Population|PART II||0||
59732240|NCT00957372|75850693|FG003|Per-Protocol Population|PART II||108||
59732241|NCT00957372|75850690|FG000|COMPLETED|PART II||0||
59732242|NCT00957372|75850691|FG001|COMPLETED|PART II||0||
59732243|NCT00957372|75850692|FG002|COMPLETED|PART II||0||
59732244|NCT00957372|75850693|FG003|COMPLETED|PART II||150||
59732245|NCT00957372|75850690|FG000|NOT COMPLETED|PART II||0||
59732246|NCT00957372|75850691|FG001|NOT COMPLETED|PART II||0||
59732247|NCT00957372|75850692|FG002|NOT COMPLETED|PART II||0||
59732248|NCT00957372|75850693|FG003|NOT COMPLETED|PART II||44||
59732249|NCT00952848|75850709|FG000|STARTED|Overall Study||18||
59732250|NCT00952848|75850709|FG000|COMPLETED|Overall Study||14||
59732251|NCT00952848|75850709|FG000|NOT COMPLETED|Overall Study||4||
59732252|NCT00952614|75850713|FG000|STARTED|Overall Study||30||
59732253|NCT00952614|75850713|FG000|Participants Started Treatment|Overall Study|29 subjects signed consent; 1 agreed for both eyes to enroll. 30 eyes rec'd drug delivery implant|30||
59732254|NCT00952614|75850713|FG000|COMPLETED|Overall Study|3 subjects died from unrelated causes, 3 were lost to follow-up & 1 had both eyes included in study.|23||
59732255|NCT00952614|75850713|FG000|NOT COMPLETED|Overall Study||7||
59732256|NCT00911859|75850721|FG000|STARTED|Treatment Period||12||
59732257|NCT00911859|75850722|FG001|STARTED|Treatment Period||54||
59732258|NCT00911859|75850723|FG002|STARTED|Treatment Period||52||
59732259|NCT00911859|75850721|FG000|Received Treatment|Treatment Period||12||
59732260|NCT00911859|75850722|FG001|Received Treatment|Treatment Period||53||
59732261|NCT00911859|75850723|FG002|Received Treatment|Treatment Period||52||
59732262|NCT00911859|75850721|FG000|COMPLETED|Treatment Period||4||
59732263|NCT00911859|75850722|FG001|COMPLETED|Treatment Period||33||
59732264|NCT00911859|75850723|FG002|COMPLETED|Treatment Period||27||
59732265|NCT00911859|75850721|FG000|NOT COMPLETED|Treatment Period||8||
59732266|NCT00911859|75850722|FG001|NOT COMPLETED|Treatment Period||21||
59732267|NCT00911859|75850723|FG002|NOT COMPLETED|Treatment Period||25||
59732268|NCT00911859|75850721|FG000|STARTED|Maintainance Period||0||
59732269|NCT00911859|75850722|FG001|STARTED|Maintainance Period||0||
59732270|NCT00911859|75850723|FG002|STARTED|Maintainance Period|Participants who received siltuximab only during the 18-month maintenance period|21||
59732271|NCT00911859|75850721|FG000|COMPLETED|Maintainance Period||0||
59732272|NCT00911859|75850722|FG001|COMPLETED|Maintainance Period||0||
59732273|NCT00911859|75850723|FG002|COMPLETED|Maintainance Period||0||
59732274|NCT00911859|75850721|FG000|NOT COMPLETED|Maintainance Period||0||
59732275|NCT00911859|75850722|FG001|NOT COMPLETED|Maintainance Period||0||
59732276|NCT00911859|75850723|FG002|NOT COMPLETED|Maintainance Period||21||
59732277|NCT00911859|75850721|FG000|STARTED|Follow-up Period|Participants followed until death or 3.5 years after the last participant was assigned to treatment|12||
59732278|NCT00911859|75850722|FG001|STARTED|Follow-up Period|Participants followed until death or 3.5 years after the last participant was assigned to treatment|53||
59732279|NCT00911859|75850723|FG002|STARTED|Follow-up Period|Participants followed until death or 3.5 years after the last participant was assigned to treatment|52||
59732280|NCT00911859|75850721|FG000|COMPLETED|Follow-up Period||1||
59732281|NCT00911859|75850722|FG001|COMPLETED|Follow-up Period||7||
59732282|NCT00911859|75850723|FG002|COMPLETED|Follow-up Period||11||
59732283|NCT00911859|75850721|FG000|NOT COMPLETED|Follow-up Period||11||
59732284|NCT00911859|75850722|FG001|NOT COMPLETED|Follow-up Period||46||
59732285|NCT00911859|75850723|FG002|NOT COMPLETED|Follow-up Period||41||
59732286|NCT00956592|75850733|FG000|STARTED|Overall Study||150||
59732287|NCT00956592|75850734|FG001|STARTED|Overall Study||150||
59732288|NCT00956592|75850733|FG000|COMPLETED|Overall Study||149||
59732289|NCT00956592|75850734|FG001|COMPLETED|Overall Study||147||
59732290|NCT00956592|75850733|FG000|NOT COMPLETED|Overall Study||1||
59732291|NCT00956592|75850734|FG001|NOT COMPLETED|Overall Study||3||
59732292|NCT02725593|75850744|FG000|STARTED|Blinded Treatment Period||39||
59732293|NCT02725593|75850745|FG001|STARTED|Blinded Treatment Period||33||
59732294|NCT02725593|75850744|FG000|Received Treatment|Blinded Treatment Period||39||
59732295|NCT02725593|75850745|FG001|Received Treatment|Blinded Treatment Period||33||
59732296|NCT02725593|75850744|FG000|COMPLETED|Blinded Treatment Period||34||
59732297|NCT02725593|75850745|FG001|COMPLETED|Blinded Treatment Period||27||
59732298|NCT02725593|75850744|FG000|NOT COMPLETED|Blinded Treatment Period||5||
59732299|NCT02725593|75850745|FG001|NOT COMPLETED|Blinded Treatment Period||6||
59732300|NCT02725593|75850744|FG000|STARTED|Long Term Extension|1 participant who completed Period 1 did not enter the long-term extension period.|33||
59732301|NCT02725593|75850745|FG001|STARTED|Long Term Extension||27||
59732302|NCT02725593|75850744|FG000|COMPLETED|Long Term Extension||32||
59732303|NCT02725593|75850745|FG001|COMPLETED|Long Term Extension||24||
59732304|NCT02725593|75850744|FG000|NOT COMPLETED|Long Term Extension||1||
59732305|NCT02725593|75850745|FG001|NOT COMPLETED|Long Term Extension||3||
59732306|NCT00911625|75850753|FG000|STARTED|Overall Study||57||
59732307|NCT00911625|75850754|FG001|STARTED|Overall Study||57||
59732308|NCT00911625|75850753|FG000|COMPLETED|Overall Study||50||
59732309|NCT00911625|75850754|FG001|COMPLETED|Overall Study||57||
59732310|NCT00911625|75850753|FG000|NOT COMPLETED|Overall Study||7||
59732311|NCT00911625|75850754|FG001|NOT COMPLETED|Overall Study||0||
59732312|NCT00596752|75850762|FG000|STARTED|Overall Study||415||
59732313|NCT00596752|75850763|FG001|STARTED|Overall Study||425||
59732314|NCT00596752|75850762|FG000|Randomized and Treated|Overall Study||415||
59732315|NCT00596752|75850763|FG001|Randomized and Treated|Overall Study||424||
59732316|NCT00596752|75850762|FG000|COMPLETED|Overall Study||289||
59732317|NCT00596752|75850763|FG001|COMPLETED|Overall Study||282||
59732318|NCT00596752|75850762|FG000|NOT COMPLETED|Overall Study||126||
59732319|NCT00596752|75850763|FG001|NOT COMPLETED|Overall Study||143||
59732320|NCT00958074|75850771|FG000|STARTED|Overall Study||4||
59732321|NCT00958074|75850772|FG001|STARTED|Overall Study||7||
59732322|NCT00958074|75850771|FG000|COMPLETED|Overall Study||4||
59732323|NCT00958074|75850772|FG001|COMPLETED|Overall Study||6||
59732324|NCT00958074|75850771|FG000|NOT COMPLETED|Overall Study||0||
59732325|NCT00958074|75850772|FG001|NOT COMPLETED|Overall Study||1||
59732326|NCT00809965|75850781|FG000|STARTED|Overall Study||5176||
59732327|NCT00809965|75850782|FG001|STARTED|Overall Study||5174||
59732328|NCT00809965|75850783|FG002|STARTED|Overall Study||5176||
59732329|NCT00809965|75850781|FG000|Treated/Safety Population|Overall Study|All randomized participants who received at least one dose of study drug|5125||
59732330|NCT00809965|75850782|FG001|Treated/Safety Population|Overall Study|All randomized participants who received at least one dose of study drug|5115||
59732331|NCT00809965|75850783|FG002|Treated/Safety Population|Overall Study|All randomized participants who received at least one dose of study drug|5110||
59732332|NCT00809965|75850781|FG000|Modified Intent-to-Treat Population|Overall Study|All randomized participants excluding 3 sites without regard to treatment exposure|5113||
59732333|NCT00809965|75850782|FG001|Modified Intent-to-Treat Population|Overall Study|All randomized participants excluding 3 sites without regard to treatment exposure|5114||
59732334|NCT00809965|75850783|FG002|Modified Intent-to-Treat Population|Overall Study|All randomized participants excluding 3 sites without regard to treatment exposure|5115||
59732335|NCT00809965|75850781|FG000|COMPLETED|Overall Study||4393||
59732336|NCT00809965|75850782|FG001|COMPLETED|Overall Study||4399||
59732337|NCT00809965|75850783|FG002|COMPLETED|Overall Study||4332||
59732338|NCT00809965|75850781|FG000|NOT COMPLETED|Overall Study||783||
59732339|NCT00809965|75850782|FG001|NOT COMPLETED|Overall Study||775||
59732340|NCT00809965|75850783|FG002|NOT COMPLETED|Overall Study||844||
59732341|NCT00597376|75850793|FG000|STARTED|Overall Study||51||
59732342|NCT00597376|75850794|FG001|STARTED|Overall Study||53||
59732343|NCT00597376|75850793|FG000|COMPLETED|Overall Study|All participants started (51) were included in primary analyses.|43||
59732344|NCT00597376|75850794|FG001|COMPLETED|Overall Study|All participants started (53) were included in primary analyses.|49||
59732345|NCT00597376|75850793|FG000|NOT COMPLETED|Overall Study||8||
59732346|NCT00597376|75850794|FG001|NOT COMPLETED|Overall Study||4||
59732347|NCT02416011|75850803|FG000|STARTED|Overall Study||575||
59732348|NCT02416011|75850804|FG001|STARTED|Overall Study||1154||
59732349|NCT02416011|75850805|FG002|STARTED|Overall Study||1167||
59732350|NCT02416011|75850803|FG000|COMPLETED|Overall Study||561||
59732351|NCT02416011|75850804|FG001|COMPLETED|Overall Study||1101||
59732352|NCT02416011|75850805|FG002|COMPLETED|Overall Study||1114||
59732353|NCT02416011|75850803|FG000|NOT COMPLETED|Overall Study||14||
59732354|NCT02416011|75850804|FG001|NOT COMPLETED|Overall Study||53||
59732355|NCT02416011|75850805|FG002|NOT COMPLETED|Overall Study||53||
59732356|NCT00910689|75850830|FG000|STARTED|Month 1: Optimal Acute Therapy Run in||55||
59732357|NCT00910689|75850831|FG001|STARTED|Month 1: Optimal Acute Therapy Run in||53||
59732358|NCT00910689|75850832|FG002|STARTED|Month 1: Optimal Acute Therapy Run in||55||
59732359|NCT00910689|75850833|FG003|STARTED|Month 1: Optimal Acute Therapy Run in||69||
59732360|NCT00910689|75850830|FG000|COMPLETED|Month 1: Optimal Acute Therapy Run in||53||
59732361|NCT00910689|75850831|FG001|COMPLETED|Month 1: Optimal Acute Therapy Run in||52||
59732362|NCT00910689|75850832|FG002|COMPLETED|Month 1: Optimal Acute Therapy Run in||50||
59732363|NCT00910689|75850833|FG003|COMPLETED|Month 1: Optimal Acute Therapy Run in||59||
59732364|NCT00910689|75850830|FG000|NOT COMPLETED|Month 1: Optimal Acute Therapy Run in||2||
59732365|NCT00910689|75850831|FG001|NOT COMPLETED|Month 1: Optimal Acute Therapy Run in||1||
59732366|NCT00910689|75850832|FG002|NOT COMPLETED|Month 1: Optimal Acute Therapy Run in||5||
59732367|NCT00910689|75850833|FG003|NOT COMPLETED|Month 1: Optimal Acute Therapy Run in||10||
59732368|NCT00910689|75850830|FG000|STARTED|Month 2- 4: Treatment Period||53||
59732369|NCT00910689|75850831|FG001|STARTED|Month 2- 4: Treatment Period||52||
59732370|NCT00910689|75850832|FG002|STARTED|Month 2- 4: Treatment Period||50||
59732371|NCT00910689|75850833|FG003|STARTED|Month 2- 4: Treatment Period||59||
59732372|NCT00910689|75850830|FG000|COMPLETED|Month 2- 4: Treatment Period||44||
59732373|NCT00910689|75850831|FG001|COMPLETED|Month 2- 4: Treatment Period||42||
59732374|NCT00910689|75850832|FG002|COMPLETED|Month 2- 4: Treatment Period||42||
59732375|NCT00910689|75850833|FG003|COMPLETED|Month 2- 4: Treatment Period||48||
59732376|NCT00910689|75850830|FG000|NOT COMPLETED|Month 2- 4: Treatment Period||9||
59732377|NCT00910689|75850831|FG001|NOT COMPLETED|Month 2- 4: Treatment Period||10||
59732378|NCT00910689|75850832|FG002|NOT COMPLETED|Month 2- 4: Treatment Period||8||
59732379|NCT00910689|75850833|FG003|NOT COMPLETED|Month 2- 4: Treatment Period||11||
59732380|NCT00910689|75850830|FG000|STARTED|Months 5 - 10: Evaluation Period I||44||
59732381|NCT00910689|75850831|FG001|STARTED|Months 5 - 10: Evaluation Period I||42||
59732382|NCT00910689|75850832|FG002|STARTED|Months 5 - 10: Evaluation Period I||42||
59732383|NCT00910689|75850833|FG003|STARTED|Months 5 - 10: Evaluation Period I||48||
59732384|NCT00910689|75850830|FG000|COMPLETED|Months 5 - 10: Evaluation Period I||40||
59732385|NCT00910689|75850831|FG001|COMPLETED|Months 5 - 10: Evaluation Period I||35||
59732386|NCT00910689|75850832|FG002|COMPLETED|Months 5 - 10: Evaluation Period I||35||
59732387|NCT00910689|75850833|FG003|COMPLETED|Months 5 - 10: Evaluation Period I||41||
59732388|NCT00910689|75850830|FG000|NOT COMPLETED|Months 5 - 10: Evaluation Period I||4||
59732389|NCT00910689|75850831|FG001|NOT COMPLETED|Months 5 - 10: Evaluation Period I||7||
59732390|NCT00910689|75850832|FG002|NOT COMPLETED|Months 5 - 10: Evaluation Period I||7||
59732391|NCT00910689|75850833|FG003|NOT COMPLETED|Months 5 - 10: Evaluation Period I||7||
59732392|NCT00910689|75850830|FG000|STARTED|Months 11- 16: Evaluation Period II||40||
59732393|NCT00910689|75850831|FG001|STARTED|Months 11- 16: Evaluation Period II||35||
59732394|NCT00910689|75850832|FG002|STARTED|Months 11- 16: Evaluation Period II||35||
59732395|NCT00910689|75850833|FG003|STARTED|Months 11- 16: Evaluation Period II||41||
59732396|NCT00910689|75850830|FG000|COMPLETED|Months 11- 16: Evaluation Period II||30||
59732397|NCT00910689|75850831|FG001|COMPLETED|Months 11- 16: Evaluation Period II||25||
59732398|NCT00910689|75850832|FG002|COMPLETED|Months 11- 16: Evaluation Period II||28||
59732399|NCT00910689|75850833|FG003|COMPLETED|Months 11- 16: Evaluation Period II||35||
59732400|NCT00910689|75850830|FG000|NOT COMPLETED|Months 11- 16: Evaluation Period II||10||
59732401|NCT00910689|75850831|FG001|NOT COMPLETED|Months 11- 16: Evaluation Period II||10||
59732402|NCT00910689|75850832|FG002|NOT COMPLETED|Months 11- 16: Evaluation Period II||7||
59732403|NCT00910689|75850833|FG003|NOT COMPLETED|Months 11- 16: Evaluation Period II||6||
59732404|NCT00807001|75850848|FG000|STARTED|Overall Study|For all groups, number of subjects who received at least one dose of study drug.|8||
59732405|NCT00807001|75850849|FG001|STARTED|Overall Study||8||
59732406|NCT00807001|75850850|FG002|STARTED|Overall Study||8||
59732407|NCT00807001|75850851|FG003|STARTED|Overall Study||8||
59732408|NCT00807001|75850852|FG004|STARTED|Overall Study||9||
59732409|NCT00807001|75850848|FG000|COMPLETED|Overall Study||8||
59732410|NCT00807001|75850849|FG001|COMPLETED|Overall Study||7||
59732411|NCT00807001|75850850|FG002|COMPLETED|Overall Study||8||
59732412|NCT00807001|75850851|FG003|COMPLETED|Overall Study||8||
59732413|NCT00807001|75850852|FG004|COMPLETED|Overall Study||9||
59732414|NCT00807001|75850848|FG000|NOT COMPLETED|Overall Study||0||
59732415|NCT00807001|75850849|FG001|NOT COMPLETED|Overall Study||1||
59732416|NCT00807001|75850850|FG002|NOT COMPLETED|Overall Study||0||
59732417|NCT00807001|75850851|FG003|NOT COMPLETED|Overall Study||0||
59732418|NCT00807001|75850852|FG004|NOT COMPLETED|Overall Study||0||
59732419|NCT00809341|75850866|FG000|STARTED|Overall Study||20||
59732420|NCT00809341|75850867|FG001|STARTED|Overall Study||5||
59732421|NCT00809341|75850866|FG000|COMPLETED|Overall Study||20||
59732422|NCT00809341|75850867|FG001|COMPLETED|Overall Study||4||
59732423|NCT00809341|75850866|FG000|NOT COMPLETED|Overall Study||0||
59732424|NCT00809341|75850867|FG001|NOT COMPLETED|Overall Study||1||
59732425|NCT01125800|75850878|FG000|STARTED|Phase I||11||
60133312|NCT00660075|76256223|FG000|NOT COMPLETED|Second Intervention (Week 11 to Week 16||0||
59732426|NCT01125800|75850879|FG001|STARTED|Phase I||16||
59732427|NCT01125800|75850880|FG002|STARTED|Phase I||11||
59732428|NCT01125800|75850881|FG003|STARTED|Phase I||21||
59732429|NCT01125800|75850882|FG004|STARTED|Phase I|None of participants were enrolled to this treatment in this period.|0||
60133313|NCT00660075|76256224|FG001|NOT COMPLETED|Second Intervention (Week 11 to Week 16||0||
59732430|NCT01125800|75850878|FG000|COMPLETED|Phase I||3||
59732431|NCT01125800|75850879|FG001|COMPLETED|Phase I||7||
59732432|NCT01125800|75850880|FG002|COMPLETED|Phase I||7||
59732433|NCT01125800|75850881|FG003|COMPLETED|Phase I||10||
59732434|NCT01125800|75850882|FG004|COMPLETED|Phase I||0||
59732435|NCT01125800|75850878|FG000|NOT COMPLETED|Phase I||8||
59732436|NCT01125800|75850879|FG001|NOT COMPLETED|Phase I||9||
59732437|NCT01125800|75850880|FG002|NOT COMPLETED|Phase I||4||
59732438|NCT01125800|75850881|FG003|NOT COMPLETED|Phase I||11||
59732439|NCT01125800|75850882|FG004|NOT COMPLETED|Phase I||0||
59732440|NCT01125800|75850878|FG000|STARTED|Phase II|None of participants were enrolled to this treatment in this period.|0||
59732441|NCT01125800|75850879|FG001|STARTED|Phase II|None of participants were enrolled to this treatment in this period.|0||
59732442|NCT01125800|75850880|FG002|STARTED|Phase II|None of participants were enrolled to this treatment in this period.|0||
59732443|NCT01125800|75850881|FG003|STARTED|Phase II|None of participants were enrolled to this treatment in this period.|1||
59732444|NCT01125800|75850882|FG004|STARTED|Phase II|Additional participants were enrolled to this treatment in this period.|16||
59732445|NCT01125800|75850878|FG000|COMPLETED|Phase II||0||
59732446|NCT01125800|75850879|FG001|COMPLETED|Phase II||0||
59732447|NCT01125800|75850880|FG002|COMPLETED|Phase II||0||
59732448|NCT01125800|75850881|FG003|COMPLETED|Phase II||0||
59732449|NCT01125800|75850882|FG004|COMPLETED|Phase II||5||
59732450|NCT01125800|75850878|FG000|NOT COMPLETED|Phase II||0||
59732451|NCT01125800|75850879|FG001|NOT COMPLETED|Phase II||0||
59732452|NCT01125800|75850880|FG002|NOT COMPLETED|Phase II||0||
59732453|NCT01125800|75850881|FG003|NOT COMPLETED|Phase II||1||
59732454|NCT01125800|75850882|FG004|NOT COMPLETED|Phase II||11||
59732455|NCT01125722|75850899|FG000|STARTED|Overall Study||37||
59732456|NCT01125722|75850900|FG001|STARTED|Overall Study||37||
59732457|NCT01125722|75850899|FG000|COMPLETED|Overall Study||34||
59732458|NCT01125722|75850900|FG001|COMPLETED|Overall Study||36||
59732459|NCT01125722|75850899|FG000|NOT COMPLETED|Overall Study||3||
59732460|NCT01125722|75850900|FG001|NOT COMPLETED|Overall Study||1||
59732461|NCT00811135|75850906|FG000|STARTED|Overall Study||88||
59732462|NCT00811135|75850906|FG000|COMPLETED|Overall Study||0||
59732463|NCT00811135|75850906|FG000|NOT COMPLETED|Overall Study||88||
59732464|NCT00811057|75850913|FG000|STARTED|Overall Study||90||
59732465|NCT00811057|75850914|FG001|STARTED|Overall Study||114||
59732466|NCT00811057|75850915|FG002|STARTED|Overall Study||97||
59732467|NCT00811057|75850913|FG000|COMPLETED|Overall Study||85||
59732468|NCT00811057|75850914|FG001|COMPLETED|Overall Study||104||
59732469|NCT00811057|75850915|FG002|COMPLETED|Overall Study||87||
59732470|NCT00811057|75850913|FG000|NOT COMPLETED|Overall Study||5||
59732471|NCT00811057|75850914|FG001|NOT COMPLETED|Overall Study||10||
59732472|NCT00811057|75850915|FG002|NOT COMPLETED|Overall Study||10||
59732473|NCT00879970|75850926|FG000|STARTED|Period 1 TZD Randomization||541||
59732474|NCT00879970|75850927|FG001|STARTED|Period 1 TZD Randomization||392||
59732475|NCT00879970|75850928|FG002|STARTED|Period 1 TZD Randomization||399||
59732476|NCT00879970|75850929|FG003|STARTED|Period 1 TZD Randomization||0||
59732477|NCT00879970|75850930|FG004|STARTED|Period 1 TZD Randomization||0||
59732478|NCT00879970|75850926|FG000|COMPLETED|Period 1 TZD Randomization||533||
59732479|NCT00879970|75850927|FG001|COMPLETED|Period 1 TZD Randomization||388||
59732480|NCT00879970|75850928|FG002|COMPLETED|Period 1 TZD Randomization||393||
59732481|NCT00879970|75850929|FG003|COMPLETED|Period 1 TZD Randomization||0||
59732482|NCT00879970|75850930|FG004|COMPLETED|Period 1 TZD Randomization||0||
59732483|NCT00879970|75850926|FG000|NOT COMPLETED|Period 1 TZD Randomization||8||
59732484|NCT00879970|75850927|FG001|NOT COMPLETED|Period 1 TZD Randomization||4||
59732485|NCT00879970|75850928|FG002|NOT COMPLETED|Period 1 TZD Randomization||6||
59732486|NCT00879970|75850929|FG003|NOT COMPLETED|Period 1 TZD Randomization||0||
59732487|NCT00879970|75850930|FG004|NOT COMPLETED|Period 1 TZD Randomization||0||
59732488|NCT00879970|75850926|FG000|STARTED|Period 2 Vitamin D Randomization||0||
59732489|NCT00879970|75850927|FG001|STARTED|Period 2 Vitamin D Randomization||0||
59732490|NCT00879970|75850928|FG002|STARTED|Period 2 Vitamin D Randomization||0||
59732491|NCT00879970|75850929|FG003|STARTED|Period 2 Vitamin D Randomization||614||
59732492|NCT00879970|75850930|FG004|STARTED|Period 2 Vitamin D Randomization||607||
59732493|NCT00879970|75850926|FG000|COMPLETED|Period 2 Vitamin D Randomization||0||
59732494|NCT00879970|75850927|FG001|COMPLETED|Period 2 Vitamin D Randomization||0||
59732495|NCT00879970|75850928|FG002|COMPLETED|Period 2 Vitamin D Randomization||0||
59732496|NCT00879970|75850929|FG003|COMPLETED|Period 2 Vitamin D Randomization||610||
59732497|NCT00879970|75850930|FG004|COMPLETED|Period 2 Vitamin D Randomization||600||
59732498|NCT00879970|75850926|FG000|NOT COMPLETED|Period 2 Vitamin D Randomization||0||
59732499|NCT00879970|75850927|FG001|NOT COMPLETED|Period 2 Vitamin D Randomization||0||
59732500|NCT00879970|75850928|FG002|NOT COMPLETED|Period 2 Vitamin D Randomization||0||
59732501|NCT00879970|75850929|FG003|NOT COMPLETED|Period 2 Vitamin D Randomization||4||
59732502|NCT00879970|75850930|FG004|NOT COMPLETED|Period 2 Vitamin D Randomization||7||
59732503|NCT00808639|75850948|FG000|STARTED|Overall Study||39||
59732504|NCT00808639|75850948|FG000|COMPLETED|Overall Study|One patient went off treatment due to disease progression before surgery.|38||
59732505|NCT00808639|75850948|FG000|NOT COMPLETED|Overall Study||1||
59732506|NCT00810901|75850954|FG000|STARTED|Overall Study||253||
59732507|NCT00810901|75850955|FG001|STARTED|Overall Study||176||
59732508|NCT00810901|75850954|FG000|1-month Follow up|Overall Study||242||
59732509|NCT00810901|75850955|FG001|1-month Follow up|Overall Study||146||
59732510|NCT00810901|75850954|FG000|6-month Follow-up|Overall Study||181||
59732511|NCT00810901|75850955|FG001|6-month Follow-up|Overall Study||122||
59732512|NCT00810901|75850954|FG000|COMPLETED|Overall Study||165||
59732513|NCT00810901|75850955|FG001|COMPLETED|Overall Study||118||
59732514|NCT00810901|75850954|FG000|NOT COMPLETED|Overall Study||88||
59732515|NCT00810901|75850955|FG001|NOT COMPLETED|Overall Study||58||
59732516|NCT00910299|75850963|FG000|STARTED|Overall Study||212||
59732517|NCT00910299|75850964|FG001|STARTED|Overall Study||211||
59732518|NCT00910299|75850963|FG000|Received at Least 1 Dose of Study Drug|Overall Study||210||
59732519|NCT00910299|75850964|FG001|Received at Least 1 Dose of Study Drug|Overall Study||210||
59732520|NCT00910299|75850963|FG000|COMPLETED|Overall Study||136||
59732521|NCT00910299|75850964|FG001|COMPLETED|Overall Study|"1 participant died of sepsis while on study drug and was considered a protocol completer."|137||
60133314|NCT00682617|76256232|FG000|STARTED|Overall Study||13||
60133315|NCT00682617|76256233|FG001|STARTED|Overall Study||28||
60133316|NCT00682617|76256232|FG000|COMPLETED|Overall Study||10||
60133317|NCT00682617|76256233|FG001|COMPLETED|Overall Study||21||
60133318|NCT00682617|76256232|FG000|NOT COMPLETED|Overall Study||3||
60133319|NCT00682617|76256233|FG001|NOT COMPLETED|Overall Study||7||
60133320|NCT00595881|76256239|FG000|STARTED|Overall Study||420||
60133321|NCT00595881|76256239|FG000|COMPLETED|Overall Study||420||
60133322|NCT00595881|76256239|FG000|NOT COMPLETED|Overall Study||0||
60133323|NCT00682851|76256246|FG000|STARTED|Overall Study||251||
60133324|NCT00682851|76256247|FG001|STARTED|Overall Study||268||
60133325|NCT00682851|76256246|FG000|COMPLETED|Overall Study||251||
60133326|NCT00682851|76256247|FG001|COMPLETED|Overall Study||268||
60133327|NCT00682851|76256246|FG000|NOT COMPLETED|Overall Study||0||
60133328|NCT00682851|76256247|FG001|NOT COMPLETED|Overall Study||0||
60133329|NCT01429051|76256253|FG000|STARTED|Titration Phase||45||
60133330|NCT01429051|76256253|FG000|COMPLETED|Titration Phase||33||
60133331|NCT01429051|76256253|FG000|NOT COMPLETED|Titration Phase||12||
60133332|NCT01429051|76256253|FG000|STARTED|Efficacy Phase|Participants titrated to 200 or 400 μg INFS in Titration Phase|15||
60133333|NCT01429051|76256253|FG000|COMPLETED|Efficacy Phase||13||
60133334|NCT01429051|76256253|FG000|NOT COMPLETED|Efficacy Phase||2||
60133335|NCT01429051|76256253|FG000|STARTED|Tolerability Phase|Participants entered directly from the Titration or Efficacy Phase|31||
60133336|NCT01429051|76256253|FG000|COMPLETED|Tolerability Phase||16||
60133337|NCT01429051|76256253|FG000|NOT COMPLETED|Tolerability Phase||15||
60133338|NCT00596271|76256267|FG000|STARTED|Overall Study||65||
60133339|NCT00596271|76256268|FG001|STARTED|Overall Study||65||
60133340|NCT00596271|76256269|FG002|STARTED|Overall Study||62||
60133341|NCT00596271|76256267|FG000|COMPLETED|Overall Study||60||
60133342|NCT00596271|76256268|FG001|COMPLETED|Overall Study||59||
60133343|NCT00596271|76256269|FG002|COMPLETED|Overall Study||61||
60133344|NCT00596271|76256267|FG000|NOT COMPLETED|Overall Study||5||
60133345|NCT00596271|76256268|FG001|NOT COMPLETED|Overall Study||6||
60133346|NCT00596271|76256269|FG002|NOT COMPLETED|Overall Study||1||
60133347|NCT02320227|76256278|FG000|STARTED|Overall Study||30||
60133348|NCT02320227|76256278|FG000|COMPLETED|Overall Study||30||
60133349|NCT02320227|76256278|FG000|NOT COMPLETED|Overall Study||0||
60133350|NCT01428661|76256286|FG000|STARTED|Double-Masked Phase||254||
60133351|NCT01428661|76256287|FG001|STARTED|Double-Masked Phase||253||
60133352|NCT01428661|76256288|FG002|STARTED|Double-Masked Phase|Does not apply.|0||
60133353|NCT01428661|76256286|FG000|COMPLETED|Double-Masked Phase||197||
60133354|NCT01428661|76256287|FG001|COMPLETED|Double-Masked Phase||204||
60133355|NCT01428661|76256288|FG002|COMPLETED|Double-Masked Phase|Does not apply.|0||
60133356|NCT01428661|76256286|FG000|NOT COMPLETED|Double-Masked Phase||57||
60133357|NCT01428661|76256287|FG001|NOT COMPLETED|Double-Masked Phase||49||
60133358|NCT01428661|76256288|FG002|NOT COMPLETED|Double-Masked Phase||0||
60133359|NCT01428661|76256286|FG000|STARTED|Open Label Extension|Does not apply.|0||
60133360|NCT01428661|76256287|FG001|STARTED|Open Label Extension|Does not apply.|0||
60133361|NCT01428661|76256288|FG002|STARTED|Open Label Extension||339||
60133362|NCT01428661|76256286|FG000|COMPLETED|Open Label Extension|Does not apply.|0||
60133363|NCT01428661|76256287|FG001|COMPLETED|Open Label Extension|Does not apply.|0||
60133364|NCT01428661|76256288|FG002|COMPLETED|Open Label Extension||19||
60133365|NCT01428661|76256286|FG000|NOT COMPLETED|Open Label Extension||0||
60133366|NCT01428661|76256287|FG001|NOT COMPLETED|Open Label Extension||0||
60133367|NCT01428661|76256288|FG002|NOT COMPLETED|Open Label Extension||320||
60133368|NCT01428583|76256296|FG000|STARTED|Overall Study||395||
60133369|NCT01428583|76256296|FG000|COMPLETED|Overall Study||158||
60133370|NCT01428583|76256296|FG000|NOT COMPLETED|Overall Study||237||
60133371|NCT00683085|76256300|FG000|STARTED|Overall Study||2||
60133372|NCT00683085|76256300|FG000|COMPLETED|Overall Study||2||
60133373|NCT00683085|76256300|FG000|NOT COMPLETED|Overall Study||0||
60133374|NCT00660543|76256304|FG000|STARTED|Overall Study||14||
60133375|NCT00660543|76256304|FG000|COMPLETED|Overall Study||14||
60133376|NCT00660543|76256304|FG000|NOT COMPLETED|Overall Study||0||
60133377|NCT01428193|76256313|FG000|STARTED|Overall Study||4||
60133378|NCT01428193|76256313|FG000|COMPLETED|Overall Study||2||
60133379|NCT01428193|76256313|FG000|NOT COMPLETED|Overall Study||2||
60133380|NCT01428115|76256317|FG000|STARTED|Overall Study||83||
60133381|NCT01428115|76256317|FG000|COMPLETED|Overall Study||62||
60133382|NCT01428115|76256317|FG000|NOT COMPLETED|Overall Study||21||
60133383|NCT01427803|76256324|FG000|STARTED|Overall Study||526||
60133384|NCT01427803|76256325|FG001|STARTED|Overall Study||252||
60133385|NCT01427803|76256324|FG000|Purchased Product|Overall Study|Only 516 participants used e-diary|525||
60133386|NCT01427803|76256325|FG001|Purchased Product|Overall Study||252||
60133387|NCT01427803|76256324|FG000|Baseline Assessment|Overall Study||516||
60133388|NCT01427803|76256325|FG001|Baseline Assessment|Overall Study|only interviewed participants were assessed|130||
60133389|NCT01427803|76256324|FG000|Took Product|Overall Study|Those who took at least one dose of investigational product. Only 502 qualified for data analysis.|508||
60133390|NCT01427803|76256325|FG001|Took Product|Overall Study|Those who took at least one dose of investigational product as logged in e diary & 1 on Health Log.|237||
60133391|NCT01427803|76256324|FG000|COMPLETED|Overall Study||463||
60133392|NCT01427803|76256325|FG001|COMPLETED|Overall Study|130 participants interviewed. Remaining subjects continued in trial to collect safety information.|226||
60133393|NCT01427803|76256324|FG000|NOT COMPLETED|Overall Study||63||
60133394|NCT01427803|76256325|FG001|NOT COMPLETED|Overall Study||26||
60133395|NCT01408537|76256329|FG000|STARTED|Overall Study||152||
60133396|NCT01408537|76256329|FG000|COMPLETED|Overall Study||144||
60133397|NCT01408537|76256329|FG000|NOT COMPLETED|Overall Study||8||
60133398|NCT00661479|76256348|FG000|STARTED|Overall Study||12||
60133399|NCT00661479|76256349|FG001|STARTED|Overall Study||3||
60133400|NCT00661479|76256350|FG002|STARTED|Overall Study||3||
60133401|NCT00661479|76256351|FG003|STARTED|Overall Study||3||
60133402|NCT00661479|76256348|FG000|COMPLETED|Overall Study||12||
60133403|NCT00661479|76256349|FG001|COMPLETED|Overall Study||3||
60133404|NCT00661479|76256350|FG002|COMPLETED|Overall Study||3||
60133405|NCT00661479|76256351|FG003|COMPLETED|Overall Study||3||
60133406|NCT00661479|76256348|FG000|NOT COMPLETED|Overall Study||0||
60133407|NCT00661479|76256349|FG001|NOT COMPLETED|Overall Study||0||
60133408|NCT00661479|76256350|FG002|NOT COMPLETED|Overall Study||0||
60133409|NCT00661479|76256351|FG003|NOT COMPLETED|Overall Study||0||
60133410|NCT01408459|76256362|FG000|STARTED|Overall Study||22||
60133411|NCT01408459|76256363|FG001|STARTED|Overall Study||15||
60133412|NCT01408459|76256362|FG000|COMPLETED|Overall Study||21||
60133413|NCT01408459|76256363|FG001|COMPLETED|Overall Study||14||
60133414|NCT01408459|76256362|FG000|NOT COMPLETED|Overall Study||1||
60133415|NCT01408459|76256363|FG001|NOT COMPLETED|Overall Study||1||
60133416|NCT00661557|76256372|FG000|STARTED|Overall Study||192||
60133417|NCT00661557|76256373|FG001|STARTED|Overall Study||79||
60133418|NCT00661557|76256372|FG000|COMPLETED|Overall Study||183||
60133419|NCT00661557|76256373|FG001|COMPLETED|Overall Study||79||
60133420|NCT00661557|76256372|FG000|NOT COMPLETED|Overall Study||9||
60133421|NCT00661557|76256373|FG001|NOT COMPLETED|Overall Study||0||
60133422|NCT01408303|76256382|FG000|STARTED|Overall Study||215||
60133423|NCT01408303|76256383|FG001|STARTED|Overall Study||216||
60133424|NCT01408303|76256384|FG002|STARTED|Overall Study||216||
60133425|NCT01408303|76256382|FG000|COMPLETED|Overall Study||209||
60133426|NCT01408303|76256383|FG001|COMPLETED|Overall Study||204||
60133427|NCT01408303|76256384|FG002|COMPLETED|Overall Study||210||
60133428|NCT01408303|76256382|FG000|NOT COMPLETED|Overall Study||6||
60133429|NCT01408303|76256383|FG001|NOT COMPLETED|Overall Study||12||
60133430|NCT01408303|76256384|FG002|NOT COMPLETED|Overall Study||6||
60133431|NCT00597675|76256394|FG000|STARTED|Blinded Phase||4||
60133432|NCT00597675|76256395|FG001|STARTED|Blinded Phase||6||
60133433|NCT00597675|76256394|FG000|COMPLETED|Blinded Phase||2||
60133434|NCT00597675|76256395|FG001|COMPLETED|Blinded Phase||5||
60133435|NCT00597675|76256394|FG000|NOT COMPLETED|Blinded Phase||2||
60133436|NCT00597675|76256395|FG001|NOT COMPLETED|Blinded Phase||1||
60133437|NCT00597675|76256394|FG000|STARTED|Open Label Phase|Patients previously on placebo were crossed over onto open label peanut OIT|2||
60133438|NCT00597675|76256395|FG001|STARTED|Open Label Phase||5||
60133439|NCT00597675|76256394|FG000|COMPLETED|Open Label Phase||2||
60133440|NCT00597675|76256395|FG001|COMPLETED|Open Label Phase||5||
60133441|NCT00597675|76256394|FG000|NOT COMPLETED|Open Label Phase||0||
60133442|NCT00597675|76256395|FG001|NOT COMPLETED|Open Label Phase||0||
60133443|NCT01408147|76256405|FG000|STARTED|Overall Study|174 participants|174||5
60133444|NCT01408147|76256406|FG001|STARTED|Overall Study|197 participants|197||6
60133445|NCT01408147|76256405|FG000|COMPLETED|Overall Study|1 clinic withdrew due to low census|174||5
60133446|NCT01408147|76256406|FG001|COMPLETED|Overall Study||196||6
60133447|NCT01408147|76256405|FG000|NOT COMPLETED|Overall Study||0||0
60133448|NCT01408147|76256406|FG001|NOT COMPLETED|Overall Study||1||0
60133449|NCT01407367|76256414|FG000|STARTED|Overall Study||108||
60133450|NCT01407367|76256415|FG001|STARTED|Overall Study||242||
60133451|NCT01407367|76256414|FG000|COMPLETED|Overall Study||68||
60133452|NCT01407367|76256415|FG001|COMPLETED|Overall Study||164||
60133453|NCT01407367|76256414|FG000|NOT COMPLETED|Overall Study||40||
60133454|NCT01407367|76256415|FG001|NOT COMPLETED|Overall Study||78||
60133455|NCT00683163|76256426|FG000|STARTED|Overall Study||22||
60133456|NCT00683163|76256427|FG001|STARTED|Overall Study||22||
60133457|NCT00683163|76256426|FG000|COMPLETED|Overall Study||22||
60133458|NCT00683163|76256427|FG001|COMPLETED|Overall Study||22||
60133459|NCT00683163|76256426|FG000|NOT COMPLETED|Overall Study||0||
60133460|NCT00683163|76256427|FG001|NOT COMPLETED|Overall Study||0||
60133461|NCT00684723|76256433|FG000|STARTED|First Intervention||27||
60133462|NCT00684723|76256434|FG001|STARTED|First Intervention||27||
60133463|NCT00684723|76256433|FG000|COMPLETED|First Intervention||27||
60133464|NCT00684723|76256434|FG001|COMPLETED|First Intervention||27||
60133465|NCT00684723|76256433|FG000|NOT COMPLETED|First Intervention||0||
60133466|NCT00684723|76256434|FG001|NOT COMPLETED|First Intervention||0||
60133467|NCT00684723|76256433|FG000|STARTED|Washout Period of 7 Days||27||
60133468|NCT00684723|76256434|FG001|STARTED|Washout Period of 7 Days||27||
60133469|NCT00684723|76256433|FG000|COMPLETED|Washout Period of 7 Days||27||
60133470|NCT00684723|76256434|FG001|COMPLETED|Washout Period of 7 Days||27||
60133471|NCT00684723|76256433|FG000|NOT COMPLETED|Washout Period of 7 Days||0||
60133472|NCT00684723|76256434|FG001|NOT COMPLETED|Washout Period of 7 Days||0||
60133473|NCT00684723|76256433|FG000|STARTED|Second Intervention||27||
60133474|NCT00684723|76256434|FG001|STARTED|Second Intervention||27||
60133475|NCT00684723|76256433|FG000|COMPLETED|Second Intervention||27||
60133476|NCT00684723|76256434|FG001|COMPLETED|Second Intervention||27||
60133477|NCT00684723|76256433|FG000|NOT COMPLETED|Second Intervention||0||
60133478|NCT00684723|76256434|FG001|NOT COMPLETED|Second Intervention||0||
60133479|NCT00598689|76256442|FG000|STARTED|Overall Study||40||
60133480|NCT00598689|76256443|FG001|STARTED|Overall Study||40||
60133481|NCT00598689|76256442|FG000|COMPLETED|Overall Study||40||
60133482|NCT00598689|76256443|FG001|COMPLETED|Overall Study||40||
60133483|NCT00598689|76256442|FG000|NOT COMPLETED|Overall Study||0||
60133484|NCT00598689|76256443|FG001|NOT COMPLETED|Overall Study||0||
60133485|NCT01405027|76256451|FG000|STARTED|Overall Study||84||
60133486|NCT01405027|76256452|FG001|STARTED|Overall Study||113||
60133487|NCT01405027|76256451|FG000|COMPLETED|Overall Study||52||
60133488|NCT01405027|76256452|FG001|COMPLETED|Overall Study||62||
60133489|NCT01405027|76256451|FG000|NOT COMPLETED|Overall Study||32||
60133490|NCT01405027|76256452|FG001|NOT COMPLETED|Overall Study||51||
60133491|NCT00663039|76256460|FG000|STARTED|Overall Study||14||
60133492|NCT00663039|76256461|FG001|STARTED|Overall Study||13||
60133493|NCT00663039|76256460|FG000|COMPLETED|Overall Study||10||
60133494|NCT00663039|76256461|FG001|COMPLETED|Overall Study||9||
60133495|NCT00663039|76256460|FG000|NOT COMPLETED|Overall Study||4||
60133496|NCT00663039|76256461|FG001|NOT COMPLETED|Overall Study||4||
60133497|NCT01412801|76256473|FG000|STARTED|Overall Study||91||
60133498|NCT01412801|76256474|FG001|STARTED|Overall Study||89||
60133499|NCT01412801|76256475|FG002|STARTED|Overall Study||90||
60133500|NCT01412801|76256476|FG003|STARTED|Overall Study||91||
60133501|NCT01412801|76256477|FG004|STARTED|Overall Study||88||
60133502|NCT01412801|76256478|FG005|STARTED|Overall Study||87||
60133503|NCT01412801|76256473|FG000|COMPLETED|Overall Study||87||
60133504|NCT01412801|76256474|FG001|COMPLETED|Overall Study||84||
60133505|NCT01412801|76256475|FG002|COMPLETED|Overall Study||83||
60133506|NCT01412801|76256476|FG003|COMPLETED|Overall Study||87||
60133507|NCT01412801|76256477|FG004|COMPLETED|Overall Study||85||
60133508|NCT01412801|76256478|FG005|COMPLETED|Overall Study||84||
60133509|NCT01412801|76256473|FG000|NOT COMPLETED|Overall Study||4||
60133510|NCT01412801|76256474|FG001|NOT COMPLETED|Overall Study||5||
60133511|NCT01412801|76256475|FG002|NOT COMPLETED|Overall Study||7||
60133512|NCT01412801|76256476|FG003|NOT COMPLETED|Overall Study||4||
60133513|NCT01412801|76256477|FG004|NOT COMPLETED|Overall Study||3||
60133514|NCT01412801|76256478|FG005|NOT COMPLETED|Overall Study||3||
60133515|NCT00663819|76256503|FG000|STARTED|Overall Study||123||
60133516|NCT00663819|76256504|FG001|STARTED|Overall Study||135||
60133517|NCT00663819|76256503|FG000|COMPLETED|Overall Study||123||
60133518|NCT00663819|76256504|FG001|COMPLETED|Overall Study||135||
60133519|NCT00663819|76256503|FG000|NOT COMPLETED|Overall Study||0||
60133520|NCT00663819|76256504|FG001|NOT COMPLETED|Overall Study||0||
60133521|NCT00664755|76256514|FG000|STARTED|Overall Study||67||
60133522|NCT00664755|76256515|FG001|STARTED|Overall Study||73||
60133523|NCT00664755|76256514|FG000|COMPLETED|Overall Study||67||
60133524|NCT00664755|76256515|FG001|COMPLETED|Overall Study||73||
60133525|NCT00664755|76256514|FG000|NOT COMPLETED|Overall Study||0||
60133526|NCT00664755|76256515|FG001|NOT COMPLETED|Overall Study||0||
60133527|NCT01525628|76256526|FG000|STARTED|Overall Study||16||
60133528|NCT01525628|76256527|FG001|STARTED|Overall Study||19||
60133529|NCT01525628|76256528|FG002|STARTED|Overall Study||16||
60133530|NCT01525628|76256529|FG003|STARTED|Overall Study||14||
60133531|NCT01525628|76256530|FG004|STARTED|Overall Study||7||
60133532|NCT01525628|76256526|FG000|COMPLETED|Overall Study||14||
60133533|NCT01525628|76256527|FG001|COMPLETED|Overall Study||14||
60133534|NCT01525628|76256528|FG002|COMPLETED|Overall Study||11||
60133535|NCT01525628|76256529|FG003|COMPLETED|Overall Study||10||
60133536|NCT01525628|76256530|FG004|COMPLETED|Overall Study||4||
60133537|NCT01525628|76256526|FG000|NOT COMPLETED|Overall Study||2||
60133538|NCT01525628|76256527|FG001|NOT COMPLETED|Overall Study||5||
60133539|NCT01525628|76256528|FG002|NOT COMPLETED|Overall Study||5||
60133540|NCT01525628|76256529|FG003|NOT COMPLETED|Overall Study||4||
60133541|NCT01525628|76256530|FG004|NOT COMPLETED|Overall Study||3||
60133542|NCT01412021|76256544|FG000|STARTED|Overall Study||375|registered participants|
60133543|NCT01412021|76256544|FG000|Case Report Forms Locked|Overall Study||368||
60133544|NCT01412021|76256544|FG000|COMPLETED|Overall Study||356|Safety Analysis|
60133545|NCT01412021|76256544|FG000|NOT COMPLETED|Overall Study||19||
60133546|NCT01426789|76256550|FG000|STARTED|Part 1||68||
60133547|NCT01426789|76256551|FG001|STARTED|Part 1||32||
60133548|NCT01426789|76256552|FG002|STARTED|Part 1||0||
60133549|NCT01426789|76256553|FG003|STARTED|Part 1||0||
60133550|NCT01426789|76256554|FG004|STARTED|Part 1||0||
60133551|NCT01426789|76256555|FG005|STARTED|Part 1||0||
60133552|NCT01426789|76256550|FG000|COMPLETED|Part 1||62||
60133553|NCT01426789|76256551|FG001|COMPLETED|Part 1||28||
60133554|NCT01426789|76256552|FG002|COMPLETED|Part 1||0||
60133555|NCT01426789|76256553|FG003|COMPLETED|Part 1||0||
60133556|NCT01426789|76256554|FG004|COMPLETED|Part 1||0||
60133557|NCT01426789|76256555|FG005|COMPLETED|Part 1||0||
60133558|NCT01426789|76256550|FG000|NOT COMPLETED|Part 1||6||
60133559|NCT01426789|76256551|FG001|NOT COMPLETED|Part 1||4||
60133560|NCT01426789|76256552|FG002|NOT COMPLETED|Part 1||0||
60133561|NCT01426789|76256553|FG003|NOT COMPLETED|Part 1||0||
60133562|NCT01426789|76256554|FG004|NOT COMPLETED|Part 1||0||
60133563|NCT01426789|76256555|FG005|NOT COMPLETED|Part 1||0||
60133564|NCT01426789|76256550|FG000|STARTED|Part 2||0||
60133565|NCT01426789|76256551|FG001|STARTED|Part 2||0||
60133566|NCT01426789|76256552|FG002|STARTED|Part 2||49||
60133567|NCT01426789|76256553|FG003|STARTED|Part 2||13||
60133568|NCT01426789|76256554|FG004|STARTED|Part 2||27||
60133569|NCT01426789|76256555|FG005|STARTED|Part 2||1||
60133570|NCT01426789|76256550|FG000|COMPLETED|Part 2||0||
60133571|NCT01426789|76256551|FG001|COMPLETED|Part 2||0||
60133572|NCT01426789|76256552|FG002|COMPLETED|Part 2||34||
60133573|NCT01426789|76256553|FG003|COMPLETED|Part 2||12||
60133574|NCT01426789|76256554|FG004|COMPLETED|Part 2||19||
60133575|NCT01426789|76256555|FG005|COMPLETED|Part 2||1||
60133576|NCT01426789|76256550|FG000|NOT COMPLETED|Part 2||0||
60133577|NCT01426789|76256551|FG001|NOT COMPLETED|Part 2||0||
60133578|NCT01426789|76256552|FG002|NOT COMPLETED|Part 2||15||
60133579|NCT01426789|76256553|FG003|NOT COMPLETED|Part 2||1||
60133580|NCT01426789|76256554|FG004|NOT COMPLETED|Part 2||8||
60133581|NCT01426789|76256555|FG005|NOT COMPLETED|Part 2||0||
60133582|NCT02320695|76256563|FG000|STARTED|Overall Study||60||
60133583|NCT02320695|76256563|FG000|Saline|Overall Study||60||
60133584|NCT02320695|76256563|FG000|Alcohol|Overall Study||60||
60133585|NCT02320695|76256563|FG000|Pain Relieving Cream|Overall Study||59||
60133586|NCT02320695|76256563|FG000|Antibiotic/Pain Relieving Ointment|Overall Study||60||
60133587|NCT02320695|76256563|FG000|Original Ointment|Overall Study||60||
60133588|NCT02320695|76256563|FG000|Pain Relief Ointment|Overall Study||60||
60133589|NCT02320695|76256563|FG000|COMPLETED|Overall Study||60||
60133590|NCT02320695|76256563|FG000|NOT COMPLETED|Overall Study||0||
60133591|NCT02078557|76256572|FG000|STARTED|Overall Study||4||
60133592|NCT02078557|76256572|FG000|COMPLETED|Overall Study||4||
60133593|NCT02078557|76256572|FG000|NOT COMPLETED|Overall Study||0||
60133594|NCT01426009|76256576|FG000|STARTED|Period 1-First Intervention (7 Days)||139||
60133595|NCT01426009|76256576|FG000|EP-101 Via Nebulizer|Period 1-First Intervention (7 Days)||23||
60133596|NCT01426009|76256576|FG000|EP-101 Via Nebulizer|Period 1-First Intervention (7 Days)||24||
60133597|NCT01426009|76256576|FG000|EP-101 Via Nebulizer|Period 1-First Intervention (7 Days)||22||
60133598|NCT01426009|76256576|FG000|EP-101 Via Nebulizer|Period 1-First Intervention (7 Days)||23||
60133599|NCT01426009|76256576|FG000|Ipratropium Bromide|Period 1-First Intervention (7 Days)||23||
60133600|NCT01426009|76256576|FG000|Placebo|Period 1-First Intervention (7 Days)||24||
60133601|NCT01426009|76256576|FG000|COMPLETED|Period 1-First Intervention (7 Days)||137||
60133602|NCT01426009|76256576|FG000|NOT COMPLETED|Period 1-First Intervention (7 Days)||2||
60133603|NCT01426009|76256576|FG000|STARTED|Washout 1||137||
60133604|NCT01426009|76256576|FG000|COMPLETED|Washout 1||135||
60133605|NCT01426009|76256576|FG000|NOT COMPLETED|Washout 1||2||
60133606|NCT01426009|76256576|FG000|STARTED|Period 2-Second Intervention (7 Days)||135||
60133607|NCT01426009|76256576|FG000|EP-101 Via Nebulizer|Period 2-Second Intervention (7 Days)||22||
60133608|NCT01426009|76256576|FG000|EP-101 Via Nebulizer|Period 2-Second Intervention (7 Days)||24||
60133609|NCT01426009|76256576|FG000|EP-101 Via Nebulizer|Period 2-Second Intervention (7 Days)||24||
60133610|NCT01426009|76256576|FG000|EP-101 Via Nebulizer|Period 2-Second Intervention (7 Days)||23||
60133611|NCT01426009|76256576|FG000|Ipratropium Bromide|Period 2-Second Intervention (7 Days)||21||
60133612|NCT01426009|76256576|FG000|Placebo|Period 2-Second Intervention (7 Days)||21||
60133613|NCT01426009|76256576|FG000|COMPLETED|Period 2-Second Intervention (7 Days)||130||
60133614|NCT01426009|76256576|FG000|NOT COMPLETED|Period 2-Second Intervention (7 Days)||5||
60133615|NCT01426009|76256576|FG000|STARTED|Washout 2||130||
60133616|NCT01426009|76256576|FG000|COMPLETED|Washout 2||129||
60133617|NCT01426009|76256576|FG000|NOT COMPLETED|Washout 2||1||
60133618|NCT01426009|76256576|FG000|STARTED|Period 3-Third Intervention (7 Days)||129||
60133619|NCT01426009|76256576|FG000|EP-101 Via Nebulizer|Period 3-Third Intervention (7 Days)||19||
60133620|NCT01426009|76256576|FG000|EP-101 Via Nebulizer|Period 3-Third Intervention (7 Days)||23||
60133621|NCT01426009|76256576|FG000|EP-101 Via Nebulizer|Period 3-Third Intervention (7 Days)||22||
60133622|NCT01426009|76256576|FG000|EP-101 Via Nebulizer|Period 3-Third Intervention (7 Days)||20||
60133623|NCT01426009|76256576|FG000|Ipratropium Bromide|Period 3-Third Intervention (7 Days)||23||
60133624|NCT01426009|76256576|FG000|Placebo|Period 3-Third Intervention (7 Days)||22||
60133625|NCT01426009|76256576|FG000|COMPLETED|Period 3-Third Intervention (7 Days)||129||
60133626|NCT01426009|76256576|FG000|NOT COMPLETED|Period 3-Third Intervention (7 Days)||0||
60133627|NCT01426009|76256576|FG000|STARTED|Washout 3||129||
60133628|NCT01426009|76256576|FG000|COMPLETED|Washout 3||128||
60133629|NCT01426009|76256576|FG000|NOT COMPLETED|Washout 3||1||
60133630|NCT01426009|76256576|FG000|STARTED|Period 4-Fourth Intervention (7 Days)||128||
60133631|NCT01426009|76256576|FG000|EP-101 Via Nebulizer|Period 4-Fourth Intervention (7 Days)||10||
60133632|NCT01426009|76256576|FG000|EP-101 Via Nebulizer|Period 4-Fourth Intervention (7 Days)||7||
60133633|NCT01426009|76256576|FG000|EP-101 Via Nebulizer|Period 4-Fourth Intervention (7 Days)||8||
60133634|NCT01426009|76256576|FG000|EP-101 Via Nebulizer|Period 4-Fourth Intervention (7 Days)||9||
60133635|NCT01426009|76256576|FG000|Ipratropium Bromide|Period 4-Fourth Intervention (7 Days)||8||
60133636|NCT01426009|76256576|FG000|Tiotropium Bromide|Period 4-Fourth Intervention (7 Days)||76||
60133637|NCT01426009|76256576|FG000|Placebo|Period 4-Fourth Intervention (7 Days)||10||
60133638|NCT01426009|76256576|FG000|COMPLETED|Period 4-Fourth Intervention (7 Days)||127||
60133639|NCT01426009|76256576|FG000|NOT COMPLETED|Period 4-Fourth Intervention (7 Days)||1||
60133640|NCT01426009|76256576|FG000|STARTED|Washout 4||127||
60133641|NCT01426009|76256576|FG000|COMPLETED|Washout 4||126||
60133642|NCT01426009|76256576|FG000|NOT COMPLETED|Washout 4||1||
60133643|NCT00685659|76256595|FG000|STARTED|Overall Study||108||
60133644|NCT00685659|76256596|FG001|STARTED|Overall Study||106||
60133645|NCT00685659|76256597|FG002|STARTED|Overall Study||107||
60133646|NCT00685659|76256595|FG000|COMPLETED|Overall Study||77||
60133647|NCT00685659|76256596|FG001|COMPLETED|Overall Study||81||
60133648|NCT00685659|76256597|FG002|COMPLETED|Overall Study||92||
60133649|NCT00685659|76256595|FG000|NOT COMPLETED|Overall Study||31||
60133650|NCT00685659|76256596|FG001|NOT COMPLETED|Overall Study||25||
60133651|NCT00685659|76256597|FG002|NOT COMPLETED|Overall Study||15||
60133652|NCT01411319|76256605|FG000|STARTED|Overall Study||25||
60133653|NCT01411319|76256605|FG000|COMPLETED|Overall Study||24||
60133654|NCT01411319|76256605|FG000|NOT COMPLETED|Overall Study||1||
60133655|NCT01543958|76256609|FG000|STARTED|Overall Study||40||
60133656|NCT01543958|76256609|FG000|COMPLETED|Overall Study||36||
60133657|NCT01543958|76256609|FG000|NOT COMPLETED|Overall Study||4||
59732522|NCT00910299|75850963|FG000|NOT COMPLETED|Overall Study||76||
59732523|NCT00910299|75850964|FG001|NOT COMPLETED|Overall Study||74||
59732524|NCT00595504|75850972|FG000|STARTED|Overall Study||16||
59732525|NCT00595504|75850973|FG001|STARTED|Overall Study||9||
59732526|NCT00595504|75850972|FG000|COMPLETED|Overall Study||14||
59732527|NCT00595504|75850973|FG001|COMPLETED|Overall Study||6||
59732528|NCT00595504|75850972|FG000|NOT COMPLETED|Overall Study||2||
59732529|NCT00595504|75850973|FG001|NOT COMPLETED|Overall Study||3||
59732530|NCT00808483|75850981|FG000|STARTED|From 3 to 5 Months After Surgery||35||
59732531|NCT00808483|75850982|FG001|STARTED|From 3 to 5 Months After Surgery||33||
59732532|NCT00808483|75850981|FG000|COMPLETED|From 3 to 5 Months After Surgery||33||
59732533|NCT00808483|75850982|FG001|COMPLETED|From 3 to 5 Months After Surgery||32||
59732534|NCT00808483|75850981|FG000|NOT COMPLETED|From 3 to 5 Months After Surgery||2||
59732535|NCT00808483|75850982|FG001|NOT COMPLETED|From 3 to 5 Months After Surgery||1||
59732536|NCT00808483|75850981|FG000|STARTED|From 5 Months to 12 Months||33||
59732537|NCT00808483|75850982|FG001|STARTED|From 5 Months to 12 Months||32||
59732538|NCT00808483|75850981|FG000|COMPLETED|From 5 Months to 12 Months||32||
59732539|NCT00808483|75850982|FG001|COMPLETED|From 5 Months to 12 Months||32||
59732540|NCT00808483|75850981|FG000|NOT COMPLETED|From 5 Months to 12 Months||1||
59732541|NCT00808483|75850982|FG001|NOT COMPLETED|From 5 Months to 12 Months||0||
59732542|NCT00810511|75850997|FG000|STARTED|Overall Study||107||
59732543|NCT00810511|75850998|FG001|STARTED|Overall Study||106||
59732544|NCT00810511|75850997|FG000|COMPLETED|Overall Study||97||
59732545|NCT00810511|75850998|FG001|COMPLETED|Overall Study||102||
59732546|NCT00810511|75850997|FG000|NOT COMPLETED|Overall Study||10||
59732547|NCT00810511|75850998|FG001|NOT COMPLETED|Overall Study||4||
59732548|NCT00596362|75851004|FG000|STARTED|Overall Study||1||
59732549|NCT00596362|75851004|FG000|COMPLETED|Overall Study||0||
59732550|NCT00596362|75851004|FG000|NOT COMPLETED|Overall Study||1||
59732551|NCT00907803|75851011|FG000|STARTED|Overall Study||45||
59732552|NCT00907803|75851012|FG001|STARTED|Overall Study||46||
59732553|NCT00907803|75851013|FG002|STARTED|Overall Study||16||
59732554|NCT00907803|75851011|FG000|COMPLETED|Overall Study||42||
59732555|NCT00907803|75851012|FG001|COMPLETED|Overall Study||43||
59732556|NCT00907803|75851013|FG002|COMPLETED|Overall Study||16||
59732557|NCT00907803|75851011|FG000|NOT COMPLETED|Overall Study||3||
59732558|NCT00907803|75851012|FG001|NOT COMPLETED|Overall Study||3||
59732559|NCT00907803|75851013|FG002|NOT COMPLETED|Overall Study||0||
59732560|NCT00808249|75851025|FG000|STARTED|Overall Study||107||
59732561|NCT00808249|75851026|FG001|STARTED|Overall Study||106||
59732562|NCT00808249|75851027|FG002|STARTED|Overall Study||105||
59732563|NCT00808249|75851028|FG003|STARTED|Overall Study||106||
59732564|NCT00808249|75851025|FG000|COMPLETED|Overall Study||90||
59732565|NCT00808249|75851026|FG001|COMPLETED|Overall Study||91||
59732566|NCT00808249|75851027|FG002|COMPLETED|Overall Study||83||
59732567|NCT00808249|75851028|FG003|COMPLETED|Overall Study||90||
59732568|NCT00808249|75851025|FG000|NOT COMPLETED|Overall Study||17||
59732569|NCT00808249|75851026|FG001|NOT COMPLETED|Overall Study||15||
59732570|NCT00808249|75851027|FG002|NOT COMPLETED|Overall Study||22||
59732571|NCT00808249|75851028|FG003|NOT COMPLETED|Overall Study||16||
59732572|NCT00908895|75851040|FG000|STARTED|Overall Study||57||
59732573|NCT00908895|75851041|FG001|STARTED|Overall Study||63||
59732574|NCT00908895|75851040|FG000|COMPLETED|Overall Study||53||
59732575|NCT00908895|75851041|FG001|COMPLETED|Overall Study||57||
59732576|NCT00908895|75851040|FG000|NOT COMPLETED|Overall Study||4||
59732577|NCT00908895|75851041|FG001|NOT COMPLETED|Overall Study||6||
59732578|NCT00591253|75851050|FG000|STARTED|Overall Study|Randomized or Treated|140||
59732579|NCT00591253|75851051|FG001|STARTED|Overall Study|Randomized or Treated|137||
59732580|NCT00591253|75851052|FG002|STARTED|Overall Study|Randomized or Treated|138||
59732581|NCT00591253|75851050|FG000|COMPLETED|Overall Study||126||
59732582|NCT00591253|75851051|FG001|COMPLETED|Overall Study||116||
59732583|NCT00591253|75851052|FG002|COMPLETED|Overall Study||123||
59732584|NCT00591253|75851050|FG000|NOT COMPLETED|Overall Study||14||
59732585|NCT00591253|75851051|FG001|NOT COMPLETED|Overall Study||21||
59732586|NCT00591253|75851052|FG002|NOT COMPLETED|Overall Study||15||
59732587|NCT00908583|75851060|FG000|STARTED|Phase 1||20||
59732588|NCT00908583|75851060|FG000|COMPLETED|Phase 1||15||
59732589|NCT00908583|75851060|FG000|NOT COMPLETED|Phase 1||5||
59732590|NCT00908583|75851060|FG000|STARTED|Phase 2||12||
59732591|NCT00908583|75851060|FG000|COMPLETED|Phase 2||10||
59732592|NCT00908583|75851060|FG000|NOT COMPLETED|Phase 2||2||
59732593|NCT00908583|75851060|FG000|STARTED|Phase 3||10||
59732594|NCT00908583|75851060|FG000|COMPLETED|Phase 3||8||
59732595|NCT00908583|75851060|FG000|NOT COMPLETED|Phase 3||2||
59732596|NCT00908583|75851060|FG000|STARTED|Phase 4||5||
59732597|NCT00908583|75851060|FG000|COMPLETED|Phase 4||3||
59732598|NCT00908583|75851060|FG000|NOT COMPLETED|Phase 4||2||
59732599|NCT00908583|75851060|FG000|STARTED|Phase 5||5||
59732600|NCT00908583|75851060|FG000|COMPLETED|Phase 5||2||
59732601|NCT00908583|75851060|FG000|NOT COMPLETED|Phase 5||3||
59732602|NCT00909363|75851081|FG000|STARTED|Overall Study||11||
59732603|NCT00909363|75851082|FG001|STARTED|Overall Study||8||
59732604|NCT00909363|75851083|FG002|STARTED|Overall Study||5||
59732605|NCT00909363|75851081|FG000|COMPLETED|Overall Study|1 patient started bleeding 3 days after starting eltrombopag; he underwent bone marrow transplant|9||
59732606|NCT00909363|75851082|FG001|COMPLETED|Overall Study||8||
59732607|NCT00909363|75851083|FG002|COMPLETED|Overall Study||5||
59732608|NCT00909363|75851081|FG000|NOT COMPLETED|Overall Study||2||
59732609|NCT00909363|75851082|FG001|NOT COMPLETED|Overall Study||0||
59732610|NCT00909363|75851083|FG002|NOT COMPLETED|Overall Study||0||
59732611|NCT00810355|75851097|FG000|STARTED|Overall Study||25||
59732612|NCT00810355|75851098|FG001|STARTED|Overall Study||25||
59732613|NCT00810355|75851099|FG002|STARTED|Overall Study||25||
59732614|NCT00810355|75851097|FG000|COMPLETED|Overall Study||11||
59732615|NCT00810355|75851098|FG001|COMPLETED|Overall Study||8||
59732616|NCT00810355|75851099|FG002|COMPLETED|Overall Study||14||
59732617|NCT00810355|75851097|FG000|NOT COMPLETED|Overall Study||14||
59732618|NCT00810355|75851098|FG001|NOT COMPLETED|Overall Study||17||
59732619|NCT00810355|75851099|FG002|NOT COMPLETED|Overall Study||11||
59732620|NCT00908349|75851107|FG000|STARTED|Overall Study||214||
59732621|NCT00908349|75851107|FG000|COMPLETED|Overall Study||179||
59732622|NCT00908349|75851107|FG000|NOT COMPLETED|Overall Study||35||
59732623|NCT01125566|75851113|FG000|STARTED|Patients Before the Switch (26Apr2013)||339|Randomised|
59732624|NCT01125566|75851114|FG001|STARTED|Patients Before the Switch (26Apr2013)||169|Randomised|
59732625|NCT01125566|75851115|FG002|STARTED|Patients Before the Switch (26Apr2013)||0|Randomised|
59732626|NCT01125566|75851113|FG000|Treated|Patients Before the Switch (26Apr2013)||337||
59732627|NCT01125566|75851114|FG001|Treated|Patients Before the Switch (26Apr2013)||169||
59732628|NCT01125566|75851115|FG002|Treated|Patients Before the Switch (26Apr2013)||0||
59732629|NCT01125566|75851113|FG000|COMPLETED|Patients Before the Switch (26Apr2013)||74||
59732630|NCT01125566|75851114|FG001|COMPLETED|Patients Before the Switch (26Apr2013)||0||
59732631|NCT01125566|75851115|FG002|COMPLETED|Patients Before the Switch (26Apr2013)||0||
59732632|NCT01125566|75851113|FG000|NOT COMPLETED|Patients Before the Switch (26Apr2013)||265||
59732633|NCT01125566|75851114|FG001|NOT COMPLETED|Patients Before the Switch (26Apr2013)||169||
59732634|NCT01125566|75851115|FG002|NOT COMPLETED|Patients Before the Switch (26Apr2013)||0||
59732635|NCT01125566|75851113|FG000|STARTED|Patients Who Switched From AV to TV||0||
59732636|NCT01125566|75851114|FG001|STARTED|Patients Who Switched From AV to TV||0||
59732637|NCT01125566|75851115|FG002|STARTED|Patients Who Switched From AV to TV||75||
59732638|NCT01125566|75851113|FG000|COMPLETED|Patients Who Switched From AV to TV||0||
59732639|NCT01125566|75851114|FG001|COMPLETED|Patients Who Switched From AV to TV||0||
59732640|NCT01125566|75851115|FG002|COMPLETED|Patients Who Switched From AV to TV||2||
59732641|NCT01125566|75851113|FG000|NOT COMPLETED|Patients Who Switched From AV to TV||0||
59732642|NCT01125566|75851114|FG001|NOT COMPLETED|Patients Who Switched From AV to TV||0||
59732643|NCT01125566|75851115|FG002|NOT COMPLETED|Patients Who Switched From AV to TV||73||
59732644|NCT00810277|75851122|FG000|STARTED|Overall Study||14||
59732645|NCT00810277|75851122|FG000|COMPLETED|Overall Study||13||
59732646|NCT00810277|75851122|FG000|NOT COMPLETED|Overall Study||1||
59732647|NCT00595582|75851126|FG000|STARTED|Overall Study||10||
59732648|NCT00595582|75851126|FG000|COMPLETED|Overall Study||0||
59732649|NCT00595582|75851126|FG000|NOT COMPLETED|Overall Study||10||
59732650|NCT00808015|75851130|FG000|STARTED|Overall Study||1377||
59732651|NCT00808015|75851130|FG000|Treated|Overall Study||1373||
59732652|NCT00808015|75851130|FG000|COMPLETED|Overall Study||1033||
59732653|NCT00808015|75851130|FG000|NOT COMPLETED|Overall Study||344||
59732654|NCT00810199|75851136|FG000|STARTED|Overall Study||279||
59732655|NCT00810199|75851137|FG001|STARTED|Overall Study||277||
59732656|NCT00810199|75851136|FG000|Received Study Drug|Overall Study||277||
59732657|NCT00810199|75851137|FG001|Received Study Drug|Overall Study||276||
59732658|NCT00810199|75851136|FG000|Completed Week 24|Overall Study||259||
59732659|NCT00810199|75851137|FG001|Completed Week 24|Overall Study||250||
59732660|NCT00810199|75851136|FG000|Completed Week 52|Overall Study||243||
59732661|NCT00810199|75851137|FG001|Completed Week 52|Overall Study||229||
59732662|NCT00810199|75851136|FG000|Completed Week 104|Overall Study||222||
59732663|NCT00810199|75851137|FG001|Completed Week 104|Overall Study||201||
59732664|NCT00810199|75851136|FG000|COMPLETED|Overall Study||220||
59732665|NCT00810199|75851137|FG001|COMPLETED|Overall Study|Completed=Completed Treatment|195||
59732666|NCT00810199|75851136|FG000|NOT COMPLETED|Overall Study||59||
59732667|NCT00810199|75851137|FG001|NOT COMPLETED|Overall Study||82||
59732668|NCT00877006|75851151|FG000|STARTED|Treatment Period||224||
59732669|NCT00877006|75851152|FG001|STARTED|Treatment Period||223||
59732670|NCT00877006|75851151|FG000|COMPLETED|Treatment Period||199||
59732671|NCT00877006|75851152|FG001|COMPLETED|Treatment Period||196||
59732672|NCT00877006|75851151|FG000|NOT COMPLETED|Treatment Period||25||
59732673|NCT00877006|75851152|FG001|NOT COMPLETED|Treatment Period||27||
59732674|NCT00877006|75851151|FG000|STARTED|Long-Term Follow-up Period||210||
59732675|NCT00877006|75851152|FG001|STARTED|Long-Term Follow-up Period||209||
59732676|NCT00877006|75851151|FG000|COMPLETED|Long-Term Follow-up Period||157||
59732677|NCT00877006|75851152|FG001|COMPLETED|Long-Term Follow-up Period||154||
59732678|NCT00877006|75851151|FG000|NOT COMPLETED|Long-Term Follow-up Period||53||
59732679|NCT00877006|75851152|FG001|NOT COMPLETED|Long-Term Follow-up Period||55||
59732680|NCT00876928|75851162|FG000|STARTED|Overall Study||56||
59732681|NCT00876928|75851163|FG001|STARTED|Overall Study||61||
59732682|NCT00876928|75851162|FG000|COMPLETED|Overall Study||53||
59732683|NCT00876928|75851163|FG001|COMPLETED|Overall Study||56||
59732684|NCT00876928|75851162|FG000|NOT COMPLETED|Overall Study||3||
59732685|NCT00876928|75851163|FG001|NOT COMPLETED|Overall Study||5||
59732686|NCT00807937|75851173|FG000|STARTED|Overall Study||93||
59732687|NCT00807937|75851174|FG001|STARTED|Overall Study||92||
59732688|NCT00807937|75851175|FG002|STARTED|Overall Study||92||
59732689|NCT00807937|75851176|FG003|STARTED|Overall Study||92||
59732690|NCT00807937|75851173|FG000|COMPLETED|Overall Study||66||
59732691|NCT00807937|75851174|FG001|COMPLETED|Overall Study||67||
59732692|NCT00807937|75851175|FG002|COMPLETED|Overall Study||78||
59732693|NCT00807937|75851176|FG003|COMPLETED|Overall Study||77||
59732694|NCT00807937|75851173|FG000|NOT COMPLETED|Overall Study||27||
59732695|NCT00807937|75851174|FG001|NOT COMPLETED|Overall Study||25||
59732696|NCT00807937|75851175|FG002|NOT COMPLETED|Overall Study||14||
59732697|NCT00807937|75851176|FG003|NOT COMPLETED|Overall Study||15||
59732698|NCT00906945|75851191|FG000|STARTED|Overall Study||3||
59732699|NCT00906945|75851192|FG001|STARTED|Overall Study||3||
59732700|NCT00906945|75851193|FG002|STARTED|Overall Study||3||
59732701|NCT00906945|75851194|FG003|STARTED|Overall Study||7||
59732702|NCT00906945|75851195|FG004|STARTED|Overall Study||7||
59732703|NCT00906945|75851196|FG005|STARTED|Overall Study||16||
59732704|NCT00906945|75851191|FG000|COMPLETED|Overall Study||3||
59732705|NCT00906945|75851192|FG001|COMPLETED|Overall Study||3||
59732706|NCT00906945|75851193|FG002|COMPLETED|Overall Study||3||
59732707|NCT00906945|75851194|FG003|COMPLETED|Overall Study||6||
59732708|NCT00906945|75851195|FG004|COMPLETED|Overall Study||6||
59732709|NCT00906945|75851196|FG005|COMPLETED|Overall Study||14||
59732710|NCT00906945|75851191|FG000|NOT COMPLETED|Overall Study||0||
59732711|NCT00906945|75851192|FG001|NOT COMPLETED|Overall Study||0||
59732712|NCT00906945|75851193|FG002|NOT COMPLETED|Overall Study||0||
59732713|NCT00906945|75851194|FG003|NOT COMPLETED|Overall Study||1||
59732714|NCT00906945|75851195|FG004|NOT COMPLETED|Overall Study||1||
59732715|NCT00906945|75851196|FG005|NOT COMPLETED|Overall Study||2||
59732716|NCT00807235|75851214|FG000|STARTED|Overall Study||11||
59732717|NCT00807235|75851215|FG001|STARTED|Overall Study||6||
59732718|NCT00807235|75851214|FG000|COMPLETED|Overall Study||10||
59732719|NCT00807235|75851215|FG001|COMPLETED|Overall Study||6||
59732720|NCT00807235|75851214|FG000|NOT COMPLETED|Overall Study||1||
59732721|NCT00807235|75851215|FG001|NOT COMPLETED|Overall Study||0||
59732722|NCT00876694|75851223|FG000|STARTED|Overall Study||125||
59732723|NCT00876694|75851224|FG001|STARTED|Overall Study||61||
59732724|NCT00876694|75851223|FG000|COMPLETED|Overall Study||104||
59732725|NCT00876694|75851224|FG001|COMPLETED|Overall Study||49||
59732726|NCT00876694|75851223|FG000|NOT COMPLETED|Overall Study||21||
59732727|NCT00876694|75851224|FG001|NOT COMPLETED|Overall Study||12||
59732728|NCT00805441|75851232|FG000|STARTED|Overall Study||94||
59732729|NCT00805441|75851233|FG001|STARTED|Overall Study||96||
59732730|NCT00805441|75851232|FG000|Full Analysis Set (FAS)|Overall Study|All randomized participants who received ≥1 dose study drug and contributed to post-baseline data.|92||
59732731|NCT00805441|75851233|FG001|Full Analysis Set (FAS)|Overall Study|All randomized participants who received ≥1 dose study drug and contributed to post-baseline data.|91||
59732732|NCT00805441|75851232|FG000|COMPLETED|Overall Study||60||
59732733|NCT00805441|75851233|FG001|COMPLETED|Overall Study||60||
59732734|NCT00805441|75851232|FG000|NOT COMPLETED|Overall Study||34||
59732735|NCT00805441|75851233|FG001|NOT COMPLETED|Overall Study||36||
59732736|NCT00590317|75851241|FG000|STARTED|Overall Study||32||
59732737|NCT00590317|75851242|FG001|STARTED|Overall Study||32||
59732738|NCT00590317|75851241|FG000|COMPLETED|Overall Study||31||
59732739|NCT00590317|75851242|FG001|COMPLETED|Overall Study||27||
59732740|NCT00590317|75851241|FG000|NOT COMPLETED|Overall Study||1||
59732741|NCT00590317|75851242|FG001|NOT COMPLETED|Overall Study||5||
59732742|NCT01139762|75851251|FG000|STARTED|Washout and Placebo Lead-In Period||1070||
59732743|NCT01139762|75851252|FG001|STARTED|Washout and Placebo Lead-In Period||0||
59732744|NCT01139762|75851253|FG002|STARTED|Washout and Placebo Lead-In Period||0||
59732745|NCT01139762|75851251|FG000|COMPLETED|Washout and Placebo Lead-In Period||696||
59732746|NCT01139762|75851252|FG001|COMPLETED|Washout and Placebo Lead-In Period||0||
59732747|NCT01139762|75851253|FG002|COMPLETED|Washout and Placebo Lead-In Period||0||
59732748|NCT01139762|75851251|FG000|NOT COMPLETED|Washout and Placebo Lead-In Period||374||
59732749|NCT01139762|75851252|FG001|NOT COMPLETED|Washout and Placebo Lead-In Period||0||
59732750|NCT01139762|75851253|FG002|NOT COMPLETED|Washout and Placebo Lead-In Period||0||
59732751|NCT01139762|75851251|FG000|STARTED|Double-Blind Randomized Active Treatment||0||
59732752|NCT01139762|75851252|FG001|STARTED|Double-Blind Randomized Active Treatment||346||
59732753|NCT01139762|75851253|FG002|STARTED|Double-Blind Randomized Active Treatment||350||
59732754|NCT01139762|75851251|FG000|Received at Least 1 Dose of Study Drug|Double-Blind Randomized Active Treatment||0||
59732755|NCT01139762|75851252|FG001|Received at Least 1 Dose of Study Drug|Double-Blind Randomized Active Treatment||345||
59732756|NCT01139762|75851253|FG002|Received at Least 1 Dose of Study Drug|Double-Blind Randomized Active Treatment||350||
59732757|NCT01139762|75851251|FG000|COMPLETED|Double-Blind Randomized Active Treatment||0||
59732758|NCT01139762|75851252|FG001|COMPLETED|Double-Blind Randomized Active Treatment||306||
59732759|NCT01139762|75851253|FG002|COMPLETED|Double-Blind Randomized Active Treatment||286||
59732760|NCT01139762|75851251|FG000|NOT COMPLETED|Double-Blind Randomized Active Treatment||0||
59732761|NCT01139762|75851252|FG001|NOT COMPLETED|Double-Blind Randomized Active Treatment||40||
59732762|NCT01139762|75851253|FG002|NOT COMPLETED|Double-Blind Randomized Active Treatment||64||
59732763|NCT00805285|75851260|FG000|STARTED|Overall Study||1||
59732764|NCT00805285|75851260|FG000|COMPLETED|Overall Study||0||
59732765|NCT00805285|75851260|FG000|NOT COMPLETED|Overall Study||1||
59732766|NCT01139450|75851267|FG000|STARTED|Overall Study||302||
59732767|NCT01139450|75851268|FG001|STARTED|Overall Study||297||
59732768|NCT01139450|75851269|FG002|STARTED|Overall Study||300||
59732769|NCT01139450|75851267|FG000|COMPLETED|Overall Study||275||
59732770|NCT01139450|75851268|FG001|COMPLETED|Overall Study||272||
59732771|NCT01139450|75851269|FG002|COMPLETED|Overall Study||262||
59732772|NCT01139450|75851267|FG000|NOT COMPLETED|Overall Study||27||
59732773|NCT01139450|75851268|FG001|NOT COMPLETED|Overall Study||25||
59732774|NCT01139450|75851269|FG002|NOT COMPLETED|Overall Study||38||
59732775|NCT00805207|75851286|FG000|STARTED|Overall Study||1||
59732776|NCT00805207|75851287|FG001|STARTED|Overall Study||9||
59732777|NCT00805207|75851288|FG002|STARTED|Overall Study||12||
59732778|NCT00805207|75851289|FG003|STARTED|Overall Study||6||
59732779|NCT00805207|75851290|FG004|STARTED|Overall Study||3||
59732780|NCT00805207|75851291|FG005|STARTED|Overall Study||12||
59732781|NCT00805207|75851292|FG006|STARTED|Overall Study||6||
59732782|NCT00805207|75851293|FG007|STARTED|Overall Study||6||
59732783|NCT00805207|75851294|FG008|STARTED|Overall Study||6||
59732784|NCT00805207|75851286|FG000|COMPLETED|Overall Study||1||
59732785|NCT00805207|75851287|FG001|COMPLETED|Overall Study||7||
59732786|NCT00805207|75851288|FG002|COMPLETED|Overall Study||11||
59732787|NCT00805207|75851289|FG003|COMPLETED|Overall Study||6||
59732788|NCT00805207|75851290|FG004|COMPLETED|Overall Study||2||
59732789|NCT00805207|75851291|FG005|COMPLETED|Overall Study||9||
59732790|NCT00805207|75851292|FG006|COMPLETED|Overall Study||6||
59732791|NCT00805207|75851293|FG007|COMPLETED|Overall Study||6||
59732792|NCT00805207|75851294|FG008|COMPLETED|Overall Study||6||
59732793|NCT00805207|75851286|FG000|NOT COMPLETED|Overall Study||0||
59732794|NCT00805207|75851287|FG001|NOT COMPLETED|Overall Study||2||
59732795|NCT00805207|75851288|FG002|NOT COMPLETED|Overall Study||1||
59732796|NCT00805207|75851289|FG003|NOT COMPLETED|Overall Study||0||
59732797|NCT00805207|75851290|FG004|NOT COMPLETED|Overall Study||1||
59732798|NCT00805207|75851291|FG005|NOT COMPLETED|Overall Study||3||
59732799|NCT00805207|75851292|FG006|NOT COMPLETED|Overall Study||0||
59732800|NCT00805207|75851293|FG007|NOT COMPLETED|Overall Study||0||
59732801|NCT00805207|75851294|FG008|NOT COMPLETED|Overall Study||0||
59732802|NCT00805675|75851321|FG000|STARTED|Overall Study||16||
59732803|NCT00805675|75851322|FG001|STARTED|Overall Study||14||
59732804|NCT00805675|75851323|FG002|STARTED|Overall Study||16||
59732805|NCT00805675|75851321|FG000|COMPLETED|Overall Study||16||
59732806|NCT00805675|75851322|FG001|COMPLETED|Overall Study||14||
59732807|NCT00805675|75851323|FG002|COMPLETED|Overall Study||15||
59732808|NCT00805675|75851321|FG000|NOT COMPLETED|Overall Study||0||
59732809|NCT00805675|75851322|FG001|NOT COMPLETED|Overall Study||0||
59732810|NCT00805675|75851323|FG002|NOT COMPLETED|Overall Study||1||
59732811|NCT03958201|75851331|FG000|STARTED|Overall Study||189||
59732812|NCT03958201|75851331|FG000|COMPLETED|Overall Study||189||
59732813|NCT03958201|75851331|FG000|NOT COMPLETED|Overall Study||0||
59732814|NCT00589303|75851337|FG000|STARTED|Overall Study||14||
59732815|NCT00589303|75851338|FG001|STARTED|Overall Study||13||
59732816|NCT00589303|75851337|FG000|COMPLETED|Overall Study||12||
59732817|NCT00589303|75851338|FG001|COMPLETED|Overall Study||12||
59732818|NCT00589303|75851337|FG000|NOT COMPLETED|Overall Study||2||
59732819|NCT00589303|75851338|FG001|NOT COMPLETED|Overall Study||1||
59732820|NCT00952380|75851349|FG000|STARTED|Overall Study||1||
59732821|NCT00952380|75851350|FG001|STARTED|Overall Study||2||
59732822|NCT00952380|75851351|FG002|STARTED|Overall Study||8||
59732823|NCT00952380|75851352|FG003|STARTED|Overall Study||7||
59732824|NCT00952380|75851353|FG004|STARTED|Overall Study||20||
59732825|NCT00952380|75851349|FG000|COMPLETED|Overall Study||1||
59732826|NCT00952380|75851350|FG001|COMPLETED|Overall Study||1||
59732827|NCT00952380|75851351|FG002|COMPLETED|Overall Study||6||
59732828|NCT00952380|75851352|FG003|COMPLETED|Overall Study||4||
59732829|NCT00952380|75851353|FG004|COMPLETED|Overall Study||14||
59732830|NCT00952380|75851349|FG000|NOT COMPLETED|Overall Study||0||
59732831|NCT00952380|75851350|FG001|NOT COMPLETED|Overall Study||1||
59732832|NCT00952380|75851351|FG002|NOT COMPLETED|Overall Study||2||
59732833|NCT00952380|75851352|FG003|NOT COMPLETED|Overall Study||3||
59732834|NCT00952380|75851353|FG004|NOT COMPLETED|Overall Study||6||
59732835|NCT00803179|75851370|FG000|STARTED|Overall Study||5||
59732836|NCT00803179|75851370|FG000|COMPLETED|Overall Study||2||
59732837|NCT00803179|75851370|FG000|NOT COMPLETED|Overall Study||3||
59732838|NCT00804193|75851377|FG000|STARTED|Overall Study||220||
59732839|NCT00804193|75851378|FG001|STARTED|Overall Study||224||
59732840|NCT00804193|75851379|FG002|STARTED|Overall Study||109||
59732841|NCT00804193|75851377|FG000|COMPLETED|Overall Study||181||
59732842|NCT00804193|75851378|FG001|COMPLETED|Overall Study||180||
59732843|NCT00804193|75851379|FG002|COMPLETED|Overall Study||77||
59732844|NCT00804193|75851377|FG000|NOT COMPLETED|Overall Study||39||
59732845|NCT00804193|75851378|FG001|NOT COMPLETED|Overall Study||44||
59732846|NCT00804193|75851379|FG002|NOT COMPLETED|Overall Study||32||
59732847|NCT00957996|75851389|FG000|STARTED|Overall Study||117||
59732848|NCT00957996|75851390|FG001|STARTED|Overall Study||117||
59732849|NCT00957996|75851389|FG000|COMPLETED|Overall Study||91||
59732850|NCT00957996|75851390|FG001|COMPLETED|Overall Study||89||
59732851|NCT00957996|75851389|FG000|NOT COMPLETED|Overall Study||26||
59732852|NCT00957996|75851390|FG001|NOT COMPLETED|Overall Study||28||
59732853|NCT00589693|75851400|FG000|STARTED|Overall Study||115||
59732854|NCT00589693|75851401|FG001|STARTED|Overall Study||112||
59732855|NCT00589693|75851400|FG000|COMPLETED|Overall Study||71||
59732856|NCT00589693|75851401|FG001|COMPLETED|Overall Study||83||
59732857|NCT00589693|75851400|FG000|NOT COMPLETED|Overall Study||44||
59732858|NCT00589693|75851401|FG001|NOT COMPLETED|Overall Study||29||
59732859|NCT00803101|75851409|FG000|STARTED|Overall Study||88||
59732860|NCT00803101|75851410|FG001|STARTED|Overall Study||88||
59732861|NCT00803101|75851409|FG000|COMPLETED|Overall Study||70||
59732862|NCT00803101|75851410|FG001|COMPLETED|Overall Study||66||
59732863|NCT00803101|75851409|FG000|NOT COMPLETED|Overall Study||18||
59732864|NCT00803101|75851410|FG001|NOT COMPLETED|Overall Study||22||
59732865|NCT00801229|75851418|FG000|STARTED|Signed Consent||38||
59732866|NCT00801229|75851419|FG001|STARTED|Signed Consent||37||
59732867|NCT00801229|75851418|FG000|COMPLETED|Signed Consent||35||
59732868|NCT00801229|75851419|FG001|COMPLETED|Signed Consent||34||
59732869|NCT00801229|75851418|FG000|NOT COMPLETED|Signed Consent||3||
59732870|NCT00801229|75851419|FG001|NOT COMPLETED|Signed Consent||3||
59732871|NCT00801229|75851418|FG000|STARTED|Received Study Drug/Placebo||35||
59732872|NCT00801229|75851419|FG001|STARTED|Received Study Drug/Placebo||34||
59732873|NCT00801229|75851418|FG000|COMPLETED|Received Study Drug/Placebo||31||
59732874|NCT00801229|75851419|FG001|COMPLETED|Received Study Drug/Placebo||30||
59732875|NCT00801229|75851418|FG000|NOT COMPLETED|Received Study Drug/Placebo||4||
59732876|NCT00801229|75851419|FG001|NOT COMPLETED|Received Study Drug/Placebo||4||
59732877|NCT00948246|75851425|FG000|STARTED|Overall Study||110||
59732878|NCT00948246|75851425|FG000|COMPLETED|Overall Study||86||
59732879|NCT00948246|75851425|FG000|NOT COMPLETED|Overall Study||24||
59732880|NCT00800683|75851431|FG000|STARTED|Overall Study|Number who started treatment|65||
59732881|NCT00800683|75851432|FG001|STARTED|Overall Study|Number who started treatment|68||
59732882|NCT00800683|75851431|FG000|COMPLETED|Overall Study|Number who completed treatment|48||
59732883|NCT00800683|75851432|FG001|COMPLETED|Overall Study|Number who completed treatment|49||
59732884|NCT00800683|75851431|FG000|NOT COMPLETED|Overall Study||17||
59732885|NCT00800683|75851432|FG001|NOT COMPLETED|Overall Study||19||
59732886|NCT01124864|75851444|FG000|STARTED|Overall Study||28||
59732887|NCT01124864|75851445|FG001|STARTED|Overall Study||35||
59732888|NCT01124864|75851446|FG002|STARTED|Overall Study||34||
59732889|NCT01124864|75851447|FG003|STARTED|Overall Study||22||
59732890|NCT01124864|75851448|FG004|STARTED|Overall Study||31||
59732891|NCT01124864|75851449|FG005|STARTED|Overall Study||3||
59732892|NCT01124864|75851444|FG000|COMPLETED|Overall Study||0||
59732893|NCT01124864|75851445|FG001|COMPLETED|Overall Study||0||
59732894|NCT01124864|75851446|FG002|COMPLETED|Overall Study||0||
59732895|NCT01124864|75851447|FG003|COMPLETED|Overall Study|1 patient ongoing at time of data cut-off 30-Jul-2013|1||
59732896|NCT01124864|75851448|FG004|COMPLETED|Overall Study|1 patient ongoing at time of data cut-off 30-Jul-2013|1||
59732897|NCT01124864|75851449|FG005|COMPLETED|Overall Study||0||
59732898|NCT01124864|75851444|FG000|NOT COMPLETED|Overall Study||28||
59732899|NCT01124864|75851445|FG001|NOT COMPLETED|Overall Study||35||
59732900|NCT01124864|75851446|FG002|NOT COMPLETED|Overall Study||34||
59732901|NCT01124864|75851447|FG003|NOT COMPLETED|Overall Study||21||
59732902|NCT01124864|75851448|FG004|NOT COMPLETED|Overall Study||30||
59732903|NCT01124864|75851449|FG005|NOT COMPLETED|Overall Study||3||
59732904|NCT01113710|75851465|FG000|STARTED|Overall Study|See Additional Study Description for further information regarding withdrawal due to Adverse Event.|687||
59732905|NCT01113710|75851465|FG000|COMPLETED|Overall Study|"Discontinued reasons for Other are listed in the Participant Flow."|418||
59732906|NCT01113710|75851465|FG000|NOT COMPLETED|Overall Study||269||
59732907|NCT01124162|75851471|FG000|STARTED|First Intervention||40||
59732908|NCT01124162|75851472|FG001|STARTED|First Intervention||40||
59732909|NCT01124162|75851471|FG000|COMPLETED|First Intervention||38||
59732910|NCT01124162|75851472|FG001|COMPLETED|First Intervention||40||
59732911|NCT01124162|75851471|FG000|NOT COMPLETED|First Intervention||2||
59732912|NCT01124162|75851472|FG001|NOT COMPLETED|First Intervention||0||
59732913|NCT01124162|75851471|FG000|STARTED|Washout of 7 Days||38||
59732914|NCT01124162|75851472|FG001|STARTED|Washout of 7 Days||40||
59732915|NCT01124162|75851471|FG000|COMPLETED|Washout of 7 Days||37||
59732916|NCT01124162|75851472|FG001|COMPLETED|Washout of 7 Days||40||
59732917|NCT01124162|75851471|FG000|NOT COMPLETED|Washout of 7 Days||1||
59732918|NCT01124162|75851472|FG001|NOT COMPLETED|Washout of 7 Days||0||
59732919|NCT01124162|75851471|FG000|STARTED|Second Intervention||37||
59732920|NCT01124162|75851472|FG001|STARTED|Second Intervention||40||
59732921|NCT01124162|75851471|FG000|COMPLETED|Second Intervention||37||
59732922|NCT01124162|75851472|FG001|COMPLETED|Second Intervention||40||
59732923|NCT01124162|75851471|FG000|NOT COMPLETED|Second Intervention||0||
59732924|NCT01124162|75851472|FG001|NOT COMPLETED|Second Intervention||0||
59732925|NCT00906399|75851481|FG000|STARTED|Year 1||500||
59732926|NCT00906399|75851482|FG001|STARTED|Year 1||501||
59732927|NCT00906399|75851483|FG002|STARTED|Year 1||515||
59732928|NCT00906399|75851484|FG003|STARTED|Year 1||0||
59732929|NCT00906399|75851485|FG004|STARTED|Year 1||0||
59732930|NCT00906399|75851486|FG005|STARTED|Year 1||0||
59732931|NCT00906399|75851487|FG006|STARTED|Year 1||0||
59732932|NCT00906399|75851481|FG000|Completed Year 1 Study Treatment|Year 1||456||
59732933|NCT00906399|75851482|FG001|Completed Year 1 Study Treatment|Year 1||438||
59732934|NCT00906399|75851483|FG002|Completed Year 1 Study Treatment|Year 1||438||
59732935|NCT00906399|75851484|FG003|Completed Year 1 Study Treatment|Year 1||0||
59732936|NCT00906399|75851485|FG004|Completed Year 1 Study Treatment|Year 1||0||
59732937|NCT00906399|75851486|FG005|Completed Year 1 Study Treatment|Year 1||0||
59732938|NCT00906399|75851487|FG006|Completed Year 1 Study Treatment|Year 1||0||
59732939|NCT00906399|75851481|FG000|COMPLETED|Year 1||456||
59732940|NCT00906399|75851482|FG001|COMPLETED|Year 1||438||
59732941|NCT00906399|75851483|FG002|COMPLETED|Year 1|1 participant discontinued treatment before end of study period but remained to complete follow-up.|439||
59732942|NCT00906399|75851484|FG003|COMPLETED|Year 1||0||
59732943|NCT00906399|75851485|FG004|COMPLETED|Year 1||0||
59732944|NCT00906399|75851486|FG005|COMPLETED|Year 1||0||
59732945|NCT00906399|75851487|FG006|COMPLETED|Year 1||0||
59732946|NCT00906399|75851481|FG000|NOT COMPLETED|Year 1||44||
59732947|NCT00906399|75851482|FG001|NOT COMPLETED|Year 1||63||
59732948|NCT00906399|75851483|FG002|NOT COMPLETED|Year 1||76||
59732949|NCT00906399|75851484|FG003|NOT COMPLETED|Year 1||0||
59732950|NCT00906399|75851485|FG004|NOT COMPLETED|Year 1||0||
59732951|NCT00906399|75851486|FG005|NOT COMPLETED|Year 1||0||
59732952|NCT00906399|75851487|FG006|NOT COMPLETED|Year 1||0||
59732953|NCT00906399|75851481|FG000|STARTED|Year 2||0||
59732954|NCT00906399|75851482|FG001|STARTED|Year 2||0||
59732955|NCT00906399|75851483|FG002|STARTED|Year 2||0||
59732956|NCT00906399|75851484|FG003|STARTED|Year 2||228||
59732957|NCT00906399|75851485|FG004|STARTED|Year 2||228||
59732958|NCT00906399|75851486|FG005|STARTED|Year 2||438||
59732959|NCT00906399|75851487|FG006|STARTED|Year 2||438||
59732960|NCT00906399|75851481|FG000|Completed Year 2 Study Treatment|Year 2||0||
59732961|NCT00906399|75851482|FG001|Completed Year 2 Study Treatment|Year 2||0||
59732962|NCT00906399|75851483|FG002|Completed Year 2 Study Treatment|Year 2||0||
59732963|NCT00906399|75851484|FG003|Completed Year 2 Study Treatment|Year 2||200||
59732964|NCT00906399|75851485|FG004|Completed Year 2 Study Treatment|Year 2||196||
59732965|NCT00906399|75851486|FG005|Completed Year 2 Study Treatment|Year 2||391||
59732966|NCT00906399|75851487|FG006|Completed Year 2 Study Treatment|Year 2||411||
59732967|NCT00906399|75851481|FG000|COMPLETED|Year 2||0||
59732968|NCT00906399|75851482|FG001|COMPLETED|Year 2||0||
59732969|NCT00906399|75851483|FG002|COMPLETED|Year 2||0||
59732970|NCT00906399|75851484|FG003|COMPLETED|Year 2||198||
59732971|NCT00906399|75851485|FG004|COMPLETED|Year 2||193||
59732972|NCT00906399|75851486|FG005|COMPLETED|Year 2||391||
59732973|NCT00906399|75851487|FG006|COMPLETED|Year 2||409||
59732974|NCT00906399|75851481|FG000|NOT COMPLETED|Year 2||0||
59732975|NCT00906399|75851482|FG001|NOT COMPLETED|Year 2||0||
59732976|NCT00906399|75851483|FG002|NOT COMPLETED|Year 2||0||
59732977|NCT00906399|75851484|FG003|NOT COMPLETED|Year 2||30||
59732978|NCT00906399|75851485|FG004|NOT COMPLETED|Year 2||35||
59732979|NCT00906399|75851486|FG005|NOT COMPLETED|Year 2||47||
59732980|NCT00906399|75851487|FG006|NOT COMPLETED|Year 2||29||
59732981|NCT01111838|75851499|FG000|STARTED|Overall Study||22||
59732982|NCT01111838|75851499|FG000|COMPLETED|Overall Study||15||
59732983|NCT01111838|75851499|FG000|NOT COMPLETED|Overall Study||7||
59732984|NCT00947856|75851505|FG000|STARTED|Treatment Period||78||
59732985|NCT00947856|75851506|FG001|STARTED|Treatment Period|Two patients in extension arm re-enrolled in retreatment arm and are represented in both arms|32||
59732986|NCT00947856|75851505|FG000|COMPLETED|Treatment Period||0||
59732987|NCT00947856|75851506|FG001|COMPLETED|Treatment Period|Patients treated until disease progression, unacceptable toxicity or study closure|0||
59732988|NCT00947856|75851505|FG000|NOT COMPLETED|Treatment Period||78||
59732989|NCT00947856|75851506|FG001|NOT COMPLETED|Treatment Period||32||
59732990|NCT00947856|75851505|FG000|STARTED|Follow-up Period||78||
59732991|NCT00947856|75851506|FG001|STARTED|Follow-up Period|All participants were followed after treatment; thus, number started will not match number completed|32||
59732992|NCT00947856|75851505|FG000|COMPLETED|Follow-up Period||27||
59732993|NCT00947856|75851506|FG001|COMPLETED|Follow-up Period|Completed survival follow-up due to death|9||
59732994|NCT00947856|75851505|FG000|NOT COMPLETED|Follow-up Period||51||
59732995|NCT00947856|75851506|FG001|NOT COMPLETED|Follow-up Period||23||
59732996|NCT00947544|75851521|FG000|STARTED|Switch-Over Period (2 Weeks)||11||
59732997|NCT00947544|75851522|FG001|STARTED|Switch-Over Period (2 Weeks)||0||
59732998|NCT00947544|75851521|FG000|COMPLETED|Switch-Over Period (2 Weeks)||11||
59732999|NCT00947544|75851522|FG001|COMPLETED|Switch-Over Period (2 Weeks)||0||
59733000|NCT00947544|75851521|FG000|NOT COMPLETED|Switch-Over Period (2 Weeks)||0||
59733001|NCT00947544|75851522|FG001|NOT COMPLETED|Switch-Over Period (2 Weeks)||0||
59733002|NCT00947544|75851521|FG000|STARTED|Safety-Extension Period (12 Months)||11||
59733003|NCT00947544|75851522|FG001|STARTED|Safety-Extension Period (12 Months)|New participants were enrolled due to DSMB approval.|6||
59733004|NCT00947544|75851521|FG000|COMPLETED|Safety-Extension Period (12 Months)||10||
59733005|NCT00947544|75851522|FG001|COMPLETED|Safety-Extension Period (12 Months)||6||
59733006|NCT00947544|75851521|FG000|NOT COMPLETED|Safety-Extension Period (12 Months)||1||
59733007|NCT00947544|75851522|FG001|NOT COMPLETED|Safety-Extension Period (12 Months)||0||
59733008|NCT00907335|75851534|FG000|STARTED|Overall Study||55||
59733009|NCT00907335|75851535|FG001|STARTED|Overall Study||55||
59733010|NCT00907335|75851534|FG000|COMPLETED|Overall Study||47||
59733011|NCT00907335|75851535|FG001|COMPLETED|Overall Study||54||
59733012|NCT00907335|75851534|FG000|NOT COMPLETED|Overall Study||8||
59733013|NCT00907335|75851535|FG001|NOT COMPLETED|Overall Study||1||
59733014|NCT00947154|75851541|FG000|STARTED|Overall Study||12||
59733015|NCT00947154|75851541|FG000|COMPLETED|Overall Study||11||
59733016|NCT00947154|75851541|FG000|NOT COMPLETED|Overall Study||1||
59733017|NCT01124006|75851549|FG000|STARTED|Overall Study||10||
59733018|NCT01124006|75851550|FG001|STARTED|Overall Study||10||
59733019|NCT01124006|75851551|FG002|STARTED|Overall Study||4||
59733020|NCT01124006|75851549|FG000|COMPLETED|Overall Study||7||
59733021|NCT01124006|75851550|FG001|COMPLETED|Overall Study||8||
59733022|NCT01124006|75851551|FG002|COMPLETED|Overall Study||2||
59733023|NCT01124006|75851549|FG000|NOT COMPLETED|Overall Study||3||
59733024|NCT01124006|75851550|FG001|NOT COMPLETED|Overall Study||2||
59733025|NCT01124006|75851551|FG002|NOT COMPLETED|Overall Study||2||
59733026|NCT00952068|75851559|FG000|STARTED|Overall Study||47||
59733027|NCT00952068|75851559|FG000|COMPLETED|Overall Study||40||
59733028|NCT00952068|75851559|FG000|NOT COMPLETED|Overall Study||7||
59733029|NCT01123850|75851563|FG000|STARTED|Overall Study||45||
59733030|NCT01123850|75851563|FG000|COMPLETED|Overall Study||0||
59733031|NCT01123850|75851563|FG000|NOT COMPLETED|Overall Study||45||
59733032|NCT01123382|75851569|FG000|STARTED|Overall Study||13||
59733033|NCT01123382|75851570|FG001|STARTED|Overall Study||12||
59733034|NCT01123382|75851569|FG000|Received Intervention|Overall Study||12||
59733035|NCT01123382|75851570|FG001|Received Intervention|Overall Study||10||
59733036|NCT01123382|75851569|FG000|COMPLETED|Overall Study||11||
59733037|NCT01123382|75851570|FG001|COMPLETED|Overall Study||6||
59733038|NCT01123382|75851569|FG000|NOT COMPLETED|Overall Study||2||
59733039|NCT01123382|75851570|FG001|NOT COMPLETED|Overall Study||6||
59733040|NCT00951912|75851579|FG000|STARTED|Overall Study||54||
59733041|NCT00951912|75851580|FG001|STARTED|Overall Study||55||
59733042|NCT00951912|75851581|FG002|STARTED|Overall Study||56||
59733043|NCT00951912|75851579|FG000|COMPLETED|Overall Study||47||
59733044|NCT00951912|75851580|FG001|COMPLETED|Overall Study||50||
59733045|NCT00951912|75851581|FG002|COMPLETED|Overall Study||54||
59733046|NCT00951912|75851579|FG000|NOT COMPLETED|Overall Study||7||
59733047|NCT00951912|75851580|FG001|NOT COMPLETED|Overall Study||5||
59733048|NCT00951912|75851581|FG002|NOT COMPLETED|Overall Study||2||
59733049|NCT01123148|75851589|FG000|STARTED|Overall Study||14||
59733050|NCT01123148|75851589|FG000|BCI Calibration >50% Accuracy|Overall Study||13||
59733051|NCT01123148|75851589|FG000|COMPLETED|Overall Study||12||
59733052|NCT01123148|75851589|FG000|NOT COMPLETED|Overall Study||2||
59733053|NCT01123070|75851597|FG000|STARTED|Part A Cohort 1 Open Label Period||3||
59733054|NCT01123070|75851598|FG001|STARTED|Part A Cohort 1 Open Label Period||0||
59733055|NCT01123070|75851599|FG002|STARTED|Part A Cohort 1 Open Label Period||0||
59733056|NCT01123070|75851600|FG003|STARTED|Part A Cohort 1 Open Label Period||0||
59733057|NCT01123070|75851597|FG000|COMPLETED|Part A Cohort 1 Open Label Period||3||
59733058|NCT01123070|75851598|FG001|COMPLETED|Part A Cohort 1 Open Label Period||0||
59733059|NCT01123070|75851599|FG002|COMPLETED|Part A Cohort 1 Open Label Period||0||
59733060|NCT01123070|75851600|FG003|COMPLETED|Part A Cohort 1 Open Label Period||0||
59733061|NCT01123070|75851597|FG000|NOT COMPLETED|Part A Cohort 1 Open Label Period||0||
59733062|NCT01123070|75851598|FG001|NOT COMPLETED|Part A Cohort 1 Open Label Period||0||
59733063|NCT01123070|75851599|FG002|NOT COMPLETED|Part A Cohort 1 Open Label Period||0||
59733064|NCT01123070|75851600|FG003|NOT COMPLETED|Part A Cohort 1 Open Label Period||0||
59733065|NCT01123070|75851597|FG000|STARTED|Part A Cohort 2 Open Label Period||0||
59733066|NCT01123070|75851598|FG001|STARTED|Part A Cohort 2 Open Label Period||3||
59733067|NCT01123070|75851599|FG002|STARTED|Part A Cohort 2 Open Label Period||0||
59733068|NCT01123070|75851600|FG003|STARTED|Part A Cohort 2 Open Label Period||0||
59733069|NCT01123070|75851597|FG000|COMPLETED|Part A Cohort 2 Open Label Period||0||
59733070|NCT01123070|75851598|FG001|COMPLETED|Part A Cohort 2 Open Label Period||3||
59733071|NCT01123070|75851599|FG002|COMPLETED|Part A Cohort 2 Open Label Period||0||
59733072|NCT01123070|75851600|FG003|COMPLETED|Part A Cohort 2 Open Label Period||0||
59733073|NCT01123070|75851597|FG000|NOT COMPLETED|Part A Cohort 2 Open Label Period||0||
59733074|NCT01123070|75851598|FG001|NOT COMPLETED|Part A Cohort 2 Open Label Period||0||
59733075|NCT01123070|75851599|FG002|NOT COMPLETED|Part A Cohort 2 Open Label Period||0||
59733076|NCT01123070|75851600|FG003|NOT COMPLETED|Part A Cohort 2 Open Label Period||0||
59733077|NCT01123070|75851597|FG000|STARTED|Part B Double Blind Period||0||
59733078|NCT01123070|75851598|FG001|STARTED|Part B Double Blind Period||0||
59733079|NCT01123070|75851599|FG002|STARTED|Part B Double Blind Period||25||
59733080|NCT01123070|75851600|FG003|STARTED|Part B Double Blind Period||23||
59733081|NCT01123070|75851597|FG000|COMPLETED|Part B Double Blind Period||0||
59733082|NCT01123070|75851598|FG001|COMPLETED|Part B Double Blind Period||0||
59733083|NCT01123070|75851599|FG002|COMPLETED|Part B Double Blind Period||21||
59733084|NCT01123070|75851600|FG003|COMPLETED|Part B Double Blind Period||20||
59733085|NCT01123070|75851597|FG000|NOT COMPLETED|Part B Double Blind Period||0||
59733086|NCT01123070|75851598|FG001|NOT COMPLETED|Part B Double Blind Period||0||
59733087|NCT01123070|75851599|FG002|NOT COMPLETED|Part B Double Blind Period||4||
59733088|NCT01123070|75851600|FG003|NOT COMPLETED|Part B Double Blind Period||3||
59733089|NCT01122680|75851611|FG000|STARTED|Period 1 (4 Weeks)|Entered this study period.|29||
59733090|NCT01122680|75851612|FG001|STARTED|Period 1 (4 Weeks)|Entered this study period.|26||
59733091|NCT01122680|75851613|FG002|STARTED|Period 1 (4 Weeks)|Entered this study period.|26||
59733092|NCT01122680|75851614|FG003|STARTED|Period 1 (4 Weeks)|Entered this study period.|24||
59733093|NCT01122680|75851611|FG000|COMPLETED|Period 1 (4 Weeks)|Completed treatment in this crossover period.|26||
59733094|NCT01122680|75851612|FG001|COMPLETED|Period 1 (4 Weeks)|Completed treatment in this crossover period.|25||
59733095|NCT01122680|75851613|FG002|COMPLETED|Period 1 (4 Weeks)|Completed treatment in this crossover period.|26||
59733096|NCT01122680|75851614|FG003|COMPLETED|Period 1 (4 Weeks)|Completed treatment in this crossover period.|24||
59733097|NCT01122680|75851611|FG000|NOT COMPLETED|Period 1 (4 Weeks)||3||
59733098|NCT01122680|75851612|FG001|NOT COMPLETED|Period 1 (4 Weeks)||1||
59733099|NCT01122680|75851613|FG002|NOT COMPLETED|Period 1 (4 Weeks)||0||
59733100|NCT01122680|75851614|FG003|NOT COMPLETED|Period 1 (4 Weeks)||0||
59733101|NCT01122680|75851611|FG000|STARTED|Period 2 (4 Weeks)|Entered this study period.|26||
59733102|NCT01122680|75851612|FG001|STARTED|Period 2 (4 Weeks)|Entered this study period.|25||
59733103|NCT01122680|75851613|FG002|STARTED|Period 2 (4 Weeks)|Entered this study period.|26||
59733104|NCT01122680|75851614|FG003|STARTED|Period 2 (4 Weeks)|Entered this study period.|24||
59733105|NCT01122680|75851611|FG000|COMPLETED|Period 2 (4 Weeks)|Completed treatment in this crossover period.|25||
59733106|NCT01122680|75851612|FG001|COMPLETED|Period 2 (4 Weeks)|Completed treatment in this crossover period.|25||
59733107|NCT01122680|75851613|FG002|COMPLETED|Period 2 (4 Weeks)|Completed treatment in this crossover period.|26||
59733108|NCT01122680|75851614|FG003|COMPLETED|Period 2 (4 Weeks)|Completed treatment in this crossover period.|23||
59733109|NCT01122680|75851611|FG000|NOT COMPLETED|Period 2 (4 Weeks)||1||
59733110|NCT01122680|75851612|FG001|NOT COMPLETED|Period 2 (4 Weeks)||0||
59733111|NCT01122680|75851613|FG002|NOT COMPLETED|Period 2 (4 Weeks)||0||
59733112|NCT01122680|75851614|FG003|NOT COMPLETED|Period 2 (4 Weeks)||1||
59733113|NCT01122680|75851611|FG000|STARTED|Period 3 (4 Weeks)|Entered this study period.|25||
59733114|NCT01122680|75851612|FG001|STARTED|Period 3 (4 Weeks)|Entered this study period.|25||
59733115|NCT01122680|75851613|FG002|STARTED|Period 3 (4 Weeks)|Entered this study period.|26||
59733116|NCT01122680|75851614|FG003|STARTED|Period 3 (4 Weeks)|Entered this study period.|23||
59733117|NCT01122680|75851611|FG000|COMPLETED|Period 3 (4 Weeks)|Completed treatment in this crossover period.|24||
59733118|NCT01122680|75851612|FG001|COMPLETED|Period 3 (4 Weeks)|Completed treatment in this crossover period.|24||
59733119|NCT01122680|75851613|FG002|COMPLETED|Period 3 (4 Weeks)|Completed treatment in this crossover period.|26||
59733120|NCT01122680|75851614|FG003|COMPLETED|Period 3 (4 Weeks)|Completed treatment in this crossover period.|23||
59733121|NCT01122680|75851611|FG000|NOT COMPLETED|Period 3 (4 Weeks)||1||
59733122|NCT01122680|75851612|FG001|NOT COMPLETED|Period 3 (4 Weeks)||1||
59733123|NCT01122680|75851613|FG002|NOT COMPLETED|Period 3 (4 Weeks)||0||
59733124|NCT01122680|75851614|FG003|NOT COMPLETED|Period 3 (4 Weeks)||0||
59733125|NCT00946998|75851626|FG000|STARTED|Overall Study||102||
59733126|NCT00946998|75851627|FG001|STARTED|Overall Study||99||
59733127|NCT00946998|75851626|FG000|Received Treatment as Randomized|Overall Study||102||
59733128|NCT00946998|75851627|FG001|Received Treatment as Randomized|Overall Study||99||
59733129|NCT00946998|75851626|FG000|COMPLETED|Overall Study||97||
59733130|NCT00946998|75851627|FG001|COMPLETED|Overall Study||96||
59733131|NCT00946998|75851626|FG000|NOT COMPLETED|Overall Study||5||
59733132|NCT00946998|75851627|FG001|NOT COMPLETED|Overall Study||3||
59733133|NCT01138826|75851633|FG000|STARTED|First Intervention Period||3||
59733134|NCT01138826|75851634|FG001|STARTED|First Intervention Period||3||
59733135|NCT01138826|75851635|FG002|STARTED|First Intervention Period||3||
59733136|NCT01138826|75851636|FG003|STARTED|First Intervention Period||3||
59733137|NCT01138826|75851637|FG004|STARTED|First Intervention Period||3||
59733138|NCT01138826|75851638|FG005|STARTED|First Intervention Period||3||
59733139|NCT01138826|75851633|FG000|COMPLETED|First Intervention Period||3||
59733140|NCT01138826|75851634|FG001|COMPLETED|First Intervention Period||3||
59733141|NCT01138826|75851635|FG002|COMPLETED|First Intervention Period||3||
59733142|NCT01138826|75851636|FG003|COMPLETED|First Intervention Period||3||
59733143|NCT01138826|75851637|FG004|COMPLETED|First Intervention Period||3||
59733144|NCT01138826|75851638|FG005|COMPLETED|First Intervention Period||3||
59733145|NCT01138826|75851633|FG000|NOT COMPLETED|First Intervention Period||0||
59733146|NCT01138826|75851634|FG001|NOT COMPLETED|First Intervention Period||0||
59733147|NCT01138826|75851635|FG002|NOT COMPLETED|First Intervention Period||0||
59733148|NCT01138826|75851636|FG003|NOT COMPLETED|First Intervention Period||0||
59733149|NCT01138826|75851637|FG004|NOT COMPLETED|First Intervention Period||0||
59733150|NCT01138826|75851638|FG005|NOT COMPLETED|First Intervention Period||0||
59733151|NCT01138826|75851633|FG000|STARTED|Washout Period I (of 16 Days)||3||
59733152|NCT01138826|75851634|FG001|STARTED|Washout Period I (of 16 Days)||3||
59733153|NCT01138826|75851635|FG002|STARTED|Washout Period I (of 16 Days)||3||
59733154|NCT01138826|75851636|FG003|STARTED|Washout Period I (of 16 Days)||3||
59733155|NCT01138826|75851637|FG004|STARTED|Washout Period I (of 16 Days)||3||
59733156|NCT01138826|75851638|FG005|STARTED|Washout Period I (of 16 Days)||3||
59733157|NCT01138826|75851633|FG000|COMPLETED|Washout Period I (of 16 Days)||2||
59733158|NCT01138826|75851634|FG001|COMPLETED|Washout Period I (of 16 Days)||2||
59733159|NCT01138826|75851635|FG002|COMPLETED|Washout Period I (of 16 Days)||3||
59733160|NCT01138826|75851636|FG003|COMPLETED|Washout Period I (of 16 Days)||3||
59733161|NCT01138826|75851637|FG004|COMPLETED|Washout Period I (of 16 Days)||2||
59733162|NCT01138826|75851638|FG005|COMPLETED|Washout Period I (of 16 Days)||3||
59733163|NCT01138826|75851633|FG000|NOT COMPLETED|Washout Period I (of 16 Days)||1||
59733164|NCT01138826|75851634|FG001|NOT COMPLETED|Washout Period I (of 16 Days)||1||
59733165|NCT01138826|75851635|FG002|NOT COMPLETED|Washout Period I (of 16 Days)||0||
59733166|NCT01138826|75851636|FG003|NOT COMPLETED|Washout Period I (of 16 Days)||0||
59733167|NCT01138826|75851637|FG004|NOT COMPLETED|Washout Period I (of 16 Days)||1||
59733168|NCT01138826|75851638|FG005|NOT COMPLETED|Washout Period I (of 16 Days)||0||
59733169|NCT01138826|75851633|FG000|STARTED|Second Intervention Period||2||
59733170|NCT01138826|75851634|FG001|STARTED|Second Intervention Period||2||
59733171|NCT01138826|75851635|FG002|STARTED|Second Intervention Period||3||
59733172|NCT01138826|75851636|FG003|STARTED|Second Intervention Period||3||
59733173|NCT01138826|75851637|FG004|STARTED|Second Intervention Period||2||
59733174|NCT01138826|75851638|FG005|STARTED|Second Intervention Period||3||
59733175|NCT01138826|75851633|FG000|COMPLETED|Second Intervention Period||2||
59733176|NCT01138826|75851634|FG001|COMPLETED|Second Intervention Period||2||
59733177|NCT01138826|75851635|FG002|COMPLETED|Second Intervention Period||3||
59733178|NCT01138826|75851636|FG003|COMPLETED|Second Intervention Period||3||
59733179|NCT01138826|75851637|FG004|COMPLETED|Second Intervention Period||2||
59733180|NCT01138826|75851638|FG005|COMPLETED|Second Intervention Period||3||
59733181|NCT01138826|75851633|FG000|NOT COMPLETED|Second Intervention Period||0||
59733182|NCT01138826|75851634|FG001|NOT COMPLETED|Second Intervention Period||0||
59733183|NCT01138826|75851635|FG002|NOT COMPLETED|Second Intervention Period||0||
59733184|NCT01138826|75851636|FG003|NOT COMPLETED|Second Intervention Period||0||
59733185|NCT01138826|75851637|FG004|NOT COMPLETED|Second Intervention Period||0||
59733186|NCT01138826|75851638|FG005|NOT COMPLETED|Second Intervention Period||0||
59733187|NCT01138826|75851633|FG000|STARTED|Washout Period II (of 16 Days)||2||
59733188|NCT01138826|75851634|FG001|STARTED|Washout Period II (of 16 Days)||2||
59733189|NCT01138826|75851635|FG002|STARTED|Washout Period II (of 16 Days)||3||
59733190|NCT01138826|75851636|FG003|STARTED|Washout Period II (of 16 Days)||3||
59733191|NCT01138826|75851637|FG004|STARTED|Washout Period II (of 16 Days)||2||
59733192|NCT01138826|75851638|FG005|STARTED|Washout Period II (of 16 Days)||3||
59733193|NCT01138826|75851633|FG000|COMPLETED|Washout Period II (of 16 Days)||2||
59733194|NCT01138826|75851634|FG001|COMPLETED|Washout Period II (of 16 Days)||2||
59733195|NCT01138826|75851635|FG002|COMPLETED|Washout Period II (of 16 Days)||3||
59733196|NCT01138826|75851636|FG003|COMPLETED|Washout Period II (of 16 Days)||3||
59733197|NCT01138826|75851637|FG004|COMPLETED|Washout Period II (of 16 Days)||2||
59733198|NCT01138826|75851638|FG005|COMPLETED|Washout Period II (of 16 Days)||3||
59733199|NCT01138826|75851633|FG000|NOT COMPLETED|Washout Period II (of 16 Days)||0||
59733200|NCT01138826|75851634|FG001|NOT COMPLETED|Washout Period II (of 16 Days)||0||
59999792|NCT01782131|76115511|FG001|Treated|Overall Study||287||
59733201|NCT01138826|75851635|FG002|NOT COMPLETED|Washout Period II (of 16 Days)||0||
59733202|NCT01138826|75851636|FG003|NOT COMPLETED|Washout Period II (of 16 Days)||0||
59733203|NCT01138826|75851637|FG004|NOT COMPLETED|Washout Period II (of 16 Days)||0||
59733204|NCT01138826|75851638|FG005|NOT COMPLETED|Washout Period II (of 16 Days)||0||
59733205|NCT01138826|75851633|FG000|STARTED|Third Intervention Period||2||
59733206|NCT01138826|75851634|FG001|STARTED|Third Intervention Period||2||
59733207|NCT01138826|75851635|FG002|STARTED|Third Intervention Period||3||
59733208|NCT01138826|75851636|FG003|STARTED|Third Intervention Period||3||
59733209|NCT01138826|75851637|FG004|STARTED|Third Intervention Period||2||
59733210|NCT01138826|75851638|FG005|STARTED|Third Intervention Period||3||
59733211|NCT01138826|75851633|FG000|COMPLETED|Third Intervention Period||2||
59733212|NCT01138826|75851634|FG001|COMPLETED|Third Intervention Period||2||
59733213|NCT01138826|75851635|FG002|COMPLETED|Third Intervention Period||3||
59733214|NCT01138826|75851636|FG003|COMPLETED|Third Intervention Period||3||
59733215|NCT01138826|75851637|FG004|COMPLETED|Third Intervention Period||2||
59733216|NCT01138826|75851638|FG005|COMPLETED|Third Intervention Period||3||
59733217|NCT01138826|75851633|FG000|NOT COMPLETED|Third Intervention Period||0||
59733218|NCT01138826|75851634|FG001|NOT COMPLETED|Third Intervention Period||0||
59733219|NCT01138826|75851635|FG002|NOT COMPLETED|Third Intervention Period||0||
59733220|NCT01138826|75851636|FG003|NOT COMPLETED|Third Intervention Period||0||
59733221|NCT01138826|75851637|FG004|NOT COMPLETED|Third Intervention Period||0||
59733222|NCT01138826|75851638|FG005|NOT COMPLETED|Third Intervention Period||0||
59733223|NCT00906087|75851646|FG000|STARTED|Initial Washout||14||
59733224|NCT00906087|75851646|FG000|Completed Screening|Initial Washout||14||
59733225|NCT00906087|75851646|FG000|Begin Washout|Initial Washout||13||
59733226|NCT00906087|75851646|FG000|Completed Washout and Continue Protocol|Initial Washout||12||
59733227|NCT00906087|75851646|FG000|COMPLETED|Initial Washout||12||
59733228|NCT00906087|75851646|FG000|NOT COMPLETED|Initial Washout||2||
59733229|NCT00906087|75851646|FG000|STARTED|Cosopt Treatment 6 Weeks||12||
59733230|NCT00906087|75851646|FG000|COMPLETED|Cosopt Treatment 6 Weeks||12||
59733231|NCT00906087|75851646|FG000|NOT COMPLETED|Cosopt Treatment 6 Weeks||0||
59733232|NCT00906087|75851646|FG000|STARTED|Final Washout Period 4 Weeks||12||
59733233|NCT00906087|75851646|FG000|COMPLETED|Final Washout Period 4 Weeks||12||
59733234|NCT00906087|75851646|FG000|NOT COMPLETED|Final Washout Period 4 Weeks||0||
59733235|NCT00907257|75851655|FG000|STARTED|Overall Study||123||
59733236|NCT00907257|75851656|FG001|STARTED|Overall Study||124||
59733237|NCT00907257|75851655|FG000|COMPLETED|Overall Study||110||
59733238|NCT00907257|75851656|FG001|COMPLETED|Overall Study||112||
59733239|NCT00907257|75851655|FG000|NOT COMPLETED|Overall Study||13||
59733240|NCT00907257|75851656|FG001|NOT COMPLETED|Overall Study||12||
59733241|NCT01138046|75851662|FG000|STARTED|Overall Study||12||
59733242|NCT01138046|75851662|FG000|COMPLETED|Overall Study||6||
59733243|NCT01138046|75851662|FG000|NOT COMPLETED|Overall Study||6||
59733244|NCT00876460|75851674|FG000|STARTED|Combination Therapy Phase||3||
59733245|NCT00876460|75851675|FG001|STARTED|Combination Therapy Phase||7||
59733246|NCT00876460|75851676|FG002|STARTED|Combination Therapy Phase||3||
59733247|NCT00876460|75851677|FG003|STARTED|Combination Therapy Phase||6||
59733248|NCT00876460|75851678|FG004|STARTED|Combination Therapy Phase||7||
59733249|NCT00876460|75851679|FG005|STARTED|Combination Therapy Phase||3||
59733250|NCT00876460|75851680|FG006|STARTED|Combination Therapy Phase||8||
59733251|NCT00876460|75851681|FG007|STARTED|Combination Therapy Phase||6||
59733252|NCT00876460|75851674|FG000|COMPLETED|Combination Therapy Phase||0||
59733253|NCT00876460|75851675|FG001|COMPLETED|Combination Therapy Phase||0||
59733254|NCT00876460|75851676|FG002|COMPLETED|Combination Therapy Phase||0||
59733255|NCT00876460|75851677|FG003|COMPLETED|Combination Therapy Phase||0||
59733256|NCT00876460|75851678|FG004|COMPLETED|Combination Therapy Phase||0||
59733257|NCT00876460|75851679|FG005|COMPLETED|Combination Therapy Phase||0||
59733258|NCT00876460|75851680|FG006|COMPLETED|Combination Therapy Phase||0||
59733259|NCT00876460|75851681|FG007|COMPLETED|Combination Therapy Phase||0||
59733260|NCT00876460|75851674|FG000|NOT COMPLETED|Combination Therapy Phase||3||
59733261|NCT00876460|75851675|FG001|NOT COMPLETED|Combination Therapy Phase||7||
59733262|NCT00876460|75851676|FG002|NOT COMPLETED|Combination Therapy Phase||3||
59733263|NCT00876460|75851677|FG003|NOT COMPLETED|Combination Therapy Phase||6||
59733264|NCT00876460|75851678|FG004|NOT COMPLETED|Combination Therapy Phase||7||
59733265|NCT00876460|75851679|FG005|NOT COMPLETED|Combination Therapy Phase||3||
59733266|NCT00876460|75851680|FG006|NOT COMPLETED|Combination Therapy Phase||8||
59733267|NCT00876460|75851681|FG007|NOT COMPLETED|Combination Therapy Phase||6||
59733268|NCT00876460|75851674|FG000|STARTED|Mono Therapy Phase||0||
59733269|NCT00876460|75851675|FG001|STARTED|Mono Therapy Phase|One patient started mono therapy phase after discontinued from combination therapy phase.|1||
59733270|NCT00876460|75851676|FG002|STARTED|Mono Therapy Phase||0||
59733271|NCT00876460|75851677|FG003|STARTED|Mono Therapy Phase|One patient started mono therapy phase after discontinued from combination therapy phase.|1||
59733272|NCT00876460|75851678|FG004|STARTED|Mono Therapy Phase|Two patients started mono therapy phase after discontinued from combination therapy phase.|2||
59733273|NCT00876460|75851679|FG005|STARTED|Mono Therapy Phase||0||
59733274|NCT00876460|75851680|FG006|STARTED|Mono Therapy Phase|One patient started mono therapy phase after discontinued from combination therapy phase.|1||
59999793|NCT01782131|76115510|FG000|COMPLETED|Overall Study||184||
59733275|NCT00876460|75851681|FG007|STARTED|Mono Therapy Phase|Three patients started mono therapy phase after discontinued from combination therapy phase.|3||
59733276|NCT00876460|75851674|FG000|COMPLETED|Mono Therapy Phase||0||
59733277|NCT00876460|75851675|FG001|COMPLETED|Mono Therapy Phase||0||
59733278|NCT00876460|75851676|FG002|COMPLETED|Mono Therapy Phase||0||
59733279|NCT00876460|75851677|FG003|COMPLETED|Mono Therapy Phase||0||
59733280|NCT00876460|75851678|FG004|COMPLETED|Mono Therapy Phase||0||
59733281|NCT00876460|75851679|FG005|COMPLETED|Mono Therapy Phase||0||
59733282|NCT00876460|75851680|FG006|COMPLETED|Mono Therapy Phase||0||
59733283|NCT00876460|75851681|FG007|COMPLETED|Mono Therapy Phase||0||
59733284|NCT00876460|75851674|FG000|NOT COMPLETED|Mono Therapy Phase||0||
59733285|NCT00876460|75851675|FG001|NOT COMPLETED|Mono Therapy Phase||1||
59733286|NCT00876460|75851676|FG002|NOT COMPLETED|Mono Therapy Phase||0||
59733287|NCT00876460|75851677|FG003|NOT COMPLETED|Mono Therapy Phase||1||
59733288|NCT00876460|75851678|FG004|NOT COMPLETED|Mono Therapy Phase||2||
59733289|NCT00876460|75851679|FG005|NOT COMPLETED|Mono Therapy Phase||0||
59733290|NCT00876460|75851680|FG006|NOT COMPLETED|Mono Therapy Phase||1||
59733291|NCT00876460|75851681|FG007|NOT COMPLETED|Mono Therapy Phase||3||
59733292|NCT00908115|75851711|FG000|STARTED|Overall Study||1258||
59733293|NCT00908115|75851711|FG000|COMPLETED|Overall Study||1244||
59733294|NCT00908115|75851711|FG000|NOT COMPLETED|Overall Study||14||
59733295|NCT01137812|75851717|FG000|STARTED|Overall Study||377||
59733296|NCT01137812|75851718|FG001|STARTED|Overall Study||378||
59733297|NCT01137812|75851717|FG000|COMPLETED|Overall Study||254||
59733298|NCT01137812|75851718|FG001|COMPLETED|Overall Study||210||
59733299|NCT01137812|75851717|FG000|NOT COMPLETED|Overall Study||123||
59733300|NCT01137812|75851718|FG001|NOT COMPLETED|Overall Study||168||
59733301|NCT01137578|75851724|FG000|STARTED|Overall Study||77||
59733302|NCT01137578|75851725|FG001|STARTED|Overall Study||14||
59733303|NCT01137578|75851726|FG002|STARTED|Overall Study||43||
59733304|NCT01137578|75851724|FG000|COMPLETED|Overall Study|Completed defined as having completed all 3 study-related imaging procedures.|61||
59733305|NCT01137578|75851725|FG001|COMPLETED|Overall Study|Completed defined as having completed all 3 study-related imaging procedures.|12||
59733306|NCT01137578|75851726|FG002|COMPLETED|Overall Study|Completed defined as having completed all 3 study-related imaging procedures.|37||
59733307|NCT01137578|75851724|FG000|NOT COMPLETED|Overall Study||16||
59733308|NCT01137578|75851725|FG001|NOT COMPLETED|Overall Study||2||
59733309|NCT01137578|75851726|FG002|NOT COMPLETED|Overall Study||6||
59733310|NCT00946920|75851756|FG000|STARTED|Overall Study|Received at least one dose of degarelix.|565||
59733311|NCT00946920|75851757|FG001|STARTED|Overall Study|Received at least one dose of goserelin acetate.|283||
59733312|NCT00946920|75851756|FG000|Full Analysis Set (FAS)|Overall Study|Received at least one dose of degarelix and had at least one post-dosing efficacy assessment.|565||
59733313|NCT00946920|75851757|FG001|Full Analysis Set (FAS)|Overall Study|Received at least one dose of goserelin and had at least one post-dosing efficacy assessment.|282||
59733314|NCT00946920|75851756|FG000|COMPLETED|Overall Study||455||
59733315|NCT00946920|75851757|FG001|COMPLETED|Overall Study||239||
59733316|NCT00946920|75851756|FG000|NOT COMPLETED|Overall Study||110||
59733317|NCT00946920|75851757|FG001|NOT COMPLETED|Overall Study||44||
59733318|NCT00946530|75851767|FG000|STARTED|Overall Study|32 dyads consisting of 1 AD patient and 1 caregiver were assigned the Bright Light Arm|32||
59733319|NCT00946530|75851768|FG001|STARTED|Overall Study|27 dyads consisting of 1 AD patient and 1 caregiver were assigned to the Dim Light (Control) arm|27||
59733320|NCT00946530|75851769|FG002|STARTED|Overall Study|32 dyads consisting of 1 AD patient and 1 caregiver were assigned the Bright Light Arm|32||
59733321|NCT00946530|75851770|FG003|STARTED|Overall Study|27 dyads consisting of 1 AD patient and 1 caregiver were assigned to the Dim Light (Control) arm|27||
59733322|NCT00946530|75851767|FG000|COMPLETED|Overall Study|31 dyads consisting of 1 AD patient and 1 caregiver completed the Bright Light Arm|31||
59733323|NCT00946530|75851768|FG001|COMPLETED|Overall Study|23 dyads consisting of 1 AD patient and 1 caregiver completed to the Dim Light (Control) arm|23||
59733324|NCT00946530|75851769|FG002|COMPLETED|Overall Study|31 dyads consisting of 1 AD patient and 1 caregiver completed the Bright Light Arm|31||
59733325|NCT00946530|75851770|FG003|COMPLETED|Overall Study|23 dyads consisting of 1 AD patient and 1 caregiver were assigned to the Dim Light (Control) arm|23||
59733326|NCT00946530|75851767|FG000|NOT COMPLETED|Overall Study||1||
59733327|NCT00946530|75851768|FG001|NOT COMPLETED|Overall Study||4||
59733328|NCT00946530|75851769|FG002|NOT COMPLETED|Overall Study||1||
59733329|NCT00946530|75851770|FG003|NOT COMPLETED|Overall Study||4||
59733330|NCT00946296|75851786|FG000|STARTED|Overall Study||21||
59733331|NCT00946296|75851787|FG001|STARTED|Overall Study||15||
59733332|NCT00946296|75851786|FG000|COMPLETED|Overall Study||18||
59733333|NCT00946296|75851787|FG001|COMPLETED|Overall Study||15||
59733334|NCT00946296|75851786|FG000|NOT COMPLETED|Overall Study||3||
59733335|NCT00946296|75851787|FG001|NOT COMPLETED|Overall Study||0||
59733336|NCT00945906|75851793|FG000|STARTED|Overall Study||61||
59733337|NCT00945906|75851793|FG000|COMPLETED|Overall Study||54||
59733338|NCT00945906|75851793|FG000|NOT COMPLETED|Overall Study||7||
59733339|NCT00594646|75851797|FG000|STARTED|Overall Study||100||
59733340|NCT00594646|75851797|FG000|COMPLETED|Overall Study||84||
59733341|NCT00594646|75851797|FG000|NOT COMPLETED|Overall Study||16||
59733342|NCT01111604|75851805|FG000|STARTED|Overall Study||54||
59733343|NCT01111604|75851806|FG001|STARTED|Overall Study||52||
59733344|NCT01111604|75851807|FG002|STARTED|Overall Study||52||
59733345|NCT01111604|75851805|FG000|Received at Least One Dose of Study Drug|Overall Study||49||
59733346|NCT01111604|75851806|FG001|Received at Least One Dose of Study Drug|Overall Study||52||
59733347|NCT01111604|75851807|FG002|Received at Least One Dose of Study Drug|Overall Study||52||
59733348|NCT01111604|75851805|FG000|COMPLETED|Overall Study||46||
59733349|NCT01111604|75851806|FG001|COMPLETED|Overall Study||52||
59733350|NCT01111604|75851807|FG002|COMPLETED|Overall Study||49||
59733351|NCT01111604|75851805|FG000|NOT COMPLETED|Overall Study||8||
59733352|NCT01111604|75851806|FG001|NOT COMPLETED|Overall Study||0||
59733353|NCT01111604|75851807|FG002|NOT COMPLETED|Overall Study||3||
59733354|NCT00950742|75851835|FG000|STARTED|Overall Study|entered and treated|16||
59733355|NCT00950742|75851836|FG001|STARTED|Overall Study|entered and treated|2||
59733356|NCT00950742|75851835|FG000|COMPLETED|Overall Study||0||
59733357|NCT00950742|75851836|FG001|COMPLETED|Overall Study||0||
59733358|NCT00950742|75851835|FG000|NOT COMPLETED|Overall Study||16||
59733359|NCT00950742|75851836|FG001|NOT COMPLETED|Overall Study||2||
59733360|NCT00955110|75851846|FG000|STARTED|Qualification Phase||78||
59733361|NCT00955110|75851846|FG000|COMPLETED|Qualification Phase||54||
59733362|NCT00955110|75851846|FG000|NOT COMPLETED|Qualification Phase||24||
59733363|NCT00955110|75851846|FG000|STARTED|Treatment Phase||41||
59733364|NCT00955110|75851846|FG000|Placebo|Treatment Phase||38||
59733365|NCT00955110|75851846|FG000|Oxymorphone ER 15 mg|Treatment Phase||37||
59733366|NCT00955110|75851846|FG000|Oxymorphone ER 30 mg|Treatment Phase||38||
59733367|NCT00955110|75851846|FG000|Oxycodone CR 30 mg|Treatment Phase||40||
59733368|NCT00955110|75851846|FG000|Oxycodone CR 60 mg|Treatment Phase||40||
59733369|NCT00955110|75851846|FG000|COMPLETED|Treatment Phase||35||
59733370|NCT00955110|75851846|FG000|NOT COMPLETED|Treatment Phase||6||
59733371|NCT00950664|75851860|FG000|STARTED|First Intervention||49||
59733372|NCT00950664|75851861|FG001|STARTED|First Intervention||53||
59733373|NCT00950664|75851860|FG000|COMPLETED|First Intervention||46||
59733374|NCT00950664|75851861|FG001|COMPLETED|First Intervention||48||
59733375|NCT00950664|75851860|FG000|NOT COMPLETED|First Intervention||3||
59733376|NCT00950664|75851861|FG001|NOT COMPLETED|First Intervention||5||
59733377|NCT00950664|75851860|FG000|STARTED|Washout Period of 4 Weeks||46||
59733378|NCT00950664|75851861|FG001|STARTED|Washout Period of 4 Weeks||48||
59733379|NCT00950664|75851860|FG000|COMPLETED|Washout Period of 4 Weeks||46||
59733380|NCT00950664|75851861|FG001|COMPLETED|Washout Period of 4 Weeks||48||
59733381|NCT00950664|75851860|FG000|NOT COMPLETED|Washout Period of 4 Weeks||0||
59733382|NCT00950664|75851861|FG001|NOT COMPLETED|Washout Period of 4 Weeks||0||
59733383|NCT00950664|75851860|FG000|STARTED|Second Intervention||46||
59733384|NCT00950664|75851861|FG001|STARTED|Second Intervention||48||
59733385|NCT00950664|75851860|FG000|COMPLETED|Second Intervention||0||
59733386|NCT00950664|75851861|FG001|COMPLETED|Second Intervention||0||
59733387|NCT00950664|75851860|FG000|NOT COMPLETED|Second Intervention||46||
59733388|NCT00950664|75851861|FG001|NOT COMPLETED|Second Intervention||48||
59733389|NCT01111526|75851867|FG000|STARTED|Overall Study||4||
59733390|NCT01111526|75851868|FG001|STARTED|Overall Study||8||
59733391|NCT01111526|75851869|FG002|STARTED|Overall Study||10||
59733392|NCT01111526|75851867|FG000|COMPLETED|Overall Study||4||
59733393|NCT01111526|75851868|FG001|COMPLETED|Overall Study||7||
59733394|NCT01111526|75851869|FG002|COMPLETED|Overall Study||8||
59733395|NCT01111526|75851867|FG000|NOT COMPLETED|Overall Study||0||
59733396|NCT01111526|75851868|FG001|NOT COMPLETED|Overall Study||1||
59733397|NCT01111526|75851869|FG002|NOT COMPLETED|Overall Study||2||
59733398|NCT01111292|75851875|FG000|STARTED|Randomization||3||
59733399|NCT01111292|75851876|FG001|STARTED|Randomization||2||
59733400|NCT01111292|75851875|FG000|COMPLETED|Randomization||3||
59733401|NCT01111292|75851876|FG001|COMPLETED|Randomization||2||
59733402|NCT01111292|75851875|FG000|NOT COMPLETED|Randomization||0||
59733403|NCT01111292|75851876|FG001|NOT COMPLETED|Randomization||0||
59733404|NCT01111292|75851875|FG000|STARTED|Treatment||3||
59733405|NCT01111292|75851876|FG001|STARTED|Treatment||2||
59733406|NCT01111292|75851875|FG000|COMPLETED|Treatment||2||
59733407|NCT01111292|75851876|FG001|COMPLETED|Treatment||1||
59733408|NCT01111292|75851875|FG000|NOT COMPLETED|Treatment||1||
59733409|NCT01111292|75851876|FG001|NOT COMPLETED|Treatment||1||
59733410|NCT01111292|75851875|FG000|STARTED|Post Treatment Biopsy||2||
59733411|NCT01111292|75851876|FG001|STARTED|Post Treatment Biopsy||1||
59733412|NCT01111292|75851875|FG000|COMPLETED|Post Treatment Biopsy||2||
59733413|NCT01111292|75851876|FG001|COMPLETED|Post Treatment Biopsy||1||
59733414|NCT01111292|75851875|FG000|NOT COMPLETED|Post Treatment Biopsy||0||
59733415|NCT01111292|75851876|FG001|NOT COMPLETED|Post Treatment Biopsy||0||
59733416|NCT01111292|75851875|FG000|STARTED|Follow-Up||2||
59733417|NCT01111292|75851876|FG001|STARTED|Follow-Up||1||
59733418|NCT01111292|75851875|FG000|COMPLETED|Follow-Up||2||
59733419|NCT01111292|75851876|FG001|COMPLETED|Follow-Up||1||
59733420|NCT01111292|75851875|FG000|NOT COMPLETED|Follow-Up||0||
59733421|NCT01111292|75851876|FG001|NOT COMPLETED|Follow-Up||0||
59733422|NCT00944658|75851884|FG000|STARTED|Treatment 12 Weeks||19||
59733423|NCT00944658|75851885|FG001|STARTED|Treatment 12 Weeks||19||
59733424|NCT00944658|75851884|FG000|COMPLETED|Treatment 12 Weeks||19||
59733425|NCT00944658|75851885|FG001|COMPLETED|Treatment 12 Weeks||17||
59733426|NCT00944658|75851884|FG000|NOT COMPLETED|Treatment 12 Weeks||0||
59733427|NCT00944658|75851885|FG001|NOT COMPLETED|Treatment 12 Weeks||2||
59733428|NCT00944658|75851884|FG000|STARTED|Follow up 4 Weeks||19||
59733429|NCT00944658|75851885|FG001|STARTED|Follow up 4 Weeks||17||
59733430|NCT00944658|75851884|FG000|COMPLETED|Follow up 4 Weeks||19||
59733431|NCT00944658|75851885|FG001|COMPLETED|Follow up 4 Weeks||17||
59733432|NCT00944658|75851884|FG000|NOT COMPLETED|Follow up 4 Weeks||0||
59733433|NCT00944658|75851885|FG001|NOT COMPLETED|Follow up 4 Weeks||0||
59733434|NCT01110200|75851893|FG000|STARTED|Overall Study||314||
59733435|NCT01110200|75851894|FG001|STARTED|Overall Study||325||
59733436|NCT01110200|75851893|FG000|COMPLETED|Overall Study||208||
59733437|NCT01110200|75851894|FG001|COMPLETED|Overall Study||204||
59733438|NCT01110200|75851893|FG000|NOT COMPLETED|Overall Study||106||
59733439|NCT01110200|75851894|FG001|NOT COMPLETED|Overall Study||121||
59733440|NCT01108796|75851904|FG000|STARTED|Overall Study||774||
59733441|NCT01108796|75851905|FG001|STARTED|Overall Study||1067||
59733442|NCT01108796|75851904|FG000|COMPLETED|Overall Study||767||
59733443|NCT01108796|75851905|FG001|COMPLETED|Overall Study||1060||
59733444|NCT01108796|75851904|FG000|NOT COMPLETED|Overall Study||7||
59733445|NCT01108796|75851905|FG001|NOT COMPLETED|Overall Study||7||
59733446|NCT01108718|75851915|FG000|STARTED|Received First Intervention (2 Months)||5||
59733447|NCT01108718|75851916|FG001|STARTED|Received First Intervention (2 Months)||7||
59733448|NCT01108718|75851915|FG000|COMPLETED|Received First Intervention (2 Months)||5||
59733449|NCT01108718|75851916|FG001|COMPLETED|Received First Intervention (2 Months)||7||
59733450|NCT01108718|75851915|FG000|NOT COMPLETED|Received First Intervention (2 Months)||0||
59733451|NCT01108718|75851916|FG001|NOT COMPLETED|Received First Intervention (2 Months)||0||
59733452|NCT01108718|75851915|FG000|STARTED|Received Second Intervention (2 Months)|Used control mattress was delivered to participant at crossover causing her to withdraw.|5||
59733453|NCT01108718|75851916|FG001|STARTED|Received Second Intervention (2 Months)||7||
59733454|NCT01108718|75851915|FG000|COMPLETED|Received Second Intervention (2 Months)||4||
59733455|NCT01108718|75851916|FG001|COMPLETED|Received Second Intervention (2 Months)||7||
59733456|NCT01108718|75851915|FG000|NOT COMPLETED|Received Second Intervention (2 Months)||1||
59733457|NCT01108718|75851916|FG001|NOT COMPLETED|Received Second Intervention (2 Months)||0||
59733458|NCT01137110|75851923|FG000|STARTED|Overall Study||35||
59733459|NCT01137110|75851924|FG001|STARTED|Overall Study||49||
59733460|NCT01137110|75851923|FG000|COMPLETED|Overall Study||34||
59733461|NCT01137110|75851924|FG001|COMPLETED|Overall Study||49||
59733462|NCT01137110|75851923|FG000|NOT COMPLETED|Overall Study||1||
59733463|NCT01137110|75851924|FG001|NOT COMPLETED|Overall Study||0||
59733464|NCT01136954|75851932|FG000|STARTED|Overall Study||72||
59733465|NCT01136954|75851933|FG001|STARTED|Overall Study||72||
59733466|NCT01136954|75851932|FG000|COMPLETED|Overall Study||48||
59733467|NCT01136954|75851933|FG001|COMPLETED|Overall Study||51||
59733468|NCT01136954|75851932|FG000|NOT COMPLETED|Overall Study||24||
59733469|NCT01136954|75851933|FG001|NOT COMPLETED|Overall Study||21||
59733470|NCT01136876|75851942|FG000|STARTED|Overall Study||28||
59733471|NCT01136876|75851943|FG001|STARTED|Overall Study||29||
59733472|NCT01136876|75851942|FG000|COMPLETED|Overall Study||23||
59733473|NCT01136876|75851943|FG001|COMPLETED|Overall Study||18||
59733474|NCT01136876|75851942|FG000|NOT COMPLETED|Overall Study||5||
59733475|NCT01136876|75851943|FG001|NOT COMPLETED|Overall Study||11||
59733476|NCT01105130|75851954|FG000|STARTED|Overall Study||48||
59733477|NCT01105130|75851955|FG001|STARTED|Overall Study||45||
59733478|NCT01105130|75851956|FG002|STARTED|Overall Study||47||
59733479|NCT01105130|75851954|FG000|COMPLETED|Overall Study||38||
59733480|NCT01105130|75851955|FG001|COMPLETED|Overall Study||34||
59733481|NCT01105130|75851956|FG002|COMPLETED|Overall Study||37||
59733482|NCT01105130|75851954|FG000|NOT COMPLETED|Overall Study||10||
59733483|NCT01105130|75851955|FG001|NOT COMPLETED|Overall Study||11||
59733484|NCT01105130|75851956|FG002|NOT COMPLETED|Overall Study||10||
59733485|NCT01108094|75851968|FG000|STARTED|Overall Study||12||
59733486|NCT01108094|75851969|FG001|STARTED|Overall Study||3||
59733487|NCT01108094|75851970|FG002|STARTED|Overall Study||4||
59733488|NCT01108094|75851971|FG003|STARTED|Overall Study||10||
59733489|NCT01108094|75851968|FG000|COMPLETED|Overall Study||9||
59733490|NCT01108094|75851969|FG001|COMPLETED|Overall Study||3||
59733491|NCT01108094|75851970|FG002|COMPLETED|Overall Study||4||
59733492|NCT01108094|75851971|FG003|COMPLETED|Overall Study||10||
59733493|NCT01108094|75851968|FG000|NOT COMPLETED|Overall Study||3||
59733494|NCT01108094|75851969|FG001|NOT COMPLETED|Overall Study||0||
59733495|NCT01108094|75851970|FG002|NOT COMPLETED|Overall Study||0||
59733496|NCT01108094|75851971|FG003|NOT COMPLETED|Overall Study||0||
59733497|NCT00954174|75851988|FG000|STARTED|Overall Study||268||
59733498|NCT00954174|75851989|FG001|STARTED|Overall Study||268||
59733499|NCT00954174|75851990|FG002|STARTED|Overall Study||51||
59733500|NCT00954174|75851991|FG003|STARTED|Overall Study||50||
59733501|NCT00954174|75851988|FG000|COMPLETED|Overall Study||142||
59733502|NCT00954174|75851989|FG001|COMPLETED|Overall Study||145||
59733503|NCT00954174|75851990|FG002|COMPLETED|Overall Study||27||
59733504|NCT00954174|75851991|FG003|COMPLETED|Overall Study||25||
59733505|NCT00954174|75851988|FG000|NOT COMPLETED|Overall Study||126||
59733506|NCT00954174|75851989|FG001|NOT COMPLETED|Overall Study||123||
59733507|NCT00954174|75851990|FG002|NOT COMPLETED|Overall Study||24||
59733508|NCT00954174|75851991|FG003|NOT COMPLETED|Overall Study||25||
59733509|NCT01136408|75852007|FG000|STARTED|Overall Study||46||
59733510|NCT01136408|75852008|FG001|STARTED|Overall Study||58||
59733511|NCT01136408|75852009|FG002|STARTED|Overall Study||62||
59733512|NCT01136408|75852007|FG000|COMPLETED|Overall Study||41||
59733513|NCT01136408|75852008|FG001|COMPLETED|Overall Study||49||
59733514|NCT01136408|75852009|FG002|COMPLETED|Overall Study||57||
59733515|NCT01136408|75852007|FG000|NOT COMPLETED|Overall Study||5||
59733516|NCT01136408|75852008|FG001|NOT COMPLETED|Overall Study||9||
59733517|NCT01136408|75852009|FG002|NOT COMPLETED|Overall Study||5||
59733518|NCT01136174|75852025|FG000|STARTED|Overall Study||12||
59733519|NCT01136174|75852026|FG001|STARTED|Overall Study||6||
59733520|NCT01136174|75852027|FG002|STARTED|Overall Study||8||
59733521|NCT01136174|75852028|FG003|STARTED|Overall Study||24||
59733522|NCT01136174|75852025|FG000|COMPLETED|Overall Study||12||
59733523|NCT01136174|75852026|FG001|COMPLETED|Overall Study||6||
59733524|NCT01136174|75852027|FG002|COMPLETED|Overall Study||8||
59733525|NCT01136174|75852028|FG003|COMPLETED|Overall Study||20||
59733526|NCT01136174|75852025|FG000|NOT COMPLETED|Overall Study||0||
59733527|NCT01136174|75852026|FG001|NOT COMPLETED|Overall Study||0||
59733528|NCT01136174|75852027|FG002|NOT COMPLETED|Overall Study||0||
59733529|NCT01136174|75852028|FG003|NOT COMPLETED|Overall Study||4||
59733530|NCT01135394|75852047|FG000|STARTED|Screening||114||
59733531|NCT01135394|75852047|FG000|COMPLETED|Screening||81||
59733532|NCT01135394|75852047|FG000|NOT COMPLETED|Screening||33||
59733533|NCT01135394|75852047|FG000|STARTED|Baseline Assessment||81||
59733534|NCT01135394|75852047|FG000|COMPLETED|Baseline Assessment||66||
59733535|NCT01135394|75852047|FG000|NOT COMPLETED|Baseline Assessment||15||
59733536|NCT01135394|75852047|FG000|STARTED|Study Treatment||66||
59733537|NCT01135394|75852047|FG000|COMPLETED|Study Treatment||62||
59733538|NCT01135394|75852047|FG000|NOT COMPLETED|Study Treatment||4||
59733539|NCT00949884|75852054|FG000|STARTED|Overall Study||420||
59733540|NCT00949884|75852055|FG001|STARTED|Overall Study||52||
59733541|NCT00949884|75852056|FG002|STARTED|Overall Study||469||
59733542|NCT00949884|75852054|FG000|COMPLETED|Overall Study||370||
59733543|NCT00949884|75852055|FG001|COMPLETED|Overall Study||37||
59733544|NCT00949884|75852056|FG002|COMPLETED|Overall Study||411||
59733545|NCT00949884|75852054|FG000|NOT COMPLETED|Overall Study||50||
59733546|NCT00949884|75852055|FG001|NOT COMPLETED|Overall Study||15||
59733547|NCT00949884|75852056|FG002|NOT COMPLETED|Overall Study||58||
59733548|NCT00949650|75852067|FG000|STARTED|Overall Study|Treated patients.|230||
59733549|NCT00949650|75852068|FG001|STARTED|Overall Study|Treated patients.|115||
59733550|NCT00949650|75852067|FG000|COMPLETED|Overall Study|On treatment at the cut-off date 17MAR2017.|0||
59733551|NCT00949650|75852068|FG001|COMPLETED|Overall Study||0||
59733552|NCT00949650|75852067|FG000|NOT COMPLETED|Overall Study||230||
59733553|NCT00949650|75852068|FG001|NOT COMPLETED|Overall Study||115||
59733554|NCT00908037|75852085|FG000|STARTED|Part1 (24 Week Dose-Finding Period)||5||
59733555|NCT00908037|75852086|FG001|STARTED|Part1 (24 Week Dose-Finding Period)||5||
59733556|NCT00908037|75852087|FG002|STARTED|Part1 (24 Week Dose-Finding Period)||5||
59733557|NCT00908037|75852088|FG003|STARTED|Part1 (24 Week Dose-Finding Period)||0||
59733558|NCT00908037|75852089|FG004|STARTED|Part1 (24 Week Dose-Finding Period)||0||
59733559|NCT00908037|75852090|FG005|STARTED|Part1 (24 Week Dose-Finding Period)||0||
59733560|NCT00908037|75852091|FG006|STARTED|Part1 (24 Week Dose-Finding Period)||0||
59733561|NCT00908037|75852092|FG007|STARTED|Part1 (24 Week Dose-Finding Period)||0||
59733562|NCT00908037|75852093|FG008|STARTED|Part1 (24 Week Dose-Finding Period)||0||
59733563|NCT00908037|75852094|FG009|STARTED|Part1 (24 Week Dose-Finding Period)||0||
59733564|NCT00908037|75852095|FG010|STARTED|Part1 (24 Week Dose-Finding Period)||0||
59733565|NCT00908037|75852096|FG011|STARTED|Part1 (24 Week Dose-Finding Period)||0||
59733566|NCT00908037|75852085|FG000|COMPLETED|Part1 (24 Week Dose-Finding Period)|Participants who completed Part 1 did not enroll in Parts 2 or 2/3|5||
59733567|NCT00908037|75852086|FG001|COMPLETED|Part1 (24 Week Dose-Finding Period)|Participants who completed Part 1 did not enroll in Parts 2 or 2/3|5||
59733568|NCT00908037|75852087|FG002|COMPLETED|Part1 (24 Week Dose-Finding Period)|Participants who completed Part 1 did not enroll in Parts 2 or 2/3|5||
59733569|NCT00908037|75852088|FG003|COMPLETED|Part1 (24 Week Dose-Finding Period)||0||
59733570|NCT00908037|75852089|FG004|COMPLETED|Part1 (24 Week Dose-Finding Period)||0||
59733571|NCT00908037|75852090|FG005|COMPLETED|Part1 (24 Week Dose-Finding Period)||0||
59733572|NCT00908037|75852091|FG006|COMPLETED|Part1 (24 Week Dose-Finding Period)||0||
59733573|NCT00908037|75852092|FG007|COMPLETED|Part1 (24 Week Dose-Finding Period)||0||
59733574|NCT00908037|75852093|FG008|COMPLETED|Part1 (24 Week Dose-Finding Period)||0||
59733575|NCT00908037|75852094|FG009|COMPLETED|Part1 (24 Week Dose-Finding Period)||0||
59733576|NCT00908037|75852095|FG010|COMPLETED|Part1 (24 Week Dose-Finding Period)||0||
59733577|NCT00908037|75852096|FG011|COMPLETED|Part1 (24 Week Dose-Finding Period)||0||
59733578|NCT00908037|75852085|FG000|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0||
59733579|NCT00908037|75852086|FG001|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0||
59733580|NCT00908037|75852087|FG002|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0||
59733581|NCT00908037|75852088|FG003|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0||
59733582|NCT00908037|75852089|FG004|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0||
59733583|NCT00908037|75852090|FG005|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0||
59733584|NCT00908037|75852091|FG006|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0||
59733585|NCT00908037|75852092|FG007|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0||
59733586|NCT00908037|75852093|FG008|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0||
59733587|NCT00908037|75852094|FG009|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0||
59733588|NCT00908037|75852095|FG010|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0||
59733589|NCT00908037|75852096|FG011|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0||
59733590|NCT00908037|75852085|FG000|STARTED|Part 2 (7 Week Randomized Period)||0||
59733591|NCT00908037|75852086|FG001|STARTED|Part 2 (7 Week Randomized Period)||0||
59733592|NCT00908037|75852087|FG002|STARTED|Part 2 (7 Week Randomized Period)||0||
59733593|NCT00908037|75852088|FG003|STARTED|Part 2 (7 Week Randomized Period)||8||
59733594|NCT00908037|75852089|FG004|STARTED|Part 2 (7 Week Randomized Period)||16||
59733595|NCT00908037|75852090|FG005|STARTED|Part 2 (7 Week Randomized Period)||9||
59733596|NCT00908037|75852091|FG006|STARTED|Part 2 (7 Week Randomized Period)||19||
59733597|NCT00908037|75852092|FG007|STARTED|Part 2 (7 Week Randomized Period)||5||
59733598|NCT00908037|75852093|FG008|STARTED|Part 2 (7 Week Randomized Period)||10||
59733599|NCT00908037|75852094|FG009|STARTED|Part 2 (7 Week Randomized Period)||0||
59733600|NCT00908037|75852095|FG010|STARTED|Part 2 (7 Week Randomized Period)||0||
59733601|NCT00908037|75852096|FG011|STARTED|Part 2 (7 Week Randomized Period)||0||
59733602|NCT00908037|75852085|FG000|COMPLETED|Part 2 (7 Week Randomized Period)||0||
59733603|NCT00908037|75852086|FG001|COMPLETED|Part 2 (7 Week Randomized Period)||0||
59733604|NCT00908037|75852087|FG002|COMPLETED|Part 2 (7 Week Randomized Period)||0||
59733605|NCT00908037|75852088|FG003|COMPLETED|Part 2 (7 Week Randomized Period)||7||
59733606|NCT00908037|75852089|FG004|COMPLETED|Part 2 (7 Week Randomized Period)||13||
59733607|NCT00908037|75852090|FG005|COMPLETED|Part 2 (7 Week Randomized Period)||9||
59733608|NCT00908037|75852091|FG006|COMPLETED|Part 2 (7 Week Randomized Period)||15||
59733609|NCT00908037|75852092|FG007|COMPLETED|Part 2 (7 Week Randomized Period)||5||
59733610|NCT00908037|75852093|FG008|COMPLETED|Part 2 (7 Week Randomized Period)||5||
59733611|NCT00908037|75852094|FG009|COMPLETED|Part 2 (7 Week Randomized Period)||0||
59733612|NCT00908037|75852095|FG010|COMPLETED|Part 2 (7 Week Randomized Period)||0||
59733613|NCT00908037|75852096|FG011|COMPLETED|Part 2 (7 Week Randomized Period)||0||
59733614|NCT00908037|75852085|FG000|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0||
59733615|NCT00908037|75852086|FG001|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0||
59733616|NCT00908037|75852087|FG002|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0||
59733617|NCT00908037|75852088|FG003|NOT COMPLETED|Part 2 (7 Week Randomized Period)||1||
59733618|NCT00908037|75852089|FG004|NOT COMPLETED|Part 2 (7 Week Randomized Period)||3||
59733619|NCT00908037|75852090|FG005|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0||
59733620|NCT00908037|75852091|FG006|NOT COMPLETED|Part 2 (7 Week Randomized Period)||4||
59733621|NCT00908037|75852092|FG007|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0||
59733622|NCT00908037|75852093|FG008|NOT COMPLETED|Part 2 (7 Week Randomized Period)||5||
59733623|NCT00908037|75852094|FG009|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0||
59733624|NCT00908037|75852095|FG010|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0||
59733625|NCT00908037|75852096|FG011|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0||
59733626|NCT00908037|75852085|FG000|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0||
59733627|NCT00908037|75852086|FG001|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0||
59733628|NCT00908037|75852087|FG002|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0||
59733629|NCT00908037|75852088|FG003|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0||
59733630|NCT00908037|75852089|FG004|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0||
59733631|NCT00908037|75852090|FG005|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0||
59733632|NCT00908037|75852091|FG006|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0||
59733633|NCT00908037|75852092|FG007|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0||
59733634|NCT00908037|75852093|FG008|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0||
59733635|NCT00908037|75852094|FG009|STARTED|Part 2/3(Eltrombopag Open-Label Period)||24||
59733636|NCT00908037|75852095|FG010|STARTED|Part 2/3(Eltrombopag Open-Label Period)|Two participants were randomized but did not receive treatment.|28||
59733637|NCT00908037|75852096|FG011|STARTED|Part 2/3(Eltrombopag Open-Label Period)||15||
59733638|NCT00908037|75852085|FG000|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0||
59733639|NCT00908037|75852086|FG001|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0||
59733640|NCT00908037|75852087|FG002|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0||
59733641|NCT00908037|75852088|FG003|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0||
59733642|NCT00908037|75852089|FG004|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0||
59733643|NCT00908037|75852090|FG005|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0||
59733644|NCT00908037|75852091|FG006|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0||
59733645|NCT00908037|75852092|FG007|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0||
59733646|NCT00908037|75852093|FG008|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0||
59733647|NCT00908037|75852094|FG009|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||21||
59733648|NCT00908037|75852095|FG010|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)|Two participants were randomized but did not receive treatment.|24||
59733649|NCT00908037|75852096|FG011|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||12||
59733650|NCT00908037|75852085|FG000|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0||
59733651|NCT00908037|75852086|FG001|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0||
59733652|NCT00908037|75852087|FG002|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0||
59733653|NCT00908037|75852088|FG003|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0||
59733654|NCT00908037|75852089|FG004|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0||
59733655|NCT00908037|75852090|FG005|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0||
59733656|NCT00908037|75852091|FG006|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0||
59733657|NCT00908037|75852092|FG007|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0||
59733658|NCT00908037|75852093|FG008|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0||
59733659|NCT00908037|75852094|FG009|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||3||
59733660|NCT00908037|75852095|FG010|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||4||
59733661|NCT00908037|75852096|FG011|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||3||
59733662|NCT00904215|75852148|FG000|STARTED|Overall Study||1095||
59733663|NCT00904215|75852148|FG000|COMPLETED|Overall Study||960||
59733664|NCT00904215|75852148|FG000|NOT COMPLETED|Overall Study||135||
59733665|NCT00905307|75852158|FG000|STARTED|Overall Study||42||
59733666|NCT00905307|75852159|FG001|STARTED|Overall Study||89||
59733667|NCT00905307|75852160|FG002|STARTED|Overall Study||90||
59733668|NCT00905307|75852161|FG003|STARTED|Overall Study||93||
59733669|NCT00905307|75852162|FG004|STARTED|Overall Study||50||
59733670|NCT00905307|75852163|FG005|STARTED|Overall Study||95||
59733671|NCT00905307|75852158|FG000|COMPLETED|Overall Study||20||
59733672|NCT00905307|75852159|FG001|COMPLETED|Overall Study||52||
59733673|NCT00905307|75852160|FG002|COMPLETED|Overall Study||53||
59733674|NCT00905307|75852161|FG003|COMPLETED|Overall Study||56||
59733675|NCT00905307|75852162|FG004|COMPLETED|Overall Study||34||
59733676|NCT00905307|75852163|FG005|COMPLETED|Overall Study||53||
59733677|NCT00905307|75852158|FG000|NOT COMPLETED|Overall Study||22||
59733678|NCT00905307|75852159|FG001|NOT COMPLETED|Overall Study||37||
59733679|NCT00905307|75852160|FG002|NOT COMPLETED|Overall Study||37||
59733680|NCT00905307|75852161|FG003|NOT COMPLETED|Overall Study||37||
59733681|NCT00905307|75852162|FG004|NOT COMPLETED|Overall Study||16||
59733682|NCT00905307|75852163|FG005|NOT COMPLETED|Overall Study||42||
59733683|NCT00907881|75852190|FG000|STARTED|Overall Study||1069||
59733684|NCT00907881|75852190|FG000|COMPLETED|Overall Study||984||
59733685|NCT00907881|75852190|FG000|NOT COMPLETED|Overall Study||85||
59733686|NCT00904917|75852198|FG000|STARTED|Overall Study||7||
59733687|NCT00904917|75852199|FG001|STARTED|Overall Study||11||
59733688|NCT00904917|75852200|FG002|STARTED|Overall Study||8||
59733689|NCT00904917|75852201|FG003|STARTED|Overall Study||8||
59733690|NCT00904917|75852198|FG000|COMPLETED|Overall Study||5||
59733691|NCT00904917|75852199|FG001|COMPLETED|Overall Study||9||
59733692|NCT00904917|75852200|FG002|COMPLETED|Overall Study||6||
59733693|NCT00904917|75852201|FG003|COMPLETED|Overall Study||6||
59733694|NCT00904917|75852198|FG000|NOT COMPLETED|Overall Study||2||
59733695|NCT00904917|75852199|FG001|NOT COMPLETED|Overall Study||2||
59733696|NCT00904917|75852200|FG002|NOT COMPLETED|Overall Study||2||
59733697|NCT00904917|75852201|FG003|NOT COMPLETED|Overall Study||2||
59733698|NCT00904839|75852216|FG000|STARTED|Overall Study|All 4 patients were randomised to Maximum Tolerable Dose analysis set.|4||
59733699|NCT00904839|75852217|FG001|STARTED|Overall Study|11 patients were randomised to Maximum Tolerable Dose analysis set.|82||
59733700|NCT00904839|75852218|FG002|STARTED|Overall Study|Randomised|42||
59733701|NCT00904839|75852216|FG000|COMPLETED|Overall Study||3||
59733702|NCT00904839|75852217|FG001|COMPLETED|Overall Study||64||
59733703|NCT00904839|75852218|FG002|COMPLETED|Overall Study||27||
59733704|NCT00904839|75852216|FG000|NOT COMPLETED|Overall Study||1||
59733705|NCT00904839|75852217|FG001|NOT COMPLETED|Overall Study||18||
59733706|NCT00904839|75852218|FG002|NOT COMPLETED|Overall Study||15||
59733707|NCT00903357|75852229|FG000|STARTED|First Intervention||27||
59733708|NCT00903357|75852230|FG001|STARTED|First Intervention||27||
59733709|NCT00903357|75852229|FG000|COMPLETED|First Intervention||22||
59733710|NCT00903357|75852230|FG001|COMPLETED|First Intervention||23||
59733711|NCT00903357|75852229|FG000|NOT COMPLETED|First Intervention||5||
59733712|NCT00903357|75852230|FG001|NOT COMPLETED|First Intervention||4||
59733713|NCT00903357|75852229|FG000|STARTED|Wash Out Period of 2 Weeks||22||
59733714|NCT00903357|75852230|FG001|STARTED|Wash Out Period of 2 Weeks||23||
59733715|NCT00903357|75852229|FG000|COMPLETED|Wash Out Period of 2 Weeks||22||
59733716|NCT00903357|75852230|FG001|COMPLETED|Wash Out Period of 2 Weeks||22||
59733717|NCT00903357|75852229|FG000|NOT COMPLETED|Wash Out Period of 2 Weeks||0||
59733718|NCT00903357|75852230|FG001|NOT COMPLETED|Wash Out Period of 2 Weeks||1||
59733719|NCT00903357|75852229|FG000|STARTED|Second Intervention||22||
59733720|NCT00903357|75852230|FG001|STARTED|Second Intervention||22||
59733721|NCT00903357|75852229|FG000|COMPLETED|Second Intervention||21||
59733722|NCT00903357|75852230|FG001|COMPLETED|Second Intervention||22||
59733723|NCT00903357|75852229|FG000|NOT COMPLETED|Second Intervention||1||
59733724|NCT00903357|75852230|FG001|NOT COMPLETED|Second Intervention||0||
59733725|NCT00904371|75852240|FG000|STARTED|Overall Study||211||
59733726|NCT00904371|75852240|FG000|COMPLETED|Overall Study||202||
59733727|NCT00904371|75852240|FG000|NOT COMPLETED|Overall Study||9||
59733728|NCT01104662|75852252|FG000|STARTED|Overall Study||20||
59733729|NCT01104662|75852253|FG001|STARTED|Overall Study||21||
59733730|NCT01104662|75852254|FG002|STARTED|Overall Study||5||
59733731|NCT01104662|75852255|FG003|STARTED|Overall Study||4||
59733732|NCT01104662|75852256|FG004|STARTED|Overall Study||15||
59733733|NCT01104662|75852257|FG005|STARTED|Overall Study||16||
59733734|NCT01104662|75852258|FG006|STARTED|Overall Study||5||
59733735|NCT01104662|75852259|FG007|STARTED|Overall Study||6||
59733736|NCT01104662|75852252|FG000|Received at Least 1 Dose of Study Drug|Overall Study||17||
59733737|NCT01104662|75852253|FG001|Received at Least 1 Dose of Study Drug|Overall Study||17||
59733738|NCT01104662|75852254|FG002|Received at Least 1 Dose of Study Drug|Overall Study||4||
59733739|NCT01104662|75852255|FG003|Received at Least 1 Dose of Study Drug|Overall Study||4||
59733740|NCT01104662|75852256|FG004|Received at Least 1 Dose of Study Drug|Overall Study||15||
59733741|NCT01104662|75852257|FG005|Received at Least 1 Dose of Study Drug|Overall Study||15||
59733742|NCT01104662|75852258|FG006|Received at Least 1 Dose of Study Drug|Overall Study||5||
59733743|NCT01104662|75852259|FG007|Received at Least 1 Dose of Study Drug|Overall Study||6||
59733744|NCT01104662|75852252|FG000|COMPLETED|Overall Study||10||
59733745|NCT01104662|75852253|FG001|COMPLETED|Overall Study||11||
59733746|NCT01104662|75852254|FG002|COMPLETED|Overall Study||4||
59733747|NCT01104662|75852255|FG003|COMPLETED|Overall Study||3||
59733748|NCT01104662|75852256|FG004|COMPLETED|Overall Study||14||
59733749|NCT01104662|75852257|FG005|COMPLETED|Overall Study||12||
59733750|NCT01104662|75852258|FG006|COMPLETED|Overall Study||5||
59733751|NCT01104662|75852259|FG007|COMPLETED|Overall Study||6||
59733752|NCT01104662|75852252|FG000|NOT COMPLETED|Overall Study||10||
59733753|NCT01104662|75852253|FG001|NOT COMPLETED|Overall Study||10||
59733754|NCT01104662|75852254|FG002|NOT COMPLETED|Overall Study||1||
59733755|NCT01104662|75852255|FG003|NOT COMPLETED|Overall Study||1||
59733756|NCT01104662|75852256|FG004|NOT COMPLETED|Overall Study||1||
59733757|NCT01104662|75852257|FG005|NOT COMPLETED|Overall Study||4||
59733758|NCT01104662|75852258|FG006|NOT COMPLETED|Overall Study||0||
59733759|NCT01104662|75852259|FG007|NOT COMPLETED|Overall Study||0||
59733760|NCT01104584|75852278|FG000|STARTED|Overall Study|screened and enrolled|460||
59733761|NCT01104584|75852278|FG000|Received Treatment|Overall Study|treatment started|439||
59733762|NCT01104584|75852278|FG000|Fulfilled Requirements of FAS Population|Overall Study||397||
59733763|NCT01104584|75852278|FG000|COMPLETED|Overall Study|study course completed|437||
59733764|NCT01104584|75852278|FG000|NOT COMPLETED|Overall Study||23||
59733765|NCT01103960|75852302|FG000|STARTED|Overall Study|Randomised and treated.|164||
59733766|NCT01103960|75852303|FG001|STARTED|Overall Study|Randomised and treated.|160||
59733767|NCT01103960|75852302|FG000|COMPLETED|Overall Study|Completed study medication.|159||
59733768|NCT01103960|75852303|FG001|COMPLETED|Overall Study|Completed study medication.|158||
59733769|NCT01103960|75852302|FG000|NOT COMPLETED|Overall Study||5||
59733770|NCT01103960|75852303|FG001|NOT COMPLETED|Overall Study||2||
59733771|NCT01107392|75852311|FG000|STARTED|Overall Study||158||
59733772|NCT01107392|75852312|FG001|STARTED|Overall Study||157||
59733773|NCT01107392|75852311|FG000|COMPLETED|Overall Study||153||
59733774|NCT01107392|75852312|FG001|COMPLETED|Overall Study||154||
59733775|NCT01107392|75852311|FG000|NOT COMPLETED|Overall Study||5||
59733776|NCT01107392|75852312|FG001|NOT COMPLETED|Overall Study||3||
59733777|NCT01106846|75852320|FG000|STARTED|Overall Study||12||
59733778|NCT01106846|75852321|FG001|STARTED|Overall Study||10||
59733779|NCT01106846|75852320|FG000|COMPLETED|Overall Study||12||
59733780|NCT01106846|75852321|FG001|COMPLETED|Overall Study||9||
59733781|NCT01106846|75852320|FG000|NOT COMPLETED|Overall Study||0||
59733782|NCT01106846|75852321|FG001|NOT COMPLETED|Overall Study||1||
59733783|NCT00902577|75852327|FG000|STARTED|Overall Study||50||
59733784|NCT00902577|75852327|FG000|FMISO/PET|Overall Study||38|"3 images lost/Not Acquired~1 Image uninterpretable"|
59733785|NCT00902577|75852327|FG000|DCE MRI|Overall Study||31|2 images lost/Not Acquired 9 Image uninterpretable|
59733786|NCT00902577|75852327|FG000|DSE MRI|Overall Study||37|2 images lost/Not Acquired 3 Image uninterpretable|
59733787|NCT00902577|75852327|FG000|DWI MRI|Overall Study||39|3 images lost/Not Acquired|
59733788|NCT00902577|75852327|FG000|COMPLETED|Overall Study||42||
59733789|NCT00902577|75852327|FG000|NOT COMPLETED|Overall Study||8||
59733790|NCT00119847|75852352|FG000|STARTED|Overall Study||149||
59733791|NCT00119847|75852353|FG001|STARTED|Overall Study||151||
59733792|NCT00119847|75852352|FG000|COMPLETED|Overall Study||118||
59733793|NCT00119847|75852353|FG001|COMPLETED|Overall Study||119||
59733794|NCT00119847|75852352|FG000|NOT COMPLETED|Overall Study||31||
59733795|NCT00119847|75852353|FG001|NOT COMPLETED|Overall Study||32||
59733796|NCT01106690|75852362|FG000|STARTED|Core Period: Baseline to Week 26||115||
59733797|NCT01106690|75852363|FG001|STARTED|Core Period: Baseline to Week 26||113||
59733798|NCT01106690|75852364|FG002|STARTED|Core Period: Baseline to Week 26||114||
59733799|NCT01106690|75852362|FG000|COMPLETED|Core Period: Baseline to Week 26||91||
59733800|NCT01106690|75852363|FG001|COMPLETED|Core Period: Baseline to Week 26||104||
59733801|NCT01106690|75852364|FG002|COMPLETED|Core Period: Baseline to Week 26||101||
59733802|NCT01106690|75852362|FG000|NOT COMPLETED|Core Period: Baseline to Week 26||24||
59733803|NCT01106690|75852363|FG001|NOT COMPLETED|Core Period: Baseline to Week 26||9||
59733804|NCT01106690|75852364|FG002|NOT COMPLETED|Core Period: Baseline to Week 26||13||
59733805|NCT01106690|75852362|FG000|STARTED|Extension Period: Week 26 to Week 52|1 pt completed core but did not enter ext: physician decision(1).|90||
59733806|NCT01106690|75852363|FG001|STARTED|Extension Period: Week 26 to Week 52|1 pt completed core but did not enter ext: physician decision(1).|103||
59733807|NCT01106690|75852364|FG002|STARTED|Extension Period: Week 26 to Week 52|5 pts completed core but did not exter ext: lost to f/u(1), not spec(2), AE(1), eGFR criteria(1).|96||
59733808|NCT01106690|75852362|FG000|COMPLETED|Extension Period: Week 26 to Week 52||78||
59733809|NCT01106690|75852363|FG001|COMPLETED|Extension Period: Week 26 to Week 52||96||
59733810|NCT01106690|75852364|FG002|COMPLETED|Extension Period: Week 26 to Week 52||89||
59733811|NCT01106690|75852362|FG000|NOT COMPLETED|Extension Period: Week 26 to Week 52||12||
59733812|NCT01106690|75852363|FG001|NOT COMPLETED|Extension Period: Week 26 to Week 52||7||
59733813|NCT01106690|75852364|FG002|NOT COMPLETED|Extension Period: Week 26 to Week 52||7||
59733814|NCT04286529|75852379|FG000|STARTED|Overall Study||4||
59733815|NCT04286529|75852380|FG001|STARTED|Overall Study||4||
59733816|NCT04286529|75852381|FG002|STARTED|Overall Study||5||
59733817|NCT04286529|75852382|FG003|STARTED|Overall Study||4||
59733818|NCT04286529|75852379|FG000|COMPLETED|Overall Study||3||
59733819|NCT04286529|75852380|FG001|COMPLETED|Overall Study||1||
59733820|NCT04286529|75852381|FG002|COMPLETED|Overall Study||3||
59733821|NCT04286529|75852382|FG003|COMPLETED|Overall Study||1||
59733822|NCT04286529|75852379|FG000|NOT COMPLETED|Overall Study||1||
59733823|NCT04286529|75852380|FG001|NOT COMPLETED|Overall Study||3||
59733824|NCT04286529|75852381|FG002|NOT COMPLETED|Overall Study||2||
59733825|NCT04286529|75852382|FG003|NOT COMPLETED|Overall Study||3||
59733826|NCT01103180|75852394|FG000|STARTED|Overall Study||35||
59733827|NCT01103180|75852395|FG001|STARTED|Overall Study||35||
59733828|NCT01103180|75852394|FG000|COMPLETED|Overall Study||13||
59733829|NCT01103180|75852395|FG001|COMPLETED|Overall Study||14||
59733830|NCT01103180|75852394|FG000|NOT COMPLETED|Overall Study||22||
59733831|NCT01103180|75852395|FG001|NOT COMPLETED|Overall Study||21||
59733832|NCT00944034|75852413|FG000|STARTED|Overall Study||188||
59733833|NCT00944034|75852414|FG001|STARTED|Overall Study||157||
59733834|NCT00944034|75852415|FG002|STARTED|Overall Study||152||
59733835|NCT00944034|75852416|FG003|STARTED|Overall Study||174||
59733836|NCT00944034|75852417|FG004|STARTED|Overall Study||164||
59733837|NCT00944034|75852418|FG005|STARTED|Overall Study||143||
59733838|NCT00944034|75852419|FG006|STARTED|Overall Study||106||
59733839|NCT00944034|75852420|FG007|STARTED|Overall Study||78||
59733840|NCT00944034|75852421|FG008|STARTED|Overall Study||73||
59733841|NCT00944034|75852422|FG009|STARTED|Overall Study||246||
59733842|NCT00944034|75852423|FG010|STARTED|Overall Study||51||
59733843|NCT00944034|75852424|FG011|STARTED|Overall Study||56||
59733844|NCT00944034|75852413|FG000|COMPLETED|Overall Study||183||
59733845|NCT00944034|75852414|FG001|COMPLETED|Overall Study||150||
59733846|NCT00944034|75852415|FG002|COMPLETED|Overall Study||143||
59733847|NCT00944034|75852416|FG003|COMPLETED|Overall Study||170||
59733848|NCT00944034|75852417|FG004|COMPLETED|Overall Study||150||
59733849|NCT00944034|75852418|FG005|COMPLETED|Overall Study||123||
59733850|NCT00944034|75852419|FG006|COMPLETED|Overall Study||102||
59733851|NCT00944034|75852420|FG007|COMPLETED|Overall Study||73||
59733852|NCT00944034|75852421|FG008|COMPLETED|Overall Study||63||
59733853|NCT00944034|75852422|FG009|COMPLETED|Overall Study||236||
59733854|NCT00944034|75852423|FG010|COMPLETED|Overall Study||50||
59733855|NCT00944034|75852424|FG011|COMPLETED|Overall Study||52||
59733856|NCT00944034|75852413|FG000|NOT COMPLETED|Overall Study||5||
59733857|NCT00944034|75852414|FG001|NOT COMPLETED|Overall Study||7||
59733858|NCT00944034|75852415|FG002|NOT COMPLETED|Overall Study||9||
59733859|NCT00944034|75852416|FG003|NOT COMPLETED|Overall Study||4||
59733860|NCT00944034|75852417|FG004|NOT COMPLETED|Overall Study||14||
59733861|NCT00944034|75852418|FG005|NOT COMPLETED|Overall Study||20||
59733862|NCT00944034|75852419|FG006|NOT COMPLETED|Overall Study||4||
59733863|NCT00944034|75852420|FG007|NOT COMPLETED|Overall Study||5||
59733864|NCT00944034|75852421|FG008|NOT COMPLETED|Overall Study||10||
59733865|NCT00944034|75852422|FG009|NOT COMPLETED|Overall Study||10||
59733866|NCT00944034|75852423|FG010|NOT COMPLETED|Overall Study||1||
59733867|NCT00944034|75852424|FG011|NOT COMPLETED|Overall Study||4||
59733868|NCT00941304|75852472|FG000|STARTED|Overall Study||31||
59733869|NCT00941304|75852473|FG001|STARTED|Overall Study||30||
59733870|NCT00941304|75852474|FG002|STARTED|Overall Study||31||
59733871|NCT00941304|75852475|FG003|STARTED|Overall Study||30||
59733872|NCT00941304|75852476|FG004|STARTED|Overall Study||31||
59733873|NCT00941304|75852472|FG000|COMPLETED|Overall Study||30||
59733874|NCT00941304|75852473|FG001|COMPLETED|Overall Study||30||
59733875|NCT00941304|75852474|FG002|COMPLETED|Overall Study||31||
59733876|NCT00941304|75852475|FG003|COMPLETED|Overall Study||30||
59733877|NCT00941304|75852476|FG004|COMPLETED|Overall Study||31||
59733878|NCT00941304|75852472|FG000|NOT COMPLETED|Overall Study||1||
59733879|NCT00941304|75852473|FG001|NOT COMPLETED|Overall Study||0||
59733880|NCT00941304|75852474|FG002|NOT COMPLETED|Overall Study||0||
59733881|NCT00941304|75852475|FG003|NOT COMPLETED|Overall Study||0||
59733882|NCT00941304|75852476|FG004|NOT COMPLETED|Overall Study||0||
59733883|NCT00941070|75852488|FG000|STARTED|Overall Study||26||
59733884|NCT00941070|75852488|FG000|COMPLETED|Overall Study||25||
59733885|NCT00941070|75852488|FG000|NOT COMPLETED|Overall Study||1||
59733886|NCT01098812|75852497|FG000|STARTED|Overall Study||95||
59733887|NCT01098812|75852498|FG001|STARTED|Overall Study||102||
59733888|NCT01098812|75852499|FG002|STARTED|Overall Study||72||
59733889|NCT01098812|75852497|FG000|COMPLETED|Overall Study||93||
59733890|NCT01098812|75852498|FG001|COMPLETED|Overall Study||101||
59733891|NCT01098812|75852499|FG002|COMPLETED|Overall Study||71||
59733892|NCT01098812|75852497|FG000|NOT COMPLETED|Overall Study||2||
59733893|NCT01098812|75852498|FG001|NOT COMPLETED|Overall Study||1||
59733894|NCT01098812|75852499|FG002|NOT COMPLETED|Overall Study||1||
59733895|NCT00903201|75852509|FG000|STARTED|Overall Study||61||
59733896|NCT00903201|75852510|FG001|STARTED|Overall Study||44||
59733897|NCT00903201|75852511|FG002|STARTED|Overall Study||41||
59733898|NCT00903201|75852509|FG000|COMPLETED|Overall Study||56||
59733899|NCT00903201|75852510|FG001|COMPLETED|Overall Study||38||
59733900|NCT00903201|75852511|FG002|COMPLETED|Overall Study||39||
59733901|NCT00903201|75852509|FG000|NOT COMPLETED|Overall Study||5||
59733902|NCT00903201|75852510|FG001|NOT COMPLETED|Overall Study||6||
59733903|NCT00903201|75852511|FG002|NOT COMPLETED|Overall Study||2||
59733904|NCT00902265|75852521|FG000|STARTED|Overall Study||138||
59733905|NCT00902265|75852521|FG000|Participants Who Received Treatment|Overall Study||137||
59733906|NCT00902265|75852521|FG000|COMPLETED|Overall Study||132||
59733907|NCT00902265|75852521|FG000|NOT COMPLETED|Overall Study||6||
59733908|NCT04061577|75852527|FG000|STARTED|Overall Study||1||
59733909|NCT04061577|75852528|FG001|STARTED|Overall Study||0||
59733910|NCT04061577|75852527|FG000|COMPLETED|Overall Study||0||
59733911|NCT04061577|75852528|FG001|COMPLETED|Overall Study||0||
59733912|NCT04061577|75852527|FG000|NOT COMPLETED|Overall Study||1||
59733913|NCT04061577|75852528|FG001|NOT COMPLETED|Overall Study||0||
59733914|NCT00943722|75852539|FG000|STARTED|Base Study||648||
59733915|NCT00943722|75852540|FG001|STARTED|Base Study||643||
59733916|NCT00943722|75852541|FG002|STARTED|Base Study||644||
59733917|NCT00943722|75852542|FG003|STARTED|Base Study||669||
59733918|NCT00943722|75852543|FG004|STARTED|Base Study||470||
59733919|NCT00943722|75852544|FG005|STARTED|Base Study||0||
59733920|NCT00943722|75852545|FG006|STARTED|Base Study||0||
59733921|NCT00943722|75852539|FG000|Vaccination 1|Base Study||646||
59733922|NCT00943722|75852540|FG001|Vaccination 1|Base Study||642||
59733923|NCT00943722|75852541|FG002|Vaccination 1|Base Study||644||
59733924|NCT00943722|75852542|FG003|Vaccination 1|Base Study||666||
59733925|NCT00943722|75852543|FG004|Vaccination 1|Base Study||468||
59733926|NCT00943722|75852544|FG005|Vaccination 1|Base Study||0||
59733927|NCT00943722|75852545|FG006|Vaccination 1|Base Study||0||
59733928|NCT00943722|75852539|FG000|Vaccination 2|Base Study||637||
59733929|NCT00943722|75852540|FG001|Vaccination 2|Base Study||633||
59733930|NCT00943722|75852541|FG002|Vaccination 2|Base Study||638||
59733931|NCT00943722|75852542|FG003|Vaccination 2|Base Study||658||
59733932|NCT00943722|75852543|FG004|Vaccination 2|Base Study||462||
59733933|NCT00943722|75852544|FG005|Vaccination 2|Base Study||0||
59733934|NCT00943722|75852545|FG006|Vaccination 2|Base Study||0||
59733935|NCT00943722|75852539|FG000|Vaccination 3|Base Study||635||
59733936|NCT00943722|75852540|FG001|Vaccination 3|Base Study||627||
59733937|NCT00943722|75852541|FG002|Vaccination 3|Base Study||637||
59733938|NCT00943722|75852542|FG003|Vaccination 3|Base Study||653||
59733939|NCT00943722|75852543|FG004|Vaccination 3|Base Study||455||
59733940|NCT00943722|75852544|FG005|Vaccination 3|Base Study||0||
59733941|NCT00943722|75852545|FG006|Vaccination 3|Base Study||0||
59733942|NCT00943722|75852539|FG000|At Least One Dose With Protocol-specified Safety Follow-up|Base Study||643||
59733943|NCT00943722|75852540|FG001|At Least One Dose With Protocol-specified Safety Follow-up|Base Study||639||
59733944|NCT00943722|75852541|FG002|At Least One Dose With Protocol-specified Safety Follow-up|Base Study||641||
59733945|NCT00943722|75852542|FG003|At Least One Dose With Protocol-specified Safety Follow-up|Base Study||662||
59733946|NCT00943722|75852543|FG004|At Least One Dose With Protocol-specified Safety Follow-up|Base Study||466||
59733947|NCT00943722|75852544|FG005|At Least One Dose With Protocol-specified Safety Follow-up|Base Study||0||
59733948|NCT00943722|75852545|FG006|At Least One Dose With Protocol-specified Safety Follow-up|Base Study||0||
59733949|NCT00943722|75852539|FG000|COMPLETED|Base Study||623||
59733950|NCT00943722|75852540|FG001|COMPLETED|Base Study||621||
59733951|NCT00943722|75852541|FG002|COMPLETED|Base Study||631||
59733952|NCT00943722|75852542|FG003|COMPLETED|Base Study||647||
59733953|NCT00943722|75852543|FG004|COMPLETED|Base Study||444||
59733954|NCT00943722|75852544|FG005|COMPLETED|Base Study||0||
59733955|NCT00943722|75852545|FG006|COMPLETED|Base Study||0||
59733956|NCT00943722|75852539|FG000|NOT COMPLETED|Base Study||25||
59733957|NCT00943722|75852540|FG001|NOT COMPLETED|Base Study||22||
59733958|NCT00943722|75852541|FG002|NOT COMPLETED|Base Study||13||
59733959|NCT00943722|75852542|FG003|NOT COMPLETED|Base Study||22||
59733960|NCT00943722|75852543|FG004|NOT COMPLETED|Base Study||26||
59733961|NCT00943722|75852544|FG005|NOT COMPLETED|Base Study||0||
59733962|NCT00943722|75852545|FG006|NOT COMPLETED|Base Study||0||
59733963|NCT00943722|75852539|FG000|STARTED|First Extension Study: EXT 1||0|The optional EXT1 included eligible participants from the base study, with the exception of 16-26 year old females.|
59733964|NCT00943722|75852540|FG001|STARTED|First Extension Study: EXT 1||0|The optional EXT1 included eligible participants from the base study, with the exception of 16-26 year old females.|
59733965|NCT00943722|75852541|FG002|STARTED|First Extension Study: EXT 1||0|The optional EXT1 included eligible participants from the base study, with the exception of 16-26 year old females.|
59733966|NCT00943722|75852542|FG003|STARTED|First Extension Study: EXT 1||0|The optional EXT1 included eligible participants from the base study, with the exception of 16-26 year old females.|
59733967|NCT00943722|75852543|FG004|STARTED|First Extension Study: EXT 1||0|The optional EXT1 included eligible participants from the base study, with the exception of 16-26 year old females.|
59733968|NCT00943722|75852544|FG005|STARTED|First Extension Study: EXT 1||1604|The optional EXT1 included eligible participants from the base study, with the exception of 16-26 year old females.|
59733969|NCT00943722|75852545|FG006|STARTED|First Extension Study: EXT 1||568|The optional EXT1 included eligible participants from the base study, with the exception of 16-26 year old females.|
59733970|NCT00943722|75852539|FG000|COMPLETED|First Extension Study: EXT 1||0||
59733971|NCT00943722|75852540|FG001|COMPLETED|First Extension Study: EXT 1||0||
59733972|NCT00943722|75852541|FG002|COMPLETED|First Extension Study: EXT 1||0||
59733973|NCT00943722|75852542|FG003|COMPLETED|First Extension Study: EXT 1||0||
59733974|NCT00943722|75852543|FG004|COMPLETED|First Extension Study: EXT 1||0||
59733975|NCT00943722|75852544|FG005|COMPLETED|First Extension Study: EXT 1||1489||
59733976|NCT00943722|75852545|FG006|COMPLETED|First Extension Study: EXT 1||527||
59733977|NCT00943722|75852539|FG000|NOT COMPLETED|First Extension Study: EXT 1||0||
59733978|NCT00943722|75852540|FG001|NOT COMPLETED|First Extension Study: EXT 1||0||
59733979|NCT00943722|75852541|FG002|NOT COMPLETED|First Extension Study: EXT 1||0||
59733980|NCT00943722|75852542|FG003|NOT COMPLETED|First Extension Study: EXT 1||0||
59733981|NCT00943722|75852543|FG004|NOT COMPLETED|First Extension Study: EXT 1||0||
59733982|NCT00943722|75852544|FG005|NOT COMPLETED|First Extension Study: EXT 1||115||
59733983|NCT00943722|75852545|FG006|NOT COMPLETED|First Extension Study: EXT 1||41||
59733984|NCT00943722|75852539|FG000|STARTED|Second Extension Study: EXT 2||0|The optional EXT2 included eligible participants from the base study, with the exception of 16-26 year old females.|
59733985|NCT00943722|75852540|FG001|STARTED|Second Extension Study: EXT 2||0|The optional EXT2 included eligible participants from the base study, with the exception of 16-26 year old females.|
59733986|NCT00943722|75852541|FG002|STARTED|Second Extension Study: EXT 2||0|The optional EXT2 included eligible participants from the base study, with the exception of 16-26 year old females.|
59733987|NCT00943722|75852542|FG003|STARTED|Second Extension Study: EXT 2||0|The optional EXT2 included eligible participants from the base study, with the exception of 16-26 year old females.|
59999794|NCT01782131|76115511|FG001|COMPLETED|Overall Study||177||
59733988|NCT00943722|75852543|FG004|STARTED|Second Extension Study: EXT 2||0|The optional EXT2 included eligible participants from the base study, with the exception of 16-26 year old females.|
59733989|NCT00943722|75852544|FG005|STARTED|Second Extension Study: EXT 2||971|The optional EXT2 included eligible participants from the base study, with the exception of 16-26 year old females.|
59733990|NCT00943722|75852545|FG006|STARTED|Second Extension Study: EXT 2||301|The optional EXT2 included eligible participants from the base study, with the exception of 16-26 year old females.|
59733991|NCT00943722|75852539|FG000|COMPLETED|Second Extension Study: EXT 2||0||
59733992|NCT00943722|75852540|FG001|COMPLETED|Second Extension Study: EXT 2||0||
59733993|NCT00943722|75852541|FG002|COMPLETED|Second Extension Study: EXT 2||0||
59733994|NCT00943722|75852542|FG003|COMPLETED|Second Extension Study: EXT 2||0||
59733995|NCT00943722|75852543|FG004|COMPLETED|Second Extension Study: EXT 2||0||
59733996|NCT00943722|75852544|FG005|COMPLETED|Second Extension Study: EXT 2||720||
59733997|NCT00943722|75852545|FG006|COMPLETED|Second Extension Study: EXT 2||202||
59733998|NCT00943722|75852539|FG000|NOT COMPLETED|Second Extension Study: EXT 2||0||
59733999|NCT00943722|75852540|FG001|NOT COMPLETED|Second Extension Study: EXT 2||0||
59734000|NCT00943722|75852541|FG002|NOT COMPLETED|Second Extension Study: EXT 2||0||
59734001|NCT00943722|75852542|FG003|NOT COMPLETED|Second Extension Study: EXT 2||0||
59734002|NCT00943722|75852543|FG004|NOT COMPLETED|Second Extension Study: EXT 2||0||
59734003|NCT00943722|75852544|FG005|NOT COMPLETED|Second Extension Study: EXT 2||251||
59734004|NCT00943722|75852545|FG006|NOT COMPLETED|Second Extension Study: EXT 2||99||
59734005|NCT00901485|75852568|FG000|STARTED|Overall Study||10||
59734006|NCT00901485|75852569|FG001|STARTED|Overall Study||13||
59734007|NCT00901485|75852568|FG000|COMPLETED|Overall Study||9||
59734008|NCT00901485|75852569|FG001|COMPLETED|Overall Study||9||
59734009|NCT00901485|75852568|FG000|NOT COMPLETED|Overall Study||1||
59734010|NCT00901485|75852569|FG001|NOT COMPLETED|Overall Study||4||
59734011|NCT00896337|75852575|FG000|STARTED|Overall Study||125||
59734012|NCT00896337|75852575|FG000|COMPLETED|Overall Study||100||
59734013|NCT00896337|75852575|FG000|NOT COMPLETED|Overall Study||25||
59734014|NCT00953706|75852586|FG000|STARTED|Part A (16-Week Double-Blind Treatment)|All subjects who received at least 1 dose of study drug (placebo)|28||
59734015|NCT00953706|75852587|FG001|STARTED|Part A (16-Week Double-Blind Treatment)|All subjects who received at least 1 dose of study drug (ivacaftor)|112||
59734016|NCT00953706|75852588|FG002|STARTED|Part A (16-Week Double-Blind Treatment)||0||
59734017|NCT00953706|75852589|FG003|STARTED|Part A (16-Week Double-Blind Treatment)||0||
59734018|NCT00953706|75852586|FG000|COMPLETED|Part A (16-Week Double-Blind Treatment)|Only 5 participants continued in Part B.|26||
59734019|NCT00953706|75852587|FG001|COMPLETED|Part A (16-Week Double-Blind Treatment)|Only 33 participants continued in Part B.|104||
59734020|NCT00953706|75852588|FG002|COMPLETED|Part A (16-Week Double-Blind Treatment)||0||
59734021|NCT00953706|75852589|FG003|COMPLETED|Part A (16-Week Double-Blind Treatment)||0||
59734022|NCT00953706|75852586|FG000|NOT COMPLETED|Part A (16-Week Double-Blind Treatment)||2||
59734023|NCT00953706|75852587|FG001|NOT COMPLETED|Part A (16-Week Double-Blind Treatment)||8||
59734024|NCT00953706|75852588|FG002|NOT COMPLETED|Part A (16-Week Double-Blind Treatment)||0||
59734025|NCT00953706|75852589|FG003|NOT COMPLETED|Part A (16-Week Double-Blind Treatment)||0||
59734026|NCT00953706|75852586|FG000|STARTED|Part B (96-Week Open-Label Extension)||0||
59734027|NCT00953706|75852587|FG001|STARTED|Part B (96-Week Open-Label Extension)||0||
59734028|NCT00953706|75852588|FG002|STARTED|Part B (96-Week Open-Label Extension)||5||
59734029|NCT00953706|75852589|FG003|STARTED|Part B (96-Week Open-Label Extension)||33||
59734030|NCT00953706|75852586|FG000|COMPLETED|Part B (96-Week Open-Label Extension)||0||
59734031|NCT00953706|75852587|FG001|COMPLETED|Part B (96-Week Open-Label Extension)||0||
59734032|NCT00953706|75852588|FG002|COMPLETED|Part B (96-Week Open-Label Extension)||0||
59734033|NCT00953706|75852589|FG003|COMPLETED|Part B (96-Week Open-Label Extension)||0||
59734034|NCT00953706|75852586|FG000|NOT COMPLETED|Part B (96-Week Open-Label Extension)||0||
59734035|NCT00953706|75852587|FG001|NOT COMPLETED|Part B (96-Week Open-Label Extension)||0||
59734036|NCT00953706|75852588|FG002|NOT COMPLETED|Part B (96-Week Open-Label Extension)||5||
59734037|NCT00953706|75852589|FG003|NOT COMPLETED|Part B (96-Week Open-Label Extension)||33||
59734038|NCT00940992|75852602|FG000|STARTED|Overall Study||32||
59734039|NCT00940992|75852603|FG001|STARTED|Overall Study||30||
59734040|NCT00940992|75852604|FG002|STARTED|Overall Study||30||
59734041|NCT00940992|75852602|FG000|COMPLETED|Overall Study||28||
59734042|NCT00940992|75852603|FG001|COMPLETED|Overall Study||28||
59734043|NCT00940992|75852604|FG002|COMPLETED|Overall Study||28||
59734044|NCT00940992|75852602|FG000|NOT COMPLETED|Overall Study||4||
59734045|NCT00940992|75852603|FG001|NOT COMPLETED|Overall Study||2||
59734046|NCT00940992|75852604|FG002|NOT COMPLETED|Overall Study||2||
59734047|NCT00938964|75852614|FG000|STARTED|Overall Study||241||
59734048|NCT00938964|75852615|FG001|STARTED|Overall Study||237||
59734049|NCT00938964|75852614|FG000|COMPLETED|Overall Study||211||
59734050|NCT00938964|75852615|FG001|COMPLETED|Overall Study||209||
59734051|NCT00938964|75852614|FG000|NOT COMPLETED|Overall Study||30||
59734052|NCT00938964|75852615|FG001|NOT COMPLETED|Overall Study||28||
59734053|NCT00938886|75852623|FG000|STARTED|Overall Study||75||
59734054|NCT00938886|75852624|FG001|STARTED|Overall Study||75||
59734055|NCT00938886|75852623|FG000|Attended 1 Counseling Session|Overall Study||70||
59734056|NCT00938886|75852624|FG001|Attended 1 Counseling Session|Overall Study||70||
59734057|NCT00938886|75852623|FG000|COMPLETED|Overall Study||68||
59734058|NCT00938886|75852624|FG001|COMPLETED|Overall Study||65||
59734059|NCT00938886|75852623|FG000|NOT COMPLETED|Overall Study||7||
59734060|NCT00938886|75852624|FG001|NOT COMPLETED|Overall Study||10||
59734061|NCT00942708|75852630|FG000|STARTED|Overall Study||6||
59734062|NCT00942708|75852630|FG000|COMPLETED|Overall Study||5||
59734063|NCT00942708|75852630|FG000|NOT COMPLETED|Overall Study||1||
59734064|NCT00937950|75852635|FG000|STARTED|Overall Study||2003||
59734065|NCT00937950|75852635|FG000|COMPLETED|Overall Study||1787||
59734066|NCT00937950|75852635|FG000|NOT COMPLETED|Overall Study||216||
59734067|NCT00942162|75852642|FG000|STARTED|Overall Study||71||
59734068|NCT00942162|75852643|FG001|STARTED|Overall Study||50||
59734069|NCT00942162|75852644|FG002|STARTED|Overall Study||2||
59734070|NCT00942162|75852642|FG000|COMPLETED|Overall Study||1||
59734071|NCT00942162|75852643|FG001|COMPLETED|Overall Study||0||
59734072|NCT00942162|75852644|FG002|COMPLETED|Overall Study||0||
59734073|NCT00942162|75852642|FG000|NOT COMPLETED|Overall Study||70||
59734074|NCT00942162|75852643|FG001|NOT COMPLETED|Overall Study||50||
59734075|NCT00942162|75852644|FG002|NOT COMPLETED|Overall Study||2||
59734076|NCT00942084|75852654|FG000|STARTED|Overall Study||32||
59734077|NCT00942084|75852654|FG000|COMPLETED|Overall Study|There were 2 infant deaths. None determined to be related to study drug.|30||
59734078|NCT00942084|75852654|FG000|NOT COMPLETED|Overall Study||2||
59734079|NCT00941928|75852658|FG000|STARTED|Overall Study||2||
59734080|NCT00941928|75852658|FG000|COMPLETED|Overall Study||0||
59734081|NCT00941928|75852658|FG000|NOT COMPLETED|Overall Study||2||
59734082|NCT00937560|75852662|FG000|STARTED|Initial Treatment||189||
59734083|NCT00937560|75852662|FG000|Received Treatment|Initial Treatment||189||
59734084|NCT00937560|75852662|FG000|COMPLETED|Initial Treatment||168||
59734085|NCT00937560|75852662|FG000|NOT COMPLETED|Initial Treatment||21||
59734086|NCT00937560|75852662|FG000|STARTED|Maintenance Treatment||168||
59734087|NCT00937560|75852662|FG000|COMPLETED|Maintenance Treatment||150||
59734088|NCT00937560|75852662|FG000|NOT COMPLETED|Maintenance Treatment||18||
59734089|NCT00594568|75852669|FG000|STARTED|Initial Treatment||501||
59734090|NCT00594568|75852670|FG001|STARTED|Initial Treatment||507||
59734091|NCT00594568|75852671|FG002|STARTED|Initial Treatment||529||
59734092|NCT00594568|75852669|FG000|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants (pts) who had at least 1 dose of study drug.|501||
59734093|NCT00594568|75852670|FG001|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants who had at least 1 dose of study drug.|506||
59734094|NCT00594568|75852671|FG002|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants who had at least 1 dose of study drug.|527||
59734095|NCT00594568|75852669|FG000|COMPLETED|Initial Treatment||189||
59734096|NCT00594568|75852670|FG001|COMPLETED|Initial Treatment||153||
59734097|NCT00594568|75852671|FG002|COMPLETED|Initial Treatment||121||
59734098|NCT00594568|75852669|FG000|NOT COMPLETED|Initial Treatment||312||
59734099|NCT00594568|75852670|FG001|NOT COMPLETED|Initial Treatment||354||
59734100|NCT00594568|75852671|FG002|NOT COMPLETED|Initial Treatment||408||
59734101|NCT00594568|75852669|FG000|STARTED|Delayed Start||189||
59734102|NCT00594568|75852670|FG001|STARTED|Delayed Start||153||
59734103|NCT00594568|75852671|FG002|STARTED|Delayed Start||121||
59734104|NCT00594568|75852669|FG000|COMPLETED|Delayed Start||91||
59734105|NCT00594568|75852670|FG001|COMPLETED|Delayed Start||76||
59734106|NCT00594568|75852671|FG002|COMPLETED|Delayed Start||55||
59734107|NCT00594568|75852669|FG000|NOT COMPLETED|Delayed Start||98||
59734108|NCT00594568|75852670|FG001|NOT COMPLETED|Delayed Start||77||
59734109|NCT00594568|75852671|FG002|NOT COMPLETED|Delayed Start||66||
59734110|NCT00594568|75852669|FG000|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional; pts entered from initial treatment and delayed start or did not enter SFU.|290||
59734111|NCT00594568|75852670|FG001|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional; pts entered from initial treatment and delayed start or did not enter SFU.|223||
59734112|NCT00594568|75852671|FG002|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional, pts entered from initial treatment and delayed start or did not enter SFU.|214||
59734113|NCT00594568|75852669|FG000|COMPLETED|Safety Follow Up (SFU)-Optional||229||
59734114|NCT00594568|75852670|FG001|COMPLETED|Safety Follow Up (SFU)-Optional||168||
59734115|NCT00594568|75852671|FG002|COMPLETED|Safety Follow Up (SFU)-Optional||172||
59734116|NCT00594568|75852669|FG000|NOT COMPLETED|Safety Follow Up (SFU)-Optional||61||
59734117|NCT00594568|75852670|FG001|NOT COMPLETED|Safety Follow Up (SFU)-Optional||55||
59734118|NCT00594568|75852671|FG002|NOT COMPLETED|Safety Follow Up (SFU)-Optional||42||
59734119|NCT00682630|75852689|FG000|STARTED|First Intervention (Day 0)||21||
59734120|NCT00682630|75852690|FG001|STARTED|First Intervention (Day 0)||21||
59734121|NCT00682630|75852689|FG000|COMPLETED|First Intervention (Day 0)||20||
59734122|NCT00682630|75852690|FG001|COMPLETED|First Intervention (Day 0)||21||
59734123|NCT00682630|75852689|FG000|NOT COMPLETED|First Intervention (Day 0)||1||
59734124|NCT00682630|75852690|FG001|NOT COMPLETED|First Intervention (Day 0)||0||
59734125|NCT00682630|75852689|FG000|STARTED|Washout (43 Days)||20||
59734126|NCT00682630|75852690|FG001|STARTED|Washout (43 Days)||21||
59734127|NCT00682630|75852689|FG000|COMPLETED|Washout (43 Days)||18||
59734128|NCT00682630|75852690|FG001|COMPLETED|Washout (43 Days)||19||
59734129|NCT00682630|75852689|FG000|NOT COMPLETED|Washout (43 Days)||2||
59734130|NCT00682630|75852690|FG001|NOT COMPLETED|Washout (43 Days)||2||
59734131|NCT00682630|75852689|FG000|STARTED|Second Intervention (Day 43)||18||
59734132|NCT00682630|75852690|FG001|STARTED|Second Intervention (Day 43)||19||
59734133|NCT00682630|75852689|FG000|COMPLETED|Second Intervention (Day 43)||18||
59734134|NCT00682630|75852690|FG001|COMPLETED|Second Intervention (Day 43)||19||
59734135|NCT00682630|75852689|FG000|NOT COMPLETED|Second Intervention (Day 43)||0||
59734136|NCT00682630|75852690|FG001|NOT COMPLETED|Second Intervention (Day 43)||0||
59734137|NCT00682630|75852689|FG000|STARTED|Follow-up (42 Days)||18||
59734138|NCT00682630|75852690|FG001|STARTED|Follow-up (42 Days)||19||
59734139|NCT00682630|75852689|FG000|COMPLETED|Follow-up (42 Days)||18||
59734140|NCT00682630|75852690|FG001|COMPLETED|Follow-up (42 Days)||19||
59734141|NCT00682630|75852689|FG000|NOT COMPLETED|Follow-up (42 Days)||0||
59734142|NCT00682630|75852690|FG001|NOT COMPLETED|Follow-up (42 Days)||0||
59734143|NCT00875056|75852699|FG000|STARTED|Overall Study||39||
59734144|NCT00875056|75852700|FG001|STARTED|Overall Study||11||
59734145|NCT00875056|75852701|FG002|STARTED|Overall Study||6||
59734146|NCT00875056|75852699|FG000|COMPLETED|Overall Study||16||
59734147|NCT00875056|75852700|FG001|COMPLETED|Overall Study||2||
59734148|NCT00875056|75852701|FG002|COMPLETED|Overall Study||0||
59734149|NCT00875056|75852699|FG000|NOT COMPLETED|Overall Study||23||
59734150|NCT00875056|75852700|FG001|NOT COMPLETED|Overall Study||9||
59734151|NCT00875056|75852701|FG002|NOT COMPLETED|Overall Study||6||
59865138|NCT03395080|75989141|FG005|STARTED|Overall Study||8|Number Started is the Safety Analysis Set defined as all subjects who received >= 1 administration of assigned study treatment (DKN-01 or paclitaxel).Subjects with carcinosarcoma were initially enrolled in the EEC group to receive monotherapy or DKN-01+paclitaxel, but as part of a subsequent protocol amendment, carcinosarcoma subjects were enrolled & received 600mg DKN-01 or 600mg DKN-01+paclitaxel. Results are reported by disease type and treatment received.|
59865139|NCT03395080|75989142|FG006|STARTED|Overall Study||4|Number Started is the Safety Analysis Set defined as all subjects who received >= 1 administration of assigned study treatment (DKN-01 or paclitaxel).Subjects with carcinosarcoma were initially enrolled in the EEC group to receive monotherapy or DKN-01+paclitaxel, but as part of a subsequent protocol amendment, carcinosarcoma subjects were enrolled & received 600mg DKN-01 or 600mg DKN-01+paclitaxel. Results are reported by disease type and treatment received.|
59865140|NCT03395080|75989143|FG007|STARTED|Overall Study||12|Number Started is the Safety Analysis Set defined as all subjects who received >= 1 administration of assigned study treatment (DKN-01 or paclitaxel).Subjects with carcinosarcoma were initially enrolled in the EEC group to receive monotherapy or DKN-01+paclitaxel, but as part of a subsequent protocol amendment, carcinosarcoma subjects were enrolled & received 600mg DKN-01 or 600mg DKN-01+paclitaxel. Results are reported by disease type and treatment received.|
59865141|NCT03395080|75989136|FG000|COMPLETED|Overall Study||26|Number Completed is the Evaluable Analysis Set defined as all subjects who received any amount of DKN-01 and had at least 1 evaluated post-baseline RECIST assessment or were discontinued due to death.|
59865142|NCT03395080|75989137|FG001|COMPLETED|Overall Study||21|Number Completed is the Evaluable Analysis Set defined as all subjects who received any amount of DKN-01 and had at least 1 evaluated post-baseline RECIST assessment or were discontinued due to death.|
59865143|NCT03395080|75989138|FG002|COMPLETED|Overall Study||13|Number Completed is the Evaluable Analysis Set defined as all subjects who received any amount of DKN-01 and had at least 1 evaluated post-baseline RECIST assessment or were discontinued due to death.|
59865144|NCT03395080|75989139|FG003|COMPLETED|Overall Study||19|Number Completed is the Evaluable Analysis Set defined as all subjects who received any amount of DKN-01 and had at least 1 evaluated post-baseline RECIST assessment or were discontinued due to death.|
59865145|NCT03395080|75989140|FG004|COMPLETED|Overall Study||1|Number Completed is the Evaluable Analysis Set defined as all subjects who received any amount of DKN-01 and had at least 1 evaluated post-baseline RECIST assessment or were discontinued due to death.|
59865146|NCT03395080|75989141|FG005|COMPLETED|Overall Study||8|Number Completed is the Evaluable Analysis Set defined as all subjects who received any amount of DKN-01 and had at least 1 evaluated post-baseline RECIST assessment or were discontinued due to death.|
59865147|NCT03395080|75989142|FG006|COMPLETED|Overall Study||4|Number Completed is the Evaluable Analysis Set defined as all subjects who received any amount of DKN-01 and had at least 1 evaluated post-baseline RECIST assessment or were discontinued due to death.|
59865148|NCT03395080|75989143|FG007|COMPLETED|Overall Study||10|Number Completed is the Evaluable Analysis Set defined as all subjects who received any amount of DKN-01 and had at least 1 evaluated post-baseline RECIST assessment or were discontinued due to death.|
59865149|NCT03395080|75989136|FG000|NOT COMPLETED|Overall Study||3||
59865150|NCT03395080|75989137|FG001|NOT COMPLETED|Overall Study||3||
59865151|NCT03395080|75989138|FG002|NOT COMPLETED|Overall Study||1||
59865152|NCT03395080|75989139|FG003|NOT COMPLETED|Overall Study||0||
59865153|NCT03395080|75989140|FG004|NOT COMPLETED|Overall Study||0||
59865154|NCT03395080|75989141|FG005|NOT COMPLETED|Overall Study||0||
59865155|NCT03395080|75989142|FG006|NOT COMPLETED|Overall Study||0||
59865156|NCT03395080|75989143|FG007|NOT COMPLETED|Overall Study||2||
59865157|NCT03354273|75989171|FG000|STARTED|Overall Study|Participants who signed informed consent form and were enrolled in the study.|730||
59865158|NCT03354273|75989171|FG000|Safety Population (Treated)|Overall Study||604||
59865159|NCT03354273|75989171|FG000|Modified Intent-to-Treat (MITT) Population|Overall Study||578||
59865160|NCT03354273|75989171|FG000|Secondary Modified Intent-to-Treat (SMITT) Population|Overall Study||578||
59865161|NCT03354273|75989171|FG000|COMPLETED|Overall Study||578||
59865162|NCT03354273|75989171|FG000|NOT COMPLETED|Overall Study||152||
59865163|NCT03304912|75989177|FG000|STARTED|Overall Study||95||
59865164|NCT03304912|75989177|FG000|COMPLETED|Overall Study||42||
59865165|NCT03304912|75989177|FG000|NOT COMPLETED|Overall Study||53||
59865166|NCT02802176|75989184|FG000|STARTED|Overall Study||16||
59865167|NCT02802176|75989185|FG001|STARTED|Overall Study||14||
59865168|NCT02802176|75989184|FG000|COMPLETED|Overall Study||16||
59865169|NCT02802176|75989185|FG001|COMPLETED|Overall Study||14||
59865170|NCT02802176|75989184|FG000|NOT COMPLETED|Overall Study||0||
59865171|NCT02802176|75989185|FG001|NOT COMPLETED|Overall Study||0||
59865172|NCT02759185|75989195|FG000|STARTED|Stage 1||20||
59865173|NCT02759185|75989196|FG001|STARTED|Stage 1||20||
59865174|NCT02759185|75989197|FG002|STARTED|Stage 1||20||
59865175|NCT02759185|75989198|FG003|STARTED|Stage 1||20||
59865176|NCT02759185|75989199|FG004|STARTED|Stage 1||0||
59865177|NCT02759185|75989200|FG005|STARTED|Stage 1||0||
59865178|NCT02759185|75989201|FG006|STARTED|Stage 1||0||
59865179|NCT02759185|75989195|FG000|COMPLETED|Stage 1||19||
59865180|NCT02759185|75989196|FG001|COMPLETED|Stage 1||19||
59865181|NCT02759185|75989197|FG002|COMPLETED|Stage 1||17||
59865182|NCT02759185|75989198|FG003|COMPLETED|Stage 1||20||
59865183|NCT02759185|75989199|FG004|COMPLETED|Stage 1||0||
59865184|NCT02759185|75989200|FG005|COMPLETED|Stage 1||0||
59865185|NCT02759185|75989201|FG006|COMPLETED|Stage 1||0||
59865186|NCT02759185|75989195|FG000|NOT COMPLETED|Stage 1||1||
59865187|NCT02759185|75989196|FG001|NOT COMPLETED|Stage 1||1||
59865188|NCT02759185|75989197|FG002|NOT COMPLETED|Stage 1||3||
59865189|NCT02759185|75989198|FG003|NOT COMPLETED|Stage 1||0||
59865190|NCT02759185|75989199|FG004|NOT COMPLETED|Stage 1||0||
59865191|NCT02759185|75989200|FG005|NOT COMPLETED|Stage 1||0||
59865192|NCT02759185|75989201|FG006|NOT COMPLETED|Stage 1||0||
59865193|NCT02759185|75989195|FG000|STARTED|Stage 2||0||
59865194|NCT02759185|75989196|FG001|STARTED|Stage 2||0||
59865195|NCT02759185|75989197|FG002|STARTED|Stage 2||0||
59865196|NCT02759185|75989198|FG003|STARTED|Stage 2||0||
59865197|NCT02759185|75989199|FG004|STARTED|Stage 2||29||
59865198|NCT02759185|75989200|FG005|STARTED|Stage 2||27||
59865199|NCT02759185|75989201|FG006|STARTED|Stage 2||18||
59865200|NCT02759185|75989195|FG000|COMPLETED|Stage 2||0||
59865201|NCT02759185|75989196|FG001|COMPLETED|Stage 2||0||
59865202|NCT02759185|75989197|FG002|COMPLETED|Stage 2||0||
59865203|NCT02759185|75989198|FG003|COMPLETED|Stage 2||0||
59865204|NCT02759185|75989199|FG004|COMPLETED|Stage 2||27||
59865205|NCT02759185|75989200|FG005|COMPLETED|Stage 2||24||
59865206|NCT02759185|75989201|FG006|COMPLETED|Stage 2||17||
59865207|NCT02759185|75989195|FG000|NOT COMPLETED|Stage 2||0||
59865208|NCT02759185|75989196|FG001|NOT COMPLETED|Stage 2||0||
59865209|NCT02759185|75989197|FG002|NOT COMPLETED|Stage 2||0||
59865210|NCT02759185|75989198|FG003|NOT COMPLETED|Stage 2||0||
59865211|NCT02759185|75989199|FG004|NOT COMPLETED|Stage 2||2||
59865212|NCT02759185|75989200|FG005|NOT COMPLETED|Stage 2||3||
59865213|NCT02759185|75989201|FG006|NOT COMPLETED|Stage 2||1||
59865214|NCT01951339|75989225|FG000|STARTED|Overall Study||15||
59865215|NCT01951339|75989226|FG001|STARTED|Overall Study||15||
59865216|NCT01951339|75989225|FG000|COMPLETED|Overall Study||13||
59865217|NCT01951339|75989226|FG001|COMPLETED|Overall Study||14||
59865218|NCT01951339|75989225|FG000|NOT COMPLETED|Overall Study||2||
59865219|NCT01951339|75989226|FG001|NOT COMPLETED|Overall Study||1||
59865220|NCT01844518|75989234|FG000|STARTED|Overall Study||173||
59865221|NCT01844518|75989235|FG001|STARTED|Overall Study||46||
59865222|NCT01844518|75989234|FG000|COMPLETED|Overall Study||132||
59865223|NCT01844518|75989235|FG001|COMPLETED|Overall Study||39||
59865224|NCT01844518|75989234|FG000|NOT COMPLETED|Overall Study||41||
59865225|NCT01844518|75989235|FG001|NOT COMPLETED|Overall Study||7||
59865226|NCT01809002|75989246|FG000|STARTED|Overall Study||112||
59865227|NCT01809002|75989247|FG001|STARTED|Overall Study||108||
59865228|NCT01809002|75989246|FG000|COMPLETED|Overall Study||91||
59865229|NCT01809002|75989247|FG001|COMPLETED|Overall Study||92||
59865230|NCT01809002|75989246|FG000|NOT COMPLETED|Overall Study||21||
59865231|NCT01809002|75989247|FG001|NOT COMPLETED|Overall Study||16||
59865232|NCT01793909|75989261|FG000|STARTED|Overall Study||30||
59865233|NCT01793909|75989262|FG001|STARTED|Overall Study||25||
59865234|NCT01793909|75989261|FG000|COMPLETED|Overall Study||20||
59865235|NCT01793909|75989262|FG001|COMPLETED|Overall Study||20||
59865236|NCT01793909|75989261|FG000|NOT COMPLETED|Overall Study||10||
59865237|NCT01793909|75989262|FG001|NOT COMPLETED|Overall Study||5||
59865238|NCT01509586|75989270|FG000|STARTED|Overall Study|Week 0|626||
59865239|NCT01509586|75989271|FG001|STARTED|Overall Study|Week 0|610||
59865240|NCT01509586|75989270|FG000|Week 3|Overall Study||574||
59865241|NCT01509586|75989271|FG001|Week 3|Overall Study||585||
59865242|NCT01509586|75989270|FG000|Week 6|Overall Study||551||
59865243|NCT01509586|75989271|FG001|Week 6|Overall Study||585||
59865244|NCT01509586|75989270|FG000|Week 10|Overall Study||537||
59865245|NCT01509586|75989271|FG001|Week 10|Overall Study||574||
59865246|NCT01509586|75989270|FG000|Week 14|Overall Study||528||
59865247|NCT01509586|75989271|FG001|Week 14|Overall Study||566||
59865248|NCT01509586|75989270|FG000|Week18|Overall Study||529||
59865249|NCT01509586|75989271|FG001|Week18|Overall Study||555||
59865250|NCT01509586|75989270|FG000|Week 32 (Month 6)|Overall Study||504||
59865251|NCT01509586|75989271|FG001|Week 32 (Month 6)|Overall Study||523||
59865252|NCT01509586|75989270|FG000|Week 46|Overall Study||483||
59865253|NCT01509586|75989271|FG001|Week 46|Overall Study||494||
59865254|NCT01509586|75989270|FG000|Week 58 (Month 12)|Overall Study||492||
59865255|NCT01509586|75989271|FG001|Week 58 (Month 12)|Overall Study||499||
59865256|NCT01509586|75989270|FG000|COMPLETED|Overall Study|final intent to treat sample|626||
59865257|NCT01509586|75989271|FG001|COMPLETED|Overall Study|final intent to treat sample|610||
59865258|NCT01509586|75989270|FG000|NOT COMPLETED|Overall Study||0||
59865259|NCT01509586|75989271|FG001|NOT COMPLETED|Overall Study||0||
59865260|NCT01364584|75989279|FG000|STARTED|Overall Study||11||
59865261|NCT01364584|75989280|FG001|STARTED|Overall Study||12||
59865262|NCT01364584|75989279|FG000|COMPLETED|Overall Study||11||
59865263|NCT01364584|75989280|FG001|COMPLETED|Overall Study||12||
59865264|NCT01364584|75989279|FG000|NOT COMPLETED|Overall Study||0||
59865265|NCT01364584|75989280|FG001|NOT COMPLETED|Overall Study||0||
59865266|NCT01044264|75989291|FG000|STARTED|Overall Study||200||
59865267|NCT01044264|75989292|FG001|STARTED|Overall Study||202||
59865268|NCT01044264|75989293|FG002|STARTED|Overall Study||200||
59865269|NCT01044264|75989291|FG000|COMPLETED|Overall Study||110||
59865270|NCT01044264|75989292|FG001|COMPLETED|Overall Study||108||
59865271|NCT01044264|75989293|FG002|COMPLETED|Overall Study||108||
59865272|NCT01044264|75989291|FG000|NOT COMPLETED|Overall Study||90||
59865273|NCT01044264|75989292|FG001|NOT COMPLETED|Overall Study||94||
59865274|NCT01044264|75989293|FG002|NOT COMPLETED|Overall Study||92||
59865275|NCT01039584|75989304|FG000|STARTED|Overall Study||246||
59865276|NCT01039584|75989305|FG001|STARTED|Overall Study||243||
59865277|NCT01039584|75989306|FG002|STARTED|Overall Study||122||
59865278|NCT01039584|75989304|FG000|COMPLETED|Overall Study||143||
59865279|NCT01039584|75989305|FG001|COMPLETED|Overall Study||146||
59865280|NCT01039584|75989306|FG002|COMPLETED|Overall Study||65||
59865281|NCT01039584|75989304|FG000|NOT COMPLETED|Overall Study||103||
59865282|NCT01039584|75989305|FG001|NOT COMPLETED|Overall Study||97||
59865283|NCT01039584|75989306|FG002|NOT COMPLETED|Overall Study||57||
59865284|NCT00920387|75989316|FG000|STARTED|Stage 1||8||
59865285|NCT00920387|75989317|FG001|STARTED|Stage 1||4||
59865286|NCT00920387|75989318|FG002|STARTED|Stage 1||0||
59865287|NCT00920387|75989316|FG000|COMPLETED|Stage 1||7||
59865288|NCT00920387|75989317|FG001|COMPLETED|Stage 1||4||
59865289|NCT00920387|75989318|FG002|COMPLETED|Stage 1||0||
59865290|NCT00920387|75989316|FG000|NOT COMPLETED|Stage 1||1||
59865291|NCT00920387|75989317|FG001|NOT COMPLETED|Stage 1||0||
59865292|NCT00920387|75989318|FG002|NOT COMPLETED|Stage 1||0||
59865293|NCT00920387|75989316|FG000|STARTED|Stage 2||0||
59865294|NCT00920387|75989317|FG001|STARTED|Stage 2||0||
59865295|NCT00920387|75989318|FG002|STARTED|Stage 2||3||
59865296|NCT00920387|75989316|FG000|COMPLETED|Stage 2||0||
59865297|NCT00920387|75989317|FG001|COMPLETED|Stage 2||0||
59865298|NCT00920387|75989318|FG002|COMPLETED|Stage 2||3||
59865299|NCT00920387|75989316|FG000|NOT COMPLETED|Stage 2||0||
59865300|NCT00920387|75989317|FG001|NOT COMPLETED|Stage 2||0||
59865301|NCT00920387|75989318|FG002|NOT COMPLETED|Stage 2||0||
59865302|NCT00786019|75989327|FG000|STARTED|Overall Study||20||
59865303|NCT00786019|75989328|FG001|STARTED|Overall Study||27||
59865304|NCT00786019|75989327|FG000|COMPLETED|Overall Study||15||
59865305|NCT00786019|75989328|FG001|COMPLETED|Overall Study||17||
59865306|NCT00786019|75989327|FG000|NOT COMPLETED|Overall Study||5||
59865307|NCT00786019|75989328|FG001|NOT COMPLETED|Overall Study||10||
59865308|NCT00679783|75989343|FG000|STARTED|Overall Study|Gave Informed consent and passed screening|4||
59865309|NCT00679783|75989344|FG001|STARTED|Overall Study|Gave Informed consent and passed screening|13||
59865310|NCT00679783|75989345|FG002|STARTED|Overall Study|Gave Informed consent and passed screening|3||
59865311|NCT00679783|75989346|FG003|STARTED|Overall Study|Gave Informed consent and passed screening|45||
59865312|NCT00679783|75989347|FG004|STARTED|Overall Study|Gave Informed consent and passed screening|5||
59865313|NCT00679783|75989348|FG005|STARTED|Overall Study|Gave Informed consent and passed screening|5||
59865314|NCT00679783|75989349|FG006|STARTED|Overall Study|Gave Informed consent and passed screening|16||
59865315|NCT00679783|75989343|FG000|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|2||
59865316|NCT00679783|75989344|FG001|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|10||
59865317|NCT00679783|75989345|FG002|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|2||
59865318|NCT00679783|75989346|FG003|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|25||
59865319|NCT00679783|75989347|FG004|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|4||
59865320|NCT00679783|75989348|FG005|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|5||
59865321|NCT00679783|75989349|FG006|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|15||
59865322|NCT00679783|75989343|FG000|NOT COMPLETED|Overall Study||2||
59865323|NCT00679783|75989344|FG001|NOT COMPLETED|Overall Study||3||
59865324|NCT00679783|75989345|FG002|NOT COMPLETED|Overall Study||1||
59865325|NCT00679783|75989346|FG003|NOT COMPLETED|Overall Study||20||
59865326|NCT00679783|75989347|FG004|NOT COMPLETED|Overall Study||1||
59865327|NCT00679783|75989348|FG005|NOT COMPLETED|Overall Study||0||
59865328|NCT00679783|75989349|FG006|NOT COMPLETED|Overall Study||1||
59865329|NCT00367003|75989365|FG000|STARTED|Overall Study||37||
59865330|NCT00367003|75989365|FG000|COMPLETED|Overall Study||28||
59865331|NCT00367003|75989365|FG000|NOT COMPLETED|Overall Study||9||
59865332|NCT03896490|75989371|FG000|STARTED|Overall Study||6||
59865333|NCT03896490|75989372|FG001|STARTED|Overall Study||6||
59865334|NCT03896490|75989371|FG000|COMPLETED|Overall Study||5||
59865335|NCT03896490|75989372|FG001|COMPLETED|Overall Study||5||
59865336|NCT03896490|75989371|FG000|NOT COMPLETED|Overall Study||1||
59865337|NCT03896490|75989372|FG001|NOT COMPLETED|Overall Study||1||
59865338|NCT03617172|75989380|FG000|STARTED|Overall Study||3||
59865339|NCT03617172|75989381|FG001|STARTED|Overall Study||3||
59865340|NCT03617172|75989380|FG000|COMPLETED|Overall Study||2||
59865341|NCT03617172|75989381|FG001|COMPLETED|Overall Study||3||
59865342|NCT03617172|75989380|FG000|NOT COMPLETED|Overall Study||1||
59865343|NCT03617172|75989381|FG001|NOT COMPLETED|Overall Study||0||
59865344|NCT03760146|75989393|FG000|STARTED|Overall Study||1514||
59865345|NCT03760146|75989394|FG001|STARTED|Overall Study||1495||
59865346|NCT03760146|75989395|FG002|STARTED|Overall Study||334||
59865347|NCT03760146|75989396|FG003|STARTED|Overall Study||111||
59865348|NCT03760146|75989397|FG004|STARTED|Overall Study||336||
59865349|NCT03760146|75989398|FG005|STARTED|Overall Study||112||
59865350|NCT03760146|75989393|FG000|Evaluable 13-Matched Immunogenicity Population|Overall Study||1435||
59865351|NCT03760146|75989394|FG001|Evaluable 13-Matched Immunogenicity Population|Overall Study||1420||
59865352|NCT03760146|75989395|FG002|Evaluable 13-Matched Immunogenicity Population|Overall Study||0||
59865353|NCT03760146|75989396|FG003|Evaluable 13-Matched Immunogenicity Population|Overall Study||0||
59865354|NCT03760146|75989397|FG004|Evaluable 13-Matched Immunogenicity Population|Overall Study||0||
59865355|NCT03760146|75989398|FG005|Evaluable 13-Matched Immunogenicity Population|Overall Study||0||
59865356|NCT03760146|75989393|FG000|Evaluable 7-Additional Immunogenicity Population|Overall Study||1433||
59865357|NCT03760146|75989394|FG001|Evaluable 7-Additional Immunogenicity Population|Overall Study||1383||
59865358|NCT03760146|75989395|FG002|Evaluable 7-Additional Immunogenicity Population|Overall Study||0||
59865359|NCT03760146|75989396|FG003|Evaluable 7-Additional Immunogenicity Population|Overall Study||0||
59865360|NCT03760146|75989397|FG004|Evaluable 7-Additional Immunogenicity Population|Overall Study||0||
59865361|NCT03760146|75989398|FG005|Evaluable 7-Additional Immunogenicity Population|Overall Study||0||
59865362|NCT03760146|75989393|FG000|Vaccination 1|Overall Study||1507||
59865363|NCT03760146|75989394|FG001|Vaccination 1|Overall Study||1490||
59865364|NCT03760146|75989395|FG002|Vaccination 1|Overall Study||334||
59865365|NCT03760146|75989396|FG003|Vaccination 1|Overall Study||111||
59865366|NCT03760146|75989397|FG004|Vaccination 1|Overall Study||335||
59865367|NCT03760146|75989398|FG005|Vaccination 1|Overall Study||112||
59865368|NCT03760146|75989393|FG000|Vaccination 2|Overall Study||1461||
59865369|NCT03760146|75989394|FG001|Vaccination 2|Overall Study||1446||
59865370|NCT03760146|75989395|FG002|Vaccination 2|Overall Study||0||
59865371|NCT03760146|75989396|FG003|Vaccination 2|Overall Study||0||
59865372|NCT03760146|75989397|FG004|Vaccination 2|Overall Study||0||
59865373|NCT03760146|75989398|FG005|Vaccination 2|Overall Study||0||
59865374|NCT03760146|75989393|FG000|Safety Population|Overall Study||1507||
59865375|NCT03760146|75989394|FG001|Safety Population|Overall Study||1490||
59865376|NCT03760146|75989395|FG002|Safety Population|Overall Study||334||
59865377|NCT03760146|75989396|FG003|Safety Population|Overall Study||111||
59865378|NCT03760146|75989397|FG004|Safety Population|Overall Study||335||
59865379|NCT03760146|75989398|FG005|Safety Population|Overall Study||112||
59865380|NCT03760146|75989393|FG000|Evaluable-20 Immunogenicity Population|Overall Study|Only for 60-64 years of age.|946||
59865381|NCT03760146|75989394|FG001|Evaluable-20 Immunogenicity Population|Overall Study||0||
59865382|NCT03760146|75989395|FG002|Evaluable-20 Immunogenicity Population|Overall Study||321||
59865383|NCT03760146|75989396|FG003|Evaluable-20 Immunogenicity Population|Overall Study||0||
59865384|NCT03760146|75989397|FG004|Evaluable-20 Immunogenicity Population|Overall Study||317||
59865385|NCT03760146|75989398|FG005|Evaluable-20 Immunogenicity Population|Overall Study||0||
59865386|NCT03760146|75989393|FG000|COMPLETED|Overall Study||1418||
59865387|NCT03760146|75989394|FG001|COMPLETED|Overall Study||1417||
59865388|NCT03760146|75989395|FG002|COMPLETED|Overall Study||323||
59865389|NCT03760146|75989396|FG003|COMPLETED|Overall Study||109||
59865390|NCT03760146|75989397|FG004|COMPLETED|Overall Study||319||
59865391|NCT03760146|75989398|FG005|COMPLETED|Overall Study||104||
59865392|NCT03760146|75989393|FG000|NOT COMPLETED|Overall Study||96||
59865393|NCT03760146|75989394|FG001|NOT COMPLETED|Overall Study||78||
59865394|NCT03760146|75989395|FG002|NOT COMPLETED|Overall Study||11||
59865395|NCT03760146|75989396|FG003|NOT COMPLETED|Overall Study||2||
59865396|NCT03760146|75989397|FG004|NOT COMPLETED|Overall Study||17||
59865397|NCT03760146|75989398|FG005|NOT COMPLETED|Overall Study||8||
59865398|NCT03877068|75989418|FG000|STARTED|Overall Study||94|Started inpatient portion of the study|
59865399|NCT03877068|75989419|FG001|STARTED|Overall Study||91|Started inpatient portion of the study|
59865400|NCT03877068|75989418|FG000|Began Optional Outpatient Portion of Study|Overall Study||52||
59865401|NCT03877068|75989419|FG001|Began Optional Outpatient Portion of Study|Overall Study||53||
59865402|NCT03877068|75989418|FG000|Completed Optional Outpatient Portion of Study|Overall Study||41||
59865403|NCT03877068|75989419|FG001|Completed Optional Outpatient Portion of Study|Overall Study||44||
59865404|NCT03877068|75989418|FG000|COMPLETED|Overall Study||85|Completed inpatient portion of the study|
59865405|NCT03877068|75989419|FG001|COMPLETED|Overall Study||88|Completed inpatient portion of the study|
59865406|NCT03877068|75989418|FG000|NOT COMPLETED|Overall Study||9||
59865407|NCT03877068|75989419|FG001|NOT COMPLETED|Overall Study||3||
59865408|NCT03760068|75989429|FG000|STARTED|Overall Study||238||
59865409|NCT03760068|75989430|FG001|STARTED|Overall Study||240||
59865410|NCT03760068|75989429|FG000|COMPLETED|Overall Study||224||
59865411|NCT03760068|75989430|FG001|COMPLETED|Overall Study||217||
59865412|NCT03760068|75989429|FG000|NOT COMPLETED|Overall Study||14||
59865413|NCT03760068|75989430|FG001|NOT COMPLETED|Overall Study||23||
59865414|NCT03759600|75989437|FG000|STARTED|Overall Study||20||
59865415|NCT03759600|75989437|FG000|COMPLETED|Overall Study||0||
59865416|NCT03759600|75989437|FG000|NOT COMPLETED|Overall Study||20||
59865417|NCT04724733|75989444|FG000|STARTED|Overall Study||22||
59865418|NCT04724733|75989445|FG001|STARTED|Overall Study||22||
59865419|NCT04724733|75989446|FG002|STARTED|Overall Study||23||
59865420|NCT04724733|75989444|FG000|4 Weeks|Overall Study||22||
59865421|NCT04724733|75989445|FG001|4 Weeks|Overall Study||21||
59865422|NCT04724733|75989446|FG002|4 Weeks|Overall Study||23||
59865423|NCT04724733|75989444|FG000|COMPLETED|Overall Study||21||
59865424|NCT04724733|75989445|FG001|COMPLETED|Overall Study||21||
59865425|NCT04724733|75989446|FG002|COMPLETED|Overall Study||22||
59865426|NCT04724733|75989444|FG000|NOT COMPLETED|Overall Study||1||
59865427|NCT04724733|75989445|FG001|NOT COMPLETED|Overall Study||1||
59865428|NCT04724733|75989446|FG002|NOT COMPLETED|Overall Study||1||
59865429|NCT04635839|75989456|FG000|STARTED|Overall Study||22||
59865430|NCT04635839|75989457|FG001|STARTED|Overall Study||24||
59865431|NCT04635839|75989456|FG000|COMPLETED|Overall Study||21||
59865432|NCT04635839|75989457|FG001|COMPLETED|Overall Study||24||
59865433|NCT04635839|75989456|FG000|NOT COMPLETED|Overall Study||1||
59865434|NCT04635839|75989457|FG001|NOT COMPLETED|Overall Study||0||
59865435|NCT04493502|75989465|FG000|STARTED|Double Blind Treatment (Week 0 - 16)||24||
59865436|NCT04493502|75989466|FG001|STARTED|Double Blind Treatment (Week 0 - 16)||48||
59865437|NCT04493502|75989465|FG000|Received at Least One Dose of Study Drug|Double Blind Treatment (Week 0 - 16)||22||
59865438|NCT04493502|75989466|FG001|Received at Least One Dose of Study Drug|Double Blind Treatment (Week 0 - 16)||45||
59865439|NCT04493502|75989465|FG000|COMPLETED|Double Blind Treatment (Week 0 - 16)||14||
59865440|NCT04493502|75989466|FG001|COMPLETED|Double Blind Treatment (Week 0 - 16)||38||
59865441|NCT04493502|75989465|FG000|NOT COMPLETED|Double Blind Treatment (Week 0 - 16)||10||
59865442|NCT04493502|75989466|FG001|NOT COMPLETED|Double Blind Treatment (Week 0 - 16)||10||
59865443|NCT04493502|75989465|FG000|STARTED|Open-label Extension (Week 16 - 36)||14||
59865444|NCT04493502|75989466|FG001|STARTED|Open-label Extension (Week 16 - 36)||38||
59865445|NCT04493502|75989465|FG000|Received at Least One Dose of Study Drug|Open-label Extension (Week 16 - 36)||13||
59865446|NCT04493502|75989466|FG001|Received at Least One Dose of Study Drug|Open-label Extension (Week 16 - 36)||36||
59865447|NCT04493502|75989465|FG000|COMPLETED|Open-label Extension (Week 16 - 36)||10||
59865448|NCT04493502|75989466|FG001|COMPLETED|Open-label Extension (Week 16 - 36)||29||
59865449|NCT04493502|75989465|FG000|NOT COMPLETED|Open-label Extension (Week 16 - 36)||4||
59865450|NCT04493502|75989466|FG001|NOT COMPLETED|Open-label Extension (Week 16 - 36)||9||
59865451|NCT04493502|75989465|FG000|STARTED|Post-treatment Follow-up (10 Weeks)||10||
59865452|NCT04493502|75989466|FG001|STARTED|Post-treatment Follow-up (10 Weeks)||29||
59865453|NCT04493502|75989465|FG000|COMPLETED|Post-treatment Follow-up (10 Weeks)||8||
59865454|NCT04493502|75989466|FG001|COMPLETED|Post-treatment Follow-up (10 Weeks)||24||
59865455|NCT04493502|75989465|FG000|NOT COMPLETED|Post-treatment Follow-up (10 Weeks)||2||
59865456|NCT04493502|75989466|FG001|NOT COMPLETED|Post-treatment Follow-up (10 Weeks)||5||
59865457|NCT04147858|75989477|FG000|STARTED|Overall Study||101||
59865458|NCT04147858|75989478|FG001|STARTED|Overall Study||104||
59865459|NCT04147858|75989479|FG002|STARTED|Overall Study|One subject in the placebo group did not have post baseline efficacy measurements and is not included in efficacy results presented.|105||
59865460|NCT04147858|75989477|FG000|COMPLETED|Overall Study||84||
59865461|NCT04147858|75989478|FG001|COMPLETED|Overall Study||82||
59865462|NCT04147858|75989479|FG002|COMPLETED|Overall Study||85||
59865463|NCT04147858|75989477|FG000|NOT COMPLETED|Overall Study||17||
59865464|NCT04147858|75989478|FG001|NOT COMPLETED|Overall Study||22||
59865465|NCT04147858|75989479|FG002|NOT COMPLETED|Overall Study||20||
59865466|NCT04146896|75989489|FG000|STARTED|Overall Study||114||
59865467|NCT04146896|75989490|FG001|STARTED|Overall Study||114||
59865468|NCT04146896|75989489|FG000|COMPLETED|Overall Study||97||
59865469|NCT04146896|75989490|FG001|COMPLETED|Overall Study||92||
59865470|NCT04146896|75989489|FG000|NOT COMPLETED|Overall Study||17||
59865471|NCT04146896|75989490|FG001|NOT COMPLETED|Overall Study||22||
59865472|NCT04072887|75989502|FG000|STARTED|Overall Study||99|All randomized participants|
59865473|NCT04072887|75989503|FG001|STARTED|Overall Study||250|All randomized participants|
59865474|NCT04072887|75989504|FG002|STARTED|Overall Study||124|All randomized participants|
59865475|NCT04072887|75989505|FG003|STARTED|Overall Study||126|All randomized participants|
59865476|NCT04072887|75989506|FG004|STARTED|Overall Study||124|All randomized participants|
59865477|NCT04072887|75989507|FG005|STARTED|Overall Study||251|All randomized participants|
59865478|NCT04072887|75989502|FG000|Pharmacokinetic (PK) Set|Overall Study||99|All randomized participants who have at least one evaluable concentration data sample|
59865479|NCT04072887|75989503|FG001|Pharmacokinetic (PK) Set|Overall Study||250|All randomized participants who have at least one evaluable concentration data sample|
59865480|NCT04072887|75989504|FG002|Pharmacokinetic (PK) Set|Overall Study||123|All randomized participants who have at least one evaluable concentration data sample|
59865481|NCT04072887|75989505|FG003|Pharmacokinetic (PK) Set|Overall Study||126|All randomized participants who have at least one evaluable concentration data sample|
59865482|NCT04072887|75989506|FG004|Pharmacokinetic (PK) Set|Overall Study||124|All randomized participants who have at least one evaluable concentration data sample|
59999795|NCT01782131|76115510|FG000|NOT COMPLETED|Overall Study||109||
59865483|NCT04072887|75989507|FG005|Pharmacokinetic (PK) Set|Overall Study||0|All randomized participants who have at least one evaluable concentration data sample|
59865484|NCT04072887|75989502|FG000|Serial Pharmacokinetic (PK) Set|Overall Study||14|The Serial PK set includes the participants who consented to participate in the PK serial subgroup|
59865485|NCT04072887|75989503|FG001|Serial Pharmacokinetic (PK) Set|Overall Study||21|The Serial PK set includes the participants who consented to participate in the PK serial subgroup|
59865486|NCT04072887|75989504|FG002|Serial Pharmacokinetic (PK) Set|Overall Study||14|The Serial PK set includes the participants who consented to participate in the PK serial subgroup|
59865487|NCT04072887|75989505|FG003|Serial Pharmacokinetic (PK) Set|Overall Study||13|The Serial PK set includes the participants who consented to participate in the PK serial subgroup|
59865488|NCT04072887|75989506|FG004|Serial Pharmacokinetic (PK) Set|Overall Study||14|The Serial PK set includes the participants who consented to participate in the PK serial subgroup|
59865489|NCT04072887|75989507|FG005|Serial Pharmacokinetic (PK) Set|Overall Study||0|The Serial PK set includes the participants who consented to participate in the PK serial subgroup|
59865490|NCT04072887|75989502|FG000|COMPLETED|Overall Study|QBW251 450 mg arm was discontinued early based on a pre-defined pharmacokinetic exposure stopping rule.|91||
59865491|NCT04072887|75989503|FG001|COMPLETED|Overall Study||233||
59865492|NCT04072887|75989504|FG002|COMPLETED|Overall Study||122||
59865493|NCT04072887|75989505|FG003|COMPLETED|Overall Study||117||
59865494|NCT04072887|75989506|FG004|COMPLETED|Overall Study||118||
59865495|NCT04072887|75989507|FG005|COMPLETED|Overall Study||236||
59865496|NCT04072887|75989502|FG000|NOT COMPLETED|Overall Study||8||
59865497|NCT04072887|75989503|FG001|NOT COMPLETED|Overall Study||17||
59865498|NCT04072887|75989504|FG002|NOT COMPLETED|Overall Study||2||
59865499|NCT04072887|75989505|FG003|NOT COMPLETED|Overall Study||9||
59865500|NCT04072887|75989506|FG004|NOT COMPLETED|Overall Study||6||
59865501|NCT04072887|75989507|FG005|NOT COMPLETED|Overall Study||15||
59865502|NCT03972813|75989545|FG000|STARTED|Overall Study||85||
59865503|NCT03972813|75989546|FG001|STARTED|Overall Study||49||
59865504|NCT03972813|75989547|FG002|STARTED|Overall Study||58||
59865505|NCT03972813|75989548|FG003|STARTED|Overall Study||55||
59865506|NCT03972813|75989549|FG004|STARTED|Overall Study||52||
59865507|NCT03972813|75989550|FG005|STARTED|Overall Study||51||
59865508|NCT03972813|75989551|FG006|STARTED|Overall Study||53||
59865509|NCT03972813|75989552|FG007|STARTED|Overall Study||55||
59865510|NCT03972813|75989553|FG008|STARTED|Overall Study||58||
59865511|NCT03972813|75989554|FG009|STARTED|Overall Study||60||
59865512|NCT03972813|75989555|FG010|STARTED|Overall Study||62||
59865513|NCT03972813|75989556|FG011|STARTED|Overall Study||55||
59865514|NCT03972813|75989557|FG012|STARTED|Overall Study||58||
59865515|NCT03972813|75989558|FG013|STARTED|Overall Study||55||
59865516|NCT03972813|75989559|FG014|STARTED|Overall Study||58||
59865517|NCT03972813|75989560|FG015|STARTED|Overall Study||56||
59865518|NCT03972813|75989561|FG016|STARTED|Overall Study||51||
59865519|NCT03972813|75989562|FG017|STARTED|Overall Study||50||
59865520|NCT03972813|75989545|FG000|COMPLETED|Overall Study||79|68 individuals completed the survey but did not answer the outcome|
59865521|NCT03972813|75989546|FG001|COMPLETED|Overall Study||45|68 individuals completed the survey but did not answer the outcome|
59865522|NCT03972813|75989547|FG002|COMPLETED|Overall Study||52|68 individuals completed the survey but did not answer the outcome|
59865523|NCT03972813|75989548|FG003|COMPLETED|Overall Study||51|68 individuals completed the survey but did not answer the outcome|
59865524|NCT03972813|75989549|FG004|COMPLETED|Overall Study||48|68 individuals completed the survey but did not answer the outcome|
59865525|NCT03972813|75989550|FG005|COMPLETED|Overall Study||49|68 individuals completed the survey but did not answer the outcome|
59865526|NCT03972813|75989551|FG006|COMPLETED|Overall Study||49|68 individuals completed the survey but did not answer the outcome|
59865527|NCT03972813|75989552|FG007|COMPLETED|Overall Study||52|68 individuals completed the survey but did not answer the outcome|
59865528|NCT03972813|75989553|FG008|COMPLETED|Overall Study||53|68 individuals completed the survey but did not answer the outcome|
59865529|NCT03972813|75989554|FG009|COMPLETED|Overall Study||58|68 individuals completed the survey but did not answer the outcome|
59865530|NCT03972813|75989555|FG010|COMPLETED|Overall Study||57|68 individuals completed the survey but did not answer the outcome|
59865531|NCT03972813|75989556|FG011|COMPLETED|Overall Study||51|68 individuals completed the survey but did not answer the outcome|
59865532|NCT03972813|75989557|FG012|COMPLETED|Overall Study||55|68 individuals completed the survey but did not answer the outcome|
59865533|NCT03972813|75989558|FG013|COMPLETED|Overall Study||52|68 individuals completed the survey but did not answer the outcome|
59865534|NCT03972813|75989559|FG014|COMPLETED|Overall Study||56|68 individuals completed the survey but did not answer the outcome|
59865535|NCT03972813|75989560|FG015|COMPLETED|Overall Study||50|68 individuals completed the survey but did not answer the outcome|
59865536|NCT03972813|75989561|FG016|COMPLETED|Overall Study||48|68 individuals completed the survey but did not answer the outcome|
59865537|NCT03972813|75989562|FG017|COMPLETED|Overall Study||48|68 individuals completed the survey but did not answer the outcome|
59865538|NCT03972813|75989545|FG000|NOT COMPLETED|Overall Study||6||
59865539|NCT03972813|75989546|FG001|NOT COMPLETED|Overall Study||4||
59865540|NCT03972813|75989547|FG002|NOT COMPLETED|Overall Study||6||
59865541|NCT03972813|75989548|FG003|NOT COMPLETED|Overall Study||4||
59865542|NCT03972813|75989549|FG004|NOT COMPLETED|Overall Study||4||
59865543|NCT03972813|75989550|FG005|NOT COMPLETED|Overall Study||2||
59865544|NCT03972813|75989551|FG006|NOT COMPLETED|Overall Study||4||
59865545|NCT03972813|75989552|FG007|NOT COMPLETED|Overall Study||3||
59865546|NCT03972813|75989553|FG008|NOT COMPLETED|Overall Study||5||
59865547|NCT03972813|75989554|FG009|NOT COMPLETED|Overall Study||2||
59865548|NCT03972813|75989555|FG010|NOT COMPLETED|Overall Study||5||
59865549|NCT03972813|75989556|FG011|NOT COMPLETED|Overall Study||4||
59865550|NCT03972813|75989557|FG012|NOT COMPLETED|Overall Study||3||
59865551|NCT03972813|75989558|FG013|NOT COMPLETED|Overall Study||3||
59865552|NCT03972813|75989559|FG014|NOT COMPLETED|Overall Study||2||
59865553|NCT03972813|75989560|FG015|NOT COMPLETED|Overall Study||6||
59865554|NCT03972813|75989561|FG016|NOT COMPLETED|Overall Study||3||
59865555|NCT03972813|75989562|FG017|NOT COMPLETED|Overall Study||2||
59865556|NCT03516812|75989600|FG000|STARTED|Overall Study||36||
59865557|NCT03516812|75989600|FG000|COMPLETED|Overall Study||30||
59865558|NCT03516812|75989600|FG000|NOT COMPLETED|Overall Study||6||
59865559|NCT03440047|75989604|FG000|STARTED|Overall Study||355||
59865560|NCT03440047|75989604|FG000|COMPLETED|Overall Study||353||
59865561|NCT03440047|75989604|FG000|NOT COMPLETED|Overall Study||2||
59865562|NCT03397134|75989611|FG000|STARTED|Double Blind||0||
59865563|NCT03397134|75989612|FG001|STARTED|Double Blind||0||
59865564|NCT03397134|75989613|FG002|STARTED|Double Blind||170||
59865565|NCT03397134|75989614|FG003|STARTED|Double Blind||171||
59865566|NCT03397134|75989615|FG004|STARTED|Double Blind||172||
59865567|NCT03397134|75989611|FG000|COMPLETED|Double Blind||0||
59865568|NCT03397134|75989612|FG001|COMPLETED|Double Blind||0||
59865569|NCT03397134|75989613|FG002|COMPLETED|Double Blind||107||
59865570|NCT03397134|75989614|FG003|COMPLETED|Double Blind||104||
59865571|NCT03397134|75989615|FG004|COMPLETED|Double Blind||122||
59865572|NCT03397134|75989611|FG000|NOT COMPLETED|Double Blind||0||
59865573|NCT03397134|75989612|FG001|NOT COMPLETED|Double Blind||0||
59865574|NCT03397134|75989613|FG002|NOT COMPLETED|Double Blind||63||
59865575|NCT03397134|75989614|FG003|NOT COMPLETED|Double Blind||67||
59865576|NCT03397134|75989615|FG004|NOT COMPLETED|Double Blind||50||
59865577|NCT03397134|75989611|FG000|STARTED|Open-Label Extension||59||
59865578|NCT03397134|75989612|FG001|STARTED|Open-Label Extension||63||
59865579|NCT03397134|75989613|FG002|STARTED|Open-Label Extension||107||
59865580|NCT03397134|75989614|FG003|STARTED|Open-Label Extension||104||
59865581|NCT03397134|75989615|FG004|STARTED|Open-Label Extension||0||
59865582|NCT03397134|75989611|FG000|COMPLETED|Open-Label Extension||35||
59865583|NCT03397134|75989612|FG001|COMPLETED|Open-Label Extension||36||
59865584|NCT03397134|75989613|FG002|COMPLETED|Open-Label Extension||72||
59865585|NCT03397134|75989614|FG003|COMPLETED|Open-Label Extension||59||
59865586|NCT03397134|75989615|FG004|COMPLETED|Open-Label Extension||0||
59865587|NCT03397134|75989611|FG000|NOT COMPLETED|Open-Label Extension||24||
59865588|NCT03397134|75989612|FG001|NOT COMPLETED|Open-Label Extension||27||
59865589|NCT03397134|75989613|FG002|NOT COMPLETED|Open-Label Extension||35||
59865590|NCT03397134|75989614|FG003|NOT COMPLETED|Open-Label Extension||45||
59865591|NCT03397134|75989615|FG004|NOT COMPLETED|Open-Label Extension||0||
59865592|NCT03397134|75989611|FG000|STARTED|Whole Study||0|"Patients who were initially randomized in the double-blind to Roluperidone 32 mg or Roluperidone 64 mg continued treatment with the same dose during the 40-week open-label treatment extension, while patients who were initially randomized to placebo crossed over to Roluperidone 32 mg or Roluperidone 64 mg in a 1:1 ratio.~The entire study included the double-blind and open-label periods from Baseline to Week 54, referred to as the whole study period."|
59865593|NCT03397134|75989612|FG001|STARTED|Whole Study||0|"Patients who were initially randomized in the double-blind to Roluperidone 32 mg or Roluperidone 64 mg continued treatment with the same dose during the 40-week open-label treatment extension, while patients who were initially randomized to placebo crossed over to Roluperidone 32 mg or Roluperidone 64 mg in a 1:1 ratio.~The entire study included the double-blind and open-label periods from Baseline to Week 54, referred to as the whole study period."|
59865594|NCT03397134|75989613|FG002|STARTED|Whole Study||229|"Patients who were initially randomized in the double-blind to Roluperidone 32 mg or Roluperidone 64 mg continued treatment with the same dose during the 40-week open-label treatment extension, while patients who were initially randomized to placebo crossed over to Roluperidone 32 mg or Roluperidone 64 mg in a 1:1 ratio.~The entire study included the double-blind and open-label periods from Baseline to Week 54, referred to as the whole study period."|
59865595|NCT03397134|75989614|FG003|STARTED|Whole Study||234|"Patients who were initially randomized in the double-blind to Roluperidone 32 mg or Roluperidone 64 mg continued treatment with the same dose during the 40-week open-label treatment extension, while patients who were initially randomized to placebo crossed over to Roluperidone 32 mg or Roluperidone 64 mg in a 1:1 ratio.~The entire study included the double-blind and open-label periods from Baseline to Week 54, referred to as the whole study period."|
59865596|NCT03397134|75989615|FG004|STARTED|Whole Study||50|"Patients who were initially randomized in the double-blind to Roluperidone 32 mg or Roluperidone 64 mg continued treatment with the same dose during the 40-week open-label treatment extension, while patients who were initially randomized to placebo crossed over to Roluperidone 32 mg or Roluperidone 64 mg in a 1:1 ratio.~The entire study included the double-blind and open-label periods from Baseline to Week 54, referred to as the whole study period."|
59865597|NCT03397134|75989611|FG000|COMPLETED|Whole Study||0||
59865598|NCT03397134|75989612|FG001|COMPLETED|Whole Study||0||
59865599|NCT03397134|75989613|FG002|COMPLETED|Whole Study||107||
59865600|NCT03397134|75989614|FG003|COMPLETED|Whole Study||95||
59865601|NCT03397134|75989615|FG004|COMPLETED|Whole Study||0||
59865602|NCT03397134|75989611|FG000|NOT COMPLETED|Whole Study||0||
59865603|NCT03397134|75989612|FG001|NOT COMPLETED|Whole Study||0||
59865604|NCT03397134|75989613|FG002|NOT COMPLETED|Whole Study||122||
59865605|NCT03397134|75989614|FG003|NOT COMPLETED|Whole Study||139||
59865606|NCT03397134|75989615|FG004|NOT COMPLETED|Whole Study||50||
59865607|NCT03122119|75989635|FG000|STARTED|Overall Study||51||
59865608|NCT03122119|75989635|FG000|COMPLETED|Overall Study||50||
59865609|NCT03122119|75989635|FG000|NOT COMPLETED|Overall Study||1||
59865610|NCT02613169|75989641|FG000|STARTED|Overall Study||150||
59865611|NCT02613169|75989642|FG001|STARTED|Overall Study||150||
59865612|NCT02613169|75989641|FG000|COMPLETED|Overall Study||132||
59865613|NCT02613169|75989642|FG001|COMPLETED|Overall Study||133||
59865614|NCT02613169|75989641|FG000|NOT COMPLETED|Overall Study||18||
59865615|NCT02613169|75989642|FG001|NOT COMPLETED|Overall Study||17||
59865616|NCT01974765|75989648|FG000|STARTED|Overall Study||59||
59865617|NCT01974765|75989648|FG000|COMPLETED|Overall Study||55||
59865618|NCT01974765|75989648|FG000|NOT COMPLETED|Overall Study||4||
59865619|NCT01725217|75989655|FG000|STARTED|Overall Study||66||
59865620|NCT01725217|75989656|FG001|STARTED|Overall Study||66||
59865621|NCT01725217|75989657|FG002|STARTED|Overall Study||66||
59865622|NCT01725217|75989655|FG000|COMPLETED|Overall Study||65||
59865623|NCT01725217|75989656|FG001|COMPLETED|Overall Study||66||
59865624|NCT01725217|75989657|FG002|COMPLETED|Overall Study||66||
59865625|NCT01725217|75989655|FG000|NOT COMPLETED|Overall Study||1||
59865626|NCT01725217|75989656|FG001|NOT COMPLETED|Overall Study||0||
59865627|NCT01725217|75989657|FG002|NOT COMPLETED|Overall Study||0||
59865628|NCT01369212|75989676|FG000|STARTED|Overall Study||102||
59865629|NCT01369212|75989677|FG001|STARTED|Overall Study||99||
59865630|NCT01369212|75989676|FG000|COMPLETED|Overall Study||95||
59865631|NCT01369212|75989677|FG001|COMPLETED|Overall Study||92||
59865632|NCT01369212|75989676|FG000|NOT COMPLETED|Overall Study||7||
59865633|NCT01369212|75989677|FG001|NOT COMPLETED|Overall Study||7||
59865634|NCT01344057|75989683|FG000|STARTED|Overall Study||63||
59865635|NCT01344057|75989683|FG000|COMPLETED|Overall Study||62||
59865636|NCT01344057|75989683|FG000|NOT COMPLETED|Overall Study||1||
59865637|NCT00886782|75989690|FG000|STARTED|Overall Study||3||
59865638|NCT00886782|75989691|FG001|STARTED|Overall Study||3||
59865639|NCT00886782|75989692|FG002|STARTED|Overall Study||5||
59865640|NCT00886782|75989690|FG000|COMPLETED|Overall Study||0||
59865641|NCT00886782|75989691|FG001|COMPLETED|Overall Study||0||
59865642|NCT00886782|75989692|FG002|COMPLETED|Overall Study||0||
59865643|NCT00886782|75989690|FG000|NOT COMPLETED|Overall Study||3||
59865644|NCT00886782|75989691|FG001|NOT COMPLETED|Overall Study||3||
59865645|NCT00886782|75989692|FG002|NOT COMPLETED|Overall Study||5||
59865646|NCT00583024|75989700|FG000|STARTED|Overall Study||32||
59865647|NCT00583024|75989700|FG000|COMPLETED|Overall Study||28||
59865648|NCT00583024|75989700|FG000|NOT COMPLETED|Overall Study||4||
59865649|NCT03435640|75989715|FG000|STARTED|Overall Study||3||
59865650|NCT03435640|75989716|FG001|STARTED|Overall Study||3||
59865651|NCT03435640|75989717|FG002|STARTED|Overall Study||4||
59865652|NCT03435640|75989718|FG003|STARTED|Overall Study||3||
59865653|NCT03435640|75989719|FG004|STARTED|Overall Study||4||
59865654|NCT03435640|75989720|FG005|STARTED|Overall Study||4||
59865655|NCT03435640|75989721|FG006|STARTED|Overall Study||4||
59865656|NCT03435640|75989722|FG007|STARTED|Overall Study||3||
59865657|NCT03435640|75989723|FG008|STARTED|Overall Study||8||
59865658|NCT03435640|75989724|FG009|STARTED|Overall Study||14||
59865659|NCT03435640|75989725|FG010|STARTED|Overall Study||14||
59865660|NCT03435640|75989715|FG000|COMPLETED|Overall Study||3||
59865661|NCT03435640|75989716|FG001|COMPLETED|Overall Study||2||
59865662|NCT03435640|75989717|FG002|COMPLETED|Overall Study||3||
59865663|NCT03435640|75989718|FG003|COMPLETED|Overall Study||1||
59865664|NCT03435640|75989719|FG004|COMPLETED|Overall Study||4||
59865665|NCT03435640|75989720|FG005|COMPLETED|Overall Study||4||
59865666|NCT03435640|75989721|FG006|COMPLETED|Overall Study||1||
59865667|NCT03435640|75989722|FG007|COMPLETED|Overall Study||3||
59865668|NCT03435640|75989723|FG008|COMPLETED|Overall Study||8||
59865669|NCT03435640|75989724|FG009|COMPLETED|Overall Study||12||
59865670|NCT03435640|75989725|FG010|COMPLETED|Overall Study||11||
59865671|NCT03435640|75989715|FG000|NOT COMPLETED|Overall Study||0||
59865672|NCT03435640|75989716|FG001|NOT COMPLETED|Overall Study||1||
59865673|NCT03435640|75989717|FG002|NOT COMPLETED|Overall Study||1||
59865674|NCT03435640|75989718|FG003|NOT COMPLETED|Overall Study||2||
59865675|NCT03435640|75989719|FG004|NOT COMPLETED|Overall Study||0||
59865676|NCT03435640|75989720|FG005|NOT COMPLETED|Overall Study||0||
59865677|NCT03435640|75989721|FG006|NOT COMPLETED|Overall Study||3||
59865678|NCT03435640|75989722|FG007|NOT COMPLETED|Overall Study||0||
59865679|NCT03435640|75989723|FG008|NOT COMPLETED|Overall Study||0||
59865680|NCT03435640|75989724|FG009|NOT COMPLETED|Overall Study||2||
59865681|NCT03435640|75989725|FG010|NOT COMPLETED|Overall Study||3||
59865682|NCT00655876|75989753|FG000|STARTED|Overall Study||168||
59865683|NCT00655876|75989754|FG001|STARTED|Overall Study||176||
59865684|NCT00655876|75989753|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|159||
59865685|NCT00655876|75989754|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|169||
59865686|NCT00655876|75989753|FG000|NOT COMPLETED|Overall Study||9||
59865687|NCT00655876|75989754|FG001|NOT COMPLETED|Overall Study||7||
59865688|NCT03092752|75989760|FG000|STARTED|Overall Study||523585|Data for these patients was available in database.|
59865689|NCT03092752|75989760|FG000|COMPLETED|Overall Study||162116|These many patients satisfies the inclusion criteria and hence included in the study.|
59865690|NCT03092752|75989760|FG000|NOT COMPLETED|Overall Study||361469||
59865691|NCT03750552|75989783|FG000|STARTED|Overall Study||98||
59865692|NCT03750552|75989784|FG001|STARTED|Overall Study||97||
59865693|NCT03750552|75989783|FG000|Safety Analysis Set|Overall Study||96||
59865694|NCT03750552|75989784|FG001|Safety Analysis Set|Overall Study||90||
59865695|NCT03750552|75989783|FG000|Full Analysis Set|Overall Study||94||
59865696|NCT03750552|75989784|FG001|Full Analysis Set|Overall Study||90||
59865697|NCT03750552|75989783|FG000|COMPLETED|Overall Study||90||
59865698|NCT03750552|75989784|FG001|COMPLETED|Overall Study||95||
59865699|NCT03750552|75989783|FG000|NOT COMPLETED|Overall Study||8||
59865700|NCT03750552|75989784|FG001|NOT COMPLETED|Overall Study||2||
59865701|NCT03750240|75989791|FG000|STARTED|Overall Study||2||
59865702|NCT03750240|75989791|FG000|COMPLETED|Overall Study||0||
59865703|NCT03750240|75989791|FG000|NOT COMPLETED|Overall Study||2||
59865704|NCT03091738|75989795|FG000|STARTED|Overall Study||10||
59865705|NCT03091738|75989795|FG000|COMPLETED|Overall Study||8||
59865706|NCT03091738|75989795|FG000|NOT COMPLETED|Overall Study||2||
59865707|NCT03193216|75989801|FG000|STARTED|Overall Study||24||
59865708|NCT03193216|75989802|FG001|STARTED|Overall Study||21||
59865709|NCT03193216|75989801|FG000|COMPLETED|Overall Study||14||
59865710|NCT03193216|75989802|FG001|COMPLETED|Overall Study||21||
59865711|NCT03193216|75989801|FG000|NOT COMPLETED|Overall Study||10||
59865712|NCT03193216|75989802|FG001|NOT COMPLETED|Overall Study||0||
59865713|NCT03091348|75989810|FG000|STARTED|Overall Study||2||
59865714|NCT03091348|75989811|FG001|STARTED|Overall Study||2||
59865715|NCT03091348|75989810|FG000|COMPLETED|Overall Study||0||
59865716|NCT03091348|75989811|FG001|COMPLETED|Overall Study||1||
59865717|NCT03091348|75989810|FG000|NOT COMPLETED|Overall Study||2||
59865718|NCT03091348|75989811|FG001|NOT COMPLETED|Overall Study||1||
59865719|NCT03751098|75989818|FG000|STARTED|Overall Study||37||74
59865720|NCT03751098|75989819|FG001|STARTED|Overall Study||33||66
59865721|NCT03751098|75989818|FG000|COMPLETED|Overall Study||37||74
59865722|NCT03751098|75989819|FG001|COMPLETED|Overall Study||32||64
59865723|NCT03751098|75989818|FG000|NOT COMPLETED|Overall Study||0||0
59865724|NCT03751098|75989819|FG001|NOT COMPLETED|Overall Study||1||2
59865725|NCT03751020|75989830|FG000|STARTED|Overall Study||36||
59865726|NCT03751020|75989831|FG001|STARTED|Overall Study||36||
59865727|NCT03751020|75989832|FG002|STARTED|Overall Study||36||
59865728|NCT03751020|75989830|FG000|Post Intervention|Overall Study||33||
59865729|NCT03751020|75989831|FG001|Post Intervention|Overall Study||33||
59865730|NCT03751020|75989832|FG002|Post Intervention|Overall Study||30||
59865731|NCT03751020|75989830|FG000|3 Month Follow Up|Overall Study||27||
59865732|NCT03751020|75989831|FG001|3 Month Follow Up|Overall Study||32||
59865733|NCT03751020|75989832|FG002|3 Month Follow Up|Overall Study||26||
59865734|NCT03751020|75989830|FG000|COMPLETED|Overall Study||27||
59865735|NCT03751020|75989831|FG001|COMPLETED|Overall Study||32||
59865736|NCT03751020|75989832|FG002|COMPLETED|Overall Study||26||
59865737|NCT03751020|75989830|FG000|NOT COMPLETED|Overall Study||9||
59865738|NCT03751020|75989831|FG001|NOT COMPLETED|Overall Study||4||
59865739|NCT03751020|75989832|FG002|NOT COMPLETED|Overall Study||10||
59865740|NCT03090100|75989842|FG000|STARTED|Overall Study||534||
59865741|NCT03090100|75989843|FG001|STARTED|Overall Study||514||
59865742|NCT03090100|75989842|FG000|Treated|Overall Study||534||
59865743|NCT03090100|75989843|FG001|Treated|Overall Study||511||
59865744|NCT03090100|75989842|FG000|COMPLETED|Overall Study||507||
59865745|NCT03090100|75989843|FG001|COMPLETED|Overall Study||466||
59865746|NCT03090100|75989842|FG000|NOT COMPLETED|Overall Study||27||
59865747|NCT03090100|75989843|FG001|NOT COMPLETED|Overall Study||48||
59865748|NCT03089944|75989849|FG000|STARTED|Overall Study||343||
59865749|NCT03089944|75989849|FG000|COMPLETED|Overall Study||331||
59865750|NCT03089944|75989849|FG000|NOT COMPLETED|Overall Study||12||
59865751|NCT03101566|75989855|FG000|STARTED|Overall Study||37||
59865752|NCT03101566|75989856|FG001|STARTED|Overall Study||38||
59865753|NCT03101566|75989855|FG000|Received at Least One Dose of Protocol Therapy|Overall Study||35||
59865754|NCT03101566|75989856|FG001|Received at Least One Dose of Protocol Therapy|Overall Study||33||
59865755|NCT03101566|75989855|FG000|Assessed for Primary and Secondary Progression-free Survival|Overall Study||32||
59865756|NCT03101566|75989856|FG001|Assessed for Primary and Secondary Progression-free Survival|Overall Study||33||
59865757|NCT03101566|75989855|FG000|COMPLETED|Overall Study||31||
59865758|NCT03101566|75989856|FG001|COMPLETED|Overall Study||31||
59865759|NCT03101566|75989855|FG000|NOT COMPLETED|Overall Study||6||
59865760|NCT03101566|75989856|FG001|NOT COMPLETED|Overall Study||7||
59865761|NCT03739866|75989872|FG000|STARTED|Overall Study||6||
59865762|NCT03739866|75989873|FG001|STARTED|Overall Study||6||
59865763|NCT03739866|75989874|FG002|STARTED|Overall Study||7||
59865764|NCT03739866|75989875|FG003|STARTED|Overall Study||6||
59865765|NCT03739866|75989876|FG004|STARTED|Overall Study||6||
59865766|NCT03739866|75989877|FG005|STARTED|Overall Study||10||
59865767|NCT03739866|75989878|FG006|STARTED|Overall Study||7||
59865768|NCT03739866|75989879|FG007|STARTED|Overall Study||5||
59865769|NCT03739866|75989872|FG000|COMPLETED|Overall Study||6||
59865770|NCT03739866|75989873|FG001|COMPLETED|Overall Study||6||
59865771|NCT03739866|75989874|FG002|COMPLETED|Overall Study||6||
59865772|NCT03739866|75989875|FG003|COMPLETED|Overall Study||5||
59865773|NCT03739866|75989876|FG004|COMPLETED|Overall Study||5||
59865774|NCT03739866|75989877|FG005|COMPLETED|Overall Study||10||
59865775|NCT03739866|75989878|FG006|COMPLETED|Overall Study||7||
59865776|NCT03739866|75989879|FG007|COMPLETED|Overall Study||5||
59865777|NCT03739866|75989872|FG000|NOT COMPLETED|Overall Study||0||
59865778|NCT03739866|75989873|FG001|NOT COMPLETED|Overall Study||0||
59865779|NCT03739866|75989874|FG002|NOT COMPLETED|Overall Study||1||
59865780|NCT03739866|75989875|FG003|NOT COMPLETED|Overall Study||1||
59865781|NCT03739866|75989876|FG004|NOT COMPLETED|Overall Study||1||
59865782|NCT03739866|75989877|FG005|NOT COMPLETED|Overall Study||0||
59865783|NCT03739866|75989878|FG006|NOT COMPLETED|Overall Study||0||
59865784|NCT03739866|75989879|FG007|NOT COMPLETED|Overall Study||0||
59865785|NCT03739242|75989903|FG000|STARTED|Overall Study||44||
59865786|NCT03739242|75989904|FG001|STARTED|Overall Study||44||
59865787|NCT03739242|75989903|FG000|COMPLETED|Overall Study||43||
59865788|NCT03739242|75989904|FG001|COMPLETED|Overall Study||42||
59865789|NCT03739242|75989903|FG000|NOT COMPLETED|Overall Study||1||
59865790|NCT03739242|75989904|FG001|NOT COMPLETED|Overall Study||2||
59865791|NCT01190202|75989914|FG000|STARTED|Overall Study||6404||
59865792|NCT01190202|75989915|FG001|STARTED|Overall Study||6414||
59865793|NCT01190202|75989916|FG002|STARTED|Overall Study||6400||
59865794|NCT01190202|75989917|FG003|STARTED|Overall Study||2400||
59865795|NCT01190202|75989914|FG000|COMPLETED|Overall Study||6404||
59865796|NCT01190202|75989915|FG001|COMPLETED|Overall Study||6414||
59865797|NCT01190202|75989916|FG002|COMPLETED|Overall Study||6400||
59865798|NCT01190202|75989917|FG003|COMPLETED|Overall Study||2400||
59865799|NCT01190202|75989914|FG000|NOT COMPLETED|Overall Study||0||
59865800|NCT01190202|75989915|FG001|NOT COMPLETED|Overall Study||0||
59865801|NCT01190202|75989916|FG002|NOT COMPLETED|Overall Study||0||
59865802|NCT01190202|75989917|FG003|NOT COMPLETED|Overall Study||0||
59865803|NCT02849626|75989961|FG000|STARTED|Core Phase (up to 23 Weeks)||149||
59865804|NCT02849626|75989962|FG001|STARTED|Core Phase (up to 23 Weeks)||31||
59865805|NCT02849626|75989963|FG002|STARTED|Core Phase (up to 23 Weeks)||0||
59865806|NCT02849626|75989964|FG003|STARTED|Core Phase (up to 23 Weeks)||0||
59865807|NCT02849626|75989961|FG000|COMPLETED|Core Phase (up to 23 Weeks)||122||
59865808|NCT02849626|75989962|FG001|COMPLETED|Core Phase (up to 23 Weeks)||24||
59865809|NCT02849626|75989963|FG002|COMPLETED|Core Phase (up to 23 Weeks)||0||
59865810|NCT02849626|75989964|FG003|COMPLETED|Core Phase (up to 23 Weeks)||0||
59865811|NCT02849626|75989961|FG000|NOT COMPLETED|Core Phase (up to 23 Weeks)||27||
59865812|NCT02849626|75989962|FG001|NOT COMPLETED|Core Phase (up to 23 Weeks)||7||
59865813|NCT02849626|75989963|FG002|NOT COMPLETED|Core Phase (up to 23 Weeks)||0||
59865814|NCT02849626|75989964|FG003|NOT COMPLETED|Core Phase (up to 23 Weeks)||0||
59865815|NCT02849626|75989961|FG000|STARTED|Extension Phase A (up to 29 Weeks)|Only eligible participants who completed Core Phase entered into Extension Phase A.|116||
59865816|NCT02849626|75989962|FG001|STARTED|Extension Phase A (up to 29 Weeks)|Only eligible participants who completed Core Phase entered into Extension Phase A.|20||
59865817|NCT02849626|75989963|FG002|STARTED|Extension Phase A (up to 29 Weeks)||0||
59865818|NCT02849626|75989964|FG003|STARTED|Extension Phase A (up to 29 Weeks)||0||
59865819|NCT02849626|75989961|FG000|COMPLETED|Extension Phase A (up to 29 Weeks)||105||
59865820|NCT02849626|75989962|FG001|COMPLETED|Extension Phase A (up to 29 Weeks)||17||
59865821|NCT02849626|75989963|FG002|COMPLETED|Extension Phase A (up to 29 Weeks)||0||
59865822|NCT02849626|75989964|FG003|COMPLETED|Extension Phase A (up to 29 Weeks)||0||
59865823|NCT02849626|75989961|FG000|NOT COMPLETED|Extension Phase A (up to 29 Weeks)||11||
59865824|NCT02849626|75989962|FG001|NOT COMPLETED|Extension Phase A (up to 29 Weeks)||3||
59865825|NCT02849626|75989963|FG002|NOT COMPLETED|Extension Phase A (up to 29 Weeks)||0||
59865826|NCT02849626|75989964|FG003|NOT COMPLETED|Extension Phase A (up to 29 Weeks)||0||
59865827|NCT02849626|75989961|FG000|STARTED|Extension Phase B (up to 89 Weeks)||0||
59865828|NCT02849626|75989962|FG001|STARTED|Extension Phase B (up to 89 Weeks)||0||
59865829|NCT02849626|75989963|FG002|STARTED|Extension Phase B (up to 89 Weeks)|Participants who completed Core and Extension Phase A and could not enroll into EAP entered into Extension Phase B.|41||
59865830|NCT02849626|75989964|FG003|STARTED|Extension Phase B (up to 89 Weeks)|Participants who completed Core and Extension Phase A and could not enroll into EAP entered into Extension Phase B.|1||
59865831|NCT02849626|75989961|FG000|COMPLETED|Extension Phase B (up to 89 Weeks)||0||
59865832|NCT02849626|75989962|FG001|COMPLETED|Extension Phase B (up to 89 Weeks)||0||
59865833|NCT02849626|75989963|FG002|COMPLETED|Extension Phase B (up to 89 Weeks)||36||
59865834|NCT02849626|75989964|FG003|COMPLETED|Extension Phase B (up to 89 Weeks)||1||
59865835|NCT02849626|75989961|FG000|NOT COMPLETED|Extension Phase B (up to 89 Weeks)||0||
59865836|NCT02849626|75989962|FG001|NOT COMPLETED|Extension Phase B (up to 89 Weeks)||0||
59865837|NCT02849626|75989963|FG002|NOT COMPLETED|Extension Phase B (up to 89 Weeks)||5||
59865838|NCT02849626|75989964|FG003|NOT COMPLETED|Extension Phase B (up to 89 Weeks)||0||
59865839|NCT03735498|75989982|FG000|STARTED|Overall Study|Total subjects who provided consent and were eligible to participate.|14||
59865840|NCT03735498|75989982|FG000|Started Intervention|Overall Study||10||
59865841|NCT03735498|75989982|FG000|COMPLETED|Overall Study|Subjects who completed all 6 sessions.|8||
59865842|NCT03735498|75989982|FG000|NOT COMPLETED|Overall Study||6||
59865843|NCT02659540|75989988|FG000|STARTED|Overall Study||10||
59865844|NCT02659540|75989989|FG001|STARTED|Overall Study||10||
59865845|NCT02659540|75989988|FG000|COMPLETED|Overall Study||4|Completed treatment through Week 18|
59865846|NCT02659540|75989989|FG001|COMPLETED|Overall Study||2|Completed treatment through Week 18|
59865847|NCT02659540|75989988|FG000|NOT COMPLETED|Overall Study||6||
59865848|NCT02659540|75989989|FG001|NOT COMPLETED|Overall Study||8||
59865849|NCT01097746|75989995|FG000|STARTED|Overall Study||33||
59865850|NCT01097746|75989995|FG000|COMPLETED|Overall Study||28||
59865851|NCT01097746|75989995|FG000|NOT COMPLETED|Overall Study||5||
59865852|NCT00176436|75990001|FG000|STARTED|Overall Study||20||
59865853|NCT00176436|75990002|FG001|STARTED|Overall Study||17||
59865854|NCT00176436|75990001|FG000|COMPLETED|Overall Study||14||
59865855|NCT00176436|75990002|FG001|COMPLETED|Overall Study||12||
59865856|NCT00176436|75990001|FG000|NOT COMPLETED|Overall Study||6||
59865857|NCT00176436|75990002|FG001|NOT COMPLETED|Overall Study||5||
59865858|NCT02930590|75990008|FG000|STARTED|First Intervention (2 Hours)||3|Cross-over trial.In total 15 participants,each of them lied on every of the three types of mattress.|
59865859|NCT02930590|75990009|FG001|STARTED|First Intervention (2 Hours)||3|Cross-over trial.In total 15 participants,each of them lied on every of the three types of mattress.|
59865860|NCT02930590|75990010|FG002|STARTED|First Intervention (2 Hours)||3|Cross-over trial.In total 15 participants,each of them lied on every of the three types of mattress.|
59865861|NCT02930590|75990011|FG003|STARTED|First Intervention (2 Hours)||2|Cross-over trial.In total 15 participants,each of them lied on every of the three types of mattress.|
59865862|NCT02930590|75990012|FG004|STARTED|First Intervention (2 Hours)||2|Cross-over trial.In total 15 participants,each of them lied on every of the three types of mattress.|
59865863|NCT02930590|75990013|FG005|STARTED|First Intervention (2 Hours)||2|Cross-over trial.In total 15 participants,each of them lied on every of the three types of mattress.|
59865864|NCT02930590|75990008|FG000|COMPLETED|First Intervention (2 Hours)||3|Cross-over trial.In total 15 participants,each of them lied on every of the three types of mattress.|
59865865|NCT02930590|75990009|FG001|COMPLETED|First Intervention (2 Hours)||3|Cross-over trial.In total 15 participants,each of them lied on every of the three types of mattress.|
59865866|NCT02930590|75990010|FG002|COMPLETED|First Intervention (2 Hours)||3|Cross-over trial.In total 15 participants,each of them lied on every of the three types of mattress.|
59865867|NCT02930590|75990011|FG003|COMPLETED|First Intervention (2 Hours)||2|Cross-over trial.In total 15 participants,each of them lied on every of the three types of mattress.|
59865868|NCT02930590|75990012|FG004|COMPLETED|First Intervention (2 Hours)||2|Cross-over trial.In total 15 participants,each of them lied on every of the three types of mattress.|
59865869|NCT02930590|75990013|FG005|COMPLETED|First Intervention (2 Hours)||2|Cross-over trial.In total 15 participants,each of them lied on every of the three types of mattress.|
59865870|NCT02930590|75990008|FG000|NOT COMPLETED|First Intervention (2 Hours)||0||
59865871|NCT02930590|75990009|FG001|NOT COMPLETED|First Intervention (2 Hours)||0||
59865872|NCT02930590|75990010|FG002|NOT COMPLETED|First Intervention (2 Hours)||0||
59865873|NCT02930590|75990011|FG003|NOT COMPLETED|First Intervention (2 Hours)||0||
59865874|NCT02930590|75990012|FG004|NOT COMPLETED|First Intervention (2 Hours)||0||
59865875|NCT02930590|75990013|FG005|NOT COMPLETED|First Intervention (2 Hours)||0||
59865876|NCT02930590|75990008|FG000|STARTED|Second Intervention (2 Hours)||3|Cross-over trial.In total 15 participants,each of them lied on every of the three types of mattress.|
59865877|NCT02930590|75990009|FG001|STARTED|Second Intervention (2 Hours)||3|Cross-over trial.In total 15 participants,each of them lied on every of the three types of mattress.|
59865878|NCT02930590|75990010|FG002|STARTED|Second Intervention (2 Hours)||3|Cross-over trial.In total 15 participants,each of them lied on every of the three types of mattress.|
59865879|NCT02930590|75990011|FG003|STARTED|Second Intervention (2 Hours)||2|Cross-over trial.In total 15 participants,each of them lied on every of the three types of mattress.|
59865880|NCT02930590|75990012|FG004|STARTED|Second Intervention (2 Hours)||2|Cross-over trial.In total 15 participants,each of them lied on every of the three types of mattress.|
59865881|NCT02930590|75990013|FG005|STARTED|Second Intervention (2 Hours)||2|Cross-over trial.In total 15 participants,each of them lied on every of the three types of mattress.|
59865882|NCT02930590|75990008|FG000|COMPLETED|Second Intervention (2 Hours)||3|Cross-over trial.In total 15 participants,each of them lied on every of the three types of mattress.|
59865883|NCT02930590|75990009|FG001|COMPLETED|Second Intervention (2 Hours)||3|Cross-over trial.In total 15 participants,each of them lied on every of the three types of mattress.|
59865884|NCT02930590|75990010|FG002|COMPLETED|Second Intervention (2 Hours)||3|Cross-over trial.In total 15 participants,each of them lied on every of the three types of mattress.|
59865885|NCT02930590|75990011|FG003|COMPLETED|Second Intervention (2 Hours)||2|Cross-over trial.In total 15 participants,each of them lied on every of the three types of mattress.|
59865886|NCT02930590|75990012|FG004|COMPLETED|Second Intervention (2 Hours)||2|Cross-over trial.In total 15 participants,each of them lied on every of the three types of mattress.|
59865887|NCT02930590|75990013|FG005|COMPLETED|Second Intervention (2 Hours)||2|Cross-over trial.In total 15 participants,each of them lied on every of the three types of mattress.|
59865888|NCT02930590|75990008|FG000|NOT COMPLETED|Second Intervention (2 Hours)||0||
59865889|NCT02930590|75990009|FG001|NOT COMPLETED|Second Intervention (2 Hours)||0||
59865890|NCT02930590|75990010|FG002|NOT COMPLETED|Second Intervention (2 Hours)||0||
59865891|NCT02930590|75990011|FG003|NOT COMPLETED|Second Intervention (2 Hours)||0||
59865892|NCT02930590|75990012|FG004|NOT COMPLETED|Second Intervention (2 Hours)||0||
59865893|NCT02930590|75990013|FG005|NOT COMPLETED|Second Intervention (2 Hours)||0||
59865894|NCT02930590|75990008|FG000|STARTED|Third Intervention (2 Hours)||3|Cross-over trial.In total 15 participants,each of them lied on every of the three types of mattress.|
59999796|NCT01782131|76115511|FG001|NOT COMPLETED|Overall Study||115||
59865895|NCT02930590|75990009|FG001|STARTED|Third Intervention (2 Hours)||3|Cross-over trial.In total 15 participants,each of them lied on every of the three types of mattress.|
59865896|NCT02930590|75990010|FG002|STARTED|Third Intervention (2 Hours)||3|Cross-over trial.In total 15 participants,each of them lied on every of the three types of mattress.|
59865897|NCT02930590|75990011|FG003|STARTED|Third Intervention (2 Hours)||2|Cross-over trial.In total 15 participants,each of them lied on every of the three types of mattress.|
59865898|NCT02930590|75990012|FG004|STARTED|Third Intervention (2 Hours)||2|Cross-over trial.In total 15 participants,each of them lied on every of the three types of mattress.|
59865899|NCT02930590|75990013|FG005|STARTED|Third Intervention (2 Hours)||2|Cross-over trial.In total 15 participants,each of them lied on every of the three types of mattress.|
59865900|NCT02930590|75990008|FG000|COMPLETED|Third Intervention (2 Hours)||3|Cross-over trial.In total 15 participants,each of them lied on every of the three types of mattress.|
59865901|NCT02930590|75990009|FG001|COMPLETED|Third Intervention (2 Hours)||3|Cross-over trial.In total 15 participants,each of them lied on every of the three types of mattress.|
59865902|NCT02930590|75990010|FG002|COMPLETED|Third Intervention (2 Hours)||3|Cross-over trial.In total 15 participants,each of them lied on every of the three types of mattress.|
59865903|NCT02930590|75990011|FG003|COMPLETED|Third Intervention (2 Hours)||2|Cross-over trial.In total 15 participants,each of them lied on every of the three types of mattress.|
59865904|NCT02930590|75990012|FG004|COMPLETED|Third Intervention (2 Hours)||2|Cross-over trial.In total 15 participants,each of them lied on every of the three types of mattress.|
59865905|NCT02930590|75990013|FG005|COMPLETED|Third Intervention (2 Hours)||2|Cross-over trial.In total 15 participants,each of them lied on every of the three types of mattress.|
59865906|NCT02930590|75990008|FG000|NOT COMPLETED|Third Intervention (2 Hours)||0||
59865907|NCT02930590|75990009|FG001|NOT COMPLETED|Third Intervention (2 Hours)||0||
59865908|NCT02930590|75990010|FG002|NOT COMPLETED|Third Intervention (2 Hours)||0||
59865909|NCT02930590|75990011|FG003|NOT COMPLETED|Third Intervention (2 Hours)||0||
59865910|NCT02930590|75990012|FG004|NOT COMPLETED|Third Intervention (2 Hours)||0||
59865911|NCT02930590|75990013|FG005|NOT COMPLETED|Third Intervention (2 Hours)||0||
59865912|NCT03733470|75990025|FG000|STARTED|Overall Study||8||
59865913|NCT03733470|75990026|FG001|STARTED|Overall Study||11||
59865914|NCT03733470|75990025|FG000|COMPLETED|Overall Study||7||
59865915|NCT03733470|75990026|FG001|COMPLETED|Overall Study||10||
59865916|NCT03733470|75990025|FG000|NOT COMPLETED|Overall Study||1||
59865917|NCT03733470|75990026|FG001|NOT COMPLETED|Overall Study||1||
59865918|NCT03732534|75990032|FG000|STARTED|Overall Study||6||
59865919|NCT03732534|75990032|FG000|COMPLETED|Overall Study||0||
59865920|NCT03732534|75990032|FG000|NOT COMPLETED|Overall Study||6||
59865921|NCT03087058|75990038|FG000|STARTED|Overall Study||14||
59865922|NCT03087058|75990039|FG001|STARTED|Overall Study||9||
59865923|NCT03087058|75990040|FG002|STARTED|Overall Study|Vifor believes the 23 enrolled subjects in Cohort 1 and 2 are representative of patients with hyperkalaemia due to CKD 6 to <18 years of age and that data are sufficient to support assessment of the PD effects, safety, and tolerability of patiromer in this population. The trial was terminated by sponsor decision on the 13 July 2022. The PD and safety of patiromer in the population aged from 0 to <6 will be assessed in a new trial with the protocol number RLY5016-208p.|0||
59865924|NCT03087058|75990038|FG000|COMPLETED|Overall Study||12||
59865925|NCT03087058|75990039|FG001|COMPLETED|Overall Study||9||
59865926|NCT03087058|75990040|FG002|COMPLETED|Overall Study||0||
59865927|NCT03087058|75990038|FG000|NOT COMPLETED|Overall Study||2||
59865928|NCT03087058|75990039|FG001|NOT COMPLETED|Overall Study||0||
59865929|NCT03087058|75990040|FG002|NOT COMPLETED|Overall Study||0||
59865930|NCT03726996|75990047|FG000|STARTED|Overall Study||4||
59865931|NCT03726996|75990047|FG000|COMPLETED|Overall Study||0||
59865932|NCT03726996|75990047|FG000|NOT COMPLETED|Overall Study||4||
59865933|NCT03882970|75990055|FG000|STARTED|Overall Study||359||
59865934|NCT03882970|75990056|FG001|STARTED|Overall Study||361||
59865935|NCT03882970|75990057|FG002|STARTED|Overall Study||359||
59865936|NCT03882970|75990058|FG003|STARTED|Overall Study||365||
59865937|NCT03882970|75990055|FG000|Received at Least One Dose of Study Drug|Overall Study||358||
59865938|NCT03882970|75990056|FG001|Received at Least One Dose of Study Drug|Overall Study||360||
59865939|NCT03882970|75990057|FG002|Received at Least One Dose of Study Drug|Overall Study||359||
59865940|NCT03882970|75990058|FG003|Received at Least One Dose of Study Drug|Overall Study||360||
59865941|NCT03882970|75990055|FG000|COMPLETED|Overall Study||333||
59865942|NCT03882970|75990056|FG001|COMPLETED|Overall Study||321||
59865943|NCT03882970|75990057|FG002|COMPLETED|Overall Study||340||
59865944|NCT03882970|75990058|FG003|COMPLETED|Overall Study||331||
59865945|NCT03882970|75990055|FG000|NOT COMPLETED|Overall Study||26||
59865946|NCT03882970|75990056|FG001|NOT COMPLETED|Overall Study||40||
59865947|NCT03882970|75990057|FG002|NOT COMPLETED|Overall Study||19||
59865948|NCT03882970|75990058|FG003|NOT COMPLETED|Overall Study||34||
59865949|NCT03730480|75990072|FG000|STARTED|Overall Study||372||
59865950|NCT03730480|75990072|FG000|COMPLETED|Overall Study||371||
59865951|NCT03730480|75990072|FG000|NOT COMPLETED|Overall Study||1||
59865952|NCT03668808|75990077|FG000|STARTED|First Intervention||13||
59865953|NCT03668808|75990078|FG001|STARTED|First Intervention||12||
59865954|NCT03668808|75990077|FG000|COMPLETED|First Intervention||11||
59865955|NCT03668808|75990078|FG001|COMPLETED|First Intervention||10||
59865956|NCT03668808|75990077|FG000|NOT COMPLETED|First Intervention||2||
59865957|NCT03668808|75990078|FG001|NOT COMPLETED|First Intervention||2||
59865958|NCT03668808|75990077|FG000|STARTED|Washout Period||11||
59865959|NCT03668808|75990078|FG001|STARTED|Washout Period||10||
59865960|NCT03668808|75990077|FG000|COMPLETED|Washout Period||11||
59865961|NCT03668808|75990078|FG001|COMPLETED|Washout Period||10||
59865962|NCT03668808|75990077|FG000|NOT COMPLETED|Washout Period||0||
59865963|NCT03668808|75990078|FG001|NOT COMPLETED|Washout Period||0||
59865964|NCT03668808|75990077|FG000|STARTED|Second Intervention||11||
59865965|NCT03668808|75990078|FG001|STARTED|Second Intervention||10||
59865966|NCT03668808|75990077|FG000|COMPLETED|Second Intervention||11||
59865967|NCT03668808|75990078|FG001|COMPLETED|Second Intervention||10||
59865968|NCT03668808|75990077|FG000|NOT COMPLETED|Second Intervention||0||
59865969|NCT03668808|75990078|FG001|NOT COMPLETED|Second Intervention||0||
59865970|NCT02982954|75990090|FG000|STARTED|Overall Study||106||
59865971|NCT02982954|75990091|FG001|STARTED|Overall Study||52||
59865972|NCT02982954|75990092|FG002|STARTED|Overall Study||28||
59865973|NCT02982954|75990093|FG003|STARTED|Overall Study||25||
59865974|NCT02982954|75990090|FG000|COMPLETED|Overall Study||0||
59865975|NCT02982954|75990091|FG001|COMPLETED|Overall Study||0||
59865976|NCT02982954|75990092|FG002|COMPLETED|Overall Study||0||
59865977|NCT02982954|75990093|FG003|COMPLETED|Overall Study||0||
59865978|NCT02982954|75990090|FG000|NOT COMPLETED|Overall Study||106||
59865979|NCT02982954|75990091|FG001|NOT COMPLETED|Overall Study||52||
59865980|NCT02982954|75990092|FG002|NOT COMPLETED|Overall Study||28||
59865981|NCT02982954|75990093|FG003|NOT COMPLETED|Overall Study||25||
59865982|NCT03724968|75990105|FG000|STARTED|Overall Study||0||
59865983|NCT03724968|75990106|FG001|STARTED|Overall Study||2||
59865984|NCT03724968|75990105|FG000|COMPLETED|Overall Study||0||
59865985|NCT03724968|75990106|FG001|COMPLETED|Overall Study||0||
59865986|NCT03724968|75990105|FG000|NOT COMPLETED|Overall Study||0||
59865987|NCT03724968|75990106|FG001|NOT COMPLETED|Overall Study||2||
59865988|NCT03724812|75990112|FG000|STARTED|Overall Study||46||
59865989|NCT03724812|75990112|FG000|Discharge|Overall Study||46||
59865990|NCT03724812|75990112|FG000|30 Day Follow-Up|Overall Study||45||
59865991|NCT03724812|75990112|FG000|6 Month Follow-Up|Overall Study||42||
59865992|NCT03724812|75990112|FG000|12-Month Follow-Up|Overall Study||42||
59865993|NCT03724812|75990112|FG000|COMPLETED|Overall Study||42||
59865994|NCT03724812|75990112|FG000|NOT COMPLETED|Overall Study||4||
59865995|NCT03722784|75990119|FG000|STARTED|Overall Study||58||116
59865996|NCT03722784|75990120|FG001|STARTED|Overall Study||30||60
59865997|NCT03722784|75990119|FG000|COMPLETED|Overall Study||56||112
59865998|NCT03722784|75990120|FG001|COMPLETED|Overall Study||28||56
59865999|NCT03722784|75990119|FG000|NOT COMPLETED|Overall Study||2||4
59866000|NCT03722784|75990120|FG001|NOT COMPLETED|Overall Study||2||4
59866001|NCT03722238|75990129|FG000|STARTED|Overall Study||608||
59866002|NCT03722238|75990130|FG001|STARTED|Overall Study||5||
59866003|NCT03722238|75990129|FG000|Safety Set|Overall Study||198||
59866004|NCT03722238|75990130|FG001|Safety Set|Overall Study||5||
59866005|NCT03722238|75990129|FG000|Actual Drug Users|Overall Study||179||
59866006|NCT03722238|75990130|FG001|Actual Drug Users|Overall Study||5||
59866007|NCT03722238|75990129|FG000|COMPLETED|Overall Study||143|Completed=Participants for whom data collection was complete before early termination of the study.|
59866008|NCT03722238|75990130|FG001|COMPLETED|Overall Study||4|Completed=Participants for whom data collection was complete before early termination of the study.|
59866009|NCT03722238|75990129|FG000|NOT COMPLETED|Overall Study||465||
59866010|NCT03722238|75990130|FG001|NOT COMPLETED|Overall Study||1||
59866011|NCT02927080|75990146|FG000|STARTED|Overall Study||6||
59866012|NCT02927080|75990147|FG001|STARTED|Overall Study||6||
59866013|NCT02927080|75990148|FG002|STARTED|Overall Study||6||
59866014|NCT02927080|75990149|FG003|STARTED|Overall Study||6||
59866015|NCT02927080|75990150|FG004|STARTED|Overall Study||7||
59866016|NCT02927080|75990151|FG005|STARTED|Overall Study||6||
59866017|NCT02927080|75990152|FG006|STARTED|Overall Study||15||
59866018|NCT02927080|75990153|FG007|STARTED|Overall Study||14||
59866019|NCT02927080|75990154|FG008|STARTED|Overall Study||15||
59866020|NCT02927080|75990155|FG009|STARTED|Overall Study||14||
59866021|NCT02927080|75990146|FG000|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||0|Patients who completed the double-blind (DB) treatment period continued into the open-label extension (OLE) period. Patients who received ACE-083 in the DB treatment period continued to receive the same dose of ACE-083 during the OLE period, and patients who received placebo during the DB treatment period were switched to receive ACE-083, 240 mg/muscle. In the OLE period, ACE-083 was administered bilaterally in either the TA or BB muscle once every 3 weeks for approximately 6 months (8 doses).|
59866022|NCT02927080|75990147|FG001|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||0|Patients who completed the double-blind (DB) treatment period continued into the open-label extension (OLE) period. Patients who received ACE-083 in the DB treatment period continued to receive the same dose of ACE-083 during the OLE period, and patients who received placebo during the DB treatment period were switched to receive ACE-083, 240 mg/muscle. In the OLE period, ACE-083 was administered bilaterally in either the TA or BB muscle once every 3 weeks for approximately 6 months (8 doses).|
59866023|NCT02927080|75990148|FG002|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||0|Patients who completed the double-blind (DB) treatment period continued into the open-label extension (OLE) period. Patients who received ACE-083 in the DB treatment period continued to receive the same dose of ACE-083 during the OLE period, and patients who received placebo during the DB treatment period were switched to receive ACE-083, 240 mg/muscle. In the OLE period, ACE-083 was administered bilaterally in either the TA or BB muscle once every 3 weeks for approximately 6 months (8 doses).|
59866024|NCT02927080|75990149|FG003|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||0|Patients who completed the double-blind (DB) treatment period continued into the open-label extension (OLE) period. Patients who received ACE-083 in the DB treatment period continued to receive the same dose of ACE-083 during the OLE period, and patients who received placebo during the DB treatment period were switched to receive ACE-083, 240 mg/muscle. In the OLE period, ACE-083 was administered bilaterally in either the TA or BB muscle once every 3 weeks for approximately 6 months (8 doses).|
59866025|NCT02927080|75990150|FG004|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||0|Patients who completed the double-blind (DB) treatment period continued into the open-label extension (OLE) period. Patients who received ACE-083 in the DB treatment period continued to receive the same dose of ACE-083 during the OLE period, and patients who received placebo during the DB treatment period were switched to receive ACE-083, 240 mg/muscle. In the OLE period, ACE-083 was administered bilaterally in either the TA or BB muscle once every 3 weeks for approximately 6 months (8 doses).|
59866026|NCT02927080|75990151|FG005|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||0|Patients who completed the double-blind (DB) treatment period continued into the open-label extension (OLE) period. Patients who received ACE-083 in the DB treatment period continued to receive the same dose of ACE-083 during the OLE period, and patients who received placebo during the DB treatment period were switched to receive ACE-083, 240 mg/muscle. In the OLE period, ACE-083 was administered bilaterally in either the TA or BB muscle once every 3 weeks for approximately 6 months (8 doses).|
59866027|NCT02927080|75990152|FG006|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||14|Patients who completed the double-blind (DB) treatment period continued into the open-label extension (OLE) period. Patients who received ACE-083 in the DB treatment period continued to receive the same dose of ACE-083 during the OLE period, and patients who received placebo during the DB treatment period were switched to receive ACE-083, 240 mg/muscle. In the OLE period, ACE-083 was administered bilaterally in either the TA or BB muscle once every 3 weeks for approximately 6 months (8 doses).|
59866028|NCT02927080|75990153|FG007|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||13|Patients who completed the double-blind (DB) treatment period continued into the open-label extension (OLE) period. Patients who received ACE-083 in the DB treatment period continued to receive the same dose of ACE-083 during the OLE period, and patients who received placebo during the DB treatment period were switched to receive ACE-083, 240 mg/muscle. In the OLE period, ACE-083 was administered bilaterally in either the TA or BB muscle once every 3 weeks for approximately 6 months (8 doses).|
59866029|NCT02927080|75990154|FG008|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||14|Patients who completed the double-blind (DB) treatment period continued into the open-label extension (OLE) period. Patients who received ACE-083 in the DB treatment period continued to receive the same dose of ACE-083 during the OLE period, and patients who received placebo during the DB treatment period were switched to receive ACE-083, 240 mg/muscle. In the OLE period, ACE-083 was administered bilaterally in either the TA or BB muscle once every 3 weeks for approximately 6 months (8 doses).|
59866030|NCT02927080|75990155|FG009|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||12|Patients who completed the double-blind (DB) treatment period continued into the open-label extension (OLE) period. Patients who received ACE-083 in the DB treatment period continued to receive the same dose of ACE-083 during the OLE period, and patients who received placebo during the DB treatment period were switched to receive ACE-083, 240 mg/muscle. In the OLE period, ACE-083 was administered bilaterally in either the TA or BB muscle once every 3 weeks for approximately 6 months (8 doses).|
59866031|NCT02927080|75990146|FG000|COMPLETED|Overall Study||6||
59866032|NCT02927080|75990147|FG001|COMPLETED|Overall Study||5||
59866033|NCT02927080|75990148|FG002|COMPLETED|Overall Study||6||
59866034|NCT02927080|75990149|FG003|COMPLETED|Overall Study||6||
59866035|NCT02927080|75990150|FG004|COMPLETED|Overall Study||6||
59866036|NCT02927080|75990151|FG005|COMPLETED|Overall Study||6||
59866037|NCT02927080|75990152|FG006|COMPLETED|Overall Study||7||
59866038|NCT02927080|75990153|FG007|COMPLETED|Overall Study||5||
59866039|NCT02927080|75990154|FG008|COMPLETED|Overall Study||12||
59866040|NCT02927080|75990155|FG009|COMPLETED|Overall Study||7||
59866041|NCT02927080|75990146|FG000|NOT COMPLETED|Overall Study||0||
59866042|NCT02927080|75990147|FG001|NOT COMPLETED|Overall Study||1||
59866043|NCT02927080|75990148|FG002|NOT COMPLETED|Overall Study||0||
59866044|NCT02927080|75990149|FG003|NOT COMPLETED|Overall Study||0||
59866045|NCT02927080|75990150|FG004|NOT COMPLETED|Overall Study||1||
59866046|NCT02927080|75990151|FG005|NOT COMPLETED|Overall Study||0||
59866047|NCT02927080|75990152|FG006|NOT COMPLETED|Overall Study||8||
59866048|NCT02927080|75990153|FG007|NOT COMPLETED|Overall Study||9||
59866049|NCT02927080|75990154|FG008|NOT COMPLETED|Overall Study||3||
59866050|NCT02927080|75990155|FG009|NOT COMPLETED|Overall Study||7||
59866051|NCT02374476|75990202|FG000|STARTED|VT Induced Ablation||145||
59866052|NCT02374476|75990203|FG001|STARTED|VT Induced Ablation||0||
59866053|NCT02374476|75990204|FG002|STARTED|VT Induced Ablation||0||
59866054|NCT02374476|75990202|FG000|COMPLETED|VT Induced Ablation||109||
59866055|NCT02374476|75990203|FG001|COMPLETED|VT Induced Ablation||0||
59866056|NCT02374476|75990204|FG002|COMPLETED|VT Induced Ablation||0||
59866057|NCT02374476|75990202|FG000|NOT COMPLETED|VT Induced Ablation||36||
59866058|NCT02374476|75990203|FG001|NOT COMPLETED|VT Induced Ablation||0||
59866059|NCT02374476|75990204|FG002|NOT COMPLETED|VT Induced Ablation||0||
59866060|NCT02374476|75990202|FG000|STARTED|Arm Assignment||0||
59866061|NCT02374476|75990203|FG001|STARTED|Arm Assignment||49||
59866062|NCT02374476|75990204|FG002|STARTED|Arm Assignment||60||
59866063|NCT02374476|75990202|FG000|COMPLETED|Arm Assignment||0||
59866064|NCT02374476|75990203|FG001|COMPLETED|Arm Assignment||49||
59866065|NCT02374476|75990204|FG002|COMPLETED|Arm Assignment||59||
59866066|NCT02374476|75990202|FG000|NOT COMPLETED|Arm Assignment||0||
59866067|NCT02374476|75990203|FG001|NOT COMPLETED|Arm Assignment||0||
59866068|NCT02374476|75990204|FG002|NOT COMPLETED|Arm Assignment||1||
59866069|NCT02918292|75990211|FG000|STARTED|Study Enrollment Prior to Transplant||32||
59866070|NCT02918292|75990211|FG000|COMPLETED|Study Enrollment Prior to Transplant||31||
59866071|NCT02918292|75990211|FG000|NOT COMPLETED|Study Enrollment Prior to Transplant||1||
59866072|NCT02918292|75990211|FG000|STARTED|Study Follow up After Transplant||31||
59866073|NCT02918292|75990211|FG000|COMPLETED|Study Follow up After Transplant||25||
59866074|NCT02918292|75990211|FG000|NOT COMPLETED|Study Follow up After Transplant||6||
59866075|NCT03720210|75990215|FG000|STARTED|Overall Study||1||
59866076|NCT03720210|75990215|FG000|COMPLETED|Overall Study||0||
59866077|NCT03720210|75990215|FG000|NOT COMPLETED|Overall Study||1||
59866078|NCT03719586|75990223|FG000|STARTED|Overall Study||177||
59866079|NCT03719586|75990224|FG001|STARTED|Overall Study||176||
59866080|NCT03719586|75990225|FG002|STARTED|Overall Study|The REGN-EB3 arm was added in 1/2019 after the trial had initially begun in November 2018.|158||
59866081|NCT03719586|75990226|FG003|STARTED|Overall Study||169||
59866082|NCT03719586|75990223|FG000|COMPLETED|Overall Study|in 8/2019 the DSMB recommended further randomization only occur to the MAb114 and REGN-EB3 arms.|169||
59866083|NCT03719586|75990224|FG001|COMPLETED|Overall Study|in 8/2019 the DSMB recommended further randomization only occur to the MAb114 and REGN-EB3 arms.|169||
59866084|NCT03719586|75990225|FG002|COMPLETED|Overall Study|in 8/2019 the DSMB recommended further randomization only occur to the MAb114 and REGN-EB3 arms.|154||
59866085|NCT03719586|75990226|FG003|COMPLETED|Overall Study|in 8/2019 the DSMB recommended further randomization only occur to the MAb114 and REGN-EB3 arms.|169||
59866086|NCT03719586|75990223|FG000|NOT COMPLETED|Overall Study||8||
59866087|NCT03719586|75990224|FG001|NOT COMPLETED|Overall Study||7||
59866088|NCT03719586|75990225|FG002|NOT COMPLETED|Overall Study||4||
59866089|NCT03719586|75990226|FG003|NOT COMPLETED|Overall Study||0||
59866090|NCT03814824|75990238|FG000|STARTED|Overall Study||67||
59866091|NCT03814824|75990239|FG001|STARTED|Overall Study||66||
59866092|NCT03814824|75990238|FG000|COMPLETED|Overall Study||67||
59866093|NCT03814824|75990239|FG001|COMPLETED|Overall Study||66||
59866094|NCT03814824|75990238|FG000|NOT COMPLETED|Overall Study||0||
59866095|NCT03814824|75990239|FG001|NOT COMPLETED|Overall Study||0||
59866096|NCT03353350|75990252|FG000|STARTED|30-week Core Treatment Period||102||
59866097|NCT03353350|75990253|FG001|STARTED|30-week Core Treatment Period||100||
59866098|NCT03353350|75990254|FG002|STARTED|30-week Core Treatment Period||101||
59866099|NCT03353350|75990255|FG003|STARTED|30-week Core Treatment Period||103||
59866100|NCT03353350|75990252|FG000|COMPLETED|30-week Core Treatment Period||80||
59866101|NCT03353350|75990253|FG001|COMPLETED|30-week Core Treatment Period||81||
59866102|NCT03353350|75990254|FG002|COMPLETED|30-week Core Treatment Period||77||
59866103|NCT03353350|75990255|FG003|COMPLETED|30-week Core Treatment Period||81||
59866104|NCT03353350|75990252|FG000|NOT COMPLETED|30-week Core Treatment Period||22||
59866105|NCT03353350|75990253|FG001|NOT COMPLETED|30-week Core Treatment Period||19||
59866106|NCT03353350|75990254|FG002|NOT COMPLETED|30-week Core Treatment Period||24||
59866107|NCT03353350|75990255|FG003|NOT COMPLETED|30-week Core Treatment Period||22||
59866108|NCT03353350|75990252|FG000|STARTED|26-week Treatment Extension Period||80||
59866109|NCT03353350|75990253|FG001|STARTED|26-week Treatment Extension Period||81||
59866110|NCT03353350|75990254|FG002|STARTED|26-week Treatment Extension Period||77||
59866111|NCT03353350|75990255|FG003|STARTED|26-week Treatment Extension Period||81||
59866112|NCT03353350|75990252|FG000|COMPLETED|26-week Treatment Extension Period||75||
59866113|NCT03353350|75990253|FG001|COMPLETED|26-week Treatment Extension Period||78||
59866114|NCT03353350|75990254|FG002|COMPLETED|26-week Treatment Extension Period||73||
59866115|NCT03353350|75990255|FG003|COMPLETED|26-week Treatment Extension Period||67||
59866116|NCT03353350|75990252|FG000|NOT COMPLETED|26-week Treatment Extension Period||5||
59866117|NCT03353350|75990253|FG001|NOT COMPLETED|26-week Treatment Extension Period||3||
59866118|NCT03353350|75990254|FG002|NOT COMPLETED|26-week Treatment Extension Period||4||
59866119|NCT03353350|75990255|FG003|NOT COMPLETED|26-week Treatment Extension Period||14||
59866120|NCT04332640|75990265|FG000|STARTED|Overall Study||79||115
59866121|NCT04332640|75990265|FG000|COMPLETED|Overall Study||79||115
59866122|NCT04332640|75990265|FG000|NOT COMPLETED|Overall Study||0||0
59866123|NCT03032068|75990269|FG000|STARTED|Overall Study||10||
59866124|NCT03032068|75990269|FG000|Preoperative Visit|Overall Study||10||
59866125|NCT03032068|75990269|FG000|Postoperative Home Care Visit 1|Overall Study||10||
59866126|NCT03032068|75990269|FG000|Postoperative Home Care Visit 2|Overall Study||10||
59866127|NCT03032068|75990269|FG000|Postoperative Home Care Visit 3|Overall Study||10||
59866128|NCT03032068|75990269|FG000|4 Weeks Postoperative Visit|Overall Study||9||
59866129|NCT03032068|75990269|FG000|8 Weeks Postoperative Visit|Overall Study||9||
59866130|NCT03032068|75990269|FG000|12 Weeks Postoperative Visit|Overall Study||9||
59866131|NCT03032068|75990269|FG000|COMPLETED|Overall Study||9||
59866132|NCT03032068|75990269|FG000|NOT COMPLETED|Overall Study||1||
59866133|NCT04188730|75990273|FG000|STARTED|Overall Study||4||
59866134|NCT04188730|75990274|FG001|STARTED|Overall Study||4||
59866135|NCT04188730|75990275|FG002|STARTED|Overall Study||4||
59866136|NCT04188730|75990276|FG003|STARTED|Overall Study||4||
59866137|NCT04188730|75990273|FG000|Period 1|Overall Study||4||
59866138|NCT04188730|75990274|FG001|Period 1|Overall Study||4||
59866139|NCT04188730|75990275|FG002|Period 1|Overall Study||4||
59999797|NCT00579124|76115519|FG000|STARTED|Overall Study||87||
59999798|NCT00579124|76115520|FG001|STARTED|Overall Study||6||
59866140|NCT04188730|75990276|FG003|Period 1|Overall Study||4||
59866141|NCT04188730|75990273|FG000|Period 2|Overall Study||3||
59866142|NCT04188730|75990274|FG001|Period 2|Overall Study||4||
59866143|NCT04188730|75990275|FG002|Period 2|Overall Study||4||
59866144|NCT04188730|75990276|FG003|Period 2|Overall Study||4||
59866145|NCT04188730|75990273|FG000|Period 3|Overall Study||3||
59866146|NCT04188730|75990274|FG001|Period 3|Overall Study||4||
59866147|NCT04188730|75990275|FG002|Period 3|Overall Study||4||
59866148|NCT04188730|75990276|FG003|Period 3|Overall Study||4||
59866149|NCT04188730|75990273|FG000|COMPLETED|Overall Study||3||
59866150|NCT04188730|75990274|FG001|COMPLETED|Overall Study||4||
59866151|NCT04188730|75990275|FG002|COMPLETED|Overall Study||4||
59866152|NCT04188730|75990276|FG003|COMPLETED|Overall Study||4||
59866153|NCT04188730|75990273|FG000|NOT COMPLETED|Overall Study||1||
59866154|NCT04188730|75990274|FG001|NOT COMPLETED|Overall Study||0||
59866155|NCT04188730|75990275|FG002|NOT COMPLETED|Overall Study||0||
59866156|NCT04188730|75990276|FG003|NOT COMPLETED|Overall Study||0||
59866157|NCT02674516|75990289|FG000|STARTED|Overall Study||17||
59866158|NCT02674516|75990290|FG001|STARTED|Overall Study||15||
59866159|NCT02674516|75990289|FG000|COMPLETED|Overall Study||13||
59866160|NCT02674516|75990290|FG001|COMPLETED|Overall Study||11||
59866161|NCT02674516|75990289|FG000|NOT COMPLETED|Overall Study||4||
59866162|NCT02674516|75990290|FG001|NOT COMPLETED|Overall Study||4||
59866163|NCT02463448|75990296|FG000|STARTED|Enrollment Through 6 Months||23||
59866164|NCT02463448|75990296|FG000|COMPLETED|Enrollment Through 6 Months||20||
59866165|NCT02463448|75990296|FG000|NOT COMPLETED|Enrollment Through 6 Months||3||
59866166|NCT02463448|75990296|FG000|STARTED|6 Months Through 12 Months||20||
59866167|NCT02463448|75990296|FG000|COMPLETED|6 Months Through 12 Months||18||
59866168|NCT02463448|75990296|FG000|NOT COMPLETED|6 Months Through 12 Months||2||
59866169|NCT02463448|75990296|FG000|STARTED|12 Months Through End of Study||18||
59866170|NCT02463448|75990296|FG000|COMPLETED|12 Months Through End of Study||17||
59866171|NCT02463448|75990296|FG000|NOT COMPLETED|12 Months Through End of Study||1||
59866172|NCT03794544|75990304|FG000|STARTED|Overall Study||27||
59866173|NCT03794544|75990305|FG001|STARTED|Overall Study||21||
59866174|NCT03794544|75990306|FG002|STARTED|Overall Study||20||
59866175|NCT03794544|75990307|FG003|STARTED|Overall Study||16||
59866176|NCT03794544|75990304|FG000|Treated|Overall Study||26||
59866177|NCT03794544|75990305|FG001|Treated|Overall Study||21||
59866178|NCT03794544|75990306|FG002|Treated|Overall Study||20||
59866179|NCT03794544|75990307|FG003|Treated|Overall Study||16||
59866180|NCT03794544|75990304|FG000|COMPLETED|Overall Study||26||
59866181|NCT03794544|75990305|FG001|COMPLETED|Overall Study||18||
59866182|NCT03794544|75990306|FG002|COMPLETED|Overall Study||19||
59866183|NCT03794544|75990307|FG003|COMPLETED|Overall Study||15||
59866184|NCT03794544|75990304|FG000|NOT COMPLETED|Overall Study||1||
59866185|NCT03794544|75990305|FG001|NOT COMPLETED|Overall Study||3||
59866186|NCT03794544|75990306|FG002|NOT COMPLETED|Overall Study||1||
59866187|NCT03794544|75990307|FG003|NOT COMPLETED|Overall Study||1||
59866188|NCT01804270|75990319|FG000|STARTED|Overall Study||2||
59866189|NCT01804270|75990320|FG001|STARTED|Overall Study||4||
59866190|NCT01804270|75990319|FG000|COMPLETED|Overall Study||1||
59866191|NCT01804270|75990320|FG001|COMPLETED|Overall Study||3||
59866192|NCT01804270|75990319|FG000|NOT COMPLETED|Overall Study||1||
59866193|NCT01804270|75990320|FG001|NOT COMPLETED|Overall Study||1||
59866194|NCT03107026|75990329|FG000|STARTED|Overall Study||163||
59866195|NCT03107026|75990330|FG001|STARTED|Overall Study||161||
59866196|NCT03107026|75990331|FG002|STARTED|Overall Study||162||
59866197|NCT03107026|75990329|FG000|COMPLETED|Overall Study||131||
59866198|NCT03107026|75990330|FG001|COMPLETED|Overall Study||123||
59866199|NCT03107026|75990331|FG002|COMPLETED|Overall Study||106||
59866200|NCT03107026|75990329|FG000|NOT COMPLETED|Overall Study||32||
59866201|NCT03107026|75990330|FG001|NOT COMPLETED|Overall Study||38||
59866202|NCT03107026|75990331|FG002|NOT COMPLETED|Overall Study||56||
59866203|NCT03717480|75990339|FG000|STARTED|Overall Study||2|Assignment to study arm|
59866204|NCT03717480|75990339|FG000|Receipt of Investigational Product/Study Treatment|Overall Study||1||
59866205|NCT03717480|75990339|FG000|COMPLETED|Overall Study||1|Survival to day 100 for evaluation of primary endpoint (severe acute GVHD-free survival rate)|
59866206|NCT03717480|75990339|FG000|NOT COMPLETED|Overall Study||1||
59866207|NCT00005044|75990345|FG000|STARTED|Overall Study||790||
59866208|NCT00005044|75990346|FG001|STARTED|Overall Study||789||
59866209|NCT00005044|75990345|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|752||
59866210|NCT00005044|75990346|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|737||
59866211|NCT00005044|75990345|FG000|NOT COMPLETED|Overall Study||38||
59866212|NCT00005044|75990346|FG001|NOT COMPLETED|Overall Study||52||
59866213|NCT03084796|75990358|FG000|STARTED|Overall Study||121||
59866214|NCT03084796|75990359|FG001|STARTED|Overall Study||123||
59866215|NCT03084796|75990360|FG002|STARTED|Overall Study||122||
59866216|NCT03084796|75990361|FG003|STARTED|Overall Study||123||
59866217|NCT03084796|75990362|FG004|STARTED|Overall Study||121||
59866218|NCT03084796|75990363|FG005|STARTED|Overall Study||123||
59866219|NCT03084796|75990358|FG000|COMPLETED|Overall Study||114||
59866220|NCT03084796|75990359|FG001|COMPLETED|Overall Study||113||
59866221|NCT03084796|75990360|FG002|COMPLETED|Overall Study||110||
59866222|NCT03084796|75990361|FG003|COMPLETED|Overall Study||119||
59866223|NCT03084796|75990362|FG004|COMPLETED|Overall Study||110||
59866224|NCT03084796|75990363|FG005|COMPLETED|Overall Study||116||
59866225|NCT03084796|75990358|FG000|NOT COMPLETED|Overall Study||7||
59866226|NCT03084796|75990359|FG001|NOT COMPLETED|Overall Study||10||
59866227|NCT03084796|75990360|FG002|NOT COMPLETED|Overall Study||12||
59866228|NCT03084796|75990361|FG003|NOT COMPLETED|Overall Study||4||
59866229|NCT03084796|75990362|FG004|NOT COMPLETED|Overall Study||11||
59866230|NCT03084796|75990363|FG005|NOT COMPLETED|Overall Study||7||
59866231|NCT03717012|75990379|FG000|STARTED|Overall Study||9||
59866232|NCT03717012|75990380|FG001|STARTED|Overall Study||10||
59866233|NCT03717012|75990379|FG000|COMPLETED|Overall Study||8||
59866234|NCT03717012|75990380|FG001|COMPLETED|Overall Study||4||
59866235|NCT03717012|75990379|FG000|NOT COMPLETED|Overall Study||1||
59866236|NCT03717012|75990380|FG001|NOT COMPLETED|Overall Study||6||
59866237|NCT01304316|75990386|FG000|STARTED|Overall Study||12||
59866238|NCT01304316|75990386|FG000|COMPLETED|Overall Study||12||
59866239|NCT01304316|75990386|FG000|NOT COMPLETED|Overall Study||0||
59866240|NCT03078556|75990393|FG000|STARTED|Treatment Period 1 (4 Days)||39||
59866241|NCT03078556|75990394|FG001|STARTED|Treatment Period 1 (4 Days)||39||
59866242|NCT03078556|75990395|FG002|STARTED|Treatment Period 1 (4 Days)||38||
59866243|NCT03078556|75990396|FG003|STARTED|Treatment Period 1 (4 Days)||38||
59866244|NCT03078556|75990393|FG000|COMPLETED|Treatment Period 1 (4 Days)||39||
59866245|NCT03078556|75990394|FG001|COMPLETED|Treatment Period 1 (4 Days)||38||
59866246|NCT03078556|75990395|FG002|COMPLETED|Treatment Period 1 (4 Days)||38||
59866247|NCT03078556|75990396|FG003|COMPLETED|Treatment Period 1 (4 Days)||38||
59866248|NCT03078556|75990393|FG000|NOT COMPLETED|Treatment Period 1 (4 Days)||0||
59866249|NCT03078556|75990394|FG001|NOT COMPLETED|Treatment Period 1 (4 Days)||1||
59866250|NCT03078556|75990395|FG002|NOT COMPLETED|Treatment Period 1 (4 Days)||0||
59866251|NCT03078556|75990396|FG003|NOT COMPLETED|Treatment Period 1 (4 Days)||0||
59866252|NCT03078556|75990393|FG000|STARTED|Washout Period 1 (7 Days)||39||
59866253|NCT03078556|75990394|FG001|STARTED|Washout Period 1 (7 Days)||38||
59866254|NCT03078556|75990395|FG002|STARTED|Washout Period 1 (7 Days)||38||
59866255|NCT03078556|75990396|FG003|STARTED|Washout Period 1 (7 Days)||38||
59866256|NCT03078556|75990393|FG000|COMPLETED|Washout Period 1 (7 Days)||37||
59866257|NCT03078556|75990394|FG001|COMPLETED|Washout Period 1 (7 Days)||36||
59866258|NCT03078556|75990395|FG002|COMPLETED|Washout Period 1 (7 Days)||37||
59866259|NCT03078556|75990396|FG003|COMPLETED|Washout Period 1 (7 Days)||37||
59866260|NCT03078556|75990393|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||2||
59866261|NCT03078556|75990394|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||2||
59866262|NCT03078556|75990395|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||1||
59866263|NCT03078556|75990396|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||1||
59866264|NCT03078556|75990393|FG000|STARTED|Treatment Period 2 (4 Days)||37||
59866265|NCT03078556|75990394|FG001|STARTED|Treatment Period 2 (4 Days)||36||
59866266|NCT03078556|75990395|FG002|STARTED|Treatment Period 2 (4 Days)||37||
59866267|NCT03078556|75990396|FG003|STARTED|Treatment Period 2 (4 Days)||37||
59866268|NCT03078556|75990393|FG000|COMPLETED|Treatment Period 2 (4 Days)||37||
59866269|NCT03078556|75990394|FG001|COMPLETED|Treatment Period 2 (4 Days)||36||
59866270|NCT03078556|75990395|FG002|COMPLETED|Treatment Period 2 (4 Days)||37||
59866271|NCT03078556|75990396|FG003|COMPLETED|Treatment Period 2 (4 Days)||37||
59866272|NCT03078556|75990393|FG000|NOT COMPLETED|Treatment Period 2 (4 Days)||0||
59866273|NCT03078556|75990394|FG001|NOT COMPLETED|Treatment Period 2 (4 Days)||0||
59866274|NCT03078556|75990395|FG002|NOT COMPLETED|Treatment Period 2 (4 Days)||0||
59866275|NCT03078556|75990396|FG003|NOT COMPLETED|Treatment Period 2 (4 Days)||0||
59866276|NCT03078556|75990393|FG000|STARTED|Washout Period 2 (7 Days)||9||
59866277|NCT03078556|75990394|FG001|STARTED|Washout Period 2 (7 Days)||7||
59866278|NCT03078556|75990395|FG002|STARTED|Washout Period 2 (7 Days)||7||
59866279|NCT03078556|75990396|FG003|STARTED|Washout Period 2 (7 Days)||9||
59866280|NCT03078556|75990393|FG000|COMPLETED|Washout Period 2 (7 Days)||9||
59866281|NCT03078556|75990394|FG001|COMPLETED|Washout Period 2 (7 Days)||7||
59866282|NCT03078556|75990395|FG002|COMPLETED|Washout Period 2 (7 Days)||7||
59866283|NCT03078556|75990396|FG003|COMPLETED|Washout Period 2 (7 Days)||9||
59866284|NCT03078556|75990393|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0||
59866285|NCT03078556|75990394|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0||
59866286|NCT03078556|75990395|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0||
59866287|NCT03078556|75990396|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0||
59866288|NCT03078556|75990393|FG000|STARTED|Treatment Period 3 (4 Days)||9||
59866289|NCT03078556|75990394|FG001|STARTED|Treatment Period 3 (4 Days)||7||
59866290|NCT03078556|75990395|FG002|STARTED|Treatment Period 3 (4 Days)||7||
59866291|NCT03078556|75990396|FG003|STARTED|Treatment Period 3 (4 Days)||9||
59866292|NCT03078556|75990393|FG000|COMPLETED|Treatment Period 3 (4 Days)||9||
59866293|NCT03078556|75990394|FG001|COMPLETED|Treatment Period 3 (4 Days)||7||
59866294|NCT03078556|75990395|FG002|COMPLETED|Treatment Period 3 (4 Days)||7||
59866295|NCT03078556|75990396|FG003|COMPLETED|Treatment Period 3 (4 Days)||9||
59866296|NCT03078556|75990393|FG000|NOT COMPLETED|Treatment Period 3 (4 Days)||0||
59866297|NCT03078556|75990394|FG001|NOT COMPLETED|Treatment Period 3 (4 Days)||0||
59866298|NCT03078556|75990395|FG002|NOT COMPLETED|Treatment Period 3 (4 Days)||0||
59866299|NCT03078556|75990396|FG003|NOT COMPLETED|Treatment Period 3 (4 Days)||0||
59866300|NCT03714672|75990425|FG000|STARTED|Overall Study||209||
59866301|NCT03714672|75990426|FG001|STARTED|Overall Study||206||
59866302|NCT03714672|75990427|FG002|STARTED|Overall Study||206||
59866303|NCT03714672|75990428|FG003|STARTED|Overall Study||208||
59866304|NCT03714672|75990425|FG000|Safety Set|Overall Study||208||
59866305|NCT03714672|75990426|FG001|Safety Set|Overall Study||205||
59866306|NCT03714672|75990427|FG002|Safety Set|Overall Study||206||
59866307|NCT03714672|75990428|FG003|Safety Set|Overall Study||207||
59866308|NCT03714672|75990425|FG000|COMPLETED|Overall Study||207||
59866309|NCT03714672|75990426|FG001|COMPLETED|Overall Study||202||
59866310|NCT03714672|75990427|FG002|COMPLETED|Overall Study||202||
59866311|NCT03714672|75990428|FG003|COMPLETED|Overall Study||207||
59866312|NCT03714672|75990425|FG000|NOT COMPLETED|Overall Study||2||
59866313|NCT03714672|75990426|FG001|NOT COMPLETED|Overall Study||4||
59866314|NCT03714672|75990427|FG002|NOT COMPLETED|Overall Study||4||
59866315|NCT03714672|75990428|FG003|NOT COMPLETED|Overall Study||1||
59866316|NCT03083470|75990444|FG000|STARTED|Overall Study||6||
59866317|NCT03083470|75990445|FG001|STARTED|Overall Study||6||
59866318|NCT03083470|75990446|FG002|STARTED|Overall Study||6||
59866319|NCT03083470|75990447|FG003|STARTED|Overall Study||6||
59866320|NCT03083470|75990448|FG004|STARTED|Overall Study||9||
59866321|NCT03083470|75990444|FG000|COMPLETED|Overall Study||6||
59866322|NCT03083470|75990445|FG001|COMPLETED|Overall Study||6||
59866323|NCT03083470|75990446|FG002|COMPLETED|Overall Study||6||
59866324|NCT03083470|75990447|FG003|COMPLETED|Overall Study||6||
59866325|NCT03083470|75990448|FG004|COMPLETED|Overall Study||7||
59866326|NCT03083470|75990444|FG000|NOT COMPLETED|Overall Study||0||
59866327|NCT03083470|75990445|FG001|NOT COMPLETED|Overall Study||0||
59866328|NCT03083470|75990446|FG002|NOT COMPLETED|Overall Study||0||
59866329|NCT03083470|75990447|FG003|NOT COMPLETED|Overall Study||0||
59866330|NCT03083470|75990448|FG004|NOT COMPLETED|Overall Study||2||
59866331|NCT05405244|75990460|FG000|STARTED|First Intervention (Single 1-Day Visit)||28||
59866332|NCT05405244|75990461|FG001|STARTED|First Intervention (Single 1-Day Visit)||27||
59866333|NCT05405244|75990460|FG000|COMPLETED|First Intervention (Single 1-Day Visit)||28||
59866334|NCT05405244|75990461|FG001|COMPLETED|First Intervention (Single 1-Day Visit)||27||
59866335|NCT05405244|75990460|FG000|NOT COMPLETED|First Intervention (Single 1-Day Visit)||0||
59866336|NCT05405244|75990461|FG001|NOT COMPLETED|First Intervention (Single 1-Day Visit)||0||
59866337|NCT05405244|75990460|FG000|STARTED|Washout (2 Weeks)||28||
59866338|NCT05405244|75990461|FG001|STARTED|Washout (2 Weeks)||27||
59866339|NCT05405244|75990460|FG000|COMPLETED|Washout (2 Weeks)||24||
59866340|NCT05405244|75990461|FG001|COMPLETED|Washout (2 Weeks)||26||
59866341|NCT05405244|75990460|FG000|NOT COMPLETED|Washout (2 Weeks)||4||
59866342|NCT05405244|75990461|FG001|NOT COMPLETED|Washout (2 Weeks)||1||
59866343|NCT05405244|75990460|FG000|STARTED|Second Intervention (Single 1-Day Visit)||24||
59866344|NCT05405244|75990461|FG001|STARTED|Second Intervention (Single 1-Day Visit)||26||
59866345|NCT05405244|75990460|FG000|COMPLETED|Second Intervention (Single 1-Day Visit)||24||
59866346|NCT05405244|75990461|FG001|COMPLETED|Second Intervention (Single 1-Day Visit)||26||
59866347|NCT05405244|75990460|FG000|NOT COMPLETED|Second Intervention (Single 1-Day Visit)||0||
59866348|NCT05405244|75990461|FG001|NOT COMPLETED|Second Intervention (Single 1-Day Visit)||0||
59866349|NCT03074500|75990474|FG000|STARTED|Overall Study||11||
59866350|NCT03074500|75990475|FG001|STARTED|Overall Study||11||
59866351|NCT03074500|75990476|FG002|STARTED|Overall Study||11||
59866352|NCT03074500|75990474|FG000|COMPLETED|Overall Study||10||
59866353|NCT03074500|75990475|FG001|COMPLETED|Overall Study||10||
59866354|NCT03074500|75990476|FG002|COMPLETED|Overall Study||10||
59866355|NCT03074500|75990474|FG000|NOT COMPLETED|Overall Study||1||
59866356|NCT03074500|75990475|FG001|NOT COMPLETED|Overall Study||1||
59866357|NCT03074500|75990476|FG002|NOT COMPLETED|Overall Study||1||
59866358|NCT03715530|75990489|FG000|STARTED|Overall Study||33||
59866359|NCT03715530|75990490|FG001|STARTED|Overall Study||42||
59866360|NCT03715530|75990491|FG002|STARTED|Overall Study||87||
59866361|NCT03715530|75990489|FG000|COMPLETED|Overall Study||30||
59866362|NCT03715530|75990490|FG001|COMPLETED|Overall Study||41||
59866363|NCT03715530|75990491|FG002|COMPLETED|Overall Study||85||
59866364|NCT03715530|75990489|FG000|NOT COMPLETED|Overall Study||3||
59866365|NCT03715530|75990490|FG001|NOT COMPLETED|Overall Study||1||
59866366|NCT03715530|75990491|FG002|NOT COMPLETED|Overall Study||2||
59866367|NCT03077698|75990501|FG000|STARTED|Progestin Monotherapy||16||
59866368|NCT03077698|75990502|FG001|STARTED|Progestin Monotherapy||0||
59866369|NCT03077698|75990501|FG000|COMPLETED|Progestin Monotherapy||6||
59866370|NCT03077698|75990502|FG001|COMPLETED|Progestin Monotherapy||0||
59866371|NCT03077698|75990501|FG000|NOT COMPLETED|Progestin Monotherapy||10||
59866372|NCT03077698|75990502|FG001|NOT COMPLETED|Progestin Monotherapy||0||
59866373|NCT03077698|75990501|FG000|STARTED|Sodium Cridanimod & Progestin Therapy|Subjects with disease progression after progestin monotherapy will roll over into treatment period 2, and receive combination treatment (Sodium Cridanimod and progestin) until documented disease progression.|6||
59866374|NCT03077698|75990502|FG001|STARTED|Sodium Cridanimod & Progestin Therapy|Subjects determined to have PrR negative status from a tumor tissue sample at Screening will enroll directly into Treatment Period 2 and receive combination treatment (Sodium Cridanimod and progestin) until documented disease progression.|9||
59999799|NCT00579124|76115519|FG000|COMPLETED|Overall Study||82||
59866375|NCT03077698|75990501|FG000|COMPLETED|Sodium Cridanimod & Progestin Therapy||0||
59866376|NCT03077698|75990502|FG001|COMPLETED|Sodium Cridanimod & Progestin Therapy||0||
59866377|NCT03077698|75990501|FG000|NOT COMPLETED|Sodium Cridanimod & Progestin Therapy||6||
59866378|NCT03077698|75990502|FG001|NOT COMPLETED|Sodium Cridanimod & Progestin Therapy||9||
59866379|NCT03077698|75990501|FG000|STARTED|Safety Follow Up||6||
59866380|NCT03077698|75990502|FG001|STARTED|Safety Follow Up||9||
59866381|NCT03077698|75990501|FG000|COMPLETED|Safety Follow Up||3||
59866382|NCT03077698|75990502|FG001|COMPLETED|Safety Follow Up||8||
59866383|NCT03077698|75990501|FG000|NOT COMPLETED|Safety Follow Up||3||
59866384|NCT03077698|75990502|FG001|NOT COMPLETED|Safety Follow Up||1||
59866385|NCT05059366|75990509|FG000|STARTED|Overall Study||8||
59866386|NCT05059366|75990510|FG001|STARTED|Overall Study||8||
59866387|NCT05059366|75990511|FG002|STARTED|Overall Study||8||
59866388|NCT05059366|75990512|FG003|STARTED|Overall Study||8||
59866389|NCT05059366|75990509|FG000|COMPLETED|Overall Study||8||
59866390|NCT05059366|75990510|FG001|COMPLETED|Overall Study||8||
59866391|NCT05059366|75990511|FG002|COMPLETED|Overall Study||8||
59866392|NCT05059366|75990512|FG003|COMPLETED|Overall Study||8||
59866393|NCT05059366|75990509|FG000|NOT COMPLETED|Overall Study||0||
59866394|NCT05059366|75990510|FG001|NOT COMPLETED|Overall Study||0||
59866395|NCT05059366|75990511|FG002|NOT COMPLETED|Overall Study||0||
59866396|NCT05059366|75990512|FG003|NOT COMPLETED|Overall Study||0||
59866397|NCT03079102|75990520|FG000|STARTED|Overall Study||30||
59866398|NCT03079102|75990521|FG001|STARTED|Overall Study||27||
59866399|NCT03079102|75990520|FG000|COMPLETED|Overall Study||30||
59866400|NCT03079102|75990521|FG001|COMPLETED|Overall Study|One subject had study drug discontinued by the PI after 3h of therapy due to progressive hemodynamic deterioration (worsening hypotension and shock). Discontinuation of study drug did not impact this deterioration.|26||
59866401|NCT03079102|75990520|FG000|NOT COMPLETED|Overall Study||0||
59866402|NCT03079102|75990521|FG001|NOT COMPLETED|Overall Study||1||
59866403|NCT02434354|75990527|FG000|STARTED|Overall Study|Consented|33||
59866404|NCT02434354|75990527|FG000|Post Consent Screening|Overall Study||30||
59866405|NCT02434354|75990527|FG000|COMPLETED|Overall Study||30||
59866406|NCT02434354|75990527|FG000|NOT COMPLETED|Overall Study||3||
59866407|NCT03076996|75990531|FG000|STARTED|Overall Study||41||
59866408|NCT03076996|75990531|FG000|COMPLETED|Overall Study||35||
59866409|NCT03076996|75990531|FG000|NOT COMPLETED|Overall Study||6||
59866410|NCT03078868|75990535|FG000|STARTED|Overall Study||3||
59866411|NCT03078868|75990535|FG000|COMPLETED|Overall Study||0||
59866412|NCT03078868|75990535|FG000|NOT COMPLETED|Overall Study||3||
59866413|NCT04524598|75990543|FG000|STARTED|Phase I - Feasibility||35||
59866414|NCT04524598|75990544|FG001|STARTED|Phase I - Feasibility||25||
59866415|NCT04524598|75990545|FG002|STARTED|Phase I - Feasibility||0||
59866416|NCT04524598|75990546|FG003|STARTED|Phase I - Feasibility||0||
59866417|NCT04524598|75990547|FG004|STARTED|Phase I - Feasibility||0||
59866418|NCT04524598|75990543|FG000|COMPLETED|Phase I - Feasibility||31||
59866419|NCT04524598|75990544|FG001|COMPLETED|Phase I - Feasibility||20||
59866420|NCT04524598|75990545|FG002|COMPLETED|Phase I - Feasibility||0||
59866421|NCT04524598|75990546|FG003|COMPLETED|Phase I - Feasibility||0||
59866422|NCT04524598|75990547|FG004|COMPLETED|Phase I - Feasibility||0||
59866423|NCT04524598|75990543|FG000|NOT COMPLETED|Phase I - Feasibility||4||
59866424|NCT04524598|75990544|FG001|NOT COMPLETED|Phase I - Feasibility||5||
59866425|NCT04524598|75990545|FG002|NOT COMPLETED|Phase I - Feasibility||0||
59866426|NCT04524598|75990546|FG003|NOT COMPLETED|Phase I - Feasibility||0||
59866427|NCT04524598|75990547|FG004|NOT COMPLETED|Phase I - Feasibility||0||
59866428|NCT04524598|75990543|FG000|STARTED|Phase II - Outcomes||0||
59866429|NCT04524598|75990544|FG001|STARTED|Phase II - Outcomes||0||
59866430|NCT04524598|75990545|FG002|STARTED|Phase II - Outcomes||80||
59866431|NCT04524598|75990546|FG003|STARTED|Phase II - Outcomes||80||
59866432|NCT04524598|75990547|FG004|STARTED|Phase II - Outcomes||0||
59866433|NCT04524598|75990543|FG000|Met PHQ-8 Threshold (Baseline >/= 10)|Phase II - Outcomes||0|Participants who met this threshold were included in the intention-to-treat analysis and the per protocol analyses.|
59866434|NCT04524598|75990544|FG001|Met PHQ-8 Threshold (Baseline >/= 10)|Phase II - Outcomes||0|Participants who met this threshold were included in the intention-to-treat analysis and the per protocol analyses.|
59866435|NCT04524598|75990545|FG002|Met PHQ-8 Threshold (Baseline >/= 10)|Phase II - Outcomes||63|Participants who met this threshold were included in the intention-to-treat analysis and the per protocol analyses.|
59866436|NCT04524598|75990546|FG003|Met PHQ-8 Threshold (Baseline >/= 10)|Phase II - Outcomes||58|Participants who met this threshold were included in the intention-to-treat analysis and the per protocol analyses.|
59866437|NCT04524598|75990547|FG004|Met PHQ-8 Threshold (Baseline >/= 10)|Phase II - Outcomes||0|Participants who met this threshold were included in the intention-to-treat analysis and the per protocol analyses.|
59866438|NCT04524598|75990543|FG000|COMPLETED|Phase II - Outcomes||0||
59866439|NCT04524598|75990544|FG001|COMPLETED|Phase II - Outcomes||0||
59866440|NCT04524598|75990545|FG002|COMPLETED|Phase II - Outcomes||54||
59866441|NCT04524598|75990546|FG003|COMPLETED|Phase II - Outcomes||67||
59866442|NCT04524598|75990547|FG004|COMPLETED|Phase II - Outcomes||0||
59866443|NCT04524598|75990543|FG000|NOT COMPLETED|Phase II - Outcomes||0||
59866444|NCT04524598|75990544|FG001|NOT COMPLETED|Phase II - Outcomes||0||
59866445|NCT04524598|75990545|FG002|NOT COMPLETED|Phase II - Outcomes||26||
59866446|NCT04524598|75990546|FG003|NOT COMPLETED|Phase II - Outcomes||13||
59866447|NCT04524598|75990547|FG004|NOT COMPLETED|Phase II - Outcomes||0||
59866448|NCT04524598|75990543|FG000|STARTED|Phase II - Control Extension||0||
59866449|NCT04524598|75990544|FG001|STARTED|Phase II - Control Extension||0||
59866450|NCT04524598|75990545|FG002|STARTED|Phase II - Control Extension||0||
59866451|NCT04524598|75990546|FG003|STARTED|Phase II - Control Extension||0||
59866452|NCT04524598|75990547|FG004|STARTED|Phase II - Control Extension||66||
59866453|NCT04524598|75990543|FG000|COMPLETED|Phase II - Control Extension||0||
59866454|NCT04524598|75990544|FG001|COMPLETED|Phase II - Control Extension||0||
59866455|NCT04524598|75990545|FG002|COMPLETED|Phase II - Control Extension||0||
59866456|NCT04524598|75990546|FG003|COMPLETED|Phase II - Control Extension||0||
59866457|NCT04524598|75990547|FG004|COMPLETED|Phase II - Control Extension||54||
59866458|NCT04524598|75990543|FG000|NOT COMPLETED|Phase II - Control Extension||0||
59866459|NCT04524598|75990544|FG001|NOT COMPLETED|Phase II - Control Extension||0||
59866460|NCT04524598|75990545|FG002|NOT COMPLETED|Phase II - Control Extension||0||
59866461|NCT04524598|75990546|FG003|NOT COMPLETED|Phase II - Control Extension||0||
59866462|NCT04524598|75990547|FG004|NOT COMPLETED|Phase II - Control Extension||12||
59866463|NCT03075904|75990561|FG000|STARTED|Overall Study||8||
59866464|NCT03075904|75990561|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8||
59866465|NCT03075904|75990561|FG000|COMPLETED|Overall Study||4|All 8 participants received all 5 weekly doses of ALXN1830 10 mg/kg in the Treatment Period.|
59866466|NCT03075904|75990561|FG000|NOT COMPLETED|Overall Study||4||
59866467|NCT03073798|75990565|FG000|STARTED|Overall Study||12||
59866468|NCT03073798|75990565|FG000|COMPLETED|Overall Study||10||
59866469|NCT03073798|75990565|FG000|NOT COMPLETED|Overall Study||2||
59866470|NCT03075826|75990570|FG000|STARTED|Overall Study||22||
59866471|NCT03075826|75990570|FG000|COMPLETED|Overall Study||16||
59866472|NCT03075826|75990570|FG000|NOT COMPLETED|Overall Study||6||
59866473|NCT03427528|75990576|FG000|STARTED|Overall Study||30||
59866474|NCT03427528|75990577|FG001|STARTED|Overall Study||30||
59866475|NCT03427528|75990576|FG000|COMPLETED|Overall Study||17||
59866476|NCT03427528|75990577|FG001|COMPLETED|Overall Study||23||
59866477|NCT03427528|75990576|FG000|NOT COMPLETED|Overall Study||13||
59866478|NCT03427528|75990577|FG001|NOT COMPLETED|Overall Study||7||
59866479|NCT02865850|75990585|FG000|STARTED|Overall Study||181||
59866480|NCT02865850|75990586|FG001|STARTED|Overall Study||188||
59866481|NCT02865850|75990585|FG000|COMPLETED|Overall Study||160||
59866482|NCT02865850|75990586|FG001|COMPLETED|Overall Study||165||
59866483|NCT02865850|75990585|FG000|NOT COMPLETED|Overall Study||21||
59866484|NCT02865850|75990586|FG001|NOT COMPLETED|Overall Study||23||
59866485|NCT03711162|75990595|FG000|STARTED|Overall Study||175||
59866486|NCT03711162|75990596|FG001|STARTED|Overall Study||175||
59866487|NCT03711162|75990597|FG002|STARTED|Overall Study||175||
59866488|NCT03711162|75990595|FG000|Treated|Overall Study||174||
59866489|NCT03711162|75990596|FG001|Treated|Overall Study||175||
59866490|NCT03711162|75990597|FG002|Treated|Overall Study||174||
59866491|NCT03711162|75990595|FG000|COMPLETED|Overall Study||0||
59866492|NCT03711162|75990596|FG001|COMPLETED|Overall Study||0||
59866493|NCT03711162|75990597|FG002|COMPLETED|Overall Study||0||
59866494|NCT03711162|75990595|FG000|NOT COMPLETED|Overall Study||175||
59866495|NCT03711162|75990596|FG001|NOT COMPLETED|Overall Study||175||
59866496|NCT03711162|75990597|FG002|NOT COMPLETED|Overall Study||175||
59866497|NCT03072160|75990613|FG000|STARTED|Overall Study||13||
59866498|NCT03072160|75990614|FG001|STARTED|Overall Study||4||
59866499|NCT03072160|75990613|FG000|COMPLETED|Overall Study||2||
59866500|NCT03072160|75990614|FG001|COMPLETED|Overall Study||0||
59866501|NCT03072160|75990613|FG000|NOT COMPLETED|Overall Study||11||
59866502|NCT03072160|75990614|FG001|NOT COMPLETED|Overall Study||4||
59866503|NCT00407602|75990652|FG000|STARTED|Overall Study||30||
59866504|NCT00407602|75990652|FG000|COMPLETED|Overall Study||23||
59866505|NCT00407602|75990652|FG000|NOT COMPLETED|Overall Study||7||
59866506|NCT03057496|75990659|FG000|STARTED|Overall Study||49||
59866507|NCT03057496|75990659|FG000|Started Home-use Trial|Overall Study||36||
59866508|NCT03057496|75990659|FG000|COMPLETED|Overall Study||31||
59866509|NCT03057496|75990659|FG000|NOT COMPLETED|Overall Study||18||
59866510|NCT05087524|75990665|FG000|STARTED|Overall Study||65||
59866511|NCT05087524|75990665|FG000|COMPLETED|Overall Study||65||
59866512|NCT05087524|75990665|FG000|NOT COMPLETED|Overall Study||0||
59866513|NCT03708744|75990669|FG000|STARTED|Overall Study||7||
59866514|NCT03708744|75990670|FG001|STARTED|Overall Study||6||
59866515|NCT03708744|75990671|FG002|STARTED|Overall Study||5||
59866516|NCT03708744|75990672|FG003|STARTED|Overall Study||6||
59866517|NCT03708744|75990669|FG000|COMPLETED|Overall Study||7||
59866518|NCT03708744|75990670|FG001|COMPLETED|Overall Study||6||
59866519|NCT03708744|75990671|FG002|COMPLETED|Overall Study||4||
59866520|NCT03708744|75990672|FG003|COMPLETED|Overall Study||6||
59866521|NCT03708744|75990669|FG000|NOT COMPLETED|Overall Study||0||
59866522|NCT03708744|75990670|FG001|NOT COMPLETED|Overall Study||0||
59866523|NCT03708744|75990671|FG002|NOT COMPLETED|Overall Study||1||
59866524|NCT03708744|75990672|FG003|NOT COMPLETED|Overall Study||0||
59866525|NCT03322384|75990682|FG000|STARTED|Overall Study||20||
59866526|NCT03322384|75990682|FG000|COMPLETED|Overall Study||14||
59866527|NCT03322384|75990682|FG000|NOT COMPLETED|Overall Study||6||
59866528|NCT02574286|75990686|FG000|STARTED|Overall Study||21||
59866529|NCT02574286|75990686|FG000|COMPLETED|Overall Study||16||
59866530|NCT02574286|75990686|FG000|NOT COMPLETED|Overall Study||5||
59866531|NCT03999684|75990690|FG000|STARTED|Overall Study||18||
59866532|NCT03999684|75990690|FG000|COMPLETED|Overall Study||18||
59866533|NCT03999684|75990690|FG000|NOT COMPLETED|Overall Study||0||
59866534|NCT02083354|75990694|FG000|STARTED|Overall Study||77||
59866535|NCT02083354|75990694|FG000|COMPLETED|Overall Study||13|These subjects show as ongoing in the clinical database even though no subjects are currently ongoing, as no changes to the data were permitted after 30-Jun-2019 due to local regulations in China.|
59866536|NCT02083354|75990694|FG000|NOT COMPLETED|Overall Study||64||
59866537|NCT04230486|75990698|FG000|STARTED|Overall Study||6||
59866538|NCT04230486|75990698|FG000|COMPLETED|Overall Study||5||
59866539|NCT04230486|75990698|FG000|NOT COMPLETED|Overall Study||1||
59866540|NCT01399918|75990704|FG000|STARTED|Overall Study||57||
59866541|NCT01399918|75990704|FG000|COMPLETED|Overall Study||55||
59866542|NCT01399918|75990704|FG000|NOT COMPLETED|Overall Study||2||
59866543|NCT00112840|75990711|FG000|STARTED|Overall Study||8||
59866544|NCT00112840|75990712|FG001|STARTED|Overall Study||6||
59866545|NCT00112840|75990713|FG002|STARTED|Overall Study||46||
59866546|NCT00112840|75990711|FG000|COMPLETED|Overall Study||6||
59866547|NCT00112840|75990712|FG001|COMPLETED|Overall Study||6||
59866548|NCT00112840|75990713|FG002|COMPLETED|Overall Study||40||
59866549|NCT00112840|75990711|FG000|NOT COMPLETED|Overall Study||2||
59866550|NCT00112840|75990712|FG001|NOT COMPLETED|Overall Study||0||
59866551|NCT00112840|75990713|FG002|NOT COMPLETED|Overall Study||6||
59866552|NCT02197572|75990726|FG000|STARTED|Overall Study||44||
59866553|NCT02197572|75990726|FG000|COMPLETED|Overall Study||0||
59866554|NCT02197572|75990726|FG000|NOT COMPLETED|Overall Study||44||
59866555|NCT03176784|75990734|FG000|STARTED|Overall Study||314||
59866556|NCT03176784|75990735|FG001|STARTED|Overall Study||315||
59866557|NCT03176784|75990736|FG002|STARTED|Overall Study||311||
59866558|NCT03176784|75990737|FG003|STARTED|Overall Study||311||
59866559|NCT03176784|75990734|FG000|COMPLETED|Overall Study||209||
59866560|NCT03176784|75990735|FG001|COMPLETED|Overall Study||202||
59866561|NCT03176784|75990736|FG002|COMPLETED|Overall Study||198||
59866562|NCT03176784|75990737|FG003|COMPLETED|Overall Study||241||
59866563|NCT03176784|75990734|FG000|NOT COMPLETED|Overall Study||105||
59866564|NCT03176784|75990735|FG001|NOT COMPLETED|Overall Study||113||
59866565|NCT03176784|75990736|FG002|NOT COMPLETED|Overall Study||113||
59866566|NCT03176784|75990737|FG003|NOT COMPLETED|Overall Study||70||
59866567|NCT03049852|75990750|FG000|STARTED|Overall Study||24||
59866568|NCT03049852|75990751|FG001|STARTED|Overall Study||25||
59866569|NCT03049852|75990752|FG002|STARTED|Overall Study||26||
59866570|NCT03049852|75990750|FG000|COMPLETED|Overall Study||24||
59866571|NCT03049852|75990751|FG001|COMPLETED|Overall Study||24||
59866572|NCT03049852|75990752|FG002|COMPLETED|Overall Study||26||
59866573|NCT03049852|75990750|FG000|NOT COMPLETED|Overall Study||0||
59866574|NCT03049852|75990751|FG001|NOT COMPLETED|Overall Study||1||
59866575|NCT03049852|75990752|FG002|NOT COMPLETED|Overall Study||0||
59866576|NCT05091528|75990764|FG000|STARTED|Overall Study||0||
59866577|NCT05091528|75990765|FG001|STARTED|Overall Study||1||
59866578|NCT05091528|75990766|FG002|STARTED|Overall Study||0||
59866579|NCT05091528|75990767|FG003|STARTED|Overall Study||1||
59866580|NCT05091528|75990764|FG000|COMPLETED|Overall Study||0||
59866581|NCT05091528|75990765|FG001|COMPLETED|Overall Study||0||
59866582|NCT05091528|75990766|FG002|COMPLETED|Overall Study||0||
59866583|NCT05091528|75990767|FG003|COMPLETED|Overall Study||0||
59866584|NCT05091528|75990764|FG000|NOT COMPLETED|Overall Study||0||
59866585|NCT05091528|75990765|FG001|NOT COMPLETED|Overall Study||1||
59866586|NCT05091528|75990766|FG002|NOT COMPLETED|Overall Study||0||
59866587|NCT05091528|75990767|FG003|NOT COMPLETED|Overall Study||1||
59866588|NCT04236258|75990777|FG000|STARTED|Overall Study||47||
59866589|NCT04236258|75990778|FG001|STARTED|Overall Study||47||
59866590|NCT04236258|75990777|FG000|COMPLETED|Overall Study||47||
59866591|NCT04236258|75990778|FG001|COMPLETED|Overall Study||47||
59866592|NCT04236258|75990777|FG000|NOT COMPLETED|Overall Study||0||
59866593|NCT04236258|75990778|FG001|NOT COMPLETED|Overall Study||0||
59866594|NCT01317004|75990790|FG000|STARTED|Overall Study||51||
59866595|NCT01317004|75990791|FG001|STARTED|Overall Study||14||
59866596|NCT01317004|75990790|FG000|Safety Set|Overall Study||50||
59866597|NCT01317004|75990791|FG001|Safety Set|Overall Study||11||
59866598|NCT01317004|75990790|FG000|COMPLETED|Overall Study||47||
59866599|NCT01317004|75990791|FG001|COMPLETED|Overall Study||5||
59866600|NCT01317004|75990790|FG000|NOT COMPLETED|Overall Study||4||
59866601|NCT01317004|75990791|FG001|NOT COMPLETED|Overall Study||9||
59866602|NCT01343056|75990801|FG000|STARTED|Overall Study||35||
59866603|NCT01343056|75990802|FG001|STARTED|Overall Study||36||
59866604|NCT01343056|75990803|FG002|STARTED|Overall Study||32||
59866605|NCT01343056|75990804|FG003|STARTED|Overall Study||38||
59866606|NCT01343056|75990801|FG000|COMPLETED|Overall Study||28||
59866607|NCT01343056|75990802|FG001|COMPLETED|Overall Study||31||
59866608|NCT01343056|75990803|FG002|COMPLETED|Overall Study||29||
59866609|NCT01343056|75990804|FG003|COMPLETED|Overall Study||29||
59866610|NCT01343056|75990801|FG000|NOT COMPLETED|Overall Study||7||
59866611|NCT01343056|75990802|FG001|NOT COMPLETED|Overall Study||5||
59866612|NCT01343056|75990803|FG002|NOT COMPLETED|Overall Study||3||
59866613|NCT01343056|75990804|FG003|NOT COMPLETED|Overall Study||9||
59866614|NCT01316692|75990818|FG000|STARTED|Overall Study||12||
59866615|NCT01316692|75990818|FG000|COMPLETED|Overall Study||0||
59866616|NCT01316692|75990818|FG000|NOT COMPLETED|Overall Study||12||
59866617|NCT01316380|75990825|FG000|STARTED|Overall Study||156||
59866618|NCT01316380|75990826|FG001|STARTED|Overall Study||154||
59866619|NCT01316380|75990827|FG002|STARTED|Overall Study||155||
59866620|NCT01316380|75990825|FG000|COMPLETED|Overall Study||154||
59866621|NCT01316380|75990826|FG001|COMPLETED|Overall Study||149||
59866622|NCT01316380|75990827|FG002|COMPLETED|Overall Study||152||
59866623|NCT01316380|75990825|FG000|NOT COMPLETED|Overall Study||2||
59866624|NCT01316380|75990826|FG001|NOT COMPLETED|Overall Study||5||
59866625|NCT01316380|75990827|FG002|NOT COMPLETED|Overall Study||3||
59866626|NCT01316224|75990835|FG000|STARTED|Overall Study||52||
59866627|NCT01316224|75990835|FG000|Completed Visit 1 to Dermatologist|Overall Study||52||
59866628|NCT01316224|75990835|FG000|Completed Visit 1 to Rheumatologist|Overall Study||49||
59866629|NCT01316224|75990835|FG000|Completed Visit 2 to Dermatologist|Overall Study||51||
59866630|NCT01316224|75990835|FG000|Completed Visit 3 to Dermatologist|Overall Study||48||
59866631|NCT01316224|75990835|FG000|Completed Visit 3 to Rheumatologist|Overall Study||39||
59866632|NCT01316224|75990835|FG000|Completed Visit 4 to Dermatologist|Overall Study||42||
59866633|NCT01316224|75990835|FG000|Completed Visit 4 to Rheumatologist|Overall Study||28||
59866634|NCT01316224|75990835|FG000|COMPLETED|Overall Study||42||
59866635|NCT01316224|75990835|FG000|NOT COMPLETED|Overall Study||10||
59866636|NCT04315298|75990858|FG000|STARTED|Overall Study||90|Randomized and Treated|
59866637|NCT04315298|75990859|FG001|STARTED|Overall Study||187|Randomized and Treated|
59866638|NCT04315298|75990860|FG002|STARTED|Overall Study||180|Randomized and Treated|
59866639|NCT04315298|75990861|FG003|STARTED|Overall Study||170|Randomized and Treated|
59866640|NCT04315298|75990862|FG004|STARTED|Overall Study||242|Randomized and Treated|
59866641|NCT04315298|75990863|FG005|STARTED|Overall Study||338|Randomized and Treated|
59866642|NCT04315298|75990864|FG006|STARTED|Overall Study||70|Randomized and Treated|
59866643|NCT04315298|75990865|FG007|STARTED|Overall Study||140|Randomized and Treated|
59866644|NCT04315298|75990866|FG008|STARTED|Overall Study||137|Randomized and Treated|
59866645|NCT04315298|75990867|FG009|STARTED|Overall Study||46|Randomized and Treated|
59866646|NCT04315298|75990868|FG010|STARTED|Overall Study||95|Randomized and Treated|
59866647|NCT04315298|75990869|FG011|STARTED|Overall Study||92|Randomized and Treated|
59866648|NCT04315298|75990870|FG012|STARTED|Overall Study||8|Randomized and Treated|
59866649|NCT04315298|75990871|FG013|STARTED|Overall Study||12|Randomized and Treated|
59866650|NCT04315298|75990872|FG014|STARTED|Overall Study||15|Randomized and Treated|
59866651|NCT04315298|75990873|FG015|STARTED|Overall Study||15|Randomized and Treated|
59866652|NCT04315298|75990874|FG016|STARTED|Overall Study||16|Randomized and Treated|
59866653|NCT04315298|75990875|FG017|STARTED|Overall Study||6|Randomized and Treated|
59866654|NCT04315298|75990876|FG018|STARTED|Overall Study||2|Randomized and Treated|
59866655|NCT04315298|75990858|FG000|COMPLETED|Overall Study||61||
59866656|NCT04315298|75990859|FG001|COMPLETED|Overall Study||117||
59866657|NCT04315298|75990860|FG002|COMPLETED|Overall Study||125||
59866658|NCT04315298|75990861|FG003|COMPLETED|Overall Study||101||
59866659|NCT04315298|75990862|FG004|COMPLETED|Overall Study||157||
59866660|NCT04315298|75990863|FG005|COMPLETED|Overall Study||209||
59866661|NCT04315298|75990864|FG006|COMPLETED|Overall Study||52||
59866662|NCT04315298|75990865|FG007|COMPLETED|Overall Study||111||
59866663|NCT04315298|75990866|FG008|COMPLETED|Overall Study||101||
59866664|NCT04315298|75990867|FG009|COMPLETED|Overall Study||29||
59866665|NCT04315298|75990868|FG010|COMPLETED|Overall Study||53||
59866666|NCT04315298|75990869|FG011|COMPLETED|Overall Study||51||
59866667|NCT04315298|75990870|FG012|COMPLETED|Overall Study||5||
59866668|NCT04315298|75990871|FG013|COMPLETED|Overall Study||8||
59866669|NCT04315298|75990872|FG014|COMPLETED|Overall Study||9||
59866670|NCT04315298|75990873|FG015|COMPLETED|Overall Study||9||
59866671|NCT04315298|75990874|FG016|COMPLETED|Overall Study||13||
59866672|NCT04315298|75990875|FG017|COMPLETED|Overall Study||5||
59866673|NCT04315298|75990876|FG018|COMPLETED|Overall Study||2||
59866674|NCT04315298|75990858|FG000|NOT COMPLETED|Overall Study||29||
59866675|NCT04315298|75990859|FG001|NOT COMPLETED|Overall Study||70||
59866676|NCT04315298|75990860|FG002|NOT COMPLETED|Overall Study||55||
59866677|NCT04315298|75990861|FG003|NOT COMPLETED|Overall Study||69||
59866678|NCT04315298|75990862|FG004|NOT COMPLETED|Overall Study||85||
59866679|NCT04315298|75990863|FG005|NOT COMPLETED|Overall Study||129||
59866680|NCT04315298|75990864|FG006|NOT COMPLETED|Overall Study||18||
59866681|NCT04315298|75990865|FG007|NOT COMPLETED|Overall Study||29||
59866682|NCT04315298|75990866|FG008|NOT COMPLETED|Overall Study||36||
59866683|NCT04315298|75990867|FG009|NOT COMPLETED|Overall Study||17||
59866684|NCT04315298|75990868|FG010|NOT COMPLETED|Overall Study||42||
59866685|NCT04315298|75990869|FG011|NOT COMPLETED|Overall Study||41||
59866686|NCT04315298|75990870|FG012|NOT COMPLETED|Overall Study||3||
59866687|NCT04315298|75990871|FG013|NOT COMPLETED|Overall Study||4||
59866688|NCT04315298|75990872|FG014|NOT COMPLETED|Overall Study||6||
59866689|NCT04315298|75990873|FG015|NOT COMPLETED|Overall Study||6||
59866690|NCT04315298|75990874|FG016|NOT COMPLETED|Overall Study||3||
59866691|NCT04315298|75990875|FG017|NOT COMPLETED|Overall Study||1||
59866692|NCT04315298|75990876|FG018|NOT COMPLETED|Overall Study||0||
59866693|NCT04308668|75990945|FG000|STARTED|Overall Study||658||
59866694|NCT04308668|75990946|FG001|STARTED|Overall Study||654||
59866695|NCT04308668|75990945|FG000|COMPLETED|Overall Study||622||
59866696|NCT04308668|75990946|FG001|COMPLETED|Overall Study||612||
59866697|NCT04308668|75990945|FG000|NOT COMPLETED|Overall Study||36||
59866698|NCT04308668|75990946|FG001|NOT COMPLETED|Overall Study||42||
59866699|NCT04451330|75990954|FG000|STARTED|Overall Study||133||
59866700|NCT04451330|75990955|FG001|STARTED|Overall Study||69||
59866701|NCT04451330|75990954|FG000|COMPLETED|Overall Study||123||
59866702|NCT04451330|75990955|FG001|COMPLETED|Overall Study||65||
59866703|NCT04451330|75990954|FG000|NOT COMPLETED|Overall Study||10||
59866704|NCT04451330|75990955|FG001|NOT COMPLETED|Overall Study||4||
59866705|NCT02493426|75990961|FG000|STARTED|Overall Study||14||
59866706|NCT02493426|75990962|FG001|STARTED|Overall Study||13||
59866707|NCT02493426|75990961|FG000|COMPLETED|Overall Study||14||
59866708|NCT02493426|75990962|FG001|COMPLETED|Overall Study||12||
59866709|NCT02493426|75990961|FG000|NOT COMPLETED|Overall Study||0||
59866710|NCT02493426|75990962|FG001|NOT COMPLETED|Overall Study||1||
59866711|NCT04448756|75990971|FG000|STARTED|Overall Study||49||
59866712|NCT04448756|75990972|FG001|STARTED|Overall Study||54||
59866713|NCT04448756|75990973|FG002|STARTED|Overall Study||46||
59866714|NCT04448756|75990971|FG000|COMPLETED|Overall Study||46||
59866715|NCT04448756|75990972|FG001|COMPLETED|Overall Study||49||
59866716|NCT04448756|75990973|FG002|COMPLETED|Overall Study||45||
59866717|NCT04448756|75990971|FG000|NOT COMPLETED|Overall Study||3||
59866718|NCT04448756|75990972|FG001|NOT COMPLETED|Overall Study||5||
59866719|NCT04448756|75990973|FG002|NOT COMPLETED|Overall Study||1||
59866720|NCT04274192|75990983|FG000|STARTED|Overall Study||1||
59866721|NCT04274192|75990984|FG001|STARTED|Overall Study||0||
59866722|NCT04274192|75990983|FG000|COMPLETED|Overall Study||0|"Using the equipment available, we were unable to administer the 6 LPM (per the protocol), so this subject did not receive all of the interventions and therefore did not complete the study.~We subsequently terminated the study due to lack of protocol feasibility and the departure of the original PI."|
59866723|NCT04274192|75990984|FG001|COMPLETED|Overall Study||0|"Using the equipment available, we were unable to administer the 6 LPM (per the protocol), so this subject did not receive all of the interventions and therefore did not complete the study.~We subsequently terminated the study due to lack of protocol feasibility and the departure of the original PI."|
59866724|NCT04274192|75990983|FG000|NOT COMPLETED|Overall Study||1||
59866725|NCT04274192|75990984|FG001|NOT COMPLETED|Overall Study||0||
59866726|NCT04387136|75990994|FG000|STARTED|Overall Study||26||
59866727|NCT04387136|75990995|FG001|STARTED|Overall Study||27||
59866728|NCT04387136|75990994|FG000|COMPLETED|Overall Study||25||
59866729|NCT04387136|75990995|FG001|COMPLETED|Overall Study||25||
59866730|NCT04387136|75990994|FG000|NOT COMPLETED|Overall Study||1||
59866731|NCT04387136|75990995|FG001|NOT COMPLETED|Overall Study||2||
59866732|NCT04252586|75991001|FG000|STARTED|Overall Study||21||
59866733|NCT04252586|75991001|FG000|COMPLETED|Overall Study||0||
59866734|NCT04252586|75991001|FG000|NOT COMPLETED|Overall Study||21||
59866735|NCT04247828|75991006|FG000|STARTED|Overall Study||30||
59866736|NCT04247828|75991006|FG000|Started - Controls|Overall Study||19||
59866737|NCT04247828|75991006|FG000|Started - Participants With SPI|Overall Study||11||
59866738|NCT04247828|75991006|FG000|COMPLETED|Overall Study|16 controls and 5 participants with SPI completed the study|21||
59866739|NCT04247828|75991006|FG000|NOT COMPLETED|Overall Study||9||
59866740|NCT04507776|75991010|FG000|STARTED|Overall Study||763||
59866741|NCT04507776|75991010|FG000|COMPLETED|Overall Study||562||
59866742|NCT04507776|75991010|FG000|NOT COMPLETED|Overall Study||201||
59866743|NCT04386902|75991019|FG000|STARTED|Overall Study||60||
59866744|NCT04386902|75991019|FG000|COMPLETED|Overall Study||50||
59866745|NCT04386902|75991019|FG000|NOT COMPLETED|Overall Study||10||
59866746|NCT04232540|75991025|FG000|STARTED|Overall Study||37||
59866747|NCT04232540|75991026|FG001|STARTED|Overall Study||20||
59866748|NCT04232540|75991025|FG000|Received MedViewer|Overall Study||34|The MedViewer report was received as planned if results were: (1) delivered to the research team member within 2 hours of initiation of hair sample processing; and (2) discussed between the patient and provider/pharmacist during their clinic visit.|
59866749|NCT04232540|75991026|FG001|Received MedViewer|Overall Study||16|The MedViewer report was received as planned if results were: (1) delivered to the research team member within 2 hours of initiation of hair sample processing; and (2) discussed between the patient and provider/pharmacist during their clinic visit.|
59866750|NCT04232540|75991025|FG000|Completed In-Depth Interview|Overall Study||24||
59866751|NCT04232540|75991026|FG001|Completed In-Depth Interview|Overall Study||14||
59866752|NCT04232540|75991025|FG000|COMPLETED|Overall Study||36||
59866753|NCT04232540|75991026|FG001|COMPLETED|Overall Study||20||
59866754|NCT04232540|75991025|FG000|NOT COMPLETED|Overall Study||1||
59866755|NCT04232540|75991026|FG001|NOT COMPLETED|Overall Study||0||
59866756|NCT04504032|75991034|FG000|STARTED|Overall Study||246||
59866757|NCT04504032|75991035|FG001|STARTED|Overall Study||251||
59866758|NCT04504032|75991034|FG000|COMPLETED|Overall Study||210||
59866759|NCT04504032|75991035|FG001|COMPLETED|Overall Study||223||
59866760|NCT04504032|75991034|FG000|NOT COMPLETED|Overall Study||36||
59866761|NCT04504032|75991035|FG001|NOT COMPLETED|Overall Study||28||
59866762|NCT04439240|75991041|FG000|STARTED|Overall Study||52||
59866763|NCT04439240|75991041|FG000|Started Protocol Therapy|Overall Study||50||
59866764|NCT04439240|75991041|FG000|Eligible|Overall Study||49||
59866765|NCT04439240|75991041|FG000|Eligible and Started Protocol Therapy|Overall Study||48|2 patients ineligible, 1 patient never started treatment, 1 patient both ineligible and never started treatment. This is the primary analysis population.|
59866766|NCT04439240|75991041|FG000|Reported Adverse Events Data|Overall Study||49|1 of the 50 treated patients had no adverse events reported|
59866767|NCT04439240|75991041|FG000|COMPLETED|Overall Study||0|Treatment continued until disease progression or intolerability.|
59866768|NCT04439240|75991041|FG000|NOT COMPLETED|Overall Study||52||
59866769|NCT04605588|75991047|FG000|STARTED|Overall Study||2||
59866770|NCT04605588|75991048|FG001|STARTED|Overall Study||5||
59866771|NCT04605588|75991047|FG000|COMPLETED|Overall Study||1||
59866772|NCT04605588|75991048|FG001|COMPLETED|Overall Study||5||
59866773|NCT04605588|75991047|FG000|NOT COMPLETED|Overall Study||1||
59866774|NCT04605588|75991048|FG001|NOT COMPLETED|Overall Study||0||
59866775|NCT04885296|75991054|FG000|STARTED|Period 1||117||
59866776|NCT04885296|75991055|FG001|STARTED|Period 1||110||
59866777|NCT04885296|75991054|FG000|COMPLETED|Period 1||112||
59866778|NCT04885296|75991055|FG001|COMPLETED|Period 1||108||
59866779|NCT04885296|75991054|FG000|NOT COMPLETED|Period 1||5||
59866780|NCT04885296|75991055|FG001|NOT COMPLETED|Period 1||2||
59866781|NCT04885296|75991054|FG000|STARTED|Period 2||112||
59866782|NCT04885296|75991055|FG001|STARTED|Period 2||108||
59866783|NCT04885296|75991054|FG000|COMPLETED|Period 2||112||
59866784|NCT04885296|75991055|FG001|COMPLETED|Period 2||107||
59866785|NCT04885296|75991054|FG000|NOT COMPLETED|Period 2||0||
59866786|NCT04885296|75991055|FG001|NOT COMPLETED|Period 2||1||
59866787|NCT04602000|75991066|FG000|STARTED|Overall Study||105||
59866788|NCT04602000|75991067|FG001|STARTED|Overall Study||111||
59866789|NCT04602000|75991068|FG002|STARTED|Overall Study||111||
59866790|NCT04602000|75991069|FG003|STARTED|Overall Study||656||
59866791|NCT04602000|75991070|FG004|STARTED|Overall Study||659||
59866792|NCT04602000|75991066|FG000|COMPLETED|Overall Study||97||
59866793|NCT04602000|75991067|FG001|COMPLETED|Overall Study||103||
59866794|NCT04602000|75991068|FG002|COMPLETED|Overall Study||105||
59866795|NCT04602000|75991069|FG003|COMPLETED|Overall Study||618||
59866796|NCT04602000|75991070|FG004|COMPLETED|Overall Study||608||
59866797|NCT04602000|75991066|FG000|NOT COMPLETED|Overall Study||8||
59866798|NCT04602000|75991067|FG001|NOT COMPLETED|Overall Study||8||
59866799|NCT04602000|75991068|FG002|NOT COMPLETED|Overall Study||6||
59866800|NCT04602000|75991069|FG003|NOT COMPLETED|Overall Study||38||
59866801|NCT04602000|75991070|FG004|NOT COMPLETED|Overall Study||51||
59866802|NCT03041116|75991086|FG000|STARTED|Double-blind||41||
59866803|NCT03041116|75991087|FG001|STARTED|Double-blind||43||
59866804|NCT03041116|75991086|FG000|Received at Least 1 Dose of Study Drug|Double-blind||41||
59866805|NCT03041116|75991087|FG001|Received at Least 1 Dose of Study Drug|Double-blind||43||
59866806|NCT03041116|75991086|FG000|COMPLETED|Double-blind||41||
59866807|NCT03041116|75991087|FG001|COMPLETED|Double-blind||37||
59866808|NCT03041116|75991086|FG000|NOT COMPLETED|Double-blind||0||
59866809|NCT03041116|75991087|FG001|NOT COMPLETED|Double-blind||6||
59866810|NCT03041116|75991086|FG000|STARTED|Open-label||41||
59866811|NCT03041116|75991087|FG001|STARTED|Open-label||37||
59866812|NCT03041116|75991086|FG000|Received At Least 1 Dose of Study Drug|Open-label||41||
59866813|NCT03041116|75991087|FG001|Received At Least 1 Dose of Study Drug|Open-label||37||
59866814|NCT03041116|75991086|FG000|COMPLETED|Open-label||0||
59866815|NCT03041116|75991087|FG001|COMPLETED|Open-label||0||
59866816|NCT03041116|75991086|FG000|NOT COMPLETED|Open-label||41||
59866817|NCT03041116|75991087|FG001|NOT COMPLETED|Open-label||37||
59866818|NCT04860258|75991104|FG000|STARTED|Overall Study||1||
59866819|NCT04860258|75991105|FG001|STARTED|Overall Study||1||
59866820|NCT04860258|75991106|FG002|STARTED|Overall Study||52||
59866821|NCT04860258|75991107|FG003|STARTED|Overall Study||33||
59866822|NCT04860258|75991108|FG004|STARTED|Overall Study||33||
59866823|NCT04860258|75991109|FG005|STARTED|Overall Study||7||
59866824|NCT04860258|75991110|FG006|STARTED|Overall Study||2||
59866825|NCT04860258|75991104|FG000|COMPLETED|Overall Study||1||
59866826|NCT04860258|75991105|FG001|COMPLETED|Overall Study||1||
59866827|NCT04860258|75991106|FG002|COMPLETED|Overall Study||48||
59866828|NCT04860258|75991107|FG003|COMPLETED|Overall Study||32||
59866829|NCT04860258|75991108|FG004|COMPLETED|Overall Study||29||
59866830|NCT04860258|75991109|FG005|COMPLETED|Overall Study||6||
59866831|NCT04860258|75991110|FG006|COMPLETED|Overall Study||2||
59866832|NCT04860258|75991104|FG000|NOT COMPLETED|Overall Study||0||
59866833|NCT04860258|75991105|FG001|NOT COMPLETED|Overall Study||0||
59866834|NCT04860258|75991106|FG002|NOT COMPLETED|Overall Study||4||
59866835|NCT04860258|75991107|FG003|NOT COMPLETED|Overall Study||1||
59866836|NCT04860258|75991108|FG004|NOT COMPLETED|Overall Study||4||
59866837|NCT04860258|75991109|FG005|NOT COMPLETED|Overall Study||1||
59866838|NCT04860258|75991110|FG006|NOT COMPLETED|Overall Study||0||
59866839|NCT03041038|75991128|FG000|STARTED|Overall Study||11||
59866840|NCT03041038|75991129|FG001|STARTED|Overall Study||9||
59866841|NCT03041038|75991128|FG000|Week 16|Overall Study||10||
59866842|NCT03041038|75991129|FG001|Week 16|Overall Study||8||
59866843|NCT03041038|75991128|FG000|Week 32|Overall Study||9||
59866844|NCT03041038|75991129|FG001|Week 32|Overall Study||8||
59866845|NCT03041038|75991128|FG000|COMPLETED|Overall Study||5||
59866846|NCT03041038|75991129|FG001|COMPLETED|Overall Study||7||
59866847|NCT03041038|75991128|FG000|NOT COMPLETED|Overall Study||6||
59866848|NCT03041038|75991129|FG001|NOT COMPLETED|Overall Study||2||
59866849|NCT04382066|75991140|FG000|STARTED|Overall Study||15|One patient withdrew the Informed Consent before any study procedure was performed.|
59866850|NCT04382066|75991141|FG001|STARTED|Overall Study||15|One patient withdrew the Informed Consent before any study procedure was performed.|
59866851|NCT04382066|75991142|FG002|STARTED|Overall Study||15|One patient withdrew the Informed Consent before any study procedure was performed.|
59866852|NCT04382066|75991140|FG000|Completed 3-day Treatment|Overall Study||14||
59866853|NCT04382066|75991141|FG001|Completed 3-day Treatment|Overall Study||15||
59866854|NCT04382066|75991142|FG002|Completed 3-day Treatment|Overall Study||15||
59866855|NCT04382066|75991140|FG000|COMPLETED|Overall Study||13|Completed Day 31 follow-up|
59866856|NCT04382066|75991141|FG001|COMPLETED|Overall Study||15|Completed Day 31 follow-up|
59866857|NCT04382066|75991142|FG002|COMPLETED|Overall Study||14|Completed Day 31 follow-up|
59866858|NCT04382066|75991140|FG000|NOT COMPLETED|Overall Study||2||
59866859|NCT04382066|75991141|FG001|NOT COMPLETED|Overall Study||0||
59866860|NCT04382066|75991142|FG002|NOT COMPLETED|Overall Study||1||
59866861|NCT04435184|75991158|FG000|STARTED|Overall Study||25||
59866862|NCT04435184|75991159|FG001|STARTED|Overall Study||25||
59866863|NCT04435184|75991158|FG000|COMPLETED|Overall Study||22||
59866864|NCT04435184|75991159|FG001|COMPLETED|Overall Study||20||
59866865|NCT04435184|75991158|FG000|NOT COMPLETED|Overall Study||3||
59866866|NCT04435184|75991159|FG001|NOT COMPLETED|Overall Study||5||
59866867|NCT03693404|75991167|FG000|STARTED|Overall Study||109||
59866868|NCT03693404|75991168|FG001|STARTED|Overall Study||81||
59866869|NCT03693404|75991167|FG000|COMPLETED|Overall Study||108||
59866870|NCT03693404|75991168|FG001|COMPLETED|Overall Study||75||
59866871|NCT03693404|75991167|FG000|NOT COMPLETED|Overall Study||1||
59866872|NCT03693404|75991168|FG001|NOT COMPLETED|Overall Study||6||
59866873|NCT03696108|75991176|FG000|STARTED|Overall Study||84||
59866874|NCT03696108|75991177|FG001|STARTED|Overall Study||85||
59866875|NCT03696108|75991176|FG000|COMPLETED|Overall Study||80||
59866876|NCT03696108|75991177|FG001|COMPLETED|Overall Study||79||
59866877|NCT03696108|75991176|FG000|NOT COMPLETED|Overall Study||4||
59866878|NCT03696108|75991177|FG001|NOT COMPLETED|Overall Study||6||
59866879|NCT04218110|75991187|FG000|STARTED|Overall Study||82||
59866880|NCT04218110|75991188|FG001|STARTED|Overall Study||81||
59866881|NCT04218110|75991189|FG002|STARTED|Overall Study||83||
59866882|NCT04218110|75991190|FG003|STARTED|Overall Study||83||
59866883|NCT04218110|75991187|FG000|Received Treatment|Overall Study||82||
59866884|NCT04218110|75991188|FG001|Received Treatment|Overall Study||81||
59866885|NCT04218110|75991189|FG002|Received Treatment|Overall Study||83||
59866886|NCT04218110|75991190|FG003|Received Treatment|Overall Study||82||
59866887|NCT04218110|75991187|FG000|COMPLETED|Overall Study||82||
59866888|NCT04218110|75991188|FG001|COMPLETED|Overall Study||81||
59866889|NCT04218110|75991189|FG002|COMPLETED|Overall Study||83||
59866890|NCT04218110|75991190|FG003|COMPLETED|Overall Study||82||
59866891|NCT04218110|75991187|FG000|NOT COMPLETED|Overall Study||0||
59866892|NCT04218110|75991188|FG001|NOT COMPLETED|Overall Study||0||
59866893|NCT04218110|75991189|FG002|NOT COMPLETED|Overall Study||0||
59866894|NCT04218110|75991190|FG003|NOT COMPLETED|Overall Study||1||
59866895|NCT04214600|75991202|FG000|STARTED|Overall Study||50||
59866896|NCT04214600|75991203|FG001|STARTED|Overall Study||50||
59866897|NCT04214600|75991202|FG000|COMPLETED|Overall Study||41||
59866898|NCT04214600|75991203|FG001|COMPLETED|Overall Study||36||
59866899|NCT04214600|75991202|FG000|NOT COMPLETED|Overall Study||9||
59866900|NCT04214600|75991203|FG001|NOT COMPLETED|Overall Study||14||
59866901|NCT04210310|75991212|FG000|STARTED|Overall Study||32||
59866902|NCT04210310|75991213|FG001|STARTED|Overall Study||1||
59866903|NCT04210310|75991212|FG000|COMPLETED|Overall Study||0||
59866904|NCT04210310|75991213|FG001|COMPLETED|Overall Study||0||
59866905|NCT04210310|75991212|FG000|NOT COMPLETED|Overall Study||32||
59866906|NCT04210310|75991213|FG001|NOT COMPLETED|Overall Study||1||
59866907|NCT04209530|75991221|FG000|STARTED|Overall Study||4||
59866908|NCT04209530|75991222|FG001|STARTED|Overall Study||3||
59866909|NCT04209530|75991221|FG000|COMPLETED|Overall Study||0||
59866910|NCT04209530|75991222|FG001|COMPLETED|Overall Study||0||
59866911|NCT04209530|75991221|FG000|NOT COMPLETED|Overall Study||4||
59866912|NCT04209530|75991222|FG001|NOT COMPLETED|Overall Study||3||
59866913|NCT04349098|75991230|FG000|STARTED|Overall Study||103||
59866914|NCT04349098|75991231|FG001|STARTED|Overall Study||87||
59866915|NCT04349098|75991230|FG000|Treated|Overall Study||102||
59866916|NCT04349098|75991231|FG001|Treated|Overall Study||86||
59866917|NCT04349098|75991230|FG000|COMPLETED|Overall Study||65||
59866918|NCT04349098|75991231|FG001|COMPLETED|Overall Study||61||
59866919|NCT04349098|75991230|FG000|NOT COMPLETED|Overall Study||38||
59866920|NCT04349098|75991231|FG001|NOT COMPLETED|Overall Study||26||
59866921|NCT04208750|75991239|FG000|STARTED|Overall Study||58||
59866922|NCT04208750|75991240|FG001|STARTED|Overall Study||61||
59866923|NCT04208750|75991239|FG000|Visit 2|Overall Study||58||
59866924|NCT04208750|75991240|FG001|Visit 2|Overall Study||61||
59866925|NCT04208750|75991239|FG000|Visit 3|Overall Study||58||
59866926|NCT04208750|75991240|FG001|Visit 3|Overall Study||53||
59866927|NCT04208750|75991239|FG000|Visit 4|Overall Study||43||
59866928|NCT04208750|75991240|FG001|Visit 4|Overall Study||47||
59866929|NCT04208750|75991239|FG000|COMPLETED|Overall Study||42||
59866930|NCT04208750|75991240|FG001|COMPLETED|Overall Study||46||
59866931|NCT04208750|75991239|FG000|NOT COMPLETED|Overall Study||16||
59866932|NCT04208750|75991240|FG001|NOT COMPLETED|Overall Study||15||
59866933|NCT04381988|75991248|FG000|STARTED|Overall Study||4||
59866934|NCT04381988|75991249|FG001|STARTED|Overall Study||0||
59866935|NCT04381988|75991248|FG000|COMPLETED|Overall Study||0||
59866936|NCT04381988|75991249|FG001|COMPLETED|Overall Study||0||
59866937|NCT04381988|75991248|FG000|NOT COMPLETED|Overall Study||4||
59866938|NCT04381988|75991249|FG001|NOT COMPLETED|Overall Study||0||
59866939|NCT04333498|75991257|FG000|STARTED|Overall Study||30||
59866940|NCT04333498|75991258|FG001|STARTED|Overall Study||30||
59866941|NCT04333498|75991257|FG000|COMPLETED|Overall Study||29||
59866942|NCT04333498|75991258|FG001|COMPLETED|Overall Study||29||
59866943|NCT04333498|75991257|FG000|NOT COMPLETED|Overall Study||1||
59866944|NCT04333498|75991258|FG001|NOT COMPLETED|Overall Study||1||
59866945|NCT03355664|75991266|FG000|STARTED|Overall Study||154||
59866946|NCT03355664|75991267|FG001|STARTED|Overall Study||156||
59866947|NCT03355664|75991266|FG000|COMPLETED|Overall Study||139||
59866948|NCT03355664|75991267|FG001|COMPLETED|Overall Study||144||
59866949|NCT03355664|75991266|FG000|NOT COMPLETED|Overall Study||15||
59866950|NCT03355664|75991267|FG001|NOT COMPLETED|Overall Study||12||
59866951|NCT04170686|75991275|FG000|STARTED|Screening||74||
59866952|NCT04170686|75991276|FG001|STARTED|Screening||72||
59866953|NCT04170686|75991275|FG000|COMPLETED|Screening||62||
59866954|NCT04170686|75991276|FG001|COMPLETED|Screening||59||
59866955|NCT04170686|75991275|FG000|NOT COMPLETED|Screening||12||
59866956|NCT04170686|75991276|FG001|NOT COMPLETED|Screening||13||
59866957|NCT04170686|75991275|FG000|STARTED|Randomization and Treatment||62||
59866958|NCT04170686|75991276|FG001|STARTED|Randomization and Treatment||59||
59866959|NCT04170686|75991275|FG000|COMPLETED|Randomization and Treatment||36||
59866960|NCT04170686|75991276|FG001|COMPLETED|Randomization and Treatment||44||
59866961|NCT04170686|75991275|FG000|NOT COMPLETED|Randomization and Treatment||26||
59866962|NCT04170686|75991276|FG001|NOT COMPLETED|Randomization and Treatment||15||
59866963|NCT03695094|75991284|FG000|STARTED|Overall Study||16||
59866964|NCT03695094|75991285|FG001|STARTED|Overall Study||15||
59866965|NCT03695094|75991284|FG000|COMPLETED|Overall Study||14||
59866966|NCT03695094|75991285|FG001|COMPLETED|Overall Study||14||
59866967|NCT03695094|75991284|FG000|NOT COMPLETED|Overall Study||2||
59866968|NCT03695094|75991285|FG001|NOT COMPLETED|Overall Study||1||
59866969|NCT04497948|75991293|FG000|STARTED|Overall Study||9||
59866970|NCT04497948|75991293|FG000|COMPLETED|Overall Study||7||
59866971|NCT04497948|75991293|FG000|NOT COMPLETED|Overall Study||2||
59866972|NCT04495374|75991303|FG000|STARTED|Overall Study||30||
59866973|NCT04495374|75991304|FG001|STARTED|Overall Study||28||
59866974|NCT04495374|75991303|FG000|COMPLETED|Overall Study||28||
59866975|NCT04495374|75991304|FG001|COMPLETED|Overall Study||27||
59866976|NCT04495374|75991303|FG000|NOT COMPLETED|Overall Study||2||
59866977|NCT04495374|75991304|FG001|NOT COMPLETED|Overall Study||1||
59866978|NCT04794270|75991310|FG000|STARTED|Period 1||35||
59866979|NCT04794270|75991311|FG001|STARTED|Period 1||36||
59866980|NCT04794270|75991310|FG000|COMPLETED|Period 1||33||
59866981|NCT04794270|75991311|FG001|COMPLETED|Period 1||36||
59866982|NCT04794270|75991310|FG000|NOT COMPLETED|Period 1||2||
59866983|NCT04794270|75991311|FG001|NOT COMPLETED|Period 1||0||
59866984|NCT04794270|75991310|FG000|STARTED|Period 2||33||
59866985|NCT04794270|75991311|FG001|STARTED|Period 2||36||
59866986|NCT04794270|75991310|FG000|COMPLETED|Period 2||32||
59866987|NCT04794270|75991311|FG001|COMPLETED|Period 2||36||
59866988|NCT04794270|75991310|FG000|NOT COMPLETED|Period 2||1||
59866989|NCT04794270|75991311|FG001|NOT COMPLETED|Period 2||0||
59866990|NCT04567186|75991317|FG000|STARTED|Period 1||38||
59866991|NCT04567186|75991318|FG001|STARTED|Period 1||40||
59866992|NCT04567186|75991317|FG000|COMPLETED|Period 1||37||
59866993|NCT04567186|75991318|FG001|COMPLETED|Period 1||37||
59866994|NCT04567186|75991317|FG000|NOT COMPLETED|Period 1||1||
59866995|NCT04567186|75991318|FG001|NOT COMPLETED|Period 1||3||
59866996|NCT04567186|75991317|FG000|STARTED|Period 2||37||
59866997|NCT04567186|75991318|FG001|STARTED|Period 2||37||
59866998|NCT04567186|75991317|FG000|COMPLETED|Period 2||37||
59866999|NCT04567186|75991318|FG001|COMPLETED|Period 2||34||
59867000|NCT04567186|75991317|FG000|NOT COMPLETED|Period 2||0||
59867001|NCT04567186|75991318|FG001|NOT COMPLETED|Period 2||3||
59867002|NCT04567186|75991317|FG000|STARTED|Period 3||37||
59867003|NCT04567186|75991318|FG001|STARTED|Period 3||34||
59867004|NCT04567186|75991317|FG000|COMPLETED|Period 3||36||
59867005|NCT04567186|75991318|FG001|COMPLETED|Period 3||34||
59867006|NCT04567186|75991317|FG000|NOT COMPLETED|Period 3||1||
59867007|NCT04567186|75991318|FG001|NOT COMPLETED|Period 3||0||
59867008|NCT04168190|75991329|FG000|STARTED|Overall Study||30||
59867009|NCT04168190|75991330|FG001|STARTED|Overall Study||30||
59867010|NCT04168190|75991331|FG002|STARTED|Overall Study||30||
59867011|NCT04168190|75991332|FG003|STARTED|Overall Study||254||
59867012|NCT04168190|75991333|FG004|STARTED|Overall Study||256||
59867013|NCT04168190|75991329|FG000|Treated|Overall Study||30||
59867014|NCT04168190|75991330|FG001|Treated|Overall Study||30||
59867015|NCT04168190|75991331|FG002|Treated|Overall Study||30||
59867016|NCT04168190|75991332|FG003|Treated|Overall Study||254||
59867017|NCT04168190|75991333|FG004|Treated|Overall Study||254||
59867018|NCT04168190|75991329|FG000|COMPLETED|Overall Study||29||
59867019|NCT04168190|75991330|FG001|COMPLETED|Overall Study||29||
59867020|NCT04168190|75991331|FG002|COMPLETED|Overall Study||30||
59867021|NCT04168190|75991332|FG003|COMPLETED|Overall Study||244||
59867022|NCT04168190|75991333|FG004|COMPLETED|Overall Study||247||
59867023|NCT04168190|75991329|FG000|NOT COMPLETED|Overall Study||1||
59867024|NCT04168190|75991330|FG001|NOT COMPLETED|Overall Study||1||
59867025|NCT04168190|75991331|FG002|NOT COMPLETED|Overall Study||0||
59867026|NCT04168190|75991332|FG003|NOT COMPLETED|Overall Study||10||
59867027|NCT04168190|75991333|FG004|NOT COMPLETED|Overall Study||9||
59867028|NCT04732338|75991347|FG000|STARTED|Overall Study||13||
59867029|NCT04732338|75991348|FG001|STARTED|Overall Study||13||
59867030|NCT04732338|75991347|FG000|COMPLETED|Overall Study||10||
59867031|NCT04732338|75991348|FG001|COMPLETED|Overall Study||10||
59867032|NCT04732338|75991347|FG000|NOT COMPLETED|Overall Study||3||
59867033|NCT04732338|75991348|FG001|NOT COMPLETED|Overall Study||3||
59867034|NCT04194008|75991354|FG000|STARTED|Baseline (Run-in) Phase||126||
59867035|NCT04194008|75991354|FG000|COMPLETED|Baseline (Run-in) Phase||99||
59867036|NCT04194008|75991354|FG000|NOT COMPLETED|Baseline (Run-in) Phase||27||
59867037|NCT04194008|75991354|FG000|STARTED|Treatment Phase With Nerivio||99||
59867038|NCT04194008|75991354|FG000|COMPLETED|Treatment Phase With Nerivio||91||
59867039|NCT04194008|75991354|FG000|NOT COMPLETED|Treatment Phase With Nerivio||8||
59867040|NCT02341534|75991360|FG000|STARTED|Overall Study||398||
59867041|NCT02341534|75991361|FG001|STARTED|Overall Study||392||
59867042|NCT02341534|75991360|FG000|COMPLETED|Overall Study||322||
59867043|NCT02341534|75991361|FG001|COMPLETED|Overall Study||325||
59867044|NCT02341534|75991360|FG000|NOT COMPLETED|Overall Study||76||
59867045|NCT02341534|75991361|FG001|NOT COMPLETED|Overall Study||67||
59867046|NCT04189952|75991367|FG000|STARTED|Treatment Period||2||
59867047|NCT04189952|75991367|FG000|COMPLETED|Treatment Period||2||
59867048|NCT04189952|75991367|FG000|NOT COMPLETED|Treatment Period||0||
59867049|NCT04189952|75991367|FG000|STARTED|Follow-up Period||2||
59867050|NCT04189952|75991367|FG000|COMPLETED|Follow-up Period||0||
59867051|NCT04189952|75991367|FG000|NOT COMPLETED|Follow-up Period||2||
59867052|NCT04716426|75991373|FG000|STARTED|Overall Study||50||
59867053|NCT04716426|75991374|FG001|STARTED|Overall Study||50||
59867054|NCT04716426|75991373|FG000|COMPLETED|Overall Study||48||
59867055|NCT04716426|75991374|FG001|COMPLETED|Overall Study||49||
59867056|NCT04716426|75991373|FG000|NOT COMPLETED|Overall Study||2||
59867057|NCT04716426|75991374|FG001|NOT COMPLETED|Overall Study||1||
59867058|NCT03694548|75991382|FG000|STARTED|Part A Survey||18||
59867059|NCT03694548|75991383|FG001|STARTED|Part A Survey||17||
59867060|NCT03694548|75991384|FG002|STARTED|Part A Survey||0||
59867061|NCT03694548|75991382|FG000|COMPLETED|Part A Survey||15||
59867062|NCT03694548|75991383|FG001|COMPLETED|Part A Survey||14||
59867063|NCT03694548|75991384|FG002|COMPLETED|Part A Survey||0||
59867064|NCT03694548|75991382|FG000|NOT COMPLETED|Part A Survey||3||
59867065|NCT03694548|75991383|FG001|NOT COMPLETED|Part A Survey||3||
59867066|NCT03694548|75991384|FG002|NOT COMPLETED|Part A Survey||0||
59867067|NCT03694548|75991382|FG000|STARTED|Part B Yoga Program||0||
59867068|NCT03694548|75991383|FG001|STARTED|Part B Yoga Program||0||
59867069|NCT03694548|75991384|FG002|STARTED|Part B Yoga Program||12||
59867070|NCT03694548|75991382|FG000|COMPLETED|Part B Yoga Program||0||
59867071|NCT03694548|75991383|FG001|COMPLETED|Part B Yoga Program||0||
59867072|NCT03694548|75991384|FG002|COMPLETED|Part B Yoga Program||1||
59867073|NCT03694548|75991382|FG000|NOT COMPLETED|Part B Yoga Program||0||
59867074|NCT03694548|75991383|FG001|NOT COMPLETED|Part B Yoga Program||0||
59867075|NCT03694548|75991384|FG002|NOT COMPLETED|Part B Yoga Program||11||
59867076|NCT04166630|75991396|FG000|STARTED|Overall Study||5||
59867077|NCT04166630|75991397|FG001|STARTED|Overall Study||17||
59867078|NCT04166630|75991396|FG000|COMPLETED|Overall Study||5||
59867079|NCT04166630|75991397|FG001|COMPLETED|Overall Study||16||
59867080|NCT04166630|75991396|FG000|NOT COMPLETED|Overall Study||0||
59867081|NCT04166630|75991397|FG001|NOT COMPLETED|Overall Study||1||
59867082|NCT04164758|75991406|FG000|STARTED|Overall Study||4||
59867083|NCT04164758|75991407|FG001|STARTED|Overall Study||4||
59867084|NCT04164758|75991408|FG002|STARTED|Overall Study||3||
59867085|NCT04164758|75991406|FG000|COMPLETED|Overall Study||3||
59867086|NCT04164758|75991407|FG001|COMPLETED|Overall Study||3||
59867087|NCT04164758|75991408|FG002|COMPLETED|Overall Study||3||
59867088|NCT04164758|75991406|FG000|NOT COMPLETED|Overall Study||1||
59867089|NCT04164758|75991407|FG001|NOT COMPLETED|Overall Study||1||
59867090|NCT04164758|75991408|FG002|NOT COMPLETED|Overall Study||0||
59867091|NCT04178720|75991418|FG000|STARTED|Overall Study||40||80
59867092|NCT04178720|75991419|FG001|STARTED|Overall Study||78||156
59867093|NCT04178720|75991418|FG000|COMPLETED|Overall Study||38||76
59867094|NCT04178720|75991419|FG001|COMPLETED|Overall Study||77||154
59867095|NCT04178720|75991418|FG000|NOT COMPLETED|Overall Study||2||4
59867096|NCT04178720|75991419|FG001|NOT COMPLETED|Overall Study||1||2
59867097|NCT04177862|75991430|FG000|STARTED|Overall Study||35|Allocated to intervention|
59867098|NCT04177862|75991431|FG001|STARTED|Overall Study||40|Allocated to intervention|
59867099|NCT04177862|75991430|FG000|COMPLETED|Overall Study||33||
59867100|NCT04177862|75991431|FG001|COMPLETED|Overall Study||33||
59867101|NCT04177862|75991430|FG000|NOT COMPLETED|Overall Study||2||
59867102|NCT04177862|75991431|FG001|NOT COMPLETED|Overall Study||7||
59867103|NCT04173572|75991440|FG000|STARTED|Overall Study||24||
59867104|NCT04173572|75991441|FG001|STARTED|Overall Study||26||
59867105|NCT04173572|75991440|FG000|Cohort 1|Overall Study||7||
59867106|NCT04173572|75991441|FG001|Cohort 1|Overall Study||6||
59867107|NCT04173572|75991440|FG000|Cohort 2|Overall Study||8||
59867108|NCT04173572|75991441|FG001|Cohort 2|Overall Study||12||
59867109|NCT04173572|75991440|FG000|Cohort 3|Overall Study||9||
59867110|NCT04173572|75991441|FG001|Cohort 3|Overall Study||8||
59867111|NCT04173572|75991440|FG000|COMPLETED|Overall Study||20||
59867112|NCT04173572|75991441|FG001|COMPLETED|Overall Study||20||
59867113|NCT04173572|75991440|FG000|NOT COMPLETED|Overall Study||4||
59867114|NCT04173572|75991441|FG001|NOT COMPLETED|Overall Study||6||
59867115|NCT04157738|75991449|FG000|STARTED|Overall Study||12||
59867116|NCT04157738|75991450|FG001|STARTED|Overall Study||12||
59867117|NCT04157738|75991449|FG000|COMPLETED|Overall Study||11||
59867118|NCT04157738|75991450|FG001|COMPLETED|Overall Study||10||
59867119|NCT04157738|75991449|FG000|NOT COMPLETED|Overall Study||1||
59867120|NCT04157738|75991450|FG001|NOT COMPLETED|Overall Study||2||
59867121|NCT04156646|75991458|FG000|STARTED|Treatment Period 1 (6 Days)||8||
59867122|NCT04156646|75991459|FG001|STARTED|Treatment Period 1 (6 Days)||8||
59867123|NCT04156646|75991458|FG000|COMPLETED|Treatment Period 1 (6 Days)||8||
59867124|NCT04156646|75991459|FG001|COMPLETED|Treatment Period 1 (6 Days)||8||
59867125|NCT04156646|75991458|FG000|NOT COMPLETED|Treatment Period 1 (6 Days)||0||
59867126|NCT04156646|75991459|FG001|NOT COMPLETED|Treatment Period 1 (6 Days)||0||
59867127|NCT04156646|75991458|FG000|STARTED|Wash-out Period (12- to 21-days)||8||
59867128|NCT04156646|75991459|FG001|STARTED|Wash-out Period (12- to 21-days)||8||
59867129|NCT04156646|75991458|FG000|COMPLETED|Wash-out Period (12- to 21-days)||8||
59867130|NCT04156646|75991459|FG001|COMPLETED|Wash-out Period (12- to 21-days)||8||
59867131|NCT04156646|75991458|FG000|NOT COMPLETED|Wash-out Period (12- to 21-days)||0||
59867132|NCT04156646|75991459|FG001|NOT COMPLETED|Wash-out Period (12- to 21-days)||0||
59867133|NCT04156646|75991458|FG000|STARTED|Treatment Period 2 (6 Days)||8||
59867134|NCT04156646|75991459|FG001|STARTED|Treatment Period 2 (6 Days)||8||
59867135|NCT04156646|75991458|FG000|COMPLETED|Treatment Period 2 (6 Days)||8||
59867136|NCT04156646|75991459|FG001|COMPLETED|Treatment Period 2 (6 Days)||8||
59867137|NCT04156646|75991458|FG000|NOT COMPLETED|Treatment Period 2 (6 Days)||0||
59867138|NCT04156646|75991459|FG001|NOT COMPLETED|Treatment Period 2 (6 Days)||0||
59867139|NCT04156646|75991458|FG000|STARTED|Wash-out Period (12- to 21-days)||8||
59867140|NCT04156646|75991459|FG001|STARTED|Wash-out Period (12- to 21-days)||8||
59867141|NCT04156646|75991458|FG000|COMPLETED|Wash-out Period (12- to 21-days)||8||
59867142|NCT04156646|75991459|FG001|COMPLETED|Wash-out Period (12- to 21-days)||8||
59867143|NCT04156646|75991458|FG000|NOT COMPLETED|Wash-out Period (12- to 21-days)||0||
59867144|NCT04156646|75991459|FG001|NOT COMPLETED|Wash-out Period (12- to 21-days)||0||
59867145|NCT04156646|75991458|FG000|STARTED|Treatment Period 3 (6 Days)||8||
59867146|NCT04156646|75991459|FG001|STARTED|Treatment Period 3 (6 Days)||8||
59867147|NCT04156646|75991458|FG000|COMPLETED|Treatment Period 3 (6 Days)||8||
59867148|NCT04156646|75991459|FG001|COMPLETED|Treatment Period 3 (6 Days)||7||
59867149|NCT04156646|75991458|FG000|NOT COMPLETED|Treatment Period 3 (6 Days)||0||
59867150|NCT04156646|75991459|FG001|NOT COMPLETED|Treatment Period 3 (6 Days)||1||
59867151|NCT04150250|75991470|FG000|STARTED|Overall Study||23||
59867152|NCT04150250|75991471|FG001|STARTED|Overall Study||24||
59867153|NCT04150250|75991470|FG000|COMPLETED|Overall Study||23||
59867154|NCT04150250|75991471|FG001|COMPLETED|Overall Study||22||
59867155|NCT04150250|75991470|FG000|NOT COMPLETED|Overall Study||0||
59867156|NCT04150250|75991471|FG001|NOT COMPLETED|Overall Study||2||
59867157|NCT04537806|75991479|FG000|STARTED|Overall Study||15||
59867158|NCT04537806|75991480|FG001|STARTED|Overall Study||14||
59867159|NCT04537806|75991479|FG000|Safety Analysis Set|Overall Study||14|Safety analysis set included all participants who initiated Investigational product (IP) (brexanolone or placebo).|
59867160|NCT04537806|75991480|FG001|Safety Analysis Set|Overall Study||14|Safety analysis set included all participants who initiated Investigational product (IP) (brexanolone or placebo).|
59867161|NCT04537806|75991479|FG000|Full Analysis Set|Overall Study||14|Full analysis set (FAS) included all randomized participants who initiated IP (brexanolone or placebo).|
59999800|NCT00579124|76115520|FG001|COMPLETED|Overall Study||6||
59999801|NCT00579124|76115519|FG000|NOT COMPLETED|Overall Study||5||
59999802|NCT00579124|76115520|FG001|NOT COMPLETED|Overall Study||0||
59999803|NCT01903733|76115530|FG000|STARTED|Overall Study||250||
59999804|NCT01903733|76115531|FG001|STARTED|Overall Study||284||
59999805|NCT01903733|76115532|FG002|STARTED|Overall Study||119||
59999806|NCT01903733|76115533|FG003|STARTED|Overall Study||167||
59999807|NCT01903733|76115530|FG000|Full Analysis Set|Overall Study||250|(participants randomized to bosutinib arm in B1871008 and all dosed participants in B1871006)|
59999808|NCT01903733|76115531|FG001|Full Analysis Set|Overall Study||284|(participants randomized to bosutinib arm in B1871008 and all dosed participants in B1871006)|
59999809|NCT01903733|76115532|FG002|Full Analysis Set|Overall Study||119|(participants randomized to bosutinib arm in B1871008 and all dosed participants in B1871006)|
60000397|NCT02593305|76116130|FG001|STARTED|Post 2||6||
59999810|NCT01903733|76115533|FG003|Full Analysis Set|Overall Study||167|(participants randomized to bosutinib arm in B1871008 and all dosed participants in B1871006)|
59999811|NCT01903733|76115530|FG000|Safety Analysis Set|Overall Study||248|(all dosed participants in B1871008 and B1871006)|
59999812|NCT01903733|76115531|FG001|Safety Analysis Set|Overall Study||284|(all dosed participants in B1871008 and B1871006)|
59999813|NCT01903733|76115532|FG002|Safety Analysis Set|Overall Study||119|(all dosed participants in B1871008 and B1871006)|
59999814|NCT01903733|76115533|FG003|Safety Analysis Set|Overall Study||167|(all dosed participants in B1871008 and B1871006)|
59999815|NCT01903733|76115530|FG000|Enrolled in B1871040|Overall Study||124||
59999816|NCT01903733|76115531|FG001|Enrolled in B1871040|Overall Study||90||
59999817|NCT01903733|76115532|FG002|Enrolled in B1871040|Overall Study||28||
59999818|NCT01903733|76115533|FG003|Enrolled in B1871040|Overall Study||18||
59999819|NCT01903733|76115530|FG000|Treated in B1871040|Overall Study||98||
59999820|NCT01903733|76115531|FG001|Treated in B1871040|Overall Study||69||
59999821|NCT01903733|76115532|FG002|Treated in B1871040|Overall Study||13||
59999822|NCT01903733|76115533|FG003|Treated in B1871040|Overall Study||8||
59999823|NCT01903733|76115530|FG000|COMPLETED|Overall Study||144||
59999824|NCT01903733|76115531|FG001|COMPLETED|Overall Study||158||
59999825|NCT01903733|76115532|FG002|COMPLETED|Overall Study||58||
59867162|NCT04537806|75991480|FG001|Full Analysis Set|Overall Study||14|Full analysis set (FAS) included all randomized participants who initiated IP (brexanolone or placebo).|
59867163|NCT04537806|75991479|FG000|COMPLETED|Overall Study||13||
59867164|NCT04537806|75991480|FG001|COMPLETED|Overall Study||13||
59867165|NCT04537806|75991479|FG000|NOT COMPLETED|Overall Study||2||
59867166|NCT04537806|75991480|FG001|NOT COMPLETED|Overall Study||1||
59867167|NCT04015232|75991488|FG000|STARTED|Overall Study||100||
59867168|NCT04015232|75991489|FG001|STARTED|Overall Study||100||
59867169|NCT04015232|75991488|FG000|COMPLETED|Overall Study||89||
59867170|NCT04015232|75991489|FG001|COMPLETED|Overall Study||93||
59867171|NCT04015232|75991488|FG000|NOT COMPLETED|Overall Study||11||
59867172|NCT04015232|75991489|FG001|NOT COMPLETED|Overall Study||7||
59867173|NCT04533204|75991501|FG000|STARTED|Overall Study||29||
59867174|NCT04533204|75991502|FG001|STARTED|Overall Study||30||
59867175|NCT04533204|75991501|FG000|COMPLETED|Overall Study||28||
59867176|NCT04533204|75991502|FG001|COMPLETED|Overall Study||29||
59867177|NCT04533204|75991501|FG000|NOT COMPLETED|Overall Study||1||
59867178|NCT04533204|75991502|FG001|NOT COMPLETED|Overall Study||1||
59867179|NCT04465422|75991510|FG000|STARTED|Overall Study||17||
59867180|NCT04465422|75991511|FG001|STARTED|Overall Study||16||
59867181|NCT04465422|75991510|FG000|COMPLETED|Overall Study||17||
59867182|NCT04465422|75991511|FG001|COMPLETED|Overall Study||14||
59867183|NCT04465422|75991510|FG000|NOT COMPLETED|Overall Study||0||
59867184|NCT04465422|75991511|FG001|NOT COMPLETED|Overall Study||2||
59867185|NCT04014062|75991521|FG000|STARTED|Period I: Dosing||71||
59867186|NCT04014062|75991522|FG001|STARTED|Period I: Dosing||71||
59867187|NCT04014062|75991521|FG000|COMPLETED|Period I: Dosing|Period I: Dosing, includes a washout period of 42 days before starting Period II: Crossover Dosing|64||
59867188|NCT04014062|75991522|FG001|COMPLETED|Period I: Dosing|Period I: Dosing, includes a washout period of 42 days before starting Period II: Crossover Dosing|65||
59867189|NCT04014062|75991521|FG000|NOT COMPLETED|Period I: Dosing||7||
59867190|NCT04014062|75991522|FG001|NOT COMPLETED|Period I: Dosing||6||
59867191|NCT04014062|75991521|FG000|STARTED|Period II: Crossover Dosing||64||
59867192|NCT04014062|75991522|FG001|STARTED|Period II: Crossover Dosing||65||
59867193|NCT04014062|75991521|FG000|COMPLETED|Period II: Crossover Dosing||64||
59867194|NCT04014062|75991522|FG001|COMPLETED|Period II: Crossover Dosing||65||
59867195|NCT04014062|75991521|FG000|NOT COMPLETED|Period II: Crossover Dosing||0||
59867196|NCT04014062|75991522|FG001|NOT COMPLETED|Period II: Crossover Dosing||0||
59867197|NCT04531098|75991536|FG000|STARTED|Stage I||0||
59867198|NCT04531098|75991537|FG001|STARTED|Stage I||67||
59867199|NCT04531098|75991538|FG002|STARTED|Stage I||134||
59867200|NCT04531098|75991536|FG000|COMPLETED|Stage I||0||
59867201|NCT04531098|75991537|FG001|COMPLETED|Stage I||62||
59867202|NCT04531098|75991538|FG002|COMPLETED|Stage I||116||
59867203|NCT04531098|75991536|FG000|NOT COMPLETED|Stage I||0||
59867204|NCT04531098|75991537|FG001|NOT COMPLETED|Stage I||5||
59867205|NCT04531098|75991538|FG002|NOT COMPLETED|Stage I||18||
59867206|NCT04531098|75991536|FG000|STARTED|Stage II||134||
59867207|NCT04531098|75991537|FG001|STARTED|Stage II||67||
59867208|NCT04531098|75991538|FG002|STARTED|Stage II||0||
59867209|NCT04531098|75991536|FG000|COMPLETED|Stage II||121||
59867210|NCT04531098|75991537|FG001|COMPLETED|Stage II||57||
59867211|NCT04531098|75991538|FG002|COMPLETED|Stage II||0||
59867212|NCT04531098|75991536|FG000|NOT COMPLETED|Stage II||13||
59867213|NCT04531098|75991537|FG001|NOT COMPLETED|Stage II||10||
59867214|NCT04531098|75991538|FG002|NOT COMPLETED|Stage II||0||
59867215|NCT04144166|75991546|FG000|STARTED|Overall Study||60||
59867216|NCT04144166|75991546|FG000|COMPLETED|Overall Study||57||
59867217|NCT04144166|75991546|FG000|NOT COMPLETED|Overall Study||3||
59867218|NCT04142450|75991555|FG000|STARTED|Overall Study||50||
59867219|NCT04142450|75991555|FG000|Safety Population|Overall Study||49|Safety Population included all treated participants.|
59867220|NCT04142450|75991555|FG000|COMPLETED|Overall Study||48||
59867221|NCT04142450|75991555|FG000|NOT COMPLETED|Overall Study||2||
59867222|NCT04529850|75991559|FG000|STARTED|Overall Study||37||
59867223|NCT04529850|75991559|FG000|COMPLETED|Overall Study||32||
59867224|NCT04529850|75991559|FG000|NOT COMPLETED|Overall Study||5||
59867225|NCT04225676|75991563|FG000|STARTED|Overall Study||5||
59867226|NCT04225676|75991563|FG000|Full Analysis, Safety and Enrolled Sets|Overall Study||5||
59867227|NCT04225676|75991563|FG000|COMPLETED|Overall Study||0||
59867228|NCT04225676|75991563|FG000|NOT COMPLETED|Overall Study||5||
59867229|NCT04142216|75991571|FG000|STARTED|Overall Study||28||
59867230|NCT04142216|75991572|FG001|STARTED|Overall Study||28||
59867231|NCT04142216|75991571|FG000|COMPLETED|Overall Study||22||
59867232|NCT04142216|75991572|FG001|COMPLETED|Overall Study||22||
59867233|NCT04142216|75991571|FG000|NOT COMPLETED|Overall Study||6||
59867234|NCT04142216|75991572|FG001|NOT COMPLETED|Overall Study||6||
59867235|NCT04140890|75991580|FG000|STARTED|Overall Study||9||
59867236|NCT04140890|75991581|FG001|STARTED|Overall Study||12||
59867237|NCT04140890|75991580|FG000|COMPLETED|Overall Study||9||
59867238|NCT04140890|75991581|FG001|COMPLETED|Overall Study||11||
59867239|NCT04140890|75991580|FG000|NOT COMPLETED|Overall Study||0||
59867240|NCT04140890|75991581|FG001|NOT COMPLETED|Overall Study||1||
59867241|NCT03700320|75991592|FG000|STARTED|Overall Study||198||
59867242|NCT03700320|75991593|FG001|STARTED|Overall Study||546||
59867243|NCT03700320|75991592|FG000|Safety Population; Received Treatment|Overall Study||196||
59867244|NCT03700320|75991593|FG001|Safety Population; Received Treatment|Overall Study||543||
59867245|NCT03700320|75991592|FG000|Entered Safety Follow-up|Overall Study||159||
59867246|NCT03700320|75991593|FG001|Entered Safety Follow-up|Overall Study||472||
59867247|NCT03700320|75991592|FG000|COMPLETED|Overall Study||136||
59867248|NCT03700320|75991593|FG001|COMPLETED|Overall Study||373||
59867249|NCT03700320|75991592|FG000|NOT COMPLETED|Overall Study||62||
59867250|NCT03700320|75991593|FG001|NOT COMPLETED|Overall Study||173||
59867251|NCT04139018|75991601|FG000|STARTED|Overall Study||14||
59867252|NCT04139018|75991602|FG001|STARTED|Overall Study||13||
59867253|NCT04139018|75991601|FG000|COMPLETED|Overall Study||11||
59867254|NCT04139018|75991602|FG001|COMPLETED|Overall Study||12||
59867255|NCT04139018|75991601|FG000|NOT COMPLETED|Overall Study||3||
59867256|NCT04139018|75991602|FG001|NOT COMPLETED|Overall Study||1||
59867257|NCT04527978|75991610|FG000|STARTED|First Wear Period (8 -0/+3 Days)||27||54
59867258|NCT04527978|75991611|FG001|STARTED|First Wear Period (8 -0/+3 Days)||28||56
59867259|NCT04527978|75991610|FG000|COMPLETED|First Wear Period (8 -0/+3 Days)||26||52
59867260|NCT04527978|75991611|FG001|COMPLETED|First Wear Period (8 -0/+3 Days)||28||56
59867261|NCT04527978|75991610|FG000|NOT COMPLETED|First Wear Period (8 -0/+3 Days)||1||2
59867262|NCT04527978|75991611|FG001|NOT COMPLETED|First Wear Period (8 -0/+3 Days)||0||0
59867263|NCT04527978|75991610|FG000|STARTED|Second Wear Period (8 -0/+3 Days)||26||52
59867264|NCT04527978|75991611|FG001|STARTED|Second Wear Period (8 -0/+3 Days)||28||56
59867265|NCT04527978|75991610|FG000|COMPLETED|Second Wear Period (8 -0/+3 Days)||26||52
59867266|NCT04527978|75991611|FG001|COMPLETED|Second Wear Period (8 -0/+3 Days)||28||56
59867267|NCT04527978|75991610|FG000|NOT COMPLETED|Second Wear Period (8 -0/+3 Days)||0||0
59867268|NCT04527978|75991611|FG001|NOT COMPLETED|Second Wear Period (8 -0/+3 Days)||0||0
59867269|NCT04136444|75991622|FG000|STARTED|Overall Study||3||
59867270|NCT04136444|75991623|FG001|STARTED|Overall Study||9||
59867271|NCT04136444|75991622|FG000|COMPLETED|Overall Study|The cohort was not completely recruited, as the study was stopped/terminated due to COVID-19.|3||
59867272|NCT04136444|75991623|FG001|COMPLETED|Overall Study||8||
59867273|NCT04136444|75991622|FG000|NOT COMPLETED|Overall Study||0||
59867274|NCT04136444|75991623|FG001|NOT COMPLETED|Overall Study||1||
59867275|NCT04425252|75991637|FG000|STARTED|Overall Study||8||
59867276|NCT04425252|75991638|FG001|STARTED|Overall Study||15||
59867277|NCT04425252|75991637|FG000|COMPLETED|Overall Study||4||
59867278|NCT04425252|75991638|FG001|COMPLETED|Overall Study||13||
59867279|NCT04425252|75991637|FG000|NOT COMPLETED|Overall Study||4||
59867280|NCT04425252|75991638|FG001|NOT COMPLETED|Overall Study||2||
59867281|NCT03696576|75991649|FG000|STARTED|Overall Study||13||
59867282|NCT03696576|75991650|FG001|STARTED|Overall Study||11||
59867283|NCT03696576|75991649|FG000|COMPLETED|Overall Study||10||
59867284|NCT03696576|75991650|FG001|COMPLETED|Overall Study||6||
59867285|NCT03696576|75991649|FG000|NOT COMPLETED|Overall Study||3||
59867286|NCT03696576|75991650|FG001|NOT COMPLETED|Overall Study||5||
59867287|NCT04003610|75991659|FG000|STARTED|Overall Study||0||
59867288|NCT04003610|75991660|FG001|STARTED|Overall Study||1||
59867289|NCT04003610|75991661|FG002|STARTED|Overall Study||6||
59867290|NCT04003610|75991659|FG000|COMPLETED|Overall Study||0||
59867291|NCT04003610|75991660|FG001|COMPLETED|Overall Study||0||
59867292|NCT04003610|75991661|FG002|COMPLETED|Overall Study||0||
59867293|NCT04003610|75991659|FG000|NOT COMPLETED|Overall Study||0||
59867294|NCT04003610|75991660|FG001|NOT COMPLETED|Overall Study||1||
59867295|NCT04003610|75991661|FG002|NOT COMPLETED|Overall Study||6||
59867296|NCT03999554|75991675|FG000|STARTED|Overall Study||42||
59867297|NCT03999554|75991676|FG001|STARTED|Overall Study||41||
59867298|NCT03999554|75991677|FG002|STARTED|Overall Study||40||
59867299|NCT03999554|75991678|FG003|STARTED|Overall Study||42||
59867300|NCT03999554|75991679|FG004|STARTED|Overall Study||41||
59867301|NCT03999554|75991675|FG000|COMPLETED|Overall Study||36||
59867302|NCT03999554|75991676|FG001|COMPLETED|Overall Study||34||
59867303|NCT03999554|75991677|FG002|COMPLETED|Overall Study||28||
59867304|NCT03999554|75991678|FG003|COMPLETED|Overall Study||35||
59867305|NCT03999554|75991679|FG004|COMPLETED|Overall Study||32||
59867306|NCT03999554|75991675|FG000|NOT COMPLETED|Overall Study||6||
59867307|NCT03999554|75991676|FG001|NOT COMPLETED|Overall Study||7||
59867308|NCT03999554|75991677|FG002|NOT COMPLETED|Overall Study||12||
59867309|NCT03999554|75991678|FG003|NOT COMPLETED|Overall Study||7||
59867310|NCT03999554|75991679|FG004|NOT COMPLETED|Overall Study||9||
59867311|NCT04129346|75991694|FG000|STARTED|Overall Study||25||
59867312|NCT04129346|75991695|FG001|STARTED|Overall Study||24||
59867313|NCT04129346|75991694|FG000|COMPLETED|Overall Study||24||
59867314|NCT04129346|75991695|FG001|COMPLETED|Overall Study||24||
59867315|NCT04129346|75991694|FG000|NOT COMPLETED|Overall Study||1||
59867316|NCT04129346|75991695|FG001|NOT COMPLETED|Overall Study||0||
59999826|NCT01903733|76115533|FG003|COMPLETED|Overall Study||48||
59999827|NCT01903733|76115530|FG000|NOT COMPLETED|Overall Study||106||
59999828|NCT01903733|76115531|FG001|NOT COMPLETED|Overall Study||126||
59999829|NCT01903733|76115532|FG002|NOT COMPLETED|Overall Study||61||
59999830|NCT01903733|76115533|FG003|NOT COMPLETED|Overall Study||119||
59999831|NCT01375205|76115555|FG000|STARTED|Overall Study||54||
59999832|NCT01375205|76115556|FG001|STARTED|Overall Study||46||
59999833|NCT01375205|76115555|FG000|COMPLETED|Overall Study||33||
59999834|NCT01375205|76115556|FG001|COMPLETED|Overall Study||33||
59999835|NCT01375205|76115555|FG000|NOT COMPLETED|Overall Study||21||
59999836|NCT01375205|76115556|FG001|NOT COMPLETED|Overall Study||13||
59999837|NCT00700271|76115564|FG000|STARTED|Overall Study||278||
59999838|NCT00700271|76115565|FG001|STARTED|Overall Study||268||
59999839|NCT00700271|76115564|FG000|COMPLETED|Overall Study||264||
59999840|NCT00700271|76115565|FG001|COMPLETED|Overall Study||256||
59999841|NCT00700271|76115564|FG000|NOT COMPLETED|Overall Study||14||
59999842|NCT00700271|76115565|FG001|NOT COMPLETED|Overall Study||12||
59999843|NCT01375049|76115571|FG000|STARTED|Overall Study||105||
59999844|NCT01375049|76115571|FG000|COMPLETED|Overall Study||55||
59999845|NCT01375049|76115571|FG000|NOT COMPLETED|Overall Study||50||
59999846|NCT01594749|76115581|FG000|STARTED|Overall Study||507||
59999847|NCT01594749|76115582|FG001|STARTED|Overall Study||508||
59999848|NCT01594749|76115581|FG000|Treated|Overall Study||503||
59999849|NCT01594749|76115582|FG001|Treated|Overall Study||498||
59999850|NCT01594749|76115581|FG000|COMPLETED|Overall Study||485||
59999851|NCT01594749|76115582|FG001|COMPLETED|Overall Study||490||
59999852|NCT01594749|76115581|FG000|NOT COMPLETED|Overall Study||22||
59999853|NCT01594749|76115582|FG001|NOT COMPLETED|Overall Study||18||
59999854|NCT02179918|76115593|FG000|STARTED|Overall Study||5||
59999855|NCT02179918|76115594|FG001|STARTED|Overall Study||3||
59999856|NCT02179918|76115595|FG002|STARTED|Overall Study||3||
59999857|NCT02179918|76115596|FG003|STARTED|Overall Study||3||
59999858|NCT02179918|76115597|FG004|STARTED|Overall Study||9||
59999859|NCT02179918|76115593|FG000|COMPLETED|Overall Study||1||
59999860|NCT02179918|76115594|FG001|COMPLETED|Overall Study||0||
59999861|NCT02179918|76115595|FG002|COMPLETED|Overall Study||1||
59999862|NCT02179918|76115596|FG003|COMPLETED|Overall Study||0||
59999863|NCT02179918|76115597|FG004|COMPLETED|Overall Study||1||
59999864|NCT02179918|76115593|FG000|NOT COMPLETED|Overall Study||4||
59999865|NCT02179918|76115594|FG001|NOT COMPLETED|Overall Study||3||
59999866|NCT02179918|76115595|FG002|NOT COMPLETED|Overall Study||2||
59999867|NCT02179918|76115596|FG003|NOT COMPLETED|Overall Study||3||
59999868|NCT02179918|76115597|FG004|NOT COMPLETED|Overall Study||8||
59999869|NCT02611479|76115610|FG000|STARTED|Baseline Enrollment||184||
59999870|NCT02611479|76115610|FG000|COMPLETED|Baseline Enrollment||171||
59999871|NCT02611479|76115610|FG000|NOT COMPLETED|Baseline Enrollment||13||
59999872|NCT02611479|76115610|FG000|STARTED|Post-Surgery Follow-up at 30-90 Days||171||
59999873|NCT02611479|76115610|FG000|COMPLETED|Post-Surgery Follow-up at 30-90 Days||169||
59999874|NCT02611479|76115610|FG000|NOT COMPLETED|Post-Surgery Follow-up at 30-90 Days||2||
59999875|NCT02611479|76115610|FG000|STARTED|Post-Surgery Follow-up at 1-Year||169||
59999876|NCT02611479|76115610|FG000|COMPLETED|Post-Surgery Follow-up at 1-Year||151||
59999877|NCT02611479|76115610|FG000|NOT COMPLETED|Post-Surgery Follow-up at 1-Year||18||
59999878|NCT02611479|76115610|FG000|STARTED|Data Cleaning||151||
59999879|NCT02611479|76115610|FG000|COMPLETED|Data Cleaning||149||
59999880|NCT02611479|76115610|FG000|NOT COMPLETED|Data Cleaning||2||
59999881|NCT02153788|76115616|FG000|STARTED|Overall Study||25||
59999882|NCT02153788|76115617|FG001|STARTED|Overall Study||19||
59999883|NCT02153788|76115616|FG000|COMPLETED|Overall Study||23||
59999884|NCT02153788|76115617|FG001|COMPLETED|Overall Study||18||
59999885|NCT02153788|76115616|FG000|NOT COMPLETED|Overall Study||2||
59999886|NCT02153788|76115617|FG001|NOT COMPLETED|Overall Study||1||
59999887|NCT02153398|76115628|FG000|STARTED|Overall Study||10||
59999888|NCT02153398|76115629|FG001|STARTED|Overall Study||10||
59999889|NCT02153398|76115630|FG002|STARTED|Overall Study||10||
59999890|NCT02153398|76115631|FG003|STARTED|Overall Study||10||
59999891|NCT02153398|76115632|FG004|STARTED|Overall Study||10||
59999892|NCT02153398|76115628|FG000|COMPLETED|Overall Study||9||
59999893|NCT02153398|76115629|FG001|COMPLETED|Overall Study||10||
59999894|NCT02153398|76115630|FG002|COMPLETED|Overall Study||9||
59999895|NCT02153398|76115631|FG003|COMPLETED|Overall Study||9||
59999896|NCT02153398|76115632|FG004|COMPLETED|Overall Study||10||
59999897|NCT02153398|76115628|FG000|NOT COMPLETED|Overall Study||1||
59999898|NCT02153398|76115629|FG001|NOT COMPLETED|Overall Study||0||
59999899|NCT02153398|76115630|FG002|NOT COMPLETED|Overall Study||1||
59999900|NCT02153398|76115631|FG003|NOT COMPLETED|Overall Study||1||
59999901|NCT02153398|76115632|FG004|NOT COMPLETED|Overall Study||0||
59999902|NCT02118766|76115646|FG000|STARTED|Overall Study||507||
59999903|NCT02118766|76115647|FG001|STARTED|Overall Study||256||
59999904|NCT02118766|76115646|FG000|Treated|Overall Study||503||
59999905|NCT02118766|76115647|FG001|Treated|Overall Study||256||
59999906|NCT02118766|76115646|FG000|COMPLETED|Overall Study||477||
59999907|NCT02118766|76115647|FG001|COMPLETED|Overall Study||225||
59999908|NCT02118766|76115646|FG000|NOT COMPLETED|Overall Study||30||
59999909|NCT02118766|76115647|FG001|NOT COMPLETED|Overall Study||31||
59999910|NCT02614287|76115655|FG000|STARTED|Open Label (OL) Treatment Phase||135||
59999911|NCT02614287|76115656|FG001|STARTED|Open Label (OL) Treatment Phase||135||
59999912|NCT02614287|76115655|FG000|Received at Least One Dose of Study Drug|Open Label (OL) Treatment Phase||135||
59999913|NCT02614287|76115656|FG001|Received at Least One Dose of Study Drug|Open Label (OL) Treatment Phase||135||
59999914|NCT02614287|76115655|FG000|COMPLETED|Open Label (OL) Treatment Phase||97||
59999915|NCT02614287|76115656|FG001|COMPLETED|Open Label (OL) Treatment Phase||113||
59999916|NCT02614287|76115655|FG000|NOT COMPLETED|Open Label (OL) Treatment Phase||38||
59999917|NCT02614287|76115656|FG001|NOT COMPLETED|Open Label (OL) Treatment Phase||22||
59999918|NCT02614287|76115655|FG000|STARTED|Post Treatment Follow-up Phase|Follow-up period was optional, few participants who completed OL period didn't enter follow-up.|112||
59999919|NCT02614287|76115656|FG001|STARTED|Post Treatment Follow-up Phase|Follow-up period was optional, few participants who completed OL period didn't enter follow-up.|124||
59999920|NCT02614287|76115655|FG000|COMPLETED|Post Treatment Follow-up Phase||103||
59999921|NCT02614287|76115656|FG001|COMPLETED|Post Treatment Follow-up Phase||119||
59999922|NCT02614287|76115655|FG000|NOT COMPLETED|Post Treatment Follow-up Phase||9||
59999923|NCT02614287|76115656|FG001|NOT COMPLETED|Post Treatment Follow-up Phase||5||
59999924|NCT01374971|76115667|FG000|STARTED|Overall Study||12||
59999925|NCT01374971|76115667|FG000|COMPLETED|Overall Study||11||
59999926|NCT01374971|76115667|FG000|NOT COMPLETED|Overall Study||1||
59999927|NCT02178592|76115673|FG000|STARTED|Randomized Phase (Up to Week 52)||69||
59999928|NCT02178592|76115674|FG001|STARTED|Randomized Phase (Up to Week 52)||44||
59999929|NCT02178592|76115673|FG000|COMPLETED|Randomized Phase (Up to Week 52)||50||
59999930|NCT02178592|76115674|FG001|COMPLETED|Randomized Phase (Up to Week 52)||35||
59999931|NCT02178592|76115673|FG000|NOT COMPLETED|Randomized Phase (Up to Week 52)||19||
59999932|NCT02178592|76115674|FG001|NOT COMPLETED|Randomized Phase (Up to Week 52)||9||
59999933|NCT02178592|76115673|FG000|STARTED|OLE Phase (Week 52 to Week 252)|As OLE phase was optional, 3 participants from DTG arm did not enter OLE from Randomized Phase.|47||
59999934|NCT02178592|76115674|FG001|STARTED|OLE Phase (Week 52 to Week 252)|As OLE phase was optional, 16 participants from EFV arm did not enter OLE from Randomized Phase.|19||
59999935|NCT02178592|76115673|FG000|COMPLETED|OLE Phase (Week 52 to Week 252)||35||
59999936|NCT02178592|76115674|FG001|COMPLETED|OLE Phase (Week 52 to Week 252)||16||
59999937|NCT02178592|76115673|FG000|NOT COMPLETED|OLE Phase (Week 52 to Week 252)||12||
59999938|NCT02178592|76115674|FG001|NOT COMPLETED|OLE Phase (Week 52 to Week 252)||3||
59999939|NCT02610777|76115685|FG000|STARTED|Overall Study||62||
59999940|NCT02610777|76115686|FG001|STARTED|Overall Study||58||
59999941|NCT02610777|76115685|FG000|Response Evaluable Population (REP)|Overall Study||53|Response Evaluable Population (REP) included all participants who received at least 1 dose of study drug, have a disease assessment at baseline, and at least 1 post baseline disease assessment.|
59999942|NCT02610777|76115686|FG001|Response Evaluable Population (REP)|Overall Study||55|Response Evaluable Population (REP) included all participants who received at least 1 dose of study drug, have a disease assessment at baseline, and at least 1 post baseline disease assessment.|
59999943|NCT02610777|76115685|FG000|COMPLETED|Overall Study||0||
59999944|NCT02610777|76115686|FG001|COMPLETED|Overall Study||0||
59999945|NCT02610777|76115685|FG000|NOT COMPLETED|Overall Study||62||
59999946|NCT02610777|76115686|FG001|NOT COMPLETED|Overall Study||58||
59999947|NCT01628692|76115700|FG000|STARTED|Overall Study||53||
59999948|NCT01628692|76115701|FG001|STARTED|Overall Study||23||
59999949|NCT01628692|76115702|FG002|STARTED|Overall Study||51||
59999950|NCT01628692|76115703|FG003|STARTED|Overall Study||20||
59999951|NCT01628692|76115704|FG004|STARTED|Overall Study||12||
59999952|NCT01628692|76115705|FG005|STARTED|Overall Study||9||
59999953|NCT01628692|76115700|FG000|COMPLETED|Overall Study||46||
59999954|NCT01628692|76115701|FG001|COMPLETED|Overall Study||17||
59999955|NCT01628692|76115702|FG002|COMPLETED|Overall Study||43||
59999956|NCT01628692|76115703|FG003|COMPLETED|Overall Study||19||
59999957|NCT01628692|76115704|FG004|COMPLETED|Overall Study||8||
59999958|NCT01628692|76115705|FG005|COMPLETED|Overall Study||0||
59999959|NCT01628692|76115700|FG000|NOT COMPLETED|Overall Study||7||
59999960|NCT01628692|76115701|FG001|NOT COMPLETED|Overall Study||6||
59999961|NCT01628692|76115702|FG002|NOT COMPLETED|Overall Study||8||
59999962|NCT01628692|76115703|FG003|NOT COMPLETED|Overall Study||1||
59999963|NCT01628692|76115704|FG004|NOT COMPLETED|Overall Study||4||
59999964|NCT01628692|76115705|FG005|NOT COMPLETED|Overall Study||9||
59999965|NCT02612727|76115724|FG000|STARTED|Overall Study||87||
59999966|NCT02612727|76115725|FG001|STARTED|Overall Study||87||
59999967|NCT02612727|76115724|FG000|COMPLETED|Overall Study||82||
59999968|NCT02612727|76115725|FG001|COMPLETED|Overall Study||83||
59999969|NCT02612727|76115724|FG000|NOT COMPLETED|Overall Study||5||
59999970|NCT02612727|76115725|FG001|NOT COMPLETED|Overall Study||4||
59999971|NCT01594827|76115733|FG000|STARTED|Overall Study||14||
59999972|NCT01594827|76115734|FG001|STARTED|Overall Study||15||
59999973|NCT01594827|76115733|FG000|COMPLETED|Overall Study||10||
59999974|NCT01594827|76115734|FG001|COMPLETED|Overall Study||15||
59999975|NCT01594827|76115733|FG000|NOT COMPLETED|Overall Study||4||
59999976|NCT01594827|76115734|FG001|NOT COMPLETED|Overall Study||0||
59999977|NCT02610231|76115742|FG000|STARTED|Overall Study||239||
59999978|NCT02610231|76115742|FG000|COMPLETED|Overall Study||179||
59999979|NCT02610231|76115742|FG000|NOT COMPLETED|Overall Study||60||
59999980|NCT02178358|76115752|FG000|STARTED|Overall Study||20||
59999981|NCT02178358|76115753|FG001|STARTED|Overall Study||74||
59999982|NCT02178358|76115754|FG002|STARTED|Overall Study||38||
59999983|NCT02178358|76115752|FG000|Received at Least 1 Dose of Study Drug|Overall Study||20||
59999984|NCT02178358|76115753|FG001|Received at Least 1 Dose of Study Drug|Overall Study||74||
59999985|NCT02178358|76115754|FG002|Received at Least 1 Dose of Study Drug|Overall Study||38||
59999986|NCT02178358|76115752|FG000|COMPLETED|Overall Study||19||
59999987|NCT02178358|76115753|FG001|COMPLETED|Overall Study||72||
59999988|NCT02178358|76115754|FG002|COMPLETED|Overall Study||36||
59999989|NCT02178358|76115752|FG000|NOT COMPLETED|Overall Study||1||
59999990|NCT02178358|76115753|FG001|NOT COMPLETED|Overall Study||2||
59999991|NCT02178358|76115754|FG002|NOT COMPLETED|Overall Study||2||
59999992|NCT01598896|76115765|FG000|STARTED|Overall Study||3||
59999993|NCT01598896|76115766|FG001|STARTED|Overall Study||4||
59999994|NCT01598896|76115765|FG000|COMPLETED|Overall Study||3||
59999995|NCT01598896|76115766|FG001|COMPLETED|Overall Study||2||
59999996|NCT01598896|76115765|FG000|NOT COMPLETED|Overall Study||0||
59999997|NCT01598896|76115766|FG001|NOT COMPLETED|Overall Study||2||
59999998|NCT01598662|76115774|FG000|STARTED|Overall Study||11||
59999999|NCT01598662|76115775|FG001|STARTED|Overall Study||21||
60000000|NCT01598662|76115774|FG000|Patients Who Received IUD|Overall Study|Subjects did not return at 6 weeks for IUD insertion.|0||
60000001|NCT01598662|76115775|FG001|Patients Who Received IUD|Overall Study||18||
60000002|NCT01598662|76115774|FG000|Patients Returned for 6 wk Postpartum|Overall Study||0||
60000003|NCT01598662|76115775|FG001|Patients Returned for 6 wk Postpartum|Overall Study||2||
60000004|NCT01598662|76115774|FG000|COMPLETED|Overall Study||0||
60000005|NCT01598662|76115775|FG001|COMPLETED|Overall Study||0||
60000006|NCT01598662|76115774|FG000|NOT COMPLETED|Overall Study||11||
60000007|NCT01598662|76115775|FG001|NOT COMPLETED|Overall Study||21||
60000008|NCT01629706|76115781|FG000|STARTED|Phase 1 PureVision||44||
60000009|NCT01629706|76115781|FG000|COMPLETED|Phase 1 PureVision||35||
60000010|NCT01629706|76115781|FG000|NOT COMPLETED|Phase 1 PureVision||9||
60000011|NCT01629706|76115781|FG000|STARTED|Phase 2 Habitual|Phase 2 enrolled 48 new participants, plus 10 participants from Phase 1|58||
60000012|NCT01629706|76115781|FG000|COMPLETED|Phase 2 Habitual||48||
60000013|NCT01629706|76115781|FG000|NOT COMPLETED|Phase 2 Habitual||10||
60000014|NCT02153086|76115789|FG000|STARTED|Overall Study||236||
60000015|NCT02153086|76115789|FG000|COMPLETED|Overall Study||232||
60000016|NCT02153086|76115789|FG000|NOT COMPLETED|Overall Study||4||
60000017|NCT02117050|76115793|FG000|STARTED|Overall Study||1||
60000018|NCT02117050|76115793|FG000|COMPLETED|Overall Study||0||
60000019|NCT02117050|76115793|FG000|NOT COMPLETED|Overall Study||1||
60000020|NCT02728895|76115800|FG000|STARTED|Overall Study||3||
60000021|NCT02728895|76115801|FG001|STARTED|Overall Study||21||
60000022|NCT02728895|76115800|FG000|COMPLETED|Overall Study||2||
60000023|NCT02728895|76115801|FG001|COMPLETED|Overall Study||16||
60000024|NCT02728895|76115800|FG000|NOT COMPLETED|Overall Study||1||
60000025|NCT02728895|76115801|FG001|NOT COMPLETED|Overall Study||5||
60000026|NCT02606877|76115809|FG000|STARTED|Overall Study||20||
60000027|NCT02606877|76115810|FG001|STARTED|Overall Study||17||
60000028|NCT02606877|76115809|FG000|COMPLETED|Overall Study||16||
60000029|NCT02606877|76115810|FG001|COMPLETED|Overall Study||16||
60000030|NCT02606877|76115809|FG000|NOT COMPLETED|Overall Study||4||
60000031|NCT02606877|76115810|FG001|NOT COMPLETED|Overall Study||1||
60000032|NCT02606643|76115820|FG000|STARTED|Overall Study||68||
60000033|NCT02606643|76115821|FG001|STARTED|Overall Study||76||
60000034|NCT02606643|76115820|FG000|COMPLETED|Overall Study||67||
60000035|NCT02606643|76115821|FG001|COMPLETED|Overall Study||73||
60000036|NCT02606643|76115820|FG000|NOT COMPLETED|Overall Study||1||
60000037|NCT02606643|76115821|FG001|NOT COMPLETED|Overall Study||3||
60000038|NCT04845633|76115835|FG000|STARTED|Overall Study||12||
60000039|NCT04845633|76115836|FG001|STARTED|Overall Study||12||
60000040|NCT04845633|76115837|FG002|STARTED|Overall Study||12||
60000041|NCT04845633|76115838|FG003|STARTED|Overall Study||12||
60000042|NCT04845633|76115835|FG000|COMPLETED|Overall Study||12||
60000043|NCT04845633|76115836|FG001|COMPLETED|Overall Study||12||
60000044|NCT04845633|76115837|FG002|COMPLETED|Overall Study||12||
60000045|NCT04845633|76115838|FG003|COMPLETED|Overall Study||12||
60000046|NCT04845633|76115835|FG000|NOT COMPLETED|Overall Study||0||
60000047|NCT04845633|76115836|FG001|NOT COMPLETED|Overall Study||0||
60000048|NCT04845633|76115837|FG002|NOT COMPLETED|Overall Study||0||
60000049|NCT04845633|76115838|FG003|NOT COMPLETED|Overall Study||0||
60000050|NCT02609607|76115852|FG000|STARTED|Overall Study||6||
60000051|NCT02609607|76115853|FG001|STARTED|Overall Study||5||
60000052|NCT02609607|76115852|FG000|COMPLETED|Overall Study||6||
60000053|NCT02609607|76115853|FG001|COMPLETED|Overall Study||4||
60000054|NCT02609607|76115852|FG000|NOT COMPLETED|Overall Study||0||
60000055|NCT02609607|76115853|FG001|NOT COMPLETED|Overall Study||1||
60000056|NCT02606253|76115862|FG000|STARTED|Overall Study||20||
60000057|NCT02606253|76115863|FG001|STARTED|Overall Study||20||
60000058|NCT02606253|76115864|FG002|STARTED|Overall Study||20||
60000059|NCT02606253|76115862|FG000|COMPLETED|Overall Study||15||
60000060|NCT02606253|76115863|FG001|COMPLETED|Overall Study||18||
60000061|NCT02606253|76115864|FG002|COMPLETED|Overall Study||20||
60000062|NCT02606253|76115862|FG000|NOT COMPLETED|Overall Study||5||
60000063|NCT02606253|76115863|FG001|NOT COMPLETED|Overall Study||2||
60000064|NCT02606253|76115864|FG002|NOT COMPLETED|Overall Study||0||
60000065|NCT02607735|76115874|FG000|STARTED|Primary Study||264||
60000066|NCT02607735|76115875|FG001|STARTED|Primary Study||152||
60000067|NCT02607735|76115876|FG002|STARTED|Primary Study||0||
60000068|NCT02607735|76115874|FG000|COMPLETED|Primary Study||257||
60000069|NCT02607735|76115875|FG001|COMPLETED|Primary Study||152||
60000070|NCT02607735|76115876|FG002|COMPLETED|Primary Study||0||
60000071|NCT02607735|76115874|FG000|NOT COMPLETED|Primary Study||7||
60000072|NCT02607735|76115875|FG001|NOT COMPLETED|Primary Study||0||
60000073|NCT02607735|76115876|FG002|NOT COMPLETED|Primary Study||0||
60000074|NCT02607735|76115874|FG000|STARTED|Deferred Treatment Substudy||0||
60000075|NCT02607735|76115875|FG001|STARTED|Deferred Treatment Substudy||0||
60000076|NCT02607735|76115876|FG002|STARTED|Deferred Treatment Substudy||147||
60000077|NCT02607735|76115874|FG000|COMPLETED|Deferred Treatment Substudy||0||
60000078|NCT02607735|76115875|FG001|COMPLETED|Deferred Treatment Substudy||0||
60000079|NCT02607735|76115876|FG002|COMPLETED|Deferred Treatment Substudy||142||
60000080|NCT02607735|76115874|FG000|NOT COMPLETED|Deferred Treatment Substudy||0||
60000081|NCT02607735|76115875|FG001|NOT COMPLETED|Deferred Treatment Substudy||0||
60000082|NCT02607735|76115876|FG002|NOT COMPLETED|Deferred Treatment Substudy||5||
60000083|NCT04772313|76115884|FG000|STARTED|MTX Run-in Period||13||
60000084|NCT04772313|76115884|FG000|COMPLETED|MTX Run-in Period||11||
60000085|NCT04772313|76115884|FG000|NOT COMPLETED|MTX Run-in Period||2||
60000086|NCT04772313|76115884|FG000|STARTED|Pegloticase + MTX Treatment Period||11||
60000087|NCT04772313|76115884|FG000|COMPLETED|Pegloticase + MTX Treatment Period||5||
60000088|NCT04772313|76115884|FG000|NOT COMPLETED|Pegloticase + MTX Treatment Period||6||
60000089|NCT04772313|76115884|FG000|STARTED|Pegloticase + MTX Extension Period|participants continuing in the optional extension period|1||
60000090|NCT04772313|76115884|FG000|COMPLETED|Pegloticase + MTX Extension Period||1||
60000091|NCT04772313|76115884|FG000|NOT COMPLETED|Pegloticase + MTX Extension Period||0||
60000092|NCT01668537|76115891|FG000|STARTED|Overall Study||327|randomized and vaccinated|
60000093|NCT01668537|76115892|FG001|STARTED|Overall Study||324|randomized and vaccinated|
60000094|NCT01668537|76115891|FG000|COMPLETED|Overall Study||305|active trial phase|
60000095|NCT01668537|76115892|FG001|COMPLETED|Overall Study||314|active trial phase|
60000096|NCT01668537|76115891|FG000|NOT COMPLETED|Overall Study||22||
60000097|NCT01668537|76115892|FG001|NOT COMPLETED|Overall Study||10||
60000098|NCT01668147|76115898|FG000|STARTED|Overall Study||13||
60000099|NCT01668147|76115898|FG000|COMPLETED|Overall Study||7||
60000100|NCT01668147|76115898|FG000|NOT COMPLETED|Overall Study||6||
60000101|NCT03036189|76115908|FG000|STARTED|Overall Study||104||
60000102|NCT03036189|76115909|FG001|STARTED|Overall Study||107||
60000103|NCT03036189|76115908|FG000|COMPLETED|Overall Study||69||
60000104|NCT03036189|76115909|FG001|COMPLETED|Overall Study||74||
60000105|NCT03036189|76115908|FG000|NOT COMPLETED|Overall Study||35||
60000106|NCT03036189|76115909|FG001|NOT COMPLETED|Overall Study||33||
60000107|NCT02600559|76115915|FG000|STARTED|Overall Study||501||
60000108|NCT02600559|76115915|FG000|COMPLETED|Overall Study||478||
60000109|NCT02600559|76115915|FG000|NOT COMPLETED|Overall Study||23||
60000110|NCT02601573|76115924|FG000|STARTED|Overall Study|Number randomized and treated.|23||
60000111|NCT02601573|76115925|FG001|STARTED|Overall Study|Number randomized and treated.|24||
60000112|NCT02601573|76115926|FG002|STARTED|Overall Study|Number randomized and treated.|17||
60000113|NCT02601573|76115927|FG003|STARTED|Overall Study|Number randomized and treated.|18||
60000114|NCT02601573|76115928|FG004|STARTED|Overall Study|Number randomized and treated.|18||
60000115|NCT02601573|76115924|FG000|COMPLETED|Overall Study||23||
60000116|NCT02601573|76115925|FG001|COMPLETED|Overall Study||20||
60000117|NCT02601573|76115926|FG002|COMPLETED|Overall Study||16||
60000118|NCT02601573|76115927|FG003|COMPLETED|Overall Study||17||
60000119|NCT02601573|76115928|FG004|COMPLETED|Overall Study||16||
60000120|NCT02601573|76115924|FG000|NOT COMPLETED|Overall Study||0||
60000121|NCT02601573|76115925|FG001|NOT COMPLETED|Overall Study||4||
60000122|NCT02601573|76115926|FG002|NOT COMPLETED|Overall Study||1||
60000123|NCT02601573|76115927|FG003|NOT COMPLETED|Overall Study||1||
60000124|NCT02601573|76115928|FG004|NOT COMPLETED|Overall Study||2||
60000125|NCT02601027|76115942|FG000|STARTED|Registration to Surgery||64||
60000126|NCT02601027|76115943|FG001|STARTED|Registration to Surgery||56||
60000127|NCT02601027|76115942|FG000|COMPLETED|Registration to Surgery||44||
60000128|NCT02601027|76115943|FG001|COMPLETED|Registration to Surgery||46||
60000129|NCT02601027|76115942|FG000|NOT COMPLETED|Registration to Surgery||20||
60000130|NCT02601027|76115943|FG001|NOT COMPLETED|Registration to Surgery||10||
60000131|NCT02601027|76115942|FG000|STARTED|Surgery to Assessments||44||
60000132|NCT02601027|76115943|FG001|STARTED|Surgery to Assessments||46||
60000133|NCT02601027|76115942|FG000|COMPLETED|Surgery to Assessments||44||
60000134|NCT02601027|76115943|FG001|COMPLETED|Surgery to Assessments||46||
60000135|NCT02601027|76115942|FG000|NOT COMPLETED|Surgery to Assessments||0||
60000136|NCT02601027|76115943|FG001|NOT COMPLETED|Surgery to Assessments||0||
60000137|NCT02600871|76115951|FG000|STARTED|Overall Study||52||
60000138|NCT02600871|76115952|FG001|STARTED|Overall Study||49||
60000139|NCT02600871|76115951|FG000|COMPLETED|Overall Study|51 subjects completed the 7-10 day follow up 39 subjects completed the 30-day follow up|39||
60000140|NCT02600871|76115952|FG001|COMPLETED|Overall Study|45 subjects completed the 7-10 day follow up 39 subjects completed the 30-day follow up|39||
60000141|NCT02600871|76115951|FG000|NOT COMPLETED|Overall Study||13||
60000142|NCT02600871|76115952|FG001|NOT COMPLETED|Overall Study||10||
60000143|NCT02598297|76115961|FG000|STARTED|Overall Study|One subject in the ruxolitinib arm was not treated with the study drug|25||
60000144|NCT02598297|76115962|FG001|STARTED|Overall Study||24||
60000145|NCT02598297|76115961|FG000|Not Treted Wit Study Drug|Overall Study||1||
60000146|NCT02598297|76115962|FG001|Not Treted Wit Study Drug|Overall Study||0||
60000147|NCT02598297|76115961|FG000|Subjects Followed for Survival|Overall Study||1||
60000148|NCT02598297|76115962|FG001|Subjects Followed for Survival|Overall Study||0||
60000149|NCT02598297|76115961|FG000|COMPLETED|Overall Study||0||
60000150|NCT02598297|76115962|FG001|COMPLETED|Overall Study||0||
60000151|NCT02598297|76115961|FG000|NOT COMPLETED|Overall Study||25||
60000152|NCT02598297|76115962|FG001|NOT COMPLETED|Overall Study||24||
60000153|NCT02596893|76115972|FG000|STARTED|Overall Double-Blind Period Weeks 0-52||174||
60000154|NCT02596893|76115973|FG001|STARTED|Overall Double-Blind Period Weeks 0-52||176||
60000155|NCT02596893|76115974|FG002|STARTED|Overall Double-Blind Period Weeks 0-52||176||
60000156|NCT02596893|76115975|FG003|STARTED|Overall Double-Blind Period Weeks 0-52||175||
60000157|NCT02596893|76115972|FG000|COMPLETED|Overall Double-Blind Period Weeks 0-52||10||
60000158|NCT02596893|76115973|FG001|COMPLETED|Overall Double-Blind Period Weeks 0-52||8||
60000159|NCT02596893|76115974|FG002|COMPLETED|Overall Double-Blind Period Weeks 0-52||14||
60000160|NCT02596893|76115975|FG003|COMPLETED|Overall Double-Blind Period Weeks 0-52||9||
60000161|NCT02596893|76115972|FG000|NOT COMPLETED|Overall Double-Blind Period Weeks 0-52||164||
60000162|NCT02596893|76115973|FG001|NOT COMPLETED|Overall Double-Blind Period Weeks 0-52||168||
60000163|NCT02596893|76115974|FG002|NOT COMPLETED|Overall Double-Blind Period Weeks 0-52||162||
60000164|NCT02596893|76115975|FG003|NOT COMPLETED|Overall Double-Blind Period Weeks 0-52||166||
60000165|NCT02596893|76115972|FG000|STARTED|Follow-Up Period Weeks 0 to 52||57||
60000166|NCT02596893|76115973|FG001|STARTED|Follow-Up Period Weeks 0 to 52||51||
60000167|NCT02596893|76115974|FG002|STARTED|Follow-Up Period Weeks 0 to 52||56||
60000168|NCT02596893|76115975|FG003|STARTED|Follow-Up Period Weeks 0 to 52||47||
60000169|NCT02596893|76115972|FG000|COMPLETED|Follow-Up Period Weeks 0 to 52||57||
60000170|NCT02596893|76115973|FG001|COMPLETED|Follow-Up Period Weeks 0 to 52||51||
60000171|NCT02596893|76115974|FG002|COMPLETED|Follow-Up Period Weeks 0 to 52||56||
60000172|NCT02596893|76115975|FG003|COMPLETED|Follow-Up Period Weeks 0 to 52||47||
60000173|NCT02596893|76115972|FG000|NOT COMPLETED|Follow-Up Period Weeks 0 to 52||0||
60000174|NCT02596893|76115973|FG001|NOT COMPLETED|Follow-Up Period Weeks 0 to 52||0||
60000175|NCT02596893|76115974|FG002|NOT COMPLETED|Follow-Up Period Weeks 0 to 52||0||
60000176|NCT02596893|76115975|FG003|NOT COMPLETED|Follow-Up Period Weeks 0 to 52||0||
60000177|NCT04352439|76115985|FG000|STARTED|Overall Study||19||
60000178|NCT04352439|76115985|FG000|COMPLETED|Overall Study||19||
60000179|NCT04352439|76115985|FG000|NOT COMPLETED|Overall Study||0||
60000180|NCT02592447|76115991|FG000|STARTED|Overall Study||29||
60000181|NCT02592447|76115992|FG001|STARTED|Overall Study||15||
60000182|NCT02592447|76115991|FG000|COMPLETED|Overall Study||27||
60000183|NCT02592447|76115992|FG001|COMPLETED|Overall Study||14||
60000184|NCT02592447|76115991|FG000|NOT COMPLETED|Overall Study||2||
60000185|NCT02592447|76115992|FG001|NOT COMPLETED|Overall Study||1||
60000186|NCT02595723|76116001|FG000|STARTED|First Intervention (4 Days)||8||
60000187|NCT02595723|76116002|FG001|STARTED|First Intervention (4 Days)||6||
60000188|NCT02595723|76116003|FG002|STARTED|First Intervention (4 Days)||7||
60000189|NCT02595723|76116001|FG000|COMPLETED|First Intervention (4 Days)||8||
60000190|NCT02595723|76116002|FG001|COMPLETED|First Intervention (4 Days)||6||
60000191|NCT02595723|76116003|FG002|COMPLETED|First Intervention (4 Days)||7||
60000192|NCT02595723|76116001|FG000|NOT COMPLETED|First Intervention (4 Days)||0||
60000193|NCT02595723|76116002|FG001|NOT COMPLETED|First Intervention (4 Days)||0||
60000194|NCT02595723|76116003|FG002|NOT COMPLETED|First Intervention (4 Days)||0||
60000195|NCT02595723|76116001|FG000|STARTED|First Washout (21 Days)||8||
60000196|NCT02595723|76116002|FG001|STARTED|First Washout (21 Days)||6||
60000197|NCT02595723|76116003|FG002|STARTED|First Washout (21 Days)||7||
60000198|NCT02595723|76116001|FG000|COMPLETED|First Washout (21 Days)||6||
60000199|NCT02595723|76116002|FG001|COMPLETED|First Washout (21 Days)||6||
60000200|NCT02595723|76116003|FG002|COMPLETED|First Washout (21 Days)||7||
60000201|NCT02595723|76116001|FG000|NOT COMPLETED|First Washout (21 Days)||2||
60000202|NCT02595723|76116002|FG001|NOT COMPLETED|First Washout (21 Days)||0||
60000203|NCT02595723|76116003|FG002|NOT COMPLETED|First Washout (21 Days)||0||
60000204|NCT02595723|76116001|FG000|STARTED|Second Intervention (4 Days)||6||
60000205|NCT02595723|76116002|FG001|STARTED|Second Intervention (4 Days)||6||
60000206|NCT02595723|76116003|FG002|STARTED|Second Intervention (4 Days)||7||
60000207|NCT02595723|76116001|FG000|COMPLETED|Second Intervention (4 Days)||6||
60000208|NCT02595723|76116002|FG001|COMPLETED|Second Intervention (4 Days)||6||
60000209|NCT02595723|76116003|FG002|COMPLETED|Second Intervention (4 Days)||7||
60000210|NCT02595723|76116001|FG000|NOT COMPLETED|Second Intervention (4 Days)||0||
60000211|NCT02595723|76116002|FG001|NOT COMPLETED|Second Intervention (4 Days)||0||
60000212|NCT02595723|76116003|FG002|NOT COMPLETED|Second Intervention (4 Days)||0||
60000213|NCT02595723|76116001|FG000|STARTED|Second Washout (21 Days)||6||
60000214|NCT02595723|76116002|FG001|STARTED|Second Washout (21 Days)||6||
60000215|NCT02595723|76116003|FG002|STARTED|Second Washout (21 Days)||7||
60000216|NCT02595723|76116001|FG000|COMPLETED|Second Washout (21 Days)||6||
60000217|NCT02595723|76116002|FG001|COMPLETED|Second Washout (21 Days)||5||
60000218|NCT02595723|76116003|FG002|COMPLETED|Second Washout (21 Days)||7||
60000219|NCT02595723|76116001|FG000|NOT COMPLETED|Second Washout (21 Days)||0||
60000220|NCT02595723|76116002|FG001|NOT COMPLETED|Second Washout (21 Days)||1||
60000221|NCT02595723|76116003|FG002|NOT COMPLETED|Second Washout (21 Days)||0||
60000222|NCT02595723|76116001|FG000|STARTED|Third Intervention (4 Days)||6||
60000223|NCT02595723|76116002|FG001|STARTED|Third Intervention (4 Days)||5||
60000224|NCT02595723|76116003|FG002|STARTED|Third Intervention (4 Days)||7||
60000225|NCT02595723|76116001|FG000|COMPLETED|Third Intervention (4 Days)||6||
60000226|NCT02595723|76116002|FG001|COMPLETED|Third Intervention (4 Days)||5||
60000227|NCT02595723|76116003|FG002|COMPLETED|Third Intervention (4 Days)||7||
60000228|NCT02595723|76116001|FG000|NOT COMPLETED|Third Intervention (4 Days)||0||
60000229|NCT02595723|76116002|FG001|NOT COMPLETED|Third Intervention (4 Days)||0||
60000230|NCT02595723|76116003|FG002|NOT COMPLETED|Third Intervention (4 Days)||0||
60000231|NCT01667679|76116013|FG000|STARTED|Treatment Period 1 (<=12 Weeks)||138||
60000232|NCT01667679|76116014|FG001|STARTED|Treatment Period 1 (<=12 Weeks)||137||
60000233|NCT01667679|76116013|FG000|COMPLETED|Treatment Period 1 (<=12 Weeks)||122||
60000234|NCT01667679|76116014|FG001|COMPLETED|Treatment Period 1 (<=12 Weeks)||107||
60000235|NCT01667679|76116013|FG000|NOT COMPLETED|Treatment Period 1 (<=12 Weeks)||16||
60000236|NCT01667679|76116014|FG001|NOT COMPLETED|Treatment Period 1 (<=12 Weeks)||30||
60000237|NCT01667679|76116013|FG000|STARTED|Treatment Period 2 (<=12 Weeks)||122||
60000238|NCT01667679|76116014|FG001|STARTED|Treatment Period 2 (<=12 Weeks)||107||
60000239|NCT01667679|76116013|FG000|COMPLETED|Treatment Period 2 (<=12 Weeks)||100||
60000240|NCT01667679|76116014|FG001|COMPLETED|Treatment Period 2 (<=12 Weeks)||85||
60000241|NCT01667679|76116013|FG000|NOT COMPLETED|Treatment Period 2 (<=12 Weeks)||22||
60000242|NCT01667679|76116014|FG001|NOT COMPLETED|Treatment Period 2 (<=12 Weeks)||22||
60000243|NCT02597049|76116025|FG000|STARTED|Overall Study||142||
60000244|NCT02597049|76116026|FG001|STARTED|Overall Study||142||
60000245|NCT02597049|76116027|FG002|STARTED|Overall Study||140||
60000246|NCT02597049|76116025|FG000|Received at Least One Dose of Study Drug|Overall Study||142||
60000247|NCT02597049|76116026|FG001|Received at Least One Dose of Study Drug|Overall Study||141||
60000248|NCT02597049|76116027|FG002|Received at Least One Dose of Study Drug|Overall Study||140||
60000249|NCT02597049|76116025|FG000|COMPLETED|Overall Study||135||
60000250|NCT02597049|76116026|FG001|COMPLETED|Overall Study||137||
60000251|NCT02597049|76116027|FG002|COMPLETED|Overall Study||137||
60000252|NCT02597049|76116025|FG000|NOT COMPLETED|Overall Study||7||
60000253|NCT02597049|76116026|FG001|NOT COMPLETED|Overall Study||5||
60000254|NCT02597049|76116027|FG002|NOT COMPLETED|Overall Study||3||
60000255|NCT02594163|76116037|FG000|STARTED|Treatment Period||12||
60000256|NCT02594163|76116038|FG001|STARTED|Treatment Period||13||
60000257|NCT02594163|76116037|FG000|COMPLETED|Treatment Period||5||
60000258|NCT02594163|76116038|FG001|COMPLETED|Treatment Period||1||
60000259|NCT02594163|76116037|FG000|NOT COMPLETED|Treatment Period||7||
60000260|NCT02594163|76116038|FG001|NOT COMPLETED|Treatment Period||12||
60000310|NCT02712983|76116060|FG007|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|3|All patients who discontinued treatment and entered Post-Treatment Efficacy Follow-Up Phase|
60000311|NCT02712983|76116061|FG008|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|0|All patients who discontinued treatment and entered Post-Treatment Efficacy Follow-Up Phase|
60000312|NCT02712983|76116053|FG000|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0||
60000313|NCT02712983|76116054|FG001|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0||
60000314|NCT02712983|76116055|FG002|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0||
60000315|NCT02712983|76116056|FG003|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0||
60000316|NCT02712983|76116057|FG004|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0||
60000317|NCT02712983|76116058|FG005|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0||
60000318|NCT02712983|76116059|FG006|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0||
60000319|NCT02712983|76116060|FG007|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0||
60000320|NCT02712983|76116061|FG008|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0||
60000321|NCT02712983|76116053|FG000|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0||
60000322|NCT02712983|76116054|FG001|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||1||
60000323|NCT02712983|76116055|FG002|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0||
60000324|NCT02712983|76116056|FG003|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||1||
60000325|NCT02712983|76116057|FG004|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||2||
60000326|NCT02712983|76116058|FG005|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||1||
60000327|NCT02712983|76116059|FG006|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||2||
60000328|NCT02712983|76116060|FG007|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||3||
60000329|NCT02712983|76116061|FG008|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0||
60000330|NCT02596971|76116084|FG000|STARTED|Overall Study||42||
60000331|NCT02596971|76116085|FG001|STARTED|Overall Study||7||
60000332|NCT02596971|76116086|FG002|STARTED|Overall Study||42||
60000333|NCT02596971|76116084|FG000|COMPLETED|Overall Study||32||
60000334|NCT02596971|76116085|FG001|COMPLETED|Overall Study||5||
60000335|NCT02596971|76116086|FG002|COMPLETED|Overall Study||33||
60000336|NCT02596971|76116084|FG000|NOT COMPLETED|Overall Study||10||
60000337|NCT02596971|76116085|FG001|NOT COMPLETED|Overall Study||2||
60000338|NCT02596971|76116086|FG002|NOT COMPLETED|Overall Study||9||
60000339|NCT02593773|76116097|FG000|STARTED|Overall Study||86||
60000340|NCT02593773|76116097|FG000|COMPLETED|Overall Study||51||
60000341|NCT02593773|76116097|FG000|NOT COMPLETED|Overall Study||35||
60000342|NCT02593539|76116101|FG000|STARTED|Overall Study||5||
60000343|NCT02593539|76116101|FG000|COMPLETED|Overall Study||4||
60000344|NCT02593539|76116101|FG000|NOT COMPLETED|Overall Study||1||
60000345|NCT00919763|76116110|FG000|STARTED|Overall Study||53||
60000346|NCT00919763|76116111|FG001|STARTED|Overall Study||49||
60000347|NCT00919763|76116110|FG000|COMPLETED|Overall Study||41||
60000348|NCT00919763|76116111|FG001|COMPLETED|Overall Study||45||
60000349|NCT00919763|76116110|FG000|NOT COMPLETED|Overall Study||12||
60000350|NCT00919763|76116111|FG001|NOT COMPLETED|Overall Study||4||
60000351|NCT00306917|76116119|FG000|STARTED|Overall Study|400 subjects were to be followed for 5 years; due to slow enrollment study closed early with 245.|121||
60000352|NCT00306917|76116120|FG001|STARTED|Overall Study|400 subjects were to be followed for 5 years; due to slow enrollment study closed early with 245.|124||
60000353|NCT00306917|76116119|FG000|Postoperative to 6 Month Follow up|Overall Study||93||
60000354|NCT00306917|76116120|FG001|Postoperative to 6 Month Follow up|Overall Study||100||
60000355|NCT00306917|76116119|FG000|12 Month Follow|Overall Study||86||
60000356|NCT00306917|76116120|FG001|12 Month Follow|Overall Study||94||
60000357|NCT00306917|76116119|FG000|24 Month Follow up|Overall Study||60||
60000358|NCT00306917|76116120|FG001|24 Month Follow up|Overall Study||71||
60000359|NCT00306917|76116119|FG000|36 Month Follow up|Overall Study||56||
60000360|NCT00306917|76116120|FG001|36 Month Follow up|Overall Study||42||
60000361|NCT00306917|76116119|FG000|48 Month Follow up|Overall Study||29||
60000362|NCT00306917|76116120|FG001|48 Month Follow up|Overall Study||22||
60000363|NCT00306917|76116119|FG000|60 Month Follow up|Overall Study||13||
60000364|NCT00306917|76116120|FG001|60 Month Follow up|Overall Study||15||
60000365|NCT00306917|76116119|FG000|COMPLETED|Overall Study||13||
60000366|NCT00306917|76116120|FG001|COMPLETED|Overall Study||15||
60000367|NCT00306917|76116119|FG000|NOT COMPLETED|Overall Study||108||
60000368|NCT00306917|76116120|FG001|NOT COMPLETED|Overall Study||109||
60000369|NCT02593305|76116129|FG000|STARTED|Baseline 1||7||
60000370|NCT02593305|76116130|FG001|STARTED|Baseline 1||6||
60000371|NCT02593305|76116131|FG002|STARTED|Baseline 1||10||
60000372|NCT02593305|76116129|FG000|COMPLETED|Baseline 1||7||
60000373|NCT02593305|76116130|FG001|COMPLETED|Baseline 1||6||
60000374|NCT02593305|76116131|FG002|COMPLETED|Baseline 1||10||
60000375|NCT02593305|76116129|FG000|NOT COMPLETED|Baseline 1||0||
60000376|NCT02593305|76116130|FG001|NOT COMPLETED|Baseline 1||0||
60000377|NCT02593305|76116131|FG002|NOT COMPLETED|Baseline 1||0||
60000378|NCT02593305|76116129|FG000|STARTED|Post 1||7||
60000379|NCT02593305|76116130|FG001|STARTED|Post 1||6||
60000380|NCT02593305|76116131|FG002|STARTED|Post 1||10||
60000381|NCT02593305|76116129|FG000|COMPLETED|Post 1||7||
60000382|NCT02593305|76116130|FG001|COMPLETED|Post 1||6||
60000383|NCT02593305|76116131|FG002|COMPLETED|Post 1||0||
60000384|NCT02593305|76116129|FG000|NOT COMPLETED|Post 1||0||
